id|nct_id|mesh_term|downcase_mesh_term|mesh_type
102566827|NCT04727242|Gemcitabine|gemcitabine|mesh-list
102566975|NCT04628338|Antiviral Agents|antiviral agents|mesh-ancestor
102567051|NCT04575311|Quemliclustat|quemliclustat|mesh-list
102567348|NCT04322305|Analgesics|analgesics|mesh-ancestor
101505694|NCT01240811|Copper|copper|mesh-list
102567781|NCT04043195|Nivolumab|nivolumab|mesh-list
102567857|NCT04005053|Antidotes|antidotes|mesh-ancestor
102568230|NCT03701581|4-Aminopyridine|4-aminopyridine|mesh-list
102568300|NCT03654716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568453|NCT03530267|Aflibercept|aflibercept|mesh-list
102568978|NCT02944500|Liraglutide|liraglutide|mesh-list
102569147|NCT02568618|Analgesics|analgesics|mesh-list
102569588|NCT01565200|Tubulin Modulators|tubulin modulators|mesh-ancestor
102570044|NCT02362321|Hormones|hormones|mesh-ancestor
102570223|NCT02394457|Hormones|hormones|mesh-ancestor
102570339|NCT00003159|Paclitaxel|paclitaxel|mesh-list
102570493|NCT00376493|Metronidazole|metronidazole|mesh-list
102570954|NCT00003255|Topotecan|topotecan|mesh-list
102571018|NCT04530409|Protective Agents|protective agents|mesh-ancestor
102571108|NCT03501979|Tucatinib|tucatinib|mesh-list
102571620|NCT05922761|Xhance|xhance|mesh-list
102571777|NCT05921149|Paclitaxel|paclitaxel|mesh-list
102571921|NCT05900466|Metformin|metformin|mesh-list
102572226|NCT05706233|Analgesics|analgesics|mesh-list
102572370|NCT05558150|Aceclofenac|aceclofenac|mesh-list
102572818|NCT04806919|Progestins|progestins|mesh-ancestor
102572894|NCT04712734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102573123|NCT04427293|Pembrolizumab|pembrolizumab|mesh-list
102573348|NCT04194528|Analgesics|analgesics|mesh-ancestor
102573424|NCT04140162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573499|NCT03978624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102573725|NCT03739710|Docetaxel|docetaxel|mesh-list
102573800|NCT03576885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102574623|NCT00330564|Sunitinib|sunitinib|mesh-list
102574767|NCT00070291|Cyclosporine|cyclosporine|mesh-list
102574921|NCT00003389|Hormones|hormones|mesh-ancestor
102575298|NCT04904978|Listerine|listerine|mesh-list
102575600|NCT05430828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102575675|NCT04184999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102576295|NCT04184297|Olodaterol|olodaterol|mesh-list
102576569|NCT04256603|Anticonvulsants|anticonvulsants|mesh-ancestor
102576715|NCT03496662|Antimetabolites|antimetabolites|mesh-ancestor
102576795|NCT04341818|Vitamin D|vitamin d|mesh-list
102577087|NCT02978443|Nivolumab|nivolumab|mesh-list
102577766|NCT00589316|Mycophenolic Acid|mycophenolic acid|mesh-list
102578386|NCT04342273|Moxifloxacin|moxifloxacin|mesh-list
102578530|NCT00003951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102578990|NCT00004923|Docetaxel|docetaxel|mesh-list
102579814|NCT00385125|Immunologic Factors|immunologic factors|mesh-ancestor
102581100|NCT02432456|Acetaminophen|acetaminophen|mesh-list
102581327|NCT04787354|Capecitabine|capecitabine|mesh-list
102581401|NCT04341038|Antiemetics|antiemetics|mesh-ancestor
102581487|NCT02541565|Glucocorticoids|glucocorticoids|mesh-ancestor
102581922|NCT00366470|Vitamin D|vitamin d|mesh-list
102582165|NCT05026320|Diclofenac|diclofenac|mesh-list
102582672|NCT02495779|Tenofovir|tenofovir|mesh-list
102582826|NCT02508259|Suramin|suramin|mesh-list
102583663|NCT02169414|Levodopa|levodopa|mesh-list
102583811|NCT02168946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102583964|NCT04739618|Immunologic Factors|immunologic factors|mesh-ancestor
102584331|NCT04193228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102585307|NCT02618720|Ornidazole|ornidazole|mesh-list
102586088|NCT02194062|Xhance|xhance|mesh-list
102586277|NCT04654988|Prednisone|prednisone|mesh-list
102586647|NCT02885636|Tocolytic Agents|tocolytic agents|mesh-ancestor
102586729|NCT02785172|Clobetasol|clobetasol|mesh-list
102587020|NCT02903407|Dexmedetomidine|dexmedetomidine|mesh-list
102587251|NCT00373802|Phenylephrine|phenylephrine|mesh-list
102587404|NCT02916745|Trioxsalen|trioxsalen|mesh-list
102587929|NCT05330377|Cladribine|cladribine|mesh-list
102588007|NCT05246943|Fibrin fragment D|fibrin fragment d|mesh-list
102588082|NCT05019222|Anesthetics|anesthetics|mesh-list
102588456|NCT03632369|Xenon|xenon|mesh-list
102588534|NCT03043430|Anesthetics, General|anesthetics, general|mesh-ancestor
102588683|NCT03043105|Leprostatic Agents|leprostatic agents|mesh-ancestor
102589211|NCT03123848|Darunavir|darunavir|mesh-list
102589283|NCT03088345|Vasopressins|vasopressins|mesh-list
102589433|NCT00375596|Histamine Agents|histamine agents|mesh-ancestor
102589584|NCT03168308|Autonomic Agents|autonomic agents|mesh-ancestor
102590108|NCT04736719|Warfarin|warfarin|mesh-list
102590549|NCT03220958|Dopamine Agents|dopamine agents|mesh-ancestor
102590699|NCT03242408|Hormones|hormones|mesh-ancestor
102590846|NCT03357614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102591305|NCT04392362|Adenosine|adenosine|mesh-list
102591469|NCT03445195|Imipenem|imipenem|mesh-list
102591530|NCT00377936|Gemcitabine|gemcitabine|mesh-list
102592728|NCT00832520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102593188|NCT03644095|Sympathomimetics|sympathomimetics|mesh-ancestor
102593636|NCT00000800|Analgesics|analgesics|mesh-ancestor
102593707|NCT00000812|Immunologic Factors|immunologic factors|mesh-ancestor
102593942|NCT00001790|Micafungin|micafungin|mesh-list
102594841|NCT00000452|Naltrexone|naltrexone|mesh-list
102595369|NCT00002198|Abacavir|abacavir|mesh-list
102595452|NCT00002300|Megestrol|megestrol|mesh-list
102595516|NCT00002312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102595747|NCT00378547|Hormones|hormones|mesh-ancestor
102595824|NCT00002372|Nelfinavir|nelfinavir|mesh-list
102596146|NCT01525927|Cisplatin|cisplatin|mesh-list
102596200|NCT02373865|Glimepiride|glimepiride|mesh-list
102596656|NCT00002618|Antidotes|antidotes|mesh-ancestor
102596950|NCT05600023|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102597486|NCT05296759|Gabapentin|gabapentin|mesh-list
102598389|NCT05440591|Metformin|metformin|mesh-list
102598844|NCT00000949|Antiviral Agents|antiviral agents|mesh-ancestor
102599148|NCT00000727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599530|NCT00002035|Antiviral Agents|antiviral agents|mesh-ancestor
102600436|NCT00003128|Paclitaxel|paclitaxel|mesh-list
102600506|NCT00002798|Antiemetics|antiemetics|mesh-ancestor
102600810|NCT00002822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102600961|NCT00002846|Aldesleukin|aldesleukin|mesh-list
102601576|NCT00003260|Leucovorin|leucovorin|mesh-list
102601649|NCT00002665|Vitamins|vitamins|mesh-ancestor
102601726|NCT00381901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602529|NCT00002785|Cobalt|cobalt|mesh-list
102603102|NCT00003776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102603706|NCT00004652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102603784|NCT00004730|Tocolytic Agents|tocolytic agents|mesh-ancestor
102603932|NCT00004826|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102604531|NCT00002893|Antidotes|antidotes|mesh-ancestor
102604615|NCT00002923|KRN 5500|krn 5500|mesh-list
102604835|NCT00003001|Leucovorin|leucovorin|mesh-list
102605058|NCT00003031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102605354|NCT00003067|Aldesleukin|aldesleukin|mesh-list
102605586|NCT00003625|Mitosis Modulators|mitosis modulators|mesh-ancestor
102605739|NCT00003667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102605815|NCT00003997|Irofulven|irofulven|mesh-list
102606196|NCT00003187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102606649|NCT00003259|Tubulin Modulators|tubulin modulators|mesh-ancestor
102606725|NCT00004255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102607560|NCT00004807|Dextromethorphan|dextromethorphan|mesh-list
102608090|NCT02116530|Antiemetics|antiemetics|mesh-list
102608171|NCT02111850|Aldesleukin|aldesleukin|mesh-list
102608689|NCT02036502|Glucocorticoids|glucocorticoids|mesh-ancestor
102608759|NCT02034162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102609657|NCT02995967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102609806|NCT01222871|Triamcinolone|triamcinolone|mesh-list
102610029|NCT03807245|Antacids|antacids|mesh-ancestor
102610251|NCT00379067|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102610400|NCT01754987|Vitamins|vitamins|mesh-ancestor
102610407|NCT01754987|Antioxidants|antioxidants|mesh-ancestor
102610474|NCT00608465|Diuretics|diuretics|mesh-ancestor
102610659|NCT00500045|Niacin|niacin|mesh-list
102610775|NCT00281879|Carmustine|carmustine|mesh-list
102611306|NCT00001067|Antimetabolites|antimetabolites|mesh-ancestor
102611372|NCT00000299|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102612201|NCT00002135|Ganciclovir|ganciclovir|mesh-list
102347442|NCT02020694|Vitamin D|vitamin d|mesh-list
102347671|NCT00218062|Modafinil|modafinil|mesh-list
102348122|NCT04560686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102348876|NCT01609010|Interferon alpha-2|interferon alpha-2|mesh-list
102349028|NCT01782872|Ropivacaine|ropivacaine|mesh-list
102349185|NCT01462695|Sunitinib|sunitinib|mesh-list
102350003|NCT05286268|Plasminogen|plasminogen|mesh-list
102350373|NCT00381862|Leucovorin|leucovorin|mesh-list
102350532|NCT00446290|Docetaxel|docetaxel|mesh-list
102350673|NCT00476242|Memantine|memantine|mesh-list
102350750|NCT00454324|Paclitaxel|paclitaxel|mesh-list
102350844|NCT01453023|Xhance|xhance|mesh-list
102351206|NCT00499408|Vitamin D|vitamin d|mesh-list
102351336|NCT00887380|Anastrozole|anastrozole|mesh-list
102351416|NCT01430403|Fluticasone|fluticasone|mesh-list
102351487|NCT00513292|Paclitaxel|paclitaxel|mesh-list
102351640|NCT01441635|Norethindrone|norethindrone|mesh-list
102351862|NCT01392183|Antiemetics|antiemetics|mesh-ancestor
102352103|NCT01614457|Ivacaftor|ivacaftor|mesh-list
102352238|NCT01399125|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102352389|NCT01396395|Vitamins|vitamins|mesh-ancestor
102352522|NCT01857583|PENTA|penta|mesh-list
102352615|NCT01721330|Naltrexone|naltrexone|mesh-list
102352762|NCT01856257|Mycophenolic Acid|mycophenolic acid|mesh-list
102353363|NCT01819129|Insulin|insulin|mesh-list
102353736|NCT04616248|Laxatives|laxatives|mesh-ancestor
102354265|NCT00608062|Estradiol|estradiol|mesh-list
102354573|NCT02139358|Gemcitabine|gemcitabine|mesh-list
102354631|NCT00626782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102354780|NCT00602290|Citalopram|citalopram|mesh-list
102355085|NCT00655642|Anesthetics|anesthetics|mesh-ancestor
102355383|NCT02995720|Antimetabolites|antimetabolites|mesh-ancestor
102355824|NCT01272778|Lorazepam|lorazepam|mesh-list
102356874|NCT03153657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102356959|NCT00747214|Hormones|hormones|mesh-ancestor
102357469|NCT00757822|Hormones|hormones|mesh-ancestor
102357693|NCT01757275|Cimetidine|cimetidine|mesh-list
102357844|NCT03837808|Nimotuzumab|nimotuzumab|mesh-list
102358221|NCT01729819|Hemostatics|hemostatics|mesh-ancestor
102358303|NCT04658927|Dexamethasone|dexamethasone|mesh-list
102358429|NCT02152696|Abortifacient Agents|abortifacient agents|mesh-ancestor
102359392|NCT02453620|Nivolumab|nivolumab|mesh-list
102359775|NCT01949051|Levocabastine|levocabastine|mesh-list
102360000|NCT01709695|Guanfacine|guanfacine|mesh-list
102360282|NCT01908803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102360800|NCT01889069|Immunologic Factors|immunologic factors|mesh-ancestor
102360952|NCT00909064|PENTA|penta|mesh-list
102361023|NCT01720108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102361864|NCT03406936|Midazolam|midazolam|mesh-list
102362458|NCT01709318|Hormones|hormones|mesh-ancestor
102362531|NCT01699178|Hormones|hormones|mesh-ancestor
102362678|NCT01698320|Tocolytic Agents|tocolytic agents|mesh-ancestor
102362979|NCT04371874|Antipyretics|antipyretics|mesh-ancestor
102363200|NCT01591616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363201|NCT01591616|Sensory System Agents|sensory system agents|mesh-ancestor
102363202|NCT01591616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102363203|NCT01591616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102363276|NCT04363216|Vitamins|vitamins|mesh-ancestor
102363645|NCT00928642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363646|NCT00928642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102363647|NCT00928642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102363648|NCT00928642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102363649|NCT04361422|Isotretinoin|isotretinoin|mesh-list
102363650|NCT04361422|Dermatologic Agents|dermatologic agents|mesh-ancestor
102363651|NCT03579615|Insulin|insulin|mesh-list
102363652|NCT03579615|Insulin Aspart|insulin aspart|mesh-list
102363653|NCT03579615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102363654|NCT03579615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363655|NCT03553875|Memantine|memantine|mesh-list
102364023|NCT03032458|Meperidine|meperidine|mesh-list
102364100|NCT00947752|(T,G)-A-L|(t,g)-a-l|mesh-list
102364251|NCT00949234|Antiviral Agents|antiviral agents|mesh-ancestor
102364552|NCT00085917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102364630|NCT01678599|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102364999|NCT04400721|Sensory System Agents|sensory system agents|mesh-ancestor
102365674|NCT01886105|Analgesics|analgesics|mesh-ancestor
102365763|NCT03016468|Treprostinil|treprostinil|mesh-list
102365829|NCT01001806|Ketorolac|ketorolac|mesh-list
102366275|NCT04760301|Tranexamic Acid|tranexamic acid|mesh-list
102366560|NCT01066624|Calcium|calcium|mesh-list
102366795|NCT02399943|Panitumumab|panitumumab|mesh-list
102367075|NCT01922427|RNS60|rns60|mesh-list
102367308|NCT03683524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102367379|NCT01379274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102367602|NCT00634179|Hormones|hormones|mesh-ancestor
102367678|NCT03188172|Immunologic Factors|immunologic factors|mesh-ancestor
102367919|NCT03467178|Paclitaxel|paclitaxel|mesh-list
102368506|NCT01221298|Antimetabolites|antimetabolites|mesh-ancestor
102368805|NCT01212952|Glucocorticoids|glucocorticoids|mesh-ancestor
102369028|NCT03444636|Fentanyl|fentanyl|mesh-list
102369181|NCT01218958|Naltrexone|naltrexone|mesh-list
102369702|NCT01286818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102370306|NCT03422874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102371729|NCT03424356|Fentanyl|fentanyl|mesh-list
102373013|NCT02731638|Voriconazole|voriconazole|mesh-list
102373164|NCT01458418|Montelukast|montelukast|mesh-list
102373301|NCT01470118|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
102373378|NCT01565902|Immunologic Factors|immunologic factors|mesh-ancestor
102373454|NCT05565664|Ketamine|ketamine|mesh-list
102373829|NCT03378960|Omeprazole|omeprazole|mesh-list
102375249|NCT03366246|Sensory System Agents|sensory system agents|mesh-ancestor
102375250|NCT03366246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102375251|NCT03366246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102375252|NCT03366246|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102375253|NCT03366246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102375553|NCT03355638|Pyranoprofen|pyranoprofen|mesh-list
102375709|NCT03349866|Apatinib|apatinib|mesh-list
102375933|NCT05584878|Chitosan|chitosan|mesh-list
102376004|NCT00709722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102376377|NCT02506998|Histamine Agents|histamine agents|mesh-ancestor
102376459|NCT02506842|Vitamins|vitamins|mesh-ancestor
102376524|NCT02506140|Analgesics|analgesics|mesh-ancestor
102377349|NCT05118490|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102377432|NCT02495688|Anesthetics|anesthetics|mesh-list
102377577|NCT02497716|Anticoagulants|anticoagulants|mesh-ancestor
102377674|NCT03342300|Doxorubicin|doxorubicin|mesh-list
102377730|NCT02494284|Aspirin|aspirin|mesh-list
102377797|NCT00706992|Antiviral Agents|antiviral agents|mesh-ancestor
102378095|NCT03109158|Cetuximab|cetuximab|mesh-list
102378233|NCT03331302|Xenon|xenon|mesh-list
102378465|NCT03319680|Dialysis Solutions|dialysis solutions|mesh-list
102378614|NCT03321318|Cholecalciferol|cholecalciferol|mesh-list
102379213|NCT02725710|Anticonvulsants|anticonvulsants|mesh-ancestor
102379371|NCT02477514|Anesthetics|anesthetics|mesh-ancestor
102379587|NCT02470026|Yohimbine|yohimbine|mesh-list
102379805|NCT04351126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102379884|NCT02859558|Tenofovir|tenofovir|mesh-list
102379959|NCT01862614|Mydriatics|mydriatics|mesh-ancestor
102380253|NCT03303924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102380329|NCT03303378|Protective Agents|protective agents|mesh-ancestor
102380556|NCT03301350|Paclitaxel|paclitaxel|mesh-list
102380775|NCT05327556|Mydriatics|mydriatics|mesh-ancestor
102380929|NCT01772537|Propofol|propofol|mesh-list
102381088|NCT00653068|Vitamins|vitamins|mesh-ancestor
102381301|NCT04122105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102381606|NCT02987920|Antitussive Agents|antitussive agents|mesh-ancestor
102382285|NCT02933697|Apixaban|apixaban|mesh-list
102382434|NCT01456689|Midazolam|midazolam|mesh-list
102382584|NCT05824832|Dexamethasone|dexamethasone|mesh-list
102382931|NCT04775680|Antibodies|antibodies|mesh-list
102383503|NCT01458015|Oxycodone|oxycodone|mesh-list
102383942|NCT02282319|Dexmedetomidine|dexmedetomidine|mesh-list
102383943|NCT02282319|Chloroprocaine|chloroprocaine|mesh-list
102383944|NCT02282319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102383945|NCT02282319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102383946|NCT02282319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383947|NCT02282319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102383948|NCT02282319|Analgesics|analgesics|mesh-ancestor
102383949|NCT02282319|Sensory System Agents|sensory system agents|mesh-ancestor
102383950|NCT02282319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102383951|NCT02282319|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102383952|NCT02282319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102383953|NCT02282319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102383954|NCT02282319|Adrenergic Agents|adrenergic agents|mesh-ancestor
102383955|NCT02282319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102383956|NCT02282319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383957|NCT02282319|Anesthetics, Local|anesthetics, local|mesh-ancestor
102383958|NCT02282319|Anesthetics|anesthetics|mesh-ancestor
102383959|NCT02772081|Poractant alfa|poractant alfa|mesh-list
102383960|NCT02772081|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
102383961|NCT02772081|Respiratory System Agents|respiratory system agents|mesh-ancestor
102383962|NCT02278965|Metformin|metformin|mesh-list
102383963|NCT02278965|Biguanides|biguanides|mesh-list
102383964|NCT02278965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102383965|NCT02278965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384001|NCT02757885|Cyclophosphamide|cyclophosphamide|mesh-list
102384002|NCT02757885|Thiotepa|thiotepa|mesh-list
102384003|NCT02757885|Fludarabine|fludarabine|mesh-list
102384004|NCT02757885|Fludarabine phosphate|fludarabine phosphate|mesh-list
102384005|NCT02757885|Hydroxyurea|hydroxyurea|mesh-list
102384006|NCT02757885|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102384007|NCT02757885|Thymoglobulin|thymoglobulin|mesh-list
102384008|NCT02757885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102384009|NCT02757885|Immunologic Factors|immunologic factors|mesh-ancestor
102384010|NCT02757885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384244|NCT01752023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102384245|NCT01752023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384247|NCT02986906|Triamcinolone|triamcinolone|mesh-list
102384466|NCT01724177|Lenalidomide|lenalidomide|mesh-list
102384695|NCT02292082|Hormones|hormones|mesh-ancestor
102384919|NCT02715726|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102385227|NCT04084548|Analgesics|analgesics|mesh-ancestor
102385375|NCT01999348|Timolol|timolol|mesh-list
102385678|NCT03289338|Protective Agents|protective agents|mesh-ancestor
102385836|NCT01959490|Paclitaxel|paclitaxel|mesh-list
102386058|NCT00160173|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102386142|NCT03475134|Nivolumab|nivolumab|mesh-list
102386357|NCT02458716|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102386435|NCT02456844|Antimetabolites|antimetabolites|mesh-ancestor
102386804|NCT04781439|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102387409|NCT03243006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102387482|NCT03253224|Tocolytic Agents|tocolytic agents|mesh-ancestor
102387703|NCT04486092|GABA Agents|gaba agents|mesh-ancestor
102388086|NCT02028754|Hormones|hormones|mesh-ancestor
102388612|NCT03230058|Natamycin|natamycin|mesh-list
102388825|NCT00170625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102389279|NCT01740323|Curcumin|curcumin|mesh-list
102389351|NCT00094887|Antioxidants|antioxidants|mesh-ancestor
102389718|NCT04943848|Iodine|iodine|mesh-list
102390398|NCT03192618|Antidotes|antidotes|mesh-ancestor
102390782|NCT01336530|Anesthetics|anesthetics|mesh-ancestor
102391000|NCT02420002|Analgesics|analgesics|mesh-ancestor
102391229|NCT04344730|Hormones|hormones|mesh-ancestor
102391458|NCT00703326|Docetaxel|docetaxel|mesh-list
102391604|NCT02429466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102391679|NCT03185130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102391754|NCT00358930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102392055|NCT02429076|Propofol|propofol|mesh-list
102392207|NCT04594798|Rituximab|rituximab|mesh-list
102392813|NCT02415270|Menthol|menthol|mesh-list
102393387|NCT02467504|Folic Acid|folic acid|mesh-list
102393581|NCT03116490|Anesthetics|anesthetics|mesh-list
102393634|NCT03177720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102393787|NCT02538016|Tolvaptan|tolvaptan|mesh-list
102394611|NCT05745714|Glucocorticoids|glucocorticoids|mesh-ancestor
102394695|NCT02393664|Propofol|propofol|mesh-list
102394761|NCT03453892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102395442|NCT02668432|Amiodarone|amiodarone|mesh-list
102395591|NCT01683071|Sensory System Agents|sensory system agents|mesh-ancestor
102395740|NCT01564277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102395897|NCT02691468|Silicon|silicon|mesh-list
102395968|NCT04775550|Glucocorticoids|glucocorticoids|mesh-ancestor
102396568|NCT02689284|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102396783|NCT02135874|Antibodies|antibodies|mesh-list
101917485|NCT05794919|Phenol|phenol|mesh-list
102397013|NCT00125931|Pentazocine|pentazocine|mesh-list
102397083|NCT04117581|Vitamins|vitamins|mesh-ancestor
102208920|NCT05209490|Iodine|iodine|mesh-list
102398428|NCT00302133|Naltrexone|naltrexone|mesh-list
102398731|NCT05800106|Sunitinib|sunitinib|mesh-list
102398732|NCT05800106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102398733|NCT05800106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102398734|NCT05800106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102398735|NCT05800106|Growth Substances|growth substances|mesh-ancestor
102398736|NCT05800106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398737|NCT05800106|Growth Inhibitors|growth inhibitors|mesh-ancestor
102398738|NCT05800106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102398739|NCT05800106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102398740|NCT05800106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398741|NCT05800080|Oxaliplatin|oxaliplatin|mesh-list
102398742|NCT05800080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102398743|NCT05800054|Docetaxel|docetaxel|mesh-list
102398744|NCT05800054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102398745|NCT05800054|Tubulin Modulators|tubulin modulators|mesh-ancestor
102398880|NCT05795491|Fluconazole|fluconazole|mesh-list
102399033|NCT05438420|Pembrolizumab|pembrolizumab|mesh-list
102399709|NCT02375022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102399710|NCT02375022|Growth Substances|growth substances|mesh-ancestor
102399711|NCT02375022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399845|NCT04505280|Lidocaine|lidocaine|mesh-list
102400077|NCT00304707|Dopamine Agents|dopamine agents|mesh-ancestor
102400300|NCT01554241|Vitamin D|vitamin d|mesh-list
102401128|NCT03148314|Abortifacient Agents|abortifacient agents|mesh-ancestor
102401204|NCT02341794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102401354|NCT04594746|Amiodarone|amiodarone|mesh-list
102401507|NCT01826838|Dasatinib|dasatinib|mesh-list
102213561|NCT05151679|Iron|iron|mesh-list
102401867|NCT03145194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402389|NCT01491035|Vortioxetine|vortioxetine|mesh-list
102402536|NCT01482767|Immunologic Factors|immunologic factors|mesh-ancestor
102402609|NCT00383643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102402910|NCT04650217|Dopamine Agents|dopamine agents|mesh-ancestor
102403064|NCT01506271|Imipenem|imipenem|mesh-list
102403288|NCT01503229|Hormones|hormones|mesh-ancestor
102403360|NCT04857164|Pembrolizumab|pembrolizumab|mesh-list
102403437|NCT00536913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102403519|NCT00464685|Hormones|hormones|mesh-ancestor
102403585|NCT01690520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102403660|NCT02954991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102403811|NCT00546897|Immunologic Factors|immunologic factors|mesh-ancestor
102404256|NCT01456169|Diuretics|diuretics|mesh-ancestor
102404338|NCT01450007|Anesthetics|anesthetics|mesh-ancestor
102404556|NCT01559012|Clonidine|clonidine|mesh-list
102405011|NCT04108676|Fluzoparib|fluzoparib|mesh-list
102405458|NCT00398307|Cisplatin|cisplatin|mesh-list
102405837|NCT00574587|Paclitaxel|paclitaxel|mesh-list
102405909|NCT00606489|Ibuprofen|ibuprofen|mesh-list
102406057|NCT01569464|Rotigotine|rotigotine|mesh-list
102406130|NCT00612339|Growth Inhibitors|growth inhibitors|mesh-ancestor
102406207|NCT01547390|Analgesics|analgesics|mesh-ancestor
102406282|NCT03571191|Denosumab|denosumab|mesh-list
102406508|NCT00627861|Metoprolol|metoprolol|mesh-list
102406659|NCT01440101|Natalizumab|natalizumab|mesh-list
102407247|NCT01438177|Bortezomib|bortezomib|mesh-list
102407397|NCT01414855|Hormones|hormones|mesh-ancestor
102407473|NCT04061239|Antiviral Agents|antiviral agents|mesh-ancestor
102407923|NCT04529460|Antibodies|antibodies|mesh-list
102408323|NCT02320695|Bacitracin|bacitracin|mesh-list
102408531|NCT04351230|Immunotoxins|immunotoxins|mesh-ancestor
102408677|NCT03137316|Hormones|hormones|mesh-list
102408904|NCT00706719|Hormones|hormones|mesh-ancestor
102408985|NCT05068206|Bevacizumab|bevacizumab|mesh-list
102409129|NCT04335084|Antimalarials|antimalarials|mesh-ancestor
102409279|NCT02994381|Immunologic Factors|immunologic factors|mesh-ancestor
102409372|NCT02969850|Vitamin D|vitamin d|mesh-list
102409430|NCT02419560|Venetoclax|venetoclax|mesh-list
102409899|NCT00720369|Ubiquinone|ubiquinone|mesh-list
102410052|NCT01272609|Timolol|timolol|mesh-list
102410258|NCT00217087|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
102410557|NCT05102058|Analgesics|analgesics|mesh-ancestor
102410628|NCT06012500|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102410629|NCT06012500|Anesthetics, General|anesthetics, general|mesh-ancestor
102410630|NCT06012500|Anesthetics|anesthetics|mesh-ancestor
102410631|NCT06012500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102410743|NCT06011629|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102410744|NCT06011629|Laxatives|laxatives|mesh-ancestor
102410745|NCT06011629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102410746|NCT06011460|Clozapine|clozapine|mesh-list
102410747|NCT06011460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102410748|NCT06011460|Serotonin Agents|serotonin agents|mesh-ancestor
102410749|NCT06011460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102410750|NCT06011460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410751|NCT06011460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410752|NCT06011460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102410753|NCT06011460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102410754|NCT06011460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102410755|NCT06011460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102410756|NCT06011460|GABA Antagonists|gaba antagonists|mesh-ancestor
102410757|NCT06011460|GABA Agents|gaba agents|mesh-ancestor
102410758|NCT06011421|Anesthetics|anesthetics|mesh-list
102410759|NCT06011421|Anesthetics, Local|anesthetics, local|mesh-list
102410760|NCT06011421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102410761|NCT06011421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410762|NCT06011421|Sensory System Agents|sensory system agents|mesh-ancestor
102410763|NCT06011421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102410764|NCT06011343|Meglumine Antimoniate|meglumine antimoniate|mesh-list
102410765|NCT06011343|Tofacitinib|tofacitinib|mesh-list
102411084|NCT05817851|Vitamins|vitamins|mesh-list
102411157|NCT05705128|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102411158|NCT05705128|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102411159|NCT05705128|Adrenergic Agents|adrenergic agents|mesh-ancestor
102411160|NCT05705128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102411161|NCT05705128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411313|NCT05605093|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
102411314|NCT05605093|Protease Inhibitors|protease inhibitors|mesh-list
102411315|NCT05605093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102411316|NCT05605093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411317|NCT05605093|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102411318|NCT05605093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102411319|NCT05605093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102411320|NCT05605093|Antiviral Agents|antiviral agents|mesh-ancestor
102411321|NCT05605093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102411322|NCT05576077|Pembrolizumab|pembrolizumab|mesh-list
102411827|NCT04771130|Posaconazole|posaconazole|mesh-list
102411901|NCT04736706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102411902|NCT04736706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411903|NCT04736706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102411904|NCT04736706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411905|NCT04736706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102412050|NCT04503551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412051|NCT04501978|Remdesivir|remdesivir|mesh-list
102412052|NCT04501978|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
102412053|NCT04501978|Bamlanivimab|bamlanivimab|mesh-list
102412054|NCT04501978|Sotrovimab|sotrovimab|mesh-list
102412055|NCT04501978|Antimetabolites|antimetabolites|mesh-ancestor
102412056|NCT04501978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412057|NCT04501978|Antiviral Agents|antiviral agents|mesh-ancestor
102412058|NCT04501978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102412201|NCT03970447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412202|NCT03970447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412203|NCT03970447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102412204|NCT03878095|Olaparib|olaparib|mesh-list
102412205|NCT03878095|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102412206|NCT03878095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102412277|NCT03775265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412278|NCT03775265|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102412279|NCT03775265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102412280|NCT03775265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102412281|NCT03775265|Alkylating Agents|alkylating agents|mesh-ancestor
102412282|NCT03775265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102412355|NCT03603808|Vaccines|vaccines|mesh-list
102412356|NCT03603808|Immunologic Factors|immunologic factors|mesh-ancestor
102412357|NCT03603808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412358|NCT03539744|Dexamethasone|dexamethasone|mesh-list
102412359|NCT03539744|Venetoclax|venetoclax|mesh-list
102412360|NCT03539744|Pomalidomide|pomalidomide|mesh-list
102412361|NCT03539744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102412362|NCT03539744|Antiemetics|antiemetics|mesh-ancestor
102412363|NCT03539744|Autonomic Agents|autonomic agents|mesh-ancestor
102412367|NCT03539744|Glucocorticoids|glucocorticoids|mesh-ancestor
102412438|NCT03478865|Vitamin A|vitamin a|mesh-list
102412580|NCT03049462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102412581|NCT03049462|Urological Agents|urological agents|mesh-ancestor
102412582|NCT02992457|Interferons|interferons|mesh-list
102412583|NCT02992457|Ribavirin|ribavirin|mesh-list
102412584|NCT02992457|Interferon-alpha|interferon-alpha|mesh-list
102412585|NCT02992457|Interferon alpha-2|interferon alpha-2|mesh-list
102412586|NCT02992457|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102412671|NCT02740920|Pembrolizumab|pembrolizumab|mesh-list
102412672|NCT02740920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102412673|NCT02740920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412674|NCT02740920|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102412675|NCT02740920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412676|NCT02629120|Sirolimus|sirolimus|mesh-list
102412677|NCT02629120|Cyclophosphamide|cyclophosphamide|mesh-list
102412678|NCT02629120|Busulfan|busulfan|mesh-list
102412679|NCT02629120|Alemtuzumab|alemtuzumab|mesh-list
102412680|NCT02629120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102412681|NCT02629120|Immunologic Factors|immunologic factors|mesh-ancestor
102412682|NCT02629120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412683|NCT02629120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102412685|NCT02629120|Alkylating Agents|alkylating agents|mesh-ancestor
102412808|NCT02105766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102412809|NCT02105766|Immunologic Factors|immunologic factors|mesh-ancestor
102412810|NCT02105766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412811|NCT02105766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102412812|NCT02105766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102412813|NCT02105766|Alkylating Agents|alkylating agents|mesh-ancestor
102412814|NCT02105766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412815|NCT02105766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412816|NCT02105766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102412817|NCT02105766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102412818|NCT02105766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102412819|NCT02105766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102412820|NCT02105766|Antifungal Agents|antifungal agents|mesh-ancestor
102412821|NCT02105766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102412822|NCT02105766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102412823|NCT02105766|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
102412824|NCT02052609|Brodalumab|brodalumab|mesh-list
102412825|NCT02052609|Dermatologic Agents|dermatologic agents|mesh-ancestor
102412826|NCT02031939|Capecitabine|capecitabine|mesh-list
102412827|NCT02031939|Oxaliplatin|oxaliplatin|mesh-list
102412828|NCT02031939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102412829|NCT02031939|Antimetabolites|antimetabolites|mesh-ancestor
102412883|NCT01327781|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102412884|NCT01327781|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102412885|NCT01319565|Aldesleukin|aldesleukin|mesh-list
102412886|NCT01319565|Cyclophosphamide|cyclophosphamide|mesh-list
102412887|NCT01319565|Fludarabine|fludarabine|mesh-list
102412888|NCT01319565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102412889|NCT01319565|Immunologic Factors|immunologic factors|mesh-ancestor
102412890|NCT01319565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412891|NCT01319565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102412960|NCT00792948|Leucovorin|leucovorin|mesh-list
102413193|NCT00066573|Hormone Antagonists|hormone antagonists|mesh-ancestor
102413194|NCT00066573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102413195|NCT00066573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413232|NCT03965845|Palbociclib|palbociclib|mesh-list
102413233|NCT03965845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102413234|NCT03965845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102413235|NCT03965845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102413236|NCT03965845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413237|NCT04766359|Paclitaxel|paclitaxel|mesh-list
102413238|NCT04766359|Cisplatin|cisplatin|mesh-list
102413239|NCT04766359|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102413246|NCT04020601|Ropivacaine|ropivacaine|mesh-list
102413572|NCT03608436|Bromides|bromides|mesh-list
102413721|NCT04025593|Lenalidomide|lenalidomide|mesh-list
102413722|NCT04025593|Decitabine|decitabine|mesh-list
102413723|NCT04025593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102413724|NCT04025593|Immunologic Factors|immunologic factors|mesh-ancestor
102413726|NCT04025593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102414028|NCT04144933|Sufentanil|sufentanil|mesh-list
102414256|NCT03916003|Primaquine|primaquine|mesh-list
102414481|NCT01482962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102414630|NCT03891901|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102414710|NCT02936388|Cisplatin|cisplatin|mesh-list
102414779|NCT03585751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102415005|NCT01462578|Antimetabolites|antimetabolites|mesh-ancestor
102415103|NCT03156361|Insulin|insulin|mesh-list
102415386|NCT04497870|Antiemetics|antiemetics|mesh-ancestor
102415471|NCT05222256|Mydriatics|mydriatics|mesh-ancestor
102415689|NCT02081443|Ticagrelor|ticagrelor|mesh-list
102416291|NCT01274247|Anesthetics|anesthetics|mesh-ancestor
102416592|NCT01275183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102417271|NCT04572828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102417493|NCT04405674|Growth Inhibitors|growth inhibitors|mesh-ancestor
102418025|NCT00799227|Hormones|hormones|mesh-ancestor
102418544|NCT04767035|Midazolam|midazolam|mesh-list
102418622|NCT05694897|Magnesium Sulfate|magnesium sulfate|mesh-list
102418783|NCT01421459|Insulin Glargine|insulin glargine|mesh-list
102419003|NCT03026894|Salicylic Acid|salicylic acid|mesh-list
102419139|NCT01459796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102419288|NCT04951986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102419442|NCT00845481|Calcitriol|calcitriol|mesh-list
102419588|NCT04401007|Lidocaine|lidocaine|mesh-list
102419664|NCT00853671|Adenosine|adenosine|mesh-list
102419808|NCT05431218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419809|NCT05431218|Vitamins|vitamins|mesh-ancestor
102419810|NCT05431218|Micronutrients|micronutrients|mesh-ancestor
102419811|NCT05431218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102419812|NCT05431062|Bupivacaine|bupivacaine|mesh-list
102419813|NCT05431062|Anesthetics, Local|anesthetics, local|mesh-ancestor
102419814|NCT05431062|Anesthetics|anesthetics|mesh-ancestor
102419815|NCT05431062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102419816|NCT05431062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419819|NCT00819507|Fluocinonide|fluocinonide|mesh-list
102420186|NCT03836352|Pembrolizumab|pembrolizumab|mesh-list
102420265|NCT03858465|Phenylephrine|phenylephrine|mesh-list
102420762|NCT02647320|Firuglipel|firuglipel|mesh-list
102420835|NCT00883233|Sensory System Agents|sensory system agents|mesh-ancestor
102421134|NCT01876771|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102421586|NCT01386125|Dermatologic Agents|dermatologic agents|mesh-ancestor
102421745|NCT01383161|Curcumin|curcumin|mesh-list
102421815|NCT03216759|Analgesics|analgesics|mesh-ancestor
102421960|NCT03836157|Bevacizumab|bevacizumab|mesh-list
102422256|NCT01833819|Analgesics|analgesics|mesh-ancestor
102422718|NCT03519984|Cytarabine|cytarabine|mesh-list
102422788|NCT00637273|Exenatide|exenatide|mesh-list
102423164|NCT03096756|Antioxidants|antioxidants|mesh-ancestor
102423239|NCT05033574|Hormones|hormones|mesh-list
102423319|NCT03096522|Phenytoin|phenytoin|mesh-list
102423462|NCT05047848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423605|NCT03596957|Tolvaptan|tolvaptan|mesh-list
102423831|NCT03406533|GABA Modulators|gaba modulators|mesh-ancestor
102424298|NCT03023501|Gabapentin|gabapentin|mesh-list
102424376|NCT05020704|Empagliflozin|empagliflozin|mesh-list
102424519|NCT04029467|Analgesics|analgesics|mesh-ancestor
102425187|NCT03074994|Anesthetics|anesthetics|mesh-list
102425337|NCT04023149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102425439|NCT03072264|Fluoxetine|fluoxetine|mesh-list
102425541|NCT04368585|TEMPO|tempo|mesh-list
102426168|NCT04354545|Lifitegrast|lifitegrast|mesh-list
102426238|NCT03585179|Hemostatics|hemostatics|mesh-ancestor
102426313|NCT03461445|Tacrolimus|tacrolimus|mesh-list
102426535|NCT03034707|Vitamins|vitamins|mesh-ancestor
102426930|NCT01011075|Paclitaxel|paclitaxel|mesh-list
102427437|NCT00971841|Antimitotic Agents|antimitotic agents|mesh-ancestor
102427438|NCT00971841|Mitosis Modulators|mitosis modulators|mesh-ancestor
102427443|NCT05395299|Ethylene|ethylene|mesh-list
102427514|NCT02083679|Gemcitabine|gemcitabine|mesh-list
102428006|NCT05056974|UB-421|ub-421|mesh-list
102428044|NCT03018171|Sufentanil|sufentanil|mesh-list
102428121|NCT03609593|Immunologic Factors|immunologic factors|mesh-ancestor
102428190|NCT00991029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102428266|NCT00929253|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102428492|NCT01001559|Norepinephrine|norepinephrine|mesh-list
102428568|NCT03063060|Vitamin D|vitamin d|mesh-list
102428939|NCT03589833|Methotrexate|methotrexate|mesh-list
102429108|NCT05853224|Lidocaine|lidocaine|mesh-list
102429457|NCT05523609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102429540|NCT05384938|Benralizumab|benralizumab|mesh-list
102429611|NCT05269615|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102429684|NCT05132920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102429685|NCT05132920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102429686|NCT05132920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102429687|NCT05129085|Dexamethasone|dexamethasone|mesh-list
102429758|NCT05070754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429759|NCT05067387|Dronabinol|dronabinol|mesh-list
102429760|NCT05067387|Hallucinogens|hallucinogens|mesh-ancestor
102429761|NCT05067387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429762|NCT05067387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102429764|NCT05067387|Analgesics|analgesics|mesh-ancestor
102429908|NCT04789915|Dopamine Agents|dopamine agents|mesh-ancestor
102430217|NCT03889743|Glucocorticoids|glucocorticoids|mesh-ancestor
102430593|NCT02785224|Autonomic Agents|autonomic agents|mesh-ancestor
102430817|NCT00678327|Etoposide|etoposide|mesh-list
102431046|NCT02085161|Autonomic Agents|autonomic agents|mesh-ancestor
102431124|NCT01101867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102431570|NCT01126593|Bupivacaine|bupivacaine|mesh-list
102431898|NCT01194453|Dexamethasone|dexamethasone|mesh-list
102432052|NCT00088595|Hormones|hormones|mesh-ancestor
102432125|NCT01201863|Hormones|hormones|mesh-ancestor
102432353|NCT01144143|Infliximab|infliximab|mesh-list
102432430|NCT00083915|Melphalan|melphalan|mesh-list
102432570|NCT04401137|Topiramate|topiramate|mesh-list
102433190|NCT01244451|Ofatumumab|ofatumumab|mesh-list
102433272|NCT04303325|Esketamine|esketamine|mesh-list
102434306|NCT04123249|Propofol|propofol|mesh-list
102434681|NCT01293825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102434907|NCT01297335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102434986|NCT01920737|Antiemetics|antiemetics|mesh-ancestor
102435060|NCT01279317|Acetic Acid|acetic acid|mesh-list
102435287|NCT01922765|Amoxicillin|amoxicillin|mesh-list
102435591|NCT05793359|Antiemetics|antiemetics|mesh-ancestor
102435890|NCT05269628|Dronabinol|dronabinol|mesh-list
102436040|NCT04601961|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102436116|NCT04246229|Protective Agents|protective agents|mesh-ancestor
102436348|NCT02760667|Cisplatin|cisplatin|mesh-list
102436494|NCT03060018|Oxitropium|oxitropium|mesh-list
102436654|NCT01455649|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102436798|NCT01311687|Hormones|hormones|mesh-ancestor
102437170|NCT01459081|Zanamivir|zanamivir|mesh-list
102438006|NCT03054168|Goserelin|goserelin|mesh-list
102438074|NCT02489695|Axitinib|axitinib|mesh-list
102438297|NCT04907838|BQ 788|bq 788|mesh-list
102438679|NCT05591755|Ketotifen|ketotifen|mesh-list
102438755|NCT05188508|Pembrolizumab|pembrolizumab|mesh-list
102439004|NCT04558866|Hormones|hormones|mesh-ancestor
102439060|NCT04211987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102439212|NCT03769311|Cetuximab|cetuximab|mesh-list
102439730|NCT05895838|Dexamethasone|dexamethasone|mesh-list
102439803|NCT05861570|Hormones|hormones|mesh-ancestor
102439905|NCT05733286|Suvorexant|suvorexant|mesh-list
102440258|NCT05324059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102440333|NCT05195918|Analgesics|analgesics|mesh-ancestor
102440653|NCT04618289|Vitamin D|vitamin d|mesh-list
102440707|NCT04396496|Daratumumab|daratumumab|mesh-list
102440779|NCT04260529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102440852|NCT04159155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102441078|NCT03856216|Immunotoxins|immunotoxins|mesh-ancestor
102441230|NCT03710772|BB 1101|bb 1101|mesh-list
102441454|NCT03172299|Aflibercept|aflibercept|mesh-list
102441534|NCT03047993|Azacitidine|azacitidine|mesh-list
102441686|NCT02671890|Gemcitabine|gemcitabine|mesh-list
102442061|NCT01248715|Oseltamivir|oseltamivir|mesh-list
102442137|NCT00217425|Prednisone|prednisone|mesh-list
102442731|NCT02292979|Dacarbazine|dacarbazine|mesh-list
102442958|NCT03008655|Hemostatics|hemostatics|mesh-ancestor
102443261|NCT01897441|Antibodies|antibodies|mesh-list
102443331|NCT04879446|Mitogens|mitogens|mesh-list
102443403|NCT01895023|Anesthetics, General|anesthetics, general|mesh-ancestor
102443556|NCT05580445|Gemcitabine|gemcitabine|mesh-list
102443928|NCT03825809|Antiemetics|antiemetics|mesh-ancestor
102444207|NCT00984659|Xhance|xhance|mesh-list
102444850|NCT04866498|Analgesics|analgesics|mesh-list
102444906|NCT03815929|Estradiol|estradiol|mesh-list
102445062|NCT00198991|Hormones|hormones|mesh-ancestor
102445287|NCT02856893|Gefitinib|gefitinib|mesh-list
102445589|NCT04781803|Cyclosporine|cyclosporine|mesh-list
102445669|NCT02835131|Hormones|hormones|mesh-ancestor
102446264|NCT02588105|Folic Acid|folic acid|mesh-list
102446416|NCT02504489|Docetaxel|docetaxel|mesh-list
102446719|NCT04832880|Glucocorticoids|glucocorticoids|mesh-ancestor
102446871|NCT02062463|Budesonide|budesonide|mesh-list
102447323|NCT01431755|Sensory System Agents|sensory system agents|mesh-ancestor
102447548|NCT00068575|Interferons|interferons|mesh-list
102447626|NCT04834674|Apatinib|apatinib|mesh-list
102447704|NCT00212147|Nitrous Oxide|nitrous oxide|mesh-list
102448088|NCT04427826|Morphine|morphine|mesh-list
102448383|NCT00585559|Antipyretics|antipyretics|mesh-ancestor
102448482|NCT05606315|Midazolam|midazolam|mesh-list
102448575|NCT03007563|Bilirubin|bilirubin|mesh-list
102448609|NCT01894451|Growth Substances|growth substances|mesh-ancestor
102448764|NCT00078559|Antiviral Agents|antiviral agents|mesh-ancestor
102448913|NCT01535001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102449138|NCT04794738|Analgesics|analgesics|mesh-ancestor
102449367|NCT04799184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102449675|NCT01625169|Etravirine|etravirine|mesh-list
102449828|NCT03138603|Metoprolol|metoprolol|mesh-list
102450205|NCT00347412|Paclitaxel|paclitaxel|mesh-list
102450422|NCT00095875|Docetaxel|docetaxel|mesh-list
102450654|NCT01490060|Hormones|hormones|mesh-ancestor
102451038|NCT01604109|Caseins|caseins|mesh-list
102451173|NCT02587962|Pembrolizumab|pembrolizumab|mesh-list
102451486|NCT00476190|Hormones|hormones|mesh-ancestor
102451549|NCT05554848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102451694|NCT01672983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102452000|NCT04425876|Fluzoparib|fluzoparib|mesh-list
102452073|NCT01687179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102452296|NCT05168475|Infliximab|infliximab|mesh-list
102452601|NCT00096161|Antimetabolites|antimetabolites|mesh-ancestor
102452818|NCT01717209|Epoprostenol|epoprostenol|mesh-list
102453426|NCT01745055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102453953|NCT05609682|Antimanic Agents|antimanic agents|mesh-ancestor
102454101|NCT00041119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102454178|NCT00551460|Immunotoxins|immunotoxins|mesh-ancestor
102454260|NCT01761747|Ponatinib|ponatinib|mesh-list
102454698|NCT00201773|Celecoxib|celecoxib|mesh-list
102455295|NCT00229619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455536|NCT02989623|Copper|copper|mesh-list
102456044|NCT00300391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102456119|NCT01860807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102456340|NCT05950113|Antimetabolites|antimetabolites|mesh-ancestor
102456418|NCT05949424|Sunitinib|sunitinib|mesh-list
102456563|NCT05582096|Incretins|incretins|mesh-ancestor
102456711|NCT05291039|Adalimumab|adalimumab|mesh-list
102456860|NCT04963712|Thymalfasin|thymalfasin|mesh-list
102457092|NCT04017468|Vancomycin|vancomycin|mesh-list
102457163|NCT03797014|Tenofovir|tenofovir|mesh-list
102457833|NCT00342355|Ritonavir|ritonavir|mesh-list
102457910|NCT05266651|Tadalafil|tadalafil|mesh-list
102458216|NCT00320749|Docetaxel|docetaxel|mesh-list
102458508|NCT01390220|GABA Modulators|gaba modulators|mesh-ancestor
102458810|NCT00352781|Autonomic Agents|autonomic agents|mesh-ancestor
102459112|NCT00365209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102459264|NCT00315341|Methadone|methadone|mesh-list
102459422|NCT01792037|Anesthetics|anesthetics|mesh-ancestor
102459720|NCT00384865|Antipyretics|antipyretics|mesh-ancestor
102459860|NCT00392951|Sirolimus|sirolimus|mesh-list
102460837|NCT05303792|Mercaptopurine|mercaptopurine|mesh-list
102461002|NCT04882813|Hormones|hormones|mesh-ancestor
102461215|NCT04401904|Dapagliflozin|dapagliflozin|mesh-list
102461288|NCT04200651|Dexamethasone|dexamethasone|mesh-list
102461752|NCT01381874|Prednisone|prednisone|mesh-list
102461810|NCT00479089|Dexamethasone|dexamethasone|mesh-list
102462097|NCT01397162|Xhance|xhance|mesh-list
102462122|NCT00420017|Amiodarone|amiodarone|mesh-list
102462331|NCT00427037|Vitamin D|vitamin d|mesh-list
102463096|NCT03590912|Mydriatics|mydriatics|mesh-ancestor
102463164|NCT05630768|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102463322|NCT00438971|Analgesics|analgesics|mesh-ancestor
102463765|NCT00525733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102464068|NCT01797991|Dexamethasone|dexamethasone|mesh-list
102464440|NCT04149626|GABA Modulators|gaba modulators|mesh-ancestor
102464591|NCT00568087|Antiviral Agents|antiviral agents|mesh-ancestor
102464818|NCT04147754|Morphine|morphine|mesh-list
102464896|NCT00550589|Cidofovir|cidofovir|mesh-list
102465113|NCT04142762|Rifampin|rifampin|mesh-list
102465185|NCT03586466|Analgesics|analgesics|mesh-ancestor
102465342|NCT03585530|Raltitrexed|raltitrexed|mesh-list
102465412|NCT00615433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102465638|NCT05702762|Trimethoprim|trimethoprim|mesh-list
102465720|NCT00578305|Folic Acid|folic acid|mesh-list
102466013|NCT00580333|Alkylating Agents|alkylating agents|mesh-ancestor
102466159|NCT00625729|Antiviral Agents|antiviral agents|mesh-ancestor
102466308|NCT00630253|Cyclosporine|cyclosporine|mesh-list
102466999|NCT01670084|Mesna|mesna|mesh-list
102467138|NCT01674686|Antimetabolites|antimetabolites|mesh-ancestor
102467212|NCT01675700|Nitroglycerin|nitroglycerin|mesh-list
102467370|NCT00660517|Xhance|xhance|mesh-list
102467448|NCT03749018|Tubulin Modulators|tubulin modulators|mesh-ancestor
102467818|NCT03546608|Tepotinib|tepotinib|mesh-list
102467974|NCT00393211|Etoricoxib|etoricoxib|mesh-list
102468201|NCT00590863|Dexetimide|dexetimide|mesh-list
102468643|NCT01678352|Imiquimod|imiquimod|mesh-list
102468793|NCT00566813|Incretins|incretins|mesh-ancestor
102468939|NCT05362799|Metformin|metformin|mesh-list
102469176|NCT01947153|Metformin|metformin|mesh-list
102469613|NCT00749749|Bupivacaine|bupivacaine|mesh-list
102469812|NCT00753337|Cobalt|cobalt|mesh-list
102470888|NCT00621179|Leuprolide|leuprolide|mesh-list
102470967|NCT00673439|PENTA|penta|mesh-list
102471184|NCT00245011|Analgesics|analgesics|mesh-ancestor
102471258|NCT00738049|Darusentan|darusentan|mesh-list
102471331|NCT00738361|Antimitotic Agents|antimitotic agents|mesh-ancestor
102471409|NCT03298802|Diuretics|diuretics|mesh-ancestor
102471636|NCT00685295|Fentanyl|fentanyl|mesh-list
102471780|NCT00687167|Zonisamide|zonisamide|mesh-list
102471787|NCT00687713|Bupropion|bupropion|mesh-list
102472151|NCT00654953|Serotonin Agents|serotonin agents|mesh-ancestor
102472231|NCT03889275|Durvalumab|durvalumab|mesh-list
102472372|NCT03721965|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102472524|NCT00542087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102472749|NCT02312258|Protease Inhibitors|protease inhibitors|mesh-ancestor
102473121|NCT03809923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102473282|NCT00721513|Docetaxel|docetaxel|mesh-list
102473348|NCT00759187|Antimetabolites|antimetabolites|mesh-ancestor
102473421|NCT01276613|Gemcitabine|gemcitabine|mesh-list
102473497|NCT03081416|Histamine Agents|histamine agents|mesh-ancestor
102473647|NCT02999633|Anesthetics|anesthetics|mesh-ancestor
102473957|NCT01276327|Hormones|hormones|mesh-ancestor
102474250|NCT01273727|Hormones|hormones|mesh-ancestor
102474324|NCT01274039|Acetazolamide|acetazolamide|mesh-list
102474506|NCT00742469|Rifaximin|rifaximin|mesh-list
102474698|NCT01270841|Enclomiphene|enclomiphene|mesh-list
102475154|NCT00772915|Lenalidomide|lenalidomide|mesh-list
102475305|NCT03602781|Nitric Oxide|nitric oxide|mesh-list
102475530|NCT04382443|Colchicine|colchicine|mesh-list
102475606|NCT00797797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102475680|NCT02151877|Antioxidants|antioxidants|mesh-ancestor
102475977|NCT00817843|Antimetabolites|antimetabolites|mesh-ancestor
102476198|NCT02348359|Growth Inhibitors|growth inhibitors|mesh-ancestor
102476500|NCT00241631|Purinergic Agents|purinergic agents|mesh-ancestor
102476949|NCT03803267|Cholinergic Agents|cholinergic agents|mesh-ancestor
102477101|NCT05742425|Growth Inhibitors|growth inhibitors|mesh-ancestor
102477626|NCT04112823|Protease Inhibitors|protease inhibitors|mesh-ancestor
102478223|NCT00853333|Anesthetics|anesthetics|mesh-ancestor
102478526|NCT00859027|Risedronic Acid|risedronic acid|mesh-list
102478677|NCT04344483|Lidocaine|lidocaine|mesh-list
102478982|NCT02697292|Antibodies|antibodies|mesh-list
102479128|NCT00883675|Docetaxel|docetaxel|mesh-list
102479804|NCT00905515|Tacrolimus|tacrolimus|mesh-list
102479881|NCT01834963|Antiviral Agents|antiviral agents|mesh-ancestor
102479956|NCT01839175|Immunologic Factors|immunologic factors|mesh-ancestor
102480101|NCT00422578|Tadalafil|tadalafil|mesh-list
102480269|NCT02506660|BB 1101|bb 1101|mesh-list
102480558|NCT04458610|Rituximab|rituximab|mesh-list
102481176|NCT05516784|Clopidogrel|clopidogrel|mesh-list
102481394|NCT03323398|Durvalumab|durvalumab|mesh-list
102481539|NCT05519592|Ropivacaine|ropivacaine|mesh-list
102481925|NCT01042093|Autonomic Agents|autonomic agents|mesh-ancestor
102482373|NCT01831505|Prednisolone|prednisolone|mesh-list
102482520|NCT00014911|Trimethoprim|trimethoprim|mesh-list
102482594|NCT04347577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102482819|NCT03213353|Guaifenesin|guaifenesin|mesh-list
102483793|NCT04673383|Serotonin Agents|serotonin agents|mesh-ancestor
102483943|NCT02793154|Exenatide|exenatide|mesh-list
102484173|NCT04346797|Eculizumab|eculizumab|mesh-list
102484538|NCT05563675|Cholinergic Agents|cholinergic agents|mesh-list
102485291|NCT04358341|Irinotecan|irinotecan|mesh-list
102485432|NCT04347005|Febuxostat|febuxostat|mesh-list
102485847|NCT04368377|PENTA|penta|mesh-list
102485963|NCT00932477|Glycerol|glycerol|mesh-list
102486184|NCT00923117|Sunitinib|sunitinib|mesh-list
102486560|NCT03126370|Emtricitabine|emtricitabine|mesh-list
102486718|NCT05026905|Vitamins|vitamins|mesh-ancestor
102486782|NCT03073876|Donepezil|donepezil|mesh-list
102487306|NCT03102736|Anesthetics|anesthetics|mesh-ancestor
102487530|NCT03127137|Lidocaine|lidocaine|mesh-list
102487898|NCT03289858|Sensory System Agents|sensory system agents|mesh-ancestor
102488050|NCT03437044|Clopidogrel|clopidogrel|mesh-list
102488273|NCT00637130|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102488650|NCT01925300|Sympatholytics|sympatholytics|mesh-ancestor
102488726|NCT03241030|Antipyretics|antipyretics|mesh-ancestor
102488948|NCT03496324|Analgesics|analgesics|mesh-ancestor
102489023|NCT01075399|Imidazole|imidazole|mesh-list
102489699|NCT01092559|Autonomic Agents|autonomic agents|mesh-ancestor
102489922|NCT03609047|Paclitaxel|paclitaxel|mesh-list
102490478|NCT01125163|Iron|iron|mesh-list
102490977|NCT01047241|Sufentanil|sufentanil|mesh-list
102491174|NCT05314270|Copper|copper|mesh-list
102491293|NCT01170247|Ketamine|ketamine|mesh-list
102491356|NCT03805672|Enoxaparin|enoxaparin|mesh-list
102491429|NCT04498351|Analgesics|analgesics|mesh-ancestor
102491728|NCT01135537|Thymoglobulin|thymoglobulin|mesh-list
102491806|NCT01138735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102491954|NCT04558502|Bismuth|bismuth|mesh-list
102492497|NCT04759196|Topiramate|topiramate|mesh-list
102492655|NCT03820466|Aspirin|aspirin|mesh-list
102493091|NCT05564286|Glucocorticoids|glucocorticoids|mesh-ancestor
102493242|NCT05560542|Antiemetics|antiemetics|mesh-ancestor
102493483|NCT04391660|Eusol|eusol|mesh-list
102493997|NCT02880020|Nivolumab|nivolumab|mesh-list
102494224|NCT04138212|Paclitaxel|paclitaxel|mesh-list
102494352|NCT01269034|Exenatide|exenatide|mesh-list
102494500|NCT02534038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102494658|NCT05485272|Fluorides|fluorides|mesh-list
102494798|NCT05478954|Antimalarials|antimalarials|mesh-ancestor
102495026|NCT00981370|Deferasirox|deferasirox|mesh-list
102495178|NCT05292976|Miotics|miotics|mesh-ancestor
102495294|NCT00731770|Xhance|xhance|mesh-list
102495705|NCT00000796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102495860|NCT00014560|Antibodies|antibodies|mesh-list
102496022|NCT00000868|Antacids|antacids|mesh-ancestor
102496686|NCT01188577|Racepinephrine|racepinephrine|mesh-list
102496765|NCT02548650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102497158|NCT01894334|Edaravone|edaravone|mesh-list
102497436|NCT00000484|Chlorothiazide|chlorothiazide|mesh-list
102497516|NCT00002092|Cimetidine|cimetidine|mesh-list
102497587|NCT00001438|Interferon alpha-2|interferon alpha-2|mesh-list
102497660|NCT00001498|Alkylating Agents|alkylating agents|mesh-ancestor
102497817|NCT00002140|Azithromycin|azithromycin|mesh-list
102498278|NCT04756622|Acetylcysteine|acetylcysteine|mesh-list
102498577|NCT03009877|Anesthetics|anesthetics|mesh-ancestor
102498650|NCT05593757|Quinidine|quinidine|mesh-list
102499105|NCT00002458|Immunologic Factors|immunologic factors|mesh-ancestor
102499510|NCT00002542|Tamoxifen|tamoxifen|mesh-list
102499564|NCT01823198|Analgesics|analgesics|mesh-ancestor
102499863|NCT05397964|Calcium|calcium|mesh-list
102500795|NCT01054079|Cinacalcet|cinacalcet|mesh-list
102501456|NCT00002902|Irinotecan|irinotecan|mesh-list
102501679|NCT01572662|Tacrolimus|tacrolimus|mesh-list
102501831|NCT00003412|Interleukin-12|interleukin-12|mesh-list
102502064|NCT00003490|Prednisone|prednisone|mesh-list
102502206|NCT00384436|Serotonin Agents|serotonin agents|mesh-ancestor
102502281|NCT00003088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102502506|NCT00003598|Tretinoin|tretinoin|mesh-list
102502672|NCT01258855|Aldesleukin|aldesleukin|mesh-list
102502739|NCT00002818|Cytarabine|cytarabine|mesh-list
102502809|NCT01260883|Ketorolac|ketorolac|mesh-list
102503565|NCT00003334|Paclitaxel|paclitaxel|mesh-list
102503640|NCT00004036|Cyclophosphamide|cyclophosphamide|mesh-list
102503713|NCT00003784|Immunologic Factors|immunologic factors|mesh-ancestor
102503793|NCT00003364|Etoposide|etoposide|mesh-list
102503861|NCT00004852|Antimetabolites|antimetabolites|mesh-ancestor
102503936|NCT00004072|Carmustine|carmustine|mesh-list
102504090|NCT00004108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504165|NCT00004918|Sargramostim|sargramostim|mesh-list
102504247|NCT05776212|Fluorides|fluorides|mesh-list
102504545|NCT05297851|Dermatologic Agents|dermatologic agents|mesh-ancestor
102504850|NCT03377491|Paclitaxel|paclitaxel|mesh-list
102505153|NCT00198978|Abortifacient Agents|abortifacient agents|mesh-ancestor
102505379|NCT00004192|Protective Agents|protective agents|mesh-ancestor
102505454|NCT00016718|Efavirenz|efavirenz|mesh-list
102505527|NCT00005050|Antimetabolites|antimetabolites|mesh-ancestor
102505582|NCT00022490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102505809|NCT00004300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102506108|NCT01289275|Nicotine|nicotine|mesh-list
102506181|NCT00005776|Antioxidants|antioxidants|mesh-ancestor
102506945|NCT00117962|Pemetrexed|pemetrexed|mesh-list
102507093|NCT01316341|Empagliflozin|empagliflozin|mesh-list
102507174|NCT01317901|Rituximab|rituximab|mesh-list
102507243|NCT01425853|Celecoxib|celecoxib|mesh-list
102507766|NCT01384591|Antiviral Agents|antiviral agents|mesh-ancestor
102508143|NCT01049243|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102508221|NCT01100723|Vitamin D|vitamin d|mesh-list
102508360|NCT04751318|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102508658|NCT01165541|Histamine Antagonists|histamine antagonists|mesh-ancestor
102508952|NCT01169519|Urological Agents|urological agents|mesh-ancestor
102509321|NCT01479127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102509633|NCT04346030|Hormones|hormones|mesh-ancestor
102510072|NCT00353834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102510228|NCT00357734|Gefitinib|gefitinib|mesh-list
102510462|NCT05902221|Rifampin|rifampin|mesh-list
102510815|NCT05649748|Treprostinil|treprostinil|mesh-list
102510895|NCT05418647|Dialysis Solutions|dialysis solutions|mesh-list
102511392|NCT03993327|Iodine|iodine|mesh-list
102511421|NCT03759028|Acetaminophen|acetaminophen|mesh-list
102511869|NCT05610384|Analgesics|analgesics|mesh-ancestor
102511945|NCT00401882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102512174|NCT01793480|Methadone|methadone|mesh-list
102512468|NCT05143502|Xhance|xhance|mesh-list
102512549|NCT05474040|Morphine|morphine|mesh-list
102512993|NCT00534794|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
102513069|NCT03463460|Pembrolizumab|pembrolizumab|mesh-list
102513213|NCT00539942|Fondaparinux|fondaparinux|mesh-list
102513596|NCT03007927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102513738|NCT00435812|Vaccines|vaccines|mesh-list
102514113|NCT01364922|Acetaminophen|acetaminophen|mesh-list
102514264|NCT05127876|Respiratory System Agents|respiratory system agents|mesh-ancestor
102514557|NCT02125292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102515612|NCT05540743|Adalimumab|adalimumab|mesh-list
102515758|NCT04545008|Antioxidants|antioxidants|mesh-ancestor
102516510|NCT00651560|Ezetimibe|ezetimibe|mesh-list
102516651|NCT02248753|Verapamil|verapamil|mesh-list
102516729|NCT00689078|Antiemetics|antiemetics|mesh-ancestor
102516951|NCT01790282|Estradiol|estradiol|mesh-list
102517024|NCT00601796|Immunologic Factors|immunologic factors|mesh-ancestor
102517254|NCT00703508|Metformin|metformin|mesh-list
102517776|NCT01295879|Vitamin D|vitamin d|mesh-list
102517861|NCT01276496|Paclitaxel|paclitaxel|mesh-list
102518122|NCT00731588|Biotin|biotin|mesh-list
102519024|NCT00781898|Naltrexone|naltrexone|mesh-list
102519049|NCT03809156|Ambrisentan|ambrisentan|mesh-list
102519570|NCT01258049|Analgesics|analgesics|mesh-ancestor
102520164|NCT03839888|Cholinergic Agents|cholinergic agents|mesh-ancestor
102520489|NCT01332461|Xhance|xhance|mesh-list
102520538|NCT01334957|Ibuprofen|ibuprofen|mesh-list
102520766|NCT01376297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102521895|NCT05946551|Famotidine|famotidine|mesh-list
102521973|NCT05945797|Hormones|hormones|mesh-ancestor
102522345|NCT05425420|Antitussive Agents|antitussive agents|mesh-ancestor
102522493|NCT04840550|Dexlansoprazole|dexlansoprazole|mesh-list
102522941|NCT03128359|Antimetabolites|antimetabolites|mesh-ancestor
102523092|NCT00788125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102523240|NCT00889226|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102523316|NCT01203722|Sirolimus|sirolimus|mesh-list
102523992|NCT02502864|Docetaxel|docetaxel|mesh-list
102524067|NCT00895232|Iron|iron|mesh-list
102524593|NCT04205994|Tolcapone|tolcapone|mesh-list
102524738|NCT03406676|Methylene Blue|methylene blue|mesh-list
102524893|NCT01725152|GABA Agents|gaba agents|mesh-ancestor
102524964|NCT01049360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102525268|NCT05404919|Tenofovir|tenofovir|mesh-list
102525491|NCT03003143|Vigabatrin|vigabatrin|mesh-list
102525571|NCT03002675|Exenatide|exenatide|mesh-list
102525647|NCT03401372|Bortezomib|bortezomib|mesh-list
102525859|NCT05363111|Daratumumab|daratumumab|mesh-list
102525934|NCT02242292|Scopolamine|scopolamine|mesh-list
102526416|NCT01639157|Buspirone|buspirone|mesh-list
102527240|NCT01623323|Xhance|xhance|mesh-list
102527425|NCT04353362|Metronidazole|metronidazole|mesh-list
102527578|NCT00955916|Cytarabine|cytarabine|mesh-list
102527798|NCT02243813|Hallucinogens|hallucinogens|mesh-ancestor
102528025|NCT00982592|Leucovorin|leucovorin|mesh-list
102529011|NCT02179892|Hormones|hormones|mesh-ancestor
102529074|NCT01044212|Psyllium|psyllium|mesh-list
102529222|NCT01099202|Epoetin Alfa|epoetin alfa|mesh-list
102529519|NCT05308160|Dapagliflozin|dapagliflozin|mesh-list
102529825|NCT01172600|Analgesics|analgesics|mesh-ancestor
102529899|NCT01173848|Vitamins|vitamins|mesh-ancestor
102530195|NCT02408016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102530641|NCT02433834|Autonomic Agents|autonomic agents|mesh-ancestor
102531097|NCT04992312|Glucagon|glucagon|mesh-list
102531178|NCT04803422|Tazobactam|tazobactam|mesh-list
102531395|NCT03602612|Cyclophosphamide|cyclophosphamide|mesh-list
102531651|NCT02484885|Xenon|xenon|mesh-list
102343736|NCT04696523|Xenon|xenon|mesh-list
102532229|NCT03009500|Lidocaine|lidocaine|mesh-list
102532441|NCT01337336|Xhance|xhance|mesh-list
102532600|NCT04743063|Losartan|losartan|mesh-list
102532979|NCT05081193|Methyltestosterone|methyltestosterone|mesh-list
102533200|NCT01354652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102533358|NCT01759277|Anesthetics|anesthetics|mesh-list
102533725|NCT01323140|Testosterone|testosterone|mesh-list
102534179|NCT01371110|Midazolam|midazolam|mesh-list
102534326|NCT01332500|Naproxen|naproxen|mesh-list
102534397|NCT01267292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102534852|NCT04351490|Cholecalciferol|cholecalciferol|mesh-list
102535070|NCT01416584|Methadone|methadone|mesh-list
102535222|NCT03349281|Glucocorticoids|glucocorticoids|mesh-ancestor
102535381|NCT02724423|Diazepam|diazepam|mesh-list
102535450|NCT02429934|Abatacept|abatacept|mesh-list
102535605|NCT01422200|Vaccines|vaccines|mesh-list
102535753|NCT02651259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102113822|NCT02307864|Narcotics|narcotics|mesh-ancestor
102114119|NCT05226832|Hormones|hormones|mesh-ancestor
102114964|NCT03161028|Vitamins|vitamins|mesh-ancestor
102115631|NCT02516618|Fasinumab|fasinumab|mesh-list
102115936|NCT02167425|Methadone|methadone|mesh-list
102116087|NCT00708422|Travoprost|travoprost|mesh-list
102116166|NCT02508350|Daptomycin|daptomycin|mesh-list
102116538|NCT02175927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102116613|NCT02169063|Listerine|listerine|mesh-list
102116760|NCT02501798|Dopamine Agents|dopamine agents|mesh-ancestor
102116836|NCT02499224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102116911|NCT02177409|Telmisartan|telmisartan|mesh-list
102117078|NCT03339362|Hormones|hormones|mesh-ancestor
102117434|NCT04292080|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102117661|NCT02568046|Leucovorin|leucovorin|mesh-list
102117734|NCT02560012|Sirolimus|sirolimus|mesh-list
102117891|NCT02487680|Chromium|chromium|mesh-list
102118110|NCT04583488|Antimitotic Agents|antimitotic agents|mesh-ancestor
102118190|NCT02186145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102118337|NCT02486744|Hormones|hormones|mesh-ancestor
102118484|NCT02183805|Tubulin Modulators|tubulin modulators|mesh-ancestor
102062346|NCT03700749|Iodine|iodine|mesh-list
102119621|NCT02199327|Interferons|interferons|mesh-list
102119773|NCT03999411|Nicotine|nicotine|mesh-list
102121205|NCT05351346|Hormones|hormones|mesh-ancestor
102121435|NCT04601857|Pembrolizumab|pembrolizumab|mesh-list
102121506|NCT04195945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102121507|NCT04195945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102121508|NCT04195945|Analgesics|analgesics|mesh-ancestor
102121509|NCT04195945|Sensory System Agents|sensory system agents|mesh-ancestor
102121510|NCT04195945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102121511|NCT04195945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102121512|NCT04172922|Sirolimus|sirolimus|mesh-list
102121513|NCT04172922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102121514|NCT04172922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102121515|NCT04172922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102121516|NCT04172922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121517|NCT04172922|Antifungal Agents|antifungal agents|mesh-ancestor
102121518|NCT04172922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102121519|NCT04172922|Immunologic Factors|immunologic factors|mesh-ancestor
102121520|NCT04172922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121521|NCT04139772|Docetaxel|docetaxel|mesh-list
102121522|NCT04139772|Abiraterone Acetate|abiraterone acetate|mesh-list
102121523|NCT04139772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121524|NCT04139772|Tubulin Modulators|tubulin modulators|mesh-ancestor
102121525|NCT04139772|Antimitotic Agents|antimitotic agents|mesh-ancestor
102121526|NCT04139772|Mitosis Modulators|mitosis modulators|mesh-ancestor
102121527|NCT04139772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121528|NCT04139772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102121529|NCT04139772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102121530|NCT04139772|Hormone Antagonists|hormone antagonists|mesh-ancestor
102121531|NCT04139772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102121532|NCT04139772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121962|NCT01682941|Hormones|hormones|mesh-ancestor
102122027|NCT01209871|Antibodies|antibodies|mesh-list
102122176|NCT00704522|Ribavirin|ribavirin|mesh-list
102122251|NCT02224131|Aspirin|aspirin|mesh-list
102122774|NCT02802813|Primaquine|primaquine|mesh-list
102122848|NCT04528329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102123053|NCT03300440|Biotin|biotin|mesh-list
102123070|NCT02467556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102123368|NCT03108326|Ustekinumab|ustekinumab|mesh-list
102123450|NCT03470532|Carticaine|carticaine|mesh-list
102123821|NCT01192035|Nevirapine|nevirapine|mesh-list
102123966|NCT01516203|Rifampin|rifampin|mesh-list
102124206|NCT05231382|Leucovorin|leucovorin|mesh-list
102124343|NCT04590326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102124344|NCT04590326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102124345|NCT05163366|Ketamine|ketamine|mesh-list
102124346|NCT05163366|Morphine|morphine|mesh-list
102124347|NCT05163366|Analgesics|analgesics|mesh-ancestor
102124348|NCT05163366|Sensory System Agents|sensory system agents|mesh-ancestor
102124349|NCT05163366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102124350|NCT05163366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124351|NCT05163366|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102124352|NCT05163366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102124353|NCT05163366|Anesthetics, General|anesthetics, general|mesh-ancestor
102124796|NCT05076682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102124947|NCT04730206|Camostat|camostat|mesh-list
102125171|NCT03295214|Acetaminophen|acetaminophen|mesh-list
102125548|NCT00833937|Zolpidem|zolpidem|mesh-list
102125924|NCT03298646|Analgesics|analgesics|mesh-ancestor
102126070|NCT03283046|Ipilimumab|ipilimumab|mesh-list
102126618|NCT03919526|Cyclophosphamide|cyclophosphamide|mesh-list
102126837|NCT03261596|Piperazine|piperazine|mesh-list
102127214|NCT00677079|Iniparib|iniparib|mesh-list
102127277|NCT00495885|Volinanserin|volinanserin|mesh-list
102127498|NCT04486508|Anticoagulants|anticoagulants|mesh-ancestor
102127499|NCT04486508|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102127500|NCT04486508|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102127501|NCT02552212|Certolizumab Pegol|certolizumab pegol|mesh-list
102127575|NCT05209529|Durvalumab|durvalumab|mesh-list
102128168|NCT03234062|Antimetabolites|antimetabolites|mesh-ancestor
102128318|NCT03226340|Niacin|niacin|mesh-list
102128405|NCT03225326|Carticaine|carticaine|mesh-list
102128696|NCT03220490|Timolol|timolol|mesh-list
102129067|NCT05476198|Anesthetics|anesthetics|mesh-list
102129217|NCT03209180|Carvedilol|carvedilol|mesh-list
102129370|NCT00508989|Vitamins|vitamins|mesh-ancestor
102129595|NCT02448290|Docetaxel|docetaxel|mesh-list
102129661|NCT00049959|Verteporfin|verteporfin|mesh-list
102129740|NCT04530305|Upadacitinib|upadacitinib|mesh-list
102129965|NCT03199664|Tacrolimus|tacrolimus|mesh-list
102130114|NCT00299715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102130189|NCT03204032|Leprostatic Agents|leprostatic agents|mesh-ancestor
102130265|NCT04469283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102130562|NCT00162279|Abatacept|abatacept|mesh-list
102130645|NCT03530085|Fludarabine|fludarabine|mesh-list
102130863|NCT03193112|Agomelatine|agomelatine|mesh-list
102131166|NCT03190304|Enalapril|enalapril|mesh-list
102131398|NCT02438072|Analgesics|analgesics|mesh-ancestor
102131838|NCT02434952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102132227|NCT04221503|Niraparib|niraparib|mesh-list
102132416|NCT02419820|APD791|apd791|mesh-list
102132455|NCT02419352|Atropine|atropine|mesh-list
102132599|NCT02423018|Anticonvulsants|anticonvulsants|mesh-ancestor
102133054|NCT03171818|Darbepoetin alfa|darbepoetin alfa|mesh-list
102133204|NCT02408042|Immunotoxins|immunotoxins|mesh-ancestor
102133577|NCT03521895|Aflibercept|aflibercept|mesh-list
102133725|NCT02295189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102133950|NCT02299401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102134127|NCT02303769|Tamsulosin|tamsulosin|mesh-list
102134174|NCT03511755|Neurotransmitter Agents|neurotransmitter agents|mesh-list
102134551|NCT02312115|Furosemide|furosemide|mesh-list
102134734|NCT03504033|Desflurane|desflurane|mesh-list
102134927|NCT02397512|Lactulose|lactulose|mesh-list
102135675|NCT00543127|Anastrozole|anastrozole|mesh-list
102135823|NCT03500133|Etoposide|etoposide|mesh-list
102135978|NCT03497715|Analgesics|analgesics|mesh-ancestor
102136064|NCT02320383|Obinutuzumab|obinutuzumab|mesh-list
102136273|NCT03494907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102136347|NCT03625505|Venetoclax|venetoclax|mesh-list
102136496|NCT05439460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102136584|NCT05436652|Prednisolone|prednisolone|mesh-list
102136722|NCT03131973|Caffeine|caffeine|mesh-list
102136800|NCT04187105|Fludarabine|fludarabine|mesh-list
102136875|NCT03703427|Antimetabolites|antimetabolites|mesh-ancestor
102137275|NCT03697889|Naproxen|naproxen|mesh-list
102137334|NCT03701321|Ichthammol|ichthammol|mesh-list
101846582|NCT00999869|Hormones|hormones|mesh-ancestor
102137734|NCT03682211|Anesthetics|anesthetics|mesh-ancestor
102137811|NCT03164018|4-Aminopyridine|4-aminopyridine|mesh-list
102137902|NCT03485625|Acetaminophen|acetaminophen|mesh-list
102138732|NCT03480321|Cilostazol|cilostazol|mesh-list
102138802|NCT03480165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102139250|NCT05084404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102139325|NCT02387918|Autonomic Agents|autonomic agents|mesh-ancestor
102139403|NCT02390882|Tamsulosin|tamsulosin|mesh-list
102139475|NCT05072782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101848596|NCT04844762|Menthol|menthol|mesh-list
102139703|NCT02911285|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102139704|NCT02911285|Antiviral Agents|antiviral agents|mesh-ancestor
102139705|NCT02911285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102139706|NCT02911285|Expectorants|expectorants|mesh-ancestor
102139707|NCT02911285|Respiratory System Agents|respiratory system agents|mesh-ancestor
102139708|NCT02911285|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102139709|NCT02911285|Antioxidants|antioxidants|mesh-ancestor
102139710|NCT02911285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139711|NCT02911285|Protective Agents|protective agents|mesh-ancestor
102139712|NCT02911285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139713|NCT02911285|Antidotes|antidotes|mesh-ancestor
102139779|NCT01064245|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102139868|NCT01624805|Antiemetics|antiemetics|mesh-ancestor
102140089|NCT05782127|Venetoclax|venetoclax|mesh-list
102140310|NCT05335252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102140311|NCT05325775|SR 142801|sr 142801|mesh-list
102140312|NCT05325775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102140313|NCT05325775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102140314|NCT05325775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102140315|NCT05325775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140316|NCT05325775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102140317|NCT05289908|Folic Acid|folic acid|mesh-list
102140318|NCT05289908|Vitamin B 12|vitamin b 12|mesh-list
102140319|NCT05289908|Dexamethasone|dexamethasone|mesh-list
102140320|NCT05289908|Pemetrexed|pemetrexed|mesh-list
102140383|NCT05209555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102140461|NCT04990388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102140462|NCT04990388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140463|NCT04990388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102140464|NCT04990388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102140467|NCT04990388|Histamine Agents|histamine agents|mesh-ancestor
102535900|NCT02664909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140691|NCT04199468|Analgesics|analgesics|mesh-ancestor
102535901|NCT02664909|Hemostatics|hemostatics|mesh-ancestor
102140768|NCT03927378|Ketamine|ketamine|mesh-list
102140769|NCT03927378|Esketamine|esketamine|mesh-list
102140770|NCT03927378|Analgesics|analgesics|mesh-ancestor
101849861|NCT03981627|Insulin Aspart|insulin aspart|mesh-list
102140915|NCT03290937|Immunoglobulin G|immunoglobulin g|mesh-list
102140916|NCT03290937|Immunologic Factors|immunologic factors|mesh-ancestor
102140917|NCT03290937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140918|NCT03290937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102140919|NCT03290937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102140920|NCT03290937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102140921|NCT03290937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102140922|NCT03290937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140923|NCT03290937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102140924|NCT03261102|Adalimumab|adalimumab|mesh-list
102140925|NCT03261102|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102140926|NCT03261102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102140927|NCT03261102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102140928|NCT03241732|Acetylcysteine|acetylcysteine|mesh-list
102140929|NCT03241732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102140930|NCT03241732|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102140931|NCT03241732|Antiviral Agents|antiviral agents|mesh-ancestor
102140932|NCT03241732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102140933|NCT03241732|Expectorants|expectorants|mesh-ancestor
102140934|NCT03241732|Respiratory System Agents|respiratory system agents|mesh-ancestor
102140935|NCT03241732|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102140936|NCT03241732|Antioxidants|antioxidants|mesh-ancestor
102140937|NCT03241732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140938|NCT03241732|Protective Agents|protective agents|mesh-ancestor
102140939|NCT03241732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140940|NCT03241732|Antidotes|antidotes|mesh-ancestor
102141003|NCT02968212|Clofazimine|clofazimine|mesh-list
102141004|NCT02968212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102141005|NCT02968212|Leprostatic Agents|leprostatic agents|mesh-ancestor
102141006|NCT02968212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102141007|NCT02968212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102141008|NCT02931253|Metformin|metformin|mesh-list
102141009|NCT02931253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102141010|NCT02931253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141011|NCT02848131|Dasatinib|dasatinib|mesh-list
102141012|NCT02848131|Quercetin|quercetin|mesh-list
102141013|NCT02848131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102141015|NCT02848131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102141306|NCT01256398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102141307|NCT01256398|Antimetabolites|antimetabolites|mesh-ancestor
102141308|NCT01256398|Dermatologic Agents|dermatologic agents|mesh-ancestor
102141309|NCT01256398|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102141310|NCT01256398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102141311|NCT01256398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102141312|NCT01256398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102141313|NCT01256398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102141314|NCT01256398|Antiviral Agents|antiviral agents|mesh-ancestor
102141315|NCT01256398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102141316|NCT01256398|Antidotes|antidotes|mesh-ancestor
102141317|NCT01256398|Protective Agents|protective agents|mesh-ancestor
102141318|NCT01256398|Vitamin B Complex|vitamin b complex|mesh-ancestor
102141319|NCT01256398|Vitamins|vitamins|mesh-ancestor
102141320|NCT01256398|Micronutrients|micronutrients|mesh-ancestor
102141321|NCT01256398|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102141322|NCT01256398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102141394|NCT01020383|Abciximab|abciximab|mesh-list
102141395|NCT01020383|Anticoagulants|anticoagulants|mesh-ancestor
102141396|NCT01020383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102141397|NCT00889876|Metformin|metformin|mesh-list
102141398|NCT00889876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102141399|NCT00889876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141400|NCT00673010|Iodine|iodine|mesh-list
102141401|NCT00673010|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102141402|NCT00673010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102141844|NCT02383238|Dapagliflozin|dapagliflozin|mesh-list
102142066|NCT02380898|Analgesics|analgesics|mesh-ancestor
102142219|NCT03661489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102142220|NCT03661489|Anesthetics, General|anesthetics, general|mesh-ancestor
102142221|NCT03661489|Anesthetics|anesthetics|mesh-ancestor
102142369|NCT02377778|Thiopental|thiopental|mesh-list
101851345|NCT00422084|Pyronaridine|pyronaridine|mesh-list
102142515|NCT04413799|Analgesics|analgesics|mesh-ancestor
102142885|NCT04057937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102142955|NCT04056845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102143029|NCT02519842|Hormones|hormones|mesh-ancestor
102143404|NCT04458285|Valsartan|valsartan|mesh-list
102143629|NCT03469167|CEGP-003|cegp-003|mesh-list
102143783|NCT03651661|Insulin|insulin|mesh-list
102143936|NCT03648697|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102144087|NCT02898259|Rituximab|rituximab|mesh-list
102144243|NCT03632187|Abatacept|abatacept|mesh-list
102144312|NCT03466749|Paclitaxel|paclitaxel|mesh-list
102144418|NCT01064791|Tacrolimus|tacrolimus|mesh-list
102144459|NCT03465345|Antioxidants|antioxidants|mesh-ancestor
102144696|NCT03654365|Caffeine|caffeine|mesh-list
102144836|NCT03460041|Tocolytic Agents|tocolytic agents|mesh-ancestor
102144910|NCT04368429|Vaccines|vaccines|mesh-list
102145058|NCT03719001|Mydriatics|mydriatics|mesh-ancestor
102145133|NCT02498236|Oxytocin|oxytocin|mesh-list
102145205|NCT02493946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145280|NCT03640273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145355|NCT02493868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102145650|NCT02481310|Prednisone|prednisone|mesh-list
102145728|NCT02480764|Valsartan|valsartan|mesh-list
102145801|NCT05665647|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102146026|NCT03564093|Sensory System Agents|sensory system agents|mesh-ancestor
102146103|NCT03422055|Anticoagulants|anticoagulants|mesh-ancestor
102146331|NCT03616561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146405|NCT03647579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102146635|NCT03424473|Tucatinib|tucatinib|mesh-list
102146711|NCT03112538|Insulin|insulin|mesh-list
102147104|NCT03410511|Nicotine|nicotine|mesh-list
102147172|NCT02359526|Hormones|hormones|mesh-ancestor
102147404|NCT03612817|Timolol|timolol|mesh-list
102147711|NCT02864407|Olodaterol|olodaterol|mesh-list
101856660|NCT00162981|Clobazam|clobazam|mesh-list
102147926|NCT03112382|Vitamin A|vitamin a|mesh-list
102148002|NCT03390465|Diuretics|diuretics|mesh-ancestor
102090881|NCT05955924|Niacin|niacin|mesh-list
102148449|NCT03612323|Piroxicam|piroxicam|mesh-list
101857428|NCT00504257|Docetaxel|docetaxel|mesh-list
102148902|NCT02817789|Analgesics|analgesics|mesh-ancestor
102148972|NCT03398811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102149058|NCT02327156|Analgesics|analgesics|mesh-ancestor
102149119|NCT00862251|Atorvastatin|atorvastatin|mesh-list
102150382|NCT05393414|Acetaminophen|acetaminophen|mesh-list
102150458|NCT02853331|Pembrolizumab|pembrolizumab|mesh-list
102150613|NCT03137498|Analgesics|analgesics|mesh-ancestor
102150680|NCT05851014|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102150681|NCT05851014|Hormone Antagonists|hormone antagonists|mesh-ancestor
102150682|NCT05851014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102150683|NCT05851014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150684|NCT05850936|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102150685|NCT05850936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102150686|NCT05850871|Aztreonam|aztreonam|mesh-list
102150687|NCT05850871|Avibactam|avibactam|mesh-list
102150688|NCT05850871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102150689|NCT05850871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102150690|NCT05850871|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102150691|NCT05850871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102150693|NCT05850832|Magnesium Sulfate|magnesium sulfate|mesh-list
102150839|NCT05849883|Omeprazole|omeprazole|mesh-list
102150994|NCT05816746|Decitabine|decitabine|mesh-list
102151053|NCT05948813|Osimertinib|osimertinib|mesh-list
102151205|NCT05947500|Avelumab|avelumab|mesh-list
102151279|NCT05937854|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102151280|NCT05937854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102151281|NCT05937854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151282|NCT05937854|Urological Agents|urological agents|mesh-ancestor
101860163|NCT03979586|Viscosupplements|viscosupplements|mesh-ancestor
102151284|NCT05933057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102151503|NCT05508009|Alkylating Agents|alkylating agents|mesh-ancestor
102151803|NCT04679948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102151953|NCT04446117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152053|NCT04114136|Nivolumab|nivolumab|mesh-list
102152439|NCT02748018|Insulin|insulin|mesh-list
102152803|NCT05487794|Testosterone|testosterone|mesh-list
102153488|NCT04231643|Dronabinol|dronabinol|mesh-list
102153779|NCT03822091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102153926|NCT02730546|Leucovorin|leucovorin|mesh-list
102154003|NCT02213575|Minocycline|minocycline|mesh-list
102536168|NCT02683707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102536467|NCT02213900|Haloperidol|haloperidol|mesh-list
102536683|NCT00552305|Lacosamide|lacosamide|mesh-list
102536933|NCT01502306|Nicotine|nicotine|mesh-list
101568266|NCT02850211|Ibuprofen|ibuprofen|mesh-list
102154134|NCT00515281|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102537276|NCT02770365|Estrogens|estrogens|mesh-ancestor
102537956|NCT02803749|Serotonin Agents|serotonin agents|mesh-ancestor
102538778|NCT02247362|Agglutinins|agglutinins|mesh-ancestor
102154142|NCT00436254|Sargramostim|sargramostim|mesh-list
102539605|NCT02227316|Acetaminophen|acetaminophen|mesh-list
102540070|NCT01696760|Aspirin|aspirin|mesh-list
102540592|NCT03140631|Protamines|protamines|mesh-list
102540962|NCT01646762|Paclitaxel|paclitaxel|mesh-list
102541337|NCT01667978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102541407|NCT01669538|Nootropic Agents|nootropic agents|mesh-ancestor
102541856|NCT01926041|Varenicline|varenicline|mesh-list
102542013|NCT02306759|Anesthetics|anesthetics|mesh-ancestor
102542537|NCT02061683|Bimatoprost|bimatoprost|mesh-list
102543739|NCT03064295|Adenosine|adenosine|mesh-list
102544486|NCT01831934|Vaccines|vaccines|mesh-list
102154145|NCT00436254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102544715|NCT00376701|Bevacizumab|bevacizumab|mesh-list
102545160|NCT04041453|Antimitotic Agents|antimitotic agents|mesh-ancestor
102545326|NCT00553202|Busulfan|busulfan|mesh-list
102545387|NCT00552110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102545469|NCT03026348|Vaccines|vaccines|mesh-list
102545538|NCT04004481|Analgesics|analgesics|mesh-ancestor
102545619|NCT00550550|Analgesics|analgesics|mesh-ancestor
102545766|NCT01880840|Azelastine|azelastine|mesh-list
102545839|NCT01379469|Carbamazepine|carbamazepine|mesh-list
102545987|NCT02299206|Zinc Oxide|zinc oxide|mesh-list
102546655|NCT00642603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102547253|NCT03866499|Gefitinib|gefitinib|mesh-list
102548321|NCT00001095|Lamivudine|lamivudine|mesh-list
102548399|NCT00002019|Amphotericin B|amphotericin b|mesh-list
102548614|NCT00002079|Zidovudine|zidovudine|mesh-list
102548691|NCT00001437|Pentoxifylline|pentoxifylline|mesh-list
102548993|NCT00002169|Nelfinavir|nelfinavir|mesh-list
102549064|NCT02278614|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102549219|NCT02977169|Cisplatin|cisplatin|mesh-list
102550361|NCT05751044|Antimetabolites|antimetabolites|mesh-ancestor
102550739|NCT04068753|Niraparib|niraparib|mesh-list
102551107|NCT01322139|Nabiximols|nabiximols|mesh-list
102551190|NCT00002643|Cobalt|cobalt|mesh-list
102551336|NCT00002691|Glucocorticoids|glucocorticoids|mesh-ancestor
102551490|NCT05751681|Hormones|hormones|mesh-ancestor
102551640|NCT02975453|Anticoagulants|anticoagulants|mesh-ancestor
102552240|NCT01658839|Travoprost|travoprost|mesh-list
102552315|NCT00000321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102552463|NCT00000333|Dopamine Agents|dopamine agents|mesh-ancestor
102552906|NCT02986880|Cholinergic Agents|cholinergic agents|mesh-ancestor
102553560|NCT03634917|Calcium|calcium|mesh-list
102553633|NCT03523221|Glucocorticoids|glucocorticoids|mesh-ancestor
102553707|NCT00421967|Adrenergic Agents|adrenergic agents|mesh-ancestor
102553782|NCT02259517|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102554012|NCT03135860|Vasodilator Agents|vasodilator agents|mesh-ancestor
102554381|NCT02922777|Tubulin Modulators|tubulin modulators|mesh-ancestor
102554681|NCT00003093|Etoposide|etoposide|mesh-list
102554851|NCT03439891|Nivolumab|nivolumab|mesh-list
102555067|NCT04005079|Ofloxacin|ofloxacin|mesh-list
102555132|NCT01767103|Chelating Agents|chelating agents|mesh-ancestor
102555289|NCT02452931|Leuprolide|leuprolide|mesh-list
102555438|NCT02694809|Bazedoxifene|bazedoxifene|mesh-list
102555523|NCT01800877|Dopamine|dopamine|mesh-list
102555960|NCT00363935|Adrenergic Agents|adrenergic agents|mesh-ancestor
102556034|NCT02489357|Pembrolizumab|pembrolizumab|mesh-list
102556411|NCT02562521|Autonomic Agents|autonomic agents|mesh-ancestor
102556787|NCT01839799|Paclitaxel|paclitaxel|mesh-list
102556858|NCT00553267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557231|NCT00550771|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102557384|NCT00557401|GABA Agonists|gaba agonists|mesh-ancestor
102557838|NCT02646449|Mirtazapine|mirtazapine|mesh-list
102558053|NCT04651595|Narcotics|narcotics|mesh-ancestor
102558579|NCT00369551|Paclitaxel|paclitaxel|mesh-list
102558951|NCT00371033|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102559279|NCT01911169|Vitamin D|vitamin d|mesh-list
102559400|NCT05725135|Propofol|propofol|mesh-list
102559473|NCT02833805|Antitubercular Agents|antitubercular agents|mesh-ancestor
102560160|NCT02788097|Hormones|hormones|mesh-ancestor
102560539|NCT02912195|Lidocaine|lidocaine|mesh-list
102560691|NCT02913521|Diclofenac|diclofenac|mesh-list
102560915|NCT02833415|Empagliflozin|empagliflozin|mesh-list
102561372|NCT01982240|Bisacodyl|bisacodyl|mesh-list
102561433|NCT03930745|TOL-463|tol-463|mesh-list
102561582|NCT02354534|Antiviral Agents|antiviral agents|mesh-ancestor
102561735|NCT02404610|Propofol|propofol|mesh-list
102562025|NCT02413034|Vancomycin|vancomycin|mesh-list
102562176|NCT03066947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102562261|NCT03068897|GABA Agents|gaba agents|mesh-ancestor
102562777|NCT03655613|Nivolumab|nivolumab|mesh-list
102562954|NCT04652414|Prednisone|prednisone|mesh-list
102562998|NCT02792465|Fulvestrant|fulvestrant|mesh-list
102563549|NCT05987657|Hormones|hormones|mesh-ancestor
102563612|NCT05986968|Antipyretics|antipyretics|mesh-ancestor
102563693|NCT05986344|Copper|copper|mesh-list
102563984|NCT05943535|Treprostinil|treprostinil|mesh-list
102564221|NCT05846451|Oxycodone|oxycodone|mesh-list
102564283|NCT05815186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102564455|NCT05761171|Antiemetics|antiemetics|mesh-ancestor
102564874|NCT05578872|Pembrolizumab|pembrolizumab|mesh-list
102564952|NCT05521048|Doxycycline|doxycycline|mesh-list
102565249|NCT05389423|Prednisone|prednisone|mesh-list
102565325|NCT05361395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102565854|NCT05129358|Furosemide|furosemide|mesh-list
102566223|NCT05000450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102566296|NCT04973930|Antidepressive Agents|antidepressive agents|mesh-ancestor
102614304|NCT00003143|Amifostine|amifostine|mesh-list
102614753|NCT00003209|Ifosfamide|ifosfamide|mesh-list
102615058|NCT00004097|Paclitaxel|paclitaxel|mesh-list
102615204|NCT00003281|Paclitaxel|paclitaxel|mesh-list
102615280|NCT00004205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615435|NCT00004253|Paclitaxel|paclitaxel|mesh-list
102616098|NCT00005615|Interferon-alpha|interferon-alpha|mesh-list
102616321|NCT05892913|Atropine|atropine|mesh-list
102616466|NCT05656352|Chrysarobin|chrysarobin|mesh-list
102274886|NCT01231841|Thymoglobulin|thymoglobulin|mesh-list
102617282|NCT03404193|Decitabine|decitabine|mesh-list
102617347|NCT02787369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617421|NCT01661881|Antimetabolites|antimetabolites|mesh-ancestor
102617644|NCT00003827|Cytarabine|cytarabine|mesh-list
102274898|NCT01231841|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102274901|NCT01133756|Lenvatinib|lenvatinib|mesh-list
102618158|NCT01887288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101907242|NCT03779672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102618968|NCT01818258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102619043|NCT04592016|Keratolytic Agents|keratolytic agents|mesh-ancestor
102274926|NCT01067287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102620527|NCT04410354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102620921|NCT01529346|Ibuprofen|ibuprofen|mesh-list
102621042|NCT01524198|Budesonide|budesonide|mesh-list
102621110|NCT01522950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102621257|NCT01518972|Prazosin|prazosin|mesh-list
102621634|NCT01499940|Vitamin D|vitamin d|mesh-list
102621771|NCT01473420|Epoetin Alfa|epoetin alfa|mesh-list
102274950|NCT00796263|Dolutegravir|dolutegravir|mesh-list
102622296|NCT01405950|Anticonvulsants|anticonvulsants|mesh-ancestor
102622441|NCT01400412|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102622669|NCT01382940|Analgesics|analgesics|mesh-ancestor
102274958|NCT00796263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102623768|NCT05586204|Vaccines|vaccines|mesh-list
102623842|NCT03021330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101912271|NCT05415826|Hormones|hormones|mesh-ancestor
102623988|NCT03346668|Gabapentin|gabapentin|mesh-list
102624504|NCT04747080|Hormones|hormones|mesh-ancestor
102624652|NCT03748134|Paclitaxel|paclitaxel|mesh-list
102624730|NCT02082678|Ondansetron|ondansetron|mesh-list
102624891|NCT03825198|Ketorolac|ketorolac|mesh-list
102624954|NCT03817320|Hormones|hormones|mesh-ancestor
102625247|NCT03770286|Fluorides|fluorides|mesh-list
102625918|NCT05338086|Vitamin D|vitamin d|mesh-list
102625986|NCT04785924|Imipenem|imipenem|mesh-list
102626205|NCT01076868|Primaquine|primaquine|mesh-list
102275031|NCT00014508|Cyclosporine|cyclosporine|mesh-list
102627157|NCT04559646|Coagulants|coagulants|mesh-ancestor
102275048|NCT00014508|Antimetabolites|antimetabolites|mesh-ancestor
102628045|NCT04272372|Ketoprofen|ketoprofen|mesh-list
102275070|NCT00005962|Gemtuzumab|gemtuzumab|mesh-list
102628548|NCT02983422|Aminophylline|aminophylline|mesh-list
102628637|NCT02549898|Cilostazol|cilostazol|mesh-list
102628912|NCT02063022|Etoposide|etoposide|mesh-list
102629147|NCT01212822|Vitamins|vitamins|mesh-ancestor
102629523|NCT04753008|Dopamine|dopamine|mesh-list
102629733|NCT00038610|Antimetabolites|antimetabolites|mesh-ancestor
102630112|NCT00093756|Paclitaxel|paclitaxel|mesh-list
102275115|NCT00005847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102631228|NCT00352794|Prednisone|prednisone|mesh-list
102275125|NCT00005644|Antimitotic Agents|antimitotic agents|mesh-ancestor
102631657|NCT02405676|Glucocorticoids|glucocorticoids|mesh-ancestor
102632092|NCT00385788|Melphalan|melphalan|mesh-list
102632167|NCT00413166|Keratolytic Agents|keratolytic agents|mesh-ancestor
102632319|NCT00478218|Antiemetics|antiemetics|mesh-ancestor
102632400|NCT00531882|Antimetabolites|antimetabolites|mesh-ancestor
102632629|NCT00539526|Travoprost|travoprost|mesh-list
102633136|NCT00527592|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102633514|NCT03856632|Liraglutide|liraglutide|mesh-list
102633586|NCT03548454|Desipramine|desipramine|mesh-list
102275161|NCT00003592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102634029|NCT05766605|Leucovorin|leucovorin|mesh-list
102634108|NCT05766176|Antibodies|antibodies|mesh-list
102275169|NCT00003592|Immunologic Factors|immunologic factors|mesh-ancestor
102634831|NCT04068610|Leucovorin|leucovorin|mesh-list
102635205|NCT01285817|Celecoxib|celecoxib|mesh-list
102635646|NCT04361370|Olaparib|olaparib|mesh-list
102635873|NCT04352400|Anticoagulants|anticoagulants|mesh-ancestor
102636102|NCT04340388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102636276|NCT04330872|Aspirin|aspirin|mesh-list
102636577|NCT03016806|Mesna|mesna|mesh-list
102637288|NCT04662684|Anticoagulants|anticoagulants|mesh-ancestor
102637730|NCT00647400|Adalimumab|adalimumab|mesh-list
102638550|NCT00762450|Triclosan|triclosan|mesh-list
102638625|NCT00770874|Cisplatin|cisplatin|mesh-list
102638766|NCT00793572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102369561|NCT04450446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369562|NCT03274752|Paroxetine|paroxetine|mesh-list
102369563|NCT03274752|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102369564|NCT03274752|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102369565|NCT03274752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102369566|NCT03274752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369567|NCT03274752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102369568|NCT03274752|Serotonin Agents|serotonin agents|mesh-ancestor
102369569|NCT03274752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369570|NCT03274752|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102369571|NCT03274752|Antidepressive Agents|antidepressive agents|mesh-ancestor
102369572|NCT03274752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102369573|NCT03274752|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102369574|NCT03274752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102369575|NCT03274752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102369576|NCT03242382|Palbociclib|palbociclib|mesh-list
102369577|NCT03242382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102369578|NCT03242382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102369579|NCT03242382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102369580|NCT03242382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369581|NCT03902418|Tenofovir|tenofovir|mesh-list
102369582|NCT03902418|Emtricitabine|emtricitabine|mesh-list
102369583|NCT03902418|Antiviral Agents|antiviral agents|mesh-ancestor
102369584|NCT03902418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102369585|NCT03902418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102369586|NCT03902418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102369587|NCT03902418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102369588|NCT03902418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369589|NCT03902418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102369590|NCT03902418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102369591|NCT03428568|Clarithromycin|clarithromycin|mesh-list
102369592|NCT03428568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102369593|NCT03428568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102369594|NCT03428568|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102369595|NCT03428568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102369596|NCT03428568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369597|NCT03428568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102369598|NCT03428568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102369599|NCT00630825|Dulaglutide|dulaglutide|mesh-list
102369600|NCT00630825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102369601|NCT00630825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369602|NCT03434340|Dexamethasone|dexamethasone|mesh-list
102369603|NCT03434340|Granisetron|granisetron|mesh-list
102369604|NCT03434340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102369605|NCT03434340|Antiemetics|antiemetics|mesh-ancestor
102369606|NCT03434340|Autonomic Agents|autonomic agents|mesh-ancestor
102369607|NCT03434340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102369608|NCT03434340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369609|NCT03434340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102369610|NCT03434340|Glucocorticoids|glucocorticoids|mesh-ancestor
102369611|NCT03434340|Hormones|hormones|mesh-ancestor
102369612|NCT03434340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102369613|NCT03434340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102369614|NCT03434340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102369615|NCT03434340|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102369616|NCT03434340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102369617|NCT03434340|Serotonin Agents|serotonin agents|mesh-ancestor
102369618|NCT03434340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102369619|NCT03434340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369620|NCT03088605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102369621|NCT03088605|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102369622|NCT01923987|Cetuximab|cetuximab|mesh-list
102369623|NCT01923987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102639055|NCT05206812|Durvalumab|durvalumab|mesh-list
102639163|NCT00824460|Iron|iron|mesh-list
102275284|NCT00003237|Paclitaxel|paclitaxel|mesh-list
102639537|NCT00887562|Idebenone|idebenone|mesh-list
102275325|NCT00002872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102640129|NCT00976404|Antiviral Agents|antiviral agents|mesh-ancestor
102369624|NCT01923987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640437|NCT01017042|Colchicine|colchicine|mesh-list
102369625|NCT03101163|Hyaluronic Acid|hyaluronic acid|mesh-list
102640675|NCT01043640|Busulfan|busulfan|mesh-list
102640791|NCT05822323|Cholinergic Agents|cholinergic agents|mesh-ancestor
102275344|NCT00002868|Antiviral Agents|antiviral agents|mesh-ancestor
102640936|NCT05802238|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102641085|NCT05327296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102641598|NCT03912233|Ivacaftor|ivacaftor|mesh-list
102642032|NCT01102218|Pentoxifylline|pentoxifylline|mesh-list
102642332|NCT01129440|Protective Agents|protective agents|mesh-ancestor
102642410|NCT01144338|Exenatide|exenatide|mesh-list
102642473|NCT01151046|Exemestane|exemestane|mesh-list
102642769|NCT01216410|Phenylephrine|phenylephrine|mesh-list
102643062|NCT01270542|Bevacizumab|bevacizumab|mesh-list
102643293|NCT01308294|Vaccines|vaccines|mesh-list
102275399|NCT05014685|Expectorants|expectorants|mesh-ancestor
102643625|NCT01347060|Xhance|xhance|mesh-list
102275408|NCT03111901|Analgesics|analgesics|mesh-ancestor
102643711|NCT01363128|Antiemetics|antiemetics|mesh-ancestor
102644009|NCT01434186|Metformin|metformin|mesh-list
102369626|NCT03101163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102644374|NCT01529502|Nitric Oxide|nitric oxide|mesh-list
102369627|NCT03101163|Immunologic Factors|immunologic factors|mesh-ancestor
102369628|NCT03101163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645327|NCT01682538|Nitisinone|nitisinone|mesh-list
102645479|NCT05463354|Vaccines|vaccines|mesh-list
102369629|NCT03101163|Viscosupplements|viscosupplements|mesh-ancestor
102369630|NCT03101163|Protective Agents|protective agents|mesh-ancestor
102646009|NCT01783470|Mirabegron|mirabegron|mesh-list
102369631|NCT01924065|Anticoagulants|anticoagulants|mesh-list
102646517|NCT05996523|Pembrolizumab|pembrolizumab|mesh-list
102646741|NCT05907759|Daratumumab|daratumumab|mesh-list
102647592|NCT05355701|Cetuximab|cetuximab|mesh-list
102647780|NCT05185999|Icodextrin|icodextrin|mesh-list
102648189|NCT04803201|Prednisone|prednisone|mesh-list
102369632|NCT03434106|Dextrans|dextrans|mesh-list
102648341|NCT04667234|Sotorasib|sotorasib|mesh-list
102648411|NCT04599478|Naltrexone|naltrexone|mesh-list
102648783|NCT04206319|Listerine|listerine|mesh-list
102648847|NCT04131504|Adalimumab|adalimumab|mesh-list
102369633|NCT03434106|Anticoagulants|anticoagulants|mesh-ancestor
102649262|NCT03477500|Ocrelizumab|ocrelizumab|mesh-list
102649548|NCT02960022|Prednisone|prednisone|mesh-list
102649615|NCT02784210|Glucocorticoids|glucocorticoids|mesh-ancestor
102369634|NCT03434106|Plasma Substitutes|plasma substitutes|mesh-ancestor
102369635|NCT03434106|Blood Substitutes|blood substitutes|mesh-ancestor
102650064|NCT01236560|Bevacizumab|bevacizumab|mesh-list
102369636|NCT01241344|Brincidofovir|brincidofovir|mesh-list
102369637|NCT01241344|Antiviral Agents|antiviral agents|mesh-ancestor
102369638|NCT01241344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102369639|NCT01925001|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102369640|NCT03009682|Olaparib|olaparib|mesh-list
102369641|NCT03009682|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102369642|NCT03009682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102369643|NCT03009682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369644|NCT03009682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102369645|NCT03431142|Aspirin|aspirin|mesh-list
102369646|NCT03431142|Clopidogrel|clopidogrel|mesh-list
102369647|NCT03431142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102369648|NCT03431142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102369649|NCT03431142|Analgesics|analgesics|mesh-ancestor
102369650|NCT03431142|Sensory System Agents|sensory system agents|mesh-ancestor
102369651|NCT03431142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102566600|NCT04871529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102566601|NCT04865887|Pembrolizumab|pembrolizumab|mesh-list
102566602|NCT04865887|Lenvatinib|lenvatinib|mesh-list
102566603|NCT04865887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102566604|NCT04865887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566605|NCT04865887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102566606|NCT04865887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566607|NCT04865887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102566608|NCT04865887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102566609|NCT04864444|Piperaquine|piperaquine|mesh-list
102566610|NCT04864444|Primaquine|primaquine|mesh-list
102566611|NCT04864444|Artenimol|artenimol|mesh-list
102566612|NCT04864444|Antimalarials|antimalarials|mesh-ancestor
102566613|NCT04864444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102566614|NCT04864444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102566615|NCT04864444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102566616|NCT04861987|Capecitabine|capecitabine|mesh-list
102566617|NCT04861987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102566618|NCT04861987|Antimetabolites|antimetabolites|mesh-ancestor
102566619|NCT04861987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566620|NCT04861987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566621|NCT04857138|Atezolizumab|atezolizumab|mesh-list
102566622|NCT04857138|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102566623|NCT04857138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566624|NCT04857138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102566625|NCT04857138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566626|NCT04855136|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
102566627|NCT04855136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102566628|NCT04855136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566629|NCT04853043|Cetuximab|cetuximab|mesh-list
102566630|NCT04853043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102566631|NCT04853043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566632|NCT04847063|Sodium thiosulfate|sodium thiosulfate|mesh-list
102566633|NCT04847063|Doxorubicin|doxorubicin|mesh-list
102566634|NCT04847063|Fluorouracil|fluorouracil|mesh-list
102566635|NCT04847063|Oxaliplatin|oxaliplatin|mesh-list
102566636|NCT04847063|Mitomycins|mitomycins|mesh-list
102566637|NCT04847063|Mitomycin|mitomycin|mesh-list
102566638|NCT04847063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566639|NCT04847063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102566640|NCT04847063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102566641|NCT04847063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102566642|NCT04847063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102566643|NCT04847063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566644|NCT04847063|Antimetabolites|antimetabolites|mesh-ancestor
102566645|NCT04847063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102566646|NCT04847063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102566647|NCT04847063|Immunologic Factors|immunologic factors|mesh-ancestor
102566648|NCT04847063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566649|NCT04847063|Alkylating Agents|alkylating agents|mesh-ancestor
102566650|NCT04847063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102566651|NCT04847063|Antidotes|antidotes|mesh-ancestor
102566652|NCT04847063|Protective Agents|protective agents|mesh-ancestor
102566653|NCT04847063|Antioxidants|antioxidants|mesh-ancestor
102566654|NCT04847063|Antitubercular Agents|antitubercular agents|mesh-ancestor
102566655|NCT04847063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102566656|NCT04847063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102566657|NCT04847063|Chelating Agents|chelating agents|mesh-ancestor
102566658|NCT04847063|Sequestering Agents|sequestering agents|mesh-ancestor
102566659|NCT04838613|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102566660|NCT04838613|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102566661|NCT04838613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566662|NCT04834024|Antibodies|antibodies|mesh-list
102566663|NCT04834024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102566664|NCT04834024|Immunologic Factors|immunologic factors|mesh-ancestor
102566665|NCT04834024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566666|NCT04826133|Calcitriol|calcitriol|mesh-list
102566667|NCT04826133|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
102566668|NCT04826133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102566669|NCT04826133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566670|NCT04826133|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102566671|NCT04826133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102566672|NCT04826133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566673|NCT04826133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102566674|NCT04826133|Vitamins|vitamins|mesh-ancestor
102566675|NCT04826133|Micronutrients|micronutrients|mesh-ancestor
102566676|NCT04826133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102566677|NCT04821817|Rocuronium|rocuronium|mesh-list
102566678|NCT04821817|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102566679|NCT04821817|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102566680|NCT04821817|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102566681|NCT04821817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102566682|NCT04821817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566683|NCT04817241|Cytarabine|cytarabine|mesh-list
102566684|NCT04817241|Decitabine|decitabine|mesh-list
102566685|NCT04817241|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
102566686|NCT04817241|Daunorubicin|daunorubicin|mesh-list
102566687|NCT04817241|Venetoclax|venetoclax|mesh-list
102566688|NCT04817241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102566689|NCT04817241|Antimetabolites|antimetabolites|mesh-ancestor
102566690|NCT04817241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566691|NCT04817241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566692|NCT04817241|Antiviral Agents|antiviral agents|mesh-ancestor
102566693|NCT04817241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102566694|NCT04817241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102566695|NCT04817241|Immunologic Factors|immunologic factors|mesh-ancestor
102566696|NCT04817241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566697|NCT04817241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102566698|NCT04817241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102566699|NCT04817241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102566700|NCT04817241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102566701|NCT04792645|Memantine|memantine|mesh-list
102566702|NCT04792645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102566703|NCT04792645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102566704|NCT04792645|Dopamine Agents|dopamine agents|mesh-ancestor
102566705|NCT04792645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102566706|NCT04792645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566707|NCT04792645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566708|NCT04792645|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102566709|NCT04792645|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102566710|NCT04791228|Doxorubicin|doxorubicin|mesh-list
102566711|NCT04791228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102566712|NCT04791228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102566713|NCT04791228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566714|NCT04791228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102566715|NCT04791228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102566716|NCT04791228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102566717|NCT04791228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566718|NCT04770896|Sorafenib|sorafenib|mesh-list
102566719|NCT04770896|Atezolizumab|atezolizumab|mesh-list
102566720|NCT04770896|Lenvatinib|lenvatinib|mesh-list
102566721|NCT04770896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566722|NCT04770896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102566723|NCT04770896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102566724|NCT04770896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566725|NCT04770896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102566726|NCT04770896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102566727|NCT04768296|Topotecan|topotecan|mesh-list
102566728|NCT04768296|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102566729|NCT04768296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102566730|NCT04768296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102566731|NCT04768296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566732|NCT04768296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566733|NCT04760626|Insulin|insulin|mesh-list
102566734|NCT04760626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102566735|NCT04760626|Insulin Glargine|insulin glargine|mesh-list
102566736|NCT04760626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102566737|NCT04760626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566738|NCT04757376|Denosumab|denosumab|mesh-list
102566739|NCT04757376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102566740|NCT04757376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566741|NCT04756037|Relugolix|relugolix|mesh-list
102566742|NCT04756037|Androgen Antagonists|androgen antagonists|mesh-ancestor
102566743|NCT04756037|Hormone Antagonists|hormone antagonists|mesh-ancestor
102566744|NCT04756037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102566745|NCT04756037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566746|NCT04751500|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102566747|NCT04751500|Metronidazole|metronidazole|mesh-list
102566748|NCT04751500|Clindamycin|clindamycin|mesh-list
102566749|NCT04751500|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102566750|NCT04751500|Misoprostol|misoprostol|mesh-list
102566751|NCT04751500|Mifepristone|mifepristone|mesh-list
102566752|NCT04751500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102566753|NCT04751500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102566754|NCT04751500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102566755|NCT04751500|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102566756|NCT04751500|Abortifacient Agents|abortifacient agents|mesh-ancestor
102566757|NCT04751500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102566758|NCT04751500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566759|NCT04751500|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102566760|NCT04751500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102566761|NCT04751500|Oxytocics|oxytocics|mesh-ancestor
102566762|NCT04751500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102566763|NCT04751500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102566764|NCT04751500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566765|NCT04751500|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102566766|NCT04751500|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102566767|NCT04751500|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102566768|NCT04751500|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102566769|NCT04751500|Contraceptive Agents|contraceptive agents|mesh-ancestor
102566770|NCT04751500|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102566771|NCT04751500|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102566772|NCT04751500|Hormone Antagonists|hormone antagonists|mesh-ancestor
102566773|NCT04751500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102566774|NCT04751500|Luteolytic Agents|luteolytic agents|mesh-ancestor
102566775|NCT04751500|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102566776|NCT04751500|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102566777|NCT04751500|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102566778|NCT04740931|Aflibercept|aflibercept|mesh-list
102566779|NCT04740931|Faricimab|faricimab|mesh-list
102566780|NCT04740931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102566781|NCT04740931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102566782|NCT04740931|Growth Substances|growth substances|mesh-ancestor
102566783|NCT04740931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566784|NCT04740931|Growth Inhibitors|growth inhibitors|mesh-ancestor
102566785|NCT04740931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566786|NCT04736173|Paclitaxel|paclitaxel|mesh-list
102566787|NCT04736173|Carboplatin|carboplatin|mesh-list
102566788|NCT04736173|Pembrolizumab|pembrolizumab|mesh-list
102566789|NCT04736173|Pemetrexed|pemetrexed|mesh-list
102566790|NCT04736173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102566791|NCT04736173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566792|NCT04736173|Tubulin Modulators|tubulin modulators|mesh-ancestor
102566793|NCT04736173|Antimitotic Agents|antimitotic agents|mesh-ancestor
102566794|NCT04736173|Mitosis Modulators|mitosis modulators|mesh-ancestor
102566795|NCT04736173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566796|NCT04736173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102566797|NCT04736173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102566798|NCT04736173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102566799|NCT04736173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102566800|NCT04736173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102566801|NCT04730037|Warfarin|warfarin|mesh-list
102566802|NCT04730037|Edoxaban|edoxaban|mesh-list
102566803|NCT04730037|Anticoagulants|anticoagulants|mesh-ancestor
102566804|NCT04730037|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102566805|NCT04730037|Antithrombins|antithrombins|mesh-ancestor
102566806|NCT04730037|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102566807|NCT04730037|Protease Inhibitors|protease inhibitors|mesh-ancestor
102566808|NCT04730037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102566809|NCT04730037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566810|NCT04729959|Atezolizumab|atezolizumab|mesh-list
102566811|NCT04729959|Immunoglobulins|immunoglobulins|mesh-list
102566812|NCT04729959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102566813|NCT04729959|Immunoglobulin G|immunoglobulin g|mesh-list
102566814|NCT04729959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102566815|NCT04729959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566816|NCT04729959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102566817|NCT04729959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566818|NCT04729959|Immunologic Factors|immunologic factors|mesh-ancestor
102566819|NCT04729959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566820|NCT04729725|Cemiplimab|cemiplimab|mesh-list
102566821|NCT04729725|Antibodies|antibodies|mesh-list
102566822|NCT04729725|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102566823|NCT04729725|Immunologic Factors|immunologic factors|mesh-ancestor
102566824|NCT04729725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566825|NCT04729725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102566826|NCT04729725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566828|NCT04727242|Dacarbazine|dacarbazine|mesh-list
102566829|NCT04727242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102566830|NCT04727242|Antimetabolites|antimetabolites|mesh-ancestor
102566831|NCT04727242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566832|NCT04727242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566833|NCT04727242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102566834|NCT04727242|Alkylating Agents|alkylating agents|mesh-ancestor
102566835|NCT04723004|Bevacizumab|bevacizumab|mesh-list
102566836|NCT04723004|Sorafenib|sorafenib|mesh-list
102566837|NCT04723004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102566838|NCT04723004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566839|NCT04723004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102566840|NCT04723004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102566841|NCT04723004|Growth Substances|growth substances|mesh-ancestor
102566842|NCT04723004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566843|NCT04723004|Growth Inhibitors|growth inhibitors|mesh-ancestor
102566844|NCT04723004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102566845|NCT04723004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102566846|NCT04723004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566847|NCT04717414|Luspatercept|luspatercept|mesh-list
102566848|NCT04717414|Hematinics|hematinics|mesh-ancestor
102566849|NCT04717375|Pembrolizumab|pembrolizumab|mesh-list
102566850|NCT04717375|Cetuximab|cetuximab|mesh-list
102566851|NCT04717375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102566852|NCT04717375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566853|NCT04717375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102566854|NCT04717375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566855|NCT04712643|Atezolizumab|atezolizumab|mesh-list
102566856|NCT04712643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102566857|NCT04712643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566858|NCT04712643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102566859|NCT04712643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566860|NCT04712097|Rituximab|rituximab|mesh-list
102566861|NCT04712097|Lenalidomide|lenalidomide|mesh-list
102566862|NCT04712097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102566863|NCT04712097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566864|NCT04712097|Immunologic Factors|immunologic factors|mesh-ancestor
102566865|NCT04712097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566866|NCT04712097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102566867|NCT04712097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102566868|NCT04712097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102566869|NCT04712097|Growth Substances|growth substances|mesh-ancestor
102566870|NCT04712097|Growth Inhibitors|growth inhibitors|mesh-ancestor
102566871|NCT04706741|Prednisone|prednisone|mesh-list
102566872|NCT04706741|Prednisolone|prednisolone|mesh-list
102566873|NCT04706741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102566874|NCT04706741|Glucocorticoids|glucocorticoids|mesh-ancestor
102566875|NCT04706741|Hormones|hormones|mesh-ancestor
102566876|NCT04706741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102566877|NCT04706741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566878|NCT04706741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102566879|NCT04706741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566880|NCT04704934|Paclitaxel|paclitaxel|mesh-list
102566881|NCT04704934|Trastuzumab|trastuzumab|mesh-list
102566882|NCT04704934|Ramucirumab|ramucirumab|mesh-list
102566883|NCT04704934|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
102566884|NCT04704934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102566885|NCT04704934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566886|NCT04704934|Tubulin Modulators|tubulin modulators|mesh-ancestor
102566887|NCT04704934|Antimitotic Agents|antimitotic agents|mesh-ancestor
102566888|NCT04704934|Mitosis Modulators|mitosis modulators|mesh-ancestor
102566889|NCT04704934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566890|NCT04704934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102566891|NCT04704934|Immunoconjugates|immunoconjugates|mesh-ancestor
102566892|NCT04704934|Immunologic Factors|immunologic factors|mesh-ancestor
102566893|NCT04704934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566894|NCT04698603|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
102566895|NCT04698603|Hallucinogens|hallucinogens|mesh-ancestor
102566896|NCT04698603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566897|NCT04698603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102566898|NCT04698603|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102566899|NCT04698603|Serotonin Agents|serotonin agents|mesh-ancestor
102566900|NCT04698603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102566901|NCT04698603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566902|NCT04698603|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102566903|NCT04696146|Complement C1s|complement c1s|mesh-list
102566904|NCT04696146|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
102566905|NCT04696146|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
102566906|NCT04696146|Immunologic Factors|immunologic factors|mesh-ancestor
102566907|NCT04696146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566908|NCT04696146|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102566909|NCT04696146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102566910|NCT04676334|Rucaparib|rucaparib|mesh-list
102566911|NCT04676334|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102566912|NCT04676334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102566913|NCT04676334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566914|NCT04676334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566915|NCT04669197|Hydroxychloroquine|hydroxychloroquine|mesh-list
102566916|NCT04669197|Paclitaxel|paclitaxel|mesh-list
102566917|NCT04669197|Gemcitabine|gemcitabine|mesh-list
102566918|NCT04669197|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102566919|NCT04669197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102566920|NCT04669197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566921|NCT04669197|Tubulin Modulators|tubulin modulators|mesh-ancestor
102566922|NCT04669197|Antimitotic Agents|antimitotic agents|mesh-ancestor
102566923|NCT04669197|Mitosis Modulators|mitosis modulators|mesh-ancestor
102566924|NCT04669197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566925|NCT04669197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102566926|NCT04669197|Antimetabolites|antimetabolites|mesh-ancestor
102566927|NCT04669197|Antimalarials|antimalarials|mesh-ancestor
102566928|NCT04669197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102566929|NCT04669197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102566930|NCT04669197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102566931|NCT04669197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102566932|NCT04669197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102566933|NCT04660812|Bevacizumab|bevacizumab|mesh-list
102566934|NCT04660812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102566935|NCT04660812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566936|NCT04660812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102566937|NCT04660812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102566938|NCT04660812|Growth Substances|growth substances|mesh-ancestor
102566939|NCT04660812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566940|NCT04660812|Growth Inhibitors|growth inhibitors|mesh-ancestor
102566941|NCT04656652|Docetaxel|docetaxel|mesh-list
102566942|NCT04656652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566943|NCT04656652|Tubulin Modulators|tubulin modulators|mesh-ancestor
102566944|NCT04656652|Antimitotic Agents|antimitotic agents|mesh-ancestor
102566945|NCT04656652|Mitosis Modulators|mitosis modulators|mesh-ancestor
102566946|NCT04656652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566947|NCT04651348|Antibodies|antibodies|mesh-list
102566948|NCT04651348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102566949|NCT04651348|Immunologic Factors|immunologic factors|mesh-ancestor
102566950|NCT04651348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566951|NCT04650581|Fulvestrant|fulvestrant|mesh-list
102566952|NCT04650581|Ipatasertib|ipatasertib|mesh-list
102566953|NCT04650581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102566954|NCT04650581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566955|NCT04650581|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102566956|NCT04650581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102566957|NCT04650581|Hormone Antagonists|hormone antagonists|mesh-ancestor
102566958|NCT04650581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102566959|NCT04650581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566960|NCT04650581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102566961|NCT04650581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102566962|NCT04650581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566963|NCT04640831|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
102566964|NCT04640831|Hallucinogens|hallucinogens|mesh-ancestor
102566965|NCT04640831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566966|NCT04640831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102566967|NCT04640831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102566968|NCT04640831|Serotonin Agents|serotonin agents|mesh-ancestor
102566969|NCT04640831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102566970|NCT04640831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566971|NCT04640831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102566972|NCT04628338|Interferons|interferons|mesh-list
102566973|NCT04628338|Interferon-gamma|interferon-gamma|mesh-list
102113891|NCT02304198|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102566974|NCT04628338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566976|NCT04628338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102566977|NCT04620603|Immunomodulating Agents|immunomodulating agents|mesh-list
102566978|NCT04620603|Immunologic Factors|immunologic factors|mesh-ancestor
102566979|NCT04620603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566980|NCT04620213|Phentolamine|phentolamine|mesh-list
102566981|NCT04620213|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102566982|NCT04620213|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102566983|NCT04620213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102566984|NCT04620213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102566985|NCT04620213|Adrenergic Agents|adrenergic agents|mesh-ancestor
102566986|NCT04620213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102566987|NCT04620213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566988|NCT04620213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566989|NCT04620213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102566990|NCT04619680|Nintedanib|nintedanib|mesh-list
102566991|NCT04619680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566992|NCT04619680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102566993|NCT04619680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102566994|NCT04619680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566995|NCT04610398|Dexamethasone|dexamethasone|mesh-list
102566996|NCT04610398|Dexamethasone acetate|dexamethasone acetate|mesh-list
102566997|NCT04610398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102566998|NCT04610398|Antiemetics|antiemetics|mesh-ancestor
102566999|NCT04610398|Autonomic Agents|autonomic agents|mesh-ancestor
102567000|NCT04610398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102567001|NCT04610398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567002|NCT04610398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102567003|NCT04610398|Glucocorticoids|glucocorticoids|mesh-ancestor
102567004|NCT04610398|Hormones|hormones|mesh-ancestor
102567005|NCT04610398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102567006|NCT04610398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102567007|NCT04610398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567008|NCT04607460|Coal Tar|coal tar|mesh-list
102567009|NCT04607460|Keratolytic Agents|keratolytic agents|mesh-ancestor
102567010|NCT04607460|Dermatologic Agents|dermatologic agents|mesh-ancestor
102567011|NCT04606069|Regadenoson|regadenoson|mesh-list
102567012|NCT04606069|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
102567013|NCT04606069|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102567014|NCT04606069|Purinergic Agonists|purinergic agonists|mesh-ancestor
102567015|NCT04606069|Purinergic Agents|purinergic agents|mesh-ancestor
102567016|NCT04606069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102567017|NCT04606069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567018|NCT04606069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567019|NCT04597411|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102567020|NCT04597411|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102567021|NCT04597411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567022|NCT04595981|Cisplatin|cisplatin|mesh-list
102567023|NCT04595981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567024|NCT04590404|Nicotine|nicotine|mesh-list
102567025|NCT04590404|Varenicline|varenicline|mesh-list
102567026|NCT04590404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102567027|NCT04590404|Autonomic Agents|autonomic agents|mesh-ancestor
102567028|NCT04590404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102567029|NCT04590404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567030|NCT04590404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102567031|NCT04590404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102567032|NCT04590404|Cholinergic Agents|cholinergic agents|mesh-ancestor
102567033|NCT04590404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102567034|NCT04590404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567035|NCT04576104|Metformin|metformin|mesh-list
102567036|NCT04576104|Megestrol|megestrol|mesh-list
102567037|NCT04576104|Megestrol Acetate|megestrol acetate|mesh-list
102567038|NCT04576104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102567039|NCT04576104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567040|NCT04576104|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102567041|NCT04576104|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102567042|NCT04576104|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102567043|NCT04576104|Contraceptive Agents|contraceptive agents|mesh-ancestor
102567044|NCT04576104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102567045|NCT04576104|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102567046|NCT04576104|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102567047|NCT04576104|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102113973|NCT02312544|Timolol|timolol|mesh-list
102567048|NCT04576104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567049|NCT04576104|Appetite Stimulants|appetite stimulants|mesh-ancestor
102567050|NCT04576104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102567052|NCT04575311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102567053|NCT04575311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567054|NCT04575311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102567055|NCT04575311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567056|NCT04567615|Nivolumab|nivolumab|mesh-list
102567057|NCT04567615|Relatlimab|relatlimab|mesh-list
102567058|NCT04567615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102567059|NCT04567615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567060|NCT04567615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102567061|NCT04567615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567062|NCT04565730|Anesthetics|anesthetics|mesh-list
102567063|NCT04565730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102567064|NCT04565730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567065|NCT04557956|Trametinib|trametinib|mesh-list
102567066|NCT04557956|Dabrafenib|dabrafenib|mesh-list
102567067|NCT04557956|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
102567068|NCT04557956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567069|NCT04557956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102567070|NCT04557956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102567071|NCT04557956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567072|NCT04557956|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102567073|NCT04557956|Protective Agents|protective agents|mesh-ancestor
102567074|NCT04557956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567075|NCT04557956|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102567076|NCT04557956|Antioxidants|antioxidants|mesh-ancestor
102567077|NCT04550494|Talazoparib|talazoparib|mesh-list
102567078|NCT04550494|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102567079|NCT04550494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102567080|NCT04550494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567081|NCT04550494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567082|NCT04549116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102567083|NCT04549116|Progesterone|progesterone|mesh-list
102567084|NCT04549116|Progestins|progestins|mesh-ancestor
102567085|NCT04549116|Hormones|hormones|mesh-ancestor
102567086|NCT04549116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102567087|NCT04549116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567088|NCT04544280|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102567089|NCT04544280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102567090|NCT04544280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102567091|NCT04544280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567092|NCT04544280|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102567093|NCT04544280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102567094|NCT04544280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567095|NCT04544280|Cholinergic Agents|cholinergic agents|mesh-ancestor
102567096|NCT04544280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102567097|NCT04541017|Mogamulizumab|mogamulizumab|mesh-list
102567098|NCT04541017|Magrolimab|magrolimab|mesh-list
102567099|NCT04541017|Immunoglobulins|immunoglobulins|mesh-list
102567100|NCT04541017|Immunoglobulin G|immunoglobulin g|mesh-list
102567101|NCT04541017|Immunologic Factors|immunologic factors|mesh-ancestor
102567102|NCT04541017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567103|NCT04541017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567104|NCT04541017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102567105|NCT04529772|Prednisone|prednisone|mesh-list
102567106|NCT04529772|Cyclophosphamide|cyclophosphamide|mesh-list
102567107|NCT04529772|Rituximab|rituximab|mesh-list
102567108|NCT04529772|Doxorubicin|doxorubicin|mesh-list
102567109|NCT04529772|Vincristine|vincristine|mesh-list
102567110|NCT04529772|Acalabrutinib|acalabrutinib|mesh-list
102567111|NCT04529772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102567112|NCT04529772|Immunologic Factors|immunologic factors|mesh-ancestor
102567113|NCT04529772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567114|NCT04529772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102275615|NCT02341027|Levonorgestrel|levonorgestrel|mesh-list
102567115|NCT04529772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102567116|NCT04529772|Alkylating Agents|alkylating agents|mesh-ancestor
102567117|NCT04529772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567118|NCT04529772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567119|NCT04529772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102567120|NCT04529772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102567121|NCT04529772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102567122|NCT04529772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102567123|NCT04529772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102567124|NCT04529772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102567125|NCT04529772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102567126|NCT04529772|Glucocorticoids|glucocorticoids|mesh-ancestor
102567127|NCT04529772|Hormones|hormones|mesh-ancestor
102567128|NCT04529772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102567129|NCT04529772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102567130|NCT04529772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102567131|NCT04529772|Tubulin Modulators|tubulin modulators|mesh-ancestor
102567132|NCT04529772|Antimitotic Agents|antimitotic agents|mesh-ancestor
102567133|NCT04529772|Mitosis Modulators|mitosis modulators|mesh-ancestor
102567134|NCT04523480|Methyltestosterone|methyltestosterone|mesh-list
102567135|NCT04523480|Testosterone|testosterone|mesh-list
102567136|NCT04523480|Testosterone undecanoate|testosterone undecanoate|mesh-list
102567137|NCT04523480|Testosterone enanthate|testosterone enanthate|mesh-list
102567138|NCT04523480|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102567139|NCT04523480|Androgens|androgens|mesh-ancestor
102567140|NCT04523480|Hormones|hormones|mesh-ancestor
102567141|NCT04523480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102567142|NCT04523480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567143|NCT04523480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102567144|NCT04523480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567145|NCT04523480|Anabolic Agents|anabolic agents|mesh-ancestor
102567146|NCT04521621|Pembrolizumab|pembrolizumab|mesh-list
102567147|NCT04521621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102567148|NCT04521621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567149|NCT04521621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102567150|NCT04521621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567151|NCT04521569|Regadenoson|regadenoson|mesh-list
102567152|NCT04521569|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
102567153|NCT04521569|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102567154|NCT04521569|Purinergic Agonists|purinergic agonists|mesh-ancestor
102567155|NCT04521569|Purinergic Agents|purinergic agents|mesh-ancestor
102567156|NCT04521569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102567157|NCT04521569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567158|NCT04521569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567159|NCT04506086|Blinatumomab|blinatumomab|mesh-list
102567160|NCT04506086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567161|NCT04504825|Dexamethasone|dexamethasone|mesh-list
102567162|NCT04504825|Cyclophosphamide|cyclophosphamide|mesh-list
102567163|NCT04504825|Bortezomib|bortezomib|mesh-list
102567164|NCT04504825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102567165|NCT04504825|Immunologic Factors|immunologic factors|mesh-ancestor
102567166|NCT04504825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567167|NCT04504825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102567168|NCT04504825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102567169|NCT04504825|Alkylating Agents|alkylating agents|mesh-ancestor
102567170|NCT04504825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567171|NCT04504825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567172|NCT04504825|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102567173|NCT04504825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102567174|NCT04504825|Antiemetics|antiemetics|mesh-ancestor
102567175|NCT04504825|Autonomic Agents|autonomic agents|mesh-ancestor
102567176|NCT04504825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102567177|NCT04504825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102567178|NCT04504825|Glucocorticoids|glucocorticoids|mesh-ancestor
102567179|NCT04504825|Hormones|hormones|mesh-ancestor
102567180|NCT04504825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102567181|NCT04504825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102567182|NCT04497142|Levetiracetam|levetiracetam|mesh-list
102567183|NCT04497142|Anticonvulsants|anticonvulsants|mesh-ancestor
102567184|NCT04497142|Nootropic Agents|nootropic agents|mesh-ancestor
102567185|NCT04495257|Nivolumab|nivolumab|mesh-list
102567186|NCT04495257|Ipilimumab|ipilimumab|mesh-list
102567187|NCT04495257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102567188|NCT04495257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567189|NCT04495257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102567190|NCT04495257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567191|NCT04477759|Atezolizumab|atezolizumab|mesh-list
102567192|NCT04477759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102567193|NCT04477759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567194|NCT04477759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102567195|NCT04477759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567196|NCT04477343|Nivolumab|nivolumab|mesh-list
102567197|NCT04477343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102567198|NCT04477343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567199|NCT04477343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102567200|NCT04477343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567201|NCT04464980|Naltrexone|naltrexone|mesh-list
102567202|NCT04464980|Buprenorphine|buprenorphine|mesh-list
102567203|NCT04464980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102567204|NCT04464980|Narcotics|narcotics|mesh-ancestor
102567205|NCT04464980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102567206|NCT04464980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567207|NCT04464980|Analgesics|analgesics|mesh-ancestor
102567208|NCT04464980|Sensory System Agents|sensory system agents|mesh-ancestor
102567209|NCT04464980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102567210|NCT04464980|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102567211|NCT04464980|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102567212|NCT04464070|Aspirin|aspirin|mesh-list
102567213|NCT04464070|Niacin|niacin|mesh-list
102567214|NCT04464070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102567215|NCT04464070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102567216|NCT04464070|Analgesics|analgesics|mesh-ancestor
102567217|NCT04464070|Sensory System Agents|sensory system agents|mesh-ancestor
102567218|NCT04464070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102567219|NCT04464070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567220|NCT04464070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102567221|NCT04464070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102567222|NCT04464070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102567223|NCT04464070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102567224|NCT04464070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567225|NCT04464070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102567226|NCT04464070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102567227|NCT04464070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102567228|NCT04464070|Antipyretics|antipyretics|mesh-ancestor
102567229|NCT04464070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102567230|NCT04464070|Antimetabolites|antimetabolites|mesh-ancestor
102567231|NCT04464070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102567232|NCT04464070|Vasodilator Agents|vasodilator agents|mesh-ancestor
102567233|NCT04464070|Vitamin B Complex|vitamin b complex|mesh-ancestor
102567234|NCT04464070|Vitamins|vitamins|mesh-ancestor
102567235|NCT04464070|Micronutrients|micronutrients|mesh-ancestor
102567236|NCT04458909|Cisplatin|cisplatin|mesh-list
102567237|NCT04458909|Carboplatin|carboplatin|mesh-list
102567238|NCT04458909|Gemcitabine|gemcitabine|mesh-list
102567239|NCT04458909|Nivolumab|nivolumab|mesh-list
102567240|NCT04458909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567241|NCT04458909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102567242|NCT04458909|Antimetabolites|antimetabolites|mesh-ancestor
102567243|NCT04458909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567244|NCT04458909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102567245|NCT04458909|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102567246|NCT04458545|Heroin|heroin|mesh-list
102567247|NCT04458545|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102567248|NCT04458545|Narcotics|narcotics|mesh-ancestor
102567249|NCT04458545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102567250|NCT04458545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567251|NCT04458545|Analgesics|analgesics|mesh-ancestor
102567252|NCT04458545|Sensory System Agents|sensory system agents|mesh-ancestor
102567253|NCT04458545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102567254|NCT04454684|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
102567255|NCT04454684|Hallucinogens|hallucinogens|mesh-ancestor
102567256|NCT04454684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567257|NCT04454684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102567258|NCT04454684|Serotonin Agents|serotonin agents|mesh-ancestor
102567259|NCT04454684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102567260|NCT04454684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567261|NCT04454684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102567262|NCT04454684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102567263|NCT04454684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102567264|NCT04454684|Adrenergic Agents|adrenergic agents|mesh-ancestor
102567265|NCT04414475|Dexamethasone|dexamethasone|mesh-list
102567266|NCT04414475|Bortezomib|bortezomib|mesh-list
102567267|NCT04414475|Pomalidomide|pomalidomide|mesh-list
102567268|NCT04414475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102567269|NCT04414475|Antiemetics|antiemetics|mesh-ancestor
102567270|NCT04414475|Autonomic Agents|autonomic agents|mesh-ancestor
102567271|NCT04414475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102567272|NCT04414475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567273|NCT04414475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102567274|NCT04414475|Glucocorticoids|glucocorticoids|mesh-ancestor
102567275|NCT04414475|Hormones|hormones|mesh-ancestor
102567276|NCT04414475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102567277|NCT04414475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102567278|NCT04414475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567279|NCT04414475|Immunologic Factors|immunologic factors|mesh-ancestor
102567280|NCT04414475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102567281|NCT04414475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102567282|NCT04414475|Growth Substances|growth substances|mesh-ancestor
102567283|NCT04414475|Growth Inhibitors|growth inhibitors|mesh-ancestor
102567284|NCT04396860|Nivolumab|nivolumab|mesh-list
102567285|NCT04396860|Ipilimumab|ipilimumab|mesh-list
102567286|NCT04396860|Temozolomide|temozolomide|mesh-list
102567287|NCT04396860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102567288|NCT04396860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567289|NCT04396860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102567290|NCT04396860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567291|NCT04396860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102567292|NCT04396860|Alkylating Agents|alkylating agents|mesh-ancestor
102567293|NCT04392622|Cisplatin|cisplatin|mesh-list
102567294|NCT04392622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567295|NCT04381650|Pembrolizumab|pembrolizumab|mesh-list
102567296|NCT04381650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102567297|NCT04381650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567298|NCT04381650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102567299|NCT04381650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567300|NCT04379596|Pembrolizumab|pembrolizumab|mesh-list
102567301|NCT04379596|Fluorouracil|fluorouracil|mesh-list
102567302|NCT04379596|Capecitabine|capecitabine|mesh-list
102567303|NCT04379596|Oxaliplatin|oxaliplatin|mesh-list
102567304|NCT04379596|Trastuzumab|trastuzumab|mesh-list
102567305|NCT04379596|Durvalumab|durvalumab|mesh-list
102567306|NCT04379596|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
102567307|NCT04379596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567308|NCT04379596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102567309|NCT04379596|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102567310|NCT04379596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567311|NCT04379596|Antimetabolites|antimetabolites|mesh-ancestor
102567312|NCT04379596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102567313|NCT04379596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102567314|NCT04379596|Immunologic Factors|immunologic factors|mesh-ancestor
102567315|NCT04379596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567316|NCT04379596|Immunoconjugates|immunoconjugates|mesh-ancestor
102567317|NCT04374630|Paclitaxel|paclitaxel|mesh-list
102567318|NCT04374630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102567319|NCT04374630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567320|NCT04374630|Tubulin Modulators|tubulin modulators|mesh-ancestor
102567321|NCT04374630|Antimitotic Agents|antimitotic agents|mesh-ancestor
102567322|NCT04374630|Mitosis Modulators|mitosis modulators|mesh-ancestor
102567323|NCT04374630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567324|NCT04354246|Pembrolizumab|pembrolizumab|mesh-list
102567325|NCT04354246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102567326|NCT04354246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567327|NCT04354246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102567328|NCT04354246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567329|NCT04352166|Buprenorphine|buprenorphine|mesh-list
102567330|NCT04352166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102567331|NCT04352166|Narcotics|narcotics|mesh-ancestor
102567332|NCT04352166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102567333|NCT04352166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567334|NCT04352166|Analgesics|analgesics|mesh-ancestor
102567335|NCT04352166|Sensory System Agents|sensory system agents|mesh-ancestor
102567336|NCT04352166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102567337|NCT04352166|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102567338|NCT04351555|Carboplatin|carboplatin|mesh-list
102567339|NCT04351555|Pemetrexed|pemetrexed|mesh-list
102567340|NCT04351555|Osimertinib|osimertinib|mesh-list
102567341|NCT04351555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567342|NCT04351555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102567343|NCT04351555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567344|NCT04351555|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102567345|NCT04351555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102567346|NCT04351555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102567347|NCT04322305|Pregabalin|pregabalin|mesh-list
102114270|NCT02155023|Insulin|insulin|mesh-list
102567349|NCT04322305|Sensory System Agents|sensory system agents|mesh-ancestor
102567350|NCT04322305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102567351|NCT04322305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567352|NCT04322305|Anticonvulsants|anticonvulsants|mesh-ancestor
102567353|NCT04322305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102567354|NCT04322305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102567355|NCT04322305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567356|NCT04322305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102567357|NCT04322305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102567358|NCT04322305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102567359|NCT04322305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102567360|NCT04322305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102567361|NCT04316702|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102567362|NCT04316702|Analgesics|analgesics|mesh-ancestor
102567363|NCT04316702|Sensory System Agents|sensory system agents|mesh-ancestor
102567364|NCT04316702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102567365|NCT04316702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567366|NCT04316702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102567367|NCT04316702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567368|NCT04316702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102567369|NCT04316702|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102567370|NCT04316702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102567371|NCT04316702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102567372|NCT04316702|Antidepressive Agents|antidepressive agents|mesh-ancestor
102567373|NCT04316702|Dopamine Agents|dopamine agents|mesh-ancestor
102567374|NCT04314375|Budesonide|budesonide|mesh-list
102567375|NCT04314375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102567376|NCT04314375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102567377|NCT04314375|Autonomic Agents|autonomic agents|mesh-ancestor
102567378|NCT04314375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102567379|NCT04314375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567380|NCT04314375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102567381|NCT04314375|Respiratory System Agents|respiratory system agents|mesh-ancestor
102567382|NCT04314375|Glucocorticoids|glucocorticoids|mesh-ancestor
102567383|NCT04314375|Hormones|hormones|mesh-ancestor
102567384|NCT04314375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102567385|NCT04292457|Propofol|propofol|mesh-list
102567386|NCT04292457|Sevoflurane|sevoflurane|mesh-list
102567387|NCT04292457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102567388|NCT04292457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102567389|NCT04292457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567390|NCT04292457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102567391|NCT04292457|Anesthetics, General|anesthetics, general|mesh-ancestor
102567392|NCT04292457|Anesthetics|anesthetics|mesh-ancestor
102567393|NCT04292457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102567394|NCT04292457|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102567395|NCT04291599|Ketorolac|ketorolac|mesh-list
102567396|NCT04291599|Morphine|morphine|mesh-list
102567397|NCT04291599|Hydromorphone|hydromorphone|mesh-list
102567398|NCT04291599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102567399|NCT04291599|Narcotics|narcotics|mesh-ancestor
102567400|NCT04291599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102567401|NCT04291599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567402|NCT04291599|Analgesics|analgesics|mesh-ancestor
102567403|NCT04291599|Sensory System Agents|sensory system agents|mesh-ancestor
102567404|NCT04291599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102567405|NCT04291599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102567406|NCT04291599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102567407|NCT04291599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102567408|NCT04291599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102567409|NCT04291599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102567410|NCT04291599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102567411|NCT04291599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567412|NCT04274179|Lamotrigine|lamotrigine|mesh-list
102567413|NCT04274179|Valproic Acid|valproic acid|mesh-list
102567414|NCT04274179|Ethosuximide|ethosuximide|mesh-list
102567415|NCT04274179|Anticonvulsants|anticonvulsants|mesh-ancestor
102567416|NCT04274179|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102567417|NCT04274179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102567418|NCT04274179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567419|NCT04274179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102567420|NCT04274179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567421|NCT04274179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102567422|NCT04274179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102567423|NCT04274179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102567424|NCT04274179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102567425|NCT04274179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102567426|NCT04274179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102567427|NCT04274179|GABA Agents|gaba agents|mesh-ancestor
102567428|NCT04274179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102567429|NCT04274179|Antimanic Agents|antimanic agents|mesh-ancestor
102567430|NCT04273932|Lithium Carbonate|lithium carbonate|mesh-list
102567431|NCT04273932|Antidepressive Agents|antidepressive agents|mesh-ancestor
102567432|NCT04273932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102567433|NCT04273932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102567434|NCT04273932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567435|NCT04273932|Antimanic Agents|antimanic agents|mesh-ancestor
102567436|NCT04273932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102567437|NCT04273932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102567438|NCT04273932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567439|NCT04272086|Bupivacaine|bupivacaine|mesh-list
102567440|NCT04272086|Anesthetics, Local|anesthetics, local|mesh-ancestor
102567441|NCT04272086|Anesthetics|anesthetics|mesh-ancestor
102567442|NCT04272086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102567443|NCT04272086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567444|NCT04272086|Sensory System Agents|sensory system agents|mesh-ancestor
102567445|NCT04272086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102567446|NCT04256707|Docetaxel|docetaxel|mesh-list
102567447|NCT04256707|Pembrolizumab|pembrolizumab|mesh-list
102567448|NCT04256707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567449|NCT04256707|Tubulin Modulators|tubulin modulators|mesh-ancestor
102567450|NCT04256707|Antimitotic Agents|antimitotic agents|mesh-ancestor
102567451|NCT04256707|Mitosis Modulators|mitosis modulators|mesh-ancestor
102567452|NCT04256707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567453|NCT04256707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102567454|NCT04256707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102567455|NCT04254107|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102567456|NCT04254107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102567457|NCT04254107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567458|NCT04254107|Immunotoxins|immunotoxins|mesh-ancestor
102567459|NCT04254107|Immunoconjugates|immunoconjugates|mesh-ancestor
102567460|NCT04254107|Immunologic Factors|immunologic factors|mesh-ancestor
102567461|NCT04254107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567462|NCT04249427|Erenumab|erenumab|mesh-list
102567463|NCT04249427|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
102567464|NCT04249427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567465|NCT04249427|Analgesics|analgesics|mesh-ancestor
102567466|NCT04249427|Sensory System Agents|sensory system agents|mesh-ancestor
102567467|NCT04249427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102567468|NCT04249427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567469|NCT04246086|Lenalidomide|lenalidomide|mesh-list
102567470|NCT04246086|Immunologic Factors|immunologic factors|mesh-ancestor
102567471|NCT04246086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567472|NCT04246086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102567473|NCT04246086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102567474|NCT04246086|Growth Substances|growth substances|mesh-ancestor
102567475|NCT04246086|Growth Inhibitors|growth inhibitors|mesh-ancestor
102567476|NCT04246086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567477|NCT04233229|Insulin|insulin|mesh-list
102567478|NCT04233229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102567479|NCT04233229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567480|NCT04232761|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
102567481|NCT04232761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567482|NCT04230304|Daratumumab|daratumumab|mesh-list
102567483|NCT04230304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567484|NCT04224272|Fulvestrant|fulvestrant|mesh-list
102567485|NCT04224272|Palbociclib|palbociclib|mesh-list
102567486|NCT04224272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102567487|NCT04224272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567488|NCT04224272|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102567489|NCT04224272|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102567490|NCT04224272|Hormone Antagonists|hormone antagonists|mesh-ancestor
102567491|NCT04224272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102567492|NCT04224272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567493|NCT04224272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102567494|NCT04224272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102638129|NCT00716586|Dorzolamide|dorzolamide|mesh-list
102567495|NCT04224272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567496|NCT04223856|Carboplatin|carboplatin|mesh-list
102567497|NCT04223856|Gemcitabine|gemcitabine|mesh-list
102567498|NCT04223856|Pembrolizumab|pembrolizumab|mesh-list
102567499|NCT04223856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567500|NCT04223856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102567501|NCT04223856|Antimetabolites|antimetabolites|mesh-ancestor
102567502|NCT04223856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567503|NCT04223856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102567504|NCT04223856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102567505|NCT04210115|Calcium, Dietary|calcium, dietary|mesh-list
102567506|NCT04210115|Leucovorin|leucovorin|mesh-list
102567507|NCT04210115|Pembrolizumab|pembrolizumab|mesh-list
102567508|NCT04210115|Oxaliplatin|oxaliplatin|mesh-list
102567509|NCT04210115|Calcium|calcium|mesh-list
102567510|NCT04210115|Levoleucovorin|levoleucovorin|mesh-list
102567511|NCT04210115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567512|NCT04210115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102567513|NCT04210115|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102567514|NCT04210115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567515|NCT04210115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102567516|NCT04210115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567517|NCT04210115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102567518|NCT04210115|Antidotes|antidotes|mesh-ancestor
102567519|NCT04210115|Protective Agents|protective agents|mesh-ancestor
102567520|NCT04210115|Vitamin B Complex|vitamin b complex|mesh-ancestor
102567521|NCT04210115|Vitamins|vitamins|mesh-ancestor
102567522|NCT04210115|Micronutrients|micronutrients|mesh-ancestor
102567523|NCT04205552|Nivolumab|nivolumab|mesh-list
102567524|NCT04205552|Relatlimab|relatlimab|mesh-list
102567525|NCT04205552|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102567526|NCT04205552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102567527|NCT04205552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567528|NCT04205552|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102567529|NCT04205552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567530|NCT04200443|Temozolomide|temozolomide|mesh-list
102567531|NCT04200443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102567532|NCT04200443|Alkylating Agents|alkylating agents|mesh-ancestor
102567533|NCT04200443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567534|NCT04200443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567535|NCT04192136|Niacinamide|niacinamide|mesh-list
102567536|NCT04192136|Niacin|niacin|mesh-list
102567537|NCT04192136|Nicotinic Acids|nicotinic acids|mesh-list
102567538|NCT04192136|Vitamin B Complex|vitamin b complex|mesh-ancestor
102567539|NCT04192136|Vitamins|vitamins|mesh-ancestor
102567540|NCT04192136|Micronutrients|micronutrients|mesh-ancestor
102567541|NCT04192136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567542|NCT04192136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102567543|NCT04192136|Antimetabolites|antimetabolites|mesh-ancestor
102567544|NCT04192136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567545|NCT04192136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102567546|NCT04192136|Vasodilator Agents|vasodilator agents|mesh-ancestor
102567547|NCT04185883|Docetaxel|docetaxel|mesh-list
102567548|NCT04185883|Bevacizumab|bevacizumab|mesh-list
102567549|NCT04185883|Carboplatin|carboplatin|mesh-list
102567550|NCT04185883|Pembrolizumab|pembrolizumab|mesh-list
102567551|NCT04185883|Pemetrexed|pemetrexed|mesh-list
102567552|NCT04185883|Everolimus|everolimus|mesh-list
102567553|NCT04185883|Atezolizumab|atezolizumab|mesh-list
102567554|NCT04185883|Palbociclib|palbociclib|mesh-list
102567555|NCT04185883|Panitumumab|panitumumab|mesh-list
102567556|NCT04185883|Trametinib|trametinib|mesh-list
102567557|NCT04185883|Afatinib|afatinib|mesh-list
102567558|NCT04185883|Sotorasib|sotorasib|mesh-list
102567559|NCT04185883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567560|NCT04185883|Tubulin Modulators|tubulin modulators|mesh-ancestor
102567561|NCT04185883|Antimitotic Agents|antimitotic agents|mesh-ancestor
102567562|NCT04185883|Mitosis Modulators|mitosis modulators|mesh-ancestor
102567563|NCT04185883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567564|NCT04185883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102567565|NCT04185883|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102567566|NCT04185883|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102567567|NCT04185883|Growth Substances|growth substances|mesh-ancestor
102567568|NCT04185883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567569|NCT04185883|Growth Inhibitors|growth inhibitors|mesh-ancestor
102114499|NCT02314182|Bevacizumab|bevacizumab|mesh-list
102567570|NCT04185883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102567571|NCT04185883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102567572|NCT04185883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102567573|NCT04185883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102567574|NCT04185883|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102567575|NCT04185883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102567576|NCT04185883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102567577|NCT04185883|Immunologic Factors|immunologic factors|mesh-ancestor
102567578|NCT04181996|Colchicine|colchicine|mesh-list
102567579|NCT04181996|Gout Suppressants|gout suppressants|mesh-ancestor
102567580|NCT04181996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102567581|NCT04181996|Tubulin Modulators|tubulin modulators|mesh-ancestor
102567582|NCT04181996|Antimitotic Agents|antimitotic agents|mesh-ancestor
102567583|NCT04181996|Mitosis Modulators|mitosis modulators|mesh-ancestor
102567584|NCT04181996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567585|NCT04181996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567586|NCT04174365|Brexpiprazole|brexpiprazole|mesh-list
102567587|NCT04174365|Serotonin Agents|serotonin agents|mesh-ancestor
102567588|NCT04174365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102567589|NCT04174365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567590|NCT04174365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567591|NCT04174365|Dopamine Agonists|dopamine agonists|mesh-ancestor
102567592|NCT04174365|Dopamine Agents|dopamine agents|mesh-ancestor
102567593|NCT04173780|Atropine|atropine|mesh-list
102567594|NCT04173780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102567595|NCT04173780|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102567596|NCT04173780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102567597|NCT04173780|Autonomic Agents|autonomic agents|mesh-ancestor
102567598|NCT04173780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102567599|NCT04173780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567600|NCT04173780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102567601|NCT04173780|Respiratory System Agents|respiratory system agents|mesh-ancestor
102567602|NCT04173780|Mydriatics|mydriatics|mesh-ancestor
102567603|NCT04173780|Parasympatholytics|parasympatholytics|mesh-ancestor
102567604|NCT04173780|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102567605|NCT04173780|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102567606|NCT04173780|Cholinergic Agents|cholinergic agents|mesh-ancestor
102567607|NCT04173780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102567608|NCT04173780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567609|NCT04167111|Vitamin D|vitamin d|mesh-list
102567610|NCT04167111|Cholecalciferol|cholecalciferol|mesh-list
102567611|NCT04167111|Vitamins|vitamins|mesh-ancestor
102567612|NCT04167111|Micronutrients|micronutrients|mesh-ancestor
102567613|NCT04167111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567614|NCT04167111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102567615|NCT04167111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102567616|NCT04153760|Aspirin|aspirin|mesh-list
102567617|NCT04153760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102567618|NCT04153760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102567619|NCT04153760|Analgesics|analgesics|mesh-ancestor
102567620|NCT04153760|Sensory System Agents|sensory system agents|mesh-ancestor
102567621|NCT04153760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102567622|NCT04153760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567623|NCT04153760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102567624|NCT04153760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102567625|NCT04153760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102567626|NCT04153760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102567627|NCT04153760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567628|NCT04153760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102567629|NCT04153760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102567630|NCT04153760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102567631|NCT04153760|Antipyretics|antipyretics|mesh-ancestor
102567632|NCT04139304|Prednisone|prednisone|mesh-list
102567633|NCT04139304|Cortisone|cortisone|mesh-list
102567634|NCT04139304|Cyclophosphamide|cyclophosphamide|mesh-list
102567635|NCT04139304|Doxorubicin|doxorubicin|mesh-list
102567636|NCT04139304|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102567637|NCT04139304|Etoposide|etoposide|mesh-list
102567638|NCT04139304|Vincristine|vincristine|mesh-list
102567639|NCT04139304|Etoposide phosphate|etoposide phosphate|mesh-list
102567640|NCT04139304|Daunorubicin|daunorubicin|mesh-list
102567641|NCT04139304|Daratumumab|daratumumab|mesh-list
102567642|NCT04139304|Podophyllotoxin|podophyllotoxin|mesh-list
102567643|NCT04139304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102567644|NCT04139304|Immunologic Factors|immunologic factors|mesh-ancestor
102567645|NCT04139304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567646|NCT04139304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102567647|NCT04139304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102567648|NCT04139304|Alkylating Agents|alkylating agents|mesh-ancestor
102567649|NCT04139304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567650|NCT04139304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567651|NCT04139304|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102567652|NCT04139304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102567653|NCT04139304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102567654|NCT04139304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102567655|NCT04139304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102567656|NCT04139304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102567657|NCT04139304|Glucocorticoids|glucocorticoids|mesh-ancestor
102567658|NCT04139304|Hormones|hormones|mesh-ancestor
102567659|NCT04139304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102567660|NCT04139304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102567661|NCT04139304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102567662|NCT04139304|Tubulin Modulators|tubulin modulators|mesh-ancestor
102567663|NCT04139304|Antimitotic Agents|antimitotic agents|mesh-ancestor
102567664|NCT04139304|Mitosis Modulators|mitosis modulators|mesh-ancestor
102567665|NCT04139304|Keratolytic Agents|keratolytic agents|mesh-ancestor
102567666|NCT04139304|Dermatologic Agents|dermatologic agents|mesh-ancestor
102567667|NCT04135690|Sorafenib|sorafenib|mesh-list
102567668|NCT04135690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567669|NCT04135690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102567670|NCT04135690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102567671|NCT04135690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567672|NCT04126317|Aflibercept|aflibercept|mesh-list
102567673|NCT04126317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102567674|NCT04126317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102567675|NCT04126317|Growth Substances|growth substances|mesh-ancestor
102567676|NCT04126317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567677|NCT04126317|Growth Inhibitors|growth inhibitors|mesh-ancestor
102567678|NCT04126317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567679|NCT04123314|Psilocybin|psilocybin|mesh-list
102567680|NCT04123314|Hallucinogens|hallucinogens|mesh-ancestor
102567681|NCT04123314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567682|NCT04123314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102567683|NCT04113382|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
102567684|NCT04113382|Laxatives|laxatives|mesh-ancestor
102567685|NCT04113382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102567686|NCT04111133|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102567687|NCT04111133|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102567688|NCT04111133|Adrenergic Agents|adrenergic agents|mesh-ancestor
102567689|NCT04111133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102567690|NCT04111133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567691|NCT04111133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567692|NCT04109924|Trifluridine|trifluridine|mesh-list
102567693|NCT04109924|Bevacizumab|bevacizumab|mesh-list
102567694|NCT04109924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102567695|NCT04109924|Irinotecan|irinotecan|mesh-list
102567696|NCT04109924|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
102567697|NCT04109924|Antibodies|antibodies|mesh-list
102567698|NCT04109924|Immunoglobulins|immunoglobulins|mesh-list
102567699|NCT04109924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102567700|NCT04109924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567701|NCT04109924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102567702|NCT04109924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102567703|NCT04109924|Growth Substances|growth substances|mesh-ancestor
102567704|NCT04109924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567705|NCT04109924|Growth Inhibitors|growth inhibitors|mesh-ancestor
102567706|NCT04109924|Immunologic Factors|immunologic factors|mesh-ancestor
102567707|NCT04109924|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102567708|NCT04109924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102567709|NCT04109924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102567710|NCT04109924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567711|NCT04109924|Antimetabolites|antimetabolites|mesh-ancestor
102567712|NCT04109924|Antiviral Agents|antiviral agents|mesh-ancestor
102567713|NCT04109924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102567714|NCT04109924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102567715|NCT04104672|Paclitaxel|paclitaxel|mesh-list
102567716|NCT04104672|Gemcitabine|gemcitabine|mesh-list
102567717|NCT04104672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102567718|NCT04104672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567719|NCT04104672|Tubulin Modulators|tubulin modulators|mesh-ancestor
102567720|NCT04104672|Antimitotic Agents|antimitotic agents|mesh-ancestor
102567721|NCT04104672|Mitosis Modulators|mitosis modulators|mesh-ancestor
102567722|NCT04104672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567723|NCT04104672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102567724|NCT04104672|Antimetabolites|antimetabolites|mesh-ancestor
102114647|NCT03498222|Carboplatin|carboplatin|mesh-list
102567725|NCT04097028|Trifluridine|trifluridine|mesh-list
102567726|NCT04097028|Oxaliplatin|oxaliplatin|mesh-list
102567727|NCT04097028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567728|NCT04097028|Antimetabolites|antimetabolites|mesh-ancestor
102567729|NCT04097028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567730|NCT04097028|Antiviral Agents|antiviral agents|mesh-ancestor
102567731|NCT04097028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102567732|NCT04093596|Cyclophosphamide|cyclophosphamide|mesh-list
102567733|NCT04093596|Fludarabine|fludarabine|mesh-list
102567734|NCT04093596|Nirogacestat|nirogacestat|mesh-list
102567735|NCT04093596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102567736|NCT04093596|Immunologic Factors|immunologic factors|mesh-ancestor
102567737|NCT04093596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567738|NCT04093596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102567739|NCT04093596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102567740|NCT04093596|Alkylating Agents|alkylating agents|mesh-ancestor
102567741|NCT04093596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567742|NCT04093596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567743|NCT04093596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102567744|NCT04093596|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
102567745|NCT04093596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102567746|NCT04092270|Doxorubicin|doxorubicin|mesh-list
102567747|NCT04092270|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102567748|NCT04092270|Peposertib|peposertib|mesh-list
102567749|NCT04092270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102567750|NCT04092270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567751|NCT04092270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102567752|NCT04092270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102567753|NCT04092270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102567754|NCT04092270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567755|NCT04092270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102567756|NCT04091750|Nivolumab|nivolumab|mesh-list
102567757|NCT04091750|Ipilimumab|ipilimumab|mesh-list
102567758|NCT04091750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102567759|NCT04091750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567760|NCT04091750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102567761|NCT04091750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567762|NCT04090398|Paclitaxel|paclitaxel|mesh-list
102567763|NCT04090398|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102567764|NCT04090398|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
102567765|NCT04090398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102567766|NCT04090398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567767|NCT04090398|Tubulin Modulators|tubulin modulators|mesh-ancestor
102567768|NCT04090398|Antimitotic Agents|antimitotic agents|mesh-ancestor
102567769|NCT04090398|Mitosis Modulators|mitosis modulators|mesh-ancestor
102567770|NCT04090398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567771|NCT04089865|Tranexamic Acid|tranexamic acid|mesh-list
102567772|NCT04089865|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102567773|NCT04089865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102567774|NCT04089865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567775|NCT04089865|Hemostatics|hemostatics|mesh-ancestor
102567776|NCT04089865|Coagulants|coagulants|mesh-ancestor
102567777|NCT04066894|Neurotransmitter Agents|neurotransmitter agents|mesh-list
102567778|NCT04066894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567779|NCT04066894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102612376|NCT02973581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612377|NCT02973581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102612378|NCT02973581|Analgesics|analgesics|mesh-ancestor
102612379|NCT02973581|Antipyretics|antipyretics|mesh-ancestor
102612380|NCT02973581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102612381|NCT02973581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102612382|NCT02973581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102612383|NCT00002435|Zidovudine|zidovudine|mesh-list
102612384|NCT00002435|Antimetabolites|antimetabolites|mesh-ancestor
102612385|NCT00002435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612386|NCT00002435|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102612387|NCT00002435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102612388|NCT00002435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612389|NCT00002435|Antiviral Agents|antiviral agents|mesh-ancestor
102612390|NCT00002435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102612391|NCT00002435|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102612392|NCT00002435|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102612393|NCT00002447|Ritonavir|ritonavir|mesh-list
102612394|NCT00002447|Saquinavir|saquinavir|mesh-list
102567780|NCT04043195|Oxaliplatin|oxaliplatin|mesh-list
102567782|NCT04043195|Ipilimumab|ipilimumab|mesh-list
102567783|NCT04043195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567784|NCT04043195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102567785|NCT04043195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102567786|NCT04043195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567787|NCT04039464|Bosentan|bosentan|mesh-list
102567788|NCT04039464|Sildenafil Citrate|sildenafil citrate|mesh-list
102567789|NCT04039464|Vasodilator Agents|vasodilator agents|mesh-ancestor
102567790|NCT04039464|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102567791|NCT04039464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102567792|NCT04039464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102567793|NCT04039464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567794|NCT04039464|Urological Agents|urological agents|mesh-ancestor
102567795|NCT04039464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102567796|NCT04039464|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102567797|NCT04038255|Nicotine|nicotine|mesh-list
102567798|NCT04038255|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102567799|NCT04038255|Autonomic Agents|autonomic agents|mesh-ancestor
102567800|NCT04038255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102567801|NCT04038255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567802|NCT04038255|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102567803|NCT04038255|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102567804|NCT04038255|Cholinergic Agents|cholinergic agents|mesh-ancestor
102567805|NCT04038255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102567806|NCT04038255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567807|NCT04031729|Aspirin|aspirin|mesh-list
102567808|NCT04031729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102567809|NCT04031729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102567810|NCT04031729|Analgesics|analgesics|mesh-ancestor
102567811|NCT04031729|Sensory System Agents|sensory system agents|mesh-ancestor
102567812|NCT04031729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102567813|NCT04031729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567814|NCT04031729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102567815|NCT04031729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102567816|NCT04031729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102567817|NCT04031729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102567818|NCT04031729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567819|NCT04031729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102567820|NCT04031729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102567821|NCT04031729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102567822|NCT04031729|Antipyretics|antipyretics|mesh-ancestor
102567823|NCT04024163|Benzonidazole|benzonidazole|mesh-list
102567824|NCT04024163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102567825|NCT04024163|Immunologic Factors|immunologic factors|mesh-ancestor
102567826|NCT04024163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567827|NCT04024163|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102567828|NCT04024163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102567829|NCT04024163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102567830|NCT04024163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102567831|NCT04023019|Thrombin|thrombin|mesh-list
102567832|NCT04023019|Hemostatics|hemostatics|mesh-ancestor
102567833|NCT04023019|Coagulants|coagulants|mesh-ancestor
102567834|NCT04014387|Zolpidem|zolpidem|mesh-list
102567835|NCT04014387|Suvorexant|suvorexant|mesh-list
102567836|NCT04014387|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102567837|NCT04014387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102567838|NCT04014387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102567839|NCT04014387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567840|NCT04014387|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102567841|NCT04014387|GABA Agonists|gaba agonists|mesh-ancestor
102567842|NCT04014387|GABA Agents|gaba agents|mesh-ancestor
102567843|NCT04014387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102567844|NCT04014387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567845|NCT04014387|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102567846|NCT04005053|Acetylcysteine|acetylcysteine|mesh-list
102567847|NCT04005053|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102567848|NCT04005053|Antiviral Agents|antiviral agents|mesh-ancestor
102567849|NCT04005053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102567850|NCT04005053|Expectorants|expectorants|mesh-ancestor
102567851|NCT04005053|Respiratory System Agents|respiratory system agents|mesh-ancestor
102567852|NCT04005053|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102567853|NCT04005053|Antioxidants|antioxidants|mesh-ancestor
102567854|NCT04005053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567855|NCT04005053|Protective Agents|protective agents|mesh-ancestor
102567856|NCT04005053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567858|NCT03997786|Etanercept|etanercept|mesh-list
102567859|NCT03997786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102567860|NCT03997786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102567861|NCT03997786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102567862|NCT03997786|Analgesics|analgesics|mesh-ancestor
102567863|NCT03997786|Sensory System Agents|sensory system agents|mesh-ancestor
102567864|NCT03997786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102567865|NCT03997786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567866|NCT03997786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102567867|NCT03997786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102567868|NCT03997786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102567869|NCT03997786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102567870|NCT03997786|Immunologic Factors|immunologic factors|mesh-ancestor
102567871|NCT03984188|Theophylline|theophylline|mesh-list
102567872|NCT03984188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102567873|NCT03984188|Autonomic Agents|autonomic agents|mesh-ancestor
102567874|NCT03984188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102567875|NCT03984188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567876|NCT03984188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102567877|NCT03984188|Respiratory System Agents|respiratory system agents|mesh-ancestor
102567878|NCT03984188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102567879|NCT03984188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102567880|NCT03984188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567881|NCT03984188|Vasodilator Agents|vasodilator agents|mesh-ancestor
102567882|NCT03984188|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102567883|NCT03984188|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102567884|NCT03984188|Purinergic Agents|purinergic agents|mesh-ancestor
102567885|NCT03984188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102567886|NCT03982225|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
102567887|NCT03982225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102567888|NCT03982225|Antimetabolites|antimetabolites|mesh-ancestor
102567889|NCT03982225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567890|NCT03982225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102567891|NCT03981796|Paclitaxel|paclitaxel|mesh-list
102567892|NCT03981796|Carboplatin|carboplatin|mesh-list
102567893|NCT03981796|Niraparib|niraparib|mesh-list
102567894|NCT03981796|Dostarlimab|dostarlimab|mesh-list
102567895|NCT03981796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102567896|NCT03981796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567897|NCT03981796|Tubulin Modulators|tubulin modulators|mesh-ancestor
102567898|NCT03981796|Antimitotic Agents|antimitotic agents|mesh-ancestor
102567899|NCT03981796|Mitosis Modulators|mitosis modulators|mesh-ancestor
102567900|NCT03981796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567901|NCT03981796|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102567902|NCT03981796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102567903|NCT03976375|Docetaxel|docetaxel|mesh-list
102567904|NCT03976375|Pembrolizumab|pembrolizumab|mesh-list
102567905|NCT03976375|Lenvatinib|lenvatinib|mesh-list
102567906|NCT03976375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567907|NCT03976375|Tubulin Modulators|tubulin modulators|mesh-ancestor
102567908|NCT03976375|Antimitotic Agents|antimitotic agents|mesh-ancestor
102567909|NCT03976375|Mitosis Modulators|mitosis modulators|mesh-ancestor
102567910|NCT03976375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567911|NCT03976375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102567912|NCT03976375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102567913|NCT03976375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102567914|NCT03976375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102567915|NCT03975647|Tucatinib|tucatinib|mesh-list
102567916|NCT03975647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567917|NCT03975647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567918|NCT03975647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102567919|NCT03975647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102567920|NCT03969901|Relebactam|relebactam|mesh-list
102567921|NCT03969901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102567922|NCT03969901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102567923|NCT03969901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567924|NCT03969901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102567925|NCT03969901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102567926|NCT03969212|Baloxavir|baloxavir|mesh-list
102567927|NCT03969212|Antiviral Agents|antiviral agents|mesh-ancestor
102567928|NCT03969212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102567929|NCT03969212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102114874|NCT03348254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102567930|NCT03969212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567931|NCT03968406|Talazoparib|talazoparib|mesh-list
102567932|NCT03968406|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102567933|NCT03968406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102567934|NCT03968406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567935|NCT03968406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567936|NCT03967977|Carboplatin|carboplatin|mesh-list
102567937|NCT03967977|Gemcitabine|gemcitabine|mesh-list
102567938|NCT03967977|Tislelizumab|tislelizumab|mesh-list
102567939|NCT03967977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567940|NCT03967977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102567941|NCT03967977|Antimetabolites|antimetabolites|mesh-ancestor
102567942|NCT03967977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567943|NCT03967977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102567944|NCT03962647|Letrozole|letrozole|mesh-list
102567945|NCT03962647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567946|NCT03962647|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102567947|NCT03962647|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102567948|NCT03962647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102567949|NCT03962647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567950|NCT03962647|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102567951|NCT03962647|Hormone Antagonists|hormone antagonists|mesh-ancestor
102567952|NCT03962647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102567953|NCT03962647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567954|NCT03961698|Paclitaxel|paclitaxel|mesh-list
102567955|NCT03961698|Bevacizumab|bevacizumab|mesh-list
102567956|NCT03961698|Atezolizumab|atezolizumab|mesh-list
102567957|NCT03961698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102567958|NCT03961698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567959|NCT03961698|Tubulin Modulators|tubulin modulators|mesh-ancestor
102567960|NCT03961698|Antimitotic Agents|antimitotic agents|mesh-ancestor
102567961|NCT03961698|Mitosis Modulators|mitosis modulators|mesh-ancestor
102567962|NCT03961698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567963|NCT03961698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102567964|NCT03961698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102567965|NCT03961698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102567966|NCT03961698|Growth Substances|growth substances|mesh-ancestor
102567967|NCT03961698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102567968|NCT03961698|Growth Inhibitors|growth inhibitors|mesh-ancestor
102567969|NCT03961698|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102567970|NCT03946878|Venetoclax|venetoclax|mesh-list
102567971|NCT03946878|Acalabrutinib|acalabrutinib|mesh-list
102567972|NCT03946878|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102567973|NCT03946878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567974|NCT03946878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102567975|NCT03946878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102567976|NCT03946878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567977|NCT03945643|Sildenafil Citrate|sildenafil citrate|mesh-list
102567978|NCT03945643|Vasodilator Agents|vasodilator agents|mesh-ancestor
102567979|NCT03945643|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102567980|NCT03945643|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102567981|NCT03945643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102567982|NCT03945643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567983|NCT03945643|Urological Agents|urological agents|mesh-ancestor
102567984|NCT03938389|Valsartan|valsartan|mesh-list
102567985|NCT03938389|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102567986|NCT03938389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102567987|NCT03938389|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102567988|NCT03938389|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102567989|NCT03938389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102567990|NCT03929666|Leucovorin|leucovorin|mesh-list
102567991|NCT03929666|Bevacizumab|bevacizumab|mesh-list
102567992|NCT03929666|Gemcitabine|gemcitabine|mesh-list
102567993|NCT03929666|Fluorouracil|fluorouracil|mesh-list
102567994|NCT03929666|Capecitabine|capecitabine|mesh-list
102567995|NCT03929666|Oxaliplatin|oxaliplatin|mesh-list
102567996|NCT03929666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102567997|NCT03929666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102567998|NCT03929666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102567999|NCT03929666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102568000|NCT03929666|Growth Substances|growth substances|mesh-ancestor
102568001|NCT03929666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114948|NCT05584826|Hallucinogens|hallucinogens|mesh-ancestor
102568002|NCT03929666|Growth Inhibitors|growth inhibitors|mesh-ancestor
102568003|NCT03929666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102568004|NCT03929666|Antimetabolites|antimetabolites|mesh-ancestor
102568005|NCT03929666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568006|NCT03929666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102568007|NCT03929666|Immunologic Factors|immunologic factors|mesh-ancestor
102568008|NCT03929666|Antidotes|antidotes|mesh-ancestor
102568009|NCT03929666|Protective Agents|protective agents|mesh-ancestor
102568010|NCT03929666|Vitamin B Complex|vitamin b complex|mesh-ancestor
102568011|NCT03929666|Vitamins|vitamins|mesh-ancestor
102568012|NCT03929666|Micronutrients|micronutrients|mesh-ancestor
102568013|NCT03926130|Mirikizumab|mirikizumab|mesh-list
102568014|NCT03926130|Ustekinumab|ustekinumab|mesh-list
102568015|NCT03926130|Dermatologic Agents|dermatologic agents|mesh-ancestor
102568016|NCT03926130|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102568017|NCT03926130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102568018|NCT03926130|Analgesics|analgesics|mesh-ancestor
102568019|NCT03926130|Sensory System Agents|sensory system agents|mesh-ancestor
102568020|NCT03926130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102568021|NCT03926130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568022|NCT03926130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102568023|NCT03926130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102568024|NCT03926130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102568025|NCT03926130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102568026|NCT03924895|Pembrolizumab|pembrolizumab|mesh-list
102568027|NCT03924895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102568028|NCT03924895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568029|NCT03924895|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102568030|NCT03924895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568031|NCT03908736|Picolinic acid|picolinic acid|mesh-list
102568032|NCT03908736|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102568033|NCT03908736|Chelating Agents|chelating agents|mesh-ancestor
102568034|NCT03908736|Sequestering Agents|sequestering agents|mesh-ancestor
102568035|NCT03908736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568036|NCT03905928|Nicotine|nicotine|mesh-list
102568037|NCT03905928|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102568038|NCT03905928|Autonomic Agents|autonomic agents|mesh-ancestor
102568039|NCT03905928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102568040|NCT03905928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568041|NCT03905928|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102568042|NCT03905928|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102568043|NCT03905928|Cholinergic Agents|cholinergic agents|mesh-ancestor
102568044|NCT03905928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102568045|NCT03905928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568046|NCT03887780|Rivaroxaban|rivaroxaban|mesh-list
102568047|NCT03887780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102568048|NCT03887780|Antithrombins|antithrombins|mesh-ancestor
102568049|NCT03887780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102568050|NCT03887780|Protease Inhibitors|protease inhibitors|mesh-ancestor
102568051|NCT03887780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102568052|NCT03887780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568053|NCT03887780|Anticoagulants|anticoagulants|mesh-ancestor
102568054|NCT03879135|Factor VIII|factor viii|mesh-list
102568055|NCT03879135|Coagulants|coagulants|mesh-ancestor
102568056|NCT03872700|Fentanyl|fentanyl|mesh-list
102568057|NCT03872700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102568058|NCT03872700|Narcotics|narcotics|mesh-ancestor
102568059|NCT03872700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102568060|NCT03872700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568061|NCT03872700|Analgesics|analgesics|mesh-ancestor
102568062|NCT03872700|Sensory System Agents|sensory system agents|mesh-ancestor
102568063|NCT03872700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102568064|NCT03872700|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102568065|NCT03872700|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102568066|NCT03872700|Anesthetics, General|anesthetics, general|mesh-ancestor
102568067|NCT03872700|Anesthetics|anesthetics|mesh-ancestor
102568068|NCT03870529|Vitamins|vitamins|mesh-list
102568069|NCT03870529|Vitamin A|vitamin a|mesh-list
102568070|NCT03870529|Anti-Infective Agents|anti-infective agents|mesh-list
102568071|NCT03870529|Retinol palmitate|retinol palmitate|mesh-list
102568072|NCT03870529|Micronutrients|micronutrients|mesh-ancestor
102568073|NCT03870529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568074|NCT03870529|Antioxidants|antioxidants|mesh-ancestor
102568075|NCT03870529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568076|NCT03870529|Protective Agents|protective agents|mesh-ancestor
102568077|NCT03870529|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102568078|NCT03870529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568079|NCT03869190|Gemcitabine|gemcitabine|mesh-list
102568080|NCT03869190|Atezolizumab|atezolizumab|mesh-list
102568081|NCT03869190|Niraparib|niraparib|mesh-list
102568082|NCT03869190|Magrolimab|magrolimab|mesh-list
102568083|NCT03869190|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
102568084|NCT03869190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568085|NCT03869190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102568086|NCT03869190|Antimetabolites|antimetabolites|mesh-ancestor
102568087|NCT03869190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568088|NCT03869190|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102568089|NCT03869190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102568090|NCT03869190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102568091|NCT03869190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102568092|NCT03869190|Immunoconjugates|immunoconjugates|mesh-ancestor
102568093|NCT03869190|Immunologic Factors|immunologic factors|mesh-ancestor
102568094|NCT03869190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568095|NCT03846310|Carboplatin|carboplatin|mesh-list
102568096|NCT03846310|Pembrolizumab|pembrolizumab|mesh-list
102568097|NCT03846310|Pemetrexed|pemetrexed|mesh-list
102568098|NCT03846310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568099|NCT03846310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102568100|NCT03846310|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102568101|NCT03846310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568102|NCT03846310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102568103|NCT03846310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102568104|NCT03846310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102568105|NCT03836040|Erenumab|erenumab|mesh-list
102568106|NCT03836040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102568107|NCT03836040|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
102568108|NCT03836040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568109|NCT03836040|Analgesics|analgesics|mesh-ancestor
102568110|NCT03836040|Sensory System Agents|sensory system agents|mesh-ancestor
102568111|NCT03836040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102568112|NCT03836040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568113|NCT03836040|Immunologic Factors|immunologic factors|mesh-ancestor
102568114|NCT03832998|Erenumab|erenumab|mesh-list
102568115|NCT03832998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102568116|NCT03832998|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
102568117|NCT03832998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568118|NCT03832998|Analgesics|analgesics|mesh-ancestor
102568119|NCT03832998|Sensory System Agents|sensory system agents|mesh-ancestor
102568120|NCT03832998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102568121|NCT03832998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568122|NCT03832998|Immunologic Factors|immunologic factors|mesh-ancestor
102568123|NCT03824483|Venetoclax|venetoclax|mesh-list
102568124|NCT03824483|Obinutuzumab|obinutuzumab|mesh-list
102568125|NCT03824483|Zanubrutinib|zanubrutinib|mesh-list
102568126|NCT03824483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568127|NCT03824483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102568128|NCT03824483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102568129|NCT03824483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102568130|NCT03824483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568131|NCT03818776|Durvalumab|durvalumab|mesh-list
102568132|NCT03818776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102568133|NCT03818776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568134|NCT03816163|Paclitaxel|paclitaxel|mesh-list
102568135|NCT03816163|Gemcitabine|gemcitabine|mesh-list
102568136|NCT03816163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102568137|NCT03816163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568138|NCT03816163|Tubulin Modulators|tubulin modulators|mesh-ancestor
102568139|NCT03816163|Antimitotic Agents|antimitotic agents|mesh-ancestor
102568140|NCT03816163|Mitosis Modulators|mitosis modulators|mesh-ancestor
102568141|NCT03816163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568142|NCT03816163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102568143|NCT03816163|Antimetabolites|antimetabolites|mesh-ancestor
102568144|NCT03796273|Ketoconazole|ketoconazole|mesh-list
102568145|NCT03796273|Antifungal Agents|antifungal agents|mesh-ancestor
102568146|NCT03796273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102568147|NCT03796273|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102568148|NCT03796273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102568149|NCT03796273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102568150|NCT03796273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568151|NCT03796273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102568152|NCT03796273|Hormone Antagonists|hormone antagonists|mesh-ancestor
102612395|NCT00002447|Efavirenz|efavirenz|mesh-list
102568153|NCT03796273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102568154|NCT03796273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568155|NCT03796273|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102568156|NCT03778229|Osimertinib|osimertinib|mesh-list
102568157|NCT03778229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568158|NCT03778229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102568159|NCT03778229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102568160|NCT03778229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568161|NCT03748823|Ravulizumab|ravulizumab|mesh-list
102568162|NCT03748823|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102568163|NCT03748823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102568164|NCT03748823|Immunologic Factors|immunologic factors|mesh-ancestor
102568165|NCT03748823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568166|NCT03744468|Tislelizumab|tislelizumab|mesh-list
102568167|NCT03744468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102568168|NCT03744468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568169|NCT03742895|Olaparib|olaparib|mesh-list
102568170|NCT03742895|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102568171|NCT03742895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102568172|NCT03742895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568173|NCT03742895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568174|NCT03739931|Durvalumab|durvalumab|mesh-list
102568175|NCT03739931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102568176|NCT03739931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568177|NCT03738800|Trifarotene|trifarotene|mesh-list
102568178|NCT03738800|Dermatologic Agents|dermatologic agents|mesh-ancestor
102568179|NCT03736889|Tislelizumab|tislelizumab|mesh-list
102568180|NCT03736889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102568181|NCT03736889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568182|NCT03719326|Paclitaxel|paclitaxel|mesh-list
102568183|NCT03719326|Doxorubicin|doxorubicin|mesh-list
102568184|NCT03719326|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102568185|NCT03719326|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102568186|NCT03719326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102568187|NCT03719326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568188|NCT03719326|Tubulin Modulators|tubulin modulators|mesh-ancestor
102568189|NCT03719326|Antimitotic Agents|antimitotic agents|mesh-ancestor
102568190|NCT03719326|Mitosis Modulators|mitosis modulators|mesh-ancestor
102369652|NCT03431142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568191|NCT03719326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568192|NCT03719326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102568193|NCT03719326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102568194|NCT03719326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102568195|NCT03719326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102568196|NCT03717909|Valproic Acid|valproic acid|mesh-list
102568197|NCT03717909|Anticonvulsants|anticonvulsants|mesh-ancestor
102568198|NCT03717909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102568199|NCT03717909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568200|NCT03717909|GABA Agents|gaba agents|mesh-ancestor
102568201|NCT03717909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102568202|NCT03717909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568203|NCT03717909|Antimanic Agents|antimanic agents|mesh-ancestor
102568204|NCT03717909|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102568205|NCT03717909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102568206|NCT03717909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102568207|NCT03715478|Dexamethasone|dexamethasone|mesh-list
102568208|NCT03715478|Pomalidomide|pomalidomide|mesh-list
102568209|NCT03715478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102568210|NCT03715478|Antiemetics|antiemetics|mesh-ancestor
102568211|NCT03715478|Autonomic Agents|autonomic agents|mesh-ancestor
102568212|NCT03715478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102568213|NCT03715478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568214|NCT03715478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102568215|NCT03715478|Glucocorticoids|glucocorticoids|mesh-ancestor
102568216|NCT03715478|Hormones|hormones|mesh-ancestor
102568217|NCT03715478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102568218|NCT03715478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102568219|NCT03715478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568220|NCT03715478|Immunologic Factors|immunologic factors|mesh-ancestor
102568221|NCT03715478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102568222|NCT03715478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102568223|NCT03715478|Growth Substances|growth substances|mesh-ancestor
102568224|NCT03715478|Growth Inhibitors|growth inhibitors|mesh-ancestor
102568225|NCT03709043|Ethanol|ethanol|mesh-list
102568226|NCT03709043|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102115169|NCT02319564|Hormones|hormones|mesh-ancestor
102568227|NCT03709043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102568228|NCT03709043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102568229|NCT03709043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568231|NCT03701581|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102568232|NCT03701581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102568233|NCT03701581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568234|NCT03700138|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102568235|NCT03700138|Immunologic Factors|immunologic factors|mesh-ancestor
102568236|NCT03700138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568237|NCT03688464|Diphenhydramine|diphenhydramine|mesh-list
102568238|NCT03688464|Promethazine|promethazine|mesh-list
102568239|NCT03688464|Melatonin|melatonin|mesh-list
102568240|NCT03688464|Antioxidants|antioxidants|mesh-ancestor
102568241|NCT03688464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568242|NCT03688464|Protective Agents|protective agents|mesh-ancestor
102568243|NCT03688464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568244|NCT03688464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102568245|NCT03688464|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102568246|NCT03688464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102568247|NCT03688464|Anesthetics, Local|anesthetics, local|mesh-ancestor
102568248|NCT03688464|Anesthetics|anesthetics|mesh-ancestor
102568249|NCT03688464|Sensory System Agents|sensory system agents|mesh-ancestor
102568250|NCT03688464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102568251|NCT03688464|Antiemetics|antiemetics|mesh-ancestor
102568252|NCT03688464|Autonomic Agents|autonomic agents|mesh-ancestor
102568253|NCT03688464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102568254|NCT03688464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102568255|NCT03688464|Histamine Antagonists|histamine antagonists|mesh-ancestor
102568256|NCT03688464|Histamine Agents|histamine agents|mesh-ancestor
102568257|NCT03688464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102568258|NCT03688464|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102568259|NCT03688464|Antipruritics|antipruritics|mesh-ancestor
102568260|NCT03688464|Dermatologic Agents|dermatologic agents|mesh-ancestor
102568261|NCT03684811|Gemcitabine|gemcitabine|mesh-list
102568262|NCT03684811|Nivolumab|nivolumab|mesh-list
102568263|NCT03684811|Azacitidine|azacitidine|mesh-list
102568264|NCT03684811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568265|NCT03684811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102568266|NCT03684811|Antimetabolites|antimetabolites|mesh-ancestor
102568267|NCT03684811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568268|NCT03684811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102568269|NCT03684811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102568270|NCT03684811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102568271|NCT03677973|Quemliclustat|quemliclustat|mesh-list
102568272|NCT03677973|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102568273|NCT03677973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568274|NCT03677973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102568275|NCT03677973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568276|NCT03666273|Pembrolizumab|pembrolizumab|mesh-list
102568277|NCT03666273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102568278|NCT03666273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568279|NCT03666273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102568280|NCT03666273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568281|NCT03666065|Insulin|insulin|mesh-list
102568282|NCT03666065|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102568283|NCT03666065|Insulin Aspart|insulin aspart|mesh-list
102568284|NCT03666065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102568285|NCT03666065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568286|NCT03656536|Gemcitabine|gemcitabine|mesh-list
102568287|NCT03656536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568288|NCT03656536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102568289|NCT03656536|Antimetabolites|antimetabolites|mesh-ancestor
102568290|NCT03656536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568291|NCT03654716|Cytarabine|cytarabine|mesh-list
102568292|NCT03654716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102568293|NCT03654716|Antimetabolites|antimetabolites|mesh-ancestor
102568294|NCT03654716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568295|NCT03654716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568296|NCT03654716|Antiviral Agents|antiviral agents|mesh-ancestor
102568297|NCT03654716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102568298|NCT03654716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102568299|NCT03654716|Immunologic Factors|immunologic factors|mesh-ancestor
102115245|NCT05515120|Protease Inhibitors|protease inhibitors|mesh-ancestor
102568301|NCT03653364|Baloxavir|baloxavir|mesh-list
102568302|NCT03653364|Antiviral Agents|antiviral agents|mesh-ancestor
102568303|NCT03653364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102568304|NCT03653364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102568305|NCT03653364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568306|NCT03646123|Doxorubicin|doxorubicin|mesh-list
102568307|NCT03646123|Nivolumab|nivolumab|mesh-list
102568308|NCT03646123|Dacarbazine|dacarbazine|mesh-list
102568309|NCT03646123|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102568310|NCT03646123|Vinblastine|vinblastine|mesh-list
102568311|NCT03646123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102568312|NCT03646123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568313|NCT03646123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102568314|NCT03646123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102568315|NCT03646123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102568316|NCT03646123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568317|NCT03646123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102568318|NCT03646123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102568319|NCT03646123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102568320|NCT03646123|Alkylating Agents|alkylating agents|mesh-ancestor
102568321|NCT03646123|Immunotoxins|immunotoxins|mesh-ancestor
102568322|NCT03646123|Immunoconjugates|immunoconjugates|mesh-ancestor
102568323|NCT03646123|Immunologic Factors|immunologic factors|mesh-ancestor
102568324|NCT03646123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568325|NCT03646123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102568326|NCT03646123|Tubulin Modulators|tubulin modulators|mesh-ancestor
102568327|NCT03646123|Antimitotic Agents|antimitotic agents|mesh-ancestor
102568328|NCT03646123|Mitosis Modulators|mitosis modulators|mesh-ancestor
102568329|NCT03629613|Antioxidants|antioxidants|mesh-list
102568330|NCT03629613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568331|NCT03629613|Protective Agents|protective agents|mesh-ancestor
102568332|NCT03629613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568333|NCT03617458|Metformin|metformin|mesh-list
102568334|NCT03617458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102568335|NCT03617458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568336|NCT03610971|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102568337|NCT03610971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102568338|NCT03610971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102568339|NCT03610971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568340|NCT03606538|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
102568341|NCT03606538|Hallucinogens|hallucinogens|mesh-ancestor
102568342|NCT03606538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568343|NCT03606538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102568344|NCT03606538|Serotonin Agents|serotonin agents|mesh-ancestor
102568345|NCT03606538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102568346|NCT03606538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568347|NCT03606538|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102568348|NCT03606538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102568349|NCT03606538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102568350|NCT03606538|Adrenergic Agents|adrenergic agents|mesh-ancestor
102568351|NCT03605927|Sirolimus|sirolimus|mesh-list
102568352|NCT03605927|Tacrolimus|tacrolimus|mesh-list
102568353|NCT03605927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102568354|NCT03605927|Immunologic Factors|immunologic factors|mesh-ancestor
102568355|NCT03605927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568356|NCT03605927|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102568357|NCT03605927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102568358|NCT03605927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568359|NCT03605927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102568360|NCT03605927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102568361|NCT03605927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102568362|NCT03605927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568363|NCT03605927|Antifungal Agents|antifungal agents|mesh-ancestor
102568364|NCT03586284|Valganciclovir|valganciclovir|mesh-list
102568365|NCT03586284|Ganciclovir|ganciclovir|mesh-list
102568366|NCT03586284|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102568367|NCT03586284|Antiviral Agents|antiviral agents|mesh-ancestor
102568368|NCT03586284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102568369|NCT03586284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102568370|NCT03586284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102568371|NCT03586284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568372|NCT03583086|Nivolumab|nivolumab|mesh-list
102568373|NCT03583086|Vorolanib|vorolanib|mesh-list
102568374|NCT03583086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102568375|NCT03583086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568376|NCT03583086|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102568377|NCT03583086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568378|NCT03583086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102568379|NCT03583086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102568380|NCT03580499|Vitamins|vitamins|mesh-list
102568381|NCT03580499|Vitamin B 6|vitamin b 6|mesh-list
102568382|NCT03580499|Pyridoxal|pyridoxal|mesh-list
102568383|NCT03580499|Pyridoxine|pyridoxine|mesh-list
102568384|NCT03580499|Vitamin B Complex|vitamin b complex|mesh-list
102568385|NCT03580499|Micronutrients|micronutrients|mesh-ancestor
102568386|NCT03580499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568387|NCT03557619|Venetoclax|venetoclax|mesh-list
102568388|NCT03557619|Levonorgestrel|levonorgestrel|mesh-list
102568389|NCT03557619|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102568390|NCT03557619|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
102568391|NCT03557619|Estradiol|estradiol|mesh-list
102568392|NCT03557619|Estrogens|estrogens|mesh-ancestor
102568393|NCT03557619|Hormones|hormones|mesh-ancestor
102568394|NCT03557619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102568395|NCT03557619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568396|NCT03557619|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102568397|NCT03557619|Contraceptive Agents|contraceptive agents|mesh-ancestor
102568398|NCT03557619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102568399|NCT03557619|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102568400|NCT03557619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568401|NCT03557619|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102568402|NCT03557619|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102568403|NCT03557619|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102568404|NCT03557619|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102568405|NCT03534804|Pembrolizumab|pembrolizumab|mesh-list
102568406|NCT03534804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102568407|NCT03534804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568408|NCT03534804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102568409|NCT03534804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568410|NCT03533582|Cisplatin|cisplatin|mesh-list
102568411|NCT03533582|Carboplatin|carboplatin|mesh-list
102568412|NCT03533582|Gemcitabine|gemcitabine|mesh-list
102568413|NCT03533582|Doxorubicin|doxorubicin|mesh-list
102568414|NCT03533582|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102568415|NCT03533582|Fluorouracil|fluorouracil|mesh-list
102568416|NCT03533582|Oxaliplatin|oxaliplatin|mesh-list
102568417|NCT03533582|Irinotecan|irinotecan|mesh-list
102568418|NCT03533582|Etoposide|etoposide|mesh-list
102568419|NCT03533582|Vincristine|vincristine|mesh-list
102568420|NCT03533582|Etoposide phosphate|etoposide phosphate|mesh-list
102568421|NCT03533582|Sorafenib|sorafenib|mesh-list
102568422|NCT03533582|Daunorubicin|daunorubicin|mesh-list
102568423|NCT03533582|Podophyllotoxin|podophyllotoxin|mesh-list
102568424|NCT03533582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568425|NCT03533582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102568426|NCT03533582|Antimetabolites|antimetabolites|mesh-ancestor
102568427|NCT03533582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568428|NCT03533582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102568429|NCT03533582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102568430|NCT03533582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102568431|NCT03533582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102568432|NCT03533582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102568433|NCT03533582|Immunologic Factors|immunologic factors|mesh-ancestor
102568434|NCT03533582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568435|NCT03533582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102568436|NCT03533582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102568437|NCT03533582|Tubulin Modulators|tubulin modulators|mesh-ancestor
102568438|NCT03533582|Antimitotic Agents|antimitotic agents|mesh-ancestor
102568439|NCT03533582|Mitosis Modulators|mitosis modulators|mesh-ancestor
102568440|NCT03533582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102568441|NCT03533582|Keratolytic Agents|keratolytic agents|mesh-ancestor
102568442|NCT03533582|Dermatologic Agents|dermatologic agents|mesh-ancestor
102568443|NCT03532477|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102568444|NCT03532477|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102568445|NCT03532477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102568446|NCT03532477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102568447|NCT03532477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568448|NCT03532477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102568449|NCT03532477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568450|NCT03532477|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102568451|NCT03532477|Antidepressive Agents|antidepressive agents|mesh-ancestor
102568452|NCT03532477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102568454|NCT03530267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102568455|NCT03530267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102568456|NCT03530267|Growth Substances|growth substances|mesh-ancestor
102568457|NCT03530267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568458|NCT03530267|Growth Inhibitors|growth inhibitors|mesh-ancestor
102568459|NCT03530267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568460|NCT03515837|Carboplatin|carboplatin|mesh-list
102568461|NCT03515837|Pembrolizumab|pembrolizumab|mesh-list
102568462|NCT03515837|Pemetrexed|pemetrexed|mesh-list
102568463|NCT03515837|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102568464|NCT03515837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568465|NCT03515837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102568466|NCT03515837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102568467|NCT03515837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568468|NCT03515837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102568469|NCT03515837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102568470|NCT03515837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102568471|NCT03505320|Leucovorin|leucovorin|mesh-list
102568472|NCT03505320|Folic Acid|folic acid|mesh-list
102568473|NCT03505320|Pembrolizumab|pembrolizumab|mesh-list
102568474|NCT03505320|Nivolumab|nivolumab|mesh-list
102568475|NCT03505320|Fluorouracil|fluorouracil|mesh-list
102568476|NCT03505320|Oxaliplatin|oxaliplatin|mesh-list
102568477|NCT03505320|Levoleucovorin|levoleucovorin|mesh-list
102568478|NCT03505320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102568479|NCT03505320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568480|NCT03505320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102275637|NCT02340481|Emollients|emollients|mesh-ancestor
102568481|NCT03505320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568482|NCT03505320|Antimetabolites|antimetabolites|mesh-ancestor
102568483|NCT03505320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102568484|NCT03505320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102568485|NCT03505320|Immunologic Factors|immunologic factors|mesh-ancestor
102568486|NCT03505320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568487|NCT03505320|Antidotes|antidotes|mesh-ancestor
102568488|NCT03505320|Protective Agents|protective agents|mesh-ancestor
102568489|NCT03505320|Vitamin B Complex|vitamin b complex|mesh-ancestor
102568490|NCT03505320|Vitamins|vitamins|mesh-ancestor
102568491|NCT03505320|Micronutrients|micronutrients|mesh-ancestor
102568492|NCT03505320|Hematinics|hematinics|mesh-ancestor
102568493|NCT03493412|Verapamil|verapamil|mesh-list
102568494|NCT03493412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102568495|NCT03493412|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102568496|NCT03493412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102568497|NCT03493412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568498|NCT03493412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102568499|NCT03493412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568500|NCT03493412|Vasodilator Agents|vasodilator agents|mesh-ancestor
102568501|NCT03475186|Ramipril|ramipril|mesh-list
102568502|NCT03475186|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102568503|NCT03475186|Protease Inhibitors|protease inhibitors|mesh-ancestor
102568504|NCT03475186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102568505|NCT03475186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568506|NCT03475186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102568507|NCT03474198|Levofloxacin|levofloxacin|mesh-list
102568508|NCT03474198|Rifampin|rifampin|mesh-list
102568509|NCT03474198|Isoniazid|isoniazid|mesh-list
102568510|NCT03474198|Linezolid|linezolid|mesh-list
102568511|NCT03474198|Pyrazinamide|pyrazinamide|mesh-list
102568512|NCT03474198|Ethambutol|ethambutol|mesh-list
102568513|NCT03474198|Rifapentine|rifapentine|mesh-list
102568514|NCT03474198|Bedaquiline|bedaquiline|mesh-list
102568515|NCT03474198|Clofazimine|clofazimine|mesh-list
102568516|NCT03474198|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102568517|NCT03474198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102568518|NCT03474198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102568519|NCT03474198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102568520|NCT03474198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102568521|NCT03474198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102568522|NCT03474198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568523|NCT03474198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568524|NCT03474198|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102115469|NCT02513342|Docetaxel|docetaxel|mesh-list
102568525|NCT03474198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102568526|NCT03474198|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102568527|NCT03474198|Antitubercular Agents|antitubercular agents|mesh-ancestor
102568528|NCT03474198|Leprostatic Agents|leprostatic agents|mesh-ancestor
102568529|NCT03474198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102568530|NCT03474198|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102568531|NCT03474198|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102568532|NCT03474198|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102568533|NCT03474198|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102568534|NCT03474198|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102568535|NCT03474198|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102568536|NCT03474198|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102568537|NCT03474198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102568538|NCT03474198|Antimetabolites|antimetabolites|mesh-ancestor
102568539|NCT03474198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102568540|NCT03474198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102568541|NCT03474198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102568542|NCT03452111|ST 1435|st 1435|mesh-list
102568543|NCT03452111|Testosterone|testosterone|mesh-list
102568544|NCT03452111|Androgens|androgens|mesh-ancestor
102568545|NCT03452111|Hormones|hormones|mesh-ancestor
102568546|NCT03452111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102568547|NCT03452111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568548|NCT03452111|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102568549|NCT03452111|Contraceptive Agents|contraceptive agents|mesh-ancestor
102568550|NCT03452111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102568551|NCT03452111|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102568552|NCT03440385|Ozanimod|ozanimod|mesh-list
102568553|NCT03440385|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101940919|NCT01123551|Analgesics|analgesics|mesh-ancestor
102568554|NCT03440385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568555|NCT03440385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102568556|NCT03440385|Immunologic Factors|immunologic factors|mesh-ancestor
102568557|NCT03440385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568558|NCT03421288|Leucovorin|leucovorin|mesh-list
102568559|NCT03421288|Docetaxel|docetaxel|mesh-list
102568560|NCT03421288|Fluorouracil|fluorouracil|mesh-list
102568561|NCT03421288|Oxaliplatin|oxaliplatin|mesh-list
102568562|NCT03421288|Atezolizumab|atezolizumab|mesh-list
102568563|NCT03421288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568564|NCT03421288|Tubulin Modulators|tubulin modulators|mesh-ancestor
102568565|NCT03421288|Antimitotic Agents|antimitotic agents|mesh-ancestor
102568566|NCT03421288|Mitosis Modulators|mitosis modulators|mesh-ancestor
102568567|NCT03421288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568568|NCT03421288|Antimetabolites|antimetabolites|mesh-ancestor
102568569|NCT03421288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102568570|NCT03421288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102568571|NCT03421288|Immunologic Factors|immunologic factors|mesh-ancestor
102568572|NCT03421288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568573|NCT03421288|Antidotes|antidotes|mesh-ancestor
102568574|NCT03421288|Protective Agents|protective agents|mesh-ancestor
102568575|NCT03421288|Vitamin B Complex|vitamin b complex|mesh-ancestor
102568576|NCT03421288|Vitamins|vitamins|mesh-ancestor
102568577|NCT03421288|Micronutrients|micronutrients|mesh-ancestor
102568578|NCT03421288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102568579|NCT03421288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102568580|NCT03418922|Nivolumab|nivolumab|mesh-list
102568581|NCT03418922|Lenvatinib|lenvatinib|mesh-list
102568582|NCT03418922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102568583|NCT03418922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568584|NCT03418922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102568585|NCT03418922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568586|NCT03418922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102568587|NCT03418922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102568588|NCT03400826|Simvastatin|simvastatin|mesh-list
102568589|NCT03400826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102568590|NCT03400826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102568591|NCT03400826|Antimetabolites|antimetabolites|mesh-ancestor
102568592|NCT03400826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568593|NCT03400826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102568594|NCT03400826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102568595|NCT03400826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102568596|NCT03400332|Nivolumab|nivolumab|mesh-list
102568597|NCT03400332|Ipilimumab|ipilimumab|mesh-list
102568598|NCT03400332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102568599|NCT03400332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568600|NCT03400332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102568601|NCT03400332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568602|NCT03386578|Tenofovir|tenofovir|mesh-list
102568603|NCT03386578|Emtricitabine|emtricitabine|mesh-list
102568604|NCT03386578|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102568605|NCT03386578|Antiviral Agents|antiviral agents|mesh-ancestor
102568606|NCT03386578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102568607|NCT03386578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102568608|NCT03386578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102568609|NCT03386578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102568610|NCT03386578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568611|NCT03386578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102568612|NCT03386578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102568613|NCT03371017|Carboplatin|carboplatin|mesh-list
102568614|NCT03371017|Gemcitabine|gemcitabine|mesh-list
102568615|NCT03371017|Capecitabine|capecitabine|mesh-list
102568616|NCT03371017|Atezolizumab|atezolizumab|mesh-list
102568617|NCT03371017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568618|NCT03371017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102568619|NCT03371017|Antimetabolites|antimetabolites|mesh-ancestor
102568620|NCT03371017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568621|NCT03371017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102568622|NCT03371017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102568623|NCT03367533|Ketamine|ketamine|mesh-list
102568624|NCT03367533|Analgesics|analgesics|mesh-ancestor
102568625|NCT03367533|Sensory System Agents|sensory system agents|mesh-ancestor
102568626|NCT03367533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102568627|NCT03367533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568628|NCT03367533|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102568629|NCT03367533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102568630|NCT03367533|Anesthetics, General|anesthetics, general|mesh-ancestor
102568631|NCT03367533|Anesthetics|anesthetics|mesh-ancestor
102568632|NCT03367533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102568633|NCT03367533|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102568634|NCT03367533|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102568635|NCT03367533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102568636|NCT03367533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568637|NCT03360721|Prednisone|prednisone|mesh-list
102568638|NCT03360721|Cortisone|cortisone|mesh-list
102568639|NCT03360721|Abiraterone Acetate|abiraterone acetate|mesh-list
102568640|NCT03360721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102568641|NCT03360721|Glucocorticoids|glucocorticoids|mesh-ancestor
102568642|NCT03360721|Hormones|hormones|mesh-ancestor
102568643|NCT03360721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102568644|NCT03360721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568645|NCT03360721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102568646|NCT03360721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568647|NCT03360721|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102568648|NCT03360721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102568649|NCT03360721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568650|NCT03360721|Hormone Antagonists|hormone antagonists|mesh-ancestor
102568651|NCT03360721|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102568652|NCT03345576|Methyltestosterone|methyltestosterone|mesh-list
102568653|NCT03345576|Testosterone|testosterone|mesh-list
102568654|NCT03345576|Testosterone undecanoate|testosterone undecanoate|mesh-list
102568655|NCT03345576|Testosterone enanthate|testosterone enanthate|mesh-list
102568656|NCT03345576|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102568657|NCT03345576|Androgens|androgens|mesh-ancestor
102568658|NCT03345576|Hormones|hormones|mesh-ancestor
102568659|NCT03345576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102568660|NCT03345576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568661|NCT03345576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102568662|NCT03345576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568663|NCT03345576|Anabolic Agents|anabolic agents|mesh-ancestor
102568664|NCT03342027|Bupropion|bupropion|mesh-list
102568665|NCT03342027|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102568666|NCT03342027|Antidepressive Agents|antidepressive agents|mesh-ancestor
102568667|NCT03342027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102568668|NCT03342027|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102568669|NCT03342027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102568670|NCT03342027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102568671|NCT03342027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568672|NCT03342027|Dopamine Agents|dopamine agents|mesh-ancestor
102568673|NCT03342027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102568674|NCT03342027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568675|NCT03342027|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102568676|NCT03342027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102568677|NCT03342027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102568678|NCT03337698|Linagliptin|linagliptin|mesh-list
102568679|NCT03337698|Bevacizumab|bevacizumab|mesh-list
102568680|NCT03337698|Atezolizumab|atezolizumab|mesh-list
102568681|NCT03337698|Carboplatin|carboplatin|mesh-list
102568682|NCT03337698|Gemcitabine|gemcitabine|mesh-list
102568683|NCT03337698|Docetaxel|docetaxel|mesh-list
102568684|NCT03337698|Pemetrexed|pemetrexed|mesh-list
102568685|NCT03337698|Ipatasertib|ipatasertib|mesh-list
102568686|NCT03337698|Evolocumab|evolocumab|mesh-list
102568687|NCT03337698|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
102568688|NCT03337698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102568689|NCT03337698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568690|NCT03337698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102568691|NCT03337698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102568692|NCT03337698|Growth Substances|growth substances|mesh-ancestor
102568693|NCT03337698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568694|NCT03337698|Growth Inhibitors|growth inhibitors|mesh-ancestor
102568695|NCT03337698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102568696|NCT03337698|Antimetabolites|antimetabolites|mesh-ancestor
102568697|NCT03337698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568698|NCT03337698|Tubulin Modulators|tubulin modulators|mesh-ancestor
102568699|NCT03337698|Antimitotic Agents|antimitotic agents|mesh-ancestor
102568700|NCT03337698|Mitosis Modulators|mitosis modulators|mesh-ancestor
102568701|NCT03337698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102568702|NCT03337698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102568703|NCT03337698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102568704|NCT03337698|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102568705|NCT03337698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102568706|NCT03337698|Incretins|incretins|mesh-ancestor
102568707|NCT03337698|Hormones|hormones|mesh-ancestor
102568708|NCT03337698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102568709|NCT03337698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102568710|NCT03337698|Protease Inhibitors|protease inhibitors|mesh-ancestor
102568711|NCT03337698|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102568712|NCT03337698|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102568713|NCT03337698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102568714|NCT03337698|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102568715|NCT03337698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102568716|NCT03337698|Immunoconjugates|immunoconjugates|mesh-ancestor
102568717|NCT03337698|Immunologic Factors|immunologic factors|mesh-ancestor
102568718|NCT03337698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102568719|NCT03334617|Trastuzumab|trastuzumab|mesh-list
102568720|NCT03334617|Durvalumab|durvalumab|mesh-list
102568721|NCT03334617|Olaparib|olaparib|mesh-list
102568722|NCT03334617|Cediranib|cediranib|mesh-list
102568723|NCT03334617|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
102568724|NCT03334617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102568725|NCT03334617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568726|NCT03334617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102568727|NCT03334617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102568728|NCT03334617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568729|NCT03334617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102568730|NCT03334617|Immunoconjugates|immunoconjugates|mesh-ancestor
102568731|NCT03334617|Immunologic Factors|immunologic factors|mesh-ancestor
102568732|NCT03334617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568733|NCT03326245|Methylphenidate|methylphenidate|mesh-list
102568734|NCT03326245|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102568735|NCT03326245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568736|NCT03326245|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102568737|NCT03326245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102568738|NCT03326245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102568739|NCT03326245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568740|NCT03326245|Dopamine Agents|dopamine agents|mesh-ancestor
102568741|NCT03326245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102568742|NCT03263572|Cytarabine|cytarabine|mesh-list
102568743|NCT03263572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102568744|NCT03263572|Methotrexate|methotrexate|mesh-list
102568745|NCT03263572|Blinatumomab|blinatumomab|mesh-list
102568746|NCT03263572|Ponatinib|ponatinib|mesh-list
102115699|NCT02511704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102568747|NCT03263572|Antibodies|antibodies|mesh-list
102568748|NCT03263572|Immunoglobulins|immunoglobulins|mesh-list
102568749|NCT03263572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102568750|NCT03263572|Muromonab-CD3|muromonab-cd3|mesh-list
102568751|NCT03263572|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102568752|NCT03263572|Immunologic Factors|immunologic factors|mesh-ancestor
102568753|NCT03263572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568754|NCT03263572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568755|NCT03263572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102568756|NCT03263572|Abortifacient Agents|abortifacient agents|mesh-ancestor
102568757|NCT03263572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102568758|NCT03263572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102568759|NCT03263572|Antimetabolites|antimetabolites|mesh-ancestor
102568760|NCT03263572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568761|NCT03263572|Dermatologic Agents|dermatologic agents|mesh-ancestor
102568762|NCT03263572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102568763|NCT03263572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102568764|NCT03263572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102568765|NCT03263572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102568766|NCT03263572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102568767|NCT03263572|Antiviral Agents|antiviral agents|mesh-ancestor
102568768|NCT03263572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102568769|NCT03263572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102568770|NCT03245541|Durvalumab|durvalumab|mesh-list
102568771|NCT03245541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102568772|NCT03245541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568773|NCT03245489|Aspirin|aspirin|mesh-list
102568774|NCT03245489|Pembrolizumab|pembrolizumab|mesh-list
102568775|NCT03245489|Clopidogrel|clopidogrel|mesh-list
102275647|NCT05253781|Analgesics|analgesics|mesh-ancestor
102568776|NCT03245489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102568777|NCT03245489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568778|NCT03245489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102568779|NCT03245489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568780|NCT03245489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102568781|NCT03245489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102568782|NCT03245489|Analgesics|analgesics|mesh-ancestor
102568783|NCT03245489|Sensory System Agents|sensory system agents|mesh-ancestor
102568784|NCT03245489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102568785|NCT03245489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568786|NCT03245489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102568787|NCT03245489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102568788|NCT03245489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102568789|NCT03245489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102568790|NCT03245489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102568791|NCT03245489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102568792|NCT03245489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102568793|NCT03245489|Antipyretics|antipyretics|mesh-ancestor
102568794|NCT03245489|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102568795|NCT03245489|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102568796|NCT03245489|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102568797|NCT03245489|Purinergic Agents|purinergic agents|mesh-ancestor
102568798|NCT03245489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102568799|NCT03240809|Brodalumab|brodalumab|mesh-list
102568800|NCT03240809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102568801|NCT03240809|Dermatologic Agents|dermatologic agents|mesh-ancestor
102568802|NCT03240809|Immunologic Factors|immunologic factors|mesh-ancestor
102568803|NCT03240809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568804|NCT03215030|Dexamethasone|dexamethasone|mesh-list
102568805|NCT03215030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102568806|NCT03215030|Antiemetics|antiemetics|mesh-ancestor
102568807|NCT03215030|Autonomic Agents|autonomic agents|mesh-ancestor
102568808|NCT03215030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102568809|NCT03215030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568810|NCT03215030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102568811|NCT03215030|Glucocorticoids|glucocorticoids|mesh-ancestor
102568812|NCT03215030|Hormones|hormones|mesh-ancestor
102568813|NCT03215030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102568814|NCT03215030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102568815|NCT03215030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568816|NCT03192995|Cocaine|cocaine|mesh-list
102568817|NCT03192995|Anesthetics, Local|anesthetics, local|mesh-ancestor
102568818|NCT03192995|Anesthetics|anesthetics|mesh-ancestor
102568819|NCT03192995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102568820|NCT03192995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568821|NCT03192995|Sensory System Agents|sensory system agents|mesh-ancestor
102568822|NCT03192995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102568823|NCT03192995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102568824|NCT03192995|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102568825|NCT03192995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102568826|NCT03192995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102568827|NCT03192995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568828|NCT03192995|Dopamine Agents|dopamine agents|mesh-ancestor
102568829|NCT03192995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102568830|NCT03190954|Raclopride|raclopride|mesh-list
102568831|NCT03190954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102568832|NCT03190954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102568833|NCT03190954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102568834|NCT03190954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568835|NCT03190954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102568836|NCT03190954|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102568837|NCT03190954|Dopamine Agents|dopamine agents|mesh-ancestor
102568838|NCT03190954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102568839|NCT03190954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568840|NCT03178552|Bevacizumab|bevacizumab|mesh-list
102568841|NCT03178552|Atezolizumab|atezolizumab|mesh-list
102568842|NCT03178552|Carboplatin|carboplatin|mesh-list
102568843|NCT03178552|Gemcitabine|gemcitabine|mesh-list
102568844|NCT03178552|Docetaxel|docetaxel|mesh-list
102568845|NCT03178552|Pemetrexed|pemetrexed|mesh-list
102568846|NCT03178552|Vemurafenib|vemurafenib|mesh-list
102568847|NCT03178552|Entrectinib|entrectinib|mesh-list
102568848|NCT03178552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102568849|NCT03178552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568850|NCT03178552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102568851|NCT03178552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102568852|NCT03178552|Growth Substances|growth substances|mesh-ancestor
102568853|NCT03178552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568854|NCT03178552|Growth Inhibitors|growth inhibitors|mesh-ancestor
102568855|NCT03178552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102568856|NCT03178552|Antimetabolites|antimetabolites|mesh-ancestor
102568857|NCT03178552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568858|NCT03178552|Tubulin Modulators|tubulin modulators|mesh-ancestor
102568859|NCT03178552|Antimitotic Agents|antimitotic agents|mesh-ancestor
102568860|NCT03178552|Mitosis Modulators|mitosis modulators|mesh-ancestor
102568861|NCT03178552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102568862|NCT03178552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102568863|NCT03178552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102568864|NCT03178552|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102568865|NCT03178552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102568866|NCT03174977|Raltegravir Potassium|raltegravir potassium|mesh-list
102568867|NCT03174977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102568868|NCT03174977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102568869|NCT03174977|Antiviral Agents|antiviral agents|mesh-ancestor
102568870|NCT03174977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102568871|NCT03174977|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102568872|NCT03174977|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102568873|NCT03174977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102568874|NCT03174977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568875|NCT03150511|Tesamorelin|tesamorelin|mesh-list
102568876|NCT03150511|Growth Substances|growth substances|mesh-ancestor
102568877|NCT03150511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568878|NCT03149809|Solifenacin Succinate|solifenacin succinate|mesh-list
102568879|NCT03149809|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102568880|NCT03149809|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102568881|NCT03149809|Cholinergic Agents|cholinergic agents|mesh-ancestor
102568882|NCT03149809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102568883|NCT03149809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568884|NCT03149809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568885|NCT03149809|Urological Agents|urological agents|mesh-ancestor
102568886|NCT03121677|Poly I-C|poly i-c|mesh-list
102568887|NCT03121677|Rituximab|rituximab|mesh-list
102568888|NCT03121677|Nivolumab|nivolumab|mesh-list
102568889|NCT03121677|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102568890|NCT03121677|Poly ICLC|poly iclc|mesh-list
102568891|NCT03121677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102568892|NCT03121677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568893|NCT03121677|Immunologic Factors|immunologic factors|mesh-ancestor
102568894|NCT03121677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568895|NCT03121677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102568896|NCT03121677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102115850|NCT02515526|GABA Agents|gaba agents|mesh-ancestor
102568897|NCT03121677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568898|NCT03121677|Interferon Inducers|interferon inducers|mesh-ancestor
102568899|NCT03121677|Laxatives|laxatives|mesh-ancestor
102568900|NCT03121677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102568901|NCT03121677|Antiviral Agents|antiviral agents|mesh-ancestor
102568902|NCT03121677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102568903|NCT03114527|Everolimus|everolimus|mesh-list
102568904|NCT03114527|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102568905|NCT03114527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102568906|NCT03114527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102568907|NCT03114527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568908|NCT03114527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102568909|NCT03114527|Immunologic Factors|immunologic factors|mesh-ancestor
102568910|NCT03114527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568911|NCT03114527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568912|NCT03110926|Leucovorin|leucovorin|mesh-list
102568913|NCT03110926|Paclitaxel|paclitaxel|mesh-list
102568914|NCT03110926|Carboplatin|carboplatin|mesh-list
102568915|NCT03110926|Oxaliplatin|oxaliplatin|mesh-list
102568916|NCT03110926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102568917|NCT03110926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568918|NCT03110926|Tubulin Modulators|tubulin modulators|mesh-ancestor
102568919|NCT03110926|Antimitotic Agents|antimitotic agents|mesh-ancestor
102568920|NCT03110926|Mitosis Modulators|mitosis modulators|mesh-ancestor
102568921|NCT03110926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568922|NCT03110926|Antidotes|antidotes|mesh-ancestor
102568923|NCT03110926|Protective Agents|protective agents|mesh-ancestor
102568924|NCT03110926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568925|NCT03110926|Vitamin B Complex|vitamin b complex|mesh-ancestor
102568926|NCT03110926|Vitamins|vitamins|mesh-ancestor
102568927|NCT03110926|Micronutrients|micronutrients|mesh-ancestor
102568928|NCT03092856|Axitinib|axitinib|mesh-list
102568929|NCT03092856|Antibodies|antibodies|mesh-list
102568930|NCT03092856|Immunologic Factors|immunologic factors|mesh-ancestor
102568931|NCT03092856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568932|NCT03092856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568933|NCT03092856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102568934|NCT03092856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102568935|NCT03092856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568936|NCT03088813|Irinotecan|irinotecan|mesh-list
102568937|NCT03088813|Topotecan|topotecan|mesh-list
102568938|NCT03088813|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102568939|NCT03088813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102568940|NCT03088813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102568941|NCT03088813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568942|NCT03088813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568943|NCT03078010|Tazobactam|tazobactam|mesh-list
102568944|NCT03078010|Piperacillin|piperacillin|mesh-list
102568945|NCT03078010|Cefepime|cefepime|mesh-list
102568946|NCT03078010|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102568947|NCT03078010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102568948|NCT03078010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102568949|NCT03078010|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102568950|NCT03078010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102568951|NCT03078010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568952|NCT03075696|Obinutuzumab|obinutuzumab|mesh-list
102568953|NCT03075696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102568954|NCT03075696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568955|NCT03043950|Panitumumab|panitumumab|mesh-list
102568956|NCT03043950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102568957|NCT03043950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568958|NCT03041688|Decitabine|decitabine|mesh-list
102568959|NCT03041688|Venetoclax|venetoclax|mesh-list
102568960|NCT03041688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102568961|NCT03041688|Antimetabolites|antimetabolites|mesh-ancestor
102568962|NCT03041688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568963|NCT03041688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568964|NCT03041688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102568965|NCT03035331|Pembrolizumab|pembrolizumab|mesh-list
102568966|NCT03035331|Vaccines|vaccines|mesh-list
102568967|NCT03035331|Immunologic Factors|immunologic factors|mesh-ancestor
102568968|NCT03035331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568969|NCT03035331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102568970|NCT03035331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568971|NCT03035331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102568972|NCT03035331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568973|NCT02989636|Nivolumab|nivolumab|mesh-list
102568974|NCT02989636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102568975|NCT02989636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568976|NCT02989636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102568977|NCT02989636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568979|NCT02944500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102568980|NCT02944500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568981|NCT02944500|Incretins|incretins|mesh-ancestor
102568982|NCT02944500|Hormones|hormones|mesh-ancestor
102568983|NCT02944500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102568984|NCT02935361|Atezolizumab|atezolizumab|mesh-list
102568985|NCT02935361|Guadecitabine|guadecitabine|mesh-list
102568986|NCT02935361|Azacitidine|azacitidine|mesh-list
102568987|NCT02935361|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102568988|NCT02935361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102568989|NCT02935361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102568990|NCT02935361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102568991|NCT02935361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102568992|NCT02935361|Immunologic Factors|immunologic factors|mesh-ancestor
102568993|NCT02935361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102568994|NCT02935361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102568995|NCT02935361|Antimetabolites|antimetabolites|mesh-ancestor
102568996|NCT02935361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102568997|NCT02932618|Factor VIII|factor viii|mesh-list
102568998|NCT02932618|Coagulants|coagulants|mesh-ancestor
102568999|NCT02923934|Nivolumab|nivolumab|mesh-list
102569000|NCT02923934|Ipilimumab|ipilimumab|mesh-list
102569001|NCT02923934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102569002|NCT02923934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569003|NCT02923934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102569004|NCT02923934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569005|NCT02913313|Nivolumab|nivolumab|mesh-list
102569006|NCT02913313|Ipilimumab|ipilimumab|mesh-list
102569007|NCT02913313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102569008|NCT02913313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569009|NCT02913313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102569010|NCT02913313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569011|NCT02908477|Docetaxel|docetaxel|mesh-list
102569012|NCT02908477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569013|NCT02908477|Tubulin Modulators|tubulin modulators|mesh-ancestor
102569014|NCT02908477|Antimitotic Agents|antimitotic agents|mesh-ancestor
102569015|NCT02908477|Mitosis Modulators|mitosis modulators|mesh-ancestor
102569016|NCT02908477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569017|NCT02892123|Paclitaxel|paclitaxel|mesh-list
102569018|NCT02892123|Vinorelbine|vinorelbine|mesh-list
102569019|NCT02892123|Capecitabine|capecitabine|mesh-list
102569020|NCT02892123|Tucatinib|tucatinib|mesh-list
102569021|NCT02892123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102569022|NCT02892123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569023|NCT02892123|Tubulin Modulators|tubulin modulators|mesh-ancestor
102569024|NCT02892123|Antimitotic Agents|antimitotic agents|mesh-ancestor
102569025|NCT02892123|Mitosis Modulators|mitosis modulators|mesh-ancestor
102569026|NCT02892123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569027|NCT02892123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102569028|NCT02892123|Antimetabolites|antimetabolites|mesh-ancestor
102569029|NCT02892123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102569030|NCT02892123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102569031|NCT02849496|Atezolizumab|atezolizumab|mesh-list
102569032|NCT02849496|Olaparib|olaparib|mesh-list
102569033|NCT02849496|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102569034|NCT02849496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102569035|NCT02849496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102569036|NCT02849496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569037|NCT02849496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102569038|NCT02849496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569039|NCT02849496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102569040|NCT02849496|Immunologic Factors|immunologic factors|mesh-ancestor
102569041|NCT02849496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569042|NCT02825160|Iloprost|iloprost|mesh-list
102569043|NCT02825160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102569044|NCT02825160|Vasodilator Agents|vasodilator agents|mesh-ancestor
102569045|NCT02756897|Venetoclax|venetoclax|mesh-list
102569046|NCT02756897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569047|NCT02754726|Paclitaxel|paclitaxel|mesh-list
102569048|NCT02754726|Gemcitabine|gemcitabine|mesh-list
102569049|NCT02754726|Nivolumab|nivolumab|mesh-list
102569050|NCT02754726|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102569051|NCT02754726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102569052|NCT02754726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569053|NCT02754726|Tubulin Modulators|tubulin modulators|mesh-ancestor
102569054|NCT02754726|Antimitotic Agents|antimitotic agents|mesh-ancestor
102569055|NCT02754726|Mitosis Modulators|mitosis modulators|mesh-ancestor
102569056|NCT02754726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569057|NCT02754726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102569058|NCT02754726|Antimetabolites|antimetabolites|mesh-ancestor
102569059|NCT02754726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102569060|NCT02754726|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102569061|NCT02733185|Vitamins|vitamins|mesh-list
102569062|NCT02733185|Edetic Acid|edetic acid|mesh-list
102569063|NCT02733185|Pentetic Acid|pentetic acid|mesh-list
102569064|NCT02733185|Micronutrients|micronutrients|mesh-ancestor
102569065|NCT02733185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569066|NCT02733185|Anticoagulants|anticoagulants|mesh-ancestor
102569067|NCT02733185|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102569068|NCT02733185|Chelating Agents|chelating agents|mesh-ancestor
102569069|NCT02733185|Sequestering Agents|sequestering agents|mesh-ancestor
102569070|NCT02733185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569071|NCT02733185|Antidotes|antidotes|mesh-ancestor
102569072|NCT02733185|Protective Agents|protective agents|mesh-ancestor
101941436|NCT03646318|Ketanserin|ketanserin|mesh-list
102275735|NCT02335255|Naftifine|naftifine|mesh-list
102275814|NCT02332057|Analgesics|analgesics|mesh-ancestor
102276117|NCT02326051|Enoxaparin|enoxaparin|mesh-list
102569073|NCT02733185|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102276416|NCT04997291|Razoxane|razoxane|mesh-list
102569074|NCT02720445|Nicotine|nicotine|mesh-list
102276574|NCT02327923|Narcotics|narcotics|mesh-ancestor
102569075|NCT02720445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102569076|NCT02720445|Autonomic Agents|autonomic agents|mesh-ancestor
102276672|NCT04994951|Hormones|hormones|mesh-ancestor
102276715|NCT03351439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102569077|NCT02720445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102277013|NCT05635955|Anesthetics|anesthetics|mesh-ancestor
102277272|NCT02985619|Hormones|hormones|mesh-ancestor
102277618|NCT01603459|Cholinergic Agents|cholinergic agents|mesh-ancestor
102569078|NCT02720445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569079|NCT02720445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102277929|NCT02819479|Mannitol|mannitol|mesh-list
102569080|NCT02720445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102569081|NCT02720445|Cholinergic Agents|cholinergic agents|mesh-ancestor
102278292|NCT02630693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569082|NCT02720445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102569083|NCT02720445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569084|NCT02713997|Etanercept|etanercept|mesh-list
102569085|NCT02713997|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
102569086|NCT02713997|Protein C Inhibitor|protein c inhibitor|mesh-list
102569087|NCT02713997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102569088|NCT02713997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102569089|NCT02713997|Analgesics|analgesics|mesh-ancestor
102569090|NCT02713997|Sensory System Agents|sensory system agents|mesh-ancestor
102278364|NCT01936870|Fesoterodine|fesoterodine|mesh-list
102569091|NCT02713997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102278449|NCT03062423|Sofosbuvir|sofosbuvir|mesh-list
102569092|NCT02713997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569093|NCT02713997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102569094|NCT02713997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102569095|NCT02713997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102569096|NCT02713997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102569097|NCT02713997|Immunologic Factors|immunologic factors|mesh-ancestor
102569098|NCT02713997|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102278585|NCT01876355|Clonidine|clonidine|mesh-list
102278781|NCT05103007|Hormones|hormones|mesh-ancestor
102569099|NCT02713997|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102569100|NCT02713997|Protease Inhibitors|protease inhibitors|mesh-ancestor
102279034|NCT04964219|Ketamine|ketamine|mesh-list
102569101|NCT02713997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102569102|NCT02713997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569103|NCT02703623|Prednisone|prednisone|mesh-list
102569104|NCT02703623|Cortisone|cortisone|mesh-list
102569105|NCT02703623|Carboplatin|carboplatin|mesh-list
102569106|NCT02703623|Ipilimumab|ipilimumab|mesh-list
102569107|NCT02703623|Abiraterone Acetate|abiraterone acetate|mesh-list
102279110|NCT04418531|Immunoglobulins|immunoglobulins|mesh-list
102569108|NCT02703623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569109|NCT02703623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102569110|NCT02703623|Glucocorticoids|glucocorticoids|mesh-ancestor
102569111|NCT02703623|Hormones|hormones|mesh-ancestor
102569112|NCT02703623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102569113|NCT02703623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569114|NCT02703623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102569115|NCT02703623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102569116|NCT02703623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102569117|NCT02703623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569118|NCT02703623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102279211|NCT04965545|Copper|copper|mesh-list
102569119|NCT02703623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102279322|NCT04431713|Incretins|incretins|mesh-ancestor
102569120|NCT02703623|Hormone Antagonists|hormone antagonists|mesh-ancestor
102279473|NCT04942769|Trace Elements|trace elements|mesh-ancestor
102279549|NCT04948151|Vasodilator Agents|vasodilator agents|mesh-ancestor
102279998|NCT02333149|Melatonin|melatonin|mesh-list
102280299|NCT04563559|Prednisolone acetate|prednisolone acetate|mesh-list
102280452|NCT03054467|Amlodipine|amlodipine|mesh-list
102569121|NCT02703623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102569122|NCT02684227|Paclitaxel|paclitaxel|mesh-list
102280901|NCT04966507|Listerine|listerine|mesh-list
102569123|NCT02684227|Carboplatin|carboplatin|mesh-list
102281203|NCT03050177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281279|NCT04882163|Dexamethasone|dexamethasone|mesh-list
102569124|NCT02684227|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102569125|NCT02684227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102569126|NCT02684227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569127|NCT02684227|Tubulin Modulators|tubulin modulators|mesh-ancestor
102281822|NCT05304169|Leuprolide|leuprolide|mesh-list
102569128|NCT02684227|Antimitotic Agents|antimitotic agents|mesh-ancestor
102569129|NCT02684227|Mitosis Modulators|mitosis modulators|mesh-ancestor
102282113|NCT01799629|Glycerol|glycerol|mesh-list
102282259|NCT05579769|Cyclophosphamide|cyclophosphamide|mesh-list
102282338|NCT04846673|Vitamins|vitamins|mesh-ancestor
102282485|NCT04850417|Analgesics|analgesics|mesh-ancestor
102282565|NCT03103399|Levodopa|levodopa|mesh-list
102282642|NCT04839653|Vancomycin|vancomycin|mesh-list
102282712|NCT02514031|Mitosis Modulators|mitosis modulators|mesh-ancestor
102282861|NCT05069779|GABA Modulators|gaba modulators|mesh-ancestor
102283016|NCT05068453|Antibodies|antibodies|mesh-list
102569130|NCT02684227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569131|NCT02623972|Cyclophosphamide|cyclophosphamide|mesh-list
102569132|NCT02623972|Doxorubicin|doxorubicin|mesh-list
102283465|NCT04816097|Glucocorticoids|glucocorticoids|mesh-ancestor
102569133|NCT02623972|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102569134|NCT02623972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102569135|NCT02623972|Immunologic Factors|immunologic factors|mesh-ancestor
102569136|NCT02623972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569137|NCT02623972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102284012|NCT05016349|Tamoxifen|tamoxifen|mesh-list
102284067|NCT03079219|Ondansetron|ondansetron|mesh-list
102569138|NCT02623972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102569139|NCT02623972|Alkylating Agents|alkylating agents|mesh-ancestor
102284373|NCT05335629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102284448|NCT05294835|Anesthetics|anesthetics|mesh-ancestor
102284526|NCT02524665|Salicylic Acid|salicylic acid|mesh-list
102569140|NCT02623972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284667|NCT03077503|Dexmedetomidine|dexmedetomidine|mesh-list
102284741|NCT02597933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102284742|NCT02597933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102284743|NCT02597933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284744|NCT04911127|Cannabidiol|cannabidiol|mesh-list
102284745|NCT04911127|Anticonvulsants|anticonvulsants|mesh-ancestor
102284746|NCT04995133|Colistin|colistin|mesh-list
102284747|NCT04995133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102284748|NCT04995133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102284749|NCT04360889|Tocopherols|tocopherols|mesh-list
102284750|NCT04360889|Vitamin E|vitamin e|mesh-list
102284751|NCT04360889|Tocotrienols|tocotrienols|mesh-list
102284752|NCT04360889|alpha-Tocopherol|alpha-tocopherol|mesh-list
102284753|NCT04360889|Antioxidants|antioxidants|mesh-ancestor
102284754|NCT04360889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284755|NCT04360889|Protective Agents|protective agents|mesh-ancestor
102284756|NCT04360889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284757|NCT04360889|Vitamins|vitamins|mesh-ancestor
102284758|NCT04360889|Micronutrients|micronutrients|mesh-ancestor
102284759|NCT03072589|Regadenoson|regadenoson|mesh-list
102284760|NCT03072589|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
102284761|NCT03072589|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102284762|NCT03072589|Purinergic Agonists|purinergic agonists|mesh-ancestor
102284763|NCT03072589|Purinergic Agents|purinergic agents|mesh-ancestor
102284764|NCT03072589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102284766|NCT03072589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284819|NCT03072121|Trimetazidine|trimetazidine|mesh-list
102569141|NCT02623972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569142|NCT02623972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102569143|NCT02623972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102569144|NCT02623972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102569145|NCT02623972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102285123|NCT04785911|Antiemetics|antiemetics|mesh-list
102569146|NCT02623972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102285267|NCT05209425|Vitamin D|vitamin d|mesh-list
102285412|NCT04801199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102285413|NCT04801199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285414|NCT04801199|Incretins|incretins|mesh-ancestor
102285415|NCT04801199|Hormones|hormones|mesh-ancestor
102285416|NCT04801199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102285417|NCT04801199|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102285418|NCT04801199|Protease Inhibitors|protease inhibitors|mesh-ancestor
102285419|NCT04801199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102285420|NCT04801199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994150|NCT03449524|CXA-10|cxa-10|mesh-list
102285443|NCT05445791|Metformin|metformin|mesh-list
102285444|NCT05445791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102285445|NCT05445791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285446|NCT04799873|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
102285447|NCT04799873|Protein C Inhibitor|protein c inhibitor|mesh-list
102285448|NCT04799873|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102285449|NCT04799873|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102285450|NCT04799873|Protease Inhibitors|protease inhibitors|mesh-ancestor
102285451|NCT04799873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102285453|NCT05201313|Lidocaine|lidocaine|mesh-list
102285488|NCT04798313|Denosumab|denosumab|mesh-list
102285562|NCT04805515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102569148|NCT02568618|Sensory System Agents|sensory system agents|mesh-ancestor
102569149|NCT02568618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102569150|NCT02568618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569151|NCT02536300|Idelalisib|idelalisib|mesh-list
102569152|NCT02536300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569153|NCT02536300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102569154|NCT02536300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569155|NCT02525692|TIC10 compound|tic10 compound|mesh-list
102569156|NCT02525692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569157|NCT02522715|Prednisone|prednisone|mesh-list
102569158|NCT02522715|Cortisone|cortisone|mesh-list
102569159|NCT02522715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102569160|NCT02522715|Glucocorticoids|glucocorticoids|mesh-ancestor
102569161|NCT02522715|Hormones|hormones|mesh-ancestor
102569162|NCT02522715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102285635|NCT02866643|Contraceptive Agents|contraceptive agents|mesh-list
102285717|NCT05613335|Hemostatics|hemostatics|mesh-ancestor
102285865|NCT05048589|Vaccines|vaccines|mesh-list
102285940|NCT05279131|Tirbanibulin|tirbanibulin|mesh-list
102286014|NCT04982367|Antifungal Agents|antifungal agents|mesh-ancestor
102569163|NCT02522715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569164|NCT02522715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102569165|NCT02522715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569166|NCT02514382|Dexamethasone|dexamethasone|mesh-list
102569167|NCT02514382|Dexamethasone acetate|dexamethasone acetate|mesh-list
102569168|NCT02514382|Bortezomib|bortezomib|mesh-list
102286456|NCT04426955|Paclitaxel|paclitaxel|mesh-list
102286534|NCT02588339|Sirolimus|sirolimus|mesh-list
102569169|NCT02514382|Ichthammol|ichthammol|mesh-list
102569170|NCT02514382|BB 1101|bb 1101|mesh-list
102286756|NCT05541185|Naproxen|naproxen|mesh-list
102286910|NCT02476617|Ritonavir|ritonavir|mesh-list
102569171|NCT02514382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102287058|NCT04979221|Cyproheptadine|cyproheptadine|mesh-list
102569172|NCT02514382|Antiemetics|antiemetics|mesh-ancestor
102287447|NCT05536271|Bisoprolol|bisoprolol|mesh-list
102569173|NCT02514382|Autonomic Agents|autonomic agents|mesh-ancestor
102287660|NCT05041907|Ritonavir|ritonavir|mesh-list
102287740|NCT02500641|Antimetabolites|antimetabolites|mesh-ancestor
102287810|NCT04971577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102569174|NCT02514382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102287899|NCT04959721|Hormones|hormones|mesh-ancestor
102287960|NCT05645705|Cariostatic Agents|cariostatic agents|mesh-ancestor
102288090|NCT04957927|Xhance|xhance|mesh-list
102569175|NCT02514382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569176|NCT02514382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102569177|NCT02514382|Glucocorticoids|glucocorticoids|mesh-ancestor
102288410|NCT04930471|Metformin|metformin|mesh-list
102569178|NCT02514382|Hormones|hormones|mesh-ancestor
102288640|NCT04935541|Narcotics|narcotics|mesh-ancestor
102288713|NCT03056599|Nivolumab|nivolumab|mesh-list
102288791|NCT02497287|Serotonin Agents|serotonin agents|mesh-ancestor
102288936|NCT03053869|Alprazolam|alprazolam|mesh-list
102369653|NCT03431142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102289392|NCT04887649|Morphine|morphine|mesh-list
102289999|NCT05231941|Lidocaine|lidocaine|mesh-list
102369654|NCT03431142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102369655|NCT03431142|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102290222|NCT05048615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102290300|NCT04868227|Vitamin D|vitamin d|mesh-list
102290369|NCT04872985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102290520|NCT04667663|Hormones|hormones|mesh-ancestor
102290613|NCT05502731|Adalimumab|adalimumab|mesh-list
102290767|NCT03042013|Naquotinib|naquotinib|mesh-list
102290820|NCT03042091|Metronidazole|metronidazole|mesh-list
102291044|NCT04853797|Calcium|calcium|mesh-list
102291121|NCT03040219|Folic Acid|folic acid|mesh-list
102369656|NCT03431142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102291197|NCT04851457|Tirofiban|tirofiban|mesh-list
102369657|NCT03431142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291357|NCT04831255|Hormones|hormones|mesh-ancestor
102291416|NCT02412111|Ivacaftor|ivacaftor|mesh-list
102369658|NCT03431142|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102369659|NCT03431142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102369660|NCT03431142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102291949|NCT04792723|Antipyretics|antipyretics|mesh-ancestor
102369661|NCT03431142|Antipyretics|antipyretics|mesh-ancestor
102569179|NCT02514382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102292259|NCT03267121|Apatinib|apatinib|mesh-list
102292319|NCT05614765|Ezetimibe|ezetimibe|mesh-list
102292387|NCT03882307|Sofosbuvir|sofosbuvir|mesh-list
102569180|NCT02514382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102292532|NCT02402907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102292616|NCT05541757|Heparin|heparin|mesh-list
102292686|NCT01666951|Tacrolimus|tacrolimus|mesh-list
102569181|NCT02514382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569182|NCT02514382|Protease Inhibitors|protease inhibitors|mesh-ancestor
102292983|NCT02343939|Cytarabine|cytarabine|mesh-list
102293131|NCT05575219|Sympatholytics|sympatholytics|mesh-ancestor
102569183|NCT02514382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102293503|NCT05580523|Aspirin|aspirin|mesh-list
102569184|NCT02514382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569185|NCT02514382|Dermatologic Agents|dermatologic agents|mesh-ancestor
102293816|NCT03913559|Analgesics|analgesics|mesh-ancestor
102293952|NCT03406247|Nivolumab|nivolumab|mesh-list
102294033|NCT02393625|Nivolumab|nivolumab|mesh-list
102569186|NCT02512718|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102569187|NCT02512718|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102294208|NCT03009019|Celecoxib|celecoxib|mesh-list
102294245|NCT02644369|Pembrolizumab|pembrolizumab|mesh-list
102294246|NCT02644369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102294247|NCT02644369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294248|NCT02644369|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102569188|NCT02512718|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102294396|NCT02378961|Velpatasvir|velpatasvir|mesh-list
102294470|NCT05522491|Olaparib|olaparib|mesh-list
102569189|NCT02512718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102569190|NCT02511067|Ranibizumab|ranibizumab|mesh-list
102569191|NCT02511067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102294766|NCT04843579|Dexamethasone|dexamethasone|mesh-list
102294841|NCT04291885|Avelumab|avelumab|mesh-list
102569192|NCT02511067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102569193|NCT02511067|Growth Substances|growth substances|mesh-ancestor
102295515|NCT05475223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102295593|NCT03383419|Antiviral Agents|antiviral agents|mesh-ancestor
102295819|NCT04524455|Glucocorticoids|glucocorticoids|mesh-ancestor
102295891|NCT05563571|Methylprednisolone|methylprednisolone|mesh-list
102569194|NCT02511067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569195|NCT02511067|Growth Inhibitors|growth inhibitors|mesh-ancestor
102296190|NCT02545075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102296275|NCT05485259|Vitamins|vitamins|mesh-ancestor
102296342|NCT04139213|Naltrexone|naltrexone|mesh-list
102569196|NCT02511067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569197|NCT02500407|Atezolizumab|atezolizumab|mesh-list
102569198|NCT02500407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102569199|NCT02500407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569200|NCT02500407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102569201|NCT02500407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569202|NCT02499354|Iron|iron|mesh-list
102569203|NCT02499354|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102569204|NCT02499354|Trace Elements|trace elements|mesh-ancestor
102569205|NCT02499354|Micronutrients|micronutrients|mesh-ancestor
102569206|NCT02499354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569207|NCT02499354|Hematinics|hematinics|mesh-ancestor
102569208|NCT02499354|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102569209|NCT02499354|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102569210|NCT02488967|Paclitaxel|paclitaxel|mesh-list
102569211|NCT02488967|Cyclophosphamide|cyclophosphamide|mesh-list
102569212|NCT02488967|Carboplatin|carboplatin|mesh-list
102569213|NCT02488967|Doxorubicin|doxorubicin|mesh-list
102569214|NCT02488967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102569215|NCT02488967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102569216|NCT02488967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102569217|NCT02488967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569218|NCT02488967|Tubulin Modulators|tubulin modulators|mesh-ancestor
102569219|NCT02488967|Antimitotic Agents|antimitotic agents|mesh-ancestor
102569220|NCT02488967|Mitosis Modulators|mitosis modulators|mesh-ancestor
102569221|NCT02488967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569222|NCT02488967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102569223|NCT02488967|Immunologic Factors|immunologic factors|mesh-ancestor
102569224|NCT02488967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569225|NCT02488967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102569226|NCT02488967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102569227|NCT02488967|Alkylating Agents|alkylating agents|mesh-ancestor
102569228|NCT02488967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102569229|NCT02488967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102569230|NCT02488967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102569231|NCT02488967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102569232|NCT02488967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102569233|NCT02458274|Dimercaprol|dimercaprol|mesh-list
102569234|NCT02458274|Chelating Agents|chelating agents|mesh-ancestor
102569235|NCT02458274|Sequestering Agents|sequestering agents|mesh-ancestor
102569236|NCT02458274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297056|NCT02320149|Sarecycline|sarecycline|mesh-list
102569237|NCT02446457|Rituximab|rituximab|mesh-list
102569238|NCT02446457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102569239|NCT02446457|Pembrolizumab|pembrolizumab|mesh-list
102569240|NCT02446457|Lenalidomide|lenalidomide|mesh-list
102569241|NCT02446457|Antibodies|antibodies|mesh-list
102569242|NCT02446457|Immunoglobulins|immunoglobulins|mesh-list
102569243|NCT02446457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102569244|NCT02446457|Immunologic Factors|immunologic factors|mesh-ancestor
102297128|NCT05451095|Sensory System Agents|sensory system agents|mesh-ancestor
102297269|NCT01660711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102569245|NCT02446457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297347|NCT05411159|Narcotics|narcotics|mesh-ancestor
102569246|NCT02446457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102297500|NCT04261075|Durvalumab|durvalumab|mesh-list
102569247|NCT02446457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102569248|NCT02446457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102569249|NCT02446457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569250|NCT02446457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102297936|NCT05208619|Anesthetics|anesthetics|mesh-list
102298008|NCT01656733|Cholinergic Agents|cholinergic agents|mesh-ancestor
102298082|NCT05107999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102298083|NCT05107999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298086|NCT05107999|Histamine Agents|histamine agents|mesh-ancestor
102298154|NCT05174611|Cholecalciferol|cholecalciferol|mesh-list
102569251|NCT02446457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102298300|NCT01364389|Hormones|hormones|mesh-ancestor
102569252|NCT02446457|Growth Substances|growth substances|mesh-ancestor
102569253|NCT02446457|Growth Inhibitors|growth inhibitors|mesh-ancestor
102569254|NCT02420613|Sirolimus|sirolimus|mesh-list
102569255|NCT02420613|Temsirolimus|temsirolimus|mesh-list
102569256|NCT02420613|Vorinostat|vorinostat|mesh-list
102569257|NCT02420613|MTOR Inhibitors|mtor inhibitors|mesh-list
102298819|NCT02495077|Tacrolimus|tacrolimus|mesh-list
102569258|NCT02420613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102569259|NCT02420613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102569260|NCT02420613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102299195|NCT02469961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102569261|NCT02420613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569262|NCT02420613|Antifungal Agents|antifungal agents|mesh-ancestor
102569263|NCT02420613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102569264|NCT02420613|Immunologic Factors|immunologic factors|mesh-ancestor
102299418|NCT04910503|Hormones|hormones|mesh-ancestor
102299644|NCT02438137|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102299864|NCT05640375|Prednisolone|prednisolone|mesh-list
102569265|NCT02420613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569266|NCT02420613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102569267|NCT02420613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102300318|NCT05651373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102369662|NCT03431142|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102369663|NCT03431142|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102300687|NCT03729609|Immunotoxins|immunotoxins|mesh-ancestor
102569268|NCT02420613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569269|NCT02420613|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102301065|NCT02217501|Antipyretics|antipyretics|mesh-ancestor
102569270|NCT02417285|Obinutuzumab|obinutuzumab|mesh-list
102569271|NCT02417285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102301507|NCT01617460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102301674|NCT02168439|Anesthetics|anesthetics|mesh-ancestor
102301736|NCT02374021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102569272|NCT02417285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102302115|NCT02531633|Prednisone|prednisone|mesh-list
102569273|NCT02409147|Nystatin|nystatin|mesh-list
102569274|NCT02409147|Prednisone|prednisone|mesh-list
102569275|NCT02409147|Thymoglobulin|thymoglobulin|mesh-list
102569276|NCT02409147|Basiliximab|basiliximab|mesh-list
102302635|NCT02161185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102302789|NCT05346731|Dexamethasone|dexamethasone|mesh-list
102302862|NCT01657877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302934|NCT02175771|Hormones|hormones|mesh-ancestor
102569277|NCT02409147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102569278|NCT02409147|Glucocorticoids|glucocorticoids|mesh-ancestor
102303463|NCT05037539|Anesthetics|anesthetics|mesh-ancestor
102303538|NCT05056883|Ivermectin|ivermectin|mesh-list
102116233|NCT02503904|Sympathomimetics|sympathomimetics|mesh-ancestor
102569279|NCT02409147|Hormones|hormones|mesh-ancestor
102612396|NCT00002447|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102303766|NCT02068443|Metformin|metformin|mesh-list
102303839|NCT02047227|Hormones|hormones|mesh-ancestor
102569280|NCT02409147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102569281|NCT02409147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304265|NCT02366689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102569282|NCT02409147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102569283|NCT02409147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102369664|NCT03431142|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102569284|NCT02409147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569285|NCT02409147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102569286|NCT02409147|Immunologic Factors|immunologic factors|mesh-ancestor
102369665|NCT03431142|Purinergic Agents|purinergic agents|mesh-ancestor
102305240|NCT02350309|Lemborexant|lemborexant|mesh-list
102305310|NCT01855750|Vincristine|vincristine|mesh-list
102305383|NCT02282293|Piperaquine|piperaquine|mesh-list
102569287|NCT02409147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102569288|NCT02409147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102569289|NCT02409147|Antifungal Agents|antifungal agents|mesh-ancestor
102569290|NCT02409147|Ionophores|ionophores|mesh-ancestor
102305974|NCT05565235|Nalbuphine|nalbuphine|mesh-list
102569291|NCT02409147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102569292|NCT02402439|Pancrelipase|pancrelipase|mesh-list
102569293|NCT02402439|Pancreatin|pancreatin|mesh-list
102569294|NCT02402439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102569295|NCT02392026|Metronidazole|metronidazole|mesh-list
102306505|NCT02447003|Pembrolizumab|pembrolizumab|mesh-list
102569296|NCT02392026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102306575|NCT02089347|Vaccines|vaccines|mesh-list
102306658|NCT04730193|Caffeine|caffeine|mesh-list
102569297|NCT02392026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102306739|NCT04685811|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102569298|NCT02392026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102569299|NCT02392026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102569300|NCT02389036|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102307092|NCT01838044|Anticonvulsants|anticonvulsants|mesh-ancestor
102569301|NCT02389036|Ciprofloxacin|ciprofloxacin|mesh-list
102569302|NCT02389036|Ceftriaxone|ceftriaxone|mesh-list
102569303|NCT02389036|Tobramycin|tobramycin|mesh-list
102569304|NCT02389036|Colistin|colistin|mesh-list
102569305|NCT02389036|Nystatin|nystatin|mesh-list
102569306|NCT02389036|Cefotaxime|cefotaxime|mesh-list
102569307|NCT02389036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102307992|NCT01625091|Naltrexone|naltrexone|mesh-list
102308142|NCT02078817|Ketamine|ketamine|mesh-list
102308296|NCT01735630|Inositol|inositol|mesh-list
102308361|NCT01766050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102308510|NCT01765582|Irinotecan|irinotecan|mesh-list
102569308|NCT02389036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102308585|NCT01733758|Incretins|incretins|mesh-ancestor
102308653|NCT02336165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308731|NCT02359877|Interferons|interferons|mesh-list
102569309|NCT02389036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102569310|NCT02389036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102308882|NCT02330549|Cenicriviroc|cenicriviroc|mesh-list
102369666|NCT03431142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102369667|NCT03831321|Diclofenac|diclofenac|mesh-list
102309109|NCT04672941|Bromides|bromides|mesh-list
102309183|NCT02005029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102309267|NCT02325713|Praziquantel|praziquantel|mesh-list
102569311|NCT02389036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569312|NCT02389036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102309633|NCT01977729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102309722|NCT01962987|Diclofenac|diclofenac|mesh-list
102569313|NCT02389036|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102309856|NCT03164473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102310008|NCT05813132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102569314|NCT02389036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102569315|NCT02389036|Antifungal Agents|antifungal agents|mesh-ancestor
102310233|NCT05287568|Venetoclax|venetoclax|mesh-list
102569316|NCT02389036|Ionophores|ionophores|mesh-ancestor
102310451|NCT04526730|Nivolumab|nivolumab|mesh-list
102569317|NCT02389036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102310603|NCT04035837|Interferons|interferons|mesh-list
102569318|NCT02369523|Bupivacaine|bupivacaine|mesh-list
102569319|NCT02369523|Ropivacaine|ropivacaine|mesh-list
102569320|NCT02369523|Anesthetics, Local|anesthetics, local|mesh-ancestor
102569321|NCT02369523|Anesthetics|anesthetics|mesh-ancestor
102569322|NCT02369523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102569323|NCT02369523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569324|NCT02369523|Sensory System Agents|sensory system agents|mesh-ancestor
102569325|NCT02369523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102569326|NCT02365649|Upadacitinib|upadacitinib|mesh-list
102569327|NCT02365649|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102569328|NCT02365649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102569329|NCT02365649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102310750|NCT03572933|Neurosteroids|neurosteroids|mesh-ancestor
102310823|NCT03179449|Hematinics|hematinics|mesh-ancestor
102310975|NCT01983462|Clonidine|clonidine|mesh-list
102311052|NCT00667069|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102311130|NCT02909335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102311275|NCT01944969|Dopamine Agents|dopamine agents|mesh-ancestor
102569330|NCT02365649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311423|NCT01970397|Hyaluronic Acid|hyaluronic acid|mesh-list
102569331|NCT02365649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102569332|NCT02344355|Ascorbic Acid|ascorbic acid|mesh-list
102569333|NCT02344355|Temozolomide|temozolomide|mesh-list
102311785|NCT01545271|Xenon|xenon|mesh-list
102569334|NCT02344355|Vitamins|vitamins|mesh-ancestor
102311947|NCT01957215|Indomethacin|indomethacin|mesh-list
102312023|NCT02320721|Insulin|insulin|mesh-list
102569335|NCT02344355|Micronutrients|micronutrients|mesh-ancestor
102312184|NCT02308748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102569336|NCT02344355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312391|NCT02304302|Dopamine Agents|dopamine agents|mesh-ancestor
102312468|NCT02274038|Pemetrexed|pemetrexed|mesh-list
102569337|NCT02344355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102569338|NCT02344355|Alkylating Agents|alkylating agents|mesh-ancestor
102569339|NCT02344355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312914|NCT01641926|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102312996|NCT02196259|Ketamine|ketamine|mesh-list
102569340|NCT02344355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569341|NCT02344355|Antioxidants|antioxidants|mesh-ancestor
102569342|NCT02344355|Protective Agents|protective agents|mesh-ancestor
102569343|NCT02339064|Apomorphine|apomorphine|mesh-list
102569344|NCT02339064|Emetics|emetics|mesh-ancestor
102569345|NCT02339064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569346|NCT02339064|Autonomic Agents|autonomic agents|mesh-ancestor
102569347|NCT02339064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102569348|NCT02339064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102569349|NCT02339064|Dopamine Agonists|dopamine agonists|mesh-ancestor
102313697|NCT05642702|Niacin|niacin|mesh-list
102569350|NCT02339064|Dopamine Agents|dopamine agents|mesh-ancestor
102313807|NCT04835870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102314033|NCT02191579|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102314182|NCT01601132|Autonomic Agents|autonomic agents|mesh-ancestor
102314255|NCT02162719|Paclitaxel|paclitaxel|mesh-list
102314405|NCT01681186|Lansoprazole|lansoprazole|mesh-list
102569351|NCT02339064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102314550|NCT02490800|Lisavanbulin|lisavanbulin|mesh-list
102314621|NCT04787744|Antiemetics|antiemetics|mesh-ancestor
102116308|NCT02255955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102569352|NCT02339064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569353|NCT02289209|Pembrolizumab|pembrolizumab|mesh-list
102315041|NCT01630135|Xhance|xhance|mesh-list
102315142|NCT02153905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102315217|NCT01599325|Azacitidine|azacitidine|mesh-list
102315292|NCT02180659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315368|NCT02239094|Adrenergic Agents|adrenergic agents|mesh-ancestor
102315441|NCT01627327|Fluticasone|fluticasone|mesh-list
102315523|NCT02126839|Tocolytic Agents|tocolytic agents|mesh-ancestor
102569354|NCT02289209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102315670|NCT01952145|Xultophy|xultophy|mesh-list
102569355|NCT02289209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569356|NCT02289209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102315891|NCT02121847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102315967|NCT05497583|Factor VIII|factor viii|mesh-list
102316047|NCT02228096|Tisagenlecleucel|tisagenlecleucel|mesh-list
102316117|NCT03602261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102316191|NCT02193776|Rifampin|rifampin|mesh-list
102316192|NCT02193776|Isoniazid|isoniazid|mesh-list
102316193|NCT02193776|Pyrazinamide|pyrazinamide|mesh-list
102316194|NCT02193776|Ethambutol|ethambutol|mesh-list
102316195|NCT02193776|Bedaquiline|bedaquiline|mesh-list
102316196|NCT02193776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102316197|NCT02193776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102316198|NCT02193776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102316199|NCT02193776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102316200|NCT02193776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102316201|NCT02193776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024984|NCT03172234|Anticonvulsants|anticonvulsants|mesh-ancestor
102316202|NCT02193776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102316203|NCT02193776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102316204|NCT02193776|Antitubercular Agents|antitubercular agents|mesh-ancestor
102316348|NCT02168816|Antimalarials|antimalarials|mesh-ancestor
102569357|NCT02289209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569358|NCT02277717|Trastuzumab|trastuzumab|mesh-list
102569359|NCT02277717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102569360|NCT02277717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569361|NCT02269280|Azacitidine|azacitidine|mesh-list
102569362|NCT02269280|Decitabine|decitabine|mesh-list
102316947|NCT01580488|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102317105|NCT01536262|Olodaterol|olodaterol|mesh-list
102317239|NCT01534078|Dacarbazine|dacarbazine|mesh-list
102569363|NCT02269280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102569364|NCT02269280|Antimetabolites|antimetabolites|mesh-ancestor
102317537|NCT01557244|Urological Agents|urological agents|mesh-ancestor
102317618|NCT02177786|Selonsertib|selonsertib|mesh-list
102317761|NCT01552408|Growth Inhibitors|growth inhibitors|mesh-ancestor
102317838|NCT01514422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102318061|NCT01486966|Isophane Insulin, Human|isophane insulin, human|mesh-list
102318286|NCT01502956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102569365|NCT02269280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569366|NCT02269280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569367|NCT02269280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102569368|NCT02233829|Dopamine|dopamine|mesh-list
102569369|NCT02233829|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102569370|NCT02233829|Sympathomimetics|sympathomimetics|mesh-ancestor
102569371|NCT02233829|Autonomic Agents|autonomic agents|mesh-ancestor
102569372|NCT02233829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102569373|NCT02233829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569374|NCT02233829|Dopamine Agents|dopamine agents|mesh-ancestor
102569375|NCT02233829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102569376|NCT02233829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569377|NCT02233829|Protective Agents|protective agents|mesh-ancestor
102569378|NCT02207712|Ranibizumab|ranibizumab|mesh-list
102569379|NCT02207712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102569380|NCT02207712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102569381|NCT02207712|Growth Substances|growth substances|mesh-ancestor
102318648|NCT02101112|Antithrombins|antithrombins|mesh-ancestor
102569382|NCT02207712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569383|NCT02207712|Growth Inhibitors|growth inhibitors|mesh-ancestor
102569384|NCT02207712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569385|NCT02187991|Paclitaxel|paclitaxel|mesh-list
102569386|NCT02187991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102569387|NCT02187991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569388|NCT02187991|Tubulin Modulators|tubulin modulators|mesh-ancestor
102569389|NCT02187991|Antimitotic Agents|antimitotic agents|mesh-ancestor
102569390|NCT02187991|Mitosis Modulators|mitosis modulators|mesh-ancestor
102569391|NCT02187991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569392|NCT02108860|Abatacept|abatacept|mesh-list
102318796|NCT02240693|BI 409306|bi 409306|mesh-list
102318870|NCT02121002|Diclofenac|diclofenac|mesh-list
102319014|NCT01896531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102569393|NCT02108860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102319235|NCT01483690|Vorinostat|vorinostat|mesh-list
102319544|NCT02226653|Evacetrapib|evacetrapib|mesh-list
102319612|NCT04774991|Azithromycin|azithromycin|mesh-list
102569394|NCT02108860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569395|NCT02108860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102319842|NCT02219087|Bupivacaine|bupivacaine|mesh-list
102319980|NCT01494532|Levodopa|levodopa|mesh-list
102569396|NCT02108860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569397|NCT02108860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102569398|NCT02108860|Immunologic Factors|immunologic factors|mesh-ancestor
102320500|NCT02097745|Dermatologic Agents|dermatologic agents|mesh-ancestor
102320578|NCT02162771|Hormones|hormones|mesh-ancestor
102320651|NCT02109133|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102320727|NCT02066389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102320810|NCT02183675|Diuretics|diuretics|mesh-ancestor
102569399|NCT02108860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320950|NCT02092285|Golimumab|golimumab|mesh-list
102569400|NCT02108860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102569401|NCT02079181|Fluorides|fluorides|mesh-list
102569402|NCT02079181|Cariostatic Agents|cariostatic agents|mesh-ancestor
102569403|NCT02079181|Protective Agents|protective agents|mesh-ancestor
102321560|NCT02117024|Antimetabolites|antimetabolites|mesh-ancestor
102569404|NCT02079181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569405|NCT02048813|Cyclophosphamide|cyclophosphamide|mesh-list
102569406|NCT02048813|Rituximab|rituximab|mesh-list
102569407|NCT02048813|Fludarabine|fludarabine|mesh-list
102569408|NCT02048813|Fludarabine phosphate|fludarabine phosphate|mesh-list
102322215|NCT05886790|Vaccines|vaccines|mesh-list
102322290|NCT05885932|Sirolimus|sirolimus|mesh-list
102322366|NCT05802056|Fluorouracil|fluorouracil|mesh-list
102322513|NCT05707351|Coagulants|coagulants|mesh-ancestor
102322589|NCT05535738|Xhance|xhance|mesh-list
102569409|NCT02048813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102569410|NCT02048813|Immunologic Factors|immunologic factors|mesh-ancestor
102322963|NCT04413201|Afatinib|afatinib|mesh-list
102569411|NCT02048813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569412|NCT02048813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102569413|NCT02048813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102569414|NCT02048813|Alkylating Agents|alkylating agents|mesh-ancestor
102569415|NCT02048813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323704|NCT01821963|Ribavirin|ribavirin|mesh-list
102569416|NCT02048813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102324079|NCT02030041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102324151|NCT02017171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102569417|NCT02048813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102324230|NCT02016170|Purinergic Agents|purinergic agents|mesh-ancestor
102324301|NCT02025907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102324378|NCT01841697|Metformin|metformin|mesh-list
102324450|NCT02023099|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102324674|NCT01964755|Zidovudine|zidovudine|mesh-list
102324752|NCT02007577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102569418|NCT02048813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102325047|NCT01802385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102569419|NCT02048813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102569420|NCT02048813|Antimetabolites|antimetabolites|mesh-ancestor
102569421|NCT02043457|Hormones|hormones|mesh-list
102369668|NCT03831321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102369669|NCT03831321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102369670|NCT03831321|Analgesics|analgesics|mesh-ancestor
102326019|NCT04069936|Nivolumab|nivolumab|mesh-list
102369671|NCT03831321|Sensory System Agents|sensory system agents|mesh-ancestor
102326318|NCT01958671|Metformin|metformin|mesh-list
102326391|NCT01944098|Anesthetics, Local|anesthetics, local|mesh-ancestor
102369672|NCT03831321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102326651|NCT01951417|Adapalene|adapalene|mesh-list
102326689|NCT01937312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102326836|NCT01995071|Ribavirin|ribavirin|mesh-list
102369673|NCT03831321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327221|NCT01415986|Temoporfin|temoporfin|mesh-list
102327289|NCT01432600|Antiemetics|antiemetics|mesh-ancestor
102369674|NCT03831321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102569422|NCT02043457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102569423|NCT02043457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569424|NCT01949662|Lorazepam|lorazepam|mesh-list
102569425|NCT01949662|Haloperidol|haloperidol|mesh-list
102569426|NCT01949662|Haloperidol decanoate|haloperidol decanoate|mesh-list
102569427|NCT01949662|Antiemetics|antiemetics|mesh-ancestor
102569428|NCT01949662|Autonomic Agents|autonomic agents|mesh-ancestor
102116381|NCT02168205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102569429|NCT01949662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102569430|NCT01949662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569431|NCT01949662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102569432|NCT01949662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102569433|NCT01949662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102569434|NCT01949662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102569435|NCT01949662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102569436|NCT01949662|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102569437|NCT01949662|Dopamine Agents|dopamine agents|mesh-ancestor
102569438|NCT01949662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102569439|NCT01949662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569440|NCT01949662|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102569441|NCT01949662|Anticonvulsants|anticonvulsants|mesh-ancestor
102569442|NCT01949662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102569443|NCT01949662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102569444|NCT01949662|GABA Modulators|gaba modulators|mesh-ancestor
102569445|NCT01949662|GABA Agents|gaba agents|mesh-ancestor
102569446|NCT01892722|Interferons|interferons|mesh-list
102327859|NCT02078284|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
102569447|NCT01892722|Interferon-beta|interferon-beta|mesh-list
102569448|NCT01892722|Interferon beta-1a|interferon beta-1a|mesh-list
102569449|NCT01892722|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102569450|NCT01892722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569451|NCT01892722|Antiviral Agents|antiviral agents|mesh-ancestor
102569452|NCT01892722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102569453|NCT01892722|Immunologic Factors|immunologic factors|mesh-ancestor
102569454|NCT01892722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569455|NCT01892722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102569456|NCT01892722|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102327935|NCT04624399|Atezolizumab|atezolizumab|mesh-list
102328000|NCT01914757|Benralizumab|benralizumab|mesh-list
102569457|NCT01892722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569458|NCT01892722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102328181|NCT01783821|Hormones|hormones|mesh-ancestor
102569459|NCT01860937|Cyclophosphamide|cyclophosphamide|mesh-list
102569460|NCT01860937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102569461|NCT01860937|Immunologic Factors|immunologic factors|mesh-ancestor
102569462|NCT01860937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569463|NCT01860937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102569464|NCT01860937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102569465|NCT01860937|Alkylating Agents|alkylating agents|mesh-ancestor
102569466|NCT01860937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569467|NCT01860937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569468|NCT01860937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102569469|NCT01770145|Levodopa|levodopa|mesh-list
102328282|NCT01408030|Bevacizumab|bevacizumab|mesh-list
102569470|NCT01770145|Carbidopa|carbidopa|mesh-list
102569471|NCT01770145|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102569472|NCT01770145|Trimethobenzamide|trimethobenzamide|mesh-list
102569473|NCT01770145|Apomorphine|apomorphine|mesh-list
102569474|NCT01770145|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102569475|NCT01770145|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102569476|NCT01770145|Dopamine Agents|dopamine agents|mesh-ancestor
102569477|NCT01770145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102569478|NCT01770145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569479|NCT01770145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569480|NCT01770145|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102569481|NCT01770145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102569482|NCT01770145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102569483|NCT01770145|Immunologic Factors|immunologic factors|mesh-ancestor
102569484|NCT01770145|Dopamine Agonists|dopamine agonists|mesh-ancestor
102569485|NCT01770145|Emetics|emetics|mesh-ancestor
102328561|NCT01401010|Doripenem|doripenem|mesh-list
102569486|NCT01770145|Autonomic Agents|autonomic agents|mesh-ancestor
102369675|NCT03831321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102328782|NCT01777269|Tamsulosin|tamsulosin|mesh-list
102569487|NCT01770145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102328933|NCT01886690|Laxatives|laxatives|mesh-ancestor
102329151|NCT05891561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329157|NCT05890118|Ustekinumab|ustekinumab|mesh-list
102329158|NCT05890118|Dermatologic Agents|dermatologic agents|mesh-ancestor
102329159|NCT05889949|Sorafenib|sorafenib|mesh-list
102329160|NCT05889949|Lenvatinib|lenvatinib|mesh-list
102329165|NCT05887804|Triamcinolone|triamcinolone|mesh-list
102569488|NCT01770145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102569489|NCT01770145|Antiemetics|antiemetics|mesh-ancestor
102569490|NCT01758081|Vitamin D|vitamin d|mesh-list
102569491|NCT01758081|Ergocalciferols|ergocalciferols|mesh-list
102569492|NCT01758081|Cholecalciferol|cholecalciferol|mesh-list
102569493|NCT01758081|Vitamins|vitamins|mesh-list
102569494|NCT01758081|Micronutrients|micronutrients|mesh-ancestor
102569495|NCT01758081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569496|NCT01758081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102569497|NCT01758081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102569498|NCT01746836|Ponatinib|ponatinib|mesh-list
102569499|NCT01746836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569500|NCT01746836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102329899|NCT03896230|Ketamine|ketamine|mesh-list
102569501|NCT01746836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102329971|NCT03798678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102330047|NCT03421496|Cannabidiol|cannabidiol|mesh-list
102330122|NCT03203525|Antifungal Agents|antifungal agents|mesh-ancestor
102369676|NCT03831321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102369677|NCT03831321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102569502|NCT01746836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330506|NCT00215813|Poly I-C|poly i-c|mesh-list
102569503|NCT01726582|Leucovorin|leucovorin|mesh-list
102569504|NCT01726582|Paclitaxel|paclitaxel|mesh-list
102569505|NCT01726582|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102569506|NCT01726582|Gemcitabine|gemcitabine|mesh-list
102569507|NCT01726582|Fluorouracil|fluorouracil|mesh-list
102569508|NCT01726582|Capecitabine|capecitabine|mesh-list
102569509|NCT01726582|Oxaliplatin|oxaliplatin|mesh-list
102569510|NCT01726582|Irinotecan|irinotecan|mesh-list
102569511|NCT01726582|Cisplatin|cisplatin|mesh-list
102569512|NCT01726582|Folfirinox|folfirinox|mesh-list
102330948|NCT01881230|Antimitotic Agents|antimitotic agents|mesh-ancestor
102331171|NCT01852292|Paclitaxel|paclitaxel|mesh-list
102331247|NCT00210184|Immunologic Factors|immunologic factors|mesh-ancestor
102331394|NCT03594214|Vitamins|vitamins|mesh-ancestor
102331552|NCT01704261|Immunologic Factors|immunologic factors|mesh-ancestor
102569513|NCT01726582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102331703|NCT03590080|Prednisolone|prednisolone|mesh-list
102569514|NCT01726582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102331926|NCT04029610|Autonomic Agents|autonomic agents|mesh-ancestor
102332070|NCT04021420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102332071|NCT04021420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332072|NCT04144582|Docetaxel|docetaxel|mesh-list
102332073|NCT04144582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102332074|NCT04144582|Tubulin Modulators|tubulin modulators|mesh-ancestor
102332075|NCT04144582|Antimitotic Agents|antimitotic agents|mesh-ancestor
102332076|NCT04144582|Mitosis Modulators|mitosis modulators|mesh-ancestor
102332077|NCT04144582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332078|NCT01611974|Maribavir|maribavir|mesh-list
102332079|NCT01611974|Antiviral Agents|antiviral agents|mesh-ancestor
102332080|NCT01611974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102332081|NCT01871870|Pancrelipase|pancrelipase|mesh-list
102332082|NCT01871870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102332083|NCT02080780|Clarithromycin|clarithromycin|mesh-list
102332084|NCT02080780|Diltiazem|diltiazem|mesh-list
102332085|NCT02080780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102332098|NCT01871558|Metformin|metformin|mesh-list
102332145|NCT04140136|Tocotrienols|tocotrienols|mesh-list
102332146|NCT04140136|Vitamin E|vitamin e|mesh-list
102332147|NCT04140136|Tocopherols|tocopherols|mesh-list
102332298|NCT01710501|Interferons|interferons|mesh-list
102569515|NCT01726582|Tubulin Modulators|tubulin modulators|mesh-ancestor
102332676|NCT03735628|Nivolumab|nivolumab|mesh-list
102569516|NCT01726582|Antimitotic Agents|antimitotic agents|mesh-ancestor
102569517|NCT01726582|Mitosis Modulators|mitosis modulators|mesh-ancestor
102569518|NCT01726582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332973|NCT01670890|Temozolomide|temozolomide|mesh-list
102333049|NCT01671982|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102333128|NCT01594281|Ranibizumab|ranibizumab|mesh-list
102569519|NCT01726582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102569520|NCT01726582|Antimetabolites|antimetabolites|mesh-ancestor
102333421|NCT01675648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102569521|NCT01726582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102569522|NCT01726582|Immunologic Factors|immunologic factors|mesh-ancestor
102569523|NCT01726582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569524|NCT01726582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102569525|NCT01726582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102569526|NCT01726582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102333716|NCT03813160|Dronabinol|dronabinol|mesh-list
102569527|NCT01726582|Antidotes|antidotes|mesh-ancestor
102569528|NCT01726582|Protective Agents|protective agents|mesh-ancestor
102569529|NCT01726582|Vitamin B Complex|vitamin b complex|mesh-ancestor
102569530|NCT01726582|Vitamins|vitamins|mesh-ancestor
102569531|NCT01726582|Micronutrients|micronutrients|mesh-ancestor
102569532|NCT01701986|Mycophenolic Acid|mycophenolic acid|mesh-list
102569533|NCT01701986|Rituximab|rituximab|mesh-list
102569534|NCT01701986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102569535|NCT01701986|Gemcitabine|gemcitabine|mesh-list
102569536|NCT01701986|Busulfan|busulfan|mesh-list
102569537|NCT01701986|Clofarabine|clofarabine|mesh-list
102569538|NCT01701986|Antibodies|antibodies|mesh-list
102569539|NCT01701986|Immunoglobulins|immunoglobulins|mesh-list
102569540|NCT01701986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102569541|NCT01701986|Tacrolimus|tacrolimus|mesh-list
102569542|NCT01701986|Thymoglobulin|thymoglobulin|mesh-list
102569543|NCT01701986|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102569544|NCT01701986|Immunologic Factors|immunologic factors|mesh-ancestor
102569545|NCT01701986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569546|NCT01701986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569547|NCT01701986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102569548|NCT01701986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102569549|NCT01701986|Antimetabolites|antimetabolites|mesh-ancestor
102569550|NCT01701986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569551|NCT01701986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102569552|NCT01701986|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102569553|NCT01701986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102569554|NCT01701986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102569555|NCT01701986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102569556|NCT01701986|Antitubercular Agents|antitubercular agents|mesh-ancestor
102569557|NCT01701986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102569558|NCT01701986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102569559|NCT01701986|Alkylating Agents|alkylating agents|mesh-ancestor
102569560|NCT01701986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102569561|NCT01701986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102569562|NCT01696734|Domperidone|domperidone|mesh-list
102569563|NCT01696734|Antiemetics|antiemetics|mesh-ancestor
102569564|NCT01696734|Autonomic Agents|autonomic agents|mesh-ancestor
102569565|NCT01696734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102569566|NCT01696734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569567|NCT01696734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102569568|NCT01696734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102569569|NCT01696734|Dopamine Agents|dopamine agents|mesh-ancestor
102569570|NCT01696734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102334301|NCT02402920|Antimitotic Agents|antimitotic agents|mesh-ancestor
102334353|NCT03455140|BCT-100|bct-100|mesh-list
102334427|NCT00085540|Romidepsin|romidepsin|mesh-list
102569571|NCT01696734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569572|NCT01687127|Folic Acid|folic acid|mesh-list
102569573|NCT01687127|Vitamin B Complex|vitamin b complex|mesh-list
102569574|NCT01687127|Calcium|calcium|mesh-list
102335101|NCT05139004|Melphalan|melphalan|mesh-list
102044119|NCT01337323|Xhance|xhance|mesh-list
102335325|NCT03642028|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102335410|NCT01808144|Febuxostat|febuxostat|mesh-list
102335474|NCT01603641|Cholinergic Agents|cholinergic agents|mesh-ancestor
102335622|NCT01769456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102335768|NCT04397770|Apatinib|apatinib|mesh-list
102335846|NCT03141424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102335920|NCT01685073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102335921|NCT01685073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335922|NCT05241028|Ensartinib|ensartinib|mesh-list
102335923|NCT05241028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102335924|NCT05241028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102335925|NCT05241028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102335926|NCT05241028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335927|NCT01572675|Celecoxib|celecoxib|mesh-list
102335928|NCT01572675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102335929|NCT01572675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102335930|NCT01572675|Analgesics|analgesics|mesh-ancestor
102335931|NCT01572675|Sensory System Agents|sensory system agents|mesh-ancestor
102335932|NCT01572675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102335933|NCT01572675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335934|NCT01572675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102335935|NCT01572675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102335936|NCT01572675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102335937|NCT01572675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102335938|NCT01572675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102335939|NCT01572675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335940|NCT05929937|Analgesics, Opioid|analgesics, opioid|mesh-list
102335941|NCT05929937|Narcotics|narcotics|mesh-ancestor
102335942|NCT05929937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102335943|NCT05929937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335945|NCT05929937|Sensory System Agents|sensory system agents|mesh-ancestor
102335947|NCT05929794|Metronidazole|metronidazole|mesh-list
102335996|NCT05929755|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102569575|NCT01687127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102569576|NCT01687127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569577|NCT01687127|Hematinics|hematinics|mesh-ancestor
102569578|NCT01687127|Vitamins|vitamins|mesh-ancestor
102569579|NCT01687127|Micronutrients|micronutrients|mesh-ancestor
102569580|NCT01565200|Trastuzumab|trastuzumab|mesh-list
102569581|NCT01565200|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102569582|NCT01565200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102569583|NCT01565200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569584|NCT01565200|Immunotoxins|immunotoxins|mesh-ancestor
102569585|NCT01565200|Immunoconjugates|immunoconjugates|mesh-ancestor
102569586|NCT01565200|Immunologic Factors|immunologic factors|mesh-ancestor
102569587|NCT01565200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569589|NCT01565200|Antimitotic Agents|antimitotic agents|mesh-ancestor
102569590|NCT01565200|Mitosis Modulators|mitosis modulators|mesh-ancestor
102569591|NCT01565200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569592|NCT01476787|Rituximab|rituximab|mesh-list
102569593|NCT01476787|Lenalidomide|lenalidomide|mesh-list
102336295|NCT05441280|Serotonin Agents|serotonin agents|mesh-ancestor
102336370|NCT05257824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102569594|NCT01476787|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102569595|NCT01476787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102569596|NCT01476787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569597|NCT01476787|Immunologic Factors|immunologic factors|mesh-ancestor
102569598|NCT01476787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569599|NCT01476787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102569600|NCT01476787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102569601|NCT01476787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102569602|NCT01476787|Growth Substances|growth substances|mesh-ancestor
102569603|NCT01476787|Growth Inhibitors|growth inhibitors|mesh-ancestor
102569604|NCT01476787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102569605|NCT01476787|Alkylating Agents|alkylating agents|mesh-ancestor
102569606|NCT01476787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569607|NCT01059786|Rituximab|rituximab|mesh-list
102569608|NCT01059786|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102569609|NCT01059786|Pentostatin|pentostatin|mesh-list
102569610|NCT01059786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102569611|NCT01059786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336820|NCT03810807|Osimertinib|osimertinib|mesh-list
102569612|NCT01059786|Immunologic Factors|immunologic factors|mesh-ancestor
102569613|NCT01059786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569614|NCT01059786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102569615|NCT01059786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102337564|NCT05245786|Copper|copper|mesh-list
102569616|NCT01059786|Alkylating Agents|alkylating agents|mesh-ancestor
102337640|NCT01923844|Pulmonary Surfactants|pulmonary surfactants|mesh-list
102337720|NCT01924624|Growth Substances|growth substances|mesh-ancestor
102569617|NCT01059786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337901|NCT01921192|Folic Acid|folic acid|mesh-list
102338015|NCT00984022|Laxatives|laxatives|mesh-ancestor
102338167|NCT01903837|Sensory System Agents|sensory system agents|mesh-ancestor
102338243|NCT01616173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102338320|NCT03036904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102569618|NCT01059786|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
102569619|NCT01059786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102569620|NCT00993408|Selexipag|selexipag|mesh-list
102339001|NCT01893658|Omalizumab|omalizumab|mesh-list
102339073|NCT01898923|Laxatives|laxatives|mesh-ancestor
102339155|NCT05603650|Listerine|listerine|mesh-list
102339547|NCT02974738|Belzutifan|belzutifan|mesh-list
102569621|NCT00993408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102339690|NCT03820180|Hormones|hormones|mesh-ancestor
102569622|NCT00871065|Sildenafil Citrate|sildenafil citrate|mesh-list
102339983|NCT02819596|Tremelimumab|tremelimumab|mesh-list
102339986|NCT02818894|Lidocaine|lidocaine|mesh-list
102340208|NCT04757974|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102340283|NCT01539291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569623|NCT00871065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569624|NCT00871065|Vasodilator Agents|vasodilator agents|mesh-ancestor
102340506|NCT01929070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102340579|NCT02223208|Hormones|hormones|mesh-ancestor
102340663|NCT02191930|Immunotoxins|immunotoxins|mesh-ancestor
102340810|NCT01894360|Belimumab|belimumab|mesh-list
102569625|NCT00871065|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102341104|NCT00436540|Clobetasol|clobetasol|mesh-list
102341178|NCT04777162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102341265|NCT00936832|Vitamins|vitamins|mesh-ancestor
102569626|NCT00871065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102341336|NCT04784104|Epinephrine|epinephrine|mesh-list
102569627|NCT00871065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102341476|NCT03300544|Vitamins|vitamins|mesh-ancestor
102569628|NCT00871065|Urological Agents|urological agents|mesh-ancestor
102341642|NCT05411380|Letrozole|letrozole|mesh-list
102341705|NCT03026907|Azathioprine|azathioprine|mesh-list
102569629|NCT00801489|Cytarabine|cytarabine|mesh-list
102569630|NCT00801489|Fludarabine|fludarabine|mesh-list
102569631|NCT00801489|Fludarabine phosphate|fludarabine phosphate|mesh-list
102342214|NCT00185692|Hormones|hormones|mesh-ancestor
102569632|NCT00801489|Decitabine|decitabine|mesh-list
102342868|NCT05819983|Ivermectin|ivermectin|mesh-list
102569633|NCT00801489|Idarubicin|idarubicin|mesh-list
102569634|NCT00801489|Gemtuzumab|gemtuzumab|mesh-list
102343015|NCT05815654|Analgesics|analgesics|mesh-list
102569635|NCT00801489|Calicheamicins|calicheamicins|mesh-list
102569636|NCT00801489|Lenograstim|lenograstim|mesh-list
102343163|NCT05688904|Imipramine|imipramine|mesh-list
102343235|NCT05603910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102343236|NCT05603910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343237|NCT05603910|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102343238|NCT05603910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343239|NCT05603910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102343240|NCT05603910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102343241|NCT05565222|Meropenem|meropenem|mesh-list
102343242|NCT05565222|Tazobactam|tazobactam|mesh-list
102343243|NCT05565222|Piperacillin|piperacillin|mesh-list
102343244|NCT05565222|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102569637|NCT00801489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569638|NCT00801489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102569639|NCT00801489|Antimetabolites|antimetabolites|mesh-ancestor
102569640|NCT00801489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569641|NCT00801489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102569642|NCT00801489|Immunologic Factors|immunologic factors|mesh-ancestor
102569643|NCT00801489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569644|NCT00801489|Antiviral Agents|antiviral agents|mesh-ancestor
102569645|NCT00801489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102569646|NCT00801489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102569647|NCT00801489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102569648|NCT00801489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102569649|NCT00801489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102569650|NCT00801489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102569651|NCT00801489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102569652|NCT00801489|Immunotoxins|immunotoxins|mesh-ancestor
102569653|NCT00801489|Immunoconjugates|immunoconjugates|mesh-ancestor
102569654|NCT00794339|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102569655|NCT00794339|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102569656|NCT00794339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569657|NCT00792662|Methylphenidate|methylphenidate|mesh-list
102569658|NCT00792662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102569659|NCT00792662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569660|NCT00792662|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102116606|NCT02500940|Vitamins|vitamins|mesh-ancestor
102569661|NCT00792662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102569662|NCT00792662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102569663|NCT00792662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569664|NCT00792662|Dopamine Agents|dopamine agents|mesh-ancestor
102569665|NCT00792662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102569666|NCT00786682|Hydroxychloroquine|hydroxychloroquine|mesh-list
102569667|NCT00786682|Docetaxel|docetaxel|mesh-list
102569668|NCT00786682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569669|NCT00786682|Tubulin Modulators|tubulin modulators|mesh-ancestor
102569670|NCT00786682|Antimitotic Agents|antimitotic agents|mesh-ancestor
102569671|NCT00786682|Mitosis Modulators|mitosis modulators|mesh-ancestor
102569672|NCT00786682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569673|NCT00786682|Antimalarials|antimalarials|mesh-ancestor
102569674|NCT00786682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102569675|NCT00786682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102569676|NCT00786682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102569677|NCT00786682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102569678|NCT00786682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102569679|NCT00675844|Dexelvucitabine|dexelvucitabine|mesh-list
102569680|NCT00675844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102569681|NCT00675844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102569682|NCT00675844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102569683|NCT00675844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569684|NCT00675844|Antiviral Agents|antiviral agents|mesh-ancestor
102569685|NCT00675844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102569686|NCT00675844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102569687|NCT00675844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102569688|NCT00592280|Pancrelipase|pancrelipase|mesh-list
102569689|NCT00592280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102569690|NCT00571714|Ribavirin|ribavirin|mesh-list
102569691|NCT00571714|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102569692|NCT00571714|Interferon-alpha|interferon-alpha|mesh-list
102569693|NCT00571714|Betaine|betaine|mesh-list
102569694|NCT00571714|Antimetabolites|antimetabolites|mesh-ancestor
102569695|NCT00571714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569696|NCT00571714|Antiviral Agents|antiviral agents|mesh-ancestor
102569697|NCT00571714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102569698|NCT00571714|Immunologic Factors|immunologic factors|mesh-ancestor
102569699|NCT00571714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569700|NCT00571714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102569701|NCT00571714|Lipotropic Agents|lipotropic agents|mesh-ancestor
102569702|NCT00571714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102569703|NCT00571714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102569704|NCT00506662|Insulin|insulin|mesh-list
102569705|NCT00506662|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102569706|NCT00506662|Insulin Detemir|insulin detemir|mesh-list
102569707|NCT00506662|Isophane Insulin, Human|isophane insulin, human|mesh-list
102569708|NCT00506662|Insulin, Isophane|insulin, isophane|mesh-list
102343385|NCT05300152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569709|NCT00506662|Isophane insulin, beef|isophane insulin, beef|mesh-list
102569710|NCT00506662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102569711|NCT00506662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569712|NCT00455039|Lapatinib|lapatinib|mesh-list
102569713|NCT00455039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569714|NCT00455039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102569715|NCT00455039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102569716|NCT00455039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569717|NCT00410956|Dexamethasone|dexamethasone|mesh-list
102569718|NCT00410956|Bevacizumab|bevacizumab|mesh-list
102569719|NCT00410956|Floxuridine|floxuridine|mesh-list
102569720|NCT00410956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102569721|NCT00410956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569722|NCT00410956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102569723|NCT00410956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102569724|NCT00410956|Growth Substances|growth substances|mesh-ancestor
102569725|NCT00410956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569726|NCT00410956|Growth Inhibitors|growth inhibitors|mesh-ancestor
102569727|NCT00410956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102569728|NCT00410956|Antiemetics|antiemetics|mesh-ancestor
102569729|NCT00410956|Autonomic Agents|autonomic agents|mesh-ancestor
102569730|NCT00410956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102569731|NCT00410956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102569732|NCT00410956|Glucocorticoids|glucocorticoids|mesh-ancestor
102569733|NCT00410956|Hormones|hormones|mesh-ancestor
102569734|NCT00410956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102569735|NCT00410956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102569736|NCT00410956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102569737|NCT00410956|Antimetabolites|antimetabolites|mesh-ancestor
102569738|NCT00410956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569739|NCT00380159|Lamivudine|lamivudine|mesh-list
102569740|NCT00380159|Emtricitabine|emtricitabine|mesh-list
102569741|NCT00380159|Dexelvucitabine|dexelvucitabine|mesh-list
102569742|NCT00380159|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102569743|NCT00380159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102569744|NCT00380159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102569745|NCT00380159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569746|NCT00380159|Antiviral Agents|antiviral agents|mesh-ancestor
102569747|NCT00380159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102569748|NCT00380159|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102569749|NCT00380159|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102569750|NCT00338377|Cyclophosphamide|cyclophosphamide|mesh-list
102569751|NCT00338377|Fludarabine|fludarabine|mesh-list
102569752|NCT00338377|Fludarabine phosphate|fludarabine phosphate|mesh-list
102569753|NCT00338377|Interleukin-2|interleukin-2|mesh-list
102569754|NCT00338377|Mesna|mesna|mesh-list
102569755|NCT00338377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102569756|NCT00338377|Immunologic Factors|immunologic factors|mesh-ancestor
102569757|NCT00338377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569758|NCT00338377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102569759|NCT00338377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102569760|NCT00338377|Alkylating Agents|alkylating agents|mesh-ancestor
102569761|NCT00338377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569762|NCT00338377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569763|NCT00338377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102569764|NCT00338377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102569765|NCT00338377|Antimetabolites|antimetabolites|mesh-ancestor
102569766|NCT00338377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102569767|NCT00338377|Analgesics|analgesics|mesh-ancestor
102569768|NCT00338377|Sensory System Agents|sensory system agents|mesh-ancestor
102569769|NCT00338377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102569770|NCT00338377|Protective Agents|protective agents|mesh-ancestor
102569771|NCT00161213|Gemcitabine|gemcitabine|mesh-list
102569772|NCT00161213|Imatinib Mesylate|imatinib mesylate|mesh-list
102569773|NCT00161213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102569774|NCT00161213|Antimetabolites|antimetabolites|mesh-ancestor
102569775|NCT00161213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569776|NCT00161213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569777|NCT00161213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102569778|NCT00161213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102569779|NCT00118131|Docetaxel|docetaxel|mesh-list
102569780|NCT00118131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569781|NCT00118131|Tubulin Modulators|tubulin modulators|mesh-ancestor
101836720|NCT00489918|Teriparatide|teriparatide|mesh-list
102569782|NCT00118131|Antimitotic Agents|antimitotic agents|mesh-ancestor
102569783|NCT00118131|Mitosis Modulators|mitosis modulators|mesh-ancestor
102569784|NCT00118131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569785|NCT00006436|Prednisone|prednisone|mesh-list
102569786|NCT00006436|Cyclophosphamide|cyclophosphamide|mesh-list
102569787|NCT00006436|Rituximab|rituximab|mesh-list
102569788|NCT00006436|Doxorubicin|doxorubicin|mesh-list
102569789|NCT00006436|Etoposide|etoposide|mesh-list
102569790|NCT00006436|Vincristine|vincristine|mesh-list
102569791|NCT00006436|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102569792|NCT00006436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102569793|NCT00006436|Immunologic Factors|immunologic factors|mesh-ancestor
102569794|NCT00006436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569795|NCT00006436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102569796|NCT00006436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102569797|NCT00006436|Alkylating Agents|alkylating agents|mesh-ancestor
102569798|NCT00006436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569799|NCT00006436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569800|NCT00006436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102569801|NCT00006436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102569802|NCT00006436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102569803|NCT00006436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102569804|NCT00006436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102569805|NCT00006436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102569806|NCT00006436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102569807|NCT00006436|Glucocorticoids|glucocorticoids|mesh-ancestor
102569808|NCT00006436|Hormones|hormones|mesh-ancestor
102569809|NCT00006436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102569810|NCT00006436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102569811|NCT00006436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102569812|NCT00006436|Tubulin Modulators|tubulin modulators|mesh-ancestor
102569813|NCT00006436|Antimitotic Agents|antimitotic agents|mesh-ancestor
102569814|NCT00006436|Mitosis Modulators|mitosis modulators|mesh-ancestor
102569815|NCT02399917|Azacitidine|azacitidine|mesh-list
102569816|NCT02399917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102569817|NCT02399917|Antimetabolites|antimetabolites|mesh-ancestor
102569818|NCT02399917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569819|NCT02399917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569820|NCT02399917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102569821|NCT00356486|Ribavirin|ribavirin|mesh-list
102569822|NCT00356486|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102569823|NCT00356486|Interferon-alpha|interferon-alpha|mesh-list
102569824|NCT00356486|Antimetabolites|antimetabolites|mesh-ancestor
102569825|NCT00356486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569826|NCT00356486|Antiviral Agents|antiviral agents|mesh-ancestor
102569827|NCT00356486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102569828|NCT00356486|Immunologic Factors|immunologic factors|mesh-ancestor
102569829|NCT00356486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569830|NCT03331835|Brodalumab|brodalumab|mesh-list
102569831|NCT03331835|Dermatologic Agents|dermatologic agents|mesh-ancestor
102569832|NCT02403895|Paclitaxel|paclitaxel|mesh-list
102569833|NCT02403895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102569834|NCT02403895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569835|NCT02403895|Tubulin Modulators|tubulin modulators|mesh-ancestor
102569836|NCT02403895|Antimitotic Agents|antimitotic agents|mesh-ancestor
102569837|NCT02403895|Mitosis Modulators|mitosis modulators|mesh-ancestor
102569838|NCT02403895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569839|NCT03987776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102569840|NCT02354833|Phenylephrine|phenylephrine|mesh-list
102569841|NCT02354833|Oxymetazoline|oxymetazoline|mesh-list
102569842|NCT02354833|Norepinephrine|norepinephrine|mesh-list
102569843|NCT02354833|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102569844|NCT02354833|Mydriatics|mydriatics|mesh-ancestor
102569845|NCT02354833|Autonomic Agents|autonomic agents|mesh-ancestor
102569846|NCT02354833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102569847|NCT02354833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569848|NCT02354833|Sympathomimetics|sympathomimetics|mesh-ancestor
102569849|NCT02354833|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102569850|NCT02354833|Nasal Decongestants|nasal decongestants|mesh-ancestor
102569851|NCT02354833|Respiratory System Agents|respiratory system agents|mesh-ancestor
102569852|NCT02354833|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102569853|NCT02354833|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102569854|NCT02354833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102569855|NCT02354833|Adrenergic Agents|adrenergic agents|mesh-ancestor
102569856|NCT02354833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102569857|NCT02354833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569858|NCT02354833|Protective Agents|protective agents|mesh-ancestor
102569859|NCT03337724|Paclitaxel|paclitaxel|mesh-list
102569860|NCT03337724|Ipatasertib|ipatasertib|mesh-list
102569861|NCT03337724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102569862|NCT03337724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569863|NCT03337724|Tubulin Modulators|tubulin modulators|mesh-ancestor
102569864|NCT03337724|Antimitotic Agents|antimitotic agents|mesh-ancestor
102569865|NCT03337724|Mitosis Modulators|mitosis modulators|mesh-ancestor
102569866|NCT03337724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569867|NCT03337724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102569868|NCT03337724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102569869|NCT03838484|Nicotine|nicotine|mesh-list
102569870|NCT03838484|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102569871|NCT03838484|Autonomic Agents|autonomic agents|mesh-ancestor
102569872|NCT03838484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102569873|NCT03838484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569874|NCT03838484|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102569875|NCT03838484|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102569876|NCT03838484|Cholinergic Agents|cholinergic agents|mesh-ancestor
102569877|NCT03838484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102569878|NCT03838484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569879|NCT03307616|Nivolumab|nivolumab|mesh-list
102569880|NCT03307616|Ipilimumab|ipilimumab|mesh-list
102569881|NCT03307616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102569882|NCT03307616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569883|NCT03307616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102569884|NCT03307616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569885|NCT05721872|Arsenic Trioxide|arsenic trioxide|mesh-list
102569886|NCT05721872|Isoascorbic acid|isoascorbic acid|mesh-list
102569887|NCT05721872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569888|NCT05721872|Antioxidants|antioxidants|mesh-ancestor
102569889|NCT05721872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569890|NCT05721872|Protective Agents|protective agents|mesh-ancestor
102569891|NCT05721872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569892|NCT02408965|Methylergonovine|methylergonovine|mesh-list
102569893|NCT02408965|Oxytocics|oxytocics|mesh-ancestor
102569894|NCT02408965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102569895|NCT02408965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569896|NCT03299426|Vaccines|vaccines|mesh-list
102569897|NCT03299426|Immunologic Factors|immunologic factors|mesh-ancestor
102569898|NCT03299426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569899|NCT03216356|Cycloserine|cycloserine|mesh-list
102569900|NCT03216356|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102569901|NCT03216356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102569902|NCT03216356|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102569903|NCT03216356|Antitubercular Agents|antitubercular agents|mesh-ancestor
102569904|NCT03216356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102569905|NCT03216356|Antimetabolites|antimetabolites|mesh-ancestor
102569906|NCT03216356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569907|NCT02411929|Ertugliflozin|ertugliflozin|mesh-list
102569908|NCT02411929|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102569909|NCT02411929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569910|NCT02411929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102569911|NCT02411929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569912|NCT00356954|Ascorbic Acid|ascorbic acid|mesh-list
102569913|NCT00356954|Antioxidants|antioxidants|mesh-ancestor
102569914|NCT00356954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569915|NCT00356954|Protective Agents|protective agents|mesh-ancestor
102569916|NCT00356954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569917|NCT00356954|Vitamins|vitamins|mesh-ancestor
102569918|NCT00356954|Micronutrients|micronutrients|mesh-ancestor
102569919|NCT02358889|Ranibizumab|ranibizumab|mesh-list
102569920|NCT02358889|hI-con1|hi-con1|mesh-list
102569921|NCT02358889|Immunoconjugates|immunoconjugates|mesh-list
102569922|NCT02358889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102569923|NCT02358889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102569924|NCT02358889|Growth Substances|growth substances|mesh-ancestor
102569925|NCT02358889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569926|NCT02358889|Growth Inhibitors|growth inhibitors|mesh-ancestor
102569927|NCT02358889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569928|NCT02358889|Immunologic Factors|immunologic factors|mesh-ancestor
102569929|NCT05721170|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102569930|NCT05721170|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102569931|NCT05721170|Adrenergic Agents|adrenergic agents|mesh-ancestor
102569932|NCT05721170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102569933|NCT05721170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569934|NCT05721170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569935|NCT00358124|Metformin|metformin|mesh-list
102569936|NCT00358124|Insulin Glargine|insulin glargine|mesh-list
102569937|NCT00358124|Rosiglitazone|rosiglitazone|mesh-list
102569938|NCT00358124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102569939|NCT00358124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569940|NCT00358202|Ceftriaxone|ceftriaxone|mesh-list
102569941|NCT00358202|Cefepime|cefepime|mesh-list
102569942|NCT00358202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102569943|NCT00358202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102569944|NCT02802566|Vitamins|vitamins|mesh-list
102569945|NCT02802566|Micronutrients|micronutrients|mesh-ancestor
102569946|NCT02802566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569947|NCT04736225|Insulin|insulin|mesh-list
102569948|NCT04736225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102569949|NCT04736225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569950|NCT03344861|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
102569951|NCT03344861|Trioxsalen|trioxsalen|mesh-list
102569952|NCT03344861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569953|NCT03344861|Dermatologic Agents|dermatologic agents|mesh-ancestor
102569954|NCT03344861|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102569955|NCT03348683|Propranolol|propranolol|mesh-list
102569956|NCT03348683|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102569957|NCT03348683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102569958|NCT03348683|Adrenergic Agents|adrenergic agents|mesh-ancestor
102569959|NCT03348683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102569960|NCT03348683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569961|NCT03348683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569962|NCT03348683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102569963|NCT03348683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102116910|NCT02177409|Amlodipine|amlodipine|mesh-list
102569964|NCT03348683|Vasodilator Agents|vasodilator agents|mesh-ancestor
102569965|NCT04344782|Bevacizumab|bevacizumab|mesh-list
102569966|NCT04344782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102569967|NCT04344782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102569968|NCT04344782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102569969|NCT04344782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102569970|NCT04344782|Growth Substances|growth substances|mesh-ancestor
102569971|NCT04344782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102569972|NCT04344782|Growth Inhibitors|growth inhibitors|mesh-ancestor
102569973|NCT00357188|Ritonavir|ritonavir|mesh-list
102569974|NCT00357188|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102569975|NCT00357188|Efavirenz|efavirenz|mesh-list
102569976|NCT00357188|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102569977|NCT00357188|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102569978|NCT00357188|Protease Inhibitors|protease inhibitors|mesh-ancestor
102569979|NCT00357188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102569980|NCT00357188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102569981|NCT00357188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102569982|NCT00357188|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102569983|NCT00357188|Antiviral Agents|antiviral agents|mesh-ancestor
102569984|NCT00357188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102569985|NCT00357188|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102569986|NCT00357188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102569987|NCT00357188|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102569988|NCT00357188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102569989|NCT00357188|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102569990|NCT00357188|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102569991|NCT00357188|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102569992|NCT00357188|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102569993|NCT00357188|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102569994|NCT02360215|Memantine|memantine|mesh-list
102569995|NCT02360215|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102569996|NCT02360215|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102569997|NCT02360215|Dopamine Agents|dopamine agents|mesh-ancestor
102569998|NCT02360215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102569999|NCT02360215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570000|NCT02360215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570001|NCT02360215|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102570002|NCT02360215|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102570003|NCT01349192|Chlorhexidine|chlorhexidine|mesh-list
102570004|NCT01349192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102570005|NCT01349192|Minocycline|minocycline|mesh-list
102570006|NCT01349192|Rifampin|rifampin|mesh-list
102570007|NCT01349192|Trimethoprim|trimethoprim|mesh-list
102570008|NCT01349192|Sulfamethoxazole|sulfamethoxazole|mesh-list
102570009|NCT01349192|Mupirocin|mupirocin|mesh-list
102570010|NCT01349192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102570011|NCT01349192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102570012|NCT01349192|Disinfectants|disinfectants|mesh-ancestor
102570013|NCT01349192|Dermatologic Agents|dermatologic agents|mesh-ancestor
102570014|NCT01349192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102570015|NCT01349192|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102570016|NCT01349192|Antitubercular Agents|antitubercular agents|mesh-ancestor
102570017|NCT01349192|Leprostatic Agents|leprostatic agents|mesh-ancestor
102570018|NCT01349192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102570019|NCT01349192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102570020|NCT01349192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570021|NCT01349192|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102570022|NCT01349192|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102570023|NCT01349192|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102570024|NCT01349192|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102570025|NCT01349192|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102570026|NCT01349192|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102570027|NCT01349192|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102570028|NCT01349192|Antimalarials|antimalarials|mesh-ancestor
102570029|NCT01349192|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102570030|NCT01349192|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102570031|NCT01349192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102570032|NCT01349192|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102570033|NCT01349192|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102570034|NCT01349192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102570035|NCT01349192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102570036|NCT02362321|Dexamethasone|dexamethasone|mesh-list
102570037|NCT02362321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102570038|NCT02362321|Antiemetics|antiemetics|mesh-ancestor
102570039|NCT02362321|Autonomic Agents|autonomic agents|mesh-ancestor
102570040|NCT02362321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102570041|NCT02362321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570042|NCT02362321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102570043|NCT02362321|Glucocorticoids|glucocorticoids|mesh-ancestor
102570045|NCT02362321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102570046|NCT02362321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102570047|NCT02362321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102570048|NCT00354991|Losartan|losartan|mesh-list
102570049|NCT00354991|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102570050|NCT00354991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102570051|NCT00354991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102570052|NCT00354991|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102570053|NCT00354991|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102570054|NCT00354991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570055|NCT00354991|Diuretics|diuretics|mesh-ancestor
102570056|NCT00354991|Natriuretic Agents|natriuretic agents|mesh-ancestor
102570057|NCT00354991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570058|NCT00354991|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102570059|NCT00354991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102570060|NCT02112578|Meclizine|meclizine|mesh-list
102570061|NCT02112578|Dimenhydrinate|dimenhydrinate|mesh-list
102570062|NCT02112578|Antiemetics|antiemetics|mesh-ancestor
102570063|NCT02112578|Autonomic Agents|autonomic agents|mesh-ancestor
102570064|NCT02112578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102570065|NCT02112578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570066|NCT02112578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102570067|NCT02112578|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102570068|NCT02112578|Histamine Antagonists|histamine antagonists|mesh-ancestor
102570069|NCT02112578|Histamine Agents|histamine agents|mesh-ancestor
102570070|NCT02112578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102570071|NCT02112578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570072|NCT02112578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102570073|NCT02112578|Cholinergic Agents|cholinergic agents|mesh-ancestor
102570074|NCT02112578|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102570075|NCT00358280|Bupivacaine|bupivacaine|mesh-list
102570076|NCT00358280|Ropivacaine|ropivacaine|mesh-list
102570077|NCT00358280|Anesthetics, Local|anesthetics, local|mesh-ancestor
102570078|NCT00358280|Anesthetics|anesthetics|mesh-ancestor
102570079|NCT00358280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102570080|NCT00358280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570081|NCT00358280|Sensory System Agents|sensory system agents|mesh-ancestor
102570082|NCT00358280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102570083|NCT05719285|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102570084|NCT05719285|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102570085|NCT05719285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102570086|NCT05719285|Antitubercular Agents|antitubercular agents|mesh-ancestor
102570087|NCT02363803|Lidocaine|lidocaine|mesh-list
102570088|NCT02363803|Anesthetics, Local|anesthetics, local|mesh-ancestor
102570089|NCT02363803|Anesthetics|anesthetics|mesh-ancestor
102570090|NCT02363803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102570091|NCT02363803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570092|NCT02363803|Sensory System Agents|sensory system agents|mesh-ancestor
102570093|NCT02363803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102570094|NCT02363803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102570095|NCT02363803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102570096|NCT02363803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102570097|NCT02363803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102570098|NCT02363803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570099|NCT03417193|Analgesics, Opioid|analgesics, opioid|mesh-list
102570100|NCT03417193|Anesthetics|anesthetics|mesh-list
102570101|NCT03417193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102570102|NCT03417193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570103|NCT03417193|Narcotics|narcotics|mesh-ancestor
102570104|NCT03417193|Analgesics|analgesics|mesh-ancestor
102570105|NCT03417193|Sensory System Agents|sensory system agents|mesh-ancestor
102570106|NCT03417193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102570107|NCT02367859|Trametinib|trametinib|mesh-list
102570108|NCT02367859|Dabrafenib|dabrafenib|mesh-list
102570109|NCT02367859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102570110|NCT02367859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102570111|NCT02367859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102570112|NCT02367859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570113|NCT02368093|Dextromethorphan|dextromethorphan|mesh-list
102570114|NCT02368093|Antitussive Agents|antitussive agents|mesh-ancestor
102570115|NCT02368093|Respiratory System Agents|respiratory system agents|mesh-ancestor
102570116|NCT02368093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102570117|NCT02368093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102570118|NCT02368093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102570119|NCT02368093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570120|NCT02368093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570121|NCT03342937|Pembrolizumab|pembrolizumab|mesh-list
102570122|NCT03342937|Capecitabine|capecitabine|mesh-list
102570123|NCT03342937|Oxaliplatin|oxaliplatin|mesh-list
102570124|NCT03342937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102570125|NCT03342937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102570126|NCT03342937|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102570127|NCT03342937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570128|NCT03342937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102570129|NCT03342937|Antimetabolites|antimetabolites|mesh-ancestor
102570130|NCT05718661|Methamphetamine|methamphetamine|mesh-list
102570131|NCT05718661|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102570132|NCT05718661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570133|NCT05718661|Sympathomimetics|sympathomimetics|mesh-ancestor
102570134|NCT05718661|Autonomic Agents|autonomic agents|mesh-ancestor
102570135|NCT05718661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102570136|NCT05718661|Dopamine Agents|dopamine agents|mesh-ancestor
102570137|NCT05718661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102570138|NCT05718661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570139|NCT05718661|Adrenergic Agents|adrenergic agents|mesh-ancestor
102570140|NCT05718661|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102570141|NCT05718661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102570142|NCT05718661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102570143|NCT05718661|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102570144|NCT00354757|Rabeprazole|rabeprazole|mesh-list
102570145|NCT00354757|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102570146|NCT00354757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102570147|NCT00354757|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102570148|NCT00354757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102570149|NCT00354757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570150|NCT02376283|Clopidogrel|clopidogrel|mesh-list
102570151|NCT02376283|Ticagrelor|ticagrelor|mesh-list
102570152|NCT02376283|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102570153|NCT02376283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102570154|NCT02376283|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102570155|NCT02376283|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102570156|NCT02376283|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102570157|NCT02376283|Purinergic Agents|purinergic agents|mesh-ancestor
102570158|NCT02376283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102570159|NCT02376283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570160|NCT02376283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570161|NCT00425347|Elotuzumab|elotuzumab|mesh-list
102570162|NCT00425347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102570163|NCT05718037|Vaccines|vaccines|mesh-list
102570164|NCT05718037|Immunologic Factors|immunologic factors|mesh-ancestor
102570165|NCT05718037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570166|NCT05717881|Propolis|propolis|mesh-list
102570167|NCT05717881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102570168|NCT00355303|Misoprostol|misoprostol|mesh-list
102570169|NCT00355303|Dinoprostone|dinoprostone|mesh-list
102570170|NCT00355303|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102570171|NCT00355303|Abortifacient Agents|abortifacient agents|mesh-ancestor
102570172|NCT00355303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102570173|NCT00355303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570174|NCT00355303|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102570175|NCT00355303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102570176|NCT00355303|Oxytocics|oxytocics|mesh-ancestor
102570177|NCT05717569|Vitamin D|vitamin d|mesh-list
102570178|NCT05717569|Vitamins|vitamins|mesh-ancestor
102570179|NCT05717569|Micronutrients|micronutrients|mesh-ancestor
102570180|NCT05717569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570181|NCT05717569|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102570182|NCT02385097|Ropivacaine|ropivacaine|mesh-list
102570183|NCT02385097|Chloroprocaine|chloroprocaine|mesh-list
102570184|NCT02385097|Anesthetics, Local|anesthetics, local|mesh-ancestor
102570185|NCT02385097|Anesthetics|anesthetics|mesh-ancestor
102570186|NCT02385097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102570187|NCT02385097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570188|NCT02385097|Sensory System Agents|sensory system agents|mesh-ancestor
102570189|NCT02385097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102570190|NCT02387359|Plecanatide|plecanatide|mesh-list
102570191|NCT02387359|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102570192|NCT02387359|Enzyme Activators|enzyme activators|mesh-ancestor
102570193|NCT02387359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570194|NCT02387359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102570195|NCT00355459|Doxycycline|doxycycline|mesh-list
102570196|NCT00355459|Tetracycline|tetracycline|mesh-list
102570197|NCT00355459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102570198|NCT00355459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102570199|NCT00355459|Antimalarials|antimalarials|mesh-ancestor
102570200|NCT00355459|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102570201|NCT00355459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102570202|NCT00355459|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102570203|NCT00355459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102570204|NCT00355459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570205|NCT02393677|Dexmedetomidine|dexmedetomidine|mesh-list
102570206|NCT02393677|Ropivacaine|ropivacaine|mesh-list
102570207|NCT02393677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102570208|NCT02393677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102570209|NCT02393677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570210|NCT02393677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102570211|NCT02393677|Analgesics|analgesics|mesh-ancestor
102570212|NCT02393677|Sensory System Agents|sensory system agents|mesh-ancestor
102570213|NCT02393677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102570214|NCT02393677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102570215|NCT02393677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102570216|NCT02393677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102570217|NCT02393677|Adrenergic Agents|adrenergic agents|mesh-ancestor
102570218|NCT02393677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102570219|NCT02393677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570220|NCT02393677|Anesthetics, Local|anesthetics, local|mesh-ancestor
102570221|NCT02393677|Anesthetics|anesthetics|mesh-ancestor
102570222|NCT02394457|Cosyntropin|cosyntropin|mesh-list
102570224|NCT02394457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102570225|NCT02394457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570226|NCT00355771|Levocetirizine|levocetirizine|mesh-list
102570227|NCT00355771|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102570228|NCT00355771|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102570229|NCT00355771|Histamine Antagonists|histamine antagonists|mesh-ancestor
102570230|NCT00355771|Histamine Agents|histamine agents|mesh-ancestor
102570231|NCT00355771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102570232|NCT00355771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570233|NCT00355771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570234|NCT05664139|Paclitaxel|paclitaxel|mesh-list
102570235|NCT05664139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102570236|NCT05664139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102570237|NCT05664139|Tubulin Modulators|tubulin modulators|mesh-ancestor
102570238|NCT05664139|Antimitotic Agents|antimitotic agents|mesh-ancestor
102570239|NCT05664139|Mitosis Modulators|mitosis modulators|mesh-ancestor
102570240|NCT05664139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570241|NCT03224351|Ivacaftor|ivacaftor|mesh-list
102570242|NCT03224351|VX-659|vx-659|mesh-list
102570243|NCT03224351|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102570244|NCT03224351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102570245|NCT03224351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570246|NCT05658055|Amoxicillin|amoxicillin|mesh-list
102570247|NCT05658055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102570248|NCT05658055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102570249|NCT05642923|Thiamine|thiamine|mesh-list
102570250|NCT05642923|Vitamins|vitamins|mesh-ancestor
102570251|NCT05642923|Micronutrients|micronutrients|mesh-ancestor
102570252|NCT05642923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570253|NCT05642923|Vitamin B Complex|vitamin b complex|mesh-ancestor
102570254|NCT03906071|Docetaxel|docetaxel|mesh-list
102570255|NCT03906071|Nivolumab|nivolumab|mesh-list
102570256|NCT03906071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102570257|NCT03906071|Tubulin Modulators|tubulin modulators|mesh-ancestor
102570258|NCT03906071|Antimitotic Agents|antimitotic agents|mesh-ancestor
102570259|NCT03906071|Mitosis Modulators|mitosis modulators|mesh-ancestor
102570260|NCT03906071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570261|NCT03906071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102570262|NCT03906071|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102570263|NCT01721876|Cytarabine|cytarabine|mesh-list
102570264|NCT01721876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102570265|NCT01721876|Antimetabolites|antimetabolites|mesh-ancestor
102570266|NCT01721876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570267|NCT01721876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102570268|NCT01721876|Antiviral Agents|antiviral agents|mesh-ancestor
102570269|NCT01721876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102570270|NCT01721876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102570271|NCT01721876|Immunologic Factors|immunologic factors|mesh-ancestor
102570272|NCT01721876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570273|NCT03224585|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102570274|NCT03224585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102570275|NCT03423641|Antiviral Agents|antiviral agents|mesh-list
102570276|NCT03423641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102570277|NCT01112072|Riboflavin|riboflavin|mesh-list
102570278|NCT01112072|Vitamin B Complex|vitamin b complex|mesh-ancestor
102570279|NCT01112072|Vitamins|vitamins|mesh-ancestor
102570280|NCT01112072|Micronutrients|micronutrients|mesh-ancestor
102570281|NCT01112072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570282|NCT01112072|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102570283|NCT01112072|Dermatologic Agents|dermatologic agents|mesh-ancestor
102570284|NCT04825795|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
102570285|NCT04825795|Protease Inhibitors|protease inhibitors|mesh-ancestor
102570286|NCT04825795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102570287|NCT04825795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570288|NCT04825795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102570289|NCT04825795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570290|NCT03226223|Methamphetamine|methamphetamine|mesh-list
102570291|NCT03226223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102570292|NCT03226223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570293|NCT03226223|Sympathomimetics|sympathomimetics|mesh-ancestor
102570294|NCT03226223|Autonomic Agents|autonomic agents|mesh-ancestor
102570295|NCT03226223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102570296|NCT03226223|Dopamine Agents|dopamine agents|mesh-ancestor
102570297|NCT03226223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102570298|NCT03226223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570299|NCT03226223|Adrenergic Agents|adrenergic agents|mesh-ancestor
102570300|NCT03226223|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102570301|NCT03226223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102570302|NCT03226223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102570303|NCT03226223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102570304|NCT05620771|Bevacizumab|bevacizumab|mesh-list
102570305|NCT05620771|Atezolizumab|atezolizumab|mesh-list
102570306|NCT05620771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102570307|NCT05620771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102570308|NCT05620771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102570309|NCT05620771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102570310|NCT05620771|Growth Substances|growth substances|mesh-ancestor
102570311|NCT05620771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570312|NCT05620771|Growth Inhibitors|growth inhibitors|mesh-ancestor
102570313|NCT05620771|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102570314|NCT05620771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570315|NCT05419297|Buprenorphine|buprenorphine|mesh-list
102570316|NCT05419297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102570317|NCT05419297|Narcotics|narcotics|mesh-ancestor
102570318|NCT05419297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102570319|NCT05419297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570320|NCT05419297|Analgesics|analgesics|mesh-ancestor
102570321|NCT05419297|Sensory System Agents|sensory system agents|mesh-ancestor
102570322|NCT05419297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102570323|NCT05419297|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102570324|NCT03226457|Empagliflozin|empagliflozin|mesh-list
102570325|NCT03226457|Furosemide|furosemide|mesh-list
102570326|NCT03226457|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102570327|NCT03226457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570328|NCT03226457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102570329|NCT03226457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570330|NCT03226457|Diuretics|diuretics|mesh-ancestor
102570331|NCT03226457|Natriuretic Agents|natriuretic agents|mesh-ancestor
102570332|NCT03226457|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102570333|NCT03226457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102570334|NCT03226691|Plerixafor|plerixafor|mesh-list
102570335|NCT03226691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102570336|NCT03226691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102570337|NCT03226691|Antiviral Agents|antiviral agents|mesh-ancestor
102570338|NCT03226691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102570340|NCT00003159|Vinorelbine|vinorelbine|mesh-list
102570341|NCT00003159|Vinblastine|vinblastine|mesh-list
102570342|NCT00003159|Docetaxel|docetaxel|mesh-list
102570343|NCT00003159|Carboplatin|carboplatin|mesh-list
102570344|NCT00003159|Gemcitabine|gemcitabine|mesh-list
102570345|NCT00003159|Ifosfamide|ifosfamide|mesh-list
102570346|NCT00003159|Mitomycins|mitomycins|mesh-list
102570347|NCT00003159|Mitomycin|mitomycin|mesh-list
102570348|NCT00003159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102570349|NCT00003159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102570350|NCT00003159|Tubulin Modulators|tubulin modulators|mesh-ancestor
102570351|NCT00003159|Antimitotic Agents|antimitotic agents|mesh-ancestor
102570352|NCT00003159|Mitosis Modulators|mitosis modulators|mesh-ancestor
102570353|NCT00003159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570354|NCT00003159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102570355|NCT00003159|Antimetabolites|antimetabolites|mesh-ancestor
102570356|NCT00003159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102570357|NCT00003159|Alkylating Agents|alkylating agents|mesh-ancestor
102570358|NCT00003159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102570359|NCT00003159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102570360|NCT00003159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102570361|NCT03228017|Aspirin|aspirin|mesh-list
102570362|NCT03228017|Atorvastatin|atorvastatin|mesh-list
102570363|NCT03228017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102570364|NCT03228017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102570365|NCT03228017|Analgesics|analgesics|mesh-ancestor
102570366|NCT03228017|Sensory System Agents|sensory system agents|mesh-ancestor
102570367|NCT03228017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102570368|NCT03228017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570369|NCT03228017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102570370|NCT03228017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102570371|NCT03228017|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102570372|NCT03228017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102570373|NCT03228017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570374|NCT03228017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102570375|NCT03228017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102570376|NCT03228017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102570377|NCT03228017|Antipyretics|antipyretics|mesh-ancestor
102570378|NCT03228017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102570379|NCT03228017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102570380|NCT03228017|Antimetabolites|antimetabolites|mesh-ancestor
102570381|NCT03228017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102570382|NCT03228017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102570383|NCT00355927|Propofol|propofol|mesh-list
102570384|NCT00355927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102570385|NCT00355927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102570386|NCT00355927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570387|NCT00355927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102570388|NCT00355927|Anesthetics, General|anesthetics, general|mesh-ancestor
102570389|NCT00355927|Anesthetics|anesthetics|mesh-ancestor
102570390|NCT00357422|Ethanol|ethanol|mesh-list
102570391|NCT00357422|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102570392|NCT00357422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102570393|NCT00357422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102570394|NCT00357422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570395|NCT00356005|Azithromycin|azithromycin|mesh-list
102570396|NCT00356005|Artesunate|artesunate|mesh-list
102570397|NCT00356005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102570398|NCT00356005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102570399|NCT00356005|Antimalarials|antimalarials|mesh-ancestor
102570400|NCT00356005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102570401|NCT00356005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102570402|NCT00356005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102570403|NCT00356005|Antiviral Agents|antiviral agents|mesh-ancestor
102570404|NCT00356005|Schistosomicides|schistosomicides|mesh-ancestor
102570405|NCT00356005|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102570406|NCT00356005|Anthelmintics|anthelmintics|mesh-ancestor
102570407|NCT00376337|Micafungin|micafungin|mesh-list
102570408|NCT00376337|Antifungal Agents|antifungal agents|mesh-list
102570409|NCT00376337|Clotrimazole|clotrimazole|mesh-list
102570410|NCT00376337|Miconazole|miconazole|mesh-list
102570411|NCT00376337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102570412|NCT00376337|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102570413|NCT00376337|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102570414|NCT00376337|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102570415|NCT00376337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102570416|NCT00376337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570417|NCT00376337|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102570418|NCT00376337|Hormone Antagonists|hormone antagonists|mesh-ancestor
102570419|NCT00376337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102570420|NCT00376337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570421|NCT00376337|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102570422|NCT00376337|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102570423|NCT00003165|Doxorubicin|doxorubicin|mesh-list
102570424|NCT00003165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102570425|NCT00003165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102570426|NCT00003165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102570427|NCT00003165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102570428|NCT00003165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102570429|NCT00003165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570430|NCT05723510|Rivaroxaban|rivaroxaban|mesh-list
102570431|NCT05723510|Apixaban|apixaban|mesh-list
102570432|NCT05723510|Edoxaban|edoxaban|mesh-list
102570433|NCT05723510|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102570434|NCT05723510|Antithrombins|antithrombins|mesh-ancestor
102570435|NCT05723510|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102570436|NCT05723510|Protease Inhibitors|protease inhibitors|mesh-ancestor
102570437|NCT05723510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102570438|NCT05723510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570439|NCT05723510|Anticoagulants|anticoagulants|mesh-ancestor
102570440|NCT00003171|Bryostatin 1|bryostatin 1|mesh-list
102570441|NCT00003171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102570442|NCT00003171|Immunologic Factors|immunologic factors|mesh-ancestor
102570443|NCT00003171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570444|NCT00003171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102570445|NCT00003183|Mitoxantrone|mitoxantrone|mesh-list
102570446|NCT00003183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570447|NCT00003183|Analgesics|analgesics|mesh-ancestor
102570448|NCT00003183|Sensory System Agents|sensory system agents|mesh-ancestor
102570449|NCT00003183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102570450|NCT00003183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102570451|NCT00003183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102570452|NCT00003183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102570453|NCT00003183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102570454|NCT00003183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570455|NCT02979223|Ascorbic Acid|ascorbic acid|mesh-list
102570456|NCT02979223|Magnesium citrate|magnesium citrate|mesh-list
102570457|NCT02979223|Picosulfate sodium|picosulfate sodium|mesh-list
102343458|NCT05141708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102570458|NCT02979223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570459|NCT02979223|Antioxidants|antioxidants|mesh-ancestor
102570460|NCT02979223|Protective Agents|protective agents|mesh-ancestor
102570461|NCT02979223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570462|NCT02979223|Vitamins|vitamins|mesh-ancestor
102570463|NCT02979223|Micronutrients|micronutrients|mesh-ancestor
102570464|NCT02979223|Cathartics|cathartics|mesh-ancestor
102570465|NCT02979223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102570466|NCT01805271|Everolimus|everolimus|mesh-list
102570467|NCT01805271|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102570468|NCT01805271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102570469|NCT01805271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102570470|NCT01805271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570471|NCT01805271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102570472|NCT01805271|Immunologic Factors|immunologic factors|mesh-ancestor
102570473|NCT01805271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570474|NCT01805271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102570475|NCT05723276|Psilocybin|psilocybin|mesh-list
102570476|NCT05723276|Hallucinogens|hallucinogens|mesh-ancestor
102570477|NCT05723276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570478|NCT05723276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102570479|NCT01768767|Ketamine|ketamine|mesh-list
102570480|NCT01768767|Analgesics|analgesics|mesh-ancestor
102570481|NCT01768767|Sensory System Agents|sensory system agents|mesh-ancestor
102570482|NCT01768767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102570483|NCT01768767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570484|NCT01768767|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102570485|NCT01768767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102570486|NCT01768767|Anesthetics, General|anesthetics, general|mesh-ancestor
102570487|NCT01768767|Anesthetics|anesthetics|mesh-ancestor
102570488|NCT01768767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102570489|NCT01768767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102117429|NCT02182401|GABA Modulators|gaba modulators|mesh-ancestor
102570490|NCT01768767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102570491|NCT01768767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102570492|NCT01768767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570494|NCT00376493|Doxycycline|doxycycline|mesh-list
102570495|NCT00376493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102570496|NCT00376493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102570497|NCT00376493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102570498|NCT00376493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102570499|NCT00376493|Antimalarials|antimalarials|mesh-ancestor
102570500|NCT00003195|Interferons|interferons|mesh-list
102570501|NCT00003195|Interferon-alpha|interferon-alpha|mesh-list
102570502|NCT00003195|Busulfan|busulfan|mesh-list
102570503|NCT00003195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102570504|NCT00003195|Antiviral Agents|antiviral agents|mesh-ancestor
102570505|NCT00003195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102570506|NCT00003195|Immunologic Factors|immunologic factors|mesh-ancestor
102570507|NCT00003195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570508|NCT00003195|Alkylating Agents|alkylating agents|mesh-ancestor
102570509|NCT00003195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570510|NCT00003195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102570511|NCT00003195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102570512|NCT00003195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102570513|NCT05716256|Urinastatin|urinastatin|mesh-list
102570514|NCT05716256|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102570515|NCT05716256|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102570516|NCT05716256|Protease Inhibitors|protease inhibitors|mesh-ancestor
102570517|NCT05716256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102570518|NCT05716256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570519|NCT00356083|Methadone|methadone|mesh-list
102570520|NCT00356083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102570521|NCT00356083|Narcotics|narcotics|mesh-ancestor
102570522|NCT00356083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102570523|NCT00356083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570524|NCT00356083|Analgesics|analgesics|mesh-ancestor
102570525|NCT00356083|Sensory System Agents|sensory system agents|mesh-ancestor
102570526|NCT00356083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102570527|NCT00356083|Antitussive Agents|antitussive agents|mesh-ancestor
102570528|NCT00356083|Respiratory System Agents|respiratory system agents|mesh-ancestor
102570529|NCT02977832|Alfuzosin|alfuzosin|mesh-list
102570530|NCT02977832|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102570531|NCT02977832|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102570532|NCT02977832|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102570533|NCT02977832|Adrenergic Agents|adrenergic agents|mesh-ancestor
102570534|NCT02977832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102570535|NCT02977832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570536|NCT02977832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570537|NCT02977832|Urological Agents|urological agents|mesh-ancestor
102570538|NCT04344236|Chlorhexidine|chlorhexidine|mesh-list
102570539|NCT04344236|Povidone-Iodine|povidone-iodine|mesh-list
102570540|NCT04344236|Povidone|povidone|mesh-list
102570541|NCT04344236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102570542|NCT04344236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102570543|NCT04344236|Disinfectants|disinfectants|mesh-ancestor
102570544|NCT04344236|Plasma Substitutes|plasma substitutes|mesh-ancestor
102570545|NCT04344236|Blood Substitutes|blood substitutes|mesh-ancestor
102570546|NCT00355537|Testosterone|testosterone|mesh-list
102570547|NCT00355537|Androgens|androgens|mesh-ancestor
102570548|NCT00355537|Hormones|hormones|mesh-ancestor
102570549|NCT00355537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102570550|NCT00355537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570551|NCT00003207|Doxorubicin|doxorubicin|mesh-list
102570552|NCT00003207|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102570553|NCT00003207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102570554|NCT00003207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102570555|NCT00003207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102570556|NCT00003207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102570557|NCT00003207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102570558|NCT00003207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570559|NCT00003387|Paclitaxel|paclitaxel|mesh-list
102570560|NCT00003387|Carboplatin|carboplatin|mesh-list
102570561|NCT00003387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102570562|NCT00003387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102570563|NCT00003387|Tubulin Modulators|tubulin modulators|mesh-ancestor
102570564|NCT00003387|Antimitotic Agents|antimitotic agents|mesh-ancestor
102570565|NCT00003387|Mitosis Modulators|mitosis modulators|mesh-ancestor
102570566|NCT00003387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570567|NCT01542021|Androgens|androgens|mesh-list
102570568|NCT01542021|Hormones|hormones|mesh-ancestor
102570569|NCT01542021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102570570|NCT01542021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570571|NCT04706897|Lidocaine|lidocaine|mesh-list
102570572|NCT04706897|Dexmedetomidine|dexmedetomidine|mesh-list
102570573|NCT04706897|Ketamine|ketamine|mesh-list
102570574|NCT04706897|Anesthetics, Local|anesthetics, local|mesh-ancestor
102570575|NCT04706897|Anesthetics|anesthetics|mesh-ancestor
102570576|NCT04706897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102570577|NCT04706897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570578|NCT04706897|Sensory System Agents|sensory system agents|mesh-ancestor
102570579|NCT04706897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102570580|NCT04706897|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102570581|NCT04706897|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102570582|NCT04706897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102570583|NCT04706897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102570584|NCT04706897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570585|NCT04706897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102570586|NCT04706897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102570587|NCT04706897|Analgesics|analgesics|mesh-ancestor
102570588|NCT04706897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102570589|NCT04706897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102570590|NCT04706897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102570591|NCT04706897|Adrenergic Agents|adrenergic agents|mesh-ancestor
102570592|NCT04706897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102570593|NCT04706897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102570594|NCT04706897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102570595|NCT04706897|Anesthetics, General|anesthetics, general|mesh-ancestor
102570596|NCT04706897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102570597|NCT04706897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102570598|NCT00003213|Dexamethasone|dexamethasone|mesh-list
102570599|NCT00003213|Dexamethasone acetate|dexamethasone acetate|mesh-list
102570600|NCT00003213|Metoclopramide|metoclopramide|mesh-list
102570601|NCT00003213|Granisetron|granisetron|mesh-list
102570602|NCT00003213|BB 1101|bb 1101|mesh-list
102570603|NCT00003213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102570604|NCT00003213|Antiemetics|antiemetics|mesh-ancestor
102570605|NCT00003213|Autonomic Agents|autonomic agents|mesh-ancestor
102570606|NCT00003213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102570607|NCT00003213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570608|NCT00003213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102570609|NCT00003213|Glucocorticoids|glucocorticoids|mesh-ancestor
102570610|NCT00003213|Hormones|hormones|mesh-ancestor
102570611|NCT00003213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102570612|NCT00003213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102570613|NCT00003213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102570614|NCT00003213|Protease Inhibitors|protease inhibitors|mesh-ancestor
102570615|NCT00003213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102570616|NCT00003213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570617|NCT00003213|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102570618|NCT00003213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102570619|NCT00003213|Dopamine Agents|dopamine agents|mesh-ancestor
102570620|NCT00003213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102570621|NCT00003213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102570622|NCT00003213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102570623|NCT00003213|Serotonin Agents|serotonin agents|mesh-ancestor
102570624|NCT01445067|Calcitonin|calcitonin|mesh-list
102570625|NCT01445067|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
102570626|NCT01445067|Katacalcin|katacalcin|mesh-list
102570627|NCT01445067|Vasodilator Agents|vasodilator agents|mesh-ancestor
102570628|NCT01445067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102570629|NCT01445067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570630|NCT01445067|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102570631|NCT02978066|Anesthetics|anesthetics|mesh-list
102570632|NCT02978066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102570633|NCT02978066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570634|NCT00003399|Dexamethasone|dexamethasone|mesh-list
102570635|NCT00003399|Paclitaxel|paclitaxel|mesh-list
102570636|NCT00003399|Etoposide|etoposide|mesh-list
102570637|NCT00003399|Cyclophosphamide|cyclophosphamide|mesh-list
102570638|NCT00003399|Melphalan|melphalan|mesh-list
102570639|NCT00003399|Carmustine|carmustine|mesh-list
102570640|NCT00003399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102570641|NCT00003399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102570642|NCT00003399|Tubulin Modulators|tubulin modulators|mesh-ancestor
102570643|NCT00003399|Antimitotic Agents|antimitotic agents|mesh-ancestor
102570644|NCT00003399|Mitosis Modulators|mitosis modulators|mesh-ancestor
102570645|NCT00003399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570646|NCT00003399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102570647|NCT00003399|Immunologic Factors|immunologic factors|mesh-ancestor
102570648|NCT00003399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570649|NCT00003399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102570650|NCT00003399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102570651|NCT00003399|Alkylating Agents|alkylating agents|mesh-ancestor
102570652|NCT00003399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102570653|NCT00003399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102570654|NCT00003399|Antiemetics|antiemetics|mesh-ancestor
102570655|NCT00003399|Autonomic Agents|autonomic agents|mesh-ancestor
102570656|NCT00003399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102570657|NCT00003399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102570658|NCT00003399|Glucocorticoids|glucocorticoids|mesh-ancestor
102570659|NCT00003399|Hormones|hormones|mesh-ancestor
102570660|NCT00003399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102570661|NCT00003399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102570662|NCT00003399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102570663|NCT00003399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102570664|NCT00003399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102570665|NCT03376061|Tranexamic Acid|tranexamic acid|mesh-list
102570666|NCT03376061|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102570667|NCT03376061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102570668|NCT03376061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570669|NCT03376061|Hemostatics|hemostatics|mesh-ancestor
102570670|NCT03376061|Coagulants|coagulants|mesh-ancestor
102570671|NCT03376295|Tiotropium Bromide|tiotropium bromide|mesh-list
102570672|NCT03376295|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102570673|NCT03376295|Autonomic Agents|autonomic agents|mesh-ancestor
102570674|NCT03376295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102570675|NCT03376295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570676|NCT03376295|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102570677|NCT03376295|Respiratory System Agents|respiratory system agents|mesh-ancestor
102570678|NCT03376295|Parasympatholytics|parasympatholytics|mesh-ancestor
102570679|NCT03376295|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102570680|NCT03376295|Cholinergic Agents|cholinergic agents|mesh-ancestor
102570681|NCT03376295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102570682|NCT03376295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570683|NCT00003219|Perillyl alcohol|perillyl alcohol|mesh-list
102570684|NCT00003219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102570685|NCT00003219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102570686|NCT00003219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570687|NCT05715788|Nitric Oxide|nitric oxide|mesh-list
102570688|NCT05715788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102570689|NCT05715788|Autonomic Agents|autonomic agents|mesh-ancestor
102570690|NCT05715788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102570691|NCT05715788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570692|NCT05715788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102570693|NCT05715788|Respiratory System Agents|respiratory system agents|mesh-ancestor
102570694|NCT05715788|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102570695|NCT05715788|Antioxidants|antioxidants|mesh-ancestor
102570696|NCT05715788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570697|NCT05715788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102570698|NCT05715788|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102570699|NCT05715788|Vasodilator Agents|vasodilator agents|mesh-ancestor
102570700|NCT05715788|Gasotransmitters|gasotransmitters|mesh-ancestor
102570701|NCT05715788|Protective Agents|protective agents|mesh-ancestor
102570702|NCT00003225|Irinotecan|irinotecan|mesh-list
102570703|NCT00003225|Amifostine|amifostine|mesh-list
102570704|NCT00003225|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102570705|NCT00003225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102570706|NCT00003225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102570707|NCT00003225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570708|NCT00003225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102570709|NCT00003225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102570710|NCT00003225|Protective Agents|protective agents|mesh-ancestor
102570711|NCT00003225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570712|NCT03838094|Calcium|calcium|mesh-list
102570713|NCT03838094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102117651|NCT02488538|Serotonin Agents|serotonin agents|mesh-ancestor
102570714|NCT03838094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570715|NCT03441269|Ibuprofen|ibuprofen|mesh-list
102570716|NCT03441269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102570717|NCT03441269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102570718|NCT03441269|Analgesics|analgesics|mesh-ancestor
102570719|NCT03441269|Sensory System Agents|sensory system agents|mesh-ancestor
102570720|NCT03441269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102570721|NCT03441269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570722|NCT03441269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102570723|NCT03441269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102570724|NCT03441269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102570725|NCT03441269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102570726|NCT03441269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570727|NCT03252353|Octreotide|octreotide|mesh-list
102570728|NCT03252353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102570729|NCT03252353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102570730|NCT03252353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102570731|NCT05355272|Hormones|hormones|mesh-list
102570732|NCT05355272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102570733|NCT05355272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570734|NCT00358358|Fluticasone|fluticasone|mesh-list
102570735|NCT00358358|Xhance|xhance|mesh-list
102570736|NCT00358358|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102570737|NCT00358358|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102570738|NCT00358358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102570739|NCT00358358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102570740|NCT00358358|Autonomic Agents|autonomic agents|mesh-ancestor
102570741|NCT00358358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102570742|NCT00358358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570743|NCT00358358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102570744|NCT00358358|Respiratory System Agents|respiratory system agents|mesh-ancestor
102570745|NCT00358358|Dermatologic Agents|dermatologic agents|mesh-ancestor
102570746|NCT00358358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102570747|NCT00358358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102570748|NCT00358358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102570749|NCT00358358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102570750|NCT00358358|Adrenergic Agents|adrenergic agents|mesh-ancestor
102570751|NCT00358358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102570752|NCT00358358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570753|NCT00358358|Glucocorticoids|glucocorticoids|mesh-ancestor
102570754|NCT00358358|Hormones|hormones|mesh-ancestor
102570755|NCT00358358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102570756|NCT00358358|Sympathomimetics|sympathomimetics|mesh-ancestor
102570757|NCT03441581|Eluxadoline|eluxadoline|mesh-list
102570758|NCT03441581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102570759|NCT02265510|Dexamethasone|dexamethasone|mesh-list
102570760|NCT02265510|Paclitaxel|paclitaxel|mesh-list
102570761|NCT02265510|Gemcitabine|gemcitabine|mesh-list
102570762|NCT02265510|Lenalidomide|lenalidomide|mesh-list
102570763|NCT02265510|Azacitidine|azacitidine|mesh-list
102570764|NCT02265510|Bortezomib|bortezomib|mesh-list
102570765|NCT02265510|Pomalidomide|pomalidomide|mesh-list
102570766|NCT02265510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102570767|NCT02265510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102570768|NCT02265510|Tubulin Modulators|tubulin modulators|mesh-ancestor
102570769|NCT02265510|Antimitotic Agents|antimitotic agents|mesh-ancestor
102570770|NCT02265510|Mitosis Modulators|mitosis modulators|mesh-ancestor
102570771|NCT02265510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570772|NCT02265510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102570773|NCT02265510|Antiemetics|antiemetics|mesh-ancestor
102570774|NCT02265510|Autonomic Agents|autonomic agents|mesh-ancestor
102570775|NCT02265510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102570776|NCT02265510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570777|NCT02265510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102570778|NCT02265510|Glucocorticoids|glucocorticoids|mesh-ancestor
102570779|NCT02265510|Hormones|hormones|mesh-ancestor
102570780|NCT02265510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102570781|NCT02265510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102570782|NCT02265510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102570783|NCT02265510|Antimetabolites|antimetabolites|mesh-ancestor
102570784|NCT02265510|Immunologic Factors|immunologic factors|mesh-ancestor
102570785|NCT02265510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102570786|NCT02265510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102570787|NCT02265510|Growth Substances|growth substances|mesh-ancestor
102570788|NCT02265510|Growth Inhibitors|growth inhibitors|mesh-ancestor
102570789|NCT02265510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102570790|NCT03254147|Warfarin|warfarin|mesh-list
102570791|NCT03254147|Rivaroxaban|rivaroxaban|mesh-list
102570792|NCT03254147|Dabigatran|dabigatran|mesh-list
102570793|NCT03254147|Apixaban|apixaban|mesh-list
102570794|NCT03254147|Edoxaban|edoxaban|mesh-list
102570795|NCT03254147|Anticoagulants|anticoagulants|mesh-ancestor
102570796|NCT03254147|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102570797|NCT03254147|Antithrombins|antithrombins|mesh-ancestor
102570798|NCT03254147|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102570799|NCT03254147|Protease Inhibitors|protease inhibitors|mesh-ancestor
102570800|NCT03254147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102570801|NCT03254147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570802|NCT03384329|Resveratrol|resveratrol|mesh-list
102570803|NCT03384329|Antioxidants|antioxidants|mesh-ancestor
102570804|NCT03384329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570805|NCT03384329|Protective Agents|protective agents|mesh-ancestor
102570806|NCT03384329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570807|NCT03384329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102570808|NCT03384329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102570809|NCT03443063|Lemborexant|lemborexant|mesh-list
102570810|NCT03443063|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102570811|NCT03443063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102570812|NCT03443063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570813|NCT03443063|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102570814|NCT03443063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102570815|NCT03443063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102570816|NCT03443063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570817|NCT05327972|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102570818|NCT05327972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102570819|NCT05327972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102570820|NCT05327972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570821|NCT05327972|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102570822|NCT05327972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102570823|NCT05327972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570824|NCT05327972|Cholinergic Agents|cholinergic agents|mesh-ancestor
102570825|NCT05327972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102570826|NCT03256253|Pregabalin|pregabalin|mesh-list
102570827|NCT03256253|Analgesics|analgesics|mesh-ancestor
102570828|NCT03256253|Sensory System Agents|sensory system agents|mesh-ancestor
102570829|NCT03256253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102570830|NCT03256253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570831|NCT03256253|Anticonvulsants|anticonvulsants|mesh-ancestor
102570832|NCT03256253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102570833|NCT03256253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102570834|NCT03256253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570835|NCT03256253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102570836|NCT03256253|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102570837|NCT03256253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102570838|NCT03256253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102570839|NCT03256253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102570840|NCT03256799|Ivacaftor|ivacaftor|mesh-list
102570841|NCT03256799|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102570842|NCT03256799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102570843|NCT03256799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570844|NCT01238211|Cytarabine|cytarabine|mesh-list
102570845|NCT01238211|Daunorubicin|daunorubicin|mesh-list
102570846|NCT01238211|Dasatinib|dasatinib|mesh-list
102570847|NCT01238211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102570848|NCT01238211|Antimetabolites|antimetabolites|mesh-ancestor
102570849|NCT01238211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570850|NCT01238211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102570851|NCT01238211|Antiviral Agents|antiviral agents|mesh-ancestor
102570852|NCT01238211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102570853|NCT01238211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102570854|NCT01238211|Immunologic Factors|immunologic factors|mesh-ancestor
102570855|NCT01238211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570856|NCT01238211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102570857|NCT01238211|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102570858|NCT01238211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102570859|NCT01238211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102570860|NCT01238211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102570861|NCT04735445|Liver Extracts|liver extracts|mesh-list
102570862|NCT04735445|Hematinics|hematinics|mesh-ancestor
102570863|NCT00003231|Docetaxel|docetaxel|mesh-list
102570864|NCT00003231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102117823|NCT05045170|Propofol|propofol|mesh-list
102570865|NCT00003231|Tubulin Modulators|tubulin modulators|mesh-ancestor
102570866|NCT00003231|Antimitotic Agents|antimitotic agents|mesh-ancestor
102570867|NCT00003231|Mitosis Modulators|mitosis modulators|mesh-ancestor
102570868|NCT00003231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570869|NCT00003405|Interferons|interferons|mesh-list
102570870|NCT00003405|Cytarabine|cytarabine|mesh-list
102570871|NCT00003405|Interferon-alpha|interferon-alpha|mesh-list
102570872|NCT00003405|Bromodeoxyuridine|bromodeoxyuridine|mesh-list
102570873|NCT00003405|5-bromouridine|5-bromouridine|mesh-list
102570874|NCT00003405|Idoxuridine|idoxuridine|mesh-list
102570875|NCT00003405|Mitoxantrone|mitoxantrone|mesh-list
102570876|NCT00003405|Idarubicin|idarubicin|mesh-list
102570877|NCT00003405|Isotretinoin|isotretinoin|mesh-list
102570878|NCT00003405|Amifostine|amifostine|mesh-list
102570879|NCT00003405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102570880|NCT00003405|Antiviral Agents|antiviral agents|mesh-ancestor
102570881|NCT00003405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102570882|NCT00003405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102570883|NCT00003405|Antimetabolites|antimetabolites|mesh-ancestor
102570884|NCT00003405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570885|NCT00003405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102570886|NCT00003405|Immunologic Factors|immunologic factors|mesh-ancestor
102570887|NCT00003405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570888|NCT00003405|Analgesics|analgesics|mesh-ancestor
102570889|NCT00003405|Sensory System Agents|sensory system agents|mesh-ancestor
102570890|NCT00003405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102570891|NCT00003405|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102570892|NCT00003405|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102570893|NCT00003405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102570894|NCT00003405|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102570895|NCT00003405|Dermatologic Agents|dermatologic agents|mesh-ancestor
102570896|NCT00003405|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102570897|NCT00003405|Protective Agents|protective agents|mesh-ancestor
102570898|NCT00003405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102570899|NCT05131646|Axitinib|axitinib|mesh-list
102570900|NCT05131646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102570901|NCT05131646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102570902|NCT05131646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102570903|NCT05131646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570904|NCT00003411|Motexafin gadolinium|motexafin gadolinium|mesh-list
102570905|NCT00003411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102570906|NCT00003411|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102570907|NCT00003411|Dermatologic Agents|dermatologic agents|mesh-ancestor
102570908|NCT00003243|Aldesleukin|aldesleukin|mesh-list
102570909|NCT00003243|Cyclophosphamide|cyclophosphamide|mesh-list
102570910|NCT00003243|Doxorubicin|doxorubicin|mesh-list
102570911|NCT00003243|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102570912|NCT00003243|Etoposide|etoposide|mesh-list
102570913|NCT00003243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102570914|NCT00003243|Immunologic Factors|immunologic factors|mesh-ancestor
102570915|NCT00003243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570916|NCT00003243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102570917|NCT00003243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102570918|NCT00003243|Alkylating Agents|alkylating agents|mesh-ancestor
102570919|NCT00003243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570920|NCT00003243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102570921|NCT00003243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102570922|NCT00003243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102570923|NCT00003243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102570924|NCT00003243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102570925|NCT00003243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102570926|NCT00003243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102570927|NCT00003243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102570928|NCT00003243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102570929|NCT00003243|Antiviral Agents|antiviral agents|mesh-ancestor
102570930|NCT00003243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102570931|NCT04344158|Sorafenib|sorafenib|mesh-list
102570932|NCT04344158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102570933|NCT04344158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102570934|NCT04344158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102570935|NCT04344158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570936|NCT00003249|Ketoconazole|ketoconazole|mesh-list
102570937|NCT00003249|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
102570938|NCT00003249|Antifungal Agents|antifungal agents|mesh-ancestor
102570939|NCT00003249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102570940|NCT00003249|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102570941|NCT00003249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102570942|NCT00003249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102570943|NCT00003249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570944|NCT00003249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102570945|NCT00003249|Hormone Antagonists|hormone antagonists|mesh-ancestor
102570946|NCT00003249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102570947|NCT00003249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570948|NCT00003249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102570949|NCT00003249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102570950|NCT00003249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102570951|NCT00003249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102570952|NCT00003249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102570953|NCT00003255|Carboplatin|carboplatin|mesh-list
102570955|NCT00003255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102570956|NCT00003255|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102570957|NCT00003255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102570958|NCT00003255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102570959|NCT00003255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570960|NCT03269435|Metoclopramide|metoclopramide|mesh-list
102570961|NCT03269435|Bupivacaine|bupivacaine|mesh-list
102570962|NCT03269435|Anesthetics, Local|anesthetics, local|mesh-ancestor
102570963|NCT03269435|Anesthetics|anesthetics|mesh-ancestor
102570964|NCT03269435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102570965|NCT03269435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570966|NCT03269435|Sensory System Agents|sensory system agents|mesh-ancestor
102570967|NCT03269435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102570968|NCT03269435|Antiemetics|antiemetics|mesh-ancestor
102570969|NCT03269435|Autonomic Agents|autonomic agents|mesh-ancestor
102570970|NCT03269435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102570971|NCT03269435|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102570972|NCT03269435|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102570973|NCT03269435|Dopamine Agents|dopamine agents|mesh-ancestor
102570974|NCT03269435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102570975|NCT03269435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570976|NCT00003261|Zidovudine|zidovudine|mesh-list
102570977|NCT00003261|Methotrexate|methotrexate|mesh-list
102570978|NCT00003261|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102570979|NCT00003261|Abortifacient Agents|abortifacient agents|mesh-ancestor
102570980|NCT00003261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102570981|NCT00003261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102570982|NCT00003261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102570983|NCT00003261|Antimetabolites|antimetabolites|mesh-ancestor
102570984|NCT00003261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102570985|NCT00003261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102570986|NCT00003261|Dermatologic Agents|dermatologic agents|mesh-ancestor
102570987|NCT00003261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102570988|NCT00003261|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102570989|NCT00003261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102570990|NCT00003261|Immunologic Factors|immunologic factors|mesh-ancestor
102570991|NCT00003261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102570992|NCT00003261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102570993|NCT00003261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102570994|NCT00003261|Antiviral Agents|antiviral agents|mesh-ancestor
102570995|NCT00003261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102570996|NCT00003261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102570997|NCT00003261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102570998|NCT03279731|Liraglutide|liraglutide|mesh-list
102570999|NCT03279731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102571000|NCT03279731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571001|NCT03279731|Incretins|incretins|mesh-ancestor
102571002|NCT03279731|Hormones|hormones|mesh-ancestor
102571003|NCT03279731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102571004|NCT04530409|Dexamethasone|dexamethasone|mesh-list
102571005|NCT04530409|Methylprednisolone|methylprednisolone|mesh-list
102571006|NCT04530409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102571007|NCT04530409|Antiemetics|antiemetics|mesh-ancestor
102571008|NCT04530409|Autonomic Agents|autonomic agents|mesh-ancestor
102571009|NCT04530409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102571010|NCT04530409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571011|NCT04530409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102571012|NCT04530409|Glucocorticoids|glucocorticoids|mesh-ancestor
102571013|NCT04530409|Hormones|hormones|mesh-ancestor
102571014|NCT04530409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102117970|NCT03326960|Propofol|propofol|mesh-list
102571015|NCT04530409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102571016|NCT04530409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571017|NCT04530409|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102571019|NCT04477837|Rivaroxaban|rivaroxaban|mesh-list
102571020|NCT04477837|Apixaban|apixaban|mesh-list
102571021|NCT04477837|Edoxaban|edoxaban|mesh-list
102571022|NCT04477837|Dabigatran|dabigatran|mesh-list
102571023|NCT04477837|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102571024|NCT04477837|Antithrombins|antithrombins|mesh-ancestor
102571025|NCT04477837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102343487|NCT05085808|Serotonin Agents|serotonin agents|mesh-ancestor
102571026|NCT04477837|Protease Inhibitors|protease inhibitors|mesh-ancestor
102571027|NCT04477837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102571028|NCT04477837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571029|NCT04477837|Anticoagulants|anticoagulants|mesh-ancestor
102571030|NCT05267821|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102571031|NCT05267821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102571032|NCT02264574|Obinutuzumab|obinutuzumab|mesh-list
102571033|NCT02264574|Chlorambucil|chlorambucil|mesh-list
102571034|NCT02264574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102571035|NCT02264574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571036|NCT02264574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102571037|NCT02264574|Alkylating Agents|alkylating agents|mesh-ancestor
102571038|NCT02264574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571039|NCT04412863|Interferons|interferons|mesh-list
102571040|NCT04412863|Interferon-alpha|interferon-alpha|mesh-list
102571041|NCT04412863|Interferon alpha-2|interferon alpha-2|mesh-list
102571042|NCT04412863|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102571043|NCT04412863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571044|NCT04412863|Antiviral Agents|antiviral agents|mesh-ancestor
102571045|NCT04412863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102571046|NCT04412863|Immunologic Factors|immunologic factors|mesh-ancestor
102571047|NCT04412863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571048|NCT03400475|Simvastatin|simvastatin|mesh-list
102571049|NCT03400475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102571050|NCT03400475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102571051|NCT03400475|Antimetabolites|antimetabolites|mesh-ancestor
102571052|NCT03400475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571053|NCT03400475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102571054|NCT03400475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102571055|NCT03400475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102571056|NCT01641900|Eszopiclone|eszopiclone|mesh-list
102571057|NCT01641900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102571058|NCT01641900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102571059|NCT01641900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571060|NCT03834571|Paclitaxel|paclitaxel|mesh-list
102571061|NCT03834571|Cisplatin|cisplatin|mesh-list
102571062|NCT03834571|Carboplatin|carboplatin|mesh-list
102571063|NCT03834571|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102571064|NCT03834571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102571065|NCT03834571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571066|NCT03834571|Tubulin Modulators|tubulin modulators|mesh-ancestor
102571067|NCT03834571|Antimitotic Agents|antimitotic agents|mesh-ancestor
102571068|NCT03834571|Mitosis Modulators|mitosis modulators|mesh-ancestor
102571069|NCT03834571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571070|NCT05088980|Lidocaine|lidocaine|mesh-list
102571071|NCT05088980|Anesthetics, Local|anesthetics, local|mesh-ancestor
102571072|NCT05088980|Anesthetics|anesthetics|mesh-ancestor
102571073|NCT05088980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102571074|NCT05088980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571075|NCT05088980|Sensory System Agents|sensory system agents|mesh-ancestor
102571076|NCT05088980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102571077|NCT05088980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102571078|NCT05088980|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102571079|NCT05088980|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102571080|NCT05088980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102571081|NCT05088980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571082|NCT00376727|Cetuximab|cetuximab|mesh-list
102571083|NCT00376727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102571084|NCT00376727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571085|NCT05468606|Imiquimod|imiquimod|mesh-list
102571086|NCT05468606|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102571087|NCT05468606|Immunologic Factors|immunologic factors|mesh-ancestor
102571088|NCT05468606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118026|NCT05464394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102571089|NCT05468606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571090|NCT05468606|Interferon Inducers|interferon inducers|mesh-ancestor
102571091|NCT04290871|Nitric Oxide|nitric oxide|mesh-list
102571092|NCT04290871|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102571093|NCT04290871|Autonomic Agents|autonomic agents|mesh-ancestor
102571094|NCT04290871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102571095|NCT04290871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571096|NCT04290871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102571097|NCT04290871|Respiratory System Agents|respiratory system agents|mesh-ancestor
102571098|NCT04290871|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102571099|NCT04290871|Antioxidants|antioxidants|mesh-ancestor
102571100|NCT04290871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571101|NCT04290871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102571102|NCT04290871|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102571103|NCT04290871|Vasodilator Agents|vasodilator agents|mesh-ancestor
102571104|NCT04290871|Gasotransmitters|gasotransmitters|mesh-ancestor
102571105|NCT04290871|Protective Agents|protective agents|mesh-ancestor
102571106|NCT03501979|Capecitabine|capecitabine|mesh-list
102571107|NCT03501979|Trastuzumab|trastuzumab|mesh-list
102571109|NCT03501979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102571110|NCT03501979|Antimetabolites|antimetabolites|mesh-ancestor
102571111|NCT03501979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571112|NCT03501979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571113|NCT03501979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102571114|NCT03501979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102571115|NCT03501979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102571116|NCT03465787|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102571117|NCT03465787|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102571118|NCT03465787|Antidepressive Agents|antidepressive agents|mesh-ancestor
102571119|NCT03465787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102571120|NCT03465787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102571121|NCT03465787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102571122|NCT03465787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102571123|NCT03465787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571124|NCT03465787|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102571125|NCT03465787|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102571126|NCT03465787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102571127|NCT03465787|Adrenergic Agents|adrenergic agents|mesh-ancestor
102571128|NCT03465787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102571129|NCT03465787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571130|NCT03465787|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102571131|NCT03465787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102571132|NCT03465787|Serotonin Agents|serotonin agents|mesh-ancestor
102571133|NCT03465787|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102571134|NCT03465787|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102571135|NCT03465787|Dopamine Agents|dopamine agents|mesh-ancestor
102571136|NCT05071352|Nefopam|nefopam|mesh-list
102571137|NCT05071352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102571138|NCT05071352|Analgesics|analgesics|mesh-ancestor
102571139|NCT05071352|Sensory System Agents|sensory system agents|mesh-ancestor
102571140|NCT05071352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102571141|NCT05071352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571142|NCT00376025|Antioxidants|antioxidants|mesh-list
102571143|NCT00376025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571144|NCT00376025|Protective Agents|protective agents|mesh-ancestor
102571145|NCT00376025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571146|NCT00376103|Temozolomide|temozolomide|mesh-list
102571147|NCT00376103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102571148|NCT00376103|Alkylating Agents|alkylating agents|mesh-ancestor
102571149|NCT00376103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571150|NCT00376103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571151|NCT03836287|Bromides|bromides|mesh-list
102571152|NCT03836287|Anticonvulsants|anticonvulsants|mesh-ancestor
102571153|NCT03403517|Dexamethasone|dexamethasone|mesh-list
102571154|NCT03403517|Methylprednisolone|methylprednisolone|mesh-list
102571155|NCT03403517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102571156|NCT03403517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102571157|NCT03403517|Prednisolone|prednisolone|mesh-list
102571158|NCT03403517|Prednisolone acetate|prednisolone acetate|mesh-list
102571159|NCT03403517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102571160|NCT03403517|Prednisolone phosphate|prednisolone phosphate|mesh-list
102571161|NCT03403517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102571162|NCT03403517|Antiemetics|antiemetics|mesh-ancestor
102571163|NCT03403517|Autonomic Agents|autonomic agents|mesh-ancestor
102571164|NCT03403517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102571165|NCT03403517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571166|NCT03403517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102571167|NCT03403517|Glucocorticoids|glucocorticoids|mesh-ancestor
102571168|NCT03403517|Hormones|hormones|mesh-ancestor
102571169|NCT03403517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102571170|NCT03403517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102571171|NCT03403517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571172|NCT03403517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102571173|NCT03403517|Protective Agents|protective agents|mesh-ancestor
102571174|NCT05247788|Ethanol|ethanol|mesh-list
102571175|NCT05247788|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102571176|NCT05247788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102571177|NCT05247788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102571178|NCT05247788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571179|NCT02263326|Lamivudine|lamivudine|mesh-list
102571180|NCT02263326|Dolutegravir|dolutegravir|mesh-list
102571181|NCT02263326|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102571182|NCT02263326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102571183|NCT02263326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102571184|NCT02263326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102571185|NCT02263326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571186|NCT02263326|Antiviral Agents|antiviral agents|mesh-ancestor
102571187|NCT02263326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102571188|NCT02263326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102571189|NCT02263326|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102571190|NCT02263326|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102571191|NCT05463848|Pembrolizumab|pembrolizumab|mesh-list
102571192|NCT05463848|Temozolomide|temozolomide|mesh-list
102571193|NCT05463848|Olaparib|olaparib|mesh-list
102571194|NCT05463848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102571195|NCT05463848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571196|NCT05463848|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102571197|NCT05463848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571198|NCT05463848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102571199|NCT05463848|Alkylating Agents|alkylating agents|mesh-ancestor
102571200|NCT05463848|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102571201|NCT05463848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102571202|NCT05647512|Dexamethasone|dexamethasone|mesh-list
102571203|NCT05647512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102571204|NCT05647512|Antiemetics|antiemetics|mesh-ancestor
102571205|NCT05647512|Autonomic Agents|autonomic agents|mesh-ancestor
102571206|NCT05647512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102571207|NCT05647512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571208|NCT05647512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102571209|NCT05647512|Glucocorticoids|glucocorticoids|mesh-ancestor
102571210|NCT05647512|Hormones|hormones|mesh-ancestor
102571211|NCT05647512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102571212|NCT05647512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102571213|NCT05647512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571214|NCT00356395|Candesartan|candesartan|mesh-list
102571215|NCT00356395|Candesartan cilexetil|candesartan cilexetil|mesh-list
102571216|NCT00356395|Ramipril|ramipril|mesh-list
102571217|NCT00356395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102571218|NCT00356395|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102571219|NCT00356395|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102571220|NCT00356395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571221|NCT00356395|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102571222|NCT00356395|Protease Inhibitors|protease inhibitors|mesh-ancestor
102571223|NCT00356395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102571224|NCT00356473|Atorvastatin|atorvastatin|mesh-list
102571225|NCT00356473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102571226|NCT00356473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102571227|NCT00356473|Antimetabolites|antimetabolites|mesh-ancestor
102571228|NCT00356473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571229|NCT00356473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102571230|NCT00356473|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102571231|NCT00356473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102571232|NCT05461508|Amoxicillin|amoxicillin|mesh-list
102571233|NCT05461508|Fucoidan|fucoidan|mesh-list
102571234|NCT05461508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102571235|NCT05461508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102571236|NCT05461508|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102571237|NCT05461508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102571238|NCT05461508|Anticoagulants|anticoagulants|mesh-ancestor
102571239|NCT05461508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571240|NCT00356941|Docetaxel|docetaxel|mesh-list
102571241|NCT00356941|Oxaliplatin|oxaliplatin|mesh-list
102571242|NCT00356941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571243|NCT00356941|Tubulin Modulators|tubulin modulators|mesh-ancestor
102571244|NCT00356941|Antimitotic Agents|antimitotic agents|mesh-ancestor
102571245|NCT00356941|Mitosis Modulators|mitosis modulators|mesh-ancestor
102571246|NCT00356941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571247|NCT03450083|Benralizumab|benralizumab|mesh-list
102571248|NCT03450083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102571249|NCT03450083|Respiratory System Agents|respiratory system agents|mesh-ancestor
102571250|NCT03580343|Tofacitinib|tofacitinib|mesh-list
102571251|NCT03580343|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102571252|NCT03580343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102571253|NCT03580343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102571254|NCT03580343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571255|NCT05445440|Leucovorin|leucovorin|mesh-list
102571256|NCT05445440|Sulfasalazine|sulfasalazine|mesh-list
102571257|NCT05445440|Methotrexate|methotrexate|mesh-list
102571258|NCT05445440|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102571259|NCT05445440|Abortifacient Agents|abortifacient agents|mesh-ancestor
102571260|NCT05445440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102571261|NCT05445440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571262|NCT05445440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102571263|NCT05445440|Antimetabolites|antimetabolites|mesh-ancestor
102571264|NCT05445440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571265|NCT05445440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571266|NCT05445440|Dermatologic Agents|dermatologic agents|mesh-ancestor
102571267|NCT05445440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102571268|NCT05445440|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102571269|NCT05445440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102571270|NCT05445440|Immunologic Factors|immunologic factors|mesh-ancestor
102571271|NCT05445440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102571272|NCT05445440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102571273|NCT05445440|Antidotes|antidotes|mesh-ancestor
102571274|NCT05445440|Protective Agents|protective agents|mesh-ancestor
102571275|NCT05445440|Vitamin B Complex|vitamin b complex|mesh-ancestor
102571276|NCT05445440|Vitamins|vitamins|mesh-ancestor
102571277|NCT05445440|Micronutrients|micronutrients|mesh-ancestor
102571278|NCT05445440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102571279|NCT05445440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102571280|NCT05445440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102571281|NCT05445440|Analgesics|analgesics|mesh-ancestor
102571282|NCT05445440|Sensory System Agents|sensory system agents|mesh-ancestor
102571283|NCT05445440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102571284|NCT05445440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102571285|NCT05445440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102571286|NCT05041322|Buspirone|buspirone|mesh-list
102571287|NCT05041322|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102571288|NCT05041322|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102571289|NCT05041322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102571290|NCT05041322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571291|NCT05041322|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102571292|NCT05041322|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102571293|NCT05041322|Serotonin Agents|serotonin agents|mesh-ancestor
102571294|NCT05041322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102571295|NCT05041322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571296|NCT00422825|Imatinib Mesylate|imatinib mesylate|mesh-list
102571297|NCT00422825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571298|NCT00422825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102571299|NCT00422825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102571300|NCT00422825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571301|NCT05229614|Pembrolizumab|pembrolizumab|mesh-list
102571302|NCT05229614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102571303|NCT05229614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571304|NCT05229614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102571305|NCT05229614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571306|NCT05445128|Plerixafor|plerixafor|mesh-list
102571307|NCT05445128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102571308|NCT05445128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102571309|NCT05445128|Antiviral Agents|antiviral agents|mesh-ancestor
102571310|NCT05445128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102571311|NCT02260986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102571312|NCT02260986|Immunologic Factors|immunologic factors|mesh-ancestor
102118253|NCT02490176|Hormones|hormones|mesh-ancestor
102571313|NCT02260986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571314|NCT05210582|Afamelanotide|afamelanotide|mesh-list
102571315|NCT05210582|Dermatologic Agents|dermatologic agents|mesh-ancestor
102571316|NCT04995536|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
102571317|NCT04995536|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102571318|NCT04995536|Immunologic Factors|immunologic factors|mesh-ancestor
102571319|NCT04995536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571320|NCT05647356|Bicalutamide|bicalutamide|mesh-list
102571321|NCT05647356|Androgen Antagonists|androgen antagonists|mesh-ancestor
102571322|NCT05647356|Hormone Antagonists|hormone antagonists|mesh-ancestor
102571323|NCT05647356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102571324|NCT05647356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571325|NCT05647356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571326|NCT05647278|Esomeprazole|esomeprazole|mesh-list
102571327|NCT05647278|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102571328|NCT05647278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102571329|NCT05647278|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102571330|NCT05647278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102571331|NCT05647278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571332|NCT00358748|Hydrocortisone|hydrocortisone|mesh-list
102571333|NCT00358748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102571334|NCT00359606|Tetrahydrouridine|tetrahydrouridine|mesh-list
102571335|NCT00359606|Antimetabolites|antimetabolites|mesh-ancestor
102571336|NCT00359606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571337|NCT00359840|Darbepoetin alfa|darbepoetin alfa|mesh-list
102571338|NCT00359840|Hematinics|hematinics|mesh-ancestor
102571339|NCT02259582|Carboplatin|carboplatin|mesh-list
102571340|NCT02259582|Pemetrexed|pemetrexed|mesh-list
102571341|NCT02259582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571342|NCT02259582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102571343|NCT02259582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571344|NCT02259582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102571345|NCT02259582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102571346|NCT00360386|Clopidogrel|clopidogrel|mesh-list
102571347|NCT00360386|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102571348|NCT00360386|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102571349|NCT00360386|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102571350|NCT00360386|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102571351|NCT00360386|Purinergic Agents|purinergic agents|mesh-ancestor
102571352|NCT00360386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102571353|NCT00360386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571354|NCT00360386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571355|NCT02977208|Gabapentin|gabapentin|mesh-list
102571356|NCT02977208|Analgesics|analgesics|mesh-ancestor
102571357|NCT02977208|Sensory System Agents|sensory system agents|mesh-ancestor
102571358|NCT02977208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102571359|NCT02977208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571360|NCT02977208|Anticonvulsants|anticonvulsants|mesh-ancestor
102571361|NCT02977208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102571362|NCT02977208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102571363|NCT02977208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102571364|NCT02977208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102571365|NCT02977208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102571366|NCT02977208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102571367|NCT02977208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102571368|NCT02977208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571369|NCT02977208|Antimanic Agents|antimanic agents|mesh-ancestor
102571370|NCT04866108|Capecitabine|capecitabine|mesh-list
102571371|NCT04866108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102571372|NCT04866108|Antimetabolites|antimetabolites|mesh-ancestor
102571373|NCT04866108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571374|NCT04866108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571375|NCT04343768|Interferons|interferons|mesh-list
102571376|NCT04343768|Ritonavir|ritonavir|mesh-list
102571377|NCT04343768|Lopinavir|lopinavir|mesh-list
102571378|NCT04343768|Interferon-beta|interferon-beta|mesh-list
102571379|NCT04343768|Interferon beta-1a|interferon beta-1a|mesh-list
102571380|NCT04343768|Hydroxychloroquine|hydroxychloroquine|mesh-list
102571381|NCT04343768|Interferon beta-1b|interferon beta-1b|mesh-list
102571382|NCT04343768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571383|NCT04343768|Antiviral Agents|antiviral agents|mesh-ancestor
102571384|NCT04343768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102571385|NCT04343768|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102571386|NCT04343768|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102571387|NCT04343768|Protease Inhibitors|protease inhibitors|mesh-ancestor
102571388|NCT04343768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102571389|NCT04343768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571390|NCT04343768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102571391|NCT04343768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102571392|NCT04343768|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102571393|NCT04343768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102571394|NCT04343768|Antimalarials|antimalarials|mesh-ancestor
102571395|NCT04343768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102571396|NCT04343768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102571397|NCT04343768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102571398|NCT04343768|Immunologic Factors|immunologic factors|mesh-ancestor
102571399|NCT04343768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571400|NCT04343768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102571401|NCT05925803|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102571402|NCT05925803|Immunologic Factors|immunologic factors|mesh-ancestor
102571403|NCT05925803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571404|NCT05925790|Antibodies|antibodies|mesh-list
102571405|NCT05925790|Immunologic Factors|immunologic factors|mesh-ancestor
102571406|NCT05925790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571407|NCT05925686|Tramadol|tramadol|mesh-list
102571408|NCT05925686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102571409|NCT05925686|Narcotics|narcotics|mesh-ancestor
102571410|NCT05925686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102571411|NCT05925686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571412|NCT05925686|Analgesics|analgesics|mesh-ancestor
102571413|NCT05925686|Sensory System Agents|sensory system agents|mesh-ancestor
102571414|NCT05925686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102571415|NCT05925530|Durvalumab|durvalumab|mesh-list
102571416|NCT05925530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102571417|NCT05925530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571418|NCT05925504|Luspatercept|luspatercept|mesh-list
102571419|NCT05925504|Hematinics|hematinics|mesh-ancestor
102571420|NCT05925491|Pembrolizumab|pembrolizumab|mesh-list
102571421|NCT05925491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102571422|NCT05925491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571423|NCT05925491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102571424|NCT05925491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571425|NCT05925309|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102571426|NCT05925309|Meropenem|meropenem|mesh-list
102571427|NCT05925309|Imipenem|imipenem|mesh-list
102571428|NCT05925309|Cefaclor|cefaclor|mesh-list
102571429|NCT05925309|Sulfamethoxazole|sulfamethoxazole|mesh-list
102571430|NCT05925309|Sulperazone|sulperazone|mesh-list
102571431|NCT05925309|Methylprednisolone|methylprednisolone|mesh-list
102571432|NCT05925309|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
102571433|NCT05925309|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102571434|NCT05925309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571435|NCT05925309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102571436|NCT05925309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102571437|NCT05925309|Antiemetics|antiemetics|mesh-ancestor
102571438|NCT05925309|Autonomic Agents|autonomic agents|mesh-ancestor
102571439|NCT05925309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102571440|NCT05925309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102571441|NCT05925309|Glucocorticoids|glucocorticoids|mesh-ancestor
102571442|NCT05925309|Hormones|hormones|mesh-ancestor
102571443|NCT05925309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102571444|NCT05925309|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102571445|NCT05925309|Protective Agents|protective agents|mesh-ancestor
102571446|NCT05925309|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102571447|NCT05925309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102571448|NCT05925283|Midazolam|midazolam|mesh-list
102571449|NCT05925283|Esketamine|esketamine|mesh-list
102571450|NCT05925283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102571451|NCT05925283|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102571452|NCT05925283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102571453|NCT05925283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571454|NCT05925283|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102571455|NCT05925283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102571456|NCT05925283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102571457|NCT05925283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102571458|NCT05925283|Anesthetics, General|anesthetics, general|mesh-ancestor
102571459|NCT05925283|Anesthetics|anesthetics|mesh-ancestor
102571460|NCT05925283|GABA Modulators|gaba modulators|mesh-ancestor
102571461|NCT05925283|GABA Agents|gaba agents|mesh-ancestor
102571462|NCT05925283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102571463|NCT05925283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571464|NCT05925283|Antidepressive Agents|antidepressive agents|mesh-ancestor
102571465|NCT05925140|Ritonavir|ritonavir|mesh-list
102571466|NCT05925140|Lopinavir|lopinavir|mesh-list
102571467|NCT05925140|Remdesivir|remdesivir|mesh-list
102571468|NCT05925140|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102571469|NCT05925140|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102571470|NCT05925140|Protease Inhibitors|protease inhibitors|mesh-ancestor
102571471|NCT05925140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102571472|NCT05925140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571473|NCT05925140|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102571474|NCT05925140|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102571475|NCT05925140|Antiviral Agents|antiviral agents|mesh-ancestor
102571476|NCT05925140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102571477|NCT05925140|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102571478|NCT05925140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102571479|NCT05925140|Antimetabolites|antimetabolites|mesh-ancestor
102571480|NCT05924971|Aspirin|aspirin|mesh-list
102571481|NCT05924971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102571482|NCT05924971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102571483|NCT05924971|Analgesics|analgesics|mesh-ancestor
102571484|NCT05924971|Sensory System Agents|sensory system agents|mesh-ancestor
102571485|NCT05924971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102571486|NCT05924971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571487|NCT05924971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102571488|NCT05924971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102571489|NCT05924971|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102571490|NCT05924971|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102571491|NCT05924971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571492|NCT05924971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102571493|NCT05924971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102571494|NCT05924971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102571495|NCT05924971|Antipyretics|antipyretics|mesh-ancestor
102571496|NCT05924893|Naltrexone|naltrexone|mesh-list
102571497|NCT05924893|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102571498|NCT05924893|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102571499|NCT05924893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571500|NCT05924893|Sensory System Agents|sensory system agents|mesh-ancestor
102571501|NCT05924893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102571502|NCT05924815|Moxifloxacin|moxifloxacin|mesh-list
102571503|NCT05924815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102571504|NCT05924815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102571505|NCT05924815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102571506|NCT05924815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102571507|NCT05924815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102571508|NCT05924815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571509|NCT05924815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571510|NCT05924672|Diphosphonates|diphosphonates|mesh-list
102571511|NCT05924672|Methylene diphosphonate|methylene diphosphonate|mesh-list
102571512|NCT05924672|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
102571513|NCT05924672|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
102571514|NCT05924672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571515|NCT05924672|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102571516|NCT05924672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571517|NCT05924672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102571518|NCT05924672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571519|NCT05924321|Moxifloxacin|moxifloxacin|mesh-list
102571520|NCT05924321|Carbetocin|carbetocin|mesh-list
102571521|NCT05924321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102571522|NCT05924321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102571523|NCT05924321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102571524|NCT05924321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102571525|NCT05924321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102571526|NCT05924321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571527|NCT05924321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571528|NCT05924321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102571529|NCT05924321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571530|NCT05924321|Oxytocics|oxytocics|mesh-ancestor
102571531|NCT05924165|Ketorolac|ketorolac|mesh-list
102571532|NCT05924165|Oxycodone|oxycodone|mesh-list
102571533|NCT05924165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102571534|NCT05924165|Narcotics|narcotics|mesh-ancestor
102571535|NCT05924165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102571536|NCT05924165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571537|NCT05924165|Analgesics|analgesics|mesh-ancestor
102571538|NCT05924165|Sensory System Agents|sensory system agents|mesh-ancestor
102571539|NCT05924165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102571540|NCT05924165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102571541|NCT05924165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102571542|NCT05924165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102571543|NCT05924165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102571544|NCT05924165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102571545|NCT05924165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102571546|NCT05924165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571547|NCT05924126|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102571548|NCT05924126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102571549|NCT05924100|Luspatercept|luspatercept|mesh-list
102571550|NCT05924100|Hematinics|hematinics|mesh-ancestor
102571551|NCT05923970|Vaccines|vaccines|mesh-list
102571552|NCT05923970|Antibodies|antibodies|mesh-list
102571553|NCT05923970|Immunoglobulins|immunoglobulins|mesh-list
102571554|NCT05923970|Immunologic Factors|immunologic factors|mesh-ancestor
102571555|NCT05923970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571556|NCT05923879|Rituximab|rituximab|mesh-list
102571557|NCT05923879|Lenalidomide|lenalidomide|mesh-list
102571558|NCT05923879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102571559|NCT05923879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571560|NCT05923879|Immunologic Factors|immunologic factors|mesh-ancestor
102571561|NCT05923879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571562|NCT05923879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102571563|NCT05923879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102571564|NCT05923879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102571565|NCT05923879|Growth Substances|growth substances|mesh-ancestor
102571566|NCT05923879|Growth Inhibitors|growth inhibitors|mesh-ancestor
102571567|NCT05923021|Sertraline|sertraline|mesh-list
102571568|NCT05923021|Antidepressive Agents|antidepressive agents|mesh-ancestor
102571569|NCT05923021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102571570|NCT05923021|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102571571|NCT05923021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102571572|NCT05923021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102571573|NCT05923021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571574|NCT05923021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102571575|NCT05923021|Serotonin Agents|serotonin agents|mesh-ancestor
102571576|NCT05923021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571577|NCT05922930|Cyclophosphamide|cyclophosphamide|mesh-list
102571578|NCT05922930|Fludarabine|fludarabine|mesh-list
102571579|NCT05922930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102571580|NCT05922930|Immunologic Factors|immunologic factors|mesh-ancestor
102571581|NCT05922930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571582|NCT05922930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102571583|NCT05922930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102571584|NCT05922930|Alkylating Agents|alkylating agents|mesh-ancestor
102571585|NCT05922930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571586|NCT05922930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571587|NCT05922930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102571588|NCT05922904|Doxorubicin|doxorubicin|mesh-list
102571589|NCT05922904|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102571590|NCT05922904|Pembrolizumab|pembrolizumab|mesh-list
102571591|NCT05922904|Dacarbazine|dacarbazine|mesh-list
102571592|NCT05922904|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102571593|NCT05922904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102571594|NCT05922904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571595|NCT05922904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102571596|NCT05922904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102571597|NCT05922904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102571598|NCT05922904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571599|NCT05922904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102571600|NCT05922904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102571601|NCT05922904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102571602|NCT05922904|Alkylating Agents|alkylating agents|mesh-ancestor
102571603|NCT05922904|Immunotoxins|immunotoxins|mesh-ancestor
102571604|NCT05922904|Immunoconjugates|immunoconjugates|mesh-ancestor
102571605|NCT05922904|Immunologic Factors|immunologic factors|mesh-ancestor
102571606|NCT05922904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571607|NCT05922839|Zanubrutinib|zanubrutinib|mesh-list
102571608|NCT05922839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571609|NCT05922839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102571610|NCT05922839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102571611|NCT05922839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571612|NCT05922800|Gamma-oryzanol|gamma-oryzanol|mesh-list
102571613|NCT05922800|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102571614|NCT05922800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102571615|NCT05922800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102571616|NCT05922800|Antimetabolites|antimetabolites|mesh-ancestor
102612397|NCT00002447|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102571617|NCT05922800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571618|NCT05922800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102571619|NCT05922761|Fluticasone|fluticasone|mesh-list
102571621|NCT05922761|Azithromycin|azithromycin|mesh-list
102571622|NCT05922761|Prednisone|prednisone|mesh-list
102571623|NCT05922761|Montelukast|montelukast|mesh-list
102571624|NCT05922761|Belumosudil|belumosudil|mesh-list
102571625|NCT05922761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102571626|NCT05922761|Glucocorticoids|glucocorticoids|mesh-ancestor
102571627|NCT05922761|Hormones|hormones|mesh-ancestor
102571628|NCT05922761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102571629|NCT05922761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571630|NCT05922761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102571631|NCT05922761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571632|NCT05922761|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102571633|NCT05922761|Autonomic Agents|autonomic agents|mesh-ancestor
102571634|NCT05922761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102571635|NCT05922761|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102571636|NCT05922761|Respiratory System Agents|respiratory system agents|mesh-ancestor
102571637|NCT05922761|Dermatologic Agents|dermatologic agents|mesh-ancestor
102571638|NCT05922761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102571639|NCT05922761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102571640|NCT05922761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102571641|NCT05922761|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102571642|NCT05922761|Hormone Antagonists|hormone antagonists|mesh-ancestor
102571643|NCT05922761|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102571644|NCT05922761|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102571645|NCT05922761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571646|NCT05922761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102571647|NCT05922761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102571648|NCT05922696|Vitamin D|vitamin d|mesh-list
102571649|NCT05922696|Cholecalciferol|cholecalciferol|mesh-list
102571650|NCT05922696|Vitamins|vitamins|mesh-ancestor
102571651|NCT05922696|Micronutrients|micronutrients|mesh-ancestor
102571652|NCT05922696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571653|NCT05922696|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102571654|NCT05922696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102571655|NCT05922605|Ketamine|ketamine|mesh-list
102571656|NCT05922605|Ropivacaine|ropivacaine|mesh-list
102571657|NCT05922605|Esketamine|esketamine|mesh-list
102571658|NCT05922605|Analgesics|analgesics|mesh-ancestor
102571659|NCT05922605|Sensory System Agents|sensory system agents|mesh-ancestor
102571660|NCT05922605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102571661|NCT05922605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571662|NCT05922605|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102571663|NCT05922605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102571664|NCT05922605|Anesthetics, General|anesthetics, general|mesh-ancestor
102571665|NCT05922605|Anesthetics|anesthetics|mesh-ancestor
102571666|NCT05922605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102571667|NCT05922605|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102571668|NCT05922605|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102571669|NCT05922605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102571670|NCT05922605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571671|NCT05922605|Anesthetics, Local|anesthetics, local|mesh-ancestor
102571672|NCT05922605|Antidepressive Agents|antidepressive agents|mesh-ancestor
102571673|NCT05922605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102571674|NCT05922501|Dexamethasone|dexamethasone|mesh-list
102571675|NCT05922501|Pomalidomide|pomalidomide|mesh-list
102571676|NCT05922501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102571677|NCT05922501|Antiemetics|antiemetics|mesh-ancestor
102571678|NCT05922501|Autonomic Agents|autonomic agents|mesh-ancestor
102571679|NCT05922501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102571680|NCT05922501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571681|NCT05922501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102571682|NCT05922501|Glucocorticoids|glucocorticoids|mesh-ancestor
102571683|NCT05922501|Hormones|hormones|mesh-ancestor
102571684|NCT05922501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102571685|NCT05922501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102571686|NCT05922501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571687|NCT05922501|Immunologic Factors|immunologic factors|mesh-ancestor
102571688|NCT05922501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102571689|NCT05922501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102571690|NCT05922501|Growth Substances|growth substances|mesh-ancestor
102571691|NCT05922501|Growth Inhibitors|growth inhibitors|mesh-ancestor
102571692|NCT05922436|Clevidipine|clevidipine|mesh-list
102571693|NCT05922436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102571694|NCT05922436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102571695|NCT05922436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571696|NCT05922436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102571697|NCT05922436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571698|NCT05922384|Etoposide|etoposide|mesh-list
102571699|NCT05922384|Melphalan|melphalan|mesh-list
102571700|NCT05922384|Carmustine|carmustine|mesh-list
102571701|NCT05922384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102571702|NCT05922384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571703|NCT05922384|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102571704|NCT05922384|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102571705|NCT05922384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102571706|NCT05922384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571707|NCT05922384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102571708|NCT05922384|Alkylating Agents|alkylating agents|mesh-ancestor
102571709|NCT05922384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102571710|NCT05922384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102571711|NCT05922384|Immunologic Factors|immunologic factors|mesh-ancestor
102571712|NCT05922384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571713|NCT05922358|Anti-Allergic Agents|anti-allergic agents|mesh-list
102571714|NCT05922345|Docetaxel|docetaxel|mesh-list
102571715|NCT05922345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571716|NCT05922345|Tubulin Modulators|tubulin modulators|mesh-ancestor
102571717|NCT05922345|Antimitotic Agents|antimitotic agents|mesh-ancestor
102571718|NCT05922345|Mitosis Modulators|mitosis modulators|mesh-ancestor
102571719|NCT05922345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571720|NCT05922306|Interferons|interferons|mesh-list
102571721|NCT05922306|Interferon-alpha|interferon-alpha|mesh-list
102571722|NCT05922306|Interferon alpha-2|interferon alpha-2|mesh-list
102571723|NCT05922306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571724|NCT05922306|Antiviral Agents|antiviral agents|mesh-ancestor
102571725|NCT05922306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102571726|NCT05922306|Immunologic Factors|immunologic factors|mesh-ancestor
102571727|NCT05922306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571728|NCT05922033|Insulin|insulin|mesh-list
102571729|NCT05922033|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102571730|NCT05922033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102571731|NCT05922033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571732|NCT05921942|Metformin|metformin|mesh-list
102571733|NCT05921942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102571734|NCT05921942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571735|NCT05921604|Gabapentin|gabapentin|mesh-list
102571736|NCT05921604|Baclofen|baclofen|mesh-list
102571737|NCT05921604|Analgesics|analgesics|mesh-ancestor
102571738|NCT05921604|Sensory System Agents|sensory system agents|mesh-ancestor
102571739|NCT05921604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102571740|NCT05921604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571741|NCT05921604|Anticonvulsants|anticonvulsants|mesh-ancestor
102571742|NCT05921604|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102571743|NCT05921604|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102571744|NCT05921604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102571745|NCT05921604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102571746|NCT05921604|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102571747|NCT05921604|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102571748|NCT05921604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102571749|NCT05921604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571750|NCT05921604|Antimanic Agents|antimanic agents|mesh-ancestor
102571751|NCT05921604|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102571752|NCT05921604|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102571753|NCT05921604|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102571754|NCT05921604|GABA Agonists|gaba agonists|mesh-ancestor
102571755|NCT05921604|GABA Agents|gaba agents|mesh-ancestor
102571756|NCT05921370|Silodosin|silodosin|mesh-list
102571757|NCT05921370|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102571758|NCT05921370|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102571759|NCT05921370|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102571760|NCT05921370|Adrenergic Agents|adrenergic agents|mesh-ancestor
102571761|NCT05921370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102571762|NCT05921370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571763|NCT05921370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571764|NCT05921370|Urological Agents|urological agents|mesh-ancestor
102571765|NCT05921292|Lidocaine|lidocaine|mesh-list
102571766|NCT05921292|Anesthetics, Local|anesthetics, local|mesh-ancestor
102571767|NCT05921292|Anesthetics|anesthetics|mesh-ancestor
102571768|NCT05921292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102571769|NCT05921292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571770|NCT05921292|Sensory System Agents|sensory system agents|mesh-ancestor
102571771|NCT05921292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102571772|NCT05921292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102571773|NCT05921292|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102571774|NCT05921292|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102571775|NCT05921292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102571776|NCT05921292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571778|NCT05921149|Carboplatin|carboplatin|mesh-list
102571779|NCT05921149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102571780|NCT05921149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571781|NCT05921149|Tubulin Modulators|tubulin modulators|mesh-ancestor
102571782|NCT05921149|Antimitotic Agents|antimitotic agents|mesh-ancestor
102571783|NCT05921149|Mitosis Modulators|mitosis modulators|mesh-ancestor
102571784|NCT05921149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571785|NCT05921097|Histamine|histamine|mesh-list
102571786|NCT05921097|Histamine Agonists|histamine agonists|mesh-ancestor
102571787|NCT05921097|Histamine Agents|histamine agents|mesh-ancestor
102571788|NCT05921097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102571789|NCT05921097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571790|NCT05921097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571791|NCT05921071|Tranexamic Acid|tranexamic acid|mesh-list
102571792|NCT05921071|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102571793|NCT05921071|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102571794|NCT05921071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571795|NCT05921071|Hemostatics|hemostatics|mesh-ancestor
102571796|NCT05921071|Coagulants|coagulants|mesh-ancestor
102571797|NCT05920980|Lidocaine|lidocaine|mesh-list
102571798|NCT05920980|Anesthetics, Local|anesthetics, local|mesh-ancestor
102571799|NCT05920980|Anesthetics|anesthetics|mesh-ancestor
102571800|NCT05920980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102571801|NCT05920980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571802|NCT05920980|Sensory System Agents|sensory system agents|mesh-ancestor
102571803|NCT05920980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102571804|NCT05920980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102571805|NCT05920980|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102571806|NCT05920980|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102571807|NCT05920980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102343537|NCT05019846|Bicalutamide|bicalutamide|mesh-list
102571808|NCT05920980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571809|NCT05920928|Capecitabine|capecitabine|mesh-list
102571810|NCT05920928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102571811|NCT05920928|Antimetabolites|antimetabolites|mesh-ancestor
102571812|NCT05920928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571813|NCT05920928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571814|NCT05920876|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102571815|NCT05920876|Immunologic Factors|immunologic factors|mesh-ancestor
102571816|NCT05920876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571817|NCT05920707|Vasopressins|vasopressins|mesh-list
102571818|NCT05920707|Arginine Vasopressin|arginine vasopressin|mesh-list
102571819|NCT05920707|Oxytocin|oxytocin|mesh-list
102571820|NCT05920707|Oxytocics|oxytocics|mesh-ancestor
102571821|NCT05920707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102571822|NCT05920707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571823|NCT05920707|Hemostatics|hemostatics|mesh-ancestor
102571824|NCT05920707|Coagulants|coagulants|mesh-ancestor
102571825|NCT05920707|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102571826|NCT05920707|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102571827|NCT05920707|Natriuretic Agents|natriuretic agents|mesh-ancestor
102571828|NCT05920538|Nicardipine|nicardipine|mesh-list
102571829|NCT05920538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102571830|NCT05920538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102571831|NCT05920538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102571832|NCT05920538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571833|NCT05920538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102571834|NCT05920538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571835|NCT05920538|Vasodilator Agents|vasodilator agents|mesh-ancestor
102571836|NCT05920512|Calcitriol|calcitriol|mesh-list
102571837|NCT05920512|Sirolimus|sirolimus|mesh-list
102571838|NCT05920512|Valproic Acid|valproic acid|mesh-list
102571839|NCT05920512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102571840|NCT05920512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102571841|NCT05920512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102571842|NCT05920512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571843|NCT05920512|Antifungal Agents|antifungal agents|mesh-ancestor
102571844|NCT05920512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102571845|NCT05920512|Immunologic Factors|immunologic factors|mesh-ancestor
102571846|NCT05920512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571847|NCT05920512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102571848|NCT05920512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571849|NCT05920512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102571850|NCT05920512|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102571851|NCT05920512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102571852|NCT05920512|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102571853|NCT05920512|Vitamins|vitamins|mesh-ancestor
102571854|NCT05920512|Micronutrients|micronutrients|mesh-ancestor
102571855|NCT05920512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102571856|NCT05920512|Anticonvulsants|anticonvulsants|mesh-ancestor
102571857|NCT05920512|GABA Agents|gaba agents|mesh-ancestor
102571858|NCT05920512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102571859|NCT05920512|Antimanic Agents|antimanic agents|mesh-ancestor
102571860|NCT05920512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102571861|NCT05920512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102571862|NCT05920512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102571863|NCT05920356|Pembrolizumab|pembrolizumab|mesh-list
102571864|NCT05920356|Sotorasib|sotorasib|mesh-list
102571865|NCT05920356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102571866|NCT05920356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571867|NCT05920356|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102571868|NCT05920356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571869|NCT05920187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102571870|NCT05920122|Chlorhexidine|chlorhexidine|mesh-list
102571871|NCT05920122|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102571872|NCT05920122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102571873|NCT05920122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102571874|NCT05920122|Disinfectants|disinfectants|mesh-ancestor
102571875|NCT05920122|Dermatologic Agents|dermatologic agents|mesh-ancestor
102571876|NCT05919992|Hydrocortisone|hydrocortisone|mesh-list
102571877|NCT05919992|Metyrapone|metyrapone|mesh-list
102571878|NCT05919992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102571879|NCT05919992|Antimetabolites|antimetabolites|mesh-ancestor
102571880|NCT05919992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571881|NCT05919992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102571882|NCT05919966|Chlorhexidine|chlorhexidine|mesh-list
102571883|NCT05919966|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102571884|NCT05919966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102571885|NCT05919966|Disinfectants|disinfectants|mesh-ancestor
102571886|NCT05919745|Acetaminophen|acetaminophen|mesh-list
102571887|NCT05919745|Ibuprofen|ibuprofen|mesh-list
102571888|NCT05919745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102571889|NCT05919745|Analgesics|analgesics|mesh-ancestor
102571890|NCT05919745|Sensory System Agents|sensory system agents|mesh-ancestor
102571891|NCT05919745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102571892|NCT05919745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571893|NCT05919745|Antipyretics|antipyretics|mesh-ancestor
102571894|NCT05919745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102571895|NCT05919745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102571896|NCT05919745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102571897|NCT05919745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102571898|NCT05919745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102571899|NCT05919745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571900|NCT05919316|Mometasone Furoate|mometasone furoate|mesh-list
102571901|NCT05919316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102571902|NCT05919316|Dermatologic Agents|dermatologic agents|mesh-ancestor
102571903|NCT05919316|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102571904|NCT05918133|Paclitaxel|paclitaxel|mesh-list
102571905|NCT05918133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102571906|NCT05918133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571907|NCT05918133|Tubulin Modulators|tubulin modulators|mesh-ancestor
102571908|NCT05918133|Antimitotic Agents|antimitotic agents|mesh-ancestor
102571909|NCT05918133|Mitosis Modulators|mitosis modulators|mesh-ancestor
102571910|NCT05918133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571911|NCT05918107|Carboplatin|carboplatin|mesh-list
102571912|NCT05918107|Pemetrexed|pemetrexed|mesh-list
102571913|NCT05918107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571914|NCT05918107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102571915|NCT05918107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571916|NCT05918107|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102571917|NCT05918107|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102571918|NCT05916950|Calcium|calcium|mesh-list
102571919|NCT05916950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102571920|NCT05916950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571922|NCT05900466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102571923|NCT05900466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571924|NCT05897268|Lenvatinib|lenvatinib|mesh-list
102571925|NCT05897268|Tislelizumab|tislelizumab|mesh-list
102571926|NCT05897268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571927|NCT05897268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102571928|NCT05897268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102571929|NCT05897268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571930|NCT05897268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102571931|NCT05895773|Povidone-Iodine|povidone-iodine|mesh-list
102571932|NCT05895773|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
102571933|NCT05895773|Povidone|povidone|mesh-list
102571934|NCT05895773|Plasma Substitutes|plasma substitutes|mesh-ancestor
102571935|NCT05895773|Blood Substitutes|blood substitutes|mesh-ancestor
102571936|NCT05895773|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102571937|NCT05895773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102571938|NCT05895773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102571939|NCT05895266|Midazolam|midazolam|mesh-list
102571940|NCT05895266|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102571941|NCT05895266|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102571942|NCT05895266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102571943|NCT05895266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571944|NCT05895266|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102571945|NCT05895266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102571946|NCT05895266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102571947|NCT05895266|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102571948|NCT05895266|Anesthetics, General|anesthetics, general|mesh-ancestor
102571949|NCT05895266|Anesthetics|anesthetics|mesh-ancestor
102571950|NCT05895266|GABA Modulators|gaba modulators|mesh-ancestor
102571951|NCT05895266|GABA Agents|gaba agents|mesh-ancestor
102571952|NCT05895266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102571953|NCT05895266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571954|NCT05895019|Propofol|propofol|mesh-list
102571955|NCT05895019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102571956|NCT05895019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102571957|NCT05895019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571958|NCT05895019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102571959|NCT05895019|Anesthetics, General|anesthetics, general|mesh-ancestor
102571960|NCT05895019|Anesthetics|anesthetics|mesh-ancestor
102571961|NCT05893056|Lenvatinib|lenvatinib|mesh-list
102571962|NCT05893056|Tislelizumab|tislelizumab|mesh-list
102571963|NCT05893056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571964|NCT05893056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102571965|NCT05893056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102571966|NCT05893056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571967|NCT05893056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102571968|NCT05891379|Immunosuppressive Agents|immunosuppressive agents|mesh-list
102571969|NCT05891379|Immunologic Factors|immunologic factors|mesh-ancestor
102571970|NCT05891379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571971|NCT05888311|Charcoal|charcoal|mesh-list
102571972|NCT05888311|Antidotes|antidotes|mesh-ancestor
102571973|NCT05888311|Protective Agents|protective agents|mesh-ancestor
102571974|NCT05888311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571975|NCT05883852|Cyclophosphamide|cyclophosphamide|mesh-list
102571976|NCT05883852|Carboplatin|carboplatin|mesh-list
102571977|NCT05883852|Docetaxel|docetaxel|mesh-list
102571978|NCT05883852|Trastuzumab|trastuzumab|mesh-list
102571979|NCT05883852|Epirubicin|epirubicin|mesh-list
102571980|NCT05883852|Pertuzumab|pertuzumab|mesh-list
102571981|NCT05883852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102571982|NCT05883852|Immunologic Factors|immunologic factors|mesh-ancestor
102571983|NCT05883852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102571984|NCT05883852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102571985|NCT05883852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102571986|NCT05883852|Alkylating Agents|alkylating agents|mesh-ancestor
102571987|NCT05883852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102571988|NCT05883852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102571989|NCT05883852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102571990|NCT05883852|Tubulin Modulators|tubulin modulators|mesh-ancestor
102571991|NCT05883852|Antimitotic Agents|antimitotic agents|mesh-ancestor
102571992|NCT05883852|Mitosis Modulators|mitosis modulators|mesh-ancestor
102571993|NCT05883852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102571994|NCT05883852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102118935|NCT02476760|Gliclazide|gliclazide|mesh-list
102571995|NCT05883852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102571996|NCT05883852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102571997|NCT05883852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102571998|NCT05857514|Indomethacin|indomethacin|mesh-list
102571999|NCT05857514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102572000|NCT05857514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102572001|NCT05857514|Analgesics|analgesics|mesh-ancestor
102572002|NCT05857514|Sensory System Agents|sensory system agents|mesh-ancestor
102343567|NCT04996823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102572003|NCT05857514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102572004|NCT05857514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572005|NCT05857514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102572006|NCT05857514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102572007|NCT05857514|Gout Suppressants|gout suppressants|mesh-ancestor
102572008|NCT05857514|Tocolytic Agents|tocolytic agents|mesh-ancestor
102572009|NCT05857514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102572010|NCT05857514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102572011|NCT05857514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102572012|NCT05857514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572013|NCT05857007|Glucocorticoids|glucocorticoids|mesh-list
102572014|NCT05857007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572015|NCT05857007|Hormones|hormones|mesh-ancestor
102572016|NCT05857007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102572017|NCT05832892|Paclitaxel|paclitaxel|mesh-list
102572018|NCT05832892|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102572019|NCT05832892|Gemcitabine|gemcitabine|mesh-list
102572020|NCT05832892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102572021|NCT05832892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572022|NCT05832892|Tubulin Modulators|tubulin modulators|mesh-ancestor
102572023|NCT05832892|Antimitotic Agents|antimitotic agents|mesh-ancestor
102572024|NCT05832892|Mitosis Modulators|mitosis modulators|mesh-ancestor
102572025|NCT05832892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572026|NCT05832892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102572027|NCT05832892|Antimetabolites|antimetabolites|mesh-ancestor
102572028|NCT05832398|Leucovorin|leucovorin|mesh-list
102572029|NCT05832398|Fluorouracil|fluorouracil|mesh-list
102572030|NCT05832398|Oxaliplatin|oxaliplatin|mesh-list
102572031|NCT05832398|Irinotecan|irinotecan|mesh-list
102572032|NCT05832398|Antimetabolites|antimetabolites|mesh-ancestor
102572033|NCT05832398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572034|NCT05832398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102572035|NCT05832398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572036|NCT05832398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102572037|NCT05832398|Immunologic Factors|immunologic factors|mesh-ancestor
102572038|NCT05832398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572039|NCT05832398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102572040|NCT05832398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102572041|NCT05832398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102572042|NCT05832398|Antidotes|antidotes|mesh-ancestor
102572043|NCT05832398|Protective Agents|protective agents|mesh-ancestor
102572044|NCT05832398|Vitamin B Complex|vitamin b complex|mesh-ancestor
102572045|NCT05832398|Vitamins|vitamins|mesh-ancestor
102572046|NCT05832398|Micronutrients|micronutrients|mesh-ancestor
102572047|NCT05828147|Rituximab|rituximab|mesh-list
102572048|NCT05828147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102572049|NCT05828147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572050|NCT05828147|Immunologic Factors|immunologic factors|mesh-ancestor
102572051|NCT05828147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572052|NCT05828147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102572053|NCT05823987|Lenvatinib|lenvatinib|mesh-list
102572054|NCT05823987|Tislelizumab|tislelizumab|mesh-list
102572055|NCT05823987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572056|NCT05823987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102572057|NCT05823987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102572058|NCT05823987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572059|NCT05823987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102572060|NCT05823467|Trimethoprim|trimethoprim|mesh-list
102572061|NCT05823467|Sulfamethoxazole|sulfamethoxazole|mesh-list
102572062|NCT05823467|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102572063|NCT05823467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102572064|NCT05823467|Antimalarials|antimalarials|mesh-ancestor
102572065|NCT05823467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102572066|NCT05823467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102572067|NCT05823467|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102572068|NCT05823467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102572069|NCT05823467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572070|NCT05823467|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102572071|NCT05823467|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102572072|NCT05823467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102572073|NCT05823337|Selenium|selenium|mesh-list
102572074|NCT05823337|Antioxidants|antioxidants|mesh-ancestor
102572075|NCT05823337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572076|NCT05823337|Protective Agents|protective agents|mesh-ancestor
102572077|NCT05823337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572078|NCT05823337|Trace Elements|trace elements|mesh-ancestor
102572079|NCT05823337|Micronutrients|micronutrients|mesh-ancestor
102572080|NCT05817591|Capsaicin|capsaicin|mesh-list
102572081|NCT05817591|Antipruritics|antipruritics|mesh-ancestor
102572082|NCT05817591|Dermatologic Agents|dermatologic agents|mesh-ancestor
102572083|NCT05817591|Sensory System Agents|sensory system agents|mesh-ancestor
102572084|NCT05817591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102572085|NCT05817591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572086|NCT05803551|Ketamine|ketamine|mesh-list
102572087|NCT05803551|Analgesics|analgesics|mesh-ancestor
102572088|NCT05803551|Sensory System Agents|sensory system agents|mesh-ancestor
102572089|NCT05803551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102572090|NCT05803551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572091|NCT05803551|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102572092|NCT05803551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102572093|NCT05803551|Anesthetics, General|anesthetics, general|mesh-ancestor
102572094|NCT05803551|Anesthetics|anesthetics|mesh-ancestor
102572095|NCT05803551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102572096|NCT05803551|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102572097|NCT05803551|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102572098|NCT05803551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102572099|NCT05803551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572100|NCT05796791|Ketamine|ketamine|mesh-list
102572101|NCT05796791|Analgesics|analgesics|mesh-ancestor
102572102|NCT05796791|Sensory System Agents|sensory system agents|mesh-ancestor
102572103|NCT05796791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102572104|NCT05796791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572105|NCT05796791|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102572106|NCT05796791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102572107|NCT05796791|Anesthetics, General|anesthetics, general|mesh-ancestor
102572108|NCT05796791|Anesthetics|anesthetics|mesh-ancestor
102572109|NCT05796791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102572110|NCT05796791|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102572111|NCT05796791|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102572112|NCT05796791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102572113|NCT05796791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572114|NCT05784844|Meropenem|meropenem|mesh-list
102572115|NCT05784844|Micafungin|micafungin|mesh-list
102572116|NCT05784844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102572117|NCT05784844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102572118|NCT05784844|Antifungal Agents|antifungal agents|mesh-ancestor
102572119|NCT05770102|Atezolizumab|atezolizumab|mesh-list
102572120|NCT05770102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102572121|NCT05770102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572122|NCT05770102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102572123|NCT05770102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572124|NCT05764733|Diphosphonates|diphosphonates|mesh-list
102572125|NCT05764733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102572126|NCT05764733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572127|NCT05759364|Papaverine|papaverine|mesh-list
102572128|NCT05759364|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102572129|NCT05759364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102572130|NCT05759364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572131|NCT05759364|Vasodilator Agents|vasodilator agents|mesh-ancestor
102572132|NCT05759364|Urological Agents|urological agents|mesh-ancestor
102572133|NCT05755035|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102572134|NCT05755035|Immunoglobulins|immunoglobulins|mesh-list
102572135|NCT05755035|Antibodies|antibodies|mesh-list
102572136|NCT05755035|gamma-Globulins|gamma-globulins|mesh-list
102572137|NCT05755035|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102572138|NCT05755035|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102572139|NCT05755035|Immunoglobulin G|immunoglobulin g|mesh-list
102572140|NCT05755035|Immunologic Factors|immunologic factors|mesh-ancestor
102572141|NCT05755035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572142|NCT05753735|Amoxicillin|amoxicillin|mesh-list
102572143|NCT05753735|Tazobactam|tazobactam|mesh-list
102572144|NCT05753735|Piperacillin|piperacillin|mesh-list
102572145|NCT05753735|Clavulanic Acids|clavulanic acids|mesh-list
102119092|NCT02475356|Levonorgestrel|levonorgestrel|mesh-list
102572146|NCT05753735|Clavulanic Acid|clavulanic acid|mesh-list
102572147|NCT05753735|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102572148|NCT05753735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102572149|NCT05753735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102572150|NCT05753735|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102572151|NCT05753735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102572152|NCT05753735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572153|NCT05749926|Vaccines|vaccines|mesh-list
102572154|NCT05749926|Immunologic Factors|immunologic factors|mesh-ancestor
102572155|NCT05749926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572156|NCT05730205|Etonogestrel|etonogestrel|mesh-list
102572157|NCT05730205|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102572158|NCT05730205|Contraceptive Agents|contraceptive agents|mesh-ancestor
102572159|NCT05730205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102572160|NCT05730205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572161|NCT05730205|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102572162|NCT05728736|Lemborexant|lemborexant|mesh-list
102572163|NCT05728736|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102572164|NCT05728736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102572165|NCT05728736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572166|NCT05728736|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102572167|NCT05728736|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102572168|NCT05728736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102572169|NCT05728736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572170|NCT05725837|Fluoxetine|fluoxetine|mesh-list
102572171|NCT05725837|Paroxetine|paroxetine|mesh-list
102572172|NCT05725837|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102572173|NCT05725837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102572174|NCT05725837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102572175|NCT05725837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572176|NCT05725837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102572177|NCT05725837|Serotonin Agents|serotonin agents|mesh-ancestor
102572178|NCT05725837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572179|NCT05725837|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102572180|NCT05725837|Antidepressive Agents|antidepressive agents|mesh-ancestor
102572181|NCT05725837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102572182|NCT05725837|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102572183|NCT05725837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102572184|NCT05725837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102572185|NCT05717140|Nivolumab|nivolumab|mesh-list
102572186|NCT05717140|Sargramostim|sargramostim|mesh-list
102572187|NCT05717140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102572188|NCT05717140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572189|NCT05717140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102572190|NCT05717140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572191|NCT05717140|Immunologic Factors|immunologic factors|mesh-ancestor
102572192|NCT05717140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572193|NCT05714345|Cyclophosphamide|cyclophosphamide|mesh-list
102572194|NCT05714345|Fludarabine|fludarabine|mesh-list
102572195|NCT05714345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102572196|NCT05714345|Immunologic Factors|immunologic factors|mesh-ancestor
102572197|NCT05714345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572198|NCT05714345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102572199|NCT05714345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102572200|NCT05714345|Alkylating Agents|alkylating agents|mesh-ancestor
102572201|NCT05714345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572202|NCT05714345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572203|NCT05714345|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102572204|NCT05711615|Doxorubicin|doxorubicin|mesh-list
102572205|NCT05711615|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102572206|NCT05711615|Peposertib|peposertib|mesh-list
102572207|NCT05711615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102572208|NCT05711615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572209|NCT05711615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102572210|NCT05711615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102572211|NCT05711615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102572212|NCT05711615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572213|NCT05711615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102572214|NCT05707208|Lidocaine|lidocaine|mesh-list
102572215|NCT05707208|Anesthetics, Local|anesthetics, local|mesh-ancestor
102572216|NCT05707208|Anesthetics|anesthetics|mesh-ancestor
102572217|NCT05707208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102612398|NCT00002447|Protease Inhibitors|protease inhibitors|mesh-ancestor
102572218|NCT05707208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572219|NCT05707208|Sensory System Agents|sensory system agents|mesh-ancestor
102572220|NCT05707208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102572221|NCT05707208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102572222|NCT05707208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102572223|NCT05707208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102572224|NCT05707208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102572225|NCT05707208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572227|NCT05706233|Sensory System Agents|sensory system agents|mesh-ancestor
102572228|NCT05706233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102572229|NCT05706233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572230|NCT05705050|Aminophylline|aminophylline|mesh-list
102572231|NCT05705050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102572232|NCT05705050|Autonomic Agents|autonomic agents|mesh-ancestor
102572233|NCT05705050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102572234|NCT05705050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572235|NCT05705050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102572236|NCT05705050|Respiratory System Agents|respiratory system agents|mesh-ancestor
102572237|NCT05705050|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102572238|NCT05705050|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102572239|NCT05705050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102572240|NCT05705050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572241|NCT05705050|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102572242|NCT05705050|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102572243|NCT05705050|Purinergic Agents|purinergic agents|mesh-ancestor
102572244|NCT05705050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102572245|NCT05705050|Protective Agents|protective agents|mesh-ancestor
102572246|NCT05693454|Tramadol|tramadol|mesh-list
102572247|NCT05693454|Levobupivacaine|levobupivacaine|mesh-list
102572248|NCT05693454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102572249|NCT05693454|Narcotics|narcotics|mesh-ancestor
102572250|NCT05693454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102572251|NCT05693454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572252|NCT05693454|Analgesics|analgesics|mesh-ancestor
102572253|NCT05693454|Sensory System Agents|sensory system agents|mesh-ancestor
102572254|NCT05693454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102572255|NCT05693454|Anesthetics, Local|anesthetics, local|mesh-ancestor
102572256|NCT05693454|Anesthetics|anesthetics|mesh-ancestor
102572257|NCT05681650|Paclitaxel|paclitaxel|mesh-list
102572258|NCT05681650|Cyclophosphamide|cyclophosphamide|mesh-list
102572259|NCT05681650|Fludarabine|fludarabine|mesh-list
102572260|NCT05681650|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102572261|NCT05681650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102572262|NCT05681650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572263|NCT05681650|Tubulin Modulators|tubulin modulators|mesh-ancestor
102572264|NCT05681650|Antimitotic Agents|antimitotic agents|mesh-ancestor
102572265|NCT05681650|Mitosis Modulators|mitosis modulators|mesh-ancestor
102572266|NCT05681650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572267|NCT05681650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102572268|NCT05681650|Immunologic Factors|immunologic factors|mesh-ancestor
102572269|NCT05681650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572270|NCT05681650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102572271|NCT05681650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102572272|NCT05681650|Alkylating Agents|alkylating agents|mesh-ancestor
102572273|NCT05681650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102572274|NCT05672108|Mitomycins|mitomycins|mesh-list
102572275|NCT05672108|Mitomycin|mitomycin|mesh-list
102572276|NCT05672108|Ethiodized Oil|ethiodized oil|mesh-list
102572277|NCT05672108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102572278|NCT05672108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572279|NCT05672108|Alkylating Agents|alkylating agents|mesh-ancestor
102572280|NCT05672108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572281|NCT05672108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102572282|NCT05672108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102572283|NCT05668429|Ibrexafungerp|ibrexafungerp|mesh-list
102572284|NCT05668429|Antifungal Agents|antifungal agents|mesh-ancestor
102572285|NCT05668429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102572286|NCT05648591|Iloperidone|iloperidone|mesh-list
102343585|NCT04952324|Vitamins|vitamins|mesh-ancestor
102572287|NCT05648591|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102572288|NCT05648591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102572289|NCT05648591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102572290|NCT05648591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572291|NCT05648591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102572292|NCT05624957|Lidocaine|lidocaine|mesh-list
102572293|NCT05624957|Epinephrine|epinephrine|mesh-list
102572294|NCT05624957|Racepinephrine|racepinephrine|mesh-list
102572295|NCT05624957|Epinephryl borate|epinephryl borate|mesh-list
102572296|NCT05624957|Anesthetics, Local|anesthetics, local|mesh-ancestor
102572297|NCT05624957|Anesthetics|anesthetics|mesh-ancestor
102572298|NCT05624957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102572299|NCT05624957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572300|NCT05624957|Sensory System Agents|sensory system agents|mesh-ancestor
102572301|NCT05624957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102572302|NCT05624957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102572303|NCT05624957|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102572304|NCT05624957|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102572305|NCT05624957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102572306|NCT05624957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572307|NCT05624957|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102572308|NCT05624957|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102572309|NCT05624957|Adrenergic Agents|adrenergic agents|mesh-ancestor
102572310|NCT05624957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102572311|NCT05624957|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102572312|NCT05624957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102572313|NCT05624957|Autonomic Agents|autonomic agents|mesh-ancestor
102572314|NCT05624957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102572315|NCT05624957|Respiratory System Agents|respiratory system agents|mesh-ancestor
102572316|NCT05624957|Mydriatics|mydriatics|mesh-ancestor
102572317|NCT05624957|Sympathomimetics|sympathomimetics|mesh-ancestor
102572318|NCT05624957|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102572319|NCT05613426|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102572320|NCT05613426|Evolocumab|evolocumab|mesh-list
102572321|NCT05613426|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102572322|NCT05613426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102572323|NCT05613426|Antimetabolites|antimetabolites|mesh-ancestor
102572324|NCT05613426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572325|NCT05613426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102572326|NCT05613426|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102572327|NCT05613426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102572328|NCT05613426|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102572329|NCT05613426|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102572330|NCT05613426|Protease Inhibitors|protease inhibitors|mesh-ancestor
102572331|NCT05610657|Mitapivat|mitapivat|mesh-list
102572332|NCT05610657|Enzyme Activators|enzyme activators|mesh-ancestor
102572333|NCT05610657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572334|NCT05603065|Paclitaxel|paclitaxel|mesh-list
102572335|NCT05603065|Tislelizumab|tislelizumab|mesh-list
102572336|NCT05603065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102572337|NCT05603065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572338|NCT05603065|Tubulin Modulators|tubulin modulators|mesh-ancestor
102572339|NCT05603065|Antimitotic Agents|antimitotic agents|mesh-ancestor
102572340|NCT05603065|Mitosis Modulators|mitosis modulators|mesh-ancestor
102572341|NCT05603065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572342|NCT05603065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102572343|NCT05601700|Paclitaxel|paclitaxel|mesh-list
102572344|NCT05601700|Carboplatin|carboplatin|mesh-list
102572345|NCT05601700|Letrozole|letrozole|mesh-list
102572346|NCT05601700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102572347|NCT05601700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572348|NCT05601700|Tubulin Modulators|tubulin modulators|mesh-ancestor
102572349|NCT05601700|Antimitotic Agents|antimitotic agents|mesh-ancestor
102572350|NCT05601700|Mitosis Modulators|mitosis modulators|mesh-ancestor
102572351|NCT05601700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572352|NCT05601700|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102572353|NCT05601700|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102572354|NCT05601700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102572355|NCT05601700|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102572356|NCT05601700|Hormone Antagonists|hormone antagonists|mesh-ancestor
102572357|NCT05601700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102572358|NCT05601700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572359|NCT05585125|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102572360|NCT05585125|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102572361|NCT05585125|Adrenergic Agents|adrenergic agents|mesh-ancestor
102572362|NCT05585125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102572363|NCT05585125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572364|NCT05585125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572365|NCT05572684|Pembrolizumab|pembrolizumab|mesh-list
102572366|NCT05572684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102572367|NCT05572684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572368|NCT05572684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102572369|NCT05572684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572371|NCT05558150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102572372|NCT05558150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102572373|NCT05558150|Analgesics|analgesics|mesh-ancestor
102572374|NCT05558150|Sensory System Agents|sensory system agents|mesh-ancestor
102572375|NCT05558150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102572376|NCT05558150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572377|NCT05558150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102572378|NCT05558150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102572379|NCT05552859|Insulin|insulin|mesh-list
102572380|NCT05552859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102572381|NCT05552859|Insulin Glargine|insulin glargine|mesh-list
102572382|NCT05552859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102572383|NCT05552859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572384|NCT05521997|Cisplatin|cisplatin|mesh-list
102572385|NCT05521997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572386|NCT05467748|Pembrolizumab|pembrolizumab|mesh-list
102572387|NCT05467748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102572388|NCT05467748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572389|NCT05467748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102572390|NCT05467748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572391|NCT05460871|Pregabalin|pregabalin|mesh-list
102572392|NCT05460871|Analgesics|analgesics|mesh-ancestor
102572393|NCT05460871|Sensory System Agents|sensory system agents|mesh-ancestor
102572394|NCT05460871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102572395|NCT05460871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572396|NCT05460871|Anticonvulsants|anticonvulsants|mesh-ancestor
102572397|NCT05460871|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102572398|NCT05460871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102572399|NCT05460871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572400|NCT05460871|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102572401|NCT05460871|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102572402|NCT05460871|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102572403|NCT05460871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102572404|NCT05460871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102572405|NCT05457998|Flutemetamol|flutemetamol|mesh-list
102572406|NCT05457998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102572407|NCT05457998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572408|NCT05438316|Ramipril|ramipril|mesh-list
102572409|NCT05438316|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102572410|NCT05438316|Protease Inhibitors|protease inhibitors|mesh-ancestor
102572411|NCT05438316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102572412|NCT05438316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572413|NCT05438316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102572414|NCT05426525|Empagliflozin|empagliflozin|mesh-list
102572415|NCT05426525|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102572416|NCT05426525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572417|NCT05426525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102572418|NCT05426525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572419|NCT05403138|Daratumumab|daratumumab|mesh-list
102572420|NCT05403138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572421|NCT05353140|Aspirin|aspirin|mesh-list
102572422|NCT05353140|Rivaroxaban|rivaroxaban|mesh-list
102572423|NCT05353140|Clopidogrel|clopidogrel|mesh-list
102572424|NCT05353140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102572425|NCT05353140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102572426|NCT05353140|Analgesics|analgesics|mesh-ancestor
102572427|NCT05353140|Sensory System Agents|sensory system agents|mesh-ancestor
102572428|NCT05353140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102572429|NCT05353140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572430|NCT05353140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102572431|NCT05353140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102572432|NCT05353140|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102572433|NCT05353140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102572434|NCT05353140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572435|NCT05353140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102572436|NCT05353140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102572437|NCT05353140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102572438|NCT05353140|Antipyretics|antipyretics|mesh-ancestor
102572439|NCT05353140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102572440|NCT05353140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102572441|NCT05353140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102572442|NCT05353140|Purinergic Agents|purinergic agents|mesh-ancestor
102572443|NCT05353140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102572444|NCT05353140|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102572445|NCT05353140|Antithrombins|antithrombins|mesh-ancestor
102572446|NCT05353140|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102572447|NCT05353140|Protease Inhibitors|protease inhibitors|mesh-ancestor
102572448|NCT05353140|Anticoagulants|anticoagulants|mesh-ancestor
102572449|NCT05351944|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102572450|NCT05351944|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102572451|NCT05351944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102572452|NCT05351944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102572453|NCT05351944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572454|NCT05351944|Adrenergic Agents|adrenergic agents|mesh-ancestor
102572455|NCT05351944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102572456|NCT05351944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572457|NCT05346393|Terlipressin|terlipressin|mesh-list
102572458|NCT05346393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102572459|NCT05346393|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102572460|NCT05340465|Iron|iron|mesh-list
102572461|NCT05340465|Dextrans|dextrans|mesh-list
102572462|NCT05340465|Darbepoetin alfa|darbepoetin alfa|mesh-list
102572463|NCT05340465|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102572464|NCT05340465|Iron-Dextran Complex|iron-dextran complex|mesh-list
102572465|NCT05340465|Trace Elements|trace elements|mesh-ancestor
102572466|NCT05340465|Micronutrients|micronutrients|mesh-ancestor
102572467|NCT05340465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572468|NCT05340465|Hematinics|hematinics|mesh-ancestor
102572469|NCT05340465|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102572470|NCT05340465|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102572471|NCT05340465|Anticoagulants|anticoagulants|mesh-ancestor
102572472|NCT05340465|Plasma Substitutes|plasma substitutes|mesh-ancestor
102572473|NCT05340465|Blood Substitutes|blood substitutes|mesh-ancestor
102572474|NCT05303090|Lenvatinib|lenvatinib|mesh-list
102572475|NCT05303090|Tislelizumab|tislelizumab|mesh-list
102572476|NCT05303090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572477|NCT05303090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102572478|NCT05303090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102572479|NCT05303090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572480|NCT05303090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102572481|NCT05303064|Olanzapine|olanzapine|mesh-list
102572482|NCT05303064|Antiemetics|antiemetics|mesh-ancestor
102572483|NCT05303064|Autonomic Agents|autonomic agents|mesh-ancestor
102572484|NCT05303064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102572485|NCT05303064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572486|NCT05303064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102572487|NCT05303064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102572488|NCT05303064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102572489|NCT05303064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102572490|NCT05303064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102572491|NCT05303064|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102572492|NCT05303064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102572493|NCT05303064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102572494|NCT05303064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572495|NCT05303064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102572496|NCT05303064|Serotonin Agents|serotonin agents|mesh-ancestor
102572497|NCT05259943|Psilocybin|psilocybin|mesh-list
102572498|NCT05259943|Hallucinogens|hallucinogens|mesh-ancestor
102572499|NCT05259943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572500|NCT05259943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102572501|NCT05251948|Capecitabine|capecitabine|mesh-list
102572502|NCT05251948|Oxaliplatin|oxaliplatin|mesh-list
102572503|NCT05251948|Atezolizumab|atezolizumab|mesh-list
102572504|NCT05251948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102572505|NCT05251948|Antimetabolites|antimetabolites|mesh-ancestor
102572506|NCT05251948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572507|NCT05251948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572508|NCT05251948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102572509|NCT05251948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102572510|NCT05243329|Psilocybin|psilocybin|mesh-list
102572511|NCT05243329|Hallucinogens|hallucinogens|mesh-ancestor
102572512|NCT05243329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572513|NCT05243329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102572514|NCT05237297|Celecoxib|celecoxib|mesh-list
102572515|NCT05237297|Naproxen|naproxen|mesh-list
102572516|NCT05237297|Aceclofenac|aceclofenac|mesh-list
102572517|NCT05237297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102572518|NCT05237297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102572519|NCT05237297|Analgesics|analgesics|mesh-ancestor
102572520|NCT05237297|Sensory System Agents|sensory system agents|mesh-ancestor
102572521|NCT05237297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102572522|NCT05237297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572523|NCT05237297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102572524|NCT05237297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102572525|NCT05237297|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102572526|NCT05237297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102572527|NCT05237297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102572528|NCT05237297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572529|NCT05237297|Gout Suppressants|gout suppressants|mesh-ancestor
102572530|NCT05216952|Misoprostol|misoprostol|mesh-list
102572531|NCT05216952|Ulipristal acetate|ulipristal acetate|mesh-list
102572532|NCT05216952|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102572533|NCT05216952|Abortifacient Agents|abortifacient agents|mesh-ancestor
102572534|NCT05216952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102572535|NCT05216952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572536|NCT05216952|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102572537|NCT05216952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102572538|NCT05216952|Oxytocics|oxytocics|mesh-ancestor
102572539|NCT05216952|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102572540|NCT05216952|Contraceptive Agents|contraceptive agents|mesh-ancestor
102572541|NCT05216952|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102572542|NCT05213676|Nitric Oxide|nitric oxide|mesh-list
102572543|NCT05213676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102572544|NCT05213676|Autonomic Agents|autonomic agents|mesh-ancestor
102572545|NCT05213676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102572546|NCT05213676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572547|NCT05213676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102572548|NCT05213676|Respiratory System Agents|respiratory system agents|mesh-ancestor
102572549|NCT05213676|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102572550|NCT05213676|Antioxidants|antioxidants|mesh-ancestor
102572551|NCT05213676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572552|NCT05213676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102572553|NCT05213676|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102572554|NCT05213676|Vasodilator Agents|vasodilator agents|mesh-ancestor
102572555|NCT05213676|Gasotransmitters|gasotransmitters|mesh-ancestor
102572556|NCT05213676|Protective Agents|protective agents|mesh-ancestor
102572557|NCT05206110|Ketorolac|ketorolac|mesh-list
102572558|NCT05206110|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102572559|NCT05206110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102572560|NCT05206110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102572561|NCT05206110|Analgesics|analgesics|mesh-ancestor
102572562|NCT05206110|Sensory System Agents|sensory system agents|mesh-ancestor
102572563|NCT05206110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102572564|NCT05206110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572565|NCT05206110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102572566|NCT05206110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102572567|NCT05206110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102572568|NCT05206110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102572569|NCT05206110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572570|NCT05183412|Methamphetamine|methamphetamine|mesh-list
102572571|NCT05183412|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102572572|NCT05183412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572573|NCT05183412|Sympathomimetics|sympathomimetics|mesh-ancestor
102572574|NCT05183412|Autonomic Agents|autonomic agents|mesh-ancestor
102572575|NCT05183412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102572576|NCT05183412|Dopamine Agents|dopamine agents|mesh-ancestor
102572577|NCT05183412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102572578|NCT05183412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572579|NCT05183412|Adrenergic Agents|adrenergic agents|mesh-ancestor
102572580|NCT05183412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102572581|NCT05183412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102572582|NCT05183412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102572583|NCT05183412|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102572584|NCT05176288|Palbociclib|palbociclib|mesh-list
102572585|NCT05176288|Avelumab|avelumab|mesh-list
102572586|NCT05176288|Axitinib|axitinib|mesh-list
102572587|NCT05176288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572588|NCT05176288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102572589|NCT05176288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102572590|NCT05176288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572591|NCT05176288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102572592|NCT05155293|Aflibercept|aflibercept|mesh-list
102572593|NCT05155293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102572594|NCT05155293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102572595|NCT05155293|Growth Substances|growth substances|mesh-ancestor
102572596|NCT05155293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572597|NCT05155293|Growth Inhibitors|growth inhibitors|mesh-ancestor
102572598|NCT05155293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572599|NCT05144243|Azacitidine|azacitidine|mesh-list
102572600|NCT05144243|Venetoclax|venetoclax|mesh-list
102572601|NCT05144243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102572602|NCT05144243|Antimetabolites|antimetabolites|mesh-ancestor
102572603|NCT05144243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572604|NCT05144243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572605|NCT05144243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102572606|NCT05139238|Labetalol|labetalol|mesh-list
102572607|NCT05139238|Nifedipine|nifedipine|mesh-list
102572608|NCT05139238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102572609|NCT05139238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102572610|NCT05139238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572611|NCT05139238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102572612|NCT05139238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572613|NCT05139238|Vasodilator Agents|vasodilator agents|mesh-ancestor
102572614|NCT05139238|Tocolytic Agents|tocolytic agents|mesh-ancestor
102572615|NCT05139238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102572616|NCT05139238|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102572617|NCT05139238|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102572618|NCT05139238|Adrenergic Agents|adrenergic agents|mesh-ancestor
102572619|NCT05139238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102572620|NCT05139238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102572621|NCT05139238|Sympathomimetics|sympathomimetics|mesh-ancestor
102572622|NCT05139238|Autonomic Agents|autonomic agents|mesh-ancestor
102572623|NCT05139238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102572624|NCT05139238|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102572625|NCT05139238|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102572626|NCT05138614|Analgesics, Opioid|analgesics, opioid|mesh-list
102572627|NCT05138614|Narcotics|narcotics|mesh-ancestor
102572628|NCT05138614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102572629|NCT05138614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572630|NCT05138614|Analgesics|analgesics|mesh-ancestor
102572631|NCT05138614|Sensory System Agents|sensory system agents|mesh-ancestor
102572632|NCT05138614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102572633|NCT05132439|Metformin|metformin|mesh-list
102572634|NCT05132439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102572635|NCT05132439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572636|NCT05120141|Listerine|listerine|mesh-list
102572637|NCT05120141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102572638|NCT05120141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102572639|NCT05103904|Lenvatinib|lenvatinib|mesh-list
102572640|NCT05103904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572641|NCT05103904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102572642|NCT05103904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102572643|NCT05103904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572644|NCT05093582|Cromakalim|cromakalim|mesh-list
102572645|NCT05093582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102572646|NCT05093582|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102572647|NCT05093582|Autonomic Agents|autonomic agents|mesh-ancestor
102572648|NCT05093582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102572649|NCT05093582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572650|NCT05093582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102572651|NCT05093582|Respiratory System Agents|respiratory system agents|mesh-ancestor
102572652|NCT05093582|Parasympatholytics|parasympatholytics|mesh-ancestor
102572653|NCT05093582|Vasodilator Agents|vasodilator agents|mesh-ancestor
102572654|NCT05090384|Prednisone|prednisone|mesh-list
102572655|NCT05090384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102572656|NCT05090384|Glucocorticoids|glucocorticoids|mesh-ancestor
102572657|NCT05090384|Hormones|hormones|mesh-ancestor
102572658|NCT05090384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102572659|NCT05090384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572660|NCT05090384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102572661|NCT05090384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572662|NCT05089734|Docetaxel|docetaxel|mesh-list
102572663|NCT05089734|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
102572664|NCT05089734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572665|NCT05089734|Tubulin Modulators|tubulin modulators|mesh-ancestor
102572666|NCT05089734|Antimitotic Agents|antimitotic agents|mesh-ancestor
102572667|NCT05089734|Mitosis Modulators|mitosis modulators|mesh-ancestor
102572668|NCT05089734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572669|NCT05089734|Immunoconjugates|immunoconjugates|mesh-ancestor
102572670|NCT05089734|Immunologic Factors|immunologic factors|mesh-ancestor
102572671|NCT05089734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572672|NCT05201183|Fludarabine|fludarabine|mesh-list
102572673|NCT05201183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572674|NCT05086692|Pembrolizumab|pembrolizumab|mesh-list
102572675|NCT05086692|Interleukin-2|interleukin-2|mesh-list
102572676|NCT05086692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102572677|NCT05086692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572678|NCT05086692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102572679|NCT05086692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572680|NCT05086692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102572681|NCT05086692|Analgesics|analgesics|mesh-ancestor
102572682|NCT05086692|Sensory System Agents|sensory system agents|mesh-ancestor
102572683|NCT05086692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102572684|NCT05086692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572685|NCT05062889|Leucovorin|leucovorin|mesh-list
102572686|NCT05062889|Trifluridine|trifluridine|mesh-list
102572687|NCT05062889|Fluorouracil|fluorouracil|mesh-list
102572688|NCT05062889|Capecitabine|capecitabine|mesh-list
102572689|NCT05062889|Oxaliplatin|oxaliplatin|mesh-list
102572690|NCT05062889|Irinotecan|irinotecan|mesh-list
102572691|NCT05062889|Levoleucovorin|levoleucovorin|mesh-list
102572692|NCT05062889|Antimetabolites|antimetabolites|mesh-ancestor
102572693|NCT05062889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572694|NCT05062889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102572695|NCT05062889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572696|NCT05062889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102572697|NCT05062889|Immunologic Factors|immunologic factors|mesh-ancestor
102572698|NCT05062889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572699|NCT05062889|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102572700|NCT05062889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102572701|NCT05062889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102572702|NCT05062889|Antidotes|antidotes|mesh-ancestor
102572703|NCT05062889|Protective Agents|protective agents|mesh-ancestor
102572704|NCT05062889|Vitamin B Complex|vitamin b complex|mesh-ancestor
102572705|NCT05062889|Vitamins|vitamins|mesh-ancestor
102572706|NCT05062889|Micronutrients|micronutrients|mesh-ancestor
102572707|NCT05062889|Antiviral Agents|antiviral agents|mesh-ancestor
102572708|NCT05062889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102572709|NCT05045703|Vitamin A|vitamin a|mesh-list
102572710|NCT05045703|Retinol palmitate|retinol palmitate|mesh-list
102572711|NCT05045703|Vitamins|vitamins|mesh-ancestor
102572712|NCT05045703|Micronutrients|micronutrients|mesh-ancestor
102572713|NCT05045703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572714|NCT05045703|Antioxidants|antioxidants|mesh-ancestor
102572715|NCT05045703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572716|NCT05045703|Protective Agents|protective agents|mesh-ancestor
102572717|NCT05045703|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102572718|NCT05045703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572719|NCT05005728|Carboplatin|carboplatin|mesh-list
102572720|NCT05005728|Docetaxel|docetaxel|mesh-list
102572721|NCT05005728|Olaparib|olaparib|mesh-list
102572722|NCT05005728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572723|NCT05005728|Tubulin Modulators|tubulin modulators|mesh-ancestor
102572724|NCT05005728|Antimitotic Agents|antimitotic agents|mesh-ancestor
102572725|NCT05005728|Mitosis Modulators|mitosis modulators|mesh-ancestor
102572726|NCT05005728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572727|NCT05005728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102572728|NCT05005728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102572729|NCT04992507|Anesthetics|anesthetics|mesh-list
102572730|NCT04992507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102572731|NCT04992507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572732|NCT04990037|Folfirinox|folfirinox|mesh-list
102572733|NCT04990037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572734|NCT04987203|Nivolumab|nivolumab|mesh-list
102572735|NCT04987203|Tivozanib|tivozanib|mesh-list
102572736|NCT04987203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102572737|NCT04987203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572738|NCT04987203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102572739|NCT04987203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572740|NCT04987203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102572741|NCT04987203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102119685|NCT02199951|Piperaquine|piperaquine|mesh-list
102572742|NCT04973254|Rilpivirine|rilpivirine|mesh-list
102572743|NCT04973254|Cabotegravir|cabotegravir|mesh-list
102612399|NCT00002447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102572744|NCT04973254|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102572745|NCT04973254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102572746|NCT04973254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102572747|NCT04973254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572748|NCT04973254|Antiviral Agents|antiviral agents|mesh-ancestor
102572749|NCT04973254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102572750|NCT04973254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102572751|NCT04973254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102572752|NCT04973254|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102572753|NCT04973254|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102572754|NCT04949828|Pancrelipase|pancrelipase|mesh-list
102572755|NCT04949828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102572756|NCT04949191|Pembrolizumab|pembrolizumab|mesh-list
102572757|NCT04949191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102572758|NCT04949191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572759|NCT04949191|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102572760|NCT04949191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572761|NCT04927884|Cyclophosphamide|cyclophosphamide|mesh-list
102572762|NCT04927884|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
102572763|NCT04927884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102572764|NCT04927884|Immunologic Factors|immunologic factors|mesh-ancestor
102572765|NCT04927884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572766|NCT04927884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102572767|NCT04927884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102572768|NCT04927884|Alkylating Agents|alkylating agents|mesh-ancestor
102572769|NCT04927884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572770|NCT04927884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572771|NCT04927884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102572772|NCT04927884|Immunoconjugates|immunoconjugates|mesh-ancestor
102572773|NCT04868773|Trifluridine|trifluridine|mesh-list
102572774|NCT04868773|Antimetabolites|antimetabolites|mesh-ancestor
102572775|NCT04868773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572776|NCT04868773|Antiviral Agents|antiviral agents|mesh-ancestor
102572777|NCT04868773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102572778|NCT04865029|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102572779|NCT04865029|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102572780|NCT04865029|Estradiol|estradiol|mesh-list
102572781|NCT04865029|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102572782|NCT04865029|Progesterone|progesterone|mesh-list
102572783|NCT04865029|Estrogens|estrogens|mesh-ancestor
102572784|NCT04865029|Hormones|hormones|mesh-ancestor
102572785|NCT04865029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102572786|NCT04865029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572787|NCT04865029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102572788|NCT04865029|Contraceptive Agents|contraceptive agents|mesh-ancestor
102572789|NCT04865029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102572790|NCT04865029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102572791|NCT04865029|Progestins|progestins|mesh-ancestor
102572792|NCT04859660|Tamsulosin|tamsulosin|mesh-list
102572793|NCT04859660|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102572794|NCT04859660|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102572795|NCT04859660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102572796|NCT04859660|Adrenergic Agents|adrenergic agents|mesh-ancestor
102572797|NCT04859660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102572798|NCT04859660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572799|NCT04859660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572800|NCT04859660|Urological Agents|urological agents|mesh-ancestor
102572801|NCT04828486|Pembrolizumab|pembrolizumab|mesh-list
102572802|NCT04828486|Futibatinib|futibatinib|mesh-list
102572803|NCT04828486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102572804|NCT04828486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572805|NCT04828486|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102572806|NCT04828486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572807|NCT04807517|Buspirone|buspirone|mesh-list
102572808|NCT04807517|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102572809|NCT04807517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102572810|NCT04807517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102572811|NCT04807517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572812|NCT04807517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102572813|NCT04807517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102572814|NCT04807517|Serotonin Agents|serotonin agents|mesh-ancestor
102572815|NCT04807517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102572816|NCT04807517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572817|NCT04806919|Progesterone|progesterone|mesh-list
102572819|NCT04806919|Hormones|hormones|mesh-ancestor
102572820|NCT04806919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102572821|NCT04806919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572822|NCT04805957|Sulforaphane|sulforaphane|mesh-list
102572823|NCT04805957|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102572824|NCT04805957|Protective Agents|protective agents|mesh-ancestor
102572825|NCT04805957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572826|NCT04805957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572827|NCT04796779|Ferrous fumarate|ferrous fumarate|mesh-list
102572828|NCT04796779|Trace Elements|trace elements|mesh-ancestor
102572829|NCT04796779|Micronutrients|micronutrients|mesh-ancestor
102572830|NCT04796779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572831|NCT04793815|Pembrolizumab|pembrolizumab|mesh-list
102572832|NCT04793815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102572833|NCT04793815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572834|NCT04793815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102572835|NCT04793815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572836|NCT04775082|Liraglutide|liraglutide|mesh-list
102572837|NCT04775082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102572838|NCT04775082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572839|NCT04775082|Incretins|incretins|mesh-ancestor
102572840|NCT04775082|Hormones|hormones|mesh-ancestor
102572841|NCT04775082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102572842|NCT04762888|Edetic Acid|edetic acid|mesh-list
102572843|NCT04762888|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102572844|NCT04762888|Chelating Agents|chelating agents|mesh-ancestor
102572845|NCT04762888|Sequestering Agents|sequestering agents|mesh-ancestor
102572846|NCT04762888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572847|NCT04762888|Anticoagulants|anticoagulants|mesh-ancestor
102572848|NCT04762888|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102572849|NCT04762888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102572850|NCT04762134|Doxycycline|doxycycline|mesh-list
102572851|NCT04762134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102572852|NCT04762134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102572853|NCT04762134|Antimalarials|antimalarials|mesh-ancestor
102572854|NCT04762134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102572855|NCT04762134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102572856|NCT04743934|Androgens|androgens|mesh-list
102572857|NCT04743934|Hormones|hormones|mesh-ancestor
102572858|NCT04743934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102572859|NCT04743934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572860|NCT04736329|Telmisartan|telmisartan|mesh-list
102572861|NCT04736329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102572862|NCT04736329|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102572863|NCT04736329|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102572864|NCT04736329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572865|NCT04735068|Hydroxychloroquine|hydroxychloroquine|mesh-list
102572866|NCT04735068|Antimalarials|antimalarials|mesh-ancestor
102572867|NCT04735068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102572868|NCT04735068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102572869|NCT04735068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102572870|NCT04735068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102572871|NCT04735068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572872|NCT04735068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102572873|NCT04730544|Nivolumab|nivolumab|mesh-list
102572874|NCT04730544|Ipilimumab|ipilimumab|mesh-list
102572875|NCT04730544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102572876|NCT04730544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572877|NCT04730544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102572878|NCT04730544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572879|NCT04721548|Minoxidil|minoxidil|mesh-list
102572880|NCT04721548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102572881|NCT04721548|Vasodilator Agents|vasodilator agents|mesh-ancestor
102572882|NCT04717089|Anesthetics|anesthetics|mesh-list
102572883|NCT04717089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102572884|NCT04717089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572885|NCT04712799|Xylometazoline|xylometazoline|mesh-list
102572886|NCT04712799|Nasal Decongestants|nasal decongestants|mesh-ancestor
102572887|NCT04712799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102572888|NCT04712799|Respiratory System Agents|respiratory system agents|mesh-ancestor
102572889|NCT04712734|Iloperidone|iloperidone|mesh-list
102572890|NCT04712734|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102572891|NCT04712734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102572892|NCT04712734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102572893|NCT04712734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572895|NCT04687098|Idarubicin|idarubicin|mesh-list
102572896|NCT04687098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102572897|NCT04687098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572898|NCT04687098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102572899|NCT04687098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102572900|NCT04687098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102572901|NCT04687098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572902|NCT04683406|Oseltamivir|oseltamivir|mesh-list
102572903|NCT04683406|Antiviral Agents|antiviral agents|mesh-ancestor
102572904|NCT04683406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102572905|NCT04683406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102572906|NCT04683406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572907|NCT04678401|Cyclophosphamide|cyclophosphamide|mesh-list
102572908|NCT04678401|Thiotepa|thiotepa|mesh-list
102572909|NCT04678401|Fludarabine|fludarabine|mesh-list
102572910|NCT04678401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102572911|NCT04678401|Immunologic Factors|immunologic factors|mesh-ancestor
102572912|NCT04678401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572913|NCT04678401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102572914|NCT04678401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102572915|NCT04678401|Alkylating Agents|alkylating agents|mesh-ancestor
102572916|NCT04678401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572917|NCT04678401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572918|NCT04678401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102572919|NCT04676087|Mogamulizumab|mogamulizumab|mesh-list
102572920|NCT04676087|Immunoglobulins|immunoglobulins|mesh-list
102572921|NCT04676087|Immunoglobulin G|immunoglobulin g|mesh-list
102572922|NCT04676087|Immunologic Factors|immunologic factors|mesh-ancestor
102572923|NCT04676087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572924|NCT04676087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572925|NCT04662086|Camostat|camostat|mesh-list
102572926|NCT04662086|Protease Inhibitors|protease inhibitors|mesh-ancestor
102572927|NCT04662086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102572928|NCT04662086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572929|NCT04662086|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102572930|NCT04662086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102572931|NCT04662073|Camostat|camostat|mesh-list
102572932|NCT04662073|Protease Inhibitors|protease inhibitors|mesh-ancestor
102572933|NCT04662073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102572934|NCT04662073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572935|NCT04662073|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102572936|NCT04662073|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102572937|NCT04647877|Phenytoin|phenytoin|mesh-list
102572938|NCT04647877|Anticonvulsants|anticonvulsants|mesh-ancestor
102572939|NCT04647877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102572940|NCT04647877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102572941|NCT04647877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102572942|NCT04647877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572943|NCT04647877|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102572944|NCT04647877|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102572945|NCT04632992|Maytansine|maytansine|mesh-list
102572946|NCT04632992|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102572947|NCT04632992|Trastuzumab|trastuzumab|mesh-list
102572948|NCT04632992|Atezolizumab|atezolizumab|mesh-list
102572949|NCT04632992|Pertuzumab|pertuzumab|mesh-list
102572950|NCT04632992|Ipatasertib|ipatasertib|mesh-list
102572951|NCT04632992|Tucatinib|tucatinib|mesh-list
102572952|NCT04632992|Pralsetinib|pralsetinib|mesh-list
102572953|NCT04632992|Entrectinib|entrectinib|mesh-list
102572954|NCT04632992|Inavolisib|inavolisib|mesh-list
102572955|NCT04632992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102572956|NCT04632992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102572957|NCT04632992|Tubulin Modulators|tubulin modulators|mesh-ancestor
102572958|NCT04632992|Antimitotic Agents|antimitotic agents|mesh-ancestor
102572959|NCT04632992|Mitosis Modulators|mitosis modulators|mesh-ancestor
102572960|NCT04632992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572961|NCT04632992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102572962|NCT04632992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102572963|NCT04632992|Immunotoxins|immunotoxins|mesh-ancestor
102572964|NCT04632992|Immunoconjugates|immunoconjugates|mesh-ancestor
102572965|NCT04632992|Immunologic Factors|immunologic factors|mesh-ancestor
102572966|NCT04632992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572967|NCT04632992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102572968|NCT04632992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102572969|NCT04632992|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
102572970|NCT04629547|Suvorexant|suvorexant|mesh-list
102572971|NCT04629547|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102572972|NCT04629547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102572973|NCT04629547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102572974|NCT04629547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572975|NCT04629547|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102572976|NCT04629547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102572977|NCT04629547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572978|NCT04617938|Analgesics, Opioid|analgesics, opioid|mesh-list
102572979|NCT04617938|Narcotics|narcotics|mesh-ancestor
102572980|NCT04617938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102572981|NCT04617938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572982|NCT04617938|Analgesics|analgesics|mesh-ancestor
102572983|NCT04617938|Sensory System Agents|sensory system agents|mesh-ancestor
102572984|NCT04617938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102572985|NCT04615403|Travoprost|travoprost|mesh-list
102572986|NCT04615403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102572987|NCT04609020|Lidocaine|lidocaine|mesh-list
102572988|NCT04609020|Anesthetics, Local|anesthetics, local|mesh-ancestor
102572989|NCT04609020|Anesthetics|anesthetics|mesh-ancestor
102572990|NCT04609020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102572991|NCT04609020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102572992|NCT04609020|Sensory System Agents|sensory system agents|mesh-ancestor
102572993|NCT04609020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102572994|NCT04609020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102572995|NCT04609020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102572996|NCT04609020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102572997|NCT04609020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102572998|NCT04609020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102572999|NCT04608539|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
102573000|NCT04608539|Hematinics|hematinics|mesh-ancestor
102573001|NCT04597437|Zanamivir|zanamivir|mesh-list
102573002|NCT04597437|Antiviral Agents|antiviral agents|mesh-ancestor
102573003|NCT04597437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102573004|NCT04597437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102573005|NCT04597437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573006|NCT04586166|Imidacloprid|imidacloprid|mesh-list
102573007|NCT04586166|Cholinergic Agents|cholinergic agents|mesh-ancestor
102573008|NCT04586166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102573009|NCT04586166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573010|NCT04586166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573011|NCT04575597|Molnupiravir|molnupiravir|mesh-list
102573012|NCT04575597|Antiviral Agents|antiviral agents|mesh-ancestor
102573013|NCT04575597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102573014|NCT04564755|Abrocitinib|abrocitinib|mesh-list
102573015|NCT04564755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102573016|NCT04564755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102573017|NCT04564755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573018|NCT04562792|Daunorubicin|daunorubicin|mesh-list
102573019|NCT04562792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102573020|NCT04562792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573021|NCT04562792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102573022|NCT04562792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102573023|NCT04562792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102573024|NCT04562792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573025|NCT04550377|Cannabidiol|cannabidiol|mesh-list
102573026|NCT04550377|Anticonvulsants|anticonvulsants|mesh-ancestor
102573027|NCT04544813|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102573028|NCT04544813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102573029|NCT04501367|Dexamethasone|dexamethasone|mesh-list
102573030|NCT04501367|Dexamethasone acetate|dexamethasone acetate|mesh-list
102573031|NCT04501367|Prednisone|prednisone|mesh-list
102573032|NCT04501367|BB 1101|bb 1101|mesh-list
102573033|NCT04501367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102573034|NCT04501367|Antiemetics|antiemetics|mesh-ancestor
102573035|NCT04501367|Autonomic Agents|autonomic agents|mesh-ancestor
102573036|NCT04501367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102573037|NCT04501367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573038|NCT04501367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102573039|NCT04501367|Glucocorticoids|glucocorticoids|mesh-ancestor
102573040|NCT04501367|Hormones|hormones|mesh-ancestor
102573041|NCT04501367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102573042|NCT04501367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102573043|NCT04501367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573044|NCT04501367|Protease Inhibitors|protease inhibitors|mesh-ancestor
102573045|NCT04501367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102573046|NCT04501367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573047|NCT04496960|Tofacitinib|tofacitinib|mesh-list
102573048|NCT04496960|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102573049|NCT04496960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102573050|NCT04496960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102573051|NCT04496960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573052|NCT04491617|Analgesics, Opioid|analgesics, opioid|mesh-list
102573053|NCT04491617|Narcotics|narcotics|mesh-ancestor
102573054|NCT04491617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102573055|NCT04491617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573056|NCT04491617|Analgesics|analgesics|mesh-ancestor
102573057|NCT04491617|Sensory System Agents|sensory system agents|mesh-ancestor
102573058|NCT04491617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102573059|NCT04490057|Bupropion|bupropion|mesh-list
102573060|NCT04490057|Nicotine|nicotine|mesh-list
102573061|NCT04490057|Varenicline|varenicline|mesh-list
102573062|NCT04490057|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102573063|NCT04490057|Autonomic Agents|autonomic agents|mesh-ancestor
102573064|NCT04490057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102573065|NCT04490057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573066|NCT04490057|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102573067|NCT04490057|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102573068|NCT04490057|Cholinergic Agents|cholinergic agents|mesh-ancestor
102573069|NCT04490057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102573070|NCT04490057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573071|NCT04490057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102573072|NCT04490057|Antidepressive Agents|antidepressive agents|mesh-ancestor
102573073|NCT04490057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102573074|NCT04490057|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102573075|NCT04490057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102573076|NCT04490057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102573077|NCT04490057|Dopamine Agents|dopamine agents|mesh-ancestor
102573078|NCT04490057|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102573079|NCT04490057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102573080|NCT04490057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102573081|NCT04487392|Estrogens|estrogens|mesh-list
102573082|NCT04487392|Hormones|hormones|mesh-ancestor
102573083|NCT04487392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102573084|NCT04487392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573085|NCT04485546|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102573086|NCT04485546|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102573087|NCT04476446|Esketamine|esketamine|mesh-list
102573088|NCT04476446|Antidepressive Agents|antidepressive agents|mesh-ancestor
102573089|NCT04476446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102573090|NCT04472416|Analgesics|analgesics|mesh-list
102573091|NCT04472416|Sensory System Agents|sensory system agents|mesh-ancestor
102573092|NCT04472416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102573093|NCT04472416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573094|NCT04466150|Ocrelizumab|ocrelizumab|mesh-list
102573095|NCT04466150|Immunologic Factors|immunologic factors|mesh-ancestor
102573096|NCT04466150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573097|NCT04439136|Afatinib|afatinib|mesh-list
102573098|NCT04439136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573099|NCT04439136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102573100|NCT04439136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102573101|NCT04439136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573102|NCT04439110|Trastuzumab|trastuzumab|mesh-list
102573103|NCT04439110|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102573104|NCT04439110|Maytansine|maytansine|mesh-list
102573105|NCT04439110|Immunoconjugates|immunoconjugates|mesh-list
102573106|NCT04439110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102573107|NCT04439110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573108|NCT04439110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102573109|NCT04439110|Tubulin Modulators|tubulin modulators|mesh-ancestor
102573110|NCT04439110|Antimitotic Agents|antimitotic agents|mesh-ancestor
102573111|NCT04439110|Mitosis Modulators|mitosis modulators|mesh-ancestor
102573112|NCT04439110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573113|NCT04439110|Immunotoxins|immunotoxins|mesh-ancestor
102573114|NCT04439110|Immunologic Factors|immunologic factors|mesh-ancestor
102573115|NCT04439110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573116|NCT04432831|Faricimab|faricimab|mesh-list
102573117|NCT04432831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102573118|NCT04432831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102573119|NCT04432831|Growth Substances|growth substances|mesh-ancestor
102573120|NCT04432831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573121|NCT04432831|Growth Inhibitors|growth inhibitors|mesh-ancestor
102573122|NCT04432831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573124|NCT04427293|Lenvatinib|lenvatinib|mesh-list
102573125|NCT04427293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102573126|NCT04427293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573127|NCT04427293|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102573128|NCT04427293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573129|NCT04427293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102573130|NCT04427293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102573131|NCT04391842|Diclofenac|diclofenac|mesh-list
102573132|NCT04391842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102573133|NCT04391842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102573134|NCT04391842|Analgesics|analgesics|mesh-ancestor
102573135|NCT04391842|Sensory System Agents|sensory system agents|mesh-ancestor
102573136|NCT04391842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102573137|NCT04391842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573138|NCT04391842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102573139|NCT04391842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102573140|NCT04391842|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102573141|NCT04391842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102573142|NCT04391842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573143|NCT04383262|Fosamprenavir|fosamprenavir|mesh-list
102573144|NCT04383262|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102573145|NCT04383262|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102573146|NCT04383262|Protease Inhibitors|protease inhibitors|mesh-ancestor
102573147|NCT04383262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102573148|NCT04383262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573149|NCT04383262|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102573150|NCT04383262|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102573151|NCT04383262|Antiviral Agents|antiviral agents|mesh-ancestor
102573152|NCT04383262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102573153|NCT04360681|Lofexidine|lofexidine|mesh-list
102573154|NCT04360681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102573155|NCT04360681|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102573156|NCT04360681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573157|NCT04360681|Sensory System Agents|sensory system agents|mesh-ancestor
102573158|NCT04360681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102573159|NCT04360681|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102573160|NCT04360681|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102573161|NCT04360681|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102573162|NCT04360681|Adrenergic Agents|adrenergic agents|mesh-ancestor
102573163|NCT04360681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102573164|NCT04360681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573165|NCT04344795|Pembrolizumab|pembrolizumab|mesh-list
102573166|NCT04344795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102573167|NCT04344795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573168|NCT04344795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102573169|NCT04344795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573170|NCT04330248|Carbamazepine|carbamazepine|mesh-list
102573171|NCT04330248|Anticonvulsants|anticonvulsants|mesh-ancestor
102573172|NCT04330248|Antimanic Agents|antimanic agents|mesh-ancestor
102573173|NCT04330248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102573174|NCT04330248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102573175|NCT04330248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573176|NCT04330248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102573177|NCT04330248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102573178|NCT04330248|Analgesics|analgesics|mesh-ancestor
102573179|NCT04330248|Sensory System Agents|sensory system agents|mesh-ancestor
102573180|NCT04330248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102573181|NCT04330248|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102573182|NCT04330248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102573183|NCT04330248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573184|NCT04330248|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102573185|NCT04330248|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102573186|NCT04328844|Pemetrexed|pemetrexed|mesh-list
102573187|NCT04328844|Avelumab|avelumab|mesh-list
102573188|NCT04328844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573189|NCT04328844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102573190|NCT04328844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573191|NCT04328844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102573192|NCT04328844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102573193|NCT04328844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102573194|NCT04327024|Allopurinol|allopurinol|mesh-list
102573195|NCT04327024|Verinurad|verinurad|mesh-list
102573196|NCT04327024|Antimetabolites|antimetabolites|mesh-ancestor
102573197|NCT04327024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573198|NCT04327024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102573199|NCT04327024|Gout Suppressants|gout suppressants|mesh-ancestor
102573200|NCT04327024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102573201|NCT04327024|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102573202|NCT04327024|Antioxidants|antioxidants|mesh-ancestor
102573203|NCT04327024|Protective Agents|protective agents|mesh-ancestor
102573204|NCT04327024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573205|NCT04315272|Azithromycin|azithromycin|mesh-list
102573206|NCT04315272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102573207|NCT04315272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102573208|NCT04304352|Cyclophosphamide|cyclophosphamide|mesh-list
102573209|NCT04304352|Capecitabine|capecitabine|mesh-list
102573210|NCT04304352|Vinorelbine|vinorelbine|mesh-list
102573211|NCT04304352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102573212|NCT04304352|Immunologic Factors|immunologic factors|mesh-ancestor
102573213|NCT04304352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573214|NCT04304352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102573215|NCT04304352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102573216|NCT04304352|Alkylating Agents|alkylating agents|mesh-ancestor
102573217|NCT04304352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573218|NCT04304352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573219|NCT04304352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102573220|NCT04304352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102573221|NCT04304352|Antimetabolites|antimetabolites|mesh-ancestor
102573222|NCT04304352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102573223|NCT04304352|Tubulin Modulators|tubulin modulators|mesh-ancestor
102573224|NCT04304352|Antimitotic Agents|antimitotic agents|mesh-ancestor
102573225|NCT04304352|Mitosis Modulators|mitosis modulators|mesh-ancestor
102573226|NCT04297592|Doxycycline|doxycycline|mesh-list
102573227|NCT04297592|Cephalexin|cephalexin|mesh-list
102573228|NCT04297592|Cefadroxil|cefadroxil|mesh-list
102573229|NCT04297592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102573230|NCT04297592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102573231|NCT04297592|Antimalarials|antimalarials|mesh-ancestor
102573232|NCT04297592|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102573233|NCT04297592|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102573234|NCT04294459|Acetaminophen|acetaminophen|mesh-list
102573235|NCT04294459|Diphenhydramine|diphenhydramine|mesh-list
102573236|NCT04294459|Promethazine|promethazine|mesh-list
102573237|NCT04294459|Methylprednisolone|methylprednisolone|mesh-list
102573238|NCT04294459|Ranitidine|ranitidine|mesh-list
102573239|NCT04294459|Montelukast|montelukast|mesh-list
102573240|NCT04294459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102573241|NCT04294459|Analgesics|analgesics|mesh-ancestor
102573242|NCT04294459|Sensory System Agents|sensory system agents|mesh-ancestor
102573243|NCT04294459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102573244|NCT04294459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573245|NCT04294459|Antipyretics|antipyretics|mesh-ancestor
102573246|NCT04294459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102573247|NCT04294459|Antiemetics|antiemetics|mesh-ancestor
102573248|NCT04294459|Autonomic Agents|autonomic agents|mesh-ancestor
102573249|NCT04294459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102573250|NCT04294459|Glucocorticoids|glucocorticoids|mesh-ancestor
102573251|NCT04294459|Hormones|hormones|mesh-ancestor
102573252|NCT04294459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102573253|NCT04294459|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102573254|NCT04294459|Protective Agents|protective agents|mesh-ancestor
102573255|NCT04294459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102573256|NCT04294459|Respiratory System Agents|respiratory system agents|mesh-ancestor
102573257|NCT04294459|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102573258|NCT04294459|Hormone Antagonists|hormone antagonists|mesh-ancestor
102573259|NCT04294459|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102573260|NCT04294459|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102573261|NCT04294459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573262|NCT04294459|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102573263|NCT04294459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102573264|NCT04294459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102573265|NCT04294459|Anesthetics, Local|anesthetics, local|mesh-ancestor
102573266|NCT04294459|Anesthetics|anesthetics|mesh-ancestor
102573267|NCT04294459|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102573268|NCT04294459|Histamine Antagonists|histamine antagonists|mesh-ancestor
102573269|NCT04294459|Histamine Agents|histamine agents|mesh-ancestor
102573270|NCT04294459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102573271|NCT04294459|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102573272|NCT04294459|Antipruritics|antipruritics|mesh-ancestor
102573273|NCT04294459|Dermatologic Agents|dermatologic agents|mesh-ancestor
102573274|NCT04294459|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102573275|NCT04294459|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102573276|NCT04291105|Cemiplimab|cemiplimab|mesh-list
102573277|NCT04291105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102573278|NCT04291105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573279|NCT04268121|Cisplatin|cisplatin|mesh-list
102573280|NCT04268121|Etoposide|etoposide|mesh-list
102573281|NCT04268121|Etoposide phosphate|etoposide phosphate|mesh-list
102573282|NCT04268121|Carboplatin|carboplatin|mesh-list
102573283|NCT04268121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573284|NCT04268121|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102573285|NCT04268121|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102573286|NCT04268121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102573287|NCT04268121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102573288|NCT04268121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573289|NCT04252612|Pramlintide|pramlintide|mesh-list
102573290|NCT04252612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102573291|NCT04252612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573292|NCT04225715|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102573293|NCT04225715|Antiviral Agents|antiviral agents|mesh-ancestor
102573294|NCT04225715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102573295|NCT04221477|Acetaminophen|acetaminophen|mesh-list
102573296|NCT04221477|Diphenhydramine|diphenhydramine|mesh-list
102573297|NCT04221477|Promethazine|promethazine|mesh-list
102573298|NCT04221477|Prednisone|prednisone|mesh-list
102573299|NCT04221477|Methylprednisolone|methylprednisolone|mesh-list
102573300|NCT04221477|Obinutuzumab|obinutuzumab|mesh-list
102573301|NCT04221477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102573302|NCT04221477|Glucocorticoids|glucocorticoids|mesh-ancestor
102573303|NCT04221477|Hormones|hormones|mesh-ancestor
102573304|NCT04221477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102573305|NCT04221477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573306|NCT04221477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102573307|NCT04221477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573308|NCT04221477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102573309|NCT04221477|Analgesics|analgesics|mesh-ancestor
102573310|NCT04221477|Sensory System Agents|sensory system agents|mesh-ancestor
102573311|NCT04221477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102573312|NCT04221477|Antipyretics|antipyretics|mesh-ancestor
102573313|NCT04221477|Antiemetics|antiemetics|mesh-ancestor
102573314|NCT04221477|Autonomic Agents|autonomic agents|mesh-ancestor
102573315|NCT04221477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102573316|NCT04221477|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102573317|NCT04221477|Protective Agents|protective agents|mesh-ancestor
102573318|NCT04221477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102573319|NCT04221477|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102573320|NCT04221477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102573321|NCT04221477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102573322|NCT04221477|Anesthetics, Local|anesthetics, local|mesh-ancestor
102573323|NCT04221477|Anesthetics|anesthetics|mesh-ancestor
102573324|NCT04221477|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102573325|NCT04221477|Histamine Antagonists|histamine antagonists|mesh-ancestor
102573326|NCT04221477|Histamine Agents|histamine agents|mesh-ancestor
102573327|NCT04221477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102573328|NCT04221477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573329|NCT04221477|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102573330|NCT04221477|Antipruritics|antipruritics|mesh-ancestor
102573331|NCT04221477|Dermatologic Agents|dermatologic agents|mesh-ancestor
102573332|NCT04210505|Povidone-Iodine|povidone-iodine|mesh-list
102573333|NCT04210505|Povidone|povidone|mesh-list
102573334|NCT04210505|Plasma Substitutes|plasma substitutes|mesh-ancestor
102573335|NCT04210505|Blood Substitutes|blood substitutes|mesh-ancestor
102573336|NCT04210505|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102573337|NCT04210505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102573338|NCT04195698|Upadacitinib|upadacitinib|mesh-list
102573339|NCT04195698|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102573340|NCT04195698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102573341|NCT04195698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102573342|NCT04195698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573343|NCT04195698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102573344|NCT04194528|Acetaminophen|acetaminophen|mesh-list
102573345|NCT04194528|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
102573346|NCT04194528|Oxycodone|oxycodone|mesh-list
102573347|NCT04194528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102573349|NCT04194528|Sensory System Agents|sensory system agents|mesh-ancestor
102573350|NCT04194528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102573351|NCT04194528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573352|NCT04194528|Antipyretics|antipyretics|mesh-ancestor
102573353|NCT04194528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102573354|NCT04194528|Narcotics|narcotics|mesh-ancestor
102573355|NCT04194528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102573356|NCT04194528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102573357|NCT04194528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102573358|NCT04194528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102573359|NCT04189614|Cofetuzumab pelidotin|cofetuzumab pelidotin|mesh-list
102573360|NCT04189614|Immunoconjugates|immunoconjugates|mesh-ancestor
102573361|NCT04189614|Immunologic Factors|immunologic factors|mesh-ancestor
102573362|NCT04189614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573363|NCT04179396|Rucaparib|rucaparib|mesh-list
102573364|NCT04179396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102573365|NCT04179396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102573366|NCT04179396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573367|NCT04179396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573368|NCT04170348|Vitamin D|vitamin d|mesh-list
102573369|NCT04170348|Ergocalciferols|ergocalciferols|mesh-list
102573370|NCT04170348|Cholecalciferol|cholecalciferol|mesh-list
102573371|NCT04170348|Vitamins|vitamins|mesh-list
102573372|NCT04170348|Trientine|trientine|mesh-list
102573373|NCT04170348|Micronutrients|micronutrients|mesh-ancestor
102573374|NCT04170348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573375|NCT04170348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102573376|NCT04170348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102573377|NCT04170348|Chelating Agents|chelating agents|mesh-ancestor
102573378|NCT04170348|Sequestering Agents|sequestering agents|mesh-ancestor
102573379|NCT04170348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573380|NCT04166487|Paclitaxel|paclitaxel|mesh-list
102573381|NCT04166487|Carboplatin|carboplatin|mesh-list
102573382|NCT04166487|Pembrolizumab|pembrolizumab|mesh-list
102573383|NCT04166487|Pemetrexed|pemetrexed|mesh-list
102573384|NCT04166487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102573385|NCT04166487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573386|NCT04166487|Tubulin Modulators|tubulin modulators|mesh-ancestor
102573387|NCT04166487|Antimitotic Agents|antimitotic agents|mesh-ancestor
102573388|NCT04166487|Mitosis Modulators|mitosis modulators|mesh-ancestor
102573389|NCT04166487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573390|NCT04166487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102573391|NCT04166487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102573392|NCT04166487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102573393|NCT04166487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102573394|NCT04166487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102573395|NCT04158440|Paclitaxel|paclitaxel|mesh-list
102573396|NCT04158440|Docetaxel|docetaxel|mesh-list
102573397|NCT04158440|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102573398|NCT04158440|Cisplatin|cisplatin|mesh-list
102573399|NCT04158440|Carboplatin|carboplatin|mesh-list
102573400|NCT04158440|Pemetrexed|pemetrexed|mesh-list
102573401|NCT04158440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102573402|NCT04158440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573403|NCT04158440|Tubulin Modulators|tubulin modulators|mesh-ancestor
102573404|NCT04158440|Antimitotic Agents|antimitotic agents|mesh-ancestor
102573405|NCT04158440|Mitosis Modulators|mitosis modulators|mesh-ancestor
102573406|NCT04158440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573407|NCT04158440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102573408|NCT04158440|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102573409|NCT04158440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102573410|NCT04140162|Dexamethasone|dexamethasone|mesh-list
102573411|NCT04140162|Lenalidomide|lenalidomide|mesh-list
102573412|NCT04140162|Bortezomib|bortezomib|mesh-list
102573413|NCT04140162|Daratumumab|daratumumab|mesh-list
102573414|NCT04140162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102573415|NCT04140162|Antiemetics|antiemetics|mesh-ancestor
102573416|NCT04140162|Autonomic Agents|autonomic agents|mesh-ancestor
102573417|NCT04140162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102573418|NCT04140162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573419|NCT04140162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102573420|NCT04140162|Glucocorticoids|glucocorticoids|mesh-ancestor
102573421|NCT04140162|Hormones|hormones|mesh-ancestor
102120368|NCT03484260|Hormones|hormones|mesh-ancestor
102573422|NCT04140162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102573423|NCT04140162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102573425|NCT04140162|Immunologic Factors|immunologic factors|mesh-ancestor
102573426|NCT04140162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102573427|NCT04140162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102573428|NCT04140162|Growth Substances|growth substances|mesh-ancestor
102573429|NCT04140162|Growth Inhibitors|growth inhibitors|mesh-ancestor
102573430|NCT04124939|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102573431|NCT04124939|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102573432|NCT04124939|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102573433|NCT04124939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102573434|NCT04124939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573435|NCT04124939|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102573436|NCT04124939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102573437|NCT04124939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573438|NCT04124939|Cholinergic Agents|cholinergic agents|mesh-ancestor
102343640|NCT04926571|Hormones|hormones|mesh-ancestor
102573439|NCT04124939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102573440|NCT04111978|Letrozole|letrozole|mesh-list
102573441|NCT04111978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573442|NCT04111978|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102573443|NCT04111978|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102573444|NCT04111978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102573445|NCT04111978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573446|NCT04111978|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102573447|NCT04111978|Hormone Antagonists|hormone antagonists|mesh-ancestor
102573448|NCT04111978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102573449|NCT04111978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573450|NCT04085458|Factor VIII|factor viii|mesh-list
102573451|NCT04085458|Coagulants|coagulants|mesh-ancestor
102573452|NCT04077580|Methenamine|methenamine|mesh-list
102573453|NCT04077580|Methenamine hippurate|methenamine hippurate|mesh-list
102573454|NCT04077580|Methenamine mandelate|methenamine mandelate|mesh-list
102573455|NCT04077580|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102573456|NCT04077580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102573457|NCT04077580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102573458|NCT04056910|Nivolumab|nivolumab|mesh-list
102573459|NCT04056910|Ivosidenib|ivosidenib|mesh-list
102573460|NCT04056910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102573461|NCT04056910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573462|NCT04056910|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102573463|NCT04056910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573464|NCT04056910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102573465|NCT04054752|Vaccines|vaccines|mesh-list
102573466|NCT04054752|Immunologic Factors|immunologic factors|mesh-ancestor
102573467|NCT04054752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573468|NCT04037527|Gemcitabine|gemcitabine|mesh-list
102573469|NCT04037527|Docetaxel|docetaxel|mesh-list
102573470|NCT04037527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102573471|NCT04037527|Antimetabolites|antimetabolites|mesh-ancestor
102573472|NCT04037527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573473|NCT04037527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573474|NCT04037527|Tubulin Modulators|tubulin modulators|mesh-ancestor
102573475|NCT04037527|Antimitotic Agents|antimitotic agents|mesh-ancestor
102573476|NCT04037527|Mitosis Modulators|mitosis modulators|mesh-ancestor
102573477|NCT03989414|Dexamethasone|dexamethasone|mesh-list
102573478|NCT03989414|Bortezomib|bortezomib|mesh-list
102573479|NCT03989414|Daratumumab|daratumumab|mesh-list
102573480|NCT03989414|Elotuzumab|elotuzumab|mesh-list
102573481|NCT03989414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102573482|NCT03989414|Antiemetics|antiemetics|mesh-ancestor
102573483|NCT03989414|Autonomic Agents|autonomic agents|mesh-ancestor
102573484|NCT03989414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102573485|NCT03989414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573486|NCT03989414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102573487|NCT03989414|Glucocorticoids|glucocorticoids|mesh-ancestor
102573488|NCT03989414|Hormones|hormones|mesh-ancestor
102573489|NCT03989414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102573490|NCT03989414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102573491|NCT03989414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573492|NCT03978624|Pembrolizumab|pembrolizumab|mesh-list
102573493|NCT03978624|Entinostat|entinostat|mesh-list
102573494|NCT03978624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102573495|NCT03978624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573496|NCT03978624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102573497|NCT03978624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120435|NCT02205879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102573498|NCT03978624|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102573500|NCT03974217|Decitabine|decitabine|mesh-list
102573501|NCT03974217|Talazoparib|talazoparib|mesh-list
102573502|NCT03974217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102573503|NCT03974217|Antimetabolites|antimetabolites|mesh-ancestor
102573504|NCT03974217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573505|NCT03974217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573506|NCT03974217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102573507|NCT03974217|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102573508|NCT03971045|Cyclophosphamide|cyclophosphamide|mesh-list
102573509|NCT03971045|Pembrolizumab|pembrolizumab|mesh-list
102573510|NCT03971045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102573511|NCT03971045|Immunologic Factors|immunologic factors|mesh-ancestor
102573512|NCT03971045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840448|NCT01026714|Analgesics|analgesics|mesh-ancestor
102573513|NCT03971045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102573514|NCT03971045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102573515|NCT03971045|Alkylating Agents|alkylating agents|mesh-ancestor
102573516|NCT03971045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573517|NCT03971045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573518|NCT03971045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102573519|NCT03971045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102573520|NCT03971045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102573521|NCT03946800|Durvalumab|durvalumab|mesh-list
102573522|NCT03946800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102573523|NCT03946800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573524|NCT03940235|Androgens|androgens|mesh-list
102573525|NCT03940235|Hormones|hormones|mesh-ancestor
102573526|NCT03940235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102573527|NCT03940235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573528|NCT03935893|Cyclophosphamide|cyclophosphamide|mesh-list
102573529|NCT03935893|Fludarabine|fludarabine|mesh-list
102573530|NCT03935893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102573531|NCT03935893|Immunologic Factors|immunologic factors|mesh-ancestor
102573532|NCT03935893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573533|NCT03935893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102573534|NCT03935893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102573535|NCT03935893|Alkylating Agents|alkylating agents|mesh-ancestor
102573536|NCT03935893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573537|NCT03935893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573538|NCT03935893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102573539|NCT03916510|Capecitabine|capecitabine|mesh-list
102573540|NCT03916510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102573541|NCT03916510|Antimetabolites|antimetabolites|mesh-ancestor
102573542|NCT03916510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573543|NCT03916510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573544|NCT03905798|Lorazepam|lorazepam|mesh-list
102573545|NCT03905798|Anticonvulsants|anticonvulsants|mesh-ancestor
102573546|NCT03905798|Antiemetics|antiemetics|mesh-ancestor
102573547|NCT03905798|Autonomic Agents|autonomic agents|mesh-ancestor
102573548|NCT03905798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102573549|NCT03905798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573550|NCT03905798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102573551|NCT03905798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102573552|NCT03905798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102573553|NCT03905798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102573554|NCT03905798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102573555|NCT03905798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102573556|NCT03905798|GABA Modulators|gaba modulators|mesh-ancestor
102573557|NCT03905798|GABA Agents|gaba agents|mesh-ancestor
102573558|NCT03905798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102573559|NCT03905798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573560|NCT03901482|Dihydroergotamine|dihydroergotamine|mesh-list
102573561|NCT03901482|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102573562|NCT03901482|Dopamine Agonists|dopamine agonists|mesh-ancestor
102573563|NCT03901482|Dopamine Agents|dopamine agents|mesh-ancestor
102573564|NCT03901482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102573565|NCT03901482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573566|NCT03901482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573567|NCT03901482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102573568|NCT03901482|Analgesics|analgesics|mesh-ancestor
102573569|NCT03901482|Sensory System Agents|sensory system agents|mesh-ancestor
102573570|NCT03901482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102573571|NCT03900377|Rituximab|rituximab|mesh-list
102573572|NCT03900377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102573573|NCT03900377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573574|NCT03900377|Immunologic Factors|immunologic factors|mesh-ancestor
102573575|NCT03900377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573576|NCT03900377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102573577|NCT03868124|Travoprost|travoprost|mesh-list
102573578|NCT03868124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102573579|NCT03868124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102573580|NCT03868124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102573581|NCT03860844|Cytarabine|cytarabine|mesh-list
102573582|NCT03860844|Dexamethasone|dexamethasone|mesh-list
102573583|NCT03860844|Cyclophosphamide|cyclophosphamide|mesh-list
102573584|NCT03860844|Doxorubicin|doxorubicin|mesh-list
102573585|NCT03860844|Methotrexate|methotrexate|mesh-list
102573586|NCT03860844|Fludarabine|fludarabine|mesh-list
102573587|NCT03860844|Etoposide|etoposide|mesh-list
102573588|NCT03860844|Vincristine|vincristine|mesh-list
102573589|NCT03860844|Daunorubicin|daunorubicin|mesh-list
102573590|NCT03860844|Asparaginase|asparaginase|mesh-list
102573591|NCT03860844|Mitoxantrone|mitoxantrone|mesh-list
102573592|NCT03860844|Idarubicin|idarubicin|mesh-list
102573593|NCT03860844|Hydroxyurea|hydroxyurea|mesh-list
102573594|NCT03860844|Pegaspargase|pegaspargase|mesh-list
102573595|NCT03860844|Montelukast|montelukast|mesh-list
102573596|NCT03860844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102573597|NCT03860844|Immunologic Factors|immunologic factors|mesh-ancestor
102573598|NCT03860844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573599|NCT03860844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102573600|NCT03860844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102573601|NCT03860844|Alkylating Agents|alkylating agents|mesh-ancestor
102573602|NCT03860844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573603|NCT03860844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573604|NCT03860844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102573605|NCT03860844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102573606|NCT03860844|Antiemetics|antiemetics|mesh-ancestor
102573607|NCT03860844|Autonomic Agents|autonomic agents|mesh-ancestor
102573608|NCT03860844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102573609|NCT03860844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102573610|NCT03860844|Glucocorticoids|glucocorticoids|mesh-ancestor
102573611|NCT03860844|Hormones|hormones|mesh-ancestor
102573612|NCT03860844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102573613|NCT03860844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102573614|NCT03860844|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102573615|NCT03860844|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102573616|NCT03860844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102573617|NCT03860844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102573618|NCT03860844|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102573619|NCT03860844|Abortifacient Agents|abortifacient agents|mesh-ancestor
102573620|NCT03860844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102573621|NCT03860844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102573622|NCT03860844|Antimetabolites|antimetabolites|mesh-ancestor
102573623|NCT03860844|Dermatologic Agents|dermatologic agents|mesh-ancestor
102573624|NCT03860844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102573625|NCT03860844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102573626|NCT03860844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102573627|NCT03860844|Antiviral Agents|antiviral agents|mesh-ancestor
102573628|NCT03860844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102573629|NCT03860844|Tubulin Modulators|tubulin modulators|mesh-ancestor
102573630|NCT03860844|Antimitotic Agents|antimitotic agents|mesh-ancestor
102573631|NCT03860844|Mitosis Modulators|mitosis modulators|mesh-ancestor
102573632|NCT03860844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102573633|NCT03860844|Respiratory System Agents|respiratory system agents|mesh-ancestor
102573634|NCT03860844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102573635|NCT03860844|Hormone Antagonists|hormone antagonists|mesh-ancestor
102573636|NCT03860844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102573637|NCT03860844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102573638|NCT03860844|Analgesics|analgesics|mesh-ancestor
102573639|NCT03860844|Sensory System Agents|sensory system agents|mesh-ancestor
102573640|NCT03860844|Antisickling Agents|antisickling agents|mesh-ancestor
102573641|NCT03853317|Avelumab|avelumab|mesh-list
102573642|NCT03853317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102573643|NCT03853317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573644|NCT03848676|Immunomodulating Agents|immunomodulating agents|mesh-list
102573645|NCT03848676|Immunologic Factors|immunologic factors|mesh-ancestor
102573646|NCT03848676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573647|NCT03845010|Verapamil|verapamil|mesh-list
102573648|NCT03845010|Sotalol|sotalol|mesh-list
102573649|NCT03845010|Flecainide|flecainide|mesh-list
102573650|NCT03845010|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102573651|NCT03845010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102573652|NCT03845010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102573653|NCT03845010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573654|NCT03845010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102573655|NCT03845010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573656|NCT03845010|Vasodilator Agents|vasodilator agents|mesh-ancestor
102573657|NCT03845010|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102573658|NCT03845010|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102573659|NCT03845010|Adrenergic Agents|adrenergic agents|mesh-ancestor
102573660|NCT03845010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102573661|NCT03845010|Sympatholytics|sympatholytics|mesh-ancestor
102573662|NCT03845010|Autonomic Agents|autonomic agents|mesh-ancestor
102573663|NCT03845010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102573664|NCT03845010|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102573665|NCT03845010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102573666|NCT03829371|Dexamethasone|dexamethasone|mesh-list
102573667|NCT03829371|Prednisone|prednisone|mesh-list
102573668|NCT03829371|Lenalidomide|lenalidomide|mesh-list
102573669|NCT03829371|Melphalan|melphalan|mesh-list
102573670|NCT03829371|Bortezomib|bortezomib|mesh-list
102573671|NCT03829371|Daratumumab|daratumumab|mesh-list
102573672|NCT03829371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102573673|NCT03829371|Antiemetics|antiemetics|mesh-ancestor
102573674|NCT03829371|Autonomic Agents|autonomic agents|mesh-ancestor
102573675|NCT03829371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102573676|NCT03829371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573677|NCT03829371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102573678|NCT03829371|Glucocorticoids|glucocorticoids|mesh-ancestor
102573679|NCT03829371|Hormones|hormones|mesh-ancestor
102573680|NCT03829371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102573681|NCT03829371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102573682|NCT03829371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573683|NCT03829371|Immunologic Factors|immunologic factors|mesh-ancestor
102573684|NCT03829371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102573685|NCT03829371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102573686|NCT03829371|Growth Substances|growth substances|mesh-ancestor
102573687|NCT03829371|Growth Inhibitors|growth inhibitors|mesh-ancestor
102573688|NCT03829371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102573689|NCT03829371|Alkylating Agents|alkylating agents|mesh-ancestor
102573690|NCT03829371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573691|NCT03829371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102573692|NCT03829371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102573693|NCT03828227|Bevacizumab|bevacizumab|mesh-list
102573694|NCT03828227|Fluorouracil|fluorouracil|mesh-list
102573695|NCT03828227|Capecitabine|capecitabine|mesh-list
102573696|NCT03828227|Oxaliplatin|oxaliplatin|mesh-list
102573697|NCT03828227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102573698|NCT03828227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573699|NCT03828227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102573700|NCT03828227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102573701|NCT03828227|Growth Substances|growth substances|mesh-ancestor
102573702|NCT03828227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573703|NCT03828227|Growth Inhibitors|growth inhibitors|mesh-ancestor
102573704|NCT03828227|Antimetabolites|antimetabolites|mesh-ancestor
102573705|NCT03828227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573706|NCT03828227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102573707|NCT03828227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102573708|NCT03828227|Immunologic Factors|immunologic factors|mesh-ancestor
102573709|NCT03785964|Nirogacestat|nirogacestat|mesh-list
102573710|NCT03785964|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
102573711|NCT03785964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102573712|NCT03785964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573713|NCT03743428|Bevacizumab|bevacizumab|mesh-list
102573714|NCT03743428|Apatinib|apatinib|mesh-list
102573715|NCT03743428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102573716|NCT03743428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573717|NCT03743428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102573718|NCT03743428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102573719|NCT03743428|Growth Substances|growth substances|mesh-ancestor
102573720|NCT03743428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573721|NCT03743428|Growth Inhibitors|growth inhibitors|mesh-ancestor
102573722|NCT03743428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102573723|NCT03743428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102573724|NCT03743428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573726|NCT03739710|Ipilimumab|ipilimumab|mesh-list
102573727|NCT03739710|Dostarlimab|dostarlimab|mesh-list
102573728|NCT03739710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573729|NCT03739710|Tubulin Modulators|tubulin modulators|mesh-ancestor
102573730|NCT03739710|Antimitotic Agents|antimitotic agents|mesh-ancestor
102573731|NCT03739710|Mitosis Modulators|mitosis modulators|mesh-ancestor
102573732|NCT03739710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573733|NCT03739710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102573734|NCT03739710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102573735|NCT03691064|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102573736|NCT03691064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102573737|NCT03691064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573738|NCT03690921|Cisplatin|cisplatin|mesh-list
102573739|NCT03690921|Fluorouracil|fluorouracil|mesh-list
102573740|NCT03690921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573741|NCT03690921|Antimetabolites|antimetabolites|mesh-ancestor
102573742|NCT03690921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573743|NCT03690921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102573744|NCT03690921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102573745|NCT03690921|Immunologic Factors|immunologic factors|mesh-ancestor
102573746|NCT03690921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573747|NCT03637660|Penicillins|penicillins|mesh-list
102573748|NCT03637660|Penicillin G Benzathine|penicillin g benzathine|mesh-list
102573749|NCT03637660|Penicillin G|penicillin g|mesh-list
102573750|NCT03637660|Penicillin G Procaine|penicillin g procaine|mesh-list
102573751|NCT03637660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102573752|NCT03637660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102573753|NCT03635489|Paclitaxel|paclitaxel|mesh-list
102573754|NCT03635489|Bevacizumab|bevacizumab|mesh-list
102573755|NCT03635489|Carboplatin|carboplatin|mesh-list
102573756|NCT03635489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102573757|NCT03635489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573758|NCT03635489|Tubulin Modulators|tubulin modulators|mesh-ancestor
102573759|NCT03635489|Antimitotic Agents|antimitotic agents|mesh-ancestor
102573760|NCT03635489|Mitosis Modulators|mitosis modulators|mesh-ancestor
102573761|NCT03635489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573762|NCT03635489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102573763|NCT03635489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102573764|NCT03635489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102573765|NCT03635489|Growth Substances|growth substances|mesh-ancestor
102573766|NCT03635489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573767|NCT03635489|Growth Inhibitors|growth inhibitors|mesh-ancestor
102573768|NCT03631784|Paclitaxel|paclitaxel|mesh-list
102573769|NCT03631784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102573770|NCT03631784|Carboplatin|carboplatin|mesh-list
102573771|NCT03631784|Pembrolizumab|pembrolizumab|mesh-list
102573772|NCT03631784|Pemetrexed|pemetrexed|mesh-list
102573773|NCT03631784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102573774|NCT03631784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573775|NCT03631784|Tubulin Modulators|tubulin modulators|mesh-ancestor
102573776|NCT03631784|Antimitotic Agents|antimitotic agents|mesh-ancestor
102573777|NCT03631784|Mitosis Modulators|mitosis modulators|mesh-ancestor
102573778|NCT03631784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573779|NCT03631784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102573780|NCT03631784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102573781|NCT03631784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102573782|NCT03631784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102573783|NCT03631784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102573784|NCT03617705|Ethanol|ethanol|mesh-list
102573785|NCT03617705|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102573786|NCT03617705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102573787|NCT03617705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102573788|NCT03617705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573789|NCT03607422|Upadacitinib|upadacitinib|mesh-list
102573790|NCT03607422|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102573791|NCT03607422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102573792|NCT03607422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102573793|NCT03607422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573794|NCT03607422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102573795|NCT03576885|Nitric Oxide|nitric oxide|mesh-list
102573796|NCT03576885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102573797|NCT03576885|Autonomic Agents|autonomic agents|mesh-ancestor
102573798|NCT03576885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102573799|NCT03576885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573801|NCT03576885|Respiratory System Agents|respiratory system agents|mesh-ancestor
102573802|NCT03576885|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102573803|NCT03576885|Antioxidants|antioxidants|mesh-ancestor
102573804|NCT03576885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573805|NCT03576885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102573806|NCT03576885|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102573807|NCT03576885|Vasodilator Agents|vasodilator agents|mesh-ancestor
102573808|NCT03576885|Gasotransmitters|gasotransmitters|mesh-ancestor
102573809|NCT03576885|Protective Agents|protective agents|mesh-ancestor
102573810|NCT03576612|Valacyclovir|valacyclovir|mesh-list
102573811|NCT03576612|Acyclovir|acyclovir|mesh-list
102573812|NCT03576612|Nivolumab|nivolumab|mesh-list
102573813|NCT03576612|Temozolomide|temozolomide|mesh-list
102573814|NCT03576612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102573815|NCT03576612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573816|NCT03576612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102573817|NCT03576612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573818|NCT03576612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102573819|NCT03576612|Alkylating Agents|alkylating agents|mesh-ancestor
102573820|NCT03576612|Antiviral Agents|antiviral agents|mesh-ancestor
102573821|NCT03576612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102573822|NCT03576105|Photosensitizing Agents|photosensitizing agents|mesh-list
102573823|NCT03576105|Methylene Blue|methylene blue|mesh-list
102573824|NCT03576105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102573825|NCT03576105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573826|NCT03576105|Dermatologic Agents|dermatologic agents|mesh-ancestor
102573827|NCT03568318|Upadacitinib|upadacitinib|mesh-list
102573828|NCT03568318|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102573829|NCT03568318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102573830|NCT03568318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102573831|NCT03568318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573832|NCT03568318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102573833|NCT03550794|Thiamine|thiamine|mesh-list
102573834|NCT03550794|Vitamins|vitamins|mesh-ancestor
102573835|NCT03550794|Micronutrients|micronutrients|mesh-ancestor
102573836|NCT03550794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573837|NCT03550794|Vitamin B Complex|vitamin b complex|mesh-ancestor
102573838|NCT03539614|Prazosin|prazosin|mesh-list
102573839|NCT03539614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102573840|NCT03539614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102573841|NCT03539614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102573842|NCT03539614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102573843|NCT03539614|Adrenergic Agents|adrenergic agents|mesh-ancestor
102573844|NCT03539614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102573845|NCT03539614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573846|NCT03539614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573847|NCT03519386|Travoprost|travoprost|mesh-list
102573848|NCT03519386|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102573849|NCT03519386|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102573850|NCT03519386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102573851|NCT03495713|Nivolumab|nivolumab|mesh-list
102573852|NCT03495713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102573853|NCT03495713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573854|NCT03495713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102573855|NCT03495713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573856|NCT03491059|Nicotine|nicotine|mesh-list
102573857|NCT03491059|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102573858|NCT03491059|Autonomic Agents|autonomic agents|mesh-ancestor
102573859|NCT03491059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102573860|NCT03491059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573861|NCT03491059|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102573862|NCT03491059|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102573863|NCT03491059|Cholinergic Agents|cholinergic agents|mesh-ancestor
102573864|NCT03491059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102573865|NCT03491059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573866|NCT03459846|Durvalumab|durvalumab|mesh-list
102573867|NCT03459846|Olaparib|olaparib|mesh-list
102120807|NCT02723084|Antimetabolites|antimetabolites|mesh-ancestor
102120808|NCT02723084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120809|NCT02723084|Antiviral Agents|antiviral agents|mesh-ancestor
102120810|NCT02723084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102120811|NCT02750943|Fluorides|fluorides|mesh-list
102120812|NCT02750943|Tin Fluorides|tin fluorides|mesh-list
102120813|NCT02750943|Fluorophosphate|fluorophosphate|mesh-list
102573868|NCT03459846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102573869|NCT03459846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573870|NCT03459846|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102573871|NCT03459846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102573872|NCT03459846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573873|NCT03456102|Pravastatin|pravastatin|mesh-list
102573874|NCT03456102|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102573875|NCT03456102|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102573876|NCT03456102|Antimetabolites|antimetabolites|mesh-ancestor
102573877|NCT03456102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573878|NCT03456102|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102573879|NCT03456102|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102573880|NCT03456102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102573881|NCT03448666|Pembrolizumab|pembrolizumab|mesh-list
102573882|NCT03448666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102573883|NCT03448666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573884|NCT03448666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102573885|NCT03448666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573886|NCT03439865|Ivacaftor|ivacaftor|mesh-list
102573887|NCT03439865|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102573888|NCT03439865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102573889|NCT03439865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573890|NCT03436654|Prednisone|prednisone|mesh-list
102573891|NCT03436654|Abiraterone Acetate|abiraterone acetate|mesh-list
102573892|NCT03436654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102573893|NCT03436654|Glucocorticoids|glucocorticoids|mesh-ancestor
102573894|NCT03436654|Hormones|hormones|mesh-ancestor
102573895|NCT03436654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102573896|NCT03436654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573897|NCT03436654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102573898|NCT03436654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573899|NCT03436654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102573900|NCT03436654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102573901|NCT03436654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573902|NCT03436654|Hormone Antagonists|hormone antagonists|mesh-ancestor
102573903|NCT03436654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102573904|NCT03427125|Sevelamer|sevelamer|mesh-list
102573905|NCT03427125|Chelating Agents|chelating agents|mesh-ancestor
102573906|NCT03427125|Sequestering Agents|sequestering agents|mesh-ancestor
102573907|NCT03427125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573908|NCT03359863|Pirfenidone|pirfenidone|mesh-list
102573909|NCT03359863|Analgesics|analgesics|mesh-ancestor
102573910|NCT03359863|Sensory System Agents|sensory system agents|mesh-ancestor
102573911|NCT03359863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102573912|NCT03359863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573913|NCT03359863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102573914|NCT03359863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102573915|NCT03359863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102573916|NCT03359863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102573917|NCT03359863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573918|NCT03341273|Azithromycin|azithromycin|mesh-list
102573919|NCT03341273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102573920|NCT03341273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102573921|NCT03332797|Palbociclib|palbociclib|mesh-list
102573922|NCT03332797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573923|NCT03332797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102573924|NCT03332797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102573925|NCT03332797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573926|NCT03319901|Venetoclax|venetoclax|mesh-list
102573927|NCT03319901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573928|NCT03307785|Paclitaxel|paclitaxel|mesh-list
102573929|NCT03307785|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102573930|NCT03307785|Bevacizumab|bevacizumab|mesh-list
102573931|NCT03307785|Carboplatin|carboplatin|mesh-list
102573932|NCT03307785|Pemetrexed|pemetrexed|mesh-list
102573933|NCT03307785|Niraparib|niraparib|mesh-list
102573934|NCT03307785|Dostarlimab|dostarlimab|mesh-list
102573935|NCT03307785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102573936|NCT03307785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102573937|NCT03307785|Tubulin Modulators|tubulin modulators|mesh-ancestor
102573938|NCT03307785|Antimitotic Agents|antimitotic agents|mesh-ancestor
102573939|NCT03307785|Mitosis Modulators|mitosis modulators|mesh-ancestor
102573940|NCT03307785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120887|NCT05783479|Estradiol|estradiol|mesh-list
102573941|NCT03307785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102573942|NCT03307785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102573943|NCT03307785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102573944|NCT03307785|Growth Substances|growth substances|mesh-ancestor
102573945|NCT03307785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573946|NCT03307785|Growth Inhibitors|growth inhibitors|mesh-ancestor
102573947|NCT03307785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102573948|NCT03307785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102573949|NCT03307785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102573950|NCT03307785|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102573951|NCT03301766|Lidocaine|lidocaine|mesh-list
102573952|NCT03301766|Anesthetics, Local|anesthetics, local|mesh-ancestor
102573953|NCT03301766|Anesthetics|anesthetics|mesh-ancestor
102573954|NCT03301766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102573955|NCT03301766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573956|NCT03301766|Sensory System Agents|sensory system agents|mesh-ancestor
102573957|NCT03301766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102573958|NCT03301766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102573959|NCT03301766|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102573960|NCT03301766|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102573961|NCT03301766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102573962|NCT03301766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573963|NCT03248167|Cannabidiol|cannabidiol|mesh-list
102573964|NCT03248167|Anticonvulsants|anticonvulsants|mesh-ancestor
102573965|NCT03243552|Levodopa|levodopa|mesh-list
102573966|NCT03243552|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102573967|NCT03243552|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102573968|NCT03243552|Dopamine Agents|dopamine agents|mesh-ancestor
102573969|NCT03243552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102573970|NCT03243552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573971|NCT03243552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573972|NCT03242278|Rivaroxaban|rivaroxaban|mesh-list
102573973|NCT03242278|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102573974|NCT03242278|Antithrombins|antithrombins|mesh-ancestor
102573975|NCT03242278|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102573976|NCT03242278|Protease Inhibitors|protease inhibitors|mesh-ancestor
102573977|NCT03242278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102573978|NCT03242278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102573979|NCT03242278|Anticoagulants|anticoagulants|mesh-ancestor
102573980|NCT03198728|Testosterone|testosterone|mesh-list
102573981|NCT03198728|Androgens|androgens|mesh-ancestor
102573982|NCT03198728|Hormones|hormones|mesh-ancestor
102573983|NCT03198728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102573984|NCT03198728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573985|NCT03151811|Dexamethasone|dexamethasone|mesh-list
102573986|NCT03151811|Dexamethasone acetate|dexamethasone acetate|mesh-list
102573987|NCT03151811|Melphalan|melphalan|mesh-list
102573988|NCT03151811|Pomalidomide|pomalidomide|mesh-list
102573989|NCT03151811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102573990|NCT03151811|Antiemetics|antiemetics|mesh-ancestor
102573991|NCT03151811|Autonomic Agents|autonomic agents|mesh-ancestor
102573992|NCT03151811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102573993|NCT03151811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102573994|NCT03151811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102573995|NCT03151811|Glucocorticoids|glucocorticoids|mesh-ancestor
102573996|NCT03151811|Hormones|hormones|mesh-ancestor
102573997|NCT03151811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102573998|NCT03151811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102573999|NCT03151811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574000|NCT03151811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102574001|NCT03151811|Alkylating Agents|alkylating agents|mesh-ancestor
102574002|NCT03151811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574003|NCT03151811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102574004|NCT03151811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102574005|NCT03151811|Immunologic Factors|immunologic factors|mesh-ancestor
102574006|NCT03151811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102574007|NCT03151811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102574008|NCT03151811|Growth Substances|growth substances|mesh-ancestor
102574009|NCT03151811|Growth Inhibitors|growth inhibitors|mesh-ancestor
102574010|NCT03148418|Atezolizumab|atezolizumab|mesh-list
102574011|NCT03148418|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102574012|NCT03148418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840949|NCT00326716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102574013|NCT03148418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102120957|NCT05780268|Antiviral Agents|antiviral agents|mesh-ancestor
102574014|NCT03148418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574015|NCT03144804|Lamivudine|lamivudine|mesh-list
102574016|NCT03144804|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102574017|NCT03144804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102574018|NCT03144804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102574019|NCT03144804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574020|NCT03144804|Antiviral Agents|antiviral agents|mesh-ancestor
102574021|NCT03144804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102574022|NCT03144804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102574023|NCT03144804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102574024|NCT03142334|Pembrolizumab|pembrolizumab|mesh-list
102574025|NCT03142334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102574026|NCT03142334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574027|NCT03142334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102574028|NCT03142334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574029|NCT03141034|Irinotecan|irinotecan|mesh-list
102574030|NCT03141034|Ramucirumab|ramucirumab|mesh-list
102574031|NCT03141034|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102574032|NCT03141034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102574033|NCT03141034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102574034|NCT03141034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574035|NCT03141034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574036|NCT03126539|Sulforaphane|sulforaphane|mesh-list
102574037|NCT03126539|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102574038|NCT03126539|Protective Agents|protective agents|mesh-ancestor
102574039|NCT03126539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574040|NCT03126539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574041|NCT03107923|Dobutamine|dobutamine|mesh-list
102574042|NCT03107923|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102574043|NCT03107923|Sympathomimetics|sympathomimetics|mesh-ancestor
102574044|NCT03107923|Autonomic Agents|autonomic agents|mesh-ancestor
102574045|NCT03107923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102574046|NCT03107923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574047|NCT03107923|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102574048|NCT03107923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102574049|NCT03107923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102574050|NCT03107923|Adrenergic Agents|adrenergic agents|mesh-ancestor
102574051|NCT03107923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102574052|NCT03107923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574053|NCT03107923|Protective Agents|protective agents|mesh-ancestor
102574054|NCT03092817|Dexamethasone|dexamethasone|mesh-list
102574055|NCT03092817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102574056|NCT03092817|Antiemetics|antiemetics|mesh-ancestor
102574057|NCT03092817|Autonomic Agents|autonomic agents|mesh-ancestor
102574058|NCT03092817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102574059|NCT03092817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574060|NCT03092817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102574061|NCT03092817|Glucocorticoids|glucocorticoids|mesh-ancestor
102574062|NCT03092817|Hormones|hormones|mesh-ancestor
102574063|NCT03092817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102574064|NCT03092817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102574065|NCT03092817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574066|NCT03064126|Paclitaxel|paclitaxel|mesh-list
102574067|NCT03064126|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102574068|NCT03064126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102574069|NCT03064126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574070|NCT03064126|Tubulin Modulators|tubulin modulators|mesh-ancestor
102574071|NCT03064126|Antimitotic Agents|antimitotic agents|mesh-ancestor
102574072|NCT03064126|Mitosis Modulators|mitosis modulators|mesh-ancestor
102574073|NCT03064126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574074|NCT03043664|Pembrolizumab|pembrolizumab|mesh-list
102574075|NCT03043664|Lanreotide|lanreotide|mesh-list
102574076|NCT03043664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102574077|NCT03043664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574078|NCT03043664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102574079|NCT03043664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574080|NCT02992522|Lenalidomide|lenalidomide|mesh-list
102574081|NCT02992522|Venetoclax|venetoclax|mesh-list
102574082|NCT02992522|Obinutuzumab|obinutuzumab|mesh-list
102574083|NCT02992522|Immunologic Factors|immunologic factors|mesh-ancestor
102574084|NCT02992522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574085|NCT02992522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102574086|NCT02992522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102574087|NCT02992522|Growth Substances|growth substances|mesh-ancestor
102574088|NCT02992522|Growth Inhibitors|growth inhibitors|mesh-ancestor
102574089|NCT02992522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574090|NCT02992522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102574091|NCT02969681|Ascorbic Acid|ascorbic acid|mesh-list
102574092|NCT02969681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574093|NCT02969681|Vitamins|vitamins|mesh-ancestor
102574094|NCT02969681|Micronutrients|micronutrients|mesh-ancestor
102574095|NCT02969681|Antioxidants|antioxidants|mesh-ancestor
102574096|NCT02969681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574097|NCT02969681|Protective Agents|protective agents|mesh-ancestor
102574098|NCT02956590|Pitavastatin|pitavastatin|mesh-list
102574099|NCT02956590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102574100|NCT02956590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102574101|NCT02956590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102574102|NCT02956590|Antimetabolites|antimetabolites|mesh-ancestor
102574103|NCT02956590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574104|NCT02956590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102574105|NCT02956590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102574106|NCT02949700|Metformin|metformin|mesh-list
102574107|NCT02949700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102574108|NCT02949700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574109|NCT02947087|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
102574110|NCT02947087|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102574111|NCT02947087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102574112|NCT02947087|Protease Inhibitors|protease inhibitors|mesh-ancestor
102574113|NCT02947087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102574114|NCT02947087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574115|NCT02864550|Doxycycline|doxycycline|mesh-list
102574116|NCT02864550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102574117|NCT02864550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102574118|NCT02864550|Antimalarials|antimalarials|mesh-ancestor
102574119|NCT02864550|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102574120|NCT02864550|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102574121|NCT02841995|Belumosudil|belumosudil|mesh-list
102574122|NCT02841995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102574123|NCT02841995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102574124|NCT02841995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574125|NCT02702414|Pembrolizumab|pembrolizumab|mesh-list
102574126|NCT02702414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102574127|NCT02702414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574128|NCT02702414|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102574129|NCT02702414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574130|NCT02640534|Metformin|metformin|mesh-list
102574131|NCT02640534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102574132|NCT02640534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574133|NCT02632409|Nivolumab|nivolumab|mesh-list
102574134|NCT02632409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102574135|NCT02632409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574136|NCT02632409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102574137|NCT02632409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574138|NCT02628366|Dialysis Solutions|dialysis solutions|mesh-list
102574139|NCT02628366|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102574140|NCT02625480|Cyclophosphamide|cyclophosphamide|mesh-list
102574141|NCT02625480|Fludarabine|fludarabine|mesh-list
102574142|NCT02625480|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
102574143|NCT02625480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102574144|NCT02625480|Immunologic Factors|immunologic factors|mesh-ancestor
102574145|NCT02625480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574146|NCT02625480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102574147|NCT02625480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102574148|NCT02625480|Alkylating Agents|alkylating agents|mesh-ancestor
102574149|NCT02625480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574150|NCT02625480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574151|NCT02625480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102574152|NCT02625480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102574153|NCT02598726|Curcumin|curcumin|mesh-list
102574154|NCT02598726|Piperine|piperine|mesh-list
102574155|NCT02598726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102574156|NCT02598726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102574157|NCT02598726|Analgesics|analgesics|mesh-ancestor
102574158|NCT02598726|Sensory System Agents|sensory system agents|mesh-ancestor
102574159|NCT02598726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102574160|NCT02598726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574161|NCT02598726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102574162|NCT02598726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102121118|NCT05517122|Niacin|niacin|mesh-list
102574163|NCT02598726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574164|NCT02598726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102574165|NCT02598726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574166|NCT02598726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102574167|NCT02586038|Thalidomide|thalidomide|mesh-list
102574168|NCT02586038|Dexamethasone|dexamethasone|mesh-list
102574169|NCT02586038|Cyclophosphamide|cyclophosphamide|mesh-list
102574170|NCT02586038|Ixazomib|ixazomib|mesh-list
102574171|NCT02586038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102574172|NCT02586038|Immunologic Factors|immunologic factors|mesh-ancestor
102574173|NCT02586038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574174|NCT02586038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102574175|NCT02586038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102574176|NCT02586038|Alkylating Agents|alkylating agents|mesh-ancestor
102574177|NCT02586038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574178|NCT02586038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574179|NCT02586038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102574180|NCT02586038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102574181|NCT02586038|Antiemetics|antiemetics|mesh-ancestor
102574182|NCT02586038|Autonomic Agents|autonomic agents|mesh-ancestor
102574183|NCT02586038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102574184|NCT02586038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102574185|NCT02586038|Glucocorticoids|glucocorticoids|mesh-ancestor
102574186|NCT02586038|Hormones|hormones|mesh-ancestor
102574187|NCT02586038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102574188|NCT02586038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102574189|NCT02586038|Leprostatic Agents|leprostatic agents|mesh-ancestor
102574190|NCT02586038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102574191|NCT02586038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102574192|NCT02586038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102574193|NCT02586038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102574194|NCT02586038|Growth Substances|growth substances|mesh-ancestor
102574195|NCT02586038|Growth Inhibitors|growth inhibitors|mesh-ancestor
102574196|NCT02586038|Protease Inhibitors|protease inhibitors|mesh-ancestor
102574197|NCT02586038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102574198|NCT02579811|Axitinib|axitinib|mesh-list
102574199|NCT02579811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574200|NCT02579811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102574201|NCT02579811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102574202|NCT02579811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574203|NCT02554383|Amoxicillin|amoxicillin|mesh-list
102574204|NCT02554383|Clavulanic Acid|clavulanic acid|mesh-list
102574205|NCT02554383|Clavulanic Acids|clavulanic acids|mesh-list
102574206|NCT02554383|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102574207|NCT02554383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102574208|NCT02554383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102574209|NCT02554383|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102574210|NCT02554383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102574211|NCT02554383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574212|NCT02519439|Ganaxolone|ganaxolone|mesh-list
102574213|NCT02519439|Neurosteroids|neurosteroids|mesh-ancestor
102574214|NCT02519439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102574215|NCT02519439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574216|NCT02519439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574217|NCT02519439|GABA Modulators|gaba modulators|mesh-ancestor
102574218|NCT02519439|GABA Agents|gaba agents|mesh-ancestor
102574219|NCT02500797|Nivolumab|nivolumab|mesh-list
102574220|NCT02500797|Ipilimumab|ipilimumab|mesh-list
102574221|NCT02500797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102574222|NCT02500797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574223|NCT02500797|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102574224|NCT02500797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574225|NCT02359175|Acetaminophen|acetaminophen|mesh-list
102574226|NCT02359175|Fentanyl|fentanyl|mesh-list
102574227|NCT02359175|Analgesics, Opioid|analgesics, opioid|mesh-list
102574228|NCT02359175|Bupivacaine|bupivacaine|mesh-list
102574229|NCT02359175|Anesthetics, Local|anesthetics, local|mesh-ancestor
102574230|NCT02359175|Anesthetics|anesthetics|mesh-ancestor
102574231|NCT02359175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102574232|NCT02359175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574233|NCT02359175|Sensory System Agents|sensory system agents|mesh-ancestor
102574234|NCT02359175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102574235|NCT02359175|Narcotics|narcotics|mesh-ancestor
102574236|NCT02359175|Analgesics|analgesics|mesh-ancestor
102574237|NCT02359175|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102574238|NCT02359175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102574239|NCT02359175|Anesthetics, General|anesthetics, general|mesh-ancestor
102574240|NCT02359175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102574241|NCT02359175|Antipyretics|antipyretics|mesh-ancestor
102574242|NCT02215980|Dexamethasone|dexamethasone|mesh-list
102574243|NCT02215980|Lenalidomide|lenalidomide|mesh-list
102574244|NCT02215980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102574245|NCT02215980|Antiemetics|antiemetics|mesh-ancestor
102574246|NCT02215980|Autonomic Agents|autonomic agents|mesh-ancestor
102574247|NCT02215980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102574248|NCT02215980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574249|NCT02215980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102574250|NCT02215980|Glucocorticoids|glucocorticoids|mesh-ancestor
102574251|NCT02215980|Hormones|hormones|mesh-ancestor
102574252|NCT02215980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102574253|NCT02215980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102574254|NCT02215980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574255|NCT02215980|Immunologic Factors|immunologic factors|mesh-ancestor
102574256|NCT02215980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102574257|NCT02215980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102574258|NCT02215980|Growth Substances|growth substances|mesh-ancestor
102574259|NCT02215980|Growth Inhibitors|growth inhibitors|mesh-ancestor
102574260|NCT02101021|Paclitaxel|paclitaxel|mesh-list
102574261|NCT02101021|Gemcitabine|gemcitabine|mesh-list
102574262|NCT02101021|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
102574263|NCT02101021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102574264|NCT02101021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574265|NCT02101021|Tubulin Modulators|tubulin modulators|mesh-ancestor
102574266|NCT02101021|Antimitotic Agents|antimitotic agents|mesh-ancestor
102574267|NCT02101021|Mitosis Modulators|mitosis modulators|mesh-ancestor
102574268|NCT02101021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574269|NCT02101021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102574270|NCT02101021|Antimetabolites|antimetabolites|mesh-ancestor
102574271|NCT02101021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102574272|NCT02101021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102574273|NCT02088632|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102574274|NCT02088632|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102574275|NCT02088632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102574276|NCT02088632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574277|NCT02088632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102574278|NCT02088632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102574279|NCT02088632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574280|NCT02088632|Cholinergic Agents|cholinergic agents|mesh-ancestor
102574281|NCT02088632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102574282|NCT02031536|Everolimus|everolimus|mesh-list
102574283|NCT02031536|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102574284|NCT02031536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102574285|NCT02031536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102574286|NCT02031536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574287|NCT02031536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102574288|NCT02031536|Immunologic Factors|immunologic factors|mesh-ancestor
102574289|NCT02031536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574290|NCT02031536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574291|NCT02023996|Trastuzumab|trastuzumab|mesh-list
102574292|NCT02023996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102574293|NCT02023996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574294|NCT02020720|Fluorides|fluorides|mesh-list
102574295|NCT02020720|Cariostatic Agents|cariostatic agents|mesh-ancestor
102574296|NCT02020720|Protective Agents|protective agents|mesh-ancestor
102574297|NCT02020720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574298|NCT02020707|Paclitaxel|paclitaxel|mesh-list
102574299|NCT02020707|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102574300|NCT02020707|Bevacizumab|bevacizumab|mesh-list
102574301|NCT02020707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102574302|NCT02020707|Endothelial Growth Factors|endothelial growth factors|mesh-list
102574303|NCT02020707|Antibodies|antibodies|mesh-list
102574304|NCT02020707|Immunoglobulins|immunoglobulins|mesh-list
102574305|NCT02020707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102574306|NCT02020707|Immunoglobulin G|immunoglobulin g|mesh-list
102574307|NCT02020707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102574308|NCT02020707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574309|NCT02020707|Tubulin Modulators|tubulin modulators|mesh-ancestor
102574310|NCT02020707|Antimitotic Agents|antimitotic agents|mesh-ancestor
102574311|NCT02020707|Mitosis Modulators|mitosis modulators|mesh-ancestor
102574312|NCT02020707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574313|NCT02020707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102574314|NCT02020707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102574315|NCT02020707|Growth Substances|growth substances|mesh-ancestor
102574316|NCT02020707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574317|NCT02020707|Growth Inhibitors|growth inhibitors|mesh-ancestor
102574318|NCT02020707|Immunologic Factors|immunologic factors|mesh-ancestor
102574319|NCT01968200|Enalapril|enalapril|mesh-list
102574320|NCT01968200|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102574321|NCT01968200|Protease Inhibitors|protease inhibitors|mesh-ancestor
102574322|NCT01968200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102574323|NCT01968200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574324|NCT01968200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102574325|NCT01964430|Paclitaxel|paclitaxel|mesh-list
102574326|NCT01964430|Gemcitabine|gemcitabine|mesh-list
102574327|NCT01964430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102574328|NCT01964430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574329|NCT01964430|Tubulin Modulators|tubulin modulators|mesh-ancestor
102574330|NCT01964430|Antimitotic Agents|antimitotic agents|mesh-ancestor
102574331|NCT01964430|Mitosis Modulators|mitosis modulators|mesh-ancestor
102574332|NCT01964430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574333|NCT01964430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102574334|NCT01964430|Antimetabolites|antimetabolites|mesh-ancestor
102574335|NCT01934868|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102574336|NCT01928394|Nivolumab|nivolumab|mesh-list
102574337|NCT01928394|Ipilimumab|ipilimumab|mesh-list
102574338|NCT01928394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102574339|NCT01928394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574340|NCT01928394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102574341|NCT01928394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574342|NCT01898494|Cisplatin|cisplatin|mesh-list
102574343|NCT01898494|Carboplatin|carboplatin|mesh-list
102574344|NCT01898494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574345|NCT01841359|Pramlintide|pramlintide|mesh-list
102574346|NCT01841359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102574347|NCT01841359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574348|NCT01824875|Capecitabine|capecitabine|mesh-list
102574349|NCT01824875|Temozolomide|temozolomide|mesh-list
102574350|NCT01824875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102574351|NCT01824875|Antimetabolites|antimetabolites|mesh-ancestor
102574352|NCT01824875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574353|NCT01824875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574354|NCT01824875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102574355|NCT01824875|Alkylating Agents|alkylating agents|mesh-ancestor
102574356|NCT01724346|Chlorambucil|chlorambucil|mesh-list
102574357|NCT01724346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102574358|NCT01724346|Alkylating Agents|alkylating agents|mesh-ancestor
102574359|NCT01724346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574360|NCT01724346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574361|NCT01579734|Tamoxifen|tamoxifen|mesh-list
102574362|NCT01579734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102574363|NCT01579734|Hormone Antagonists|hormone antagonists|mesh-ancestor
102574364|NCT01579734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102574365|NCT01579734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574366|NCT01579734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102574367|NCT01579734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574368|NCT01579734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102574369|NCT01579734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102574370|NCT01579734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102574371|NCT01566240|Paclitaxel|paclitaxel|mesh-list
102574372|NCT01566240|Carboplatin|carboplatin|mesh-list
102574373|NCT01566240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102574374|NCT01566240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574375|NCT01566240|Tubulin Modulators|tubulin modulators|mesh-ancestor
102574376|NCT01566240|Antimitotic Agents|antimitotic agents|mesh-ancestor
102574377|NCT01566240|Mitosis Modulators|mitosis modulators|mesh-ancestor
102574378|NCT01566240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574379|NCT01390584|Prednisone|prednisone|mesh-list
102574380|NCT01390584|Cyclophosphamide|cyclophosphamide|mesh-list
102574381|NCT01390584|Dacarbazine|dacarbazine|mesh-list
102574382|NCT01390584|Doxorubicin|doxorubicin|mesh-list
102574383|NCT01390584|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102574384|NCT01390584|Etoposide|etoposide|mesh-list
102574385|NCT01390584|Vincristine|vincristine|mesh-list
102574386|NCT01390584|Etoposide phosphate|etoposide phosphate|mesh-list
102121336|NCT05063786|Antimitotic Agents|antimitotic agents|mesh-ancestor
102574387|NCT01390584|Bleomycin|bleomycin|mesh-list
102574388|NCT01390584|Vinblastine|vinblastine|mesh-list
102574389|NCT01390584|Podophyllotoxin|podophyllotoxin|mesh-list
102574390|NCT01390584|Procarbazine|procarbazine|mesh-list
102574391|NCT01390584|Imidazole|imidazole|mesh-list
102574392|NCT01390584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102574393|NCT01390584|Immunologic Factors|immunologic factors|mesh-ancestor
102574394|NCT01390584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574395|NCT01390584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102574396|NCT01390584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102574397|NCT01390584|Alkylating Agents|alkylating agents|mesh-ancestor
102574398|NCT01390584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574399|NCT01390584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574400|NCT01390584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102574401|NCT01390584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102574402|NCT01390584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102574403|NCT01390584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102574404|NCT01390584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102574405|NCT01390584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102574406|NCT01390584|Glucocorticoids|glucocorticoids|mesh-ancestor
102574407|NCT01390584|Hormones|hormones|mesh-ancestor
102574408|NCT01390584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102574409|NCT01390584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102574410|NCT01390584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102574411|NCT01390584|Tubulin Modulators|tubulin modulators|mesh-ancestor
102574412|NCT01390584|Antimitotic Agents|antimitotic agents|mesh-ancestor
102574413|NCT01390584|Mitosis Modulators|mitosis modulators|mesh-ancestor
102574414|NCT01390584|Keratolytic Agents|keratolytic agents|mesh-ancestor
102574415|NCT01390584|Dermatologic Agents|dermatologic agents|mesh-ancestor
102574416|NCT01374841|Cyclophosphamide|cyclophosphamide|mesh-list
102574417|NCT01374841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102574418|NCT01374841|Immunologic Factors|immunologic factors|mesh-ancestor
102574419|NCT01374841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574420|NCT01374841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102574421|NCT01374841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102574422|NCT01374841|Alkylating Agents|alkylating agents|mesh-ancestor
102574423|NCT01374841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574424|NCT01374841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574425|NCT01374841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102574426|NCT01216683|Rituximab|rituximab|mesh-list
102574427|NCT01216683|Lenalidomide|lenalidomide|mesh-list
102574428|NCT01216683|Bortezomib|bortezomib|mesh-list
102574429|NCT01216683|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102574430|NCT01216683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102574431|NCT01216683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574432|NCT01216683|Immunologic Factors|immunologic factors|mesh-ancestor
102574433|NCT01216683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574434|NCT01216683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102574435|NCT01216683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102574436|NCT01216683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102574437|NCT01216683|Growth Substances|growth substances|mesh-ancestor
102574438|NCT01216683|Growth Inhibitors|growth inhibitors|mesh-ancestor
102574439|NCT01216683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102574440|NCT01216683|Alkylating Agents|alkylating agents|mesh-ancestor
102574441|NCT01216683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574442|NCT01166113|Prednisone|prednisone|mesh-list
102574443|NCT01166113|Cyclophosphamide|cyclophosphamide|mesh-list
102574444|NCT01166113|Pomalidomide|pomalidomide|mesh-list
102574445|NCT01166113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102574446|NCT01166113|Immunologic Factors|immunologic factors|mesh-ancestor
102574447|NCT01166113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574448|NCT01166113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102574449|NCT01166113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102574450|NCT01166113|Alkylating Agents|alkylating agents|mesh-ancestor
102574451|NCT01166113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574452|NCT01166113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574453|NCT01166113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102574454|NCT01166113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102574455|NCT01166113|Glucocorticoids|glucocorticoids|mesh-ancestor
102574456|NCT01166113|Hormones|hormones|mesh-ancestor
102574457|NCT01166113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102574458|NCT01166113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102574459|NCT01166113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102574460|NCT01166113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102574461|NCT01166113|Growth Substances|growth substances|mesh-ancestor
102574462|NCT01166113|Growth Inhibitors|growth inhibitors|mesh-ancestor
102574463|NCT01160107|Prednisone|prednisone|mesh-list
102574464|NCT01160107|Melphalan|melphalan|mesh-list
102574465|NCT01160107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102574466|NCT01160107|Glucocorticoids|glucocorticoids|mesh-ancestor
102574467|NCT01160107|Hormones|hormones|mesh-ancestor
102574468|NCT01160107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102574469|NCT01160107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574470|NCT01160107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102574471|NCT01160107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574472|NCT01160107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102574473|NCT01160107|Alkylating Agents|alkylating agents|mesh-ancestor
102574474|NCT01160107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574475|NCT01160107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102574476|NCT01160107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102574477|NCT01160107|Immunologic Factors|immunologic factors|mesh-ancestor
102574478|NCT01145495|Rituximab|rituximab|mesh-list
102574479|NCT01145495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102574480|NCT01145495|Lenalidomide|lenalidomide|mesh-list
102574481|NCT01145495|Antibodies|antibodies|mesh-list
102574482|NCT01145495|Immunoglobulins|immunoglobulins|mesh-list
102574483|NCT01145495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102574484|NCT01145495|Immunologic Factors|immunologic factors|mesh-ancestor
102574485|NCT01145495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574486|NCT01145495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574487|NCT01145495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102574488|NCT01145495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102574489|NCT01145495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102574490|NCT01145495|Growth Substances|growth substances|mesh-ancestor
102574491|NCT01145495|Growth Inhibitors|growth inhibitors|mesh-ancestor
102574492|NCT01124695|Tamoxifen|tamoxifen|mesh-list
102574493|NCT01124695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102574494|NCT01124695|Hormone Antagonists|hormone antagonists|mesh-ancestor
102574495|NCT01124695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102574496|NCT01124695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574497|NCT01124695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102574498|NCT01124695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574499|NCT01124695|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102574500|NCT01124695|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102574501|NCT01124695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102574502|NCT01084083|Paclitaxel|paclitaxel|mesh-list
102574503|NCT01084083|Cetuximab|cetuximab|mesh-list
102574504|NCT01084083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102574505|NCT01084083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574506|NCT01084083|Tubulin Modulators|tubulin modulators|mesh-ancestor
102574507|NCT01084083|Antimitotic Agents|antimitotic agents|mesh-ancestor
102574508|NCT01084083|Mitosis Modulators|mitosis modulators|mesh-ancestor
102574509|NCT01084083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574510|NCT01084083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102574511|NCT01079780|Irinotecan|irinotecan|mesh-list
102574512|NCT01079780|Cetuximab|cetuximab|mesh-list
102574513|NCT01079780|Ramucirumab|ramucirumab|mesh-list
102574514|NCT01079780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102574515|NCT01079780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102574516|NCT01079780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102574517|NCT01079780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574518|NCT01079780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574519|NCT01079780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102574520|NCT01063179|Thalidomide|thalidomide|mesh-list
102574521|NCT01063179|Prednisone|prednisone|mesh-list
102574522|NCT01063179|Bortezomib|bortezomib|mesh-list
102574523|NCT01063179|Melphalan|melphalan|mesh-list
102574524|NCT01063179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102574525|NCT01063179|Glucocorticoids|glucocorticoids|mesh-ancestor
102574526|NCT01063179|Hormones|hormones|mesh-ancestor
102574527|NCT01063179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102574528|NCT01063179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574529|NCT01063179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102574530|NCT01063179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574531|NCT01063179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102574532|NCT01063179|Alkylating Agents|alkylating agents|mesh-ancestor
102574533|NCT01063179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574534|NCT01063179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102574535|NCT01063179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102574536|NCT01063179|Immunologic Factors|immunologic factors|mesh-ancestor
102574537|NCT01063179|Leprostatic Agents|leprostatic agents|mesh-ancestor
102574538|NCT01063179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102574539|NCT01063179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102574540|NCT01063179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102574541|NCT01063179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102574542|NCT01063179|Growth Substances|growth substances|mesh-ancestor
102574543|NCT01063179|Growth Inhibitors|growth inhibitors|mesh-ancestor
102574544|NCT01013961|Rituximab|rituximab|mesh-list
102574545|NCT01013961|Alemtuzumab|alemtuzumab|mesh-list
102574546|NCT01013961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102574547|NCT01013961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574548|NCT01013961|Immunologic Factors|immunologic factors|mesh-ancestor
102574549|NCT01013961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574550|NCT01013961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102574551|NCT00834093|Immunomodulating Agents|immunomodulating agents|mesh-list
102574552|NCT00834093|Immunologic Factors|immunologic factors|mesh-ancestor
102574553|NCT00834093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574554|NCT00783510|Adalimumab|adalimumab|mesh-list
102574555|NCT00783510|Methotrexate|methotrexate|mesh-list
102574556|NCT00783510|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102574557|NCT00783510|Abortifacient Agents|abortifacient agents|mesh-ancestor
102574558|NCT00783510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102574559|NCT00783510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574560|NCT00783510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102574561|NCT00783510|Antimetabolites|antimetabolites|mesh-ancestor
102574562|NCT00783510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574563|NCT00783510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574564|NCT00783510|Dermatologic Agents|dermatologic agents|mesh-ancestor
102574565|NCT00783510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102574566|NCT00783510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102574567|NCT00783510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102574568|NCT00783510|Immunologic Factors|immunologic factors|mesh-ancestor
102574569|NCT00783510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102574570|NCT00783510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102574571|NCT00783510|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102574572|NCT00783510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102574573|NCT00779194|Sirolimus|sirolimus|mesh-list
102574574|NCT00779194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102574575|NCT00779194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102574576|NCT00779194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102574577|NCT00779194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574578|NCT00779194|Antifungal Agents|antifungal agents|mesh-ancestor
102574579|NCT00779194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102574580|NCT00779194|Immunologic Factors|immunologic factors|mesh-ancestor
102574581|NCT00779194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574582|NCT00665600|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102574583|NCT00665600|Albuterol|albuterol|mesh-list
102574584|NCT00665600|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102574585|NCT00665600|Autonomic Agents|autonomic agents|mesh-ancestor
102574586|NCT00665600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102574587|NCT00665600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574588|NCT00665600|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102574589|NCT00665600|Respiratory System Agents|respiratory system agents|mesh-ancestor
102574590|NCT00665600|Tocolytic Agents|tocolytic agents|mesh-ancestor
102574591|NCT00665600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102574592|NCT00665600|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102574593|NCT00665600|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102574594|NCT00665600|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102574595|NCT00665600|Adrenergic Agents|adrenergic agents|mesh-ancestor
102574596|NCT00665600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102574597|NCT00665600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574598|NCT00606294|Misonidazole|misonidazole|mesh-list
102574599|NCT00606294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574600|NCT00606294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102574601|NCT00606294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102574602|NCT00606294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102574603|NCT00551928|Prednisone|prednisone|mesh-list
102574604|NCT00551928|Lenalidomide|lenalidomide|mesh-list
102574605|NCT00551928|Melphalan|melphalan|mesh-list
102574606|NCT00551928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102574607|NCT00551928|Glucocorticoids|glucocorticoids|mesh-ancestor
102574608|NCT00551928|Hormones|hormones|mesh-ancestor
102574609|NCT00551928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102574610|NCT00551928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574611|NCT00551928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102574612|NCT00551928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574613|NCT00551928|Immunologic Factors|immunologic factors|mesh-ancestor
102574614|NCT00551928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102574615|NCT00551928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102574616|NCT00551928|Growth Substances|growth substances|mesh-ancestor
102574617|NCT00551928|Growth Inhibitors|growth inhibitors|mesh-ancestor
102574618|NCT00551928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102574619|NCT00551928|Alkylating Agents|alkylating agents|mesh-ancestor
102574620|NCT00551928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574621|NCT00551928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102574622|NCT00551928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102574624|NCT00330564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574625|NCT00330564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102574626|NCT00330564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102574627|NCT00330564|Growth Substances|growth substances|mesh-ancestor
102574628|NCT00330564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574629|NCT00330564|Growth Inhibitors|growth inhibitors|mesh-ancestor
102574630|NCT00330564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102574631|NCT00330564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102574632|NCT00330564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574633|NCT00316888|Cisplatin|cisplatin|mesh-list
102574634|NCT00316888|Fluorouracil|fluorouracil|mesh-list
102574635|NCT00316888|Cetuximab|cetuximab|mesh-list
102574636|NCT00316888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574637|NCT00316888|Antimetabolites|antimetabolites|mesh-ancestor
102574638|NCT00316888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574639|NCT00316888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102574640|NCT00316888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102574641|NCT00316888|Immunologic Factors|immunologic factors|mesh-ancestor
102574642|NCT00316888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574643|NCT00316888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102574644|NCT00309478|Tamoxifen|tamoxifen|mesh-list
102574645|NCT00309478|Cyclophosphamide|cyclophosphamide|mesh-list
102574646|NCT00309478|Fluorouracil|fluorouracil|mesh-list
102574647|NCT00309478|Methotrexate|methotrexate|mesh-list
102574648|NCT00309478|Goserelin|goserelin|mesh-list
102574649|NCT00309478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102574650|NCT00309478|Immunologic Factors|immunologic factors|mesh-ancestor
102574651|NCT00309478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574652|NCT00309478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102574653|NCT00309478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102574654|NCT00309478|Alkylating Agents|alkylating agents|mesh-ancestor
102574655|NCT00309478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574656|NCT00309478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574657|NCT00309478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102574658|NCT00309478|Antimetabolites|antimetabolites|mesh-ancestor
102574659|NCT00309478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102574660|NCT00309478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102574661|NCT00309478|Abortifacient Agents|abortifacient agents|mesh-ancestor
102574662|NCT00309478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102574663|NCT00309478|Dermatologic Agents|dermatologic agents|mesh-ancestor
102574664|NCT00309478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102574665|NCT00309478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102574666|NCT00309478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102574667|NCT00309478|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102574668|NCT00309478|Hormone Antagonists|hormone antagonists|mesh-ancestor
102574669|NCT00309478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102574670|NCT00309478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102574671|NCT00309478|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102574672|NCT00309478|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102574673|NCT00309478|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102574674|NCT00295646|Tamoxifen|tamoxifen|mesh-list
102574675|NCT00295646|Zoledronic Acid|zoledronic acid|mesh-list
102574676|NCT00295646|Anastrozole|anastrozole|mesh-list
102574677|NCT00295646|Goserelin|goserelin|mesh-list
102574678|NCT00295646|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102574679|NCT00295646|Hormone Antagonists|hormone antagonists|mesh-ancestor
102574680|NCT00295646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102574681|NCT00295646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574682|NCT00295646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102574683|NCT00295646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574684|NCT00295646|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102574685|NCT00295646|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102574686|NCT00295646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102574687|NCT00295646|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102574688|NCT00295646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102574689|NCT00295646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102574690|NCT00295646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574691|NCT00274924|Prednisone|prednisone|mesh-list
102574692|NCT00274924|Cyclophosphamide|cyclophosphamide|mesh-list
102574693|NCT00274924|Ifosfamide|ifosfamide|mesh-list
102574694|NCT00274924|Rituximab|rituximab|mesh-list
102574695|NCT00274924|Carboplatin|carboplatin|mesh-list
102574696|NCT00274924|Doxorubicin|doxorubicin|mesh-list
102574697|NCT00274924|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102574698|NCT00274924|Etoposide|etoposide|mesh-list
102574699|NCT00274924|Vincristine|vincristine|mesh-list
102574700|NCT00274924|Podophyllotoxin|podophyllotoxin|mesh-list
102574701|NCT00274924|Lenograstim|lenograstim|mesh-list
102574702|NCT00274924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102574703|NCT00274924|Immunologic Factors|immunologic factors|mesh-ancestor
102574704|NCT00274924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574705|NCT00274924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102574706|NCT00274924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102574707|NCT00274924|Alkylating Agents|alkylating agents|mesh-ancestor
102574708|NCT00274924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574709|NCT00274924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574710|NCT00274924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102574711|NCT00274924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102574712|NCT00274924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102574713|NCT00274924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102574714|NCT00274924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102574715|NCT00274924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102574716|NCT00274924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102574717|NCT00274924|Glucocorticoids|glucocorticoids|mesh-ancestor
102574718|NCT00274924|Hormones|hormones|mesh-ancestor
102574719|NCT00274924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102574720|NCT00274924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102343698|NCT04785651|Hemostatics|hemostatics|mesh-ancestor
102574721|NCT00274924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102574722|NCT00274924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102574723|NCT00274924|Tubulin Modulators|tubulin modulators|mesh-ancestor
102574724|NCT00274924|Antimitotic Agents|antimitotic agents|mesh-ancestor
102574725|NCT00274924|Mitosis Modulators|mitosis modulators|mesh-ancestor
102574726|NCT00274924|Keratolytic Agents|keratolytic agents|mesh-ancestor
102574727|NCT00274924|Dermatologic Agents|dermatologic agents|mesh-ancestor
102574728|NCT00104884|Romidepsin|romidepsin|mesh-list
102574729|NCT00104884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102574730|NCT00104884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574731|NCT00104884|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102574732|NCT00104884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102574733|NCT00104884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574734|NCT00096174|Cisplatin|cisplatin|mesh-list
102574735|NCT00096174|Cetuximab|cetuximab|mesh-list
102574736|NCT00096174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574737|NCT00096174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102574738|NCT00080938|Temozolomide|temozolomide|mesh-list
102574739|NCT00080938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102574740|NCT00080938|Alkylating Agents|alkylating agents|mesh-ancestor
102574741|NCT00080938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574742|NCT00080938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574743|NCT00074282|Cyclophosphamide|cyclophosphamide|mesh-list
102574744|NCT00074282|Rituximab|rituximab|mesh-list
102574745|NCT00074282|Alemtuzumab|alemtuzumab|mesh-list
102574746|NCT00074282|Pentostatin|pentostatin|mesh-list
102574747|NCT00074282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102574748|NCT00074282|Immunologic Factors|immunologic factors|mesh-ancestor
102574749|NCT00074282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574750|NCT00074282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102574751|NCT00074282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102574752|NCT00074282|Alkylating Agents|alkylating agents|mesh-ancestor
102574753|NCT00074282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574754|NCT00074282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574755|NCT00074282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102574756|NCT00074282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102574757|NCT00074282|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
102574758|NCT00074282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102121727|NCT02787005|Pembrolizumab|pembrolizumab|mesh-list
102574759|NCT00071981|Molgramostim|molgramostim|mesh-list
102574760|NCT00071981|Vaccines|vaccines|mesh-list
102574761|NCT00071981|Sargramostim|sargramostim|mesh-list
102574762|NCT00071981|Freund's Adjuvant|freund's adjuvant|mesh-list
102574763|NCT00071981|Immunologic Factors|immunologic factors|mesh-ancestor
102574764|NCT00071981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574765|NCT00071981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574766|NCT00071981|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102574768|NCT00070291|Cyclosporins|cyclosporins|mesh-list
102574769|NCT00070291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102574770|NCT00070291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574771|NCT00070291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102574772|NCT00070291|Immunologic Factors|immunologic factors|mesh-ancestor
102574773|NCT00070291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574774|NCT00070291|Antifungal Agents|antifungal agents|mesh-ancestor
102574775|NCT00070291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102574776|NCT00070291|Dermatologic Agents|dermatologic agents|mesh-ancestor
102574777|NCT00070291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102574778|NCT00070291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102574779|NCT00064350|Sorafenib|sorafenib|mesh-list
102574780|NCT00064350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574781|NCT00064350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102574782|NCT00064350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102574783|NCT00064350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574784|NCT00060346|Prednisone|prednisone|mesh-list
102574785|NCT00060346|Cyclophosphamide|cyclophosphamide|mesh-list
102574786|NCT00060346|Rituximab|rituximab|mesh-list
102574787|NCT00060346|Doxorubicin|doxorubicin|mesh-list
102574788|NCT00060346|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102574789|NCT00060346|Vincristine|vincristine|mesh-list
102574790|NCT00060346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102574791|NCT00060346|Immunologic Factors|immunologic factors|mesh-ancestor
102574792|NCT00060346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574793|NCT00060346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102574794|NCT00060346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102574795|NCT00060346|Alkylating Agents|alkylating agents|mesh-ancestor
102574796|NCT00060346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574797|NCT00060346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574798|NCT00060346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102574799|NCT00060346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102574800|NCT00060346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102574801|NCT00060346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102574802|NCT00060346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102574803|NCT00060346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102574804|NCT00060346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102574805|NCT00060346|Glucocorticoids|glucocorticoids|mesh-ancestor
102574806|NCT00060346|Hormones|hormones|mesh-ancestor
102574807|NCT00060346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102574808|NCT00060346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102574809|NCT00060346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102574810|NCT00060346|Tubulin Modulators|tubulin modulators|mesh-ancestor
102574811|NCT00060346|Antimitotic Agents|antimitotic agents|mesh-ancestor
102574812|NCT00060346|Mitosis Modulators|mitosis modulators|mesh-ancestor
102574813|NCT00057954|Cyclosporine|cyclosporine|mesh-list
102574814|NCT00057954|Mycophenolic Acid|mycophenolic acid|mesh-list
102574815|NCT00057954|Methotrexate|methotrexate|mesh-list
102574816|NCT00057954|Pentostatin|pentostatin|mesh-list
102574817|NCT00057954|Cyclosporins|cyclosporins|mesh-list
102574818|NCT00057954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102574819|NCT00057954|Abortifacient Agents|abortifacient agents|mesh-ancestor
102574820|NCT00057954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102574821|NCT00057954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574822|NCT00057954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102574823|NCT00057954|Antimetabolites|antimetabolites|mesh-ancestor
102574824|NCT00057954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574825|NCT00057954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574826|NCT00057954|Dermatologic Agents|dermatologic agents|mesh-ancestor
102574827|NCT00057954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102574828|NCT00057954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102574829|NCT00057954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102574830|NCT00057954|Immunologic Factors|immunologic factors|mesh-ancestor
102574831|NCT00057954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102574832|NCT00057954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102574833|NCT00057954|Antifungal Agents|antifungal agents|mesh-ancestor
102574834|NCT00057954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102574835|NCT00057954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102574836|NCT00057954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102574837|NCT00057954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102121785|NCT02526368|Carbamide Peroxide|carbamide peroxide|mesh-list
102574838|NCT00057954|Antitubercular Agents|antitubercular agents|mesh-ancestor
102574839|NCT00057954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102574840|NCT00057954|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
102574841|NCT00049530|Interferons|interferons|mesh-list
102574842|NCT00049530|Interferon-alpha|interferon-alpha|mesh-list
102574843|NCT00049530|Interferon alpha-2|interferon alpha-2|mesh-list
102574844|NCT00049530|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102574845|NCT00049530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574846|NCT00049530|Antiviral Agents|antiviral agents|mesh-ancestor
102574847|NCT00049530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102574848|NCT00049530|Immunologic Factors|immunologic factors|mesh-ancestor
102574849|NCT00049530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574850|NCT00045305|Cyclosporine|cyclosporine|mesh-list
102574851|NCT00045305|Mycophenolic Acid|mycophenolic acid|mesh-list
102574852|NCT00045305|Methotrexate|methotrexate|mesh-list
102574853|NCT00045305|Pentostatin|pentostatin|mesh-list
102574854|NCT00045305|Methoxsalen|methoxsalen|mesh-list
102574855|NCT00045305|Cyclosporins|cyclosporins|mesh-list
102574856|NCT00045305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102574857|NCT00045305|Abortifacient Agents|abortifacient agents|mesh-ancestor
102574858|NCT00045305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102574859|NCT00045305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574860|NCT00045305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102574861|NCT00045305|Antimetabolites|antimetabolites|mesh-ancestor
102574862|NCT00045305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574863|NCT00045305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574864|NCT00045305|Dermatologic Agents|dermatologic agents|mesh-ancestor
102574865|NCT00045305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102574866|NCT00045305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102574867|NCT00045305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102574868|NCT00045305|Immunologic Factors|immunologic factors|mesh-ancestor
102574869|NCT00045305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102574870|NCT00045305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102574871|NCT00045305|Antifungal Agents|antifungal agents|mesh-ancestor
102574872|NCT00045305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102574873|NCT00045305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102574874|NCT00045305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102574875|NCT00045305|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102574876|NCT00045305|Antitubercular Agents|antitubercular agents|mesh-ancestor
102574877|NCT00045305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102574878|NCT00045305|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
102574879|NCT00045305|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102574880|NCT00033657|Paclitaxel|paclitaxel|mesh-list
102574881|NCT00033657|Camptothecin|camptothecin|mesh-list
102574882|NCT00033657|Cisplatin|cisplatin|mesh-list
102574883|NCT00033657|Irinotecan|irinotecan|mesh-list
102574884|NCT00033657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102574885|NCT00033657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574886|NCT00033657|Tubulin Modulators|tubulin modulators|mesh-ancestor
102574887|NCT00033657|Antimitotic Agents|antimitotic agents|mesh-ancestor
102574888|NCT00033657|Mitosis Modulators|mitosis modulators|mesh-ancestor
102574889|NCT00033657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574890|NCT00033657|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102574891|NCT00033657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102574892|NCT00033657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102574893|NCT00003389|Prednisone|prednisone|mesh-list
102574894|NCT00003389|Cyclophosphamide|cyclophosphamide|mesh-list
102574895|NCT00003389|Dacarbazine|dacarbazine|mesh-list
102574896|NCT00003389|Mechlorethamine|mechlorethamine|mesh-list
102574897|NCT00003389|Doxorubicin|doxorubicin|mesh-list
102574898|NCT00003389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102574899|NCT00003389|Etoposide|etoposide|mesh-list
102574900|NCT00003389|Vincristine|vincristine|mesh-list
102574901|NCT00003389|Etoposide phosphate|etoposide phosphate|mesh-list
102574902|NCT00003389|Bleomycin|bleomycin|mesh-list
102574903|NCT00003389|Vinblastine|vinblastine|mesh-list
102574904|NCT00003389|Podophyllotoxin|podophyllotoxin|mesh-list
102574905|NCT00003389|Imidazole|imidazole|mesh-list
102574906|NCT00003389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102574907|NCT00003389|Immunologic Factors|immunologic factors|mesh-ancestor
102574908|NCT00003389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574909|NCT00003389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102574910|NCT00003389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102574911|NCT00003389|Alkylating Agents|alkylating agents|mesh-ancestor
102574912|NCT00003389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574913|NCT00003389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121865|NCT01898104|GABA Agents|gaba agents|mesh-ancestor
102574914|NCT00003389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102574915|NCT00003389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102574916|NCT00003389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102574917|NCT00003389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102574918|NCT00003389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102574919|NCT00003389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102574920|NCT00003389|Glucocorticoids|glucocorticoids|mesh-ancestor
102574922|NCT00003389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102574923|NCT00003389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102574924|NCT00003389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102574925|NCT00003389|Tubulin Modulators|tubulin modulators|mesh-ancestor
102574926|NCT00003389|Antimitotic Agents|antimitotic agents|mesh-ancestor
102574927|NCT00003389|Mitosis Modulators|mitosis modulators|mesh-ancestor
102574928|NCT00003389|Keratolytic Agents|keratolytic agents|mesh-ancestor
102574929|NCT00003389|Dermatologic Agents|dermatologic agents|mesh-ancestor
102574930|NCT00003138|Epoetin Alfa|epoetin alfa|mesh-list
102574931|NCT00003138|Lenograstim|lenograstim|mesh-list
102574932|NCT00003138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102574933|NCT00003138|Immunologic Factors|immunologic factors|mesh-ancestor
102574934|NCT00003138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574935|NCT00003138|Hematinics|hematinics|mesh-ancestor
102574936|NCT00002525|Leucovorin|leucovorin|mesh-list
102574937|NCT00002525|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
102574938|NCT00002525|Tetrahydrofolates|tetrahydrofolates|mesh-list
102574939|NCT00002525|Fluorouracil|fluorouracil|mesh-list
102574940|NCT00002525|Calcium|calcium|mesh-list
102574941|NCT00002525|Levoleucovorin|levoleucovorin|mesh-list
101841867|NCT00290758|Estrogens|estrogens|mesh-ancestor
102574942|NCT00002525|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102574943|NCT00002525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574944|NCT00002525|Antimetabolites|antimetabolites|mesh-ancestor
102574945|NCT00002525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574946|NCT00002525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102574947|NCT00002525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574948|NCT00002525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102574949|NCT00002525|Immunologic Factors|immunologic factors|mesh-ancestor
102574950|NCT00002525|Antidotes|antidotes|mesh-ancestor
102574951|NCT00002525|Protective Agents|protective agents|mesh-ancestor
102574952|NCT00002525|Vitamin B Complex|vitamin b complex|mesh-ancestor
102574953|NCT00002525|Vitamins|vitamins|mesh-ancestor
102574954|NCT00002525|Micronutrients|micronutrients|mesh-ancestor
102574955|NCT05475522|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102574956|NCT05475522|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102574957|NCT05475522|Dermatologic Agents|dermatologic agents|mesh-ancestor
102574958|NCT02259348|Aldesleukin|aldesleukin|mesh-list
102574959|NCT02259348|Cyclophosphamide|cyclophosphamide|mesh-list
102574960|NCT02259348|Melphalan|melphalan|mesh-list
102574961|NCT02259348|Mechlorethamine|mechlorethamine|mesh-list
102574962|NCT02259348|Thiotepa|thiotepa|mesh-list
102574963|NCT02259348|Rituximab|rituximab|mesh-list
102574964|NCT02259348|Fludarabine|fludarabine|mesh-list
102574965|NCT02259348|Fludarabine phosphate|fludarabine phosphate|mesh-list
102574966|NCT02259348|Interleukin-2|interleukin-2|mesh-list
102574967|NCT02259348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102574968|NCT02259348|Immunologic Factors|immunologic factors|mesh-ancestor
102574969|NCT02259348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574970|NCT02259348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102574971|NCT02259348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102574972|NCT02259348|Alkylating Agents|alkylating agents|mesh-ancestor
102574973|NCT02259348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574974|NCT02259348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102574975|NCT02259348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102574976|NCT02259348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102574977|NCT02259348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102574978|NCT02259348|Antimetabolites|antimetabolites|mesh-ancestor
102574979|NCT02259348|Antiviral Agents|antiviral agents|mesh-ancestor
102574980|NCT02259348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102574981|NCT02259348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102574982|NCT02259348|Analgesics|analgesics|mesh-ancestor
102574983|NCT02259348|Sensory System Agents|sensory system agents|mesh-ancestor
102574984|NCT02259348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102574985|NCT02259348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102574986|NCT02259348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102574987|NCT00357019|Isospaglumic acid|isospaglumic acid|mesh-list
102574988|NCT00357019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102574989|NCT00357019|Autonomic Agents|autonomic agents|mesh-ancestor
102574990|NCT00357019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102574991|NCT00357019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102574992|NCT00357019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102121941|NCT01745965|Trastuzumab|trastuzumab|mesh-list
102574993|NCT00357019|Respiratory System Agents|respiratory system agents|mesh-ancestor
102574994|NCT00357019|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102574995|NCT00357019|Histamine Antagonists|histamine antagonists|mesh-ancestor
102574996|NCT00357019|Histamine Agents|histamine agents|mesh-ancestor
102574997|NCT00357019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102574998|NCT00357019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102574999|NCT00357019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102575000|NCT00357019|Protective Agents|protective agents|mesh-ancestor
102575001|NCT00357019|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102575002|NCT03994705|Cyclophosphamide|cyclophosphamide|mesh-list
102575003|NCT03994705|Fludarabine|fludarabine|mesh-list
102575004|NCT03994705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102575005|NCT03994705|Immunologic Factors|immunologic factors|mesh-ancestor
102575006|NCT03994705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575007|NCT03994705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102575008|NCT03994705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102575009|NCT03994705|Alkylating Agents|alkylating agents|mesh-ancestor
102575010|NCT03994705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575011|NCT03994705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102575012|NCT03994705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102575013|NCT03587207|Vaccines|vaccines|mesh-list
102575014|NCT03587207|Immunologic Factors|immunologic factors|mesh-ancestor
102575015|NCT03587207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575016|NCT03592121|Phenylephrine|phenylephrine|mesh-list
102575017|NCT03592121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102575018|NCT03592121|Mydriatics|mydriatics|mesh-ancestor
102575019|NCT03592121|Autonomic Agents|autonomic agents|mesh-ancestor
102575020|NCT03592121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102575021|NCT03592121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575022|NCT03592121|Sympathomimetics|sympathomimetics|mesh-ancestor
102575023|NCT03592121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102575024|NCT03592121|Nasal Decongestants|nasal decongestants|mesh-ancestor
102575025|NCT03592121|Respiratory System Agents|respiratory system agents|mesh-ancestor
102575026|NCT03592121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102575027|NCT03592121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102575028|NCT03592121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102575029|NCT03592121|Adrenergic Agents|adrenergic agents|mesh-ancestor
102575030|NCT03592121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102575031|NCT03592121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575032|NCT03592121|Protective Agents|protective agents|mesh-ancestor
102575033|NCT04332809|Gentamicins|gentamicins|mesh-list
102575034|NCT04332809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102575035|NCT04332809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102575036|NCT04332809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102575037|NCT04332809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102575038|NCT04332809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575039|NCT03596723|Prednisolone|prednisolone|mesh-list
102575040|NCT03596723|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102575041|NCT03596723|Methylprednisolone|methylprednisolone|mesh-list
102575042|NCT03596723|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102575043|NCT03596723|Prednisolone acetate|prednisolone acetate|mesh-list
102575044|NCT03596723|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102575045|NCT03596723|Prednisolone phosphate|prednisolone phosphate|mesh-list
102575046|NCT03596723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102575047|NCT03596723|Glucocorticoids|glucocorticoids|mesh-ancestor
102575048|NCT03596723|Hormones|hormones|mesh-ancestor
102575049|NCT03596723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102575050|NCT03596723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575051|NCT03596723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102575052|NCT03596723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102575053|NCT03596723|Antiemetics|antiemetics|mesh-ancestor
102575054|NCT03596723|Autonomic Agents|autonomic agents|mesh-ancestor
102575055|NCT03596723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102575056|NCT03596723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102575057|NCT03596723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102575058|NCT03596723|Protective Agents|protective agents|mesh-ancestor
102575059|NCT03463889|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102575060|NCT03463889|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102575061|NCT03463889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575062|NCT03472469|Acetaminophen|acetaminophen|mesh-list
102575063|NCT03472469|Ketorolac|ketorolac|mesh-list
102575064|NCT03472469|Naproxen|naproxen|mesh-list
102575065|NCT03472469|Celecoxib|celecoxib|mesh-list
102575066|NCT03472469|Lidocaine|lidocaine|mesh-list
102575067|NCT03472469|Pregabalin|pregabalin|mesh-list
102575068|NCT03472469|Gabapentin|gabapentin|mesh-list
102575069|NCT03472469|Tramadol|tramadol|mesh-list
102575070|NCT03472469|Anesthetics, Local|anesthetics, local|mesh-ancestor
102575071|NCT03472469|Anesthetics|anesthetics|mesh-ancestor
102575072|NCT03472469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102575073|NCT03472469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575074|NCT03472469|Sensory System Agents|sensory system agents|mesh-ancestor
102575075|NCT03472469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102575076|NCT03472469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102575077|NCT03472469|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102575078|NCT03472469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102575079|NCT03472469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102575080|NCT03472469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575081|NCT03472469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102575082|NCT03472469|Analgesics|analgesics|mesh-ancestor
102575083|NCT03472469|Antipyretics|antipyretics|mesh-ancestor
102575084|NCT03472469|Anticonvulsants|anticonvulsants|mesh-ancestor
102575085|NCT03472469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102575086|NCT03472469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102575087|NCT03472469|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102575088|NCT03472469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102575089|NCT03472469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102575090|NCT03472469|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102575091|NCT03472469|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102575092|NCT03472469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102575093|NCT03472469|Antimanic Agents|antimanic agents|mesh-ancestor
102575094|NCT03472469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102575095|NCT03472469|Narcotics|narcotics|mesh-ancestor
102575096|NCT03472469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102575097|NCT03472469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102575098|NCT03472469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102575099|NCT03472469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102575100|NCT03472469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102575101|NCT03472469|Gout Suppressants|gout suppressants|mesh-ancestor
102575102|NCT03472469|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102575103|NCT04926233|Bromides|bromides|mesh-list
102575104|NCT04926233|Tiotropium Bromide|tiotropium bromide|mesh-list
102575105|NCT04926233|Olodaterol|olodaterol|mesh-list
102575106|NCT04926233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102575107|NCT04926233|Autonomic Agents|autonomic agents|mesh-ancestor
102575108|NCT04926233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102575109|NCT04926233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575110|NCT04926233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102575111|NCT04926233|Respiratory System Agents|respiratory system agents|mesh-ancestor
102575112|NCT04926233|Parasympatholytics|parasympatholytics|mesh-ancestor
102575113|NCT04926233|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102575114|NCT04926233|Cholinergic Agents|cholinergic agents|mesh-ancestor
102575115|NCT04926233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102575116|NCT04926233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575117|NCT04926233|Anticonvulsants|anticonvulsants|mesh-ancestor
102575118|NCT04943159|Afamelanotide|afamelanotide|mesh-list
102575119|NCT04943159|Dermatologic Agents|dermatologic agents|mesh-ancestor
102575120|NCT04525157|Afamelanotide|afamelanotide|mesh-list
102575121|NCT04525157|Dermatologic Agents|dermatologic agents|mesh-ancestor
102575122|NCT04734665|Bevacizumab|bevacizumab|mesh-list
102575123|NCT04734665|Niraparib|niraparib|mesh-list
102575124|NCT04734665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102575125|NCT04734665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102575126|NCT04734665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102575127|NCT04734665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102575128|NCT04734665|Growth Substances|growth substances|mesh-ancestor
102575129|NCT04734665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575130|NCT04734665|Growth Inhibitors|growth inhibitors|mesh-ancestor
102575131|NCT04734665|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102575132|NCT04734665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102575133|NCT04734665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575134|NCT02258334|Vaccines|vaccines|mesh-list
102575135|NCT02258334|Immunologic Factors|immunologic factors|mesh-ancestor
102575136|NCT02258334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575137|NCT03478163|Clindamycin|clindamycin|mesh-list
102575138|NCT03478163|Clindamycin palmitate|clindamycin palmitate|mesh-list
102575139|NCT03478163|Clindamycin phosphate|clindamycin phosphate|mesh-list
102575140|NCT03478163|Cefazolin|cefazolin|mesh-list
102575141|NCT03478163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102575142|NCT03478163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102122078|NCT00526396|Cisplatin|cisplatin|mesh-list
102575143|NCT03478163|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102575144|NCT03478163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102575145|NCT03478163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575146|NCT05646810|Lidocaine|lidocaine|mesh-list
102575147|NCT05646810|Anesthetics, Local|anesthetics, local|mesh-ancestor
102575148|NCT05646810|Anesthetics|anesthetics|mesh-ancestor
102575149|NCT05646810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102575150|NCT05646810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575151|NCT05646810|Sensory System Agents|sensory system agents|mesh-ancestor
102575152|NCT05646810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102575153|NCT05646810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102575154|NCT05646810|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102575155|NCT05646810|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102575156|NCT05646810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102575157|NCT05646810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575158|NCT04960202|Ritonavir|ritonavir|mesh-list
102575159|NCT04960202|Nirmatrelvir|nirmatrelvir|mesh-list
102575160|NCT04960202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102575161|NCT04960202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102575162|NCT04960202|Protease Inhibitors|protease inhibitors|mesh-ancestor
102575163|NCT04960202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102575164|NCT04960202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575165|NCT04960202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102575166|NCT04960202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102575167|NCT04960202|Antiviral Agents|antiviral agents|mesh-ancestor
102575168|NCT04960202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102575169|NCT04960202|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102575170|NCT04960202|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102575171|NCT02959112|Indomethacin|indomethacin|mesh-list
102575172|NCT02959112|Epinephrine|epinephrine|mesh-list
102575173|NCT02959112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102575174|NCT02959112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102575175|NCT02959112|Adrenergic Agents|adrenergic agents|mesh-ancestor
102575176|NCT02959112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102575177|NCT02959112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575178|NCT02959112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575179|NCT02959112|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102575180|NCT02959112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102575181|NCT02959112|Autonomic Agents|autonomic agents|mesh-ancestor
102575182|NCT02959112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102575183|NCT02959112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102575184|NCT02959112|Respiratory System Agents|respiratory system agents|mesh-ancestor
102575185|NCT02959112|Mydriatics|mydriatics|mesh-ancestor
102575186|NCT02959112|Sympathomimetics|sympathomimetics|mesh-ancestor
102575187|NCT02959112|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102575188|NCT02959112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102575189|NCT02959112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102575190|NCT02959112|Analgesics|analgesics|mesh-ancestor
102575191|NCT02959112|Sensory System Agents|sensory system agents|mesh-ancestor
102575192|NCT02959112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102575193|NCT02959112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102575194|NCT02959112|Gout Suppressants|gout suppressants|mesh-ancestor
102575195|NCT02959112|Tocolytic Agents|tocolytic agents|mesh-ancestor
102575196|NCT02959112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102575197|NCT02959112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102575198|NCT02959112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102575199|NCT05377034|Bevacizumab|bevacizumab|mesh-list
102575200|NCT05377034|Atezolizumab|atezolizumab|mesh-list
102575201|NCT05377034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102575202|NCT05377034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102575203|NCT05377034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102575204|NCT05377034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102575205|NCT05377034|Growth Substances|growth substances|mesh-ancestor
102575206|NCT05377034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575207|NCT05377034|Growth Inhibitors|growth inhibitors|mesh-ancestor
102575208|NCT05377034|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102575209|NCT05377034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575210|NCT03622619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102575211|NCT03622619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102575212|NCT03622619|Lubricant Eye Drops|lubricant eye drops|mesh-list
102575213|NCT03622619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102575214|NCT03622619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102575215|NCT04428359|Vitamin D|vitamin d|mesh-list
102575216|NCT04428359|Vitamins|vitamins|mesh-ancestor
102575217|NCT04428359|Micronutrients|micronutrients|mesh-ancestor
102575218|NCT04428359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122150|NCT05258682|Antidotes|antidotes|mesh-ancestor
102575219|NCT04428359|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102575220|NCT02257632|Ranibizumab|ranibizumab|mesh-list
102575221|NCT02257632|Aflibercept|aflibercept|mesh-list
102575222|NCT02257632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102575223|NCT02257632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102575224|NCT02257632|Growth Substances|growth substances|mesh-ancestor
102575225|NCT02257632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575226|NCT02257632|Growth Inhibitors|growth inhibitors|mesh-ancestor
102575227|NCT02257632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102575228|NCT05436054|Picosulfate sodium|picosulfate sodium|mesh-list
102575229|NCT05436054|Cathartics|cathartics|mesh-ancestor
102575230|NCT05436054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102575231|NCT01642914|Linaclotide|linaclotide|mesh-list
102575232|NCT01642914|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102575233|NCT01642914|Enzyme Activators|enzyme activators|mesh-ancestor
102575234|NCT01642914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575235|NCT01642914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102575236|NCT04486352|Bevacizumab|bevacizumab|mesh-list
102575237|NCT04486352|Trastuzumab|trastuzumab|mesh-list
102575238|NCT04486352|Atezolizumab|atezolizumab|mesh-list
102575239|NCT04486352|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102575240|NCT04486352|Letrozole|letrozole|mesh-list
102575241|NCT04486352|Maytansine|maytansine|mesh-list
102575242|NCT04486352|Talazoparib|talazoparib|mesh-list
102575243|NCT04486352|Ipatasertib|ipatasertib|mesh-list
102575244|NCT04486352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102575245|NCT04486352|Inavolisib|inavolisib|mesh-list
102575246|NCT04486352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102575247|NCT04486352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102575248|NCT04486352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102575249|NCT04486352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102575250|NCT04486352|Growth Substances|growth substances|mesh-ancestor
102575251|NCT04486352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575252|NCT04486352|Growth Inhibitors|growth inhibitors|mesh-ancestor
102575253|NCT04486352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102575254|NCT04486352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575255|NCT04486352|Immunologic Factors|immunologic factors|mesh-ancestor
102575256|NCT04486352|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102575257|NCT04486352|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102575258|NCT04486352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102575259|NCT04486352|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102575260|NCT04486352|Hormone Antagonists|hormone antagonists|mesh-ancestor
102575261|NCT04486352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102575262|NCT04486352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102575263|NCT04486352|Tubulin Modulators|tubulin modulators|mesh-ancestor
102575264|NCT04486352|Antimitotic Agents|antimitotic agents|mesh-ancestor
102575265|NCT04486352|Mitosis Modulators|mitosis modulators|mesh-ancestor
102575266|NCT04486352|Immunotoxins|immunotoxins|mesh-ancestor
102575267|NCT04486352|Immunoconjugates|immunoconjugates|mesh-ancestor
102575268|NCT04486352|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102575269|NCT04486352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102575270|NCT04486352|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
102575271|NCT01642602|Dexlansoprazole|dexlansoprazole|mesh-list
102575272|NCT01642602|Lansoprazole|lansoprazole|mesh-list
102575273|NCT01642602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102575274|NCT01642602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102575275|NCT01642602|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102575276|NCT01642602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102575277|NCT01642602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575278|NCT02256540|Resveratrol|resveratrol|mesh-list
102575279|NCT02256540|Estradiol|estradiol|mesh-list
102575280|NCT02256540|Estrogens|estrogens|mesh-ancestor
102575281|NCT02256540|Hormones|hormones|mesh-ancestor
102575282|NCT02256540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102575283|NCT02256540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575284|NCT02256540|Antioxidants|antioxidants|mesh-ancestor
102575285|NCT02256540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575286|NCT02256540|Protective Agents|protective agents|mesh-ancestor
102575287|NCT02256540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102575288|NCT02256540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102575289|NCT05646264|Agomelatine|agomelatine|mesh-list
102575290|NCT05646264|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102575291|NCT05646264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102575292|NCT05646264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575293|NCT01640184|Vitamin D|vitamin d|mesh-list
102575294|NCT01640184|Vitamins|vitamins|mesh-ancestor
102575295|NCT01640184|Micronutrients|micronutrients|mesh-ancestor
102575296|NCT01640184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575297|NCT01640184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102575299|NCT04904978|Sodium Fluoride|sodium fluoride|mesh-list
102575300|NCT04904978|Cariostatic Agents|cariostatic agents|mesh-ancestor
102575301|NCT04904978|Protective Agents|protective agents|mesh-ancestor
102575302|NCT04904978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575303|NCT04904978|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102575304|NCT04904978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102575305|NCT03631433|Acetaminophen|acetaminophen|mesh-list
102575306|NCT03631433|Ibuprofen|ibuprofen|mesh-list
102575307|NCT03631433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102575308|NCT03631433|Analgesics|analgesics|mesh-ancestor
102575309|NCT03631433|Sensory System Agents|sensory system agents|mesh-ancestor
102575310|NCT03631433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102575311|NCT03631433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575312|NCT03631433|Antipyretics|antipyretics|mesh-ancestor
102575313|NCT03631433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102575314|NCT03631433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102575315|NCT03631433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102575316|NCT03631433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102575317|NCT03631433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102575318|NCT03631433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575319|NCT02973659|Oxybutynin|oxybutynin|mesh-list
102575320|NCT02973659|Parasympatholytics|parasympatholytics|mesh-ancestor
102575321|NCT02973659|Autonomic Agents|autonomic agents|mesh-ancestor
102575322|NCT02973659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102575323|NCT02973659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575324|NCT02973659|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102575325|NCT02973659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102575326|NCT02973659|Cholinergic Agents|cholinergic agents|mesh-ancestor
102575327|NCT02973659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102575328|NCT02973659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575329|NCT02973659|Urological Agents|urological agents|mesh-ancestor
102575330|NCT04439396|Ketorolac|ketorolac|mesh-list
102575331|NCT04439396|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102575332|NCT04439396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102575333|NCT04439396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102575334|NCT04439396|Analgesics|analgesics|mesh-ancestor
102575335|NCT04439396|Sensory System Agents|sensory system agents|mesh-ancestor
102575336|NCT04439396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102575337|NCT04439396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575338|NCT04439396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102575339|NCT04439396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102575340|NCT04439396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102575341|NCT04439396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102575342|NCT04439396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575343|NCT02255760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102575344|NCT02255760|Immunologic Factors|immunologic factors|mesh-ancestor
102575345|NCT02255760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575346|NCT00360464|Azithromycin|azithromycin|mesh-list
102575347|NCT00360464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102575348|NCT00360464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102575349|NCT04825496|Cyclophosphamide|cyclophosphamide|mesh-list
102575350|NCT04825496|Fludarabine|fludarabine|mesh-list
102575351|NCT04825496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102575352|NCT04825496|Immunologic Factors|immunologic factors|mesh-ancestor
102575353|NCT04825496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575354|NCT04825496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102575355|NCT04825496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102575356|NCT04825496|Alkylating Agents|alkylating agents|mesh-ancestor
102575357|NCT04825496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575358|NCT04825496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102575359|NCT04825496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102575360|NCT05651256|Botulinum Toxins|botulinum toxins|mesh-list
102575361|NCT05651256|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102575362|NCT05651256|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102575363|NCT05651256|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102575364|NCT05651256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102575365|NCT05651256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575366|NCT05651256|Cholinergic Agents|cholinergic agents|mesh-ancestor
102575367|NCT05651256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102575368|NCT05651256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575369|NCT05651256|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102575370|NCT05651256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102575371|NCT04297631|Tobramycin|tobramycin|mesh-list
102575372|NCT04297631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102575373|NCT04297631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102575374|NCT04812470|Melphalan|melphalan|mesh-list
102575375|NCT04812470|Interleukin-2|interleukin-2|mesh-list
102575376|NCT04812470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102575377|NCT04812470|Alkylating Agents|alkylating agents|mesh-ancestor
101842291|NCT00981929|Narcotics|narcotics|mesh-ancestor
102575378|NCT04812470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575379|NCT04812470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102575380|NCT04812470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102575381|NCT04812470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102575382|NCT04812470|Immunologic Factors|immunologic factors|mesh-ancestor
102575383|NCT04812470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575384|NCT04812470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102575385|NCT04812470|Analgesics|analgesics|mesh-ancestor
102575386|NCT04812470|Sensory System Agents|sensory system agents|mesh-ancestor
102575387|NCT04812470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102575388|NCT02976194|Ranibizumab|ranibizumab|mesh-list
102575389|NCT02976194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102575390|NCT02976194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102575391|NCT02976194|Growth Substances|growth substances|mesh-ancestor
102575392|NCT02976194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575393|NCT02976194|Growth Inhibitors|growth inhibitors|mesh-ancestor
102575394|NCT02976194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102575395|NCT00360776|Tipifarnib|tipifarnib|mesh-list
102575396|NCT00360776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102575397|NCT02976740|Immunologic Factors|immunologic factors|mesh-list
102575398|NCT02976740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575399|NCT04342910|Paclitaxel|paclitaxel|mesh-list
102575400|NCT04342910|Irinotecan|irinotecan|mesh-list
102575401|NCT04342910|Apatinib|apatinib|mesh-list
102575402|NCT04342910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102575403|NCT04342910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102575404|NCT04342910|Tubulin Modulators|tubulin modulators|mesh-ancestor
102575405|NCT04342910|Antimitotic Agents|antimitotic agents|mesh-ancestor
102575406|NCT04342910|Mitosis Modulators|mitosis modulators|mesh-ancestor
102575407|NCT04342910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575408|NCT04342910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102575409|NCT04342910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102575410|NCT04342910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102575411|NCT04342910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102575412|NCT04714073|Itraconazole|itraconazole|mesh-list
102575413|NCT04714073|Antifungal Agents|antifungal agents|mesh-ancestor
102575414|NCT04714073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102575415|NCT04714073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102575416|NCT04714073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102575417|NCT04714073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102575418|NCT04714073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575419|NCT04714073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102575420|NCT04714073|Hormone Antagonists|hormone antagonists|mesh-ancestor
102575421|NCT04714073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102575422|NCT04714073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575423|NCT04714073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102575424|NCT04342676|Panitumumab|panitumumab|mesh-list
102575425|NCT04342676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102575426|NCT04342676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102575427|NCT01641822|Tobramycin|tobramycin|mesh-list
102575428|NCT01641822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102575429|NCT01641822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102575430|NCT05364762|Cyclophosphamide|cyclophosphamide|mesh-list
102575431|NCT05364762|Tacrolimus|tacrolimus|mesh-list
102575432|NCT05364762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102575433|NCT05364762|Immunologic Factors|immunologic factors|mesh-ancestor
102575434|NCT05364762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575435|NCT05364762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102575436|NCT05364762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102575437|NCT05364762|Alkylating Agents|alkylating agents|mesh-ancestor
102575438|NCT05364762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575439|NCT05364762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102575440|NCT05364762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102575441|NCT05364762|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102575442|NCT05364762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102575443|NCT04871958|Insulin|insulin|mesh-list
102575444|NCT04871958|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102575445|NCT04871958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575446|NCT04342598|Vitamin D|vitamin d|mesh-list
102575447|NCT04342598|Vitamins|vitamins|mesh-ancestor
102575448|NCT04342598|Micronutrients|micronutrients|mesh-ancestor
102575449|NCT04342598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575450|NCT04342598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102575451|NCT00360854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102575452|NCT00360854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102575453|NCT00360854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102575454|NCT00360854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102575455|NCT00360854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575456|NCT05641818|Vitamin D|vitamin d|mesh-list
102575457|NCT05641818|Vitamins|vitamins|mesh-ancestor
102575458|NCT05641818|Micronutrients|micronutrients|mesh-ancestor
102575459|NCT05641818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575460|NCT05641818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102575461|NCT04762082|Tadalafil|tadalafil|mesh-list
102575462|NCT04762082|Vasodilator Agents|vasodilator agents|mesh-ancestor
102575463|NCT04762082|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102575464|NCT04762082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102575465|NCT04762082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102575466|NCT04762082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575467|NCT04762082|Urological Agents|urological agents|mesh-ancestor
102575468|NCT03514277|Bupivacaine|bupivacaine|mesh-list
102575469|NCT03514277|Anesthetics, Local|anesthetics, local|mesh-ancestor
102575470|NCT03514277|Anesthetics|anesthetics|mesh-ancestor
102575471|NCT03514277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102575472|NCT03514277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575473|NCT03514277|Sensory System Agents|sensory system agents|mesh-ancestor
102575474|NCT03514277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102575475|NCT05334108|Ecopipam|ecopipam|mesh-list
102575476|NCT05334108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102575477|NCT05334108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102575478|NCT05334108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102575479|NCT05334108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575480|NCT05334108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102575481|NCT05334108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102575482|NCT05334108|Dopamine Agents|dopamine agents|mesh-ancestor
102575483|NCT05334108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102575484|NCT05334108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575485|NCT03984656|Lidocaine|lidocaine|mesh-list
102575486|NCT03984656|Anesthetics, Local|anesthetics, local|mesh-ancestor
102575487|NCT03984656|Anesthetics|anesthetics|mesh-ancestor
102575488|NCT03984656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102575489|NCT03984656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575490|NCT03984656|Sensory System Agents|sensory system agents|mesh-ancestor
102575491|NCT03984656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102575492|NCT03984656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102575493|NCT03984656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102575494|NCT03984656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102575495|NCT03984656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102575496|NCT03984656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575497|NCT05299944|Cannabidiol|cannabidiol|mesh-list
102575498|NCT05299944|Anticonvulsants|anticonvulsants|mesh-ancestor
102575499|NCT04329494|Leucovorin|leucovorin|mesh-list
102575500|NCT04329494|Cisplatin|cisplatin|mesh-list
102575501|NCT04329494|Doxorubicin|doxorubicin|mesh-list
102575502|NCT04329494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102575503|NCT04329494|Fluorouracil|fluorouracil|mesh-list
102575504|NCT04329494|Oxaliplatin|oxaliplatin|mesh-list
102575505|NCT04329494|Irinotecan|irinotecan|mesh-list
102575506|NCT04329494|Daunorubicin|daunorubicin|mesh-list
102575507|NCT04329494|Mitomycins|mitomycins|mesh-list
102575508|NCT04329494|Mitomycin|mitomycin|mesh-list
102575509|NCT04329494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102575510|NCT04329494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102575511|NCT04329494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102575512|NCT04329494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102575513|NCT04329494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102575514|NCT04329494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575515|NCT04329494|Antimetabolites|antimetabolites|mesh-ancestor
102575516|NCT04329494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102122491|NCT00735657|Iodine|iodine|mesh-list
102575517|NCT04329494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102575518|NCT04329494|Immunologic Factors|immunologic factors|mesh-ancestor
102575519|NCT04329494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575520|NCT04329494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102575521|NCT04329494|Antidotes|antidotes|mesh-ancestor
102575522|NCT04329494|Protective Agents|protective agents|mesh-ancestor
102575523|NCT04329494|Vitamin B Complex|vitamin b complex|mesh-ancestor
102575524|NCT04329494|Vitamins|vitamins|mesh-ancestor
102575525|NCT04329494|Micronutrients|micronutrients|mesh-ancestor
102575526|NCT04329494|Alkylating Agents|alkylating agents|mesh-ancestor
101842433|NCT01047579|Rivastigmine|rivastigmine|mesh-list
102575527|NCT04329494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102575528|NCT03655301|Metformin|metformin|mesh-list
102575529|NCT03655301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102575530|NCT03655301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575531|NCT04870866|Niacinamide|niacinamide|mesh-list
102575532|NCT04870866|Niacin|niacin|mesh-list
102575533|NCT04870866|Nicotinic Acids|nicotinic acids|mesh-list
102575534|NCT04870866|Vitamin B Complex|vitamin b complex|mesh-ancestor
102575535|NCT04870866|Vitamins|vitamins|mesh-ancestor
102575536|NCT04870866|Micronutrients|micronutrients|mesh-ancestor
102575537|NCT04870866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575538|NCT04870866|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102575539|NCT04870866|Antimetabolites|antimetabolites|mesh-ancestor
102575540|NCT04870866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575541|NCT04870866|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102575542|NCT04870866|Vasodilator Agents|vasodilator agents|mesh-ancestor
102575543|NCT03657407|Glycerol|glycerol|mesh-list
102575544|NCT03657407|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102575545|NCT03657407|Protective Agents|protective agents|mesh-ancestor
102575546|NCT03657407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575547|NCT01639560|Varenicline|varenicline|mesh-list
102575548|NCT01639560|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102575549|NCT01639560|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102575550|NCT01639560|Cholinergic Agents|cholinergic agents|mesh-ancestor
102575551|NCT01639560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102575552|NCT01639560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575553|NCT01639560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575554|NCT04243616|Paclitaxel|paclitaxel|mesh-list
102575555|NCT04243616|Cyclophosphamide|cyclophosphamide|mesh-list
102575556|NCT04243616|Carboplatin|carboplatin|mesh-list
102575557|NCT04243616|Doxorubicin|doxorubicin|mesh-list
102575558|NCT04243616|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102575559|NCT04243616|Cemiplimab|cemiplimab|mesh-list
102575560|NCT04243616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102575561|NCT04243616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102575562|NCT04243616|Tubulin Modulators|tubulin modulators|mesh-ancestor
102575563|NCT04243616|Antimitotic Agents|antimitotic agents|mesh-ancestor
102575564|NCT04243616|Mitosis Modulators|mitosis modulators|mesh-ancestor
102575565|NCT04243616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575566|NCT04243616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102575567|NCT04243616|Immunologic Factors|immunologic factors|mesh-ancestor
102575568|NCT04243616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575569|NCT04243616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102575570|NCT04243616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102575571|NCT04243616|Alkylating Agents|alkylating agents|mesh-ancestor
102575572|NCT04243616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102575573|NCT04243616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102575574|NCT04243616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102575575|NCT04243616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102575576|NCT04243616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102575577|NCT04243616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102575578|NCT03954314|Tranexamic Acid|tranexamic acid|mesh-list
102575579|NCT03954314|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102575580|NCT03954314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102575581|NCT03954314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575582|NCT03954314|Hemostatics|hemostatics|mesh-ancestor
102575583|NCT03954314|Coagulants|coagulants|mesh-ancestor
102575584|NCT03952130|Insulin|insulin|mesh-list
102575585|NCT03952130|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102575586|NCT03952130|Insulin Glargine|insulin glargine|mesh-list
102575587|NCT03952130|Insulin Lispro|insulin lispro|mesh-list
102575588|NCT03952130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102575589|NCT03952130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575590|NCT03661541|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
102575591|NCT03661541|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102575592|NCT03661541|Immunologic Factors|immunologic factors|mesh-ancestor
102575593|NCT03661541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575594|NCT03925532|Denosumab|denosumab|mesh-list
102575595|NCT03925532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102575596|NCT03925532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575597|NCT05430828|Evolocumab|evolocumab|mesh-list
102575598|NCT05430828|Alirocumab|alirocumab|mesh-list
102575599|NCT05430828|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102575601|NCT05430828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102575602|NCT05430828|Antimetabolites|antimetabolites|mesh-ancestor
102575603|NCT05430828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575604|NCT05430828|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102575605|NCT05430828|Protease Inhibitors|protease inhibitors|mesh-ancestor
102575606|NCT05430828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102575607|NCT05430828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102575608|NCT01640964|Terlipressin|terlipressin|mesh-list
102575609|NCT01640964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102575610|NCT01640964|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102575611|NCT03663101|Lidocaine|lidocaine|mesh-list
102575612|NCT03663101|Botulinum Toxins|botulinum toxins|mesh-list
102575613|NCT03663101|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102575614|NCT03663101|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102575615|NCT03663101|Anesthetics, Local|anesthetics, local|mesh-ancestor
102575616|NCT03663101|Anesthetics|anesthetics|mesh-ancestor
102575617|NCT03663101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102575618|NCT03663101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575619|NCT03663101|Sensory System Agents|sensory system agents|mesh-ancestor
102575620|NCT03663101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102575621|NCT03663101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102575622|NCT03663101|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102575623|NCT03663101|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102575624|NCT03663101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102575625|NCT03663101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575626|NCT03663101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102575627|NCT03663101|Cholinergic Agents|cholinergic agents|mesh-ancestor
102575628|NCT03663101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102575629|NCT03663101|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102575630|NCT05430048|Bisoprolol|bisoprolol|mesh-list
102575631|NCT05430048|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
102575632|NCT05430048|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102575633|NCT05430048|Sympatholytics|sympatholytics|mesh-ancestor
102575634|NCT05430048|Autonomic Agents|autonomic agents|mesh-ancestor
102575635|NCT05430048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102575636|NCT05430048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575637|NCT05430048|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102575638|NCT05430048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102575639|NCT05430048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102575640|NCT05430048|Adrenergic Agents|adrenergic agents|mesh-ancestor
102575641|NCT05430048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102575642|NCT05430048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575643|NCT05430048|Hemostatics|hemostatics|mesh-ancestor
102575644|NCT05430048|Coagulants|coagulants|mesh-ancestor
102575645|NCT05430048|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102575646|NCT05430048|Natriuretic Agents|natriuretic agents|mesh-ancestor
102575647|NCT02975570|Levofloxacin|levofloxacin|mesh-list
102575648|NCT02975570|Linezolid|linezolid|mesh-list
102575649|NCT02975570|Pyrazinamide|pyrazinamide|mesh-list
102575650|NCT02975570|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102575651|NCT02975570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102575652|NCT02975570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102575653|NCT02975570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102575654|NCT02975570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102575655|NCT02975570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102575656|NCT02975570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575657|NCT02975570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102575658|NCT02975570|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102575659|NCT02975570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102575660|NCT02975570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102575661|NCT02975570|Antitubercular Agents|antitubercular agents|mesh-ancestor
102575662|NCT04184999|Dexamethasone|dexamethasone|mesh-list
102575663|NCT04184999|Prednisolone|prednisolone|mesh-list
102575664|NCT04184999|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102575665|NCT04184999|Methylprednisolone|methylprednisolone|mesh-list
102575666|NCT04184999|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102343724|NCT04735510|Cyclosporine|cyclosporine|mesh-list
102575667|NCT04184999|Prednisolone acetate|prednisolone acetate|mesh-list
102575668|NCT04184999|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102575669|NCT04184999|Prednisolone phosphate|prednisolone phosphate|mesh-list
102575670|NCT04184999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102575671|NCT04184999|Antiemetics|antiemetics|mesh-ancestor
102575672|NCT04184999|Autonomic Agents|autonomic agents|mesh-ancestor
102575673|NCT04184999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102122628|NCT04282278|Apatinib|apatinib|mesh-list
102575674|NCT04184999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575676|NCT04184999|Glucocorticoids|glucocorticoids|mesh-ancestor
102575677|NCT04184999|Hormones|hormones|mesh-ancestor
102575678|NCT04184999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102575679|NCT04184999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102575680|NCT04184999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102575681|NCT04184999|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102575682|NCT04184999|Protective Agents|protective agents|mesh-ancestor
102575683|NCT03524339|Tamsulosin|tamsulosin|mesh-list
102575684|NCT03524339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102575685|NCT03524339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102575686|NCT03524339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102575687|NCT03524339|Adrenergic Agents|adrenergic agents|mesh-ancestor
102575688|NCT03524339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102575689|NCT03524339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575690|NCT03524339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575691|NCT03524339|Urological Agents|urological agents|mesh-ancestor
102575692|NCT03667547|Raltegravir Potassium|raltegravir potassium|mesh-list
102575693|NCT03667547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102575694|NCT03667547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102575695|NCT03667547|Antiviral Agents|antiviral agents|mesh-ancestor
102575696|NCT03667547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102575697|NCT03667547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102575698|NCT03667547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102575699|NCT03667547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102575700|NCT03667547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575701|NCT00361010|Levetiracetam|levetiracetam|mesh-list
102575702|NCT00361010|Anticonvulsants|anticonvulsants|mesh-ancestor
102575703|NCT00361010|Nootropic Agents|nootropic agents|mesh-ancestor
102575704|NCT00361088|Bortezomib|bortezomib|mesh-list
102575705|NCT00361088|Tipifarnib|tipifarnib|mesh-list
102575706|NCT00361088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102575707|NCT04172402|Gemcitabine|gemcitabine|mesh-list
102575708|NCT04172402|Nivolumab|nivolumab|mesh-list
102575709|NCT04172402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102575710|NCT04172402|Antimetabolites|antimetabolites|mesh-ancestor
102575711|NCT04172402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575712|NCT04172402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102575713|NCT04172402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102575714|NCT04172402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102575715|NCT04662242|Selenium|selenium|mesh-list
102575716|NCT04662242|Antioxidants|antioxidants|mesh-ancestor
102575717|NCT04662242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575718|NCT04662242|Protective Agents|protective agents|mesh-ancestor
102575719|NCT04662242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575720|NCT04662242|Trace Elements|trace elements|mesh-ancestor
102575721|NCT04662242|Micronutrients|micronutrients|mesh-ancestor
102575722|NCT04160546|Aspirin|aspirin|mesh-list
102575723|NCT04160546|Ponatinib|ponatinib|mesh-list
102575724|NCT04160546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102575725|NCT04160546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102575726|NCT04160546|Analgesics|analgesics|mesh-ancestor
102575727|NCT04160546|Sensory System Agents|sensory system agents|mesh-ancestor
102575728|NCT04160546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102575729|NCT04160546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575730|NCT04160546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102575731|NCT04160546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102575732|NCT04160546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102575733|NCT04160546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102575734|NCT04160546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575735|NCT04160546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102575736|NCT04160546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102575737|NCT04160546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102575738|NCT04160546|Antipyretics|antipyretics|mesh-ancestor
102575739|NCT04160546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102575740|NCT04160546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102575741|NCT03675581|Nintedanib|nintedanib|mesh-list
102575742|NCT03675581|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
102575743|NCT03675581|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
102575744|NCT03675581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102575745|NCT03675581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102575746|NCT03675581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102575747|NCT03675581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575748|NCT03675581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102575749|NCT03675581|Contraceptive Agents|contraceptive agents|mesh-ancestor
102575750|NCT03675581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102575751|NCT03675581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575752|NCT03675581|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102575753|NCT03675581|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102575754|NCT03675581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102575755|NCT03675581|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102575756|NCT03675581|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102575757|NCT03675581|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
102575758|NCT03675581|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102575759|NCT03675581|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102575760|NCT05142228|Erenumab|erenumab|mesh-list
102575761|NCT05142228|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
102575762|NCT05142228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575763|NCT05142228|Analgesics|analgesics|mesh-ancestor
102575764|NCT05142228|Sensory System Agents|sensory system agents|mesh-ancestor
102575765|NCT05142228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102575766|NCT05142228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575767|NCT00362102|Cetuximab|cetuximab|mesh-list
102575768|NCT00362102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102575769|NCT00362102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102575770|NCT05122026|Isoniazid|isoniazid|mesh-list
102575771|NCT05122026|Rifapentine|rifapentine|mesh-list
102575772|NCT05122026|Antitubercular Agents|antitubercular agents|mesh-ancestor
102575773|NCT05122026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102575774|NCT05122026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102575775|NCT05122026|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102575776|NCT05122026|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102575777|NCT05122026|Antimetabolites|antimetabolites|mesh-ancestor
102575778|NCT05122026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575779|NCT05122026|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102575780|NCT05122026|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102575781|NCT05122026|Leprostatic Agents|leprostatic agents|mesh-ancestor
102575782|NCT02958878|Tamsulosin|tamsulosin|mesh-list
102575783|NCT02958878|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102575784|NCT02958878|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102575785|NCT02958878|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102575786|NCT02958878|Adrenergic Agents|adrenergic agents|mesh-ancestor
102575787|NCT02958878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102575788|NCT02958878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575789|NCT02958878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575790|NCT02958878|Urological Agents|urological agents|mesh-ancestor
102575791|NCT02976116|Gefitinib|gefitinib|mesh-list
102575792|NCT02976116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102575793|NCT02976116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102575794|NCT02976116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102575795|NCT02976116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575796|NCT01600716|Botulinum Toxins|botulinum toxins|mesh-list
102575797|NCT01600716|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102575798|NCT01600716|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102575799|NCT01600716|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102575800|NCT01600716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102575801|NCT01600716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575802|NCT01600716|Cholinergic Agents|cholinergic agents|mesh-ancestor
102575803|NCT01600716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102575804|NCT01600716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575805|NCT01600716|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102575806|NCT01600716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102575807|NCT02975258|Nitric Oxide|nitric oxide|mesh-list
102575808|NCT02975258|Methacholine Chloride|methacholine chloride|mesh-list
102575809|NCT02975258|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102575810|NCT02975258|Autonomic Agents|autonomic agents|mesh-ancestor
102575811|NCT02975258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102575812|NCT02975258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575813|NCT02975258|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102575814|NCT02975258|Respiratory System Agents|respiratory system agents|mesh-ancestor
102575815|NCT02975258|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102575816|NCT02975258|Antioxidants|antioxidants|mesh-ancestor
102575817|NCT02975258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575818|NCT02975258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102575819|NCT02975258|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102575820|NCT02975258|Vasodilator Agents|vasodilator agents|mesh-ancestor
102575821|NCT02975258|Gasotransmitters|gasotransmitters|mesh-ancestor
102575822|NCT02975258|Protective Agents|protective agents|mesh-ancestor
102575823|NCT02975258|Miotics|miotics|mesh-ancestor
102575824|NCT02975258|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102575825|NCT02975258|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
102575826|NCT02975258|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102575827|NCT02975258|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102575828|NCT02975258|Cholinergic Agents|cholinergic agents|mesh-ancestor
102575829|NCT04844814|Prednisone|prednisone|mesh-list
102575830|NCT04844814|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102575831|NCT04844814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102575832|NCT04844814|Glucocorticoids|glucocorticoids|mesh-ancestor
102575833|NCT04844814|Hormones|hormones|mesh-ancestor
102575834|NCT04844814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102575835|NCT04844814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575836|NCT04844814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102575837|NCT04844814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102575838|NCT04844814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102575839|NCT02975102|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102575840|NCT02975102|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102575841|NCT04833114|Carboplatin|carboplatin|mesh-list
102575842|NCT04833114|Etoposide|etoposide|mesh-list
102575843|NCT04833114|Rituximab|rituximab|mesh-list
102575844|NCT04833114|Ifosfamide|ifosfamide|mesh-list
102575845|NCT04833114|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
102575846|NCT04833114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102575847|NCT04833114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102575848|NCT04833114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102575849|NCT04833114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102575850|NCT04833114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102575851|NCT04833114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575852|NCT04833114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102575853|NCT04833114|Immunologic Factors|immunologic factors|mesh-ancestor
102575854|NCT04833114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575855|NCT04833114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102575856|NCT04833114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102575857|NCT04833114|Alkylating Agents|alkylating agents|mesh-ancestor
102575858|NCT04833114|Immunoconjugates|immunoconjugates|mesh-ancestor
102575859|NCT00376883|Pamidronate|pamidronate|mesh-list
102575860|NCT00376883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102575861|NCT00376883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575862|NCT05314673|Bevacizumab|bevacizumab|mesh-list
102575863|NCT05314673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102575864|NCT05314673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102575865|NCT05314673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102575866|NCT05314673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102575867|NCT05314673|Growth Substances|growth substances|mesh-ancestor
102575868|NCT05314673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575869|NCT05314673|Growth Inhibitors|growth inhibitors|mesh-ancestor
102575870|NCT04112069|Insulin Lispro|insulin lispro|mesh-list
102575871|NCT04112069|Insulin Aspart|insulin aspart|mesh-list
102575872|NCT04112069|Pancrelipase|pancrelipase|mesh-list
102575873|NCT04112069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102575874|NCT04112069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575875|NCT04112069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102575876|NCT04098575|Empagliflozin|empagliflozin|mesh-list
102575877|NCT04098575|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102575878|NCT04098575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575879|NCT04098575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102575880|NCT04098575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575881|NCT03776240|Trastuzumab|trastuzumab|mesh-list
102575882|NCT03776240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102575883|NCT03776240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102575884|NCT04832100|Pregabalin|pregabalin|mesh-list
102575885|NCT04832100|Imipramine|imipramine|mesh-list
102575886|NCT04832100|Analgesics|analgesics|mesh-ancestor
102575887|NCT04832100|Sensory System Agents|sensory system agents|mesh-ancestor
102575888|NCT04832100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102575889|NCT04832100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575890|NCT04832100|Anticonvulsants|anticonvulsants|mesh-ancestor
102122821|NCT03311750|Panitumumab|panitumumab|mesh-list
102575891|NCT04832100|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102575892|NCT04832100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102575893|NCT04832100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575894|NCT04832100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102575895|NCT04832100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102575896|NCT04832100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102575897|NCT04832100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102575898|NCT04832100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102575899|NCT04832100|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102575900|NCT04832100|Antidepressive Agents|antidepressive agents|mesh-ancestor
102575901|NCT04832100|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102575902|NCT04832100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102575903|NCT04832100|Adrenergic Agents|adrenergic agents|mesh-ancestor
102575904|NCT04832100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102575905|NCT02976272|Bortezomib|bortezomib|mesh-list
102575906|NCT02976272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102575907|NCT00361790|Aripiprazole|aripiprazole|mesh-list
102575908|NCT00361790|Escitalopram|escitalopram|mesh-list
102575909|NCT00361790|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102575910|NCT00361790|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102575911|NCT00361790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102575912|NCT00361790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575913|NCT00361790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102575914|NCT00361790|Serotonin Agents|serotonin agents|mesh-ancestor
102575915|NCT00361790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575916|NCT00361790|Antidepressive Agents|antidepressive agents|mesh-ancestor
102575917|NCT00361790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102575918|NCT00361790|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102575919|NCT00361790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102575920|NCT00361790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102575921|NCT00361790|Dopamine Agonists|dopamine agonists|mesh-ancestor
102575922|NCT00361790|Dopamine Agents|dopamine agents|mesh-ancestor
102575923|NCT00361790|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102575924|NCT00361790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102575925|NCT00361790|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102575926|NCT00361790|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102575927|NCT00361790|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102575928|NCT00361790|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102575929|NCT04570332|Pembrolizumab|pembrolizumab|mesh-list
102575930|NCT04570332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102575931|NCT04570332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102575932|NCT04570332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102575933|NCT04570332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575934|NCT00361868|Metformin|metformin|mesh-list
102575935|NCT00361868|Rosiglitazone|rosiglitazone|mesh-list
102575936|NCT00361868|Fenofibrate|fenofibrate|mesh-list
102575937|NCT00361868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102575938|NCT00361868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575939|NCT00361868|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102575940|NCT00361868|Antimetabolites|antimetabolites|mesh-ancestor
102575941|NCT00361868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575942|NCT00361868|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102575943|NCT04564872|Linagliptin|linagliptin|mesh-list
102575944|NCT04564872|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102575945|NCT04564872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575946|NCT04564872|Incretins|incretins|mesh-ancestor
102575947|NCT04564872|Hormones|hormones|mesh-ancestor
102575948|NCT04564872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102575949|NCT04564872|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102575950|NCT04564872|Protease Inhibitors|protease inhibitors|mesh-ancestor
102575951|NCT04564872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102575952|NCT04564872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575953|NCT04343144|Nivolumab|nivolumab|mesh-list
102575954|NCT04343144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102575955|NCT04343144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102575956|NCT04343144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102575957|NCT04343144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575958|NCT04075409|Padsevonil|padsevonil|mesh-list
102575959|NCT04075409|Anticonvulsants|anticonvulsants|mesh-ancestor
102575960|NCT03743246|Cyclophosphamide|cyclophosphamide|mesh-list
102575961|NCT03743246|Fludarabine|fludarabine|mesh-list
102575962|NCT03743246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102575963|NCT03743246|Immunologic Factors|immunologic factors|mesh-ancestor
102575964|NCT03743246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575965|NCT03743246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102575966|NCT03743246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102575967|NCT03743246|Alkylating Agents|alkylating agents|mesh-ancestor
102122901|NCT03302390|Lidocaine|lidocaine|mesh-list
102575968|NCT03743246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575969|NCT03743246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102575970|NCT03743246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102575971|NCT03703778|Ascorbic Acid|ascorbic acid|mesh-list
102575972|NCT03703778|Methyltestosterone|methyltestosterone|mesh-list
102575973|NCT03703778|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
102575974|NCT03703778|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
102575975|NCT03703778|Androgens|androgens|mesh-list
102575976|NCT03703778|Hormones|hormones|mesh-ancestor
102575977|NCT03703778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102575978|NCT03703778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575979|NCT03703778|Antioxidants|antioxidants|mesh-ancestor
102575980|NCT03703778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102575981|NCT03703778|Protective Agents|protective agents|mesh-ancestor
102575982|NCT03703778|Vitamins|vitamins|mesh-ancestor
102575983|NCT03703778|Micronutrients|micronutrients|mesh-ancestor
102575984|NCT03703778|Estrogens|estrogens|mesh-ancestor
102575985|NCT03703778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102575986|NCT03703778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102575987|NCT03703778|Anabolic Agents|anabolic agents|mesh-ancestor
102575988|NCT05346666|Midazolam|midazolam|mesh-list
102575989|NCT05346666|Phenobarbital|phenobarbital|mesh-list
102575990|NCT05346666|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102575991|NCT05346666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102575992|NCT05346666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102575993|NCT05346666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102575994|NCT05346666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102575995|NCT05346666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102575996|NCT05346666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102575997|NCT05346666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102575998|NCT05346666|Anesthetics, General|anesthetics, general|mesh-ancestor
102575999|NCT05346666|Anesthetics|anesthetics|mesh-ancestor
102576000|NCT05346666|GABA Modulators|gaba modulators|mesh-ancestor
102576001|NCT05346666|GABA Agents|gaba agents|mesh-ancestor
102576002|NCT05346666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102576003|NCT05346666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576004|NCT05346666|Anticonvulsants|anticonvulsants|mesh-ancestor
102576005|NCT05346666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102576006|NCT05346666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102576007|NCT05346666|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102576008|NCT05346666|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102576009|NCT05346666|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102576010|NCT00361166|Pimavanserin|pimavanserin|mesh-list
102576011|NCT00361166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102576012|NCT00361166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102576013|NCT00361166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102576014|NCT00361166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102576015|NCT00361166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102576016|NCT00361166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576017|NCT00361166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102576018|NCT00361166|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102576019|NCT00361166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102576020|NCT00361166|Serotonin Agents|serotonin agents|mesh-ancestor
102576021|NCT00361166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102576022|NCT00361166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576023|NCT03674294|Dexamethasone|dexamethasone|mesh-list
102576024|NCT03674294|Aprepitant|aprepitant|mesh-list
102576025|NCT03674294|Palonosetron|palonosetron|mesh-list
102576026|NCT03674294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102576027|NCT03674294|Antiemetics|antiemetics|mesh-ancestor
102576028|NCT03674294|Autonomic Agents|autonomic agents|mesh-ancestor
102576029|NCT03674294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102576030|NCT03674294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576031|NCT03674294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102576032|NCT03674294|Glucocorticoids|glucocorticoids|mesh-ancestor
102576033|NCT03674294|Hormones|hormones|mesh-ancestor
102576034|NCT03674294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102576035|NCT03674294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102576036|NCT03674294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102576037|NCT03674294|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102576038|NCT03674294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102576039|NCT03674294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576040|NCT03674294|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102576041|NCT03674294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102576042|NCT03674294|Serotonin Agents|serotonin agents|mesh-ancestor
102576043|NCT00377273|Fluorouracil|fluorouracil|mesh-list
102576044|NCT00377273|Antimetabolites|antimetabolites|mesh-ancestor
102576045|NCT00377273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576046|NCT00377273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102576047|NCT00377273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102576048|NCT00377273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102576049|NCT00377273|Immunologic Factors|immunologic factors|mesh-ancestor
102576050|NCT00377273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576051|NCT03706313|Bupivacaine|bupivacaine|mesh-list
102576052|NCT03706313|Anesthetics, Local|anesthetics, local|mesh-ancestor
102576053|NCT03706313|Anesthetics|anesthetics|mesh-ancestor
102576054|NCT03706313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102576055|NCT03706313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576056|NCT03706313|Sensory System Agents|sensory system agents|mesh-ancestor
102576057|NCT03706313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102576058|NCT05369364|Dexamethasone|dexamethasone|mesh-list
102576059|NCT05369364|Zanubrutinib|zanubrutinib|mesh-list
102576060|NCT05369364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102576061|NCT05369364|Antiemetics|antiemetics|mesh-ancestor
102576062|NCT05369364|Autonomic Agents|autonomic agents|mesh-ancestor
102576063|NCT05369364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102576064|NCT05369364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576065|NCT05369364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102576066|NCT05369364|Glucocorticoids|glucocorticoids|mesh-ancestor
102576067|NCT05369364|Hormones|hormones|mesh-ancestor
102576068|NCT05369364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102576069|NCT05369364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102576070|NCT05369364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102576071|NCT05369364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102576072|NCT05369364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102576073|NCT05369364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576074|NCT00361244|Irinotecan|irinotecan|mesh-list
102576075|NCT00361244|Cetuximab|cetuximab|mesh-list
102576076|NCT00361244|Sunitinib|sunitinib|mesh-list
102576077|NCT00361244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102576078|NCT00361244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102576079|NCT00361244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102576080|NCT00361244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576081|NCT00361244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102576082|NCT00361244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102576083|NCT00361244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102576084|NCT00361244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102576085|NCT00361244|Growth Substances|growth substances|mesh-ancestor
102576086|NCT00361244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576087|NCT00361244|Growth Inhibitors|growth inhibitors|mesh-ancestor
102576088|NCT00361244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102576089|NCT03381482|Anesthetics|anesthetics|mesh-list
102576090|NCT03381482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102576091|NCT03381482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576092|NCT03545165|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102576093|NCT03545165|177Lu-PSMA-617|177lu-psma-617|mesh-list
102576094|NCT03545165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102576095|NCT03545165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576096|NCT04968522|Methylphenidate|methylphenidate|mesh-list
102576097|NCT04968522|Dextroamphetamine|dextroamphetamine|mesh-list
102576098|NCT04968522|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102576099|NCT04968522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576100|NCT04968522|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102576101|NCT04968522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102576102|NCT04968522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102576103|NCT04968522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576104|NCT04968522|Dopamine Agents|dopamine agents|mesh-ancestor
102576105|NCT04968522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102576106|NCT00361322|Clindamycin|clindamycin|mesh-list
102576107|NCT00361322|Clindamycin palmitate|clindamycin palmitate|mesh-list
102576108|NCT00361322|Clindamycin phosphate|clindamycin phosphate|mesh-list
102576109|NCT00361322|Salicylic Acid|salicylic acid|mesh-list
102576110|NCT00361322|Salicylates|salicylates|mesh-list
102576111|NCT00361322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102576112|NCT00361322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102576113|NCT00361322|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102576114|NCT00361322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102576115|NCT00361322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576116|NCT00361322|Antifungal Agents|antifungal agents|mesh-ancestor
102576117|NCT00361322|Keratolytic Agents|keratolytic agents|mesh-ancestor
102576118|NCT00361322|Dermatologic Agents|dermatologic agents|mesh-ancestor
102576119|NCT00361322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102576120|NCT00361322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102576121|NCT00361322|Analgesics|analgesics|mesh-ancestor
102576122|NCT00361322|Sensory System Agents|sensory system agents|mesh-ancestor
102576123|NCT00361322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102576124|NCT00361322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576125|NCT00361322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102576126|NCT00361322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102576127|NCT00361322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102576128|NCT02974712|Fentanyl|fentanyl|mesh-list
102576129|NCT02974712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102576130|NCT02974712|Narcotics|narcotics|mesh-ancestor
102576131|NCT02974712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102576132|NCT02974712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576133|NCT02974712|Analgesics|analgesics|mesh-ancestor
102576134|NCT02974712|Sensory System Agents|sensory system agents|mesh-ancestor
102576135|NCT02974712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102576136|NCT02974712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102576137|NCT02974712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102576138|NCT02974712|Anesthetics, General|anesthetics, general|mesh-ancestor
102576139|NCT02974712|Anesthetics|anesthetics|mesh-ancestor
102576140|NCT02974556|Capecitabine|capecitabine|mesh-list
102576141|NCT02974556|Oxaliplatin|oxaliplatin|mesh-list
102576142|NCT02974556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102576143|NCT02974556|Antimetabolites|antimetabolites|mesh-ancestor
102576144|NCT02974556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576145|NCT02974556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102576146|NCT04523142|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102576147|NCT04523142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102576148|NCT03557333|Dihydroergotamine|dihydroergotamine|mesh-list
102576149|NCT03557333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102576150|NCT03557333|Dopamine Agonists|dopamine agonists|mesh-ancestor
102576151|NCT03557333|Dopamine Agents|dopamine agents|mesh-ancestor
102576152|NCT03557333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102576153|NCT03557333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576154|NCT03557333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576155|NCT03557333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102576156|NCT03557333|Analgesics|analgesics|mesh-ancestor
102576157|NCT03557333|Sensory System Agents|sensory system agents|mesh-ancestor
102576158|NCT03557333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102576159|NCT04957368|Midazolam|midazolam|mesh-list
102576160|NCT04957368|Nitrous Oxide|nitrous oxide|mesh-list
102576161|NCT04957368|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102576162|NCT04957368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102576163|NCT04957368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102576164|NCT04957368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576165|NCT04957368|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102576166|NCT04957368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102576167|NCT04957368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102576168|NCT04957368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102576169|NCT04957368|Anesthetics, General|anesthetics, general|mesh-ancestor
102576170|NCT04957368|Anesthetics|anesthetics|mesh-ancestor
102576171|NCT04957368|GABA Modulators|gaba modulators|mesh-ancestor
102576172|NCT04957368|GABA Agents|gaba agents|mesh-ancestor
102576173|NCT04957368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102576174|NCT04957368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576175|NCT04957368|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102576176|NCT04957368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102576177|NCT04957368|Analgesics|analgesics|mesh-ancestor
102576178|NCT04957368|Sensory System Agents|sensory system agents|mesh-ancestor
102576179|NCT04957368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102576180|NCT04818450|Gabapentin|gabapentin|mesh-list
102576181|NCT04818450|Analgesics|analgesics|mesh-ancestor
102576182|NCT04818450|Sensory System Agents|sensory system agents|mesh-ancestor
102576183|NCT04818450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102576184|NCT04818450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576185|NCT04818450|Anticonvulsants|anticonvulsants|mesh-ancestor
102576186|NCT04818450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102576187|NCT04818450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102576188|NCT04818450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102576189|NCT04818450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102576190|NCT04818450|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102576191|NCT04818450|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102576192|NCT04818450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102576193|NCT04818450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576194|NCT04818450|Antimanic Agents|antimanic agents|mesh-ancestor
102576195|NCT04841148|Hydroxychloroquine|hydroxychloroquine|mesh-list
102576196|NCT04841148|Palbociclib|palbociclib|mesh-list
102576197|NCT04841148|Avelumab|avelumab|mesh-list
102576198|NCT04841148|Antimalarials|antimalarials|mesh-ancestor
102576199|NCT04841148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102576200|NCT04841148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102576201|NCT04841148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102576202|NCT04841148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102576203|NCT04841148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576204|NCT04841148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102576205|NCT04841148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102576206|NCT04841148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102576207|NCT04841148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102576208|NCT04829760|Psyllium|psyllium|mesh-list
102576209|NCT04829760|Cathartics|cathartics|mesh-ancestor
102576210|NCT04829760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102576211|NCT05289804|Lidocaine|lidocaine|mesh-list
102576212|NCT05289804|Anesthetics, Local|anesthetics, local|mesh-list
102576213|NCT05289804|Prilocaine|prilocaine|mesh-list
102576214|NCT05289804|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
102576215|NCT05289804|Anesthetics|anesthetics|mesh-list
102576216|NCT05289804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102576217|NCT05289804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576218|NCT05289804|Sensory System Agents|sensory system agents|mesh-ancestor
102576219|NCT05289804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102576220|NCT05289804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102576221|NCT05289804|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102576222|NCT05289804|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102576223|NCT05289804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102576224|NCT05289804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576225|NCT05289804|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
102576226|NCT05448872|Valsartan|valsartan|mesh-list
102576227|NCT05448872|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102576228|NCT05448872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102576229|NCT05448872|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102576230|NCT05448872|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102576231|NCT05448872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576232|NCT04817826|Durvalumab|durvalumab|mesh-list
102576233|NCT04817826|Tremelimumab|tremelimumab|mesh-list
102576234|NCT04817826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102576235|NCT04817826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102576236|NCT00362258|Irbesartan|irbesartan|mesh-list
102576237|NCT00362258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102576238|NCT00362258|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102576239|NCT00362258|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102576240|NCT00362258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576241|NCT00362726|Rosiglitazone|rosiglitazone|mesh-list
102576242|NCT00362726|Ritonavir|ritonavir|mesh-list
102576243|NCT00362726|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102576244|NCT00362726|Maleic acid|maleic acid|mesh-list
102576245|NCT00362726|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102576246|NCT00362726|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102576247|NCT00362726|Protease Inhibitors|protease inhibitors|mesh-ancestor
102576248|NCT00362726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102576249|NCT00362726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576250|NCT00362726|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102576251|NCT00362726|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102576252|NCT00362726|Antiviral Agents|antiviral agents|mesh-ancestor
102576253|NCT00362726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102576254|NCT00362726|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102576255|NCT00362726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102576256|NCT00362726|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102576257|NCT00362726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576258|NCT04474470|Cetuximab|cetuximab|mesh-list
102576259|NCT04474470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102576260|NCT04474470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102576261|NCT05330754|Caffeine|caffeine|mesh-list
102576262|NCT05330754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102576263|NCT05330754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576264|NCT05330754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102576265|NCT05330754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102638130|NCT00716586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102576266|NCT05330754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576267|NCT05330754|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102576268|NCT05330754|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102576269|NCT05330754|Purinergic Agents|purinergic agents|mesh-ancestor
102576270|NCT05330754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102576271|NCT02271932|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102576272|NCT02271932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102576273|NCT04448184|Tranexamic Acid|tranexamic acid|mesh-list
102576274|NCT04448184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102576275|NCT04448184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102576276|NCT04448184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576277|NCT04448184|Hemostatics|hemostatics|mesh-ancestor
102576278|NCT04448184|Coagulants|coagulants|mesh-ancestor
102576279|NCT04426968|Interferons|interferons|mesh-list
102576280|NCT04426968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102576281|NCT04426968|Antiviral Agents|antiviral agents|mesh-ancestor
102576282|NCT04426968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102576283|NCT04887948|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102576284|NCT04887948|Immunologic Factors|immunologic factors|mesh-ancestor
102576285|NCT04887948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576286|NCT03829488|Plasma-lyte 148|plasma-lyte 148|mesh-list
102576287|NCT03829488|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102576288|NCT03829488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102576289|NCT04049123|Insulin Lispro|insulin lispro|mesh-list
102576290|NCT04049123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102576291|NCT04049123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576292|NCT04051463|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102576293|NCT04051463|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102576294|NCT04184297|Tiotropium Bromide|tiotropium bromide|mesh-list
102576296|NCT04184297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102576297|NCT04184297|Autonomic Agents|autonomic agents|mesh-ancestor
102576298|NCT04184297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102576299|NCT04184297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576300|NCT04184297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102576301|NCT04184297|Respiratory System Agents|respiratory system agents|mesh-ancestor
102576302|NCT04184297|Parasympatholytics|parasympatholytics|mesh-ancestor
102576303|NCT04184297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102576304|NCT04184297|Cholinergic Agents|cholinergic agents|mesh-ancestor
102576305|NCT04184297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102576306|NCT04184297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576307|NCT04031885|Paclitaxel|paclitaxel|mesh-list
102576308|NCT04031885|Docetaxel|docetaxel|mesh-list
102576309|NCT04031885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102576310|NCT04031885|Capecitabine|capecitabine|mesh-list
102576311|NCT04031885|Fulvestrant|fulvestrant|mesh-list
102576312|NCT04031885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102576313|NCT04031885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102576314|NCT04031885|Tubulin Modulators|tubulin modulators|mesh-ancestor
102576315|NCT04031885|Antimitotic Agents|antimitotic agents|mesh-ancestor
102576316|NCT04031885|Mitosis Modulators|mitosis modulators|mesh-ancestor
102576317|NCT04031885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576318|NCT04031885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102576319|NCT04031885|Antimetabolites|antimetabolites|mesh-ancestor
102576320|NCT04031885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102576321|NCT04031885|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102576322|NCT04031885|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102576323|NCT04031885|Hormone Antagonists|hormone antagonists|mesh-ancestor
102576324|NCT04031885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102576325|NCT04031885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576326|NCT01638000|Solifenacin Succinate|solifenacin succinate|mesh-list
102576327|NCT01638000|Mirabegron|mirabegron|mesh-list
102576328|NCT01638000|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102576329|NCT01638000|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102576330|NCT01638000|Cholinergic Agents|cholinergic agents|mesh-ancestor
102576331|NCT01638000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102576332|NCT01638000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576333|NCT01638000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576334|NCT01638000|Urological Agents|urological agents|mesh-ancestor
102576335|NCT01638000|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102576336|NCT01638000|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102576337|NCT01638000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102576338|NCT01638000|Adrenergic Agents|adrenergic agents|mesh-ancestor
102576339|NCT04023695|Lidocaine|lidocaine|mesh-list
102576340|NCT04023695|Epinephrine|epinephrine|mesh-list
102576341|NCT04023695|Anesthetics, Local|anesthetics, local|mesh-ancestor
102576342|NCT04023695|Anesthetics|anesthetics|mesh-ancestor
102576343|NCT04023695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102576344|NCT04023695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576345|NCT04023695|Sensory System Agents|sensory system agents|mesh-ancestor
102576346|NCT04023695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102576347|NCT04023695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102576348|NCT04023695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102576349|NCT04023695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102576350|NCT04023695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102576351|NCT04023695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576352|NCT04023695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102576353|NCT04023695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102576354|NCT04023695|Adrenergic Agents|adrenergic agents|mesh-ancestor
102576355|NCT04023695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102576356|NCT04023695|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102576357|NCT04023695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102576358|NCT04023695|Autonomic Agents|autonomic agents|mesh-ancestor
102576359|NCT04023695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102576360|NCT04023695|Respiratory System Agents|respiratory system agents|mesh-ancestor
102576361|NCT04023695|Mydriatics|mydriatics|mesh-ancestor
102576362|NCT04023695|Sympathomimetics|sympathomimetics|mesh-ancestor
102576363|NCT04023695|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102576364|NCT04211909|Sofosbuvir|sofosbuvir|mesh-list
102576365|NCT04211909|Velpatasvir|velpatasvir|mesh-list
102576366|NCT04211909|Antiviral Agents|antiviral agents|mesh-ancestor
102576367|NCT04211909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102576368|NCT04223843|Tiotropium Bromide|tiotropium bromide|mesh-list
102576369|NCT04223843|Olodaterol|olodaterol|mesh-list
102576370|NCT04223843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102576371|NCT04223843|Autonomic Agents|autonomic agents|mesh-ancestor
102576372|NCT04223843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102576373|NCT04223843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576374|NCT04223843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102576375|NCT04223843|Respiratory System Agents|respiratory system agents|mesh-ancestor
102576376|NCT04223843|Parasympatholytics|parasympatholytics|mesh-ancestor
102576377|NCT04223843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102576378|NCT04223843|Cholinergic Agents|cholinergic agents|mesh-ancestor
102576379|NCT04223843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102576380|NCT04223843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576381|NCT05722951|Metformin|metformin|mesh-list
102576382|NCT05722951|Levetiracetam|levetiracetam|mesh-list
102576383|NCT05722951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102576384|NCT05722951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576385|NCT05722951|Anticonvulsants|anticonvulsants|mesh-ancestor
102576386|NCT05722951|Nootropic Agents|nootropic agents|mesh-ancestor
102576387|NCT04838652|Pembrolizumab|pembrolizumab|mesh-list
102576388|NCT04838652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102576389|NCT04838652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102576390|NCT04838652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102576391|NCT04838652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576392|NCT05722795|Imatinib Mesylate|imatinib mesylate|mesh-list
102576393|NCT05722795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102576394|NCT05722795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102576395|NCT05722795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102576396|NCT05722795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576397|NCT03778554|Metoprolol|metoprolol|mesh-list
102576398|NCT03778554|Carvedilol|carvedilol|mesh-list
102576399|NCT03778554|Nebivolol|nebivolol|mesh-list
102576400|NCT03778554|Bisoprolol|bisoprolol|mesh-list
102576401|NCT03778554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102576402|NCT03778554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102576403|NCT03778554|Sympatholytics|sympatholytics|mesh-ancestor
102576404|NCT03778554|Autonomic Agents|autonomic agents|mesh-ancestor
102576405|NCT03778554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102576406|NCT03778554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576407|NCT03778554|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102576408|NCT03778554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102576409|NCT03778554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102576410|NCT03778554|Adrenergic Agents|adrenergic agents|mesh-ancestor
102576411|NCT03778554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102576412|NCT03778554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576413|NCT03778554|Antioxidants|antioxidants|mesh-ancestor
102576414|NCT03778554|Protective Agents|protective agents|mesh-ancestor
102576415|NCT03778554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102576416|NCT03778554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102576417|NCT03778554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102576418|NCT03778554|Vasodilator Agents|vasodilator agents|mesh-ancestor
102576419|NCT03778554|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102576420|NCT03778554|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102576421|NCT03778554|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102576422|NCT03778554|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102576423|NCT03778554|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102576424|NCT04810494|Lidocaine|lidocaine|mesh-list
102576425|NCT04810494|Anesthetics, Local|anesthetics, local|mesh-ancestor
102576426|NCT04810494|Anesthetics|anesthetics|mesh-ancestor
102576427|NCT04810494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102576428|NCT04810494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576429|NCT04810494|Sensory System Agents|sensory system agents|mesh-ancestor
102576430|NCT04810494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102576431|NCT04810494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102576432|NCT04810494|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102576433|NCT04810494|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102576434|NCT04810494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102576435|NCT04810494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576436|NCT05722405|Lenalidomide|lenalidomide|mesh-list
102576437|NCT05722405|Ixazomib|ixazomib|mesh-list
102576438|NCT05722405|Glycine|glycine|mesh-list
102576439|NCT05722405|Immunologic Factors|immunologic factors|mesh-ancestor
102576440|NCT05722405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576441|NCT05722405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102576442|NCT05722405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102576443|NCT05722405|Growth Substances|growth substances|mesh-ancestor
102576444|NCT05722405|Growth Inhibitors|growth inhibitors|mesh-ancestor
102576445|NCT05722405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102576446|NCT05722405|Protease Inhibitors|protease inhibitors|mesh-ancestor
102576447|NCT05722405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102576448|NCT05722405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576449|NCT05722405|Glycine Agents|glycine agents|mesh-ancestor
102576450|NCT05722405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102576451|NCT04259658|Calcium|calcium|mesh-list
102576452|NCT04259658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102576453|NCT04259658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576454|NCT02767531|Orlistat|orlistat|mesh-list
102576455|NCT02767531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102576456|NCT02767531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576457|NCT02767531|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102576458|NCT02767531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102576459|NCT04419246|Tranexamic Acid|tranexamic acid|mesh-list
102576460|NCT04419246|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102576461|NCT04419246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102576462|NCT04419246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576463|NCT04419246|Hemostatics|hemostatics|mesh-ancestor
102576464|NCT04419246|Coagulants|coagulants|mesh-ancestor
102576465|NCT02521753|Metformin|metformin|mesh-list
102576466|NCT02521753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102576467|NCT02521753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576468|NCT04229303|Voriconazole|voriconazole|mesh-list
102576469|NCT04229303|Antifungal Agents|antifungal agents|mesh-ancestor
102576470|NCT04229303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102576471|NCT04229303|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102576472|NCT04229303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102576473|NCT04229303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102576474|NCT04229303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576475|NCT04229303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102576476|NCT04229303|Hormone Antagonists|hormone antagonists|mesh-ancestor
102576477|NCT04229303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102576478|NCT04229303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576479|NCT04229303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102576480|NCT05263986|Adagrasib|adagrasib|mesh-list
102576481|NCT05263986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102576482|NCT00357643|Vitamin D|vitamin d|mesh-list
102576483|NCT00357643|Calcium|calcium|mesh-list
102576484|NCT00357643|Vitamins|vitamins|mesh-ancestor
102576485|NCT00357643|Micronutrients|micronutrients|mesh-ancestor
102576486|NCT00357643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576487|NCT00357643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102576488|NCT00357643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102576489|NCT05395494|Cycloserine|cycloserine|mesh-list
102576490|NCT05395494|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102576491|NCT05395494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102576492|NCT05395494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102576493|NCT05395494|Antitubercular Agents|antitubercular agents|mesh-ancestor
102576494|NCT05395494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102576495|NCT05395494|Antimetabolites|antimetabolites|mesh-ancestor
102576496|NCT05395494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576497|NCT00357721|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102576498|NCT00357721|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102576499|NCT00357721|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102576500|NCT00357721|Protease Inhibitors|protease inhibitors|mesh-ancestor
102576501|NCT00357721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102576502|NCT00357721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576503|NCT00357721|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102576504|NCT00357721|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102576505|NCT00357721|Antiviral Agents|antiviral agents|mesh-ancestor
102576506|NCT00357721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102576507|NCT03504410|Cytarabine|cytarabine|mesh-list
102576508|NCT03504410|Fludarabine|fludarabine|mesh-list
102576509|NCT03504410|Etoposide|etoposide|mesh-list
102576510|NCT03504410|Mitoxantrone|mitoxantrone|mesh-list
102576511|NCT03504410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102576512|NCT03504410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102576513|NCT03504410|Antimetabolites|antimetabolites|mesh-ancestor
102576514|NCT03504410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576515|NCT03504410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102576516|NCT03504410|Immunologic Factors|immunologic factors|mesh-ancestor
102576517|NCT03504410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576518|NCT03504410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102576519|NCT03504410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102576520|NCT03504410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102576521|NCT03504410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102576522|NCT03504410|Antiviral Agents|antiviral agents|mesh-ancestor
102576523|NCT03504410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102576524|NCT03504410|Analgesics|analgesics|mesh-ancestor
102576525|NCT03504410|Sensory System Agents|sensory system agents|mesh-ancestor
102576526|NCT03504410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102576527|NCT02464969|Apixaban|apixaban|mesh-list
102576528|NCT02464969|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102576529|NCT02464969|Antithrombins|antithrombins|mesh-ancestor
102576530|NCT02464969|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102576531|NCT02464969|Protease Inhibitors|protease inhibitors|mesh-ancestor
102576532|NCT02464969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102576533|NCT02464969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576534|NCT02464969|Anticoagulants|anticoagulants|mesh-ancestor
102576535|NCT05392530|Macitentan|macitentan|mesh-list
102576536|NCT05392530|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
102576537|NCT05392530|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102576538|NCT05392530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576539|NCT05392530|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
102576540|NCT03498014|Analgesics, Opioid|analgesics, opioid|mesh-list
102576541|NCT03498014|Narcotics|narcotics|mesh-ancestor
102576542|NCT03498014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102576543|NCT03498014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576544|NCT03498014|Analgesics|analgesics|mesh-ancestor
102576545|NCT03498014|Sensory System Agents|sensory system agents|mesh-ancestor
102576546|NCT03498014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102576547|NCT02460133|Ritonavir|ritonavir|mesh-list
102576548|NCT02460133|Ribavirin|ribavirin|mesh-list
102576549|NCT02460133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102576550|NCT02460133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102576551|NCT02460133|Protease Inhibitors|protease inhibitors|mesh-ancestor
102576552|NCT02460133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102576553|NCT02460133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576554|NCT02460133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102576555|NCT02460133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102576556|NCT02460133|Antiviral Agents|antiviral agents|mesh-ancestor
102576557|NCT02460133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102576558|NCT02460133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102576559|NCT02460133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102576560|NCT02460133|Antimetabolites|antimetabolites|mesh-ancestor
102576561|NCT02220452|Anesthetics|anesthetics|mesh-list
102576562|NCT02220452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102576563|NCT02220452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576564|NCT04256603|Gabapentin|gabapentin|mesh-list
102576565|NCT04256603|Analgesics|analgesics|mesh-ancestor
102123500|NCT00709956|Iloprost|iloprost|mesh-list
102576566|NCT04256603|Sensory System Agents|sensory system agents|mesh-ancestor
102576567|NCT04256603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102576568|NCT04256603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576570|NCT04256603|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102576571|NCT04256603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102576572|NCT04256603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102576573|NCT04256603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102576574|NCT04256603|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102576575|NCT04256603|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102576576|NCT04256603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102576577|NCT04256603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576578|NCT04256603|Antimanic Agents|antimanic agents|mesh-ancestor
102576579|NCT05721079|Methoxsalen|methoxsalen|mesh-list
102576580|NCT05721079|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102576581|NCT05721079|Dermatologic Agents|dermatologic agents|mesh-ancestor
102576582|NCT00362570|Temozolomide|temozolomide|mesh-list
102576583|NCT00362570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102576584|NCT00362570|Alkylating Agents|alkylating agents|mesh-ancestor
102576585|NCT00362570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576586|NCT00362570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102576587|NCT00357253|Capecitabine|capecitabine|mesh-list
102576588|NCT00357253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102576589|NCT00357253|Antimetabolites|antimetabolites|mesh-ancestor
102576590|NCT00357253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576591|NCT00357253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102576592|NCT02386735|Prednisone|prednisone|mesh-list
102576593|NCT02386735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102576594|NCT02386735|Glucocorticoids|glucocorticoids|mesh-ancestor
102576595|NCT02386735|Hormones|hormones|mesh-ancestor
102576596|NCT02386735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102576597|NCT02386735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576598|NCT02386735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102576599|NCT02386735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102576600|NCT02068430|Riboflavin|riboflavin|mesh-list
102576601|NCT02068430|Vitamin B Complex|vitamin b complex|mesh-ancestor
102576602|NCT02068430|Vitamins|vitamins|mesh-ancestor
102576603|NCT02068430|Micronutrients|micronutrients|mesh-ancestor
102576604|NCT02068430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576605|NCT02068430|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102576606|NCT02068430|Dermatologic Agents|dermatologic agents|mesh-ancestor
102576607|NCT03138512|Nivolumab|nivolumab|mesh-list
102576608|NCT03138512|Ipilimumab|ipilimumab|mesh-list
102576609|NCT03138512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102576610|NCT03138512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102576611|NCT03138512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102576612|NCT03138512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576613|NCT03127592|Etodolac|etodolac|mesh-list
102576614|NCT03127592|Cyclobenzaprine|cyclobenzaprine|mesh-list
102576615|NCT03127592|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102576616|NCT03127592|Antidepressive Agents|antidepressive agents|mesh-ancestor
102576617|NCT03127592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102576618|NCT03127592|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102576619|NCT03127592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576620|NCT03127592|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102576621|NCT03127592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102576622|NCT03127592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102576623|NCT03127592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102576624|NCT03127592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102576625|NCT03127592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102576626|NCT03127592|Analgesics|analgesics|mesh-ancestor
102576627|NCT03127592|Sensory System Agents|sensory system agents|mesh-ancestor
102576628|NCT03127592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102576629|NCT03127592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102576630|NCT03127592|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102576631|NCT03127592|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102576632|NCT03127592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102576633|NCT03127592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576634|NCT02444234|Tedizolid|tedizolid|mesh-list
102576635|NCT02444234|Oxazolidinones|oxazolidinones|mesh-list
102576636|NCT02444234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102576637|NCT02444234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102576638|NCT02444234|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102576639|NCT02444234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102576640|NCT02444234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576641|NCT02444936|Vaccines|vaccines|mesh-list
102576642|NCT02444936|Immunologic Factors|immunologic factors|mesh-ancestor
102576643|NCT02444936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576644|NCT02445326|Dexamethasone|dexamethasone|mesh-list
102576645|NCT02445326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102576646|NCT02445326|Antiemetics|antiemetics|mesh-ancestor
102576647|NCT02445326|Autonomic Agents|autonomic agents|mesh-ancestor
102576648|NCT02445326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102576649|NCT02445326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576650|NCT02445326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102576651|NCT02445326|Glucocorticoids|glucocorticoids|mesh-ancestor
102576652|NCT02445326|Hormones|hormones|mesh-ancestor
102576653|NCT02445326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102576654|NCT02445326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102576655|NCT02445326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102576656|NCT04344457|Hydroxychloroquine|hydroxychloroquine|mesh-list
102576657|NCT04344457|Azithromycin|azithromycin|mesh-list
102576658|NCT04344457|Indomethacin|indomethacin|mesh-list
102576659|NCT04344457|Antimalarials|antimalarials|mesh-ancestor
102576660|NCT04344457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102576661|NCT04344457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102576662|NCT04344457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102576663|NCT04344457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102576664|NCT04344457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576665|NCT04344457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102576666|NCT04344457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102576667|NCT04344457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102576668|NCT04344457|Analgesics|analgesics|mesh-ancestor
102576669|NCT04344457|Sensory System Agents|sensory system agents|mesh-ancestor
102576670|NCT04344457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102576671|NCT04344457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576672|NCT04344457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102576673|NCT04344457|Gout Suppressants|gout suppressants|mesh-ancestor
102576674|NCT04344457|Tocolytic Agents|tocolytic agents|mesh-ancestor
102576675|NCT04344457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102576676|NCT04344457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102576677|NCT04344457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102576678|NCT05720533|Disitamab vedotin|disitamab vedotin|mesh-list
102576679|NCT05720533|Immunoconjugates|immunoconjugates|mesh-ancestor
102576680|NCT05720533|Immunologic Factors|immunologic factors|mesh-ancestor
102576681|NCT05720533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576682|NCT02446496|Cefadroxil|cefadroxil|mesh-list
102576683|NCT02446496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102576684|NCT02446496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102576685|NCT00355693|Propofol|propofol|mesh-list
102576686|NCT00355693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102576687|NCT00355693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102576688|NCT00355693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576689|NCT00355693|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102576690|NCT00355693|Anesthetics, General|anesthetics, general|mesh-ancestor
102576691|NCT00355693|Anesthetics|anesthetics|mesh-ancestor
102576692|NCT02448368|Verinurad|verinurad|mesh-list
102576693|NCT02448368|Gout Suppressants|gout suppressants|mesh-ancestor
102576694|NCT02448368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102576695|NCT02448914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102576696|NCT02448914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102576697|NCT02448914|Immunologic Factors|immunologic factors|mesh-ancestor
102576698|NCT02448914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576699|NCT02448914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102576700|NCT02448914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102576701|NCT02448914|Dopamine Agonists|dopamine agonists|mesh-ancestor
102576702|NCT02448914|Dopamine Agents|dopamine agents|mesh-ancestor
102576703|NCT02448914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102576704|NCT02448914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576705|NCT03496662|Paclitaxel|paclitaxel|mesh-list
102576706|NCT03496662|Gemcitabine|gemcitabine|mesh-list
102576707|NCT03496662|Nivolumab|nivolumab|mesh-list
102576708|NCT03496662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102576709|NCT03496662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102576710|NCT03496662|Tubulin Modulators|tubulin modulators|mesh-ancestor
102576711|NCT03496662|Antimitotic Agents|antimitotic agents|mesh-ancestor
102576712|NCT03496662|Mitosis Modulators|mitosis modulators|mesh-ancestor
102576713|NCT03496662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576714|NCT03496662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102123640|NCT04506138|Antimitotic Agents|antimitotic agents|mesh-ancestor
102576716|NCT03496662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102576717|NCT03496662|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102576718|NCT05002309|Antidepressive Agents|antidepressive agents|mesh-list
102576719|NCT05002309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102576720|NCT05720065|Botulinum Toxins|botulinum toxins|mesh-list
102576721|NCT05720065|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102576722|NCT05720065|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102576723|NCT05720065|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102576724|NCT05720065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102576725|NCT05720065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576726|NCT05720065|Cholinergic Agents|cholinergic agents|mesh-ancestor
102576727|NCT05720065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102576728|NCT05720065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576729|NCT05720065|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102576730|NCT05720065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102576731|NCT05719831|Amoxicillin|amoxicillin|mesh-list
102576732|NCT05719831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102576733|NCT05719831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102576734|NCT01152541|Riboflavin|riboflavin|mesh-list
102576735|NCT01152541|Dextrans|dextrans|mesh-list
102576736|NCT01152541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102576737|NCT01152541|Vitamin B Complex|vitamin b complex|mesh-ancestor
102576738|NCT01152541|Vitamins|vitamins|mesh-ancestor
102576739|NCT01152541|Micronutrients|micronutrients|mesh-ancestor
102576740|NCT01152541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576741|NCT01152541|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102576742|NCT01152541|Dermatologic Agents|dermatologic agents|mesh-ancestor
102576743|NCT01152541|Anticoagulants|anticoagulants|mesh-ancestor
102576744|NCT01152541|Plasma Substitutes|plasma substitutes|mesh-ancestor
102576745|NCT01152541|Blood Substitutes|blood substitutes|mesh-ancestor
102576746|NCT01638546|Temozolomide|temozolomide|mesh-list
102576747|NCT01638546|Veliparib|veliparib|mesh-list
102576748|NCT01638546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102576749|NCT01638546|Alkylating Agents|alkylating agents|mesh-ancestor
102576750|NCT01638546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576751|NCT01638546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102576752|NCT01638546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102576753|NCT01638546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102576754|NCT04948489|Norethindrone|norethindrone|mesh-list
102576755|NCT04948489|Norethindrone Acetate|norethindrone acetate|mesh-list
102576756|NCT04948489|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102576757|NCT04948489|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102576758|NCT04948489|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102576759|NCT04948489|Contraceptive Agents|contraceptive agents|mesh-ancestor
102576760|NCT04948489|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102576761|NCT04948489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576762|NCT04948489|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102576763|NCT04948489|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102576764|NCT05723341|Morphine|morphine|mesh-list
102576765|NCT05723341|Bupivacaine|bupivacaine|mesh-list
102576766|NCT05723341|Anesthetics, Local|anesthetics, local|mesh-ancestor
102576767|NCT05723341|Anesthetics|anesthetics|mesh-ancestor
102576768|NCT05723341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102576769|NCT05723341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576770|NCT05723341|Sensory System Agents|sensory system agents|mesh-ancestor
102576771|NCT05723341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102576772|NCT05723341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102576773|NCT05723341|Narcotics|narcotics|mesh-ancestor
102576774|NCT05723341|Analgesics|analgesics|mesh-ancestor
102576775|NCT05718583|Butyric Acid|butyric acid|mesh-list
102576776|NCT05718583|Histamine Antagonists|histamine antagonists|mesh-ancestor
102576777|NCT05718583|Histamine Agents|histamine agents|mesh-ancestor
102576778|NCT05718583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102576779|NCT05718583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576780|NCT05718583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576781|NCT00363350|Rituximab|rituximab|mesh-list
102576782|NCT00363350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102576783|NCT00363350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102576784|NCT00363350|Immunologic Factors|immunologic factors|mesh-ancestor
102576785|NCT00363350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576786|NCT00363350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102576787|NCT05717335|Thrombin|thrombin|mesh-list
102576788|NCT05717335|Hemostatics|hemostatics|mesh-ancestor
102123720|NCT01220271|Temozolomide|temozolomide|mesh-list
102576789|NCT05717335|Coagulants|coagulants|mesh-ancestor
102576790|NCT05717257|Dapagliflozin|dapagliflozin|mesh-list
102576791|NCT05717257|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102576792|NCT05717257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576793|NCT05717257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102576794|NCT05717257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576796|NCT04341818|Ergocalciferols|ergocalciferols|mesh-list
102576797|NCT04341818|Cholecalciferol|cholecalciferol|mesh-list
102576798|NCT04341818|Vitamins|vitamins|mesh-list
102576799|NCT04341818|Micronutrients|micronutrients|mesh-ancestor
102576800|NCT04341818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576801|NCT04341818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102576802|NCT04341818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102576803|NCT00362804|Tetrabenazine|tetrabenazine|mesh-list
102576804|NCT00362804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102576805|NCT00362804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102576806|NCT00362804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102576807|NCT00362804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576808|NCT00362804|Adrenergic Agents|adrenergic agents|mesh-ancestor
102576809|NCT00362804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102576810|NCT00362804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576811|NCT02451488|Sargramostim|sargramostim|mesh-list
102576812|NCT02451488|Immunologic Factors|immunologic factors|mesh-ancestor
102576813|NCT02451488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576814|NCT03172494|Insulin|insulin|mesh-list
102576815|NCT03172494|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102576816|NCT03172494|Liraglutide|liraglutide|mesh-list
102576817|NCT03172494|Insulin, Long-Acting|insulin, long-acting|mesh-list
102576818|NCT03172494|Xultophy|xultophy|mesh-list
102576819|NCT03172494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102576820|NCT03172494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576821|NCT03172494|Incretins|incretins|mesh-ancestor
102576822|NCT03172494|Hormones|hormones|mesh-ancestor
102576823|NCT03172494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102576824|NCT02452346|Tosedostat|tosedostat|mesh-list
102576825|NCT02452346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102576826|NCT02452346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576827|NCT02959255|Esomeprazole|esomeprazole|mesh-list
102576828|NCT02959255|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102576829|NCT02959255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102576830|NCT02959255|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102576831|NCT02959255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102576832|NCT02959255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576833|NCT05716945|Fluorometholone|fluorometholone|mesh-list
102576834|NCT05716945|Dexamethasone|dexamethasone|mesh-list
102576835|NCT05716945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102576836|NCT05716945|Antiemetics|antiemetics|mesh-ancestor
102576837|NCT05716945|Autonomic Agents|autonomic agents|mesh-ancestor
102576838|NCT05716945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102576839|NCT05716945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576840|NCT05716945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102576841|NCT05716945|Glucocorticoids|glucocorticoids|mesh-ancestor
102576842|NCT05716945|Hormones|hormones|mesh-ancestor
102576843|NCT05716945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102576844|NCT05716945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102576845|NCT05716945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102576846|NCT05716945|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102576847|NCT03012620|Pembrolizumab|pembrolizumab|mesh-list
102576848|NCT03012620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102576849|NCT03012620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102576850|NCT03012620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102576851|NCT03012620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576852|NCT05716867|Cystatins|cystatins|mesh-list
102576853|NCT05716867|Salivary Cystatins|salivary cystatins|mesh-list
102576854|NCT05716867|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
102576855|NCT05716867|Protease Inhibitors|protease inhibitors|mesh-ancestor
102576856|NCT05716867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102576857|NCT05716867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576858|NCT04341584|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102576859|NCT04341584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102576860|NCT01345136|Everolimus|everolimus|mesh-list
102576861|NCT01345136|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102576862|NCT01345136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102576863|NCT01345136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102576864|NCT01345136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576865|NCT01345136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102576866|NCT01345136|Immunologic Factors|immunologic factors|mesh-ancestor
102576867|NCT01345136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576868|NCT01345136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102576869|NCT04341428|Lansoprazole|lansoprazole|mesh-list
102576870|NCT04341428|Dexlansoprazole|dexlansoprazole|mesh-list
102576871|NCT04341428|Fexuprazan|fexuprazan|mesh-list
102576872|NCT04341428|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102576873|NCT04341428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102576874|NCT04341428|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102576875|NCT04341428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102576876|NCT04341428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576877|NCT02453360|Bupivacaine|bupivacaine|mesh-list
102576878|NCT02453360|Anesthetics, Local|anesthetics, local|mesh-ancestor
102576879|NCT02453360|Anesthetics|anesthetics|mesh-ancestor
102576880|NCT02453360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102576881|NCT02453360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576882|NCT02453360|Sensory System Agents|sensory system agents|mesh-ancestor
102576883|NCT02453360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102576884|NCT03140670|Rucaparib|rucaparib|mesh-list
102576885|NCT03140670|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102576886|NCT03140670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102576887|NCT03140670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576888|NCT03140670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102576889|NCT02453672|Bevacizumab|bevacizumab|mesh-list
102576890|NCT02453672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102576891|NCT02453672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102576892|NCT02453672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102576893|NCT02453672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102576894|NCT02453672|Growth Substances|growth substances|mesh-ancestor
102576895|NCT02453672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576896|NCT02453672|Growth Inhibitors|growth inhibitors|mesh-ancestor
102576897|NCT03119064|Irinotecan|irinotecan|mesh-list
102576898|NCT03119064|Temozolomide|temozolomide|mesh-list
102576899|NCT03119064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102576900|NCT03119064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102576901|NCT03119064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102576902|NCT03119064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576903|NCT03119064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102576904|NCT03119064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102576905|NCT03119064|Alkylating Agents|alkylating agents|mesh-ancestor
102576906|NCT02453750|Bronchodilator Agents|bronchodilator agents|mesh-list
102576907|NCT02453750|Autonomic Agents|autonomic agents|mesh-ancestor
102576908|NCT02453750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102576909|NCT02453750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576910|NCT02453750|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102576911|NCT02453750|Respiratory System Agents|respiratory system agents|mesh-ancestor
102576912|NCT03831295|Antibodies|antibodies|mesh-list
102576913|NCT03831295|Immunologic Factors|immunologic factors|mesh-ancestor
102576914|NCT03831295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576915|NCT02454296|Lidocaine|lidocaine|mesh-list
102576916|NCT02454296|Anesthetics, Local|anesthetics, local|mesh-ancestor
102576917|NCT02454296|Anesthetics|anesthetics|mesh-ancestor
102576918|NCT02454296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102576919|NCT02454296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576920|NCT02454296|Sensory System Agents|sensory system agents|mesh-ancestor
102576921|NCT02454296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102576922|NCT02454296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102576923|NCT02454296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102576924|NCT02454296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102576925|NCT02454296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102576926|NCT02454296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576927|NCT03836833|Lamivudine|lamivudine|mesh-list
102576928|NCT03836833|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102576929|NCT03836833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102576930|NCT03836833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102576931|NCT03836833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576932|NCT03836833|Antiviral Agents|antiviral agents|mesh-ancestor
102576933|NCT03836833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102576934|NCT03836833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102576935|NCT03836833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102576936|NCT05710471|Aflibercept|aflibercept|mesh-list
102576937|NCT05710471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102576938|NCT05710471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102576939|NCT05710471|Growth Substances|growth substances|mesh-ancestor
102576940|NCT05710471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576941|NCT05710471|Growth Inhibitors|growth inhibitors|mesh-ancestor
102576942|NCT05710471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102576943|NCT00358969|Guanfacine|guanfacine|mesh-list
102576944|NCT00358969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102576945|NCT00358969|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102576946|NCT00358969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102576947|NCT00358969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102576948|NCT00358969|Adrenergic Agents|adrenergic agents|mesh-ancestor
102576949|NCT00358969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102576950|NCT00358969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576951|NCT00358969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576952|NCT02896712|Modafinil|modafinil|mesh-list
102576953|NCT02896712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102576954|NCT02896712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576955|NCT02896712|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102576956|NCT02896712|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102576957|NCT02896712|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102576958|NCT02896712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576959|NCT05346601|Chiauranib|chiauranib|mesh-list
102576960|NCT05346601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102576961|NCT05346601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102576962|NCT05346601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102576963|NCT05346601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576964|NCT04344379|Azithromycin|azithromycin|mesh-list
102576965|NCT04344379|Hydroxychloroquine|hydroxychloroquine|mesh-list
102576966|NCT04344379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102576967|NCT04344379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102576968|NCT04344379|Antimalarials|antimalarials|mesh-ancestor
102576969|NCT04344379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102576970|NCT04344379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102576971|NCT04344379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102576972|NCT04344379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576973|NCT04344379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102576974|NCT00359125|Mifepristone|mifepristone|mesh-list
102576975|NCT00359125|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102576976|NCT00359125|Abortifacient Agents|abortifacient agents|mesh-ancestor
102576977|NCT00359125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102576978|NCT00359125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102576979|NCT00359125|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102576980|NCT00359125|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102576981|NCT00359125|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102576982|NCT00359125|Contraceptive Agents|contraceptive agents|mesh-ancestor
102576983|NCT00359125|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102576984|NCT00359125|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102576985|NCT00359125|Hormone Antagonists|hormone antagonists|mesh-ancestor
102576986|NCT00359125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102576987|NCT00359125|Luteolytic Agents|luteolytic agents|mesh-ancestor
102576988|NCT00359125|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102576989|NCT00359125|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102576990|NCT03042468|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102576991|NCT03042468|177Lu-PSMA-617|177lu-psma-617|mesh-list
102576992|NCT03042468|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102576993|NCT03042468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576994|NCT04450836|Trifluridine|trifluridine|mesh-list
102576995|NCT04450836|Antimetabolites|antimetabolites|mesh-ancestor
102576996|NCT04450836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102576997|NCT04450836|Antiviral Agents|antiviral agents|mesh-ancestor
102576998|NCT04450836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102576999|NCT05679193|Propranolol|propranolol|mesh-list
102577000|NCT05679193|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102577001|NCT05679193|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102577002|NCT05679193|Adrenergic Agents|adrenergic agents|mesh-ancestor
102577003|NCT05679193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102577004|NCT05679193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577005|NCT05679193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577006|NCT05679193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102577007|NCT05679193|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102577008|NCT05679193|Vasodilator Agents|vasodilator agents|mesh-ancestor
102577009|NCT04795752|Cyclosporine|cyclosporine|mesh-list
102577010|NCT04795752|Cyclosporins|cyclosporins|mesh-list
102577011|NCT04795752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102577012|NCT04795752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577013|NCT04795752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102577014|NCT04795752|Immunologic Factors|immunologic factors|mesh-ancestor
102577015|NCT04795752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577016|NCT04795752|Antifungal Agents|antifungal agents|mesh-ancestor
102577017|NCT04795752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102577018|NCT04795752|Dermatologic Agents|dermatologic agents|mesh-ancestor
102577019|NCT04795752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102577020|NCT04795752|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102577021|NCT02977741|Olanzapine|olanzapine|mesh-list
102577022|NCT02977741|Antiemetics|antiemetics|mesh-ancestor
102577023|NCT02977741|Autonomic Agents|autonomic agents|mesh-ancestor
102577024|NCT02977741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102577025|NCT02977741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577026|NCT02977741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102577027|NCT02977741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102577028|NCT02977741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102577029|NCT02977741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102577030|NCT02977741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102577031|NCT02977741|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102577032|NCT02977741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102577033|NCT02977741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102577034|NCT02977741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577035|NCT02977741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102577036|NCT02977741|Serotonin Agents|serotonin agents|mesh-ancestor
102577037|NCT04334070|Clofazimine|clofazimine|mesh-list
102577038|NCT04334070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102577039|NCT04334070|Leprostatic Agents|leprostatic agents|mesh-ancestor
102577040|NCT04334070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102577041|NCT04334070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102577042|NCT05292001|Dextrans|dextrans|mesh-list
102577043|NCT05292001|Iron-Dextran Complex|iron-dextran complex|mesh-list
102577044|NCT05292001|Anticoagulants|anticoagulants|mesh-ancestor
102577045|NCT05292001|Plasma Substitutes|plasma substitutes|mesh-ancestor
102577046|NCT05292001|Blood Substitutes|blood substitutes|mesh-ancestor
102577047|NCT05292001|Hematinics|hematinics|mesh-ancestor
102577048|NCT01634178|Apremilast|apremilast|mesh-list
102577049|NCT01634178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102577050|NCT01634178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102577051|NCT01634178|Analgesics|analgesics|mesh-ancestor
102577052|NCT01634178|Sensory System Agents|sensory system agents|mesh-ancestor
102577053|NCT01634178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102577054|NCT01634178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577055|NCT01634178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102577056|NCT01634178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102577057|NCT01634178|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102577058|NCT01634178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102577059|NCT01634178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102577060|NCT01634178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577061|NCT00359359|Sagopilone|sagopilone|mesh-list
102577062|NCT00359359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102577063|NCT04782804|Capecitabine|capecitabine|mesh-list
102577064|NCT04782804|Tislelizumab|tislelizumab|mesh-list
102577065|NCT04782804|Antibodies|antibodies|mesh-list
102577066|NCT04782804|Immunologic Factors|immunologic factors|mesh-ancestor
102577067|NCT04782804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577068|NCT04782804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102577069|NCT04782804|Antimetabolites|antimetabolites|mesh-ancestor
102577070|NCT04782804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577071|NCT04782804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102577072|NCT04782804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102577073|NCT04227288|Betamethasone|betamethasone|mesh-list
102577074|NCT04227288|Betamethasone Valerate|betamethasone valerate|mesh-list
102577075|NCT04227288|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102577076|NCT04227288|Betamethasone benzoate|betamethasone benzoate|mesh-list
102577077|NCT04227288|Calcipotriene|calcipotriene|mesh-list
102577078|NCT04227288|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102577079|NCT04227288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102577080|NCT04227288|Glucocorticoids|glucocorticoids|mesh-ancestor
102577081|NCT04227288|Hormones|hormones|mesh-ancestor
102577082|NCT04227288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102577083|NCT04227288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577084|NCT04227288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102577085|NCT04227288|Respiratory System Agents|respiratory system agents|mesh-ancestor
102124011|NCT01510119|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102577086|NCT04227288|Dermatologic Agents|dermatologic agents|mesh-ancestor
102577088|NCT02978443|Ipilimumab|ipilimumab|mesh-list
102577089|NCT02978443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102577090|NCT02978443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102577091|NCT02978443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102577092|NCT02978443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577093|NCT02465450|Lenabasum|lenabasum|mesh-list
102577094|NCT02465450|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102577095|NCT02465450|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102577096|NCT02465450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102577097|NCT02465450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577098|NCT02465450|Hormones|hormones|mesh-ancestor
102577099|NCT02465450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102577100|NCT02465450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577101|NCT00608972|Bevacizumab|bevacizumab|mesh-list
102577102|NCT00608972|Carboplatin|carboplatin|mesh-list
102577103|NCT00608972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102577104|NCT00608972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102577105|NCT00608972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102577106|NCT00608972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102577107|NCT00608972|Growth Substances|growth substances|mesh-ancestor
102577108|NCT00608972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577109|NCT00608972|Growth Inhibitors|growth inhibitors|mesh-ancestor
102577110|NCT02729714|Suvorexant|suvorexant|mesh-list
102577111|NCT02729714|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102577112|NCT02729714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102577113|NCT02729714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102577114|NCT02729714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577115|NCT02729714|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102577116|NCT02729714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102577117|NCT02729714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577118|NCT04802382|Fibrin fragment D|fibrin fragment d|mesh-list
102577119|NCT04802382|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102577120|NCT04802382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102577121|NCT04802382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577122|NCT04802382|Hemostatics|hemostatics|mesh-ancestor
102577123|NCT04802382|Coagulants|coagulants|mesh-ancestor
102577124|NCT05648916|Celecoxib|celecoxib|mesh-list
102577125|NCT05648916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102577126|NCT05648916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102577127|NCT05648916|Analgesics|analgesics|mesh-ancestor
102577128|NCT05648916|Sensory System Agents|sensory system agents|mesh-ancestor
102577129|NCT05648916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102577130|NCT05648916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577131|NCT05648916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102577132|NCT05648916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102577133|NCT05648916|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102577134|NCT05648916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102577135|NCT05648916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102577136|NCT05648916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577137|NCT05458609|Naltrexone|naltrexone|mesh-list
102577138|NCT05458609|Lemborexant|lemborexant|mesh-list
102577139|NCT05458609|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102577140|NCT05458609|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102577141|NCT05458609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577142|NCT05458609|Sensory System Agents|sensory system agents|mesh-ancestor
102577143|NCT05458609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102577144|NCT05458609|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102577145|NCT05458609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102577146|NCT05458609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577147|NCT05458609|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102577148|NCT05458609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102577149|NCT05458609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102577150|NCT05648058|Diphenhydramine|diphenhydramine|mesh-list
102577151|NCT05648058|Promethazine|promethazine|mesh-list
102577152|NCT05648058|Nefopam|nefopam|mesh-list
102577153|NCT05648058|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102577154|NCT05648058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102577155|NCT05648058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102577156|NCT05648058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577157|NCT05648058|Anesthetics, Local|anesthetics, local|mesh-ancestor
102577158|NCT05648058|Anesthetics|anesthetics|mesh-ancestor
102577159|NCT05648058|Sensory System Agents|sensory system agents|mesh-ancestor
102577160|NCT05648058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102577161|NCT05648058|Antiemetics|antiemetics|mesh-ancestor
102577162|NCT05648058|Autonomic Agents|autonomic agents|mesh-ancestor
102577163|NCT05648058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102577164|NCT05648058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102577165|NCT05648058|Histamine Antagonists|histamine antagonists|mesh-ancestor
102577166|NCT05648058|Histamine Agents|histamine agents|mesh-ancestor
102577167|NCT05648058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102577168|NCT05648058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577169|NCT05648058|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102577170|NCT05648058|Antipruritics|antipruritics|mesh-ancestor
102577171|NCT05648058|Dermatologic Agents|dermatologic agents|mesh-ancestor
102577172|NCT05648058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102577173|NCT05648058|Analgesics|analgesics|mesh-ancestor
102577174|NCT05649085|Cobalt|cobalt|mesh-list
102577175|NCT05649085|Chromium|chromium|mesh-list
102577176|NCT05649085|Trace Elements|trace elements|mesh-ancestor
102577177|NCT05649085|Micronutrients|micronutrients|mesh-ancestor
102577178|NCT05649085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577179|NCT05639712|Fentanyl|fentanyl|mesh-list
102577180|NCT05639712|Morphine|morphine|mesh-list
102577181|NCT05639712|Oxycodone|oxycodone|mesh-list
102577182|NCT05639712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102577183|NCT05639712|Narcotics|narcotics|mesh-ancestor
102577184|NCT05639712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102577185|NCT05639712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577186|NCT05639712|Analgesics|analgesics|mesh-ancestor
102577187|NCT05639712|Sensory System Agents|sensory system agents|mesh-ancestor
102577188|NCT05639712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102577189|NCT05639712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102577190|NCT05639712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102577191|NCT05639712|Anesthetics, General|anesthetics, general|mesh-ancestor
102577192|NCT05639712|Anesthetics|anesthetics|mesh-ancestor
102577193|NCT05210101|Sotrovimab|sotrovimab|mesh-list
102577194|NCT05210101|Antiviral Agents|antiviral agents|mesh-ancestor
102577195|NCT05210101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102577196|NCT02959411|Tolvaptan|tolvaptan|mesh-list
102577197|NCT02959411|Diuretics|diuretics|mesh-list
102577198|NCT02959411|Natriuretic Agents|natriuretic agents|mesh-ancestor
102577199|NCT02959411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577200|NCT02959411|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102577201|NCT02959411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577202|NCT05426161|Botulinum Toxins|botulinum toxins|mesh-list
102577203|NCT05426161|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102577204|NCT05426161|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102577205|NCT05426161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102577206|NCT05426161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102577207|NCT05426161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577208|NCT05426161|Cholinergic Agents|cholinergic agents|mesh-ancestor
102577209|NCT05426161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102577210|NCT05426161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577211|NCT05426161|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102577212|NCT05426161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102577213|NCT05630833|Nitrofurantoin|nitrofurantoin|mesh-list
102577214|NCT05630833|Gepotidacin|gepotidacin|mesh-list
102577215|NCT05630833|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102577216|NCT05630833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102577217|NCT05630833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102577218|NCT05630833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102577219|NCT05630833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102577220|NCT05630833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577221|NCT05630833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102577222|NCT00359671|Docetaxel|docetaxel|mesh-list
102577223|NCT00359671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102577224|NCT00359671|Tubulin Modulators|tubulin modulators|mesh-ancestor
102577225|NCT00359671|Antimitotic Agents|antimitotic agents|mesh-ancestor
102577226|NCT00359671|Mitosis Modulators|mitosis modulators|mesh-ancestor
102577227|NCT00359671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577228|NCT02977897|Octreotide|octreotide|mesh-list
102577229|NCT02977897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102577230|NCT02977897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102577231|NCT02977897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102577232|NCT05114941|Immunoglobulins|immunoglobulins|mesh-list
102577233|NCT05114941|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102577234|NCT05114941|Antibodies|antibodies|mesh-list
102577235|NCT05114941|gamma-Globulins|gamma-globulins|mesh-list
102577236|NCT05114941|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102577237|NCT05114941|Immunologic Factors|immunologic factors|mesh-ancestor
102577238|NCT05114941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577239|NCT00359905|Tamsulosin|tamsulosin|mesh-list
102577240|NCT00359905|Silodosin|silodosin|mesh-list
102577241|NCT00359905|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102577242|NCT00359905|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102577243|NCT00359905|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102577244|NCT00359905|Adrenergic Agents|adrenergic agents|mesh-ancestor
102577245|NCT00359905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102577246|NCT00359905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577247|NCT00359905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577248|NCT00359905|Urological Agents|urological agents|mesh-ancestor
102577249|NCT05086939|Hyaluronic Acid|hyaluronic acid|mesh-list
102577250|NCT05086939|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102577251|NCT05086939|Immunologic Factors|immunologic factors|mesh-ancestor
102577252|NCT05086939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577253|NCT05086939|Viscosupplements|viscosupplements|mesh-ancestor
102577254|NCT05086939|Protective Agents|protective agents|mesh-ancestor
102577255|NCT00358813|Casopitant|casopitant|mesh-list
102577256|NCT00358813|Antiemetics|antiemetics|mesh-ancestor
102577257|NCT00358813|Autonomic Agents|autonomic agents|mesh-ancestor
102577258|NCT00358813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102577259|NCT00358813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577260|NCT00358813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102577261|NCT00358813|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102577262|NCT00358813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102577263|NCT00358813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577264|NCT04871191|Rituximab|rituximab|mesh-list
102577265|NCT04871191|Abatacept|abatacept|mesh-list
102577266|NCT04871191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102577267|NCT04871191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102577268|NCT04871191|Immunologic Factors|immunologic factors|mesh-ancestor
102577269|NCT04871191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577270|NCT04871191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102577271|NCT04871191|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102577272|NCT04871191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577273|NCT04871191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102577274|NCT02976805|Bisacodyl|bisacodyl|mesh-list
102577275|NCT02976805|Cathartics|cathartics|mesh-ancestor
102577276|NCT02976805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102577277|NCT02976805|Laxatives|laxatives|mesh-ancestor
102577278|NCT04835623|Cyclosporine|cyclosporine|mesh-list
102577279|NCT04835623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102577280|NCT04835623|Cyclosporins|cyclosporins|mesh-list
102577281|NCT04835623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102577282|NCT04835623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577283|NCT04835623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102577284|NCT04835623|Immunologic Factors|immunologic factors|mesh-ancestor
102577285|NCT04835623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577286|NCT04835623|Antifungal Agents|antifungal agents|mesh-ancestor
102577287|NCT04835623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102577288|NCT04835623|Dermatologic Agents|dermatologic agents|mesh-ancestor
102577289|NCT04835623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102577290|NCT04835623|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102577291|NCT04835623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102577292|NCT04500613|Dexamethasone|dexamethasone|mesh-list
102577293|NCT04500613|Dexamethasone acetate|dexamethasone acetate|mesh-list
102577294|NCT04500613|Bupivacaine|bupivacaine|mesh-list
102577295|NCT04500613|BB 1101|bb 1101|mesh-list
102577296|NCT04500613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102577297|NCT04500613|Antiemetics|antiemetics|mesh-ancestor
102577298|NCT04500613|Autonomic Agents|autonomic agents|mesh-ancestor
102577299|NCT04500613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102577300|NCT04500613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577301|NCT04500613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102577302|NCT04500613|Glucocorticoids|glucocorticoids|mesh-ancestor
102577303|NCT04500613|Hormones|hormones|mesh-ancestor
102577304|NCT04500613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102577305|NCT04500613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102577306|NCT04500613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102577307|NCT04500613|Protease Inhibitors|protease inhibitors|mesh-ancestor
102577308|NCT04500613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102577309|NCT04500613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577310|NCT04500613|Anesthetics, Local|anesthetics, local|mesh-ancestor
102577311|NCT04500613|Anesthetics|anesthetics|mesh-ancestor
102577312|NCT04500613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102577313|NCT04500613|Sensory System Agents|sensory system agents|mesh-ancestor
102577314|NCT04833907|Prednisone|prednisone|mesh-list
102577315|NCT04833907|Levetiracetam|levetiracetam|mesh-list
102577316|NCT04833907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102577317|NCT04833907|Glucocorticoids|glucocorticoids|mesh-ancestor
102577318|NCT04833907|Hormones|hormones|mesh-ancestor
102577319|NCT04833907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102577320|NCT04833907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577321|NCT04833907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102577322|NCT04833907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102577323|NCT04833907|Anticonvulsants|anticonvulsants|mesh-ancestor
102577324|NCT04833907|Nootropic Agents|nootropic agents|mesh-ancestor
102577325|NCT02976259|Dolutegravir|dolutegravir|mesh-list
102577326|NCT02976259|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102577327|NCT02976259|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102577328|NCT02976259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102577329|NCT02976259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577330|NCT02976259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102577331|NCT02976259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102577332|NCT02976259|Antiviral Agents|antiviral agents|mesh-ancestor
102577333|NCT02976259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102577334|NCT00360295|Azithromycin|azithromycin|mesh-list
102577335|NCT00360295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102577336|NCT00360295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102577337|NCT02976727|Vitamin D|vitamin d|mesh-list
102577338|NCT02976727|Lidocaine|lidocaine|mesh-list
102577339|NCT02976727|Prilocaine|prilocaine|mesh-list
102577340|NCT02976727|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
102577341|NCT02976727|Calcipotriene|calcipotriene|mesh-list
102577342|NCT02976727|Vitamins|vitamins|mesh-ancestor
102577343|NCT02976727|Micronutrients|micronutrients|mesh-ancestor
102577344|NCT02976727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577345|NCT02976727|Anesthetics, Local|anesthetics, local|mesh-ancestor
102577346|NCT02976727|Anesthetics|anesthetics|mesh-ancestor
102577347|NCT02976727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102577348|NCT02976727|Sensory System Agents|sensory system agents|mesh-ancestor
102577349|NCT02976727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102577350|NCT02976727|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102577351|NCT02976727|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102577352|NCT02976727|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102577353|NCT02976727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102577354|NCT02976727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577355|NCT02976727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102577356|NCT02976727|Dermatologic Agents|dermatologic agents|mesh-ancestor
102577357|NCT02976727|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
102577358|NCT02977117|Dialysis Solutions|dialysis solutions|mesh-list
102577359|NCT02977117|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102577360|NCT00360607|Metronidazole|metronidazole|mesh-list
102577361|NCT00360607|Amikacin|amikacin|mesh-list
102577362|NCT00360607|Ceftazidime|ceftazidime|mesh-list
102577363|NCT00360607|Sulbactam|sulbactam|mesh-list
102577364|NCT00360607|Cefoperazone|cefoperazone|mesh-list
102577365|NCT00360607|Sulperazone|sulperazone|mesh-list
102577366|NCT00360607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102577367|NCT00360607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102577368|NCT00360607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102577369|NCT00360607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102577370|NCT00360607|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102577371|NCT00360607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102577372|NCT00360607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577373|NCT00360607|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102577374|NCT00360763|Candesartan|candesartan|mesh-list
102577375|NCT00360763|Candesartan cilexetil|candesartan cilexetil|mesh-list
102577376|NCT00360763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102577377|NCT00360763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102577378|NCT00360763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102577379|NCT00360763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577380|NCT04032301|Ketamine|ketamine|mesh-list
102577381|NCT04032301|Analgesics|analgesics|mesh-ancestor
102577382|NCT04032301|Sensory System Agents|sensory system agents|mesh-ancestor
102577383|NCT04032301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102577384|NCT04032301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577385|NCT04032301|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102577386|NCT04032301|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102577387|NCT04032301|Anesthetics, General|anesthetics, general|mesh-ancestor
102577388|NCT04032301|Anesthetics|anesthetics|mesh-ancestor
102577389|NCT04032301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102577390|NCT04032301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102577391|NCT04032301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102577392|NCT04032301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102577393|NCT04032301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577394|NCT04010305|Dexmedetomidine|dexmedetomidine|mesh-list
102577395|NCT04010305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102577396|NCT04010305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102577397|NCT04010305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577398|NCT04010305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102577399|NCT04010305|Analgesics|analgesics|mesh-ancestor
102577400|NCT04010305|Sensory System Agents|sensory system agents|mesh-ancestor
102577401|NCT04010305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102577402|NCT04010305|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102577403|NCT04010305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102577404|NCT04010305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102577405|NCT04010305|Adrenergic Agents|adrenergic agents|mesh-ancestor
102577406|NCT04010305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102577407|NCT04010305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577408|NCT00361933|Valganciclovir|valganciclovir|mesh-list
102577409|NCT00361933|Antiviral Agents|antiviral agents|mesh-ancestor
102577410|NCT00361933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102577411|NCT04786093|Durvalumab|durvalumab|mesh-list
102577412|NCT04786093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102577413|NCT04786093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102577414|NCT02976571|Bupivacaine|bupivacaine|mesh-list
102577415|NCT02976571|Anesthetics, Local|anesthetics, local|mesh-ancestor
102577416|NCT02976571|Anesthetics|anesthetics|mesh-ancestor
102577417|NCT02976571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102577418|NCT02976571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577419|NCT02976571|Sensory System Agents|sensory system agents|mesh-ancestor
102577420|NCT02976571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102577421|NCT04731025|Vancomycin|vancomycin|mesh-list
102577422|NCT04731025|Gentamicins|gentamicins|mesh-list
102577423|NCT04731025|Cefazolin|cefazolin|mesh-list
102577424|NCT04731025|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102577425|NCT04731025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102577426|NCT04731025|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102577427|NCT04731025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102577428|NCT04731025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577429|NCT04730635|Donepezil|donepezil|mesh-list
102577430|NCT04730635|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102577431|NCT04730635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102577432|NCT04730635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577433|NCT04730635|Cholinergic Agents|cholinergic agents|mesh-ancestor
102577434|NCT04730635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102577435|NCT04730635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577436|NCT04730635|Nootropic Agents|nootropic agents|mesh-ancestor
102577437|NCT04686799|Doxycycline|doxycycline|mesh-list
102577438|NCT04686799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102577439|NCT04686799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102577440|NCT04686799|Antimalarials|antimalarials|mesh-ancestor
102577441|NCT04686799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102577442|NCT04686799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102577443|NCT04676035|Vitamin K|vitamin k|mesh-list
102577444|NCT04676035|Vitamin K 1|vitamin k 1|mesh-list
102577445|NCT04676035|Midazolam|midazolam|mesh-list
102577446|NCT04676035|Omeprazole|omeprazole|mesh-list
102577447|NCT04676035|Warfarin|warfarin|mesh-list
102577448|NCT04676035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102577449|NCT04676035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102577450|NCT04676035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102577451|NCT04676035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577452|NCT04676035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102577453|NCT04676035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102577454|NCT04676035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102577455|NCT04676035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102577456|NCT04676035|Anesthetics, General|anesthetics, general|mesh-ancestor
102577457|NCT04676035|Anesthetics|anesthetics|mesh-ancestor
102577458|NCT04676035|GABA Modulators|gaba modulators|mesh-ancestor
102577459|NCT04676035|GABA Agents|gaba agents|mesh-ancestor
102577460|NCT04676035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102577461|NCT04676035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577462|NCT04676035|Anticoagulants|anticoagulants|mesh-ancestor
102577463|NCT04676035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102577464|NCT04676035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102577465|NCT04676035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102577466|NCT04676035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102577467|NCT04676035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102577468|NCT04676035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102577469|NCT04676035|Hemostatics|hemostatics|mesh-ancestor
102577470|NCT04676035|Coagulants|coagulants|mesh-ancestor
102577471|NCT04676035|Vitamins|vitamins|mesh-ancestor
102577472|NCT04676035|Micronutrients|micronutrients|mesh-ancestor
102577473|NCT03926299|Clobetasol|clobetasol|mesh-list
102577474|NCT03926299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102577475|NCT03926299|Glucocorticoids|glucocorticoids|mesh-ancestor
102577476|NCT03926299|Hormones|hormones|mesh-ancestor
102577477|NCT03926299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102577478|NCT03926299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577479|NCT04359199|Cisplatin|cisplatin|mesh-list
102577480|NCT04359199|Pembrolizumab|pembrolizumab|mesh-list
102577481|NCT04359199|Nivolumab|nivolumab|mesh-list
102577482|NCT04359199|Cetuximab|cetuximab|mesh-list
102577483|NCT04359199|Durvalumab|durvalumab|mesh-list
102577484|NCT04359199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102577485|NCT04359199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102577486|NCT04359199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102577487|NCT04359199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577488|NCT03875911|Mitomycins|mitomycins|mesh-list
102577489|NCT03875911|Mitomycin|mitomycin|mesh-list
102577490|NCT03875911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102577491|NCT03875911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102577492|NCT03875911|Alkylating Agents|alkylating agents|mesh-ancestor
102577493|NCT03875911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577494|NCT03875911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102577495|NCT03875911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102577496|NCT00361075|Estradiol|estradiol|mesh-list
102577497|NCT00361075|Estrogens|estrogens|mesh-list
102577498|NCT00361075|Progesterone|progesterone|mesh-list
102577499|NCT00361075|Hormones|hormones|mesh-ancestor
102577500|NCT00361075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102577501|NCT00361075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577502|NCT00361075|Progestins|progestins|mesh-ancestor
102577503|NCT03844633|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102577504|NCT03844633|Medroxyprogesterone|medroxyprogesterone|mesh-list
102577505|NCT03844633|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102577506|NCT03844633|Contraceptive Agents|contraceptive agents|mesh-ancestor
102577507|NCT03844633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102577508|NCT03844633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577509|NCT03844633|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102577510|NCT03844633|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102577511|NCT03844633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102577512|NCT03844633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102577513|NCT03844633|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102577514|NCT03844633|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102577515|NCT03844633|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102577516|NCT00362089|Dronabinol|dronabinol|mesh-list
102577517|NCT00362089|Hallucinogens|hallucinogens|mesh-ancestor
102577518|NCT00362089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577519|NCT00362089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102577520|NCT00362089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102577521|NCT00362089|Analgesics|analgesics|mesh-ancestor
102577522|NCT00362089|Sensory System Agents|sensory system agents|mesh-ancestor
102577523|NCT00362089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102577524|NCT00362089|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102577525|NCT00362089|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102577526|NCT00362089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102577527|NCT00362089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577528|NCT00362089|Hormones|hormones|mesh-ancestor
102577529|NCT00362089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102577530|NCT04666987|Liraglutide|liraglutide|mesh-list
102577531|NCT04666987|Xultophy|xultophy|mesh-list
102577532|NCT04666987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102577533|NCT04666987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577534|NCT04666987|Incretins|incretins|mesh-ancestor
102577535|NCT04666987|Hormones|hormones|mesh-ancestor
102577536|NCT04666987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102577537|NCT04318717|Pembrolizumab|pembrolizumab|mesh-list
102577538|NCT04318717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102577539|NCT04318717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102577540|NCT04318717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102577541|NCT04318717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124502|NCT01007721|Xhance|xhance|mesh-list
102577542|NCT03822637|Acetylcysteine|acetylcysteine|mesh-list
102577543|NCT03822637|Albuterol|albuterol|mesh-list
102577544|NCT03822637|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102577545|NCT03822637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102577546|NCT03822637|Autonomic Agents|autonomic agents|mesh-ancestor
102577547|NCT03822637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102577548|NCT03822637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577549|NCT03822637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102577550|NCT03822637|Respiratory System Agents|respiratory system agents|mesh-ancestor
102577551|NCT03822637|Tocolytic Agents|tocolytic agents|mesh-ancestor
102577552|NCT03822637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102577553|NCT03822637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102577554|NCT03822637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102577555|NCT03822637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102577556|NCT03822637|Adrenergic Agents|adrenergic agents|mesh-ancestor
102577557|NCT03822637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102577558|NCT03822637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577559|NCT03822637|Antiviral Agents|antiviral agents|mesh-ancestor
102577560|NCT03822637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102577561|NCT03822637|Expectorants|expectorants|mesh-ancestor
102577562|NCT03822637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102577563|NCT03822637|Antioxidants|antioxidants|mesh-ancestor
102577564|NCT03822637|Protective Agents|protective agents|mesh-ancestor
102577565|NCT03822637|Antidotes|antidotes|mesh-ancestor
102577566|NCT05444101|Nicotine|nicotine|mesh-list
102577567|NCT05444101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102577568|NCT05444101|Autonomic Agents|autonomic agents|mesh-ancestor
102577569|NCT05444101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102577570|NCT05444101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577571|NCT05444101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102577572|NCT05444101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102577573|NCT05444101|Cholinergic Agents|cholinergic agents|mesh-ancestor
102577574|NCT05444101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102577575|NCT05444101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577576|NCT02412306|Blinatumomab|blinatumomab|mesh-list
102577577|NCT02412306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102577578|NCT05616468|Cyclophosphamide|cyclophosphamide|mesh-list
102577579|NCT05616468|Fludarabine|fludarabine|mesh-list
102577580|NCT05616468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102577581|NCT05616468|Immunologic Factors|immunologic factors|mesh-ancestor
102577582|NCT05616468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577583|NCT05616468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102577584|NCT05616468|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102577585|NCT05616468|Alkylating Agents|alkylating agents|mesh-ancestor
102577586|NCT05616468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577587|NCT05616468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102577588|NCT05616468|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102577589|NCT03654768|Imatinib Mesylate|imatinib mesylate|mesh-list
102577590|NCT03654768|Dasatinib|dasatinib|mesh-list
102577591|NCT03654768|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
102577592|NCT03654768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102577593|NCT03654768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102577594|NCT03654768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102577595|NCT03654768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577596|NCT01352221|Ferric maltol|ferric maltol|mesh-list
102577597|NCT01352221|Hematinics|hematinics|mesh-ancestor
102577598|NCT03583710|Cisplatin|cisplatin|mesh-list
102577599|NCT03583710|Etoposide|etoposide|mesh-list
102577600|NCT03583710|Etoposide phosphate|etoposide phosphate|mesh-list
102577601|NCT03583710|Podophyllotoxin|podophyllotoxin|mesh-list
102577602|NCT03583710|Mitotane|mitotane|mesh-list
102577603|NCT03583710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343821|NCT04585711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102577604|NCT03583710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102577605|NCT03583710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102577606|NCT03583710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102577607|NCT03583710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102577608|NCT03583710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577609|NCT03583710|Keratolytic Agents|keratolytic agents|mesh-ancestor
102577610|NCT03583710|Dermatologic Agents|dermatologic agents|mesh-ancestor
102577611|NCT03583710|Tubulin Modulators|tubulin modulators|mesh-ancestor
102577612|NCT03583710|Antimitotic Agents|antimitotic agents|mesh-ancestor
102577613|NCT03583710|Mitosis Modulators|mitosis modulators|mesh-ancestor
102577614|NCT03583710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102577615|NCT05195034|Dexmedetomidine|dexmedetomidine|mesh-list
102577616|NCT05195034|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102577617|NCT05195034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102577618|NCT05195034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577619|NCT05195034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102577620|NCT05195034|Analgesics|analgesics|mesh-ancestor
102577621|NCT05195034|Sensory System Agents|sensory system agents|mesh-ancestor
102577622|NCT05195034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102577623|NCT05195034|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102577624|NCT05195034|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102577625|NCT05195034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102577626|NCT05195034|Adrenergic Agents|adrenergic agents|mesh-ancestor
102577627|NCT05195034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102577628|NCT05195034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577629|NCT05496894|Mitoxantrone|mitoxantrone|mesh-list
102577630|NCT05496894|Analgesics|analgesics|mesh-ancestor
102577631|NCT05496894|Sensory System Agents|sensory system agents|mesh-ancestor
102577632|NCT05496894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102577633|NCT05496894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577634|NCT05496894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102577635|NCT05496894|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102577636|NCT05496894|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102577637|NCT05496894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102577638|NCT05496894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577639|NCT02065362|Cyclophosphamide|cyclophosphamide|mesh-list
102577640|NCT02065362|Fludarabine|fludarabine|mesh-list
102577641|NCT02065362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102577642|NCT02065362|Immunologic Factors|immunologic factors|mesh-ancestor
102577643|NCT02065362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577644|NCT02065362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102577645|NCT02065362|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102577646|NCT02065362|Alkylating Agents|alkylating agents|mesh-ancestor
102577647|NCT02065362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577648|NCT02065362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102577649|NCT02065362|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102577650|NCT02021604|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
102577651|NCT02021604|Dopamine Agents|dopamine agents|mesh-ancestor
102577652|NCT02021604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102577653|NCT02021604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577654|NCT02021604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577655|NCT03518034|Testosterone|testosterone|mesh-list
102577656|NCT03518034|Androgens|androgens|mesh-ancestor
102577657|NCT03518034|Hormones|hormones|mesh-ancestor
102577658|NCT03518034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102577659|NCT03518034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577660|NCT04789668|Atezolizumab|atezolizumab|mesh-list
102577661|NCT04789668|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102577662|NCT04789668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577663|NCT04789668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102577664|NCT04789668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102577665|NCT04448886|Pembrolizumab|pembrolizumab|mesh-list
102577666|NCT04448886|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
102577667|NCT04448886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102577668|NCT04448886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102577669|NCT04448886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102577670|NCT04448886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577671|NCT04448886|Immunoconjugates|immunoconjugates|mesh-ancestor
102577672|NCT04448886|Immunologic Factors|immunologic factors|mesh-ancestor
102577673|NCT04448886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577674|NCT02389218|Sotalol|sotalol|mesh-list
102577675|NCT02389218|Flecainide|flecainide|mesh-list
102577676|NCT02389218|Propafenone|propafenone|mesh-list
102577677|NCT02389218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102577678|NCT02389218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102577679|NCT02389218|Adrenergic Agents|adrenergic agents|mesh-ancestor
102577680|NCT02389218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102577681|NCT02389218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577682|NCT02389218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577683|NCT02389218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102577684|NCT02389218|Sympatholytics|sympatholytics|mesh-ancestor
102577685|NCT02389218|Autonomic Agents|autonomic agents|mesh-ancestor
102577686|NCT02389218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102577687|NCT02389218|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102577688|NCT02389218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102577689|NCT02389218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102577690|NCT01953120|Abatacept|abatacept|mesh-list
102577691|NCT01953120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102577692|NCT01953120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577693|NCT01953120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102577694|NCT01953120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102577695|NCT01953120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102577696|NCT01953120|Immunologic Factors|immunologic factors|mesh-ancestor
102577697|NCT01953120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577698|NCT01953120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102577699|NCT01634100|Empagliflozin|empagliflozin|mesh-list
102577700|NCT01634100|Rifampin|rifampin|mesh-list
102577701|NCT01634100|Probenecid|probenecid|mesh-list
102577702|NCT01634100|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102577703|NCT01634100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577704|NCT01634100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102577705|NCT01634100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577706|NCT01634100|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102577707|NCT01634100|Antitubercular Agents|antitubercular agents|mesh-ancestor
102577708|NCT01634100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102577709|NCT01634100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102577710|NCT01634100|Leprostatic Agents|leprostatic agents|mesh-ancestor
102577711|NCT01634100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102577712|NCT01634100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102577713|NCT01634100|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102577714|NCT01634100|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102577715|NCT01634100|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102577716|NCT01634100|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102577717|NCT01634100|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102577718|NCT01634100|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102577719|NCT01634100|Uricosuric Agents|uricosuric agents|mesh-ancestor
102577720|NCT01634100|Gout Suppressants|gout suppressants|mesh-ancestor
102577721|NCT01634100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102577722|NCT03662659|Nivolumab|nivolumab|mesh-list
102577723|NCT03662659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102577724|NCT03662659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102577725|NCT03662659|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102577726|NCT03662659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577727|NCT03661645|Dexamethasone|dexamethasone|mesh-list
102577728|NCT03661645|Dexamethasone acetate|dexamethasone acetate|mesh-list
102577729|NCT03661645|Methylprednisolone|methylprednisolone|mesh-list
102577730|NCT03661645|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102577731|NCT03661645|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102577732|NCT03661645|BB 1101|bb 1101|mesh-list
102577733|NCT03661645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102577734|NCT03661645|Antiemetics|antiemetics|mesh-ancestor
102577735|NCT03661645|Autonomic Agents|autonomic agents|mesh-ancestor
102577736|NCT03661645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102577737|NCT03661645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577738|NCT03661645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102577739|NCT03661645|Glucocorticoids|glucocorticoids|mesh-ancestor
102577740|NCT03661645|Hormones|hormones|mesh-ancestor
102577741|NCT03661645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102577742|NCT03661645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102577743|NCT03661645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102577744|NCT03661645|Protease Inhibitors|protease inhibitors|mesh-ancestor
102577745|NCT03661645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102577746|NCT03661645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577747|NCT03661645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102577748|NCT03661645|Protective Agents|protective agents|mesh-ancestor
102577749|NCT01633944|Buprenorphine|buprenorphine|mesh-list
102577750|NCT01633944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102577751|NCT01633944|Narcotics|narcotics|mesh-ancestor
102577752|NCT01633944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102577753|NCT01633944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577754|NCT01633944|Analgesics|analgesics|mesh-ancestor
102577755|NCT01633944|Sensory System Agents|sensory system agents|mesh-ancestor
102577756|NCT01633944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102577757|NCT01633944|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102577758|NCT04592419|Aflibercept|aflibercept|mesh-list
102577759|NCT04592419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102577760|NCT04592419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102577761|NCT04592419|Growth Substances|growth substances|mesh-ancestor
102577762|NCT04592419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577763|NCT04592419|Growth Inhibitors|growth inhibitors|mesh-ancestor
102577764|NCT04592419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102577765|NCT00589316|Iodine|iodine|mesh-list
102577767|NCT00589316|Cadexomer iodine|cadexomer iodine|mesh-list
102577768|NCT00589316|Cyclophosphamide|cyclophosphamide|mesh-list
102577769|NCT00589316|Fludarabine|fludarabine|mesh-list
102577770|NCT00589316|Fludarabine phosphate|fludarabine phosphate|mesh-list
102577771|NCT00589316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102577772|NCT00589316|Tacrolimus|tacrolimus|mesh-list
102577773|NCT00589316|Antibodies|antibodies|mesh-list
102577774|NCT00589316|Immunoglobulins|immunoglobulins|mesh-list
102577775|NCT00589316|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102577776|NCT00589316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102577777|NCT00589316|Immunologic Factors|immunologic factors|mesh-ancestor
102577778|NCT00589316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577779|NCT00589316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102577780|NCT00589316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102577781|NCT00589316|Alkylating Agents|alkylating agents|mesh-ancestor
102577782|NCT00589316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577783|NCT00589316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102577784|NCT00589316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102577785|NCT00589316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102577786|NCT00589316|Antimetabolites|antimetabolites|mesh-ancestor
102577787|NCT00589316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102577788|NCT00589316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102577789|NCT00589316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102577790|NCT00589316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102577791|NCT00589316|Antitubercular Agents|antitubercular agents|mesh-ancestor
102577792|NCT00589316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102577793|NCT00589316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102577794|NCT00589316|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102577795|NCT00589316|Trace Elements|trace elements|mesh-ancestor
102577796|NCT00589316|Micronutrients|micronutrients|mesh-ancestor
102577797|NCT00362245|Amikacin|amikacin|mesh-list
102577798|NCT00362245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102577799|NCT00362245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102577800|NCT00361543|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
102577801|NCT00361543|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102577802|NCT00361543|Hormone Antagonists|hormone antagonists|mesh-ancestor
102577803|NCT00361543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102577804|NCT00361543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577805|NCT00361543|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102577806|NCT00361543|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102577807|NCT00361543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102577808|NCT00003417|Carmustine|carmustine|mesh-list
102577809|NCT00003417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102577810|NCT00003417|Alkylating Agents|alkylating agents|mesh-ancestor
102577811|NCT00003417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577812|NCT00003417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102577813|NCT04329429|Trastuzumab|trastuzumab|mesh-list
102577814|NCT04329429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102577815|NCT04329429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102577816|NCT00003423|Cytarabine|cytarabine|mesh-list
102577817|NCT00003423|Dexamethasone|dexamethasone|mesh-list
102577818|NCT00003423|Prednisolone|prednisolone|mesh-list
102577819|NCT00003423|Cyclophosphamide|cyclophosphamide|mesh-list
102577820|NCT00003423|Methotrexate|methotrexate|mesh-list
102577821|NCT00003423|Etoposide|etoposide|mesh-list
102577822|NCT00003423|Vincristine|vincristine|mesh-list
102577823|NCT00003423|Daunorubicin|daunorubicin|mesh-list
102577824|NCT00003423|Asparaginase|asparaginase|mesh-list
102577825|NCT00003423|Mercaptopurine|mercaptopurine|mesh-list
102577826|NCT00003423|Thioguanine|thioguanine|mesh-list
102577827|NCT00003423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102577828|NCT00003423|Immunologic Factors|immunologic factors|mesh-ancestor
102577829|NCT00003423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577830|NCT00003423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102577831|NCT00003423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102577832|NCT00003423|Alkylating Agents|alkylating agents|mesh-ancestor
102577833|NCT00003423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577834|NCT00003423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102577835|NCT00003423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102577836|NCT00003423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102577837|NCT00003423|Antiemetics|antiemetics|mesh-ancestor
102577838|NCT00003423|Autonomic Agents|autonomic agents|mesh-ancestor
102577839|NCT00003423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102577840|NCT00003423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102577841|NCT00003423|Glucocorticoids|glucocorticoids|mesh-ancestor
102577842|NCT00003423|Hormones|hormones|mesh-ancestor
102577843|NCT00003423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102577844|NCT00003423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102577845|NCT00003423|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102577846|NCT00003423|Abortifacient Agents|abortifacient agents|mesh-ancestor
102577847|NCT00003423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102577848|NCT00003423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102577849|NCT00003423|Antimetabolites|antimetabolites|mesh-ancestor
102577850|NCT00003423|Dermatologic Agents|dermatologic agents|mesh-ancestor
102577851|NCT00003423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102577852|NCT00003423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102577853|NCT00003423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102577854|NCT00003423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102577855|NCT00003423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102577856|NCT00003423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102577857|NCT00003423|Antiviral Agents|antiviral agents|mesh-ancestor
102577858|NCT00003423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102577859|NCT00003423|Tubulin Modulators|tubulin modulators|mesh-ancestor
102577860|NCT00003423|Antimitotic Agents|antimitotic agents|mesh-ancestor
102577861|NCT00003423|Mitosis Modulators|mitosis modulators|mesh-ancestor
102577862|NCT00003423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102577863|NCT00003273|Leucovorin|leucovorin|mesh-list
102577864|NCT00003273|Cyclophosphamide|cyclophosphamide|mesh-list
102577865|NCT00003273|Temozolomide|temozolomide|mesh-list
102577866|NCT00003273|Thiotepa|thiotepa|mesh-list
102577867|NCT00003273|Carboplatin|carboplatin|mesh-list
102577868|NCT00003273|Methotrexate|methotrexate|mesh-list
102577869|NCT00003273|Etoposide|etoposide|mesh-list
102577870|NCT00003273|Vincristine|vincristine|mesh-list
102577871|NCT00003273|Levoleucovorin|levoleucovorin|mesh-list
102577872|NCT00003273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102577873|NCT00003273|Immunologic Factors|immunologic factors|mesh-ancestor
102577874|NCT00003273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577875|NCT00003273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102577876|NCT00003273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102577877|NCT00003273|Alkylating Agents|alkylating agents|mesh-ancestor
102577878|NCT00003273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577879|NCT00003273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102577880|NCT00003273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102577881|NCT00003273|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102577882|NCT00003273|Abortifacient Agents|abortifacient agents|mesh-ancestor
102577883|NCT00003273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102577884|NCT00003273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102577885|NCT00003273|Antimetabolites|antimetabolites|mesh-ancestor
102577886|NCT00003273|Dermatologic Agents|dermatologic agents|mesh-ancestor
102577887|NCT00003273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102577888|NCT00003273|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102577889|NCT00003273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102577890|NCT00003273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102577891|NCT00003273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102577892|NCT00003273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102577893|NCT00003273|Antidotes|antidotes|mesh-ancestor
102577894|NCT00003273|Protective Agents|protective agents|mesh-ancestor
102577895|NCT00003273|Vitamin B Complex|vitamin b complex|mesh-ancestor
102577896|NCT00003273|Vitamins|vitamins|mesh-ancestor
102577897|NCT00003273|Micronutrients|micronutrients|mesh-ancestor
102577898|NCT00003273|Tubulin Modulators|tubulin modulators|mesh-ancestor
102577899|NCT00003273|Antimitotic Agents|antimitotic agents|mesh-ancestor
102577900|NCT00003273|Mitosis Modulators|mitosis modulators|mesh-ancestor
102577901|NCT04329585|Flumazenil|flumazenil|mesh-list
102577902|NCT04329585|Antidotes|antidotes|mesh-ancestor
102577903|NCT04329585|Protective Agents|protective agents|mesh-ancestor
102577904|NCT04329585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577905|NCT04329585|GABA Modulators|gaba modulators|mesh-ancestor
102577906|NCT04329585|GABA Agents|gaba agents|mesh-ancestor
102577907|NCT04329585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102577908|NCT04329585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577909|NCT00003279|Antibodies|antibodies|mesh-list
102577910|NCT00003279|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102577911|NCT00003279|BCG Vaccine|bcg vaccine|mesh-list
102577912|NCT00003279|Immunologic Factors|immunologic factors|mesh-ancestor
102577913|NCT00003279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577914|NCT00003279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102577915|NCT00383487|Calcitriol|calcitriol|mesh-list
102577916|NCT00383487|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
102577917|NCT00383487|Naproxen|naproxen|mesh-list
102124852|NCT04015622|Docetaxel|docetaxel|mesh-list
102577918|NCT00383487|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
102577919|NCT00383487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102577920|NCT00383487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102577921|NCT00383487|Analgesics|analgesics|mesh-ancestor
102577922|NCT00383487|Sensory System Agents|sensory system agents|mesh-ancestor
102577923|NCT00383487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102577924|NCT00383487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577925|NCT00383487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102577926|NCT00383487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102577927|NCT00383487|Gout Suppressants|gout suppressants|mesh-ancestor
102577928|NCT00383487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102577929|NCT00383487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102577930|NCT00383487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577931|NCT00383487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102577932|NCT00383487|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102577933|NCT00383487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102577934|NCT00383487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102577935|NCT00383487|Vitamins|vitamins|mesh-ancestor
102577936|NCT00383487|Micronutrients|micronutrients|mesh-ancestor
102577937|NCT00383487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102577938|NCT00383487|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102577939|NCT00003429|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102577940|NCT00003429|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102577941|NCT00003429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577942|NCT00003435|Antiviral Agents|antiviral agents|mesh-list
102577943|NCT00003435|Melphalan|melphalan|mesh-list
102577944|NCT00003435|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102577945|NCT00003435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102577946|NCT00003435|Alkylating Agents|alkylating agents|mesh-ancestor
102577947|NCT00003435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577948|NCT00003435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102577949|NCT00003435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102577950|NCT00003435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102577951|NCT00003435|Immunologic Factors|immunologic factors|mesh-ancestor
102577952|NCT00003435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577953|NCT00003435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102577954|NCT00003441|Irofulven|irofulven|mesh-list
102577955|NCT00003441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102577956|NCT00003441|Alkylating Agents|alkylating agents|mesh-ancestor
102577957|NCT00003441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577958|NCT00003441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102577959|NCT00002805|Cobalt|cobalt|mesh-list
102577960|NCT00002805|Cytarabine|cytarabine|mesh-list
102577961|NCT00002805|Hydrocortisone|hydrocortisone|mesh-list
102577962|NCT00002805|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102577963|NCT00002805|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102577964|NCT00002805|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102577965|NCT00002805|Methotrexate|methotrexate|mesh-list
102577966|NCT00002805|Etoposide|etoposide|mesh-list
102577967|NCT00002805|Mitoxantrone|mitoxantrone|mesh-list
102577968|NCT00002805|Cladribine|cladribine|mesh-list
102577969|NCT00002805|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102577970|NCT00002805|Abortifacient Agents|abortifacient agents|mesh-ancestor
102577971|NCT00002805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102577972|NCT00002805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102577973|NCT00002805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102577974|NCT00002805|Antimetabolites|antimetabolites|mesh-ancestor
102577975|NCT00002805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102577976|NCT00002805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102577977|NCT00002805|Dermatologic Agents|dermatologic agents|mesh-ancestor
102577978|NCT00002805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102577979|NCT00002805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102577980|NCT00002805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102577981|NCT00002805|Immunologic Factors|immunologic factors|mesh-ancestor
102577982|NCT00002805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102577983|NCT00002805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102577984|NCT00002805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102577985|NCT00002805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102577986|NCT00002805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102577987|NCT00002805|Antiviral Agents|antiviral agents|mesh-ancestor
102577988|NCT00002805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102577989|NCT00002805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102577990|NCT00002805|Analgesics|analgesics|mesh-ancestor
102577991|NCT00002805|Sensory System Agents|sensory system agents|mesh-ancestor
102577992|NCT00002805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102577993|NCT00002805|Trace Elements|trace elements|mesh-ancestor
102577994|NCT00002805|Micronutrients|micronutrients|mesh-ancestor
102577995|NCT00003297|Topotecan|topotecan|mesh-list
102577996|NCT00003297|Mitoxantrone|mitoxantrone|mesh-list
102577997|NCT00003297|Thiotepa|thiotepa|mesh-list
102577998|NCT00003297|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102577999|NCT00003297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102578000|NCT00003297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102578001|NCT00003297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578002|NCT00003297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578003|NCT00003297|Analgesics|analgesics|mesh-ancestor
102578004|NCT00003297|Sensory System Agents|sensory system agents|mesh-ancestor
102578005|NCT00003297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102578006|NCT00003297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578007|NCT00003297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102578008|NCT00003297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102578009|NCT00003297|Alkylating Agents|alkylating agents|mesh-ancestor
102578010|NCT00003297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102578011|NCT00003297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102578012|NCT00003297|Immunologic Factors|immunologic factors|mesh-ancestor
102578013|NCT00003447|Gemcitabine|gemcitabine|mesh-list
102578014|NCT00003447|Vinorelbine|vinorelbine|mesh-list
102578015|NCT00003447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102578016|NCT00003447|Antimetabolites|antimetabolites|mesh-ancestor
102578017|NCT00003447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578018|NCT00003447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578019|NCT00003447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102578020|NCT00003447|Tubulin Modulators|tubulin modulators|mesh-ancestor
102578021|NCT00003447|Antimitotic Agents|antimitotic agents|mesh-ancestor
102578022|NCT00003447|Mitosis Modulators|mitosis modulators|mesh-ancestor
102578023|NCT00003315|Amphotericin B|amphotericin b|mesh-list
102578024|NCT00003315|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102578025|NCT00003315|Sargramostim|sargramostim|mesh-list
102578026|NCT00003315|Immunologic Factors|immunologic factors|mesh-ancestor
102578027|NCT00003315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578028|NCT00003315|Amebicides|amebicides|mesh-ancestor
102578029|NCT00003315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102578030|NCT00003315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102578031|NCT00003315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102578032|NCT00003315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102578033|NCT00003315|Antifungal Agents|antifungal agents|mesh-ancestor
102578034|NCT00002817|Sargramostim|sargramostim|mesh-list
102578035|NCT00002817|Immunologic Factors|immunologic factors|mesh-ancestor
102578036|NCT00002817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578037|NCT00003465|Temozolomide|temozolomide|mesh-list
102578038|NCT00003465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102578039|NCT00003465|Alkylating Agents|alkylating agents|mesh-ancestor
102578040|NCT00003465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578041|NCT00003465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578042|NCT00002823|Etoposide|etoposide|mesh-list
102578043|NCT00002823|Vinorelbine|vinorelbine|mesh-list
102578044|NCT00002823|Vinblastine|vinblastine|mesh-list
102578045|NCT00002823|Vindesine|vindesine|mesh-list
102578046|NCT00002823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578047|NCT00002823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102578048|NCT00002823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102578049|NCT00002823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102578050|NCT00002823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102578051|NCT00002823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578052|NCT00002823|Tubulin Modulators|tubulin modulators|mesh-ancestor
102578053|NCT00002823|Antimitotic Agents|antimitotic agents|mesh-ancestor
102578054|NCT00002823|Mitosis Modulators|mitosis modulators|mesh-ancestor
102578055|NCT00361621|Prednisone|prednisone|mesh-list
102578056|NCT00361621|Cyclophosphamide|cyclophosphamide|mesh-list
102578057|NCT00361621|Rituximab|rituximab|mesh-list
102578058|NCT00361621|Doxorubicin|doxorubicin|mesh-list
102578059|NCT00361621|Vincristine|vincristine|mesh-list
102578060|NCT00361621|Bortezomib|bortezomib|mesh-list
102578061|NCT00361621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102578062|NCT00361621|Immunologic Factors|immunologic factors|mesh-ancestor
102578063|NCT00361621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578064|NCT00361621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102578065|NCT00361621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102578066|NCT00361621|Alkylating Agents|alkylating agents|mesh-ancestor
102578067|NCT00361621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578068|NCT00361621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578069|NCT00361621|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102578070|NCT00361621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102578071|NCT00361621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102578072|NCT00361621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102578073|NCT00361621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102578074|NCT00361621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102578075|NCT00361621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102578076|NCT00361621|Glucocorticoids|glucocorticoids|mesh-ancestor
102578077|NCT00361621|Hormones|hormones|mesh-ancestor
102578078|NCT00361621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102578079|NCT00361621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102578080|NCT00361621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102578081|NCT00361621|Tubulin Modulators|tubulin modulators|mesh-ancestor
102578082|NCT00361621|Antimitotic Agents|antimitotic agents|mesh-ancestor
102578083|NCT00361621|Mitosis Modulators|mitosis modulators|mesh-ancestor
102578084|NCT00003327|Paclitaxel|paclitaxel|mesh-list
102578085|NCT00003327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102578086|NCT00003327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578087|NCT00003327|Tubulin Modulators|tubulin modulators|mesh-ancestor
102578088|NCT00003327|Antimitotic Agents|antimitotic agents|mesh-ancestor
102578089|NCT00003327|Mitosis Modulators|mitosis modulators|mesh-ancestor
102578090|NCT00003327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578091|NCT00003339|Interleukin-12|interleukin-12|mesh-list
102578092|NCT00003339|Freund's Adjuvant|freund's adjuvant|mesh-list
102578093|NCT00003339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102578094|NCT00003339|Immunologic Factors|immunologic factors|mesh-ancestor
102578095|NCT00003339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578096|NCT00003339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102578097|NCT00003339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102578098|NCT00003339|Growth Substances|growth substances|mesh-ancestor
102578099|NCT00003339|Growth Inhibitors|growth inhibitors|mesh-ancestor
102578100|NCT00003339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578101|NCT00002829|Interferons|interferons|mesh-list
102578102|NCT00002829|Interferon-alpha|interferon-alpha|mesh-list
102578103|NCT00002829|Cyclophosphamide|cyclophosphamide|mesh-list
102578104|NCT00002829|Etoposide|etoposide|mesh-list
102578105|NCT00002829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102578106|NCT00002829|Immunologic Factors|immunologic factors|mesh-ancestor
102578107|NCT00002829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578108|NCT00002829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102578109|NCT00002829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102578110|NCT00002829|Alkylating Agents|alkylating agents|mesh-ancestor
102578111|NCT00002829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578112|NCT00002829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578113|NCT00002829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102578114|NCT00002829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102578115|NCT00002829|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102578116|NCT00002829|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102578117|NCT00002829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102578118|NCT00002829|Antiviral Agents|antiviral agents|mesh-ancestor
102578119|NCT00002829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102578120|NCT03614221|Tacrolimus|tacrolimus|mesh-list
102578121|NCT03614221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102578122|NCT03614221|Immunologic Factors|immunologic factors|mesh-ancestor
102578123|NCT03614221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578124|NCT03614221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102578125|NCT03614221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102578126|NCT03614221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578127|NCT00003345|Irinotecan|irinotecan|mesh-list
102578128|NCT00003345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578129|NCT00003345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102578130|NCT00003345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102578131|NCT00003345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102578132|NCT00003345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578133|NCT03596905|Plecanatide|plecanatide|mesh-list
102578134|NCT03596905|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102578135|NCT03596905|Enzyme Activators|enzyme activators|mesh-ancestor
102578136|NCT03596905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578137|NCT03596905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102578138|NCT00002835|Leucovorin|leucovorin|mesh-list
102578139|NCT00002835|Interferons|interferons|mesh-list
102578140|NCT00002835|Cytarabine|cytarabine|mesh-list
102578141|NCT00002835|Interferon-alpha|interferon-alpha|mesh-list
102578142|NCT00002835|Methylprednisolone|methylprednisolone|mesh-list
102578143|NCT00002835|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102578144|NCT00002835|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102578145|NCT00002835|Prednisolone|prednisolone|mesh-list
102578146|NCT00002835|Prednisolone acetate|prednisolone acetate|mesh-list
102578147|NCT00002835|Cyclophosphamide|cyclophosphamide|mesh-list
102578148|NCT00002835|Melphalan|melphalan|mesh-list
102578149|NCT00002835|Ifosfamide|ifosfamide|mesh-list
102578150|NCT00002835|Carmustine|carmustine|mesh-list
102578151|NCT00002835|Cisplatin|cisplatin|mesh-list
102578152|NCT00002835|Methotrexate|methotrexate|mesh-list
102578153|NCT00002835|Etoposide|etoposide|mesh-list
102578154|NCT00002835|Vincristine|vincristine|mesh-list
102578155|NCT00002835|Mitoxantrone|mitoxantrone|mesh-list
102578156|NCT00002835|Idarubicin|idarubicin|mesh-list
102578157|NCT00002835|Bleomycin|bleomycin|mesh-list
102578158|NCT00002835|Levoleucovorin|levoleucovorin|mesh-list
102578159|NCT00002835|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102578160|NCT00002835|Prednisolone phosphate|prednisolone phosphate|mesh-list
102578161|NCT00002835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102578162|NCT00002835|Immunologic Factors|immunologic factors|mesh-ancestor
102578163|NCT00002835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578164|NCT00002835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102578165|NCT00002835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102578166|NCT00002835|Alkylating Agents|alkylating agents|mesh-ancestor
102578167|NCT00002835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578168|NCT00002835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578169|NCT00002835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102578170|NCT00002835|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102578171|NCT00002835|Abortifacient Agents|abortifacient agents|mesh-ancestor
102578172|NCT00002835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102578173|NCT00002835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102578174|NCT00002835|Antimetabolites|antimetabolites|mesh-ancestor
102578175|NCT00002835|Dermatologic Agents|dermatologic agents|mesh-ancestor
102578176|NCT00002835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102578177|NCT00002835|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102578178|NCT00002835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102578179|NCT00002835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102578180|NCT00002835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102578181|NCT00002835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102578182|NCT00002835|Antiviral Agents|antiviral agents|mesh-ancestor
102578183|NCT00002835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102578184|NCT00002835|Antidotes|antidotes|mesh-ancestor
102578185|NCT00002835|Protective Agents|protective agents|mesh-ancestor
102578186|NCT00002835|Vitamin B Complex|vitamin b complex|mesh-ancestor
102578187|NCT00002835|Vitamins|vitamins|mesh-ancestor
102578188|NCT00002835|Micronutrients|micronutrients|mesh-ancestor
102578189|NCT00002835|Tubulin Modulators|tubulin modulators|mesh-ancestor
102578190|NCT00002835|Antimitotic Agents|antimitotic agents|mesh-ancestor
102578191|NCT00002835|Mitosis Modulators|mitosis modulators|mesh-ancestor
102578192|NCT00002835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102578193|NCT00002835|Antiemetics|antiemetics|mesh-ancestor
102578194|NCT00002835|Autonomic Agents|autonomic agents|mesh-ancestor
102578195|NCT00002835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102578196|NCT00002835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102578197|NCT00002835|Glucocorticoids|glucocorticoids|mesh-ancestor
102578198|NCT00002835|Hormones|hormones|mesh-ancestor
102578199|NCT00002835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102578200|NCT00002835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102578201|NCT00002835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102578202|NCT00002835|Analgesics|analgesics|mesh-ancestor
102578203|NCT00002835|Sensory System Agents|sensory system agents|mesh-ancestor
102578204|NCT00002835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102578205|NCT00003351|Irinotecan|irinotecan|mesh-list
102578206|NCT00003351|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102578207|NCT00003351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102578208|NCT00003351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102578209|NCT00003351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578210|NCT00003351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578211|NCT00361153|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
102578212|NCT00361153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102578213|NCT00361153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102578214|NCT00361153|Antimetabolites|antimetabolites|mesh-ancestor
102578215|NCT00361153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578216|NCT00361153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102578217|NCT00002847|Interferons|interferons|mesh-list
102578218|NCT00002847|Interferon-alpha|interferon-alpha|mesh-list
102578219|NCT00002847|Aldesleukin|aldesleukin|mesh-list
102578220|NCT00002847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578221|NCT00002847|Antiviral Agents|antiviral agents|mesh-ancestor
102578222|NCT00002847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102578223|NCT00002847|Immunologic Factors|immunologic factors|mesh-ancestor
102578224|NCT00002847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578225|NCT00002847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102578226|NCT00002847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102578227|NCT03576001|Methyltestosterone|methyltestosterone|mesh-list
102578228|NCT03576001|Testosterone|testosterone|mesh-list
102578229|NCT03576001|Testosterone undecanoate|testosterone undecanoate|mesh-list
102578230|NCT03576001|Testosterone enanthate|testosterone enanthate|mesh-list
102578231|NCT03576001|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102578232|NCT03576001|Androgens|androgens|mesh-ancestor
102578233|NCT03576001|Hormones|hormones|mesh-ancestor
102578234|NCT03576001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102578235|NCT03576001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578236|NCT03576001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102578237|NCT03576001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578238|NCT03576001|Anabolic Agents|anabolic agents|mesh-ancestor
102578239|NCT04220827|Paclitaxel|paclitaxel|mesh-list
102578240|NCT04220827|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102578241|NCT04220827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102578242|NCT04220827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578243|NCT04220827|Tubulin Modulators|tubulin modulators|mesh-ancestor
102578244|NCT04220827|Antimitotic Agents|antimitotic agents|mesh-ancestor
102578245|NCT04220827|Mitosis Modulators|mitosis modulators|mesh-ancestor
102578246|NCT04220827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578247|NCT00002865|Leucovorin|leucovorin|mesh-list
102578248|NCT00002865|Cobalt|cobalt|mesh-list
102578249|NCT00002865|Cytarabine|cytarabine|mesh-list
102578250|NCT00002865|Dexamethasone|dexamethasone|mesh-list
102578251|NCT00002865|Hydrocortisone|hydrocortisone|mesh-list
102578252|NCT00002865|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102578253|NCT00002865|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102578254|NCT00002865|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102578255|NCT00002865|Cyclophosphamide|cyclophosphamide|mesh-list
102578256|NCT00002865|Ifosfamide|ifosfamide|mesh-list
102578257|NCT00002865|Doxorubicin|doxorubicin|mesh-list
102578258|NCT00002865|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102578259|NCT00002865|Methotrexate|methotrexate|mesh-list
102578260|NCT00002865|Etoposide|etoposide|mesh-list
102578261|NCT00002865|Vincristine|vincristine|mesh-list
102578262|NCT00002865|Levoleucovorin|levoleucovorin|mesh-list
102578263|NCT00002865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102578264|NCT00002865|Immunologic Factors|immunologic factors|mesh-ancestor
102578265|NCT00002865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578266|NCT00002865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102578267|NCT00002865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102578268|NCT00002865|Alkylating Agents|alkylating agents|mesh-ancestor
102578269|NCT00002865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578270|NCT00002865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578271|NCT00002865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102578272|NCT00002865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102578273|NCT00002865|Antiemetics|antiemetics|mesh-ancestor
102578274|NCT00002865|Autonomic Agents|autonomic agents|mesh-ancestor
102578275|NCT00002865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102578276|NCT00002865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102578277|NCT00002865|Glucocorticoids|glucocorticoids|mesh-ancestor
102578278|NCT00002865|Hormones|hormones|mesh-ancestor
102578279|NCT00002865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102578280|NCT00002865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102578281|NCT00002865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102578282|NCT00002865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102578283|NCT00002865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102578284|NCT00002865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102578285|NCT00002865|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102578286|NCT00002865|Abortifacient Agents|abortifacient agents|mesh-ancestor
102578287|NCT00002865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102578288|NCT00002865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102578289|NCT00002865|Antimetabolites|antimetabolites|mesh-ancestor
102578290|NCT00002865|Dermatologic Agents|dermatologic agents|mesh-ancestor
102578291|NCT00002865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102578292|NCT00002865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102578293|NCT00002865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102578294|NCT00002865|Antiviral Agents|antiviral agents|mesh-ancestor
102578295|NCT00002865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102578296|NCT00002865|Antidotes|antidotes|mesh-ancestor
102578297|NCT00002865|Protective Agents|protective agents|mesh-ancestor
102578298|NCT00002865|Vitamin B Complex|vitamin b complex|mesh-ancestor
102578299|NCT00002865|Vitamins|vitamins|mesh-ancestor
102578300|NCT00002865|Micronutrients|micronutrients|mesh-ancestor
102578301|NCT00002865|Tubulin Modulators|tubulin modulators|mesh-ancestor
102578302|NCT00002865|Antimitotic Agents|antimitotic agents|mesh-ancestor
102578303|NCT00002865|Mitosis Modulators|mitosis modulators|mesh-ancestor
102125231|NCT00963885|Lactams|lactams|mesh-list
102578304|NCT00002865|Trace Elements|trace elements|mesh-ancestor
102578305|NCT00361309|Sunitinib|sunitinib|mesh-list
102578306|NCT00361309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578307|NCT00361309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102578308|NCT00361309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102578309|NCT00361309|Growth Substances|growth substances|mesh-ancestor
102578310|NCT00361309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578311|NCT00361309|Growth Inhibitors|growth inhibitors|mesh-ancestor
102578312|NCT00361309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102578313|NCT00361309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102578314|NCT00361309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578315|NCT04154943|Cemiplimab|cemiplimab|mesh-list
102578316|NCT04154943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102578317|NCT04154943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578318|NCT00361387|Methylphenidate|methylphenidate|mesh-list
102578319|NCT00361387|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102578320|NCT00361387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578321|NCT00361387|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102578322|NCT00361387|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102578323|NCT00361387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102343850|NCT04501718|Etoposide|etoposide|mesh-list
102578324|NCT00361387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578325|NCT00361387|Dopamine Agents|dopamine agents|mesh-ancestor
102578326|NCT00361387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102578327|NCT04530487|Cyclosporine|cyclosporine|mesh-list
102578328|NCT04530487|Mycophenolic Acid|mycophenolic acid|mesh-list
102578329|NCT04530487|Fludarabine|fludarabine|mesh-list
102578330|NCT04530487|Fludarabine phosphate|fludarabine phosphate|mesh-list
102578331|NCT04530487|Etoposide|etoposide|mesh-list
102578332|NCT04530487|Etoposide phosphate|etoposide phosphate|mesh-list
102578333|NCT04530487|Melphalan|melphalan|mesh-list
102578334|NCT04530487|Mechlorethamine|mechlorethamine|mesh-list
102578335|NCT04530487|Thiotepa|thiotepa|mesh-list
102578336|NCT04530487|Podophyllotoxin|podophyllotoxin|mesh-list
102578337|NCT04530487|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102578338|NCT04530487|Tacrolimus|tacrolimus|mesh-list
102578339|NCT04530487|Cyclosporins|cyclosporins|mesh-list
102578340|NCT04530487|Thymoglobulin|thymoglobulin|mesh-list
102578341|NCT04530487|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102578342|NCT04530487|Immunoglobulins|immunoglobulins|mesh-list
102578343|NCT04530487|Antibodies|antibodies|mesh-list
102578344|NCT04530487|gamma-Globulins|gamma-globulins|mesh-list
102578345|NCT04530487|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102578346|NCT04530487|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102578347|NCT04530487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578348|NCT04530487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102578349|NCT04530487|Antimetabolites|antimetabolites|mesh-ancestor
102578350|NCT04530487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578351|NCT04530487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102578352|NCT04530487|Immunologic Factors|immunologic factors|mesh-ancestor
102578353|NCT04530487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578354|NCT04530487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102578355|NCT04530487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102578356|NCT04530487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102578357|NCT04530487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102578358|NCT04530487|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102578359|NCT04530487|Antifungal Agents|antifungal agents|mesh-ancestor
102578360|NCT04530487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102578361|NCT04530487|Dermatologic Agents|dermatologic agents|mesh-ancestor
102578362|NCT04530487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102578363|NCT04530487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102578364|NCT04530487|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102578365|NCT04530487|Antitubercular Agents|antitubercular agents|mesh-ancestor
102578366|NCT04530487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102578367|NCT04530487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102578368|NCT04530487|Alkylating Agents|alkylating agents|mesh-ancestor
102578369|NCT04530487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102578370|NCT04530487|Keratolytic Agents|keratolytic agents|mesh-ancestor
102578371|NCT04530487|Tubulin Modulators|tubulin modulators|mesh-ancestor
102578372|NCT04530487|Antimitotic Agents|antimitotic agents|mesh-ancestor
102578373|NCT04530487|Mitosis Modulators|mitosis modulators|mesh-ancestor
102578374|NCT00003369|Tirapazamine|tirapazamine|mesh-list
102578375|NCT00003369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578376|NCT04342351|Valsartan|valsartan|mesh-list
102578377|NCT04342351|Perindopril|perindopril|mesh-list
102578378|NCT04342351|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102578379|NCT04342351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102578380|NCT04342351|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102578381|NCT04342351|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102578382|NCT04342351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578383|NCT04342351|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102578384|NCT04342351|Protease Inhibitors|protease inhibitors|mesh-ancestor
102578385|NCT04342351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102578387|NCT04342273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102578388|NCT04342273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102578389|NCT04342273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102578390|NCT04342273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102578391|NCT04342273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102578392|NCT04342273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343862|NCT04501705|Apatinib|apatinib|mesh-list
102578393|NCT04342273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578394|NCT03504241|Mycophenolic Acid|mycophenolic acid|mesh-list
102578395|NCT03504241|Sirolimus|sirolimus|mesh-list
102578396|NCT03504241|Prednisone|prednisone|mesh-list
102578397|NCT03504241|Alemtuzumab|alemtuzumab|mesh-list
102578398|NCT03504241|Abatacept|abatacept|mesh-list
102578399|NCT03504241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102578400|NCT03504241|Glucocorticoids|glucocorticoids|mesh-ancestor
102578401|NCT03504241|Hormones|hormones|mesh-ancestor
102578402|NCT03504241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102578403|NCT03504241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578404|NCT03504241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102578405|NCT03504241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578406|NCT03504241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102578407|NCT03504241|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102578408|NCT03504241|Antitubercular Agents|antitubercular agents|mesh-ancestor
102578409|NCT03504241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102578410|NCT03504241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102578411|NCT03504241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102578412|NCT03504241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578413|NCT03504241|Antifungal Agents|antifungal agents|mesh-ancestor
102578414|NCT03504241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102578415|NCT03504241|Immunologic Factors|immunologic factors|mesh-ancestor
102578416|NCT03504241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102578417|NCT03504241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102578418|NCT03504241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102578419|NCT00003375|Vincristine|vincristine|mesh-list
102578420|NCT00003375|Lomustine|lomustine|mesh-list
102578421|NCT00003375|Procarbazine|procarbazine|mesh-list
102578422|NCT00003375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102578423|NCT00003375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578424|NCT00003375|Tubulin Modulators|tubulin modulators|mesh-ancestor
102578425|NCT00003375|Antimitotic Agents|antimitotic agents|mesh-ancestor
102578426|NCT00003375|Mitosis Modulators|mitosis modulators|mesh-ancestor
102578427|NCT00003375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578428|NCT00003375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102578429|NCT00003375|Alkylating Agents|alkylating agents|mesh-ancestor
102578430|NCT03499249|Acetylcysteine|acetylcysteine|mesh-list
102578431|NCT03499249|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102578432|NCT03499249|Antiviral Agents|antiviral agents|mesh-ancestor
102578433|NCT03499249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102578434|NCT03499249|Expectorants|expectorants|mesh-ancestor
102578435|NCT03499249|Respiratory System Agents|respiratory system agents|mesh-ancestor
102578436|NCT03499249|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102578437|NCT03499249|Antioxidants|antioxidants|mesh-ancestor
102578438|NCT03499249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578439|NCT03499249|Protective Agents|protective agents|mesh-ancestor
102578440|NCT03499249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578441|NCT03499249|Antidotes|antidotes|mesh-ancestor
102578442|NCT03498391|Ketamine|ketamine|mesh-list
102578443|NCT03498391|Propofol|propofol|mesh-list
102578444|NCT03498391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102578445|NCT03498391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102578446|NCT03498391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578447|NCT03498391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102578448|NCT03498391|Anesthetics, General|anesthetics, general|mesh-ancestor
102578449|NCT03498391|Anesthetics|anesthetics|mesh-ancestor
102578450|NCT03498391|Analgesics|analgesics|mesh-ancestor
102578451|NCT03498391|Sensory System Agents|sensory system agents|mesh-ancestor
102578452|NCT03498391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102578453|NCT03498391|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102578454|NCT03498391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102578455|NCT03498391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102578456|NCT03498391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102578457|NCT03498391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578458|NCT00003939|Trabectedin|trabectedin|mesh-list
102578459|NCT00003939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102578460|NCT00003939|Alkylating Agents|alkylating agents|mesh-ancestor
102578461|NCT00003939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578462|NCT00003939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578463|NCT00003543|Fluorouracil|fluorouracil|mesh-list
102578464|NCT00003543|Vincristine|vincristine|mesh-list
102578465|NCT00003543|Carmustine|carmustine|mesh-list
102578466|NCT00003543|Streptozocin|streptozocin|mesh-list
102578467|NCT00003543|Antibodies|antibodies|mesh-list
102578468|NCT00003543|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102578469|NCT00003543|Immunologic Factors|immunologic factors|mesh-ancestor
102578470|NCT00003543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578471|NCT00003543|Antimetabolites|antimetabolites|mesh-ancestor
102578472|NCT00003543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578473|NCT00003543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102578474|NCT00003543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578475|NCT00003543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102578476|NCT00003543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102578477|NCT00003543|Tubulin Modulators|tubulin modulators|mesh-ancestor
102578478|NCT00003543|Antimitotic Agents|antimitotic agents|mesh-ancestor
102578479|NCT00003543|Mitosis Modulators|mitosis modulators|mesh-ancestor
102578480|NCT00003543|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102578481|NCT00003543|Alkylating Agents|alkylating agents|mesh-ancestor
102578482|NCT00003543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102578483|NCT00003549|Cyclophosphamide|cyclophosphamide|mesh-list
102578484|NCT00003549|Fluorouracil|fluorouracil|mesh-list
102578485|NCT00003549|Methotrexate|methotrexate|mesh-list
102578486|NCT00003549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102578487|NCT00003549|Immunologic Factors|immunologic factors|mesh-ancestor
102578488|NCT00003549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578489|NCT00003549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102578490|NCT00003549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102578491|NCT00003549|Alkylating Agents|alkylating agents|mesh-ancestor
102578492|NCT00003549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578493|NCT00003549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578494|NCT00003549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102578495|NCT00003549|Antimetabolites|antimetabolites|mesh-ancestor
102578496|NCT00003549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102578497|NCT00003549|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102578498|NCT00003549|Abortifacient Agents|abortifacient agents|mesh-ancestor
102578499|NCT00003549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102578500|NCT00003549|Dermatologic Agents|dermatologic agents|mesh-ancestor
102578501|NCT00003549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102578502|NCT00003549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102578503|NCT00003549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102578504|NCT00002883|Fluorouracil|fluorouracil|mesh-list
102578505|NCT00002883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578506|NCT00002883|Antimetabolites|antimetabolites|mesh-ancestor
102578507|NCT00002883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578508|NCT00002883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102578509|NCT00002883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102578510|NCT00002883|Immunologic Factors|immunologic factors|mesh-ancestor
102578511|NCT00002883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578512|NCT03492463|Nicotine|nicotine|mesh-list
102578513|NCT03492463|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102578514|NCT03492463|Autonomic Agents|autonomic agents|mesh-ancestor
102578515|NCT03492463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102578516|NCT03492463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578517|NCT03492463|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102578518|NCT03492463|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102578519|NCT03492463|Cholinergic Agents|cholinergic agents|mesh-ancestor
102578520|NCT03492463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102578521|NCT03492463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578522|NCT00003945|Topotecan|topotecan|mesh-list
102578523|NCT00003945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578524|NCT00003945|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102578525|NCT00003945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102578526|NCT00003945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102578527|NCT00003945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578528|NCT00003951|Exatecan|exatecan|mesh-list
102125449|NCT04415840|Hemostatics|hemostatics|mesh-ancestor
102578529|NCT00003951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102578531|NCT00003951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102578532|NCT00003951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578533|NCT00003951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578534|NCT00003957|Cytarabine|cytarabine|mesh-list
102578535|NCT00003957|Paclitaxel|paclitaxel|mesh-list
102578536|NCT00003957|Etoposide|etoposide|mesh-list
102578537|NCT00003957|Cyclophosphamide|cyclophosphamide|mesh-list
102578538|NCT00003957|Melphalan|melphalan|mesh-list
102578539|NCT00003957|Mitoxantrone|mitoxantrone|mesh-list
102578540|NCT00003957|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102578541|NCT00003957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578542|NCT00003957|Tubulin Modulators|tubulin modulators|mesh-ancestor
102578543|NCT00003957|Antimitotic Agents|antimitotic agents|mesh-ancestor
102578544|NCT00003957|Mitosis Modulators|mitosis modulators|mesh-ancestor
102578545|NCT00003957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578546|NCT00003957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102578547|NCT00003957|Immunologic Factors|immunologic factors|mesh-ancestor
102578548|NCT00003957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578549|NCT00003957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102578550|NCT00003957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102578551|NCT00003957|Alkylating Agents|alkylating agents|mesh-ancestor
102578552|NCT00003957|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102578553|NCT00003957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102578554|NCT00003957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102578555|NCT00003957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102578556|NCT00003957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102578557|NCT00003957|Antimetabolites|antimetabolites|mesh-ancestor
102578558|NCT00003957|Antiviral Agents|antiviral agents|mesh-ancestor
102578559|NCT00003957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102578560|NCT00003957|Analgesics|analgesics|mesh-ancestor
102578561|NCT00003957|Sensory System Agents|sensory system agents|mesh-ancestor
102578562|NCT00003957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102578563|NCT00004833|Immunoglobulins|immunoglobulins|mesh-list
102578564|NCT00004833|Antibodies|antibodies|mesh-list
102578565|NCT00004833|gamma-Globulins|gamma-globulins|mesh-list
102578566|NCT00004833|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102578567|NCT00004833|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102578568|NCT00004833|Immunologic Factors|immunologic factors|mesh-ancestor
102578569|NCT00004833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578570|NCT00003555|Paclitaxel|paclitaxel|mesh-list
102578571|NCT00003555|Amifostine|amifostine|mesh-list
102578572|NCT00003555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102578573|NCT00003555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578574|NCT00003555|Tubulin Modulators|tubulin modulators|mesh-ancestor
102578575|NCT00003555|Antimitotic Agents|antimitotic agents|mesh-ancestor
102578576|NCT00003555|Mitosis Modulators|mitosis modulators|mesh-ancestor
102578577|NCT00003555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578578|NCT00003555|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102578579|NCT00003555|Protective Agents|protective agents|mesh-ancestor
102578580|NCT00003555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578581|NCT00003963|Rituximab|rituximab|mesh-list
102578582|NCT00003963|Vinorelbine|vinorelbine|mesh-list
102578583|NCT00003963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102578584|NCT00003963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578585|NCT00003963|Immunologic Factors|immunologic factors|mesh-ancestor
102578586|NCT00003963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578587|NCT00003963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102578588|NCT00003963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102578589|NCT00003963|Tubulin Modulators|tubulin modulators|mesh-ancestor
102578590|NCT00003963|Antimitotic Agents|antimitotic agents|mesh-ancestor
102578591|NCT00003963|Mitosis Modulators|mitosis modulators|mesh-ancestor
102578592|NCT00003963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578593|NCT00004845|Naproxen|naproxen|mesh-list
102578594|NCT00004845|Rofecoxib|rofecoxib|mesh-list
102578595|NCT00004845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102578596|NCT00004845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102578597|NCT00004845|Analgesics|analgesics|mesh-ancestor
102578598|NCT00004845|Sensory System Agents|sensory system agents|mesh-ancestor
102578599|NCT00004845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102578600|NCT00004845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578601|NCT00004845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102578602|NCT00004845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102578603|NCT00004845|Gout Suppressants|gout suppressants|mesh-ancestor
102578604|NCT00004845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102578605|NCT00004845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102578606|NCT00004845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578607|NCT00004845|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102578608|NCT00003981|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
102578609|NCT00003981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578610|NCT00003981|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102578611|NCT00003981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102578612|NCT00003981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578613|NCT00003993|Aldesleukin|aldesleukin|mesh-list
102578614|NCT00003993|Bryostatin 1|bryostatin 1|mesh-list
102578615|NCT00003993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578616|NCT00003993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102578617|NCT00003993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102578618|NCT00003993|Antiviral Agents|antiviral agents|mesh-ancestor
102578619|NCT00003993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102578620|NCT00003993|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102578621|NCT00003993|Immunologic Factors|immunologic factors|mesh-ancestor
102578622|NCT00003993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578623|NCT00004857|Fludarabine|fludarabine|mesh-list
102578624|NCT00004857|Fludarabine phosphate|fludarabine phosphate|mesh-list
102578625|NCT00004857|Alemtuzumab|alemtuzumab|mesh-list
102578626|NCT00004857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578627|NCT00004857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102578628|NCT00004857|Antimetabolites|antimetabolites|mesh-ancestor
102578629|NCT00004857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578630|NCT00004857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102578631|NCT00004857|Immunologic Factors|immunologic factors|mesh-ancestor
102578632|NCT00004857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578633|NCT00004857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102578634|NCT03476239|Blinatumomab|blinatumomab|mesh-list
102578635|NCT03476239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578636|NCT00004863|Paclitaxel|paclitaxel|mesh-list
102578637|NCT00004863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102578638|NCT00004863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578639|NCT00004863|Tubulin Modulators|tubulin modulators|mesh-ancestor
102578640|NCT00004863|Antimitotic Agents|antimitotic agents|mesh-ancestor
102578641|NCT00004863|Mitosis Modulators|mitosis modulators|mesh-ancestor
102578642|NCT00004863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578643|NCT00004875|Heparin|heparin|mesh-list
102578644|NCT00004875|Enoxaparin|enoxaparin|mesh-list
102578645|NCT00004875|Anticoagulants|anticoagulants|mesh-ancestor
102578646|NCT00004875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102578647|NCT00004875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102578648|NCT00004875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578649|NCT00003561|Interferons|interferons|mesh-list
102578650|NCT00003561|Interferon-alpha|interferon-alpha|mesh-list
102578651|NCT00003561|Sargramostim|sargramostim|mesh-list
102578652|NCT00003561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578653|NCT00003561|Antiviral Agents|antiviral agents|mesh-ancestor
102578654|NCT00003561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102578655|NCT00003561|Immunologic Factors|immunologic factors|mesh-ancestor
102578656|NCT00003561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578657|NCT00003567|Temozolomide|temozolomide|mesh-list
102578658|NCT00003567|Carmustine|carmustine|mesh-list
102578659|NCT00003567|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
102578660|NCT00003567|Sargramostim|sargramostim|mesh-list
102578661|NCT00003567|Immunologic Factors|immunologic factors|mesh-ancestor
102578662|NCT00003567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578663|NCT00003567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102578664|NCT00003567|Alkylating Agents|alkylating agents|mesh-ancestor
102578665|NCT00003567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578666|NCT00003567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578667|NCT00003567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102578668|NCT00003573|Cyclophosphamide|cyclophosphamide|mesh-list
102578669|NCT00003573|Cisplatin|cisplatin|mesh-list
102578670|NCT00003573|Etoposide|etoposide|mesh-list
102578671|NCT00003573|Vincristine|vincristine|mesh-list
102578672|NCT00003573|Lenograstim|lenograstim|mesh-list
102578673|NCT00003573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102578674|NCT00003573|Immunologic Factors|immunologic factors|mesh-ancestor
102578675|NCT00003573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578676|NCT00003573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102578677|NCT00003573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102578678|NCT00003573|Alkylating Agents|alkylating agents|mesh-ancestor
102578679|NCT00003573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578680|NCT00003573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578681|NCT00003573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102578682|NCT00003573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102578683|NCT00003573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102578684|NCT00003573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102578685|NCT00003573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102578686|NCT00003573|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102578687|NCT00003573|Tubulin Modulators|tubulin modulators|mesh-ancestor
102578688|NCT00003573|Antimitotic Agents|antimitotic agents|mesh-ancestor
102578689|NCT00003573|Mitosis Modulators|mitosis modulators|mesh-ancestor
102578690|NCT03468985|Nivolumab|nivolumab|mesh-list
102578691|NCT03468985|Ipilimumab|ipilimumab|mesh-list
102578692|NCT03468985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102578693|NCT03468985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578694|NCT03468985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102578695|NCT03468985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578696|NCT00003585|Interferons|interferons|mesh-list
102578697|NCT00003585|Interferon-alpha|interferon-alpha|mesh-list
102578698|NCT00003585|Aldesleukin|aldesleukin|mesh-list
102578699|NCT00003585|Fluorouracil|fluorouracil|mesh-list
102578700|NCT00003585|Isotretinoin|isotretinoin|mesh-list
102578701|NCT00003585|Antimetabolites|antimetabolites|mesh-ancestor
102578702|NCT00003585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578703|NCT00003585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102578704|NCT00003585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578705|NCT00003585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102578706|NCT00003585|Immunologic Factors|immunologic factors|mesh-ancestor
102578707|NCT00003585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578708|NCT00003585|Antiviral Agents|antiviral agents|mesh-ancestor
102578709|NCT00003585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102578710|NCT00003585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102578711|NCT00003585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102578712|NCT00003585|Dermatologic Agents|dermatologic agents|mesh-ancestor
102578713|NCT00003591|Paclitaxel|paclitaxel|mesh-list
102578714|NCT00003591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102578715|NCT00003591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578716|NCT00003591|Tubulin Modulators|tubulin modulators|mesh-ancestor
102578717|NCT00003591|Antimitotic Agents|antimitotic agents|mesh-ancestor
102578718|NCT00003591|Mitosis Modulators|mitosis modulators|mesh-ancestor
102578719|NCT00003591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578720|NCT02975323|Carvedilol|carvedilol|mesh-list
102578721|NCT02975323|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102578722|NCT02975323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102578723|NCT02975323|Adrenergic Agents|adrenergic agents|mesh-ancestor
102578724|NCT02975323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102578725|NCT02975323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578726|NCT02975323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578727|NCT02975323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102578728|NCT02975323|Antioxidants|antioxidants|mesh-ancestor
102578729|NCT02975323|Protective Agents|protective agents|mesh-ancestor
102578730|NCT02975323|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102578731|NCT02975323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102578732|NCT02975323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102578733|NCT02975323|Vasodilator Agents|vasodilator agents|mesh-ancestor
102578734|NCT02975323|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102578735|NCT02975323|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102578736|NCT00003597|Carboplatin|carboplatin|mesh-list
102578737|NCT00003597|Etoposide|etoposide|mesh-list
102578738|NCT00003597|Ifosfamide|ifosfamide|mesh-list
102578739|NCT00003597|Lenograstim|lenograstim|mesh-list
102578740|NCT00003597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578741|NCT00003597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102578742|NCT00003597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102578743|NCT00003597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102578744|NCT00003597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102578745|NCT00003597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578746|NCT00003597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102578747|NCT00003597|Alkylating Agents|alkylating agents|mesh-ancestor
102578748|NCT00003597|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102578749|NCT00003597|Immunologic Factors|immunologic factors|mesh-ancestor
102578750|NCT00003597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578751|NCT00004005|Leucovorin|leucovorin|mesh-list
102578752|NCT00004005|Fluorouracil|fluorouracil|mesh-list
102578753|NCT00004005|Irinotecan|irinotecan|mesh-list
102578754|NCT00004005|Calcium|calcium|mesh-list
102578755|NCT00004005|Levoleucovorin|levoleucovorin|mesh-list
102578756|NCT00004005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102578757|NCT00004005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578758|NCT00004005|Antimetabolites|antimetabolites|mesh-ancestor
102578759|NCT00004005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578760|NCT00004005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102578761|NCT00004005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578762|NCT00004005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102578763|NCT00004005|Immunologic Factors|immunologic factors|mesh-ancestor
102578764|NCT00004005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102578765|NCT00004005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102578766|NCT00004005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102578767|NCT00004005|Antidotes|antidotes|mesh-ancestor
102578768|NCT00004005|Protective Agents|protective agents|mesh-ancestor
102578769|NCT00004005|Vitamin B Complex|vitamin b complex|mesh-ancestor
102578770|NCT00004005|Vitamins|vitamins|mesh-ancestor
102578771|NCT00004005|Micronutrients|micronutrients|mesh-ancestor
102578772|NCT00003603|Dexamethasone|dexamethasone|mesh-list
102578773|NCT00003603|Prednisolone|prednisolone|mesh-list
102578774|NCT00003603|Cyclophosphamide|cyclophosphamide|mesh-list
102578775|NCT00003603|Melphalan|melphalan|mesh-list
102578776|NCT00003603|Lomustine|lomustine|mesh-list
102578777|NCT00003603|Idarubicin|idarubicin|mesh-list
102578778|NCT00003603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102578779|NCT00003603|Immunologic Factors|immunologic factors|mesh-ancestor
102578780|NCT00003603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578781|NCT00003603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102578782|NCT00003603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102578783|NCT00003603|Alkylating Agents|alkylating agents|mesh-ancestor
102578784|NCT00003603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578785|NCT00003603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578786|NCT00003603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102578787|NCT00003603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102578788|NCT00003603|Antiemetics|antiemetics|mesh-ancestor
102578789|NCT00003603|Autonomic Agents|autonomic agents|mesh-ancestor
102578790|NCT00003603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102578791|NCT00003603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102578792|NCT00003603|Glucocorticoids|glucocorticoids|mesh-ancestor
102578793|NCT00003603|Hormones|hormones|mesh-ancestor
102578794|NCT00003603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102578795|NCT00003603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102578796|NCT00003603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102578797|NCT00003603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102578798|NCT00003603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102578799|NCT00003603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102578800|NCT00004887|Paclitaxel|paclitaxel|mesh-list
102578801|NCT00004887|Vinblastine|vinblastine|mesh-list
102578802|NCT00004887|Carboplatin|carboplatin|mesh-list
102578803|NCT00004887|Ifosfamide|ifosfamide|mesh-list
102578804|NCT00004887|Mitomycins|mitomycins|mesh-list
102578805|NCT00004887|Mitomycin|mitomycin|mesh-list
102578806|NCT00004887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102578807|NCT00004887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578808|NCT00004887|Tubulin Modulators|tubulin modulators|mesh-ancestor
102578809|NCT00004887|Antimitotic Agents|antimitotic agents|mesh-ancestor
102578810|NCT00004887|Mitosis Modulators|mitosis modulators|mesh-ancestor
102578811|NCT00004887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578812|NCT00004887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102578813|NCT00004887|Alkylating Agents|alkylating agents|mesh-ancestor
102578814|NCT00004887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102578815|NCT00004887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102578816|NCT00004887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102578817|NCT00004893|Interleukin-12|interleukin-12|mesh-list
102578818|NCT00004893|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102578819|NCT00004893|Immunologic Factors|immunologic factors|mesh-ancestor
102578820|NCT00004893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578821|NCT00004893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102578822|NCT00004893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102578823|NCT00004893|Growth Substances|growth substances|mesh-ancestor
102578824|NCT00004893|Growth Inhibitors|growth inhibitors|mesh-ancestor
102578825|NCT00004893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578826|NCT04513951|Leucovorin|leucovorin|mesh-list
102578827|NCT04513951|Fluorouracil|fluorouracil|mesh-list
102578828|NCT04513951|Oxaliplatin|oxaliplatin|mesh-list
102578829|NCT04513951|Irinotecan|irinotecan|mesh-list
102578830|NCT04513951|Cetuximab|cetuximab|mesh-list
102578831|NCT04513951|Avelumab|avelumab|mesh-list
102578832|NCT04513951|Levoleucovorin|levoleucovorin|mesh-list
102578833|NCT04513951|Antimetabolites|antimetabolites|mesh-ancestor
102578834|NCT04513951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578835|NCT04513951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102578836|NCT04513951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578837|NCT04513951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102578838|NCT04513951|Immunologic Factors|immunologic factors|mesh-ancestor
102578839|NCT04513951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578840|NCT04513951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102578841|NCT04513951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102578842|NCT04513951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102578843|NCT04513951|Antidotes|antidotes|mesh-ancestor
102578844|NCT04513951|Protective Agents|protective agents|mesh-ancestor
102578845|NCT04513951|Vitamin B Complex|vitamin b complex|mesh-ancestor
102578846|NCT04513951|Vitamins|vitamins|mesh-ancestor
102578847|NCT04513951|Micronutrients|micronutrients|mesh-ancestor
102578848|NCT04513951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102578849|NCT00004011|Paclitaxel|paclitaxel|mesh-list
102578850|NCT00004011|Carboplatin|carboplatin|mesh-list
102578851|NCT00004011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102578852|NCT00004011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578853|NCT00004011|Tubulin Modulators|tubulin modulators|mesh-ancestor
102578854|NCT00004011|Antimitotic Agents|antimitotic agents|mesh-ancestor
102578855|NCT00004011|Mitosis Modulators|mitosis modulators|mesh-ancestor
102578856|NCT00004011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578857|NCT00004017|Antibodies|antibodies|mesh-list
102578858|NCT00004017|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102578859|NCT00004017|Immunologic Factors|immunologic factors|mesh-ancestor
102578860|NCT00004017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578861|NCT00004905|Interferons|interferons|mesh-list
102578862|NCT00004905|Cytarabine|cytarabine|mesh-list
102578863|NCT00004905|Interferon-alpha|interferon-alpha|mesh-list
102578864|NCT00004905|Cyclophosphamide|cyclophosphamide|mesh-list
102578865|NCT00004905|Etoposide|etoposide|mesh-list
102578866|NCT00004905|Idarubicin|idarubicin|mesh-list
102578867|NCT00004905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102578868|NCT00004905|Immunologic Factors|immunologic factors|mesh-ancestor
102578869|NCT00004905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578870|NCT00004905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102578871|NCT00004905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102578872|NCT00004905|Alkylating Agents|alkylating agents|mesh-ancestor
102578873|NCT00004905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578874|NCT00004905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578875|NCT00004905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102578876|NCT00004905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102578877|NCT00004905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102578878|NCT00004905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102578879|NCT00004905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102578880|NCT00004905|Antiviral Agents|antiviral agents|mesh-ancestor
102578881|NCT00004905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102578882|NCT00004905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102578883|NCT00004905|Antimetabolites|antimetabolites|mesh-ancestor
102578884|NCT00004905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102578885|NCT00004029|Sargramostim|sargramostim|mesh-list
102578886|NCT00004029|Vaccines|vaccines|mesh-list
102578887|NCT00004029|Immunologic Factors|immunologic factors|mesh-ancestor
102578888|NCT00004029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578889|NCT00362323|Metformin|metformin|mesh-list
102578890|NCT00362323|Fenofibrate|fenofibrate|mesh-list
102578891|NCT00362323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102578892|NCT00362323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578893|NCT00362323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102578894|NCT00362323|Antimetabolites|antimetabolites|mesh-ancestor
102578895|NCT00362323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578896|NCT00362323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102578897|NCT00004917|Epoetin Alfa|epoetin alfa|mesh-list
102578898|NCT00004917|Hematinics|hematinics|mesh-ancestor
102578899|NCT00421915|Etanercept|etanercept|mesh-list
102578900|NCT00421915|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102578901|NCT00421915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102578902|NCT00421915|Analgesics|analgesics|mesh-ancestor
102578903|NCT00421915|Sensory System Agents|sensory system agents|mesh-ancestor
102578904|NCT00421915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102578905|NCT00421915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578906|NCT00421915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102578907|NCT00421915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102578908|NCT00421915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102578909|NCT00421915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102578910|NCT00421915|Immunologic Factors|immunologic factors|mesh-ancestor
102578911|NCT00362713|Ipilimumab|ipilimumab|mesh-list
102343957|NCT04117178|Memantine|memantine|mesh-list
102578912|NCT00362713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102578913|NCT00362713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578914|NCT00362713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102578915|NCT00362713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578916|NCT00004047|Exatecan|exatecan|mesh-list
102578917|NCT00004047|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102578918|NCT00004047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102578919|NCT00004047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102578920|NCT00004047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578921|NCT00004047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578922|NCT00003627|Fluorouracil|fluorouracil|mesh-list
102578923|NCT00003627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578924|NCT00003627|Antimetabolites|antimetabolites|mesh-ancestor
102578925|NCT00003627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578926|NCT00003627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102578927|NCT00003627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102578928|NCT00003627|Immunologic Factors|immunologic factors|mesh-ancestor
102578929|NCT00003627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578930|NCT00004059|Fluorouracil|fluorouracil|mesh-list
102578931|NCT00004059|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
102578932|NCT00004059|Antimetabolites|antimetabolites|mesh-ancestor
102578933|NCT00004059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578934|NCT00004059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102578935|NCT00004059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578936|NCT00004059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102578937|NCT00004059|Immunologic Factors|immunologic factors|mesh-ancestor
102578938|NCT00004059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578939|NCT00004059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102578940|NCT00004059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102578941|NCT00003633|Prednisone|prednisone|mesh-list
102578942|NCT00003633|Docetaxel|docetaxel|mesh-list
102578943|NCT00003633|Mitoxantrone|mitoxantrone|mesh-list
102578944|NCT00003633|Estramustine|estramustine|mesh-list
102578945|NCT00003633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578946|NCT00003633|Tubulin Modulators|tubulin modulators|mesh-ancestor
102578947|NCT00003633|Antimitotic Agents|antimitotic agents|mesh-ancestor
102578948|NCT00003633|Mitosis Modulators|mitosis modulators|mesh-ancestor
102578949|NCT00003633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578950|NCT00003633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102578951|NCT00003633|Glucocorticoids|glucocorticoids|mesh-ancestor
102578952|NCT00003633|Hormones|hormones|mesh-ancestor
102578953|NCT00003633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102578954|NCT00003633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578955|NCT00003633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102578956|NCT00003633|Analgesics|analgesics|mesh-ancestor
102578957|NCT00003633|Sensory System Agents|sensory system agents|mesh-ancestor
102578958|NCT00003633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102578959|NCT00003633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102578960|NCT00003633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102578961|NCT00003633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102578962|NCT00003633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102578963|NCT00003633|Alkylating Agents|alkylating agents|mesh-ancestor
102578964|NCT00003639|Interferons|interferons|mesh-list
102578965|NCT00003639|Interferon-alpha|interferon-alpha|mesh-list
102578966|NCT00003639|Dexamethasone|dexamethasone|mesh-list
102578967|NCT00003639|Idarubicin|idarubicin|mesh-list
102578968|NCT00003639|Chlorambucil|chlorambucil|mesh-list
102578969|NCT00003639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102578970|NCT00003639|Antiemetics|antiemetics|mesh-ancestor
102578971|NCT00003639|Autonomic Agents|autonomic agents|mesh-ancestor
102578972|NCT00003639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102578973|NCT00003639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102578974|NCT00003639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102578975|NCT00003639|Glucocorticoids|glucocorticoids|mesh-ancestor
102578976|NCT00003639|Hormones|hormones|mesh-ancestor
102578977|NCT00003639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102578978|NCT00003639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102578979|NCT00003639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578980|NCT00003639|Antiviral Agents|antiviral agents|mesh-ancestor
102578981|NCT00003639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102578982|NCT00003639|Immunologic Factors|immunologic factors|mesh-ancestor
102578983|NCT00003639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102578984|NCT00003639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102578985|NCT00003639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102578986|NCT00003639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102578987|NCT00003639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578988|NCT00003639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102578989|NCT00003639|Alkylating Agents|alkylating agents|mesh-ancestor
102578991|NCT00004923|Irinotecan|irinotecan|mesh-list
102578992|NCT00004923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102578993|NCT00004923|Tubulin Modulators|tubulin modulators|mesh-ancestor
102578994|NCT00004923|Antimitotic Agents|antimitotic agents|mesh-ancestor
102578995|NCT00004923|Mitosis Modulators|mitosis modulators|mesh-ancestor
102578996|NCT00004923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102578997|NCT00004923|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102578998|NCT00004923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102578999|NCT00004923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102579000|NCT00004071|Prednisone|prednisone|mesh-list
102579001|NCT00004071|Mitoxantrone|mitoxantrone|mesh-list
102579002|NCT00004071|Leflunomide|leflunomide|mesh-list
102579003|NCT00004071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102579004|NCT00004071|Glucocorticoids|glucocorticoids|mesh-ancestor
102579005|NCT00004071|Hormones|hormones|mesh-ancestor
102579006|NCT00004071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102579007|NCT00004071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579008|NCT00004071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102579009|NCT00004071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579010|NCT00004071|Analgesics|analgesics|mesh-ancestor
102579011|NCT00004071|Sensory System Agents|sensory system agents|mesh-ancestor
102579012|NCT00004071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102579013|NCT00004071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102579014|NCT00004071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102579015|NCT00004071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102579016|NCT00004071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579017|NCT00004071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102579018|NCT00004071|Immunologic Factors|immunologic factors|mesh-ancestor
102579019|NCT00004077|Paclitaxel|paclitaxel|mesh-list
102579020|NCT00004077|Ifosfamide|ifosfamide|mesh-list
102579021|NCT00004077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102579022|NCT00004077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579023|NCT00004077|Tubulin Modulators|tubulin modulators|mesh-ancestor
102579024|NCT00004077|Antimitotic Agents|antimitotic agents|mesh-ancestor
102579025|NCT00004077|Mitosis Modulators|mitosis modulators|mesh-ancestor
102579026|NCT00004077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579027|NCT00004077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102579028|NCT00004077|Alkylating Agents|alkylating agents|mesh-ancestor
102579029|NCT00004083|Cisplatin|cisplatin|mesh-list
102579030|NCT00004083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579031|NCT00004941|Infliximab|infliximab|mesh-list
102579032|NCT00004941|Antibodies|antibodies|mesh-list
102579033|NCT00004941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102579034|NCT00004941|Immunologic Factors|immunologic factors|mesh-ancestor
102579035|NCT00004941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579036|NCT00004941|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102579037|NCT00004941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102579038|NCT00004941|Dermatologic Agents|dermatologic agents|mesh-ancestor
102579039|NCT00004941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102579040|NCT00004941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102579041|NCT00003657|Carboplatin|carboplatin|mesh-list
102579042|NCT00003657|Etoposide|etoposide|mesh-list
102579043|NCT00003657|Ifosfamide|ifosfamide|mesh-list
102579044|NCT00003657|Amifostine|amifostine|mesh-list
102579045|NCT00003657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579046|NCT00003657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102579047|NCT00003657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102579048|NCT00003657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102579049|NCT00003657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102579050|NCT00003657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579051|NCT00003657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579052|NCT00003657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102579053|NCT00003657|Alkylating Agents|alkylating agents|mesh-ancestor
102579054|NCT00003657|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102579055|NCT00003657|Protective Agents|protective agents|mesh-ancestor
102579056|NCT00004089|Paclitaxel|paclitaxel|mesh-list
102579057|NCT00004089|Fluorouracil|fluorouracil|mesh-list
102579058|NCT00004089|Hydroxyurea|hydroxyurea|mesh-list
102579059|NCT00004089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102579060|NCT00004089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579061|NCT00004089|Tubulin Modulators|tubulin modulators|mesh-ancestor
102579062|NCT00004089|Antimitotic Agents|antimitotic agents|mesh-ancestor
102579063|NCT00004089|Mitosis Modulators|mitosis modulators|mesh-ancestor
102579064|NCT00004089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579065|NCT00004089|Antimetabolites|antimetabolites|mesh-ancestor
102125970|NCT03293108|Vitamin D|vitamin d|mesh-list
102579066|NCT00004089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102579067|NCT00004089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102579068|NCT00004089|Immunologic Factors|immunologic factors|mesh-ancestor
102579069|NCT00004089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579070|NCT00004089|Antisickling Agents|antisickling agents|mesh-ancestor
102579071|NCT00004089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102579072|NCT00004089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102579073|NCT00004095|Gemcitabine|gemcitabine|mesh-list
102579074|NCT00004095|Irinotecan|irinotecan|mesh-list
102579075|NCT00004095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102579076|NCT00004095|Antimetabolites|antimetabolites|mesh-ancestor
102579077|NCT00004095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579078|NCT00004095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579079|NCT00004095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102579080|NCT00004095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102579081|NCT00004095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102579082|NCT00003663|Dexamethasone|dexamethasone|mesh-list
102579083|NCT00003663|Rituximab|rituximab|mesh-list
102579084|NCT00003663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102579085|NCT00003663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579086|NCT00003663|Immunologic Factors|immunologic factors|mesh-ancestor
102579087|NCT00003663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579088|NCT00003663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102579089|NCT00003663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102579090|NCT00003663|Antiemetics|antiemetics|mesh-ancestor
102579091|NCT00003663|Autonomic Agents|autonomic agents|mesh-ancestor
102579092|NCT00003663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102579093|NCT00003663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102579094|NCT00003663|Glucocorticoids|glucocorticoids|mesh-ancestor
102579095|NCT00003663|Hormones|hormones|mesh-ancestor
102579096|NCT00003663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102579097|NCT00003663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102579098|NCT00004107|Epratuzumab|epratuzumab|mesh-list
102579099|NCT00004107|Antibodies|antibodies|mesh-list
102579100|NCT00004107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102579101|NCT00004107|Immunologic Factors|immunologic factors|mesh-ancestor
102343993|NCT04094961|Glucocorticoids|glucocorticoids|mesh-ancestor
102579102|NCT00004107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579103|NCT00004107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102579104|NCT00004107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579105|NCT00004113|Temozolomide|temozolomide|mesh-list
102579106|NCT00004113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102579107|NCT00004113|Alkylating Agents|alkylating agents|mesh-ancestor
102579108|NCT00004113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579109|NCT00004113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579110|NCT00003675|Topotecan|topotecan|mesh-list
102579111|NCT00003675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102579112|NCT00003675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102579113|NCT00003675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102579114|NCT00003675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579115|NCT00003675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579116|NCT00004137|Paclitaxel|paclitaxel|mesh-list
102579117|NCT00004137|Carboplatin|carboplatin|mesh-list
102579118|NCT00004137|Topotecan|topotecan|mesh-list
102579119|NCT00004137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102579120|NCT00004137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579121|NCT00004137|Tubulin Modulators|tubulin modulators|mesh-ancestor
102579122|NCT00004137|Antimitotic Agents|antimitotic agents|mesh-ancestor
102579123|NCT00004137|Mitosis Modulators|mitosis modulators|mesh-ancestor
102579124|NCT00004137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579125|NCT00004137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102579126|NCT00004137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102579127|NCT00004137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102579128|NCT00003681|Epoetin Alfa|epoetin alfa|mesh-list
102579129|NCT00003681|Amifostine|amifostine|mesh-list
102579130|NCT00003681|Hematinics|hematinics|mesh-ancestor
102579131|NCT00003681|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102579132|NCT00003681|Protective Agents|protective agents|mesh-ancestor
102579133|NCT00003681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579134|NCT00005007|Etanercept|etanercept|mesh-list
102579135|NCT00005007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102579136|NCT00005007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102579137|NCT00005007|Analgesics|analgesics|mesh-ancestor
102579138|NCT00005007|Sensory System Agents|sensory system agents|mesh-ancestor
102579139|NCT00005007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102579140|NCT00005007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126045|NCT03283202|Cyclophosphamide|cyclophosphamide|mesh-list
102579141|NCT00005007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102579142|NCT00005007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102579143|NCT00005007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102579144|NCT00005007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102579145|NCT00005007|Immunologic Factors|immunologic factors|mesh-ancestor
102579146|NCT00384579|Botulinum Toxins|botulinum toxins|mesh-list
102579147|NCT00384579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102579148|NCT00384579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102579149|NCT00384579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579150|NCT00384579|Cholinergic Agents|cholinergic agents|mesh-ancestor
102579151|NCT00384579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102579152|NCT00384579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579153|NCT00004149|Arsenic Trioxide|arsenic trioxide|mesh-list
102579154|NCT00004149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579155|NCT00384657|Iron|iron|mesh-list
102579156|NCT00384657|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102579157|NCT00384657|Trace Elements|trace elements|mesh-ancestor
102579158|NCT00384657|Micronutrients|micronutrients|mesh-ancestor
102579159|NCT00384657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579160|NCT00384657|Hematinics|hematinics|mesh-ancestor
102579161|NCT00005013|Sertraline|sertraline|mesh-list
102579162|NCT00005013|Antidepressive Agents|antidepressive agents|mesh-ancestor
102579163|NCT00005013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102579164|NCT00005013|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102579165|NCT00005013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102579166|NCT00005013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102579167|NCT00005013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579168|NCT00005013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102579169|NCT00005013|Serotonin Agents|serotonin agents|mesh-ancestor
102579170|NCT00005013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579171|NCT00004161|Fenretinide|fenretinide|mesh-list
102579172|NCT00004161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579173|NCT00004161|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102579174|NCT00004161|Protective Agents|protective agents|mesh-ancestor
102579175|NCT00004161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579176|NCT00004173|Paclitaxel|paclitaxel|mesh-list
102579177|NCT00004173|Oxaliplatin|oxaliplatin|mesh-list
102579178|NCT00004173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102579179|NCT00004173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579180|NCT00004173|Tubulin Modulators|tubulin modulators|mesh-ancestor
102579181|NCT00004173|Antimitotic Agents|antimitotic agents|mesh-ancestor
102579182|NCT00004173|Mitosis Modulators|mitosis modulators|mesh-ancestor
102579183|NCT00004173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579184|NCT00005025|Ganciclovir|ganciclovir|mesh-list
102579185|NCT00005025|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102579186|NCT00005025|Antiviral Agents|antiviral agents|mesh-ancestor
102579187|NCT00005025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102579188|NCT00005025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102579189|NCT00005025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102579190|NCT00005025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579191|NCT00004179|Prednisone|prednisone|mesh-list
102579192|NCT00004179|Cyclophosphamide|cyclophosphamide|mesh-list
102579193|NCT00004179|Rituximab|rituximab|mesh-list
102579194|NCT00004179|Doxorubicin|doxorubicin|mesh-list
102579195|NCT00004179|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102579196|NCT00004179|Vincristine|vincristine|mesh-list
102579197|NCT00004179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102579198|NCT00004179|Immunologic Factors|immunologic factors|mesh-ancestor
102579199|NCT00004179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579200|NCT00004179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102579201|NCT00004179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102579202|NCT00004179|Alkylating Agents|alkylating agents|mesh-ancestor
102579203|NCT00004179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579204|NCT00004179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579205|NCT00004179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102579206|NCT00004179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102579207|NCT00004179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102579208|NCT00004179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102579209|NCT00004179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102579210|NCT00004179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102579211|NCT00004179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102579212|NCT00004179|Glucocorticoids|glucocorticoids|mesh-ancestor
102579213|NCT00004179|Hormones|hormones|mesh-ancestor
102579214|NCT00004179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102579215|NCT00004179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102579216|NCT00004179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102579217|NCT00004179|Tubulin Modulators|tubulin modulators|mesh-ancestor
102579218|NCT00004179|Antimitotic Agents|antimitotic agents|mesh-ancestor
102579219|NCT00004179|Mitosis Modulators|mitosis modulators|mesh-ancestor
102579220|NCT00003687|Morphine|morphine|mesh-list
102579221|NCT00003687|Dextromethorphan|dextromethorphan|mesh-list
102579222|NCT00003687|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102579223|NCT00003687|Narcotics|narcotics|mesh-ancestor
102579224|NCT00003687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102579225|NCT00003687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579226|NCT00003687|Analgesics|analgesics|mesh-ancestor
102579227|NCT00003687|Sensory System Agents|sensory system agents|mesh-ancestor
102579228|NCT00003687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102579229|NCT00003687|Antitussive Agents|antitussive agents|mesh-ancestor
102579230|NCT00003687|Respiratory System Agents|respiratory system agents|mesh-ancestor
102579231|NCT00003687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102579232|NCT00003687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102579233|NCT00003687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102579234|NCT00003687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579235|NCT00004197|Prednisone|prednisone|mesh-list
102579236|NCT00004197|Cyclophosphamide|cyclophosphamide|mesh-list
102579237|NCT00004197|Doxorubicin|doxorubicin|mesh-list
102579238|NCT00004197|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102579239|NCT00004197|Vincristine|vincristine|mesh-list
102579240|NCT00004197|Mitoxantrone|mitoxantrone|mesh-list
102579241|NCT00004197|Sargramostim|sargramostim|mesh-list
102579242|NCT00004197|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
102579243|NCT00004197|Vaccines|vaccines|mesh-list
101846146|NCT01060683|Chrysarobin|chrysarobin|mesh-list
102579244|NCT00004197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102579245|NCT00004197|Immunologic Factors|immunologic factors|mesh-ancestor
102579246|NCT00004197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579247|NCT00004197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102579248|NCT00004197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102579249|NCT00004197|Alkylating Agents|alkylating agents|mesh-ancestor
102579250|NCT00004197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579251|NCT00004197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579252|NCT00004197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102579253|NCT00004197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102579254|NCT00004197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102579255|NCT00004197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102579256|NCT00004197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102579257|NCT00004197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102579258|NCT00004197|Glucocorticoids|glucocorticoids|mesh-ancestor
102579259|NCT00004197|Hormones|hormones|mesh-ancestor
102579260|NCT00004197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102579261|NCT00004197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102579262|NCT00004197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102579263|NCT00004197|Tubulin Modulators|tubulin modulators|mesh-ancestor
102579264|NCT00004197|Antimitotic Agents|antimitotic agents|mesh-ancestor
102579265|NCT00004197|Mitosis Modulators|mitosis modulators|mesh-ancestor
102579266|NCT00004197|Analgesics|analgesics|mesh-ancestor
102579267|NCT00004197|Sensory System Agents|sensory system agents|mesh-ancestor
102579268|NCT00004197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102579269|NCT00004197|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102579270|NCT00003693|Dolastatin 10|dolastatin 10|mesh-list
102579271|NCT00003693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579272|NCT00003693|Tubulin Modulators|tubulin modulators|mesh-ancestor
102579273|NCT00003693|Antimitotic Agents|antimitotic agents|mesh-ancestor
102579274|NCT00003693|Mitosis Modulators|mitosis modulators|mesh-ancestor
102579275|NCT00003693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579276|NCT00005031|Irofulven|irofulven|mesh-list
102579277|NCT00005031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102579278|NCT00005031|Alkylating Agents|alkylating agents|mesh-ancestor
102579279|NCT00005031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579280|NCT00005031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102126193|NCT03269318|Purinergic Agents|purinergic agents|mesh-ancestor
102126194|NCT03284762|Rivaroxaban|rivaroxaban|mesh-list
102126195|NCT03284762|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102126196|NCT03284762|Antithrombins|antithrombins|mesh-ancestor
102126197|NCT03284762|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102126198|NCT03284762|Protease Inhibitors|protease inhibitors|mesh-ancestor
102126199|NCT03284762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102126200|NCT03284762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126201|NCT03284762|Anticoagulants|anticoagulants|mesh-ancestor
102126211|NCT04172558|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102579281|NCT00005037|Temozolomide|temozolomide|mesh-list
102579282|NCT00005037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102579283|NCT00005037|Alkylating Agents|alkylating agents|mesh-ancestor
102579284|NCT00005037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579285|NCT00005037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579286|NCT00004203|Oxaliplatin|oxaliplatin|mesh-list
102579287|NCT00004203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579288|NCT00004209|Mitomycins|mitomycins|mesh-list
102579289|NCT00004209|Mitomycin|mitomycin|mesh-list
102579290|NCT00004209|Vinblastine|vinblastine|mesh-list
102579291|NCT00004209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579292|NCT00004209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102579293|NCT00004209|Alkylating Agents|alkylating agents|mesh-ancestor
102579294|NCT00004209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579295|NCT00004209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102579296|NCT00004209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102579297|NCT00004209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102579298|NCT00004209|Tubulin Modulators|tubulin modulators|mesh-ancestor
102579299|NCT00004209|Antimitotic Agents|antimitotic agents|mesh-ancestor
102579300|NCT00004209|Mitosis Modulators|mitosis modulators|mesh-ancestor
102579301|NCT00005049|Carboplatin|carboplatin|mesh-list
102579302|NCT00005049|Floxuridine|floxuridine|mesh-list
102579303|NCT00005049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579304|NCT00005049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102579305|NCT00005049|Antimetabolites|antimetabolites|mesh-ancestor
102579306|NCT00005049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579307|NCT00004215|Cytarabine|cytarabine|mesh-list
102579308|NCT00004215|Daunorubicin|daunorubicin|mesh-list
102579309|NCT00004215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102579310|NCT00004215|Antimetabolites|antimetabolites|mesh-ancestor
102579311|NCT00004215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579312|NCT00004215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579313|NCT00004215|Antiviral Agents|antiviral agents|mesh-ancestor
102579314|NCT00004215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102579315|NCT00004215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102579316|NCT00004215|Immunologic Factors|immunologic factors|mesh-ancestor
102579317|NCT00004215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579318|NCT00004215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102579319|NCT00004215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102579320|NCT00004215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102579321|NCT00004215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102579322|NCT00004221|Paclitaxel|paclitaxel|mesh-list
102579323|NCT00004221|Cyclophosphamide|cyclophosphamide|mesh-list
102579324|NCT00004221|Carboplatin|carboplatin|mesh-list
102579325|NCT00004221|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102579326|NCT00004221|Topotecan|topotecan|mesh-list
102579327|NCT00004221|Lenograstim|lenograstim|mesh-list
102579328|NCT00004221|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102579329|NCT00004221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579330|NCT00004221|Tubulin Modulators|tubulin modulators|mesh-ancestor
102579331|NCT00004221|Antimitotic Agents|antimitotic agents|mesh-ancestor
102579332|NCT00004221|Mitosis Modulators|mitosis modulators|mesh-ancestor
102579333|NCT00004221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579334|NCT00004221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102579335|NCT00004221|Immunologic Factors|immunologic factors|mesh-ancestor
102579336|NCT00004221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579337|NCT00004221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102579338|NCT00004221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102579339|NCT00004221|Alkylating Agents|alkylating agents|mesh-ancestor
102579340|NCT00004221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102579341|NCT00004221|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102579342|NCT00004221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102579343|NCT00004221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102579344|NCT00004221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102579345|NCT00003711|Irinotecan|irinotecan|mesh-list
102579346|NCT00003711|Pemetrexed|pemetrexed|mesh-list
102579347|NCT00003711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102579348|NCT00003711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102579349|NCT00003711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102579350|NCT00003711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579351|NCT00003711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579352|NCT00003711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102579353|NCT00003711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102579354|NCT00004227|Cetuximab|cetuximab|mesh-list
102579355|NCT00004227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102579356|NCT00004227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102126277|NCT03268226|Hormones|hormones|mesh-ancestor
102579357|NCT00003621|Etoposide|etoposide|mesh-list
102579358|NCT00003621|Carmustine|carmustine|mesh-list
102579359|NCT00003621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579360|NCT00003621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102579361|NCT00003621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102579362|NCT00003621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102579363|NCT00003621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102579364|NCT00003621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579365|NCT00003621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102579366|NCT00003621|Alkylating Agents|alkylating agents|mesh-ancestor
102579367|NCT00385359|Albuterol|albuterol|mesh-list
102579368|NCT00385359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102579369|NCT00385359|Autonomic Agents|autonomic agents|mesh-ancestor
102579370|NCT00385359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102579371|NCT00385359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579372|NCT00385359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102579373|NCT00385359|Respiratory System Agents|respiratory system agents|mesh-ancestor
102579374|NCT00385359|Tocolytic Agents|tocolytic agents|mesh-ancestor
102579375|NCT00385359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102579376|NCT00385359|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102579377|NCT00385359|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102579378|NCT00385359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102579379|NCT00385359|Adrenergic Agents|adrenergic agents|mesh-ancestor
102579380|NCT00385359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102579381|NCT00385359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579382|NCT00004233|Leucovorin|leucovorin|mesh-list
102579383|NCT00004233|Fluorouracil|fluorouracil|mesh-list
102579384|NCT00004233|Calcium|calcium|mesh-list
102579385|NCT00004233|Levoleucovorin|levoleucovorin|mesh-list
102579386|NCT00004233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102579387|NCT00004233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579388|NCT00004233|Antimetabolites|antimetabolites|mesh-ancestor
102579389|NCT00004233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579390|NCT00004233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102579391|NCT00004233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579392|NCT00004233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102579393|NCT00004233|Immunologic Factors|immunologic factors|mesh-ancestor
102579394|NCT00004233|Antidotes|antidotes|mesh-ancestor
102579395|NCT00004233|Protective Agents|protective agents|mesh-ancestor
102579396|NCT00004233|Vitamin B Complex|vitamin b complex|mesh-ancestor
102579397|NCT00004233|Vitamins|vitamins|mesh-ancestor
102579398|NCT00004233|Micronutrients|micronutrients|mesh-ancestor
102579399|NCT00003717|Paclitaxel|paclitaxel|mesh-list
102579400|NCT00003717|Estramustine|estramustine|mesh-list
102579401|NCT00003717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102579402|NCT00003717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579403|NCT00003717|Tubulin Modulators|tubulin modulators|mesh-ancestor
102579404|NCT00003717|Antimitotic Agents|antimitotic agents|mesh-ancestor
102579405|NCT00003717|Mitosis Modulators|mitosis modulators|mesh-ancestor
102579406|NCT00003717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579407|NCT00003717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102579408|NCT00003717|Alkylating Agents|alkylating agents|mesh-ancestor
102579409|NCT00003717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102579410|NCT00003723|Gemcitabine|gemcitabine|mesh-list
102579411|NCT00003723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102579412|NCT00003723|Antimetabolites|antimetabolites|mesh-ancestor
102579413|NCT00003723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579414|NCT00003723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579415|NCT00005061|Bevacizumab|bevacizumab|mesh-list
102579416|NCT00005061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102579417|NCT00005061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579418|NCT00005061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102579419|NCT00005061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102579420|NCT00005061|Growth Substances|growth substances|mesh-ancestor
102579421|NCT00005061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579422|NCT00005061|Growth Inhibitors|growth inhibitors|mesh-ancestor
102579423|NCT00004245|Salicylates|salicylates|mesh-list
102579424|NCT00004245|Sodium Salicylate|sodium salicylate|mesh-list
102579425|NCT00004245|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
102579426|NCT00004245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102579427|NCT00004245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102579428|NCT00004245|Analgesics|analgesics|mesh-ancestor
102579429|NCT00004245|Sensory System Agents|sensory system agents|mesh-ancestor
102579430|NCT00004245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102579431|NCT00004245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579432|NCT00004245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102579433|NCT00004245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102579434|NCT00004245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102579435|NCT00004245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102579436|NCT00004245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579437|NCT00004251|Letrozole|letrozole|mesh-list
102579438|NCT00004251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579439|NCT00004251|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102579440|NCT00004251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102579441|NCT00004251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102579442|NCT00004251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579443|NCT00004251|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102579444|NCT00004251|Hormone Antagonists|hormone antagonists|mesh-ancestor
102579445|NCT00004251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102579446|NCT00004251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579447|NCT00005067|Motexafin lutetium|motexafin lutetium|mesh-list
102579448|NCT00005067|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102579449|NCT00005067|Dermatologic Agents|dermatologic agents|mesh-ancestor
102579450|NCT00003729|Cytarabine|cytarabine|mesh-list
102579451|NCT00003729|Fludarabine|fludarabine|mesh-list
102579452|NCT00003729|Fludarabine phosphate|fludarabine phosphate|mesh-list
102579453|NCT00003729|Idarubicin|idarubicin|mesh-list
102579454|NCT00003729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579455|NCT00003729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102579456|NCT00003729|Antimetabolites|antimetabolites|mesh-ancestor
102579457|NCT00003729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579458|NCT00003729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102579459|NCT00003729|Immunologic Factors|immunologic factors|mesh-ancestor
102579460|NCT00003729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579461|NCT00003729|Antiviral Agents|antiviral agents|mesh-ancestor
102579462|NCT00003729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102579463|NCT00003729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102579464|NCT00003729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102579465|NCT00003729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102579466|NCT00003729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102579467|NCT00004263|Cytarabine|cytarabine|mesh-list
102579468|NCT00004263|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
102579469|NCT00004263|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102579470|NCT00004263|Antimetabolites|antimetabolites|mesh-ancestor
102579471|NCT00004263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579472|NCT00004263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579473|NCT00004263|Antiviral Agents|antiviral agents|mesh-ancestor
102579474|NCT00004263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102579475|NCT00004263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102579476|NCT00004263|Immunologic Factors|immunologic factors|mesh-ancestor
102579477|NCT00004263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579478|NCT00004263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102579479|NCT00004263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102579480|NCT00003735|Topotecan|topotecan|mesh-list
102579481|NCT00003735|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
102579482|NCT00003735|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102579483|NCT00003735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102579484|NCT00003735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102579485|NCT00003735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579486|NCT00003735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579487|NCT00003735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102579488|NCT00005073|Zoledronic Acid|zoledronic acid|mesh-list
102579489|NCT00005073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102579490|NCT00005073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579491|NCT00004275|Hormones|hormones|mesh-list
102579492|NCT00004275|Oxandrolone|oxandrolone|mesh-list
102579493|NCT00004275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102579494|NCT00004275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579495|NCT00004275|Androgens|androgens|mesh-ancestor
102579496|NCT00004275|Anabolic Agents|anabolic agents|mesh-ancestor
102579497|NCT00003741|Antibodies|antibodies|mesh-list
102579498|NCT00003741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102579499|NCT00003741|Immunologic Factors|immunologic factors|mesh-ancestor
102579500|NCT00003741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579501|NCT00003747|Carboplatin|carboplatin|mesh-list
102579502|NCT00003747|Temozolomide|temozolomide|mesh-list
102579503|NCT00003747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579504|NCT00003747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102579505|NCT00003747|Alkylating Agents|alkylating agents|mesh-ancestor
102579506|NCT00003747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579507|NCT00004311|Leuprolide|leuprolide|mesh-list
102579508|NCT00004311|Spironolactone|spironolactone|mesh-list
102579509|NCT00004311|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102579510|NCT00004311|Fertility Agents|fertility agents|mesh-ancestor
102579511|NCT00004311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102579512|NCT00004311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579513|NCT00004311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102579514|NCT00004311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579515|NCT00004311|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102579516|NCT00004311|Hormone Antagonists|hormone antagonists|mesh-ancestor
102579517|NCT00004311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102579518|NCT00004311|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102579519|NCT00004311|Diuretics|diuretics|mesh-ancestor
102579520|NCT00004311|Natriuretic Agents|natriuretic agents|mesh-ancestor
102579521|NCT00004317|Leucovorin|leucovorin|mesh-list
102579522|NCT00004317|Pyrimethamine|pyrimethamine|mesh-list
102579523|NCT00004317|Sulfadiazine|sulfadiazine|mesh-list
102579524|NCT00004317|Spiramycin|spiramycin|mesh-list
102579525|NCT00004317|Calcium|calcium|mesh-list
102579526|NCT00004317|Levoleucovorin|levoleucovorin|mesh-list
102579527|NCT00004317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102579528|NCT00004317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579529|NCT00004317|Antidotes|antidotes|mesh-ancestor
102579530|NCT00004317|Protective Agents|protective agents|mesh-ancestor
102579531|NCT00004317|Vitamin B Complex|vitamin b complex|mesh-ancestor
102579532|NCT00004317|Vitamins|vitamins|mesh-ancestor
102579533|NCT00004317|Micronutrients|micronutrients|mesh-ancestor
102579534|NCT00004317|Antimalarials|antimalarials|mesh-ancestor
102579535|NCT00004317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102579536|NCT00004317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102579537|NCT00004317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102579538|NCT00004317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102579539|NCT00004317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102579540|NCT00004317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579541|NCT00004317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102579542|NCT00004317|Coccidiostats|coccidiostats|mesh-ancestor
102579543|NCT00005091|Exatecan|exatecan|mesh-list
102579544|NCT00005091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102579545|NCT00005091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102579546|NCT00005091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102579547|NCT00005091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579548|NCT00005091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579549|NCT00004323|Cyclosporine|cyclosporine|mesh-list
102579550|NCT00004323|Methylprednisolone|methylprednisolone|mesh-list
102579551|NCT00004323|Cyclophosphamide|cyclophosphamide|mesh-list
102579552|NCT00004323|Methotrexate|methotrexate|mesh-list
102579553|NCT00004323|Cyclosporins|cyclosporins|mesh-list
102579554|NCT00004323|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102579555|NCT00004323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102579556|NCT00004323|Immunologic Factors|immunologic factors|mesh-ancestor
102579557|NCT00004323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579558|NCT00004323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102579559|NCT00004323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102579560|NCT00004323|Alkylating Agents|alkylating agents|mesh-ancestor
102579561|NCT00004323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579562|NCT00004323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579563|NCT00004323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102579564|NCT00004323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102579565|NCT00004323|Abortifacient Agents|abortifacient agents|mesh-ancestor
102579566|NCT00004323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102579567|NCT00004323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102579568|NCT00004323|Antimetabolites|antimetabolites|mesh-ancestor
102579569|NCT00004323|Dermatologic Agents|dermatologic agents|mesh-ancestor
102579570|NCT00004323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102579571|NCT00004323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102579572|NCT00004323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102579573|NCT00004323|Antifungal Agents|antifungal agents|mesh-ancestor
102579574|NCT00004323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102579575|NCT00004323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102579576|NCT00004323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102579577|NCT00004323|Antiemetics|antiemetics|mesh-ancestor
102579578|NCT00004323|Autonomic Agents|autonomic agents|mesh-ancestor
102579579|NCT00004323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102579580|NCT00004323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102579581|NCT00004323|Glucocorticoids|glucocorticoids|mesh-ancestor
102579582|NCT00004323|Hormones|hormones|mesh-ancestor
102579583|NCT00004323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102579584|NCT00004323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102579585|NCT00004323|Protective Agents|protective agents|mesh-ancestor
102579586|NCT00003753|Dexamethasone|dexamethasone|mesh-list
102579587|NCT00003753|Irinotecan|irinotecan|mesh-list
102579588|NCT00003753|Floxuridine|floxuridine|mesh-list
102579589|NCT00003753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102579590|NCT00003753|Antiemetics|antiemetics|mesh-ancestor
102579591|NCT00003753|Autonomic Agents|autonomic agents|mesh-ancestor
102579592|NCT00003753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102579593|NCT00003753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579594|NCT00003753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102579595|NCT00003753|Glucocorticoids|glucocorticoids|mesh-ancestor
102579596|NCT00003753|Hormones|hormones|mesh-ancestor
102579597|NCT00003753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102579598|NCT00003753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102579599|NCT00003753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579600|NCT00003753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102579601|NCT00003753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102579602|NCT00003753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102579603|NCT00003753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579604|NCT00003753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102579605|NCT00003753|Antimetabolites|antimetabolites|mesh-ancestor
102579606|NCT00003759|Valrubicin|valrubicin|mesh-list
102579607|NCT00003759|BCG Vaccine|bcg vaccine|mesh-list
102579608|NCT00003759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102579609|NCT00003759|Immunologic Factors|immunologic factors|mesh-ancestor
102579610|NCT00003759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579611|NCT00003759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579612|NCT00003759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102579613|NCT00003759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102579614|NCT00003759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102579615|NCT00003759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579616|NCT00003765|Carmustine|carmustine|mesh-list
102579617|NCT00003765|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
102579618|NCT00003765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102579619|NCT00003765|Alkylating Agents|alkylating agents|mesh-ancestor
102579620|NCT00003765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579621|NCT00003765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579622|NCT00003765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102579623|NCT00003771|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102579624|NCT00003771|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102579625|NCT00003771|Norethindrone|norethindrone|mesh-list
102579626|NCT00003771|Norethindrone Acetate|norethindrone acetate|mesh-list
102579627|NCT00003771|Estradiol|estradiol|mesh-list
102579628|NCT00003771|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102579629|NCT00003771|Estrogens|estrogens|mesh-ancestor
102579630|NCT00003771|Hormones|hormones|mesh-ancestor
102579631|NCT00003771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102579632|NCT00003771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579633|NCT00003771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102579634|NCT00003771|Contraceptive Agents|contraceptive agents|mesh-ancestor
102579635|NCT00003771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102579636|NCT00003771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102579637|NCT00003771|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102579638|NCT00003771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102579639|NCT00003771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102579640|NCT00004359|Methoxsalen|methoxsalen|mesh-list
102579641|NCT00004359|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102579642|NCT00004359|Dermatologic Agents|dermatologic agents|mesh-ancestor
102579643|NCT00004401|Immunoglobulins|immunoglobulins|mesh-list
102579644|NCT00004401|Antibodies|antibodies|mesh-list
102579645|NCT00004401|gamma-Globulins|gamma-globulins|mesh-list
102579646|NCT00004401|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102579647|NCT00004401|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102579648|NCT00004401|Immunologic Factors|immunologic factors|mesh-ancestor
102579649|NCT00004401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579650|NCT00003783|Leucovorin|leucovorin|mesh-list
102579651|NCT00003783|Cytarabine|cytarabine|mesh-list
102579652|NCT00003783|Dexamethasone|dexamethasone|mesh-list
102579653|NCT00003783|Prednisone|prednisone|mesh-list
102579654|NCT00003783|Cyclophosphamide|cyclophosphamide|mesh-list
102579655|NCT00003783|Methotrexate|methotrexate|mesh-list
102579656|NCT00003783|Etoposide|etoposide|mesh-list
102579657|NCT00003783|Vincristine|vincristine|mesh-list
102579658|NCT00003783|Daunorubicin|daunorubicin|mesh-list
102579659|NCT00003783|Asparaginase|asparaginase|mesh-list
102579660|NCT00003783|Mercaptopurine|mercaptopurine|mesh-list
102579661|NCT00003783|Idarubicin|idarubicin|mesh-list
102579662|NCT00003783|Levoleucovorin|levoleucovorin|mesh-list
102579663|NCT00003783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102579664|NCT00003783|Immunologic Factors|immunologic factors|mesh-ancestor
102579665|NCT00003783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579666|NCT00003783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102579667|NCT00003783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102579668|NCT00003783|Alkylating Agents|alkylating agents|mesh-ancestor
102579669|NCT00003783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579670|NCT00003783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579671|NCT00003783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102579672|NCT00003783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102579673|NCT00003783|Antiemetics|antiemetics|mesh-ancestor
102579674|NCT00003783|Autonomic Agents|autonomic agents|mesh-ancestor
102579675|NCT00003783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102579676|NCT00003783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102579677|NCT00003783|Glucocorticoids|glucocorticoids|mesh-ancestor
102579678|NCT00003783|Hormones|hormones|mesh-ancestor
102579679|NCT00003783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102579680|NCT00003783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102579681|NCT00003783|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102579682|NCT00003783|Abortifacient Agents|abortifacient agents|mesh-ancestor
102579683|NCT00003783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102579684|NCT00003783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102579685|NCT00003783|Antimetabolites|antimetabolites|mesh-ancestor
102579686|NCT00003783|Dermatologic Agents|dermatologic agents|mesh-ancestor
102579687|NCT00003783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102579688|NCT00003783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102579689|NCT00003783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102579690|NCT00003783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102579691|NCT00003783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102579692|NCT00003783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102579693|NCT00003783|Antiviral Agents|antiviral agents|mesh-ancestor
102579694|NCT00003783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102579695|NCT00003783|Antidotes|antidotes|mesh-ancestor
102579696|NCT00003783|Protective Agents|protective agents|mesh-ancestor
102579697|NCT00003783|Vitamin B Complex|vitamin b complex|mesh-ancestor
102579698|NCT00003783|Vitamins|vitamins|mesh-ancestor
102579699|NCT00003783|Micronutrients|micronutrients|mesh-ancestor
102579700|NCT00003783|Tubulin Modulators|tubulin modulators|mesh-ancestor
102579701|NCT00003783|Antimitotic Agents|antimitotic agents|mesh-ancestor
102579702|NCT00003783|Mitosis Modulators|mitosis modulators|mesh-ancestor
102579703|NCT00003783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102579704|NCT00003789|Melphalan|melphalan|mesh-list
102579705|NCT00003789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102579706|NCT00003789|Alkylating Agents|alkylating agents|mesh-ancestor
102579707|NCT00003789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579708|NCT00003789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579709|NCT00003789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102579710|NCT00003789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102579711|NCT00003789|Immunologic Factors|immunologic factors|mesh-ancestor
102579712|NCT00003789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579713|NCT00004407|Immunoglobulins|immunoglobulins|mesh-list
102579714|NCT00004407|Antibodies|antibodies|mesh-list
102579715|NCT00004407|gamma-Globulins|gamma-globulins|mesh-list
102579716|NCT00004407|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102579717|NCT00004407|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102579718|NCT00004407|Immunologic Factors|immunologic factors|mesh-ancestor
102579719|NCT00004407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579720|NCT00004419|Mitogens|mitogens|mesh-list
102579721|NCT00004419|Mitosis Modulators|mitosis modulators|mesh-ancestor
102579722|NCT00004419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579723|NCT00004431|Baclofen|baclofen|mesh-list
102579724|NCT00004431|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102579725|NCT00004431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579726|NCT00004431|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102579727|NCT00004431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102579728|NCT00004431|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102579729|NCT00004431|GABA Agonists|gaba agonists|mesh-ancestor
102579730|NCT00004431|GABA Agents|gaba agents|mesh-ancestor
102579731|NCT00004431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102579732|NCT00004431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579733|NCT00384891|BCG Vaccine|bcg vaccine|mesh-list
102579734|NCT00384891|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102579735|NCT00384891|Immunologic Factors|immunologic factors|mesh-ancestor
102579736|NCT00384891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579737|NCT00384969|Sorafenib|sorafenib|mesh-list
102579738|NCT00384969|Everolimus|everolimus|mesh-list
102579739|NCT00384969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579740|NCT00384969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102579741|NCT00384969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102579742|NCT00384969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579743|NCT00384969|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102579744|NCT00384969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102579745|NCT00384969|Immunologic Factors|immunologic factors|mesh-ancestor
102579746|NCT00384969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579747|NCT00385437|Mirtazapine|mirtazapine|mesh-list
102579748|NCT00385437|Antidepressive Agents|antidepressive agents|mesh-ancestor
102579749|NCT00385437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102579750|NCT00385437|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102579751|NCT00385437|Histamine Antagonists|histamine antagonists|mesh-ancestor
102579752|NCT00385437|Histamine Agents|histamine agents|mesh-ancestor
102579753|NCT00385437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102579754|NCT00385437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579755|NCT00385437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579756|NCT00385437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102579757|NCT00385437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102579758|NCT00385437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102579759|NCT00385437|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102579760|NCT00385437|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102579761|NCT00385437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102579762|NCT00385437|Adrenergic Agents|adrenergic agents|mesh-ancestor
102579763|NCT00385437|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102579764|NCT00385437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102579765|NCT00385437|Serotonin Agents|serotonin agents|mesh-ancestor
102579766|NCT00385437|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102579767|NCT00004467|Acetylcysteine|acetylcysteine|mesh-list
102579768|NCT00004467|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102579769|NCT00004467|Antiviral Agents|antiviral agents|mesh-ancestor
102579770|NCT00004467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102579771|NCT00004467|Expectorants|expectorants|mesh-ancestor
102579772|NCT00004467|Respiratory System Agents|respiratory system agents|mesh-ancestor
102579773|NCT00004467|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102579774|NCT00004467|Antioxidants|antioxidants|mesh-ancestor
102579775|NCT00004467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579776|NCT00004467|Protective Agents|protective agents|mesh-ancestor
102579777|NCT00004467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579778|NCT00004467|Antidotes|antidotes|mesh-ancestor
102579779|NCT00004479|Midodrine|midodrine|mesh-list
102579780|NCT00004479|Sympathomimetics|sympathomimetics|mesh-ancestor
102579781|NCT00004479|Autonomic Agents|autonomic agents|mesh-ancestor
102579782|NCT00004479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102579783|NCT00004479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579784|NCT00004479|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102579785|NCT00004479|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102579786|NCT00004479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102579787|NCT00004479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102579788|NCT00004479|Adrenergic Agents|adrenergic agents|mesh-ancestor
102579789|NCT00004479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102579790|NCT00004479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579791|NCT00004485|Cyclosporine|cyclosporine|mesh-list
102579792|NCT00004485|Mycophenolic Acid|mycophenolic acid|mesh-list
102579793|NCT00004485|Fludarabine|fludarabine|mesh-list
102579794|NCT00004485|Cyclosporins|cyclosporins|mesh-list
102579795|NCT00004485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579796|NCT00004485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579797|NCT00004485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102579798|NCT00004485|Immunologic Factors|immunologic factors|mesh-ancestor
102579799|NCT00004485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579800|NCT00004485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102579801|NCT00004485|Antifungal Agents|antifungal agents|mesh-ancestor
102579802|NCT00004485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102579803|NCT00004485|Dermatologic Agents|dermatologic agents|mesh-ancestor
102579804|NCT00004485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102579805|NCT00004485|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102579806|NCT00004485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102579807|NCT00004485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102579808|NCT00004485|Antitubercular Agents|antitubercular agents|mesh-ancestor
102579809|NCT00004485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102579810|NCT00385125|Rituximab|rituximab|mesh-list
102579811|NCT00385125|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102579812|NCT00385125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102579813|NCT00385125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579815|NCT00385125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579816|NCT00385125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102579817|NCT00385125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102579818|NCT00385125|Alkylating Agents|alkylating agents|mesh-ancestor
102579819|NCT00385125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579820|NCT00003819|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
102579821|NCT00003819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102579822|NCT00003819|Immunologic Factors|immunologic factors|mesh-ancestor
102579823|NCT00003819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579824|NCT00003825|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
102579825|NCT00003825|Anticoagulants|anticoagulants|mesh-ancestor
102579826|NCT00004551|Nicotine|nicotine|mesh-list
102579827|NCT00004551|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102579828|NCT00004551|Autonomic Agents|autonomic agents|mesh-ancestor
102579829|NCT00004551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102579830|NCT00004551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579831|NCT00004551|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102579832|NCT00004551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102579833|NCT00004551|Cholinergic Agents|cholinergic agents|mesh-ancestor
102579834|NCT00004551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102579835|NCT00004551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579836|NCT02678312|Enalapril|enalapril|mesh-list
102579837|NCT02678312|Enalaprilat|enalaprilat|mesh-list
102579838|NCT02678312|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102579839|NCT02678312|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102579840|NCT02678312|Protease Inhibitors|protease inhibitors|mesh-ancestor
102579841|NCT02678312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102579842|NCT02678312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579843|NCT02678312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102579844|NCT02678312|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102579845|NCT00003843|Irinotecan|irinotecan|mesh-list
102579846|NCT00003843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102579847|NCT00003843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102579848|NCT00003843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102579849|NCT00003843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579850|NCT00003843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579851|NCT00003849|Rituximab|rituximab|mesh-list
102579852|NCT00003849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102579853|NCT00003849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579854|NCT00003849|Immunologic Factors|immunologic factors|mesh-ancestor
102579855|NCT00003849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579856|NCT00003849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102579857|NCT00004575|Miconazole|miconazole|mesh-list
102579858|NCT00004575|Bradykinin|bradykinin|mesh-list
102579859|NCT00004575|Kininogens|kininogens|mesh-list
102579860|NCT00004575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102579861|NCT00004575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579862|NCT00004575|Antifungal Agents|antifungal agents|mesh-ancestor
102579863|NCT00004575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102579864|NCT00004575|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102579865|NCT00004575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102579866|NCT00004575|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102579867|NCT00004575|Hormone Antagonists|hormone antagonists|mesh-ancestor
102579868|NCT00004575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102579869|NCT00004575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579870|NCT00004575|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102579871|NCT00004575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102579872|NCT00004575|Vasodilator Agents|vasodilator agents|mesh-ancestor
102579873|NCT00004575|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
102579874|NCT00004575|Protease Inhibitors|protease inhibitors|mesh-ancestor
102579875|NCT00004581|Ritonavir|ritonavir|mesh-list
102579876|NCT00004581|Lopinavir|lopinavir|mesh-list
102579877|NCT00004581|Nevirapine|nevirapine|mesh-list
102579878|NCT00004581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102579879|NCT00004581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102579880|NCT00004581|Protease Inhibitors|protease inhibitors|mesh-ancestor
102579881|NCT00004581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102579882|NCT00004581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579883|NCT00004581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102579884|NCT00004581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102579885|NCT00004581|Antiviral Agents|antiviral agents|mesh-ancestor
102579886|NCT00004581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102579887|NCT00004581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102579888|NCT00004581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102579889|NCT00004581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102579890|NCT00004581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102579891|NCT00004581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102579892|NCT00004581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102579893|NCT00004257|Fluorouracil|fluorouracil|mesh-list
102579894|NCT00004257|Oxaliplatin|oxaliplatin|mesh-list
102579895|NCT00004257|Antimetabolites|antimetabolites|mesh-ancestor
102579896|NCT00004257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579897|NCT00004257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102579898|NCT00004257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579899|NCT00004257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102579900|NCT00004257|Immunologic Factors|immunologic factors|mesh-ancestor
102579901|NCT00004257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579902|NCT00004647|Mexiletine|mexiletine|mesh-list
102579903|NCT00004647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102579904|NCT00004647|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102579905|NCT00004647|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102579906|NCT00004647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102579907|NCT00004647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579908|NCT02469116|Carboplatin|carboplatin|mesh-list
102579909|NCT02469116|Docetaxel|docetaxel|mesh-list
102579910|NCT02469116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579911|NCT02469116|Tubulin Modulators|tubulin modulators|mesh-ancestor
102579912|NCT02469116|Antimitotic Agents|antimitotic agents|mesh-ancestor
102579913|NCT02469116|Mitosis Modulators|mitosis modulators|mesh-ancestor
102579914|NCT02469116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579915|NCT00362960|Losartan|losartan|mesh-list
102579916|NCT00362960|Olmesartan|olmesartan|mesh-list
102579917|NCT00362960|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
102579918|NCT00362960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102579919|NCT00362960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102579920|NCT00362960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102579921|NCT00362960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102579922|NCT00362960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579923|NCT00003867|Capecitabine|capecitabine|mesh-list
102579924|NCT00003867|Irinotecan|irinotecan|mesh-list
102579925|NCT00003867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102579926|NCT00003867|Antimetabolites|antimetabolites|mesh-ancestor
102579927|NCT00003867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579928|NCT00003867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579929|NCT00003867|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102579930|NCT00003867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102579931|NCT00003867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102579932|NCT00004665|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
102579933|NCT00004665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102579934|NCT00004665|Immunologic Factors|immunologic factors|mesh-ancestor
102579935|NCT00004665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579936|NCT00363584|Capecitabine|capecitabine|mesh-list
102579937|NCT00363584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102579938|NCT00363584|Antimetabolites|antimetabolites|mesh-ancestor
102579939|NCT00363584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579940|NCT00363584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579941|NCT00003873|Fluorouracil|fluorouracil|mesh-list
102579942|NCT00003873|Eniluracil|eniluracil|mesh-list
102579943|NCT00003873|Antimetabolites|antimetabolites|mesh-ancestor
102579944|NCT00003873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344039|NCT03979599|Analgesics|analgesics|mesh-ancestor
102579945|NCT00003873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102579946|NCT00003873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579947|NCT00003873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102579948|NCT00003873|Immunologic Factors|immunologic factors|mesh-ancestor
102579949|NCT00003873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579950|NCT00003873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102579951|NCT00363116|Daclizumab|daclizumab|mesh-list
102579952|NCT00363116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102579953|NCT00363116|Immunologic Factors|immunologic factors|mesh-ancestor
102579954|NCT00363116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579955|NCT00004689|Clarithromycin|clarithromycin|mesh-list
102579956|NCT00004689|Rifampin|rifampin|mesh-list
102579957|NCT00004689|Ethambutol|ethambutol|mesh-list
102579958|NCT00004689|Streptomycin|streptomycin|mesh-list
102579959|NCT00004689|Thioacetazone|thioacetazone|mesh-list
102579960|NCT00004689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102126871|NCT03798080|Metformin|metformin|mesh-list
102579961|NCT00004689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102579962|NCT00004689|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102579963|NCT00004689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102579964|NCT00004689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102579965|NCT00004689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102579966|NCT00004689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102579967|NCT00004689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102579968|NCT00004689|Antitubercular Agents|antitubercular agents|mesh-ancestor
102579969|NCT00004689|Leprostatic Agents|leprostatic agents|mesh-ancestor
102579970|NCT00004689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102579971|NCT00004689|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102579972|NCT00004689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102579973|NCT00004689|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102579974|NCT00004689|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102579975|NCT00004689|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102579976|NCT00004689|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102579977|NCT00004695|Interleukin-2|interleukin-2|mesh-list
102579978|NCT00004695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579979|NCT00004695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102579980|NCT00004695|Analgesics|analgesics|mesh-ancestor
102579981|NCT00004695|Sensory System Agents|sensory system agents|mesh-ancestor
102579982|NCT00004695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102579983|NCT00004695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579984|NCT02570984|Omalizumab|omalizumab|mesh-list
102579985|NCT02570984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102579986|NCT02570984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102579987|NCT02570984|Respiratory System Agents|respiratory system agents|mesh-ancestor
102579988|NCT00004731|Ubiquinone|ubiquinone|mesh-list
102579989|NCT00004731|Coenzyme Q10|coenzyme q10|mesh-list
102579990|NCT00004731|Micronutrients|micronutrients|mesh-ancestor
102579991|NCT00004731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102579992|NCT00004731|Vitamins|vitamins|mesh-ancestor
102579993|NCT00003885|Arsenic Trioxide|arsenic trioxide|mesh-list
102579994|NCT00003885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579995|NCT00003891|Lurtotecan|lurtotecan|mesh-list
102579996|NCT00003891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102579997|NCT02472314|Bupivacaine|bupivacaine|mesh-list
102579998|NCT02472314|Anesthetics, Local|anesthetics, local|mesh-ancestor
102579999|NCT02472314|Anesthetics|anesthetics|mesh-ancestor
102580000|NCT02472314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102580001|NCT02472314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580002|NCT02472314|Sensory System Agents|sensory system agents|mesh-ancestor
102580003|NCT02472314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102580004|NCT00004755|Meglumine Antimoniate|meglumine antimoniate|mesh-list
102580005|NCT00004755|Allopurinol|allopurinol|mesh-list
102580006|NCT00004755|Antimetabolites|antimetabolites|mesh-ancestor
102580007|NCT00004755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580008|NCT00004755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102344043|NCT03979599|Anesthetics|anesthetics|mesh-ancestor
102580009|NCT00004755|Gout Suppressants|gout suppressants|mesh-ancestor
102580010|NCT00004755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102580011|NCT00004755|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102580012|NCT00004755|Antioxidants|antioxidants|mesh-ancestor
102580013|NCT00004755|Protective Agents|protective agents|mesh-ancestor
102580014|NCT00004755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580015|NCT00004755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102580016|NCT00004755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102580017|NCT00004755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102580018|NCT00003897|Sargramostim|sargramostim|mesh-list
102580019|NCT00003897|Immunologic Factors|immunologic factors|mesh-ancestor
102580020|NCT00003897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580021|NCT00003909|Motexafin gadolinium|motexafin gadolinium|mesh-list
102580022|NCT00003909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102580023|NCT00003909|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102580024|NCT00003909|Dermatologic Agents|dermatologic agents|mesh-ancestor
102580025|NCT00004767|Sodium Benzoate|sodium benzoate|mesh-list
102580026|NCT00004767|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
102580027|NCT00004767|Phenylacetic acid|phenylacetic acid|mesh-list
102580028|NCT00004767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102580029|NCT00004767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102580030|NCT00004767|Antimetabolites|antimetabolites|mesh-ancestor
102580031|NCT00004767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580032|NCT00004767|Antifungal Agents|antifungal agents|mesh-ancestor
102580033|NCT00004767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102580034|NCT00004785|Dexamethasone|dexamethasone|mesh-list
102580035|NCT00004785|Methylprednisolone|methylprednisolone|mesh-list
102580036|NCT00004785|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102580037|NCT00004785|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102580038|NCT00004785|Prednisolone|prednisolone|mesh-list
102580039|NCT00004785|Prednisolone acetate|prednisolone acetate|mesh-list
102580040|NCT00004785|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102580041|NCT00004785|Prednisolone phosphate|prednisolone phosphate|mesh-list
102580042|NCT00004785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102580043|NCT00004785|Antiemetics|antiemetics|mesh-ancestor
102580044|NCT00004785|Autonomic Agents|autonomic agents|mesh-ancestor
102580045|NCT00004785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102580046|NCT00004785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580047|NCT00004785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102580048|NCT00004785|Glucocorticoids|glucocorticoids|mesh-ancestor
102580049|NCT00004785|Hormones|hormones|mesh-ancestor
102580050|NCT00004785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102580051|NCT00004785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102580052|NCT00004785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102580053|NCT00004785|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102580054|NCT00004785|Protective Agents|protective agents|mesh-ancestor
102580055|NCT00004815|Hormones|hormones|mesh-list
102580056|NCT00004815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102580057|NCT00004815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580058|NCT02279823|Minoxidil|minoxidil|mesh-list
102580059|NCT02279823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102580060|NCT02279823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102580061|NCT02279823|Vasodilator Agents|vasodilator agents|mesh-ancestor
102580062|NCT04040361|Pembrolizumab|pembrolizumab|mesh-list
102580063|NCT04040361|Ramucirumab|ramucirumab|mesh-list
102580064|NCT04040361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102580065|NCT04040361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102580066|NCT04040361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102580067|NCT04040361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580068|NCT00386061|Rimonabant|rimonabant|mesh-list
102580069|NCT00386061|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102580070|NCT00386061|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
102580071|NCT00386061|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102580072|NCT00386061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102580073|NCT00386061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580074|NCT00386061|Hormones|hormones|mesh-ancestor
102580075|NCT00386061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102580076|NCT00386061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580077|NCT00005571|Eculizumab|eculizumab|mesh-list
102580078|NCT00005571|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102580079|NCT00005571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102580080|NCT00005571|Immunologic Factors|immunologic factors|mesh-ancestor
102344051|NCT03979599|Tocolytic Agents|tocolytic agents|mesh-ancestor
102580081|NCT00005571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580082|NCT00005577|Gemcitabine|gemcitabine|mesh-list
102580083|NCT00005577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102580084|NCT00005577|Antimetabolites|antimetabolites|mesh-ancestor
102580085|NCT00005577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580086|NCT00005577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102580087|NCT00005583|Doxorubicin|doxorubicin|mesh-list
102580088|NCT00005583|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102580089|NCT00005583|Epirubicin|epirubicin|mesh-list
102580090|NCT00005583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102580091|NCT00005583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102580092|NCT00005583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102580093|NCT00005583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102580094|NCT00005583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102580095|NCT00005583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580096|NCT00005589|Cytarabine|cytarabine|mesh-list
102580097|NCT00005589|Cyclophosphamide|cyclophosphamide|mesh-list
102580098|NCT00005589|Melphalan|melphalan|mesh-list
102580099|NCT00005589|Carmustine|carmustine|mesh-list
102580100|NCT00005589|Rituximab|rituximab|mesh-list
102580101|NCT00005589|Etoposide|etoposide|mesh-list
102580102|NCT00005589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102580103|NCT00005589|Immunologic Factors|immunologic factors|mesh-ancestor
102580104|NCT00005589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580105|NCT00005589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102580106|NCT00005589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102580107|NCT00005589|Alkylating Agents|alkylating agents|mesh-ancestor
102580108|NCT00005589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580109|NCT00005589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102580110|NCT00005589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102580111|NCT00005589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102580112|NCT00005589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102580113|NCT00005589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102580114|NCT00005589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102580115|NCT00005589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102580116|NCT00005589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102580117|NCT00005589|Antimetabolites|antimetabolites|mesh-ancestor
102580118|NCT00005589|Antiviral Agents|antiviral agents|mesh-ancestor
102580119|NCT00005589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102580120|NCT00005601|Cytarabine|cytarabine|mesh-list
102580121|NCT00005601|Dexamethasone|dexamethasone|mesh-list
102580122|NCT00005601|Rituximab|rituximab|mesh-list
102580123|NCT00005601|Sargramostim|sargramostim|mesh-list
102580124|NCT00005601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102580125|NCT00005601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102580126|NCT00005601|Immunologic Factors|immunologic factors|mesh-ancestor
102580127|NCT00005601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580128|NCT00005601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102580129|NCT00005601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102580130|NCT00005601|Antiemetics|antiemetics|mesh-ancestor
102580131|NCT00005601|Autonomic Agents|autonomic agents|mesh-ancestor
102580132|NCT00005601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102580133|NCT00005601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102580134|NCT00005601|Glucocorticoids|glucocorticoids|mesh-ancestor
102580135|NCT00005601|Hormones|hormones|mesh-ancestor
102580136|NCT00005601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102580137|NCT00005601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102580138|NCT00005601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102580139|NCT00005601|Antimetabolites|antimetabolites|mesh-ancestor
102580140|NCT00005601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580141|NCT00005601|Antiviral Agents|antiviral agents|mesh-ancestor
102580142|NCT00005601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102580143|NCT00005601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102580144|NCT00005607|Leucovorin|leucovorin|mesh-list
102580145|NCT00005607|Fluorouracil|fluorouracil|mesh-list
102580146|NCT00005607|Irinotecan|irinotecan|mesh-list
102580147|NCT00005607|Calcium|calcium|mesh-list
102580148|NCT00005607|Levoleucovorin|levoleucovorin|mesh-list
102580149|NCT00005607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102580150|NCT00005607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580151|NCT00005607|Antimetabolites|antimetabolites|mesh-ancestor
102580152|NCT00005607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580153|NCT00005607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102580154|NCT00005607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102580155|NCT00005607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102580156|NCT00005607|Immunologic Factors|immunologic factors|mesh-ancestor
102580157|NCT00005607|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102580158|NCT00005607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102580159|NCT00005607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102580160|NCT00005607|Antidotes|antidotes|mesh-ancestor
102580161|NCT00005607|Protective Agents|protective agents|mesh-ancestor
102580162|NCT00005607|Vitamin B Complex|vitamin b complex|mesh-ancestor
102580163|NCT00005607|Vitamins|vitamins|mesh-ancestor
102580164|NCT00005607|Micronutrients|micronutrients|mesh-ancestor
102580165|NCT00005613|Cyclophosphamide|cyclophosphamide|mesh-list
102580166|NCT00005613|Carmustine|carmustine|mesh-list
102580167|NCT00005613|Etoposide|etoposide|mesh-list
102580168|NCT00005613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102580169|NCT00005613|Immunologic Factors|immunologic factors|mesh-ancestor
102580170|NCT00005613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580171|NCT00005613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102580172|NCT00005613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102580173|NCT00005613|Alkylating Agents|alkylating agents|mesh-ancestor
102580174|NCT00005613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580175|NCT00005613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102580176|NCT00005613|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102580177|NCT00005613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102580178|NCT00005613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102580179|NCT00005613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102580180|NCT00005613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102580181|NCT00005625|Trabectedin|trabectedin|mesh-list
102580182|NCT00005625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102580183|NCT00005625|Alkylating Agents|alkylating agents|mesh-ancestor
102580184|NCT00005625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580185|NCT00005625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102580186|NCT00005631|Rituximab|rituximab|mesh-list
102580187|NCT00005631|Carboplatin|carboplatin|mesh-list
102580188|NCT00005631|Etoposide|etoposide|mesh-list
102580189|NCT00005631|Ifosfamide|ifosfamide|mesh-list
102580190|NCT00005631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102580191|NCT00005631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102580192|NCT00005631|Immunologic Factors|immunologic factors|mesh-ancestor
102580193|NCT00005631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580194|NCT00005631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102580195|NCT00005631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102580196|NCT00005631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102580197|NCT00005631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102580198|NCT00005631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102580199|NCT00005631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580200|NCT00005631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102580201|NCT00005631|Alkylating Agents|alkylating agents|mesh-ancestor
102580202|NCT00005637|Temozolomide|temozolomide|mesh-list
102580203|NCT00005637|Carmustine|carmustine|mesh-list
102580204|NCT00005637|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102580205|NCT00005637|Alkylating Agents|alkylating agents|mesh-ancestor
102580206|NCT00005637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580207|NCT00005637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102580208|NCT00005643|Doxorubicin|doxorubicin|mesh-list
102580209|NCT00005643|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102580210|NCT00005643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102580211|NCT00005643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102580212|NCT00005643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102580213|NCT00005643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102580214|NCT00005643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102580215|NCT00005643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580216|NCT00005649|Paclitaxel|paclitaxel|mesh-list
102580217|NCT00005649|Capecitabine|capecitabine|mesh-list
102580218|NCT00005649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102580219|NCT00005649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102580220|NCT00005649|Tubulin Modulators|tubulin modulators|mesh-ancestor
102580221|NCT00005649|Antimitotic Agents|antimitotic agents|mesh-ancestor
102580222|NCT00005649|Mitosis Modulators|mitosis modulators|mesh-ancestor
102580223|NCT00005649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580224|NCT00005649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102580225|NCT00005649|Antimetabolites|antimetabolites|mesh-ancestor
102580226|NCT00005673|Capravirine|capravirine|mesh-list
102580227|NCT00005673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102580228|NCT00005673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102580229|NCT00005673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102580230|NCT00005673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580231|NCT00005673|Antiviral Agents|antiviral agents|mesh-ancestor
102580232|NCT00005673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102580233|NCT00005673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102580234|NCT00005673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102580235|NCT02247349|Nivolumab|nivolumab|mesh-list
102580236|NCT02247349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102580237|NCT02247349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102580238|NCT02247349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102580239|NCT02247349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580240|NCT03390673|Bevacizumab|bevacizumab|mesh-list
102580241|NCT03390673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102580242|NCT03390673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102580243|NCT03390673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102580244|NCT03390673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102580245|NCT03390673|Growth Substances|growth substances|mesh-ancestor
102580246|NCT03390673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580247|NCT03390673|Growth Inhibitors|growth inhibitors|mesh-ancestor
102580248|NCT02974933|Pemetrexed|pemetrexed|mesh-list
102580249|NCT02974933|Apatinib|apatinib|mesh-list
102580250|NCT02974933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102580251|NCT02974933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102580252|NCT02974933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580253|NCT02974933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102580254|NCT02974933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102580255|NCT02974933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102580256|NCT00005769|Hormones|hormones|mesh-list
102580257|NCT00005769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102580258|NCT00005769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580259|NCT00005775|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
102580260|NCT00005775|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102580261|NCT00005775|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102580262|NCT00005787|Epoetin Alfa|epoetin alfa|mesh-list
102580263|NCT00005787|Flt3 ligand protein|flt3 ligand protein|mesh-list
102580264|NCT00005787|Sargramostim|sargramostim|mesh-list
102580265|NCT00005787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102580266|NCT00005787|Immunologic Factors|immunologic factors|mesh-ancestor
102580267|NCT00005787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580268|NCT00005787|Hematinics|hematinics|mesh-ancestor
102580269|NCT00005787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102580270|NCT00005787|Protective Agents|protective agents|mesh-ancestor
102580271|NCT00005793|Cytarabine|cytarabine|mesh-list
102580272|NCT00005793|Etoposide|etoposide|mesh-list
102580273|NCT00005793|Daunorubicin|daunorubicin|mesh-list
102580274|NCT00005793|Topotecan|topotecan|mesh-list
102580275|NCT00005793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102580276|NCT00005793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102580277|NCT00005793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102580278|NCT00005793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102580279|NCT00005793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102580280|NCT00005793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580281|NCT00005793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102580282|NCT00005793|Antimetabolites|antimetabolites|mesh-ancestor
102580283|NCT00005793|Antiviral Agents|antiviral agents|mesh-ancestor
102580284|NCT00005793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102580285|NCT00005793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102580286|NCT00005793|Immunologic Factors|immunologic factors|mesh-ancestor
102580287|NCT00005793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580288|NCT00005793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102580289|NCT00005793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102580290|NCT00005799|Cyclosporine|cyclosporine|mesh-list
102580291|NCT00005799|Mycophenolic Acid|mycophenolic acid|mesh-list
102580292|NCT00005799|Fludarabine|fludarabine|mesh-list
102580293|NCT00005799|Fludarabine phosphate|fludarabine phosphate|mesh-list
102580294|NCT00005799|Cyclosporins|cyclosporins|mesh-list
102580295|NCT00005799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102580296|NCT00005799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102580297|NCT00005799|Antimetabolites|antimetabolites|mesh-ancestor
102580298|NCT00005799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580299|NCT00005799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102580300|NCT00005799|Immunologic Factors|immunologic factors|mesh-ancestor
102580301|NCT00005799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580302|NCT00005799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102580303|NCT00005799|Antifungal Agents|antifungal agents|mesh-ancestor
102580304|NCT00005799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102580305|NCT00005799|Dermatologic Agents|dermatologic agents|mesh-ancestor
102580306|NCT00005799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102580307|NCT00005799|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102580308|NCT00005799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102580309|NCT00005799|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102580310|NCT00005799|Antitubercular Agents|antitubercular agents|mesh-ancestor
102580311|NCT00005799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102580312|NCT00386373|Imatinib Mesylate|imatinib mesylate|mesh-list
102580313|NCT00386373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102580314|NCT00386373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102580315|NCT00386373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102580316|NCT00386373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580317|NCT00005811|Topotecan|topotecan|mesh-list
102580318|NCT00005811|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102580319|NCT00005811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102580320|NCT00005811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102580321|NCT00005811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580322|NCT00005811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102580323|NCT02520518|Dapagliflozin|dapagliflozin|mesh-list
102580324|NCT02520518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102580325|NCT02520518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580326|NCT02520518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102580327|NCT02520518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580328|NCT01689987|Sirolimus|sirolimus|mesh-list
102580329|NCT01689987|Hydroxychloroquine|hydroxychloroquine|mesh-list
102580330|NCT01689987|Dexamethasone|dexamethasone|mesh-list
102580331|NCT01689987|Dexamethasone acetate|dexamethasone acetate|mesh-list
102580332|NCT01689987|Cyclophosphamide|cyclophosphamide|mesh-list
102580333|NCT01689987|Ichthammol|ichthammol|mesh-list
102580334|NCT01689987|BB 1101|bb 1101|mesh-list
102580335|NCT01689987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102580336|NCT01689987|Immunologic Factors|immunologic factors|mesh-ancestor
102580337|NCT01689987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580338|NCT01689987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102580339|NCT01689987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102580340|NCT01689987|Alkylating Agents|alkylating agents|mesh-ancestor
102580341|NCT01689987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580342|NCT01689987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102580343|NCT01689987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102580344|NCT01689987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102580345|NCT01689987|Antiemetics|antiemetics|mesh-ancestor
102580346|NCT01689987|Autonomic Agents|autonomic agents|mesh-ancestor
102580347|NCT01689987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102580348|NCT01689987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102580349|NCT01689987|Glucocorticoids|glucocorticoids|mesh-ancestor
102580350|NCT01689987|Hormones|hormones|mesh-ancestor
102580351|NCT01689987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102580352|NCT01689987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102580353|NCT01689987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102580354|NCT01689987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102580355|NCT01689987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102580356|NCT01689987|Antifungal Agents|antifungal agents|mesh-ancestor
102580357|NCT01689987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102580358|NCT01689987|Antimalarials|antimalarials|mesh-ancestor
102580359|NCT01689987|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102580360|NCT01689987|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102580361|NCT01689987|Protease Inhibitors|protease inhibitors|mesh-ancestor
102580362|NCT01689987|Dermatologic Agents|dermatologic agents|mesh-ancestor
102580363|NCT01680939|Ibuprofen|ibuprofen|mesh-list
102580364|NCT01680939|Morphine|morphine|mesh-list
102580365|NCT01680939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102580366|NCT01680939|Narcotics|narcotics|mesh-ancestor
102580367|NCT01680939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102580368|NCT01680939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580369|NCT01680939|Analgesics|analgesics|mesh-ancestor
102580370|NCT01680939|Sensory System Agents|sensory system agents|mesh-ancestor
102580371|NCT01680939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102580372|NCT01680939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102580373|NCT01680939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102580374|NCT01680939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102580375|NCT01680939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102580376|NCT01680939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102580377|NCT01680939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102580378|NCT01680939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580379|NCT01689597|Morphine|morphine|mesh-list
102580380|NCT01689597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102580381|NCT01689597|Narcotics|narcotics|mesh-ancestor
102580382|NCT01689597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102580383|NCT01689597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580384|NCT01689597|Analgesics|analgesics|mesh-ancestor
102580385|NCT01689597|Sensory System Agents|sensory system agents|mesh-ancestor
102580386|NCT01689597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102580387|NCT02163733|Osimertinib|osimertinib|mesh-list
102580388|NCT02163733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102580389|NCT02163733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102580390|NCT02163733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102580391|NCT02163733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580392|NCT02483000|Biotin|biotin|mesh-list
102580393|NCT02483000|Cytarabine|cytarabine|mesh-list
102580394|NCT02483000|Etoposide|etoposide|mesh-list
102580395|NCT02483000|Podophyllotoxin|podophyllotoxin|mesh-list
102580396|NCT02483000|Etoposide phosphate|etoposide phosphate|mesh-list
102580397|NCT02483000|Melphalan|melphalan|mesh-list
102580398|NCT02483000|Mechlorethamine|mechlorethamine|mesh-list
102580399|NCT02483000|Carmustine|carmustine|mesh-list
102580400|NCT02483000|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102580401|NCT02483000|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
102580402|NCT02483000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102580403|NCT02483000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102580404|NCT02483000|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102580405|NCT02483000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102580406|NCT02483000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102580407|NCT02483000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580408|NCT02483000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102580409|NCT02483000|Antimetabolites|antimetabolites|mesh-ancestor
102580410|NCT02483000|Antiviral Agents|antiviral agents|mesh-ancestor
102580411|NCT02483000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102580412|NCT02483000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102580413|NCT02483000|Immunologic Factors|immunologic factors|mesh-ancestor
102580414|NCT02483000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580415|NCT02483000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102580416|NCT02483000|Alkylating Agents|alkylating agents|mesh-ancestor
102580417|NCT02483000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102580418|NCT02483000|Chelating Agents|chelating agents|mesh-ancestor
102580419|NCT02483000|Sequestering Agents|sequestering agents|mesh-ancestor
102580420|NCT02483000|Keratolytic Agents|keratolytic agents|mesh-ancestor
102580421|NCT02483000|Dermatologic Agents|dermatologic agents|mesh-ancestor
102580422|NCT02483000|Tubulin Modulators|tubulin modulators|mesh-ancestor
102580423|NCT02483000|Antimitotic Agents|antimitotic agents|mesh-ancestor
102580424|NCT02483000|Mitosis Modulators|mitosis modulators|mesh-ancestor
102580425|NCT02483000|Vitamin B Complex|vitamin b complex|mesh-ancestor
102580426|NCT02483000|Vitamins|vitamins|mesh-ancestor
102580427|NCT02483000|Micronutrients|micronutrients|mesh-ancestor
102580428|NCT02420210|Dexamethasone|dexamethasone|mesh-list
102580429|NCT02420210|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102580430|NCT02420210|Obinutuzumab|obinutuzumab|mesh-list
102580431|NCT02420210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102580432|NCT02420210|Antiemetics|antiemetics|mesh-ancestor
102580433|NCT02420210|Autonomic Agents|autonomic agents|mesh-ancestor
102580434|NCT02420210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102580435|NCT02420210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580436|NCT02420210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102580437|NCT02420210|Glucocorticoids|glucocorticoids|mesh-ancestor
102580438|NCT02420210|Hormones|hormones|mesh-ancestor
102580439|NCT02420210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102580440|NCT02420210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102580441|NCT02420210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102580442|NCT02420210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102580443|NCT02420210|Alkylating Agents|alkylating agents|mesh-ancestor
102580444|NCT02420210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580445|NCT02420210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102580446|NCT04829799|Ketorolac|ketorolac|mesh-list
102580447|NCT04829799|Lidocaine|lidocaine|mesh-list
102580448|NCT04829799|Phenylephrine|phenylephrine|mesh-list
102580449|NCT04829799|Oxymetazoline|oxymetazoline|mesh-list
102580450|NCT04829799|Anesthetics, Local|anesthetics, local|mesh-ancestor
102580451|NCT04829799|Anesthetics|anesthetics|mesh-ancestor
102580452|NCT04829799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102580453|NCT04829799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580454|NCT04829799|Sensory System Agents|sensory system agents|mesh-ancestor
102580455|NCT04829799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102580456|NCT04829799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102580457|NCT04829799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102580458|NCT04829799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102580459|NCT04829799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102580460|NCT04829799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580461|NCT04829799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102580462|NCT04829799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102580463|NCT04829799|Analgesics|analgesics|mesh-ancestor
102580464|NCT04829799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102580465|NCT04829799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102580466|NCT04829799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102580467|NCT04829799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102580468|NCT04829799|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102580469|NCT04829799|Mydriatics|mydriatics|mesh-ancestor
102580470|NCT04829799|Autonomic Agents|autonomic agents|mesh-ancestor
102580471|NCT04829799|Sympathomimetics|sympathomimetics|mesh-ancestor
102580472|NCT04829799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102580473|NCT04829799|Nasal Decongestants|nasal decongestants|mesh-ancestor
102580474|NCT04829799|Respiratory System Agents|respiratory system agents|mesh-ancestor
102580475|NCT04829799|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102580476|NCT04829799|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102580477|NCT04829799|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102580478|NCT04829799|Adrenergic Agents|adrenergic agents|mesh-ancestor
102580479|NCT04829799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102580480|NCT04829799|Protective Agents|protective agents|mesh-ancestor
102580481|NCT01789333|Riboflavin|riboflavin|mesh-list
102580482|NCT01789333|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102580483|NCT01789333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102580484|NCT01789333|Vitamin B Complex|vitamin b complex|mesh-ancestor
102580485|NCT01789333|Vitamins|vitamins|mesh-ancestor
102580486|NCT01789333|Micronutrients|micronutrients|mesh-ancestor
102580487|NCT01789333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580488|NCT01789333|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102580489|NCT01789333|Dermatologic Agents|dermatologic agents|mesh-ancestor
102580490|NCT02524106|Bococizumab|bococizumab|mesh-list
102580491|NCT02524106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102580492|NCT02524106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102580493|NCT02524106|Antimetabolites|antimetabolites|mesh-ancestor
102580494|NCT02524106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580495|NCT02524106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102580496|NCT01761877|Sulindac|sulindac|mesh-list
102580497|NCT01761877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102580498|NCT01761877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102580499|NCT01761877|Analgesics|analgesics|mesh-ancestor
102580500|NCT01761877|Sensory System Agents|sensory system agents|mesh-ancestor
102580501|NCT01761877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102580502|NCT01761877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580503|NCT01761877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102580504|NCT01761877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102580505|NCT01761877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102580506|NCT01761877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102580507|NCT01761877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102580508|NCT01761877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580509|NCT02488070|Edetic Acid|edetic acid|mesh-list
102580510|NCT02488070|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102580511|NCT02488070|Chelating Agents|chelating agents|mesh-ancestor
102580512|NCT02488070|Sequestering Agents|sequestering agents|mesh-ancestor
102580513|NCT02488070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580514|NCT02488070|Anticoagulants|anticoagulants|mesh-ancestor
102580515|NCT02488070|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102580516|NCT02488070|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102580517|NCT04116541|Trametinib|trametinib|mesh-list
102580518|NCT04116541|Dabrafenib|dabrafenib|mesh-list
102580519|NCT04116541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102580520|NCT04116541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102580521|NCT04116541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102580522|NCT04116541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580523|NCT03306979|Acetylcysteine|acetylcysteine|mesh-list
102580524|NCT03306979|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102580525|NCT03306979|Antiviral Agents|antiviral agents|mesh-ancestor
102580526|NCT03306979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102580527|NCT03306979|Expectorants|expectorants|mesh-ancestor
102580528|NCT03306979|Respiratory System Agents|respiratory system agents|mesh-ancestor
102580529|NCT03306979|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102580530|NCT03306979|Antioxidants|antioxidants|mesh-ancestor
102580531|NCT03306979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580532|NCT03306979|Protective Agents|protective agents|mesh-ancestor
102580533|NCT03306979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580534|NCT03306979|Antidotes|antidotes|mesh-ancestor
102580535|NCT00362869|Levofloxacin|levofloxacin|mesh-list
102580536|NCT00362869|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102580537|NCT00362869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102580538|NCT00362869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102580539|NCT00362869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102580540|NCT00362869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102580541|NCT00362869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102580542|NCT00362869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580543|NCT00362869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102580544|NCT00362869|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102580545|NCT00362869|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102580546|NCT03257215|Vitamin D|vitamin d|mesh-list
102580547|NCT03257215|Ergocalciferols|ergocalciferols|mesh-list
102580548|NCT03257215|Cholecalciferol|cholecalciferol|mesh-list
102580549|NCT03257215|Vitamins|vitamins|mesh-list
102580550|NCT03257215|Micronutrients|micronutrients|mesh-ancestor
102580551|NCT03257215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580552|NCT03257215|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102580553|NCT03257215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102580554|NCT02422940|4-Aminopyridine|4-aminopyridine|mesh-list
102580555|NCT02422940|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102580556|NCT02422940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102580557|NCT02422940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580558|NCT00588523|Temozolomide|temozolomide|mesh-list
102580559|NCT00588523|Busulfan|busulfan|mesh-list
102580560|NCT00588523|Thiotepa|thiotepa|mesh-list
102580561|NCT00588523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102580562|NCT00588523|Alkylating Agents|alkylating agents|mesh-ancestor
102580563|NCT00588523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580564|NCT00588523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102580565|NCT00588523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102580566|NCT00588523|Immunologic Factors|immunologic factors|mesh-ancestor
102580567|NCT00588523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580568|NCT00588523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102580569|NCT02974387|Loteprednol Etabonate|loteprednol etabonate|mesh-list
102580570|NCT02974387|Fluorometholone|fluorometholone|mesh-list
102580571|NCT02974387|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102580572|NCT02974387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102580573|NCT02974387|Glucocorticoids|glucocorticoids|mesh-ancestor
102580574|NCT02974387|Hormones|hormones|mesh-ancestor
102580575|NCT02974387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102580576|NCT02974387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580577|NCT00493831|Nicotine|nicotine|mesh-list
102580578|NCT00493831|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102580579|NCT00493831|Autonomic Agents|autonomic agents|mesh-ancestor
102580580|NCT00493831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102580581|NCT00493831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580582|NCT00493831|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102580583|NCT00493831|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102580584|NCT00493831|Cholinergic Agents|cholinergic agents|mesh-ancestor
102580585|NCT00493831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102580586|NCT00493831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580587|NCT00430183|Docetaxel|docetaxel|mesh-list
102580588|NCT00430183|Leuprolide|leuprolide|mesh-list
102580589|NCT00430183|Goserelin|goserelin|mesh-list
102580590|NCT00430183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102580591|NCT00430183|Tubulin Modulators|tubulin modulators|mesh-ancestor
102580592|NCT00430183|Antimitotic Agents|antimitotic agents|mesh-ancestor
102580593|NCT00430183|Mitosis Modulators|mitosis modulators|mesh-ancestor
102580594|NCT00430183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580595|NCT00430183|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102580596|NCT00430183|Fertility Agents|fertility agents|mesh-ancestor
102580597|NCT00430183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102580598|NCT00430183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580599|NCT00430183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102580600|NCT00362947|Parnaparin|parnaparin|mesh-list
102580601|NCT00362947|Anticoagulants|anticoagulants|mesh-ancestor
102580602|NCT00362947|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102580603|NCT00362947|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102580604|NCT00362947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580605|NCT00363025|Daunorubicin|daunorubicin|mesh-list
102580606|NCT00363025|Idarubicin|idarubicin|mesh-list
102580607|NCT00363025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102580608|NCT00363025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102580609|NCT00363025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102580610|NCT00363025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102580611|NCT00363025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102580612|NCT00363025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580613|NCT02444143|Tacrolimus|tacrolimus|mesh-list
102580614|NCT02444143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102580615|NCT02444143|Immunologic Factors|immunologic factors|mesh-ancestor
102580616|NCT02444143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580617|NCT02444143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102580618|NCT02444143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102580619|NCT02444143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580620|NCT03161431|Pembrolizumab|pembrolizumab|mesh-list
102580621|NCT03161431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102580622|NCT03161431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102580623|NCT03161431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102580624|NCT03161431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580625|NCT02445859|Cefuroxime|cefuroxime|mesh-list
102580626|NCT02445859|Cefuroxime axetil|cefuroxime axetil|mesh-list
102580627|NCT02445859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102580628|NCT02445859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102580629|NCT02446483|Rabeprazole|rabeprazole|mesh-list
102580630|NCT02446483|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102580631|NCT02446483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102580632|NCT02446483|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102580633|NCT02446483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102580634|NCT02446483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580635|NCT00362635|Clevudine|clevudine|mesh-list
102580636|NCT00362635|Antiviral Agents|antiviral agents|mesh-ancestor
102580637|NCT00362635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102580638|NCT04744753|Calcium|calcium|mesh-list
102580639|NCT04744753|Ionophores|ionophores|mesh-list
102580640|NCT04744753|Calcium Ionophores|calcium ionophores|mesh-list
102580641|NCT04744753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102580642|NCT04744753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580643|NCT04744753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102580644|NCT04744753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580645|NCT02420041|Triamcinolone|triamcinolone|mesh-list
102580646|NCT02420041|Lidocaine|lidocaine|mesh-list
102580647|NCT02420041|Anesthetics, Local|anesthetics, local|mesh-ancestor
102580648|NCT02420041|Anesthetics|anesthetics|mesh-ancestor
102580649|NCT02420041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102580650|NCT02420041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580651|NCT02420041|Sensory System Agents|sensory system agents|mesh-ancestor
102580652|NCT02420041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102580653|NCT02420041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102580654|NCT02420041|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102580655|NCT02420041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102580656|NCT02420041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102580657|NCT02420041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580658|NCT02420041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102580659|NCT02420041|Glucocorticoids|glucocorticoids|mesh-ancestor
102580660|NCT02420041|Hormones|hormones|mesh-ancestor
102580661|NCT02420041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102580662|NCT02421211|Sofosbuvir|sofosbuvir|mesh-list
102580663|NCT02421211|Ledipasvir|ledipasvir|mesh-list
102580664|NCT02421211|Simeprevir|simeprevir|mesh-list
102580665|NCT02421211|Antiviral Agents|antiviral agents|mesh-ancestor
102580666|NCT02421211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102580667|NCT02421211|Protease Inhibitors|protease inhibitors|mesh-ancestor
102580668|NCT02421211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102580669|NCT02421211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580670|NCT00363259|Ribavirin|ribavirin|mesh-list
102580671|NCT00363259|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102580672|NCT00363259|Antimetabolites|antimetabolites|mesh-ancestor
102580673|NCT00363259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580674|NCT00363259|Antiviral Agents|antiviral agents|mesh-ancestor
102580675|NCT00363259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102580676|NCT03089905|Dexmedetomidine|dexmedetomidine|mesh-list
102580677|NCT03089905|Remifentanil|remifentanil|mesh-list
102580678|NCT03089905|Sevoflurane|sevoflurane|mesh-list
102580679|NCT03089905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102580680|NCT03089905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102580681|NCT03089905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580682|NCT03089905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102580683|NCT03089905|Analgesics|analgesics|mesh-ancestor
102580684|NCT03089905|Sensory System Agents|sensory system agents|mesh-ancestor
102580685|NCT03089905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102580686|NCT03089905|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102580687|NCT03089905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102580688|NCT03089905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102580689|NCT03089905|Adrenergic Agents|adrenergic agents|mesh-ancestor
102580690|NCT03089905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102580691|NCT03089905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580692|NCT03089905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102580693|NCT03089905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102580694|NCT03089905|Anesthetics, General|anesthetics, general|mesh-ancestor
102580695|NCT03089905|Anesthetics|anesthetics|mesh-ancestor
102580696|NCT03089905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102580697|NCT03089905|Narcotics|narcotics|mesh-ancestor
102580698|NCT02424968|Cyclosporine|cyclosporine|mesh-list
102580699|NCT02424968|Mycophenolic Acid|mycophenolic acid|mesh-list
102580700|NCT02424968|Cyclosporins|cyclosporins|mesh-list
102580701|NCT02424968|Thymoglobulin|thymoglobulin|mesh-list
102580702|NCT02424968|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102580703|NCT02424968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102580704|NCT02424968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580705|NCT02424968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102580706|NCT02424968|Immunologic Factors|immunologic factors|mesh-ancestor
102580707|NCT02424968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580708|NCT02424968|Antifungal Agents|antifungal agents|mesh-ancestor
102580709|NCT02424968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102580710|NCT02424968|Dermatologic Agents|dermatologic agents|mesh-ancestor
102580711|NCT02424968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102580712|NCT02424968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102580713|NCT02424968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102580714|NCT02424968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102580715|NCT02424968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102580716|NCT02424968|Antitubercular Agents|antitubercular agents|mesh-ancestor
102580717|NCT02424968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102580718|NCT02424799|GSK2646264|gsk2646264|mesh-list
102580719|NCT02424799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102580720|NCT02424799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102580721|NCT02424799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580722|NCT02492750|Dexamethasone|dexamethasone|mesh-list
102580723|NCT02492750|Dexamethasone acetate|dexamethasone acetate|mesh-list
102580724|NCT02492750|Lenalidomide|lenalidomide|mesh-list
102580725|NCT02492750|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102580726|NCT02492750|Ichthammol|ichthammol|mesh-list
102580727|NCT02492750|BB 1101|bb 1101|mesh-list
102580728|NCT02492750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102580729|NCT02492750|Antiemetics|antiemetics|mesh-ancestor
102580730|NCT02492750|Autonomic Agents|autonomic agents|mesh-ancestor
102580731|NCT02492750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102580732|NCT02492750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580733|NCT02492750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102580734|NCT02492750|Glucocorticoids|glucocorticoids|mesh-ancestor
102580735|NCT02492750|Hormones|hormones|mesh-ancestor
102580736|NCT02492750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102344076|NCT03935958|Analgesics|analgesics|mesh-ancestor
102580737|NCT02492750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102580738|NCT02492750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102580739|NCT02492750|Immunologic Factors|immunologic factors|mesh-ancestor
102580740|NCT02492750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102580741|NCT02492750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102580742|NCT02492750|Growth Substances|growth substances|mesh-ancestor
102580743|NCT02492750|Growth Inhibitors|growth inhibitors|mesh-ancestor
102580744|NCT02492750|Protease Inhibitors|protease inhibitors|mesh-ancestor
102580745|NCT02492750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102580746|NCT02492750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580747|NCT02492750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102580748|NCT02492750|Dermatologic Agents|dermatologic agents|mesh-ancestor
102580749|NCT00363337|Aripiprazole|aripiprazole|mesh-list
102580750|NCT00363337|Antidepressive Agents|antidepressive agents|mesh-ancestor
102580751|NCT00363337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102580752|NCT00363337|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102580753|NCT00363337|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102580754|NCT00363337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102580755|NCT00363337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580756|NCT00363337|Dopamine Agonists|dopamine agonists|mesh-ancestor
102580757|NCT00363337|Dopamine Agents|dopamine agents|mesh-ancestor
102580758|NCT00363337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102580759|NCT00363337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580760|NCT00363337|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102580761|NCT00363337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102580762|NCT00363337|Serotonin Agents|serotonin agents|mesh-ancestor
102580763|NCT00363337|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102580764|NCT00363337|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102580765|NCT00363337|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102580766|NCT00363337|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102580767|NCT02493452|Plecanatide|plecanatide|mesh-list
102580768|NCT02493452|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102580769|NCT02493452|Enzyme Activators|enzyme activators|mesh-ancestor
102580770|NCT02493452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580771|NCT02493452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102580772|NCT02429869|Everolimus|everolimus|mesh-list
102580773|NCT02429869|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102580774|NCT02429869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102580775|NCT02429869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102580776|NCT02429869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580777|NCT02429869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102580778|NCT02429869|Immunologic Factors|immunologic factors|mesh-ancestor
102580779|NCT02429869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580780|NCT02429869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102580781|NCT02428478|Desipramine|desipramine|mesh-list
102580782|NCT02428478|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102580783|NCT02428478|Antidepressive Agents|antidepressive agents|mesh-ancestor
102580784|NCT02428478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102580785|NCT02428478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102580786|NCT02428478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580787|NCT02428478|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102580788|NCT02428478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102580789|NCT02428478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102580790|NCT02428478|Adrenergic Agents|adrenergic agents|mesh-ancestor
102580791|NCT02428478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102127688|NCT03248648|Autonomic Agents|autonomic agents|mesh-ancestor
102580792|NCT02428478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580793|NCT04341493|Hydroxychloroquine|hydroxychloroquine|mesh-list
102580794|NCT04341493|Nitazoxanide|nitazoxanide|mesh-list
102580795|NCT04341493|Antimalarials|antimalarials|mesh-ancestor
102580796|NCT04341493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102580797|NCT04341493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102580798|NCT04341493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102580799|NCT04341493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102580800|NCT04341493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580801|NCT04341493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102580802|NCT02432287|Metformin|metformin|mesh-list
102580803|NCT02432287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102580804|NCT02432287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580805|NCT02532998|Fludrocortisone|fludrocortisone|mesh-list
102580806|NCT02532998|Eplerenone|eplerenone|mesh-list
102580807|NCT02532998|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102580808|NCT02532998|Hormone Antagonists|hormone antagonists|mesh-ancestor
102580809|NCT02532998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102580810|NCT02532998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580811|NCT02532998|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102580812|NCT02532998|Diuretics|diuretics|mesh-ancestor
102580813|NCT02532998|Natriuretic Agents|natriuretic agents|mesh-ancestor
102580814|NCT02532998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102580815|NCT02532998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102580816|NCT03026101|Nitroglycerin|nitroglycerin|mesh-list
102580817|NCT03026101|Vasodilator Agents|vasodilator agents|mesh-ancestor
102580818|NCT02453581|Artefenomel|artefenomel|mesh-list
102580819|NCT02453581|Antimalarials|antimalarials|mesh-ancestor
102580820|NCT02453581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102580821|NCT02453581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102580822|NCT02453581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102580823|NCT02533466|Listerine|listerine|mesh-list
102580824|NCT02533466|Fluorides|fluorides|mesh-list
102580825|NCT02533466|Sodium Fluoride|sodium fluoride|mesh-list
102580826|NCT02533466|Cariostatic Agents|cariostatic agents|mesh-ancestor
102580827|NCT02533466|Protective Agents|protective agents|mesh-ancestor
102580828|NCT02533466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580829|NCT02533466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102580830|NCT02533466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102580831|NCT02974244|Exenatide|exenatide|mesh-list
102580832|NCT02974244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102580833|NCT02974244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580834|NCT02974244|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102580835|NCT02974244|Incretins|incretins|mesh-ancestor
102580836|NCT02974244|Hormones|hormones|mesh-ancestor
102580837|NCT02974244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102580838|NCT02436031|Desipramine|desipramine|mesh-list
102580839|NCT02436031|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102580840|NCT02436031|Antidepressive Agents|antidepressive agents|mesh-ancestor
102580841|NCT02436031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102580842|NCT02436031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102580843|NCT02436031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580844|NCT02436031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102580845|NCT02436031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102580846|NCT02436031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102580847|NCT02436031|Adrenergic Agents|adrenergic agents|mesh-ancestor
102580848|NCT02436031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102580849|NCT02436031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580850|NCT02454283|Vanoxerine|vanoxerine|mesh-list
102580851|NCT02454283|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102580852|NCT02454283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102580853|NCT02454283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102580854|NCT02454283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580855|NCT02454283|Dopamine Agents|dopamine agents|mesh-ancestor
102580856|NCT02454283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102580857|NCT02454283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580858|NCT02437669|Hydromorphone|hydromorphone|mesh-list
102580859|NCT02437669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102580860|NCT02437669|Narcotics|narcotics|mesh-ancestor
102580861|NCT02437669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102580862|NCT02437669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580863|NCT02437669|Analgesics|analgesics|mesh-ancestor
102580864|NCT02437669|Sensory System Agents|sensory system agents|mesh-ancestor
102580865|NCT02437669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102580866|NCT02430818|Ketamine|ketamine|mesh-list
102580867|NCT02430818|Morphine|morphine|mesh-list
102580868|NCT02430818|Analgesics|analgesics|mesh-ancestor
102580869|NCT02430818|Sensory System Agents|sensory system agents|mesh-ancestor
102580870|NCT02430818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102580871|NCT02430818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580872|NCT02430818|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102580873|NCT02430818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102580874|NCT02430818|Anesthetics, General|anesthetics, general|mesh-ancestor
102580875|NCT02430818|Anesthetics|anesthetics|mesh-ancestor
102580876|NCT02430818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102580877|NCT02430818|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102580878|NCT02430818|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102580879|NCT02430818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102580880|NCT02430818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580881|NCT02430818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102580882|NCT02430818|Narcotics|narcotics|mesh-ancestor
102580883|NCT02455453|Estradiol|estradiol|mesh-list
102580884|NCT02455453|Estrogens|estrogens|mesh-ancestor
102580885|NCT02455453|Hormones|hormones|mesh-ancestor
102580886|NCT02455453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102580887|NCT02455453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580888|NCT02533934|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102580889|NCT02533934|Antiviral Agents|antiviral agents|mesh-ancestor
102580890|NCT02533934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102580891|NCT02519023|Acetaminophen|acetaminophen|mesh-list
102580892|NCT02519023|Ibuprofen|ibuprofen|mesh-list
102580893|NCT02519023|Epinephrine|epinephrine|mesh-list
102580894|NCT02519023|Oxycodone|oxycodone|mesh-list
102580895|NCT02519023|Bupivacaine|bupivacaine|mesh-list
102580896|NCT02519023|Anesthetics, Local|anesthetics, local|mesh-ancestor
102580897|NCT02519023|Anesthetics|anesthetics|mesh-ancestor
102580898|NCT02519023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102580899|NCT02519023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580900|NCT02519023|Sensory System Agents|sensory system agents|mesh-ancestor
102580901|NCT02519023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102580902|NCT02519023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102580903|NCT02519023|Analgesics|analgesics|mesh-ancestor
102580904|NCT02519023|Antipyretics|antipyretics|mesh-ancestor
102580905|NCT02519023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102580906|NCT02519023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102580907|NCT02519023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102580908|NCT02519023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102580909|NCT02519023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102580910|NCT02519023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580911|NCT02519023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102580912|NCT02519023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102580913|NCT02519023|Adrenergic Agents|adrenergic agents|mesh-ancestor
102580914|NCT02519023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102580915|NCT02519023|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102580916|NCT02519023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102580917|NCT02519023|Autonomic Agents|autonomic agents|mesh-ancestor
102580918|NCT02519023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102580919|NCT02519023|Respiratory System Agents|respiratory system agents|mesh-ancestor
102580920|NCT02519023|Mydriatics|mydriatics|mesh-ancestor
102580921|NCT02519023|Sympathomimetics|sympathomimetics|mesh-ancestor
102580922|NCT02519023|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102580923|NCT02519023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102580924|NCT02519023|Narcotics|narcotics|mesh-ancestor
102580925|NCT02497040|Bupivacaine|bupivacaine|mesh-list
102580926|NCT02497040|Levobupivacaine|levobupivacaine|mesh-list
102580927|NCT02497040|Anesthetics, Local|anesthetics, local|mesh-ancestor
102580928|NCT02497040|Anesthetics|anesthetics|mesh-ancestor
102580929|NCT02497040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102580930|NCT02497040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580931|NCT02497040|Sensory System Agents|sensory system agents|mesh-ancestor
102580932|NCT02497040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102580933|NCT02523235|Ropivacaine|ropivacaine|mesh-list
102580934|NCT02523235|Anesthetics, Local|anesthetics, local|mesh-ancestor
102580935|NCT02523235|Anesthetics|anesthetics|mesh-ancestor
102580936|NCT02523235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102580937|NCT02523235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580938|NCT02523235|Sensory System Agents|sensory system agents|mesh-ancestor
102580939|NCT02523235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102580940|NCT02498522|Metformin|metformin|mesh-list
102580941|NCT02498522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102580942|NCT02498522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580943|NCT02919787|Irinotecan|irinotecan|mesh-list
102580944|NCT02919787|Fluorouracil|fluorouracil|mesh-list
102127839|NCT02550106|Omalizumab|omalizumab|mesh-list
102580945|NCT02919787|Oxaliplatin|oxaliplatin|mesh-list
102580946|NCT02919787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102580947|NCT02919787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102580948|NCT02919787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102580949|NCT02919787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580950|NCT02919787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102580951|NCT02919787|Antimetabolites|antimetabolites|mesh-ancestor
102580952|NCT02919787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102580953|NCT02919787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102580954|NCT02919787|Immunologic Factors|immunologic factors|mesh-ancestor
102580955|NCT02919787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580956|NCT02459275|Metoclopramide|metoclopramide|mesh-list
102580957|NCT02459275|Antiemetics|antiemetics|mesh-ancestor
102580958|NCT02459275|Autonomic Agents|autonomic agents|mesh-ancestor
102580959|NCT02459275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102580960|NCT02459275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580961|NCT02459275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102580962|NCT02459275|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102580963|NCT02459275|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102580964|NCT02459275|Dopamine Agents|dopamine agents|mesh-ancestor
102580965|NCT02459275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102580966|NCT02459275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580967|NCT02524561|Estradiol|estradiol|mesh-list
102580968|NCT02524561|Progesterone|progesterone|mesh-list
102580969|NCT02524561|Estrogens|estrogens|mesh-ancestor
102580970|NCT02524561|Hormones|hormones|mesh-ancestor
102580971|NCT02524561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102580972|NCT02524561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580973|NCT02524561|Progestins|progestins|mesh-ancestor
102580974|NCT02431598|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
102580975|NCT02431598|Chelating Agents|chelating agents|mesh-ancestor
102580976|NCT02431598|Sequestering Agents|sequestering agents|mesh-ancestor
102580977|NCT02431598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580978|NCT04743739|Cyclosporine|cyclosporine|mesh-list
102580979|NCT04743739|Rituximab|rituximab|mesh-list
102580980|NCT04743739|Cyclosporins|cyclosporins|mesh-list
102580981|NCT04743739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102580982|NCT04743739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102580983|NCT04743739|Immunologic Factors|immunologic factors|mesh-ancestor
102580984|NCT04743739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580985|NCT04743739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102580986|NCT04743739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102580987|NCT04743739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580988|NCT04743739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102580989|NCT04743739|Antifungal Agents|antifungal agents|mesh-ancestor
102580990|NCT04743739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102580991|NCT04743739|Dermatologic Agents|dermatologic agents|mesh-ancestor
102580992|NCT04743739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102580993|NCT02461693|Caffeine|caffeine|mesh-list
102580994|NCT02461693|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102580995|NCT02461693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102580996|NCT02461693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102580997|NCT02461693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102580998|NCT02461693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102580999|NCT02461693|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102581000|NCT02461693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102581001|NCT02461693|Purinergic Agents|purinergic agents|mesh-ancestor
102581002|NCT02461693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102581003|NCT02525653|Paclitaxel|paclitaxel|mesh-list
102581004|NCT02525653|Gemcitabine|gemcitabine|mesh-list
102581005|NCT02525653|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102581006|NCT02525653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102581007|NCT02525653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102581008|NCT02525653|Tubulin Modulators|tubulin modulators|mesh-ancestor
102581009|NCT02525653|Antimitotic Agents|antimitotic agents|mesh-ancestor
102581010|NCT02525653|Mitosis Modulators|mitosis modulators|mesh-ancestor
102581011|NCT02525653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581012|NCT02525653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102581013|NCT02525653|Antimetabolites|antimetabolites|mesh-ancestor
102581014|NCT02431754|Tadalafil|tadalafil|mesh-list
102581015|NCT02431754|Vasodilator Agents|vasodilator agents|mesh-ancestor
102581016|NCT02431754|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102581017|NCT02431754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102581018|NCT02431754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102581019|NCT02431754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581020|NCT02431754|Urological Agents|urological agents|mesh-ancestor
102581021|NCT02500628|Metformin|metformin|mesh-list
102581022|NCT02500628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102581023|NCT02500628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581024|NCT02526667|Chlorhexidine|chlorhexidine|mesh-list
102581025|NCT02526667|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102581026|NCT02526667|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102581027|NCT02526667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102581028|NCT02526667|Disinfectants|disinfectants|mesh-ancestor
102581029|NCT02526667|Dermatologic Agents|dermatologic agents|mesh-ancestor
102581030|NCT02535806|Cytarabine|cytarabine|mesh-list
102581031|NCT02535806|Dexamethasone|dexamethasone|mesh-list
102581032|NCT02535806|Hydrocortisone|hydrocortisone|mesh-list
102581033|NCT02535806|Methotrexate|methotrexate|mesh-list
102581034|NCT02535806|Vincristine|vincristine|mesh-list
102581035|NCT02535806|Bortezomib|bortezomib|mesh-list
102581036|NCT02535806|Mitoxantrone|mitoxantrone|mesh-list
102581037|NCT02535806|Pegaspargase|pegaspargase|mesh-list
102581038|NCT02535806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102581039|NCT02535806|Antiemetics|antiemetics|mesh-ancestor
102581040|NCT02535806|Autonomic Agents|autonomic agents|mesh-ancestor
102581041|NCT02535806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102581042|NCT02535806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581043|NCT02535806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102581044|NCT02535806|Glucocorticoids|glucocorticoids|mesh-ancestor
102581045|NCT02535806|Hormones|hormones|mesh-ancestor
102581046|NCT02535806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102581047|NCT02535806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102581048|NCT02535806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102581049|NCT02535806|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102581050|NCT02535806|Abortifacient Agents|abortifacient agents|mesh-ancestor
102581051|NCT02535806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102581052|NCT02535806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102581053|NCT02535806|Antimetabolites|antimetabolites|mesh-ancestor
102581054|NCT02535806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581055|NCT02535806|Dermatologic Agents|dermatologic agents|mesh-ancestor
102581056|NCT02535806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102581057|NCT02535806|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102581058|NCT02535806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102581059|NCT02535806|Immunologic Factors|immunologic factors|mesh-ancestor
102581060|NCT02535806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102581061|NCT02535806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102581062|NCT02535806|Antiviral Agents|antiviral agents|mesh-ancestor
102581063|NCT02535806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102581064|NCT02535806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102581065|NCT02535806|Tubulin Modulators|tubulin modulators|mesh-ancestor
102581066|NCT02535806|Antimitotic Agents|antimitotic agents|mesh-ancestor
102581067|NCT02535806|Mitosis Modulators|mitosis modulators|mesh-ancestor
102581068|NCT02535806|Analgesics|analgesics|mesh-ancestor
102581069|NCT02535806|Sensory System Agents|sensory system agents|mesh-ancestor
102581070|NCT02535806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102581071|NCT02535806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102581072|NCT02536040|Fluorides|fluorides|mesh-list
102581073|NCT02536040|Cariostatic Agents|cariostatic agents|mesh-ancestor
102581074|NCT02536040|Protective Agents|protective agents|mesh-ancestor
102581075|NCT02536040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581076|NCT02537444|Pembrolizumab|pembrolizumab|mesh-list
102581077|NCT02537444|Acalabrutinib|acalabrutinib|mesh-list
102581078|NCT02537444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102581079|NCT02537444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102581080|NCT02537444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102581081|NCT02537444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581082|NCT02464033|Vitamin D|vitamin d|mesh-list
102581083|NCT02464033|Cholecalciferol|cholecalciferol|mesh-list
102581084|NCT02464033|Etanercept|etanercept|mesh-list
102581085|NCT02464033|Vitamins|vitamins|mesh-ancestor
102581086|NCT02464033|Micronutrients|micronutrients|mesh-ancestor
102581087|NCT02464033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581088|NCT02464033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102581089|NCT02464033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102581090|NCT02464033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102581091|NCT02464033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102581092|NCT02464033|Analgesics|analgesics|mesh-ancestor
102581093|NCT02464033|Sensory System Agents|sensory system agents|mesh-ancestor
102581094|NCT02464033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102581095|NCT02464033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102581096|NCT02464033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102581097|NCT02464033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102581098|NCT02464033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102581099|NCT02464033|Immunologic Factors|immunologic factors|mesh-ancestor
102581101|NCT02432456|Ibuprofen|ibuprofen|mesh-list
102581102|NCT02432456|Ketamine|ketamine|mesh-list
102581103|NCT02432456|Narcotics|narcotics|mesh-list
102581104|NCT02432456|Methocarbamol|methocarbamol|mesh-list
102581105|NCT02432456|Pantoprazole|pantoprazole|mesh-list
102581106|NCT02432456|Analgesics|analgesics|mesh-ancestor
102581107|NCT02432456|Sensory System Agents|sensory system agents|mesh-ancestor
102581108|NCT02432456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102581109|NCT02432456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581110|NCT02432456|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102581111|NCT02432456|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102581112|NCT02432456|Anesthetics, General|anesthetics, general|mesh-ancestor
102581113|NCT02432456|Anesthetics|anesthetics|mesh-ancestor
102581114|NCT02432456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102581115|NCT02432456|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102581116|NCT02432456|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102581117|NCT02432456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102581118|NCT02432456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581119|NCT02432456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102581120|NCT02432456|Antipyretics|antipyretics|mesh-ancestor
102581121|NCT02432456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102581122|NCT02432456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102581123|NCT02432456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102581124|NCT02432456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102581125|NCT02432456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102581126|NCT02432456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102581127|NCT02432456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102581128|NCT02432456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102581129|NCT02432456|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102581130|NCT02432456|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102581131|NCT02531971|Fentanyl|fentanyl|mesh-list
102581132|NCT02531971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102581133|NCT02531971|Narcotics|narcotics|mesh-ancestor
102581134|NCT02531971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102581135|NCT02531971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581136|NCT02531971|Analgesics|analgesics|mesh-ancestor
102581137|NCT02531971|Sensory System Agents|sensory system agents|mesh-ancestor
102581138|NCT02531971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102581139|NCT02531971|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102581140|NCT02531971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102581141|NCT02531971|Anesthetics, General|anesthetics, general|mesh-ancestor
102581142|NCT02531971|Anesthetics|anesthetics|mesh-ancestor
102581143|NCT02464657|Cytarabine|cytarabine|mesh-list
102581144|NCT02464657|Dexamethasone|dexamethasone|mesh-list
102581145|NCT02464657|Methylprednisolone|methylprednisolone|mesh-list
102581146|NCT02464657|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102581147|NCT02464657|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102581148|NCT02464657|Prednisolone|prednisolone|mesh-list
102581149|NCT02464657|Prednisolone acetate|prednisolone acetate|mesh-list
102581150|NCT02464657|Nivolumab|nivolumab|mesh-list
102581151|NCT02464657|Idarubicin|idarubicin|mesh-list
102581152|NCT02464657|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102581153|NCT02464657|Prednisolone phosphate|prednisolone phosphate|mesh-list
102581154|NCT02464657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102581155|NCT02464657|Antiemetics|antiemetics|mesh-ancestor
102581156|NCT02464657|Autonomic Agents|autonomic agents|mesh-ancestor
102581157|NCT02464657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102581158|NCT02464657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581159|NCT02464657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102581160|NCT02464657|Glucocorticoids|glucocorticoids|mesh-ancestor
102581161|NCT02464657|Hormones|hormones|mesh-ancestor
102581162|NCT02464657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102581163|NCT02464657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102581164|NCT02464657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102581165|NCT02464657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102581166|NCT02464657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102581167|NCT02464657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581168|NCT02464657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102128058|NCT03239600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102581169|NCT02464657|Antimetabolites|antimetabolites|mesh-ancestor
102581170|NCT02464657|Antiviral Agents|antiviral agents|mesh-ancestor
102581171|NCT02464657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102581172|NCT02464657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102581173|NCT02464657|Immunologic Factors|immunologic factors|mesh-ancestor
102581174|NCT02464657|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102581175|NCT02464657|Protective Agents|protective agents|mesh-ancestor
102581176|NCT02464657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102581177|NCT02464657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102581178|NCT02464657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102581179|NCT02464657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102581180|NCT02535949|Tranexamic Acid|tranexamic acid|mesh-list
102581181|NCT02535949|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102581182|NCT02535949|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102581183|NCT02535949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581184|NCT02535949|Hemostatics|hemostatics|mesh-ancestor
102581185|NCT02535949|Coagulants|coagulants|mesh-ancestor
102581186|NCT02536105|Methylphenidate|methylphenidate|mesh-list
102581187|NCT02536105|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102581188|NCT02536105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581189|NCT02536105|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102581190|NCT02536105|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102581191|NCT02536105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102581192|NCT02536105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581193|NCT02536105|Dopamine Agents|dopamine agents|mesh-ancestor
102581194|NCT02536105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102581195|NCT02758951|Bevacizumab|bevacizumab|mesh-list
102581196|NCT02758951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102581197|NCT02758951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102581198|NCT02758951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102581199|NCT02758951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102581200|NCT02758951|Growth Substances|growth substances|mesh-ancestor
102581201|NCT02758951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581202|NCT02758951|Growth Inhibitors|growth inhibitors|mesh-ancestor
102581203|NCT02436668|Paclitaxel|paclitaxel|mesh-list
102581204|NCT02436668|Gemcitabine|gemcitabine|mesh-list
102581205|NCT02436668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102581206|NCT02436668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102581207|NCT02436668|Tubulin Modulators|tubulin modulators|mesh-ancestor
102581208|NCT02436668|Antimitotic Agents|antimitotic agents|mesh-ancestor
102581209|NCT02436668|Mitosis Modulators|mitosis modulators|mesh-ancestor
102581210|NCT02436668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581211|NCT02436668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102581212|NCT02436668|Antimetabolites|antimetabolites|mesh-ancestor
102581213|NCT02503982|Valganciclovir|valganciclovir|mesh-list
102581214|NCT02503982|Antiviral Agents|antiviral agents|mesh-ancestor
102581215|NCT02503982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102581216|NCT02438540|Metformin|metformin|mesh-list
102581217|NCT02438540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102581218|NCT02438540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581219|NCT02506634|Esomeprazole|esomeprazole|mesh-list
102581220|NCT02506634|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102581221|NCT02506634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102581222|NCT02506634|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102581223|NCT02506634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102581224|NCT02506634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581225|NCT02506868|Darbepoetin alfa|darbepoetin alfa|mesh-list
102581226|NCT02506868|Hematinics|hematinics|mesh-ancestor
102581227|NCT02541422|Acetylcysteine|acetylcysteine|mesh-list
102581228|NCT02541422|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102581229|NCT02541422|Antiviral Agents|antiviral agents|mesh-ancestor
102581230|NCT02541422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102581231|NCT02541422|Expectorants|expectorants|mesh-ancestor
102581232|NCT02541422|Respiratory System Agents|respiratory system agents|mesh-ancestor
102581233|NCT02541422|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102581234|NCT02541422|Antioxidants|antioxidants|mesh-ancestor
102581235|NCT02541422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581236|NCT02541422|Protective Agents|protective agents|mesh-ancestor
102581237|NCT02541422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581238|NCT02541422|Antidotes|antidotes|mesh-ancestor
102581239|NCT02439164|Midazolam|midazolam|mesh-list
102581240|NCT02439164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102581241|NCT02439164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102581242|NCT02439164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102581243|NCT02439164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581244|NCT02439164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102581245|NCT02439164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102581246|NCT02439164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102581247|NCT02439164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102581248|NCT02439164|Anesthetics, General|anesthetics, general|mesh-ancestor
102581249|NCT02439164|Anesthetics|anesthetics|mesh-ancestor
102581250|NCT02439164|GABA Modulators|gaba modulators|mesh-ancestor
102581251|NCT02439164|GABA Agents|gaba agents|mesh-ancestor
102581252|NCT02439164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102581253|NCT02439164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581254|NCT02440178|Micafungin|micafungin|mesh-list
102581255|NCT02440178|Antifungal Agents|antifungal agents|mesh-ancestor
102581256|NCT02440178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102581257|NCT05078606|Anesthetics|anesthetics|mesh-list
102581258|NCT05078606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102581259|NCT05078606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581260|NCT02546570|Oxytocin|oxytocin|mesh-list
102581261|NCT02546570|Oxytocics|oxytocics|mesh-ancestor
102581262|NCT02546570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102581263|NCT02546570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581264|NCT02548910|Sodium Citrate|sodium citrate|mesh-list
102581265|NCT02548910|Citric Acid|citric acid|mesh-list
102581266|NCT02548910|Anticoagulants|anticoagulants|mesh-ancestor
102581267|NCT02548910|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102581268|NCT02548910|Chelating Agents|chelating agents|mesh-ancestor
102581269|NCT02548910|Sequestering Agents|sequestering agents|mesh-ancestor
102581270|NCT02548910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581271|NCT02510144|Chlorhexidine|chlorhexidine|mesh-list
102581272|NCT02510144|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102581273|NCT02510144|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102581274|NCT02510144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102581275|NCT02510144|Disinfectants|disinfectants|mesh-ancestor
102581276|NCT02510144|Dermatologic Agents|dermatologic agents|mesh-ancestor
102581277|NCT02538679|Epinephrine|epinephrine|mesh-list
102581278|NCT02538679|Racepinephrine|racepinephrine|mesh-list
102581279|NCT02538679|Bupivacaine|bupivacaine|mesh-list
102581280|NCT02538679|Epinephryl borate|epinephryl borate|mesh-list
102581281|NCT02538679|Anesthetics, Local|anesthetics, local|mesh-ancestor
102581282|NCT02538679|Anesthetics|anesthetics|mesh-ancestor
102581283|NCT02538679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102581284|NCT02538679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581285|NCT02538679|Sensory System Agents|sensory system agents|mesh-ancestor
102581286|NCT02538679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102581287|NCT02538679|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102581288|NCT02538679|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102581289|NCT02538679|Adrenergic Agents|adrenergic agents|mesh-ancestor
102581290|NCT02538679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102581291|NCT02538679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581292|NCT02538679|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102581293|NCT02538679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102581294|NCT02538679|Autonomic Agents|autonomic agents|mesh-ancestor
102581295|NCT02538679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102581296|NCT02538679|Respiratory System Agents|respiratory system agents|mesh-ancestor
102581297|NCT02538679|Mydriatics|mydriatics|mesh-ancestor
102581298|NCT02538679|Sympathomimetics|sympathomimetics|mesh-ancestor
102581299|NCT02538679|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102581300|NCT02511236|Nicotine|nicotine|mesh-list
102581301|NCT02511236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102581302|NCT02511236|Autonomic Agents|autonomic agents|mesh-ancestor
102581303|NCT02511236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102581304|NCT02511236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581305|NCT02511236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102581306|NCT02511236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102581307|NCT02511236|Cholinergic Agents|cholinergic agents|mesh-ancestor
102581308|NCT02511236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102581309|NCT02511236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581310|NCT02551094|Colchicine|colchicine|mesh-list
102581311|NCT02551094|Gout Suppressants|gout suppressants|mesh-ancestor
102581312|NCT02551094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102581313|NCT02551094|Tubulin Modulators|tubulin modulators|mesh-ancestor
102581314|NCT02551094|Antimitotic Agents|antimitotic agents|mesh-ancestor
102581315|NCT02551094|Mitosis Modulators|mitosis modulators|mesh-ancestor
102581316|NCT02551094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581317|NCT02551094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102581318|NCT02513498|Ixazomib|ixazomib|mesh-list
102581319|NCT02513498|Glycine|glycine|mesh-list
102581320|NCT02513498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581321|NCT02513498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102581322|NCT02513498|Protease Inhibitors|protease inhibitors|mesh-ancestor
102344095|NCT03915444|Paclitaxel|paclitaxel|mesh-list
102581323|NCT02513498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102581324|NCT02513498|Glycine Agents|glycine agents|mesh-ancestor
102581325|NCT02513498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102581326|NCT02513498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581328|NCT04787354|Oxaliplatin|oxaliplatin|mesh-list
102581329|NCT04787354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102581330|NCT04787354|Antimetabolites|antimetabolites|mesh-ancestor
102581331|NCT04787354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581332|NCT04787354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102581333|NCT02514044|Adderall|adderall|mesh-list
102581334|NCT02514044|Dextroamphetamine|dextroamphetamine|mesh-list
102581335|NCT02514044|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102581336|NCT02514044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581337|NCT02514044|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102581338|NCT02514044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102581339|NCT02514044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102581340|NCT02514044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581341|NCT02514044|Dopamine Agents|dopamine agents|mesh-ancestor
102581342|NCT02514044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102581343|NCT02555228|Simethicone|simethicone|mesh-list
102581344|NCT02555228|Antifoaming Agents|antifoaming agents|mesh-ancestor
102581345|NCT02555228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581346|NCT02555228|Emollients|emollients|mesh-ancestor
102581347|NCT02555228|Dermatologic Agents|dermatologic agents|mesh-ancestor
102581348|NCT02556788|Trifarotene|trifarotene|mesh-list
102581349|NCT02556788|Dermatologic Agents|dermatologic agents|mesh-ancestor
102581350|NCT02516150|Ethanol|ethanol|mesh-list
102581351|NCT02516150|Glucagon|glucagon|mesh-list
102581352|NCT02516150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102581353|NCT02516150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102581354|NCT02516150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102581355|NCT02516150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581356|NCT02516150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102581357|NCT02516150|Hormones|hormones|mesh-ancestor
102581358|NCT02516150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102581359|NCT04025060|Caffeine|caffeine|mesh-list
102581360|NCT04025060|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102581361|NCT04025060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581362|NCT04025060|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102581363|NCT04025060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102581364|NCT04025060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581365|NCT04025060|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102581366|NCT04025060|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102581367|NCT04025060|Purinergic Agents|purinergic agents|mesh-ancestor
102581368|NCT04025060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102581369|NCT04542434|Niclosamide|niclosamide|mesh-list
102581370|NCT04542434|Anticestodal Agents|anticestodal agents|mesh-ancestor
102581371|NCT04542434|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102581372|NCT04542434|Anthelmintics|anthelmintics|mesh-ancestor
102581373|NCT04542434|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102581374|NCT04542434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102581375|NCT04542434|Antinematodal Agents|antinematodal agents|mesh-ancestor
102581376|NCT04186286|Propranolol|propranolol|mesh-list
102581377|NCT04186286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102581378|NCT04186286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102581379|NCT04186286|Adrenergic Agents|adrenergic agents|mesh-ancestor
102581380|NCT04186286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102581381|NCT04186286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581382|NCT04186286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581383|NCT04186286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102581384|NCT04186286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102581385|NCT04186286|Vasodilator Agents|vasodilator agents|mesh-ancestor
102581386|NCT04341038|Methylprednisolone|methylprednisolone|mesh-list
102581387|NCT04341038|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102581388|NCT04341038|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102581389|NCT04341038|Prednisolone|prednisolone|mesh-list
102581390|NCT04341038|Prednisolone acetate|prednisolone acetate|mesh-list
102581391|NCT04341038|Tacrolimus|tacrolimus|mesh-list
102581392|NCT04341038|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102581393|NCT04341038|Prednisolone phosphate|prednisolone phosphate|mesh-list
102581394|NCT04341038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102581395|NCT04341038|Immunologic Factors|immunologic factors|mesh-ancestor
102581396|NCT04341038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581397|NCT04341038|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102581398|NCT04341038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102581399|NCT04341038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581400|NCT04341038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102581402|NCT04341038|Autonomic Agents|autonomic agents|mesh-ancestor
102581403|NCT04341038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102581404|NCT04341038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102581405|NCT04341038|Glucocorticoids|glucocorticoids|mesh-ancestor
102581406|NCT04341038|Hormones|hormones|mesh-ancestor
102581407|NCT04341038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102581408|NCT04341038|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102581409|NCT04341038|Protective Agents|protective agents|mesh-ancestor
102581410|NCT04341038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102581411|NCT04341038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102581412|NCT02561702|Mexiletine|mexiletine|mesh-list
102581413|NCT02561702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102581414|NCT02561702|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102581415|NCT02561702|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102581416|NCT02561702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102581417|NCT02561702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581418|NCT02563496|Chloroquine|chloroquine|mesh-list
102581419|NCT02563496|Tafenoquine|tafenoquine|mesh-list
102581420|NCT02563496|Amebicides|amebicides|mesh-ancestor
102581421|NCT02563496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102581422|NCT02563496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102581423|NCT02563496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102581424|NCT02563496|Antimalarials|antimalarials|mesh-ancestor
102581425|NCT02563496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102581426|NCT02540161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102581427|NCT02540161|Immunologic Factors|immunologic factors|mesh-ancestor
102581428|NCT02540161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581429|NCT02568644|Ketoprofen|ketoprofen|mesh-list
102581430|NCT02568644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
102581431|NCT02568644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102581432|NCT02568644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102581433|NCT02568644|Analgesics|analgesics|mesh-ancestor
102581434|NCT02568644|Sensory System Agents|sensory system agents|mesh-ancestor
102581435|NCT02568644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102581436|NCT02568644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581437|NCT02568644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102581438|NCT02568644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102581439|NCT02568644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102581440|NCT02568644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581441|NCT02541409|Interferons|interferons|mesh-list
102581442|NCT02541409|Ribavirin|ribavirin|mesh-list
102581443|NCT02541409|Interferon-alpha|interferon-alpha|mesh-list
102581444|NCT02541409|Interferon alpha-2|interferon alpha-2|mesh-list
102581445|NCT02541409|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102581446|NCT02541409|Sofosbuvir|sofosbuvir|mesh-list
102581447|NCT02541409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102581448|NCT02541409|Antiviral Agents|antiviral agents|mesh-ancestor
102581449|NCT02541409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102581450|NCT02541409|Antimetabolites|antimetabolites|mesh-ancestor
102581451|NCT02541409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581452|NCT02541409|Immunologic Factors|immunologic factors|mesh-ancestor
102581453|NCT02541409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581454|NCT02569658|Tranexamic Acid|tranexamic acid|mesh-list
102581455|NCT02569658|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102581456|NCT02569658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102581457|NCT02569658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581458|NCT02569658|Hemostatics|hemostatics|mesh-ancestor
102581459|NCT02569658|Coagulants|coagulants|mesh-ancestor
102581460|NCT02541565|Prednisone|prednisone|mesh-list
102581461|NCT02541565|Cortisone|cortisone|mesh-list
102581462|NCT02541565|Cyclophosphamide|cyclophosphamide|mesh-list
102581463|NCT02541565|Rituximab|rituximab|mesh-list
102581464|NCT02541565|Doxorubicin|doxorubicin|mesh-list
102581465|NCT02541565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102581466|NCT02541565|Pembrolizumab|pembrolizumab|mesh-list
102581467|NCT02541565|Vincristine|vincristine|mesh-list
102581468|NCT02541565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102581469|NCT02541565|Antibodies|antibodies|mesh-list
102581470|NCT02541565|Immunoglobulins|immunoglobulins|mesh-list
102581471|NCT02541565|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102581472|NCT02541565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102128359|NCT03225950|Antibodies|antibodies|mesh-list
102581473|NCT02541565|Immunologic Factors|immunologic factors|mesh-ancestor
102581474|NCT02541565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581475|NCT02541565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102581476|NCT02541565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102581477|NCT02541565|Alkylating Agents|alkylating agents|mesh-ancestor
102581478|NCT02541565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581479|NCT02541565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102581480|NCT02541565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102581481|NCT02541565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102581482|NCT02541565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102581483|NCT02541565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102581484|NCT02541565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102581485|NCT02541565|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102581486|NCT02541565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102581488|NCT02541565|Hormones|hormones|mesh-ancestor
102581489|NCT02541565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102581490|NCT02541565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102581491|NCT02541565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102581492|NCT02541565|Tubulin Modulators|tubulin modulators|mesh-ancestor
102581493|NCT02541565|Antimitotic Agents|antimitotic agents|mesh-ancestor
102581494|NCT02541565|Mitosis Modulators|mitosis modulators|mesh-ancestor
102581495|NCT04707950|Tranexamic Acid|tranexamic acid|mesh-list
102581496|NCT04707950|Oxytocin|oxytocin|mesh-list
102581497|NCT04707950|Oxytocics|oxytocics|mesh-ancestor
102581498|NCT04707950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102581499|NCT04707950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581500|NCT04707950|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102581501|NCT04707950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102581502|NCT04707950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581503|NCT04707950|Hemostatics|hemostatics|mesh-ancestor
102581504|NCT04707950|Coagulants|coagulants|mesh-ancestor
102581505|NCT04044560|Blinatumomab|blinatumomab|mesh-list
102581506|NCT04044560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102581507|NCT03807440|Empagliflozin|empagliflozin|mesh-list
102581508|NCT03807440|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102581509|NCT03807440|Linagliptin|linagliptin|mesh-list
102581510|NCT03807440|Metformin|metformin|mesh-list
102581511|NCT03807440|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
102581512|NCT03807440|Glucagon|glucagon|mesh-list
102581513|NCT03807440|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102581514|NCT03807440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581515|NCT03807440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102581516|NCT03807440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581517|NCT03807440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102581518|NCT03807440|Hormones|hormones|mesh-ancestor
102581519|NCT03807440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102581520|NCT03807440|Incretins|incretins|mesh-ancestor
102581521|NCT03807440|Protease Inhibitors|protease inhibitors|mesh-ancestor
102581522|NCT03807440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102581523|NCT03256916|Nelfinavir|nelfinavir|mesh-list
102581524|NCT03256916|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102581525|NCT03256916|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102581526|NCT03256916|Protease Inhibitors|protease inhibitors|mesh-ancestor
102581527|NCT03256916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102581528|NCT03256916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581529|NCT03256916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102581530|NCT03256916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102581531|NCT03256916|Antiviral Agents|antiviral agents|mesh-ancestor
102581532|NCT03256916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102581533|NCT02579876|Immunomodulating Agents|immunomodulating agents|mesh-list
102581534|NCT02579876|Immunologic Factors|immunologic factors|mesh-list
102581535|NCT02579876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581536|NCT00364052|Valganciclovir|valganciclovir|mesh-list
102581537|NCT00364052|Ganciclovir|ganciclovir|mesh-list
102581538|NCT00364052|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102581539|NCT00364052|Antiviral Agents|antiviral agents|mesh-ancestor
102581540|NCT00364052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102581541|NCT00364052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102581542|NCT00364052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102581543|NCT00364052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581544|NCT02582840|Dapagliflozin|dapagliflozin|mesh-list
102581545|NCT02582840|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102581546|NCT02582840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581547|NCT02582840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102581548|NCT02582840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581549|NCT00364988|Pioglitazone|pioglitazone|mesh-list
102581550|NCT00364988|Losartan|losartan|mesh-list
102128439|NCT02929589|Narcotics|narcotics|mesh-ancestor
102581551|NCT00364988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102581552|NCT00364988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581553|NCT00364988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102581554|NCT00364988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102581555|NCT00364988|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102581556|NCT00364988|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102581557|NCT00364988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581558|NCT00365222|Temozolomide|temozolomide|mesh-list
102581559|NCT00365222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102581560|NCT00365222|Alkylating Agents|alkylating agents|mesh-ancestor
102581561|NCT00365222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581562|NCT00365222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102581563|NCT03119012|Aspirin|aspirin|mesh-list
102581564|NCT03119012|Clopidogrel|clopidogrel|mesh-list
102581565|NCT03119012|Ticagrelor|ticagrelor|mesh-list
102581566|NCT03119012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102581567|NCT03119012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102581568|NCT03119012|Analgesics|analgesics|mesh-ancestor
102581569|NCT03119012|Sensory System Agents|sensory system agents|mesh-ancestor
102581570|NCT03119012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102581571|NCT03119012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581572|NCT03119012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102581573|NCT03119012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102581574|NCT03119012|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102581575|NCT03119012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102581576|NCT03119012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581577|NCT03119012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102581578|NCT03119012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102581579|NCT03119012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102581580|NCT03119012|Antipyretics|antipyretics|mesh-ancestor
102581581|NCT03119012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102581582|NCT03119012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102581583|NCT03119012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102581584|NCT03119012|Purinergic Agents|purinergic agents|mesh-ancestor
102581585|NCT03119012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102581586|NCT02584868|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
102581587|NCT02584868|Plasma Substitutes|plasma substitutes|mesh-ancestor
102581588|NCT02584868|Blood Substitutes|blood substitutes|mesh-ancestor
102581589|NCT02791568|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102581590|NCT02791568|Hematinics|hematinics|mesh-ancestor
102581591|NCT02791568|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102581592|NCT02791568|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102581593|NCT05248022|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102581594|NCT05248022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581595|NCT05248022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102581596|NCT05248022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102581597|NCT05247554|Hydroxychloroquine|hydroxychloroquine|mesh-list
102581598|NCT05247554|Prednisone|prednisone|mesh-list
102581599|NCT05247554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102581600|NCT05247554|Glucocorticoids|glucocorticoids|mesh-ancestor
102581601|NCT05247554|Hormones|hormones|mesh-ancestor
102581602|NCT05247554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102581603|NCT05247554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581604|NCT05247554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102581605|NCT05247554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102581606|NCT05247554|Antimalarials|antimalarials|mesh-ancestor
102581607|NCT05247554|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102581608|NCT05247554|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102581609|NCT05247554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102581610|NCT05247554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102581611|NCT05247554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581612|NCT05247554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102581613|NCT02596022|Ketamine|ketamine|mesh-list
102581614|NCT02596022|Analgesics|analgesics|mesh-ancestor
102581615|NCT02596022|Sensory System Agents|sensory system agents|mesh-ancestor
102581616|NCT02596022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102581617|NCT02596022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581618|NCT02596022|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102581619|NCT02596022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102581620|NCT02596022|Anesthetics, General|anesthetics, general|mesh-ancestor
102581621|NCT02596022|Anesthetics|anesthetics|mesh-ancestor
102581622|NCT02596022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102581623|NCT02596022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102581624|NCT02596022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102581625|NCT02596022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102581626|NCT02596022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581627|NCT00364442|Fluticasone|fluticasone|mesh-list
102581628|NCT00364442|Xhance|xhance|mesh-list
102581629|NCT00364442|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102581630|NCT00364442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102581631|NCT00364442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102581632|NCT00364442|Autonomic Agents|autonomic agents|mesh-ancestor
102581633|NCT00364442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102581634|NCT00364442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581635|NCT00364442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102581636|NCT00364442|Respiratory System Agents|respiratory system agents|mesh-ancestor
102581637|NCT00364442|Dermatologic Agents|dermatologic agents|mesh-ancestor
102581638|NCT00364442|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102581639|NCT00364442|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102581640|NCT00364442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102581641|NCT00364442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102581642|NCT00364442|Adrenergic Agents|adrenergic agents|mesh-ancestor
102581643|NCT00364442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102581644|NCT00364442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581645|NCT05371574|Clonidine|clonidine|mesh-list
102581646|NCT05371574|Analgesics|analgesics|mesh-ancestor
102581647|NCT05371574|Sensory System Agents|sensory system agents|mesh-ancestor
102581648|NCT05371574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102581649|NCT05371574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581650|NCT05371574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102581651|NCT05371574|Sympatholytics|sympatholytics|mesh-ancestor
102581652|NCT05371574|Autonomic Agents|autonomic agents|mesh-ancestor
102581653|NCT05371574|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102581654|NCT05371574|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102581655|NCT05371574|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102581656|NCT05371574|Adrenergic Agents|adrenergic agents|mesh-ancestor
102581657|NCT05371574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102581658|NCT05371574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581659|NCT05371340|Quercetin|quercetin|mesh-list
102581660|NCT05371340|Antioxidants|antioxidants|mesh-ancestor
102581661|NCT05371340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581662|NCT05371340|Protective Agents|protective agents|mesh-ancestor
102581663|NCT05371340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581664|NCT02601170|Hyaluronic Acid|hyaluronic acid|mesh-list
102581665|NCT02601170|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102581666|NCT02601170|Immunologic Factors|immunologic factors|mesh-ancestor
102581667|NCT02601170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581668|NCT02601170|Viscosupplements|viscosupplements|mesh-ancestor
102581669|NCT02601170|Protective Agents|protective agents|mesh-ancestor
102581670|NCT00366002|Darifenacin|darifenacin|mesh-list
102581671|NCT00366002|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102581672|NCT00366002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102581673|NCT00366002|Cholinergic Agents|cholinergic agents|mesh-ancestor
102581674|NCT00366002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102581675|NCT00366002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581676|NCT00366002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581677|NCT00366002|Urological Agents|urological agents|mesh-ancestor
102581678|NCT00422240|Adapalene|adapalene|mesh-list
102581679|NCT00422240|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
102581680|NCT00422240|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102581681|NCT00422240|Dermatologic Agents|dermatologic agents|mesh-ancestor
102581682|NCT00422240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102581683|NCT00422240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102581684|NCT00422240|Analgesics|analgesics|mesh-ancestor
102581685|NCT00422240|Sensory System Agents|sensory system agents|mesh-ancestor
102581686|NCT00422240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102581687|NCT00422240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581688|NCT00422240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102581689|NCT00422240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102581690|NCT02605304|Ribavirin|ribavirin|mesh-list
102581691|NCT02605304|Sofosbuvir|sofosbuvir|mesh-list
102581692|NCT02605304|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102581693|NCT02605304|Ledipasvir|ledipasvir|mesh-list
102581694|NCT02605304|Antimetabolites|antimetabolites|mesh-ancestor
102581695|NCT02605304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581696|NCT02605304|Antiviral Agents|antiviral agents|mesh-ancestor
102581697|NCT02605304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102581698|NCT05365880|Lidocaine|lidocaine|mesh-list
102128587|NCT02424851|Bortezomib|bortezomib|mesh-list
102581699|NCT05365880|Anesthetics, Local|anesthetics, local|mesh-ancestor
102581700|NCT05365880|Anesthetics|anesthetics|mesh-ancestor
102581701|NCT05365880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102581702|NCT05365880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581703|NCT05365880|Sensory System Agents|sensory system agents|mesh-ancestor
102581704|NCT05365880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102581705|NCT05365880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102581706|NCT05365880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102581707|NCT05365880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102581708|NCT05365880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102581709|NCT05365880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581710|NCT05362994|Sirolimus|sirolimus|mesh-list
102581711|NCT05362994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102581712|NCT05362994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102581713|NCT05362994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102581714|NCT05362994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102581715|NCT05362994|Antifungal Agents|antifungal agents|mesh-ancestor
102581716|NCT05362994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102581717|NCT05362994|Immunologic Factors|immunologic factors|mesh-ancestor
102581718|NCT05362994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581719|NCT02607254|Pregabalin|pregabalin|mesh-list
102581720|NCT02607254|Analgesics|analgesics|mesh-ancestor
102581721|NCT02607254|Sensory System Agents|sensory system agents|mesh-ancestor
102581722|NCT02607254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102581723|NCT02607254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581724|NCT02607254|Anticonvulsants|anticonvulsants|mesh-ancestor
102581725|NCT02607254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102581726|NCT02607254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102581727|NCT02607254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344137|NCT03869034|Antidotes|antidotes|mesh-ancestor
102581728|NCT02607254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102581729|NCT02607254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102581730|NCT02607254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102581731|NCT02607254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102581732|NCT02607254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102581733|NCT02611154|Testosterone|testosterone|mesh-list
102581734|NCT02611154|Androgens|androgens|mesh-ancestor
102581735|NCT02611154|Hormones|hormones|mesh-ancestor
102581736|NCT02611154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102581737|NCT02611154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581738|NCT02617784|Oseltamivir|oseltamivir|mesh-list
102581739|NCT02617784|Antiviral Agents|antiviral agents|mesh-ancestor
102581740|NCT02617784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102581741|NCT02617784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102581742|NCT02617784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581743|NCT00365612|Tenofovir|tenofovir|mesh-list
102581744|NCT00365612|Emtricitabine|emtricitabine|mesh-list
102581745|NCT00365612|Efavirenz|efavirenz|mesh-list
102581746|NCT00365612|Antiviral Agents|antiviral agents|mesh-ancestor
102581747|NCT00365612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102581748|NCT00365612|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102581749|NCT00365612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102581750|NCT00365612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102581751|NCT00365612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581752|NCT00365612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102581753|NCT00365612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102581754|NCT00365612|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102581755|NCT00365612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102581756|NCT00365612|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102581757|NCT00365612|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102581758|NCT00365612|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102581759|NCT00365612|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102581760|NCT02974166|Ibuprofen|ibuprofen|mesh-list
102581761|NCT02974166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102581762|NCT02974166|Cyclobenzaprine|cyclobenzaprine|mesh-list
102581763|NCT02974166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102581764|NCT02974166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102581765|NCT02974166|Analgesics|analgesics|mesh-ancestor
102581766|NCT02974166|Sensory System Agents|sensory system agents|mesh-ancestor
102581767|NCT02974166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102581768|NCT02974166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581769|NCT02974166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102581770|NCT02974166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102581771|NCT02974166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102581772|NCT02974166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581773|NCT02974166|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102581774|NCT02974166|Antidepressive Agents|antidepressive agents|mesh-ancestor
102581775|NCT02974166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102581776|NCT02974166|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102581777|NCT02974166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102581778|NCT02974166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102581779|NCT02974166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102581780|NCT05731778|Listerine|listerine|mesh-list
102581781|NCT05731778|Fluorides|fluorides|mesh-list
102581782|NCT05731778|Sodium Fluoride|sodium fluoride|mesh-list
102581783|NCT05731778|Tin Fluorides|tin fluorides|mesh-list
102581784|NCT05731778|Cariostatic Agents|cariostatic agents|mesh-ancestor
102581785|NCT05731778|Protective Agents|protective agents|mesh-ancestor
102581786|NCT05731778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581787|NCT05731778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102581788|NCT05731778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102581789|NCT05477264|Tislelizumab|tislelizumab|mesh-list
102581790|NCT05477264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102581791|NCT05477264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102581792|NCT00422318|Benzbromarone|benzbromarone|mesh-list
102581793|NCT00422318|Uricosuric Agents|uricosuric agents|mesh-ancestor
102581794|NCT00422318|Gout Suppressants|gout suppressants|mesh-ancestor
102581795|NCT00422318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102581796|NCT00364754|Tesmilifene|tesmilifene|mesh-list
102581797|NCT00364754|Histamine Antagonists|histamine antagonists|mesh-ancestor
102581798|NCT00364754|Histamine Agents|histamine agents|mesh-ancestor
102581799|NCT00364754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102581800|NCT00364754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581801|NCT00364754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581802|NCT00364754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102581803|NCT00366236|Nitazoxanide|nitazoxanide|mesh-list
102581804|NCT00366236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102581805|NCT00366236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102581806|NCT04741880|Lidocaine|lidocaine|mesh-list
102581807|NCT04741880|Anesthetics, Local|anesthetics, local|mesh-ancestor
102581808|NCT04741880|Anesthetics|anesthetics|mesh-ancestor
102581809|NCT04741880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102581810|NCT04741880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581811|NCT04741880|Sensory System Agents|sensory system agents|mesh-ancestor
102581812|NCT04741880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102581813|NCT04741880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102581814|NCT04741880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102581815|NCT04741880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102581816|NCT04741880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102581817|NCT04741880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581818|NCT04742504|Benralizumab|benralizumab|mesh-list
102581819|NCT04742504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102581820|NCT04742504|Respiratory System Agents|respiratory system agents|mesh-ancestor
102581821|NCT00365924|Teriparatide|teriparatide|mesh-list
102581822|NCT00365924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102581823|NCT00365924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581824|NCT00365924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102581825|NCT05360030|Ketamine|ketamine|mesh-list
102581826|NCT05360030|Naloxone|naloxone|mesh-list
102581827|NCT05360030|Analgesics|analgesics|mesh-ancestor
102581828|NCT05360030|Sensory System Agents|sensory system agents|mesh-ancestor
102581829|NCT05360030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102581830|NCT05360030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581831|NCT05360030|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102581832|NCT05360030|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102581833|NCT05360030|Anesthetics, General|anesthetics, general|mesh-ancestor
102581834|NCT05360030|Anesthetics|anesthetics|mesh-ancestor
102581835|NCT05360030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102581836|NCT05360030|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102581837|NCT05360030|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102581838|NCT05360030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102581839|NCT05360030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581840|NCT05360030|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102581841|NCT04158362|Paclitaxel|paclitaxel|mesh-list
102581842|NCT04158362|Capecitabine|capecitabine|mesh-list
102581843|NCT04158362|Letrozole|letrozole|mesh-list
102581844|NCT04158362|Fulvestrant|fulvestrant|mesh-list
102581845|NCT04158362|Anastrozole|anastrozole|mesh-list
102581846|NCT04158362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102581847|NCT04158362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102581848|NCT04158362|Tubulin Modulators|tubulin modulators|mesh-ancestor
102581849|NCT04158362|Antimitotic Agents|antimitotic agents|mesh-ancestor
102581850|NCT04158362|Mitosis Modulators|mitosis modulators|mesh-ancestor
102581851|NCT04158362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581852|NCT04158362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102581853|NCT04158362|Antimetabolites|antimetabolites|mesh-ancestor
102581854|NCT04158362|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102581855|NCT04158362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102581856|NCT04158362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102581857|NCT04158362|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102581858|NCT04158362|Hormone Antagonists|hormone antagonists|mesh-ancestor
102581859|NCT04158362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102581860|NCT04158362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581861|NCT04158362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102581862|NCT04158362|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102581863|NCT05272202|Propofol|propofol|mesh-list
102581864|NCT05272202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102581865|NCT05272202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102581866|NCT05272202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581867|NCT05272202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102581868|NCT05272202|Anesthetics, General|anesthetics, general|mesh-ancestor
102581869|NCT05272202|Anesthetics|anesthetics|mesh-ancestor
102581870|NCT01575834|Denosumab|denosumab|mesh-list
102581871|NCT01575834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102581872|NCT01575834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581873|NCT05707442|Acetazolamide|acetazolamide|mesh-list
102581874|NCT05707442|Anticonvulsants|anticonvulsants|mesh-ancestor
102581875|NCT05707442|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102581876|NCT05707442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102581877|NCT05707442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581878|NCT05707442|Diuretics|diuretics|mesh-ancestor
102581879|NCT05707442|Natriuretic Agents|natriuretic agents|mesh-ancestor
102581880|NCT05707442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581881|NCT04604132|Paclitaxel|paclitaxel|mesh-list
102581882|NCT04604132|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102581883|NCT04604132|Atezolizumab|atezolizumab|mesh-list
102581884|NCT04604132|Ramucirumab|ramucirumab|mesh-list
102581885|NCT04604132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102581886|NCT04604132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102581887|NCT04604132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102581888|NCT04604132|Tubulin Modulators|tubulin modulators|mesh-ancestor
102581889|NCT04604132|Antimitotic Agents|antimitotic agents|mesh-ancestor
102581890|NCT04604132|Mitosis Modulators|mitosis modulators|mesh-ancestor
102581891|NCT04604132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581892|NCT04604132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102581893|NCT04604132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102581894|NCT04604132|Immunologic Factors|immunologic factors|mesh-ancestor
102581895|NCT04604132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581896|NCT05193188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102581897|NCT05193188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581898|NCT05193188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102581899|NCT05193188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102581900|NCT04799262|Prednisone|prednisone|mesh-list
102581901|NCT04799262|Tofacitinib|tofacitinib|mesh-list
102581902|NCT04799262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102581903|NCT04799262|Glucocorticoids|glucocorticoids|mesh-ancestor
102581904|NCT04799262|Hormones|hormones|mesh-ancestor
102581905|NCT04799262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102581906|NCT04799262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581907|NCT04799262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102581908|NCT04799262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102581909|NCT04799262|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102581910|NCT04799262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102581911|NCT04799262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102581912|NCT04799262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581913|NCT00851136|Bevacizumab|bevacizumab|mesh-list
102581914|NCT00851136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102581915|NCT00851136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102581916|NCT00851136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102581917|NCT00851136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102581918|NCT00851136|Growth Substances|growth substances|mesh-ancestor
102581919|NCT00851136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581920|NCT00851136|Growth Inhibitors|growth inhibitors|mesh-ancestor
102581921|NCT00366470|Cholecalciferol|cholecalciferol|mesh-list
102581923|NCT00366470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102581924|NCT00366470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581925|NCT00366470|Vitamins|vitamins|mesh-ancestor
102581926|NCT00366470|Micronutrients|micronutrients|mesh-ancestor
102581927|NCT00366470|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102581928|NCT04537286|Paclitaxel|paclitaxel|mesh-list
102581929|NCT04537286|Cisplatin|cisplatin|mesh-list
102581930|NCT04537286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102581931|NCT04537286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102581932|NCT04537286|Tubulin Modulators|tubulin modulators|mesh-ancestor
102581933|NCT04537286|Antimitotic Agents|antimitotic agents|mesh-ancestor
102581934|NCT04537286|Mitosis Modulators|mitosis modulators|mesh-ancestor
102581935|NCT04537286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581936|NCT02620904|Mifepristone|mifepristone|mesh-list
102581937|NCT02620904|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102581938|NCT02620904|Abortifacient Agents|abortifacient agents|mesh-ancestor
102581939|NCT02620904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102581940|NCT02620904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581941|NCT02620904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102581942|NCT02620904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102581943|NCT02620904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102581944|NCT02620904|Contraceptive Agents|contraceptive agents|mesh-ancestor
102581945|NCT02620904|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102581946|NCT02620904|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102581947|NCT02620904|Hormone Antagonists|hormone antagonists|mesh-ancestor
102581948|NCT02620904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102581949|NCT02620904|Luteolytic Agents|luteolytic agents|mesh-ancestor
102581950|NCT02620904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102581951|NCT02620904|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102581952|NCT00300768|Ivermectin|ivermectin|mesh-list
102581953|NCT00300768|Moxidectin|moxidectin|mesh-list
102581954|NCT00300768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102581955|NCT00300768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102581956|NCT00300768|Anthelmintics|anthelmintics|mesh-ancestor
102581957|NCT00300768|Antinematodal Agents|antinematodal agents|mesh-ancestor
102581958|NCT02621060|Magnesium Oxide|magnesium oxide|mesh-list
102581959|NCT02621060|Antacids|antacids|mesh-ancestor
102581960|NCT02621060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581961|NCT02621060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102581962|NCT04740554|Prednisone|prednisone|mesh-list
102581963|NCT04740554|Deflazacort|deflazacort|mesh-list
102581964|NCT04740554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102581965|NCT04740554|Glucocorticoids|glucocorticoids|mesh-ancestor
102581966|NCT04740554|Hormones|hormones|mesh-ancestor
102581967|NCT04740554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102581968|NCT04740554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102581969|NCT04740554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102581970|NCT04740554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102581971|NCT04740554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102581972|NCT04740554|Immunologic Factors|immunologic factors|mesh-ancestor
102581973|NCT02624180|Colchicine|colchicine|mesh-list
102581974|NCT02624180|Gout Suppressants|gout suppressants|mesh-ancestor
102581975|NCT02624180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102581976|NCT02624180|Tubulin Modulators|tubulin modulators|mesh-ancestor
102581977|NCT02624180|Antimitotic Agents|antimitotic agents|mesh-ancestor
102581978|NCT02624180|Mitosis Modulators|mitosis modulators|mesh-ancestor
102581979|NCT02624180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581980|NCT02624180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102581981|NCT05068232|Carboplatin|carboplatin|mesh-list
102581982|NCT05068232|Etoposide|etoposide|mesh-list
102581983|NCT05068232|Durvalumab|durvalumab|mesh-list
102581984|NCT05068232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102581985|NCT05068232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102581986|NCT05068232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102581987|NCT05068232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102581988|NCT05068232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102581989|NCT05068232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581990|NCT05068232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102581991|NCT04326764|Panobinostat|panobinostat|mesh-list
102581992|NCT04326764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102581993|NCT04326764|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102581994|NCT04326764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102581995|NCT04326764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102581996|NCT02628236|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102581997|NCT02628236|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102581998|NCT02628236|Dermatologic Agents|dermatologic agents|mesh-ancestor
102581999|NCT02629094|Eplerenone|eplerenone|mesh-list
102582000|NCT02629094|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102582001|NCT02629094|Hormone Antagonists|hormone antagonists|mesh-ancestor
102582002|NCT02629094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102582003|NCT02629094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582004|NCT02629094|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102582005|NCT02629094|Diuretics|diuretics|mesh-ancestor
102582006|NCT02629094|Natriuretic Agents|natriuretic agents|mesh-ancestor
102582007|NCT02629094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102582008|NCT02630030|Ixazomib|ixazomib|mesh-list
102582009|NCT02630030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102582010|NCT02630030|Protease Inhibitors|protease inhibitors|mesh-ancestor
102582011|NCT02630030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102582012|NCT02630030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582013|NCT04289792|Paclitaxel|paclitaxel|mesh-list
102582014|NCT04289792|Gemcitabine|gemcitabine|mesh-list
102582015|NCT04289792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102582016|NCT04289792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102582017|NCT04289792|Tubulin Modulators|tubulin modulators|mesh-ancestor
102582018|NCT04289792|Antimitotic Agents|antimitotic agents|mesh-ancestor
102582019|NCT04289792|Mitosis Modulators|mitosis modulators|mesh-ancestor
102582020|NCT04289792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582021|NCT04289792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102582022|NCT04289792|Antimetabolites|antimetabolites|mesh-ancestor
102582023|NCT02631590|Gemcitabine|gemcitabine|mesh-list
102582024|NCT02631590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102582025|NCT02631590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102582026|NCT02631590|Antimetabolites|antimetabolites|mesh-ancestor
102582027|NCT02631590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582028|NCT02253654|Epoetin Alfa|epoetin alfa|mesh-list
102582029|NCT02253654|Hematinics|hematinics|mesh-ancestor
102582030|NCT02252406|Ranolazine|ranolazine|mesh-list
102582031|NCT02252406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102582032|NCT02252406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102582033|NCT02252406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582034|NCT02252016|Grazoprevir|grazoprevir|mesh-list
102582035|NCT02252016|Antiviral Agents|antiviral agents|mesh-ancestor
102582036|NCT02252016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102582037|NCT04784442|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
102582038|NCT04784442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102582039|NCT04784442|Antimetabolites|antimetabolites|mesh-ancestor
102582040|NCT04784442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582041|NCT04784442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102582042|NCT04784442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102582043|NCT04784442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102582044|NCT04784442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582045|NCT02706847|Upadacitinib|upadacitinib|mesh-list
102582046|NCT02706847|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102582047|NCT02706847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102582048|NCT02706847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102582049|NCT02706847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582050|NCT02706847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102582051|NCT02470741|Letrozole|letrozole|mesh-list
102582052|NCT02470741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102582053|NCT02470741|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102582054|NCT02470741|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102582055|NCT02470741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102582056|NCT02470741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582057|NCT02470741|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102582058|NCT02470741|Hormone Antagonists|hormone antagonists|mesh-ancestor
102582059|NCT02470741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102582060|NCT02470741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582061|NCT02544607|Ketamine|ketamine|mesh-list
102582062|NCT02544607|Analgesics|analgesics|mesh-ancestor
102582063|NCT02544607|Sensory System Agents|sensory system agents|mesh-ancestor
102582064|NCT02544607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102582065|NCT02544607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582066|NCT02544607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102582067|NCT02544607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102582068|NCT02544607|Anesthetics, General|anesthetics, general|mesh-ancestor
102582069|NCT02544607|Anesthetics|anesthetics|mesh-ancestor
102582070|NCT02544607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102582071|NCT02544607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102582072|NCT02544607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102582073|NCT02544607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102582074|NCT02544607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582075|NCT00363571|Acetazolamide|acetazolamide|mesh-list
102582076|NCT00363571|Anticonvulsants|anticonvulsants|mesh-ancestor
102582077|NCT00363571|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102582078|NCT00363571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102582079|NCT00363571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582080|NCT00363571|Diuretics|diuretics|mesh-ancestor
102582081|NCT00363571|Natriuretic Agents|natriuretic agents|mesh-ancestor
102582082|NCT00363571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582083|NCT04744675|Triamcinolone|triamcinolone|mesh-list
102582084|NCT04744675|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102582085|NCT04744675|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102582086|NCT04744675|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102582087|NCT04744675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102582088|NCT04744675|Glucocorticoids|glucocorticoids|mesh-ancestor
102582089|NCT04744675|Hormones|hormones|mesh-ancestor
102582090|NCT04744675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102582091|NCT04744675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582092|NCT04744675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102582093|NCT04744675|Immunologic Factors|immunologic factors|mesh-ancestor
102582094|NCT04744675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102582095|NCT04744675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582096|NCT02471521|Rocuronium|rocuronium|mesh-list
102582097|NCT02471521|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102582098|NCT02471521|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102582099|NCT02471521|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102582100|NCT02471521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102582101|NCT02471521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582102|NCT02624479|Sodium thiosulfate|sodium thiosulfate|mesh-list
102582103|NCT02624479|Antidotes|antidotes|mesh-ancestor
102582104|NCT02624479|Protective Agents|protective agents|mesh-ancestor
102582105|NCT02624479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582106|NCT02624479|Antioxidants|antioxidants|mesh-ancestor
102582107|NCT02624479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582108|NCT02624479|Antitubercular Agents|antitubercular agents|mesh-ancestor
102582109|NCT02624479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102582110|NCT02624479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102582111|NCT02624479|Chelating Agents|chelating agents|mesh-ancestor
102582112|NCT02624479|Sequestering Agents|sequestering agents|mesh-ancestor
102582113|NCT02472223|Povidone-Iodine|povidone-iodine|mesh-list
102582114|NCT02472223|Povidone|povidone|mesh-list
102582115|NCT02472223|Lubricant Eye Drops|lubricant eye drops|mesh-list
102582116|NCT02472223|Plasma Substitutes|plasma substitutes|mesh-ancestor
102582117|NCT02472223|Blood Substitutes|blood substitutes|mesh-ancestor
102582118|NCT02472223|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102582119|NCT02472223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102582120|NCT02472223|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102582121|NCT02472223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102582122|NCT02247960|Ciprofloxacin|ciprofloxacin|mesh-list
102582123|NCT02247960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102582124|NCT02247960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102582125|NCT02247960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102582126|NCT02247960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102582127|NCT02247960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102582128|NCT02247960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582129|NCT02247960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102582130|NCT02247960|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102582131|NCT02247960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102582132|NCT02473783|Sertraline|sertraline|mesh-list
102582133|NCT02473783|Antidepressive Agents|antidepressive agents|mesh-ancestor
102582134|NCT02473783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102582135|NCT02473783|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102582136|NCT02473783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102582137|NCT02473783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102582138|NCT02473783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582139|NCT02473783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102582140|NCT02473783|Serotonin Agents|serotonin agents|mesh-ancestor
102582141|NCT02473783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582142|NCT02247804|Timolol|timolol|mesh-list
102582143|NCT02247804|Bimatoprost|bimatoprost|mesh-list
102582144|NCT02247804|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102582145|NCT02247804|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102582146|NCT02247804|Adrenergic Agents|adrenergic agents|mesh-ancestor
102582147|NCT02247804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102582148|NCT02247804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582149|NCT02247804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582150|NCT02247804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102582151|NCT02247804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102582152|NCT00366938|Lumiracoxib|lumiracoxib|mesh-list
101849046|NCT00425750|Docetaxel|docetaxel|mesh-list
102582153|NCT00366938|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102582154|NCT00366938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102582155|NCT00366938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102582156|NCT00366938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582157|NCT00366938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102582158|NCT00366938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102582159|NCT00366938|Analgesics|analgesics|mesh-ancestor
102582160|NCT00366938|Sensory System Agents|sensory system agents|mesh-ancestor
102582161|NCT00366938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102582162|NCT00366938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582163|NCT00366938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102582164|NCT00366938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102582166|NCT05026320|Naproxen|naproxen|mesh-list
102582167|NCT05026320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102582168|NCT05026320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102582169|NCT05026320|Analgesics|analgesics|mesh-ancestor
102582170|NCT05026320|Sensory System Agents|sensory system agents|mesh-ancestor
102582171|NCT05026320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102582172|NCT05026320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582173|NCT05026320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102582174|NCT05026320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102582175|NCT05026320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102582176|NCT05026320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102582177|NCT05026320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582178|NCT05026320|Gout Suppressants|gout suppressants|mesh-ancestor
102582179|NCT04068272|Bosentan|bosentan|mesh-list
102582180|NCT04068272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102582181|NCT04068272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102582182|NCT04068272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582183|NCT02243202|Canagliflozin|canagliflozin|mesh-list
102582184|NCT02243202|Phentermine|phentermine|mesh-list
102582185|NCT02243202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102582186|NCT02243202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582187|NCT02243202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102582188|NCT02243202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582189|NCT02243202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102582190|NCT02243202|Appetite Depressants|appetite depressants|mesh-ancestor
102582191|NCT02243202|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102582192|NCT02243202|Sympathomimetics|sympathomimetics|mesh-ancestor
102582193|NCT02243202|Autonomic Agents|autonomic agents|mesh-ancestor
102582194|NCT02243202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102582195|NCT02243202|Adrenergic Agents|adrenergic agents|mesh-ancestor
102582196|NCT02243202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102582197|NCT04050410|Moxonidine|moxonidine|mesh-list
102582198|NCT04050410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102582199|NCT02207946|Botulinum Toxins|botulinum toxins|mesh-list
102582200|NCT02207946|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102582201|NCT02207946|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102582202|NCT02207946|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102582203|NCT02207946|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102582204|NCT02207946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102582205|NCT02207946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582206|NCT02207946|Cholinergic Agents|cholinergic agents|mesh-ancestor
102582207|NCT02207946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102582208|NCT02207946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582209|NCT02207946|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102582210|NCT02207946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102582211|NCT04235036|Rituximab|rituximab|mesh-list
102582212|NCT04235036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102582213|NCT04235036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102582214|NCT04235036|Immunologic Factors|immunologic factors|mesh-ancestor
102582215|NCT04235036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582216|NCT04235036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102582217|NCT02560051|Ketoconazole|ketoconazole|mesh-list
102582218|NCT02560051|Docetaxel|docetaxel|mesh-list
102582219|NCT02560051|Doxorubicin|doxorubicin|mesh-list
102582220|NCT02560051|Estramustine|estramustine|mesh-list
102582221|NCT02560051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102582222|NCT02560051|Tubulin Modulators|tubulin modulators|mesh-ancestor
102582223|NCT02560051|Antimitotic Agents|antimitotic agents|mesh-ancestor
102582224|NCT02560051|Mitosis Modulators|mitosis modulators|mesh-ancestor
102582225|NCT02560051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582226|NCT02560051|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102582227|NCT02560051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102582228|NCT02560051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102582229|NCT02560051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102582230|NCT02560051|Antifungal Agents|antifungal agents|mesh-ancestor
102582231|NCT02560051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102582232|NCT02560051|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102582233|NCT02560051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102582234|NCT02560051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102582235|NCT02560051|Hormone Antagonists|hormone antagonists|mesh-ancestor
102582236|NCT02560051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102582237|NCT02560051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582238|NCT02560051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102582239|NCT02560051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102582240|NCT02560051|Alkylating Agents|alkylating agents|mesh-ancestor
102582241|NCT02560051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102582242|NCT03786770|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102582243|NCT03786770|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102582244|NCT03786770|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102582245|NCT03786770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102582246|NCT03786770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582247|NCT03786770|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102582248|NCT03786770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102582249|NCT03786770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582250|NCT03786770|Cholinergic Agents|cholinergic agents|mesh-ancestor
102582251|NCT03786770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102582252|NCT00367718|Bortezomib|bortezomib|mesh-list
102582253|NCT00367718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102582254|NCT02474407|Diazepam|diazepam|mesh-list
102582255|NCT02474407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102582256|NCT02474407|Anticonvulsants|anticonvulsants|mesh-ancestor
102582257|NCT02474407|Antiemetics|antiemetics|mesh-ancestor
102582258|NCT02474407|Autonomic Agents|autonomic agents|mesh-ancestor
102582259|NCT02474407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102582260|NCT02474407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582261|NCT02474407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102582262|NCT02474407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102582263|NCT02474407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102582264|NCT02474407|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102582265|NCT02474407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102582266|NCT02474407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102582267|NCT02474407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102582268|NCT02474407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102582269|NCT02474407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102582270|NCT02474407|Anesthetics, General|anesthetics, general|mesh-ancestor
102582271|NCT02474407|Anesthetics|anesthetics|mesh-ancestor
102582272|NCT02474407|GABA Modulators|gaba modulators|mesh-ancestor
102582273|NCT02474407|GABA Agents|gaba agents|mesh-ancestor
102582274|NCT02474407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102582275|NCT02474407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582276|NCT05588492|Rifamycins|rifamycins|mesh-list
102582277|NCT05588492|Rifamycin SV|rifamycin sv|mesh-list
102582278|NCT05588492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102582279|NCT05588492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102582280|NCT05588492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102582281|NCT03777956|Lacosamide|lacosamide|mesh-list
102582282|NCT03777956|Anticonvulsants|anticonvulsants|mesh-ancestor
102582283|NCT03777956|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102582284|NCT03777956|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102582285|NCT03777956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102582286|NCT03777956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582287|NCT02481505|Chloroprocaine|chloroprocaine|mesh-list
102582288|NCT02481505|Anesthetics, Local|anesthetics, local|mesh-ancestor
102582289|NCT02481505|Anesthetics|anesthetics|mesh-ancestor
102129181|NCT03223064|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102582290|NCT02481505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102344164|NCT03790111|Cisplatin|cisplatin|mesh-list
102582291|NCT02481505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582292|NCT02481505|Sensory System Agents|sensory system agents|mesh-ancestor
102582293|NCT02481505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102582294|NCT02563093|Vaccines|vaccines|mesh-list
102582295|NCT02563093|Immunologic Factors|immunologic factors|mesh-ancestor
102582296|NCT02563093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582297|NCT02564029|Lorazepam|lorazepam|mesh-list
102582298|NCT02564029|PF-06372865|pf-06372865|mesh-list
102582299|NCT02564029|Anticonvulsants|anticonvulsants|mesh-ancestor
102582300|NCT02564029|Antiemetics|antiemetics|mesh-ancestor
102582301|NCT02564029|Autonomic Agents|autonomic agents|mesh-ancestor
102582302|NCT02564029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102582303|NCT02564029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582304|NCT02564029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102582305|NCT02564029|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102582306|NCT02564029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102582307|NCT02564029|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102582308|NCT02564029|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102582309|NCT02564029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102582310|NCT02564029|GABA Modulators|gaba modulators|mesh-ancestor
102582311|NCT02564029|GABA Agents|gaba agents|mesh-ancestor
102582312|NCT02564029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102582313|NCT02564029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582314|NCT05588336|Morphine|morphine|mesh-list
102582315|NCT05588336|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102582316|NCT05588336|Narcotics|narcotics|mesh-ancestor
102582317|NCT05588336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102582318|NCT05588336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582319|NCT05588336|Analgesics|analgesics|mesh-ancestor
102582320|NCT05588336|Sensory System Agents|sensory system agents|mesh-ancestor
102582321|NCT05588336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102582322|NCT02564497|Abatacept|abatacept|mesh-list
102582323|NCT02564497|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102582324|NCT02564497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582325|NCT02564497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102582326|NCT02564497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102582327|NCT02564497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102582328|NCT02564497|Immunologic Factors|immunologic factors|mesh-ancestor
102582329|NCT02564497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582330|NCT02564497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102582331|NCT02565901|Sirolimus|sirolimus|mesh-list
102582332|NCT02565901|Carboplatin|carboplatin|mesh-list
102582333|NCT02565901|Docetaxel|docetaxel|mesh-list
102582334|NCT02565901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102582335|NCT02565901|Tubulin Modulators|tubulin modulators|mesh-ancestor
102582336|NCT02565901|Antimitotic Agents|antimitotic agents|mesh-ancestor
102582337|NCT02565901|Mitosis Modulators|mitosis modulators|mesh-ancestor
102582338|NCT02565901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582339|NCT02565901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102582340|NCT02565901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102582341|NCT02565901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102582342|NCT02565901|Antifungal Agents|antifungal agents|mesh-ancestor
102582343|NCT02565901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102582344|NCT02565901|Immunologic Factors|immunologic factors|mesh-ancestor
102582345|NCT02565901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582346|NCT03926624|Cytarabine|cytarabine|mesh-list
102582347|NCT03926624|Fludarabine|fludarabine|mesh-list
102582348|NCT03926624|Etoposide|etoposide|mesh-list
102582349|NCT03926624|Azacitidine|azacitidine|mesh-list
102582350|NCT03926624|Decitabine|decitabine|mesh-list
102582351|NCT03926624|Venetoclax|venetoclax|mesh-list
102582352|NCT03926624|Mitoxantrone|mitoxantrone|mesh-list
102582353|NCT03926624|Idarubicin|idarubicin|mesh-list
102582354|NCT03926624|Cladribine|cladribine|mesh-list
102582355|NCT03926624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102582356|NCT03926624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102582357|NCT03926624|Antimetabolites|antimetabolites|mesh-ancestor
102582358|NCT03926624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582359|NCT03926624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102582360|NCT03926624|Immunologic Factors|immunologic factors|mesh-ancestor
102582361|NCT03926624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582362|NCT03926624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102582363|NCT03926624|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102582364|NCT03926624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102582365|NCT03926624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102582366|NCT03926624|Antiviral Agents|antiviral agents|mesh-ancestor
102582367|NCT03926624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102582368|NCT03926624|Analgesics|analgesics|mesh-ancestor
102582369|NCT03926624|Sensory System Agents|sensory system agents|mesh-ancestor
102582370|NCT03926624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102582371|NCT03926624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102582372|NCT05588102|Fluvoxamine|fluvoxamine|mesh-list
102582373|NCT05588102|Citalopram|citalopram|mesh-list
102582374|NCT05588102|Fluoxetine|fluoxetine|mesh-list
102582375|NCT05588102|Paroxetine|paroxetine|mesh-list
102582376|NCT05588102|Sertraline|sertraline|mesh-list
102582377|NCT05588102|Escitalopram|escitalopram|mesh-list
102582378|NCT05588102|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
102582379|NCT05588102|Serotonin|serotonin|mesh-list
102582380|NCT05588102|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102582381|NCT05588102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102582382|NCT05588102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582383|NCT05588102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102582384|NCT05588102|Serotonin Agents|serotonin agents|mesh-ancestor
102582385|NCT05588102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582386|NCT05588102|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102582387|NCT05588102|Antidepressive Agents|antidepressive agents|mesh-ancestor
102582388|NCT05588102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102582389|NCT05588102|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102582390|NCT05588102|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102582391|NCT05588102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102582392|NCT05588102|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102582393|NCT05588102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102582394|NCT05588102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102582395|NCT05588102|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102582396|NCT05588102|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102582397|NCT05588102|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102582398|NCT04744441|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102582399|NCT04744441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102582400|NCT03551210|Levofloxacin|levofloxacin|mesh-list
102582401|NCT03551210|Ofloxacin|ofloxacin|mesh-list
102582402|NCT03551210|Nemonoxacin|nemonoxacin|mesh-list
102582403|NCT03551210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102582404|NCT03551210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102582405|NCT03551210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102582406|NCT03551210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102582407|NCT03551210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102582408|NCT03551210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102582409|NCT03551210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582410|NCT03551210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102582411|NCT03551210|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102582412|NCT03551210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102582413|NCT02482675|Caseins|caseins|mesh-list
102582414|NCT02482675|Chelating Agents|chelating agents|mesh-ancestor
102582415|NCT02482675|Sequestering Agents|sequestering agents|mesh-ancestor
102582416|NCT02482675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582417|NCT00364195|Tesmilifene|tesmilifene|mesh-list
102582418|NCT00364195|Histamine Antagonists|histamine antagonists|mesh-ancestor
102582419|NCT00364195|Histamine Agents|histamine agents|mesh-ancestor
102582420|NCT00364195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102582421|NCT00364195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582422|NCT00364195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582423|NCT00364195|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102582424|NCT02566369|Trifarotene|trifarotene|mesh-list
102582425|NCT02566369|Dermatologic Agents|dermatologic agents|mesh-ancestor
102582426|NCT02569723|Oxaliplatin|oxaliplatin|mesh-list
102582427|NCT02569723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102582428|NCT02570425|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
102582429|NCT02570425|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102582430|NCT02570425|Respiratory System Agents|respiratory system agents|mesh-ancestor
102582431|NCT02571439|Ropivacaine|ropivacaine|mesh-list
102582432|NCT02571439|Anesthetics, Local|anesthetics, local|mesh-ancestor
102582433|NCT02571439|Anesthetics|anesthetics|mesh-ancestor
102582434|NCT02571439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102582435|NCT02571439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582436|NCT02571439|Sensory System Agents|sensory system agents|mesh-ancestor
102582437|NCT02571439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102582438|NCT02573857|Artefenomel|artefenomel|mesh-list
102582439|NCT02573857|Antimalarials|antimalarials|mesh-ancestor
102582440|NCT02573857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102582441|NCT02573857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102582442|NCT02573857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102129362|NCT00508989|Niacin|niacin|mesh-list
102582443|NCT03678428|Leucovorin|leucovorin|mesh-list
102582444|NCT03678428|Oxaliplatin|oxaliplatin|mesh-list
102582445|NCT03678428|Irinotecan|irinotecan|mesh-list
102582446|NCT03678428|Floxuridine|floxuridine|mesh-list
102582447|NCT03678428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102582448|NCT03678428|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102582449|NCT03678428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102582450|NCT03678428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102582451|NCT03678428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582452|NCT03678428|Antidotes|antidotes|mesh-ancestor
102582453|NCT03678428|Protective Agents|protective agents|mesh-ancestor
102582454|NCT03678428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582455|NCT03678428|Vitamin B Complex|vitamin b complex|mesh-ancestor
102582456|NCT03678428|Vitamins|vitamins|mesh-ancestor
102582457|NCT03678428|Micronutrients|micronutrients|mesh-ancestor
102582458|NCT03678428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102582459|NCT03678428|Antimetabolites|antimetabolites|mesh-ancestor
102582460|NCT02577601|Levonorgestrel|levonorgestrel|mesh-list
102582461|NCT02577601|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102582462|NCT02577601|Ulipristal acetate|ulipristal acetate|mesh-list
102582463|NCT02577601|Contraceptives, Oral|contraceptives, oral|mesh-list
102582464|NCT02577601|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
102582465|NCT02577601|Estradiol|estradiol|mesh-list
102582466|NCT02577601|Estrogens|estrogens|mesh-ancestor
102582467|NCT02577601|Hormones|hormones|mesh-ancestor
102582468|NCT02577601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102582469|NCT02577601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582470|NCT02577601|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102582471|NCT02577601|Contraceptive Agents|contraceptive agents|mesh-ancestor
102582472|NCT02577601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102582473|NCT02577601|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102582474|NCT02577601|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102582475|NCT02577601|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102582476|NCT02577991|Triamcinolone|triamcinolone|mesh-list
102582477|NCT02577991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102582478|NCT02577991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582479|NCT02577991|Glucocorticoids|glucocorticoids|mesh-ancestor
102582480|NCT02577991|Hormones|hormones|mesh-ancestor
102582481|NCT02577991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102582482|NCT02207634|Evolocumab|evolocumab|mesh-list
102582483|NCT02207634|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102582484|NCT02207634|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102582485|NCT02207634|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102582486|NCT02207634|Antimetabolites|antimetabolites|mesh-ancestor
102582487|NCT02207634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582488|NCT02207634|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102582489|NCT02207634|Protease Inhibitors|protease inhibitors|mesh-ancestor
102582490|NCT02207634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102582491|NCT02207634|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102582492|NCT02484859|Metoprolol|metoprolol|mesh-list
102582493|NCT02484859|Remifentanil|remifentanil|mesh-list
102582494|NCT02484859|Tramadol|tramadol|mesh-list
102582495|NCT02484859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102582496|NCT02484859|Narcotics|narcotics|mesh-ancestor
102582497|NCT02484859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102582498|NCT02484859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582499|NCT02484859|Analgesics|analgesics|mesh-ancestor
102582500|NCT02484859|Sensory System Agents|sensory system agents|mesh-ancestor
102582501|NCT02484859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102582502|NCT02484859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102582503|NCT02484859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102582504|NCT02484859|Sympatholytics|sympatholytics|mesh-ancestor
102582505|NCT02484859|Autonomic Agents|autonomic agents|mesh-ancestor
102582506|NCT02484859|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102582507|NCT02484859|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102582508|NCT02484859|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102582509|NCT02484859|Adrenergic Agents|adrenergic agents|mesh-ancestor
102582510|NCT02484859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102582511|NCT02484859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582512|NCT04341727|Azithromycin|azithromycin|mesh-list
102582513|NCT04341727|Hydroxychloroquine|hydroxychloroquine|mesh-list
102582514|NCT04341727|Chloroquine|chloroquine|mesh-list
102582515|NCT04341727|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
102582516|NCT04341727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102582517|NCT04341727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102582518|NCT04341727|Antimalarials|antimalarials|mesh-ancestor
102582519|NCT04341727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102582520|NCT04341727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102582521|NCT04341727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102582522|NCT04341727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582523|NCT04341727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102582524|NCT04341727|Amebicides|amebicides|mesh-ancestor
102582525|NCT04341727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102582526|NCT04341727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102582527|NCT04341727|Analgesics|analgesics|mesh-ancestor
102582528|NCT04341727|Sensory System Agents|sensory system agents|mesh-ancestor
102582529|NCT04341727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102582530|NCT04341727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582531|NCT04341727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102582532|NCT04341727|Filaricides|filaricides|mesh-ancestor
102582533|NCT04341727|Antinematodal Agents|antinematodal agents|mesh-ancestor
102582534|NCT04341727|Anthelmintics|anthelmintics|mesh-ancestor
102582535|NCT00367094|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102582536|NCT00367094|Benazepril|benazepril|mesh-list
102582537|NCT00367094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102582538|NCT00367094|Diuretics|diuretics|mesh-ancestor
102582539|NCT00367094|Natriuretic Agents|natriuretic agents|mesh-ancestor
102582540|NCT00367094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582541|NCT00367094|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102582542|NCT00367094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102582543|NCT00367094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582544|NCT00367094|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102582545|NCT00367094|Protease Inhibitors|protease inhibitors|mesh-ancestor
102582546|NCT00367094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102582547|NCT02581111|Naloxone|naloxone|mesh-list
102582548|NCT02581111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102582549|NCT02581111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582550|NCT02581111|Sensory System Agents|sensory system agents|mesh-ancestor
102582551|NCT02581111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102582552|NCT05587400|Dobutamine|dobutamine|mesh-list
102582553|NCT05587400|Nitric Oxide|nitric oxide|mesh-list
102582554|NCT05587400|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102582555|NCT05587400|Autonomic Agents|autonomic agents|mesh-ancestor
102582556|NCT05587400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102582557|NCT05587400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582558|NCT05587400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102582559|NCT05587400|Respiratory System Agents|respiratory system agents|mesh-ancestor
102582560|NCT05587400|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102582561|NCT05587400|Antioxidants|antioxidants|mesh-ancestor
102582562|NCT05587400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582563|NCT05587400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102582564|NCT05587400|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102582565|NCT05587400|Vasodilator Agents|vasodilator agents|mesh-ancestor
102582566|NCT05587400|Gasotransmitters|gasotransmitters|mesh-ancestor
102582567|NCT05587400|Protective Agents|protective agents|mesh-ancestor
102582568|NCT05587400|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102582569|NCT05587400|Sympathomimetics|sympathomimetics|mesh-ancestor
102582570|NCT05587400|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102582571|NCT05587400|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102582572|NCT05587400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102582573|NCT05587400|Adrenergic Agents|adrenergic agents|mesh-ancestor
102582574|NCT04339868|Terlipressin|terlipressin|mesh-list
102582575|NCT04339868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102582576|NCT04339868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102582577|NCT00367172|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102582578|NCT00367172|Antiviral Agents|antiviral agents|mesh-ancestor
102582579|NCT00367172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102582580|NCT00367250|Trastuzumab|trastuzumab|mesh-list
102582581|NCT00367250|Cetuximab|cetuximab|mesh-list
102582582|NCT00367250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102582583|NCT00367250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102582584|NCT02489227|Adalimumab|adalimumab|mesh-list
102582585|NCT02489227|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102582586|NCT02489227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102582587|NCT02489227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102582588|NCT02490631|Chlorhexidine|chlorhexidine|mesh-list
102344173|NCT03780543|Antiviral Agents|antiviral agents|mesh-ancestor
102582589|NCT02490631|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102582590|NCT02490631|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102582591|NCT02490631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102582592|NCT02490631|Disinfectants|disinfectants|mesh-ancestor
102582593|NCT02490631|Dermatologic Agents|dermatologic agents|mesh-ancestor
102582594|NCT02207556|Doxycycline|doxycycline|mesh-list
102582595|NCT02207556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102582596|NCT02207556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102582597|NCT02207556|Antimalarials|antimalarials|mesh-ancestor
102582598|NCT02207556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102582599|NCT02207556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102582600|NCT02572609|Ambroxol|ambroxol|mesh-list
102582601|NCT02572609|Expectorants|expectorants|mesh-ancestor
102582602|NCT02572609|Respiratory System Agents|respiratory system agents|mesh-ancestor
102582603|NCT02587117|Prednisolone|prednisolone|mesh-list
102582604|NCT02587117|Lycopene|lycopene|mesh-list
102582605|NCT02587117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102582606|NCT02587117|Glucocorticoids|glucocorticoids|mesh-ancestor
102582607|NCT02587117|Hormones|hormones|mesh-ancestor
102582608|NCT02587117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102582609|NCT02587117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582610|NCT02587117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102582611|NCT02587117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102582612|NCT02587117|Protective Agents|protective agents|mesh-ancestor
102582613|NCT02587117|Antioxidants|antioxidants|mesh-ancestor
102582614|NCT02587117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582615|NCT02587117|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102582616|NCT02587117|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102582617|NCT02587351|Metoprolol|metoprolol|mesh-list
102582618|NCT02587351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102582619|NCT02587351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102582620|NCT02587351|Sympatholytics|sympatholytics|mesh-ancestor
102582621|NCT02587351|Autonomic Agents|autonomic agents|mesh-ancestor
102582622|NCT02587351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102582623|NCT02587351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582624|NCT02587351|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102582625|NCT02587351|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102582626|NCT02587351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102582627|NCT02587351|Adrenergic Agents|adrenergic agents|mesh-ancestor
102582628|NCT02587351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102582629|NCT02587351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582630|NCT05553314|Carvedilol|carvedilol|mesh-list
102582631|NCT05553314|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102582632|NCT05553314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102582633|NCT05553314|Adrenergic Agents|adrenergic agents|mesh-ancestor
102582634|NCT05553314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102582635|NCT05553314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582636|NCT05553314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582637|NCT05553314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102582638|NCT05553314|Antioxidants|antioxidants|mesh-ancestor
102582639|NCT05553314|Protective Agents|protective agents|mesh-ancestor
102582640|NCT05553314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102582641|NCT05553314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102582642|NCT05553314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102582643|NCT05553314|Vasodilator Agents|vasodilator agents|mesh-ancestor
102582644|NCT05553314|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102582645|NCT05553314|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102582646|NCT00422396|Fenofibrate|fenofibrate|mesh-list
102582647|NCT00422396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102582648|NCT00422396|Antimetabolites|antimetabolites|mesh-ancestor
102582649|NCT00422396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582650|NCT00422396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102582651|NCT00364273|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102582652|NCT00364273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102582653|NCT00364273|Autonomic Agents|autonomic agents|mesh-ancestor
102582654|NCT00364273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102582655|NCT00364273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582656|NCT00364273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102582657|NCT00364273|Respiratory System Agents|respiratory system agents|mesh-ancestor
102582658|NCT00364273|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102582659|NCT00364273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102582660|NCT00364273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102582661|NCT00364273|Adrenergic Agents|adrenergic agents|mesh-ancestor
102582662|NCT00364273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102582663|NCT00364273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582664|NCT02495467|Nitroglycerin|nitroglycerin|mesh-list
102582665|NCT02495467|Vasodilator Agents|vasodilator agents|mesh-ancestor
102582666|NCT05249023|Butyric Acid|butyric acid|mesh-list
102582667|NCT05249023|Histamine Antagonists|histamine antagonists|mesh-ancestor
102582668|NCT05249023|Histamine Agents|histamine agents|mesh-ancestor
102582669|NCT05249023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102582670|NCT05249023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129555|NCT00422019|Rilotumumab|rilotumumab|mesh-list
102582671|NCT05249023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582673|NCT02495779|Emtricitabine|emtricitabine|mesh-list
102582674|NCT02495779|Antiviral Agents|antiviral agents|mesh-ancestor
102582675|NCT02495779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102582676|NCT02495779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102582677|NCT02495779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102582678|NCT02495779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102582679|NCT02495779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582680|NCT02495779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102582681|NCT02495779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102582682|NCT05216497|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
102582683|NCT05216497|Antiviral Agents|antiviral agents|mesh-ancestor
102582684|NCT05216497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102582685|NCT02502487|Ropivacaine|ropivacaine|mesh-list
102582686|NCT02502487|Tetracaine|tetracaine|mesh-list
102582687|NCT02502487|Anesthetics, Local|anesthetics, local|mesh-ancestor
102582688|NCT02502487|Anesthetics|anesthetics|mesh-ancestor
102582689|NCT02502487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102582690|NCT02502487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582691|NCT02502487|Sensory System Agents|sensory system agents|mesh-ancestor
102582692|NCT02502487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102582693|NCT03238196|Fulvestrant|fulvestrant|mesh-list
102582694|NCT03238196|Palbociclib|palbociclib|mesh-list
102582695|NCT03238196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102582696|NCT03238196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102582697|NCT03238196|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102582698|NCT03238196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102582699|NCT03238196|Hormone Antagonists|hormone antagonists|mesh-ancestor
102582700|NCT03238196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102582701|NCT03238196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582702|NCT03238196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102582703|NCT03238196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102582704|NCT03238196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582705|NCT02632045|Fulvestrant|fulvestrant|mesh-list
102582706|NCT02632045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102582707|NCT02632045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102582708|NCT02632045|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102582709|NCT02632045|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102582710|NCT02632045|Hormone Antagonists|hormone antagonists|mesh-ancestor
102582711|NCT02632045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102582712|NCT02632045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582713|NCT02503735|Sofosbuvir|sofosbuvir|mesh-list
102582714|NCT02503735|Ledipasvir|ledipasvir|mesh-list
102582715|NCT02503735|Antiviral Agents|antiviral agents|mesh-ancestor
102582716|NCT02503735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102582717|NCT04001881|Anesthetics|anesthetics|mesh-list
102582718|NCT04001881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102582719|NCT04001881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582720|NCT03019640|Cytarabine|cytarabine|mesh-list
102582721|NCT03019640|Rituximab|rituximab|mesh-list
102582722|NCT03019640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102582723|NCT03019640|Etoposide|etoposide|mesh-list
102582724|NCT03019640|Lenalidomide|lenalidomide|mesh-list
102582725|NCT03019640|Etoposide phosphate|etoposide phosphate|mesh-list
102582726|NCT03019640|Melphalan|melphalan|mesh-list
102582727|NCT03019640|Mechlorethamine|mechlorethamine|mesh-list
102582728|NCT03019640|Carmustine|carmustine|mesh-list
102582729|NCT03019640|Podophyllotoxin|podophyllotoxin|mesh-list
102582730|NCT03019640|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102582731|NCT03019640|Antibodies|antibodies|mesh-list
102582732|NCT03019640|Immunoglobulins|immunoglobulins|mesh-list
102582733|NCT03019640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102582734|NCT03019640|Lenograstim|lenograstim|mesh-list
102582735|NCT03019640|Immunologic Factors|immunologic factors|mesh-ancestor
102582736|NCT03019640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582737|NCT03019640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102582738|NCT03019640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102582739|NCT03019640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102582740|NCT03019640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102582741|NCT03019640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102582742|NCT03019640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102582743|NCT03019640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582744|NCT03019640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102582745|NCT03019640|Antimetabolites|antimetabolites|mesh-ancestor
102582746|NCT03019640|Antiviral Agents|antiviral agents|mesh-ancestor
102582747|NCT03019640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102582748|NCT03019640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102582749|NCT03019640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102582750|NCT03019640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102582751|NCT03019640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102582752|NCT03019640|Growth Substances|growth substances|mesh-ancestor
102582753|NCT03019640|Growth Inhibitors|growth inhibitors|mesh-ancestor
102582754|NCT03019640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102582755|NCT03019640|Alkylating Agents|alkylating agents|mesh-ancestor
102582756|NCT03019640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102582757|NCT03019640|Keratolytic Agents|keratolytic agents|mesh-ancestor
102582758|NCT03019640|Dermatologic Agents|dermatologic agents|mesh-ancestor
102582759|NCT03019640|Tubulin Modulators|tubulin modulators|mesh-ancestor
102582760|NCT03019640|Antimitotic Agents|antimitotic agents|mesh-ancestor
102582761|NCT03019640|Mitosis Modulators|mitosis modulators|mesh-ancestor
102582762|NCT02136901|Hyaluronic Acid|hyaluronic acid|mesh-list
102582763|NCT02136901|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102582764|NCT02136901|Immunologic Factors|immunologic factors|mesh-ancestor
102582765|NCT02136901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582766|NCT02136901|Viscosupplements|viscosupplements|mesh-ancestor
102582767|NCT02136901|Protective Agents|protective agents|mesh-ancestor
102582768|NCT02507011|Carvedilol|carvedilol|mesh-list
102582769|NCT02507011|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102582770|NCT02507011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102582771|NCT02507011|Adrenergic Agents|adrenergic agents|mesh-ancestor
102582772|NCT02507011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102582773|NCT02507011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582774|NCT02507011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582775|NCT02507011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102582776|NCT02507011|Antioxidants|antioxidants|mesh-ancestor
102582777|NCT02507011|Protective Agents|protective agents|mesh-ancestor
102582778|NCT02507011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102582779|NCT02507011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102582780|NCT02507011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102582781|NCT02507011|Vasodilator Agents|vasodilator agents|mesh-ancestor
102582782|NCT02507011|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102582783|NCT02507011|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102582784|NCT02977286|Methylnaltrexone|methylnaltrexone|mesh-list
102582785|NCT02977286|Naloxegol|naloxegol|mesh-list
102582786|NCT02977286|Bisacodyl|bisacodyl|mesh-list
102582787|NCT02977286|Magnesium citrate|magnesium citrate|mesh-list
102582788|NCT02977286|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
102582789|NCT02977286|Cathartics|cathartics|mesh-ancestor
102582790|NCT02977286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102582791|NCT02977286|Laxatives|laxatives|mesh-ancestor
102582792|NCT02977286|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102582793|NCT02977286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582794|NCT02977286|Sensory System Agents|sensory system agents|mesh-ancestor
102582795|NCT02977286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102582796|NCT02977286|Antidiarrheals|antidiarrheals|mesh-ancestor
102582797|NCT05345210|Amoxicillin|amoxicillin|mesh-list
102582798|NCT05345210|Clarithromycin|clarithromycin|mesh-list
102582799|NCT05345210|Tetracycline|tetracycline|mesh-list
102582800|NCT05345210|Furazolidone|furazolidone|mesh-list
102582801|NCT05345210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102582802|NCT05345210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102582803|NCT05345210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102582804|NCT05345210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102582805|NCT05345210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582806|NCT05345210|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102344178|NCT03780543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102582807|NCT05345210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102582808|NCT05345210|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102582809|NCT05345210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102582810|NCT05345210|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
102582811|NCT05345210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102582812|NCT05345210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102582813|NCT05345210|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102582814|NCT02976896|Apatinib|apatinib|mesh-list
102582815|NCT02976896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102582816|NCT02976896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102582817|NCT02976896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102582818|NCT02976896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582819|NCT01810705|Asparaginase|asparaginase|mesh-list
102582820|NCT01810705|Eryaspase|eryaspase|mesh-list
102582821|NCT01810705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102582822|NCT02508103|Oxytocin|oxytocin|mesh-list
102582823|NCT02508103|Oxytocics|oxytocics|mesh-ancestor
102582824|NCT02508103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102582825|NCT02508103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582827|NCT02508259|Antinematodal Agents|antinematodal agents|mesh-ancestor
102582828|NCT02508259|Anthelmintics|anthelmintics|mesh-ancestor
102582829|NCT02508259|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102582830|NCT02508259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102582831|NCT02508259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102582832|NCT02508259|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102582833|NCT02508259|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102582834|NCT02848820|Amoxicillin|amoxicillin|mesh-list
102582835|NCT02848820|Gentamicins|gentamicins|mesh-list
102582836|NCT02848820|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102582837|NCT02848820|Clavulanic Acids|clavulanic acids|mesh-list
102582838|NCT02848820|Clavulanic Acid|clavulanic acid|mesh-list
102582839|NCT02848820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102582840|NCT02848820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102582841|NCT02848820|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102582842|NCT02848820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102582843|NCT02848820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582844|NCT02848820|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102582845|NCT00534469|Cytarabine|cytarabine|mesh-list
102582846|NCT00534469|Aldesleukin|aldesleukin|mesh-list
102582847|NCT00534469|Etoposide|etoposide|mesh-list
102582848|NCT00534469|Idarubicin|idarubicin|mesh-list
102582849|NCT00534469|Busulfan|busulfan|mesh-list
102582850|NCT00534469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102582851|NCT00534469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102582852|NCT00534469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102582853|NCT00534469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102582854|NCT00534469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102582855|NCT00534469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582856|NCT00534469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102582857|NCT00534469|Antimetabolites|antimetabolites|mesh-ancestor
102582858|NCT00534469|Antiviral Agents|antiviral agents|mesh-ancestor
102582859|NCT00534469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102582860|NCT00534469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102582861|NCT00534469|Immunologic Factors|immunologic factors|mesh-ancestor
102582862|NCT00534469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582863|NCT00534469|Alkylating Agents|alkylating agents|mesh-ancestor
102582864|NCT00534469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102582865|NCT00534469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102582866|NCT00534469|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102582867|NCT00534469|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102582868|NCT00534469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102582869|NCT02240628|Lidocaine|lidocaine|mesh-list
102582870|NCT02240628|Tetracaine|tetracaine|mesh-list
102582871|NCT02240628|Anesthetics, Local|anesthetics, local|mesh-ancestor
102582872|NCT02240628|Anesthetics|anesthetics|mesh-ancestor
102582873|NCT02240628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102582874|NCT02240628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582875|NCT02240628|Sensory System Agents|sensory system agents|mesh-ancestor
102582876|NCT02240628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102582877|NCT02240628|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102582878|NCT02240628|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102582879|NCT02240628|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102582880|NCT02240628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102582881|NCT02240628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582882|NCT02589067|Chlorhexidine|chlorhexidine|mesh-list
102344182|NCT03772314|Adderall|adderall|mesh-list
102582883|NCT02589067|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102582884|NCT02589067|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102582885|NCT02589067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102582886|NCT02589067|Disinfectants|disinfectants|mesh-ancestor
102582887|NCT02589067|Dermatologic Agents|dermatologic agents|mesh-ancestor
102582888|NCT02511379|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102582889|NCT02511379|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102582890|NCT02207400|Listerine|listerine|mesh-list
102582891|NCT02207400|Fluorides|fluorides|mesh-list
102582892|NCT02207400|Sodium Fluoride|sodium fluoride|mesh-list
102582893|NCT02207400|Cariostatic Agents|cariostatic agents|mesh-ancestor
102582894|NCT02207400|Protective Agents|protective agents|mesh-ancestor
102582895|NCT02207400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582896|NCT02207400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102582897|NCT02207400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102582898|NCT02511535|Vaccines|vaccines|mesh-list
102582899|NCT02511535|Immunologic Factors|immunologic factors|mesh-ancestor
102129784|NCT03195530|Anesthetics|anesthetics|mesh-ancestor
102582900|NCT02511535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582901|NCT03545035|Rituximab|rituximab|mesh-list
102582902|NCT03545035|Idelalisib|idelalisib|mesh-list
102582903|NCT03545035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102582904|NCT03545035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102582905|NCT03545035|Immunologic Factors|immunologic factors|mesh-ancestor
102582906|NCT03545035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582907|NCT03545035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102582908|NCT03545035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102582909|NCT03545035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582910|NCT02589847|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102582911|NCT02589847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102582912|NCT02589847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102582913|NCT02589847|Antitubercular Agents|antitubercular agents|mesh-ancestor
102582914|NCT02592421|Dapagliflozin|dapagliflozin|mesh-list
102582915|NCT02592421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102582916|NCT02592421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582917|NCT02592421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102582918|NCT02592421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582919|NCT02512783|Lidocaine|lidocaine|mesh-list
102582920|NCT02512783|Propofol|propofol|mesh-list
102582921|NCT02512783|Anesthetics, Local|anesthetics, local|mesh-ancestor
102582922|NCT02512783|Anesthetics|anesthetics|mesh-ancestor
102582923|NCT02512783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102582924|NCT02512783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582925|NCT02512783|Sensory System Agents|sensory system agents|mesh-ancestor
102582926|NCT02512783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102582927|NCT02512783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102582928|NCT02512783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102582929|NCT02512783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102582930|NCT02512783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102582931|NCT02512783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582932|NCT02512783|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102582933|NCT02512783|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102582934|NCT02512783|Anesthetics, General|anesthetics, general|mesh-ancestor
102582935|NCT02513095|Dantrolene|dantrolene|mesh-list
102582936|NCT02513095|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102582937|NCT02513095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582938|NCT02513095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102582939|NCT02513095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102582940|NCT02513719|Everolimus|everolimus|mesh-list
102582941|NCT02513719|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102582942|NCT02513719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102582943|NCT02513719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102582944|NCT02513719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582945|NCT02513719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102582946|NCT02513719|Immunologic Factors|immunologic factors|mesh-ancestor
102582947|NCT02513719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582948|NCT02513719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102582949|NCT00363727|Ropinirole|ropinirole|mesh-list
102582950|NCT00363727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102582951|NCT00363727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102582952|NCT00363727|Dopamine Agonists|dopamine agonists|mesh-ancestor
102582953|NCT00363727|Dopamine Agents|dopamine agents|mesh-ancestor
102582954|NCT00363727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102582955|NCT00363727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582956|NCT00363727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582957|NCT04340869|Theobromine|theobromine|mesh-list
102582958|NCT04340869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102582959|NCT04340869|Autonomic Agents|autonomic agents|mesh-ancestor
102582960|NCT04340869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102582961|NCT04340869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582962|NCT04340869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102582963|NCT04340869|Respiratory System Agents|respiratory system agents|mesh-ancestor
102582964|NCT04340869|Vasodilator Agents|vasodilator agents|mesh-ancestor
102582965|NCT00366067|Phenytoin|phenytoin|mesh-list
102582966|NCT00366067|Anticonvulsants|anticonvulsants|mesh-ancestor
102582967|NCT00366067|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102582968|NCT00366067|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102582969|NCT00366067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102582970|NCT00366067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582971|NCT00366067|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102582972|NCT00366067|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102582973|NCT00364429|Lorazepam|lorazepam|mesh-list
102582974|NCT00364429|Risperidone|risperidone|mesh-list
102582975|NCT00364429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102582976|NCT00364429|Serotonin Agents|serotonin agents|mesh-ancestor
102582977|NCT00364429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102582978|NCT00364429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102582979|NCT00364429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102582980|NCT00364429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102582981|NCT00364429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102582982|NCT00364429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102582983|NCT00364429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102582984|NCT00364429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102582985|NCT00364429|Dopamine Agents|dopamine agents|mesh-ancestor
102582986|NCT00364429|Anticonvulsants|anticonvulsants|mesh-ancestor
102582987|NCT00364429|Antiemetics|antiemetics|mesh-ancestor
102582988|NCT00364429|Autonomic Agents|autonomic agents|mesh-ancestor
102582989|NCT00364429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102582990|NCT00364429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102582991|NCT00364429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102582992|NCT00364429|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102582993|NCT00364429|GABA Modulators|gaba modulators|mesh-ancestor
102582994|NCT00364429|GABA Agents|gaba agents|mesh-ancestor
102582995|NCT02593903|Trimethoprim|trimethoprim|mesh-list
102582996|NCT02593903|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102582997|NCT02593903|Sulfamethoxazole|sulfamethoxazole|mesh-list
102582998|NCT02593903|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102582999|NCT02593903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102583000|NCT02593903|Antimalarials|antimalarials|mesh-ancestor
102583001|NCT02593903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102583002|NCT02593903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102583003|NCT02593903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102583004|NCT02593903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102583005|NCT02593903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583006|NCT02593903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102583007|NCT02593903|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102583008|NCT02593903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102583009|NCT02593903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102583010|NCT02596867|Propranolol|propranolol|mesh-list
102583011|NCT02596867|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102583012|NCT02596867|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102583013|NCT02596867|Adrenergic Agents|adrenergic agents|mesh-ancestor
102583014|NCT02596867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102583015|NCT02596867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583016|NCT02596867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344193|NCT03772314|Dopamine Agents|dopamine agents|mesh-ancestor
102583017|NCT02596867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102583018|NCT02596867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102583019|NCT02596867|Vasodilator Agents|vasodilator agents|mesh-ancestor
102583020|NCT02597101|Metformin|metformin|mesh-list
102583021|NCT02597101|Saxagliptin|saxagliptin|mesh-list
102583022|NCT02597101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102583023|NCT02597101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583024|NCT02597101|Incretins|incretins|mesh-ancestor
102583025|NCT02597101|Hormones|hormones|mesh-ancestor
102583026|NCT02597101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102583027|NCT02597101|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102583028|NCT02597101|Protease Inhibitors|protease inhibitors|mesh-ancestor
102583029|NCT02597101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102583030|NCT02597101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583031|NCT02600611|Vancomycin|vancomycin|mesh-list
102583032|NCT02600611|Iclaprim|iclaprim|mesh-list
102583033|NCT02600611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102583034|NCT02600611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102583035|NCT02600611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102583036|NCT02600611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102583037|NCT02600611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583038|NCT02600767|Lumefantrine|lumefantrine|mesh-list
102583039|NCT02600767|Artemether|artemether|mesh-list
102583040|NCT02600767|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102583041|NCT02600767|Antimalarials|antimalarials|mesh-ancestor
102583042|NCT02600767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102583043|NCT02600767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102583044|NCT02600767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102583045|NCT00365287|Cyclosporine|cyclosporine|mesh-list
102583046|NCT00365287|Mycophenolic Acid|mycophenolic acid|mesh-list
102583047|NCT00365287|Cyclophosphamide|cyclophosphamide|mesh-list
102583048|NCT00365287|Fludarabine|fludarabine|mesh-list
102583049|NCT00365287|Fludarabine phosphate|fludarabine phosphate|mesh-list
102583050|NCT00365287|Cyclosporins|cyclosporins|mesh-list
102583051|NCT00365287|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102583052|NCT00365287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102583053|NCT00365287|Immunologic Factors|immunologic factors|mesh-ancestor
102583054|NCT00365287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583055|NCT00365287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102583056|NCT00365287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102583057|NCT00365287|Alkylating Agents|alkylating agents|mesh-ancestor
102583058|NCT00365287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583059|NCT00365287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102583060|NCT00365287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102583061|NCT00365287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102583062|NCT00365287|Antimetabolites|antimetabolites|mesh-ancestor
102583063|NCT00365287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102583064|NCT00365287|Antifungal Agents|antifungal agents|mesh-ancestor
102583065|NCT00365287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102583066|NCT00365287|Dermatologic Agents|dermatologic agents|mesh-ancestor
102583067|NCT00365287|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102583068|NCT00365287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102583069|NCT00365287|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102583070|NCT00365287|Antitubercular Agents|antitubercular agents|mesh-ancestor
102583071|NCT00365287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102583072|NCT04743193|Sevoflurane|sevoflurane|mesh-list
102583073|NCT04743193|Anesthetics|anesthetics|mesh-ancestor
102583074|NCT04743193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102583075|NCT04743193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583076|NCT04743193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102583077|NCT04743193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102583078|NCT04743193|Anesthetics, General|anesthetics, general|mesh-ancestor
102583079|NCT05572645|Trastuzumab|trastuzumab|mesh-list
102583080|NCT05572645|Pertuzumab|pertuzumab|mesh-list
102583081|NCT05572645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102583082|NCT05572645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102583083|NCT02608177|Linagliptin|linagliptin|mesh-list
102583084|NCT02608177|Glipizide|glipizide|mesh-list
102583085|NCT02608177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102583086|NCT02608177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583087|NCT02608177|Incretins|incretins|mesh-ancestor
102583088|NCT02608177|Hormones|hormones|mesh-ancestor
102583089|NCT02608177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102583090|NCT02608177|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102583091|NCT02608177|Protease Inhibitors|protease inhibitors|mesh-ancestor
102583092|NCT02608177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102583093|NCT02608177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583094|NCT02608489|Hyaluronic Acid|hyaluronic acid|mesh-list
102583095|NCT02608489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102583096|NCT02608489|Immunologic Factors|immunologic factors|mesh-ancestor
102583097|NCT02608489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583098|NCT02608489|Viscosupplements|viscosupplements|mesh-ancestor
102583099|NCT02608489|Protective Agents|protective agents|mesh-ancestor
102583100|NCT02611765|Penicillins|penicillins|mesh-list
102583101|NCT02611765|Penicillin G|penicillin g|mesh-list
102583102|NCT02611765|Penicillin G Benzathine|penicillin g benzathine|mesh-list
102583103|NCT02611765|Penicillin G Procaine|penicillin g procaine|mesh-list
102583104|NCT02611765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102583105|NCT02611765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102583106|NCT05552287|Infliximab|infliximab|mesh-list
102583107|NCT05552287|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102583108|NCT05552287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102583109|NCT05552287|Dermatologic Agents|dermatologic agents|mesh-ancestor
102583110|NCT05552287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102583111|NCT05552287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102583112|NCT02616523|Lidocaine|lidocaine|mesh-list
102583113|NCT02616523|Fentanyl|fentanyl|mesh-list
102583114|NCT02616523|Dexmedetomidine|dexmedetomidine|mesh-list
102583115|NCT02616523|Anesthetics, Local|anesthetics, local|mesh-ancestor
102583116|NCT02616523|Anesthetics|anesthetics|mesh-ancestor
102583117|NCT02616523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102583118|NCT02616523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583119|NCT02616523|Sensory System Agents|sensory system agents|mesh-ancestor
102583120|NCT02616523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102583121|NCT02616523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102583122|NCT02616523|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102583123|NCT02616523|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102583124|NCT02616523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102583125|NCT02616523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583126|NCT02616523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102583127|NCT02616523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102583128|NCT02616523|Analgesics|analgesics|mesh-ancestor
102583129|NCT02616523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102583130|NCT02616523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102583131|NCT02616523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102583132|NCT02616523|Adrenergic Agents|adrenergic agents|mesh-ancestor
102583133|NCT02616523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102583134|NCT02616523|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102583135|NCT02616523|Narcotics|narcotics|mesh-ancestor
102583136|NCT02616523|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102583137|NCT02616523|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102583138|NCT02616523|Anesthetics, General|anesthetics, general|mesh-ancestor
102583139|NCT05732155|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
102583140|NCT05732155|Hallucinogens|hallucinogens|mesh-ancestor
102583141|NCT05732155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583142|NCT05732155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102583143|NCT05732155|Serotonin Agents|serotonin agents|mesh-ancestor
102583144|NCT05732155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102583145|NCT05732155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583146|NCT05732155|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102583147|NCT05732155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102583148|NCT05732155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102583149|NCT05732155|Adrenergic Agents|adrenergic agents|mesh-ancestor
102583150|NCT05528419|Valsartan|valsartan|mesh-list
102583151|NCT05528419|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102583152|NCT05528419|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102583153|NCT05528419|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102583154|NCT05528419|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102583155|NCT05528419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583156|NCT05485831|Cannabidiol|cannabidiol|mesh-list
102583157|NCT05485831|Anticonvulsants|anticonvulsants|mesh-ancestor
102583158|NCT05480293|Ranibizumab|ranibizumab|mesh-list
102583159|NCT05480293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102583160|NCT05480293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102583161|NCT05480293|Growth Substances|growth substances|mesh-ancestor
102583162|NCT05480293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583163|NCT05480293|Growth Inhibitors|growth inhibitors|mesh-ancestor
102583164|NCT05480293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102583165|NCT05449327|Rivaroxaban|rivaroxaban|mesh-list
102583166|NCT05449327|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102583167|NCT05449327|Antithrombins|antithrombins|mesh-ancestor
102583168|NCT05449327|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102583169|NCT05449327|Protease Inhibitors|protease inhibitors|mesh-ancestor
102583170|NCT05449327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102583171|NCT05449327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583172|NCT05449327|Anticoagulants|anticoagulants|mesh-ancestor
102583173|NCT00365755|Cyclophosphamide|cyclophosphamide|mesh-list
102583174|NCT00365755|Melphalan|melphalan|mesh-list
102583175|NCT00365755|Carboplatin|carboplatin|mesh-list
102583176|NCT00365755|Etoposide|etoposide|mesh-list
102583177|NCT00365755|Vincristine|vincristine|mesh-list
102583178|NCT00365755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102583179|NCT00365755|Immunologic Factors|immunologic factors|mesh-ancestor
102583180|NCT00365755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583181|NCT00365755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102583182|NCT00365755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102583183|NCT00365755|Alkylating Agents|alkylating agents|mesh-ancestor
102583184|NCT00365755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583185|NCT00365755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102583186|NCT00365755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102583187|NCT00365755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102583188|NCT00365755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102583189|NCT00365755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102583190|NCT00365755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102583191|NCT00365755|Tubulin Modulators|tubulin modulators|mesh-ancestor
102583192|NCT00365755|Antimitotic Agents|antimitotic agents|mesh-ancestor
102583193|NCT00365755|Mitosis Modulators|mitosis modulators|mesh-ancestor
102583194|NCT05730907|Simendan|simendan|mesh-list
102583195|NCT05730907|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102583196|NCT05730907|Vasodilator Agents|vasodilator agents|mesh-ancestor
102583197|NCT05730907|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102583198|NCT05730907|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102130081|NCT00396357|Protease Inhibitors|protease inhibitors|mesh-ancestor
102583199|NCT05730907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102583200|NCT05730907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583201|NCT05730907|Protective Agents|protective agents|mesh-ancestor
102583202|NCT05730907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583203|NCT05355337|Pramipexole|pramipexole|mesh-list
102583204|NCT05355337|Antioxidants|antioxidants|mesh-ancestor
102583205|NCT05355337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583206|NCT05355337|Protective Agents|protective agents|mesh-ancestor
102583207|NCT05355337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583208|NCT05355337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102583209|NCT05355337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102583210|NCT05355337|Dopamine Agonists|dopamine agonists|mesh-ancestor
102583211|NCT05355337|Dopamine Agents|dopamine agents|mesh-ancestor
102583212|NCT05355337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102583213|NCT04340401|Capecitabine|capecitabine|mesh-list
102583214|NCT04340401|Oxaliplatin|oxaliplatin|mesh-list
102583215|NCT04340401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102583216|NCT04340401|Antimetabolites|antimetabolites|mesh-ancestor
102583217|NCT04340401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583218|NCT04340401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102583219|NCT04143607|Gefitinib|gefitinib|mesh-list
102583220|NCT04143607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102583221|NCT04143607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102583222|NCT04143607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102583223|NCT04143607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583224|NCT04802863|Imipenem|imipenem|mesh-list
102583225|NCT04802863|Cilastatin|cilastatin|mesh-list
102583226|NCT04802863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102583227|NCT04802863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102583228|NCT04802863|Protease Inhibitors|protease inhibitors|mesh-ancestor
102583229|NCT04802863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102583230|NCT04802863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583231|NCT04622839|Acetaminophen|acetaminophen|mesh-list
102583232|NCT04622839|Ibuprofen|ibuprofen|mesh-list
102583233|NCT04622839|Diclofenac|diclofenac|mesh-list
102583234|NCT04622839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102583235|NCT04622839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102583236|NCT04622839|Analgesics|analgesics|mesh-ancestor
102583237|NCT04622839|Sensory System Agents|sensory system agents|mesh-ancestor
102583238|NCT04622839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102583239|NCT04622839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583240|NCT04622839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102583241|NCT04622839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102583242|NCT04622839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102583243|NCT04622839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102583244|NCT04622839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583245|NCT04622839|Antipyretics|antipyretics|mesh-ancestor
102583246|NCT02619799|Magnesium Sulfate|magnesium sulfate|mesh-list
102583247|NCT02619799|Midazolam|midazolam|mesh-list
102583248|NCT02619799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102583249|NCT02619799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102583250|NCT02619799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102583251|NCT02619799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583252|NCT02619799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102583253|NCT02619799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102583254|NCT02619799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102583255|NCT02619799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102583256|NCT02619799|Anesthetics, General|anesthetics, general|mesh-ancestor
102583257|NCT02619799|Anesthetics|anesthetics|mesh-ancestor
102583258|NCT02619799|GABA Modulators|gaba modulators|mesh-ancestor
102583259|NCT02619799|GABA Agents|gaba agents|mesh-ancestor
102583260|NCT02619799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102583261|NCT02619799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583262|NCT02619799|Analgesics|analgesics|mesh-ancestor
102583263|NCT02619799|Sensory System Agents|sensory system agents|mesh-ancestor
102583264|NCT02619799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102583265|NCT02619799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102583266|NCT02619799|Anticonvulsants|anticonvulsants|mesh-ancestor
102583267|NCT02619799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102583268|NCT02619799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102583269|NCT02619799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102583270|NCT02619799|Tocolytic Agents|tocolytic agents|mesh-ancestor
102583271|NCT02619799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102583272|NCT04592809|Midazolam|midazolam|mesh-list
102583273|NCT04592809|Ketamine|ketamine|mesh-list
102583274|NCT04592809|Analgesics|analgesics|mesh-ancestor
102583275|NCT04592809|Sensory System Agents|sensory system agents|mesh-ancestor
102130156|NCT03204578|Midazolam|midazolam|mesh-list
102583276|NCT04592809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102583277|NCT04592809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583278|NCT04592809|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102583279|NCT04592809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102583280|NCT04592809|Anesthetics, General|anesthetics, general|mesh-ancestor
102583281|NCT04592809|Anesthetics|anesthetics|mesh-ancestor
102583282|NCT04592809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102583283|NCT04592809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102583284|NCT04592809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102583285|NCT04592809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102583286|NCT04592809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583287|NCT04592809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102583288|NCT04592809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102583289|NCT04592809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102583290|NCT04592809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102583291|NCT04592809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102583292|NCT04592809|GABA Modulators|gaba modulators|mesh-ancestor
102583293|NCT04592809|GABA Agents|gaba agents|mesh-ancestor
102583294|NCT04741165|Bevacizumab|bevacizumab|mesh-list
102583295|NCT04741165|Lenvatinib|lenvatinib|mesh-list
102583296|NCT04741165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102583297|NCT04741165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102583298|NCT04741165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102583299|NCT04741165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102583300|NCT04741165|Growth Substances|growth substances|mesh-ancestor
102583301|NCT04741165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583302|NCT04741165|Growth Inhibitors|growth inhibitors|mesh-ancestor
102583303|NCT04741165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102583304|NCT04741165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102583305|NCT04741165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583306|NCT02625181|Promethazine|promethazine|mesh-list
102583307|NCT02625181|Diphenhydramine|diphenhydramine|mesh-list
102583308|NCT02625181|Meclizine|meclizine|mesh-list
102583309|NCT02625181|Dexamethasone|dexamethasone|mesh-list
102583310|NCT02625181|Fentanyl|fentanyl|mesh-list
102583311|NCT02625181|Sufentanil|sufentanil|mesh-list
102583312|NCT02625181|Scopolamine|scopolamine|mesh-list
102583313|NCT02625181|Oxymorphone|oxymorphone|mesh-list
102583314|NCT02625181|Meperidine|meperidine|mesh-list
102583315|NCT02625181|Droperidol|droperidol|mesh-list
102583316|NCT02625181|Ketamine|ketamine|mesh-list
102583317|NCT02625181|Morphine|morphine|mesh-list
102583318|NCT02625181|Remifentanil|remifentanil|mesh-list
102583319|NCT02625181|Oxycodone|oxycodone|mesh-list
102583320|NCT02625181|Methadone|methadone|mesh-list
102583321|NCT02625181|Hydromorphone|hydromorphone|mesh-list
102583322|NCT02625181|Hydrocodone|hydrocodone|mesh-list
102583323|NCT02625181|Alfentanil|alfentanil|mesh-list
102583324|NCT02625181|Haloperidol|haloperidol|mesh-list
102583325|NCT02625181|Ondansetron|ondansetron|mesh-list
102583326|NCT02625181|Aprepitant|aprepitant|mesh-list
102583327|NCT02625181|Metoclopramide|metoclopramide|mesh-list
102583328|NCT02625181|Palonosetron|palonosetron|mesh-list
102583329|NCT02625181|Granisetron|granisetron|mesh-list
102583330|NCT02625181|Ramosetron|ramosetron|mesh-list
102583331|NCT02625181|Tropisetron|tropisetron|mesh-list
102583332|NCT02625181|Dolasetron|dolasetron|mesh-list
102583333|NCT02625181|Anesthetics|anesthetics|mesh-list
102583334|NCT02625181|Propofol|propofol|mesh-list
102583335|NCT02625181|Sevoflurane|sevoflurane|mesh-list
102583336|NCT02625181|Desflurane|desflurane|mesh-list
102583337|NCT02625181|Isoflurane|isoflurane|mesh-list
102583338|NCT02625181|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102583339|NCT02625181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102583340|NCT02625181|Antiemetics|antiemetics|mesh-ancestor
102583341|NCT02625181|Autonomic Agents|autonomic agents|mesh-ancestor
102583342|NCT02625181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102583343|NCT02625181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583344|NCT02625181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102583345|NCT02625181|Glucocorticoids|glucocorticoids|mesh-ancestor
102583346|NCT02625181|Hormones|hormones|mesh-ancestor
102583347|NCT02625181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102583348|NCT02625181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102583349|NCT02625181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102583350|NCT02625181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102583351|NCT02625181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102583352|NCT02625181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102130280|NCT03203408|Hylan|hylan|mesh-list
102583353|NCT02625181|Anesthetics, General|anesthetics, general|mesh-ancestor
102583354|NCT02625181|Analgesics|analgesics|mesh-ancestor
102583355|NCT02625181|Sensory System Agents|sensory system agents|mesh-ancestor
102583356|NCT02625181|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102583357|NCT02625181|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102583358|NCT02625181|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102583359|NCT02625181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102583360|NCT02625181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583361|NCT02625181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102583362|NCT02625181|Narcotics|narcotics|mesh-ancestor
102583363|NCT02625181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102583364|NCT02625181|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102583365|NCT02625181|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102583366|NCT02625181|Antipruritics|antipruritics|mesh-ancestor
102583367|NCT02625181|Dermatologic Agents|dermatologic agents|mesh-ancestor
102583368|NCT02625181|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102583369|NCT02625181|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102583370|NCT02625181|Serotonin Agents|serotonin agents|mesh-ancestor
102583371|NCT02625181|Antitussive Agents|antitussive agents|mesh-ancestor
102583372|NCT02625181|Respiratory System Agents|respiratory system agents|mesh-ancestor
102583373|NCT02625181|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102583374|NCT02625181|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102583375|NCT02625181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102583376|NCT02625181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102583377|NCT02625181|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102583378|NCT02625181|Dopamine Agents|dopamine agents|mesh-ancestor
102583379|NCT02625181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102583380|NCT02625181|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102583381|NCT02625181|Mydriatics|mydriatics|mesh-ancestor
102583382|NCT02625181|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102583383|NCT02625181|Cholinergic Agents|cholinergic agents|mesh-ancestor
102583384|NCT02625181|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102583385|NCT02625181|Parasympatholytics|parasympatholytics|mesh-ancestor
102583386|NCT02625181|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102583387|NCT02625181|Histamine Antagonists|histamine antagonists|mesh-ancestor
102583388|NCT02625181|Histamine Agents|histamine agents|mesh-ancestor
102583389|NCT02625181|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102583390|NCT02625181|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102583391|NCT02625181|Anesthetics, Local|anesthetics, local|mesh-ancestor
102583392|NCT02630017|Methylphenidate|methylphenidate|mesh-list
102583393|NCT02630017|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102583394|NCT02630017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583395|NCT02630017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102583396|NCT02630017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102583397|NCT02630017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102583398|NCT02630017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583399|NCT02630017|Dopamine Agents|dopamine agents|mesh-ancestor
102583400|NCT02630017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102583401|NCT02630719|Timolol|timolol|mesh-list
102583402|NCT02630719|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102583403|NCT02630719|Lubricant Eye Drops|lubricant eye drops|mesh-list
102583404|NCT02630719|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102583405|NCT02630719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102583406|NCT02630719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102583407|NCT02630719|Adrenergic Agents|adrenergic agents|mesh-ancestor
102583408|NCT02630719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102583409|NCT02630719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583410|NCT02630719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583411|NCT02630719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102583412|NCT02630719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102583413|NCT04979377|Insulin|insulin|mesh-list
102583414|NCT04979377|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102583415|NCT04979377|Hormones|hormones|mesh-list
102583416|NCT04979377|Testosterone|testosterone|mesh-list
102583417|NCT04979377|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
102583418|NCT04979377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102583419|NCT04979377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583420|NCT04979377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102583421|NCT04979377|Androgens|androgens|mesh-ancestor
102583422|NCT04979377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102583423|NCT04979377|Immunologic Factors|immunologic factors|mesh-ancestor
102583424|NCT02633371|Oxybutynin|oxybutynin|mesh-list
102583425|NCT02633371|Parasympatholytics|parasympatholytics|mesh-ancestor
102583426|NCT02633371|Autonomic Agents|autonomic agents|mesh-ancestor
102583427|NCT02633371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102583428|NCT02633371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583429|NCT02633371|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102583430|NCT02633371|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102583431|NCT02633371|Cholinergic Agents|cholinergic agents|mesh-ancestor
102583432|NCT02633371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102583433|NCT02633371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583434|NCT02633371|Urological Agents|urological agents|mesh-ancestor
102583435|NCT04159519|Budesonide|budesonide|mesh-list
102583436|NCT04159519|Albuterol|albuterol|mesh-list
102583437|NCT04159519|Formoterol Fumarate|formoterol fumarate|mesh-list
102583438|NCT04159519|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
102583439|NCT04159519|Benralizumab|benralizumab|mesh-list
102583440|NCT04159519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102583441|NCT04159519|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102583442|NCT04159519|Autonomic Agents|autonomic agents|mesh-ancestor
102583443|NCT04159519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102583444|NCT04159519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583445|NCT04159519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102583446|NCT04159519|Respiratory System Agents|respiratory system agents|mesh-ancestor
102583447|NCT04159519|Glucocorticoids|glucocorticoids|mesh-ancestor
102583448|NCT04159519|Hormones|hormones|mesh-ancestor
102583449|NCT04159519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102583450|NCT04159519|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102583451|NCT04159519|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102583452|NCT04159519|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102583453|NCT04159519|Adrenergic Agents|adrenergic agents|mesh-ancestor
102583454|NCT04159519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102583455|NCT04159519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583456|NCT04159519|Tocolytic Agents|tocolytic agents|mesh-ancestor
102583457|NCT04159519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102583458|NCT04913311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102583459|NCT04913311|Dimercaprol|dimercaprol|mesh-list
102583460|NCT04913311|Chelating Agents|chelating agents|mesh-ancestor
102583461|NCT04913311|Sequestering Agents|sequestering agents|mesh-ancestor
101850354|NCT01234532|Entinostat|entinostat|mesh-list
102583462|NCT04913311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583463|NCT04913311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102583464|NCT04913311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102583465|NCT04054375|Prednisone|prednisone|mesh-list
102583466|NCT04054375|Prednisolone|prednisolone|mesh-list
102583467|NCT04054375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102583468|NCT04054375|Glucocorticoids|glucocorticoids|mesh-ancestor
102583469|NCT04054375|Hormones|hormones|mesh-ancestor
102583470|NCT04054375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102583471|NCT04054375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583472|NCT04054375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102583473|NCT04054375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102583474|NCT02634073|Lamivudine|lamivudine|mesh-list
102583475|NCT02634073|Sorbitol|sorbitol|mesh-list
102583476|NCT02634073|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102583477|NCT02634073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102583478|NCT02634073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102583479|NCT02634073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583480|NCT02634073|Antiviral Agents|antiviral agents|mesh-ancestor
102583481|NCT02634073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102583482|NCT02634073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102583483|NCT02634073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102583484|NCT02634073|Cathartics|cathartics|mesh-ancestor
102583485|NCT02634073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102583486|NCT00366691|Loteprednol Etabonate|loteprednol etabonate|mesh-list
102583487|NCT00366691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102583488|NCT00367393|Pimecrolimus|pimecrolimus|mesh-list
102583489|NCT00367393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102583490|NCT00367393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102583491|NCT00367393|Analgesics|analgesics|mesh-ancestor
102583492|NCT00367393|Sensory System Agents|sensory system agents|mesh-ancestor
102583493|NCT00367393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102583494|NCT00367393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583495|NCT00367393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102583496|NCT00367393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102583497|NCT00367393|Dermatologic Agents|dermatologic agents|mesh-ancestor
102583498|NCT00367393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102583499|NCT00367393|Immunologic Factors|immunologic factors|mesh-ancestor
102583500|NCT00367393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102583501|NCT00367393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102583502|NCT00367393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583503|NCT00367471|Paclitaxel|paclitaxel|mesh-list
102583504|NCT00367471|Carboplatin|carboplatin|mesh-list
102583505|NCT00367471|Trastuzumab|trastuzumab|mesh-list
102583506|NCT00367471|Lapatinib|lapatinib|mesh-list
102583507|NCT00367471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102583508|NCT00367471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102583509|NCT00367471|Tubulin Modulators|tubulin modulators|mesh-ancestor
102583510|NCT00367471|Antimitotic Agents|antimitotic agents|mesh-ancestor
102583511|NCT00367471|Mitosis Modulators|mitosis modulators|mesh-ancestor
102583512|NCT00367471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583513|NCT00367471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102583514|NCT00367471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102583515|NCT00367471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102583516|NCT02207244|Adalimumab|adalimumab|mesh-list
102583517|NCT02207244|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102583518|NCT02207244|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102583519|NCT02207244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102583520|NCT02207244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102583521|NCT02207244|Immunologic Factors|immunologic factors|mesh-ancestor
102583522|NCT02207244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583523|NCT02207088|Ritonavir|ritonavir|mesh-list
102583524|NCT02207088|Ribavirin|ribavirin|mesh-list
102583525|NCT02207088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102583526|NCT02207088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102583527|NCT02207088|Protease Inhibitors|protease inhibitors|mesh-ancestor
102583528|NCT02207088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102583529|NCT02207088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583530|NCT02207088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102583531|NCT02207088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102583532|NCT02207088|Antiviral Agents|antiviral agents|mesh-ancestor
102583533|NCT02207088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102583534|NCT02207088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102583535|NCT02207088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102583536|NCT02207088|Antimetabolites|antimetabolites|mesh-ancestor
102583537|NCT02638597|Gemfibrozil|gemfibrozil|mesh-list
102583538|NCT02638597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102583539|NCT02638597|Antimetabolites|antimetabolites|mesh-ancestor
102583540|NCT02638597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583541|NCT02638597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102583542|NCT02638597|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102583543|NCT02638597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102583544|NCT02638597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102583545|NCT02206620|Donepezil|donepezil|mesh-list
102583546|NCT02206620|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102583547|NCT02206620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102583548|NCT02206620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583549|NCT02206620|Cholinergic Agents|cholinergic agents|mesh-ancestor
102583550|NCT02206620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102583551|NCT02206620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583552|NCT02206620|Nootropic Agents|nootropic agents|mesh-ancestor
102583553|NCT02239926|Ranolazine|ranolazine|mesh-list
102583554|NCT02239926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102583555|NCT02239926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102583556|NCT02239926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583557|NCT02239692|Picosulfate sodium|picosulfate sodium|mesh-list
102583558|NCT02239692|Cathartics|cathartics|mesh-ancestor
102583559|NCT02239692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102583560|NCT02641561|Indomethacin|indomethacin|mesh-list
102583561|NCT02641561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102583562|NCT02641561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102583563|NCT02641561|Analgesics|analgesics|mesh-ancestor
102583564|NCT02641561|Sensory System Agents|sensory system agents|mesh-ancestor
102583565|NCT02641561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102583566|NCT02641561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583567|NCT02641561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102583568|NCT02641561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102583569|NCT02641561|Gout Suppressants|gout suppressants|mesh-ancestor
102583570|NCT02641561|Tocolytic Agents|tocolytic agents|mesh-ancestor
102583571|NCT02641561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102583572|NCT02641561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102583573|NCT02641561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102583574|NCT02641561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583575|NCT02206152|Acetylcysteine|acetylcysteine|mesh-list
102583576|NCT02206152|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102583577|NCT02206152|Antiviral Agents|antiviral agents|mesh-ancestor
102583578|NCT02206152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102583579|NCT02206152|Expectorants|expectorants|mesh-ancestor
102583580|NCT02206152|Respiratory System Agents|respiratory system agents|mesh-ancestor
102583581|NCT02206152|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102583582|NCT02206152|Antioxidants|antioxidants|mesh-ancestor
102583583|NCT02206152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583584|NCT02206152|Protective Agents|protective agents|mesh-ancestor
102583585|NCT02206152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583586|NCT02206152|Antidotes|antidotes|mesh-ancestor
102583587|NCT00367081|Pyrimethamine|pyrimethamine|mesh-list
102583588|NCT00367081|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102583589|NCT00367081|Sulfadiazine|sulfadiazine|mesh-list
102583590|NCT00367081|Antimalarials|antimalarials|mesh-ancestor
102583591|NCT00367081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102583592|NCT00367081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102583593|NCT00367081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102583594|NCT00367081|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102583595|NCT00367081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102583596|NCT00367081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583597|NCT00367081|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102583598|NCT00367081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102583599|NCT00367081|Coccidiostats|coccidiostats|mesh-ancestor
102583600|NCT04146571|Ensartinib|ensartinib|mesh-list
102583601|NCT04146571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102583602|NCT04146571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102583603|NCT04146571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102583604|NCT04146571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583605|NCT02204982|Rituximab|rituximab|mesh-list
102583606|NCT02204982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102583607|NCT02204982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102583608|NCT02204982|Immunologic Factors|immunologic factors|mesh-ancestor
102583609|NCT02204982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583610|NCT02204982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102583611|NCT05342376|Dexmedetomidine|dexmedetomidine|mesh-list
102583612|NCT05342376|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102583613|NCT05342376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102583614|NCT05342376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583615|NCT05342376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102583616|NCT05342376|Analgesics|analgesics|mesh-ancestor
102583617|NCT05342376|Sensory System Agents|sensory system agents|mesh-ancestor
102583618|NCT05342376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102583619|NCT05342376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102583620|NCT05342376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102583621|NCT05342376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102583622|NCT05342376|Adrenergic Agents|adrenergic agents|mesh-ancestor
102583623|NCT05342376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102583624|NCT05342376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583625|NCT02237196|Immunomodulating Agents|immunomodulating agents|mesh-list
102583626|NCT02237196|Immunologic Factors|immunologic factors|mesh-list
102583627|NCT02237196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583628|NCT04776096|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
102583629|NCT04776096|Bepotastine besilate|bepotastine besilate|mesh-list
102583630|NCT04776096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102583631|NCT04776096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102583632|NCT04776096|Analgesics|analgesics|mesh-ancestor
102583633|NCT04776096|Sensory System Agents|sensory system agents|mesh-ancestor
102583634|NCT04776096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102583635|NCT04776096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583636|NCT04776096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102583637|NCT04776096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102583638|NCT04776096|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102583639|NCT04776096|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102583640|NCT04776096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102583641|NCT04776096|Histamine Antagonists|histamine antagonists|mesh-ancestor
102583642|NCT04776096|Histamine Agents|histamine agents|mesh-ancestor
102583643|NCT04776096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102583644|NCT04776096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583645|NCT03260491|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
102583646|NCT03260491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102583647|NCT03260491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102583648|NCT03250273|Nivolumab|nivolumab|mesh-list
102583649|NCT03250273|Entinostat|entinostat|mesh-list
102583650|NCT03250273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102583651|NCT03250273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102583652|NCT03250273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102583653|NCT03250273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583654|NCT03250273|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102583655|NCT03250273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102583656|NCT02203032|Ustekinumab|ustekinumab|mesh-list
102583657|NCT02203032|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102583658|NCT02203032|Dermatologic Agents|dermatologic agents|mesh-ancestor
102583659|NCT02203032|Immunologic Factors|immunologic factors|mesh-ancestor
102583660|NCT02203032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583661|NCT03587701|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102583662|NCT03587701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102583664|NCT02169414|Carbidopa|carbidopa|mesh-list
102583665|NCT02169414|Opicapone|opicapone|mesh-list
102583666|NCT02169414|Benserazide|benserazide|mesh-list
102583667|NCT02169414|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102583668|NCT02169414|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102583669|NCT02169414|Dopamine Agents|dopamine agents|mesh-ancestor
102583670|NCT02169414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102583671|NCT02169414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583672|NCT02169414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583673|NCT02169414|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102583674|NCT02169414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102583675|NCT02169414|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102583676|NCT03213457|Norethindrone|norethindrone|mesh-list
102583677|NCT03213457|Norethindrone Acetate|norethindrone acetate|mesh-list
102583678|NCT03213457|Estradiol|estradiol|mesh-list
102583679|NCT03213457|Estrogens|estrogens|mesh-ancestor
102583680|NCT03213457|Hormones|hormones|mesh-ancestor
102583681|NCT03213457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102583682|NCT03213457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583683|NCT03213457|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102583684|NCT03213457|Contraceptive Agents|contraceptive agents|mesh-ancestor
102583685|NCT03213457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102583686|NCT03213457|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102583687|NCT03213457|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102583688|NCT03213457|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102583689|NCT03213457|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102583690|NCT02201940|Sofosbuvir|sofosbuvir|mesh-list
102583691|NCT02201940|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102583692|NCT02201940|Velpatasvir|velpatasvir|mesh-list
102583693|NCT02201940|Antiviral Agents|antiviral agents|mesh-ancestor
102583694|NCT02201940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102583695|NCT05588869|Cyclosporine|cyclosporine|mesh-list
102583696|NCT05588869|Cyclosporins|cyclosporins|mesh-list
102583697|NCT05588869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102583698|NCT05588869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583699|NCT05588869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102583700|NCT05588869|Immunologic Factors|immunologic factors|mesh-ancestor
102583701|NCT05588869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583702|NCT05588869|Antifungal Agents|antifungal agents|mesh-ancestor
102583703|NCT05588869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102583704|NCT05588869|Dermatologic Agents|dermatologic agents|mesh-ancestor
102583705|NCT05588869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102583706|NCT05588869|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102583707|NCT02169336|Dexmedetomidine|dexmedetomidine|mesh-list
102583708|NCT02169336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102583709|NCT02169336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102583710|NCT02169336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583711|NCT02169336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102583712|NCT02169336|Analgesics|analgesics|mesh-ancestor
102583713|NCT02169336|Sensory System Agents|sensory system agents|mesh-ancestor
102583714|NCT02169336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102583715|NCT02169336|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102583716|NCT02169336|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102583717|NCT02169336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102583718|NCT02169336|Adrenergic Agents|adrenergic agents|mesh-ancestor
102583719|NCT02169336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102583720|NCT02169336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583721|NCT03043807|Docetaxel|docetaxel|mesh-list
102583722|NCT03043807|Leuprolide|leuprolide|mesh-list
102583723|NCT03043807|Abiraterone Acetate|abiraterone acetate|mesh-list
102583724|NCT03043807|Bicalutamide|bicalutamide|mesh-list
102583725|NCT03043807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102583726|NCT03043807|Tubulin Modulators|tubulin modulators|mesh-ancestor
102583727|NCT03043807|Antimitotic Agents|antimitotic agents|mesh-ancestor
102583728|NCT03043807|Mitosis Modulators|mitosis modulators|mesh-ancestor
102583729|NCT03043807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583730|NCT03043807|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102583731|NCT03043807|Fertility Agents|fertility agents|mesh-ancestor
102583732|NCT03043807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102583733|NCT03043807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583734|NCT03043807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102583735|NCT03043807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102583736|NCT03043807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102583737|NCT03043807|Hormone Antagonists|hormone antagonists|mesh-ancestor
101850595|NCT03979989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102583738|NCT03043807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102583739|NCT03043807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102583740|NCT03043807|Androgen Antagonists|androgen antagonists|mesh-ancestor
102583741|NCT02609828|Tanezumab|tanezumab|mesh-list
102583742|NCT02609828|Analgesics|analgesics|mesh-ancestor
102583743|NCT02609828|Sensory System Agents|sensory system agents|mesh-ancestor
102583744|NCT02609828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102583745|NCT02609828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583746|NCT05588557|Bupivacaine|bupivacaine|mesh-list
102583747|NCT05588557|Anesthetics, Local|anesthetics, local|mesh-ancestor
102583748|NCT05588557|Anesthetics|anesthetics|mesh-ancestor
102583749|NCT05588557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102583750|NCT05588557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583751|NCT05588557|Sensory System Agents|sensory system agents|mesh-ancestor
102583752|NCT05588557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102583753|NCT01632306|Leucovorin|leucovorin|mesh-list
102583754|NCT01632306|Paclitaxel|paclitaxel|mesh-list
102583755|NCT01632306|Gemcitabine|gemcitabine|mesh-list
102583756|NCT01632306|Fluorouracil|fluorouracil|mesh-list
102583757|NCT01632306|Oxaliplatin|oxaliplatin|mesh-list
102583758|NCT01632306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102583759|NCT01632306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102583760|NCT01632306|Tubulin Modulators|tubulin modulators|mesh-ancestor
102583761|NCT01632306|Antimitotic Agents|antimitotic agents|mesh-ancestor
102583762|NCT01632306|Mitosis Modulators|mitosis modulators|mesh-ancestor
102583763|NCT01632306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583764|NCT01632306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102583765|NCT01632306|Antimetabolites|antimetabolites|mesh-ancestor
102583766|NCT01632306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102583767|NCT01632306|Immunologic Factors|immunologic factors|mesh-ancestor
102583768|NCT01632306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583769|NCT01632306|Antidotes|antidotes|mesh-ancestor
102583770|NCT01632306|Protective Agents|protective agents|mesh-ancestor
102583771|NCT01632306|Vitamin B Complex|vitamin b complex|mesh-ancestor
102583772|NCT01632306|Vitamins|vitamins|mesh-ancestor
102583773|NCT01632306|Micronutrients|micronutrients|mesh-ancestor
102583774|NCT02201784|Ropivacaine|ropivacaine|mesh-list
102583775|NCT02201784|Levobupivacaine|levobupivacaine|mesh-list
102583776|NCT02201784|Anesthetics, Local|anesthetics, local|mesh-ancestor
102583777|NCT02201784|Anesthetics|anesthetics|mesh-ancestor
102583778|NCT02201784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102583779|NCT02201784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583780|NCT02201784|Sensory System Agents|sensory system agents|mesh-ancestor
102583781|NCT02201784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102583782|NCT05587933|Parasympatholytics|parasympatholytics|mesh-list
102583783|NCT05587933|Autonomic Agents|autonomic agents|mesh-ancestor
102583784|NCT05587933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102583785|NCT05587933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583786|NCT02018263|Cocaine|cocaine|mesh-list
102583787|NCT02018263|Nicotine|nicotine|mesh-list
102583788|NCT02018263|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102583789|NCT02018263|Autonomic Agents|autonomic agents|mesh-ancestor
102583790|NCT02018263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102583791|NCT02018263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583792|NCT02018263|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102583793|NCT02018263|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102583794|NCT02018263|Cholinergic Agents|cholinergic agents|mesh-ancestor
102583795|NCT02018263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102583796|NCT02018263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583797|NCT02018263|Anesthetics, Local|anesthetics, local|mesh-ancestor
102583798|NCT02018263|Anesthetics|anesthetics|mesh-ancestor
102583799|NCT02018263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102583800|NCT02018263|Sensory System Agents|sensory system agents|mesh-ancestor
102583801|NCT02018263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102583802|NCT02018263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102583803|NCT02018263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102583804|NCT02018263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102583805|NCT02018263|Dopamine Agents|dopamine agents|mesh-ancestor
102583806|NCT02168946|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102583807|NCT02168946|Meropenem|meropenem|mesh-list
102583808|NCT02168946|Vaborbactam|vaborbactam|mesh-list
102583809|NCT02168946|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102344230|NCT03699631|Antimetabolites|antimetabolites|mesh-ancestor
102583810|NCT02168946|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
102583812|NCT02168946|Antitubercular Agents|antitubercular agents|mesh-ancestor
102583813|NCT02168946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102583814|NCT02168946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583815|NCT02650856|Tranexamic Acid|tranexamic acid|mesh-list
102583816|NCT02650856|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102583817|NCT02650856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102583818|NCT02650856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583819|NCT02650856|Hemostatics|hemostatics|mesh-ancestor
102583820|NCT02650856|Coagulants|coagulants|mesh-ancestor
102583821|NCT02168478|Neomycin|neomycin|mesh-list
102583822|NCT02168478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102583823|NCT02168478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102583824|NCT02168478|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102583825|NCT02168478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102583826|NCT02168478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583827|NCT00367874|Buprenorphine|buprenorphine|mesh-list
102583828|NCT00367874|Valproic Acid|valproic acid|mesh-list
102583829|NCT00367874|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102583830|NCT00367874|Narcotics|narcotics|mesh-ancestor
102583831|NCT00367874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102583832|NCT00367874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583833|NCT00367874|Analgesics|analgesics|mesh-ancestor
102583834|NCT00367874|Sensory System Agents|sensory system agents|mesh-ancestor
102583835|NCT00367874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102583836|NCT00367874|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102583837|NCT00367874|Anticonvulsants|anticonvulsants|mesh-ancestor
102583838|NCT00367874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102583839|NCT00367874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583840|NCT00367874|GABA Agents|gaba agents|mesh-ancestor
102583841|NCT00367874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102583842|NCT00367874|Antimanic Agents|antimanic agents|mesh-ancestor
102583843|NCT00367874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102583844|NCT00367874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102583845|NCT00367562|Valsartan|valsartan|mesh-list
102583846|NCT00367562|Enalapril|enalapril|mesh-list
102583847|NCT00367562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102583848|NCT00367562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102583849|NCT00367562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102583850|NCT00367562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583851|NCT00367562|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102583852|NCT00367562|Protease Inhibitors|protease inhibitors|mesh-ancestor
102583853|NCT00367562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102583854|NCT02302976|Exenatide|exenatide|mesh-list
102583855|NCT02302976|Cocaine|cocaine|mesh-list
102583856|NCT02302976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102583857|NCT02302976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583858|NCT02302976|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102583859|NCT02302976|Incretins|incretins|mesh-ancestor
102583860|NCT02302976|Hormones|hormones|mesh-ancestor
102583861|NCT02302976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102583862|NCT02302976|Anesthetics, Local|anesthetics, local|mesh-ancestor
102583863|NCT02302976|Anesthetics|anesthetics|mesh-ancestor
102583864|NCT02302976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102583865|NCT02302976|Sensory System Agents|sensory system agents|mesh-ancestor
102583866|NCT02302976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102583867|NCT02302976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102583868|NCT02302976|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102583869|NCT02302976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102583870|NCT02302976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102583871|NCT02302976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583872|NCT02302976|Dopamine Agents|dopamine agents|mesh-ancestor
102583873|NCT02302976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102583874|NCT05073692|Liraglutide|liraglutide|mesh-list
102583875|NCT05073692|Empagliflozin|empagliflozin|mesh-list
102583876|NCT05073692|Exenatide|exenatide|mesh-list
102583877|NCT05073692|Glimepiride|glimepiride|mesh-list
102583878|NCT05073692|Linagliptin|linagliptin|mesh-list
102583879|NCT05073692|Saxagliptin|saxagliptin|mesh-list
102583880|NCT05073692|Alogliptin|alogliptin|mesh-list
102583881|NCT05073692|Glipizide|glipizide|mesh-list
102583882|NCT05073692|Glucagon|glucagon|mesh-list
102583883|NCT05073692|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102583884|NCT05073692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102583885|NCT05073692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583886|NCT05073692|Incretins|incretins|mesh-ancestor
102583887|NCT05073692|Hormones|hormones|mesh-ancestor
102583888|NCT05073692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102583889|NCT05073692|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102583890|NCT05073692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583891|NCT05073692|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102583892|NCT05073692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102583893|NCT05073692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102583894|NCT05073692|Immunologic Factors|immunologic factors|mesh-ancestor
102583895|NCT05073692|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102583896|NCT05073692|Protease Inhibitors|protease inhibitors|mesh-ancestor
102583897|NCT05073692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102583898|NCT05073692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102583899|NCT02244164|Liraglutide|liraglutide|mesh-list
102583900|NCT02244164|Exenatide|exenatide|mesh-list
102583901|NCT02244164|Lixisenatide|lixisenatide|mesh-list
102583902|NCT02244164|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
102583903|NCT02244164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102583904|NCT02244164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583905|NCT02244164|Incretins|incretins|mesh-ancestor
102583906|NCT02244164|Hormones|hormones|mesh-ancestor
102583907|NCT02244164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102583908|NCT02244164|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102583909|NCT02244164|Protease Inhibitors|protease inhibitors|mesh-ancestor
102583910|NCT02244164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102583911|NCT02244164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583912|NCT02152670|Raclopride|raclopride|mesh-list
102583913|NCT02152670|Methylphenidate|methylphenidate|mesh-list
102583914|NCT02152670|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
102583915|NCT02152670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102583916|NCT02152670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583917|NCT02152670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102583918|NCT02152670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102583919|NCT02152670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102583920|NCT02152670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583921|NCT02152670|Dopamine Agents|dopamine agents|mesh-ancestor
102583922|NCT02152670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102583923|NCT02152670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102583924|NCT02152670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102583925|NCT02152670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102583926|NCT02152670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102583927|NCT02152670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102583928|NCT02152670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102583929|NCT02028806|Leucovorin|leucovorin|mesh-list
102583930|NCT02028806|Oxaliplatin|oxaliplatin|mesh-list
102583931|NCT02028806|Irinotecan|irinotecan|mesh-list
102583932|NCT02028806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102583933|NCT02028806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102583934|NCT02028806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102583935|NCT02028806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102583936|NCT02028806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583937|NCT02028806|Antidotes|antidotes|mesh-ancestor
102583938|NCT02028806|Protective Agents|protective agents|mesh-ancestor
102583939|NCT02028806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583940|NCT02028806|Vitamin B Complex|vitamin b complex|mesh-ancestor
102583941|NCT02028806|Vitamins|vitamins|mesh-ancestor
102583942|NCT02028806|Micronutrients|micronutrients|mesh-ancestor
102583943|NCT01756118|Dactolisib|dactolisib|mesh-list
102583944|NCT01756118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102583945|NCT04339712|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102583946|NCT04339712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102583947|NCT02656160|4-Aminopyridine|4-aminopyridine|mesh-list
102583948|NCT02656160|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102583949|NCT02656160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102583950|NCT02656160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583951|NCT02657252|Polidocanol|polidocanol|mesh-list
102583952|NCT02657252|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102583953|NCT02657252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102583954|NCT04740086|Calcium|calcium|mesh-list
102583955|NCT04740086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102583956|NCT04740086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583957|NCT04739618|Pembrolizumab|pembrolizumab|mesh-list
102583958|NCT04739618|Ipilimumab|ipilimumab|mesh-list
102583959|NCT04739618|Sargramostim|sargramostim|mesh-list
102583960|NCT04739618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102583961|NCT04739618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130833|NCT02449070|Vitamins|vitamins|mesh-ancestor
102583962|NCT04739618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102583963|NCT04739618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583965|NCT04739618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583966|NCT02684942|Fentanyl|fentanyl|mesh-list
102583967|NCT02684942|Meperidine|meperidine|mesh-list
102583968|NCT02684942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102583969|NCT02684942|Narcotics|narcotics|mesh-ancestor
102583970|NCT02684942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102583971|NCT02684942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583972|NCT02684942|Analgesics|analgesics|mesh-ancestor
102583973|NCT02684942|Sensory System Agents|sensory system agents|mesh-ancestor
102583974|NCT02684942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102583975|NCT02684942|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102583976|NCT02684942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102583977|NCT02684942|Anesthetics, General|anesthetics, general|mesh-ancestor
102583978|NCT02684942|Anesthetics|anesthetics|mesh-ancestor
102583979|NCT04739774|Itraconazole|itraconazole|mesh-list
102583980|NCT04739774|Antifungal Agents|antifungal agents|mesh-ancestor
102583981|NCT04739774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102583982|NCT04739774|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102583983|NCT04739774|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102583984|NCT04739774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102583985|NCT04739774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102583986|NCT04739774|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102583987|NCT04739774|Hormone Antagonists|hormone antagonists|mesh-ancestor
102583988|NCT04739774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102583989|NCT04739774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583990|NCT04739774|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102583991|NCT02660918|Bupivacaine|bupivacaine|mesh-list
102583992|NCT02660918|Anesthetics, Local|anesthetics, local|mesh-ancestor
102583993|NCT02660918|Anesthetics|anesthetics|mesh-ancestor
102583994|NCT02660918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102583995|NCT02660918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102583996|NCT02660918|Sensory System Agents|sensory system agents|mesh-ancestor
102583997|NCT02660918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102583998|NCT00367315|Lumiracoxib|lumiracoxib|mesh-list
102583999|NCT00367315|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102584000|NCT00367315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102584001|NCT00367315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102584002|NCT00367315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584003|NCT00367315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102584004|NCT00367315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102584005|NCT00367315|Analgesics|analgesics|mesh-ancestor
102584006|NCT00367315|Sensory System Agents|sensory system agents|mesh-ancestor
102584007|NCT00367315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102584008|NCT00367315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584009|NCT00367315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102584010|NCT00367315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102584011|NCT01192555|Cyclophosphamide|cyclophosphamide|mesh-list
102584012|NCT01192555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102584013|NCT01192555|Immunologic Factors|immunologic factors|mesh-ancestor
102584014|NCT01192555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584015|NCT01192555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102584016|NCT01192555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102584017|NCT01192555|Alkylating Agents|alkylating agents|mesh-ancestor
102584018|NCT01192555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584019|NCT01192555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102584020|NCT01192555|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102584021|NCT05441761|Dexamethasone|dexamethasone|mesh-list
102584022|NCT05441761|Gemcitabine|gemcitabine|mesh-list
102584023|NCT05441761|Mitoxantrone|mitoxantrone|mesh-list
102584024|NCT05441761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102584025|NCT05441761|Antiemetics|antiemetics|mesh-ancestor
102584026|NCT05441761|Autonomic Agents|autonomic agents|mesh-ancestor
102584027|NCT05441761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102584028|NCT05441761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584029|NCT05441761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102584030|NCT05441761|Glucocorticoids|glucocorticoids|mesh-ancestor
102584031|NCT05441761|Hormones|hormones|mesh-ancestor
102584032|NCT05441761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102584033|NCT05441761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102130908|NCT03528915|Rifamycin SV|rifamycin sv|mesh-list
102584034|NCT05441761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102584035|NCT05441761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102584036|NCT05441761|Antimetabolites|antimetabolites|mesh-ancestor
102584037|NCT05441761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584038|NCT05441761|Analgesics|analgesics|mesh-ancestor
102584039|NCT05441761|Sensory System Agents|sensory system agents|mesh-ancestor
102584040|NCT05441761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102584041|NCT05441761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102584042|NCT05441761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102584043|NCT05587621|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
102584044|NCT05587621|Ezetimibe|ezetimibe|mesh-list
102584045|NCT05587621|Evolocumab|evolocumab|mesh-list
102584046|NCT05587621|Alirocumab|alirocumab|mesh-list
102584047|NCT05587621|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102584048|NCT05587621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102584049|NCT05587621|Antimetabolites|antimetabolites|mesh-ancestor
102584050|NCT05587621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584051|NCT05587621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102584052|NCT05587621|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102584053|NCT05587621|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102584054|NCT05587621|Protease Inhibitors|protease inhibitors|mesh-ancestor
102584055|NCT05587621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102584056|NCT05587621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102584057|NCT05587621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584058|NCT04739215|Dapagliflozin|dapagliflozin|mesh-list
102584059|NCT04739215|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102584060|NCT04739215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584061|NCT04739215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102584062|NCT04739215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584063|NCT02688829|Sirolimus|sirolimus|mesh-list
102584064|NCT02688829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102584065|NCT02688829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102584066|NCT02688829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102584067|NCT02688829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102584068|NCT02688829|Antifungal Agents|antifungal agents|mesh-ancestor
102584069|NCT02688829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102584070|NCT02688829|Immunologic Factors|immunologic factors|mesh-ancestor
102584071|NCT02688829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584072|NCT02688842|Sirolimus|sirolimus|mesh-list
102584073|NCT02688842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102584074|NCT02688842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102584075|NCT02688842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102584076|NCT02688842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102584077|NCT02688842|Antifungal Agents|antifungal agents|mesh-ancestor
102584078|NCT02688842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102584079|NCT02688842|Immunologic Factors|immunologic factors|mesh-ancestor
102584080|NCT02688842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584081|NCT02689063|Acetaminophen|acetaminophen|mesh-list
102584082|NCT02689063|Ibuprofen|ibuprofen|mesh-list
102584083|NCT02689063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102584084|NCT02689063|Analgesics|analgesics|mesh-ancestor
102584085|NCT02689063|Sensory System Agents|sensory system agents|mesh-ancestor
102584086|NCT02689063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102584087|NCT02689063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584088|NCT02689063|Antipyretics|antipyretics|mesh-ancestor
102584089|NCT02689063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102584090|NCT02689063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102584091|NCT02689063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102584092|NCT02689063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102584093|NCT02689063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102344246|NCT03686150|Micronutrients|micronutrients|mesh-ancestor
102584094|NCT02689063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584095|NCT02690935|Immunomodulating Agents|immunomodulating agents|mesh-list
102584096|NCT02690935|Immunologic Factors|immunologic factors|mesh-ancestor
102584097|NCT02690935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584098|NCT00367861|Imatinib Mesylate|imatinib mesylate|mesh-list
102584099|NCT00367861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102584100|NCT00367861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102584101|NCT00367861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102584102|NCT00367861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584103|NCT02666846|Ibuprofen|ibuprofen|mesh-list
102584104|NCT02666846|Diclofenac|diclofenac|mesh-list
102584105|NCT02666846|Salicylates|salicylates|mesh-list
102584106|NCT02666846|Methyl salicylate|methyl salicylate|mesh-list
102584107|NCT02666846|Menthol|menthol|mesh-list
102584108|NCT02666846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102584109|NCT02666846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102584110|NCT02666846|Analgesics|analgesics|mesh-ancestor
102584111|NCT02666846|Sensory System Agents|sensory system agents|mesh-ancestor
102584112|NCT02666846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102584113|NCT02666846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584114|NCT02666846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102584115|NCT02666846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102584116|NCT02666846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102584117|NCT02666846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102584118|NCT02666846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584119|NCT02666846|Antipruritics|antipruritics|mesh-ancestor
102584120|NCT02666846|Dermatologic Agents|dermatologic agents|mesh-ancestor
102584121|NCT02643979|Ketamine|ketamine|mesh-list
102584122|NCT02643979|Propofol|propofol|mesh-list
102584123|NCT02643979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102584124|NCT02643979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102584125|NCT02643979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584126|NCT02643979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102584127|NCT02643979|Anesthetics, General|anesthetics, general|mesh-ancestor
102584128|NCT02643979|Anesthetics|anesthetics|mesh-ancestor
102584129|NCT02643979|Analgesics|analgesics|mesh-ancestor
102584130|NCT02643979|Sensory System Agents|sensory system agents|mesh-ancestor
102584131|NCT02643979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102584132|NCT02643979|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102584133|NCT02643979|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102584134|NCT02643979|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102584135|NCT02643979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102584136|NCT02643979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584137|NCT05587231|Fluorometholone|fluorometholone|mesh-list
102584138|NCT05587231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102584139|NCT05587231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584140|NCT05587231|Glucocorticoids|glucocorticoids|mesh-ancestor
102584141|NCT05587231|Hormones|hormones|mesh-ancestor
102584142|NCT05587231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102584143|NCT05587231|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102584144|NCT02667704|Nintedanib|nintedanib|mesh-list
102584145|NCT02667704|Bosentan|bosentan|mesh-list
102584146|NCT02667704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102584147|NCT02667704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102584148|NCT02667704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102584149|NCT02667704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584150|NCT02667704|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102584151|NCT02667704|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102584152|NCT02645617|Imidacloprid|imidacloprid|mesh-list
102584153|NCT02645617|Cholinergic Agents|cholinergic agents|mesh-ancestor
102584154|NCT02645617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102584155|NCT02645617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584156|NCT02645617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584157|NCT02694601|Caffeine|caffeine|mesh-list
102584158|NCT02694601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102584159|NCT02694601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584160|NCT02694601|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102584161|NCT02694601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102584162|NCT02694601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584163|NCT02694601|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102344250|NCT03678233|Testosterone|testosterone|mesh-list
102584164|NCT02694601|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102584165|NCT02694601|Purinergic Agents|purinergic agents|mesh-ancestor
102584166|NCT02694601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102584167|NCT02690948|Pembrolizumab|pembrolizumab|mesh-list
102584168|NCT02690948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102584169|NCT02690948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102584170|NCT02690948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102584171|NCT02690948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584172|NCT02698735|Gentamicins|gentamicins|mesh-list
102584173|NCT02698735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102584174|NCT02698735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102584175|NCT02698735|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102584176|NCT02698735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102584177|NCT02698735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584178|NCT02691416|Propofol|propofol|mesh-list
102584179|NCT02691416|Sevoflurane|sevoflurane|mesh-list
102584180|NCT02691416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102584181|NCT02691416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102584182|NCT02691416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584183|NCT02691416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102584184|NCT02691416|Anesthetics, General|anesthetics, general|mesh-ancestor
102584185|NCT02691416|Anesthetics|anesthetics|mesh-ancestor
102584186|NCT02691416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102584187|NCT02691416|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102584188|NCT02650999|Pembrolizumab|pembrolizumab|mesh-list
102584189|NCT02650999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102584190|NCT02650999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102584191|NCT02650999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102584192|NCT02650999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584193|NCT05502211|Lidocaine|lidocaine|mesh-list
102584194|NCT05502211|Fentanyl|fentanyl|mesh-list
102584195|NCT05502211|Anesthetics, Local|anesthetics, local|mesh-ancestor
102584196|NCT05502211|Anesthetics|anesthetics|mesh-ancestor
102584197|NCT05502211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102584198|NCT05502211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584199|NCT05502211|Sensory System Agents|sensory system agents|mesh-ancestor
102584200|NCT05502211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102584201|NCT05502211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102584202|NCT05502211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102584203|NCT05502211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102584204|NCT05502211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102584205|NCT05502211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584206|NCT05502211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102584207|NCT05502211|Narcotics|narcotics|mesh-ancestor
102584208|NCT05502211|Analgesics|analgesics|mesh-ancestor
102584209|NCT05502211|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102584210|NCT05502211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102584211|NCT05502211|Anesthetics, General|anesthetics, general|mesh-ancestor
102584212|NCT02674412|Buspirone|buspirone|mesh-list
102584213|NCT02674412|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102584214|NCT02674412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102584215|NCT02674412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102584216|NCT02674412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584217|NCT02674412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102584218|NCT02674412|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102584219|NCT02674412|Serotonin Agents|serotonin agents|mesh-ancestor
102584220|NCT02674412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102584221|NCT02674412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584222|NCT04708106|Menthol|menthol|mesh-list
102584223|NCT04708106|Antipruritics|antipruritics|mesh-ancestor
102584224|NCT04708106|Dermatologic Agents|dermatologic agents|mesh-ancestor
102584225|NCT02697188|Methyltestosterone|methyltestosterone|mesh-list
102584226|NCT02697188|Testosterone|testosterone|mesh-list
102584227|NCT02697188|Testosterone undecanoate|testosterone undecanoate|mesh-list
102584228|NCT02697188|Testosterone enanthate|testosterone enanthate|mesh-list
102584229|NCT02697188|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102584230|NCT02697188|Androgens|androgens|mesh-ancestor
102584231|NCT02697188|Hormones|hormones|mesh-ancestor
102584232|NCT02697188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102584233|NCT02697188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584234|NCT02697188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102584235|NCT02697188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102584236|NCT02697188|Anabolic Agents|anabolic agents|mesh-ancestor
102584237|NCT04707560|Heparin|heparin|mesh-list
102584238|NCT04707560|Anticoagulants|anticoagulants|mesh-ancestor
102584239|NCT04707560|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102584240|NCT04707560|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102584241|NCT04707560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584242|NCT02653183|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102584243|NCT02653183|Laxatives|laxatives|mesh-ancestor
102584244|NCT02653183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102584245|NCT02701400|Durvalumab|durvalumab|mesh-list
102584246|NCT02701400|Ipilimumab|ipilimumab|mesh-list
102584247|NCT02701400|Tremelimumab|tremelimumab|mesh-list
102584248|NCT02701400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102584249|NCT02701400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102584250|NCT02701400|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102584251|NCT02701400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584252|NCT05403710|Botulinum Toxins|botulinum toxins|mesh-list
102584253|NCT05403710|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102584254|NCT05403710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102584255|NCT05403710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584256|NCT05403710|Cholinergic Agents|cholinergic agents|mesh-ancestor
102584257|NCT05403710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102584258|NCT05403710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584259|NCT02703350|Insulin Lispro|insulin lispro|mesh-list
102584260|NCT02703350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102584261|NCT02703350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584262|NCT05470465|Oxycodone|oxycodone|mesh-list
102584263|NCT05470465|Paroxetine|paroxetine|mesh-list
102584264|NCT05470465|Escitalopram|escitalopram|mesh-list
102584265|NCT05470465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102584266|NCT05470465|Narcotics|narcotics|mesh-ancestor
102584267|NCT05470465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102584268|NCT05470465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584269|NCT05470465|Analgesics|analgesics|mesh-ancestor
102584270|NCT05470465|Sensory System Agents|sensory system agents|mesh-ancestor
102584271|NCT05470465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102584272|NCT05470465|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102584273|NCT05470465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102584274|NCT05470465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102584275|NCT05470465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584276|NCT05470465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102584277|NCT05470465|Serotonin Agents|serotonin agents|mesh-ancestor
102584278|NCT05470465|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102584279|NCT05470465|Antidepressive Agents|antidepressive agents|mesh-ancestor
102584280|NCT05470465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102584281|NCT05470465|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102584282|NCT05470465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102584283|NCT05470465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102584284|NCT00368030|Eszopiclone|eszopiclone|mesh-list
102584285|NCT00368030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102584286|NCT00368030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102584287|NCT00368030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584288|NCT02656069|Glucagon|glucagon|mesh-list
102584289|NCT02656069|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102584290|NCT02656069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102584291|NCT02656069|Hormones|hormones|mesh-ancestor
102584292|NCT02656069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102584293|NCT02656069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584294|NCT02656069|Incretins|incretins|mesh-ancestor
102584295|NCT05351762|Paclitaxel|paclitaxel|mesh-list
102584296|NCT05351762|Nimotuzumab|nimotuzumab|mesh-list
102584297|NCT05351762|Nedaplatin|nedaplatin|mesh-list
102584298|NCT05351762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102584299|NCT05351762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102584300|NCT05351762|Tubulin Modulators|tubulin modulators|mesh-ancestor
102584301|NCT05351762|Antimitotic Agents|antimitotic agents|mesh-ancestor
102584302|NCT05351762|Mitosis Modulators|mitosis modulators|mesh-ancestor
102584303|NCT05351762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584304|NCT05351762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102584305|NCT02708641|Pembrolizumab|pembrolizumab|mesh-list
102344257|NCT03629327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102584306|NCT02708641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102584307|NCT02708641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102584308|NCT02708641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102584309|NCT02708641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584310|NCT02710981|Sildenafil Citrate|sildenafil citrate|mesh-list
102584311|NCT02710981|Clomiphene|clomiphene|mesh-list
102584312|NCT02710981|Enclomiphene|enclomiphene|mesh-list
102584313|NCT02710981|Zuclomiphene|zuclomiphene|mesh-list
102584314|NCT02710981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584315|NCT02710981|Vasodilator Agents|vasodilator agents|mesh-ancestor
102584316|NCT02710981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102584317|NCT02710981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102584318|NCT02710981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102584319|NCT02710981|Urological Agents|urological agents|mesh-ancestor
102584320|NCT02710981|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102584321|NCT02710981|Hormone Antagonists|hormone antagonists|mesh-ancestor
102584322|NCT02710981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102584323|NCT02710981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584324|NCT02710981|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102584325|NCT02710981|Fertility Agents|fertility agents|mesh-ancestor
102584326|NCT02710981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102584327|NCT02710981|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102584328|NCT02710981|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102584329|NCT04193228|Carbon Fiber|carbon fiber|mesh-list
102584330|NCT04193228|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102131217|NCT02443142|Ibuprofen|ibuprofen|mesh-list
102584332|NCT04738838|Oxytocin|oxytocin|mesh-list
102584333|NCT04738838|Oxytocics|oxytocics|mesh-ancestor
102584334|NCT04738838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102584335|NCT04738838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584336|NCT04739917|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
102584337|NCT04739917|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102584338|NCT04739917|Immunologic Factors|immunologic factors|mesh-ancestor
102584339|NCT04739917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584340|NCT02659501|Acetaminophen|acetaminophen|mesh-list
102584341|NCT02659501|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
102584342|NCT02659501|Epinephrine|epinephrine|mesh-list
102584343|NCT02659501|Diazepam|diazepam|mesh-list
102584344|NCT02659501|Morphine|morphine|mesh-list
102584345|NCT02659501|Hydrocodone|hydrocodone|mesh-list
102584346|NCT02659501|Bupivacaine|bupivacaine|mesh-list
102584347|NCT02659501|Anesthetics, Local|anesthetics, local|mesh-ancestor
102584348|NCT02659501|Anesthetics|anesthetics|mesh-ancestor
102584349|NCT02659501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102584350|NCT02659501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584351|NCT02659501|Sensory System Agents|sensory system agents|mesh-ancestor
102584352|NCT02659501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102584353|NCT02659501|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102584354|NCT02659501|Narcotics|narcotics|mesh-ancestor
102584355|NCT02659501|Analgesics|analgesics|mesh-ancestor
102584356|NCT02659501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102584357|NCT02659501|Antipyretics|antipyretics|mesh-ancestor
102584358|NCT02659501|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102584359|NCT02659501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102584360|NCT02659501|Adrenergic Agents|adrenergic agents|mesh-ancestor
102584361|NCT02659501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102584362|NCT02659501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584363|NCT02659501|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102584364|NCT02659501|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102584365|NCT02659501|Autonomic Agents|autonomic agents|mesh-ancestor
102584366|NCT02659501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102584367|NCT02659501|Respiratory System Agents|respiratory system agents|mesh-ancestor
102584368|NCT02659501|Mydriatics|mydriatics|mesh-ancestor
102584369|NCT02659501|Sympathomimetics|sympathomimetics|mesh-ancestor
102584370|NCT02659501|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102584371|NCT02659501|Antitussive Agents|antitussive agents|mesh-ancestor
102584372|NCT02659501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102584373|NCT02659501|Anticonvulsants|anticonvulsants|mesh-ancestor
102584374|NCT02659501|Antiemetics|antiemetics|mesh-ancestor
102584375|NCT02659501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102584376|NCT02659501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102584377|NCT02659501|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102584378|NCT02659501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102584379|NCT02659501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102344258|NCT03629327|Analgesics|analgesics|mesh-ancestor
102584380|NCT02659501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102584381|NCT02659501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102584382|NCT02659501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102584383|NCT02659501|Anesthetics, General|anesthetics, general|mesh-ancestor
102584384|NCT02659501|GABA Modulators|gaba modulators|mesh-ancestor
102584385|NCT02659501|GABA Agents|gaba agents|mesh-ancestor
102584386|NCT02659501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102584387|NCT02659501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102584388|NCT02659501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102584389|NCT00367939|Amlodipine|amlodipine|mesh-list
102584390|NCT00367939|Valsartan|valsartan|mesh-list
102584391|NCT00367939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102584392|NCT00367939|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102584393|NCT00367939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102584394|NCT00367939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584395|NCT00367939|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102584396|NCT00367939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584397|NCT00367939|Vasodilator Agents|vasodilator agents|mesh-ancestor
102584398|NCT00367939|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102584399|NCT00367939|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102584400|NCT02720107|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102584401|NCT02720107|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102584402|NCT02720107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584403|NCT02720107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102584404|NCT02720107|Immunologic Factors|immunologic factors|mesh-ancestor
102584405|NCT02720107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584406|NCT02722837|Sofosbuvir|sofosbuvir|mesh-list
102584407|NCT02722837|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102584408|NCT02722837|Velpatasvir|velpatasvir|mesh-list
102584409|NCT02722837|Antiviral Agents|antiviral agents|mesh-ancestor
102584410|NCT02722837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102584411|NCT02710526|Buprenorphine|buprenorphine|mesh-list
102584412|NCT02710526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102584413|NCT02710526|Narcotics|narcotics|mesh-ancestor
102584414|NCT02710526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102584415|NCT02710526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584416|NCT02710526|Analgesics|analgesics|mesh-ancestor
102584417|NCT02710526|Sensory System Agents|sensory system agents|mesh-ancestor
102584418|NCT02710526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102584419|NCT02710526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102584420|NCT02664961|Bevacizumab|bevacizumab|mesh-list
102584421|NCT02664961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102584422|NCT02664961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102584423|NCT02664961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102584424|NCT02664961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102584425|NCT02664961|Growth Substances|growth substances|mesh-ancestor
102584426|NCT02664961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584427|NCT02664961|Growth Inhibitors|growth inhibitors|mesh-ancestor
102584428|NCT02665273|Bupivacaine|bupivacaine|mesh-list
102584429|NCT02665273|Anesthetics, Local|anesthetics, local|mesh-ancestor
102584430|NCT02665273|Anesthetics|anesthetics|mesh-ancestor
102584431|NCT02665273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102584432|NCT02665273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584433|NCT02665273|Sensory System Agents|sensory system agents|mesh-ancestor
102584434|NCT02665273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102584435|NCT02713178|Bupivacaine|bupivacaine|mesh-list
102584436|NCT02713178|Anesthetics, Local|anesthetics, local|mesh-ancestor
102584437|NCT02713178|Anesthetics|anesthetics|mesh-ancestor
102584438|NCT02713178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102584439|NCT02713178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584440|NCT02713178|Sensory System Agents|sensory system agents|mesh-ancestor
102584441|NCT02713178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102584442|NCT04130438|Nebivolol|nebivolol|mesh-list
102584443|NCT04130438|Diltiazem|diltiazem|mesh-list
102584444|NCT04130438|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102584445|NCT04130438|Vasodilator Agents|vasodilator agents|mesh-ancestor
102584446|NCT04130438|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102584447|NCT04130438|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102584448|NCT04130438|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102584449|NCT04130438|Adrenergic Agents|adrenergic agents|mesh-ancestor
102584450|NCT04130438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102584451|NCT04130438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584452|NCT04130438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584453|NCT04130438|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102584454|NCT04130438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102584455|NCT04130438|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102584456|NCT04048850|Grazoprevir|grazoprevir|mesh-list
102584457|NCT04048850|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
102584458|NCT04048850|Antiviral Agents|antiviral agents|mesh-ancestor
102584459|NCT04048850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102584460|NCT05261672|Midazolam|midazolam|mesh-list
102584461|NCT05261672|Bupivacaine|bupivacaine|mesh-list
102584462|NCT05261672|Anesthetics, Local|anesthetics, local|mesh-ancestor
102584463|NCT05261672|Anesthetics|anesthetics|mesh-ancestor
102584464|NCT05261672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102584465|NCT05261672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584466|NCT05261672|Sensory System Agents|sensory system agents|mesh-ancestor
102584467|NCT05261672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102584468|NCT05261672|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102584469|NCT05261672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102584470|NCT05261672|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102584471|NCT05261672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102584472|NCT05261672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102584473|NCT05261672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102584474|NCT05261672|Anesthetics, General|anesthetics, general|mesh-ancestor
102584475|NCT05261672|GABA Modulators|gaba modulators|mesh-ancestor
102584476|NCT05261672|GABA Agents|gaba agents|mesh-ancestor
102584477|NCT05261672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102584478|NCT05261672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584479|NCT02714504|Voriconazole|voriconazole|mesh-list
102584480|NCT02714504|Posaconazole|posaconazole|mesh-list
102584481|NCT02714504|Antifungal Agents|antifungal agents|mesh-ancestor
102584482|NCT02714504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102584483|NCT02714504|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102584484|NCT02714504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102584485|NCT02714504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102584486|NCT02714504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584487|NCT02714504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102584488|NCT02714504|Hormone Antagonists|hormone antagonists|mesh-ancestor
102584489|NCT02714504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102584490|NCT02714504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584491|NCT02714504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102584492|NCT02714504|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102584493|NCT02714504|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102584494|NCT02714504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102584495|NCT05221502|Bedaquiline|bedaquiline|mesh-list
102584496|NCT05221502|Diarylquinolines|diarylquinolines|mesh-list
102584497|NCT05221502|Antitubercular Agents|antitubercular agents|mesh-ancestor
102584498|NCT05221502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102584499|NCT05221502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102584500|NCT00368576|Darapladib|darapladib|mesh-list
102584501|NCT00368576|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
102584502|NCT00368576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102584503|NCT00368576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584504|NCT02730247|Paclitaxel|paclitaxel|mesh-list
102584505|NCT02730247|Ramucirumab|ramucirumab|mesh-list
102584506|NCT02730247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102584507|NCT02730247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102584508|NCT02730247|Tubulin Modulators|tubulin modulators|mesh-ancestor
102584509|NCT02730247|Antimitotic Agents|antimitotic agents|mesh-ancestor
102584510|NCT02730247|Mitosis Modulators|mitosis modulators|mesh-ancestor
102584511|NCT02730247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584512|NCT03889106|Ribavirin|ribavirin|mesh-list
102584513|NCT03889106|Antimetabolites|antimetabolites|mesh-ancestor
102584514|NCT03889106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584515|NCT03889106|Antiviral Agents|antiviral agents|mesh-ancestor
102584516|NCT03889106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102584517|NCT00368329|Carboplatin|carboplatin|mesh-list
102584518|NCT00368329|Fluorouracil|fluorouracil|mesh-list
102584519|NCT00368329|Capecitabine|capecitabine|mesh-list
102584520|NCT00368329|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102584521|NCT00368329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102584522|NCT00368329|Antimetabolites|antimetabolites|mesh-ancestor
102584523|NCT00368329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584524|NCT00368329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102584525|NCT00368329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102584526|NCT00368329|Immunologic Factors|immunologic factors|mesh-ancestor
102584527|NCT00368329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584528|NCT00368329|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102584529|NCT02670343|Methyltestosterone|methyltestosterone|mesh-list
102584530|NCT02670343|Testosterone|testosterone|mesh-list
102584531|NCT02670343|Testosterone undecanoate|testosterone undecanoate|mesh-list
102584532|NCT02670343|Testosterone enanthate|testosterone enanthate|mesh-list
102584533|NCT02670343|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102584534|NCT02670343|Androgens|androgens|mesh-ancestor
102584535|NCT02670343|Hormones|hormones|mesh-ancestor
102584536|NCT02670343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102584537|NCT02670343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584538|NCT02670343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102584539|NCT02670343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102584540|NCT02670343|Anabolic Agents|anabolic agents|mesh-ancestor
102584541|NCT03697850|Atezolizumab|atezolizumab|mesh-list
102584542|NCT03697850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102584543|NCT03697850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584544|NCT03697850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102584545|NCT03697850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102584546|NCT02730884|ON 01910|on 01910|mesh-list
102584547|NCT02730884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102584548|NCT02730884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102584549|NCT02730884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102584550|NCT02730884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584551|NCT02732587|Saracatinib|saracatinib|mesh-list
102584552|NCT02732587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102584553|NCT02732587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102584554|NCT02732587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584555|NCT02731820|Vitamin D|vitamin d|mesh-list
102584556|NCT02731820|Cholecalciferol|cholecalciferol|mesh-list
102584557|NCT02731820|Potassium Citrate|potassium citrate|mesh-list
102584558|NCT02731820|Calcium Carbonate|calcium carbonate|mesh-list
102584559|NCT02731820|Calcium|calcium|mesh-list
102584560|NCT02731820|Vitamins|vitamins|mesh-ancestor
102584561|NCT02731820|Micronutrients|micronutrients|mesh-ancestor
102584562|NCT02731820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584563|NCT02731820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102584564|NCT02731820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102584565|NCT02731820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584566|NCT02731820|Antacids|antacids|mesh-ancestor
102584567|NCT02731820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102584568|NCT02731820|Diuretics|diuretics|mesh-ancestor
102584569|NCT02731820|Natriuretic Agents|natriuretic agents|mesh-ancestor
102584570|NCT02731820|Expectorants|expectorants|mesh-ancestor
102584571|NCT02731820|Respiratory System Agents|respiratory system agents|mesh-ancestor
102584572|NCT02732899|Sirolimus|sirolimus|mesh-list
102584573|NCT02732899|Aflibercept|aflibercept|mesh-list
102584574|NCT02732899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102584575|NCT02732899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102584576|NCT02732899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102584577|NCT02732899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102584578|NCT02732899|Antifungal Agents|antifungal agents|mesh-ancestor
102584579|NCT02732899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102584580|NCT02732899|Immunologic Factors|immunologic factors|mesh-ancestor
102584581|NCT02732899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344280|NCT03618641|Nivolumab|nivolumab|mesh-list
102584582|NCT02732899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102584583|NCT02732899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102584584|NCT02732899|Growth Substances|growth substances|mesh-ancestor
102584585|NCT02732899|Growth Inhibitors|growth inhibitors|mesh-ancestor
102584586|NCT02733757|Clonidine|clonidine|mesh-list
102584587|NCT02733757|Analgesics|analgesics|mesh-ancestor
102584588|NCT02733757|Sensory System Agents|sensory system agents|mesh-ancestor
102584589|NCT02733757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102584590|NCT02733757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584591|NCT02733757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102584592|NCT02733757|Sympatholytics|sympatholytics|mesh-ancestor
102584593|NCT02733757|Autonomic Agents|autonomic agents|mesh-ancestor
102584594|NCT02733757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102584595|NCT02733757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102584596|NCT02733757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102584597|NCT02733757|Adrenergic Agents|adrenergic agents|mesh-ancestor
102584598|NCT02733757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102584599|NCT02733757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584600|NCT00368264|Infliximab|infliximab|mesh-list
102584601|NCT00368264|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102584602|NCT00368264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102584603|NCT00368264|Dermatologic Agents|dermatologic agents|mesh-ancestor
102584604|NCT00368264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102584605|NCT00368264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102584606|NCT02734147|Ascorbic Acid|ascorbic acid|mesh-list
102584607|NCT02734147|Antioxidants|antioxidants|mesh-ancestor
102584608|NCT02734147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584609|NCT02734147|Protective Agents|protective agents|mesh-ancestor
102584610|NCT02734147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584611|NCT02734147|Vitamins|vitamins|mesh-ancestor
102584612|NCT02734147|Micronutrients|micronutrients|mesh-ancestor
102584613|NCT00368342|Azithromycin|azithromycin|mesh-list
102584614|NCT00368342|Clarithromycin|clarithromycin|mesh-list
102584615|NCT00368342|Erythromycin|erythromycin|mesh-list
102584616|NCT00368342|Erythromycin Estolate|erythromycin estolate|mesh-list
102584617|NCT00368342|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
102584618|NCT00368342|Erythromycin stearate|erythromycin stearate|mesh-list
102584619|NCT00368342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102584620|NCT00368342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102584621|NCT00368342|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102584622|NCT00368342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102584623|NCT00368342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584624|NCT00368342|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102584625|NCT00368342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102584626|NCT00368342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102584627|NCT03609008|Cromakalim|cromakalim|mesh-list
102584628|NCT03609008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102584629|NCT03609008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102584630|NCT03609008|Autonomic Agents|autonomic agents|mesh-ancestor
102584631|NCT03609008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102584632|NCT03609008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584633|NCT03609008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102584634|NCT03609008|Respiratory System Agents|respiratory system agents|mesh-ancestor
102584635|NCT03609008|Parasympatholytics|parasympatholytics|mesh-ancestor
102584636|NCT03609008|Vasodilator Agents|vasodilator agents|mesh-ancestor
102584637|NCT02734238|Methyltestosterone|methyltestosterone|mesh-list
102584638|NCT02734238|Testosterone|testosterone|mesh-list
102584639|NCT02734238|Testosterone undecanoate|testosterone undecanoate|mesh-list
102584640|NCT02734238|Testosterone enanthate|testosterone enanthate|mesh-list
102584641|NCT02734238|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102584642|NCT02734238|Androgens|androgens|mesh-ancestor
102584643|NCT02734238|Hormones|hormones|mesh-ancestor
102584644|NCT02734238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102584645|NCT02734238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584646|NCT02734238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102584647|NCT02734238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102584648|NCT02734238|Anabolic Agents|anabolic agents|mesh-ancestor
102584649|NCT04707547|Nivolumab|nivolumab|mesh-list
102584650|NCT04707547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102584651|NCT04707547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102584652|NCT04707547|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102584653|NCT04707547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584654|NCT02736175|Dexamethasone|dexamethasone|mesh-list
102584655|NCT02736175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102584656|NCT02736175|Antiemetics|antiemetics|mesh-ancestor
102584657|NCT02736175|Autonomic Agents|autonomic agents|mesh-ancestor
102584658|NCT02736175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102584659|NCT02736175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584660|NCT02736175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102584661|NCT02736175|Glucocorticoids|glucocorticoids|mesh-ancestor
102584662|NCT02736175|Hormones|hormones|mesh-ancestor
102584663|NCT02736175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102584664|NCT02736175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102584665|NCT02736175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102584666|NCT00369356|Prednisone|prednisone|mesh-list
102584667|NCT00369356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102584668|NCT00369356|Glucocorticoids|glucocorticoids|mesh-ancestor
102584669|NCT00369356|Hormones|hormones|mesh-ancestor
102584670|NCT00369356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102584671|NCT00369356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584672|NCT00369356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102584673|NCT00369356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102584674|NCT04947085|Ketamine|ketamine|mesh-list
102584675|NCT04947085|Analgesics|analgesics|mesh-ancestor
102584676|NCT04947085|Sensory System Agents|sensory system agents|mesh-ancestor
102584677|NCT04947085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102584678|NCT04947085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584679|NCT04947085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102584680|NCT04947085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102584681|NCT04947085|Anesthetics, General|anesthetics, general|mesh-ancestor
102584682|NCT04947085|Anesthetics|anesthetics|mesh-ancestor
102584683|NCT04947085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102584684|NCT04947085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102584685|NCT04947085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102584686|NCT04947085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102584687|NCT04947085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584688|NCT03357224|Atezolizumab|atezolizumab|mesh-list
102584689|NCT03357224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102584690|NCT03357224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584691|NCT03357224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102584692|NCT03357224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102584693|NCT02679469|Nalmefene|nalmefene|mesh-list
102584694|NCT02679469|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102584695|NCT02679469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584696|NCT02679469|Sensory System Agents|sensory system agents|mesh-ancestor
102584697|NCT02679469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102584698|NCT02681809|Fibrinolysin|fibrinolysin|mesh-list
102584699|NCT02681809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102584700|NCT02681809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102584701|NCT02681809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584702|NCT05445661|Mannitol|mannitol|mesh-list
102584703|NCT05445661|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102584704|NCT05445661|Diuretics|diuretics|mesh-ancestor
102584705|NCT05445661|Natriuretic Agents|natriuretic agents|mesh-ancestor
102584706|NCT05445661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584707|NCT04805125|Vaccines|vaccines|mesh-list
102131588|NCT02436902|Sorafenib|sorafenib|mesh-list
102584708|NCT04805125|Immunologic Factors|immunologic factors|mesh-ancestor
102584709|NCT04805125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584710|NCT00368017|Pioglitazone|pioglitazone|mesh-list
102584711|NCT00368017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102584712|NCT00368017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584713|NCT00367627|Albendazole|albendazole|mesh-list
102584714|NCT00367627|Anthelmintics|anthelmintics|mesh-ancestor
102584715|NCT00367627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102584716|NCT00367627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102584717|NCT00367627|Anticestodal Agents|anticestodal agents|mesh-ancestor
102584718|NCT00367627|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102584719|NCT00367627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102584720|NCT00367627|Tubulin Modulators|tubulin modulators|mesh-ancestor
102584721|NCT00367627|Antimitotic Agents|antimitotic agents|mesh-ancestor
102584722|NCT00367627|Mitosis Modulators|mitosis modulators|mesh-ancestor
102584723|NCT00367627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584724|NCT00367627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102584725|NCT05443789|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
102584726|NCT05443789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102584727|NCT05443789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584728|NCT05424523|Omalizumab|omalizumab|mesh-list
102584729|NCT05424523|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102584730|NCT05424523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102584731|NCT05424523|Respiratory System Agents|respiratory system agents|mesh-ancestor
102584732|NCT05442931|Magnesium Sulfate|magnesium sulfate|mesh-list
102584733|NCT05442931|Pregabalin|pregabalin|mesh-list
102584734|NCT05442931|Nitroglycerin|nitroglycerin|mesh-list
102584735|NCT05442931|Analgesics|analgesics|mesh-ancestor
102584736|NCT05442931|Sensory System Agents|sensory system agents|mesh-ancestor
102584737|NCT05442931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102584738|NCT05442931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584739|NCT05442931|Anticonvulsants|anticonvulsants|mesh-ancestor
102584740|NCT05442931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102584741|NCT05442931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102584742|NCT05442931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584743|NCT05442931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102584744|NCT05442931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102584745|NCT05442931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102584746|NCT05442931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102584747|NCT05442931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102584748|NCT05442931|Anesthetics|anesthetics|mesh-ancestor
102584749|NCT05442931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102584750|NCT05442931|Tocolytic Agents|tocolytic agents|mesh-ancestor
102584751|NCT05442931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102584752|NCT05442931|Vasodilator Agents|vasodilator agents|mesh-ancestor
102584753|NCT05439499|Letrozole|letrozole|mesh-list
102584754|NCT05439499|Anastrozole|anastrozole|mesh-list
102584755|NCT05439499|Goserelin|goserelin|mesh-list
102584756|NCT05439499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102584757|NCT05439499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102584758|NCT05439499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102584759|NCT05439499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102584760|NCT05439499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584761|NCT05439499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102584762|NCT05439499|Hormone Antagonists|hormone antagonists|mesh-ancestor
102584763|NCT05439499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102584764|NCT05439499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584765|NCT05439499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102584766|NCT04003987|Bupivacaine|bupivacaine|mesh-list
102584767|NCT04003987|Anesthetics, Local|anesthetics, local|mesh-ancestor
102584768|NCT04003987|Anesthetics|anesthetics|mesh-ancestor
102584769|NCT04003987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102584770|NCT04003987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584771|NCT04003987|Sensory System Agents|sensory system agents|mesh-ancestor
102584772|NCT04003987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102584773|NCT05448001|Lansoprazole|lansoprazole|mesh-list
102584774|NCT05448001|Dexlansoprazole|dexlansoprazole|mesh-list
102584775|NCT05448001|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102584776|NCT05448001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102584777|NCT05448001|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102584778|NCT05448001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102584779|NCT05448001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584780|NCT05447455|Anesthetics|anesthetics|mesh-list
102584781|NCT05447455|Anesthetics, Local|anesthetics, local|mesh-list
102584782|NCT05447455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102584783|NCT05447455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584784|NCT05447455|Sensory System Agents|sensory system agents|mesh-ancestor
102584785|NCT05447455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102584786|NCT00369733|Darbepoetin alfa|darbepoetin alfa|mesh-list
102584787|NCT00369733|Hematinics|hematinics|mesh-ancestor
102584788|NCT00368719|Tacrolimus|tacrolimus|mesh-list
102584789|NCT00368719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102584790|NCT00368719|Immunologic Factors|immunologic factors|mesh-ancestor
102584791|NCT00368719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584792|NCT00368719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102584793|NCT00368719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102584794|NCT00368719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584795|NCT00369811|Fentanyl|fentanyl|mesh-list
102584796|NCT00369811|Oxycodone|oxycodone|mesh-list
102584797|NCT00369811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102584798|NCT00369811|Narcotics|narcotics|mesh-ancestor
102584799|NCT00369811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102584800|NCT00369811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584801|NCT00369811|Analgesics|analgesics|mesh-ancestor
102584802|NCT00369811|Sensory System Agents|sensory system agents|mesh-ancestor
102584803|NCT00369811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102584804|NCT00369811|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102584805|NCT00369811|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102584806|NCT00369811|Anesthetics, General|anesthetics, general|mesh-ancestor
102584807|NCT00369811|Anesthetics|anesthetics|mesh-ancestor
102584808|NCT03615547|Clomiphene|clomiphene|mesh-list
102584809|NCT03615547|Enclomiphene|enclomiphene|mesh-list
102584810|NCT03615547|Zuclomiphene|zuclomiphene|mesh-list
102584811|NCT03615547|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102584812|NCT03615547|Hormone Antagonists|hormone antagonists|mesh-ancestor
102584813|NCT03615547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102584814|NCT03615547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584815|NCT03615547|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102584816|NCT03615547|Fertility Agents|fertility agents|mesh-ancestor
102584817|NCT03615547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102584818|NCT03615547|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102584819|NCT03615547|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102584820|NCT03105128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102584821|NCT03105128|Immunologic Factors|immunologic factors|mesh-ancestor
102584822|NCT03105128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584823|NCT03122509|Durvalumab|durvalumab|mesh-list
102584824|NCT03122509|Tremelimumab|tremelimumab|mesh-list
102584825|NCT03122509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102584826|NCT03122509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102584827|NCT03113695|Lenalidomide|lenalidomide|mesh-list
102584828|NCT03113695|Obinutuzumab|obinutuzumab|mesh-list
102584829|NCT03113695|Immunologic Factors|immunologic factors|mesh-ancestor
102584830|NCT03113695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584831|NCT03113695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102584832|NCT03113695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102584833|NCT03113695|Growth Substances|growth substances|mesh-ancestor
102584834|NCT03113695|Growth Inhibitors|growth inhibitors|mesh-ancestor
102584835|NCT03113695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102584836|NCT03113695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102584837|NCT05315947|Brivaracetam|brivaracetam|mesh-list
102584838|NCT05315947|Anticonvulsants|anticonvulsants|mesh-ancestor
102584839|NCT00369434|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
102584840|NCT00369434|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102584841|NCT00369434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102584842|NCT00369434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102584843|NCT00369434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584844|NCT00369434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102584845|NCT00369434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584846|NCT00369434|Antidepressive Agents|antidepressive agents|mesh-ancestor
102584847|NCT00369434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102584848|NCT05444738|Oxytocin|oxytocin|mesh-list
102584849|NCT05444738|Oxytocics|oxytocics|mesh-ancestor
102584850|NCT05444738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102584851|NCT05444738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584852|NCT05243953|Cromakalim|cromakalim|mesh-list
102584853|NCT05243953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102584854|NCT05243953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102584855|NCT05243953|Autonomic Agents|autonomic agents|mesh-ancestor
102584856|NCT05243953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102584857|NCT05243953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584858|NCT05243953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102584859|NCT05243953|Respiratory System Agents|respiratory system agents|mesh-ancestor
102584860|NCT05243953|Parasympatholytics|parasympatholytics|mesh-ancestor
102584861|NCT05243953|Vasodilator Agents|vasodilator agents|mesh-ancestor
102584862|NCT02757313|Dronabinol|dronabinol|mesh-list
102584863|NCT02757313|Hallucinogens|hallucinogens|mesh-ancestor
102584864|NCT02757313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584865|NCT02757313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102584866|NCT02757313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102584867|NCT02757313|Analgesics|analgesics|mesh-ancestor
102584868|NCT02757313|Sensory System Agents|sensory system agents|mesh-ancestor
102584869|NCT02757313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102584870|NCT02757313|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102584871|NCT02757313|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102584872|NCT02757313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102584873|NCT02757313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584874|NCT02757313|Hormones|hormones|mesh-ancestor
102584875|NCT02757313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102584876|NCT02514278|Capecitabine|capecitabine|mesh-list
102584877|NCT02514278|Folfirinox|folfirinox|mesh-list
102584878|NCT02514278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102584879|NCT02514278|Antimetabolites|antimetabolites|mesh-ancestor
102584880|NCT02514278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584881|NCT02514278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102584882|NCT02379806|Enoxaparin|enoxaparin|mesh-list
102584883|NCT02379806|Anticoagulants|anticoagulants|mesh-ancestor
102584884|NCT02379806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102584885|NCT02379806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102584886|NCT02379806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584887|NCT02358356|Capecitabine|capecitabine|mesh-list
102584888|NCT02358356|Temozolomide|temozolomide|mesh-list
102584889|NCT02358356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102584890|NCT02358356|Antimetabolites|antimetabolites|mesh-ancestor
102584891|NCT02358356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584892|NCT02358356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102584893|NCT02358356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102584894|NCT02358356|Alkylating Agents|alkylating agents|mesh-ancestor
102584895|NCT04700761|Analgesics, Opioid|analgesics, opioid|mesh-list
102584896|NCT04700761|Anesthetics|anesthetics|mesh-list
102584897|NCT04700761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102584898|NCT04700761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584899|NCT04700761|Narcotics|narcotics|mesh-ancestor
102584900|NCT04700761|Analgesics|analgesics|mesh-ancestor
102584901|NCT04700761|Sensory System Agents|sensory system agents|mesh-ancestor
102584902|NCT04700761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102584903|NCT02315768|Obinutuzumab|obinutuzumab|mesh-list
102584904|NCT02315768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102584905|NCT02315768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102584906|NCT02162810|Prednisolone|prednisolone|mesh-list
102584907|NCT02162810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102584908|NCT02162810|Glucocorticoids|glucocorticoids|mesh-ancestor
102584909|NCT02162810|Hormones|hormones|mesh-ancestor
102584910|NCT02162810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102584911|NCT02162810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584912|NCT02162810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102584913|NCT02162810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102584914|NCT00368498|Teicoplanin|teicoplanin|mesh-list
102584915|NCT00368498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102584916|NCT00368498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102584917|NCT05172817|Adalimumab|adalimumab|mesh-list
102584918|NCT05172817|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102584919|NCT05172817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102584920|NCT05172817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102584921|NCT05145907|Pembrolizumab|pembrolizumab|mesh-list
102584922|NCT05145907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102584923|NCT05145907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102584924|NCT05145907|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102584925|NCT05145907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584926|NCT04563325|Ceftriaxone|ceftriaxone|mesh-list
102584927|NCT04563325|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102584928|NCT04563325|Dicloxacillin|dicloxacillin|mesh-list
102584929|NCT04563325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102584930|NCT04563325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102584931|NCT04563325|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102584932|NCT04563325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102584933|NCT04563325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584934|NCT04545151|Verapamil|verapamil|mesh-list
102584935|NCT04545151|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102584936|NCT04545151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102584937|NCT04545151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102584938|NCT04545151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584939|NCT04545151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102584940|NCT04545151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584941|NCT04545151|Vasodilator Agents|vasodilator agents|mesh-ancestor
102584942|NCT00961142|Fludarabine|fludarabine|mesh-list
102584943|NCT00961142|Melphalan|melphalan|mesh-list
102584944|NCT00961142|Thiotepa|thiotepa|mesh-list
102584945|NCT00961142|Thymoglobulin|thymoglobulin|mesh-list
102584946|NCT00961142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102584947|NCT00961142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584948|NCT00961142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102584949|NCT00961142|Immunologic Factors|immunologic factors|mesh-ancestor
102584950|NCT00961142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584951|NCT00961142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102584952|NCT00961142|Alkylating Agents|alkylating agents|mesh-ancestor
102584953|NCT00961142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102584954|NCT04523701|SMOFlipid|smoflipid|mesh-list
102584955|NCT04523701|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102584956|NCT04523701|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102584957|NCT04523701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102584958|NCT04338373|Atropine|atropine|mesh-list
102584959|NCT04338373|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102584960|NCT04338373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102584961|NCT04338373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102584962|NCT04338373|Autonomic Agents|autonomic agents|mesh-ancestor
102584963|NCT04338373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102584964|NCT04338373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584965|NCT04338373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102584966|NCT04338373|Respiratory System Agents|respiratory system agents|mesh-ancestor
102584967|NCT04338373|Mydriatics|mydriatics|mesh-ancestor
102584968|NCT04338373|Parasympatholytics|parasympatholytics|mesh-ancestor
102584969|NCT04338373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102584970|NCT04338373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102584971|NCT04338373|Cholinergic Agents|cholinergic agents|mesh-ancestor
102584972|NCT04338373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102584973|NCT04338373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584974|NCT00369031|polysaccharide-K|polysaccharide-k|mesh-list
102584975|NCT00369031|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102584976|NCT00369031|Immunologic Factors|immunologic factors|mesh-ancestor
102584977|NCT00369031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102584978|NCT00369031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102584979|NCT00369031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102584980|NCT00369031|Antiviral Agents|antiviral agents|mesh-ancestor
102584981|NCT00369031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102584982|NCT00369031|Interferon Inducers|interferon inducers|mesh-ancestor
102584983|NCT00369031|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102584984|NCT00369031|Protective Agents|protective agents|mesh-ancestor
102584985|NCT05443178|Isoniazid|isoniazid|mesh-list
102584986|NCT05443178|Ethambutol|ethambutol|mesh-list
102584987|NCT05443178|Chloroquine|chloroquine|mesh-list
102584988|NCT05443178|Antitubercular Agents|antitubercular agents|mesh-ancestor
102584989|NCT05443178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102584990|NCT05443178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102584991|NCT05443178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102584992|NCT05443178|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102584993|NCT05443178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102584994|NCT05443178|Antimetabolites|antimetabolites|mesh-ancestor
102584995|NCT05443178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102584996|NCT05443178|Amebicides|amebicides|mesh-ancestor
102584997|NCT05443178|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102584998|NCT05443178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102584999|NCT05443178|Antimalarials|antimalarials|mesh-ancestor
102585000|NCT05443178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102585001|NCT05061901|Lisinopril|lisinopril|mesh-list
102585002|NCT05061901|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102585003|NCT05061901|Protease Inhibitors|protease inhibitors|mesh-ancestor
102585004|NCT05061901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102585005|NCT05061901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585006|NCT05061901|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102131887|NCT05157698|Dopamine Agents|dopamine agents|mesh-ancestor
102585007|NCT05061901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102585008|NCT05061901|Protective Agents|protective agents|mesh-ancestor
102585009|NCT05061901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585010|NCT04338919|Aspirin|aspirin|mesh-list
102585011|NCT04338919|Ticagrelor|ticagrelor|mesh-list
102585012|NCT04338919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102585013|NCT04338919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102585014|NCT04338919|Analgesics|analgesics|mesh-ancestor
102585015|NCT04338919|Sensory System Agents|sensory system agents|mesh-ancestor
102585016|NCT04338919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102585017|NCT04338919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585018|NCT04338919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102585019|NCT04338919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102585020|NCT04338919|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102585021|NCT04338919|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102585022|NCT04338919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585023|NCT04338919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102585024|NCT04338919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102585025|NCT04338919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102585026|NCT04338919|Antipyretics|antipyretics|mesh-ancestor
102585027|NCT04338919|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102585028|NCT04338919|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102585029|NCT04338919|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102585030|NCT04338919|Purinergic Agents|purinergic agents|mesh-ancestor
102585031|NCT04338919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102585032|NCT05451290|Gemcitabine|gemcitabine|mesh-list
102585033|NCT05451290|Tegafur|tegafur|mesh-list
102585034|NCT05451290|Oxaliplatin|oxaliplatin|mesh-list
102585035|NCT05451290|Apatinib|apatinib|mesh-list
102585036|NCT05451290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102585037|NCT05451290|Antimetabolites|antimetabolites|mesh-ancestor
102585038|NCT05451290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585039|NCT05451290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102585040|NCT05451290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102585041|NCT05451290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102585042|NCT00369889|Bevacizumab|bevacizumab|mesh-list
102585043|NCT00369889|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102585044|NCT00369889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102585045|NCT00369889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102585046|NCT00369889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102585047|NCT00369889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102585048|NCT00369889|Growth Substances|growth substances|mesh-ancestor
102585049|NCT00369889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585050|NCT00369889|Growth Inhibitors|growth inhibitors|mesh-ancestor
102585051|NCT00369889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102585052|NCT00369889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102585053|NCT00369889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585054|NCT00369044|Prednisone|prednisone|mesh-list
102585055|NCT00369044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102585056|NCT00369044|Glucocorticoids|glucocorticoids|mesh-ancestor
102585057|NCT00369044|Hormones|hormones|mesh-ancestor
102585058|NCT00369044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102585059|NCT00369044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585060|NCT00369044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102585061|NCT00369044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102585062|NCT00370045|Bivalirudin|bivalirudin|mesh-list
102585063|NCT00370045|Eptifibatide|eptifibatide|mesh-list
102585064|NCT00370045|Antithrombins|antithrombins|mesh-ancestor
102585065|NCT00370045|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102585066|NCT00370045|Protease Inhibitors|protease inhibitors|mesh-ancestor
102585067|NCT00370045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102585068|NCT00370045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585069|NCT00370045|Anticoagulants|anticoagulants|mesh-ancestor
102585070|NCT00370045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102585071|NCT05451056|Sotorasib|sotorasib|mesh-list
102585072|NCT05451056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102585073|NCT05451056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585074|NCT05451056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102585075|NCT05451056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102585076|NCT05441150|Ketamine|ketamine|mesh-list
102585077|NCT05441150|Analgesics|analgesics|mesh-ancestor
102585078|NCT05441150|Sensory System Agents|sensory system agents|mesh-ancestor
102585079|NCT05441150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102585080|NCT05441150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585081|NCT05441150|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102585082|NCT05441150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102585083|NCT05441150|Anesthetics, General|anesthetics, general|mesh-ancestor
102585084|NCT05441150|Anesthetics|anesthetics|mesh-ancestor
102585085|NCT05441150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102585086|NCT05441150|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102585087|NCT05441150|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102585088|NCT05441150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102585089|NCT05441150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585090|NCT04270214|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102585091|NCT04270214|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102585092|NCT04270214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102585093|NCT04270214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585094|NCT04270214|Cholinergic Agents|cholinergic agents|mesh-ancestor
102585095|NCT04270214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102585096|NCT04270214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585097|NCT05438810|Fulvestrant|fulvestrant|mesh-list
102585098|NCT05438810|Goserelin|goserelin|mesh-list
102585099|NCT05438810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102585100|NCT05438810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102585101|NCT05438810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102585102|NCT05438810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102585103|NCT05438810|Hormone Antagonists|hormone antagonists|mesh-ancestor
102585104|NCT05438810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102585105|NCT05438810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585106|NCT05451121|Dexmedetomidine|dexmedetomidine|mesh-list
102585107|NCT05451121|Propofol|propofol|mesh-list
102585108|NCT05451121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102585109|NCT05451121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102585110|NCT05451121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585111|NCT05451121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102585112|NCT05451121|Analgesics|analgesics|mesh-ancestor
102585113|NCT05451121|Sensory System Agents|sensory system agents|mesh-ancestor
102585114|NCT05451121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102585115|NCT05451121|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102585116|NCT05451121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102585117|NCT05451121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102585118|NCT05451121|Adrenergic Agents|adrenergic agents|mesh-ancestor
102585119|NCT05451121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102585120|NCT05451121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585121|NCT05451121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102585122|NCT05451121|Anesthetics, General|anesthetics, general|mesh-ancestor
102585123|NCT05451121|Anesthetics|anesthetics|mesh-ancestor
102585124|NCT04967443|Prazosin|prazosin|mesh-list
102585125|NCT04967443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102585126|NCT04967443|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102585127|NCT04967443|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102585128|NCT04967443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102585129|NCT04967443|Adrenergic Agents|adrenergic agents|mesh-ancestor
102585130|NCT04967443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102585131|NCT04967443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585132|NCT04967443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585133|NCT04697017|Salicylic Acid|salicylic acid|mesh-list
102585134|NCT04697017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102585135|NCT04697017|Antifungal Agents|antifungal agents|mesh-ancestor
102585136|NCT04697017|Keratolytic Agents|keratolytic agents|mesh-ancestor
102585137|NCT04697017|Dermatologic Agents|dermatologic agents|mesh-ancestor
102585138|NCT02230956|Botulinum Toxins|botulinum toxins|mesh-list
102585139|NCT02230956|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102585140|NCT02230956|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102585141|NCT02230956|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102585142|NCT02230956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102585143|NCT02230956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585144|NCT02230956|Cholinergic Agents|cholinergic agents|mesh-ancestor
102585145|NCT02230956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102585146|NCT02230956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585147|NCT02230956|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102585148|NCT02230956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102585149|NCT05450042|Paclitaxel|paclitaxel|mesh-list
102585150|NCT05450042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102585151|NCT05450042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102585152|NCT05450042|Tubulin Modulators|tubulin modulators|mesh-ancestor
102585153|NCT05450042|Antimitotic Agents|antimitotic agents|mesh-ancestor
102585154|NCT05450042|Mitosis Modulators|mitosis modulators|mesh-ancestor
102585155|NCT05450042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585156|NCT05447936|Vitamin D|vitamin d|mesh-list
102585157|NCT05447936|Vitamins|vitamins|mesh-ancestor
102585158|NCT05447936|Micronutrients|micronutrients|mesh-ancestor
102585159|NCT05447936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585160|NCT05447936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102585161|NCT04739384|Ticagrelor|ticagrelor|mesh-list
102585162|NCT04739384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102585163|NCT04739384|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102585164|NCT04739384|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102585165|NCT04739384|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102585166|NCT04739384|Purinergic Agents|purinergic agents|mesh-ancestor
102585167|NCT04739384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102585168|NCT04739384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585169|NCT04739384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585170|NCT04704596|Anesthetics|anesthetics|mesh-list
102585171|NCT04704596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102585172|NCT04704596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585173|NCT05450497|Dexmedetomidine|dexmedetomidine|mesh-list
102585174|NCT05450497|Propofol|propofol|mesh-list
102585175|NCT05450497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102585176|NCT05450497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102585177|NCT05450497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585178|NCT05450497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102585179|NCT05450497|Analgesics|analgesics|mesh-ancestor
102585180|NCT05450497|Sensory System Agents|sensory system agents|mesh-ancestor
102585181|NCT05450497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102585182|NCT05450497|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102585183|NCT05450497|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102585184|NCT05450497|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102585185|NCT05450497|Adrenergic Agents|adrenergic agents|mesh-ancestor
102585186|NCT05450497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102585187|NCT05450497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585188|NCT05450497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102585189|NCT05450497|Anesthetics, General|anesthetics, general|mesh-ancestor
102585190|NCT05450497|Anesthetics|anesthetics|mesh-ancestor
102585191|NCT02230332|Alendronate|alendronate|mesh-list
102585192|NCT02230332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102585193|NCT02230332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585194|NCT05449028|Bismuth|bismuth|mesh-list
102585195|NCT05449028|Antacids|antacids|mesh-ancestor
102585196|NCT05449028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585197|NCT05449028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102585198|NCT04845139|Nivolumab|nivolumab|mesh-list
102585199|NCT04845139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102585200|NCT04845139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102585201|NCT04845139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102585202|NCT04845139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585203|NCT04738526|Lithium Carbonate|lithium carbonate|mesh-list
102585204|NCT04738526|Antidepressive Agents|antidepressive agents|mesh-ancestor
102585205|NCT04738526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102585206|NCT04738526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102585207|NCT04738526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585208|NCT04738526|Antimanic Agents|antimanic agents|mesh-ancestor
102585209|NCT04738526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102585210|NCT04738526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102585211|NCT04738526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585212|NCT05449483|Paclitaxel|paclitaxel|mesh-list
102585213|NCT05449483|Tislelizumab|tislelizumab|mesh-list
102585214|NCT05449483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102585215|NCT05449483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102585216|NCT05449483|Tubulin Modulators|tubulin modulators|mesh-ancestor
102585217|NCT05449483|Antimitotic Agents|antimitotic agents|mesh-ancestor
102585218|NCT05449483|Mitosis Modulators|mitosis modulators|mesh-ancestor
102585219|NCT05449483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585220|NCT05449483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102585221|NCT05448404|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102585222|NCT05448404|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102585223|NCT05448404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585224|NCT04793659|Fasudil|fasudil|mesh-list
102585225|NCT04793659|1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine|1-(5-isoquinolinesulfonyl)-2-methylpiperazine|mesh-list
102585226|NCT04793659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102585227|NCT04793659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102585228|NCT04793659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132108|NCT03181880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102585229|NCT04793659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102585230|NCT04793659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585231|NCT04793659|Vasodilator Agents|vasodilator agents|mesh-ancestor
102585232|NCT04793659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102585233|NCT04793659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102585234|NCT05448937|Eugenol|eugenol|mesh-list
102585235|NCT05448937|Zinc Oxide|zinc oxide|mesh-list
102585236|NCT05448937|Dermatologic Agents|dermatologic agents|mesh-ancestor
102585237|NCT05448937|Sunscreening Agents|sunscreening agents|mesh-ancestor
102585238|NCT05448937|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102585239|NCT05448937|Protective Agents|protective agents|mesh-ancestor
102585240|NCT05448937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585241|NCT05448937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102585242|NCT00370201|Colchicine|colchicine|mesh-list
102585243|NCT00370201|Gout Suppressants|gout suppressants|mesh-ancestor
102585244|NCT00370201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102585245|NCT00370201|Tubulin Modulators|tubulin modulators|mesh-ancestor
102585246|NCT00370201|Antimitotic Agents|antimitotic agents|mesh-ancestor
102585247|NCT00370201|Mitosis Modulators|mitosis modulators|mesh-ancestor
102585248|NCT00370201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585249|NCT00370201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102585250|NCT05448781|Paclitaxel|paclitaxel|mesh-list
102585251|NCT05448781|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102585252|NCT05448781|Carboplatin|carboplatin|mesh-list
102585253|NCT05448781|Pemetrexed|pemetrexed|mesh-list
102585254|NCT05448781|Endostatins|endostatins|mesh-list
102585255|NCT05448781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102585256|NCT05448781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102585257|NCT05448781|Tubulin Modulators|tubulin modulators|mesh-ancestor
102585258|NCT05448781|Antimitotic Agents|antimitotic agents|mesh-ancestor
102585259|NCT05448781|Mitosis Modulators|mitosis modulators|mesh-ancestor
102585260|NCT05448781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585261|NCT05448781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102585262|NCT05448781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102585263|NCT05448781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102585264|NCT05448781|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102585265|NCT05448781|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102585266|NCT05448781|Growth Substances|growth substances|mesh-ancestor
102585267|NCT05448781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585268|NCT05448781|Growth Inhibitors|growth inhibitors|mesh-ancestor
102585269|NCT03134755|Mometasone Furoate|mometasone furoate|mesh-list
102585270|NCT03134755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102585271|NCT03134755|Dermatologic Agents|dermatologic agents|mesh-ancestor
102585272|NCT03134755|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102585273|NCT04475432|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102585274|NCT04475432|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102585275|NCT00370825|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102585276|NCT00370825|Miltefosine|miltefosine|mesh-list
102585277|NCT00370825|Antifungal Agents|antifungal agents|mesh-ancestor
102585278|NCT00370825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102585279|NCT00370825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102585280|NCT00370825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102585281|NCT00370825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102585282|NCT04450316|Naltrexone|naltrexone|mesh-list
102585283|NCT04450316|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102585284|NCT04450316|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102585285|NCT04450316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585286|NCT04450316|Sensory System Agents|sensory system agents|mesh-ancestor
102585287|NCT04450316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102585288|NCT02535247|Pembrolizumab|pembrolizumab|mesh-list
102585289|NCT02535247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102585290|NCT02535247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102585291|NCT02535247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102585292|NCT02535247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585293|NCT04417920|Mitomycins|mitomycins|mesh-list
102585294|NCT04417920|Mitomycin|mitomycin|mesh-list
102585295|NCT04417920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102585296|NCT04417920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102585297|NCT04417920|Alkylating Agents|alkylating agents|mesh-ancestor
102585298|NCT04417920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585299|NCT04417920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102585300|NCT04417920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102585301|NCT02626130|Tremelimumab|tremelimumab|mesh-list
102585302|NCT02626130|Ipilimumab|ipilimumab|mesh-list
102132182|NCT03184766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102585303|NCT02626130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102585304|NCT02626130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102585305|NCT02626130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102585306|NCT02626130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585308|NCT02618720|Amebicides|amebicides|mesh-ancestor
102585309|NCT02618720|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102585310|NCT02618720|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102585311|NCT02618720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102585312|NCT02618720|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
102585313|NCT03758989|Prednisone|prednisone|mesh-list
102585314|NCT03758989|Cyclophosphamide|cyclophosphamide|mesh-list
102585315|NCT03758989|Rituximab|rituximab|mesh-list
102585316|NCT03758989|Doxorubicin|doxorubicin|mesh-list
102585317|NCT03758989|Vincristine|vincristine|mesh-list
102585318|NCT03758989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102585319|NCT03758989|Immunologic Factors|immunologic factors|mesh-ancestor
102585320|NCT03758989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585321|NCT03758989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102585322|NCT03758989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102585323|NCT03758989|Alkylating Agents|alkylating agents|mesh-ancestor
102585324|NCT03758989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585325|NCT03758989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102585326|NCT03758989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102585327|NCT03758989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102585328|NCT03758989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102585329|NCT03758989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102585330|NCT03758989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102585331|NCT03758989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102585332|NCT03758989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102585333|NCT03758989|Glucocorticoids|glucocorticoids|mesh-ancestor
102585334|NCT03758989|Hormones|hormones|mesh-ancestor
102585335|NCT03758989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102585336|NCT03758989|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102585337|NCT03758989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102585338|NCT03758989|Tubulin Modulators|tubulin modulators|mesh-ancestor
102585339|NCT03758989|Antimitotic Agents|antimitotic agents|mesh-ancestor
102585340|NCT03758989|Mitosis Modulators|mitosis modulators|mesh-ancestor
102585341|NCT02042989|Vorinostat|vorinostat|mesh-list
102585342|NCT02042989|Ixazomib|ixazomib|mesh-list
102585343|NCT02042989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102585344|NCT02042989|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102585345|NCT02042989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102585346|NCT02042989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585347|NCT02042989|Protease Inhibitors|protease inhibitors|mesh-ancestor
102585348|NCT04093531|Ustekinumab|ustekinumab|mesh-list
102585349|NCT04093531|Dermatologic Agents|dermatologic agents|mesh-ancestor
102585350|NCT05208944|Cemiplimab|cemiplimab|mesh-list
102585351|NCT05208944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102585352|NCT05208944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102585353|NCT01809379|Cisplatin|cisplatin|mesh-list
102585354|NCT01809379|Doxorubicin|doxorubicin|mesh-list
102585355|NCT01809379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102585356|NCT01809379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102585357|NCT01809379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102585358|NCT01809379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102585359|NCT01809379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102585360|NCT01809379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585361|NCT02229396|Dapagliflozin|dapagliflozin|mesh-list
102585362|NCT02229396|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102585363|NCT02229396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585364|NCT02229396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102585365|NCT02229396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585366|NCT05202158|Gentamicins|gentamicins|mesh-list
102585367|NCT05202158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102585368|NCT05202158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102585369|NCT05202158|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102585370|NCT05202158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102585371|NCT05202158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585372|NCT00370370|Triamcinolone|triamcinolone|mesh-list
102585373|NCT00370370|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102585374|NCT00370370|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102585375|NCT00370370|Bevacizumab|bevacizumab|mesh-list
102585376|NCT00370370|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102585377|NCT00370370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102585378|NCT00370370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102585379|NCT00370370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102585380|NCT00370370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102585381|NCT00370370|Growth Substances|growth substances|mesh-ancestor
102585382|NCT00370370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585383|NCT00370370|Growth Inhibitors|growth inhibitors|mesh-ancestor
102585384|NCT00370370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102585385|NCT00370370|Glucocorticoids|glucocorticoids|mesh-ancestor
102585386|NCT00370370|Hormones|hormones|mesh-ancestor
102585387|NCT00370370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102585388|NCT00370370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102585389|NCT00370370|Immunologic Factors|immunologic factors|mesh-ancestor
102585390|NCT00370370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102585391|NCT00370370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585392|NCT02197416|Dabigatran|dabigatran|mesh-list
102585393|NCT02197416|Antithrombins|antithrombins|mesh-ancestor
102585394|NCT02197416|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102585395|NCT02197416|Protease Inhibitors|protease inhibitors|mesh-ancestor
102585396|NCT02197416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102585397|NCT02197416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585398|NCT02197416|Anticoagulants|anticoagulants|mesh-ancestor
102585399|NCT00370591|Fluticasone|fluticasone|mesh-list
102585400|NCT00370591|Xhance|xhance|mesh-list
102585401|NCT00370591|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102585402|NCT00370591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102585403|NCT00370591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102585404|NCT00370591|Autonomic Agents|autonomic agents|mesh-ancestor
102585405|NCT00370591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102585406|NCT00370591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585407|NCT00370591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102585408|NCT00370591|Respiratory System Agents|respiratory system agents|mesh-ancestor
102585409|NCT00370591|Dermatologic Agents|dermatologic agents|mesh-ancestor
102585410|NCT00370591|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102585411|NCT00370591|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102585412|NCT00370591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102585413|NCT00370591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102585414|NCT00370591|Adrenergic Agents|adrenergic agents|mesh-ancestor
102585415|NCT00370591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102585416|NCT00370591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585417|NCT03956173|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102585418|NCT03956173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585419|NCT00371527|Ipratropium|ipratropium|mesh-list
102585420|NCT00371527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102585421|NCT00371527|Autonomic Agents|autonomic agents|mesh-ancestor
102585422|NCT00371527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102585423|NCT00371527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585424|NCT00371527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102585425|NCT00371527|Respiratory System Agents|respiratory system agents|mesh-ancestor
102585426|NCT00371527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102585427|NCT00371527|Cholinergic Agents|cholinergic agents|mesh-ancestor
102585428|NCT00371527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102585429|NCT00371527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585430|NCT00392756|Hormones|hormones|mesh-list
102585431|NCT00392756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102585432|NCT00392756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585433|NCT04027322|Dexamethasone|dexamethasone|mesh-list
102585434|NCT04027322|Budesonide|budesonide|mesh-list
102585435|NCT04027322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102585436|NCT04027322|Antiemetics|antiemetics|mesh-ancestor
102585437|NCT04027322|Autonomic Agents|autonomic agents|mesh-ancestor
102585438|NCT04027322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102585439|NCT04027322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585440|NCT04027322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102585441|NCT04027322|Glucocorticoids|glucocorticoids|mesh-ancestor
102585442|NCT04027322|Hormones|hormones|mesh-ancestor
102585443|NCT04027322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102585444|NCT04027322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102585445|NCT04027322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102585446|NCT04027322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102585447|NCT04027322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102585448|NCT04027322|Respiratory System Agents|respiratory system agents|mesh-ancestor
102585449|NCT03845257|Dimercaprol|dimercaprol|mesh-list
102585450|NCT03845257|Chelating Agents|chelating agents|mesh-ancestor
102585451|NCT03845257|Sequestering Agents|sequestering agents|mesh-ancestor
102585452|NCT03845257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585453|NCT00371072|Mitomycins|mitomycins|mesh-list
102585454|NCT00371072|Mitomycin|mitomycin|mesh-list
102585455|NCT00371072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102585456|NCT00371072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102585457|NCT00371072|Alkylating Agents|alkylating agents|mesh-ancestor
102585458|NCT00371072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585459|NCT00371072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102585460|NCT00371072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102585461|NCT05454332|Caffeine|caffeine|mesh-list
102585462|NCT05454332|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102585463|NCT05454332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585464|NCT05454332|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102585465|NCT05454332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102585466|NCT05454332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585467|NCT05454332|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102585468|NCT05454332|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102585469|NCT05454332|Purinergic Agents|purinergic agents|mesh-ancestor
102585470|NCT05454332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102585471|NCT03924518|Granisetron|granisetron|mesh-list
102585472|NCT03924518|Serotonin|serotonin|mesh-list
102585473|NCT03924518|Antiemetics|antiemetics|mesh-ancestor
102585474|NCT03924518|Autonomic Agents|autonomic agents|mesh-ancestor
102585475|NCT03924518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102585476|NCT03924518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585477|NCT03924518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102585478|NCT03924518|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102585479|NCT03924518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102585480|NCT03924518|Serotonin Agents|serotonin agents|mesh-ancestor
102585481|NCT03924518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102585482|NCT03924518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585483|NCT03924518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102585484|NCT05454085|Bisphenol A|bisphenol a|mesh-list
102585485|NCT05454085|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102585486|NCT05454085|Estrogens|estrogens|mesh-ancestor
102585487|NCT05454085|Hormones|hormones|mesh-ancestor
102585488|NCT05454085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102585489|NCT05454085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585490|NCT05454085|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102585491|NCT05454085|Antioxidants|antioxidants|mesh-ancestor
102585492|NCT05454085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585493|NCT05454085|Protective Agents|protective agents|mesh-ancestor
102585494|NCT03886922|Cromakalim|cromakalim|mesh-list
102585495|NCT03886922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102585496|NCT03886922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102585497|NCT03886922|Autonomic Agents|autonomic agents|mesh-ancestor
102585498|NCT03886922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102585499|NCT03886922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585500|NCT03886922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102585501|NCT03886922|Respiratory System Agents|respiratory system agents|mesh-ancestor
102585502|NCT03886922|Parasympatholytics|parasympatholytics|mesh-ancestor
102585503|NCT03886922|Vasodilator Agents|vasodilator agents|mesh-ancestor
102585504|NCT05453552|Cyclophosphamide|cyclophosphamide|mesh-list
102585505|NCT05453552|Busulfan|busulfan|mesh-list
102585506|NCT05453552|Fludarabine|fludarabine|mesh-list
102585507|NCT05453552|Decitabine|decitabine|mesh-list
102585508|NCT05453552|Lenograstim|lenograstim|mesh-list
102585509|NCT05453552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102585510|NCT05453552|Immunologic Factors|immunologic factors|mesh-ancestor
102585511|NCT05453552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585512|NCT05453552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102585513|NCT05453552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102585514|NCT05453552|Alkylating Agents|alkylating agents|mesh-ancestor
102585515|NCT05453552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585516|NCT05453552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102585517|NCT05453552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102585518|NCT05453552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102585519|NCT05453552|Antimetabolites|antimetabolites|mesh-ancestor
102585520|NCT05453552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102585521|NCT05453552|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102585522|NCT03787082|Chlorhexidine|chlorhexidine|mesh-list
102585523|NCT03787082|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102585524|NCT03787082|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102585525|NCT03787082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102585526|NCT03787082|Disinfectants|disinfectants|mesh-ancestor
102585527|NCT03787082|Dermatologic Agents|dermatologic agents|mesh-ancestor
102585528|NCT02165202|Rilpivirine|rilpivirine|mesh-list
102585529|NCT02165202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102585530|NCT02165202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102585531|NCT02165202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102585532|NCT02165202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585533|NCT02165202|Antiviral Agents|antiviral agents|mesh-ancestor
102585534|NCT02165202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102585535|NCT02165202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102585536|NCT02165202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102585537|NCT01628874|Lidocaine|lidocaine|mesh-list
102585538|NCT01628874|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
102585539|NCT01628874|Anesthetics, Local|anesthetics, local|mesh-ancestor
102585540|NCT01628874|Anesthetics|anesthetics|mesh-ancestor
102585541|NCT01628874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102585542|NCT01628874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585543|NCT01628874|Sensory System Agents|sensory system agents|mesh-ancestor
102585544|NCT01628874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102585545|NCT01628874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102585546|NCT01628874|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102585547|NCT01628874|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102585548|NCT01628874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102585549|NCT01628874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585550|NCT01628874|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
102585551|NCT04891718|Nivolumab|nivolumab|mesh-list
102585552|NCT04891718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102585553|NCT04891718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102585554|NCT04891718|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102585555|NCT04891718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585556|NCT03770689|Capecitabine|capecitabine|mesh-list
102585557|NCT03770689|Peposertib|peposertib|mesh-list
102585558|NCT03770689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102585559|NCT03770689|Antimetabolites|antimetabolites|mesh-ancestor
102585560|NCT03770689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585561|NCT03770689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102585562|NCT03770689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102585563|NCT03770689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102585564|NCT00371306|Metformin|metformin|mesh-list
102585565|NCT00371306|Glyburide|glyburide|mesh-list
102585566|NCT00371306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102585567|NCT00371306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585568|NCT02196714|Glycopyrrolate|glycopyrrolate|mesh-list
102585569|NCT02196714|Formoterol Fumarate|formoterol fumarate|mesh-list
102585570|NCT02196714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102585571|NCT02196714|Autonomic Agents|autonomic agents|mesh-ancestor
102585572|NCT02196714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102585573|NCT02196714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585574|NCT02196714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102585575|NCT02196714|Respiratory System Agents|respiratory system agents|mesh-ancestor
102585576|NCT02196714|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102585577|NCT02196714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102585578|NCT02196714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102585579|NCT02196714|Adrenergic Agents|adrenergic agents|mesh-ancestor
102585580|NCT02196714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102585581|NCT02196714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585582|NCT02196714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102585583|NCT02196714|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102585584|NCT02196714|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102585585|NCT02196714|Cholinergic Agents|cholinergic agents|mesh-ancestor
102585586|NCT05453929|Rocuronium|rocuronium|mesh-list
102585587|NCT05453929|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102585588|NCT05453929|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102585589|NCT05453929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102585590|NCT05453929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102585591|NCT05453929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585592|NCT00370760|Dexamethasone|dexamethasone|mesh-list
102585593|NCT00370760|Colchicine|colchicine|mesh-list
102585594|NCT00370760|Heparin|heparin|mesh-list
102585595|NCT00370760|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102585596|NCT00370760|Tinzaparin|tinzaparin|mesh-list
102585597|NCT00370760|Dalteparin|dalteparin|mesh-list
102585598|NCT00370760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102585599|NCT00370760|Antiemetics|antiemetics|mesh-ancestor
102585600|NCT00370760|Autonomic Agents|autonomic agents|mesh-ancestor
102585601|NCT00370760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102585602|NCT00370760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585603|NCT00370760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102132485|NCT02419118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102585604|NCT00370760|Glucocorticoids|glucocorticoids|mesh-ancestor
102585605|NCT00370760|Hormones|hormones|mesh-ancestor
102585606|NCT00370760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102585607|NCT00370760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102585608|NCT00370760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102585609|NCT00370760|Anticoagulants|anticoagulants|mesh-ancestor
102585610|NCT00370760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102585611|NCT00370760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102585612|NCT00370760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585613|NCT00370760|Gout Suppressants|gout suppressants|mesh-ancestor
102585614|NCT00370760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102585615|NCT00370760|Tubulin Modulators|tubulin modulators|mesh-ancestor
102585616|NCT00370760|Antimitotic Agents|antimitotic agents|mesh-ancestor
102585617|NCT00370760|Mitosis Modulators|mitosis modulators|mesh-ancestor
102585618|NCT05203562|Letrozole|letrozole|mesh-list
102585619|NCT05203562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102585620|NCT05203562|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102585621|NCT05203562|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102585622|NCT05203562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102585623|NCT05203562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585624|NCT05203562|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102585625|NCT05203562|Hormone Antagonists|hormone antagonists|mesh-ancestor
102585626|NCT05203562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102585627|NCT05203562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585628|NCT04766762|Flunarizine|flunarizine|mesh-list
102585629|NCT04766762|Anticonvulsants|anticonvulsants|mesh-ancestor
102585630|NCT04766762|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102585631|NCT04766762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102585632|NCT04766762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585633|NCT04766762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102585634|NCT04766762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585635|NCT04766762|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102585636|NCT04766762|Histamine Antagonists|histamine antagonists|mesh-ancestor
102585637|NCT04766762|Histamine Agents|histamine agents|mesh-ancestor
102585638|NCT04766762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102585639|NCT04766762|Vasodilator Agents|vasodilator agents|mesh-ancestor
102585640|NCT04330040|Olaparib|olaparib|mesh-list
102585641|NCT04330040|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102585642|NCT04330040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102585643|NCT04330040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585644|NCT04330040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102585645|NCT02737891|Metoprolol|metoprolol|mesh-list
102585646|NCT02737891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102585647|NCT02737891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102585648|NCT02737891|Sympatholytics|sympatholytics|mesh-ancestor
102585649|NCT02737891|Autonomic Agents|autonomic agents|mesh-ancestor
102585650|NCT02737891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102585651|NCT02737891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585652|NCT02737891|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102585653|NCT02737891|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102585654|NCT02737891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102585655|NCT02737891|Adrenergic Agents|adrenergic agents|mesh-ancestor
102585656|NCT02737891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102585657|NCT02737891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585658|NCT05055050|Imiquimod|imiquimod|mesh-list
102585659|NCT05055050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102585660|NCT05055050|Immunologic Factors|immunologic factors|mesh-ancestor
102585661|NCT05055050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585662|NCT05055050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102585663|NCT05055050|Interferon Inducers|interferon inducers|mesh-ancestor
102585664|NCT02196558|Quetmolimab|quetmolimab|mesh-list
102585665|NCT02196558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102585666|NCT04809662|Imiquimod|imiquimod|mesh-list
102585667|NCT04809662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102585668|NCT04809662|Immunologic Factors|immunologic factors|mesh-ancestor
102585669|NCT04809662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585670|NCT04809662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102585671|NCT04809662|Interferon Inducers|interferon inducers|mesh-ancestor
102585672|NCT02196324|Serlopitant|serlopitant|mesh-list
102585673|NCT02196324|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102585674|NCT02196324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102585675|NCT02196324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585676|NCT02196324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585677|NCT05450419|Vitamin D|vitamin d|mesh-list
102585678|NCT05450419|Cholecalciferol|cholecalciferol|mesh-list
102585679|NCT05450419|Vitamins|vitamins|mesh-ancestor
102585680|NCT05450419|Micronutrients|micronutrients|mesh-ancestor
102585681|NCT05450419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585682|NCT05450419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102585683|NCT05450419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102585684|NCT05443009|Lidocaine|lidocaine|mesh-list
102585685|NCT05443009|Carticaine|carticaine|mesh-list
102585686|NCT05443009|Anesthetics, Local|anesthetics, local|mesh-ancestor
102585687|NCT05443009|Anesthetics|anesthetics|mesh-ancestor
102585688|NCT05443009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102585689|NCT05443009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585690|NCT05443009|Sensory System Agents|sensory system agents|mesh-ancestor
102585691|NCT05443009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102585692|NCT05443009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102585693|NCT05443009|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102585694|NCT05443009|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102585695|NCT05443009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102585696|NCT05443009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585697|NCT00370669|Triamcinolone|triamcinolone|mesh-list
102585698|NCT00370669|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102585699|NCT00370669|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102585700|NCT00370669|Bevacizumab|bevacizumab|mesh-list
102585701|NCT00370669|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102585702|NCT00370669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102585703|NCT00370669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102585704|NCT00370669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102585705|NCT00370669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102585706|NCT00370669|Growth Substances|growth substances|mesh-ancestor
102585707|NCT00370669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585708|NCT00370669|Growth Inhibitors|growth inhibitors|mesh-ancestor
102585709|NCT00370669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102585710|NCT00370669|Glucocorticoids|glucocorticoids|mesh-ancestor
102585711|NCT00370669|Hormones|hormones|mesh-ancestor
102585712|NCT00370669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102585713|NCT00370669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102585714|NCT00370669|Immunologic Factors|immunologic factors|mesh-ancestor
102585715|NCT00370669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102585716|NCT00370669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585717|NCT05378971|Pomalidomide|pomalidomide|mesh-list
102585718|NCT05378971|Immunologic Factors|immunologic factors|mesh-ancestor
102585719|NCT05378971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585720|NCT05378971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102585721|NCT05378971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102585722|NCT05378971|Growth Substances|growth substances|mesh-ancestor
102585723|NCT05378971|Growth Inhibitors|growth inhibitors|mesh-ancestor
102585724|NCT05378971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102585725|NCT02740543|Fluticasone|fluticasone|mesh-list
102585726|NCT02740543|Xhance|xhance|mesh-list
102585727|NCT02740543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102585728|NCT02740543|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102585729|NCT02740543|Autonomic Agents|autonomic agents|mesh-ancestor
102585730|NCT02740543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102585731|NCT02740543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585732|NCT02740543|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102585733|NCT02740543|Respiratory System Agents|respiratory system agents|mesh-ancestor
102585734|NCT02740543|Dermatologic Agents|dermatologic agents|mesh-ancestor
102585735|NCT02740543|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102585736|NCT00370747|Ecabet|ecabet|mesh-list
102585737|NCT00370747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102585738|NCT00370747|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102585739|NCT00370747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102585740|NCT00370747|Protease Inhibitors|protease inhibitors|mesh-ancestor
102585741|NCT00370747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102585742|NCT00370747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585743|NCT00370747|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102585744|NCT00370747|Protective Agents|protective agents|mesh-ancestor
102585745|NCT00370747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585746|NCT00370747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102585747|NCT02752256|Plasminogen|plasminogen|mesh-list
102585748|NCT02752256|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102585749|NCT02752256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102585750|NCT02752256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102585751|NCT02752256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132639|NCT03058757|Mitomycins|mitomycins|mesh-list
102585752|NCT02227446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102585753|NCT02227446|Vancomycin|vancomycin|mesh-list
102585754|NCT02227446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102585755|NCT04738058|Lactoferrin|lactoferrin|mesh-list
102585756|NCT04738058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102585757|NCT02227368|Ticagrelor|ticagrelor|mesh-list
102585758|NCT02227368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585759|NCT02227368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585760|NCT02227368|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102585761|NCT02227368|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102585762|NCT02227368|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102585763|NCT02227368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102585764|NCT02227368|Purinergic Agents|purinergic agents|mesh-ancestor
102585765|NCT02227368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102585766|NCT02162862|Bupropion|bupropion|mesh-list
102585767|NCT02162862|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102585768|NCT02162862|Antidepressive Agents|antidepressive agents|mesh-ancestor
102585769|NCT02162862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102585770|NCT02162862|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102585771|NCT02162862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102585772|NCT02162862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102585773|NCT02162862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585774|NCT02162862|Dopamine Agents|dopamine agents|mesh-ancestor
102585775|NCT02162862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102585776|NCT02162862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585777|NCT02162862|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102585778|NCT02162862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102585779|NCT02162862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102585780|NCT05277727|Fucoidan|fucoidan|mesh-list
102585781|NCT05277727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102585782|NCT05277727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102585783|NCT05277727|Anticoagulants|anticoagulants|mesh-ancestor
102585784|NCT05277727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102585785|NCT02226198|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102585786|NCT02226198|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102585787|NCT02226198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102585788|NCT02226198|Antimetabolites|antimetabolites|mesh-ancestor
102585789|NCT02226198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585790|NCT02226198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102585791|NCT02226198|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102585792|NCT02226198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102585793|NCT02754518|Valsartan|valsartan|mesh-list
102585794|NCT02754518|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102585795|NCT02754518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102585796|NCT02754518|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102585797|NCT02754518|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102585798|NCT02754518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585799|NCT02751385|Nintedanib|nintedanib|mesh-list
102585800|NCT02751385|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
102585801|NCT02751385|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
102585802|NCT02751385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102585803|NCT02751385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102585804|NCT02751385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102585805|NCT02751385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585806|NCT02751385|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102585807|NCT02751385|Contraceptive Agents|contraceptive agents|mesh-ancestor
102585808|NCT02751385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102585809|NCT02751385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585810|NCT02751385|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102585811|NCT02751385|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102585812|NCT02751385|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102585813|NCT02751385|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102585814|NCT02751385|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102585815|NCT02751385|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
102585816|NCT02751385|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102585817|NCT02751385|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102585818|NCT05349032|Curcumin|curcumin|mesh-list
102585819|NCT05349032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102585820|NCT05349032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102132711|NCT02416388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102585821|NCT05349032|Analgesics|analgesics|mesh-ancestor
102585822|NCT05349032|Sensory System Agents|sensory system agents|mesh-ancestor
102585823|NCT05349032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102585824|NCT05349032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585825|NCT05349032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102585826|NCT05349032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102585827|NCT05349032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102585828|NCT05349032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102585829|NCT05349032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585830|NCT05057689|Fentanyl|fentanyl|mesh-list
102585831|NCT05057689|Midazolam|midazolam|mesh-list
102585832|NCT05057689|Dexmedetomidine|dexmedetomidine|mesh-list
102585833|NCT05057689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102585834|NCT05057689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102585835|NCT05057689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585836|NCT05057689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102585837|NCT05057689|Analgesics|analgesics|mesh-ancestor
102585838|NCT05057689|Sensory System Agents|sensory system agents|mesh-ancestor
102585839|NCT05057689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102585840|NCT05057689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102585841|NCT05057689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102585842|NCT05057689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102585843|NCT05057689|Adrenergic Agents|adrenergic agents|mesh-ancestor
102585844|NCT05057689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102585845|NCT05057689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585846|NCT05057689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102585847|NCT05057689|Narcotics|narcotics|mesh-ancestor
102585848|NCT05057689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102585849|NCT05057689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102585850|NCT05057689|Anesthetics, General|anesthetics, general|mesh-ancestor
102585851|NCT05057689|Anesthetics|anesthetics|mesh-ancestor
102585852|NCT05057689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102585853|NCT05057689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102585854|NCT05057689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102585855|NCT05057689|GABA Modulators|gaba modulators|mesh-ancestor
102585856|NCT05057689|GABA Agents|gaba agents|mesh-ancestor
102585857|NCT05032183|Leucovorin|leucovorin|mesh-list
102585858|NCT05032183|Cytarabine|cytarabine|mesh-list
102585859|NCT05032183|Dexamethasone|dexamethasone|mesh-list
102585860|NCT05032183|Dexamethasone acetate|dexamethasone acetate|mesh-list
102585861|NCT05032183|Prednisone|prednisone|mesh-list
102585862|NCT05032183|Cortisone|cortisone|mesh-list
102585863|NCT05032183|Cyclophosphamide|cyclophosphamide|mesh-list
102585864|NCT05032183|Rituximab|rituximab|mesh-list
102585865|NCT05032183|Methotrexate|methotrexate|mesh-list
102585866|NCT05032183|Vincristine|vincristine|mesh-list
102585867|NCT05032183|Mercaptopurine|mercaptopurine|mesh-list
102585868|NCT05032183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102585869|NCT05032183|Antibodies|antibodies|mesh-list
102585870|NCT05032183|Immunoglobulins|immunoglobulins|mesh-list
102585871|NCT05032183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102585872|NCT05032183|Lenograstim|lenograstim|mesh-list
102585873|NCT05032183|BB 1101|bb 1101|mesh-list
102585874|NCT05032183|Mesna|mesna|mesh-list
102585875|NCT05032183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102585876|NCT05032183|Immunologic Factors|immunologic factors|mesh-ancestor
102585877|NCT05032183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585878|NCT05032183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102585879|NCT05032183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102585880|NCT05032183|Alkylating Agents|alkylating agents|mesh-ancestor
102585881|NCT05032183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585882|NCT05032183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102585883|NCT05032183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102585884|NCT05032183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102585885|NCT05032183|Antiemetics|antiemetics|mesh-ancestor
102585886|NCT05032183|Autonomic Agents|autonomic agents|mesh-ancestor
102585887|NCT05032183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102585888|NCT05032183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102585889|NCT05032183|Glucocorticoids|glucocorticoids|mesh-ancestor
102585890|NCT05032183|Hormones|hormones|mesh-ancestor
102585891|NCT05032183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102585892|NCT05032183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102585893|NCT05032183|Protease Inhibitors|protease inhibitors|mesh-ancestor
102585894|NCT05032183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102585895|NCT05032183|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102585896|NCT05032183|Abortifacient Agents|abortifacient agents|mesh-ancestor
102585897|NCT05032183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102585898|NCT05032183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102585899|NCT05032183|Antimetabolites|antimetabolites|mesh-ancestor
102585900|NCT05032183|Dermatologic Agents|dermatologic agents|mesh-ancestor
102585901|NCT05032183|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102585902|NCT05032183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102585903|NCT05032183|Antiviral Agents|antiviral agents|mesh-ancestor
102585904|NCT05032183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102585905|NCT05032183|Antidotes|antidotes|mesh-ancestor
102585906|NCT05032183|Protective Agents|protective agents|mesh-ancestor
102585907|NCT05032183|Vitamin B Complex|vitamin b complex|mesh-ancestor
102585908|NCT05032183|Vitamins|vitamins|mesh-ancestor
102585909|NCT05032183|Micronutrients|micronutrients|mesh-ancestor
102585910|NCT05032183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102585911|NCT05032183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102585912|NCT05032183|Tubulin Modulators|tubulin modulators|mesh-ancestor
102585913|NCT05032183|Antimitotic Agents|antimitotic agents|mesh-ancestor
102585914|NCT05032183|Mitosis Modulators|mitosis modulators|mesh-ancestor
102585915|NCT04737980|Dexamethasone|dexamethasone|mesh-list
102585916|NCT04737980|Bupivacaine|bupivacaine|mesh-list
102585917|NCT04737980|Ropivacaine|ropivacaine|mesh-list
102585918|NCT04737980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102585919|NCT04737980|Antiemetics|antiemetics|mesh-ancestor
102585920|NCT04737980|Autonomic Agents|autonomic agents|mesh-ancestor
102585921|NCT04737980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102585922|NCT04737980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585923|NCT04737980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102585924|NCT04737980|Glucocorticoids|glucocorticoids|mesh-ancestor
102585925|NCT04737980|Hormones|hormones|mesh-ancestor
102585926|NCT04737980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102585927|NCT04737980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102585928|NCT04737980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102585929|NCT04737980|Anesthetics, Local|anesthetics, local|mesh-ancestor
102585930|NCT04737980|Anesthetics|anesthetics|mesh-ancestor
102585931|NCT04737980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102585932|NCT04737980|Sensory System Agents|sensory system agents|mesh-ancestor
102585933|NCT00371696|Acetaminophen|acetaminophen|mesh-list
102585934|NCT00371696|Diclofenac|diclofenac|mesh-list
102585935|NCT00371696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102585936|NCT00371696|Analgesics|analgesics|mesh-ancestor
102585937|NCT00371696|Sensory System Agents|sensory system agents|mesh-ancestor
102585938|NCT00371696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102585939|NCT00371696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585940|NCT00371696|Antipyretics|antipyretics|mesh-ancestor
102585941|NCT00371696|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102585942|NCT00371696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102585943|NCT00371696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102585944|NCT00371696|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102585945|NCT00371696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102585946|NCT00371696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585947|NCT02756624|Cetirizine|cetirizine|mesh-list
102585948|NCT02756624|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102585949|NCT02756624|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102585950|NCT02756624|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102585951|NCT02756624|Histamine Antagonists|histamine antagonists|mesh-ancestor
102585952|NCT02756624|Histamine Agents|histamine agents|mesh-ancestor
102585953|NCT02756624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102585954|NCT02756624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585955|NCT02756624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585956|NCT02958800|Olanzapine|olanzapine|mesh-list
102585957|NCT02958800|Risperidone|risperidone|mesh-list
102585958|NCT02958800|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102585959|NCT02958800|Antipsychotic Agents|antipsychotic agents|mesh-list
102585960|NCT02958800|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102585961|NCT02958800|Serotonin Agents|serotonin agents|mesh-ancestor
102585962|NCT02958800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102585963|NCT02958800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585964|NCT02958800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585965|NCT02958800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102585966|NCT02958800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102585967|NCT02958800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102585968|NCT02958800|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102585969|NCT02958800|Dopamine Agents|dopamine agents|mesh-ancestor
102585970|NCT02958800|Antiemetics|antiemetics|mesh-ancestor
102585971|NCT02958800|Autonomic Agents|autonomic agents|mesh-ancestor
102585972|NCT02958800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102585973|NCT02958800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102585974|NCT02958800|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102585975|NCT02958800|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102585976|NCT02958800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102585977|NCT02958800|Antidepressive Agents|antidepressive agents|mesh-ancestor
102585978|NCT00372086|Rosiglitazone|rosiglitazone|mesh-list
102585979|NCT00372086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102585980|NCT00372086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102585981|NCT04738045|Ritonavir|ritonavir|mesh-list
102585982|NCT04738045|Lopinavir|lopinavir|mesh-list
102585983|NCT04738045|Remdesivir|remdesivir|mesh-list
102585984|NCT04738045|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102585985|NCT04738045|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102585986|NCT04738045|Protease Inhibitors|protease inhibitors|mesh-ancestor
102585987|NCT04738045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102585988|NCT04738045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585989|NCT04738045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102585990|NCT04738045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102585991|NCT04738045|Antiviral Agents|antiviral agents|mesh-ancestor
102585992|NCT04738045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102585993|NCT04738045|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102585994|NCT04738045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102585995|NCT04738045|Antimetabolites|antimetabolites|mesh-ancestor
102585996|NCT02226120|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102585997|NCT02226120|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102585998|NCT02226120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102585999|NCT04587973|Dexmedetomidine|dexmedetomidine|mesh-list
102586000|NCT04587973|Ropivacaine|ropivacaine|mesh-list
102586001|NCT04587973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102586002|NCT04587973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102586003|NCT04587973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586004|NCT04587973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102586005|NCT04587973|Analgesics|analgesics|mesh-ancestor
102586006|NCT04587973|Sensory System Agents|sensory system agents|mesh-ancestor
102586007|NCT04587973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102586008|NCT04587973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102586009|NCT04587973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102586010|NCT04587973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102586011|NCT04587973|Adrenergic Agents|adrenergic agents|mesh-ancestor
102586012|NCT04587973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102586013|NCT04587973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586014|NCT04587973|Anesthetics, Local|anesthetics, local|mesh-ancestor
102586015|NCT04587973|Anesthetics|anesthetics|mesh-ancestor
102586016|NCT02753881|Doxorubicin|doxorubicin|mesh-list
102586017|NCT02753881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102586018|NCT02753881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102586019|NCT02753881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102586020|NCT02753881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102586021|NCT02753881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102586022|NCT02753881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102586023|NCT02753881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586024|NCT00425360|Gemcitabine|gemcitabine|mesh-list
102586025|NCT00425360|Capecitabine|capecitabine|mesh-list
102586026|NCT00425360|Sargramostim|sargramostim|mesh-list
102586027|NCT00425360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102586028|NCT00425360|Antimetabolites|antimetabolites|mesh-ancestor
102586029|NCT00425360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586030|NCT00425360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102586031|NCT00425360|Immunologic Factors|immunologic factors|mesh-ancestor
102586032|NCT00425360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586033|NCT04337606|Decitabine|decitabine|mesh-list
102586034|NCT04337606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102586035|NCT04337606|Antimetabolites|antimetabolites|mesh-ancestor
102586036|NCT04337606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586037|NCT04337606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102586038|NCT04337606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102586039|NCT01190306|Riboflavin|riboflavin|mesh-list
102586040|NCT01190306|Vitamin B Complex|vitamin b complex|mesh-ancestor
102586041|NCT01190306|Vitamins|vitamins|mesh-ancestor
102586042|NCT01190306|Micronutrients|micronutrients|mesh-ancestor
102586043|NCT01190306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586044|NCT01190306|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102586045|NCT01190306|Dermatologic Agents|dermatologic agents|mesh-ancestor
102586046|NCT02759575|Pembrolizumab|pembrolizumab|mesh-list
102586047|NCT02759575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102586048|NCT02759575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102586049|NCT02759575|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102638131|NCT00716586|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102586050|NCT02759575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586051|NCT05320718|Ropivacaine|ropivacaine|mesh-list
102586052|NCT05320718|Anesthetics, Local|anesthetics, local|mesh-ancestor
102586053|NCT05320718|Anesthetics|anesthetics|mesh-ancestor
102586054|NCT05320718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102586055|NCT05320718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586056|NCT05320718|Sensory System Agents|sensory system agents|mesh-ancestor
102586057|NCT05320718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102586058|NCT02739698|Paclitaxel|paclitaxel|mesh-list
102586059|NCT02739698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102586060|NCT02739698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102586061|NCT02739698|Tubulin Modulators|tubulin modulators|mesh-ancestor
102586062|NCT02739698|Antimitotic Agents|antimitotic agents|mesh-ancestor
102586063|NCT02739698|Mitosis Modulators|mitosis modulators|mesh-ancestor
102586064|NCT02739698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586065|NCT04336904|Favipiravir|favipiravir|mesh-list
102586066|NCT04336904|Antiviral Agents|antiviral agents|mesh-ancestor
102586067|NCT04336904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102586068|NCT02767934|Pembrolizumab|pembrolizumab|mesh-list
102586069|NCT02767934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102586070|NCT02767934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102586071|NCT02767934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102586072|NCT02767934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586073|NCT02194998|Ritonavir|ritonavir|mesh-list
102586074|NCT02194998|Ribavirin|ribavirin|mesh-list
102586075|NCT02194998|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102586076|NCT02194998|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102586077|NCT02194998|Protease Inhibitors|protease inhibitors|mesh-ancestor
102586078|NCT02194998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102586079|NCT02194998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586080|NCT02194998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102586081|NCT02194998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102586082|NCT02194998|Antiviral Agents|antiviral agents|mesh-ancestor
102586083|NCT02194998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102586084|NCT02194998|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102586085|NCT02194998|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102586086|NCT02194998|Antimetabolites|antimetabolites|mesh-ancestor
102586087|NCT02194062|Fluticasone|fluticasone|mesh-list
102586089|NCT02194062|Budesonide|budesonide|mesh-list
102586090|NCT02194062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102586091|NCT02194062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102586092|NCT02194062|Autonomic Agents|autonomic agents|mesh-ancestor
102586093|NCT02194062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102586094|NCT02194062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586095|NCT02194062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102586096|NCT02194062|Respiratory System Agents|respiratory system agents|mesh-ancestor
102586097|NCT02194062|Dermatologic Agents|dermatologic agents|mesh-ancestor
102586098|NCT02194062|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102586099|NCT02194062|Glucocorticoids|glucocorticoids|mesh-ancestor
102586100|NCT02194062|Hormones|hormones|mesh-ancestor
102586101|NCT02194062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102586102|NCT02768558|Nivolumab|nivolumab|mesh-list
102586103|NCT02768558|Etoposide|etoposide|mesh-list
102586104|NCT02768558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102586105|NCT02768558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102586106|NCT02768558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102586107|NCT02768558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586108|NCT02768558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102586109|NCT02768558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102586110|NCT02768558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102586111|NCT02768558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102586112|NCT02192970|Bevacizumab|bevacizumab|mesh-list
102586113|NCT02192970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102586114|NCT02192970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102586115|NCT02192970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102586116|NCT02192970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102586117|NCT02192970|Growth Substances|growth substances|mesh-ancestor
102586118|NCT02192970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586119|NCT02192970|Growth Inhibitors|growth inhibitors|mesh-ancestor
102586120|NCT05457296|Hydrocortisone|hydrocortisone|mesh-list
102586121|NCT05457296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102586122|NCT05456438|Tea Tree Oil|tea tree oil|mesh-list
102586123|NCT05456438|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102586124|NCT05456438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102586125|NCT02744846|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102586126|NCT02744846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102586127|NCT02762071|Bupivacaine|bupivacaine|mesh-list
102586128|NCT02762071|Anesthetics, Local|anesthetics, local|mesh-ancestor
102586129|NCT02762071|Anesthetics|anesthetics|mesh-ancestor
102586130|NCT02762071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102586131|NCT02762071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586132|NCT02762071|Sensory System Agents|sensory system agents|mesh-ancestor
102586133|NCT02762071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102586134|NCT04336891|Methyltestosterone|methyltestosterone|mesh-list
102586135|NCT04336891|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102586136|NCT04336891|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102586137|NCT04336891|Estradiol|estradiol|mesh-list
102586138|NCT04336891|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102586139|NCT04336891|Testosterone|testosterone|mesh-list
102586140|NCT04336891|Testosterone undecanoate|testosterone undecanoate|mesh-list
102586141|NCT04336891|Testosterone enanthate|testosterone enanthate|mesh-list
102586142|NCT04336891|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102586143|NCT04336891|Estrogens|estrogens|mesh-ancestor
102586144|NCT04336891|Hormones|hormones|mesh-ancestor
102586145|NCT04336891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102586146|NCT04336891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586147|NCT04336891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102586148|NCT04336891|Contraceptive Agents|contraceptive agents|mesh-ancestor
102586149|NCT04336891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102586150|NCT04336891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102586151|NCT04336891|Androgens|androgens|mesh-ancestor
102586152|NCT04336891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102586153|NCT04336891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102586154|NCT04336891|Anabolic Agents|anabolic agents|mesh-ancestor
102586155|NCT04337918|Nitric Oxide|nitric oxide|mesh-list
102586156|NCT04337918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102586157|NCT04337918|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102586158|NCT04337918|Autonomic Agents|autonomic agents|mesh-ancestor
102586159|NCT04337918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102586160|NCT04337918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586161|NCT04337918|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102586162|NCT04337918|Respiratory System Agents|respiratory system agents|mesh-ancestor
102586163|NCT04337918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102586164|NCT04337918|Antioxidants|antioxidants|mesh-ancestor
102586165|NCT04337918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586166|NCT04337918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102586167|NCT04337918|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102586168|NCT04337918|Vasodilator Agents|vasodilator agents|mesh-ancestor
102586169|NCT04337918|Gasotransmitters|gasotransmitters|mesh-ancestor
102586170|NCT04337918|Protective Agents|protective agents|mesh-ancestor
102586171|NCT02747186|Lidocaine|lidocaine|mesh-list
102586172|NCT02747186|Anesthetics, Local|anesthetics, local|mesh-ancestor
102586173|NCT02747186|Anesthetics|anesthetics|mesh-ancestor
102586174|NCT02747186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102586175|NCT02747186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586176|NCT02747186|Sensory System Agents|sensory system agents|mesh-ancestor
102586177|NCT02747186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102586178|NCT02747186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102586179|NCT02747186|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102586180|NCT02747186|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102586181|NCT02747186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102586182|NCT02747186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586183|NCT02766517|Capsaicin|capsaicin|mesh-list
102586184|NCT02766517|Antipruritics|antipruritics|mesh-ancestor
102586185|NCT02766517|Dermatologic Agents|dermatologic agents|mesh-ancestor
102586186|NCT02766517|Sensory System Agents|sensory system agents|mesh-ancestor
102586187|NCT02766517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102586188|NCT02766517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586189|NCT04336046|Bupivacaine|bupivacaine|mesh-list
102586190|NCT04336046|Anesthetics, Local|anesthetics, local|mesh-ancestor
102586191|NCT04336046|Anesthetics|anesthetics|mesh-ancestor
102586192|NCT04336046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102586193|NCT04336046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586194|NCT04336046|Sensory System Agents|sensory system agents|mesh-ancestor
102586195|NCT04336046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102586196|NCT05348239|Copper|copper|mesh-list
102586197|NCT05348239|Chlorophyllin|chlorophyllin|mesh-list
102586198|NCT05348239|Trace Elements|trace elements|mesh-ancestor
102133098|NCT02406092|Prednisone|prednisone|mesh-list
102586199|NCT05348239|Micronutrients|micronutrients|mesh-ancestor
102586200|NCT05348239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586201|NCT05348239|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
102586202|NCT05348239|Protective Agents|protective agents|mesh-ancestor
102586203|NCT02766673|Albuterol|albuterol|mesh-list
102586204|NCT02766673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102586205|NCT02766673|Autonomic Agents|autonomic agents|mesh-ancestor
102586206|NCT02766673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102586207|NCT02766673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586208|NCT02766673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102586209|NCT02766673|Respiratory System Agents|respiratory system agents|mesh-ancestor
102586210|NCT02766673|Tocolytic Agents|tocolytic agents|mesh-ancestor
102586211|NCT02766673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102586212|NCT02766673|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102586213|NCT02766673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102586214|NCT02766673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102586215|NCT02766673|Adrenergic Agents|adrenergic agents|mesh-ancestor
102586216|NCT02766673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102586217|NCT02766673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586218|NCT00372008|Testosterone|testosterone|mesh-list
102586219|NCT00372008|Androgens|androgens|mesh-ancestor
102586220|NCT00372008|Hormones|hormones|mesh-ancestor
102586221|NCT00372008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102586222|NCT00372008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586223|NCT02973763|Aflutinib|aflutinib|mesh-list
102586224|NCT02973763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102586225|NCT02973763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102586226|NCT02973763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586227|NCT04337593|Pegaspargase|pegaspargase|mesh-list
102586228|NCT04337593|Basiliximab|basiliximab|mesh-list
102586229|NCT04337593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102586230|NCT04337593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102586231|NCT04337593|Immunologic Factors|immunologic factors|mesh-ancestor
102586232|NCT04337593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586233|NCT05339581|Pembrolizumab|pembrolizumab|mesh-list
102586234|NCT05339581|Tislelizumab|tislelizumab|mesh-list
102586235|NCT05339581|Lenvatinib|lenvatinib|mesh-list
102586236|NCT05339581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102586237|NCT05339581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102586238|NCT05339581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102586239|NCT05339581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586240|NCT05339581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102586241|NCT05339581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102586242|NCT04064684|Budesonide|budesonide|mesh-list
102586243|NCT04064684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102586244|NCT04064684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102586245|NCT04064684|Autonomic Agents|autonomic agents|mesh-ancestor
102586246|NCT04064684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102586247|NCT04064684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586248|NCT04064684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102586249|NCT04064684|Respiratory System Agents|respiratory system agents|mesh-ancestor
102586250|NCT04064684|Glucocorticoids|glucocorticoids|mesh-ancestor
102586251|NCT04064684|Hormones|hormones|mesh-ancestor
102586252|NCT04064684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102586253|NCT02192190|Celecoxib|celecoxib|mesh-list
102586254|NCT02192190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102586255|NCT02192190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102586256|NCT02192190|Analgesics|analgesics|mesh-ancestor
102586257|NCT02192190|Sensory System Agents|sensory system agents|mesh-ancestor
102586258|NCT02192190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102586259|NCT02192190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586260|NCT02192190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102586261|NCT02192190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102586262|NCT02192190|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102586263|NCT02192190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102586264|NCT02192190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102586265|NCT02192190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586266|NCT02748889|Carboplatin|carboplatin|mesh-list
102586267|NCT02748889|Etoposide|etoposide|mesh-list
102586268|NCT02748889|Atezolizumab|atezolizumab|mesh-list
102586269|NCT02748889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102586270|NCT02748889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102586271|NCT02748889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102586272|NCT02748889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102586273|NCT02748889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102638132|NCT00716586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102586274|NCT02748889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586275|NCT02748889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102586276|NCT02748889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102586278|NCT04654988|Azathioprine|azathioprine|mesh-list
102586279|NCT04654988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102586280|NCT04654988|Glucocorticoids|glucocorticoids|mesh-ancestor
102586281|NCT04654988|Hormones|hormones|mesh-ancestor
102586282|NCT04654988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102586283|NCT04654988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586284|NCT04654988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102586285|NCT04654988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102586286|NCT04654988|Antimetabolites|antimetabolites|mesh-ancestor
102586287|NCT04654988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586288|NCT04654988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102586289|NCT04654988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102586290|NCT04654988|Immunologic Factors|immunologic factors|mesh-ancestor
102586291|NCT04654988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102586292|NCT02224560|Cannabidiol|cannabidiol|mesh-list
102586293|NCT02224560|Anticonvulsants|anticonvulsants|mesh-ancestor
102586294|NCT00372710|Zoledronic Acid|zoledronic acid|mesh-list
102586295|NCT00372710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102586296|NCT00372710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586297|NCT02973776|Clobetasol|clobetasol|mesh-list
102586298|NCT02973776|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102586299|NCT02973776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102586300|NCT02973776|Glucocorticoids|glucocorticoids|mesh-ancestor
102586301|NCT02973776|Hormones|hormones|mesh-ancestor
102586302|NCT02973776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102586303|NCT02973776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586304|NCT02161458|Dexetimide|dexetimide|mesh-list
102586305|NCT02161458|Citalopram|citalopram|mesh-list
102586306|NCT02161458|Escitalopram|escitalopram|mesh-list
102586307|NCT02161458|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102586308|NCT02161458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102586309|NCT02161458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102586310|NCT02161458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586311|NCT02161458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102586312|NCT02161458|Serotonin Agents|serotonin agents|mesh-ancestor
102586313|NCT02161458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586314|NCT02161458|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102586315|NCT02161458|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102586316|NCT02161458|Parasympatholytics|parasympatholytics|mesh-ancestor
102586317|NCT02161458|Autonomic Agents|autonomic agents|mesh-ancestor
102586318|NCT02161458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102586319|NCT02161458|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102586320|NCT02161458|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102586321|NCT02161458|Cholinergic Agents|cholinergic agents|mesh-ancestor
102586322|NCT02161458|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102586323|NCT02161458|Antidepressive Agents|antidepressive agents|mesh-ancestor
102586324|NCT02161458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102586325|NCT04507022|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102586326|NCT04507022|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102586327|NCT04507022|Estradiol|estradiol|mesh-list
102586328|NCT04507022|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102586329|NCT04507022|Progesterone|progesterone|mesh-list
102586330|NCT04507022|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102586331|NCT04507022|Estrogens|estrogens|mesh-ancestor
102586332|NCT04507022|Hormones|hormones|mesh-ancestor
102586333|NCT04507022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102586334|NCT04507022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586335|NCT04507022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102586336|NCT04507022|Contraceptive Agents|contraceptive agents|mesh-ancestor
102586337|NCT04507022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102586338|NCT04507022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102586339|NCT04507022|Progestins|progestins|mesh-ancestor
102586340|NCT04507022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102586341|NCT04507022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102586342|NCT04507022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586343|NCT04507022|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102586344|NCT04507022|Hormone Antagonists|hormone antagonists|mesh-ancestor
102133241|NCT03171584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102586345|NCT00372788|Pemetrexed|pemetrexed|mesh-list
102586346|NCT00372788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102586347|NCT00372788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102586348|NCT00372788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586349|NCT00372788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102586350|NCT00372788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102586351|NCT00372476|Imatinib Mesylate|imatinib mesylate|mesh-list
102586352|NCT00372476|Vinorelbine|vinorelbine|mesh-list
102586353|NCT00372476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102586354|NCT00372476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102586355|NCT00372476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102586356|NCT00372476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586357|NCT00372476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102586358|NCT00372476|Tubulin Modulators|tubulin modulators|mesh-ancestor
102586359|NCT00372476|Antimitotic Agents|antimitotic agents|mesh-ancestor
102586360|NCT00372476|Mitosis Modulators|mitosis modulators|mesh-ancestor
102586361|NCT04737967|Memantine|memantine|mesh-list
102586362|NCT04737967|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102586363|NCT04737967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102586364|NCT04737967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102586365|NCT04737967|Dopamine Agents|dopamine agents|mesh-ancestor
102586366|NCT04737967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102586367|NCT04737967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586368|NCT04737967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586369|NCT04737967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102586370|NCT04737967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102586371|NCT04737967|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102586372|NCT04737967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102586373|NCT04737967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102586374|NCT04737967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102586375|NCT04737967|Antidepressive Agents|antidepressive agents|mesh-ancestor
102586376|NCT04737967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102586377|NCT04766918|Hyaluronic Acid|hyaluronic acid|mesh-list
102586378|NCT04766918|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102586379|NCT04766918|Immunologic Factors|immunologic factors|mesh-ancestor
102586380|NCT04766918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586381|NCT04766918|Viscosupplements|viscosupplements|mesh-ancestor
102586382|NCT04766918|Protective Agents|protective agents|mesh-ancestor
102586383|NCT03365414|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102586384|NCT04367090|Docetaxel|docetaxel|mesh-list
102586385|NCT04367090|Trastuzumab|trastuzumab|mesh-list
102586386|NCT04367090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102586387|NCT04367090|Tubulin Modulators|tubulin modulators|mesh-ancestor
102586388|NCT04367090|Antimitotic Agents|antimitotic agents|mesh-ancestor
102586389|NCT04367090|Mitosis Modulators|mitosis modulators|mesh-ancestor
102586390|NCT04367090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586391|NCT04367090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102586392|NCT04233476|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
102586393|NCT04233476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102586394|NCT00371995|Amphotericin B|amphotericin b|mesh-list
102586395|NCT00371995|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102586396|NCT00371995|Miltefosine|miltefosine|mesh-list
102586397|NCT00371995|Amebicides|amebicides|mesh-ancestor
102586398|NCT00371995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102586399|NCT00371995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102586400|NCT00371995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102586401|NCT00371995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102586402|NCT00371995|Antifungal Agents|antifungal agents|mesh-ancestor
102586403|NCT00371995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102586404|NCT04193306|Alirocumab|alirocumab|mesh-list
102586405|NCT04193306|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102586406|NCT04193306|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102586407|NCT04193306|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102586408|NCT04193306|Antimetabolites|antimetabolites|mesh-ancestor
102586409|NCT04193306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586410|NCT04193306|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102586411|NCT04193306|Protease Inhibitors|protease inhibitors|mesh-ancestor
102586412|NCT04193306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102586413|NCT04193306|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102586414|NCT02303678|D2C7-(scdsFv)-PE38KDEL|d2c7-(scdsfv)-pe38kdel|mesh-list
102586415|NCT02303678|Immunoconjugates|immunoconjugates|mesh-ancestor
102586416|NCT02303678|Immunologic Factors|immunologic factors|mesh-ancestor
102586417|NCT02303678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586418|NCT00372307|Pimecrolimus|pimecrolimus|mesh-list
102586419|NCT00372307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102586420|NCT00372307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102586421|NCT00372307|Analgesics|analgesics|mesh-ancestor
102586422|NCT00372307|Sensory System Agents|sensory system agents|mesh-ancestor
102586423|NCT00372307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102586424|NCT00372307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586425|NCT00372307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102586426|NCT00372307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102586427|NCT00372307|Dermatologic Agents|dermatologic agents|mesh-ancestor
102586428|NCT00372307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102586429|NCT00372307|Immunologic Factors|immunologic factors|mesh-ancestor
102586430|NCT00372307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102586431|NCT00372307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102586432|NCT00372307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586433|NCT04647110|Crizotinib|crizotinib|mesh-list
102586434|NCT04647110|Ceritinib|ceritinib|mesh-list
102586435|NCT04647110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344358|NCT03410030|Antimetabolites|antimetabolites|mesh-ancestor
102586436|NCT04647110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102586437|NCT04647110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102586438|NCT04647110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586439|NCT04061330|Ketamine|ketamine|mesh-list
102586440|NCT04061330|Morphine|morphine|mesh-list
102586441|NCT04061330|Analgesics|analgesics|mesh-ancestor
102586442|NCT04061330|Sensory System Agents|sensory system agents|mesh-ancestor
102586443|NCT04061330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102586444|NCT04061330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586445|NCT04061330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102586446|NCT04061330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102586447|NCT04061330|Anesthetics, General|anesthetics, general|mesh-ancestor
102586448|NCT04061330|Anesthetics|anesthetics|mesh-ancestor
102586449|NCT04061330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102586450|NCT04061330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102586451|NCT04061330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102586452|NCT04061330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102586453|NCT04061330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586454|NCT04061330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102586455|NCT04061330|Narcotics|narcotics|mesh-ancestor
102586456|NCT00372632|Pyrimethamine|pyrimethamine|mesh-list
102586457|NCT00372632|Sulfadoxine|sulfadoxine|mesh-list
102586458|NCT00372632|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
102586459|NCT00372632|Antimalarials|antimalarials|mesh-ancestor
102586460|NCT00372632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102586461|NCT00372632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102586462|NCT00372632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102586463|NCT00372632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102586464|NCT00372632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102586465|NCT00372632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586466|NCT00372632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102586467|NCT04792021|Acetylcysteine|acetylcysteine|mesh-list
102586468|NCT04792021|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102586469|NCT04792021|Antiviral Agents|antiviral agents|mesh-ancestor
102586470|NCT04792021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102586471|NCT04792021|Expectorants|expectorants|mesh-ancestor
102586472|NCT04792021|Respiratory System Agents|respiratory system agents|mesh-ancestor
102586473|NCT04792021|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102586474|NCT04792021|Antioxidants|antioxidants|mesh-ancestor
102586475|NCT04792021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586476|NCT04792021|Protective Agents|protective agents|mesh-ancestor
102586477|NCT04792021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586478|NCT04792021|Antidotes|antidotes|mesh-ancestor
102586479|NCT04333927|Immunomodulating Agents|immunomodulating agents|mesh-list
102586480|NCT04333927|Immunologic Factors|immunologic factors|mesh-ancestor
102586481|NCT04333927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586482|NCT04334005|Vitamin D|vitamin d|mesh-list
102586483|NCT04334005|Vitamins|vitamins|mesh-ancestor
102586484|NCT04334005|Micronutrients|micronutrients|mesh-ancestor
102586485|NCT04334005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586486|NCT04334005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102586487|NCT00966914|Paclitaxel|paclitaxel|mesh-list
102586488|NCT00966914|Docetaxel|docetaxel|mesh-list
102586489|NCT00966914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102586490|NCT00966914|Cisplatin|cisplatin|mesh-list
102586491|NCT00966914|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
102586492|NCT00966914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102586493|NCT00966914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102586494|NCT00966914|Tubulin Modulators|tubulin modulators|mesh-ancestor
102586495|NCT00966914|Antimitotic Agents|antimitotic agents|mesh-ancestor
102586496|NCT00966914|Mitosis Modulators|mitosis modulators|mesh-ancestor
102586497|NCT00966914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586498|NCT00966914|Protective Agents|protective agents|mesh-ancestor
102586499|NCT00966914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586500|NCT04432285|Botulinum Toxins|botulinum toxins|mesh-list
102586501|NCT04432285|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102586502|NCT04432285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102586503|NCT04432285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586504|NCT04432285|Cholinergic Agents|cholinergic agents|mesh-ancestor
102586505|NCT04432285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102586506|NCT04432285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586507|NCT04430959|Candesartan|candesartan|mesh-list
102586508|NCT04430959|Candesartan cilexetil|candesartan cilexetil|mesh-list
102586509|NCT04430959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102586510|NCT04430959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102586511|NCT04430959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102586512|NCT04430959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586513|NCT04737655|Beclomethasone|beclomethasone|mesh-list
102586514|NCT04737655|Glycopyrrolate|glycopyrrolate|mesh-list
102586515|NCT04737655|Formoterol Fumarate|formoterol fumarate|mesh-list
102586516|NCT04737655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102586517|NCT04737655|Autonomic Agents|autonomic agents|mesh-ancestor
102586518|NCT04737655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102586519|NCT04737655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586520|NCT04737655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102586521|NCT04737655|Respiratory System Agents|respiratory system agents|mesh-ancestor
102586522|NCT04737655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102586523|NCT04737655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102586524|NCT04737655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102586525|NCT04737655|Adrenergic Agents|adrenergic agents|mesh-ancestor
102586526|NCT04737655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102586527|NCT04737655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586528|NCT04737655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102586529|NCT04737655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102586530|NCT04737655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102586531|NCT04737655|Cholinergic Agents|cholinergic agents|mesh-ancestor
102586532|NCT04737655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102586533|NCT04737655|Glucocorticoids|glucocorticoids|mesh-ancestor
102586534|NCT04737655|Hormones|hormones|mesh-ancestor
102586535|NCT04737655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102586536|NCT05063396|Analgesics, Opioid|analgesics, opioid|mesh-list
102586537|NCT05063396|Anesthetics|anesthetics|mesh-list
102586538|NCT05063396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102586539|NCT05063396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586540|NCT05063396|Narcotics|narcotics|mesh-ancestor
102586541|NCT05063396|Analgesics|analgesics|mesh-ancestor
102586542|NCT05063396|Sensory System Agents|sensory system agents|mesh-ancestor
102586543|NCT05063396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102586544|NCT05055752|Aspirin|aspirin|mesh-list
102586545|NCT05055752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102586546|NCT05055752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102586547|NCT05055752|Analgesics|analgesics|mesh-ancestor
102586548|NCT05055752|Sensory System Agents|sensory system agents|mesh-ancestor
102586549|NCT05055752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102586550|NCT05055752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586551|NCT05055752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102586552|NCT05055752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102586553|NCT05055752|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102586554|NCT05055752|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102586555|NCT05055752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586556|NCT05055752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102586557|NCT05055752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102586558|NCT05055752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102586559|NCT05055752|Antipyretics|antipyretics|mesh-ancestor
102586560|NCT04209140|Lithium Carbonate|lithium carbonate|mesh-list
102586561|NCT04209140|Antidepressive Agents|antidepressive agents|mesh-ancestor
102586562|NCT04209140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102586563|NCT04209140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102586564|NCT04209140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586565|NCT04209140|Antimanic Agents|antimanic agents|mesh-ancestor
102586566|NCT04209140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102586567|NCT04209140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102586568|NCT04209140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586569|NCT00372541|Ceftriaxone|ceftriaxone|mesh-list
102586570|NCT00372541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102133463|NCT04465851|Analgesics|analgesics|mesh-ancestor
102586571|NCT00372541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102586572|NCT04762381|Dexamethasone|dexamethasone|mesh-list
102586573|NCT04762381|Glucocorticoids|glucocorticoids|mesh-list
102586574|NCT04762381|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102586575|NCT04762381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102586576|NCT04762381|Antiemetics|antiemetics|mesh-ancestor
102586577|NCT04762381|Autonomic Agents|autonomic agents|mesh-ancestor
102344363|NCT03410030|Micronutrients|micronutrients|mesh-ancestor
102586578|NCT04762381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102586579|NCT04762381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586580|NCT04762381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102586581|NCT04762381|Hormones|hormones|mesh-ancestor
102586582|NCT04762381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102586583|NCT04762381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102586584|NCT04762381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102586585|NCT01547468|Analgesics, Opioid|analgesics, opioid|mesh-list
102586586|NCT01547468|Narcotics|narcotics|mesh-ancestor
102586587|NCT01547468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102586588|NCT01547468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586589|NCT01547468|Analgesics|analgesics|mesh-ancestor
102586590|NCT01547468|Sensory System Agents|sensory system agents|mesh-ancestor
102586591|NCT01547468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102586592|NCT04333628|Chloroquine|chloroquine|mesh-list
102586593|NCT04333628|Amebicides|amebicides|mesh-ancestor
102586594|NCT04333628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102586595|NCT04333628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102586596|NCT04333628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102586597|NCT04333628|Antimalarials|antimalarials|mesh-ancestor
102586598|NCT04333628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102586599|NCT00373412|Vaccines|vaccines|mesh-list
102586600|NCT00373412|Immunologic Factors|immunologic factors|mesh-ancestor
102586601|NCT00373412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586602|NCT00373178|Metformin|metformin|mesh-list
102586603|NCT00373178|Rosiglitazone|rosiglitazone|mesh-list
102586604|NCT00373178|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102586605|NCT00373178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586606|NCT03254732|Pembrolizumab|pembrolizumab|mesh-list
102586607|NCT03254732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102586608|NCT03254732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102586609|NCT03254732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102586610|NCT03254732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586611|NCT02923466|Interferon-beta|interferon-beta|mesh-list
102586612|NCT02923466|Avelumab|avelumab|mesh-list
102586613|NCT02923466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102586614|NCT02923466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102586615|NCT02923466|Antiviral Agents|antiviral agents|mesh-ancestor
102586616|NCT02923466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102586617|NCT02923466|Immunologic Factors|immunologic factors|mesh-ancestor
102586618|NCT02923466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586619|NCT00813566|Deoxyglucose|deoxyglucose|mesh-list
102586620|NCT00813566|Antimetabolites|antimetabolites|mesh-ancestor
102586621|NCT00813566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586622|NCT00813566|Antiviral Agents|antiviral agents|mesh-ancestor
102586623|NCT00813566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102586624|NCT02885012|Ambrisentan|ambrisentan|mesh-list
102586625|NCT02885012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102586626|NCT00372853|Tremelimumab|tremelimumab|mesh-list
102586627|NCT00372853|Ipilimumab|ipilimumab|mesh-list
102586628|NCT00372853|Sunitinib|sunitinib|mesh-list
102586629|NCT00372853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102586630|NCT00372853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102586631|NCT00372853|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102586632|NCT00372853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586633|NCT00372853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102586634|NCT00372853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102586635|NCT00372853|Growth Substances|growth substances|mesh-ancestor
102586636|NCT00372853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586637|NCT00372853|Growth Inhibitors|growth inhibitors|mesh-ancestor
102586638|NCT00372853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102586639|NCT00372853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102586640|NCT02885636|Albuterol|albuterol|mesh-list
102586641|NCT02885636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102586642|NCT02885636|Autonomic Agents|autonomic agents|mesh-ancestor
102586643|NCT02885636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102586644|NCT02885636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133553|NCT02410694|Ixazomib|ixazomib|mesh-list
102586645|NCT02885636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102586646|NCT02885636|Respiratory System Agents|respiratory system agents|mesh-ancestor
102586648|NCT02885636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102586649|NCT02885636|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102586650|NCT02885636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102586651|NCT02885636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102586652|NCT02885636|Adrenergic Agents|adrenergic agents|mesh-ancestor
102586653|NCT02885636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102586654|NCT02885636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586655|NCT00373087|Entacapone|entacapone|mesh-list
102586656|NCT00373087|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102586657|NCT00373087|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102586658|NCT00373087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586659|NCT00373087|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102586660|NCT00373087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102586661|NCT02892110|Varenicline|varenicline|mesh-list
102586662|NCT02892110|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102586663|NCT02892110|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102586664|NCT02892110|Cholinergic Agents|cholinergic agents|mesh-ancestor
102586665|NCT02892110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102586666|NCT02892110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586667|NCT02892110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586668|NCT02779166|Celecoxib|celecoxib|mesh-list
102586669|NCT02779166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102586670|NCT02779166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102586671|NCT02779166|Analgesics|analgesics|mesh-ancestor
102586672|NCT02779166|Sensory System Agents|sensory system agents|mesh-ancestor
102586673|NCT02779166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102586674|NCT02779166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586675|NCT02779166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102586676|NCT02779166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102586677|NCT02779166|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102586678|NCT02779166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102586679|NCT02779166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102586680|NCT02779166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586681|NCT00373165|Ganciclovir|ganciclovir|mesh-list
102586682|NCT00373165|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102586683|NCT00373165|Antiviral Agents|antiviral agents|mesh-ancestor
102586684|NCT00373165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102586685|NCT00373165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102586686|NCT00373165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102586687|NCT00373165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586688|NCT04333550|Deferoxamine|deferoxamine|mesh-list
102586689|NCT04333550|Siderophores|siderophores|mesh-ancestor
102586690|NCT04333550|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102586691|NCT04333550|Chelating Agents|chelating agents|mesh-ancestor
102586692|NCT04333550|Sequestering Agents|sequestering agents|mesh-ancestor
102586693|NCT04333550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586694|NCT02827838|Durvalumab|durvalumab|mesh-list
102586695|NCT02827838|Immunoglobulins|immunoglobulins|mesh-list
102586696|NCT02827838|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102586697|NCT02827838|Immunoglobulin G|immunoglobulin g|mesh-list
102586698|NCT02827838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102586699|NCT02827838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102586700|NCT02827838|Immunologic Factors|immunologic factors|mesh-ancestor
102586701|NCT02827838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586702|NCT02902172|Acetaminophen|acetaminophen|mesh-list
102586703|NCT02902172|Ibuprofen|ibuprofen|mesh-list
102586704|NCT02902172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102586705|NCT02902172|Analgesics|analgesics|mesh-ancestor
102586706|NCT02902172|Sensory System Agents|sensory system agents|mesh-ancestor
102586707|NCT02902172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102586708|NCT02902172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586709|NCT02902172|Antipyretics|antipyretics|mesh-ancestor
102586710|NCT02902172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102586711|NCT02902172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102586712|NCT02902172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102586713|NCT02902172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102586714|NCT02902172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102586715|NCT02902172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586716|NCT04208347|Oxaliplatin|oxaliplatin|mesh-list
102586717|NCT04208347|Apatinib|apatinib|mesh-list
102586718|NCT04208347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102586719|NCT04208347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102586720|NCT04208347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102586721|NCT04208347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586722|NCT02777749|Bupivacaine|bupivacaine|mesh-list
102586723|NCT02777749|Anesthetics, Local|anesthetics, local|mesh-ancestor
102586724|NCT02777749|Anesthetics|anesthetics|mesh-ancestor
102586725|NCT02777749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102586726|NCT02777749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586727|NCT02777749|Sensory System Agents|sensory system agents|mesh-ancestor
102586728|NCT02777749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102586730|NCT02785172|Halobetasol|halobetasol|mesh-list
102586731|NCT02785172|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102586732|NCT02785172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102586733|NCT02785172|Glucocorticoids|glucocorticoids|mesh-ancestor
102586734|NCT02785172|Hormones|hormones|mesh-ancestor
102586735|NCT02785172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102586736|NCT02785172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586737|NCT02582125|Nivolumab|nivolumab|mesh-list
102586738|NCT02582125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102586739|NCT02582125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102586740|NCT02582125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102586741|NCT02582125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586742|NCT02785406|Suvorexant|suvorexant|mesh-list
102586743|NCT02785406|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102586744|NCT02785406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102586745|NCT02785406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102586746|NCT02785406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586747|NCT02785406|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102586748|NCT02785406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102586749|NCT02785406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586750|NCT02062489|Tamoxifen|tamoxifen|mesh-list
102586751|NCT02062489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102586752|NCT02062489|Hormone Antagonists|hormone antagonists|mesh-ancestor
102586753|NCT02062489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102586754|NCT02062489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586755|NCT02062489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102586756|NCT02062489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102586757|NCT02062489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102586758|NCT02062489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102586759|NCT02062489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102586760|NCT02780869|Thrombin|thrombin|mesh-list
102586761|NCT02780869|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
102586762|NCT02780869|Hemostatics|hemostatics|mesh-ancestor
102586763|NCT02780869|Coagulants|coagulants|mesh-ancestor
102586764|NCT02908490|Sildenafil Citrate|sildenafil citrate|mesh-list
102586765|NCT02908490|Vasodilator Agents|vasodilator agents|mesh-ancestor
102586766|NCT02908490|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102586767|NCT02908490|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102586768|NCT02908490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102586769|NCT02908490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586770|NCT02908490|Urological Agents|urological agents|mesh-ancestor
102586771|NCT02911844|Fulvestrant|fulvestrant|mesh-list
102586772|NCT02911844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102586773|NCT02911844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102586774|NCT02911844|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102586775|NCT02911844|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102586776|NCT02911844|Hormone Antagonists|hormone antagonists|mesh-ancestor
102586777|NCT02911844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102586778|NCT02911844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586779|NCT02790788|Methylprednisolone|methylprednisolone|mesh-list
102586780|NCT02790788|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102586781|NCT02790788|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102586782|NCT02790788|Prednisolone|prednisolone|mesh-list
102586783|NCT02790788|Prednisolone acetate|prednisolone acetate|mesh-list
102586784|NCT02790788|Hydrocortisone|hydrocortisone|mesh-list
102586785|NCT02790788|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102586786|NCT02790788|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102586787|NCT02790788|Prednisolone phosphate|prednisolone phosphate|mesh-list
102586788|NCT02790788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102586789|NCT02790788|Antiemetics|antiemetics|mesh-ancestor
102586790|NCT02790788|Autonomic Agents|autonomic agents|mesh-ancestor
102586791|NCT02790788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102586792|NCT02790788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586793|NCT02790788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102586794|NCT02790788|Glucocorticoids|glucocorticoids|mesh-ancestor
102586795|NCT02790788|Hormones|hormones|mesh-ancestor
102586796|NCT02790788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102586797|NCT02790788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102586798|NCT02790788|Protective Agents|protective agents|mesh-ancestor
102586799|NCT02790788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102586800|NCT02790788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102586801|NCT02888665|Doxorubicin|doxorubicin|mesh-list
102586802|NCT02888665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102586803|NCT02888665|Pembrolizumab|pembrolizumab|mesh-list
102586804|NCT02888665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102586805|NCT02888665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102586806|NCT02888665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102586807|NCT02888665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102586808|NCT02888665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102586809|NCT02888665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586810|NCT02888665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102586811|NCT02888665|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102586812|NCT02781571|Sofosbuvir|sofosbuvir|mesh-list
102586813|NCT02781571|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102586814|NCT02781571|Velpatasvir|velpatasvir|mesh-list
102586815|NCT02781571|Antiviral Agents|antiviral agents|mesh-ancestor
102586816|NCT02781571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102586817|NCT02918630|Nicotine|nicotine|mesh-list
102586818|NCT02918630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102586819|NCT02918630|Autonomic Agents|autonomic agents|mesh-ancestor
102586820|NCT02918630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102586821|NCT02918630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586822|NCT02918630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102586823|NCT02918630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102586824|NCT02918630|Cholinergic Agents|cholinergic agents|mesh-ancestor
102586825|NCT02918630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102586826|NCT02918630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586827|NCT02781649|Ribavirin|ribavirin|mesh-list
102586828|NCT02781649|Sofosbuvir|sofosbuvir|mesh-list
102586829|NCT02781649|Grazoprevir|grazoprevir|mesh-list
102586830|NCT02781649|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
102586831|NCT02781649|Antimetabolites|antimetabolites|mesh-ancestor
102586832|NCT02781649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586833|NCT02781649|Antiviral Agents|antiviral agents|mesh-ancestor
102586834|NCT02781649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102586835|NCT02794844|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
102586836|NCT02794844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102586837|NCT02794844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586838|NCT02783443|Anesthetics|anesthetics|mesh-list
102586839|NCT02783443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102586840|NCT02783443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586841|NCT00373568|Miltefosine|miltefosine|mesh-list
102586842|NCT00373568|Antifungal Agents|antifungal agents|mesh-ancestor
102586843|NCT00373568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102586844|NCT00373568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102586845|NCT00373568|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102586846|NCT00373568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102586847|NCT03002012|Fluconazole|fluconazole|mesh-list
102586848|NCT03002012|Sertraline|sertraline|mesh-list
102586849|NCT03002012|Antidepressive Agents|antidepressive agents|mesh-ancestor
102586850|NCT03002012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102586851|NCT03002012|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102586852|NCT03002012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102586853|NCT03002012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102586854|NCT03002012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586855|NCT03002012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102586856|NCT03002012|Serotonin Agents|serotonin agents|mesh-ancestor
102586857|NCT03002012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586858|NCT03002012|Antifungal Agents|antifungal agents|mesh-ancestor
102586859|NCT03002012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102586860|NCT03002012|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102586861|NCT03002012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102586862|NCT03002012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102586863|NCT03002012|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102586864|NCT03002012|Hormone Antagonists|hormone antagonists|mesh-ancestor
102586865|NCT03002012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102586866|NCT03002012|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102133761|NCT02289261|Analgesics|analgesics|mesh-ancestor
102586867|NCT03002012|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102586868|NCT00373646|Thalidomide|thalidomide|mesh-list
102586869|NCT00373646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102586870|NCT00373646|Immunologic Factors|immunologic factors|mesh-ancestor
102586871|NCT00373646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586872|NCT00373646|Leprostatic Agents|leprostatic agents|mesh-ancestor
102586873|NCT00373646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102586874|NCT00373646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102586875|NCT00373646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102586876|NCT00373646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102586877|NCT00373646|Growth Substances|growth substances|mesh-ancestor
102586878|NCT00373646|Growth Inhibitors|growth inhibitors|mesh-ancestor
102586879|NCT00373646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102586880|NCT03001453|Epinephrine|epinephrine|mesh-list
102586881|NCT03001453|Bupivacaine|bupivacaine|mesh-list
102586882|NCT03001453|Anesthetics, Local|anesthetics, local|mesh-ancestor
102586883|NCT03001453|Anesthetics|anesthetics|mesh-ancestor
102586884|NCT03001453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102586885|NCT03001453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586886|NCT03001453|Sensory System Agents|sensory system agents|mesh-ancestor
102586887|NCT03001453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102586888|NCT03001453|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102586889|NCT03001453|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102586890|NCT03001453|Adrenergic Agents|adrenergic agents|mesh-ancestor
102586891|NCT03001453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102586892|NCT03001453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586893|NCT03001453|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102586894|NCT03001453|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102586895|NCT03001453|Autonomic Agents|autonomic agents|mesh-ancestor
102586896|NCT03001453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102586897|NCT03001453|Respiratory System Agents|respiratory system agents|mesh-ancestor
102586898|NCT03001453|Mydriatics|mydriatics|mesh-ancestor
102586899|NCT03001453|Sympathomimetics|sympathomimetics|mesh-ancestor
102586900|NCT03001453|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102586901|NCT03001843|Ketamine|ketamine|mesh-list
102586902|NCT03001843|Narcotics|narcotics|mesh-list
102586903|NCT03001843|Analgesics|analgesics|mesh-ancestor
102586904|NCT03001843|Sensory System Agents|sensory system agents|mesh-ancestor
102586905|NCT03001843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102586906|NCT03001843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586907|NCT03001843|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102586908|NCT03001843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102586909|NCT03001843|Anesthetics, General|anesthetics, general|mesh-ancestor
102586910|NCT03001843|Anesthetics|anesthetics|mesh-ancestor
102586911|NCT03001843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102586912|NCT03001843|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102586913|NCT03001843|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102586914|NCT03001843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102586915|NCT03001843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586916|NCT02785159|Tazarotene|tazarotene|mesh-list
102586917|NCT02785159|Dermatologic Agents|dermatologic agents|mesh-ancestor
102586918|NCT02785159|Keratolytic Agents|keratolytic agents|mesh-ancestor
102586919|NCT02786719|Cyclophosphamide|cyclophosphamide|mesh-list
102586920|NCT02786719|Doxorubicin|doxorubicin|mesh-list
102586921|NCT02786719|Etoposide|etoposide|mesh-list
102586922|NCT02786719|Vincristine|vincristine|mesh-list
102586923|NCT02786719|Topotecan|topotecan|mesh-list
102586924|NCT02786719|Sargramostim|sargramostim|mesh-list
102586925|NCT02786719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102586926|NCT02786719|Immunologic Factors|immunologic factors|mesh-ancestor
102586927|NCT02786719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586928|NCT02786719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102586929|NCT02786719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102586930|NCT02786719|Alkylating Agents|alkylating agents|mesh-ancestor
102586931|NCT02786719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586932|NCT02786719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102586933|NCT02786719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102586934|NCT02786719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102586935|NCT02786719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102586936|NCT02786719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102586937|NCT02786719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102586938|NCT02786719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102586939|NCT02786719|Tubulin Modulators|tubulin modulators|mesh-ancestor
102586940|NCT02786719|Antimitotic Agents|antimitotic agents|mesh-ancestor
102586941|NCT02786719|Mitosis Modulators|mitosis modulators|mesh-ancestor
102586942|NCT02786719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102586943|NCT03003949|Estradiol|estradiol|mesh-list
102586944|NCT03003949|Progesterone|progesterone|mesh-list
102586945|NCT03003949|Estrogens|estrogens|mesh-ancestor
102586946|NCT03003949|Hormones|hormones|mesh-ancestor
102586947|NCT03003949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102586948|NCT03003949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586949|NCT03003949|Progestins|progestins|mesh-ancestor
102586950|NCT03007225|Chlorotrianisene|chlorotrianisene|mesh-list
102586951|NCT03007225|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102586952|NCT03007225|Estrogens|estrogens|mesh-ancestor
102586953|NCT03007225|Hormones|hormones|mesh-ancestor
102586954|NCT03007225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102586955|NCT03007225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586956|NCT03007225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102586957|NCT03007225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102586958|NCT02800148|Azelaic acid|azelaic acid|mesh-list
102586959|NCT02800148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102586960|NCT02800148|Dermatologic Agents|dermatologic agents|mesh-ancestor
102586961|NCT02902081|Cannabidiol|cannabidiol|mesh-list
102586962|NCT02902081|Anticonvulsants|anticonvulsants|mesh-ancestor
102586963|NCT02791945|Acetylcysteine|acetylcysteine|mesh-list
102586964|NCT02791945|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102586965|NCT02791945|Antiviral Agents|antiviral agents|mesh-ancestor
102586966|NCT02791945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102586967|NCT02791945|Expectorants|expectorants|mesh-ancestor
102586968|NCT02791945|Respiratory System Agents|respiratory system agents|mesh-ancestor
102586969|NCT02791945|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102586970|NCT02791945|Antioxidants|antioxidants|mesh-ancestor
102586971|NCT02791945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102586972|NCT02791945|Protective Agents|protective agents|mesh-ancestor
102586973|NCT02791945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586974|NCT02791945|Antidotes|antidotes|mesh-ancestor
102586975|NCT02793817|Loteprednol Etabonate|loteprednol etabonate|mesh-list
102586976|NCT02793817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102586977|NCT00374192|Eszopiclone|eszopiclone|mesh-list
102586978|NCT00374192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102586979|NCT00374192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102586980|NCT00374192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586981|NCT02806544|Tamoxifen|tamoxifen|mesh-list
102586982|NCT02806544|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102586983|NCT02806544|Hormone Antagonists|hormone antagonists|mesh-ancestor
102586984|NCT02806544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102586985|NCT02806544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586986|NCT02806544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102586987|NCT02806544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102586988|NCT02806544|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102586989|NCT02806544|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102586990|NCT02806544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102586991|NCT00374348|Aripiprazole|aripiprazole|mesh-list
102586992|NCT00374348|Antidepressive Agents|antidepressive agents|mesh-ancestor
102586993|NCT00374348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102586994|NCT00374348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102586995|NCT00374348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102586996|NCT00374348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102586997|NCT00374348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102586998|NCT00374348|Dopamine Agonists|dopamine agonists|mesh-ancestor
102586999|NCT00374348|Dopamine Agents|dopamine agents|mesh-ancestor
102587000|NCT00374348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102587001|NCT00374348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587002|NCT00374348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102587003|NCT00374348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102587004|NCT00374348|Serotonin Agents|serotonin agents|mesh-ancestor
102587005|NCT00374348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102587006|NCT00374348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102587007|NCT00374348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102587008|NCT00374348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102587009|NCT02933372|Varenicline|varenicline|mesh-list
102587010|NCT02933372|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102587011|NCT02933372|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102587012|NCT02933372|Cholinergic Agents|cholinergic agents|mesh-ancestor
102587013|NCT02933372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102587014|NCT02933372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587015|NCT02933372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587016|NCT02902237|Thromboplastin|thromboplastin|mesh-list
102587017|NCT02902237|Hemostatics|hemostatics|mesh-ancestor
102587018|NCT02902237|Coagulants|coagulants|mesh-ancestor
102587019|NCT02903407|Midazolam|midazolam|mesh-list
102587021|NCT02903407|Propofol|propofol|mesh-list
102587022|NCT02903407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102587023|NCT02903407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102587024|NCT02903407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587025|NCT02903407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102587026|NCT02903407|Analgesics|analgesics|mesh-ancestor
102587027|NCT02903407|Sensory System Agents|sensory system agents|mesh-ancestor
102587028|NCT02903407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102587029|NCT02903407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102587030|NCT02903407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102587031|NCT02903407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102587032|NCT02903407|Adrenergic Agents|adrenergic agents|mesh-ancestor
102587033|NCT02903407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102587034|NCT02903407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587035|NCT02903407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102587036|NCT02903407|Anesthetics, General|anesthetics, general|mesh-ancestor
102587037|NCT02903407|Anesthetics|anesthetics|mesh-ancestor
102587038|NCT02903407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102587039|NCT02903407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102587040|NCT02903407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102587041|NCT02903407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102587042|NCT02903407|GABA Modulators|gaba modulators|mesh-ancestor
102587043|NCT02903407|GABA Agents|gaba agents|mesh-ancestor
102587044|NCT02905981|Citric Acid|citric acid|mesh-list
102587045|NCT02905981|Sodium Citrate|sodium citrate|mesh-list
102587046|NCT02905981|Anticoagulants|anticoagulants|mesh-ancestor
102587047|NCT02905981|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102587048|NCT02905981|Chelating Agents|chelating agents|mesh-ancestor
102587049|NCT02905981|Sequestering Agents|sequestering agents|mesh-ancestor
102587050|NCT02905981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587051|NCT00374023|Vitamin A|vitamin a|mesh-list
102587052|NCT00374023|Vitamins|vitamins|mesh-ancestor
102587053|NCT00374023|Micronutrients|micronutrients|mesh-ancestor
102587054|NCT00374023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587055|NCT02812238|Niacinamide|niacinamide|mesh-list
102587056|NCT02812238|Niacin|niacin|mesh-list
102587057|NCT02812238|Nicotinic Acids|nicotinic acids|mesh-list
102587058|NCT02812238|Vitamin B Complex|vitamin b complex|mesh-ancestor
102587059|NCT02812238|Vitamins|vitamins|mesh-ancestor
102587060|NCT02812238|Micronutrients|micronutrients|mesh-ancestor
102587061|NCT02812238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587062|NCT02812238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102587063|NCT02812238|Antimetabolites|antimetabolites|mesh-ancestor
102587064|NCT02812238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587065|NCT02812238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102587066|NCT02812238|Vasodilator Agents|vasodilator agents|mesh-ancestor
102587067|NCT03015961|Bupivacaine|bupivacaine|mesh-list
102587068|NCT03015961|Anesthetics, Local|anesthetics, local|mesh-ancestor
102587069|NCT03015961|Anesthetics|anesthetics|mesh-ancestor
102587070|NCT03015961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102587071|NCT03015961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587072|NCT03015961|Sensory System Agents|sensory system agents|mesh-ancestor
102587073|NCT03015961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102587074|NCT03018223|Mycophenolic Acid|mycophenolic acid|mesh-list
102587075|NCT03018223|Sirolimus|sirolimus|mesh-list
102587076|NCT03018223|Cyclophosphamide|cyclophosphamide|mesh-list
102587077|NCT03018223|Busulfan|busulfan|mesh-list
102587078|NCT03018223|Fludarabine|fludarabine|mesh-list
102587079|NCT03018223|Lenograstim|lenograstim|mesh-list
102587080|NCT03018223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102587081|NCT03018223|Immunologic Factors|immunologic factors|mesh-ancestor
102587082|NCT03018223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587083|NCT03018223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102587084|NCT03018223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102587085|NCT03018223|Alkylating Agents|alkylating agents|mesh-ancestor
102587086|NCT03018223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587087|NCT03018223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102587088|NCT03018223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102587089|NCT03018223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102587090|NCT03018223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102587091|NCT03018223|Antitubercular Agents|antitubercular agents|mesh-ancestor
102587092|NCT03018223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102587093|NCT03018223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102587094|NCT03018223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102587095|NCT03018223|Antifungal Agents|antifungal agents|mesh-ancestor
102587096|NCT03018223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102587097|NCT03018925|Golimumab|golimumab|mesh-list
102587098|NCT03018925|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102587099|NCT03018925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102587100|NCT03018925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102587101|NCT03018925|Immunologic Factors|immunologic factors|mesh-ancestor
102587102|NCT03018925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587103|NCT03019783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102587104|NCT03019783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102587105|NCT03019783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102587106|NCT03019783|Protease Inhibitors|protease inhibitors|mesh-ancestor
102587107|NCT03019783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102587108|NCT03019783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587109|NCT03019783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102587110|NCT03019783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102587111|NCT03019783|Antiviral Agents|antiviral agents|mesh-ancestor
102587112|NCT03019783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102587113|NCT03019939|Isavuconazole|isavuconazole|mesh-list
102587114|NCT03019939|Antifungal Agents|antifungal agents|mesh-ancestor
102587115|NCT03019939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102587116|NCT03020095|Ritonavir|ritonavir|mesh-list
102587117|NCT03020095|Ribavirin|ribavirin|mesh-list
102587118|NCT03020095|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102587119|NCT03020095|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102587120|NCT03020095|Protease Inhibitors|protease inhibitors|mesh-ancestor
102587121|NCT03020095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102587122|NCT03020095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587123|NCT03020095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102587124|NCT03020095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102587125|NCT03020095|Antiviral Agents|antiviral agents|mesh-ancestor
102587126|NCT03020095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102587127|NCT03020095|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102587128|NCT03020095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102587129|NCT03020095|Antimetabolites|antimetabolites|mesh-ancestor
102587130|NCT02934698|Ivacaftor|ivacaftor|mesh-list
102587131|NCT02934698|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102587132|NCT02934698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102587133|NCT02934698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587134|NCT03021343|Colchicine|colchicine|mesh-list
102587135|NCT03021343|Gout Suppressants|gout suppressants|mesh-ancestor
102587136|NCT03021343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102587137|NCT03021343|Tubulin Modulators|tubulin modulators|mesh-ancestor
102587138|NCT03021343|Antimitotic Agents|antimitotic agents|mesh-ancestor
102587139|NCT03021343|Mitosis Modulators|mitosis modulators|mesh-ancestor
102587140|NCT03021343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587141|NCT03021343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102587142|NCT03025945|Nepafenac|nepafenac|mesh-list
102587143|NCT03025945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102587144|NCT03025945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102587145|NCT03025945|Analgesics|analgesics|mesh-ancestor
102587146|NCT03025945|Sensory System Agents|sensory system agents|mesh-ancestor
102587147|NCT03025945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102587148|NCT03025945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587149|NCT03025945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102587150|NCT03025945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102587151|NCT02937506|Fentanyl|fentanyl|mesh-list
102587152|NCT02937506|Midazolam|midazolam|mesh-list
102587153|NCT02937506|Propofol|propofol|mesh-list
102587154|NCT02937506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102587155|NCT02937506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102587156|NCT02937506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587157|NCT02937506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102587158|NCT02937506|Anesthetics, General|anesthetics, general|mesh-ancestor
102587159|NCT02937506|Anesthetics|anesthetics|mesh-ancestor
102587160|NCT02937506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102587161|NCT02937506|Narcotics|narcotics|mesh-ancestor
102587162|NCT02937506|Analgesics|analgesics|mesh-ancestor
102587163|NCT02937506|Sensory System Agents|sensory system agents|mesh-ancestor
102587164|NCT02937506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102587165|NCT02937506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102587166|NCT02937506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102587167|NCT02937506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102587168|NCT02937506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102587169|NCT02937506|GABA Modulators|gaba modulators|mesh-ancestor
102587170|NCT02937506|GABA Agents|gaba agents|mesh-ancestor
102587171|NCT02937506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102587172|NCT02937506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587173|NCT03026803|Capecitabine|capecitabine|mesh-list
102587174|NCT03026803|Oxaliplatin|oxaliplatin|mesh-list
102587175|NCT03026803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102587176|NCT03026803|Antimetabolites|antimetabolites|mesh-ancestor
102587177|NCT03026803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587178|NCT03026803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102587179|NCT03027661|Bupivacaine|bupivacaine|mesh-list
102587180|NCT03027661|Anesthetics, Local|anesthetics, local|mesh-ancestor
102587181|NCT03027661|Anesthetics|anesthetics|mesh-ancestor
102587182|NCT03027661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102587183|NCT03027661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587184|NCT03027661|Sensory System Agents|sensory system agents|mesh-ancestor
102587185|NCT03027661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102587186|NCT03022526|Fentanyl|fentanyl|mesh-list
102587187|NCT03022526|Bupivacaine|bupivacaine|mesh-list
102587188|NCT03022526|Anesthetics, Local|anesthetics, local|mesh-ancestor
102587189|NCT03022526|Anesthetics|anesthetics|mesh-ancestor
102587190|NCT03022526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102587191|NCT03022526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587192|NCT03022526|Sensory System Agents|sensory system agents|mesh-ancestor
102587193|NCT03022526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102587194|NCT03022526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102587195|NCT03022526|Narcotics|narcotics|mesh-ancestor
102587196|NCT03022526|Analgesics|analgesics|mesh-ancestor
102587197|NCT03022526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102587198|NCT03022526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102587199|NCT03022526|Anesthetics, General|anesthetics, general|mesh-ancestor
102587200|NCT02794441|Dexamethasone|dexamethasone|mesh-list
102587201|NCT02794441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102587202|NCT02794441|Antiemetics|antiemetics|mesh-ancestor
102587203|NCT02794441|Autonomic Agents|autonomic agents|mesh-ancestor
102587204|NCT02794441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102587205|NCT02794441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587206|NCT02794441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102587207|NCT02794441|Glucocorticoids|glucocorticoids|mesh-ancestor
102587208|NCT02794441|Hormones|hormones|mesh-ancestor
102587209|NCT02794441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102587210|NCT02794441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102587211|NCT02794441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102587212|NCT02941640|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102587213|NCT02941640|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
102587214|NCT02941640|beta-Endorphin|beta-endorphin|mesh-list
102587215|NCT02941640|Hormones|hormones|mesh-ancestor
102587216|NCT02941640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102587217|NCT02941640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587218|NCT02941640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102587219|NCT02941640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587220|NCT02823080|Cetrorelix|cetrorelix|mesh-list
102587221|NCT02823080|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102587222|NCT02823080|Fertility Agents|fertility agents|mesh-ancestor
102587223|NCT02823080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102587224|NCT02823080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587225|NCT02823080|Hormone Antagonists|hormone antagonists|mesh-ancestor
102587226|NCT02823080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102587227|NCT03022916|Efinaconazole|efinaconazole|mesh-list
102587228|NCT03022916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102587229|NCT03022916|Antifungal Agents|antifungal agents|mesh-ancestor
102587230|NCT03022916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102587231|NCT03031795|Ketorolac|ketorolac|mesh-list
102587232|NCT03031795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102587233|NCT03031795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102587234|NCT03031795|Analgesics|analgesics|mesh-ancestor
102587235|NCT03031795|Sensory System Agents|sensory system agents|mesh-ancestor
102587236|NCT03031795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102587237|NCT03031795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587238|NCT03031795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102587239|NCT03031795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102587240|NCT03031795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102587241|NCT03031795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102587242|NCT03031795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587243|NCT02942654|Insulin Lispro|insulin lispro|mesh-list
102587244|NCT02942654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102587245|NCT02942654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587246|NCT02909959|Sulforaphane|sulforaphane|mesh-list
102587247|NCT02909959|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102587248|NCT02909959|Protective Agents|protective agents|mesh-ancestor
102134157|NCT03511833|Ketamine|ketamine|mesh-list
102587249|NCT02909959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587250|NCT02909959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102587252|NCT00373802|Oxymetazoline|oxymetazoline|mesh-list
102587253|NCT00373802|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102587254|NCT00373802|Mydriatics|mydriatics|mesh-ancestor
102587255|NCT00373802|Autonomic Agents|autonomic agents|mesh-ancestor
102587256|NCT00373802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102587257|NCT00373802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587258|NCT00373802|Sympathomimetics|sympathomimetics|mesh-ancestor
102587259|NCT00373802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102587260|NCT00373802|Nasal Decongestants|nasal decongestants|mesh-ancestor
102587261|NCT00373802|Respiratory System Agents|respiratory system agents|mesh-ancestor
102587262|NCT00373802|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102587263|NCT00373802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102587264|NCT00373802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102587265|NCT00373802|Adrenergic Agents|adrenergic agents|mesh-ancestor
102587266|NCT00373802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102587267|NCT00373802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587268|NCT00373802|Protective Agents|protective agents|mesh-ancestor
102587269|NCT02945150|Grazoprevir|grazoprevir|mesh-list
102587270|NCT02945150|Antiviral Agents|antiviral agents|mesh-ancestor
102587271|NCT02945150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102587272|NCT03032965|Adenosine|adenosine|mesh-list
102587273|NCT03032965|Isoproterenol|isoproterenol|mesh-list
102587274|NCT03032965|Analgesics|analgesics|mesh-ancestor
102587275|NCT03032965|Sensory System Agents|sensory system agents|mesh-ancestor
102587276|NCT03032965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102587277|NCT03032965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587278|NCT03032965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102587279|NCT03032965|Vasodilator Agents|vasodilator agents|mesh-ancestor
102587280|NCT03032965|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102587281|NCT03032965|Purinergic Agonists|purinergic agonists|mesh-ancestor
102587282|NCT03032965|Purinergic Agents|purinergic agents|mesh-ancestor
102587283|NCT03032965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102587284|NCT03032965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587285|NCT03032965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102587286|NCT03032965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102587287|NCT03032965|Adrenergic Agents|adrenergic agents|mesh-ancestor
102587288|NCT03032965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102587289|NCT03032965|Autonomic Agents|autonomic agents|mesh-ancestor
102587290|NCT03032965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102587291|NCT03032965|Respiratory System Agents|respiratory system agents|mesh-ancestor
102587292|NCT03032965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102587293|NCT03032965|Sympathomimetics|sympathomimetics|mesh-ancestor
102587294|NCT03032965|Protective Agents|protective agents|mesh-ancestor
102587295|NCT02948426|Interferon-gamma|interferon-gamma|mesh-list
102587296|NCT02948426|Antiviral Agents|antiviral agents|mesh-ancestor
102587297|NCT02948426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102587298|NCT03030638|Olodaterol|olodaterol|mesh-list
102587299|NCT03030638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102587300|NCT03030638|Autonomic Agents|autonomic agents|mesh-ancestor
102587301|NCT03030638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102587302|NCT03030638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587303|NCT03030638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102587304|NCT03030638|Respiratory System Agents|respiratory system agents|mesh-ancestor
102587305|NCT02949674|Bupivacaine|bupivacaine|mesh-list
102587306|NCT02949674|Ropivacaine|ropivacaine|mesh-list
102587307|NCT02949674|Anesthetics, Local|anesthetics, local|mesh-ancestor
102587308|NCT02949674|Anesthetics|anesthetics|mesh-ancestor
102587309|NCT02949674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102587310|NCT02949674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587311|NCT02949674|Sensory System Agents|sensory system agents|mesh-ancestor
102587312|NCT02949674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102587313|NCT03033511|Dexamethasone|dexamethasone|mesh-list
102587314|NCT03033511|Dexamethasone acetate|dexamethasone acetate|mesh-list
102587315|NCT03033511|BB 1101|bb 1101|mesh-list
102587316|NCT03033511|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
102587317|NCT03033511|Immunoconjugates|immunoconjugates|mesh-list
102587318|NCT03033511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102587319|NCT03033511|Antiemetics|antiemetics|mesh-ancestor
102587320|NCT03033511|Autonomic Agents|autonomic agents|mesh-ancestor
102587321|NCT03033511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102587322|NCT03033511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587323|NCT03033511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102587324|NCT03033511|Glucocorticoids|glucocorticoids|mesh-ancestor
102587325|NCT03033511|Hormones|hormones|mesh-ancestor
102134214|NCT04480268|Paclitaxel|paclitaxel|mesh-list
102587326|NCT03033511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102587327|NCT03033511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102587328|NCT03033511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102587329|NCT03033511|Protease Inhibitors|protease inhibitors|mesh-ancestor
102587330|NCT03033511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102587331|NCT03033511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587332|NCT03033511|Immunologic Factors|immunologic factors|mesh-ancestor
102587333|NCT02951312|Glycopyrrolate|glycopyrrolate|mesh-list
102587334|NCT02951312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102587335|NCT02951312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102587336|NCT02951312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102587337|NCT02951312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102587338|NCT02951312|Cholinergic Agents|cholinergic agents|mesh-ancestor
102587339|NCT02951312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102587340|NCT02951312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587341|NCT02951312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587342|NCT03035929|Dexamethasone|dexamethasone|mesh-list
102587343|NCT03035929|Dexamethasone acetate|dexamethasone acetate|mesh-list
102587344|NCT03035929|BB 1101|bb 1101|mesh-list
102587345|NCT03035929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102587346|NCT03035929|Antiemetics|antiemetics|mesh-ancestor
102587347|NCT03035929|Autonomic Agents|autonomic agents|mesh-ancestor
102587348|NCT03035929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102587349|NCT03035929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587350|NCT03035929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102587351|NCT03035929|Glucocorticoids|glucocorticoids|mesh-ancestor
102587352|NCT03035929|Hormones|hormones|mesh-ancestor
102587353|NCT03035929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102587354|NCT03035929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102587355|NCT03035929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102587356|NCT03035929|Protease Inhibitors|protease inhibitors|mesh-ancestor
102587357|NCT03035929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102587358|NCT03035929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587359|NCT02951702|Vancomycin|vancomycin|mesh-list
102587360|NCT02951702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102587361|NCT02951702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102587362|NCT02831816|Ethanol|ethanol|mesh-list
102587363|NCT02831816|Chlorhexidine|chlorhexidine|mesh-list
102587364|NCT02831816|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102587365|NCT02831816|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102587366|NCT02831816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102587367|NCT02831816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102587368|NCT02831816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587369|NCT02831816|Disinfectants|disinfectants|mesh-ancestor
102587370|NCT02831816|Dermatologic Agents|dermatologic agents|mesh-ancestor
102587371|NCT03036163|Macozinone|macozinone|mesh-list
102587372|NCT03036163|Antitubercular Agents|antitubercular agents|mesh-ancestor
102587373|NCT03036163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102587374|NCT03036163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102587375|NCT02953886|Fluorides|fluorides|mesh-list
102587376|NCT02953886|Cariostatic Agents|cariostatic agents|mesh-ancestor
102587377|NCT02953886|Protective Agents|protective agents|mesh-ancestor
102587378|NCT02953886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587379|NCT02802241|Peppermint oil|peppermint oil|mesh-list
102587380|NCT02802241|Antiemetics|antiemetics|mesh-ancestor
102587381|NCT02802241|Autonomic Agents|autonomic agents|mesh-ancestor
102587382|NCT02802241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102587383|NCT02802241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587384|NCT02802241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102587385|NCT02802241|Parasympatholytics|parasympatholytics|mesh-ancestor
102587386|NCT03035708|Varenicline|varenicline|mesh-list
102587387|NCT03035708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102587388|NCT03035708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102587389|NCT03035708|Cholinergic Agents|cholinergic agents|mesh-ancestor
102587390|NCT03035708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102587391|NCT03035708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587392|NCT03035708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587393|NCT00374426|Sertraline|sertraline|mesh-list
102587394|NCT00374426|Antidepressive Agents|antidepressive agents|mesh-ancestor
102587395|NCT00374426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102587396|NCT00374426|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102587397|NCT00374426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102587398|NCT00374426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102587399|NCT00374426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134289|NCT02304627|Insulin|insulin|mesh-list
102587400|NCT00374426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102587401|NCT00374426|Serotonin Agents|serotonin agents|mesh-ancestor
102587402|NCT00374426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587403|NCT02916745|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
102587405|NCT02916745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102587406|NCT02916745|Dermatologic Agents|dermatologic agents|mesh-ancestor
102587407|NCT02916745|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102587408|NCT02954198|Mycophenolic Acid|mycophenolic acid|mesh-list
102587409|NCT02954198|Prednisone|prednisone|mesh-list
102587410|NCT02954198|Methylprednisolone|methylprednisolone|mesh-list
102587411|NCT02954198|Everolimus|everolimus|mesh-list
102587412|NCT02954198|Tacrolimus|tacrolimus|mesh-list
102587413|NCT02954198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102587414|NCT02954198|Glucocorticoids|glucocorticoids|mesh-ancestor
102587415|NCT02954198|Hormones|hormones|mesh-ancestor
102587416|NCT02954198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102587417|NCT02954198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587418|NCT02954198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102587419|NCT02954198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102587420|NCT02954198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102587421|NCT02954198|Immunologic Factors|immunologic factors|mesh-ancestor
102587422|NCT02954198|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102587423|NCT02954198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102587424|NCT02954198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587425|NCT02954198|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102587426|NCT02954198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102587427|NCT02954198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102587428|NCT02954198|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102587429|NCT02954198|Antitubercular Agents|antitubercular agents|mesh-ancestor
102587430|NCT02954198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102587431|NCT02954198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102587432|NCT02954198|Antiemetics|antiemetics|mesh-ancestor
102587433|NCT02954198|Autonomic Agents|autonomic agents|mesh-ancestor
102587434|NCT02954198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102587435|NCT02954198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102587436|NCT02954198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102587437|NCT02954198|Protective Agents|protective agents|mesh-ancestor
102587438|NCT02956070|Dexamethasone|dexamethasone|mesh-list
102587439|NCT02956070|Dexamethasone acetate|dexamethasone acetate|mesh-list
102587440|NCT02956070|BB 1101|bb 1101|mesh-list
102587441|NCT02956070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102587442|NCT02956070|Antiemetics|antiemetics|mesh-ancestor
102587443|NCT02956070|Autonomic Agents|autonomic agents|mesh-ancestor
102587444|NCT02956070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102587445|NCT02956070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587446|NCT02956070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102587447|NCT02956070|Glucocorticoids|glucocorticoids|mesh-ancestor
102587448|NCT02956070|Hormones|hormones|mesh-ancestor
102587449|NCT02956070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102587450|NCT02956070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102587451|NCT02956070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102587452|NCT02956070|Protease Inhibitors|protease inhibitors|mesh-ancestor
102587453|NCT02956070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102587454|NCT02956070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587455|NCT02956616|Ketorolac|ketorolac|mesh-list
102587456|NCT02956616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102587457|NCT02956616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102587458|NCT02956616|Analgesics|analgesics|mesh-ancestor
102587459|NCT02956616|Sensory System Agents|sensory system agents|mesh-ancestor
102587460|NCT02956616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102587461|NCT02956616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587462|NCT02956616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102587463|NCT02956616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102587464|NCT02956616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102587465|NCT02956616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102587466|NCT02956616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587467|NCT02958956|Pioglitazone|pioglitazone|mesh-list
102587468|NCT02958956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102587469|NCT02958956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587470|NCT05829551|Ritonavir|ritonavir|mesh-list
102587471|NCT05829551|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102587472|NCT05829551|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102587473|NCT05829551|Protease Inhibitors|protease inhibitors|mesh-ancestor
102134364|NCT02394002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102587474|NCT05829551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102587475|NCT05829551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587476|NCT05829551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102587477|NCT05829551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102587478|NCT05829551|Antiviral Agents|antiviral agents|mesh-ancestor
102587479|NCT05829551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102587480|NCT05829551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102587481|NCT05829551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102587482|NCT05829460|Progestins|progestins|mesh-list
102587483|NCT05829460|Hormones|hormones|mesh-ancestor
102587484|NCT05829460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102587485|NCT05829460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587486|NCT05829317|Magnesium Sulfate|magnesium sulfate|mesh-list
102587487|NCT05829317|Analgesics|analgesics|mesh-ancestor
102587488|NCT05829317|Sensory System Agents|sensory system agents|mesh-ancestor
102587489|NCT05829317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102587490|NCT05829317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587491|NCT05829317|Anesthetics|anesthetics|mesh-ancestor
102587492|NCT05829317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102587493|NCT05829317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102587494|NCT05829317|Anticonvulsants|anticonvulsants|mesh-ancestor
102587495|NCT05829317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102587496|NCT05829317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102587497|NCT05829317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587498|NCT05829317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102587499|NCT05829317|Tocolytic Agents|tocolytic agents|mesh-ancestor
102587500|NCT05829317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102587501|NCT05829148|Pregabalin|pregabalin|mesh-list
102587502|NCT05829148|Dexmedetomidine|dexmedetomidine|mesh-list
102587503|NCT05829148|Melatonin|melatonin|mesh-list
102587504|NCT05829148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102587505|NCT05829148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102587506|NCT05829148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587507|NCT05829148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102587508|NCT05829148|Analgesics|analgesics|mesh-ancestor
102587509|NCT05829148|Sensory System Agents|sensory system agents|mesh-ancestor
102587510|NCT05829148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102587511|NCT05829148|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102587512|NCT05829148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102587513|NCT05829148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102587514|NCT05829148|Adrenergic Agents|adrenergic agents|mesh-ancestor
102587515|NCT05829148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102587516|NCT05829148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587517|NCT05829148|Anticonvulsants|anticonvulsants|mesh-ancestor
102587518|NCT05829148|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102587519|NCT05829148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102587520|NCT05829148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102587521|NCT05829148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102587522|NCT05829148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102587523|NCT05829148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102587524|NCT05829148|Antioxidants|antioxidants|mesh-ancestor
102587525|NCT05829148|Protective Agents|protective agents|mesh-ancestor
102587526|NCT05829057|Interleukin-2|interleukin-2|mesh-list
102587527|NCT05829057|Antibodies|antibodies|mesh-list
102587528|NCT05829057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102587529|NCT05829057|Immunologic Factors|immunologic factors|mesh-ancestor
102587530|NCT05829057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587531|NCT05829057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102587532|NCT05829057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102587533|NCT05829057|Analgesics|analgesics|mesh-ancestor
102587534|NCT05829057|Sensory System Agents|sensory system agents|mesh-ancestor
102587535|NCT05829057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102587536|NCT05829044|Melatonin|melatonin|mesh-list
102587537|NCT05829044|Antioxidants|antioxidants|mesh-ancestor
102587538|NCT05829044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587539|NCT05829044|Protective Agents|protective agents|mesh-ancestor
102587540|NCT05829044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587541|NCT05829044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102587542|NCT05828836|Allopurinol|allopurinol|mesh-list
102587543|NCT05828836|Antimetabolites|antimetabolites|mesh-ancestor
102587544|NCT05828836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587545|NCT05828836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102587546|NCT05828836|Gout Suppressants|gout suppressants|mesh-ancestor
102587547|NCT05828836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102587548|NCT05828836|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102587549|NCT05828836|Antioxidants|antioxidants|mesh-ancestor
102587550|NCT05828836|Protective Agents|protective agents|mesh-ancestor
102587551|NCT05828836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587552|NCT05828810|Chlorhexidine|chlorhexidine|mesh-list
102587553|NCT05828810|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
102587554|NCT05828810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102587555|NCT05828810|Disinfectants|disinfectants|mesh-ancestor
102587556|NCT05828550|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102587557|NCT05828550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102587558|NCT05828381|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102587559|NCT05828381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102587560|NCT05828199|Dexmedetomidine|dexmedetomidine|mesh-list
102587561|NCT05828199|Ketamine|ketamine|mesh-list
102587562|NCT05828199|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102587563|NCT05828199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102587564|NCT05828199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587565|NCT05828199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102587566|NCT05828199|Analgesics|analgesics|mesh-ancestor
102587567|NCT05828199|Sensory System Agents|sensory system agents|mesh-ancestor
102587568|NCT05828199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102587569|NCT05828199|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102587570|NCT05828199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102587571|NCT05828199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102587572|NCT05828199|Adrenergic Agents|adrenergic agents|mesh-ancestor
102587573|NCT05828199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102587574|NCT05828199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587575|NCT05828199|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102587576|NCT05828199|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102587577|NCT05828199|Anesthetics, General|anesthetics, general|mesh-ancestor
102587578|NCT05828199|Anesthetics|anesthetics|mesh-ancestor
102587579|NCT05828199|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102587580|NCT05828199|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102587581|NCT05827991|Minoxidil|minoxidil|mesh-list
102587582|NCT05827991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102587583|NCT05827991|Vasodilator Agents|vasodilator agents|mesh-ancestor
102587584|NCT05827796|Paclitaxel|paclitaxel|mesh-list
102587585|NCT05827796|Gemcitabine|gemcitabine|mesh-list
102587586|NCT05827796|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102587587|NCT05827796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102587588|NCT05827796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102587589|NCT05827796|Tubulin Modulators|tubulin modulators|mesh-ancestor
102587590|NCT05827796|Antimitotic Agents|antimitotic agents|mesh-ancestor
102587591|NCT05827796|Mitosis Modulators|mitosis modulators|mesh-ancestor
102587592|NCT05827796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587593|NCT05827796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102587594|NCT05827796|Antimetabolites|antimetabolites|mesh-ancestor
102587595|NCT05827770|Temozolomide|temozolomide|mesh-list
102587596|NCT05827770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102587597|NCT05827770|Alkylating Agents|alkylating agents|mesh-ancestor
102587598|NCT05827770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587599|NCT05827770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102587600|NCT05827497|Methotrexate|methotrexate|mesh-list
102587601|NCT05827497|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102587602|NCT05827497|Abortifacient Agents|abortifacient agents|mesh-ancestor
102587603|NCT05827497|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102587604|NCT05827497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587605|NCT05827497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102587606|NCT05827497|Antimetabolites|antimetabolites|mesh-ancestor
102587607|NCT05827497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587608|NCT05827497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102587609|NCT05827497|Dermatologic Agents|dermatologic agents|mesh-ancestor
102587610|NCT05827497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102587611|NCT05827497|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102587612|NCT05827497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102587613|NCT05827497|Immunologic Factors|immunologic factors|mesh-ancestor
102587614|NCT05827497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102587615|NCT05827497|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102587616|NCT05827263|Salicylic Acid|salicylic acid|mesh-list
102587617|NCT05827263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102587618|NCT05827263|Antifungal Agents|antifungal agents|mesh-ancestor
102587619|NCT05827263|Keratolytic Agents|keratolytic agents|mesh-ancestor
102587620|NCT05827263|Dermatologic Agents|dermatologic agents|mesh-ancestor
102587621|NCT05826119|Magnesium Sulfate|magnesium sulfate|mesh-list
102587622|NCT05826119|Analgesics|analgesics|mesh-ancestor
102587623|NCT05826119|Sensory System Agents|sensory system agents|mesh-ancestor
102587624|NCT05826119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102587625|NCT05826119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587626|NCT05826119|Anesthetics|anesthetics|mesh-ancestor
102587627|NCT05826119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102587628|NCT05826119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102587629|NCT05826119|Anticonvulsants|anticonvulsants|mesh-ancestor
102587630|NCT05826119|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102587631|NCT05826119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102587632|NCT05826119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587633|NCT05826119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102587634|NCT05826119|Tocolytic Agents|tocolytic agents|mesh-ancestor
102587635|NCT05826119|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102587636|NCT05825443|Paclitaxel|paclitaxel|mesh-list
102587637|NCT05825443|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102587638|NCT05825443|Cisplatin|cisplatin|mesh-list
102587639|NCT05825443|Carboplatin|carboplatin|mesh-list
102587640|NCT05825443|Pemetrexed|pemetrexed|mesh-list
102587641|NCT05825443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102587642|NCT05825443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102587643|NCT05825443|Tubulin Modulators|tubulin modulators|mesh-ancestor
102587644|NCT05825443|Antimitotic Agents|antimitotic agents|mesh-ancestor
102587645|NCT05825443|Mitosis Modulators|mitosis modulators|mesh-ancestor
102587646|NCT05825443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587647|NCT05825443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102587648|NCT05825443|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102587649|NCT05825443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102587650|NCT05822934|Carboplatin|carboplatin|mesh-list
102587651|NCT05822934|Gemcitabine|gemcitabine|mesh-list
102587652|NCT05822934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102587653|NCT05822934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102587654|NCT05822934|Antimetabolites|antimetabolites|mesh-ancestor
102587655|NCT05822934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587656|NCT05821972|Dexmedetomidine|dexmedetomidine|mesh-list
102587657|NCT05821972|Ketamine|ketamine|mesh-list
102587658|NCT05821972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102587659|NCT05821972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102587660|NCT05821972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587661|NCT05821972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102587662|NCT05821972|Analgesics|analgesics|mesh-ancestor
102587663|NCT05821972|Sensory System Agents|sensory system agents|mesh-ancestor
102587664|NCT05821972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102587665|NCT05821972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102587666|NCT05821972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102587667|NCT05821972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102587668|NCT05821972|Adrenergic Agents|adrenergic agents|mesh-ancestor
102587669|NCT05821972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102587670|NCT05821972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587671|NCT05821972|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102587672|NCT05821972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102587673|NCT05821972|Anesthetics, General|anesthetics, general|mesh-ancestor
102587674|NCT05821972|Anesthetics|anesthetics|mesh-ancestor
102587675|NCT05821972|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102587676|NCT05821972|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102587677|NCT05774236|Dinoprostone|dinoprostone|mesh-list
102587678|NCT05774236|Oxytocics|oxytocics|mesh-ancestor
102587679|NCT05774236|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102587680|NCT05774236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587681|NCT05748587|Iron|iron|mesh-list
102587682|NCT05748587|Deferoxamine|deferoxamine|mesh-list
102587683|NCT05748587|Trace Elements|trace elements|mesh-ancestor
102587684|NCT05748587|Micronutrients|micronutrients|mesh-ancestor
102587685|NCT05748587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587686|NCT05748587|Siderophores|siderophores|mesh-ancestor
102587687|NCT05748587|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102587688|NCT05748587|Chelating Agents|chelating agents|mesh-ancestor
102587689|NCT05748587|Sequestering Agents|sequestering agents|mesh-ancestor
102587690|NCT05748587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587691|NCT05728814|Dostarlimab|dostarlimab|mesh-list
102587692|NCT05728814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102587693|NCT05707468|Hormones|hormones|mesh-list
102587694|NCT05707468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102587695|NCT05707468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587696|NCT05698381|Acetic Acid|acetic acid|mesh-list
102587697|NCT05698381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102587698|NCT05698381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102587699|NCT05683535|Atropine|atropine|mesh-list
102587700|NCT05683535|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102587701|NCT05683535|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102587702|NCT05683535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102587703|NCT05683535|Autonomic Agents|autonomic agents|mesh-ancestor
102587704|NCT05683535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102587705|NCT05683535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587706|NCT05683535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102587707|NCT05683535|Respiratory System Agents|respiratory system agents|mesh-ancestor
102587708|NCT05683535|Mydriatics|mydriatics|mesh-ancestor
102587709|NCT05683535|Parasympatholytics|parasympatholytics|mesh-ancestor
102587710|NCT05683535|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102587711|NCT05683535|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102587712|NCT05683535|Cholinergic Agents|cholinergic agents|mesh-ancestor
102587713|NCT05683535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102587714|NCT05683535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587715|NCT05678244|Acetaminophen|acetaminophen|mesh-list
102587716|NCT05678244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102587717|NCT05678244|Analgesics|analgesics|mesh-ancestor
102587718|NCT05678244|Sensory System Agents|sensory system agents|mesh-ancestor
102587719|NCT05678244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102587720|NCT05678244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587721|NCT05678244|Antipyretics|antipyretics|mesh-ancestor
102587722|NCT05676034|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
102587723|NCT05676034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102587724|NCT05675800|Psilocybin|psilocybin|mesh-list
102587725|NCT05675800|Hallucinogens|hallucinogens|mesh-ancestor
102587726|NCT05675800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587727|NCT05675800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102587728|NCT05675319|Dexamethasone|dexamethasone|mesh-list
102587729|NCT05675319|Dexamethasone acetate|dexamethasone acetate|mesh-list
102587730|NCT05675319|Lenalidomide|lenalidomide|mesh-list
102587731|NCT05675319|Bortezomib|bortezomib|mesh-list
102587732|NCT05675319|Daratumumab|daratumumab|mesh-list
102587733|NCT05675319|Pomalidomide|pomalidomide|mesh-list
102587734|NCT05675319|Ixazomib|ixazomib|mesh-list
102587735|NCT05675319|Elotuzumab|elotuzumab|mesh-list
102587736|NCT05675319|BB 1101|bb 1101|mesh-list
102587737|NCT05675319|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102587738|NCT05675319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102587739|NCT05675319|Antiemetics|antiemetics|mesh-ancestor
102587740|NCT05675319|Autonomic Agents|autonomic agents|mesh-ancestor
102587741|NCT05675319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102587742|NCT05675319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587743|NCT05675319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102587744|NCT05675319|Glucocorticoids|glucocorticoids|mesh-ancestor
102587745|NCT05675319|Hormones|hormones|mesh-ancestor
102587746|NCT05675319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102587747|NCT05675319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102587748|NCT05675319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102587749|NCT05675319|Protease Inhibitors|protease inhibitors|mesh-ancestor
102587750|NCT05675319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102587751|NCT05675319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587752|NCT05675319|Immunologic Factors|immunologic factors|mesh-ancestor
102587753|NCT05675319|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102587754|NCT05675319|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102587755|NCT05675319|Growth Substances|growth substances|mesh-ancestor
102587756|NCT05675319|Growth Inhibitors|growth inhibitors|mesh-ancestor
102587757|NCT05674487|Misoprostol|misoprostol|mesh-list
102587758|NCT05674487|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102587759|NCT05674487|Abortifacient Agents|abortifacient agents|mesh-ancestor
102587760|NCT05674487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102587761|NCT05674487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587762|NCT05674487|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102587763|NCT05674487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102587764|NCT05674487|Oxytocics|oxytocics|mesh-ancestor
102587765|NCT05644873|Magnesium Sulfate|magnesium sulfate|mesh-list
102587766|NCT05644873|Analgesics|analgesics|mesh-ancestor
102587767|NCT05644873|Sensory System Agents|sensory system agents|mesh-ancestor
102587768|NCT05644873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102587769|NCT05644873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587770|NCT05644873|Anesthetics|anesthetics|mesh-ancestor
102587771|NCT05644873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102587772|NCT05644873|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102587773|NCT05644873|Anticonvulsants|anticonvulsants|mesh-ancestor
102587774|NCT05644873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102587775|NCT05644873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102587776|NCT05644873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587777|NCT05644873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102587778|NCT05644873|Tocolytic Agents|tocolytic agents|mesh-ancestor
102587779|NCT05644873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102587780|NCT05641376|Dexmedetomidine|dexmedetomidine|mesh-list
102587781|NCT05641376|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102587782|NCT05641376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102587783|NCT05641376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587784|NCT05641376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102587785|NCT05641376|Analgesics|analgesics|mesh-ancestor
102587786|NCT05641376|Sensory System Agents|sensory system agents|mesh-ancestor
102587787|NCT05641376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102587788|NCT05641376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102587789|NCT05641376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102587790|NCT05641376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102587791|NCT05641376|Adrenergic Agents|adrenergic agents|mesh-ancestor
102587792|NCT05641376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102587793|NCT05641376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587794|NCT05615311|Vitamin D|vitamin d|mesh-list
102587795|NCT05615311|Ergocalciferols|ergocalciferols|mesh-list
102587796|NCT05615311|Cholecalciferol|cholecalciferol|mesh-list
102587797|NCT05615311|Vitamins|vitamins|mesh-list
102587798|NCT05615311|Micronutrients|micronutrients|mesh-ancestor
102587799|NCT05615311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587800|NCT05615311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102587801|NCT05615311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102587802|NCT05607615|Betadex|betadex|mesh-list
102587803|NCT05607615|Sequestering Agents|sequestering agents|mesh-ancestor
102587804|NCT05607615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587805|NCT05593939|Niacinamide|niacinamide|mesh-list
102587806|NCT05593939|Niacin|niacin|mesh-list
102587807|NCT05593939|Nicotinic Acids|nicotinic acids|mesh-list
102587808|NCT05593939|Vitamin B Complex|vitamin b complex|mesh-ancestor
102587809|NCT05593939|Vitamins|vitamins|mesh-ancestor
102587810|NCT05593939|Micronutrients|micronutrients|mesh-ancestor
102587811|NCT05593939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587812|NCT05593939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102587813|NCT05593939|Antimetabolites|antimetabolites|mesh-ancestor
102587814|NCT05593939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587815|NCT05593939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102587816|NCT05593939|Vasodilator Agents|vasodilator agents|mesh-ancestor
102587817|NCT05577845|Ramosetron|ramosetron|mesh-list
102587818|NCT05577845|Antiemetics|antiemetics|mesh-ancestor
102587819|NCT05577845|Autonomic Agents|autonomic agents|mesh-ancestor
102587820|NCT05577845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102587821|NCT05577845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587822|NCT05577845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102587823|NCT05577845|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102587824|NCT05577845|Serotonin Agents|serotonin agents|mesh-ancestor
102587825|NCT05577845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102587826|NCT05577845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587827|NCT05527912|Rituximab|rituximab|mesh-list
102587828|NCT05527912|Zanubrutinib|zanubrutinib|mesh-list
102587829|NCT05527912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102587830|NCT05527912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102587831|NCT05527912|Immunologic Factors|immunologic factors|mesh-ancestor
102587832|NCT05527912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587833|NCT05527912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102587834|NCT05527912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102587835|NCT05527912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102587836|NCT05527912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587837|NCT05504083|Benzbromarone|benzbromarone|mesh-list
102587838|NCT05504083|Uricosuric Agents|uricosuric agents|mesh-ancestor
102587839|NCT05504083|Gout Suppressants|gout suppressants|mesh-ancestor
102587840|NCT05504083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102587841|NCT05491187|Fentanyl|fentanyl|mesh-list
102587842|NCT05491187|Bupivacaine|bupivacaine|mesh-list
102587843|NCT05491187|Anesthetics, Local|anesthetics, local|mesh-ancestor
102587844|NCT05491187|Anesthetics|anesthetics|mesh-ancestor
102587845|NCT05491187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102587846|NCT05491187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587847|NCT05491187|Sensory System Agents|sensory system agents|mesh-ancestor
102587848|NCT05491187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102587849|NCT05491187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102587850|NCT05491187|Narcotics|narcotics|mesh-ancestor
102587851|NCT05491187|Analgesics|analgesics|mesh-ancestor
102587852|NCT05491187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102587853|NCT05491187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102587854|NCT05491187|Anesthetics, General|anesthetics, general|mesh-ancestor
102587855|NCT05480878|Nitazoxanide|nitazoxanide|mesh-list
102587856|NCT05480878|Escitalopram|escitalopram|mesh-list
102587857|NCT05480878|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102587858|NCT05480878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102587859|NCT05480878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102587860|NCT05480878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587861|NCT05480878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102587862|NCT05480878|Serotonin Agents|serotonin agents|mesh-ancestor
102587863|NCT05480878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587864|NCT05480878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102587865|NCT05480878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102587866|NCT05462730|Methylprednisolone|methylprednisolone|mesh-list
102587867|NCT05462730|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102587868|NCT05462730|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102587869|NCT05462730|Prednisolone|prednisolone|mesh-list
102587870|NCT05462730|Prednisolone acetate|prednisolone acetate|mesh-list
102587871|NCT05462730|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102587872|NCT05462730|Prednisolone phosphate|prednisolone phosphate|mesh-list
102587873|NCT05462730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102587874|NCT05462730|Antiemetics|antiemetics|mesh-ancestor
102587875|NCT05462730|Autonomic Agents|autonomic agents|mesh-ancestor
102587876|NCT05462730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102587877|NCT05462730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587878|NCT05462730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102587879|NCT05462730|Glucocorticoids|glucocorticoids|mesh-ancestor
102587880|NCT05462730|Hormones|hormones|mesh-ancestor
102587881|NCT05462730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102587882|NCT05462730|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102587883|NCT05462730|Protective Agents|protective agents|mesh-ancestor
102587884|NCT05462730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102587885|NCT05462730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102587886|NCT05462236|Pembrolizumab|pembrolizumab|mesh-list
102587887|NCT05462236|Irinotecan|irinotecan|mesh-list
102587888|NCT05462236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102587889|NCT05462236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102587890|NCT05462236|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102587891|NCT05462236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587892|NCT05462236|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102587893|NCT05462236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102587894|NCT05462236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102587895|NCT05414331|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102587896|NCT05414331|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102587897|NCT05414331|Adrenergic Agents|adrenergic agents|mesh-ancestor
102587898|NCT05414331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102587899|NCT05414331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587900|NCT05414331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587901|NCT05398367|Galactogogues|galactogogues|mesh-list
102587902|NCT05398367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587903|NCT05383716|Pembrolizumab|pembrolizumab|mesh-list
102587904|NCT05383716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102587905|NCT05383716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102587906|NCT05383716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102587907|NCT05383716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587908|NCT05378945|Varenicline|varenicline|mesh-list
102587909|NCT05378945|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102587910|NCT05378945|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102587911|NCT05378945|Cholinergic Agents|cholinergic agents|mesh-ancestor
102587912|NCT05378945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102587913|NCT05378945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587914|NCT05378945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587915|NCT05362877|Salicylic Acid|salicylic acid|mesh-list
102587916|NCT05362877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102587917|NCT05362877|Antifungal Agents|antifungal agents|mesh-ancestor
102587918|NCT05362877|Keratolytic Agents|keratolytic agents|mesh-ancestor
102587919|NCT05362877|Dermatologic Agents|dermatologic agents|mesh-ancestor
102587920|NCT05358587|Anesthetics|anesthetics|mesh-list
102587921|NCT05358587|Anesthetics, Local|anesthetics, local|mesh-list
102587922|NCT05358587|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102587923|NCT05358587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102587924|NCT05358587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587925|NCT05358587|Sensory System Agents|sensory system agents|mesh-ancestor
102587926|NCT05358587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102587927|NCT05330377|Cytarabine|cytarabine|mesh-list
102587928|NCT05330377|Mitoxantrone|mitoxantrone|mesh-list
102587930|NCT05330377|Lenograstim|lenograstim|mesh-list
102587931|NCT05330377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102587932|NCT05330377|Antimetabolites|antimetabolites|mesh-ancestor
102587933|NCT05330377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102587934|NCT05330377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102587935|NCT05330377|Antiviral Agents|antiviral agents|mesh-ancestor
102587936|NCT05330377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102587937|NCT05330377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102587938|NCT05330377|Immunologic Factors|immunologic factors|mesh-ancestor
102587939|NCT05330377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587940|NCT05330377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102587941|NCT05330377|Analgesics|analgesics|mesh-ancestor
102587942|NCT05330377|Sensory System Agents|sensory system agents|mesh-ancestor
102587943|NCT05330377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102587944|NCT05330377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102587945|NCT05330377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102587946|NCT05330377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102587947|NCT05326087|Cetrorelix|cetrorelix|mesh-list
102587948|NCT05326087|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102587949|NCT05326087|Fertility Agents|fertility agents|mesh-ancestor
102587950|NCT05326087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102587951|NCT05326087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587952|NCT05326087|Hormone Antagonists|hormone antagonists|mesh-ancestor
102587953|NCT05326087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102587954|NCT05323435|Vaccines|vaccines|mesh-list
102587955|NCT05323435|Immunologic Factors|immunologic factors|mesh-ancestor
102587956|NCT05323435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587957|NCT05322252|Misoprostol|misoprostol|mesh-list
102587958|NCT05322252|Mifepristone|mifepristone|mesh-list
102587959|NCT05322252|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102587960|NCT05322252|Abortifacient Agents|abortifacient agents|mesh-ancestor
102587961|NCT05322252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102587962|NCT05322252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587963|NCT05322252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102587964|NCT05322252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102587965|NCT05322252|Oxytocics|oxytocics|mesh-ancestor
102587966|NCT05322252|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102587967|NCT05322252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102587968|NCT05322252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102587969|NCT05322252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102587970|NCT05322252|Contraceptive Agents|contraceptive agents|mesh-ancestor
102587971|NCT05322252|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102587972|NCT05322252|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102587973|NCT05322252|Hormone Antagonists|hormone antagonists|mesh-ancestor
102587974|NCT05322252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102587975|NCT05322252|Luteolytic Agents|luteolytic agents|mesh-ancestor
102587976|NCT05322252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102587977|NCT05322252|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102587978|NCT05293912|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102587979|NCT05293912|Immunologic Factors|immunologic factors|mesh-ancestor
102587980|NCT05293912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587981|NCT05288062|Dexamethasone|dexamethasone|mesh-list
102587982|NCT05288062|Dexamethasone acetate|dexamethasone acetate|mesh-list
102587983|NCT05288062|Lenalidomide|lenalidomide|mesh-list
102587984|NCT05288062|Pomalidomide|pomalidomide|mesh-list
102587985|NCT05288062|Ichthammol|ichthammol|mesh-list
102587986|NCT05288062|BB 1101|bb 1101|mesh-list
102587987|NCT05288062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102587988|NCT05288062|Antiemetics|antiemetics|mesh-ancestor
102587989|NCT05288062|Autonomic Agents|autonomic agents|mesh-ancestor
102587990|NCT05288062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102587991|NCT05288062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102587992|NCT05288062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102587993|NCT05288062|Glucocorticoids|glucocorticoids|mesh-ancestor
102587994|NCT05288062|Hormones|hormones|mesh-ancestor
102587995|NCT05288062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102587996|NCT05288062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102587997|NCT05288062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102587998|NCT05288062|Protease Inhibitors|protease inhibitors|mesh-ancestor
102587999|NCT05288062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102588000|NCT05288062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588001|NCT05288062|Immunologic Factors|immunologic factors|mesh-ancestor
102588002|NCT05288062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102134883|NCT03501615|Immunoconjugates|immunoconjugates|mesh-ancestor
102588003|NCT05288062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102588004|NCT05288062|Growth Substances|growth substances|mesh-ancestor
102588005|NCT05288062|Growth Inhibitors|growth inhibitors|mesh-ancestor
102588006|NCT05288062|Dermatologic Agents|dermatologic agents|mesh-ancestor
102588008|NCT05246943|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102588009|NCT05246943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102588010|NCT05246943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588011|NCT05246943|Hemostatics|hemostatics|mesh-ancestor
102588012|NCT05246943|Coagulants|coagulants|mesh-ancestor
102588013|NCT05212454|Capecitabine|capecitabine|mesh-list
102588014|NCT05212454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102588015|NCT05212454|Antimetabolites|antimetabolites|mesh-ancestor
102588016|NCT05212454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588017|NCT05212454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102588018|NCT05157581|Methoxsalen|methoxsalen|mesh-list
102588019|NCT05157581|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102588020|NCT05157581|Dermatologic Agents|dermatologic agents|mesh-ancestor
102588021|NCT05096845|Vaccines|vaccines|mesh-list
102588022|NCT05096845|Immunologic Factors|immunologic factors|mesh-ancestor
102588023|NCT05096845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588024|NCT05091866|Progesterone|progesterone|mesh-list
102588025|NCT05091866|Progestins|progestins|mesh-list
102588026|NCT05091866|Hormones|hormones|mesh-ancestor
102588027|NCT05091866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102588028|NCT05091866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588029|NCT05084989|Vaccines|vaccines|mesh-list
102588030|NCT05084989|Immunologic Factors|immunologic factors|mesh-ancestor
102588031|NCT05084989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588032|NCT05079828|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102588033|NCT05079828|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102588034|NCT05079828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588035|NCT05042700|Melatonin|melatonin|mesh-list
102588036|NCT05042700|Antioxidants|antioxidants|mesh-ancestor
102588037|NCT05042700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588038|NCT05042700|Protective Agents|protective agents|mesh-ancestor
102588039|NCT05042700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588040|NCT05042700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102588041|NCT05010954|Lansoprazole|lansoprazole|mesh-list
102588042|NCT05010954|Dexlansoprazole|dexlansoprazole|mesh-list
102588043|NCT05010954|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102588044|NCT05010954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102588045|NCT05010954|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102588046|NCT05010954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102588047|NCT05010954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588048|NCT05001724|Docetaxel|docetaxel|mesh-list
102588049|NCT05001724|Lenvatinib|lenvatinib|mesh-list
102588050|NCT05001724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102588051|NCT05001724|Tubulin Modulators|tubulin modulators|mesh-ancestor
102588052|NCT05001724|Antimitotic Agents|antimitotic agents|mesh-ancestor
102588053|NCT05001724|Mitosis Modulators|mitosis modulators|mesh-ancestor
102588054|NCT05001724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588055|NCT05001724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102588056|NCT05001724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102588057|NCT04996368|Tranexamic Acid|tranexamic acid|mesh-list
102588058|NCT04996368|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102588059|NCT04996368|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102588060|NCT04996368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588061|NCT04996368|Hemostatics|hemostatics|mesh-ancestor
102588062|NCT04996368|Coagulants|coagulants|mesh-ancestor
102588063|NCT04994444|Nicotine|nicotine|mesh-list
102588064|NCT04994444|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102588065|NCT04994444|Autonomic Agents|autonomic agents|mesh-ancestor
102588066|NCT04994444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102588067|NCT04994444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588068|NCT04994444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102588069|NCT04994444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102588070|NCT04994444|Cholinergic Agents|cholinergic agents|mesh-ancestor
102588071|NCT04994444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102588072|NCT04994444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588073|NCT04987892|Tamsulosin|tamsulosin|mesh-list
102588074|NCT04987892|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102588075|NCT04987892|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102588076|NCT04987892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102588077|NCT04987892|Adrenergic Agents|adrenergic agents|mesh-ancestor
102134985|NCT02441439|Iron|iron|mesh-list
102588078|NCT04987892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102588079|NCT04987892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588080|NCT04987892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588081|NCT04987892|Urological Agents|urological agents|mesh-ancestor
102588083|NCT05019222|Sevoflurane|sevoflurane|mesh-list
102588084|NCT05019222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102588085|NCT05019222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588086|NCT05019222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102588087|NCT05019222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102588088|NCT05019222|Anesthetics, General|anesthetics, general|mesh-ancestor
102588089|NCT04966702|Ivermectin|ivermectin|mesh-list
102588090|NCT04966702|Albendazole|albendazole|mesh-list
102588091|NCT04966702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102588092|NCT04966702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102588093|NCT04966702|Anthelmintics|anthelmintics|mesh-ancestor
102588094|NCT04966702|Anticestodal Agents|anticestodal agents|mesh-ancestor
102588095|NCT04966702|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102588096|NCT04966702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102588097|NCT04966702|Tubulin Modulators|tubulin modulators|mesh-ancestor
102588098|NCT04966702|Antimitotic Agents|antimitotic agents|mesh-ancestor
102588099|NCT04966702|Mitosis Modulators|mitosis modulators|mesh-ancestor
102588100|NCT04966702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588101|NCT04966702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102588102|NCT04966663|Carboplatin|carboplatin|mesh-list
102588103|NCT04966663|Gemcitabine|gemcitabine|mesh-list
102588104|NCT04966663|Nivolumab|nivolumab|mesh-list
102588105|NCT04966663|Pemetrexed|pemetrexed|mesh-list
102588106|NCT04966663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102588107|NCT04966663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102588108|NCT04966663|Antimetabolites|antimetabolites|mesh-ancestor
102588109|NCT04966663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588110|NCT04966663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102588111|NCT04966663|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102588112|NCT04966663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102588113|NCT04966663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102344415|NCT03138720|Gemcitabine|gemcitabine|mesh-list
102588114|NCT04966663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102588115|NCT04922593|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102588116|NCT04922593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102588117|NCT04922593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102588118|NCT04922593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102588119|NCT04922593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588120|NCT04922593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102588121|NCT04922593|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102588122|NCT04922593|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102588123|NCT04922593|Serotonin Agents|serotonin agents|mesh-ancestor
102588124|NCT04922593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102588125|NCT04922593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588126|NCT04922593|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102588127|NCT04922593|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102588128|NCT04922593|Dopamine Agents|dopamine agents|mesh-ancestor
102588129|NCT04902950|Tranexamic Acid|tranexamic acid|mesh-list
102588130|NCT04902950|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102588131|NCT04902950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102588132|NCT04902950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588133|NCT04902950|Hemostatics|hemostatics|mesh-ancestor
102588134|NCT04902950|Coagulants|coagulants|mesh-ancestor
102588135|NCT04889118|Pembrolizumab|pembrolizumab|mesh-list
102588136|NCT04889118|Lenvatinib|lenvatinib|mesh-list
102588137|NCT04889118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102588138|NCT04889118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102588139|NCT04889118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102588140|NCT04889118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588141|NCT04889118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102588142|NCT04889118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102588143|NCT04819971|Docetaxel|docetaxel|mesh-list
102588144|NCT04819971|Oxaliplatin|oxaliplatin|mesh-list
102588145|NCT04819971|Trastuzumab|trastuzumab|mesh-list
102588146|NCT04819971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102588147|NCT04819971|Tubulin Modulators|tubulin modulators|mesh-ancestor
102588148|NCT04819971|Antimitotic Agents|antimitotic agents|mesh-ancestor
102588149|NCT04819971|Mitosis Modulators|mitosis modulators|mesh-ancestor
102588150|NCT04819971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588151|NCT04819971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102588152|NCT04724148|Fentanyl|fentanyl|mesh-list
102588153|NCT04724148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102588154|NCT04724148|Narcotics|narcotics|mesh-ancestor
102588155|NCT04724148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102588156|NCT04724148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588157|NCT04724148|Analgesics|analgesics|mesh-ancestor
102588158|NCT04724148|Sensory System Agents|sensory system agents|mesh-ancestor
102588159|NCT04724148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102588160|NCT04724148|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102588161|NCT04724148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102588162|NCT04724148|Anesthetics, General|anesthetics, general|mesh-ancestor
102588163|NCT04724148|Anesthetics|anesthetics|mesh-ancestor
102588164|NCT04703803|Lidocaine|lidocaine|mesh-list
102588165|NCT04703803|Anesthetics, Local|anesthetics, local|mesh-ancestor
102588166|NCT04703803|Anesthetics|anesthetics|mesh-ancestor
102588167|NCT04703803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102588168|NCT04703803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588169|NCT04703803|Sensory System Agents|sensory system agents|mesh-ancestor
102588170|NCT04703803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102588171|NCT04703803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102588172|NCT04703803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102588173|NCT04703803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102588174|NCT04703803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102588175|NCT04703803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588176|NCT04681417|Carboplatin|carboplatin|mesh-list
102588177|NCT04681417|Etoposide|etoposide|mesh-list
102588178|NCT04681417|Etoposide phosphate|etoposide phosphate|mesh-list
102588179|NCT04681417|Vincristine|vincristine|mesh-list
102588180|NCT04681417|Melphalan|melphalan|mesh-list
102588181|NCT04681417|Topotecan|topotecan|mesh-list
102588182|NCT04681417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102588183|NCT04681417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102588184|NCT04681417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102588185|NCT04681417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102588186|NCT04681417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102588187|NCT04681417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588188|NCT04681417|Tubulin Modulators|tubulin modulators|mesh-ancestor
102588189|NCT04681417|Antimitotic Agents|antimitotic agents|mesh-ancestor
102588190|NCT04681417|Mitosis Modulators|mitosis modulators|mesh-ancestor
102588191|NCT04681417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102588192|NCT04681417|Alkylating Agents|alkylating agents|mesh-ancestor
102588193|NCT04681417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102588194|NCT04681417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102588195|NCT04681417|Immunologic Factors|immunologic factors|mesh-ancestor
102588196|NCT04681417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588197|NCT04681417|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102588198|NCT04670978|Bevacizumab|bevacizumab|mesh-list
102588199|NCT04670978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102588200|NCT04670978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102588201|NCT04670978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102588202|NCT04670978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102588203|NCT04670978|Growth Substances|growth substances|mesh-ancestor
102588204|NCT04670978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588205|NCT04670978|Growth Inhibitors|growth inhibitors|mesh-ancestor
102588206|NCT04639180|Apatinib|apatinib|mesh-list
102588207|NCT04639180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102588208|NCT04639180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102588209|NCT04639180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102588210|NCT04639180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588211|NCT04531943|Progesterone|progesterone|mesh-list
102588212|NCT04531943|Estrogens|estrogens|mesh-list
102588213|NCT04531943|Progestins|progestins|mesh-ancestor
102588214|NCT04531943|Hormones|hormones|mesh-ancestor
102588215|NCT04531943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102588216|NCT04531943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588217|NCT04522973|Ethanol|ethanol|mesh-list
102588218|NCT04522973|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102588219|NCT04522973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102588220|NCT04522973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102588221|NCT04522973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588222|NCT04520048|Acetylcholine|acetylcholine|mesh-list
102588223|NCT04520048|Vasodilator Agents|vasodilator agents|mesh-ancestor
102588224|NCT04520048|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102588225|NCT04520048|Cholinergic Agents|cholinergic agents|mesh-ancestor
102588226|NCT04520048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102588227|NCT04520048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588228|NCT04520048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588229|NCT04516850|Steroid delta-isomerase|steroid delta-isomerase|mesh-list
102588230|NCT04516850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102588231|NCT04516850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588232|NCT04503460|Fluticasone|fluticasone|mesh-list
102588233|NCT04503460|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102588234|NCT04503460|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102588235|NCT04503460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102588236|NCT04503460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102588237|NCT04503460|Autonomic Agents|autonomic agents|mesh-ancestor
102588238|NCT04503460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102588239|NCT04503460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588240|NCT04503460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102588241|NCT04503460|Respiratory System Agents|respiratory system agents|mesh-ancestor
102588242|NCT04503460|Dermatologic Agents|dermatologic agents|mesh-ancestor
102588243|NCT04503460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102588244|NCT04503460|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102588245|NCT04503460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102588246|NCT04503460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102588247|NCT04503460|Adrenergic Agents|adrenergic agents|mesh-ancestor
102588248|NCT04503460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102588249|NCT04503460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588250|NCT04503460|Glucocorticoids|glucocorticoids|mesh-ancestor
102588251|NCT04503460|Hormones|hormones|mesh-ancestor
102588252|NCT04503460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102588253|NCT04503460|Sympathomimetics|sympathomimetics|mesh-ancestor
102588254|NCT04460326|Insulin|insulin|mesh-list
102588255|NCT04460326|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102588256|NCT04460326|Insulin Glargine|insulin glargine|mesh-list
102588257|NCT04460326|Insulin Aspart|insulin aspart|mesh-list
102588258|NCT04460326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102588259|NCT04460326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588260|NCT04414748|Cetrorelix|cetrorelix|mesh-list
102588261|NCT04414748|Dydrogesterone|dydrogesterone|mesh-list
102588262|NCT04414748|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102588263|NCT04414748|Fertility Agents|fertility agents|mesh-ancestor
102588264|NCT04414748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102588265|NCT04414748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588266|NCT04414748|Hormone Antagonists|hormone antagonists|mesh-ancestor
102588267|NCT04414748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102588268|NCT04414748|Progestins|progestins|mesh-ancestor
102588269|NCT04414748|Hormones|hormones|mesh-ancestor
102588270|NCT04395196|Choline|choline|mesh-list
102588271|NCT04395196|Lipotropic Agents|lipotropic agents|mesh-ancestor
102588272|NCT04395196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102588273|NCT04395196|Antimetabolites|antimetabolites|mesh-ancestor
102588274|NCT04395196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588275|NCT04395196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102588276|NCT04395196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102588277|NCT04395196|Nootropic Agents|nootropic agents|mesh-ancestor
102588278|NCT04234113|Pembrolizumab|pembrolizumab|mesh-list
102588279|NCT04234113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102588280|NCT04234113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102588281|NCT04234113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102588282|NCT04234113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588283|NCT04233515|Anticoagulants|anticoagulants|mesh-list
102588284|NCT04169373|Upadacitinib|upadacitinib|mesh-list
102588285|NCT04169373|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102588286|NCT04169373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102588287|NCT04169373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102588288|NCT04169373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588289|NCT04169373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102588290|NCT04167514|Protease Inhibitors|protease inhibitors|mesh-list
102588291|NCT04167514|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
102588292|NCT04167514|Protein C Inhibitor|protein c inhibitor|mesh-list
102588293|NCT04167514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102588294|NCT04167514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588295|NCT04167514|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102588296|NCT04167514|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102588297|NCT04150042|Vitamins|vitamins|mesh-list
102588298|NCT04150042|Ascorbic Acid|ascorbic acid|mesh-list
102588299|NCT04150042|Vitamin B 12|vitamin b 12|mesh-list
102588300|NCT04150042|Hydroxocobalamin|hydroxocobalamin|mesh-list
102588301|NCT04150042|Ethanol|ethanol|mesh-list
102588302|NCT04150042|Melphalan|melphalan|mesh-list
102588303|NCT04150042|Carmustine|carmustine|mesh-list
102588304|NCT04150042|Micronutrients|micronutrients|mesh-ancestor
102588305|NCT04150042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588306|NCT04150042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102588307|NCT04150042|Alkylating Agents|alkylating agents|mesh-ancestor
102588308|NCT04150042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588309|NCT04150042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102588310|NCT04150042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102588311|NCT04150042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102588312|NCT04150042|Immunologic Factors|immunologic factors|mesh-ancestor
102588313|NCT04150042|Antioxidants|antioxidants|mesh-ancestor
102588314|NCT04150042|Protective Agents|protective agents|mesh-ancestor
102588315|NCT04150042|Vitamin B Complex|vitamin b complex|mesh-ancestor
102588316|NCT04150042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102588317|NCT04150042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102588318|NCT04150042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102588319|NCT04150042|Hematinics|hematinics|mesh-ancestor
102588320|NCT04141644|Ipilimumab|ipilimumab|mesh-list
102588321|NCT04141644|Osimertinib|osimertinib|mesh-list
102588322|NCT04141644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102588323|NCT04141644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102588324|NCT04141644|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102588325|NCT04141644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588326|NCT04141644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102588327|NCT04141644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102588328|NCT04125927|Cysteamine|cysteamine|mesh-list
102588329|NCT04125927|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
102344421|NCT03138720|Mitosis Modulators|mitosis modulators|mesh-ancestor
102588330|NCT04125927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588331|NCT04093024|Nintedanib|nintedanib|mesh-list
102588332|NCT04093024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102588333|NCT04093024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102588334|NCT04093024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102588335|NCT04093024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588336|NCT04091503|Temozolomide|temozolomide|mesh-list
102588337|NCT04091503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102588338|NCT04091503|Alkylating Agents|alkylating agents|mesh-ancestor
102588339|NCT04091503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588340|NCT04091503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102588341|NCT04067752|Dialysis Solutions|dialysis solutions|mesh-list
102588342|NCT04067752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102588343|NCT04044534|Insulin|insulin|mesh-list
102588344|NCT04044534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102588345|NCT04044534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588346|NCT04014790|KRN 7000|krn 7000|mesh-list
102588347|NCT04014790|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102588348|NCT04014790|Immunologic Factors|immunologic factors|mesh-ancestor
102588349|NCT04014790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588350|NCT04014790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102588351|NCT03971474|Gemcitabine|gemcitabine|mesh-list
102588352|NCT03971474|Docetaxel|docetaxel|mesh-list
102588353|NCT03971474|Pembrolizumab|pembrolizumab|mesh-list
102588354|NCT03971474|Pemetrexed|pemetrexed|mesh-list
102588355|NCT03971474|Ramucirumab|ramucirumab|mesh-list
102588356|NCT03971474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102588357|NCT03971474|Antibodies|antibodies|mesh-list
102588358|NCT03971474|Immunoglobulins|immunoglobulins|mesh-list
102588359|NCT03971474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102588360|NCT03971474|Lexatumumab|lexatumumab|mesh-list
102588361|NCT03971474|Immunologic Factors|immunologic factors|mesh-ancestor
102588362|NCT03971474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588363|NCT03971474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102588364|NCT03971474|Antimetabolites|antimetabolites|mesh-ancestor
102588365|NCT03971474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588366|NCT03971474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102588367|NCT03971474|Tubulin Modulators|tubulin modulators|mesh-ancestor
102588368|NCT03971474|Antimitotic Agents|antimitotic agents|mesh-ancestor
102588369|NCT03971474|Mitosis Modulators|mitosis modulators|mesh-ancestor
102588370|NCT03971474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102588371|NCT03971474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102588372|NCT03971474|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102588373|NCT03971474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102588374|NCT03965234|Cisplatin|cisplatin|mesh-list
102588375|NCT03965234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102588376|NCT03921060|Denosumab|denosumab|mesh-list
102588377|NCT03921060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102588378|NCT03921060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588379|NCT03859973|BI 425809|bi 425809|mesh-list
102588380|NCT03859973|Nootropic Agents|nootropic agents|mesh-ancestor
102588381|NCT03827070|Afatinib|afatinib|mesh-list
102588382|NCT03827070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102588383|NCT03827070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102588384|NCT03827070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102588385|NCT03827070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588386|NCT03820986|Pembrolizumab|pembrolizumab|mesh-list
102588387|NCT03820986|Lenvatinib|lenvatinib|mesh-list
102588388|NCT03820986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102588389|NCT03820986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102588390|NCT03820986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102588391|NCT03820986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588392|NCT03820986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102588393|NCT03820986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102588394|NCT03805789|Protease Inhibitors|protease inhibitors|mesh-list
102588395|NCT03805789|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
102588396|NCT03805789|Protein C Inhibitor|protein c inhibitor|mesh-list
102588397|NCT03805789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102588398|NCT03805789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588399|NCT03805789|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102588400|NCT03805789|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102588401|NCT03748303|Pregnanolone|pregnanolone|mesh-list
102588402|NCT03748303|Anesthetics|anesthetics|mesh-ancestor
102588403|NCT03748303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102588404|NCT03748303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588405|NCT03680053|Cetrorelix|cetrorelix|mesh-list
102588406|NCT03680053|Dydrogesterone|dydrogesterone|mesh-list
102588407|NCT03680053|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102588408|NCT03680053|Fertility Agents|fertility agents|mesh-ancestor
102588409|NCT03680053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102588410|NCT03680053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588411|NCT03680053|Hormone Antagonists|hormone antagonists|mesh-ancestor
102588412|NCT03680053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102588413|NCT03680053|Progestins|progestins|mesh-ancestor
102588414|NCT03680053|Hormones|hormones|mesh-ancestor
102588415|NCT03673007|Contraceptive Agents|contraceptive agents|mesh-list
102588416|NCT03673007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102588417|NCT03673007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588418|NCT03672630|Azithromycin|azithromycin|mesh-list
102588419|NCT03672630|Rifampin|rifampin|mesh-list
102588420|NCT03672630|Ethambutol|ethambutol|mesh-list
102588421|NCT03672630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102588422|NCT03672630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102588423|NCT03672630|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102588424|NCT03672630|Antitubercular Agents|antitubercular agents|mesh-ancestor
102588425|NCT03672630|Leprostatic Agents|leprostatic agents|mesh-ancestor
102588426|NCT03672630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102588427|NCT03672630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102588428|NCT03672630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588429|NCT03672630|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102588430|NCT03672630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102588431|NCT03672630|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102588432|NCT03672630|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102588433|NCT03672630|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102588434|NCT03672630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102588435|NCT03657602|Levonorgestrel|levonorgestrel|mesh-list
102588436|NCT03657602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102588437|NCT03657602|Contraceptive Agents|contraceptive agents|mesh-ancestor
102588438|NCT03657602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102588439|NCT03657602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588440|NCT03657602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102588441|NCT03657602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102588442|NCT03657602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102588443|NCT03656718|Nivolumab|nivolumab|mesh-list
102588444|NCT03656718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102588445|NCT03656718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102588446|NCT03656718|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102588447|NCT03656718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588448|NCT03646175|Choline|choline|mesh-list
102588449|NCT03646175|Lipotropic Agents|lipotropic agents|mesh-ancestor
102588450|NCT03646175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102588451|NCT03646175|Antimetabolites|antimetabolites|mesh-ancestor
102588452|NCT03646175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588453|NCT03646175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102588454|NCT03646175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102588455|NCT03646175|Nootropic Agents|nootropic agents|mesh-ancestor
102588457|NCT03632369|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102588458|NCT03632369|Anesthetics, General|anesthetics, general|mesh-ancestor
102588459|NCT03632369|Anesthetics|anesthetics|mesh-ancestor
102588460|NCT03632369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102588461|NCT03632369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588462|NCT03625687|Antiviral Agents|antiviral agents|mesh-list
102588463|NCT03625687|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102588464|NCT03625687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102588465|NCT03598842|Metronidazole|metronidazole|mesh-list
102588466|NCT03598842|Ivermectin|ivermectin|mesh-list
102588467|NCT03598842|Albendazole|albendazole|mesh-list
102588468|NCT03598842|Antiparasitic Agents|antiparasitic agents|mesh-list
102588469|NCT03598842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102588470|NCT03598842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102588471|NCT03598842|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102588472|NCT03598842|Anthelmintics|anthelmintics|mesh-ancestor
102588473|NCT03598842|Anticestodal Agents|anticestodal agents|mesh-ancestor
102588474|NCT03598842|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102588475|NCT03598842|Tubulin Modulators|tubulin modulators|mesh-ancestor
102588476|NCT03598842|Antimitotic Agents|antimitotic agents|mesh-ancestor
102588477|NCT03598842|Mitosis Modulators|mitosis modulators|mesh-ancestor
102588478|NCT03598842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588479|NCT03598842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102588480|NCT03471364|Ketoconazole|ketoconazole|mesh-list
102588481|NCT03471364|Antifungal Agents|antifungal agents|mesh-ancestor
102588482|NCT03471364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102588483|NCT03471364|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102588484|NCT03471364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102588485|NCT03471364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102588486|NCT03471364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588487|NCT03471364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102588488|NCT03471364|Hormone Antagonists|hormone antagonists|mesh-ancestor
102588489|NCT03471364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102588490|NCT03471364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588491|NCT03471364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102588492|NCT03469284|Methylene Blue|methylene blue|mesh-list
102588493|NCT03469284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102588494|NCT03469284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588495|NCT03425331|Nivolumab|nivolumab|mesh-list
102588496|NCT03425331|Ipilimumab|ipilimumab|mesh-list
102588497|NCT03425331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102588498|NCT03425331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102588499|NCT03425331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102588500|NCT03425331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588501|NCT03276832|Pembrolizumab|pembrolizumab|mesh-list
102588502|NCT03276832|Imiquimod|imiquimod|mesh-list
102588503|NCT03276832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102588504|NCT03276832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102588505|NCT03276832|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102588506|NCT03276832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588507|NCT03276832|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102588508|NCT03276832|Immunologic Factors|immunologic factors|mesh-ancestor
102588509|NCT03276832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588510|NCT03276832|Interferon Inducers|interferon inducers|mesh-ancestor
102588511|NCT03149211|UB-421|ub-421|mesh-list
102588512|NCT03149211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102588513|NCT03149211|Antiviral Agents|antiviral agents|mesh-ancestor
102588514|NCT03149211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102588515|NCT03141671|Prednisone|prednisone|mesh-list
102588516|NCT03141671|Bicalutamide|bicalutamide|mesh-list
102588517|NCT03141671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102588518|NCT03141671|Glucocorticoids|glucocorticoids|mesh-ancestor
102588519|NCT03141671|Hormones|hormones|mesh-ancestor
102588520|NCT03141671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102588521|NCT03141671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588522|NCT03141671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102588523|NCT03141671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102588524|NCT03141671|Androgen Antagonists|androgen antagonists|mesh-ancestor
102588525|NCT03141671|Hormone Antagonists|hormone antagonists|mesh-ancestor
102588526|NCT03043430|Midazolam|midazolam|mesh-list
102588527|NCT03043430|Ketamine|ketamine|mesh-list
102588528|NCT03043430|Analgesics|analgesics|mesh-ancestor
102588529|NCT03043430|Sensory System Agents|sensory system agents|mesh-ancestor
102588530|NCT03043430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102588531|NCT03043430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588532|NCT03043430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102588533|NCT03043430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102588535|NCT03043430|Anesthetics|anesthetics|mesh-ancestor
102588536|NCT03043430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102588537|NCT03043430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102588538|NCT03043430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102588539|NCT03043430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102588540|NCT03043430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588541|NCT03043430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102588542|NCT03043430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102588543|NCT03043430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102588544|NCT03043430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102588545|NCT03043430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102588546|NCT03043430|GABA Modulators|gaba modulators|mesh-ancestor
102588547|NCT03043430|GABA Agents|gaba agents|mesh-ancestor
102588548|NCT03035890|Immunomodulating Agents|immunomodulating agents|mesh-list
102588549|NCT03035890|Immunologic Factors|immunologic factors|mesh-ancestor
102588550|NCT03035890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588551|NCT03004261|Ganciclovir|ganciclovir|mesh-list
102588552|NCT03004261|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102588553|NCT03004261|Foscarnet|foscarnet|mesh-list
102588554|NCT03004261|Antiviral Agents|antiviral agents|mesh-ancestor
102588555|NCT03004261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102588556|NCT03004261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102588557|NCT03004261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102588558|NCT03004261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588559|NCT03004261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102588560|NCT02856425|Pembrolizumab|pembrolizumab|mesh-list
102588561|NCT02856425|Nintedanib|nintedanib|mesh-list
102588562|NCT02856425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102588563|NCT02856425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102588564|NCT02856425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102588565|NCT02856425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588566|NCT02856425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102588567|NCT02856425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102588568|NCT02785952|Nivolumab|nivolumab|mesh-list
102588569|NCT02785952|Ipilimumab|ipilimumab|mesh-list
102588570|NCT02785952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102588571|NCT02785952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102588572|NCT02785952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102588573|NCT02785952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588574|NCT02652195|Oxytocin|oxytocin|mesh-list
102588575|NCT02652195|Oxytocics|oxytocics|mesh-ancestor
102588576|NCT02652195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102588577|NCT02652195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588578|NCT02567409|Cisplatin|cisplatin|mesh-list
102588579|NCT02567409|Gemcitabine|gemcitabine|mesh-list
102588580|NCT02567409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102588581|NCT02567409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102588582|NCT02567409|Antimetabolites|antimetabolites|mesh-ancestor
102588583|NCT02567409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588584|NCT02443727|Oxytocin|oxytocin|mesh-list
102588585|NCT02443727|Oxytocics|oxytocics|mesh-ancestor
102588586|NCT02443727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102588587|NCT02443727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588588|NCT02429700|Paclitaxel|paclitaxel|mesh-list
102588589|NCT02429700|Etoposide|etoposide|mesh-list
102588590|NCT02429700|Carboplatin|carboplatin|mesh-list
102588591|NCT02429700|Bleomycin|bleomycin|mesh-list
102588592|NCT02429700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102588593|NCT02429700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102588594|NCT02429700|Tubulin Modulators|tubulin modulators|mesh-ancestor
102588595|NCT02429700|Antimitotic Agents|antimitotic agents|mesh-ancestor
102588596|NCT02429700|Mitosis Modulators|mitosis modulators|mesh-ancestor
102588597|NCT02429700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588598|NCT02429700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102588599|NCT02429700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102588600|NCT02429700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102588601|NCT02429700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102588602|NCT02429687|Paclitaxel|paclitaxel|mesh-list
102588603|NCT02429687|Etoposide|etoposide|mesh-list
102588604|NCT02429687|Carboplatin|carboplatin|mesh-list
102588605|NCT02429687|Bleomycin|bleomycin|mesh-list
102588606|NCT02429687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102588607|NCT02429687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102588608|NCT02429687|Tubulin Modulators|tubulin modulators|mesh-ancestor
102588609|NCT02429687|Antimitotic Agents|antimitotic agents|mesh-ancestor
102588610|NCT02429687|Mitosis Modulators|mitosis modulators|mesh-ancestor
102588611|NCT02429687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588612|NCT02429687|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102344445|NCT03112590|Antiviral Agents|antiviral agents|mesh-ancestor
102588613|NCT02429687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102588614|NCT02429687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102588615|NCT02429687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102588616|NCT02194829|Paclitaxel|paclitaxel|mesh-list
102588617|NCT02194829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102588618|NCT02194829|Gemcitabine|gemcitabine|mesh-list
102588619|NCT02194829|Adavosertib|adavosertib|mesh-list
102588620|NCT02194829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102588621|NCT02194829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102588622|NCT02194829|Tubulin Modulators|tubulin modulators|mesh-ancestor
102588623|NCT02194829|Antimitotic Agents|antimitotic agents|mesh-ancestor
102588624|NCT02194829|Mitosis Modulators|mitosis modulators|mesh-ancestor
102588625|NCT02194829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588626|NCT02194829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102588627|NCT02194829|Antimetabolites|antimetabolites|mesh-ancestor
102588628|NCT02194829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102588629|NCT01370460|Tranexamic Acid|tranexamic acid|mesh-list
102588630|NCT01370460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102588631|NCT01370460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102588632|NCT01370460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588633|NCT01370460|Hemostatics|hemostatics|mesh-ancestor
102588634|NCT01370460|Coagulants|coagulants|mesh-ancestor
102588635|NCT00621192|Meropenem|meropenem|mesh-list
102588636|NCT00621192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102588637|NCT00621192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102588638|NCT00364286|Dasatinib|dasatinib|mesh-list
102588639|NCT00364286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102588640|NCT00364286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102588641|NCT00364286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102588642|NCT00364286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588643|NCT00255346|Dasatinib|dasatinib|mesh-list
102588644|NCT00255346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102588645|NCT00255346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102588646|NCT00255346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102588647|NCT00255346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588648|NCT02834624|Poractant alfa|poractant alfa|mesh-list
102588649|NCT02834624|Calfactant|calfactant|mesh-list
102588650|NCT02834624|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
102588651|NCT02834624|Respiratory System Agents|respiratory system agents|mesh-ancestor
102588652|NCT02837744|Hemostatics|hemostatics|mesh-list
102588653|NCT02837744|Coagulants|coagulants|mesh-ancestor
102588654|NCT02918617|Fluorides|fluorides|mesh-list
102588655|NCT02918617|Cariostatic Agents|cariostatic agents|mesh-ancestor
102588656|NCT02918617|Protective Agents|protective agents|mesh-ancestor
102588657|NCT02918617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588658|NCT02839772|Glycerol|glycerol|mesh-list
102588659|NCT02839772|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102588660|NCT02839772|Protective Agents|protective agents|mesh-ancestor
102588661|NCT02839772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588662|NCT03041636|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
102588663|NCT03041636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102588664|NCT03041636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102588665|NCT03041636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588666|NCT03043105|Thalidomide|thalidomide|mesh-list
102588667|NCT03043105|Prednisone|prednisone|mesh-list
102588668|NCT03043105|Cyclophosphamide|cyclophosphamide|mesh-list
102588669|NCT03043105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102588670|NCT03043105|Immunologic Factors|immunologic factors|mesh-ancestor
102588671|NCT03043105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588672|NCT03043105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102588673|NCT03043105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102588674|NCT03043105|Alkylating Agents|alkylating agents|mesh-ancestor
102588675|NCT03043105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588676|NCT03043105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102588677|NCT03043105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102588678|NCT03043105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102588679|NCT03043105|Glucocorticoids|glucocorticoids|mesh-ancestor
102588680|NCT03043105|Hormones|hormones|mesh-ancestor
102588681|NCT03043105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102588682|NCT03043105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102588684|NCT03043105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102588685|NCT03043105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102588686|NCT03043105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102588687|NCT03043105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102588688|NCT03043105|Growth Substances|growth substances|mesh-ancestor
102588689|NCT03043105|Growth Inhibitors|growth inhibitors|mesh-ancestor
102588690|NCT00374647|Mycophenolic Acid|mycophenolic acid|mesh-list
102588691|NCT00374647|Sirolimus|sirolimus|mesh-list
102588692|NCT00374647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102588693|NCT00374647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102588694|NCT00374647|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102588695|NCT00374647|Antitubercular Agents|antitubercular agents|mesh-ancestor
102588696|NCT00374647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102588697|NCT00374647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102588698|NCT00374647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102588699|NCT00374647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588700|NCT00374647|Antifungal Agents|antifungal agents|mesh-ancestor
102588701|NCT00374647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102588702|NCT00374647|Immunologic Factors|immunologic factors|mesh-ancestor
102588703|NCT00374647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588704|NCT02964416|Tramadol|tramadol|mesh-list
102588705|NCT02964416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102588706|NCT02964416|Narcotics|narcotics|mesh-ancestor
102588707|NCT02964416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102588708|NCT02964416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588709|NCT02964416|Analgesics|analgesics|mesh-ancestor
102588710|NCT02964416|Sensory System Agents|sensory system agents|mesh-ancestor
102588711|NCT02964416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102588712|NCT02812771|Efinaconazole|efinaconazole|mesh-list
102588713|NCT02812771|Antifungal Agents|antifungal agents|mesh-ancestor
102588714|NCT02812771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102588715|NCT02969876|Vortioxetine|vortioxetine|mesh-list
102588716|NCT02969876|Antidepressive Agents|antidepressive agents|mesh-ancestor
102588717|NCT02969876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102588718|NCT02969876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102588719|NCT02969876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102588720|NCT02969876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102588721|NCT02969876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588722|NCT02969876|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102588723|NCT02969876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102588724|NCT02969876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102588725|NCT02969876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588726|NCT02969876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102588727|NCT02969876|Serotonin Agents|serotonin agents|mesh-ancestor
102588728|NCT02969876|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102588729|NCT02969876|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102588730|NCT02969876|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102588731|NCT02969876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102588732|NCT02970032|Heparin|heparin|mesh-list
102588733|NCT02970032|Calcium heparin|calcium heparin|mesh-list
102588734|NCT02970032|Anticoagulants|anticoagulants|mesh-ancestor
102588735|NCT02970032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102588736|NCT02970032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102588737|NCT02970032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588738|NCT02813551|Torsemide|torsemide|mesh-list
102588739|NCT02813551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102588740|NCT02813551|Diuretics|diuretics|mesh-ancestor
102588741|NCT02813551|Natriuretic Agents|natriuretic agents|mesh-ancestor
102588742|NCT02813551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588743|NCT02813551|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102588744|NCT02813551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102588745|NCT02813551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588746|NCT02817763|Dipyrone|dipyrone|mesh-list
102588747|NCT02817763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102588748|NCT02817763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102588749|NCT02817763|Analgesics|analgesics|mesh-ancestor
102588750|NCT02817763|Sensory System Agents|sensory system agents|mesh-ancestor
102588751|NCT02817763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102588752|NCT02817763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588753|NCT02817763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102588754|NCT02817763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102588755|NCT02817763|Antipyretics|antipyretics|mesh-ancestor
102588756|NCT02846792|Nivolumab|nivolumab|mesh-list
102588757|NCT02846792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102588758|NCT02846792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102588759|NCT02846792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102588760|NCT02846792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588761|NCT03053401|Anesthetics|anesthetics|mesh-list
102588762|NCT03053401|Anesthetics, Local|anesthetics, local|mesh-list
102588763|NCT03053401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102588764|NCT03053401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588765|NCT03053401|Sensory System Agents|sensory system agents|mesh-ancestor
102588766|NCT03053401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102588767|NCT03054103|Midazolam|midazolam|mesh-list
102588768|NCT03054103|Ketamine|ketamine|mesh-list
102588769|NCT03054103|Analgesics|analgesics|mesh-ancestor
102588770|NCT03054103|Sensory System Agents|sensory system agents|mesh-ancestor
102588771|NCT03054103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102588772|NCT03054103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588773|NCT03054103|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102588774|NCT03054103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102588775|NCT03054103|Anesthetics, General|anesthetics, general|mesh-ancestor
102588776|NCT03054103|Anesthetics|anesthetics|mesh-ancestor
102588777|NCT03054103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102588778|NCT03054103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102588779|NCT03054103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102588780|NCT03054103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102588781|NCT03054103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588782|NCT03054103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102588783|NCT03054103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102588784|NCT03054103|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102588785|NCT03054103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102588786|NCT03054103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102588787|NCT03054103|GABA Modulators|gaba modulators|mesh-ancestor
102588788|NCT03054103|GABA Agents|gaba agents|mesh-ancestor
102588789|NCT03043274|Cangrelor|cangrelor|mesh-list
102588790|NCT03043274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102588791|NCT03043274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102588792|NCT03043274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102588793|NCT03043274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102588794|NCT03043274|Purinergic Agents|purinergic agents|mesh-ancestor
102588795|NCT03043274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102588796|NCT03043274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588797|NCT03043274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588798|NCT03054805|Magnesium Oxide|magnesium oxide|mesh-list
102588799|NCT03054805|Antacids|antacids|mesh-ancestor
102588800|NCT03054805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588801|NCT03054805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102588802|NCT00374101|Omeprazole|omeprazole|mesh-list
102588803|NCT00374101|Pantoprazole|pantoprazole|mesh-list
102588804|NCT00374101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102588805|NCT00374101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102588806|NCT00374101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102588807|NCT00374101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102588808|NCT00374101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588809|NCT00373789|Botulinum Toxins|botulinum toxins|mesh-list
102588810|NCT00373789|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102588811|NCT00373789|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102588812|NCT00373789|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102588813|NCT00373789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102588814|NCT00373789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588815|NCT00373789|Cholinergic Agents|cholinergic agents|mesh-ancestor
102588816|NCT00373789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102588817|NCT00373789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588818|NCT00373789|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102588819|NCT00373789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102588820|NCT03062605|Povidone-Iodine|povidone-iodine|mesh-list
102588821|NCT03062605|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102588822|NCT03062605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102588823|NCT03050294|Desoximetasone|desoximetasone|mesh-list
102588824|NCT03050294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102588825|NCT03050294|Glucocorticoids|glucocorticoids|mesh-ancestor
102588826|NCT03050294|Hormones|hormones|mesh-ancestor
102588827|NCT03050294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102588828|NCT03050294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588829|NCT02831569|Loxoprofen|loxoprofen|mesh-list
102588830|NCT02831569|Methocarbamol|methocarbamol|mesh-list
102588831|NCT02831569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102588832|NCT02831569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102588833|NCT02831569|Analgesics|analgesics|mesh-ancestor
102588834|NCT02831569|Sensory System Agents|sensory system agents|mesh-ancestor
102588835|NCT02831569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102588836|NCT02831569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588837|NCT02831569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102588838|NCT02831569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102588839|NCT02831569|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102588840|NCT02831569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102588841|NCT03065179|Nivolumab|nivolumab|mesh-list
102588842|NCT03065179|Ipilimumab|ipilimumab|mesh-list
102588843|NCT03065179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102588844|NCT03065179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102588845|NCT03065179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102588846|NCT03065179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588847|NCT02988050|Lidocaine|lidocaine|mesh-list
102588848|NCT02988050|Epinephrine|epinephrine|mesh-list
102588849|NCT02988050|Dexmedetomidine|dexmedetomidine|mesh-list
102588850|NCT02988050|Remifentanil|remifentanil|mesh-list
102588851|NCT02988050|Bupivacaine|bupivacaine|mesh-list
102588852|NCT02988050|Propofol|propofol|mesh-list
102588853|NCT02988050|Anesthetics, Local|anesthetics, local|mesh-ancestor
102588854|NCT02988050|Anesthetics|anesthetics|mesh-ancestor
102588855|NCT02988050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102588856|NCT02988050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588857|NCT02988050|Sensory System Agents|sensory system agents|mesh-ancestor
102588858|NCT02988050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102588859|NCT02988050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102588860|NCT02988050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102588861|NCT02988050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102588862|NCT02988050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102588863|NCT02988050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588864|NCT02988050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102588865|NCT02988050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102588866|NCT02988050|Analgesics|analgesics|mesh-ancestor
102588867|NCT02988050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102588868|NCT02988050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102588869|NCT02988050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102588870|NCT02988050|Adrenergic Agents|adrenergic agents|mesh-ancestor
102588871|NCT02988050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102588872|NCT02988050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102588873|NCT02988050|Anesthetics, General|anesthetics, general|mesh-ancestor
102588874|NCT02988050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102588875|NCT02988050|Narcotics|narcotics|mesh-ancestor
102588876|NCT02988050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102588877|NCT02988050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102588878|NCT02988050|Autonomic Agents|autonomic agents|mesh-ancestor
102588879|NCT02988050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102588880|NCT02988050|Respiratory System Agents|respiratory system agents|mesh-ancestor
102588881|NCT02988050|Mydriatics|mydriatics|mesh-ancestor
102588882|NCT02988050|Sympathomimetics|sympathomimetics|mesh-ancestor
102588883|NCT02988050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102588884|NCT02988986|Tamoxifen|tamoxifen|mesh-list
102588885|NCT02988986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102588886|NCT02988986|Hormone Antagonists|hormone antagonists|mesh-ancestor
102588887|NCT02988986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102588888|NCT02988986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588889|NCT02988986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102588890|NCT02988986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102588891|NCT02988986|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102588892|NCT02988986|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102588893|NCT02988986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102588894|NCT02832115|Lidocaine|lidocaine|mesh-list
102588895|NCT02832115|Nitroglycerin|nitroglycerin|mesh-list
102588896|NCT02832115|Anesthetics, Local|anesthetics, local|mesh-list
102588897|NCT02832115|Anesthetics|anesthetics|mesh-list
102588898|NCT02832115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102588899|NCT02832115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588900|NCT02832115|Sensory System Agents|sensory system agents|mesh-ancestor
102588901|NCT02832115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102588902|NCT02832115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102588903|NCT02832115|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102588904|NCT02832115|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102588905|NCT02832115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102588906|NCT02832115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588907|NCT02832115|Vasodilator Agents|vasodilator agents|mesh-ancestor
102588908|NCT03054506|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102588909|NCT03054506|Laxatives|laxatives|mesh-ancestor
102588910|NCT03054506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102588911|NCT02935699|Diphenhydramine|diphenhydramine|mesh-list
102588912|NCT02935699|Promethazine|promethazine|mesh-list
102588913|NCT02935699|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102588914|NCT02935699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102588915|NCT02935699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102588916|NCT02935699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588917|NCT02935699|Anesthetics, Local|anesthetics, local|mesh-ancestor
102588918|NCT02935699|Anesthetics|anesthetics|mesh-ancestor
102588919|NCT02935699|Sensory System Agents|sensory system agents|mesh-ancestor
102588920|NCT02935699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102588921|NCT02935699|Antiemetics|antiemetics|mesh-ancestor
102588922|NCT02935699|Autonomic Agents|autonomic agents|mesh-ancestor
102588923|NCT02935699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102588924|NCT02935699|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102588925|NCT02935699|Histamine Antagonists|histamine antagonists|mesh-ancestor
102588926|NCT02935699|Histamine Agents|histamine agents|mesh-ancestor
102588927|NCT02935699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102588928|NCT02935699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588929|NCT02935699|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102588930|NCT02935699|Antipruritics|antipruritics|mesh-ancestor
102588931|NCT02935699|Dermatologic Agents|dermatologic agents|mesh-ancestor
102588932|NCT02936479|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
102588933|NCT02936479|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
102588934|NCT02936479|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102588935|NCT02936479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102588936|NCT02936479|Immunologic Factors|immunologic factors|mesh-ancestor
102588937|NCT02936479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588938|NCT02841241|Esmolol|esmolol|mesh-list
102588939|NCT02841241|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102588940|NCT02841241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102588941|NCT02841241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102588942|NCT02841241|Adrenergic Agents|adrenergic agents|mesh-ancestor
102588943|NCT02841241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102588944|NCT02841241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588945|NCT02841241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588946|NCT00374881|Phenylephrine|phenylephrine|mesh-list
102588947|NCT00374881|Oxymetazoline|oxymetazoline|mesh-list
102588948|NCT00374881|Morphine|morphine|mesh-list
102588949|NCT00374881|Sorbitol|sorbitol|mesh-list
102588950|NCT00374881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102588951|NCT00374881|Narcotics|narcotics|mesh-ancestor
102588952|NCT00374881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102588953|NCT00374881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588954|NCT00374881|Analgesics|analgesics|mesh-ancestor
102588955|NCT00374881|Sensory System Agents|sensory system agents|mesh-ancestor
102588956|NCT00374881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102588957|NCT00374881|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102588958|NCT00374881|Mydriatics|mydriatics|mesh-ancestor
102588959|NCT00374881|Autonomic Agents|autonomic agents|mesh-ancestor
102588960|NCT00374881|Sympathomimetics|sympathomimetics|mesh-ancestor
102588961|NCT00374881|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102588962|NCT00374881|Nasal Decongestants|nasal decongestants|mesh-ancestor
102588963|NCT00374881|Respiratory System Agents|respiratory system agents|mesh-ancestor
102588964|NCT00374881|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102588965|NCT00374881|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102588966|NCT00374881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102588967|NCT00374881|Adrenergic Agents|adrenergic agents|mesh-ancestor
102588968|NCT00374881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102588969|NCT00374881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588970|NCT00374881|Protective Agents|protective agents|mesh-ancestor
102588971|NCT00374881|Cathartics|cathartics|mesh-ancestor
102588972|NCT00374881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102588973|NCT00374959|Ceftriaxone|ceftriaxone|mesh-list
102588974|NCT00374959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102588975|NCT00374959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102588976|NCT02846233|Metformin|metformin|mesh-list
102588977|NCT02846233|Empagliflozin|empagliflozin|mesh-list
102588978|NCT02846233|Dulaglutide|dulaglutide|mesh-list
102588979|NCT02846233|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102588980|NCT02846233|rGLP-1 protein|rglp-1 protein|mesh-list
102588981|NCT02846233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102135861|NCT03377699|Insulin|insulin|mesh-list
102588982|NCT02846233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588983|NCT02846233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588984|NCT02846233|Incretins|incretins|mesh-ancestor
102588985|NCT02846233|Hormones|hormones|mesh-ancestor
102588986|NCT02846233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102588987|NCT02865590|Cimetidine|cimetidine|mesh-list
102588988|NCT02865590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102588989|NCT02865590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102588990|NCT02865590|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102588991|NCT02865590|Histamine Antagonists|histamine antagonists|mesh-ancestor
102588992|NCT02865590|Histamine Agents|histamine agents|mesh-ancestor
102588993|NCT02865590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102588994|NCT02865590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102588995|NCT02865590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102588996|NCT02865590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102588997|NCT02865590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102588998|NCT02865590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102588999|NCT02868242|Sofosbuvir|sofosbuvir|mesh-list
102589000|NCT02868242|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102589001|NCT02868242|Ledipasvir|ledipasvir|mesh-list
102589002|NCT02868242|Antiviral Agents|antiviral agents|mesh-ancestor
102589003|NCT02868242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102589004|NCT03075553|Nivolumab|nivolumab|mesh-list
102589005|NCT03075553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102589006|NCT03075553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102589007|NCT03075553|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102589008|NCT03075553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589009|NCT03054740|Ethyl Chloride|ethyl chloride|mesh-list
102589010|NCT03054740|Anesthetics, Local|anesthetics, local|mesh-ancestor
102589011|NCT03054740|Anesthetics|anesthetics|mesh-ancestor
102589012|NCT03054740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102589013|NCT03054740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589014|NCT03054740|Sensory System Agents|sensory system agents|mesh-ancestor
102589015|NCT03054740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102589016|NCT02997722|Ketamine|ketamine|mesh-list
102589017|NCT02997722|Analgesics|analgesics|mesh-ancestor
102589018|NCT02997722|Sensory System Agents|sensory system agents|mesh-ancestor
102589019|NCT02997722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102589020|NCT02997722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589021|NCT02997722|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102589022|NCT02997722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102589023|NCT02997722|Anesthetics, General|anesthetics, general|mesh-ancestor
102589024|NCT02997722|Anesthetics|anesthetics|mesh-ancestor
102589025|NCT02997722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102589026|NCT02997722|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102589027|NCT02997722|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102589028|NCT02997722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102589029|NCT02997722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589030|NCT03108482|Celecoxib|celecoxib|mesh-list
102589031|NCT03108482|Tramadol|tramadol|mesh-list
102589032|NCT03108482|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102589033|NCT03108482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102589034|NCT03108482|Analgesics|analgesics|mesh-ancestor
102589035|NCT03108482|Sensory System Agents|sensory system agents|mesh-ancestor
102589036|NCT03108482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102589037|NCT03108482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589038|NCT03108482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102589039|NCT03108482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102589040|NCT03108482|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102589041|NCT03108482|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102589042|NCT03108482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102589043|NCT03108482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589044|NCT03108482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102589045|NCT03108482|Narcotics|narcotics|mesh-ancestor
102589046|NCT03108482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102589047|NCT02850601|Dexamethasone|dexamethasone|mesh-list
102589048|NCT02850601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102589049|NCT02850601|Antiemetics|antiemetics|mesh-ancestor
102589050|NCT02850601|Autonomic Agents|autonomic agents|mesh-ancestor
102589051|NCT02850601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102589052|NCT02850601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589053|NCT02850601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102589054|NCT02850601|Glucocorticoids|glucocorticoids|mesh-ancestor
102589055|NCT02850601|Hormones|hormones|mesh-ancestor
102589056|NCT02850601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102589057|NCT02850601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102589058|NCT02850601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102589059|NCT03056456|Insulin Lispro|insulin lispro|mesh-list
102589060|NCT03056456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102589061|NCT03056456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589062|NCT03057704|Lidocaine|lidocaine|mesh-list
102589063|NCT03057704|Anesthetics, Local|anesthetics, local|mesh-ancestor
102589064|NCT03057704|Anesthetics|anesthetics|mesh-ancestor
102589065|NCT03057704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102589066|NCT03057704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589067|NCT03057704|Sensory System Agents|sensory system agents|mesh-ancestor
102589068|NCT03057704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102589069|NCT03057704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102589070|NCT03057704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102589071|NCT03057704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102589072|NCT03057704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102589073|NCT03057704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589074|NCT02874092|Ticagrelor|ticagrelor|mesh-list
102589075|NCT02874092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102589076|NCT02874092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102589077|NCT02874092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102589078|NCT02874092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102589079|NCT02874092|Purinergic Agents|purinergic agents|mesh-ancestor
102589080|NCT02874092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102589081|NCT02874092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589082|NCT02874092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589083|NCT02876900|Asenapine|asenapine|mesh-list
102589084|NCT02876900|Maleic acid|maleic acid|mesh-list
102589085|NCT02876900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102589086|NCT02876900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589087|NCT02876900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102589088|NCT02876900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102589089|NCT02876900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102589090|NCT02876900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589091|NCT02876900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102589092|NCT02878382|Calcipotriene|calcipotriene|mesh-list
102589093|NCT02878382|Dermatologic Agents|dermatologic agents|mesh-ancestor
102589094|NCT03117140|Dexamethasone|dexamethasone|mesh-list
102589095|NCT03117140|Clonidine|clonidine|mesh-list
102589096|NCT03117140|Buprenorphine|buprenorphine|mesh-list
102589097|NCT03117140|Ropivacaine|ropivacaine|mesh-list
102589098|NCT03117140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102589099|NCT03117140|Antiemetics|antiemetics|mesh-ancestor
102589100|NCT03117140|Autonomic Agents|autonomic agents|mesh-ancestor
102589101|NCT03117140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102589102|NCT03117140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589103|NCT03117140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102589104|NCT03117140|Glucocorticoids|glucocorticoids|mesh-ancestor
102589105|NCT03117140|Hormones|hormones|mesh-ancestor
102589106|NCT03117140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102589107|NCT03117140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102589108|NCT03117140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102589109|NCT03117140|Anesthetics, Local|anesthetics, local|mesh-ancestor
102589110|NCT03117140|Anesthetics|anesthetics|mesh-ancestor
102589111|NCT03117140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102589112|NCT03117140|Sensory System Agents|sensory system agents|mesh-ancestor
102589113|NCT03117140|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102589114|NCT03117140|Narcotics|narcotics|mesh-ancestor
102589115|NCT03117140|Analgesics|analgesics|mesh-ancestor
102589116|NCT03117140|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102589117|NCT03117140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102589118|NCT03117140|Sympatholytics|sympatholytics|mesh-ancestor
102589119|NCT03117140|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102589120|NCT03117140|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102589121|NCT03117140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102589122|NCT03117140|Adrenergic Agents|adrenergic agents|mesh-ancestor
102589123|NCT03117140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102589124|NCT03117140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589125|NCT03118466|Cytarabine|cytarabine|mesh-list
102589126|NCT03118466|Etoposide|etoposide|mesh-list
102589127|NCT03118466|Mitoxantrone|mitoxantrone|mesh-list
102589128|NCT03118466|Lenalidomide|lenalidomide|mesh-list
102589129|NCT03118466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102589130|NCT03118466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102589131|NCT03118466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102589132|NCT03118466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102589133|NCT03118466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102589134|NCT03118466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589135|NCT03118466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102589136|NCT03118466|Antimetabolites|antimetabolites|mesh-ancestor
102589137|NCT03118466|Antiviral Agents|antiviral agents|mesh-ancestor
102589138|NCT03118466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102589139|NCT03118466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102589140|NCT03118466|Immunologic Factors|immunologic factors|mesh-ancestor
102589141|NCT03118466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589142|NCT03118466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102589143|NCT03118466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102589144|NCT03118466|Growth Substances|growth substances|mesh-ancestor
102589145|NCT03118466|Growth Inhibitors|growth inhibitors|mesh-ancestor
102589146|NCT03118466|Analgesics|analgesics|mesh-ancestor
102589147|NCT03118466|Sensory System Agents|sensory system agents|mesh-ancestor
102589148|NCT03118466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102589149|NCT03068312|Ivacaftor|ivacaftor|mesh-list
102589150|NCT03068312|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102589151|NCT03068312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102589152|NCT03068312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589153|NCT03119168|Simethicone|simethicone|mesh-list
102589154|NCT03119168|Antifoaming Agents|antifoaming agents|mesh-ancestor
102589155|NCT03119168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589156|NCT03119168|Emollients|emollients|mesh-ancestor
102589157|NCT03119168|Dermatologic Agents|dermatologic agents|mesh-ancestor
102589158|NCT03070730|Atenolol|atenolol|mesh-list
102589159|NCT03070730|Droxidopa|droxidopa|mesh-list
102589160|NCT03070730|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102589161|NCT03070730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102589162|NCT03070730|Sympatholytics|sympatholytics|mesh-ancestor
102589163|NCT03070730|Autonomic Agents|autonomic agents|mesh-ancestor
102589164|NCT03070730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102589165|NCT03070730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589166|NCT03070730|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102589167|NCT03070730|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102589168|NCT03070730|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102589169|NCT03070730|Adrenergic Agents|adrenergic agents|mesh-ancestor
102589170|NCT03070730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102589171|NCT03070730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589172|NCT03070730|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102589173|NCT03070730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102589174|NCT05405270|Imiquimod|imiquimod|mesh-list
102589175|NCT05405270|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102589176|NCT05405270|Immunologic Factors|immunologic factors|mesh-ancestor
102589177|NCT05405270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589178|NCT05405270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102589179|NCT05405270|Interferon Inducers|interferon inducers|mesh-ancestor
102589180|NCT03121820|Memantine|memantine|mesh-list
102589181|NCT03121820|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102589182|NCT03121820|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102589183|NCT03121820|Dopamine Agents|dopamine agents|mesh-ancestor
102589184|NCT03121820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102589185|NCT03121820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589186|NCT03121820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589187|NCT03121820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102589188|NCT03121820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102589189|NCT03123614|Loteprednol Etabonate|loteprednol etabonate|mesh-list
102589190|NCT03123614|Prednisolone|prednisolone|mesh-list
102589191|NCT03123614|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102589192|NCT03123614|Methylprednisolone|methylprednisolone|mesh-list
102589193|NCT03123614|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102589194|NCT03123614|Prednisolone acetate|prednisolone acetate|mesh-list
102589195|NCT03123614|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102589196|NCT03123614|Prednisolone phosphate|prednisolone phosphate|mesh-list
102589197|NCT03123614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102589198|NCT03123614|Glucocorticoids|glucocorticoids|mesh-ancestor
102589199|NCT03123614|Hormones|hormones|mesh-ancestor
102589200|NCT03123614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102589201|NCT03123614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589202|NCT03123614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102589203|NCT03123614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102589204|NCT03123614|Antiemetics|antiemetics|mesh-ancestor
102136091|NCT03704831|Anesthetics, Local|anesthetics, local|mesh-list
102589205|NCT03123614|Autonomic Agents|autonomic agents|mesh-ancestor
102589206|NCT03123614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102589207|NCT03123614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102589208|NCT03123614|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102589209|NCT03123614|Protective Agents|protective agents|mesh-ancestor
102589210|NCT03123614|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102589212|NCT03123848|Cobicistat|cobicistat|mesh-list
102589213|NCT03123848|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
102589214|NCT03123848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102589215|NCT03123848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102589216|NCT03123848|Protease Inhibitors|protease inhibitors|mesh-ancestor
102589217|NCT03123848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102589218|NCT03123848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589219|NCT03123848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102589220|NCT03123848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102589221|NCT03123848|Antiviral Agents|antiviral agents|mesh-ancestor
102589222|NCT03123848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102589223|NCT03123848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102589224|NCT03123848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102589225|NCT02946073|Buprenorphine|buprenorphine|mesh-list
102589226|NCT02946073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102589227|NCT02946073|Narcotics|narcotics|mesh-ancestor
102589228|NCT02946073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102589229|NCT02946073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589230|NCT02946073|Analgesics|analgesics|mesh-ancestor
102589231|NCT02946073|Sensory System Agents|sensory system agents|mesh-ancestor
102589232|NCT02946073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102589233|NCT02946073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102589234|NCT03071744|Fentanyl|fentanyl|mesh-list
102589235|NCT03071744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102589236|NCT03071744|Narcotics|narcotics|mesh-ancestor
102589237|NCT03071744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102589238|NCT03071744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589239|NCT03071744|Analgesics|analgesics|mesh-ancestor
102589240|NCT03071744|Sensory System Agents|sensory system agents|mesh-ancestor
102589241|NCT03071744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102589242|NCT03071744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102589243|NCT03071744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102589244|NCT03071744|Anesthetics, General|anesthetics, general|mesh-ancestor
102589245|NCT03071744|Anesthetics|anesthetics|mesh-ancestor
102589246|NCT03074630|Dapagliflozin|dapagliflozin|mesh-list
102589247|NCT03074630|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102589248|NCT03074630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102589249|NCT03074630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102589250|NCT03074630|Antimetabolites|antimetabolites|mesh-ancestor
102589251|NCT03074630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589252|NCT03074630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102589253|NCT03074630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102589254|NCT03074630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102589255|NCT03074630|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102589256|NCT03074630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102344539|NCT02779855|Paclitaxel|paclitaxel|mesh-list
102589257|NCT03074630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589258|NCT05404334|Androgens|androgens|mesh-list
102589259|NCT05404334|Hormones|hormones|mesh-ancestor
102589260|NCT05404334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102589261|NCT05404334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589262|NCT00374894|Succimer|succimer|mesh-list
102589263|NCT00374894|Antidotes|antidotes|mesh-ancestor
102589264|NCT00374894|Protective Agents|protective agents|mesh-ancestor
102589265|NCT00374894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589266|NCT00374894|Chelating Agents|chelating agents|mesh-ancestor
102589267|NCT00374894|Sequestering Agents|sequestering agents|mesh-ancestor
102589268|NCT00374894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589269|NCT03088267|Amphetamine|amphetamine|mesh-list
102589270|NCT03088267|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102589271|NCT03088267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589272|NCT03088267|Sympathomimetics|sympathomimetics|mesh-ancestor
102589273|NCT03088267|Autonomic Agents|autonomic agents|mesh-ancestor
102589274|NCT03088267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102589275|NCT03088267|Dopamine Agents|dopamine agents|mesh-ancestor
102589276|NCT03088267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102589277|NCT03088267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589278|NCT03088267|Adrenergic Agents|adrenergic agents|mesh-ancestor
102589279|NCT03088267|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102589280|NCT03088267|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102589281|NCT03088267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102589282|NCT03088267|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102589284|NCT03088345|Arginine Vasopressin|arginine vasopressin|mesh-list
102589285|NCT03088345|Hemostatics|hemostatics|mesh-ancestor
102589286|NCT03088345|Coagulants|coagulants|mesh-ancestor
102589287|NCT03088345|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102589288|NCT03088345|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102589289|NCT03088345|Natriuretic Agents|natriuretic agents|mesh-ancestor
102589290|NCT03088345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589291|NCT03127514|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
102589292|NCT03127514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102589293|NCT02858713|Betamethasone|betamethasone|mesh-list
102589294|NCT02858713|Betamethasone Valerate|betamethasone valerate|mesh-list
102589295|NCT02858713|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102589296|NCT02858713|Betamethasone benzoate|betamethasone benzoate|mesh-list
102589297|NCT02858713|Calcipotriene|calcipotriene|mesh-list
102589298|NCT02858713|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102589299|NCT02858713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102589300|NCT02858713|Glucocorticoids|glucocorticoids|mesh-ancestor
102589301|NCT02858713|Hormones|hormones|mesh-ancestor
102589302|NCT02858713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102589303|NCT02858713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589304|NCT02858713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102589305|NCT02858713|Respiratory System Agents|respiratory system agents|mesh-ancestor
102589306|NCT02858713|Dermatologic Agents|dermatologic agents|mesh-ancestor
102589307|NCT00375050|Riluzole|riluzole|mesh-list
102589308|NCT00375050|Anticonvulsants|anticonvulsants|mesh-ancestor
102589309|NCT00375050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102589310|NCT00375050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102589311|NCT00375050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102589312|NCT00375050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589313|NCT00375050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589314|NCT00375050|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102589315|NCT00375050|Protective Agents|protective agents|mesh-ancestor
102589316|NCT02860507|Glycopyrrolate|glycopyrrolate|mesh-list
102589317|NCT02860507|Neostigmine|neostigmine|mesh-list
102589318|NCT02860507|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102589319|NCT02860507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102589320|NCT02860507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589321|NCT02860507|Cholinergic Agents|cholinergic agents|mesh-ancestor
102589322|NCT02860507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102589323|NCT02860507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589324|NCT02860507|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102589325|NCT02860507|Autonomic Agents|autonomic agents|mesh-ancestor
102589326|NCT02860507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102589327|NCT02860507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102589328|NCT02860507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102589329|NCT02860507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102589330|NCT03082196|Fluorides|fluorides|mesh-list
102589331|NCT03082196|Sodium Fluoride|sodium fluoride|mesh-list
102344551|NCT02661035|Allopurinol|allopurinol|mesh-list
102589332|NCT03082196|Fluorides, Topical|fluorides, topical|mesh-list
102589333|NCT03082196|Cariostatic Agents|cariostatic agents|mesh-ancestor
102589334|NCT03082196|Protective Agents|protective agents|mesh-ancestor
102589335|NCT03082196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589336|NCT02861131|Neostigmine|neostigmine|mesh-list
102589337|NCT02861131|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102589338|NCT02861131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102589339|NCT02861131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589340|NCT02861131|Cholinergic Agents|cholinergic agents|mesh-ancestor
102589341|NCT02861131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102589342|NCT02861131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589343|NCT02861131|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102589344|NCT02861131|Autonomic Agents|autonomic agents|mesh-ancestor
102589345|NCT02861131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102589346|NCT05057858|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102589347|NCT05057858|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102589348|NCT05057858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102589349|NCT05057858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102589350|NCT05057858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589351|NCT05057858|Antiviral Agents|antiviral agents|mesh-ancestor
102589352|NCT05057858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102589353|NCT05057858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102589354|NCT05057858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102589355|NCT04707092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102589356|NCT04707092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102589357|NCT02953561|Azacitidine|azacitidine|mesh-list
102589358|NCT02953561|Avelumab|avelumab|mesh-list
102589359|NCT02953561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102589360|NCT02953561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102589361|NCT02953561|Antimetabolites|antimetabolites|mesh-ancestor
102589362|NCT02953561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589363|NCT02953561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102589364|NCT02953561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102589365|NCT02953561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102589366|NCT02953561|Immunologic Factors|immunologic factors|mesh-ancestor
102589367|NCT02953561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589368|NCT03090620|Lorazepam|lorazepam|mesh-list
102589369|NCT03090620|Physostigmine|physostigmine|mesh-list
102589370|NCT03090620|Anticonvulsants|anticonvulsants|mesh-ancestor
102589371|NCT03090620|Antiemetics|antiemetics|mesh-ancestor
102589372|NCT03090620|Autonomic Agents|autonomic agents|mesh-ancestor
102589373|NCT03090620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102589374|NCT03090620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589375|NCT03090620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102589376|NCT03090620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102589377|NCT03090620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102589378|NCT03090620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102589379|NCT03090620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102589380|NCT03090620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102589381|NCT03090620|GABA Modulators|gaba modulators|mesh-ancestor
102589382|NCT03090620|GABA Agents|gaba agents|mesh-ancestor
102589383|NCT03090620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102589384|NCT03090620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589385|NCT03090620|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102589386|NCT03090620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102589387|NCT03090620|Cholinergic Agents|cholinergic agents|mesh-ancestor
102589388|NCT03090620|Miotics|miotics|mesh-ancestor
102589389|NCT02953873|Mycophenolic Acid|mycophenolic acid|mesh-list
102589390|NCT02953873|Prednisone|prednisone|mesh-list
102589391|NCT02953873|Methylprednisolone|methylprednisolone|mesh-list
102589392|NCT02953873|Tacrolimus|tacrolimus|mesh-list
102589393|NCT02953873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102589394|NCT02953873|Glucocorticoids|glucocorticoids|mesh-ancestor
102589395|NCT02953873|Hormones|hormones|mesh-ancestor
102589396|NCT02953873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102589397|NCT02953873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589398|NCT02953873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102589399|NCT02953873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102589400|NCT02953873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102589401|NCT02953873|Immunologic Factors|immunologic factors|mesh-ancestor
102589402|NCT02953873|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102589403|NCT02953873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102589404|NCT02953873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589405|NCT02953873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102589406|NCT02953873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102589407|NCT02953873|Antitubercular Agents|antitubercular agents|mesh-ancestor
102589408|NCT02953873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102589409|NCT02953873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102589410|NCT02953873|Antiemetics|antiemetics|mesh-ancestor
102589411|NCT02953873|Autonomic Agents|autonomic agents|mesh-ancestor
102589412|NCT02953873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102589413|NCT02953873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102589414|NCT02953873|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102589415|NCT02953873|Protective Agents|protective agents|mesh-ancestor
102589416|NCT03091478|Pembrolizumab|pembrolizumab|mesh-list
102589417|NCT03091478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102589418|NCT03091478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102589419|NCT03091478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102589420|NCT03091478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589421|NCT02867605|Hyaluronic Acid|hyaluronic acid|mesh-list
102589422|NCT02867605|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102589423|NCT02867605|Immunologic Factors|immunologic factors|mesh-ancestor
102589424|NCT02867605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589425|NCT02867605|Viscosupplements|viscosupplements|mesh-ancestor
102589426|NCT02867605|Protective Agents|protective agents|mesh-ancestor
102589427|NCT00375596|Ketotifen|ketotifen|mesh-list
102589428|NCT00375596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
102589429|NCT00375596|Antipruritics|antipruritics|mesh-ancestor
102589430|NCT00375596|Dermatologic Agents|dermatologic agents|mesh-ancestor
102589431|NCT00375596|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102589432|NCT00375596|Histamine Antagonists|histamine antagonists|mesh-ancestor
102589434|NCT00375596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102589435|NCT00375596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589436|NCT00375596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589437|NCT00375596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102589438|NCT03093272|Prednisone|prednisone|mesh-list
102589439|NCT03093272|Docetaxel|docetaxel|mesh-list
102589440|NCT03093272|Leuprolide|leuprolide|mesh-list
102589441|NCT03093272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102589442|NCT03093272|Tubulin Modulators|tubulin modulators|mesh-ancestor
102589443|NCT03093272|Antimitotic Agents|antimitotic agents|mesh-ancestor
102589444|NCT03093272|Mitosis Modulators|mitosis modulators|mesh-ancestor
102589445|NCT03093272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589446|NCT03093272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102589447|NCT03093272|Glucocorticoids|glucocorticoids|mesh-ancestor
102589448|NCT03093272|Hormones|hormones|mesh-ancestor
102589449|NCT03093272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102589450|NCT03093272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589451|NCT03093272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102589452|NCT03093272|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102589453|NCT03093272|Fertility Agents|fertility agents|mesh-ancestor
102589454|NCT03093272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102589455|NCT03100123|Aspirin|aspirin|mesh-list
102589456|NCT03100123|Heparin|heparin|mesh-list
102589457|NCT03100123|Enoxaparin|enoxaparin|mesh-list
102589458|NCT03100123|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102589459|NCT03100123|Tinzaparin|tinzaparin|mesh-list
102589460|NCT03100123|Dalteparin|dalteparin|mesh-list
102589461|NCT03100123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102589462|NCT03100123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102589463|NCT03100123|Analgesics|analgesics|mesh-ancestor
102589464|NCT03100123|Sensory System Agents|sensory system agents|mesh-ancestor
102589465|NCT03100123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102589466|NCT03100123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589467|NCT03100123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102589468|NCT03100123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102589469|NCT03100123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102589470|NCT03100123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102589471|NCT03100123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589472|NCT03100123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102589473|NCT03100123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102589474|NCT03100123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102589475|NCT03100123|Antipyretics|antipyretics|mesh-ancestor
102589476|NCT03100123|Anticoagulants|anticoagulants|mesh-ancestor
102589477|NCT02957305|Misoprostol|misoprostol|mesh-list
102589478|NCT02957305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102589479|NCT02957305|Abortifacient Agents|abortifacient agents|mesh-ancestor
102589480|NCT02957305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102589481|NCT02957305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589482|NCT02957305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102589483|NCT02957305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102589484|NCT02957305|Oxytocics|oxytocics|mesh-ancestor
102589485|NCT04611152|Aflibercept|aflibercept|mesh-list
102589486|NCT04611152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102589487|NCT04611152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102589488|NCT04611152|Growth Substances|growth substances|mesh-ancestor
102589489|NCT04611152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589490|NCT04611152|Growth Inhibitors|growth inhibitors|mesh-ancestor
102589491|NCT04611152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102589492|NCT03104725|Acetylcysteine|acetylcysteine|mesh-list
102589493|NCT03104725|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102589494|NCT03104725|Antiviral Agents|antiviral agents|mesh-ancestor
102589495|NCT03104725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102589496|NCT03104725|Expectorants|expectorants|mesh-ancestor
102589497|NCT03104725|Respiratory System Agents|respiratory system agents|mesh-ancestor
102589498|NCT03104725|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102589499|NCT03104725|Antioxidants|antioxidants|mesh-ancestor
102589500|NCT03104725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589501|NCT03104725|Protective Agents|protective agents|mesh-ancestor
102589502|NCT03104725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136389|NCT05404906|Antimetabolites|antimetabolites|mesh-ancestor
102589503|NCT03104725|Antidotes|antidotes|mesh-ancestor
102589504|NCT03154658|Ropivacaine|ropivacaine|mesh-list
102589505|NCT03154658|Anesthetics, Local|anesthetics, local|mesh-ancestor
102589506|NCT03154658|Anesthetics|anesthetics|mesh-ancestor
102589507|NCT03154658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102589508|NCT03154658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589509|NCT03154658|Sensory System Agents|sensory system agents|mesh-ancestor
102589510|NCT03154658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102589511|NCT03098420|Dexamethasone|dexamethasone|mesh-list
102589512|NCT03098420|Dexamethasone acetate|dexamethasone acetate|mesh-list
102589513|NCT03098420|Morphine|morphine|mesh-list
102589514|NCT03098420|Bupivacaine|bupivacaine|mesh-list
102589515|NCT03098420|Ropivacaine|ropivacaine|mesh-list
102589516|NCT03098420|BB 1101|bb 1101|mesh-list
102589517|NCT03098420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102589518|NCT03098420|Antiemetics|antiemetics|mesh-ancestor
102589519|NCT03098420|Autonomic Agents|autonomic agents|mesh-ancestor
102589520|NCT03098420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102589521|NCT03098420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589522|NCT03098420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102589523|NCT03098420|Glucocorticoids|glucocorticoids|mesh-ancestor
102589524|NCT03098420|Hormones|hormones|mesh-ancestor
102589525|NCT03098420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102589526|NCT03098420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102589527|NCT03098420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102589528|NCT03098420|Protease Inhibitors|protease inhibitors|mesh-ancestor
102589529|NCT03098420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102589530|NCT03098420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589531|NCT03098420|Anesthetics, Local|anesthetics, local|mesh-ancestor
102589532|NCT03098420|Anesthetics|anesthetics|mesh-ancestor
102589533|NCT03098420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102589534|NCT03098420|Sensory System Agents|sensory system agents|mesh-ancestor
102589535|NCT03098420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102589536|NCT03098420|Narcotics|narcotics|mesh-ancestor
102589537|NCT03098420|Analgesics|analgesics|mesh-ancestor
102589538|NCT02878057|Apatinib|apatinib|mesh-list
102589539|NCT02878057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102589540|NCT02878057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102589541|NCT02878057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102589542|NCT02878057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589543|NCT00422617|Alefacept|alefacept|mesh-list
102589544|NCT00422617|Dermatologic Agents|dermatologic agents|mesh-ancestor
102589545|NCT00422617|Immunologic Factors|immunologic factors|mesh-ancestor
102589546|NCT00422617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589547|NCT03104738|Insulin|insulin|mesh-list
102589548|NCT03104738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102589549|NCT03104738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589550|NCT03163472|Anesthetics|anesthetics|mesh-list
102589551|NCT03163472|Anesthetics, Local|anesthetics, local|mesh-list
102589552|NCT03163472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102589553|NCT03163472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589554|NCT03163472|Sensory System Agents|sensory system agents|mesh-ancestor
102589555|NCT03163472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102589556|NCT04468568|Terbutaline|terbutaline|mesh-list
102589557|NCT04468568|Atosiban|atosiban|mesh-list
102589558|NCT04468568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102589559|NCT04468568|Autonomic Agents|autonomic agents|mesh-ancestor
102589560|NCT04468568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102589561|NCT04468568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589562|NCT04468568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102589563|NCT04468568|Respiratory System Agents|respiratory system agents|mesh-ancestor
102589564|NCT04468568|Sympathomimetics|sympathomimetics|mesh-ancestor
102589565|NCT04468568|Tocolytic Agents|tocolytic agents|mesh-ancestor
102589566|NCT04468568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102589567|NCT04468568|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102589568|NCT04468568|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102589569|NCT04468568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102589570|NCT04468568|Adrenergic Agents|adrenergic agents|mesh-ancestor
102589571|NCT04468568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102589572|NCT04468568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589573|NCT04468568|Hormone Antagonists|hormone antagonists|mesh-ancestor
102589574|NCT04468568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102589575|NCT03168308|Glycopyrrolate|glycopyrrolate|mesh-list
102589576|NCT03168308|Neostigmine|neostigmine|mesh-list
102589577|NCT03168308|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102589578|NCT03168308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102589579|NCT03168308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589580|NCT03168308|Cholinergic Agents|cholinergic agents|mesh-ancestor
102589581|NCT03168308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102589582|NCT03168308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589583|NCT03168308|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102589585|NCT03168308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102589586|NCT03168308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102589587|NCT03168308|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102589588|NCT03168308|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102589589|NCT03109015|Sunitinib|sunitinib|mesh-list
102589590|NCT03109015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102589591|NCT03109015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102589592|NCT03109015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102589593|NCT03109015|Growth Substances|growth substances|mesh-ancestor
102589594|NCT03109015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589595|NCT03109015|Growth Inhibitors|growth inhibitors|mesh-ancestor
102589596|NCT03109015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102589597|NCT03109015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102589598|NCT03109015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589599|NCT03115177|Doxycycline|doxycycline|mesh-list
102589600|NCT03115177|Cefazolin|cefazolin|mesh-list
102589601|NCT03115177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102589602|NCT03115177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102589603|NCT03115177|Antimalarials|antimalarials|mesh-ancestor
102589604|NCT03115177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102589605|NCT03115177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102589606|NCT03174158|Nicotine|nicotine|mesh-list
102589607|NCT03174158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102589608|NCT03174158|Autonomic Agents|autonomic agents|mesh-ancestor
102589609|NCT03174158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102589610|NCT03174158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589611|NCT03174158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102589612|NCT03174158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102589613|NCT03174158|Cholinergic Agents|cholinergic agents|mesh-ancestor
102589614|NCT03174158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102589615|NCT03174158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589616|NCT03115801|Pembrolizumab|pembrolizumab|mesh-list
102589617|NCT03115801|Nivolumab|nivolumab|mesh-list
102589618|NCT03115801|Atezolizumab|atezolizumab|mesh-list
102589619|NCT03115801|Immunomodulating Agents|immunomodulating agents|mesh-list
102589620|NCT03115801|Immunologic Factors|immunologic factors|mesh-list
102589621|NCT03115801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102589622|NCT03115801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102589623|NCT03115801|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102589624|NCT03115801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589625|NCT03115801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589626|NCT00422708|Anesthetics|anesthetics|mesh-list
102589627|NCT00422708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102589628|NCT00422708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589629|NCT03117517|Metformin|metformin|mesh-list
102589630|NCT03117517|Pioglitazone|pioglitazone|mesh-list
102589631|NCT03117517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102589632|NCT03117517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589633|NCT00375284|Pramipexole|pramipexole|mesh-list
102589634|NCT00375284|Antioxidants|antioxidants|mesh-ancestor
102589635|NCT00375284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589636|NCT00375284|Protective Agents|protective agents|mesh-ancestor
102589637|NCT00375284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589638|NCT00375284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102589639|NCT00375284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102589640|NCT00375284|Dopamine Agonists|dopamine agonists|mesh-ancestor
102589641|NCT00375284|Dopamine Agents|dopamine agents|mesh-ancestor
102589642|NCT00375284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102589643|NCT02966275|Glucagon|glucagon|mesh-list
102589644|NCT02966275|Pancrelipase|pancrelipase|mesh-list
102589645|NCT02966275|Pancreatin|pancreatin|mesh-list
102589646|NCT02966275|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102589647|NCT02966275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102589648|NCT02966275|Hormones|hormones|mesh-ancestor
102589649|NCT02966275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102589650|NCT02966275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589651|NCT02966275|Incretins|incretins|mesh-ancestor
102589652|NCT03795350|Beclomethasone|beclomethasone|mesh-list
102589653|NCT03795350|Glycopyrrolate|glycopyrrolate|mesh-list
102589654|NCT03795350|Bromides|bromides|mesh-list
102589655|NCT03795350|Formoterol Fumarate|formoterol fumarate|mesh-list
102589656|NCT03795350|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102589657|NCT03795350|Autonomic Agents|autonomic agents|mesh-ancestor
102589658|NCT03795350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102589659|NCT03795350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589660|NCT03795350|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102589661|NCT03795350|Respiratory System Agents|respiratory system agents|mesh-ancestor
102589662|NCT03795350|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102589663|NCT03795350|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102589664|NCT03795350|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102589665|NCT03795350|Adrenergic Agents|adrenergic agents|mesh-ancestor
102589666|NCT03795350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102589667|NCT03795350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589668|NCT03795350|Anticonvulsants|anticonvulsants|mesh-ancestor
102589669|NCT03795350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102589670|NCT03795350|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102589671|NCT03795350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102589672|NCT03795350|Cholinergic Agents|cholinergic agents|mesh-ancestor
102589673|NCT03795350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102589674|NCT03795350|Glucocorticoids|glucocorticoids|mesh-ancestor
102589675|NCT03795350|Hormones|hormones|mesh-ancestor
102589676|NCT03795350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102589677|NCT03118843|Velpatasvir|velpatasvir|mesh-list
102589678|NCT03118843|Antiviral Agents|antiviral agents|mesh-ancestor
102589679|NCT03118843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102589680|NCT02222922|Fluconazole|fluconazole|mesh-list
102589681|NCT02222922|Avelumab|avelumab|mesh-list
102589682|NCT02222922|Cofetuzumab pelidotin|cofetuzumab pelidotin|mesh-list
102589683|NCT02222922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102589684|NCT02222922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102589685|NCT02222922|Antifungal Agents|antifungal agents|mesh-ancestor
102589686|NCT02222922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102589687|NCT02222922|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102589688|NCT02222922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102589689|NCT02222922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102589690|NCT02222922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589691|NCT02222922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102589692|NCT02222922|Hormone Antagonists|hormone antagonists|mesh-ancestor
102589693|NCT02222922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102589694|NCT02222922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589695|NCT02222922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102589696|NCT02222922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102589697|NCT02222922|Immunoconjugates|immunoconjugates|mesh-ancestor
102589698|NCT02222922|Immunologic Factors|immunologic factors|mesh-ancestor
102589699|NCT03503942|Metformin|metformin|mesh-list
102589700|NCT03503942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102589701|NCT03503942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589702|NCT03122587|Dihydrotachysterol|dihydrotachysterol|mesh-list
102589703|NCT03122587|Vitamins|vitamins|mesh-ancestor
102589704|NCT03122587|Micronutrients|micronutrients|mesh-ancestor
102589705|NCT03122587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589706|NCT03122587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102589707|NCT02161146|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
102589708|NCT02161146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102589709|NCT02161146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102589710|NCT02161146|Analgesics|analgesics|mesh-ancestor
102589711|NCT02161146|Sensory System Agents|sensory system agents|mesh-ancestor
102589712|NCT02161146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102589713|NCT02161146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589714|NCT02161146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102589715|NCT02161146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102589716|NCT02161146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102589717|NCT02161146|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102589718|NCT02161146|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102589719|NCT02161146|Histamine Antagonists|histamine antagonists|mesh-ancestor
102589720|NCT02161146|Histamine Agents|histamine agents|mesh-ancestor
102589721|NCT02161146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102589722|NCT02161146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589723|NCT03447782|Naltrexone|naltrexone|mesh-list
102589724|NCT03447782|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102589725|NCT03447782|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102589726|NCT03447782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589727|NCT03447782|Sensory System Agents|sensory system agents|mesh-ancestor
102589728|NCT03447782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102589729|NCT03123055|Pembrolizumab|pembrolizumab|mesh-list
102589730|NCT03123055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102589731|NCT03123055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102589732|NCT03123055|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102136658|NCT03012061|Xhance|xhance|mesh-list
102589733|NCT03123055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589734|NCT02969317|Tiotropium Bromide|tiotropium bromide|mesh-list
102589735|NCT02969317|Olodaterol|olodaterol|mesh-list
102589736|NCT02969317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102589737|NCT02969317|Autonomic Agents|autonomic agents|mesh-ancestor
102589738|NCT02969317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102589739|NCT02969317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589740|NCT02969317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102589741|NCT02969317|Respiratory System Agents|respiratory system agents|mesh-ancestor
102589742|NCT02969317|Parasympatholytics|parasympatholytics|mesh-ancestor
102589743|NCT02969317|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102589744|NCT02969317|Cholinergic Agents|cholinergic agents|mesh-ancestor
102589745|NCT02969317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102589746|NCT02969317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589747|NCT00375362|Nitroglycerin|nitroglycerin|mesh-list
102589748|NCT00375362|Vasodilator Agents|vasodilator agents|mesh-ancestor
102589749|NCT05347082|Cholecalciferol|cholecalciferol|mesh-list
102589750|NCT05347082|Vitamin D|vitamin d|mesh-list
102589751|NCT05347082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102589752|NCT05347082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589753|NCT05347082|Vitamins|vitamins|mesh-ancestor
102589754|NCT05347082|Micronutrients|micronutrients|mesh-ancestor
102589755|NCT05347082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102589756|NCT03087578|Mirabegron|mirabegron|mesh-list
102589757|NCT03087578|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102589758|NCT03087578|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102589759|NCT03087578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102589760|NCT03087578|Adrenergic Agents|adrenergic agents|mesh-ancestor
102589761|NCT03087578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102589762|NCT03087578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589763|NCT03087578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589764|NCT03087578|Urological Agents|urological agents|mesh-ancestor
102589765|NCT02807558|Azacitidine|azacitidine|mesh-list
102589766|NCT02807558|Daratumumab|daratumumab|mesh-list
102589767|NCT02807558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102589768|NCT02807558|Antimetabolites|antimetabolites|mesh-ancestor
102589769|NCT02807558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589770|NCT02807558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102589771|NCT02807558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102589772|NCT05324384|Sirolimus|sirolimus|mesh-list
102589773|NCT05324384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102589774|NCT05324384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102589775|NCT05324384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102589776|NCT05324384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102589777|NCT05324384|Antifungal Agents|antifungal agents|mesh-ancestor
102589778|NCT05324384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102589779|NCT05324384|Immunologic Factors|immunologic factors|mesh-ancestor
102589780|NCT05324384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589781|NCT02975557|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102589782|NCT02975557|Lubricant Eye Drops|lubricant eye drops|mesh-list
102589783|NCT02975557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102589784|NCT02975557|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102589785|NCT02975557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102589786|NCT02975557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102589787|NCT02975557|Adrenergic Agents|adrenergic agents|mesh-ancestor
102589788|NCT02975557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102589789|NCT02975557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589790|NCT02975557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589791|NCT02975557|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102589792|NCT02975557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102589793|NCT04736810|Gemcitabine|gemcitabine|mesh-list
102589794|NCT04736810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102589795|NCT04736810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102589796|NCT04736810|Antimetabolites|antimetabolites|mesh-ancestor
102589797|NCT04736810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589798|NCT03132571|Naltrexone|naltrexone|mesh-list
102589799|NCT03132571|Bupropion|bupropion|mesh-list
102589800|NCT03132571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102589801|NCT03132571|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102589802|NCT03132571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589803|NCT03132571|Sensory System Agents|sensory system agents|mesh-ancestor
102589804|NCT03132571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102589805|NCT03132571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102589806|NCT03132571|Antidepressive Agents|antidepressive agents|mesh-ancestor
102589807|NCT03132571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102589808|NCT03132571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102589809|NCT03132571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102589810|NCT03132571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102589811|NCT03132571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589812|NCT03132571|Dopamine Agents|dopamine agents|mesh-ancestor
102589813|NCT03132571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102589814|NCT03132571|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102589815|NCT03132571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102589816|NCT03132571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102589817|NCT05267054|Rituximab|rituximab|mesh-list
102589818|NCT05267054|Tislelizumab|tislelizumab|mesh-list
102589819|NCT05267054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102589820|NCT05267054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102589821|NCT05267054|Immunologic Factors|immunologic factors|mesh-ancestor
102589822|NCT05267054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589823|NCT05267054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102589824|NCT02374424|Obinutuzumab|obinutuzumab|mesh-list
102589825|NCT02374424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102589826|NCT02374424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102589827|NCT02002130|Aluminum sulfate|aluminum sulfate|mesh-list
102589828|NCT02002130|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
102589829|NCT02002130|Butyric Acid|butyric acid|mesh-list
102589830|NCT02002130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102589831|NCT02002130|Immunologic Factors|immunologic factors|mesh-ancestor
102589832|NCT02002130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589833|NCT02002130|GABA Agents|gaba agents|mesh-ancestor
102589834|NCT02002130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102589835|NCT02002130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589836|NCT02002130|Histamine Antagonists|histamine antagonists|mesh-ancestor
102589837|NCT02002130|Histamine Agents|histamine agents|mesh-ancestor
102589838|NCT01306994|Adenosine|adenosine|mesh-list
102589839|NCT01306994|Analgesics|analgesics|mesh-ancestor
102589840|NCT01306994|Sensory System Agents|sensory system agents|mesh-ancestor
102589841|NCT01306994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102589842|NCT01306994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589843|NCT01306994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102589844|NCT01306994|Vasodilator Agents|vasodilator agents|mesh-ancestor
102589845|NCT01306994|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102589846|NCT01306994|Purinergic Agonists|purinergic agonists|mesh-ancestor
102589847|NCT01306994|Purinergic Agents|purinergic agents|mesh-ancestor
102589848|NCT01306994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102589849|NCT01306994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589850|NCT02979301|Tamoxifen|tamoxifen|mesh-list
102589851|NCT02979301|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102589852|NCT02979301|Hormone Antagonists|hormone antagonists|mesh-ancestor
102589853|NCT02979301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102589854|NCT02979301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589855|NCT02979301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102589856|NCT02979301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102589857|NCT02979301|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102589858|NCT02979301|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102589859|NCT02979301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102589860|NCT00375440|Tranexamic Acid|tranexamic acid|mesh-list
102589861|NCT00375440|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102589862|NCT00375440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102589863|NCT00375440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589864|NCT00375440|Hemostatics|hemostatics|mesh-ancestor
102589865|NCT00375440|Coagulants|coagulants|mesh-ancestor
102589866|NCT05113004|Mycophenolic Acid|mycophenolic acid|mesh-list
102344771|NCT06017297|Gemcitabine|gemcitabine|mesh-list
102589867|NCT05113004|Hydroxychloroquine|hydroxychloroquine|mesh-list
102589868|NCT05113004|Leflunomide|leflunomide|mesh-list
102589869|NCT05113004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102589870|NCT05113004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102589871|NCT05113004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102589872|NCT05113004|Antitubercular Agents|antitubercular agents|mesh-ancestor
102589873|NCT05113004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102589874|NCT05113004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102589875|NCT05113004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102589876|NCT05113004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589877|NCT05113004|Antimalarials|antimalarials|mesh-ancestor
102589878|NCT05113004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102589879|NCT05113004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102589880|NCT05113004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102589881|NCT05113004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102589882|NCT05113004|Immunologic Factors|immunologic factors|mesh-ancestor
102589883|NCT05113004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589884|NCT02983981|Desoximetasone|desoximetasone|mesh-list
102589885|NCT02983981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102589886|NCT02983981|Glucocorticoids|glucocorticoids|mesh-ancestor
102589887|NCT02983981|Hormones|hormones|mesh-ancestor
102589888|NCT02983981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102589889|NCT02983981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589890|NCT00375583|Albendazole|albendazole|mesh-list
102589891|NCT00375583|Anthelmintics|anthelmintics|mesh-ancestor
102589892|NCT00375583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102589893|NCT00375583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102589894|NCT00375583|Anticestodal Agents|anticestodal agents|mesh-ancestor
102589895|NCT00375583|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102589896|NCT00375583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102589897|NCT00375583|Tubulin Modulators|tubulin modulators|mesh-ancestor
102589898|NCT00375583|Antimitotic Agents|antimitotic agents|mesh-ancestor
102589899|NCT00375583|Mitosis Modulators|mitosis modulators|mesh-ancestor
102589900|NCT00375583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589901|NCT00375583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102589902|NCT03143569|Heparin|heparin|mesh-list
102589903|NCT03143569|Calcium heparin|calcium heparin|mesh-list
102589904|NCT03143569|Anticoagulants|anticoagulants|mesh-ancestor
102589905|NCT03143569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102589906|NCT03143569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102589907|NCT03143569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589908|NCT03149887|Bupivacaine|bupivacaine|mesh-list
102589909|NCT03149887|Anesthetics, Local|anesthetics, local|mesh-ancestor
102589910|NCT03149887|Anesthetics|anesthetics|mesh-ancestor
102589911|NCT03149887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102589912|NCT03149887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589913|NCT03149887|Sensory System Agents|sensory system agents|mesh-ancestor
102589914|NCT03149887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102589915|NCT02988349|Listerine|listerine|mesh-list
102589916|NCT02988349|Sodium Fluoride|sodium fluoride|mesh-list
102589917|NCT02988349|Cariostatic Agents|cariostatic agents|mesh-ancestor
102589918|NCT02988349|Protective Agents|protective agents|mesh-ancestor
102589919|NCT02988349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589920|NCT02988349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102589921|NCT02988349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102589922|NCT02159352|Ritonavir|ritonavir|mesh-list
102589923|NCT02159352|Lopinavir|lopinavir|mesh-list
102589924|NCT02159352|Darunavir|darunavir|mesh-list
102589925|NCT02159352|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102589926|NCT02159352|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102589927|NCT02159352|Protease Inhibitors|protease inhibitors|mesh-ancestor
102589928|NCT02159352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102589929|NCT02159352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589930|NCT02159352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102589931|NCT02159352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102589932|NCT02159352|Antiviral Agents|antiviral agents|mesh-ancestor
102589933|NCT02159352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102589934|NCT02159352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102589935|NCT02159352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102589936|NCT02187744|Carboplatin|carboplatin|mesh-list
102589937|NCT02187744|Docetaxel|docetaxel|mesh-list
102589938|NCT02187744|Trastuzumab|trastuzumab|mesh-list
102589939|NCT02187744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102589940|NCT02187744|Tubulin Modulators|tubulin modulators|mesh-ancestor
101856776|NCT00384176|Antidotes|antidotes|mesh-ancestor
102589941|NCT02187744|Antimitotic Agents|antimitotic agents|mesh-ancestor
102589942|NCT02187744|Mitosis Modulators|mitosis modulators|mesh-ancestor
102589943|NCT02187744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589944|NCT02187744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102589945|NCT03154333|Diacerein|diacerein|mesh-list
102589946|NCT03154333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102589947|NCT04393441|Lubricant Eye Drops|lubricant eye drops|mesh-list
102589948|NCT04393441|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102589949|NCT04393441|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102589950|NCT02995915|Bupropion|bupropion|mesh-list
102589951|NCT02995915|Nicotine|nicotine|mesh-list
102589952|NCT02995915|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102589953|NCT02995915|Autonomic Agents|autonomic agents|mesh-ancestor
102589954|NCT02995915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102589955|NCT02995915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589956|NCT02995915|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102589957|NCT02995915|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102589958|NCT02995915|Cholinergic Agents|cholinergic agents|mesh-ancestor
102589959|NCT02995915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102589960|NCT02995915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589961|NCT02995915|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102589962|NCT02995915|Antidepressive Agents|antidepressive agents|mesh-ancestor
102589963|NCT02995915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102589964|NCT02995915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102589965|NCT02995915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102589966|NCT02995915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102589967|NCT02995915|Dopamine Agents|dopamine agents|mesh-ancestor
102589968|NCT02995915|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102589969|NCT02995915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102589970|NCT02995915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102589971|NCT03163303|Nicotine|nicotine|mesh-list
102589972|NCT03163303|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102589973|NCT03163303|Autonomic Agents|autonomic agents|mesh-ancestor
102589974|NCT03163303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102589975|NCT03163303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589976|NCT03163303|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102589977|NCT03163303|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102589978|NCT03163303|Cholinergic Agents|cholinergic agents|mesh-ancestor
102589979|NCT03163303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102589980|NCT03163303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589981|NCT03000283|Conivaptan|conivaptan|mesh-list
102589982|NCT03000283|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102589983|NCT03000283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589984|NCT03000283|Natriuretic Agents|natriuretic agents|mesh-ancestor
102589985|NCT03000283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589986|NCT03168295|Dapagliflozin|dapagliflozin|mesh-list
102589987|NCT03168295|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102589988|NCT03168295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102589989|NCT03168295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102589990|NCT03168295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589991|NCT03168841|Efinaconazole|efinaconazole|mesh-list
102589992|NCT03168841|Antifungal Agents|antifungal agents|mesh-ancestor
102589993|NCT03168841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102589994|NCT03865615|Oxytocin|oxytocin|mesh-list
102589995|NCT03865615|Oxytocics|oxytocics|mesh-ancestor
102589996|NCT03865615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102589997|NCT03865615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102589998|NCT03185546|Nicotine|nicotine|mesh-list
102589999|NCT03185546|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102590000|NCT03185546|Autonomic Agents|autonomic agents|mesh-ancestor
102590001|NCT03185546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102590002|NCT03185546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590003|NCT03185546|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102590004|NCT03185546|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102590005|NCT03185546|Cholinergic Agents|cholinergic agents|mesh-ancestor
102590006|NCT03185546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102590007|NCT03185546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590008|NCT02186652|Pantoprazole|pantoprazole|mesh-list
102590009|NCT02186652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102590010|NCT02186652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102590011|NCT02186652|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102590012|NCT02186652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102590013|NCT02186652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590014|NCT03606889|Bupivacaine|bupivacaine|mesh-list
102590015|NCT03606889|Anesthetics, Local|anesthetics, local|mesh-ancestor
102590016|NCT03606889|Anesthetics|anesthetics|mesh-ancestor
102590017|NCT03606889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102590018|NCT03606889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590019|NCT03606889|Sensory System Agents|sensory system agents|mesh-ancestor
102590020|NCT03606889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102590021|NCT05363917|Folic Acid|folic acid|mesh-list
102590022|NCT05363917|Vitamin B Complex|vitamin b complex|mesh-list
102590023|NCT05363917|Hematinics|hematinics|mesh-ancestor
102590024|NCT05363917|Vitamins|vitamins|mesh-ancestor
102590025|NCT05363917|Micronutrients|micronutrients|mesh-ancestor
102590026|NCT05363917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590027|NCT03187730|Nicotine|nicotine|mesh-list
102590028|NCT03187730|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102590029|NCT03187730|Autonomic Agents|autonomic agents|mesh-ancestor
102590030|NCT03187730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102590031|NCT03187730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590032|NCT03187730|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102590033|NCT03187730|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102136917|NCT02440425|Paclitaxel|paclitaxel|mesh-list
102590034|NCT03187730|Cholinergic Agents|cholinergic agents|mesh-ancestor
102590035|NCT03187730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102590036|NCT03187730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590037|NCT03261193|Bupivacaine|bupivacaine|mesh-list
102590038|NCT03261193|Anesthetics, Local|anesthetics, local|mesh-ancestor
102590039|NCT03261193|Anesthetics|anesthetics|mesh-ancestor
102590040|NCT03261193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102590041|NCT03261193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590042|NCT03261193|Sensory System Agents|sensory system agents|mesh-ancestor
102590043|NCT03261193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102590044|NCT00375661|Interferons|interferons|mesh-list
102590045|NCT00375661|Ribavirin|ribavirin|mesh-list
102590046|NCT00375661|Interferon-alpha|interferon-alpha|mesh-list
102590047|NCT00375661|Interferon alpha-2|interferon alpha-2|mesh-list
102590048|NCT00375661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102590049|NCT00375661|Antiviral Agents|antiviral agents|mesh-ancestor
102590050|NCT00375661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102590051|NCT00375661|Antimetabolites|antimetabolites|mesh-ancestor
102590052|NCT00375661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344804|NCT06017167|BB 1101|bb 1101|mesh-list
102590053|NCT00375661|Immunologic Factors|immunologic factors|mesh-ancestor
102590054|NCT00375661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590055|NCT04736186|Loperamide|loperamide|mesh-list
102590056|NCT04736186|Antidiarrheals|antidiarrheals|mesh-list
102590057|NCT04736186|Bentonite|bentonite|mesh-list
102590058|NCT04736186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102590059|NCT04736186|Antidotes|antidotes|mesh-ancestor
102590060|NCT04736186|Protective Agents|protective agents|mesh-ancestor
102590061|NCT04736186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590062|NCT04941170|Bupivacaine|bupivacaine|mesh-list
102590063|NCT04941170|Anesthetics, Local|anesthetics, local|mesh-ancestor
102590064|NCT04941170|Anesthetics|anesthetics|mesh-ancestor
102590065|NCT04941170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102590066|NCT04941170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590067|NCT04941170|Sensory System Agents|sensory system agents|mesh-ancestor
102590068|NCT04941170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102590069|NCT05357911|Digoxin|digoxin|mesh-list
102590070|NCT05357911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102590071|NCT05357911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102590072|NCT05357911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102590073|NCT05357911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590074|NCT05357911|Protective Agents|protective agents|mesh-ancestor
102590075|NCT05357911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590076|NCT03374839|Nivolumab|nivolumab|mesh-list
102590077|NCT03374839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102590078|NCT03374839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102590079|NCT03374839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102590080|NCT03374839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590081|NCT03347929|Naproxen|naproxen|mesh-list
102590082|NCT03347929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102590083|NCT03347929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102590084|NCT03347929|Analgesics|analgesics|mesh-ancestor
102590085|NCT03347929|Sensory System Agents|sensory system agents|mesh-ancestor
102590086|NCT03347929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102590087|NCT03347929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590088|NCT03347929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102590089|NCT03347929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102590090|NCT03347929|Gout Suppressants|gout suppressants|mesh-ancestor
102590091|NCT03347929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102590092|NCT03347929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102590093|NCT03347929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590094|NCT02221674|Tapentadol|tapentadol|mesh-list
102590095|NCT02221674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102590096|NCT02221674|Narcotics|narcotics|mesh-ancestor
102590097|NCT02221674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102590098|NCT02221674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590099|NCT02221674|Analgesics|analgesics|mesh-ancestor
102344834|NCT06017141|Fentanyl|fentanyl|mesh-list
102590100|NCT02221674|Sensory System Agents|sensory system agents|mesh-ancestor
102590101|NCT02221674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102590102|NCT02221674|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102590103|NCT02221674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102590104|NCT02221674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102590105|NCT02221674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590106|NCT02221674|Adrenergic Agents|adrenergic agents|mesh-ancestor
102590107|NCT02221674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102136989|NCT03487809|Hormones|hormones|mesh-ancestor
102590109|NCT04736719|Apixaban|apixaban|mesh-list
102590110|NCT04736719|Anticoagulants|anticoagulants|mesh-ancestor
102590111|NCT04736719|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102590112|NCT04736719|Antithrombins|antithrombins|mesh-ancestor
102590113|NCT04736719|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102590114|NCT04736719|Protease Inhibitors|protease inhibitors|mesh-ancestor
102590115|NCT04736719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102590116|NCT04736719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590117|NCT02221284|Alogliptin|alogliptin|mesh-list
102590118|NCT02221284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102590119|NCT02221284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590120|NCT02221284|Incretins|incretins|mesh-ancestor
102590121|NCT02221284|Hormones|hormones|mesh-ancestor
102590122|NCT02221284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102590123|NCT02221284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102590124|NCT02221284|Protease Inhibitors|protease inhibitors|mesh-ancestor
102590125|NCT02221284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102590126|NCT02221284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590127|NCT04736108|Prednisolone|prednisolone|mesh-list
102590128|NCT04736108|Goserelin|goserelin|mesh-list
102590129|NCT04736108|Abiraterone Acetate|abiraterone acetate|mesh-list
102590130|NCT04736108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102590131|NCT04736108|Glucocorticoids|glucocorticoids|mesh-ancestor
102590132|NCT04736108|Hormones|hormones|mesh-ancestor
102590133|NCT04736108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102590134|NCT04736108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590135|NCT04736108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102590136|NCT04736108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102590137|NCT04736108|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102590138|NCT04736108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102590139|NCT04736108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590140|NCT04736108|Hormone Antagonists|hormone antagonists|mesh-ancestor
102590141|NCT04736108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102590142|NCT02971033|Ezetimibe|ezetimibe|mesh-list
102590143|NCT02971033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102590144|NCT02971033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102590145|NCT02971033|Antimetabolites|antimetabolites|mesh-ancestor
102590146|NCT02971033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590147|NCT02971033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102590148|NCT05406674|Cisplatin|cisplatin|mesh-list
102590149|NCT05406674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102590150|NCT05341375|Anesthetics|anesthetics|mesh-list
102590151|NCT05341375|Esketamine|esketamine|mesh-list
102590152|NCT05341375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102590153|NCT05341375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590154|NCT05341375|Antidepressive Agents|antidepressive agents|mesh-ancestor
102590155|NCT05341375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102590156|NCT03196232|Pembrolizumab|pembrolizumab|mesh-list
102590157|NCT03196232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102344851|NCT06017037|Citalopram|citalopram|mesh-list
102590158|NCT03196232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102590159|NCT03196232|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102590160|NCT03196232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590161|NCT04356716|Sildenafil Citrate|sildenafil citrate|mesh-list
102590162|NCT04356716|Vasodilator Agents|vasodilator agents|mesh-ancestor
102590163|NCT04356716|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102590164|NCT04356716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102590165|NCT04356716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102590166|NCT04356716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590167|NCT04356716|Urological Agents|urological agents|mesh-ancestor
102590168|NCT03200587|Avelumab|avelumab|mesh-list
102590169|NCT03200587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102590170|NCT03200587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102590171|NCT03198884|Dolutegravir|dolutegravir|mesh-list
102590172|NCT03198884|Darunavir|darunavir|mesh-list
102590173|NCT03198884|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102590174|NCT03198884|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102590175|NCT03198884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102590176|NCT03198884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590177|NCT03198884|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102590178|NCT03198884|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102590179|NCT03198884|Antiviral Agents|antiviral agents|mesh-ancestor
102137064|NCT04308837|Antiemetics|antiemetics|mesh-ancestor
102590180|NCT03198884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102590181|NCT03198884|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102590182|NCT03198884|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102590183|NCT03198884|Protease Inhibitors|protease inhibitors|mesh-ancestor
102590184|NCT01801189|Pregabalin|pregabalin|mesh-list
102590185|NCT01801189|Analgesics|analgesics|mesh-ancestor
102590186|NCT01801189|Sensory System Agents|sensory system agents|mesh-ancestor
102590187|NCT01801189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102590188|NCT01801189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590189|NCT01801189|Anticonvulsants|anticonvulsants|mesh-ancestor
102590190|NCT01801189|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102590191|NCT01801189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102590192|NCT01801189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590193|NCT01801189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102590194|NCT01801189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102590195|NCT01801189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102590196|NCT01801189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102590197|NCT01801189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102590198|NCT04275362|Cimetidine|cimetidine|mesh-list
102590199|NCT04275362|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102590200|NCT04275362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102590201|NCT04275362|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102590202|NCT04275362|Histamine Antagonists|histamine antagonists|mesh-ancestor
102590203|NCT04275362|Histamine Agents|histamine agents|mesh-ancestor
102590204|NCT04275362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102590205|NCT04275362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590206|NCT04275362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590207|NCT04275362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102590208|NCT04275362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102590209|NCT04275362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102590210|NCT05178043|Nivolumab|nivolumab|mesh-list
102590211|NCT05178043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102590212|NCT05178043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102590213|NCT05178043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102590214|NCT05178043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590215|NCT00716755|Olanzapine|olanzapine|mesh-list
102590216|NCT00716755|Risperidone|risperidone|mesh-list
102590217|NCT00716755|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102590218|NCT00716755|Serotonin Agents|serotonin agents|mesh-ancestor
102590219|NCT00716755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102590220|NCT00716755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590221|NCT00716755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590222|NCT00716755|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102590223|NCT00716755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102590224|NCT00716755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102590225|NCT00716755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102590226|NCT00716755|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102590227|NCT00716755|Dopamine Agents|dopamine agents|mesh-ancestor
102590228|NCT00716755|Antiemetics|antiemetics|mesh-ancestor
102590229|NCT00716755|Autonomic Agents|autonomic agents|mesh-ancestor
102590230|NCT00716755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102590231|NCT00716755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102590232|NCT00716755|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102590233|NCT00716755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102590234|NCT00716755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102590235|NCT05406050|Eldecalcitol|eldecalcitol|mesh-list
102590236|NCT05406050|Vitamin D|vitamin d|mesh-list
102590237|NCT05406050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102590238|NCT05406050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590239|NCT05406050|Vitamins|vitamins|mesh-ancestor
102590240|NCT05406050|Micronutrients|micronutrients|mesh-ancestor
102590241|NCT03202550|Oxycodone|oxycodone|mesh-list
102590242|NCT03202550|Lorazepam|lorazepam|mesh-list
102590243|NCT03202550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102590244|NCT03202550|Narcotics|narcotics|mesh-ancestor
102590245|NCT03202550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102590246|NCT03202550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590247|NCT03202550|Analgesics|analgesics|mesh-ancestor
102590248|NCT03202550|Sensory System Agents|sensory system agents|mesh-ancestor
102590249|NCT03202550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102590250|NCT03202550|Anticonvulsants|anticonvulsants|mesh-ancestor
102590251|NCT03202550|Antiemetics|antiemetics|mesh-ancestor
102590252|NCT03202550|Autonomic Agents|autonomic agents|mesh-ancestor
102590253|NCT03202550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102590254|NCT03202550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102590255|NCT03202550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102590256|NCT03202550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102590257|NCT03202550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102590258|NCT03202550|GABA Modulators|gaba modulators|mesh-ancestor
102590259|NCT03202550|GABA Agents|gaba agents|mesh-ancestor
102590260|NCT03202550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102590261|NCT03202550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590262|NCT04088786|Irinotecan|irinotecan|mesh-list
102590263|NCT04088786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102590264|NCT04088786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102590265|NCT04088786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102590266|NCT04088786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590267|NCT04088786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102590268|NCT00392821|Everolimus|everolimus|mesh-list
102590269|NCT00392821|Sorafenib|sorafenib|mesh-list
102590270|NCT00392821|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102590271|NCT00392821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102590272|NCT00392821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102590273|NCT00392821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590274|NCT00392821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102590275|NCT00392821|Immunologic Factors|immunologic factors|mesh-ancestor
102590276|NCT00392821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590277|NCT00392821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102590278|NCT04708171|Anesthetics|anesthetics|mesh-list
102590279|NCT04708171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102590280|NCT04708171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590281|NCT03290378|Tramadol|tramadol|mesh-list
102590282|NCT03290378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102590283|NCT03290378|Narcotics|narcotics|mesh-ancestor
102590284|NCT03290378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102590285|NCT03290378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590286|NCT03290378|Analgesics|analgesics|mesh-ancestor
102590287|NCT03290378|Sensory System Agents|sensory system agents|mesh-ancestor
102590288|NCT03290378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102590289|NCT02076217|Copper|copper|mesh-list
102590290|NCT02076217|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102590291|NCT02076217|Contraceptive Agents|contraceptive agents|mesh-list
102590292|NCT02076217|Medroxyprogesterone|medroxyprogesterone|mesh-list
102590293|NCT02076217|Etonogestrel|etonogestrel|mesh-list
102590294|NCT02076217|Desogestrel|desogestrel|mesh-list
102590295|NCT02076217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102590296|NCT02076217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590297|NCT02076217|Trace Elements|trace elements|mesh-ancestor
102590298|NCT02076217|Micronutrients|micronutrients|mesh-ancestor
102590299|NCT02076217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102590300|NCT02076217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102590301|NCT02076217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102590302|NCT02076217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102590303|NCT02076217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102590304|NCT02076217|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102590305|NCT02076217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102590306|NCT02076217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102590307|NCT02076217|Progestins|progestins|mesh-ancestor
102590308|NCT02076217|Hormones|hormones|mesh-ancestor
102590309|NCT02076217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102590310|NCT03291080|Tretinoin|tretinoin|mesh-list
102590311|NCT03291080|Isotretinoin|isotretinoin|mesh-list
102590312|NCT03291080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102590313|NCT03291080|Keratolytic Agents|keratolytic agents|mesh-ancestor
102590314|NCT03291080|Dermatologic Agents|dermatologic agents|mesh-ancestor
102590315|NCT04874545|Propofol|propofol|mesh-list
102590316|NCT04874545|Sevoflurane|sevoflurane|mesh-list
102590317|NCT04874545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102590318|NCT04874545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102590319|NCT04874545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344913|NCT06012331|Mitogens|mitogens|mesh-list
102590320|NCT04874545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102590321|NCT04874545|Anesthetics, General|anesthetics, general|mesh-ancestor
102590322|NCT04874545|Anesthetics|anesthetics|mesh-ancestor
102590323|NCT04874545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102590324|NCT04874545|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102590325|NCT03181009|Omalizumab|omalizumab|mesh-list
102590326|NCT03181009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102590327|NCT03181009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102590328|NCT03181009|Respiratory System Agents|respiratory system agents|mesh-ancestor
102590329|NCT04430569|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102590330|NCT04430569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102590331|NCT04430569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102590332|NCT04430569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590333|NCT03296072|Listerine|listerine|mesh-list
102137237|NCT01652092|Vidarabine|vidarabine|mesh-list
102590334|NCT03296072|Fluorides|fluorides|mesh-list
102590335|NCT03296072|Sodium Fluoride|sodium fluoride|mesh-list
102590336|NCT03296072|Tin Fluorides|tin fluorides|mesh-list
102590337|NCT03296072|Cariostatic Agents|cariostatic agents|mesh-ancestor
102590338|NCT03296072|Protective Agents|protective agents|mesh-ancestor
102590339|NCT03296072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590340|NCT03296072|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102590341|NCT03296072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102590342|NCT03185065|Amantadine|amantadine|mesh-list
102590343|NCT03185065|Methylphenidate|methylphenidate|mesh-list
102590344|NCT03185065|Modafinil|modafinil|mesh-list
102590345|NCT03185065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102590346|NCT03185065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590347|NCT03185065|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102590348|NCT03185065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102590349|NCT03185065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102590350|NCT03185065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590351|NCT03185065|Dopamine Agents|dopamine agents|mesh-ancestor
102590352|NCT03185065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102590353|NCT03185065|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102590354|NCT03185065|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102590355|NCT03185065|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102344917|NCT06011330|Antibodies|antibodies|mesh-list
102344918|NCT06011330|Immunologic Factors|immunologic factors|mesh-ancestor
102344919|NCT06011330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344920|NCT06011330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344921|NCT06011330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102590356|NCT03185065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102590357|NCT03185065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102590358|NCT03185065|Antiviral Agents|antiviral agents|mesh-ancestor
102590359|NCT03185065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102590360|NCT03185065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102590361|NCT03185065|Analgesics|analgesics|mesh-ancestor
102590362|NCT03185065|Sensory System Agents|sensory system agents|mesh-ancestor
102590363|NCT03185065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102590364|NCT02220894|Paclitaxel|paclitaxel|mesh-list
102590365|NCT02220894|Carboplatin|carboplatin|mesh-list
102590366|NCT02220894|Pembrolizumab|pembrolizumab|mesh-list
102590367|NCT02220894|Pemetrexed|pemetrexed|mesh-list
102590368|NCT02220894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102590369|NCT02220894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102590370|NCT02220894|Tubulin Modulators|tubulin modulators|mesh-ancestor
102590371|NCT02220894|Antimitotic Agents|antimitotic agents|mesh-ancestor
102590372|NCT02220894|Mitosis Modulators|mitosis modulators|mesh-ancestor
102590373|NCT02220894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590374|NCT02220894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102590375|NCT02220894|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102590376|NCT02220894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102590377|NCT02220894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102590378|NCT02220894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102590379|NCT02159040|Azacitidine|azacitidine|mesh-list
102590380|NCT02159040|Deferasirox|deferasirox|mesh-list
102590381|NCT02159040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102590382|NCT02159040|Antimetabolites|antimetabolites|mesh-ancestor
102590383|NCT02159040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590384|NCT02159040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102590385|NCT02159040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102590386|NCT02159040|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102590387|NCT02159040|Chelating Agents|chelating agents|mesh-ancestor
102590388|NCT02159040|Sequestering Agents|sequestering agents|mesh-ancestor
102590389|NCT03189589|Nemiralisib|nemiralisib|mesh-list
102590390|NCT03189589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102590391|NCT03189589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102590392|NCT03189589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590393|NCT03216902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102590394|NCT03216902|Latanoprost|latanoprost|mesh-list
102590395|NCT03216902|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102590396|NCT03190213|Pembrolizumab|pembrolizumab|mesh-list
102590397|NCT03190213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102590398|NCT03190213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102590399|NCT03190213|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102590400|NCT03190213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590401|NCT01632150|Thalidomide|thalidomide|mesh-list
102590402|NCT01632150|Dexamethasone|dexamethasone|mesh-list
102590403|NCT01632150|Dexamethasone acetate|dexamethasone acetate|mesh-list
102590404|NCT01632150|Cyclophosphamide|cyclophosphamide|mesh-list
102590405|NCT01632150|Elotuzumab|elotuzumab|mesh-list
102590406|NCT01632150|BB 1101|bb 1101|mesh-list
102590407|NCT01632150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102590408|NCT01632150|Immunologic Factors|immunologic factors|mesh-ancestor
102137289|NCT03692819|Metronidazole|metronidazole|mesh-list
102137290|NCT03692819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102590409|NCT01632150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590410|NCT01632150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102590411|NCT01632150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102344957|NCT05980572|Glucocorticoids|glucocorticoids|mesh-ancestor
102344958|NCT05980572|Hormones|hormones|mesh-ancestor
102344959|NCT05980572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102344960|NCT05980572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344961|NCT05980572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102344962|NCT05980572|Analgesics|analgesics|mesh-ancestor
102590412|NCT01632150|Alkylating Agents|alkylating agents|mesh-ancestor
102590413|NCT01632150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590414|NCT01632150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102590415|NCT01632150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102590416|NCT01632150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102590417|NCT01632150|Antiemetics|antiemetics|mesh-ancestor
102590418|NCT01632150|Autonomic Agents|autonomic agents|mesh-ancestor
102590419|NCT01632150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102590420|NCT01632150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102590421|NCT01632150|Glucocorticoids|glucocorticoids|mesh-ancestor
102590422|NCT01632150|Hormones|hormones|mesh-ancestor
102590423|NCT01632150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102590424|NCT01632150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102590425|NCT01632150|Protease Inhibitors|protease inhibitors|mesh-ancestor
102590426|NCT01632150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102590427|NCT01632150|Leprostatic Agents|leprostatic agents|mesh-ancestor
102590428|NCT01632150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102590429|NCT01632150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102590430|NCT01632150|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102590431|NCT01632150|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102590432|NCT01632150|Growth Substances|growth substances|mesh-ancestor
102590433|NCT01632150|Growth Inhibitors|growth inhibitors|mesh-ancestor
102590434|NCT02185014|Adalimumab|adalimumab|mesh-list
102590435|NCT02185014|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102590436|NCT02185014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102590437|NCT02185014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102590438|NCT03297944|Zolpidem|zolpidem|mesh-list
102590439|NCT03297944|Alprazolam|alprazolam|mesh-list
102590440|NCT03297944|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102590441|NCT03297944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102590442|NCT03297944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102590443|NCT03297944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590444|NCT03297944|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102590445|NCT03297944|GABA Agonists|gaba agonists|mesh-ancestor
102590446|NCT03297944|GABA Agents|gaba agents|mesh-ancestor
102590447|NCT03297944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102590448|NCT03297944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590449|NCT03297944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102590450|NCT03297944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102590451|NCT03297944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102590452|NCT03297944|GABA Modulators|gaba modulators|mesh-ancestor
102590453|NCT04333004|Pembrolizumab|pembrolizumab|mesh-list
102590454|NCT04333004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102590455|NCT04333004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102590456|NCT04333004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102590457|NCT04333004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590458|NCT03219866|Budesonide|budesonide|mesh-list
102590459|NCT03219866|Tiotropium Bromide|tiotropium bromide|mesh-list
102590460|NCT03219866|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102590461|NCT03219866|Ipratropium|ipratropium|mesh-list
102590462|NCT03219866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102590463|NCT03219866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102590464|NCT03219866|Autonomic Agents|autonomic agents|mesh-ancestor
102590465|NCT03219866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102590466|NCT03219866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344981|NCT05952453|Carboplatin|carboplatin|mesh-list
102590467|NCT03219866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102590468|NCT03219866|Respiratory System Agents|respiratory system agents|mesh-ancestor
102590469|NCT03219866|Glucocorticoids|glucocorticoids|mesh-ancestor
102590470|NCT03219866|Hormones|hormones|mesh-ancestor
102590471|NCT03219866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102590472|NCT03219866|Parasympatholytics|parasympatholytics|mesh-ancestor
102590473|NCT03219866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102590474|NCT03219866|Cholinergic Agents|cholinergic agents|mesh-ancestor
102590475|NCT03219866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102590476|NCT03219866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590477|NCT03219866|Sympathomimetics|sympathomimetics|mesh-ancestor
102590478|NCT03300674|Lidocaine|lidocaine|mesh-list
102590479|NCT03300674|Hydromorphone|hydromorphone|mesh-list
102590480|NCT03300674|Anesthetics, Local|anesthetics, local|mesh-ancestor
102590481|NCT03300674|Anesthetics|anesthetics|mesh-ancestor
102590482|NCT03300674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102590483|NCT03300674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590484|NCT03300674|Sensory System Agents|sensory system agents|mesh-ancestor
102590485|NCT03300674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102590486|NCT03300674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102590487|NCT03300674|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102590488|NCT03300674|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102590489|NCT03300674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102590490|NCT03300674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590491|NCT03300674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102590492|NCT03300674|Narcotics|narcotics|mesh-ancestor
102590493|NCT03300674|Analgesics|analgesics|mesh-ancestor
102590494|NCT02158806|Aspirin|aspirin|mesh-list
102590495|NCT02158806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102590496|NCT02158806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102590497|NCT02158806|Analgesics|analgesics|mesh-ancestor
102590498|NCT02158806|Sensory System Agents|sensory system agents|mesh-ancestor
102590499|NCT02158806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102344996|NCT05936086|Cyclosporins|cyclosporins|mesh-list
102344997|NCT05936086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102344998|NCT05936086|Antiemetics|antiemetics|mesh-ancestor
102344999|NCT05936086|Autonomic Agents|autonomic agents|mesh-ancestor
102345000|NCT05936086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102345001|NCT05936086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345004|NCT05936086|Hormones|hormones|mesh-ancestor
102590500|NCT02158806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590501|NCT02158806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102590502|NCT02158806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102590503|NCT02158806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102590504|NCT02158806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102590505|NCT02158806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590506|NCT02158806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102590507|NCT02158806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102590508|NCT02158806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102590509|NCT02158806|Antipyretics|antipyretics|mesh-ancestor
102590510|NCT03197389|Pembrolizumab|pembrolizumab|mesh-list
102590511|NCT03197389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102590512|NCT03197389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102590513|NCT03197389|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102590514|NCT03197389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590515|NCT03198871|Acetaminophen|acetaminophen|mesh-list
102590516|NCT03198871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102590517|NCT03198871|Analgesics|analgesics|mesh-ancestor
102590518|NCT03198871|Sensory System Agents|sensory system agents|mesh-ancestor
102590519|NCT03198871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102590520|NCT03198871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590521|NCT03198871|Antipyretics|antipyretics|mesh-ancestor
102590522|NCT02157948|Denosumab|denosumab|mesh-list
102590523|NCT02157948|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102590524|NCT02157948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590525|NCT03220958|Diphenhydramine|diphenhydramine|mesh-list
102590526|NCT03220958|Promethazine|promethazine|mesh-list
102590527|NCT03220958|Metoclopramide|metoclopramide|mesh-list
102590528|NCT03220958|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102590529|NCT03220958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102590530|NCT03220958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102590531|NCT03220958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590532|NCT03220958|Anesthetics, Local|anesthetics, local|mesh-ancestor
102590533|NCT03220958|Anesthetics|anesthetics|mesh-ancestor
102590534|NCT03220958|Sensory System Agents|sensory system agents|mesh-ancestor
102590535|NCT03220958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102590536|NCT03220958|Antiemetics|antiemetics|mesh-ancestor
102590537|NCT03220958|Autonomic Agents|autonomic agents|mesh-ancestor
102590538|NCT03220958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102590539|NCT03220958|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102590540|NCT03220958|Histamine Antagonists|histamine antagonists|mesh-ancestor
102590541|NCT03220958|Histamine Agents|histamine agents|mesh-ancestor
102590542|NCT03220958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102590543|NCT03220958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590544|NCT03220958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102590545|NCT03220958|Antipruritics|antipruritics|mesh-ancestor
102590546|NCT03220958|Dermatologic Agents|dermatologic agents|mesh-ancestor
102590547|NCT03220958|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102137441|NCT03696095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102137442|NCT03700229|Rituximab|rituximab|mesh-list
102137443|NCT03700229|Bortezomib|bortezomib|mesh-list
102137444|NCT03700229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102137445|NCT03700229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102137446|NCT03700229|Immunologic Factors|immunologic factors|mesh-ancestor
102137447|NCT03700229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137448|NCT03700229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102137449|NCT03695861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102137450|NCT03695861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102137452|NCT03695705|Rifaximin|rifaximin|mesh-list
102590548|NCT03220958|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102590550|NCT02182830|Empagliflozin|empagliflozin|mesh-list
102345038|NCT05918822|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102345039|NCT05918822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102345040|NCT05918822|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102345041|NCT05918822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102345042|NCT05918822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345043|NCT05918822|Antiviral Agents|antiviral agents|mesh-ancestor
102345044|NCT05918822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102590551|NCT02182830|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102590552|NCT02182830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590553|NCT02182830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102590554|NCT02182830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590555|NCT03424681|Modafinil|modafinil|mesh-list
102590556|NCT03424681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102590557|NCT03424681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590558|NCT03424681|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102590559|NCT03424681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102590560|NCT03424681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102590561|NCT03424681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590562|NCT03303794|Bupivacaine|bupivacaine|mesh-list
102590563|NCT03303794|Anesthetics, Local|anesthetics, local|mesh-ancestor
102590564|NCT03303794|Anesthetics|anesthetics|mesh-ancestor
102590565|NCT03303794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102590566|NCT03303794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590567|NCT03303794|Sensory System Agents|sensory system agents|mesh-ancestor
102590568|NCT03303794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102590569|NCT03305822|Insulin Lispro|insulin lispro|mesh-list
102590570|NCT03305822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102590571|NCT03305822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590572|NCT03435614|Analgesics|analgesics|mesh-list
102590573|NCT03435614|Narcotics|narcotics|mesh-list
102590574|NCT03435614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102590575|NCT03435614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590576|NCT03435614|Sensory System Agents|sensory system agents|mesh-ancestor
102590577|NCT03435614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102590578|NCT03437564|Vortioxetine|vortioxetine|mesh-list
102590579|NCT03437564|Antidepressive Agents|antidepressive agents|mesh-ancestor
102590580|NCT03437564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102590581|NCT03437564|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102590582|NCT03437564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102590583|NCT03437564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102590584|NCT03437564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590585|NCT03437564|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102590586|NCT03437564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102590587|NCT03437564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102590588|NCT03437564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590589|NCT03437564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102590590|NCT03437564|Serotonin Agents|serotonin agents|mesh-ancestor
102590591|NCT03437564|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102590592|NCT03437564|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102590593|NCT03437564|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102590594|NCT03437564|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102590595|NCT03438266|Hyaluronic Acid|hyaluronic acid|mesh-list
102590596|NCT03438266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102590597|NCT03438266|Immunologic Factors|immunologic factors|mesh-ancestor
102590598|NCT03438266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590599|NCT03438266|Viscosupplements|viscosupplements|mesh-ancestor
102590600|NCT03438266|Protective Agents|protective agents|mesh-ancestor
102590601|NCT03315104|Immunoglobulins|immunoglobulins|mesh-list
102590602|NCT03315104|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102590603|NCT03315104|gamma-Globulins|gamma-globulins|mesh-list
102590604|NCT03315104|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102590605|NCT03315104|Immunologic Factors|immunologic factors|mesh-ancestor
102590606|NCT03315104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590607|NCT03228914|Phenylephrine|phenylephrine|mesh-list
102590608|NCT03228914|Epinephrine|epinephrine|mesh-list
102590609|NCT03228914|Oxymetazoline|oxymetazoline|mesh-list
102590610|NCT03228914|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102590611|NCT03228914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102590612|NCT03228914|Adrenergic Agents|adrenergic agents|mesh-ancestor
102590613|NCT03228914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102590614|NCT03228914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590615|NCT03228914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590616|NCT03228914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102590617|NCT03228914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102590618|NCT03228914|Autonomic Agents|autonomic agents|mesh-ancestor
102590619|NCT03228914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102590620|NCT03228914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102590621|NCT03228914|Respiratory System Agents|respiratory system agents|mesh-ancestor
102590622|NCT03228914|Mydriatics|mydriatics|mesh-ancestor
102590623|NCT03228914|Sympathomimetics|sympathomimetics|mesh-ancestor
102590624|NCT03228914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102590625|NCT03228914|Nasal Decongestants|nasal decongestants|mesh-ancestor
102590626|NCT03228914|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102590627|NCT03228914|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102590628|NCT03228914|Protective Agents|protective agents|mesh-ancestor
102590629|NCT03316976|Dexlansoprazole|dexlansoprazole|mesh-list
102590630|NCT03316976|Lansoprazole|lansoprazole|mesh-list
102590631|NCT03316976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102590632|NCT03316976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102590633|NCT03316976|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102590634|NCT03316976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102590635|NCT03316976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590636|NCT03234374|Bupivacaine|bupivacaine|mesh-list
102590637|NCT03234374|Anesthetics, Local|anesthetics, local|mesh-ancestor
102590638|NCT03234374|Anesthetics|anesthetics|mesh-ancestor
102590639|NCT03234374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102590640|NCT03234374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590641|NCT03234374|Sensory System Agents|sensory system agents|mesh-ancestor
102590642|NCT03234374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102590643|NCT04332536|Codeine|codeine|mesh-list
102590644|NCT04332536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102590645|NCT04332536|Narcotics|narcotics|mesh-ancestor
102590646|NCT04332536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102590647|NCT04332536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590648|NCT04332536|Analgesics|analgesics|mesh-ancestor
102590649|NCT04332536|Sensory System Agents|sensory system agents|mesh-ancestor
102590650|NCT04332536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102590651|NCT04332536|Antitussive Agents|antitussive agents|mesh-ancestor
102590652|NCT04332536|Respiratory System Agents|respiratory system agents|mesh-ancestor
102590653|NCT03236168|Ivermectin|ivermectin|mesh-list
102590654|NCT03236168|Permethrin|permethrin|mesh-list
102590655|NCT03236168|Malathion|malathion|mesh-list
102590656|NCT03236168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102590657|NCT03236168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102590658|NCT03236168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102590659|NCT03236168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590660|NCT03236168|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102590661|NCT03236168|Cholinergic Agents|cholinergic agents|mesh-ancestor
102590662|NCT03236168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102590663|NCT03236168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590664|NCT03306589|Molgramostim|molgramostim|mesh-list
102590665|NCT03306589|Sargramostim|sargramostim|mesh-list
102590666|NCT03306589|Cantharidin|cantharidin|mesh-list
102590667|NCT03306589|Immunologic Factors|immunologic factors|mesh-ancestor
102590668|NCT03306589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590669|NCT03306589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102590670|NCT03306589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102590671|NCT03306589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590672|NCT03312517|Suvorexant|suvorexant|mesh-list
102590673|NCT03312517|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102590674|NCT03312517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102590675|NCT03312517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102590676|NCT03312517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590677|NCT03312517|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102590678|NCT03312517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102590679|NCT03312517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590680|NCT03315559|Nemiralisib|nemiralisib|mesh-list
102590681|NCT03315559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102590682|NCT03315559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102590683|NCT03315559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590684|NCT03239522|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102590685|NCT03239522|Glycine|glycine|mesh-list
102590686|NCT03239522|Glycine Agents|glycine agents|mesh-ancestor
102590687|NCT03239522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102590688|NCT03239522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590689|NCT03239522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590690|NCT03210337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102590691|NCT03242408|Methyltestosterone|methyltestosterone|mesh-list
102590692|NCT03242408|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102590693|NCT03242408|Testosterone|testosterone|mesh-list
102590694|NCT03242408|Testosterone undecanoate|testosterone undecanoate|mesh-list
102590695|NCT03242408|Testosterone enanthate|testosterone enanthate|mesh-list
102590696|NCT03242408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102590697|NCT03242408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102590698|NCT03242408|Anabolic Agents|anabolic agents|mesh-ancestor
102590700|NCT03242408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102590701|NCT03242408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590702|NCT03242408|Androgens|androgens|mesh-ancestor
102590703|NCT03459794|Ivermectin|ivermectin|mesh-list
102590704|NCT03459794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102590705|NCT03459794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102590706|NCT03211117|Docetaxel|docetaxel|mesh-list
102590707|NCT03211117|Doxorubicin|doxorubicin|mesh-list
102590708|NCT03211117|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102590709|NCT03211117|Pembrolizumab|pembrolizumab|mesh-list
102590710|NCT03211117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102590711|NCT03211117|Tubulin Modulators|tubulin modulators|mesh-ancestor
102590712|NCT03211117|Antimitotic Agents|antimitotic agents|mesh-ancestor
102590713|NCT03211117|Mitosis Modulators|mitosis modulators|mesh-ancestor
102590714|NCT03211117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590715|NCT03211117|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102590716|NCT03211117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102590717|NCT03211117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102590718|NCT03211117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102590719|NCT03211117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102590720|NCT03211117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102590721|NCT00376285|Fenofibrate|fenofibrate|mesh-list
102590722|NCT00376285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102590723|NCT00376285|Antimetabolites|antimetabolites|mesh-ancestor
102590724|NCT00376285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590725|NCT00376285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102590726|NCT03460652|Serdexmethylphenidate and dexmethylphenidate|serdexmethylphenidate and dexmethylphenidate|mesh-list
102590727|NCT03460652|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102590728|NCT03460652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590729|NCT03321097|Botulinum Toxins|botulinum toxins|mesh-list
102345084|NCT05896163|Obinutuzumab|obinutuzumab|mesh-list
102590730|NCT03321097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102590731|NCT03321097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102590732|NCT03321097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590733|NCT03321097|Cholinergic Agents|cholinergic agents|mesh-ancestor
102590734|NCT03321097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102590735|NCT03321097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590736|NCT03245762|Oxytocin|oxytocin|mesh-list
102590737|NCT03245762|Oxytocics|oxytocics|mesh-ancestor
102590738|NCT03245762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102590739|NCT03245762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590740|NCT03322657|Glycopyrrolate|glycopyrrolate|mesh-list
102590741|NCT03322657|Neostigmine|neostigmine|mesh-list
102590742|NCT03322657|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102590743|NCT03322657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102590744|NCT03322657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590745|NCT03322657|Cholinergic Agents|cholinergic agents|mesh-ancestor
102590746|NCT03322657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102590747|NCT03322657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590748|NCT03322657|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102590749|NCT03322657|Autonomic Agents|autonomic agents|mesh-ancestor
102590750|NCT03322657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102590751|NCT03322657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102590752|NCT03322657|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102590753|NCT03322657|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102590754|NCT03324451|Insulin|insulin|mesh-list
102590755|NCT03324451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102590756|NCT03324451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590757|NCT03247790|Lasmiditan|lasmiditan|mesh-list
102590758|NCT03247790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102590759|NCT03247790|Serotonin Agents|serotonin agents|mesh-ancestor
102590760|NCT03247790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102590761|NCT03247790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590762|NCT03247790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590763|NCT03249272|Adenosine|adenosine|mesh-list
102590764|NCT03249272|Regadenoson|regadenoson|mesh-list
102590765|NCT03249272|Analgesics|analgesics|mesh-ancestor
102590766|NCT03249272|Sensory System Agents|sensory system agents|mesh-ancestor
102590767|NCT03249272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102590768|NCT03249272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590769|NCT03249272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102590770|NCT03249272|Vasodilator Agents|vasodilator agents|mesh-ancestor
102137670|NCT02691494|Estrogens|estrogens|mesh-ancestor
102590771|NCT03249272|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102590772|NCT03249272|Purinergic Agonists|purinergic agonists|mesh-ancestor
102590773|NCT03249272|Purinergic Agents|purinergic agents|mesh-ancestor
102590774|NCT03249272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102590775|NCT03249272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590776|NCT03249272|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
102590777|NCT03468920|Acetaminophen|acetaminophen|mesh-list
102590778|NCT03468920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102590779|NCT03468920|Analgesics|analgesics|mesh-ancestor
102590780|NCT03468920|Sensory System Agents|sensory system agents|mesh-ancestor
102590781|NCT03468920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102590782|NCT03468920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590783|NCT03468920|Antipyretics|antipyretics|mesh-ancestor
102590784|NCT02181816|Amlodipine|amlodipine|mesh-list
102590785|NCT02181816|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
102590786|NCT02181816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102590787|NCT02181816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102590788|NCT02181816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102590789|NCT02181816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590790|NCT02181816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102590791|NCT02181816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590792|NCT02181816|Vasodilator Agents|vasodilator agents|mesh-ancestor
102590793|NCT02181816|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102590794|NCT02181816|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102590795|NCT03256136|Carboplatin|carboplatin|mesh-list
102590796|NCT03256136|Nivolumab|nivolumab|mesh-list
102590797|NCT03256136|Pemetrexed|pemetrexed|mesh-list
102590798|NCT03256136|Ipilimumab|ipilimumab|mesh-list
102590799|NCT03256136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102590800|NCT03256136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102590801|NCT03256136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102590802|NCT03256136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590803|NCT03256136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102590804|NCT03256136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102590805|NCT03256136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102590806|NCT03344510|Anesthetics|anesthetics|mesh-list
102590807|NCT03344510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102590808|NCT03344510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590809|NCT03478982|Alprazolam|alprazolam|mesh-list
102590810|NCT03478982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102590811|NCT03478982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102590812|NCT03478982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590813|NCT03478982|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102590814|NCT03478982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102590815|NCT03478982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102590816|NCT03478982|GABA Modulators|gaba modulators|mesh-ancestor
102590817|NCT03478982|GABA Agents|gaba agents|mesh-ancestor
102590818|NCT03478982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102590819|NCT03478982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590820|NCT03270332|Albuterol|albuterol|mesh-list
102590821|NCT03270332|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102590822|NCT03270332|Autonomic Agents|autonomic agents|mesh-ancestor
102590823|NCT03270332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102590824|NCT03270332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590825|NCT03270332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102590826|NCT03270332|Respiratory System Agents|respiratory system agents|mesh-ancestor
102590827|NCT03270332|Tocolytic Agents|tocolytic agents|mesh-ancestor
102590828|NCT03270332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102590829|NCT03270332|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102590830|NCT03270332|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102590831|NCT03270332|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102590832|NCT03270332|Adrenergic Agents|adrenergic agents|mesh-ancestor
102590833|NCT03270332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102590834|NCT03270332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590835|NCT03355820|Antibodies|antibodies|mesh-list
102590836|NCT03355820|Immunologic Factors|immunologic factors|mesh-ancestor
102590837|NCT03355820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590838|NCT03357614|Amoxicillin|amoxicillin|mesh-list
102590839|NCT03357614|Ciprofloxacin|ciprofloxacin|mesh-list
102590840|NCT03357614|Clavulanic Acid|clavulanic acid|mesh-list
102590841|NCT03357614|Clavulanic Acids|clavulanic acids|mesh-list
102590842|NCT03357614|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102590843|NCT03357614|Ertapenem|ertapenem|mesh-list
102590844|NCT03357614|Lactams|lactams|mesh-list
102590845|NCT03357614|Probenecid|probenecid|mesh-list
102590847|NCT03357614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102590848|NCT03357614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102590849|NCT03357614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102590850|NCT03357614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102590851|NCT03357614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590852|NCT03357614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102590853|NCT03357614|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102590854|NCT03357614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102590855|NCT03357614|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102590856|NCT03357614|Uricosuric Agents|uricosuric agents|mesh-ancestor
102590857|NCT03357614|Gout Suppressants|gout suppressants|mesh-ancestor
102590858|NCT03357614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102590859|NCT03275870|Hydroxychloroquine|hydroxychloroquine|mesh-list
102590860|NCT03275870|Antimalarials|antimalarials|mesh-ancestor
102590861|NCT03275870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102590862|NCT03275870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102590863|NCT03275870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102590864|NCT03275870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102590865|NCT03275870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590866|NCT03275870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102590867|NCT02216214|Mirabegron|mirabegron|mesh-list
102590868|NCT02216214|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102345105|NCT05883644|Durvalumab|durvalumab|mesh-list
102590869|NCT02216214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102590870|NCT02216214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102590871|NCT02216214|Adrenergic Agents|adrenergic agents|mesh-ancestor
102590872|NCT02216214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102590873|NCT02216214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590874|NCT02216214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590875|NCT02216214|Urological Agents|urological agents|mesh-ancestor
102590876|NCT00376376|Levofloxacin|levofloxacin|mesh-list
102590877|NCT00376376|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102590878|NCT00376376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102590879|NCT00376376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102590880|NCT00376376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102590881|NCT00376376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102590882|NCT00376376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102590883|NCT00376376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590884|NCT00376376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102590885|NCT00376376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102590886|NCT00376376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102590887|NCT02181504|Ranibizumab|ranibizumab|mesh-list
102590888|NCT02181504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102590889|NCT02181504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102590890|NCT02181504|Growth Substances|growth substances|mesh-ancestor
102590891|NCT02181504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590892|NCT02181504|Growth Inhibitors|growth inhibitors|mesh-ancestor
102590893|NCT02181504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102590894|NCT02213094|Vitamins|vitamins|mesh-list
102590895|NCT02213094|Niacinamide|niacinamide|mesh-list
102590896|NCT02213094|Niacin|niacin|mesh-list
102590897|NCT02213094|Nicotinic Acids|nicotinic acids|mesh-list
102590898|NCT02213094|Vitamin B Complex|vitamin b complex|mesh-list
102590899|NCT02213094|Micronutrients|micronutrients|mesh-ancestor
102590900|NCT02213094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590901|NCT02213094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102590902|NCT02213094|Antimetabolites|antimetabolites|mesh-ancestor
102590903|NCT02213094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590904|NCT02213094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102590905|NCT02213094|Vasodilator Agents|vasodilator agents|mesh-ancestor
102590906|NCT01629966|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
102590907|NCT01629966|Antidepressive Agents|antidepressive agents|mesh-ancestor
102590908|NCT01629966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102590909|NCT01629966|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102590910|NCT01629966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102590911|NCT01629966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102590912|NCT01629966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590913|NCT01629966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102590914|NCT01629966|Serotonin Agents|serotonin agents|mesh-ancestor
102590915|NCT01629966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590916|NCT01629966|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102590917|NCT01629966|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102590918|NCT02177838|Cetuximab|cetuximab|mesh-list
102590919|NCT02177838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102590920|NCT02177838|Antibodies|antibodies|mesh-list
102590921|NCT02177838|Immunoglobulins|immunoglobulins|mesh-list
102590922|NCT02177838|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102590923|NCT02177838|Immunologic Factors|immunologic factors|mesh-ancestor
102590924|NCT02177838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590925|NCT02177838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102590926|NCT03283436|Bupivacaine|bupivacaine|mesh-list
102590927|NCT03283436|Anesthetics, Local|anesthetics, local|mesh-ancestor
102590928|NCT03283436|Anesthetics|anesthetics|mesh-ancestor
102590929|NCT03283436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102590930|NCT03283436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590931|NCT03283436|Sensory System Agents|sensory system agents|mesh-ancestor
102590932|NCT03283436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102590933|NCT00376064|Octreotide|octreotide|mesh-list
102590934|NCT00376064|Cabergoline|cabergoline|mesh-list
102590935|NCT00376064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102590936|NCT00376064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102590937|NCT00376064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102590938|NCT00376064|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102590939|NCT00376064|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102590940|NCT00376064|Dopamine Agonists|dopamine agonists|mesh-ancestor
102590941|NCT00376064|Dopamine Agents|dopamine agents|mesh-ancestor
102590942|NCT00376064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102590943|NCT00376064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590944|NCT00376064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590945|NCT03581084|Acetylcysteine|acetylcysteine|mesh-list
102590946|NCT03581084|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102590947|NCT03581084|Antiviral Agents|antiviral agents|mesh-ancestor
102590948|NCT03581084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102590949|NCT03581084|Expectorants|expectorants|mesh-ancestor
102590950|NCT03581084|Respiratory System Agents|respiratory system agents|mesh-ancestor
102590951|NCT03581084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102590952|NCT03581084|Antioxidants|antioxidants|mesh-ancestor
102590953|NCT03581084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590954|NCT03581084|Protective Agents|protective agents|mesh-ancestor
102590955|NCT03581084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590956|NCT03581084|Antidotes|antidotes|mesh-ancestor
102590957|NCT03383588|Epinephrine|epinephrine|mesh-list
102590958|NCT03383588|Fentanyl|fentanyl|mesh-list
102590959|NCT03383588|Morphine|morphine|mesh-list
102590960|NCT03383588|Bupivacaine|bupivacaine|mesh-list
102590961|NCT03383588|Anesthetics, Local|anesthetics, local|mesh-ancestor
102590962|NCT03383588|Anesthetics|anesthetics|mesh-ancestor
102590963|NCT03383588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102590964|NCT03383588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590965|NCT03383588|Sensory System Agents|sensory system agents|mesh-ancestor
102590966|NCT03383588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102590967|NCT03383588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102590968|NCT03383588|Narcotics|narcotics|mesh-ancestor
102590969|NCT03383588|Analgesics|analgesics|mesh-ancestor
102590970|NCT03383588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102590971|NCT03383588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102590972|NCT03383588|Anesthetics, General|anesthetics, general|mesh-ancestor
102590973|NCT03383588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102590974|NCT03383588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102590975|NCT03383588|Adrenergic Agents|adrenergic agents|mesh-ancestor
102590976|NCT03383588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102590977|NCT03383588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102590978|NCT03383588|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102590979|NCT03383588|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102590980|NCT03383588|Autonomic Agents|autonomic agents|mesh-ancestor
102590981|NCT03383588|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102590982|NCT03383588|Respiratory System Agents|respiratory system agents|mesh-ancestor
102590983|NCT03383588|Mydriatics|mydriatics|mesh-ancestor
102590984|NCT03383588|Sympathomimetics|sympathomimetics|mesh-ancestor
102590985|NCT03383588|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102590986|NCT03388268|Vancomycin|vancomycin|mesh-list
102590987|NCT03388268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102590988|NCT03388268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102590989|NCT03393494|Adapalene|adapalene|mesh-list
102590990|NCT03393494|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102590991|NCT03393494|Dermatologic Agents|dermatologic agents|mesh-ancestor
102590992|NCT03393494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102590993|NCT03393494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102590994|NCT03393494|Analgesics|analgesics|mesh-ancestor
102590995|NCT03393494|Sensory System Agents|sensory system agents|mesh-ancestor
102590996|NCT03393494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102590997|NCT03393494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102590998|NCT03393494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102590999|NCT03393494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102345115|NCT05882903|Glucocorticoids|glucocorticoids|mesh-ancestor
102345116|NCT05882903|Hormones|hormones|mesh-ancestor
102345117|NCT05882903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102345118|NCT05882903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345119|NCT05882903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102591000|NCT03588806|Oxycodone|oxycodone|mesh-list
102591001|NCT03588806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102591002|NCT03588806|Narcotics|narcotics|mesh-ancestor
102591003|NCT03588806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102591004|NCT03588806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591005|NCT03588806|Analgesics|analgesics|mesh-ancestor
102591006|NCT03588806|Sensory System Agents|sensory system agents|mesh-ancestor
102591007|NCT03588806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102591008|NCT02176356|Bimatoprost|bimatoprost|mesh-list
102591009|NCT02176356|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102591010|NCT02176356|Botulinum Toxins|botulinum toxins|mesh-list
102591011|NCT02176356|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102591012|NCT02176356|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102591013|NCT02176356|Hyaluronic Acid|hyaluronic acid|mesh-list
102591014|NCT02176356|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102591015|NCT02176356|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102591016|NCT02176356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102591017|NCT02176356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591018|NCT02176356|Cholinergic Agents|cholinergic agents|mesh-ancestor
102591019|NCT02176356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102591020|NCT02176356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591021|NCT02176356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102591022|NCT02176356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102591023|NCT02176356|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102591024|NCT02176356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102591025|NCT02176356|Immunologic Factors|immunologic factors|mesh-ancestor
102591026|NCT02176356|Viscosupplements|viscosupplements|mesh-ancestor
102591027|NCT02176356|Protective Agents|protective agents|mesh-ancestor
102591028|NCT03591068|Fluticasone|fluticasone|mesh-list
102591029|NCT03591068|Xhance|xhance|mesh-list
102591030|NCT03591068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102591031|NCT03591068|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102591032|NCT03591068|Autonomic Agents|autonomic agents|mesh-ancestor
102591033|NCT03591068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102591034|NCT03591068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591035|NCT03591068|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102591036|NCT03591068|Respiratory System Agents|respiratory system agents|mesh-ancestor
102591037|NCT03591068|Dermatologic Agents|dermatologic agents|mesh-ancestor
102591038|NCT03591068|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102591039|NCT03395990|Chloroprocaine|chloroprocaine|mesh-list
102591040|NCT03395990|Procaine|procaine|mesh-list
102591041|NCT03395990|Anesthetics, Local|anesthetics, local|mesh-ancestor
102591042|NCT03395990|Anesthetics|anesthetics|mesh-ancestor
102591043|NCT03395990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102591044|NCT03395990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591045|NCT03395990|Sensory System Agents|sensory system agents|mesh-ancestor
102591046|NCT03395990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102591047|NCT02175966|Ribavirin|ribavirin|mesh-list
102591048|NCT02175966|Sofosbuvir|sofosbuvir|mesh-list
102591049|NCT02175966|Antimetabolites|antimetabolites|mesh-ancestor
102591050|NCT02175966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591051|NCT02175966|Antiviral Agents|antiviral agents|mesh-ancestor
102591052|NCT02175966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102591053|NCT02136576|Listerine|listerine|mesh-list
102591054|NCT02136576|Sodium Fluoride|sodium fluoride|mesh-list
102591055|NCT02136576|Cariostatic Agents|cariostatic agents|mesh-ancestor
102591056|NCT02136576|Protective Agents|protective agents|mesh-ancestor
102591057|NCT02136576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591058|NCT02136576|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102591059|NCT02136576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102591060|NCT03398330|Oxycodone|oxycodone|mesh-list
102591061|NCT03398330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102591062|NCT03398330|Narcotics|narcotics|mesh-ancestor
102591063|NCT03398330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102591064|NCT03398330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591065|NCT03398330|Analgesics|analgesics|mesh-ancestor
102591066|NCT03398330|Sensory System Agents|sensory system agents|mesh-ancestor
102591067|NCT03398330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102591068|NCT00376766|Levetiracetam|levetiracetam|mesh-list
102591069|NCT00376766|Anticonvulsants|anticonvulsants|mesh-ancestor
102591070|NCT00376766|Nootropic Agents|nootropic agents|mesh-ancestor
102591071|NCT03403712|Dexamethasone|dexamethasone|mesh-list
102591072|NCT03403712|Palonosetron|palonosetron|mesh-list
102137971|NCT03165500|Analgesics|analgesics|mesh-ancestor
102591073|NCT03403712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102591074|NCT03403712|Antiemetics|antiemetics|mesh-ancestor
102591075|NCT03403712|Autonomic Agents|autonomic agents|mesh-ancestor
102591076|NCT03403712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102591077|NCT03403712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591078|NCT03403712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102591079|NCT03403712|Glucocorticoids|glucocorticoids|mesh-ancestor
102591080|NCT03403712|Hormones|hormones|mesh-ancestor
102591081|NCT03403712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102591082|NCT03403712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102591083|NCT03403712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102591084|NCT03403712|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102591085|NCT03403712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102591086|NCT03403712|Serotonin Agents|serotonin agents|mesh-ancestor
102591087|NCT03403712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102591088|NCT03403712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591089|NCT03404648|Choline|choline|mesh-list
102591090|NCT03404648|Lipotropic Agents|lipotropic agents|mesh-ancestor
102591091|NCT03404648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102591092|NCT03404648|Antimetabolites|antimetabolites|mesh-ancestor
102591093|NCT03404648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591094|NCT03404648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102591095|NCT03404648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102591096|NCT03404648|Nootropic Agents|nootropic agents|mesh-ancestor
102591097|NCT03383198|Bupivacaine|bupivacaine|mesh-list
102591098|NCT03383198|Anesthetics, Local|anesthetics, local|mesh-ancestor
102591099|NCT03383198|Anesthetics|anesthetics|mesh-ancestor
102591100|NCT03383198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102591101|NCT03383198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591102|NCT03383198|Sensory System Agents|sensory system agents|mesh-ancestor
102591103|NCT03383198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102591104|NCT03413618|Rivaroxaban|rivaroxaban|mesh-list
102591105|NCT03413618|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102591106|NCT03413618|Antithrombins|antithrombins|mesh-ancestor
102591107|NCT03413618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102591108|NCT03413618|Protease Inhibitors|protease inhibitors|mesh-ancestor
102591109|NCT03413618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102591110|NCT03413618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591111|NCT03413618|Anticoagulants|anticoagulants|mesh-ancestor
102591112|NCT03523988|Acetaminophen|acetaminophen|mesh-list
102591113|NCT03523988|Ibuprofen|ibuprofen|mesh-list
102591114|NCT03523988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102591115|NCT03523988|Analgesics|analgesics|mesh-ancestor
102591116|NCT03523988|Sensory System Agents|sensory system agents|mesh-ancestor
102591117|NCT03523988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102591118|NCT03523988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591119|NCT03523988|Antipyretics|antipyretics|mesh-ancestor
102591120|NCT03523988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102591121|NCT03523988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102591122|NCT03523988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102591123|NCT03523988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102591124|NCT03523988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102591125|NCT03523988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591126|NCT03525548|Ivacaftor|ivacaftor|mesh-list
102591127|NCT03525548|Elexacaftor|elexacaftor|mesh-list
102591128|NCT03525548|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102591129|NCT03525548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102591130|NCT03525548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591131|NCT03528512|Fentanyl|fentanyl|mesh-list
102591132|NCT03528512|Midazolam|midazolam|mesh-list
102591133|NCT03528512|Ketamine|ketamine|mesh-list
102591134|NCT03528512|Analgesics|analgesics|mesh-ancestor
102591135|NCT03528512|Sensory System Agents|sensory system agents|mesh-ancestor
102591136|NCT03528512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102591137|NCT03528512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591138|NCT03528512|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102591139|NCT03528512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102591140|NCT03528512|Anesthetics, General|anesthetics, general|mesh-ancestor
102591141|NCT03528512|Anesthetics|anesthetics|mesh-ancestor
102591142|NCT03528512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102591143|NCT03528512|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102591144|NCT03528512|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102591145|NCT03528512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102591146|NCT03528512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591147|NCT03528512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102591148|NCT03528512|Narcotics|narcotics|mesh-ancestor
102591149|NCT03528512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102591150|NCT03528512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102591151|NCT03528512|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102591152|NCT03528512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102591153|NCT03528512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102591154|NCT03528512|GABA Modulators|gaba modulators|mesh-ancestor
102591155|NCT03528512|GABA Agents|gaba agents|mesh-ancestor
102591156|NCT02133924|Prednisone|prednisone|mesh-list
102591157|NCT02133924|Methylprednisolone|methylprednisolone|mesh-list
102591158|NCT02133924|Natalizumab|natalizumab|mesh-list
102591159|NCT02133924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102591160|NCT02133924|Glucocorticoids|glucocorticoids|mesh-ancestor
102591161|NCT02133924|Hormones|hormones|mesh-ancestor
102591162|NCT02133924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102591163|NCT02133924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591164|NCT02133924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102591165|NCT02133924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102591166|NCT02133924|Antiemetics|antiemetics|mesh-ancestor
102591167|NCT02133924|Autonomic Agents|autonomic agents|mesh-ancestor
102591168|NCT02133924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102591169|NCT02133924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102591170|NCT02133924|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102591171|NCT02133924|Protective Agents|protective agents|mesh-ancestor
102591172|NCT02133924|Immunologic Factors|immunologic factors|mesh-ancestor
102591173|NCT03537404|Ritonavir|ritonavir|mesh-list
102591174|NCT03537404|Tenofovir|tenofovir|mesh-list
102591175|NCT03537404|Raltegravir Potassium|raltegravir potassium|mesh-list
102591176|NCT03537404|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102591177|NCT03537404|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102591178|NCT03537404|Protease Inhibitors|protease inhibitors|mesh-ancestor
102591179|NCT03537404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102591180|NCT03537404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591181|NCT03537404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102591182|NCT03537404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102591183|NCT03537404|Antiviral Agents|antiviral agents|mesh-ancestor
102591184|NCT03537404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102591185|NCT03537404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102591186|NCT03537404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102591187|NCT03537404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102591188|NCT03537404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102591189|NCT03537404|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102591190|NCT03537404|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102591191|NCT03626714|Tacrolimus|tacrolimus|mesh-list
102591192|NCT03626714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102591193|NCT03626714|Immunologic Factors|immunologic factors|mesh-ancestor
102591194|NCT03626714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591195|NCT03626714|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102591196|NCT03626714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102591197|NCT03626714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591198|NCT03538808|Varenicline|varenicline|mesh-list
102591199|NCT03538808|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102591200|NCT03538808|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102591201|NCT03538808|Cholinergic Agents|cholinergic agents|mesh-ancestor
102591202|NCT03538808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102591203|NCT03538808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591204|NCT03538808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591205|NCT00377000|Clindamycin|clindamycin|mesh-list
102591206|NCT00377000|Clindamycin palmitate|clindamycin palmitate|mesh-list
102591207|NCT00377000|Clindamycin phosphate|clindamycin phosphate|mesh-list
102591208|NCT00377000|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102591209|NCT00377000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102591210|NCT00377000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102591211|NCT00377000|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102591212|NCT00377000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102591213|NCT00377000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591214|NCT00377000|Dermatologic Agents|dermatologic agents|mesh-ancestor
102591215|NCT02173548|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102591216|NCT02173548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102591217|NCT04501640|Mirabegron|mirabegron|mesh-list
102591218|NCT04501640|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102591219|NCT04501640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102591220|NCT04501640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102591221|NCT04501640|Adrenergic Agents|adrenergic agents|mesh-ancestor
102591222|NCT04501640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102591223|NCT04501640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591224|NCT04501640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591225|NCT04501640|Urological Agents|urological agents|mesh-ancestor
102591226|NCT04757610|Ranibizumab|ranibizumab|mesh-list
102591227|NCT04757610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102591228|NCT04757610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102591229|NCT04757610|Growth Substances|growth substances|mesh-ancestor
102591230|NCT04757610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591231|NCT04757610|Growth Inhibitors|growth inhibitors|mesh-ancestor
102591232|NCT04757610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102591233|NCT03633344|Silicon|silicon|mesh-list
102591234|NCT03633344|Trace Elements|trace elements|mesh-ancestor
102591235|NCT03633344|Micronutrients|micronutrients|mesh-ancestor
102591236|NCT03633344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591237|NCT02171130|Glucagon|glucagon|mesh-list
102591238|NCT02171130|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102591239|NCT02171130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102591240|NCT02171130|Hormones|hormones|mesh-ancestor
102591241|NCT02171130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102591242|NCT02171130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591243|NCT02171130|Incretins|incretins|mesh-ancestor
102591244|NCT04749810|Eculizumab|eculizumab|mesh-list
102591245|NCT04749810|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102591246|NCT04749810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102591247|NCT04749810|Immunologic Factors|immunologic factors|mesh-ancestor
102591248|NCT04749810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591249|NCT00377078|Lactoferrin|lactoferrin|mesh-list
102591250|NCT00377078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102591251|NCT04495712|Spironolactone|spironolactone|mesh-list
102591252|NCT04495712|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102591253|NCT04495712|Hormone Antagonists|hormone antagonists|mesh-ancestor
102591254|NCT04495712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102591255|NCT04495712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591256|NCT04495712|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102591257|NCT04495712|Diuretics|diuretics|mesh-ancestor
102591258|NCT04495712|Natriuretic Agents|natriuretic agents|mesh-ancestor
102591259|NCT03553940|Vaccines|vaccines|mesh-list
102591260|NCT03553940|Immunologic Factors|immunologic factors|mesh-ancestor
102591261|NCT03553940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591262|NCT04456634|Lumefantrine|lumefantrine|mesh-list
102591263|NCT04456634|Artemether|artemether|mesh-list
102591264|NCT04456634|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102591265|NCT04456634|Antimalarials|antimalarials|mesh-ancestor
102591266|NCT04456634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102591267|NCT04456634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102591268|NCT04456634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102591269|NCT00377624|Hyaluronic Acid|hyaluronic acid|mesh-list
102591270|NCT00377624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102591271|NCT00377624|Immunologic Factors|immunologic factors|mesh-ancestor
102591272|NCT00377624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591273|NCT00377624|Viscosupplements|viscosupplements|mesh-ancestor
102591274|NCT00377624|Protective Agents|protective agents|mesh-ancestor
102591275|NCT03562988|Vitamins|vitamins|mesh-list
102591276|NCT03562988|Ascorbic Acid|ascorbic acid|mesh-list
102591277|NCT03562988|Micronutrients|micronutrients|mesh-ancestor
102591278|NCT03562988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591279|NCT03562988|Antioxidants|antioxidants|mesh-ancestor
102591280|NCT03562988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591281|NCT03562988|Protective Agents|protective agents|mesh-ancestor
102591282|NCT03644108|Guaifenesin|guaifenesin|mesh-list
102591283|NCT03644108|Expectorants|expectorants|mesh-ancestor
102591284|NCT03644108|Respiratory System Agents|respiratory system agents|mesh-ancestor
102591285|NCT04713956|Cyclophosphamide|cyclophosphamide|mesh-list
102591286|NCT04713956|Busulfan|busulfan|mesh-list
102591287|NCT04713956|Fludarabine|fludarabine|mesh-list
102591288|NCT04713956|Decitabine|decitabine|mesh-list
102591289|NCT04713956|Lenograstim|lenograstim|mesh-list
102591290|NCT04713956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102591291|NCT04713956|Immunologic Factors|immunologic factors|mesh-ancestor
102591292|NCT04713956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591293|NCT04713956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102591294|NCT04713956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102591295|NCT04713956|Alkylating Agents|alkylating agents|mesh-ancestor
102591296|NCT04713956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591297|NCT04713956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102591298|NCT04713956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102591299|NCT04713956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102591300|NCT04713956|Antimetabolites|antimetabolites|mesh-ancestor
102138200|NCT03484611|Progesterone|progesterone|mesh-list
102591301|NCT04713956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102591302|NCT04713956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102591303|NCT04425746|Afamelanotide|afamelanotide|mesh-list
102591304|NCT04425746|Dermatologic Agents|dermatologic agents|mesh-ancestor
102591306|NCT04392362|Analgesics|analgesics|mesh-ancestor
102345221|NCT05851781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102345222|NCT05851781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345232|NCT05841472|Carboplatin|carboplatin|mesh-list
102345233|NCT05841472|Pemetrexed|pemetrexed|mesh-list
102345234|NCT05841472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102345235|NCT05841472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102345236|NCT05841472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345237|NCT05841472|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102591307|NCT04392362|Sensory System Agents|sensory system agents|mesh-ancestor
102591308|NCT04392362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102591309|NCT04392362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591310|NCT04392362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102591311|NCT04392362|Vasodilator Agents|vasodilator agents|mesh-ancestor
102591312|NCT04392362|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102591313|NCT04392362|Purinergic Agonists|purinergic agonists|mesh-ancestor
102591314|NCT04392362|Purinergic Agents|purinergic agents|mesh-ancestor
102591315|NCT04392362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102591316|NCT04392362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591317|NCT04734782|Antibodies|antibodies|mesh-list
102591318|NCT04734782|Immunologic Factors|immunologic factors|mesh-ancestor
102591319|NCT04734782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591320|NCT04390022|Ivermectin|ivermectin|mesh-list
102591321|NCT04390022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102591322|NCT04390022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102591323|NCT04370834|Immunoglobulins|immunoglobulins|mesh-list
102591324|NCT04370834|Immunoglobulin G|immunoglobulin g|mesh-list
102591325|NCT04370834|Immunologic Factors|immunologic factors|mesh-ancestor
102591326|NCT04370834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591327|NCT03570476|Olaparib|olaparib|mesh-list
102591328|NCT03570476|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102591329|NCT03570476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102591330|NCT03570476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591331|NCT03570476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102591332|NCT03571724|Menthol|menthol|mesh-list
102591333|NCT03571724|Nicotine|nicotine|mesh-list
102591334|NCT03571724|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102591335|NCT03571724|Autonomic Agents|autonomic agents|mesh-ancestor
102591336|NCT03571724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102591337|NCT03571724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591338|NCT03571724|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102591339|NCT03571724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102591340|NCT03571724|Cholinergic Agents|cholinergic agents|mesh-ancestor
102591341|NCT03571724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102591342|NCT03571724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591343|NCT03571724|Antipruritics|antipruritics|mesh-ancestor
102591344|NCT03571724|Dermatologic Agents|dermatologic agents|mesh-ancestor
102591345|NCT03572972|Warfarin|warfarin|mesh-list
102591346|NCT03572972|Rivaroxaban|rivaroxaban|mesh-list
102591347|NCT03572972|Dabigatran|dabigatran|mesh-list
102591348|NCT03572972|Apixaban|apixaban|mesh-list
102591349|NCT03572972|Anticoagulants|anticoagulants|mesh-ancestor
102591350|NCT03572972|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102591351|NCT03572972|Antithrombins|antithrombins|mesh-ancestor
102591352|NCT03572972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102591353|NCT03572972|Protease Inhibitors|protease inhibitors|mesh-ancestor
102591354|NCT03572972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102591355|NCT03572972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591356|NCT04352660|Mitomycins|mitomycins|mesh-list
102591357|NCT04352660|Mitomycin|mitomycin|mesh-list
102591358|NCT04352660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102591359|NCT04352660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102591360|NCT04352660|Alkylating Agents|alkylating agents|mesh-ancestor
102591361|NCT04352660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591362|NCT04352660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102591363|NCT04352660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102591364|NCT04342130|Morphine|morphine|mesh-list
102591365|NCT04342130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102591366|NCT04342130|Narcotics|narcotics|mesh-ancestor
102591367|NCT04342130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102591368|NCT04342130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591369|NCT04342130|Analgesics|analgesics|mesh-ancestor
102591370|NCT04342130|Sensory System Agents|sensory system agents|mesh-ancestor
102591371|NCT04342130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102591372|NCT04338074|Tranexamic Acid|tranexamic acid|mesh-list
102591373|NCT04338074|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102591374|NCT04338074|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102591375|NCT04338074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591376|NCT04338074|Hemostatics|hemostatics|mesh-ancestor
102138287|NCT05382442|Vitamins|vitamins|mesh-ancestor
102591377|NCT04338074|Coagulants|coagulants|mesh-ancestor
102591378|NCT03964220|Tiotropium Bromide|tiotropium bromide|mesh-list
102591379|NCT03964220|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102591380|NCT03964220|Autonomic Agents|autonomic agents|mesh-ancestor
102591381|NCT03964220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102591382|NCT03964220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591383|NCT03964220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102591384|NCT03964220|Respiratory System Agents|respiratory system agents|mesh-ancestor
102591385|NCT03964220|Parasympatholytics|parasympatholytics|mesh-ancestor
102591386|NCT03964220|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102591387|NCT03964220|Cholinergic Agents|cholinergic agents|mesh-ancestor
102591388|NCT03964220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102591389|NCT03964220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591390|NCT04337138|Gemtuzumab|gemtuzumab|mesh-list
102591391|NCT04337138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102591392|NCT04337138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102591393|NCT04337138|Immunotoxins|immunotoxins|mesh-ancestor
102591394|NCT04337138|Immunoconjugates|immunoconjugates|mesh-ancestor
102591395|NCT04337138|Immunologic Factors|immunologic factors|mesh-ancestor
102591396|NCT04337138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591397|NCT00422773|Cetuximab|cetuximab|mesh-list
102591398|NCT00422773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102591399|NCT00422773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102591400|NCT03329209|Vedolizumab|vedolizumab|mesh-list
102591401|NCT03329209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102591402|NCT03661346|Labetalol|labetalol|mesh-list
102591403|NCT03661346|Esmolol|esmolol|mesh-list
102591404|NCT03661346|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102591405|NCT03661346|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102591406|NCT03661346|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102591407|NCT03661346|Adrenergic Agents|adrenergic agents|mesh-ancestor
102591408|NCT03661346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102591409|NCT03661346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591410|NCT03661346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591411|NCT03661346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102591412|NCT03661346|Sympathomimetics|sympathomimetics|mesh-ancestor
102591413|NCT03661346|Autonomic Agents|autonomic agents|mesh-ancestor
102345284|NCT05805891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102345285|NCT05803083|Hyaluronic Acid|hyaluronic acid|mesh-list
102345286|NCT05803083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102345287|NCT05803083|Immunologic Factors|immunologic factors|mesh-ancestor
102345288|NCT05803083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345289|NCT05803083|Viscosupplements|viscosupplements|mesh-ancestor
102345290|NCT05803083|Protective Agents|protective agents|mesh-ancestor
102345302|NCT05783648|Tranexamic Acid|tranexamic acid|mesh-list
102345303|NCT05783648|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102345304|NCT05783648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102345305|NCT05783648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345306|NCT05783648|Hemostatics|hemostatics|mesh-ancestor
102345307|NCT05783648|Coagulants|coagulants|mesh-ancestor
102345317|NCT05761951|Pembrolizumab|pembrolizumab|mesh-list
102345318|NCT05761951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102345319|NCT05761951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102345320|NCT05761951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102345321|NCT05761951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345322|NCT05761405|Ceftriaxone|ceftriaxone|mesh-list
102345323|NCT05761405|Amikacin|amikacin|mesh-list
102591414|NCT03661346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102591415|NCT03661346|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102591416|NCT03661346|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102591417|NCT03329911|Paclitaxel|paclitaxel|mesh-list
102591418|NCT03329911|Carboplatin|carboplatin|mesh-list
102591419|NCT03329911|Bevacizumab|bevacizumab|mesh-list
102591420|NCT03329911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102591421|NCT03329911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102591422|NCT03329911|Tubulin Modulators|tubulin modulators|mesh-ancestor
102591423|NCT03329911|Antimitotic Agents|antimitotic agents|mesh-ancestor
102591424|NCT03329911|Mitosis Modulators|mitosis modulators|mesh-ancestor
102591425|NCT03329911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591426|NCT03329911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102591427|NCT03329911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102591428|NCT03329911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102591429|NCT03329911|Growth Substances|growth substances|mesh-ancestor
102591430|NCT03329911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591431|NCT03329911|Growth Inhibitors|growth inhibitors|mesh-ancestor
102591432|NCT04322396|Azithromycin|azithromycin|mesh-list
102591433|NCT04322396|Hydroxychloroquine|hydroxychloroquine|mesh-list
102591434|NCT04322396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102591435|NCT04322396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102591436|NCT04322396|Antimalarials|antimalarials|mesh-ancestor
102591437|NCT04322396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102591438|NCT04322396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102591439|NCT04322396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102591440|NCT04322396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591441|NCT04322396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102591442|NCT03961100|Entrectinib|entrectinib|mesh-list
102591443|NCT03961100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102591444|NCT03961100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102591445|NCT03961100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591446|NCT03336853|Hybenx|hybenx|mesh-list
102591447|NCT03336853|Dental Disinfectants|dental disinfectants|mesh-ancestor
102591448|NCT03336853|Disinfectants|disinfectants|mesh-ancestor
102591449|NCT03336853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102591450|NCT03225313|Bupivacaine|bupivacaine|mesh-list
102138355|NCT05306548|Triamcinolone|triamcinolone|mesh-list
102591451|NCT03225313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102591452|NCT03225313|Anesthetics, Local|anesthetics, local|mesh-ancestor
102591453|NCT03225313|Anesthetics|anesthetics|mesh-ancestor
102591454|NCT03225313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102591455|NCT03225313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591456|NCT03225313|Sensory System Agents|sensory system agents|mesh-ancestor
102591457|NCT03225313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102591458|NCT03949244|Latanoprost|latanoprost|mesh-list
102591459|NCT03949244|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102591460|NCT03949244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102591461|NCT03948386|Bupivacaine|bupivacaine|mesh-list
102591462|NCT03948386|Mepivacaine|mepivacaine|mesh-list
102591463|NCT03948386|Anesthetics, Local|anesthetics, local|mesh-ancestor
102591464|NCT03948386|Anesthetics|anesthetics|mesh-ancestor
102591465|NCT03948386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102591466|NCT03948386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591467|NCT03948386|Sensory System Agents|sensory system agents|mesh-ancestor
102591468|NCT03948386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102591470|NCT03445195|Sulbactam|sulbactam|mesh-list
102591471|NCT03445195|Durlobactam|durlobactam|mesh-list
102591472|NCT03445195|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
102591473|NCT03445195|Cilastatin|cilastatin|mesh-list
102591474|NCT03445195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102591475|NCT03445195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102591476|NCT03445195|Protease Inhibitors|protease inhibitors|mesh-ancestor
102591477|NCT03445195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102591478|NCT03445195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591479|NCT03445195|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102591480|NCT04277936|Levetiracetam|levetiracetam|mesh-list
102591481|NCT04277936|Anticonvulsants|anticonvulsants|mesh-ancestor
102591482|NCT04277936|Nootropic Agents|nootropic agents|mesh-ancestor
102591483|NCT03670160|Clonidine|clonidine|mesh-list
102591484|NCT03670160|Phenobarbital|phenobarbital|mesh-list
102591485|NCT03670160|Analgesics|analgesics|mesh-ancestor
102591486|NCT03670160|Sensory System Agents|sensory system agents|mesh-ancestor
102591487|NCT03670160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102591488|NCT03670160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591489|NCT03670160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102591490|NCT03670160|Sympatholytics|sympatholytics|mesh-ancestor
102591491|NCT03670160|Autonomic Agents|autonomic agents|mesh-ancestor
102591492|NCT03670160|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102591493|NCT03670160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102591494|NCT03670160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102591495|NCT03670160|Adrenergic Agents|adrenergic agents|mesh-ancestor
102591496|NCT03670160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102591497|NCT03670160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591498|NCT03670160|Anticonvulsants|anticonvulsants|mesh-ancestor
102591499|NCT03670160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102591500|NCT03670160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102591501|NCT03670160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102591502|NCT03670160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102591503|NCT03670160|GABA Modulators|gaba modulators|mesh-ancestor
102591504|NCT03670160|GABA Agents|gaba agents|mesh-ancestor
102591505|NCT03670160|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102591506|NCT03670160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102591507|NCT03670160|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102591508|NCT00375895|Cyclosporine|cyclosporine|mesh-list
102591509|NCT00375895|Cyclosporins|cyclosporins|mesh-list
102591510|NCT00375895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102591511|NCT00375895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591512|NCT00375895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102591513|NCT00375895|Immunologic Factors|immunologic factors|mesh-ancestor
102591514|NCT00375895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591515|NCT00375895|Antifungal Agents|antifungal agents|mesh-ancestor
102591516|NCT00375895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102591517|NCT00375895|Dermatologic Agents|dermatologic agents|mesh-ancestor
102591518|NCT00375895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102591519|NCT00375895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102591520|NCT03338803|Linagliptin|linagliptin|mesh-list
102591521|NCT03338803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102591522|NCT03338803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591523|NCT03338803|Incretins|incretins|mesh-ancestor
102591524|NCT03338803|Hormones|hormones|mesh-ancestor
102591525|NCT03338803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102591526|NCT03338803|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102591527|NCT03338803|Protease Inhibitors|protease inhibitors|mesh-ancestor
102591528|NCT03338803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102591529|NCT03338803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138438|NCT05348824|Eusol|eusol|mesh-list
102591531|NCT00377936|Paclitaxel|paclitaxel|mesh-list
102591532|NCT00377936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102591533|NCT00377936|Antimetabolites|antimetabolites|mesh-ancestor
102591534|NCT00377936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591535|NCT00377936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102591536|NCT00377936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102591537|NCT00377936|Tubulin Modulators|tubulin modulators|mesh-ancestor
102591538|NCT00377936|Antimitotic Agents|antimitotic agents|mesh-ancestor
102591539|NCT00377936|Mitosis Modulators|mitosis modulators|mesh-ancestor
102591540|NCT03696758|Metoprolol|metoprolol|mesh-list
102591541|NCT03696758|Sildenafil Citrate|sildenafil citrate|mesh-list
102591542|NCT03696758|Vasodilator Agents|vasodilator agents|mesh-ancestor
102591543|NCT03696758|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102591544|NCT03696758|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102591545|NCT03696758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102591546|NCT03696758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591547|NCT03696758|Urological Agents|urological agents|mesh-ancestor
102591548|NCT03696758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102591549|NCT03696758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102591550|NCT03696758|Sympatholytics|sympatholytics|mesh-ancestor
102591551|NCT03696758|Autonomic Agents|autonomic agents|mesh-ancestor
102591552|NCT03696758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102591553|NCT03696758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591554|NCT03696758|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102591555|NCT03696758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102591556|NCT03696758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102591557|NCT03696758|Adrenergic Agents|adrenergic agents|mesh-ancestor
102591558|NCT03696758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102591559|NCT03233737|Anesthetics|anesthetics|mesh-list
102591560|NCT03233737|Tetracaine|tetracaine|mesh-list
102591561|NCT03233737|Benzocaine|benzocaine|mesh-list
102591562|NCT03233737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102591563|NCT03233737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591564|NCT03233737|Anesthetics, Local|anesthetics, local|mesh-ancestor
102591565|NCT03233737|Sensory System Agents|sensory system agents|mesh-ancestor
102591566|NCT03233737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102591567|NCT03711578|Tenalisib|tenalisib|mesh-list
102591568|NCT03711578|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
102591569|NCT03711578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102591570|NCT03711578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591571|NCT03463915|Triamcinolone|triamcinolone|mesh-list
102591572|NCT03463915|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102591573|NCT03463915|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102591574|NCT03463915|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102591575|NCT03463915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102591576|NCT03463915|Glucocorticoids|glucocorticoids|mesh-ancestor
102591577|NCT03463915|Hormones|hormones|mesh-ancestor
102591578|NCT03463915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102591579|NCT03463915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591580|NCT03463915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102591581|NCT03463915|Immunologic Factors|immunologic factors|mesh-ancestor
102591582|NCT03463915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102591583|NCT03463915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591584|NCT03473665|Celecoxib|celecoxib|mesh-list
102591585|NCT03473665|Diclofenac|diclofenac|mesh-list
102591586|NCT03473665|Indomethacin|indomethacin|mesh-list
102591587|NCT03473665|Meloxicam|meloxicam|mesh-list
102345347|NCT05724134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102345363|NCT05691478|Cisplatin|cisplatin|mesh-list
102345364|NCT05691478|Doxorubicin|doxorubicin|mesh-list
102345365|NCT05691478|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102345366|NCT05691478|Methotrexate|methotrexate|mesh-list
102345367|NCT05691478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102345368|NCT05691478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102345369|NCT05691478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102345370|NCT05691478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102345371|NCT05691478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102345372|NCT05691478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345373|NCT05691478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102345374|NCT05691478|Abortifacient Agents|abortifacient agents|mesh-ancestor
102345375|NCT05691478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102591588|NCT03473665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102591589|NCT03473665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102591590|NCT03473665|Analgesics|analgesics|mesh-ancestor
102591591|NCT03473665|Sensory System Agents|sensory system agents|mesh-ancestor
102591592|NCT03473665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102591593|NCT03473665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591594|NCT03473665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102591595|NCT03473665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102591596|NCT03473665|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102591597|NCT03473665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102591598|NCT03473665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102591599|NCT03473665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591600|NCT03473665|Gout Suppressants|gout suppressants|mesh-ancestor
102591601|NCT03473665|Tocolytic Agents|tocolytic agents|mesh-ancestor
102591602|NCT03473665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102591603|NCT03717506|Clindamycin|clindamycin|mesh-list
102591604|NCT03717506|Clindamycin palmitate|clindamycin palmitate|mesh-list
102591605|NCT03717506|Clindamycin phosphate|clindamycin phosphate|mesh-list
102591606|NCT03717506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102591607|NCT03717506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102591608|NCT03717506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102591609|NCT03717506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102591610|NCT03717506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591611|NCT03861338|Buprenorphine|buprenorphine|mesh-list
102591612|NCT03861338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102591613|NCT03861338|Narcotics|narcotics|mesh-ancestor
102591614|NCT03861338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102591615|NCT03861338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591616|NCT03861338|Analgesics|analgesics|mesh-ancestor
102591617|NCT03861338|Sensory System Agents|sensory system agents|mesh-ancestor
102591618|NCT03861338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102591619|NCT03861338|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102591620|NCT00377780|Docetaxel|docetaxel|mesh-list
102591621|NCT00377780|Doxorubicin|doxorubicin|mesh-list
102591622|NCT00377780|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102591623|NCT00377780|Trastuzumab|trastuzumab|mesh-list
102591624|NCT00377780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102591625|NCT00377780|Tubulin Modulators|tubulin modulators|mesh-ancestor
102591626|NCT00377780|Antimitotic Agents|antimitotic agents|mesh-ancestor
102591627|NCT00377780|Mitosis Modulators|mitosis modulators|mesh-ancestor
102591628|NCT00377780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591629|NCT00377780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102591630|NCT00377780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102591631|NCT00377780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102591632|NCT00377780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102591633|NCT00377780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102591634|NCT00376519|Cyclosporine|cyclosporine|mesh-list
102591635|NCT00376519|Mycophenolic Acid|mycophenolic acid|mesh-list
102591636|NCT00376519|Cyclophosphamide|cyclophosphamide|mesh-list
102591637|NCT00376519|Fludarabine|fludarabine|mesh-list
102591638|NCT00376519|Fludarabine phosphate|fludarabine phosphate|mesh-list
102591639|NCT00376519|Cyclosporins|cyclosporins|mesh-list
102591640|NCT00376519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102591641|NCT00376519|Immunologic Factors|immunologic factors|mesh-ancestor
102591642|NCT00376519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591643|NCT00376519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102591644|NCT00376519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102591645|NCT00376519|Alkylating Agents|alkylating agents|mesh-ancestor
102591646|NCT00376519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591647|NCT00376519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102591648|NCT00376519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102591649|NCT00376519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102591650|NCT00376519|Antimetabolites|antimetabolites|mesh-ancestor
102591651|NCT00376519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102591652|NCT00376519|Antifungal Agents|antifungal agents|mesh-ancestor
102591653|NCT00376519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102591654|NCT00376519|Dermatologic Agents|dermatologic agents|mesh-ancestor
102591655|NCT00376519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102591656|NCT00376519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102591657|NCT00376519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102591658|NCT00376519|Antitubercular Agents|antitubercular agents|mesh-ancestor
102591659|NCT00376519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102591660|NCT00422864|Leucovorin|leucovorin|mesh-list
102591661|NCT00422864|Fluorouracil|fluorouracil|mesh-list
102591662|NCT00422864|Oxaliplatin|oxaliplatin|mesh-list
102591663|NCT00422864|Antimetabolites|antimetabolites|mesh-ancestor
102591664|NCT00422864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591665|NCT00422864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102591666|NCT00422864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102591667|NCT00422864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102591668|NCT00422864|Immunologic Factors|immunologic factors|mesh-ancestor
102591669|NCT00422864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591670|NCT00422864|Antidotes|antidotes|mesh-ancestor
102591671|NCT00422864|Protective Agents|protective agents|mesh-ancestor
102591672|NCT00422864|Vitamin B Complex|vitamin b complex|mesh-ancestor
102591673|NCT00422864|Vitamins|vitamins|mesh-ancestor
102138573|NCT03480945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138574|NCT03480945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102138575|NCT03480945|Vasodilator Agents|vasodilator agents|mesh-ancestor
102138576|NCT03480945|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102138577|NCT03483207|Heparin|heparin|mesh-list
102138578|NCT03483207|Warfarin|warfarin|mesh-list
102138579|NCT03483207|Anticoagulants|anticoagulants|mesh-ancestor
102591674|NCT00422864|Micronutrients|micronutrients|mesh-ancestor
102591675|NCT03373591|Bupivacaine|bupivacaine|mesh-list
102591676|NCT03373591|Anesthetics, Local|anesthetics, local|mesh-ancestor
102591677|NCT03373591|Anesthetics|anesthetics|mesh-ancestor
102591678|NCT03373591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102591679|NCT03373591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591680|NCT03373591|Sensory System Agents|sensory system agents|mesh-ancestor
102591681|NCT03373591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102591682|NCT03378973|Dexmedetomidine|dexmedetomidine|mesh-list
102591683|NCT03378973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102591684|NCT03378973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102591685|NCT03378973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591686|NCT03378973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102591687|NCT03378973|Analgesics|analgesics|mesh-ancestor
102591688|NCT03378973|Sensory System Agents|sensory system agents|mesh-ancestor
102591689|NCT03378973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102591690|NCT03378973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102591691|NCT03378973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102591692|NCT03378973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102591693|NCT03378973|Adrenergic Agents|adrenergic agents|mesh-ancestor
102591694|NCT03378973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102591695|NCT03378973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591696|NCT04121078|Rifampin|rifampin|mesh-list
102591697|NCT04121078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102591698|NCT04121078|Antitubercular Agents|antitubercular agents|mesh-ancestor
102591699|NCT04121078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102591700|NCT04121078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102591701|NCT04121078|Leprostatic Agents|leprostatic agents|mesh-ancestor
102591702|NCT04121078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102591703|NCT04121078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102591704|NCT04121078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591705|NCT04121078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102591706|NCT04121078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102591707|NCT04121078|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102591708|NCT04121078|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102591709|NCT04121078|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102591710|NCT04121078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102591711|NCT03248947|Buprenorphine|buprenorphine|mesh-list
102591712|NCT03248947|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102591713|NCT03248947|Naloxone|naloxone|mesh-list
102591714|NCT03248947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102591715|NCT03248947|Narcotics|narcotics|mesh-ancestor
102591716|NCT03248947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102591717|NCT03248947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591718|NCT03248947|Analgesics|analgesics|mesh-ancestor
102591719|NCT03248947|Sensory System Agents|sensory system agents|mesh-ancestor
102591720|NCT03248947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102591721|NCT03248947|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102591722|NCT04114058|Bupivacaine|bupivacaine|mesh-list
102591723|NCT04114058|Anesthetics, Local|anesthetics, local|mesh-ancestor
102591724|NCT04114058|Anesthetics|anesthetics|mesh-ancestor
102591725|NCT04114058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102591726|NCT04114058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591727|NCT04114058|Sensory System Agents|sensory system agents|mesh-ancestor
102591728|NCT04114058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102591729|NCT03862040|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102591730|NCT03862040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102591731|NCT00376831|Fentanyl|fentanyl|mesh-list
102591732|NCT00376831|Midazolam|midazolam|mesh-list
102591733|NCT00376831|Ketamine|ketamine|mesh-list
102591734|NCT00376831|Analgesics|analgesics|mesh-ancestor
102591735|NCT00376831|Sensory System Agents|sensory system agents|mesh-ancestor
102345424|NCT05675410|Etoposide phosphate|etoposide phosphate|mesh-list
102591736|NCT00376831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102591737|NCT00376831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591738|NCT00376831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102591739|NCT00376831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102591740|NCT00376831|Anesthetics, General|anesthetics, general|mesh-ancestor
102591741|NCT00376831|Anesthetics|anesthetics|mesh-ancestor
102591742|NCT00376831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102591743|NCT00376831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102591744|NCT00376831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102591745|NCT00376831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102591746|NCT00376831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591747|NCT00376831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102591748|NCT00376831|Narcotics|narcotics|mesh-ancestor
102591749|NCT00376831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102591750|NCT00376831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102591751|NCT00376831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102591752|NCT00376831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102591753|NCT00376831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102591754|NCT00376831|GABA Modulators|gaba modulators|mesh-ancestor
102591755|NCT00376831|GABA Agents|gaba agents|mesh-ancestor
102591756|NCT03857750|Rocuronium|rocuronium|mesh-list
102591757|NCT03857750|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102591758|NCT03857750|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102591759|NCT03857750|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102591760|NCT03857750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102591761|NCT03857750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591762|NCT03828422|Calcium|calcium|mesh-list
102591763|NCT03828422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102591764|NCT03828422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591765|NCT03852524|Methylnaltrexone|methylnaltrexone|mesh-list
102591766|NCT03852524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102591767|NCT03852524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591768|NCT03852524|Sensory System Agents|sensory system agents|mesh-ancestor
102591769|NCT03852524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102591770|NCT04081610|Hyaluronic Acid|hyaluronic acid|mesh-list
102591771|NCT04081610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102591772|NCT04081610|Immunologic Factors|immunologic factors|mesh-ancestor
102591773|NCT04081610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591774|NCT04081610|Viscosupplements|viscosupplements|mesh-ancestor
102591775|NCT04081610|Protective Agents|protective agents|mesh-ancestor
102591776|NCT03840278|Pancrelipase|pancrelipase|mesh-list
102591777|NCT03840278|Pancreatin|pancreatin|mesh-list
102591778|NCT03840278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102591779|NCT03838874|Bupivacaine|bupivacaine|mesh-list
102591780|NCT03838874|Mepivacaine|mepivacaine|mesh-list
102591781|NCT03838874|Anesthetics, Local|anesthetics, local|mesh-ancestor
102591782|NCT03838874|Anesthetics|anesthetics|mesh-ancestor
102591783|NCT03838874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102591784|NCT03838874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591785|NCT03838874|Sensory System Agents|sensory system agents|mesh-ancestor
102591786|NCT03838874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102591787|NCT04045964|Nicotine|nicotine|mesh-list
102591788|NCT04045964|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102591789|NCT04045964|Autonomic Agents|autonomic agents|mesh-ancestor
102591790|NCT04045964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102591791|NCT04045964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591792|NCT04045964|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102591793|NCT04045964|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102591794|NCT04045964|Cholinergic Agents|cholinergic agents|mesh-ancestor
102591795|NCT04045964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102591796|NCT04045964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591797|NCT05314400|Liver Extracts|liver extracts|mesh-list
102591798|NCT05314400|Hematinics|hematinics|mesh-ancestor
102591799|NCT04039412|Levofloxacin|levofloxacin|mesh-list
102591800|NCT04039412|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102591801|NCT04039412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102591802|NCT04039412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102591803|NCT04039412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102591804|NCT04039412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102591805|NCT04039412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102591806|NCT04039412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591807|NCT04039412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102591808|NCT04039412|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102591809|NCT04039412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102591810|NCT03831854|Lamotrigine|lamotrigine|mesh-list
102591811|NCT03831854|Ketamine|ketamine|mesh-list
102591812|NCT03831854|Analgesics|analgesics|mesh-ancestor
102591813|NCT03831854|Sensory System Agents|sensory system agents|mesh-ancestor
102591814|NCT03831854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102591815|NCT03831854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591816|NCT03831854|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102591817|NCT03831854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102591818|NCT03831854|Anesthetics, General|anesthetics, general|mesh-ancestor
102591819|NCT03831854|Anesthetics|anesthetics|mesh-ancestor
102591820|NCT03831854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102591821|NCT03831854|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102591822|NCT03831854|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102591823|NCT03831854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102591824|NCT03831854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591825|NCT03831854|Anticonvulsants|anticonvulsants|mesh-ancestor
102591826|NCT03831854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102591827|NCT03831854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102591828|NCT03831854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102591829|NCT03831854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102591830|NCT03831854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102591831|NCT03831854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102591832|NCT03831854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102591833|NCT03806270|Midazolam|midazolam|mesh-list
102591834|NCT03806270|Hydroxyzine|hydroxyzine|mesh-list
102591835|NCT03806270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102591836|NCT03806270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102591837|NCT03806270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102591838|NCT03806270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591839|NCT03806270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102591840|NCT03806270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102591841|NCT03806270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102591842|NCT03806270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102591843|NCT03806270|Anesthetics, General|anesthetics, general|mesh-ancestor
102591844|NCT03806270|Anesthetics|anesthetics|mesh-ancestor
102591845|NCT03806270|GABA Modulators|gaba modulators|mesh-ancestor
102591846|NCT03806270|GABA Agents|gaba agents|mesh-ancestor
102591847|NCT03806270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102591848|NCT03806270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591849|NCT03806270|Antipruritics|antipruritics|mesh-ancestor
102591850|NCT03806270|Dermatologic Agents|dermatologic agents|mesh-ancestor
102591851|NCT03806270|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102591852|NCT03806270|Histamine Antagonists|histamine antagonists|mesh-ancestor
102591853|NCT03806270|Histamine Agents|histamine agents|mesh-ancestor
102591854|NCT03497845|Vaccines|vaccines|mesh-list
102591855|NCT03497845|Immunologic Factors|immunologic factors|mesh-ancestor
102591856|NCT03497845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591857|NCT04036292|Varenicline|varenicline|mesh-list
102591858|NCT04036292|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102591859|NCT04036292|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102591860|NCT04036292|Cholinergic Agents|cholinergic agents|mesh-ancestor
102591861|NCT04036292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102591862|NCT04036292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591863|NCT04036292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591864|NCT03501043|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102591865|NCT03501043|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102591866|NCT03501043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102591867|NCT03501043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591868|NCT03501043|Cholinergic Agents|cholinergic agents|mesh-ancestor
102591869|NCT03501043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102591870|NCT03501043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591871|NCT00377390|Omalizumab|omalizumab|mesh-list
102591872|NCT00377390|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102591873|NCT00377390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102591874|NCT00377390|Respiratory System Agents|respiratory system agents|mesh-ancestor
102591875|NCT03820388|Propofol|propofol|mesh-list
102591876|NCT03820388|Etomidate|etomidate|mesh-list
102591877|NCT03820388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102591878|NCT03820388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102591879|NCT03820388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591880|NCT03820388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102591881|NCT03820388|Anesthetics, General|anesthetics, general|mesh-ancestor
102591882|NCT03820388|Anesthetics|anesthetics|mesh-ancestor
102591883|NCT03264157|Vaccines|vaccines|mesh-list
102591884|NCT03264157|Immunologic Factors|immunologic factors|mesh-ancestor
102591885|NCT03264157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591886|NCT04029584|Rifampin|rifampin|mesh-list
102591887|NCT04029584|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102591888|NCT04029584|Antitubercular Agents|antitubercular agents|mesh-ancestor
102591889|NCT04029584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102591890|NCT04029584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102591891|NCT04029584|Leprostatic Agents|leprostatic agents|mesh-ancestor
102591892|NCT04029584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102591893|NCT04029584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102591894|NCT04029584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591895|NCT04029584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102591896|NCT04029584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102591897|NCT04029584|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102591898|NCT04029584|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102591899|NCT04029584|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102591900|NCT04029584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102591901|NCT04028960|Insulin|insulin|mesh-list
102591902|NCT04028960|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102591903|NCT04028960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102345507|NCT05658484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102345508|NCT05658484|Immunologic Factors|immunologic factors|mesh-ancestor
102591904|NCT04028960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591905|NCT03502915|Nitrous Oxide|nitrous oxide|mesh-list
102591906|NCT03502915|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102591907|NCT03502915|Anesthetics, General|anesthetics, general|mesh-ancestor
102591908|NCT03502915|Anesthetics|anesthetics|mesh-ancestor
102591909|NCT03502915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102591910|NCT03502915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591911|NCT03502915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102591912|NCT03502915|Analgesics|analgesics|mesh-ancestor
102591913|NCT03502915|Sensory System Agents|sensory system agents|mesh-ancestor
102591914|NCT03502915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102591915|NCT03506347|Vancomycin|vancomycin|mesh-list
102591916|NCT03506347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102591917|NCT03506347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102591918|NCT03266419|Rocuronium|rocuronium|mesh-list
102591919|NCT03266419|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102591920|NCT03266419|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102591921|NCT03266419|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102591922|NCT03266419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102591923|NCT03266419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591924|NCT00377468|Dronabinol|dronabinol|mesh-list
102591925|NCT00377468|Hallucinogens|hallucinogens|mesh-ancestor
102591926|NCT00377468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591927|NCT00377468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102591928|NCT00377468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102591929|NCT00377468|Analgesics|analgesics|mesh-ancestor
102591930|NCT00377468|Sensory System Agents|sensory system agents|mesh-ancestor
102591931|NCT00377468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102591932|NCT00377468|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102591933|NCT00377468|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102591934|NCT00377468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102591935|NCT00377468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591936|NCT00377468|Hormones|hormones|mesh-ancestor
102591937|NCT00377468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102591938|NCT03799484|Lidocaine|lidocaine|mesh-list
102591939|NCT03799484|Prilocaine|prilocaine|mesh-list
102591940|NCT03799484|Petrolatum|petrolatum|mesh-list
102591941|NCT03799484|Botulinum Toxins|botulinum toxins|mesh-list
102591942|NCT03799484|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102591943|NCT03799484|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102591944|NCT03799484|Anesthetics, Local|anesthetics, local|mesh-ancestor
102591945|NCT03799484|Anesthetics|anesthetics|mesh-ancestor
102591946|NCT03799484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102591947|NCT03799484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591948|NCT03799484|Sensory System Agents|sensory system agents|mesh-ancestor
102591949|NCT03799484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102591950|NCT03799484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102591951|NCT03799484|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102591952|NCT03799484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102591953|NCT03799484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102591954|NCT03799484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591955|NCT03799484|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102591956|NCT03799484|Cholinergic Agents|cholinergic agents|mesh-ancestor
102591957|NCT03799484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102591958|NCT03799484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102591959|NCT03799484|Emollients|emollients|mesh-ancestor
102591960|NCT03799484|Dermatologic Agents|dermatologic agents|mesh-ancestor
102591961|NCT00377546|Ketorolac|ketorolac|mesh-list
102591962|NCT00377546|Nepafenac|nepafenac|mesh-list
102591963|NCT00377546|Bromfenac|bromfenac|mesh-list
102591964|NCT00377546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102591965|NCT00377546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102591966|NCT00377546|Analgesics|analgesics|mesh-ancestor
102591967|NCT00377546|Sensory System Agents|sensory system agents|mesh-ancestor
102591968|NCT00377546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102591969|NCT00377546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591970|NCT00377546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102591971|NCT00377546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102591972|NCT00377546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102591973|NCT00377546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102591974|NCT00377546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591975|NCT04290494|Plasminogen|plasminogen|mesh-list
102591976|NCT04290494|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102591977|NCT04290494|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102591978|NCT04290494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591979|NCT04005404|Ropivacaine|ropivacaine|mesh-list
102591980|NCT04005404|Anesthetics, Local|anesthetics, local|mesh-ancestor
102591981|NCT04005404|Anesthetics|anesthetics|mesh-ancestor
102591982|NCT04005404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102591983|NCT04005404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102591984|NCT04005404|Sensory System Agents|sensory system agents|mesh-ancestor
102591985|NCT04005404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102591986|NCT03232892|Trametinib|trametinib|mesh-list
102591987|NCT03232892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102591988|NCT03232892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102591989|NCT03232892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102591990|NCT03232892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102591991|NCT03510481|Lumefantrine|lumefantrine|mesh-list
102591992|NCT03510481|Artemether|artemether|mesh-list
102591993|NCT03510481|Antimalarials|antimalarials|mesh-ancestor
102591994|NCT03510481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102591995|NCT03510481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102591996|NCT03510481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102591997|NCT03109418|Ketamine|ketamine|mesh-list
102591998|NCT03109418|Analgesics|analgesics|mesh-ancestor
102591999|NCT03109418|Sensory System Agents|sensory system agents|mesh-ancestor
102592000|NCT03109418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102592001|NCT03109418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592002|NCT03109418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102592003|NCT03109418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102592004|NCT03109418|Anesthetics, General|anesthetics, general|mesh-ancestor
102592005|NCT03109418|Anesthetics|anesthetics|mesh-ancestor
102592006|NCT03109418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102592007|NCT03109418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102592008|NCT03109418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102592009|NCT03109418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102592010|NCT03109418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592011|NCT03404167|Zoliflodacin|zoliflodacin|mesh-list
102592012|NCT03404167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102592013|NCT03404167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102592014|NCT03404167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102592015|NCT03404167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592016|NCT03404167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102592017|NCT03771560|Leucovorin|leucovorin|mesh-list
102592018|NCT03771560|Folic Acid|folic acid|mesh-list
102592019|NCT03771560|Levoleucovorin|levoleucovorin|mesh-list
102592020|NCT03771560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592021|NCT03771560|Antidotes|antidotes|mesh-ancestor
102592022|NCT03771560|Protective Agents|protective agents|mesh-ancestor
102592023|NCT03771560|Vitamin B Complex|vitamin b complex|mesh-ancestor
102592024|NCT03771560|Vitamins|vitamins|mesh-ancestor
102592025|NCT03771560|Micronutrients|micronutrients|mesh-ancestor
102592026|NCT03771560|Hematinics|hematinics|mesh-ancestor
102592027|NCT03767738|Aflibercept|aflibercept|mesh-list
102592028|NCT03767738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102592029|NCT03767738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102592030|NCT03767738|Growth Substances|growth substances|mesh-ancestor
102592031|NCT03767738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592032|NCT03767738|Growth Inhibitors|growth inhibitors|mesh-ancestor
102592033|NCT03767738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102592034|NCT02973620|Simendan|simendan|mesh-list
102592035|NCT02973620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102592036|NCT02973620|Vasodilator Agents|vasodilator agents|mesh-ancestor
102592037|NCT02973620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102592038|NCT02973620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102592039|NCT02973620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102592040|NCT02973620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592041|NCT02973620|Protective Agents|protective agents|mesh-ancestor
102592042|NCT02973620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592043|NCT05313386|Dexmedetomidine|dexmedetomidine|mesh-list
102592044|NCT05313386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102592045|NCT05313386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102592046|NCT05313386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592047|NCT05313386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102592048|NCT05313386|Analgesics|analgesics|mesh-ancestor
102592049|NCT05313386|Sensory System Agents|sensory system agents|mesh-ancestor
102592050|NCT05313386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102592051|NCT05313386|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102592052|NCT05313386|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102592053|NCT05313386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102592054|NCT05313386|Adrenergic Agents|adrenergic agents|mesh-ancestor
102592055|NCT05313386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102592056|NCT05313386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592057|NCT04018664|Nalbuphine|nalbuphine|mesh-list
102592058|NCT04018664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102592059|NCT04018664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102592060|NCT04018664|Narcotics|narcotics|mesh-ancestor
102592061|NCT04018664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102592062|NCT04018664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592063|NCT04018664|Analgesics|analgesics|mesh-ancestor
102592064|NCT04018664|Sensory System Agents|sensory system agents|mesh-ancestor
102592065|NCT04018664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102592066|NCT03031340|Pregabalin|pregabalin|mesh-list
102592067|NCT03031340|Analgesics|analgesics|mesh-ancestor
102592068|NCT03031340|Sensory System Agents|sensory system agents|mesh-ancestor
102592069|NCT03031340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102592070|NCT03031340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592071|NCT03031340|Anticonvulsants|anticonvulsants|mesh-ancestor
102592072|NCT03031340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102592073|NCT03031340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102592074|NCT03031340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592075|NCT03031340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102592076|NCT03031340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102592077|NCT03031340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102592078|NCT03031340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102592079|NCT03031340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102592080|NCT03405259|Fluorides|fluorides|mesh-list
102592081|NCT03405259|Fluorides, Topical|fluorides, topical|mesh-list
102592082|NCT03405259|Cariostatic Agents|cariostatic agents|mesh-ancestor
102592083|NCT03405259|Protective Agents|protective agents|mesh-ancestor
102592084|NCT03405259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592085|NCT03513757|Lidocaine|lidocaine|mesh-list
102592086|NCT03513757|Glycopyrrolate|glycopyrrolate|mesh-list
102592087|NCT03513757|Dexmedetomidine|dexmedetomidine|mesh-list
102592088|NCT03513757|Nitrous Oxide|nitrous oxide|mesh-list
102592089|NCT03513757|Propofol|propofol|mesh-list
102592090|NCT03513757|Sevoflurane|sevoflurane|mesh-list
102592091|NCT03513757|Anesthetics, Local|anesthetics, local|mesh-ancestor
102592092|NCT03513757|Anesthetics|anesthetics|mesh-ancestor
102592093|NCT03513757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102592094|NCT03513757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592095|NCT03513757|Sensory System Agents|sensory system agents|mesh-ancestor
102592096|NCT03513757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102592097|NCT03513757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102592098|NCT03513757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102592099|NCT03513757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102592100|NCT03513757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102592101|NCT03513757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592102|NCT03513757|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102592103|NCT03513757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102592104|NCT03513757|Analgesics|analgesics|mesh-ancestor
102592105|NCT03513757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102592106|NCT03513757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102592107|NCT03513757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102592108|NCT03513757|Adrenergic Agents|adrenergic agents|mesh-ancestor
102592109|NCT03513757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102592110|NCT03513757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102592111|NCT03513757|Anesthetics, General|anesthetics, general|mesh-ancestor
102592112|NCT03513757|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102592113|NCT03513757|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102592114|NCT03513757|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102592115|NCT03513757|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102592116|NCT03513757|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102592117|NCT03513757|Cholinergic Agents|cholinergic agents|mesh-ancestor
101858964|NCT01063920|Naproxen|naproxen|mesh-list
102592118|NCT03760640|Insulin Lispro|insulin lispro|mesh-list
102592119|NCT03760640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102592120|NCT03760640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592121|NCT03275623|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102592122|NCT03275623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102592123|NCT03756038|Lorazepam|lorazepam|mesh-list
102592124|NCT03756038|Anticonvulsants|anticonvulsants|mesh-ancestor
102592125|NCT03756038|Antiemetics|antiemetics|mesh-ancestor
102592126|NCT03756038|Autonomic Agents|autonomic agents|mesh-ancestor
102592127|NCT03756038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102592128|NCT03756038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592129|NCT03756038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102592130|NCT03756038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102592131|NCT03756038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102592132|NCT03756038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102592133|NCT03756038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102592134|NCT03756038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102592135|NCT03756038|GABA Modulators|gaba modulators|mesh-ancestor
102592136|NCT03756038|GABA Agents|gaba agents|mesh-ancestor
102592137|NCT03756038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102592138|NCT03756038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592139|NCT03754556|Levonorgestrel|levonorgestrel|mesh-list
102592140|NCT03754556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102592141|NCT03754556|Contraceptive Agents|contraceptive agents|mesh-ancestor
102592142|NCT03754556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102592143|NCT03754556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592144|NCT03754556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102592145|NCT03754556|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102592146|NCT03754556|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102592147|NCT03521479|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
102592148|NCT03521479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102592149|NCT03521479|Immunologic Factors|immunologic factors|mesh-ancestor
102592150|NCT03521479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592151|NCT01495988|Bevacizumab|bevacizumab|mesh-list
102592152|NCT01495988|Vemurafenib|vemurafenib|mesh-list
102592153|NCT01495988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102592154|NCT01495988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102592155|NCT01495988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102592156|NCT01495988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102592157|NCT01495988|Growth Substances|growth substances|mesh-ancestor
102592158|NCT01495988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592159|NCT01495988|Growth Inhibitors|growth inhibitors|mesh-ancestor
102592160|NCT01495988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102592161|NCT01495988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102592162|NCT01495988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592163|NCT02934932|Brexpiprazole|brexpiprazole|mesh-list
102592164|NCT02934932|Serotonin Agents|serotonin agents|mesh-ancestor
102592165|NCT02934932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102592166|NCT02934932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592167|NCT02934932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592168|NCT02934932|Dopamine Agonists|dopamine agonists|mesh-ancestor
102592169|NCT02934932|Dopamine Agents|dopamine agents|mesh-ancestor
102592170|NCT03415243|Acetaminophen|acetaminophen|mesh-list
102592171|NCT03415243|Phenylephrine|phenylephrine|mesh-list
102592172|NCT03415243|Oxymetazoline|oxymetazoline|mesh-list
102592173|NCT03415243|Dextromethorphan|dextromethorphan|mesh-list
102592174|NCT03415243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102592175|NCT03415243|Analgesics|analgesics|mesh-ancestor
102592176|NCT03415243|Sensory System Agents|sensory system agents|mesh-ancestor
102592177|NCT03415243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102592178|NCT03415243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592179|NCT03415243|Antipyretics|antipyretics|mesh-ancestor
102592180|NCT03415243|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102592181|NCT03415243|Mydriatics|mydriatics|mesh-ancestor
102345526|NCT05636189|Anesthetics|anesthetics|mesh-list
102345527|NCT05636189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102345529|NCT05629702|Temozolomide|temozolomide|mesh-list
102592182|NCT03415243|Autonomic Agents|autonomic agents|mesh-ancestor
102592183|NCT03415243|Sympathomimetics|sympathomimetics|mesh-ancestor
102592184|NCT03415243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102592185|NCT03415243|Nasal Decongestants|nasal decongestants|mesh-ancestor
102592186|NCT03415243|Respiratory System Agents|respiratory system agents|mesh-ancestor
102592187|NCT03415243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102592188|NCT03415243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102592189|NCT03415243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102592190|NCT03415243|Adrenergic Agents|adrenergic agents|mesh-ancestor
102592191|NCT03415243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102592192|NCT03415243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592193|NCT03415243|Protective Agents|protective agents|mesh-ancestor
102592194|NCT03415243|Antitussive Agents|antitussive agents|mesh-ancestor
102592195|NCT03415243|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102592196|NCT03415243|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102592197|NCT02892500|Betamethasone|betamethasone|mesh-list
102592198|NCT02892500|Betamethasone Valerate|betamethasone valerate|mesh-list
102592199|NCT02892500|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102592200|NCT02892500|Betamethasone benzoate|betamethasone benzoate|mesh-list
102592201|NCT02892500|Bupivacaine|bupivacaine|mesh-list
102592202|NCT02892500|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102592203|NCT02892500|Anesthetics, Local|anesthetics, local|mesh-ancestor
102592204|NCT02892500|Anesthetics|anesthetics|mesh-ancestor
102592205|NCT02892500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102592206|NCT02892500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592207|NCT02892500|Sensory System Agents|sensory system agents|mesh-ancestor
102592208|NCT02892500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102592209|NCT02892500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102592210|NCT02892500|Glucocorticoids|glucocorticoids|mesh-ancestor
102592211|NCT02892500|Hormones|hormones|mesh-ancestor
102592212|NCT02892500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102592213|NCT02892500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102592214|NCT02892500|Respiratory System Agents|respiratory system agents|mesh-ancestor
102592215|NCT00378872|Tranexamic Acid|tranexamic acid|mesh-list
102592216|NCT00378872|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102592217|NCT00378872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102592218|NCT00378872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592219|NCT00378872|Hemostatics|hemostatics|mesh-ancestor
102592220|NCT00378872|Coagulants|coagulants|mesh-ancestor
102592221|NCT00378404|Docetaxel|docetaxel|mesh-list
102592222|NCT00378404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102592223|NCT00378404|Tubulin Modulators|tubulin modulators|mesh-ancestor
102592224|NCT00378404|Antimitotic Agents|antimitotic agents|mesh-ancestor
102592225|NCT00378404|Mitosis Modulators|mitosis modulators|mesh-ancestor
102592226|NCT00378404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592227|NCT03742154|Varenicline|varenicline|mesh-list
102592228|NCT03742154|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102592229|NCT03742154|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102592230|NCT03742154|Cholinergic Agents|cholinergic agents|mesh-ancestor
102592231|NCT03742154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102592232|NCT03742154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592233|NCT03742154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592234|NCT02734940|Lidocaine|lidocaine|mesh-list
102592235|NCT02734940|Fentanyl|fentanyl|mesh-list
102592236|NCT02734940|Ketamine|ketamine|mesh-list
102592237|NCT02734940|Dexmedetomidine|dexmedetomidine|mesh-list
102592238|NCT02734940|Morphine|morphine|mesh-list
102592239|NCT02734940|Anesthetics, Local|anesthetics, local|mesh-ancestor
102592240|NCT02734940|Anesthetics|anesthetics|mesh-ancestor
102592241|NCT02734940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102592242|NCT02734940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592243|NCT02734940|Sensory System Agents|sensory system agents|mesh-ancestor
102592244|NCT02734940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102592245|NCT02734940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102592246|NCT02734940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102592247|NCT02734940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102592248|NCT02734940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102592249|NCT02734940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592250|NCT02734940|Analgesics|analgesics|mesh-ancestor
102592251|NCT02734940|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102592252|NCT02734940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102592253|NCT02734940|Anesthetics, General|anesthetics, general|mesh-ancestor
102592254|NCT02734940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102592255|NCT02734940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102592256|NCT02734940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102592257|NCT02734940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102592258|NCT02734940|Narcotics|narcotics|mesh-ancestor
102592259|NCT02734940|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102592260|NCT02734940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102592261|NCT02734940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102592262|NCT02734940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102592263|NCT02734940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102592264|NCT02734940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102592265|NCT02734940|Adrenergic Agents|adrenergic agents|mesh-ancestor
102592266|NCT00378092|Risperidone|risperidone|mesh-list
102592267|NCT00378092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102592268|NCT00378092|Serotonin Agents|serotonin agents|mesh-ancestor
102592269|NCT00378092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102592270|NCT00378092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592271|NCT00378092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592272|NCT00378092|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102592273|NCT00378092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102592274|NCT00378092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102592275|NCT00378092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102592276|NCT00378092|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102592277|NCT00378092|Dopamine Agents|dopamine agents|mesh-ancestor
102592278|NCT01347632|Metronidazole|metronidazole|mesh-list
102592279|NCT01347632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102592280|NCT01347632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102592281|NCT01347632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102592282|NCT01347632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102592283|NCT02679560|Bupivacaine|bupivacaine|mesh-list
102592284|NCT02679560|Ropivacaine|ropivacaine|mesh-list
102592285|NCT02679560|Anesthetics, Local|anesthetics, local|mesh-ancestor
102592286|NCT02679560|Anesthetics|anesthetics|mesh-ancestor
102592287|NCT02679560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102592288|NCT02679560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592289|NCT02679560|Sensory System Agents|sensory system agents|mesh-ancestor
102592290|NCT02679560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102592291|NCT03723980|Propolis|propolis|mesh-list
102592292|NCT03723980|Calcium|calcium|mesh-list
102592293|NCT03723980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102592294|NCT03723980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592295|NCT03723980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102592296|NCT01240304|Gemcitabine|gemcitabine|mesh-list
102592297|NCT01240304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102592298|NCT01240304|Antimetabolites|antimetabolites|mesh-ancestor
102592299|NCT01240304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592300|NCT01240304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102592301|NCT02614586|Ondansetron|ondansetron|mesh-list
102592302|NCT02614586|Antiemetics|antiemetics|mesh-ancestor
102592303|NCT02614586|Autonomic Agents|autonomic agents|mesh-ancestor
102592304|NCT02614586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102592305|NCT02614586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592306|NCT02614586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102592307|NCT02614586|Antipruritics|antipruritics|mesh-ancestor
102592308|NCT02614586|Dermatologic Agents|dermatologic agents|mesh-ancestor
102592309|NCT02614586|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102592310|NCT02614586|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102592311|NCT02614586|Serotonin Agents|serotonin agents|mesh-ancestor
102592312|NCT02614586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102592313|NCT02614586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592314|NCT01211756|Oxytocin|oxytocin|mesh-list
102592315|NCT01211756|Oxytocics|oxytocics|mesh-ancestor
102592316|NCT01211756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102592317|NCT01211756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592318|NCT03591458|Amitriptyline|amitriptyline|mesh-list
102592319|NCT03591458|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102592320|NCT03591458|Antidepressive Agents|antidepressive agents|mesh-ancestor
102592321|NCT03591458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102592322|NCT03591458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102592323|NCT03591458|Analgesics|analgesics|mesh-ancestor
102592324|NCT03591458|Sensory System Agents|sensory system agents|mesh-ancestor
102592325|NCT03591458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102592326|NCT03591458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592327|NCT03591458|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102345540|NCT05626998|Gabapentin|gabapentin|mesh-list
102592328|NCT03591458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102592329|NCT03591458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102592330|NCT03591458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592331|NCT03591458|Adrenergic Agents|adrenergic agents|mesh-ancestor
102592332|NCT03591458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102592333|NCT03565328|Niacinamide|niacinamide|mesh-list
102592334|NCT03565328|Niacin|niacin|mesh-list
102592335|NCT03565328|Nicotinic Acids|nicotinic acids|mesh-list
102592336|NCT03565328|Vitamin B Complex|vitamin b complex|mesh-ancestor
102592337|NCT03565328|Vitamins|vitamins|mesh-ancestor
102592338|NCT03565328|Micronutrients|micronutrients|mesh-ancestor
102592339|NCT03565328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592340|NCT03565328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102592341|NCT03565328|Antimetabolites|antimetabolites|mesh-ancestor
102592342|NCT03565328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592343|NCT03565328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102592344|NCT03565328|Vasodilator Agents|vasodilator agents|mesh-ancestor
102592345|NCT01206296|Gemcitabine|gemcitabine|mesh-list
102592346|NCT01206296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102592347|NCT01206296|Antimetabolites|antimetabolites|mesh-ancestor
102592348|NCT01206296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592349|NCT01206296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102592350|NCT02593682|Suvorexant|suvorexant|mesh-list
102592351|NCT02593682|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102592352|NCT02593682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102592353|NCT02593682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102592354|NCT02593682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592355|NCT02593682|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102592356|NCT02593682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102592357|NCT02593682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592358|NCT01200602|Megestrol|megestrol|mesh-list
102592359|NCT01200602|Megestrol Acetate|megestrol acetate|mesh-list
102592360|NCT01200602|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102592361|NCT01200602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102592362|NCT01200602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102592363|NCT01200602|Contraceptive Agents|contraceptive agents|mesh-ancestor
102592364|NCT01200602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102592365|NCT01200602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592366|NCT01200602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102592367|NCT01200602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102592368|NCT01200602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102592369|NCT01200602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102592370|NCT01200602|Appetite Stimulants|appetite stimulants|mesh-ancestor
102592371|NCT01200602|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102592372|NCT01194908|Tamoxifen|tamoxifen|mesh-list
102592373|NCT01194908|Decitabine|decitabine|mesh-list
102592374|NCT01194908|Panobinostat|panobinostat|mesh-list
102592375|NCT01194908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102592376|NCT01194908|Antimetabolites|antimetabolites|mesh-ancestor
102592377|NCT01194908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592378|NCT01194908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102592379|NCT01194908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102592380|NCT01194908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102592381|NCT01194908|Hormone Antagonists|hormone antagonists|mesh-ancestor
102592382|NCT01194908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102592383|NCT01194908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592384|NCT01194908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102592385|NCT01194908|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102592386|NCT01194908|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102592387|NCT01194908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102592388|NCT01194908|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102592389|NCT01163084|Leuprolide|leuprolide|mesh-list
102592390|NCT01163084|Goserelin|goserelin|mesh-list
102592391|NCT01163084|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102592392|NCT01163084|Fertility Agents|fertility agents|mesh-ancestor
102592393|NCT01163084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102592394|NCT01163084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592395|NCT01163084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102592396|NCT01163084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102592397|NCT01155518|Clomiphene|clomiphene|mesh-list
102592398|NCT01155518|Testosterone|testosterone|mesh-list
102592399|NCT01155518|Androgens|androgens|mesh-ancestor
102592400|NCT01155518|Hormones|hormones|mesh-ancestor
102592401|NCT01155518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102592402|NCT01155518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592403|NCT01155518|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102592404|NCT01155518|Hormone Antagonists|hormone antagonists|mesh-ancestor
102592405|NCT01155518|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102592406|NCT01155518|Fertility Agents|fertility agents|mesh-ancestor
102592407|NCT01155518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102592408|NCT01155518|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102592409|NCT01155518|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102592410|NCT03490916|Acetazolamide|acetazolamide|mesh-list
102592411|NCT03490916|Anticonvulsants|anticonvulsants|mesh-ancestor
102592412|NCT03490916|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102592413|NCT03490916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102592414|NCT03490916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592415|NCT03490916|Diuretics|diuretics|mesh-ancestor
102592416|NCT03490916|Natriuretic Agents|natriuretic agents|mesh-ancestor
102592417|NCT03490916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592418|NCT03333746|Nivolumab|nivolumab|mesh-list
102592419|NCT03333746|Lenalidomide|lenalidomide|mesh-list
102592420|NCT03333746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102592421|NCT03333746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102592422|NCT03333746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102592423|NCT03333746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592424|NCT03333746|Immunologic Factors|immunologic factors|mesh-ancestor
102592425|NCT03333746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592426|NCT03333746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102592427|NCT03333746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102592428|NCT03333746|Growth Substances|growth substances|mesh-ancestor
102592429|NCT03333746|Growth Inhibitors|growth inhibitors|mesh-ancestor
102592430|NCT01139996|Clonidine|clonidine|mesh-list
102592431|NCT01139996|Analgesics|analgesics|mesh-ancestor
102592432|NCT01139996|Sensory System Agents|sensory system agents|mesh-ancestor
102592433|NCT01139996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102592434|NCT01139996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592435|NCT01139996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102592436|NCT01139996|Sympatholytics|sympatholytics|mesh-ancestor
102592437|NCT01139996|Autonomic Agents|autonomic agents|mesh-ancestor
102592438|NCT01139996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102592439|NCT01139996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102592440|NCT01139996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102592441|NCT01139996|Adrenergic Agents|adrenergic agents|mesh-ancestor
102592442|NCT01139996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102592443|NCT01139996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592444|NCT02417870|Aldesleukin|aldesleukin|mesh-list
102592445|NCT02417870|Interleukin-2|interleukin-2|mesh-list
102592446|NCT02417870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102592447|NCT02417870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102592448|NCT02417870|Analgesics|analgesics|mesh-ancestor
102592449|NCT02417870|Sensory System Agents|sensory system agents|mesh-ancestor
102592450|NCT02417870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102592451|NCT02417870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592452|NCT02417870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102592453|NCT02417870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102592454|NCT02417870|Antiviral Agents|antiviral agents|mesh-ancestor
102592455|NCT02417870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102592456|NCT01131884|Alendronate|alendronate|mesh-list
102592457|NCT01131884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102592458|NCT01131884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592459|NCT02389712|Lamotrigine|lamotrigine|mesh-list
102592460|NCT02389712|Fluoxetine|fluoxetine|mesh-list
102592461|NCT02389712|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102592462|NCT02389712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102592463|NCT02389712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102592464|NCT02389712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592465|NCT02389712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102592466|NCT02389712|Serotonin Agents|serotonin agents|mesh-ancestor
102592467|NCT02389712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592468|NCT02389712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102345545|NCT05626998|Analgesics|analgesics|mesh-ancestor
102592469|NCT02389712|Antidepressive Agents|antidepressive agents|mesh-ancestor
102592470|NCT02389712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102592471|NCT02389712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102592472|NCT02389712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102592473|NCT02389712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102592474|NCT02389712|Anticonvulsants|anticonvulsants|mesh-ancestor
102592475|NCT02389712|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102592476|NCT02389712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102592477|NCT02389712|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102592478|NCT02389712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102592479|NCT02389712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102592480|NCT02389712|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102592481|NCT02369744|Tamsulosin|tamsulosin|mesh-list
102592482|NCT02369744|Silodosin|silodosin|mesh-list
102592483|NCT02369744|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102592484|NCT02369744|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102592485|NCT02369744|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102592486|NCT02369744|Adrenergic Agents|adrenergic agents|mesh-ancestor
102592487|NCT02369744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102592488|NCT02369744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592489|NCT02369744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592490|NCT02369744|Urological Agents|urological agents|mesh-ancestor
102592491|NCT03577171|Entecavir|entecavir|mesh-list
102592492|NCT03577171|Antiviral Agents|antiviral agents|mesh-ancestor
102592493|NCT03577171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102592494|NCT02367170|Midazolam|midazolam|mesh-list
102592495|NCT02367170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102592496|NCT02367170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102592497|NCT02367170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102592498|NCT02367170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592499|NCT02367170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102592500|NCT02367170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102592501|NCT02367170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102592502|NCT02367170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102592503|NCT02367170|Anesthetics, General|anesthetics, general|mesh-ancestor
102592504|NCT02367170|Anesthetics|anesthetics|mesh-ancestor
102592505|NCT02367170|GABA Modulators|gaba modulators|mesh-ancestor
102592506|NCT02367170|GABA Agents|gaba agents|mesh-ancestor
102592507|NCT02367170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102592508|NCT02367170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592509|NCT01078844|Memantine|memantine|mesh-list
102592510|NCT01078844|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102592511|NCT01078844|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102592512|NCT01078844|Dopamine Agents|dopamine agents|mesh-ancestor
102592513|NCT01078844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102592514|NCT01078844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592515|NCT01078844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592516|NCT01078844|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102592517|NCT01078844|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102592518|NCT00376051|Citalopram|citalopram|mesh-list
102592519|NCT00376051|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102592520|NCT00376051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102592521|NCT00376051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102592522|NCT00376051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592523|NCT00376051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102592524|NCT00376051|Serotonin Agents|serotonin agents|mesh-ancestor
102592525|NCT00376051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592526|NCT00376051|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102592527|NCT00376051|Antidepressive Agents|antidepressive agents|mesh-ancestor
102592528|NCT00376051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102592529|NCT01072526|Cyclosporine|cyclosporine|mesh-list
102592530|NCT01072526|Lubricant Eye Drops|lubricant eye drops|mesh-list
102592531|NCT01072526|Cyclosporins|cyclosporins|mesh-list
102592532|NCT01072526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102592533|NCT01072526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592534|NCT01072526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102592535|NCT01072526|Immunologic Factors|immunologic factors|mesh-ancestor
102592536|NCT01072526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592537|NCT01072526|Antifungal Agents|antifungal agents|mesh-ancestor
102592538|NCT01072526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102592539|NCT01072526|Dermatologic Agents|dermatologic agents|mesh-ancestor
102592540|NCT01072526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102592541|NCT01072526|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102592542|NCT01072526|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102592543|NCT01072526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102592544|NCT05312840|Carboplatin|carboplatin|mesh-list
102592545|NCT05312840|Gemcitabine|gemcitabine|mesh-list
102592546|NCT05312840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102592547|NCT05312840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102592548|NCT05312840|Antimetabolites|antimetabolites|mesh-ancestor
102592549|NCT05312840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592550|NCT00376129|Alefacept|alefacept|mesh-list
102592551|NCT00376129|Dermatologic Agents|dermatologic agents|mesh-ancestor
102592552|NCT00376129|Immunologic Factors|immunologic factors|mesh-ancestor
102592553|NCT00376129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592554|NCT01035944|Chitosan|chitosan|mesh-list
102592555|NCT01035944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102592556|NCT01035944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102592557|NCT01035944|Antimetabolites|antimetabolites|mesh-ancestor
102592558|NCT01035944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592559|NCT01035944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102592560|NCT01035944|Chelating Agents|chelating agents|mesh-ancestor
102592561|NCT01035944|Sequestering Agents|sequestering agents|mesh-ancestor
102592562|NCT01035944|Hemostatics|hemostatics|mesh-ancestor
102592563|NCT01035944|Coagulants|coagulants|mesh-ancestor
102592564|NCT00378638|Bevacizumab|bevacizumab|mesh-list
102592565|NCT00378638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102592566|NCT00378638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102592567|NCT00378638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102592568|NCT00378638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102592569|NCT00378638|Growth Substances|growth substances|mesh-ancestor
102592570|NCT00378638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592571|NCT00378638|Growth Inhibitors|growth inhibitors|mesh-ancestor
102592572|NCT03582553|Naringenin|naringenin|mesh-list
102592573|NCT03582553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102592574|NCT03582553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102592575|NCT03582553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102592576|NCT03582553|Hormone Antagonists|hormone antagonists|mesh-ancestor
102592577|NCT03582553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102139477|NCT05072782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102592578|NCT03582553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592579|NCT01025492|Fenofibric acid|fenofibric acid|mesh-list
102592580|NCT01025492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102592581|NCT01025492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102592582|NCT01025492|Antimetabolites|antimetabolites|mesh-ancestor
102592583|NCT01025492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592584|NCT01025492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102592585|NCT04331834|Hydroxychloroquine|hydroxychloroquine|mesh-list
102592586|NCT04331834|Antimalarials|antimalarials|mesh-ancestor
102592587|NCT04331834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102592588|NCT04331834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102592589|NCT04331834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102592590|NCT04331834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102592591|NCT04331834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592592|NCT04331834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102592593|NCT01023620|Pioglitazone|pioglitazone|mesh-list
102592594|NCT01023620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102592595|NCT01023620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592596|NCT03595579|Bupropion|bupropion|mesh-list
102592597|NCT03595579|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102592598|NCT03595579|Antidepressive Agents|antidepressive agents|mesh-ancestor
102592599|NCT03595579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102592600|NCT03595579|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102592601|NCT03595579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102592602|NCT03595579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102592603|NCT03595579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592604|NCT03595579|Dopamine Agents|dopamine agents|mesh-ancestor
102592605|NCT03595579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102592606|NCT03595579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592607|NCT03595579|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102592608|NCT03595579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102592609|NCT03595579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102592610|NCT02200328|Metronidazole|metronidazole|mesh-list
102592611|NCT02200328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102592612|NCT02200328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102592613|NCT02200328|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102592614|NCT02200328|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102592615|NCT04327843|Haloperidol|haloperidol|mesh-list
102592616|NCT04327843|Haloperidol decanoate|haloperidol decanoate|mesh-list
102592617|NCT04327843|Antiemetics|antiemetics|mesh-ancestor
102592618|NCT04327843|Autonomic Agents|autonomic agents|mesh-ancestor
102592619|NCT04327843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102592620|NCT04327843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592621|NCT04327843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102592622|NCT04327843|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102592623|NCT04327843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102592624|NCT04327843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102592625|NCT04327843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102592626|NCT04327843|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102592627|NCT04327843|Dopamine Agents|dopamine agents|mesh-ancestor
102592628|NCT04327843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102592629|NCT04327843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592630|NCT04327843|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102592631|NCT02147834|Ranolazine|ranolazine|mesh-list
102592632|NCT02147834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102592633|NCT02147834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102592634|NCT02147834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592635|NCT00979550|Imiquimod|imiquimod|mesh-list
102592636|NCT00979550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102592637|NCT00979550|Immunologic Factors|immunologic factors|mesh-ancestor
102592638|NCT00979550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592639|NCT00979550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102592640|NCT00979550|Interferon Inducers|interferon inducers|mesh-ancestor
102592641|NCT00966992|Zoledronic Acid|zoledronic acid|mesh-list
102592642|NCT00966992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102592643|NCT00966992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592644|NCT00379730|Prednisolone|prednisolone|mesh-list
102592645|NCT00379730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102592646|NCT00379730|Glucocorticoids|glucocorticoids|mesh-ancestor
102592647|NCT00379730|Hormones|hormones|mesh-ancestor
102592648|NCT00379730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102592649|NCT00379730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592650|NCT00379730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102592651|NCT00379730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102592652|NCT02074904|Topiramate|topiramate|mesh-list
102592653|NCT02074904|Anticonvulsants|anticonvulsants|mesh-ancestor
102592654|NCT02074904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102592655|NCT02074904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592656|NCT02043860|Melphalan|melphalan|mesh-list
102592657|NCT02043860|Immunologic Factors|immunologic factors|mesh-ancestor
102592658|NCT02043860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592659|NCT02043860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102592660|NCT02043860|Alkylating Agents|alkylating agents|mesh-ancestor
102592661|NCT02043860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592662|NCT02043860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102592663|NCT02043860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102592664|NCT02043860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102592665|NCT01974284|Ethanol|ethanol|mesh-list
102592666|NCT01974284|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102592667|NCT01974284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102592668|NCT01974284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102592669|NCT01974284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592670|NCT00869414|Insulin|insulin|mesh-list
102592671|NCT00869414|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102592672|NCT00869414|Insulin Glargine|insulin glargine|mesh-list
102592673|NCT00869414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102592674|NCT00869414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592675|NCT00843986|Conivaptan|conivaptan|mesh-list
102592676|NCT00843986|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102592677|NCT00843986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592678|NCT00843986|Natriuretic Agents|natriuretic agents|mesh-ancestor
102592679|NCT00843986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592680|NCT03608839|Dexamethasone|dexamethasone|mesh-list
102592681|NCT03608839|Dexamethasone acetate|dexamethasone acetate|mesh-list
102592682|NCT03608839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102592683|NCT03608839|BB 1101|bb 1101|mesh-list
102592684|NCT03608839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102592685|NCT03608839|Antiemetics|antiemetics|mesh-ancestor
102592686|NCT03608839|Autonomic Agents|autonomic agents|mesh-ancestor
102592687|NCT03608839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102592688|NCT03608839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592689|NCT03608839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102592690|NCT03608839|Glucocorticoids|glucocorticoids|mesh-ancestor
102592691|NCT03608839|Hormones|hormones|mesh-ancestor
102592692|NCT03608839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102592693|NCT03608839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102592694|NCT03608839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102592695|NCT03608839|Protease Inhibitors|protease inhibitors|mesh-ancestor
102592696|NCT03608839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102592697|NCT03608839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592698|NCT00845702|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
102592699|NCT00845702|Chelating Agents|chelating agents|mesh-ancestor
102592700|NCT00845702|Sequestering Agents|sequestering agents|mesh-ancestor
102592701|NCT00845702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592702|NCT03610399|Primaquine|primaquine|mesh-list
102592703|NCT03610399|Antimalarials|antimalarials|mesh-ancestor
102592704|NCT03610399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102592705|NCT03610399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102592706|NCT03610399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102592707|NCT03610633|Oxytocin|oxytocin|mesh-list
102592708|NCT03610633|Oxytocics|oxytocics|mesh-ancestor
102592709|NCT03610633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102592710|NCT03610633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592711|NCT00832520|Mirtazapine|mirtazapine|mesh-list
102592712|NCT00832520|Antidepressive Agents|antidepressive agents|mesh-ancestor
102592713|NCT00832520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102592714|NCT00832520|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102592715|NCT00832520|Histamine Antagonists|histamine antagonists|mesh-ancestor
102592716|NCT00832520|Histamine Agents|histamine agents|mesh-ancestor
102592717|NCT00832520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102592718|NCT00832520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592719|NCT00832520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592720|NCT00832520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102592721|NCT00832520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102592722|NCT00832520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102592723|NCT00832520|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102592724|NCT00832520|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102592725|NCT00832520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102592726|NCT00832520|Adrenergic Agents|adrenergic agents|mesh-ancestor
102592727|NCT00832520|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102592729|NCT00832520|Serotonin Agents|serotonin agents|mesh-ancestor
102592730|NCT00832520|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102592731|NCT03545893|Ibuprofen|ibuprofen|mesh-list
102592732|NCT03545893|Oxycodone|oxycodone|mesh-list
102592733|NCT03545893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102592734|NCT03545893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102592735|NCT03545893|Analgesics|analgesics|mesh-ancestor
102592736|NCT03545893|Sensory System Agents|sensory system agents|mesh-ancestor
102592737|NCT03545893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102592738|NCT03545893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592739|NCT03545893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102592740|NCT03545893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102592741|NCT03545893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102592742|NCT03545893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102592743|NCT03545893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592744|NCT03545893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102592745|NCT03545893|Narcotics|narcotics|mesh-ancestor
102592746|NCT03545893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102592747|NCT01877564|Metformin|metformin|mesh-list
102592748|NCT01877564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102592749|NCT01877564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592750|NCT00376987|Zinc Oxide|zinc oxide|mesh-list
102592751|NCT00376987|Dermatologic Agents|dermatologic agents|mesh-ancestor
102592752|NCT00376987|Sunscreening Agents|sunscreening agents|mesh-ancestor
102592753|NCT00376987|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102592754|NCT00376987|Protective Agents|protective agents|mesh-ancestor
102592755|NCT00376987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592756|NCT01889420|Everolimus|everolimus|mesh-list
102592757|NCT01889420|Pomalidomide|pomalidomide|mesh-list
102592758|NCT01889420|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102592759|NCT01889420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102592760|NCT01889420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102592761|NCT01889420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592762|NCT01889420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102592763|NCT01889420|Immunologic Factors|immunologic factors|mesh-ancestor
102592764|NCT01889420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592765|NCT01889420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102592766|NCT01889420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102592767|NCT01889420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102592768|NCT01889420|Growth Substances|growth substances|mesh-ancestor
102592769|NCT01889420|Growth Inhibitors|growth inhibitors|mesh-ancestor
102592770|NCT00379028|Fluticasone|fluticasone|mesh-list
102592771|NCT00379028|Budesonide|budesonide|mesh-list
102592772|NCT00379028|Formoterol Fumarate|formoterol fumarate|mesh-list
102592773|NCT00379028|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102592774|NCT00379028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102592775|NCT00379028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102592776|NCT00379028|Autonomic Agents|autonomic agents|mesh-ancestor
102592777|NCT00379028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102592778|NCT00379028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592779|NCT00379028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102592780|NCT00379028|Respiratory System Agents|respiratory system agents|mesh-ancestor
102592781|NCT00379028|Dermatologic Agents|dermatologic agents|mesh-ancestor
102592782|NCT00379028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102592783|NCT00379028|Glucocorticoids|glucocorticoids|mesh-ancestor
102592784|NCT00379028|Hormones|hormones|mesh-ancestor
102592785|NCT00379028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102592786|NCT00379028|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102592787|NCT00379028|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102592788|NCT00379028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102592789|NCT00379028|Adrenergic Agents|adrenergic agents|mesh-ancestor
102592790|NCT00379028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102592791|NCT00379028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592792|NCT05286554|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102592793|NCT05286554|Hormones|hormones|mesh-list
102592794|NCT05286554|Progesterone|progesterone|mesh-list
102592795|NCT05286554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102592796|NCT05286554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592797|NCT05286554|Progestins|progestins|mesh-ancestor
102592798|NCT05286554|Luteolytic Agents|luteolytic agents|mesh-ancestor
102592799|NCT05286554|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102592800|NCT05286554|Contraceptive Agents|contraceptive agents|mesh-ancestor
102592801|NCT05286554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102592802|NCT05286554|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102592803|NCT05286554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102592804|NCT05286554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102592805|NCT00379262|Fluorouracil|fluorouracil|mesh-list
102592806|NCT00379262|Capecitabine|capecitabine|mesh-list
102592807|NCT00379262|Antimetabolites|antimetabolites|mesh-ancestor
102592808|NCT00379262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592809|NCT00379262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102592810|NCT00379262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102592811|NCT00379262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102592812|NCT00379262|Immunologic Factors|immunologic factors|mesh-ancestor
102592813|NCT00379262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592814|NCT00793520|Milnacipran|milnacipran|mesh-list
102592815|NCT00793520|Levomilnacipran|levomilnacipran|mesh-list
102592816|NCT00793520|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102592817|NCT00793520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102592818|NCT00793520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102592819|NCT00793520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592820|NCT00793520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102592821|NCT00793520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592822|NCT00793520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102592823|NCT00793520|Analgesics|analgesics|mesh-ancestor
102592824|NCT00793520|Sensory System Agents|sensory system agents|mesh-ancestor
102592825|NCT00793520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102592826|NCT00793520|Antidepressive Agents|antidepressive agents|mesh-ancestor
102592827|NCT00793520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102592828|NCT03621085|Ketamine|ketamine|mesh-list
102592829|NCT03621085|Analgesics|analgesics|mesh-ancestor
102592830|NCT03621085|Sensory System Agents|sensory system agents|mesh-ancestor
102592831|NCT03621085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102592832|NCT03621085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592833|NCT03621085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102592834|NCT03621085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102592835|NCT03621085|Anesthetics, General|anesthetics, general|mesh-ancestor
102592836|NCT03621085|Anesthetics|anesthetics|mesh-ancestor
102592837|NCT03621085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102592838|NCT03621085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102592839|NCT03621085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102592840|NCT03621085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102592841|NCT03621085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592842|NCT00795236|Melatonin|melatonin|mesh-list
102592843|NCT00795236|Antioxidants|antioxidants|mesh-ancestor
102592844|NCT00795236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592845|NCT00795236|Protective Agents|protective agents|mesh-ancestor
102592846|NCT00795236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592847|NCT00795236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102592848|NCT00790478|Melatonin|melatonin|mesh-list
102592849|NCT00790478|Antioxidants|antioxidants|mesh-ancestor
102592850|NCT00790478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592851|NCT00790478|Protective Agents|protective agents|mesh-ancestor
102592852|NCT00790478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592853|NCT00790478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102592854|NCT04490239|Heparin|heparin|mesh-list
102592855|NCT04490239|Calcium heparin|calcium heparin|mesh-list
102592856|NCT04490239|Anticoagulants|anticoagulants|mesh-ancestor
102592857|NCT04490239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102592858|NCT04490239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102592859|NCT04490239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592860|NCT00791336|Nelfinavir|nelfinavir|mesh-list
102592861|NCT00791336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102592862|NCT00791336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102592863|NCT00791336|Protease Inhibitors|protease inhibitors|mesh-ancestor
102592864|NCT00791336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102592865|NCT00791336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592866|NCT00791336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102592867|NCT00791336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102592868|NCT00791336|Antiviral Agents|antiviral agents|mesh-ancestor
102592869|NCT00791336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102592870|NCT00771602|Rituximab|rituximab|mesh-list
102592871|NCT00771602|Alemtuzumab|alemtuzumab|mesh-list
102592872|NCT00771602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102592873|NCT00771602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102592874|NCT00771602|Immunologic Factors|immunologic factors|mesh-ancestor
102592875|NCT00771602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592876|NCT00771602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102592877|NCT01804166|Infliximab|infliximab|mesh-list
102592878|NCT01804166|Golimumab|golimumab|mesh-list
102592879|NCT01804166|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102592880|NCT01804166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102592881|NCT01804166|Dermatologic Agents|dermatologic agents|mesh-ancestor
102592882|NCT01804166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102592883|NCT01804166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102592884|NCT01804166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102592885|NCT01804166|Immunologic Factors|immunologic factors|mesh-ancestor
102345573|NCT05601882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102592886|NCT01804166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592887|NCT04459585|Dabigatran|dabigatran|mesh-list
102592888|NCT04459585|Antithrombins|antithrombins|mesh-ancestor
102592889|NCT04459585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102592890|NCT04459585|Protease Inhibitors|protease inhibitors|mesh-ancestor
102592891|NCT04459585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102592892|NCT04459585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592893|NCT04459585|Anticoagulants|anticoagulants|mesh-ancestor
102592894|NCT05080556|Carboplatin|carboplatin|mesh-list
102592895|NCT05080556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102592896|NCT01797380|Escitalopram|escitalopram|mesh-list
102592897|NCT01797380|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102592898|NCT01797380|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102592899|NCT01797380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102592900|NCT01797380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592901|NCT01797380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102592902|NCT01797380|Serotonin Agents|serotonin agents|mesh-ancestor
102592903|NCT01797380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592904|NCT00732680|Botulinum Toxins|botulinum toxins|mesh-list
102592905|NCT00732680|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102592906|NCT00732680|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102592907|NCT00732680|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102592908|NCT00732680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102592909|NCT00732680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592910|NCT00732680|Cholinergic Agents|cholinergic agents|mesh-ancestor
102592911|NCT00732680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102592912|NCT00732680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592913|NCT00732680|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102592914|NCT00732680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102592915|NCT00726830|Morphine|morphine|mesh-list
102592916|NCT00726830|Oxycodone|oxycodone|mesh-list
102592917|NCT00726830|Methadone|methadone|mesh-list
102592918|NCT00726830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102592919|NCT00726830|Narcotics|narcotics|mesh-ancestor
102592920|NCT00726830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102592921|NCT00726830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592922|NCT00726830|Analgesics|analgesics|mesh-ancestor
102592923|NCT00726830|Sensory System Agents|sensory system agents|mesh-ancestor
102592924|NCT00726830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102592925|NCT00726830|Antitussive Agents|antitussive agents|mesh-ancestor
102592926|NCT00726830|Respiratory System Agents|respiratory system agents|mesh-ancestor
102592927|NCT00691652|Rituximab|rituximab|mesh-list
102592928|NCT00691652|Clofarabine|clofarabine|mesh-list
102592929|NCT00691652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102592930|NCT00691652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102592931|NCT00691652|Immunologic Factors|immunologic factors|mesh-ancestor
102592932|NCT00691652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592933|NCT00691652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102592934|NCT00691652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102592935|NCT00691652|Antimetabolites|antimetabolites|mesh-ancestor
102592936|NCT00691652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592937|NCT00691574|Melatonin|melatonin|mesh-list
102592938|NCT00691574|Antioxidants|antioxidants|mesh-ancestor
102592939|NCT00691574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592940|NCT00691574|Protective Agents|protective agents|mesh-ancestor
102592941|NCT00691574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592942|NCT00691574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102592943|NCT00685880|Betamethasone|betamethasone|mesh-list
102592944|NCT00685880|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
102592945|NCT00685880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102592946|NCT00685880|Glucocorticoids|glucocorticoids|mesh-ancestor
102592947|NCT00685880|Hormones|hormones|mesh-ancestor
102592948|NCT00685880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102592949|NCT00685880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592950|NCT00685880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102592951|NCT00685880|Respiratory System Agents|respiratory system agents|mesh-ancestor
102592952|NCT00685880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102592953|NCT00685880|Autonomic Agents|autonomic agents|mesh-ancestor
102592954|NCT00685880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102592955|NCT00681044|Melphalan|melphalan|mesh-list
102592956|NCT00681044|Immunologic Factors|immunologic factors|mesh-ancestor
102592957|NCT00681044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592958|NCT00681044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102592959|NCT00681044|Alkylating Agents|alkylating agents|mesh-ancestor
102592960|NCT00681044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592961|NCT00681044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102592962|NCT00681044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102592963|NCT00681044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102592964|NCT03632083|Contact Lens Solutions|contact lens solutions|mesh-list
102592965|NCT03632083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102592966|NCT03632083|Disinfectants|disinfectants|mesh-ancestor
102592967|NCT03632083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102592968|NCT03633487|Guaifenesin|guaifenesin|mesh-list
102592969|NCT03633487|Expectorants|expectorants|mesh-ancestor
102592970|NCT03633487|Respiratory System Agents|respiratory system agents|mesh-ancestor
102592971|NCT00423020|Epoetin Alfa|epoetin alfa|mesh-list
102592972|NCT00423020|Hematinics|hematinics|mesh-ancestor
102592973|NCT01756586|Dexamethasone|dexamethasone|mesh-list
102592974|NCT01756586|Bupivacaine|bupivacaine|mesh-list
102592975|NCT01756586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102592976|NCT01756586|Antiemetics|antiemetics|mesh-ancestor
102592977|NCT01756586|Autonomic Agents|autonomic agents|mesh-ancestor
102592978|NCT01756586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102592979|NCT01756586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592980|NCT01756586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102592981|NCT01756586|Glucocorticoids|glucocorticoids|mesh-ancestor
102592982|NCT01756586|Hormones|hormones|mesh-ancestor
102592983|NCT01756586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102592984|NCT01756586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102592985|NCT01756586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102592986|NCT01756586|Anesthetics, Local|anesthetics, local|mesh-ancestor
102592987|NCT01756586|Anesthetics|anesthetics|mesh-ancestor
102592988|NCT01756586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102592989|NCT01756586|Sensory System Agents|sensory system agents|mesh-ancestor
102592990|NCT03636061|Varenicline|varenicline|mesh-list
102592991|NCT03636061|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102592992|NCT03636061|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102592993|NCT03636061|Cholinergic Agents|cholinergic agents|mesh-ancestor
102592994|NCT03636061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102592995|NCT03636061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102592996|NCT03636061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102592997|NCT00661466|Bupivacaine|bupivacaine|mesh-list
102592998|NCT00661466|Anesthetics, Local|anesthetics, local|mesh-ancestor
102592999|NCT00661466|Anesthetics|anesthetics|mesh-ancestor
102593000|NCT00661466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102593001|NCT00661466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593002|NCT00661466|Sensory System Agents|sensory system agents|mesh-ancestor
102593003|NCT00661466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102593004|NCT00639626|Insulin Detemir|insulin detemir|mesh-list
102593005|NCT00639626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102593006|NCT00639626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593007|NCT01718444|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102593008|NCT01718444|Clomiphene|clomiphene|mesh-list
102593009|NCT01718444|Enclomiphene|enclomiphene|mesh-list
102593010|NCT01718444|Zuclomiphene|zuclomiphene|mesh-list
102593011|NCT01718444|Medroxyprogesterone|medroxyprogesterone|mesh-list
102593012|NCT01718444|Progestins|progestins|mesh-list
102593013|NCT01718444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102593014|NCT01718444|Hormone Antagonists|hormone antagonists|mesh-ancestor
102593015|NCT01718444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102593016|NCT01718444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593017|NCT01718444|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102593018|NCT01718444|Fertility Agents|fertility agents|mesh-ancestor
102593019|NCT01718444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102593020|NCT01718444|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102593021|NCT01718444|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102593022|NCT01718444|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102593023|NCT01718444|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102593024|NCT01718444|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102593025|NCT01718444|Contraceptive Agents|contraceptive agents|mesh-ancestor
102593026|NCT01718444|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102593027|NCT01718444|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102593028|NCT01718444|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102593029|NCT01718444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102593030|NCT01718444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102593031|NCT01718444|Hormones|hormones|mesh-ancestor
102593032|NCT00638222|Carvedilol|carvedilol|mesh-list
102593033|NCT00638222|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102593034|NCT00638222|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102593035|NCT00638222|Adrenergic Agents|adrenergic agents|mesh-ancestor
102593036|NCT00638222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102593037|NCT00638222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593038|NCT00638222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593039|NCT00638222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102593040|NCT00638222|Antioxidants|antioxidants|mesh-ancestor
102593041|NCT00638222|Protective Agents|protective agents|mesh-ancestor
102593042|NCT00638222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102593043|NCT00638222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102593044|NCT00638222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102593045|NCT00638222|Vasodilator Agents|vasodilator agents|mesh-ancestor
102593046|NCT00638222|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102593047|NCT00638222|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102593048|NCT00634322|Leucovorin|leucovorin|mesh-list
102593049|NCT00634322|Antidotes|antidotes|mesh-ancestor
102593050|NCT00634322|Protective Agents|protective agents|mesh-ancestor
102593051|NCT00634322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593052|NCT00634322|Vitamin B Complex|vitamin b complex|mesh-ancestor
102593053|NCT00634322|Vitamins|vitamins|mesh-ancestor
102593054|NCT00634322|Micronutrients|micronutrients|mesh-ancestor
102593055|NCT00379886|Thiopental|thiopental|mesh-list
102593056|NCT00379886|Propofol|propofol|mesh-list
102593057|NCT00379886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102593058|NCT00379886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102593059|NCT00379886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593060|NCT00379886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102593061|NCT00379886|Anesthetics, General|anesthetics, general|mesh-ancestor
102593062|NCT00379886|Anesthetics|anesthetics|mesh-ancestor
102593063|NCT00379886|Anticonvulsants|anticonvulsants|mesh-ancestor
102593064|NCT00379886|GABA Modulators|gaba modulators|mesh-ancestor
102593065|NCT00379886|GABA Agents|gaba agents|mesh-ancestor
102593066|NCT00379886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102593067|NCT00379886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593068|NCT01705106|Celecoxib|celecoxib|mesh-list
102593069|NCT01705106|Capecitabine|capecitabine|mesh-list
102593070|NCT01705106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102593071|NCT01705106|Antimetabolites|antimetabolites|mesh-ancestor
102593072|NCT01705106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593073|NCT01705106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102593074|NCT01705106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102593075|NCT01705106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102593076|NCT01705106|Analgesics|analgesics|mesh-ancestor
102593077|NCT01705106|Sensory System Agents|sensory system agents|mesh-ancestor
102593078|NCT01705106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102593079|NCT01705106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593080|NCT01705106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102593081|NCT01705106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102593082|NCT01705106|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102593083|NCT01705106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102593084|NCT01705106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102593085|NCT00624650|Phenylephrine|phenylephrine|mesh-list
102593086|NCT00624650|Dobutamine|dobutamine|mesh-list
102593087|NCT00624650|Furosemide|furosemide|mesh-list
102593088|NCT00624650|Vasopressins|vasopressins|mesh-list
102593089|NCT00624650|Arginine Vasopressin|arginine vasopressin|mesh-list
102593090|NCT00624650|Epinephrine|epinephrine|mesh-list
102593091|NCT00624650|Racepinephrine|racepinephrine|mesh-list
102593092|NCT00624650|Oxymetazoline|oxymetazoline|mesh-list
102593093|NCT00624650|Norepinephrine|norepinephrine|mesh-list
102593094|NCT00624650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
102593095|NCT00624650|Epinephryl borate|epinephryl borate|mesh-list
102593096|NCT00624650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102593097|NCT00624650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102593098|NCT00624650|Adrenergic Agents|adrenergic agents|mesh-ancestor
102593099|NCT00624650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102593100|NCT00624650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593101|NCT00624650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140006|NCT05797740|Immunologic Factors|immunologic factors|mesh-ancestor
102593102|NCT00624650|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102593103|NCT00624650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102593104|NCT00624650|Autonomic Agents|autonomic agents|mesh-ancestor
102593105|NCT00624650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102593106|NCT00624650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102593107|NCT00624650|Respiratory System Agents|respiratory system agents|mesh-ancestor
102593108|NCT00624650|Mydriatics|mydriatics|mesh-ancestor
102593109|NCT00624650|Sympathomimetics|sympathomimetics|mesh-ancestor
102593110|NCT00624650|Diuretics|diuretics|mesh-ancestor
102593111|NCT00624650|Natriuretic Agents|natriuretic agents|mesh-ancestor
102593112|NCT00624650|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102593113|NCT00624650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102593114|NCT00624650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102593115|NCT00624650|Nasal Decongestants|nasal decongestants|mesh-ancestor
102593116|NCT00624650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102593117|NCT00624650|Protective Agents|protective agents|mesh-ancestor
102593118|NCT00624650|Hemostatics|hemostatics|mesh-ancestor
102593119|NCT00624650|Coagulants|coagulants|mesh-ancestor
102593120|NCT00624650|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102593121|NCT00624650|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102593122|NCT00377065|Raltegravir Potassium|raltegravir potassium|mesh-list
102593123|NCT00377065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102593124|NCT00377065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102593125|NCT00377065|Antiviral Agents|antiviral agents|mesh-ancestor
102593126|NCT00377065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102593127|NCT00377065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102593128|NCT00377065|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102593129|NCT00377065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102593130|NCT00377065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593131|NCT00377143|Warfarin|warfarin|mesh-list
102593132|NCT00377143|Anticoagulants|anticoagulants|mesh-ancestor
102593133|NCT00610532|Probenecid|probenecid|mesh-list
102593134|NCT00610532|Phenytoin|phenytoin|mesh-list
102593135|NCT00610532|Anticonvulsants|anticonvulsants|mesh-ancestor
102593136|NCT00610532|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102593137|NCT00610532|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102593138|NCT00610532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102593139|NCT00610532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593140|NCT00610532|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102593141|NCT00610532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102593142|NCT00610532|Uricosuric Agents|uricosuric agents|mesh-ancestor
102593143|NCT00610532|Gout Suppressants|gout suppressants|mesh-ancestor
102593144|NCT00610532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102593145|NCT03642457|Bupivacaine|bupivacaine|mesh-list
102593146|NCT03642457|Anesthetics, Local|anesthetics, local|mesh-ancestor
102593147|NCT03642457|Anesthetics|anesthetics|mesh-ancestor
102593148|NCT03642457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102593149|NCT03642457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593150|NCT03642457|Sensory System Agents|sensory system agents|mesh-ancestor
102593151|NCT03642457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102593152|NCT00379418|Abciximab|abciximab|mesh-list
102593153|NCT00379418|Anticoagulants|anticoagulants|mesh-ancestor
102593154|NCT00379418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102593155|NCT00379496|Antidepressive Agents|antidepressive agents|mesh-list
102593156|NCT00379496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102593157|NCT00378716|Leucovorin|leucovorin|mesh-list
102593158|NCT00378716|Fluorouracil|fluorouracil|mesh-list
102593159|NCT00378716|Tegafur|tegafur|mesh-list
102593160|NCT00378716|Calcium|calcium|mesh-list
102593161|NCT00378716|Levoleucovorin|levoleucovorin|mesh-list
102593162|NCT00378716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102593163|NCT00378716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593164|NCT00378716|Antimetabolites|antimetabolites|mesh-ancestor
102593165|NCT00378716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593166|NCT00378716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102593167|NCT00378716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102593168|NCT00378716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102593169|NCT00378716|Immunologic Factors|immunologic factors|mesh-ancestor
102593170|NCT00378716|Antidotes|antidotes|mesh-ancestor
102593171|NCT00378716|Protective Agents|protective agents|mesh-ancestor
102593172|NCT00378716|Vitamin B Complex|vitamin b complex|mesh-ancestor
102593173|NCT00378716|Vitamins|vitamins|mesh-ancestor
102593174|NCT00378716|Micronutrients|micronutrients|mesh-ancestor
102593175|NCT03644095|Phenylpropanolamine|phenylpropanolamine|mesh-list
102593176|NCT03644095|Guaifenesin|guaifenesin|mesh-list
102345586|NCT05592223|Antitubercular Agents|antitubercular agents|mesh-ancestor
102593177|NCT03644095|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
102140082|NCT05792774|Bupivacaine|bupivacaine|mesh-list
102593178|NCT03644095|Expectorants|expectorants|mesh-ancestor
102593179|NCT03644095|Respiratory System Agents|respiratory system agents|mesh-ancestor
102593180|NCT03644095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102593181|NCT03644095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102593182|NCT03644095|Adrenergic Agents|adrenergic agents|mesh-ancestor
102593183|NCT03644095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102593184|NCT03644095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593185|NCT03644095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593186|NCT03644095|Appetite Depressants|appetite depressants|mesh-ancestor
102593187|NCT03644095|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102593189|NCT03644095|Autonomic Agents|autonomic agents|mesh-ancestor
102593190|NCT03644095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102593191|NCT03644095|Nasal Decongestants|nasal decongestants|mesh-ancestor
102593192|NCT03644095|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102593193|NCT01633814|Estradiol|estradiol|mesh-list
102593194|NCT01633814|Estrogens|estrogens|mesh-ancestor
102593195|NCT01633814|Hormones|hormones|mesh-ancestor
102593196|NCT01633814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102593197|NCT01633814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593198|NCT04585490|Paclitaxel|paclitaxel|mesh-list
102593199|NCT04585490|Cisplatin|cisplatin|mesh-list
102593200|NCT04585490|Carboplatin|carboplatin|mesh-list
102593201|NCT04585490|Pemetrexed|pemetrexed|mesh-list
102593202|NCT04585490|Durvalumab|durvalumab|mesh-list
102593203|NCT04585490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102593204|NCT04585490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102593205|NCT04585490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102593206|NCT04585490|Tubulin Modulators|tubulin modulators|mesh-ancestor
102593207|NCT04585490|Antimitotic Agents|antimitotic agents|mesh-ancestor
102593208|NCT04585490|Mitosis Modulators|mitosis modulators|mesh-ancestor
102593209|NCT04585490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593210|NCT04585490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102593211|NCT04585490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102593212|NCT04585490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102593213|NCT04585490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102593214|NCT04585490|Immunologic Factors|immunologic factors|mesh-ancestor
102593215|NCT04585490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593216|NCT04714099|Cyclosporine|cyclosporine|mesh-list
102593217|NCT04714099|Cyclosporins|cyclosporins|mesh-list
102593218|NCT04714099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102593219|NCT04714099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593220|NCT04714099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102593221|NCT04714099|Immunologic Factors|immunologic factors|mesh-ancestor
102593222|NCT04714099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593223|NCT04714099|Antifungal Agents|antifungal agents|mesh-ancestor
102593224|NCT04714099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102593225|NCT04714099|Dermatologic Agents|dermatologic agents|mesh-ancestor
102593226|NCT04714099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102593227|NCT04714099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102593228|NCT04566770|Vaccines|vaccines|mesh-list
102593229|NCT04566770|Immunologic Factors|immunologic factors|mesh-ancestor
102593230|NCT04566770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593231|NCT04342663|Fluvoxamine|fluvoxamine|mesh-list
102593232|NCT04342663|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102593233|NCT04342663|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102593234|NCT04342663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102593235|NCT04342663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593236|NCT04342663|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102593237|NCT04342663|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102593238|NCT04342663|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102593239|NCT04342663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102593240|NCT04342663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593241|NCT04342663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102593242|NCT04342663|Serotonin Agents|serotonin agents|mesh-ancestor
102593243|NCT04342663|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102593244|NCT04342663|Antidepressive Agents|antidepressive agents|mesh-ancestor
102593245|NCT04342663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102593246|NCT04342663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102593247|NCT04342663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102593248|NCT04342663|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102593249|NCT00589550|Interferons|interferons|mesh-list
102593250|NCT00589550|Interferon-alpha|interferon-alpha|mesh-list
102593251|NCT00589550|Interferon alpha-2|interferon alpha-2|mesh-list
102593252|NCT00589550|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102593253|NCT00589550|Sorafenib|sorafenib|mesh-list
102593254|NCT00589550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102593255|NCT00589550|Antiviral Agents|antiviral agents|mesh-ancestor
102140153|NCT05634148|Dexmedetomidine|dexmedetomidine|mesh-list
102593256|NCT00589550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102593257|NCT00589550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102593258|NCT00589550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102593259|NCT00589550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593260|NCT00589550|Immunologic Factors|immunologic factors|mesh-ancestor
102593261|NCT00589550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593262|NCT01636466|Everolimus|everolimus|mesh-list
102593263|NCT01636466|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102593264|NCT01636466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102593265|NCT01636466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102593266|NCT01636466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593267|NCT01636466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102593268|NCT01636466|Immunologic Factors|immunologic factors|mesh-ancestor
102593269|NCT01636466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593270|NCT01636466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102593271|NCT00568802|Hydroxyurea|hydroxyurea|mesh-list
102593272|NCT00568802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102593273|NCT00568802|Antisickling Agents|antisickling agents|mesh-ancestor
102593274|NCT00568802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102593275|NCT00568802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593276|NCT00568802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102593277|NCT03949621|Vedolizumab|vedolizumab|mesh-list
102593278|NCT03949621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102593279|NCT04429880|Oxytocin|oxytocin|mesh-list
102593280|NCT04429880|Oxytocics|oxytocics|mesh-ancestor
102593281|NCT04429880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102593282|NCT04429880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593283|NCT01692158|Heparin|heparin|mesh-list
102593284|NCT01692158|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102593285|NCT01692158|Tinzaparin|tinzaparin|mesh-list
102593286|NCT01692158|Dalteparin|dalteparin|mesh-list
102593287|NCT01692158|Anticoagulants|anticoagulants|mesh-ancestor
102593288|NCT01692158|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102593289|NCT01692158|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102593290|NCT01692158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593291|NCT01570634|Antidiarrheals|antidiarrheals|mesh-list
102593292|NCT01570634|Loperamide|loperamide|mesh-list
102593293|NCT01570634|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
102593294|NCT01570634|Calcium|calcium|mesh-list
102593295|NCT01570634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102593296|NCT01570634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593297|NCT01570634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102593298|NCT03928327|Itraconazole|itraconazole|mesh-list
102593299|NCT03928327|Rifampin|rifampin|mesh-list
102593300|NCT03928327|Antifungal Agents|antifungal agents|mesh-ancestor
102593301|NCT03928327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102593302|NCT03928327|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102593303|NCT03928327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102593304|NCT03928327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102593305|NCT03928327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593306|NCT03928327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102593307|NCT03928327|Hormone Antagonists|hormone antagonists|mesh-ancestor
102593308|NCT03928327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102593309|NCT03928327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593310|NCT03928327|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102593311|NCT03928327|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102593312|NCT03928327|Antitubercular Agents|antitubercular agents|mesh-ancestor
102593313|NCT03928327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102593314|NCT03928327|Leprostatic Agents|leprostatic agents|mesh-ancestor
102593315|NCT03928327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102593316|NCT03928327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102593317|NCT03928327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102593318|NCT03928327|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102593319|NCT03928327|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102593320|NCT03928327|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102593321|NCT03928327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102593322|NCT01055756|Loratadine|loratadine|mesh-list
102593323|NCT01055756|Pseudoephedrine|pseudoephedrine|mesh-list
102593324|NCT01055756|Ephedrine|ephedrine|mesh-list
102593325|NCT01055756|Antipruritics|antipruritics|mesh-ancestor
102593326|NCT01055756|Dermatologic Agents|dermatologic agents|mesh-ancestor
102593327|NCT01055756|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102593328|NCT01055756|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102140230|NCT05453500|Glucocorticoids|glucocorticoids|mesh-ancestor
102593329|NCT01055756|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102593330|NCT01055756|Histamine Antagonists|histamine antagonists|mesh-ancestor
102593331|NCT01055756|Histamine Agents|histamine agents|mesh-ancestor
102593332|NCT01055756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102593333|NCT01055756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593334|NCT01055756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593335|NCT01055756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102593336|NCT01055756|Autonomic Agents|autonomic agents|mesh-ancestor
102593337|NCT01055756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102593338|NCT01055756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102593339|NCT01055756|Respiratory System Agents|respiratory system agents|mesh-ancestor
102593340|NCT01055756|Nasal Decongestants|nasal decongestants|mesh-ancestor
102593341|NCT01055756|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102593342|NCT01055756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102593343|NCT01055756|Sympathomimetics|sympathomimetics|mesh-ancestor
102593344|NCT01055756|Adrenergic Agents|adrenergic agents|mesh-ancestor
102593345|NCT00652574|Dasatinib|dasatinib|mesh-list
102593346|NCT00652574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102593347|NCT00652574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102593348|NCT00652574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102593349|NCT00652574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593350|NCT01550510|Ascorbic Acid|ascorbic acid|mesh-list
102593351|NCT01550510|Irinotecan|irinotecan|mesh-list
102593352|NCT01550510|Camptothecin|camptothecin|mesh-list
102593353|NCT01550510|Vitamins|vitamins|mesh-ancestor
102593354|NCT01550510|Micronutrients|micronutrients|mesh-ancestor
102593355|NCT01550510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593356|NCT01550510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102593357|NCT01550510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102593358|NCT01550510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102593359|NCT01550510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593360|NCT01550510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102593361|NCT01550510|Antioxidants|antioxidants|mesh-ancestor
102593362|NCT01550510|Protective Agents|protective agents|mesh-ancestor
102593363|NCT01550510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102593364|NCT04333225|Hydroxychloroquine|hydroxychloroquine|mesh-list
102593365|NCT04333225|Antimalarials|antimalarials|mesh-ancestor
102593366|NCT04333225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102593367|NCT04333225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102593368|NCT04333225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102593369|NCT04333225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102593370|NCT04333225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593371|NCT04333225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102593372|NCT00556400|Contraceptive Agents|contraceptive agents|mesh-list
102593373|NCT00556400|Contraceptives, Oral|contraceptives, oral|mesh-list
102593374|NCT00556400|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
102593375|NCT00556400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102593376|NCT00556400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593377|NCT00556400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102593378|NCT00521924|Cyclosporine|cyclosporine|mesh-list
102593379|NCT00521924|Chloroquine|chloroquine|mesh-list
102593380|NCT00521924|Sulfasalazine|sulfasalazine|mesh-list
102593381|NCT00521924|Infliximab|infliximab|mesh-list
102593382|NCT00521924|Methotrexate|methotrexate|mesh-list
102593383|NCT00521924|Antirheumatic Agents|antirheumatic agents|mesh-list
102593384|NCT00521924|Cyclosporins|cyclosporins|mesh-list
102593385|NCT00521924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102593386|NCT00521924|Abortifacient Agents|abortifacient agents|mesh-ancestor
102593387|NCT00521924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102593388|NCT00521924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593389|NCT00521924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102593390|NCT00521924|Antimetabolites|antimetabolites|mesh-ancestor
102593391|NCT00521924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593392|NCT00521924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102593393|NCT00521924|Dermatologic Agents|dermatologic agents|mesh-ancestor
102593394|NCT00521924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102593395|NCT00521924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102593396|NCT00521924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102593397|NCT00521924|Immunologic Factors|immunologic factors|mesh-ancestor
102593398|NCT00521924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102593399|NCT00521924|Antifungal Agents|antifungal agents|mesh-ancestor
102593400|NCT00521924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102593401|NCT00521924|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102593402|NCT00521924|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102593403|NCT00521924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102593404|NCT00521924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102593405|NCT00521924|Amebicides|amebicides|mesh-ancestor
102593406|NCT00521924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102593407|NCT00521924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102593408|NCT00521924|Antimalarials|antimalarials|mesh-ancestor
102593409|NCT00521924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102593410|NCT00521924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102593411|NCT00521924|Analgesics|analgesics|mesh-ancestor
102593412|NCT00521924|Sensory System Agents|sensory system agents|mesh-ancestor
102593413|NCT00521924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102593414|NCT03927781|Pregabalin|pregabalin|mesh-list
102593415|NCT03927781|Analgesics|analgesics|mesh-ancestor
102593416|NCT03927781|Sensory System Agents|sensory system agents|mesh-ancestor
102593417|NCT03927781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102593418|NCT03927781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593419|NCT03927781|Anticonvulsants|anticonvulsants|mesh-ancestor
102593420|NCT03927781|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102593421|NCT03927781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102593422|NCT03927781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593423|NCT03927781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102593424|NCT03927781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102593425|NCT03927781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102593426|NCT03927781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102593427|NCT03927781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102593428|NCT00379964|Caspofungin|caspofungin|mesh-list
102593429|NCT00379964|Antifungal Agents|antifungal agents|mesh-ancestor
102593430|NCT00379964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102593431|NCT00379964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102593432|NCT00379964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593433|NCT01545518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102593434|NCT01545518|Immunologic Factors|immunologic factors|mesh-ancestor
102593435|NCT01545518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593436|NCT01526408|Famciclovir|famciclovir|mesh-list
102593437|NCT01526408|Antiviral Agents|antiviral agents|mesh-ancestor
102593438|NCT01526408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102593439|NCT01526408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102593440|NCT01526408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102593441|NCT01526408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593442|NCT04713644|Propofol|propofol|mesh-list
102593443|NCT04713644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102593444|NCT04713644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102593445|NCT04713644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593446|NCT04713644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102593447|NCT04713644|Anesthetics, General|anesthetics, general|mesh-ancestor
102593448|NCT04713644|Anesthetics|anesthetics|mesh-ancestor
102593449|NCT00000734|Zidovudine|zidovudine|mesh-list
102593450|NCT00000734|Trimethoprim|trimethoprim|mesh-list
102593451|NCT00000734|Sulfamethoxazole|sulfamethoxazole|mesh-list
102593452|NCT00000734|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102593453|NCT00000734|Antimetabolites|antimetabolites|mesh-ancestor
102593454|NCT00000734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593455|NCT00000734|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102593456|NCT00000734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102593457|NCT00000734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102593458|NCT00000734|Antiviral Agents|antiviral agents|mesh-ancestor
102593459|NCT00000734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102593460|NCT00000734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102593461|NCT00000734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102593462|NCT00000734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102593463|NCT00000734|Antimalarials|antimalarials|mesh-ancestor
102593464|NCT00000734|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102593465|NCT00000734|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102593466|NCT00000734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102593467|NCT00000734|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102593468|NCT00000734|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102593469|NCT00000734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102593470|NCT00000734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102593471|NCT03663283|Bupivacaine|bupivacaine|mesh-list
102593472|NCT03663283|Anesthetics, Local|anesthetics, local|mesh-ancestor
102593473|NCT03663283|Anesthetics|anesthetics|mesh-ancestor
102593474|NCT03663283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102593475|NCT03663283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593476|NCT03663283|Sensory System Agents|sensory system agents|mesh-ancestor
102593477|NCT03663283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102593478|NCT00000764|Interferons|interferons|mesh-list
102593479|NCT00000764|Interferon-alpha|interferon-alpha|mesh-list
102593480|NCT00000764|Interferon alpha-2|interferon alpha-2|mesh-list
102593481|NCT00000764|Isotretinoin|isotretinoin|mesh-list
102593482|NCT00000764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102593483|NCT00000764|Antiviral Agents|antiviral agents|mesh-ancestor
102593484|NCT00000764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102593485|NCT00000764|Immunologic Factors|immunologic factors|mesh-ancestor
102593486|NCT00000764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593487|NCT00000764|Dermatologic Agents|dermatologic agents|mesh-ancestor
102593488|NCT03909763|Danazol|danazol|mesh-list
102593489|NCT03909763|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102593490|NCT03909763|Hormone Antagonists|hormone antagonists|mesh-ancestor
102593491|NCT03909763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102593492|NCT03909763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593493|NCT00484718|Celecoxib|celecoxib|mesh-list
102593494|NCT00484718|Oxycodone|oxycodone|mesh-list
102593495|NCT00484718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102593496|NCT00484718|Narcotics|narcotics|mesh-ancestor
102593497|NCT00484718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102593498|NCT00484718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593499|NCT00484718|Analgesics|analgesics|mesh-ancestor
102593500|NCT00484718|Sensory System Agents|sensory system agents|mesh-ancestor
102593501|NCT00484718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102593502|NCT00484718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102593503|NCT00484718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102593504|NCT00484718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102593505|NCT00484718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102593506|NCT00484718|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102593507|NCT00484718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102593508|NCT00484718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102593509|NCT00484718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593510|NCT03665155|Daratumumab|daratumumab|mesh-list
102593511|NCT03665155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102593512|NCT00477230|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
102593513|NCT00448682|Leucovorin|leucovorin|mesh-list
102593514|NCT00448682|Docetaxel|docetaxel|mesh-list
102593515|NCT00448682|Oxaliplatin|oxaliplatin|mesh-list
102593516|NCT00448682|Floxuridine|floxuridine|mesh-list
102593517|NCT00448682|Levoleucovorin|levoleucovorin|mesh-list
102593518|NCT00448682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102593519|NCT00448682|Tubulin Modulators|tubulin modulators|mesh-ancestor
102593520|NCT00448682|Antimitotic Agents|antimitotic agents|mesh-ancestor
102593521|NCT00448682|Mitosis Modulators|mitosis modulators|mesh-ancestor
102593522|NCT00448682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593523|NCT00448682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593524|NCT00448682|Antidotes|antidotes|mesh-ancestor
102593525|NCT00448682|Protective Agents|protective agents|mesh-ancestor
102593526|NCT00448682|Vitamin B Complex|vitamin b complex|mesh-ancestor
102593527|NCT00448682|Vitamins|vitamins|mesh-ancestor
102593528|NCT00448682|Micronutrients|micronutrients|mesh-ancestor
102593529|NCT00448682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102593530|NCT00448682|Antimetabolites|antimetabolites|mesh-ancestor
102593531|NCT04713488|Vaccines|vaccines|mesh-list
102593532|NCT04713488|Immunologic Factors|immunologic factors|mesh-ancestor
102593533|NCT04713488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593534|NCT03675451|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102593535|NCT03675451|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102593536|NCT03675451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593537|NCT00380120|Warfarin|warfarin|mesh-list
102593538|NCT00380120|Anticoagulants|anticoagulants|mesh-ancestor
102593539|NCT00000770|Zidovudine|zidovudine|mesh-list
102593540|NCT00000770|Nevirapine|nevirapine|mesh-list
102593541|NCT00000770|Didanosine|didanosine|mesh-list
102593542|NCT00000770|Antimetabolites|antimetabolites|mesh-ancestor
102593543|NCT00000770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593544|NCT00000770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102593545|NCT00000770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102593546|NCT00000770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102593547|NCT00000770|Antiviral Agents|antiviral agents|mesh-ancestor
102593548|NCT00000770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102593549|NCT00000770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102593550|NCT00000770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102593551|NCT00000770|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102593552|NCT00000770|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102593553|NCT00368654|Methotrexate|methotrexate|mesh-list
102593554|NCT00368654|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102593555|NCT00368654|Abortifacient Agents|abortifacient agents|mesh-ancestor
102593556|NCT00368654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102593557|NCT00368654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593558|NCT00368654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102593559|NCT00368654|Antimetabolites|antimetabolites|mesh-ancestor
102593560|NCT00368654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593561|NCT00368654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102593562|NCT00368654|Dermatologic Agents|dermatologic agents|mesh-ancestor
102593563|NCT00368654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102593564|NCT00368654|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102593565|NCT00368654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102593566|NCT00368654|Immunologic Factors|immunologic factors|mesh-ancestor
102593567|NCT00368654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102593568|NCT00368654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102593569|NCT00000776|Fluconazole|fluconazole|mesh-list
102593570|NCT00000776|Amphotericin B|amphotericin b|mesh-list
102593571|NCT00000776|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102593572|NCT00000776|Flucytosine|flucytosine|mesh-list
102593573|NCT00000776|Dexamethasone|dexamethasone|mesh-list
102593574|NCT00000776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102593575|NCT00000776|Antiemetics|antiemetics|mesh-ancestor
102593576|NCT00000776|Autonomic Agents|autonomic agents|mesh-ancestor
102593577|NCT00000776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102593578|NCT00000776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593579|NCT00000776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102593580|NCT00000776|Glucocorticoids|glucocorticoids|mesh-ancestor
102593581|NCT00000776|Hormones|hormones|mesh-ancestor
102593582|NCT00000776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102593583|NCT00000776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102593584|NCT00000776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102593585|NCT00000776|Antifungal Agents|antifungal agents|mesh-ancestor
102593586|NCT00000776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102593587|NCT00000776|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102593588|NCT00000776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102593589|NCT00000776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102593590|NCT00000776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593591|NCT00000776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102593592|NCT00000776|Hormone Antagonists|hormone antagonists|mesh-ancestor
102593593|NCT00000776|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102593594|NCT00000776|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102593595|NCT00000776|Amebicides|amebicides|mesh-ancestor
102593596|NCT00000776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102593597|NCT00000776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102593598|NCT00000776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102593599|NCT00000776|Antimetabolites|antimetabolites|mesh-ancestor
102593600|NCT04283773|Antibodies|antibodies|mesh-list
102593601|NCT04283773|Immunoglobulins|immunoglobulins|mesh-list
102593602|NCT04283773|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102593603|NCT04283773|Immunologic Factors|immunologic factors|mesh-ancestor
102593604|NCT04283773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593605|NCT00329732|Lidocaine|lidocaine|mesh-list
102593606|NCT00329732|Bupivacaine|bupivacaine|mesh-list
102593607|NCT00329732|Anesthetics, Local|anesthetics, local|mesh-ancestor
102593608|NCT00329732|Anesthetics|anesthetics|mesh-ancestor
102593609|NCT00329732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102593610|NCT00329732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593611|NCT00329732|Sensory System Agents|sensory system agents|mesh-ancestor
102593612|NCT00329732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102593613|NCT00329732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102593614|NCT00329732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102593615|NCT00329732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102593616|NCT00329732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102593617|NCT00329732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593618|NCT00000782|Vaccines|vaccines|mesh-list
102593619|NCT00000782|Immunologic Factors|immunologic factors|mesh-ancestor
102593620|NCT00000782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593621|NCT00000800|Zidovudine|zidovudine|mesh-list
102593622|NCT00000800|Methadone|methadone|mesh-list
102593623|NCT00000800|Antimetabolites|antimetabolites|mesh-ancestor
102593624|NCT00000800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593625|NCT00000800|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102593626|NCT00000800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102593627|NCT00000800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102593628|NCT00000800|Antiviral Agents|antiviral agents|mesh-ancestor
102593629|NCT00000800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102593630|NCT00000800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102593631|NCT00000800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102593632|NCT00000800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102593633|NCT00000800|Narcotics|narcotics|mesh-ancestor
102593634|NCT00000800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102593635|NCT00000800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593637|NCT00000800|Sensory System Agents|sensory system agents|mesh-ancestor
102593638|NCT00000800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102593639|NCT00000800|Antitussive Agents|antitussive agents|mesh-ancestor
102593640|NCT00000800|Respiratory System Agents|respiratory system agents|mesh-ancestor
102593641|NCT03679975|Riluzole|riluzole|mesh-list
102593642|NCT03679975|Anticonvulsants|anticonvulsants|mesh-ancestor
102593643|NCT03679975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102593644|NCT03679975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102593645|NCT03679975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102593646|NCT03679975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593647|NCT03679975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593648|NCT03679975|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102593649|NCT03679975|Protective Agents|protective agents|mesh-ancestor
102593650|NCT03887299|Disinfectants|disinfectants|mesh-list
102593651|NCT03887299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102593652|NCT03684265|Meloxicam|meloxicam|mesh-list
102593653|NCT03684265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102593654|NCT03684265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102593655|NCT03684265|Analgesics|analgesics|mesh-ancestor
102593656|NCT03684265|Sensory System Agents|sensory system agents|mesh-ancestor
102593657|NCT03684265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102593658|NCT03684265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593659|NCT03684265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102593660|NCT03684265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102593661|NCT03684265|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102593662|NCT03684265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102593663|NCT03684265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102593664|NCT03684265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593665|NCT00218036|Dexetimide|dexetimide|mesh-list
102593666|NCT00218036|Modafinil|modafinil|mesh-list
102593667|NCT00218036|Citalopram|citalopram|mesh-list
102593668|NCT00218036|Escitalopram|escitalopram|mesh-list
102593669|NCT00218036|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102593670|NCT00218036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102593671|NCT00218036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102593672|NCT00218036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593673|NCT00218036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102593674|NCT00218036|Serotonin Agents|serotonin agents|mesh-ancestor
102593675|NCT00218036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593676|NCT00218036|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102593677|NCT00218036|Antidepressive Agents|antidepressive agents|mesh-ancestor
102593678|NCT00218036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102593679|NCT00218036|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102593680|NCT00218036|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102593681|NCT00218036|Parasympatholytics|parasympatholytics|mesh-ancestor
102593682|NCT00218036|Autonomic Agents|autonomic agents|mesh-ancestor
102593683|NCT00218036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102593684|NCT00218036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102593685|NCT00218036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102593686|NCT00218036|Cholinergic Agents|cholinergic agents|mesh-ancestor
102593687|NCT00218036|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102593688|NCT00218036|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102593689|NCT00218036|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102593690|NCT00218036|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102593691|NCT00233090|Modafinil|modafinil|mesh-list
102593692|NCT00233090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102593693|NCT00233090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593694|NCT00233090|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102593695|NCT00233090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102593696|NCT00233090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102593697|NCT00233090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593698|NCT02921906|Acetaminophen|acetaminophen|mesh-list
102593699|NCT02921906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102593700|NCT02921906|Analgesics|analgesics|mesh-ancestor
102593701|NCT02921906|Sensory System Agents|sensory system agents|mesh-ancestor
102593702|NCT02921906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102593703|NCT02921906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593704|NCT02921906|Antipyretics|antipyretics|mesh-ancestor
102593705|NCT00000812|Thalidomide|thalidomide|mesh-list
102593706|NCT00000812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102593708|NCT00000812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593709|NCT00000812|Leprostatic Agents|leprostatic agents|mesh-ancestor
102593710|NCT00000812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102593711|NCT00000812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102593712|NCT00000812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102593713|NCT00000812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102593714|NCT00000812|Growth Substances|growth substances|mesh-ancestor
102593715|NCT00000812|Growth Inhibitors|growth inhibitors|mesh-ancestor
102593716|NCT00000812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102593717|NCT00000818|Zidovudine|zidovudine|mesh-list
102593718|NCT00000818|Antimetabolites|antimetabolites|mesh-ancestor
102593719|NCT00000818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593720|NCT00000818|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102593721|NCT00000818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102593722|NCT00000818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102593723|NCT00000818|Antiviral Agents|antiviral agents|mesh-ancestor
102593724|NCT00000818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102593725|NCT00000818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102593726|NCT00000818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102593727|NCT00177866|Celecoxib|celecoxib|mesh-list
102593728|NCT00177866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102593729|NCT00177866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102593730|NCT00177866|Analgesics|analgesics|mesh-ancestor
102593731|NCT00177866|Sensory System Agents|sensory system agents|mesh-ancestor
102593732|NCT00177866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102593733|NCT00177866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593734|NCT00177866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102593735|NCT00177866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102593736|NCT00177866|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102593737|NCT00177866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102593738|NCT00177866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102593739|NCT00177866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593740|NCT00089414|Drospirenone|drospirenone|mesh-list
102593741|NCT00089414|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102593742|NCT00089414|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
102593743|NCT00089414|Estradiol|estradiol|mesh-list
102593744|NCT00089414|Progesterone|progesterone|mesh-list
102593745|NCT00089414|Estrogens|estrogens|mesh-ancestor
102593746|NCT00089414|Hormones|hormones|mesh-ancestor
102593747|NCT00089414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102593748|NCT00089414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593749|NCT00089414|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102593750|NCT00089414|Contraceptive Agents|contraceptive agents|mesh-ancestor
102593751|NCT00089414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102593752|NCT00089414|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102593753|NCT00089414|Progestins|progestins|mesh-ancestor
102593754|NCT00089414|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102593755|NCT00089414|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102593756|NCT00089414|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102593757|NCT00089414|Hormone Antagonists|hormone antagonists|mesh-ancestor
102593758|NCT00089414|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102593759|NCT00089414|Diuretics|diuretics|mesh-ancestor
102593760|NCT00089414|Natriuretic Agents|natriuretic agents|mesh-ancestor
102593761|NCT00075608|Melphalan|melphalan|mesh-list
102593762|NCT00075608|Immunologic Factors|immunologic factors|mesh-ancestor
102593763|NCT00075608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593764|NCT00075608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102593765|NCT00075608|Alkylating Agents|alkylating agents|mesh-ancestor
102593766|NCT00075608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593767|NCT00075608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102593768|NCT00075608|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102593769|NCT00075608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102593770|NCT03704467|Carboplatin|carboplatin|mesh-list
102593771|NCT03704467|Avelumab|avelumab|mesh-list
102593772|NCT03704467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102593773|NCT03704467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102593774|NCT00000842|Mitogens|mitogens|mesh-list
102593775|NCT00000842|Mitosis Modulators|mitosis modulators|mesh-ancestor
102593776|NCT00000842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593777|NCT02145260|Dialysis Solutions|dialysis solutions|mesh-list
102593778|NCT02145260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102593779|NCT00000848|Indinavir|indinavir|mesh-list
102593780|NCT00000848|Saquinavir|saquinavir|mesh-list
102593781|NCT00000848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102593782|NCT00000848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102593783|NCT00000848|Protease Inhibitors|protease inhibitors|mesh-ancestor
102593784|NCT00000848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102593785|NCT00000848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593786|NCT00000848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102593787|NCT00000848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102593788|NCT00000848|Antiviral Agents|antiviral agents|mesh-ancestor
102593789|NCT00000848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102593790|NCT00000848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102593791|NCT00000848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102593792|NCT01795586|Carboplatin|carboplatin|mesh-list
102593793|NCT01795586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102593794|NCT02212574|Cyclophosphamide|cyclophosphamide|mesh-list
102593795|NCT02212574|Lomustine|lomustine|mesh-list
102593796|NCT02212574|Vincristine|vincristine|mesh-list
102593797|NCT02212574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102593798|NCT02212574|Immunologic Factors|immunologic factors|mesh-ancestor
102593799|NCT02212574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593800|NCT02212574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102593801|NCT02212574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102593802|NCT02212574|Alkylating Agents|alkylating agents|mesh-ancestor
102593803|NCT02212574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593804|NCT02212574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102593805|NCT02212574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102593806|NCT02212574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102593807|NCT02212574|Tubulin Modulators|tubulin modulators|mesh-ancestor
102593808|NCT02212574|Antimitotic Agents|antimitotic agents|mesh-ancestor
102593809|NCT02212574|Mitosis Modulators|mitosis modulators|mesh-ancestor
102593810|NCT00000854|Nandrolone Decanoate|nandrolone decanoate|mesh-list
102593811|NCT00000854|Nandrolone|nandrolone|mesh-list
102593812|NCT00000854|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
102593813|NCT00000854|Androgens|androgens|mesh-ancestor
102593814|NCT00000854|Hormones|hormones|mesh-ancestor
102593815|NCT00000854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102593816|NCT00000854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593817|NCT00000854|Anabolic Agents|anabolic agents|mesh-ancestor
102593818|NCT00000854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102593819|NCT04298918|Trastuzumab|trastuzumab|mesh-list
102593820|NCT04298918|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102593821|NCT04298918|Venetoclax|venetoclax|mesh-list
102593822|NCT04298918|Maytansine|maytansine|mesh-list
102593823|NCT04298918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102593824|NCT04298918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102593825|NCT04298918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102593826|NCT04298918|Tubulin Modulators|tubulin modulators|mesh-ancestor
102593827|NCT04298918|Antimitotic Agents|antimitotic agents|mesh-ancestor
102593828|NCT04298918|Mitosis Modulators|mitosis modulators|mesh-ancestor
102593829|NCT04298918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593830|NCT04298918|Immunotoxins|immunotoxins|mesh-ancestor
102593831|NCT04298918|Immunoconjugates|immunoconjugates|mesh-ancestor
102593832|NCT04298918|Immunologic Factors|immunologic factors|mesh-ancestor
102593833|NCT04298918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593834|NCT00001676|Fludarabine|fludarabine|mesh-list
102593835|NCT00001676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102593836|NCT03714919|Acetaminophen|acetaminophen|mesh-list
102593837|NCT03714919|Dexmedetomidine|dexmedetomidine|mesh-list
102593838|NCT03714919|Ketamine|ketamine|mesh-list
102593839|NCT03714919|Dextromethorphan|dextromethorphan|mesh-list
102593840|NCT03714919|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102593841|NCT03714919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102593842|NCT03714919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593843|NCT03714919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102593844|NCT03714919|Analgesics|analgesics|mesh-ancestor
102593845|NCT03714919|Sensory System Agents|sensory system agents|mesh-ancestor
102593846|NCT03714919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102593847|NCT03714919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102593848|NCT03714919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102593849|NCT03714919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102593850|NCT03714919|Adrenergic Agents|adrenergic agents|mesh-ancestor
102593851|NCT03714919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102593852|NCT03714919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593853|NCT03714919|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102593854|NCT03714919|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102593855|NCT03714919|Anesthetics, General|anesthetics, general|mesh-ancestor
102593856|NCT03714919|Anesthetics|anesthetics|mesh-ancestor
102593857|NCT03714919|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102593858|NCT03714919|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102593859|NCT03714919|Antipyretics|antipyretics|mesh-ancestor
102593860|NCT03714919|Antitussive Agents|antitussive agents|mesh-ancestor
102593861|NCT03714919|Respiratory System Agents|respiratory system agents|mesh-ancestor
102593862|NCT00000872|Lamivudine|lamivudine|mesh-list
102593863|NCT00000872|Zidovudine|zidovudine|mesh-list
102593864|NCT00000872|Nevirapine|nevirapine|mesh-list
102593865|NCT00000872|Abacavir|abacavir|mesh-list
102593866|NCT00000872|Stavudine|stavudine|mesh-list
102593867|NCT00000872|Nelfinavir|nelfinavir|mesh-list
102593868|NCT00000872|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102593869|NCT00000872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102593870|NCT00000872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102593871|NCT00000872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593872|NCT00000872|Antiviral Agents|antiviral agents|mesh-ancestor
102593873|NCT00000872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102593874|NCT00000872|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102593875|NCT00000872|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102593876|NCT00000872|Antimetabolites|antimetabolites|mesh-ancestor
102593877|NCT00000872|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102593878|NCT00000872|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102593879|NCT00000872|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102593880|NCT00000872|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102593881|NCT00000872|Protease Inhibitors|protease inhibitors|mesh-ancestor
102593882|NCT00000878|Lamivudine|lamivudine|mesh-list
102593883|NCT00000878|Zidovudine|zidovudine|mesh-list
102593884|NCT00000878|Stavudine|stavudine|mesh-list
102593885|NCT00000878|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102593886|NCT00000878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102593887|NCT00000878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102593888|NCT00000878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593889|NCT00000878|Antiviral Agents|antiviral agents|mesh-ancestor
102593890|NCT00000878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102593891|NCT00000878|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102593892|NCT00000878|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102593893|NCT00000878|Antimetabolites|antimetabolites|mesh-ancestor
102593894|NCT04204057|Tenalisib|tenalisib|mesh-list
102593895|NCT04204057|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
102593896|NCT04204057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102593897|NCT04204057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593898|NCT00001736|Cysteamine|cysteamine|mesh-list
102593899|NCT00001736|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
102593900|NCT00001736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593901|NCT00000884|polysaccharide-K|polysaccharide-k|mesh-list
102593902|NCT00000884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102593903|NCT00000884|Immunologic Factors|immunologic factors|mesh-ancestor
102345607|NCT05582174|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102593904|NCT00000884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593905|NCT00000884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102593906|NCT00000884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102593907|NCT00000884|Antiviral Agents|antiviral agents|mesh-ancestor
102593908|NCT00000884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102593909|NCT00000884|Interferon Inducers|interferon inducers|mesh-ancestor
102593910|NCT00000884|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102593911|NCT00000884|Protective Agents|protective agents|mesh-ancestor
102593912|NCT00000896|Lamivudine|lamivudine|mesh-list
102593913|NCT00000896|Zidovudine|zidovudine|mesh-list
102593914|NCT00000896|Nevirapine|nevirapine|mesh-list
102593915|NCT00000896|Stavudine|stavudine|mesh-list
102593916|NCT00000896|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
102593917|NCT00000896|Indinavir|indinavir|mesh-list
102593918|NCT00000896|Interleukin-12|interleukin-12|mesh-list
102593919|NCT00000896|Sargramostim|sargramostim|mesh-list
102593920|NCT00000896|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102593921|NCT00000896|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102593922|NCT00000896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102593923|NCT00000896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593924|NCT00000896|Antiviral Agents|antiviral agents|mesh-ancestor
102593925|NCT00000896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102593926|NCT00000896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102593927|NCT00000896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102593928|NCT00000896|Antimetabolites|antimetabolites|mesh-ancestor
102593929|NCT00000896|Immunologic Factors|immunologic factors|mesh-ancestor
102593930|NCT00000896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593931|NCT00000896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102593932|NCT00000896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102593933|NCT00000896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102140842|NCT03601923|Niraparib|niraparib|mesh-list
102593934|NCT00000896|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102593935|NCT00000896|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102593936|NCT00000896|Protease Inhibitors|protease inhibitors|mesh-ancestor
102593937|NCT00000896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102593938|NCT00000896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102593939|NCT00000896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102593940|NCT00000896|Growth Substances|growth substances|mesh-ancestor
102593941|NCT00000896|Growth Inhibitors|growth inhibitors|mesh-ancestor
102593943|NCT00001790|Antifungal Agents|antifungal agents|mesh-ancestor
102593944|NCT00001790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102593945|NCT00000902|Ritonavir|ritonavir|mesh-list
102593946|NCT00000902|Nelfinavir|nelfinavir|mesh-list
102593947|NCT00000902|Lamivudine|lamivudine|mesh-list
102593948|NCT00000902|Zidovudine|zidovudine|mesh-list
102593949|NCT00000902|Nevirapine|nevirapine|mesh-list
102593950|NCT00000902|Stavudine|stavudine|mesh-list
102593951|NCT00000902|Didanosine|didanosine|mesh-list
102593952|NCT00000902|Zalcitabine|zalcitabine|mesh-list
102593953|NCT00000902|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102593954|NCT00000902|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102593955|NCT00000902|Protease Inhibitors|protease inhibitors|mesh-ancestor
102593956|NCT00000902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102593957|NCT00000902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593958|NCT00000902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102593959|NCT00000902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102593960|NCT00000902|Antiviral Agents|antiviral agents|mesh-ancestor
102593961|NCT00000902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102593962|NCT00000902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102593963|NCT00000902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102593964|NCT00000902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102593965|NCT00000902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102593966|NCT00000902|Antimetabolites|antimetabolites|mesh-ancestor
102593967|NCT00000902|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102593968|NCT00000902|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102593969|NCT04331600|Chloroquine|chloroquine|mesh-list
102593970|NCT04331600|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
102593971|NCT04331600|Amebicides|amebicides|mesh-ancestor
102593972|NCT04331600|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102593973|NCT04331600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102593974|NCT04331600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102593975|NCT04331600|Antimalarials|antimalarials|mesh-ancestor
102593976|NCT04331600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102593977|NCT04331600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102593978|NCT04331600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102593979|NCT04331600|Analgesics|analgesics|mesh-ancestor
102593980|NCT04331600|Sensory System Agents|sensory system agents|mesh-ancestor
102593981|NCT04331600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102593982|NCT04331600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593983|NCT04331600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102593984|NCT04331600|Filaricides|filaricides|mesh-ancestor
102593985|NCT04331600|Antinematodal Agents|antinematodal agents|mesh-ancestor
102593986|NCT04331600|Anthelmintics|anthelmintics|mesh-ancestor
102593987|NCT00000188|Selegiline|selegiline|mesh-list
102593988|NCT00000188|Antidepressive Agents|antidepressive agents|mesh-ancestor
102593989|NCT00000188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102593990|NCT00000188|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102593991|NCT00000188|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102593992|NCT00000188|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102593993|NCT00000188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102593994|NCT00000188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102593995|NCT00000188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102593996|NCT00000188|Protective Agents|protective agents|mesh-ancestor
102593997|NCT00000188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102593998|NCT00000914|Ritonavir|ritonavir|mesh-list
102593999|NCT00000914|Nelfinavir|nelfinavir|mesh-list
102594000|NCT00000914|Indinavir|indinavir|mesh-list
102594001|NCT00000914|Efavirenz|efavirenz|mesh-list
102594002|NCT00000914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102594003|NCT00000914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102594004|NCT00000914|Protease Inhibitors|protease inhibitors|mesh-ancestor
102594005|NCT00000914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102594006|NCT00000914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594007|NCT00000914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102594008|NCT00000914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102594009|NCT00000914|Antiviral Agents|antiviral agents|mesh-ancestor
102594010|NCT00000914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102594011|NCT00000914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102594012|NCT00000914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102594013|NCT00000914|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102594014|NCT00000914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102594015|NCT00000914|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102594016|NCT00000914|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102594017|NCT00000914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102594018|NCT00000914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102594019|NCT00000914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102594020|NCT00000920|Ritonavir|ritonavir|mesh-list
102594021|NCT00000920|Saquinavir|saquinavir|mesh-list
102594022|NCT00000920|Lamivudine|lamivudine|mesh-list
102594023|NCT00000920|Zidovudine|zidovudine|mesh-list
102594024|NCT00000920|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102594025|NCT00000920|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102594026|NCT00000920|Protease Inhibitors|protease inhibitors|mesh-ancestor
102594027|NCT00000920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102594028|NCT00000920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594029|NCT00000920|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102594030|NCT00000920|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102594031|NCT00000920|Antiviral Agents|antiviral agents|mesh-ancestor
102594032|NCT00000920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102594033|NCT00000920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102594034|NCT00000920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102594035|NCT00000920|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102594036|NCT00000920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102594037|NCT00000920|Antimetabolites|antimetabolites|mesh-ancestor
102594038|NCT00000938|Doxycycline|doxycycline|mesh-list
102594039|NCT00000938|Ceftriaxone|ceftriaxone|mesh-list
102594040|NCT00000938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102594041|NCT00000938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102594042|NCT00000938|Antimalarials|antimalarials|mesh-ancestor
102594043|NCT00000938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102594044|NCT00000938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102594045|NCT00001862|Etanercept|etanercept|mesh-list
102594046|NCT00001862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102594047|NCT00001862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102594048|NCT00001862|Analgesics|analgesics|mesh-ancestor
102594049|NCT00001862|Sensory System Agents|sensory system agents|mesh-ancestor
102594050|NCT00001862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102594051|NCT00001862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594052|NCT00001862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102594053|NCT00001862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102594054|NCT00001862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102594055|NCT00001862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102594056|NCT00001862|Immunologic Factors|immunologic factors|mesh-ancestor
102594057|NCT00000194|Cycloserine|cycloserine|mesh-list
102594058|NCT00000194|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102594059|NCT00000194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102594060|NCT00000194|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102594061|NCT00000194|Antitubercular Agents|antitubercular agents|mesh-ancestor
102594062|NCT00000194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102594063|NCT00000194|Antimetabolites|antimetabolites|mesh-ancestor
102594064|NCT00000194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594065|NCT00000200|Methadone|methadone|mesh-list
102594066|NCT00000200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102594067|NCT00000200|Narcotics|narcotics|mesh-ancestor
102594068|NCT00000200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102594069|NCT00000200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594070|NCT00000200|Analgesics|analgesics|mesh-ancestor
102594071|NCT00000200|Sensory System Agents|sensory system agents|mesh-ancestor
102594072|NCT00000200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102594073|NCT00000200|Antitussive Agents|antitussive agents|mesh-ancestor
102594074|NCT00000200|Respiratory System Agents|respiratory system agents|mesh-ancestor
102594075|NCT00000206|Buprenorphine|buprenorphine|mesh-list
102594076|NCT00000206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102594077|NCT00000206|Narcotics|narcotics|mesh-ancestor
102594078|NCT00000206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102594079|NCT00000206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594080|NCT00000206|Analgesics|analgesics|mesh-ancestor
102594081|NCT00000206|Sensory System Agents|sensory system agents|mesh-ancestor
102594082|NCT00000206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102594083|NCT00000206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102594084|NCT00000944|Lamivudine|lamivudine|mesh-list
102594085|NCT00000944|Zidovudine|zidovudine|mesh-list
102594086|NCT00000944|Indinavir|indinavir|mesh-list
102594087|NCT00000944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102594088|NCT00000944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102594089|NCT00000944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102594090|NCT00000944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594091|NCT00000944|Antiviral Agents|antiviral agents|mesh-ancestor
102594092|NCT00000944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102594093|NCT00000944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102594094|NCT00000944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102594095|NCT00000944|Antimetabolites|antimetabolites|mesh-ancestor
102594096|NCT00000944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102594097|NCT00000944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102594098|NCT00000944|Protease Inhibitors|protease inhibitors|mesh-ancestor
102594099|NCT00000950|Pyridoxine|pyridoxine|mesh-list
102594100|NCT00000950|Vitamin B 6|vitamin b 6|mesh-list
102594101|NCT00000950|Rifampin|rifampin|mesh-list
102594102|NCT00000950|Isoniazid|isoniazid|mesh-list
102594103|NCT00000950|Pyrazinamide|pyrazinamide|mesh-list
102594104|NCT00000950|Ethambutol|ethambutol|mesh-list
102594105|NCT00000950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102594106|NCT00000950|Antitubercular Agents|antitubercular agents|mesh-ancestor
102594107|NCT00000950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102594108|NCT00000950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102594109|NCT00000950|Leprostatic Agents|leprostatic agents|mesh-ancestor
102594110|NCT00000950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102594111|NCT00000950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102594112|NCT00000950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594113|NCT00000950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102594114|NCT00000950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102594115|NCT00000950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102594116|NCT00000950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102594117|NCT00000950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102594118|NCT00000950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102594119|NCT00000950|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102594120|NCT00000950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102594121|NCT00000950|Antimetabolites|antimetabolites|mesh-ancestor
102594122|NCT00000950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102054452|NCT05200429|Ivacaftor|ivacaftor|mesh-list
102594123|NCT00000950|Vitamin B Complex|vitamin b complex|mesh-ancestor
102594124|NCT00000950|Vitamins|vitamins|mesh-ancestor
102594125|NCT00000950|Micronutrients|micronutrients|mesh-ancestor
102594126|NCT00000950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594127|NCT00000218|Carbamazepine|carbamazepine|mesh-list
102594128|NCT00000218|Anticonvulsants|anticonvulsants|mesh-ancestor
102594129|NCT00000218|Antimanic Agents|antimanic agents|mesh-ancestor
102594130|NCT00000218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102594131|NCT00000218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102594132|NCT00000218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594133|NCT00000218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102594134|NCT00000218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102594135|NCT00000218|Analgesics|analgesics|mesh-ancestor
102594136|NCT00000218|Sensory System Agents|sensory system agents|mesh-ancestor
102594137|NCT00000218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102594138|NCT00000218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102594139|NCT00000218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102594140|NCT00000218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594141|NCT00000218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102594142|NCT00000218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102594143|NCT00000224|Buprenorphine|buprenorphine|mesh-list
102594144|NCT00000224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102594145|NCT00000224|Narcotics|narcotics|mesh-ancestor
102594146|NCT00000224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102594147|NCT00000224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594148|NCT00000224|Analgesics|analgesics|mesh-ancestor
102594149|NCT00000224|Sensory System Agents|sensory system agents|mesh-ancestor
102594150|NCT00000224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102594151|NCT00000224|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102594152|NCT04332991|Hydroxychloroquine|hydroxychloroquine|mesh-list
102594153|NCT04332991|Antimalarials|antimalarials|mesh-ancestor
102594154|NCT04332991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102594155|NCT04332991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102594156|NCT04332991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102594157|NCT04332991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102594158|NCT04332991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594159|NCT04332991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102594160|NCT00000230|Buprenorphine|buprenorphine|mesh-list
102594161|NCT00000230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102594162|NCT00000230|Narcotics|narcotics|mesh-ancestor
102594163|NCT00000230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102594164|NCT00000230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594165|NCT00000230|Analgesics|analgesics|mesh-ancestor
102594166|NCT00000230|Sensory System Agents|sensory system agents|mesh-ancestor
102594167|NCT00000230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102594168|NCT00000230|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102594169|NCT00000236|Buprenorphine|buprenorphine|mesh-list
102594170|NCT00000236|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102594171|NCT00000236|Naloxone|naloxone|mesh-list
102594172|NCT00000236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102594173|NCT00000236|Narcotics|narcotics|mesh-ancestor
102594174|NCT00000236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102594175|NCT00000236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594176|NCT00000236|Analgesics|analgesics|mesh-ancestor
102594177|NCT00000236|Sensory System Agents|sensory system agents|mesh-ancestor
102594178|NCT00000236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102594179|NCT00000236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102594180|NCT00000974|Pentamidine|pentamidine|mesh-list
102594181|NCT00000974|Antifungal Agents|antifungal agents|mesh-ancestor
102594182|NCT00000974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102594183|NCT00000974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102594184|NCT00000974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102594185|NCT00000974|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102594186|NCT00000242|Carbamazepine|carbamazepine|mesh-list
102594187|NCT00000242|Anticonvulsants|anticonvulsants|mesh-ancestor
102594188|NCT00000242|Antimanic Agents|antimanic agents|mesh-ancestor
102594189|NCT00000242|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102594190|NCT00000242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102594191|NCT00000242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594192|NCT00000242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102594193|NCT00000242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102594194|NCT00000242|Analgesics|analgesics|mesh-ancestor
102594195|NCT00000242|Sensory System Agents|sensory system agents|mesh-ancestor
102594196|NCT00000242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102594197|NCT00000242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102594198|NCT00000242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102594199|NCT00000242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594200|NCT00000242|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102594201|NCT00000242|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102594202|NCT00000980|Spiramycin|spiramycin|mesh-list
102594203|NCT00000980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102594204|NCT00000980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102594205|NCT00000980|Coccidiostats|coccidiostats|mesh-ancestor
102594206|NCT00000980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102594207|NCT00000980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102594208|NCT00000992|Itraconazole|itraconazole|mesh-list
102594209|NCT00000992|Antifungal Agents|antifungal agents|mesh-ancestor
102594210|NCT00000992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102594211|NCT00000992|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102594212|NCT00000992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102594213|NCT00000992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102594214|NCT00000992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594215|NCT00000992|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102594216|NCT00000992|Hormone Antagonists|hormone antagonists|mesh-ancestor
102594217|NCT00000992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102594218|NCT00000992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594219|NCT00000992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102594220|NCT00000254|Nitrous Oxide|nitrous oxide|mesh-list
102594221|NCT00000254|Isoflurane|isoflurane|mesh-list
102594222|NCT00000254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102594223|NCT00000254|Anesthetics, General|anesthetics, general|mesh-ancestor
102594224|NCT00000254|Anesthetics|anesthetics|mesh-ancestor
102594225|NCT00000254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102594226|NCT00000254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594227|NCT00000254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102594228|NCT00000254|Analgesics|analgesics|mesh-ancestor
102594229|NCT00000254|Sensory System Agents|sensory system agents|mesh-ancestor
102594230|NCT00000254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102594231|NCT00000260|Nitrous Oxide|nitrous oxide|mesh-list
102594232|NCT00000260|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102594233|NCT00000260|Anesthetics, General|anesthetics, general|mesh-ancestor
102594234|NCT00000260|Anesthetics|anesthetics|mesh-ancestor
102594235|NCT00000260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102594236|NCT00000260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594237|NCT00000260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102594238|NCT00000260|Analgesics|analgesics|mesh-ancestor
102594239|NCT00000260|Sensory System Agents|sensory system agents|mesh-ancestor
102594240|NCT00000260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102594241|NCT00000266|Flupenthixol|flupenthixol|mesh-list
102594242|NCT00000266|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
102594243|NCT00000266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102594244|NCT00000266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102594245|NCT00000266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102594246|NCT00000266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594247|NCT00000266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102594248|NCT00000266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102594249|NCT00000266|Dopamine Agents|dopamine agents|mesh-ancestor
102594250|NCT00000266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102594251|NCT00000266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594252|NCT00001016|Leucovorin|leucovorin|mesh-list
102594253|NCT00001016|Trimetrexate|trimetrexate|mesh-list
102594254|NCT00001016|Calcium|calcium|mesh-list
102594255|NCT00001016|Levoleucovorin|levoleucovorin|mesh-list
102594256|NCT00001016|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102594257|NCT00001016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594258|NCT00001016|Antidotes|antidotes|mesh-ancestor
102594259|NCT00001016|Protective Agents|protective agents|mesh-ancestor
102594260|NCT00001016|Vitamin B Complex|vitamin b complex|mesh-ancestor
102594261|NCT00001016|Vitamins|vitamins|mesh-ancestor
102594262|NCT00001016|Micronutrients|micronutrients|mesh-ancestor
102594263|NCT00001016|Antifungal Agents|antifungal agents|mesh-ancestor
102594264|NCT00001016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102594265|NCT00001016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102594266|NCT00001016|Antimetabolites|antimetabolites|mesh-ancestor
102594267|NCT00001016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594268|NCT00001016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102594269|NCT00001016|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102594270|NCT00001016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102594271|NCT03811951|Insulin|insulin|mesh-list
102594272|NCT03811951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102594273|NCT03811951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594274|NCT04332289|Deuterium Oxide|deuterium oxide|mesh-list
102594275|NCT04332289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102594276|NCT04332289|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102594277|NCT04332289|Protective Agents|protective agents|mesh-ancestor
102594278|NCT04332289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594279|NCT00001022|Zidovudine|zidovudine|mesh-list
102594280|NCT00001022|Didanosine|didanosine|mesh-list
102594281|NCT00001022|Zalcitabine|zalcitabine|mesh-list
102594282|NCT00001022|Antimetabolites|antimetabolites|mesh-ancestor
102594283|NCT00001022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594284|NCT00001022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102594285|NCT00001022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102594286|NCT00001022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102594287|NCT00001022|Antiviral Agents|antiviral agents|mesh-ancestor
102594288|NCT00001022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102594289|NCT00001022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102594290|NCT00001022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102594291|NCT05218148|Oxaliplatin|oxaliplatin|mesh-list
102594292|NCT05218148|Trastuzumab|trastuzumab|mesh-list
102594293|NCT05218148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102594294|NCT05218148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102594295|NCT00001934|Daclizumab|daclizumab|mesh-list
102594296|NCT00001934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102594297|NCT00001934|Immunologic Factors|immunologic factors|mesh-ancestor
102594298|NCT00001934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594299|NCT00000278|Disulfiram|disulfiram|mesh-list
102594300|NCT00000278|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102594301|NCT00000278|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
102594302|NCT00000278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102594303|NCT00000278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594304|NCT00001028|Dapsone|dapsone|mesh-list
102594305|NCT00001028|Pentamidine|pentamidine|mesh-list
102594306|NCT00001028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102594307|NCT00001028|Antimalarials|antimalarials|mesh-ancestor
102594308|NCT00001028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102594309|NCT00001028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102594310|NCT00001028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102594311|NCT00001028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102594312|NCT00001028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594313|NCT00001028|Leprostatic Agents|leprostatic agents|mesh-ancestor
102594314|NCT00001028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102594315|NCT00001028|Antifungal Agents|antifungal agents|mesh-ancestor
102594316|NCT00001028|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102594317|NCT00001940|Voriconazole|voriconazole|mesh-list
102594318|NCT00001940|Antifungal Agents|antifungal agents|mesh-ancestor
102594319|NCT00001940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102594320|NCT00001940|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102594321|NCT00001940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102594322|NCT00001940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102594323|NCT00001940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594324|NCT00001940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102594325|NCT00001940|Hormone Antagonists|hormone antagonists|mesh-ancestor
102594326|NCT00001940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102594327|NCT00001940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594328|NCT00001940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102594329|NCT03907033|Bupivacaine|bupivacaine|mesh-list
102594330|NCT03907033|Anesthetics, Local|anesthetics, local|mesh-ancestor
102594331|NCT03907033|Anesthetics|anesthetics|mesh-ancestor
102594332|NCT03907033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102594333|NCT03907033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594334|NCT03907033|Sensory System Agents|sensory system agents|mesh-ancestor
102594335|NCT03907033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102594336|NCT00001034|Ganciclovir|ganciclovir|mesh-list
102594337|NCT00001034|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102594338|NCT00001034|Antiviral Agents|antiviral agents|mesh-ancestor
102594339|NCT00001034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102594340|NCT00001034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102594341|NCT00001034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102594342|NCT00001034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594343|NCT03818815|Amoxicillin|amoxicillin|mesh-list
102594344|NCT03818815|Clavulanic Acid|clavulanic acid|mesh-list
102594345|NCT03818815|Clavulanic Acids|clavulanic acids|mesh-list
102594346|NCT03818815|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102594347|NCT03818815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102594348|NCT03818815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102594349|NCT03818815|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102594350|NCT03818815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102594351|NCT03818815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594352|NCT00001958|Hydroxyurea|hydroxyurea|mesh-list
102594353|NCT00001958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102594354|NCT00001958|Antisickling Agents|antisickling agents|mesh-ancestor
102594355|NCT00001958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102594356|NCT00001958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594357|NCT00001958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102594358|NCT00001964|Cyclosporine|cyclosporine|mesh-list
102594359|NCT00001964|Cyclosporins|cyclosporins|mesh-list
102594360|NCT00001964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102594361|NCT00001964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594362|NCT00001964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102594363|NCT00001964|Immunologic Factors|immunologic factors|mesh-ancestor
102594364|NCT00001964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594365|NCT00001964|Antifungal Agents|antifungal agents|mesh-ancestor
102594366|NCT00001964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102594367|NCT00001964|Dermatologic Agents|dermatologic agents|mesh-ancestor
102594368|NCT00001964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102594369|NCT00001964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102594370|NCT03801265|Ropivacaine|ropivacaine|mesh-list
102594371|NCT03801265|Anesthetics, Local|anesthetics, local|mesh-ancestor
102594372|NCT03801265|Anesthetics|anesthetics|mesh-ancestor
102594373|NCT03801265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102594374|NCT03801265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594375|NCT03801265|Sensory System Agents|sensory system agents|mesh-ancestor
102594376|NCT03801265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102594377|NCT00000290|Cocaine|cocaine|mesh-list
102594378|NCT00000290|Anesthetics, Local|anesthetics, local|mesh-ancestor
102594379|NCT00000290|Anesthetics|anesthetics|mesh-ancestor
102594380|NCT00000290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102594381|NCT00000290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594382|NCT00000290|Sensory System Agents|sensory system agents|mesh-ancestor
102594383|NCT00000290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102594384|NCT00000290|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102594385|NCT00000290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102594386|NCT00000290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102594387|NCT00000290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102594388|NCT00000290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594389|NCT00000290|Dopamine Agents|dopamine agents|mesh-ancestor
102594390|NCT00000290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102594391|NCT00000212|Desipramine|desipramine|mesh-list
102594392|NCT00000212|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102594393|NCT00000212|Antidepressive Agents|antidepressive agents|mesh-ancestor
102594394|NCT00000212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102594395|NCT00000212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102594396|NCT00000212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594397|NCT00000212|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102594398|NCT00000212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102594399|NCT00000212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102594400|NCT00000212|Adrenergic Agents|adrenergic agents|mesh-ancestor
102594401|NCT00000212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102594402|NCT00000212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594403|NCT00000302|Buprenorphine|buprenorphine|mesh-list
102594404|NCT00000302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102594405|NCT00000302|Narcotics|narcotics|mesh-ancestor
102594406|NCT00000302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102594407|NCT00000302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594408|NCT00000302|Analgesics|analgesics|mesh-ancestor
102594409|NCT00000302|Sensory System Agents|sensory system agents|mesh-ancestor
102594410|NCT00000302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102594411|NCT00000302|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102594412|NCT00001052|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102594413|NCT00001052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102594414|NCT00001052|Immunologic Factors|immunologic factors|mesh-ancestor
102594415|NCT00001052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594416|NCT00001052|Antacids|antacids|mesh-ancestor
102594417|NCT00001052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594418|NCT00001052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102594419|NCT00001058|Ritonavir|ritonavir|mesh-list
102594420|NCT00001058|Indinavir|indinavir|mesh-list
102594421|NCT00001058|Clarithromycin|clarithromycin|mesh-list
102594422|NCT00001058|Ethambutol|ethambutol|mesh-list
102594423|NCT00001058|Rifabutin|rifabutin|mesh-list
102594424|NCT00001058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102594425|NCT00001058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102594426|NCT00001058|Protease Inhibitors|protease inhibitors|mesh-ancestor
102594427|NCT00001058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102594428|NCT00001058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594429|NCT00001058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102594430|NCT00001058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102594431|NCT00001058|Antiviral Agents|antiviral agents|mesh-ancestor
102594432|NCT00001058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102594433|NCT00001058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102594434|NCT00001058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102594435|NCT00001058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102594436|NCT00001058|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102594437|NCT00001058|Antitubercular Agents|antitubercular agents|mesh-ancestor
102594438|NCT00001058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102594439|NCT00000308|Amphetamine|amphetamine|mesh-list
102594440|NCT00000308|Dextroamphetamine|dextroamphetamine|mesh-list
102594441|NCT00000308|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102594442|NCT00000308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594443|NCT00000308|Sympathomimetics|sympathomimetics|mesh-ancestor
102594444|NCT00000308|Autonomic Agents|autonomic agents|mesh-ancestor
102594445|NCT00000308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102594446|NCT00000308|Dopamine Agents|dopamine agents|mesh-ancestor
102594447|NCT00000308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102594448|NCT00000308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594449|NCT00000308|Adrenergic Agents|adrenergic agents|mesh-ancestor
102594450|NCT00000308|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102594451|NCT00000308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102594452|NCT00000308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102594453|NCT00000308|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102594454|NCT00001994|Atovaquone|atovaquone|mesh-list
102594455|NCT00001994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102594456|NCT00001994|Antimalarials|antimalarials|mesh-ancestor
102594457|NCT00001994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102594458|NCT00001994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102594459|NCT00001994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102594460|NCT00001994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594461|NCT00000320|Buprenorphine|buprenorphine|mesh-list
102594462|NCT00000320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102594463|NCT00000320|Narcotics|narcotics|mesh-ancestor
102594464|NCT00000320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102594465|NCT00000320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594466|NCT00000320|Analgesics|analgesics|mesh-ancestor
102594467|NCT00000320|Sensory System Agents|sensory system agents|mesh-ancestor
102594468|NCT00000320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102594469|NCT00000320|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102594470|NCT00000326|Heroin|heroin|mesh-list
102594471|NCT00000326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102594472|NCT00000326|Narcotics|narcotics|mesh-ancestor
102594473|NCT00000326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102594474|NCT00000326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594475|NCT00000326|Analgesics|analgesics|mesh-ancestor
102594476|NCT00000326|Sensory System Agents|sensory system agents|mesh-ancestor
102594477|NCT00000326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102594478|NCT03978403|Zolmitriptan|zolmitriptan|mesh-list
102594479|NCT03978403|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102594480|NCT03978403|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102594481|NCT03978403|Serotonin Agents|serotonin agents|mesh-ancestor
102594482|NCT03978403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102594483|NCT03978403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594484|NCT03978403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594485|NCT00002000|Valacyclovir|valacyclovir|mesh-list
102594486|NCT00002000|Acyclovir|acyclovir|mesh-list
102594487|NCT00002000|Antiviral Agents|antiviral agents|mesh-ancestor
102594488|NCT00002000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102594489|NCT03979807|Bromides|bromides|mesh-list
102594490|NCT03979807|Tiotropium Bromide|tiotropium bromide|mesh-list
102594491|NCT03979807|Olodaterol|olodaterol|mesh-list
102594492|NCT03979807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102594493|NCT03979807|Autonomic Agents|autonomic agents|mesh-ancestor
102594494|NCT03979807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102594495|NCT03979807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594496|NCT03979807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102594497|NCT03979807|Respiratory System Agents|respiratory system agents|mesh-ancestor
102594498|NCT03979807|Parasympatholytics|parasympatholytics|mesh-ancestor
102594499|NCT03979807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102594500|NCT03979807|Cholinergic Agents|cholinergic agents|mesh-ancestor
102594501|NCT03979807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102594502|NCT03979807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594503|NCT03979807|Anticonvulsants|anticonvulsants|mesh-ancestor
102594504|NCT00001082|Adefovir|adefovir|mesh-list
102594505|NCT00001082|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
102594506|NCT00001082|Antiviral Agents|antiviral agents|mesh-ancestor
102594507|NCT00001082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102594508|NCT00001082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102594509|NCT00001082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102594510|NCT00001082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102594511|NCT00001082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594512|NCT00002006|Zidovudine|zidovudine|mesh-list
102594513|NCT00002006|Sargramostim|sargramostim|mesh-list
102594514|NCT00002006|Antimetabolites|antimetabolites|mesh-ancestor
102594515|NCT00002006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594516|NCT00002006|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102594517|NCT00002006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102594518|NCT00002006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102594519|NCT00002006|Antiviral Agents|antiviral agents|mesh-ancestor
102594520|NCT00002006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102594521|NCT00002006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102594522|NCT00002006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102594523|NCT00002006|Immunologic Factors|immunologic factors|mesh-ancestor
102594524|NCT00002006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594525|NCT04169113|Opiate Alkaloids|opiate alkaloids|mesh-list
102594526|NCT04169113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102594527|NCT04169113|Narcotics|narcotics|mesh-ancestor
102594528|NCT04169113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102594529|NCT04169113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594530|NCT04169113|Analgesics|analgesics|mesh-ancestor
102594531|NCT04169113|Sensory System Agents|sensory system agents|mesh-ancestor
102594532|NCT04169113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102594533|NCT00002012|Interferons|interferons|mesh-list
102594534|NCT00002012|Interferon-alpha|interferon-alpha|mesh-list
102594535|NCT00002012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102594536|NCT00002012|Antiviral Agents|antiviral agents|mesh-ancestor
102594537|NCT00002012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102594538|NCT00002012|Immunologic Factors|immunologic factors|mesh-ancestor
102594539|NCT00002012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594540|NCT00380276|Tarenflurbil|tarenflurbil|mesh-list
102594541|NCT00380276|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
102594542|NCT00380276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102594543|NCT00380276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594544|NCT00380354|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
102594545|NCT00380354|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102594546|NCT00380354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102594547|NCT00380354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102594548|NCT00380354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594549|NCT03799783|Dexmedetomidine|dexmedetomidine|mesh-list
102594550|NCT03799783|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102594551|NCT03799783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102594552|NCT03799783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594553|NCT03799783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102594554|NCT03799783|Analgesics|analgesics|mesh-ancestor
102594555|NCT03799783|Sensory System Agents|sensory system agents|mesh-ancestor
102594556|NCT03799783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102594557|NCT03799783|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102594558|NCT03799783|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102594559|NCT03799783|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102594560|NCT03799783|Adrenergic Agents|adrenergic agents|mesh-ancestor
102594561|NCT03799783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102594562|NCT03799783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594563|NCT00001088|Bupivacaine|bupivacaine|mesh-list
102594564|NCT00001088|Anesthetics, Local|anesthetics, local|mesh-ancestor
102594565|NCT00001088|Anesthetics|anesthetics|mesh-ancestor
102594566|NCT00001088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102594567|NCT00001088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594568|NCT00001088|Sensory System Agents|sensory system agents|mesh-ancestor
102594569|NCT00001088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102594570|NCT00001094|Lamivudine|lamivudine|mesh-list
102594571|NCT00001094|Zidovudine|zidovudine|mesh-list
102594572|NCT00001094|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
102594573|NCT00001094|Delavirdine|delavirdine|mesh-list
102594574|NCT00001094|Nelfinavir|nelfinavir|mesh-list
102594575|NCT00001094|Saquinavir|saquinavir|mesh-list
102594576|NCT00001094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102594577|NCT00001094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102594578|NCT00001094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102594579|NCT00001094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594580|NCT00001094|Antiviral Agents|antiviral agents|mesh-ancestor
102594581|NCT00001094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102594582|NCT00001094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102594583|NCT00001094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102594584|NCT00001094|Antimetabolites|antimetabolites|mesh-ancestor
102594585|NCT00001094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102594586|NCT00001094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102594587|NCT00001094|Protease Inhibitors|protease inhibitors|mesh-ancestor
102594588|NCT00001094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102594589|NCT00001094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102594590|NCT00001100|Ganciclovir|ganciclovir|mesh-list
102594591|NCT00001100|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102594592|NCT00001100|Antiviral Agents|antiviral agents|mesh-ancestor
102594593|NCT00001100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102594594|NCT00001100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102594595|NCT00001100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102594596|NCT00001100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594597|NCT00000332|Nimodipine|nimodipine|mesh-list
102594598|NCT00000332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102594599|NCT00000332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102594600|NCT00000332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102594601|NCT00000332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594602|NCT00000332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102594603|NCT00000332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594604|NCT00000332|Vasodilator Agents|vasodilator agents|mesh-ancestor
102594605|NCT00000338|Lisuride|lisuride|mesh-list
102594606|NCT00000338|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102594607|NCT00000338|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102594608|NCT00000338|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102594609|NCT00000338|Serotonin Agents|serotonin agents|mesh-ancestor
102594610|NCT00000338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102594611|NCT00000338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594612|NCT00000338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141545|NCT00070564|Tubulin Modulators|tubulin modulators|mesh-ancestor
102594613|NCT00000338|Dopamine Agonists|dopamine agonists|mesh-ancestor
102594614|NCT00000338|Dopamine Agents|dopamine agents|mesh-ancestor
102594615|NCT04085341|Sunitinib|sunitinib|mesh-list
102594616|NCT04085341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102594617|NCT04085341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102594618|NCT04085341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102594619|NCT04085341|Growth Substances|growth substances|mesh-ancestor
102594620|NCT04085341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594621|NCT04085341|Growth Inhibitors|growth inhibitors|mesh-ancestor
102594622|NCT04085341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102594623|NCT04085341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102594624|NCT04085341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594625|NCT00002018|Interferons|interferons|mesh-list
102594626|NCT00002018|Interferon-alpha|interferon-alpha|mesh-list
101861450|NCT00276744|Mitomycin|mitomycin|mesh-list
102594627|NCT00002018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102594628|NCT00002018|Antiviral Agents|antiviral agents|mesh-ancestor
102594629|NCT00002018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102594630|NCT00002018|Immunologic Factors|immunologic factors|mesh-ancestor
102594631|NCT00002018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594632|NCT00002024|Ganciclovir|ganciclovir|mesh-list
102594633|NCT00002024|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102594634|NCT00002024|Antiviral Agents|antiviral agents|mesh-ancestor
102594635|NCT00002024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102594636|NCT00002024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102594637|NCT00002024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102594638|NCT00002024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594639|NCT00001106|Zidovudine|zidovudine|mesh-list
102594640|NCT00001106|Antimetabolites|antimetabolites|mesh-ancestor
102594641|NCT00001106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594642|NCT00001106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102594643|NCT00001106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102594644|NCT00001106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102594645|NCT00001106|Antiviral Agents|antiviral agents|mesh-ancestor
102594646|NCT00001106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102594647|NCT00001106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102594648|NCT00001106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102594649|NCT00000344|Buprenorphine|buprenorphine|mesh-list
102594650|NCT00000344|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102594651|NCT00000344|Naloxone|naloxone|mesh-list
102594652|NCT00000344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102594653|NCT00000344|Narcotics|narcotics|mesh-ancestor
102594654|NCT00000344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102594655|NCT00000344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594656|NCT00000344|Analgesics|analgesics|mesh-ancestor
102594657|NCT00000344|Sensory System Agents|sensory system agents|mesh-ancestor
102594658|NCT00000344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102594659|NCT00000344|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102594660|NCT04103515|Cimetidine|cimetidine|mesh-list
102594661|NCT04103515|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102594662|NCT04103515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102594663|NCT04103515|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102594664|NCT04103515|Histamine Antagonists|histamine antagonists|mesh-ancestor
102594665|NCT04103515|Histamine Agents|histamine agents|mesh-ancestor
102594666|NCT04103515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102594667|NCT04103515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594668|NCT04103515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594669|NCT04103515|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102594670|NCT04103515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102594671|NCT04103515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102594672|NCT00002030|Pentamidine|pentamidine|mesh-list
102594673|NCT00002030|Antifungal Agents|antifungal agents|mesh-ancestor
102594674|NCT00002030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102594675|NCT00002030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102594676|NCT00002030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102594677|NCT00002030|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102594678|NCT00001112|Interferons|interferons|mesh-list
102594679|NCT00001112|Zidovudine|zidovudine|mesh-list
102594680|NCT00001112|Interferon-gamma|interferon-gamma|mesh-list
102594681|NCT00001112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102594682|NCT00001112|Antiviral Agents|antiviral agents|mesh-ancestor
102594683|NCT00001112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102594684|NCT00001112|Antimetabolites|antimetabolites|mesh-ancestor
102594685|NCT00001112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594686|NCT00001112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102141618|NCT02993731|Antimetabolites|antimetabolites|mesh-ancestor
102594687|NCT00001112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102594688|NCT00001112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102594689|NCT00001112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102594690|NCT00001112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102594691|NCT00002036|Immune Sera|immune sera|mesh-list
102594692|NCT00002036|Immunologic Factors|immunologic factors|mesh-ancestor
102594693|NCT00002036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594694|NCT03782701|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102594695|NCT03782701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102594696|NCT03782701|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102594697|NCT03782701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102594698|NCT03782701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102594699|NCT03782701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102594700|NCT03782701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102594701|NCT03782701|Adrenergic Agents|adrenergic agents|mesh-ancestor
102594702|NCT03782701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102594703|NCT03782701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594704|NCT03782701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594705|NCT00000374|Olanzapine|olanzapine|mesh-list
102594706|NCT00000374|Risperidone|risperidone|mesh-list
102594707|NCT00000374|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102594708|NCT00000374|Serotonin Agents|serotonin agents|mesh-ancestor
102594709|NCT00000374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102594710|NCT00000374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594711|NCT00000374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594712|NCT00000374|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102594713|NCT00000374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102594714|NCT00000374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102594715|NCT00000374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102594716|NCT00000374|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102594717|NCT00000374|Dopamine Agents|dopamine agents|mesh-ancestor
102594718|NCT00000374|Antiemetics|antiemetics|mesh-ancestor
102594719|NCT00000374|Autonomic Agents|autonomic agents|mesh-ancestor
102594720|NCT00000374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102594721|NCT00000374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102594722|NCT00000374|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102594723|NCT00000374|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102594724|NCT00000374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102594725|NCT00002042|Epoetin Alfa|epoetin alfa|mesh-list
102594726|NCT00002042|Hematinics|hematinics|mesh-ancestor
102594727|NCT03789175|Niacinamide|niacinamide|mesh-list
102594728|NCT03789175|Niacin|niacin|mesh-list
102594729|NCT03789175|Nicotinic Acids|nicotinic acids|mesh-list
102594730|NCT03789175|Vitamin B Complex|vitamin b complex|mesh-ancestor
102594731|NCT03789175|Vitamins|vitamins|mesh-ancestor
102594732|NCT03789175|Micronutrients|micronutrients|mesh-ancestor
102594733|NCT03789175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594734|NCT03789175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102594735|NCT03789175|Antimetabolites|antimetabolites|mesh-ancestor
102594736|NCT03789175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594737|NCT03789175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102594738|NCT03789175|Vasodilator Agents|vasodilator agents|mesh-ancestor
102594739|NCT00002048|Zidovudine|zidovudine|mesh-list
102594740|NCT00002048|Antimetabolites|antimetabolites|mesh-ancestor
102594741|NCT00002048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594742|NCT00002048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102594743|NCT00002048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102594744|NCT00002048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102594745|NCT00002048|Antiviral Agents|antiviral agents|mesh-ancestor
102594746|NCT00002048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102594747|NCT00002048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102594748|NCT00002048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102594749|NCT00002054|Pentamidine|pentamidine|mesh-list
102594750|NCT00002054|Antifungal Agents|antifungal agents|mesh-ancestor
102594751|NCT00002054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102594752|NCT00002054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102594753|NCT00002054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102594754|NCT00002054|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102594755|NCT00002060|Inosine Pranobex|inosine pranobex|mesh-list
102594756|NCT00002060|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102594757|NCT00002060|Immunologic Factors|immunologic factors|mesh-ancestor
102594758|NCT00002060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594759|NCT00002060|Antiviral Agents|antiviral agents|mesh-ancestor
102594760|NCT00002060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102594761|NCT00002066|Thymopentin|thymopentin|mesh-list
102594762|NCT00002066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102594763|NCT00002066|Immunologic Factors|immunologic factors|mesh-ancestor
102594764|NCT00002066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594765|NCT00002072|Epoetin Alfa|epoetin alfa|mesh-list
102594766|NCT00002072|Hematinics|hematinics|mesh-ancestor
102594767|NCT00002078|Interferons|interferons|mesh-list
102594768|NCT00002078|Interferon-alpha|interferon-alpha|mesh-list
102594769|NCT00002078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102594770|NCT00002078|Antiviral Agents|antiviral agents|mesh-ancestor
102594771|NCT00002078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102594772|NCT00002078|Immunologic Factors|immunologic factors|mesh-ancestor
102594773|NCT00002078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594774|NCT00000440|Naltrexone|naltrexone|mesh-list
102594775|NCT00000440|Sertraline|sertraline|mesh-list
102594776|NCT00000440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102594777|NCT00000440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102594778|NCT00000440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594779|NCT00000440|Sensory System Agents|sensory system agents|mesh-ancestor
102594780|NCT00000440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102594781|NCT00000440|Antidepressive Agents|antidepressive agents|mesh-ancestor
102594782|NCT00000440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102594783|NCT00000440|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102594784|NCT00000440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102594785|NCT00000440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102594786|NCT00000440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594787|NCT00000440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102594788|NCT00000440|Serotonin Agents|serotonin agents|mesh-ancestor
102594789|NCT00002084|Valacyclovir|valacyclovir|mesh-list
102594790|NCT00002084|Acyclovir|acyclovir|mesh-list
102594791|NCT00002084|Antiviral Agents|antiviral agents|mesh-ancestor
102594792|NCT00002084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102594793|NCT00000446|Sertraline|sertraline|mesh-list
102594794|NCT00000446|Antidepressive Agents|antidepressive agents|mesh-ancestor
102594795|NCT00000446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102594796|NCT00000446|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102594797|NCT00000446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102594798|NCT00000446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102594799|NCT00000446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594800|NCT00000446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102594801|NCT00000446|Serotonin Agents|serotonin agents|mesh-ancestor
102594802|NCT00000446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594803|NCT04131517|Padsevonil|padsevonil|mesh-list
102594804|NCT04131517|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
102594805|NCT04131517|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
102594806|NCT04131517|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102594807|NCT04131517|Contraceptive Agents|contraceptive agents|mesh-ancestor
102594808|NCT04131517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102594809|NCT04131517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594810|NCT04131517|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102594811|NCT04131517|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102594812|NCT04131517|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102594813|NCT04131517|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102594814|NCT04131517|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102594815|NCT04131517|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
102594816|NCT04131517|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102594817|NCT04131517|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102594818|NCT04131517|Anticonvulsants|anticonvulsants|mesh-ancestor
102594819|NCT00001256|Prednisone|prednisone|mesh-list
102594820|NCT00001256|Methotrexate|methotrexate|mesh-list
102594821|NCT00001256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102594822|NCT00001256|Glucocorticoids|glucocorticoids|mesh-ancestor
102594823|NCT00001256|Hormones|hormones|mesh-ancestor
102594824|NCT00001256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102594825|NCT00001256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594826|NCT00001256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102594827|NCT00001256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102594828|NCT00001256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102594829|NCT00001256|Abortifacient Agents|abortifacient agents|mesh-ancestor
102594830|NCT00001256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102594831|NCT00001256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102594832|NCT00001256|Antimetabolites|antimetabolites|mesh-ancestor
102594833|NCT00001256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594834|NCT00001256|Dermatologic Agents|dermatologic agents|mesh-ancestor
102594835|NCT00001256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102594836|NCT00001256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102594837|NCT00001256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102594838|NCT00001256|Immunologic Factors|immunologic factors|mesh-ancestor
102594839|NCT00001256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102594840|NCT00001256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102594842|NCT00000452|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102594843|NCT00000452|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102594844|NCT00000452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594845|NCT00000452|Sensory System Agents|sensory system agents|mesh-ancestor
102594846|NCT00000452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102594847|NCT00000458|Sertraline|sertraline|mesh-list
102594848|NCT00000458|Antidepressive Agents|antidepressive agents|mesh-ancestor
102594849|NCT00000458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102594850|NCT00000458|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102594851|NCT00000458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102594852|NCT00000458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102594853|NCT00000458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594854|NCT00000458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102594855|NCT00000458|Serotonin Agents|serotonin agents|mesh-ancestor
102594856|NCT00000458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594857|NCT03782233|Bromides|bromides|mesh-list
102594858|NCT03782233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102594859|NCT03782233|Rocuronium|rocuronium|mesh-list
102594860|NCT03782233|Anticonvulsants|anticonvulsants|mesh-ancestor
102594861|NCT03782233|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102594862|NCT03782233|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102594863|NCT03782233|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102594864|NCT03782233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102594865|NCT03782233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594866|NCT00002090|Azithromycin|azithromycin|mesh-list
102594867|NCT00002090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102594868|NCT00002090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102594869|NCT00002096|Zidovudine|zidovudine|mesh-list
102594870|NCT00002096|Didanosine|didanosine|mesh-list
102594871|NCT00002096|Ganciclovir|ganciclovir|mesh-list
102594872|NCT00002096|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102594873|NCT00002096|Antimetabolites|antimetabolites|mesh-ancestor
102594874|NCT00002096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594875|NCT00002096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102594876|NCT00002096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102594877|NCT00002096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102594878|NCT00002096|Antiviral Agents|antiviral agents|mesh-ancestor
102594879|NCT00002096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102594880|NCT00002096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102594881|NCT00002096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102594882|NCT00002102|Leucovorin|leucovorin|mesh-list
102594883|NCT00002102|Trimetrexate|trimetrexate|mesh-list
102594884|NCT00002102|Calcium|calcium|mesh-list
102594885|NCT00002102|Levoleucovorin|levoleucovorin|mesh-list
102594886|NCT00002102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102594887|NCT00002102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594888|NCT00002102|Antidotes|antidotes|mesh-ancestor
102594889|NCT00002102|Protective Agents|protective agents|mesh-ancestor
102594890|NCT00002102|Vitamin B Complex|vitamin b complex|mesh-ancestor
102594891|NCT00002102|Vitamins|vitamins|mesh-ancestor
102594892|NCT00002102|Micronutrients|micronutrients|mesh-ancestor
102594893|NCT00002102|Antifungal Agents|antifungal agents|mesh-ancestor
102594894|NCT00002102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102594895|NCT00002102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102594896|NCT00002102|Antimetabolites|antimetabolites|mesh-ancestor
102594897|NCT00002102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594898|NCT00002102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102594899|NCT00002102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102594900|NCT00002102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102594901|NCT00002108|Lamivudine|lamivudine|mesh-list
102594902|NCT00002108|Zidovudine|zidovudine|mesh-list
102594903|NCT00002108|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102594904|NCT00002108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102594905|NCT00002108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102594906|NCT00002108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594907|NCT00002108|Antiviral Agents|antiviral agents|mesh-ancestor
102594908|NCT00002108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102594909|NCT00002108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102594910|NCT00002108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102594911|NCT00002108|Antimetabolites|antimetabolites|mesh-ancestor
102594912|NCT00381134|Losartan|losartan|mesh-list
102594913|NCT00381134|Spironolactone|spironolactone|mesh-list
102594914|NCT00381134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102594915|NCT00381134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102594916|NCT00381134|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102594917|NCT00381134|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102594918|NCT00381134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594919|NCT00381134|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102594920|NCT00381134|Hormone Antagonists|hormone antagonists|mesh-ancestor
102594921|NCT00381134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102594922|NCT00381134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594923|NCT00381134|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102594924|NCT00381134|Diuretics|diuretics|mesh-ancestor
102594925|NCT00381134|Natriuretic Agents|natriuretic agents|mesh-ancestor
102594926|NCT00000506|Phentermine|phentermine|mesh-list
102594927|NCT00000506|Fenfluramine|fenfluramine|mesh-list
102594928|NCT00000506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102594929|NCT00000506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594930|NCT00000506|Appetite Depressants|appetite depressants|mesh-ancestor
102594931|NCT00000506|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102594932|NCT00000506|Sympathomimetics|sympathomimetics|mesh-ancestor
102594933|NCT00000506|Autonomic Agents|autonomic agents|mesh-ancestor
102594934|NCT00000506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102594935|NCT00000506|Adrenergic Agents|adrenergic agents|mesh-ancestor
102594936|NCT00000506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102594937|NCT00000506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594938|NCT00000506|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102594939|NCT00000506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102594940|NCT00000506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102594941|NCT00000506|Serotonin Agents|serotonin agents|mesh-ancestor
102594942|NCT00000512|Niacin|niacin|mesh-list
102594943|NCT00000512|Nicotinic Acids|nicotinic acids|mesh-list
102594944|NCT00000512|Lovastatin|lovastatin|mesh-list
102594945|NCT00000512|L 647318|l 647318|mesh-list
102594946|NCT00000512|Dihydromevinolin|dihydromevinolin|mesh-list
102594947|NCT00000512|Colestipol|colestipol|mesh-list
102594948|NCT00000512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102594949|NCT00000512|Antimetabolites|antimetabolites|mesh-ancestor
102594950|NCT00000512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594951|NCT00000512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102594952|NCT00000512|Vasodilator Agents|vasodilator agents|mesh-ancestor
102594953|NCT00000512|Vitamin B Complex|vitamin b complex|mesh-ancestor
102594954|NCT00000512|Vitamins|vitamins|mesh-ancestor
102594955|NCT00000512|Micronutrients|micronutrients|mesh-ancestor
102594956|NCT00000512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594957|NCT00000512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102594958|NCT00000512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102594959|NCT00000512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102594960|NCT00000512|Sequestering Agents|sequestering agents|mesh-ancestor
102594961|NCT00380822|Miglitol|miglitol|mesh-list
102594962|NCT00380822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102594963|NCT00380822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594964|NCT00380822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102594965|NCT00380822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594966|NCT00380822|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102594967|NCT00000542|Amlodipine|amlodipine|mesh-list
102594968|NCT00000542|Lisinopril|lisinopril|mesh-list
102594969|NCT00000542|Chlorthalidone|chlorthalidone|mesh-list
102594970|NCT00000542|Doxazosin|doxazosin|mesh-list
102594971|NCT00000542|Pravastatin|pravastatin|mesh-list
102594972|NCT00000542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102594973|NCT00000542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102594974|NCT00000542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102594975|NCT00000542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102345655|NCT05554354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102594976|NCT00000542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102594977|NCT00000542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102594978|NCT00000542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102594979|NCT00000542|Vasodilator Agents|vasodilator agents|mesh-ancestor
102594980|NCT00000542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102594981|NCT00000542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102594982|NCT00000542|Antimetabolites|antimetabolites|mesh-ancestor
102594983|NCT00000542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102594984|NCT00000542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102594985|NCT00000542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102594986|NCT00000542|Protease Inhibitors|protease inhibitors|mesh-ancestor
102594987|NCT00000542|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102594988|NCT00000542|Protective Agents|protective agents|mesh-ancestor
102594989|NCT00000542|Diuretics|diuretics|mesh-ancestor
102141923|NCT02384876|Nasal Decongestants|nasal decongestants|mesh-ancestor
102594990|NCT00000542|Natriuretic Agents|natriuretic agents|mesh-ancestor
102594991|NCT00000542|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102594992|NCT00000542|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102594993|NCT00000542|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102594994|NCT00000542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102594995|NCT00000542|Adrenergic Agents|adrenergic agents|mesh-ancestor
102594996|NCT00000542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102594997|NCT00002120|Leucovorin|leucovorin|mesh-list
102594998|NCT00002120|Trimethoprim|trimethoprim|mesh-list
102594999|NCT00002120|Dapsone|dapsone|mesh-list
102595000|NCT00002120|Sulfamethoxazole|sulfamethoxazole|mesh-list
102595001|NCT00002120|Trimetrexate|trimetrexate|mesh-list
102595002|NCT00002120|Calcium|calcium|mesh-list
102595003|NCT00002120|Levoleucovorin|levoleucovorin|mesh-list
102595004|NCT00002120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102595005|NCT00002120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102595006|NCT00002120|Antidotes|antidotes|mesh-ancestor
102595007|NCT00002120|Protective Agents|protective agents|mesh-ancestor
102595008|NCT00002120|Vitamin B Complex|vitamin b complex|mesh-ancestor
102595009|NCT00002120|Vitamins|vitamins|mesh-ancestor
102595010|NCT00002120|Micronutrients|micronutrients|mesh-ancestor
102595011|NCT00002120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102595012|NCT00002120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595013|NCT00002120|Antimalarials|antimalarials|mesh-ancestor
102595014|NCT00002120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102595015|NCT00002120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102595016|NCT00002120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102595017|NCT00002120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595018|NCT00002120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595019|NCT00002120|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102595020|NCT00002120|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102595021|NCT00002120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102595022|NCT00002120|Leprostatic Agents|leprostatic agents|mesh-ancestor
102595023|NCT00002120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102595024|NCT00002120|Antifungal Agents|antifungal agents|mesh-ancestor
102595025|NCT00002120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102595026|NCT00002120|Antimetabolites|antimetabolites|mesh-ancestor
102595027|NCT00002120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102595028|NCT00002126|Lenograstim|lenograstim|mesh-list
102595029|NCT00002126|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102595030|NCT00002126|Immunologic Factors|immunologic factors|mesh-ancestor
102595031|NCT00002126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102595032|NCT03231397|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102595033|NCT03231397|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102595034|NCT03231397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595035|NCT03189433|Dantrolene|dantrolene|mesh-list
102595036|NCT03189433|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102595037|NCT03189433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102595038|NCT03189433|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102595039|NCT03189433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102595040|NCT00002132|Itraconazole|itraconazole|mesh-list
102595041|NCT00002132|Fluconazole|fluconazole|mesh-list
102595042|NCT00002132|Antifungal Agents|antifungal agents|mesh-ancestor
102595043|NCT00002132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595044|NCT00002132|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102595045|NCT00002132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102595046|NCT00002132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595047|NCT00002132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595048|NCT00002132|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102595049|NCT00002132|Hormone Antagonists|hormone antagonists|mesh-ancestor
102595050|NCT00002132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102595051|NCT00002132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102595052|NCT00002132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102595053|NCT00002132|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102595054|NCT00002132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102595055|NCT00002144|Foscarnet|foscarnet|mesh-list
102595056|NCT00002144|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
102595057|NCT00002144|Antiviral Agents|antiviral agents|mesh-ancestor
102595058|NCT00002144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595059|NCT00002144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102595060|NCT00002144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102595061|NCT00002144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595062|NCT00002144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595063|NCT00000578|Beclomethasone|beclomethasone|mesh-list
102595064|NCT00000578|Theophylline|theophylline|mesh-list
102595065|NCT00000578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102595066|NCT00000578|Glucocorticoids|glucocorticoids|mesh-ancestor
102595067|NCT00000578|Hormones|hormones|mesh-ancestor
102595068|NCT00000578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102595069|NCT00000578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102595070|NCT00000578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102595071|NCT00000578|Respiratory System Agents|respiratory system agents|mesh-ancestor
102595072|NCT00000578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102595073|NCT00000578|Autonomic Agents|autonomic agents|mesh-ancestor
102595074|NCT00000578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102595075|NCT00000578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102595076|NCT00000578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595077|NCT00000578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595078|NCT00000578|Vasodilator Agents|vasodilator agents|mesh-ancestor
102595079|NCT00000578|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102595080|NCT00000578|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102595081|NCT00000578|Purinergic Agents|purinergic agents|mesh-ancestor
102595082|NCT00000578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102595083|NCT03774745|Mifepristone|mifepristone|mesh-list
102595084|NCT03774745|Progesterone|progesterone|mesh-list
102595085|NCT03774745|Progestins|progestins|mesh-ancestor
102595086|NCT03774745|Hormones|hormones|mesh-ancestor
102595087|NCT03774745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102595088|NCT03774745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102595089|NCT03774745|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102595090|NCT03774745|Abortifacient Agents|abortifacient agents|mesh-ancestor
102595091|NCT03774745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102595092|NCT03774745|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102595093|NCT03774745|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102595094|NCT03774745|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102595095|NCT03774745|Contraceptive Agents|contraceptive agents|mesh-ancestor
102595096|NCT03774745|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102595097|NCT03774745|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102595098|NCT03774745|Hormone Antagonists|hormone antagonists|mesh-ancestor
102595099|NCT03774745|Luteolytic Agents|luteolytic agents|mesh-ancestor
102595100|NCT03774745|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102595101|NCT03774745|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102595102|NCT00000584|Immunoglobulins|immunoglobulins|mesh-list
102595103|NCT00000584|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102595104|NCT00000584|Antibodies|antibodies|mesh-list
102595105|NCT00000584|Immunologic Factors|immunologic factors|mesh-ancestor
102595106|NCT00000584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102595107|NCT00000590|Immunoglobulins|immunoglobulins|mesh-list
102595108|NCT00000590|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102595109|NCT00000590|Antibodies|antibodies|mesh-list
102595110|NCT00000590|Immunologic Factors|immunologic factors|mesh-ancestor
102595111|NCT00000590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102595112|NCT00000614|Warfarin|warfarin|mesh-list
102595113|NCT00000614|Anticoagulants|anticoagulants|mesh-ancestor
102595114|NCT02973464|Valganciclovir|valganciclovir|mesh-list
102595115|NCT02973464|Ganciclovir|ganciclovir|mesh-list
102595116|NCT02973464|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102595117|NCT02973464|Antiviral Agents|antiviral agents|mesh-ancestor
102595118|NCT02973464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595119|NCT02973464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102595120|NCT02973464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595121|NCT02973464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595122|NCT00000626|Doxorubicin|doxorubicin|mesh-list
102595123|NCT00000626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102595124|NCT00000626|Bleomycin|bleomycin|mesh-list
102595125|NCT00000626|Dacarbazine|dacarbazine|mesh-list
102595126|NCT00000626|Vinblastine|vinblastine|mesh-list
102595127|NCT00000626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102595128|NCT00000626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102595129|NCT00000626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102595130|NCT00000626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102595131|NCT00000626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595132|NCT00000626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595133|NCT00000626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102595134|NCT00000626|Alkylating Agents|alkylating agents|mesh-ancestor
102595135|NCT00000626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102595136|NCT00000626|Tubulin Modulators|tubulin modulators|mesh-ancestor
102595137|NCT00000626|Antimitotic Agents|antimitotic agents|mesh-ancestor
102595138|NCT00000626|Mitosis Modulators|mitosis modulators|mesh-ancestor
102595139|NCT03109873|Metformin|metformin|mesh-list
102595140|NCT03109873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102595141|NCT03109873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102595142|NCT04713254|Metoprolol|metoprolol|mesh-list
102595143|NCT04713254|Midazolam|midazolam|mesh-list
102595144|NCT04713254|Bupropion|bupropion|mesh-list
102595145|NCT04713254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102595146|NCT04713254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102595147|NCT04713254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102595148|NCT04713254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102595149|NCT04713254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102595150|NCT04713254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102595151|NCT04713254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102595152|NCT04713254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102595153|NCT04713254|Anesthetics, General|anesthetics, general|mesh-ancestor
102595154|NCT04713254|Anesthetics|anesthetics|mesh-ancestor
102595155|NCT04713254|GABA Modulators|gaba modulators|mesh-ancestor
102595156|NCT04713254|GABA Agents|gaba agents|mesh-ancestor
102595157|NCT04713254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102595158|NCT04713254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595159|NCT04713254|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102595160|NCT04713254|Antidepressive Agents|antidepressive agents|mesh-ancestor
102595161|NCT04713254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102595162|NCT04713254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102595163|NCT04713254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102595164|NCT04713254|Dopamine Agents|dopamine agents|mesh-ancestor
102595165|NCT04713254|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102595166|NCT04713254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102595167|NCT04713254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595168|NCT04713254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102595169|NCT04713254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102595170|NCT04713254|Sympatholytics|sympatholytics|mesh-ancestor
102595171|NCT04713254|Autonomic Agents|autonomic agents|mesh-ancestor
102595172|NCT04713254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102595173|NCT04713254|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102595174|NCT04713254|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102595175|NCT04713254|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102595176|NCT04713254|Adrenergic Agents|adrenergic agents|mesh-ancestor
102595177|NCT00002156|Ganciclovir|ganciclovir|mesh-list
102595178|NCT00002156|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102595179|NCT00002156|Fomivirsen|fomivirsen|mesh-list
102595180|NCT00002156|Antiviral Agents|antiviral agents|mesh-ancestor
102595181|NCT00002156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595182|NCT00002156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102595183|NCT00002156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595184|NCT00002156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595185|NCT04092907|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102595186|NCT04092907|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102595187|NCT00002162|Lamivudine|lamivudine|mesh-list
102595188|NCT00002162|Zidovudine|zidovudine|mesh-list
102595189|NCT00002162|Stavudine|stavudine|mesh-list
102595190|NCT00002162|Didanosine|didanosine|mesh-list
102595191|NCT00002162|Zalcitabine|zalcitabine|mesh-list
102595192|NCT00002162|Saquinavir|saquinavir|mesh-list
102595193|NCT00002162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102595194|NCT00002162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102595195|NCT00002162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595196|NCT00002162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595197|NCT00002162|Antiviral Agents|antiviral agents|mesh-ancestor
102595198|NCT00002162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595199|NCT00002162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102595200|NCT00002162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102595201|NCT00002162|Antimetabolites|antimetabolites|mesh-ancestor
102595202|NCT00002162|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102595203|NCT00002162|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102595204|NCT00002162|Protease Inhibitors|protease inhibitors|mesh-ancestor
102595205|NCT00002162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102595206|NCT00002162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102595207|NCT00000638|Pyridoxine|pyridoxine|mesh-list
102595208|NCT00000638|Vitamin B 6|vitamin b 6|mesh-list
102595209|NCT00000638|Rifampin|rifampin|mesh-list
102595210|NCT00000638|Isoniazid|isoniazid|mesh-list
102595211|NCT00000638|Pyrazinamide|pyrazinamide|mesh-list
102595212|NCT00000638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102595213|NCT00000638|Antitubercular Agents|antitubercular agents|mesh-ancestor
102595214|NCT00000638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102595215|NCT00000638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595216|NCT00000638|Leprostatic Agents|leprostatic agents|mesh-ancestor
102595217|NCT00000638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102595218|NCT00000638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595219|NCT00000638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595220|NCT00000638|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102595221|NCT00000638|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102595222|NCT00000638|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102595223|NCT00000638|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102595224|NCT00000638|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102595225|NCT00000638|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102595226|NCT00000638|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102595227|NCT00000638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102595228|NCT00000638|Antimetabolites|antimetabolites|mesh-ancestor
102595229|NCT00000638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102595230|NCT00000638|Vitamin B Complex|vitamin b complex|mesh-ancestor
102595231|NCT00000638|Vitamins|vitamins|mesh-ancestor
102595232|NCT00000638|Micronutrients|micronutrients|mesh-ancestor
102595233|NCT00000638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102595234|NCT00000650|Ditiocarb|ditiocarb|mesh-list
102595235|NCT00000650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102595236|NCT00000650|Immunologic Factors|immunologic factors|mesh-ancestor
102595237|NCT00000650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102595238|NCT00000650|Antiviral Agents|antiviral agents|mesh-ancestor
102595239|NCT00000650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595240|NCT00000650|Chelating Agents|chelating agents|mesh-ancestor
102595241|NCT00000650|Sequestering Agents|sequestering agents|mesh-ancestor
102595242|NCT00000650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595243|NCT00000656|Zidovudine|zidovudine|mesh-list
102595244|NCT00000656|Didanosine|didanosine|mesh-list
102595245|NCT00000656|Antimetabolites|antimetabolites|mesh-ancestor
102595246|NCT00000656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595247|NCT00000656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102595248|NCT00000656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102595249|NCT00000656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595250|NCT00000656|Antiviral Agents|antiviral agents|mesh-ancestor
102595251|NCT00000656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595252|NCT00000656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102595253|NCT00000656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102595254|NCT00000662|Zidovudine|zidovudine|mesh-list
102595255|NCT00000662|Antimetabolites|antimetabolites|mesh-ancestor
102595256|NCT00000662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595257|NCT00000662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102595258|NCT00000662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102595259|NCT00000662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595260|NCT00000662|Antiviral Agents|antiviral agents|mesh-ancestor
102595261|NCT00000662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595262|NCT00000662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102595263|NCT00000662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102595264|NCT00002168|Lamivudine|lamivudine|mesh-list
102595265|NCT00002168|Zidovudine|zidovudine|mesh-list
102595266|NCT00002168|Stavudine|stavudine|mesh-list
102595267|NCT00002168|Didanosine|didanosine|mesh-list
102595268|NCT00002168|Indinavir|indinavir|mesh-list
102595269|NCT00002168|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102595270|NCT00002168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102595271|NCT00002168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595272|NCT00002168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595273|NCT00002168|Antiviral Agents|antiviral agents|mesh-ancestor
102595274|NCT00002168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595275|NCT00002168|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102595276|NCT00002168|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102595277|NCT00002168|Antimetabolites|antimetabolites|mesh-ancestor
102595278|NCT00002168|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102595279|NCT00002168|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102595280|NCT00002168|Protease Inhibitors|protease inhibitors|mesh-ancestor
102595281|NCT00001442|Paclitaxel|paclitaxel|mesh-list
102595282|NCT00001442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102595283|NCT00001442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102595284|NCT00001442|Tubulin Modulators|tubulin modulators|mesh-ancestor
102595285|NCT00001442|Antimitotic Agents|antimitotic agents|mesh-ancestor
102595286|NCT00001442|Mitosis Modulators|mitosis modulators|mesh-ancestor
102595287|NCT00001442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595288|NCT00002174|Thalidomide|thalidomide|mesh-list
102595289|NCT00002174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102595290|NCT00002174|Immunologic Factors|immunologic factors|mesh-ancestor
102595291|NCT00002174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102595292|NCT00002174|Leprostatic Agents|leprostatic agents|mesh-ancestor
102595293|NCT00002174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102595294|NCT00002174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595295|NCT00002174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102595296|NCT00002174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102595297|NCT00002174|Growth Substances|growth substances|mesh-ancestor
102595298|NCT00002174|Growth Inhibitors|growth inhibitors|mesh-ancestor
102595299|NCT00002174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102595300|NCT00000668|Ganciclovir|ganciclovir|mesh-list
102595301|NCT00000668|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102595302|NCT00000668|Antiviral Agents|antiviral agents|mesh-ancestor
102595303|NCT00000668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595304|NCT00000668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102595305|NCT00000668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595306|NCT00000668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595307|NCT00000680|Zidovudine|zidovudine|mesh-list
102595308|NCT00000680|Aldesleukin|aldesleukin|mesh-list
102595309|NCT00000680|Antimetabolites|antimetabolites|mesh-ancestor
102595310|NCT00000680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595311|NCT00000680|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102595312|NCT00000680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102595313|NCT00000680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595314|NCT00000680|Antiviral Agents|antiviral agents|mesh-ancestor
102595315|NCT00000680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595316|NCT00000680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102595317|NCT00000680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102595318|NCT00000680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102595319|NCT00000692|Miglustat|miglustat|mesh-list
102595320|NCT00000692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595321|NCT00000692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595322|NCT00000692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102595323|NCT00000692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102595324|NCT00000692|Antiviral Agents|antiviral agents|mesh-ancestor
102595325|NCT00000692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595326|NCT00000692|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102595327|NCT00000692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102595328|NCT00000692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102595329|NCT00000698|Ganciclovir|ganciclovir|mesh-list
102595330|NCT00000698|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102595331|NCT00000698|Antiviral Agents|antiviral agents|mesh-ancestor
102595332|NCT00000698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595333|NCT00000698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102595334|NCT00000698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595335|NCT00000698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595336|NCT03764449|Balovaptan|balovaptan|mesh-list
102595337|NCT03764449|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102595338|NCT03764449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595339|NCT03764449|Natriuretic Agents|natriuretic agents|mesh-ancestor
102595340|NCT03764449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102595341|NCT00002180|Tenofovir|tenofovir|mesh-list
102595342|NCT00002180|Antiviral Agents|antiviral agents|mesh-ancestor
102595343|NCT00002180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595344|NCT00002180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102595345|NCT00002180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102595346|NCT00002180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595347|NCT00002180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595348|NCT00002180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102595349|NCT00002180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102595350|NCT00002186|Acyclovir|acyclovir|mesh-list
102595351|NCT00002186|Antiviral Agents|antiviral agents|mesh-ancestor
102595352|NCT00002186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595353|NCT00001502|Carboplatin|carboplatin|mesh-list
102595354|NCT00001502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102595355|NCT00002192|Azithromycin|azithromycin|mesh-list
102595356|NCT00002192|Clarithromycin|clarithromycin|mesh-list
102595357|NCT00002192|Ethambutol|ethambutol|mesh-list
102595358|NCT00002192|Rifapentine|rifapentine|mesh-list
102595359|NCT00002192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102595360|NCT00002192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595361|NCT00002192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102595362|NCT00002192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595363|NCT00002192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595364|NCT00002192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102595365|NCT00002192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102595366|NCT00002192|Antitubercular Agents|antitubercular agents|mesh-ancestor
102595367|NCT00002192|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102595368|NCT00002192|Leprostatic Agents|leprostatic agents|mesh-ancestor
102595370|NCT00002198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102595371|NCT00002198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102595372|NCT00002198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595373|NCT00002198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595374|NCT00002198|Antiviral Agents|antiviral agents|mesh-ancestor
102595375|NCT00002198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595376|NCT00002198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102595377|NCT00002198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102595378|NCT00000704|Zalcitabine|zalcitabine|mesh-list
102595379|NCT00000704|Antimetabolites|antimetabolites|mesh-ancestor
102595380|NCT00000704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595381|NCT00000704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102595382|NCT00000704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102595383|NCT00000704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595384|NCT00000704|Antiviral Agents|antiviral agents|mesh-ancestor
102595385|NCT00000704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595386|NCT00000704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102595387|NCT00000704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102595388|NCT00000728|Zidovudine|zidovudine|mesh-list
102595389|NCT00000728|Aldesleukin|aldesleukin|mesh-list
102595390|NCT00000728|Antimetabolites|antimetabolites|mesh-ancestor
102595391|NCT00000728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595392|NCT00000728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102595393|NCT00000728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102595394|NCT00000728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595395|NCT00000728|Antiviral Agents|antiviral agents|mesh-ancestor
102595396|NCT00000728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595397|NCT00000728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102595398|NCT00000728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102595399|NCT00000728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102595400|NCT00001520|Neostigmine|neostigmine|mesh-list
102595401|NCT00001520|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102595402|NCT00001520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595403|NCT00001520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595404|NCT00001520|Cholinergic Agents|cholinergic agents|mesh-ancestor
102595405|NCT00001520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102595406|NCT00001520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102595407|NCT00001520|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102595408|NCT00001520|Autonomic Agents|autonomic agents|mesh-ancestor
102595409|NCT00001520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102595410|NCT00001526|Daclizumab|daclizumab|mesh-list
102595411|NCT00001526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102595412|NCT00001526|Immunologic Factors|immunologic factors|mesh-ancestor
102595413|NCT00001526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102595414|NCT00002294|Fluconazole|fluconazole|mesh-list
102595415|NCT00002294|Antifungal Agents|antifungal agents|mesh-ancestor
102595416|NCT00002294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595417|NCT00002294|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102595418|NCT00002294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102595419|NCT00002294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595420|NCT00002294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595421|NCT00002294|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102595422|NCT00002294|Hormone Antagonists|hormone antagonists|mesh-ancestor
102595423|NCT00002294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102595424|NCT00002294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102595425|NCT00002294|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102595426|NCT00002294|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102595427|NCT03758365|Triamcinolone|triamcinolone|mesh-list
102595428|NCT03758365|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102595429|NCT03758365|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102595430|NCT03758365|Hydrocortisone|hydrocortisone|mesh-list
102595431|NCT03758365|Betamethasone|betamethasone|mesh-list
102595432|NCT03758365|Betamethasone Valerate|betamethasone valerate|mesh-list
102595433|NCT03758365|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102595434|NCT03758365|Betamethasone benzoate|betamethasone benzoate|mesh-list
102595435|NCT03758365|Clobetasol|clobetasol|mesh-list
102595436|NCT03758365|Desonide|desonide|mesh-list
102595437|NCT03758365|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
102595438|NCT03758365|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102595439|NCT03758365|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102595440|NCT03758365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102595441|NCT03758365|Glucocorticoids|glucocorticoids|mesh-ancestor
102595442|NCT03758365|Hormones|hormones|mesh-ancestor
102142376|NCT02377778|Anesthetics|anesthetics|mesh-ancestor
102595443|NCT03758365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102595444|NCT03758365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102595445|NCT03758365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102595446|NCT03758365|Immunologic Factors|immunologic factors|mesh-ancestor
102595447|NCT03758365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595448|NCT03758365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595449|NCT03758365|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102595450|NCT03758365|Respiratory System Agents|respiratory system agents|mesh-ancestor
102595451|NCT03758365|Dermatologic Agents|dermatologic agents|mesh-ancestor
102595453|NCT00002300|Megestrol Acetate|megestrol acetate|mesh-list
102595454|NCT00002300|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102595455|NCT00002300|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102595456|NCT00002300|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102595457|NCT00002300|Contraceptive Agents|contraceptive agents|mesh-ancestor
102595458|NCT00002300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102595459|NCT00002300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102595460|NCT00002300|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102595461|NCT00002300|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102595462|NCT00002300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102595463|NCT00002300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102595464|NCT00002300|Appetite Stimulants|appetite stimulants|mesh-ancestor
102595465|NCT00002300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102595466|NCT00002306|Fluconazole|fluconazole|mesh-list
102595467|NCT00002306|Antifungal Agents|antifungal agents|mesh-ancestor
102595468|NCT00002306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595469|NCT00002306|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102595470|NCT00002306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102595471|NCT00002306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595472|NCT00002306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595473|NCT00002306|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102595474|NCT00002306|Hormone Antagonists|hormone antagonists|mesh-ancestor
102595475|NCT00002306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102595476|NCT00002306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102595477|NCT00002306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102595478|NCT00002306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102595479|NCT00002210|Delavirdine|delavirdine|mesh-list
102595480|NCT00002210|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102595481|NCT00002210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102595482|NCT00002210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595483|NCT00002210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595484|NCT00002210|Antiviral Agents|antiviral agents|mesh-ancestor
102595485|NCT00002210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595486|NCT00002210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102595487|NCT00002210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102595488|NCT00002216|Lamivudine|lamivudine|mesh-list
102595489|NCT00002216|Zidovudine|zidovudine|mesh-list
102595490|NCT00002216|Abacavir|abacavir|mesh-list
102595491|NCT00002216|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
102595492|NCT00002216|Nelfinavir|nelfinavir|mesh-list
102595493|NCT00002216|Amprenavir|amprenavir|mesh-list
102595494|NCT00002216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102595495|NCT00002216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102595496|NCT00002216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595497|NCT00002216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595498|NCT00002216|Antiviral Agents|antiviral agents|mesh-ancestor
102595499|NCT00002216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595500|NCT00002216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102595501|NCT00002216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102595502|NCT00002216|Antimetabolites|antimetabolites|mesh-ancestor
102595503|NCT00002216|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102595504|NCT00002216|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102595505|NCT00002216|Protease Inhibitors|protease inhibitors|mesh-ancestor
102595506|NCT00002216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102595507|NCT00002216|Antitubercular Agents|antitubercular agents|mesh-ancestor
102595508|NCT00002216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102595509|NCT00002222|Valganciclovir|valganciclovir|mesh-list
102595510|NCT00002222|Antiviral Agents|antiviral agents|mesh-ancestor
102595511|NCT00002222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595512|NCT00002312|Zidovudine|zidovudine|mesh-list
102595513|NCT00002312|Delavirdine|delavirdine|mesh-list
102595514|NCT00002312|Antimetabolites|antimetabolites|mesh-ancestor
102595515|NCT00002312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595517|NCT00002312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102595518|NCT00002312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595519|NCT00002312|Antiviral Agents|antiviral agents|mesh-ancestor
102595520|NCT00002312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595521|NCT00002312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102595522|NCT00002312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102595523|NCT00002318|Doxorubicin|doxorubicin|mesh-list
102595524|NCT00002318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102595525|NCT00002318|Bleomycin|bleomycin|mesh-list
102595526|NCT00002318|Vincristine|vincristine|mesh-list
102595527|NCT00002318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102595528|NCT00002318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102595529|NCT00002318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102595530|NCT00002318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102595531|NCT00002318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595532|NCT00002318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595533|NCT00002318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102595534|NCT00002318|Tubulin Modulators|tubulin modulators|mesh-ancestor
102595535|NCT00002318|Antimitotic Agents|antimitotic agents|mesh-ancestor
102595536|NCT00002318|Mitosis Modulators|mitosis modulators|mesh-ancestor
102595537|NCT00002228|Enfuvirtide|enfuvirtide|mesh-list
102595538|NCT00002228|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102595539|NCT00002228|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102595540|NCT00002228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595541|NCT00002228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102595542|NCT00002228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102595543|NCT00002228|Antiviral Agents|antiviral agents|mesh-ancestor
102595544|NCT00002228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595545|NCT04714177|Edaravone|edaravone|mesh-list
102595546|NCT04714177|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102595547|NCT04714177|Antioxidants|antioxidants|mesh-ancestor
102595548|NCT04714177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595549|NCT04714177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102595550|NCT04714177|Protective Agents|protective agents|mesh-ancestor
102595551|NCT04714177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102595552|NCT00001628|Angiotensin II|angiotensin ii|mesh-list
102595553|NCT00001628|Giapreza|giapreza|mesh-list
102595554|NCT00001628|Angiotensinogen|angiotensinogen|mesh-list
102595555|NCT00001628|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
102595556|NCT00001628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102595557|NCT00001628|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102595558|NCT00001628|Protease Inhibitors|protease inhibitors|mesh-ancestor
102595559|NCT00001628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595560|NCT00001628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595561|NCT00001628|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102595562|NCT00002234|Lamivudine|lamivudine|mesh-list
102595563|NCT00002234|Efavirenz|efavirenz|mesh-list
102595564|NCT00002234|Didanosine|didanosine|mesh-list
102595565|NCT00002234|Adefovir|adefovir|mesh-list
102595566|NCT00002234|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
102595567|NCT00002234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102595568|NCT00002234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102595569|NCT00002234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595570|NCT00002234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595571|NCT00002234|Antiviral Agents|antiviral agents|mesh-ancestor
102595572|NCT00002234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595573|NCT00002234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102595574|NCT00002234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102595575|NCT00002234|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102595576|NCT00002234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102595577|NCT00002234|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102595578|NCT00002234|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102595579|NCT00002234|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102595580|NCT00002234|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102595581|NCT00002234|Antimetabolites|antimetabolites|mesh-ancestor
102595582|NCT04070287|Antibodies|antibodies|mesh-list
102595583|NCT04070287|Immunoglobulins|immunoglobulins|mesh-list
102595584|NCT04070287|Immunologic Factors|immunologic factors|mesh-ancestor
102595585|NCT04070287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102595586|NCT00002324|Zidovudine|zidovudine|mesh-list
102595587|NCT00002324|Nevirapine|nevirapine|mesh-list
102595588|NCT00002324|Antimetabolites|antimetabolites|mesh-ancestor
102595589|NCT00002324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595590|NCT00002324|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102595591|NCT00002324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102595592|NCT00002324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595593|NCT00002324|Antiviral Agents|antiviral agents|mesh-ancestor
102595594|NCT00002324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595595|NCT00002324|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102595596|NCT00002324|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102595597|NCT00002324|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102595598|NCT00002324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102595599|NCT00002330|Ganciclovir|ganciclovir|mesh-list
102595600|NCT00002330|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102595601|NCT00002330|Antiviral Agents|antiviral agents|mesh-ancestor
102595602|NCT00002330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595603|NCT00002330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102595604|NCT00002330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595605|NCT00002330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595606|NCT03740659|Levofloxacin|levofloxacin|mesh-list
102595607|NCT03740659|Ofloxacin|ofloxacin|mesh-list
102595608|NCT03740659|Dexamethasone|dexamethasone|mesh-list
102595609|NCT03740659|Dexamethasone acetate|dexamethasone acetate|mesh-list
102595610|NCT03740659|BB 1101|bb 1101|mesh-list
102595611|NCT03740659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102595612|NCT03740659|Antiemetics|antiemetics|mesh-ancestor
102595613|NCT03740659|Autonomic Agents|autonomic agents|mesh-ancestor
102595614|NCT03740659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102595615|NCT03740659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102595616|NCT03740659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102595617|NCT03740659|Glucocorticoids|glucocorticoids|mesh-ancestor
102595618|NCT03740659|Hormones|hormones|mesh-ancestor
102595619|NCT03740659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102595620|NCT03740659|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102595621|NCT03740659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102595622|NCT03740659|Protease Inhibitors|protease inhibitors|mesh-ancestor
102595623|NCT03740659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102345682|NCT05538910|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102595624|NCT03740659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595625|NCT03740659|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102595626|NCT03740659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595627|NCT03740659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102595628|NCT03740659|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102595629|NCT03740659|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102595630|NCT03740659|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102595631|NCT03740659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102595632|NCT00002336|Clarithromycin|clarithromycin|mesh-list
102595633|NCT00002336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102595634|NCT00002336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595635|NCT00002336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102595636|NCT00002336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595637|NCT00002336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595638|NCT00002336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102595639|NCT00002336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102595640|NCT00001646|Voriconazole|voriconazole|mesh-list
102595641|NCT00001646|Amphotericin B|amphotericin b|mesh-list
102595642|NCT00001646|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102595643|NCT00001646|Antifungal Agents|antifungal agents|mesh-ancestor
102595644|NCT00001646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595645|NCT00001646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102595646|NCT00001646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102595647|NCT00001646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595648|NCT00001646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595649|NCT00001646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102595650|NCT00001646|Hormone Antagonists|hormone antagonists|mesh-ancestor
102595651|NCT00001646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102595652|NCT00001646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102595653|NCT00001646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102595654|NCT00001646|Amebicides|amebicides|mesh-ancestor
102595655|NCT00001646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102595656|NCT00001646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102595657|NCT00001646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102595658|NCT00001658|Amoxicillin|amoxicillin|mesh-list
102595659|NCT00001658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102595660|NCT00001658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595661|NCT00002252|Octreotide|octreotide|mesh-list
102595662|NCT00002252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102595663|NCT00002252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102595664|NCT00002252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102595665|NCT00002348|Mitoguazone|mitoguazone|mesh-list
102595666|NCT00002348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102595667|NCT00002348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595668|NCT00002348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595669|NCT02721277|SMOFlipid|smoflipid|mesh-list
102595670|NCT02721277|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102595671|NCT02721277|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102595672|NCT02721277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102595673|NCT00378235|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
102595674|NCT00378235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102595675|NCT00002270|Interferons|interferons|mesh-list
102595676|NCT00002270|Interferon-alpha|interferon-alpha|mesh-list
102595677|NCT00002270|Interferon alpha-2|interferon alpha-2|mesh-list
102595678|NCT00002270|Zidovudine|zidovudine|mesh-list
102595679|NCT00002270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102595680|NCT00002270|Antiviral Agents|antiviral agents|mesh-ancestor
102595681|NCT00002270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595682|NCT00002270|Immunologic Factors|immunologic factors|mesh-ancestor
102595683|NCT00002270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102595684|NCT00002270|Antimetabolites|antimetabolites|mesh-ancestor
102595685|NCT00002270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595686|NCT00002270|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102595687|NCT00002270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102595688|NCT00002270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595689|NCT00002270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102595690|NCT00002270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102595691|NCT00002354|Stavudine|stavudine|mesh-list
102595692|NCT00002354|Indinavir|indinavir|mesh-list
102595693|NCT00002354|Antimetabolites|antimetabolites|mesh-ancestor
102595694|NCT00002354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595695|NCT00002354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102595696|NCT00002354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102595697|NCT00002354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595698|NCT00002354|Antiviral Agents|antiviral agents|mesh-ancestor
102595699|NCT00002354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595700|NCT00002354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102595701|NCT00002354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102595702|NCT00002354|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102595703|NCT00002354|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102595704|NCT00002354|Protease Inhibitors|protease inhibitors|mesh-ancestor
102595705|NCT00002360|Didanosine|didanosine|mesh-list
102595706|NCT00002360|Antimetabolites|antimetabolites|mesh-ancestor
102595707|NCT00002360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595708|NCT00002360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102595709|NCT00002360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102595710|NCT00002360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595711|NCT00002360|Antiviral Agents|antiviral agents|mesh-ancestor
102595712|NCT00002360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595713|NCT00002360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102595714|NCT00002360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102595715|NCT00002276|Zidovudine|zidovudine|mesh-list
102595716|NCT00002276|Ibuprofen|ibuprofen|mesh-list
102595717|NCT00002276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102595718|NCT00002276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102595719|NCT00002276|Analgesics|analgesics|mesh-ancestor
102595720|NCT00002276|Sensory System Agents|sensory system agents|mesh-ancestor
102595721|NCT00002276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102595722|NCT00002276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102595723|NCT00002276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102595724|NCT00002276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102595725|NCT00002276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102595726|NCT00002276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595727|NCT00002276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595728|NCT00002276|Antimetabolites|antimetabolites|mesh-ancestor
102595729|NCT00002276|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102595730|NCT00002276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102595731|NCT00002276|Antiviral Agents|antiviral agents|mesh-ancestor
102595732|NCT00002276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595733|NCT00002276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102595734|NCT00002276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102595735|NCT00378547|Acetaminophen|acetaminophen|mesh-list
102595736|NCT00378547|Dexamethasone|dexamethasone|mesh-list
102595737|NCT00378547|Dexamethasone acetate|dexamethasone acetate|mesh-list
102595738|NCT00378547|Pregabalin|pregabalin|mesh-list
102595739|NCT00378547|BB 1101|bb 1101|mesh-list
102595740|NCT00378547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102595741|NCT00378547|Antiemetics|antiemetics|mesh-ancestor
102595742|NCT00378547|Autonomic Agents|autonomic agents|mesh-ancestor
102595743|NCT00378547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102595744|NCT00378547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102595745|NCT00378547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102595746|NCT00378547|Glucocorticoids|glucocorticoids|mesh-ancestor
102595748|NCT00378547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102595749|NCT00378547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102595750|NCT00378547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102595751|NCT00378547|Protease Inhibitors|protease inhibitors|mesh-ancestor
102595752|NCT00378547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595753|NCT00378547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595754|NCT00378547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102595755|NCT00378547|Analgesics|analgesics|mesh-ancestor
102595756|NCT00378547|Sensory System Agents|sensory system agents|mesh-ancestor
102595757|NCT00378547|Antipyretics|antipyretics|mesh-ancestor
102595758|NCT00378547|Anticonvulsants|anticonvulsants|mesh-ancestor
102595759|NCT00378547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102595760|NCT00378547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102595761|NCT00378547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102595762|NCT00378547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102595763|NCT00378547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102595764|NCT00378547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102595765|NCT00378547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102595766|NCT00002282|Fluconazole|fluconazole|mesh-list
102595767|NCT00002282|Clotrimazole|clotrimazole|mesh-list
102595768|NCT00002282|Miconazole|miconazole|mesh-list
102595769|NCT00002282|Antifungal Agents|antifungal agents|mesh-ancestor
102595770|NCT00002282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595771|NCT00002282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102595772|NCT00002282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102595773|NCT00002282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595774|NCT00002282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595775|NCT00002282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102595776|NCT00002282|Hormone Antagonists|hormone antagonists|mesh-ancestor
102595777|NCT00002282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102595778|NCT00002282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102595779|NCT00002282|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102595780|NCT00002282|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102595781|NCT00002282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102595782|NCT00002282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102595783|NCT02658877|Omalizumab|omalizumab|mesh-list
102595784|NCT02658877|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102595785|NCT02658877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102595786|NCT02658877|Respiratory System Agents|respiratory system agents|mesh-ancestor
102595787|NCT00002288|Zidovudine|zidovudine|mesh-list
102595788|NCT00002288|Antimetabolites|antimetabolites|mesh-ancestor
102595789|NCT00002288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595790|NCT00002288|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102595791|NCT00002288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102595792|NCT00002288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595793|NCT00002288|Antiviral Agents|antiviral agents|mesh-ancestor
102595794|NCT00002288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595795|NCT00002288|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102595796|NCT00002288|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102595797|NCT00002366|Ritonavir|ritonavir|mesh-list
102595798|NCT00002366|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102595799|NCT00002366|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102595800|NCT00002366|Protease Inhibitors|protease inhibitors|mesh-ancestor
102595801|NCT00002366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595802|NCT00002366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595803|NCT00002366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102595804|NCT00002366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102595805|NCT00002366|Antiviral Agents|antiviral agents|mesh-ancestor
102595806|NCT00002366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595807|NCT00002366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102595808|NCT00002366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102595809|NCT00378313|Paclitaxel|paclitaxel|mesh-list
102595810|NCT00378313|Gemcitabine|gemcitabine|mesh-list
102595811|NCT00378313|Epirubicin|epirubicin|mesh-list
102595812|NCT00378313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102595813|NCT00378313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101851735|NCT00395304|Xhance|xhance|mesh-list
102595814|NCT00378313|Tubulin Modulators|tubulin modulators|mesh-ancestor
102595815|NCT00378313|Antimitotic Agents|antimitotic agents|mesh-ancestor
102595816|NCT00378313|Mitosis Modulators|mitosis modulators|mesh-ancestor
102595817|NCT00378313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595818|NCT00378313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102595819|NCT00378313|Antimetabolites|antimetabolites|mesh-ancestor
102595820|NCT00378313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102595821|NCT00378313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102595822|NCT00378313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102595823|NCT00378313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595825|NCT00002372|Indinavir|indinavir|mesh-list
102595826|NCT00002372|Saquinavir|saquinavir|mesh-list
102595827|NCT00002372|Amprenavir|amprenavir|mesh-list
102595828|NCT00002372|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102595829|NCT00002372|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102595830|NCT00002372|Protease Inhibitors|protease inhibitors|mesh-ancestor
102595831|NCT00002372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595832|NCT00002372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595833|NCT00002372|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102595834|NCT00002372|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102595835|NCT00002372|Antiviral Agents|antiviral agents|mesh-ancestor
102595836|NCT00002372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595837|NCT00002372|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102595838|NCT00002372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102595839|NCT00002372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102595840|NCT00002372|Antitubercular Agents|antitubercular agents|mesh-ancestor
102595841|NCT00002372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102595842|NCT00002378|Ritonavir|ritonavir|mesh-list
102595843|NCT00002378|Nelfinavir|nelfinavir|mesh-list
102595844|NCT00002378|Saquinavir|saquinavir|mesh-list
102595845|NCT00002378|Lamivudine|lamivudine|mesh-list
102595846|NCT00002378|Zidovudine|zidovudine|mesh-list
102595847|NCT00002378|Stavudine|stavudine|mesh-list
102595848|NCT00002378|Delavirdine|delavirdine|mesh-list
102595849|NCT00002378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102595850|NCT00002378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102595851|NCT00002378|Protease Inhibitors|protease inhibitors|mesh-ancestor
102595852|NCT00002378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595853|NCT00002378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595854|NCT00002378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102595855|NCT00002378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102595856|NCT00002378|Antiviral Agents|antiviral agents|mesh-ancestor
102595857|NCT00002378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595858|NCT00002378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102595859|NCT00002378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102595860|NCT00002378|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102595861|NCT00002378|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102595862|NCT00002378|Antimetabolites|antimetabolites|mesh-ancestor
102595863|NCT02589145|Pyridoxine|pyridoxine|mesh-list
102595864|NCT02589145|Dexamethasone|dexamethasone|mesh-list
102595865|NCT02589145|Rituximab|rituximab|mesh-list
102595866|NCT02589145|Gemcitabine|gemcitabine|mesh-list
102595867|NCT02589145|Lenalidomide|lenalidomide|mesh-list
102595868|NCT02589145|Melphalan|melphalan|mesh-list
102595869|NCT02589145|Busulfan|busulfan|mesh-list
102595870|NCT02589145|Vorinostat|vorinostat|mesh-list
102595871|NCT02589145|Enoxaparin|enoxaparin|mesh-list
102595872|NCT02589145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102595873|NCT02589145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102595874|NCT02589145|Immunologic Factors|immunologic factors|mesh-ancestor
102595875|NCT02589145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102595876|NCT02589145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102595877|NCT02589145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102595878|NCT02589145|Antiemetics|antiemetics|mesh-ancestor
102595879|NCT02589145|Autonomic Agents|autonomic agents|mesh-ancestor
102595880|NCT02589145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102595881|NCT02589145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102595882|NCT02589145|Glucocorticoids|glucocorticoids|mesh-ancestor
102595883|NCT02589145|Hormones|hormones|mesh-ancestor
102595884|NCT02589145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102595885|NCT02589145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102595886|NCT02589145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102595887|NCT02589145|Antimetabolites|antimetabolites|mesh-ancestor
102595888|NCT02589145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595889|NCT02589145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102595890|NCT02589145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102595891|NCT02589145|Growth Substances|growth substances|mesh-ancestor
102595892|NCT02589145|Growth Inhibitors|growth inhibitors|mesh-ancestor
102595893|NCT02589145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102595894|NCT02589145|Alkylating Agents|alkylating agents|mesh-ancestor
102595895|NCT02589145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102595896|NCT02589145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102595897|NCT02589145|Anticoagulants|anticoagulants|mesh-ancestor
102595898|NCT02589145|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102595899|NCT02589145|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102595900|NCT02589145|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102595901|NCT02589145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595902|NCT02589145|Vitamin B Complex|vitamin b complex|mesh-ancestor
102595903|NCT02589145|Vitamins|vitamins|mesh-ancestor
102595904|NCT02589145|Micronutrients|micronutrients|mesh-ancestor
102595905|NCT00002384|Cidofovir|cidofovir|mesh-list
102595906|NCT00002384|Antiviral Agents|antiviral agents|mesh-ancestor
102595907|NCT00002384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595908|NCT00002384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595909|NCT00002384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595910|NCT02568007|Cyproheptadine|cyproheptadine|mesh-list
102595911|NCT02568007|Antipruritics|antipruritics|mesh-ancestor
102595912|NCT02568007|Dermatologic Agents|dermatologic agents|mesh-ancestor
102595913|NCT02568007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102595914|NCT02568007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102595915|NCT02568007|Histamine Antagonists|histamine antagonists|mesh-ancestor
102595916|NCT02568007|Histamine Agents|histamine agents|mesh-ancestor
102345696|NCT05533775|Rituximab|rituximab|mesh-list
102595917|NCT02568007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102595918|NCT02568007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595919|NCT02568007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102595920|NCT02568007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102595921|NCT02568007|Serotonin Agents|serotonin agents|mesh-ancestor
102595922|NCT02568007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102595923|NCT00002390|Abacavir|abacavir|mesh-list
102595924|NCT00002390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102595925|NCT00002390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102595926|NCT00002390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595927|NCT00002390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595928|NCT00002390|Antiviral Agents|antiviral agents|mesh-ancestor
102595929|NCT00002390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595930|NCT00002390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102595931|NCT00002390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102595932|NCT00002396|Tenofovir|tenofovir|mesh-list
102595933|NCT00002396|Antiviral Agents|antiviral agents|mesh-ancestor
102595934|NCT00002396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595935|NCT00002396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102595936|NCT00002396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102595937|NCT00002396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595938|NCT00002396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595939|NCT00002396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102595940|NCT00002396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102595941|NCT00002402|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102595942|NCT00002402|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102595943|NCT00002402|Immunologic Factors|immunologic factors|mesh-ancestor
102595944|NCT00002402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102595945|NCT00002402|Antacids|antacids|mesh-ancestor
102595946|NCT00002402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595947|NCT00002402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102595948|NCT00002420|Stavudine|stavudine|mesh-list
102595949|NCT00002420|Didanosine|didanosine|mesh-list
102595950|NCT00002420|Delavirdine|delavirdine|mesh-list
102595951|NCT00002420|Emivirine|emivirine|mesh-list
102595952|NCT00002420|Hydroxyurea|hydroxyurea|mesh-list
102595953|NCT00002420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102595954|NCT00002420|Antisickling Agents|antisickling agents|mesh-ancestor
102595955|NCT00002420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595956|NCT00002420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595957|NCT00002420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102595958|NCT00002420|Antimetabolites|antimetabolites|mesh-ancestor
102595959|NCT00002420|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102595960|NCT00002420|Antiviral Agents|antiviral agents|mesh-ancestor
102595961|NCT00002420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102595962|NCT00002420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102595963|NCT00002420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102595964|NCT00381368|Ibandronic Acid|ibandronic acid|mesh-list
102595965|NCT00381368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102595966|NCT00381368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102595967|NCT04024501|Verinurad|verinurad|mesh-list
102595968|NCT04024501|Gout Suppressants|gout suppressants|mesh-ancestor
102595969|NCT04024501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102595970|NCT05709626|Aspirin|aspirin|mesh-list
102595971|NCT05709626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102595972|NCT05709626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102595973|NCT05709626|Analgesics|analgesics|mesh-ancestor
102595974|NCT05709626|Sensory System Agents|sensory system agents|mesh-ancestor
102595975|NCT05709626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102595976|NCT05709626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102595977|NCT05709626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102595978|NCT05709626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102595979|NCT05709626|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102595980|NCT05709626|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102595981|NCT05709626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595982|NCT05709626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102595983|NCT05709626|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102595984|NCT05709626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102595985|NCT05709626|Antipyretics|antipyretics|mesh-ancestor
102595986|NCT03538015|Carvedilol|carvedilol|mesh-list
102595987|NCT03538015|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102595988|NCT03538015|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102595989|NCT03538015|Adrenergic Agents|adrenergic agents|mesh-ancestor
102595990|NCT03538015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102595991|NCT03538015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102595992|NCT03538015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102595993|NCT03538015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102595994|NCT03538015|Antioxidants|antioxidants|mesh-ancestor
102595995|NCT03538015|Protective Agents|protective agents|mesh-ancestor
102595996|NCT03538015|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102595997|NCT03538015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102595998|NCT03538015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102595999|NCT03538015|Vasodilator Agents|vasodilator agents|mesh-ancestor
102596000|NCT03538015|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102596001|NCT03538015|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102596002|NCT03342157|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
102596003|NCT03342157|Sennosides|sennosides|mesh-list
102596004|NCT03342157|Antidiarrheals|antidiarrheals|mesh-ancestor
102596005|NCT03342157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102596006|NCT03342157|Laxatives|laxatives|mesh-ancestor
102596007|NCT04331210|Diclofenac|diclofenac|mesh-list
102596008|NCT04331210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102596009|NCT04331210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102596010|NCT04331210|Analgesics|analgesics|mesh-ancestor
102596011|NCT04331210|Sensory System Agents|sensory system agents|mesh-ancestor
102596012|NCT04331210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102596013|NCT04331210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596014|NCT04331210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102596015|NCT04331210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102596016|NCT04331210|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102596017|NCT04331210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102596018|NCT04331210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596019|NCT00002426|Adefovir|adefovir|mesh-list
102596020|NCT00002426|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
102596021|NCT00002426|Antiviral Agents|antiviral agents|mesh-ancestor
102596022|NCT00002426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102596023|NCT00002426|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102596024|NCT00002426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102596025|NCT00002426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102596026|NCT00002426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596027|NCT00002432|Foscarnet|foscarnet|mesh-list
102596028|NCT00002432|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
102596029|NCT00002432|Antiviral Agents|antiviral agents|mesh-ancestor
102596030|NCT00002432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102596031|NCT00002432|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102596032|NCT00002432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102596033|NCT00002432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102596034|NCT00002432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596035|NCT05701436|Leucovorin|leucovorin|mesh-list
102596036|NCT05701436|Doxorubicin|doxorubicin|mesh-list
102596037|NCT05701436|Fluorouracil|fluorouracil|mesh-list
102596038|NCT05701436|Oxaliplatin|oxaliplatin|mesh-list
102596039|NCT05701436|Raltitrexed|raltitrexed|mesh-list
102596040|NCT05701436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596041|NCT05701436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102596042|NCT05701436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102596043|NCT05701436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102596044|NCT05701436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102596045|NCT05701436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596046|NCT05701436|Antimetabolites|antimetabolites|mesh-ancestor
102596047|NCT05701436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102596048|NCT05701436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102596049|NCT05701436|Immunologic Factors|immunologic factors|mesh-ancestor
102596050|NCT05701436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596051|NCT05701436|Antidotes|antidotes|mesh-ancestor
102596052|NCT05701436|Protective Agents|protective agents|mesh-ancestor
102596053|NCT05701436|Vitamin B Complex|vitamin b complex|mesh-ancestor
102596054|NCT05701436|Vitamins|vitamins|mesh-ancestor
102596055|NCT05701436|Micronutrients|micronutrients|mesh-ancestor
102596056|NCT05701436|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102596057|NCT02487277|Paclitaxel|paclitaxel|mesh-list
102596058|NCT02487277|Gemcitabine|gemcitabine|mesh-list
102596059|NCT02487277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102596060|NCT02487277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596061|NCT02487277|Tubulin Modulators|tubulin modulators|mesh-ancestor
102596062|NCT02487277|Antimitotic Agents|antimitotic agents|mesh-ancestor
102596063|NCT02487277|Mitosis Modulators|mitosis modulators|mesh-ancestor
102596064|NCT02487277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596065|NCT02487277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102596066|NCT02487277|Antimetabolites|antimetabolites|mesh-ancestor
102596067|NCT00002438|Itraconazole|itraconazole|mesh-list
102596068|NCT00002438|Antifungal Agents|antifungal agents|mesh-ancestor
102596069|NCT00002438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102596070|NCT00002438|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102596071|NCT00002438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102596072|NCT00002438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102596073|NCT00002438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596074|NCT00002438|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102596075|NCT00002438|Hormone Antagonists|hormone antagonists|mesh-ancestor
102596076|NCT00002438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102596077|NCT00002438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596078|NCT00002438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102596079|NCT00002444|Nitazoxanide|nitazoxanide|mesh-list
102596080|NCT00002444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102596081|NCT00002444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102596082|NCT02436265|Dexamethasone|dexamethasone|mesh-list
102596083|NCT02436265|Ropivacaine|ropivacaine|mesh-list
102596084|NCT02436265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102596085|NCT02436265|Antiemetics|antiemetics|mesh-ancestor
102596086|NCT02436265|Autonomic Agents|autonomic agents|mesh-ancestor
102596087|NCT02436265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102596088|NCT02436265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596089|NCT02436265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102596090|NCT02436265|Glucocorticoids|glucocorticoids|mesh-ancestor
102596091|NCT02436265|Hormones|hormones|mesh-ancestor
102596092|NCT02436265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102596093|NCT02436265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102596094|NCT02436265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596095|NCT02436265|Anesthetics, Local|anesthetics, local|mesh-ancestor
102596096|NCT02436265|Anesthetics|anesthetics|mesh-ancestor
102596097|NCT02436265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102596098|NCT02436265|Sensory System Agents|sensory system agents|mesh-ancestor
102596099|NCT05751746|Magnesium Sulfate|magnesium sulfate|mesh-list
102596100|NCT05751746|Analgesics|analgesics|mesh-ancestor
102596101|NCT05751746|Sensory System Agents|sensory system agents|mesh-ancestor
102596102|NCT05751746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102596103|NCT05751746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596104|NCT05751746|Anesthetics|anesthetics|mesh-ancestor
102596105|NCT05751746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102596106|NCT05751746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102596107|NCT05751746|Anticonvulsants|anticonvulsants|mesh-ancestor
102596108|NCT05751746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102596109|NCT05751746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102596110|NCT05751746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596111|NCT05751746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102596112|NCT05751746|Tocolytic Agents|tocolytic agents|mesh-ancestor
102596113|NCT05751746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102596114|NCT00002450|Tenofovir|tenofovir|mesh-list
102596115|NCT00002450|Antiviral Agents|antiviral agents|mesh-ancestor
102596116|NCT00002450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102596117|NCT00002450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102596118|NCT00002450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102596119|NCT00002450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102596120|NCT00002450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596121|NCT00002450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102596122|NCT00002450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102596123|NCT03277183|Epoetin Alfa|epoetin alfa|mesh-list
102596124|NCT03277183|Hematinics|hematinics|mesh-ancestor
102596125|NCT00002456|Cyclosporine|cyclosporine|mesh-list
102596126|NCT00002456|Methotrexate|methotrexate|mesh-list
102596127|NCT00002456|Cyclosporins|cyclosporins|mesh-list
102596128|NCT00002456|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102596129|NCT00002456|Abortifacient Agents|abortifacient agents|mesh-ancestor
102596130|NCT00002456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102596131|NCT00002456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596132|NCT00002456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102596133|NCT00002456|Antimetabolites|antimetabolites|mesh-ancestor
102596134|NCT00002456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596135|NCT00002456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596136|NCT00002456|Dermatologic Agents|dermatologic agents|mesh-ancestor
102596137|NCT00002456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102596138|NCT00002456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102596139|NCT00002456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102596140|NCT00002456|Immunologic Factors|immunologic factors|mesh-ancestor
102596141|NCT00002456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102596142|NCT00002456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102596143|NCT00002456|Antifungal Agents|antifungal agents|mesh-ancestor
102596144|NCT00002456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102596145|NCT00002456|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102596147|NCT01525927|Carboplatin|carboplatin|mesh-list
102596148|NCT01525927|Etoposide|etoposide|mesh-list
102596149|NCT01525927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596150|NCT01525927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102596151|NCT01525927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102596152|NCT01525927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102596153|NCT01525927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102596154|NCT01525927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596155|NCT00002474|Cyclophosphamide|cyclophosphamide|mesh-list
102596156|NCT00002474|Carboplatin|carboplatin|mesh-list
102596157|NCT00002474|Mitoxantrone|mitoxantrone|mesh-list
102596158|NCT00002474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102596159|NCT00002474|Immunologic Factors|immunologic factors|mesh-ancestor
102596160|NCT00002474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596161|NCT00002474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102596162|NCT00002474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102596163|NCT00002474|Alkylating Agents|alkylating agents|mesh-ancestor
102596164|NCT00002474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596165|NCT00002474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596166|NCT00002474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102596167|NCT00002474|Analgesics|analgesics|mesh-ancestor
102596168|NCT00002474|Sensory System Agents|sensory system agents|mesh-ancestor
102596169|NCT00002474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102596170|NCT00002474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102596171|NCT00002474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102596172|NCT00002474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102596173|NCT00002492|Doxorubicin|doxorubicin|mesh-list
102596174|NCT00002492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102596175|NCT00002492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596176|NCT00002492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102596177|NCT00002492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102596178|NCT00002492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102596179|NCT00002492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102596180|NCT00002492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596181|NCT05751512|Methotrexate|methotrexate|mesh-list
102596182|NCT05751512|Cetuximab|cetuximab|mesh-list
102596183|NCT05751512|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102596184|NCT05751512|Abortifacient Agents|abortifacient agents|mesh-ancestor
102596185|NCT05751512|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102596186|NCT05751512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596187|NCT05751512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102596188|NCT05751512|Antimetabolites|antimetabolites|mesh-ancestor
102596189|NCT05751512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596190|NCT05751512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596191|NCT05751512|Dermatologic Agents|dermatologic agents|mesh-ancestor
102596192|NCT05751512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102596193|NCT05751512|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102596194|NCT05751512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102596195|NCT05751512|Immunologic Factors|immunologic factors|mesh-ancestor
102596196|NCT05751512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102596197|NCT05751512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102596198|NCT05751512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102596199|NCT02373865|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102596201|NCT02373865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102596202|NCT02373865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596203|NCT02373865|Incretins|incretins|mesh-ancestor
102596204|NCT02373865|Hormones|hormones|mesh-ancestor
102596205|NCT02373865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102596206|NCT02373865|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102596207|NCT02373865|Protease Inhibitors|protease inhibitors|mesh-ancestor
102596208|NCT02373865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102596209|NCT02373865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596210|NCT02373865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102596211|NCT02373865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102596212|NCT02373865|Immunologic Factors|immunologic factors|mesh-ancestor
102596213|NCT00002498|Cyclophosphamide|cyclophosphamide|mesh-list
102596214|NCT00002498|Fluorouracil|fluorouracil|mesh-list
102596215|NCT00002498|Methotrexate|methotrexate|mesh-list
102596216|NCT00002498|Mitoxantrone|mitoxantrone|mesh-list
102596217|NCT00002498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102596218|NCT00002498|Immunologic Factors|immunologic factors|mesh-ancestor
102596219|NCT00002498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596220|NCT00002498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102596221|NCT00002498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102596222|NCT00002498|Alkylating Agents|alkylating agents|mesh-ancestor
102596223|NCT00002498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596224|NCT00002498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596225|NCT00002498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102596226|NCT00002498|Antimetabolites|antimetabolites|mesh-ancestor
102596227|NCT00002498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102596228|NCT00002498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102596229|NCT00002498|Abortifacient Agents|abortifacient agents|mesh-ancestor
102596230|NCT00002498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102596231|NCT00002498|Dermatologic Agents|dermatologic agents|mesh-ancestor
102596232|NCT00002498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102596233|NCT00002498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102596234|NCT00002498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102596235|NCT00002498|Analgesics|analgesics|mesh-ancestor
102596236|NCT00002498|Sensory System Agents|sensory system agents|mesh-ancestor
102596237|NCT00002498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102596238|NCT00002498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102596239|NCT00002498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102596240|NCT00002504|Interferons|interferons|mesh-list
102596241|NCT00002504|Interferon-alpha|interferon-alpha|mesh-list
102596242|NCT00002504|Aldesleukin|aldesleukin|mesh-list
102596243|NCT00002504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596244|NCT00002504|Antiviral Agents|antiviral agents|mesh-ancestor
102596245|NCT00002504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102596246|NCT00002504|Immunologic Factors|immunologic factors|mesh-ancestor
102596247|NCT00002504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596248|NCT00002504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102596249|NCT00002504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102596250|NCT02360059|Metformin|metformin|mesh-list
102596251|NCT02360059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102596252|NCT02360059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596253|NCT00002510|Cyclophosphamide|cyclophosphamide|mesh-list
102596254|NCT00002510|Etoposide|etoposide|mesh-list
102596255|NCT00002510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102596256|NCT00002510|Immunologic Factors|immunologic factors|mesh-ancestor
102596257|NCT00002510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596258|NCT00002510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102596259|NCT00002510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102596260|NCT00002510|Alkylating Agents|alkylating agents|mesh-ancestor
102596261|NCT00002510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596262|NCT00002510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596263|NCT00002510|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102596264|NCT00002510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102596265|NCT00002510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102596266|NCT00002510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102596267|NCT00002510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102596268|NCT01500109|Acetaminophen|acetaminophen|mesh-list
102596269|NCT01500109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102596270|NCT01500109|Analgesics|analgesics|mesh-ancestor
102596271|NCT01500109|Sensory System Agents|sensory system agents|mesh-ancestor
102596272|NCT01500109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102596273|NCT01500109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596274|NCT01500109|Antipyretics|antipyretics|mesh-ancestor
102596275|NCT00002516|Cobalt|cobalt|mesh-list
102596276|NCT00002516|Dactinomycin|dactinomycin|mesh-list
102596277|NCT00002516|Cyclophosphamide|cyclophosphamide|mesh-list
102596278|NCT00002516|Ifosfamide|ifosfamide|mesh-list
102596279|NCT00002516|Doxorubicin|doxorubicin|mesh-list
102596280|NCT00002516|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102596281|NCT00002516|Etoposide|etoposide|mesh-list
102596282|NCT00002516|Vincristine|vincristine|mesh-list
102596283|NCT00002516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102596284|NCT00002516|Immunologic Factors|immunologic factors|mesh-ancestor
102596285|NCT00002516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596286|NCT00002516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102596287|NCT00002516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102596288|NCT00002516|Alkylating Agents|alkylating agents|mesh-ancestor
102596289|NCT00002516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596290|NCT00002516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596291|NCT00002516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102596292|NCT00002516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102596293|NCT00002516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102596294|NCT00002516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102596295|NCT00002516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102596296|NCT00002516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102596297|NCT00002516|Tubulin Modulators|tubulin modulators|mesh-ancestor
102596298|NCT00002516|Antimitotic Agents|antimitotic agents|mesh-ancestor
102596299|NCT00002516|Mitosis Modulators|mitosis modulators|mesh-ancestor
102596300|NCT00002516|Trace Elements|trace elements|mesh-ancestor
102596301|NCT00002516|Micronutrients|micronutrients|mesh-ancestor
102596302|NCT00002516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102596303|NCT00002516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102596304|NCT00002516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102596305|NCT00002516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102596306|NCT00002522|Cyclophosphamide|cyclophosphamide|mesh-list
102596307|NCT00002522|Etoposide|etoposide|mesh-list
102596308|NCT00002522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102596309|NCT00002522|Immunologic Factors|immunologic factors|mesh-ancestor
102596310|NCT00002522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596311|NCT00002522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102596312|NCT00002522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102596313|NCT00002522|Alkylating Agents|alkylating agents|mesh-ancestor
102596314|NCT00002522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596315|NCT00002522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596316|NCT00002522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102596317|NCT00002522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102596318|NCT00002522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102596319|NCT00002522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102596320|NCT00002522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102596321|NCT00002528|Tamoxifen|tamoxifen|mesh-list
102596322|NCT00002528|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102596323|NCT00002528|Hormone Antagonists|hormone antagonists|mesh-ancestor
102596324|NCT00002528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102596325|NCT00002528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596326|NCT00002528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102596327|NCT00002528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596328|NCT00002528|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102596329|NCT00002528|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102596330|NCT00002528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102596331|NCT02341495|Vitamin D|vitamin d|mesh-list
102596332|NCT02341495|Cholecalciferol|cholecalciferol|mesh-list
102596333|NCT02341495|Azacitidine|azacitidine|mesh-list
102596334|NCT02341495|Deferasirox|deferasirox|mesh-list
102596335|NCT02341495|Vitamins|vitamins|mesh-ancestor
102596336|NCT02341495|Micronutrients|micronutrients|mesh-ancestor
102596337|NCT02341495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596338|NCT02341495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102596339|NCT02341495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102596340|NCT02341495|Antimetabolites|antimetabolites|mesh-ancestor
102596341|NCT02341495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596342|NCT02341495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596343|NCT02341495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102596344|NCT02341495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102596345|NCT02341495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102596346|NCT02341495|Chelating Agents|chelating agents|mesh-ancestor
102596347|NCT02341495|Sequestering Agents|sequestering agents|mesh-ancestor
102596348|NCT00002534|Cytarabine|cytarabine|mesh-list
102596349|NCT00002534|Methylprednisolone|methylprednisolone|mesh-list
102596350|NCT00002534|Cyclophosphamide|cyclophosphamide|mesh-list
102596351|NCT00002534|Thiotepa|thiotepa|mesh-list
102596352|NCT00002534|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102596353|NCT00002534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102596354|NCT00002534|Immunologic Factors|immunologic factors|mesh-ancestor
102596355|NCT00002534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596356|NCT00002534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102596357|NCT00002534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102596358|NCT00002534|Alkylating Agents|alkylating agents|mesh-ancestor
102596359|NCT00002534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596360|NCT00002534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596361|NCT00002534|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102596362|NCT00002534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102596363|NCT00002534|Antimetabolites|antimetabolites|mesh-ancestor
102596364|NCT00002534|Antiviral Agents|antiviral agents|mesh-ancestor
102596365|NCT00002534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102596366|NCT00002534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102596367|NCT00002534|Antiemetics|antiemetics|mesh-ancestor
102596368|NCT00002534|Autonomic Agents|autonomic agents|mesh-ancestor
102596369|NCT00002534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102596370|NCT00002534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102596371|NCT00002534|Glucocorticoids|glucocorticoids|mesh-ancestor
102596372|NCT00002534|Hormones|hormones|mesh-ancestor
102596373|NCT00002534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102596374|NCT00002534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102596375|NCT00002534|Protective Agents|protective agents|mesh-ancestor
102596376|NCT00002546|Ifosfamide|ifosfamide|mesh-list
102596377|NCT00002546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596378|NCT00002546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102596379|NCT00002546|Alkylating Agents|alkylating agents|mesh-ancestor
102596380|NCT00002546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596381|NCT00378625|Artesunate|artesunate|mesh-list
102596382|NCT00378625|Antimalarials|antimalarials|mesh-ancestor
102596383|NCT00378625|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102596384|NCT00378625|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102596385|NCT00378625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102596386|NCT00378625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596387|NCT00378625|Antiviral Agents|antiviral agents|mesh-ancestor
102596388|NCT00378625|Schistosomicides|schistosomicides|mesh-ancestor
102596389|NCT00378625|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102596390|NCT00378625|Anthelmintics|anthelmintics|mesh-ancestor
102596391|NCT04005391|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102596392|NCT04005391|Contraceptive Agents|contraceptive agents|mesh-list
102596393|NCT04005391|Levonorgestrel|levonorgestrel|mesh-list
102596394|NCT04005391|Medroxyprogesterone|medroxyprogesterone|mesh-list
102596395|NCT04005391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102596396|NCT04005391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596397|NCT04005391|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102596398|NCT04005391|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102596399|NCT04005391|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102596400|NCT04005391|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102596401|NCT04005391|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102596402|NCT04005391|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102596403|NCT04005391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102596404|NCT04005391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596405|NCT00002552|Leucovorin|leucovorin|mesh-list
102596406|NCT00002552|Cytarabine|cytarabine|mesh-list
102596407|NCT00002552|Hydrocortisone|hydrocortisone|mesh-list
102596408|NCT00002552|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102596409|NCT00002552|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102596410|NCT00002552|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102596411|NCT00002552|Cyclophosphamide|cyclophosphamide|mesh-list
102596412|NCT00002552|Carmustine|carmustine|mesh-list
102596413|NCT00002552|Methotrexate|methotrexate|mesh-list
102596414|NCT00002552|Etoposide|etoposide|mesh-list
102596415|NCT00002552|Sargramostim|sargramostim|mesh-list
102596416|NCT00002552|Levoleucovorin|levoleucovorin|mesh-list
102596417|NCT00002552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102596418|NCT00002552|Immunologic Factors|immunologic factors|mesh-ancestor
102596419|NCT00002552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596420|NCT00002552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102596421|NCT00002552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102596422|NCT00002552|Alkylating Agents|alkylating agents|mesh-ancestor
102596423|NCT00002552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596424|NCT00002552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596425|NCT00002552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102596426|NCT00002552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102596427|NCT00002552|Abortifacient Agents|abortifacient agents|mesh-ancestor
102596428|NCT00002552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102596429|NCT00002552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102596430|NCT00002552|Antimetabolites|antimetabolites|mesh-ancestor
102596431|NCT00002552|Dermatologic Agents|dermatologic agents|mesh-ancestor
102596432|NCT00002552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102596433|NCT00002552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102596434|NCT00002552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102596435|NCT00002552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102596436|NCT00002552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102596437|NCT00002552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102596438|NCT00002552|Antiviral Agents|antiviral agents|mesh-ancestor
102596439|NCT00002552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102596440|NCT00002552|Antidotes|antidotes|mesh-ancestor
102596441|NCT00002552|Protective Agents|protective agents|mesh-ancestor
102596442|NCT00002552|Vitamin B Complex|vitamin b complex|mesh-ancestor
102596443|NCT00002552|Vitamins|vitamins|mesh-ancestor
102596444|NCT00002552|Micronutrients|micronutrients|mesh-ancestor
102596445|NCT00002552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102596446|NCT00378781|Minocycline|minocycline|mesh-list
102596447|NCT00378781|Heparin|heparin|mesh-list
102596448|NCT00378781|Anticoagulants|anticoagulants|mesh-ancestor
102596449|NCT00378781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102596450|NCT00378781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102596451|NCT00378781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596452|NCT00378781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102596453|NCT00378781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102596454|NCT00377923|Progesterone|progesterone|mesh-list
102596455|NCT00377923|Progestins|progestins|mesh-ancestor
102596456|NCT00377923|Hormones|hormones|mesh-ancestor
102596457|NCT00377923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102596458|NCT00377923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596459|NCT00002570|Leucovorin|leucovorin|mesh-list
102596460|NCT00002570|Fluorouracil|fluorouracil|mesh-list
102596461|NCT00002570|Calcium|calcium|mesh-list
102596462|NCT00002570|Levoleucovorin|levoleucovorin|mesh-list
102596463|NCT00002570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102596464|NCT00002570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596465|NCT00002570|Antimetabolites|antimetabolites|mesh-ancestor
102596466|NCT00002570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596467|NCT00002570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102596468|NCT00002570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596469|NCT00002570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102596470|NCT00002570|Immunologic Factors|immunologic factors|mesh-ancestor
102596471|NCT00002570|Antidotes|antidotes|mesh-ancestor
102596472|NCT00002570|Protective Agents|protective agents|mesh-ancestor
102596473|NCT00002570|Vitamin B Complex|vitamin b complex|mesh-ancestor
102596474|NCT00002570|Vitamins|vitamins|mesh-ancestor
102596475|NCT00002570|Micronutrients|micronutrients|mesh-ancestor
102596476|NCT00002576|Prednisolone|prednisolone|mesh-list
102596477|NCT00002576|Cyclophosphamide|cyclophosphamide|mesh-list
102596478|NCT00002576|Doxorubicin|doxorubicin|mesh-list
102596479|NCT00002576|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102596480|NCT00002576|Vincristine|vincristine|mesh-list
102596481|NCT00002576|Mitoxantrone|mitoxantrone|mesh-list
102596482|NCT00002576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102596483|NCT00002576|Immunologic Factors|immunologic factors|mesh-ancestor
102596484|NCT00002576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596485|NCT00002576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102596486|NCT00002576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102596487|NCT00002576|Alkylating Agents|alkylating agents|mesh-ancestor
102596488|NCT00002576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596489|NCT00002576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596490|NCT00002576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102596491|NCT00002576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102596492|NCT00002576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102596493|NCT00002576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102596494|NCT00002576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102596495|NCT00002576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102596496|NCT00002576|Tubulin Modulators|tubulin modulators|mesh-ancestor
102596497|NCT00002576|Antimitotic Agents|antimitotic agents|mesh-ancestor
102596498|NCT00002576|Mitosis Modulators|mitosis modulators|mesh-ancestor
102596499|NCT00002576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102596500|NCT00002576|Glucocorticoids|glucocorticoids|mesh-ancestor
102596501|NCT00002576|Hormones|hormones|mesh-ancestor
102596502|NCT00002576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102596503|NCT00002576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102596504|NCT00002576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102596505|NCT00002576|Analgesics|analgesics|mesh-ancestor
102596506|NCT00002576|Sensory System Agents|sensory system agents|mesh-ancestor
102596507|NCT00002582|Tamoxifen|tamoxifen|mesh-list
102596508|NCT00002582|Cyclophosphamide|cyclophosphamide|mesh-list
102596509|NCT00002582|Doxorubicin|doxorubicin|mesh-list
102596510|NCT00002582|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102596511|NCT00002582|Fluorouracil|fluorouracil|mesh-list
102596512|NCT00002582|Methotrexate|methotrexate|mesh-list
102596513|NCT00002582|Leuprolide|leuprolide|mesh-list
102596514|NCT00002582|Goserelin|goserelin|mesh-list
102596515|NCT00002582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102596516|NCT00002582|Immunologic Factors|immunologic factors|mesh-ancestor
102596517|NCT00002582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596518|NCT00002582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102596519|NCT00002582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102596520|NCT00002582|Alkylating Agents|alkylating agents|mesh-ancestor
102596521|NCT00002582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596522|NCT00002582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596523|NCT00002582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102596524|NCT00002582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102596525|NCT00002582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102596526|NCT00002582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102596527|NCT00002582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102596528|NCT00002582|Antimetabolites|antimetabolites|mesh-ancestor
102596529|NCT00002582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102596530|NCT00002582|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102596531|NCT00002582|Abortifacient Agents|abortifacient agents|mesh-ancestor
102596532|NCT00002582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102596533|NCT00002582|Dermatologic Agents|dermatologic agents|mesh-ancestor
102596534|NCT00002582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102596535|NCT00002582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102596536|NCT00002582|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102596537|NCT00002582|Hormone Antagonists|hormone antagonists|mesh-ancestor
102596538|NCT00002582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102596539|NCT00002582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102596540|NCT00002582|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102596541|NCT00002582|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102596542|NCT00002582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102596543|NCT00002582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102596544|NCT00002582|Fertility Agents|fertility agents|mesh-ancestor
102596545|NCT00002588|Etoposide|etoposide|mesh-list
102596546|NCT00002588|Topotecan|topotecan|mesh-list
102596547|NCT00002588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102596548|NCT00002588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596549|NCT00002588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102596550|NCT00002588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102596551|NCT00002588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102596552|NCT00002588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596553|NCT00002588|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102596554|NCT02239627|Clonidine|clonidine|mesh-list
102596555|NCT02239627|Analgesics|analgesics|mesh-ancestor
102596556|NCT02239627|Sensory System Agents|sensory system agents|mesh-ancestor
102596557|NCT02239627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102596558|NCT02239627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596559|NCT02239627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102596560|NCT02239627|Sympatholytics|sympatholytics|mesh-ancestor
102596561|NCT02239627|Autonomic Agents|autonomic agents|mesh-ancestor
102596562|NCT02239627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102596563|NCT02239627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102596564|NCT02239627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102596565|NCT02239627|Adrenergic Agents|adrenergic agents|mesh-ancestor
102596566|NCT02239627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102596567|NCT02239627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596568|NCT05750576|Chlorhexidine|chlorhexidine|mesh-list
102596569|NCT05750576|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102596570|NCT05750576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102596571|NCT05750576|Disinfectants|disinfectants|mesh-ancestor
102596572|NCT00002594|Cyclophosphamide|cyclophosphamide|mesh-list
102143489|NCT00455403|Chloroquine|chloroquine|mesh-list
102596573|NCT00002594|Melphalan|melphalan|mesh-list
102596574|NCT00002594|Molgramostim|molgramostim|mesh-list
102596575|NCT00002594|Sargramostim|sargramostim|mesh-list
102596576|NCT00002594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102596577|NCT00002594|Immunologic Factors|immunologic factors|mesh-ancestor
102596578|NCT00002594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596579|NCT00002594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102596580|NCT00002594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102596581|NCT00002594|Alkylating Agents|alkylating agents|mesh-ancestor
102596582|NCT00002594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596583|NCT00002594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596584|NCT00002594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102596585|NCT02234011|Ketamine|ketamine|mesh-list
102596586|NCT02234011|Analgesics|analgesics|mesh-ancestor
102596587|NCT02234011|Sensory System Agents|sensory system agents|mesh-ancestor
102596588|NCT02234011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102596589|NCT02234011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596590|NCT02234011|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102596591|NCT02234011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102596592|NCT02234011|Anesthetics, General|anesthetics, general|mesh-ancestor
102596593|NCT02234011|Anesthetics|anesthetics|mesh-ancestor
102596594|NCT02234011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102596595|NCT02234011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102596596|NCT02234011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102596597|NCT02234011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102596598|NCT02234011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596599|NCT00002600|Cyclophosphamide|cyclophosphamide|mesh-list
102596600|NCT00002600|Carboplatin|carboplatin|mesh-list
102596601|NCT00002600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102596602|NCT00002600|Immunologic Factors|immunologic factors|mesh-ancestor
102596603|NCT00002600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596604|NCT00002600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102596605|NCT00002600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102596606|NCT00002600|Alkylating Agents|alkylating agents|mesh-ancestor
102596607|NCT00002600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596608|NCT00002600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596609|NCT00002600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102596610|NCT02177773|Octreotide|octreotide|mesh-list
102596611|NCT02177773|Edotreotide|edotreotide|mesh-list
102596612|NCT02177773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102596613|NCT02177773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102596614|NCT02177773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596615|NCT02177773|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102596616|NCT02177773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596617|NCT02144155|Oxytocin|oxytocin|mesh-list
102596618|NCT02144155|Oxytocics|oxytocics|mesh-ancestor
102596619|NCT02144155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102596620|NCT02144155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596621|NCT00002618|Leucovorin|leucovorin|mesh-list
102596622|NCT00002618|Cobalt|cobalt|mesh-list
102596623|NCT00002618|Cytarabine|cytarabine|mesh-list
102596624|NCT00002618|Prednisone|prednisone|mesh-list
102596625|NCT00002618|Doxorubicin|doxorubicin|mesh-list
102596626|NCT00002618|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102596627|NCT00002618|Methotrexate|methotrexate|mesh-list
102596628|NCT00002618|Vincristine|vincristine|mesh-list
102596629|NCT00002618|Mercaptopurine|mercaptopurine|mesh-list
102596630|NCT00002618|Levoleucovorin|levoleucovorin|mesh-list
102596631|NCT00002618|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102596632|NCT00002618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596633|NCT00002618|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102596634|NCT00002618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102596635|NCT00002618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102596636|NCT00002618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345729|NCT05521828|Progestins|progestins|mesh-ancestor
102596637|NCT00002618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596638|NCT00002618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102596639|NCT00002618|Glucocorticoids|glucocorticoids|mesh-ancestor
102596640|NCT00002618|Hormones|hormones|mesh-ancestor
102596641|NCT00002618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102596642|NCT00002618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102596643|NCT00002618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102596644|NCT00002618|Abortifacient Agents|abortifacient agents|mesh-ancestor
102596645|NCT00002618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102596646|NCT00002618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102596647|NCT00002618|Antimetabolites|antimetabolites|mesh-ancestor
102596648|NCT00002618|Dermatologic Agents|dermatologic agents|mesh-ancestor
102596649|NCT00002618|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102596650|NCT00002618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102596651|NCT00002618|Immunologic Factors|immunologic factors|mesh-ancestor
102596652|NCT00002618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102596653|NCT00002618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102596654|NCT00002618|Antiviral Agents|antiviral agents|mesh-ancestor
102596655|NCT00002618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102596657|NCT00002618|Protective Agents|protective agents|mesh-ancestor
102596658|NCT00002618|Vitamin B Complex|vitamin b complex|mesh-ancestor
102596659|NCT00002618|Vitamins|vitamins|mesh-ancestor
102596660|NCT00002618|Micronutrients|micronutrients|mesh-ancestor
102596661|NCT00002618|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102596662|NCT00002618|Tubulin Modulators|tubulin modulators|mesh-ancestor
102596663|NCT00002618|Antimitotic Agents|antimitotic agents|mesh-ancestor
102596664|NCT00002618|Mitosis Modulators|mitosis modulators|mesh-ancestor
102596665|NCT00002618|Trace Elements|trace elements|mesh-ancestor
102596666|NCT02145169|Nitrous Oxide|nitrous oxide|mesh-list
102596667|NCT02145169|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102596668|NCT02145169|Anesthetics, General|anesthetics, general|mesh-ancestor
102596669|NCT02145169|Anesthetics|anesthetics|mesh-ancestor
102596670|NCT02145169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102596671|NCT02145169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596672|NCT02145169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102596673|NCT02145169|Analgesics|analgesics|mesh-ancestor
102596674|NCT02145169|Sensory System Agents|sensory system agents|mesh-ancestor
102596675|NCT02145169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102596676|NCT02110069|Sirolimus|sirolimus|mesh-list
102596677|NCT02110069|Vincristine|vincristine|mesh-list
102596678|NCT02110069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102596679|NCT02110069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596680|NCT02110069|Tubulin Modulators|tubulin modulators|mesh-ancestor
102596681|NCT02110069|Antimitotic Agents|antimitotic agents|mesh-ancestor
102596682|NCT02110069|Mitosis Modulators|mitosis modulators|mesh-ancestor
102596683|NCT02110069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596684|NCT02110069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102596685|NCT02110069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102596686|NCT02110069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102596687|NCT02110069|Antifungal Agents|antifungal agents|mesh-ancestor
102596688|NCT02110069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102596689|NCT02110069|Immunologic Factors|immunologic factors|mesh-ancestor
102596690|NCT02110069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596691|NCT00002630|Cobalt|cobalt|mesh-list
102596692|NCT00002630|Cyclophosphamide|cyclophosphamide|mesh-list
102596693|NCT00002630|Melphalan|melphalan|mesh-list
102596694|NCT00002630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102596695|NCT00002630|Immunologic Factors|immunologic factors|mesh-ancestor
102596696|NCT00002630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596697|NCT00002630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102596698|NCT00002630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102596699|NCT00002630|Alkylating Agents|alkylating agents|mesh-ancestor
102596700|NCT00002630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596701|NCT00002630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596702|NCT00002630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102596703|NCT00002630|Trace Elements|trace elements|mesh-ancestor
102596704|NCT00002630|Micronutrients|micronutrients|mesh-ancestor
102596705|NCT00002642|Cobalt|cobalt|mesh-list
102596706|NCT00002642|Etoposide|etoposide|mesh-list
102596707|NCT00002642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596708|NCT00002642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102596709|NCT00002642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102596710|NCT00002642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102596711|NCT00002642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102596712|NCT00002642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596713|NCT00002642|Trace Elements|trace elements|mesh-ancestor
102596714|NCT00002642|Micronutrients|micronutrients|mesh-ancestor
102596715|NCT00002642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596716|NCT03983941|Ropivacaine|ropivacaine|mesh-list
102596717|NCT03983941|Anesthetics, Local|anesthetics, local|mesh-ancestor
102596718|NCT03983941|Anesthetics|anesthetics|mesh-ancestor
102596719|NCT03983941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102596720|NCT03983941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596721|NCT03983941|Sensory System Agents|sensory system agents|mesh-ancestor
102596722|NCT03983941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102596723|NCT05750030|Bevacizumab|bevacizumab|mesh-list
102596724|NCT05750030|Atezolizumab|atezolizumab|mesh-list
102596725|NCT05750030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102596726|NCT05750030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596727|NCT05750030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102596728|NCT05750030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102596729|NCT05750030|Growth Substances|growth substances|mesh-ancestor
102596730|NCT05750030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596731|NCT05750030|Growth Inhibitors|growth inhibitors|mesh-ancestor
102596732|NCT05750030|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102596733|NCT05750030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596734|NCT04331054|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
102596735|NCT04331054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102596736|NCT04331054|Respiratory System Agents|respiratory system agents|mesh-ancestor
102596737|NCT00002654|Cobalt|cobalt|mesh-list
102596738|NCT00002654|Trace Elements|trace elements|mesh-ancestor
102596739|NCT00002654|Micronutrients|micronutrients|mesh-ancestor
102596740|NCT00002654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596741|NCT01426555|Zoledronic Acid|zoledronic acid|mesh-list
102596742|NCT01426555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102596743|NCT01426555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596744|NCT01434745|Simvastatin|simvastatin|mesh-list
102596745|NCT01434745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102596746|NCT01434745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102596747|NCT01434745|Antimetabolites|antimetabolites|mesh-ancestor
102596748|NCT01434745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596749|NCT01434745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102596750|NCT01434745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102596751|NCT01434745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102596752|NCT01401049|Lidocaine|lidocaine|mesh-list
102596753|NCT01401049|Propofol|propofol|mesh-list
102596754|NCT01401049|Fospropofol|fospropofol|mesh-list
102596755|NCT01401049|Anesthetics, Local|anesthetics, local|mesh-ancestor
102596756|NCT01401049|Anesthetics|anesthetics|mesh-ancestor
102596757|NCT01401049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102596758|NCT01401049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596759|NCT01401049|Sensory System Agents|sensory system agents|mesh-ancestor
102596760|NCT01401049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102596761|NCT01401049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102596762|NCT01401049|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102596763|NCT01401049|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102596764|NCT01401049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102596765|NCT01401049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596766|NCT01401049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102596767|NCT01401049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102596768|NCT01401049|Anesthetics, General|anesthetics, general|mesh-ancestor
102596769|NCT00381758|Methylphenidate|methylphenidate|mesh-list
102596770|NCT00381758|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102596771|NCT00381758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596772|NCT00381758|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102596773|NCT00381758|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102596774|NCT00381758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102596775|NCT00381758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596776|NCT00381758|Dopamine Agents|dopamine agents|mesh-ancestor
102596777|NCT00381758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102596778|NCT01402531|Bevacizumab|bevacizumab|mesh-list
102596779|NCT01402531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102596780|NCT01402531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596781|NCT01402531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102596782|NCT01402531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102596783|NCT01402531|Growth Substances|growth substances|mesh-ancestor
102596784|NCT01402531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596785|NCT01402531|Growth Inhibitors|growth inhibitors|mesh-ancestor
102596786|NCT00381836|Darbepoetin alfa|darbepoetin alfa|mesh-list
102596787|NCT00381836|Hematinics|hematinics|mesh-ancestor
102596788|NCT01971853|Analgesics|analgesics|mesh-list
102596789|NCT01971853|Sensory System Agents|sensory system agents|mesh-ancestor
102596790|NCT01971853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102596791|NCT01971853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596792|NCT00002678|Dexamethasone|dexamethasone|mesh-list
102596793|NCT00002678|Prednisone|prednisone|mesh-list
102596794|NCT00002678|Melphalan|melphalan|mesh-list
102596795|NCT00002678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102596796|NCT00002678|Antiemetics|antiemetics|mesh-ancestor
102596797|NCT00002678|Autonomic Agents|autonomic agents|mesh-ancestor
102596798|NCT00002678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102596799|NCT00002678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596800|NCT00002678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102143716|NCT05014516|Anesthetics|anesthetics|mesh-ancestor
102596801|NCT00002678|Glucocorticoids|glucocorticoids|mesh-ancestor
102596802|NCT00002678|Hormones|hormones|mesh-ancestor
102596803|NCT00002678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102596804|NCT00002678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102596805|NCT00002678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596806|NCT00002678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102596807|NCT00002678|Alkylating Agents|alkylating agents|mesh-ancestor
102596808|NCT00002678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596809|NCT00002678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102596810|NCT00002678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102596811|NCT00002678|Immunologic Factors|immunologic factors|mesh-ancestor
102596812|NCT01397695|Bevacizumab|bevacizumab|mesh-list
102596813|NCT01397695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102596814|NCT01397695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596815|NCT01397695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102596816|NCT01397695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102596817|NCT01397695|Growth Substances|growth substances|mesh-ancestor
102596818|NCT01397695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596819|NCT01397695|Growth Inhibitors|growth inhibitors|mesh-ancestor
102596820|NCT00002684|Paclitaxel|paclitaxel|mesh-list
102596821|NCT00002684|Ifosfamide|ifosfamide|mesh-list
102596822|NCT00002684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102596823|NCT00002684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596824|NCT00002684|Tubulin Modulators|tubulin modulators|mesh-ancestor
102596825|NCT00002684|Antimitotic Agents|antimitotic agents|mesh-ancestor
102596826|NCT00002684|Mitosis Modulators|mitosis modulators|mesh-ancestor
102596827|NCT00002684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596828|NCT00002684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102596829|NCT00002684|Alkylating Agents|alkylating agents|mesh-ancestor
102596830|NCT02972918|Simendan|simendan|mesh-list
102596831|NCT02972918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102596832|NCT02972918|Vasodilator Agents|vasodilator agents|mesh-ancestor
102596833|NCT02972918|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102596834|NCT02972918|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102596835|NCT02972918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102596836|NCT02972918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596837|NCT02972918|Protective Agents|protective agents|mesh-ancestor
102596838|NCT02972918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596839|NCT05600491|Temozolomide|temozolomide|mesh-list
102596840|NCT05600491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102596841|NCT05600491|Alkylating Agents|alkylating agents|mesh-ancestor
102596842|NCT05600491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596843|NCT05600491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596844|NCT00002696|Cyclophosphamide|cyclophosphamide|mesh-list
102596845|NCT00002696|Doxorubicin|doxorubicin|mesh-list
102596846|NCT00002696|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102596847|NCT00002696|Fluorouracil|fluorouracil|mesh-list
102596848|NCT00002696|Methotrexate|methotrexate|mesh-list
102596849|NCT00002696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102596850|NCT00002696|Immunologic Factors|immunologic factors|mesh-ancestor
102596851|NCT00002696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596852|NCT00002696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102596853|NCT00002696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102596854|NCT00002696|Alkylating Agents|alkylating agents|mesh-ancestor
102596855|NCT00002696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596856|NCT00002696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596857|NCT00002696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102596858|NCT00002696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102596859|NCT00002696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102596860|NCT00002696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102596861|NCT00002696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102596862|NCT00002696|Antimetabolites|antimetabolites|mesh-ancestor
102596863|NCT00002696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102596864|NCT00002696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102596865|NCT00002696|Abortifacient Agents|abortifacient agents|mesh-ancestor
102596866|NCT00002696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102596867|NCT00002696|Dermatologic Agents|dermatologic agents|mesh-ancestor
102596868|NCT00002696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102596869|NCT00002696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102596870|NCT00002702|Aldesleukin|aldesleukin|mesh-list
102596871|NCT00002702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596872|NCT00002702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102596873|NCT00002702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102596874|NCT00002702|Antiviral Agents|antiviral agents|mesh-ancestor
102596875|NCT00002702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102596876|NCT01890577|Darbepoetin alfa|darbepoetin alfa|mesh-list
102596877|NCT01890577|Hematinics|hematinics|mesh-ancestor
102596878|NCT01315873|Bortezomib|bortezomib|mesh-list
102596879|NCT01315873|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102596880|NCT01315873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596881|NCT01315873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102596882|NCT01315873|Alkylating Agents|alkylating agents|mesh-ancestor
102596883|NCT01315873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596884|NCT01895959|Hyaluronic Acid|hyaluronic acid|mesh-list
102596885|NCT01895959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102596886|NCT01895959|Immunologic Factors|immunologic factors|mesh-ancestor
102596887|NCT01895959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596888|NCT01895959|Viscosupplements|viscosupplements|mesh-ancestor
102596889|NCT01895959|Protective Agents|protective agents|mesh-ancestor
102596890|NCT01303003|Dexamethasone|dexamethasone|mesh-list
102596891|NCT01303003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102596892|NCT01303003|Antiemetics|antiemetics|mesh-ancestor
102596893|NCT01303003|Autonomic Agents|autonomic agents|mesh-ancestor
102596894|NCT01303003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102596895|NCT01303003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596896|NCT01303003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102596897|NCT01303003|Glucocorticoids|glucocorticoids|mesh-ancestor
102596898|NCT01303003|Hormones|hormones|mesh-ancestor
102596899|NCT01303003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102596900|NCT01303003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102596901|NCT01303003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596902|NCT00002714|Prednisone|prednisone|mesh-list
102596903|NCT00002714|Doxorubicin|doxorubicin|mesh-list
102596904|NCT00002714|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102596905|NCT00002714|Bleomycin|bleomycin|mesh-list
102596906|NCT00002714|Etoposide|etoposide|mesh-list
102596907|NCT00002714|Vincristine|vincristine|mesh-list
102596908|NCT00002714|Vinblastine|vinblastine|mesh-list
102596909|NCT00002714|Mechlorethamine|mechlorethamine|mesh-list
102596910|NCT00002714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102596911|NCT00002714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596912|NCT00002714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102596913|NCT00002714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102596914|NCT00002714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102596915|NCT00002714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596916|NCT00002714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102596917|NCT00002714|Glucocorticoids|glucocorticoids|mesh-ancestor
102596918|NCT00002714|Hormones|hormones|mesh-ancestor
102596919|NCT00002714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102596920|NCT00002714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596921|NCT00002714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102596922|NCT00002714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102596923|NCT00002714|Tubulin Modulators|tubulin modulators|mesh-ancestor
102596924|NCT00002714|Antimitotic Agents|antimitotic agents|mesh-ancestor
102596925|NCT00002714|Mitosis Modulators|mitosis modulators|mesh-ancestor
102596926|NCT00002714|Alkylating Agents|alkylating agents|mesh-ancestor
102596927|NCT00002714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102596928|NCT00002720|Tamoxifen|tamoxifen|mesh-list
102596929|NCT00002720|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102596930|NCT00002720|Hormone Antagonists|hormone antagonists|mesh-ancestor
102596931|NCT00002720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102596932|NCT00002720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596933|NCT00002720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102596934|NCT00002720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596935|NCT00002720|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102596936|NCT00002720|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102596937|NCT00002720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102596938|NCT01821859|Bevacizumab|bevacizumab|mesh-list
102596939|NCT01821859|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102596940|NCT01821859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102596941|NCT01821859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596942|NCT01821859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102596943|NCT01821859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102596944|NCT01821859|Growth Substances|growth substances|mesh-ancestor
102596945|NCT01821859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596946|NCT01821859|Growth Inhibitors|growth inhibitors|mesh-ancestor
102596947|NCT05600023|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102596948|NCT05600023|Nitrofurantoin|nitrofurantoin|mesh-list
102596949|NCT05600023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102143876|NCT03650881|Adapalene|adapalene|mesh-list
102596951|NCT01194427|Tamoxifen|tamoxifen|mesh-list
102596952|NCT01194427|Vorinostat|vorinostat|mesh-list
102596953|NCT01194427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102596954|NCT01194427|Hormone Antagonists|hormone antagonists|mesh-ancestor
102596955|NCT01194427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102596956|NCT01194427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596957|NCT01194427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102596958|NCT01194427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596959|NCT01194427|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102596960|NCT01194427|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102596961|NCT01194427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102596962|NCT01194427|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102596963|NCT01194427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102596964|NCT01194427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596965|NCT05599555|Vaccines|vaccines|mesh-list
102596966|NCT05599555|Immunologic Factors|immunologic factors|mesh-ancestor
102596967|NCT05599555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596968|NCT00002738|Leucovorin|leucovorin|mesh-list
102596969|NCT00002738|Trimetrexate|trimetrexate|mesh-list
102596970|NCT00002738|Calcium|calcium|mesh-list
102596971|NCT00002738|Levoleucovorin|levoleucovorin|mesh-list
102596972|NCT00002738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102596973|NCT00002738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596974|NCT00002738|Antidotes|antidotes|mesh-ancestor
102596975|NCT00002738|Protective Agents|protective agents|mesh-ancestor
102596976|NCT00002738|Vitamin B Complex|vitamin b complex|mesh-ancestor
102596977|NCT00002738|Vitamins|vitamins|mesh-ancestor
102596978|NCT00002738|Micronutrients|micronutrients|mesh-ancestor
102596979|NCT00002738|Antifungal Agents|antifungal agents|mesh-ancestor
102596980|NCT00002738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102596981|NCT00002738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102596982|NCT00002738|Antimetabolites|antimetabolites|mesh-ancestor
102596983|NCT00002738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102596984|NCT00002738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102596985|NCT00002738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102596986|NCT00002738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102596987|NCT04706455|Hyaluronic Acid|hyaluronic acid|mesh-list
102596988|NCT04706455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102596989|NCT04706455|Immunologic Factors|immunologic factors|mesh-ancestor
102596990|NCT04706455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102596991|NCT04706455|Viscosupplements|viscosupplements|mesh-ancestor
102596992|NCT04706455|Protective Agents|protective agents|mesh-ancestor
102596993|NCT00002744|Cobalt|cobalt|mesh-list
102596994|NCT00002744|Cytarabine|cytarabine|mesh-list
102596995|NCT00002744|Dexamethasone|dexamethasone|mesh-list
102596996|NCT00002744|Prednisone|prednisone|mesh-list
102596997|NCT00002744|Hydrocortisone|hydrocortisone|mesh-list
102596998|NCT00002744|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102596999|NCT00002744|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102597000|NCT00002744|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102597001|NCT00002744|Cyclophosphamide|cyclophosphamide|mesh-list
102597002|NCT00002744|Doxorubicin|doxorubicin|mesh-list
102597003|NCT00002744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102597004|NCT00002744|Methotrexate|methotrexate|mesh-list
102597005|NCT00002744|Vincristine|vincristine|mesh-list
102597006|NCT00002744|Daunorubicin|daunorubicin|mesh-list
102597007|NCT00002744|Asparaginase|asparaginase|mesh-list
102597008|NCT00002744|Mercaptopurine|mercaptopurine|mesh-list
102597009|NCT00002744|Pegaspargase|pegaspargase|mesh-list
102597010|NCT00002744|Thioguanine|thioguanine|mesh-list
102597011|NCT00002744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102597012|NCT00002744|Immunologic Factors|immunologic factors|mesh-ancestor
102597013|NCT00002744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597014|NCT00002744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102597015|NCT00002744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102597016|NCT00002744|Alkylating Agents|alkylating agents|mesh-ancestor
102597017|NCT00002744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597018|NCT00002744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597019|NCT00002744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102597020|NCT00002744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102597021|NCT00002744|Antiemetics|antiemetics|mesh-ancestor
102597022|NCT00002744|Autonomic Agents|autonomic agents|mesh-ancestor
102143945|NCT04447053|Belimumab|belimumab|mesh-list
102597023|NCT00002744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102597024|NCT00002744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102597025|NCT00002744|Glucocorticoids|glucocorticoids|mesh-ancestor
102597026|NCT00002744|Hormones|hormones|mesh-ancestor
102597027|NCT00002744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102597028|NCT00002744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102597029|NCT00002744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102597030|NCT00002744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102597031|NCT00002744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102597032|NCT00002744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102597033|NCT00002744|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102597034|NCT00002744|Abortifacient Agents|abortifacient agents|mesh-ancestor
102597035|NCT00002744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102597036|NCT00002744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102597037|NCT00002744|Antimetabolites|antimetabolites|mesh-ancestor
102597038|NCT00002744|Dermatologic Agents|dermatologic agents|mesh-ancestor
102597039|NCT00002744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102597040|NCT00002744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102597041|NCT00002744|Antiviral Agents|antiviral agents|mesh-ancestor
102597042|NCT00002744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102597043|NCT00002744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102597044|NCT00002744|Tubulin Modulators|tubulin modulators|mesh-ancestor
102597045|NCT00002744|Antimitotic Agents|antimitotic agents|mesh-ancestor
102597046|NCT00002744|Mitosis Modulators|mitosis modulators|mesh-ancestor
102597047|NCT00002744|Trace Elements|trace elements|mesh-ancestor
102597048|NCT00002744|Micronutrients|micronutrients|mesh-ancestor
102597049|NCT01788475|Dexamethasone|dexamethasone|mesh-list
102597050|NCT01788475|Dexamethasone acetate|dexamethasone acetate|mesh-list
102597051|NCT01788475|BB 1101|bb 1101|mesh-list
102597052|NCT01788475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102597053|NCT01788475|Antiemetics|antiemetics|mesh-ancestor
102597054|NCT01788475|Autonomic Agents|autonomic agents|mesh-ancestor
102597055|NCT01788475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102597056|NCT01788475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597057|NCT01788475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102597058|NCT01788475|Glucocorticoids|glucocorticoids|mesh-ancestor
102597059|NCT01788475|Hormones|hormones|mesh-ancestor
102597060|NCT01788475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102597061|NCT01788475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102597062|NCT01788475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597063|NCT01788475|Protease Inhibitors|protease inhibitors|mesh-ancestor
102597064|NCT01788475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102597065|NCT01788475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597066|NCT01183897|Immunomodulating Agents|immunomodulating agents|mesh-list
102597067|NCT01183897|Immunologic Factors|immunologic factors|mesh-ancestor
102597068|NCT01183897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597069|NCT00381914|Vitamin D|vitamin d|mesh-list
102597070|NCT00381914|Ergocalciferols|ergocalciferols|mesh-list
102597071|NCT00381914|Cholecalciferol|cholecalciferol|mesh-list
102597072|NCT00381914|Vitamins|vitamins|mesh-list
102597073|NCT00381914|Micronutrients|micronutrients|mesh-ancestor
102597074|NCT00381914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597075|NCT00381914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102597076|NCT00381914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102597077|NCT00423007|Bromfenac|bromfenac|mesh-list
102597078|NCT00423007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102597079|NCT00423007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102597080|NCT00423007|Analgesics|analgesics|mesh-ancestor
102597081|NCT00423007|Sensory System Agents|sensory system agents|mesh-ancestor
102597082|NCT00423007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102597083|NCT00423007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597084|NCT00423007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102597085|NCT00423007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102597086|NCT04713787|Albendazole|albendazole|mesh-list
102597087|NCT04713787|Oxfendazole|oxfendazole|mesh-list
102597088|NCT04713787|Anthelmintics|anthelmintics|mesh-ancestor
102597089|NCT04713787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102597090|NCT04713787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102597091|NCT04713787|Anticestodal Agents|anticestodal agents|mesh-ancestor
102597092|NCT04713787|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102597093|NCT04713787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102597094|NCT04713787|Tubulin Modulators|tubulin modulators|mesh-ancestor
102597095|NCT04713787|Antimitotic Agents|antimitotic agents|mesh-ancestor
102597096|NCT04713787|Mitosis Modulators|mitosis modulators|mesh-ancestor
102597097|NCT04713787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597098|NCT04713787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597099|NCT04713787|Antinematodal Agents|antinematodal agents|mesh-ancestor
102597100|NCT00002750|Melphalan|melphalan|mesh-list
102597101|NCT00002750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102597102|NCT00002750|Alkylating Agents|alkylating agents|mesh-ancestor
102597103|NCT00002750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597104|NCT00002750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597105|NCT00002750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102597106|NCT00002750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102597107|NCT00002750|Immunologic Factors|immunologic factors|mesh-ancestor
102597108|NCT00002750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597109|NCT00002756|Leucovorin|leucovorin|mesh-list
102597110|NCT00002756|Cytarabine|cytarabine|mesh-list
102597111|NCT00002756|Prednisone|prednisone|mesh-list
102597112|NCT00002756|Hydrocortisone|hydrocortisone|mesh-list
102597113|NCT00002756|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102597114|NCT00002756|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102597115|NCT00002756|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102597116|NCT00002756|Cyclophosphamide|cyclophosphamide|mesh-list
102597117|NCT00002756|Methotrexate|methotrexate|mesh-list
102597118|NCT00002756|Etoposide|etoposide|mesh-list
102597119|NCT00002756|Vincristine|vincristine|mesh-list
102597120|NCT00002756|Daunorubicin|daunorubicin|mesh-list
102597121|NCT00002756|Asparaginase|asparaginase|mesh-list
102597122|NCT00002756|Mercaptopurine|mercaptopurine|mesh-list
102597123|NCT00002756|Levoleucovorin|levoleucovorin|mesh-list
102597124|NCT00002756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102597125|NCT00002756|Immunologic Factors|immunologic factors|mesh-ancestor
102597126|NCT00002756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597127|NCT00002756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102597128|NCT00002756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102597129|NCT00002756|Alkylating Agents|alkylating agents|mesh-ancestor
102597130|NCT00002756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597131|NCT00002756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597132|NCT00002756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102597133|NCT00002756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102597134|NCT00002756|Glucocorticoids|glucocorticoids|mesh-ancestor
102597135|NCT00002756|Hormones|hormones|mesh-ancestor
102597136|NCT00002756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102597137|NCT00002756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102597138|NCT00002756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102597139|NCT00002756|Abortifacient Agents|abortifacient agents|mesh-ancestor
102597140|NCT00002756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102597141|NCT00002756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102597142|NCT00002756|Antimetabolites|antimetabolites|mesh-ancestor
102597143|NCT00002756|Dermatologic Agents|dermatologic agents|mesh-ancestor
102597144|NCT00002756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102597145|NCT00002756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102597146|NCT00002756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102597147|NCT00002756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102597148|NCT00002756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102597149|NCT00002756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102597150|NCT00002756|Antiviral Agents|antiviral agents|mesh-ancestor
102597151|NCT00002756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102597152|NCT00002756|Antidotes|antidotes|mesh-ancestor
102597153|NCT00002756|Protective Agents|protective agents|mesh-ancestor
102597154|NCT00002756|Vitamin B Complex|vitamin b complex|mesh-ancestor
102597155|NCT00002756|Vitamins|vitamins|mesh-ancestor
102597156|NCT00002756|Micronutrients|micronutrients|mesh-ancestor
102597157|NCT00002756|Tubulin Modulators|tubulin modulators|mesh-ancestor
102597158|NCT00002756|Antimitotic Agents|antimitotic agents|mesh-ancestor
102597159|NCT00002756|Mitosis Modulators|mitosis modulators|mesh-ancestor
102597160|NCT00002756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102597161|NCT01183429|Tretinoin|tretinoin|mesh-list
102597162|NCT01183429|Isotretinoin|isotretinoin|mesh-list
102597163|NCT01183429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597164|NCT01183429|Keratolytic Agents|keratolytic agents|mesh-ancestor
102597165|NCT01183429|Dermatologic Agents|dermatologic agents|mesh-ancestor
102597166|NCT01157533|Vancomycin|vancomycin|mesh-list
102597167|NCT01157533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102597168|NCT01157533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102597169|NCT05749016|Paclitaxel|paclitaxel|mesh-list
102597170|NCT05749016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102597171|NCT05749016|Carboplatin|carboplatin|mesh-list
102597172|NCT05749016|Pertuzumab|pertuzumab|mesh-list
102597173|NCT05749016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102597174|NCT05749016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597175|NCT05749016|Tubulin Modulators|tubulin modulators|mesh-ancestor
102597176|NCT05749016|Antimitotic Agents|antimitotic agents|mesh-ancestor
102597177|NCT05749016|Mitosis Modulators|mitosis modulators|mesh-ancestor
102597178|NCT05749016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597179|NCT05749016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102597180|NCT01756573|Bupivacaine|bupivacaine|mesh-list
102597181|NCT01756573|Anesthetics, Local|anesthetics, local|mesh-ancestor
102597182|NCT01756573|Anesthetics|anesthetics|mesh-ancestor
102597183|NCT01756573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102597184|NCT01756573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597185|NCT01756573|Sensory System Agents|sensory system agents|mesh-ancestor
102597186|NCT01756573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102597187|NCT01126801|Estradiol|estradiol|mesh-list
102597188|NCT01126801|Estrogens|estrogens|mesh-ancestor
102597189|NCT01126801|Hormones|hormones|mesh-ancestor
102597190|NCT01126801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102597191|NCT01126801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597192|NCT01702909|Interleukin-2|interleukin-2|mesh-list
102597193|NCT01702909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597194|NCT01702909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102597195|NCT01702909|Analgesics|analgesics|mesh-ancestor
102597196|NCT01702909|Sensory System Agents|sensory system agents|mesh-ancestor
102597197|NCT01702909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102597198|NCT01702909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597199|NCT00002768|Cytarabine|cytarabine|mesh-list
102597200|NCT00002768|Methotrexate|methotrexate|mesh-list
102597201|NCT00002768|Etoposide|etoposide|mesh-list
102597202|NCT00002768|Busulfan|busulfan|mesh-list
102597203|NCT00002768|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102597204|NCT00002768|Abortifacient Agents|abortifacient agents|mesh-ancestor
102597205|NCT00002768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102597206|NCT00002768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597207|NCT00002768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102597208|NCT00002768|Antimetabolites|antimetabolites|mesh-ancestor
102597209|NCT00002768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597210|NCT00002768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597211|NCT00002768|Dermatologic Agents|dermatologic agents|mesh-ancestor
102597212|NCT00002768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102597213|NCT00002768|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102597214|NCT00002768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102597215|NCT00002768|Immunologic Factors|immunologic factors|mesh-ancestor
102597216|NCT00002768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102597217|NCT00002768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102597218|NCT00002768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102597219|NCT00002768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102597220|NCT00002768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102597221|NCT00002768|Antiviral Agents|antiviral agents|mesh-ancestor
102597222|NCT00002768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102597223|NCT00002768|Alkylating Agents|alkylating agents|mesh-ancestor
102597224|NCT00002768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102597225|NCT00002768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102597226|NCT00002774|Cisplatin|cisplatin|mesh-list
102597227|NCT00002774|Fluorouracil|fluorouracil|mesh-list
102597228|NCT00002774|Tirapazamine|tirapazamine|mesh-list
102597229|NCT00002774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597230|NCT00002774|Antimetabolites|antimetabolites|mesh-ancestor
102597231|NCT00002774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597232|NCT00002774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102597233|NCT00002774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102597234|NCT00002774|Immunologic Factors|immunologic factors|mesh-ancestor
102597235|NCT00002774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597236|NCT00002780|Aldesleukin|aldesleukin|mesh-list
102597237|NCT00002780|Cyclophosphamide|cyclophosphamide|mesh-list
102597238|NCT00002780|Thiotepa|thiotepa|mesh-list
102597239|NCT00002780|Carboplatin|carboplatin|mesh-list
102597240|NCT00002780|Sargramostim|sargramostim|mesh-list
102597241|NCT00002780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102597242|NCT00002780|Immunologic Factors|immunologic factors|mesh-ancestor
102597243|NCT00002780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597244|NCT00002780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102597245|NCT00002780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102597246|NCT00002780|Alkylating Agents|alkylating agents|mesh-ancestor
102597247|NCT00002780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597248|NCT00002780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597249|NCT00002780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102597250|NCT00002780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102597251|NCT00002780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102597252|NCT00002780|Antiviral Agents|antiviral agents|mesh-ancestor
102597253|NCT00002780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102597254|NCT01692691|Dacarbazine|dacarbazine|mesh-list
102597255|NCT01692691|Carmustine|carmustine|mesh-list
102597256|NCT01692691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102597257|NCT01692691|Alkylating Agents|alkylating agents|mesh-ancestor
102597258|NCT01692691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597259|NCT01692691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597260|NCT01127503|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
102597261|NCT01127503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102597262|NCT01127503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597263|NCT01122511|Dexamethasone|dexamethasone|mesh-list
102597264|NCT01122511|Ranibizumab|ranibizumab|mesh-list
102597265|NCT01122511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102597266|NCT01122511|Antiemetics|antiemetics|mesh-ancestor
102597267|NCT01122511|Autonomic Agents|autonomic agents|mesh-ancestor
102597268|NCT01122511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102597269|NCT01122511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597270|NCT01122511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102597271|NCT01122511|Glucocorticoids|glucocorticoids|mesh-ancestor
102597272|NCT01122511|Hormones|hormones|mesh-ancestor
102597273|NCT01122511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102597274|NCT01122511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102597275|NCT01122511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597276|NCT01122511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102597277|NCT01122511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102597278|NCT01122511|Growth Substances|growth substances|mesh-ancestor
102597279|NCT01122511|Growth Inhibitors|growth inhibitors|mesh-ancestor
102597280|NCT05535218|Pembrolizumab|pembrolizumab|mesh-list
102597281|NCT05535218|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
102597282|NCT05535218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102597283|NCT05535218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597284|NCT05535218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102597285|NCT05535218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597286|NCT05535218|Immunoconjugates|immunoconjugates|mesh-ancestor
102597287|NCT05535218|Immunologic Factors|immunologic factors|mesh-ancestor
102597288|NCT05535218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597289|NCT05531708|Cyclophosphamide|cyclophosphamide|mesh-list
102597290|NCT05531708|Fludarabine|fludarabine|mesh-list
102597291|NCT05531708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102597292|NCT05531708|Immunologic Factors|immunologic factors|mesh-ancestor
102597293|NCT05531708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597294|NCT05531708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102597295|NCT05531708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102597296|NCT05531708|Alkylating Agents|alkylating agents|mesh-ancestor
102597297|NCT05531708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597298|NCT05531708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597299|NCT05531708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102597300|NCT01663285|Gemcitabine|gemcitabine|mesh-list
102597301|NCT01663285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597302|NCT01663285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102597303|NCT01663285|Antimetabolites|antimetabolites|mesh-ancestor
102597304|NCT01663285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597305|NCT00002786|Aldesleukin|aldesleukin|mesh-list
102597306|NCT00002786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597307|NCT00002786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102597308|NCT00002786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102597309|NCT00002786|Antiviral Agents|antiviral agents|mesh-ancestor
102597310|NCT00002786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102597311|NCT00378937|Acetaminophen|acetaminophen|mesh-list
102597312|NCT00378937|Morphine|morphine|mesh-list
102597313|NCT00378937|Oxycodone|oxycodone|mesh-list
102597314|NCT00378937|Codeine|codeine|mesh-list
102597315|NCT00378937|Dextropropoxyphene|dextropropoxyphene|mesh-list
102597316|NCT00378937|Levopropoxyphene|levopropoxyphene|mesh-list
102597317|NCT00378937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102597318|NCT00378937|Narcotics|narcotics|mesh-ancestor
102597319|NCT00378937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102597320|NCT00378937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597321|NCT00378937|Analgesics|analgesics|mesh-ancestor
102597322|NCT00378937|Sensory System Agents|sensory system agents|mesh-ancestor
102597323|NCT00378937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102597324|NCT00378937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102597325|NCT00378937|Antipyretics|antipyretics|mesh-ancestor
102597326|NCT00378937|Antitussive Agents|antitussive agents|mesh-ancestor
102597327|NCT00378937|Respiratory System Agents|respiratory system agents|mesh-ancestor
102597328|NCT00002792|Cyclosporine|cyclosporine|mesh-list
102597329|NCT00002792|Cyclophosphamide|cyclophosphamide|mesh-list
102597330|NCT00002792|Busulfan|busulfan|mesh-list
102144252|NCT05110209|Bevacizumab|bevacizumab|mesh-list
102597331|NCT00002792|Methotrexate|methotrexate|mesh-list
102597332|NCT00002792|Tacrolimus|tacrolimus|mesh-list
102597333|NCT00002792|Cyclosporins|cyclosporins|mesh-list
102597334|NCT00002792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102597335|NCT00002792|Immunologic Factors|immunologic factors|mesh-ancestor
102597336|NCT00002792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597337|NCT00002792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102597338|NCT00002792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102597339|NCT00002792|Alkylating Agents|alkylating agents|mesh-ancestor
102597340|NCT00002792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597341|NCT00002792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597342|NCT00002792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102597343|NCT00002792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102597344|NCT00002792|Abortifacient Agents|abortifacient agents|mesh-ancestor
102597345|NCT00002792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102597346|NCT00002792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102597347|NCT00002792|Antimetabolites|antimetabolites|mesh-ancestor
102597348|NCT00002792|Dermatologic Agents|dermatologic agents|mesh-ancestor
102597349|NCT00002792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102597350|NCT00002792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102597351|NCT00002792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102597352|NCT00002792|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102597353|NCT00002792|Antifungal Agents|antifungal agents|mesh-ancestor
102597354|NCT00002792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102597355|NCT01090141|Micafungin|micafungin|mesh-list
102597356|NCT01090141|Antifungal Agents|antifungal agents|mesh-ancestor
102597357|NCT01090141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102597358|NCT01048723|Everolimus|everolimus|mesh-list
102597359|NCT01048723|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102597360|NCT01048723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102597361|NCT01048723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102597362|NCT01048723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597363|NCT01048723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102597364|NCT01048723|Immunologic Factors|immunologic factors|mesh-ancestor
102597365|NCT01048723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597366|NCT01048723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597367|NCT05513612|Cyclophosphamide|cyclophosphamide|mesh-list
102597368|NCT05513612|Fludarabine|fludarabine|mesh-list
102597369|NCT05513612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102597370|NCT05513612|Immunologic Factors|immunologic factors|mesh-ancestor
102597371|NCT05513612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597372|NCT05513612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102597373|NCT05513612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102597374|NCT05513612|Alkylating Agents|alkylating agents|mesh-ancestor
102597375|NCT05513612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597376|NCT05513612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597377|NCT05513612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102597378|NCT05594407|Lidocaine|lidocaine|mesh-list
102597379|NCT05594407|Dexmedetomidine|dexmedetomidine|mesh-list
102597380|NCT05594407|Ketamine|ketamine|mesh-list
102597381|NCT05594407|Remifentanil|remifentanil|mesh-list
102597382|NCT05594407|Anesthetics, Local|anesthetics, local|mesh-ancestor
102597383|NCT05594407|Anesthetics|anesthetics|mesh-ancestor
102597384|NCT05594407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102597385|NCT05594407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597386|NCT05594407|Sensory System Agents|sensory system agents|mesh-ancestor
102597387|NCT05594407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102597388|NCT05594407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102597389|NCT05594407|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102597390|NCT05594407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102597391|NCT05594407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102597392|NCT05594407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597393|NCT05594407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102597394|NCT05594407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102597395|NCT05594407|Analgesics|analgesics|mesh-ancestor
102597396|NCT05594407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102597397|NCT05594407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102597398|NCT05594407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102597399|NCT05594407|Adrenergic Agents|adrenergic agents|mesh-ancestor
102597400|NCT05594407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102597401|NCT05594407|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102597402|NCT05594407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102597403|NCT05594407|Anesthetics, General|anesthetics, general|mesh-ancestor
102597404|NCT05594407|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102597405|NCT05594407|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102597406|NCT05594407|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102597407|NCT05594407|Narcotics|narcotics|mesh-ancestor
102597408|NCT00379717|Docetaxel|docetaxel|mesh-list
102597409|NCT00379717|Cisplatin|cisplatin|mesh-list
102597410|NCT00379717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597411|NCT00379717|Tubulin Modulators|tubulin modulators|mesh-ancestor
102597412|NCT00379717|Antimitotic Agents|antimitotic agents|mesh-ancestor
102597413|NCT00379717|Mitosis Modulators|mitosis modulators|mesh-ancestor
102597414|NCT00379717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597415|NCT04706377|Vitamin B 12|vitamin b 12|mesh-list
102597416|NCT04706377|Vitamins|vitamins|mesh-ancestor
102597417|NCT04706377|Micronutrients|micronutrients|mesh-ancestor
102597418|NCT04706377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597419|NCT04706377|Vitamin B Complex|vitamin b complex|mesh-ancestor
102597420|NCT01583647|Niacin|niacin|mesh-list
102597421|NCT01583647|Niacinamide|niacinamide|mesh-list
102597422|NCT01583647|Nicotinic Acids|nicotinic acids|mesh-list
102597423|NCT01583647|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102597424|NCT01583647|Antimetabolites|antimetabolites|mesh-ancestor
102597425|NCT01583647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597426|NCT01583647|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102597427|NCT01583647|Vasodilator Agents|vasodilator agents|mesh-ancestor
102597428|NCT01583647|Vitamin B Complex|vitamin b complex|mesh-ancestor
102597429|NCT01583647|Vitamins|vitamins|mesh-ancestor
102597430|NCT01583647|Micronutrients|micronutrients|mesh-ancestor
102597431|NCT01583647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597432|NCT04403516|Dexamethasone|dexamethasone|mesh-list
102597433|NCT04403516|Prednisolone|prednisolone|mesh-list
102597434|NCT04403516|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102597435|NCT04403516|Methylprednisolone|methylprednisolone|mesh-list
102597436|NCT04403516|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102597437|NCT04403516|Prednisolone acetate|prednisolone acetate|mesh-list
102597438|NCT04403516|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102597439|NCT04403516|Prednisolone phosphate|prednisolone phosphate|mesh-list
102597440|NCT04403516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102597441|NCT04403516|Antiemetics|antiemetics|mesh-ancestor
102597442|NCT04403516|Autonomic Agents|autonomic agents|mesh-ancestor
102597443|NCT04403516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102597444|NCT04403516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597445|NCT04403516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102597446|NCT04403516|Glucocorticoids|glucocorticoids|mesh-ancestor
102597447|NCT04403516|Hormones|hormones|mesh-ancestor
102597448|NCT04403516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102597449|NCT04403516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102597450|NCT04403516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597451|NCT04403516|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102597452|NCT04403516|Protective Agents|protective agents|mesh-ancestor
102597453|NCT01555489|Ascorbic Acid|ascorbic acid|mesh-list
102597454|NCT01555489|Vitamins|vitamins|mesh-ancestor
102597455|NCT01555489|Micronutrients|micronutrients|mesh-ancestor
102597456|NCT01555489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597457|NCT01555489|Antioxidants|antioxidants|mesh-ancestor
102597458|NCT01555489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597459|NCT01555489|Protective Agents|protective agents|mesh-ancestor
102597460|NCT05243654|Metformin|metformin|mesh-list
102597461|NCT05243654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102597462|NCT05243654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597463|NCT01035073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102597464|NCT01035073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102597465|NCT01035073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102597466|NCT01035073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102597467|NCT01035073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597468|NCT01035073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102597469|NCT01035073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597470|NCT01035073|Analgesics|analgesics|mesh-ancestor
102597471|NCT01035073|Sensory System Agents|sensory system agents|mesh-ancestor
102597472|NCT01035073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102597473|NCT01035073|Antidepressive Agents|antidepressive agents|mesh-ancestor
102597474|NCT01035073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102597475|NCT01035073|Dopamine Agents|dopamine agents|mesh-ancestor
102597476|NCT04331743|Mitoxantrone|mitoxantrone|mesh-list
102597477|NCT04331743|Analgesics|analgesics|mesh-ancestor
102597478|NCT04331743|Sensory System Agents|sensory system agents|mesh-ancestor
102597479|NCT04331743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102597480|NCT04331743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597481|NCT04331743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597482|NCT04331743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102597483|NCT04331743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102597484|NCT04331743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102597485|NCT04331743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597487|NCT05296759|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102597488|NCT05296759|Botulinum Toxins|botulinum toxins|mesh-list
102597489|NCT05296759|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102597490|NCT05296759|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102597491|NCT05296759|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102597492|NCT05296759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102597493|NCT05296759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597494|NCT05296759|Cholinergic Agents|cholinergic agents|mesh-ancestor
102597495|NCT05296759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102597496|NCT05296759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597497|NCT05296759|Analgesics|analgesics|mesh-ancestor
102597498|NCT05296759|Sensory System Agents|sensory system agents|mesh-ancestor
102597499|NCT05296759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102597500|NCT05296759|Anticonvulsants|anticonvulsants|mesh-ancestor
102597501|NCT05296759|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102597502|NCT05296759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102597503|NCT05296759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102597504|NCT05296759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102597505|NCT05296759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102597506|NCT05296759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102597507|NCT05296759|Antimanic Agents|antimanic agents|mesh-ancestor
102597508|NCT05296759|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102597509|NCT05296759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102597510|NCT05296759|Antidepressive Agents|antidepressive agents|mesh-ancestor
102597511|NCT05296759|Dopamine Agents|dopamine agents|mesh-ancestor
102597512|NCT05296759|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102597513|NCT05546047|Tacrolimus|tacrolimus|mesh-list
102597514|NCT05546047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102597515|NCT05546047|Immunologic Factors|immunologic factors|mesh-ancestor
102597516|NCT05546047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597517|NCT05546047|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102597518|NCT05546047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102597519|NCT05546047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597520|NCT01532635|Mycophenolic Acid|mycophenolic acid|mesh-list
102597521|NCT01532635|Cyclophosphamide|cyclophosphamide|mesh-list
102597522|NCT01532635|Tacrolimus|tacrolimus|mesh-list
102597523|NCT01532635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102597524|NCT01532635|Immunologic Factors|immunologic factors|mesh-ancestor
102597525|NCT01532635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597526|NCT01532635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102597527|NCT01532635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102597528|NCT01532635|Alkylating Agents|alkylating agents|mesh-ancestor
102597529|NCT01532635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597530|NCT01532635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597531|NCT01532635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102597532|NCT01532635|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102597533|NCT01532635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102597534|NCT01532635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102597535|NCT01532635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102597536|NCT01532635|Antitubercular Agents|antitubercular agents|mesh-ancestor
102597537|NCT01532635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102597538|NCT01532635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102597539|NCT00986947|Rituximab|rituximab|mesh-list
102597540|NCT00986947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102597541|NCT00986947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597542|NCT00986947|Immunologic Factors|immunologic factors|mesh-ancestor
102597543|NCT00986947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597544|NCT00986947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102597545|NCT00539617|Leucovorin|leucovorin|mesh-list
102597546|NCT00539617|Fluorouracil|fluorouracil|mesh-list
102597547|NCT00539617|Oxaliplatin|oxaliplatin|mesh-list
102597548|NCT00539617|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102597549|NCT00539617|Antimetabolites|antimetabolites|mesh-ancestor
102597550|NCT00539617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597551|NCT00539617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102597552|NCT00539617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597553|NCT00539617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102597554|NCT00539617|Immunologic Factors|immunologic factors|mesh-ancestor
102597555|NCT00539617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597556|NCT00539617|Antidotes|antidotes|mesh-ancestor
102597557|NCT00539617|Protective Agents|protective agents|mesh-ancestor
102597558|NCT00539617|Vitamin B Complex|vitamin b complex|mesh-ancestor
102597559|NCT00539617|Vitamins|vitamins|mesh-ancestor
102597560|NCT00539617|Micronutrients|micronutrients|mesh-ancestor
102597561|NCT00539617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102597562|NCT00539617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102597563|NCT05467514|Liraglutide|liraglutide|mesh-list
102597564|NCT05467514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102597565|NCT05467514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597566|NCT05467514|Incretins|incretins|mesh-ancestor
102597567|NCT05467514|Hormones|hormones|mesh-ancestor
102597568|NCT05467514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102597569|NCT00976339|Vitamin D|vitamin d|mesh-list
102597570|NCT00976339|Cholecalciferol|cholecalciferol|mesh-list
102597571|NCT00976339|Vitamins|vitamins|mesh-ancestor
102597572|NCT00976339|Micronutrients|micronutrients|mesh-ancestor
102597573|NCT00976339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597574|NCT00976339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102345779|NCT05418972|Nivolumab|nivolumab|mesh-list
102597575|NCT00976339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102597576|NCT04579640|Vitamin D|vitamin d|mesh-list
102597577|NCT04579640|Vitamins|vitamins|mesh-ancestor
102597578|NCT04579640|Micronutrients|micronutrients|mesh-ancestor
102597579|NCT04579640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597580|NCT04579640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102597581|NCT00523939|Cytarabine|cytarabine|mesh-list
102597582|NCT00523939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102597583|NCT00523939|Antimetabolites|antimetabolites|mesh-ancestor
102597584|NCT00523939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597585|NCT00523939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597586|NCT00523939|Antiviral Agents|antiviral agents|mesh-ancestor
102597587|NCT00523939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102597588|NCT00523939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102597589|NCT00523939|Immunologic Factors|immunologic factors|mesh-ancestor
102597590|NCT00523939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597591|NCT00382538|Mifepristone|mifepristone|mesh-list
102597592|NCT00382538|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102597593|NCT00382538|Abortifacient Agents|abortifacient agents|mesh-ancestor
102597594|NCT00382538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102597595|NCT00382538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597596|NCT00382538|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102597597|NCT00382538|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102597598|NCT00382538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102597599|NCT00382538|Contraceptive Agents|contraceptive agents|mesh-ancestor
102597600|NCT00382538|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102597601|NCT00382538|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102597602|NCT00382538|Hormone Antagonists|hormone antagonists|mesh-ancestor
102597603|NCT00382538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102597604|NCT00382538|Luteolytic Agents|luteolytic agents|mesh-ancestor
102597605|NCT00382538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102597606|NCT00382538|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102597607|NCT00954187|Pregabalin|pregabalin|mesh-list
102597608|NCT00954187|Gabapentin|gabapentin|mesh-list
102597609|NCT00954187|Analgesics|analgesics|mesh-ancestor
102597610|NCT00954187|Sensory System Agents|sensory system agents|mesh-ancestor
102597611|NCT00954187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102597612|NCT00954187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597613|NCT00954187|Anticonvulsants|anticonvulsants|mesh-ancestor
102597614|NCT00954187|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102597615|NCT00954187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102597616|NCT00954187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597617|NCT00954187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102597618|NCT00954187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102597619|NCT00954187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102597620|NCT00954187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102597621|NCT00954187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102597622|NCT00954187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102597623|NCT00954187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102597624|NCT00954187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102597625|NCT00954187|Antimanic Agents|antimanic agents|mesh-ancestor
102597626|NCT00947791|Midazolam|midazolam|mesh-list
102597627|NCT00947791|Ketamine|ketamine|mesh-list
102597628|NCT00947791|Analgesics|analgesics|mesh-ancestor
102597629|NCT00947791|Sensory System Agents|sensory system agents|mesh-ancestor
102597630|NCT00947791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102597631|NCT00947791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597632|NCT00947791|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102597633|NCT00947791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102597634|NCT00947791|Anesthetics, General|anesthetics, general|mesh-ancestor
102597635|NCT00947791|Anesthetics|anesthetics|mesh-ancestor
102597636|NCT00947791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102597637|NCT00947791|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102597638|NCT00947791|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102597639|NCT00947791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102597640|NCT00947791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597641|NCT00947791|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102597642|NCT00947791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102597643|NCT00947791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102597644|NCT00947791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102597645|NCT00947791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102597646|NCT00947791|GABA Modulators|gaba modulators|mesh-ancestor
102597647|NCT00947791|GABA Agents|gaba agents|mesh-ancestor
102597648|NCT05136326|Capecitabine|capecitabine|mesh-list
102597649|NCT05136326|Temozolomide|temozolomide|mesh-list
102597650|NCT05136326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102597651|NCT05136326|Antimetabolites|antimetabolites|mesh-ancestor
102597652|NCT05136326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597653|NCT05136326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597654|NCT05136326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102597655|NCT05136326|Alkylating Agents|alkylating agents|mesh-ancestor
102597656|NCT05387941|Dexamethasone|dexamethasone|mesh-list
102597657|NCT05387941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102597658|NCT05387941|Antiemetics|antiemetics|mesh-ancestor
102597659|NCT05387941|Autonomic Agents|autonomic agents|mesh-ancestor
102597660|NCT05387941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102597661|NCT05387941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597662|NCT05387941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102597663|NCT05387941|Glucocorticoids|glucocorticoids|mesh-ancestor
102597664|NCT05387941|Hormones|hormones|mesh-ancestor
102597665|NCT05387941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102597666|NCT05387941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102597667|NCT05387941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597668|NCT00379015|Cyclophosphamide|cyclophosphamide|mesh-list
102597669|NCT00379015|Docetaxel|docetaxel|mesh-list
102597670|NCT00379015|Trastuzumab|trastuzumab|mesh-list
102597671|NCT00379015|Epirubicin|epirubicin|mesh-list
102597672|NCT00379015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102597673|NCT00379015|Immunologic Factors|immunologic factors|mesh-ancestor
102597674|NCT00379015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597675|NCT00379015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102597676|NCT00379015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102597677|NCT00379015|Alkylating Agents|alkylating agents|mesh-ancestor
102597678|NCT00379015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597679|NCT00379015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597680|NCT00379015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102597681|NCT00379015|Tubulin Modulators|tubulin modulators|mesh-ancestor
102597682|NCT00379015|Antimitotic Agents|antimitotic agents|mesh-ancestor
102597683|NCT00379015|Mitosis Modulators|mitosis modulators|mesh-ancestor
102597684|NCT00379015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102597685|NCT00379015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102597686|NCT00379015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102597687|NCT00379015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102597688|NCT00379015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102597689|NCT00911053|Melatonin|melatonin|mesh-list
102597690|NCT00911053|Antioxidants|antioxidants|mesh-ancestor
102597691|NCT00911053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597692|NCT00911053|Protective Agents|protective agents|mesh-ancestor
102597693|NCT00911053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597694|NCT00911053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102597695|NCT04713176|Remdesivir|remdesivir|mesh-list
102597696|NCT04713176|Antimetabolites|antimetabolites|mesh-ancestor
102597697|NCT04713176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597698|NCT04713176|Antiviral Agents|antiviral agents|mesh-ancestor
102597699|NCT04713176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102597700|NCT04713410|Prednisolone|prednisolone|mesh-list
102597701|NCT04713410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102597702|NCT04713410|Glucocorticoids|glucocorticoids|mesh-ancestor
102597703|NCT04713410|Hormones|hormones|mesh-ancestor
102597704|NCT04713410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102597705|NCT04713410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597706|NCT04713410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102597707|NCT04713410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597708|NCT04713332|Vitamin E|vitamin e|mesh-list
102597709|NCT04713332|Tocopherols|tocopherols|mesh-list
102597710|NCT04713332|alpha-Tocopherol|alpha-tocopherol|mesh-list
102597711|NCT04713332|Vitamins|vitamins|mesh-ancestor
102597712|NCT04713332|Micronutrients|micronutrients|mesh-ancestor
102597713|NCT04713332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597714|NCT04713332|Antioxidants|antioxidants|mesh-ancestor
102597715|NCT04713332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597716|NCT04713332|Protective Agents|protective agents|mesh-ancestor
102597717|NCT00476827|Paclitaxel|paclitaxel|mesh-list
102597718|NCT00476827|Vinorelbine|vinorelbine|mesh-list
102597719|NCT00476827|Docetaxel|docetaxel|mesh-list
102597720|NCT00476827|Bevacizumab|bevacizumab|mesh-list
102597721|NCT00476827|Gemcitabine|gemcitabine|mesh-list
102597722|NCT00476827|Irinotecan|irinotecan|mesh-list
102597723|NCT00476827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102597724|NCT00476827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597725|NCT00476827|Tubulin Modulators|tubulin modulators|mesh-ancestor
102597726|NCT00476827|Antimitotic Agents|antimitotic agents|mesh-ancestor
102597727|NCT00476827|Mitosis Modulators|mitosis modulators|mesh-ancestor
102597728|NCT00476827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597729|NCT00476827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102597730|NCT00476827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102597731|NCT00476827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102597732|NCT00476827|Growth Substances|growth substances|mesh-ancestor
102597733|NCT00476827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597734|NCT00476827|Growth Inhibitors|growth inhibitors|mesh-ancestor
102597735|NCT00476827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102597736|NCT00476827|Antimetabolites|antimetabolites|mesh-ancestor
102597737|NCT00476827|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102597738|NCT00476827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102597739|NCT00476827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102597740|NCT00459121|Paclitaxel|paclitaxel|mesh-list
102597741|NCT00459121|Carboplatin|carboplatin|mesh-list
102597742|NCT00459121|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102597743|NCT00459121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597744|NCT00459121|Tubulin Modulators|tubulin modulators|mesh-ancestor
102597745|NCT00459121|Antimitotic Agents|antimitotic agents|mesh-ancestor
102597746|NCT00459121|Mitosis Modulators|mitosis modulators|mesh-ancestor
102597747|NCT00459121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597748|NCT00904423|Vitamin D|vitamin d|mesh-list
102597749|NCT00904423|Vitamins|vitamins|mesh-ancestor
102597750|NCT00904423|Micronutrients|micronutrients|mesh-ancestor
102597751|NCT00904423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597752|NCT00904423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102597753|NCT05328895|Betahistine|betahistine|mesh-list
102597754|NCT05328895|Vasodilator Agents|vasodilator agents|mesh-ancestor
102597755|NCT05328895|Histamine Agonists|histamine agonists|mesh-ancestor
102597756|NCT05328895|Histamine Agents|histamine agents|mesh-ancestor
102597757|NCT05328895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102597758|NCT05328895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597759|NCT05328895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597760|NCT00879619|Prednisone|prednisone|mesh-list
102597761|NCT00879619|Cortisone|cortisone|mesh-list
102597762|NCT00879619|Docetaxel|docetaxel|mesh-list
102597763|NCT00879619|Sunitinib|sunitinib|mesh-list
102597764|NCT00879619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597765|NCT00879619|Tubulin Modulators|tubulin modulators|mesh-ancestor
102597766|NCT00879619|Antimitotic Agents|antimitotic agents|mesh-ancestor
102597767|NCT00879619|Mitosis Modulators|mitosis modulators|mesh-ancestor
102597768|NCT00879619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597769|NCT00879619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102597770|NCT00879619|Glucocorticoids|glucocorticoids|mesh-ancestor
102597771|NCT00879619|Hormones|hormones|mesh-ancestor
102597772|NCT00879619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102597773|NCT00879619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597774|NCT00879619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102597775|NCT00879619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102597776|NCT00879619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102597777|NCT00879619|Growth Substances|growth substances|mesh-ancestor
102597778|NCT00879619|Growth Inhibitors|growth inhibitors|mesh-ancestor
102597779|NCT00879619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102597780|NCT00879619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102597781|NCT00822679|Eszopiclone|eszopiclone|mesh-list
102597782|NCT00822679|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102597783|NCT00822679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102597784|NCT00822679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597785|NCT00323635|Tolterodine Tartrate|tolterodine tartrate|mesh-list
102597786|NCT00323635|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102144693|NCT03655535|PAZ320|paz320|mesh-list
102597787|NCT00323635|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102597788|NCT00323635|Cholinergic Agents|cholinergic agents|mesh-ancestor
102597789|NCT00323635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102345788|NCT05409066|Rituximab|rituximab|mesh-list
102597790|NCT00323635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597791|NCT00323635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597792|NCT00323635|Urological Agents|urological agents|mesh-ancestor
102597793|NCT00314353|Bevacizumab|bevacizumab|mesh-list
102597794|NCT00314353|Capecitabine|capecitabine|mesh-list
102597795|NCT00314353|Oxaliplatin|oxaliplatin|mesh-list
102597796|NCT00314353|Irinotecan|irinotecan|mesh-list
102597797|NCT00314353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102597798|NCT00314353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597799|NCT00314353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102597800|NCT00314353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102597801|NCT00314353|Growth Substances|growth substances|mesh-ancestor
102597802|NCT00314353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597803|NCT00314353|Growth Inhibitors|growth inhibitors|mesh-ancestor
102597804|NCT00314353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102597805|NCT00314353|Antimetabolites|antimetabolites|mesh-ancestor
102597806|NCT00314353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597807|NCT00314353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102597808|NCT00314353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102597809|NCT00314353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102597810|NCT00279409|Aripiprazole|aripiprazole|mesh-list
102597811|NCT00279409|Antidepressive Agents|antidepressive agents|mesh-ancestor
102597812|NCT00279409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102597813|NCT00279409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102597814|NCT00279409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102597815|NCT00279409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102597816|NCT00279409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597817|NCT00279409|Dopamine Agonists|dopamine agonists|mesh-ancestor
102597818|NCT00279409|Dopamine Agents|dopamine agents|mesh-ancestor
102597819|NCT00279409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102597820|NCT00279409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597821|NCT00279409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102597822|NCT00279409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102597823|NCT00279409|Serotonin Agents|serotonin agents|mesh-ancestor
102597824|NCT00279409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102597825|NCT00279409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102597826|NCT00279409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102597827|NCT00279409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102597828|NCT00379249|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102597829|NCT00379249|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102597830|NCT00379249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102597831|NCT00379249|Antimetabolites|antimetabolites|mesh-ancestor
102597832|NCT00379249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597833|NCT00379249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102597834|NCT00379249|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102597835|NCT00379249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102597836|NCT00801931|Cyclophosphamide|cyclophosphamide|mesh-list
102597837|NCT00801931|Melphalan|melphalan|mesh-list
102597838|NCT00801931|Busulfan|busulfan|mesh-list
102597839|NCT00801931|Thiotepa|thiotepa|mesh-list
102597840|NCT00801931|Fludarabine|fludarabine|mesh-list
102597841|NCT00801931|Alemtuzumab|alemtuzumab|mesh-list
102597842|NCT00801931|Phenytoin|phenytoin|mesh-list
102597843|NCT00801931|Fosphenytoin|fosphenytoin|mesh-list
102597844|NCT00801931|Thymoglobulin|thymoglobulin|mesh-list
102597845|NCT00801931|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102597846|NCT00801931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102597847|NCT00801931|Immunologic Factors|immunologic factors|mesh-ancestor
102597848|NCT00801931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597849|NCT00801931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102597850|NCT00801931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102597851|NCT00801931|Alkylating Agents|alkylating agents|mesh-ancestor
102597852|NCT00801931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597853|NCT00801931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597854|NCT00801931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102597855|NCT00801931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102597856|NCT00801931|Anticonvulsants|anticonvulsants|mesh-ancestor
102597857|NCT00801931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102597858|NCT00801931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102597859|NCT00801931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102597860|NCT00801931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102345791|NCT05409066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597861|NCT00801931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102597862|NCT00780481|Bradykinin|bradykinin|mesh-list
102597863|NCT00780481|Kininogens|kininogens|mesh-list
102597864|NCT00780481|Vasodilator Agents|vasodilator agents|mesh-ancestor
102597865|NCT00780481|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
102597866|NCT00780481|Protease Inhibitors|protease inhibitors|mesh-ancestor
102597867|NCT00780481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102597868|NCT00780481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597869|NCT05345990|Immunoglobulins|immunoglobulins|mesh-list
102597870|NCT05345990|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102597871|NCT05345990|Antibodies|antibodies|mesh-list
102597872|NCT05345990|Immunologic Factors|immunologic factors|mesh-ancestor
102597873|NCT05345990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597874|NCT00019747|Thalidomide|thalidomide|mesh-list
102597875|NCT00019747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102597876|NCT00019747|Immunologic Factors|immunologic factors|mesh-ancestor
102597877|NCT00019747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597878|NCT00019747|Leprostatic Agents|leprostatic agents|mesh-ancestor
102597879|NCT00019747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102597880|NCT00019747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102597881|NCT00019747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102597882|NCT00019747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102597883|NCT00019747|Growth Substances|growth substances|mesh-ancestor
102597884|NCT00019747|Growth Inhibitors|growth inhibitors|mesh-ancestor
102597885|NCT00019747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597886|NCT05048719|Dulaglutide|dulaglutide|mesh-list
102597887|NCT05048719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102597888|NCT05048719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597889|NCT00759577|Solifenacin Succinate|solifenacin succinate|mesh-list
102597890|NCT00759577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102597891|NCT00759577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102597892|NCT00759577|Cholinergic Agents|cholinergic agents|mesh-ancestor
102597893|NCT00759577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102597894|NCT00759577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597895|NCT00759577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597896|NCT00759577|Urological Agents|urological agents|mesh-ancestor
102597897|NCT00746239|Dexetimide|dexetimide|mesh-list
102597898|NCT00746239|Citalopram|citalopram|mesh-list
102597899|NCT00746239|Escitalopram|escitalopram|mesh-list
102597900|NCT00746239|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102597901|NCT00746239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102597902|NCT00746239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102597903|NCT00746239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597904|NCT00746239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102597905|NCT00746239|Serotonin Agents|serotonin agents|mesh-ancestor
102597906|NCT00746239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597907|NCT00746239|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102597908|NCT00746239|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102597909|NCT00746239|Parasympatholytics|parasympatholytics|mesh-ancestor
102597910|NCT00746239|Autonomic Agents|autonomic agents|mesh-ancestor
102597911|NCT00746239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102597912|NCT00746239|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102597913|NCT00746239|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102597914|NCT00746239|Cholinergic Agents|cholinergic agents|mesh-ancestor
102597915|NCT00746239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102597916|NCT00746239|Antidepressive Agents|antidepressive agents|mesh-ancestor
102597917|NCT00746239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102597918|NCT04977674|Naltrexone|naltrexone|mesh-list
102597919|NCT04977674|Ketamine|ketamine|mesh-list
102597920|NCT04977674|Analgesics|analgesics|mesh-ancestor
102597921|NCT04977674|Sensory System Agents|sensory system agents|mesh-ancestor
102597922|NCT04977674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102597923|NCT04977674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597924|NCT04977674|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102597925|NCT04977674|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102597926|NCT04977674|Anesthetics, General|anesthetics, general|mesh-ancestor
102597927|NCT04977674|Anesthetics|anesthetics|mesh-ancestor
102597928|NCT04977674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102597929|NCT04977674|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102597930|NCT04977674|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102597931|NCT04977674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102597932|NCT04977674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597933|NCT04977674|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102597934|NCT04977674|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102597935|NCT04965038|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102597936|NCT04965038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102597937|NCT04965038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102597938|NCT04965038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597939|NCT00402883|Folic Acid|folic acid|mesh-list
102597940|NCT00402883|Vitamin B 12|vitamin b 12|mesh-list
102597941|NCT00402883|Bevacizumab|bevacizumab|mesh-list
102597942|NCT00402883|Carboplatin|carboplatin|mesh-list
102597943|NCT00402883|Pemetrexed|pemetrexed|mesh-list
102597944|NCT00402883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102597945|NCT00402883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597946|NCT00402883|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102597947|NCT00402883|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102597948|NCT00402883|Growth Substances|growth substances|mesh-ancestor
102597949|NCT00402883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597950|NCT00402883|Growth Inhibitors|growth inhibitors|mesh-ancestor
102597951|NCT00402883|Vitamins|vitamins|mesh-ancestor
102597952|NCT00402883|Micronutrients|micronutrients|mesh-ancestor
102597953|NCT00402883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102597954|NCT00402883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597955|NCT00402883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102597956|NCT00402883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102597957|NCT00402883|Hematinics|hematinics|mesh-ancestor
102597958|NCT00402883|Vitamin B Complex|vitamin b complex|mesh-ancestor
102597959|NCT04939844|Lenalidomide|lenalidomide|mesh-list
102597960|NCT04939844|Bortezomib|bortezomib|mesh-list
102597961|NCT04939844|Immunologic Factors|immunologic factors|mesh-ancestor
102597962|NCT04939844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597963|NCT04939844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102597964|NCT04939844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102597965|NCT04939844|Growth Substances|growth substances|mesh-ancestor
102597966|NCT04939844|Growth Inhibitors|growth inhibitors|mesh-ancestor
102597967|NCT04939844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597968|NCT05295212|Atezolizumab|atezolizumab|mesh-list
102597969|NCT05295212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102597970|NCT05295212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597971|NCT05295212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102597972|NCT05295212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597973|NCT05286320|Pembrolizumab|pembrolizumab|mesh-list
102597974|NCT05286320|Lenvatinib|lenvatinib|mesh-list
102597975|NCT05286320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102597976|NCT05286320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597977|NCT05286320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102597978|NCT05286320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597979|NCT05286320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102597980|NCT05286320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102597981|NCT00728845|Hydroxychloroquine|hydroxychloroquine|mesh-list
102597982|NCT00728845|Paclitaxel|paclitaxel|mesh-list
102597983|NCT00728845|Bevacizumab|bevacizumab|mesh-list
102597984|NCT00728845|Carboplatin|carboplatin|mesh-list
102597985|NCT00728845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102597986|NCT00728845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102597987|NCT00728845|Tubulin Modulators|tubulin modulators|mesh-ancestor
102597988|NCT00728845|Antimitotic Agents|antimitotic agents|mesh-ancestor
102597989|NCT00728845|Mitosis Modulators|mitosis modulators|mesh-ancestor
102597990|NCT00728845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102597991|NCT00728845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102597992|NCT00728845|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102597993|NCT00728845|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102597994|NCT00728845|Growth Substances|growth substances|mesh-ancestor
102597995|NCT00728845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102597996|NCT00728845|Growth Inhibitors|growth inhibitors|mesh-ancestor
102597997|NCT00728845|Antimalarials|antimalarials|mesh-ancestor
102597998|NCT00728845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102597999|NCT00728845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102598000|NCT00728845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102598001|NCT00728845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102598002|NCT00728845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102598003|NCT00726037|Denileukin diftitox|denileukin diftitox|mesh-list
102598004|NCT00726037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102598005|NCT05278676|Dotinurad|dotinurad|mesh-list
102598006|NCT05278676|Uricosuric Agents|uricosuric agents|mesh-ancestor
102598007|NCT05278676|Gout Suppressants|gout suppressants|mesh-ancestor
102598008|NCT05278676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102598009|NCT00703885|Alprazolam|alprazolam|mesh-list
102598010|NCT00703885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102598011|NCT00703885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102598012|NCT00703885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144920|NCT04774965|Anesthetics|anesthetics|mesh-ancestor
102598013|NCT00703885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102598014|NCT00703885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102598015|NCT00703885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102598016|NCT00703885|GABA Modulators|gaba modulators|mesh-ancestor
102598017|NCT00703885|GABA Agents|gaba agents|mesh-ancestor
102598018|NCT00703885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102598019|NCT00703885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598020|NCT00703339|Treprostinil|treprostinil|mesh-list
102598021|NCT00703339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102598022|NCT04330586|Ciclesonide|ciclesonide|mesh-list
102598023|NCT04330586|Glucocorticoids|glucocorticoids|mesh-ancestor
102598024|NCT04330586|Hormones|hormones|mesh-ancestor
102598025|NCT04330586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102598026|NCT04330586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598027|NCT04330586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102598028|NCT00382694|Fludarabine|fludarabine|mesh-list
102598029|NCT00382694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102598030|NCT04508036|Fibrin fragment D|fibrin fragment d|mesh-list
102598031|NCT04508036|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102598032|NCT04508036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102598033|NCT04508036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598034|NCT04508036|Hemostatics|hemostatics|mesh-ancestor
102598035|NCT04508036|Coagulants|coagulants|mesh-ancestor
102598036|NCT04828057|Timolol|timolol|mesh-list
102598037|NCT04828057|Bimatoprost|bimatoprost|mesh-list
102598038|NCT04828057|Travoprost|travoprost|mesh-list
102598039|NCT04828057|Latanoprost|latanoprost|mesh-list
102598040|NCT04828057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598041|NCT04828057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102598042|NCT04828057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102598043|NCT04828057|Adrenergic Agents|adrenergic agents|mesh-ancestor
102598044|NCT04828057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102598045|NCT04828057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598046|NCT04828057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102598047|NCT04828057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102598048|NCT04828057|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102598049|NCT04828057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102598050|NCT02973451|Bupivacaine|bupivacaine|mesh-list
102598051|NCT02973451|Anesthetics, Local|anesthetics, local|mesh-ancestor
102598052|NCT02973451|Anesthetics|anesthetics|mesh-ancestor
102598053|NCT02973451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102598054|NCT02973451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598055|NCT02973451|Sensory System Agents|sensory system agents|mesh-ancestor
102598056|NCT02973451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102598057|NCT00000199|Piracetam|piracetam|mesh-list
102598058|NCT00000199|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102598059|NCT00000199|Protective Agents|protective agents|mesh-ancestor
102598060|NCT00000199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598061|NCT00000199|Nootropic Agents|nootropic agents|mesh-ancestor
102598062|NCT00668785|Ranibizumab|ranibizumab|mesh-list
102598063|NCT00668785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102598064|NCT00668785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102598065|NCT00668785|Growth Substances|growth substances|mesh-ancestor
102598066|NCT00668785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598067|NCT00668785|Growth Inhibitors|growth inhibitors|mesh-ancestor
102598068|NCT00668785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102598069|NCT00655057|Citalopram|citalopram|mesh-list
102598070|NCT00655057|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102598071|NCT00655057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102598072|NCT00655057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102598073|NCT00655057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598074|NCT00655057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102598075|NCT00655057|Serotonin Agents|serotonin agents|mesh-ancestor
102598076|NCT00655057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598077|NCT00655057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102598078|NCT00655057|Antidepressive Agents|antidepressive agents|mesh-ancestor
102598079|NCT00655057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102598080|NCT00000211|Buprenorphine|buprenorphine|mesh-list
102598081|NCT00000211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102598082|NCT00000211|Narcotics|narcotics|mesh-ancestor
102598083|NCT00000211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102598084|NCT00000211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598085|NCT00000211|Analgesics|analgesics|mesh-ancestor
102598086|NCT00000211|Sensory System Agents|sensory system agents|mesh-ancestor
102598087|NCT00000211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102598088|NCT00000211|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102598089|NCT04358432|Ezetimibe|ezetimibe|mesh-list
102145000|NCT02417103|Hormones|hormones|mesh-ancestor
102598090|NCT04358432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102598091|NCT04358432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102598092|NCT04358432|Antimetabolites|antimetabolites|mesh-ancestor
102598093|NCT04358432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598094|NCT04358432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102598095|NCT00000217|Carbamazepine|carbamazepine|mesh-list
102598096|NCT00000217|Anticonvulsants|anticonvulsants|mesh-ancestor
102598097|NCT00000217|Antimanic Agents|antimanic agents|mesh-ancestor
102598098|NCT00000217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102598099|NCT00000217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102598100|NCT00000217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598101|NCT00000217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102598102|NCT00000217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102598103|NCT00000217|Analgesics|analgesics|mesh-ancestor
102598104|NCT00000217|Sensory System Agents|sensory system agents|mesh-ancestor
102598105|NCT00000217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102598106|NCT00000217|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102598107|NCT00000217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102598108|NCT00000217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598109|NCT00000217|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102598110|NCT00000217|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102598111|NCT00000223|Buprenorphine|buprenorphine|mesh-list
102598112|NCT00000223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102598113|NCT00000223|Narcotics|narcotics|mesh-ancestor
102598114|NCT00000223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102598115|NCT00000223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598116|NCT00000223|Analgesics|analgesics|mesh-ancestor
102598117|NCT00000223|Sensory System Agents|sensory system agents|mesh-ancestor
102598118|NCT00000223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102598119|NCT00000223|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102598120|NCT00000229|Buprenorphine|buprenorphine|mesh-list
102598121|NCT00000229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102598122|NCT00000229|Narcotics|narcotics|mesh-ancestor
102598123|NCT00000229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102598124|NCT00000229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598125|NCT00000229|Analgesics|analgesics|mesh-ancestor
102598126|NCT00000229|Sensory System Agents|sensory system agents|mesh-ancestor
102598127|NCT00000229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102598128|NCT00000229|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102598129|NCT00000235|Buprenorphine|buprenorphine|mesh-list
102598130|NCT00000235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102598131|NCT00000235|Narcotics|narcotics|mesh-ancestor
102598132|NCT00000235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102598133|NCT00000235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598134|NCT00000235|Analgesics|analgesics|mesh-ancestor
102598135|NCT00000235|Sensory System Agents|sensory system agents|mesh-ancestor
102598136|NCT00000235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102598137|NCT00000235|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102598138|NCT00000241|Flupenthixol|flupenthixol|mesh-list
102598139|NCT00000241|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
102598140|NCT00000241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102598141|NCT00000241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102598142|NCT00000241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102598143|NCT00000241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598144|NCT00000241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102598145|NCT00000241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102598146|NCT00000241|Dopamine Agents|dopamine agents|mesh-ancestor
102598147|NCT00000241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102598148|NCT00000241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598149|NCT00000253|Nitrous Oxide|nitrous oxide|mesh-list
102598150|NCT00000253|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102598151|NCT00000253|Anesthetics, General|anesthetics, general|mesh-ancestor
102598152|NCT00000253|Anesthetics|anesthetics|mesh-ancestor
102598153|NCT00000253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102598154|NCT00000253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598155|NCT00000253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102598156|NCT00000253|Analgesics|analgesics|mesh-ancestor
102598157|NCT00000253|Sensory System Agents|sensory system agents|mesh-ancestor
102598158|NCT00000253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102598159|NCT00000259|Nitrous Oxide|nitrous oxide|mesh-list
102598160|NCT00000259|Sevoflurane|sevoflurane|mesh-list
102598161|NCT00000259|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102598162|NCT00000259|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102598163|NCT00000259|Anesthetics, General|anesthetics, general|mesh-ancestor
102598164|NCT00000259|Anesthetics|anesthetics|mesh-ancestor
102598165|NCT00000259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102598166|NCT00000259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598167|NCT00000259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102598168|NCT00000259|Analgesics|analgesics|mesh-ancestor
102598169|NCT00000259|Sensory System Agents|sensory system agents|mesh-ancestor
102598170|NCT00000259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102598171|NCT04330664|Adagrasib|adagrasib|mesh-list
102598172|NCT04330664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102598173|NCT00379405|Ritonavir|ritonavir|mesh-list
102598174|NCT00379405|Saquinavir|saquinavir|mesh-list
102598175|NCT00379405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102598176|NCT00379405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102598177|NCT00379405|Protease Inhibitors|protease inhibitors|mesh-ancestor
102598178|NCT00379405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102598179|NCT00379405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598180|NCT00379405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102598181|NCT00379405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102598182|NCT00379405|Antiviral Agents|antiviral agents|mesh-ancestor
102598183|NCT00379405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102598184|NCT00379405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102598185|NCT00379405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102598186|NCT00379483|Deferasirox|deferasirox|mesh-list
102598187|NCT00379483|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102598188|NCT00379483|Chelating Agents|chelating agents|mesh-ancestor
102598189|NCT00379483|Sequestering Agents|sequestering agents|mesh-ancestor
102598190|NCT00379483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598191|NCT00607477|Minoxidil|minoxidil|mesh-list
102598192|NCT00607477|Hydralazine|hydralazine|mesh-list
102598193|NCT00607477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102598194|NCT00607477|Vasodilator Agents|vasodilator agents|mesh-ancestor
102598195|NCT04423861|Nitazoxanide|nitazoxanide|mesh-list
102598196|NCT04423861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102598197|NCT04423861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102598198|NCT00000271|Desipramine|desipramine|mesh-list
102598199|NCT00000271|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102598200|NCT00000271|Antidepressive Agents|antidepressive agents|mesh-ancestor
102598201|NCT00000271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102598202|NCT00000271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102598203|NCT00000271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598204|NCT00000271|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102598205|NCT00000271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102598206|NCT00000271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102598207|NCT00000271|Adrenergic Agents|adrenergic agents|mesh-ancestor
102598208|NCT00000271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102598209|NCT00000271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598210|NCT00000277|Mazindol|mazindol|mesh-list
102598211|NCT00000277|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102598212|NCT00000277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598213|NCT00000277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102598214|NCT00000277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102598215|NCT00000277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102598216|NCT00000277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598217|NCT00000277|Adrenergic Agents|adrenergic agents|mesh-ancestor
102598218|NCT00000277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102598219|NCT00000277|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102598220|NCT00000277|Dopamine Agents|dopamine agents|mesh-ancestor
102598221|NCT00599131|Docetaxel|docetaxel|mesh-list
102598222|NCT00599131|Fluorouracil|fluorouracil|mesh-list
102598223|NCT00599131|Cetuximab|cetuximab|mesh-list
102598224|NCT00599131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102598225|NCT00599131|Tubulin Modulators|tubulin modulators|mesh-ancestor
102598226|NCT00599131|Antimitotic Agents|antimitotic agents|mesh-ancestor
102598227|NCT00599131|Mitosis Modulators|mitosis modulators|mesh-ancestor
102598228|NCT00599131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598229|NCT00599131|Antimetabolites|antimetabolites|mesh-ancestor
102598230|NCT00599131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102598231|NCT00599131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102598232|NCT00599131|Immunologic Factors|immunologic factors|mesh-ancestor
102598233|NCT00599131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598234|NCT00599131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102598235|NCT04302350|Nitrous Oxide|nitrous oxide|mesh-list
102598236|NCT04302350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102598237|NCT04302350|Anesthetics, General|anesthetics, general|mesh-ancestor
102598238|NCT04302350|Anesthetics|anesthetics|mesh-ancestor
102598239|NCT04302350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102145156|NCT01160211|Lapatinib|lapatinib|mesh-list
102598240|NCT04302350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598241|NCT04302350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102598242|NCT04302350|Analgesics|analgesics|mesh-ancestor
102598243|NCT04302350|Sensory System Agents|sensory system agents|mesh-ancestor
102598244|NCT04302350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102598245|NCT00584935|Rituximab|rituximab|mesh-list
102598246|NCT00584935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102598247|NCT00584935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102598248|NCT00584935|Immunologic Factors|immunologic factors|mesh-ancestor
102598249|NCT00584935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598250|NCT00584935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102598251|NCT04295486|Aspirin|aspirin|mesh-list
102598252|NCT04295486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102598253|NCT04295486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102598254|NCT04295486|Analgesics|analgesics|mesh-ancestor
102598255|NCT04295486|Sensory System Agents|sensory system agents|mesh-ancestor
102598256|NCT04295486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102598257|NCT04295486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598258|NCT04295486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102598259|NCT04295486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102598260|NCT04295486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102598261|NCT04295486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102598262|NCT04295486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598263|NCT04295486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102598264|NCT04295486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102598265|NCT04295486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102598266|NCT04295486|Antipyretics|antipyretics|mesh-ancestor
102598267|NCT00000289|Ondansetron|ondansetron|mesh-list
102598268|NCT00000289|Antiemetics|antiemetics|mesh-ancestor
102598269|NCT00000289|Autonomic Agents|autonomic agents|mesh-ancestor
102598270|NCT00000289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102598271|NCT00000289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598272|NCT00000289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102598273|NCT00000289|Antipruritics|antipruritics|mesh-ancestor
102598274|NCT00000289|Dermatologic Agents|dermatologic agents|mesh-ancestor
102598275|NCT00000289|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102598276|NCT00000289|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102598277|NCT00000289|Serotonin Agents|serotonin agents|mesh-ancestor
102598278|NCT00000289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102598279|NCT00000289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598280|NCT00000295|Progesterone|progesterone|mesh-list
102598281|NCT00000295|Progestins|progestins|mesh-ancestor
102598282|NCT00000295|Hormones|hormones|mesh-ancestor
102598283|NCT00000295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102598284|NCT00000295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598285|NCT00000733|Ribavirin|ribavirin|mesh-list
102598286|NCT00000733|Antimetabolites|antimetabolites|mesh-ancestor
102598287|NCT00000733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598288|NCT00000733|Antiviral Agents|antiviral agents|mesh-ancestor
102598289|NCT00000733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102598290|NCT04246723|Ritonavir|ritonavir|mesh-list
102598291|NCT04246723|Sofosbuvir|sofosbuvir|mesh-list
102598292|NCT04246723|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102598293|NCT04246723|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102598294|NCT04246723|Protease Inhibitors|protease inhibitors|mesh-ancestor
102598295|NCT04246723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102598296|NCT04246723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598297|NCT04246723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102598298|NCT04246723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102598299|NCT04246723|Antiviral Agents|antiviral agents|mesh-ancestor
102598300|NCT04246723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102598301|NCT04246723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102598302|NCT04246723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102598303|NCT00000301|Amantadine|amantadine|mesh-list
102598304|NCT00000301|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102598305|NCT00000301|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102598306|NCT00000301|Antiviral Agents|antiviral agents|mesh-ancestor
102598307|NCT00000301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102598308|NCT00000301|Dopamine Agents|dopamine agents|mesh-ancestor
102598309|NCT00000301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102598310|NCT00000301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598311|NCT00000301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598312|NCT00000301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102598313|NCT00000301|Analgesics|analgesics|mesh-ancestor
102598314|NCT00000301|Sensory System Agents|sensory system agents|mesh-ancestor
102598315|NCT00000301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102598316|NCT00000307|Naltrexone|naltrexone|mesh-list
102598317|NCT00000307|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102598318|NCT00000307|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102598319|NCT00000307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598320|NCT00000307|Sensory System Agents|sensory system agents|mesh-ancestor
102598321|NCT00000307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102598322|NCT00000313|Fenfluramine|fenfluramine|mesh-list
102598323|NCT00000313|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102598324|NCT00000313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102598325|NCT00000313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102598326|NCT00000313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598327|NCT00000313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102598328|NCT00000313|Serotonin Agents|serotonin agents|mesh-ancestor
102598329|NCT00000313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598330|NCT00000319|Buprenorphine|buprenorphine|mesh-list
102598331|NCT00000319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102598332|NCT00000319|Narcotics|narcotics|mesh-ancestor
102598333|NCT00000319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102598334|NCT00000319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598335|NCT00000319|Analgesics|analgesics|mesh-ancestor
102598336|NCT00000319|Sensory System Agents|sensory system agents|mesh-ancestor
102598337|NCT00000319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102598338|NCT00000319|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102598339|NCT00000325|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
102598340|NCT00000325|Hormones|hormones|mesh-ancestor
102598341|NCT00000325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102598342|NCT00000325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598343|NCT04181203|Leuprolide|leuprolide|mesh-list
102598344|NCT04181203|Goserelin|goserelin|mesh-list
102598345|NCT04181203|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102598346|NCT04181203|Hormones|hormones|mesh-list
102598347|NCT04181203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102598348|NCT04181203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598349|NCT04181203|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102598350|NCT04181203|Fertility Agents|fertility agents|mesh-ancestor
102598351|NCT04181203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102598352|NCT04181203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102598353|NCT04181203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102598354|NCT04181203|Luteolytic Agents|luteolytic agents|mesh-ancestor
102598355|NCT04181203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102598356|NCT04181203|Contraceptive Agents|contraceptive agents|mesh-ancestor
102598357|NCT04181203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102598358|NCT03521102|Acetaminophen|acetaminophen|mesh-list
102598359|NCT03521102|Hydromorphone|hydromorphone|mesh-list
102598360|NCT03521102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102598361|NCT03521102|Analgesics|analgesics|mesh-ancestor
102598362|NCT03521102|Sensory System Agents|sensory system agents|mesh-ancestor
102598363|NCT03521102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102598364|NCT03521102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598365|NCT03521102|Antipyretics|antipyretics|mesh-ancestor
102598366|NCT03521102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102598367|NCT03521102|Narcotics|narcotics|mesh-ancestor
102598368|NCT03521102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102598369|NCT00000763|O-(Chloroacetylcarbamoyl)fumagillol|o-(chloroacetylcarbamoyl)fumagillol|mesh-list
102598370|NCT00000763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102598371|NCT00000763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102598372|NCT00000763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102598373|NCT00000763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102598374|NCT00000763|Growth Substances|growth substances|mesh-ancestor
102598375|NCT00000763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598376|NCT00000763|Growth Inhibitors|growth inhibitors|mesh-ancestor
102598377|NCT00380263|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
102598378|NCT00380263|Growth Substances|growth substances|mesh-ancestor
102598379|NCT00380263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598380|NCT00380263|Vasodilator Agents|vasodilator agents|mesh-ancestor
102598381|NCT00380263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102598382|NCT00380263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598383|NCT00000769|Interleukin-4|interleukin-4|mesh-list
102598384|NCT00000769|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102598385|NCT00000769|Immunologic Factors|immunologic factors|mesh-ancestor
102598386|NCT00000769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598387|NCT00000769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102598388|NCT00000769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102145291|NCT01063283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102598390|NCT05440591|Dapagliflozin|dapagliflozin|mesh-list
102598391|NCT05440591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102598392|NCT05440591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598393|NCT05440591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102598394|NCT05440591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598395|NCT04099303|Vaccines|vaccines|mesh-list
102598396|NCT04099303|Immunologic Factors|immunologic factors|mesh-ancestor
102598397|NCT04099303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598398|NCT00379951|Ertapenem|ertapenem|mesh-list
102598399|NCT00379951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102598400|NCT00379951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102598401|NCT00000337|Selegiline|selegiline|mesh-list
102598402|NCT00000337|Antidepressive Agents|antidepressive agents|mesh-ancestor
102598403|NCT00000337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102598404|NCT00000337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102598405|NCT00000337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102598406|NCT00000337|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102598407|NCT00000337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102598408|NCT00000337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598409|NCT00000337|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102598410|NCT00000337|Protective Agents|protective agents|mesh-ancestor
102598411|NCT00000337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598412|NCT00000781|Zidovudine|zidovudine|mesh-list
102598413|NCT00000781|Nevirapine|nevirapine|mesh-list
102598414|NCT00000781|Didanosine|didanosine|mesh-list
102598415|NCT00000781|Zalcitabine|zalcitabine|mesh-list
102598416|NCT00000781|Antimetabolites|antimetabolites|mesh-ancestor
102598417|NCT00000781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598418|NCT00000781|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102598419|NCT00000781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102598420|NCT00000781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102598421|NCT00000781|Antiviral Agents|antiviral agents|mesh-ancestor
102598422|NCT00000781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102598423|NCT00000781|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102598424|NCT00000781|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102598425|NCT00000781|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102598426|NCT00000781|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102598427|NCT00000349|Flupenthixol|flupenthixol|mesh-list
102598428|NCT00000349|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
102598429|NCT00000349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102598430|NCT00000349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102598431|NCT00000349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102598432|NCT00000349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598433|NCT00000349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102598434|NCT00000349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102598435|NCT00000349|Dopamine Agents|dopamine agents|mesh-ancestor
102598436|NCT00000349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102598437|NCT00000349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598438|NCT00000805|Ganciclovir|ganciclovir|mesh-list
102598439|NCT00000805|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102598440|NCT00000805|Antiviral Agents|antiviral agents|mesh-ancestor
102598441|NCT00000805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102598442|NCT00000805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102598443|NCT00000805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102598444|NCT00000805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598445|NCT04270682|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
102598446|NCT04270682|Cathartics|cathartics|mesh-ancestor
102598447|NCT04270682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102598448|NCT00000355|Buprenorphine|buprenorphine|mesh-list
102598449|NCT00000355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102598450|NCT00000355|Narcotics|narcotics|mesh-ancestor
102598451|NCT00000355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102598452|NCT00000355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598453|NCT00000355|Analgesics|analgesics|mesh-ancestor
102598454|NCT00000355|Sensory System Agents|sensory system agents|mesh-ancestor
102598455|NCT00000355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102598456|NCT00000355|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102598457|NCT04022785|Azacitidine|azacitidine|mesh-list
102598458|NCT04022785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102598459|NCT04022785|Antimetabolites|antimetabolites|mesh-ancestor
102598460|NCT04022785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598461|NCT04022785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102598462|NCT04022785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102598463|NCT00000361|Methotrexate|methotrexate|mesh-list
102145371|NCT04451655|Insulin|insulin|mesh-list
102598464|NCT00000361|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102598465|NCT00000361|Abortifacient Agents|abortifacient agents|mesh-ancestor
102598466|NCT00000361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102598467|NCT00000361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598468|NCT00000361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102598469|NCT00000361|Antimetabolites|antimetabolites|mesh-ancestor
102598470|NCT00000361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598471|NCT00000361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102598472|NCT00000361|Dermatologic Agents|dermatologic agents|mesh-ancestor
102598473|NCT00000361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102598474|NCT00000361|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102598475|NCT00000361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102598476|NCT00000361|Immunologic Factors|immunologic factors|mesh-ancestor
102598477|NCT00000361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102598478|NCT00000361|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102598479|NCT00000811|Azithromycin|azithromycin|mesh-list
102598480|NCT00000811|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102598481|NCT00000811|Trimethoprim|trimethoprim|mesh-list
102598482|NCT00000811|Sulfamethoxazole|sulfamethoxazole|mesh-list
102598483|NCT00000811|Atovaquone|atovaquone|mesh-list
102598484|NCT00000811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102598485|NCT00000811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102598486|NCT00000811|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102598487|NCT00000811|Antimalarials|antimalarials|mesh-ancestor
102598488|NCT00000811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102598489|NCT00000811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102598490|NCT00000811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102598491|NCT00000811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102598492|NCT00000811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598493|NCT00000811|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102598494|NCT00000811|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102598495|NCT00000811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102598496|NCT00000373|Olanzapine|olanzapine|mesh-list
102598497|NCT00000373|Fluoxetine|fluoxetine|mesh-list
102598498|NCT00000373|Antiemetics|antiemetics|mesh-ancestor
102598499|NCT00000373|Autonomic Agents|autonomic agents|mesh-ancestor
102598500|NCT00000373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102598501|NCT00000373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598502|NCT00000373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102598503|NCT00000373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102598504|NCT00000373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102598505|NCT00000373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102598506|NCT00000373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102345809|NCT05388877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345814|NCT05371899|Chiauranib|chiauranib|mesh-list
102345815|NCT05371899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102598507|NCT00000373|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102598508|NCT00000373|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102598509|NCT00000373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102598510|NCT00000373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598511|NCT00000373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102598512|NCT00000373|Serotonin Agents|serotonin agents|mesh-ancestor
102598513|NCT00000373|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102598514|NCT00000373|Antidepressive Agents|antidepressive agents|mesh-ancestor
102598515|NCT00000373|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102598516|NCT00000373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102598517|NCT00000373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102598518|NCT00000823|Zidovudine|zidovudine|mesh-list
102598519|NCT00000823|Didanosine|didanosine|mesh-list
102598520|NCT00000823|Antimetabolites|antimetabolites|mesh-ancestor
102598521|NCT00000823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598522|NCT00000823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102598523|NCT00000823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102598524|NCT00000823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102598525|NCT00000823|Antiviral Agents|antiviral agents|mesh-ancestor
102598526|NCT00000823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102598527|NCT00000823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102598528|NCT00000823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102598529|NCT00000379|Fluoxetine|fluoxetine|mesh-list
102598530|NCT00000379|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102598531|NCT00000379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102598532|NCT00000379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102598533|NCT00000379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598534|NCT00000379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102598535|NCT00000379|Serotonin Agents|serotonin agents|mesh-ancestor
102598536|NCT00000379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598537|NCT00000379|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102598538|NCT00000379|Antidepressive Agents|antidepressive agents|mesh-ancestor
102598539|NCT00000379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102598540|NCT00000379|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102598541|NCT00000379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102598542|NCT00000379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102598543|NCT00000385|Lithium Carbonate|lithium carbonate|mesh-list
102598544|NCT00000385|Antidepressive Agents|antidepressive agents|mesh-ancestor
102598545|NCT00000385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102598546|NCT00000385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102598547|NCT00000385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598548|NCT00000385|Antimanic Agents|antimanic agents|mesh-ancestor
102598549|NCT00000385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102598550|NCT00000385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102598551|NCT00000385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598552|NCT00002894|Paclitaxel|paclitaxel|mesh-list
102598553|NCT00002894|Carboplatin|carboplatin|mesh-list
102598554|NCT00002894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102598555|NCT00002894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102598556|NCT00002894|Tubulin Modulators|tubulin modulators|mesh-ancestor
102598557|NCT00002894|Antimitotic Agents|antimitotic agents|mesh-ancestor
102598558|NCT00002894|Mitosis Modulators|mitosis modulators|mesh-ancestor
102598559|NCT00002894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598560|NCT00000829|Vaccines|vaccines|mesh-list
102598561|NCT00000829|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102598562|NCT00000829|Immunologic Factors|immunologic factors|mesh-ancestor
102598563|NCT00000829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598564|NCT03282344|Nivolumab|nivolumab|mesh-list
102598565|NCT03282344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102598566|NCT03282344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102598567|NCT03282344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102598568|NCT03282344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598569|NCT00000403|Doxycycline|doxycycline|mesh-list
102598570|NCT00000403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102598571|NCT00000403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102598572|NCT00000403|Antimalarials|antimalarials|mesh-ancestor
102598573|NCT00000403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102598574|NCT00000403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102598575|NCT00000841|Lamivudine|lamivudine|mesh-list
102598576|NCT00000841|Zidovudine|zidovudine|mesh-list
102598577|NCT00000841|Stavudine|stavudine|mesh-list
102598578|NCT00000841|Indinavir|indinavir|mesh-list
102598579|NCT00000841|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102598580|NCT00000841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102598581|NCT00000841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102598582|NCT00000841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598583|NCT00000841|Antiviral Agents|antiviral agents|mesh-ancestor
102598584|NCT00000841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102598585|NCT00000841|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102598586|NCT00000841|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102598587|NCT00000841|Antimetabolites|antimetabolites|mesh-ancestor
102598588|NCT00000841|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102598589|NCT00000841|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102598590|NCT00000841|Protease Inhibitors|protease inhibitors|mesh-ancestor
102598591|NCT04226456|Acetylcysteine|acetylcysteine|mesh-list
102598592|NCT04226456|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102598593|NCT04226456|Antiviral Agents|antiviral agents|mesh-ancestor
102598594|NCT04226456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102598595|NCT04226456|Expectorants|expectorants|mesh-ancestor
102598596|NCT04226456|Respiratory System Agents|respiratory system agents|mesh-ancestor
102598597|NCT04226456|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102598598|NCT04226456|Antioxidants|antioxidants|mesh-ancestor
102598599|NCT04226456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598600|NCT04226456|Protective Agents|protective agents|mesh-ancestor
102598601|NCT04226456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598602|NCT04226456|Antidotes|antidotes|mesh-ancestor
102598603|NCT00000415|Calcium|calcium|mesh-list
102598604|NCT00000415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102598605|NCT00000415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598606|NCT00000847|polysaccharide-K|polysaccharide-k|mesh-list
102598607|NCT00000847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102598608|NCT00000847|Immunologic Factors|immunologic factors|mesh-ancestor
102598609|NCT00000847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598610|NCT00000847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102598611|NCT00000847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102598612|NCT00000847|Antiviral Agents|antiviral agents|mesh-ancestor
102598613|NCT00000847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102598614|NCT00000847|Interferon Inducers|interferon inducers|mesh-ancestor
102598615|NCT00000847|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102598616|NCT00000847|Protective Agents|protective agents|mesh-ancestor
102598617|NCT04195568|Calcium Carbonate|calcium carbonate|mesh-list
102598618|NCT04195568|Antacids|antacids|mesh-ancestor
102598619|NCT04195568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598620|NCT04195568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102598621|NCT00000439|Valproic Acid|valproic acid|mesh-list
102598622|NCT00000439|Anticonvulsants|anticonvulsants|mesh-ancestor
102598623|NCT00000439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102598624|NCT00000439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598625|NCT00000439|GABA Agents|gaba agents|mesh-ancestor
102598626|NCT00000439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102598627|NCT00000439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598628|NCT00000439|Antimanic Agents|antimanic agents|mesh-ancestor
102598629|NCT00000439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102598630|NCT00000439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102598631|NCT00000439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102598632|NCT00002912|Etoposide|etoposide|mesh-list
102598633|NCT00002912|Mitoxantrone|mitoxantrone|mesh-list
102598634|NCT00002912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102598635|NCT00002912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102345825|NCT05339256|Buprenorphine|buprenorphine|mesh-list
102598636|NCT00002912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102598637|NCT00002912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102598638|NCT00002912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102598639|NCT00002912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598640|NCT00002912|Analgesics|analgesics|mesh-ancestor
102598641|NCT00002912|Sensory System Agents|sensory system agents|mesh-ancestor
102598642|NCT00002912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102598643|NCT00002912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598644|NCT04183790|Ivacaftor|ivacaftor|mesh-list
102598645|NCT04183790|Elexacaftor|elexacaftor|mesh-list
102598646|NCT04183790|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102598647|NCT04183790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102598648|NCT04183790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598649|NCT00000445|Naltrexone|naltrexone|mesh-list
102598650|NCT00000445|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102598651|NCT00000445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102598652|NCT00000445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598653|NCT00000445|Sensory System Agents|sensory system agents|mesh-ancestor
102598654|NCT00000445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102598655|NCT00000451|Naltrexone|naltrexone|mesh-list
102598656|NCT00000451|Sertraline|sertraline|mesh-list
102598657|NCT00000451|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102598658|NCT00000451|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102598659|NCT00000451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598660|NCT00000451|Sensory System Agents|sensory system agents|mesh-ancestor
102598661|NCT00000451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102598662|NCT00000451|Antidepressive Agents|antidepressive agents|mesh-ancestor
102598663|NCT00000451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102598664|NCT00000451|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102598665|NCT00000451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102598666|NCT00000451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102598667|NCT00000451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598668|NCT00000451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102598669|NCT00000451|Serotonin Agents|serotonin agents|mesh-ancestor
102598670|NCT00000865|Lamivudine|lamivudine|mesh-list
102598671|NCT00000865|Zidovudine|zidovudine|mesh-list
102598672|NCT00000865|Abacavir|abacavir|mesh-list
102598673|NCT00000865|Stavudine|stavudine|mesh-list
102598674|NCT00000865|Didanosine|didanosine|mesh-list
102598675|NCT00000865|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102598676|NCT00000865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102598677|NCT00000865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102598678|NCT00000865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598679|NCT00000865|Antiviral Agents|antiviral agents|mesh-ancestor
102598680|NCT00000865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102598681|NCT00000865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102598682|NCT00000865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102598683|NCT00000865|Antimetabolites|antimetabolites|mesh-ancestor
102598684|NCT00000469|Aspirin|aspirin|mesh-list
102598685|NCT00000469|Lovastatin|lovastatin|mesh-list
102598686|NCT00000469|L 647318|l 647318|mesh-list
102598687|NCT00000469|Dihydromevinolin|dihydromevinolin|mesh-list
102598688|NCT00000469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102598689|NCT00000469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102598690|NCT00000469|Analgesics|analgesics|mesh-ancestor
102598691|NCT00000469|Sensory System Agents|sensory system agents|mesh-ancestor
102598692|NCT00000469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102598693|NCT00000469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598694|NCT00000469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102598695|NCT00000469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102598696|NCT00000469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102598697|NCT00000469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102598698|NCT00000469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598699|NCT00000469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102598700|NCT00000469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102598701|NCT00000469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102598702|NCT00000469|Antipyretics|antipyretics|mesh-ancestor
102598703|NCT00000469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102598704|NCT00000469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102598705|NCT00000469|Antimetabolites|antimetabolites|mesh-ancestor
102598706|NCT00000469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102598707|NCT00000469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102598708|NCT00000889|Aldesleukin|aldesleukin|mesh-list
102598709|NCT00000889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102598710|NCT00000889|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102598711|NCT00000889|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102598712|NCT00000889|Antiviral Agents|antiviral agents|mesh-ancestor
102598713|NCT00000889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102598714|NCT00000505|Plasminogen|plasminogen|mesh-list
102598715|NCT00000505|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102598716|NCT00000505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102598717|NCT00000505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102598718|NCT00000505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598719|NCT00000901|Lamivudine|lamivudine|mesh-list
102598720|NCT00000901|Stavudine|stavudine|mesh-list
102598721|NCT00000901|Indinavir|indinavir|mesh-list
102598722|NCT00000901|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102598723|NCT00000901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102598724|NCT00000901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102598725|NCT00000901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598726|NCT00000901|Antiviral Agents|antiviral agents|mesh-ancestor
102598727|NCT00000901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102598728|NCT00000901|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102598729|NCT00000901|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102598730|NCT00000901|Antimetabolites|antimetabolites|mesh-ancestor
102598731|NCT00000901|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102598732|NCT00000901|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102598733|NCT00000901|Protease Inhibitors|protease inhibitors|mesh-ancestor
102598734|NCT00000541|Vitamins|vitamins|mesh-list
102598735|NCT00000541|Folic Acid|folic acid|mesh-list
102598736|NCT00000541|Vitamin E|vitamin e|mesh-list
102598737|NCT00000541|Vitamin B 12|vitamin b 12|mesh-list
102598738|NCT00000541|Vitamin B 6|vitamin b 6|mesh-list
102598739|NCT00000541|Pyridoxal|pyridoxal|mesh-list
102598740|NCT00000541|Pyridoxine|pyridoxine|mesh-list
102598741|NCT00000541|Beta Carotene|beta carotene|mesh-list
102598742|NCT00000541|Vitamin B Complex|vitamin b complex|mesh-list
102598743|NCT00000541|Carotenoids|carotenoids|mesh-list
102598744|NCT00000541|Micronutrients|micronutrients|mesh-ancestor
102598745|NCT00000541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598746|NCT00000541|Antioxidants|antioxidants|mesh-ancestor
102598747|NCT00000541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598748|NCT00000541|Protective Agents|protective agents|mesh-ancestor
102598749|NCT00000541|Hematinics|hematinics|mesh-ancestor
102598750|NCT00000541|Provitamins|provitamins|mesh-ancestor
102598751|NCT00000913|Ritonavir|ritonavir|mesh-list
102598752|NCT00000913|Nelfinavir|nelfinavir|mesh-list
102598753|NCT00000913|Saquinavir|saquinavir|mesh-list
102598754|NCT00000913|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102598755|NCT00000913|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102598756|NCT00000913|Protease Inhibitors|protease inhibitors|mesh-ancestor
102598757|NCT00000913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102598758|NCT00000913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598759|NCT00000913|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102598760|NCT00000913|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102598761|NCT00000913|Antiviral Agents|antiviral agents|mesh-ancestor
102598762|NCT00000913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102598763|NCT00000913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102598764|NCT00000913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102598765|NCT00000547|Enalapril|enalapril|mesh-list
102598766|NCT00000547|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102598767|NCT00000547|Protease Inhibitors|protease inhibitors|mesh-ancestor
102598768|NCT00000547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102598769|NCT00000547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598770|NCT00000547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102598771|NCT00002930|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102598772|NCT00002930|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102598773|NCT00002930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598774|NCT00000577|Colchicine|colchicine|mesh-list
102598775|NCT00000577|Albuterol|albuterol|mesh-list
102598776|NCT00000577|Hormones|hormones|mesh-list
102598777|NCT00000577|Adrenergic Agents|adrenergic agents|mesh-list
102598778|NCT00000577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-list
102598779|NCT00000577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102598780|NCT00000577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598781|NCT00000577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102598782|NCT00000577|Autonomic Agents|autonomic agents|mesh-ancestor
102598783|NCT00000577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102598784|NCT00000577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102598785|NCT00000577|Respiratory System Agents|respiratory system agents|mesh-ancestor
102598786|NCT00000577|Tocolytic Agents|tocolytic agents|mesh-ancestor
102598787|NCT00000577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102598788|NCT00000577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102598789|NCT00000577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102598790|NCT00000577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102598791|NCT00000577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598792|NCT00000577|Gout Suppressants|gout suppressants|mesh-ancestor
102598793|NCT00000577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102598794|NCT00000577|Tubulin Modulators|tubulin modulators|mesh-ancestor
102598795|NCT00000577|Antimitotic Agents|antimitotic agents|mesh-ancestor
102598796|NCT00000577|Mitosis Modulators|mitosis modulators|mesh-ancestor
102598797|NCT00000577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102598798|NCT03321799|Anti-Infective Agents|anti-infective agents|mesh-list
102598799|NCT03321799|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102598800|NCT03015896|Nivolumab|nivolumab|mesh-list
102598801|NCT03015896|Lenalidomide|lenalidomide|mesh-list
102598802|NCT03015896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102598803|NCT03015896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102598804|NCT03015896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102598805|NCT03015896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598806|NCT03015896|Immunologic Factors|immunologic factors|mesh-ancestor
102598807|NCT03015896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598808|NCT03015896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102598809|NCT03015896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102598810|NCT03015896|Growth Substances|growth substances|mesh-ancestor
102598811|NCT03015896|Growth Inhibitors|growth inhibitors|mesh-ancestor
102598812|NCT02994836|Adalimumab|adalimumab|mesh-list
102598813|NCT02994836|Infliximab|infliximab|mesh-list
102598814|NCT02994836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102598815|NCT02994836|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102598816|NCT02994836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102598817|NCT02994836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102598818|NCT02994836|Dermatologic Agents|dermatologic agents|mesh-ancestor
102598819|NCT02994836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102598820|NCT00000937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102598821|NCT00000937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102598822|NCT00000613|Genistein|genistein|mesh-list
102598823|NCT00000613|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102598824|NCT00000613|Protective Agents|protective agents|mesh-ancestor
102598825|NCT00000613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598826|NCT00000613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102598827|NCT00000613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102598828|NCT00000613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102598829|NCT00000613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598830|NCT00000613|Phytoestrogens|phytoestrogens|mesh-ancestor
102598831|NCT00000613|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102598832|NCT00000613|Estrogens|estrogens|mesh-ancestor
102598833|NCT00000613|Hormones|hormones|mesh-ancestor
102598834|NCT00000613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102598835|NCT02909348|Pembrolizumab|pembrolizumab|mesh-list
102598836|NCT02909348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102598837|NCT02909348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102598838|NCT02909348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102598839|NCT02909348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598840|NCT00000949|Aldesleukin|aldesleukin|mesh-list
102598841|NCT00000949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102145739|NCT03434691|Analgesics|analgesics|mesh-ancestor
102598842|NCT00000949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102598843|NCT00000949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102598845|NCT00000949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102598846|NCT00002936|Etoposide|etoposide|mesh-list
102598847|NCT00002936|Altretamine|altretamine|mesh-list
102598848|NCT00002936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102598849|NCT00002936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102598850|NCT00002936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102598851|NCT00002936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102598852|NCT00002936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102598853|NCT00002936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598854|NCT00002936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102598855|NCT00002936|Alkylating Agents|alkylating agents|mesh-ancestor
102598856|NCT00000649|Zidovudine|zidovudine|mesh-list
102598857|NCT00000649|Nevirapine|nevirapine|mesh-list
102598858|NCT00000649|Antimetabolites|antimetabolites|mesh-ancestor
102598859|NCT00000649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598860|NCT00000649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102598861|NCT00000649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102598862|NCT00000649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102598863|NCT00000649|Antiviral Agents|antiviral agents|mesh-ancestor
102598864|NCT00000649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102598865|NCT00000649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102598866|NCT00000649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102598867|NCT00000649|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102598868|NCT00000649|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102598869|NCT00000961|Zidovudine|zidovudine|mesh-list
102598870|NCT00000961|Immune Sera|immune sera|mesh-list
102598871|NCT00000961|Antimetabolites|antimetabolites|mesh-ancestor
102598872|NCT00000961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598873|NCT00000961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102598874|NCT00000961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102598875|NCT00000961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102598876|NCT00000961|Antiviral Agents|antiviral agents|mesh-ancestor
102598877|NCT00000961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102598878|NCT00000961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102598879|NCT00000961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102598880|NCT00000961|Immunologic Factors|immunologic factors|mesh-ancestor
102598881|NCT00000961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598882|NCT04048304|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102598883|NCT04048304|Vancomycin|vancomycin|mesh-list
102598884|NCT04048304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102598885|NCT00000655|Trimethoprim|trimethoprim|mesh-list
102598886|NCT00000655|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102598887|NCT00000655|Atovaquone|atovaquone|mesh-list
102598888|NCT00000655|Sulfamethoxazole|sulfamethoxazole|mesh-list
102598889|NCT00000655|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102598890|NCT00000655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102598891|NCT00000655|Antimalarials|antimalarials|mesh-ancestor
102598892|NCT00000655|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102598893|NCT00000655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102598894|NCT00000655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102598895|NCT00000655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102598896|NCT00000655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598897|NCT00000655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102598898|NCT00000655|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102598899|NCT00000655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102598900|NCT00000655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102598901|NCT00002948|Topotecan|topotecan|mesh-list
102598902|NCT00002948|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102598903|NCT00002948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102598904|NCT00002948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102598905|NCT00002948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598906|NCT00002948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102598907|NCT02594293|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102598908|NCT02594293|Antiviral Agents|antiviral agents|mesh-ancestor
102598909|NCT02594293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102598910|NCT00000967|Interferons|interferons|mesh-list
102598911|NCT00000967|Interferon-alpha|interferon-alpha|mesh-list
102598912|NCT00000967|Interferon alpha-2|interferon alpha-2|mesh-list
102598913|NCT00000967|Zidovudine|zidovudine|mesh-list
102598914|NCT00000967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102598915|NCT00000967|Antiviral Agents|antiviral agents|mesh-ancestor
102598916|NCT00000967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102598917|NCT00000967|Immunologic Factors|immunologic factors|mesh-ancestor
102145811|NCT04941196|Ticagrelor|ticagrelor|mesh-list
102598918|NCT00000967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598919|NCT00000967|Antimetabolites|antimetabolites|mesh-ancestor
102598920|NCT00000967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598921|NCT00000967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102598922|NCT00000967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102598923|NCT00000967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102598924|NCT00000967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102598925|NCT00000967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102598926|NCT00000661|Zidovudine|zidovudine|mesh-list
102598927|NCT00000661|Oxazepam|oxazepam|mesh-list
102598928|NCT00000661|Antimetabolites|antimetabolites|mesh-ancestor
102598929|NCT00000661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345845|NCT05335993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102598930|NCT00000661|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102598931|NCT00000661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102598932|NCT00000661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102598933|NCT00000661|Antiviral Agents|antiviral agents|mesh-ancestor
102598934|NCT00000661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102598935|NCT00000661|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102598936|NCT00000661|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102598937|NCT00000661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102598938|NCT00000661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102598939|NCT00000661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102598940|NCT00000661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102598941|NCT00000661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102598942|NCT00000661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102598943|NCT00000661|GABA Modulators|gaba modulators|mesh-ancestor
102598944|NCT00000661|GABA Agents|gaba agents|mesh-ancestor
102598945|NCT00000661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102598946|NCT00000979|Zidovudine|zidovudine|mesh-list
102598947|NCT00000979|Didanosine|didanosine|mesh-list
102598948|NCT00000979|Antimetabolites|antimetabolites|mesh-ancestor
102598949|NCT00000979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598950|NCT00000979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102598951|NCT00000979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102598952|NCT00000979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102598953|NCT00000979|Antiviral Agents|antiviral agents|mesh-ancestor
102598954|NCT00000979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102598955|NCT00000979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102598956|NCT00000979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102598957|NCT00000991|Zidovudine|zidovudine|mesh-list
102598958|NCT00000991|Trimethoprim|trimethoprim|mesh-list
102598959|NCT00000991|Sulfamethoxazole|sulfamethoxazole|mesh-list
102598960|NCT00000991|Dapsone|dapsone|mesh-list
102598961|NCT00000991|Pentamidine|pentamidine|mesh-list
102598962|NCT00000991|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102598963|NCT00000991|Antimetabolites|antimetabolites|mesh-ancestor
102598964|NCT00000991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598965|NCT00000991|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102598966|NCT00000991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102598967|NCT00000991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102598968|NCT00000991|Antiviral Agents|antiviral agents|mesh-ancestor
102598969|NCT00000991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102598970|NCT00000991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102598971|NCT00000991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102598972|NCT00000991|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102598973|NCT00000991|Antimalarials|antimalarials|mesh-ancestor
102598974|NCT00000991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102598975|NCT00000991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102598976|NCT00000991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102598977|NCT00000991|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102598978|NCT00000991|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102598979|NCT00000991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102598980|NCT00000991|Leprostatic Agents|leprostatic agents|mesh-ancestor
102598981|NCT00000991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102598982|NCT00000991|Antifungal Agents|antifungal agents|mesh-ancestor
102598983|NCT00000991|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102598984|NCT00000673|Ganciclovir|ganciclovir|mesh-list
102598985|NCT00000673|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102598986|NCT00000673|Antiviral Agents|antiviral agents|mesh-ancestor
102598987|NCT00000673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102598988|NCT00000673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102598989|NCT00000673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102598990|NCT00000673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598991|NCT00000685|Zidovudine|zidovudine|mesh-list
102598992|NCT00000685|Antimetabolites|antimetabolites|mesh-ancestor
102598993|NCT00000685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102598994|NCT00000685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102598995|NCT00000685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102598996|NCT00000685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102598997|NCT00000685|Antiviral Agents|antiviral agents|mesh-ancestor
102598998|NCT00000685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102598999|NCT00000685|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102599000|NCT00000685|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102599001|NCT00002972|Paclitaxel|paclitaxel|mesh-list
102599002|NCT00002972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102345847|NCT05327023|Mycophenolic Acid|mycophenolic acid|mesh-list
102599003|NCT00002972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102599004|NCT00002972|Tubulin Modulators|tubulin modulators|mesh-ancestor
102599005|NCT00002972|Antimitotic Agents|antimitotic agents|mesh-ancestor
102599006|NCT00002972|Mitosis Modulators|mitosis modulators|mesh-ancestor
102599007|NCT00002972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599008|NCT00000691|Foscarnet|foscarnet|mesh-list
102599009|NCT00000691|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
102599010|NCT00000691|Antiviral Agents|antiviral agents|mesh-ancestor
102599011|NCT00000691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599012|NCT00000691|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102599013|NCT00000691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102599014|NCT00000691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599015|NCT00000691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599016|NCT00002984|Paclitaxel|paclitaxel|mesh-list
102599017|NCT00002984|Fluorouracil|fluorouracil|mesh-list
102599018|NCT00002984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102599019|NCT00002984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102599020|NCT00002984|Tubulin Modulators|tubulin modulators|mesh-ancestor
102599021|NCT00002984|Antimitotic Agents|antimitotic agents|mesh-ancestor
102599022|NCT00002984|Mitosis Modulators|mitosis modulators|mesh-ancestor
102599023|NCT00002984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599024|NCT00002984|Antimetabolites|antimetabolites|mesh-ancestor
102599025|NCT00002984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102599026|NCT00002984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102599027|NCT00002984|Immunologic Factors|immunologic factors|mesh-ancestor
102599028|NCT00002984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102599029|NCT00002990|BCG Vaccine|bcg vaccine|mesh-list
102599030|NCT00002990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102599031|NCT00002990|Immunologic Factors|immunologic factors|mesh-ancestor
102599032|NCT00002990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102599033|NCT00000997|Zalcitabine|zalcitabine|mesh-list
102599034|NCT00000997|Antimetabolites|antimetabolites|mesh-ancestor
102599035|NCT00000997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599036|NCT00000997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102599037|NCT00000997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102599038|NCT00000997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599039|NCT00000997|Antiviral Agents|antiviral agents|mesh-ancestor
102599040|NCT00000997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599041|NCT00000997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102599042|NCT00000997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102599043|NCT00000697|Foscarnet|foscarnet|mesh-list
102599044|NCT00000697|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
102599045|NCT00000697|Antiviral Agents|antiviral agents|mesh-ancestor
102599046|NCT00000697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599047|NCT00000697|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102599048|NCT00000697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102599049|NCT00000697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599050|NCT00000697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599051|NCT00001009|Dextrans|dextrans|mesh-list
102599052|NCT00001009|Anticoagulants|anticoagulants|mesh-ancestor
102599053|NCT00001009|Plasma Substitutes|plasma substitutes|mesh-ancestor
102599054|NCT00001009|Blood Substitutes|blood substitutes|mesh-ancestor
102599055|NCT00000703|Leucovorin|leucovorin|mesh-list
102599056|NCT00000703|Cytarabine|cytarabine|mesh-list
102599057|NCT00000703|Zidovudine|zidovudine|mesh-list
102599058|NCT00000703|Dexamethasone|dexamethasone|mesh-list
102599059|NCT00000703|Cyclophosphamide|cyclophosphamide|mesh-list
102599060|NCT00000703|Doxorubicin|doxorubicin|mesh-list
102599061|NCT00000703|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102599062|NCT00000703|Methotrexate|methotrexate|mesh-list
102599063|NCT00000703|Vincristine|vincristine|mesh-list
102599064|NCT00000703|Bleomycin|bleomycin|mesh-list
102599065|NCT00000703|Allopurinol|allopurinol|mesh-list
102599066|NCT00000703|Levoleucovorin|levoleucovorin|mesh-list
102599067|NCT00000703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102599068|NCT00000703|Immunologic Factors|immunologic factors|mesh-ancestor
102599069|NCT00000703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102599070|NCT00000703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102599071|NCT00000703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102599072|NCT00000703|Alkylating Agents|alkylating agents|mesh-ancestor
102599073|NCT00000703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599074|NCT00000703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102599075|NCT00000703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102599076|NCT00000703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102599077|NCT00000703|Antiemetics|antiemetics|mesh-ancestor
102599078|NCT00000703|Autonomic Agents|autonomic agents|mesh-ancestor
102599079|NCT00000703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102599080|NCT00000703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102599081|NCT00000703|Glucocorticoids|glucocorticoids|mesh-ancestor
102599082|NCT00000703|Hormones|hormones|mesh-ancestor
102599083|NCT00000703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102599084|NCT00000703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102599085|NCT00000703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102599086|NCT00000703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102599087|NCT00000703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102599088|NCT00000703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599089|NCT00000703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102599090|NCT00000703|Abortifacient Agents|abortifacient agents|mesh-ancestor
102599091|NCT00000703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102599092|NCT00000703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102599093|NCT00000703|Antimetabolites|antimetabolites|mesh-ancestor
102599094|NCT00000703|Dermatologic Agents|dermatologic agents|mesh-ancestor
102599095|NCT00000703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102599096|NCT00000703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102599097|NCT00000703|Antiviral Agents|antiviral agents|mesh-ancestor
102599098|NCT00000703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599099|NCT00000703|Antidotes|antidotes|mesh-ancestor
102599100|NCT00000703|Protective Agents|protective agents|mesh-ancestor
102599101|NCT00000703|Vitamin B Complex|vitamin b complex|mesh-ancestor
102599102|NCT00000703|Vitamins|vitamins|mesh-ancestor
102599103|NCT00000703|Micronutrients|micronutrients|mesh-ancestor
102599104|NCT00000703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102599105|NCT00000703|Tubulin Modulators|tubulin modulators|mesh-ancestor
102599106|NCT00000703|Antimitotic Agents|antimitotic agents|mesh-ancestor
102599107|NCT00000703|Mitosis Modulators|mitosis modulators|mesh-ancestor
102599108|NCT00000703|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102599109|NCT00000703|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102599110|NCT00000703|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102599111|NCT00000703|Gout Suppressants|gout suppressants|mesh-ancestor
102599112|NCT00000703|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102599113|NCT00000703|Antioxidants|antioxidants|mesh-ancestor
102599114|NCT00001015|Ribavirin|ribavirin|mesh-list
102599115|NCT00001015|Antimetabolites|antimetabolites|mesh-ancestor
102599116|NCT00001015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599117|NCT00001015|Antiviral Agents|antiviral agents|mesh-ancestor
102599118|NCT00001015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599119|NCT00000709|Zidovudine|zidovudine|mesh-list
102599120|NCT00000709|Antimetabolites|antimetabolites|mesh-ancestor
102599121|NCT00000709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599122|NCT00000709|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102599123|NCT00000709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102599124|NCT00000709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599125|NCT00000709|Antiviral Agents|antiviral agents|mesh-ancestor
102599126|NCT00000709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599127|NCT00000709|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102599128|NCT00000709|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102599129|NCT00001027|Pentamidine|pentamidine|mesh-list
102599130|NCT00001027|Antifungal Agents|antifungal agents|mesh-ancestor
102599131|NCT00001027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599132|NCT00001027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102599133|NCT00001027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102599134|NCT00001027|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102599135|NCT00000727|Zidovudine|zidovudine|mesh-list
102599136|NCT00000727|Pyrimethamine|pyrimethamine|mesh-list
102599137|NCT00000727|Sulfadoxine|sulfadoxine|mesh-list
102599138|NCT00000727|Trimethoprim|trimethoprim|mesh-list
102599139|NCT00000727|Sulfamethoxazole|sulfamethoxazole|mesh-list
102599140|NCT00000727|Pentamidine|pentamidine|mesh-list
102599141|NCT00000727|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102599142|NCT00000727|Antimetabolites|antimetabolites|mesh-ancestor
102599143|NCT00000727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599144|NCT00000727|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102599145|NCT00000727|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102599146|NCT00000727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599147|NCT00000727|Antiviral Agents|antiviral agents|mesh-ancestor
102146035|NCT03429621|Antifoaming Agents|antifoaming agents|mesh-ancestor
102599149|NCT00000727|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102599150|NCT00000727|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102599151|NCT00000727|Antimalarials|antimalarials|mesh-ancestor
102599152|NCT00000727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102599153|NCT00000727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102599154|NCT00000727|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102599155|NCT00000727|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102599156|NCT00000727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102599157|NCT00000727|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102599158|NCT00000727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102599159|NCT00000727|Antifungal Agents|antifungal agents|mesh-ancestor
102599160|NCT00000727|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102599161|NCT00000727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102599162|NCT00001039|Clarithromycin|clarithromycin|mesh-list
102599163|NCT00001039|Ethambutol|ethambutol|mesh-list
102599164|NCT00001039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102599165|NCT00001039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599166|NCT00001039|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102599167|NCT00001039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599168|NCT00001039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599169|NCT00001039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102599170|NCT00001039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102599171|NCT00001039|Antitubercular Agents|antitubercular agents|mesh-ancestor
102599172|NCT00001057|Zidovudine|zidovudine|mesh-list
102599173|NCT00001057|Didanosine|didanosine|mesh-list
102599174|NCT00001057|Antimetabolites|antimetabolites|mesh-ancestor
102599175|NCT00001057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599176|NCT00001057|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102599177|NCT00001057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102599178|NCT00001057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599179|NCT00001057|Antiviral Agents|antiviral agents|mesh-ancestor
102599180|NCT00001057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599181|NCT00001057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102599182|NCT00001057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102599183|NCT00002293|Nystatin|nystatin|mesh-list
102599184|NCT00002293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102599185|NCT00002293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599186|NCT00002293|Antifungal Agents|antifungal agents|mesh-ancestor
102599187|NCT00002293|Ionophores|ionophores|mesh-ancestor
102599188|NCT00002293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102599189|NCT00002293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599190|NCT00002299|Interferons|interferons|mesh-list
102599191|NCT00002299|Interferon-beta|interferon-beta|mesh-list
102599192|NCT00002299|Ganciclovir|ganciclovir|mesh-list
102599193|NCT00002299|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102599194|NCT00002299|Interferon beta-1b|interferon beta-1b|mesh-list
102599195|NCT00002299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102599196|NCT00002299|Antiviral Agents|antiviral agents|mesh-ancestor
102599197|NCT00002299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599198|NCT00002299|Immunologic Factors|immunologic factors|mesh-ancestor
102599199|NCT00002299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102599200|NCT00002299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102599201|NCT00002299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599202|NCT00002299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599203|NCT00002299|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102599204|NCT00001063|Zidovudine|zidovudine|mesh-list
102599205|NCT00001063|Stavudine|stavudine|mesh-list
102599206|NCT00001063|Didanosine|didanosine|mesh-list
102599207|NCT00001063|Antimetabolites|antimetabolites|mesh-ancestor
102599208|NCT00001063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599209|NCT00001063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102599210|NCT00001063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102599211|NCT00001063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599212|NCT00001063|Antiviral Agents|antiviral agents|mesh-ancestor
102599213|NCT00001063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599214|NCT00001063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102599215|NCT00001063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102599216|NCT00002305|Fluconazole|fluconazole|mesh-list
102599217|NCT00002305|Amphotericin B|amphotericin b|mesh-list
102599218|NCT00002305|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102599219|NCT00002305|Flucytosine|flucytosine|mesh-list
102599220|NCT00002305|Antifungal Agents|antifungal agents|mesh-ancestor
102599221|NCT00002305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599222|NCT00002305|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102146118|NCT03127371|Nitrous Oxide|nitrous oxide|mesh-list
102599223|NCT00002305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102599224|NCT00002305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599225|NCT00002305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599226|NCT00002305|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102599227|NCT00002305|Hormone Antagonists|hormone antagonists|mesh-ancestor
102599228|NCT00002305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102599229|NCT00002305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102599230|NCT00002305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102599231|NCT00002305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102599232|NCT00002305|Amebicides|amebicides|mesh-ancestor
102599233|NCT00002305|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102599234|NCT00002305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102599235|NCT00002305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102599236|NCT00002305|Antimetabolites|antimetabolites|mesh-ancestor
102599237|NCT00001081|Nitazoxanide|nitazoxanide|mesh-list
102599238|NCT00001081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102599239|NCT00001081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599240|NCT00002311|Wobenzym|wobenzym|mesh-list
102599241|NCT00002311|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102599242|NCT00002311|Immunologic Factors|immunologic factors|mesh-ancestor
102599243|NCT00002311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102599244|NCT00002317|Leucovorin|leucovorin|mesh-list
102599245|NCT00002317|Trimetrexate|trimetrexate|mesh-list
102599246|NCT00002317|Calcium|calcium|mesh-list
102599247|NCT00002317|Levoleucovorin|levoleucovorin|mesh-list
102599248|NCT00002317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102599249|NCT00002317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102599250|NCT00002317|Antidotes|antidotes|mesh-ancestor
102599251|NCT00002317|Protective Agents|protective agents|mesh-ancestor
102599252|NCT00002317|Vitamin B Complex|vitamin b complex|mesh-ancestor
102599253|NCT00002317|Vitamins|vitamins|mesh-ancestor
102599254|NCT00002317|Micronutrients|micronutrients|mesh-ancestor
102599255|NCT00002317|Antifungal Agents|antifungal agents|mesh-ancestor
102599256|NCT00002317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599257|NCT00002317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102599258|NCT00002317|Antimetabolites|antimetabolites|mesh-ancestor
102599259|NCT00002317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599260|NCT00002317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102599261|NCT00002317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102599262|NCT00002317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599263|NCT00001123|Ribavirin|ribavirin|mesh-list
102599264|NCT00001123|Antimetabolites|antimetabolites|mesh-ancestor
102599265|NCT00001123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599266|NCT00001123|Antiviral Agents|antiviral agents|mesh-ancestor
102599267|NCT00001123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599268|NCT00002323|Zidovudine|zidovudine|mesh-list
102599269|NCT00002323|Nevirapine|nevirapine|mesh-list
102599270|NCT00002323|Antimetabolites|antimetabolites|mesh-ancestor
102599271|NCT00002323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599272|NCT00002323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102599273|NCT00002323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102599274|NCT00002323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599275|NCT00002323|Antiviral Agents|antiviral agents|mesh-ancestor
102599276|NCT00002323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599277|NCT00002323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102599278|NCT00002323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102599279|NCT00002323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102599280|NCT00002323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102599281|NCT00380965|Nabilone|nabilone|mesh-list
102599282|NCT00380965|Antiemetics|antiemetics|mesh-ancestor
102599283|NCT00380965|Autonomic Agents|autonomic agents|mesh-ancestor
102599284|NCT00380965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102599285|NCT00380965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102599286|NCT00380965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102599287|NCT00380965|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102599288|NCT00380965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102599289|NCT00380965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102599290|NCT00380965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102599291|NCT00001135|Nevirapine|nevirapine|mesh-list
102599292|NCT00001135|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102599293|NCT00001135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102599294|NCT00001135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599295|NCT00001135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599296|NCT00001135|Antiviral Agents|antiviral agents|mesh-ancestor
102599297|NCT00001135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599298|NCT00001135|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102599299|NCT00001135|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102599300|NCT00001135|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102599301|NCT00001135|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102599302|NCT00003002|Sargramostim|sargramostim|mesh-list
102599303|NCT00003002|Immunologic Factors|immunologic factors|mesh-ancestor
102599304|NCT00003002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102599305|NCT00001891|Dobutamine|dobutamine|mesh-list
102599306|NCT00001891|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102599307|NCT00001891|Sympathomimetics|sympathomimetics|mesh-ancestor
102599308|NCT00001891|Autonomic Agents|autonomic agents|mesh-ancestor
102599309|NCT00001891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102599310|NCT00001891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102599311|NCT00001891|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102599312|NCT00001891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102599313|NCT00001891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102599314|NCT00001891|Adrenergic Agents|adrenergic agents|mesh-ancestor
102599315|NCT00001891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102599316|NCT00001891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599317|NCT00001891|Protective Agents|protective agents|mesh-ancestor
102599318|NCT00383864|Interferons|interferons|mesh-list
102599319|NCT00383864|Ribavirin|ribavirin|mesh-list
102599320|NCT00383864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102599321|NCT00383864|Antiviral Agents|antiviral agents|mesh-ancestor
102599322|NCT00383864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599323|NCT00383864|Antimetabolites|antimetabolites|mesh-ancestor
102599324|NCT00383864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599325|NCT00001903|Immunoglobulins|immunoglobulins|mesh-list
102599326|NCT00001903|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102599327|NCT00001903|Antibodies|antibodies|mesh-list
102599328|NCT00001903|Immunologic Factors|immunologic factors|mesh-ancestor
102599329|NCT00001903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102599330|NCT00002335|Emtricitabine|emtricitabine|mesh-list
102599331|NCT00002335|Antiviral Agents|antiviral agents|mesh-ancestor
102599332|NCT00002335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599333|NCT00002335|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102599334|NCT00002335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102599335|NCT00002335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599336|NCT00002335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599337|NCT00002335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102599338|NCT00002335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102599339|NCT00002341|Itraconazole|itraconazole|mesh-list
102599340|NCT00002341|Antifungal Agents|antifungal agents|mesh-ancestor
102599341|NCT00002341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102345878|NCT05322707|Glucocorticoids|glucocorticoids|mesh-ancestor
102599342|NCT00002341|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102599343|NCT00002341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102599344|NCT00002341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599345|NCT00002341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599346|NCT00002341|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102599347|NCT00002341|Hormone Antagonists|hormone antagonists|mesh-ancestor
102599348|NCT00002341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102599349|NCT00002341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102599350|NCT00002341|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102599351|NCT00002347|Zidovudine|zidovudine|mesh-list
102599352|NCT00002347|Nevirapine|nevirapine|mesh-list
102599353|NCT00002347|Zalcitabine|zalcitabine|mesh-list
102599354|NCT00002347|Saquinavir|saquinavir|mesh-list
102599355|NCT00002347|Antimetabolites|antimetabolites|mesh-ancestor
102599356|NCT00002347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599357|NCT00002347|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102599358|NCT00002347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102599359|NCT00002347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599360|NCT00002347|Antiviral Agents|antiviral agents|mesh-ancestor
102599361|NCT00002347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599362|NCT00002347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102599363|NCT00002347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102599364|NCT00002347|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102599365|NCT00002347|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102599366|NCT00002347|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102599367|NCT00002347|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102599368|NCT00002347|Protease Inhibitors|protease inhibitors|mesh-ancestor
102599369|NCT00002347|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102599370|NCT00002347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102599371|NCT00001237|Molgramostim|molgramostim|mesh-list
102599372|NCT00001237|Sargramostim|sargramostim|mesh-list
102599373|NCT00001237|Immunologic Factors|immunologic factors|mesh-ancestor
102599374|NCT00001237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102599375|NCT00001237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102599376|NCT00001933|Nefiracetam|nefiracetam|mesh-list
102599377|NCT00001933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102599378|NCT00001933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102599379|NCT00001933|Protective Agents|protective agents|mesh-ancestor
102599380|NCT00001933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102599381|NCT00001933|Nootropic Agents|nootropic agents|mesh-ancestor
102599382|NCT00001249|Antibodies|antibodies|mesh-list
102599383|NCT00001249|Immunologic Factors|immunologic factors|mesh-ancestor
102599384|NCT00001249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102599385|NCT00380575|Conivaptan|conivaptan|mesh-list
102599386|NCT00380575|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102599387|NCT00380575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599388|NCT00380575|Natriuretic Agents|natriuretic agents|mesh-ancestor
102599389|NCT00380575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102599390|NCT00001963|Chrysarobin|chrysarobin|mesh-list
102599391|NCT00001963|Nitric Oxide|nitric oxide|mesh-list
102599392|NCT00001963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102599393|NCT00001963|Autonomic Agents|autonomic agents|mesh-ancestor
102599394|NCT00001963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102599395|NCT00001963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102599396|NCT00001963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102599397|NCT00001963|Respiratory System Agents|respiratory system agents|mesh-ancestor
102599398|NCT00001963|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102599399|NCT00001963|Antioxidants|antioxidants|mesh-ancestor
102599400|NCT00001963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599401|NCT00001963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102599402|NCT00001963|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102599403|NCT00001963|Vasodilator Agents|vasodilator agents|mesh-ancestor
102599404|NCT00001963|Gasotransmitters|gasotransmitters|mesh-ancestor
102599405|NCT00001963|Protective Agents|protective agents|mesh-ancestor
102599406|NCT00001963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102599407|NCT00001963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102599408|NCT00001963|Analgesics|analgesics|mesh-ancestor
102599409|NCT00001963|Sensory System Agents|sensory system agents|mesh-ancestor
102599410|NCT00001963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102599411|NCT00001963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102599412|NCT00002377|Valganciclovir|valganciclovir|mesh-list
102599413|NCT00002377|Ganciclovir|ganciclovir|mesh-list
102599414|NCT00002377|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102599415|NCT00002377|Antiviral Agents|antiviral agents|mesh-ancestor
102599416|NCT00002377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599417|NCT00002377|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102599418|NCT00002377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599419|NCT00002377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599420|NCT00001339|Doxorubicin|doxorubicin|mesh-list
102599421|NCT00001339|Etoposide|etoposide|mesh-list
102599422|NCT00001339|Vincristine|vincristine|mesh-list
102599423|NCT00001339|Mitotane|mitotane|mesh-list
102599424|NCT00001339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102599425|NCT00001339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102599426|NCT00001339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102599427|NCT00001339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102599428|NCT00001339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599429|NCT00001339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599430|NCT00001339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102599431|NCT00001339|Tubulin Modulators|tubulin modulators|mesh-ancestor
102599432|NCT00001339|Antimitotic Agents|antimitotic agents|mesh-ancestor
102599433|NCT00001339|Mitosis Modulators|mitosis modulators|mesh-ancestor
102599434|NCT00001339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102599435|NCT00001993|Miglustat|miglustat|mesh-list
102599436|NCT00001993|Zidovudine|zidovudine|mesh-list
102599437|NCT00001993|Antimetabolites|antimetabolites|mesh-ancestor
102599438|NCT00001993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599439|NCT00001993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102599440|NCT00001993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102599441|NCT00001993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599442|NCT00001993|Antiviral Agents|antiviral agents|mesh-ancestor
102599443|NCT00001993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599444|NCT00001993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102599445|NCT00001993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102599446|NCT00001993|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102599447|NCT00001993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102599448|NCT00001993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102599449|NCT00001999|Ganciclovir|ganciclovir|mesh-list
102599450|NCT00001999|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102599451|NCT00001999|Immunoglobulins|immunoglobulins|mesh-list
102599452|NCT00001999|Antibodies|antibodies|mesh-list
102599453|NCT00001999|Antiviral Agents|antiviral agents|mesh-ancestor
102599454|NCT00001999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599455|NCT00001999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102599456|NCT00001999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599457|NCT00001999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599458|NCT00001999|Immunologic Factors|immunologic factors|mesh-ancestor
102599459|NCT00001999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102599460|NCT00002383|Saquinavir|saquinavir|mesh-list
102599461|NCT00002383|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102599462|NCT00002383|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102599463|NCT00002383|Protease Inhibitors|protease inhibitors|mesh-ancestor
102599464|NCT00002383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599465|NCT00002383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599466|NCT00002383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102599467|NCT00002383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102599468|NCT00002383|Antiviral Agents|antiviral agents|mesh-ancestor
102599469|NCT00002383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599470|NCT00002383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102599471|NCT00002383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102599472|NCT00002389|Lamivudine|lamivudine|mesh-list
102599473|NCT00002389|Zidovudine|zidovudine|mesh-list
102599474|NCT00002389|Abacavir|abacavir|mesh-list
102599475|NCT00002389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102599476|NCT00002389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102599477|NCT00002389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599478|NCT00002389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599479|NCT00002389|Antiviral Agents|antiviral agents|mesh-ancestor
102599480|NCT00002389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599481|NCT00002389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102599482|NCT00002389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102599483|NCT00002389|Antimetabolites|antimetabolites|mesh-ancestor
102599484|NCT00001357|Interleukin-2|interleukin-2|mesh-list
102599485|NCT00001357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102599486|NCT00001357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102599487|NCT00001357|Analgesics|analgesics|mesh-ancestor
102599488|NCT00001357|Sensory System Agents|sensory system agents|mesh-ancestor
102599489|NCT00001357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102599490|NCT00001357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102599491|NCT00001381|Suramin|suramin|mesh-list
102599492|NCT00001381|Antinematodal Agents|antinematodal agents|mesh-ancestor
102599493|NCT00001381|Anthelmintics|anthelmintics|mesh-ancestor
102599494|NCT00001381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102599495|NCT00001381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599496|NCT00001381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102599497|NCT00001381|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102599498|NCT00001381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102599499|NCT00002011|Methoxsalen|methoxsalen|mesh-list
102599500|NCT00002011|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102599501|NCT00002011|Dermatologic Agents|dermatologic agents|mesh-ancestor
102599502|NCT00002017|Interleukin-2|interleukin-2|mesh-list
102599503|NCT00002017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102599504|NCT00002017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102599505|NCT00002017|Analgesics|analgesics|mesh-ancestor
102599506|NCT00002017|Sensory System Agents|sensory system agents|mesh-ancestor
102599507|NCT00002017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102599508|NCT00002017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102599509|NCT00002023|Zidovudine|zidovudine|mesh-list
102599510|NCT00002023|Antimetabolites|antimetabolites|mesh-ancestor
102599511|NCT00002023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599512|NCT00002023|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102599513|NCT00002023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102599514|NCT00002023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599515|NCT00002023|Antiviral Agents|antiviral agents|mesh-ancestor
102599516|NCT00002023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599517|NCT00002023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102599518|NCT00002023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102599519|NCT00002029|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102599520|NCT00002029|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102599521|NCT00002029|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102599522|NCT00002029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102599523|NCT00002035|Zidovudine|zidovudine|mesh-list
102599524|NCT00002035|Didanosine|didanosine|mesh-list
102599525|NCT00002035|Antimetabolites|antimetabolites|mesh-ancestor
102599526|NCT00002035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599527|NCT00002035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102599528|NCT00002035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102599529|NCT00002035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599531|NCT00002035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599532|NCT00002035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102599533|NCT00002035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102599534|NCT00002041|Amphotericin B|amphotericin b|mesh-list
102599535|NCT00002041|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102599536|NCT00002041|Amebicides|amebicides|mesh-ancestor
102599537|NCT00002041|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102599538|NCT00002041|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102599539|NCT00002041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599540|NCT00002041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102599541|NCT00002041|Antifungal Agents|antifungal agents|mesh-ancestor
102599542|NCT00002047|Zidovudine|zidovudine|mesh-list
102599543|NCT00002047|Antimetabolites|antimetabolites|mesh-ancestor
102599544|NCT00002047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599545|NCT00002047|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102599546|NCT00002047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102599547|NCT00002047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599548|NCT00002047|Antiviral Agents|antiviral agents|mesh-ancestor
102599549|NCT00002047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599550|NCT00002047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102599551|NCT00002047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102599552|NCT00002053|Pentamidine|pentamidine|mesh-list
102599553|NCT00002053|Antifungal Agents|antifungal agents|mesh-ancestor
102599554|NCT00002053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599555|NCT00002053|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102599556|NCT00002053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102599557|NCT00002053|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102599558|NCT00002059|Inosine Pranobex|inosine pranobex|mesh-list
102599559|NCT00002059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102599560|NCT00002059|Immunologic Factors|immunologic factors|mesh-ancestor
102599561|NCT00002059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102599562|NCT00002059|Antiviral Agents|antiviral agents|mesh-ancestor
102599563|NCT00002059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599564|NCT00002065|Disulfiram|disulfiram|mesh-list
102599565|NCT00002065|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102599566|NCT00002065|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
102599567|NCT00002065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599568|NCT00002065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599569|NCT00002071|Epoetin Alfa|epoetin alfa|mesh-list
102599570|NCT00002071|Hematinics|hematinics|mesh-ancestor
102599571|NCT00002395|Topotecan|topotecan|mesh-list
102599572|NCT00002395|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102599573|NCT00002395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102599574|NCT00002395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599575|NCT00002395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599576|NCT00002395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102599577|NCT00002401|Lamivudine|lamivudine|mesh-list
102599578|NCT00002401|Zidovudine|zidovudine|mesh-list
102599579|NCT00002401|Delavirdine|delavirdine|mesh-list
102599580|NCT00002401|Indinavir|indinavir|mesh-list
102599581|NCT00002401|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102599582|NCT00002401|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102599583|NCT00002401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599584|NCT00002401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599585|NCT00002401|Antiviral Agents|antiviral agents|mesh-ancestor
102599586|NCT00002401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599587|NCT00002401|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102599588|NCT00002401|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102599589|NCT00002401|Antimetabolites|antimetabolites|mesh-ancestor
102599590|NCT00002401|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102599591|NCT00002401|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102599592|NCT00002401|Protease Inhibitors|protease inhibitors|mesh-ancestor
102599593|NCT00002407|Lamivudine|lamivudine|mesh-list
102599594|NCT00002407|Nevirapine|nevirapine|mesh-list
102599595|NCT00002407|Stavudine|stavudine|mesh-list
102599596|NCT00002407|Didanosine|didanosine|mesh-list
102599597|NCT00002407|Indinavir|indinavir|mesh-list
102599598|NCT00002407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102599599|NCT00002407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102599600|NCT00002407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599601|NCT00002407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599602|NCT00002407|Antiviral Agents|antiviral agents|mesh-ancestor
102599603|NCT00002407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599604|NCT00002407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102599605|NCT00002407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102599606|NCT00002407|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102599607|NCT00002407|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102599608|NCT00002407|Antimetabolites|antimetabolites|mesh-ancestor
102599609|NCT00002407|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102599610|NCT00002407|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102599611|NCT00002407|Protease Inhibitors|protease inhibitors|mesh-ancestor
102599612|NCT00002413|Emivirine|emivirine|mesh-list
102599613|NCT00002413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102599614|NCT00002413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102599615|NCT00002413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599616|NCT00002413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599617|NCT00002413|Antiviral Agents|antiviral agents|mesh-ancestor
102599618|NCT00002413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599619|NCT00002419|Efavirenz|efavirenz|mesh-list
102599620|NCT00002419|Abacavir|abacavir|mesh-list
102599621|NCT00002419|Adefovir|adefovir|mesh-list
102599622|NCT00002419|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
102599623|NCT00002419|Amprenavir|amprenavir|mesh-list
102599624|NCT00002419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102599625|NCT00002419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102599626|NCT00002419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599627|NCT00002419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599628|NCT00002419|Antiviral Agents|antiviral agents|mesh-ancestor
101866430|NCT00203502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102599629|NCT00002419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599630|NCT00002419|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102599631|NCT00002419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102599632|NCT00002419|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102599633|NCT00002419|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102599634|NCT00002419|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102599635|NCT00002419|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102599636|NCT00002419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102599637|NCT00002419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102599638|NCT00002419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102599639|NCT00002419|Antitubercular Agents|antitubercular agents|mesh-ancestor
102599640|NCT00002419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102599641|NCT00002419|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102599642|NCT00002419|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102599643|NCT00002419|Protease Inhibitors|protease inhibitors|mesh-ancestor
102599644|NCT00381511|Heparin|heparin|mesh-list
102599645|NCT00381511|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102599646|NCT00381511|Tinzaparin|tinzaparin|mesh-list
102599647|NCT00381511|Dalteparin|dalteparin|mesh-list
102599648|NCT00381511|Anticoagulants|anticoagulants|mesh-ancestor
102599649|NCT00381511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102599650|NCT00381511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102599651|NCT00381511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599652|NCT00002425|Saquinavir|saquinavir|mesh-list
102599653|NCT00002425|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102599654|NCT00002425|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102599655|NCT00002425|Protease Inhibitors|protease inhibitors|mesh-ancestor
102599656|NCT00002425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599657|NCT00002425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599658|NCT00002425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102599659|NCT00002425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102599660|NCT00002425|Antiviral Agents|antiviral agents|mesh-ancestor
102599661|NCT00002425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599662|NCT00002425|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102599663|NCT00002425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102599664|NCT00002431|Chlorhexidine|chlorhexidine|mesh-list
102599665|NCT00002431|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102599666|NCT00002431|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102599667|NCT00002431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599668|NCT00002431|Disinfectants|disinfectants|mesh-ancestor
102599669|NCT00002431|Dermatologic Agents|dermatologic agents|mesh-ancestor
102599670|NCT00002077|Fluconazole|fluconazole|mesh-list
102599671|NCT00002077|Antifungal Agents|antifungal agents|mesh-ancestor
102599672|NCT00002077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599673|NCT00002077|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102599674|NCT00002077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102599675|NCT00002077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599676|NCT00002077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599677|NCT00002077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102599678|NCT00002077|Hormone Antagonists|hormone antagonists|mesh-ancestor
102146572|NCT03642509|Anticoagulants|anticoagulants|mesh-ancestor
102599679|NCT00002077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102599680|NCT00002077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102599681|NCT00002077|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102599682|NCT00002077|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102599683|NCT00002089|Azithromycin|azithromycin|mesh-list
102599684|NCT00002089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102599685|NCT00002089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599686|NCT00002095|Ganciclovir|ganciclovir|mesh-list
102599687|NCT00002095|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102599688|NCT00002095|Antiviral Agents|antiviral agents|mesh-ancestor
102599689|NCT00002095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102345908|NCT05282121|Empagliflozin|empagliflozin|mesh-list
102345909|NCT05282121|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102345911|NCT05282121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102599690|NCT00002095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102599691|NCT00002095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599692|NCT00002095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599693|NCT00002101|Clarithromycin|clarithromycin|mesh-list
102599694|NCT00002101|Ethambutol|ethambutol|mesh-list
102599695|NCT00002101|Rifabutin|rifabutin|mesh-list
102599696|NCT00002101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102599697|NCT00002101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599698|NCT00002101|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102599699|NCT00002101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599700|NCT00002101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599701|NCT00002101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102599702|NCT00002101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102599703|NCT00002101|Antitubercular Agents|antitubercular agents|mesh-ancestor
102599704|NCT00002101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102599705|NCT02335424|Pembrolizumab|pembrolizumab|mesh-list
102599706|NCT02335424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102599707|NCT02335424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102599708|NCT02335424|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102599709|NCT02335424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599710|NCT00002107|Aldesleukin|aldesleukin|mesh-list
102599711|NCT00002107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102599712|NCT00002107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102599713|NCT00002107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102599714|NCT00002107|Antiviral Agents|antiviral agents|mesh-ancestor
102599715|NCT00002107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599716|NCT00002113|Fluconazole|fluconazole|mesh-list
102599717|NCT00002113|Flucytosine|flucytosine|mesh-list
102599718|NCT00002113|Antifungal Agents|antifungal agents|mesh-ancestor
102599719|NCT00002113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599720|NCT00002113|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102599721|NCT00002113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102599722|NCT00002113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599723|NCT00002113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599724|NCT00002113|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102599725|NCT00002113|Hormone Antagonists|hormone antagonists|mesh-ancestor
102599726|NCT00002113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102599727|NCT00002113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102599728|NCT00002113|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102599729|NCT00002113|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102599730|NCT00002113|Antimetabolites|antimetabolites|mesh-ancestor
102599731|NCT00002437|Cidofovir|cidofovir|mesh-list
102599732|NCT00002437|Probenecid|probenecid|mesh-list
102599733|NCT00002437|Uricosuric Agents|uricosuric agents|mesh-ancestor
102599734|NCT00002437|Gout Suppressants|gout suppressants|mesh-ancestor
102599735|NCT00002437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102599736|NCT00002437|Antiviral Agents|antiviral agents|mesh-ancestor
102599737|NCT00002437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599738|NCT00002437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599739|NCT00002437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599740|NCT04329650|Methylprednisolone|methylprednisolone|mesh-list
102599741|NCT04329650|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102599742|NCT04329650|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102599743|NCT04329650|Prednisolone|prednisolone|mesh-list
102599744|NCT04329650|Prednisolone acetate|prednisolone acetate|mesh-list
102599745|NCT04329650|Siltuximab|siltuximab|mesh-list
102599746|NCT04329650|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102599747|NCT04329650|Prednisolone phosphate|prednisolone phosphate|mesh-list
102599748|NCT04329650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102599749|NCT04329650|Antiemetics|antiemetics|mesh-ancestor
102599750|NCT04329650|Autonomic Agents|autonomic agents|mesh-ancestor
102599751|NCT04329650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102599752|NCT04329650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102599753|NCT04329650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102599754|NCT04329650|Glucocorticoids|glucocorticoids|mesh-ancestor
102599755|NCT04329650|Hormones|hormones|mesh-ancestor
102599756|NCT04329650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102599757|NCT04329650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102599758|NCT04329650|Protective Agents|protective agents|mesh-ancestor
102599759|NCT04329650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102599760|NCT04329650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102599761|NCT00002443|Zidovudine|zidovudine|mesh-list
102599762|NCT00002443|Indinavir|indinavir|mesh-list
102599763|NCT00002443|Antimetabolites|antimetabolites|mesh-ancestor
102599764|NCT00002443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599765|NCT00002443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102599766|NCT00002443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102599767|NCT00002443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599768|NCT00002443|Antiviral Agents|antiviral agents|mesh-ancestor
102599769|NCT00002443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599770|NCT00002443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102599771|NCT00002443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102599772|NCT00002443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102599773|NCT00002443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102599774|NCT00002443|Protease Inhibitors|protease inhibitors|mesh-ancestor
102599775|NCT00001561|Immunoglobulins|immunoglobulins|mesh-list
102599776|NCT00001561|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102599777|NCT00001561|Antibodies|antibodies|mesh-list
102599778|NCT00001561|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
102599779|NCT00001561|Immunologic Factors|immunologic factors|mesh-ancestor
102599780|NCT00001561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102599781|NCT00002449|Aldesleukin|aldesleukin|mesh-list
102599782|NCT00002449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102599783|NCT00002449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102599784|NCT00002449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102599785|NCT00002449|Antiviral Agents|antiviral agents|mesh-ancestor
102599786|NCT00002449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599787|NCT00003014|Carboplatin|carboplatin|mesh-list
102599788|NCT00003014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102599789|NCT00002125|Foscarnet|foscarnet|mesh-list
102599790|NCT00002125|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
102599791|NCT00002125|Antiviral Agents|antiviral agents|mesh-ancestor
102599792|NCT00002125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599793|NCT00002125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102599794|NCT00002125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102599795|NCT00002125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599796|NCT00002125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599797|NCT00001579|Leucovorin|leucovorin|mesh-list
102599798|NCT00001579|Fluorouracil|fluorouracil|mesh-list
102599799|NCT00001579|Eniluracil|eniluracil|mesh-list
102599800|NCT00001579|Antimetabolites|antimetabolites|mesh-ancestor
102599801|NCT00001579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599802|NCT00001579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102599803|NCT00001579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102599804|NCT00001579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102599805|NCT00001579|Immunologic Factors|immunologic factors|mesh-ancestor
102599806|NCT00001579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102599807|NCT00001579|Antidotes|antidotes|mesh-ancestor
102599808|NCT00001579|Protective Agents|protective agents|mesh-ancestor
102599809|NCT00001579|Vitamin B Complex|vitamin b complex|mesh-ancestor
102599810|NCT00001579|Vitamins|vitamins|mesh-ancestor
102599811|NCT00001579|Micronutrients|micronutrients|mesh-ancestor
102599812|NCT00001579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599813|NCT00003020|Immunotoxins|immunotoxins|mesh-list
102599814|NCT00003020|Immunoconjugates|immunoconjugates|mesh-ancestor
102599815|NCT00003020|Immunologic Factors|immunologic factors|mesh-ancestor
102599816|NCT00003020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102599817|NCT00002131|Vesnarinone|vesnarinone|mesh-list
102599818|NCT00002131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102599819|NCT00002131|Immunologic Factors|immunologic factors|mesh-ancestor
102599820|NCT00002131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102599821|NCT00002131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102599822|NCT00002131|Antiviral Agents|antiviral agents|mesh-ancestor
102599823|NCT00002131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599824|NCT00002131|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102599825|NCT00002131|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102599826|NCT00002131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599827|NCT00002131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599828|NCT00002131|Protective Agents|protective agents|mesh-ancestor
102599829|NCT00380887|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
102146721|NCT02357732|Nivolumab|nivolumab|mesh-list
102599830|NCT00380887|Estrogens|estrogens|mesh-ancestor
102599831|NCT00380887|Hormones|hormones|mesh-ancestor
102369678|NCT03831321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599832|NCT00380887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102599833|NCT00380887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102599834|NCT00002461|Cyclophosphamide|cyclophosphamide|mesh-list
102599835|NCT00002461|Carmustine|carmustine|mesh-list
102599836|NCT00002461|Etoposide|etoposide|mesh-list
102599837|NCT00002461|Sargramostim|sargramostim|mesh-list
102599838|NCT00002461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102599839|NCT00002461|Immunologic Factors|immunologic factors|mesh-ancestor
102599840|NCT00002461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102599841|NCT00002461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102599842|NCT00002461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102599843|NCT00002461|Alkylating Agents|alkylating agents|mesh-ancestor
102599844|NCT00002461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599845|NCT00002461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102599846|NCT00002461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102599847|NCT00002461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102599848|NCT00002461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102599849|NCT00002461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102599850|NCT00002461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599851|NCT00003026|Bicalutamide|bicalutamide|mesh-list
102599852|NCT00003026|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102599853|NCT00003026|Flutamide|flutamide|mesh-list
102599854|NCT00003026|Androgen Antagonists|androgen antagonists|mesh-ancestor
102599855|NCT00003026|Hormone Antagonists|hormone antagonists|mesh-ancestor
102599856|NCT00003026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102599857|NCT00003026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102599858|NCT00003026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102599859|NCT00003026|Luteolytic Agents|luteolytic agents|mesh-ancestor
102599860|NCT00003026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102599861|NCT00003026|Contraceptive Agents|contraceptive agents|mesh-ancestor
102599862|NCT00003026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102599863|NCT00003026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102599864|NCT00003026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102599865|NCT00002143|Acitretin|acitretin|mesh-list
102599866|NCT00002143|Keratolytic Agents|keratolytic agents|mesh-ancestor
102599867|NCT00002143|Dermatologic Agents|dermatologic agents|mesh-ancestor
102599868|NCT00002149|Amoxicillin|amoxicillin|mesh-list
102599869|NCT00002149|Clavulanic Acid|clavulanic acid|mesh-list
102599870|NCT00002149|Clavulanic Acids|clavulanic acids|mesh-list
102599871|NCT00002149|Pseudoephedrine|pseudoephedrine|mesh-list
102599872|NCT00002149|Ephedrine|ephedrine|mesh-list
102599873|NCT00002149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102599874|NCT00002149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599875|NCT00002149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102599876|NCT00002149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599877|NCT00002149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599878|NCT00002149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102599879|NCT00002149|Autonomic Agents|autonomic agents|mesh-ancestor
102599880|NCT00002149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102599881|NCT00002149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102599882|NCT00002149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102599883|NCT00002149|Respiratory System Agents|respiratory system agents|mesh-ancestor
102599884|NCT00002149|Nasal Decongestants|nasal decongestants|mesh-ancestor
102599885|NCT00002149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102599886|NCT00002149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102599887|NCT00002149|Sympathomimetics|sympathomimetics|mesh-ancestor
102599888|NCT00002149|Adrenergic Agents|adrenergic agents|mesh-ancestor
102599889|NCT00002149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102599890|NCT03868046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102599891|NCT03868046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599892|NCT03868046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102599893|NCT03868046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102599894|NCT02973295|Silymarin|silymarin|mesh-list
102599895|NCT02973295|Antioxidants|antioxidants|mesh-ancestor
102599896|NCT02973295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599897|NCT02973295|Protective Agents|protective agents|mesh-ancestor
102599898|NCT02973295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102599899|NCT00003032|Tamoxifen|tamoxifen|mesh-list
102599900|NCT00003032|Cyclophosphamide|cyclophosphamide|mesh-list
102599901|NCT00003032|Mitoxantrone|mitoxantrone|mesh-list
102599902|NCT00003032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102599903|NCT00003032|Immunologic Factors|immunologic factors|mesh-ancestor
102599904|NCT00003032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146798|NCT04259996|Progestins|progestins|mesh-ancestor
102599905|NCT00003032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102599906|NCT00003032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102599907|NCT00003032|Alkylating Agents|alkylating agents|mesh-ancestor
102599908|NCT00003032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599909|NCT00003032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102599910|NCT00003032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102599911|NCT00003032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102599912|NCT00003032|Hormone Antagonists|hormone antagonists|mesh-ancestor
102599913|NCT00003032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102599914|NCT00003032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102599915|NCT00003032|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102599916|NCT00003032|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102599917|NCT00003032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102599918|NCT00003032|Analgesics|analgesics|mesh-ancestor
102599919|NCT00003032|Sensory System Agents|sensory system agents|mesh-ancestor
102599920|NCT00003032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102599921|NCT00003032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102599922|NCT00003032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102599923|NCT00003032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599924|NCT00002155|Lamivudine|lamivudine|mesh-list
102599925|NCT00002155|Zidovudine|zidovudine|mesh-list
102599926|NCT00002155|Indinavir|indinavir|mesh-list
102599927|NCT00002155|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102599928|NCT00002155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102599929|NCT00002155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599930|NCT00002155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599931|NCT00002155|Antiviral Agents|antiviral agents|mesh-ancestor
102599932|NCT00002155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599933|NCT00002155|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102599934|NCT00002155|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102599935|NCT00002155|Antimetabolites|antimetabolites|mesh-ancestor
102599936|NCT00002155|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102599937|NCT00002155|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102599938|NCT00002155|Protease Inhibitors|protease inhibitors|mesh-ancestor
102599939|NCT00003038|Suramin|suramin|mesh-list
102599940|NCT00003038|Doxorubicin|doxorubicin|mesh-list
102599941|NCT00003038|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102599942|NCT00003038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102599943|NCT00003038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102599944|NCT00003038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102599945|NCT00003038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102599946|NCT00003038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599947|NCT00003038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599948|NCT00003038|Antinematodal Agents|antinematodal agents|mesh-ancestor
102599949|NCT00003038|Anthelmintics|anthelmintics|mesh-ancestor
102599950|NCT00003038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102599951|NCT00003038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599952|NCT00003038|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102599953|NCT00003038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102599954|NCT00003044|Cisplatin|cisplatin|mesh-list
102599955|NCT00003044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102599956|NCT00002161|Adefovir|adefovir|mesh-list
102599957|NCT00002161|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
102599958|NCT00002161|Antiviral Agents|antiviral agents|mesh-ancestor
102599959|NCT00002161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102599960|NCT00002161|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102599961|NCT00002161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102599962|NCT00002161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599963|NCT00002161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599964|NCT00002167|Tin etiopurpurin|tin etiopurpurin|mesh-list
102599965|NCT00002167|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102599966|NCT00002167|Dermatologic Agents|dermatologic agents|mesh-ancestor
102599967|NCT03805022|Doxorubicin|doxorubicin|mesh-list
102599968|NCT03805022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102599969|NCT03805022|Ifosfamide|ifosfamide|mesh-list
102599970|NCT03805022|Isophosphamide mustard|isophosphamide mustard|mesh-list
102599971|NCT03805022|Dacarbazine|dacarbazine|mesh-list
102599972|NCT03805022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102599973|NCT03805022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102599974|NCT03805022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102599975|NCT03805022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102599976|NCT03805022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102599977|NCT03805022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599978|NCT03805022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102599979|NCT03805022|Alkylating Agents|alkylating agents|mesh-ancestor
102599980|NCT05752435|Bleomycin|bleomycin|mesh-list
102599981|NCT05752435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102599982|NCT05752435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102599983|NCT00003050|Tamoxifen|tamoxifen|mesh-list
102599984|NCT00003050|Paclitaxel|paclitaxel|mesh-list
102599985|NCT00003050|Cyclophosphamide|cyclophosphamide|mesh-list
102599986|NCT00003050|Doxorubicin|doxorubicin|mesh-list
102599987|NCT00003050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102599988|NCT00003050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102599989|NCT00003050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102599990|NCT00003050|Tubulin Modulators|tubulin modulators|mesh-ancestor
102599991|NCT00003050|Antimitotic Agents|antimitotic agents|mesh-ancestor
102599992|NCT00003050|Mitosis Modulators|mitosis modulators|mesh-ancestor
102599993|NCT00003050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102599994|NCT00003050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102599995|NCT00003050|Immunologic Factors|immunologic factors|mesh-ancestor
102599996|NCT00003050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102599997|NCT00003050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102599998|NCT00003050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102599999|NCT00003050|Alkylating Agents|alkylating agents|mesh-ancestor
102600000|NCT00003050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102600001|NCT00003050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102600002|NCT00003050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102600003|NCT00003050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102600004|NCT00003050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600005|NCT00003050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102600006|NCT00003050|Hormone Antagonists|hormone antagonists|mesh-ancestor
102600007|NCT00003050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102600008|NCT00003050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102600009|NCT00003050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102600010|NCT00003050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102600011|NCT00003050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102600012|NCT00002179|Lamivudine|lamivudine|mesh-list
102600013|NCT00002179|Zidovudine|zidovudine|mesh-list
102600014|NCT00002179|Indinavir|indinavir|mesh-list
102600015|NCT00002179|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102600016|NCT00002179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102600017|NCT00002179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600018|NCT00002179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600019|NCT00002179|Antiviral Agents|antiviral agents|mesh-ancestor
102600020|NCT00002179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102600021|NCT00002179|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102600022|NCT00002179|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102600023|NCT00002179|Antimetabolites|antimetabolites|mesh-ancestor
102600024|NCT00002179|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102600025|NCT00002179|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102600026|NCT00002179|Protease Inhibitors|protease inhibitors|mesh-ancestor
102600027|NCT00003056|Cyclosporine|cyclosporine|mesh-list
102600028|NCT00003056|Methotrexate|methotrexate|mesh-list
102600029|NCT00003056|Cyclosporins|cyclosporins|mesh-list
102600030|NCT00003056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102600031|NCT00003056|Abortifacient Agents|abortifacient agents|mesh-ancestor
102600032|NCT00003056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102600033|NCT00003056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102600034|NCT00003056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102600035|NCT00003056|Antimetabolites|antimetabolites|mesh-ancestor
102600036|NCT00003056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600037|NCT00003056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102600038|NCT00003056|Dermatologic Agents|dermatologic agents|mesh-ancestor
102600039|NCT00003056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600040|NCT00003056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102600041|NCT00003056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102600042|NCT00003056|Immunologic Factors|immunologic factors|mesh-ancestor
102600043|NCT00003056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102600044|NCT00003056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102600045|NCT00003056|Antifungal Agents|antifungal agents|mesh-ancestor
102600046|NCT00003056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102345928|NCT05226663|Fluorides|fluorides|mesh-list
102600047|NCT00003056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102600048|NCT00002185|Nelfinavir|nelfinavir|mesh-list
102600049|NCT00002185|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102600050|NCT00002185|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102600051|NCT00002185|Protease Inhibitors|protease inhibitors|mesh-ancestor
102600052|NCT00002185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102146951|NCT03640247|Oxycodone|oxycodone|mesh-list
102146952|NCT03640247|Tramadol|tramadol|mesh-list
102600053|NCT00002185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600054|NCT00002185|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102600055|NCT00002185|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102600056|NCT00002185|Antiviral Agents|antiviral agents|mesh-ancestor
102600057|NCT00002185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102600058|NCT05752279|Plasma-lyte 148|plasma-lyte 148|mesh-list
102600059|NCT05752279|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102600060|NCT05752279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102600061|NCT00003062|Temozolomide|temozolomide|mesh-list
102600062|NCT00003062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102600063|NCT00003062|Alkylating Agents|alkylating agents|mesh-ancestor
102600064|NCT00003062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600065|NCT00003062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102600066|NCT00002191|Albendazole|albendazole|mesh-list
102600067|NCT00002191|Anthelmintics|anthelmintics|mesh-ancestor
102600068|NCT00002191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102600069|NCT00002191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102600070|NCT00002191|Anticestodal Agents|anticestodal agents|mesh-ancestor
102600071|NCT00002191|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102600072|NCT00002191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102600073|NCT00002191|Tubulin Modulators|tubulin modulators|mesh-ancestor
102600074|NCT00002191|Antimitotic Agents|antimitotic agents|mesh-ancestor
102600075|NCT00002191|Mitosis Modulators|mitosis modulators|mesh-ancestor
102600076|NCT00002191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600077|NCT00002191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102600078|NCT00383396|Cyclosporine|cyclosporine|mesh-list
102600079|NCT00383396|Cyclosporins|cyclosporins|mesh-list
102600080|NCT00383396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600081|NCT00383396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600082|NCT00383396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102600083|NCT00383396|Immunologic Factors|immunologic factors|mesh-ancestor
102600084|NCT00383396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102600085|NCT00383396|Antifungal Agents|antifungal agents|mesh-ancestor
102600086|NCT00383396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102600087|NCT00383396|Dermatologic Agents|dermatologic agents|mesh-ancestor
102600088|NCT00383396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102600089|NCT00383396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102600090|NCT00002197|Abacavir|abacavir|mesh-list
102600091|NCT00002197|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102600092|NCT00002197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102600093|NCT00002197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600094|NCT00002197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600095|NCT00002197|Antiviral Agents|antiviral agents|mesh-ancestor
102600096|NCT00002197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102600097|NCT00002197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102600098|NCT00002197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102600099|NCT00003068|Cyclophosphamide|cyclophosphamide|mesh-list
102600100|NCT00003068|Thiotepa|thiotepa|mesh-list
102600101|NCT00003068|Mitoxantrone|mitoxantrone|mesh-list
102600102|NCT00003068|Amifostine|amifostine|mesh-list
102600103|NCT00003068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102600104|NCT00003068|Immunologic Factors|immunologic factors|mesh-ancestor
102600105|NCT00003068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102600106|NCT00003068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102600107|NCT00003068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102600108|NCT00003068|Alkylating Agents|alkylating agents|mesh-ancestor
102600109|NCT00003068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600110|NCT00003068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102600111|NCT00003068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102600112|NCT00003068|Analgesics|analgesics|mesh-ancestor
102600113|NCT00003068|Sensory System Agents|sensory system agents|mesh-ancestor
102600114|NCT00003068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102600115|NCT00003068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102600116|NCT00003068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102600117|NCT00003068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600118|NCT00003068|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102600119|NCT00003068|Protective Agents|protective agents|mesh-ancestor
102600120|NCT00003080|Tamoxifen|tamoxifen|mesh-list
102600121|NCT00003080|Melphalan|melphalan|mesh-list
102600122|NCT00003080|Thiotepa|thiotepa|mesh-list
102600123|NCT00003080|Mitoxantrone|mitoxantrone|mesh-list
102600124|NCT00003080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600125|NCT00003080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102600126|NCT00003080|Alkylating Agents|alkylating agents|mesh-ancestor
102600127|NCT00003080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102600128|NCT00003080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102147027|NCT02749721|Serotonin Agents|serotonin agents|mesh-ancestor
102600129|NCT00003080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102600130|NCT00003080|Immunologic Factors|immunologic factors|mesh-ancestor
102600131|NCT00003080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102600132|NCT00003080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102600133|NCT00003080|Hormone Antagonists|hormone antagonists|mesh-ancestor
102600134|NCT00003080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102600135|NCT00003080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102600136|NCT00003080|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102600137|NCT00003080|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102600138|NCT00003080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102600139|NCT00003080|Analgesics|analgesics|mesh-ancestor
102600140|NCT00003080|Sensory System Agents|sensory system agents|mesh-ancestor
102600141|NCT00003080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102600142|NCT00003080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102600143|NCT00003080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102600144|NCT00003080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600145|NCT00002203|Lamivudine|lamivudine|mesh-list
102600146|NCT00002203|Zidovudine|zidovudine|mesh-list
102600147|NCT00002203|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
102600148|NCT00002203|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102600149|NCT00002203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102600150|NCT00002203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600151|NCT00002203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600152|NCT00002203|Antiviral Agents|antiviral agents|mesh-ancestor
102600153|NCT00002203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102600154|NCT00002203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102600155|NCT00002203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102600156|NCT00002203|Antimetabolites|antimetabolites|mesh-ancestor
102600157|NCT01568918|Tamsulosin|tamsulosin|mesh-list
102600158|NCT01568918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102600159|NCT01568918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102600160|NCT01568918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102600161|NCT01568918|Adrenergic Agents|adrenergic agents|mesh-ancestor
102600162|NCT01568918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102600163|NCT01568918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600164|NCT01568918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102600165|NCT01568918|Urological Agents|urological agents|mesh-ancestor
102600166|NCT00003086|Cyclophosphamide|cyclophosphamide|mesh-list
102600167|NCT00003086|Carboplatin|carboplatin|mesh-list
102600168|NCT00003086|Doxorubicin|doxorubicin|mesh-list
102600169|NCT00003086|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102600170|NCT00003086|Fluorouracil|fluorouracil|mesh-list
102600171|NCT00003086|Melphalan|melphalan|mesh-list
102600172|NCT00003086|Ifosfamide|ifosfamide|mesh-list
102600173|NCT00003086|Thiotepa|thiotepa|mesh-list
102600174|NCT00003086|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
102600175|NCT00003086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102600176|NCT00003086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600177|NCT00003086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102600178|NCT00003086|Immunologic Factors|immunologic factors|mesh-ancestor
102600179|NCT00003086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102600180|NCT00003086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102600181|NCT00003086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102600182|NCT00003086|Alkylating Agents|alkylating agents|mesh-ancestor
102600183|NCT00003086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102600184|NCT00003086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102600185|NCT00003086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102600186|NCT00003086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102600187|NCT00003086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600188|NCT00003086|Antimetabolites|antimetabolites|mesh-ancestor
102600189|NCT00003086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102600190|NCT00003086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102600191|NCT00003086|Analgesics|analgesics|mesh-ancestor
102600192|NCT00003086|Sensory System Agents|sensory system agents|mesh-ancestor
102600193|NCT00003086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102600194|NCT00003092|Paclitaxel|paclitaxel|mesh-list
102600195|NCT00003092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102600196|NCT00003092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102600197|NCT00003092|Tubulin Modulators|tubulin modulators|mesh-ancestor
102600198|NCT00003092|Antimitotic Agents|antimitotic agents|mesh-ancestor
102600199|NCT00003092|Mitosis Modulators|mitosis modulators|mesh-ancestor
102600200|NCT00003092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600201|NCT00381199|Amitriptyline|amitriptyline|mesh-list
102600202|NCT00381199|Nabilone|nabilone|mesh-list
102600203|NCT00381199|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102147099|NCT02359604|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102600204|NCT00381199|Antidepressive Agents|antidepressive agents|mesh-ancestor
102600205|NCT00381199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102600206|NCT00381199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102600207|NCT00381199|Analgesics|analgesics|mesh-ancestor
102600208|NCT00381199|Sensory System Agents|sensory system agents|mesh-ancestor
102600209|NCT00381199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102600210|NCT00381199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102600211|NCT00381199|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102600212|NCT00381199|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102600213|NCT00381199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102600214|NCT00381199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600215|NCT00381199|Adrenergic Agents|adrenergic agents|mesh-ancestor
102600216|NCT00381199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102600217|NCT00381199|Antiemetics|antiemetics|mesh-ancestor
102600218|NCT00381199|Autonomic Agents|autonomic agents|mesh-ancestor
102600219|NCT00381199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102600220|NCT00381199|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102600221|NCT00381199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102600222|NCT00381199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102600223|NCT00002509|Cyclophosphamide|cyclophosphamide|mesh-list
102600224|NCT00002509|Carboplatin|carboplatin|mesh-list
102600225|NCT00002509|Etoposide|etoposide|mesh-list
102600226|NCT00002509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102600227|NCT00002509|Immunologic Factors|immunologic factors|mesh-ancestor
102600228|NCT00002509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102600229|NCT00002509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102600230|NCT00002509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102600231|NCT00002509|Alkylating Agents|alkylating agents|mesh-ancestor
102600232|NCT00002509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600233|NCT00002509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102600234|NCT00002509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102600235|NCT00002509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102600236|NCT00002509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102600237|NCT00002509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102600238|NCT00002509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600239|NCT00002515|Carboplatin|carboplatin|mesh-list
102600240|NCT00002515|Topotecan|topotecan|mesh-list
102600241|NCT00002515|Thiotepa|thiotepa|mesh-list
102600242|NCT00002515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102600243|NCT00002515|Immunologic Factors|immunologic factors|mesh-ancestor
102600244|NCT00002515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102600245|NCT00002515|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102600246|NCT00002515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102600247|NCT00002515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600248|NCT00002515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600249|NCT00002515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102600250|NCT00002515|Alkylating Agents|alkylating agents|mesh-ancestor
102600251|NCT00002515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102600252|NCT00002515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102600253|NCT00002521|Cyclophosphamide|cyclophosphamide|mesh-list
102600254|NCT00002521|Etoposide|etoposide|mesh-list
102600255|NCT00002521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102600256|NCT00002521|Immunologic Factors|immunologic factors|mesh-ancestor
102600257|NCT00002521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102600258|NCT00002521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102600259|NCT00002521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102600260|NCT00002521|Alkylating Agents|alkylating agents|mesh-ancestor
102369679|NCT04450134|Fexofenadine|fexofenadine|mesh-list
102600261|NCT00002521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600262|NCT00002521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102600263|NCT00002521|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102600264|NCT00002521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102600265|NCT00002521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102600266|NCT00002521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102600267|NCT00002521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600268|NCT00003110|Bleomycin|bleomycin|mesh-list
102600269|NCT00003110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102600270|NCT00003110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102600271|NCT00002215|Nelfinavir|nelfinavir|mesh-list
102600272|NCT00002215|Emivirine|emivirine|mesh-list
102600273|NCT00002215|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102600274|NCT00002215|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102600275|NCT00002215|Protease Inhibitors|protease inhibitors|mesh-ancestor
102600276|NCT00002215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600277|NCT00002215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600278|NCT00002215|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102600279|NCT00002215|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102600280|NCT00002215|Antiviral Agents|antiviral agents|mesh-ancestor
102600281|NCT00002215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102600282|NCT00002215|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102600283|NCT00002215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102600284|NCT00003116|Cyclosporine|cyclosporine|mesh-list
102600285|NCT00003116|Cyclophosphamide|cyclophosphamide|mesh-list
102600286|NCT00003116|Busulfan|busulfan|mesh-list
102600287|NCT00003116|Cyclosporins|cyclosporins|mesh-list
102600288|NCT00003116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102600289|NCT00003116|Immunologic Factors|immunologic factors|mesh-ancestor
102600290|NCT00003116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102600291|NCT00003116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102600292|NCT00003116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102600293|NCT00003116|Alkylating Agents|alkylating agents|mesh-ancestor
102600294|NCT00003116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600295|NCT00003116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102600296|NCT00003116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102600297|NCT00003116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600298|NCT00003116|Antifungal Agents|antifungal agents|mesh-ancestor
102600299|NCT00003116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102600300|NCT00003116|Dermatologic Agents|dermatologic agents|mesh-ancestor
102600301|NCT00003116|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102600302|NCT00002227|Lamivudine|lamivudine|mesh-list
102600303|NCT00002227|Efavirenz|efavirenz|mesh-list
102600304|NCT00002227|Stavudine|stavudine|mesh-list
102600305|NCT00002227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102600306|NCT00002227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102600307|NCT00002227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600308|NCT00002227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600309|NCT00002227|Antiviral Agents|antiviral agents|mesh-ancestor
102600310|NCT00002227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102600311|NCT00002227|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102600312|NCT00002227|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102600313|NCT00002227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102600314|NCT00002227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102600315|NCT00002227|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102600316|NCT00002227|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102600317|NCT00002227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102600318|NCT00002227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102600319|NCT00002227|Antimetabolites|antimetabolites|mesh-ancestor
102600320|NCT00002233|Lamivudine|lamivudine|mesh-list
102600321|NCT00002233|Abacavir|abacavir|mesh-list
102600322|NCT00002233|Indinavir|indinavir|mesh-list
102600323|NCT00002233|Amprenavir|amprenavir|mesh-list
102600324|NCT00002233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102600325|NCT00002233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102600326|NCT00002233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600327|NCT00002233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600328|NCT00002233|Antiviral Agents|antiviral agents|mesh-ancestor
102600329|NCT00002233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102600330|NCT00002233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102600331|NCT00002233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102600332|NCT00002233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102600333|NCT00002233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102600334|NCT00002233|Protease Inhibitors|protease inhibitors|mesh-ancestor
102600335|NCT00002233|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102600336|NCT00002233|Antitubercular Agents|antitubercular agents|mesh-ancestor
102600337|NCT00002233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102600338|NCT00002527|Aspirin|aspirin|mesh-list
102600339|NCT00002527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102600340|NCT00002527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102600341|NCT00002527|Analgesics|analgesics|mesh-ancestor
102600342|NCT00002527|Sensory System Agents|sensory system agents|mesh-ancestor
102600343|NCT00002527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102600344|NCT00002527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102600345|NCT00002527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102600346|NCT00002527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102600347|NCT00002527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102600348|NCT00002527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102600349|NCT00002527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600350|NCT00002527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102600351|NCT00002527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102600352|NCT00002527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600353|NCT00002527|Antipyretics|antipyretics|mesh-ancestor
102600354|NCT00002533|Fluconazole|fluconazole|mesh-list
102600355|NCT00002533|Antifungal Agents|antifungal agents|mesh-ancestor
102600356|NCT00002533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102600357|NCT00002533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102600358|NCT00002533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102600359|NCT00002533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600360|NCT00002533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600361|NCT00002533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102600362|NCT00002533|Hormone Antagonists|hormone antagonists|mesh-ancestor
102600363|NCT00002533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102600364|NCT00002533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102600365|NCT00002533|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102600366|NCT00002533|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102600367|NCT00002539|Doxorubicin|doxorubicin|mesh-list
102600368|NCT00002539|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102600369|NCT00002539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102600370|NCT00002539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102600371|NCT00002539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102600372|NCT00002539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102600373|NCT00002539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600374|NCT00002539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600375|NCT00381589|Bromides|bromides|mesh-list
102600376|NCT00381589|Ipratropium|ipratropium|mesh-list
102600377|NCT00381589|Anticonvulsants|anticonvulsants|mesh-ancestor
102600378|NCT00381589|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102600379|NCT00381589|Autonomic Agents|autonomic agents|mesh-ancestor
102600380|NCT00381589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102600381|NCT00381589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102600382|NCT00381589|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102600383|NCT00381589|Respiratory System Agents|respiratory system agents|mesh-ancestor
102600384|NCT00381589|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102600385|NCT00381589|Cholinergic Agents|cholinergic agents|mesh-ancestor
102600386|NCT00381589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102600387|NCT00381589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600388|NCT00002239|Ritonavir|ritonavir|mesh-list
102600389|NCT00002239|Amprenavir|amprenavir|mesh-list
102600390|NCT00002239|Abacavir|abacavir|mesh-list
102600391|NCT00002239|Enfuvirtide|enfuvirtide|mesh-list
102600392|NCT00002239|Efavirenz|efavirenz|mesh-list
102600393|NCT00002239|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102600394|NCT00002239|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102600395|NCT00002239|Protease Inhibitors|protease inhibitors|mesh-ancestor
102600396|NCT00002239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600397|NCT00002239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600398|NCT00002239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102600399|NCT00002239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102600400|NCT00002239|Antiviral Agents|antiviral agents|mesh-ancestor
102600401|NCT00002239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102600402|NCT00002239|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102600403|NCT00002239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102600404|NCT00002239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102600405|NCT00002239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102600406|NCT00002239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102600407|NCT00002239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102600408|NCT00002239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102600409|NCT00002239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102600410|NCT00002239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102600411|NCT00002239|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102600412|NCT00002239|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102600413|NCT00002239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102600414|NCT00002239|Antitubercular Agents|antitubercular agents|mesh-ancestor
102600415|NCT00002239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102600416|NCT00383474|Bortezomib|bortezomib|mesh-list
102600417|NCT00383474|Tipifarnib|tipifarnib|mesh-list
102600418|NCT00383474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102600419|NCT00002245|Lamivudine|lamivudine|mesh-list
102600420|NCT00002245|Abacavir|abacavir|mesh-list
102600421|NCT00002245|Amprenavir|amprenavir|mesh-list
102600422|NCT00002245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102600423|NCT00002245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102600424|NCT00002245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600425|NCT00002245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600426|NCT00002245|Antiviral Agents|antiviral agents|mesh-ancestor
102600427|NCT00002245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102147322|NCT03149432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102600428|NCT00002245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102600429|NCT00002245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102600430|NCT00002245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102600431|NCT00002245|Antitubercular Agents|antitubercular agents|mesh-ancestor
102600432|NCT00002245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102600433|NCT00002245|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102600434|NCT00002245|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102600435|NCT00002245|Protease Inhibitors|protease inhibitors|mesh-ancestor
102600437|NCT00003128|Ifosfamide|ifosfamide|mesh-list
102600438|NCT00003128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102600439|NCT00003128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102600440|NCT00003128|Tubulin Modulators|tubulin modulators|mesh-ancestor
102600441|NCT00003128|Antimitotic Agents|antimitotic agents|mesh-ancestor
102600442|NCT00003128|Mitosis Modulators|mitosis modulators|mesh-ancestor
102600443|NCT00003128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600444|NCT00003128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102600445|NCT00003128|Alkylating Agents|alkylating agents|mesh-ancestor
102600446|NCT04331197|Letrozole|letrozole|mesh-list
102600447|NCT04331197|Clomiphene|clomiphene|mesh-list
102600448|NCT04331197|Enclomiphene|enclomiphene|mesh-list
102600449|NCT04331197|Zuclomiphene|zuclomiphene|mesh-list
102600450|NCT04331197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600451|NCT04331197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102600452|NCT04331197|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102600453|NCT04331197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102600454|NCT04331197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600455|NCT04331197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102600456|NCT04331197|Hormone Antagonists|hormone antagonists|mesh-ancestor
102600457|NCT04331197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102600458|NCT04331197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102600459|NCT04331197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102600460|NCT04331197|Fertility Agents|fertility agents|mesh-ancestor
102600461|NCT04331197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102600462|NCT04331197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102600463|NCT04331197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102600464|NCT05751733|Sunitinib|sunitinib|mesh-list
102600465|NCT05751733|Imatinib Mesylate|imatinib mesylate|mesh-list
102600466|NCT05751733|Apatinib|apatinib|mesh-list
102600467|NCT05751733|Dasatinib|dasatinib|mesh-list
102600468|NCT05751733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102600469|NCT05751733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102600470|NCT05751733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102600471|NCT05751733|Growth Substances|growth substances|mesh-ancestor
102600472|NCT05751733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102600473|NCT05751733|Growth Inhibitors|growth inhibitors|mesh-ancestor
102600474|NCT05751733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102600475|NCT05751733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600476|NCT05751733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600477|NCT00002798|Cytarabine|cytarabine|mesh-list
102600478|NCT00002798|Aldesleukin|aldesleukin|mesh-list
102600479|NCT00002798|Dexamethasone|dexamethasone|mesh-list
102600480|NCT00002798|Hydrocortisone|hydrocortisone|mesh-list
102600481|NCT00002798|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102600482|NCT00002798|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102600483|NCT00002798|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102600484|NCT00002798|Cyclophosphamide|cyclophosphamide|mesh-list
102600485|NCT00002798|Busulfan|busulfan|mesh-list
102600486|NCT00002798|Methotrexate|methotrexate|mesh-list
102600487|NCT00002798|Fludarabine|fludarabine|mesh-list
102600488|NCT00002798|Fludarabine phosphate|fludarabine phosphate|mesh-list
102600489|NCT00002798|Etoposide|etoposide|mesh-list
102600490|NCT00002798|Etoposide phosphate|etoposide phosphate|mesh-list
102600491|NCT00002798|Daunorubicin|daunorubicin|mesh-list
102600492|NCT00002798|Interleukin-2|interleukin-2|mesh-list
102600493|NCT00002798|Asparaginase|asparaginase|mesh-list
102600494|NCT00002798|Idarubicin|idarubicin|mesh-list
102600495|NCT00002798|Thioguanine|thioguanine|mesh-list
102600496|NCT00002798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102600497|NCT00002798|Immunologic Factors|immunologic factors|mesh-ancestor
102600498|NCT00002798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102600499|NCT00002798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102600500|NCT00002798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102600501|NCT00002798|Alkylating Agents|alkylating agents|mesh-ancestor
102600502|NCT00002798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600503|NCT00002798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102147398|NCT02350400|Irinotecan|irinotecan|mesh-list
102600504|NCT00002798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102600505|NCT00002798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102600507|NCT00002798|Autonomic Agents|autonomic agents|mesh-ancestor
102600508|NCT00002798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102600509|NCT00002798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102600510|NCT00002798|Glucocorticoids|glucocorticoids|mesh-ancestor
102600511|NCT00002798|Hormones|hormones|mesh-ancestor
102600512|NCT00002798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102600513|NCT00002798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102600514|NCT00002798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102600515|NCT00002798|Abortifacient Agents|abortifacient agents|mesh-ancestor
102600516|NCT00002798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102600517|NCT00002798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102600518|NCT00002798|Antimetabolites|antimetabolites|mesh-ancestor
102600519|NCT00002798|Dermatologic Agents|dermatologic agents|mesh-ancestor
102600520|NCT00002798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600521|NCT00002798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102600522|NCT00002798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102600523|NCT00002798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102600524|NCT00002798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102600525|NCT00002798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102600526|NCT00002798|Antiviral Agents|antiviral agents|mesh-ancestor
102600527|NCT00002798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102600528|NCT00002798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102600529|NCT00002798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102600530|NCT00002798|Analgesics|analgesics|mesh-ancestor
102600531|NCT00002798|Sensory System Agents|sensory system agents|mesh-ancestor
102600532|NCT00002798|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102600533|NCT00002798|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102600534|NCT00002251|Ganciclovir|ganciclovir|mesh-list
102600535|NCT00002251|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102600536|NCT00002251|Antiviral Agents|antiviral agents|mesh-ancestor
102600537|NCT00002251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102600538|NCT00002251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102600539|NCT00002251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600540|NCT00002251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600541|NCT00002257|Ganciclovir|ganciclovir|mesh-list
102600542|NCT00002257|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102600543|NCT00002257|Antiviral Agents|antiviral agents|mesh-ancestor
102600544|NCT00002257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102600545|NCT00002257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102600546|NCT00002257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600547|NCT00002257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600548|NCT00003134|Irinotecan|irinotecan|mesh-list
102600549|NCT00003134|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102600550|NCT00003134|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102600551|NCT00003134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600552|NCT00003134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600553|NCT00003134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102600554|NCT00002545|Carmustine|carmustine|mesh-list
102600555|NCT00002545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102600556|NCT00002545|Alkylating Agents|alkylating agents|mesh-ancestor
102600557|NCT00002545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600558|NCT00002545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102600559|NCT00002804|Cobalt|cobalt|mesh-list
102600560|NCT00002804|Doxorubicin|doxorubicin|mesh-list
102600561|NCT00002804|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102600562|NCT00002804|Vincristine|vincristine|mesh-list
102600563|NCT00002804|Ifosfamide|ifosfamide|mesh-list
102600564|NCT00002804|Lenograstim|lenograstim|mesh-list
102600565|NCT00002804|Mesna|mesna|mesh-list
102600566|NCT00002804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102600567|NCT00002804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102600568|NCT00002804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102600569|NCT00002804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102600570|NCT00002804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600571|NCT00002804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600572|NCT00002804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102600573|NCT00002804|Immunologic Factors|immunologic factors|mesh-ancestor
102600574|NCT00002804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102600575|NCT00002804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102600576|NCT00002804|Tubulin Modulators|tubulin modulators|mesh-ancestor
102600577|NCT00002804|Antimitotic Agents|antimitotic agents|mesh-ancestor
102600578|NCT00002804|Mitosis Modulators|mitosis modulators|mesh-ancestor
102147471|NCT04656067|Oxytocics|oxytocics|mesh-ancestor
102600579|NCT00002804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102600580|NCT00002804|Alkylating Agents|alkylating agents|mesh-ancestor
102600581|NCT00002804|Protective Agents|protective agents|mesh-ancestor
102600582|NCT00002804|Trace Elements|trace elements|mesh-ancestor
102600583|NCT00002804|Micronutrients|micronutrients|mesh-ancestor
102600584|NCT00002810|Melphalan|melphalan|mesh-list
102600585|NCT00002810|Immunologic Factors|immunologic factors|mesh-ancestor
102600586|NCT00002810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102600587|NCT00002810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102600588|NCT00002810|Alkylating Agents|alkylating agents|mesh-ancestor
102600589|NCT00002810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600590|NCT00002810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102600591|NCT00002810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102600592|NCT00002810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102600593|NCT00003140|Letrozole|letrozole|mesh-list
102600594|NCT00003140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102600595|NCT00003140|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102600596|NCT00003140|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102600597|NCT00003140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600598|NCT00003140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600599|NCT00003140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102600600|NCT00003140|Hormone Antagonists|hormone antagonists|mesh-ancestor
102600601|NCT00003140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102600602|NCT00003140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102600603|NCT00003392|Paclitaxel|paclitaxel|mesh-list
102600604|NCT00003392|Cyclophosphamide|cyclophosphamide|mesh-list
102600605|NCT00003392|Carboplatin|carboplatin|mesh-list
102600606|NCT00003392|Melphalan|melphalan|mesh-list
102600607|NCT00003392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102600608|NCT00003392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102600609|NCT00003392|Tubulin Modulators|tubulin modulators|mesh-ancestor
102600610|NCT00003392|Antimitotic Agents|antimitotic agents|mesh-ancestor
102600611|NCT00003392|Mitosis Modulators|mitosis modulators|mesh-ancestor
102600612|NCT00003392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345960|NCT05142735|Acetylcysteine|acetylcysteine|mesh-list
102600613|NCT00003392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102600614|NCT00003392|Immunologic Factors|immunologic factors|mesh-ancestor
102600615|NCT00003392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102600616|NCT00003392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102600617|NCT00003392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102600618|NCT00003392|Alkylating Agents|alkylating agents|mesh-ancestor
102600619|NCT00003392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102600620|NCT00002551|Leucovorin|leucovorin|mesh-list
102600621|NCT00002551|Levamisole|levamisole|mesh-list
102600622|NCT00002551|Fluorouracil|fluorouracil|mesh-list
102600623|NCT00002551|Calcium|calcium|mesh-list
102600624|NCT00002551|Levoleucovorin|levoleucovorin|mesh-list
102600625|NCT00002551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102600626|NCT00002551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102600627|NCT00002551|Antimetabolites|antimetabolites|mesh-ancestor
102600628|NCT00002551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600629|NCT00002551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102600630|NCT00002551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102600631|NCT00002551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102600632|NCT00002551|Immunologic Factors|immunologic factors|mesh-ancestor
102600633|NCT00002551|Antidotes|antidotes|mesh-ancestor
102600634|NCT00002551|Protective Agents|protective agents|mesh-ancestor
102600635|NCT00002551|Vitamin B Complex|vitamin b complex|mesh-ancestor
102600636|NCT00002551|Vitamins|vitamins|mesh-ancestor
102600637|NCT00002551|Micronutrients|micronutrients|mesh-ancestor
102600638|NCT00002551|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102600639|NCT00002551|Antinematodal Agents|antinematodal agents|mesh-ancestor
102600640|NCT00002551|Anthelmintics|anthelmintics|mesh-ancestor
102600641|NCT00002551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102600642|NCT00002551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102600643|NCT00002551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102600644|NCT00003146|Melphalan|melphalan|mesh-list
102600645|NCT00003146|Busulfan|busulfan|mesh-list
102600646|NCT00003146|Thiotepa|thiotepa|mesh-list
102600647|NCT00003146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102600648|NCT00003146|Alkylating Agents|alkylating agents|mesh-ancestor
102600649|NCT00003146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600650|NCT00003146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102600651|NCT00003146|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102600652|NCT00003146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102600653|NCT00003146|Immunologic Factors|immunologic factors|mesh-ancestor
102600654|NCT00003146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102600655|NCT00003398|Cyclophosphamide|cyclophosphamide|mesh-list
102600656|NCT00003398|Thiotepa|thiotepa|mesh-list
102600657|NCT00003398|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102600658|NCT00003398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102600659|NCT00003398|Immunologic Factors|immunologic factors|mesh-ancestor
102600660|NCT00003398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102600661|NCT00003398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102600662|NCT00003398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102600663|NCT00003398|Alkylating Agents|alkylating agents|mesh-ancestor
102600664|NCT00003398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600665|NCT00003398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102600666|NCT00003398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102600667|NCT00002263|Zidovudine|zidovudine|mesh-list
102600668|NCT00002263|Sargramostim|sargramostim|mesh-list
102600669|NCT00002263|Antimetabolites|antimetabolites|mesh-ancestor
102600670|NCT00002263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600671|NCT00002263|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102600672|NCT00002263|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102600673|NCT00002263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600674|NCT00002263|Antiviral Agents|antiviral agents|mesh-ancestor
102600675|NCT00002263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102600676|NCT00002263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102600677|NCT00002263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102600678|NCT00002263|Immunologic Factors|immunologic factors|mesh-ancestor
102600679|NCT00002263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102600680|NCT00002816|Leucovorin|leucovorin|mesh-list
102600681|NCT00002816|Cobalt|cobalt|mesh-list
102600682|NCT00002816|Cytarabine|cytarabine|mesh-list
102600683|NCT00002816|Dexamethasone|dexamethasone|mesh-list
102600684|NCT00002816|Hydrocortisone|hydrocortisone|mesh-list
102600685|NCT00002816|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102600686|NCT00002816|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102600687|NCT00002816|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102600688|NCT00002816|Methotrexate|methotrexate|mesh-list
102600689|NCT00002816|Etoposide|etoposide|mesh-list
102600690|NCT00002816|Vincristine|vincristine|mesh-list
102600691|NCT00002816|Asparaginase|asparaginase|mesh-list
102600692|NCT00002816|Ifosfamide|ifosfamide|mesh-list
102600693|NCT00002816|Idarubicin|idarubicin|mesh-list
102600694|NCT00002816|Pegaspargase|pegaspargase|mesh-list
102600695|NCT00002816|Thioguanine|thioguanine|mesh-list
102600696|NCT00002816|Levoleucovorin|levoleucovorin|mesh-list
102600697|NCT00002816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102600698|NCT00002816|Antiemetics|antiemetics|mesh-ancestor
102600699|NCT00002816|Autonomic Agents|autonomic agents|mesh-ancestor
102600700|NCT00002816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102600701|NCT00002816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102600702|NCT00002816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102600703|NCT00002816|Glucocorticoids|glucocorticoids|mesh-ancestor
102600704|NCT00002816|Hormones|hormones|mesh-ancestor
102600705|NCT00002816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102600706|NCT00002816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102600707|NCT00002816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102600708|NCT00002816|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102600709|NCT00002816|Abortifacient Agents|abortifacient agents|mesh-ancestor
102600710|NCT00002816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102600711|NCT00002816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102600712|NCT00002816|Antimetabolites|antimetabolites|mesh-ancestor
102600713|NCT00002816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600714|NCT00002816|Dermatologic Agents|dermatologic agents|mesh-ancestor
102600715|NCT00002816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600716|NCT00002816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102600717|NCT00002816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102600718|NCT00002816|Immunologic Factors|immunologic factors|mesh-ancestor
102600719|NCT00002816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102600720|NCT00002816|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102600721|NCT00002816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102600722|NCT00002816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102600723|NCT00002816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102600724|NCT00002816|Antiviral Agents|antiviral agents|mesh-ancestor
102600725|NCT00002816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102600726|NCT00002816|Antidotes|antidotes|mesh-ancestor
102600727|NCT00002816|Protective Agents|protective agents|mesh-ancestor
102600728|NCT00002816|Vitamin B Complex|vitamin b complex|mesh-ancestor
102600729|NCT00002816|Vitamins|vitamins|mesh-ancestor
102147627|NCT03823365|Blinatumomab|blinatumomab|mesh-list
102600730|NCT00002816|Micronutrients|micronutrients|mesh-ancestor
102600731|NCT00002816|Tubulin Modulators|tubulin modulators|mesh-ancestor
102600732|NCT00002816|Antimitotic Agents|antimitotic agents|mesh-ancestor
102600733|NCT00002816|Mitosis Modulators|mitosis modulators|mesh-ancestor
102600734|NCT00002816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102600735|NCT00002816|Alkylating Agents|alkylating agents|mesh-ancestor
102600736|NCT00002816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102600737|NCT00002816|Trace Elements|trace elements|mesh-ancestor
102600738|NCT00002269|Zidovudine|zidovudine|mesh-list
102600739|NCT00002269|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
102600740|NCT00002269|Antimetabolites|antimetabolites|mesh-ancestor
102600741|NCT00002269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600742|NCT00002269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102369680|NCT04450134|Famotidine|famotidine|mesh-list
102600743|NCT00002269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102600744|NCT00002269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600745|NCT00002269|Antiviral Agents|antiviral agents|mesh-ancestor
102600746|NCT00002269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102600747|NCT00002269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102600748|NCT00002269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102600749|NCT00002275|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102600750|NCT00002275|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102600751|NCT00002275|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102600752|NCT00002275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102600753|NCT00003152|Interferons|interferons|mesh-list
102600754|NCT00003152|Interferon-alpha|interferon-alpha|mesh-list
102600755|NCT00003152|Prednisone|prednisone|mesh-list
102600756|NCT00003152|Cyclophosphamide|cyclophosphamide|mesh-list
102600757|NCT00003152|Vincristine|vincristine|mesh-list
102600758|NCT00003152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102600759|NCT00003152|Immunologic Factors|immunologic factors|mesh-ancestor
102600760|NCT00003152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102600761|NCT00003152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102600762|NCT00003152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102600763|NCT00003152|Alkylating Agents|alkylating agents|mesh-ancestor
102600764|NCT00003152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600765|NCT00003152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102600766|NCT00003152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102600767|NCT00003152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102600768|NCT00003152|Glucocorticoids|glucocorticoids|mesh-ancestor
102600769|NCT00003152|Hormones|hormones|mesh-ancestor
102600770|NCT00003152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102600771|NCT00003152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102600772|NCT00003152|Antiviral Agents|antiviral agents|mesh-ancestor
102600773|NCT00003152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102600774|NCT00003152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102600775|NCT00003152|Tubulin Modulators|tubulin modulators|mesh-ancestor
102600776|NCT00003152|Antimitotic Agents|antimitotic agents|mesh-ancestor
102600777|NCT00003152|Mitosis Modulators|mitosis modulators|mesh-ancestor
102600778|NCT05751421|Meloxicam|meloxicam|mesh-list
102600779|NCT05751421|Bupivacaine|bupivacaine|mesh-list
102600780|NCT05751421|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102600781|NCT05751421|Anesthetics, Local|anesthetics, local|mesh-ancestor
102600782|NCT05751421|Anesthetics|anesthetics|mesh-ancestor
102600783|NCT05751421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102600784|NCT05751421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102600785|NCT05751421|Sensory System Agents|sensory system agents|mesh-ancestor
102600786|NCT05751421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102600787|NCT05751421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102600788|NCT05751421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102600789|NCT05751421|Analgesics|analgesics|mesh-ancestor
102600790|NCT05751421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102600791|NCT05751421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102600792|NCT05751421|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102600793|NCT05751421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102600794|NCT05751421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600795|NCT05751421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600796|NCT00002822|Cyclophosphamide|cyclophosphamide|mesh-list
102600797|NCT00002822|Ifosfamide|ifosfamide|mesh-list
102600798|NCT00002822|Carboplatin|carboplatin|mesh-list
102600799|NCT00002822|Doxorubicin|doxorubicin|mesh-list
102600800|NCT00002822|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102600801|NCT00002822|Etoposide|etoposide|mesh-list
102600802|NCT00002822|Vincristine|vincristine|mesh-list
102600803|NCT00002822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102600804|NCT00002822|Immunologic Factors|immunologic factors|mesh-ancestor
102600805|NCT00002822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102600806|NCT00002822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102345988|NCT05115110|Risdiplam|risdiplam|mesh-list
102600807|NCT00002822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102600808|NCT00002822|Alkylating Agents|alkylating agents|mesh-ancestor
102600809|NCT00002822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600811|NCT00002822|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102600812|NCT00002822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102600813|NCT00002822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102600814|NCT00002822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102600815|NCT00002822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600816|NCT00002822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102600817|NCT00002822|Tubulin Modulators|tubulin modulators|mesh-ancestor
102600818|NCT00002822|Antimitotic Agents|antimitotic agents|mesh-ancestor
102600819|NCT00002822|Mitosis Modulators|mitosis modulators|mesh-ancestor
102600820|NCT00002281|Zidovudine|zidovudine|mesh-list
102600821|NCT00002281|Epoetin Alfa|epoetin alfa|mesh-list
102600822|NCT00002281|Antimetabolites|antimetabolites|mesh-ancestor
102600823|NCT00002281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600824|NCT00002281|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102600825|NCT00002281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102600826|NCT00002281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600827|NCT00002281|Antiviral Agents|antiviral agents|mesh-ancestor
102600828|NCT00002281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102600829|NCT00002281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102600830|NCT00002281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102600831|NCT00002281|Hematinics|hematinics|mesh-ancestor
102600832|NCT00002287|Zidovudine|zidovudine|mesh-list
102600833|NCT00002287|Antimetabolites|antimetabolites|mesh-ancestor
102600834|NCT00002287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600835|NCT00002287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102600836|NCT00002287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102600837|NCT00002287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600838|NCT00002287|Antiviral Agents|antiviral agents|mesh-ancestor
102600839|NCT00002287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102600840|NCT00002287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102600841|NCT00002287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102600842|NCT00002828|Fluorouracil|fluorouracil|mesh-list
102600843|NCT00002828|Raltitrexed|raltitrexed|mesh-list
102600844|NCT00002828|Antimetabolites|antimetabolites|mesh-ancestor
102600845|NCT00002828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600846|NCT00002828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102600847|NCT00002828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102600848|NCT00002828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102600849|NCT00002828|Immunologic Factors|immunologic factors|mesh-ancestor
102600850|NCT00002828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102600851|NCT00002828|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102600852|NCT00002828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600853|NCT00003410|Motexafin gadolinium|motexafin gadolinium|mesh-list
102600854|NCT00003410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102600855|NCT00003410|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102600856|NCT00003410|Dermatologic Agents|dermatologic agents|mesh-ancestor
102600857|NCT00384020|Paroxetine|paroxetine|mesh-list
102600858|NCT00384020|Escitalopram|escitalopram|mesh-list
102600859|NCT00384020|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102600860|NCT00384020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102600861|NCT00384020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102600862|NCT00384020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600863|NCT00384020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102600864|NCT00384020|Serotonin Agents|serotonin agents|mesh-ancestor
102600865|NCT00384020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102600866|NCT00384020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102600867|NCT00384020|Antidepressive Agents|antidepressive agents|mesh-ancestor
102600868|NCT00384020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102600869|NCT00384020|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102600870|NCT00384020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102600871|NCT00384020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600872|NCT00002557|Leucovorin|leucovorin|mesh-list
102600873|NCT00002557|Doxorubicin|doxorubicin|mesh-list
102600874|NCT00002557|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102600875|NCT00002557|Etoposide|etoposide|mesh-list
102600876|NCT00002557|Methotrexate|methotrexate|mesh-list
102600877|NCT00002557|Calcium|calcium|mesh-list
102600878|NCT00002557|Levoleucovorin|levoleucovorin|mesh-list
102600879|NCT00002557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102600880|NCT00002557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102600881|NCT00002557|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102600882|NCT00002557|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102600883|NCT00002557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600884|NCT00002557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600885|NCT00002557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102600886|NCT00002557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102600887|NCT00002557|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102600888|NCT00002557|Abortifacient Agents|abortifacient agents|mesh-ancestor
102600889|NCT00002557|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102600890|NCT00002557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102600891|NCT00002557|Antimetabolites|antimetabolites|mesh-ancestor
102600892|NCT00002557|Dermatologic Agents|dermatologic agents|mesh-ancestor
102600893|NCT00002557|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102600894|NCT00002557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102600895|NCT00002557|Immunologic Factors|immunologic factors|mesh-ancestor
102600896|NCT00002557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102600897|NCT00002557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102600898|NCT00002557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102600899|NCT00002557|Antidotes|antidotes|mesh-ancestor
102600900|NCT00002557|Protective Agents|protective agents|mesh-ancestor
102600901|NCT00002557|Vitamin B Complex|vitamin b complex|mesh-ancestor
102600902|NCT00002557|Vitamins|vitamins|mesh-ancestor
102600903|NCT00002557|Micronutrients|micronutrients|mesh-ancestor
102600904|NCT00003158|Paclitaxel|paclitaxel|mesh-list
102600905|NCT00003158|Etoposide|etoposide|mesh-list
102600906|NCT00003158|Carboplatin|carboplatin|mesh-list
102600907|NCT00003158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102600908|NCT00003158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102600909|NCT00003158|Tubulin Modulators|tubulin modulators|mesh-ancestor
102600910|NCT00003158|Antimitotic Agents|antimitotic agents|mesh-ancestor
102600911|NCT00003158|Mitosis Modulators|mitosis modulators|mesh-ancestor
102600912|NCT00003158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600913|NCT00003158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102600914|NCT00003158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102600915|NCT00003158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600916|NCT00003416|Interferons|interferons|mesh-list
102600917|NCT00003416|Interferon-alpha|interferon-alpha|mesh-list
102600918|NCT00003416|Dexamethasone|dexamethasone|mesh-list
102600919|NCT00003416|Melphalan|melphalan|mesh-list
102600920|NCT00003416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102600921|NCT00003416|Antiemetics|antiemetics|mesh-ancestor
102600922|NCT00003416|Autonomic Agents|autonomic agents|mesh-ancestor
102600923|NCT00003416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102600924|NCT00003416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102600925|NCT00003416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102600926|NCT00003416|Glucocorticoids|glucocorticoids|mesh-ancestor
102600927|NCT00003416|Hormones|hormones|mesh-ancestor
102600928|NCT00003416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102600929|NCT00003416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102600930|NCT00003416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102600931|NCT00003416|Antiviral Agents|antiviral agents|mesh-ancestor
102600932|NCT00003416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102600933|NCT00003416|Immunologic Factors|immunologic factors|mesh-ancestor
102600934|NCT00003416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102600935|NCT00003416|Alkylating Agents|alkylating agents|mesh-ancestor
102600936|NCT00003416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600937|NCT00003416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102600938|NCT00003416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102600939|NCT00002569|Vincristine|vincristine|mesh-list
102600940|NCT00002569|Lomustine|lomustine|mesh-list
102600941|NCT00002569|Procarbazine|procarbazine|mesh-list
102600942|NCT00002569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102600943|NCT00002569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102600944|NCT00002569|Tubulin Modulators|tubulin modulators|mesh-ancestor
102600945|NCT00002569|Antimitotic Agents|antimitotic agents|mesh-ancestor
102600946|NCT00002569|Mitosis Modulators|mitosis modulators|mesh-ancestor
102600947|NCT00002569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600948|NCT00002569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102600949|NCT00002569|Alkylating Agents|alkylating agents|mesh-ancestor
102600950|NCT00002840|Vincristine|vincristine|mesh-list
102600951|NCT00002840|Lomustine|lomustine|mesh-list
102600952|NCT00002840|Procarbazine|procarbazine|mesh-list
102600953|NCT00002840|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102600954|NCT00002840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102600955|NCT00002840|Tubulin Modulators|tubulin modulators|mesh-ancestor
102600956|NCT00002840|Antimitotic Agents|antimitotic agents|mesh-ancestor
102600957|NCT00002840|Mitosis Modulators|mitosis modulators|mesh-ancestor
102600958|NCT00002840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600959|NCT00002840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102600960|NCT00002840|Alkylating Agents|alkylating agents|mesh-ancestor
102600962|NCT00002846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102600963|NCT00002846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102600964|NCT00002846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102600965|NCT00002846|Antiviral Agents|antiviral agents|mesh-ancestor
102600966|NCT00002846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102600967|NCT05720767|Itraconazole|itraconazole|mesh-list
102600968|NCT05720767|Rifampin|rifampin|mesh-list
102600969|NCT05720767|Antifungal Agents|antifungal agents|mesh-ancestor
102600970|NCT05720767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102600971|NCT05720767|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102600972|NCT05720767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102600973|NCT05720767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600974|NCT05720767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102600975|NCT05720767|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102600976|NCT05720767|Hormone Antagonists|hormone antagonists|mesh-ancestor
102600977|NCT05720767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102600978|NCT05720767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102600979|NCT05720767|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102600980|NCT05720767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102600981|NCT05720767|Antitubercular Agents|antitubercular agents|mesh-ancestor
102600982|NCT05720767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102600983|NCT05720767|Leprostatic Agents|leprostatic agents|mesh-ancestor
102600984|NCT05720767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102600985|NCT05720767|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102600986|NCT05720767|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102600987|NCT05720767|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102600988|NCT05720767|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102600989|NCT05720767|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102600990|NCT05720767|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102600991|NCT05751031|Raltegravir Potassium|raltegravir potassium|mesh-list
102600992|NCT05751031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102600993|NCT05751031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102600994|NCT05751031|Antiviral Agents|antiviral agents|mesh-ancestor
102600995|NCT05751031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102600996|NCT05751031|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102600997|NCT05751031|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102600998|NCT05751031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102600999|NCT05751031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601000|NCT00002852|Paclitaxel|paclitaxel|mesh-list
102601001|NCT00002852|Carboplatin|carboplatin|mesh-list
102601002|NCT00002852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102601003|NCT00002852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601004|NCT00002852|Tubulin Modulators|tubulin modulators|mesh-ancestor
102601005|NCT00002852|Antimitotic Agents|antimitotic agents|mesh-ancestor
102601006|NCT00002852|Mitosis Modulators|mitosis modulators|mesh-ancestor
102601007|NCT00002852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601008|NCT00003422|Leucovorin|leucovorin|mesh-list
102601009|NCT00003422|Fluorouracil|fluorouracil|mesh-list
102601010|NCT00003422|Calcium|calcium|mesh-list
102601011|NCT00003422|Levoleucovorin|levoleucovorin|mesh-list
102601012|NCT00003422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102601013|NCT00003422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601014|NCT00003422|Antimetabolites|antimetabolites|mesh-ancestor
102601015|NCT00003422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601016|NCT00003422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102601017|NCT00003422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601018|NCT00003422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102346007|NCT05049863|Mycophenolic Acid|mycophenolic acid|mesh-list
102601019|NCT00003422|Immunologic Factors|immunologic factors|mesh-ancestor
102601020|NCT00003422|Antidotes|antidotes|mesh-ancestor
102601021|NCT00003422|Protective Agents|protective agents|mesh-ancestor
102601022|NCT00003422|Vitamin B Complex|vitamin b complex|mesh-ancestor
102601023|NCT00003422|Vitamins|vitamins|mesh-ancestor
102601024|NCT00003422|Micronutrients|micronutrients|mesh-ancestor
102601025|NCT00003176|Temozolomide|temozolomide|mesh-list
102601026|NCT00003176|Carmustine|carmustine|mesh-list
102601027|NCT00003176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102601028|NCT00003176|Alkylating Agents|alkylating agents|mesh-ancestor
102601029|NCT00003176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601030|NCT00003176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601031|NCT00002858|Cyclophosphamide|cyclophosphamide|mesh-list
102601032|NCT00002858|Doxorubicin|doxorubicin|mesh-list
102601033|NCT00002858|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102601034|NCT00002858|Etoposide|etoposide|mesh-list
102147925|NCT03112382|Vitamins|vitamins|mesh-list
102601035|NCT00002858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102601036|NCT00002858|Immunologic Factors|immunologic factors|mesh-ancestor
102601037|NCT00002858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601038|NCT00002858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102601039|NCT00002858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102601040|NCT00002858|Alkylating Agents|alkylating agents|mesh-ancestor
102601041|NCT00002858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601042|NCT00002858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601043|NCT00002858|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102601044|NCT00002858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102601045|NCT00002858|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102601046|NCT00002858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102601047|NCT00002858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102601048|NCT00002858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102601049|NCT00002864|Tamoxifen|tamoxifen|mesh-list
102601050|NCT00002864|Octreotide|octreotide|mesh-list
102601051|NCT00002864|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102601052|NCT00002864|Hormone Antagonists|hormone antagonists|mesh-ancestor
102601053|NCT00002864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102601054|NCT00002864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601055|NCT00002864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102601056|NCT00002864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601057|NCT00002864|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102601058|NCT00002864|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102601059|NCT00002864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102601060|NCT00002864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102601061|NCT00002870|Cyclophosphamide|cyclophosphamide|mesh-list
102601062|NCT00002870|Thiotepa|thiotepa|mesh-list
102601063|NCT00002870|Fluorouracil|fluorouracil|mesh-list
102601064|NCT00002870|Epirubicin|epirubicin|mesh-list
102601065|NCT00002870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102601066|NCT00002870|Immunologic Factors|immunologic factors|mesh-ancestor
102601067|NCT00002870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601068|NCT00002870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102601069|NCT00002870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102601070|NCT00002870|Alkylating Agents|alkylating agents|mesh-ancestor
102601071|NCT00002870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601072|NCT00002870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601073|NCT00002870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102601074|NCT00002870|Antimetabolites|antimetabolites|mesh-ancestor
102601075|NCT00002870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102601076|NCT00002870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102601077|NCT00002870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102601078|NCT00002870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102601079|NCT00002870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102601080|NCT00002581|Tamoxifen|tamoxifen|mesh-list
102601081|NCT00002581|Cyclophosphamide|cyclophosphamide|mesh-list
102601082|NCT00002581|Fluorouracil|fluorouracil|mesh-list
102601083|NCT00002581|Methotrexate|methotrexate|mesh-list
102601084|NCT00002581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102601085|NCT00002581|Immunologic Factors|immunologic factors|mesh-ancestor
102601086|NCT00002581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601087|NCT00002581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102601088|NCT00002581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102601089|NCT00002581|Alkylating Agents|alkylating agents|mesh-ancestor
102601090|NCT00002581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601091|NCT00002581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601092|NCT00002581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102601093|NCT00002581|Antimetabolites|antimetabolites|mesh-ancestor
102601094|NCT00002581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102601095|NCT00002581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102601096|NCT00002581|Abortifacient Agents|abortifacient agents|mesh-ancestor
102601097|NCT00002581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102601098|NCT00002581|Dermatologic Agents|dermatologic agents|mesh-ancestor
102601099|NCT00002581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102601100|NCT00002581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102601101|NCT00002581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102601102|NCT00002581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102601103|NCT00002581|Hormone Antagonists|hormone antagonists|mesh-ancestor
102601104|NCT00002581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102601105|NCT00002581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102601106|NCT00002581|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102601107|NCT00002581|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102601108|NCT00002581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102601109|NCT00003182|Gemcitabine|gemcitabine|mesh-list
102601110|NCT00003182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601111|NCT00003182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102346029|NCT05020899|Autonomic Agents|autonomic agents|mesh-ancestor
102346030|NCT05020899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102346031|NCT05020899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346032|NCT05020899|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102601112|NCT00003182|Antimetabolites|antimetabolites|mesh-ancestor
102601113|NCT00003182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601114|NCT00002587|Paclitaxel|paclitaxel|mesh-list
102601115|NCT00002587|Topotecan|topotecan|mesh-list
102601116|NCT00002587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102601117|NCT00002587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601118|NCT00002587|Tubulin Modulators|tubulin modulators|mesh-ancestor
102601119|NCT00002587|Antimitotic Agents|antimitotic agents|mesh-ancestor
102601120|NCT00002587|Mitosis Modulators|mitosis modulators|mesh-ancestor
102601121|NCT00002587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601122|NCT00002587|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102601123|NCT00002587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102601124|NCT00002587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102601125|NCT00002876|Etoposide|etoposide|mesh-list
102601126|NCT00002876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601127|NCT00002876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102601128|NCT00002876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102601129|NCT00002876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102601130|NCT00002876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102601131|NCT00002876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601132|NCT00002593|Leucovorin|leucovorin|mesh-list
102601133|NCT00002593|Levamisole|levamisole|mesh-list
102601134|NCT00002593|Fluorouracil|fluorouracil|mesh-list
102601135|NCT00002593|Calcium|calcium|mesh-list
102601136|NCT00002593|Levoleucovorin|levoleucovorin|mesh-list
102601137|NCT00002593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102601138|NCT00002593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601139|NCT00002593|Antimetabolites|antimetabolites|mesh-ancestor
102601140|NCT00002593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601141|NCT00002593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102601142|NCT00002593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601143|NCT00002593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102601144|NCT00002593|Immunologic Factors|immunologic factors|mesh-ancestor
102601145|NCT00002593|Antidotes|antidotes|mesh-ancestor
102601146|NCT00002593|Protective Agents|protective agents|mesh-ancestor
102601147|NCT00002593|Vitamin B Complex|vitamin b complex|mesh-ancestor
102601148|NCT00002593|Vitamins|vitamins|mesh-ancestor
102601149|NCT00002593|Micronutrients|micronutrients|mesh-ancestor
102601150|NCT00002593|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102601151|NCT00002593|Antinematodal Agents|antinematodal agents|mesh-ancestor
102601152|NCT00002593|Anthelmintics|anthelmintics|mesh-ancestor
102601153|NCT00002593|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102601154|NCT00002593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102601155|NCT00002593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102601156|NCT00003194|Cyclophosphamide|cyclophosphamide|mesh-list
102601157|NCT00003194|Thiotepa|thiotepa|mesh-list
102601158|NCT00003194|Carboplatin|carboplatin|mesh-list
102601159|NCT00003194|Etoposide|etoposide|mesh-list
102601160|NCT00003194|Topotecan|topotecan|mesh-list
102601161|NCT00003194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102601162|NCT00003194|Immunologic Factors|immunologic factors|mesh-ancestor
102601163|NCT00003194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601164|NCT00003194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102601165|NCT00003194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102601166|NCT00003194|Alkylating Agents|alkylating agents|mesh-ancestor
102601167|NCT00003194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601168|NCT00003194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601169|NCT00003194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102601170|NCT00003194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102601171|NCT00003194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102601172|NCT00003194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102601173|NCT00003194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102601174|NCT00003194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102601175|NCT00002882|Interferons|interferons|mesh-list
102601176|NCT00002882|Interferon-alpha|interferon-alpha|mesh-list
102601177|NCT00002882|Interferon alpha-2|interferon alpha-2|mesh-list
102601178|NCT00002882|Aldesleukin|aldesleukin|mesh-list
102601179|NCT00002882|Cisplatin|cisplatin|mesh-list
102601180|NCT00002882|Interleukin-2|interleukin-2|mesh-list
102601181|NCT00002882|Dacarbazine|dacarbazine|mesh-list
102601182|NCT00002882|Vinblastine|vinblastine|mesh-list
102148072|NCT02346110|Epinephryl borate|epinephryl borate|mesh-list
102601183|NCT00002882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601184|NCT00002882|Antiviral Agents|antiviral agents|mesh-ancestor
102601185|NCT00002882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102601186|NCT00002882|Immunologic Factors|immunologic factors|mesh-ancestor
101867996|NCT01220284|Antimitotic Agents|antimitotic agents|mesh-ancestor
102601187|NCT00002882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601188|NCT00002882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102601189|NCT00002882|Analgesics|analgesics|mesh-ancestor
102601190|NCT00002882|Sensory System Agents|sensory system agents|mesh-ancestor
102601191|NCT00002882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102601192|NCT00002882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102601193|NCT00002882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102601194|NCT00002882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102601195|NCT00002882|Alkylating Agents|alkylating agents|mesh-ancestor
102601196|NCT00002882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601197|NCT00002882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102601198|NCT00002882|Tubulin Modulators|tubulin modulators|mesh-ancestor
102601199|NCT00002882|Antimitotic Agents|antimitotic agents|mesh-ancestor
102601200|NCT00002882|Mitosis Modulators|mitosis modulators|mesh-ancestor
102601201|NCT00002888|Paclitaxel|paclitaxel|mesh-list
102601202|NCT00002888|Fluorouracil|fluorouracil|mesh-list
102601203|NCT00002888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102601204|NCT00002888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601205|NCT00002888|Tubulin Modulators|tubulin modulators|mesh-ancestor
102601206|NCT00002888|Antimitotic Agents|antimitotic agents|mesh-ancestor
102601207|NCT00002888|Mitosis Modulators|mitosis modulators|mesh-ancestor
102601208|NCT00002888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601209|NCT00002888|Antimetabolites|antimetabolites|mesh-ancestor
102601210|NCT00002888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102601211|NCT00002888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102601212|NCT00002888|Immunologic Factors|immunologic factors|mesh-ancestor
102601213|NCT00002888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601214|NCT00002599|Cobalt|cobalt|mesh-list
102601215|NCT00002599|Interferons|interferons|mesh-list
102601216|NCT00002599|Interferon-alpha|interferon-alpha|mesh-list
102601217|NCT00002599|Prednisone|prednisone|mesh-list
102601218|NCT00002599|Methylprednisolone|methylprednisolone|mesh-list
102601219|NCT00002599|Cyclophosphamide|cyclophosphamide|mesh-list
102601220|NCT00002599|Melphalan|melphalan|mesh-list
102601221|NCT00002599|Carmustine|carmustine|mesh-list
102601222|NCT00002599|Doxorubicin|doxorubicin|mesh-list
102601223|NCT00002599|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102601224|NCT00002599|Vincristine|vincristine|mesh-list
102601225|NCT00002599|Sargramostim|sargramostim|mesh-list
102601226|NCT00002599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102601227|NCT00002599|Immunologic Factors|immunologic factors|mesh-ancestor
102601228|NCT00002599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601229|NCT00002599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102601230|NCT00002599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102601231|NCT00002599|Alkylating Agents|alkylating agents|mesh-ancestor
102601232|NCT00002599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601233|NCT00002599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601234|NCT00002599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102601235|NCT00002599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102601236|NCT00002599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102601237|NCT00002599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102601238|NCT00002599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102601239|NCT00002599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102601240|NCT00002599|Glucocorticoids|glucocorticoids|mesh-ancestor
102601241|NCT00002599|Hormones|hormones|mesh-ancestor
102601242|NCT00002599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102601243|NCT00002599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102601244|NCT00002599|Antiviral Agents|antiviral agents|mesh-ancestor
102601245|NCT00002599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102601246|NCT00002599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102601247|NCT00002599|Tubulin Modulators|tubulin modulators|mesh-ancestor
102601248|NCT00002599|Antimitotic Agents|antimitotic agents|mesh-ancestor
102601249|NCT00002599|Mitosis Modulators|mitosis modulators|mesh-ancestor
102601250|NCT00002599|Antiemetics|antiemetics|mesh-ancestor
102601251|NCT00002599|Autonomic Agents|autonomic agents|mesh-ancestor
102601252|NCT00002599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102601253|NCT00002599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102601254|NCT00002599|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102601255|NCT00002599|Protective Agents|protective agents|mesh-ancestor
102601256|NCT00002599|Trace Elements|trace elements|mesh-ancestor
102601257|NCT00002599|Micronutrients|micronutrients|mesh-ancestor
102601258|NCT00003440|Paclitaxel|paclitaxel|mesh-list
102601259|NCT00003440|Trastuzumab|trastuzumab|mesh-list
102601260|NCT00003440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102601261|NCT00003440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601262|NCT00003440|Tubulin Modulators|tubulin modulators|mesh-ancestor
102601263|NCT00003440|Antimitotic Agents|antimitotic agents|mesh-ancestor
102601264|NCT00003440|Mitosis Modulators|mitosis modulators|mesh-ancestor
102601265|NCT00003440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601266|NCT00003440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102601267|NCT00003200|Docetaxel|docetaxel|mesh-list
102601268|NCT00003200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601269|NCT00003200|Tubulin Modulators|tubulin modulators|mesh-ancestor
102601270|NCT00003200|Antimitotic Agents|antimitotic agents|mesh-ancestor
102601271|NCT00003200|Mitosis Modulators|mitosis modulators|mesh-ancestor
102601272|NCT00003200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601273|NCT00003446|Leucovorin|leucovorin|mesh-list
102601274|NCT00003446|Trimetrexate|trimetrexate|mesh-list
102601275|NCT00003446|Fluorouracil|fluorouracil|mesh-list
102601276|NCT00003446|Calcium|calcium|mesh-list
102601277|NCT00003446|Levoleucovorin|levoleucovorin|mesh-list
102601278|NCT00003446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102601279|NCT00003446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601280|NCT00003446|Antimetabolites|antimetabolites|mesh-ancestor
102601281|NCT00003446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601282|NCT00003446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102601283|NCT00003446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601284|NCT00003446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102601285|NCT00003446|Immunologic Factors|immunologic factors|mesh-ancestor
102601286|NCT00003446|Antidotes|antidotes|mesh-ancestor
102601287|NCT00003446|Protective Agents|protective agents|mesh-ancestor
102601288|NCT00003446|Vitamin B Complex|vitamin b complex|mesh-ancestor
102601289|NCT00003446|Vitamins|vitamins|mesh-ancestor
102601290|NCT00003446|Micronutrients|micronutrients|mesh-ancestor
102601291|NCT00003446|Antifungal Agents|antifungal agents|mesh-ancestor
102601292|NCT00003446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102601293|NCT00003446|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102601294|NCT00003446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102601295|NCT00003938|Amphotericin B|amphotericin b|mesh-list
102601296|NCT00003938|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102601297|NCT00003938|Amebicides|amebicides|mesh-ancestor
102601298|NCT00003938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102601299|NCT00003938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102601300|NCT00003938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102601301|NCT00003938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102601302|NCT00003938|Antifungal Agents|antifungal agents|mesh-ancestor
102601303|NCT00003212|Doxorubicin|doxorubicin|mesh-list
102601304|NCT00003212|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102601305|NCT00003212|Ifosfamide|ifosfamide|mesh-list
102601306|NCT00003212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102601307|NCT00003212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601308|NCT00003212|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102601309|NCT00003212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102601310|NCT00003212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102601311|NCT00003212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601312|NCT00003212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102601313|NCT00003212|Alkylating Agents|alkylating agents|mesh-ancestor
102601314|NCT00002611|Dactinomycin|dactinomycin|mesh-list
102601315|NCT00002611|Cyclophosphamide|cyclophosphamide|mesh-list
102601316|NCT00002611|Doxorubicin|doxorubicin|mesh-list
102601317|NCT00002611|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102601318|NCT00002611|Etoposide|etoposide|mesh-list
102601319|NCT00002611|Vincristine|vincristine|mesh-list
102601320|NCT00002611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102601321|NCT00002611|Immunologic Factors|immunologic factors|mesh-ancestor
102601322|NCT00002611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601323|NCT00002611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102601324|NCT00002611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102601325|NCT00002611|Alkylating Agents|alkylating agents|mesh-ancestor
102601326|NCT00002611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601327|NCT00002611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601328|NCT00002611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102369681|NCT04450134|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102601329|NCT00002611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102601330|NCT00002611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102601331|NCT00002611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102601332|NCT00002611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102601333|NCT00002611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102601334|NCT00002611|Tubulin Modulators|tubulin modulators|mesh-ancestor
102601335|NCT00002611|Antimitotic Agents|antimitotic agents|mesh-ancestor
102601336|NCT00002611|Mitosis Modulators|mitosis modulators|mesh-ancestor
102601337|NCT00002611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102601338|NCT00002611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102601339|NCT00002611|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102601340|NCT00002611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102601341|NCT00003944|Paclitaxel|paclitaxel|mesh-list
102601342|NCT00003944|Cyclophosphamide|cyclophosphamide|mesh-list
102601343|NCT00003944|Carboplatin|carboplatin|mesh-list
102601344|NCT00003944|Topotecan|topotecan|mesh-list
102601345|NCT00003944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102601346|NCT00003944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601347|NCT00003944|Tubulin Modulators|tubulin modulators|mesh-ancestor
102601348|NCT00003944|Antimitotic Agents|antimitotic agents|mesh-ancestor
102601349|NCT00003944|Mitosis Modulators|mitosis modulators|mesh-ancestor
102601350|NCT00003944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601351|NCT00003944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102601352|NCT00003944|Immunologic Factors|immunologic factors|mesh-ancestor
102601353|NCT00003944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601354|NCT00003944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102601355|NCT00003944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102601356|NCT00003944|Alkylating Agents|alkylating agents|mesh-ancestor
102601357|NCT00003944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102601358|NCT00003944|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102601359|NCT00003944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102601360|NCT00003944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102601361|NCT00003950|Cyclosporine|cyclosporine|mesh-list
102601362|NCT00003950|Irinotecan|irinotecan|mesh-list
102601363|NCT00003950|Cyclosporins|cyclosporins|mesh-list
102601364|NCT00003950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102601365|NCT00003950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102601366|NCT00003950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102601367|NCT00003950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601368|NCT00003950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601369|NCT00003950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102601370|NCT00003950|Immunologic Factors|immunologic factors|mesh-ancestor
102601371|NCT00003950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601372|NCT00003950|Antifungal Agents|antifungal agents|mesh-ancestor
102601373|NCT00003950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102601374|NCT00003950|Dermatologic Agents|dermatologic agents|mesh-ancestor
102601375|NCT00003950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102601376|NCT00003950|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102601377|NCT00003464|Temozolomide|temozolomide|mesh-list
102601378|NCT00003464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102601379|NCT00003464|Alkylating Agents|alkylating agents|mesh-ancestor
102601380|NCT00003464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601381|NCT00003464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601382|NCT00003230|Paclitaxel|paclitaxel|mesh-list
102601383|NCT00003230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102601384|NCT00003230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601385|NCT00003230|Tubulin Modulators|tubulin modulators|mesh-ancestor
102601386|NCT00003230|Antimitotic Agents|antimitotic agents|mesh-ancestor
102601387|NCT00003230|Mitosis Modulators|mitosis modulators|mesh-ancestor
102601388|NCT00003230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601389|NCT00003956|Leucovorin|leucovorin|mesh-list
102601390|NCT00003956|Fluorouracil|fluorouracil|mesh-list
102601391|NCT00003956|Calcium|calcium|mesh-list
102601392|NCT00003956|Levoleucovorin|levoleucovorin|mesh-list
102601393|NCT00003956|Lonafarnib|lonafarnib|mesh-list
102601394|NCT00003956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102601395|NCT00003956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601396|NCT00003956|Antimetabolites|antimetabolites|mesh-ancestor
102601397|NCT00003956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601398|NCT00003956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102601399|NCT00003956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601400|NCT00003956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102601401|NCT00003956|Immunologic Factors|immunologic factors|mesh-ancestor
102601402|NCT00003956|Antidotes|antidotes|mesh-ancestor
102346079|NCT04856319|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102601403|NCT00003956|Protective Agents|protective agents|mesh-ancestor
102601404|NCT00003956|Vitamin B Complex|vitamin b complex|mesh-ancestor
102601405|NCT00003956|Vitamins|vitamins|mesh-ancestor
102601406|NCT00003956|Micronutrients|micronutrients|mesh-ancestor
102601407|NCT00003956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102601408|NCT00002623|Carboplatin|carboplatin|mesh-list
102601409|NCT00002623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601410|NCT00003962|Aldesleukin|aldesleukin|mesh-list
102601411|NCT00003962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601412|NCT00003962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102148302|NCT02419612|Protease Inhibitors|protease inhibitors|mesh-ancestor
102601413|NCT00003962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102601414|NCT00003962|Antiviral Agents|antiviral agents|mesh-ancestor
102601415|NCT00003962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102601416|NCT00003968|Bryostatin 1|bryostatin 1|mesh-list
102601417|NCT00003968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102601418|NCT00003968|Immunologic Factors|immunologic factors|mesh-ancestor
102601419|NCT00003968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601420|NCT00003968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601421|NCT00003974|Cyclophosphamide|cyclophosphamide|mesh-list
102601422|NCT00003974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102601423|NCT00003974|Immunologic Factors|immunologic factors|mesh-ancestor
102601424|NCT00003974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601425|NCT00003974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102601426|NCT00003974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102601427|NCT00003974|Alkylating Agents|alkylating agents|mesh-ancestor
102601428|NCT00003974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601429|NCT00003974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601430|NCT00003974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102601431|NCT00002635|Lenograstim|lenograstim|mesh-list
102601432|NCT00002635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102601433|NCT00002635|Immunologic Factors|immunologic factors|mesh-ancestor
102601434|NCT00002635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601435|NCT00003242|Paclitaxel|paclitaxel|mesh-list
102601436|NCT00003242|Bryostatin 1|bryostatin 1|mesh-list
102601437|NCT00003242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102601438|NCT00003242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601439|NCT00003242|Tubulin Modulators|tubulin modulators|mesh-ancestor
102601440|NCT00003242|Antimitotic Agents|antimitotic agents|mesh-ancestor
102601441|NCT00003242|Mitosis Modulators|mitosis modulators|mesh-ancestor
102601442|NCT00003242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601443|NCT00003242|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102601444|NCT00003242|Immunologic Factors|immunologic factors|mesh-ancestor
102601445|NCT00003242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601446|NCT05664061|Fluticasone|fluticasone|mesh-list
102601447|NCT05664061|Xhance|xhance|mesh-list
102601448|NCT05664061|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102601449|NCT05664061|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102601450|NCT05664061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102601451|NCT05664061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102601452|NCT05664061|Autonomic Agents|autonomic agents|mesh-ancestor
102601453|NCT05664061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102601454|NCT05664061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601455|NCT05664061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102601456|NCT05664061|Respiratory System Agents|respiratory system agents|mesh-ancestor
102601457|NCT05664061|Dermatologic Agents|dermatologic agents|mesh-ancestor
102601458|NCT05664061|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102601459|NCT05664061|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102601460|NCT05664061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102601461|NCT05664061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102601462|NCT05664061|Adrenergic Agents|adrenergic agents|mesh-ancestor
102601463|NCT05664061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102601464|NCT05664061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601465|NCT05664061|Glucocorticoids|glucocorticoids|mesh-ancestor
102601466|NCT05664061|Hormones|hormones|mesh-ancestor
102601467|NCT05664061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102601468|NCT05664061|Sympathomimetics|sympathomimetics|mesh-ancestor
102601469|NCT00003248|Rituximab|rituximab|mesh-list
102601470|NCT00003248|Fludarabine|fludarabine|mesh-list
102601471|NCT00003248|Fludarabine phosphate|fludarabine phosphate|mesh-list
102601472|NCT00003248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102601473|NCT00003248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601474|NCT00003248|Immunologic Factors|immunologic factors|mesh-ancestor
102601475|NCT00003248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601476|NCT00003248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102601477|NCT00003248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102601478|NCT00003248|Antimetabolites|antimetabolites|mesh-ancestor
102601479|NCT00003248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601480|NCT00003248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102601481|NCT05663905|Ambroxol|ambroxol|mesh-list
102601482|NCT05663905|Expectorants|expectorants|mesh-ancestor
102601483|NCT05663905|Respiratory System Agents|respiratory system agents|mesh-ancestor
102601484|NCT00002641|Doxorubicin|doxorubicin|mesh-list
102601485|NCT00002641|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102601486|NCT00002641|Ifosfamide|ifosfamide|mesh-list
102601487|NCT00002641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102601488|NCT00002641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601489|NCT00002641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102601490|NCT00002641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102601491|NCT00002641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102601492|NCT00002641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601493|NCT00002641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102601494|NCT00002641|Alkylating Agents|alkylating agents|mesh-ancestor
102601495|NCT00003992|Tamoxifen|tamoxifen|mesh-list
102601496|NCT00003992|Paclitaxel|paclitaxel|mesh-list
102601497|NCT00003992|Cyclophosphamide|cyclophosphamide|mesh-list
102601498|NCT00003992|Doxorubicin|doxorubicin|mesh-list
102601499|NCT00003992|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102601500|NCT00003992|Trastuzumab|trastuzumab|mesh-list
102601501|NCT00003992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102601502|NCT00003992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601503|NCT00003992|Tubulin Modulators|tubulin modulators|mesh-ancestor
102601504|NCT00003992|Antimitotic Agents|antimitotic agents|mesh-ancestor
102601505|NCT00003992|Mitosis Modulators|mitosis modulators|mesh-ancestor
102601506|NCT00003992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601507|NCT00003992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102601508|NCT00003992|Immunologic Factors|immunologic factors|mesh-ancestor
102601509|NCT00003992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601510|NCT00003992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102601511|NCT00003992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102601512|NCT00003992|Alkylating Agents|alkylating agents|mesh-ancestor
102601513|NCT00003992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102601514|NCT00003992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102601515|NCT00003992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102601516|NCT00003992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102601517|NCT00003992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102601518|NCT00003992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102601519|NCT00003992|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102601520|NCT00003992|Hormone Antagonists|hormone antagonists|mesh-ancestor
102346092|NCT04830813|Chiauranib|chiauranib|mesh-list
102601521|NCT00003992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102601522|NCT00003992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102601523|NCT00003992|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102601524|NCT00003992|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102601525|NCT00003992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102601526|NCT00002647|Verteporfin|verteporfin|mesh-list
102601527|NCT00002647|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102601528|NCT00002647|Dermatologic Agents|dermatologic agents|mesh-ancestor
102601529|NCT00002653|Prednisone|prednisone|mesh-list
102601530|NCT00002653|Cyclophosphamide|cyclophosphamide|mesh-list
102601531|NCT00002653|Melphalan|melphalan|mesh-list
102601532|NCT00002653|Carmustine|carmustine|mesh-list
102601533|NCT00002653|Doxorubicin|doxorubicin|mesh-list
102601534|NCT00002653|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102601535|NCT00002653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102601536|NCT00002653|Immunologic Factors|immunologic factors|mesh-ancestor
102601537|NCT00002653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601538|NCT00002653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102601539|NCT00002653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102601540|NCT00002653|Alkylating Agents|alkylating agents|mesh-ancestor
102601541|NCT00002653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601542|NCT00002653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601543|NCT00002653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102601544|NCT00002653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102601545|NCT00002653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102601546|NCT00002653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102601547|NCT00002653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102601548|NCT00002653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102601549|NCT00002653|Glucocorticoids|glucocorticoids|mesh-ancestor
102601550|NCT00002653|Hormones|hormones|mesh-ancestor
102601551|NCT00002653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102601552|NCT00002653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102601553|NCT00003254|Fluorouracil|fluorouracil|mesh-list
102601554|NCT00003254|Eniluracil|eniluracil|mesh-list
102601555|NCT00003254|Antimetabolites|antimetabolites|mesh-ancestor
102601556|NCT00003254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601557|NCT00003254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102601558|NCT00003254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601559|NCT00003254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102601560|NCT00003254|Immunologic Factors|immunologic factors|mesh-ancestor
102601561|NCT00003254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601562|NCT00003254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102601563|NCT00002659|Cisplatin|cisplatin|mesh-list
102601564|NCT00002659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601565|NCT00003998|Paclitaxel|paclitaxel|mesh-list
102601566|NCT00003998|Docetaxel|docetaxel|mesh-list
102601567|NCT00003998|Carboplatin|carboplatin|mesh-list
102601568|NCT00003998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102601569|NCT00003998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601570|NCT00003998|Tubulin Modulators|tubulin modulators|mesh-ancestor
102601571|NCT00003998|Antimitotic Agents|antimitotic agents|mesh-ancestor
102601572|NCT00003998|Mitosis Modulators|mitosis modulators|mesh-ancestor
102601573|NCT00003998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601574|NCT00004004|Procarbazine|procarbazine|mesh-list
102601575|NCT00004004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346113|NCT04759586|Prednisone|prednisone|mesh-list
102601577|NCT00003260|Fluorouracil|fluorouracil|mesh-list
102601578|NCT00003260|Oxaliplatin|oxaliplatin|mesh-list
102601579|NCT00003260|Irinotecan|irinotecan|mesh-list
102601580|NCT00003260|Calcium|calcium|mesh-list
102601581|NCT00003260|Levoleucovorin|levoleucovorin|mesh-list
102601582|NCT00003260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102601583|NCT00003260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601584|NCT00003260|Antimetabolites|antimetabolites|mesh-ancestor
102601585|NCT00003260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601586|NCT00003260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102601587|NCT00003260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601588|NCT00003260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102601589|NCT00003260|Immunologic Factors|immunologic factors|mesh-ancestor
102601590|NCT00003260|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102601591|NCT00003260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102601592|NCT00003260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102601593|NCT00003260|Antidotes|antidotes|mesh-ancestor
102601594|NCT00003260|Protective Agents|protective agents|mesh-ancestor
102601595|NCT00003260|Vitamin B Complex|vitamin b complex|mesh-ancestor
102601596|NCT00003260|Vitamins|vitamins|mesh-ancestor
102601597|NCT00003260|Micronutrients|micronutrients|mesh-ancestor
102601598|NCT00002665|Leucovorin|leucovorin|mesh-list
102601599|NCT00002665|Cytarabine|cytarabine|mesh-list
102601600|NCT00002665|Dexamethasone|dexamethasone|mesh-list
102601601|NCT00002665|Prednisone|prednisone|mesh-list
102601602|NCT00002665|Cyclophosphamide|cyclophosphamide|mesh-list
102601603|NCT00002665|Doxorubicin|doxorubicin|mesh-list
102601604|NCT00002665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102601605|NCT00002665|Methotrexate|methotrexate|mesh-list
102601606|NCT00002665|Etoposide|etoposide|mesh-list
102601607|NCT00002665|Vincristine|vincristine|mesh-list
102601608|NCT00002665|Daunorubicin|daunorubicin|mesh-list
102601609|NCT00002665|Asparaginase|asparaginase|mesh-list
102601610|NCT00002665|Mercaptopurine|mercaptopurine|mesh-list
102601611|NCT00002665|Thioguanine|thioguanine|mesh-list
102601612|NCT00002665|Levoleucovorin|levoleucovorin|mesh-list
102601613|NCT00002665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102601614|NCT00002665|Immunologic Factors|immunologic factors|mesh-ancestor
102601615|NCT00002665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601616|NCT00002665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102601617|NCT00002665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102601618|NCT00002665|Alkylating Agents|alkylating agents|mesh-ancestor
102601619|NCT00002665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601620|NCT00002665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601621|NCT00002665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102601622|NCT00002665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102601623|NCT00002665|Antiemetics|antiemetics|mesh-ancestor
102601624|NCT00002665|Autonomic Agents|autonomic agents|mesh-ancestor
102601625|NCT00002665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102601626|NCT00002665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102601627|NCT00002665|Glucocorticoids|glucocorticoids|mesh-ancestor
102601628|NCT00002665|Hormones|hormones|mesh-ancestor
102601629|NCT00002665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102601630|NCT00002665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102601631|NCT00002665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102601632|NCT00002665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102601633|NCT00002665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102601634|NCT00002665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102601635|NCT00002665|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102601636|NCT00002665|Abortifacient Agents|abortifacient agents|mesh-ancestor
102601637|NCT00002665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102601638|NCT00002665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102601639|NCT00002665|Antimetabolites|antimetabolites|mesh-ancestor
102601640|NCT00002665|Dermatologic Agents|dermatologic agents|mesh-ancestor
102601641|NCT00002665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102601642|NCT00002665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102601643|NCT00002665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102601644|NCT00002665|Antiviral Agents|antiviral agents|mesh-ancestor
102346136|NCT04759586|Lenograstim|lenograstim|mesh-list
102601645|NCT00002665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102601646|NCT00002665|Antidotes|antidotes|mesh-ancestor
102601647|NCT00002665|Protective Agents|protective agents|mesh-ancestor
102601648|NCT00002665|Vitamin B Complex|vitamin b complex|mesh-ancestor
102601650|NCT00002665|Micronutrients|micronutrients|mesh-ancestor
102601651|NCT00002665|Tubulin Modulators|tubulin modulators|mesh-ancestor
102601652|NCT00002665|Antimitotic Agents|antimitotic agents|mesh-ancestor
102601653|NCT00002665|Mitosis Modulators|mitosis modulators|mesh-ancestor
102601654|NCT00003536|Methotrexate|methotrexate|mesh-list
102601655|NCT00003536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102601656|NCT00003536|Abortifacient Agents|abortifacient agents|mesh-ancestor
102601657|NCT00003536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102601658|NCT00003536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601659|NCT00003536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102601660|NCT00003536|Antimetabolites|antimetabolites|mesh-ancestor
102601661|NCT00003536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601662|NCT00003536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601663|NCT00003536|Dermatologic Agents|dermatologic agents|mesh-ancestor
102601664|NCT00003536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102601665|NCT00003536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102601666|NCT00003536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102601667|NCT00003536|Immunologic Factors|immunologic factors|mesh-ancestor
102601668|NCT00003536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102601669|NCT00003536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102601670|NCT00003542|Interferons|interferons|mesh-list
102601671|NCT00003542|Interferon-alpha|interferon-alpha|mesh-list
102601672|NCT00003542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601673|NCT00003542|Antiviral Agents|antiviral agents|mesh-ancestor
102601674|NCT00003542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102601675|NCT00003542|Immunologic Factors|immunologic factors|mesh-ancestor
102601676|NCT00003542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601677|NCT00004010|Prednisone|prednisone|mesh-list
102601678|NCT00004010|Cyclophosphamide|cyclophosphamide|mesh-list
102601679|NCT00004010|Dacarbazine|dacarbazine|mesh-list
102601680|NCT00004010|Doxorubicin|doxorubicin|mesh-list
102601681|NCT00004010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102601682|NCT00004010|Etoposide|etoposide|mesh-list
102601683|NCT00004010|Vincristine|vincristine|mesh-list
102601684|NCT00004010|Bleomycin|bleomycin|mesh-list
102601685|NCT00004010|Vinblastine|vinblastine|mesh-list
102601686|NCT00004010|Procarbazine|procarbazine|mesh-list
102601687|NCT00004010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102601688|NCT00004010|Immunologic Factors|immunologic factors|mesh-ancestor
102601689|NCT00004010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601690|NCT00004010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102601691|NCT00004010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102601692|NCT00004010|Alkylating Agents|alkylating agents|mesh-ancestor
102601693|NCT00004010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601694|NCT00004010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601695|NCT00004010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102601696|NCT00004010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102601697|NCT00004010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102601698|NCT00004010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102601699|NCT00004010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102601700|NCT00004010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102601701|NCT00004010|Glucocorticoids|glucocorticoids|mesh-ancestor
102601702|NCT00004010|Hormones|hormones|mesh-ancestor
102601703|NCT00004010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102601704|NCT00004010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102601705|NCT00004010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102601706|NCT00004010|Tubulin Modulators|tubulin modulators|mesh-ancestor
102601707|NCT00004010|Antimitotic Agents|antimitotic agents|mesh-ancestor
102601708|NCT00004010|Mitosis Modulators|mitosis modulators|mesh-ancestor
102601709|NCT00004016|Interferons|interferons|mesh-list
102601710|NCT00004016|Interferon-gamma|interferon-gamma|mesh-list
102601711|NCT00004016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601712|NCT00004016|Antiviral Agents|antiviral agents|mesh-ancestor
102601713|NCT00004016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102601714|NCT00004022|Aldesleukin|aldesleukin|mesh-list
102601715|NCT00004022|Muromonab-CD3|muromonab-cd3|mesh-list
102601716|NCT00004022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601717|NCT00004022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102601718|NCT00004022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102601719|NCT00004022|Antiviral Agents|antiviral agents|mesh-ancestor
102601720|NCT00004022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102601721|NCT00004022|Immunologic Factors|immunologic factors|mesh-ancestor
102601722|NCT00004022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601723|NCT00004022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102601724|NCT00381901|Trastuzumab|trastuzumab|mesh-list
102601725|NCT00381901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102601727|NCT00003278|Dexamethasone|dexamethasone|mesh-list
102601728|NCT00003278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102601729|NCT00003278|Antiemetics|antiemetics|mesh-ancestor
102601730|NCT00003278|Autonomic Agents|autonomic agents|mesh-ancestor
102601731|NCT00003278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102601732|NCT00003278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601733|NCT00003278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102601734|NCT00003278|Glucocorticoids|glucocorticoids|mesh-ancestor
102601735|NCT00003278|Hormones|hormones|mesh-ancestor
102601736|NCT00003278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102601737|NCT00003278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102601738|NCT00003278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601739|NCT00004028|Carmustine|carmustine|mesh-list
102601740|NCT00004028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102601741|NCT00004028|Alkylating Agents|alkylating agents|mesh-ancestor
102601742|NCT00004028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601743|NCT00004028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601744|NCT00003554|Prednisone|prednisone|mesh-list
102601745|NCT00003554|Rituximab|rituximab|mesh-list
102601746|NCT00003554|Melphalan|melphalan|mesh-list
102601747|NCT00003554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102601748|NCT00003554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601749|NCT00003554|Immunologic Factors|immunologic factors|mesh-ancestor
102601750|NCT00003554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601751|NCT00003554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102601752|NCT00003554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102601753|NCT00003554|Glucocorticoids|glucocorticoids|mesh-ancestor
102601754|NCT00003554|Hormones|hormones|mesh-ancestor
102601755|NCT00003554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102601756|NCT00003554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102601757|NCT00003554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102601758|NCT00003554|Alkylating Agents|alkylating agents|mesh-ancestor
102601759|NCT00003554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601760|NCT00003554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102601761|NCT00003554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102601762|NCT00003284|Paclitaxel|paclitaxel|mesh-list
102601763|NCT00003284|Etoposide|etoposide|mesh-list
102601764|NCT00003284|Carboplatin|carboplatin|mesh-list
102601765|NCT00003284|Ifosfamide|ifosfamide|mesh-list
102601766|NCT00003284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102601767|NCT00003284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601768|NCT00003284|Tubulin Modulators|tubulin modulators|mesh-ancestor
102601769|NCT00003284|Antimitotic Agents|antimitotic agents|mesh-ancestor
102601770|NCT00003284|Mitosis Modulators|mitosis modulators|mesh-ancestor
102601771|NCT00003284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601772|NCT00003284|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102601773|NCT00003284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102601774|NCT00003284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102601775|NCT00003284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102601776|NCT00003284|Alkylating Agents|alkylating agents|mesh-ancestor
102601777|NCT00384410|Nabilone|nabilone|mesh-list
102601778|NCT00384410|Antiemetics|antiemetics|mesh-ancestor
102601779|NCT00384410|Autonomic Agents|autonomic agents|mesh-ancestor
102601780|NCT00384410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102601781|NCT00384410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601782|NCT00384410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102601783|NCT00384410|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102601784|NCT00384410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102601785|NCT00384410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102601786|NCT00384410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102601787|NCT00004040|Interferons|interferons|mesh-list
102601788|NCT00004040|Interferon-alpha|interferon-alpha|mesh-list
102601789|NCT00004040|Rituximab|rituximab|mesh-list
102601790|NCT00004040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102601791|NCT00004040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601792|NCT00004040|Immunologic Factors|immunologic factors|mesh-ancestor
102601793|NCT00004040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601794|NCT00004040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102601795|NCT00004040|Antiviral Agents|antiviral agents|mesh-ancestor
102601796|NCT00004040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102601797|NCT00004046|Exatecan|exatecan|mesh-list
102601798|NCT00004046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102601799|NCT00004046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102148674|NCT02331602|Dabigatran|dabigatran|mesh-list
102601800|NCT00004046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102601801|NCT00004046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601802|NCT00004046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601803|NCT00003560|Carboplatin|carboplatin|mesh-list
102601804|NCT00003560|Docetaxel|docetaxel|mesh-list
102601805|NCT00003560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601806|NCT00003560|Tubulin Modulators|tubulin modulators|mesh-ancestor
102601807|NCT00003560|Antimitotic Agents|antimitotic agents|mesh-ancestor
102601808|NCT00003560|Mitosis Modulators|mitosis modulators|mesh-ancestor
102601809|NCT00003560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601810|NCT00003290|Hormones|hormones|mesh-list
102601811|NCT00003290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102601812|NCT00003290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601813|NCT05748925|Dapagliflozin|dapagliflozin|mesh-list
102601814|NCT05748925|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102601815|NCT05748925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601816|NCT05748925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102601817|NCT05748925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601818|NCT00003572|Mycophenolic Acid|mycophenolic acid|mesh-list
102601819|NCT00003572|Tacrolimus|tacrolimus|mesh-list
102601820|NCT00003572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102601821|NCT00003572|Immunologic Factors|immunologic factors|mesh-ancestor
102601822|NCT00003572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601823|NCT00003572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102601824|NCT00003572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102601825|NCT00003572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601826|NCT00003572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102601827|NCT00003572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601828|NCT00003572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102601829|NCT00003572|Antitubercular Agents|antitubercular agents|mesh-ancestor
102601830|NCT00003572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102601831|NCT00003572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102601832|NCT00002689|Dexamethasone|dexamethasone|mesh-list
102601833|NCT00002689|Fluorouracil|fluorouracil|mesh-list
102601834|NCT00002689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102601835|NCT00002689|Antiemetics|antiemetics|mesh-ancestor
102601836|NCT00002689|Autonomic Agents|autonomic agents|mesh-ancestor
102601837|NCT00002689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102601838|NCT00002689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601839|NCT00002689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102601840|NCT00002689|Glucocorticoids|glucocorticoids|mesh-ancestor
102601841|NCT00002689|Hormones|hormones|mesh-ancestor
102601842|NCT00002689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102601843|NCT00002689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102601844|NCT00002689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601845|NCT00002689|Antimetabolites|antimetabolites|mesh-ancestor
102601846|NCT00002689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601847|NCT00002689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102601848|NCT00002689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102601849|NCT00002689|Immunologic Factors|immunologic factors|mesh-ancestor
102601850|NCT00003296|Doxorubicin|doxorubicin|mesh-list
102601851|NCT00003296|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102601852|NCT00003296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102601853|NCT00003296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601854|NCT00003296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102601855|NCT00003296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102601856|NCT00003296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102601857|NCT00003296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601858|NCT00004064|Oregovomab|oregovomab|mesh-list
102601859|NCT00004064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102601860|NCT00004064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601861|NCT00382057|Anastrozole|anastrozole|mesh-list
102601862|NCT00382057|Goserelin|goserelin|mesh-list
102601863|NCT00382057|Testosterone|testosterone|mesh-list
102601864|NCT00382057|Androgens|androgens|mesh-ancestor
102601865|NCT00382057|Hormones|hormones|mesh-ancestor
102601866|NCT00382057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102601867|NCT00382057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601868|NCT00382057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102601869|NCT00382057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601870|NCT00382057|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102601871|NCT00382057|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102601872|NCT00382057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102601873|NCT00382057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601874|NCT00382057|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102601875|NCT00382057|Hormone Antagonists|hormone antagonists|mesh-ancestor
102601876|NCT00003578|Cytarabine|cytarabine|mesh-list
102601877|NCT00003578|Prednisone|prednisone|mesh-list
102601878|NCT00003578|Cyclophosphamide|cyclophosphamide|mesh-list
102601879|NCT00003578|Melphalan|melphalan|mesh-list
102601880|NCT00003578|Carmustine|carmustine|mesh-list
102601881|NCT00003578|Doxorubicin|doxorubicin|mesh-list
102601882|NCT00003578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102601883|NCT00003578|Etoposide|etoposide|mesh-list
102601884|NCT00003578|Vincristine|vincristine|mesh-list
102601885|NCT00003578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102601886|NCT00003578|Immunologic Factors|immunologic factors|mesh-ancestor
102601887|NCT00003578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601888|NCT00003578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102601889|NCT00003578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102601890|NCT00003578|Alkylating Agents|alkylating agents|mesh-ancestor
102601891|NCT00003578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601892|NCT00003578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601893|NCT00003578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102601894|NCT00003578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102601895|NCT00003578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102601896|NCT00003578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102601897|NCT00003578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102601898|NCT00003578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102601899|NCT00003578|Glucocorticoids|glucocorticoids|mesh-ancestor
102601900|NCT00003578|Hormones|hormones|mesh-ancestor
102601901|NCT00003578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102601902|NCT00003578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102601903|NCT00003578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102601904|NCT00003578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102601905|NCT00003578|Antimetabolites|antimetabolites|mesh-ancestor
102601906|NCT00003578|Antiviral Agents|antiviral agents|mesh-ancestor
102601907|NCT00003578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102601908|NCT00003578|Tubulin Modulators|tubulin modulators|mesh-ancestor
102601909|NCT00003578|Antimitotic Agents|antimitotic agents|mesh-ancestor
102601910|NCT00003578|Mitosis Modulators|mitosis modulators|mesh-ancestor
102601911|NCT00003584|Prednisone|prednisone|mesh-list
102601912|NCT00003584|Estramustine|estramustine|mesh-list
102601913|NCT00003584|Vinorelbine|vinorelbine|mesh-list
102601914|NCT00003584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102601915|NCT00003584|Glucocorticoids|glucocorticoids|mesh-ancestor
102601916|NCT00003584|Hormones|hormones|mesh-ancestor
102601917|NCT00003584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102601918|NCT00003584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601919|NCT00003584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102601920|NCT00003584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601921|NCT00003584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102601922|NCT00003584|Tubulin Modulators|tubulin modulators|mesh-ancestor
102601923|NCT00003584|Antimitotic Agents|antimitotic agents|mesh-ancestor
102601924|NCT00003584|Mitosis Modulators|mitosis modulators|mesh-ancestor
102601925|NCT00003584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601926|NCT00003584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102601927|NCT00003584|Alkylating Agents|alkylating agents|mesh-ancestor
102601928|NCT00002701|Cytarabine|cytarabine|mesh-list
102601929|NCT00002701|Cyclophosphamide|cyclophosphamide|mesh-list
102601930|NCT00002701|Busulfan|busulfan|mesh-list
102601931|NCT00002701|Methotrexate|methotrexate|mesh-list
102601932|NCT00002701|Etoposide|etoposide|mesh-list
102601933|NCT00002701|Mitoxantrone|mitoxantrone|mesh-list
102601934|NCT00002701|Mercaptopurine|mercaptopurine|mesh-list
102601935|NCT00002701|Idarubicin|idarubicin|mesh-list
102601936|NCT00002701|Tretinoin|tretinoin|mesh-list
102601937|NCT00002701|Thioguanine|thioguanine|mesh-list
102601938|NCT00002701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102601939|NCT00002701|Immunologic Factors|immunologic factors|mesh-ancestor
102601940|NCT00002701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601941|NCT00002701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102601942|NCT00002701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102601943|NCT00002701|Alkylating Agents|alkylating agents|mesh-ancestor
102601944|NCT00002701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601945|NCT00002701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601946|NCT00002701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102601947|NCT00002701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102601948|NCT00002701|Abortifacient Agents|abortifacient agents|mesh-ancestor
102601949|NCT00002701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102601950|NCT00002701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102601951|NCT00002701|Antimetabolites|antimetabolites|mesh-ancestor
102601952|NCT00002701|Dermatologic Agents|dermatologic agents|mesh-ancestor
102601953|NCT00002701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102601954|NCT00002701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102601955|NCT00002701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102601956|NCT00002701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102601957|NCT00002701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102601958|NCT00002701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102601959|NCT00002701|Antiviral Agents|antiviral agents|mesh-ancestor
102601960|NCT00002701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102601961|NCT00002701|Analgesics|analgesics|mesh-ancestor
102601962|NCT00002701|Sensory System Agents|sensory system agents|mesh-ancestor
102601963|NCT00002701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102601964|NCT00002701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102601965|NCT00002701|Keratolytic Agents|keratolytic agents|mesh-ancestor
102601966|NCT00004070|Interleukin-12|interleukin-12|mesh-list
102601967|NCT00004070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102601968|NCT00004070|Immunologic Factors|immunologic factors|mesh-ancestor
102601969|NCT00004070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601970|NCT00004070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102346192|NCT04741438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601971|NCT00004070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102601972|NCT00004070|Growth Substances|growth substances|mesh-ancestor
102601973|NCT00004070|Growth Inhibitors|growth inhibitors|mesh-ancestor
102601974|NCT00004070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601975|NCT00004082|Carboplatin|carboplatin|mesh-list
102601976|NCT00004082|Gemcitabine|gemcitabine|mesh-list
102601977|NCT00004082|Docetaxel|docetaxel|mesh-list
102601978|NCT00004082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601979|NCT00004082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102601980|NCT00004082|Antimetabolites|antimetabolites|mesh-ancestor
102601981|NCT00004082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601982|NCT00004082|Tubulin Modulators|tubulin modulators|mesh-ancestor
102601983|NCT00004082|Antimitotic Agents|antimitotic agents|mesh-ancestor
102601984|NCT00004082|Mitosis Modulators|mitosis modulators|mesh-ancestor
102601985|NCT00002707|Tamoxifen|tamoxifen|mesh-list
102601986|NCT00002707|Cyclophosphamide|cyclophosphamide|mesh-list
102601987|NCT00002707|Docetaxel|docetaxel|mesh-list
102601988|NCT00002707|Doxorubicin|doxorubicin|mesh-list
102601989|NCT00002707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102601990|NCT00002707|Immunologic Factors|immunologic factors|mesh-ancestor
102601991|NCT00002707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102601992|NCT00002707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102601993|NCT00002707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102601994|NCT00002707|Alkylating Agents|alkylating agents|mesh-ancestor
102601995|NCT00002707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102601996|NCT00002707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102601997|NCT00002707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102601998|NCT00002707|Tubulin Modulators|tubulin modulators|mesh-ancestor
102601999|NCT00002707|Antimitotic Agents|antimitotic agents|mesh-ancestor
102602000|NCT00002707|Mitosis Modulators|mitosis modulators|mesh-ancestor
102602001|NCT00002707|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102602002|NCT00002707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102602003|NCT00002707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102602004|NCT00002707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102602005|NCT00002707|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102602006|NCT00002707|Hormone Antagonists|hormone antagonists|mesh-ancestor
102602007|NCT00002707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102602008|NCT00002707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102602009|NCT00002707|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102602010|NCT00002707|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102602011|NCT00002707|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102602012|NCT00003596|Fluorouracil|fluorouracil|mesh-list
102602013|NCT00003596|Mitomycins|mitomycins|mesh-list
102602014|NCT00003596|Mitomycin|mitomycin|mesh-list
102602015|NCT00003596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602016|NCT00003596|Antimetabolites|antimetabolites|mesh-ancestor
102602017|NCT00003596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602018|NCT00003596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102602019|NCT00003596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102602020|NCT00003596|Immunologic Factors|immunologic factors|mesh-ancestor
102602021|NCT00003596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602022|NCT00003596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102602023|NCT00003596|Alkylating Agents|alkylating agents|mesh-ancestor
102602024|NCT00003596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102602025|NCT00003596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102602026|NCT00002719|Cytarabine|cytarabine|mesh-list
102602027|NCT00002719|Etoposide|etoposide|mesh-list
102602028|NCT00002719|Mitoxantrone|mitoxantrone|mesh-list
102602029|NCT00002719|Idarubicin|idarubicin|mesh-list
102602030|NCT00002719|Carmustine|carmustine|mesh-list
102602031|NCT00002719|Amsacrine|amsacrine|mesh-list
102602032|NCT00002719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102602033|NCT00002719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602034|NCT00002719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102602035|NCT00002719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102602036|NCT00002719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102602037|NCT00002719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602038|NCT00002719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102602039|NCT00002719|Antimetabolites|antimetabolites|mesh-ancestor
102602040|NCT00002719|Antiviral Agents|antiviral agents|mesh-ancestor
102602041|NCT00002719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102602042|NCT00002719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102602043|NCT00002719|Immunologic Factors|immunologic factors|mesh-ancestor
102602044|NCT00002719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602045|NCT00002719|Analgesics|analgesics|mesh-ancestor
102602046|NCT00002719|Sensory System Agents|sensory system agents|mesh-ancestor
102602047|NCT00002719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102602048|NCT00002719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102602049|NCT00002719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102602050|NCT00002719|Alkylating Agents|alkylating agents|mesh-ancestor
102602051|NCT00003326|Paclitaxel|paclitaxel|mesh-list
102602052|NCT00003326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102602053|NCT00003326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602054|NCT00003326|Tubulin Modulators|tubulin modulators|mesh-ancestor
102602055|NCT00003326|Antimitotic Agents|antimitotic agents|mesh-ancestor
102602056|NCT00003326|Mitosis Modulators|mitosis modulators|mesh-ancestor
102602057|NCT00003326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602058|NCT00002725|Bryostatin 1|bryostatin 1|mesh-list
102602059|NCT00002725|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102602060|NCT00002725|Immunologic Factors|immunologic factors|mesh-ancestor
102602061|NCT00002725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602062|NCT00002725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602063|NCT00003602|Cytarabine|cytarabine|mesh-list
102602064|NCT00003602|Etoposide|etoposide|mesh-list
102602065|NCT00003602|Mitoxantrone|mitoxantrone|mesh-list
102602066|NCT00003602|Idarubicin|idarubicin|mesh-list
102602067|NCT00003602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102602068|NCT00003602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602069|NCT00003602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102602070|NCT00003602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102602071|NCT00003602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102602072|NCT00003602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602073|NCT00003602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102602074|NCT00003602|Antimetabolites|antimetabolites|mesh-ancestor
102602075|NCT00003602|Antiviral Agents|antiviral agents|mesh-ancestor
102602076|NCT00003602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102602077|NCT00003602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102602078|NCT00003602|Immunologic Factors|immunologic factors|mesh-ancestor
102602079|NCT00003602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602080|NCT00003602|Analgesics|analgesics|mesh-ancestor
102602081|NCT00003602|Sensory System Agents|sensory system agents|mesh-ancestor
102602082|NCT00003602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102602083|NCT00003602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102602084|NCT04609423|Vitamin D|vitamin d|mesh-list
102602085|NCT04609423|Cod Liver Oil|cod liver oil|mesh-list
102602086|NCT04609423|Vitamins|vitamins|mesh-ancestor
102602087|NCT04609423|Micronutrients|micronutrients|mesh-ancestor
102602088|NCT04609423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602089|NCT04609423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102602090|NCT00003332|Gemcitabine|gemcitabine|mesh-list
102602091|NCT00003332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602092|NCT00003332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102602093|NCT00003332|Antimetabolites|antimetabolites|mesh-ancestor
102602094|NCT00003332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602095|NCT00004094|Paclitaxel|paclitaxel|mesh-list
102602096|NCT00004094|Carboplatin|carboplatin|mesh-list
102602097|NCT00004094|Fluorouracil|fluorouracil|mesh-list
102602098|NCT00004094|Hydroxyurea|hydroxyurea|mesh-list
102602099|NCT00004094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102602100|NCT00004094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602101|NCT00004094|Tubulin Modulators|tubulin modulators|mesh-ancestor
102602102|NCT00004094|Antimitotic Agents|antimitotic agents|mesh-ancestor
102602103|NCT00004094|Mitosis Modulators|mitosis modulators|mesh-ancestor
102602104|NCT00004094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602105|NCT00004094|Antimetabolites|antimetabolites|mesh-ancestor
102602106|NCT00004094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102602107|NCT00004094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102602108|NCT00004094|Immunologic Factors|immunologic factors|mesh-ancestor
102602109|NCT00004094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602110|NCT00004094|Antisickling Agents|antisickling agents|mesh-ancestor
102602111|NCT00004094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102602112|NCT00004094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102602113|NCT00004100|Gemcitabine|gemcitabine|mesh-list
102602114|NCT00004100|Vinorelbine|vinorelbine|mesh-list
102602115|NCT00004100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602116|NCT00004100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102602117|NCT00004100|Antimetabolites|antimetabolites|mesh-ancestor
102602118|NCT00004100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602119|NCT00004100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102602120|NCT00004100|Tubulin Modulators|tubulin modulators|mesh-ancestor
102602121|NCT00004100|Antimitotic Agents|antimitotic agents|mesh-ancestor
102602122|NCT00004100|Mitosis Modulators|mitosis modulators|mesh-ancestor
102602123|NCT00002737|Interferons|interferons|mesh-list
102602124|NCT00002737|Interferon-alpha|interferon-alpha|mesh-list
102602125|NCT00002737|Isotretinoin|isotretinoin|mesh-list
102602126|NCT00002737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602127|NCT00002737|Antiviral Agents|antiviral agents|mesh-ancestor
102602128|NCT00002737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102602129|NCT00002737|Immunologic Factors|immunologic factors|mesh-ancestor
102602130|NCT00002737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602131|NCT00002737|Dermatologic Agents|dermatologic agents|mesh-ancestor
102602132|NCT00003338|Epratuzumab|epratuzumab|mesh-list
102602133|NCT00003338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102602134|NCT00003338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602135|NCT00003620|Alvocidib|alvocidib|mesh-list
102602136|NCT00003620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602137|NCT00003620|Growth Inhibitors|growth inhibitors|mesh-ancestor
102602138|NCT00003620|Growth Substances|growth substances|mesh-ancestor
102602139|NCT00003620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602140|NCT00003620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102602141|NCT00003620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102602142|NCT00003620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602143|NCT00003344|Irinotecan|irinotecan|mesh-list
102602144|NCT00003344|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102602145|NCT00003344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102602146|NCT00003344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102602147|NCT00003344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602148|NCT00003344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602149|NCT00003626|Dolastatin 10|dolastatin 10|mesh-list
102602150|NCT00003626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602151|NCT00003626|Tubulin Modulators|tubulin modulators|mesh-ancestor
102602152|NCT00003626|Antimitotic Agents|antimitotic agents|mesh-ancestor
102602153|NCT00003626|Mitosis Modulators|mitosis modulators|mesh-ancestor
102346223|NCT04648540|Acetaminophen|acetaminophen|mesh-list
102602154|NCT00003626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602155|NCT00003632|Cytarabine|cytarabine|mesh-list
102602156|NCT00003632|Methotrexate|methotrexate|mesh-list
102602157|NCT00003632|Etoposide|etoposide|mesh-list
102602158|NCT00003632|Melphalan|melphalan|mesh-list
102602159|NCT00003632|Carmustine|carmustine|mesh-list
102602160|NCT00003632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102602161|NCT00003632|Abortifacient Agents|abortifacient agents|mesh-ancestor
102602162|NCT00003632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102602163|NCT00003632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602164|NCT00003632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102602165|NCT00003632|Antimetabolites|antimetabolites|mesh-ancestor
102602166|NCT00003632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602167|NCT00003632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602168|NCT00003632|Dermatologic Agents|dermatologic agents|mesh-ancestor
102602169|NCT00003632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102602170|NCT00003632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102602171|NCT00003632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102602172|NCT00003632|Immunologic Factors|immunologic factors|mesh-ancestor
102602173|NCT00003632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102602174|NCT00003632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102602175|NCT00003632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102602176|NCT00003632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102602177|NCT00003632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102602178|NCT00003632|Antiviral Agents|antiviral agents|mesh-ancestor
102602179|NCT00003632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102602180|NCT00003632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102602181|NCT00003632|Alkylating Agents|alkylating agents|mesh-ancestor
102602182|NCT00003632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102602183|NCT00004112|Prednisone|prednisone|mesh-list
102602184|NCT00004112|Cyclophosphamide|cyclophosphamide|mesh-list
102602185|NCT00004112|Rituximab|rituximab|mesh-list
102602186|NCT00004112|Doxorubicin|doxorubicin|mesh-list
102602187|NCT00004112|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102602188|NCT00004112|Vincristine|vincristine|mesh-list
102602189|NCT00004112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102602190|NCT00004112|Immunologic Factors|immunologic factors|mesh-ancestor
102602191|NCT00004112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602192|NCT00004112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102602193|NCT00004112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102602194|NCT00004112|Alkylating Agents|alkylating agents|mesh-ancestor
102602195|NCT00004112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602196|NCT00004112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602197|NCT00004112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102602198|NCT00004112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102602199|NCT00004112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102602200|NCT00004112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102602201|NCT00004112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102602202|NCT00004112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102602203|NCT00004112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102602204|NCT00004112|Glucocorticoids|glucocorticoids|mesh-ancestor
102602205|NCT00004112|Hormones|hormones|mesh-ancestor
102602206|NCT00004112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102602207|NCT00004112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102602208|NCT00004112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102602209|NCT00004112|Tubulin Modulators|tubulin modulators|mesh-ancestor
102602210|NCT00004112|Antimitotic Agents|antimitotic agents|mesh-ancestor
102602211|NCT00004112|Mitosis Modulators|mitosis modulators|mesh-ancestor
102602212|NCT00003350|Paclitaxel|paclitaxel|mesh-list
102602213|NCT00003350|Doxorubicin|doxorubicin|mesh-list
102602214|NCT00003350|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102602215|NCT00003350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102602216|NCT00003350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602217|NCT00003350|Tubulin Modulators|tubulin modulators|mesh-ancestor
102602218|NCT00003350|Antimitotic Agents|antimitotic agents|mesh-ancestor
102602219|NCT00003350|Mitosis Modulators|mitosis modulators|mesh-ancestor
102602220|NCT00003350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602221|NCT00003350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102602222|NCT00003350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102602223|NCT00003350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102602224|NCT00003350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102602225|NCT05584267|Immunomodulating Agents|immunomodulating agents|mesh-list
102602226|NCT05584267|Immunologic Factors|immunologic factors|mesh-ancestor
102602227|NCT05584267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602228|NCT00003356|Aldesleukin|aldesleukin|mesh-list
102602229|NCT00003356|Rituximab|rituximab|mesh-list
102602230|NCT00003356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102602231|NCT00003356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602232|NCT00003356|Immunologic Factors|immunologic factors|mesh-ancestor
102602233|NCT00003356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602234|NCT00003356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102602235|NCT00003356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102602236|NCT00003356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102602237|NCT00003356|Antiviral Agents|antiviral agents|mesh-ancestor
102602238|NCT00003356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102602239|NCT00003638|Cyclophosphamide|cyclophosphamide|mesh-list
102602240|NCT00003638|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
102602241|NCT00003638|Detox adjuvant|detox adjuvant|mesh-list
102602242|NCT00003638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102602243|NCT00003638|Immunologic Factors|immunologic factors|mesh-ancestor
102602244|NCT00003638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602245|NCT00003638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102602246|NCT00003638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102602247|NCT00003638|Alkylating Agents|alkylating agents|mesh-ancestor
102602248|NCT00003638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602249|NCT00003638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602250|NCT00003638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102602251|NCT00003638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102602252|NCT00004142|Fluorouracil|fluorouracil|mesh-list
102602253|NCT00004142|Floxuridine|floxuridine|mesh-list
102602254|NCT00004142|Antimetabolites|antimetabolites|mesh-ancestor
102149123|NCT00862251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102602255|NCT00004142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602256|NCT00004142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102602257|NCT00004142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602258|NCT00004142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102602259|NCT00004142|Immunologic Factors|immunologic factors|mesh-ancestor
102602260|NCT00004142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602261|NCT00002749|Carboplatin|carboplatin|mesh-list
102602262|NCT00002749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602263|NCT00003362|Sargramostim|sargramostim|mesh-list
102602264|NCT00003362|Freund's Adjuvant|freund's adjuvant|mesh-list
102602265|NCT00003362|Immunologic Factors|immunologic factors|mesh-ancestor
102602266|NCT00003362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602267|NCT00003362|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102602268|NCT00003650|Cytarabine|cytarabine|mesh-list
102602269|NCT00003650|Dexamethasone|dexamethasone|mesh-list
102602270|NCT00003650|Prednisone|prednisone|mesh-list
102602271|NCT00003650|Methylprednisolone|methylprednisolone|mesh-list
102602272|NCT00003650|Cyclophosphamide|cyclophosphamide|mesh-list
102602273|NCT00003650|Methotrexate|methotrexate|mesh-list
102602274|NCT00003650|Etoposide|etoposide|mesh-list
102602275|NCT00003650|Vincristine|vincristine|mesh-list
102602276|NCT00003650|Daunorubicin|daunorubicin|mesh-list
102602277|NCT00003650|Asparaginase|asparaginase|mesh-list
102602278|NCT00003650|Mitoxantrone|mitoxantrone|mesh-list
102602279|NCT00003650|Mercaptopurine|mercaptopurine|mesh-list
102602280|NCT00003650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102602281|NCT00003650|Immunologic Factors|immunologic factors|mesh-ancestor
102602282|NCT00003650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602283|NCT00003650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102602284|NCT00003650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102602285|NCT00003650|Alkylating Agents|alkylating agents|mesh-ancestor
102602286|NCT00003650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602287|NCT00003650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602288|NCT00003650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102602289|NCT00003650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102602290|NCT00003650|Antiemetics|antiemetics|mesh-ancestor
102602291|NCT00003650|Autonomic Agents|autonomic agents|mesh-ancestor
102602292|NCT00003650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102602293|NCT00003650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102602294|NCT00003650|Glucocorticoids|glucocorticoids|mesh-ancestor
102602295|NCT00003650|Hormones|hormones|mesh-ancestor
102602296|NCT00003650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102602297|NCT00003650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102602298|NCT00003650|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102602299|NCT00003650|Abortifacient Agents|abortifacient agents|mesh-ancestor
102602300|NCT00003650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102602301|NCT00003650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102602302|NCT00003650|Antimetabolites|antimetabolites|mesh-ancestor
102602303|NCT00003650|Dermatologic Agents|dermatologic agents|mesh-ancestor
102602304|NCT00003650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102602305|NCT00003650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102602306|NCT00003650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102602307|NCT00003650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102602308|NCT00003650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102602309|NCT00003650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102602310|NCT00003650|Antiviral Agents|antiviral agents|mesh-ancestor
102602311|NCT00003650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102602312|NCT00003650|Tubulin Modulators|tubulin modulators|mesh-ancestor
102602313|NCT00003650|Antimitotic Agents|antimitotic agents|mesh-ancestor
102602314|NCT00003650|Mitosis Modulators|mitosis modulators|mesh-ancestor
102602315|NCT00003650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102602316|NCT00003650|Protective Agents|protective agents|mesh-ancestor
102602317|NCT00003650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102602318|NCT00003650|Analgesics|analgesics|mesh-ancestor
102602319|NCT00003650|Sensory System Agents|sensory system agents|mesh-ancestor
102602320|NCT00002755|Tamoxifen|tamoxifen|mesh-list
102602321|NCT00002755|Cobalt|cobalt|mesh-list
102602322|NCT00002755|Cyclophosphamide|cyclophosphamide|mesh-list
102602323|NCT00002755|Thiotepa|thiotepa|mesh-list
102602324|NCT00002755|Doxorubicin|doxorubicin|mesh-list
102602325|NCT00002755|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102602326|NCT00002755|Fluorouracil|fluorouracil|mesh-list
102602327|NCT00002755|Methotrexate|methotrexate|mesh-list
102602328|NCT00002755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102602329|NCT00002755|Immunologic Factors|immunologic factors|mesh-ancestor
102602330|NCT00002755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602331|NCT00002755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102602332|NCT00002755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102602333|NCT00002755|Alkylating Agents|alkylating agents|mesh-ancestor
102602334|NCT00002755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602335|NCT00002755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602336|NCT00002755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102602337|NCT00002755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102602338|NCT00002755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102602339|NCT00002755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102602340|NCT00002755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102602341|NCT00002755|Antimetabolites|antimetabolites|mesh-ancestor
102602342|NCT00002755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102602343|NCT00002755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102602344|NCT00002755|Abortifacient Agents|abortifacient agents|mesh-ancestor
102602345|NCT00002755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102602346|NCT00002755|Dermatologic Agents|dermatologic agents|mesh-ancestor
102602347|NCT00002755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102602348|NCT00002755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102602349|NCT00002755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102602350|NCT00002755|Hormone Antagonists|hormone antagonists|mesh-ancestor
102602351|NCT00002755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102602352|NCT00002755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102602353|NCT00002755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102602354|NCT00002755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102602355|NCT00002755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102602356|NCT00002755|Trace Elements|trace elements|mesh-ancestor
102602357|NCT00002755|Micronutrients|micronutrients|mesh-ancestor
102602358|NCT00002761|Interferons|interferons|mesh-list
102602359|NCT00002761|Cytarabine|cytarabine|mesh-list
102602360|NCT00002761|Interferon-gamma|interferon-gamma|mesh-list
102602361|NCT00002761|Cyclosporine|cyclosporine|mesh-list
102602362|NCT00002761|Cyclophosphamide|cyclophosphamide|mesh-list
102602363|NCT00002761|Busulfan|busulfan|mesh-list
102602364|NCT00002761|Idarubicin|idarubicin|mesh-list
102602365|NCT00002761|Cyclosporins|cyclosporins|mesh-list
102602366|NCT00002761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102602367|NCT00002761|Immunologic Factors|immunologic factors|mesh-ancestor
102602368|NCT00002761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602369|NCT00002761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102602370|NCT00002761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102602371|NCT00002761|Alkylating Agents|alkylating agents|mesh-ancestor
102602372|NCT00002761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602373|NCT00002761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602374|NCT00002761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102602375|NCT00002761|Antiviral Agents|antiviral agents|mesh-ancestor
102602376|NCT00002761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102602377|NCT00002761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102602378|NCT00002761|Antimetabolites|antimetabolites|mesh-ancestor
102602379|NCT00002761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102602380|NCT00002761|Antifungal Agents|antifungal agents|mesh-ancestor
102602381|NCT00002761|Dermatologic Agents|dermatologic agents|mesh-ancestor
102602382|NCT00002761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102602383|NCT00002761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102602384|NCT00002761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102602385|NCT00002761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102602386|NCT00382135|Tadalafil|tadalafil|mesh-list
102602387|NCT00382135|Vasodilator Agents|vasodilator agents|mesh-ancestor
102602388|NCT00382135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102602389|NCT00382135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102602390|NCT00382135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102602391|NCT00382135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602392|NCT00382135|Urological Agents|urological agents|mesh-ancestor
102602393|NCT00003662|Cyclosporine|cyclosporine|mesh-list
102602394|NCT00003662|Methylprednisolone|methylprednisolone|mesh-list
102602395|NCT00003662|Cyclophosphamide|cyclophosphamide|mesh-list
102602396|NCT00003662|Melphalan|melphalan|mesh-list
102602397|NCT00003662|Busulfan|busulfan|mesh-list
102602398|NCT00003662|Cyclosporins|cyclosporins|mesh-list
102602399|NCT00003662|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102602400|NCT00003662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102602401|NCT00003662|Immunologic Factors|immunologic factors|mesh-ancestor
102602402|NCT00003662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602403|NCT00003662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102602404|NCT00003662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102602405|NCT00003662|Alkylating Agents|alkylating agents|mesh-ancestor
102602406|NCT00003662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602407|NCT00003662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602408|NCT00003662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102602409|NCT00003662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102602410|NCT00003662|Antifungal Agents|antifungal agents|mesh-ancestor
102602411|NCT00003662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102602412|NCT00003662|Dermatologic Agents|dermatologic agents|mesh-ancestor
102602413|NCT00003662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102602414|NCT00003662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102602415|NCT00003662|Antiemetics|antiemetics|mesh-ancestor
102602416|NCT00003662|Autonomic Agents|autonomic agents|mesh-ancestor
102602417|NCT00003662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102602418|NCT00003662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102602419|NCT00003662|Glucocorticoids|glucocorticoids|mesh-ancestor
102602420|NCT00003662|Hormones|hormones|mesh-ancestor
102602421|NCT00003662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102602422|NCT00003662|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102602423|NCT00003662|Protective Agents|protective agents|mesh-ancestor
102602424|NCT00004154|Fenretinide|fenretinide|mesh-list
102602425|NCT00004154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602426|NCT00004154|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102602427|NCT00004154|Protective Agents|protective agents|mesh-ancestor
102602428|NCT00004154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602429|NCT00002767|Interferons|interferons|mesh-list
102602430|NCT00002767|Interferon-alpha|interferon-alpha|mesh-list
102602431|NCT00002767|Detox adjuvant|detox adjuvant|mesh-list
102602432|NCT00002767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602433|NCT00002767|Antiviral Agents|antiviral agents|mesh-ancestor
102602434|NCT00002767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102602435|NCT00002767|Immunologic Factors|immunologic factors|mesh-ancestor
102602436|NCT00002767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602437|NCT00002767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102602438|NCT00002773|Interferons|interferons|mesh-list
102602439|NCT00002773|Interferon-alpha|interferon-alpha|mesh-list
102602440|NCT00002773|Cyclophosphamide|cyclophosphamide|mesh-list
102602441|NCT00002773|Sargramostim|sargramostim|mesh-list
102602442|NCT00002773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102602443|NCT00002773|Immunologic Factors|immunologic factors|mesh-ancestor
102602444|NCT00002773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602445|NCT00002773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102602446|NCT00002773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102602447|NCT00002773|Alkylating Agents|alkylating agents|mesh-ancestor
102602448|NCT00002773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602449|NCT00002773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602450|NCT00002773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102602451|NCT00002773|Antiviral Agents|antiviral agents|mesh-ancestor
102602452|NCT00002773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102602453|NCT00004160|Paclitaxel|paclitaxel|mesh-list
102602454|NCT00004160|Gemcitabine|gemcitabine|mesh-list
102602455|NCT00004160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102602456|NCT00004160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602457|NCT00004160|Tubulin Modulators|tubulin modulators|mesh-ancestor
102602458|NCT00004160|Antimitotic Agents|antimitotic agents|mesh-ancestor
102602459|NCT00004160|Mitosis Modulators|mitosis modulators|mesh-ancestor
102602460|NCT00004160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602461|NCT00004160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102602462|NCT00004160|Antimetabolites|antimetabolites|mesh-ancestor
102602463|NCT00003368|Irinotecan|irinotecan|mesh-list
102602464|NCT00003368|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102602465|NCT00003368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102602466|NCT00003368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102602467|NCT00003368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602468|NCT00003368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602469|NCT00003674|Dalteparin|dalteparin|mesh-list
102602470|NCT00003674|Tinzaparin|tinzaparin|mesh-list
102602471|NCT00003674|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102602472|NCT00003674|Anticoagulants|anticoagulants|mesh-ancestor
102346305|NCT04558112|Levodopa|levodopa|mesh-list
102602473|NCT00003674|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102602474|NCT00003674|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102602475|NCT00003674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602476|NCT00003380|Doxorubicin|doxorubicin|mesh-list
102602477|NCT00003380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102602478|NCT00003380|Etoposide|etoposide|mesh-list
102602479|NCT00003380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102602480|NCT00003380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602481|NCT00003380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102602482|NCT00003380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102602483|NCT00003380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102602484|NCT00003380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602485|NCT00003380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102602486|NCT00002779|Fludarabine|fludarabine|mesh-list
102602487|NCT00002779|Fludarabine phosphate|fludarabine phosphate|mesh-list
102602488|NCT00002779|Octreotide|octreotide|mesh-list
102602489|NCT00002779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602490|NCT00002779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102602491|NCT00002779|Antimetabolites|antimetabolites|mesh-ancestor
102602492|NCT00002779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602493|NCT00002779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102602494|NCT00002779|Immunologic Factors|immunologic factors|mesh-ancestor
102602495|NCT00002779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602496|NCT00002779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102602497|NCT00002779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102602498|NCT00003680|Tamoxifen|tamoxifen|mesh-list
102602499|NCT00003680|Cyclophosphamide|cyclophosphamide|mesh-list
102602500|NCT00003680|Thiotepa|thiotepa|mesh-list
102602501|NCT00003680|Fluorouracil|fluorouracil|mesh-list
102602502|NCT00003680|Methotrexate|methotrexate|mesh-list
102602503|NCT00003680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102602504|NCT00003680|Immunologic Factors|immunologic factors|mesh-ancestor
102602505|NCT00003680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602506|NCT00003680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102602507|NCT00003680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102602508|NCT00003680|Alkylating Agents|alkylating agents|mesh-ancestor
102602509|NCT00003680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602510|NCT00003680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602511|NCT00003680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102602512|NCT00003680|Antimetabolites|antimetabolites|mesh-ancestor
102602513|NCT00003680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102602514|NCT00003680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102602515|NCT00003680|Abortifacient Agents|abortifacient agents|mesh-ancestor
102602516|NCT00003680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102602517|NCT00003680|Dermatologic Agents|dermatologic agents|mesh-ancestor
102602518|NCT00003680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102602519|NCT00003680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102602520|NCT00003680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102602521|NCT00003680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102602522|NCT00003680|Hormone Antagonists|hormone antagonists|mesh-ancestor
102602523|NCT00003680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102602524|NCT00003680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102602525|NCT00003680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102602526|NCT00003680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102602527|NCT00003680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102602528|NCT00002785|Leucovorin|leucovorin|mesh-list
102602530|NCT00002785|Cytarabine|cytarabine|mesh-list
102602531|NCT00002785|Cyclosporine|cyclosporine|mesh-list
102602532|NCT00002785|Dexamethasone|dexamethasone|mesh-list
102602533|NCT00002785|Prednisone|prednisone|mesh-list
102602534|NCT00002785|Methylprednisolone|methylprednisolone|mesh-list
102602535|NCT00002785|Hydrocortisone|hydrocortisone|mesh-list
102602536|NCT00002785|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102602537|NCT00002785|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102602538|NCT00002785|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102602539|NCT00002785|Cyclophosphamide|cyclophosphamide|mesh-list
102602540|NCT00002785|Methotrexate|methotrexate|mesh-list
102602541|NCT00002785|Etoposide|etoposide|mesh-list
102602542|NCT00002785|Vincristine|vincristine|mesh-list
102602543|NCT00002785|Daunorubicin|daunorubicin|mesh-list
102602544|NCT00002785|Asparaginase|asparaginase|mesh-list
102602545|NCT00002785|Mercaptopurine|mercaptopurine|mesh-list
102602546|NCT00002785|Pegaspargase|pegaspargase|mesh-list
102602547|NCT00002785|Cyclosporins|cyclosporins|mesh-list
102602548|NCT00002785|Levoleucovorin|levoleucovorin|mesh-list
102602549|NCT00002785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102602550|NCT00002785|Immunologic Factors|immunologic factors|mesh-ancestor
102602551|NCT00002785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602552|NCT00002785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102602553|NCT00002785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102602554|NCT00002785|Alkylating Agents|alkylating agents|mesh-ancestor
102602555|NCT00002785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602556|NCT00002785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602557|NCT00002785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102602558|NCT00002785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102602559|NCT00002785|Antiemetics|antiemetics|mesh-ancestor
102602560|NCT00002785|Autonomic Agents|autonomic agents|mesh-ancestor
102602561|NCT00002785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102602562|NCT00002785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102602563|NCT00002785|Glucocorticoids|glucocorticoids|mesh-ancestor
102602564|NCT00002785|Hormones|hormones|mesh-ancestor
102602565|NCT00002785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102602566|NCT00002785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102602567|NCT00002785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102602568|NCT00002785|Abortifacient Agents|abortifacient agents|mesh-ancestor
102602569|NCT00002785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102602570|NCT00002785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102602571|NCT00002785|Antimetabolites|antimetabolites|mesh-ancestor
102602572|NCT00002785|Dermatologic Agents|dermatologic agents|mesh-ancestor
102602573|NCT00002785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102602574|NCT00002785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102602575|NCT00002785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102602576|NCT00002785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102602577|NCT00002785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102602578|NCT00002785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102602579|NCT00002785|Antiviral Agents|antiviral agents|mesh-ancestor
102602580|NCT00002785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102602581|NCT00002785|Antidotes|antidotes|mesh-ancestor
102602582|NCT00002785|Protective Agents|protective agents|mesh-ancestor
102602583|NCT00002785|Vitamin B Complex|vitamin b complex|mesh-ancestor
102602584|NCT00002785|Vitamins|vitamins|mesh-ancestor
102602585|NCT00002785|Micronutrients|micronutrients|mesh-ancestor
102602586|NCT00002785|Tubulin Modulators|tubulin modulators|mesh-ancestor
102602587|NCT00002785|Antimitotic Agents|antimitotic agents|mesh-ancestor
102602588|NCT00002785|Mitosis Modulators|mitosis modulators|mesh-ancestor
102602589|NCT00002785|Antifungal Agents|antifungal agents|mesh-ancestor
102602590|NCT00002785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102602591|NCT00002785|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102602592|NCT00002785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102602593|NCT00002785|Trace Elements|trace elements|mesh-ancestor
102602594|NCT00004184|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102602595|NCT00004184|Antibodies|antibodies|mesh-list
102602596|NCT00004184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102602597|NCT00004184|Sargramostim|sargramostim|mesh-list
102602598|NCT00004184|Aluminum sulfate|aluminum sulfate|mesh-list
102602599|NCT00004184|Immunologic Factors|immunologic factors|mesh-ancestor
102602600|NCT00004184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602601|NCT00004184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102602602|NCT00004184|Antacids|antacids|mesh-ancestor
102602603|NCT00004184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602604|NCT00004184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102602605|NCT00003386|Paclitaxel|paclitaxel|mesh-list
102602606|NCT00003386|Cyclophosphamide|cyclophosphamide|mesh-list
102602607|NCT00003386|Carboplatin|carboplatin|mesh-list
102602608|NCT00003386|Vaccines|vaccines|mesh-list
102602609|NCT00003386|BCG Vaccine|bcg vaccine|mesh-list
102602610|NCT00003386|Immunologic Factors|immunologic factors|mesh-ancestor
102602611|NCT00003386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602612|NCT00003386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102602613|NCT00003386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602614|NCT00003386|Tubulin Modulators|tubulin modulators|mesh-ancestor
102602615|NCT00003386|Antimitotic Agents|antimitotic agents|mesh-ancestor
102602616|NCT00003386|Mitosis Modulators|mitosis modulators|mesh-ancestor
102602617|NCT00003386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602618|NCT00003386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102602619|NCT00003386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102602620|NCT00003386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102602621|NCT00003386|Alkylating Agents|alkylating agents|mesh-ancestor
102602622|NCT00003386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102602623|NCT00003386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102602624|NCT00384566|Metoprolol|metoprolol|mesh-list
102602625|NCT00384566|Carvedilol|carvedilol|mesh-list
102602626|NCT00384566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102602627|NCT00384566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102602628|NCT00384566|Sympatholytics|sympatholytics|mesh-ancestor
102602629|NCT00384566|Autonomic Agents|autonomic agents|mesh-ancestor
102602630|NCT00384566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102602631|NCT00384566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602632|NCT00384566|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102602633|NCT00384566|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102602634|NCT00384566|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102602635|NCT00384566|Adrenergic Agents|adrenergic agents|mesh-ancestor
102602636|NCT00384566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102602637|NCT00384566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602638|NCT00384566|Antioxidants|antioxidants|mesh-ancestor
102602639|NCT00384566|Protective Agents|protective agents|mesh-ancestor
102602640|NCT00384566|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102602641|NCT00384566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102602642|NCT00384566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102602643|NCT00384566|Vasodilator Agents|vasodilator agents|mesh-ancestor
102602644|NCT00384566|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102602645|NCT00384566|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102602646|NCT00004832|Amifampridine|amifampridine|mesh-list
102602647|NCT00004832|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102602648|NCT00004832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102602649|NCT00004832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602650|NCT00004832|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102602651|NCT00004832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102602652|NCT00004832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602653|NCT00002791|Doxorubicin|doxorubicin|mesh-list
102602654|NCT00002791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102602655|NCT00002791|Ifosfamide|ifosfamide|mesh-list
102602656|NCT00002791|Dacarbazine|dacarbazine|mesh-list
102602657|NCT00002791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102602658|NCT00002791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602659|NCT00002791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102602660|NCT00002791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102602661|NCT00002791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102602662|NCT00002791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602663|NCT00002791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102602664|NCT00002791|Alkylating Agents|alkylating agents|mesh-ancestor
102602665|NCT00004190|Gemcitabine|gemcitabine|mesh-list
102602666|NCT00004190|Oxaliplatin|oxaliplatin|mesh-list
102602667|NCT00004190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102602668|NCT00004190|Antimetabolites|antimetabolites|mesh-ancestor
102602669|NCT00004190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602670|NCT00004190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602671|NCT00004196|Interferons|interferons|mesh-list
102602672|NCT00004196|Interferon-alpha|interferon-alpha|mesh-list
102602673|NCT00004196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602674|NCT00004196|Antiviral Agents|antiviral agents|mesh-ancestor
102602675|NCT00004196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102602676|NCT00004196|Immunologic Factors|immunologic factors|mesh-ancestor
102602677|NCT00004196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602678|NCT00004838|Succimer|succimer|mesh-list
102602679|NCT00004838|Antidotes|antidotes|mesh-ancestor
102602680|NCT00004838|Protective Agents|protective agents|mesh-ancestor
102602681|NCT00004838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602682|NCT00004838|Chelating Agents|chelating agents|mesh-ancestor
102602683|NCT00004838|Sequestering Agents|sequestering agents|mesh-ancestor
102602684|NCT00004838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602685|NCT00004202|Paclitaxel|paclitaxel|mesh-list
102602686|NCT00004202|Carboplatin|carboplatin|mesh-list
102602687|NCT00004202|Efaproxiral|efaproxiral|mesh-list
102602688|NCT00004202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102602689|NCT00004202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602690|NCT00004202|Tubulin Modulators|tubulin modulators|mesh-ancestor
102602691|NCT00004202|Antimitotic Agents|antimitotic agents|mesh-ancestor
102602692|NCT00004202|Mitosis Modulators|mitosis modulators|mesh-ancestor
102602693|NCT00004202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602694|NCT00004202|Antisickling Agents|antisickling agents|mesh-ancestor
102602695|NCT00003686|Pilocarpine|pilocarpine|mesh-list
102602696|NCT00003686|Miotics|miotics|mesh-ancestor
102602697|NCT00003686|Autonomic Agents|autonomic agents|mesh-ancestor
102602698|NCT00003686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102602699|NCT00003686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602700|NCT00003686|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102602701|NCT00003686|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102602702|NCT00003686|Cholinergic Agents|cholinergic agents|mesh-ancestor
102602703|NCT00003686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102602704|NCT00003686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602705|NCT05495035|Dexamethasone|dexamethasone|mesh-list
102602706|NCT05495035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102602707|NCT05495035|Antiemetics|antiemetics|mesh-ancestor
102602708|NCT05495035|Autonomic Agents|autonomic agents|mesh-ancestor
102602709|NCT05495035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102602710|NCT05495035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602711|NCT05495035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102602712|NCT05495035|Glucocorticoids|glucocorticoids|mesh-ancestor
102602713|NCT05495035|Hormones|hormones|mesh-ancestor
102602714|NCT05495035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102602715|NCT05495035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102602716|NCT05495035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602717|NCT00004856|Trastuzumab|trastuzumab|mesh-list
102602718|NCT00004856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102602719|NCT00004856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602720|NCT00003698|Fosbretabulin|fosbretabulin|mesh-list
102602721|NCT00003698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102602722|NCT00003698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602723|NCT00004862|Cytarabine|cytarabine|mesh-list
102602724|NCT00004862|Fludarabine|fludarabine|mesh-list
102602725|NCT00004862|Fludarabine phosphate|fludarabine phosphate|mesh-list
102602726|NCT00004862|Oblimersen|oblimersen|mesh-list
102602727|NCT00004862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602728|NCT00004862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102602729|NCT00004862|Antimetabolites|antimetabolites|mesh-ancestor
102602730|NCT00004862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602731|NCT00004862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102602732|NCT00004862|Immunologic Factors|immunologic factors|mesh-ancestor
102602733|NCT00004862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602734|NCT00004862|Antiviral Agents|antiviral agents|mesh-ancestor
102602735|NCT00004862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102602736|NCT00004220|Gemcitabine|gemcitabine|mesh-list
102602737|NCT00004220|Oxaliplatin|oxaliplatin|mesh-list
102602738|NCT00004220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102602739|NCT00004220|Antimetabolites|antimetabolites|mesh-ancestor
102602740|NCT00004220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602741|NCT00004220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602742|NCT00003704|Capecitabine|capecitabine|mesh-list
102602743|NCT00003704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102602744|NCT00003704|Antimetabolites|antimetabolites|mesh-ancestor
102602745|NCT00003704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602746|NCT00003704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602747|NCT00004868|Semaxinib|semaxinib|mesh-list
102602748|NCT00004868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102602749|NCT00004868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102602750|NCT00004868|Growth Substances|growth substances|mesh-ancestor
102602751|NCT00004868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602752|NCT00004868|Growth Inhibitors|growth inhibitors|mesh-ancestor
102602753|NCT00004868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602754|NCT00004868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102602755|NCT00004868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102602756|NCT00004868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602757|NCT00003710|Irinotecan|irinotecan|mesh-list
102602758|NCT00003710|Mitomycins|mitomycins|mesh-list
102602759|NCT00003710|Mitomycin|mitomycin|mesh-list
101869544|NCT00113841|Curcumin|curcumin|mesh-list
102602760|NCT00003710|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102602761|NCT00003710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102602762|NCT00003710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102602763|NCT00003710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602764|NCT00003710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602765|NCT00003710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102602766|NCT00003710|Alkylating Agents|alkylating agents|mesh-ancestor
102602767|NCT00003710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102602768|NCT00004232|Cyclosporine|cyclosporine|mesh-list
102602769|NCT00004232|Prednisone|prednisone|mesh-list
102602770|NCT00004232|Methylprednisolone|methylprednisolone|mesh-list
102602771|NCT00004232|Cyclosporins|cyclosporins|mesh-list
102602772|NCT00004232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102602773|NCT00004232|Glucocorticoids|glucocorticoids|mesh-ancestor
102602774|NCT00004232|Hormones|hormones|mesh-ancestor
102602775|NCT00004232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102602776|NCT00004232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602777|NCT00004232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102602778|NCT00004232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602779|NCT00004232|Immunologic Factors|immunologic factors|mesh-ancestor
102602780|NCT00004232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102602781|NCT00004232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602782|NCT00004232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102602783|NCT00004232|Antifungal Agents|antifungal agents|mesh-ancestor
102602784|NCT00004232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102602785|NCT00004232|Dermatologic Agents|dermatologic agents|mesh-ancestor
102602786|NCT00004232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102602787|NCT00004232|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102602788|NCT00004232|Antiemetics|antiemetics|mesh-ancestor
102602789|NCT00004232|Autonomic Agents|autonomic agents|mesh-ancestor
102602790|NCT00004232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102602791|NCT00004232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102602792|NCT00004232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102149647|NCT04554836|Cetuximab|cetuximab|mesh-list
102602793|NCT00004232|Protective Agents|protective agents|mesh-ancestor
102602794|NCT00004874|Iodine|iodine|mesh-list
102602795|NCT00004874|Tositumomab I-131|tositumomab i-131|mesh-list
102602796|NCT00004874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102602797|NCT00004874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102602798|NCT00004874|Trace Elements|trace elements|mesh-ancestor
102602799|NCT00004874|Micronutrients|micronutrients|mesh-ancestor
102602800|NCT00004874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602801|NCT00004874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602802|NCT00004244|Interferons|interferons|mesh-list
102602803|NCT00004244|Interferon-alpha|interferon-alpha|mesh-list
102602804|NCT00004244|Interleukin-12|interleukin-12|mesh-list
102602805|NCT00004244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602806|NCT00004244|Antiviral Agents|antiviral agents|mesh-ancestor
102602807|NCT00004244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102602808|NCT00004244|Immunologic Factors|immunologic factors|mesh-ancestor
102602809|NCT00004244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602810|NCT00004244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102602811|NCT00004244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102602812|NCT00004244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102602813|NCT00004244|Growth Substances|growth substances|mesh-ancestor
102602814|NCT00004244|Growth Inhibitors|growth inhibitors|mesh-ancestor
102602815|NCT00004880|Vaccines|vaccines|mesh-list
102602816|NCT00004880|Immunologic Factors|immunologic factors|mesh-ancestor
102602817|NCT00004880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602818|NCT00004250|Dactinomycin|dactinomycin|mesh-list
102602819|NCT00004250|Melphalan|melphalan|mesh-list
102602820|NCT00004250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102602821|NCT00004250|Alkylating Agents|alkylating agents|mesh-ancestor
102602822|NCT00004250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602823|NCT00004250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602824|NCT00004250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102602825|NCT00004250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102602826|NCT00004250|Immunologic Factors|immunologic factors|mesh-ancestor
102602827|NCT00004250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602828|NCT00004250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102602829|NCT00004250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102602830|NCT00004250|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102602831|NCT00004250|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102602832|NCT00004250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102602833|NCT00004250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102602834|NCT00003728|Leucovorin|leucovorin|mesh-list
102602835|NCT00003728|Cytarabine|cytarabine|mesh-list
102602836|NCT00003728|Dexamethasone|dexamethasone|mesh-list
102602837|NCT00003728|Methylprednisolone|methylprednisolone|mesh-list
102602838|NCT00003728|Prednisolone|prednisolone|mesh-list
102602839|NCT00003728|Hydrocortisone|hydrocortisone|mesh-list
102602840|NCT00003728|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102602841|NCT00003728|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102602842|NCT00003728|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102602843|NCT00003728|Cyclophosphamide|cyclophosphamide|mesh-list
102602844|NCT00003728|Doxorubicin|doxorubicin|mesh-list
102602845|NCT00003728|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102602846|NCT00003728|Methotrexate|methotrexate|mesh-list
102602847|NCT00003728|Etoposide|etoposide|mesh-list
102602848|NCT00003728|Vincristine|vincristine|mesh-list
102602849|NCT00003728|Daunorubicin|daunorubicin|mesh-list
102602850|NCT00003728|Asparaginase|asparaginase|mesh-list
102602851|NCT00003728|Mitoxantrone|mitoxantrone|mesh-list
102602852|NCT00003728|Mercaptopurine|mercaptopurine|mesh-list
102602853|NCT00003728|Thioguanine|thioguanine|mesh-list
102602854|NCT00003728|Vindesine|vindesine|mesh-list
102602855|NCT00003728|Levoleucovorin|levoleucovorin|mesh-list
102602856|NCT00003728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102602857|NCT00003728|Immunologic Factors|immunologic factors|mesh-ancestor
102602858|NCT00003728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602859|NCT00003728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102602860|NCT00003728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102602861|NCT00003728|Alkylating Agents|alkylating agents|mesh-ancestor
102602862|NCT00003728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602863|NCT00003728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602864|NCT00003728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102602865|NCT00003728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102602866|NCT00003728|Antiemetics|antiemetics|mesh-ancestor
102602867|NCT00003728|Autonomic Agents|autonomic agents|mesh-ancestor
102602868|NCT00003728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102602869|NCT00003728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102602870|NCT00003728|Glucocorticoids|glucocorticoids|mesh-ancestor
102602871|NCT00003728|Hormones|hormones|mesh-ancestor
102602872|NCT00003728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102602873|NCT00003728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102602874|NCT00003728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102602875|NCT00003728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102602876|NCT00003728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102602877|NCT00003728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102602878|NCT00003728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102602879|NCT00003728|Abortifacient Agents|abortifacient agents|mesh-ancestor
102602880|NCT00003728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102602881|NCT00003728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102602882|NCT00003728|Antimetabolites|antimetabolites|mesh-ancestor
102602883|NCT00003728|Dermatologic Agents|dermatologic agents|mesh-ancestor
102602884|NCT00003728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102602885|NCT00003728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102602886|NCT00003728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102602887|NCT00003728|Antiviral Agents|antiviral agents|mesh-ancestor
102602888|NCT00003728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102602889|NCT00003728|Antidotes|antidotes|mesh-ancestor
102602890|NCT00003728|Protective Agents|protective agents|mesh-ancestor
102602891|NCT00003728|Vitamin B Complex|vitamin b complex|mesh-ancestor
102602892|NCT00003728|Vitamins|vitamins|mesh-ancestor
102602893|NCT00003728|Micronutrients|micronutrients|mesh-ancestor
102602894|NCT00003728|Tubulin Modulators|tubulin modulators|mesh-ancestor
102602895|NCT00003728|Antimitotic Agents|antimitotic agents|mesh-ancestor
102602896|NCT00003728|Mitosis Modulators|mitosis modulators|mesh-ancestor
102602897|NCT00003728|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102602898|NCT00003728|Analgesics|analgesics|mesh-ancestor
102602899|NCT00003728|Sensory System Agents|sensory system agents|mesh-ancestor
102602900|NCT00004886|Docetaxel|docetaxel|mesh-list
102602901|NCT00004886|Dofequidar|dofequidar|mesh-list
102602902|NCT00004886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602903|NCT00004886|Tubulin Modulators|tubulin modulators|mesh-ancestor
102602904|NCT00004886|Antimitotic Agents|antimitotic agents|mesh-ancestor
102602905|NCT00004886|Mitosis Modulators|mitosis modulators|mesh-ancestor
102602906|NCT00004886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602907|NCT00003734|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102602908|NCT00003734|Flutamide|flutamide|mesh-list
102602909|NCT00003734|Luteolytic Agents|luteolytic agents|mesh-ancestor
102602910|NCT00003734|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102602911|NCT00003734|Contraceptive Agents|contraceptive agents|mesh-ancestor
102602912|NCT00003734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102602913|NCT00003734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602914|NCT00003734|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102602915|NCT00003734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102602916|NCT00003734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602917|NCT00003734|Androgen Antagonists|androgen antagonists|mesh-ancestor
102602918|NCT00003734|Hormone Antagonists|hormone antagonists|mesh-ancestor
102602919|NCT00003734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102602920|NCT00003740|Trastuzumab|trastuzumab|mesh-list
102602921|NCT00003740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102602922|NCT00003740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602923|NCT05477875|Acetaminophen|acetaminophen|mesh-list
102602924|NCT05477875|Dronabinol|dronabinol|mesh-list
102602925|NCT05477875|Codeine|codeine|mesh-list
102602926|NCT05477875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102602927|NCT05477875|Analgesics|analgesics|mesh-ancestor
102602928|NCT05477875|Sensory System Agents|sensory system agents|mesh-ancestor
102602929|NCT05477875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102602930|NCT05477875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602931|NCT05477875|Antipyretics|antipyretics|mesh-ancestor
102602932|NCT05477875|Hallucinogens|hallucinogens|mesh-ancestor
102602933|NCT05477875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102602934|NCT05477875|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102602935|NCT05477875|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102602936|NCT05477875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102602937|NCT05477875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602938|NCT05477875|Hormones|hormones|mesh-ancestor
102602939|NCT05477875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102602940|NCT05477875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102602941|NCT05477875|Narcotics|narcotics|mesh-ancestor
102602942|NCT05477875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102602943|NCT05477875|Antitussive Agents|antitussive agents|mesh-ancestor
102602944|NCT05477875|Respiratory System Agents|respiratory system agents|mesh-ancestor
102602945|NCT00004256|Sargramostim|sargramostim|mesh-list
102602946|NCT00004256|Immunologic Factors|immunologic factors|mesh-ancestor
102602947|NCT00004256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602948|NCT00004262|Motexafin gadolinium|motexafin gadolinium|mesh-list
102602949|NCT00004262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602950|NCT00004262|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102602951|NCT00004262|Dermatologic Agents|dermatologic agents|mesh-ancestor
102602952|NCT00004892|Carmustine|carmustine|mesh-list
102602953|NCT00004892|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
102602954|NCT00004892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102602955|NCT00004892|Alkylating Agents|alkylating agents|mesh-ancestor
102602956|NCT00004892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602957|NCT00004892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602958|NCT00004892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102602959|NCT00004268|Midodrine|midodrine|mesh-list
102602960|NCT00004268|Sympathomimetics|sympathomimetics|mesh-ancestor
102602961|NCT00004268|Autonomic Agents|autonomic agents|mesh-ancestor
102602962|NCT00004268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102602963|NCT00004268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602964|NCT00004268|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102602965|NCT00004268|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102602966|NCT00004268|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102602967|NCT00004268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102602968|NCT00004268|Adrenergic Agents|adrenergic agents|mesh-ancestor
102602969|NCT00004268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102602970|NCT00004268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602971|NCT00004274|Estrogens|estrogens|mesh-list
102602972|NCT00004274|Hormones|hormones|mesh-ancestor
102602973|NCT00004274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102602974|NCT00004274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602975|NCT00004904|Methylprednisolone|methylprednisolone|mesh-list
102602976|NCT00004904|Cyclophosphamide|cyclophosphamide|mesh-list
102602977|NCT00004904|Etoposide|etoposide|mesh-list
102602978|NCT00004904|Cladribine|cladribine|mesh-list
102602979|NCT00004904|Tacrolimus|tacrolimus|mesh-list
102602980|NCT00004904|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102602981|NCT00004904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102602982|NCT00004904|Immunologic Factors|immunologic factors|mesh-ancestor
102602983|NCT00004904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102602984|NCT00004904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102602985|NCT00004904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102602986|NCT00004904|Alkylating Agents|alkylating agents|mesh-ancestor
102602987|NCT00004904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102602988|NCT00004904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102602989|NCT00004904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102602990|NCT00004904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102602991|NCT00004904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102602992|NCT00004904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102602993|NCT00004904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102602994|NCT00004904|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102602995|NCT00004904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102602996|NCT00004904|Antiemetics|antiemetics|mesh-ancestor
102602997|NCT00004904|Autonomic Agents|autonomic agents|mesh-ancestor
102602998|NCT00004904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102602999|NCT00004904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102603000|NCT00004904|Glucocorticoids|glucocorticoids|mesh-ancestor
102603001|NCT00004904|Hormones|hormones|mesh-ancestor
102603002|NCT00004904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102603003|NCT00004904|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102603004|NCT00004904|Protective Agents|protective agents|mesh-ancestor
102603005|NCT00004286|Immunoglobulins|immunoglobulins|mesh-list
102603006|NCT00004286|Antibodies|antibodies|mesh-list
102603007|NCT00004286|gamma-Globulins|gamma-globulins|mesh-list
102603008|NCT00004286|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102603009|NCT00004286|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102603010|NCT00004286|Immunologic Factors|immunologic factors|mesh-ancestor
102603011|NCT00004286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603012|NCT00003746|Cladribine|cladribine|mesh-list
102603013|NCT00003746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603014|NCT00003746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102603015|NCT00003746|Immunologic Factors|immunologic factors|mesh-ancestor
102603016|NCT00003746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603017|NCT00003752|Bexarotene|bexarotene|mesh-list
102603018|NCT00003752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603019|NCT00003758|Cytarabine|cytarabine|mesh-list
102603020|NCT00003758|Idarubicin|idarubicin|mesh-list
102603021|NCT00003758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102603022|NCT00003758|Antimetabolites|antimetabolites|mesh-ancestor
102603023|NCT00003758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603024|NCT00003758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603025|NCT00003758|Antiviral Agents|antiviral agents|mesh-ancestor
102603026|NCT00003758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102603027|NCT00003758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102603028|NCT00003758|Immunologic Factors|immunologic factors|mesh-ancestor
102603029|NCT00003758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603030|NCT00003758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102603031|NCT00003758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102603032|NCT00003758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102603033|NCT00003758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102603034|NCT00004310|Clomipramine|clomipramine|mesh-list
102603035|NCT00004310|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102603036|NCT00004310|Antidepressive Agents|antidepressive agents|mesh-ancestor
102603037|NCT00004310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102603038|NCT00004310|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102603039|NCT00004310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102603040|NCT00004310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102603041|NCT00004310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603042|NCT00004310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102603043|NCT00004310|Serotonin Agents|serotonin agents|mesh-ancestor
102603044|NCT00004310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603045|NCT00004922|Irinotecan|irinotecan|mesh-list
102603046|NCT00004922|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102603047|NCT00004922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102603048|NCT00004922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102603049|NCT00004922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603050|NCT00004922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603051|NCT00004316|Capsaicin|capsaicin|mesh-list
102603052|NCT00004316|Antipruritics|antipruritics|mesh-ancestor
102603053|NCT00004316|Dermatologic Agents|dermatologic agents|mesh-ancestor
102603054|NCT00004316|Sensory System Agents|sensory system agents|mesh-ancestor
102346331|NCT04473482|Ethanol|ethanol|mesh-list
102603055|NCT00004316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102603056|NCT00004316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603057|NCT00004928|Zoledronic Acid|zoledronic acid|mesh-list
102603058|NCT00004928|Calcitriol|calcitriol|mesh-list
102603059|NCT00004928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102603060|NCT00004928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603061|NCT00004928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102603062|NCT00004928|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102603063|NCT00004928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102603064|NCT00004928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603065|NCT00004928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102603066|NCT00004928|Vitamins|vitamins|mesh-ancestor
102603067|NCT00004928|Micronutrients|micronutrients|mesh-ancestor
102603068|NCT00004328|Enalapril|enalapril|mesh-list
102603069|NCT00004328|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
102603070|NCT00004328|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102603071|NCT00004328|Protease Inhibitors|protease inhibitors|mesh-ancestor
102603072|NCT00004328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102603073|NCT00004328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603074|NCT00004328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102603075|NCT00004328|Chelating Agents|chelating agents|mesh-ancestor
102603076|NCT00004328|Sequestering Agents|sequestering agents|mesh-ancestor
102603077|NCT00004934|Paclitaxel|paclitaxel|mesh-list
102603078|NCT00004934|Carboplatin|carboplatin|mesh-list
102603079|NCT00004934|Epirubicin|epirubicin|mesh-list
102603080|NCT00004934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102603081|NCT00004934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603082|NCT00004934|Tubulin Modulators|tubulin modulators|mesh-ancestor
102603083|NCT00004934|Antimitotic Agents|antimitotic agents|mesh-ancestor
102603084|NCT00004934|Mitosis Modulators|mitosis modulators|mesh-ancestor
102603085|NCT00004934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603086|NCT00004934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102603087|NCT00004934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102603088|NCT00004934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102603089|NCT00004934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102603090|NCT00003776|Leucovorin|leucovorin|mesh-list
102603091|NCT00003776|Trimetrexate|trimetrexate|mesh-list
102603092|NCT00003776|Doxorubicin|doxorubicin|mesh-list
102603093|NCT00003776|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102603094|NCT00003776|Methotrexate|methotrexate|mesh-list
102603095|NCT00003776|Ifosfamide|ifosfamide|mesh-list
102603096|NCT00003776|Calcium|calcium|mesh-list
102603097|NCT00003776|Levoleucovorin|levoleucovorin|mesh-list
102603098|NCT00003776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603099|NCT00003776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102603100|NCT00003776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102603101|NCT00003776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102149943|NCT04282239|Analgesics|analgesics|mesh-ancestor
102603103|NCT00003776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603104|NCT00003776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102603105|NCT00003776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603106|NCT00003776|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102603107|NCT00003776|Abortifacient Agents|abortifacient agents|mesh-ancestor
102603108|NCT00003776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102603109|NCT00003776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102603110|NCT00003776|Antimetabolites|antimetabolites|mesh-ancestor
102603111|NCT00003776|Dermatologic Agents|dermatologic agents|mesh-ancestor
102603112|NCT00003776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102603113|NCT00003776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102603114|NCT00003776|Immunologic Factors|immunologic factors|mesh-ancestor
102603115|NCT00003776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102603116|NCT00003776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102603117|NCT00003776|Antidotes|antidotes|mesh-ancestor
102603118|NCT00003776|Protective Agents|protective agents|mesh-ancestor
102603119|NCT00003776|Vitamin B Complex|vitamin b complex|mesh-ancestor
102603120|NCT00003776|Vitamins|vitamins|mesh-ancestor
102603121|NCT00003776|Micronutrients|micronutrients|mesh-ancestor
102603122|NCT00003776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102603123|NCT00003776|Alkylating Agents|alkylating agents|mesh-ancestor
102603124|NCT00003776|Antifungal Agents|antifungal agents|mesh-ancestor
102603125|NCT00003776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102603126|NCT00003788|Carmustine|carmustine|mesh-list
102603127|NCT00003788|Lomustine|lomustine|mesh-list
102603128|NCT00003788|Procarbazine|procarbazine|mesh-list
102603129|NCT00003788|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
102603130|NCT00003788|Trioxsalen|trioxsalen|mesh-list
102603131|NCT00003788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102603132|NCT00003788|Alkylating Agents|alkylating agents|mesh-ancestor
102603133|NCT00003788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603134|NCT00003788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603135|NCT00003788|Dermatologic Agents|dermatologic agents|mesh-ancestor
102603136|NCT00003788|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102603137|NCT00004340|Calcitriol|calcitriol|mesh-list
102603138|NCT00004340|Hormones|hormones|mesh-list
102603139|NCT00004340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102603140|NCT00004340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603141|NCT00004340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102603142|NCT00004340|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102603143|NCT00004340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102603144|NCT00004340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603145|NCT00004340|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102603146|NCT00004340|Vitamins|vitamins|mesh-ancestor
102603147|NCT00004340|Micronutrients|micronutrients|mesh-ancestor
102603148|NCT00004340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102603149|NCT00004346|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
102603150|NCT00004346|Lovastatin|lovastatin|mesh-list
102603151|NCT00004346|L 647318|l 647318|mesh-list
102603152|NCT00004346|Dihydromevinolin|dihydromevinolin|mesh-list
102603153|NCT00004346|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102603154|NCT00004346|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102603155|NCT00004346|Antimetabolites|antimetabolites|mesh-ancestor
102603156|NCT00004346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603157|NCT00004346|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102603158|NCT00004346|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102603159|NCT00004346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102603160|NCT00004346|Cathartics|cathartics|mesh-ancestor
102603161|NCT00004346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102603162|NCT00384800|Thalidomide|thalidomide|mesh-list
102603163|NCT00384800|Tegafur|tegafur|mesh-list
102603164|NCT00384800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102603165|NCT00384800|Immunologic Factors|immunologic factors|mesh-ancestor
102603166|NCT00384800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603167|NCT00384800|Leprostatic Agents|leprostatic agents|mesh-ancestor
102603168|NCT00384800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102603169|NCT00384800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102603170|NCT00384800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102603171|NCT00384800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102603172|NCT00384800|Growth Substances|growth substances|mesh-ancestor
102603173|NCT00384800|Growth Inhibitors|growth inhibitors|mesh-ancestor
102603174|NCT00384800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603175|NCT00384800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102603176|NCT00384800|Antimetabolites|antimetabolites|mesh-ancestor
102603177|NCT00384800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603178|NCT00384878|Leucovorin|leucovorin|mesh-list
102603179|NCT00384878|Fluorouracil|fluorouracil|mesh-list
102603180|NCT00384878|Cetuximab|cetuximab|mesh-list
102603181|NCT00384878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603182|NCT00384878|Antimetabolites|antimetabolites|mesh-ancestor
102603183|NCT00384878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603184|NCT00384878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102603185|NCT00384878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102603186|NCT00384878|Immunologic Factors|immunologic factors|mesh-ancestor
102603187|NCT00384878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603188|NCT00384878|Antidotes|antidotes|mesh-ancestor
102603189|NCT00384878|Protective Agents|protective agents|mesh-ancestor
102603190|NCT00384878|Vitamin B Complex|vitamin b complex|mesh-ancestor
102603191|NCT00384878|Vitamins|vitamins|mesh-ancestor
102603192|NCT00384878|Micronutrients|micronutrients|mesh-ancestor
102603193|NCT00384878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102603194|NCT02972762|Propofol|propofol|mesh-list
102603195|NCT02972762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102603196|NCT02972762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102603197|NCT02972762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603198|NCT02972762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102603199|NCT02972762|Anesthetics, General|anesthetics, general|mesh-ancestor
102603200|NCT02972762|Anesthetics|anesthetics|mesh-ancestor
102603201|NCT00004358|Calcitonin|calcitonin|mesh-list
102603202|NCT00004358|Salmon calcitonin|salmon calcitonin|mesh-list
102603203|NCT00004358|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
102603204|NCT00004358|Katacalcin|katacalcin|mesh-list
102603205|NCT00004358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102603206|NCT00004358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603207|NCT00004358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102603208|NCT00004358|Vasodilator Agents|vasodilator agents|mesh-ancestor
102603209|NCT00004364|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
102603210|NCT00004364|Hemostatics|hemostatics|mesh-ancestor
102603211|NCT00004364|Coagulants|coagulants|mesh-ancestor
102603212|NCT00004364|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102603213|NCT00004364|Natriuretic Agents|natriuretic agents|mesh-ancestor
102603214|NCT00004364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603215|NCT00005000|Lamivudine|lamivudine|mesh-list
102603216|NCT00005000|Zidovudine|zidovudine|mesh-list
102603217|NCT00005000|Efavirenz|efavirenz|mesh-list
102603218|NCT00005000|Stavudine|stavudine|mesh-list
102603219|NCT00005000|Didanosine|didanosine|mesh-list
102603220|NCT00005000|Nelfinavir|nelfinavir|mesh-list
102603221|NCT00005000|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
102603222|NCT00005000|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102603223|NCT00005000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102603224|NCT00005000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102603225|NCT00005000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603226|NCT00005000|Antiviral Agents|antiviral agents|mesh-ancestor
102603227|NCT00005000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102603228|NCT00005000|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102603229|NCT00005000|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102603230|NCT00005000|Antimetabolites|antimetabolites|mesh-ancestor
102603231|NCT00005000|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102603232|NCT00005000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102603233|NCT00005000|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102603234|NCT00005000|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102603235|NCT00005000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102603236|NCT00005000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102603237|NCT00005000|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102603238|NCT00005000|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102603239|NCT00005000|Protease Inhibitors|protease inhibitors|mesh-ancestor
102603240|NCT00005000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102603241|NCT00005000|Immunologic Factors|immunologic factors|mesh-ancestor
102603242|NCT00005000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603243|NCT00004376|Guanfacine|guanfacine|mesh-list
102603244|NCT00004376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102603245|NCT00004376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102603246|NCT00004376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102603247|NCT00004376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102603248|NCT00004376|Adrenergic Agents|adrenergic agents|mesh-ancestor
102603249|NCT00004376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102603250|NCT00004376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603251|NCT00004376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603252|NCT00005006|Alendronate|alendronate|mesh-list
102603253|NCT00005006|Teriparatide|teriparatide|mesh-list
102603254|NCT00005006|Hormones|hormones|mesh-list
102603255|NCT00005006|Parathyroid Hormone|parathyroid hormone|mesh-list
102603256|NCT00005006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102603257|NCT00005006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603258|NCT00005006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102603259|NCT00005006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102603260|NCT00004382|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
102603261|NCT00004382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102603262|NCT00004382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603263|NCT00005012|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102603264|NCT00005012|Antiviral Agents|antiviral agents|mesh-ancestor
102603265|NCT00005012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102603266|NCT00004400|Testosterone|testosterone|mesh-list
102603267|NCT00004400|Androgens|androgens|mesh-ancestor
102603268|NCT00004400|Hormones|hormones|mesh-ancestor
102603269|NCT00004400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102603270|NCT00004400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603271|NCT00003812|Paclitaxel|paclitaxel|mesh-list
102603272|NCT00003812|Etoposide|etoposide|mesh-list
102603273|NCT00003812|Carboplatin|carboplatin|mesh-list
102603274|NCT00003812|Topotecan|topotecan|mesh-list
102603275|NCT00003812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102603276|NCT00003812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603277|NCT00003812|Tubulin Modulators|tubulin modulators|mesh-ancestor
102603278|NCT00003812|Antimitotic Agents|antimitotic agents|mesh-ancestor
102603279|NCT00003812|Mitosis Modulators|mitosis modulators|mesh-ancestor
102603280|NCT00003812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603281|NCT00003812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102603282|NCT00003812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102603283|NCT00003812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102603284|NCT00003812|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102603285|NCT00005018|Efavirenz|efavirenz|mesh-list
102603286|NCT00005018|Abacavir|abacavir|mesh-list
102603287|NCT00005018|Didanosine|didanosine|mesh-list
102603288|NCT00005018|Hydroxyurea|hydroxyurea|mesh-list
102603289|NCT00005018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102603290|NCT00005018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102603291|NCT00005018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102603292|NCT00005018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603293|NCT00005018|Antiviral Agents|antiviral agents|mesh-ancestor
102603294|NCT00005018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102603295|NCT00005018|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102603296|NCT00005018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102603297|NCT00005018|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102603298|NCT00005018|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102603299|NCT00005018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102603300|NCT00005018|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102603301|NCT00005018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603302|NCT00005018|Antisickling Agents|antisickling agents|mesh-ancestor
102603303|NCT00005018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102603304|NCT00005018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102603305|NCT00005018|Antimetabolites|antimetabolites|mesh-ancestor
102603306|NCT00003824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102603307|NCT00003824|Ciprofloxacin|ciprofloxacin|mesh-list
102603308|NCT00003824|Cephalexin|cephalexin|mesh-list
102603309|NCT00003824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102603310|NCT00003824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102603311|NCT00003824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102603312|NCT00003824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102603313|NCT00003824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603314|NCT00003824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603315|NCT00003824|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102603316|NCT00003824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102603317|NCT00004406|Hormones|hormones|mesh-list
102603318|NCT00004406|Parathyroid Hormone|parathyroid hormone|mesh-list
102603319|NCT00004406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102603320|NCT00004406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603321|NCT00004406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102603322|NCT00005024|Cyclophosphamide|cyclophosphamide|mesh-list
102603323|NCT00005024|Carboplatin|carboplatin|mesh-list
102603324|NCT00005024|Doxorubicin|doxorubicin|mesh-list
102603325|NCT00005024|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102603326|NCT00005024|Granisetron|granisetron|mesh-list
102603327|NCT00005024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102603328|NCT00005024|Immunologic Factors|immunologic factors|mesh-ancestor
102603329|NCT00005024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603330|NCT00005024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102603331|NCT00005024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102603332|NCT00005024|Alkylating Agents|alkylating agents|mesh-ancestor
102603333|NCT00005024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603334|NCT00005024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603335|NCT00005024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102603336|NCT00005024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102603337|NCT00005024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102603338|NCT00005024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102603339|NCT00005024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102603340|NCT00005024|Antiemetics|antiemetics|mesh-ancestor
102603341|NCT00005024|Autonomic Agents|autonomic agents|mesh-ancestor
102603342|NCT00005024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102603343|NCT00005024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102603344|NCT00005024|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102603345|NCT00005024|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102603346|NCT00005024|Serotonin Agents|serotonin agents|mesh-ancestor
102603347|NCT00005024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102603348|NCT00005030|Lonafarnib|lonafarnib|mesh-list
102603349|NCT00005030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102603350|NCT00005030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603351|NCT00004424|Fentanyl|fentanyl|mesh-list
102603352|NCT00004424|Midazolam|midazolam|mesh-list
102603353|NCT00004424|Propofol|propofol|mesh-list
102603354|NCT00004424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102603355|NCT00004424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102603356|NCT00004424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603357|NCT00004424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102603358|NCT00004424|Anesthetics, General|anesthetics, general|mesh-ancestor
102603359|NCT00004424|Anesthetics|anesthetics|mesh-ancestor
102603360|NCT00004424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102603361|NCT00004424|Narcotics|narcotics|mesh-ancestor
102603362|NCT00004424|Analgesics|analgesics|mesh-ancestor
102603363|NCT00004424|Sensory System Agents|sensory system agents|mesh-ancestor
102603364|NCT00004424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102603365|NCT00004424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102603366|NCT00004424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102603367|NCT00004424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102603368|NCT00004424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102603369|NCT00004424|GABA Modulators|gaba modulators|mesh-ancestor
102603370|NCT00004424|GABA Agents|gaba agents|mesh-ancestor
102603371|NCT00004424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102603372|NCT00004424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603373|NCT00004430|Prednisolone|prednisolone|mesh-list
102603374|NCT00004430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102603375|NCT00004430|Glucocorticoids|glucocorticoids|mesh-ancestor
102603376|NCT00004430|Hormones|hormones|mesh-ancestor
102603377|NCT00004430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102603378|NCT00004430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603379|NCT00004430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102603380|NCT00004430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603381|NCT00003842|Interleukin-4|interleukin-4|mesh-list
102603382|NCT00003842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102603383|NCT00003842|Immunologic Factors|immunologic factors|mesh-ancestor
102603384|NCT00003842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603385|NCT00003842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603386|NCT00003842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102603387|NCT00005036|Leucovorin|leucovorin|mesh-list
102603388|NCT00005036|Fluorouracil|fluorouracil|mesh-list
102603389|NCT00005036|Oxaliplatin|oxaliplatin|mesh-list
102603390|NCT00005036|Irinotecan|irinotecan|mesh-list
102603391|NCT00005036|Calcium|calcium|mesh-list
102603392|NCT00005036|Levoleucovorin|levoleucovorin|mesh-list
102603393|NCT00005036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102603394|NCT00005036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603395|NCT00005036|Antimetabolites|antimetabolites|mesh-ancestor
102603396|NCT00005036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603397|NCT00005036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102603398|NCT00005036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603399|NCT00005036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102603400|NCT00005036|Immunologic Factors|immunologic factors|mesh-ancestor
102603401|NCT00005036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102603402|NCT00005036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102603403|NCT00005036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102603404|NCT00005036|Antidotes|antidotes|mesh-ancestor
102603405|NCT00005036|Protective Agents|protective agents|mesh-ancestor
102603406|NCT00005036|Vitamin B Complex|vitamin b complex|mesh-ancestor
102603407|NCT00005036|Vitamins|vitamins|mesh-ancestor
102603408|NCT00005036|Micronutrients|micronutrients|mesh-ancestor
102603409|NCT00004436|Prednisone|prednisone|mesh-list
102603410|NCT00004436|Leuprolide|leuprolide|mesh-list
102603411|NCT00004436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102603412|NCT00004436|Glucocorticoids|glucocorticoids|mesh-ancestor
102603413|NCT00004436|Hormones|hormones|mesh-ancestor
102603414|NCT00004436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102603415|NCT00004436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603416|NCT00004436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102603417|NCT00004436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603418|NCT00004436|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102603419|NCT00004436|Fertility Agents|fertility agents|mesh-ancestor
102603420|NCT00004436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102603421|NCT00005042|Semaxinib|semaxinib|mesh-list
102603422|NCT00005042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102603423|NCT00005042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102603424|NCT00005042|Growth Substances|growth substances|mesh-ancestor
102603425|NCT00005042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603426|NCT00005042|Growth Inhibitors|growth inhibitors|mesh-ancestor
102603427|NCT00005042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603428|NCT00005042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102603429|NCT00005042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102603430|NCT00005042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603431|NCT00004442|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102603432|NCT00004442|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
102603433|NCT00004442|Cholic Acids|cholic acids|mesh-list
102603434|NCT00004442|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102603435|NCT00004442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102603436|NCT00004442|Cathartics|cathartics|mesh-ancestor
102603437|NCT05444569|Liraglutide|liraglutide|mesh-list
102603438|NCT05444569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102603439|NCT05444569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603440|NCT05444569|Incretins|incretins|mesh-ancestor
102603441|NCT05444569|Hormones|hormones|mesh-ancestor
102603442|NCT05444569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102603443|NCT00004448|Prednisone|prednisone|mesh-list
102603444|NCT00004448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102603445|NCT00004448|Glucocorticoids|glucocorticoids|mesh-ancestor
102603446|NCT00004448|Hormones|hormones|mesh-ancestor
102603447|NCT00004448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102603448|NCT00004448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603449|NCT00004448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102603450|NCT00004448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603451|NCT00003860|Carboplatin|carboplatin|mesh-list
102603452|NCT00003860|Etoposide|etoposide|mesh-list
102603453|NCT00003860|Ifosfamide|ifosfamide|mesh-list
102603454|NCT00003860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603455|NCT00003860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102603456|NCT00003860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102603457|NCT00003860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102603458|NCT00003860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102603459|NCT00003860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603460|NCT00003860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102603461|NCT00003860|Alkylating Agents|alkylating agents|mesh-ancestor
102603462|NCT00005048|Paclitaxel|paclitaxel|mesh-list
102603463|NCT00005048|Estramustine|estramustine|mesh-list
102603464|NCT00005048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102603465|NCT00005048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603466|NCT00005048|Tubulin Modulators|tubulin modulators|mesh-ancestor
102603467|NCT00005048|Antimitotic Agents|antimitotic agents|mesh-ancestor
102603468|NCT00005048|Mitosis Modulators|mitosis modulators|mesh-ancestor
102603469|NCT00005048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603470|NCT00005048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102603471|NCT00005048|Alkylating Agents|alkylating agents|mesh-ancestor
102603472|NCT00005048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102603473|NCT04756765|Talazoparib|talazoparib|mesh-list
102603474|NCT04756765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102603475|NCT04756765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102603476|NCT04756765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603477|NCT04756765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603478|NCT00004466|Atorvastatin|atorvastatin|mesh-list
102603479|NCT00004466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102150322|NCT03125187|Heparin|heparin|mesh-list
102603480|NCT00004466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102603481|NCT00004466|Antimetabolites|antimetabolites|mesh-ancestor
102603482|NCT00004466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603483|NCT00004466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102603484|NCT00004466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102603485|NCT00004466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102603486|NCT00005054|Temozolomide|temozolomide|mesh-list
102603487|NCT00005054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102603488|NCT00005054|Alkylating Agents|alkylating agents|mesh-ancestor
102603489|NCT00005054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603490|NCT00005054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603491|NCT00004478|Droxidopa|droxidopa|mesh-list
102603492|NCT00004478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102346346|NCT04439318|Trametinib|trametinib|mesh-list
102603493|NCT00004478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102603494|NCT00003878|Carmustine|carmustine|mesh-list
102603495|NCT00003878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102603496|NCT00003878|Alkylating Agents|alkylating agents|mesh-ancestor
102603497|NCT00003878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603498|NCT00003878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603499|NCT00005060|Docetaxel|docetaxel|mesh-list
102603500|NCT00005060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603501|NCT00005060|Tubulin Modulators|tubulin modulators|mesh-ancestor
102603502|NCT00005060|Antimitotic Agents|antimitotic agents|mesh-ancestor
102603503|NCT00005060|Mitosis Modulators|mitosis modulators|mesh-ancestor
102603504|NCT00005060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603505|NCT00003884|Zoledronic Acid|zoledronic acid|mesh-list
102603506|NCT00003884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102603507|NCT00003884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603508|NCT00005066|Carmustine|carmustine|mesh-list
102603509|NCT00005066|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
102603510|NCT00005066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102603511|NCT00005066|Alkylating Agents|alkylating agents|mesh-ancestor
102603512|NCT00005066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603513|NCT00005066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603514|NCT00005066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102603515|NCT04711915|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
102603516|NCT04711915|Hallucinogens|hallucinogens|mesh-ancestor
102603517|NCT04711915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603518|NCT04711915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102603519|NCT04711915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102603520|NCT04711915|Serotonin Agents|serotonin agents|mesh-ancestor
102603521|NCT04711915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102603522|NCT04711915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603523|NCT04711915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102603524|NCT00005072|Interleukin-2|interleukin-2|mesh-list
102603525|NCT00005072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603526|NCT00005072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102603527|NCT00005072|Analgesics|analgesics|mesh-ancestor
102603528|NCT00005072|Sensory System Agents|sensory system agents|mesh-ancestor
102603529|NCT00005072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102603530|NCT00005072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603531|NCT00004496|Hormones|hormones|mesh-list
102603532|NCT00004496|alpha-MSH|alpha-msh|mesh-list
102603533|NCT00004496|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102603534|NCT00004496|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
102603535|NCT00004496|beta-Endorphin|beta-endorphin|mesh-list
102603536|NCT00004496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102603537|NCT00004496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603538|NCT00004496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102603539|NCT00004496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603540|NCT00003902|Capecitabine|capecitabine|mesh-list
102603541|NCT00003902|Vinorelbine|vinorelbine|mesh-list
102603542|NCT00003902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102603543|NCT00003902|Antimetabolites|antimetabolites|mesh-ancestor
102603544|NCT00003902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603545|NCT00003902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603546|NCT00003902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102603547|NCT00003902|Tubulin Modulators|tubulin modulators|mesh-ancestor
102603548|NCT00003902|Antimitotic Agents|antimitotic agents|mesh-ancestor
102603549|NCT00003902|Mitosis Modulators|mitosis modulators|mesh-ancestor
102603550|NCT00003908|Carboplatin|carboplatin|mesh-list
102603551|NCT00003908|Docetaxel|docetaxel|mesh-list
102603552|NCT00003908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603553|NCT00003908|Tubulin Modulators|tubulin modulators|mesh-ancestor
102150389|NCT05393414|Analgesics|analgesics|mesh-ancestor
102603554|NCT00003908|Antimitotic Agents|antimitotic agents|mesh-ancestor
102603555|NCT00003908|Mitosis Modulators|mitosis modulators|mesh-ancestor
102603556|NCT00003908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603557|NCT00382837|Epratuzumab|epratuzumab|mesh-list
102603558|NCT00382837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102603559|NCT00382837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603560|NCT00003914|Dolastatin 10|dolastatin 10|mesh-list
102603561|NCT00003914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603562|NCT00003914|Tubulin Modulators|tubulin modulators|mesh-ancestor
102603563|NCT00003914|Antimitotic Agents|antimitotic agents|mesh-ancestor
102603564|NCT00003914|Mitosis Modulators|mitosis modulators|mesh-ancestor
102346347|NCT04439318|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
102603565|NCT00003914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603566|NCT00005078|Paclitaxel|paclitaxel|mesh-list
102603567|NCT00005078|Carboplatin|carboplatin|mesh-list
102603568|NCT00005078|Tirapazamine|tirapazamine|mesh-list
102603569|NCT00005078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102603570|NCT00005078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603571|NCT00005078|Tubulin Modulators|tubulin modulators|mesh-ancestor
102603572|NCT00005078|Antimitotic Agents|antimitotic agents|mesh-ancestor
102603573|NCT00005078|Mitosis Modulators|mitosis modulators|mesh-ancestor
102603574|NCT00005078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603575|NCT04698031|Aspirin|aspirin|mesh-list
102603576|NCT04698031|Clopidogrel|clopidogrel|mesh-list
102603577|NCT04698031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102603578|NCT04698031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102603579|NCT04698031|Analgesics|analgesics|mesh-ancestor
102603580|NCT04698031|Sensory System Agents|sensory system agents|mesh-ancestor
102603581|NCT04698031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102603582|NCT04698031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603583|NCT04698031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102603584|NCT04698031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102603585|NCT04698031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102603586|NCT04698031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102603587|NCT04698031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603588|NCT04698031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102603589|NCT04698031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102603590|NCT04698031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102603591|NCT04698031|Antipyretics|antipyretics|mesh-ancestor
102603592|NCT04698031|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102603593|NCT04698031|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102603594|NCT04698031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102603595|NCT04698031|Purinergic Agents|purinergic agents|mesh-ancestor
102603596|NCT04698031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102603597|NCT00003920|Cyclosporine|cyclosporine|mesh-list
102603598|NCT00003920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102603599|NCT00003920|Antibodies|antibodies|mesh-list
102603600|NCT00003920|Immunoglobulins|immunoglobulins|mesh-list
102603601|NCT00003920|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102603602|NCT00003920|Cyclosporins|cyclosporins|mesh-list
102603603|NCT00003920|Immunologic Factors|immunologic factors|mesh-ancestor
102603604|NCT00003920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603605|NCT00003920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603606|NCT00003920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102603607|NCT00003920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603608|NCT00003920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102603609|NCT00003920|Antifungal Agents|antifungal agents|mesh-ancestor
102603610|NCT00003920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102603611|NCT00003920|Dermatologic Agents|dermatologic agents|mesh-ancestor
102603612|NCT00003920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102603613|NCT00003920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102603614|NCT00003926|Melphalan|melphalan|mesh-list
102603615|NCT00003926|Busulfan|busulfan|mesh-list
102603616|NCT00003926|Thiotepa|thiotepa|mesh-list
102603617|NCT00003926|Lenograstim|lenograstim|mesh-list
102603618|NCT00003926|Amifostine|amifostine|mesh-list
102603619|NCT00003926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102603620|NCT00003926|Immunologic Factors|immunologic factors|mesh-ancestor
102603621|NCT00003926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603622|NCT00003926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102603623|NCT00003926|Alkylating Agents|alkylating agents|mesh-ancestor
102603624|NCT00003926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603625|NCT00003926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603626|NCT00003926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102603627|NCT00003926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102603628|NCT00003926|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102603629|NCT00003926|Protective Agents|protective agents|mesh-ancestor
102603630|NCT05122819|Anesthetics|anesthetics|mesh-list
102603631|NCT05122819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102603632|NCT05122819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603633|NCT00005090|Cyclophosphamide|cyclophosphamide|mesh-list
102603634|NCT00005090|Dacarbazine|dacarbazine|mesh-list
102603635|NCT00005090|Carmustine|carmustine|mesh-list
102603636|NCT00005090|Doxorubicin|doxorubicin|mesh-list
102603637|NCT00005090|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102603638|NCT00005090|Etoposide|etoposide|mesh-list
102603639|NCT00005090|Bleomycin|bleomycin|mesh-list
102603640|NCT00005090|Vinblastine|vinblastine|mesh-list
102603641|NCT00005090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102603642|NCT00005090|Immunologic Factors|immunologic factors|mesh-ancestor
102603643|NCT00005090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603644|NCT00005090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102603645|NCT00005090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102603646|NCT00005090|Alkylating Agents|alkylating agents|mesh-ancestor
102603647|NCT00005090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603648|NCT00005090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603649|NCT00005090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102603650|NCT00005090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102603651|NCT00005090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102603652|NCT00005090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102603653|NCT00005090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102603654|NCT00005090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102603655|NCT00005090|Tubulin Modulators|tubulin modulators|mesh-ancestor
102603656|NCT00005090|Antimitotic Agents|antimitotic agents|mesh-ancestor
102603657|NCT00005090|Mitosis Modulators|mitosis modulators|mesh-ancestor
102603658|NCT00004580|Ritonavir|ritonavir|mesh-list
102603659|NCT00004580|Lopinavir|lopinavir|mesh-list
102603660|NCT00004580|Nevirapine|nevirapine|mesh-list
102603661|NCT00004580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102603662|NCT00004580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102603663|NCT00004580|Protease Inhibitors|protease inhibitors|mesh-ancestor
102603664|NCT00004580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102603665|NCT00004580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603666|NCT00004580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102603667|NCT00004580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102603668|NCT00004580|Antiviral Agents|antiviral agents|mesh-ancestor
102603669|NCT00004580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102603670|NCT00004580|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102603671|NCT00004580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102603672|NCT00004580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102603673|NCT00004580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102603674|NCT00004580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102603675|NCT00004580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102603676|NCT00005096|Docetaxel|docetaxel|mesh-list
102603677|NCT00005096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603678|NCT00005096|Tubulin Modulators|tubulin modulators|mesh-ancestor
102603679|NCT00005096|Antimitotic Agents|antimitotic agents|mesh-ancestor
102603680|NCT00005096|Mitosis Modulators|mitosis modulators|mesh-ancestor
102603681|NCT00005096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603682|NCT00004640|Chlorhexidine|chlorhexidine|mesh-list
102603683|NCT00004640|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102603684|NCT00004640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102603685|NCT00004640|Disinfectants|disinfectants|mesh-ancestor
102603686|NCT05104099|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
102603687|NCT05104099|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102603688|NCT05104099|Dermatologic Agents|dermatologic agents|mesh-ancestor
102603689|NCT00004646|Prednisone|prednisone|mesh-list
102603690|NCT00004646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102603691|NCT00004646|Glucocorticoids|glucocorticoids|mesh-ancestor
102603692|NCT00004646|Hormones|hormones|mesh-ancestor
102603693|NCT00004646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102603694|NCT00004646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603695|NCT00004646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102603696|NCT00004646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603697|NCT00005108|Estradiol|estradiol|mesh-list
102603698|NCT00005108|Progesterone|progesterone|mesh-list
102603699|NCT00005108|Estrogens|estrogens|mesh-ancestor
102150540|NCT03373305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102603700|NCT00005108|Hormones|hormones|mesh-ancestor
102603701|NCT00005108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102603702|NCT00005108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603703|NCT00005108|Progestins|progestins|mesh-ancestor
102603704|NCT00004652|Pimozide|pimozide|mesh-list
102603705|NCT00004652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102603707|NCT00004652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102603708|NCT00004652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603709|NCT00004652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102603710|NCT00004652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102603711|NCT00004652|Dopamine Agents|dopamine agents|mesh-ancestor
102603712|NCT00004652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102603713|NCT00004652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603714|NCT00004652|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102603715|NCT00005120|Calanolide A|calanolide a|mesh-list
102603716|NCT00005120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102603717|NCT00005120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102603718|NCT00005120|Antiviral Agents|antiviral agents|mesh-ancestor
102603719|NCT00005120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102603720|NCT00004664|Megestrol|megestrol|mesh-list
102603721|NCT00004664|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102603722|NCT00004664|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102603723|NCT00004664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102603724|NCT00004664|Contraceptive Agents|contraceptive agents|mesh-ancestor
102603725|NCT00004664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102603726|NCT00004664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603727|NCT00004664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102603728|NCT00004664|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102603729|NCT00004664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102603730|NCT00004664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603731|NCT00004682|Immunoglobulins|immunoglobulins|mesh-list
102603732|NCT00004682|Antibodies|antibodies|mesh-list
102603733|NCT00004682|gamma-Globulins|gamma-globulins|mesh-list
102603734|NCT00004682|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102603735|NCT00004682|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102603736|NCT00004682|Immunologic Factors|immunologic factors|mesh-ancestor
102603737|NCT00004682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603738|NCT00004688|Mercaptopurine|mercaptopurine|mesh-list
102603739|NCT00004688|Carmustine|carmustine|mesh-list
102603740|NCT00004688|Streptozocin|streptozocin|mesh-list
102603741|NCT00004688|Antimetabolites|antimetabolites|mesh-ancestor
102603742|NCT00004688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603743|NCT00004688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102603744|NCT00004688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603745|NCT00004688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102603746|NCT00004688|Immunologic Factors|immunologic factors|mesh-ancestor
102603747|NCT00004688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603748|NCT00004688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102603749|NCT00004688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102603750|NCT00004688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102603751|NCT00004688|Alkylating Agents|alkylating agents|mesh-ancestor
102603752|NCT00004688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102603753|NCT00004694|Heparin|heparin|mesh-list
102603754|NCT00004694|Anticoagulants|anticoagulants|mesh-ancestor
102603755|NCT00004694|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102603756|NCT00004694|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102603757|NCT00004694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603758|NCT04608409|Paclitaxel|paclitaxel|mesh-list
102603759|NCT04608409|Lapatinib|lapatinib|mesh-list
102603760|NCT04608409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102603761|NCT04608409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603762|NCT04608409|Tubulin Modulators|tubulin modulators|mesh-ancestor
102603763|NCT04608409|Antimitotic Agents|antimitotic agents|mesh-ancestor
102603764|NCT04608409|Mitosis Modulators|mitosis modulators|mesh-ancestor
102603765|NCT04608409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603766|NCT04608409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102603767|NCT04608409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102603768|NCT00004700|Mitogens|mitogens|mesh-list
102603769|NCT00004700|Mitosis Modulators|mitosis modulators|mesh-ancestor
102603770|NCT00004700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603771|NCT00004730|Magnesium Sulfate|magnesium sulfate|mesh-list
102603772|NCT00004730|Analgesics|analgesics|mesh-ancestor
102603773|NCT00004730|Sensory System Agents|sensory system agents|mesh-ancestor
102603774|NCT00004730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102603775|NCT00004730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603776|NCT00004730|Anesthetics|anesthetics|mesh-ancestor
102603777|NCT00004730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102603778|NCT00004730|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102603779|NCT00004730|Anticonvulsants|anticonvulsants|mesh-ancestor
102603780|NCT00004730|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102603781|NCT00004730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102603782|NCT00004730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603783|NCT00004730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102603785|NCT00004730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102603786|NCT00004736|Lamivudine|lamivudine|mesh-list
102603787|NCT00004736|Zidovudine|zidovudine|mesh-list
102603788|NCT00004736|Stavudine|stavudine|mesh-list
102603789|NCT00004736|Nelfinavir|nelfinavir|mesh-list
102603790|NCT00004736|Isoniazid|isoniazid|mesh-list
102603791|NCT00004736|Pyrazinamide|pyrazinamide|mesh-list
102603792|NCT00004736|Ethambutol|ethambutol|mesh-list
102603793|NCT00004736|Rifabutin|rifabutin|mesh-list
102603794|NCT00004736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102603795|NCT00004736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102603796|NCT00004736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102603797|NCT00004736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603798|NCT00004736|Antiviral Agents|antiviral agents|mesh-ancestor
102603799|NCT00004736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102603800|NCT00004736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102603801|NCT00004736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102603802|NCT00004736|Antimetabolites|antimetabolites|mesh-ancestor
102603803|NCT00004736|Antitubercular Agents|antitubercular agents|mesh-ancestor
102603804|NCT00004736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102603805|NCT00004736|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102603806|NCT00004736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102603807|NCT00004736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102603808|NCT00004736|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102603809|NCT00004736|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102603810|NCT00004736|Protease Inhibitors|protease inhibitors|mesh-ancestor
102603811|NCT00004736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102603812|NCT00004748|Methotrexate|methotrexate|mesh-list
102603813|NCT00004748|Colchicine|colchicine|mesh-list
102603814|NCT00004748|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102603815|NCT00004748|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102603816|NCT00004748|Abortifacient Agents|abortifacient agents|mesh-ancestor
102603817|NCT00004748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102603818|NCT00004748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603819|NCT00004748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102603820|NCT00004748|Antimetabolites|antimetabolites|mesh-ancestor
102603821|NCT00004748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603822|NCT00004748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603823|NCT00004748|Dermatologic Agents|dermatologic agents|mesh-ancestor
102603824|NCT00004748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102603825|NCT00004748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102603826|NCT00004748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102603827|NCT00004748|Immunologic Factors|immunologic factors|mesh-ancestor
102603828|NCT00004748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102603829|NCT00004748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102603830|NCT00004748|Gout Suppressants|gout suppressants|mesh-ancestor
102603831|NCT00004748|Tubulin Modulators|tubulin modulators|mesh-ancestor
102603832|NCT00004748|Antimitotic Agents|antimitotic agents|mesh-ancestor
102603833|NCT00004748|Mitosis Modulators|mitosis modulators|mesh-ancestor
102603834|NCT00004748|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102603835|NCT00004748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102603836|NCT04585477|Durvalumab|durvalumab|mesh-list
102603837|NCT04585477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102603838|NCT04585477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603839|NCT00004754|Epoprostenol|epoprostenol|mesh-list
102603840|NCT00004754|Tezosentan|tezosentan|mesh-list
102603841|NCT00004754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102603842|NCT00004754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102603843|NCT00004754|Vasodilator Agents|vasodilator agents|mesh-ancestor
102603844|NCT00005576|Aldesleukin|aldesleukin|mesh-list
102603845|NCT00005576|Interleukin-2|interleukin-2|mesh-list
102603846|NCT00005576|Dinutuximab|dinutuximab|mesh-list
102603847|NCT00005576|Isotretinoin|isotretinoin|mesh-list
102603848|NCT00005576|Antibodies|antibodies|mesh-list
102603849|NCT00005576|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102603850|NCT00005576|Sargramostim|sargramostim|mesh-list
102603851|NCT00005576|Immunologic Factors|immunologic factors|mesh-ancestor
102603852|NCT00005576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603853|NCT00005576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603854|NCT00005576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102603855|NCT00005576|Analgesics|analgesics|mesh-ancestor
102603856|NCT00005576|Sensory System Agents|sensory system agents|mesh-ancestor
102603857|NCT00005576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102603858|NCT00005576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102603859|NCT00005576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102603860|NCT00005576|Antiviral Agents|antiviral agents|mesh-ancestor
102603861|NCT00005576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102603862|NCT00005576|Dermatologic Agents|dermatologic agents|mesh-ancestor
102603863|NCT04713163|Vaccines|vaccines|mesh-list
102603864|NCT04713163|Immunologic Factors|immunologic factors|mesh-ancestor
102603865|NCT04713163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603866|NCT00004772|Immunoglobulins|immunoglobulins|mesh-list
102603867|NCT00004772|Antibodies|antibodies|mesh-list
102603868|NCT00004772|gamma-Globulins|gamma-globulins|mesh-list
102603869|NCT00004772|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102603870|NCT00004772|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102603871|NCT00004772|Immunologic Factors|immunologic factors|mesh-ancestor
102603872|NCT00004772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603873|NCT04712929|Fluconazole|fluconazole|mesh-list
102603874|NCT04712929|Antifungal Agents|antifungal agents|mesh-ancestor
102603875|NCT04712929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102603876|NCT04712929|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102603877|NCT04712929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102603878|NCT04712929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102603879|NCT04712929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603880|NCT04712929|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102603881|NCT04712929|Hormone Antagonists|hormone antagonists|mesh-ancestor
102603882|NCT04712929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102603883|NCT04712929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603884|NCT04712929|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102603885|NCT04712929|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102603886|NCT00004784|Methotrexate|methotrexate|mesh-list
102603887|NCT00004784|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102603888|NCT00004784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102603889|NCT00004784|Abortifacient Agents|abortifacient agents|mesh-ancestor
102603890|NCT00004784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102603891|NCT00004784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603892|NCT00004784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102603893|NCT00004784|Antimetabolites|antimetabolites|mesh-ancestor
102603894|NCT00004784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603895|NCT00004784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603896|NCT00004784|Dermatologic Agents|dermatologic agents|mesh-ancestor
102603897|NCT00004784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102603898|NCT00004784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102603899|NCT00004784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102603900|NCT00004784|Immunologic Factors|immunologic factors|mesh-ancestor
102603901|NCT00004784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102603902|NCT00004784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102603903|NCT00004784|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102603904|NCT00004784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102603905|NCT00004796|Lactulose|lactulose|mesh-list
102603906|NCT00004796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102603907|NCT00004802|Dichlorphenamide|dichlorphenamide|mesh-list
102603908|NCT00004802|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102603909|NCT00004802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102346373|NCT04422392|Paclitaxel|paclitaxel|mesh-list
102603910|NCT00004802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603911|NCT00004808|Fluconazole|fluconazole|mesh-list
102603912|NCT00004808|Antifungal Agents|antifungal agents|mesh-ancestor
102603913|NCT00004808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102603914|NCT00004808|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102603915|NCT00004808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102603916|NCT00004808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102603917|NCT00004808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603918|NCT00004808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102603919|NCT00004808|Hormone Antagonists|hormone antagonists|mesh-ancestor
102603920|NCT00004808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102603921|NCT00004808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603922|NCT00004808|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102603923|NCT00004808|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102603924|NCT00004814|Glatiramer Acetate|glatiramer acetate|mesh-list
102603925|NCT00004814|(T,G)-A-L|(t,g)-a-l|mesh-list
102603926|NCT00004814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102603927|NCT00004814|Immunologic Factors|immunologic factors|mesh-ancestor
102603928|NCT00004814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603929|NCT00004814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102603930|NCT00004814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102603931|NCT00004826|Clozapine|clozapine|mesh-list
102603933|NCT00004826|Serotonin Agents|serotonin agents|mesh-ancestor
102603934|NCT00004826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102603935|NCT00004826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603936|NCT00004826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603937|NCT00004826|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102603938|NCT00004826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102603939|NCT00004826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102603940|NCT00004826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102603941|NCT00004826|GABA Antagonists|gaba antagonists|mesh-ancestor
102603942|NCT00004826|GABA Agents|gaba agents|mesh-ancestor
102603943|NCT04555603|Pembrolizumab|pembrolizumab|mesh-list
102603944|NCT04555603|Avelumab|avelumab|mesh-list
102603945|NCT04555603|Axitinib|axitinib|mesh-list
102603946|NCT04555603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102603947|NCT04555603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603948|NCT04555603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102603949|NCT04555603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603950|NCT04555603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102603951|NCT04555603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102603952|NCT04552327|Diclofenac|diclofenac|mesh-list
102603953|NCT04552327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102603954|NCT04552327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102603955|NCT04552327|Analgesics|analgesics|mesh-ancestor
102603956|NCT04552327|Sensory System Agents|sensory system agents|mesh-ancestor
102603957|NCT04552327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102603958|NCT04552327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603959|NCT04552327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102603960|NCT04552327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102603961|NCT04552327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102603962|NCT04552327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102603963|NCT04552327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603964|NCT00004778|Dexamethasone|dexamethasone|mesh-list
102603965|NCT00004778|Betamethasone|betamethasone|mesh-list
102603966|NCT00004778|Hormones|hormones|mesh-list
102603967|NCT00004778|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
102603968|NCT00004778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102603969|NCT00004778|Antiemetics|antiemetics|mesh-ancestor
102603970|NCT00004778|Autonomic Agents|autonomic agents|mesh-ancestor
102603971|NCT00004778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102603972|NCT00004778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603973|NCT00004778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102603974|NCT00004778|Glucocorticoids|glucocorticoids|mesh-ancestor
102603975|NCT00004778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102603976|NCT00004778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102603977|NCT00004778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603978|NCT00004778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102603979|NCT00004778|Respiratory System Agents|respiratory system agents|mesh-ancestor
102603980|NCT00005612|Paclitaxel|paclitaxel|mesh-list
102603981|NCT00005612|Etoposide|etoposide|mesh-list
102603982|NCT00005612|Cyclophosphamide|cyclophosphamide|mesh-list
102603983|NCT00005612|Carboplatin|carboplatin|mesh-list
102603984|NCT00005612|Topotecan|topotecan|mesh-list
102603985|NCT00005612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102603986|NCT00005612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102603987|NCT00005612|Tubulin Modulators|tubulin modulators|mesh-ancestor
102603988|NCT00005612|Antimitotic Agents|antimitotic agents|mesh-ancestor
102603989|NCT00005612|Mitosis Modulators|mitosis modulators|mesh-ancestor
102603990|NCT00005612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102603991|NCT00005612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102603992|NCT00005612|Immunologic Factors|immunologic factors|mesh-ancestor
102603993|NCT00005612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102603994|NCT00005612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102603995|NCT00005612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102603996|NCT00005612|Alkylating Agents|alkylating agents|mesh-ancestor
102603997|NCT00005612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102603998|NCT00005612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102603999|NCT00005612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102604000|NCT00005612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102604001|NCT00005612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102604002|NCT00005618|Arsenic Trioxide|arsenic trioxide|mesh-list
102604003|NCT00005618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604004|NCT00005624|Tacedinaline|tacedinaline|mesh-list
102604005|NCT00005624|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
102604006|NCT00005624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102604007|NCT00005624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604008|NCT00005624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604009|NCT00385502|Econazole|econazole|mesh-list
102604010|NCT00385502|Antifungal Agents|antifungal agents|mesh-ancestor
102604011|NCT00385502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102604012|NCT00385502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102604013|NCT00385502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102604014|NCT00385502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102604015|NCT00385502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604016|NCT00385502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102604017|NCT00385502|Hormone Antagonists|hormone antagonists|mesh-ancestor
102604018|NCT00385502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102604019|NCT00385502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604020|NCT00005630|Sargramostim|sargramostim|mesh-list
102604021|NCT00005630|Immunologic Factors|immunologic factors|mesh-ancestor
102604022|NCT00005630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604023|NCT00005636|Pemetrexed|pemetrexed|mesh-list
102604024|NCT00005636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604025|NCT00005636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102604026|NCT00005636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604027|NCT00005636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102604028|NCT00005636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102604029|NCT00005642|Semaxinib|semaxinib|mesh-list
102604030|NCT00005642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102604031|NCT00005642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102604032|NCT00005642|Growth Substances|growth substances|mesh-ancestor
102604033|NCT00005642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604034|NCT00005642|Growth Inhibitors|growth inhibitors|mesh-ancestor
102604035|NCT00005642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604036|NCT00005642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102604037|NCT00005642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102604038|NCT00005642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604039|NCT00005648|Gemcitabine|gemcitabine|mesh-list
102604040|NCT00005648|Tipifarnib|tipifarnib|mesh-list
102604041|NCT00005648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102604042|NCT00005648|Antimetabolites|antimetabolites|mesh-ancestor
102604043|NCT00005648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604044|NCT00005648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604045|NCT00005654|Metformin|metformin|mesh-list
102604046|NCT00005654|Clomiphene|clomiphene|mesh-list
102604047|NCT00005654|Enclomiphene|enclomiphene|mesh-list
102604048|NCT00005654|Zuclomiphene|zuclomiphene|mesh-list
102604049|NCT00005654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102604050|NCT00005654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604051|NCT00005654|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102604052|NCT00005654|Hormone Antagonists|hormone antagonists|mesh-ancestor
102604053|NCT00005654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102604054|NCT00005654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102604055|NCT00005654|Fertility Agents|fertility agents|mesh-ancestor
102604056|NCT00005654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102604057|NCT00005654|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102604058|NCT00005654|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102604059|NCT00005684|Heparin|heparin|mesh-list
102604060|NCT00005684|Warfarin|warfarin|mesh-list
102604061|NCT00005684|Anticoagulants|anticoagulants|mesh-ancestor
102604062|NCT00005684|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102604063|NCT00005684|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102604064|NCT00005684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604065|NCT00386282|Misoprostol|misoprostol|mesh-list
102604066|NCT00386282|Mifepristone|mifepristone|mesh-list
102604067|NCT00386282|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102604068|NCT00386282|Abortifacient Agents|abortifacient agents|mesh-ancestor
102604069|NCT00386282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102604070|NCT00386282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604071|NCT00386282|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102604072|NCT00386282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102604073|NCT00386282|Oxytocics|oxytocics|mesh-ancestor
102604074|NCT00386282|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102604075|NCT00386282|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102604076|NCT00386282|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102604077|NCT00386282|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102604078|NCT00386282|Contraceptive Agents|contraceptive agents|mesh-ancestor
102604079|NCT00386282|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102150913|NCT05849597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102604080|NCT00386282|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102604081|NCT00386282|Hormone Antagonists|hormone antagonists|mesh-ancestor
102604082|NCT00386282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102604083|NCT00386282|Luteolytic Agents|luteolytic agents|mesh-ancestor
102604084|NCT00386282|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102604085|NCT00386282|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102604086|NCT04456699|Leucovorin|leucovorin|mesh-list
102604087|NCT04456699|Bevacizumab|bevacizumab|mesh-list
102604088|NCT04456699|Fluorouracil|fluorouracil|mesh-list
102604089|NCT04456699|Capecitabine|capecitabine|mesh-list
102604090|NCT04456699|Olaparib|olaparib|mesh-list
102604091|NCT04456699|Levoleucovorin|levoleucovorin|mesh-list
102604092|NCT04456699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102604093|NCT04456699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604094|NCT04456699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102604095|NCT04456699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102604096|NCT04456699|Growth Substances|growth substances|mesh-ancestor
102604097|NCT04456699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604098|NCT04456699|Growth Inhibitors|growth inhibitors|mesh-ancestor
102604099|NCT04456699|Antimetabolites|antimetabolites|mesh-ancestor
102604100|NCT04456699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604101|NCT04456699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102604102|NCT04456699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102604103|NCT04456699|Immunologic Factors|immunologic factors|mesh-ancestor
102604104|NCT04456699|Antidotes|antidotes|mesh-ancestor
102604105|NCT04456699|Protective Agents|protective agents|mesh-ancestor
102604106|NCT04456699|Vitamin B Complex|vitamin b complex|mesh-ancestor
102604107|NCT04456699|Vitamins|vitamins|mesh-ancestor
102604108|NCT04456699|Micronutrients|micronutrients|mesh-ancestor
102604109|NCT04456699|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102604110|NCT04456699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102604111|NCT00385658|Simvastatin|simvastatin|mesh-list
102604112|NCT00385658|Ezetimibe|ezetimibe|mesh-list
102604113|NCT00385658|Fenofibrate|fenofibrate|mesh-list
102604114|NCT00385658|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102604115|NCT00385658|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102604116|NCT00385658|Antimetabolites|antimetabolites|mesh-ancestor
102604117|NCT00385658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604118|NCT00385658|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102604119|NCT00385658|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102604120|NCT00385658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102604121|NCT00005762|Ritonavir|ritonavir|mesh-list
102604122|NCT00005762|Nelfinavir|nelfinavir|mesh-list
102604123|NCT00005762|Indinavir|indinavir|mesh-list
102604124|NCT00005762|Saquinavir|saquinavir|mesh-list
102604125|NCT00005762|Amprenavir|amprenavir|mesh-list
102604126|NCT00005762|Efavirenz|efavirenz|mesh-list
102604127|NCT00005762|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102604128|NCT00005762|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102604129|NCT00005762|Protease Inhibitors|protease inhibitors|mesh-ancestor
102604130|NCT00005762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102604131|NCT00005762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604132|NCT00005762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102604133|NCT00005762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102604134|NCT00005762|Antiviral Agents|antiviral agents|mesh-ancestor
102604135|NCT00005762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102604136|NCT00005762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102604137|NCT00005762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102604138|NCT00005762|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102604139|NCT00005762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102604140|NCT00005762|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102604141|NCT00005762|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102604142|NCT00005762|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102604143|NCT00005762|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102604144|NCT00005762|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102604145|NCT00005762|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102604146|NCT00005762|Antitubercular Agents|antitubercular agents|mesh-ancestor
102604147|NCT00005762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102604148|NCT00005768|Estrogens|estrogens|mesh-list
102604149|NCT00005768|Hormones|hormones|mesh-ancestor
102604150|NCT00005768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102604151|NCT00005768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604152|NCT00005774|Pulmonary Surfactants|pulmonary surfactants|mesh-list
102604153|NCT00005774|Respiratory System Agents|respiratory system agents|mesh-ancestor
102604154|NCT00005786|Arsenic Trioxide|arsenic trioxide|mesh-list
102604155|NCT00005786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604156|NCT00005792|Etoposide|etoposide|mesh-list
102604157|NCT00005792|Melphalan|melphalan|mesh-list
102604158|NCT00005792|Topotecan|topotecan|mesh-list
102604159|NCT00005792|Etoposide phosphate|etoposide phosphate|mesh-list
102604160|NCT00005792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102604161|NCT00005792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604162|NCT00005792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102604163|NCT00005792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102604164|NCT00005792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102604165|NCT00005792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604166|NCT00005792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102604167|NCT00005792|Alkylating Agents|alkylating agents|mesh-ancestor
102604168|NCT00005792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102604169|NCT00005792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102604170|NCT00005792|Immunologic Factors|immunologic factors|mesh-ancestor
102604171|NCT00005792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604172|NCT00005792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102604173|NCT00005798|Cyclophosphamide|cyclophosphamide|mesh-list
102604174|NCT00005798|Thiotepa|thiotepa|mesh-list
102604175|NCT00005798|Carboplatin|carboplatin|mesh-list
102604176|NCT00005798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102604177|NCT00005798|Immunologic Factors|immunologic factors|mesh-ancestor
102604178|NCT00005798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604179|NCT00005798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102604180|NCT00005798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102604181|NCT00005798|Alkylating Agents|alkylating agents|mesh-ancestor
102604182|NCT00005798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604183|NCT00005798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604184|NCT00005798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102604185|NCT00005810|Carboplatin|carboplatin|mesh-list
102604186|NCT00005810|Docetaxel|docetaxel|mesh-list
102604187|NCT00005810|Estramustine|estramustine|mesh-list
102604188|NCT00005810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604189|NCT00005810|Tubulin Modulators|tubulin modulators|mesh-ancestor
102604190|NCT00005810|Antimitotic Agents|antimitotic agents|mesh-ancestor
102604191|NCT00005810|Mitosis Modulators|mitosis modulators|mesh-ancestor
102604192|NCT00005810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604193|NCT00005810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102346390|NCT04414761|Cetrorelix|cetrorelix|mesh-list
102604194|NCT00005810|Alkylating Agents|alkylating agents|mesh-ancestor
102604195|NCT00005810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102604196|NCT00385970|Leucovorin|leucovorin|mesh-list
102604197|NCT00385970|polysaccharide-K|polysaccharide-k|mesh-list
102604198|NCT00385970|Tegafur|tegafur|mesh-list
102604199|NCT00385970|Calcium|calcium|mesh-list
102604200|NCT00385970|Levoleucovorin|levoleucovorin|mesh-list
102604201|NCT00385970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102604202|NCT00385970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604203|NCT00385970|Antidotes|antidotes|mesh-ancestor
102604204|NCT00385970|Protective Agents|protective agents|mesh-ancestor
102604205|NCT00385970|Vitamin B Complex|vitamin b complex|mesh-ancestor
102604206|NCT00385970|Vitamins|vitamins|mesh-ancestor
102604207|NCT00385970|Micronutrients|micronutrients|mesh-ancestor
102604208|NCT00385970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102604209|NCT00385970|Antimetabolites|antimetabolites|mesh-ancestor
102604210|NCT00385970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604211|NCT00385970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604212|NCT00385970|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102604213|NCT00385970|Immunologic Factors|immunologic factors|mesh-ancestor
102604214|NCT00385970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102604215|NCT00385970|Antiviral Agents|antiviral agents|mesh-ancestor
102604216|NCT00385970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102604217|NCT00385970|Interferon Inducers|interferon inducers|mesh-ancestor
102604218|NCT00385970|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102604219|NCT05006677|Vitamin K|vitamin k|mesh-list
102604220|NCT05006677|Anticoagulants|anticoagulants|mesh-list
102604221|NCT05006677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
102604222|NCT05006677|Vitamins|vitamins|mesh-ancestor
102604223|NCT05006677|Micronutrients|micronutrients|mesh-ancestor
102604224|NCT05006677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604225|NCT05006677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102604226|NCT05006677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102604227|NCT05006677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604228|NCT05006677|Hemostatics|hemostatics|mesh-ancestor
102604229|NCT05006677|Coagulants|coagulants|mesh-ancestor
102604230|NCT00386126|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102604231|NCT00386126|Hematinics|hematinics|mesh-ancestor
102604232|NCT05296603|Lenvatinib|lenvatinib|mesh-list
102604233|NCT05296603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604234|NCT05296603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102604235|NCT05296603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102604236|NCT05296603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604237|NCT04569890|Hydroxychloroquine|hydroxychloroquine|mesh-list
102604238|NCT04569890|Prednisone|prednisone|mesh-list
102604239|NCT04569890|Certolizumab Pegol|certolizumab pegol|mesh-list
102604240|NCT04569890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102604241|NCT04569890|Glucocorticoids|glucocorticoids|mesh-ancestor
102604242|NCT04569890|Hormones|hormones|mesh-ancestor
102604243|NCT04569890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102604244|NCT04569890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604245|NCT04569890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102604246|NCT04569890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604247|NCT04569890|Antimalarials|antimalarials|mesh-ancestor
102604248|NCT04569890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102604249|NCT04569890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102604250|NCT04569890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102604251|NCT04569890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102604252|NCT04569890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604253|NCT04569890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102604254|NCT04569890|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102604255|NCT04569890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102604256|NCT04569890|Immunologic Factors|immunologic factors|mesh-ancestor
102604257|NCT00423163|Voriconazole|voriconazole|mesh-list
102604258|NCT00423163|Micafungin|micafungin|mesh-list
102604259|NCT00423163|Antifungal Agents|antifungal agents|mesh-ancestor
102604260|NCT00423163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102604261|NCT00423163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102604262|NCT00423163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102604263|NCT00423163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102604264|NCT00423163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604265|NCT00423163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102604266|NCT00423163|Hormone Antagonists|hormone antagonists|mesh-ancestor
102604267|NCT00423163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102346401|NCT04414761|Contraceptive Agents|contraceptive agents|mesh-ancestor
102604268|NCT00423163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604269|NCT00423163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102604270|NCT04379635|Paclitaxel|paclitaxel|mesh-list
102604271|NCT04379635|Carboplatin|carboplatin|mesh-list
102604272|NCT04379635|Pemetrexed|pemetrexed|mesh-list
102604273|NCT04379635|Tislelizumab|tislelizumab|mesh-list
102604274|NCT04379635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102604275|NCT04379635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604276|NCT04379635|Tubulin Modulators|tubulin modulators|mesh-ancestor
102604277|NCT04379635|Antimitotic Agents|antimitotic agents|mesh-ancestor
102604278|NCT04379635|Mitosis Modulators|mitosis modulators|mesh-ancestor
102604279|NCT04379635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604280|NCT04379635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102604281|NCT04379635|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102604282|NCT04379635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102604283|NCT04379635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102604284|NCT04568876|Palmidrol|palmidrol|mesh-list
102604285|NCT04568876|Analgesics|analgesics|mesh-ancestor
102604286|NCT04568876|Sensory System Agents|sensory system agents|mesh-ancestor
102604287|NCT04568876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102604288|NCT04568876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604289|NCT04568876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102604290|NCT04568876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102604291|NCT04568876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102604292|NCT04568876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102604293|NCT04568876|Antiviral Agents|antiviral agents|mesh-ancestor
102604294|NCT04568876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102604295|NCT04568876|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102604296|NCT04568876|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102604297|NCT04568876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102604298|NCT04568876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604299|NCT04568876|Hormones|hormones|mesh-ancestor
102604300|NCT04568876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102604301|NCT02210702|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102604302|NCT02210702|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102604303|NCT02210702|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102604304|NCT02210702|Norethindrone|norethindrone|mesh-list
102604305|NCT02210702|Norethindrone Acetate|norethindrone acetate|mesh-list
102604306|NCT02210702|Estradiol|estradiol|mesh-list
102151134|NCT05947669|Methylprednisolone|methylprednisolone|mesh-list
102604307|NCT02210702|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102604308|NCT02210702|Estrogens|estrogens|mesh-ancestor
102604309|NCT02210702|Hormones|hormones|mesh-ancestor
102604310|NCT02210702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102604311|NCT02210702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604312|NCT02210702|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102604313|NCT02210702|Contraceptive Agents|contraceptive agents|mesh-ancestor
102604314|NCT02210702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102604315|NCT02210702|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102604316|NCT02210702|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102604317|NCT02210702|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102604318|NCT02210702|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102604319|NCT04568096|Tamoxifen|tamoxifen|mesh-list
102604320|NCT04568096|Tretinoin|tretinoin|mesh-list
102604321|NCT04568096|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102604322|NCT04568096|Hormone Antagonists|hormone antagonists|mesh-ancestor
102604323|NCT04568096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102604324|NCT04568096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604325|NCT04568096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102604326|NCT04568096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604327|NCT04568096|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102604328|NCT04568096|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102604329|NCT04568096|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102604330|NCT04568096|Keratolytic Agents|keratolytic agents|mesh-ancestor
102604331|NCT04568096|Dermatologic Agents|dermatologic agents|mesh-ancestor
102604332|NCT04568018|Pulmonary Surfactants|pulmonary surfactants|mesh-list
102604333|NCT04568018|Respiratory System Agents|respiratory system agents|mesh-ancestor
102604334|NCT02278172|Vitamin D|vitamin d|mesh-list
102604335|NCT02278172|Ergocalciferols|ergocalciferols|mesh-list
102604336|NCT02278172|Cholecalciferol|cholecalciferol|mesh-list
102604337|NCT02278172|Vitamins|vitamins|mesh-list
102604338|NCT02278172|Micronutrients|micronutrients|mesh-ancestor
102604339|NCT02278172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604340|NCT02278172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102604341|NCT02278172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102604342|NCT04971031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102604343|NCT04971031|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102604344|NCT04566224|Pyrithione zinc|pyrithione zinc|mesh-list
102604345|NCT04566224|Keratolytic Agents|keratolytic agents|mesh-ancestor
102604346|NCT04566224|Dermatologic Agents|dermatologic agents|mesh-ancestor
102604347|NCT02210858|Tipifarnib|tipifarnib|mesh-list
102604348|NCT02210858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604349|NCT04565678|Mitapivat|mitapivat|mesh-list
102604350|NCT04565678|Enzyme Activators|enzyme activators|mesh-ancestor
102604351|NCT04565678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604352|NCT04564430|Clonidine|clonidine|mesh-list
102604353|NCT04564430|Analgesics|analgesics|mesh-ancestor
102604354|NCT04564430|Sensory System Agents|sensory system agents|mesh-ancestor
102604355|NCT04564430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102604356|NCT04564430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604357|NCT04564430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102604358|NCT04564430|Sympatholytics|sympatholytics|mesh-ancestor
102604359|NCT04564430|Autonomic Agents|autonomic agents|mesh-ancestor
102604360|NCT04564430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102604361|NCT04564430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102604362|NCT04564430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102604363|NCT04564430|Adrenergic Agents|adrenergic agents|mesh-ancestor
102604364|NCT04564430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102604365|NCT04564430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604366|NCT04564040|Acalabrutinib|acalabrutinib|mesh-list
102604367|NCT04564040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604368|NCT00005804|Cyclophosphamide|cyclophosphamide|mesh-list
102604369|NCT00005804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102604370|NCT00005804|Immunologic Factors|immunologic factors|mesh-ancestor
102604371|NCT00005804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604372|NCT00005804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102604373|NCT00005804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102604374|NCT00005804|Alkylating Agents|alkylating agents|mesh-ancestor
102604375|NCT00005804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604376|NCT00005804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604377|NCT00005804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102604378|NCT04563962|Methamphetamine|methamphetamine|mesh-list
102604379|NCT04563962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102604380|NCT04563962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151211|NCT05947461|Diclofenac|diclofenac|mesh-list
102604381|NCT04563962|Sympathomimetics|sympathomimetics|mesh-ancestor
102604382|NCT04563962|Autonomic Agents|autonomic agents|mesh-ancestor
102604383|NCT04563962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102604384|NCT04563962|Dopamine Agents|dopamine agents|mesh-ancestor
102604385|NCT04563962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102604386|NCT04563962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604387|NCT04563962|Adrenergic Agents|adrenergic agents|mesh-ancestor
102604388|NCT04563962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102604389|NCT04563962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102604390|NCT04563962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102604391|NCT04563962|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102604392|NCT02211482|Lamivudine|lamivudine|mesh-list
102346410|NCT04414761|Fertility Agents|fertility agents|mesh-ancestor
102346411|NCT04400994|Rituximab|rituximab|mesh-list
102346412|NCT04400994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102346413|NCT04400994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346414|NCT04400994|Immunologic Factors|immunologic factors|mesh-ancestor
102346415|NCT04400994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604393|NCT02211482|Dolutegravir|dolutegravir|mesh-list
102604394|NCT02211482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102604395|NCT02211482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102604396|NCT02211482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102604397|NCT02211482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604398|NCT02211482|Antiviral Agents|antiviral agents|mesh-ancestor
102604399|NCT02211482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102604400|NCT02211482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102604401|NCT02211482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102604402|NCT02211482|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102604403|NCT02211482|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102604404|NCT04929847|Emollients|emollients|mesh-list
102604405|NCT04929847|Dermatologic Agents|dermatologic agents|mesh-ancestor
102604406|NCT04561934|Fluorides|fluorides|mesh-list
102604407|NCT04561934|Cariostatic Agents|cariostatic agents|mesh-ancestor
102604408|NCT04561934|Protective Agents|protective agents|mesh-ancestor
102604409|NCT04561934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604410|NCT04330495|Hydroxychloroquine|hydroxychloroquine|mesh-list
102604411|NCT04330495|Antimalarials|antimalarials|mesh-ancestor
102604412|NCT04330495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102604413|NCT04330495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102604414|NCT04330495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102604415|NCT04330495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102604416|NCT04330495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604417|NCT04330495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102604418|NCT04563260|Palonosetron|palonosetron|mesh-list
102604419|NCT04563260|Antiemetics|antiemetics|mesh-ancestor
102604420|NCT04563260|Autonomic Agents|autonomic agents|mesh-ancestor
102604421|NCT04563260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102604422|NCT04563260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604423|NCT04563260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102604424|NCT04563260|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102604425|NCT04563260|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102604426|NCT04563260|Serotonin Agents|serotonin agents|mesh-ancestor
102604427|NCT04563260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102604428|NCT04563260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604429|NCT04173793|Ezetimibe|ezetimibe|mesh-list
102604430|NCT04173793|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102604431|NCT04173793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102604432|NCT04173793|Antimetabolites|antimetabolites|mesh-ancestor
102604433|NCT04173793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604434|NCT04173793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102604435|NCT04561466|Bezafibrate|bezafibrate|mesh-list
102604436|NCT04561466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102604437|NCT04561466|Antimetabolites|antimetabolites|mesh-ancestor
102604438|NCT04561466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604439|NCT04561466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102604440|NCT04561856|Dexamethasone|dexamethasone|mesh-list
102604441|NCT04561856|Dexamethasone acetate|dexamethasone acetate|mesh-list
102604442|NCT04561856|BB 1101|bb 1101|mesh-list
102604443|NCT04561856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102604444|NCT04561856|Antiemetics|antiemetics|mesh-ancestor
102604445|NCT04561856|Autonomic Agents|autonomic agents|mesh-ancestor
102604446|NCT04561856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102604447|NCT04561856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604448|NCT04561856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102604449|NCT04561856|Glucocorticoids|glucocorticoids|mesh-ancestor
102604450|NCT04561856|Hormones|hormones|mesh-ancestor
102604451|NCT04561856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102604452|NCT04561856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102604453|NCT04561856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604454|NCT04561856|Protease Inhibitors|protease inhibitors|mesh-ancestor
102151283|NCT05933057|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
102604455|NCT04561856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102604456|NCT04561856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604457|NCT00382681|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102604458|NCT04173403|Ezetimibe|ezetimibe|mesh-list
102604459|NCT04173403|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102604460|NCT04173403|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102604461|NCT04173403|Antimetabolites|antimetabolites|mesh-ancestor
102604462|NCT04173403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604463|NCT04173403|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102604464|NCT03539887|Ketamine|ketamine|mesh-list
101871228|NCT03892330|Alkylating Agents|alkylating agents|mesh-ancestor
102604465|NCT03539887|Analgesics|analgesics|mesh-ancestor
102604466|NCT03539887|Sensory System Agents|sensory system agents|mesh-ancestor
102604467|NCT03539887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102604468|NCT03539887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604469|NCT03539887|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102604470|NCT03539887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102604471|NCT03539887|Anesthetics, General|anesthetics, general|mesh-ancestor
102604472|NCT03539887|Anesthetics|anesthetics|mesh-ancestor
102604473|NCT03539887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102604474|NCT03539887|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102604475|NCT03539887|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102604476|NCT03539887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102604477|NCT03539887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604478|NCT04123717|Acetaminophen|acetaminophen|mesh-list
102604479|NCT04123717|Ibuprofen|ibuprofen|mesh-list
102604480|NCT04123717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102604481|NCT04123717|Analgesics|analgesics|mesh-ancestor
102604482|NCT04123717|Sensory System Agents|sensory system agents|mesh-ancestor
102604483|NCT04123717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102604484|NCT04123717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604485|NCT04123717|Antipyretics|antipyretics|mesh-ancestor
102604486|NCT04123717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102604487|NCT04123717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102604488|NCT04123717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102604489|NCT04123717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102604490|NCT04123717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102604491|NCT04123717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604492|NCT03472495|Diltiazem|diltiazem|mesh-list
102604493|NCT03472495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102604494|NCT03472495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102604495|NCT03472495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102604496|NCT03472495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604497|NCT03472495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102604498|NCT03472495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604499|NCT03472495|Vasodilator Agents|vasodilator agents|mesh-ancestor
102604500|NCT04094701|Analgesics, Opioid|analgesics, opioid|mesh-list
102604501|NCT04094701|Narcotics|narcotics|mesh-ancestor
102604502|NCT04094701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102604503|NCT04094701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604504|NCT04094701|Analgesics|analgesics|mesh-ancestor
102604505|NCT04094701|Sensory System Agents|sensory system agents|mesh-ancestor
102604506|NCT04094701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102604507|NCT03351361|Nivolumab|nivolumab|mesh-list
102604508|NCT03351361|Ipilimumab|ipilimumab|mesh-list
102604509|NCT03351361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102604510|NCT03351361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604511|NCT03351361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102604512|NCT03351361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604513|NCT03234907|Vedolizumab|vedolizumab|mesh-list
102604514|NCT03234907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102604515|NCT04330027|Mitogens|mitogens|mesh-list
102604516|NCT04330027|Mitosis Modulators|mitosis modulators|mesh-ancestor
102604517|NCT04330027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604518|NCT00002893|Leucovorin|leucovorin|mesh-list
102604519|NCT00002893|Fluorouracil|fluorouracil|mesh-list
102604520|NCT00002893|Raltitrexed|raltitrexed|mesh-list
102604521|NCT00002893|Calcium|calcium|mesh-list
102604522|NCT00002893|Levoleucovorin|levoleucovorin|mesh-list
102604523|NCT00002893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102604524|NCT00002893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604525|NCT00002893|Antimetabolites|antimetabolites|mesh-ancestor
102604526|NCT00002893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604527|NCT00002893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102604528|NCT00002893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604529|NCT00002893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102604530|NCT00002893|Immunologic Factors|immunologic factors|mesh-ancestor
102604532|NCT00002893|Protective Agents|protective agents|mesh-ancestor
102604533|NCT00002893|Vitamin B Complex|vitamin b complex|mesh-ancestor
102604534|NCT00002893|Vitamins|vitamins|mesh-ancestor
102604535|NCT00002893|Micronutrients|micronutrients|mesh-ancestor
102604536|NCT00002893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102604537|NCT00002893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102604538|NCT03905941|Metformin|metformin|mesh-list
102604539|NCT03905941|Contraceptive Agents|contraceptive agents|mesh-list
102604540|NCT03905941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102604541|NCT03905941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604542|NCT03905941|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102604543|NCT03818581|Suvorexant|suvorexant|mesh-list
102604544|NCT03818581|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102604545|NCT03818581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102604546|NCT03818581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102604547|NCT03818581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604548|NCT03818581|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102604549|NCT03818581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102604550|NCT03818581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604551|NCT00002905|Zidovudine|zidovudine|mesh-list
102604552|NCT00002905|Didanosine|didanosine|mesh-list
102604553|NCT00002905|Cyclophosphamide|cyclophosphamide|mesh-list
102604554|NCT00002905|Prednimustine|prednimustine|mesh-list
102604555|NCT00002905|Doxorubicin|doxorubicin|mesh-list
102604556|NCT00002905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102604557|NCT00002905|Etoposide|etoposide|mesh-list
102604558|NCT00002905|Mitoxantrone|mitoxantrone|mesh-list
102604559|NCT00002905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102604560|NCT00002905|Immunologic Factors|immunologic factors|mesh-ancestor
102604561|NCT00002905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604562|NCT00002905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102604563|NCT00002905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102604564|NCT00002905|Alkylating Agents|alkylating agents|mesh-ancestor
102604565|NCT00002905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604566|NCT00002905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604567|NCT00002905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102604568|NCT00002905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102604569|NCT00002905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102604570|NCT00002905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102604571|NCT00002905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102604572|NCT00002905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102604573|NCT00002905|Antimetabolites|antimetabolites|mesh-ancestor
102604574|NCT00002905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102604575|NCT00002905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102604576|NCT00002905|Antiviral Agents|antiviral agents|mesh-ancestor
102604577|NCT00002905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102604578|NCT00002905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102604579|NCT00002905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102604580|NCT00002905|Analgesics|analgesics|mesh-ancestor
102604581|NCT00002905|Sensory System Agents|sensory system agents|mesh-ancestor
102604582|NCT00002905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102604583|NCT00002911|Marimastat|marimastat|mesh-list
102604584|NCT00002911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102604585|NCT00002911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604586|NCT00002917|Paclitaxel|paclitaxel|mesh-list
102604587|NCT00002917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102604588|NCT00002917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604589|NCT00002917|Tubulin Modulators|tubulin modulators|mesh-ancestor
102604590|NCT00002917|Antimitotic Agents|antimitotic agents|mesh-ancestor
102604591|NCT00002917|Mitosis Modulators|mitosis modulators|mesh-ancestor
102604592|NCT00002917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604593|NCT00383695|Capecitabine|capecitabine|mesh-list
102604594|NCT00383695|Oxaliplatin|oxaliplatin|mesh-list
102604595|NCT00383695|Cetuximab|cetuximab|mesh-list
102604596|NCT00383695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102604597|NCT00383695|Antimetabolites|antimetabolites|mesh-ancestor
102604598|NCT00383695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604599|NCT00383695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604600|NCT00383695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102604601|NCT00383851|Temozolomide|temozolomide|mesh-list
102604602|NCT00383851|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
102604603|NCT00383851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102604604|NCT00383851|Alkylating Agents|alkylating agents|mesh-ancestor
102604605|NCT00383851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604606|NCT00383851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604607|NCT00383851|Chelating Agents|chelating agents|mesh-ancestor
102604608|NCT00383851|Sequestering Agents|sequestering agents|mesh-ancestor
102604609|NCT00383851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102604610|NCT00383851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102604611|NCT00383851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102604612|NCT00383851|Growth Substances|growth substances|mesh-ancestor
102604613|NCT00383851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604614|NCT00383851|Growth Inhibitors|growth inhibitors|mesh-ancestor
102604616|NCT00002923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604617|NCT00002923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102604618|NCT00002923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102604619|NCT00002923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604620|NCT02636569|Diclofenac|diclofenac|mesh-list
102604621|NCT02636569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102604622|NCT02636569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102604623|NCT02636569|Analgesics|analgesics|mesh-ancestor
102604624|NCT02636569|Sensory System Agents|sensory system agents|mesh-ancestor
102604625|NCT02636569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102604626|NCT02636569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604627|NCT02636569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102604628|NCT02636569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102604629|NCT02636569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102604630|NCT02636569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102604631|NCT02636569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604632|NCT00002935|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
102604633|NCT00002935|Trioxsalen|trioxsalen|mesh-list
102604634|NCT00002935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604635|NCT00002935|Dermatologic Agents|dermatologic agents|mesh-ancestor
102604636|NCT00002935|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102604637|NCT00002941|Cyclophosphamide|cyclophosphamide|mesh-list
102604638|NCT00002941|Carmustine|carmustine|mesh-list
102604639|NCT00002941|Etoposide|etoposide|mesh-list
102604640|NCT00002941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102604641|NCT00002941|Immunologic Factors|immunologic factors|mesh-ancestor
102604642|NCT00002941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604643|NCT00002941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102604644|NCT00002941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102604645|NCT00002941|Alkylating Agents|alkylating agents|mesh-ancestor
102604646|NCT00002941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604647|NCT00002941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604648|NCT00002941|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102604649|NCT00002941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102604650|NCT00002941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102604651|NCT00002941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102604652|NCT00002941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102604653|NCT00002953|Paclitaxel|paclitaxel|mesh-list
102604654|NCT00002953|Cyclophosphamide|cyclophosphamide|mesh-list
102604655|NCT00002953|Epirubicin|epirubicin|mesh-list
102604656|NCT00002953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102604657|NCT00002953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604658|NCT00002953|Tubulin Modulators|tubulin modulators|mesh-ancestor
102604659|NCT00002953|Antimitotic Agents|antimitotic agents|mesh-ancestor
102604660|NCT00002953|Mitosis Modulators|mitosis modulators|mesh-ancestor
102604661|NCT00002953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604662|NCT00002953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102604663|NCT00002953|Immunologic Factors|immunologic factors|mesh-ancestor
102604664|NCT00002953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604665|NCT00002953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102604666|NCT00002953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102604667|NCT00002953|Alkylating Agents|alkylating agents|mesh-ancestor
102604668|NCT00002953|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102604669|NCT00002953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102604670|NCT00002953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102604671|NCT00002953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102604672|NCT00002953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102604673|NCT03693781|Colchicine|colchicine|mesh-list
102604674|NCT03693781|Gout Suppressants|gout suppressants|mesh-ancestor
102604675|NCT03693781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102604676|NCT03693781|Tubulin Modulators|tubulin modulators|mesh-ancestor
102604677|NCT03693781|Antimitotic Agents|antimitotic agents|mesh-ancestor
102604678|NCT03693781|Mitosis Modulators|mitosis modulators|mesh-ancestor
102151505|NCT05508009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604679|NCT03693781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604680|NCT03693781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604681|NCT02283853|Interferons|interferons|mesh-list
102604682|NCT02283853|Interferon-beta|interferon-beta|mesh-list
102604683|NCT02283853|Interferon beta-1a|interferon beta-1a|mesh-list
102346431|NCT04367688|Tenofovir|tenofovir|mesh-list
102346432|NCT04367688|Emtricitabine|emtricitabine|mesh-list
102604684|NCT02283853|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102604685|NCT02283853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604686|NCT02283853|Antiviral Agents|antiviral agents|mesh-ancestor
102604687|NCT02283853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102604688|NCT02283853|Dermatologic Agents|dermatologic agents|mesh-ancestor
102604689|NCT02283853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102604690|NCT02283853|Immunologic Factors|immunologic factors|mesh-ancestor
102604691|NCT02283853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604692|NCT02283853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102604693|NCT03668041|Gabapentin|gabapentin|mesh-list
102604694|NCT03668041|Trazodone|trazodone|mesh-list
102604695|NCT03668041|Eszopiclone|eszopiclone|mesh-list
102604696|NCT03668041|Analgesics|analgesics|mesh-ancestor
102604697|NCT03668041|Sensory System Agents|sensory system agents|mesh-ancestor
102604698|NCT03668041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102604699|NCT03668041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604700|NCT03668041|Anticonvulsants|anticonvulsants|mesh-ancestor
102604701|NCT03668041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102604702|NCT03668041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102604703|NCT03668041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102604704|NCT03668041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102604705|NCT03668041|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102604706|NCT03668041|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102604707|NCT03668041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102604708|NCT03668041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604709|NCT03668041|Antimanic Agents|antimanic agents|mesh-ancestor
102604710|NCT03668041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102604711|NCT03668041|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102604712|NCT03668041|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102604713|NCT03668041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102604714|NCT03668041|Serotonin Agents|serotonin agents|mesh-ancestor
102604715|NCT03668041|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102604716|NCT03668041|Antidepressive Agents|antidepressive agents|mesh-ancestor
102604717|NCT00002965|Interferons|interferons|mesh-list
102604718|NCT00002965|Interferon-alpha|interferon-alpha|mesh-list
102604719|NCT00002965|Interferon alpha-2|interferon alpha-2|mesh-list
102604720|NCT00002965|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
102604721|NCT00002965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604722|NCT00002965|Antiviral Agents|antiviral agents|mesh-ancestor
102604723|NCT00002965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102604724|NCT00002965|Immunologic Factors|immunologic factors|mesh-ancestor
102604725|NCT00002965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604726|NCT00002971|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
102604727|NCT00002971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604728|NCT00002971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102604729|NCT00002971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604730|NCT00002977|Melphalan|melphalan|mesh-list
102604731|NCT00002977|Thiotepa|thiotepa|mesh-list
102604732|NCT00002977|Immunologic Factors|immunologic factors|mesh-ancestor
102604733|NCT00002977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604734|NCT00002977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102604735|NCT00002977|Alkylating Agents|alkylating agents|mesh-ancestor
102604736|NCT00002977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604737|NCT00002977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604738|NCT00002977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102604739|NCT00002977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102604740|NCT00003391|Antibodies|antibodies|mesh-list
102604741|NCT00003391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102604742|NCT00003391|Immunologic Factors|immunologic factors|mesh-ancestor
102604743|NCT00003391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604744|NCT00003397|Dexamethasone|dexamethasone|mesh-list
102604745|NCT00003397|Paclitaxel|paclitaxel|mesh-list
102604746|NCT00003397|Etoposide|etoposide|mesh-list
102604747|NCT00003397|Cyclophosphamide|cyclophosphamide|mesh-list
102604748|NCT00003397|Rituximab|rituximab|mesh-list
102604749|NCT00003397|Gemcitabine|gemcitabine|mesh-list
102604750|NCT00003397|Melphalan|melphalan|mesh-list
102604751|NCT00003397|Carmustine|carmustine|mesh-list
102604752|NCT00003397|Sargramostim|sargramostim|mesh-list
102604753|NCT00003397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102604754|NCT00003397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604755|NCT00003397|Tubulin Modulators|tubulin modulators|mesh-ancestor
102151612|NCT05261269|Niraparib|niraparib|mesh-list
102604756|NCT00003397|Antimitotic Agents|antimitotic agents|mesh-ancestor
102604757|NCT00003397|Mitosis Modulators|mitosis modulators|mesh-ancestor
102604758|NCT00003397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604759|NCT00003397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102604760|NCT00003397|Immunologic Factors|immunologic factors|mesh-ancestor
102604761|NCT00003397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604762|NCT00003397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102604763|NCT00003397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102604764|NCT00003397|Alkylating Agents|alkylating agents|mesh-ancestor
102604765|NCT00003397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102604766|NCT00003397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102604767|NCT00003397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102604768|NCT00003397|Antiemetics|antiemetics|mesh-ancestor
102604769|NCT00003397|Autonomic Agents|autonomic agents|mesh-ancestor
102604770|NCT00003397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102604771|NCT00003397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102604772|NCT00003397|Glucocorticoids|glucocorticoids|mesh-ancestor
102604773|NCT00003397|Hormones|hormones|mesh-ancestor
102604774|NCT00003397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102604775|NCT00003397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102604776|NCT00003397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102604777|NCT00003397|Antimetabolites|antimetabolites|mesh-ancestor
102604778|NCT00003397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102604779|NCT00003397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102604780|NCT00003397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102604781|NCT00003409|Motexafin gadolinium|motexafin gadolinium|mesh-list
102604782|NCT00003409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604783|NCT00003409|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102604784|NCT00003409|Dermatologic Agents|dermatologic agents|mesh-ancestor
102604785|NCT00003415|Topotecan|topotecan|mesh-list
102604786|NCT00003415|Amifostine|amifostine|mesh-list
102604787|NCT00003415|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102604788|NCT00003415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102604789|NCT00003415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102604790|NCT00003415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604791|NCT00003415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604792|NCT00003415|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102604793|NCT00003415|Protective Agents|protective agents|mesh-ancestor
102604794|NCT00003415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604795|NCT00002989|Cyclophosphamide|cyclophosphamide|mesh-list
102604796|NCT00002989|Melphalan|melphalan|mesh-list
102604797|NCT00002989|Busulfan|busulfan|mesh-list
102604798|NCT00002989|Idarubicin|idarubicin|mesh-list
102604799|NCT00002989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102604800|NCT00002989|Immunologic Factors|immunologic factors|mesh-ancestor
102604801|NCT00002989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604802|NCT00002989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102604803|NCT00002989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102604804|NCT00002989|Alkylating Agents|alkylating agents|mesh-ancestor
102604805|NCT00002989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604806|NCT00002989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604807|NCT00002989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102604808|NCT00002989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102604809|NCT00002989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102604810|NCT00002989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102346438|NCT04367688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346439|NCT04367688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102346440|NCT04367688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102346446|NCT04318678|Cyclophosphamide|cyclophosphamide|mesh-list
102346447|NCT04318678|Rituximab|rituximab|mesh-list
102604811|NCT00002989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102604812|NCT00002995|Dactinomycin|dactinomycin|mesh-list
102604813|NCT00002995|Cyclophosphamide|cyclophosphamide|mesh-list
102604814|NCT00002995|Vincristine|vincristine|mesh-list
102604815|NCT00002995|Sargramostim|sargramostim|mesh-list
102604816|NCT00002995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102604817|NCT00002995|Immunologic Factors|immunologic factors|mesh-ancestor
102604818|NCT00002995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604819|NCT00002995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102604820|NCT00002995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102604821|NCT00002995|Alkylating Agents|alkylating agents|mesh-ancestor
102604822|NCT00002995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604823|NCT00002995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604824|NCT00002995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102604825|NCT00002995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102604826|NCT00002995|Tubulin Modulators|tubulin modulators|mesh-ancestor
102604827|NCT00002995|Antimitotic Agents|antimitotic agents|mesh-ancestor
102604828|NCT00002995|Mitosis Modulators|mitosis modulators|mesh-ancestor
102604829|NCT00002995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102604830|NCT00002995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102604831|NCT00002995|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102604832|NCT00002995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102604833|NCT00002995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102604834|NCT00002995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102604836|NCT00003001|Gemcitabine|gemcitabine|mesh-list
102604837|NCT00003001|Fluorouracil|fluorouracil|mesh-list
102604838|NCT00003001|Calcium|calcium|mesh-list
102604839|NCT00003001|Levoleucovorin|levoleucovorin|mesh-list
102604840|NCT00003001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102604841|NCT00003001|Antimetabolites|antimetabolites|mesh-ancestor
102604842|NCT00003001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604843|NCT00003001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604844|NCT00003001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102604845|NCT00003001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604846|NCT00003001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102604847|NCT00003001|Immunologic Factors|immunologic factors|mesh-ancestor
102604848|NCT00003001|Antidotes|antidotes|mesh-ancestor
102604849|NCT00003001|Protective Agents|protective agents|mesh-ancestor
102604850|NCT00003001|Vitamin B Complex|vitamin b complex|mesh-ancestor
102604851|NCT00003001|Vitamins|vitamins|mesh-ancestor
102604852|NCT00003001|Micronutrients|micronutrients|mesh-ancestor
102604853|NCT00003421|Prednisolone|prednisolone|mesh-list
102604854|NCT00003421|Doxorubicin|doxorubicin|mesh-list
102604855|NCT00003421|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102604856|NCT00003421|Bleomycin|bleomycin|mesh-list
102604857|NCT00003421|Etoposide|etoposide|mesh-list
102604858|NCT00003421|Vincristine|vincristine|mesh-list
102604859|NCT00003421|Dacarbazine|dacarbazine|mesh-list
102604860|NCT00003421|Vinblastine|vinblastine|mesh-list
102604861|NCT00003421|Procarbazine|procarbazine|mesh-list
102604862|NCT00003421|Chlorambucil|chlorambucil|mesh-list
102604863|NCT00003421|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102604864|NCT00003421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604865|NCT00003421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102604866|NCT00003421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102604867|NCT00003421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102604868|NCT00003421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604869|NCT00003421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102604870|NCT00003421|Tubulin Modulators|tubulin modulators|mesh-ancestor
102604871|NCT00003421|Antimitotic Agents|antimitotic agents|mesh-ancestor
102604872|NCT00003421|Mitosis Modulators|mitosis modulators|mesh-ancestor
102604873|NCT00003421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102604874|NCT00003421|Glucocorticoids|glucocorticoids|mesh-ancestor
102604875|NCT00003421|Hormones|hormones|mesh-ancestor
102604876|NCT00003421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102604877|NCT00003421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604878|NCT00003421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102604879|NCT00003421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102604880|NCT00003421|Alkylating Agents|alkylating agents|mesh-ancestor
102604881|NCT00003427|Oxaliplatin|oxaliplatin|mesh-list
102604882|NCT00003427|Irinotecan|irinotecan|mesh-list
102604883|NCT00003427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604884|NCT00003427|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102604885|NCT00003427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102604886|NCT00003427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102604887|NCT00003427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604888|NCT00003439|Interleukin-12|interleukin-12|mesh-list
102604889|NCT00003439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102604890|NCT00003439|Immunologic Factors|immunologic factors|mesh-ancestor
102604891|NCT00003439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604892|NCT00003439|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102604893|NCT00003439|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102604894|NCT00003439|Growth Substances|growth substances|mesh-ancestor
102604895|NCT00003439|Growth Inhibitors|growth inhibitors|mesh-ancestor
102604896|NCT00003439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604897|NCT00003007|Interferons|interferons|mesh-list
102604898|NCT00003007|Interferon-alpha|interferon-alpha|mesh-list
102604899|NCT00003007|Dexamethasone|dexamethasone|mesh-list
102604900|NCT00003007|Cyclophosphamide|cyclophosphamide|mesh-list
102604901|NCT00003007|Melphalan|melphalan|mesh-list
102604902|NCT00003007|Sargramostim|sargramostim|mesh-list
102604903|NCT00003007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102604904|NCT00003007|Immunologic Factors|immunologic factors|mesh-ancestor
102604905|NCT00003007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151730|NCT04877821|Antimitotic Agents|antimitotic agents|mesh-ancestor
102604906|NCT00003007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102604907|NCT00003007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102604908|NCT00003007|Alkylating Agents|alkylating agents|mesh-ancestor
102604909|NCT00003007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604910|NCT00003007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604911|NCT00003007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102604912|NCT00003007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102604913|NCT00003007|Antiemetics|antiemetics|mesh-ancestor
102604914|NCT00003007|Autonomic Agents|autonomic agents|mesh-ancestor
102604915|NCT00003007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102604916|NCT00003007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102604917|NCT00003007|Glucocorticoids|glucocorticoids|mesh-ancestor
102604918|NCT00003007|Hormones|hormones|mesh-ancestor
102604919|NCT00003007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102604920|NCT00003007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102604921|NCT00003007|Antiviral Agents|antiviral agents|mesh-ancestor
102604922|NCT00003007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102604923|NCT01478035|Phenytoin|phenytoin|mesh-list
102604924|NCT01478035|Anticonvulsants|anticonvulsants|mesh-ancestor
102604925|NCT01478035|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102604926|NCT01478035|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102604927|NCT01478035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102604928|NCT01478035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604929|NCT01478035|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102604930|NCT01478035|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102604931|NCT00003013|Tamoxifen|tamoxifen|mesh-list
102604932|NCT00003013|Paclitaxel|paclitaxel|mesh-list
102604933|NCT00003013|Cyclophosphamide|cyclophosphamide|mesh-list
102604934|NCT00003013|Doxorubicin|doxorubicin|mesh-list
102604935|NCT00003013|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102604936|NCT00003013|Fluorouracil|fluorouracil|mesh-list
102604937|NCT00003013|Methotrexate|methotrexate|mesh-list
102604938|NCT00003013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102604939|NCT00003013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604940|NCT00003013|Tubulin Modulators|tubulin modulators|mesh-ancestor
102604941|NCT00003013|Antimitotic Agents|antimitotic agents|mesh-ancestor
102604942|NCT00003013|Mitosis Modulators|mitosis modulators|mesh-ancestor
102604943|NCT00003013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604944|NCT00003013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102604945|NCT00003013|Immunologic Factors|immunologic factors|mesh-ancestor
102604946|NCT00003013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102604947|NCT00003013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102604948|NCT00003013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102604949|NCT00003013|Alkylating Agents|alkylating agents|mesh-ancestor
102604950|NCT00003013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102604951|NCT00003013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102604952|NCT00003013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102604953|NCT00003013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102604954|NCT00003013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102604955|NCT00003013|Antimetabolites|antimetabolites|mesh-ancestor
102604956|NCT00003013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102604957|NCT00003013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102604958|NCT00003013|Abortifacient Agents|abortifacient agents|mesh-ancestor
102604959|NCT00003013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102604960|NCT00003013|Dermatologic Agents|dermatologic agents|mesh-ancestor
102604961|NCT00003013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102604962|NCT00003013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102604963|NCT00003013|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102604964|NCT00003013|Hormone Antagonists|hormone antagonists|mesh-ancestor
102604965|NCT00003013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102604966|NCT00003013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102604967|NCT00003013|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102604968|NCT00003013|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102604969|NCT00003013|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102604970|NCT00003445|Docetaxel|docetaxel|mesh-list
102604971|NCT00003445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604972|NCT00003445|Tubulin Modulators|tubulin modulators|mesh-ancestor
102604973|NCT00003445|Antimitotic Agents|antimitotic agents|mesh-ancestor
102604974|NCT00003445|Mitosis Modulators|mitosis modulators|mesh-ancestor
102604975|NCT00003445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604976|NCT00003451|Interferons|interferons|mesh-list
102604977|NCT00003451|Interferon-alpha|interferon-alpha|mesh-list
102604978|NCT00003451|Interleukin-12|interleukin-12|mesh-list
102604979|NCT00003451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604980|NCT00003451|Antiviral Agents|antiviral agents|mesh-ancestor
102604981|NCT00003451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102604982|NCT00003451|Immunologic Factors|immunologic factors|mesh-ancestor
102604983|NCT00003451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151806|NCT04679948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102604984|NCT00003451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102604985|NCT00003451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102604986|NCT00003451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102604987|NCT00003451|Growth Substances|growth substances|mesh-ancestor
102604988|NCT00003451|Growth Inhibitors|growth inhibitors|mesh-ancestor
102604989|NCT00003463|Irinotecan|irinotecan|mesh-list
102604990|NCT00003463|Carmustine|carmustine|mesh-list
102604991|NCT00003463|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102604992|NCT00003463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102604993|NCT00003463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102604994|NCT00003463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102604995|NCT00003463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102604996|NCT00003463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102604997|NCT00003463|Alkylating Agents|alkylating agents|mesh-ancestor
102604998|NCT00003019|Methotrexate|methotrexate|mesh-list
102604999|NCT00003019|Vinblastine|vinblastine|mesh-list
102605000|NCT00003019|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102605001|NCT00003019|Abortifacient Agents|abortifacient agents|mesh-ancestor
102605002|NCT00003019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102605003|NCT00003019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605004|NCT00003019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102605005|NCT00003019|Antimetabolites|antimetabolites|mesh-ancestor
102605006|NCT00003019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605007|NCT00003019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605008|NCT00003019|Dermatologic Agents|dermatologic agents|mesh-ancestor
102605009|NCT00003019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102605010|NCT00003019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102605011|NCT00003019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102605012|NCT00003019|Immunologic Factors|immunologic factors|mesh-ancestor
102605013|NCT00003019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102605014|NCT00003019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102605015|NCT00003019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102605016|NCT00003019|Tubulin Modulators|tubulin modulators|mesh-ancestor
102605017|NCT00003019|Antimitotic Agents|antimitotic agents|mesh-ancestor
102605018|NCT00003019|Mitosis Modulators|mitosis modulators|mesh-ancestor
102605019|NCT00003493|Dexamethasone|dexamethasone|mesh-list
102605020|NCT00003493|Doxorubicin|doxorubicin|mesh-list
102605021|NCT00003493|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102605022|NCT00003493|Vincristine|vincristine|mesh-list
102605023|NCT00003493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102605024|NCT00003493|Antiemetics|antiemetics|mesh-ancestor
102605025|NCT00003493|Autonomic Agents|autonomic agents|mesh-ancestor
102605026|NCT00003493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102605027|NCT00003493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605028|NCT00003493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102605029|NCT00003493|Glucocorticoids|glucocorticoids|mesh-ancestor
102605030|NCT00003493|Hormones|hormones|mesh-ancestor
102605031|NCT00003493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102605032|NCT00003493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102605033|NCT00003493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605034|NCT00003493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102605035|NCT00003493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102605036|NCT00003493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102605037|NCT00003493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102605038|NCT00003493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605039|NCT00003493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102605040|NCT00003493|Tubulin Modulators|tubulin modulators|mesh-ancestor
102605041|NCT00003493|Antimitotic Agents|antimitotic agents|mesh-ancestor
102605042|NCT00003493|Mitosis Modulators|mitosis modulators|mesh-ancestor
102605043|NCT00003031|Voriconazole|voriconazole|mesh-list
102605044|NCT00003031|Amphotericin B|amphotericin b|mesh-list
102605045|NCT00003031|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102605046|NCT00003031|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
102605047|NCT00003031|Deoxycholic Acid|deoxycholic acid|mesh-list
102605048|NCT00003031|Antifungal Agents|antifungal agents|mesh-ancestor
102605049|NCT00003031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102605050|NCT00003031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102605051|NCT00003031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102605052|NCT00003031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102605053|NCT00003031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605054|NCT00003031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102605055|NCT00003031|Hormone Antagonists|hormone antagonists|mesh-ancestor
102605056|NCT00003031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102605057|NCT00003031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605059|NCT00003031|Amebicides|amebicides|mesh-ancestor
102605060|NCT00003031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102605061|NCT00003031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102605062|NCT00003031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102605063|NCT00003031|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102605064|NCT00003031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102605065|NCT00003517|Leuprolide|leuprolide|mesh-list
102605066|NCT00003517|Flutamide|flutamide|mesh-list
102605067|NCT00003517|Bicalutamide|bicalutamide|mesh-list
102605068|NCT00003517|Hormones|hormones|mesh-list
102605069|NCT00003517|Androgen Antagonists|androgen antagonists|mesh-list
102605070|NCT00003517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102605071|NCT00003517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605072|NCT00003517|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102605073|NCT00003517|Fertility Agents|fertility agents|mesh-ancestor
102605074|NCT00003517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102605075|NCT00003517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102605076|NCT00003517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605077|NCT00003517|Hormone Antagonists|hormone antagonists|mesh-ancestor
102605078|NCT00003037|Gemcitabine|gemcitabine|mesh-list
102605079|NCT00003037|Docetaxel|docetaxel|mesh-list
102605080|NCT00003037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605081|NCT00003037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102605082|NCT00003037|Antimetabolites|antimetabolites|mesh-ancestor
102605083|NCT00003037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605084|NCT00003037|Tubulin Modulators|tubulin modulators|mesh-ancestor
102605085|NCT00003037|Antimitotic Agents|antimitotic agents|mesh-ancestor
102605086|NCT00003037|Mitosis Modulators|mitosis modulators|mesh-ancestor
102605087|NCT00002803|Cyclophosphamide|cyclophosphamide|mesh-list
102605088|NCT00002803|Doxorubicin|doxorubicin|mesh-list
102605089|NCT00002803|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102605090|NCT00002803|Vincristine|vincristine|mesh-list
102605091|NCT00002803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102605092|NCT00002803|Immunologic Factors|immunologic factors|mesh-ancestor
102605093|NCT00002803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605094|NCT00002803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102605095|NCT00002803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102605096|NCT00002803|Alkylating Agents|alkylating agents|mesh-ancestor
102605097|NCT00002803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605098|NCT00002803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605099|NCT00002803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102605100|NCT00002803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102605101|NCT00002803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102605102|NCT00002803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102605103|NCT00002803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102605104|NCT00002803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102605105|NCT00002803|Tubulin Modulators|tubulin modulators|mesh-ancestor
102605106|NCT00002803|Antimitotic Agents|antimitotic agents|mesh-ancestor
102605107|NCT00002803|Mitosis Modulators|mitosis modulators|mesh-ancestor
102605108|NCT00383929|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102605109|NCT00383929|Candesartan|candesartan|mesh-list
102605110|NCT00383929|Candesartan cilexetil|candesartan cilexetil|mesh-list
102605111|NCT00383929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102605112|NCT00383929|Diuretics|diuretics|mesh-ancestor
102605113|NCT00383929|Natriuretic Agents|natriuretic agents|mesh-ancestor
102605114|NCT00383929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605115|NCT00383929|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102605116|NCT00383929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102605117|NCT00383929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605118|NCT00383929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102605119|NCT00383929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102605120|NCT00003541|Prednisone|prednisone|mesh-list
102605121|NCT00003541|Cyclophosphamide|cyclophosphamide|mesh-list
102605122|NCT00003541|Ifosfamide|ifosfamide|mesh-list
102605123|NCT00003541|Carboplatin|carboplatin|mesh-list
102605124|NCT00003541|Doxorubicin|doxorubicin|mesh-list
102605125|NCT00003541|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102605126|NCT00003541|Etoposide|etoposide|mesh-list
102605127|NCT00003541|Vincristine|vincristine|mesh-list
102605128|NCT00003541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102605129|NCT00003541|Immunologic Factors|immunologic factors|mesh-ancestor
102605130|NCT00003541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605131|NCT00003541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102605132|NCT00003541|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102605133|NCT00003541|Alkylating Agents|alkylating agents|mesh-ancestor
102605134|NCT00003541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605135|NCT00003541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605136|NCT00003541|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102605137|NCT00003541|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102605138|NCT00003541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102605139|NCT00003541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102605140|NCT00003541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102605141|NCT00003541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102605142|NCT00003541|Glucocorticoids|glucocorticoids|mesh-ancestor
102605143|NCT00003541|Hormones|hormones|mesh-ancestor
102605144|NCT00003541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102605145|NCT00003541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102605146|NCT00003541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102605147|NCT00003541|Tubulin Modulators|tubulin modulators|mesh-ancestor
102605148|NCT00003541|Antimitotic Agents|antimitotic agents|mesh-ancestor
102605149|NCT00003541|Mitosis Modulators|mitosis modulators|mesh-ancestor
102605150|NCT00002809|Cyclophosphamide|cyclophosphamide|mesh-list
102605151|NCT00002809|Methotrexate|methotrexate|mesh-list
102605152|NCT00002809|Tacrolimus|tacrolimus|mesh-list
102605153|NCT00002809|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102605154|NCT00002809|Sargramostim|sargramostim|mesh-list
102605155|NCT00002809|Immunoglobulins|immunoglobulins|mesh-list
102605156|NCT00002809|Antibodies|antibodies|mesh-list
102605157|NCT00002809|gamma-Globulins|gamma-globulins|mesh-list
102605158|NCT00002809|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102605159|NCT00002809|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102605160|NCT00002809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102605161|NCT00002809|Immunologic Factors|immunologic factors|mesh-ancestor
102605162|NCT00002809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605163|NCT00002809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102605164|NCT00002809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102605165|NCT00002809|Alkylating Agents|alkylating agents|mesh-ancestor
102605166|NCT00002809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605167|NCT00002809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605168|NCT00002809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102605169|NCT00002809|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102605170|NCT00002809|Abortifacient Agents|abortifacient agents|mesh-ancestor
102605171|NCT00002809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102605172|NCT00002809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102346469|NCT04284774|Tipifarnib|tipifarnib|mesh-list
102605173|NCT00002809|Antimetabolites|antimetabolites|mesh-ancestor
102605174|NCT00002809|Dermatologic Agents|dermatologic agents|mesh-ancestor
102605175|NCT00002809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102605176|NCT00002809|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102605177|NCT00002809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102605178|NCT00002809|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102605179|NCT00383539|Vaccines|vaccines|mesh-list
102605180|NCT00383539|Immunologic Factors|immunologic factors|mesh-ancestor
102605181|NCT00383539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605182|NCT00002827|Cobalt|cobalt|mesh-list
102605183|NCT00002827|Doxorubicin|doxorubicin|mesh-list
102605184|NCT00002827|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102605185|NCT00002827|Bleomycin|bleomycin|mesh-list
102605186|NCT00002827|Etoposide|etoposide|mesh-list
102605187|NCT00002827|Dexrazoxane|dexrazoxane|mesh-list
102605188|NCT00002827|Vincristine|vincristine|mesh-list
102605189|NCT00002827|Razoxane|razoxane|mesh-list
102605190|NCT00002827|Lenograstim|lenograstim|mesh-list
102605191|NCT00002827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102605192|NCT00002827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605193|NCT00002827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102605194|NCT00002827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102605195|NCT00002827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102605196|NCT00002827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605197|NCT00002827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102605198|NCT00002827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102605199|NCT00002827|Immunologic Factors|immunologic factors|mesh-ancestor
102605200|NCT00002827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152030|NCT04222972|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102152031|NCT04222972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102152040|NCT04147260|Ciprofloxacin|ciprofloxacin|mesh-list
102152041|NCT04147260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102152042|NCT04147260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102152043|NCT04147260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102152044|NCT04147260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102152045|NCT04147260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102152050|NCT04114136|Metformin|metformin|mesh-list
102605201|NCT00002827|Tubulin Modulators|tubulin modulators|mesh-ancestor
102605202|NCT00002827|Antimitotic Agents|antimitotic agents|mesh-ancestor
102605203|NCT00002827|Mitosis Modulators|mitosis modulators|mesh-ancestor
102605204|NCT00002827|Trace Elements|trace elements|mesh-ancestor
102605205|NCT00002827|Micronutrients|micronutrients|mesh-ancestor
102605206|NCT00002827|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102605207|NCT00002827|Protective Agents|protective agents|mesh-ancestor
102605208|NCT00384475|Ciclesonide|ciclesonide|mesh-list
102605209|NCT00384475|Glucocorticoids|glucocorticoids|mesh-ancestor
102605210|NCT00384475|Hormones|hormones|mesh-ancestor
102605211|NCT00384475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102605212|NCT00384475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605213|NCT00384475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102605214|NCT00003565|Docetaxel|docetaxel|mesh-list
102605215|NCT00003565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605216|NCT00003565|Tubulin Modulators|tubulin modulators|mesh-ancestor
102605217|NCT00003565|Antimitotic Agents|antimitotic agents|mesh-ancestor
102605218|NCT00003565|Mitosis Modulators|mitosis modulators|mesh-ancestor
102605219|NCT00003565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605220|NCT00003049|Leucovorin|leucovorin|mesh-list
102605221|NCT00003049|Fluorouracil|fluorouracil|mesh-list
102605222|NCT00003049|Calcium|calcium|mesh-list
102605223|NCT00003049|Levoleucovorin|levoleucovorin|mesh-list
102605224|NCT00003049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102605225|NCT00003049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605226|NCT00003049|Antimetabolites|antimetabolites|mesh-ancestor
102605227|NCT00003049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605228|NCT00003049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102605229|NCT00003049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605230|NCT00003049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102605231|NCT00003049|Immunologic Factors|immunologic factors|mesh-ancestor
102605232|NCT00003049|Antidotes|antidotes|mesh-ancestor
102346475|NCT04267848|Pembrolizumab|pembrolizumab|mesh-list
102605233|NCT00003049|Protective Agents|protective agents|mesh-ancestor
102605234|NCT00003049|Vitamin B Complex|vitamin b complex|mesh-ancestor
102605235|NCT00003049|Vitamins|vitamins|mesh-ancestor
102605236|NCT00003049|Micronutrients|micronutrients|mesh-ancestor
102605237|NCT00003055|Irinotecan|irinotecan|mesh-list
102605238|NCT00003055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605239|NCT00003055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102605240|NCT00003055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102605241|NCT00003055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102605242|NCT00003055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605243|NCT00002833|Cytarabine|cytarabine|mesh-list
102605244|NCT00002833|Cyclosporine|cyclosporine|mesh-list
102605245|NCT00002833|Methylprednisolone|methylprednisolone|mesh-list
102605246|NCT00002833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102605247|NCT00002833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102605248|NCT00002833|Prednisolone|prednisolone|mesh-list
102605249|NCT00002833|Prednisolone acetate|prednisolone acetate|mesh-list
102605250|NCT00002833|Fludarabine|fludarabine|mesh-list
102605251|NCT00002833|Fludarabine phosphate|fludarabine phosphate|mesh-list
102605252|NCT00002833|Idarubicin|idarubicin|mesh-list
102605253|NCT00002833|Cladribine|cladribine|mesh-list
102605254|NCT00002833|Cyclosporins|cyclosporins|mesh-list
102605255|NCT00002833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102605256|NCT00002833|Prednisolone phosphate|prednisolone phosphate|mesh-list
102605257|NCT00002833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605258|NCT00002833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102605259|NCT00002833|Antimetabolites|antimetabolites|mesh-ancestor
102605260|NCT00002833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605261|NCT00002833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102605262|NCT00002833|Immunologic Factors|immunologic factors|mesh-ancestor
102605263|NCT00002833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605264|NCT00002833|Antiviral Agents|antiviral agents|mesh-ancestor
102605265|NCT00002833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102605266|NCT00002833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102605267|NCT00002833|Antifungal Agents|antifungal agents|mesh-ancestor
102605268|NCT00002833|Dermatologic Agents|dermatologic agents|mesh-ancestor
102605269|NCT00002833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102605270|NCT00002833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102605271|NCT00002833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102605272|NCT00002833|Antiemetics|antiemetics|mesh-ancestor
102605273|NCT00002833|Autonomic Agents|autonomic agents|mesh-ancestor
102605274|NCT00002833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102152104|NCT03997968|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102605275|NCT00002833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102605276|NCT00002833|Glucocorticoids|glucocorticoids|mesh-ancestor
102605277|NCT00002833|Hormones|hormones|mesh-ancestor
102605278|NCT00002833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102605279|NCT00002833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102605280|NCT00002833|Protective Agents|protective agents|mesh-ancestor
102605281|NCT00002833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102605282|NCT00002833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102605283|NCT00002833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102605284|NCT00002833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102605285|NCT00003061|Cytarabine|cytarabine|mesh-list
102605286|NCT00003061|Methotrexate|methotrexate|mesh-list
102605287|NCT00003061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102605288|NCT00003061|Abortifacient Agents|abortifacient agents|mesh-ancestor
102605289|NCT00003061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102605290|NCT00003061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605291|NCT00003061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102605292|NCT00003061|Antimetabolites|antimetabolites|mesh-ancestor
102605293|NCT00003061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605294|NCT00003061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605295|NCT00003061|Dermatologic Agents|dermatologic agents|mesh-ancestor
102605296|NCT00003061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102605297|NCT00003061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102605298|NCT00003061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102605299|NCT00003061|Immunologic Factors|immunologic factors|mesh-ancestor
102605300|NCT00003061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102605301|NCT00003061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102605302|NCT00003061|Antiviral Agents|antiviral agents|mesh-ancestor
102605303|NCT00003061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102605304|NCT00003577|Cyclophosphamide|cyclophosphamide|mesh-list
102605305|NCT00003577|Fluorouracil|fluorouracil|mesh-list
102605306|NCT00003577|Methotrexate|methotrexate|mesh-list
102605307|NCT00003577|Epirubicin|epirubicin|mesh-list
102605308|NCT00003577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102605309|NCT00003577|Immunologic Factors|immunologic factors|mesh-ancestor
102605310|NCT00003577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605311|NCT00003577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102605312|NCT00003577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102605313|NCT00003577|Alkylating Agents|alkylating agents|mesh-ancestor
102605314|NCT00003577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605315|NCT00003577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605316|NCT00003577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102605317|NCT00003577|Antimetabolites|antimetabolites|mesh-ancestor
102605318|NCT00003577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102605319|NCT00003577|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102605320|NCT00003577|Abortifacient Agents|abortifacient agents|mesh-ancestor
102605321|NCT00003577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102605322|NCT00003577|Dermatologic Agents|dermatologic agents|mesh-ancestor
102605323|NCT00003577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102605324|NCT00003577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102605325|NCT00003577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102605326|NCT00003577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102605327|NCT00003577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102605328|NCT00003577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102605329|NCT00002839|Fluorouracil|fluorouracil|mesh-list
102605330|NCT00002839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605331|NCT00002839|Antimetabolites|antimetabolites|mesh-ancestor
102605332|NCT00002839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605333|NCT00002839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102605334|NCT00002839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102605335|NCT00002839|Immunologic Factors|immunologic factors|mesh-ancestor
102605336|NCT00002839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605337|NCT00003583|Etoposide|etoposide|mesh-list
102605338|NCT00003583|Amifostine|amifostine|mesh-list
102605339|NCT00003583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605340|NCT00003583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102605341|NCT00003583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102605342|NCT00003583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102605343|NCT00003583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102605344|NCT00003583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605345|NCT00003583|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102605346|NCT00003583|Protective Agents|protective agents|mesh-ancestor
102605347|NCT00003583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605348|NCT00002845|Aldesleukin|aldesleukin|mesh-list
102605349|NCT00002845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605350|NCT00002845|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102605351|NCT00002845|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102605352|NCT00002845|Antiviral Agents|antiviral agents|mesh-ancestor
102605353|NCT00002845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102152182|NCT03741478|Serotonin Agents|serotonin agents|mesh-ancestor
102605355|NCT00003067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605356|NCT00003067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102605357|NCT00003067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102605358|NCT00003067|Antiviral Agents|antiviral agents|mesh-ancestor
102605359|NCT00003067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102605360|NCT00003589|Paclitaxel|paclitaxel|mesh-list
102605361|NCT00003589|Gemcitabine|gemcitabine|mesh-list
102605362|NCT00003589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102605363|NCT00003589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605364|NCT00003589|Tubulin Modulators|tubulin modulators|mesh-ancestor
102605365|NCT00003589|Antimitotic Agents|antimitotic agents|mesh-ancestor
102605366|NCT00003589|Mitosis Modulators|mitosis modulators|mesh-ancestor
102605367|NCT00003589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605368|NCT00003589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102605369|NCT00003589|Antimetabolites|antimetabolites|mesh-ancestor
102605370|NCT00003595|Prednisone|prednisone|mesh-list
102605371|NCT00003595|Cyclophosphamide|cyclophosphamide|mesh-list
102605372|NCT00003595|Rituximab|rituximab|mesh-list
102605373|NCT00003595|Doxorubicin|doxorubicin|mesh-list
102605374|NCT00003595|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102605375|NCT00003595|Vincristine|vincristine|mesh-list
102605376|NCT00003595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102605377|NCT00003595|Immunologic Factors|immunologic factors|mesh-ancestor
102346487|NCT04267848|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102605378|NCT00003595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605379|NCT00003595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102605380|NCT00003595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102605381|NCT00003595|Alkylating Agents|alkylating agents|mesh-ancestor
102605382|NCT00003595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605383|NCT00003595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605384|NCT00003595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102605385|NCT00003595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102605386|NCT00003595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102605387|NCT00003595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102605388|NCT00003595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102605389|NCT00003595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102605390|NCT00003595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102605391|NCT00003595|Glucocorticoids|glucocorticoids|mesh-ancestor
102605392|NCT00003595|Hormones|hormones|mesh-ancestor
102605393|NCT00003595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102605394|NCT00003595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102605395|NCT00003595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102605396|NCT00003595|Tubulin Modulators|tubulin modulators|mesh-ancestor
102605397|NCT00003595|Antimitotic Agents|antimitotic agents|mesh-ancestor
102605398|NCT00003595|Mitosis Modulators|mitosis modulators|mesh-ancestor
102605399|NCT00003073|Cytarabine|cytarabine|mesh-list
102605400|NCT00003073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102605401|NCT00003073|Antimetabolites|antimetabolites|mesh-ancestor
102605402|NCT00003073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605403|NCT00003073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605404|NCT00003073|Antiviral Agents|antiviral agents|mesh-ancestor
102605405|NCT00003073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102605406|NCT00003073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102605407|NCT00003073|Immunologic Factors|immunologic factors|mesh-ancestor
102605408|NCT00003073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605409|NCT00003079|Cytarabine|cytarabine|mesh-list
102605410|NCT00003079|Bryostatin 1|bryostatin 1|mesh-list
102605411|NCT00003079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102605412|NCT00003079|Antimetabolites|antimetabolites|mesh-ancestor
102605413|NCT00003079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605414|NCT00003079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605415|NCT00003079|Antiviral Agents|antiviral agents|mesh-ancestor
102605416|NCT00003079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102605417|NCT00003079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102605418|NCT00003079|Immunologic Factors|immunologic factors|mesh-ancestor
102605419|NCT00003079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605420|NCT00003079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102605421|NCT00002869|Interferons|interferons|mesh-list
102605422|NCT00002869|Cytarabine|cytarabine|mesh-list
102605423|NCT00002869|Interferon-alpha|interferon-alpha|mesh-list
102605424|NCT00002869|Hydroxyurea|hydroxyurea|mesh-list
102605425|NCT00002869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605426|NCT00002869|Antiviral Agents|antiviral agents|mesh-ancestor
102605427|NCT00002869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102605428|NCT00002869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102605429|NCT00002869|Antimetabolites|antimetabolites|mesh-ancestor
102605430|NCT00002869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605431|NCT00002869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102605432|NCT00002869|Immunologic Factors|immunologic factors|mesh-ancestor
102605433|NCT00002869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605434|NCT00002869|Antisickling Agents|antisickling agents|mesh-ancestor
102605435|NCT00002869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102605436|NCT00002869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102605437|NCT00002875|Cyclophosphamide|cyclophosphamide|mesh-list
102605438|NCT00002875|Lomustine|lomustine|mesh-list
102605439|NCT00002875|Cisplatin|cisplatin|mesh-list
102605440|NCT00002875|Vincristine|vincristine|mesh-list
102605441|NCT00002875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102605442|NCT00002875|Immunologic Factors|immunologic factors|mesh-ancestor
102605443|NCT00002875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605444|NCT00002875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102605445|NCT00002875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102605446|NCT00002875|Alkylating Agents|alkylating agents|mesh-ancestor
102605447|NCT00002875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605448|NCT00002875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605449|NCT00002875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102605450|NCT00002875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102605451|NCT00002875|Tubulin Modulators|tubulin modulators|mesh-ancestor
102605452|NCT00002875|Antimitotic Agents|antimitotic agents|mesh-ancestor
102605453|NCT00002875|Mitosis Modulators|mitosis modulators|mesh-ancestor
102605454|NCT00003613|Carmustine|carmustine|mesh-list
102605455|NCT00003613|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
102605456|NCT00003613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102605457|NCT00003613|Alkylating Agents|alkylating agents|mesh-ancestor
102605458|NCT00003613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605459|NCT00003613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605460|NCT00003613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102605461|NCT00002881|Suramin|suramin|mesh-list
102605462|NCT00002881|Hydrocortisone|hydrocortisone|mesh-list
102605463|NCT00002881|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102605464|NCT00002881|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102605465|NCT00002881|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102605466|NCT00002881|Leuprolide|leuprolide|mesh-list
102605467|NCT00002881|Goserelin|goserelin|mesh-list
102605468|NCT00002881|Flutamide|flutamide|mesh-list
102605469|NCT00002881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102605470|NCT00002881|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102605471|NCT00002881|Fertility Agents|fertility agents|mesh-ancestor
102605472|NCT00002881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102605473|NCT00002881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605474|NCT00002881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102605475|NCT00002881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605476|NCT00002881|Androgen Antagonists|androgen antagonists|mesh-ancestor
102605477|NCT00002881|Hormone Antagonists|hormone antagonists|mesh-ancestor
102605478|NCT00002881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102605479|NCT00002881|Antinematodal Agents|antinematodal agents|mesh-ancestor
102605480|NCT00002881|Anthelmintics|anthelmintics|mesh-ancestor
102605481|NCT00002881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102605482|NCT00002881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102605483|NCT00002881|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102605484|NCT00002881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102605485|NCT00003091|Interferons|interferons|mesh-list
102605486|NCT00003091|Interferon-alpha|interferon-alpha|mesh-list
102605487|NCT00003091|Aldesleukin|aldesleukin|mesh-list
102605488|NCT00003091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605489|NCT00003091|Antiviral Agents|antiviral agents|mesh-ancestor
102605490|NCT00003091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102605491|NCT00003091|Immunologic Factors|immunologic factors|mesh-ancestor
102605492|NCT00003091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605493|NCT00003091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102605494|NCT00003091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102605495|NCT00003619|Vitamin E|vitamin e|mesh-list
102605496|NCT00003619|Cytarabine|cytarabine|mesh-list
102605497|NCT00003619|Fludarabine|fludarabine|mesh-list
102605498|NCT00003619|Fludarabine phosphate|fludarabine phosphate|mesh-list
102605499|NCT00003619|Etoposide|etoposide|mesh-list
102605500|NCT00003619|Busulfan|busulfan|mesh-list
102605501|NCT00003619|Topotecan|topotecan|mesh-list
102605502|NCT00003619|Isotretinoin|isotretinoin|mesh-list
102605503|NCT00003619|Vitamins|vitamins|mesh-ancestor
102605504|NCT00003619|Micronutrients|micronutrients|mesh-ancestor
102605505|NCT00003619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605506|NCT00003619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605507|NCT00003619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102605508|NCT00003619|Antimetabolites|antimetabolites|mesh-ancestor
102605509|NCT00003619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605510|NCT00003619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102605511|NCT00003619|Immunologic Factors|immunologic factors|mesh-ancestor
102605512|NCT00003619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102605513|NCT00003619|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102605514|NCT00003619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102605515|NCT00003619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102605516|NCT00003619|Antiviral Agents|antiviral agents|mesh-ancestor
102605517|NCT00003619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102605518|NCT00003619|Alkylating Agents|alkylating agents|mesh-ancestor
102605519|NCT00003619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102605520|NCT00003619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102605521|NCT00003619|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102605522|NCT00003619|Antioxidants|antioxidants|mesh-ancestor
102605523|NCT00003619|Protective Agents|protective agents|mesh-ancestor
102605524|NCT00003619|Dermatologic Agents|dermatologic agents|mesh-ancestor
102605525|NCT00002887|Etoposide|etoposide|mesh-list
102605526|NCT00002887|Vinorelbine|vinorelbine|mesh-list
102605527|NCT00002887|Hydroxyurea|hydroxyurea|mesh-list
102605528|NCT00002887|Vinblastine|vinblastine|mesh-list
102605529|NCT00002887|Vindesine|vindesine|mesh-list
102605530|NCT00002887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605531|NCT00002887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102605532|NCT00002887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102605533|NCT00002887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102605534|NCT00002887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102605535|NCT00002887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605536|NCT00002887|Tubulin Modulators|tubulin modulators|mesh-ancestor
102605537|NCT00002887|Antimitotic Agents|antimitotic agents|mesh-ancestor
102605538|NCT00002887|Mitosis Modulators|mitosis modulators|mesh-ancestor
102605539|NCT00002887|Antisickling Agents|antisickling agents|mesh-ancestor
102605540|NCT00002887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102605541|NCT00003937|Cisplatin|cisplatin|mesh-list
102605542|NCT00003937|Doxorubicin|doxorubicin|mesh-list
102605543|NCT00003937|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102605544|NCT00003937|Methotrexate|methotrexate|mesh-list
102605545|NCT00003937|Etoposide|etoposide|mesh-list
102605546|NCT00003937|Ifosfamide|ifosfamide|mesh-list
102605547|NCT00003937|Dexrazoxane|dexrazoxane|mesh-list
102605548|NCT00003937|Razoxane|razoxane|mesh-list
102605549|NCT00003937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605550|NCT00003937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102605551|NCT00003937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102605552|NCT00003937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102605553|NCT00003937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102605554|NCT00003937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605555|NCT00003937|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102605556|NCT00003937|Abortifacient Agents|abortifacient agents|mesh-ancestor
102605557|NCT00003937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102605558|NCT00003937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605559|NCT00003937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102605560|NCT00003937|Antimetabolites|antimetabolites|mesh-ancestor
102605561|NCT00003937|Dermatologic Agents|dermatologic agents|mesh-ancestor
102605562|NCT00003937|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102605563|NCT00003937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102605564|NCT00003937|Immunologic Factors|immunologic factors|mesh-ancestor
102605565|NCT00003937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102605566|NCT00003937|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102605567|NCT00003937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102605568|NCT00003937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102605569|NCT00003937|Alkylating Agents|alkylating agents|mesh-ancestor
102605570|NCT00003937|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102605571|NCT00003937|Protective Agents|protective agents|mesh-ancestor
102605572|NCT00003937|Antimitotic Agents|antimitotic agents|mesh-ancestor
102605573|NCT00003937|Mitosis Modulators|mitosis modulators|mesh-ancestor
102605574|NCT00003625|Cyclosporine|cyclosporine|mesh-list
102605575|NCT00003625|Etoposide|etoposide|mesh-list
102605576|NCT00003625|Vincristine|vincristine|mesh-list
102605577|NCT00003625|Cyclosporins|cyclosporins|mesh-list
102605578|NCT00003625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102605579|NCT00003625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605580|NCT00003625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102605581|NCT00003625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102605582|NCT00003625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102605583|NCT00003625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605584|NCT00003625|Tubulin Modulators|tubulin modulators|mesh-ancestor
102605585|NCT00003625|Antimitotic Agents|antimitotic agents|mesh-ancestor
102605587|NCT00003625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102605588|NCT00003625|Immunologic Factors|immunologic factors|mesh-ancestor
102605589|NCT00003625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605590|NCT00003625|Antifungal Agents|antifungal agents|mesh-ancestor
102605591|NCT00003625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102605592|NCT00003625|Dermatologic Agents|dermatologic agents|mesh-ancestor
102605593|NCT00003625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102605594|NCT00003625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102605595|NCT00003637|Fluorouracil|fluorouracil|mesh-list
102605596|NCT00003637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605597|NCT00003637|Antimetabolites|antimetabolites|mesh-ancestor
102605598|NCT00003637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605599|NCT00003637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102605600|NCT00003637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102605601|NCT00003637|Immunologic Factors|immunologic factors|mesh-ancestor
102605602|NCT00003637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605603|NCT00003943|Paclitaxel|paclitaxel|mesh-list
102605604|NCT00003943|Cyclophosphamide|cyclophosphamide|mesh-list
102605605|NCT00003943|Carboplatin|carboplatin|mesh-list
102605606|NCT00003943|Topotecan|topotecan|mesh-list
102605607|NCT00003943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102605608|NCT00003943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605609|NCT00003943|Tubulin Modulators|tubulin modulators|mesh-ancestor
102605610|NCT00003943|Antimitotic Agents|antimitotic agents|mesh-ancestor
102605611|NCT00003943|Mitosis Modulators|mitosis modulators|mesh-ancestor
102605612|NCT00003943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605613|NCT00003943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102605614|NCT00003943|Immunologic Factors|immunologic factors|mesh-ancestor
102605615|NCT00003943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605616|NCT00003943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102605617|NCT00003943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102605618|NCT00003943|Alkylating Agents|alkylating agents|mesh-ancestor
102605619|NCT00003943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102605620|NCT00003943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102605621|NCT00003943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102605622|NCT00003943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102605623|NCT00003955|Dactinomycin|dactinomycin|mesh-list
102605624|NCT00003955|Cyclophosphamide|cyclophosphamide|mesh-list
102605625|NCT00003955|Irinotecan|irinotecan|mesh-list
102605626|NCT00003955|Vincristine|vincristine|mesh-list
102605627|NCT00003955|Sargramostim|sargramostim|mesh-list
102605628|NCT00003955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102605629|NCT00003955|Immunologic Factors|immunologic factors|mesh-ancestor
102605630|NCT00003955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605631|NCT00003955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102605632|NCT00003955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102605633|NCT00003955|Alkylating Agents|alkylating agents|mesh-ancestor
102605634|NCT00003955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605635|NCT00003955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605636|NCT00003955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102605637|NCT00003955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102605638|NCT00003955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102605639|NCT00003955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102605640|NCT00003955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102605641|NCT00003955|Tubulin Modulators|tubulin modulators|mesh-ancestor
102605642|NCT00003955|Antimitotic Agents|antimitotic agents|mesh-ancestor
102605643|NCT00003955|Mitosis Modulators|mitosis modulators|mesh-ancestor
102605644|NCT00003955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102605645|NCT00003955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102605646|NCT00003955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102605647|NCT00003955|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102605648|NCT00003955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102605649|NCT00003103|Docetaxel|docetaxel|mesh-list
102605650|NCT00003103|Oblimersen|oblimersen|mesh-list
102605651|NCT00003103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605652|NCT00003103|Tubulin Modulators|tubulin modulators|mesh-ancestor
102605653|NCT00003103|Antimitotic Agents|antimitotic agents|mesh-ancestor
102605654|NCT00003103|Mitosis Modulators|mitosis modulators|mesh-ancestor
102605655|NCT00003103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605656|NCT00003109|Irinotecan|irinotecan|mesh-list
102605657|NCT00003109|Raltitrexed|raltitrexed|mesh-list
102605658|NCT00003109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102605659|NCT00003109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102605660|NCT00003109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102152495|NCT02484391|Vitamins|vitamins|mesh-ancestor
102605661|NCT00003109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605662|NCT00003109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605663|NCT00003109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102605664|NCT00003109|Antimetabolites|antimetabolites|mesh-ancestor
102605665|NCT00003109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102605666|NCT00003643|Paclitaxel|paclitaxel|mesh-list
102605667|NCT00003643|Etoposide|etoposide|mesh-list
102605668|NCT00003643|Bleomycin|bleomycin|mesh-list
102605669|NCT00003643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102605670|NCT00003643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605671|NCT00003643|Tubulin Modulators|tubulin modulators|mesh-ancestor
102605672|NCT00003643|Antimitotic Agents|antimitotic agents|mesh-ancestor
102605673|NCT00003643|Mitosis Modulators|mitosis modulators|mesh-ancestor
102605674|NCT00003643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605675|NCT00003643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102605676|NCT00003643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102605677|NCT00003643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102605678|NCT00003643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102605679|NCT00003961|Sargramostim|sargramostim|mesh-list
102605680|NCT00003961|Immunologic Factors|immunologic factors|mesh-ancestor
102605681|NCT00003961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605682|NCT00003661|Cyclosporine|cyclosporine|mesh-list
102605683|NCT00003661|Methylprednisolone|methylprednisolone|mesh-list
102605684|NCT00003661|Melphalan|melphalan|mesh-list
102605685|NCT00003661|Busulfan|busulfan|mesh-list
102605686|NCT00003661|Cyclosporins|cyclosporins|mesh-list
102605687|NCT00003661|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102605688|NCT00003661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102605689|NCT00003661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605690|NCT00003661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102605691|NCT00003661|Immunologic Factors|immunologic factors|mesh-ancestor
102605692|NCT00003661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605693|NCT00003661|Antifungal Agents|antifungal agents|mesh-ancestor
102605694|NCT00003661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102605695|NCT00003661|Dermatologic Agents|dermatologic agents|mesh-ancestor
102605696|NCT00003661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102605697|NCT00003661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102605698|NCT00003661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102605699|NCT00003661|Antiemetics|antiemetics|mesh-ancestor
102605700|NCT00003661|Autonomic Agents|autonomic agents|mesh-ancestor
102605701|NCT00003661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102605702|NCT00003661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102605703|NCT00003661|Glucocorticoids|glucocorticoids|mesh-ancestor
102605704|NCT00003661|Hormones|hormones|mesh-ancestor
102605705|NCT00003661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102605706|NCT00003661|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102605707|NCT00003661|Protective Agents|protective agents|mesh-ancestor
102605708|NCT00003661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605709|NCT00003661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102605710|NCT00003661|Alkylating Agents|alkylating agents|mesh-ancestor
102605711|NCT00003661|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102605712|NCT00003967|Etoposide|etoposide|mesh-list
102605713|NCT00003967|Topotecan|topotecan|mesh-list
102605714|NCT00003967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102605715|NCT00003967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605716|NCT00003967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102605717|NCT00003967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102605718|NCT00003967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102605719|NCT00003967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605720|NCT00003967|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102605721|NCT00003115|Hydromorphone|hydromorphone|mesh-list
102605722|NCT00003115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102605723|NCT00003115|Narcotics|narcotics|mesh-ancestor
102605724|NCT00003115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102605725|NCT00003115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605726|NCT00003115|Analgesics|analgesics|mesh-ancestor
102605727|NCT00003115|Sensory System Agents|sensory system agents|mesh-ancestor
102605728|NCT00003115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102605729|NCT00003667|Cyclophosphamide|cyclophosphamide|mesh-list
102605730|NCT00003667|Doxorubicin|doxorubicin|mesh-list
102605731|NCT00003667|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102605732|NCT00003667|Vincristine|vincristine|mesh-list
102605733|NCT00003667|Dexrazoxane|dexrazoxane|mesh-list
102605734|NCT00003667|Razoxane|razoxane|mesh-list
102605735|NCT00003667|Glycerol|glycerol|mesh-list
102605736|NCT00003667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102605737|NCT00003667|Immunologic Factors|immunologic factors|mesh-ancestor
102605738|NCT00003667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605740|NCT00003667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102605741|NCT00003667|Alkylating Agents|alkylating agents|mesh-ancestor
102605742|NCT00003667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605743|NCT00003667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605744|NCT00003667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102605745|NCT00003667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102605746|NCT00003667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102605747|NCT00003667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102605748|NCT00003667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102605749|NCT00003667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102605750|NCT00003667|Tubulin Modulators|tubulin modulators|mesh-ancestor
102605751|NCT00003667|Antimitotic Agents|antimitotic agents|mesh-ancestor
102605752|NCT00003667|Mitosis Modulators|mitosis modulators|mesh-ancestor
102605753|NCT00003667|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102605754|NCT00003667|Protective Agents|protective agents|mesh-ancestor
102605755|NCT00003667|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102605756|NCT00003673|Gemtuzumab|gemtuzumab|mesh-list
102605757|NCT00003673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102605758|NCT00003673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605759|NCT00003673|Immunotoxins|immunotoxins|mesh-ancestor
102605760|NCT00003673|Immunoconjugates|immunoconjugates|mesh-ancestor
102605761|NCT00003673|Immunologic Factors|immunologic factors|mesh-ancestor
102605762|NCT00003673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605763|NCT00003679|Tamoxifen|tamoxifen|mesh-list
102605764|NCT00003679|Cyclophosphamide|cyclophosphamide|mesh-list
102605765|NCT00003679|Docetaxel|docetaxel|mesh-list
102605766|NCT00003679|Doxorubicin|doxorubicin|mesh-list
102605767|NCT00003679|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102605768|NCT00003679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102605769|NCT00003679|Immunologic Factors|immunologic factors|mesh-ancestor
102605770|NCT00003679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605771|NCT00003679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102605772|NCT00003679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102605773|NCT00003679|Alkylating Agents|alkylating agents|mesh-ancestor
102605774|NCT00003679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605775|NCT00003679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605776|NCT00003679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102605777|NCT00003679|Tubulin Modulators|tubulin modulators|mesh-ancestor
102605778|NCT00003679|Antimitotic Agents|antimitotic agents|mesh-ancestor
102605779|NCT00003679|Mitosis Modulators|mitosis modulators|mesh-ancestor
102605780|NCT00003679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102605781|NCT00003679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102605782|NCT00003679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102605783|NCT00003679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102605784|NCT00003679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102605785|NCT00003679|Hormone Antagonists|hormone antagonists|mesh-ancestor
102605786|NCT00003679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102605787|NCT00003679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102605788|NCT00003679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102605789|NCT00003679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102605790|NCT00003679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102605791|NCT00003985|KRN 7000|krn 7000|mesh-list
102605792|NCT00003985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102605793|NCT00003985|Immunologic Factors|immunologic factors|mesh-ancestor
102605794|NCT00003985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605795|NCT00003985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605796|NCT00384553|Rituximab|rituximab|mesh-list
102605797|NCT00384553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102605798|NCT00384553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605799|NCT00384553|Immunologic Factors|immunologic factors|mesh-ancestor
102605800|NCT00384553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605801|NCT00384553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102605802|NCT00003991|Aldesleukin|aldesleukin|mesh-list
102605803|NCT00003991|Histamine|histamine|mesh-list
102605804|NCT00003991|Histamine phosphate|histamine phosphate|mesh-list
102605805|NCT00003991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605806|NCT00003991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102605807|NCT00003991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102605808|NCT00003991|Antiviral Agents|antiviral agents|mesh-ancestor
102605809|NCT00003991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102605810|NCT00003991|Histamine Agonists|histamine agonists|mesh-ancestor
102605811|NCT00003991|Histamine Agents|histamine agents|mesh-ancestor
102605812|NCT00003991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102605813|NCT00003991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605814|NCT00003991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605816|NCT00003997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102605817|NCT00003997|Alkylating Agents|alkylating agents|mesh-ancestor
102605818|NCT00003997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605819|NCT00003997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605820|NCT00384631|Bevacizumab|bevacizumab|mesh-list
102605821|NCT00384631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102605822|NCT00384631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605823|NCT00384631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102605824|NCT00384631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102605825|NCT00384631|Growth Substances|growth substances|mesh-ancestor
102605826|NCT00384631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605827|NCT00384631|Growth Inhibitors|growth inhibitors|mesh-ancestor
102605828|NCT00003127|Paclitaxel|paclitaxel|mesh-list
102605829|NCT00003127|Carboplatin|carboplatin|mesh-list
102605830|NCT00003127|Amifostine|amifostine|mesh-list
102605831|NCT00003127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102605832|NCT00003127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605833|NCT00003127|Tubulin Modulators|tubulin modulators|mesh-ancestor
102605834|NCT00003127|Antimitotic Agents|antimitotic agents|mesh-ancestor
102605835|NCT00003127|Mitosis Modulators|mitosis modulators|mesh-ancestor
102605836|NCT00003127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605837|NCT00003127|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102605838|NCT00003127|Protective Agents|protective agents|mesh-ancestor
102605839|NCT00003127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605840|NCT00004003|Gemcitabine|gemcitabine|mesh-list
102605841|NCT00004003|Fluorouracil|fluorouracil|mesh-list
102605842|NCT00004003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605843|NCT00004003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102605844|NCT00004003|Antimetabolites|antimetabolites|mesh-ancestor
102605845|NCT00004003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605846|NCT00004003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102605847|NCT00004003|Immunologic Factors|immunologic factors|mesh-ancestor
102605848|NCT00004003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605849|NCT00004009|Tipifarnib|tipifarnib|mesh-list
102605850|NCT00004009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605851|NCT00003133|Paclitaxel|paclitaxel|mesh-list
102605852|NCT00003133|Gemcitabine|gemcitabine|mesh-list
102605853|NCT00003133|Doxorubicin|doxorubicin|mesh-list
102605854|NCT00003133|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102605855|NCT00003133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102605856|NCT00003133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605857|NCT00003133|Tubulin Modulators|tubulin modulators|mesh-ancestor
102605858|NCT00003133|Antimitotic Agents|antimitotic agents|mesh-ancestor
102605859|NCT00003133|Mitosis Modulators|mitosis modulators|mesh-ancestor
102605860|NCT00003133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605861|NCT00003133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102605862|NCT00003133|Antimetabolites|antimetabolites|mesh-ancestor
102605863|NCT00003133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102605864|NCT00003133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102605865|NCT00003133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102605866|NCT00003133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102605867|NCT00003691|Paclitaxel|paclitaxel|mesh-list
102605868|NCT00003691|Doxorubicin|doxorubicin|mesh-list
102605869|NCT00003691|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102605870|NCT00003691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102605871|NCT00003691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605872|NCT00003691|Tubulin Modulators|tubulin modulators|mesh-ancestor
102605873|NCT00003691|Antimitotic Agents|antimitotic agents|mesh-ancestor
102605874|NCT00003691|Mitosis Modulators|mitosis modulators|mesh-ancestor
102605875|NCT00003691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605876|NCT00003691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102605877|NCT00003691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102605878|NCT00003691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102605879|NCT00003691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102605880|NCT00003139|Pilocarpine|pilocarpine|mesh-list
102605881|NCT00003139|Miotics|miotics|mesh-ancestor
102605882|NCT00003139|Autonomic Agents|autonomic agents|mesh-ancestor
102605883|NCT00003139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102605884|NCT00003139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605885|NCT00003139|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102605886|NCT00003139|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102605887|NCT00003139|Cholinergic Agents|cholinergic agents|mesh-ancestor
102152702|NCT05702359|Vitamins|vitamins|mesh-list
102152710|NCT05690282|Acetaminophen|acetaminophen|mesh-list
102605888|NCT00003139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102605889|NCT00003139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605890|NCT00003697|Vadimezan|vadimezan|mesh-list
102605891|NCT00003697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605892|NCT02972983|Daptomycin|daptomycin|mesh-list
102605893|NCT02972983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102605894|NCT02972983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102605895|NCT00003709|Carbendazim|carbendazim|mesh-list
102605896|NCT00003709|Antinematodal Agents|antinematodal agents|mesh-ancestor
102605897|NCT00003709|Anthelmintics|anthelmintics|mesh-ancestor
102605898|NCT00003709|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102605899|NCT00003709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102605900|NCT00003145|Cyclosporine|cyclosporine|mesh-list
102605901|NCT00003145|Mycophenolic Acid|mycophenolic acid|mesh-list
102605902|NCT00003145|Fludarabine|fludarabine|mesh-list
102605903|NCT00003145|Fludarabine phosphate|fludarabine phosphate|mesh-list
102605904|NCT00003145|Cyclosporins|cyclosporins|mesh-list
102605905|NCT00003145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605906|NCT00003145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102605907|NCT00003145|Antimetabolites|antimetabolites|mesh-ancestor
102605908|NCT00003145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605909|NCT00003145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102605910|NCT00003145|Immunologic Factors|immunologic factors|mesh-ancestor
102605911|NCT00003145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605912|NCT00003145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102605913|NCT00003145|Antifungal Agents|antifungal agents|mesh-ancestor
102605914|NCT00003145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102605915|NCT00003145|Dermatologic Agents|dermatologic agents|mesh-ancestor
102605916|NCT00003145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102605917|NCT00003145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102605918|NCT00003145|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102605919|NCT00003145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102605920|NCT00003145|Antitubercular Agents|antitubercular agents|mesh-ancestor
102605921|NCT00003145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102605922|NCT00004039|Interferons|interferons|mesh-list
102605923|NCT00004039|Interferon-alpha|interferon-alpha|mesh-list
102605924|NCT00004039|Prednisone|prednisone|mesh-list
102605925|NCT00004039|Cyclophosphamide|cyclophosphamide|mesh-list
102605926|NCT00004039|Rituximab|rituximab|mesh-list
102605927|NCT00004039|Doxorubicin|doxorubicin|mesh-list
102605928|NCT00004039|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102605929|NCT00004039|Vincristine|vincristine|mesh-list
102605930|NCT00004039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102605931|NCT00004039|Immunologic Factors|immunologic factors|mesh-ancestor
102605932|NCT00004039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605933|NCT00004039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102605934|NCT00004039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102605935|NCT00004039|Alkylating Agents|alkylating agents|mesh-ancestor
102605936|NCT00004039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605937|NCT00004039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605938|NCT00004039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102605939|NCT00004039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102605940|NCT00004039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102605941|NCT00004039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102605942|NCT00004039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102605943|NCT00004039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102605944|NCT00004039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102605945|NCT00004039|Glucocorticoids|glucocorticoids|mesh-ancestor
102605946|NCT00004039|Hormones|hormones|mesh-ancestor
102605947|NCT00004039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102605948|NCT00004039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102605949|NCT00004039|Antiviral Agents|antiviral agents|mesh-ancestor
102605950|NCT00004039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102605951|NCT00004039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102605952|NCT00004039|Tubulin Modulators|tubulin modulators|mesh-ancestor
102605953|NCT00004039|Antimitotic Agents|antimitotic agents|mesh-ancestor
102605954|NCT00004039|Mitosis Modulators|mitosis modulators|mesh-ancestor
102605955|NCT00003151|Amoxicillin|amoxicillin|mesh-list
102605956|NCT00003151|Metronidazole|metronidazole|mesh-list
102605957|NCT00003151|Clarithromycin|clarithromycin|mesh-list
102605958|NCT00003151|Tetracycline|tetracycline|mesh-list
102605959|NCT00003151|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
102605960|NCT00003151|Omeprazole|omeprazole|mesh-list
102605961|NCT00003151|Bismuth|bismuth|mesh-list
102605962|NCT00003151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102605963|NCT00003151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102605964|NCT00003151|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102605965|NCT00003151|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102605966|NCT00003151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102605967|NCT00003151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102605968|NCT00003151|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102605969|NCT00003151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102605970|NCT00003151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605971|NCT00003151|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102605972|NCT00003151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102605973|NCT00003151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102605974|NCT00003151|Antacids|antacids|mesh-ancestor
102605975|NCT00004045|Exatecan|exatecan|mesh-list
102605976|NCT00004045|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102605977|NCT00004045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102605978|NCT00004045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102605979|NCT00004045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605980|NCT00004045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605981|NCT00003715|Interferons|interferons|mesh-list
102605982|NCT00003715|Interferon-alpha|interferon-alpha|mesh-list
102605983|NCT00003715|Cyclophosphamide|cyclophosphamide|mesh-list
102605984|NCT00003715|Vaccines|vaccines|mesh-list
102605985|NCT00003715|BCG Vaccine|bcg vaccine|mesh-list
102605986|NCT00003715|Immunologic Factors|immunologic factors|mesh-ancestor
102605987|NCT00003715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102605988|NCT00003715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102605989|NCT00003715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102605990|NCT00003715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102605991|NCT00003715|Alkylating Agents|alkylating agents|mesh-ancestor
102605992|NCT00003715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102605993|NCT00003715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102605994|NCT00003715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102605995|NCT00003715|Antiviral Agents|antiviral agents|mesh-ancestor
102605996|NCT00003715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102605997|NCT00003715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102605998|NCT00004051|Irinotecan|irinotecan|mesh-list
102605999|NCT00004051|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102606000|NCT00004051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102606001|NCT00004051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102606002|NCT00004051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606003|NCT00004051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606004|NCT00003727|Interferons|interferons|mesh-list
102606005|NCT00003727|Interferon-alpha|interferon-alpha|mesh-list
102606006|NCT00003727|Cyclophosphamide|cyclophosphamide|mesh-list
102606007|NCT00003727|Melphalan|melphalan|mesh-list
102606008|NCT00003727|Carmustine|carmustine|mesh-list
102606009|NCT00003727|Gemcitabine|gemcitabine|mesh-list
102606010|NCT00003727|Etoposide|etoposide|mesh-list
102606011|NCT00003727|Sargramostim|sargramostim|mesh-list
102606012|NCT00003727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102606013|NCT00003727|Immunologic Factors|immunologic factors|mesh-ancestor
102606014|NCT00003727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606015|NCT00003727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102606016|NCT00003727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102606017|NCT00003727|Alkylating Agents|alkylating agents|mesh-ancestor
102606018|NCT00003727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606019|NCT00003727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606020|NCT00003727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102606021|NCT00003727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102606022|NCT00003727|Antimetabolites|antimetabolites|mesh-ancestor
102606023|NCT00003727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102606024|NCT00003727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102606025|NCT00003727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102606026|NCT00003727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102606027|NCT00003727|Antiviral Agents|antiviral agents|mesh-ancestor
102606028|NCT00003727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102606029|NCT00003157|Gemcitabine|gemcitabine|mesh-list
102606030|NCT00003157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606031|NCT00003157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102606032|NCT00003157|Antimetabolites|antimetabolites|mesh-ancestor
102606033|NCT00003157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606034|NCT00004057|Paclitaxel|paclitaxel|mesh-list
102606035|NCT00004057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102606036|NCT00004057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606037|NCT00004057|Tubulin Modulators|tubulin modulators|mesh-ancestor
102606038|NCT00004057|Antimitotic Agents|antimitotic agents|mesh-ancestor
102606039|NCT00004057|Mitosis Modulators|mitosis modulators|mesh-ancestor
102606040|NCT00004057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606041|NCT00004063|Interferons|interferons|mesh-list
102152892|NCT05358704|Leucovorin|leucovorin|mesh-list
102606042|NCT00004063|Interferon-alpha|interferon-alpha|mesh-list
102606043|NCT00004063|Gemcitabine|gemcitabine|mesh-list
102606044|NCT00004063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606045|NCT00004063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102606046|NCT00004063|Antimetabolites|antimetabolites|mesh-ancestor
102606047|NCT00004063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606048|NCT00004063|Antiviral Agents|antiviral agents|mesh-ancestor
102606049|NCT00004063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102606050|NCT00004063|Immunologic Factors|immunologic factors|mesh-ancestor
102606051|NCT00004063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606052|NCT00003733|Paclitaxel|paclitaxel|mesh-list
102606053|NCT00003733|Carboplatin|carboplatin|mesh-list
102606054|NCT00003733|Topotecan|topotecan|mesh-list
102606055|NCT00003733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102606056|NCT00003733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606057|NCT00003733|Tubulin Modulators|tubulin modulators|mesh-ancestor
102606058|NCT00003733|Antimitotic Agents|antimitotic agents|mesh-ancestor
102606059|NCT00003733|Mitosis Modulators|mitosis modulators|mesh-ancestor
102606060|NCT00003733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606061|NCT00003733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102606062|NCT00003733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102606063|NCT00003733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102606064|NCT00003739|Lenograstim|lenograstim|mesh-list
102606065|NCT00003739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102606066|NCT00003739|Immunologic Factors|immunologic factors|mesh-ancestor
102606067|NCT00003739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606068|NCT00003745|Topotecan|topotecan|mesh-list
102606069|NCT00003745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102606070|NCT00003745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102606071|NCT00003745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102606072|NCT00003745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606073|NCT00003745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606074|NCT00003163|Cyclophosphamide|cyclophosphamide|mesh-list
102606075|NCT00003163|Melphalan|melphalan|mesh-list
102606076|NCT00003163|Sargramostim|sargramostim|mesh-list
102606077|NCT00003163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102606078|NCT00003163|Immunologic Factors|immunologic factors|mesh-ancestor
102606079|NCT00003163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606080|NCT00003163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102606081|NCT00003163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102606082|NCT00003163|Alkylating Agents|alkylating agents|mesh-ancestor
102606083|NCT00003163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606084|NCT00003163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606085|NCT00003163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102606086|NCT00004081|Docetaxel|docetaxel|mesh-list
102606087|NCT00004081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606088|NCT00004081|Tubulin Modulators|tubulin modulators|mesh-ancestor
102606089|NCT00004081|Antimitotic Agents|antimitotic agents|mesh-ancestor
102606090|NCT00004081|Mitosis Modulators|mitosis modulators|mesh-ancestor
102606091|NCT00004081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606092|NCT00003751|Penicillamine|penicillamine|mesh-list
102606093|NCT00003751|Antidotes|antidotes|mesh-ancestor
102606094|NCT00003751|Protective Agents|protective agents|mesh-ancestor
102606095|NCT00003751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606096|NCT00003751|Chelating Agents|chelating agents|mesh-ancestor
102606097|NCT00003751|Sequestering Agents|sequestering agents|mesh-ancestor
102606098|NCT00003751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606099|NCT00003751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102606100|NCT00004087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102606101|NCT00004087|Antibodies|antibodies|mesh-list
102606102|NCT00004087|Immunoglobulins|immunoglobulins|mesh-list
102606103|NCT00004087|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102606104|NCT00004087|Immunologic Factors|immunologic factors|mesh-ancestor
102606105|NCT00004087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606106|NCT00004087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606107|NCT00003757|Rituximab|rituximab|mesh-list
102606108|NCT00003757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102606109|NCT00003757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606110|NCT00003757|Immunologic Factors|immunologic factors|mesh-ancestor
102606111|NCT00003757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606112|NCT00003757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102606113|NCT00003175|Fluorouracil|fluorouracil|mesh-list
102606114|NCT00003175|Antimetabolites|antimetabolites|mesh-ancestor
102606115|NCT00003175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606116|NCT00003175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102606117|NCT00003175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606118|NCT00003175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102606119|NCT00003175|Immunologic Factors|immunologic factors|mesh-ancestor
102606120|NCT00003175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606121|NCT00004099|Leucovorin|leucovorin|mesh-list
102606122|NCT00004099|Fluorouracil|fluorouracil|mesh-list
102606123|NCT00004099|Calcium|calcium|mesh-list
102606124|NCT00004099|Levoleucovorin|levoleucovorin|mesh-list
102606125|NCT00004099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606126|NCT00004099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102606127|NCT00004099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606128|NCT00004099|Antimetabolites|antimetabolites|mesh-ancestor
102606129|NCT00004099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606130|NCT00004099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102606131|NCT00004099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102606132|NCT00004099|Immunologic Factors|immunologic factors|mesh-ancestor
102606133|NCT00004099|Antidotes|antidotes|mesh-ancestor
102606134|NCT00004099|Protective Agents|protective agents|mesh-ancestor
102606135|NCT00004099|Vitamin B Complex|vitamin b complex|mesh-ancestor
102606136|NCT00004099|Vitamins|vitamins|mesh-ancestor
102606137|NCT00004099|Micronutrients|micronutrients|mesh-ancestor
102606138|NCT00003763|Folic Acid|folic acid|mesh-list
102606139|NCT00003763|Hematinics|hematinics|mesh-ancestor
102606140|NCT00003763|Vitamin B Complex|vitamin b complex|mesh-ancestor
102606141|NCT00003763|Vitamins|vitamins|mesh-ancestor
102606142|NCT00003763|Micronutrients|micronutrients|mesh-ancestor
102606143|NCT00003763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606144|NCT00003181|Aldesleukin|aldesleukin|mesh-list
102606145|NCT00003181|Vinblastine|vinblastine|mesh-list
102606146|NCT00003181|Sargramostim|sargramostim|mesh-list
102606147|NCT00003181|Immunologic Factors|immunologic factors|mesh-ancestor
102606148|NCT00003181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606149|NCT00003181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606150|NCT00003181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102606151|NCT00003181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102606152|NCT00003181|Antiviral Agents|antiviral agents|mesh-ancestor
102606153|NCT00003181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102606154|NCT00003181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102606155|NCT00003181|Tubulin Modulators|tubulin modulators|mesh-ancestor
102606156|NCT00003181|Antimitotic Agents|antimitotic agents|mesh-ancestor
102606157|NCT00003181|Mitosis Modulators|mitosis modulators|mesh-ancestor
102606158|NCT00003181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606159|NCT00004105|Paclitaxel|paclitaxel|mesh-list
102606160|NCT00004105|Vinorelbine|vinorelbine|mesh-list
102606161|NCT00004105|Estramustine|estramustine|mesh-list
102606162|NCT00004105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102606163|NCT00004105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606164|NCT00004105|Tubulin Modulators|tubulin modulators|mesh-ancestor
102606165|NCT00004105|Antimitotic Agents|antimitotic agents|mesh-ancestor
102606166|NCT00004105|Mitosis Modulators|mitosis modulators|mesh-ancestor
102606167|NCT00004105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606168|NCT00004105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102606169|NCT00004105|Alkylating Agents|alkylating agents|mesh-ancestor
102606170|NCT00004105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102606171|NCT00003187|Cytarabine|cytarabine|mesh-list
102606172|NCT00003187|Cyclosporine|cyclosporine|mesh-list
102606173|NCT00003187|Methylprednisolone|methylprednisolone|mesh-list
102606174|NCT00003187|Cyclophosphamide|cyclophosphamide|mesh-list
102606175|NCT00003187|Methotrexate|methotrexate|mesh-list
102606176|NCT00003187|Cyclosporins|cyclosporins|mesh-list
102606177|NCT00003187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102606178|NCT00003187|Immunologic Factors|immunologic factors|mesh-ancestor
102606179|NCT00003187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606180|NCT00003187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102606181|NCT00003187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102606182|NCT00003187|Alkylating Agents|alkylating agents|mesh-ancestor
102606183|NCT00003187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606184|NCT00003187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606185|NCT00003187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102606186|NCT00003187|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102606187|NCT00003187|Abortifacient Agents|abortifacient agents|mesh-ancestor
102606188|NCT00003187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102606189|NCT00003187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102606190|NCT00003187|Antimetabolites|antimetabolites|mesh-ancestor
102606191|NCT00003187|Dermatologic Agents|dermatologic agents|mesh-ancestor
102606192|NCT00003187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102606193|NCT00003187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102606194|NCT00003187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102606195|NCT00003187|Antiviral Agents|antiviral agents|mesh-ancestor
102606197|NCT00003187|Antifungal Agents|antifungal agents|mesh-ancestor
102606198|NCT00003187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102606199|NCT00003187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102606200|NCT00003187|Antiemetics|antiemetics|mesh-ancestor
102606201|NCT00003187|Autonomic Agents|autonomic agents|mesh-ancestor
102606202|NCT00003187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102606203|NCT00003187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102606204|NCT00003187|Glucocorticoids|glucocorticoids|mesh-ancestor
102606205|NCT00003187|Hormones|hormones|mesh-ancestor
102606206|NCT00003187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102606207|NCT00003187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102606208|NCT00003187|Protective Agents|protective agents|mesh-ancestor
102606209|NCT00003769|Perillyl alcohol|perillyl alcohol|mesh-list
102606210|NCT00003769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606211|NCT00003769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102606212|NCT00003769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606213|NCT00003775|Leflunomide|leflunomide|mesh-list
102606214|NCT00003775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102606215|NCT00003775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606216|NCT00003775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102606217|NCT00003775|Immunologic Factors|immunologic factors|mesh-ancestor
102606218|NCT00003775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606219|NCT00004123|Doxorubicin|doxorubicin|mesh-list
102606220|NCT00004123|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102606221|NCT00004123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102606222|NCT00004123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606223|NCT00004123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102606224|NCT00004123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102606225|NCT00004123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102606226|NCT00004123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606227|NCT00003781|Docetaxel|docetaxel|mesh-list
102606228|NCT00003781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606229|NCT00003781|Tubulin Modulators|tubulin modulators|mesh-ancestor
102606230|NCT00003781|Antimitotic Agents|antimitotic agents|mesh-ancestor
102606231|NCT00003781|Mitosis Modulators|mitosis modulators|mesh-ancestor
102606232|NCT00003781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606233|NCT00003193|Paclitaxel|paclitaxel|mesh-list
102606234|NCT00003193|Amifostine|amifostine|mesh-list
102606235|NCT00003193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102606236|NCT00003193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606237|NCT00003193|Tubulin Modulators|tubulin modulators|mesh-ancestor
102606238|NCT00003193|Antimitotic Agents|antimitotic agents|mesh-ancestor
102606239|NCT00003193|Mitosis Modulators|mitosis modulators|mesh-ancestor
102606240|NCT00003193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606241|NCT00003193|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102606242|NCT00003193|Protective Agents|protective agents|mesh-ancestor
102606243|NCT00003193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606244|NCT00004135|Cyclophosphamide|cyclophosphamide|mesh-list
102606245|NCT00004135|Fludarabine|fludarabine|mesh-list
102606246|NCT00004135|Fludarabine phosphate|fludarabine phosphate|mesh-list
102606247|NCT00004135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102606248|NCT00004135|Immunologic Factors|immunologic factors|mesh-ancestor
102606249|NCT00004135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606250|NCT00004135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102606251|NCT00004135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102606252|NCT00004135|Alkylating Agents|alkylating agents|mesh-ancestor
102606253|NCT00004135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606254|NCT00004135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606255|NCT00004135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102606256|NCT00004135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102606257|NCT00004135|Antimetabolites|antimetabolites|mesh-ancestor
102606258|NCT00004141|Dacarbazine|dacarbazine|mesh-list
102606259|NCT00004141|Molgramostim|molgramostim|mesh-list
102606260|NCT00004141|Sargramostim|sargramostim|mesh-list
102606261|NCT00004141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606262|NCT00004141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102606263|NCT00004141|Alkylating Agents|alkylating agents|mesh-ancestor
102606264|NCT00004141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606265|NCT00004141|Immunologic Factors|immunologic factors|mesh-ancestor
102606266|NCT00004141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606267|NCT02972905|Nemiralisib|nemiralisib|mesh-list
102606268|NCT02972905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102606269|NCT02972905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102606270|NCT02972905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606271|NCT00003799|Leucovorin|leucovorin|mesh-list
102606272|NCT00003799|Fluorouracil|fluorouracil|mesh-list
102606273|NCT00003799|Oxaliplatin|oxaliplatin|mesh-list
102606274|NCT00003799|Calcium|calcium|mesh-list
102606275|NCT00003799|Levoleucovorin|levoleucovorin|mesh-list
102606276|NCT00003799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102606277|NCT00003799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606278|NCT00003799|Antimetabolites|antimetabolites|mesh-ancestor
102606279|NCT00003799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606280|NCT00003799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102606281|NCT00003799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606282|NCT00003799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102606283|NCT00003799|Immunologic Factors|immunologic factors|mesh-ancestor
102606284|NCT00003799|Antidotes|antidotes|mesh-ancestor
102606285|NCT00003799|Protective Agents|protective agents|mesh-ancestor
102606286|NCT00003799|Vitamin B Complex|vitamin b complex|mesh-ancestor
102606287|NCT00003799|Vitamins|vitamins|mesh-ancestor
102606288|NCT00003799|Micronutrients|micronutrients|mesh-ancestor
102606289|NCT00003205|Bryostatin 1|bryostatin 1|mesh-list
102606290|NCT00003205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102606291|NCT00003205|Immunologic Factors|immunologic factors|mesh-ancestor
102606292|NCT00003205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606293|NCT00003205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606294|NCT00003211|Cyclophosphamide|cyclophosphamide|mesh-list
102606295|NCT00003211|Vincristine|vincristine|mesh-list
102606296|NCT00003211|Amifostine|amifostine|mesh-list
102606297|NCT00003211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102606298|NCT00003211|Immunologic Factors|immunologic factors|mesh-ancestor
102606299|NCT00003211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606300|NCT00003211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102606301|NCT00003211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102606302|NCT00003211|Alkylating Agents|alkylating agents|mesh-ancestor
102606303|NCT00003211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606304|NCT00003211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606305|NCT00003211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102606306|NCT00003211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102606307|NCT00003211|Tubulin Modulators|tubulin modulators|mesh-ancestor
102606308|NCT00003211|Antimitotic Agents|antimitotic agents|mesh-ancestor
102606309|NCT00003211|Mitosis Modulators|mitosis modulators|mesh-ancestor
102606310|NCT00003211|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102606311|NCT00003211|Protective Agents|protective agents|mesh-ancestor
102606312|NCT00003805|Vancomycin|vancomycin|mesh-list
102606313|NCT00003805|Tazobactam|tazobactam|mesh-list
102606314|NCT00003805|Piperacillin|piperacillin|mesh-list
102606315|NCT00003805|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102606316|NCT00003805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102606317|NCT00003805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102606318|NCT00003805|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102606319|NCT00003805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102606320|NCT00003805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606321|NCT00004159|Paclitaxel|paclitaxel|mesh-list
102606322|NCT00004159|Gemcitabine|gemcitabine|mesh-list
102606323|NCT00004159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102606324|NCT00004159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606325|NCT00004159|Tubulin Modulators|tubulin modulators|mesh-ancestor
102606326|NCT00004159|Antimitotic Agents|antimitotic agents|mesh-ancestor
102606327|NCT00004159|Mitosis Modulators|mitosis modulators|mesh-ancestor
102606328|NCT00004159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606329|NCT00004159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102606330|NCT00004159|Antimetabolites|antimetabolites|mesh-ancestor
102606331|NCT00003811|Etoposide|etoposide|mesh-list
102606332|NCT00003811|Bleomycin|bleomycin|mesh-list
102606333|NCT00003811|Amifostine|amifostine|mesh-list
102606334|NCT00003811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606335|NCT00003811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102606336|NCT00003811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102606337|NCT00003811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102606338|NCT00003811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102606339|NCT00003811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606340|NCT00003811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102606341|NCT00003811|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102606342|NCT00003811|Protective Agents|protective agents|mesh-ancestor
102606343|NCT00003811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606344|NCT00004177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102153155|NCT04984616|Atorvastatin|atorvastatin|mesh-list
102606345|NCT00004177|Antibodies|antibodies|mesh-list
102606346|NCT00004177|Immunoglobulins|immunoglobulins|mesh-list
102606347|NCT00004177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102606348|NCT00004177|Immunologic Factors|immunologic factors|mesh-ancestor
102346511|NCT04195555|Ivosidenib|ivosidenib|mesh-list
102606349|NCT00004177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606350|NCT00004177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606351|NCT00003817|Ondansetron|ondansetron|mesh-list
102606352|NCT00003817|Granisetron|granisetron|mesh-list
102606353|NCT00003817|Tropisetron|tropisetron|mesh-list
102606354|NCT00003817|Dolasetron|dolasetron|mesh-list
102606355|NCT00003817|Antiemetics|antiemetics|mesh-ancestor
102606356|NCT00003817|Autonomic Agents|autonomic agents|mesh-ancestor
102606357|NCT00003817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102606358|NCT00003817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606359|NCT00003817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102606360|NCT00003817|Antipruritics|antipruritics|mesh-ancestor
102606361|NCT00003817|Dermatologic Agents|dermatologic agents|mesh-ancestor
102606362|NCT00003817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102606363|NCT00003817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102606364|NCT00003817|Serotonin Agents|serotonin agents|mesh-ancestor
102606365|NCT00003817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102606366|NCT00003817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606367|NCT00003829|Cyclophosphamide|cyclophosphamide|mesh-list
102606368|NCT00003829|Fludarabine|fludarabine|mesh-list
102606369|NCT00003829|Fludarabine phosphate|fludarabine phosphate|mesh-list
102606370|NCT00003829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102606371|NCT00003829|Immunologic Factors|immunologic factors|mesh-ancestor
102606372|NCT00003829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606373|NCT00003829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102606374|NCT00003829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102606375|NCT00003829|Alkylating Agents|alkylating agents|mesh-ancestor
102606376|NCT00003829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606377|NCT00003829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606378|NCT00003829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102606379|NCT00003829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102606380|NCT00003829|Antimetabolites|antimetabolites|mesh-ancestor
102606381|NCT04329403|Adapalene|adapalene|mesh-list
102606382|NCT04329403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102606383|NCT04329403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102606384|NCT04329403|Analgesics|analgesics|mesh-ancestor
102606385|NCT04329403|Sensory System Agents|sensory system agents|mesh-ancestor
102606386|NCT04329403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102606387|NCT04329403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606388|NCT04329403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102606389|NCT04329403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102606390|NCT04329403|Dermatologic Agents|dermatologic agents|mesh-ancestor
102606391|NCT00003217|Cytarabine|cytarabine|mesh-list
102606392|NCT00003217|Dexamethasone|dexamethasone|mesh-list
102606393|NCT00003217|Cyclophosphamide|cyclophosphamide|mesh-list
102606394|NCT00003217|Doxorubicin|doxorubicin|mesh-list
102606395|NCT00003217|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102606396|NCT00003217|Methotrexate|methotrexate|mesh-list
102606397|NCT00003217|Vincristine|vincristine|mesh-list
102606398|NCT00003217|Lenograstim|lenograstim|mesh-list
102606399|NCT00003217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102606400|NCT00003217|Immunologic Factors|immunologic factors|mesh-ancestor
102606401|NCT00003217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606402|NCT00003217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102606403|NCT00003217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102606404|NCT00003217|Alkylating Agents|alkylating agents|mesh-ancestor
102606405|NCT00003217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606406|NCT00003217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606407|NCT00003217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102606408|NCT00003217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102606409|NCT00003217|Antiemetics|antiemetics|mesh-ancestor
102606410|NCT00003217|Autonomic Agents|autonomic agents|mesh-ancestor
102606411|NCT00003217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102606412|NCT00003217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102606413|NCT00003217|Glucocorticoids|glucocorticoids|mesh-ancestor
102606414|NCT00003217|Hormones|hormones|mesh-ancestor
102055354|NCT02239614|Antacids|antacids|mesh-ancestor
102606415|NCT00003217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102606416|NCT00003217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102606417|NCT00003217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102606418|NCT00003217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102606419|NCT00003217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102606420|NCT00003217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102606421|NCT00003217|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102153238|NCT04799431|Poly I-C|poly i-c|mesh-list
102606422|NCT00003217|Abortifacient Agents|abortifacient agents|mesh-ancestor
102606423|NCT00003217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102606424|NCT00003217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102606425|NCT00003217|Antimetabolites|antimetabolites|mesh-ancestor
102606426|NCT00003217|Dermatologic Agents|dermatologic agents|mesh-ancestor
102606427|NCT00003217|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102606428|NCT00003217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102606429|NCT00003217|Antiviral Agents|antiviral agents|mesh-ancestor
102606430|NCT00003217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102606431|NCT00003217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102606432|NCT00003217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102606433|NCT00003217|Tubulin Modulators|tubulin modulators|mesh-ancestor
102606434|NCT00003217|Antimitotic Agents|antimitotic agents|mesh-ancestor
102606435|NCT00003217|Mitosis Modulators|mitosis modulators|mesh-ancestor
102606436|NCT00004183|Capecitabine|capecitabine|mesh-list
102606437|NCT00004183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102606438|NCT00004183|Antimetabolites|antimetabolites|mesh-ancestor
102606439|NCT00004183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606440|NCT00004183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606441|NCT00003223|Fenretinide|fenretinide|mesh-list
102606442|NCT00003223|Retinamide|retinamide|mesh-list
102606443|NCT00003223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606444|NCT00003223|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102606445|NCT00003223|Protective Agents|protective agents|mesh-ancestor
102606446|NCT00003223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606447|NCT00004189|Cisplatin|cisplatin|mesh-list
102606448|NCT00004189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606449|NCT00003229|Aldesleukin|aldesleukin|mesh-list
102606450|NCT00003229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606451|NCT00003229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102606452|NCT00003229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102606453|NCT00003229|Antiviral Agents|antiviral agents|mesh-ancestor
102606454|NCT00003229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102606455|NCT00003835|Leucovorin|leucovorin|mesh-list
102606456|NCT00003835|Fluorouracil|fluorouracil|mesh-list
102606457|NCT00003835|Irinotecan|irinotecan|mesh-list
102606458|NCT00003835|Calcium|calcium|mesh-list
102606459|NCT00003835|Levoleucovorin|levoleucovorin|mesh-list
102606460|NCT00003835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102606461|NCT00003835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606462|NCT00003835|Antimetabolites|antimetabolites|mesh-ancestor
102606463|NCT00003835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606464|NCT00003835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102606465|NCT00003835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606466|NCT00003835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102606467|NCT00003835|Immunologic Factors|immunologic factors|mesh-ancestor
102606468|NCT00003835|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102606469|NCT00003835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102606470|NCT00003835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102606471|NCT00003835|Antidotes|antidotes|mesh-ancestor
102606472|NCT00003835|Protective Agents|protective agents|mesh-ancestor
102346528|NCT04181060|Antibodies|antibodies|mesh-list
102606473|NCT00003835|Vitamin B Complex|vitamin b complex|mesh-ancestor
102606474|NCT00003835|Vitamins|vitamins|mesh-ancestor
102606475|NCT00003835|Micronutrients|micronutrients|mesh-ancestor
102606476|NCT00003847|Doxorubicin|doxorubicin|mesh-list
102606477|NCT00003847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102606478|NCT00003847|Vincristine|vincristine|mesh-list
102606479|NCT00003847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102606480|NCT00003847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606481|NCT00003847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102606482|NCT00003847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102606483|NCT00003847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102606484|NCT00003847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606485|NCT00003847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102606486|NCT00003847|Tubulin Modulators|tubulin modulators|mesh-ancestor
102606487|NCT00003847|Antimitotic Agents|antimitotic agents|mesh-ancestor
102606488|NCT00003847|Mitosis Modulators|mitosis modulators|mesh-ancestor
102606489|NCT00004195|Eniluracil|eniluracil|mesh-list
102606490|NCT00004195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606491|NCT00004195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102606492|NCT00003853|Esorubicin|esorubicin|mesh-list
102606493|NCT00003853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102153303|NCT04609189|Micronutrients|micronutrients|mesh-ancestor
102606494|NCT00003853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606495|NCT00385021|Leucovorin|leucovorin|mesh-list
102606496|NCT00385021|Fluorouracil|fluorouracil|mesh-list
102606497|NCT00385021|Oxaliplatin|oxaliplatin|mesh-list
102606498|NCT00385021|Bevacizumab|bevacizumab|mesh-list
102606499|NCT00385021|Antimetabolites|antimetabolites|mesh-ancestor
102606500|NCT00385021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606501|NCT00385021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102606502|NCT00385021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606503|NCT00385021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102606504|NCT00385021|Immunologic Factors|immunologic factors|mesh-ancestor
102606505|NCT00385021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606506|NCT00385021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102606507|NCT00385021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102606508|NCT00385021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102606509|NCT00385021|Growth Substances|growth substances|mesh-ancestor
102606510|NCT00385021|Growth Inhibitors|growth inhibitors|mesh-ancestor
102606511|NCT00385021|Antidotes|antidotes|mesh-ancestor
102606512|NCT00385021|Protective Agents|protective agents|mesh-ancestor
102606513|NCT00385021|Vitamin B Complex|vitamin b complex|mesh-ancestor
102606514|NCT00385021|Vitamins|vitamins|mesh-ancestor
102606515|NCT00385021|Micronutrients|micronutrients|mesh-ancestor
102606516|NCT00004201|Carboplatin|carboplatin|mesh-list
102606517|NCT00004201|Gemcitabine|gemcitabine|mesh-list
102606518|NCT00004201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606519|NCT00004201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102606520|NCT00004201|Antimetabolites|antimetabolites|mesh-ancestor
102346539|NCT04181060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346540|NCT04181060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102346541|NCT04181060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102346542|NCT04151940|Immunomodulating Agents|immunomodulating agents|mesh-list
102346543|NCT04151940|Immunologic Factors|immunologic factors|mesh-ancestor
102346544|NCT04151940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346545|NCT04103398|Sorafenib|sorafenib|mesh-list
102346546|NCT04103398|Chlorotrianisene|chlorotrianisene|mesh-list
102346552|NCT04103398|Estrogens|estrogens|mesh-ancestor
102606521|NCT00004201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606522|NCT00003241|Phenylacetic acid|phenylacetic acid|mesh-list
102606523|NCT00003241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102606524|NCT00003241|Antimetabolites|antimetabolites|mesh-ancestor
102606525|NCT00003241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606526|NCT00003241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606527|NCT00003859|Cyclophosphamide|cyclophosphamide|mesh-list
102606528|NCT00003859|Carboplatin|carboplatin|mesh-list
102606529|NCT00003859|Etoposide|etoposide|mesh-list
102606530|NCT00003859|Vincristine|vincristine|mesh-list
102606531|NCT00003859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102606532|NCT00003859|Immunologic Factors|immunologic factors|mesh-ancestor
102606533|NCT00003859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606534|NCT00003859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102606535|NCT00003859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102606536|NCT00003859|Alkylating Agents|alkylating agents|mesh-ancestor
102606537|NCT00003859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606538|NCT00003859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606539|NCT00003859|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102606540|NCT00003859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102606541|NCT00003859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102606542|NCT00003859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102606543|NCT00003859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102606544|NCT00003859|Tubulin Modulators|tubulin modulators|mesh-ancestor
102606545|NCT00003859|Antimitotic Agents|antimitotic agents|mesh-ancestor
102606546|NCT00003859|Mitosis Modulators|mitosis modulators|mesh-ancestor
102606547|NCT00003865|Toremifene|toremifene|mesh-list
102606548|NCT00003865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102606549|NCT00003865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606550|NCT00003865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102606551|NCT00003865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102606552|NCT00003865|Hormone Antagonists|hormone antagonists|mesh-ancestor
102606553|NCT00003865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102606554|NCT00003865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606555|NCT00003865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102606556|NCT00004207|Daunorubicin|daunorubicin|mesh-list
102606557|NCT00004207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606558|NCT00004207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102606559|NCT00004207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606560|NCT00004207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102606561|NCT00004207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102606562|NCT00004207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102606563|NCT00004219|Granisetron|granisetron|mesh-list
102606564|NCT00004219|Antiemetics|antiemetics|mesh-ancestor
102606565|NCT00004219|Autonomic Agents|autonomic agents|mesh-ancestor
102606566|NCT00004219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102606567|NCT00004219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606568|NCT00004219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102606569|NCT00004219|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102606570|NCT00004219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102606571|NCT00004219|Serotonin Agents|serotonin agents|mesh-ancestor
102606572|NCT00004219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102606573|NCT00004219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606574|NCT00003877|Paclitaxel|paclitaxel|mesh-list
102606575|NCT00003877|Cyclophosphamide|cyclophosphamide|mesh-list
102606576|NCT00003877|Carboplatin|carboplatin|mesh-list
102606577|NCT00003877|Thiotepa|thiotepa|mesh-list
102606578|NCT00003877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102606579|NCT00003877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606580|NCT00003877|Tubulin Modulators|tubulin modulators|mesh-ancestor
102606581|NCT00003877|Antimitotic Agents|antimitotic agents|mesh-ancestor
102606582|NCT00003877|Mitosis Modulators|mitosis modulators|mesh-ancestor
102606583|NCT00003877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606584|NCT00003877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102606585|NCT00003877|Immunologic Factors|immunologic factors|mesh-ancestor
102606586|NCT00003877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606587|NCT00003877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102606588|NCT00003877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102606589|NCT00003877|Alkylating Agents|alkylating agents|mesh-ancestor
102606590|NCT00003877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102606591|NCT00003883|Itraconazole|itraconazole|mesh-list
102606592|NCT00003883|Fluconazole|fluconazole|mesh-list
101873334|NCT01174888|Analgesics|analgesics|mesh-ancestor
102606593|NCT00003883|Antifungal Agents|antifungal agents|mesh-ancestor
102606594|NCT00003883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102606595|NCT00003883|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102606596|NCT00003883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102606597|NCT00003883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102606598|NCT00003883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606599|NCT00003883|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102606600|NCT00003883|Hormone Antagonists|hormone antagonists|mesh-ancestor
102606601|NCT00003883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102606602|NCT00003883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606603|NCT00003883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102606604|NCT00003883|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102606605|NCT00003883|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102606606|NCT04225819|Vitamin D|vitamin d|mesh-list
102606607|NCT04225819|Cholecalciferol|cholecalciferol|mesh-list
102606608|NCT04225819|Vitamins|vitamins|mesh-ancestor
102606609|NCT04225819|Micronutrients|micronutrients|mesh-ancestor
102606610|NCT04225819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606611|NCT04225819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102606612|NCT04225819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102606613|NCT00003253|Paclitaxel|paclitaxel|mesh-list
102606614|NCT00003253|Antineoplastic Agents|antineoplastic agents|mesh-list
102606615|NCT00003253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102606616|NCT00003253|Tubulin Modulators|tubulin modulators|mesh-ancestor
102606617|NCT00003253|Antimitotic Agents|antimitotic agents|mesh-ancestor
102606618|NCT00003253|Mitosis Modulators|mitosis modulators|mesh-ancestor
102606619|NCT00003253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606620|NCT00004237|Cyclophosphamide|cyclophosphamide|mesh-list
102606621|NCT00004237|Doxorubicin|doxorubicin|mesh-list
102606622|NCT00004237|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102606623|NCT00004237|Vinorelbine|vinorelbine|mesh-list
102606624|NCT00004237|Epirubicin|epirubicin|mesh-list
102606625|NCT00004237|Mitoxantrone|mitoxantrone|mesh-list
102606626|NCT00004237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102606627|NCT00004237|Immunologic Factors|immunologic factors|mesh-ancestor
102606628|NCT00004237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606629|NCT00004237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102606630|NCT00004237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102606631|NCT00004237|Alkylating Agents|alkylating agents|mesh-ancestor
102606632|NCT00004237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606633|NCT00004237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606634|NCT00004237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102606635|NCT00004237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102606636|NCT00004237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102606637|NCT00004237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102606638|NCT00004237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102606639|NCT00004237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102606640|NCT00004237|Tubulin Modulators|tubulin modulators|mesh-ancestor
102606641|NCT00004237|Antimitotic Agents|antimitotic agents|mesh-ancestor
102606642|NCT00004237|Mitosis Modulators|mitosis modulators|mesh-ancestor
102606643|NCT00004237|Analgesics|analgesics|mesh-ancestor
102606644|NCT00004237|Sensory System Agents|sensory system agents|mesh-ancestor
102606645|NCT00004237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102606646|NCT00003259|Vinorelbine|vinorelbine|mesh-list
102606647|NCT00003259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102153518|NCT04174196|Cc-486|cc-486|mesh-list
102606648|NCT00003259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606650|NCT00003259|Antimitotic Agents|antimitotic agents|mesh-ancestor
102606651|NCT00003259|Mitosis Modulators|mitosis modulators|mesh-ancestor
102606652|NCT00003259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606653|NCT00003913|Methylprednisolone|methylprednisolone|mesh-list
102606654|NCT00003913|Cyclophosphamide|cyclophosphamide|mesh-list
102606655|NCT00003913|Busulfan|busulfan|mesh-list
102606656|NCT00003913|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102606657|NCT00003913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102606658|NCT00003913|Immunologic Factors|immunologic factors|mesh-ancestor
102606659|NCT00003913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606660|NCT00003913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102606661|NCT00003913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102606662|NCT00003913|Alkylating Agents|alkylating agents|mesh-ancestor
102606663|NCT00003913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606664|NCT00003913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606665|NCT00003913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102606666|NCT00003913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102606667|NCT00003913|Antiemetics|antiemetics|mesh-ancestor
102606668|NCT00003913|Autonomic Agents|autonomic agents|mesh-ancestor
102606669|NCT00003913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102606670|NCT00003913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102606671|NCT00003913|Glucocorticoids|glucocorticoids|mesh-ancestor
102606672|NCT00003913|Hormones|hormones|mesh-ancestor
102606673|NCT00003913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102606674|NCT00003913|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102606675|NCT00003913|Protective Agents|protective agents|mesh-ancestor
102606676|NCT00004243|Docetaxel|docetaxel|mesh-list
102606677|NCT00004243|Oxaliplatin|oxaliplatin|mesh-list
102606678|NCT00004243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606679|NCT00004243|Tubulin Modulators|tubulin modulators|mesh-ancestor
102606680|NCT00004243|Antimitotic Agents|antimitotic agents|mesh-ancestor
102606681|NCT00004243|Mitosis Modulators|mitosis modulators|mesh-ancestor
102606682|NCT00004243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606683|NCT00004249|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
102606684|NCT00004249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102606685|NCT00004249|Immunologic Factors|immunologic factors|mesh-ancestor
102606686|NCT00004249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606687|NCT00003925|Leucovorin|leucovorin|mesh-list
102606688|NCT00003925|Gemcitabine|gemcitabine|mesh-list
102606689|NCT00003925|Tegafur|tegafur|mesh-list
102606690|NCT00003925|Calcium|calcium|mesh-list
102606691|NCT00003925|Levoleucovorin|levoleucovorin|mesh-list
102606692|NCT00003925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102606693|NCT00003925|Antimetabolites|antimetabolites|mesh-ancestor
102606694|NCT00003925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606695|NCT00003925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606696|NCT00003925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102606697|NCT00003925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606698|NCT00003925|Antidotes|antidotes|mesh-ancestor
102606699|NCT00003925|Protective Agents|protective agents|mesh-ancestor
102606700|NCT00003925|Vitamin B Complex|vitamin b complex|mesh-ancestor
102606701|NCT00003925|Vitamins|vitamins|mesh-ancestor
102606702|NCT00003925|Micronutrients|micronutrients|mesh-ancestor
102606703|NCT00004255|Methylprednisolone|methylprednisolone|mesh-list
102606704|NCT00004255|Cyclophosphamide|cyclophosphamide|mesh-list
102606705|NCT00004255|Fludarabine|fludarabine|mesh-list
102606706|NCT00004255|Fludarabine phosphate|fludarabine phosphate|mesh-list
102606707|NCT00004255|Tacrolimus|tacrolimus|mesh-list
102606708|NCT00004255|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102606709|NCT00004255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102606710|NCT00004255|Immunologic Factors|immunologic factors|mesh-ancestor
102606711|NCT00004255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606712|NCT00004255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102606713|NCT00004255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102606714|NCT00004255|Alkylating Agents|alkylating agents|mesh-ancestor
102606715|NCT00004255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606716|NCT00004255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606717|NCT00004255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102606718|NCT00004255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102606719|NCT00004255|Antimetabolites|antimetabolites|mesh-ancestor
102606720|NCT00004255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102606721|NCT00004255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102606722|NCT00004255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102606723|NCT00004255|Antiemetics|antiemetics|mesh-ancestor
102606724|NCT00004255|Autonomic Agents|autonomic agents|mesh-ancestor
102606726|NCT00004255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102606727|NCT00004255|Glucocorticoids|glucocorticoids|mesh-ancestor
102606728|NCT00004255|Hormones|hormones|mesh-ancestor
102606729|NCT00004255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102606730|NCT00004255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102606731|NCT00004255|Protective Agents|protective agents|mesh-ancestor
102606732|NCT00004261|Antibodies|antibodies|mesh-list
102606733|NCT00004261|Immunologic Factors|immunologic factors|mesh-ancestor
102606734|NCT00004261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606735|NCT00004297|Diazepam|diazepam|mesh-list
102346573|NCT04067726|Vitamin D|vitamin d|mesh-list
102346574|NCT04067726|Cholecalciferol|cholecalciferol|mesh-list
102346575|NCT04067726|Denosumab|denosumab|mesh-list
102346576|NCT04067726|Calcium|calcium|mesh-list
102346577|NCT04067726|Vitamins|vitamins|mesh-ancestor
102606736|NCT00004297|Lorazepam|lorazepam|mesh-list
102606737|NCT00004297|Anticonvulsants|anticonvulsants|mesh-ancestor
102606738|NCT00004297|Antiemetics|antiemetics|mesh-ancestor
102606739|NCT00004297|Autonomic Agents|autonomic agents|mesh-ancestor
102606740|NCT00004297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102606741|NCT00004297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606742|NCT00004297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102606743|NCT00004297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102606744|NCT00004297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102606745|NCT00004297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102606746|NCT00004297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102606747|NCT00004297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102606748|NCT00004297|GABA Modulators|gaba modulators|mesh-ancestor
102606749|NCT00004297|GABA Agents|gaba agents|mesh-ancestor
102606750|NCT00004297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102606751|NCT00004297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606752|NCT00004297|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102606753|NCT00004297|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102606754|NCT00004297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102606755|NCT00004297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102606756|NCT00004297|Anesthetics, General|anesthetics, general|mesh-ancestor
102606757|NCT00004297|Anesthetics|anesthetics|mesh-ancestor
102606758|NCT00004855|Ritonavir|ritonavir|mesh-list
102606759|NCT00004855|Lopinavir|lopinavir|mesh-list
102606760|NCT00004855|Lamivudine|lamivudine|mesh-list
102606761|NCT00004855|Nevirapine|nevirapine|mesh-list
102606762|NCT00004855|Abacavir|abacavir|mesh-list
102606763|NCT00004855|Stavudine|stavudine|mesh-list
102606764|NCT00004855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102606765|NCT00004855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102606766|NCT00004855|Protease Inhibitors|protease inhibitors|mesh-ancestor
102606767|NCT00004855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102606768|NCT00004855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606769|NCT00004855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102606770|NCT00004855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102606771|NCT00004855|Antiviral Agents|antiviral agents|mesh-ancestor
102606772|NCT00004855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102606773|NCT00004855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102606774|NCT00004855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102606775|NCT00004855|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102606776|NCT00004855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102606777|NCT00004855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102606778|NCT00004855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102606779|NCT00004855|Antimetabolites|antimetabolites|mesh-ancestor
102606780|NCT00003289|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
102606781|NCT00003289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606782|NCT00003289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102606783|NCT00003289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102606784|NCT00003289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606785|NCT00004861|Gemcitabine|gemcitabine|mesh-list
102606786|NCT00004861|Tacedinaline|tacedinaline|mesh-list
102606787|NCT00004861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102606788|NCT00004861|Antimetabolites|antimetabolites|mesh-ancestor
102606789|NCT00004861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606790|NCT00004861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606791|NCT00004861|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102606792|NCT00004861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102606793|NCT00004315|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102606794|NCT00004315|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102606795|NCT00004315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102606796|NCT04074343|Irinotecan|irinotecan|mesh-list
102606797|NCT04074343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102606798|NCT04074343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102606799|NCT04074343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102153599|NCT04023669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606800|NCT04074343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606801|NCT04074343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606802|NCT00003301|Irinotecan|irinotecan|mesh-list
102606803|NCT00003301|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102606804|NCT00003301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102606805|NCT00003301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102606806|NCT00003301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606807|NCT00003301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606808|NCT00003307|Amifostine|amifostine|mesh-list
102606809|NCT00003307|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102606810|NCT00003307|Protective Agents|protective agents|mesh-ancestor
102606811|NCT00003307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606812|NCT00004327|Octreotide|octreotide|mesh-list
102606813|NCT00004327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102606814|NCT00004327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102606815|NCT00004327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606816|NCT00003313|Paclitaxel|paclitaxel|mesh-list
102606817|NCT00003313|Carboplatin|carboplatin|mesh-list
102606818|NCT00003313|Amifostine|amifostine|mesh-list
102606819|NCT00003313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102606820|NCT00003313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606821|NCT00003313|Tubulin Modulators|tubulin modulators|mesh-ancestor
102606822|NCT00003313|Antimitotic Agents|antimitotic agents|mesh-ancestor
102606823|NCT00003313|Mitosis Modulators|mitosis modulators|mesh-ancestor
102606824|NCT00003313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606825|NCT00003313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606826|NCT00003313|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102606827|NCT00003313|Protective Agents|protective agents|mesh-ancestor
102606828|NCT00004867|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102606829|NCT00004867|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102606830|NCT00004867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606831|NCT00004873|Docetaxel|docetaxel|mesh-list
102606832|NCT00004873|Fluorouracil|fluorouracil|mesh-list
102606833|NCT00004873|Epirubicin|epirubicin|mesh-list
102606834|NCT00004873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606835|NCT00004873|Tubulin Modulators|tubulin modulators|mesh-ancestor
102606836|NCT00004873|Antimitotic Agents|antimitotic agents|mesh-ancestor
102606837|NCT00004873|Mitosis Modulators|mitosis modulators|mesh-ancestor
102606838|NCT00004873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606839|NCT00004873|Antimetabolites|antimetabolites|mesh-ancestor
102606840|NCT00004873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102606841|NCT00004873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102606842|NCT00004873|Immunologic Factors|immunologic factors|mesh-ancestor
102606843|NCT00004873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606844|NCT00004873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102606845|NCT00004873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102606846|NCT00004873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102606847|NCT00004873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102606848|NCT00004879|Panitumumab|panitumumab|mesh-list
102606849|NCT00004879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102606850|NCT00004879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606851|NCT00004339|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
102606852|NCT00004339|Trientine|trientine|mesh-list
102606853|NCT00004339|Chelating Agents|chelating agents|mesh-ancestor
102606854|NCT00004339|Sequestering Agents|sequestering agents|mesh-ancestor
102606855|NCT00004339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606856|NCT00004339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102606857|NCT00004339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102606858|NCT00004339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102606859|NCT00004339|Growth Substances|growth substances|mesh-ancestor
102606860|NCT00004339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606861|NCT00004339|Growth Inhibitors|growth inhibitors|mesh-ancestor
102606862|NCT00004339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606863|NCT00003331|Leucovorin|leucovorin|mesh-list
102606864|NCT00003331|Fluorouracil|fluorouracil|mesh-list
102606865|NCT00003331|Topotecan|topotecan|mesh-list
102606866|NCT00003331|Calcium|calcium|mesh-list
102606867|NCT00003331|Levoleucovorin|levoleucovorin|mesh-list
102606868|NCT00003331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102606869|NCT00003331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606870|NCT00003331|Antimetabolites|antimetabolites|mesh-ancestor
102606871|NCT00003331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606872|NCT00003331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102606873|NCT00003331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606874|NCT00003331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102606875|NCT00003331|Immunologic Factors|immunologic factors|mesh-ancestor
102606876|NCT00003331|Antidotes|antidotes|mesh-ancestor
102606877|NCT00003331|Protective Agents|protective agents|mesh-ancestor
102606878|NCT00003331|Vitamin B Complex|vitamin b complex|mesh-ancestor
102606879|NCT00003331|Vitamins|vitamins|mesh-ancestor
102606880|NCT00003331|Micronutrients|micronutrients|mesh-ancestor
102346582|NCT04064840|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102606881|NCT00003331|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102606882|NCT00003331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102606883|NCT00003331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102606884|NCT00004885|Leucovorin|leucovorin|mesh-list
102606885|NCT00004885|Fluorouracil|fluorouracil|mesh-list
102606886|NCT00004885|Irinotecan|irinotecan|mesh-list
102606887|NCT00004885|Calcium|calcium|mesh-list
102606888|NCT00004885|Levoleucovorin|levoleucovorin|mesh-list
102606889|NCT00004885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102606890|NCT00004885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606891|NCT00004885|Antimetabolites|antimetabolites|mesh-ancestor
102606892|NCT00004885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606893|NCT00004885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102606894|NCT00004885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606895|NCT00004885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102606896|NCT00004885|Immunologic Factors|immunologic factors|mesh-ancestor
102606897|NCT00004885|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102606898|NCT00004885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102606899|NCT00004885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102606900|NCT00004885|Antidotes|antidotes|mesh-ancestor
102606901|NCT00004885|Protective Agents|protective agents|mesh-ancestor
102606902|NCT00004885|Vitamin B Complex|vitamin b complex|mesh-ancestor
102606903|NCT00004885|Vitamins|vitamins|mesh-ancestor
102606904|NCT00004885|Micronutrients|micronutrients|mesh-ancestor
102606905|NCT00004891|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102606906|NCT00004891|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102606907|NCT00004891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606908|NCT00003337|Epratuzumab|epratuzumab|mesh-list
102606909|NCT00003337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102606910|NCT00003337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606911|NCT00003343|Prednisone|prednisone|mesh-list
102606912|NCT00003343|Mitoxantrone|mitoxantrone|mesh-list
102606913|NCT00003343|Prinomastat|prinomastat|mesh-list
102606914|NCT00003343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102606915|NCT00003343|Glucocorticoids|glucocorticoids|mesh-ancestor
102606916|NCT00003343|Hormones|hormones|mesh-ancestor
102606917|NCT00003343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102606918|NCT00003343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606919|NCT00003343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102606920|NCT00003343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606921|NCT00003343|Analgesics|analgesics|mesh-ancestor
102606922|NCT00003343|Sensory System Agents|sensory system agents|mesh-ancestor
102606923|NCT00003343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102606924|NCT00003343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102606925|NCT00003343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102606926|NCT00003343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102606927|NCT00003343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606928|NCT00003343|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
102606929|NCT00003343|Protease Inhibitors|protease inhibitors|mesh-ancestor
102606930|NCT00004903|Interferons|interferons|mesh-list
102606931|NCT00004903|Cytarabine|cytarabine|mesh-list
102606932|NCT00004903|Interferon-alpha|interferon-alpha|mesh-list
102606933|NCT00004903|Cyclophosphamide|cyclophosphamide|mesh-list
102606934|NCT00004903|Melphalan|melphalan|mesh-list
102606935|NCT00004903|Etoposide|etoposide|mesh-list
102606936|NCT00004903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102606937|NCT00004903|Immunologic Factors|immunologic factors|mesh-ancestor
102606938|NCT00004903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606939|NCT00004903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102606940|NCT00004903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102606941|NCT00004903|Alkylating Agents|alkylating agents|mesh-ancestor
102606942|NCT00004903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606943|NCT00004903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606944|NCT00004903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102606945|NCT00004903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102606946|NCT00004903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102606947|NCT00004903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102606948|NCT00004903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102153751|NCT03826563|Protective Agents|protective agents|mesh-ancestor
102606949|NCT00004903|Antiviral Agents|antiviral agents|mesh-ancestor
102606950|NCT00004903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102606951|NCT00004903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102606952|NCT00004903|Antimetabolites|antimetabolites|mesh-ancestor
102606953|NCT00004357|Methylprednisolone|methylprednisolone|mesh-list
102606954|NCT00004357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102606955|NCT00004357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102606956|NCT00004357|Prednisolone|prednisolone|mesh-list
102606957|NCT00004357|Prednisolone acetate|prednisolone acetate|mesh-list
102606958|NCT00004357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102606959|NCT00004357|Prednisolone phosphate|prednisolone phosphate|mesh-list
102606960|NCT00004357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102606961|NCT00004357|Antiemetics|antiemetics|mesh-ancestor
102606962|NCT00004357|Autonomic Agents|autonomic agents|mesh-ancestor
102606963|NCT00004357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102606964|NCT00004357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606965|NCT00004357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102606966|NCT00004357|Glucocorticoids|glucocorticoids|mesh-ancestor
102606967|NCT00004357|Hormones|hormones|mesh-ancestor
102606968|NCT00004357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102606969|NCT00004357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102606970|NCT00004357|Protective Agents|protective agents|mesh-ancestor
102606971|NCT00004357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102606972|NCT00004357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606973|NCT00004363|Chlorpropamide|chlorpropamide|mesh-list
102606974|NCT00004363|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
102606975|NCT00004363|Hemostatics|hemostatics|mesh-ancestor
102606976|NCT00004363|Coagulants|coagulants|mesh-ancestor
102606977|NCT00004363|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102606978|NCT00004363|Natriuretic Agents|natriuretic agents|mesh-ancestor
102606979|NCT00004363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606980|NCT00004363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102606981|NCT04069117|Letrozole|letrozole|mesh-list
102606982|NCT04069117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606983|NCT04069117|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102606984|NCT04069117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102606985|NCT04069117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102606986|NCT04069117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102606987|NCT04069117|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102606988|NCT04069117|Hormone Antagonists|hormone antagonists|mesh-ancestor
102606989|NCT04069117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102606990|NCT04069117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102606991|NCT00004921|Paclitaxel|paclitaxel|mesh-list
102606992|NCT00004921|Cyclophosphamide|cyclophosphamide|mesh-list
102606993|NCT00004921|Carboplatin|carboplatin|mesh-list
102606994|NCT00004921|Melphalan|melphalan|mesh-list
102606995|NCT00004921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102606996|NCT00004921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102606997|NCT00004921|Tubulin Modulators|tubulin modulators|mesh-ancestor
102606998|NCT00004921|Antimitotic Agents|antimitotic agents|mesh-ancestor
102606999|NCT00004921|Mitosis Modulators|mitosis modulators|mesh-ancestor
102607000|NCT00004921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607001|NCT00004921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102607002|NCT00004921|Immunologic Factors|immunologic factors|mesh-ancestor
102607003|NCT00004921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607004|NCT00004921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102607005|NCT00004921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102607006|NCT00004921|Alkylating Agents|alkylating agents|mesh-ancestor
102607007|NCT00004921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102607008|NCT00004933|Hydroxyurea|hydroxyurea|mesh-list
102607009|NCT00004933|Homoharringtonine|homoharringtonine|mesh-list
102607010|NCT00004933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102607011|NCT00004933|Antisickling Agents|antisickling agents|mesh-ancestor
102607012|NCT00004933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607013|NCT00004933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607014|NCT00004933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102607015|NCT00004933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102607016|NCT00004933|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102607017|NCT00004981|Lamivudine|lamivudine|mesh-list
102607018|NCT00004981|Zidovudine|zidovudine|mesh-list
102607019|NCT00004981|Abacavir|abacavir|mesh-list
102607020|NCT00004981|Dideoxynucleosides|dideoxynucleosides|mesh-list
102607021|NCT00004981|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
102607022|NCT00004981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102607023|NCT00004981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102607024|NCT00004981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607025|NCT00004981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607026|NCT00004981|Antiviral Agents|antiviral agents|mesh-ancestor
102607027|NCT00004981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102607028|NCT00004981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102607029|NCT00004981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102607030|NCT00004981|Antimetabolites|antimetabolites|mesh-ancestor
102607031|NCT00004993|Hormones|hormones|mesh-list
102607032|NCT00004993|Parathyroid Hormone|parathyroid hormone|mesh-list
102607033|NCT00004993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102607034|NCT00004993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607035|NCT00004993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102607036|NCT00004999|Lamivudine|lamivudine|mesh-list
102607037|NCT00004999|Zidovudine|zidovudine|mesh-list
102607038|NCT00004999|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
102607039|NCT00004999|Capravirine|capravirine|mesh-list
102607040|NCT00004999|Nelfinavir|nelfinavir|mesh-list
102607041|NCT00004999|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102607042|NCT00004999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102607043|NCT00004999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607044|NCT00004999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607045|NCT00004999|Antiviral Agents|antiviral agents|mesh-ancestor
102607046|NCT00004999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102607047|NCT00004999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102607048|NCT00004999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102607049|NCT00004999|Antimetabolites|antimetabolites|mesh-ancestor
102607050|NCT00004999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102607051|NCT00004999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102607052|NCT00004999|Protease Inhibitors|protease inhibitors|mesh-ancestor
102607053|NCT00003361|Decitabine|decitabine|mesh-list
102607054|NCT00003361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102607055|NCT00003361|Antimetabolites|antimetabolites|mesh-ancestor
102607056|NCT00003361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607057|NCT00003361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102607058|NCT00003361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607059|NCT00003367|Vitamin E|vitamin e|mesh-list
102607060|NCT00003367|Vitamins|vitamins|mesh-ancestor
102607061|NCT00003367|Micronutrients|micronutrients|mesh-ancestor
102607062|NCT00003367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607063|NCT00003367|Antioxidants|antioxidants|mesh-ancestor
102607064|NCT00003367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607065|NCT00003367|Protective Agents|protective agents|mesh-ancestor
102607066|NCT00003379|Paclitaxel|paclitaxel|mesh-list
102607067|NCT00003379|Cisplatin|cisplatin|mesh-list
102607068|NCT00003379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102607069|NCT00003379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102607070|NCT00003379|Tubulin Modulators|tubulin modulators|mesh-ancestor
102607071|NCT00003379|Antimitotic Agents|antimitotic agents|mesh-ancestor
102607072|NCT00003379|Mitosis Modulators|mitosis modulators|mesh-ancestor
102607073|NCT00003379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607074|NCT00003385|Paclitaxel|paclitaxel|mesh-list
102607075|NCT00003385|Carboplatin|carboplatin|mesh-list
102607076|NCT00003385|Doxorubicin|doxorubicin|mesh-list
102607077|NCT00003385|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102607078|NCT00003385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102607079|NCT00003385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102607080|NCT00003385|Tubulin Modulators|tubulin modulators|mesh-ancestor
102607081|NCT00003385|Antimitotic Agents|antimitotic agents|mesh-ancestor
102607082|NCT00003385|Mitosis Modulators|mitosis modulators|mesh-ancestor
102607083|NCT00003385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607084|NCT00003385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102607085|NCT00003385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102607086|NCT00003385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102607087|NCT00003385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607088|NCT00004381|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
102607089|NCT00004381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607090|NCT00004381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607091|NCT00005005|Alendronate|alendronate|mesh-list
102607092|NCT00005005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102607093|NCT00005005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607094|NCT00004393|Risperidone|risperidone|mesh-list
102607095|NCT00004393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102607096|NCT00004393|Serotonin Agents|serotonin agents|mesh-ancestor
102607097|NCT00004393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102607098|NCT00004393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607099|NCT00004393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607100|NCT00004393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102607101|NCT00004393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102607102|NCT00004393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102607103|NCT00004393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102607104|NCT00004393|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102607105|NCT00004393|Dopamine Agents|dopamine agents|mesh-ancestor
102607106|NCT00004399|Magnesium Sulfate|magnesium sulfate|mesh-list
102607107|NCT00004399|Nimodipine|nimodipine|mesh-list
102607108|NCT00004399|Analgesics|analgesics|mesh-ancestor
102607109|NCT00004399|Sensory System Agents|sensory system agents|mesh-ancestor
102607110|NCT00004399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102607111|NCT00004399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607112|NCT00004399|Anesthetics|anesthetics|mesh-ancestor
102607113|NCT00004399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102607114|NCT00004399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102607115|NCT00004399|Anticonvulsants|anticonvulsants|mesh-ancestor
102607116|NCT00004399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102607117|NCT00004399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102607118|NCT00004399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607119|NCT00004399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102607120|NCT00004399|Tocolytic Agents|tocolytic agents|mesh-ancestor
102607121|NCT00004399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102607122|NCT00004399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102607123|NCT00004399|Vasodilator Agents|vasodilator agents|mesh-ancestor
102607124|NCT00004423|Aminosalicylic Acid|aminosalicylic acid|mesh-list
102607125|NCT00004423|Antitubercular Agents|antitubercular agents|mesh-ancestor
102607126|NCT00004423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102607127|NCT00004423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102607128|NCT00005017|Ritonavir|ritonavir|mesh-list
102607129|NCT00005017|Amprenavir|amprenavir|mesh-list
102607130|NCT00005017|Lamivudine|lamivudine|mesh-list
102607131|NCT00005017|Abacavir|abacavir|mesh-list
102607132|NCT00005017|Stavudine|stavudine|mesh-list
102607133|NCT00005017|Efavirenz|efavirenz|mesh-list
102607134|NCT00005017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102607135|NCT00005017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102607136|NCT00005017|Protease Inhibitors|protease inhibitors|mesh-ancestor
102607137|NCT00005017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607138|NCT00005017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607139|NCT00005017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102607140|NCT00005017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102607141|NCT00005017|Antiviral Agents|antiviral agents|mesh-ancestor
102607142|NCT00005017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102607143|NCT00005017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102607144|NCT00005017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102607145|NCT00005017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102607146|NCT00005017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102607147|NCT00005017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102607148|NCT00005017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102607149|NCT00005017|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102607150|NCT00005017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102607151|NCT00005017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102607152|NCT00005017|Antimetabolites|antimetabolites|mesh-ancestor
102607153|NCT00005017|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102607154|NCT00005017|Antitubercular Agents|antitubercular agents|mesh-ancestor
102607155|NCT00005017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102607156|NCT00005023|Sargramostim|sargramostim|mesh-list
102607157|NCT00005023|Immunologic Factors|immunologic factors|mesh-ancestor
102607158|NCT00005023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607159|NCT00005029|Topotecan|topotecan|mesh-list
102607160|NCT00005029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102607161|NCT00005029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102607162|NCT00005029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607163|NCT00005029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607164|NCT00005029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102607165|NCT00005035|Oxaliplatin|oxaliplatin|mesh-list
102607166|NCT00005035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102607167|NCT00004429|Hormones|hormones|mesh-list
102607168|NCT00004429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102607169|NCT00004429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607170|NCT00005041|Tipifarnib|tipifarnib|mesh-list
102607171|NCT00005041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346591|NCT04050462|Nivolumab|nivolumab|mesh-list
102607172|NCT00004441|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
102607173|NCT00004441|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102607174|NCT00004441|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102607175|NCT00004441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102607176|NCT00004441|Antiviral Agents|antiviral agents|mesh-ancestor
102607177|NCT00004441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102607178|NCT00004465|Shiga Toxins|shiga toxins|mesh-list
102607179|NCT00004465|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102607180|NCT00004465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607181|NCT00004465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607182|NCT00005569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
102607183|NCT00005569|Protease Inhibitors|protease inhibitors|mesh-list
102607184|NCT00005569|Secretory Leukocyte Peptidase Inhibitor|secretory leukocyte peptidase inhibitor|mesh-list
102607185|NCT00005569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607186|NCT00005569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607187|NCT00005569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102607188|NCT00005569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102607189|NCT00005569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102607190|NCT00005569|Antiviral Agents|antiviral agents|mesh-ancestor
102607191|NCT00005569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102607192|NCT00005569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102607193|NCT00005575|Imipramine|imipramine|mesh-list
102607194|NCT00005575|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102607195|NCT00005575|Antidepressive Agents|antidepressive agents|mesh-ancestor
102607196|NCT00005575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102607197|NCT00005575|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102607198|NCT00005575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102607199|NCT00005575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102607200|NCT00005575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607201|NCT00005575|Adrenergic Agents|adrenergic agents|mesh-ancestor
102607202|NCT00005575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102607203|NCT00005575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607204|NCT00005059|Paclitaxel|paclitaxel|mesh-list
102607205|NCT00005059|Carboplatin|carboplatin|mesh-list
102607206|NCT00005059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102607207|NCT00005059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102607208|NCT00005059|Tubulin Modulators|tubulin modulators|mesh-ancestor
102607209|NCT00005059|Antimitotic Agents|antimitotic agents|mesh-ancestor
102607210|NCT00005059|Mitosis Modulators|mitosis modulators|mesh-ancestor
102607211|NCT00005059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607212|NCT00005065|Paclitaxel|paclitaxel|mesh-list
102607213|NCT00005065|Carboplatin|carboplatin|mesh-list
102607214|NCT00005065|Motexafin gadolinium|motexafin gadolinium|mesh-list
102607215|NCT00005065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102607216|NCT00005065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102607217|NCT00005065|Tubulin Modulators|tubulin modulators|mesh-ancestor
102607218|NCT00005065|Antimitotic Agents|antimitotic agents|mesh-ancestor
102607219|NCT00005065|Mitosis Modulators|mitosis modulators|mesh-ancestor
102607220|NCT00005065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607221|NCT00005065|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102607222|NCT00005065|Dermatologic Agents|dermatologic agents|mesh-ancestor
102607223|NCT00386191|Clopidogrel|clopidogrel|mesh-list
102607224|NCT00386191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102607225|NCT00386191|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102607226|NCT00386191|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102607227|NCT00386191|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102607228|NCT00386191|Purinergic Agents|purinergic agents|mesh-ancestor
102607229|NCT00386191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102607230|NCT00386191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607231|NCT00386191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607232|NCT00386269|Codeine|codeine|mesh-list
102607233|NCT00386269|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102607234|NCT00386269|Narcotics|narcotics|mesh-ancestor
102607235|NCT00386269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102607236|NCT00386269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607237|NCT00386269|Analgesics|analgesics|mesh-ancestor
102607238|NCT00386269|Sensory System Agents|sensory system agents|mesh-ancestor
102607239|NCT00386269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102607240|NCT00386269|Antitussive Agents|antitussive agents|mesh-ancestor
102607241|NCT00386269|Respiratory System Agents|respiratory system agents|mesh-ancestor
102607242|NCT00005581|Paclitaxel|paclitaxel|mesh-list
102607243|NCT00005581|Cyclophosphamide|cyclophosphamide|mesh-list
102607244|NCT00005581|Fluorouracil|fluorouracil|mesh-list
102607245|NCT00005581|Epirubicin|epirubicin|mesh-list
102607246|NCT00005581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102607247|NCT00005581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102607248|NCT00005581|Tubulin Modulators|tubulin modulators|mesh-ancestor
102607249|NCT00005581|Antimitotic Agents|antimitotic agents|mesh-ancestor
102607250|NCT00005581|Mitosis Modulators|mitosis modulators|mesh-ancestor
102607251|NCT00005581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607252|NCT00005581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102607253|NCT00005581|Immunologic Factors|immunologic factors|mesh-ancestor
102154055|NCT01728259|Hormones|hormones|mesh-ancestor
102607254|NCT00005581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607255|NCT00005581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102607256|NCT00005581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102607257|NCT00005581|Alkylating Agents|alkylating agents|mesh-ancestor
102607258|NCT00005581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102607259|NCT00005581|Antimetabolites|antimetabolites|mesh-ancestor
102607260|NCT00005581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102607261|NCT00005581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102607262|NCT00005581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102607263|NCT00005581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102607264|NCT00005581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607265|NCT00005077|Oxaliplatin|oxaliplatin|mesh-list
102607266|NCT00005077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102607267|NCT00004489|Cholecalciferol|cholecalciferol|mesh-list
102607268|NCT00004489|Vitamin D|vitamin d|mesh-list
102607269|NCT00004489|Alendronate|alendronate|mesh-list
102607270|NCT00004489|Calcium Carbonate|calcium carbonate|mesh-list
102607271|NCT00004489|Calcium|calcium|mesh-list
102607272|NCT00004489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102607273|NCT00004489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607274|NCT00004489|Vitamins|vitamins|mesh-ancestor
102607275|NCT00004489|Micronutrients|micronutrients|mesh-ancestor
102607276|NCT00004489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102607277|NCT00004489|Antacids|antacids|mesh-ancestor
102607278|NCT00004489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607279|NCT00004489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102607280|NCT00005593|Carboplatin|carboplatin|mesh-list
102607281|NCT00005593|Fludarabine|fludarabine|mesh-list
102607282|NCT00005593|Fludarabine phosphate|fludarabine phosphate|mesh-list
102607283|NCT00005593|Topotecan|topotecan|mesh-list
102607284|NCT00005593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102607285|NCT00005593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102607286|NCT00005593|Antimetabolites|antimetabolites|mesh-ancestor
102607287|NCT00005593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607288|NCT00005593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102607289|NCT00005593|Immunologic Factors|immunologic factors|mesh-ancestor
102607290|NCT00005593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607291|NCT00005593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102607292|NCT00005593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102607293|NCT00005593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607294|NCT00004495|Folic Acid|folic acid|mesh-list
102607295|NCT00004495|Pyridoxine|pyridoxine|mesh-list
102607296|NCT00004495|Vitamin B 12|vitamin b 12|mesh-list
102607297|NCT00004495|Hydroxocobalamin|hydroxocobalamin|mesh-list
102607298|NCT00004495|Hematinics|hematinics|mesh-ancestor
102607299|NCT00004495|Vitamin B Complex|vitamin b complex|mesh-ancestor
102607300|NCT00004495|Vitamins|vitamins|mesh-ancestor
102607301|NCT00004495|Micronutrients|micronutrients|mesh-ancestor
102607302|NCT00004495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607303|NCT00005089|Prednisone|prednisone|mesh-list
102607304|NCT00005089|Cyclophosphamide|cyclophosphamide|mesh-list
102607305|NCT00005089|Rituximab|rituximab|mesh-list
102607306|NCT00005089|Doxorubicin|doxorubicin|mesh-list
102607307|NCT00005089|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102607308|NCT00005089|Vincristine|vincristine|mesh-list
102607309|NCT00005089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102607310|NCT00005089|Immunologic Factors|immunologic factors|mesh-ancestor
102607311|NCT00005089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607312|NCT00005089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102607313|NCT00005089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102607314|NCT00005089|Alkylating Agents|alkylating agents|mesh-ancestor
102607315|NCT00005089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607316|NCT00005089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102607317|NCT00005089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102607318|NCT00005089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102607319|NCT00005089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102607320|NCT00005089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102607321|NCT00005089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102607322|NCT00005089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607323|NCT00005089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102607324|NCT00005089|Glucocorticoids|glucocorticoids|mesh-ancestor
102607325|NCT00005089|Hormones|hormones|mesh-ancestor
102607326|NCT00005089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102607327|NCT00005089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102607328|NCT00005089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102607329|NCT00005089|Tubulin Modulators|tubulin modulators|mesh-ancestor
102607330|NCT00005089|Antimitotic Agents|antimitotic agents|mesh-ancestor
102607331|NCT00005089|Mitosis Modulators|mitosis modulators|mesh-ancestor
102607332|NCT00005599|Paclitaxel|paclitaxel|mesh-list
102607333|NCT00005599|Bryostatin 1|bryostatin 1|mesh-list
102607334|NCT00005599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102607335|NCT00005599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102607336|NCT00005599|Tubulin Modulators|tubulin modulators|mesh-ancestor
102607337|NCT00005599|Antimitotic Agents|antimitotic agents|mesh-ancestor
102607338|NCT00005599|Mitosis Modulators|mitosis modulators|mesh-ancestor
102607339|NCT00005599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607340|NCT00005599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102607341|NCT00005599|Immunologic Factors|immunologic factors|mesh-ancestor
102607342|NCT00005599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607343|NCT00004567|Mycophenolic Acid|mycophenolic acid|mesh-list
102607344|NCT00004567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102607345|NCT00004567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102607346|NCT00004567|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102607347|NCT00004567|Antitubercular Agents|antitubercular agents|mesh-ancestor
102607348|NCT00004567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102607349|NCT00004567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102607350|NCT00004567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607351|NCT00004567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607352|NCT00005113|Cyclosporine|cyclosporine|mesh-list
102607353|NCT00005113|Sirolimus|sirolimus|mesh-list
102607354|NCT00005113|Tacrolimus|tacrolimus|mesh-list
102607355|NCT00005113|Cyclosporins|cyclosporins|mesh-list
102607356|NCT00005113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102607357|NCT00005113|Immunologic Factors|immunologic factors|mesh-ancestor
102607358|NCT00005113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607359|NCT00005113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102607360|NCT00005113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607361|NCT00005113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607362|NCT00005113|Antifungal Agents|antifungal agents|mesh-ancestor
102607363|NCT00005113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102607364|NCT00005113|Dermatologic Agents|dermatologic agents|mesh-ancestor
102607365|NCT00005113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102607366|NCT00005113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102607367|NCT00005113|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102607368|NCT00005113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102607369|NCT00004573|Ganciclovir|ganciclovir|mesh-list
102607370|NCT00004573|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102607371|NCT00004573|Antiviral Agents|antiviral agents|mesh-ancestor
102607372|NCT00004573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102607373|NCT00004573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102607374|NCT00004573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607375|NCT00004573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607376|NCT00005623|Cyproterone Acetate|cyproterone acetate|mesh-list
102607377|NCT00005623|Cyproterone|cyproterone|mesh-list
102607378|NCT00005623|Androgen Antagonists|androgen antagonists|mesh-ancestor
102607379|NCT00005623|Hormone Antagonists|hormone antagonists|mesh-ancestor
102607380|NCT00005623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102607381|NCT00005623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607382|NCT00005623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102607383|NCT00005623|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102607384|NCT00005623|Contraceptive Agents|contraceptive agents|mesh-ancestor
102607385|NCT00005623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102607386|NCT00005119|Calcium|calcium|mesh-list
102607387|NCT00005119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102607388|NCT00005119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607389|NCT00004585|Lamivudine|lamivudine|mesh-list
102607390|NCT00004585|Zidovudine|zidovudine|mesh-list
102607391|NCT00004585|Efavirenz|efavirenz|mesh-list
102607392|NCT00004585|Abacavir|abacavir|mesh-list
102607393|NCT00004585|Dideoxynucleosides|dideoxynucleosides|mesh-list
102607394|NCT00004585|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
102607395|NCT00004585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102607396|NCT00004585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102607397|NCT00004585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607398|NCT00004585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607399|NCT00004585|Antiviral Agents|antiviral agents|mesh-ancestor
102607400|NCT00004585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102607401|NCT00004585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102607402|NCT00004585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102607403|NCT00004585|Antimetabolites|antimetabolites|mesh-ancestor
102607404|NCT00004585|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102607405|NCT00004585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102607406|NCT00004585|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102607407|NCT00004585|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102607408|NCT00004585|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102607409|NCT00004585|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102607410|NCT00005635|Paclitaxel|paclitaxel|mesh-list
102607411|NCT00005635|Trastuzumab|trastuzumab|mesh-list
102607412|NCT00005635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102607413|NCT00005635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102607414|NCT00005635|Tubulin Modulators|tubulin modulators|mesh-ancestor
102607415|NCT00005635|Antimitotic Agents|antimitotic agents|mesh-ancestor
102607416|NCT00005635|Mitosis Modulators|mitosis modulators|mesh-ancestor
102607417|NCT00005635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607418|NCT00005635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102607419|NCT00005641|Leucovorin|leucovorin|mesh-list
102607420|NCT00005641|Cyclosporine|cyclosporine|mesh-list
102607421|NCT00005641|Methylprednisolone|methylprednisolone|mesh-list
102607422|NCT00005641|Cyclophosphamide|cyclophosphamide|mesh-list
102607423|NCT00005641|Busulfan|busulfan|mesh-list
102607424|NCT00005641|Methotrexate|methotrexate|mesh-list
102607425|NCT00005641|Cyclosporins|cyclosporins|mesh-list
102607426|NCT00005641|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102607427|NCT00005641|Levoleucovorin|levoleucovorin|mesh-list
102607428|NCT00005641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102607429|NCT00005641|Immunologic Factors|immunologic factors|mesh-ancestor
102607430|NCT00005641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607431|NCT00005641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102607432|NCT00005641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102607433|NCT00005641|Alkylating Agents|alkylating agents|mesh-ancestor
102607434|NCT00005641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607435|NCT00005641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102607436|NCT00005641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102607437|NCT00005641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102607438|NCT00005641|Abortifacient Agents|abortifacient agents|mesh-ancestor
102607439|NCT00005641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102607440|NCT00005641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102607441|NCT00005641|Antimetabolites|antimetabolites|mesh-ancestor
102607442|NCT00005641|Dermatologic Agents|dermatologic agents|mesh-ancestor
102607443|NCT00005641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607444|NCT00005641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102607445|NCT00005641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102607446|NCT00005641|Antidotes|antidotes|mesh-ancestor
102607447|NCT00005641|Protective Agents|protective agents|mesh-ancestor
102607448|NCT00005641|Vitamin B Complex|vitamin b complex|mesh-ancestor
102607449|NCT00005641|Vitamins|vitamins|mesh-ancestor
102607450|NCT00005641|Micronutrients|micronutrients|mesh-ancestor
102607451|NCT00005641|Antifungal Agents|antifungal agents|mesh-ancestor
102607452|NCT00005641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102607453|NCT00005641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102607454|NCT00005641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102607455|NCT00005641|Antiemetics|antiemetics|mesh-ancestor
102607456|NCT00005641|Autonomic Agents|autonomic agents|mesh-ancestor
102607457|NCT00005641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102607458|NCT00005641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102607459|NCT00005641|Glucocorticoids|glucocorticoids|mesh-ancestor
102607460|NCT00005641|Hormones|hormones|mesh-ancestor
102607461|NCT00005641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102607462|NCT00005641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102607463|NCT00005647|Paclitaxel|paclitaxel|mesh-list
102607464|NCT00005647|Semaxinib|semaxinib|mesh-list
102607465|NCT00005647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102607466|NCT00005647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102607467|NCT00005647|Tubulin Modulators|tubulin modulators|mesh-ancestor
102607468|NCT00005647|Antimitotic Agents|antimitotic agents|mesh-ancestor
102607469|NCT00005647|Mitosis Modulators|mitosis modulators|mesh-ancestor
102607470|NCT00005647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607471|NCT00005647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102607472|NCT00005647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102607473|NCT00005647|Growth Substances|growth substances|mesh-ancestor
102607474|NCT00005647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607475|NCT00005647|Growth Inhibitors|growth inhibitors|mesh-ancestor
102607476|NCT00005647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102607477|NCT00005647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607478|NCT00005665|Interferons|interferons|mesh-list
102607479|NCT00005665|Interferon-alpha|interferon-alpha|mesh-list
102607480|NCT00005665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102607481|NCT00005665|Antiviral Agents|antiviral agents|mesh-ancestor
102607482|NCT00005665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102607483|NCT00005665|Immunologic Factors|immunologic factors|mesh-ancestor
102607484|NCT00005665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607485|NCT00004669|Hydrocortisone|hydrocortisone|mesh-list
102607486|NCT00004669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102607487|NCT00385411|Valproic Acid|valproic acid|mesh-list
102607488|NCT00385411|Anticonvulsants|anticonvulsants|mesh-ancestor
102607489|NCT00385411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607490|NCT00385411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607491|NCT00385411|GABA Agents|gaba agents|mesh-ancestor
102607492|NCT00385411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102607493|NCT00385411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607494|NCT00385411|Antimanic Agents|antimanic agents|mesh-ancestor
102607495|NCT00385411|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102607496|NCT00385411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102607497|NCT00385411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102607498|NCT00004699|Mitogens|mitogens|mesh-list
102607499|NCT00004699|Mitosis Modulators|mitosis modulators|mesh-ancestor
102607500|NCT00004699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607501|NCT00004705|Amiloride|amiloride|mesh-list
102607502|NCT00004705|Diuretics|diuretics|mesh-ancestor
102607503|NCT00004705|Natriuretic Agents|natriuretic agents|mesh-ancestor
102607504|NCT00004705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607505|NCT00004705|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
102607506|NCT00004705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102607507|NCT00004705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102607508|NCT00004705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607509|NCT00004705|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
102607510|NCT00004705|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102607511|NCT00004747|Immunoglobulins|immunoglobulins|mesh-list
102607512|NCT00004747|Antibodies|antibodies|mesh-list
102607513|NCT00004747|gamma-Globulins|gamma-globulins|mesh-list
102607514|NCT00004747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102607515|NCT00004747|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102607516|NCT00004747|Immunologic Factors|immunologic factors|mesh-ancestor
102607517|NCT00004747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607518|NCT00004759|Methylprednisolone|methylprednisolone|mesh-list
102607519|NCT00004759|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102607520|NCT00004759|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102607521|NCT00004759|Prednisolone|prednisolone|mesh-list
102607522|NCT00004759|Prednisolone acetate|prednisolone acetate|mesh-list
102607523|NCT00004759|Tirilazad|tirilazad|mesh-list
102607524|NCT00004759|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102607525|NCT00004759|Prednisolone phosphate|prednisolone phosphate|mesh-list
102607526|NCT00004759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102607527|NCT00004759|Antiemetics|antiemetics|mesh-ancestor
102607528|NCT00004759|Autonomic Agents|autonomic agents|mesh-ancestor
102607529|NCT00004759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102607530|NCT00004759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607531|NCT00004759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102607532|NCT00004759|Glucocorticoids|glucocorticoids|mesh-ancestor
102607533|NCT00004759|Hormones|hormones|mesh-ancestor
102607534|NCT00004759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102607535|NCT00004759|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102607536|NCT00004759|Protective Agents|protective agents|mesh-ancestor
102607537|NCT00004759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102607538|NCT00004759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102607539|NCT00004759|Antioxidants|antioxidants|mesh-ancestor
102607540|NCT00004759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607541|NCT00004771|Leuprolide|leuprolide|mesh-list
102607542|NCT00004771|Testosterone|testosterone|mesh-list
102607543|NCT00004771|Androgens|androgens|mesh-ancestor
102607544|NCT00004771|Hormones|hormones|mesh-ancestor
102607545|NCT00004771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102607546|NCT00004771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607547|NCT00004771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102607548|NCT00004771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102607549|NCT00004771|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102607550|NCT00004771|Fertility Agents|fertility agents|mesh-ancestor
102607551|NCT00004771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102607552|NCT00004789|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
102607553|NCT00004789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607554|NCT00004789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607555|NCT00004795|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
102607556|NCT00004795|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102607557|NCT00004795|Immunologic Factors|immunologic factors|mesh-ancestor
102607558|NCT00004795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607559|NCT00004807|Topiramate|topiramate|mesh-list
102607561|NCT00004807|Donepezil|donepezil|mesh-list
102607562|NCT00004807|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102607563|NCT00004807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607564|NCT00004807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607565|NCT00004807|Cholinergic Agents|cholinergic agents|mesh-ancestor
102607566|NCT00004807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102607567|NCT00004807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607568|NCT00004807|Nootropic Agents|nootropic agents|mesh-ancestor
102607569|NCT00004807|Anticonvulsants|anticonvulsants|mesh-ancestor
102607570|NCT00004807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102607571|NCT00004807|Antitussive Agents|antitussive agents|mesh-ancestor
102607572|NCT00004807|Respiratory System Agents|respiratory system agents|mesh-ancestor
102607573|NCT00004807|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102607574|NCT00004807|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102607575|NCT00004825|Insulin|insulin|mesh-list
102607576|NCT00004825|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102607577|NCT00004825|Mitogens|mitogens|mesh-list
102607578|NCT00004825|Mecasermin|mecasermin|mesh-list
102607579|NCT00004825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102607580|NCT00004825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607581|NCT00004825|Mitosis Modulators|mitosis modulators|mesh-ancestor
102607582|NCT00004825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607583|NCT00004825|Growth Substances|growth substances|mesh-ancestor
102607584|NCT00385645|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102607585|NCT00385645|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
102607586|NCT00385645|Zidovudine|zidovudine|mesh-list
102607587|NCT00385645|Lamivudine|lamivudine|mesh-list
102607588|NCT00385645|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102607589|NCT00385645|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102607590|NCT00385645|Protease Inhibitors|protease inhibitors|mesh-ancestor
102607591|NCT00385645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607592|NCT00385645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607593|NCT00385645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102607594|NCT00385645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102607595|NCT00385645|Antiviral Agents|antiviral agents|mesh-ancestor
102607596|NCT00385645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102607597|NCT00385645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102607598|NCT00385645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102607599|NCT00385645|Antimetabolites|antimetabolites|mesh-ancestor
102607600|NCT00385957|Lamivudine|lamivudine|mesh-list
102607601|NCT00385957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102607602|NCT00385957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102607603|NCT00385957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607604|NCT00385957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607605|NCT00385957|Antiviral Agents|antiviral agents|mesh-ancestor
102607606|NCT00385957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102607607|NCT00385957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102607608|NCT00385957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102607609|NCT00005107|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
102607610|NCT00005107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607611|NCT00005107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607612|NCT00005773|Nitric Oxide|nitric oxide|mesh-list
102607613|NCT00005773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102607614|NCT00005773|Autonomic Agents|autonomic agents|mesh-ancestor
102607615|NCT00005773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102607616|NCT00005773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607617|NCT00005773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102607618|NCT00005773|Respiratory System Agents|respiratory system agents|mesh-ancestor
102607619|NCT00005773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102607620|NCT00005773|Antioxidants|antioxidants|mesh-ancestor
102607621|NCT00005773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607622|NCT00005773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102607623|NCT00005773|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102607624|NCT00005773|Vasodilator Agents|vasodilator agents|mesh-ancestor
102607625|NCT00005773|Gasotransmitters|gasotransmitters|mesh-ancestor
102607626|NCT00005773|Protective Agents|protective agents|mesh-ancestor
102607627|NCT00005779|Interleukin-12|interleukin-12|mesh-list
102607628|NCT00005779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102607629|NCT00005779|Immunologic Factors|immunologic factors|mesh-ancestor
102607630|NCT00005779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607631|NCT00005779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102607632|NCT00005779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102607633|NCT00005779|Growth Substances|growth substances|mesh-ancestor
102607634|NCT00005779|Growth Inhibitors|growth inhibitors|mesh-ancestor
102607635|NCT00005779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102607636|NCT00005791|Fluorouracil|fluorouracil|mesh-list
102607637|NCT00005791|Irinotecan|irinotecan|mesh-list
102607638|NCT00005791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102607639|NCT00005791|Antimetabolites|antimetabolites|mesh-ancestor
102607640|NCT00005791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607641|NCT00005791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102607642|NCT00005791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102607643|NCT00005791|Immunologic Factors|immunologic factors|mesh-ancestor
102607644|NCT00005791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607645|NCT00005791|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102607646|NCT00005791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102607647|NCT00005791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607648|NCT00005797|Cyclophosphamide|cyclophosphamide|mesh-list
102607649|NCT00005797|Busulfan|busulfan|mesh-list
102607650|NCT00005797|Etoposide|etoposide|mesh-list
102607651|NCT00005797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102607652|NCT00005797|Immunologic Factors|immunologic factors|mesh-ancestor
102607653|NCT00005797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607654|NCT00005797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102607655|NCT00005797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102607656|NCT00005797|Alkylating Agents|alkylating agents|mesh-ancestor
102607657|NCT00005797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607658|NCT00005797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102607659|NCT00005797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102607660|NCT00005797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102607661|NCT00005797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102607662|NCT00005797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102607663|NCT00005797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607664|NCT00005815|Thalidomide|thalidomide|mesh-list
102607665|NCT00005815|Temozolomide|temozolomide|mesh-list
102607666|NCT00005815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102607667|NCT00005815|Alkylating Agents|alkylating agents|mesh-ancestor
102607668|NCT00005815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607669|NCT00005815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102607670|NCT00005815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102607671|NCT00005815|Immunologic Factors|immunologic factors|mesh-ancestor
102607672|NCT00005815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607673|NCT00005815|Leprostatic Agents|leprostatic agents|mesh-ancestor
102607674|NCT00005815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102607675|NCT00005815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102607676|NCT00005815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102607677|NCT00005815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102607678|NCT00005815|Growth Substances|growth substances|mesh-ancestor
102607679|NCT00005815|Growth Inhibitors|growth inhibitors|mesh-ancestor
102607680|NCT02132754|Pembrolizumab|pembrolizumab|mesh-list
102607681|NCT02132754|MK-4166|mk-4166|mesh-list
102607682|NCT02132754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102607683|NCT02132754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102607684|NCT02132754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102607685|NCT02132754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607686|NCT02151786|Lansoprazole|lansoprazole|mesh-list
102607687|NCT02151786|Dexlansoprazole|dexlansoprazole|mesh-list
102607688|NCT02151786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102607689|NCT02151786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102607690|NCT02151786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102607691|NCT02151786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607692|NCT02151786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607693|NCT02106156|Interferons|interferons|mesh-list
102607694|NCT02106156|Ribavirin|ribavirin|mesh-list
102607695|NCT02106156|Interferon-alpha|interferon-alpha|mesh-list
102607696|NCT02106156|Interferon alpha-2|interferon alpha-2|mesh-list
102607697|NCT02106156|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102607698|NCT02106156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102607699|NCT02106156|Antiviral Agents|antiviral agents|mesh-ancestor
102607700|NCT02106156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102607701|NCT02106156|Antimetabolites|antimetabolites|mesh-ancestor
102607702|NCT02106156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607703|NCT02106156|Immunologic Factors|immunologic factors|mesh-ancestor
102607704|NCT02106156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607705|NCT02131272|Insulin|insulin|mesh-list
102607706|NCT02131272|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102607707|NCT02131272|Insulin Detemir|insulin detemir|mesh-list
102607708|NCT02131272|Isophane Insulin, Human|isophane insulin, human|mesh-list
102607709|NCT02131272|Insulin, Isophane|insulin, isophane|mesh-list
102607710|NCT02131272|Isophane insulin, beef|isophane insulin, beef|mesh-list
102607711|NCT02131272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102607712|NCT02131272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607713|NCT02130882|Benralizumab|benralizumab|mesh-list
102607714|NCT02130882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102607715|NCT02130882|Respiratory System Agents|respiratory system agents|mesh-ancestor
102607716|NCT02149836|Ezogabine|ezogabine|mesh-list
102607717|NCT02149836|Anticonvulsants|anticonvulsants|mesh-ancestor
102607718|NCT02149836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102607719|NCT02149836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607720|NCT02130024|Ranibizumab|ranibizumab|mesh-list
102607721|NCT02130024|Aflibercept|aflibercept|mesh-list
102607722|NCT02130024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102607723|NCT02130024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102607724|NCT02130024|Growth Substances|growth substances|mesh-ancestor
102607725|NCT02130024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607726|NCT02130024|Growth Inhibitors|growth inhibitors|mesh-ancestor
102607727|NCT02130024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102607728|NCT02105688|Grazoprevir|grazoprevir|mesh-list
102607729|NCT02105688|Antiviral Agents|antiviral agents|mesh-ancestor
102607730|NCT02105688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102607731|NCT02105454|Ribavirin|ribavirin|mesh-list
102607732|NCT02105454|Grazoprevir|grazoprevir|mesh-list
102607733|NCT02105454|Antimetabolites|antimetabolites|mesh-ancestor
102607734|NCT02105454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607735|NCT02105454|Antiviral Agents|antiviral agents|mesh-ancestor
102607736|NCT02105454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102607737|NCT02104752|Curcumin|curcumin|mesh-list
102607738|NCT02104752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102607739|NCT02104752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102607740|NCT02104752|Analgesics|analgesics|mesh-ancestor
102607741|NCT02104752|Sensory System Agents|sensory system agents|mesh-ancestor
102607742|NCT02104752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102607743|NCT02104752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607744|NCT02104752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102607745|NCT02104752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102607746|NCT02104752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102607747|NCT02104752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607748|NCT02104752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607749|NCT02128932|Insulin Glargine|insulin glargine|mesh-list
102607750|NCT02128932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102607751|NCT02128932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607752|NCT02128542|Sofosbuvir|sofosbuvir|mesh-list
102607753|NCT02128542|Antiviral Agents|antiviral agents|mesh-ancestor
102607754|NCT02128542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102607755|NCT02127372|Cisplatin|cisplatin|mesh-list
102607756|NCT02127372|Docetaxel|docetaxel|mesh-list
102607757|NCT02127372|Imatinib Mesylate|imatinib mesylate|mesh-list
102607758|NCT02127372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102607759|NCT02127372|Tubulin Modulators|tubulin modulators|mesh-ancestor
102607760|NCT02127372|Antimitotic Agents|antimitotic agents|mesh-ancestor
102607761|NCT02127372|Mitosis Modulators|mitosis modulators|mesh-ancestor
102607762|NCT02127372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607763|NCT02127372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102607764|NCT02127372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607765|NCT02125734|Bromides|bromides|mesh-list
102607766|NCT02125734|Tiotropium Bromide|tiotropium bromide|mesh-list
102607767|NCT02125734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102607768|NCT02125734|Autonomic Agents|autonomic agents|mesh-ancestor
102607769|NCT02125734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102607770|NCT02125734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607771|NCT02125734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102607772|NCT02125734|Respiratory System Agents|respiratory system agents|mesh-ancestor
102607773|NCT02125734|Parasympatholytics|parasympatholytics|mesh-ancestor
102607774|NCT02125734|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102607775|NCT02125734|Cholinergic Agents|cholinergic agents|mesh-ancestor
102607776|NCT02125734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102607777|NCT02125734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607778|NCT02125734|Anticonvulsants|anticonvulsants|mesh-ancestor
102607779|NCT02124798|Belimumab|belimumab|mesh-list
102607780|NCT02124798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102607781|NCT02124798|Immunologic Factors|immunologic factors|mesh-ancestor
102607782|NCT02124798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607783|NCT04735770|Levobupivacaine|levobupivacaine|mesh-list
102607784|NCT04735770|Anesthetics|anesthetics|mesh-ancestor
102607785|NCT04735770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102607786|NCT04735770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607787|NCT04735770|Anesthetics, Local|anesthetics, local|mesh-ancestor
102607788|NCT04735770|Sensory System Agents|sensory system agents|mesh-ancestor
102607789|NCT04735770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102607790|NCT02146248|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102607791|NCT02146248|Contraceptive Agents|contraceptive agents|mesh-list
102607792|NCT02146248|Medroxyprogesterone|medroxyprogesterone|mesh-list
102607793|NCT02146248|Contraceptives, Oral|contraceptives, oral|mesh-list
102607794|NCT02146248|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
102607795|NCT02146248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102607796|NCT02146248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607797|NCT02146248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102607798|NCT02146248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102607799|NCT02146248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102607800|NCT02146248|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102607801|NCT02146248|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102607802|NCT02146248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102607803|NCT02146248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102607804|NCT02124564|Lacosamide|lacosamide|mesh-list
102607805|NCT02124564|Anticonvulsants|anticonvulsants|mesh-ancestor
102607806|NCT02124564|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102607807|NCT02124564|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102607808|NCT02124564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102607809|NCT02124564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607810|NCT02100696|Etrolizumab|etrolizumab|mesh-list
102607811|NCT02100696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102607812|NCT02100696|Immunologic Factors|immunologic factors|mesh-ancestor
102607813|NCT02100696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607814|NCT02123472|Cephalexin|cephalexin|mesh-list
102607815|NCT02123472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102607816|NCT02123472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102607817|NCT02145078|Gemcitabine|gemcitabine|mesh-list
102607818|NCT02145078|Docetaxel|docetaxel|mesh-list
102607819|NCT02145078|Pemetrexed|pemetrexed|mesh-list
102607820|NCT02145078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102607821|NCT02145078|Antimetabolites|antimetabolites|mesh-ancestor
102607822|NCT02145078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607823|NCT02145078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102607824|NCT02145078|Tubulin Modulators|tubulin modulators|mesh-ancestor
102607825|NCT02145078|Antimitotic Agents|antimitotic agents|mesh-ancestor
102607826|NCT02145078|Mitosis Modulators|mitosis modulators|mesh-ancestor
102607827|NCT02145078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607828|NCT02145078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102607829|NCT02145078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102607830|NCT02100228|Vitamin K|vitamin k|mesh-list
102607831|NCT02100228|Heparin|heparin|mesh-list
102607832|NCT02100228|Apixaban|apixaban|mesh-list
102607833|NCT02100228|Vitamins|vitamins|mesh-ancestor
102607834|NCT02100228|Micronutrients|micronutrients|mesh-ancestor
102607835|NCT02100228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607836|NCT02100228|Anticoagulants|anticoagulants|mesh-ancestor
102607837|NCT02100228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102607838|NCT02100228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102607839|NCT02100228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607840|NCT02100228|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102607841|NCT02100228|Antithrombins|antithrombins|mesh-ancestor
102607842|NCT02100228|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102607843|NCT02100228|Protease Inhibitors|protease inhibitors|mesh-ancestor
102607844|NCT02100228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607845|NCT02100228|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102607846|NCT02100228|Hemostatics|hemostatics|mesh-ancestor
102607847|NCT02100228|Coagulants|coagulants|mesh-ancestor
102607848|NCT02099838|Metformin|metformin|mesh-list
102607849|NCT02099838|Pioglitazone|pioglitazone|mesh-list
102607850|NCT02099838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102607851|NCT02099838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607852|NCT02099682|Lansoprazole|lansoprazole|mesh-list
102607853|NCT02099682|Dexlansoprazole|dexlansoprazole|mesh-list
102607854|NCT02099682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102607855|NCT02099682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102607856|NCT02099682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102607857|NCT02099682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607858|NCT02099682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607859|NCT02098746|Pioglitazone|pioglitazone|mesh-list
102607860|NCT02098746|Glimepiride|glimepiride|mesh-list
102607861|NCT02098746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102607862|NCT02098746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607863|NCT02098746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102607864|NCT02098746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102607865|NCT02098746|Immunologic Factors|immunologic factors|mesh-ancestor
102607866|NCT02122770|Itraconazole|itraconazole|mesh-list
102607867|NCT02122770|Fluconazole|fluconazole|mesh-list
102607868|NCT02122770|Paclitaxel|paclitaxel|mesh-list
102607869|NCT02122770|Docetaxel|docetaxel|mesh-list
102607870|NCT02122770|Carboplatin|carboplatin|mesh-list
102607871|NCT02122770|Pevonedistat|pevonedistat|mesh-list
102607872|NCT02122770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102607873|NCT02122770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102607874|NCT02122770|Tubulin Modulators|tubulin modulators|mesh-ancestor
102607875|NCT02122770|Antimitotic Agents|antimitotic agents|mesh-ancestor
102607876|NCT02122770|Mitosis Modulators|mitosis modulators|mesh-ancestor
102607877|NCT02122770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607878|NCT02122770|Antifungal Agents|antifungal agents|mesh-ancestor
102607879|NCT02122770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102607880|NCT02122770|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102607881|NCT02122770|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102607882|NCT02122770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607883|NCT02122770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102607884|NCT02122770|Hormone Antagonists|hormone antagonists|mesh-ancestor
102607885|NCT02122770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102607886|NCT02122770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607887|NCT02122770|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102607888|NCT02122770|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102607889|NCT02122770|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102607890|NCT02122380|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102607891|NCT02122380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102607892|NCT02122380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607893|NCT02122380|Incretins|incretins|mesh-ancestor
102607894|NCT02122380|Hormones|hormones|mesh-ancestor
102369682|NCT04450134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102607895|NCT02122380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102607896|NCT02122380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102607897|NCT02122380|Protease Inhibitors|protease inhibitors|mesh-ancestor
102607898|NCT02122380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607899|NCT02122380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607900|NCT02121756|Dipyridamole|dipyridamole|mesh-list
102607901|NCT02121756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102607902|NCT02121756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607903|NCT02121756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607904|NCT02121756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102607905|NCT02121756|Vasodilator Agents|vasodilator agents|mesh-ancestor
102607906|NCT02141490|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102607907|NCT02141490|Hematinics|hematinics|mesh-ancestor
102607908|NCT02141490|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102607909|NCT02141490|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102607910|NCT02097108|Raltegravir Potassium|raltegravir potassium|mesh-list
102607911|NCT02097108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102607912|NCT02097108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102607913|NCT02097108|Antiviral Agents|antiviral agents|mesh-ancestor
102607914|NCT02097108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102607915|NCT02097108|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102607916|NCT02097108|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102607917|NCT02097108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607918|NCT02097108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607919|NCT02096952|Methylphenidate|methylphenidate|mesh-list
102607920|NCT02096952|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102607921|NCT02096952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607922|NCT02096952|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102607923|NCT02096952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102607924|NCT02096952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102607925|NCT02096952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607926|NCT02096952|Dopamine Agents|dopamine agents|mesh-ancestor
102607927|NCT02096952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102607928|NCT02120898|Imiquimod|imiquimod|mesh-list
102607929|NCT02120898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102607930|NCT02120898|Immunologic Factors|immunologic factors|mesh-ancestor
102607931|NCT02120898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607932|NCT02120898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102607933|NCT02120898|Interferon Inducers|interferon inducers|mesh-ancestor
102607934|NCT02120664|Corticosterone|corticosterone|mesh-list
102607935|NCT02120664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102607936|NCT01627860|Topiramate|topiramate|mesh-list
102607937|NCT01627860|Anticonvulsants|anticonvulsants|mesh-ancestor
102607938|NCT01627860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102607939|NCT01627860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607940|NCT04732494|Tislelizumab|tislelizumab|mesh-list
102607941|NCT04732494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102607942|NCT04732494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102607943|NCT01627782|Ketamine|ketamine|mesh-list
102607944|NCT01627782|Analgesics|analgesics|mesh-ancestor
102607945|NCT01627782|Sensory System Agents|sensory system agents|mesh-ancestor
102607946|NCT01627782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102607947|NCT01627782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607948|NCT01627782|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102607949|NCT01627782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102607950|NCT01627782|Anesthetics, General|anesthetics, general|mesh-ancestor
102607951|NCT01627782|Anesthetics|anesthetics|mesh-ancestor
102607952|NCT01627782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102607953|NCT01627782|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102607954|NCT01627782|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102607955|NCT01627782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102607956|NCT01627782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607957|NCT02119650|Pemetrexed|pemetrexed|mesh-list
102607958|NCT02119650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102607959|NCT02119650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607960|NCT02119650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607961|NCT02119650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102607962|NCT02119650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102607963|NCT02119416|Caffeine|caffeine|mesh-list
102607964|NCT02119416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102607965|NCT02119416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607966|NCT02119416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102607967|NCT02119416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607968|NCT02119416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607969|NCT02119416|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102607970|NCT02119416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102607971|NCT02119416|Purinergic Agents|purinergic agents|mesh-ancestor
102607972|NCT02119416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102607973|NCT02140164|Minocycline|minocycline|mesh-list
102607974|NCT02140164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102607975|NCT02140164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102607976|NCT02119260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102607977|NCT02119104|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102607978|NCT02119104|Immunologic Factors|immunologic factors|mesh-ancestor
102607979|NCT02119104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607980|NCT02119026|Bevacizumab|bevacizumab|mesh-list
102607981|NCT02119026|Capecitabine|capecitabine|mesh-list
102607982|NCT02119026|Oxaliplatin|oxaliplatin|mesh-list
102607983|NCT02119026|Irinotecan|irinotecan|mesh-list
102607984|NCT02119026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102607985|NCT02119026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102607986|NCT02119026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102607987|NCT02119026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102607988|NCT02119026|Growth Substances|growth substances|mesh-ancestor
102607989|NCT02119026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102607990|NCT02119026|Growth Inhibitors|growth inhibitors|mesh-ancestor
102607991|NCT02119026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102607992|NCT02119026|Antimetabolites|antimetabolites|mesh-ancestor
102607993|NCT02119026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102607994|NCT02119026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102607995|NCT02119026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102607996|NCT02119026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102607997|NCT02095158|Phenylephrine|phenylephrine|mesh-list
102607998|NCT02095158|Oxymetazoline|oxymetazoline|mesh-list
102607999|NCT02095158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102608000|NCT02095158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102608001|NCT02095158|Adrenergic Agents|adrenergic agents|mesh-ancestor
102608002|NCT02095158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102608003|NCT02095158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608004|NCT02095158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608005|NCT02095158|Sympathomimetics|sympathomimetics|mesh-ancestor
102608006|NCT02095158|Autonomic Agents|autonomic agents|mesh-ancestor
102608007|NCT02095158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102608008|NCT02095158|Nasal Decongestants|nasal decongestants|mesh-ancestor
102608009|NCT02095158|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102608010|NCT02095158|Respiratory System Agents|respiratory system agents|mesh-ancestor
102608011|NCT02095158|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102608012|NCT02095158|Mydriatics|mydriatics|mesh-ancestor
102608013|NCT02095158|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102608014|NCT02095158|Protective Agents|protective agents|mesh-ancestor
102608015|NCT02118714|Atrasentan|atrasentan|mesh-list
102608016|NCT02118714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102608017|NCT02118714|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
102608018|NCT02118714|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102608019|NCT02118714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608020|NCT02138916|Benralizumab|benralizumab|mesh-list
102608021|NCT02138916|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102608022|NCT02138916|Respiratory System Agents|respiratory system agents|mesh-ancestor
102608023|NCT02118012|Ribavirin|ribavirin|mesh-list
102608024|NCT02118012|Antimetabolites|antimetabolites|mesh-ancestor
102608025|NCT02118012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608026|NCT02118012|Antiviral Agents|antiviral agents|mesh-ancestor
102608027|NCT02118012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102608028|NCT02138838|Cinacalcet|cinacalcet|mesh-list
102608029|NCT02138838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102608030|NCT02138838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608031|NCT02138838|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
102608032|NCT02138838|Hormone Antagonists|hormone antagonists|mesh-ancestor
102608033|NCT02138838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102608034|NCT02092350|Grazoprevir|grazoprevir|mesh-list
102608035|NCT02092350|Antiviral Agents|antiviral agents|mesh-ancestor
102608036|NCT02092350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102608037|NCT02138136|Lubiprostone|lubiprostone|mesh-list
102608038|NCT02138136|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102608039|NCT02138136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102608040|NCT02138136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608041|NCT02116608|Povidone-Iodine|povidone-iodine|mesh-list
102608042|NCT02116608|Silver Nitrate|silver nitrate|mesh-list
102608043|NCT02116608|Hydrocortisone|hydrocortisone|mesh-list
102608044|NCT02116608|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
102608045|NCT02116608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102608046|NCT02116608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102608047|NCT02116608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102608048|NCT02116608|Dermatologic Agents|dermatologic agents|mesh-ancestor
102608049|NCT02092116|Romidepsin|romidepsin|mesh-list
102608050|NCT02092116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102608051|NCT02092116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102608052|NCT02092116|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102608053|NCT02092116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102608054|NCT02092116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608055|NCT02091414|Cyclosporine|cyclosporine|mesh-list
102608056|NCT02091414|Mycophenolic Acid|mycophenolic acid|mesh-list
102608057|NCT02091414|Cyclosporins|cyclosporins|mesh-list
102608058|NCT02091414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102608059|NCT02091414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608060|NCT02091414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102608061|NCT02091414|Immunologic Factors|immunologic factors|mesh-ancestor
102608062|NCT02091414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608063|NCT02091414|Antifungal Agents|antifungal agents|mesh-ancestor
102608064|NCT02091414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102608065|NCT02091414|Dermatologic Agents|dermatologic agents|mesh-ancestor
102608066|NCT02091414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102608067|NCT02091414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102608068|NCT02091414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102608069|NCT02091414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102608070|NCT02091414|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102608071|NCT02091414|Antitubercular Agents|antitubercular agents|mesh-ancestor
102608072|NCT02091414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102608073|NCT04731558|Enoxaparin|enoxaparin|mesh-list
102608074|NCT04731558|Dalteparin|dalteparin|mesh-list
102608075|NCT04731558|Tinzaparin|tinzaparin|mesh-list
102608076|NCT04731558|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102608077|NCT04731558|Anticoagulants|anticoagulants|mesh-ancestor
102608078|NCT04731558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102608079|NCT04731558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102608080|NCT04731558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608081|NCT02116530|Dexamethasone|dexamethasone|mesh-list
102608082|NCT02116530|Cyclophosphamide|cyclophosphamide|mesh-list
102608083|NCT02116530|Doxorubicin|doxorubicin|mesh-list
102608084|NCT02116530|Ondansetron|ondansetron|mesh-list
102608085|NCT02116530|Olanzapine|olanzapine|mesh-list
102608086|NCT02116530|Aprepitant|aprepitant|mesh-list
102608087|NCT02116530|Fosaprepitant|fosaprepitant|mesh-list
102608088|NCT02116530|Palonosetron|palonosetron|mesh-list
102154356|NCT02237755|Citric Acid|citric acid|mesh-list
102608089|NCT02116530|Granisetron|granisetron|mesh-list
102608091|NCT02116530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102608092|NCT02116530|Immunologic Factors|immunologic factors|mesh-ancestor
102608093|NCT02116530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608094|NCT02116530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102608095|NCT02116530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102608096|NCT02116530|Alkylating Agents|alkylating agents|mesh-ancestor
102608097|NCT02116530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608098|NCT02116530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102608099|NCT02116530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102608100|NCT02116530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102608101|NCT02116530|Autonomic Agents|autonomic agents|mesh-ancestor
102608102|NCT02116530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102608103|NCT02116530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102608104|NCT02116530|Glucocorticoids|glucocorticoids|mesh-ancestor
102608105|NCT02116530|Hormones|hormones|mesh-ancestor
102608106|NCT02116530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102608107|NCT02116530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102608108|NCT02116530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102608109|NCT02116530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102608110|NCT02116530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102608111|NCT02116530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102608112|NCT02116530|Antipruritics|antipruritics|mesh-ancestor
102608113|NCT02116530|Dermatologic Agents|dermatologic agents|mesh-ancestor
102608114|NCT02116530|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102608115|NCT02116530|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102608116|NCT02116530|Serotonin Agents|serotonin agents|mesh-ancestor
102608117|NCT02116530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102608118|NCT02116530|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102608119|NCT02116530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102608120|NCT02116530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102608121|NCT02116530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102608122|NCT02116530|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102608123|NCT02116530|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102608124|NCT02116530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102608125|NCT02116530|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102608126|NCT02072226|Aspirin|aspirin|mesh-list
102608127|NCT02072226|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102608128|NCT02072226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102608129|NCT02072226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102608130|NCT02072226|Analgesics|analgesics|mesh-ancestor
102608131|NCT02072226|Sensory System Agents|sensory system agents|mesh-ancestor
102608132|NCT02072226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102608133|NCT02072226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608134|NCT02072226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102608135|NCT02072226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102608136|NCT02072226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102608137|NCT02072226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102608138|NCT02072226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608139|NCT02072226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102608140|NCT02072226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102608141|NCT02072226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102608142|NCT02072226|Antipyretics|antipyretics|mesh-ancestor
102608143|NCT04730856|Tinzaparin|tinzaparin|mesh-list
102608144|NCT04730856|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102608145|NCT04730856|Dalteparin|dalteparin|mesh-list
102608146|NCT04730856|Anticoagulants|anticoagulants|mesh-ancestor
102608147|NCT04730856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102608148|NCT04730856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102608149|NCT04730856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608150|NCT02114892|Resveratrol|resveratrol|mesh-list
102608151|NCT02114892|Antioxidants|antioxidants|mesh-ancestor
102608152|NCT02114892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608153|NCT02114892|Protective Agents|protective agents|mesh-ancestor
102608154|NCT02114892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608155|NCT02114892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102608156|NCT02114892|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102608157|NCT02070744|Ivacaftor|ivacaftor|mesh-list
102608158|NCT02070744|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102608159|NCT02070744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102608160|NCT02070744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608161|NCT04741698|Propranolol|propranolol|mesh-list
102154357|NCT02237755|Sodium Citrate|sodium citrate|mesh-list
102608162|NCT04741698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102608163|NCT04741698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102608164|NCT04741698|Adrenergic Agents|adrenergic agents|mesh-ancestor
102608165|NCT04741698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102346650|NCT03934814|Rituximab|rituximab|mesh-list
102608166|NCT04741698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608167|NCT04741698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608168|NCT04741698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102608169|NCT04741698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102608170|NCT04741698|Vasodilator Agents|vasodilator agents|mesh-ancestor
102608172|NCT02111850|Cyclophosphamide|cyclophosphamide|mesh-list
102608173|NCT02111850|Fludarabine|fludarabine|mesh-list
102608174|NCT02111850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102608175|NCT02111850|Immunologic Factors|immunologic factors|mesh-ancestor
102608176|NCT02111850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608177|NCT02111850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102608178|NCT02111850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102608179|NCT02111850|Alkylating Agents|alkylating agents|mesh-ancestor
102608180|NCT02111850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608181|NCT02111850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102608182|NCT02111850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102608183|NCT02111850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102608184|NCT02111850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102608185|NCT02111850|Antiviral Agents|antiviral agents|mesh-ancestor
102608186|NCT02111850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102608187|NCT02085252|Bicalutamide|bicalutamide|mesh-list
102608188|NCT02085252|Leuprolide|leuprolide|mesh-list
102608189|NCT02085252|Androgen Antagonists|androgen antagonists|mesh-ancestor
102608190|NCT02085252|Hormone Antagonists|hormone antagonists|mesh-ancestor
102608191|NCT02085252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102608192|NCT02085252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608193|NCT02085252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102608194|NCT02085252|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102608195|NCT02085252|Fertility Agents|fertility agents|mesh-ancestor
102608196|NCT02085252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102608197|NCT02085252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102608198|NCT02084238|Interleukin-2|interleukin-2|mesh-list
102608199|NCT02084238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102608200|NCT02084238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102608201|NCT02084238|Analgesics|analgesics|mesh-ancestor
102608202|NCT02084238|Sensory System Agents|sensory system agents|mesh-ancestor
102608203|NCT02084238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102608204|NCT02084238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608205|NCT02084082|Metformin|metformin|mesh-list
102608206|NCT02084082|Linagliptin|linagliptin|mesh-list
102608207|NCT02084082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102608208|NCT02084082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608209|NCT02084082|Incretins|incretins|mesh-ancestor
102608210|NCT02084082|Hormones|hormones|mesh-ancestor
102608211|NCT02084082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102608212|NCT02084082|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102608213|NCT02084082|Protease Inhibitors|protease inhibitors|mesh-ancestor
102608214|NCT02084082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102608215|NCT02084082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608216|NCT02083926|Ketamine|ketamine|mesh-list
102608217|NCT02083926|Analgesics|analgesics|mesh-ancestor
102608218|NCT02083926|Sensory System Agents|sensory system agents|mesh-ancestor
102608219|NCT02083926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102608220|NCT02083926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608221|NCT02083926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102608222|NCT02083926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102608223|NCT02083926|Anesthetics, General|anesthetics, general|mesh-ancestor
102608224|NCT02083926|Anesthetics|anesthetics|mesh-ancestor
102608225|NCT02083926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102608226|NCT02083926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102608227|NCT02083926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102608228|NCT02083926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102608229|NCT02083926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608230|NCT02083380|Piperaquine|piperaquine|mesh-list
102608231|NCT02083380|Artefenomel|artefenomel|mesh-list
102608232|NCT02083380|Antimalarials|antimalarials|mesh-ancestor
102608233|NCT02083380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102608234|NCT02083380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102608235|NCT02083380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102608236|NCT02109744|Decitabine|decitabine|mesh-list
102608237|NCT02109744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102608238|NCT02109744|Antimetabolites|antimetabolites|mesh-ancestor
102608239|NCT02109744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608240|NCT02109744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102608241|NCT02109744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102608242|NCT02066298|Mometasone Furoate|mometasone furoate|mesh-list
102608243|NCT02066298|Tiotropium Bromide|tiotropium bromide|mesh-list
102608244|NCT02066298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102608245|NCT02066298|Autonomic Agents|autonomic agents|mesh-ancestor
102608246|NCT02066298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102608247|NCT02066298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608248|NCT02066298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102608249|NCT02066298|Respiratory System Agents|respiratory system agents|mesh-ancestor
102608250|NCT02066298|Parasympatholytics|parasympatholytics|mesh-ancestor
102608251|NCT02066298|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102608252|NCT02066298|Cholinergic Agents|cholinergic agents|mesh-ancestor
102608253|NCT02066298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102608254|NCT02066298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608255|NCT02066298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102608256|NCT02066298|Dermatologic Agents|dermatologic agents|mesh-ancestor
102608257|NCT02066298|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102608258|NCT02082912|Cycloserine|cycloserine|mesh-list
102608259|NCT02082912|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102608260|NCT02082912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102608261|NCT02082912|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102608262|NCT02082912|Antitubercular Agents|antitubercular agents|mesh-ancestor
102608263|NCT02082912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102608264|NCT02082912|Antimetabolites|antimetabolites|mesh-ancestor
102608265|NCT02082912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608266|NCT02082522|Cisplatin|cisplatin|mesh-list
102608267|NCT02082522|Gemcitabine|gemcitabine|mesh-list
102608268|NCT02082522|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
102608269|NCT02082522|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
102608270|NCT02082522|Trioxsalen|trioxsalen|mesh-list
102608271|NCT02082522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102608272|NCT02082522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102608273|NCT02082522|Antimetabolites|antimetabolites|mesh-ancestor
102608274|NCT02082522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608275|NCT02082522|Dermatologic Agents|dermatologic agents|mesh-ancestor
102608276|NCT02082522|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102608277|NCT04723446|Chlorhexidine|chlorhexidine|mesh-list
102608278|NCT04723446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102608279|NCT04723446|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102608280|NCT04723446|Cetylpyridinium|cetylpyridinium|mesh-list
102608281|NCT04723446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102608282|NCT04723446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102608283|NCT04723446|Disinfectants|disinfectants|mesh-ancestor
102608284|NCT04723446|Dermatologic Agents|dermatologic agents|mesh-ancestor
102608285|NCT02082210|Ramucirumab|ramucirumab|mesh-list
102608286|NCT02082210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102608287|NCT02107014|Naltrexone|naltrexone|mesh-list
102608288|NCT02107014|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102608289|NCT02107014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102608290|NCT02107014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608291|NCT02107014|Sensory System Agents|sensory system agents|mesh-ancestor
102608292|NCT02107014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102608293|NCT01624974|Montelukast|montelukast|mesh-list
102608294|NCT01624974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102608295|NCT01624974|Respiratory System Agents|respiratory system agents|mesh-ancestor
102608296|NCT01624974|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102608297|NCT01624974|Hormone Antagonists|hormone antagonists|mesh-ancestor
102608298|NCT01624974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102608299|NCT01624974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608300|NCT01624974|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102608301|NCT01624974|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102608302|NCT01624974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608303|NCT01624662|Fluticasone|fluticasone|mesh-list
102608304|NCT01624662|Xhance|xhance|mesh-list
102608305|NCT01624662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102608306|NCT01624662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102608307|NCT01624662|Autonomic Agents|autonomic agents|mesh-ancestor
102608308|NCT01624662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102608309|NCT01624662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608310|NCT01624662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102608311|NCT01624662|Respiratory System Agents|respiratory system agents|mesh-ancestor
102608312|NCT01624662|Dermatologic Agents|dermatologic agents|mesh-ancestor
102608313|NCT01624662|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102608314|NCT02106390|Vaccines|vaccines|mesh-list
102608315|NCT02106390|Immunologic Factors|immunologic factors|mesh-ancestor
102608316|NCT02106390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608317|NCT02064894|Ibuprofen|ibuprofen|mesh-list
102608318|NCT02064894|Morphine|morphine|mesh-list
102608319|NCT02064894|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102608320|NCT02064894|Narcotics|narcotics|mesh-ancestor
102608321|NCT02064894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102608322|NCT02064894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608323|NCT02064894|Analgesics|analgesics|mesh-ancestor
102608324|NCT02064894|Sensory System Agents|sensory system agents|mesh-ancestor
102608325|NCT02064894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102608326|NCT02064894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102608327|NCT02064894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102608328|NCT02064894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102608329|NCT02064894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102608330|NCT02064894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102608331|NCT02064894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102608332|NCT02064894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608333|NCT02064816|Interferon beta-1a|interferon beta-1a|mesh-list
102608334|NCT02064816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102608335|NCT02064816|Immunologic Factors|immunologic factors|mesh-ancestor
102608336|NCT02064816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608337|NCT02064816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102608338|NCT02064816|Antiviral Agents|antiviral agents|mesh-ancestor
102608339|NCT02064816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102608340|NCT01624194|Oxytocin|oxytocin|mesh-list
102608341|NCT01624194|Oxytocics|oxytocics|mesh-ancestor
102608342|NCT01624194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102608343|NCT01624194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608344|NCT02079636|Gemcitabine|gemcitabine|mesh-list
102608345|NCT02079636|Pembrolizumab|pembrolizumab|mesh-list
102608346|NCT02079636|Pemetrexed|pemetrexed|mesh-list
102608347|NCT02079636|Ramucirumab|ramucirumab|mesh-list
102608348|NCT02079636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102608349|NCT02079636|Antimetabolites|antimetabolites|mesh-ancestor
102608350|NCT02079636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608351|NCT02079636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102608352|NCT02079636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102608353|NCT02079636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102608354|NCT02079636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102608355|NCT02079636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102608356|NCT02079636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102608357|NCT02079246|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
102608358|NCT02079246|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102608359|NCT02079246|Serotonin Agents|serotonin agents|mesh-ancestor
102608360|NCT02079246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102608361|NCT02079246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608362|NCT02079246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608363|NCT02047110|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102608364|NCT02047110|Immunologic Factors|immunologic factors|mesh-ancestor
102608365|NCT02047110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608366|NCT02045862|Solifenacin Succinate|solifenacin succinate|mesh-list
102608367|NCT02045862|Mirabegron|mirabegron|mesh-list
102608368|NCT02045862|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102608369|NCT02045862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102608370|NCT02045862|Cholinergic Agents|cholinergic agents|mesh-ancestor
102608371|NCT02045862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102608372|NCT02045862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608373|NCT02045862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608374|NCT02045862|Urological Agents|urological agents|mesh-ancestor
102608375|NCT02045862|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102608376|NCT02045862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102608377|NCT02045862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102608378|NCT02045862|Adrenergic Agents|adrenergic agents|mesh-ancestor
102608379|NCT04182984|Mycophenolic Acid|mycophenolic acid|mesh-list
102608380|NCT04182984|Prednisone|prednisone|mesh-list
102608381|NCT04182984|Azathioprine|azathioprine|mesh-list
102608382|NCT04182984|Bromides|bromides|mesh-list
102608383|NCT04182984|Tacrolimus|tacrolimus|mesh-list
102608384|NCT04182984|Immunosuppressive Agents|immunosuppressive agents|mesh-list
102608385|NCT04182984|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
102608386|NCT04182984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102608387|NCT04182984|Glucocorticoids|glucocorticoids|mesh-ancestor
102608388|NCT04182984|Hormones|hormones|mesh-ancestor
102608389|NCT04182984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102608390|NCT04182984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608391|NCT04182984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102608392|NCT04182984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102608393|NCT04182984|Immunologic Factors|immunologic factors|mesh-ancestor
102608394|NCT04182984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102608395|NCT04182984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102608396|NCT04182984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608397|NCT04182984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102608398|NCT04182984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102608399|NCT04182984|Antitubercular Agents|antitubercular agents|mesh-ancestor
102608400|NCT04182984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102608401|NCT04182984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102608402|NCT04182984|Anticonvulsants|anticonvulsants|mesh-ancestor
102608403|NCT04182984|Antimetabolites|antimetabolites|mesh-ancestor
102608404|NCT04182984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102608405|NCT04182984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102608406|NCT04182984|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102608407|NCT04182984|Cholinergic Agents|cholinergic agents|mesh-ancestor
102608408|NCT04182984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102608409|NCT02044302|Morphine|morphine|mesh-list
102608410|NCT02044302|Narcotics|narcotics|mesh-list
102608411|NCT02044302|Analgesics|analgesics|mesh-list
102608412|NCT02044302|Bupivacaine|bupivacaine|mesh-list
102608413|NCT02044302|Botulinum Toxins|botulinum toxins|mesh-list
102608414|NCT02044302|Anesthetics, Local|anesthetics, local|mesh-ancestor
102608415|NCT02044302|Anesthetics|anesthetics|mesh-ancestor
102608416|NCT02044302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102608417|NCT02044302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608418|NCT02044302|Sensory System Agents|sensory system agents|mesh-ancestor
102608419|NCT02044302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102608420|NCT02044302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102608421|NCT02044302|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102608422|NCT02044302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102608423|NCT02044302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608424|NCT02044302|Cholinergic Agents|cholinergic agents|mesh-ancestor
102608425|NCT02044302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102608426|NCT02062944|Sirolimus|sirolimus|mesh-list
102608427|NCT02062944|Immunosuppressive Agents|immunosuppressive agents|mesh-list
102608428|NCT02062944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102608429|NCT02062944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102608430|NCT02062944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102608431|NCT02062944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102608432|NCT02062944|Antifungal Agents|antifungal agents|mesh-ancestor
102608433|NCT02062944|Immunologic Factors|immunologic factors|mesh-ancestor
102608434|NCT02062944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608435|NCT02062632|Doxepin|doxepin|mesh-list
102608436|NCT02062632|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102608437|NCT02062632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102608438|NCT02062632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102608439|NCT02062632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608440|NCT02062632|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102608441|NCT02062632|Antidepressive Agents|antidepressive agents|mesh-ancestor
102608442|NCT02062632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102608443|NCT02062632|Histamine Antagonists|histamine antagonists|mesh-ancestor
102608444|NCT02062632|Histamine Agents|histamine agents|mesh-ancestor
102608445|NCT02062632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102608446|NCT02062632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608447|NCT02043366|Flurbiprofen|flurbiprofen|mesh-list
102608448|NCT02043366|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
102608449|NCT02043366|Sufentanil|sufentanil|mesh-list
102608450|NCT02043366|Remifentanil|remifentanil|mesh-list
102608451|NCT02043366|Butorphanol|butorphanol|mesh-list
102608452|NCT02043366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102608453|NCT02043366|Narcotics|narcotics|mesh-ancestor
102608454|NCT02043366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102608455|NCT02043366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608456|NCT02043366|Analgesics|analgesics|mesh-ancestor
102608457|NCT02043366|Sensory System Agents|sensory system agents|mesh-ancestor
102608458|NCT02043366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102608459|NCT02043366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102608460|NCT02043366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102154358|NCT02237755|Clomiphene|clomiphene|mesh-list
102608461|NCT02043366|Anesthetics, General|anesthetics, general|mesh-ancestor
102608462|NCT02043366|Anesthetics|anesthetics|mesh-ancestor
102608463|NCT02043366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102608464|NCT02043366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102608465|NCT02043366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102608466|NCT02043366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102608467|NCT02043366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102608468|NCT02043366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102608469|NCT02043366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608470|NCT02043366|Antitussive Agents|antitussive agents|mesh-ancestor
102608471|NCT02043366|Respiratory System Agents|respiratory system agents|mesh-ancestor
102608472|NCT02043366|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102608473|NCT02060370|Sunitinib|sunitinib|mesh-list
102608474|NCT02060370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102608475|NCT02060370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102608476|NCT02060370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102608477|NCT02060370|Growth Substances|growth substances|mesh-ancestor
102608478|NCT02060370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608479|NCT02060370|Growth Inhibitors|growth inhibitors|mesh-ancestor
102608480|NCT02060370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102608481|NCT02060370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102608482|NCT02060370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608483|NCT01622088|Pramipexole|pramipexole|mesh-list
102608484|NCT01622088|Antioxidants|antioxidants|mesh-ancestor
102608485|NCT01622088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608486|NCT01622088|Protective Agents|protective agents|mesh-ancestor
102608487|NCT01622088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608488|NCT01622088|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102608489|NCT01622088|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102608490|NCT01622088|Dopamine Agonists|dopamine agonists|mesh-ancestor
102608491|NCT01622088|Dopamine Agents|dopamine agents|mesh-ancestor
102608492|NCT01622088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102608493|NCT02021292|Macitentan|macitentan|mesh-list
102608494|NCT02021292|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
102608495|NCT02021292|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102608496|NCT02021292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608497|NCT02021292|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
102608498|NCT02043132|Tranexamic Acid|tranexamic acid|mesh-list
102608499|NCT02043132|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
102608500|NCT02043132|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102608501|NCT02043132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608502|NCT02043132|Hemostatics|hemostatics|mesh-ancestor
102608503|NCT02043132|Coagulants|coagulants|mesh-ancestor
102608504|NCT02059434|Tiotropium Bromide|tiotropium bromide|mesh-list
102608505|NCT02059434|LAS190792|las190792|mesh-list
102608506|NCT02059434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102608507|NCT02059434|Autonomic Agents|autonomic agents|mesh-ancestor
102608508|NCT02059434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102608509|NCT02059434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608510|NCT02059434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102608511|NCT02059434|Respiratory System Agents|respiratory system agents|mesh-ancestor
102608512|NCT02059434|Parasympatholytics|parasympatholytics|mesh-ancestor
102608513|NCT02059434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102608514|NCT02059434|Cholinergic Agents|cholinergic agents|mesh-ancestor
102608515|NCT02059434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102608516|NCT02059434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608517|NCT02059434|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102608518|NCT02059434|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102608519|NCT02059434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102608520|NCT02059434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102608521|NCT02059434|Adrenergic Agents|adrenergic agents|mesh-ancestor
102608522|NCT02059278|Latanoprost|latanoprost|mesh-list
102608523|NCT02059278|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102608524|NCT02059278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102608525|NCT02020512|Bimatoprost|bimatoprost|mesh-list
102608526|NCT02020512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102608527|NCT02019420|Linezolid|linezolid|mesh-list
102608528|NCT02019420|Tedizolid|tedizolid|mesh-list
102608529|NCT02019420|Tedizolid phosphate|tedizolid phosphate|mesh-list
102608530|NCT02019420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102608531|NCT02019420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102608532|NCT02019420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102608533|NCT02019420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102608534|NCT02019420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608535|NCT02058966|Entacapone|entacapone|mesh-list
102608536|NCT02058966|Methamphetamine|methamphetamine|mesh-list
102608537|NCT02058966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102608538|NCT02058966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102608539|NCT02058966|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102608540|NCT02058966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102608541|NCT02058966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608542|NCT02058966|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102608543|NCT02058966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608544|NCT02058966|Sympathomimetics|sympathomimetics|mesh-ancestor
102608545|NCT02058966|Autonomic Agents|autonomic agents|mesh-ancestor
102608546|NCT02058966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102608547|NCT02058966|Dopamine Agents|dopamine agents|mesh-ancestor
102608548|NCT02058966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102608549|NCT02058966|Adrenergic Agents|adrenergic agents|mesh-ancestor
102608550|NCT02058966|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102608551|NCT02058966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102608552|NCT02058966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102608553|NCT02058966|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102608554|NCT02017860|Everolimus|everolimus|mesh-list
102608555|NCT02017860|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102608556|NCT02017860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102608557|NCT02017860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102608558|NCT02017860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608559|NCT02017860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102608560|NCT02017860|Immunologic Factors|immunologic factors|mesh-ancestor
102608561|NCT02017860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608562|NCT02017860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102608563|NCT02040870|Ceritinib|ceritinib|mesh-list
102608564|NCT02040870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102608565|NCT02040870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102608566|NCT02040870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102608567|NCT02040870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608568|NCT04720716|Sorafenib|sorafenib|mesh-list
102608569|NCT04720716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102608570|NCT04720716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102608571|NCT04720716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102608572|NCT04720716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608573|NCT02039778|Temozolomide|temozolomide|mesh-list
102608574|NCT02039778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102608575|NCT02039778|Alkylating Agents|alkylating agents|mesh-ancestor
102608576|NCT02039778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608577|NCT02039778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102608578|NCT02015676|Paclitaxel|paclitaxel|mesh-list
102608579|NCT02015676|Trastuzumab|trastuzumab|mesh-list
102608580|NCT02015676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102608581|NCT02015676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102608582|NCT02015676|Tubulin Modulators|tubulin modulators|mesh-ancestor
102608583|NCT02015676|Antimitotic Agents|antimitotic agents|mesh-ancestor
102608584|NCT02015676|Mitosis Modulators|mitosis modulators|mesh-ancestor
102608585|NCT02015676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608586|NCT02015676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102608587|NCT02058108|Telbivudine|telbivudine|mesh-list
102608588|NCT02058108|Antiviral Agents|antiviral agents|mesh-ancestor
102608589|NCT02058108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102608590|NCT02058108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102608591|NCT02058108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102608592|NCT02058108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608593|NCT04678362|Avelumab|avelumab|mesh-list
102608594|NCT04678362|Talazoparib|talazoparib|mesh-list
101875325|NCT03272698|Ketamine|ketamine|mesh-list
102608595|NCT04678362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102608596|NCT04678362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102608597|NCT04678362|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102608598|NCT04678362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102608599|NCT04678362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608600|NCT04678050|Dexmedetomidine|dexmedetomidine|mesh-list
102608601|NCT04678050|Ketamine|ketamine|mesh-list
102608602|NCT04678050|Propofol|propofol|mesh-list
102608603|NCT04678050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102608604|NCT04678050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102608605|NCT04678050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608606|NCT04678050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102608607|NCT04678050|Analgesics|analgesics|mesh-ancestor
102608608|NCT04678050|Sensory System Agents|sensory system agents|mesh-ancestor
102608609|NCT04678050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102608610|NCT04678050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102608611|NCT04678050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102608612|NCT04678050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102608613|NCT04678050|Adrenergic Agents|adrenergic agents|mesh-ancestor
102608614|NCT04678050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102608615|NCT04678050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608616|NCT04678050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102608617|NCT04678050|Anesthetics, General|anesthetics, general|mesh-ancestor
102608618|NCT04678050|Anesthetics|anesthetics|mesh-ancestor
102608619|NCT04678050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102608620|NCT04678050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102608621|NCT04678050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102608622|NCT02038920|Vedolizumab|vedolizumab|mesh-list
102608623|NCT02038920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102608624|NCT01622868|Lapatinib|lapatinib|mesh-list
102608625|NCT01622868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102608626|NCT01622868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102608627|NCT01622868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102608628|NCT01622868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608629|NCT02014740|Metformin|metformin|mesh-list
102608630|NCT02014740|Liraglutide|liraglutide|mesh-list
102608631|NCT02014740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102608632|NCT02014740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608633|NCT02014740|Incretins|incretins|mesh-ancestor
102608634|NCT02014740|Hormones|hormones|mesh-ancestor
102608635|NCT02014740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102608636|NCT02014584|Dutasteride|dutasteride|mesh-list
102608637|NCT02014584|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102608638|NCT02014584|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102608639|NCT02014584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102608640|NCT02014584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608641|NCT02014584|Hormone Antagonists|hormone antagonists|mesh-ancestor
102608642|NCT02014584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102608643|NCT02014584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608644|NCT02037984|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102608645|NCT02037984|Immunologic Factors|immunologic factors|mesh-ancestor
102608646|NCT02037984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608647|NCT02036580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102608648|NCT02036580|Immunologic Factors|immunologic factors|mesh-ancestor
102608649|NCT02036580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608650|NCT02057250|Hydroxychloroquine|hydroxychloroquine|mesh-list
102608651|NCT02057250|Sulfasalazine|sulfasalazine|mesh-list
102608652|NCT02057250|Methotrexate|methotrexate|mesh-list
102608653|NCT02057250|Leflunomide|leflunomide|mesh-list
102608654|NCT02057250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102608655|NCT02057250|Abortifacient Agents|abortifacient agents|mesh-ancestor
102608656|NCT02057250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102608657|NCT02057250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608658|NCT02057250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102608659|NCT02057250|Antimetabolites|antimetabolites|mesh-ancestor
102608660|NCT02057250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608661|NCT02057250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102608662|NCT02057250|Dermatologic Agents|dermatologic agents|mesh-ancestor
102608663|NCT02057250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102608664|NCT02057250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102608665|NCT02057250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102608666|NCT02057250|Immunologic Factors|immunologic factors|mesh-ancestor
102608667|NCT02057250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102608668|NCT02057250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102608669|NCT02057250|Antimalarials|antimalarials|mesh-ancestor
102608670|NCT02057250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102608671|NCT02057250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102608672|NCT02057250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102608673|NCT02057250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102608674|NCT02057250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102608675|NCT02057250|Analgesics|analgesics|mesh-ancestor
102608676|NCT02057250|Sensory System Agents|sensory system agents|mesh-ancestor
102608677|NCT02057250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102608678|NCT02057250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102608679|NCT02057250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102608680|NCT02036502|Dexamethasone|dexamethasone|mesh-list
102608681|NCT02036502|Pembrolizumab|pembrolizumab|mesh-list
102608682|NCT02036502|Lenalidomide|lenalidomide|mesh-list
102608683|NCT02036502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102608684|NCT02036502|Antiemetics|antiemetics|mesh-ancestor
102608685|NCT02036502|Autonomic Agents|autonomic agents|mesh-ancestor
102608686|NCT02036502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102608687|NCT02036502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608688|NCT02036502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102608690|NCT02036502|Hormones|hormones|mesh-ancestor
102608691|NCT02036502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102608692|NCT02036502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102608693|NCT02036502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102608694|NCT02036502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102608695|NCT02036502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102608696|NCT02036502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608697|NCT02036502|Immunologic Factors|immunologic factors|mesh-ancestor
102608698|NCT02036502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102608699|NCT02036502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102608700|NCT02036502|Growth Substances|growth substances|mesh-ancestor
102608701|NCT02036502|Growth Inhibitors|growth inhibitors|mesh-ancestor
102608702|NCT02056626|Carvedilol|carvedilol|mesh-list
102608703|NCT02056626|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102608704|NCT02056626|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102608705|NCT02056626|Adrenergic Agents|adrenergic agents|mesh-ancestor
102608706|NCT02056626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102608707|NCT02056626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608708|NCT02056626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608709|NCT02056626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102608710|NCT02056626|Antioxidants|antioxidants|mesh-ancestor
102608711|NCT02056626|Protective Agents|protective agents|mesh-ancestor
102608712|NCT02056626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102608713|NCT02056626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102608714|NCT02056626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102608715|NCT02056626|Vasodilator Agents|vasodilator agents|mesh-ancestor
102608716|NCT02056626|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102608717|NCT02056626|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102608718|NCT02056392|Moxifloxacin|moxifloxacin|mesh-list
102608719|NCT02056392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102608720|NCT02056392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102608721|NCT02056392|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102608722|NCT02056392|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102608723|NCT02056392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102608724|NCT02056392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608725|NCT02056392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102608726|NCT02034552|Prednisone|prednisone|mesh-list
102608727|NCT02034552|Abiraterone Acetate|abiraterone acetate|mesh-list
102608728|NCT02034552|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
102608729|NCT02034552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102608730|NCT02034552|Glucocorticoids|glucocorticoids|mesh-ancestor
102608731|NCT02034552|Hormones|hormones|mesh-ancestor
102608732|NCT02034552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102608733|NCT02034552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608734|NCT02034552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102608735|NCT02034552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102608736|NCT02034552|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102608737|NCT02034552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102608738|NCT02034552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608739|NCT02034552|Hormone Antagonists|hormone antagonists|mesh-ancestor
102608740|NCT02034552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102608741|NCT02011386|Golimumab|golimumab|mesh-list
102608742|NCT02011386|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102608743|NCT02011386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102608744|NCT02011386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102608745|NCT02011386|Immunologic Factors|immunologic factors|mesh-ancestor
102608746|NCT02011386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608747|NCT02034162|Mebendazole|mebendazole|mesh-list
102608748|NCT02034162|Piperazine|piperazine|mesh-list
102608749|NCT02034162|Piperazine citrate|piperazine citrate|mesh-list
102608750|NCT02034162|DMP 777|dmp 777|mesh-list
102608751|NCT02034162|Antinematodal Agents|antinematodal agents|mesh-ancestor
102608752|NCT02034162|Anthelmintics|anthelmintics|mesh-ancestor
102608753|NCT02034162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102608754|NCT02034162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102608755|NCT02034162|Tubulin Modulators|tubulin modulators|mesh-ancestor
102608756|NCT02034162|Antimitotic Agents|antimitotic agents|mesh-ancestor
102608757|NCT02034162|Mitosis Modulators|mitosis modulators|mesh-ancestor
102608758|NCT02034162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608760|NCT02034162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102608761|NCT02034006|Ranibizumab|ranibizumab|mesh-list
102608762|NCT02034006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102608763|NCT02034006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102608764|NCT02034006|Growth Substances|growth substances|mesh-ancestor
102608765|NCT02034006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608766|NCT02034006|Growth Inhibitors|growth inhibitors|mesh-ancestor
102608767|NCT02034006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102608768|NCT02052960|Cisplatin|cisplatin|mesh-list
102608769|NCT02052960|Fluorouracil|fluorouracil|mesh-list
102608770|NCT02052960|Cetuximab|cetuximab|mesh-list
102608771|NCT02052960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102608772|NCT02052960|Antimetabolites|antimetabolites|mesh-ancestor
102608773|NCT02052960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608774|NCT02052960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102608775|NCT02052960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102608776|NCT02052960|Immunologic Factors|immunologic factors|mesh-ancestor
102608777|NCT02052960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608778|NCT02052960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102608779|NCT02008890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102608780|NCT02008890|Immunologic Factors|immunologic factors|mesh-ancestor
102608781|NCT02008890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608782|NCT02052414|Gabapentin|gabapentin|mesh-list
102608783|NCT02052414|Analgesics|analgesics|mesh-ancestor
102608784|NCT02052414|Sensory System Agents|sensory system agents|mesh-ancestor
102608785|NCT02052414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102608786|NCT02052414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608787|NCT02052414|Anticonvulsants|anticonvulsants|mesh-ancestor
102608788|NCT02052414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102608789|NCT02052414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102608790|NCT02052414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102608791|NCT02052414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102608792|NCT02052414|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102608793|NCT02052414|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102608794|NCT02052414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102608795|NCT02052414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608796|NCT02052414|Antimanic Agents|antimanic agents|mesh-ancestor
102608797|NCT02031276|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102608798|NCT02031276|Immunologic Factors|immunologic factors|mesh-ancestor
102608799|NCT02031276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608800|NCT01363440|Aflibercept|aflibercept|mesh-list
102608801|NCT01363440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102608802|NCT01363440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102608803|NCT01363440|Growth Substances|growth substances|mesh-ancestor
102608804|NCT01363440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608805|NCT01363440|Growth Inhibitors|growth inhibitors|mesh-ancestor
102608806|NCT01363440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102608807|NCT02007096|Bupivacaine|bupivacaine|mesh-list
102608808|NCT02007096|Anesthetics, Local|anesthetics, local|mesh-ancestor
102608809|NCT02007096|Anesthetics|anesthetics|mesh-ancestor
102608810|NCT02007096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102608811|NCT02007096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608812|NCT02007096|Sensory System Agents|sensory system agents|mesh-ancestor
102608813|NCT02007096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102608814|NCT02006706|Methylprednisolone|methylprednisolone|mesh-list
102608815|NCT02006706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102608816|NCT02006706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102608817|NCT02006706|Prednisolone|prednisolone|mesh-list
102608818|NCT02006706|Prednisolone acetate|prednisolone acetate|mesh-list
102608819|NCT02006706|Rituximab|rituximab|mesh-list
102608820|NCT02006706|Methotrexate|methotrexate|mesh-list
102608821|NCT02006706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102608822|NCT02006706|Prednisolone phosphate|prednisolone phosphate|mesh-list
102608823|NCT02006706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102608824|NCT02006706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102608825|NCT02006706|Immunologic Factors|immunologic factors|mesh-ancestor
102608826|NCT02006706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608827|NCT02006706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102608828|NCT02006706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102608829|NCT02006706|Abortifacient Agents|abortifacient agents|mesh-ancestor
102608830|NCT02006706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102608831|NCT02006706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102608832|NCT02006706|Antimetabolites|antimetabolites|mesh-ancestor
102155640|NCT04443543|Fluorouracil|fluorouracil|mesh-list
102608833|NCT02006706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608834|NCT02006706|Dermatologic Agents|dermatologic agents|mesh-ancestor
102608835|NCT02006706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102608836|NCT02006706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102608837|NCT02006706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102608838|NCT02006706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102608839|NCT02006706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102608840|NCT02006706|Antiemetics|antiemetics|mesh-ancestor
102608841|NCT02006706|Autonomic Agents|autonomic agents|mesh-ancestor
102608842|NCT02006706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102608843|NCT02006706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102608844|NCT02006706|Glucocorticoids|glucocorticoids|mesh-ancestor
102608845|NCT02006706|Hormones|hormones|mesh-ancestor
102608846|NCT02006706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102608847|NCT02006706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102608848|NCT02006706|Protective Agents|protective agents|mesh-ancestor
102608849|NCT02006706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102608850|NCT02049138|Upadacitinib|upadacitinib|mesh-list
102608851|NCT02049138|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102608852|NCT02049138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102608853|NCT02049138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102608854|NCT02049138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608855|NCT02049138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102608856|NCT02048904|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102608857|NCT02048904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102608858|NCT02048904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608859|NCT02048904|Incretins|incretins|mesh-ancestor
102608860|NCT02048904|Hormones|hormones|mesh-ancestor
102608861|NCT02048904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102608862|NCT02048904|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102608863|NCT02048904|Protease Inhibitors|protease inhibitors|mesh-ancestor
102608864|NCT02048904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102608865|NCT02048904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608866|NCT02006628|Cannabidiol|cannabidiol|mesh-list
102608867|NCT02006628|Anticonvulsants|anticonvulsants|mesh-ancestor
102608868|NCT02029638|Acetaminophen|acetaminophen|mesh-list
102608869|NCT02029638|Diphenhydramine|diphenhydramine|mesh-list
102608870|NCT02029638|Promethazine|promethazine|mesh-list
102608871|NCT02029638|Mycophenolic Acid|mycophenolic acid|mesh-list
102608872|NCT02029638|Prednisone|prednisone|mesh-list
102608873|NCT02029638|Methylprednisolone|methylprednisolone|mesh-list
102608874|NCT02029638|Cyclophosphamide|cyclophosphamide|mesh-list
102608875|NCT02029638|Fludarabine|fludarabine|mesh-list
102608876|NCT02029638|Thymoglobulin|thymoglobulin|mesh-list
102608877|NCT02029638|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102608878|NCT02029638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102608879|NCT02029638|Immunologic Factors|immunologic factors|mesh-ancestor
102608880|NCT02029638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608881|NCT02029638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102608882|NCT02029638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102608883|NCT02029638|Alkylating Agents|alkylating agents|mesh-ancestor
102608884|NCT02029638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608885|NCT02029638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102608886|NCT02029638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102608887|NCT02029638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102608888|NCT02029638|Glucocorticoids|glucocorticoids|mesh-ancestor
102608889|NCT02029638|Hormones|hormones|mesh-ancestor
102608890|NCT02029638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102608891|NCT02029638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102608892|NCT02029638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102608893|NCT02029638|Analgesics|analgesics|mesh-ancestor
102608894|NCT02029638|Sensory System Agents|sensory system agents|mesh-ancestor
102608895|NCT02029638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102608896|NCT02029638|Antipyretics|antipyretics|mesh-ancestor
102608897|NCT02029638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102608898|NCT02029638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102608899|NCT02029638|Antitubercular Agents|antitubercular agents|mesh-ancestor
102608900|NCT02029638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102608901|NCT02029638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102608902|NCT02029638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102608903|NCT02029638|Antiemetics|antiemetics|mesh-ancestor
102608904|NCT02029638|Autonomic Agents|autonomic agents|mesh-ancestor
102608905|NCT02029638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102608906|NCT02029638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102608907|NCT02029638|Protective Agents|protective agents|mesh-ancestor
102608908|NCT02029638|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102608909|NCT02029638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102608910|NCT02029638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102608911|NCT02029638|Anesthetics, Local|anesthetics, local|mesh-ancestor
102608912|NCT02029638|Anesthetics|anesthetics|mesh-ancestor
102608913|NCT02029638|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102608914|NCT02029638|Histamine Antagonists|histamine antagonists|mesh-ancestor
102608915|NCT02029638|Histamine Agents|histamine agents|mesh-ancestor
102608916|NCT02029638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102608917|NCT02029638|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102608918|NCT02029638|Antipruritics|antipruritics|mesh-ancestor
102608919|NCT02029638|Dermatologic Agents|dermatologic agents|mesh-ancestor
102608920|NCT02047734|Interferons|interferons|mesh-list
102608921|NCT02047734|Interferon-beta|interferon-beta|mesh-list
102608922|NCT02047734|Interferon beta-1a|interferon beta-1a|mesh-list
102608923|NCT02047734|Ozanimod|ozanimod|mesh-list
102608924|NCT02047734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102608925|NCT02047734|Antiviral Agents|antiviral agents|mesh-ancestor
102608926|NCT02047734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102608927|NCT02047734|Immunologic Factors|immunologic factors|mesh-ancestor
102608928|NCT02047734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608929|NCT02047734|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102608930|NCT02047734|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102608931|NCT02047734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608932|NCT02047734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102608933|NCT01994850|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102608934|NCT01994850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102608935|NCT01994850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102608936|NCT01994850|Immunotoxins|immunotoxins|mesh-ancestor
102608937|NCT01994850|Immunoconjugates|immunoconjugates|mesh-ancestor
102608938|NCT01994850|Immunologic Factors|immunologic factors|mesh-ancestor
102346705|NCT03793166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102608939|NCT01994850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608940|NCT01994382|Rituximab|rituximab|mesh-list
102608941|NCT01994382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102608942|NCT01994382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102608943|NCT01994382|Immunologic Factors|immunologic factors|mesh-ancestor
102608944|NCT01994382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608945|NCT01994382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102608946|NCT02003898|Insulin|insulin|mesh-list
102608947|NCT02003898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102608948|NCT02003898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608949|NCT01994226|Naproxen|naproxen|mesh-list
102608950|NCT01994226|Colchicine|colchicine|mesh-list
102608951|NCT01994226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102608952|NCT01994226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102608953|NCT01994226|Analgesics|analgesics|mesh-ancestor
102608954|NCT01994226|Sensory System Agents|sensory system agents|mesh-ancestor
102608955|NCT01994226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102608956|NCT01994226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608957|NCT01994226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102608958|NCT01994226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102608959|NCT01994226|Gout Suppressants|gout suppressants|mesh-ancestor
102608960|NCT01994226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102608961|NCT01994226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102608962|NCT01994226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608963|NCT01994226|Tubulin Modulators|tubulin modulators|mesh-ancestor
102608964|NCT01994226|Antimitotic Agents|antimitotic agents|mesh-ancestor
102608965|NCT01994226|Mitosis Modulators|mitosis modulators|mesh-ancestor
102608966|NCT01994226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102608967|NCT02002884|Botulinum Toxins|botulinum toxins|mesh-list
102608968|NCT02002884|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102608969|NCT02002884|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102608970|NCT02002884|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102608971|NCT02002884|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102608972|NCT02002884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102608973|NCT02002884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608974|NCT02002884|Cholinergic Agents|cholinergic agents|mesh-ancestor
102608975|NCT02002884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102608976|NCT02002884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608977|NCT02002884|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102608978|NCT02002884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102608979|NCT02023866|Cysteamine|cysteamine|mesh-list
102608980|NCT02023866|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
102608981|NCT02023866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608982|NCT01967940|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102608983|NCT01967940|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102608984|NCT01967940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102608985|NCT01967940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102608986|NCT01967940|Protease Inhibitors|protease inhibitors|mesh-ancestor
102608987|NCT01967940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102608988|NCT01967940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102608989|NCT01967940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102608990|NCT01967940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102608991|NCT01967940|Antiviral Agents|antiviral agents|mesh-ancestor
102608992|NCT01967940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102608993|NCT01990560|Mifepristone|mifepristone|mesh-list
102608994|NCT01990560|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102608995|NCT01990560|Abortifacient Agents|abortifacient agents|mesh-ancestor
102608996|NCT01990560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102608997|NCT01990560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102608998|NCT01990560|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102608999|NCT01990560|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102609000|NCT01990560|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102609001|NCT01990560|Contraceptive Agents|contraceptive agents|mesh-ancestor
102609002|NCT01990560|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102609003|NCT01990560|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102609004|NCT01990560|Hormone Antagonists|hormone antagonists|mesh-ancestor
102609005|NCT01990560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102609006|NCT01990560|Luteolytic Agents|luteolytic agents|mesh-ancestor
102609007|NCT01990560|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102609008|NCT01990560|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102609009|NCT01967628|Vitamin D|vitamin d|mesh-list
102609010|NCT01967628|Cholecalciferol|cholecalciferol|mesh-list
102609011|NCT01967628|Vitamins|vitamins|mesh-ancestor
102609012|NCT01967628|Micronutrients|micronutrients|mesh-ancestor
102609013|NCT01967628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609014|NCT01967628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102609015|NCT01967628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102609016|NCT01998906|Paclitaxel|paclitaxel|mesh-list
102609017|NCT01998906|Doxorubicin|doxorubicin|mesh-list
102609018|NCT01998906|Trastuzumab|trastuzumab|mesh-list
102609019|NCT01998906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102609020|NCT01998906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102609021|NCT01998906|Tubulin Modulators|tubulin modulators|mesh-ancestor
102609022|NCT01998906|Antimitotic Agents|antimitotic agents|mesh-ancestor
102609023|NCT01998906|Mitosis Modulators|mitosis modulators|mesh-ancestor
102609024|NCT01998906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609025|NCT01998906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102609026|NCT01998906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102609027|NCT01998906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102609028|NCT01998906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102609029|NCT01998906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102609030|NCT01967550|Diclofenac|diclofenac|mesh-list
102609031|NCT01967550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102609032|NCT01967550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102609033|NCT01967550|Analgesics|analgesics|mesh-ancestor
102609034|NCT01967550|Sensory System Agents|sensory system agents|mesh-ancestor
102609035|NCT01967550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102609036|NCT01967550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609037|NCT01967550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102609038|NCT01967550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102609039|NCT01967550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102609040|NCT01967550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102609041|NCT01967550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609042|NCT01989546|Talazoparib|talazoparib|mesh-list
102609043|NCT01989546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102609044|NCT01989546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102609045|NCT01989546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609046|NCT01989546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102609047|NCT01989468|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102609048|NCT01989468|Immunologic Factors|immunologic factors|mesh-ancestor
102609049|NCT01989468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609050|NCT01989156|Menthol|menthol|mesh-list
102609051|NCT01989156|Antipruritics|antipruritics|mesh-ancestor
102609052|NCT01989156|Dermatologic Agents|dermatologic agents|mesh-ancestor
102609053|NCT01965834|Fenofibrate|fenofibrate|mesh-list
102609054|NCT01965834|Fenofibric acid|fenofibric acid|mesh-list
102609055|NCT01965834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102609056|NCT01965834|Antimetabolites|antimetabolites|mesh-ancestor
102609057|NCT01965834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609058|NCT01965834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102609059|NCT01965834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102609060|NCT01996332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102609061|NCT01996332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102609062|NCT01996332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102609063|NCT01996332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102609064|NCT01996332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609065|NCT01987596|Lenograstim|lenograstim|mesh-list
102609066|NCT01987596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102609067|NCT01987596|Immunologic Factors|immunologic factors|mesh-ancestor
102346717|NCT03725202|Upadacitinib|upadacitinib|mesh-list
102346718|NCT03725202|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102346719|NCT03725202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102346720|NCT03725202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102346721|NCT03725202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346722|NCT03725202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102346723|NCT03701308|Cytarabine|cytarabine|mesh-list
102609068|NCT01987596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609069|NCT01964898|Nicotine|nicotine|mesh-list
102609070|NCT01964898|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102609071|NCT01964898|Autonomic Agents|autonomic agents|mesh-ancestor
102609072|NCT01964898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102609073|NCT01964898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609074|NCT01964898|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102609075|NCT01964898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102609076|NCT01964898|Cholinergic Agents|cholinergic agents|mesh-ancestor
102609077|NCT01964898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102609078|NCT01964898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609079|NCT01964352|Tiotropium Bromide|tiotropium bromide|mesh-list
102609080|NCT01964352|Olodaterol|olodaterol|mesh-list
102609081|NCT01964352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102609082|NCT01964352|Autonomic Agents|autonomic agents|mesh-ancestor
102609083|NCT01964352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102609084|NCT01964352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609085|NCT01964352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102609086|NCT01964352|Respiratory System Agents|respiratory system agents|mesh-ancestor
102609087|NCT01964352|Parasympatholytics|parasympatholytics|mesh-ancestor
102609088|NCT01964352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102609089|NCT01964352|Cholinergic Agents|cholinergic agents|mesh-ancestor
102609090|NCT01964352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102609091|NCT01964352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609092|NCT01946412|Ivacaftor|ivacaftor|mesh-list
102609093|NCT01946412|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102609094|NCT01946412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102609095|NCT01946412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609096|NCT01945866|Dexamethasone|dexamethasone|mesh-list
102609097|NCT01945866|Ranibizumab|ranibizumab|mesh-list
102609098|NCT01945866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102609099|NCT01945866|Antiemetics|antiemetics|mesh-ancestor
102609100|NCT01945866|Autonomic Agents|autonomic agents|mesh-ancestor
102609101|NCT01945866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102609102|NCT01945866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609103|NCT01945866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102609104|NCT01945866|Glucocorticoids|glucocorticoids|mesh-ancestor
102609105|NCT01945866|Hormones|hormones|mesh-ancestor
102609106|NCT01945866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102609107|NCT01945866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102609108|NCT01945866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102609109|NCT01945866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102609110|NCT01945866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102609111|NCT01945866|Growth Substances|growth substances|mesh-ancestor
102609112|NCT01945866|Growth Inhibitors|growth inhibitors|mesh-ancestor
102609113|NCT01986114|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102609114|NCT01986114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102609115|NCT01986114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102609116|NCT01986114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102609117|NCT01986114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609118|NCT01986114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102609119|NCT01986114|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102609120|NCT01986114|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102609121|NCT01986114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102609122|NCT01986114|Adrenergic Agents|adrenergic agents|mesh-ancestor
102609123|NCT01986114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102609124|NCT01986114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609125|NCT01986114|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102609126|NCT01986114|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102609127|NCT01986114|Serotonin Agents|serotonin agents|mesh-ancestor
102609128|NCT01986114|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102609129|NCT01986114|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102609130|NCT01986114|Dopamine Agents|dopamine agents|mesh-ancestor
102609131|NCT01945242|Alogliptin|alogliptin|mesh-list
102609132|NCT01945242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102609133|NCT01945242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609134|NCT01945242|Incretins|incretins|mesh-ancestor
102609135|NCT01945242|Hormones|hormones|mesh-ancestor
102609136|NCT01945242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102609137|NCT01945242|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102609138|NCT01945242|Protease Inhibitors|protease inhibitors|mesh-ancestor
102609139|NCT01945242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102609140|NCT01945242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609141|NCT01945086|Ustekinumab|ustekinumab|mesh-list
102609142|NCT01945086|Dermatologic Agents|dermatologic agents|mesh-ancestor
102609143|NCT04658160|Imidacloprid|imidacloprid|mesh-list
102609144|NCT04658160|Cholinergic Agents|cholinergic agents|mesh-ancestor
102609145|NCT04658160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102609146|NCT04658160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609147|NCT04658160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609148|NCT01963728|Insulin|insulin|mesh-list
102609149|NCT01963728|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102609150|NCT01963728|Insulin Glargine|insulin glargine|mesh-list
102609151|NCT01963728|Insulin, Isophane|insulin, isophane|mesh-list
102609152|NCT01963728|Isophane Insulin, Human|isophane insulin, human|mesh-list
102609153|NCT01963728|Isophane insulin, beef|isophane insulin, beef|mesh-list
102609154|NCT01963728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102609155|NCT01963728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609156|NCT01962948|Paclitaxel|paclitaxel|mesh-list
102609157|NCT01962948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102609158|NCT01962948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102609159|NCT01962948|Tubulin Modulators|tubulin modulators|mesh-ancestor
102609160|NCT01962948|Antimitotic Agents|antimitotic agents|mesh-ancestor
102609161|NCT01962948|Mitosis Modulators|mitosis modulators|mesh-ancestor
102609162|NCT01962948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609163|NCT01985334|Glycopyrrolate|glycopyrrolate|mesh-list
102609164|NCT01985334|Bromides|bromides|mesh-list
102609165|NCT01985334|Anticonvulsants|anticonvulsants|mesh-ancestor
102609166|NCT01985334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609167|NCT01985334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102609168|NCT01985334|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102609169|NCT01985334|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102609170|NCT01985334|Cholinergic Agents|cholinergic agents|mesh-ancestor
102609171|NCT01985334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102609172|NCT01985334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609173|NCT01944774|Moxifloxacin|moxifloxacin|mesh-list
102609174|NCT01944774|Nemonoxacin|nemonoxacin|mesh-list
102609175|NCT01944774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102609176|NCT01944774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102609177|NCT01944774|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102609178|NCT01944774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102609179|NCT01944774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102609180|NCT01944774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609181|NCT01944774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102609182|NCT04665648|Nicorandil|nicorandil|mesh-list
102609183|NCT04665648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102609184|NCT04665648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102609185|NCT04665648|Vasodilator Agents|vasodilator agents|mesh-ancestor
102609186|NCT04665648|Vitamin B Complex|vitamin b complex|mesh-ancestor
102609187|NCT04665648|Vitamins|vitamins|mesh-ancestor
102609188|NCT04665648|Micronutrients|micronutrients|mesh-ancestor
102609189|NCT04665648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609190|NCT01944462|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102609191|NCT01944462|Immunologic Factors|immunologic factors|mesh-ancestor
102609192|NCT01944462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609193|NCT01942590|Clenbuterol|clenbuterol|mesh-list
102609194|NCT01942590|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102609195|NCT01942590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102609196|NCT01942590|Adrenergic Agents|adrenergic agents|mesh-ancestor
102609197|NCT01942590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102609198|NCT01942590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609199|NCT01942590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609200|NCT01942590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102609201|NCT01942590|Autonomic Agents|autonomic agents|mesh-ancestor
102609202|NCT01942590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102609203|NCT01942590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102609204|NCT01942590|Respiratory System Agents|respiratory system agents|mesh-ancestor
102609205|NCT01942590|Sympathomimetics|sympathomimetics|mesh-ancestor
102609206|NCT01984242|Bevacizumab|bevacizumab|mesh-list
102609207|NCT01984242|Atezolizumab|atezolizumab|mesh-list
102609208|NCT01984242|Sunitinib|sunitinib|mesh-list
102609209|NCT01984242|Antibodies|antibodies|mesh-list
102609210|NCT01984242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102609211|NCT01984242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102609212|NCT01984242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102609213|NCT01984242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101875942|NCT01299922|Immunologic Factors|immunologic factors|mesh-ancestor
102609214|NCT01984242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102609215|NCT01984242|Growth Substances|growth substances|mesh-ancestor
102609216|NCT01984242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609217|NCT01984242|Growth Inhibitors|growth inhibitors|mesh-ancestor
102609218|NCT01984242|Immunologic Factors|immunologic factors|mesh-ancestor
102609219|NCT01984242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102609220|NCT01984242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609221|NCT01984242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102609222|NCT01984242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102609223|NCT01960842|Levodopa|levodopa|mesh-list
102609224|NCT01960842|Carbidopa|carbidopa|mesh-list
102609225|NCT01960842|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102609226|NCT01960842|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102609227|NCT01960842|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102609228|NCT01960842|Dopamine Agents|dopamine agents|mesh-ancestor
102609229|NCT01960842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102609230|NCT01960842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609231|NCT01960842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609232|NCT01960842|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102609233|NCT01960842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102609234|NCT01960842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102609235|NCT01960842|Immunologic Factors|immunologic factors|mesh-ancestor
102609236|NCT01960842|Dopamine Agonists|dopamine agonists|mesh-ancestor
102609237|NCT01984164|Candesartan|candesartan|mesh-list
102609238|NCT01984164|Candesartan cilexetil|candesartan cilexetil|mesh-list
102609239|NCT01984164|Lisinopril|lisinopril|mesh-list
102609240|NCT01984164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102609241|NCT01984164|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102609242|NCT01984164|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102609243|NCT01984164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609244|NCT01984164|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102609245|NCT01984164|Protease Inhibitors|protease inhibitors|mesh-ancestor
102609246|NCT01984164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102609247|NCT01984164|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102609248|NCT01984164|Protective Agents|protective agents|mesh-ancestor
102609249|NCT01984164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609250|NCT01983774|Esomeprazole|esomeprazole|mesh-list
102609251|NCT01983774|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102609252|NCT01983774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102609253|NCT01983774|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102609254|NCT01983774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102609255|NCT01983774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609256|NCT01982682|Mycophenolic Acid|mycophenolic acid|mesh-list
102609257|NCT01982682|Cyclophosphamide|cyclophosphamide|mesh-list
102609258|NCT01982682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102609259|NCT01982682|Immunologic Factors|immunologic factors|mesh-ancestor
102609260|NCT01982682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609261|NCT01982682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102609262|NCT01982682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102609263|NCT01982682|Alkylating Agents|alkylating agents|mesh-ancestor
102609264|NCT01982682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609265|NCT01982682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102609266|NCT01982682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102609267|NCT01982682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102609268|NCT01982682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102609269|NCT01982682|Antitubercular Agents|antitubercular agents|mesh-ancestor
102609270|NCT01982682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102609271|NCT01982682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102609272|NCT01982682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102609273|NCT01940484|Epoetin Alfa|epoetin alfa|mesh-list
102609274|NCT01940484|Hematinics|hematinics|mesh-ancestor
102609275|NCT01960296|Clopidogrel|clopidogrel|mesh-list
102609276|NCT01960296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102609277|NCT01960296|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102609278|NCT01960296|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102609279|NCT01960296|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102609280|NCT01960296|Purinergic Agents|purinergic agents|mesh-ancestor
102609281|NCT01960296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102609282|NCT01960296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609283|NCT01960296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609284|NCT01939314|Bupivacaine|bupivacaine|mesh-list
102609285|NCT01939314|Anesthetics, Local|anesthetics, local|mesh-ancestor
102609286|NCT01939314|Anesthetics|anesthetics|mesh-ancestor
102609287|NCT01939314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102609288|NCT01939314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609289|NCT01939314|Sensory System Agents|sensory system agents|mesh-ancestor
102609290|NCT01939314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102609291|NCT01939158|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102609292|NCT01939158|Immunologic Factors|immunologic factors|mesh-ancestor
102609293|NCT01939158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609294|NCT01939002|Interferons|interferons|mesh-list
102609295|NCT01939002|Interferon-beta|interferon-beta|mesh-list
102609296|NCT01939002|Interferon beta-1a|interferon beta-1a|mesh-list
102609297|NCT01939002|Naproxen|naproxen|mesh-list
102609298|NCT01939002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
102609299|NCT01939002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102609300|NCT01939002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102609301|NCT01939002|Antiviral Agents|antiviral agents|mesh-ancestor
102609302|NCT01939002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102609303|NCT01939002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102609304|NCT01939002|Analgesics|analgesics|mesh-ancestor
102609305|NCT01939002|Sensory System Agents|sensory system agents|mesh-ancestor
102609306|NCT01939002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102609307|NCT01939002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609308|NCT01939002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102609309|NCT01939002|Gout Suppressants|gout suppressants|mesh-ancestor
102609310|NCT01939002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102609311|NCT01939002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102609312|NCT01939002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609313|NCT01939002|Immunologic Factors|immunologic factors|mesh-ancestor
102609314|NCT01939002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102609315|NCT01938846|Paclitaxel|paclitaxel|mesh-list
102609316|NCT01938846|Exemestane|exemestane|mesh-list
102609317|NCT01938846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102609318|NCT01938846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102609319|NCT01938846|Tubulin Modulators|tubulin modulators|mesh-ancestor
102609320|NCT01938846|Antimitotic Agents|antimitotic agents|mesh-ancestor
102609321|NCT01938846|Mitosis Modulators|mitosis modulators|mesh-ancestor
102609322|NCT01938846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609323|NCT01938846|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102609324|NCT01938846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102609325|NCT01938846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102609326|NCT01938846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102609327|NCT01938846|Hormone Antagonists|hormone antagonists|mesh-ancestor
102609328|NCT01938846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102609329|NCT01938846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609330|NCT01960140|Simvastatin|simvastatin|mesh-list
102609331|NCT01960140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102609332|NCT01960140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102609333|NCT01960140|Antimetabolites|antimetabolites|mesh-ancestor
102609334|NCT01960140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609335|NCT01960140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102609336|NCT01960140|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102609337|NCT01960140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102609338|NCT01959672|Calcium, Dietary|calcium, dietary|mesh-list
102609339|NCT01959672|Leucovorin|leucovorin|mesh-list
102609340|NCT01959672|Folic Acid|folic acid|mesh-list
102609341|NCT01959672|Nelfinavir|nelfinavir|mesh-list
102609342|NCT01959672|Gemcitabine|gemcitabine|mesh-list
102609343|NCT01959672|Fluorouracil|fluorouracil|mesh-list
102609344|NCT01959672|Oregovomab|oregovomab|mesh-list
102609345|NCT01959672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102609346|NCT01959672|Antibodies|antibodies|mesh-list
102609347|NCT01959672|Immunoglobulins|immunoglobulins|mesh-list
102609348|NCT01959672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102609349|NCT01959672|Calcium|calcium|mesh-list
102609350|NCT01959672|Levoleucovorin|levoleucovorin|mesh-list
102609351|NCT01959672|Immunologic Factors|immunologic factors|mesh-ancestor
102609352|NCT01959672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609353|NCT01959672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102609354|NCT01959672|Antimetabolites|antimetabolites|mesh-ancestor
102609355|NCT01959672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609356|NCT01959672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102609357|NCT01959672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102609358|NCT01959672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102609359|NCT01959672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102609360|NCT01959672|Antidotes|antidotes|mesh-ancestor
102609361|NCT01959672|Protective Agents|protective agents|mesh-ancestor
102609362|NCT01959672|Vitamin B Complex|vitamin b complex|mesh-ancestor
102609363|NCT01959672|Vitamins|vitamins|mesh-ancestor
102609364|NCT01959672|Micronutrients|micronutrients|mesh-ancestor
102609365|NCT01959672|Hematinics|hematinics|mesh-ancestor
102609366|NCT01959672|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102609367|NCT01959672|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102609368|NCT01959672|Protease Inhibitors|protease inhibitors|mesh-ancestor
102609369|NCT01959672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102609370|NCT01959672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102609371|NCT01959672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102609372|NCT01959672|Antiviral Agents|antiviral agents|mesh-ancestor
102609373|NCT01959672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102609374|NCT01980888|Rituximab|rituximab|mesh-list
102609375|NCT01980888|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102609376|NCT01980888|Idelalisib|idelalisib|mesh-list
102609377|NCT01980888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102609378|NCT01980888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102609379|NCT01980888|Immunologic Factors|immunologic factors|mesh-ancestor
102609380|NCT01980888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609381|NCT01980888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102609382|NCT01980888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102609383|NCT01980888|Alkylating Agents|alkylating agents|mesh-ancestor
102609384|NCT01980888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609385|NCT01980888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102609386|NCT04650282|Lidocaine|lidocaine|mesh-list
102609387|NCT04650282|Anesthetics, Local|anesthetics, local|mesh-ancestor
102609388|NCT04650282|Anesthetics|anesthetics|mesh-ancestor
102609389|NCT04650282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102609390|NCT04650282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609391|NCT04650282|Sensory System Agents|sensory system agents|mesh-ancestor
102609392|NCT04650282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102609393|NCT04650282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102609394|NCT04650282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102609395|NCT04650282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102609396|NCT04650282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102346749|NCT03691649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102609397|NCT04650282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609398|NCT01937364|Baclofen|baclofen|mesh-list
102609399|NCT01937364|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102609400|NCT01937364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609401|NCT01937364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102609402|NCT01937364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102609403|NCT01937364|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102609404|NCT01937364|GABA Agonists|gaba agonists|mesh-ancestor
102609405|NCT01937364|GABA Agents|gaba agents|mesh-ancestor
102609406|NCT01937364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102609407|NCT01937364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609408|NCT01979952|Nintedanib|nintedanib|mesh-list
102609409|NCT01979952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102609410|NCT01979952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102609411|NCT01979952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102609412|NCT01979952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609413|NCT01999218|Metformin|metformin|mesh-list
102609414|NCT01999218|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102609415|NCT01999218|Glimepiride|glimepiride|mesh-list
102609416|NCT01999218|Ertugliflozin|ertugliflozin|mesh-list
102609417|NCT01999218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102609418|NCT01999218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609419|NCT01999218|Incretins|incretins|mesh-ancestor
102609420|NCT01999218|Hormones|hormones|mesh-ancestor
102609421|NCT01999218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102609422|NCT01999218|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102609423|NCT01999218|Protease Inhibitors|protease inhibitors|mesh-ancestor
102609424|NCT01999218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102609425|NCT01999218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609426|NCT01999218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102609427|NCT01999218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102609428|NCT01999218|Immunologic Factors|immunologic factors|mesh-ancestor
102609429|NCT01999218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102609430|NCT01936974|Bevacizumab|bevacizumab|mesh-list
102609431|NCT01936974|Carboplatin|carboplatin|mesh-list
102609432|NCT01936974|Gemcitabine|gemcitabine|mesh-list
102609433|NCT01936974|Oxaliplatin|oxaliplatin|mesh-list
102609434|NCT01936974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102609435|NCT01936974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102609436|NCT01936974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102609437|NCT01936974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102609438|NCT01936974|Growth Substances|growth substances|mesh-ancestor
102609439|NCT01936974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609440|NCT01936974|Growth Inhibitors|growth inhibitors|mesh-ancestor
102609441|NCT01936974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102609442|NCT01936974|Antimetabolites|antimetabolites|mesh-ancestor
102609443|NCT01936974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609444|NCT01959516|Glycopyrrolate|glycopyrrolate|mesh-list
102609445|NCT01959516|Tiotropium Bromide|tiotropium bromide|mesh-list
102609446|NCT01959516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102609447|NCT01959516|Autonomic Agents|autonomic agents|mesh-ancestor
102609448|NCT01959516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102609449|NCT01959516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609450|NCT01959516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102609451|NCT01959516|Respiratory System Agents|respiratory system agents|mesh-ancestor
102609452|NCT01959516|Parasympatholytics|parasympatholytics|mesh-ancestor
102609453|NCT01959516|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102609454|NCT01959516|Cholinergic Agents|cholinergic agents|mesh-ancestor
102609455|NCT01959516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102609456|NCT01959516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609457|NCT01959516|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102609458|NCT01959516|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102609459|NCT01979016|Emollients|emollients|mesh-list
102609460|NCT01979016|Dermatologic Agents|dermatologic agents|mesh-ancestor
102609461|NCT01935336|Ponatinib|ponatinib|mesh-list
102609462|NCT01935336|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102609463|NCT01935336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102609464|NCT01935336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102609465|NCT01935336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609466|NCT01935336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102609467|NCT01978236|Trametinib|trametinib|mesh-list
102609468|NCT01978236|Dabrafenib|dabrafenib|mesh-list
102609469|NCT01978236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102609470|NCT01978236|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102609471|NCT01978236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102609472|NCT01978236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609473|NCT01934790|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
102609474|NCT01934790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102609475|NCT01934556|Ranibizumab|ranibizumab|mesh-list
102609476|NCT01934556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102609477|NCT01934556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102609478|NCT01934556|Growth Substances|growth substances|mesh-ancestor
102609479|NCT01934556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609480|NCT01934556|Growth Inhibitors|growth inhibitors|mesh-ancestor
102609481|NCT01934556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102609482|NCT04411212|Lenograstim|lenograstim|mesh-list
102609483|NCT04411212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102609484|NCT04411212|Immunologic Factors|immunologic factors|mesh-ancestor
102609485|NCT04411212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609486|NCT01620138|Cabergoline|cabergoline|mesh-list
102609487|NCT01620138|Pasireotide|pasireotide|mesh-list
102609488|NCT01620138|Hormones|hormones|mesh-ancestor
102609489|NCT01620138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102609490|NCT01620138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609491|NCT01620138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102609492|NCT01620138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102609493|NCT01620138|Dopamine Agonists|dopamine agonists|mesh-ancestor
102609494|NCT01620138|Dopamine Agents|dopamine agents|mesh-ancestor
102609495|NCT01620138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102609496|NCT01620138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609497|NCT01932996|Nicotine|nicotine|mesh-list
102609498|NCT01932996|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102609499|NCT01932996|Autonomic Agents|autonomic agents|mesh-ancestor
102609500|NCT01932996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102609501|NCT01932996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609502|NCT01932996|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102609503|NCT01932996|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102609504|NCT01932996|Cholinergic Agents|cholinergic agents|mesh-ancestor
102609505|NCT01932996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102609506|NCT01932996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609507|NCT01932762|Ribavirin|ribavirin|mesh-list
102609508|NCT01932762|Grazoprevir|grazoprevir|mesh-list
102609509|NCT01932762|Antimetabolites|antimetabolites|mesh-ancestor
102609510|NCT01932762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609511|NCT01932762|Antiviral Agents|antiviral agents|mesh-ancestor
102609512|NCT01932762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102609513|NCT01977456|Eptifibatide|eptifibatide|mesh-list
102609514|NCT01977456|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102609515|NCT01957644|Azacitidine|azacitidine|mesh-list
102609516|NCT01957644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102609517|NCT01957644|Antimetabolites|antimetabolites|mesh-ancestor
102609518|NCT01957644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609519|NCT01957644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102609520|NCT01957644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102609521|NCT01931202|Escitalopram|escitalopram|mesh-list
102609522|NCT01931202|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102609523|NCT01931202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102609524|NCT01931202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102609525|NCT01931202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609526|NCT01931202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102609527|NCT01931202|Serotonin Agents|serotonin agents|mesh-ancestor
102609528|NCT01931202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609529|NCT01930890|Mycophenolic Acid|mycophenolic acid|mesh-list
102609530|NCT01930890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102609531|NCT01930890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102609532|NCT01930890|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102609533|NCT01930890|Antitubercular Agents|antitubercular agents|mesh-ancestor
102609534|NCT01930890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102609535|NCT01930890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102609536|NCT01930890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102609537|NCT01930890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609538|NCT01930188|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102609539|NCT01930188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102609540|NCT01930188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609541|NCT01930188|Incretins|incretins|mesh-ancestor
102609542|NCT01930188|Hormones|hormones|mesh-ancestor
102609543|NCT01930188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102609544|NCT01930188|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102609545|NCT01930188|Protease Inhibitors|protease inhibitors|mesh-ancestor
102609546|NCT01930188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102609547|NCT01930188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609548|NCT01976364|Methotrexate|methotrexate|mesh-list
102609549|NCT01976364|Tofacitinib|tofacitinib|mesh-list
102609550|NCT01976364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102609551|NCT01976364|Abortifacient Agents|abortifacient agents|mesh-ancestor
102609552|NCT01976364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102609553|NCT01976364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609554|NCT01976364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102609555|NCT01976364|Antimetabolites|antimetabolites|mesh-ancestor
102609556|NCT01976364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609557|NCT01976364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102609558|NCT01976364|Dermatologic Agents|dermatologic agents|mesh-ancestor
102609559|NCT01976364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102609560|NCT01976364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102609561|NCT01976364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102609562|NCT01976364|Immunologic Factors|immunologic factors|mesh-ancestor
102609563|NCT01976364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102609564|NCT01976364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102609565|NCT01976364|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102609566|NCT01976364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102609567|NCT01929876|Itraconazole|itraconazole|mesh-list
102609568|NCT01929876|Antifungal Agents|antifungal agents|mesh-ancestor
102609569|NCT01929876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102609570|NCT01929876|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102609571|NCT01929876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102609572|NCT01929876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102609573|NCT01929876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609574|NCT01929876|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102609575|NCT01929876|Hormone Antagonists|hormone antagonists|mesh-ancestor
102609576|NCT01929876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102609577|NCT01929876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609578|NCT01929876|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102609579|NCT01928940|Trametinib|trametinib|mesh-list
102156389|NCT03578263|Oxytocin|oxytocin|mesh-list
102609580|NCT01928940|Dabrafenib|dabrafenib|mesh-list
102609581|NCT01928940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102609582|NCT01928940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102609583|NCT01928940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102609584|NCT01928940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609585|NCT01954056|Hydrocortisone|hydrocortisone|mesh-list
102609586|NCT01954056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102609587|NCT01975272|Iron|iron|mesh-list
102609588|NCT01975272|Ferrous fumarate|ferrous fumarate|mesh-list
102609589|NCT01975272|Ferric Compounds|ferric compounds|mesh-list
102609590|NCT01975272|Trace Elements|trace elements|mesh-ancestor
102609591|NCT01975272|Micronutrients|micronutrients|mesh-ancestor
102609592|NCT01975272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609593|NCT01975272|Hematinics|hematinics|mesh-ancestor
102609594|NCT03965039|Fluorides|fluorides|mesh-list
102609595|NCT03965039|Tin Fluorides|tin fluorides|mesh-list
102609596|NCT03965039|Fluorophosphate|fluorophosphate|mesh-list
102609597|NCT03965039|Cariostatic Agents|cariostatic agents|mesh-ancestor
102609598|NCT03965039|Protective Agents|protective agents|mesh-ancestor
102609599|NCT03965039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609600|NCT03961295|Vedolizumab|vedolizumab|mesh-list
102609601|NCT03961295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102609602|NCT03935399|Oxytocin|oxytocin|mesh-list
102609603|NCT03935399|Oxytocics|oxytocics|mesh-ancestor
102609604|NCT03935399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102609605|NCT03935399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609606|NCT03571607|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102609607|NCT03571607|Immunologic Factors|immunologic factors|mesh-ancestor
102609608|NCT03571607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609609|NCT03993119|Anticoagulants|anticoagulants|mesh-list
102609610|NCT03910439|Avelumab|avelumab|mesh-list
102609611|NCT03910439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102609612|NCT03910439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102609613|NCT03895307|Anesthetics|anesthetics|mesh-list
102609614|NCT03895307|Anesthetics, Local|anesthetics, local|mesh-list
102609615|NCT03895307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102609616|NCT03895307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609617|NCT03895307|Sensory System Agents|sensory system agents|mesh-ancestor
102609618|NCT03895307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102609619|NCT03888755|Icatibant|icatibant|mesh-list
102609620|NCT03888755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102609621|NCT03888755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102609622|NCT03888755|Analgesics|analgesics|mesh-ancestor
102609623|NCT03888755|Sensory System Agents|sensory system agents|mesh-ancestor
102609624|NCT03888755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102609625|NCT03888755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609626|NCT03888755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102609627|NCT03888755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102609628|NCT03888755|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
102609629|NCT03888755|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
102609630|NCT03888755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609631|NCT03888755|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102609632|NCT03888755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102609633|NCT03888755|Immunologic Factors|immunologic factors|mesh-ancestor
102609634|NCT00378755|Bortezomib|bortezomib|mesh-list
102609635|NCT00378755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102609636|NCT00378833|Niacin|niacin|mesh-list
102609637|NCT00378833|Niacinamide|niacinamide|mesh-list
102609638|NCT00378833|Nicotinic Acids|nicotinic acids|mesh-list
102609639|NCT00378833|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102609640|NCT00378833|Antimetabolites|antimetabolites|mesh-ancestor
102609641|NCT00378833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609642|NCT00378833|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102609643|NCT00378833|Vasodilator Agents|vasodilator agents|mesh-ancestor
102609644|NCT00378833|Vitamin B Complex|vitamin b complex|mesh-ancestor
102609645|NCT00378833|Vitamins|vitamins|mesh-ancestor
102609646|NCT00378833|Micronutrients|micronutrients|mesh-ancestor
102609647|NCT00378833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609648|NCT02995967|Botulinum Toxins|botulinum toxins|mesh-list
102609649|NCT02995967|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102609650|NCT02995967|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102609651|NCT02995967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102609652|NCT02995967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102609653|NCT02995967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609654|NCT02995967|Cholinergic Agents|cholinergic agents|mesh-ancestor
102609655|NCT02995967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102609656|NCT02995967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609658|NCT02995967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102609659|NCT03888365|Treprostinil|treprostinil|mesh-list
102609660|NCT03888365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102609661|NCT00377975|Pioglitazone|pioglitazone|mesh-list
102609662|NCT00377975|Ephedrine|ephedrine|mesh-list
102609663|NCT00377975|Caffeine|caffeine|mesh-list
102609664|NCT00377975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102609665|NCT00377975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609666|NCT00377975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102609667|NCT00377975|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102609668|NCT00377975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102609669|NCT00377975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609670|NCT00377975|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102609671|NCT00377975|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102609672|NCT00377975|Purinergic Agents|purinergic agents|mesh-ancestor
102609673|NCT00377975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102609674|NCT00377975|Sympathomimetics|sympathomimetics|mesh-ancestor
102609675|NCT00377975|Autonomic Agents|autonomic agents|mesh-ancestor
102609676|NCT00377975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102609677|NCT00377975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102609678|NCT00377975|Adrenergic Agents|adrenergic agents|mesh-ancestor
102609679|NCT02994251|Gemcitabine|gemcitabine|mesh-list
102609680|NCT02994251|Doxorubicin|doxorubicin|mesh-list
102609681|NCT02994251|Mitomycins|mitomycins|mesh-list
102609682|NCT02994251|Mitomycin|mitomycin|mesh-list
102609683|NCT02994251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102609684|NCT02994251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102609685|NCT02994251|Antimetabolites|antimetabolites|mesh-ancestor
102609686|NCT02994251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609687|NCT02994251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102609688|NCT02994251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102609689|NCT02994251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102609690|NCT02994251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102609691|NCT02994251|Alkylating Agents|alkylating agents|mesh-ancestor
102609692|NCT02994251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102609693|NCT02936999|Vitamin D|vitamin d|mesh-list
102609694|NCT02936999|Cholecalciferol|cholecalciferol|mesh-list
102609695|NCT02936999|Vitamins|vitamins|mesh-ancestor
102609696|NCT02936999|Micronutrients|micronutrients|mesh-ancestor
102609697|NCT02936999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609698|NCT02936999|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102609699|NCT02936999|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102609700|NCT02826551|Bupivacaine|bupivacaine|mesh-list
102609701|NCT02826551|Anesthetics, Local|anesthetics, local|mesh-ancestor
102609702|NCT02826551|Anesthetics|anesthetics|mesh-ancestor
102609703|NCT02826551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102609704|NCT02826551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609705|NCT02826551|Sensory System Agents|sensory system agents|mesh-ancestor
102609706|NCT02826551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102609707|NCT00378443|Prednisone|prednisone|mesh-list
102609708|NCT00378443|Losartan|losartan|mesh-list
102609709|NCT00378443|Cilazapril|cilazapril|mesh-list
102346823|NCT03596424|Anesthetics|anesthetics|mesh-ancestor
102609710|NCT00378443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102609711|NCT00378443|Glucocorticoids|glucocorticoids|mesh-ancestor
102609712|NCT00378443|Hormones|hormones|mesh-ancestor
102609713|NCT00378443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102609714|NCT00378443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609715|NCT00378443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102609716|NCT00378443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102609717|NCT00378443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102609718|NCT00378443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102609719|NCT00378443|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102609720|NCT00378443|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102609721|NCT00378443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609722|NCT00378443|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102609723|NCT00378443|Protease Inhibitors|protease inhibitors|mesh-ancestor
102609724|NCT00378443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102609725|NCT01340573|Interferons|interferons|mesh-list
102609726|NCT01340573|Ribavirin|ribavirin|mesh-list
102609727|NCT01340573|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102609728|NCT01340573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102609729|NCT01340573|Antiviral Agents|antiviral agents|mesh-ancestor
102609730|NCT01340573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102609731|NCT01340573|Antimetabolites|antimetabolites|mesh-ancestor
102154359|NCT02237755|Enclomiphene|enclomiphene|mesh-list
102609732|NCT01340573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609733|NCT01340885|Rivastigmine|rivastigmine|mesh-list
102609734|NCT01340885|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102609735|NCT01340885|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102609736|NCT01340885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102609737|NCT01340885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102609738|NCT01340885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609739|NCT01340885|Adrenergic Agents|adrenergic agents|mesh-ancestor
102609740|NCT01340885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102609741|NCT01340885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609742|NCT01340885|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102609743|NCT01340885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102609744|NCT01340885|Cholinergic Agents|cholinergic agents|mesh-ancestor
102609745|NCT01340885|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102609746|NCT01340885|Protective Agents|protective agents|mesh-ancestor
102609747|NCT01326923|Cetuximab|cetuximab|mesh-list
102609748|NCT01326923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102609749|NCT01326923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102609750|NCT03855059|Dexamethasone|dexamethasone|mesh-list
102609751|NCT03855059|Dexamethasone acetate|dexamethasone acetate|mesh-list
102609752|NCT03855059|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102609753|NCT03855059|BB 1101|bb 1101|mesh-list
102609754|NCT03855059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102609755|NCT03855059|Antiemetics|antiemetics|mesh-ancestor
102609756|NCT03855059|Autonomic Agents|autonomic agents|mesh-ancestor
102609757|NCT03855059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102609758|NCT03855059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609759|NCT03855059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102609760|NCT03855059|Glucocorticoids|glucocorticoids|mesh-ancestor
102609761|NCT03855059|Hormones|hormones|mesh-ancestor
102609762|NCT03855059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102609763|NCT03855059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102609764|NCT03855059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102609765|NCT03855059|Protease Inhibitors|protease inhibitors|mesh-ancestor
102609766|NCT03855059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102609767|NCT03855059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609768|NCT01301963|Plerixafor|plerixafor|mesh-list
102609769|NCT01301963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102609770|NCT01301963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102609771|NCT01301963|Antiviral Agents|antiviral agents|mesh-ancestor
102609772|NCT01301963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102609773|NCT01262339|Botulinum Toxins|botulinum toxins|mesh-list
102609774|NCT01262339|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102609775|NCT01262339|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102609776|NCT01262339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102609777|NCT01262339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609778|NCT01262339|Cholinergic Agents|cholinergic agents|mesh-ancestor
102609779|NCT01262339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102609780|NCT01262339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609781|NCT01262339|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102609782|NCT01262339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102609783|NCT02708849|Lamotrigine|lamotrigine|mesh-list
102609784|NCT02708849|Ketamine|ketamine|mesh-list
102609785|NCT02708849|Analgesics|analgesics|mesh-ancestor
102609786|NCT02708849|Sensory System Agents|sensory system agents|mesh-ancestor
102609787|NCT02708849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102609788|NCT02708849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609789|NCT02708849|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102609790|NCT02708849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102609791|NCT02708849|Anesthetics, General|anesthetics, general|mesh-ancestor
102609792|NCT02708849|Anesthetics|anesthetics|mesh-ancestor
102609793|NCT02708849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102609794|NCT02708849|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102609795|NCT02708849|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102609796|NCT02708849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102609797|NCT02708849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609798|NCT02708849|Anticonvulsants|anticonvulsants|mesh-ancestor
102609799|NCT02708849|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102609800|NCT02708849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102609801|NCT02708849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102609802|NCT02708849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102609803|NCT02708849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102609804|NCT02708849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102609805|NCT02708849|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102609807|NCT01222871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102609808|NCT01222871|Glucocorticoids|glucocorticoids|mesh-ancestor
102609809|NCT01222871|Hormones|hormones|mesh-ancestor
102609810|NCT01222871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102609811|NCT01222871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609812|NCT01219673|Minocycline|minocycline|mesh-list
102609813|NCT01219673|Modafinil|modafinil|mesh-list
102609814|NCT01219673|Bupropion|bupropion|mesh-list
102609815|NCT01219673|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102609816|NCT01219673|Antidepressive Agents|antidepressive agents|mesh-ancestor
102609817|NCT01219673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102609818|NCT01219673|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102609819|NCT01219673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102609820|NCT01219673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102609821|NCT01219673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609822|NCT01219673|Dopamine Agents|dopamine agents|mesh-ancestor
102609823|NCT01219673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102609824|NCT01219673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609825|NCT01219673|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102609826|NCT01219673|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102609827|NCT01219673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102609828|NCT01219673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102609829|NCT01219673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102609830|NCT01219673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102609831|NCT01219673|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102609832|NCT01219673|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102609833|NCT01219673|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102609834|NCT01216631|Methylprednisolone|methylprednisolone|mesh-list
102609835|NCT01216631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102609836|NCT01216631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102609837|NCT01216631|Prednisolone|prednisolone|mesh-list
102609838|NCT01216631|Prednisolone acetate|prednisolone acetate|mesh-list
102609839|NCT01216631|Infliximab|infliximab|mesh-list
102609840|NCT01216631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102609841|NCT01216631|Prednisolone phosphate|prednisolone phosphate|mesh-list
102609842|NCT01216631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102609843|NCT01216631|Antiemetics|antiemetics|mesh-ancestor
102609844|NCT01216631|Autonomic Agents|autonomic agents|mesh-ancestor
102609845|NCT01216631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102609846|NCT01216631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609847|NCT01216631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102609848|NCT01216631|Glucocorticoids|glucocorticoids|mesh-ancestor
102609849|NCT01216631|Hormones|hormones|mesh-ancestor
102609850|NCT01216631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102609851|NCT01216631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102609852|NCT01216631|Protective Agents|protective agents|mesh-ancestor
102609853|NCT01216631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101876590|NCT01081002|Anesthetics|anesthetics|mesh-ancestor
102609854|NCT01216631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102609855|NCT01216631|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102609856|NCT01216631|Dermatologic Agents|dermatologic agents|mesh-ancestor
102609857|NCT01216631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102609858|NCT02693717|Pemetrexed|pemetrexed|mesh-list
102609859|NCT02693717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102609860|NCT02693717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102609861|NCT02693717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609862|NCT02693717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102609863|NCT02693717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102609864|NCT03860753|Pioglitazone|pioglitazone|mesh-list
102609865|NCT03860753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102609866|NCT03860753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609867|NCT02687165|Cycloserine|cycloserine|mesh-list
102609868|NCT02687165|Milnacipran|milnacipran|mesh-list
102609869|NCT02687165|Levomilnacipran|levomilnacipran|mesh-list
102609870|NCT02687165|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102609871|NCT02687165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102609872|NCT02687165|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102609873|NCT02687165|Antitubercular Agents|antitubercular agents|mesh-ancestor
102609874|NCT02687165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102609875|NCT02687165|Antimetabolites|antimetabolites|mesh-ancestor
102609876|NCT02687165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609877|NCT02687165|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102609878|NCT02687165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102609879|NCT02687165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102609880|NCT02687165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102609881|NCT02687165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609882|NCT02687165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102609883|NCT02687165|Analgesics|analgesics|mesh-ancestor
102609884|NCT02687165|Sensory System Agents|sensory system agents|mesh-ancestor
102609885|NCT02687165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102609886|NCT02687165|Antidepressive Agents|antidepressive agents|mesh-ancestor
102609887|NCT02687165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102609888|NCT01169753|Modafinil|modafinil|mesh-list
102609889|NCT01169753|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102609890|NCT01169753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609891|NCT01169753|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102609892|NCT01169753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102609893|NCT01169753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102609894|NCT01169753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609895|NCT02654639|Bevacizumab|bevacizumab|mesh-list
102609896|NCT02654639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102609897|NCT02654639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102609898|NCT02654639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102609899|NCT02654639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102609900|NCT02654639|Growth Substances|growth substances|mesh-ancestor
102609901|NCT02654639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609902|NCT02654639|Growth Inhibitors|growth inhibitors|mesh-ancestor
102609903|NCT02634827|Decitabine|decitabine|mesh-list
102609904|NCT02634827|Midostaurin|midostaurin|mesh-list
102609905|NCT02634827|Staurosporine|staurosporine|mesh-list
102609906|NCT02634827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102609907|NCT02634827|Antimetabolites|antimetabolites|mesh-ancestor
102609908|NCT02634827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609909|NCT02634827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102609910|NCT02634827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102609911|NCT02634827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102609912|NCT02506985|Warfarin|warfarin|mesh-list
102609913|NCT02506985|Rivaroxaban|rivaroxaban|mesh-list
102609914|NCT02506985|Anticoagulants|anticoagulants|mesh-ancestor
102609915|NCT02506985|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102609916|NCT02506985|Antithrombins|antithrombins|mesh-ancestor
102609917|NCT02506985|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102609918|NCT02506985|Protease Inhibitors|protease inhibitors|mesh-ancestor
102609919|NCT02506985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102609920|NCT02506985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609921|NCT01150409|Hydrocortisone|hydrocortisone|mesh-list
102609922|NCT01150409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102609923|NCT01133639|Ketorolac|ketorolac|mesh-list
101876660|NCT00143312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102609924|NCT01133639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102609925|NCT01133639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102609926|NCT01133639|Analgesics|analgesics|mesh-ancestor
102609927|NCT01133639|Sensory System Agents|sensory system agents|mesh-ancestor
102609928|NCT01133639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102609929|NCT01133639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609930|NCT01133639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102609931|NCT01133639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102609932|NCT01133639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102609933|NCT01133639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102609934|NCT01133639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609935|NCT00378911|Sunitinib|sunitinib|mesh-list
102609936|NCT00378911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102609937|NCT00378911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102609938|NCT00378911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102609939|NCT00378911|Growth Substances|growth substances|mesh-ancestor
102609940|NCT00378911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609941|NCT00378911|Growth Inhibitors|growth inhibitors|mesh-ancestor
102609942|NCT00378911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102609943|NCT00378911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102609944|NCT00378911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609945|NCT03822377|Ticagrelor|ticagrelor|mesh-list
102609946|NCT03822377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102609947|NCT03822377|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102609948|NCT03822377|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102609949|NCT03822377|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102609950|NCT03822377|Purinergic Agents|purinergic agents|mesh-ancestor
102609951|NCT03822377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102609952|NCT03822377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609953|NCT03822377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609954|NCT02501759|Pentetic Acid|pentetic acid|mesh-list
102609955|NCT02501759|Antidotes|antidotes|mesh-ancestor
102609956|NCT02501759|Protective Agents|protective agents|mesh-ancestor
102609957|NCT02501759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609958|NCT02501759|Chelating Agents|chelating agents|mesh-ancestor
102609959|NCT02501759|Sequestering Agents|sequestering agents|mesh-ancestor
102609960|NCT02501759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609961|NCT02501759|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102609962|NCT02499887|Prednisone|prednisone|mesh-list
102609963|NCT02499887|Albuterol|albuterol|mesh-list
102609964|NCT02499887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102609965|NCT02499887|Glucocorticoids|glucocorticoids|mesh-ancestor
102609966|NCT02499887|Hormones|hormones|mesh-ancestor
102609967|NCT02499887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102609968|NCT02499887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102609969|NCT02499887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102609970|NCT02499887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102609971|NCT02499887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102609972|NCT02499887|Autonomic Agents|autonomic agents|mesh-ancestor
102609973|NCT02499887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102609974|NCT02499887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102609975|NCT02499887|Respiratory System Agents|respiratory system agents|mesh-ancestor
102609976|NCT02499887|Tocolytic Agents|tocolytic agents|mesh-ancestor
102609977|NCT02499887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102609978|NCT02499887|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102609979|NCT02499887|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102609980|NCT02499887|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102609981|NCT02499887|Adrenergic Agents|adrenergic agents|mesh-ancestor
102609982|NCT02499887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102609983|NCT02499887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609984|NCT02504099|Ritonavir|ritonavir|mesh-list
102609985|NCT02504099|Ribavirin|ribavirin|mesh-list
102609986|NCT02504099|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102609987|NCT02504099|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102609988|NCT02504099|Protease Inhibitors|protease inhibitors|mesh-ancestor
102609989|NCT02504099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102609990|NCT02504099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102609991|NCT02504099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102609992|NCT02504099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102609993|NCT02504099|Antiviral Agents|antiviral agents|mesh-ancestor
102609994|NCT02504099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102609995|NCT02504099|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102609996|NCT02504099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102609997|NCT02504099|Antimetabolites|antimetabolites|mesh-ancestor
102609998|NCT02450591|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102609999|NCT02450591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102610000|NCT02450591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102610001|NCT02450591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102610002|NCT02450591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610003|NCT01094561|Secretin|secretin|mesh-list
102610004|NCT01094561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102610005|NCT01094561|Hormones|hormones|mesh-ancestor
102610006|NCT01094561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102610007|NCT01094561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610008|NCT01074437|Prednisolone|prednisolone|mesh-list
102610009|NCT01074437|Propranolol|propranolol|mesh-list
102610010|NCT01074437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102610011|NCT01074437|Glucocorticoids|glucocorticoids|mesh-ancestor
102610012|NCT01074437|Hormones|hormones|mesh-ancestor
102610013|NCT01074437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102610014|NCT01074437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610015|NCT01074437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102610016|NCT01074437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102610017|NCT01074437|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102610018|NCT01074437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102610019|NCT01074437|Adrenergic Agents|adrenergic agents|mesh-ancestor
102610020|NCT01074437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102610021|NCT01074437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610022|NCT01074437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102610023|NCT01074437|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102610024|NCT01074437|Vasodilator Agents|vasodilator agents|mesh-ancestor
102610025|NCT03807245|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102610026|NCT03807245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102610027|NCT03807245|Immunologic Factors|immunologic factors|mesh-ancestor
102610028|NCT03807245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610030|NCT03807245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610031|NCT03807245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102610032|NCT03796013|Entrectinib|entrectinib|mesh-list
102610033|NCT03796013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102610034|NCT03796013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102610035|NCT03796013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610036|NCT03793751|Dexmedetomidine|dexmedetomidine|mesh-list
102610037|NCT03793751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102610038|NCT03793751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102610039|NCT03793751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610040|NCT03793751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102610041|NCT03793751|Analgesics|analgesics|mesh-ancestor
102610042|NCT03793751|Sensory System Agents|sensory system agents|mesh-ancestor
102610043|NCT03793751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102610044|NCT03793751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102610045|NCT03793751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102610046|NCT03793751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102610047|NCT03793751|Adrenergic Agents|adrenergic agents|mesh-ancestor
102610048|NCT03793751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102610049|NCT03793751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610050|NCT02351063|Angiotensin II|angiotensin ii|mesh-list
102610051|NCT02351063|Diuretics|diuretics|mesh-list
102610052|NCT02351063|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102610053|NCT02351063|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
102610054|NCT02351063|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
102610055|NCT02351063|Natriuretic Agents|natriuretic agents|mesh-ancestor
102610056|NCT02351063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610057|NCT02351063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610058|NCT02351063|Protease Inhibitors|protease inhibitors|mesh-ancestor
102610059|NCT02351063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102610060|NCT02351063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102610061|NCT02351063|Hormone Antagonists|hormone antagonists|mesh-ancestor
102610062|NCT02351063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102610063|NCT02351063|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102610064|NCT01016561|Cisplatin|cisplatin|mesh-list
102610065|NCT01016561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102610066|NCT01009931|Dexamethasone|dexamethasone|mesh-list
102610067|NCT01009931|Dexamethasone acetate|dexamethasone acetate|mesh-list
102610068|NCT01009931|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
102610069|NCT01009931|Choline|choline|mesh-list
102610070|NCT01009931|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102610071|NCT01009931|BB 1101|bb 1101|mesh-list
102610072|NCT01009931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102610073|NCT01009931|Antiemetics|antiemetics|mesh-ancestor
102610074|NCT01009931|Autonomic Agents|autonomic agents|mesh-ancestor
102610075|NCT01009931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102610076|NCT01009931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610077|NCT01009931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102610078|NCT01009931|Glucocorticoids|glucocorticoids|mesh-ancestor
102610079|NCT01009931|Hormones|hormones|mesh-ancestor
102610080|NCT01009931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102610081|NCT01009931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102610082|NCT01009931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102610083|NCT01009931|Protease Inhibitors|protease inhibitors|mesh-ancestor
102610084|NCT01009931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102610085|NCT01009931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610086|NCT01009931|Lipotropic Agents|lipotropic agents|mesh-ancestor
102610087|NCT01009931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102610088|NCT01009931|Antimetabolites|antimetabolites|mesh-ancestor
102610089|NCT01009931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102610090|NCT01009931|Nootropic Agents|nootropic agents|mesh-ancestor
102610091|NCT01009931|Analgesics|analgesics|mesh-ancestor
102610092|NCT01009931|Sensory System Agents|sensory system agents|mesh-ancestor
102610093|NCT01009931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102610094|NCT01009931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102610095|NCT01009931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102610096|NCT03792191|Fentanyl|fentanyl|mesh-list
102610097|NCT03792191|Bupivacaine|bupivacaine|mesh-list
102610098|NCT03792191|Anesthetics, Local|anesthetics, local|mesh-ancestor
102610099|NCT03792191|Anesthetics|anesthetics|mesh-ancestor
102610100|NCT03792191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102610101|NCT03792191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610102|NCT03792191|Sensory System Agents|sensory system agents|mesh-ancestor
102610103|NCT03792191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102610104|NCT03792191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102610105|NCT03792191|Narcotics|narcotics|mesh-ancestor
102610106|NCT03792191|Analgesics|analgesics|mesh-ancestor
102610107|NCT03792191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102610108|NCT03792191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102610109|NCT03792191|Anesthetics, General|anesthetics, general|mesh-ancestor
102610110|NCT00986999|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102610111|NCT00986999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102610112|NCT00986999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102610113|NCT00986999|Antimetabolites|antimetabolites|mesh-ancestor
102610114|NCT00986999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610115|NCT00986999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102610116|NCT00986999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102610117|NCT00986999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102610118|NCT00983645|Cyclosporine|cyclosporine|mesh-list
102610119|NCT00983645|Tacrolimus|tacrolimus|mesh-list
102610120|NCT00983645|Cyclosporins|cyclosporins|mesh-list
102610121|NCT00983645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102610122|NCT00983645|Immunologic Factors|immunologic factors|mesh-ancestor
102610123|NCT00983645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610124|NCT00983645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102610125|NCT00983645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102610126|NCT00983645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610127|NCT00983645|Antifungal Agents|antifungal agents|mesh-ancestor
102610128|NCT00983645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102610129|NCT00983645|Dermatologic Agents|dermatologic agents|mesh-ancestor
102610130|NCT00983645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102610131|NCT00978419|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102610132|NCT00978419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102610133|NCT00978419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102610134|NCT00978419|Antimetabolites|antimetabolites|mesh-ancestor
102369683|NCT04450134|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102610135|NCT00978419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610136|NCT00978419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102610137|NCT00978419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102610138|NCT00978419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102610139|NCT00957827|Cephalexin|cephalexin|mesh-list
102610140|NCT00957827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102610141|NCT00957827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102610142|NCT00962429|Thioctic Acid|thioctic acid|mesh-list
102610143|NCT00962429|Antioxidants|antioxidants|mesh-ancestor
102610144|NCT00962429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610145|NCT00962429|Protective Agents|protective agents|mesh-ancestor
102610146|NCT00962429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610147|NCT00962429|Vitamin B Complex|vitamin b complex|mesh-ancestor
102610148|NCT00962429|Vitamins|vitamins|mesh-ancestor
102610149|NCT00962429|Micronutrients|micronutrients|mesh-ancestor
102610150|NCT00949403|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
102610151|NCT00949403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610152|NCT00920309|Sirolimus|sirolimus|mesh-list
102610153|NCT00920309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102610154|NCT00920309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102610155|NCT00920309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102610156|NCT00920309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102610157|NCT00920309|Antifungal Agents|antifungal agents|mesh-ancestor
102610158|NCT00920309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102610159|NCT00920309|Immunologic Factors|immunologic factors|mesh-ancestor
102610160|NCT00920309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610161|NCT02075411|Bupivacaine|bupivacaine|mesh-list
102610162|NCT02075411|Anesthetics, Local|anesthetics, local|mesh-ancestor
102610163|NCT02075411|Anesthetics|anesthetics|mesh-ancestor
102610164|NCT02075411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102610165|NCT02075411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610166|NCT02075411|Sensory System Agents|sensory system agents|mesh-ancestor
102610167|NCT02075411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102610168|NCT03753113|Minoxidil|minoxidil|mesh-list
102610169|NCT03753113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102610170|NCT03753113|Vasodilator Agents|vasodilator agents|mesh-ancestor
102610171|NCT02075021|Paclitaxel|paclitaxel|mesh-list
102610172|NCT02075021|Lenalidomide|lenalidomide|mesh-list
102610173|NCT02075021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102610174|NCT02075021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102154360|NCT02237755|Zuclomiphene|zuclomiphene|mesh-list
102610175|NCT02075021|Tubulin Modulators|tubulin modulators|mesh-ancestor
102610176|NCT02075021|Antimitotic Agents|antimitotic agents|mesh-ancestor
102610177|NCT02075021|Mitosis Modulators|mitosis modulators|mesh-ancestor
102610178|NCT02075021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610179|NCT02075021|Immunologic Factors|immunologic factors|mesh-ancestor
102610180|NCT02075021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610181|NCT02075021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102610182|NCT02075021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102610183|NCT02075021|Growth Substances|growth substances|mesh-ancestor
102610184|NCT02075021|Growth Inhibitors|growth inhibitors|mesh-ancestor
102610185|NCT02057237|Mitotane|mitotane|mesh-list
102610186|NCT02057237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102610187|NCT02057237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102610188|NCT00378677|Cyclosporine|cyclosporine|mesh-list
102610189|NCT00378677|Cyclosporins|cyclosporins|mesh-list
102610190|NCT00378677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102610191|NCT00378677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610192|NCT00378677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102610193|NCT00378677|Immunologic Factors|immunologic factors|mesh-ancestor
102610194|NCT00378677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610195|NCT00378677|Antifungal Agents|antifungal agents|mesh-ancestor
102610196|NCT00378677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102610197|NCT00378677|Dermatologic Agents|dermatologic agents|mesh-ancestor
102610198|NCT00378677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102610199|NCT00378677|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102610200|NCT00850421|Botulinum Toxins|botulinum toxins|mesh-list
102610201|NCT00850421|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102610202|NCT00850421|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102610203|NCT00850421|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102610204|NCT00850421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102610205|NCT00850421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610206|NCT00850421|Cholinergic Agents|cholinergic agents|mesh-ancestor
102610207|NCT00850421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101876943|NCT00139776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102610208|NCT00850421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610209|NCT00850421|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102610210|NCT00850421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102610211|NCT02017379|Erythromycin|erythromycin|mesh-list
102610212|NCT02017379|Erythromycin Estolate|erythromycin estolate|mesh-list
102610213|NCT02017379|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
102610214|NCT02017379|Erythromycin stearate|erythromycin stearate|mesh-list
102610215|NCT02017379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102610216|NCT02017379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102610217|NCT02017379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102610218|NCT02017379|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102610219|NCT02017379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102610220|NCT02017379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610221|NCT01997567|Ropivacaine|ropivacaine|mesh-list
102610222|NCT01997567|Anesthetics, Local|anesthetics, local|mesh-ancestor
102610223|NCT01997567|Anesthetics|anesthetics|mesh-ancestor
102610224|NCT01997567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102610225|NCT01997567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610226|NCT01997567|Sensory System Agents|sensory system agents|mesh-ancestor
102610227|NCT01997567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102610228|NCT00825227|Modafinil|modafinil|mesh-list
102610229|NCT00825227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102610230|NCT00825227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610231|NCT00825227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102610232|NCT00825227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102610233|NCT00825227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102610234|NCT00825227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610235|NCT01978535|Iron|iron|mesh-list
102610236|NCT01978535|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102610237|NCT01978535|Trace Elements|trace elements|mesh-ancestor
102610238|NCT01978535|Micronutrients|micronutrients|mesh-ancestor
102610239|NCT01978535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610240|NCT01978535|Hematinics|hematinics|mesh-ancestor
102610241|NCT00808769|Omeprazole|omeprazole|mesh-list
102610242|NCT00808769|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
102610243|NCT00808769|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102610244|NCT00808769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102610245|NCT00808769|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102610246|NCT00808769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102610247|NCT00808769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610248|NCT00379067|Tamsulosin|tamsulosin|mesh-list
102610249|NCT00379067|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102610250|NCT00379067|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102610252|NCT00379067|Adrenergic Agents|adrenergic agents|mesh-ancestor
102610253|NCT00379067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102610254|NCT00379067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610255|NCT00379067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610256|NCT00379067|Urological Agents|urological agents|mesh-ancestor
102610257|NCT00378287|Rabeprazole|rabeprazole|mesh-list
102610258|NCT00378287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102610259|NCT00378287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102610260|NCT00378287|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102610261|NCT00378287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102610262|NCT00378287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610263|NCT01938833|Paclitaxel|paclitaxel|mesh-list
102610264|NCT01938833|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102610265|NCT01938833|Romidepsin|romidepsin|mesh-list
102610266|NCT01938833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102610267|NCT01938833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102610268|NCT01938833|Tubulin Modulators|tubulin modulators|mesh-ancestor
102610269|NCT01938833|Antimitotic Agents|antimitotic agents|mesh-ancestor
102610270|NCT01938833|Mitosis Modulators|mitosis modulators|mesh-ancestor
102610271|NCT01938833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610272|NCT01938833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102610273|NCT01938833|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102610274|NCT01938833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102610275|NCT01893359|Riboflavin|riboflavin|mesh-list
102610276|NCT01893359|Dextrans|dextrans|mesh-list
102610277|NCT01893359|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102610278|NCT01893359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102610279|NCT01893359|Vitamin B Complex|vitamin b complex|mesh-ancestor
102610280|NCT01893359|Vitamins|vitamins|mesh-ancestor
102610281|NCT01893359|Micronutrients|micronutrients|mesh-ancestor
102610282|NCT01893359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610283|NCT01893359|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102610284|NCT01893359|Dermatologic Agents|dermatologic agents|mesh-ancestor
102610285|NCT01893359|Anticoagulants|anticoagulants|mesh-ancestor
102610286|NCT01893359|Plasma Substitutes|plasma substitutes|mesh-ancestor
102610287|NCT01893359|Blood Substitutes|blood substitutes|mesh-ancestor
102610288|NCT00795665|Bevacizumab|bevacizumab|mesh-list
102610289|NCT00795665|Carmustine|carmustine|mesh-list
102610290|NCT00795665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102610291|NCT00795665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102610292|NCT00795665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102610293|NCT00795665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102610294|NCT00795665|Growth Substances|growth substances|mesh-ancestor
102610295|NCT00795665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610296|NCT00795665|Growth Inhibitors|growth inhibitors|mesh-ancestor
102610297|NCT00795665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102610298|NCT00795665|Alkylating Agents|alkylating agents|mesh-ancestor
102610299|NCT00795665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610300|NCT00791843|Hormones|hormones|mesh-list
102610301|NCT00791843|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
102610302|NCT00791843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102610303|NCT00791843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610304|NCT01836809|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
102610305|NCT01836809|Natriuretic Agents|natriuretic agents|mesh-ancestor
102610306|NCT01836809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610307|NCT00780455|Interferons|interferons|mesh-list
102610308|NCT00780455|Interferon-beta|interferon-beta|mesh-list
102610309|NCT00780455|Interferon beta-1b|interferon beta-1b|mesh-list
102610310|NCT00780455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102610311|NCT00780455|Antiviral Agents|antiviral agents|mesh-ancestor
102610312|NCT00780455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102610313|NCT00780455|Immunologic Factors|immunologic factors|mesh-ancestor
102610314|NCT00780455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610315|NCT00780455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102610316|NCT00755261|Bevacizumab|bevacizumab|mesh-list
102610317|NCT00755261|Doxorubicin|doxorubicin|mesh-list
102610318|NCT00755261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102610319|NCT00755261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102610320|NCT00755261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102610321|NCT00755261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102610322|NCT00755261|Growth Substances|growth substances|mesh-ancestor
102610323|NCT00755261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610324|NCT00755261|Growth Inhibitors|growth inhibitors|mesh-ancestor
102610325|NCT00755261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102610326|NCT00755261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102610327|NCT00755261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102610328|NCT00755261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102610329|NCT00755261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610330|NCT03724877|Cholinergic Agents|cholinergic agents|mesh-list
102610331|NCT03724877|Muscarinic Antagonists|muscarinic antagonists|mesh-list
102610332|NCT03724877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102610333|NCT03724877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610334|NCT03724877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610335|NCT03724877|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102610336|NCT00746603|Simvastatin|simvastatin|mesh-list
102610337|NCT00746603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102610338|NCT00746603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102610339|NCT00746603|Antimetabolites|antimetabolites|mesh-ancestor
102610340|NCT00746603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610341|NCT00746603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102610342|NCT00746603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102610343|NCT00746603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102610344|NCT04713527|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102610345|NCT04713527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102610346|NCT00716807|Nalbuphine|nalbuphine|mesh-list
102610347|NCT00716807|Naloxone|naloxone|mesh-list
102610348|NCT00716807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102610349|NCT00716807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610350|NCT00716807|Sensory System Agents|sensory system agents|mesh-ancestor
102610351|NCT00716807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102610352|NCT00716807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102610353|NCT00716807|Narcotics|narcotics|mesh-ancestor
102610354|NCT00716807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102610355|NCT00716807|Analgesics|analgesics|mesh-ancestor
102610356|NCT03426137|Ketorolac|ketorolac|mesh-list
102610357|NCT03426137|Oxycodone|oxycodone|mesh-list
102610358|NCT03426137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102610359|NCT03426137|Narcotics|narcotics|mesh-ancestor
102610360|NCT03426137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102610361|NCT03426137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610362|NCT03426137|Analgesics|analgesics|mesh-ancestor
102610363|NCT03426137|Sensory System Agents|sensory system agents|mesh-ancestor
102610364|NCT03426137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102610365|NCT03426137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102610366|NCT03426137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102610367|NCT03426137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102610368|NCT03426137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102610369|NCT03426137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102610370|NCT03426137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102610371|NCT03426137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610372|NCT01760993|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102610373|NCT01760993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102610374|NCT01760993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610375|NCT01760993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102610376|NCT01760993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102610377|NCT01760993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102610378|NCT01760993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610379|NCT01760993|Dopamine Agents|dopamine agents|mesh-ancestor
102610380|NCT01760993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102610381|NCT00669461|Lubiprostone|lubiprostone|mesh-list
102610382|NCT00669461|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102610383|NCT00669461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102610384|NCT00669461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610385|NCT00673595|Varenicline|varenicline|mesh-list
102610386|NCT00673595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102610387|NCT00673595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102610388|NCT00673595|Cholinergic Agents|cholinergic agents|mesh-ancestor
102610389|NCT00673595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102610390|NCT00673595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610391|NCT00673595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610392|NCT03248141|Factor VIII|factor viii|mesh-list
102610393|NCT03248141|Coagulants|coagulants|mesh-ancestor
102610394|NCT00378365|Arsenic Trioxide|arsenic trioxide|mesh-list
102610395|NCT00378365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102610396|NCT05313425|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102610397|NCT05313425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102610398|NCT01754987|Ascorbic Acid|ascorbic acid|mesh-list
102610399|NCT01754987|Sorafenib|sorafenib|mesh-list
102610401|NCT01754987|Micronutrients|micronutrients|mesh-ancestor
102610402|NCT01754987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610403|NCT01754987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102610404|NCT01754987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102610405|NCT01754987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102610406|NCT01754987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610408|NCT01754987|Protective Agents|protective agents|mesh-ancestor
102610409|NCT00652457|Memantine|memantine|mesh-list
102610410|NCT00652457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102610411|NCT00652457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102610412|NCT00652457|Dopamine Agents|dopamine agents|mesh-ancestor
102610413|NCT00652457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102610414|NCT00652457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610415|NCT00652457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610416|NCT00652457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102610417|NCT00652457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102610418|NCT00625703|Linezolid|linezolid|mesh-list
102610419|NCT00625703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102610420|NCT00625703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102610421|NCT00625703|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102610422|NCT00625703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102610423|NCT00625703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610424|NCT00616577|Ropivacaine|ropivacaine|mesh-list
102610425|NCT00616577|Anesthetics, Local|anesthetics, local|mesh-ancestor
102610426|NCT00616577|Anesthetics|anesthetics|mesh-ancestor
102610427|NCT00616577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102610428|NCT00616577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610429|NCT00616577|Sensory System Agents|sensory system agents|mesh-ancestor
102610430|NCT00616577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102610431|NCT00616343|Zonisamide|zonisamide|mesh-list
102610432|NCT00616343|Anticonvulsants|anticonvulsants|mesh-ancestor
102610433|NCT00616343|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102610434|NCT00616343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102610435|NCT00616343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610436|NCT00616343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102610437|NCT00616343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610438|NCT05599919|Nitric Oxide|nitric oxide|mesh-list
102610439|NCT05599919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102610440|NCT05599919|Autonomic Agents|autonomic agents|mesh-ancestor
102610441|NCT05599919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102610442|NCT05599919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610443|NCT05599919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102610444|NCT05599919|Respiratory System Agents|respiratory system agents|mesh-ancestor
102610445|NCT05599919|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102610446|NCT05599919|Antioxidants|antioxidants|mesh-ancestor
102610447|NCT05599919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610448|NCT05599919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102610449|NCT05599919|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102610450|NCT05599919|Vasodilator Agents|vasodilator agents|mesh-ancestor
102610451|NCT05599919|Gasotransmitters|gasotransmitters|mesh-ancestor
102610452|NCT05599919|Protective Agents|protective agents|mesh-ancestor
102610453|NCT05599841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102610454|NCT01645709|Verapamil|verapamil|mesh-list
102610455|NCT01645709|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102610456|NCT01645709|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102610457|NCT01645709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102610458|NCT01645709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610459|NCT01645709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102610460|NCT01645709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610461|NCT01645709|Vasodilator Agents|vasodilator agents|mesh-ancestor
102610462|NCT00608465|Ramipril|ramipril|mesh-list
102610463|NCT00608465|Eplerenone|eplerenone|mesh-list
102610464|NCT00608465|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102610465|NCT00608465|Protease Inhibitors|protease inhibitors|mesh-ancestor
102610466|NCT00608465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102610467|NCT00608465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610468|NCT00608465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102610469|NCT00608465|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102610470|NCT00608465|Hormone Antagonists|hormone antagonists|mesh-ancestor
102154361|NCT02237755|Anticoagulants|anticoagulants|mesh-ancestor
102610471|NCT00608465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102610472|NCT00608465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610473|NCT00608465|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102610475|NCT00608465|Natriuretic Agents|natriuretic agents|mesh-ancestor
102610476|NCT00608777|Betamethasone|betamethasone|mesh-list
102610477|NCT00608777|Calcipotriene|calcipotriene|mesh-list
102610478|NCT00608777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102610479|NCT00608777|Glucocorticoids|glucocorticoids|mesh-ancestor
102610480|NCT00608777|Hormones|hormones|mesh-ancestor
102610481|NCT00608777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102610482|NCT00608777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610483|NCT00608777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102610484|NCT00608777|Respiratory System Agents|respiratory system agents|mesh-ancestor
102610485|NCT00608777|Dermatologic Agents|dermatologic agents|mesh-ancestor
102610486|NCT00379457|Dactinomycin|dactinomycin|mesh-list
102610487|NCT00379457|Cyclophosphamide|cyclophosphamide|mesh-list
102610488|NCT00379457|Ifosfamide|ifosfamide|mesh-list
102610489|NCT00379457|Carboplatin|carboplatin|mesh-list
102610490|NCT00379457|Doxorubicin|doxorubicin|mesh-list
102610491|NCT00379457|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102610492|NCT00379457|Etoposide|etoposide|mesh-list
102610493|NCT00379457|Vincristine|vincristine|mesh-list
102610494|NCT00379457|Topotecan|topotecan|mesh-list
102610495|NCT00379457|Vinorelbine|vinorelbine|mesh-list
102610496|NCT00379457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102610497|NCT00379457|Immunologic Factors|immunologic factors|mesh-ancestor
102610498|NCT00379457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610499|NCT00379457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102610500|NCT00379457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102610501|NCT00379457|Alkylating Agents|alkylating agents|mesh-ancestor
102610502|NCT00379457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610503|NCT00379457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102610504|NCT00379457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102610505|NCT00379457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102610506|NCT00379457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102610507|NCT00379457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102610508|NCT00379457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102610509|NCT00379457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102610510|NCT00379457|Tubulin Modulators|tubulin modulators|mesh-ancestor
102610511|NCT00379457|Antimitotic Agents|antimitotic agents|mesh-ancestor
102610512|NCT00379457|Mitosis Modulators|mitosis modulators|mesh-ancestor
102610513|NCT00379457|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102610514|NCT00379457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102610515|NCT00379457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102610516|NCT00379457|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102610517|NCT00379457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102610518|NCT01629329|Aspirin|aspirin|mesh-list
102610519|NCT01629329|Acetaminophen|acetaminophen|mesh-list
102610520|NCT01629329|Prochlorperazine|prochlorperazine|mesh-list
102610521|NCT01629329|Caffeine|caffeine|mesh-list
102610522|NCT01629329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102610523|NCT01629329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102610524|NCT01629329|Analgesics|analgesics|mesh-ancestor
102610525|NCT01629329|Sensory System Agents|sensory system agents|mesh-ancestor
102610526|NCT01629329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102610527|NCT01629329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610528|NCT01629329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102610529|NCT01629329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102610530|NCT01629329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102610531|NCT01629329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102610532|NCT01629329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610533|NCT01629329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102610534|NCT01629329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102610535|NCT01629329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102610536|NCT01629329|Antipyretics|antipyretics|mesh-ancestor
102610537|NCT01629329|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102610538|NCT01629329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102610539|NCT01629329|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102610540|NCT01629329|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102610541|NCT01629329|Purinergic Agents|purinergic agents|mesh-ancestor
102610542|NCT01629329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102610543|NCT01629329|Antiemetics|antiemetics|mesh-ancestor
102610544|NCT01629329|Autonomic Agents|autonomic agents|mesh-ancestor
102610545|NCT01629329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102610546|NCT01629329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102610547|NCT01629329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102610548|NCT01629329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102610549|NCT01629329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102610550|NCT01629329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102610551|NCT01629329|Dopamine Agents|dopamine agents|mesh-ancestor
102610552|NCT01606709|Leuprolide|leuprolide|mesh-list
102610553|NCT01606709|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102610554|NCT01606709|Fertility Agents|fertility agents|mesh-ancestor
102610555|NCT01606709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102610556|NCT01606709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610557|NCT01606709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102610558|NCT01606709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102610559|NCT00423059|Bevacizumab|bevacizumab|mesh-list
102610560|NCT00423059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102610561|NCT00423059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102610562|NCT00423059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102610563|NCT00423059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102610564|NCT00423059|Growth Substances|growth substances|mesh-ancestor
102610565|NCT00423059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610566|NCT00423059|Growth Inhibitors|growth inhibitors|mesh-ancestor
102610567|NCT00585611|Atorvastatin|atorvastatin|mesh-list
102610568|NCT00585611|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102610569|NCT00585611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102610570|NCT00585611|Antimetabolites|antimetabolites|mesh-ancestor
102610571|NCT00585611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610572|NCT00585611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102610573|NCT00585611|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102610574|NCT00585611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102610575|NCT00379691|Phenylephrine|phenylephrine|mesh-list
102610576|NCT00379691|Oxymetazoline|oxymetazoline|mesh-list
102610577|NCT00379691|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102610578|NCT00379691|Mydriatics|mydriatics|mesh-ancestor
102610579|NCT00379691|Autonomic Agents|autonomic agents|mesh-ancestor
102610580|NCT00379691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102610581|NCT00379691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610582|NCT00379691|Sympathomimetics|sympathomimetics|mesh-ancestor
102610583|NCT00379691|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102610584|NCT00379691|Nasal Decongestants|nasal decongestants|mesh-ancestor
102610585|NCT00379691|Respiratory System Agents|respiratory system agents|mesh-ancestor
102610586|NCT00379691|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102610587|NCT00379691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102610588|NCT00379691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102610589|NCT00379691|Adrenergic Agents|adrenergic agents|mesh-ancestor
102610590|NCT00379691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102610591|NCT00379691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610592|NCT00379691|Protective Agents|protective agents|mesh-ancestor
102610593|NCT01685333|Epoetin Alfa|epoetin alfa|mesh-list
102610594|NCT01685333|Hematinics|hematinics|mesh-ancestor
102610595|NCT01556009|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102610596|NCT01556009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102610597|NCT01556009|Dermatologic Agents|dermatologic agents|mesh-ancestor
102610598|NCT00546455|Fenretinide|fenretinide|mesh-list
102610599|NCT00546455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102610600|NCT00546455|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102610601|NCT00546455|Protective Agents|protective agents|mesh-ancestor
102610602|NCT00546455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610603|NCT00000737|Megestrol|megestrol|mesh-list
102610604|NCT00000737|Megestrol Acetate|megestrol acetate|mesh-list
102610605|NCT00000737|Dronabinol|dronabinol|mesh-list
102610606|NCT00000737|Hallucinogens|hallucinogens|mesh-ancestor
102610607|NCT00000737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610608|NCT00000737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102610609|NCT00000737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102610610|NCT00000737|Analgesics|analgesics|mesh-ancestor
102610611|NCT00000737|Sensory System Agents|sensory system agents|mesh-ancestor
102610612|NCT00000737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102610613|NCT00000737|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102610614|NCT00000737|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102610615|NCT00000737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102610616|NCT00000737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610617|NCT00000737|Hormones|hormones|mesh-ancestor
102610618|NCT00000737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102610619|NCT00000737|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102610620|NCT00000737|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102157452|NCT02733614|SRX246|srx246|mesh-list
102610621|NCT00000737|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102610622|NCT00000737|Contraceptive Agents|contraceptive agents|mesh-ancestor
102610623|NCT00000737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102610624|NCT00000737|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102610625|NCT00000737|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102610626|NCT00000737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102610627|NCT00000737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102610628|NCT00000737|Appetite Stimulants|appetite stimulants|mesh-ancestor
102610629|NCT00000737|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102610630|NCT00528437|Carboplatin|carboplatin|mesh-list
102610631|NCT00528437|Temozolomide|temozolomide|mesh-list
102610632|NCT00528437|Thiotepa|thiotepa|mesh-list
102610633|NCT00528437|Tretinoin|tretinoin|mesh-list
102610634|NCT00528437|Isotretinoin|isotretinoin|mesh-list
102610635|NCT00528437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102610636|NCT00528437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102610637|NCT00528437|Alkylating Agents|alkylating agents|mesh-ancestor
102610638|NCT00528437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610639|NCT00528437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102610640|NCT00528437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102610641|NCT00528437|Immunologic Factors|immunologic factors|mesh-ancestor
102610642|NCT00528437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610643|NCT00528437|Keratolytic Agents|keratolytic agents|mesh-ancestor
102610644|NCT00528437|Dermatologic Agents|dermatologic agents|mesh-ancestor
102610645|NCT00000743|Zidovudine|zidovudine|mesh-list
102610646|NCT00000743|Antimetabolites|antimetabolites|mesh-ancestor
102610647|NCT00000743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610648|NCT00000743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102610649|NCT00000743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102610650|NCT00000743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102610651|NCT00000743|Antiviral Agents|antiviral agents|mesh-ancestor
102610652|NCT00000743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102610653|NCT00000743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102610654|NCT00000743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102610655|NCT00506909|Oxytocin|oxytocin|mesh-list
102610656|NCT00506909|Oxytocics|oxytocics|mesh-ancestor
102610657|NCT00506909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102610658|NCT00506909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610660|NCT00500045|Nicotinic Acids|nicotinic acids|mesh-list
102610661|NCT00500045|Niacinamide|niacinamide|mesh-list
102610662|NCT00500045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102610663|NCT00500045|Antimetabolites|antimetabolites|mesh-ancestor
102610664|NCT00500045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610665|NCT00500045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102610666|NCT00500045|Vasodilator Agents|vasodilator agents|mesh-ancestor
102610667|NCT00500045|Vitamin B Complex|vitamin b complex|mesh-ancestor
102610668|NCT00500045|Vitamins|vitamins|mesh-ancestor
102610669|NCT00500045|Micronutrients|micronutrients|mesh-ancestor
102610670|NCT00500045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610671|NCT00000767|Vaccines|vaccines|mesh-list
102610672|NCT00000767|Immunologic Factors|immunologic factors|mesh-ancestor
102610673|NCT00000767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610674|NCT05383547|Bortezomib|bortezomib|mesh-list
102610675|NCT05383547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102610676|NCT00456989|Docetaxel|docetaxel|mesh-list
102610677|NCT00456989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102610678|NCT00456989|Tubulin Modulators|tubulin modulators|mesh-ancestor
102610679|NCT00456989|Antimitotic Agents|antimitotic agents|mesh-ancestor
102610680|NCT00456989|Mitosis Modulators|mitosis modulators|mesh-ancestor
102610681|NCT00456989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610682|NCT00000773|Atovaquone|atovaquone|mesh-list
102610683|NCT00000773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102610684|NCT00000773|Antimalarials|antimalarials|mesh-ancestor
102610685|NCT00000773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102610686|NCT00000773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102610687|NCT00000773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102610688|NCT00000773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610689|NCT00428207|Insulin|insulin|mesh-list
102610690|NCT00428207|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102610691|NCT00428207|Insulin Aspart|insulin aspart|mesh-list
102610692|NCT00428207|Insulin, Long-Acting|insulin, long-acting|mesh-list
102610693|NCT00428207|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102610694|NCT00428207|Insulin Lispro|insulin lispro|mesh-list
102610695|NCT00428207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102610696|NCT00428207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610697|NCT00000791|Zidovudine|zidovudine|mesh-list
102154362|NCT02237755|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102610698|NCT00000791|Antimetabolites|antimetabolites|mesh-ancestor
102610699|NCT00000791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610700|NCT00000791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102610701|NCT00000791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102610702|NCT00000791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102610703|NCT00000791|Antiviral Agents|antiviral agents|mesh-ancestor
102610704|NCT00000791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102610705|NCT00000791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102610706|NCT00000791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102610707|NCT00379847|Conivaptan|conivaptan|mesh-list
102610708|NCT00379847|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102610709|NCT00379847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610710|NCT00379847|Natriuretic Agents|natriuretic agents|mesh-ancestor
102610711|NCT00379847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610712|NCT00374543|Ziprasidone|ziprasidone|mesh-list
102610713|NCT00374543|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102610714|NCT00374543|Serotonin Agents|serotonin agents|mesh-ancestor
102610715|NCT00374543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102610716|NCT00374543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610717|NCT00374543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610718|NCT00374543|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102610719|NCT00374543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102610720|NCT00374543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102610721|NCT00374543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102610722|NCT00374543|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102610723|NCT00374543|Dopamine Agents|dopamine agents|mesh-ancestor
102610724|NCT00000803|Zidovudine|zidovudine|mesh-list
102610725|NCT00000803|Didanosine|didanosine|mesh-list
102610726|NCT00000803|Delavirdine|delavirdine|mesh-list
102610727|NCT00000803|Antimetabolites|antimetabolites|mesh-ancestor
102610728|NCT00000803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610729|NCT00000803|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102610730|NCT00000803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102610731|NCT00000803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102610732|NCT00000803|Antiviral Agents|antiviral agents|mesh-ancestor
102610733|NCT00000803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102610734|NCT00000803|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102610735|NCT00000803|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102610736|NCT00299195|Sulindac|sulindac|mesh-list
102610737|NCT00299195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102610738|NCT00299195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102610739|NCT00299195|Analgesics|analgesics|mesh-ancestor
102610740|NCT00299195|Sensory System Agents|sensory system agents|mesh-ancestor
102610741|NCT00299195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102610742|NCT00299195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610743|NCT00299195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102610744|NCT00299195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102610745|NCT00299195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102610746|NCT00299195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102610747|NCT00299195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102610748|NCT00299195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610749|NCT01351415|Bevacizumab|bevacizumab|mesh-list
102610750|NCT01351415|Docetaxel|docetaxel|mesh-list
102610751|NCT01351415|Pemetrexed|pemetrexed|mesh-list
102610752|NCT01351415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102610753|NCT01351415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102610754|NCT01351415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102610755|NCT01351415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102610756|NCT01351415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102610757|NCT01351415|Growth Substances|growth substances|mesh-ancestor
102610758|NCT01351415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610759|NCT01351415|Growth Inhibitors|growth inhibitors|mesh-ancestor
102610760|NCT01351415|Tubulin Modulators|tubulin modulators|mesh-ancestor
102610761|NCT01351415|Antimitotic Agents|antimitotic agents|mesh-ancestor
102610762|NCT01351415|Mitosis Modulators|mitosis modulators|mesh-ancestor
102610763|NCT01351415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610764|NCT01351415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102610765|NCT01351415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102055729|NCT02143622|Cetuximab|cetuximab|mesh-list
102610766|NCT01351415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102610767|NCT01351415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102610768|NCT00281879|Cytarabine|cytarabine|mesh-list
102610769|NCT00281879|Cyclosporine|cyclosporine|mesh-list
102610770|NCT00281879|Mycophenolic Acid|mycophenolic acid|mesh-list
102610771|NCT00281879|Methylprednisolone|methylprednisolone|mesh-list
102610772|NCT00281879|Cyclophosphamide|cyclophosphamide|mesh-list
102610773|NCT00281879|Melphalan|melphalan|mesh-list
102610774|NCT00281879|Busulfan|busulfan|mesh-list
102610776|NCT00281879|Methotrexate|methotrexate|mesh-list
102610777|NCT00281879|Fludarabine|fludarabine|mesh-list
102610778|NCT00281879|Fludarabine phosphate|fludarabine phosphate|mesh-list
102610779|NCT00281879|Etoposide|etoposide|mesh-list
102610780|NCT00281879|Tacrolimus|tacrolimus|mesh-list
102610781|NCT00281879|Cyclosporins|cyclosporins|mesh-list
102610782|NCT00281879|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102610783|NCT00281879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102610784|NCT00281879|Immunologic Factors|immunologic factors|mesh-ancestor
102610785|NCT00281879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610786|NCT00281879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102610787|NCT00281879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102610788|NCT00281879|Alkylating Agents|alkylating agents|mesh-ancestor
102610789|NCT00281879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610790|NCT00281879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102610791|NCT00281879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102610792|NCT00281879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102610793|NCT00281879|Abortifacient Agents|abortifacient agents|mesh-ancestor
102610794|NCT00281879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102610795|NCT00281879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102610796|NCT00281879|Antimetabolites|antimetabolites|mesh-ancestor
102610797|NCT00281879|Dermatologic Agents|dermatologic agents|mesh-ancestor
102610798|NCT00281879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102610799|NCT00281879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102610800|NCT00281879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102610801|NCT00281879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102610802|NCT00281879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102610803|NCT00281879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102610804|NCT00281879|Antiviral Agents|antiviral agents|mesh-ancestor
102610805|NCT00281879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102610806|NCT00281879|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102610807|NCT00281879|Antifungal Agents|antifungal agents|mesh-ancestor
102610808|NCT00281879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102610809|NCT00281879|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102610810|NCT00281879|Antitubercular Agents|antitubercular agents|mesh-ancestor
102610811|NCT00281879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102610812|NCT00281879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102610813|NCT00281879|Antiemetics|antiemetics|mesh-ancestor
102610814|NCT00281879|Autonomic Agents|autonomic agents|mesh-ancestor
102610815|NCT00281879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102610816|NCT00281879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102610817|NCT00281879|Glucocorticoids|glucocorticoids|mesh-ancestor
102610818|NCT00281879|Hormones|hormones|mesh-ancestor
102610819|NCT00281879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102610820|NCT00281879|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102610821|NCT00281879|Protective Agents|protective agents|mesh-ancestor
102610822|NCT00000809|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102610823|NCT00000809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102610824|NCT00000809|Immunologic Factors|immunologic factors|mesh-ancestor
102610825|NCT00000809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610826|NCT00000809|Antacids|antacids|mesh-ancestor
102610827|NCT00000809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610828|NCT00000809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102610829|NCT05091203|Vitamin D|vitamin d|mesh-list
102610830|NCT05091203|Vitamins|vitamins|mesh-ancestor
102610831|NCT05091203|Micronutrients|micronutrients|mesh-ancestor
102610832|NCT05091203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610833|NCT05091203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102610834|NCT00240227|Prazosin|prazosin|mesh-list
102610835|NCT00240227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102610836|NCT00240227|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102610837|NCT00240227|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102610838|NCT00240227|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102610839|NCT00240227|Adrenergic Agents|adrenergic agents|mesh-ancestor
102610840|NCT00240227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102610841|NCT00240227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610842|NCT00240227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610843|NCT00205049|Pentoxifylline|pentoxifylline|mesh-list
102610844|NCT00205049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102610845|NCT00205049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102610846|NCT00205049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610847|NCT00205049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102610848|NCT00205049|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102610849|NCT00205049|Protective Agents|protective agents|mesh-ancestor
102610850|NCT00205049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610851|NCT00205049|Vasodilator Agents|vasodilator agents|mesh-ancestor
102610852|NCT00205049|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102610853|NCT00205049|Antioxidants|antioxidants|mesh-ancestor
102610854|NCT00000833|Ribavirin|ribavirin|mesh-list
102610855|NCT00000833|Didanosine|didanosine|mesh-list
102610856|NCT00000833|Antimetabolites|antimetabolites|mesh-ancestor
102610857|NCT00000833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610858|NCT00000833|Antiviral Agents|antiviral agents|mesh-ancestor
102610859|NCT00000833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102610860|NCT00000833|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102610861|NCT00000833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102610862|NCT00000833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102610863|NCT00000833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102610864|NCT00000833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102610865|NCT00000839|Didanosine|didanosine|mesh-list
102610866|NCT00000839|Antimetabolites|antimetabolites|mesh-ancestor
102610867|NCT00000839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610868|NCT00000839|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102610869|NCT00000839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102610870|NCT00000839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102610871|NCT00000839|Antiviral Agents|antiviral agents|mesh-ancestor
102610872|NCT00000839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102610873|NCT00000839|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102610874|NCT00000839|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102610875|NCT00133679|Sildenafil Citrate|sildenafil citrate|mesh-list
102610876|NCT00133679|Vasodilator Agents|vasodilator agents|mesh-ancestor
102610877|NCT00133679|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102610878|NCT00133679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102610879|NCT00133679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102610880|NCT00133679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610881|NCT00133679|Urological Agents|urological agents|mesh-ancestor
102610882|NCT00000875|Acetaminophen|acetaminophen|mesh-list
102610883|NCT00000875|Diphenhydramine|diphenhydramine|mesh-list
102610884|NCT00000875|Promethazine|promethazine|mesh-list
102610885|NCT00000875|Lamivudine|lamivudine|mesh-list
102610886|NCT00000875|Zidovudine|zidovudine|mesh-list
102610887|NCT00000875|Aldesleukin|aldesleukin|mesh-list
102610888|NCT00000875|Indinavir|indinavir|mesh-list
102610889|NCT00000875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102610890|NCT00000875|Analgesics|analgesics|mesh-ancestor
102610891|NCT00000875|Sensory System Agents|sensory system agents|mesh-ancestor
102610892|NCT00000875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102610893|NCT00000875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610894|NCT00000875|Antipyretics|antipyretics|mesh-ancestor
102610895|NCT00000875|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102610896|NCT00000875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102610897|NCT00000875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102610898|NCT00000875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610899|NCT00000875|Antiviral Agents|antiviral agents|mesh-ancestor
102610900|NCT00000875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102610901|NCT00000875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102610902|NCT00000875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102610903|NCT00000875|Antimetabolites|antimetabolites|mesh-ancestor
102610904|NCT00000875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102610905|NCT00000875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102610906|NCT00000875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102610907|NCT00000875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102610908|NCT00000875|Anesthetics, Local|anesthetics, local|mesh-ancestor
102610909|NCT00000875|Anesthetics|anesthetics|mesh-ancestor
102610910|NCT00000875|Antiemetics|antiemetics|mesh-ancestor
102610911|NCT00000875|Autonomic Agents|autonomic agents|mesh-ancestor
102610912|NCT00000875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102610913|NCT00000875|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102610914|NCT00000875|Histamine Antagonists|histamine antagonists|mesh-ancestor
102610915|NCT00000875|Histamine Agents|histamine agents|mesh-ancestor
102610916|NCT00000875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102610917|NCT00000875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102610918|NCT00000875|Antipruritics|antipruritics|mesh-ancestor
102610919|NCT00000875|Dermatologic Agents|dermatologic agents|mesh-ancestor
102610920|NCT00000875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102610921|NCT00000875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102610922|NCT00000875|Protease Inhibitors|protease inhibitors|mesh-ancestor
102610923|NCT04941833|Desogestrel|desogestrel|mesh-list
102610924|NCT04941833|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102610925|NCT04941833|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102610926|NCT04941833|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102610927|NCT04941833|Contraceptive Agents|contraceptive agents|mesh-ancestor
102610928|NCT04941833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102610929|NCT04941833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610930|NCT04941833|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102610931|NCT04941833|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102610932|NCT04941833|Progestins|progestins|mesh-ancestor
102610933|NCT04941833|Hormones|hormones|mesh-ancestor
102610934|NCT04941833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102610935|NCT04841369|Vaccines|vaccines|mesh-list
102610936|NCT04841369|Immunologic Factors|immunologic factors|mesh-ancestor
102610937|NCT04841369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102610938|NCT00002975|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102610939|NCT00002975|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102610940|NCT00002975|Dermatologic Agents|dermatologic agents|mesh-ancestor
102610941|NCT00521885|Enoxaparin|enoxaparin|mesh-list
102610942|NCT00521885|Fondaparinux|fondaparinux|mesh-list
102610943|NCT00521885|Anticoagulants|anticoagulants|mesh-ancestor
102610944|NCT00521885|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102610945|NCT00521885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102610946|NCT00521885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610947|NCT00521885|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102610948|NCT00521885|Antithrombins|antithrombins|mesh-ancestor
102610949|NCT00521885|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102610950|NCT00521885|Protease Inhibitors|protease inhibitors|mesh-ancestor
102610951|NCT00521885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102610952|NCT05239013|Nitroglycerin|nitroglycerin|mesh-list
102610953|NCT05239013|Vasodilator Agents|vasodilator agents|mesh-ancestor
102610954|NCT00000881|Cidofovir|cidofovir|mesh-list
102610955|NCT00000881|Probenecid|probenecid|mesh-list
102610956|NCT00000881|Uricosuric Agents|uricosuric agents|mesh-ancestor
102610957|NCT00000881|Gout Suppressants|gout suppressants|mesh-ancestor
102610958|NCT00000881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102610959|NCT00000881|Antiviral Agents|antiviral agents|mesh-ancestor
102610960|NCT00000881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102610961|NCT00000881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102610962|NCT00000881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610963|NCT00000887|Lamivudine|lamivudine|mesh-list
102610964|NCT00000887|Zidovudine|zidovudine|mesh-list
102610965|NCT00000887|Nelfinavir|nelfinavir|mesh-list
102610966|NCT00000887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102610967|NCT00000887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102610968|NCT00000887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102610969|NCT00000887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610970|NCT00000887|Antiviral Agents|antiviral agents|mesh-ancestor
102610971|NCT00000887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102610972|NCT00000887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102610973|NCT00000887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102610974|NCT00000887|Antimetabolites|antimetabolites|mesh-ancestor
102610975|NCT00000887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102610976|NCT00000887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102610977|NCT00000887|Protease Inhibitors|protease inhibitors|mesh-ancestor
102610978|NCT00000119|Heparin|heparin|mesh-list
102610979|NCT00000119|Anticoagulants|anticoagulants|mesh-ancestor
102610980|NCT00000119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102610981|NCT00000119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102610982|NCT00000119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610983|NCT00000923|Lamivudine|lamivudine|mesh-list
102610984|NCT00000923|Zidovudine|zidovudine|mesh-list
102610985|NCT00000923|Stavudine|stavudine|mesh-list
102610986|NCT00000923|Didanosine|didanosine|mesh-list
102610987|NCT00000923|Aldesleukin|aldesleukin|mesh-list
102610988|NCT00000923|Indinavir|indinavir|mesh-list
102610989|NCT00000923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102610990|NCT00000923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102610991|NCT00000923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102610992|NCT00000923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102610993|NCT00000923|Antiviral Agents|antiviral agents|mesh-ancestor
102610994|NCT00000923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102610995|NCT00000923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102610996|NCT00000923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102610997|NCT00000923|Antimetabolites|antimetabolites|mesh-ancestor
102610998|NCT00000923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102610999|NCT00000923|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102611000|NCT00000923|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102611001|NCT00000923|Protease Inhibitors|protease inhibitors|mesh-ancestor
102611002|NCT00000161|Aspirin|aspirin|mesh-list
102611003|NCT00000161|Vitamins|vitamins|mesh-list
102154363|NCT02237755|Chelating Agents|chelating agents|mesh-ancestor
102611004|NCT00000161|Vitamin E|vitamin e|mesh-list
102611005|NCT00000161|Beta Carotene|beta carotene|mesh-list
102611006|NCT00000161|Carotenoids|carotenoids|mesh-list
102611007|NCT00000161|Micronutrients|micronutrients|mesh-ancestor
102611008|NCT00000161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611009|NCT00000161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102611010|NCT00000161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102611011|NCT00000161|Analgesics|analgesics|mesh-ancestor
102611012|NCT00000161|Sensory System Agents|sensory system agents|mesh-ancestor
102611013|NCT00000161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102611014|NCT00000161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102611015|NCT00000161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102611016|NCT00000161|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102611017|NCT00000161|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102611018|NCT00000161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611019|NCT00000161|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102611020|NCT00000161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102611021|NCT00000161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611022|NCT00000161|Antipyretics|antipyretics|mesh-ancestor
102611023|NCT00000161|Antioxidants|antioxidants|mesh-ancestor
102611024|NCT00000161|Protective Agents|protective agents|mesh-ancestor
102611025|NCT00000161|Provitamins|provitamins|mesh-ancestor
102611026|NCT00000929|Nonoxynol|nonoxynol|mesh-list
102611027|NCT00000929|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
102611028|NCT00000929|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
102611029|NCT00000929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611030|NCT00000929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102611031|NCT00000929|Contraceptive Agents|contraceptive agents|mesh-ancestor
102611032|NCT00000929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102611033|NCT00000929|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102611034|NCT00000935|Immunoglobulins|immunoglobulins|mesh-list
102611035|NCT00000935|Antibodies|antibodies|mesh-list
102611036|NCT00000935|gamma-Globulins|gamma-globulins|mesh-list
102611037|NCT00000935|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102611038|NCT00000935|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102346900|NCT03499704|Metformin|metformin|mesh-list
102611039|NCT00000935|Immunologic Factors|immunologic factors|mesh-ancestor
102611040|NCT00000935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611041|NCT00000197|Propranolol|propranolol|mesh-list
102611042|NCT00000197|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102611043|NCT00000197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102611044|NCT00000197|Adrenergic Agents|adrenergic agents|mesh-ancestor
102611045|NCT00000197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102611046|NCT00000197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611047|NCT00000197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611048|NCT00000197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102611049|NCT00000197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102611050|NCT00000197|Vasodilator Agents|vasodilator agents|mesh-ancestor
102611051|NCT00000947|Azithromycin|azithromycin|mesh-list
102611052|NCT00000947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102611053|NCT00000947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611054|NCT00000203|Buprenorphine|buprenorphine|mesh-list
102611055|NCT00000203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102611056|NCT00000203|Narcotics|narcotics|mesh-ancestor
102611057|NCT00000203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102611058|NCT00000203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611059|NCT00000203|Analgesics|analgesics|mesh-ancestor
102611060|NCT00000203|Sensory System Agents|sensory system agents|mesh-ancestor
102611061|NCT00000203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102611062|NCT00000203|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102611063|NCT00000209|Buprenorphine|buprenorphine|mesh-list
102611064|NCT00000209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102611065|NCT00000209|Narcotics|narcotics|mesh-ancestor
102611066|NCT00000209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102611067|NCT00000209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611068|NCT00000209|Analgesics|analgesics|mesh-ancestor
102611069|NCT00000209|Sensory System Agents|sensory system agents|mesh-ancestor
102611070|NCT00000209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102611071|NCT00000209|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102611072|NCT00000215|Pergolide|pergolide|mesh-list
102611073|NCT00000215|Dopamine Agonists|dopamine agonists|mesh-ancestor
102611074|NCT00000215|Dopamine Agents|dopamine agents|mesh-ancestor
102611075|NCT00000215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102611076|NCT00000215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157892|NCT05084534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157893|NCT05084534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102157894|NCT05084534|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102157895|NCT05084534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102157896|NCT05084534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102157897|NCT05084534|Adrenergic Agents|adrenergic agents|mesh-ancestor
102611077|NCT00000215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611078|NCT00000953|Acyclovir|acyclovir|mesh-list
102611079|NCT00000953|Sorivudine|sorivudine|mesh-list
102611080|NCT00000953|Antiviral Agents|antiviral agents|mesh-ancestor
102611081|NCT00000953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611082|NCT00000953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611083|NCT00000953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611084|NCT00000983|Zidovudine|zidovudine|mesh-list
102611085|NCT00000983|Antimetabolites|antimetabolites|mesh-ancestor
102611086|NCT00000983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611087|NCT00000983|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102611088|NCT00000983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102611089|NCT00000983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611090|NCT00000983|Antiviral Agents|antiviral agents|mesh-ancestor
102611091|NCT00000983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611092|NCT00000983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102611093|NCT00000983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102611094|NCT00000227|Buprenorphine|buprenorphine|mesh-list
102611095|NCT00000227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102611096|NCT00000227|Narcotics|narcotics|mesh-ancestor
102611097|NCT00000227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102611098|NCT00000227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611099|NCT00000227|Analgesics|analgesics|mesh-ancestor
102611100|NCT00000227|Sensory System Agents|sensory system agents|mesh-ancestor
102611101|NCT00000227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102611102|NCT00000227|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102611103|NCT00000233|Buprenorphine|buprenorphine|mesh-list
102611104|NCT00000233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102611105|NCT00000233|Narcotics|narcotics|mesh-ancestor
102611106|NCT00000233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102611107|NCT00000233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611108|NCT00000233|Analgesics|analgesics|mesh-ancestor
102611109|NCT00000233|Sensory System Agents|sensory system agents|mesh-ancestor
102611110|NCT00000233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102611111|NCT00000233|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102611112|NCT00000239|Buprenorphine|buprenorphine|mesh-list
102611113|NCT00000239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102611114|NCT00000239|Narcotics|narcotics|mesh-ancestor
102611115|NCT00000239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102611116|NCT00000239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611117|NCT00000239|Analgesics|analgesics|mesh-ancestor
102611118|NCT00000239|Sensory System Agents|sensory system agents|mesh-ancestor
102611119|NCT00000239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102611120|NCT00000239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102611121|NCT00000245|Desipramine|desipramine|mesh-list
102611122|NCT00000245|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102611123|NCT00000245|Antidepressive Agents|antidepressive agents|mesh-ancestor
102611124|NCT00000245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102611125|NCT00000245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611126|NCT00000245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611127|NCT00000245|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102611128|NCT00000245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102611129|NCT00000245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102611130|NCT00000245|Adrenergic Agents|adrenergic agents|mesh-ancestor
102611131|NCT00000245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102611132|NCT00000245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611133|NCT00000263|Ethanol|ethanol|mesh-list
102611134|NCT00000263|Nitrous Oxide|nitrous oxide|mesh-list
102611135|NCT00000263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102611136|NCT00000263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611137|NCT00000263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102611138|NCT00000263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611139|NCT00000263|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102611140|NCT00000263|Anesthetics, General|anesthetics, general|mesh-ancestor
102611141|NCT00000263|Anesthetics|anesthetics|mesh-ancestor
102611142|NCT00000263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102611143|NCT00000263|Analgesics|analgesics|mesh-ancestor
102611144|NCT00000263|Sensory System Agents|sensory system agents|mesh-ancestor
102611145|NCT00000263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102611146|NCT00000269|Pergolide|pergolide|mesh-list
102611147|NCT00000269|Dopamine Agonists|dopamine agonists|mesh-ancestor
102611148|NCT00000269|Dopamine Agents|dopamine agents|mesh-ancestor
102611149|NCT00000269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102611150|NCT00000269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611151|NCT00000269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611152|NCT04030559|Niraparib|niraparib|mesh-list
102611153|NCT04030559|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102611154|NCT04030559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611155|NCT04030559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611156|NCT04030559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102611157|NCT03967223|Cyclophosphamide|cyclophosphamide|mesh-list
102611158|NCT03967223|Fludarabine|fludarabine|mesh-list
102611159|NCT03967223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102611160|NCT03967223|Immunologic Factors|immunologic factors|mesh-ancestor
102611161|NCT03967223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611162|NCT03967223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102611163|NCT03967223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102611164|NCT03967223|Alkylating Agents|alkylating agents|mesh-ancestor
102611165|NCT03967223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611166|NCT03967223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102611167|NCT03967223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102611168|NCT00000989|Zidovudine|zidovudine|mesh-list
102611169|NCT00000989|Ganciclovir|ganciclovir|mesh-list
102611170|NCT00000989|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102611171|NCT00000989|Sargramostim|sargramostim|mesh-list
102611172|NCT00000989|Antimetabolites|antimetabolites|mesh-ancestor
102611173|NCT00000989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611174|NCT00000989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102611175|NCT00000989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102611176|NCT00000989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611177|NCT00000989|Antiviral Agents|antiviral agents|mesh-ancestor
102611178|NCT00000989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611179|NCT00000989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102611180|NCT00000989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102611181|NCT00000989|Immunologic Factors|immunologic factors|mesh-ancestor
102611182|NCT00000989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611183|NCT00000995|Zidovudine|zidovudine|mesh-list
102611184|NCT00000995|Ganciclovir|ganciclovir|mesh-list
102611185|NCT00000995|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102611186|NCT00000995|Antimetabolites|antimetabolites|mesh-ancestor
102611187|NCT00000995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611188|NCT00000995|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102611189|NCT00000995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102611190|NCT00000995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611191|NCT00000995|Antiviral Agents|antiviral agents|mesh-ancestor
102611192|NCT00000995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611193|NCT00000995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102611194|NCT00000995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102611195|NCT00001025|Zidovudine|zidovudine|mesh-list
102611196|NCT00001025|Didanosine|didanosine|mesh-list
102611197|NCT00001025|Antimetabolites|antimetabolites|mesh-ancestor
102611198|NCT00001025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611199|NCT00001025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102611200|NCT00001025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102611201|NCT00001025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611202|NCT00001025|Antiviral Agents|antiviral agents|mesh-ancestor
102611203|NCT00001025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611204|NCT00001025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102611205|NCT00001025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102611206|NCT03121001|Mycophenolic Acid|mycophenolic acid|mesh-list
102611207|NCT03121001|Sirolimus|sirolimus|mesh-list
102611208|NCT03121001|Cyclophosphamide|cyclophosphamide|mesh-list
102611209|NCT03121001|Fludarabine|fludarabine|mesh-list
102611210|NCT03121001|Thymoglobulin|thymoglobulin|mesh-list
102611211|NCT03121001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102611212|NCT03121001|Immunologic Factors|immunologic factors|mesh-ancestor
102611213|NCT03121001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611214|NCT03121001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102611215|NCT03121001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102611216|NCT03121001|Alkylating Agents|alkylating agents|mesh-ancestor
102611217|NCT03121001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611218|NCT03121001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102611219|NCT03121001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102611220|NCT03121001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102611221|NCT03121001|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102611222|NCT03121001|Antitubercular Agents|antitubercular agents|mesh-ancestor
102611223|NCT03121001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102611224|NCT03121001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611225|NCT03121001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611226|NCT03121001|Antifungal Agents|antifungal agents|mesh-ancestor
102611227|NCT03055247|Ibuprofen|ibuprofen|mesh-list
102611228|NCT03055247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102611229|NCT03055247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102611230|NCT03055247|Analgesics|analgesics|mesh-ancestor
102611231|NCT03055247|Sensory System Agents|sensory system agents|mesh-ancestor
102611232|NCT03055247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102611233|NCT03055247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611234|NCT03055247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102611235|NCT03055247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102611236|NCT03055247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102611237|NCT03055247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611238|NCT03055247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611239|NCT00001049|Zidovudine|zidovudine|mesh-list
102611240|NCT00001049|Didanosine|didanosine|mesh-list
102611241|NCT00001049|Antimetabolites|antimetabolites|mesh-ancestor
102611242|NCT00001049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611243|NCT00001049|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102611244|NCT00001049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102611245|NCT00001049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611246|NCT00001049|Antiviral Agents|antiviral agents|mesh-ancestor
102611247|NCT00001049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611248|NCT00001049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102611249|NCT00001049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102611250|NCT00001055|polysaccharide-K|polysaccharide-k|mesh-list
102611251|NCT00001055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102611252|NCT00001055|Immunologic Factors|immunologic factors|mesh-ancestor
102611253|NCT00001055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611254|NCT00001055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102611255|NCT00001055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102611256|NCT00001055|Antiviral Agents|antiviral agents|mesh-ancestor
102611257|NCT00001055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611258|NCT00001055|Interferon Inducers|interferon inducers|mesh-ancestor
102611259|NCT00001055|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102611260|NCT00001055|Protective Agents|protective agents|mesh-ancestor
102611261|NCT00000275|Flupenthixol|flupenthixol|mesh-list
102611262|NCT00000275|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
102611263|NCT00000275|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102611264|NCT00000275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102611265|NCT00000275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102611266|NCT00000275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611267|NCT00000275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102611268|NCT00000275|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102611269|NCT00000275|Dopamine Agents|dopamine agents|mesh-ancestor
102611270|NCT00000275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102611271|NCT00000275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611272|NCT00001061|Ganciclovir|ganciclovir|mesh-list
102611273|NCT00001061|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102611274|NCT00001061|Foscarnet|foscarnet|mesh-list
102611275|NCT00001061|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
102611276|NCT00001061|Antiviral Agents|antiviral agents|mesh-ancestor
102611277|NCT00001061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611278|NCT00001061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102611279|NCT00001061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611280|NCT00001061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611281|NCT00001061|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102611282|NCT00000281|Amantadine|amantadine|mesh-list
102611283|NCT00000281|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102611284|NCT00000281|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102611285|NCT00000281|Antiviral Agents|antiviral agents|mesh-ancestor
102611286|NCT00000281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611287|NCT00000281|Dopamine Agents|dopamine agents|mesh-ancestor
102611288|NCT00000281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102611289|NCT00000281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611290|NCT00000281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611291|NCT00000281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102611292|NCT00000281|Analgesics|analgesics|mesh-ancestor
102611293|NCT00000281|Sensory System Agents|sensory system agents|mesh-ancestor
102611294|NCT00000281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102611295|NCT00001067|Lamivudine|lamivudine|mesh-list
102611296|NCT00001067|Zidovudine|zidovudine|mesh-list
102611297|NCT00001067|Stavudine|stavudine|mesh-list
102611298|NCT00001067|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102611299|NCT00001067|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102611300|NCT00001067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611301|NCT00001067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611302|NCT00001067|Antiviral Agents|antiviral agents|mesh-ancestor
102611303|NCT00001067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611304|NCT00001067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102611305|NCT00001067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102611307|NCT00001079|Methyltestosterone|methyltestosterone|mesh-list
102611308|NCT00001079|Megestrol|megestrol|mesh-list
102611309|NCT00001079|Megestrol Acetate|megestrol acetate|mesh-list
102611310|NCT00001079|Testosterone|testosterone|mesh-list
102611311|NCT00001079|Testosterone undecanoate|testosterone undecanoate|mesh-list
102611312|NCT00001079|Testosterone enanthate|testosterone enanthate|mesh-list
102611313|NCT00001079|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102611314|NCT00001079|Androgens|androgens|mesh-ancestor
102611315|NCT00001079|Hormones|hormones|mesh-ancestor
102611316|NCT00001079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102611317|NCT00001079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611318|NCT00001079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102611319|NCT00001079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102611320|NCT00001079|Anabolic Agents|anabolic agents|mesh-ancestor
102611321|NCT00001079|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102611322|NCT00001079|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102611323|NCT00001079|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102611324|NCT00001079|Contraceptive Agents|contraceptive agents|mesh-ancestor
102611325|NCT00001079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102611326|NCT00001079|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102611327|NCT00001079|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102611328|NCT00001079|Appetite Stimulants|appetite stimulants|mesh-ancestor
102611329|NCT00001079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102611330|NCT00000293|Nefazodone|nefazodone|mesh-list
102611331|NCT00000293|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102611332|NCT00000293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102611333|NCT00000293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102611334|NCT00000293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611335|NCT00000293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102611336|NCT00000293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611337|NCT00000293|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102611338|NCT00000293|Antidepressive Agents|antidepressive agents|mesh-ancestor
102611339|NCT00000293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102611340|NCT00000293|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102611341|NCT00000293|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102611342|NCT00000293|Serotonin Agents|serotonin agents|mesh-ancestor
102611343|NCT00001091|Ritonavir|ritonavir|mesh-list
102611344|NCT00001091|Nelfinavir|nelfinavir|mesh-list
102611345|NCT00001091|Lamivudine|lamivudine|mesh-list
102611346|NCT00001091|Nevirapine|nevirapine|mesh-list
102611347|NCT00001091|Stavudine|stavudine|mesh-list
102611348|NCT00001091|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102611349|NCT00001091|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102611350|NCT00001091|Protease Inhibitors|protease inhibitors|mesh-ancestor
102611351|NCT00001091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611352|NCT00001091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611353|NCT00001091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102611354|NCT00001091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102611355|NCT00001091|Antiviral Agents|antiviral agents|mesh-ancestor
102611356|NCT00001091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611357|NCT00001091|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102611358|NCT00001091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102611359|NCT00001091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102611360|NCT00001091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102611361|NCT00001091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102611362|NCT00001091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102611363|NCT00001091|Antimetabolites|antimetabolites|mesh-ancestor
102611364|NCT00000299|Buprenorphine|buprenorphine|mesh-list
102611365|NCT00000299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102611366|NCT00000299|Narcotics|narcotics|mesh-ancestor
102611367|NCT00000299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102611368|NCT00000299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611369|NCT00000299|Analgesics|analgesics|mesh-ancestor
102611370|NCT00000299|Sensory System Agents|sensory system agents|mesh-ancestor
102158197|NCT01362530|Antiemetics|antiemetics|mesh-ancestor
102158198|NCT01362530|Autonomic Agents|autonomic agents|mesh-ancestor
102158199|NCT01362530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102158200|NCT01362530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158201|NCT01362530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102158202|NCT01362530|Antipruritics|antipruritics|mesh-ancestor
102158203|NCT01362530|Dermatologic Agents|dermatologic agents|mesh-ancestor
102158204|NCT01362530|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102611371|NCT00000299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102611373|NCT00000305|Dextroamphetamine|dextroamphetamine|mesh-list
102611374|NCT00000305|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102611375|NCT00000305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611376|NCT00000305|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102611377|NCT00000305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102611378|NCT00000305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102611379|NCT00000305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611380|NCT00000305|Dopamine Agents|dopamine agents|mesh-ancestor
102611381|NCT00000305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102611382|NCT00000311|Buprenorphine|buprenorphine|mesh-list
102611383|NCT00000311|Methadone|methadone|mesh-list
102611384|NCT00000311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102611385|NCT00000311|Narcotics|narcotics|mesh-ancestor
102611386|NCT00000311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102611387|NCT00000311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611388|NCT00000311|Analgesics|analgesics|mesh-ancestor
102611389|NCT00000311|Sensory System Agents|sensory system agents|mesh-ancestor
102611390|NCT00000311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102611391|NCT00000311|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102611392|NCT00000311|Antitussive Agents|antitussive agents|mesh-ancestor
102611393|NCT00000311|Respiratory System Agents|respiratory system agents|mesh-ancestor
102611394|NCT00000317|Risperidone|risperidone|mesh-list
102611395|NCT00000317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102611396|NCT00000317|Serotonin Agents|serotonin agents|mesh-ancestor
102611397|NCT00000317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102611398|NCT00000317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611399|NCT00000317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611400|NCT00000317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102611401|NCT00000317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102611402|NCT00000317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102611403|NCT00000317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102611404|NCT00000317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102611405|NCT00000317|Dopamine Agents|dopamine agents|mesh-ancestor
102611406|NCT00001115|Acyclovir|acyclovir|mesh-list
102611407|NCT00001115|Antiviral Agents|antiviral agents|mesh-ancestor
102611408|NCT00001115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611409|NCT00001757|Voriconazole|voriconazole|mesh-list
102611410|NCT00001757|Antifungal Agents|antifungal agents|mesh-ancestor
102611411|NCT00001757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611412|NCT00001757|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102611413|NCT00001757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102611414|NCT00001757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611415|NCT00001757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611416|NCT00001757|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102611417|NCT00001757|Hormone Antagonists|hormone antagonists|mesh-ancestor
102611418|NCT00001757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102611419|NCT00001757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611420|NCT00001757|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102611421|NCT00001133|Ritonavir|ritonavir|mesh-list
102611422|NCT00001133|Indinavir|indinavir|mesh-list
102611423|NCT00001133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102611424|NCT00001133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102611425|NCT00001133|Protease Inhibitors|protease inhibitors|mesh-ancestor
102611426|NCT00001133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611427|NCT00001133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611428|NCT00001133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102611429|NCT00001133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102611430|NCT00001133|Antiviral Agents|antiviral agents|mesh-ancestor
102611431|NCT00001133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611432|NCT00001133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102611433|NCT00001133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102611434|NCT00000329|Analgesics, Opioid|analgesics, opioid|mesh-list
102611435|NCT00000329|Narcotics|narcotics|mesh-ancestor
102611436|NCT00000329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102611437|NCT00000329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611438|NCT00000329|Analgesics|analgesics|mesh-ancestor
102611439|NCT00000329|Sensory System Agents|sensory system agents|mesh-ancestor
102611440|NCT00000329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102611441|NCT00000335|Morphine|morphine|mesh-list
102611442|NCT00000335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102611443|NCT00000335|Narcotics|narcotics|mesh-ancestor
102158274|NCT03326661|Penicillins|penicillins|mesh-list
102611444|NCT00000335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102611445|NCT00000335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611446|NCT00000335|Analgesics|analgesics|mesh-ancestor
102611447|NCT00000335|Sensory System Agents|sensory system agents|mesh-ancestor
102611448|NCT00000335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102611449|NCT00000341|Buprenorphine|buprenorphine|mesh-list
102611450|NCT00000341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102611451|NCT00000341|Narcotics|narcotics|mesh-ancestor
102611452|NCT00000341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102611453|NCT00000341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611454|NCT00000341|Analgesics|analgesics|mesh-ancestor
102611455|NCT00000341|Sensory System Agents|sensory system agents|mesh-ancestor
102611456|NCT00000341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102611457|NCT00000341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102611458|NCT00000347|Risperidone|risperidone|mesh-list
102611459|NCT00000347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102611460|NCT00000347|Serotonin Agents|serotonin agents|mesh-ancestor
102611461|NCT00000347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102611462|NCT00000347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611463|NCT00000347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611464|NCT00000347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102611465|NCT00000347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102611466|NCT00000347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102611467|NCT00000347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102611468|NCT00000347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102611469|NCT00000347|Dopamine Agents|dopamine agents|mesh-ancestor
102611470|NCT00001835|Oxaliplatin|oxaliplatin|mesh-list
102611471|NCT00001835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102611472|NCT00001193|Melphalan|melphalan|mesh-list
102611473|NCT00001193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102611474|NCT00001193|Alkylating Agents|alkylating agents|mesh-ancestor
102611475|NCT00001193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611476|NCT00001193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102611477|NCT00001193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102611478|NCT00001193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102611479|NCT00001193|Immunologic Factors|immunologic factors|mesh-ancestor
102611480|NCT00001193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611481|NCT00000353|Buprenorphine|buprenorphine|mesh-list
102611482|NCT00000353|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102611483|NCT00000353|Naloxone|naloxone|mesh-list
102611484|NCT00000353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102611485|NCT00000353|Narcotics|narcotics|mesh-ancestor
102611486|NCT00000353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102611487|NCT00000353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611488|NCT00000353|Analgesics|analgesics|mesh-ancestor
102611489|NCT00000353|Sensory System Agents|sensory system agents|mesh-ancestor
102611490|NCT00000353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102611491|NCT00000353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102611492|NCT00000377|Nortriptyline|nortriptyline|mesh-list
102611493|NCT00000377|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102611494|NCT00000377|Antidepressive Agents|antidepressive agents|mesh-ancestor
102611495|NCT00000377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102611496|NCT00000377|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102611497|NCT00000377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102611498|NCT00000377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102611499|NCT00000377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611500|NCT00000377|Adrenergic Agents|adrenergic agents|mesh-ancestor
102611501|NCT00000377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102611502|NCT00000377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611503|NCT00001865|Daclizumab|daclizumab|mesh-list
102611504|NCT00001865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102611505|NCT00001865|Immunologic Factors|immunologic factors|mesh-ancestor
102611506|NCT00001865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611507|NCT00000389|Fluvoxamine|fluvoxamine|mesh-list
102611508|NCT00000389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102611509|NCT00000389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102611510|NCT00000389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102611511|NCT00000389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611512|NCT00000389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102611513|NCT00000389|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102611514|NCT00000389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102611515|NCT00000389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102611516|NCT00000389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158353|NCT03325803|Lidocaine|lidocaine|mesh-list
102611517|NCT00000389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102611518|NCT00000389|Serotonin Agents|serotonin agents|mesh-ancestor
102611519|NCT00000389|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102611520|NCT00000389|Antidepressive Agents|antidepressive agents|mesh-ancestor
102611521|NCT00000389|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102611522|NCT00000389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102611523|NCT00000389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611524|NCT00000389|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102611525|NCT00001877|Pentoxifylline|pentoxifylline|mesh-list
102611526|NCT00001877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102611527|NCT00001877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611528|NCT00001877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611529|NCT00001877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102611530|NCT00001877|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102611531|NCT00001877|Protective Agents|protective agents|mesh-ancestor
102611532|NCT00001877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611533|NCT00001877|Vasodilator Agents|vasodilator agents|mesh-ancestor
102611534|NCT00001877|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102611535|NCT00001877|Antioxidants|antioxidants|mesh-ancestor
102611536|NCT00380939|Atorvastatin|atorvastatin|mesh-list
102611537|NCT00380939|Pravastatin|pravastatin|mesh-list
102611538|NCT00380939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102611539|NCT00380939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102611540|NCT00380939|Antimetabolites|antimetabolites|mesh-ancestor
102611541|NCT00380939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611542|NCT00380939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102611543|NCT00380939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102611544|NCT00380939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611545|NCT00001889|Dobutamine|dobutamine|mesh-list
102611546|NCT00001889|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102611547|NCT00001889|Sympathomimetics|sympathomimetics|mesh-ancestor
102611548|NCT00001889|Autonomic Agents|autonomic agents|mesh-ancestor
102611549|NCT00001889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102611550|NCT00001889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611551|NCT00001889|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102611552|NCT00001889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102611553|NCT00001889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102611554|NCT00001889|Adrenergic Agents|adrenergic agents|mesh-ancestor
102611555|NCT00001889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102611556|NCT00001889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611557|NCT00001889|Protective Agents|protective agents|mesh-ancestor
102611558|NCT00001901|Etanercept|etanercept|mesh-list
102611559|NCT00001901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102611560|NCT00001901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102611561|NCT00001901|Analgesics|analgesics|mesh-ancestor
102611562|NCT00001901|Sensory System Agents|sensory system agents|mesh-ancestor
102611563|NCT00001901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102611564|NCT00001901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611565|NCT00001901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102611566|NCT00001901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102611567|NCT00001901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102611568|NCT00001901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102611569|NCT00001901|Immunologic Factors|immunologic factors|mesh-ancestor
102611570|NCT00000437|Naltrexone|naltrexone|mesh-list
102611571|NCT00000437|Nicotine|nicotine|mesh-list
102611572|NCT00000437|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102611573|NCT00000437|Autonomic Agents|autonomic agents|mesh-ancestor
102611574|NCT00000437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102611575|NCT00000437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611576|NCT00000437|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102611577|NCT00000437|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102611578|NCT00000437|Cholinergic Agents|cholinergic agents|mesh-ancestor
102611579|NCT00000437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102611580|NCT00000437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611581|NCT00000437|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102611582|NCT00000437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102611583|NCT00000437|Sensory System Agents|sensory system agents|mesh-ancestor
102611584|NCT00000443|Ondansetron|ondansetron|mesh-list
102611585|NCT00000443|Antiemetics|antiemetics|mesh-ancestor
102611586|NCT00000443|Autonomic Agents|autonomic agents|mesh-ancestor
102611587|NCT00000443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102611588|NCT00000443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611589|NCT00000443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102611590|NCT00000443|Antipruritics|antipruritics|mesh-ancestor
102158454|NCT04493463|Hormones|hormones|mesh-ancestor
102611591|NCT00000443|Dermatologic Agents|dermatologic agents|mesh-ancestor
102346946|NCT03362515|Furosemide|furosemide|mesh-list
102611592|NCT00000443|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102611593|NCT00000443|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102611594|NCT00000443|Serotonin Agents|serotonin agents|mesh-ancestor
102611595|NCT00000443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102611596|NCT00000443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611597|NCT00000449|Naltrexone|naltrexone|mesh-list
102611598|NCT00000449|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102611599|NCT00000449|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102611600|NCT00000449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611601|NCT00000449|Sensory System Agents|sensory system agents|mesh-ancestor
102611602|NCT00000449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102611603|NCT00000455|Naltrexone|naltrexone|mesh-list
102611604|NCT00000455|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102611605|NCT00000455|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102611606|NCT00000455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611607|NCT00000455|Sensory System Agents|sensory system agents|mesh-ancestor
102611608|NCT00000455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102611609|NCT00001307|Capsaicin|capsaicin|mesh-list
102611610|NCT00001307|Antipruritics|antipruritics|mesh-ancestor
102611611|NCT00001307|Dermatologic Agents|dermatologic agents|mesh-ancestor
102611612|NCT00001307|Sensory System Agents|sensory system agents|mesh-ancestor
102611613|NCT00001307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102611614|NCT00001307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611615|NCT04713761|Carboplatin|carboplatin|mesh-list
102611616|NCT04713761|Pemetrexed|pemetrexed|mesh-list
102611617|NCT04713761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102611618|NCT04713761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611619|NCT04713761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611620|NCT04713761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102611621|NCT04713761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102611622|NCT00001937|Fluconazole|fluconazole|mesh-list
102611623|NCT00001937|Antifungal Agents|antifungal agents|mesh-ancestor
102611624|NCT00001937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611625|NCT00001937|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102611626|NCT00001937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102611627|NCT00001937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611628|NCT00001937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611629|NCT00001937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102611630|NCT00001937|Hormone Antagonists|hormone antagonists|mesh-ancestor
102611631|NCT00001937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102611632|NCT00001937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611633|NCT00001937|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102611634|NCT00001937|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102611635|NCT00001325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102611636|NCT00001325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102611637|NCT00001325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611638|NCT04331327|Mitogens|mitogens|mesh-list
102611639|NCT04331327|Mitosis Modulators|mitosis modulators|mesh-ancestor
102611640|NCT04331327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611641|NCT00001955|Celecoxib|celecoxib|mesh-list
102611642|NCT00001955|Etanercept|etanercept|mesh-list
102611643|NCT00001955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102611644|NCT00001955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102611645|NCT00001955|Analgesics|analgesics|mesh-ancestor
102611646|NCT00001955|Sensory System Agents|sensory system agents|mesh-ancestor
102611647|NCT00001955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102611648|NCT00001955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611649|NCT00001955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102611650|NCT00001955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102611651|NCT00001955|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102611652|NCT00001955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102611653|NCT00001955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611654|NCT00001955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611655|NCT00001955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102611656|NCT00001955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102611657|NCT00001955|Immunologic Factors|immunologic factors|mesh-ancestor
102611658|NCT04943783|Atorvastatin|atorvastatin|mesh-list
102611659|NCT04943783|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102611660|NCT04943783|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102611661|NCT04943783|Antimetabolites|antimetabolites|mesh-ancestor
102369684|NCT04450134|Histamine Antagonists|histamine antagonists|mesh-ancestor
102611662|NCT04943783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158501|NCT05229536|Vaccines|vaccines|mesh-list
102611663|NCT04943783|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102611664|NCT04943783|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102611665|NCT04943783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611666|NCT00000605|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102611667|NCT00000605|Medroxyprogesterone|medroxyprogesterone|mesh-list
102611668|NCT00000605|Hormones|hormones|mesh-list
102611669|NCT00000605|Estrogens|estrogens|mesh-list
102611670|NCT00000605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102611671|NCT00000605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611672|NCT00000605|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102611673|NCT00000605|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102611674|NCT00000605|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102611675|NCT00000605|Contraceptive Agents|contraceptive agents|mesh-ancestor
102611676|NCT00000605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102611677|NCT00000605|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102611678|NCT00000605|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102611679|NCT00000605|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102611680|NCT00000605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102611681|NCT00000605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102611682|NCT00000617|Azithromycin|azithromycin|mesh-list
102611683|NCT00000617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102611684|NCT00000617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611685|NCT00000623|Decitabine|decitabine|mesh-list
102611686|NCT00000623|Sildenafil Citrate|sildenafil citrate|mesh-list
102611687|NCT00000623|Deferiprone|deferiprone|mesh-list
102611688|NCT00000623|Deferoxamine|deferoxamine|mesh-list
102611689|NCT00000623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102611690|NCT00000623|Antimetabolites|antimetabolites|mesh-ancestor
102611691|NCT00000623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611692|NCT00000623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102611693|NCT00000623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611694|NCT00000623|Vasodilator Agents|vasodilator agents|mesh-ancestor
102611695|NCT00000623|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102611696|NCT00000623|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102611697|NCT00000623|Urological Agents|urological agents|mesh-ancestor
102611698|NCT00000623|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102611699|NCT00000623|Chelating Agents|chelating agents|mesh-ancestor
102611700|NCT00000623|Sequestering Agents|sequestering agents|mesh-ancestor
102611701|NCT00000623|Siderophores|siderophores|mesh-ancestor
102611702|NCT00001991|Atovaquone|atovaquone|mesh-list
102611703|NCT00001991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611704|NCT00001991|Antimalarials|antimalarials|mesh-ancestor
102611705|NCT00001991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102611706|NCT00001991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102611707|NCT00001991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611708|NCT00001991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611709|NCT00001997|Zidovudine|zidovudine|mesh-list
102611710|NCT00001997|Didanosine|didanosine|mesh-list
102611711|NCT00001997|Interleukin-2|interleukin-2|mesh-list
102611712|NCT00001997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102611713|NCT00001997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102611714|NCT00001997|Analgesics|analgesics|mesh-ancestor
102611715|NCT00001997|Sensory System Agents|sensory system agents|mesh-ancestor
102611716|NCT00001997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102611717|NCT00001997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611718|NCT00001997|Antimetabolites|antimetabolites|mesh-ancestor
102611719|NCT00001997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611720|NCT00001997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102611721|NCT00001997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102611722|NCT00001997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611723|NCT00001997|Antiviral Agents|antiviral agents|mesh-ancestor
102611724|NCT00001997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611725|NCT00001997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102611726|NCT00001997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102611727|NCT00002003|Etoposide|etoposide|mesh-list
102611728|NCT00002003|Mitoxantrone|mitoxantrone|mesh-list
102611729|NCT00002003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102611730|NCT00002003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102611731|NCT00002003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102611732|NCT00002003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102611733|NCT00002003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102369685|NCT04450134|Histamine Agents|histamine agents|mesh-ancestor
102611734|NCT00002003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611735|NCT00002003|Analgesics|analgesics|mesh-ancestor
102158577|NCT05465031|Valsartan|valsartan|mesh-list
102611736|NCT00002003|Sensory System Agents|sensory system agents|mesh-ancestor
102611737|NCT00002003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102611738|NCT00002003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611739|NCT00002009|Sargramostim|sargramostim|mesh-list
102611740|NCT00002009|Immunologic Factors|immunologic factors|mesh-ancestor
102611741|NCT00002009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611742|NCT00000629|Zidovudine|zidovudine|mesh-list
102611743|NCT00000629|Valproic Acid|valproic acid|mesh-list
102611744|NCT00000629|Antimetabolites|antimetabolites|mesh-ancestor
102611745|NCT00000629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611746|NCT00000629|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102611747|NCT00000629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102611748|NCT00000629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611749|NCT00000629|Antiviral Agents|antiviral agents|mesh-ancestor
102611750|NCT00000629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611751|NCT00000629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102611752|NCT00000629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102611753|NCT00000629|Anticonvulsants|anticonvulsants|mesh-ancestor
102611754|NCT00000629|GABA Agents|gaba agents|mesh-ancestor
102611755|NCT00000629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102611756|NCT00000629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611757|NCT00000629|Antimanic Agents|antimanic agents|mesh-ancestor
102611758|NCT00000629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102611759|NCT00000629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102611760|NCT00000629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102611761|NCT00000647|Interferons|interferons|mesh-list
102611762|NCT00000647|Interferon-alpha|interferon-alpha|mesh-list
102611763|NCT00000647|Zidovudine|zidovudine|mesh-list
102611764|NCT00000647|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
102611765|NCT00000647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102611766|NCT00000647|Antiviral Agents|antiviral agents|mesh-ancestor
102611767|NCT00000647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611768|NCT00000647|Immunologic Factors|immunologic factors|mesh-ancestor
102611769|NCT00000647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611770|NCT00000647|Antimetabolites|antimetabolites|mesh-ancestor
102611771|NCT00000647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611772|NCT00000647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102611773|NCT00000647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102611774|NCT00000647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611775|NCT00000647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102611776|NCT00000647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102611777|NCT00000653|Zalcitabine|zalcitabine|mesh-list
102611778|NCT00000653|Antimetabolites|antimetabolites|mesh-ancestor
102611779|NCT00000653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611780|NCT00000653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102611781|NCT00000653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102611782|NCT00000653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611783|NCT00000653|Antiviral Agents|antiviral agents|mesh-ancestor
102611784|NCT00000653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611785|NCT00000653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102611786|NCT00000653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102611787|NCT00001409|Interleukin-2|interleukin-2|mesh-list
102611788|NCT00001409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102611789|NCT00001409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102611790|NCT00001409|Analgesics|analgesics|mesh-ancestor
102611791|NCT00001409|Sensory System Agents|sensory system agents|mesh-ancestor
102611792|NCT00001409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102611793|NCT00001409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611794|NCT00000659|Zidovudine|zidovudine|mesh-list
102611795|NCT00000659|Antimetabolites|antimetabolites|mesh-ancestor
102611796|NCT00000659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611797|NCT00000659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102611798|NCT00000659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102611799|NCT00000659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611800|NCT00000659|Antiviral Agents|antiviral agents|mesh-ancestor
102611801|NCT00000659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611802|NCT00000659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102611803|NCT00000659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102611804|NCT00381017|Interferons|interferons|mesh-list
102611805|NCT00381017|Interferon-alpha|interferon-alpha|mesh-list
102611806|NCT00381017|Interferon alpha-2|interferon alpha-2|mesh-list
102611807|NCT00381017|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102611808|NCT00381017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102611809|NCT00381017|Antiviral Agents|antiviral agents|mesh-ancestor
102611810|NCT00381017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611811|NCT00381017|Immunologic Factors|immunologic factors|mesh-ancestor
102611812|NCT00381017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611813|NCT00002015|Ganciclovir|ganciclovir|mesh-list
102611814|NCT00002015|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102611815|NCT00002015|Antiviral Agents|antiviral agents|mesh-ancestor
102611816|NCT00002015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611817|NCT00002015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102611818|NCT00002015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611819|NCT00002015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611820|NCT00002021|Foscarnet|foscarnet|mesh-list
102611821|NCT00002021|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
102611822|NCT00002021|Antiviral Agents|antiviral agents|mesh-ancestor
102611823|NCT00002021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611824|NCT00002021|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102611825|NCT00002021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102611826|NCT00002021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611827|NCT00002021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611828|NCT00002027|Diclazuril|diclazuril|mesh-list
102611829|NCT00002027|Coccidiostats|coccidiostats|mesh-ancestor
102611830|NCT00002027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102611831|NCT00002027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102611832|NCT00002027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611833|NCT00000695|Interferons|interferons|mesh-list
102611834|NCT00000695|Zidovudine|zidovudine|mesh-list
102611835|NCT00000695|Interferon-beta|interferon-beta|mesh-list
102611836|NCT00000695|Interferon beta-1b|interferon beta-1b|mesh-list
102611837|NCT00000695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102611838|NCT00000695|Antiviral Agents|antiviral agents|mesh-ancestor
102611839|NCT00000695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611840|NCT00000695|Antimetabolites|antimetabolites|mesh-ancestor
102611841|NCT00000695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611842|NCT00000695|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102611843|NCT00000695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102611844|NCT00000695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611845|NCT00000695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102611846|NCT00000695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102611847|NCT00000695|Immunologic Factors|immunologic factors|mesh-ancestor
102611848|NCT00000695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611849|NCT00000695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102611850|NCT00000701|Zidovudine|zidovudine|mesh-list
102611851|NCT00000701|Antimetabolites|antimetabolites|mesh-ancestor
102611852|NCT00000701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611853|NCT00000701|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102611854|NCT00000701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102611855|NCT00000701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611856|NCT00000701|Antiviral Agents|antiviral agents|mesh-ancestor
102611857|NCT00000701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611858|NCT00000701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102611859|NCT00000701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102611860|NCT00000713|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
102611861|NCT00000713|Antiviral Agents|antiviral agents|mesh-ancestor
102611862|NCT00000713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611863|NCT00000725|Interferons|interferons|mesh-list
102611864|NCT00000725|Interferon-alpha|interferon-alpha|mesh-list
102611865|NCT00000725|Interferon alpha-2|interferon alpha-2|mesh-list
102611866|NCT00000725|Zidovudine|zidovudine|mesh-list
102611867|NCT00000725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102611868|NCT00000725|Antiviral Agents|antiviral agents|mesh-ancestor
102611869|NCT00000725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611870|NCT00000725|Immunologic Factors|immunologic factors|mesh-ancestor
102611871|NCT00000725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611872|NCT00000725|Antimetabolites|antimetabolites|mesh-ancestor
102611873|NCT00000725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611874|NCT00000725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102611875|NCT00000725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102611876|NCT00000725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611877|NCT00000725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102611878|NCT00000725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102611879|NCT00002033|Zidovudine|zidovudine|mesh-list
102611880|NCT00002033|Antimetabolites|antimetabolites|mesh-ancestor
102611881|NCT00002033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611882|NCT00002033|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102611883|NCT00002033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102611884|NCT00002033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611885|NCT00002033|Antiviral Agents|antiviral agents|mesh-ancestor
102611886|NCT00002033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611887|NCT00002033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102611888|NCT00002033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102611889|NCT00002039|Foscarnet|foscarnet|mesh-list
102611890|NCT00002039|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
102611891|NCT00002039|Antiviral Agents|antiviral agents|mesh-ancestor
102611892|NCT00002039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611893|NCT00002039|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102611894|NCT00002039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102611895|NCT00002039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611896|NCT00002039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611897|NCT00000731|Acetaminophen|acetaminophen|mesh-list
102611898|NCT00000731|Zidovudine|zidovudine|mesh-list
102611899|NCT00000731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102611900|NCT00000731|Analgesics|analgesics|mesh-ancestor
102611901|NCT00000731|Sensory System Agents|sensory system agents|mesh-ancestor
102611902|NCT00000731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102611903|NCT00000731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611904|NCT00000731|Antipyretics|antipyretics|mesh-ancestor
102611905|NCT00000731|Antimetabolites|antimetabolites|mesh-ancestor
102611906|NCT00000731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611907|NCT00000731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102611908|NCT00000731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102611909|NCT00000731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611910|NCT00000731|Antiviral Agents|antiviral agents|mesh-ancestor
102611911|NCT00000731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611912|NCT00000731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102611913|NCT00000731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102611914|NCT00002045|Zidovudine|zidovudine|mesh-list
102611915|NCT00002045|Antimetabolites|antimetabolites|mesh-ancestor
102611916|NCT00002045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611917|NCT00002045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102611918|NCT00002045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102611919|NCT00002045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611920|NCT00002045|Antiviral Agents|antiviral agents|mesh-ancestor
102611921|NCT00002045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611922|NCT00002045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102611923|NCT00002045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102611924|NCT00002051|Thymopentin|thymopentin|mesh-list
102346983|NCT03245151|Everolimus|everolimus|mesh-list
102611925|NCT00002051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102611926|NCT00002051|Immunologic Factors|immunologic factors|mesh-ancestor
102611927|NCT00002051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611928|NCT00001499|Paclitaxel|paclitaxel|mesh-list
102611929|NCT00001499|Cisplatin|cisplatin|mesh-list
102611930|NCT00001499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102611931|NCT00001499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102611932|NCT00001499|Tubulin Modulators|tubulin modulators|mesh-ancestor
102611933|NCT00001499|Antimitotic Agents|antimitotic agents|mesh-ancestor
102611934|NCT00001499|Mitosis Modulators|mitosis modulators|mesh-ancestor
102611935|NCT00001499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611936|NCT00002057|Nystatin|nystatin|mesh-list
102611937|NCT00002057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102611938|NCT00002057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611939|NCT00002057|Antifungal Agents|antifungal agents|mesh-ancestor
102611940|NCT00002057|Ionophores|ionophores|mesh-ancestor
102611941|NCT00002057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102611942|NCT00002057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611943|NCT00002297|Inosine Pranobex|inosine pranobex|mesh-list
102611944|NCT00002297|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102611945|NCT00002297|Immunologic Factors|immunologic factors|mesh-ancestor
102611946|NCT00002297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611947|NCT00002297|Antiviral Agents|antiviral agents|mesh-ancestor
102611948|NCT00002297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611949|NCT00001535|Interleukin-2|interleukin-2|mesh-list
102611950|NCT00001535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102611951|NCT00001535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102611952|NCT00001535|Analgesics|analgesics|mesh-ancestor
102611953|NCT00001535|Sensory System Agents|sensory system agents|mesh-ancestor
102611954|NCT00001535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102611955|NCT00001535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611956|NCT00002303|Epoetin Alfa|epoetin alfa|mesh-list
102611957|NCT00002303|Hematinics|hematinics|mesh-ancestor
102611958|NCT00002063|Zidovudine|zidovudine|mesh-list
102611959|NCT00002063|Antimetabolites|antimetabolites|mesh-ancestor
102611960|NCT00002063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611961|NCT00002063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102611962|NCT00002063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102611963|NCT00002063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611964|NCT00002063|Antiviral Agents|antiviral agents|mesh-ancestor
102611965|NCT00002063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611966|NCT00002063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102611967|NCT00002063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102611968|NCT00002069|Ditiocarb|ditiocarb|mesh-list
102611969|NCT00002069|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102611970|NCT00002069|Immunologic Factors|immunologic factors|mesh-ancestor
102611971|NCT00002069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102611972|NCT00002069|Antiviral Agents|antiviral agents|mesh-ancestor
102611973|NCT00002069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611974|NCT00002069|Chelating Agents|chelating agents|mesh-ancestor
102611975|NCT00002069|Sequestering Agents|sequestering agents|mesh-ancestor
102611976|NCT00002069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611977|NCT00001565|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
102611978|NCT00001565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102611979|NCT00002309|Azithromycin|azithromycin|mesh-list
102611980|NCT00002309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102611981|NCT00002309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611982|NCT00002315|Acyclovir|acyclovir|mesh-list
102611983|NCT00002315|5-propynylarabinofuranosyluracil|5-propynylarabinofuranosyluracil|mesh-list
102611984|NCT00002315|Antiviral Agents|antiviral agents|mesh-ancestor
102611985|NCT00002315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611986|NCT00002075|Fluconazole|fluconazole|mesh-list
102611987|NCT00002075|Amphotericin B|amphotericin b|mesh-list
102611988|NCT00002075|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102611989|NCT00002075|Flucytosine|flucytosine|mesh-list
102611990|NCT00002075|Antifungal Agents|antifungal agents|mesh-ancestor
102611991|NCT00002075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102611992|NCT00002075|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102611993|NCT00002075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102611994|NCT00002075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102611995|NCT00002075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102611996|NCT00002075|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102611997|NCT00002075|Hormone Antagonists|hormone antagonists|mesh-ancestor
102611998|NCT00002075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102611999|NCT00002075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102612000|NCT00002075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102612001|NCT00002075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102612002|NCT00002075|Amebicides|amebicides|mesh-ancestor
102612003|NCT00002075|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102612004|NCT00002075|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102612005|NCT00002075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102612006|NCT00002075|Antimetabolites|antimetabolites|mesh-ancestor
102612007|NCT00001577|Melphalan|melphalan|mesh-list
102612008|NCT00001577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102612009|NCT00001577|Alkylating Agents|alkylating agents|mesh-ancestor
102612010|NCT00001577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612011|NCT00001577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102612012|NCT00001577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102612013|NCT00001577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102612014|NCT00001577|Immunologic Factors|immunologic factors|mesh-ancestor
102612015|NCT00001577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102612016|NCT00002081|Zidovudine|zidovudine|mesh-list
102612017|NCT00002081|Zalcitabine|zalcitabine|mesh-list
102612018|NCT00002081|Antimetabolites|antimetabolites|mesh-ancestor
102612019|NCT00002081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612020|NCT00002081|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102612021|NCT00002081|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102612022|NCT00002081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612023|NCT00002081|Antiviral Agents|antiviral agents|mesh-ancestor
102612024|NCT00002081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102612025|NCT00002081|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102612026|NCT00002081|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102612027|NCT00002093|Doxorubicin|doxorubicin|mesh-list
102612028|NCT00002093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102612029|NCT00002093|Daunorubicin|daunorubicin|mesh-list
102612030|NCT00002093|Bleomycin|bleomycin|mesh-list
102612031|NCT00002093|Vincristine|vincristine|mesh-list
102612032|NCT00002093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102612033|NCT00002093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102612034|NCT00002093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102612035|NCT00002093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102612036|NCT00002093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612037|NCT00002093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612038|NCT00002093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102612039|NCT00002093|Tubulin Modulators|tubulin modulators|mesh-ancestor
102612040|NCT00002093|Antimitotic Agents|antimitotic agents|mesh-ancestor
102612041|NCT00002093|Mitosis Modulators|mitosis modulators|mesh-ancestor
102612042|NCT00002099|Didanosine|didanosine|mesh-list
102612043|NCT00002099|Lentinan|lentinan|mesh-list
102612044|NCT00002099|Antimetabolites|antimetabolites|mesh-ancestor
102612045|NCT00002099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612046|NCT00002099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102612047|NCT00002099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102612048|NCT00002099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612049|NCT00002099|Antiviral Agents|antiviral agents|mesh-ancestor
102612050|NCT00002099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102612051|NCT00002099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102612052|NCT00002099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102612053|NCT00002099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102612054|NCT00002099|Immunologic Factors|immunologic factors|mesh-ancestor
102612055|NCT00002099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102612056|NCT00002099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102612057|NCT00002321|Aldesleukin|aldesleukin|mesh-list
102612058|NCT00002321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102612059|NCT00002321|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102612060|NCT00002321|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102612061|NCT00002321|Antiviral Agents|antiviral agents|mesh-ancestor
102612062|NCT00002321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102612063|NCT00002327|Cidofovir|cidofovir|mesh-list
102612064|NCT00002327|Antiviral Agents|antiviral agents|mesh-ancestor
102612065|NCT00002327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102612066|NCT00002327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612067|NCT00002327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612068|NCT00002333|Saquinavir|saquinavir|mesh-list
102612069|NCT00002333|Zalcitabine|zalcitabine|mesh-list
102612070|NCT00002333|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102612071|NCT00002333|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102612072|NCT00002333|Protease Inhibitors|protease inhibitors|mesh-ancestor
102612073|NCT00002333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612074|NCT00002333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612075|NCT00002333|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102612076|NCT00002333|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102612077|NCT00002333|Antiviral Agents|antiviral agents|mesh-ancestor
102612078|NCT00002333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102612079|NCT00002333|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102612080|NCT00002333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102612081|NCT00002333|Antimetabolites|antimetabolites|mesh-ancestor
102612082|NCT00002333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102612083|NCT00002333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102612084|NCT00002339|Fluconazole|fluconazole|mesh-list
102612085|NCT00002339|Antifungal Agents|antifungal agents|mesh-ancestor
102612086|NCT00002339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102612087|NCT00002339|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102612088|NCT00002339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102612089|NCT00002339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612090|NCT00002339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612091|NCT00002339|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102612092|NCT00002339|Hormone Antagonists|hormone antagonists|mesh-ancestor
102612093|NCT00002339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102612094|NCT00002339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102612095|NCT00002339|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102612096|NCT00002339|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102612097|NCT00002105|Doxorubicin|doxorubicin|mesh-list
102612098|NCT00002105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102612099|NCT00002105|Bleomycin|bleomycin|mesh-list
102612100|NCT00002105|Vincristine|vincristine|mesh-list
102612101|NCT00002105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102612102|NCT00002105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102612103|NCT00002105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102612104|NCT00002105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102612105|NCT00002105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612106|NCT00002105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612107|NCT00002105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102612108|NCT00002105|Tubulin Modulators|tubulin modulators|mesh-ancestor
102612109|NCT00002105|Antimitotic Agents|antimitotic agents|mesh-ancestor
102612110|NCT00002105|Mitosis Modulators|mitosis modulators|mesh-ancestor
102612111|NCT00002345|Megestrol|megestrol|mesh-list
102612112|NCT00002345|Megestrol Acetate|megestrol acetate|mesh-list
102612113|NCT00002345|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102612114|NCT00002345|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102612115|NCT00002345|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102612116|NCT00002345|Contraceptive Agents|contraceptive agents|mesh-ancestor
102612117|NCT00002345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102612118|NCT00002345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102612119|NCT00002345|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102612120|NCT00002345|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102612121|NCT00002345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102612122|NCT00002345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102612123|NCT00002345|Appetite Stimulants|appetite stimulants|mesh-ancestor
102612124|NCT00002345|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102612125|NCT00002111|Saquinavir|saquinavir|mesh-list
102612126|NCT00002111|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102612127|NCT00002111|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102612128|NCT00002111|Protease Inhibitors|protease inhibitors|mesh-ancestor
102612129|NCT00002111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612130|NCT00002111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612131|NCT00002111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102612132|NCT00002111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102612133|NCT00002111|Antiviral Agents|antiviral agents|mesh-ancestor
102612134|NCT00002111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102612135|NCT00002111|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102612136|NCT00002111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102612137|NCT00002351|Indinavir|indinavir|mesh-list
102612138|NCT00002351|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102612139|NCT00002351|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102612140|NCT00002351|Protease Inhibitors|protease inhibitors|mesh-ancestor
102612141|NCT00002351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612142|NCT00002351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612143|NCT00002351|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102612144|NCT00002351|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102612145|NCT00002351|Antiviral Agents|antiviral agents|mesh-ancestor
102612146|NCT00002351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102612147|NCT00002357|Zidovudine|zidovudine|mesh-list
102612148|NCT00002357|Antimetabolites|antimetabolites|mesh-ancestor
102612149|NCT00002357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612150|NCT00002357|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102612151|NCT00002357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102612152|NCT00002357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612153|NCT00002357|Antiviral Agents|antiviral agents|mesh-ancestor
102612154|NCT00002357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102612155|NCT00002357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102612156|NCT00002357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102612157|NCT00002117|Zidovudine|zidovudine|mesh-list
102612158|NCT00002117|Zalcitabine|zalcitabine|mesh-list
102612159|NCT00002117|Antimetabolites|antimetabolites|mesh-ancestor
102612160|NCT00002117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612161|NCT00002117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102612162|NCT00002117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102612163|NCT00002117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612164|NCT00002117|Antiviral Agents|antiviral agents|mesh-ancestor
102612165|NCT00002117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102612166|NCT00002117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102612167|NCT00002117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102612168|NCT00002123|Didanosine|didanosine|mesh-list
102612169|NCT00002123|Delavirdine|delavirdine|mesh-list
102612170|NCT00002123|Antimetabolites|antimetabolites|mesh-ancestor
102612171|NCT00002123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612172|NCT00002123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102612173|NCT00002123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102612174|NCT00002123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612175|NCT00002123|Antiviral Agents|antiviral agents|mesh-ancestor
102612176|NCT00002123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102612177|NCT00002123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102612178|NCT00002123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102612179|NCT00381173|Cyclophosphamide|cyclophosphamide|mesh-list
102612180|NCT00381173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102612181|NCT00381173|Immunologic Factors|immunologic factors|mesh-ancestor
102612182|NCT00381173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102612183|NCT00381173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102612184|NCT00381173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102612185|NCT00381173|Alkylating Agents|alkylating agents|mesh-ancestor
102612186|NCT00381173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612187|NCT00381173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102612188|NCT00381173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102612189|NCT00002129|Vesnarinone|vesnarinone|mesh-list
102612190|NCT00002129|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102612191|NCT00002129|Immunologic Factors|immunologic factors|mesh-ancestor
102612192|NCT00002129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102612193|NCT00002129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102612194|NCT00002129|Antiviral Agents|antiviral agents|mesh-ancestor
102612195|NCT00002129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102612196|NCT00002129|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102612197|NCT00002129|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102612198|NCT00002129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612199|NCT00002129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612200|NCT00002129|Protective Agents|protective agents|mesh-ancestor
102612202|NCT00002135|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102612203|NCT00002135|Antiviral Agents|antiviral agents|mesh-ancestor
102612204|NCT00002135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102612205|NCT00002135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102612206|NCT00002135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612207|NCT00002135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612208|NCT00002141|Abacavir|abacavir|mesh-list
102612209|NCT00002141|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102612210|NCT00002141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102612211|NCT00002141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612212|NCT00002141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612213|NCT00002141|Antiviral Agents|antiviral agents|mesh-ancestor
102612214|NCT00002141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102612215|NCT00002141|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102612216|NCT00002141|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102612217|NCT00002369|Lamivudine|lamivudine|mesh-list
102612218|NCT00002369|Zidovudine|zidovudine|mesh-list
102612219|NCT00002369|Stavudine|stavudine|mesh-list
102612220|NCT00002369|Indinavir|indinavir|mesh-list
102347001|NCT03202628|Ixazomib|ixazomib|mesh-list
102612221|NCT00002369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102612222|NCT00002369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102612223|NCT00002369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612224|NCT00002369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612225|NCT00002369|Antiviral Agents|antiviral agents|mesh-ancestor
102612226|NCT00002369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102612227|NCT00002369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102612228|NCT00002369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102612229|NCT00002369|Antimetabolites|antimetabolites|mesh-ancestor
102612230|NCT00002369|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102612231|NCT00002369|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102612232|NCT00002369|Protease Inhibitors|protease inhibitors|mesh-ancestor
102612233|NCT00002375|Nelfinavir|nelfinavir|mesh-list
102612234|NCT00002375|Indinavir|indinavir|mesh-list
102612235|NCT00002375|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102612236|NCT00002375|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102612237|NCT00002375|Protease Inhibitors|protease inhibitors|mesh-ancestor
102612238|NCT00002375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612239|NCT00002375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612240|NCT00002375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102612241|NCT00002375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102612242|NCT00002375|Antiviral Agents|antiviral agents|mesh-ancestor
102612243|NCT00002375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102612244|NCT00002381|Nevirapine|nevirapine|mesh-list
102612245|NCT00002381|Stavudine|stavudine|mesh-list
102612246|NCT00002381|Nelfinavir|nelfinavir|mesh-list
102612247|NCT00002381|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102612248|NCT00002381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102612249|NCT00002381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612250|NCT00002381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612251|NCT00002381|Antiviral Agents|antiviral agents|mesh-ancestor
102612252|NCT00002381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102612253|NCT00002381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102612254|NCT00002381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102612255|NCT00002381|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102612256|NCT00002381|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102612257|NCT00002381|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102612258|NCT00002381|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102612259|NCT00002381|Protease Inhibitors|protease inhibitors|mesh-ancestor
102612260|NCT00002381|Antimetabolites|antimetabolites|mesh-ancestor
102612261|NCT00002387|Efavirenz|efavirenz|mesh-list
102612262|NCT00002387|Indinavir|indinavir|mesh-list
102612263|NCT00002387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102612264|NCT00002387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102612265|NCT00002387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612266|NCT00002387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612267|NCT00002387|Antiviral Agents|antiviral agents|mesh-ancestor
102154364|NCT02237755|Sequestering Agents|sequestering agents|mesh-ancestor
102347443|NCT02020694|Ergocalciferols|ergocalciferols|mesh-list
102347444|NCT02020694|Cholecalciferol|cholecalciferol|mesh-list
102347445|NCT02020694|Vitamins|vitamins|mesh-list
102347446|NCT02020694|Micronutrients|micronutrients|mesh-ancestor
102347447|NCT02020694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347448|NCT02020694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102347449|NCT02020694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102347450|NCT02019875|Clarithromycin|clarithromycin|mesh-list
102347451|NCT02019875|Rifampin|rifampin|mesh-list
102347452|NCT02019875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102347453|NCT02019875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102347454|NCT02019875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102347455|NCT02019875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102347456|NCT02019875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347457|NCT02019875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102347458|NCT02019875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102347459|NCT02019875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102347460|NCT02019875|Antitubercular Agents|antitubercular agents|mesh-ancestor
102347461|NCT02019875|Leprostatic Agents|leprostatic agents|mesh-ancestor
102347462|NCT02019875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102347463|NCT02019875|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102347464|NCT02019875|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102347465|NCT02019875|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102347466|NCT02019875|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102347002|NCT03202628|Ichthammol|ichthammol|mesh-list
102347467|NCT02019875|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102347468|NCT02019875|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102347469|NCT01907009|Melphalan|melphalan|mesh-list
102347470|NCT01907009|Lenograstim|lenograstim|mesh-list
102347471|NCT01907009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102347472|NCT01907009|Alkylating Agents|alkylating agents|mesh-ancestor
102347473|NCT01907009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347474|NCT01907009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347475|NCT01907009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102347476|NCT01907009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102347477|NCT01907009|Immunologic Factors|immunologic factors|mesh-ancestor
102347478|NCT01907009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347479|NCT01907009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102347480|NCT01882933|Oxaliplatin|oxaliplatin|mesh-list
102347481|NCT01882933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347482|NCT01718743|Lenalidomide|lenalidomide|mesh-list
102347483|NCT01718743|Ixazomib|ixazomib|mesh-list
102347484|NCT01718743|Glycine|glycine|mesh-list
102347485|NCT01718743|Immunologic Factors|immunologic factors|mesh-ancestor
102347486|NCT01718743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347487|NCT01718743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102347488|NCT01718743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102347489|NCT01718743|Growth Substances|growth substances|mesh-ancestor
102347490|NCT01718743|Growth Inhibitors|growth inhibitors|mesh-ancestor
102347491|NCT01718743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347492|NCT01718743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347493|NCT01718743|Protease Inhibitors|protease inhibitors|mesh-ancestor
102347494|NCT01718743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102347495|NCT01718743|Glycine Agents|glycine agents|mesh-ancestor
102347496|NCT01718743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102347497|NCT01701674|Aldesleukin|aldesleukin|mesh-list
102347498|NCT01701674|Cyclophosphamide|cyclophosphamide|mesh-list
102347499|NCT01701674|Fludarabine|fludarabine|mesh-list
102347500|NCT01701674|Ipilimumab|ipilimumab|mesh-list
102347501|NCT01701674|Interleukin-2|interleukin-2|mesh-list
102347502|NCT01701674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102347503|NCT01701674|Immunologic Factors|immunologic factors|mesh-ancestor
102347504|NCT01701674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347505|NCT01701674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102347506|NCT01701674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102347507|NCT01701674|Alkylating Agents|alkylating agents|mesh-ancestor
102347508|NCT01701674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347509|NCT01701674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347510|NCT01701674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102347511|NCT01701674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102347512|NCT01701674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102347513|NCT01701674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102347514|NCT01701674|Analgesics|analgesics|mesh-ancestor
102347515|NCT01701674|Sensory System Agents|sensory system agents|mesh-ancestor
102159179|NCT02488473|Analgesics|analgesics|mesh-ancestor
102347516|NCT01701674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102347517|NCT01701674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102347518|NCT01701674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102347519|NCT01701674|Antiviral Agents|antiviral agents|mesh-ancestor
102347520|NCT01701674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102347521|NCT01686126|Metformin|metformin|mesh-list
102347522|NCT01686126|Levonorgestrel|levonorgestrel|mesh-list
102347523|NCT01686126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102347524|NCT01686126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347525|NCT01686126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102347526|NCT01686126|Contraceptive Agents|contraceptive agents|mesh-ancestor
102347527|NCT01686126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102347528|NCT01686126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102347529|NCT01686126|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102347530|NCT01686126|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102347531|NCT01531582|Minocycline|minocycline|mesh-list
102347532|NCT01531582|Tetracycline|tetracycline|mesh-list
102347533|NCT01531582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102347534|NCT01531582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102347535|NCT01531582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102347536|NCT01531582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102347537|NCT01531582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347538|NCT01512888|Busulfan|busulfan|mesh-list
102347539|NCT01512888|Alkylating Agents|alkylating agents|mesh-ancestor
102347540|NCT01512888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347541|NCT01512888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102347542|NCT01512888|Immunologic Factors|immunologic factors|mesh-ancestor
102347543|NCT01512888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347544|NCT01512888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102347545|NCT01512888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347546|NCT01512888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102347547|NCT01493453|Cyclophosphamide|cyclophosphamide|mesh-list
102347548|NCT01493453|Fludarabine|fludarabine|mesh-list
102347549|NCT01493453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102347550|NCT01493453|Immunologic Factors|immunologic factors|mesh-ancestor
102347551|NCT01493453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347552|NCT01493453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102347553|NCT01493453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102347554|NCT01493453|Alkylating Agents|alkylating agents|mesh-ancestor
102347555|NCT01493453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347556|NCT01493453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347557|NCT01493453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102347558|NCT01208662|Dexamethasone|dexamethasone|mesh-list
102347559|NCT01208662|Lenalidomide|lenalidomide|mesh-list
102347560|NCT01208662|Bortezomib|bortezomib|mesh-list
102347561|NCT01208662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102347562|NCT01208662|Antiemetics|antiemetics|mesh-ancestor
102347563|NCT01208662|Autonomic Agents|autonomic agents|mesh-ancestor
102347564|NCT01208662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102347565|NCT01208662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347566|NCT01208662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102347567|NCT01208662|Glucocorticoids|glucocorticoids|mesh-ancestor
102347568|NCT01208662|Hormones|hormones|mesh-ancestor
102347569|NCT01208662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102347570|NCT01208662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102347571|NCT01208662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347572|NCT01208662|Immunologic Factors|immunologic factors|mesh-ancestor
102347573|NCT01208662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102347574|NCT01208662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102347575|NCT01208662|Growth Substances|growth substances|mesh-ancestor
102347576|NCT01208662|Growth Inhibitors|growth inhibitors|mesh-ancestor
102347577|NCT00667199|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
102347578|NCT00667199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347579|NCT00460486|Formaldehyde|formaldehyde|mesh-list
102347580|NCT00460486|Disinfectants|disinfectants|mesh-ancestor
102347581|NCT00460486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102347582|NCT00378105|Dexamethasone|dexamethasone|mesh-list
102347583|NCT00378105|Lenalidomide|lenalidomide|mesh-list
102347584|NCT00378105|Bortezomib|bortezomib|mesh-list
102347585|NCT00378105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102347586|NCT00378105|Antiemetics|antiemetics|mesh-ancestor
102347587|NCT00378105|Autonomic Agents|autonomic agents|mesh-ancestor
102347588|NCT00378105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102347589|NCT00378105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347590|NCT00378105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102347591|NCT00378105|Glucocorticoids|glucocorticoids|mesh-ancestor
102347592|NCT00378105|Hormones|hormones|mesh-ancestor
102347593|NCT00378105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102347594|NCT00378105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102347595|NCT00378105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347596|NCT00378105|Immunologic Factors|immunologic factors|mesh-ancestor
102347597|NCT00378105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102347598|NCT00378105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102347599|NCT00378105|Growth Substances|growth substances|mesh-ancestor
102347600|NCT00378105|Growth Inhibitors|growth inhibitors|mesh-ancestor
102347601|NCT00139477|Metformin|metformin|mesh-list
102347602|NCT00139477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102347603|NCT00139477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347604|NCT00082706|Leucovorin|leucovorin|mesh-list
102347605|NCT00082706|Cisplatin|cisplatin|mesh-list
102347606|NCT00082706|Gemcitabine|gemcitabine|mesh-list
102347607|NCT00082706|Fluorouracil|fluorouracil|mesh-list
102347608|NCT00082706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347609|NCT00082706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102347610|NCT00082706|Antimetabolites|antimetabolites|mesh-ancestor
102347611|NCT00082706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347612|NCT00082706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102347613|NCT00082706|Immunologic Factors|immunologic factors|mesh-ancestor
102347614|NCT00082706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347615|NCT00082706|Antidotes|antidotes|mesh-ancestor
102347616|NCT00082706|Protective Agents|protective agents|mesh-ancestor
102347617|NCT00082706|Vitamin B Complex|vitamin b complex|mesh-ancestor
102347618|NCT00082706|Vitamins|vitamins|mesh-ancestor
102347619|NCT00082706|Micronutrients|micronutrients|mesh-ancestor
102347620|NCT00004935|Trastuzumab|trastuzumab|mesh-list
102347621|NCT00004935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102347622|NCT00004935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347623|NCT00119158|Fluticasone|fluticasone|mesh-list
102347624|NCT00119158|Xhance|xhance|mesh-list
102347625|NCT00119158|Pimecrolimus|pimecrolimus|mesh-list
102347626|NCT00119158|Tacrolimus|tacrolimus|mesh-list
102347627|NCT00119158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102347628|NCT00119158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102347629|NCT00119158|Autonomic Agents|autonomic agents|mesh-ancestor
102347630|NCT00119158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102347631|NCT00119158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347632|NCT00119158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102347633|NCT00119158|Respiratory System Agents|respiratory system agents|mesh-ancestor
102347634|NCT00119158|Dermatologic Agents|dermatologic agents|mesh-ancestor
102347635|NCT00119158|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102347636|NCT00119158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102347637|NCT00119158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102347638|NCT00119158|Analgesics|analgesics|mesh-ancestor
102347639|NCT00119158|Sensory System Agents|sensory system agents|mesh-ancestor
102347640|NCT00119158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102347641|NCT00119158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102347642|NCT00119158|Immunologic Factors|immunologic factors|mesh-ancestor
102347643|NCT00119158|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102347644|NCT00119158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102347645|NCT00119158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347646|NCT00119392|Cyclosporine|cyclosporine|mesh-list
102347647|NCT00119392|Mycophenolic Acid|mycophenolic acid|mesh-list
102347648|NCT00119392|Rituximab|rituximab|mesh-list
102347649|NCT00119392|Fludarabine|fludarabine|mesh-list
102347650|NCT00119392|Fludarabine phosphate|fludarabine phosphate|mesh-list
102347651|NCT00119392|Cyclosporins|cyclosporins|mesh-list
102347652|NCT00119392|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102347027|NCT03165734|Hydroxyurea|hydroxyurea|mesh-list
102347653|NCT00119392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102347654|NCT00119392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347655|NCT00119392|Immunologic Factors|immunologic factors|mesh-ancestor
102347656|NCT00119392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347657|NCT00119392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102347658|NCT00119392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102347659|NCT00119392|Antimetabolites|antimetabolites|mesh-ancestor
102347660|NCT00119392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347661|NCT00119392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102347662|NCT00119392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102347663|NCT00119392|Antifungal Agents|antifungal agents|mesh-ancestor
102347664|NCT00119392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102347665|NCT00119392|Dermatologic Agents|dermatologic agents|mesh-ancestor
102347666|NCT00119392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102347667|NCT00119392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102159330|NCT04049786|Anesthetics|anesthetics|mesh-ancestor
102347668|NCT00119392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102347669|NCT00119392|Antitubercular Agents|antitubercular agents|mesh-ancestor
102347670|NCT00119392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102347672|NCT00218062|Amphetamine|amphetamine|mesh-list
102347673|NCT00218062|Dextroamphetamine|dextroamphetamine|mesh-list
102347674|NCT00218062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102347675|NCT00218062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347676|NCT00218062|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102347677|NCT00218062|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102347678|NCT00218062|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102347679|NCT00218062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347680|NCT00218062|Sympathomimetics|sympathomimetics|mesh-ancestor
102347681|NCT00218062|Autonomic Agents|autonomic agents|mesh-ancestor
102347682|NCT00218062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102347683|NCT00218062|Dopamine Agents|dopamine agents|mesh-ancestor
102347684|NCT00218062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102347685|NCT00218062|Adrenergic Agents|adrenergic agents|mesh-ancestor
102347686|NCT00218062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102347687|NCT00218062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102347688|NCT00218062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102347689|NCT00218062|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102347690|NCT00121186|Methotrexate|methotrexate|mesh-list
102347691|NCT00121186|Fludarabine phosphate|fludarabine phosphate|mesh-list
102347692|NCT00121186|Fludarabine|fludarabine|mesh-list
102347693|NCT00121186|Melphalan|melphalan|mesh-list
102347694|NCT00121186|Tacrolimus|tacrolimus|mesh-list
102347695|NCT00121186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102347696|NCT00121186|Abortifacient Agents|abortifacient agents|mesh-ancestor
102347697|NCT00121186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102347698|NCT00121186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347699|NCT00121186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102347700|NCT00121186|Antimetabolites|antimetabolites|mesh-ancestor
102347701|NCT00121186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347702|NCT00121186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347703|NCT00121186|Dermatologic Agents|dermatologic agents|mesh-ancestor
102347704|NCT00121186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102347705|NCT00121186|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102347706|NCT00121186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102347707|NCT00121186|Immunologic Factors|immunologic factors|mesh-ancestor
102347708|NCT00121186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102347709|NCT00121186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102347710|NCT00121186|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102347711|NCT00121186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102347712|NCT00121186|Alkylating Agents|alkylating agents|mesh-ancestor
102347713|NCT00121186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102347714|NCT00121810|Mycophenolic Acid|mycophenolic acid|mesh-list
102347715|NCT00121810|Sirolimus|sirolimus|mesh-list
102347716|NCT00121810|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
102347717|NCT00121810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102347718|NCT00121810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347719|NCT00121810|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102347720|NCT00121810|Antitubercular Agents|antitubercular agents|mesh-ancestor
102347721|NCT00121810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102347722|NCT00121810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102347723|NCT00121810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102347724|NCT00121810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347725|NCT00121810|Antifungal Agents|antifungal agents|mesh-ancestor
102347726|NCT00121810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102347727|NCT00121810|Immunologic Factors|immunologic factors|mesh-ancestor
102347728|NCT00121810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347729|NCT00053014|Cyclosporine|cyclosporine|mesh-list
102347730|NCT00053014|Mycophenolic Acid|mycophenolic acid|mesh-list
102347731|NCT00053014|Fludarabine|fludarabine|mesh-list
102347732|NCT00053014|Cyclosporins|cyclosporins|mesh-list
102347733|NCT00053014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347734|NCT00053014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347735|NCT00053014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102347736|NCT00053014|Immunologic Factors|immunologic factors|mesh-ancestor
102347737|NCT00053014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347738|NCT00053014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102347739|NCT00053014|Antifungal Agents|antifungal agents|mesh-ancestor
102347740|NCT00053014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102347741|NCT00053014|Dermatologic Agents|dermatologic agents|mesh-ancestor
102347742|NCT00053014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102347743|NCT00053014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102347744|NCT00053014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102347745|NCT00053014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102347746|NCT00053014|Antitubercular Agents|antitubercular agents|mesh-ancestor
102347747|NCT00053014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102347748|NCT00123604|Metoprolol|metoprolol|mesh-list
102347749|NCT00123604|Carvedilol|carvedilol|mesh-list
102347750|NCT00123604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102347751|NCT00123604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102347752|NCT00123604|Sympatholytics|sympatholytics|mesh-ancestor
102347753|NCT00123604|Autonomic Agents|autonomic agents|mesh-ancestor
102347754|NCT00123604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102347755|NCT00123604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347756|NCT00123604|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102347757|NCT00123604|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102347758|NCT00123604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102347759|NCT00123604|Adrenergic Agents|adrenergic agents|mesh-ancestor
102347760|NCT00123604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102347761|NCT00123604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347762|NCT00123604|Antioxidants|antioxidants|mesh-ancestor
102347763|NCT00123604|Protective Agents|protective agents|mesh-ancestor
102347764|NCT00123604|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102347765|NCT00123604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102347766|NCT00123604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102347767|NCT00123604|Vasodilator Agents|vasodilator agents|mesh-ancestor
102347768|NCT00123604|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102347769|NCT00123604|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102347770|NCT00221338|Gabapentin|gabapentin|mesh-list
102347771|NCT00221338|Analgesics|analgesics|mesh-ancestor
102347772|NCT00221338|Sensory System Agents|sensory system agents|mesh-ancestor
102347773|NCT00221338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102347774|NCT00221338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347775|NCT00221338|Anticonvulsants|anticonvulsants|mesh-ancestor
102347776|NCT00221338|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102347777|NCT00221338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102347778|NCT00221338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102347779|NCT00221338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102347780|NCT00221338|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102347781|NCT00221338|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102347782|NCT00221338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102347783|NCT00221338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347784|NCT00221338|Antimanic Agents|antimanic agents|mesh-ancestor
102347785|NCT00223678|Sirolimus|sirolimus|mesh-list
102347786|NCT00223678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102347787|NCT00223678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102347788|NCT00223678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102347789|NCT00223678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347790|NCT00223678|Antifungal Agents|antifungal agents|mesh-ancestor
102347791|NCT00223678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102347792|NCT00223678|Immunologic Factors|immunologic factors|mesh-ancestor
102347793|NCT00223678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347794|NCT00053482|Vaccines|vaccines|mesh-list
102347048|NCT03096275|Hormones|hormones|mesh-ancestor
102347795|NCT00053482|Immunologic Factors|immunologic factors|mesh-ancestor
102347796|NCT00053482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347797|NCT00130780|Bevacizumab|bevacizumab|mesh-list
102347798|NCT00130780|Docetaxel|docetaxel|mesh-list
102347799|NCT00130780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102347800|NCT00130780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347801|NCT00130780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102347802|NCT00130780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102347803|NCT00130780|Growth Substances|growth substances|mesh-ancestor
102347804|NCT00130780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347805|NCT00130780|Growth Inhibitors|growth inhibitors|mesh-ancestor
102347806|NCT00130780|Tubulin Modulators|tubulin modulators|mesh-ancestor
102347807|NCT00130780|Antimitotic Agents|antimitotic agents|mesh-ancestor
102347808|NCT00130780|Mitosis Modulators|mitosis modulators|mesh-ancestor
102347809|NCT00130780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347810|NCT00225784|Gemcitabine|gemcitabine|mesh-list
102347811|NCT00225784|Cetuximab|cetuximab|mesh-list
102347812|NCT00225784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102347813|NCT00225784|Antimetabolites|antimetabolites|mesh-ancestor
102347814|NCT00225784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347815|NCT00225784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347816|NCT00225784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102347817|NCT02092168|Opicapone|opicapone|mesh-list
102612268|NCT00002387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102159479|NCT02479581|Floxacillin|floxacillin|mesh-list
102347818|NCT02092168|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102347819|NCT02092168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102347820|NCT02092168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347821|NCT02092168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102347822|NCT02092168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102347823|NCT00133978|Selenium|selenium|mesh-list
102347824|NCT00133978|Antioxidants|antioxidants|mesh-list
102347825|NCT00133978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347826|NCT00133978|Protective Agents|protective agents|mesh-ancestor
102347827|NCT00133978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347828|NCT00133978|Trace Elements|trace elements|mesh-ancestor
102347829|NCT00133978|Micronutrients|micronutrients|mesh-ancestor
102347830|NCT01897324|Hormones|hormones|mesh-list
102347831|NCT01897324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102347832|NCT01897324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347833|NCT00254410|Cyclophosphamide|cyclophosphamide|mesh-list
102347834|NCT00254410|Rituximab|rituximab|mesh-list
102347835|NCT00254410|Fludarabine|fludarabine|mesh-list
102347836|NCT00254410|Mitoxantrone|mitoxantrone|mesh-list
102347837|NCT00254410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102347838|NCT00254410|Immunologic Factors|immunologic factors|mesh-ancestor
102347839|NCT00254410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347840|NCT00254410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102347841|NCT00254410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102347842|NCT00254410|Alkylating Agents|alkylating agents|mesh-ancestor
102347843|NCT00254410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347844|NCT00254410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347845|NCT00254410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102347846|NCT00254410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102347847|NCT00254410|Analgesics|analgesics|mesh-ancestor
102347848|NCT00254410|Sensory System Agents|sensory system agents|mesh-ancestor
102347849|NCT00254410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102347850|NCT00254410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102347851|NCT00254410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102347852|NCT00254410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102347853|NCT00254488|Valproic Acid|valproic acid|mesh-list
102347854|NCT00254488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102347855|NCT00254488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102347856|NCT00254488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347857|NCT00254488|Antimanic Agents|antimanic agents|mesh-ancestor
102347858|NCT00254488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102347859|NCT00254488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102347860|NCT00254488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347861|NCT00254488|Anticonvulsants|anticonvulsants|mesh-ancestor
102347862|NCT00254488|GABA Agents|gaba agents|mesh-ancestor
102347863|NCT00254488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102347864|NCT01899118|Capecitabine|capecitabine|mesh-list
102347865|NCT01899118|Oxaliplatin|oxaliplatin|mesh-list
102347866|NCT01899118|Nimotuzumab|nimotuzumab|mesh-list
102347867|NCT01899118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102347868|NCT01899118|Antimetabolites|antimetabolites|mesh-ancestor
102347869|NCT01899118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347870|NCT01899118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347871|NCT01899118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102347872|NCT00231868|Paclitaxel|paclitaxel|mesh-list
102347873|NCT00231868|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102347874|NCT00231868|Carboplatin|carboplatin|mesh-list
102347875|NCT00231868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102347876|NCT00231868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347877|NCT00231868|Tubulin Modulators|tubulin modulators|mesh-ancestor
102347878|NCT00231868|Antimitotic Agents|antimitotic agents|mesh-ancestor
102347879|NCT00231868|Mitosis Modulators|mitosis modulators|mesh-ancestor
102347880|NCT00231868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347881|NCT00257686|Pravastatin|pravastatin|mesh-list
102347882|NCT00257686|Pitavastatin|pitavastatin|mesh-list
102347883|NCT00257686|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102347884|NCT00257686|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102347885|NCT00257686|Antimetabolites|antimetabolites|mesh-ancestor
102347886|NCT00257686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347887|NCT00257686|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102347888|NCT00257686|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102347889|NCT00257686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102347890|NCT01469013|Methotrexate|methotrexate|mesh-list
102347891|NCT01469013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102347892|NCT01469013|Abortifacient Agents|abortifacient agents|mesh-ancestor
102347893|NCT01469013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102347894|NCT01469013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347895|NCT01469013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102347896|NCT01469013|Antimetabolites|antimetabolites|mesh-ancestor
102347897|NCT01469013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347898|NCT01469013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347899|NCT01469013|Dermatologic Agents|dermatologic agents|mesh-ancestor
102347900|NCT01469013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102347901|NCT01469013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102347902|NCT01469013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102347903|NCT01469013|Immunologic Factors|immunologic factors|mesh-ancestor
102347904|NCT01469013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102347905|NCT01469013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102347906|NCT01493427|Travoprost|travoprost|mesh-list
102347907|NCT01493427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102347908|NCT01523457|Folfirinox|folfirinox|mesh-list
102347909|NCT01523457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347910|NCT01523301|Rotigotine|rotigotine|mesh-list
102347911|NCT01523301|Dopamine Agonists|dopamine agonists|mesh-ancestor
102347912|NCT01523301|Dopamine Agents|dopamine agents|mesh-ancestor
102347913|NCT01523301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102347914|NCT01523301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347915|NCT01523301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347916|NCT01766336|Inositol|inositol|mesh-list
102347917|NCT01766336|Vitamin B Complex|vitamin b complex|mesh-ancestor
102347918|NCT01766336|Vitamins|vitamins|mesh-ancestor
102347919|NCT01766336|Micronutrients|micronutrients|mesh-ancestor
102347920|NCT01766336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347921|NCT01797302|Vitamin D|vitamin d|mesh-list
102347922|NCT01797302|Cholecalciferol|cholecalciferol|mesh-list
102347923|NCT01797302|Vitamins|vitamins|mesh-ancestor
102347924|NCT01797302|Micronutrients|micronutrients|mesh-ancestor
102347925|NCT01797302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347926|NCT01797302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102347927|NCT01797302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102347928|NCT01804946|Oseltamivir|oseltamivir|mesh-list
102347929|NCT01804946|Antiviral Agents|antiviral agents|mesh-ancestor
102347930|NCT01804946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102347931|NCT01804946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102347932|NCT01804946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347933|NCT01795898|Fentanyl|fentanyl|mesh-list
102347934|NCT01795898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102347935|NCT01795898|Narcotics|narcotics|mesh-ancestor
102347936|NCT01795898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102347937|NCT01795898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347938|NCT01795898|Analgesics|analgesics|mesh-ancestor
102347939|NCT01795898|Sensory System Agents|sensory system agents|mesh-ancestor
102347940|NCT01795898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102347941|NCT01795898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102347942|NCT01795898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102347943|NCT01795898|Anesthetics, General|anesthetics, general|mesh-ancestor
102347944|NCT01795898|Anesthetics|anesthetics|mesh-ancestor
102347945|NCT01736696|Tofacitinib|tofacitinib|mesh-list
102347946|NCT01736696|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102347947|NCT01736696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102347948|NCT01736696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102347949|NCT01736696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347950|NCT01609478|Mometasone Furoate|mometasone furoate|mesh-list
102347951|NCT01609478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102347952|NCT01609478|Dermatologic Agents|dermatologic agents|mesh-ancestor
102347953|NCT01609478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102347954|NCT01764464|Gabapentin|gabapentin|mesh-list
102347955|NCT01764464|Analgesics|analgesics|mesh-ancestor
102347956|NCT01764464|Sensory System Agents|sensory system agents|mesh-ancestor
102347957|NCT01764464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102347958|NCT01764464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347959|NCT01764464|Anticonvulsants|anticonvulsants|mesh-ancestor
102347960|NCT01764464|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102347961|NCT01764464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102347962|NCT01764464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102347963|NCT01764464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102347964|NCT01764464|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102347965|NCT01764464|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102347966|NCT01764464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102347967|NCT01764464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347968|NCT01764464|Antimanic Agents|antimanic agents|mesh-ancestor
102347969|NCT01763918|Evolocumab|evolocumab|mesh-list
102347970|NCT01763918|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102347971|NCT01763918|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102347972|NCT01763918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102347973|NCT01763918|Antimetabolites|antimetabolites|mesh-ancestor
102347974|NCT01763918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347975|NCT01763918|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102347976|NCT01763918|Protease Inhibitors|protease inhibitors|mesh-ancestor
102347977|NCT01763918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102347978|NCT01763918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102347979|NCT01606748|Gemcitabine|gemcitabine|mesh-list
102347980|NCT01606748|Necitumumab|necitumumab|mesh-list
102347981|NCT01606748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347982|NCT01606748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102347983|NCT01606748|Antimetabolites|antimetabolites|mesh-ancestor
102347984|NCT01606748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347985|NCT01606748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102347986|NCT01597622|Belimumab|belimumab|mesh-list
102347987|NCT01597622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102347988|NCT01597622|Immunologic Factors|immunologic factors|mesh-ancestor
102347989|NCT01597622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347990|NCT01761266|Sorafenib|sorafenib|mesh-list
102347991|NCT01761266|Lenvatinib|lenvatinib|mesh-list
102347992|NCT01761266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347993|NCT01761266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102347994|NCT01761266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102347995|NCT01761266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347996|NCT01759862|Aminophylline|aminophylline|mesh-list
102347997|NCT01759862|Theophylline|theophylline|mesh-list
102347998|NCT01759862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102347999|NCT01759862|Autonomic Agents|autonomic agents|mesh-ancestor
102348000|NCT01759862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102348001|NCT01759862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348002|NCT01759862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102348003|NCT01759862|Respiratory System Agents|respiratory system agents|mesh-ancestor
102348004|NCT01759862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102348005|NCT01759862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102348006|NCT01759862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348007|NCT01759862|Vasodilator Agents|vasodilator agents|mesh-ancestor
102348008|NCT01759862|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102348009|NCT01759862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102348010|NCT01759862|Purinergic Agents|purinergic agents|mesh-ancestor
102348011|NCT01759862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102348012|NCT01759862|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102348013|NCT01759862|Protective Agents|protective agents|mesh-ancestor
102348014|NCT01790828|Factor VIII|factor viii|mesh-list
102348015|NCT01790828|Coagulants|coagulants|mesh-ancestor
102348016|NCT01790594|Mycophenolic Acid|mycophenolic acid|mesh-list
102348017|NCT01790594|Methylprednisolone|methylprednisolone|mesh-list
102348018|NCT01790594|Abatacept|abatacept|mesh-list
102348019|NCT01790594|Tacrolimus|tacrolimus|mesh-list
102348020|NCT01790594|Thymoglobulin|thymoglobulin|mesh-list
102348021|NCT01790594|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102348022|NCT01790594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102348023|NCT01790594|Immunologic Factors|immunologic factors|mesh-ancestor
102348024|NCT01790594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348025|NCT01790594|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102348026|NCT01790594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102348027|NCT01790594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348028|NCT01790594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102348029|NCT01790594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102348030|NCT01790594|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102348031|NCT01790594|Antitubercular Agents|antitubercular agents|mesh-ancestor
102348032|NCT01790594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102348033|NCT01790594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102348034|NCT01790594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102348035|NCT01790594|Antiemetics|antiemetics|mesh-ancestor
102348036|NCT01790594|Autonomic Agents|autonomic agents|mesh-ancestor
102348037|NCT01790594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102348038|NCT01790594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102348039|NCT01790594|Glucocorticoids|glucocorticoids|mesh-ancestor
102348040|NCT01790594|Hormones|hormones|mesh-ancestor
102348041|NCT01790594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102348042|NCT01790594|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102348043|NCT01790594|Protective Agents|protective agents|mesh-ancestor
102348044|NCT01790594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102348045|NCT01790594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102348046|NCT01790594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102348047|NCT01790516|Cetuximab|cetuximab|mesh-list
102348048|NCT01790516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102348049|NCT01790516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102348050|NCT01790438|Insulin|insulin|mesh-list
102348051|NCT01790438|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102348052|NCT01790438|Isophane Insulin, Human|isophane insulin, human|mesh-list
102348053|NCT01790438|Insulin, Isophane|insulin, isophane|mesh-list
102348054|NCT01790438|Isophane insulin, beef|isophane insulin, beef|mesh-list
102348055|NCT01790438|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102348056|NCT01790438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348057|NCT01790126|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102348058|NCT01790126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102348059|NCT01790126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102348060|NCT01790126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102348061|NCT01790126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348062|NCT01790126|Luteolytic Agents|luteolytic agents|mesh-ancestor
102348063|NCT01790126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102348064|NCT01790126|Contraceptive Agents|contraceptive agents|mesh-ancestor
102348065|NCT01790126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102348066|NCT01734902|Scopolamine|scopolamine|mesh-list
102348067|NCT01734902|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102348068|NCT01734902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102348069|NCT01734902|Antiemetics|antiemetics|mesh-ancestor
102348070|NCT01734902|Autonomic Agents|autonomic agents|mesh-ancestor
102348071|NCT01734902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102348072|NCT01734902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348073|NCT01734902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102348074|NCT01734902|Mydriatics|mydriatics|mesh-ancestor
102348075|NCT01734902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102348076|NCT01734902|Cholinergic Agents|cholinergic agents|mesh-ancestor
102348077|NCT01734902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102348078|NCT01734902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348079|NCT01734902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102348080|NCT01734902|Parasympatholytics|parasympatholytics|mesh-ancestor
102348081|NCT01789970|Hydrocodone|hydrocodone|mesh-list
102348082|NCT01789970|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102348083|NCT01789970|Narcotics|narcotics|mesh-ancestor
102348084|NCT01789970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102348085|NCT01789970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348086|NCT01789970|Analgesics|analgesics|mesh-ancestor
102348087|NCT01789970|Sensory System Agents|sensory system agents|mesh-ancestor
102348088|NCT01789970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102348089|NCT01789970|Antitussive Agents|antitussive agents|mesh-ancestor
102348090|NCT01789970|Respiratory System Agents|respiratory system agents|mesh-ancestor
102348091|NCT01788566|Gemcitabine|gemcitabine|mesh-list
102348092|NCT01788566|Necitumumab|necitumumab|mesh-list
102348093|NCT01788566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102348094|NCT01788566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102348095|NCT01788566|Antimetabolites|antimetabolites|mesh-ancestor
102348096|NCT01788566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348097|NCT01788566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102348098|NCT01733732|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102348099|NCT01733732|Lubricant Eye Drops|lubricant eye drops|mesh-list
102348100|NCT01733732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102348101|NCT01732796|Ribavirin|ribavirin|mesh-list
102348102|NCT01732796|Antimetabolites|antimetabolites|mesh-ancestor
102348103|NCT01732796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348104|NCT01732796|Antiviral Agents|antiviral agents|mesh-ancestor
102348105|NCT01732796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102348106|NCT01732640|Paclitaxel|paclitaxel|mesh-list
102348107|NCT01732640|Cisplatin|cisplatin|mesh-list
102348108|NCT01732640|Carboplatin|carboplatin|mesh-list
102348109|NCT01732640|Afatinib|afatinib|mesh-list
102348110|NCT01732640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102348111|NCT01732640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102348112|NCT01732640|Tubulin Modulators|tubulin modulators|mesh-ancestor
102348113|NCT01732640|Antimitotic Agents|antimitotic agents|mesh-ancestor
102348114|NCT01732640|Mitosis Modulators|mitosis modulators|mesh-ancestor
102348115|NCT01732640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348116|NCT01732640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102348117|NCT01732640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102348118|NCT04560686|Atezolizumab|atezolizumab|mesh-list
102348119|NCT04560686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102348120|NCT04560686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348121|NCT04560686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102348123|NCT01757288|Paclitaxel|paclitaxel|mesh-list
102348124|NCT01757288|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102348125|NCT01757288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102348126|NCT01757288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102348127|NCT01757288|Tubulin Modulators|tubulin modulators|mesh-ancestor
102348128|NCT01757288|Antimitotic Agents|antimitotic agents|mesh-ancestor
102348129|NCT01757288|Mitosis Modulators|mitosis modulators|mesh-ancestor
102348130|NCT01757288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348131|NCT01731938|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102348132|NCT01731938|Hemostatics|hemostatics|mesh-ancestor
102348133|NCT01731938|Coagulants|coagulants|mesh-ancestor
102348134|NCT01731002|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102348135|NCT01731002|Latanoprost|latanoprost|mesh-list
102348136|NCT01731002|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102348137|NCT01783886|Aflibercept|aflibercept|mesh-list
102348138|NCT01783886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102348139|NCT01783886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102348140|NCT01783886|Growth Substances|growth substances|mesh-ancestor
102348141|NCT01783886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348142|NCT01783886|Growth Inhibitors|growth inhibitors|mesh-ancestor
102348143|NCT01783886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102348144|NCT01609556|Maytansine|maytansine|mesh-list
102348145|NCT01609556|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
102348146|NCT01609556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102348147|NCT01609556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102348148|NCT01609556|Tubulin Modulators|tubulin modulators|mesh-ancestor
102348149|NCT01609556|Antimitotic Agents|antimitotic agents|mesh-ancestor
102348150|NCT01609556|Mitosis Modulators|mitosis modulators|mesh-ancestor
102348151|NCT01609556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348152|NCT01609556|Immunoconjugates|immunoconjugates|mesh-ancestor
102348153|NCT01609556|Immunologic Factors|immunologic factors|mesh-ancestor
102348154|NCT01609556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348155|NCT00234832|Sibutramine|sibutramine|mesh-list
102348156|NCT00234832|Antidepressive Agents|antidepressive agents|mesh-ancestor
102348157|NCT00234832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102348158|NCT00234832|Appetite Depressants|appetite depressants|mesh-ancestor
102348159|NCT00234832|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102348160|NCT00259090|Fulvestrant|fulvestrant|mesh-list
102348161|NCT00259090|Anastrozole|anastrozole|mesh-list
102348162|NCT00259090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102348163|NCT00259090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102348164|NCT00259090|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102348165|NCT00259090|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102348166|NCT00259090|Hormone Antagonists|hormone antagonists|mesh-ancestor
102348167|NCT00259090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102348168|NCT00259090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348169|NCT00259090|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102348170|NCT00259090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102348171|NCT00259090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102348172|NCT00259090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348173|NCT00236938|Epoetin Alfa|epoetin alfa|mesh-list
102348174|NCT00236938|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102348175|NCT00236938|Hematinics|hematinics|mesh-ancestor
102348176|NCT01898728|Iodine|iodine|mesh-list
102348177|NCT01898728|Cadexomer iodine|cadexomer iodine|mesh-list
102348178|NCT01898728|Povidone-Iodine|povidone-iodine|mesh-list
102348179|NCT01898728|Povidone|povidone|mesh-list
102348180|NCT01898728|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102348181|NCT01898728|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102348182|NCT01898728|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102348183|NCT01898728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102348184|NCT01898728|Trace Elements|trace elements|mesh-ancestor
102348185|NCT01898728|Micronutrients|micronutrients|mesh-ancestor
102348186|NCT01898728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348187|NCT01898728|Plasma Substitutes|plasma substitutes|mesh-ancestor
102348188|NCT01898728|Blood Substitutes|blood substitutes|mesh-ancestor
102348189|NCT00260962|Olanzapine|olanzapine|mesh-list
102348190|NCT00260962|Antiemetics|antiemetics|mesh-ancestor
102348191|NCT00260962|Autonomic Agents|autonomic agents|mesh-ancestor
102348192|NCT00260962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102348193|NCT00260962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348194|NCT00260962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102348195|NCT00260962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102348196|NCT00260962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102348197|NCT00260962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102348198|NCT00260962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102348199|NCT00260962|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102348200|NCT00260962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102348201|NCT00260962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102348202|NCT00260962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348203|NCT00260962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102348204|NCT00260962|Serotonin Agents|serotonin agents|mesh-ancestor
102348205|NCT00237718|Vitamin E|vitamin e|mesh-list
102348206|NCT00237718|Tocopherols|tocopherols|mesh-list
102348207|NCT00237718|Tocotrienols|tocotrienols|mesh-list
102348208|NCT00237718|alpha-Tocopherol|alpha-tocopherol|mesh-list
102348209|NCT00237718|Thioctic Acid|thioctic acid|mesh-list
102348210|NCT00237718|Vitamins|vitamins|mesh-ancestor
102348211|NCT00237718|Micronutrients|micronutrients|mesh-ancestor
102348212|NCT00237718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348213|NCT00237718|Antioxidants|antioxidants|mesh-ancestor
102348214|NCT00237718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348215|NCT00237718|Protective Agents|protective agents|mesh-ancestor
102348216|NCT00237718|Vitamin B Complex|vitamin b complex|mesh-ancestor
102348217|NCT00238108|Melatonin|melatonin|mesh-list
102348218|NCT00238108|Antioxidants|antioxidants|mesh-ancestor
102348219|NCT00238108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348220|NCT00238108|Protective Agents|protective agents|mesh-ancestor
102348221|NCT00238108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348222|NCT00238108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102348223|NCT00266110|Trastuzumab|trastuzumab|mesh-list
102348224|NCT00266110|Vinorelbine|vinorelbine|mesh-list
102348225|NCT00266110|Sargramostim|sargramostim|mesh-list
102348226|NCT00266110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102348227|NCT00266110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102348228|NCT00266110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102348229|NCT00266110|Tubulin Modulators|tubulin modulators|mesh-ancestor
102348230|NCT00266110|Antimitotic Agents|antimitotic agents|mesh-ancestor
102348231|NCT00266110|Mitosis Modulators|mitosis modulators|mesh-ancestor
102348232|NCT00266110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348233|NCT00266110|Immunologic Factors|immunologic factors|mesh-ancestor
102348234|NCT00266110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348235|NCT00240526|Immunoglobulins|immunoglobulins|mesh-list
102348236|NCT00240526|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102348237|NCT00240526|Antibodies|antibodies|mesh-list
102348238|NCT00240526|Immunologic Factors|immunologic factors|mesh-ancestor
102348239|NCT00240526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348240|NCT00242632|Memantine|memantine|mesh-list
102348241|NCT00242632|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102348242|NCT00242632|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102348243|NCT00242632|Dopamine Agents|dopamine agents|mesh-ancestor
102348244|NCT00242632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102348245|NCT00242632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348246|NCT00242632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348247|NCT00242632|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102348248|NCT00242632|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102348249|NCT01899430|Metformin|metformin|mesh-list
102348250|NCT01899430|Liraglutide|liraglutide|mesh-list
102348251|NCT01899430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102348252|NCT01899430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348253|NCT01899430|Incretins|incretins|mesh-ancestor
102348254|NCT01899430|Hormones|hormones|mesh-ancestor
102348255|NCT01899430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102348256|NCT00267670|Pentoxifylline|pentoxifylline|mesh-list
102348257|NCT00267670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102348258|NCT00267670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102348259|NCT00267670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348260|NCT00267670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102348261|NCT00267670|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102348262|NCT00267670|Protective Agents|protective agents|mesh-ancestor
102348263|NCT00267670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348264|NCT00267670|Vasodilator Agents|vasodilator agents|mesh-ancestor
102348265|NCT00267670|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102348266|NCT00267670|Antioxidants|antioxidants|mesh-ancestor
102348267|NCT00247624|Eszopiclone|eszopiclone|mesh-list
102348268|NCT00247624|Fluoxetine|fluoxetine|mesh-list
102348269|NCT00247624|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102348270|NCT00247624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102348271|NCT00247624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102348272|NCT00247624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159956|NCT05553522|Tucatinib|tucatinib|mesh-list
102348273|NCT00247624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102348274|NCT00247624|Serotonin Agents|serotonin agents|mesh-ancestor
102348275|NCT00247624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348276|NCT00247624|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102348277|NCT00247624|Antidepressive Agents|antidepressive agents|mesh-ancestor
102348278|NCT00247624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102348279|NCT00247624|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102348280|NCT00247624|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102348281|NCT00247624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102348282|NCT00247624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102348283|NCT00247624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102348284|NCT00248560|Gemcitabine|gemcitabine|mesh-list
102348285|NCT00248560|Docetaxel|docetaxel|mesh-list
102348286|NCT00248560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102348287|NCT00248560|Antimetabolites|antimetabolites|mesh-ancestor
102348288|NCT00248560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348289|NCT00248560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102348290|NCT00248560|Tubulin Modulators|tubulin modulators|mesh-ancestor
102348291|NCT00248560|Antimitotic Agents|antimitotic agents|mesh-ancestor
102348292|NCT00248560|Mitosis Modulators|mitosis modulators|mesh-ancestor
102348293|NCT00268762|Argatroban|argatroban|mesh-list
102348294|NCT00268762|Antithrombins|antithrombins|mesh-ancestor
102348295|NCT00268762|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102348296|NCT00268762|Protease Inhibitors|protease inhibitors|mesh-ancestor
102348297|NCT00268762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102348298|NCT00268762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348299|NCT00268762|Anticoagulants|anticoagulants|mesh-ancestor
102348300|NCT00268762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102348301|NCT00270634|Tacrolimus|tacrolimus|mesh-list
102348302|NCT00270634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102348303|NCT00270634|Immunologic Factors|immunologic factors|mesh-ancestor
102348304|NCT00270634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348305|NCT00270634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102348306|NCT00270634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102348307|NCT00270634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348308|NCT04110340|Ciprofloxacin|ciprofloxacin|mesh-list
102348309|NCT04110340|Gentamicins|gentamicins|mesh-list
102348310|NCT04110340|Streptomycin|streptomycin|mesh-list
102348311|NCT04110340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102348312|NCT04110340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102348313|NCT04110340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102348314|NCT04110340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102348315|NCT04110340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102348316|NCT04110340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348317|NCT04110340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102348318|NCT04110340|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102348319|NCT04110340|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102348320|NCT04110340|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102348321|NCT00270790|Carboplatin|carboplatin|mesh-list
102348322|NCT00270790|Amifostine|amifostine|mesh-list
102348323|NCT00270790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102348324|NCT00270790|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102348325|NCT00270790|Protective Agents|protective agents|mesh-ancestor
102348326|NCT00270790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348327|NCT00271570|Infliximab|infliximab|mesh-list
102348328|NCT00271570|Immunoglobulins|immunoglobulins|mesh-list
102348329|NCT00271570|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102348330|NCT00271570|Antibodies|antibodies|mesh-list
102348331|NCT00271570|gamma-Globulins|gamma-globulins|mesh-list
102348332|NCT00271570|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102348333|NCT00271570|Immunologic Factors|immunologic factors|mesh-ancestor
102348334|NCT00271570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348335|NCT00271570|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102348336|NCT00271570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102348337|NCT00271570|Dermatologic Agents|dermatologic agents|mesh-ancestor
102348338|NCT00271570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102348339|NCT00271570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102348340|NCT05237596|Acetaminophen|acetaminophen|mesh-list
102348341|NCT05237596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102348342|NCT05237596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
102348343|NCT05237596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102348344|NCT05237596|Analgesics|analgesics|mesh-ancestor
102348345|NCT05237596|Sensory System Agents|sensory system agents|mesh-ancestor
102348346|NCT05237596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102348347|NCT05237596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160011|NCT05457556|Rituximab|rituximab|mesh-list
102348348|NCT05237596|Antipyretics|antipyretics|mesh-ancestor
102348349|NCT05237596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102348350|NCT02102932|Metformin|metformin|mesh-list
102348351|NCT02102932|Empagliflozin|empagliflozin|mesh-list
102348352|NCT02102932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102348353|NCT02102932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348354|NCT02102932|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102348355|NCT02102932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348356|NCT00273754|Caffeine|caffeine|mesh-list
102348357|NCT00273754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102348358|NCT00273754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348359|NCT00273754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102348360|NCT00273754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102348361|NCT00273754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348362|NCT00273754|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102348363|NCT00273754|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102348364|NCT00273754|Purinergic Agents|purinergic agents|mesh-ancestor
102348365|NCT00273754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102348366|NCT04751344|Bupivacaine|bupivacaine|mesh-list
102348367|NCT04751344|Anesthetics, Local|anesthetics, local|mesh-ancestor
102348368|NCT04751344|Anesthetics|anesthetics|mesh-ancestor
102348369|NCT04751344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102348370|NCT04751344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348371|NCT04751344|Sensory System Agents|sensory system agents|mesh-ancestor
102348372|NCT04751344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102348373|NCT05211232|Tislelizumab|tislelizumab|mesh-list
102348374|NCT05211232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102348375|NCT05211232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102348376|NCT00273910|Imiquimod|imiquimod|mesh-list
102348377|NCT00273910|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
102348378|NCT00273910|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102348379|NCT00273910|Immunologic Factors|immunologic factors|mesh-ancestor
102348380|NCT00273910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348381|NCT00273910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102348382|NCT00273910|Interferon Inducers|interferon inducers|mesh-ancestor
102348383|NCT00274768|Capecitabine|capecitabine|mesh-list
102348384|NCT00274768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102348385|NCT00274768|Antimetabolites|antimetabolites|mesh-ancestor
102348386|NCT00274768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348387|NCT00274768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102348388|NCT00280384|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
102348389|NCT00280384|Botulinum Toxins|botulinum toxins|mesh-list
102348390|NCT00280384|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102348391|NCT00280384|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102348392|NCT00280384|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102348393|NCT00280384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102348394|NCT00280384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348395|NCT00280384|Cholinergic Agents|cholinergic agents|mesh-ancestor
102348396|NCT00280384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102348397|NCT00280384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348398|NCT00280384|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102348399|NCT00280384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102348400|NCT00280384|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102348401|NCT01763996|Febuxostat|febuxostat|mesh-list
102348402|NCT01763996|Gout Suppressants|gout suppressants|mesh-ancestor
102348403|NCT01763996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102348404|NCT01790464|Lidocaine|lidocaine|mesh-list
102348405|NCT01790464|Anesthetics, Local|anesthetics, local|mesh-ancestor
102348406|NCT01790464|Anesthetics|anesthetics|mesh-ancestor
102348407|NCT01790464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102348408|NCT01790464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348409|NCT01790464|Sensory System Agents|sensory system agents|mesh-ancestor
102348410|NCT01790464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102348411|NCT01790464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102348412|NCT01790464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102348413|NCT01790464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102348414|NCT01790464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102348415|NCT01790464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348416|NCT01790542|Iron|iron|mesh-list
102348417|NCT01790542|Trace Elements|trace elements|mesh-ancestor
102348418|NCT01790542|Micronutrients|micronutrients|mesh-ancestor
102348419|NCT01790542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348420|NCT01899820|Lumefantrine|lumefantrine|mesh-list
102348421|NCT01899820|Artemether|artemether|mesh-list
102160087|NCT05382338|Lomustine|lomustine|mesh-list
102348422|NCT01899820|Piperaquine|piperaquine|mesh-list
102348423|NCT01899820|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102348424|NCT01899820|Artenimol|artenimol|mesh-list
102348425|NCT01899820|Antimalarials|antimalarials|mesh-ancestor
102348426|NCT01899820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102348427|NCT01899820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102348428|NCT01899820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102348429|NCT02100748|Morphine|morphine|mesh-list
102348430|NCT02100748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102348431|NCT02100748|Narcotics|narcotics|mesh-ancestor
102348432|NCT02100748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102348433|NCT02100748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348434|NCT02100748|Analgesics|analgesics|mesh-ancestor
102348435|NCT02100748|Sensory System Agents|sensory system agents|mesh-ancestor
102348436|NCT02100748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102348437|NCT00283504|Omalizumab|omalizumab|mesh-list
102348438|NCT00283504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102348439|NCT00283504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102348440|NCT00283504|Respiratory System Agents|respiratory system agents|mesh-ancestor
102348441|NCT00283816|Metformin|metformin|mesh-list
102348442|NCT00283816|Contraceptive Agents|contraceptive agents|mesh-list
102348443|NCT00283816|Contraceptives, Oral|contraceptives, oral|mesh-list
102348444|NCT00283816|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
102348445|NCT00283816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102348446|NCT00283816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348447|NCT00283816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102348448|NCT00283816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102348449|NCT00284518|Botulinum Toxins|botulinum toxins|mesh-list
102348450|NCT00284518|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102348451|NCT00284518|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102348452|NCT00284518|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102348453|NCT00284518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102348454|NCT00284518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348455|NCT00284518|Cholinergic Agents|cholinergic agents|mesh-ancestor
102348456|NCT00284518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102348457|NCT00284518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348458|NCT00284518|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102348459|NCT00284518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102348460|NCT04339426|Azithromycin|azithromycin|mesh-list
102348461|NCT04339426|Atovaquone|atovaquone|mesh-list
102348462|NCT04339426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102348463|NCT04339426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102348464|NCT04339426|Antimalarials|antimalarials|mesh-ancestor
102348465|NCT04339426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102348466|NCT04339426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102348467|NCT04339426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102348468|NCT04339426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348469|NCT01899898|Anticonvulsants|anticonvulsants|mesh-list
102348470|NCT00287716|Pirfenidone|pirfenidone|mesh-list
102348471|NCT00287716|Analgesics|analgesics|mesh-ancestor
102348472|NCT00287716|Sensory System Agents|sensory system agents|mesh-ancestor
102348473|NCT00287716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102348474|NCT00287716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348475|NCT00287716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102348476|NCT00287716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102348477|NCT00287716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102348478|NCT00287716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102348479|NCT00287716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102348480|NCT00287872|Thalidomide|thalidomide|mesh-list
102348481|NCT00287872|Bortezomib|bortezomib|mesh-list
102348482|NCT00287872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102348483|NCT00287872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102348484|NCT00287872|Immunologic Factors|immunologic factors|mesh-ancestor
102348485|NCT00287872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348486|NCT00287872|Leprostatic Agents|leprostatic agents|mesh-ancestor
102348487|NCT00287872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102348488|NCT00287872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102348489|NCT00287872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102348490|NCT00287872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102348491|NCT00287872|Growth Substances|growth substances|mesh-ancestor
102348492|NCT00287872|Growth Inhibitors|growth inhibitors|mesh-ancestor
102348493|NCT00288574|Fluoxetine|fluoxetine|mesh-list
102348494|NCT00288574|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102348495|NCT00288574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102348496|NCT00288574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102348497|NCT00288574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348498|NCT00288574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102348499|NCT00288574|Serotonin Agents|serotonin agents|mesh-ancestor
102348500|NCT00288574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348501|NCT00288574|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102348502|NCT00288574|Antidepressive Agents|antidepressive agents|mesh-ancestor
102348503|NCT00288574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102348504|NCT00288574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102348505|NCT00288574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102348506|NCT00288574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102348507|NCT04079218|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102348508|NCT04079218|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102348509|NCT04079218|Estradiol|estradiol|mesh-list
102348510|NCT04079218|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102348511|NCT04079218|Estrogens|estrogens|mesh-ancestor
102348512|NCT04079218|Hormones|hormones|mesh-ancestor
102348513|NCT04079218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102348514|NCT04079218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348515|NCT04079218|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102348516|NCT04079218|Contraceptive Agents|contraceptive agents|mesh-ancestor
102348517|NCT04079218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102348518|NCT04079218|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102348519|NCT04061590|Cisplatin|cisplatin|mesh-list
102348520|NCT04061590|Pembrolizumab|pembrolizumab|mesh-list
102348521|NCT04061590|Pemetrexed|pemetrexed|mesh-list
102348522|NCT04061590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102348523|NCT04061590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102348524|NCT04061590|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102348525|NCT04061590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348526|NCT04061590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102348527|NCT04061590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102348528|NCT04061590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102348529|NCT01791088|Sirolimus|sirolimus|mesh-list
102348530|NCT01791088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102348531|NCT01791088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102348532|NCT01791088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102348533|NCT01791088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102348534|NCT01791088|Antifungal Agents|antifungal agents|mesh-ancestor
102348535|NCT01791088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102348536|NCT01791088|Immunologic Factors|immunologic factors|mesh-ancestor
102348537|NCT01791088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348538|NCT00291226|Glycine|glycine|mesh-list
102348539|NCT00291226|Glycine Agents|glycine agents|mesh-ancestor
102348540|NCT00291226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102348541|NCT00291226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348542|NCT00291226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348543|NCT01791166|Antibodies|antibodies|mesh-list
102348544|NCT01791166|Immunologic Factors|immunologic factors|mesh-ancestor
102348545|NCT01791166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348546|NCT00291694|Celecoxib|celecoxib|mesh-list
102348547|NCT00291694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102348548|NCT00291694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102348549|NCT00291694|Analgesics|analgesics|mesh-ancestor
102348550|NCT00291694|Sensory System Agents|sensory system agents|mesh-ancestor
102348551|NCT00291694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102348552|NCT00291694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348553|NCT00291694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102348554|NCT00291694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102348555|NCT00291694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102348556|NCT00291694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102348557|NCT00291694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102348558|NCT00291694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348559|NCT00292162|Metoprolol|metoprolol|mesh-list
102348560|NCT00292162|Carvedilol|carvedilol|mesh-list
102348561|NCT00292162|Ramipril|ramipril|mesh-list
102348562|NCT00292162|Enalapril|enalapril|mesh-list
102348563|NCT00292162|Lisinopril|lisinopril|mesh-list
102348564|NCT00292162|Bisoprolol|bisoprolol|mesh-list
102348565|NCT00292162|Perindopril|perindopril|mesh-list
102348566|NCT00292162|Captopril|captopril|mesh-list
102348567|NCT00292162|Spironolactone|spironolactone|mesh-list
102348568|NCT00292162|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102348569|NCT00292162|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
102348570|NCT00292162|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102348571|NCT00292162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102348572|NCT00292162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102348573|NCT00292162|Sympatholytics|sympatholytics|mesh-ancestor
102348574|NCT00292162|Autonomic Agents|autonomic agents|mesh-ancestor
102348575|NCT00292162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102348576|NCT00292162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348577|NCT00292162|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102348578|NCT00292162|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102348579|NCT00292162|Adrenergic Agents|adrenergic agents|mesh-ancestor
102348580|NCT00292162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102348581|NCT00292162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348582|NCT00292162|Hormone Antagonists|hormone antagonists|mesh-ancestor
102348583|NCT00292162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102348584|NCT00292162|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102348585|NCT00292162|Diuretics|diuretics|mesh-ancestor
102348586|NCT00292162|Natriuretic Agents|natriuretic agents|mesh-ancestor
102348587|NCT00292162|Antioxidants|antioxidants|mesh-ancestor
102348588|NCT00292162|Protective Agents|protective agents|mesh-ancestor
102348589|NCT00292162|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102348590|NCT00292162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102348591|NCT00292162|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102348592|NCT00292162|Vasodilator Agents|vasodilator agents|mesh-ancestor
102348593|NCT00292162|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102348594|NCT00292162|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102348595|NCT00292162|Protease Inhibitors|protease inhibitors|mesh-ancestor
102348596|NCT00292162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102348597|NCT00292162|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102348598|NCT00296296|Cyclosporine|cyclosporine|mesh-list
102348599|NCT00296296|Tacrolimus|tacrolimus|mesh-list
102348600|NCT00296296|Cyclosporins|cyclosporins|mesh-list
102348601|NCT00296296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102348602|NCT00296296|Immunologic Factors|immunologic factors|mesh-ancestor
102348603|NCT00296296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348604|NCT00296296|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102348605|NCT00296296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102348606|NCT00296296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348607|NCT00296296|Antifungal Agents|antifungal agents|mesh-ancestor
102348608|NCT00296296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102348609|NCT00296296|Dermatologic Agents|dermatologic agents|mesh-ancestor
102348610|NCT00296296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102348611|NCT01791400|Sumatriptan|sumatriptan|mesh-list
102348612|NCT01791400|Metoclopramide|metoclopramide|mesh-list
102348613|NCT01791400|Antiemetics|antiemetics|mesh-ancestor
102348614|NCT01791400|Autonomic Agents|autonomic agents|mesh-ancestor
102348615|NCT01791400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102348616|NCT01791400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348617|NCT01791400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102348618|NCT01791400|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102348619|NCT01791400|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102348620|NCT01791400|Dopamine Agents|dopamine agents|mesh-ancestor
102348621|NCT01791400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102348622|NCT01791400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348623|NCT01791400|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102348624|NCT01791400|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102348625|NCT01791400|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102348626|NCT01791400|Serotonin Agents|serotonin agents|mesh-ancestor
102348627|NCT00300430|Calcium, Dietary|calcium, dietary|mesh-list
102348628|NCT00300430|Atorvastatin|atorvastatin|mesh-list
102348629|NCT00300430|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102348630|NCT00300430|Simvastatin|simvastatin|mesh-list
102348631|NCT00300430|Fenofibrate|fenofibrate|mesh-list
102348632|NCT00300430|Calcium|calcium|mesh-list
102348633|NCT00300430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102348634|NCT00300430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348635|NCT00300430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102348636|NCT00300430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102348637|NCT00300430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102348638|NCT00300430|Antimetabolites|antimetabolites|mesh-ancestor
102348639|NCT00300430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348640|NCT00300430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102348641|NCT00300430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102348642|NCT00300430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102348643|NCT02104414|Epinephrine|epinephrine|mesh-list
102348644|NCT02104414|Bupivacaine|bupivacaine|mesh-list
102348645|NCT02104414|Anesthetics, Local|anesthetics, local|mesh-ancestor
102348646|NCT02104414|Anesthetics|anesthetics|mesh-ancestor
102348647|NCT02104414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102348648|NCT02104414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348649|NCT02104414|Sensory System Agents|sensory system agents|mesh-ancestor
102348650|NCT02104414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102348651|NCT02104414|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102348652|NCT02104414|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102348653|NCT02104414|Adrenergic Agents|adrenergic agents|mesh-ancestor
102348654|NCT02104414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102348655|NCT02104414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348656|NCT02104414|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102348657|NCT02104414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102348658|NCT02104414|Autonomic Agents|autonomic agents|mesh-ancestor
102348659|NCT02104414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102348660|NCT02104414|Respiratory System Agents|respiratory system agents|mesh-ancestor
102348661|NCT02104414|Mydriatics|mydriatics|mesh-ancestor
102348662|NCT02104414|Sympathomimetics|sympathomimetics|mesh-ancestor
102348663|NCT02104414|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102348664|NCT02100826|Cephalexin|cephalexin|mesh-list
102348665|NCT02100826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102348666|NCT02100826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102348667|NCT03587272|Sirolimus|sirolimus|mesh-list
102348668|NCT03587272|Alemtuzumab|alemtuzumab|mesh-list
102348669|NCT03587272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102348670|NCT03587272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102348671|NCT03587272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102348672|NCT03587272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102348673|NCT03587272|Antifungal Agents|antifungal agents|mesh-ancestor
102348674|NCT03587272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102348675|NCT03587272|Immunologic Factors|immunologic factors|mesh-ancestor
102348676|NCT03587272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348677|NCT03587272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102348678|NCT02101918|Aflibercept|aflibercept|mesh-list
102348679|NCT02101918|Endothelial Growth Factors|endothelial growth factors|mesh-list
102348680|NCT02101918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102348681|NCT02101918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102348682|NCT02101918|Growth Substances|growth substances|mesh-ancestor
102348683|NCT02101918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348684|NCT02101918|Growth Inhibitors|growth inhibitors|mesh-ancestor
102348685|NCT02101918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102348686|NCT00300742|Topiramate|topiramate|mesh-list
102348687|NCT00300742|Anticonvulsants|anticonvulsants|mesh-ancestor
102348688|NCT00300742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102348689|NCT00300742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348690|NCT00301756|Belinostat|belinostat|mesh-list
102348691|NCT00301756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102348692|NCT00301756|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102348693|NCT00301756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102348694|NCT00301756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348695|NCT00302068|Sertraline|sertraline|mesh-list
102348696|NCT00302068|Antidepressive Agents|antidepressive agents|mesh-ancestor
102348697|NCT00302068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102348698|NCT00302068|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102348699|NCT00302068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102348700|NCT00302068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102348701|NCT00302068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348702|NCT00302068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102348703|NCT00302068|Serotonin Agents|serotonin agents|mesh-ancestor
102348704|NCT00302068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348705|NCT00302848|Drospirenone|drospirenone|mesh-list
102348706|NCT00302848|Contraceptive Agents|contraceptive agents|mesh-list
102348707|NCT00302848|Levonorgestrel|levonorgestrel|mesh-list
102348708|NCT00302848|Contraceptives, Oral|contraceptives, oral|mesh-list
102348709|NCT00302848|Progestins|progestins|mesh-list
102348710|NCT00302848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102348711|NCT00302848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348712|NCT00302848|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102348713|NCT00302848|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102348714|NCT00302848|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102348715|NCT00302848|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102348716|NCT00302848|Hormone Antagonists|hormone antagonists|mesh-ancestor
102348717|NCT00302848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102348718|NCT00302848|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102348719|NCT00302848|Diuretics|diuretics|mesh-ancestor
102348720|NCT00302848|Natriuretic Agents|natriuretic agents|mesh-ancestor
102348721|NCT00302848|Hormones|hormones|mesh-ancestor
102348722|NCT00303862|Cediranib|cediranib|mesh-list
102348723|NCT00303862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102160396|NCT04684368|Mesna|mesna|mesh-list
102348724|NCT00303862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348725|NCT00303862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102348726|NCT00303862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102348727|NCT00304096|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
102348728|NCT00304096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102348729|NCT00304096|Immunologic Factors|immunologic factors|mesh-ancestor
102348730|NCT00304096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348731|NCT05267392|Durvalumab|durvalumab|mesh-list
102348732|NCT05267392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102348733|NCT05267392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102348734|NCT00142168|Rituximab|rituximab|mesh-list
102348735|NCT00142168|Lenalidomide|lenalidomide|mesh-list
102348736|NCT00142168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102348737|NCT00142168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102348738|NCT00142168|Immunologic Factors|immunologic factors|mesh-ancestor
102348739|NCT00142168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348740|NCT00142168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102348741|NCT00142168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102348742|NCT00142168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102348743|NCT00142168|Growth Substances|growth substances|mesh-ancestor
102348744|NCT00142168|Growth Inhibitors|growth inhibitors|mesh-ancestor
102348745|NCT02501434|Heparin|heparin|mesh-list
102348746|NCT02501434|Calcium heparin|calcium heparin|mesh-list
102348747|NCT02501434|Anticoagulants|anticoagulants|mesh-ancestor
102348748|NCT02501434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102348749|NCT02501434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102348750|NCT02501434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348751|NCT00147316|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102348752|NCT00147316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102348753|NCT00147316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102348754|NCT00147316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348755|NCT00148798|Cisplatin|cisplatin|mesh-list
102348756|NCT00148798|Cetuximab|cetuximab|mesh-list
102348757|NCT00148798|Vinorelbine|vinorelbine|mesh-list
102348758|NCT00148798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102348759|NCT00148798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102348760|NCT00148798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102348761|NCT00148798|Tubulin Modulators|tubulin modulators|mesh-ancestor
102348762|NCT00148798|Antimitotic Agents|antimitotic agents|mesh-ancestor
102348763|NCT00148798|Mitosis Modulators|mitosis modulators|mesh-ancestor
102348764|NCT00148798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348765|NCT00149734|Ondansetron|ondansetron|mesh-list
102348766|NCT00149734|Antiemetics|antiemetics|mesh-ancestor
102348767|NCT00149734|Autonomic Agents|autonomic agents|mesh-ancestor
102348768|NCT00149734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102348769|NCT00149734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348770|NCT00149734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102348771|NCT00149734|Antipruritics|antipruritics|mesh-ancestor
102348772|NCT00149734|Dermatologic Agents|dermatologic agents|mesh-ancestor
102348773|NCT00149734|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102348774|NCT00149734|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102348775|NCT00149734|Serotonin Agents|serotonin agents|mesh-ancestor
102348776|NCT00149734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102348777|NCT00149734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348778|NCT00198328|Bleomycin|bleomycin|mesh-list
102348779|NCT00198328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102348780|NCT00198328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102348781|NCT00305578|Memantine|memantine|mesh-list
102348782|NCT00305578|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102348783|NCT00305578|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102348784|NCT00305578|Dopamine Agents|dopamine agents|mesh-ancestor
102348785|NCT00305578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102348786|NCT00305578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348787|NCT00305578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348788|NCT00305578|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102348789|NCT00305578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102348790|NCT01492101|Etirinotecan pegol|etirinotecan pegol|mesh-list
102348791|NCT01492101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102348792|NCT01492101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102348793|NCT01492101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102348794|NCT01492101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102348795|NCT01492101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348796|NCT01468311|Daclizumab|daclizumab|mesh-list
102348797|NCT01468311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102348798|NCT01468311|Immunologic Factors|immunologic factors|mesh-ancestor
102348799|NCT01468311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348800|NCT00306202|Dasatinib|dasatinib|mesh-list
102348801|NCT00306202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102348802|NCT00306202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102348803|NCT00306202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102348804|NCT00306202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348805|NCT00325078|Infliximab|infliximab|mesh-list
102348806|NCT00325078|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102348807|NCT00325078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102348808|NCT00325078|Dermatologic Agents|dermatologic agents|mesh-ancestor
102348809|NCT00325078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102348810|NCT00325078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102348811|NCT00325780|Pitavastatin|pitavastatin|mesh-list
102348812|NCT00325780|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102348813|NCT00325780|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102348814|NCT00325780|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102348815|NCT00325780|Antimetabolites|antimetabolites|mesh-ancestor
102348816|NCT00325780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348817|NCT00325780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102348818|NCT00325780|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102348819|NCT00326170|Azacitidine|azacitidine|mesh-list
102348820|NCT00326170|Tretinoin|tretinoin|mesh-list
102348821|NCT00326170|Valproic Acid|valproic acid|mesh-list
102348822|NCT00326170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102348823|NCT00326170|Antimetabolites|antimetabolites|mesh-ancestor
102348824|NCT00326170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348825|NCT00326170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102348826|NCT00326170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102348827|NCT00326170|Keratolytic Agents|keratolytic agents|mesh-ancestor
102348828|NCT00326170|Dermatologic Agents|dermatologic agents|mesh-ancestor
102348829|NCT00326170|Anticonvulsants|anticonvulsants|mesh-ancestor
102348830|NCT00326170|GABA Agents|gaba agents|mesh-ancestor
102348831|NCT00326170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102348832|NCT00326170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348833|NCT00326170|Antimanic Agents|antimanic agents|mesh-ancestor
102348834|NCT00326170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102348835|NCT00326170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102348836|NCT00326170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102348837|NCT00326872|Cediranib|cediranib|mesh-list
102348838|NCT00326872|Maleic acid|maleic acid|mesh-list
102348839|NCT00326872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102348840|NCT00326872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348841|NCT00326872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102348842|NCT00326872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102348843|NCT05266690|Dextrans|dextrans|mesh-list
102348844|NCT05266690|Anticoagulants|anticoagulants|mesh-ancestor
102348845|NCT05266690|Plasma Substitutes|plasma substitutes|mesh-ancestor
102348846|NCT05266690|Blood Substitutes|blood substitutes|mesh-ancestor
102348847|NCT01730534|Dapagliflozin|dapagliflozin|mesh-list
102348848|NCT01730534|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102348849|NCT01730534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348850|NCT01730534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102348851|NCT01730534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348852|NCT05266534|Terlipressin|terlipressin|mesh-list
102348853|NCT05266534|Carbetocin|carbetocin|mesh-list
102348854|NCT05266534|Oxytocics|oxytocics|mesh-ancestor
102348855|NCT05266534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102348856|NCT05266534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348857|NCT05266534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102348858|NCT05266534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102348859|NCT01730378|Vaccines|vaccines|mesh-list
102348860|NCT01730378|Immunologic Factors|immunologic factors|mesh-ancestor
102348861|NCT01730378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348862|NCT00331162|Alemtuzumab|alemtuzumab|mesh-list
102348863|NCT00331162|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102348864|NCT00331162|Immunologic Factors|immunologic factors|mesh-ancestor
102348865|NCT00331162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348866|NCT00331162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102348867|NCT00331162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102348868|NCT00331162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102348869|NCT01790308|Liraglutide|liraglutide|mesh-list
102348870|NCT01790308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102348871|NCT01790308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348872|NCT01790308|Incretins|incretins|mesh-ancestor
102348873|NCT01790308|Hormones|hormones|mesh-ancestor
102348874|NCT01790308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102348875|NCT01609010|Interferons|interferons|mesh-list
102348877|NCT01609010|Rituximab|rituximab|mesh-list
102348878|NCT01609010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102348879|NCT01609010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102348880|NCT01609010|Immunologic Factors|immunologic factors|mesh-ancestor
102348881|NCT01609010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348882|NCT01609010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102348883|NCT01609010|Antiviral Agents|antiviral agents|mesh-ancestor
102348884|NCT01609010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102348885|NCT01608308|Acetaminophen|acetaminophen|mesh-list
102348886|NCT01608308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102348887|NCT01608308|Analgesics|analgesics|mesh-ancestor
102348888|NCT01608308|Sensory System Agents|sensory system agents|mesh-ancestor
102348889|NCT01608308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102348890|NCT01608308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348891|NCT01608308|Antipyretics|antipyretics|mesh-ancestor
102348892|NCT00332644|Bupropion|bupropion|mesh-list
102348893|NCT00332644|Nicotine|nicotine|mesh-list
102348894|NCT00332644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102348895|NCT00332644|Autonomic Agents|autonomic agents|mesh-ancestor
102348896|NCT00332644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102348897|NCT00332644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348898|NCT00332644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102348899|NCT00332644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102348900|NCT00332644|Cholinergic Agents|cholinergic agents|mesh-ancestor
102348901|NCT00332644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102348902|NCT00332644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348903|NCT00332644|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102348904|NCT00332644|Antidepressive Agents|antidepressive agents|mesh-ancestor
102348905|NCT00332644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102348906|NCT00332644|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102348907|NCT00332644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102348908|NCT00332644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102348909|NCT00332644|Dopamine Agents|dopamine agents|mesh-ancestor
102348910|NCT00332644|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102348911|NCT00332644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102348912|NCT00332644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102348913|NCT01755416|Insulin|insulin|mesh-list
102348914|NCT01755416|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102348915|NCT01755416|Liraglutide|liraglutide|mesh-list
102348916|NCT01755416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102348917|NCT01755416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348918|NCT01755416|Incretins|incretins|mesh-ancestor
102348919|NCT01755416|Hormones|hormones|mesh-ancestor
102348920|NCT01755416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102348921|NCT01755026|Cefazolin|cefazolin|mesh-list
102348922|NCT01755026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102348923|NCT01755026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102348924|NCT00333814|Dexamethasone|dexamethasone|mesh-list
102348925|NCT00333814|Dexamethasone acetate|dexamethasone acetate|mesh-list
102348926|NCT00333814|BB 1101|bb 1101|mesh-list
102348927|NCT00333814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102348928|NCT00333814|Antiemetics|antiemetics|mesh-ancestor
102348929|NCT00333814|Autonomic Agents|autonomic agents|mesh-ancestor
102348930|NCT00333814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102348931|NCT00333814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348932|NCT00333814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102348933|NCT00333814|Glucocorticoids|glucocorticoids|mesh-ancestor
102348934|NCT00333814|Hormones|hormones|mesh-ancestor
102348935|NCT00333814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102348936|NCT00333814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102348937|NCT00333814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102348938|NCT00333814|Protease Inhibitors|protease inhibitors|mesh-ancestor
102348939|NCT00333814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102348940|NCT00333814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348941|NCT01728584|Bromides|bromides|mesh-list
102348942|NCT01728584|Rocuronium|rocuronium|mesh-list
102348943|NCT01728584|Anticonvulsants|anticonvulsants|mesh-ancestor
102348944|NCT01728584|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102348945|NCT01728584|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102348946|NCT01728584|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102348947|NCT01728584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102348948|NCT01728584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348949|NCT00315328|Atropine|atropine|mesh-list
102348950|NCT00315328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102348951|NCT00315328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102348952|NCT00315328|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102348953|NCT00315328|Autonomic Agents|autonomic agents|mesh-ancestor
102348954|NCT00315328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102348955|NCT00315328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348956|NCT00315328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102348957|NCT00315328|Respiratory System Agents|respiratory system agents|mesh-ancestor
102348958|NCT00315328|Mydriatics|mydriatics|mesh-ancestor
102348959|NCT00315328|Parasympatholytics|parasympatholytics|mesh-ancestor
102348960|NCT00315328|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102348961|NCT00315328|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102348962|NCT00315328|Cholinergic Agents|cholinergic agents|mesh-ancestor
102348963|NCT00315328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102348964|NCT00315328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348965|NCT01522443|Prednisone|prednisone|mesh-list
102348966|NCT01522443|Mitoxantrone|mitoxantrone|mesh-list
102348967|NCT01522443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102348968|NCT01522443|Glucocorticoids|glucocorticoids|mesh-ancestor
102348969|NCT01522443|Hormones|hormones|mesh-ancestor
102348970|NCT01522443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102348971|NCT01522443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348972|NCT01522443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102348973|NCT01522443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102348974|NCT01522443|Analgesics|analgesics|mesh-ancestor
102348975|NCT01522443|Sensory System Agents|sensory system agents|mesh-ancestor
102348976|NCT01522443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102348977|NCT01522443|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102348978|NCT01522443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102348979|NCT01522443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102348980|NCT01522443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348981|NCT00336232|Vitamin K|vitamin k|mesh-list
102348982|NCT00336232|Vitamin K 1|vitamin k 1|mesh-list
102348983|NCT00336232|Vitamins|vitamins|mesh-ancestor
102348984|NCT00336232|Micronutrients|micronutrients|mesh-ancestor
102348985|NCT00336232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102348986|NCT00336232|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102348987|NCT00336232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102348988|NCT00336232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348989|NCT00336232|Hemostatics|hemostatics|mesh-ancestor
102348990|NCT00336232|Coagulants|coagulants|mesh-ancestor
102348991|NCT00336700|Gemcitabine|gemcitabine|mesh-list
102348992|NCT00336700|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102348993|NCT00336700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102348994|NCT00336700|Antimetabolites|antimetabolites|mesh-ancestor
102348995|NCT00336700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102348996|NCT00336700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102348997|NCT00336700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102348998|NCT00336700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102348999|NCT01468233|Adalimumab|adalimumab|mesh-list
102349000|NCT01468233|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102349001|NCT01468233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102349002|NCT01468233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102349003|NCT01754402|Dexamethasone|dexamethasone|mesh-list
102349004|NCT01754402|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102349005|NCT01754402|Pomalidomide|pomalidomide|mesh-list
102349006|NCT01754402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102349007|NCT01754402|Antiemetics|antiemetics|mesh-ancestor
102349008|NCT01754402|Autonomic Agents|autonomic agents|mesh-ancestor
102349009|NCT01754402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102349010|NCT01754402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349011|NCT01754402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102349012|NCT01754402|Glucocorticoids|glucocorticoids|mesh-ancestor
102349013|NCT01754402|Hormones|hormones|mesh-ancestor
102349014|NCT01754402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102349015|NCT01754402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102349016|NCT01754402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102349017|NCT01754402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102349018|NCT01754402|Alkylating Agents|alkylating agents|mesh-ancestor
102349019|NCT01754402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349020|NCT01754402|Immunologic Factors|immunologic factors|mesh-ancestor
102349021|NCT01754402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102349022|NCT01754402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102349023|NCT01754402|Growth Substances|growth substances|mesh-ancestor
102349024|NCT01754402|Growth Inhibitors|growth inhibitors|mesh-ancestor
102349025|NCT01521897|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102349026|NCT01521897|Immunologic Factors|immunologic factors|mesh-ancestor
102349027|NCT01521897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349029|NCT01782872|Anesthetics, Local|anesthetics, local|mesh-ancestor
102349030|NCT01782872|Anesthetics|anesthetics|mesh-ancestor
102349031|NCT01782872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102349032|NCT01782872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349033|NCT01782872|Sensory System Agents|sensory system agents|mesh-ancestor
102347095|NCT02997228|Growth Inhibitors|growth inhibitors|mesh-ancestor
102349034|NCT01782872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102349035|NCT01490697|Cycloserine|cycloserine|mesh-list
102349036|NCT01490697|Mifepristone|mifepristone|mesh-list
102349037|NCT01490697|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102349038|NCT01490697|Abortifacient Agents|abortifacient agents|mesh-ancestor
102349039|NCT01490697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102349040|NCT01490697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349041|NCT01490697|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102349042|NCT01490697|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102349043|NCT01490697|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102349044|NCT01490697|Contraceptive Agents|contraceptive agents|mesh-ancestor
102349045|NCT01490697|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102349046|NCT01490697|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102349047|NCT01490697|Hormone Antagonists|hormone antagonists|mesh-ancestor
102349048|NCT01490697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102349049|NCT01490697|Luteolytic Agents|luteolytic agents|mesh-ancestor
102349050|NCT01490697|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102349051|NCT01490697|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102349052|NCT01490697|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102349053|NCT01490697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102349054|NCT01490697|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102349055|NCT01490697|Antitubercular Agents|antitubercular agents|mesh-ancestor
102349056|NCT01490697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102349057|NCT01490697|Antimetabolites|antimetabolites|mesh-ancestor
102349058|NCT01490697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349059|NCT01728194|Escitalopram|escitalopram|mesh-list
102349060|NCT01728194|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102349061|NCT01728194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102349062|NCT01728194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102349063|NCT01728194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349064|NCT01728194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102349065|NCT01728194|Serotonin Agents|serotonin agents|mesh-ancestor
102349066|NCT01728194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349067|NCT04408911|Midazolam|midazolam|mesh-list
102349068|NCT04408911|Lormetazepam|lormetazepam|mesh-list
102349069|NCT04408911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102349070|NCT04408911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102349071|NCT04408911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102349072|NCT04408911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349073|NCT04408911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102349074|NCT04408911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102349075|NCT04408911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102349076|NCT04408911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102349077|NCT04408911|Anesthetics, General|anesthetics, general|mesh-ancestor
102349078|NCT04408911|Anesthetics|anesthetics|mesh-ancestor
102349079|NCT04408911|GABA Modulators|gaba modulators|mesh-ancestor
102349080|NCT04408911|GABA Agents|gaba agents|mesh-ancestor
102349081|NCT04408911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102349082|NCT04408911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349083|NCT01466673|Moxifloxacin|moxifloxacin|mesh-list
102349084|NCT01466673|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102349085|NCT01466673|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102349086|NCT01466673|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102349087|NCT01466673|Desogestrel|desogestrel|mesh-list
102349088|NCT01466673|Norgestimate|norgestimate|mesh-list
102349089|NCT01466673|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102349090|NCT01466673|Estradiol|estradiol|mesh-list
102349091|NCT01466673|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102349092|NCT01466673|Estrogens|estrogens|mesh-ancestor
102349093|NCT01466673|Hormones|hormones|mesh-ancestor
102349094|NCT01466673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102349095|NCT01466673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349096|NCT01466673|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102349097|NCT01466673|Contraceptive Agents|contraceptive agents|mesh-ancestor
102349098|NCT01466673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102160773|NCT03959085|Micronutrients|micronutrients|mesh-ancestor
102349099|NCT01466673|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102349100|NCT01466673|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102349101|NCT01466673|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102349102|NCT01466673|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102349103|NCT01466673|Progestins|progestins|mesh-ancestor
102349104|NCT01466673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102349105|NCT01466673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102349106|NCT01466673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102349107|NCT01466673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102349108|NCT01466673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102349109|NCT01466673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349110|NCT01466673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102349111|NCT01466673|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102349112|NCT01753856|Vitamin D|vitamin d|mesh-list
102349113|NCT01753856|Denosumab|denosumab|mesh-list
102349114|NCT01753856|Teriparatide|teriparatide|mesh-list
102349115|NCT01753856|Tetracycline|tetracycline|mesh-list
102349116|NCT01753856|Demeclocycline|demeclocycline|mesh-list
102349117|NCT01753856|Calcium|calcium|mesh-list
102349118|NCT01753856|Vitamins|vitamins|mesh-ancestor
102349119|NCT01753856|Micronutrients|micronutrients|mesh-ancestor
102349120|NCT01753856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349121|NCT01753856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102349122|NCT01753856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102349123|NCT01753856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102349124|NCT01753856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102349125|NCT01753856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102349126|NCT01753856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102349127|NCT01753856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349128|NCT01753310|Botulinum Toxins|botulinum toxins|mesh-list
102349129|NCT01753310|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102349130|NCT01753310|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102349131|NCT01753310|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102349132|NCT01753310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102349133|NCT01753310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349134|NCT01753310|Cholinergic Agents|cholinergic agents|mesh-ancestor
102349135|NCT01753310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102349136|NCT01753310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349137|NCT01753310|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102349138|NCT01753310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102349139|NCT01521117|Donepezil|donepezil|mesh-list
102349140|NCT01521117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102349141|NCT01521117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102349142|NCT01521117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349143|NCT01521117|Cholinergic Agents|cholinergic agents|mesh-ancestor
102349144|NCT01521117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102349145|NCT01521117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349146|NCT01521117|Nootropic Agents|nootropic agents|mesh-ancestor
102349147|NCT01466595|Rifaximin|rifaximin|mesh-list
102349148|NCT01466595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102349149|NCT01466595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102349150|NCT01466595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102349151|NCT02073747|Albuterol|albuterol|mesh-list
102349152|NCT02073747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102349153|NCT02073747|Autonomic Agents|autonomic agents|mesh-ancestor
102349154|NCT02073747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102349155|NCT02073747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349156|NCT02073747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102349157|NCT02073747|Respiratory System Agents|respiratory system agents|mesh-ancestor
102349158|NCT02073747|Tocolytic Agents|tocolytic agents|mesh-ancestor
102349159|NCT02073747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102349160|NCT02073747|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102349161|NCT02073747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102349162|NCT02073747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102349163|NCT02073747|Adrenergic Agents|adrenergic agents|mesh-ancestor
102349164|NCT02073747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102349165|NCT02073747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349166|NCT01465659|Temozolomide|temozolomide|mesh-list
102349167|NCT01465659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102349168|NCT01465659|Alkylating Agents|alkylating agents|mesh-ancestor
102349169|NCT01465659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349170|NCT01465659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102349171|NCT01462929|Bromides|bromides|mesh-list
102349172|NCT01462929|Tiotropium Bromide|tiotropium bromide|mesh-list
102160849|NCT03796156|Aspirin|aspirin|mesh-list
102349173|NCT01462929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102349174|NCT01462929|Autonomic Agents|autonomic agents|mesh-ancestor
102349175|NCT01462929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102349176|NCT01462929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349177|NCT01462929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102349178|NCT01462929|Respiratory System Agents|respiratory system agents|mesh-ancestor
102349179|NCT01462929|Parasympatholytics|parasympatholytics|mesh-ancestor
102349180|NCT01462929|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102349181|NCT01462929|Cholinergic Agents|cholinergic agents|mesh-ancestor
102349182|NCT01462929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102349183|NCT01462929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349184|NCT01462929|Anticonvulsants|anticonvulsants|mesh-ancestor
102349186|NCT01462695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102349187|NCT01462695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102349188|NCT01462695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102349189|NCT01462695|Growth Substances|growth substances|mesh-ancestor
102349190|NCT01462695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349191|NCT01462695|Growth Inhibitors|growth inhibitors|mesh-ancestor
102349192|NCT01462695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102349193|NCT01462695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102349194|NCT01462695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349195|NCT01465347|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
102349196|NCT01465347|Antioxidants|antioxidants|mesh-ancestor
102349197|NCT01465347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349198|NCT01465347|Protective Agents|protective agents|mesh-ancestor
102349199|NCT01465347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349200|NCT01465347|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102349201|NCT01465347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102349202|NCT01465191|Morphine|morphine|mesh-list
102349203|NCT01465191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102349204|NCT01465191|Narcotics|narcotics|mesh-ancestor
102349205|NCT01465191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102349206|NCT01465191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349207|NCT01465191|Analgesics|analgesics|mesh-ancestor
102349208|NCT01465191|Sensory System Agents|sensory system agents|mesh-ancestor
102349209|NCT01465191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102349210|NCT01519947|Epoetin Alfa|epoetin alfa|mesh-list
102349211|NCT01519947|Hematinics|hematinics|mesh-ancestor
102349212|NCT01462227|Naltrexone|naltrexone|mesh-list
102349213|NCT01462227|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102349214|NCT01462227|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102349215|NCT01462227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349216|NCT01462227|Sensory System Agents|sensory system agents|mesh-ancestor
102349217|NCT01462227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102349218|NCT01464879|Testosterone|testosterone|mesh-list
102349219|NCT01464879|Androgens|androgens|mesh-ancestor
102349220|NCT01464879|Hormones|hormones|mesh-ancestor
102349221|NCT01464879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102349222|NCT01464879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349223|NCT03026205|Cetylpyridinium|cetylpyridinium|mesh-list
102349224|NCT03026205|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102349225|NCT03026205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102349226|NCT01519791|Certolizumab Pegol|certolizumab pegol|mesh-list
102349227|NCT01519791|Methotrexate|methotrexate|mesh-list
102349228|NCT01519791|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102349229|NCT01519791|Abortifacient Agents|abortifacient agents|mesh-ancestor
102349230|NCT01519791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102349231|NCT01519791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349232|NCT01519791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102349233|NCT01519791|Antimetabolites|antimetabolites|mesh-ancestor
102349234|NCT01519791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349235|NCT01519791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102349236|NCT01519791|Dermatologic Agents|dermatologic agents|mesh-ancestor
102349237|NCT01519791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102349238|NCT01519791|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102349239|NCT01519791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102349240|NCT01519791|Immunologic Factors|immunologic factors|mesh-ancestor
102349241|NCT01519791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102349242|NCT01519791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102349243|NCT01519791|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102349244|NCT01519791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102349245|NCT01439373|Interferons|interferons|mesh-list
102349246|NCT01439373|Ribavirin|ribavirin|mesh-list
102349247|NCT01439373|Interferon-alpha|interferon-alpha|mesh-list
102349248|NCT01439373|Interferon alpha-2|interferon alpha-2|mesh-list
102349249|NCT01439373|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102349250|NCT01439373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102349251|NCT01439373|Antiviral Agents|antiviral agents|mesh-ancestor
102349252|NCT01439373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102349253|NCT01439373|Antimetabolites|antimetabolites|mesh-ancestor
102349254|NCT01439373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349255|NCT01439373|Immunologic Factors|immunologic factors|mesh-ancestor
102349256|NCT01439373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349257|NCT01461369|Diclofenac|diclofenac|mesh-list
102349258|NCT01461369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102349259|NCT01461369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102349260|NCT01461369|Analgesics|analgesics|mesh-ancestor
102349261|NCT01461369|Sensory System Agents|sensory system agents|mesh-ancestor
102349262|NCT01461369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102349263|NCT01461369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349264|NCT01461369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102349265|NCT01461369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102349266|NCT01461369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102349267|NCT01461369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102349268|NCT01461369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349269|NCT01727258|Fluorides|fluorides|mesh-list
102349270|NCT01727258|Cariostatic Agents|cariostatic agents|mesh-ancestor
102349271|NCT01727258|Protective Agents|protective agents|mesh-ancestor
102349272|NCT01727258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349273|NCT01781234|Insulin|insulin|mesh-list
102349274|NCT01781234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102349275|NCT01781234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349276|NCT01752842|Fenofibrate|fenofibrate|mesh-list
102349277|NCT01752842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102349278|NCT01752842|Antimetabolites|antimetabolites|mesh-ancestor
102349279|NCT01752842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349280|NCT01752842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102349281|NCT01461057|Capecitabine|capecitabine|mesh-list
102349282|NCT01461057|Trastuzumab|trastuzumab|mesh-list
102349283|NCT01461057|Pertuzumab|pertuzumab|mesh-list
102349284|NCT01461057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102349285|NCT01461057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102349286|NCT01461057|Antimetabolites|antimetabolites|mesh-ancestor
102349287|NCT01461057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349288|NCT01461057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102349289|NCT04567407|Ropivacaine|ropivacaine|mesh-list
102349290|NCT04567407|Anesthetics, Local|anesthetics, local|mesh-ancestor
102349291|NCT04567407|Anesthetics|anesthetics|mesh-ancestor
102349292|NCT04567407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102349293|NCT04567407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349294|NCT04567407|Sensory System Agents|sensory system agents|mesh-ancestor
102349295|NCT04567407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102349296|NCT01519635|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102349297|NCT01519635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102349298|NCT01519635|Diuretics|diuretics|mesh-ancestor
102349299|NCT01519635|Natriuretic Agents|natriuretic agents|mesh-ancestor
102349300|NCT01519635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349301|NCT01519635|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102349302|NCT01519635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102349303|NCT01519635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349304|NCT01519323|Vemurafenib|vemurafenib|mesh-list
102349305|NCT01519323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102349306|NCT01519323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102349307|NCT01519323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102349308|NCT01519323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349309|NCT01519245|Tranexamic Acid|tranexamic acid|mesh-list
102349310|NCT01519245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102349311|NCT01519245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102349312|NCT01519245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349313|NCT01519245|Hemostatics|hemostatics|mesh-ancestor
102349314|NCT01519245|Coagulants|coagulants|mesh-ancestor
102349315|NCT01519167|Fentanyl|fentanyl|mesh-list
102349316|NCT01519167|Midazolam|midazolam|mesh-list
102349317|NCT01519167|Dexmedetomidine|dexmedetomidine|mesh-list
102349318|NCT01519167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102349319|NCT01519167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102347104|NCT02997228|Vitamins|vitamins|mesh-ancestor
102349320|NCT01519167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349321|NCT01519167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102161002|NCT03339635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102349322|NCT01519167|Analgesics|analgesics|mesh-ancestor
102349323|NCT01519167|Sensory System Agents|sensory system agents|mesh-ancestor
102349324|NCT01519167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102349325|NCT01519167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102349326|NCT01519167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102349327|NCT01519167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102349328|NCT01519167|Adrenergic Agents|adrenergic agents|mesh-ancestor
102349329|NCT01519167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102349330|NCT01519167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349331|NCT01519167|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102349332|NCT01519167|Narcotics|narcotics|mesh-ancestor
102349333|NCT01519167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102349334|NCT01519167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102349335|NCT01519167|Anesthetics, General|anesthetics, general|mesh-ancestor
102349336|NCT01519167|Anesthetics|anesthetics|mesh-ancestor
102349337|NCT01519167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102349338|NCT01519167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102349339|NCT01519167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102349340|NCT01519167|GABA Modulators|gaba modulators|mesh-ancestor
102349341|NCT01519167|GABA Agents|gaba agents|mesh-ancestor
102349342|NCT00318136|Paclitaxel|paclitaxel|mesh-list
102349343|NCT00318136|Bevacizumab|bevacizumab|mesh-list
102349344|NCT00318136|Carboplatin|carboplatin|mesh-list
102349345|NCT00318136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102349346|NCT00318136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102349347|NCT00318136|Tubulin Modulators|tubulin modulators|mesh-ancestor
102349348|NCT00318136|Antimitotic Agents|antimitotic agents|mesh-ancestor
102349349|NCT00318136|Mitosis Modulators|mitosis modulators|mesh-ancestor
102349350|NCT00318136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349351|NCT00318136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102349352|NCT00318136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102349353|NCT00318136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102349354|NCT00318136|Growth Substances|growth substances|mesh-ancestor
102349355|NCT00318136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349356|NCT00318136|Growth Inhibitors|growth inhibitors|mesh-ancestor
102349357|NCT00318292|Epinephrine|epinephrine|mesh-list
102349358|NCT00318292|Bupivacaine|bupivacaine|mesh-list
102349359|NCT00318292|Anesthetics, Local|anesthetics, local|mesh-ancestor
102349360|NCT00318292|Anesthetics|anesthetics|mesh-ancestor
102349361|NCT00318292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102349362|NCT00318292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349363|NCT00318292|Sensory System Agents|sensory system agents|mesh-ancestor
102349364|NCT00318292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102349365|NCT00318292|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102349366|NCT00318292|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102349367|NCT00318292|Adrenergic Agents|adrenergic agents|mesh-ancestor
102349368|NCT00318292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102349369|NCT00318292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349370|NCT00318292|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102349371|NCT00318292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102349372|NCT00318292|Autonomic Agents|autonomic agents|mesh-ancestor
102349373|NCT00318292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102349374|NCT00318292|Respiratory System Agents|respiratory system agents|mesh-ancestor
102349375|NCT00318292|Mydriatics|mydriatics|mesh-ancestor
102349376|NCT00318292|Sympathomimetics|sympathomimetics|mesh-ancestor
102349377|NCT00318292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102349378|NCT01791868|Valproic Acid|valproic acid|mesh-list
102349379|NCT01791868|Anticonvulsants|anticonvulsants|mesh-ancestor
102349380|NCT01791868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102349381|NCT01791868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349382|NCT01791868|GABA Agents|gaba agents|mesh-ancestor
102349383|NCT01791868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102349384|NCT01791868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349385|NCT01791868|Antimanic Agents|antimanic agents|mesh-ancestor
102349386|NCT01791868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102349387|NCT01791868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102349388|NCT01791868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102349389|NCT03793114|Cosyntropin|cosyntropin|mesh-list
102349390|NCT03793114|Hormones|hormones|mesh-ancestor
102349391|NCT03793114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102349392|NCT03793114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349393|NCT00348946|Androgens|androgens|mesh-list
102349394|NCT00348946|Oxandrolone|oxandrolone|mesh-list
102349395|NCT00348946|Hormones|hormones|mesh-ancestor
102349396|NCT00348946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102349397|NCT00348946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349398|NCT00348946|Anabolic Agents|anabolic agents|mesh-ancestor
102349399|NCT00349336|Bevacizumab|bevacizumab|mesh-list
102349400|NCT00349336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102349401|NCT00349336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102349402|NCT00349336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102349403|NCT00349336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102349404|NCT00349336|Growth Substances|growth substances|mesh-ancestor
102349405|NCT00349336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349406|NCT00349336|Growth Inhibitors|growth inhibitors|mesh-ancestor
102349407|NCT04751188|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102349408|NCT04751188|Bezafibrate|bezafibrate|mesh-list
102349409|NCT04751188|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102349410|NCT04751188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102349411|NCT04751188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102349412|NCT04751188|Antimetabolites|antimetabolites|mesh-ancestor
102349413|NCT04751188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349414|NCT04751188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102349415|NCT00352612|Clindamycin|clindamycin|mesh-list
102349416|NCT00352612|Clindamycin palmitate|clindamycin palmitate|mesh-list
102349417|NCT00352612|Clindamycin phosphate|clindamycin phosphate|mesh-list
102349418|NCT00352612|Cephalexin|cephalexin|mesh-list
102349419|NCT00352612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102349420|NCT00352612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102349421|NCT00352612|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102349422|NCT00352612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102349423|NCT00352612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349424|NCT00323362|Gemcitabine|gemcitabine|mesh-list
102349425|NCT00323362|Imatinib Mesylate|imatinib mesylate|mesh-list
102349426|NCT00323362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102349427|NCT00323362|Antimetabolites|antimetabolites|mesh-ancestor
102349428|NCT00323362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349429|NCT00323362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102349430|NCT00323362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102349431|NCT00323362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102349432|NCT00390364|Everolimus|everolimus|mesh-list
102349433|NCT00390364|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102349434|NCT00390364|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102349435|NCT00390364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102349436|NCT00390364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102349437|NCT00390364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349438|NCT00390364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102349439|NCT00390364|Immunologic Factors|immunologic factors|mesh-ancestor
102349440|NCT00390364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349441|NCT00390364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102349442|NCT00354640|Anastrozole|anastrozole|mesh-list
102349443|NCT00354640|Simvastatin|simvastatin|mesh-list
102349444|NCT00354640|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102349445|NCT00354640|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102349446|NCT00354640|Antimetabolites|antimetabolites|mesh-ancestor
102349447|NCT00354640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349448|NCT00354640|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102349449|NCT00354640|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102349450|NCT00354640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102349451|NCT00354640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102349452|NCT00354640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102349453|NCT00354640|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102349454|NCT00354640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102349455|NCT00354640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102349456|NCT00354640|Hormone Antagonists|hormone antagonists|mesh-ancestor
102349457|NCT00354640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102349458|NCT00354640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349459|NCT00392392|Paclitaxel|paclitaxel|mesh-list
102349460|NCT00392392|Bevacizumab|bevacizumab|mesh-list
102349461|NCT00392392|Trastuzumab|trastuzumab|mesh-list
102349462|NCT00392392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102349463|NCT00392392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102349464|NCT00392392|Tubulin Modulators|tubulin modulators|mesh-ancestor
102349465|NCT00392392|Antimitotic Agents|antimitotic agents|mesh-ancestor
102349466|NCT00392392|Mitosis Modulators|mitosis modulators|mesh-ancestor
102349467|NCT00392392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349468|NCT00392392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102349469|NCT00392392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102349470|NCT00392392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102349471|NCT00392392|Growth Substances|growth substances|mesh-ancestor
102349472|NCT00392392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349473|NCT00392392|Growth Inhibitors|growth inhibitors|mesh-ancestor
102349474|NCT01519089|Tofacitinib|tofacitinib|mesh-list
102349475|NCT01519089|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102349476|NCT01519089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102349477|NCT01519089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102349478|NCT01519089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349479|NCT00392704|Paclitaxel|paclitaxel|mesh-list
102349480|NCT00392704|Bevacizumab|bevacizumab|mesh-list
102349481|NCT00392704|Fluorouracil|fluorouracil|mesh-list
102349482|NCT00392704|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102349483|NCT00392704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102349484|NCT00392704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102349485|NCT00392704|Tubulin Modulators|tubulin modulators|mesh-ancestor
102349486|NCT00392704|Antimitotic Agents|antimitotic agents|mesh-ancestor
102349487|NCT00392704|Mitosis Modulators|mitosis modulators|mesh-ancestor
102349488|NCT00392704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349489|NCT00392704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102349490|NCT00392704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102349491|NCT00392704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102349492|NCT00392704|Growth Substances|growth substances|mesh-ancestor
102349493|NCT00392704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349494|NCT00392704|Growth Inhibitors|growth inhibitors|mesh-ancestor
102349495|NCT00392704|Antimetabolites|antimetabolites|mesh-ancestor
102349496|NCT00392704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102349497|NCT00392704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102349498|NCT00392704|Immunologic Factors|immunologic factors|mesh-ancestor
102349499|NCT00392704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102349500|NCT00392704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102349501|NCT00392782|Fludarabine|fludarabine|mesh-list
102349502|NCT00392782|Fludarabine phosphate|fludarabine phosphate|mesh-list
102349503|NCT00392782|Thiotepa|thiotepa|mesh-list
102349504|NCT00392782|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102349505|NCT00392782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102349506|NCT00392782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102349507|NCT00392782|Antimetabolites|antimetabolites|mesh-ancestor
102349508|NCT00392782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349509|NCT00392782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102349510|NCT00392782|Immunologic Factors|immunologic factors|mesh-ancestor
102349511|NCT00392782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349512|NCT00392782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102349513|NCT00392782|Alkylating Agents|alkylating agents|mesh-ancestor
102349514|NCT00392782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102349515|NCT01518699|Moxifloxacin|moxifloxacin|mesh-list
102349516|NCT01518699|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102349517|NCT01518699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102349518|NCT01518699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102349519|NCT01518699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102349520|NCT01518699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102349521|NCT01518699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102349522|NCT01518699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349523|NCT01518699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102349524|NCT01518699|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102349525|NCT01518699|Contraceptive Agents|contraceptive agents|mesh-ancestor
102349526|NCT01518699|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102349527|NCT01518699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349528|NCT01518699|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102349529|NCT01518699|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102349530|NCT01518699|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102349531|NCT01518309|Pimavanserin|pimavanserin|mesh-list
102349532|NCT01518309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102349533|NCT01518309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102349534|NCT01518309|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102349535|NCT01518309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102349536|NCT01518309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102349537|NCT01518309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349538|NCT01518309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102349539|NCT01518309|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102349540|NCT01518309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102349541|NCT01518309|Serotonin Agents|serotonin agents|mesh-ancestor
102349542|NCT01518309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102349543|NCT01518309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161235|NCT02724579|Vincristine|vincristine|mesh-list
102349544|NCT01419717|Denosumab|denosumab|mesh-list
102349545|NCT01419717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102349546|NCT01419717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349547|NCT01458951|Tofacitinib|tofacitinib|mesh-list
102349548|NCT01458951|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102349549|NCT01458951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102349550|NCT01458951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102349551|NCT01458951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349552|NCT01458639|Xenon|xenon|mesh-list
102349553|NCT01458639|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102349554|NCT01458639|Anesthetics, General|anesthetics, general|mesh-ancestor
102349555|NCT01458639|Anesthetics|anesthetics|mesh-ancestor
102349556|NCT01458639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102349557|NCT01458639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349558|NCT00393796|Sunitinib|sunitinib|mesh-list
102349559|NCT00393796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102349560|NCT00393796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102349561|NCT00393796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102349562|NCT00393796|Growth Substances|growth substances|mesh-ancestor
102349563|NCT00393796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349564|NCT00393796|Growth Inhibitors|growth inhibitors|mesh-ancestor
102349565|NCT00393796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102349566|NCT00393796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102349567|NCT00393796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349568|NCT00393874|Prazosin|prazosin|mesh-list
102349569|NCT00393874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102349570|NCT00393874|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102349571|NCT00393874|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102349572|NCT00393874|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102349573|NCT00393874|Adrenergic Agents|adrenergic agents|mesh-ancestor
102349574|NCT00393874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102349575|NCT00393874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349576|NCT00393874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349577|NCT00394888|Dermatologic Agents|dermatologic agents|mesh-list
102349578|NCT01458171|Immunoglobulins|immunoglobulins|mesh-list
102349579|NCT01458171|Antibodies|antibodies|mesh-list
102349580|NCT01458171|gamma-Globulins|gamma-globulins|mesh-list
102349581|NCT01458171|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102349582|NCT01458171|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102349583|NCT01458171|Immunologic Factors|immunologic factors|mesh-ancestor
102349584|NCT01458171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349585|NCT00395044|Gabapentin|gabapentin|mesh-list
102349586|NCT00395044|Analgesics|analgesics|mesh-ancestor
102349587|NCT00395044|Sensory System Agents|sensory system agents|mesh-ancestor
102349588|NCT00395044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102349589|NCT00395044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349590|NCT00395044|Anticonvulsants|anticonvulsants|mesh-ancestor
102349591|NCT00395044|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102349592|NCT00395044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102349593|NCT00395044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102349594|NCT00395044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102349595|NCT00395044|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102349596|NCT00395044|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102349597|NCT00395044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102349598|NCT00395044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349599|NCT00395044|Antimanic Agents|antimanic agents|mesh-ancestor
102349600|NCT01457703|Letrozole|letrozole|mesh-list
102349601|NCT01457703|Cetrorelix|cetrorelix|mesh-list
102349602|NCT01457703|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
102349603|NCT01457703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102349604|NCT01457703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102349605|NCT01457703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102349606|NCT01457703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102349607|NCT01457703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349608|NCT01457703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102349609|NCT01457703|Hormone Antagonists|hormone antagonists|mesh-ancestor
102349610|NCT01457703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102349611|NCT01457703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349612|NCT01457703|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102349613|NCT01457703|Fertility Agents|fertility agents|mesh-ancestor
102349614|NCT01457703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102349615|NCT01457703|Hormones|hormones|mesh-ancestor
102349616|NCT02076321|Acetaminophen|acetaminophen|mesh-list
102349617|NCT02076321|Ibuprofen|ibuprofen|mesh-list
102349618|NCT02076321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102349619|NCT02076321|Analgesics|analgesics|mesh-ancestor
102349620|NCT02076321|Sensory System Agents|sensory system agents|mesh-ancestor
102349621|NCT02076321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102349622|NCT02076321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349623|NCT02076321|Antipyretics|antipyretics|mesh-ancestor
102349624|NCT02076321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102349625|NCT02076321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102349626|NCT02076321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102349627|NCT02076321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102349628|NCT02076321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102349629|NCT02076321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349630|NCT00358462|Azithromycin|azithromycin|mesh-list
102349631|NCT00358462|Doxycycline|doxycycline|mesh-list
102349632|NCT00358462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102349633|NCT00358462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102349634|NCT00358462|Antimalarials|antimalarials|mesh-ancestor
102349635|NCT00358462|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102349636|NCT00358462|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102349637|NCT01437267|Vaccines|vaccines|mesh-list
102349638|NCT01437267|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102349639|NCT01437267|Immunologic Factors|immunologic factors|mesh-ancestor
102349640|NCT01437267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349641|NCT01437111|Vitamin D|vitamin d|mesh-list
102349642|NCT01437111|Cholecalciferol|cholecalciferol|mesh-list
102349643|NCT01437111|Alendronate|alendronate|mesh-list
102349644|NCT01437111|Vitamins|vitamins|mesh-ancestor
102349645|NCT01437111|Micronutrients|micronutrients|mesh-ancestor
102349646|NCT01437111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349647|NCT01437111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102349648|NCT01437111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102349649|NCT04065555|Cetuximab|cetuximab|mesh-list
102349650|NCT04065555|Avelumab|avelumab|mesh-list
102349651|NCT04065555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102349652|NCT04065555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102349653|NCT04065555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102349654|NCT04065555|Immunologic Factors|immunologic factors|mesh-ancestor
102349655|NCT04065555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349656|NCT00360724|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102349657|NCT00360724|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102349658|NCT00360724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102349659|NCT00360724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102349660|NCT00360724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349661|NCT00360724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102349662|NCT00360724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349663|NCT00360724|Analgesics|analgesics|mesh-ancestor
102349664|NCT00360724|Sensory System Agents|sensory system agents|mesh-ancestor
102349665|NCT00360724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102349666|NCT00360724|Antidepressive Agents|antidepressive agents|mesh-ancestor
102349667|NCT00360724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102349668|NCT00360724|Dopamine Agents|dopamine agents|mesh-ancestor
102349669|NCT00398398|Capecitabine|capecitabine|mesh-list
102349670|NCT00398398|Oxaliplatin|oxaliplatin|mesh-list
102349671|NCT00398398|Cetuximab|cetuximab|mesh-list
102349672|NCT00398398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102349673|NCT00398398|Antimetabolites|antimetabolites|mesh-ancestor
102349674|NCT00398398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349675|NCT00398398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102349676|NCT00398398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102349677|NCT00398476|Fluticasone|fluticasone|mesh-list
102349678|NCT00398476|Xhance|xhance|mesh-list
102349679|NCT00398476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102349680|NCT00398476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102349681|NCT00398476|Autonomic Agents|autonomic agents|mesh-ancestor
102349682|NCT00398476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102349683|NCT00398476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349684|NCT00398476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102349685|NCT00398476|Respiratory System Agents|respiratory system agents|mesh-ancestor
102349686|NCT00398476|Dermatologic Agents|dermatologic agents|mesh-ancestor
102349687|NCT00398476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102349688|NCT01436643|Fluoxetine|fluoxetine|mesh-list
102349689|NCT01436643|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102349690|NCT01436643|Citalopram|citalopram|mesh-list
102349691|NCT01436643|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102349692|NCT01436643|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102349693|NCT01436643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102349694|NCT01436643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102161399|NCT00946712|Paclitaxel|paclitaxel|mesh-list
102349695|NCT01436643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349696|NCT01436643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102349697|NCT01436643|Serotonin Agents|serotonin agents|mesh-ancestor
102349698|NCT01436643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349699|NCT01436643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102349700|NCT01436643|Antidepressive Agents|antidepressive agents|mesh-ancestor
102349701|NCT01436643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102349702|NCT01436643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102349703|NCT01436643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102349704|NCT01436643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102349705|NCT01436643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102349706|NCT01436643|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102349707|NCT01436643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102349708|NCT01436643|Immunologic Factors|immunologic factors|mesh-ancestor
102349709|NCT00361972|Lansoprazole|lansoprazole|mesh-list
102349710|NCT00361972|Dexlansoprazole|dexlansoprazole|mesh-list
102349711|NCT00361972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102349712|NCT00361972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102349713|NCT00361972|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102349714|NCT00361972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102349715|NCT00361972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349716|NCT00362440|Metformin|metformin|mesh-list
102349717|NCT00362440|Pioglitazone|pioglitazone|mesh-list
102349718|NCT00362440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102349719|NCT00362440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349720|NCT02109640|Oxycodone|oxycodone|mesh-list
102349721|NCT02109640|Naloxone|naloxone|mesh-list
102349722|NCT02109640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102349723|NCT02109640|Narcotics|narcotics|mesh-ancestor
102349724|NCT02109640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102349725|NCT02109640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349726|NCT02109640|Analgesics|analgesics|mesh-ancestor
102349727|NCT02109640|Sensory System Agents|sensory system agents|mesh-ancestor
102349728|NCT02109640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102349729|NCT02109640|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102349730|NCT01454739|Factor VIII|factor viii|mesh-list
102349731|NCT01454739|Coagulants|coagulants|mesh-ancestor
102349732|NCT00366106|Dexamethasone|dexamethasone|mesh-list
102349733|NCT00366106|Doxorubicin|doxorubicin|mesh-list
102349734|NCT00366106|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102349735|NCT00366106|Bortezomib|bortezomib|mesh-list
102349736|NCT00366106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102349737|NCT00366106|Antiemetics|antiemetics|mesh-ancestor
102349738|NCT00366106|Autonomic Agents|autonomic agents|mesh-ancestor
102349739|NCT00366106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102349740|NCT00366106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349741|NCT00366106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102349742|NCT00366106|Glucocorticoids|glucocorticoids|mesh-ancestor
102349743|NCT00366106|Hormones|hormones|mesh-ancestor
102349744|NCT00366106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102349745|NCT00366106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102349746|NCT00366106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102349747|NCT00366106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102349748|NCT00366106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102349749|NCT00366106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102349750|NCT00366106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102349751|NCT00366106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349752|NCT00368290|Modafinil|modafinil|mesh-list
102349753|NCT00368290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102349754|NCT00368290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349755|NCT00368290|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102349756|NCT00368290|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102349757|NCT00368290|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102349758|NCT00368290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349759|NCT00369226|Methotrexate|methotrexate|mesh-list
102349760|NCT00369226|Bortezomib|bortezomib|mesh-list
102349761|NCT00369226|Tacrolimus|tacrolimus|mesh-list
102349762|NCT00369226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102349763|NCT00369226|Abortifacient Agents|abortifacient agents|mesh-ancestor
102349764|NCT00369226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102349765|NCT00369226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349766|NCT00369226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102349767|NCT00369226|Antimetabolites|antimetabolites|mesh-ancestor
102612269|NCT00002387|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102161465|NCT00412594|Rituximab|rituximab|mesh-list
102349768|NCT00369226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349769|NCT00369226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102349770|NCT00369226|Dermatologic Agents|dermatologic agents|mesh-ancestor
102349771|NCT00369226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102349772|NCT00369226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102349773|NCT00369226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102349774|NCT00369226|Immunologic Factors|immunologic factors|mesh-ancestor
102349775|NCT00369226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102349776|NCT00369226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102349777|NCT00369226|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102349778|NCT01416441|Aripiprazole|aripiprazole|mesh-list
102349779|NCT01416441|Antidepressive Agents|antidepressive agents|mesh-ancestor
102349780|NCT01416441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102349781|NCT01416441|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102349782|NCT01416441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102349783|NCT01416441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102349784|NCT01416441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349785|NCT01416441|Dopamine Agonists|dopamine agonists|mesh-ancestor
102349786|NCT01416441|Dopamine Agents|dopamine agents|mesh-ancestor
102349787|NCT01416441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102349788|NCT01416441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349789|NCT01416441|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102349790|NCT01416441|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102349791|NCT01416441|Serotonin Agents|serotonin agents|mesh-ancestor
102349792|NCT01416441|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102349793|NCT01416441|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102349794|NCT01416441|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102349795|NCT01416441|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102349796|NCT00406276|Docetaxel|docetaxel|mesh-list
102349797|NCT00406276|Everolimus|everolimus|mesh-list
102349798|NCT00406276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102349799|NCT00406276|Tubulin Modulators|tubulin modulators|mesh-ancestor
102349800|NCT00406276|Antimitotic Agents|antimitotic agents|mesh-ancestor
102349801|NCT00406276|Mitosis Modulators|mitosis modulators|mesh-ancestor
102349802|NCT00406276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349803|NCT00406276|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102349804|NCT00406276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102349805|NCT00406276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102349806|NCT00406276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102349807|NCT00406276|Immunologic Factors|immunologic factors|mesh-ancestor
102349808|NCT00406276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349809|NCT00408070|Paclitaxel|paclitaxel|mesh-list
102349810|NCT00408070|Bevacizumab|bevacizumab|mesh-list
102349811|NCT00408070|Carboplatin|carboplatin|mesh-list
102349812|NCT00408070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102349813|NCT00408070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102349814|NCT00408070|Tubulin Modulators|tubulin modulators|mesh-ancestor
102349815|NCT00408070|Antimitotic Agents|antimitotic agents|mesh-ancestor
102349816|NCT00408070|Mitosis Modulators|mitosis modulators|mesh-ancestor
102349817|NCT00408070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349818|NCT00408070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102349819|NCT00408070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102349820|NCT00408070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102349821|NCT00408070|Growth Substances|growth substances|mesh-ancestor
102349822|NCT00408070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349823|NCT00408070|Growth Inhibitors|growth inhibitors|mesh-ancestor
102349824|NCT00408460|Paclitaxel|paclitaxel|mesh-list
102349825|NCT00408460|Imatinib Mesylate|imatinib mesylate|mesh-list
102349826|NCT00408460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102349827|NCT00408460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102349828|NCT00408460|Tubulin Modulators|tubulin modulators|mesh-ancestor
102349829|NCT00408460|Antimitotic Agents|antimitotic agents|mesh-ancestor
102349830|NCT00408460|Mitosis Modulators|mitosis modulators|mesh-ancestor
102349831|NCT00408460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349832|NCT00408460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102349833|NCT00408460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102349834|NCT02111200|Sodium Benzoate|sodium benzoate|mesh-list
102349835|NCT02111200|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
102349836|NCT02111200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102349837|NCT02111200|Antifungal Agents|antifungal agents|mesh-ancestor
102349838|NCT02111200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102349839|NCT02111746|Bupivacaine|bupivacaine|mesh-list
102349840|NCT02111746|Anesthetics, Local|anesthetics, local|mesh-ancestor
102349841|NCT02111746|Anesthetics|anesthetics|mesh-ancestor
102349842|NCT02111746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102349843|NCT02111746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349844|NCT02111746|Sensory System Agents|sensory system agents|mesh-ancestor
102349845|NCT02111746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102349846|NCT01793272|Pentoxifylline|pentoxifylline|mesh-list
102349847|NCT01793272|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102349848|NCT01793272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102349849|NCT01793272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349850|NCT01793272|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102349851|NCT01793272|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102349852|NCT01793272|Protective Agents|protective agents|mesh-ancestor
102349853|NCT01793272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349854|NCT01793272|Vasodilator Agents|vasodilator agents|mesh-ancestor
102349855|NCT01793272|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102349856|NCT01793272|Antioxidants|antioxidants|mesh-ancestor
102349857|NCT00410488|Dexamethasone|dexamethasone|mesh-list
102349858|NCT00410488|Dexamethasone acetate|dexamethasone acetate|mesh-list
102349859|NCT00410488|Doxorubicin|doxorubicin|mesh-list
102349860|NCT00410488|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102349861|NCT00410488|Vincristine|vincristine|mesh-list
102349862|NCT00410488|Ifosfamide|ifosfamide|mesh-list
102349863|NCT00410488|Dexrazoxane|dexrazoxane|mesh-list
102349864|NCT00410488|Palonosetron|palonosetron|mesh-list
102349865|NCT00410488|BB 1101|bb 1101|mesh-list
102349866|NCT00410488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102349867|NCT00410488|Antiemetics|antiemetics|mesh-ancestor
102349868|NCT00410488|Autonomic Agents|autonomic agents|mesh-ancestor
102349869|NCT00410488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102349870|NCT00410488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349871|NCT00410488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102349872|NCT00410488|Glucocorticoids|glucocorticoids|mesh-ancestor
102349873|NCT00410488|Hormones|hormones|mesh-ancestor
102349874|NCT00410488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102349875|NCT00410488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102349876|NCT00410488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102349877|NCT00410488|Protease Inhibitors|protease inhibitors|mesh-ancestor
102349878|NCT00410488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102349879|NCT00410488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349880|NCT00410488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102349881|NCT00410488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102349882|NCT00410488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102349883|NCT00410488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102349884|NCT00410488|Tubulin Modulators|tubulin modulators|mesh-ancestor
102349885|NCT00410488|Antimitotic Agents|antimitotic agents|mesh-ancestor
102349886|NCT00410488|Mitosis Modulators|mitosis modulators|mesh-ancestor
102349887|NCT00410488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102349888|NCT00410488|Alkylating Agents|alkylating agents|mesh-ancestor
102349889|NCT00410488|Protective Agents|protective agents|mesh-ancestor
102349890|NCT00410488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102349891|NCT00410488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102349892|NCT00410488|Serotonin Agents|serotonin agents|mesh-ancestor
102349893|NCT00410488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102349894|NCT00410488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102349895|NCT01793350|Benphothiamine|benphothiamine|mesh-list
102349896|NCT01793350|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102349897|NCT01793350|Immunologic Factors|immunologic factors|mesh-ancestor
102349898|NCT01793350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349899|NCT01793350|Chelating Agents|chelating agents|mesh-ancestor
102349900|NCT01793350|Sequestering Agents|sequestering agents|mesh-ancestor
102349901|NCT01793350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349902|NCT03127774|Sodium thiosulfate|sodium thiosulfate|mesh-list
102349903|NCT03127774|Antidotes|antidotes|mesh-ancestor
102349904|NCT03127774|Protective Agents|protective agents|mesh-ancestor
102349905|NCT03127774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349906|NCT03127774|Antioxidants|antioxidants|mesh-ancestor
102349907|NCT03127774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349908|NCT03127774|Antitubercular Agents|antitubercular agents|mesh-ancestor
102349909|NCT03127774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102349910|NCT03127774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102349911|NCT03127774|Chelating Agents|chelating agents|mesh-ancestor
102349912|NCT03127774|Sequestering Agents|sequestering agents|mesh-ancestor
102349913|NCT00416494|Bevacizumab|bevacizumab|mesh-list
102349914|NCT00416494|Capecitabine|capecitabine|mesh-list
102349915|NCT00416494|Oxaliplatin|oxaliplatin|mesh-list
102161613|NCT02468180|Polidocanol|polidocanol|mesh-list
102349916|NCT00416494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102349917|NCT00416494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102349918|NCT00416494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102349919|NCT00416494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102349920|NCT00416494|Growth Substances|growth substances|mesh-ancestor
102349921|NCT00416494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349922|NCT00416494|Growth Inhibitors|growth inhibitors|mesh-ancestor
102349923|NCT00416494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102349924|NCT00416494|Antimetabolites|antimetabolites|mesh-ancestor
102349925|NCT00416494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349926|NCT02845882|Cytarabine|cytarabine|mesh-list
102349927|NCT02845882|Dexamethasone|dexamethasone|mesh-list
102349928|NCT02845882|Dexamethasone acetate|dexamethasone acetate|mesh-list
102349929|NCT02845882|Prednisone|prednisone|mesh-list
102349930|NCT02845882|Cyclophosphamide|cyclophosphamide|mesh-list
102349931|NCT02845882|Ifosfamide|ifosfamide|mesh-list
102349932|NCT02845882|Doxorubicin|doxorubicin|mesh-list
102349933|NCT02845882|Methotrexate|methotrexate|mesh-list
102349934|NCT02845882|Etoposide|etoposide|mesh-list
102349935|NCT02845882|Vincristine|vincristine|mesh-list
102349936|NCT02845882|Daunorubicin|daunorubicin|mesh-list
102349937|NCT02845882|Asparaginase|asparaginase|mesh-list
102349938|NCT02845882|Mercaptopurine|mercaptopurine|mesh-list
102349939|NCT02845882|Vindesine|vindesine|mesh-list
102349940|NCT02845882|Pegaspargase|pegaspargase|mesh-list
102349941|NCT02845882|BB 1101|bb 1101|mesh-list
102349942|NCT02845882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102349943|NCT02845882|Immunologic Factors|immunologic factors|mesh-ancestor
102349944|NCT02845882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102349945|NCT02845882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102349946|NCT02845882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102349947|NCT02845882|Alkylating Agents|alkylating agents|mesh-ancestor
102349948|NCT02845882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349949|NCT02845882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102349950|NCT02845882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102349951|NCT02845882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102349952|NCT02845882|Antiemetics|antiemetics|mesh-ancestor
102349953|NCT02845882|Autonomic Agents|autonomic agents|mesh-ancestor
102349954|NCT02845882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102349955|NCT02845882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102349956|NCT02845882|Glucocorticoids|glucocorticoids|mesh-ancestor
102349957|NCT02845882|Hormones|hormones|mesh-ancestor
102349958|NCT02845882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102349959|NCT02845882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102349960|NCT02845882|Protease Inhibitors|protease inhibitors|mesh-ancestor
102349961|NCT02845882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102349962|NCT02845882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102349963|NCT02845882|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102349964|NCT02845882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102349965|NCT02845882|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102349966|NCT02845882|Abortifacient Agents|abortifacient agents|mesh-ancestor
102349967|NCT02845882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102349968|NCT02845882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102349969|NCT02845882|Antimetabolites|antimetabolites|mesh-ancestor
102349970|NCT02845882|Dermatologic Agents|dermatologic agents|mesh-ancestor
102349971|NCT02845882|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102349972|NCT02845882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102349973|NCT02845882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102349974|NCT02845882|Antiviral Agents|antiviral agents|mesh-ancestor
102349975|NCT02845882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102349976|NCT02845882|Tubulin Modulators|tubulin modulators|mesh-ancestor
102349977|NCT02845882|Antimitotic Agents|antimitotic agents|mesh-ancestor
102349978|NCT02845882|Mitosis Modulators|mitosis modulators|mesh-ancestor
102349979|NCT00417274|Quinacrine|quinacrine|mesh-list
102349980|NCT00417274|Anticestodal Agents|anticestodal agents|mesh-ancestor
102349981|NCT00417274|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102349982|NCT00417274|Anthelmintics|anthelmintics|mesh-ancestor
102349983|NCT00417274|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102349984|NCT00417274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102349985|NCT00417274|Antimalarials|antimalarials|mesh-ancestor
102349986|NCT00417274|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102349987|NCT00417274|Antinematodal Agents|antinematodal agents|mesh-ancestor
102349988|NCT00417274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102349989|NCT00417274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102349990|NCT00417274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102349991|NCT04749940|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102349992|NCT04749940|Laxatives|laxatives|mesh-ancestor
102349993|NCT04749940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102161684|NCT02036125|Antiemetics|antiemetics|mesh-ancestor
102349994|NCT05286346|Tenofovir|tenofovir|mesh-list
102349995|NCT05286346|Antiviral Agents|antiviral agents|mesh-ancestor
102349996|NCT05286346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102349997|NCT05286346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102349998|NCT05286346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102349999|NCT05286346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102350000|NCT05286346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350001|NCT05286346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102350002|NCT05286346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102350004|NCT05286268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102350005|NCT05286268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102350006|NCT05286268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350007|NCT00422032|Clofarabine|clofarabine|mesh-list
102350008|NCT00422032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102350009|NCT00422032|Antimetabolites|antimetabolites|mesh-ancestor
102350010|NCT00422032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350011|NCT00422032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350012|NCT01388920|Tesamorelin|tesamorelin|mesh-list
102350013|NCT01388920|Growth Substances|growth substances|mesh-ancestor
102350014|NCT01388920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350015|NCT00423358|Vitamin D|vitamin d|mesh-list
102350016|NCT00423358|Ergocalciferols|ergocalciferols|mesh-list
102350017|NCT00423358|Vitamins|vitamins|mesh-ancestor
102350018|NCT00423358|Micronutrients|micronutrients|mesh-ancestor
102350019|NCT00423358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350020|NCT00423358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102350021|NCT00423358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102350022|NCT00424840|Bevacizumab|bevacizumab|mesh-list
102350023|NCT00424840|Carboplatin|carboplatin|mesh-list
102350024|NCT00424840|Bortezomib|bortezomib|mesh-list
102350025|NCT00424840|Docetaxel|docetaxel|mesh-list
102350026|NCT00424840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102350027|NCT00424840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350028|NCT00424840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102350029|NCT00424840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102350030|NCT00424840|Growth Substances|growth substances|mesh-ancestor
102350031|NCT00424840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350032|NCT00424840|Growth Inhibitors|growth inhibitors|mesh-ancestor
102350033|NCT00424840|Tubulin Modulators|tubulin modulators|mesh-ancestor
102350034|NCT00424840|Antimitotic Agents|antimitotic agents|mesh-ancestor
102350035|NCT00424840|Mitosis Modulators|mitosis modulators|mesh-ancestor
102350036|NCT00424840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350037|NCT00425386|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102350038|NCT00425386|Sunitinib|sunitinib|mesh-list
102350039|NCT00425386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350040|NCT00425386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102350041|NCT00425386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102350042|NCT00425386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350043|NCT00425386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102350044|NCT00425386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102350045|NCT00425386|Growth Substances|growth substances|mesh-ancestor
102350046|NCT00425386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350047|NCT00425386|Growth Inhibitors|growth inhibitors|mesh-ancestor
102350048|NCT01164202|Sunitinib|sunitinib|mesh-list
102350049|NCT01164202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350050|NCT01164202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102350051|NCT01164202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102350052|NCT01164202|Growth Substances|growth substances|mesh-ancestor
102350053|NCT01164202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350054|NCT01164202|Growth Inhibitors|growth inhibitors|mesh-ancestor
102350055|NCT01164202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102350056|NCT01164202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102350057|NCT01164202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350058|NCT02112370|Epinephrine|epinephrine|mesh-list
102350059|NCT02112370|Racepinephrine|racepinephrine|mesh-list
102350060|NCT02112370|Ropivacaine|ropivacaine|mesh-list
102350061|NCT02112370|Epinephryl borate|epinephryl borate|mesh-list
102350062|NCT02112370|Anesthetics, Local|anesthetics, local|mesh-ancestor
102350063|NCT02112370|Anesthetics|anesthetics|mesh-ancestor
102350064|NCT02112370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102350065|NCT02112370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350066|NCT02112370|Sensory System Agents|sensory system agents|mesh-ancestor
102350067|NCT02112370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102350068|NCT02112370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102350069|NCT02112370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102350070|NCT02112370|Adrenergic Agents|adrenergic agents|mesh-ancestor
102161763|NCT05121038|Antidotes|antidotes|mesh-ancestor
102350071|NCT02112370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102350072|NCT02112370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350073|NCT02112370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102350074|NCT02112370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102350075|NCT02112370|Autonomic Agents|autonomic agents|mesh-ancestor
102350076|NCT02112370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102350077|NCT02112370|Respiratory System Agents|respiratory system agents|mesh-ancestor
102350078|NCT02112370|Mydriatics|mydriatics|mesh-ancestor
102350079|NCT02112370|Sympathomimetics|sympathomimetics|mesh-ancestor
102350080|NCT02112370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102350081|NCT00427336|Cyclophosphamide|cyclophosphamide|mesh-list
102350082|NCT00427336|Fludarabine|fludarabine|mesh-list
102350083|NCT00427336|Fludarabine phosphate|fludarabine phosphate|mesh-list
102350084|NCT00427336|Thymoglobulin|thymoglobulin|mesh-list
102350085|NCT00427336|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102350086|NCT00427336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102350087|NCT00427336|Immunologic Factors|immunologic factors|mesh-ancestor
102350088|NCT00427336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350089|NCT00427336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102350090|NCT00427336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101881681|NCT01086956|Sufentanil|sufentanil|mesh-list
102350091|NCT00427336|Alkylating Agents|alkylating agents|mesh-ancestor
102350092|NCT00427336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350093|NCT00427336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350094|NCT00427336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102350095|NCT00427336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102350096|NCT00427336|Antimetabolites|antimetabolites|mesh-ancestor
102350097|NCT00371176|Cycloserine|cycloserine|mesh-list
102350098|NCT00371176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102350099|NCT00371176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102350100|NCT00371176|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102350101|NCT00371176|Antitubercular Agents|antitubercular agents|mesh-ancestor
102350102|NCT00371176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102350103|NCT00371176|Antimetabolites|antimetabolites|mesh-ancestor
102350104|NCT00371176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350105|NCT00428584|Interferons|interferons|mesh-list
102350106|NCT00428584|Interferon-beta|interferon-beta|mesh-list
102350107|NCT00428584|Interferon beta-1a|interferon beta-1a|mesh-list
102350108|NCT00428584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350109|NCT00428584|Antiviral Agents|antiviral agents|mesh-ancestor
102350110|NCT00428584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102350111|NCT00428584|Immunologic Factors|immunologic factors|mesh-ancestor
102350112|NCT00428584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350113|NCT00428584|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102350114|NCT05187286|Apixaban|apixaban|mesh-list
102350115|NCT05187286|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102350116|NCT05187286|Antithrombins|antithrombins|mesh-ancestor
102350117|NCT05187286|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102350118|NCT05187286|Protease Inhibitors|protease inhibitors|mesh-ancestor
102350119|NCT05187286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102350120|NCT05187286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350121|NCT05187286|Anticoagulants|anticoagulants|mesh-ancestor
102350122|NCT00372970|Botulinum Toxins|botulinum toxins|mesh-list
102350123|NCT00372970|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102350124|NCT00372970|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102350125|NCT00372970|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102350126|NCT00372970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102350127|NCT00372970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350128|NCT00372970|Cholinergic Agents|cholinergic agents|mesh-ancestor
102350129|NCT00372970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102350130|NCT00372970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350131|NCT00372970|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102350132|NCT00372970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102350133|NCT00373360|Treprostinil|treprostinil|mesh-list
102350134|NCT00373360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102350135|NCT00455650|Mecamylamine|mecamylamine|mesh-list
102350136|NCT00455650|Varenicline|varenicline|mesh-list
102350137|NCT00455650|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102350138|NCT00455650|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102350139|NCT00455650|Cholinergic Agents|cholinergic agents|mesh-ancestor
102350140|NCT00455650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102350141|NCT00455650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350142|NCT00455650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350143|NCT00455650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102161833|NCT02475135|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102350144|NCT00455650|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
102350145|NCT00455650|Autonomic Agents|autonomic agents|mesh-ancestor
102350146|NCT00455650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102350147|NCT00455650|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102350148|NCT00455650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102350149|NCT00431626|Dutasteride|dutasteride|mesh-list
102350150|NCT00431626|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102350151|NCT00431626|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102350152|NCT00431626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102350153|NCT00431626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350154|NCT00431626|Hormone Antagonists|hormone antagonists|mesh-ancestor
102350155|NCT00431626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102350156|NCT00431626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350157|NCT00455962|Estradiol|estradiol|mesh-list
102350158|NCT00455962|Progesterone|progesterone|mesh-list
102350159|NCT00455962|Estrogens|estrogens|mesh-ancestor
102350160|NCT00455962|Hormones|hormones|mesh-ancestor
102350161|NCT00455962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102350162|NCT00455962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350163|NCT00455962|Progestins|progestins|mesh-ancestor
102350164|NCT00434356|Paclitaxel|paclitaxel|mesh-list
102350165|NCT00434356|Bevacizumab|bevacizumab|mesh-list
102350166|NCT00434356|Sunitinib|sunitinib|mesh-list
102350167|NCT00434356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102350168|NCT00434356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350169|NCT00434356|Tubulin Modulators|tubulin modulators|mesh-ancestor
102350170|NCT00434356|Antimitotic Agents|antimitotic agents|mesh-ancestor
102350171|NCT00434356|Mitosis Modulators|mitosis modulators|mesh-ancestor
102350172|NCT00434356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350173|NCT00434356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102350174|NCT00434356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102350175|NCT00434356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102350176|NCT00434356|Growth Substances|growth substances|mesh-ancestor
102350177|NCT00434356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350178|NCT00434356|Growth Inhibitors|growth inhibitors|mesh-ancestor
102350179|NCT00434356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102350180|NCT00434356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102350181|NCT00376948|Gemcitabine|gemcitabine|mesh-list
102350182|NCT00376948|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102350183|NCT00376948|Genistein|genistein|mesh-list
102350184|NCT00376948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102350185|NCT00376948|Antimetabolites|antimetabolites|mesh-ancestor
102350186|NCT00376948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350187|NCT00376948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350188|NCT00376948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102350189|NCT00376948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102350190|NCT00376948|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102350191|NCT00376948|Protective Agents|protective agents|mesh-ancestor
102350192|NCT00376948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350193|NCT00376948|Phytoestrogens|phytoestrogens|mesh-ancestor
102350194|NCT00376948|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102350195|NCT00376948|Estrogens|estrogens|mesh-ancestor
102350196|NCT00376948|Hormones|hormones|mesh-ancestor
102350197|NCT00376948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102350198|NCT03396874|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102350199|NCT03396874|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102350200|NCT03396874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350201|NCT00438100|Capecitabine|capecitabine|mesh-list
102350202|NCT00438100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102350203|NCT00438100|Antimetabolites|antimetabolites|mesh-ancestor
102350204|NCT00438100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350205|NCT00438100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350206|NCT00456508|Ecallantide|ecallantide|mesh-list
102350207|NCT00456508|Analgesics|analgesics|mesh-ancestor
102350208|NCT00456508|Sensory System Agents|sensory system agents|mesh-ancestor
102350209|NCT00456508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102350210|NCT00456508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350211|NCT00456508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102350212|NCT00456508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102350213|NCT00456508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102350214|NCT00456508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102350215|NCT00457366|Lorazepam|lorazepam|mesh-list
102350216|NCT00457366|Haloperidol|haloperidol|mesh-list
102350217|NCT00457366|Benztropine|benztropine|mesh-list
102350218|NCT00457366|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102350219|NCT00457366|Haloperidol decanoate|haloperidol decanoate|mesh-list
102161908|NCT04227314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102350220|NCT00457366|Antidepressive Agents|antidepressive agents|mesh-ancestor
102350221|NCT00457366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102350222|NCT00457366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102350223|NCT00457366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102350224|NCT00457366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102350225|NCT00457366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350226|NCT00457366|Antiemetics|antiemetics|mesh-ancestor
102350227|NCT00457366|Autonomic Agents|autonomic agents|mesh-ancestor
102350228|NCT00457366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102350229|NCT00457366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102350230|NCT00457366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102350231|NCT00457366|Dopamine Agents|dopamine agents|mesh-ancestor
102350232|NCT00457366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102350233|NCT00457366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350234|NCT00457366|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102350235|NCT00457366|Anticonvulsants|anticonvulsants|mesh-ancestor
102350236|NCT00457366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102350237|NCT00457366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102350238|NCT00457366|GABA Modulators|gaba modulators|mesh-ancestor
102350239|NCT00457366|GABA Agents|gaba agents|mesh-ancestor
102350240|NCT00457366|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102350241|NCT00457366|Parasympatholytics|parasympatholytics|mesh-ancestor
102350242|NCT00457366|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102350243|NCT00457366|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102350244|NCT00457366|Cholinergic Agents|cholinergic agents|mesh-ancestor
102350245|NCT00457366|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102350246|NCT00457366|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102350247|NCT00457366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102350248|NCT00458848|Prednisone|prednisone|mesh-list
102350249|NCT00458848|Methylprednisolone|methylprednisolone|mesh-list
102350250|NCT00458848|Methotrexate|methotrexate|mesh-list
102350251|NCT00458848|Etoposide|etoposide|mesh-list
102350252|NCT00458848|Vincristine|vincristine|mesh-list
102350253|NCT00458848|Imatinib Mesylate|imatinib mesylate|mesh-list
102350254|NCT00458848|Daunorubicin|daunorubicin|mesh-list
102350255|NCT00458848|Asparaginase|asparaginase|mesh-list
102350256|NCT00458848|Mitoxantrone|mitoxantrone|mesh-list
102350257|NCT00458848|Mercaptopurine|mercaptopurine|mesh-list
102350258|NCT00458848|Idarubicin|idarubicin|mesh-list
102350259|NCT00458848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102350260|NCT00458848|Glucocorticoids|glucocorticoids|mesh-ancestor
102350261|NCT00458848|Hormones|hormones|mesh-ancestor
102350262|NCT00458848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102350263|NCT00458848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350264|NCT00458848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102350265|NCT00458848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350266|NCT00458848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102350267|NCT00458848|Abortifacient Agents|abortifacient agents|mesh-ancestor
102350268|NCT00458848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102350269|NCT00458848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102350270|NCT00458848|Antimetabolites|antimetabolites|mesh-ancestor
102350271|NCT00458848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350272|NCT00458848|Dermatologic Agents|dermatologic agents|mesh-ancestor
102350273|NCT00458848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102350274|NCT00458848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102350275|NCT00458848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102350276|NCT00458848|Immunologic Factors|immunologic factors|mesh-ancestor
102350277|NCT00458848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102350278|NCT00458848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102350279|NCT00458848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102350280|NCT00458848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102350281|NCT00458848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102350282|NCT00458848|Tubulin Modulators|tubulin modulators|mesh-ancestor
102350283|NCT00458848|Antimitotic Agents|antimitotic agents|mesh-ancestor
102350284|NCT00458848|Mitosis Modulators|mitosis modulators|mesh-ancestor
102350285|NCT00458848|Antiemetics|antiemetics|mesh-ancestor
102350286|NCT00458848|Autonomic Agents|autonomic agents|mesh-ancestor
102350287|NCT00458848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102350288|NCT00458848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102350289|NCT00458848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102350290|NCT00458848|Protective Agents|protective agents|mesh-ancestor
102350291|NCT00458848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102350292|NCT00458848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102350293|NCT00458848|Analgesics|analgesics|mesh-ancestor
102350294|NCT00458848|Sensory System Agents|sensory system agents|mesh-ancestor
102350295|NCT00438802|Alefacept|alefacept|mesh-list
102350296|NCT00438802|Dermatologic Agents|dermatologic agents|mesh-ancestor
102161985|NCT02048215|Sympathomimetics|sympathomimetics|mesh-ancestor
102350297|NCT00438802|Immunologic Factors|immunologic factors|mesh-ancestor
102350298|NCT00438802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350299|NCT00377572|Omalizumab|omalizumab|mesh-list
102350300|NCT00377572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102350301|NCT00377572|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102350302|NCT00377572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102350303|NCT00377572|Respiratory System Agents|respiratory system agents|mesh-ancestor
102350304|NCT00377572|Immunologic Factors|immunologic factors|mesh-ancestor
102350305|NCT00377572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350306|NCT00438880|Rituximab|rituximab|mesh-list
102350307|NCT00438880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102350308|NCT00438880|Antibodies|antibodies|mesh-list
102350309|NCT00438880|Immunoglobulins|immunoglobulins|mesh-list
102350310|NCT00438880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102350311|NCT00438880|Immunologic Factors|immunologic factors|mesh-ancestor
102350312|NCT00438880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350313|NCT00438880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350314|NCT00438880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102350315|NCT00378352|Epoetin Alfa|epoetin alfa|mesh-list
102350316|NCT00378352|Hematinics|hematinics|mesh-ancestor
102350317|NCT00462280|Lovastatin|lovastatin|mesh-list
102350318|NCT00462280|L 647318|l 647318|mesh-list
102350319|NCT00462280|Dihydromevinolin|dihydromevinolin|mesh-list
102350320|NCT00462280|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102350321|NCT00462280|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102350322|NCT00462280|Antimetabolites|antimetabolites|mesh-ancestor
102350323|NCT00462280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350324|NCT00462280|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102350325|NCT00462280|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102350326|NCT00462280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102350327|NCT00381004|Cyclophosphamide|cyclophosphamide|mesh-list
102350328|NCT00381004|Rituximab|rituximab|mesh-list
102350329|NCT00381004|Fludarabine|fludarabine|mesh-list
102350330|NCT00381004|Fludarabine phosphate|fludarabine phosphate|mesh-list
102350331|NCT00381004|Sargramostim|sargramostim|mesh-list
102350332|NCT00381004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102350333|NCT00381004|Immunologic Factors|immunologic factors|mesh-ancestor
102350334|NCT00381004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350335|NCT00381004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102350336|NCT00381004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102350337|NCT00381004|Alkylating Agents|alkylating agents|mesh-ancestor
102350338|NCT00381004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350339|NCT00381004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350340|NCT00381004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102350341|NCT00381004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102350342|NCT00381004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102350343|NCT00381004|Antimetabolites|antimetabolites|mesh-ancestor
102350344|NCT00381550|Fludarabine|fludarabine|mesh-list
102350345|NCT00381550|Fludarabine phosphate|fludarabine phosphate|mesh-list
102350346|NCT00381550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350347|NCT00381550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102350348|NCT00381550|Antimetabolites|antimetabolites|mesh-ancestor
102350349|NCT00381550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350350|NCT00381550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102350351|NCT00381550|Immunologic Factors|immunologic factors|mesh-ancestor
102350352|NCT00381550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350353|NCT00440830|Nicotine|nicotine|mesh-list
102350354|NCT00440830|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102350355|NCT00440830|Autonomic Agents|autonomic agents|mesh-ancestor
102350356|NCT00440830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102350357|NCT00440830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350358|NCT00440830|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102350359|NCT00440830|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102350360|NCT00440830|Cholinergic Agents|cholinergic agents|mesh-ancestor
102350361|NCT00440830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102350362|NCT00440830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350363|NCT00427804|Calcitriol|calcitriol|mesh-list
102350364|NCT00427804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102350365|NCT00427804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350366|NCT00427804|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102350367|NCT00427804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102350368|NCT00427804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350369|NCT00427804|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102350370|NCT00427804|Vitamins|vitamins|mesh-ancestor
102350371|NCT00427804|Micronutrients|micronutrients|mesh-ancestor
102350372|NCT00427804|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102350374|NCT00381862|Dexamethasone|dexamethasone|mesh-list
102350375|NCT00381862|Fluorouracil|fluorouracil|mesh-list
102350376|NCT00381862|Oxaliplatin|oxaliplatin|mesh-list
102350377|NCT00381862|Irinotecan|irinotecan|mesh-list
102350378|NCT00381862|Camptothecin|camptothecin|mesh-list
102350379|NCT00381862|Aprepitant|aprepitant|mesh-list
102350380|NCT00381862|Palonosetron|palonosetron|mesh-list
102350381|NCT00381862|Levoleucovorin|levoleucovorin|mesh-list
102350382|NCT00381862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102350383|NCT00381862|Antiemetics|antiemetics|mesh-ancestor
102350384|NCT00381862|Autonomic Agents|autonomic agents|mesh-ancestor
102350385|NCT00381862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102350386|NCT00381862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350387|NCT00381862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102350388|NCT00381862|Glucocorticoids|glucocorticoids|mesh-ancestor
102350389|NCT00381862|Hormones|hormones|mesh-ancestor
102350390|NCT00381862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102350391|NCT00381862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102350392|NCT00381862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350393|NCT00381862|Antimetabolites|antimetabolites|mesh-ancestor
102350394|NCT00381862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350395|NCT00381862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102350396|NCT00381862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102350397|NCT00381862|Immunologic Factors|immunologic factors|mesh-ancestor
102350398|NCT00381862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102350399|NCT00381862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102350400|NCT00381862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102350401|NCT00381862|Antidotes|antidotes|mesh-ancestor
102350402|NCT00381862|Protective Agents|protective agents|mesh-ancestor
102350403|NCT00381862|Vitamin B Complex|vitamin b complex|mesh-ancestor
102350404|NCT00381862|Vitamins|vitamins|mesh-ancestor
102350405|NCT00381862|Micronutrients|micronutrients|mesh-ancestor
102350406|NCT00381862|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102350407|NCT00381862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102350408|NCT00381862|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102350409|NCT00381862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102350410|NCT00381862|Serotonin Agents|serotonin agents|mesh-ancestor
102350411|NCT00381862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102350412|NCT00464698|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102350413|NCT00464698|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102350414|NCT00464698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102350415|NCT00464698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102350416|NCT00464698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350417|NCT00464698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102350418|NCT00464698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350419|NCT00464698|Analgesics|analgesics|mesh-ancestor
102350420|NCT00464698|Sensory System Agents|sensory system agents|mesh-ancestor
102350421|NCT00464698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102350422|NCT00464698|Antidepressive Agents|antidepressive agents|mesh-ancestor
102350423|NCT00464698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102350424|NCT00464698|Dopamine Agents|dopamine agents|mesh-ancestor
102350425|NCT00465088|Niacin|niacin|mesh-list
102350426|NCT00465088|Niacinamide|niacinamide|mesh-list
102350427|NCT00465088|Nicotinic Acids|nicotinic acids|mesh-list
102350428|NCT00465088|Atorvastatin|atorvastatin|mesh-list
102350429|NCT00465088|Simvastatin|simvastatin|mesh-list
102350430|NCT00465088|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102350431|NCT00465088|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102350432|NCT00465088|Antimetabolites|antimetabolites|mesh-ancestor
102350433|NCT00465088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350434|NCT00465088|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102350435|NCT00465088|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102350436|NCT00465088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102350437|NCT00465088|Vasodilator Agents|vasodilator agents|mesh-ancestor
102350438|NCT00465088|Vitamin B Complex|vitamin b complex|mesh-ancestor
102350439|NCT00465088|Vitamins|vitamins|mesh-ancestor
102350440|NCT00465088|Micronutrients|micronutrients|mesh-ancestor
102350441|NCT00465088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350442|NCT01796782|Capecitabine|capecitabine|mesh-list
102350443|NCT01796782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102350444|NCT01796782|Antimetabolites|antimetabolites|mesh-ancestor
102350445|NCT01796782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350446|NCT01796782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350447|NCT00466960|Paclitaxel|paclitaxel|mesh-list
102350448|NCT00466960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102350449|NCT00466960|Sargramostim|sargramostim|mesh-list
102350450|NCT00466960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102350451|NCT00466960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350452|NCT00466960|Tubulin Modulators|tubulin modulators|mesh-ancestor
102350453|NCT00466960|Antimitotic Agents|antimitotic agents|mesh-ancestor
102350454|NCT00466960|Mitosis Modulators|mitosis modulators|mesh-ancestor
102350455|NCT00466960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350456|NCT00466960|Immunologic Factors|immunologic factors|mesh-ancestor
102350457|NCT00466960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350458|NCT00383266|Carboplatin|carboplatin|mesh-list
102350459|NCT00383266|Pemetrexed|pemetrexed|mesh-list
102350460|NCT00383266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350461|NCT00383266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102350462|NCT00383266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350463|NCT00383266|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102350464|NCT00383266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102350465|NCT00384670|Vaccines|vaccines|mesh-list
102350466|NCT00384670|Immunologic Factors|immunologic factors|mesh-ancestor
102350467|NCT00384670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350468|NCT00467350|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
102350469|NCT00467350|Laxatives|laxatives|mesh-ancestor
102350470|NCT00467350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102350471|NCT00444028|Loxapine|loxapine|mesh-list
102350472|NCT00444028|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102350473|NCT00444028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102350474|NCT00444028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102350475|NCT00444028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350476|NCT00444028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102350477|NCT00444028|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102350478|NCT00444028|Dopamine Agents|dopamine agents|mesh-ancestor
102350479|NCT00444028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102350480|NCT00444028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350481|NCT00444964|Hormones|hormones|mesh-list
102350482|NCT00444964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102350483|NCT00444964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350484|NCT00445588|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102350485|NCT00445588|Sorafenib|sorafenib|mesh-list
102350486|NCT00445588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350487|NCT00445588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102350488|NCT00445588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102350489|NCT00445588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350490|NCT00445744|Cyclophosphamide|cyclophosphamide|mesh-list
102350491|NCT00445744|Busulfan|busulfan|mesh-list
102350492|NCT00445744|Methotrexate|methotrexate|mesh-list
102350493|NCT00445744|Tacrolimus|tacrolimus|mesh-list
102350494|NCT00445744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102350495|NCT00445744|Immunologic Factors|immunologic factors|mesh-ancestor
102350496|NCT00445744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350497|NCT00445744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102350498|NCT00445744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102350499|NCT00445744|Alkylating Agents|alkylating agents|mesh-ancestor
102350500|NCT00445744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350501|NCT00445744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350502|NCT00445744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102350503|NCT00445744|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102350504|NCT00445744|Abortifacient Agents|abortifacient agents|mesh-ancestor
102350505|NCT00445744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102350506|NCT00445744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102350507|NCT00445744|Antimetabolites|antimetabolites|mesh-ancestor
102350508|NCT00445744|Dermatologic Agents|dermatologic agents|mesh-ancestor
102350509|NCT00445744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102350510|NCT00445744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102350511|NCT00445744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102350512|NCT00445744|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102350513|NCT00468208|Abatacept|abatacept|mesh-list
102350514|NCT00468208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102350515|NCT00468208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350516|NCT00468208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102350517|NCT00468208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350518|NCT00468208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102350519|NCT00468208|Immunologic Factors|immunologic factors|mesh-ancestor
102350520|NCT00468208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350521|NCT00468208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102350522|NCT00385138|Clopidogrel|clopidogrel|mesh-list
102162205|NCT05341323|Ketamine|ketamine|mesh-list
102350523|NCT00385138|Cangrelor|cangrelor|mesh-list
102350524|NCT00385138|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102350525|NCT00385138|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102350526|NCT00385138|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102350527|NCT00385138|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102350528|NCT00385138|Purinergic Agents|purinergic agents|mesh-ancestor
102350529|NCT00385138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102350530|NCT00385138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350531|NCT00385138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350533|NCT00446290|Capecitabine|capecitabine|mesh-list
102350534|NCT00446290|Oxaliplatin|oxaliplatin|mesh-list
102350535|NCT00446290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350536|NCT00446290|Tubulin Modulators|tubulin modulators|mesh-ancestor
102350537|NCT00446290|Antimitotic Agents|antimitotic agents|mesh-ancestor
102350538|NCT00446290|Mitosis Modulators|mitosis modulators|mesh-ancestor
102350539|NCT00446290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350540|NCT00446290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102350541|NCT00446290|Antimetabolites|antimetabolites|mesh-ancestor
102350542|NCT00385216|Nicotine|nicotine|mesh-list
102350543|NCT00385216|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102350544|NCT00385216|Autonomic Agents|autonomic agents|mesh-ancestor
102350545|NCT00385216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102350546|NCT00385216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350547|NCT00385216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102350548|NCT00385216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102350549|NCT00385216|Cholinergic Agents|cholinergic agents|mesh-ancestor
102350550|NCT00385216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102350551|NCT00385216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350552|NCT00385996|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102350553|NCT00385996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350554|NCT00385996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102350555|NCT00385996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102350556|NCT00385996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350557|NCT00470392|Clobetasol|clobetasol|mesh-list
102350558|NCT00470392|Imiquimod|imiquimod|mesh-list
102350559|NCT00470392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102350560|NCT00470392|Immunologic Factors|immunologic factors|mesh-ancestor
102350561|NCT00470392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350562|NCT00470392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350563|NCT00470392|Interferon Inducers|interferon inducers|mesh-ancestor
102350564|NCT00470392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102350565|NCT00470392|Glucocorticoids|glucocorticoids|mesh-ancestor
102350566|NCT00470392|Hormones|hormones|mesh-ancestor
102350567|NCT00470392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102350568|NCT00470548|Paclitaxel|paclitaxel|mesh-list
102350569|NCT00470548|Pemetrexed|pemetrexed|mesh-list
102350570|NCT00470548|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102350571|NCT00470548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102350572|NCT00470548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350573|NCT00470548|Tubulin Modulators|tubulin modulators|mesh-ancestor
102350574|NCT00470548|Antimitotic Agents|antimitotic agents|mesh-ancestor
102350575|NCT00470548|Mitosis Modulators|mitosis modulators|mesh-ancestor
102350576|NCT00470548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350577|NCT00470548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102350578|NCT00470548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102350579|NCT00470548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102350580|NCT00388414|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102350581|NCT00388414|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102350582|NCT00388414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102350583|NCT00388414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102350584|NCT00388414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350585|NCT00388414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102350586|NCT00388414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350587|NCT00388414|Analgesics|analgesics|mesh-ancestor
102350588|NCT00388414|Sensory System Agents|sensory system agents|mesh-ancestor
102350589|NCT00388414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102350590|NCT00388414|Antidepressive Agents|antidepressive agents|mesh-ancestor
102350591|NCT00388414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102350592|NCT00388414|Dopamine Agents|dopamine agents|mesh-ancestor
102350593|NCT00475150|Cediranib|cediranib|mesh-list
102350594|NCT00475150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102350595|NCT00475150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350596|NCT00475150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350597|NCT00475150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102350598|NCT00451048|Sunitinib|sunitinib|mesh-list
102350599|NCT00451048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350600|NCT00451048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102350601|NCT00451048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102350602|NCT00451048|Growth Substances|growth substances|mesh-ancestor
102350603|NCT00451048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350604|NCT00451048|Growth Inhibitors|growth inhibitors|mesh-ancestor
102350605|NCT00451048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102350606|NCT00451048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102350607|NCT00451048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350608|NCT00388804|Leuprolide|leuprolide|mesh-list
102350609|NCT00388804|Goserelin|goserelin|mesh-list
102350610|NCT00388804|Flutamide|flutamide|mesh-list
102350611|NCT00388804|Bicalutamide|bicalutamide|mesh-list
102350612|NCT00388804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102350613|NCT00388804|Fertility Agents|fertility agents|mesh-ancestor
102350614|NCT00388804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102350615|NCT00388804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350616|NCT00388804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102350617|NCT00388804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350618|NCT00388804|Androgen Antagonists|androgen antagonists|mesh-ancestor
102350619|NCT00388804|Hormone Antagonists|hormone antagonists|mesh-ancestor
102350620|NCT00388804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102350621|NCT00389818|Prednisone|prednisone|mesh-list
102350622|NCT00389818|Cyclophosphamide|cyclophosphamide|mesh-list
102350623|NCT00389818|Rituximab|rituximab|mesh-list
102350624|NCT00389818|Doxorubicin|doxorubicin|mesh-list
102350625|NCT00389818|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102350626|NCT00389818|Vincristine|vincristine|mesh-list
102350627|NCT00389818|Sargramostim|sargramostim|mesh-list
102350628|NCT00389818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102350629|NCT00389818|Immunologic Factors|immunologic factors|mesh-ancestor
102350630|NCT00389818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350631|NCT00389818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102350632|NCT00389818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102350633|NCT00389818|Alkylating Agents|alkylating agents|mesh-ancestor
102350634|NCT00389818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350635|NCT00389818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350636|NCT00389818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102350637|NCT00389818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102350638|NCT00389818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102350639|NCT00389818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102350640|NCT00389818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102350641|NCT00389818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102350642|NCT00389818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102350643|NCT00389818|Glucocorticoids|glucocorticoids|mesh-ancestor
102350644|NCT00389818|Hormones|hormones|mesh-ancestor
102350645|NCT00389818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102350646|NCT00389818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102350647|NCT00389818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102350648|NCT00389818|Tubulin Modulators|tubulin modulators|mesh-ancestor
102350649|NCT00389818|Antimitotic Agents|antimitotic agents|mesh-ancestor
102350650|NCT00389818|Mitosis Modulators|mitosis modulators|mesh-ancestor
102350651|NCT00452374|Cytarabine|cytarabine|mesh-list
102350652|NCT00452374|Rituximab|rituximab|mesh-list
102350653|NCT00452374|Oxaliplatin|oxaliplatin|mesh-list
102350654|NCT00452374|Fludarabine|fludarabine|mesh-list
102350655|NCT00452374|Fludarabine phosphate|fludarabine phosphate|mesh-list
102350656|NCT00452374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102350657|NCT00452374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350658|NCT00452374|Immunologic Factors|immunologic factors|mesh-ancestor
102350659|NCT00452374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350660|NCT00452374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102350661|NCT00452374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102350662|NCT00452374|Antimetabolites|antimetabolites|mesh-ancestor
102350663|NCT00452374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350664|NCT00452374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102350665|NCT00452374|Antiviral Agents|antiviral agents|mesh-ancestor
102350666|NCT00452374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102350667|NCT03286114|Pembrolizumab|pembrolizumab|mesh-list
102350668|NCT03286114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102350669|NCT03286114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350670|NCT03286114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102350671|NCT03286114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350672|NCT00476242|Naltrexone|naltrexone|mesh-list
102350674|NCT00476242|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102350675|NCT00476242|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102350676|NCT00476242|Dopamine Agents|dopamine agents|mesh-ancestor
102350677|NCT00476242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102350678|NCT00476242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350679|NCT00476242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350680|NCT00476242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102350681|NCT00476242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102350682|NCT00476242|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102350683|NCT00476242|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102350684|NCT00476242|Sensory System Agents|sensory system agents|mesh-ancestor
102350685|NCT00476242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102350686|NCT00476788|Insulin|insulin|mesh-list
102350687|NCT00476788|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102350688|NCT00476788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102350689|NCT00476788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350690|NCT01795144|Glucagon|glucagon|mesh-list
102350691|NCT01795144|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102350692|NCT01795144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102350693|NCT01795144|Hormones|hormones|mesh-ancestor
102350694|NCT01795144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102350695|NCT01795144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350696|NCT01795144|Incretins|incretins|mesh-ancestor
102350697|NCT01436175|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102350698|NCT01436175|Antidepressive Agents|antidepressive agents|mesh-list
102350699|NCT01436175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102350700|NCT01436175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102350701|NCT01436175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350702|NCT01436175|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102350703|NCT01436175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102350704|NCT01436175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102350705|NCT01436175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350706|NCT01436175|Dopamine Agents|dopamine agents|mesh-ancestor
102350707|NCT01436175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102350708|NCT00453388|Cyclosporine|cyclosporine|mesh-list
102350709|NCT00453388|Mycophenolic Acid|mycophenolic acid|mesh-list
102350710|NCT00453388|Cyclophosphamide|cyclophosphamide|mesh-list
102350711|NCT00453388|Fludarabine|fludarabine|mesh-list
102350712|NCT00453388|Fludarabine phosphate|fludarabine phosphate|mesh-list
102350713|NCT00453388|Cyclosporins|cyclosporins|mesh-list
102350714|NCT00453388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102350715|NCT00453388|Immunologic Factors|immunologic factors|mesh-ancestor
102350716|NCT00453388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350717|NCT00453388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102350718|NCT00453388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102350719|NCT00453388|Alkylating Agents|alkylating agents|mesh-ancestor
102350720|NCT00453388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350721|NCT00453388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350722|NCT00453388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102350723|NCT00453388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102350724|NCT00453388|Antimetabolites|antimetabolites|mesh-ancestor
102350725|NCT00453388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102350726|NCT00453388|Antifungal Agents|antifungal agents|mesh-ancestor
102350727|NCT00453388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102350728|NCT00453388|Dermatologic Agents|dermatologic agents|mesh-ancestor
102350729|NCT00453388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102350730|NCT00453388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102350731|NCT00453388|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102350732|NCT00453388|Antitubercular Agents|antitubercular agents|mesh-ancestor
102350733|NCT00453388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102350734|NCT00389974|Sunitinib|sunitinib|mesh-list
102350735|NCT00389974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350736|NCT00389974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102350737|NCT00389974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102350738|NCT00389974|Growth Substances|growth substances|mesh-ancestor
102350739|NCT00389974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350740|NCT00389974|Growth Inhibitors|growth inhibitors|mesh-ancestor
102350741|NCT00389974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102350742|NCT00389974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102350743|NCT00389974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350744|NCT01453725|Golimumab|golimumab|mesh-list
102350745|NCT01453725|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102350746|NCT01453725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102350747|NCT01453725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102350748|NCT01453725|Immunologic Factors|immunologic factors|mesh-ancestor
102350749|NCT01453725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350751|NCT00454324|Carboplatin|carboplatin|mesh-list
102350752|NCT00454324|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102350753|NCT00454324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102350754|NCT00454324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350755|NCT00454324|Tubulin Modulators|tubulin modulators|mesh-ancestor
102350756|NCT00454324|Antimitotic Agents|antimitotic agents|mesh-ancestor
102350757|NCT00454324|Mitosis Modulators|mitosis modulators|mesh-ancestor
102350758|NCT00454324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350759|NCT02110264|Naltrexone|naltrexone|mesh-list
102350760|NCT02110264|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102350761|NCT02110264|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102350762|NCT02110264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350763|NCT02110264|Sensory System Agents|sensory system agents|mesh-ancestor
102350764|NCT02110264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102350765|NCT01795222|Midazolam|midazolam|mesh-list
102350766|NCT01795222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102350767|NCT01795222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102350768|NCT01795222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102350769|NCT01795222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350770|NCT01795222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102350771|NCT01795222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102350772|NCT01795222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102350773|NCT01795222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102350774|NCT01795222|Anesthetics, General|anesthetics, general|mesh-ancestor
102350775|NCT01795222|Anesthetics|anesthetics|mesh-ancestor
102350776|NCT01795222|GABA Modulators|gaba modulators|mesh-ancestor
102350777|NCT01795222|GABA Agents|gaba agents|mesh-ancestor
102350778|NCT01795222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102350779|NCT01795222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350780|NCT01415349|Omeprazole|omeprazole|mesh-list
102350781|NCT01415349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102350782|NCT01415349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102350783|NCT01415349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102350784|NCT01415349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102350785|NCT01415349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350786|NCT00528190|Itraconazole|itraconazole|mesh-list
102350787|NCT00528190|Antifungal Agents|antifungal agents|mesh-ancestor
102350788|NCT00528190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102350789|NCT00528190|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102350790|NCT00528190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102350791|NCT00528190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102350792|NCT00528190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350793|NCT00528190|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102350794|NCT00528190|Hormone Antagonists|hormone antagonists|mesh-ancestor
102350795|NCT00528190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102350796|NCT00528190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350797|NCT00528190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102350798|NCT02334813|Dexamethasone|dexamethasone|mesh-list
102350799|NCT02334813|Prednisone|prednisone|mesh-list
102350800|NCT02334813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102350801|NCT02334813|Antiemetics|antiemetics|mesh-ancestor
102350802|NCT02334813|Autonomic Agents|autonomic agents|mesh-ancestor
102350803|NCT02334813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102350804|NCT02334813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350805|NCT02334813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102350806|NCT02334813|Glucocorticoids|glucocorticoids|mesh-ancestor
102350807|NCT02334813|Hormones|hormones|mesh-ancestor
102350808|NCT02334813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102350809|NCT02334813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102350810|NCT02334813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350811|NCT00478036|Prednisolone|prednisolone|mesh-list
102350812|NCT00478036|Prednisolone acetate|prednisolone acetate|mesh-list
102350813|NCT00478036|Ketorolac|ketorolac|mesh-list
102350814|NCT00478036|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102350815|NCT00478036|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102350816|NCT00478036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102350817|NCT00478036|Glucocorticoids|glucocorticoids|mesh-ancestor
102350818|NCT00478036|Hormones|hormones|mesh-ancestor
102350819|NCT00478036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102162534|NCT02477397|Xhance|xhance|mesh-list
102350820|NCT00478036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350821|NCT00478036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102350822|NCT00478036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350823|NCT00478036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102350824|NCT00478036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102350825|NCT00478036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102350826|NCT00478036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102350827|NCT00478036|Analgesics|analgesics|mesh-ancestor
102350828|NCT00478036|Sensory System Agents|sensory system agents|mesh-ancestor
102350829|NCT00478036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102350830|NCT00478036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102350831|NCT00478036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102350832|NCT00478036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350833|NCT00478036|Laxatives|laxatives|mesh-ancestor
102350834|NCT04048863|Imidacloprid|imidacloprid|mesh-list
102350835|NCT04048863|Cholinergic Agents|cholinergic agents|mesh-ancestor
102350836|NCT04048863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102350837|NCT04048863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350838|NCT04048863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350839|NCT04522557|Interferon alpha-2|interferon alpha-2|mesh-list
102350840|NCT04522557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350841|NCT04522557|Antiviral Agents|antiviral agents|mesh-ancestor
102350842|NCT04522557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102350843|NCT01453023|Fluticasone|fluticasone|mesh-list
102350845|NCT01453023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102350846|NCT01453023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102350847|NCT01453023|Autonomic Agents|autonomic agents|mesh-ancestor
102350848|NCT01453023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102350849|NCT01453023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350850|NCT01453023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102350851|NCT01453023|Respiratory System Agents|respiratory system agents|mesh-ancestor
102350852|NCT01453023|Dermatologic Agents|dermatologic agents|mesh-ancestor
102350853|NCT01453023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102350854|NCT01452789|Morphine|morphine|mesh-list
102350855|NCT01452789|Buprenorphine|buprenorphine|mesh-list
102350856|NCT01452789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102350857|NCT01452789|Narcotics|narcotics|mesh-ancestor
102350858|NCT01452789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102350859|NCT01452789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350860|NCT01452789|Analgesics|analgesics|mesh-ancestor
102350861|NCT01452789|Sensory System Agents|sensory system agents|mesh-ancestor
102350862|NCT01452789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102350863|NCT01452789|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102350864|NCT00478192|Conivaptan|conivaptan|mesh-list
102350865|NCT00478192|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102350866|NCT00478192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350867|NCT00478192|Natriuretic Agents|natriuretic agents|mesh-ancestor
102350868|NCT00478192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350869|NCT01414257|Methotrexate|methotrexate|mesh-list
102350870|NCT01414257|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102350871|NCT01414257|Abortifacient Agents|abortifacient agents|mesh-ancestor
102350872|NCT01414257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102350873|NCT01414257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350874|NCT01414257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102350875|NCT01414257|Antimetabolites|antimetabolites|mesh-ancestor
102350876|NCT01414257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350877|NCT01414257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350878|NCT01414257|Dermatologic Agents|dermatologic agents|mesh-ancestor
102350879|NCT01414257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102350880|NCT01414257|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102350881|NCT01414257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102350882|NCT01414257|Immunologic Factors|immunologic factors|mesh-ancestor
102350883|NCT01414257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102350884|NCT01414257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102350885|NCT00528268|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
102350886|NCT00528268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350887|NCT00528580|Simvastatin|simvastatin|mesh-list
102350888|NCT00528580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102350889|NCT00528580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102350890|NCT00528580|Antimetabolites|antimetabolites|mesh-ancestor
102350891|NCT00528580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350892|NCT00528580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102350893|NCT00528580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102162573|NCT02049541|Immunologic Factors|immunologic factors|mesh-ancestor
102350894|NCT00528580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102350895|NCT00529126|Epinephrine|epinephrine|mesh-list
102350896|NCT00529126|Bupivacaine|bupivacaine|mesh-list
102350897|NCT00529126|Anesthetics, Local|anesthetics, local|mesh-ancestor
102350898|NCT00529126|Anesthetics|anesthetics|mesh-ancestor
102350899|NCT00529126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102350900|NCT00529126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350901|NCT00529126|Sensory System Agents|sensory system agents|mesh-ancestor
102350902|NCT00529126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102350903|NCT00529126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102350904|NCT00529126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102350905|NCT00529126|Adrenergic Agents|adrenergic agents|mesh-ancestor
102350906|NCT00529126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102350907|NCT00529126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350908|NCT00529126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102350909|NCT00529126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102350910|NCT00529126|Autonomic Agents|autonomic agents|mesh-ancestor
102350911|NCT00529126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102350912|NCT00529126|Respiratory System Agents|respiratory system agents|mesh-ancestor
102350913|NCT00529126|Mydriatics|mydriatics|mesh-ancestor
102350914|NCT00529126|Sympathomimetics|sympathomimetics|mesh-ancestor
102350915|NCT00529126|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102350916|NCT00529204|Exenatide|exenatide|mesh-list
102350917|NCT00529204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102350918|NCT00529204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350919|NCT00529204|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102350920|NCT00529204|Incretins|incretins|mesh-ancestor
102350921|NCT00529204|Hormones|hormones|mesh-ancestor
102350922|NCT00529204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102350923|NCT01451541|Ciclesonide|ciclesonide|mesh-list
102350924|NCT01451541|Glucocorticoids|glucocorticoids|mesh-ancestor
102350925|NCT01451541|Hormones|hormones|mesh-ancestor
102350926|NCT01451541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102350927|NCT01451541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350928|NCT01451541|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102350929|NCT00530764|Nabiximols|nabiximols|mesh-list
102350930|NCT00530764|Dronabinol|dronabinol|mesh-list
102350931|NCT00530764|Cannabidiol|cannabidiol|mesh-list
102350932|NCT00530764|Analgesics|analgesics|mesh-ancestor
102350933|NCT00530764|Sensory System Agents|sensory system agents|mesh-ancestor
102350934|NCT00530764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102350935|NCT00530764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350936|NCT00530764|Anticonvulsants|anticonvulsants|mesh-ancestor
102350937|NCT00530764|Hallucinogens|hallucinogens|mesh-ancestor
102350938|NCT00530764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102350939|NCT00530764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102350940|NCT00530764|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102350941|NCT00530764|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102350942|NCT00530764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102350943|NCT00530764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350944|NCT00530764|Hormones|hormones|mesh-ancestor
102350945|NCT00530764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102350946|NCT00532480|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102350947|NCT00532480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102350948|NCT00532480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102350949|NCT00532480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102350950|NCT00532480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350951|NCT00532480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102350952|NCT00532480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350953|NCT00532480|Analgesics|analgesics|mesh-ancestor
102350954|NCT00532480|Sensory System Agents|sensory system agents|mesh-ancestor
102350955|NCT00532480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102350956|NCT00532480|Antidepressive Agents|antidepressive agents|mesh-ancestor
102350957|NCT00532480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102350958|NCT00532480|Dopamine Agents|dopamine agents|mesh-ancestor
102350959|NCT00483262|Bortezomib|bortezomib|mesh-list
102350960|NCT00483262|Temsirolimus|temsirolimus|mesh-list
102350961|NCT00483262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350962|NCT00483262|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102350963|NCT00483262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102350964|NCT00483262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102350965|NCT00483262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350966|NCT00483262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102350967|NCT00483262|Immunologic Factors|immunologic factors|mesh-ancestor
102162646|NCT04347434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102350968|NCT00483262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350969|NCT00483496|Titanium dioxide|titanium dioxide|mesh-list
102350970|NCT00483496|Sunscreening Agents|sunscreening agents|mesh-ancestor
102350971|NCT00483496|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102350972|NCT00483496|Protective Agents|protective agents|mesh-ancestor
102350973|NCT00483496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350974|NCT00483496|Dermatologic Agents|dermatologic agents|mesh-ancestor
102350975|NCT00483496|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102350976|NCT00485836|Ranibizumab|ranibizumab|mesh-list
102350977|NCT00485836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102350978|NCT00485836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102350979|NCT00485836|Growth Substances|growth substances|mesh-ancestor
102350980|NCT00485836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102350981|NCT00485836|Growth Inhibitors|growth inhibitors|mesh-ancestor
102350982|NCT00485836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350983|NCT00488488|Tigecycline|tigecycline|mesh-list
102350984|NCT00488488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102350985|NCT00488488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102350986|NCT00488488|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102350987|NCT00488488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102350988|NCT00488488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350989|NCT01450761|Carboplatin|carboplatin|mesh-list
102350990|NCT01450761|Etoposide|etoposide|mesh-list
102350991|NCT01450761|Ipilimumab|ipilimumab|mesh-list
102350992|NCT01450761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102350993|NCT01450761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102350994|NCT01450761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102350995|NCT01450761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102350996|NCT01450761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102350997|NCT01450761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102350998|NCT01450761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102350999|NCT01450761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102351000|NCT00491374|Mometasone Furoate|mometasone furoate|mesh-list
102351001|NCT00491374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102351002|NCT00491374|Dermatologic Agents|dermatologic agents|mesh-ancestor
102351003|NCT00491374|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102351004|NCT00538642|Ziprasidone|ziprasidone|mesh-list
102351005|NCT00538642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102351006|NCT00538642|Serotonin Agents|serotonin agents|mesh-ancestor
102351007|NCT00538642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102351008|NCT00538642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351009|NCT00538642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351010|NCT00538642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102351011|NCT00538642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102351012|NCT00538642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102351013|NCT00538642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102351014|NCT00538642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102351015|NCT00538642|Dopamine Agents|dopamine agents|mesh-ancestor
102351016|NCT01433991|Lenvatinib|lenvatinib|mesh-list
102351017|NCT01433991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102351018|NCT01433991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102351019|NCT01433991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102351020|NCT01433991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351021|NCT01450683|Itraconazole|itraconazole|mesh-list
102351022|NCT01450683|Antifungal Agents|antifungal agents|mesh-ancestor
102351023|NCT01450683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102351024|NCT01450683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102347196|NCT02227199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102351025|NCT01450683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102351026|NCT01450683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102351027|NCT01450683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351028|NCT01450683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102351029|NCT01450683|Hormone Antagonists|hormone antagonists|mesh-ancestor
102351030|NCT01450683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102351031|NCT01450683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351032|NCT01450683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102351033|NCT01433055|Minocycline|minocycline|mesh-list
102351034|NCT01433055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102351035|NCT01433055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102351036|NCT01450137|Glucocorticoids|glucocorticoids|mesh-list
102351037|NCT01450137|Hormones|hormones|mesh-ancestor
102351038|NCT01450137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102351039|NCT01450137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351040|NCT04075149|Spironolactone|spironolactone|mesh-list
102162721|NCT02415400|Hemostatics|hemostatics|mesh-ancestor
102351041|NCT04075149|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102351042|NCT04075149|Hormone Antagonists|hormone antagonists|mesh-ancestor
102351043|NCT04075149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102351044|NCT04075149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351045|NCT04075149|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102351046|NCT04075149|Diuretics|diuretics|mesh-ancestor
102351047|NCT04075149|Natriuretic Agents|natriuretic agents|mesh-ancestor
102351048|NCT01412229|Paclitaxel|paclitaxel|mesh-list
102351049|NCT01412229|Carboplatin|carboplatin|mesh-list
102351050|NCT01412229|Cetuximab|cetuximab|mesh-list
102351051|NCT01412229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102351052|NCT01412229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102351053|NCT01412229|Tubulin Modulators|tubulin modulators|mesh-ancestor
102351054|NCT01412229|Antimitotic Agents|antimitotic agents|mesh-ancestor
102351055|NCT01412229|Mitosis Modulators|mitosis modulators|mesh-ancestor
102351056|NCT01412229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351057|NCT01412229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102351058|NCT01432275|Insulin|insulin|mesh-list
102351059|NCT01432275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102351060|NCT01432275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351061|NCT01411995|Lidocaine|lidocaine|mesh-list
102351062|NCT01411995|Anesthetics, Local|anesthetics, local|mesh-ancestor
102351063|NCT01411995|Anesthetics|anesthetics|mesh-ancestor
102351064|NCT01411995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102351065|NCT01411995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351066|NCT01411995|Sensory System Agents|sensory system agents|mesh-ancestor
102351067|NCT01411995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102351068|NCT01411995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102351069|NCT01411995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102351070|NCT01411995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102351071|NCT01411995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102351072|NCT01411995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351073|NCT01411215|Etanercept|etanercept|mesh-list
102351074|NCT01411215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102351075|NCT01411215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102351076|NCT01411215|Analgesics|analgesics|mesh-ancestor
102351077|NCT01411215|Sensory System Agents|sensory system agents|mesh-ancestor
102351078|NCT01411215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102351079|NCT01411215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351080|NCT01411215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102351081|NCT01411215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102351082|NCT01411215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102351083|NCT01411215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102351084|NCT01411215|Immunologic Factors|immunologic factors|mesh-ancestor
102351085|NCT01449279|Ipilimumab|ipilimumab|mesh-list
102351086|NCT01449279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102351087|NCT01449279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102351088|NCT01449279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102351089|NCT01449279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351090|NCT01431963|Lamotrigine|lamotrigine|mesh-list
102351091|NCT01431963|Anticonvulsants|anticonvulsants|mesh-ancestor
102351092|NCT01431963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102351093|NCT01431963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102351094|NCT01431963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351095|NCT01431963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102351096|NCT01431963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351097|NCT01431963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102351098|NCT01431963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102351099|NCT01431963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102351100|NCT01431963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102351101|NCT01431963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102351102|NCT01447407|Vaccines|vaccines|mesh-list
102351103|NCT01447407|Aluminum sulfate|aluminum sulfate|mesh-list
102351104|NCT01447407|Immunologic Factors|immunologic factors|mesh-ancestor
102351105|NCT01447407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351106|NCT01447407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102351107|NCT01446237|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102351108|NCT01446237|Dermatologic Agents|dermatologic agents|mesh-ancestor
102351109|NCT00540982|Vinorelbine|vinorelbine|mesh-list
102351110|NCT00540982|Lidocaine|lidocaine|mesh-list
102351111|NCT00540982|Anesthetics, Local|anesthetics, local|mesh-ancestor
102351112|NCT00540982|Anesthetics|anesthetics|mesh-ancestor
102351113|NCT00540982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102351114|NCT00540982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351115|NCT00540982|Sensory System Agents|sensory system agents|mesh-ancestor
102351116|NCT00540982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102351117|NCT00540982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102351118|NCT00540982|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102351119|NCT00540982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102351120|NCT00540982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102351121|NCT00540982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351122|NCT00540982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102351123|NCT00540982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102351124|NCT00540982|Tubulin Modulators|tubulin modulators|mesh-ancestor
102351125|NCT00540982|Antimitotic Agents|antimitotic agents|mesh-ancestor
102351126|NCT00540982|Mitosis Modulators|mitosis modulators|mesh-ancestor
102351127|NCT00542620|Insulin|insulin|mesh-list
102351128|NCT00542620|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102351129|NCT00542620|Insulin Aspart|insulin aspart|mesh-list
102351130|NCT00542620|Insulin, Long-Acting|insulin, long-acting|mesh-list
102351131|NCT00542620|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102351132|NCT00542620|Insulin Detemir|insulin detemir|mesh-list
102351133|NCT00542620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102351134|NCT00542620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351135|NCT00543400|Heparin|heparin|mesh-list
102351136|NCT00543400|Calcium heparin|calcium heparin|mesh-list
102351137|NCT00543400|Anticoagulants|anticoagulants|mesh-ancestor
102351138|NCT00543400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102351139|NCT00543400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102351140|NCT00543400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351141|NCT01796938|Lacosamide|lacosamide|mesh-list
102351142|NCT01796938|Anticonvulsants|anticonvulsants|mesh-ancestor
102351143|NCT01796938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102351144|NCT01796938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102351145|NCT01796938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102351146|NCT01796938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351147|NCT00492544|Vaccines|vaccines|mesh-list
102351148|NCT00492544|Immunologic Factors|immunologic factors|mesh-ancestor
102351149|NCT00492544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351150|NCT00492622|Omeprazole|omeprazole|mesh-list
102351151|NCT00492622|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102351152|NCT00492622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102351153|NCT00492622|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102351154|NCT00492622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102351155|NCT00492622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351156|NCT00494494|Nepafenac|nepafenac|mesh-list
102351157|NCT00494494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102351158|NCT00494494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102351159|NCT00494494|Analgesics|analgesics|mesh-ancestor
102351160|NCT00494494|Sensory System Agents|sensory system agents|mesh-ancestor
102351161|NCT00494494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102351162|NCT00494494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351163|NCT00494494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102351164|NCT00494494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102351165|NCT03145558|Doxorubicin|doxorubicin|mesh-list
102351166|NCT03145558|Tirapazamine|tirapazamine|mesh-list
102351167|NCT03145558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102351168|NCT03145558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102351169|NCT03145558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102351170|NCT03145558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102351171|NCT03145558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102351172|NCT03145558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351173|NCT00497770|Pemetrexed|pemetrexed|mesh-list
102351174|NCT00497770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102351175|NCT00497770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102351176|NCT00497770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351177|NCT00497770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102351178|NCT00497770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102351179|NCT00498550|Clozapine|clozapine|mesh-list
102351180|NCT00498550|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102351181|NCT00498550|Serotonin Agents|serotonin agents|mesh-ancestor
102351182|NCT00498550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102351183|NCT00498550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351184|NCT00498550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351185|NCT00498550|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102351186|NCT00498550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102351187|NCT00498550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102351188|NCT00498550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102351189|NCT00498550|GABA Antagonists|gaba antagonists|mesh-ancestor
102351190|NCT00498550|GABA Agents|gaba agents|mesh-ancestor
102351191|NCT00498628|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102351192|NCT00498628|Antidepressive Agents|antidepressive agents|mesh-ancestor
102351193|NCT00498628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102351194|NCT00498628|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102351195|NCT00498628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102351196|NCT00498628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102351197|NCT00498628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351198|NCT01446159|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102351199|NCT01446159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102351200|NCT01446159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102351201|NCT01446159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351202|NCT01446159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102351203|NCT01446159|Hormone Antagonists|hormone antagonists|mesh-ancestor
102351204|NCT01446159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102351205|NCT01446159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351207|NCT00499408|Cholecalciferol|cholecalciferol|mesh-list
102351208|NCT00499408|Vitamins|vitamins|mesh-ancestor
102351209|NCT00499408|Micronutrients|micronutrients|mesh-ancestor
102351210|NCT00499408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351211|NCT00499408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102351212|NCT00499408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102351213|NCT03019666|Niacinamide|niacinamide|mesh-list
102351214|NCT03019666|Niacin|niacin|mesh-list
102351215|NCT03019666|Nicotinic Acids|nicotinic acids|mesh-list
102351216|NCT03019666|Vitamin B Complex|vitamin b complex|mesh-ancestor
102351217|NCT03019666|Vitamins|vitamins|mesh-ancestor
102351218|NCT03019666|Micronutrients|micronutrients|mesh-ancestor
102351219|NCT03019666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351220|NCT03019666|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102351221|NCT03019666|Antimetabolites|antimetabolites|mesh-ancestor
102351222|NCT03019666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351223|NCT03019666|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102351224|NCT03019666|Vasodilator Agents|vasodilator agents|mesh-ancestor
102351225|NCT00500578|Ribavirin|ribavirin|mesh-list
102351226|NCT00500578|Antimetabolites|antimetabolites|mesh-ancestor
102351227|NCT00500578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351228|NCT00500578|Antiviral Agents|antiviral agents|mesh-ancestor
102351229|NCT00500578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102351230|NCT01430559|Meloxicam|meloxicam|mesh-list
102351231|NCT01430559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102351232|NCT01430559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102351233|NCT01430559|Analgesics|analgesics|mesh-ancestor
102351234|NCT01430559|Sensory System Agents|sensory system agents|mesh-ancestor
102351235|NCT01430559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102351236|NCT01430559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351237|NCT01430559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102351238|NCT01430559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102351239|NCT01430559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102351240|NCT01430559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102351241|NCT01430559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102351242|NCT01430559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351243|NCT00500656|Icatibant|icatibant|mesh-list
102351244|NCT00500656|Tranexamic Acid|tranexamic acid|mesh-list
102351245|NCT00500656|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102351246|NCT00500656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102351247|NCT00500656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351248|NCT00500656|Hemostatics|hemostatics|mesh-ancestor
102351249|NCT00500656|Coagulants|coagulants|mesh-ancestor
102351250|NCT00500656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102351251|NCT00500656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102351252|NCT00500656|Analgesics|analgesics|mesh-ancestor
102351253|NCT00500656|Sensory System Agents|sensory system agents|mesh-ancestor
102351254|NCT00500656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102351255|NCT00500656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351256|NCT00500656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102351257|NCT00500656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102351258|NCT00500656|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
102351259|NCT00500656|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
102351260|NCT00500656|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102351261|NCT00500656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102351262|NCT00500656|Immunologic Factors|immunologic factors|mesh-ancestor
102351263|NCT01409811|Zoledronic Acid|zoledronic acid|mesh-list
102351264|NCT01409811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102351265|NCT01409811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351266|NCT01445847|Lidocaine|lidocaine|mesh-list
102351267|NCT01445847|Anesthetics, Local|anesthetics, local|mesh-ancestor
102351268|NCT01445847|Anesthetics|anesthetics|mesh-ancestor
102351269|NCT01445847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102351270|NCT01445847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351271|NCT01445847|Sensory System Agents|sensory system agents|mesh-ancestor
102351272|NCT01445847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102351273|NCT01445847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102351274|NCT01445847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102351275|NCT01445847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102351276|NCT01445847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102351277|NCT01445847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351278|NCT00502216|Naltrexone|naltrexone|mesh-list
102351279|NCT00502216|Varenicline|varenicline|mesh-list
102351280|NCT00502216|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102351281|NCT00502216|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102351282|NCT00502216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351283|NCT00502216|Sensory System Agents|sensory system agents|mesh-ancestor
102351284|NCT00502216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102351285|NCT00502216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102351286|NCT00502216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102351287|NCT00502216|Cholinergic Agents|cholinergic agents|mesh-ancestor
102351288|NCT00502216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102351289|NCT00502216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351290|NCT00545662|Choline|choline|mesh-list
102351291|NCT00545662|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
102351292|NCT00545662|Lipotropic Agents|lipotropic agents|mesh-ancestor
102351293|NCT00545662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102351294|NCT00545662|Antimetabolites|antimetabolites|mesh-ancestor
102351295|NCT00545662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351296|NCT00545662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102351297|NCT00545662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102351298|NCT00545662|Nootropic Agents|nootropic agents|mesh-ancestor
102351299|NCT00545974|Memantine|memantine|mesh-list
102351300|NCT00545974|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102351301|NCT00545974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102351302|NCT00545974|Dopamine Agents|dopamine agents|mesh-ancestor
102351303|NCT00545974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102351304|NCT00545974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351305|NCT00545974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351306|NCT00545974|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102351307|NCT00545974|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102351308|NCT00548470|Varenicline|varenicline|mesh-list
102351309|NCT00548470|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102351310|NCT00548470|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102351311|NCT00548470|Cholinergic Agents|cholinergic agents|mesh-ancestor
102351312|NCT00548470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102351313|NCT00548470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351314|NCT00548470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351315|NCT02675452|Itraconazole|itraconazole|mesh-list
102351316|NCT02675452|Azacitidine|azacitidine|mesh-list
102351317|NCT02675452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102351318|NCT02675452|Antimetabolites|antimetabolites|mesh-ancestor
102351319|NCT02675452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351320|NCT02675452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102351321|NCT02675452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102351322|NCT02675452|Antifungal Agents|antifungal agents|mesh-ancestor
102351323|NCT02675452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102351324|NCT02675452|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102351325|NCT02675452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102351326|NCT02675452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102351327|NCT02675452|Hormone Antagonists|hormone antagonists|mesh-ancestor
102351328|NCT02675452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102351329|NCT02675452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351330|NCT02675452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102351331|NCT00509002|Gefitinib|gefitinib|mesh-list
102351332|NCT00509002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102351333|NCT00509002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102351334|NCT00509002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102351335|NCT00509002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163024|NCT03313869|Selenium|selenium|mesh-list
102351337|NCT00887380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102351338|NCT00887380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102351339|NCT00887380|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102351340|NCT00887380|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102351341|NCT00887380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102351342|NCT00887380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351343|NCT00887380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102351344|NCT00887380|Hormone Antagonists|hormone antagonists|mesh-ancestor
102351345|NCT00887380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102351346|NCT00887380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351347|NCT00551200|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
102351348|NCT00551200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102351349|NCT00557284|Montelukast|montelukast|mesh-list
102351350|NCT00557284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102351351|NCT00557284|Respiratory System Agents|respiratory system agents|mesh-ancestor
102351352|NCT00557284|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102351353|NCT00557284|Hormone Antagonists|hormone antagonists|mesh-ancestor
102351354|NCT00557284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102351355|NCT00557284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351356|NCT00557284|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102351357|NCT00557284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102351358|NCT00557284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351359|NCT00557362|Voriconazole|voriconazole|mesh-list
102351360|NCT00557362|Natamycin|natamycin|mesh-list
102351361|NCT00557362|Antifungal Agents|antifungal agents|mesh-ancestor
102351362|NCT00557362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102351363|NCT00557362|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102351364|NCT00557362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102351365|NCT00557362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102351366|NCT00557362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351367|NCT00557362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102351368|NCT00557362|Hormone Antagonists|hormone antagonists|mesh-ancestor
102351369|NCT00557362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102351370|NCT00557362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351371|NCT00557362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102351372|NCT00557362|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102351373|NCT00557362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102351374|NCT00512278|Infliximab|infliximab|mesh-list
102351375|NCT00512278|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102351376|NCT00512278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102351377|NCT00512278|Dermatologic Agents|dermatologic agents|mesh-ancestor
102351378|NCT00512278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102351379|NCT00512278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102351380|NCT01445535|Prednisone|prednisone|mesh-list
102351381|NCT01445535|Cyclophosphamide|cyclophosphamide|mesh-list
102351382|NCT01445535|Rituximab|rituximab|mesh-list
102351383|NCT01445535|Doxorubicin|doxorubicin|mesh-list
102351384|NCT01445535|Etoposide|etoposide|mesh-list
102351385|NCT01445535|Vincristine|vincristine|mesh-list
102351386|NCT01445535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102351387|NCT01445535|Immunologic Factors|immunologic factors|mesh-ancestor
102351388|NCT01445535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351389|NCT01445535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102351390|NCT01445535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102351391|NCT01445535|Alkylating Agents|alkylating agents|mesh-ancestor
102351392|NCT01445535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351393|NCT01445535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102351394|NCT01445535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102351395|NCT01445535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102351396|NCT01445535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102351397|NCT01445535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102351398|NCT01445535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102351399|NCT01445535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102351400|NCT01445535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102351401|NCT01445535|Glucocorticoids|glucocorticoids|mesh-ancestor
102351402|NCT01445535|Hormones|hormones|mesh-ancestor
102351403|NCT01445535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102351404|NCT01445535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102351405|NCT01445535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102351406|NCT01445535|Tubulin Modulators|tubulin modulators|mesh-ancestor
102163100|NCT05278065|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102351407|NCT01445535|Antimitotic Agents|antimitotic agents|mesh-ancestor
102351408|NCT01445535|Mitosis Modulators|mitosis modulators|mesh-ancestor
102351409|NCT01409031|Sildenafil Citrate|sildenafil citrate|mesh-list
102351410|NCT01409031|Vasodilator Agents|vasodilator agents|mesh-ancestor
102351411|NCT01409031|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102351412|NCT01409031|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102351413|NCT01409031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102351414|NCT01409031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351415|NCT01409031|Urological Agents|urological agents|mesh-ancestor
102351417|NCT01430403|Xhance|xhance|mesh-list
102351418|NCT01430403|Omalizumab|omalizumab|mesh-list
102351419|NCT01430403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102351420|NCT01430403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102351421|NCT01430403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102351422|NCT01430403|Autonomic Agents|autonomic agents|mesh-ancestor
102351423|NCT01430403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102351424|NCT01430403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351425|NCT01430403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102351426|NCT01430403|Respiratory System Agents|respiratory system agents|mesh-ancestor
102351427|NCT01430403|Dermatologic Agents|dermatologic agents|mesh-ancestor
102351428|NCT01430403|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102351429|NCT01430403|Immunologic Factors|immunologic factors|mesh-ancestor
102351430|NCT01408641|Topiramate|topiramate|mesh-list
102351431|NCT01408641|Anticonvulsants|anticonvulsants|mesh-ancestor
102351432|NCT01408641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102351433|NCT01408641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351434|NCT01429077|Levodopa|levodopa|mesh-list
102351435|NCT01429077|Carbidopa|carbidopa|mesh-list
102351436|NCT01429077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102351437|NCT01429077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102351438|NCT01429077|Dopamine Agents|dopamine agents|mesh-ancestor
102351439|NCT01429077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102351440|NCT01429077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351441|NCT01429077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351442|NCT01429077|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102351443|NCT01429077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102351444|NCT01408563|Fludarabine|fludarabine|mesh-list
102351445|NCT01408563|Melphalan|melphalan|mesh-list
102351446|NCT01408563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102351447|NCT01408563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351448|NCT01408563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102351449|NCT01408563|Immunologic Factors|immunologic factors|mesh-ancestor
102351450|NCT01408563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351451|NCT01408563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102351452|NCT01408563|Alkylating Agents|alkylating agents|mesh-ancestor
102351453|NCT01408563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102351454|NCT01442493|Methadone|methadone|mesh-list
102351455|NCT01442493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102351456|NCT01442493|Narcotics|narcotics|mesh-ancestor
102351457|NCT01442493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102351458|NCT01442493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351459|NCT01442493|Analgesics|analgesics|mesh-ancestor
102351460|NCT01442493|Sensory System Agents|sensory system agents|mesh-ancestor
102351461|NCT01442493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102351462|NCT01442493|Antitussive Agents|antitussive agents|mesh-ancestor
102351463|NCT01442493|Respiratory System Agents|respiratory system agents|mesh-ancestor
102351464|NCT04407975|Betamethasone|betamethasone|mesh-list
102351465|NCT04407975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102351466|NCT04407975|Glucocorticoids|glucocorticoids|mesh-ancestor
102351467|NCT04407975|Hormones|hormones|mesh-ancestor
102351468|NCT04407975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102351469|NCT04407975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351470|NCT04407975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102351471|NCT04407975|Respiratory System Agents|respiratory system agents|mesh-ancestor
102351472|NCT01428063|Interferons|interferons|mesh-list
102351473|NCT01428063|Ribavirin|ribavirin|mesh-list
102351474|NCT01428063|Interferon-alpha|interferon-alpha|mesh-list
102351475|NCT01428063|Interferon alpha-2|interferon alpha-2|mesh-list
102351476|NCT01428063|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102351477|NCT01428063|Asunaprevir|asunaprevir|mesh-list
102351478|NCT01428063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102351479|NCT01428063|Antiviral Agents|antiviral agents|mesh-ancestor
102351480|NCT01428063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102351481|NCT01428063|Antimetabolites|antimetabolites|mesh-ancestor
102351482|NCT01428063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351483|NCT01428063|Immunologic Factors|immunologic factors|mesh-ancestor
102351484|NCT01428063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351485|NCT01428063|Protease Inhibitors|protease inhibitors|mesh-ancestor
102351486|NCT01428063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102351488|NCT00513292|Cyclophosphamide|cyclophosphamide|mesh-list
102351489|NCT00513292|Trastuzumab|trastuzumab|mesh-list
102351490|NCT00513292|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102351491|NCT00513292|Epirubicin|epirubicin|mesh-list
102351492|NCT00513292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102351493|NCT00513292|Antibodies|antibodies|mesh-list
102351494|NCT00513292|Immunoglobulins|immunoglobulins|mesh-list
102351495|NCT00513292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102351496|NCT00513292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102351497|NCT00513292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102351498|NCT00513292|Tubulin Modulators|tubulin modulators|mesh-ancestor
102351499|NCT00513292|Antimitotic Agents|antimitotic agents|mesh-ancestor
102351500|NCT00513292|Mitosis Modulators|mitosis modulators|mesh-ancestor
102351501|NCT00513292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351502|NCT00513292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102351503|NCT00513292|Immunologic Factors|immunologic factors|mesh-ancestor
102351504|NCT00513292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351505|NCT00513292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102351506|NCT00513292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102351507|NCT00513292|Alkylating Agents|alkylating agents|mesh-ancestor
102351508|NCT00513292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102351509|NCT00513292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102351510|NCT00513292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102351511|NCT00513292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102351512|NCT00513292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102351513|NCT00513370|Adalimumab|adalimumab|mesh-list
102351514|NCT00513370|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102351515|NCT00513370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102351516|NCT00513370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102351517|NCT00559468|Bromides|bromides|mesh-list
102351518|NCT00559468|Propofol|propofol|mesh-list
102351519|NCT00559468|Sevoflurane|sevoflurane|mesh-list
102351520|NCT00559468|Rocuronium|rocuronium|mesh-list
102351521|NCT00559468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102351522|NCT00559468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102351523|NCT00559468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351524|NCT00559468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102351525|NCT00559468|Anesthetics, General|anesthetics, general|mesh-ancestor
102351526|NCT00559468|Anesthetics|anesthetics|mesh-ancestor
102351527|NCT00559468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102351528|NCT00559468|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102351529|NCT00559468|Anticonvulsants|anticonvulsants|mesh-ancestor
102351530|NCT00559468|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102351531|NCT00559468|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102351532|NCT00559468|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102351533|NCT00559468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102351534|NCT00513526|Vaccines|vaccines|mesh-list
102351535|NCT00513526|Immunologic Factors|immunologic factors|mesh-ancestor
102351536|NCT00513526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351537|NCT00561418|Vorinostat|vorinostat|mesh-list
102351538|NCT00561418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102351539|NCT00561418|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102351540|NCT00561418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102351541|NCT00561418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351542|NCT00514852|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102351543|NCT00514852|Lubricant Eye Drops|lubricant eye drops|mesh-list
102351544|NCT00514852|Glycerol|glycerol|mesh-list
102351545|NCT00514852|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102351546|NCT00514852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102351547|NCT00514852|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102351548|NCT00514852|Protective Agents|protective agents|mesh-ancestor
102351549|NCT00514852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351550|NCT00514852|Laxatives|laxatives|mesh-ancestor
102351551|NCT00514852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102351552|NCT00555880|Midodrine|midodrine|mesh-list
102351553|NCT00555880|Sympathomimetics|sympathomimetics|mesh-ancestor
102351554|NCT00555880|Autonomic Agents|autonomic agents|mesh-ancestor
102351555|NCT00555880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102351556|NCT00555880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351557|NCT00555880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102351558|NCT00555880|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102351559|NCT00555880|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102163251|NCT00703677|Antimanic Agents|antimanic agents|mesh-ancestor
102351560|NCT00555880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102351561|NCT00555880|Adrenergic Agents|adrenergic agents|mesh-ancestor
102351562|NCT00555880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102351563|NCT00555880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351564|NCT00563290|Dasatinib|dasatinib|mesh-list
102351565|NCT00563290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102351566|NCT00563290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102351567|NCT00563290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102351568|NCT00563290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351569|NCT00556504|Ribavirin|ribavirin|mesh-list
102351570|NCT00556504|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102351571|NCT00556504|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102351572|NCT00556504|Antimetabolites|antimetabolites|mesh-ancestor
102351573|NCT00556504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351574|NCT00556504|Antiviral Agents|antiviral agents|mesh-ancestor
102351575|NCT00556504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102351576|NCT02128828|Cenicriviroc|cenicriviroc|mesh-list
102351577|NCT02128828|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102351578|NCT02128828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351579|NCT02128828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102351580|NCT02128828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102351581|NCT02128828|Antiviral Agents|antiviral agents|mesh-ancestor
102351582|NCT02128828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102351583|NCT00520234|Caspofungin|caspofungin|mesh-list
102351584|NCT00520234|Antifungal Agents|antifungal agents|mesh-ancestor
102351585|NCT00520234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102351586|NCT00520234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102351587|NCT00520234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351588|NCT00520468|Cyclosporine|cyclosporine|mesh-list
102351589|NCT00520468|Prednisone|prednisone|mesh-list
102351590|NCT00520468|Epoetin Alfa|epoetin alfa|mesh-list
102351591|NCT00520468|Darbepoetin alfa|darbepoetin alfa|mesh-list
102351592|NCT00520468|Cyclosporins|cyclosporins|mesh-list
102351593|NCT00520468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102351594|NCT00520468|Glucocorticoids|glucocorticoids|mesh-ancestor
102351595|NCT00520468|Hormones|hormones|mesh-ancestor
102351596|NCT00520468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102351597|NCT00520468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351598|NCT00520468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102351599|NCT00520468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102351600|NCT00520468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102351601|NCT00520468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351602|NCT00520468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102351603|NCT00520468|Immunologic Factors|immunologic factors|mesh-ancestor
102351604|NCT00520468|Antifungal Agents|antifungal agents|mesh-ancestor
102351605|NCT00520468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102351606|NCT00520468|Dermatologic Agents|dermatologic agents|mesh-ancestor
102351607|NCT00520468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102351608|NCT00520468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102351609|NCT00520468|Hematinics|hematinics|mesh-ancestor
102351610|NCT05560516|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102351611|NCT05560516|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102351612|NCT05560516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102351613|NCT05560516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102351614|NCT05560516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351615|NCT05560516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102351616|NCT05560516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351617|NCT05560516|Analgesics|analgesics|mesh-ancestor
102351618|NCT05560516|Sensory System Agents|sensory system agents|mesh-ancestor
102351619|NCT05560516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102351620|NCT05560516|Antidepressive Agents|antidepressive agents|mesh-ancestor
102351621|NCT05560516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102351622|NCT05560516|Dopamine Agents|dopamine agents|mesh-ancestor
102351623|NCT05559268|Denosumab|denosumab|mesh-list
102351624|NCT05559268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102351625|NCT05559268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351626|NCT02121418|Cytarabine|cytarabine|mesh-list
102351627|NCT02121418|Decitabine|decitabine|mesh-list
102351628|NCT02121418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102351629|NCT02121418|Antimetabolites|antimetabolites|mesh-ancestor
102351630|NCT02121418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351631|NCT02121418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102351632|NCT02121418|Antiviral Agents|antiviral agents|mesh-ancestor
102351633|NCT02121418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102351634|NCT02121418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102351635|NCT02121418|Immunologic Factors|immunologic factors|mesh-ancestor
102351636|NCT02121418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351637|NCT02121418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102351638|NCT01441635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102351639|NCT01441635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102351641|NCT01441635|Norethindrone Acetate|norethindrone acetate|mesh-list
102351642|NCT01441635|Estradiol|estradiol|mesh-list
102351643|NCT01441635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102351644|NCT01441635|Progesterone|progesterone|mesh-list
102351645|NCT01441635|Estrogens|estrogens|mesh-ancestor
102351646|NCT01441635|Hormones|hormones|mesh-ancestor
102351647|NCT01441635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102351648|NCT01441635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351649|NCT01441635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102351650|NCT01441635|Contraceptive Agents|contraceptive agents|mesh-ancestor
102351651|NCT01441635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102351652|NCT01441635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102351653|NCT01441635|Progestins|progestins|mesh-ancestor
102351654|NCT01441635|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102351655|NCT01441635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102351656|NCT01441635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102351657|NCT01427907|Calcium|calcium|mesh-list
102351658|NCT01427907|Sevelamer|sevelamer|mesh-list
102351659|NCT01427907|Calcium acetate|calcium acetate|mesh-list
102351660|NCT01427907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102351661|NCT01427907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351662|NCT01427907|Chelating Agents|chelating agents|mesh-ancestor
102351663|NCT01427907|Sequestering Agents|sequestering agents|mesh-ancestor
102351664|NCT01427907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351665|NCT02985333|Dexamethasone|dexamethasone|mesh-list
102351666|NCT02985333|Paclitaxel|paclitaxel|mesh-list
102351667|NCT02985333|Cyclophosphamide|cyclophosphamide|mesh-list
102351668|NCT02985333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102351669|NCT02985333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102351670|NCT02985333|Tubulin Modulators|tubulin modulators|mesh-ancestor
102351671|NCT02985333|Antimitotic Agents|antimitotic agents|mesh-ancestor
102351672|NCT02985333|Mitosis Modulators|mitosis modulators|mesh-ancestor
102351673|NCT02985333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351674|NCT02985333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102351675|NCT02985333|Immunologic Factors|immunologic factors|mesh-ancestor
102351676|NCT02985333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351677|NCT02985333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102351678|NCT02985333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102351679|NCT02985333|Alkylating Agents|alkylating agents|mesh-ancestor
102351680|NCT02985333|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102351681|NCT02985333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102351682|NCT02985333|Antiemetics|antiemetics|mesh-ancestor
102351683|NCT02985333|Autonomic Agents|autonomic agents|mesh-ancestor
102351684|NCT02985333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102351685|NCT02985333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102351686|NCT02985333|Glucocorticoids|glucocorticoids|mesh-ancestor
102351687|NCT02985333|Hormones|hormones|mesh-ancestor
102351688|NCT02985333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102351689|NCT02985333|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102351690|NCT01427751|Dexamethasone|dexamethasone|mesh-list
102351691|NCT01427751|Ranibizumab|ranibizumab|mesh-list
102351692|NCT01427751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102351693|NCT01427751|Antiemetics|antiemetics|mesh-ancestor
102351694|NCT01427751|Autonomic Agents|autonomic agents|mesh-ancestor
102351695|NCT01427751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102351696|NCT01427751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351697|NCT01427751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102351698|NCT01427751|Glucocorticoids|glucocorticoids|mesh-ancestor
102351699|NCT01427751|Hormones|hormones|mesh-ancestor
102351700|NCT01427751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102351701|NCT01427751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102351702|NCT01427751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102351703|NCT01427751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102351704|NCT01427751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102351705|NCT01427751|Growth Substances|growth substances|mesh-ancestor
102351706|NCT01427751|Growth Inhibitors|growth inhibitors|mesh-ancestor
102351707|NCT01920061|Docetaxel|docetaxel|mesh-list
102351708|NCT01920061|Gedatolisib|gedatolisib|mesh-list
102351709|NCT01920061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102351710|NCT01920061|Tubulin Modulators|tubulin modulators|mesh-ancestor
102351711|NCT01920061|Antimitotic Agents|antimitotic agents|mesh-ancestor
102351712|NCT01920061|Mitosis Modulators|mitosis modulators|mesh-ancestor
102351713|NCT01920061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351714|NCT01920061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102351715|NCT01920061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102351716|NCT01426347|Vitamin D|vitamin d|mesh-list
102351717|NCT01426347|Ergocalciferols|ergocalciferols|mesh-list
102351718|NCT01426347|Vitamins|vitamins|mesh-ancestor
102351719|NCT01426347|Micronutrients|micronutrients|mesh-ancestor
102351720|NCT01426347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351721|NCT01426347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102351722|NCT01426347|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102351723|NCT04612309|Immunomodulating Agents|immunomodulating agents|mesh-list
102351724|NCT04612309|Immunologic Factors|immunologic factors|mesh-ancestor
102351725|NCT04612309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351726|NCT04415983|Metronidazole|metronidazole|mesh-list
102351727|NCT04415983|Clarithromycin|clarithromycin|mesh-list
102351728|NCT04415983|Nitazoxanide|nitazoxanide|mesh-list
102351729|NCT04415983|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
102351730|NCT04415983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102351731|NCT04415983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102351732|NCT04415983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102351733|NCT04415983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102351734|NCT04415983|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102351735|NCT04415983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102351736|NCT04415983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351737|NCT04415983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102351738|NCT04415983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102351739|NCT01426269|Metronidazole|metronidazole|mesh-list
102351740|NCT01426269|Doxycycline|doxycycline|mesh-list
102351741|NCT01426269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102351742|NCT01426269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102351743|NCT01426269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102351744|NCT01426269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102351745|NCT01426269|Antimalarials|antimalarials|mesh-ancestor
102351746|NCT01426113|Timolol|timolol|mesh-list
102351747|NCT01426113|Bimatoprost|bimatoprost|mesh-list
102351748|NCT01426113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102351749|NCT01426113|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102351750|NCT01426113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102351751|NCT01426113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102351752|NCT01426113|Adrenergic Agents|adrenergic agents|mesh-ancestor
102351753|NCT01426113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102351754|NCT01426113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351755|NCT01426113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351756|NCT01426113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102351757|NCT01426113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102351758|NCT01393899|Tofacitinib|tofacitinib|mesh-list
102351759|NCT01393899|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102351760|NCT01393899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102351761|NCT01393899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102351762|NCT01393899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351763|NCT02078193|Abatacept|abatacept|mesh-list
102351764|NCT02078193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102351765|NCT02078193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351766|NCT02078193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102351767|NCT02078193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102351768|NCT02078193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102351769|NCT02078193|Immunologic Factors|immunologic factors|mesh-ancestor
102351770|NCT02078193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351771|NCT02078193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102351772|NCT01405911|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102351773|NCT01405911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102351774|NCT01405911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351775|NCT01405911|Incretins|incretins|mesh-ancestor
102351776|NCT01405911|Hormones|hormones|mesh-ancestor
102351777|NCT01405911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102351778|NCT01405911|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102351779|NCT01405911|Protease Inhibitors|protease inhibitors|mesh-ancestor
102351780|NCT01405911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102351781|NCT01405911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351782|NCT01425801|Albuterol|albuterol|mesh-list
102351783|NCT01425801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102351784|NCT01425801|Autonomic Agents|autonomic agents|mesh-ancestor
102351785|NCT01425801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102351786|NCT01425801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351787|NCT01425801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102351788|NCT01425801|Respiratory System Agents|respiratory system agents|mesh-ancestor
102351789|NCT01425801|Tocolytic Agents|tocolytic agents|mesh-ancestor
102351790|NCT01425801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102351791|NCT01425801|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102351792|NCT01425801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102351793|NCT01425801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102351794|NCT01425801|Adrenergic Agents|adrenergic agents|mesh-ancestor
102351795|NCT01425801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102351796|NCT01425801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351797|NCT02335125|Psychotropic Drugs|psychotropic drugs|mesh-list
102351798|NCT02076243|Paclitaxel|paclitaxel|mesh-list
102351799|NCT02076243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102351800|NCT02076243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102351801|NCT02076243|Tubulin Modulators|tubulin modulators|mesh-ancestor
102351802|NCT02076243|Antimitotic Agents|antimitotic agents|mesh-ancestor
102351803|NCT02076243|Mitosis Modulators|mitosis modulators|mesh-ancestor
102351804|NCT02076243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351805|NCT01392963|Botulinum Toxins|botulinum toxins|mesh-list
102351806|NCT01392963|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102351807|NCT01392963|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102351808|NCT01392963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102351809|NCT01392963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102351810|NCT01392963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351811|NCT01392963|Cholinergic Agents|cholinergic agents|mesh-ancestor
102351812|NCT01392963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102351813|NCT01392963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351814|NCT01392963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102351815|NCT01392963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102351816|NCT01392573|Insulin|insulin|mesh-list
102351817|NCT01392573|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102351818|NCT01392573|Liraglutide|liraglutide|mesh-list
102351819|NCT01392573|Insulin, Long-Acting|insulin, long-acting|mesh-list
102351820|NCT01392573|Xultophy|xultophy|mesh-list
102351821|NCT01392573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102351822|NCT01392573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351823|NCT01392573|Incretins|incretins|mesh-ancestor
102351824|NCT01392573|Hormones|hormones|mesh-ancestor
102351825|NCT01392573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102351826|NCT01392495|Imatinib Mesylate|imatinib mesylate|mesh-list
102351827|NCT01392495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102351828|NCT01392495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102351829|NCT01392495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102351830|NCT01392495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351831|NCT01405053|Rufinamide|rufinamide|mesh-list
102351832|NCT01405053|Anticonvulsants|anticonvulsants|mesh-list
102351833|NCT01405053|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102351834|NCT01405053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102351835|NCT01405053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102351836|NCT01405053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351837|NCT01403805|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102351838|NCT01403805|Immunologic Factors|immunologic factors|mesh-ancestor
102351839|NCT01403805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351840|NCT01392183|Diphenhydramine|diphenhydramine|mesh-list
102351841|NCT01392183|Sirolimus|sirolimus|mesh-list
102351842|NCT01392183|Temsirolimus|temsirolimus|mesh-list
102351843|NCT01392183|MTOR Inhibitors|mtor inhibitors|mesh-list
102351844|NCT01392183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102351845|NCT01392183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102351846|NCT01392183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351847|NCT01392183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102351848|NCT01392183|Immunologic Factors|immunologic factors|mesh-ancestor
102351849|NCT01392183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351850|NCT01392183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102351851|NCT01392183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102351852|NCT01392183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102351853|NCT01392183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102351854|NCT01392183|Antifungal Agents|antifungal agents|mesh-ancestor
102351855|NCT01392183|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102351856|NCT01392183|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102351857|NCT01392183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102351858|NCT01392183|Anesthetics, Local|anesthetics, local|mesh-ancestor
102351859|NCT01392183|Anesthetics|anesthetics|mesh-ancestor
102351860|NCT01392183|Sensory System Agents|sensory system agents|mesh-ancestor
102351861|NCT01392183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102351863|NCT01392183|Autonomic Agents|autonomic agents|mesh-ancestor
102351864|NCT01392183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102351865|NCT01392183|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102351866|NCT01392183|Histamine Antagonists|histamine antagonists|mesh-ancestor
102351867|NCT01392183|Histamine Agents|histamine agents|mesh-ancestor
102351868|NCT01392183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102351869|NCT01392183|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102351870|NCT01402947|Ciprofloxacin|ciprofloxacin|mesh-list
102351871|NCT01402947|Mesalamine|mesalamine|mesh-list
102351872|NCT01402947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102351873|NCT01402947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102351874|NCT01402947|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102351875|NCT01402947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102351876|NCT01402947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102351877|NCT01402947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351878|NCT01402947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102351879|NCT01402947|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102351880|NCT01402947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102351881|NCT01402947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102351882|NCT01402947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102351883|NCT01402947|Analgesics|analgesics|mesh-ancestor
102351884|NCT01402947|Sensory System Agents|sensory system agents|mesh-ancestor
102351885|NCT01402947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102351886|NCT01402947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351887|NCT01402947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102351888|NCT01402947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102351889|NCT03025893|Sunitinib|sunitinib|mesh-list
102351890|NCT03025893|Lomustine|lomustine|mesh-list
102351891|NCT03025893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102351892|NCT03025893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102351893|NCT03025893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102351894|NCT03025893|Growth Substances|growth substances|mesh-ancestor
102351895|NCT03025893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351896|NCT03025893|Growth Inhibitors|growth inhibitors|mesh-ancestor
102351897|NCT03025893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102351898|NCT03025893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102351899|NCT03025893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351900|NCT03025893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102351901|NCT03025893|Alkylating Agents|alkylating agents|mesh-ancestor
102351902|NCT01402869|Lidocaine|lidocaine|mesh-list
102351903|NCT01402869|Epinephrine|epinephrine|mesh-list
102351904|NCT01402869|Prilocaine|prilocaine|mesh-list
102351905|NCT01402869|Anesthetics, Local|anesthetics, local|mesh-ancestor
102351906|NCT01402869|Anesthetics|anesthetics|mesh-ancestor
102351907|NCT01402869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102351908|NCT01402869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351909|NCT01402869|Sensory System Agents|sensory system agents|mesh-ancestor
102351910|NCT01402869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102351911|NCT01402869|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102351912|NCT01402869|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102351913|NCT01402869|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102351914|NCT01402869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102351915|NCT01402869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351916|NCT01402869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102351917|NCT01402869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102351918|NCT01402869|Adrenergic Agents|adrenergic agents|mesh-ancestor
102351919|NCT01402869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102351920|NCT01402869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102351921|NCT01402869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102351922|NCT01402869|Autonomic Agents|autonomic agents|mesh-ancestor
102351923|NCT01402869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102351924|NCT01402869|Respiratory System Agents|respiratory system agents|mesh-ancestor
102351925|NCT01402869|Mydriatics|mydriatics|mesh-ancestor
102351926|NCT01402869|Sympathomimetics|sympathomimetics|mesh-ancestor
102351927|NCT01402869|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102351928|NCT01391793|Dexamethasone|dexamethasone|mesh-list
102351929|NCT01391793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102351930|NCT01391793|Antiemetics|antiemetics|mesh-ancestor
102351931|NCT01391793|Autonomic Agents|autonomic agents|mesh-ancestor
102351932|NCT01391793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102351933|NCT01391793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351934|NCT01391793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102351935|NCT01391793|Glucocorticoids|glucocorticoids|mesh-ancestor
102351936|NCT01391793|Hormones|hormones|mesh-ancestor
102351937|NCT01391793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102351938|NCT01391793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102351939|NCT01391793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102351940|NCT01422915|Colestipol|colestipol|mesh-list
102351941|NCT01422915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102347250|NCT01858740|Thiotepa|thiotepa|mesh-list
102351942|NCT01422915|Antimetabolites|antimetabolites|mesh-ancestor
102351943|NCT01422915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351944|NCT01422915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102351945|NCT01422915|Sequestering Agents|sequestering agents|mesh-ancestor
102351946|NCT01727024|Tiotropium Bromide|tiotropium bromide|mesh-list
102351947|NCT01727024|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102351948|NCT01727024|Autonomic Agents|autonomic agents|mesh-ancestor
102351949|NCT01727024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102351950|NCT01727024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351951|NCT01727024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102351952|NCT01727024|Respiratory System Agents|respiratory system agents|mesh-ancestor
102351953|NCT01727024|Parasympatholytics|parasympatholytics|mesh-ancestor
102351954|NCT01727024|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102351955|NCT01727024|Cholinergic Agents|cholinergic agents|mesh-ancestor
102351956|NCT01727024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102351957|NCT01727024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351958|NCT01422213|Vortioxetine|vortioxetine|mesh-list
102351959|NCT01422213|Antidepressive Agents|antidepressive agents|mesh-ancestor
102351960|NCT01422213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102351961|NCT01422213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102351962|NCT01422213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102351963|NCT01422213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102351964|NCT01422213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351965|NCT01422213|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102351966|NCT01422213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102351967|NCT01422213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102351968|NCT01422213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351969|NCT01422213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102351970|NCT01422213|Serotonin Agents|serotonin agents|mesh-ancestor
102351971|NCT01422213|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102351972|NCT01422213|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102351973|NCT01422213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102351974|NCT01422213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102351975|NCT01390857|Valacyclovir|valacyclovir|mesh-list
102351976|NCT01390857|Antiviral Agents|antiviral agents|mesh-ancestor
102351977|NCT01390857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102351978|NCT01725386|Capecitabine|capecitabine|mesh-list
102351979|NCT01725386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102351980|NCT01725386|Antimetabolites|antimetabolites|mesh-ancestor
102351981|NCT01725386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351982|NCT01725386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102351983|NCT01402011|Lidocaine|lidocaine|mesh-list
102351984|NCT01402011|Anesthetics, Local|anesthetics, local|mesh-ancestor
102351985|NCT01402011|Anesthetics|anesthetics|mesh-ancestor
102351986|NCT01402011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102351987|NCT01402011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102351988|NCT01402011|Sensory System Agents|sensory system agents|mesh-ancestor
102351989|NCT01402011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102351990|NCT01402011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102351991|NCT01402011|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102351992|NCT01402011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102351993|NCT01402011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102351994|NCT01402011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102351995|NCT01421667|Rituximab|rituximab|mesh-list
102351996|NCT01421667|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102351997|NCT01421667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102351998|NCT01421667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102351999|NCT01421667|Immunologic Factors|immunologic factors|mesh-ancestor
102352000|NCT01421667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352001|NCT01421667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102352002|NCT01421667|Immunotoxins|immunotoxins|mesh-ancestor
102352003|NCT01421667|Immunoconjugates|immunoconjugates|mesh-ancestor
102352004|NCT01891669|PF-06263507|pf-06263507|mesh-list
102352005|NCT01891669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102352006|NCT01891669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102352007|NCT01891669|Antimitotic Agents|antimitotic agents|mesh-ancestor
102352008|NCT01891669|Mitosis Modulators|mitosis modulators|mesh-ancestor
102352009|NCT01891669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352010|NCT01421511|Linezolid|linezolid|mesh-list
102352011|NCT01421511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102352012|NCT01421511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102352013|NCT01421511|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102352014|NCT01421511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102352015|NCT01421511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352016|NCT01891357|Paclitaxel|paclitaxel|mesh-list
102352017|NCT01891357|Trastuzumab|trastuzumab|mesh-list
102352018|NCT01891357|Lapatinib|lapatinib|mesh-list
102352019|NCT01891357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102352020|NCT01891357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102352021|NCT01891357|Tubulin Modulators|tubulin modulators|mesh-ancestor
102352022|NCT01891357|Antimitotic Agents|antimitotic agents|mesh-ancestor
102352023|NCT01891357|Mitosis Modulators|mitosis modulators|mesh-ancestor
102352024|NCT01891357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352025|NCT01891357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102352026|NCT01891357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102352027|NCT01891357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102352028|NCT01420965|Cyclophosphamide|cyclophosphamide|mesh-list
102352029|NCT01420965|Antibodies|antibodies|mesh-list
102352030|NCT01420965|Immunoglobulins|immunoglobulins|mesh-list
102352031|NCT01420965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102352032|NCT01420965|Immunologic Factors|immunologic factors|mesh-ancestor
102352033|NCT01420965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352034|NCT01420965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102352035|NCT01420965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102352036|NCT01420965|Alkylating Agents|alkylating agents|mesh-ancestor
102352037|NCT01420965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352038|NCT01420965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102352039|NCT01420965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102352040|NCT04033575|Listerine|listerine|mesh-list
102352041|NCT04033575|Fluorides|fluorides|mesh-list
102352042|NCT04033575|Sodium Fluoride|sodium fluoride|mesh-list
102352043|NCT04033575|Tin Fluorides|tin fluorides|mesh-list
102352044|NCT04033575|Cariostatic Agents|cariostatic agents|mesh-ancestor
102352045|NCT04033575|Protective Agents|protective agents|mesh-ancestor
102352046|NCT04033575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352047|NCT04033575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102352048|NCT04033575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102352049|NCT03842085|Antibodies|antibodies|mesh-list
102352050|NCT03842085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102352051|NCT03842085|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102352052|NCT03842085|Immunologic Factors|immunologic factors|mesh-ancestor
102352053|NCT03842085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352054|NCT01390389|Ubiquinone|ubiquinone|mesh-list
102352055|NCT01390389|Coenzyme Q10|coenzyme q10|mesh-list
102352056|NCT01390389|Micronutrients|micronutrients|mesh-ancestor
102352057|NCT01390389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352058|NCT01390389|Vitamins|vitamins|mesh-ancestor
102352059|NCT03835533|Nivolumab|nivolumab|mesh-list
102352060|NCT03835533|Poly ICLC|poly iclc|mesh-list
102352061|NCT03835533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102352062|NCT03835533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102352063|NCT03835533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102352064|NCT03835533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352065|NCT03835533|Interferon Inducers|interferon inducers|mesh-ancestor
102352066|NCT03835533|Immunologic Factors|immunologic factors|mesh-ancestor
102352067|NCT03835533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352068|NCT01401465|Mometasone Furoate|mometasone furoate|mesh-list
102352069|NCT01401465|Ciclesonide|ciclesonide|mesh-list
102352070|NCT01401465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102352071|NCT01401465|Dermatologic Agents|dermatologic agents|mesh-ancestor
102352072|NCT01401465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102352073|NCT01401465|Glucocorticoids|glucocorticoids|mesh-ancestor
102352074|NCT01401465|Hormones|hormones|mesh-ancestor
102352075|NCT01401465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102352076|NCT01401465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352077|NCT01890967|Atorvastatin|atorvastatin|mesh-list
102352078|NCT01890967|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102352079|NCT01890967|Simvastatin|simvastatin|mesh-list
102352080|NCT01890967|Ezetimibe|ezetimibe|mesh-list
102352081|NCT01890967|Pravastatin|pravastatin|mesh-list
102352082|NCT01890967|Pitavastatin|pitavastatin|mesh-list
102352083|NCT01890967|Lovastatin|lovastatin|mesh-list
102352084|NCT01890967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102352085|NCT01890967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102352086|NCT01890967|Antimetabolites|antimetabolites|mesh-ancestor
102352087|NCT01890967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352088|NCT01890967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102352089|NCT01890967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102352090|NCT01890967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102352091|NCT01863667|Glimepiride|glimepiride|mesh-list
102352092|NCT01863667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102352093|NCT01863667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102352094|NCT01863667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352095|NCT01863667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102352096|NCT01863667|Immunologic Factors|immunologic factors|mesh-ancestor
102352097|NCT01614769|Glimepiride|glimepiride|mesh-list
102352098|NCT01614769|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102352099|NCT01614769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102352100|NCT01614769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352101|NCT01614769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102352102|NCT01614769|Immunologic Factors|immunologic factors|mesh-ancestor
102352104|NCT01614457|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102352105|NCT01614457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102352106|NCT01614457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352107|NCT01835431|Insulin|insulin|mesh-list
102352108|NCT01835431|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102352109|NCT01835431|Insulin Aspart|insulin aspart|mesh-list
102352110|NCT01835431|Insulin, Long-Acting|insulin, long-acting|mesh-list
102352111|NCT01835431|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102352112|NCT01835431|Insulin Detemir|insulin detemir|mesh-list
102352113|NCT01835431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102352114|NCT01835431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352115|NCT01880593|Ketamine|ketamine|mesh-list
102352116|NCT01880593|Lithium Carbonate|lithium carbonate|mesh-list
102352117|NCT01880593|Analgesics|analgesics|mesh-ancestor
102352118|NCT01880593|Sensory System Agents|sensory system agents|mesh-ancestor
102352119|NCT01880593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102352120|NCT01880593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352121|NCT01880593|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102352122|NCT01880593|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102352123|NCT01880593|Anesthetics, General|anesthetics, general|mesh-ancestor
102352124|NCT01880593|Anesthetics|anesthetics|mesh-ancestor
102352125|NCT01880593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102352126|NCT01880593|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102352127|NCT01880593|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102352128|NCT01880593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102352129|NCT01880593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352130|NCT01880593|Antidepressive Agents|antidepressive agents|mesh-ancestor
102352131|NCT01880593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102352132|NCT01880593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102352133|NCT01880593|Antimanic Agents|antimanic agents|mesh-ancestor
102352134|NCT01880593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102352135|NCT01400451|Ipilimumab|ipilimumab|mesh-list
102352136|NCT01400451|Vemurafenib|vemurafenib|mesh-list
102352137|NCT01400451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102352138|NCT01400451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102352139|NCT01400451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102352140|NCT01400451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352141|NCT01400451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102352142|NCT01400451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102352143|NCT01400139|Hydrocodone|hydrocodone|mesh-list
102352144|NCT01400139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102352145|NCT01400139|Narcotics|narcotics|mesh-ancestor
102352146|NCT01400139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102352147|NCT01400139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352148|NCT01400139|Analgesics|analgesics|mesh-ancestor
102352149|NCT01400139|Sensory System Agents|sensory system agents|mesh-ancestor
102352150|NCT01400139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102352151|NCT01400139|Antitussive Agents|antitussive agents|mesh-ancestor
102352152|NCT01400139|Respiratory System Agents|respiratory system agents|mesh-ancestor
102352153|NCT01399905|Carbidopa|carbidopa|mesh-list
102352154|NCT01399905|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102352155|NCT01399905|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102352156|NCT01399905|Dopamine Agents|dopamine agents|mesh-ancestor
102352157|NCT01399905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102352158|NCT01399905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352159|NCT01399905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352160|NCT01399905|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102352161|NCT01399905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102352162|NCT01725308|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102352163|NCT01725308|Antidepressive Agents|antidepressive agents|mesh-ancestor
102352164|NCT01725308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102352165|NCT01725308|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102352166|NCT01725308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102352167|NCT01725308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102352168|NCT01725308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352169|NCT01724528|Allopurinol|allopurinol|mesh-list
102352170|NCT01724528|Febuxostat|febuxostat|mesh-list
102352171|NCT01724528|Antimetabolites|antimetabolites|mesh-ancestor
102352172|NCT01724528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352173|NCT01724528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102352174|NCT01724528|Gout Suppressants|gout suppressants|mesh-ancestor
102352175|NCT01724528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102352176|NCT01724528|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102352177|NCT01724528|Antioxidants|antioxidants|mesh-ancestor
102352178|NCT01724528|Protective Agents|protective agents|mesh-ancestor
102352179|NCT01724528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352180|NCT01750268|Topiramate|topiramate|mesh-list
102352181|NCT01750268|Anticonvulsants|anticonvulsants|mesh-ancestor
102352182|NCT01750268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102352183|NCT01750268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352184|NCT01880437|Cytarabine|cytarabine|mesh-list
102352185|NCT01880437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102352186|NCT01880437|Antimetabolites|antimetabolites|mesh-ancestor
102352187|NCT01880437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352188|NCT01880437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102352189|NCT01880437|Antiviral Agents|antiviral agents|mesh-ancestor
102352190|NCT01880437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102352191|NCT01880437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102352192|NCT01880437|Immunologic Factors|immunologic factors|mesh-ancestor
102352193|NCT01880437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352194|NCT01861717|Lanreotide|lanreotide|mesh-list
102352195|NCT01861717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102352196|NCT01834729|Alfuzosin|alfuzosin|mesh-list
102352197|NCT01834729|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102352198|NCT01834729|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102352199|NCT01834729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102352200|NCT01834729|Adrenergic Agents|adrenergic agents|mesh-ancestor
102352201|NCT01834729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102352202|NCT01834729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352203|NCT01834729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352204|NCT01834729|Urological Agents|urological agents|mesh-ancestor
102352205|NCT01860703|Moxifloxacin|moxifloxacin|mesh-list
102352206|NCT01860703|Deferiprone|deferiprone|mesh-list
102352207|NCT01860703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102352208|NCT01860703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102352209|NCT01860703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102352210|NCT01860703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102352211|NCT01860703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102352212|NCT01860703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352213|NCT01860703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102352214|NCT01860703|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102352215|NCT01860703|Chelating Agents|chelating agents|mesh-ancestor
102352216|NCT01860703|Sequestering Agents|sequestering agents|mesh-ancestor
102352217|NCT01399593|Eculizumab|eculizumab|mesh-list
102352218|NCT01399593|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102352219|NCT01399593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102352220|NCT01399593|Immunologic Factors|immunologic factors|mesh-ancestor
102352221|NCT01399593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352222|NCT01388985|Vaccines|vaccines|mesh-list
102352223|NCT01388985|Immunologic Factors|immunologic factors|mesh-ancestor
102352224|NCT01388985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352225|NCT01388361|Insulin|insulin|mesh-list
102352226|NCT01388361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102352227|NCT01388361|Insulin Aspart|insulin aspart|mesh-list
102352228|NCT01388361|Liraglutide|liraglutide|mesh-list
102352229|NCT01388361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102352230|NCT01388361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352231|NCT01388361|Incretins|incretins|mesh-ancestor
102352232|NCT01388361|Hormones|hormones|mesh-ancestor
102352233|NCT01388361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102352234|NCT05368935|Nitazoxanide|nitazoxanide|mesh-list
102352235|NCT05368935|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102163923|NCT02021006|Cefixime|cefixime|mesh-list
102352236|NCT05368935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102352237|NCT01399125|Rivastigmine|rivastigmine|mesh-list
102352239|NCT01399125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102352240|NCT01399125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352241|NCT01399125|Cholinergic Agents|cholinergic agents|mesh-ancestor
102352242|NCT01399125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102352243|NCT01399125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352244|NCT01399125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102352245|NCT01399125|Protective Agents|protective agents|mesh-ancestor
102352246|NCT01399047|Mycophenolic Acid|mycophenolic acid|mesh-list
102352247|NCT01399047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102352248|NCT01399047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102352249|NCT01399047|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102352250|NCT01399047|Antitubercular Agents|antitubercular agents|mesh-ancestor
102352251|NCT01399047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102352252|NCT01399047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102352253|NCT01399047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102352254|NCT01399047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352255|NCT01387347|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102352256|NCT01387347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102352257|NCT04040439|Dexmedetomidine|dexmedetomidine|mesh-list
102352258|NCT04040439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102352259|NCT04040439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102352260|NCT04040439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352261|NCT04040439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102352262|NCT04040439|Analgesics|analgesics|mesh-ancestor
102352263|NCT04040439|Sensory System Agents|sensory system agents|mesh-ancestor
102352264|NCT04040439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102352265|NCT04040439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102352266|NCT04040439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102352267|NCT04040439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102352268|NCT04040439|Adrenergic Agents|adrenergic agents|mesh-ancestor
102352269|NCT04040439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102352270|NCT04040439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352271|NCT04012827|Doxorubicin|doxorubicin|mesh-list
102352272|NCT04012827|Apatinib|apatinib|mesh-list
102352273|NCT04012827|Ifosfamide|ifosfamide|mesh-list
102352274|NCT04012827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102352275|NCT04012827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102352276|NCT04012827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102352277|NCT04012827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102352278|NCT04012827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102352279|NCT04012827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352280|NCT04012827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102352281|NCT04012827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102352282|NCT04012827|Alkylating Agents|alkylating agents|mesh-ancestor
102352283|NCT01879579|Insulin|insulin|mesh-list
102352284|NCT01879579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102352285|NCT01879579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352286|NCT01386645|Acetylcysteine|acetylcysteine|mesh-list
102352287|NCT01386645|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102352288|NCT01386645|Antiviral Agents|antiviral agents|mesh-ancestor
102352289|NCT01386645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102352290|NCT01386645|Expectorants|expectorants|mesh-ancestor
102352291|NCT01386645|Respiratory System Agents|respiratory system agents|mesh-ancestor
102352292|NCT01386645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102352293|NCT01386645|Antioxidants|antioxidants|mesh-ancestor
102352294|NCT01386645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352295|NCT01386645|Protective Agents|protective agents|mesh-ancestor
102352296|NCT01386645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352297|NCT01386645|Antidotes|antidotes|mesh-ancestor
102352298|NCT01831765|Insulin|insulin|mesh-list
102352299|NCT01831765|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102352300|NCT01831765|Insulin Aspart|insulin aspart|mesh-list
102352301|NCT01831765|Insulin, Long-Acting|insulin, long-acting|mesh-list
102352302|NCT01831765|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102352303|NCT01831765|Insulin Detemir|insulin detemir|mesh-list
102352304|NCT01831765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102352305|NCT01831765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352306|NCT01830595|Lactoferrin|lactoferrin|mesh-list
102352307|NCT01830595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102352308|NCT01748162|Fluticasone|fluticasone|mesh-list
102352309|NCT01748162|Prednisolone|prednisolone|mesh-list
102352310|NCT01748162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102352311|NCT01748162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102352312|NCT01748162|Autonomic Agents|autonomic agents|mesh-ancestor
102352313|NCT01748162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102352314|NCT01748162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352315|NCT01748162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102352316|NCT01748162|Respiratory System Agents|respiratory system agents|mesh-ancestor
102352317|NCT01748162|Dermatologic Agents|dermatologic agents|mesh-ancestor
102352318|NCT01748162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102352319|NCT01748162|Glucocorticoids|glucocorticoids|mesh-ancestor
102352320|NCT01748162|Hormones|hormones|mesh-ancestor
102352321|NCT01748162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102352322|NCT01748162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102352323|NCT01748162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102352324|NCT01723904|Rotigotine|rotigotine|mesh-list
102352325|NCT01723904|Dopamine Agonists|dopamine agonists|mesh-ancestor
102352326|NCT01723904|Dopamine Agents|dopamine agents|mesh-ancestor
102352327|NCT01723904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102352328|NCT01723904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352329|NCT01723904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352330|NCT01830127|Ribavirin|ribavirin|mesh-list
102352331|NCT01830127|Antimetabolites|antimetabolites|mesh-ancestor
102352332|NCT01830127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352333|NCT01830127|Antiviral Agents|antiviral agents|mesh-ancestor
102352334|NCT01830127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102352335|NCT01614067|Ganirelix|ganirelix|mesh-list
102352336|NCT01614067|Hormone Antagonists|hormone antagonists|mesh-ancestor
102352337|NCT01614067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102352338|NCT01614067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352339|NCT01397409|Ranibizumab|ranibizumab|mesh-list
102352340|NCT01397409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102352341|NCT01397409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102352342|NCT01397409|Growth Substances|growth substances|mesh-ancestor
102352343|NCT01397409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352344|NCT01397409|Growth Inhibitors|growth inhibitors|mesh-ancestor
102352345|NCT01397409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102352346|NCT04766775|Fluorides|fluorides|mesh-list
102352347|NCT04766775|Cariostatic Agents|cariostatic agents|mesh-ancestor
102352348|NCT04766775|Protective Agents|protective agents|mesh-ancestor
102352349|NCT04766775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352350|NCT01777334|Tiotropium Bromide|tiotropium bromide|mesh-list
102352351|NCT01777334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102352352|NCT01777334|Autonomic Agents|autonomic agents|mesh-ancestor
102352353|NCT01777334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102352354|NCT01777334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352355|NCT01777334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102352356|NCT01777334|Respiratory System Agents|respiratory system agents|mesh-ancestor
102352357|NCT01777334|Parasympatholytics|parasympatholytics|mesh-ancestor
102352358|NCT01777334|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102352359|NCT01777334|Cholinergic Agents|cholinergic agents|mesh-ancestor
102352360|NCT01777334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102352361|NCT01777334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352362|NCT03024879|Erythromycin|erythromycin|mesh-list
102352363|NCT03024879|Erythromycin Estolate|erythromycin estolate|mesh-list
102352364|NCT03024879|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
102352365|NCT03024879|Erythromycin stearate|erythromycin stearate|mesh-list
102352366|NCT03024879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102352367|NCT03024879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102352368|NCT03024879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102352369|NCT03024879|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102352370|NCT03024879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102352371|NCT03024879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352372|NCT01383993|Voriconazole|voriconazole|mesh-list
102352373|NCT01383993|Antifungal Agents|antifungal agents|mesh-ancestor
102352374|NCT01383993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102352375|NCT01383993|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102352376|NCT01383993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102352377|NCT01383993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102352378|NCT01383993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352379|NCT01383993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102352380|NCT01383993|Hormone Antagonists|hormone antagonists|mesh-ancestor
102352381|NCT01383993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102352382|NCT01383993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352383|NCT01383993|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102352384|NCT01396395|Nicorandil|nicorandil|mesh-list
102352385|NCT01396395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102352386|NCT01396395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102352387|NCT01396395|Vasodilator Agents|vasodilator agents|mesh-ancestor
102352388|NCT01396395|Vitamin B Complex|vitamin b complex|mesh-ancestor
102352390|NCT01396395|Micronutrients|micronutrients|mesh-ancestor
102352391|NCT01396395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352392|NCT01396083|Dexamethasone|dexamethasone|mesh-list
102352393|NCT01396083|Ranibizumab|ranibizumab|mesh-list
102352394|NCT01396083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102352395|NCT01396083|Antiemetics|antiemetics|mesh-ancestor
102352396|NCT01396083|Autonomic Agents|autonomic agents|mesh-ancestor
102352397|NCT01396083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102352398|NCT01396083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352399|NCT01396083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102352400|NCT01396083|Glucocorticoids|glucocorticoids|mesh-ancestor
102352401|NCT01396083|Hormones|hormones|mesh-ancestor
102352402|NCT01396083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102352403|NCT01396083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102352404|NCT01396083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102352405|NCT01396083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102352406|NCT01396083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102352407|NCT01396083|Growth Substances|growth substances|mesh-ancestor
102352408|NCT01396083|Growth Inhibitors|growth inhibitors|mesh-ancestor
102352409|NCT01776008|Anastrozole|anastrozole|mesh-list
102352410|NCT01776008|Goserelin|goserelin|mesh-list
102352411|NCT01776008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102352412|NCT01776008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102352413|NCT01776008|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102352414|NCT01776008|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102352415|NCT01776008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102352416|NCT01776008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352417|NCT01776008|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102352418|NCT01776008|Hormone Antagonists|hormone antagonists|mesh-ancestor
102352419|NCT01776008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102352420|NCT01776008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352421|NCT01858363|Paclitaxel|paclitaxel|mesh-list
102352422|NCT01858363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102352423|NCT01858363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102352424|NCT01858363|Tubulin Modulators|tubulin modulators|mesh-ancestor
102352425|NCT01858363|Antimitotic Agents|antimitotic agents|mesh-ancestor
102352426|NCT01858363|Mitosis Modulators|mitosis modulators|mesh-ancestor
102352427|NCT01858363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352428|NCT01877551|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
102352429|NCT01877551|Antiviral Agents|antiviral agents|mesh-ancestor
102352430|NCT01877551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102352431|NCT01877551|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102352432|NCT01877551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102352433|NCT01396005|Buprenorphine|buprenorphine|mesh-list
102352434|NCT01396005|Methadone|methadone|mesh-list
102352435|NCT01396005|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102352436|NCT01396005|Naloxone|naloxone|mesh-list
102352437|NCT01396005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102352438|NCT01396005|Narcotics|narcotics|mesh-ancestor
102352439|NCT01396005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102352440|NCT01396005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352441|NCT01396005|Analgesics|analgesics|mesh-ancestor
102352442|NCT01396005|Sensory System Agents|sensory system agents|mesh-ancestor
102352443|NCT01396005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102352444|NCT01396005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102352445|NCT01396005|Antitussive Agents|antitussive agents|mesh-ancestor
102352446|NCT01396005|Respiratory System Agents|respiratory system agents|mesh-ancestor
102352447|NCT03024957|Dexmedetomidine|dexmedetomidine|mesh-list
102352448|NCT03024957|Morphine|morphine|mesh-list
102352449|NCT03024957|Bupivacaine|bupivacaine|mesh-list
102352450|NCT03024957|Anesthetics, Local|anesthetics, local|mesh-ancestor
102352451|NCT03024957|Anesthetics|anesthetics|mesh-ancestor
102352452|NCT03024957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102352453|NCT03024957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352454|NCT03024957|Sensory System Agents|sensory system agents|mesh-ancestor
102352455|NCT03024957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102352456|NCT03024957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102352457|NCT03024957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102352458|NCT03024957|Analgesics|analgesics|mesh-ancestor
102352459|NCT03024957|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102352460|NCT03024957|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102352461|NCT03024957|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102352462|NCT03024957|Adrenergic Agents|adrenergic agents|mesh-ancestor
102352463|NCT03024957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102352464|NCT03024957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352465|NCT03024957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102352466|NCT03024957|Narcotics|narcotics|mesh-ancestor
102352467|NCT03025113|Ketoprofen|ketoprofen|mesh-list
102352468|NCT03025113|Amitriptyline|amitriptyline|mesh-list
102352469|NCT03025113|Cyclobenzaprine|cyclobenzaprine|mesh-list
102352470|NCT03025113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102352471|NCT03025113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102352472|NCT03025113|Analgesics|analgesics|mesh-ancestor
102352473|NCT03025113|Sensory System Agents|sensory system agents|mesh-ancestor
102352474|NCT03025113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102352475|NCT03025113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352476|NCT03025113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102352477|NCT03025113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102352478|NCT03025113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102352479|NCT03025113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102352480|NCT03025113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352481|NCT03025113|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102352482|NCT03025113|Antidepressive Agents|antidepressive agents|mesh-ancestor
102352483|NCT03025113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102352484|NCT03025113|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102352485|NCT03025113|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102352486|NCT03025113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102352487|NCT03025113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102352488|NCT03025113|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102352489|NCT03025113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102352490|NCT03025113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102352491|NCT03025113|Adrenergic Agents|adrenergic agents|mesh-ancestor
102352492|NCT03025113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102352493|NCT01877083|Lenvatinib|lenvatinib|mesh-list
102352494|NCT01877083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102352495|NCT01877083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102352496|NCT01877083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102352497|NCT01877083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352498|NCT01380327|Immunomodulating Agents|immunomodulating agents|mesh-list
102352499|NCT01380327|Immunologic Factors|immunologic factors|mesh-list
102352500|NCT01380327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352501|NCT01829425|Tolterodine Tartrate|tolterodine tartrate|mesh-list
102352502|NCT01829425|Oxybutynin|oxybutynin|mesh-list
102352503|NCT01829425|Cholinergic Antagonists|cholinergic antagonists|mesh-list
102352504|NCT01829425|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102352505|NCT01829425|Cholinergic Agents|cholinergic agents|mesh-ancestor
102352506|NCT01829425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102352507|NCT01829425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352508|NCT01829425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352509|NCT01829425|Urological Agents|urological agents|mesh-ancestor
102352510|NCT01829425|Parasympatholytics|parasympatholytics|mesh-ancestor
102352511|NCT01829425|Autonomic Agents|autonomic agents|mesh-ancestor
102352512|NCT01829425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102352513|NCT01394991|Epoetin Alfa|epoetin alfa|mesh-list
102352514|NCT01394991|Hematinics|hematinics|mesh-ancestor
102352515|NCT01394523|Bupivacaine|bupivacaine|mesh-list
102352516|NCT01394523|Anesthetics, Local|anesthetics, local|mesh-ancestor
102352517|NCT01394523|Anesthetics|anesthetics|mesh-ancestor
102352518|NCT01394523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102352519|NCT01394523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352520|NCT01394523|Sensory System Agents|sensory system agents|mesh-ancestor
102352521|NCT01394523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102352523|NCT01857583|Edoxaban|edoxaban|mesh-list
102352524|NCT01857583|Fondaparinux|fondaparinux|mesh-list
102352525|NCT01857583|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102352526|NCT01857583|Antithrombins|antithrombins|mesh-ancestor
102352527|NCT01857583|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102352528|NCT01857583|Protease Inhibitors|protease inhibitors|mesh-ancestor
102352529|NCT01857583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102352530|NCT01857583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352531|NCT01857583|Anticoagulants|anticoagulants|mesh-ancestor
102352532|NCT01857583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102352533|NCT01857583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102352534|NCT04000347|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102164222|NCT03103334|Dermatologic Agents|dermatologic agents|mesh-ancestor
102352535|NCT04000347|Dermatologic Agents|dermatologic agents|mesh-ancestor
102352536|NCT00211185|Prednisone|prednisone|mesh-list
102352537|NCT00211185|Cyclophosphamide|cyclophosphamide|mesh-list
102352538|NCT00211185|Doxorubicin|doxorubicin|mesh-list
102352539|NCT00211185|Vincristine|vincristine|mesh-list
102352540|NCT00211185|Denileukin diftitox|denileukin diftitox|mesh-list
102352541|NCT00211185|Lenograstim|lenograstim|mesh-list
102352542|NCT00211185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102352543|NCT00211185|Immunologic Factors|immunologic factors|mesh-ancestor
102352544|NCT00211185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352545|NCT00211185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102352546|NCT00211185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102352547|NCT00211185|Alkylating Agents|alkylating agents|mesh-ancestor
102352548|NCT00211185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352549|NCT00211185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102352550|NCT00211185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102352551|NCT00211185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102352552|NCT00211185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102352553|NCT00211185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102352554|NCT00211185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102352555|NCT00211185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102352556|NCT00211185|Glucocorticoids|glucocorticoids|mesh-ancestor
102352557|NCT00211185|Hormones|hormones|mesh-ancestor
102352558|NCT00211185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102352559|NCT00211185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102352560|NCT00211185|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102352561|NCT00211185|Tubulin Modulators|tubulin modulators|mesh-ancestor
102352562|NCT00211185|Antimitotic Agents|antimitotic agents|mesh-ancestor
102352563|NCT00211185|Mitosis Modulators|mitosis modulators|mesh-ancestor
102352564|NCT00211185|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102352565|NCT00219297|Epothilone B|epothilone b|mesh-list
102352566|NCT00219297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102352567|NCT00219297|Tubulin Modulators|tubulin modulators|mesh-ancestor
102352568|NCT00219297|Antimitotic Agents|antimitotic agents|mesh-ancestor
102352569|NCT00219297|Mitosis Modulators|mitosis modulators|mesh-ancestor
102352570|NCT00219297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352571|NCT01857271|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102352572|NCT01857271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102352573|NCT01857271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102352574|NCT01857271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102352575|NCT01857271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352576|NCT01721486|Acetaminophen|acetaminophen|mesh-list
102352577|NCT01721486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102352578|NCT01721486|Analgesics|analgesics|mesh-ancestor
102352579|NCT01721486|Sensory System Agents|sensory system agents|mesh-ancestor
102352580|NCT01721486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102352581|NCT01721486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352582|NCT01721486|Antipyretics|antipyretics|mesh-ancestor
102352583|NCT01721408|Imipenem|imipenem|mesh-list
102352584|NCT01721408|Tigecycline|tigecycline|mesh-list
102352585|NCT01721408|Cilastatin|cilastatin|mesh-list
102352586|NCT01721408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102352587|NCT01721408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102352588|NCT01721408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102352589|NCT01721408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102352590|NCT01721408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352591|NCT01721408|Protease Inhibitors|protease inhibitors|mesh-ancestor
102352592|NCT03998709|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102352593|NCT03998709|Somatostatin|somatostatin|mesh-list
102352594|NCT03998709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352595|NCT03998709|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101884207|NCT03600883|Anesthetics|anesthetics|mesh-ancestor
102352596|NCT03998709|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102352597|NCT03998709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102352598|NCT03998709|Hormones|hormones|mesh-ancestor
102352599|NCT03998709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102352600|NCT01744496|Rotigotine|rotigotine|mesh-list
102352601|NCT01744496|Dopamine Agonists|dopamine agonists|mesh-ancestor
102352602|NCT01744496|Dopamine Agents|dopamine agents|mesh-ancestor
102352603|NCT01744496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102352604|NCT01744496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352605|NCT01744496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352606|NCT04007055|Ticagrelor|ticagrelor|mesh-list
102352607|NCT04007055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102352608|NCT04007055|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102352609|NCT04007055|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102352610|NCT04007055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102352611|NCT04007055|Purinergic Agents|purinergic agents|mesh-ancestor
102352612|NCT04007055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102352613|NCT04007055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352614|NCT04007055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352616|NCT01721330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102352617|NCT01721330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102352618|NCT01721330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352619|NCT01721330|Sensory System Agents|sensory system agents|mesh-ancestor
102352620|NCT01721330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102352621|NCT03592407|Pembrolizumab|pembrolizumab|mesh-list
102352622|NCT03592407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102352623|NCT03592407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102352624|NCT03592407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102352625|NCT03592407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352626|NCT03595371|Dapansutrile|dapansutrile|mesh-list
102352627|NCT03595371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102352628|NCT05634057|Anisodamine|anisodamine|mesh-list
102352629|NCT05634057|Heparin|heparin|mesh-list
102352630|NCT05634057|Calcium heparin|calcium heparin|mesh-list
102352631|NCT05634057|Anticoagulants|anticoagulants|mesh-ancestor
102352632|NCT05634057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102352633|NCT05634057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102352634|NCT05634057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352635|NCT05634057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102352636|NCT05634057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102352637|NCT05634057|Adrenergic Agents|adrenergic agents|mesh-ancestor
102352638|NCT05634057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102352639|NCT05634057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352640|NCT05634057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102352641|NCT05634057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102352642|NCT05634057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102352643|NCT05634057|Analgesics|analgesics|mesh-ancestor
102352644|NCT05634057|Sensory System Agents|sensory system agents|mesh-ancestor
102352645|NCT05634057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102352646|NCT05634057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102352647|NCT05634057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102352648|NCT05634057|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102352649|NCT05634057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102352650|NCT05634057|Parasympatholytics|parasympatholytics|mesh-ancestor
102352651|NCT05634057|Autonomic Agents|autonomic agents|mesh-ancestor
102352652|NCT05634057|Vasodilator Agents|vasodilator agents|mesh-ancestor
102352653|NCT05634057|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102352654|NCT05634057|Antioxidants|antioxidants|mesh-ancestor
102352655|NCT05634057|Protective Agents|protective agents|mesh-ancestor
102352656|NCT03596385|Metoprolol|metoprolol|mesh-list
102352657|NCT03596385|Atenolol|atenolol|mesh-list
102352658|NCT03596385|Carvedilol|carvedilol|mesh-list
102352659|NCT03596385|Bisoprolol|bisoprolol|mesh-list
102352660|NCT03596385|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102352661|NCT03596385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102352662|NCT03596385|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102352663|NCT03596385|Sympatholytics|sympatholytics|mesh-ancestor
102352664|NCT03596385|Autonomic Agents|autonomic agents|mesh-ancestor
102352665|NCT03596385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102352666|NCT03596385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352667|NCT03596385|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102352668|NCT03596385|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102352669|NCT03596385|Adrenergic Agents|adrenergic agents|mesh-ancestor
102352670|NCT03596385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102352671|NCT03596385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352672|NCT03596385|Antioxidants|antioxidants|mesh-ancestor
102352673|NCT03596385|Protective Agents|protective agents|mesh-ancestor
102352674|NCT03596385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102352675|NCT03596385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102352676|NCT03596385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102352677|NCT03596385|Vasodilator Agents|vasodilator agents|mesh-ancestor
102352678|NCT03596385|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102352679|NCT03596385|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102352680|NCT01828021|Margetuximab|margetuximab|mesh-list
102352681|NCT01828021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102352682|NCT03784599|Trastuzumab|trastuzumab|mesh-list
102352683|NCT03784599|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102352684|NCT03784599|Osimertinib|osimertinib|mesh-list
102352685|NCT03784599|Maytansine|maytansine|mesh-list
102352686|NCT03784599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102164369|NCT03100604|Desflurane|desflurane|mesh-list
102352687|NCT03784599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102352688|NCT03784599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102352689|NCT03784599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102352690|NCT03784599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352691|NCT03784599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102352692|NCT03784599|Tubulin Modulators|tubulin modulators|mesh-ancestor
102352693|NCT03784599|Antimitotic Agents|antimitotic agents|mesh-ancestor
102352694|NCT03784599|Mitosis Modulators|mitosis modulators|mesh-ancestor
102352695|NCT03784599|Immunotoxins|immunotoxins|mesh-ancestor
102352696|NCT03784599|Immunoconjugates|immunoconjugates|mesh-ancestor
102352697|NCT03784599|Immunologic Factors|immunologic factors|mesh-ancestor
102352698|NCT03784599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352699|NCT01827943|Sirolimus|sirolimus|mesh-list
102352700|NCT01827943|Temsirolimus|temsirolimus|mesh-list
102352701|NCT01827943|MTOR Inhibitors|mtor inhibitors|mesh-list
102352702|NCT01827943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102352703|NCT01827943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102352704|NCT01827943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352705|NCT01827943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102352706|NCT01827943|Immunologic Factors|immunologic factors|mesh-ancestor
102352707|NCT01827943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352708|NCT01827943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102352709|NCT01827943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102352710|NCT01827943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102352711|NCT01827943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102352712|NCT01827943|Antifungal Agents|antifungal agents|mesh-ancestor
102352713|NCT02985255|Docetaxel|docetaxel|mesh-list
102352714|NCT02985255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102352715|NCT02985255|Tubulin Modulators|tubulin modulators|mesh-ancestor
102352716|NCT02985255|Antimitotic Agents|antimitotic agents|mesh-ancestor
102352717|NCT02985255|Mitosis Modulators|mitosis modulators|mesh-ancestor
102352718|NCT02985255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352719|NCT00214851|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102352720|NCT00214851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102352721|NCT00217971|Dronabinol|dronabinol|mesh-list
102352722|NCT00217971|Hallucinogens|hallucinogens|mesh-ancestor
102352723|NCT00217971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352724|NCT00217971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102352725|NCT00217971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102352726|NCT00217971|Analgesics|analgesics|mesh-ancestor
102352727|NCT00217971|Sensory System Agents|sensory system agents|mesh-ancestor
102352728|NCT00217971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102352729|NCT00217971|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102352730|NCT00217971|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102352731|NCT00217971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102352732|NCT00217971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352733|NCT00217971|Hormones|hormones|mesh-ancestor
102352734|NCT00217971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102352735|NCT03976323|Cisplatin|cisplatin|mesh-list
102352736|NCT03976323|Carboplatin|carboplatin|mesh-list
102352737|NCT03976323|Pembrolizumab|pembrolizumab|mesh-list
102352738|NCT03976323|Pemetrexed|pemetrexed|mesh-list
102352739|NCT03976323|Olaparib|olaparib|mesh-list
102352740|NCT03976323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102352741|NCT03976323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102352742|NCT03976323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102352743|NCT03976323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352744|NCT03976323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102352745|NCT03976323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102352746|NCT03976323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102352747|NCT03976323|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102352748|NCT00217581|Bevacizumab|bevacizumab|mesh-list
102352749|NCT00217581|Docetaxel|docetaxel|mesh-list
102352750|NCT00217581|Oxaliplatin|oxaliplatin|mesh-list
102352751|NCT00217581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102352752|NCT00217581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102352753|NCT00217581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102352754|NCT00217581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102352755|NCT00217581|Growth Substances|growth substances|mesh-ancestor
102352756|NCT00217581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352757|NCT00217581|Growth Inhibitors|growth inhibitors|mesh-ancestor
102352758|NCT00217581|Tubulin Modulators|tubulin modulators|mesh-ancestor
102352759|NCT00217581|Antimitotic Agents|antimitotic agents|mesh-ancestor
102352760|NCT00217581|Mitosis Modulators|mitosis modulators|mesh-ancestor
102352761|NCT00217581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352763|NCT01856257|Methylprednisolone|methylprednisolone|mesh-list
102352764|NCT01856257|Abatacept|abatacept|mesh-list
102352765|NCT01856257|Tacrolimus|tacrolimus|mesh-list
102352766|NCT01856257|Thymoglobulin|thymoglobulin|mesh-list
102352767|NCT01856257|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102352768|NCT01856257|Basiliximab|basiliximab|mesh-list
102352769|NCT01856257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102352770|NCT01856257|Immunologic Factors|immunologic factors|mesh-ancestor
102352771|NCT01856257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352772|NCT01856257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102352773|NCT01856257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102352774|NCT01856257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352775|NCT01856257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102352776|NCT01856257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102352777|NCT01856257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102352778|NCT01856257|Antitubercular Agents|antitubercular agents|mesh-ancestor
102352779|NCT01856257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102352780|NCT01856257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102352781|NCT01856257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102352782|NCT01856257|Antiemetics|antiemetics|mesh-ancestor
102352783|NCT01856257|Autonomic Agents|autonomic agents|mesh-ancestor
102352784|NCT01856257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102352785|NCT01856257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102352786|NCT01856257|Glucocorticoids|glucocorticoids|mesh-ancestor
102352787|NCT01856257|Hormones|hormones|mesh-ancestor
102352788|NCT01856257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102352789|NCT01856257|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102352790|NCT01856257|Protective Agents|protective agents|mesh-ancestor
102352791|NCT01856257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102352792|NCT01856257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102352793|NCT01856257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102352794|NCT00215943|Zoledronic Acid|zoledronic acid|mesh-list
102352795|NCT00215943|Thalidomide|thalidomide|mesh-list
102352796|NCT00215943|Dexamethasone|dexamethasone|mesh-list
102352797|NCT00215943|Doxorubicin|doxorubicin|mesh-list
102352798|NCT00215943|Vincristine|vincristine|mesh-list
102352799|NCT00215943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102352800|NCT00215943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102352801|NCT00215943|Antiemetics|antiemetics|mesh-ancestor
102352802|NCT00215943|Autonomic Agents|autonomic agents|mesh-ancestor
102352803|NCT00215943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102352804|NCT00215943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352805|NCT00215943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102352806|NCT00215943|Glucocorticoids|glucocorticoids|mesh-ancestor
102352807|NCT00215943|Hormones|hormones|mesh-ancestor
102352808|NCT00215943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102352809|NCT00215943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102352810|NCT00215943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102352811|NCT00215943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102352812|NCT00215943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102352813|NCT00215943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102352814|NCT00215943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102352815|NCT00215943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352816|NCT00215943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102352817|NCT00215943|Tubulin Modulators|tubulin modulators|mesh-ancestor
102352818|NCT00215943|Antimitotic Agents|antimitotic agents|mesh-ancestor
102352819|NCT00215943|Mitosis Modulators|mitosis modulators|mesh-ancestor
102352820|NCT00215943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102352821|NCT00215943|Immunologic Factors|immunologic factors|mesh-ancestor
102352822|NCT00215943|Leprostatic Agents|leprostatic agents|mesh-ancestor
102352823|NCT00215943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102352824|NCT00215943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102352825|NCT00215943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102352826|NCT00215943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102352827|NCT00215943|Growth Substances|growth substances|mesh-ancestor
102352828|NCT00215943|Growth Inhibitors|growth inhibitors|mesh-ancestor
102352829|NCT00215943|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102352830|NCT01827163|Paclitaxel|paclitaxel|mesh-list
102352831|NCT01827163|Trastuzumab|trastuzumab|mesh-list
102352832|NCT01827163|Lapatinib|lapatinib|mesh-list
102352833|NCT01827163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102352834|NCT01827163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102164528|NCT03098342|Amorolfine|amorolfine|mesh-list
102352835|NCT01827163|Tubulin Modulators|tubulin modulators|mesh-ancestor
102352836|NCT01827163|Antimitotic Agents|antimitotic agents|mesh-ancestor
102352837|NCT01827163|Mitosis Modulators|mitosis modulators|mesh-ancestor
102352838|NCT01827163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352839|NCT01827163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102352840|NCT01827163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102352841|NCT01827163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102352842|NCT00215553|Pulmonary Surfactants|pulmonary surfactants|mesh-list
102352843|NCT00215553|Respiratory System Agents|respiratory system agents|mesh-ancestor
102352844|NCT00214461|Vaccines|vaccines|mesh-list
102352845|NCT00214461|Immunologic Factors|immunologic factors|mesh-ancestor
102352846|NCT00214461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352847|NCT03599973|Plasma-lyte 148|plasma-lyte 148|mesh-list
102352848|NCT03599973|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102352849|NCT03599973|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102352850|NCT00211887|Interferons|interferons|mesh-list
102352851|NCT00211887|Interferon-beta|interferon-beta|mesh-list
102352852|NCT00211887|Interferon beta-1a|interferon beta-1a|mesh-list
102352853|NCT00211887|Glatiramer Acetate|glatiramer acetate|mesh-list
102352854|NCT00211887|(T,G)-A-L|(t,g)-a-l|mesh-list
102352855|NCT00211887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102352856|NCT00211887|Antiviral Agents|antiviral agents|mesh-ancestor
102352857|NCT00211887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102352858|NCT00211887|Immunologic Factors|immunologic factors|mesh-ancestor
102352859|NCT00211887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352860|NCT00211887|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102352861|NCT00211887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102352862|NCT00211887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102352863|NCT04002453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102352864|NCT04002453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102352865|NCT03592485|Acetaminophen|acetaminophen|mesh-list
102352866|NCT03592485|Oxycodone|oxycodone|mesh-list
102352867|NCT03592485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102352868|NCT03592485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352869|NCT03592485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102352870|NCT03592485|Analgesics|analgesics|mesh-ancestor
102352871|NCT03592485|Sensory System Agents|sensory system agents|mesh-ancestor
102352872|NCT03592485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102352873|NCT03592485|Antipyretics|antipyretics|mesh-ancestor
102352874|NCT03592485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102352875|NCT03592485|Narcotics|narcotics|mesh-ancestor
102352876|NCT04199013|Fentanyl|fentanyl|mesh-list
102352877|NCT04199013|Ropivacaine|ropivacaine|mesh-list
102352878|NCT04199013|Anesthetics, Local|anesthetics, local|mesh-ancestor
102352879|NCT04199013|Anesthetics|anesthetics|mesh-ancestor
102352880|NCT04199013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102352881|NCT04199013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352882|NCT04199013|Sensory System Agents|sensory system agents|mesh-ancestor
102352883|NCT04199013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102352884|NCT04199013|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102352885|NCT04199013|Narcotics|narcotics|mesh-ancestor
102352886|NCT04199013|Analgesics|analgesics|mesh-ancestor
102352887|NCT04199013|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102352888|NCT04199013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102352889|NCT04199013|Anesthetics, General|anesthetics, general|mesh-ancestor
102352890|NCT04198467|Hyaluronic Acid|hyaluronic acid|mesh-list
102352891|NCT04198467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102352892|NCT04198467|Immunologic Factors|immunologic factors|mesh-ancestor
102352893|NCT04198467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352894|NCT04198467|Viscosupplements|viscosupplements|mesh-ancestor
102352895|NCT04198467|Protective Agents|protective agents|mesh-ancestor
102352896|NCT03599427|Lidocaine|lidocaine|mesh-list
102352897|NCT03599427|Anesthetics, Local|anesthetics, local|mesh-ancestor
102352898|NCT03599427|Anesthetics|anesthetics|mesh-ancestor
102352899|NCT03599427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102352900|NCT03599427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352901|NCT03599427|Sensory System Agents|sensory system agents|mesh-ancestor
102352902|NCT03599427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102352903|NCT03599427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102352904|NCT03599427|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102352905|NCT03599427|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102352906|NCT03599427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102352907|NCT03599427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352908|NCT01855789|Methotrexate|methotrexate|mesh-list
102352909|NCT01855789|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102164597|NCT05071118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102352910|NCT01855789|Abortifacient Agents|abortifacient agents|mesh-ancestor
102352911|NCT01855789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102352912|NCT01855789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352913|NCT01855789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102352914|NCT01855789|Antimetabolites|antimetabolites|mesh-ancestor
102352915|NCT01855789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352916|NCT01855789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102352917|NCT01855789|Dermatologic Agents|dermatologic agents|mesh-ancestor
102352918|NCT01855789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102352919|NCT01855789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102352920|NCT01855789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102352921|NCT01855789|Immunologic Factors|immunologic factors|mesh-ancestor
102352922|NCT01855789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102352923|NCT01855789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102352924|NCT04198233|Diazepam|diazepam|mesh-list
102352925|NCT04198233|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102352926|NCT04198233|Anticonvulsants|anticonvulsants|mesh-ancestor
102352927|NCT04198233|Antiemetics|antiemetics|mesh-ancestor
102352928|NCT04198233|Autonomic Agents|autonomic agents|mesh-ancestor
102352929|NCT04198233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102352930|NCT04198233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352931|NCT04198233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102352932|NCT04198233|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102352933|NCT04198233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102352934|NCT04198233|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102352935|NCT04198233|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102352936|NCT04198233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102352937|NCT04198233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102352938|NCT04198233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102352939|NCT04198233|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102352940|NCT04198233|Anesthetics, General|anesthetics, general|mesh-ancestor
102352941|NCT04198233|Anesthetics|anesthetics|mesh-ancestor
102352942|NCT04198233|GABA Modulators|gaba modulators|mesh-ancestor
102352943|NCT04198233|GABA Agents|gaba agents|mesh-ancestor
102352944|NCT04198233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102352945|NCT04198233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352946|NCT03591471|Prednisone|prednisone|mesh-list
102352947|NCT03591471|Benazepril|benazepril|mesh-list
102352948|NCT03591471|Heparin|heparin|mesh-list
102352949|NCT03591471|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102352950|NCT03591471|Tinzaparin|tinzaparin|mesh-list
102352951|NCT03591471|Dalteparin|dalteparin|mesh-list
102352952|NCT03591471|Calcium heparin|calcium heparin|mesh-list
102352953|NCT03591471|Dipyridamole|dipyridamole|mesh-list
102352954|NCT03591471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352955|NCT03591471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102352956|NCT03591471|Glucocorticoids|glucocorticoids|mesh-ancestor
102352957|NCT03591471|Hormones|hormones|mesh-ancestor
102352958|NCT03591471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102352959|NCT03591471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102352960|NCT03591471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102352961|NCT03591471|Anticoagulants|anticoagulants|mesh-ancestor
102352962|NCT03591471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102352963|NCT03591471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102347285|NCT01682083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102352964|NCT03591471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352965|NCT03591471|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102352966|NCT03591471|Protease Inhibitors|protease inhibitors|mesh-ancestor
102352967|NCT03591471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102352968|NCT03591471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102352969|NCT03591471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102352970|NCT03591471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102352971|NCT03591471|Vasodilator Agents|vasodilator agents|mesh-ancestor
102352972|NCT04406805|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
102352973|NCT04406805|Natriuretic Agents|natriuretic agents|mesh-ancestor
102352974|NCT04406805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352975|NCT01876381|Tolvaptan|tolvaptan|mesh-list
102352976|NCT01876381|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102352977|NCT01876381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352978|NCT01876381|Natriuretic Agents|natriuretic agents|mesh-ancestor
102352979|NCT01876381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352980|NCT03591003|Antibodies|antibodies|mesh-list
102352981|NCT03591003|Antibodies, Blocking|antibodies, blocking|mesh-list
102352982|NCT03591003|Immunologic Factors|immunologic factors|mesh-ancestor
102352983|NCT03591003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352984|NCT01875991|Etanercept|etanercept|mesh-list
102352985|NCT01875991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102352986|NCT01875991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102352987|NCT01875991|Analgesics|analgesics|mesh-ancestor
102352988|NCT01875991|Sensory System Agents|sensory system agents|mesh-ancestor
102352989|NCT01875991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102352990|NCT01875991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102352991|NCT01875991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102352992|NCT01875991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102352993|NCT01875991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102352994|NCT01875991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102352995|NCT01875991|Immunologic Factors|immunologic factors|mesh-ancestor
102352996|NCT04203927|Empagliflozin|empagliflozin|mesh-list
102352997|NCT04203927|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102352998|NCT04203927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102352999|NCT04203927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102353000|NCT04203927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353001|NCT01855243|Insulin|insulin|mesh-list
102353002|NCT01855243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102353003|NCT01855243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102353004|NCT01855243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353005|NCT04196829|Fluorides|fluorides|mesh-list
102353006|NCT04196829|Cariostatic Agents|cariostatic agents|mesh-ancestor
102353007|NCT04196829|Protective Agents|protective agents|mesh-ancestor
102353008|NCT04196829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353009|NCT01825837|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102353010|NCT01825837|Anticonvulsants|anticonvulsants|mesh-ancestor
102353011|NCT01825837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102353012|NCT01825837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102353013|NCT01825837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102353014|NCT01825837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353015|NCT01854697|Interferons|interferons|mesh-list
102353016|NCT01854697|Ribavirin|ribavirin|mesh-list
102353017|NCT01854697|Interferon-alpha|interferon-alpha|mesh-list
102353018|NCT01854697|Interferon alpha-2|interferon alpha-2|mesh-list
102353019|NCT01854697|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102353020|NCT01854697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102353021|NCT01854697|Antiviral Agents|antiviral agents|mesh-ancestor
102353022|NCT01854697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102353023|NCT01854697|Antimetabolites|antimetabolites|mesh-ancestor
102353024|NCT01854697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353025|NCT01854697|Immunologic Factors|immunologic factors|mesh-ancestor
102353026|NCT01854697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353027|NCT03594123|Brexpiprazole|brexpiprazole|mesh-list
102353028|NCT03594123|Serotonin Agents|serotonin agents|mesh-ancestor
102353029|NCT03594123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102353030|NCT03594123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353031|NCT03594123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353032|NCT03594123|Dopamine Agonists|dopamine agonists|mesh-ancestor
102353033|NCT03594123|Dopamine Agents|dopamine agents|mesh-ancestor
102353034|NCT01824823|Afatinib|afatinib|mesh-list
102353035|NCT01824823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102353036|NCT01824823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102353037|NCT01824823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102353038|NCT01824823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353039|NCT03598725|Prednisone|prednisone|mesh-list
102353040|NCT03598725|Rituximab|rituximab|mesh-list
102353041|NCT03598725|Factor VIII|factor viii|mesh-list
102353042|NCT03598725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102353043|NCT03598725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102353044|NCT03598725|Immunologic Factors|immunologic factors|mesh-ancestor
102353045|NCT03598725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353046|NCT03598725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102353047|NCT03598725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102353048|NCT03598725|Glucocorticoids|glucocorticoids|mesh-ancestor
102353049|NCT03598725|Hormones|hormones|mesh-ancestor
102353050|NCT03598725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102353051|NCT03598725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102353052|NCT03598725|Coagulants|coagulants|mesh-ancestor
102353053|NCT04766307|Interleukin-2|interleukin-2|mesh-list
102353054|NCT04766307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102353055|NCT04766307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102353056|NCT04766307|Analgesics|analgesics|mesh-ancestor
102353057|NCT04766307|Sensory System Agents|sensory system agents|mesh-ancestor
102353058|NCT04766307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102353059|NCT04766307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353060|NCT01875367|Trastuzumab|trastuzumab|mesh-list
102353061|NCT01875367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102353062|NCT01875367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102353063|NCT04194957|Fluorouracil|fluorouracil|mesh-list
102353064|NCT04194957|Capecitabine|capecitabine|mesh-list
102353065|NCT04194957|Antimetabolites|antimetabolites|mesh-ancestor
102353066|NCT04194957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353067|NCT04194957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102353068|NCT04194957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102353069|NCT04194957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102353070|NCT04194957|Immunologic Factors|immunologic factors|mesh-ancestor
102353071|NCT04194957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353072|NCT04194255|Ferrous fumarate|ferrous fumarate|mesh-list
102353073|NCT04194255|Trace Elements|trace elements|mesh-ancestor
102353074|NCT04194255|Micronutrients|micronutrients|mesh-ancestor
102353075|NCT04194255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353076|NCT04406883|Simvastatin|simvastatin|mesh-list
102353077|NCT04406883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102353078|NCT04406883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102353079|NCT04406883|Antimetabolites|antimetabolites|mesh-ancestor
102353080|NCT04406883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353081|NCT04406883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102353082|NCT04406883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102353083|NCT04406883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102353084|NCT03597867|Diclofenac|diclofenac|mesh-list
102353085|NCT03597867|Indomethacin|indomethacin|mesh-list
102353086|NCT03597867|Nepafenac|nepafenac|mesh-list
102353087|NCT03597867|Bromfenac|bromfenac|mesh-list
102353088|NCT03597867|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102353089|NCT03597867|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102353090|NCT03597867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102353091|NCT03597867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102353092|NCT03597867|Analgesics|analgesics|mesh-ancestor
102353093|NCT03597867|Sensory System Agents|sensory system agents|mesh-ancestor
102353094|NCT03597867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102353095|NCT03597867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353096|NCT03597867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102353097|NCT03597867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102353098|NCT03597867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102353099|NCT03597867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102353100|NCT03597867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353101|NCT03597867|Gout Suppressants|gout suppressants|mesh-ancestor
102353102|NCT03597867|Tocolytic Agents|tocolytic agents|mesh-ancestor
102353103|NCT03597867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102353104|NCT03597555|Sodium Oxybate|sodium oxybate|mesh-list
102353105|NCT03597555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102353106|NCT03597555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102353107|NCT03597555|Anesthetics, General|anesthetics, general|mesh-ancestor
102353108|NCT03597555|Anesthetics|anesthetics|mesh-ancestor
102353109|NCT03597555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102353110|NCT03597555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353111|NCT03597477|Dexmedetomidine|dexmedetomidine|mesh-list
102353112|NCT03597477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102353113|NCT03597477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102353114|NCT03597477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353115|NCT03597477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102353116|NCT03597477|Analgesics|analgesics|mesh-ancestor
102353117|NCT03597477|Sensory System Agents|sensory system agents|mesh-ancestor
102353118|NCT03597477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102353119|NCT03597477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102353120|NCT03597477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102353121|NCT03597477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102353122|NCT03597477|Adrenergic Agents|adrenergic agents|mesh-ancestor
102353123|NCT03597477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102353124|NCT03597477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353125|NCT04193319|Fluconazole|fluconazole|mesh-list
102353126|NCT04193319|Fluzoparib|fluzoparib|mesh-list
102353127|NCT04193319|Antifungal Agents|antifungal agents|mesh-ancestor
102353128|NCT04193319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102353129|NCT04193319|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102353130|NCT04193319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102353131|NCT04193319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102353132|NCT04193319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353133|NCT04193319|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102353134|NCT04193319|Hormone Antagonists|hormone antagonists|mesh-ancestor
102353135|NCT04193319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102353136|NCT04193319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353137|NCT04193319|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102353138|NCT04193319|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102353139|NCT04193319|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102353140|NCT04193319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102353141|NCT04192617|Methotrexate|methotrexate|mesh-list
102353142|NCT04192617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102353143|NCT04192617|Abortifacient Agents|abortifacient agents|mesh-ancestor
102353144|NCT04192617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102353145|NCT04192617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353146|NCT04192617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102353147|NCT04192617|Antimetabolites|antimetabolites|mesh-ancestor
102353148|NCT04192617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353149|NCT04192617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102353150|NCT04192617|Dermatologic Agents|dermatologic agents|mesh-ancestor
102353151|NCT04192617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102353152|NCT04192617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102353153|NCT04192617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102353154|NCT04192617|Immunologic Factors|immunologic factors|mesh-ancestor
102353155|NCT04192617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102353156|NCT04192617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102353157|NCT04026009|Vaccines|vaccines|mesh-list
102353158|NCT04026009|Immunologic Factors|immunologic factors|mesh-ancestor
102353159|NCT04026009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353160|NCT01874665|Ponatinib|ponatinib|mesh-list
102353161|NCT01874665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102353162|NCT01874665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102353163|NCT01874665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102353164|NCT01874665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353165|NCT04766151|Nitroglycerin|nitroglycerin|mesh-list
102353166|NCT04766151|Vasodilator Agents|vasodilator agents|mesh-ancestor
102353167|NCT04028739|Curcumin|curcumin|mesh-list
102353168|NCT04028739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102353169|NCT04028739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102353170|NCT04028739|Analgesics|analgesics|mesh-ancestor
102353171|NCT04028739|Sensory System Agents|sensory system agents|mesh-ancestor
102353172|NCT04028739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102353173|NCT04028739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353174|NCT04028739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102353175|NCT04028739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102353176|NCT04028739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102353177|NCT04028739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102353178|NCT04028739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353179|NCT04028505|Terlipressin|terlipressin|mesh-list
102353180|NCT04028505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102353181|NCT04028505|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102353182|NCT04190745|Paclitaxel|paclitaxel|mesh-list
102353183|NCT04190745|Apatinib|apatinib|mesh-list
102353184|NCT04190745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102353185|NCT04190745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102353186|NCT04190745|Tubulin Modulators|tubulin modulators|mesh-ancestor
102353187|NCT04190745|Antimitotic Agents|antimitotic agents|mesh-ancestor
102353188|NCT04190745|Mitosis Modulators|mitosis modulators|mesh-ancestor
102353189|NCT04190745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353190|NCT04190745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102353191|NCT04190745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102353192|NCT04028349|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
102353193|NCT04028349|Antiviral Agents|antiviral agents|mesh-ancestor
102353194|NCT04028349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102353195|NCT04198623|Montelukast|montelukast|mesh-list
102353196|NCT04198623|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102353197|NCT04198623|Respiratory System Agents|respiratory system agents|mesh-ancestor
102353198|NCT04198623|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102353199|NCT04198623|Hormone Antagonists|hormone antagonists|mesh-ancestor
102353200|NCT04198623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102353201|NCT04198623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353202|NCT04198623|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102353203|NCT04198623|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102353204|NCT04198623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353205|NCT01873729|Naltrexone|naltrexone|mesh-list
102353206|NCT01873729|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102353207|NCT01873729|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102353208|NCT01873729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353209|NCT01873729|Sensory System Agents|sensory system agents|mesh-ancestor
102353210|NCT01873729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102353211|NCT01873495|Homoharringtonine|homoharringtonine|mesh-list
102353212|NCT01873495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102353213|NCT01873495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102353214|NCT01873495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102353215|NCT01873495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102353216|NCT01873495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353217|NCT04027959|Vitamin B 12|vitamin b 12|mesh-list
102353218|NCT04027959|Hydroxocobalamin|hydroxocobalamin|mesh-list
102353219|NCT04027959|Vitamins|vitamins|mesh-ancestor
102353220|NCT04027959|Micronutrients|micronutrients|mesh-ancestor
102353221|NCT04027959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353222|NCT04027959|Vitamin B Complex|vitamin b complex|mesh-ancestor
102353223|NCT04027959|Hematinics|hematinics|mesh-ancestor
102353224|NCT04344951|Chloroquine|chloroquine|mesh-list
102353225|NCT04344951|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
102353226|NCT04344951|Amebicides|amebicides|mesh-ancestor
102353227|NCT04344951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102353228|NCT04344951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102353229|NCT04344951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102353230|NCT04344951|Antimalarials|antimalarials|mesh-ancestor
102353231|NCT04344951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102353232|NCT04344951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102353233|NCT04344951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102353234|NCT04344951|Analgesics|analgesics|mesh-ancestor
102353235|NCT04344951|Sensory System Agents|sensory system agents|mesh-ancestor
102353236|NCT04344951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102353237|NCT04344951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353238|NCT04344951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102353239|NCT04344951|Filaricides|filaricides|mesh-ancestor
102353240|NCT04344951|Antinematodal Agents|antinematodal agents|mesh-ancestor
102353241|NCT04344951|Anthelmintics|anthelmintics|mesh-ancestor
102353242|NCT01822561|Eplerenone|eplerenone|mesh-list
102353243|NCT01822561|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102353244|NCT01822561|Hormone Antagonists|hormone antagonists|mesh-ancestor
102353245|NCT01822561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102353246|NCT01822561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353247|NCT01822561|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102353248|NCT01822561|Diuretics|diuretics|mesh-ancestor
102353249|NCT01822561|Natriuretic Agents|natriuretic agents|mesh-ancestor
102353250|NCT01822561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102353251|NCT02080455|Atorvastatin|atorvastatin|mesh-list
102353252|NCT02080455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102353253|NCT02080455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102353254|NCT02080455|Antimetabolites|antimetabolites|mesh-ancestor
102353255|NCT02080455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353256|NCT02080455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102353257|NCT02080455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102353258|NCT02080455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102353259|NCT01852591|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102353260|NCT01852591|Immunologic Factors|immunologic factors|mesh-ancestor
102353261|NCT01852591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353262|NCT04021173|Fibrinolysin|fibrinolysin|mesh-list
102353263|NCT04021173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102353264|NCT04021173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102353265|NCT04021173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353266|NCT01852045|Botulinum Toxins|botulinum toxins|mesh-list
102353267|NCT01852045|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102353268|NCT01852045|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102353269|NCT01852045|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102353270|NCT01852045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102353271|NCT01852045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353272|NCT01852045|Cholinergic Agents|cholinergic agents|mesh-ancestor
102353273|NCT01852045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102353274|NCT01852045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353275|NCT01852045|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102353276|NCT01852045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102353277|NCT03960957|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102353278|NCT03960957|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102353279|NCT03960957|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102353280|NCT03960957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102353281|NCT03960957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353282|NCT03960957|Cholinergic Agents|cholinergic agents|mesh-ancestor
102353283|NCT03960957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102353284|NCT03960957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353285|NCT03960957|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102353286|NCT03960957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102353287|NCT04027179|Chlorhexidine|chlorhexidine|mesh-list
102353288|NCT04027179|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102353289|NCT04027179|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102353290|NCT04027179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102353291|NCT04027179|Disinfectants|disinfectants|mesh-ancestor
102353292|NCT04027179|Dermatologic Agents|dermatologic agents|mesh-ancestor
102353293|NCT04199169|Vaccines|vaccines|mesh-list
102353294|NCT04199169|Immunologic Factors|immunologic factors|mesh-ancestor
102353295|NCT04199169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353296|NCT03022929|Anti-Infective Agents|anti-infective agents|mesh-list
102353297|NCT03022929|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102353298|NCT01821391|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
102353299|NCT01821391|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102353300|NCT01821391|Dermatologic Agents|dermatologic agents|mesh-ancestor
102353301|NCT04020705|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
102353302|NCT04020705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102353303|NCT04020705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102353304|NCT04020705|Nootropic Agents|nootropic agents|mesh-ancestor
102353305|NCT01873417|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102353306|NCT01873417|Dermatologic Agents|dermatologic agents|mesh-ancestor
102353307|NCT01873417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102353308|NCT01873417|Immunologic Factors|immunologic factors|mesh-ancestor
102353309|NCT01873417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353310|NCT03950427|Bupropion|bupropion|mesh-list
102353311|NCT03950427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102353312|NCT03950427|Antidepressive Agents|antidepressive agents|mesh-ancestor
102353313|NCT03950427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102353314|NCT03950427|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102353315|NCT03950427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102353316|NCT03950427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102353317|NCT03950427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353318|NCT03950427|Dopamine Agents|dopamine agents|mesh-ancestor
102353319|NCT03950427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102353320|NCT03950427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353321|NCT03950427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102353322|NCT03950427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102353323|NCT03950427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102353324|NCT01872715|Doxycycline|doxycycline|mesh-list
102353325|NCT01872715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102353326|NCT01872715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102353327|NCT01872715|Antimalarials|antimalarials|mesh-ancestor
102353328|NCT01872715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102353329|NCT01872715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102353330|NCT01613599|Rituximab|rituximab|mesh-list
102353331|NCT01613599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102353332|NCT01613599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102353333|NCT01613599|Immunologic Factors|immunologic factors|mesh-ancestor
102353334|NCT01613599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353335|NCT01613599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102353336|NCT03930771|Capecitabine|capecitabine|mesh-list
102353337|NCT03930771|Temozolomide|temozolomide|mesh-list
102353338|NCT03930771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102353339|NCT03930771|Antimetabolites|antimetabolites|mesh-ancestor
102353340|NCT03930771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353341|NCT03930771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102353342|NCT03930771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102353343|NCT03930771|Alkylating Agents|alkylating agents|mesh-ancestor
102353344|NCT04024683|Ropivacaine|ropivacaine|mesh-list
102353345|NCT04024683|Anesthetics, Local|anesthetics, local|mesh-ancestor
102353346|NCT04024683|Anesthetics|anesthetics|mesh-ancestor
102353347|NCT04024683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102353348|NCT04024683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353349|NCT04024683|Sensory System Agents|sensory system agents|mesh-ancestor
102353350|NCT04024683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102353351|NCT04024527|Amoxicillin|amoxicillin|mesh-list
102353352|NCT04024527|Metronidazole|metronidazole|mesh-list
102353353|NCT04024527|Esomeprazole|esomeprazole|mesh-list
102353354|NCT04024527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102353355|NCT04024527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102353356|NCT04024527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102353357|NCT04024527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102353358|NCT04024527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102353359|NCT04024527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102353360|NCT04024527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102165066|NCT01651000|Vitamins|vitamins|mesh-ancestor
102353361|NCT04024527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102353362|NCT04024527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353364|NCT01819129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102353365|NCT01819129|Insulin Glargine|insulin glargine|mesh-list
102353366|NCT01819129|Insulin Aspart|insulin aspart|mesh-list
102353367|NCT01819129|Insulin, Long-Acting|insulin, long-acting|mesh-list
102353368|NCT01819129|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102353369|NCT01819129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102353370|NCT01819129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353371|NCT04025775|Insulin|insulin|mesh-list
102353372|NCT04025775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102353373|NCT04025775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353374|NCT04022811|Tobramycin|tobramycin|mesh-list
102353375|NCT04022811|Dexamethasone|dexamethasone|mesh-list
102353376|NCT04022811|Bromfenac|bromfenac|mesh-list
102353377|NCT04022811|Hyaluronic Acid|hyaluronic acid|mesh-list
102353378|NCT04022811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102353379|NCT04022811|Antiemetics|antiemetics|mesh-ancestor
102353380|NCT04022811|Autonomic Agents|autonomic agents|mesh-ancestor
102353381|NCT04022811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102353382|NCT04022811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353383|NCT04022811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102353384|NCT04022811|Glucocorticoids|glucocorticoids|mesh-ancestor
102353385|NCT04022811|Hormones|hormones|mesh-ancestor
102353386|NCT04022811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102353387|NCT04022811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102353388|NCT04022811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102353389|NCT04022811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102353390|NCT04022811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102353391|NCT04022811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102353392|NCT04022811|Immunologic Factors|immunologic factors|mesh-ancestor
102353393|NCT04022811|Viscosupplements|viscosupplements|mesh-ancestor
102353394|NCT04022811|Protective Agents|protective agents|mesh-ancestor
102353395|NCT04022811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102353396|NCT04022811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102353397|NCT04022811|Analgesics|analgesics|mesh-ancestor
102353398|NCT04022811|Sensory System Agents|sensory system agents|mesh-ancestor
102353399|NCT04022811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102353400|NCT04145583|Voriconazole|voriconazole|mesh-list
102353401|NCT04145583|Antifungal Agents|antifungal agents|mesh-ancestor
102353402|NCT04145583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102353403|NCT04145583|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102353404|NCT04145583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102353405|NCT04145583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102353406|NCT04145583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353407|NCT04145583|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102353408|NCT04145583|Hormone Antagonists|hormone antagonists|mesh-ancestor
102353409|NCT04145583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102353410|NCT04145583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353411|NCT04145583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102353412|NCT04022421|Hydroxychloroquine|hydroxychloroquine|mesh-list
102353413|NCT04022421|Antimalarials|antimalarials|mesh-ancestor
102353414|NCT04022421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102353415|NCT04022421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102353416|NCT04022421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102353417|NCT04022421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102353418|NCT04022421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353419|NCT04022421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102353420|NCT04145193|Leucovorin|leucovorin|mesh-list
102353421|NCT04145193|Fluorouracil|fluorouracil|mesh-list
102353422|NCT04145193|Oxaliplatin|oxaliplatin|mesh-list
102353423|NCT04145193|Durvalumab|durvalumab|mesh-list
102353424|NCT04145193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102353425|NCT04145193|Antimetabolites|antimetabolites|mesh-ancestor
102353426|NCT04145193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353427|NCT04145193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102353428|NCT04145193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102353429|NCT04145193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102353430|NCT04145193|Immunologic Factors|immunologic factors|mesh-ancestor
102353431|NCT04145193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353432|NCT04145193|Antidotes|antidotes|mesh-ancestor
102353433|NCT04145193|Protective Agents|protective agents|mesh-ancestor
102353434|NCT04145193|Vitamin B Complex|vitamin b complex|mesh-ancestor
102353435|NCT04145193|Vitamins|vitamins|mesh-ancestor
102353436|NCT04145193|Micronutrients|micronutrients|mesh-ancestor
102165123|NCT02071303|Narcotics|narcotics|mesh-ancestor
102353437|NCT04145193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102353438|NCT04147845|Triamcinolone|triamcinolone|mesh-list
102353439|NCT04147845|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102353440|NCT04147845|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102353441|NCT04147845|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102353442|NCT04147845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102353443|NCT04147845|Glucocorticoids|glucocorticoids|mesh-ancestor
102353444|NCT04147845|Hormones|hormones|mesh-ancestor
102353445|NCT04147845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102353446|NCT04147845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353447|NCT04147845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102353448|NCT04147845|Immunologic Factors|immunologic factors|mesh-ancestor
102353449|NCT04147845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102353450|NCT04147845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353451|NCT01849783|Thalidomide|thalidomide|mesh-list
102353452|NCT01849783|Dexamethasone|dexamethasone|mesh-list
102353453|NCT01849783|Cyclophosphamide|cyclophosphamide|mesh-list
102353454|NCT01849783|Melphalan|melphalan|mesh-list
102353455|NCT01849783|Doxorubicin|doxorubicin|mesh-list
102353456|NCT01849783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102353457|NCT01849783|Etoposide|etoposide|mesh-list
102353458|NCT01849783|Etoposide phosphate|etoposide phosphate|mesh-list
102353459|NCT01849783|Bortezomib|bortezomib|mesh-list
102353460|NCT01849783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102353461|NCT01849783|Immunologic Factors|immunologic factors|mesh-ancestor
102353462|NCT01849783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353463|NCT01849783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102353464|NCT01849783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102353465|NCT01849783|Alkylating Agents|alkylating agents|mesh-ancestor
102353466|NCT01849783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353467|NCT01849783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102353468|NCT01849783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102353469|NCT01849783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102353470|NCT01849783|Antiemetics|antiemetics|mesh-ancestor
102353471|NCT01849783|Autonomic Agents|autonomic agents|mesh-ancestor
102353472|NCT01849783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102353473|NCT01849783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102353474|NCT01849783|Glucocorticoids|glucocorticoids|mesh-ancestor
102353475|NCT01849783|Hormones|hormones|mesh-ancestor
102353476|NCT01849783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102353477|NCT01849783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102353478|NCT01849783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102353479|NCT01849783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102353480|NCT01849783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102353481|NCT01849783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102353482|NCT01849783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102353483|NCT01849783|Leprostatic Agents|leprostatic agents|mesh-ancestor
102353484|NCT01849783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102353485|NCT01849783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102353486|NCT01849783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102353487|NCT01849783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102353488|NCT01849783|Growth Substances|growth substances|mesh-ancestor
102353489|NCT01849783|Growth Inhibitors|growth inhibitors|mesh-ancestor
102353490|NCT01611883|Ezetimibe|ezetimibe|mesh-list
102353491|NCT01611883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102353492|NCT01611883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102353493|NCT01611883|Antimetabolites|antimetabolites|mesh-ancestor
102353494|NCT01611883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353495|NCT01611883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102353496|NCT04170517|Progesterone|progesterone|mesh-list
102353497|NCT04170517|Progestins|progestins|mesh-ancestor
102353498|NCT04170517|Hormones|hormones|mesh-ancestor
102353499|NCT04170517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102353500|NCT04170517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353501|NCT01848457|Methotrexate|methotrexate|mesh-list
102353502|NCT01848457|Pantoprazole|pantoprazole|mesh-list
102353503|NCT01848457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102353504|NCT01848457|Abortifacient Agents|abortifacient agents|mesh-ancestor
102353505|NCT01848457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102353506|NCT01848457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353507|NCT01848457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102353508|NCT01848457|Antimetabolites|antimetabolites|mesh-ancestor
102353509|NCT01848457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353510|NCT01848457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102353511|NCT01848457|Dermatologic Agents|dermatologic agents|mesh-ancestor
102165211|NCT02071615|Caffeine|caffeine|mesh-list
102353512|NCT01848457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102353513|NCT01848457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102353514|NCT01848457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102353515|NCT01848457|Immunologic Factors|immunologic factors|mesh-ancestor
102353516|NCT01848457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102353517|NCT01848457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102353518|NCT01848457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102353519|NCT01848457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102353520|NCT01848457|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102353521|NCT01870999|Aripiprazole|aripiprazole|mesh-list
102353522|NCT01870999|Antidepressive Agents|antidepressive agents|mesh-ancestor
102353523|NCT01870999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102353524|NCT01870999|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102353525|NCT01870999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102353526|NCT01870999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102353527|NCT01870999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353528|NCT01870999|Dopamine Agonists|dopamine agonists|mesh-ancestor
102353529|NCT01870999|Dopamine Agents|dopamine agents|mesh-ancestor
102353530|NCT01870999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102353531|NCT01870999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353532|NCT01870999|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102353533|NCT01870999|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102353534|NCT01870999|Serotonin Agents|serotonin agents|mesh-ancestor
102353535|NCT01870999|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102353536|NCT01870999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102353537|NCT01870999|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102353538|NCT01870999|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102353539|NCT01870921|Ticagrelor|ticagrelor|mesh-list
102353540|NCT01870921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102353541|NCT01870921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102353542|NCT01870921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102353543|NCT01870921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102353544|NCT01870921|Purinergic Agents|purinergic agents|mesh-ancestor
102353545|NCT01870921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102353546|NCT01870921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353547|NCT01870921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353548|NCT00526474|Vorapaxar|vorapaxar|mesh-list
102353549|NCT00526474|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102353550|NCT01848145|Ofatumumab|ofatumumab|mesh-list
102353551|NCT01848145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102353552|NCT00527644|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102353553|NCT00527644|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
102353554|NCT00527644|beta-Endorphin|beta-endorphin|mesh-list
102353555|NCT00527644|Hormones|hormones|mesh-ancestor
102353556|NCT00527644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102353557|NCT00527644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353558|NCT00527644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102353559|NCT00527644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353560|NCT01847443|Nicotine|nicotine|mesh-list
102353561|NCT01847443|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102353562|NCT01847443|Autonomic Agents|autonomic agents|mesh-ancestor
102353563|NCT01847443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102353564|NCT01847443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353565|NCT01847443|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102353566|NCT01847443|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102353567|NCT01847443|Cholinergic Agents|cholinergic agents|mesh-ancestor
102353568|NCT01847443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102353569|NCT01847443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353570|NCT00527878|Ranitidine|ranitidine|mesh-list
102353571|NCT00527878|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
102353572|NCT00527878|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102353573|NCT00527878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102353574|NCT00527878|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102353575|NCT00527878|Histamine Antagonists|histamine antagonists|mesh-ancestor
102353576|NCT00527878|Histamine Agents|histamine agents|mesh-ancestor
102353577|NCT00527878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102353578|NCT00527878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353579|NCT00527878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353580|NCT05558878|Ambroxol|ambroxol|mesh-list
102353581|NCT05558878|Expectorants|expectorants|mesh-ancestor
102353582|NCT05558878|Respiratory System Agents|respiratory system agents|mesh-ancestor
102353583|NCT05621434|Maleic acid|maleic acid|mesh-list
102353584|NCT05621434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102165270|NCT02074189|Gemcitabine|gemcitabine|mesh-list
102353585|NCT05621434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353586|NCT01870843|Escitalopram|escitalopram|mesh-list
102353587|NCT01870843|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102353588|NCT01870843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102353589|NCT01870843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102353590|NCT01870843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353591|NCT01870843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102353592|NCT01870843|Serotonin Agents|serotonin agents|mesh-ancestor
102353593|NCT01870843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353594|NCT01816477|Ropivacaine|ropivacaine|mesh-list
102353595|NCT01816477|Anesthetics, Local|anesthetics, local|mesh-ancestor
102353596|NCT01816477|Anesthetics|anesthetics|mesh-ancestor
102353597|NCT01816477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102353598|NCT01816477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353599|NCT01816477|Sensory System Agents|sensory system agents|mesh-ancestor
102353600|NCT01816477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102353601|NCT01846507|Tranexamic Acid|tranexamic acid|mesh-list
102353602|NCT01846507|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102353603|NCT01846507|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102353604|NCT01846507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353605|NCT01846507|Hemostatics|hemostatics|mesh-ancestor
102353606|NCT01846507|Coagulants|coagulants|mesh-ancestor
102353607|NCT01846039|Hyaluronic Acid|hyaluronic acid|mesh-list
102353608|NCT01846039|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102353609|NCT01846039|Immunologic Factors|immunologic factors|mesh-ancestor
102353610|NCT01846039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353611|NCT01846039|Viscosupplements|viscosupplements|mesh-ancestor
102353612|NCT01846039|Protective Agents|protective agents|mesh-ancestor
102353613|NCT01610167|Listerine|listerine|mesh-list
102353614|NCT01610167|Fluorides|fluorides|mesh-list
102353615|NCT01610167|Sodium Fluoride|sodium fluoride|mesh-list
102353616|NCT01610167|Cariostatic Agents|cariostatic agents|mesh-ancestor
102353617|NCT01610167|Protective Agents|protective agents|mesh-ancestor
102353618|NCT01610167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353619|NCT01610167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102353620|NCT01610167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102353621|NCT04478500|Minocycline|minocycline|mesh-list
102353622|NCT04478500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102353623|NCT04478500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102353624|NCT01816243|Fentanyl|fentanyl|mesh-list
102353625|NCT01816243|Morphine|morphine|mesh-list
102353626|NCT01816243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102353627|NCT01816243|Narcotics|narcotics|mesh-ancestor
102353628|NCT01816243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102353629|NCT01816243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353630|NCT01816243|Analgesics|analgesics|mesh-ancestor
102353631|NCT01816243|Sensory System Agents|sensory system agents|mesh-ancestor
102353632|NCT01816243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102353633|NCT01816243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102353634|NCT01816243|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102353635|NCT01816243|Anesthetics, General|anesthetics, general|mesh-ancestor
102353636|NCT01816243|Anesthetics|anesthetics|mesh-ancestor
102353637|NCT05576896|Hydroxychloroquine|hydroxychloroquine|mesh-list
102353638|NCT05576896|Cetuximab|cetuximab|mesh-list
102353639|NCT05576896|Panitumumab|panitumumab|mesh-list
102353640|NCT05576896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102353641|NCT05576896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102353642|NCT05576896|Antimalarials|antimalarials|mesh-ancestor
102353643|NCT05576896|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102353644|NCT05576896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102353645|NCT05576896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102353646|NCT05576896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102353647|NCT05576896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353648|NCT05576896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102353649|NCT01845805|Azacitidine|azacitidine|mesh-list
102353650|NCT01845805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102353651|NCT01845805|Antimetabolites|antimetabolites|mesh-ancestor
102353652|NCT01845805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353653|NCT01845805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102353654|NCT01845805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102353655|NCT05575804|Capecitabine|capecitabine|mesh-list
102353656|NCT05575804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102353657|NCT05575804|Antimetabolites|antimetabolites|mesh-ancestor
102353658|NCT05575804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353659|NCT05575804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102353660|NCT01845025|Fluticasone|fluticasone|mesh-list
102353661|NCT01845025|Xhance|xhance|mesh-list
102353662|NCT01845025|Formoterol Fumarate|formoterol fumarate|mesh-list
102353663|NCT01845025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102353664|NCT01845025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102353665|NCT01845025|Autonomic Agents|autonomic agents|mesh-ancestor
102353666|NCT01845025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102353667|NCT01845025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353668|NCT01845025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102353669|NCT01845025|Respiratory System Agents|respiratory system agents|mesh-ancestor
102353670|NCT01845025|Dermatologic Agents|dermatologic agents|mesh-ancestor
102353671|NCT01845025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102353672|NCT01845025|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102353673|NCT01845025|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102353674|NCT01845025|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102353675|NCT01845025|Adrenergic Agents|adrenergic agents|mesh-ancestor
102353676|NCT01845025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102353677|NCT01845025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353678|NCT04148872|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102353679|NCT04148872|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102353680|NCT04148872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102353681|NCT04148872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885329|NCT05932277|Omeprazole|omeprazole|mesh-list
102353682|NCT04148872|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102353683|NCT04148872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102353684|NCT04148872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353685|NCT04148872|Cholinergic Agents|cholinergic agents|mesh-ancestor
102353686|NCT04148872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102353687|NCT05072236|Lidocaine|lidocaine|mesh-list
102353688|NCT05072236|Anesthetics, Local|anesthetics, local|mesh-ancestor
102353689|NCT05072236|Anesthetics|anesthetics|mesh-ancestor
102353690|NCT05072236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102353691|NCT05072236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353692|NCT05072236|Sensory System Agents|sensory system agents|mesh-ancestor
102353693|NCT05072236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102353694|NCT05072236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102353695|NCT05072236|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102353696|NCT05072236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102353697|NCT05072236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102353698|NCT05072236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353699|NCT04847440|Tenofovir|tenofovir|mesh-list
102353700|NCT04847440|Antiviral Agents|antiviral agents|mesh-ancestor
102353701|NCT04847440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102353702|NCT04847440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102353703|NCT04847440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102353704|NCT04847440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102353705|NCT04847440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353706|NCT04847440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102353707|NCT04847440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102353708|NCT03519412|Pembrolizumab|pembrolizumab|mesh-list
102353709|NCT03519412|Temozolomide|temozolomide|mesh-list
102353710|NCT03519412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102353711|NCT03519412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102353712|NCT03519412|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102353713|NCT03519412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353714|NCT03519412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102353715|NCT03519412|Alkylating Agents|alkylating agents|mesh-ancestor
102353716|NCT01870297|Liraglutide|liraglutide|mesh-list
102353717|NCT01870297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102353718|NCT01870297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353719|NCT01870297|Incretins|incretins|mesh-ancestor
102353720|NCT01870297|Hormones|hormones|mesh-ancestor
102353721|NCT01870297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102353722|NCT01814761|Bimatoprost|bimatoprost|mesh-list
102353723|NCT01814761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102353724|NCT04616248|Poly I-C|poly i-c|mesh-list
102353725|NCT04616248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102353726|NCT04616248|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102353727|NCT04616248|Antibodies|antibodies|mesh-list
102353728|NCT04616248|Immunoglobulins|immunoglobulins|mesh-list
102353729|NCT04616248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102353730|NCT04616248|Poly ICLC|poly iclc|mesh-list
102353731|NCT04616248|Flt3 ligand protein|flt3 ligand protein|mesh-list
102353732|NCT04616248|Immunologic Factors|immunologic factors|mesh-ancestor
102353733|NCT04616248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353734|NCT04616248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102353735|NCT04616248|Interferon Inducers|interferon inducers|mesh-ancestor
102353737|NCT04616248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102353738|NCT04616248|Antiviral Agents|antiviral agents|mesh-ancestor
102353739|NCT04616248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102353740|NCT04616248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102353741|NCT04616248|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102353742|NCT04616248|Protective Agents|protective agents|mesh-ancestor
102353743|NCT01798030|Vitamin D|vitamin d|mesh-list
102353744|NCT01798030|Vitamins|vitamins|mesh-ancestor
102353745|NCT01798030|Micronutrients|micronutrients|mesh-ancestor
102353746|NCT01798030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353747|NCT01798030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102353748|NCT03329950|Pembrolizumab|pembrolizumab|mesh-list
102353749|NCT03329950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102353750|NCT03329950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102353751|NCT03329950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102353752|NCT03329950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353753|NCT01814371|Mupirocin|mupirocin|mesh-list
102353754|NCT01814371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102353755|NCT01814371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102353756|NCT01814371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102353757|NCT01814371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102353758|NCT01814371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353759|NCT03232138|Sulforaphane|sulforaphane|mesh-list
102353760|NCT03232138|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102353761|NCT03232138|Protective Agents|protective agents|mesh-ancestor
102353762|NCT03232138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353763|NCT03232138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102353764|NCT01814137|Insulin|insulin|mesh-list
102353765|NCT01814137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102353766|NCT01814137|Insulin Aspart|insulin aspart|mesh-list
102353767|NCT01814137|Insulin, Long-Acting|insulin, long-acting|mesh-list
102353768|NCT01814137|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102353769|NCT01814137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102353770|NCT01814137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353771|NCT01813435|Aspirin|aspirin|mesh-list
102353772|NCT01813435|Clopidogrel|clopidogrel|mesh-list
102353773|NCT01813435|Ticagrelor|ticagrelor|mesh-list
102353774|NCT01813435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102353775|NCT01813435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102353776|NCT01813435|Analgesics|analgesics|mesh-ancestor
102353777|NCT01813435|Sensory System Agents|sensory system agents|mesh-ancestor
102353778|NCT01813435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102353779|NCT01813435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353780|NCT01813435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102353781|NCT01813435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102353782|NCT01813435|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102353783|NCT01813435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102353784|NCT01813435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353785|NCT01813435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102353786|NCT01813435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102353787|NCT01813435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102353788|NCT01813435|Antipyretics|antipyretics|mesh-ancestor
102353789|NCT01813435|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102353790|NCT01813435|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102353791|NCT01813435|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102353792|NCT01813435|Purinergic Agents|purinergic agents|mesh-ancestor
102353793|NCT01813435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102353794|NCT01798498|Hyaluronic Acid|hyaluronic acid|mesh-list
102353795|NCT01798498|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102353796|NCT01798498|Immunologic Factors|immunologic factors|mesh-ancestor
102353797|NCT01798498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353798|NCT01798498|Viscosupplements|viscosupplements|mesh-ancestor
102353799|NCT01798498|Protective Agents|protective agents|mesh-ancestor
102353800|NCT01813357|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102353801|NCT01813357|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102353802|NCT01813357|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102353803|NCT01813357|Antimetabolites|antimetabolites|mesh-ancestor
102353804|NCT01813357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353805|NCT01813357|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102353806|NCT01813357|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102353807|NCT01813357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102353808|NCT02346526|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
102353809|NCT02346526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102353810|NCT03944902|Niraparib|niraparib|mesh-list
102353811|NCT03944902|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102353812|NCT03944902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102353813|NCT03944902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353814|NCT03944902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102353815|NCT01811953|Metformin|metformin|mesh-list
102353816|NCT01811953|Empagliflozin|empagliflozin|mesh-list
102353817|NCT01811953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102353818|NCT01811953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353819|NCT01811953|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102353820|NCT01811953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353821|NCT03895762|Fentanyl|fentanyl|mesh-list
102353822|NCT03895762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102353823|NCT03895762|Narcotics|narcotics|mesh-ancestor
102353824|NCT03895762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102353825|NCT03895762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353826|NCT03895762|Analgesics|analgesics|mesh-ancestor
102353827|NCT03895762|Sensory System Agents|sensory system agents|mesh-ancestor
102347318|NCT00721526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102353828|NCT03895762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102353829|NCT03895762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102353830|NCT03895762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102353831|NCT03895762|Anesthetics, General|anesthetics, general|mesh-ancestor
102353832|NCT03895762|Anesthetics|anesthetics|mesh-ancestor
102353833|NCT01033552|Cyclosporine|cyclosporine|mesh-list
102353834|NCT01033552|Mycophenolic Acid|mycophenolic acid|mesh-list
102353835|NCT01033552|Cyclophosphamide|cyclophosphamide|mesh-list
102353836|NCT01033552|Fludarabine|fludarabine|mesh-list
102353837|NCT01033552|Cyclosporins|cyclosporins|mesh-list
102353838|NCT01033552|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102353839|NCT01033552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102353840|NCT01033552|Immunologic Factors|immunologic factors|mesh-ancestor
102353841|NCT01033552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353842|NCT01033552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102353843|NCT01033552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102353844|NCT01033552|Alkylating Agents|alkylating agents|mesh-ancestor
102353845|NCT01033552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353846|NCT01033552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102353847|NCT01033552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102353848|NCT01033552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102353849|NCT01033552|Antifungal Agents|antifungal agents|mesh-ancestor
102353850|NCT01033552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102353851|NCT01033552|Dermatologic Agents|dermatologic agents|mesh-ancestor
102353852|NCT01033552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102353853|NCT01033552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102353854|NCT01033552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102353855|NCT01033552|Antitubercular Agents|antitubercular agents|mesh-ancestor
102353856|NCT01033552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102353857|NCT00997906|Paclitaxel|paclitaxel|mesh-list
102353858|NCT00997906|Carboplatin|carboplatin|mesh-list
102353859|NCT00997906|Gemcitabine|gemcitabine|mesh-list
102353860|NCT00997906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102353861|NCT00997906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102353862|NCT00997906|Tubulin Modulators|tubulin modulators|mesh-ancestor
102353863|NCT00997906|Antimitotic Agents|antimitotic agents|mesh-ancestor
102353864|NCT00997906|Mitosis Modulators|mitosis modulators|mesh-ancestor
102353865|NCT00997906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353866|NCT00997906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102353867|NCT00997906|Antimetabolites|antimetabolites|mesh-ancestor
102353868|NCT05246644|Acetaminophen|acetaminophen|mesh-list
102353869|NCT05246644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102353870|NCT05246644|Analgesics|analgesics|mesh-ancestor
102353871|NCT05246644|Sensory System Agents|sensory system agents|mesh-ancestor
102353872|NCT05246644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102353873|NCT05246644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353874|NCT05246644|Antipyretics|antipyretics|mesh-ancestor
102353875|NCT01798576|Interferons|interferons|mesh-list
102353876|NCT01798576|Ribavirin|ribavirin|mesh-list
102353877|NCT01798576|Interferon-alpha|interferon-alpha|mesh-list
102353878|NCT01798576|Interferon alpha-2|interferon alpha-2|mesh-list
102353879|NCT01798576|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102353880|NCT01798576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102353881|NCT01798576|Antiviral Agents|antiviral agents|mesh-ancestor
102353882|NCT01798576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102353883|NCT01798576|Antimetabolites|antimetabolites|mesh-ancestor
102353884|NCT01798576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353885|NCT01798576|Immunologic Factors|immunologic factors|mesh-ancestor
102353886|NCT01798576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165577|NCT03558919|Mirabegron|mirabegron|mesh-list
102353887|NCT00565084|Ibuprofen|ibuprofen|mesh-list
102353888|NCT00565084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102353889|NCT00565084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102353890|NCT00565084|Analgesics|analgesics|mesh-ancestor
102353891|NCT00565084|Sensory System Agents|sensory system agents|mesh-ancestor
102353892|NCT00565084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102353893|NCT00565084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353894|NCT00565084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102353895|NCT00565084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102353896|NCT00565084|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102353897|NCT00565084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102353898|NCT00565084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353899|NCT01810783|Brexpiprazole|brexpiprazole|mesh-list
102353900|NCT01810783|Serotonin Agents|serotonin agents|mesh-ancestor
102353901|NCT01810783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102353902|NCT01810783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353903|NCT01810783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353904|NCT01810783|Dopamine Agonists|dopamine agonists|mesh-ancestor
102353905|NCT01810783|Dopamine Agents|dopamine agents|mesh-ancestor
102353906|NCT01807117|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102353907|NCT01807117|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102353908|NCT01807117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353909|NCT01613131|Estradiol|estradiol|mesh-list
102353910|NCT01613131|Estrogens|estrogens|mesh-ancestor
102353911|NCT01613131|Hormones|hormones|mesh-ancestor
102353912|NCT01613131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102353913|NCT01613131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353914|NCT05362942|Cytarabine|cytarabine|mesh-list
102353915|NCT05362942|Azacitidine|azacitidine|mesh-list
102353916|NCT05362942|Decitabine|decitabine|mesh-list
102353917|NCT05362942|Venetoclax|venetoclax|mesh-list
102353918|NCT05362942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102353919|NCT05362942|Antimetabolites|antimetabolites|mesh-ancestor
102353920|NCT05362942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353921|NCT05362942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102353922|NCT05362942|Antiviral Agents|antiviral agents|mesh-ancestor
102353923|NCT05362942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102353924|NCT05362942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102353925|NCT05362942|Immunologic Factors|immunologic factors|mesh-ancestor
102353926|NCT05362942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353927|NCT05362942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102353928|NCT01868893|Obinutuzumab|obinutuzumab|mesh-list
102353929|NCT01868893|Chlorambucil|chlorambucil|mesh-list
102353930|NCT01868893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102353931|NCT01868893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102353932|NCT01868893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102353933|NCT01868893|Alkylating Agents|alkylating agents|mesh-ancestor
102353934|NCT01868893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353935|NCT01868503|Lapatinib|lapatinib|mesh-list
102353936|NCT01868503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102353937|NCT01868503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102353938|NCT01868503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102353939|NCT01868503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353940|NCT05204368|Meropenem|meropenem|mesh-list
102353941|NCT05204368|Imipenem|imipenem|mesh-list
102353942|NCT05204368|Cilastatin|cilastatin|mesh-list
102353943|NCT05204368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102353944|NCT05204368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102353945|NCT05204368|Protease Inhibitors|protease inhibitors|mesh-ancestor
102353946|NCT05204368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102353947|NCT05204368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353948|NCT01868035|Tositumomab I-131|tositumomab i-131|mesh-list
102353949|NCT01868035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102353950|NCT04414969|Asparaginase|asparaginase|mesh-list
102353951|NCT04414969|Pegaspargase|pegaspargase|mesh-list
102353952|NCT04414969|Antibodies|antibodies|mesh-list
102353953|NCT04414969|Immunoglobulins|immunoglobulins|mesh-list
102353954|NCT04414969|Immunologic Factors|immunologic factors|mesh-ancestor
102353955|NCT04414969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353956|NCT04414969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102353957|NCT01609933|Interferons|interferons|mesh-list
102353958|NCT01609933|Ritonavir|ritonavir|mesh-list
102353959|NCT01609933|Ribavirin|ribavirin|mesh-list
102353960|NCT01609933|Interferon-alpha|interferon-alpha|mesh-list
102353961|NCT01609933|Interferon alpha-2|interferon alpha-2|mesh-list
102353962|NCT01609933|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102353963|NCT01609933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102353964|NCT01609933|Antiviral Agents|antiviral agents|mesh-ancestor
102353965|NCT01609933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102353966|NCT01609933|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102353967|NCT01609933|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102353968|NCT01609933|Protease Inhibitors|protease inhibitors|mesh-ancestor
102353969|NCT01609933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102353970|NCT01609933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353971|NCT01609933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102353972|NCT01609933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102353973|NCT01609933|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102353974|NCT01609933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102353975|NCT01609933|Antimetabolites|antimetabolites|mesh-ancestor
102353976|NCT01609933|Immunologic Factors|immunologic factors|mesh-ancestor
102353977|NCT01609933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353978|NCT05361772|Colchicine|colchicine|mesh-list
102353979|NCT05361772|Gout Suppressants|gout suppressants|mesh-ancestor
102353980|NCT05361772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102353981|NCT05361772|Tubulin Modulators|tubulin modulators|mesh-ancestor
102353982|NCT05361772|Antimitotic Agents|antimitotic agents|mesh-ancestor
102353983|NCT05361772|Mitosis Modulators|mitosis modulators|mesh-ancestor
102353984|NCT05361772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102353985|NCT05361772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102353986|NCT03031210|Amoxicillin|amoxicillin|mesh-list
102353987|NCT03031210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102353988|NCT03031210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102353989|NCT02958514|Tobramycin|tobramycin|mesh-list
102353990|NCT02958514|Dexamethasone|dexamethasone|mesh-list
102353991|NCT02958514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102353992|NCT02958514|Antiemetics|antiemetics|mesh-ancestor
102353993|NCT02958514|Autonomic Agents|autonomic agents|mesh-ancestor
102353994|NCT02958514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102353995|NCT02958514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102353996|NCT02958514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102353997|NCT02958514|Glucocorticoids|glucocorticoids|mesh-ancestor
102353998|NCT02958514|Hormones|hormones|mesh-ancestor
102353999|NCT02958514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102354000|NCT02958514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102354001|NCT02958514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102354002|NCT02958514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102354003|NCT02958514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102354004|NCT01867021|Vaccines|vaccines|mesh-list
102354005|NCT01867021|Immunologic Factors|immunologic factors|mesh-ancestor
102354006|NCT01867021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354007|NCT01866709|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
102354008|NCT01866709|Chelating Agents|chelating agents|mesh-ancestor
102354009|NCT01866709|Sequestering Agents|sequestering agents|mesh-ancestor
102354010|NCT01866709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354011|NCT01841593|Raltegravir Potassium|raltegravir potassium|mesh-list
102354012|NCT01841593|Amlodipine|amlodipine|mesh-list
102354013|NCT01841593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102354014|NCT01841593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102354015|NCT01841593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102354016|NCT01841593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354017|NCT01841593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102354018|NCT01841593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354019|NCT01841593|Vasodilator Agents|vasodilator agents|mesh-ancestor
102354020|NCT01841593|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102354021|NCT01841593|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102354022|NCT01841593|Antiviral Agents|antiviral agents|mesh-ancestor
102354023|NCT01841593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102354024|NCT01841593|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102354025|NCT01841593|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102354026|NCT01841593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102354027|NCT02454322|Magnesium Sulfate|magnesium sulfate|mesh-list
102354028|NCT02454322|Analgesics|analgesics|mesh-ancestor
102354029|NCT02454322|Sensory System Agents|sensory system agents|mesh-ancestor
102354030|NCT02454322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102354031|NCT02454322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354032|NCT02454322|Anesthetics|anesthetics|mesh-ancestor
102354033|NCT02454322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102354034|NCT02454322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102354035|NCT02454322|Anticonvulsants|anticonvulsants|mesh-ancestor
102354036|NCT02454322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102354037|NCT02454322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102354038|NCT02454322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612270|NCT00002387|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102354039|NCT02454322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102354040|NCT02454322|Tocolytic Agents|tocolytic agents|mesh-ancestor
102354041|NCT02454322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102354042|NCT04505566|Ketorolac|ketorolac|mesh-list
102354043|NCT04505566|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102354044|NCT04505566|Lubricant Eye Drops|lubricant eye drops|mesh-list
102354045|NCT04505566|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102354046|NCT04505566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102354047|NCT04505566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102354048|NCT04505566|Analgesics|analgesics|mesh-ancestor
102354049|NCT04505566|Sensory System Agents|sensory system agents|mesh-ancestor
102354050|NCT04505566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102354051|NCT04505566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354052|NCT04505566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102354053|NCT04505566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102354054|NCT04505566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102354055|NCT04505566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102354056|NCT04505566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354057|NCT05076292|Glucagon|glucagon|mesh-list
102354058|NCT05076292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102354059|NCT05076292|Hormones|hormones|mesh-ancestor
102354060|NCT05076292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102354061|NCT05076292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354062|NCT04789330|Phenylephrine|phenylephrine|mesh-list
102354063|NCT04789330|Oxymetazoline|oxymetazoline|mesh-list
102354064|NCT04789330|Norepinephrine|norepinephrine|mesh-list
102354065|NCT04789330|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102354066|NCT04789330|Mydriatics|mydriatics|mesh-ancestor
102354067|NCT04789330|Autonomic Agents|autonomic agents|mesh-ancestor
102354068|NCT04789330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102354069|NCT04789330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354070|NCT04789330|Sympathomimetics|sympathomimetics|mesh-ancestor
102354071|NCT04789330|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102354072|NCT04789330|Nasal Decongestants|nasal decongestants|mesh-ancestor
102354073|NCT04789330|Respiratory System Agents|respiratory system agents|mesh-ancestor
102354074|NCT04789330|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102354075|NCT04789330|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102354076|NCT04789330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102354077|NCT04789330|Adrenergic Agents|adrenergic agents|mesh-ancestor
102354078|NCT04789330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102354079|NCT04789330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354080|NCT04789330|Protective Agents|protective agents|mesh-ancestor
102354081|NCT02339038|Sofosbuvir|sofosbuvir|mesh-list
102354082|NCT02339038|Ledipasvir|ledipasvir|mesh-list
102354083|NCT02339038|Antiviral Agents|antiviral agents|mesh-ancestor
102354084|NCT02339038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102354085|NCT04497298|Vaccines|vaccines|mesh-list
102354086|NCT04497298|Immunologic Factors|immunologic factors|mesh-ancestor
102354087|NCT04497298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354088|NCT04387786|Albuterol|albuterol|mesh-list
102354089|NCT04387786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102354090|NCT04387786|Autonomic Agents|autonomic agents|mesh-ancestor
102354091|NCT04387786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102354092|NCT04387786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354093|NCT04387786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102354094|NCT04387786|Respiratory System Agents|respiratory system agents|mesh-ancestor
102354095|NCT04387786|Tocolytic Agents|tocolytic agents|mesh-ancestor
102354096|NCT04387786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102354097|NCT04387786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102354098|NCT04387786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102354099|NCT04387786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102354100|NCT04387786|Adrenergic Agents|adrenergic agents|mesh-ancestor
102354101|NCT04387786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102354102|NCT04387786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354103|NCT00569530|Calfactant|calfactant|mesh-list
102354104|NCT00569530|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
102354105|NCT00569530|Respiratory System Agents|respiratory system agents|mesh-ancestor
102354106|NCT04509622|Cytarabine|cytarabine|mesh-list
102354107|NCT04509622|Venetoclax|venetoclax|mesh-list
102354108|NCT04509622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102354109|NCT04509622|Antimetabolites|antimetabolites|mesh-ancestor
102354110|NCT04509622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354111|NCT04509622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102354112|NCT04509622|Antiviral Agents|antiviral agents|mesh-ancestor
102354113|NCT04509622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102354114|NCT04509622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102354115|NCT04509622|Immunologic Factors|immunologic factors|mesh-ancestor
102354116|NCT04509622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354117|NCT00570700|Dasatinib|dasatinib|mesh-list
102354118|NCT00570700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102354119|NCT00570700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102354120|NCT00570700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102354121|NCT00570700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354122|NCT00573508|Solifenacin Succinate|solifenacin succinate|mesh-list
102354123|NCT00573508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102354124|NCT00573508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102354125|NCT00573508|Cholinergic Agents|cholinergic agents|mesh-ancestor
102354126|NCT00573508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102354127|NCT00573508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354128|NCT00573508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354129|NCT00573508|Urological Agents|urological agents|mesh-ancestor
102354130|NCT00574834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102354131|NCT00574834|Ramipril|ramipril|mesh-list
102354132|NCT00574834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102354133|NCT00574834|Diuretics|diuretics|mesh-ancestor
102354134|NCT00574834|Natriuretic Agents|natriuretic agents|mesh-ancestor
102354135|NCT00574834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354136|NCT00574834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102354137|NCT00574834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102354138|NCT00574834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354139|NCT00574834|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102354140|NCT00574834|Protease Inhibitors|protease inhibitors|mesh-ancestor
102354141|NCT00574834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102354142|NCT04259398|Propofol|propofol|mesh-list
102354143|NCT04259398|Sevoflurane|sevoflurane|mesh-list
102354144|NCT04259398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102354145|NCT04259398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102354146|NCT04259398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354147|NCT04259398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102354148|NCT04259398|Anesthetics, General|anesthetics, general|mesh-ancestor
102354149|NCT04259398|Anesthetics|anesthetics|mesh-ancestor
102354150|NCT04259398|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102354151|NCT04259398|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102354152|NCT01592110|Risperidone|risperidone|mesh-list
102354153|NCT01592110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102354154|NCT01592110|Serotonin Agents|serotonin agents|mesh-ancestor
102354155|NCT01592110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102354156|NCT01592110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354157|NCT01592110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354158|NCT01592110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102354159|NCT01592110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102354160|NCT01592110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102354161|NCT01592110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102354162|NCT01592110|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102354163|NCT01592110|Dopamine Agents|dopamine agents|mesh-ancestor
102354164|NCT00578734|Pulmonary Surfactants|pulmonary surfactants|mesh-list
102354165|NCT00578734|Respiratory System Agents|respiratory system agents|mesh-ancestor
102354166|NCT00578968|Tiotropium Bromide|tiotropium bromide|mesh-list
102354167|NCT00578968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102354168|NCT00578968|Autonomic Agents|autonomic agents|mesh-ancestor
102354169|NCT00578968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102354170|NCT00578968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354171|NCT00578968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102354172|NCT00578968|Respiratory System Agents|respiratory system agents|mesh-ancestor
102354173|NCT00578968|Parasympatholytics|parasympatholytics|mesh-ancestor
102354174|NCT00578968|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102354175|NCT00578968|Cholinergic Agents|cholinergic agents|mesh-ancestor
102354176|NCT00578968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102354177|NCT00578968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354178|NCT00579280|Valproic Acid|valproic acid|mesh-list
102354179|NCT00579280|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102354180|NCT00579280|Antidepressive Agents|antidepressive agents|mesh-ancestor
102354181|NCT00579280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102354182|NCT00579280|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102354183|NCT00579280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102354184|NCT00579280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102354185|NCT00579280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354186|NCT00579280|Anticonvulsants|anticonvulsants|mesh-ancestor
102354187|NCT00579280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102354188|NCT00579280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354189|NCT00579280|GABA Agents|gaba agents|mesh-ancestor
102354190|NCT00579280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102354191|NCT00579280|Antimanic Agents|antimanic agents|mesh-ancestor
102354192|NCT00580294|Oxymorphone|oxymorphone|mesh-list
102354193|NCT00580294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102354194|NCT00580294|Narcotics|narcotics|mesh-ancestor
102354195|NCT00580294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102354196|NCT00580294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354197|NCT00580294|Analgesics|analgesics|mesh-ancestor
102354198|NCT00580294|Sensory System Agents|sensory system agents|mesh-ancestor
102354199|NCT00580294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102354200|NCT00580294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102354201|NCT00580372|Cyclophosphamide|cyclophosphamide|mesh-list
102354202|NCT00580372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102354203|NCT00580372|Immunologic Factors|immunologic factors|mesh-ancestor
102354204|NCT00580372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354205|NCT00580372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102354206|NCT00580372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102354207|NCT00580372|Alkylating Agents|alkylating agents|mesh-ancestor
102354208|NCT00580372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354209|NCT00580372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102354210|NCT00580372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102354211|NCT02134210|Etanercept|etanercept|mesh-list
102354212|NCT02134210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102354213|NCT02134210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102354214|NCT02134210|Analgesics|analgesics|mesh-ancestor
102354215|NCT02134210|Sensory System Agents|sensory system agents|mesh-ancestor
102354216|NCT02134210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102354217|NCT02134210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354218|NCT02134210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102354219|NCT02134210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102354220|NCT02134210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102354221|NCT02134210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102354222|NCT02134210|Immunologic Factors|immunologic factors|mesh-ancestor
102354223|NCT00607594|Saracatinib|saracatinib|mesh-list
102354224|NCT00607594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102354225|NCT00607594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102354226|NCT00607594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354227|NCT01866319|Pembrolizumab|pembrolizumab|mesh-list
102354228|NCT01866319|Ipilimumab|ipilimumab|mesh-list
102354229|NCT01866319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102354230|NCT01866319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102354231|NCT01866319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102354232|NCT01866319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354233|NCT00607672|Candesartan|candesartan|mesh-list
102354234|NCT00607672|Candesartan cilexetil|candesartan cilexetil|mesh-list
102354235|NCT00607672|Ramipril|ramipril|mesh-list
102354236|NCT00607672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102354237|NCT00607672|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102354238|NCT00607672|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102354239|NCT00607672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354240|NCT00607672|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102354241|NCT00607672|Protease Inhibitors|protease inhibitors|mesh-ancestor
102354242|NCT00607672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102354243|NCT01802515|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102354244|NCT01802515|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102354245|NCT01802515|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102354246|NCT01802515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102354247|NCT01802515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354248|NCT01802515|Adrenergic Agents|adrenergic agents|mesh-ancestor
102354249|NCT01802515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102354250|NCT01802515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354251|NCT01802437|Fluoxetine|fluoxetine|mesh-list
102354252|NCT01802437|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102354253|NCT01802437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102354254|NCT01802437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102354255|NCT01802437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354256|NCT01802437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102354257|NCT01802437|Serotonin Agents|serotonin agents|mesh-ancestor
102354258|NCT01802437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354259|NCT01802437|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102354260|NCT01802437|Antidepressive Agents|antidepressive agents|mesh-ancestor
102354261|NCT01802437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102354262|NCT01802437|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102354263|NCT01802437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102354264|NCT01802437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102354266|NCT00608062|Ganirelix|ganirelix|mesh-list
102354267|NCT00608062|Estrogens|estrogens|mesh-ancestor
102354268|NCT00608062|Hormones|hormones|mesh-ancestor
102354269|NCT00608062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102354270|NCT00608062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354271|NCT00608062|Hormone Antagonists|hormone antagonists|mesh-ancestor
102354272|NCT02135146|Plasma-lyte 148|plasma-lyte 148|mesh-list
102354273|NCT02135146|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102354274|NCT02135146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102354275|NCT02829268|Dantrolene|dantrolene|mesh-list
102354276|NCT02829268|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102354277|NCT02829268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354278|NCT02829268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102354279|NCT02829268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102354280|NCT02202772|Cisplatin|cisplatin|mesh-list
102354281|NCT02202772|Gemcitabine|gemcitabine|mesh-list
102354282|NCT02202772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102354283|NCT02202772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102354284|NCT02202772|Antimetabolites|antimetabolites|mesh-ancestor
102354285|NCT02202772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354286|NCT00582400|Arsenic Trioxide|arsenic trioxide|mesh-list
102354287|NCT00582400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102354288|NCT01801735|Meloxicam|meloxicam|mesh-list
102354289|NCT01801735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102354290|NCT01801735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102354291|NCT01801735|Analgesics|analgesics|mesh-ancestor
102354292|NCT01801735|Sensory System Agents|sensory system agents|mesh-ancestor
102354293|NCT01801735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102354294|NCT01801735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354295|NCT01801735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102354296|NCT01801735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102354297|NCT01801735|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102354298|NCT01801735|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102354299|NCT01801735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102354300|NCT01801735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354301|NCT00612430|Bevacizumab|bevacizumab|mesh-list
102354302|NCT00612430|Etoposide|etoposide|mesh-list
102354303|NCT00612430|Etoposide phosphate|etoposide phosphate|mesh-list
102354304|NCT00612430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102354305|NCT00612430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102354306|NCT00612430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102354307|NCT00612430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102354308|NCT00612430|Growth Substances|growth substances|mesh-ancestor
102354309|NCT00612430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354310|NCT00612430|Growth Inhibitors|growth inhibitors|mesh-ancestor
102354311|NCT00612430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102354312|NCT00612430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102354313|NCT00612430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102354314|NCT00612430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102354315|NCT00612430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354316|NCT01571128|Tenofovir|tenofovir|mesh-list
102354317|NCT01571128|Emtricitabine|emtricitabine|mesh-list
102354318|NCT01571128|Antiviral Agents|antiviral agents|mesh-ancestor
102354319|NCT01571128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102354320|NCT01571128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102354321|NCT01571128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102354322|NCT01571128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102354323|NCT01571128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354324|NCT01571128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102354325|NCT01571128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102354326|NCT00614458|Raltegravir Potassium|raltegravir potassium|mesh-list
102354327|NCT00614458|Valproic Acid|valproic acid|mesh-list
102354328|NCT00614458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102354329|NCT00614458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102354330|NCT00614458|Antiviral Agents|antiviral agents|mesh-ancestor
102354331|NCT00614458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102354332|NCT00614458|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102354333|NCT00614458|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102354334|NCT00614458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102354335|NCT00614458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354336|NCT00614458|Anticonvulsants|anticonvulsants|mesh-ancestor
102354337|NCT00614458|GABA Agents|gaba agents|mesh-ancestor
102354338|NCT00614458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102354339|NCT00614458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354340|NCT00614458|Antimanic Agents|antimanic agents|mesh-ancestor
102354341|NCT00614458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102354342|NCT00614458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102354343|NCT00614458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102354344|NCT01429168|Etoricoxib|etoricoxib|mesh-list
102354345|NCT01429168|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102354346|NCT01429168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102354347|NCT01429168|Analgesics|analgesics|mesh-ancestor
102354348|NCT01429168|Sensory System Agents|sensory system agents|mesh-ancestor
102354349|NCT01429168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102354350|NCT01429168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354351|NCT01429168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102354352|NCT01429168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102354353|NCT01429168|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102354354|NCT01429168|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102354355|NCT01429168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102354356|NCT01429168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354357|NCT00771160|Montelukast|montelukast|mesh-list
102354358|NCT00771160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102354359|NCT00771160|Respiratory System Agents|respiratory system agents|mesh-ancestor
102354360|NCT00771160|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102354361|NCT00771160|Hormone Antagonists|hormone antagonists|mesh-ancestor
102354362|NCT00771160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102354363|NCT00771160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354364|NCT00771160|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102354365|NCT00771160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102354366|NCT00771160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354367|NCT00756418|Theophylline|theophylline|mesh-list
102354368|NCT00756418|Montelukast|montelukast|mesh-list
102354369|NCT00756418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102354370|NCT00756418|Respiratory System Agents|respiratory system agents|mesh-ancestor
102354371|NCT00756418|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102354372|NCT00756418|Hormone Antagonists|hormone antagonists|mesh-ancestor
102354373|NCT00756418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102354374|NCT00756418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354375|NCT00756418|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102354376|NCT00756418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102354377|NCT00756418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354378|NCT00756418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102354379|NCT00756418|Autonomic Agents|autonomic agents|mesh-ancestor
102354380|NCT00756418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102354381|NCT00756418|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102354382|NCT00756418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102354383|NCT00756418|Vasodilator Agents|vasodilator agents|mesh-ancestor
102354384|NCT00756418|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102354385|NCT00756418|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102347355|NCT00670358|Prednisone|prednisone|mesh-list
102354386|NCT00756418|Purinergic Agents|purinergic agents|mesh-ancestor
102354387|NCT00756418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102354388|NCT00615472|Remifentanil|remifentanil|mesh-list
102354389|NCT00615472|Propofol|propofol|mesh-list
102354390|NCT00615472|Isoflurane|isoflurane|mesh-list
102354391|NCT00615472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102354392|NCT00615472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102354393|NCT00615472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354394|NCT00615472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102354395|NCT00615472|Anesthetics, General|anesthetics, general|mesh-ancestor
102354396|NCT00615472|Anesthetics|anesthetics|mesh-ancestor
102354397|NCT00615472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102354398|NCT00615472|Narcotics|narcotics|mesh-ancestor
102354399|NCT00615472|Analgesics|analgesics|mesh-ancestor
102354400|NCT00615472|Sensory System Agents|sensory system agents|mesh-ancestor
102354401|NCT00615472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102354402|NCT00615472|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102354403|NCT00615784|Bexarotene|bexarotene|mesh-list
102354404|NCT00615784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102354405|NCT00755794|Montelukast|montelukast|mesh-list
102354406|NCT00755794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102354407|NCT00755794|Respiratory System Agents|respiratory system agents|mesh-ancestor
102354408|NCT00755794|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102354409|NCT00755794|Hormone Antagonists|hormone antagonists|mesh-ancestor
102612271|NCT00002387|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102354410|NCT00755794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102354411|NCT00755794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354412|NCT00755794|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102354413|NCT00755794|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102354414|NCT00755794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354415|NCT00652444|Simvastatin|simvastatin|mesh-list
102354416|NCT00652444|Ezetimibe|ezetimibe|mesh-list
102354417|NCT00652444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102354418|NCT00652444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102354419|NCT00652444|Antimetabolites|antimetabolites|mesh-ancestor
102354420|NCT00652444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354421|NCT00652444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102354422|NCT00652444|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102354423|NCT00652444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102354424|NCT00585910|Methylphenidate|methylphenidate|mesh-list
102354425|NCT00585910|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102354426|NCT00585910|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102354427|NCT00585910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354428|NCT00585910|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102354429|NCT00585910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102354430|NCT00585910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102354431|NCT00585910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354432|NCT00585910|Dopamine Agents|dopamine agents|mesh-ancestor
102354433|NCT00585910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102354434|NCT00585910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102354435|NCT00585910|Adrenergic Agents|adrenergic agents|mesh-ancestor
102354436|NCT00489346|Fluticasone|fluticasone|mesh-list
102354437|NCT00489346|Xhance|xhance|mesh-list
102354438|NCT00489346|Montelukast|montelukast|mesh-list
102354439|NCT00489346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102354440|NCT00489346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102354441|NCT00489346|Autonomic Agents|autonomic agents|mesh-ancestor
102354442|NCT00489346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102354443|NCT00489346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354444|NCT00489346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102354445|NCT00489346|Respiratory System Agents|respiratory system agents|mesh-ancestor
102354446|NCT00489346|Dermatologic Agents|dermatologic agents|mesh-ancestor
102354447|NCT00489346|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102354448|NCT00489346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354449|NCT00489346|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102354450|NCT00489346|Hormone Antagonists|hormone antagonists|mesh-ancestor
102354451|NCT00489346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102354452|NCT00489346|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102354453|NCT00489346|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102354454|NCT00617188|Fulvestrant|fulvestrant|mesh-list
102354455|NCT00617188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102354456|NCT00617188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102354457|NCT00617188|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102354458|NCT00617188|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102354459|NCT00617188|Hormone Antagonists|hormone antagonists|mesh-ancestor
102354460|NCT00617188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102354461|NCT00617188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354462|NCT00618436|Phenytoin|phenytoin|mesh-list
102354463|NCT00618436|Levetiracetam|levetiracetam|mesh-list
102354464|NCT00618436|Anticonvulsants|anticonvulsants|mesh-ancestor
102354465|NCT00618436|Nootropic Agents|nootropic agents|mesh-ancestor
102354466|NCT00618436|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102354467|NCT00618436|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102354468|NCT00618436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102354469|NCT00618436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354470|NCT00618436|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102354471|NCT00618436|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102354472|NCT00619060|Niacin|niacin|mesh-list
102354473|NCT00619060|Nicotinic Acids|nicotinic acids|mesh-list
102354474|NCT00619060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102354475|NCT00619060|Antimetabolites|antimetabolites|mesh-ancestor
102354476|NCT00619060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354477|NCT00619060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102354478|NCT00619060|Vasodilator Agents|vasodilator agents|mesh-ancestor
102354479|NCT00619060|Vitamin B Complex|vitamin b complex|mesh-ancestor
102354480|NCT00619060|Vitamins|vitamins|mesh-ancestor
102166172|NCT03993717|Vaccines|vaccines|mesh-list
102354481|NCT00619060|Micronutrients|micronutrients|mesh-ancestor
102354482|NCT00619060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354483|NCT05247424|Heparin|heparin|mesh-list
102354484|NCT05247424|Calcium heparin|calcium heparin|mesh-list
102354485|NCT05247424|Anticoagulants|anticoagulants|mesh-ancestor
102354486|NCT05247424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102354487|NCT05247424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102354488|NCT05247424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354489|NCT00092716|Atorvastatin|atorvastatin|mesh-list
102354490|NCT00092716|Ezetimibe|ezetimibe|mesh-list
102354491|NCT00092716|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102354492|NCT00092716|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102354493|NCT00092716|Antimetabolites|antimetabolites|mesh-ancestor
102354494|NCT00092716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354495|NCT00092716|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102354496|NCT00092716|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102354497|NCT00092716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102354498|NCT00619684|Lenalidomide|lenalidomide|mesh-list
102354499|NCT00619684|Immunologic Factors|immunologic factors|mesh-ancestor
102354500|NCT00619684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354501|NCT00619684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102354502|NCT00619684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102354503|NCT00619684|Growth Substances|growth substances|mesh-ancestor
102354504|NCT00619684|Growth Inhibitors|growth inhibitors|mesh-ancestor
102354505|NCT00619684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102354506|NCT00588406|Prednisone|prednisone|mesh-list
102354507|NCT00588406|Budesonide|budesonide|mesh-list
102354508|NCT00588406|Bromides|bromides|mesh-list
102354509|NCT00588406|Albuterol|albuterol|mesh-list
102354510|NCT00588406|Ipratropium|ipratropium|mesh-list
102354511|NCT00588406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102354512|NCT00588406|Glucocorticoids|glucocorticoids|mesh-ancestor
102354513|NCT00588406|Hormones|hormones|mesh-ancestor
102354514|NCT00588406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102354515|NCT00588406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354516|NCT00588406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102354517|NCT00588406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102354518|NCT00588406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102354519|NCT00588406|Autonomic Agents|autonomic agents|mesh-ancestor
102354520|NCT00588406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102354521|NCT00588406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102354522|NCT00588406|Respiratory System Agents|respiratory system agents|mesh-ancestor
102354523|NCT00588406|Anticonvulsants|anticonvulsants|mesh-ancestor
102354524|NCT00588406|Tocolytic Agents|tocolytic agents|mesh-ancestor
102354525|NCT00588406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102354526|NCT00588406|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102354527|NCT00588406|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102354528|NCT00588406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102354529|NCT00588406|Adrenergic Agents|adrenergic agents|mesh-ancestor
102354530|NCT00588406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102354531|NCT00588406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354532|NCT00588406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102354533|NCT00588406|Cholinergic Agents|cholinergic agents|mesh-ancestor
102354534|NCT00668434|Prednisone|prednisone|mesh-list
102354535|NCT00668434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102354536|NCT00668434|Glucocorticoids|glucocorticoids|mesh-ancestor
102354537|NCT00668434|Hormones|hormones|mesh-ancestor
102354538|NCT00668434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102354539|NCT00668434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354540|NCT00668434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102354541|NCT00668434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102354542|NCT00668902|Pantoprazole|pantoprazole|mesh-list
102354543|NCT00668902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102354544|NCT00668902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102354545|NCT00668902|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102354546|NCT00668902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102354547|NCT00668902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354548|NCT00589888|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102354549|NCT00589888|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102354550|NCT00589888|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102354551|NCT00589888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102354552|NCT00621946|Dexetimide|dexetimide|mesh-list
102354553|NCT00621946|Citalopram|citalopram|mesh-list
102354554|NCT00621946|Escitalopram|escitalopram|mesh-list
102354555|NCT00621946|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102354556|NCT00621946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102354557|NCT00621946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102354558|NCT00621946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354559|NCT00621946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102354560|NCT00621946|Serotonin Agents|serotonin agents|mesh-ancestor
102354561|NCT00621946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354562|NCT00621946|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102354563|NCT00621946|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102354564|NCT00621946|Parasympatholytics|parasympatholytics|mesh-ancestor
102354565|NCT00621946|Autonomic Agents|autonomic agents|mesh-ancestor
102354566|NCT00621946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102354567|NCT00621946|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102354568|NCT00621946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102354569|NCT00621946|Cholinergic Agents|cholinergic agents|mesh-ancestor
102354570|NCT00621946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102354571|NCT00621946|Antidepressive Agents|antidepressive agents|mesh-ancestor
102354572|NCT00621946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102354574|NCT02139358|Trastuzumab|trastuzumab|mesh-list
102354575|NCT02139358|Pertuzumab|pertuzumab|mesh-list
102354576|NCT02139358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102354577|NCT02139358|Antimetabolites|antimetabolites|mesh-ancestor
102354578|NCT02139358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354579|NCT02139358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102354580|NCT02139358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102354581|NCT02140372|Colchicine|colchicine|mesh-list
102354582|NCT02140372|Gout Suppressants|gout suppressants|mesh-ancestor
102354583|NCT02140372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102354584|NCT02140372|Tubulin Modulators|tubulin modulators|mesh-ancestor
102354585|NCT02140372|Antimitotic Agents|antimitotic agents|mesh-ancestor
102354586|NCT02140372|Mitosis Modulators|mitosis modulators|mesh-ancestor
102354587|NCT02140372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354588|NCT02140372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102354589|NCT00670774|Eculizumab|eculizumab|mesh-list
102354590|NCT00670774|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102354591|NCT00670774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102354592|NCT00670774|Immunologic Factors|immunologic factors|mesh-ancestor
102354593|NCT00670774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354594|NCT00672100|Ropivacaine|ropivacaine|mesh-list
102354595|NCT00672100|Anesthetics, Local|anesthetics, local|mesh-ancestor
102354596|NCT00672100|Anesthetics|anesthetics|mesh-ancestor
101886256|NCT05498155|Olaparib|olaparib|mesh-list
102354597|NCT00672100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102354598|NCT00672100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354599|NCT00672100|Sensory System Agents|sensory system agents|mesh-ancestor
102354600|NCT00672100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102354601|NCT00593866|Gemcitabine|gemcitabine|mesh-list
102354602|NCT00593866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102354603|NCT00593866|Antimetabolites|antimetabolites|mesh-ancestor
102354604|NCT00593866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354605|NCT00593866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102354606|NCT00624910|Bupivacaine|bupivacaine|mesh-list
102354607|NCT00624910|Anesthetics, Local|anesthetics, local|mesh-ancestor
102354608|NCT00624910|Anesthetics|anesthetics|mesh-ancestor
102354609|NCT00624910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102354610|NCT00624910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354611|NCT00624910|Sensory System Agents|sensory system agents|mesh-ancestor
102354612|NCT00624910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102354613|NCT00626626|Alemtuzumab|alemtuzumab|mesh-list
102354614|NCT00626626|Clofarabine|clofarabine|mesh-list
102354615|NCT00626626|Cyclophosphamide|cyclophosphamide|mesh-list
102354616|NCT00626626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102354617|NCT00626626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102354618|NCT00626626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102354619|NCT00626626|Antimetabolites|antimetabolites|mesh-ancestor
102354620|NCT00626626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354621|NCT00626626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102354622|NCT00626626|Immunologic Factors|immunologic factors|mesh-ancestor
102354623|NCT00626626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354624|NCT00626626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102354625|NCT00626626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102354626|NCT00626626|Alkylating Agents|alkylating agents|mesh-ancestor
102354627|NCT00626626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102354628|NCT00626782|Ranibizumab|ranibizumab|mesh-list
102354629|NCT00626782|Mitomycins|mitomycins|mesh-list
102166322|NCT02465866|Dermatologic Agents|dermatologic agents|mesh-ancestor
102354630|NCT00626782|Mitomycin|mitomycin|mesh-list
102354632|NCT00626782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102354633|NCT00626782|Growth Substances|growth substances|mesh-ancestor
102354634|NCT00626782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354635|NCT00626782|Growth Inhibitors|growth inhibitors|mesh-ancestor
102354636|NCT00626782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102354637|NCT00626782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102354638|NCT00626782|Alkylating Agents|alkylating agents|mesh-ancestor
102354639|NCT00626782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354640|NCT00626782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102354641|NCT00626782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102354642|NCT00594256|Sodium Oxybate|sodium oxybate|mesh-list
102354643|NCT00594256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102354644|NCT00594256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102354645|NCT00594256|Anesthetics, General|anesthetics, general|mesh-ancestor
102354646|NCT00594256|Anesthetics|anesthetics|mesh-ancestor
102354647|NCT00594256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102354648|NCT00594256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354649|NCT00627406|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102354650|NCT00627406|Buserelin|buserelin|mesh-list
102354651|NCT00627406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102354652|NCT00627406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354653|NCT00627406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102354654|NCT00627406|Fertility Agents|fertility agents|mesh-ancestor
102354655|NCT00673738|Docetaxel|docetaxel|mesh-list
102354656|NCT00673738|Cetuximab|cetuximab|mesh-list
102354657|NCT00673738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102354658|NCT00673738|Tubulin Modulators|tubulin modulators|mesh-ancestor
102354659|NCT00673738|Antimitotic Agents|antimitotic agents|mesh-ancestor
102354660|NCT00673738|Mitosis Modulators|mitosis modulators|mesh-ancestor
102354661|NCT00673738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354662|NCT00673738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102354663|NCT00674206|Gemcitabine|gemcitabine|mesh-list
102354664|NCT00674206|Oxaliplatin|oxaliplatin|mesh-list
102354665|NCT00674206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102354666|NCT00674206|Antimetabolites|antimetabolites|mesh-ancestor
102354667|NCT00674206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354668|NCT00674206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102354669|NCT00595270|Vaccines|vaccines|mesh-list
102354670|NCT00595270|Immunologic Factors|immunologic factors|mesh-ancestor
102354671|NCT00595270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354672|NCT00628498|Defibrotide|defibrotide|mesh-list
102354673|NCT00628498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102354674|NCT00628498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102354675|NCT00628498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354676|NCT00628498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102354677|NCT00629122|Clotrimazole|clotrimazole|mesh-list
102354678|NCT00629122|Miconazole|miconazole|mesh-list
102354679|NCT00629122|Nystatin|nystatin|mesh-list
102354680|NCT00629122|Tacrolimus|tacrolimus|mesh-list
102354681|NCT00629122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102354682|NCT00629122|Immunologic Factors|immunologic factors|mesh-ancestor
102354683|NCT00629122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354684|NCT00629122|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102354685|NCT00629122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102354686|NCT00629122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354687|NCT00629122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102354688|NCT00629122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102354689|NCT00629122|Antifungal Agents|antifungal agents|mesh-ancestor
102354690|NCT00629122|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102354691|NCT00629122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102354692|NCT00629122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102354693|NCT00629122|Hormone Antagonists|hormone antagonists|mesh-ancestor
102354694|NCT00629122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102354695|NCT00629122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102354696|NCT00629122|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102354697|NCT00629122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102354698|NCT00629122|Ionophores|ionophores|mesh-ancestor
102354699|NCT00629122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102354700|NCT00596440|Nicotine|nicotine|mesh-list
102354701|NCT00596440|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102354702|NCT00596440|Autonomic Agents|autonomic agents|mesh-ancestor
102354703|NCT00596440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102166398|NCT03555487|Nootropic Agents|nootropic agents|mesh-ancestor
102354704|NCT00596440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354705|NCT00596440|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102354706|NCT00596440|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102354707|NCT00596440|Cholinergic Agents|cholinergic agents|mesh-ancestor
102354708|NCT00596440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102354709|NCT00596440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354710|NCT00632632|Cycloserine|cycloserine|mesh-list
102354711|NCT00632632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102354712|NCT00632632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102354713|NCT00632632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102354714|NCT00632632|Antitubercular Agents|antitubercular agents|mesh-ancestor
102354715|NCT00632632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102354716|NCT00632632|Antimetabolites|antimetabolites|mesh-ancestor
102354717|NCT00632632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354718|NCT00633256|Isoniazid|isoniazid|mesh-list
102354719|NCT00633256|Cycloserine|cycloserine|mesh-list
102354720|NCT00633256|Antitubercular Agents|antitubercular agents|mesh-ancestor
102354721|NCT00633256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102354722|NCT00633256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102354723|NCT00633256|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102354724|NCT00633256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102354725|NCT00633256|Antimetabolites|antimetabolites|mesh-ancestor
102354726|NCT00633256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354727|NCT00633256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102354728|NCT00633256|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102354729|NCT00633256|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102354730|NCT00634270|Sirolimus|sirolimus|mesh-list
102354731|NCT00634270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102354732|NCT00634270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102354733|NCT00634270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102354734|NCT00634270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102354735|NCT00634270|Antifungal Agents|antifungal agents|mesh-ancestor
102354736|NCT00634270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102354737|NCT00634270|Immunologic Factors|immunologic factors|mesh-ancestor
102354738|NCT00634270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354739|NCT00678418|Naltrexone|naltrexone|mesh-list
102354740|NCT00678418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102354741|NCT00678418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102354742|NCT00678418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354743|NCT00678418|Sensory System Agents|sensory system agents|mesh-ancestor
102354744|NCT00678418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102354745|NCT00600340|Paclitaxel|paclitaxel|mesh-list
102354746|NCT00600340|Bevacizumab|bevacizumab|mesh-list
102354747|NCT00600340|Capecitabine|capecitabine|mesh-list
102354748|NCT00600340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102354749|NCT00600340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102354750|NCT00600340|Tubulin Modulators|tubulin modulators|mesh-ancestor
102354751|NCT00600340|Antimitotic Agents|antimitotic agents|mesh-ancestor
102354752|NCT00600340|Mitosis Modulators|mitosis modulators|mesh-ancestor
102354753|NCT00600340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354754|NCT00600340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102354755|NCT00600340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102354756|NCT00600340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102354757|NCT00600340|Growth Substances|growth substances|mesh-ancestor
102354758|NCT00600340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354759|NCT00600340|Growth Inhibitors|growth inhibitors|mesh-ancestor
102354760|NCT00600340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102354761|NCT00600340|Antimetabolites|antimetabolites|mesh-ancestor
102354762|NCT01799356|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102354763|NCT01799356|Moxifloxacin|moxifloxacin|mesh-list
102354764|NCT01799356|Metronidazole|metronidazole|mesh-list
102354765|NCT01799356|Ofloxacin|ofloxacin|mesh-list
102354766|NCT01799356|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102354767|NCT01799356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102354768|NCT01799356|Antitubercular Agents|antitubercular agents|mesh-ancestor
102354769|NCT01799356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102354770|NCT01799356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102354771|NCT01799356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102354772|NCT01799356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354773|NCT01799356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102354774|NCT01799356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102354775|NCT01799356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102354776|NCT01799356|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102354777|NCT01799356|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102354778|NCT01799356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102354779|NCT00602290|Methylphenidate|methylphenidate|mesh-list
102354781|NCT00602290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102354782|NCT00602290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354783|NCT00602290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102354784|NCT00602290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102354785|NCT00602290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102354786|NCT00602290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354787|NCT00602290|Dopamine Agents|dopamine agents|mesh-ancestor
102354788|NCT00602290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102354789|NCT00602290|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102354790|NCT00602290|Serotonin Agents|serotonin agents|mesh-ancestor
102354791|NCT00602290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102354792|NCT00602290|Antidepressive Agents|antidepressive agents|mesh-ancestor
102354793|NCT00602290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102354794|NCT00637780|Sulfasalazine|sulfasalazine|mesh-list
102354795|NCT00637780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102354796|NCT00637780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102354797|NCT00637780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102354798|NCT00637780|Analgesics|analgesics|mesh-ancestor
102354799|NCT00637780|Sensory System Agents|sensory system agents|mesh-ancestor
102354800|NCT00637780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102354801|NCT00637780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354802|NCT00637780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102354803|NCT00637780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102354804|NCT00637780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102354805|NCT01799902|Solifenacin Succinate|solifenacin succinate|mesh-list
102354806|NCT01799902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102354807|NCT01799902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102354808|NCT01799902|Cholinergic Agents|cholinergic agents|mesh-ancestor
102354809|NCT01799902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102354810|NCT01799902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354811|NCT01799902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354812|NCT01799902|Urological Agents|urological agents|mesh-ancestor
102354813|NCT00602446|Deferasirox|deferasirox|mesh-list
102354814|NCT00602446|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102354815|NCT00602446|Chelating Agents|chelating agents|mesh-ancestor
102354816|NCT00602446|Sequestering Agents|sequestering agents|mesh-ancestor
102354817|NCT00602446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354818|NCT00602836|Cyclophosphamide|cyclophosphamide|mesh-list
102354819|NCT00602836|Rituximab|rituximab|mesh-list
102354820|NCT00602836|Lenalidomide|lenalidomide|mesh-list
102354821|NCT00602836|Pentostatin|pentostatin|mesh-list
102354822|NCT00602836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102354823|NCT00602836|Immunologic Factors|immunologic factors|mesh-ancestor
102354824|NCT00602836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354825|NCT00602836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102354826|NCT00602836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102354827|NCT00602836|Alkylating Agents|alkylating agents|mesh-ancestor
102354828|NCT00602836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354829|NCT00602836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102354830|NCT00602836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102354831|NCT00602836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102354832|NCT00602836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102354833|NCT00602836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102354834|NCT00602836|Growth Substances|growth substances|mesh-ancestor
102354835|NCT00602836|Growth Inhibitors|growth inhibitors|mesh-ancestor
102354836|NCT00602836|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
102354837|NCT00602836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102354838|NCT00683332|Tigecycline|tigecycline|mesh-list
102354839|NCT00683332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102354840|NCT00683332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102354841|NCT00683332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102354842|NCT00683332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102354843|NCT00683332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354844|NCT00683410|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102354845|NCT00683410|Immunologic Factors|immunologic factors|mesh-ancestor
102354846|NCT00683410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354847|NCT00640822|Calcitriol|calcitriol|mesh-list
102354848|NCT00640822|Hydrocortisone|hydrocortisone|mesh-list
102354849|NCT00640822|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102354850|NCT00640822|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102354851|NCT00640822|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102354852|NCT00640822|1 alpha,24-dihydroxyvitamin D3|1 alpha,24-dihydroxyvitamin d3|mesh-list
102354853|NCT00640822|Calcipotriene|calcipotriene|mesh-list
102354854|NCT00640822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102354855|NCT00640822|Dermatologic Agents|dermatologic agents|mesh-ancestor
102354856|NCT00640822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102354857|NCT00640822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354858|NCT00640822|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102354859|NCT00640822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102354860|NCT00640822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354861|NCT00640822|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102354862|NCT00640822|Vitamins|vitamins|mesh-ancestor
102354863|NCT00640822|Micronutrients|micronutrients|mesh-ancestor
102354864|NCT00640822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102354865|NCT00640978|Everolimus|everolimus|mesh-list
102354866|NCT00640978|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102354867|NCT00640978|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102354868|NCT00640978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102354869|NCT00640978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102354870|NCT00640978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354871|NCT00640978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102354872|NCT00640978|Immunologic Factors|immunologic factors|mesh-ancestor
102354873|NCT00640978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354874|NCT00640978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102354875|NCT00642694|Dexetimide|dexetimide|mesh-list
102354876|NCT00642694|Citalopram|citalopram|mesh-list
102354877|NCT00642694|Escitalopram|escitalopram|mesh-list
102354878|NCT00642694|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102354879|NCT00642694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102354880|NCT00642694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102354881|NCT00642694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354882|NCT00642694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102354883|NCT00642694|Serotonin Agents|serotonin agents|mesh-ancestor
102354884|NCT00642694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354885|NCT00642694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102354886|NCT00642694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102354887|NCT00642694|Parasympatholytics|parasympatholytics|mesh-ancestor
102354888|NCT00642694|Autonomic Agents|autonomic agents|mesh-ancestor
102354889|NCT00642694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102354890|NCT00642694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102354891|NCT00642694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102354892|NCT00642694|Cholinergic Agents|cholinergic agents|mesh-ancestor
102354893|NCT00642694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102354894|NCT00642694|Antidepressive Agents|antidepressive agents|mesh-ancestor
102354895|NCT00642694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102354896|NCT00705874|Leucovorin|leucovorin|mesh-list
102354897|NCT00705874|Bevacizumab|bevacizumab|mesh-list
102354898|NCT00705874|Sunitinib|sunitinib|mesh-list
102354899|NCT00705874|Gemcitabine|gemcitabine|mesh-list
102354900|NCT00705874|Docetaxel|docetaxel|mesh-list
102354901|NCT00705874|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102354902|NCT00705874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102354903|NCT00705874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102354904|NCT00705874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102354905|NCT00705874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102354906|NCT00705874|Growth Substances|growth substances|mesh-ancestor
102354907|NCT00705874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354908|NCT00705874|Growth Inhibitors|growth inhibitors|mesh-ancestor
102354909|NCT00705874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102354910|NCT00705874|Antimetabolites|antimetabolites|mesh-ancestor
102354911|NCT00705874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354912|NCT00705874|Tubulin Modulators|tubulin modulators|mesh-ancestor
102354913|NCT00705874|Antimitotic Agents|antimitotic agents|mesh-ancestor
102354914|NCT00705874|Mitosis Modulators|mitosis modulators|mesh-ancestor
102354915|NCT00705874|Antidotes|antidotes|mesh-ancestor
102354916|NCT00705874|Protective Agents|protective agents|mesh-ancestor
102354917|NCT00705874|Vitamin B Complex|vitamin b complex|mesh-ancestor
102354918|NCT00705874|Vitamins|vitamins|mesh-ancestor
102354919|NCT00705874|Micronutrients|micronutrients|mesh-ancestor
102354920|NCT00705874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102354921|NCT00705874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102354922|NCT00647998|Darbepoetin alfa|darbepoetin alfa|mesh-list
102354923|NCT00647998|Hematinics|hematinics|mesh-ancestor
102354924|NCT00649792|4-Aminopyridine|4-aminopyridine|mesh-list
102354925|NCT00649792|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102354926|NCT00649792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102354927|NCT00649792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354928|NCT00687076|Aspirin|aspirin|mesh-list
102354929|NCT00687076|Niacin|niacin|mesh-list
102354930|NCT00687076|Nicotinic Acids|nicotinic acids|mesh-list
102354931|NCT00687076|Clopidogrel|clopidogrel|mesh-list
102354932|NCT00687076|Ezetimibe|ezetimibe|mesh-list
102354933|NCT00687076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102354934|NCT00687076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102354935|NCT00687076|Analgesics|analgesics|mesh-ancestor
102354936|NCT00687076|Sensory System Agents|sensory system agents|mesh-ancestor
102354937|NCT00687076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102354938|NCT00687076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354939|NCT00687076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102354940|NCT00687076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102354941|NCT00687076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102354942|NCT00687076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102354943|NCT00687076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354944|NCT00687076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102354945|NCT00687076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102354946|NCT00687076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102354947|NCT00687076|Antipyretics|antipyretics|mesh-ancestor
102354948|NCT00687076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102354949|NCT00687076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102354950|NCT00687076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102354951|NCT00687076|Purinergic Agents|purinergic agents|mesh-ancestor
102354952|NCT00687076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102354953|NCT00687076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102354954|NCT00687076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102354955|NCT00687076|Antimetabolites|antimetabolites|mesh-ancestor
102354956|NCT00687076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102354957|NCT00687076|Vasodilator Agents|vasodilator agents|mesh-ancestor
102354958|NCT00687076|Vitamin B Complex|vitamin b complex|mesh-ancestor
102354959|NCT00687076|Vitamins|vitamins|mesh-ancestor
102354960|NCT00687076|Micronutrients|micronutrients|mesh-ancestor
102354961|NCT00687544|Ribavirin|ribavirin|mesh-list
102354962|NCT00687544|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102354963|NCT00687544|Antimetabolites|antimetabolites|mesh-ancestor
102354964|NCT00687544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354965|NCT00687544|Antiviral Agents|antiviral agents|mesh-ancestor
102354966|NCT00687544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102354967|NCT02143648|Nalbuphine|nalbuphine|mesh-list
102354968|NCT02143648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102354969|NCT02143648|Narcotics|narcotics|mesh-ancestor
102354970|NCT02143648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102354971|NCT02143648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354972|NCT02143648|Analgesics|analgesics|mesh-ancestor
102354973|NCT02143648|Sensory System Agents|sensory system agents|mesh-ancestor
102354974|NCT02143648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102354975|NCT02997982|Valacyclovir|valacyclovir|mesh-list
102354976|NCT02997982|Antiviral Agents|antiviral agents|mesh-ancestor
102354977|NCT02997982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102354978|NCT00689572|Ondansetron|ondansetron|mesh-list
102354979|NCT00689572|Antiemetics|antiemetics|mesh-ancestor
102354980|NCT00689572|Autonomic Agents|autonomic agents|mesh-ancestor
102354981|NCT00689572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102354982|NCT00689572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102354983|NCT00689572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102354984|NCT00689572|Antipruritics|antipruritics|mesh-ancestor
102354985|NCT00689572|Dermatologic Agents|dermatologic agents|mesh-ancestor
102354986|NCT00689572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102354987|NCT00689572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102354988|NCT00689572|Serotonin Agents|serotonin agents|mesh-ancestor
102354989|NCT00689572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102354990|NCT00689572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102354991|NCT01840579|Paclitaxel|paclitaxel|mesh-list
102354992|NCT01840579|Etoposide|etoposide|mesh-list
102354993|NCT01840579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102354994|NCT01840579|Carboplatin|carboplatin|mesh-list
102354995|NCT01840579|Pembrolizumab|pembrolizumab|mesh-list
102354996|NCT01840579|Pemetrexed|pemetrexed|mesh-list
102354997|NCT01840579|Ipilimumab|ipilimumab|mesh-list
102354998|NCT01840579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102354999|NCT01840579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102355000|NCT01840579|Tubulin Modulators|tubulin modulators|mesh-ancestor
102355001|NCT01840579|Antimitotic Agents|antimitotic agents|mesh-ancestor
102355002|NCT01840579|Mitosis Modulators|mitosis modulators|mesh-ancestor
102347392|NCT00569127|Bevacizumab|bevacizumab|mesh-list
102355003|NCT01840579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355004|NCT01840579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102355005|NCT01840579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102355006|NCT01840579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102355007|NCT01840579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102355008|NCT01840579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102355009|NCT01840579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102355010|NCT01840579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102355011|NCT00651040|Prednisone|prednisone|mesh-list
102355012|NCT00651040|Prednisolone|prednisolone|mesh-list
102355013|NCT00651040|Methotrexate|methotrexate|mesh-list
102355014|NCT00651040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102355015|NCT00651040|Glucocorticoids|glucocorticoids|mesh-ancestor
102355016|NCT00651040|Hormones|hormones|mesh-ancestor
102355017|NCT00651040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102355018|NCT00651040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355019|NCT00651040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102355020|NCT00651040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102355021|NCT00651040|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102355022|NCT00651040|Abortifacient Agents|abortifacient agents|mesh-ancestor
102355023|NCT00651040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102355024|NCT00651040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102355025|NCT00651040|Antimetabolites|antimetabolites|mesh-ancestor
102355026|NCT00651040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355027|NCT00651040|Dermatologic Agents|dermatologic agents|mesh-ancestor
102355028|NCT00651040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102355029|NCT00651040|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102355030|NCT00651040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102355031|NCT00651040|Immunologic Factors|immunologic factors|mesh-ancestor
102355032|NCT00651040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102355033|NCT00651040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102355034|NCT00654784|Idebenone|idebenone|mesh-list
102355035|NCT00654784|Antioxidants|antioxidants|mesh-ancestor
102355036|NCT00654784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355037|NCT00654784|Protective Agents|protective agents|mesh-ancestor
102355038|NCT00654784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355039|NCT02997514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102355040|NCT01801111|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102355041|NCT01801111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102355042|NCT01801111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102355043|NCT01801111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102355044|NCT01801111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355045|NCT00691600|Trimethoprim|trimethoprim|mesh-list
102355046|NCT00691600|Sulfamethoxazole|sulfamethoxazole|mesh-list
102355047|NCT00691600|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102355048|NCT00691600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102355049|NCT00691600|Antimalarials|antimalarials|mesh-ancestor
102355050|NCT00691600|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102355051|NCT00691600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102355052|NCT00691600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102355053|NCT00691600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102355054|NCT00691600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355055|NCT00691600|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102355056|NCT00691600|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102355057|NCT00691600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102355058|NCT00655642|Promethazine|promethazine|mesh-list
102355059|NCT00655642|Diphenhydramine|diphenhydramine|mesh-list
102355060|NCT00655642|Ondansetron|ondansetron|mesh-list
102355061|NCT00655642|Metoclopramide|metoclopramide|mesh-list
102355062|NCT00655642|Antiemetics|antiemetics|mesh-ancestor
102355063|NCT00655642|Autonomic Agents|autonomic agents|mesh-ancestor
102355064|NCT00655642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102355065|NCT00655642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355066|NCT00655642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102355067|NCT00655642|Antipruritics|antipruritics|mesh-ancestor
102355068|NCT00655642|Dermatologic Agents|dermatologic agents|mesh-ancestor
102355069|NCT00655642|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102355070|NCT00655642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102355071|NCT00655642|Serotonin Agents|serotonin agents|mesh-ancestor
102355072|NCT00655642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102355073|NCT00655642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355074|NCT00655642|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102355075|NCT00655642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102355076|NCT00655642|Dopamine Agents|dopamine agents|mesh-ancestor
102355077|NCT00655642|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102355078|NCT00655642|Histamine Antagonists|histamine antagonists|mesh-ancestor
102355079|NCT00655642|Histamine Agents|histamine agents|mesh-ancestor
102355080|NCT00655642|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102355081|NCT00655642|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102355082|NCT00655642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102355083|NCT00655642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102355084|NCT00655642|Anesthetics, Local|anesthetics, local|mesh-ancestor
102355086|NCT00655642|Sensory System Agents|sensory system agents|mesh-ancestor
102355087|NCT00656656|Dexamethasone|dexamethasone|mesh-list
102355088|NCT00656656|Rituximab|rituximab|mesh-list
102355089|NCT00656656|Azathioprine|azathioprine|mesh-list
102355090|NCT00656656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102355091|NCT00656656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102355092|NCT00656656|Immunologic Factors|immunologic factors|mesh-ancestor
102355093|NCT00656656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355094|NCT00656656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102355095|NCT00656656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102355096|NCT00656656|Antiemetics|antiemetics|mesh-ancestor
102355097|NCT00656656|Autonomic Agents|autonomic agents|mesh-ancestor
102355098|NCT00656656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102355099|NCT00656656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102355100|NCT00656656|Glucocorticoids|glucocorticoids|mesh-ancestor
102355101|NCT00656656|Hormones|hormones|mesh-ancestor
102355102|NCT00656656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102355103|NCT00656656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102355104|NCT00656656|Antimetabolites|antimetabolites|mesh-ancestor
102355105|NCT00656656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355106|NCT00656656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102355107|NCT00656656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102355108|NCT01773889|Interferon alpha-2|interferon alpha-2|mesh-list
102355109|NCT01773889|Denileukin diftitox|denileukin diftitox|mesh-list
102355110|NCT01773889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102355111|NCT01773889|Antiviral Agents|antiviral agents|mesh-ancestor
102355112|NCT01773889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102355113|NCT00656968|Esomeprazole|esomeprazole|mesh-list
102355114|NCT00656968|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102355115|NCT00656968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102355116|NCT00656968|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102355117|NCT00656968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102355118|NCT00656968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355119|NCT00657280|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102355120|NCT00657280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102355121|NCT00657280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355122|NCT00657280|Incretins|incretins|mesh-ancestor
102355123|NCT00657280|Hormones|hormones|mesh-ancestor
102355124|NCT00657280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102355125|NCT00657280|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102355126|NCT00657280|Protease Inhibitors|protease inhibitors|mesh-ancestor
102355127|NCT00657280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102355128|NCT00657280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355129|NCT00693160|Ketorolac|ketorolac|mesh-list
102355130|NCT00693160|Remifentanil|remifentanil|mesh-list
102355131|NCT00693160|Capsaicin|capsaicin|mesh-list
102355132|NCT00693160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102355133|NCT00693160|Narcotics|narcotics|mesh-ancestor
102355134|NCT00693160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102355135|NCT00693160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355136|NCT00693160|Analgesics|analgesics|mesh-ancestor
102355137|NCT00693160|Sensory System Agents|sensory system agents|mesh-ancestor
102355138|NCT00693160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102355139|NCT00693160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102355140|NCT00693160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102355141|NCT00693160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102355142|NCT00693160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102355143|NCT00693160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102355144|NCT00693160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102355145|NCT00693160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355146|NCT00693160|Antipruritics|antipruritics|mesh-ancestor
102355147|NCT00693160|Dermatologic Agents|dermatologic agents|mesh-ancestor
102355148|NCT00695188|Methotrexate|methotrexate|mesh-list
102355149|NCT00695188|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102355150|NCT00695188|Abortifacient Agents|abortifacient agents|mesh-ancestor
102355151|NCT00695188|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102355152|NCT00695188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355153|NCT00695188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102355154|NCT00695188|Antimetabolites|antimetabolites|mesh-ancestor
102166847|NCT05039606|Nedaplatin|nedaplatin|mesh-list
102355155|NCT00695188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355156|NCT00695188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102355157|NCT00695188|Dermatologic Agents|dermatologic agents|mesh-ancestor
102355158|NCT00695188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102355159|NCT00695188|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102355160|NCT00695188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102355161|NCT00695188|Immunologic Factors|immunologic factors|mesh-ancestor
102355162|NCT00695188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102355163|NCT00695188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102355164|NCT00706264|Silicon|silicon|mesh-list
102355165|NCT00706264|Trace Elements|trace elements|mesh-ancestor
102355166|NCT00706264|Micronutrients|micronutrients|mesh-ancestor
102355167|NCT00706264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355168|NCT00695500|Varenicline|varenicline|mesh-list
102355169|NCT00695500|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102355170|NCT00695500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102355171|NCT00695500|Cholinergic Agents|cholinergic agents|mesh-ancestor
102355172|NCT00695500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102355173|NCT00695500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355174|NCT00695500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355175|NCT00695578|Bacitracin|bacitracin|mesh-list
102355176|NCT00695578|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102355177|NCT00695578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102355178|NCT00695578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102355179|NCT01792102|Dexamethasone|dexamethasone|mesh-list
102355180|NCT01792102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102355181|NCT01792102|Antiemetics|antiemetics|mesh-ancestor
102355182|NCT01792102|Autonomic Agents|autonomic agents|mesh-ancestor
102355183|NCT01792102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102355184|NCT01792102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355185|NCT01792102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102355186|NCT01792102|Glucocorticoids|glucocorticoids|mesh-ancestor
102355187|NCT01792102|Hormones|hormones|mesh-ancestor
102355188|NCT01792102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102355189|NCT01792102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102355190|NCT01792102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102355191|NCT02996734|Denosumab|denosumab|mesh-list
102355192|NCT02996734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102355193|NCT02996734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355194|NCT00699010|Oxycodone|oxycodone|mesh-list
102355195|NCT00699010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102355196|NCT00699010|Narcotics|narcotics|mesh-ancestor
102355197|NCT00699010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102355198|NCT00699010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355199|NCT00699010|Analgesics|analgesics|mesh-ancestor
102355200|NCT00699010|Sensory System Agents|sensory system agents|mesh-ancestor
102355201|NCT00699010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102355202|NCT00706810|Hydroxyurea|hydroxyurea|mesh-list
102355203|NCT00706810|Verapamil|verapamil|mesh-list
102355204|NCT00706810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102355205|NCT00706810|Antisickling Agents|antisickling agents|mesh-ancestor
102355206|NCT00706810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102355207|NCT00706810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355208|NCT00706810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102355209|NCT00706810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102355210|NCT00706810|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102355211|NCT00706810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102355212|NCT00706810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102355213|NCT00706810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355214|NCT00706810|Vasodilator Agents|vasodilator agents|mesh-ancestor
102355215|NCT00661960|Efavirenz|efavirenz|mesh-list
102355216|NCT00661960|Raltegravir Potassium|raltegravir potassium|mesh-list
102355217|NCT00661960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102355218|NCT00661960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102355219|NCT00661960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102355220|NCT00661960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355221|NCT00661960|Antiviral Agents|antiviral agents|mesh-ancestor
102355222|NCT00661960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102355223|NCT00661960|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102355224|NCT00661960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102355225|NCT00661960|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102355226|NCT00661960|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102355227|NCT00661960|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102355228|NCT00661960|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102355229|NCT00661960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102355230|NCT00661960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102355231|NCT00661960|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102355232|NCT00661960|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102355233|NCT00662818|Acetaminophen|acetaminophen|mesh-list
102355234|NCT00662818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102355235|NCT00662818|Analgesics|analgesics|mesh-ancestor
102355236|NCT00662818|Sensory System Agents|sensory system agents|mesh-ancestor
102355237|NCT00662818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102355238|NCT00662818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355239|NCT00662818|Antipyretics|antipyretics|mesh-ancestor
102355240|NCT00699556|Nicotine|nicotine|mesh-list
102355241|NCT00699556|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102355242|NCT00699556|Autonomic Agents|autonomic agents|mesh-ancestor
102355243|NCT00699556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102355244|NCT00699556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355245|NCT00699556|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102355246|NCT00699556|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102355247|NCT00699556|Cholinergic Agents|cholinergic agents|mesh-ancestor
102355248|NCT00699556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102355249|NCT00699556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355250|NCT00700336|Cisplatin|cisplatin|mesh-list
102355251|NCT00700336|Pemetrexed|pemetrexed|mesh-list
102355252|NCT00700336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102355253|NCT00700336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102355254|NCT00700336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355255|NCT00700336|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102355256|NCT00700336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102355257|NCT01795846|Immunomodulating Agents|immunomodulating agents|mesh-list
102355258|NCT01795846|Immunologic Factors|immunologic factors|mesh-ancestor
102355259|NCT01795846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355260|NCT00701896|Nicotine|nicotine|mesh-list
102355261|NCT00701896|Varenicline|varenicline|mesh-list
102355262|NCT00701896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102355263|NCT00701896|Autonomic Agents|autonomic agents|mesh-ancestor
102355264|NCT00701896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102355265|NCT00701896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355266|NCT00701896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102355267|NCT00701896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102355268|NCT00701896|Cholinergic Agents|cholinergic agents|mesh-ancestor
102355269|NCT00701896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102355270|NCT00701896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355271|NCT01839487|Dexamethasone|dexamethasone|mesh-list
102355272|NCT01839487|Paclitaxel|paclitaxel|mesh-list
102355273|NCT01839487|Gemcitabine|gemcitabine|mesh-list
102355274|NCT01839487|Enoxaparin|enoxaparin|mesh-list
102355275|NCT01839487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102355276|NCT01839487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102355277|NCT01839487|Tubulin Modulators|tubulin modulators|mesh-ancestor
102355278|NCT01839487|Antimitotic Agents|antimitotic agents|mesh-ancestor
102355279|NCT01839487|Mitosis Modulators|mitosis modulators|mesh-ancestor
102355280|NCT01839487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355281|NCT01839487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102355282|NCT01839487|Antiemetics|antiemetics|mesh-ancestor
102355283|NCT01839487|Autonomic Agents|autonomic agents|mesh-ancestor
102355284|NCT01839487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102355285|NCT01839487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355286|NCT01839487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102355287|NCT01839487|Glucocorticoids|glucocorticoids|mesh-ancestor
102355288|NCT01839487|Hormones|hormones|mesh-ancestor
102355289|NCT01839487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102355290|NCT01839487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102355291|NCT01839487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102355292|NCT01839487|Antimetabolites|antimetabolites|mesh-ancestor
102355293|NCT01839487|Anticoagulants|anticoagulants|mesh-ancestor
102355294|NCT01839487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102355295|NCT01839487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102355296|NCT00665470|Aldesleukin|aldesleukin|mesh-list
102355297|NCT00665470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102355298|NCT00665470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102355299|NCT00665470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102355300|NCT00665470|Antiviral Agents|antiviral agents|mesh-ancestor
102355301|NCT00665470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102355302|NCT00666406|Factor VIII|factor viii|mesh-list
102355303|NCT00666406|Coagulants|coagulants|mesh-ancestor
102355304|NCT02995954|Amlodipine|amlodipine|mesh-list
102355305|NCT02995954|Perindopril|perindopril|mesh-list
102355306|NCT02995954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102355307|NCT02995954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102355308|NCT02995954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102355309|NCT02995954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355310|NCT02995954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102355311|NCT02995954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355312|NCT02995954|Vasodilator Agents|vasodilator agents|mesh-ancestor
102355313|NCT02995954|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102355314|NCT02995954|Protease Inhibitors|protease inhibitors|mesh-ancestor
102355315|NCT02995954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102355316|NCT01799941|Quinidine|quinidine|mesh-list
102355317|NCT01799941|Dextromethorphan|dextromethorphan|mesh-list
102355318|NCT01799941|Antitussive Agents|antitussive agents|mesh-ancestor
102355319|NCT01799941|Respiratory System Agents|respiratory system agents|mesh-ancestor
102355320|NCT01799941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102355321|NCT01799941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102355322|NCT01799941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102355323|NCT01799941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355324|NCT01799941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355325|NCT01799941|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102355326|NCT01799941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102355327|NCT01799941|Adrenergic Agents|adrenergic agents|mesh-ancestor
102355328|NCT01799941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102355329|NCT01799941|Antimalarials|antimalarials|mesh-ancestor
102355330|NCT01799941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102355331|NCT01799941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102355332|NCT01799941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102355333|NCT01799941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102355334|NCT01799941|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102355335|NCT01799941|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102355336|NCT01799941|Cholinergic Agents|cholinergic agents|mesh-ancestor
102355337|NCT01799941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102355338|NCT01799941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102355339|NCT01799941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102355340|NCT01799941|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102355341|NCT01799941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102355342|NCT00702364|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102355343|NCT00702364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102355344|NCT00702364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102355345|NCT00702364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102355346|NCT00702364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355347|NCT00702364|Adrenergic Agents|adrenergic agents|mesh-ancestor
102355348|NCT00702364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102355349|NCT00702364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355350|NCT00713284|Sirolimus|sirolimus|mesh-list
102355351|NCT00713284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102355352|NCT00713284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102355353|NCT00713284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102355354|NCT00713284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102355355|NCT00713284|Antifungal Agents|antifungal agents|mesh-ancestor
102355356|NCT00713284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102355357|NCT00713284|Immunologic Factors|immunologic factors|mesh-ancestor
102355358|NCT00713284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355359|NCT00702754|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
102355360|NCT00702754|Botulinum Toxins|botulinum toxins|mesh-list
102355361|NCT00702754|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102355362|NCT00702754|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102355363|NCT00702754|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101887082|NCT04641975|Mirabegron|mirabegron|mesh-list
102355364|NCT00702754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102355365|NCT00702754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355366|NCT00702754|Cholinergic Agents|cholinergic agents|mesh-ancestor
102355367|NCT00702754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102355368|NCT00702754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355369|NCT00702754|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102355370|NCT00702754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102355371|NCT00702754|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102355372|NCT02995720|Amlodipine|amlodipine|mesh-list
102355373|NCT02995720|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102355374|NCT02995720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102355375|NCT02995720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102355376|NCT02995720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102355377|NCT02995720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167069|NCT03293511|Oxytocin|oxytocin|mesh-list
102355378|NCT02995720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102355379|NCT02995720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355380|NCT02995720|Vasodilator Agents|vasodilator agents|mesh-ancestor
102355381|NCT02995720|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102355382|NCT02995720|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102355384|NCT02995720|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102355385|NCT02995720|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102355386|NCT02995720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102355387|NCT02990728|Metformin|metformin|mesh-list
102355388|NCT02990728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102355389|NCT02990728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355390|NCT02995330|Cyclophosphamide|cyclophosphamide|mesh-list
102355391|NCT02995330|Methyltestosterone|methyltestosterone|mesh-list
102355392|NCT02995330|Testosterone|testosterone|mesh-list
102355393|NCT02995330|Testosterone undecanoate|testosterone undecanoate|mesh-list
102355394|NCT02995330|Testosterone enanthate|testosterone enanthate|mesh-list
102355395|NCT02995330|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102355396|NCT02995330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102355397|NCT02995330|Immunologic Factors|immunologic factors|mesh-ancestor
102355398|NCT02995330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355399|NCT02995330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102355400|NCT02995330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102355401|NCT02995330|Alkylating Agents|alkylating agents|mesh-ancestor
102355402|NCT02995330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355403|NCT02995330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102355404|NCT02995330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102355405|NCT02995330|Androgens|androgens|mesh-ancestor
102355406|NCT02995330|Hormones|hormones|mesh-ancestor
102355407|NCT02995330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102355408|NCT02995330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102355409|NCT02995330|Anabolic Agents|anabolic agents|mesh-ancestor
102355410|NCT02990884|Ketamine|ketamine|mesh-list
102355411|NCT02990884|Analgesics|analgesics|mesh-ancestor
102355412|NCT02990884|Sensory System Agents|sensory system agents|mesh-ancestor
102355413|NCT02990884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102355414|NCT02990884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355415|NCT02990884|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102355416|NCT02990884|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102355417|NCT02990884|Anesthetics, General|anesthetics, general|mesh-ancestor
102355418|NCT02990884|Anesthetics|anesthetics|mesh-ancestor
102355419|NCT02990884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102355420|NCT02990884|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102355421|NCT02990884|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102355422|NCT02990884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102355423|NCT02990884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355424|NCT02990416|Pembrolizumab|pembrolizumab|mesh-list
102355425|NCT02990416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102355426|NCT02990416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102355427|NCT02990416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102355428|NCT02990416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355429|NCT02999776|Etanercept|etanercept|mesh-list
102355430|NCT02999776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102355431|NCT02999776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102355432|NCT02999776|Analgesics|analgesics|mesh-ancestor
102355433|NCT02999776|Sensory System Agents|sensory system agents|mesh-ancestor
102355434|NCT02999776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102355435|NCT02999776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355436|NCT02999776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102355437|NCT02999776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102355438|NCT02999776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102355439|NCT02999776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102355440|NCT02999776|Immunologic Factors|immunologic factors|mesh-ancestor
102355441|NCT02996656|Cefazolin|cefazolin|mesh-list
102355442|NCT02996656|Ceftriaxone|ceftriaxone|mesh-list
102355443|NCT02996656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102355444|NCT02996656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102355445|NCT04387630|Metformin|metformin|mesh-list
102355446|NCT04387630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102355447|NCT04387630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355448|NCT04270318|Pemetrexed|pemetrexed|mesh-list
102355449|NCT04270318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102355450|NCT04270318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102355451|NCT04270318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355452|NCT04270318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102355453|NCT04270318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102355454|NCT02999854|Cyclophosphamide|cyclophosphamide|mesh-list
102355455|NCT02999854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102355456|NCT02999854|Immunologic Factors|immunologic factors|mesh-ancestor
102355457|NCT02999854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355458|NCT02999854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102355459|NCT02999854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102355460|NCT02999854|Alkylating Agents|alkylating agents|mesh-ancestor
102355461|NCT02999854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355462|NCT02999854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102355463|NCT02999854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102355464|NCT04270708|Dexmedetomidine|dexmedetomidine|mesh-list
102355465|NCT04270708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102355466|NCT04270708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102355467|NCT04270708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355468|NCT04270708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102355469|NCT04270708|Analgesics|analgesics|mesh-ancestor
102355470|NCT04270708|Sensory System Agents|sensory system agents|mesh-ancestor
102355471|NCT04270708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102355472|NCT04270708|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102355473|NCT04270708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102355474|NCT04270708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102355475|NCT04270708|Adrenergic Agents|adrenergic agents|mesh-ancestor
102355476|NCT04270708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102355477|NCT04270708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355478|NCT00704938|Aldesleukin|aldesleukin|mesh-list
102355479|NCT00704938|Cyclophosphamide|cyclophosphamide|mesh-list
102355480|NCT00704938|Fludarabine|fludarabine|mesh-list
102355481|NCT00704938|Fludarabine phosphate|fludarabine phosphate|mesh-list
102355482|NCT00704938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102355483|NCT00704938|Immunologic Factors|immunologic factors|mesh-ancestor
102355484|NCT00704938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355485|NCT00704938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102355486|NCT00704938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102355487|NCT00704938|Alkylating Agents|alkylating agents|mesh-ancestor
102355488|NCT00704938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355489|NCT00704938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102355490|NCT00704938|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102355491|NCT00704938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102355492|NCT00704938|Antimetabolites|antimetabolites|mesh-ancestor
102355493|NCT00704938|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102355494|NCT00704938|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102355495|NCT00704938|Antiviral Agents|antiviral agents|mesh-ancestor
102355496|NCT00704938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102355497|NCT02994082|Bupropion|bupropion|mesh-list
102355498|NCT02994082|Nicotine|nicotine|mesh-list
102355499|NCT02994082|Varenicline|varenicline|mesh-list
102355500|NCT02994082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102355501|NCT02994082|Autonomic Agents|autonomic agents|mesh-ancestor
102355502|NCT02994082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102355503|NCT02994082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355504|NCT02994082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102355505|NCT02994082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102355506|NCT02994082|Cholinergic Agents|cholinergic agents|mesh-ancestor
102355507|NCT02994082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102369686|NCT04450134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102355508|NCT02994082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355509|NCT02994082|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102355510|NCT02994082|Antidepressive Agents|antidepressive agents|mesh-ancestor
102355511|NCT02994082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102355512|NCT02994082|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102355513|NCT02994082|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102355514|NCT02994082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102355515|NCT02994082|Dopamine Agents|dopamine agents|mesh-ancestor
102355516|NCT02994082|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102355517|NCT02994082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102355518|NCT02994082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102355519|NCT02995096|Sirolimus|sirolimus|mesh-list
102355520|NCT02995096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102355521|NCT02995096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102355522|NCT02995096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102355523|NCT02995096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102355524|NCT02995096|Antifungal Agents|antifungal agents|mesh-ancestor
102355525|NCT02995096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102355526|NCT02995096|Immunologic Factors|immunologic factors|mesh-ancestor
102355527|NCT02995096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355528|NCT01275976|Complement C1s|complement c1s|mesh-list
102355529|NCT01275976|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
102355530|NCT01275976|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
102355531|NCT01275976|Immunologic Factors|immunologic factors|mesh-ancestor
102355532|NCT01275976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355533|NCT01275976|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102355534|NCT01275976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102355535|NCT01270438|Leucovorin|leucovorin|mesh-list
102355536|NCT01270438|Bevacizumab|bevacizumab|mesh-list
102355537|NCT01270438|Fluorouracil|fluorouracil|mesh-list
102355538|NCT01270438|Oxaliplatin|oxaliplatin|mesh-list
102355539|NCT01270438|Calcium|calcium|mesh-list
102355540|NCT01270438|Levoleucovorin|levoleucovorin|mesh-list
102355541|NCT01270438|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
102355542|NCT01270438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102355543|NCT01270438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102355544|NCT01270438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102355545|NCT01270438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102355546|NCT01270438|Growth Substances|growth substances|mesh-ancestor
102355547|NCT01270438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355548|NCT01270438|Growth Inhibitors|growth inhibitors|mesh-ancestor
102355549|NCT01270438|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102355550|NCT01270438|Antimetabolites|antimetabolites|mesh-ancestor
102355551|NCT01270438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355552|NCT01270438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102355553|NCT01270438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102355554|NCT01270438|Immunologic Factors|immunologic factors|mesh-ancestor
102355555|NCT01270438|Antidotes|antidotes|mesh-ancestor
102355556|NCT01270438|Protective Agents|protective agents|mesh-ancestor
102355557|NCT01270438|Vitamin B Complex|vitamin b complex|mesh-ancestor
102355558|NCT01270438|Vitamins|vitamins|mesh-ancestor
102355559|NCT01270438|Micronutrients|micronutrients|mesh-ancestor
102355560|NCT01270438|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
102355561|NCT01270438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102355562|NCT01270672|Carvedilol|carvedilol|mesh-list
102355563|NCT01270672|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
102355564|NCT01270672|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102355565|NCT01270672|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102355566|NCT01270672|Adrenergic Agents|adrenergic agents|mesh-ancestor
102355567|NCT01270672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102355568|NCT01270672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355569|NCT01270672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355570|NCT01270672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102355571|NCT01270672|Antioxidants|antioxidants|mesh-ancestor
102355572|NCT01270672|Protective Agents|protective agents|mesh-ancestor
102355573|NCT01270672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102355574|NCT01270672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102355575|NCT01270672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102355576|NCT01270672|Vasodilator Agents|vasodilator agents|mesh-ancestor
102355577|NCT01270672|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101887292|NCT04311502|Rifampin|rifampin|mesh-list
102355578|NCT01270672|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102355579|NCT01270672|Hallucinogens|hallucinogens|mesh-ancestor
102355580|NCT01270672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102355581|NCT01270672|Serotonin Agents|serotonin agents|mesh-ancestor
102355582|NCT01270672|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102355583|NCT01270672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102355584|NCT01276210|Sorafenib|sorafenib|mesh-list
102355585|NCT01276210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102355586|NCT01276210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102355587|NCT01276210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102355588|NCT01276210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355589|NCT00727636|Vaccines|vaccines|mesh-list
102355590|NCT00727636|Immunologic Factors|immunologic factors|mesh-ancestor
102355591|NCT00727636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355592|NCT01270750|Bosentan|bosentan|mesh-list
102355593|NCT01270750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102355594|NCT01270750|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102355595|NCT01270750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355596|NCT00709696|Varenicline|varenicline|mesh-list
102355597|NCT00709696|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102355598|NCT00709696|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102355599|NCT00709696|Cholinergic Agents|cholinergic agents|mesh-ancestor
102355600|NCT00709696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102355601|NCT00709696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355602|NCT00709696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355603|NCT01270984|Imatinib Mesylate|imatinib mesylate|mesh-list
102355604|NCT01270984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102355605|NCT01270984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102355606|NCT01270984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102355607|NCT01270984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355608|NCT02992678|Pentoxifylline|pentoxifylline|mesh-list
102355609|NCT02992678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102355610|NCT02992678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102355611|NCT02992678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355612|NCT02992678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102355613|NCT02992678|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102355614|NCT02992678|Protective Agents|protective agents|mesh-ancestor
102355615|NCT02992678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355616|NCT02992678|Vasodilator Agents|vasodilator agents|mesh-ancestor
102355617|NCT02992678|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102355618|NCT02992678|Antioxidants|antioxidants|mesh-ancestor
102355619|NCT02992912|Atezolizumab|atezolizumab|mesh-list
102355620|NCT02992912|Antibodies|antibodies|mesh-list
102355621|NCT02992912|Immunologic Factors|immunologic factors|mesh-ancestor
102355622|NCT02992912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355623|NCT02992912|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102355624|NCT02992912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355625|NCT02992912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102355626|NCT02992912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102355627|NCT01271140|Insulin|insulin|mesh-list
102355628|NCT01271140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102355629|NCT01271140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355630|NCT01271374|Losartan|losartan|mesh-list
102355631|NCT01271374|Amlodipine|amlodipine|mesh-list
102355632|NCT01271374|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102355633|NCT01271374|Olmesartan|olmesartan|mesh-list
102355634|NCT01271374|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
102355635|NCT01271374|Spironolactone|spironolactone|mesh-list
102355636|NCT01271374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102355637|NCT01271374|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102355638|NCT01271374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102355639|NCT01271374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355640|NCT01271374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102355641|NCT01271374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355642|NCT01271374|Vasodilator Agents|vasodilator agents|mesh-ancestor
102355643|NCT01271374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102355644|NCT01271374|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102355645|NCT01271374|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102355646|NCT01271374|Diuretics|diuretics|mesh-ancestor
102355647|NCT01271374|Natriuretic Agents|natriuretic agents|mesh-ancestor
102347411|NCT00505063|Vaccines|vaccines|mesh-list
102355648|NCT01271374|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102355649|NCT01271374|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102355650|NCT01271374|Hormone Antagonists|hormone antagonists|mesh-ancestor
102355651|NCT01271374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102355652|NCT01271374|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102355653|NCT01276834|Everolimus|everolimus|mesh-list
102355654|NCT01276834|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102355655|NCT01276834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102355656|NCT01276834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102355657|NCT01276834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355658|NCT01276834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102355659|NCT01276834|Immunologic Factors|immunologic factors|mesh-ancestor
102355660|NCT01276834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355661|NCT01276834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102355662|NCT01276912|Insulin Glargine|insulin glargine|mesh-list
102355663|NCT01276912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102355664|NCT01276912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355665|NCT00711490|Sirolimus|sirolimus|mesh-list
102355666|NCT00711490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102355667|NCT00711490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102355668|NCT00711490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102355669|NCT00711490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102355670|NCT00711490|Antifungal Agents|antifungal agents|mesh-ancestor
102355671|NCT00711490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102355672|NCT00711490|Immunologic Factors|immunologic factors|mesh-ancestor
102355673|NCT00711490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355674|NCT01271998|Tedizolid phosphate|tedizolid phosphate|mesh-list
102355675|NCT01271998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102355676|NCT01271998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102355677|NCT00717418|Cyclosporine|cyclosporine|mesh-list
102355678|NCT00717418|Lubricant Eye Drops|lubricant eye drops|mesh-list
102355679|NCT00717418|Cyclosporins|cyclosporins|mesh-list
102355680|NCT00717418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102355681|NCT00717418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355682|NCT00717418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102355683|NCT00717418|Immunologic Factors|immunologic factors|mesh-ancestor
102355684|NCT00717418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355685|NCT00717418|Antifungal Agents|antifungal agents|mesh-ancestor
102355686|NCT00717418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102355687|NCT00717418|Dermatologic Agents|dermatologic agents|mesh-ancestor
102355688|NCT00717418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102355689|NCT00717418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102355690|NCT00717418|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102355691|NCT00717418|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102355692|NCT00717574|Nitrous Oxide|nitrous oxide|mesh-list
102355693|NCT00717574|Propofol|propofol|mesh-list
102355694|NCT00717574|Sevoflurane|sevoflurane|mesh-list
102355695|NCT00717574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102355696|NCT00717574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102355697|NCT00717574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355698|NCT00717574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102355699|NCT00717574|Anesthetics, General|anesthetics, general|mesh-ancestor
102355700|NCT00717574|Anesthetics|anesthetics|mesh-ancestor
102355701|NCT00717574|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102355702|NCT00717574|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102355703|NCT00717574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102355704|NCT00717574|Analgesics|analgesics|mesh-ancestor
102355705|NCT00717574|Sensory System Agents|sensory system agents|mesh-ancestor
102355706|NCT00717574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102355707|NCT00719134|Rizatriptan|rizatriptan|mesh-list
102355708|NCT00719134|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102355709|NCT00719134|Serotonin Agents|serotonin agents|mesh-ancestor
102355710|NCT00719134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102355711|NCT00719134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355712|NCT00719134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355713|NCT01277770|Thymoglobulin|thymoglobulin|mesh-list
102355714|NCT01277770|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102355715|NCT01277770|Immunologic Factors|immunologic factors|mesh-ancestor
102355716|NCT01277770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355717|NCT01277770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102355718|NCT00721162|Ramucirumab|ramucirumab|mesh-list
102355719|NCT00721162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102355720|NCT01838941|Betaine|betaine|mesh-list
102355721|NCT01838941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102355722|NCT01838941|Lipotropic Agents|lipotropic agents|mesh-ancestor
102355723|NCT01838941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102355724|NCT01838941|Antimetabolites|antimetabolites|mesh-ancestor
102355725|NCT01838941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355726|NCT01838941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102355727|NCT01773109|Irinotecan|irinotecan|mesh-list
102355728|NCT01773109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
102355729|NCT01773109|Etirinotecan pegol|etirinotecan pegol|mesh-list
102355730|NCT01773109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102355731|NCT01773109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102355732|NCT01773109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355733|NCT01773109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102355734|NCT01773109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102355735|NCT01772719|Zoledronic Acid|zoledronic acid|mesh-list
102355736|NCT01772719|Simvastatin|simvastatin|mesh-list
102355737|NCT01772719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102355738|NCT01772719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102355739|NCT01772719|Antimetabolites|antimetabolites|mesh-ancestor
102355740|NCT01772719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355741|NCT01772719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102355742|NCT01772719|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102355743|NCT01772719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102355744|NCT01772719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102355745|NCT01772719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355746|NCT05582265|Paclitaxel|paclitaxel|mesh-list
102355747|NCT05582265|Cisplatin|cisplatin|mesh-list
102355748|NCT05582265|Tislelizumab|tislelizumab|mesh-list
102167444|NCT02112019|Hydrocortisone|hydrocortisone|mesh-list
102355749|NCT05582265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102355750|NCT05582265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102355751|NCT05582265|Tubulin Modulators|tubulin modulators|mesh-ancestor
102355752|NCT05582265|Antimitotic Agents|antimitotic agents|mesh-ancestor
102355753|NCT05582265|Mitosis Modulators|mitosis modulators|mesh-ancestor
102355754|NCT05582265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355755|NCT05582265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102355756|NCT04144101|Etoricoxib|etoricoxib|mesh-list
102355757|NCT04144101|Aceclofenac|aceclofenac|mesh-list
102355758|NCT04144101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102355759|NCT04144101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102355760|NCT04144101|Analgesics|analgesics|mesh-ancestor
102355761|NCT04144101|Sensory System Agents|sensory system agents|mesh-ancestor
102355762|NCT04144101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102355763|NCT04144101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355764|NCT04144101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102355765|NCT04144101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102355766|NCT04144101|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102355767|NCT04144101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102355768|NCT04144101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102355769|NCT04144101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355770|NCT01278004|Ethosuximide|ethosuximide|mesh-list
102355771|NCT01278004|Anticonvulsants|anticonvulsants|mesh-ancestor
102355772|NCT01278238|Phenylephrine|phenylephrine|mesh-list
102355773|NCT01278238|Oxymetazoline|oxymetazoline|mesh-list
102355774|NCT01278238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102355775|NCT01278238|Mydriatics|mydriatics|mesh-ancestor
102355776|NCT01278238|Autonomic Agents|autonomic agents|mesh-ancestor
102355777|NCT01278238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102355778|NCT01278238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355779|NCT01278238|Sympathomimetics|sympathomimetics|mesh-ancestor
102355780|NCT01278238|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102355781|NCT01278238|Nasal Decongestants|nasal decongestants|mesh-ancestor
102355782|NCT01278238|Respiratory System Agents|respiratory system agents|mesh-ancestor
102355783|NCT01278238|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102355784|NCT01278238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102355785|NCT01278238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102355786|NCT01278238|Adrenergic Agents|adrenergic agents|mesh-ancestor
102355787|NCT01278238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102355788|NCT01278238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355789|NCT01278238|Protective Agents|protective agents|mesh-ancestor
102355790|NCT02706795|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102347416|NCT00350272|Lamivudine|lamivudine|mesh-list
102355791|NCT02706795|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102355792|NCT02706795|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102355793|NCT02706795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102355794|NCT02706795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355795|NCT02706795|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102355796|NCT02706795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102355797|NCT02706795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355798|NCT02706795|Cholinergic Agents|cholinergic agents|mesh-ancestor
102355799|NCT02706795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102355800|NCT01272310|Interferons|interferons|mesh-list
102355801|NCT01272310|Ribavirin|ribavirin|mesh-list
102355802|NCT01272310|Interferon-alpha|interferon-alpha|mesh-list
102355803|NCT01272310|Interferon alpha-2|interferon alpha-2|mesh-list
102355804|NCT01272310|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102355805|NCT01272310|Hydroxychloroquine|hydroxychloroquine|mesh-list
102355806|NCT01272310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102355807|NCT01272310|Antiviral Agents|antiviral agents|mesh-ancestor
102355808|NCT01272310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102355809|NCT01272310|Antimetabolites|antimetabolites|mesh-ancestor
102355810|NCT01272310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355811|NCT01272310|Immunologic Factors|immunologic factors|mesh-ancestor
102355812|NCT01272310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355813|NCT01272310|Antimalarials|antimalarials|mesh-ancestor
102355814|NCT01272310|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102355815|NCT01272310|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102355816|NCT01272310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102355817|NCT01272310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102355818|NCT04386850|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
102355819|NCT04386850|Calcifediol|calcifediol|mesh-list
102355820|NCT04386850|Vitamins|vitamins|mesh-ancestor
102355821|NCT04386850|Micronutrients|micronutrients|mesh-ancestor
102355822|NCT04386850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167515|NCT03553537|Prednisone|prednisone|mesh-list
102355823|NCT04386850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102355825|NCT01272778|Anticonvulsants|anticonvulsants|mesh-ancestor
102355826|NCT01272778|Antiemetics|antiemetics|mesh-ancestor
102355827|NCT01272778|Autonomic Agents|autonomic agents|mesh-ancestor
102355828|NCT01272778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102355829|NCT01272778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355830|NCT01272778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102355831|NCT01272778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102355832|NCT01272778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102355833|NCT01272778|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102355834|NCT01272778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102355835|NCT01272778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102355836|NCT01272778|GABA Modulators|gaba modulators|mesh-ancestor
102355837|NCT01272778|GABA Agents|gaba agents|mesh-ancestor
102355838|NCT01272778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102355839|NCT01272778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355840|NCT01272856|Abatacept|abatacept|mesh-list
102355841|NCT01272856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102355842|NCT01272856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355843|NCT01272856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102355844|NCT01272856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102355845|NCT01272856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102355846|NCT01272856|Immunologic Factors|immunologic factors|mesh-ancestor
102355847|NCT01272856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355848|NCT01272856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102355849|NCT01273090|Imetelstat|imetelstat|mesh-list
102355850|NCT01273090|Motesanib diphosphate|motesanib diphosphate|mesh-list
102355851|NCT01273090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102355852|NCT01273090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355853|NCT01273090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102355854|NCT01273246|Vaccines|vaccines|mesh-list
102355855|NCT01273246|Immunologic Factors|immunologic factors|mesh-ancestor
102355856|NCT01273246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355857|NCT00730522|Vigabatrin|vigabatrin|mesh-list
102355858|NCT00730522|Anticonvulsants|anticonvulsants|mesh-ancestor
102355859|NCT00730522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102355860|NCT00730522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355861|NCT00730522|GABA Agents|gaba agents|mesh-ancestor
102355862|NCT00730522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102355863|NCT00730522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355864|NCT04345276|Ritonavir|ritonavir|mesh-list
102355865|NCT04345276|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102355866|NCT04345276|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102355867|NCT04345276|Protease Inhibitors|protease inhibitors|mesh-ancestor
102355868|NCT04345276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102355869|NCT04345276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355870|NCT04345276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102355871|NCT04345276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102355872|NCT04345276|Antiviral Agents|antiviral agents|mesh-ancestor
102355873|NCT04345276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102355874|NCT04345276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102355875|NCT04345276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102355876|NCT01273558|Canagliflozin|canagliflozin|mesh-list
102355877|NCT01273558|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102355878|NCT01273558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355879|NCT01273558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102355880|NCT01273558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355881|NCT00733096|Methylprednisolone|methylprednisolone|mesh-list
102355882|NCT00733096|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102355883|NCT00733096|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102355884|NCT00733096|Prednisolone|prednisolone|mesh-list
102355885|NCT00733096|Prednisolone acetate|prednisolone acetate|mesh-list
102355886|NCT00733096|Etanercept|etanercept|mesh-list
102355887|NCT00733096|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102355888|NCT00733096|Prednisolone phosphate|prednisolone phosphate|mesh-list
102355889|NCT00733096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102355890|NCT00733096|Antiemetics|antiemetics|mesh-ancestor
102355891|NCT00733096|Autonomic Agents|autonomic agents|mesh-ancestor
102355892|NCT00733096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102355893|NCT00733096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355894|NCT00733096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102355895|NCT00733096|Glucocorticoids|glucocorticoids|mesh-ancestor
102355896|NCT00733096|Hormones|hormones|mesh-ancestor
102355897|NCT00733096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102355898|NCT00733096|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102355899|NCT00733096|Protective Agents|protective agents|mesh-ancestor
102355900|NCT00733096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102355901|NCT00733096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102355902|NCT00733096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102355903|NCT00733096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102355904|NCT00733096|Analgesics|analgesics|mesh-ancestor
102355905|NCT00733096|Sensory System Agents|sensory system agents|mesh-ancestor
102355906|NCT00733096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102355907|NCT00733096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102355908|NCT00733096|Immunologic Factors|immunologic factors|mesh-ancestor
102355909|NCT02991196|Nivolumab|nivolumab|mesh-list
102355910|NCT02991196|DS-8273a|ds-8273a|mesh-list
102355911|NCT02991196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102355912|NCT02991196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102355913|NCT02991196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102355914|NCT02991196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355915|NCT01278784|Acetylcysteine|acetylcysteine|mesh-list
102355916|NCT01278784|Chitosan|chitosan|mesh-list
102355917|NCT01278784|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102355918|NCT01278784|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102355919|NCT01278784|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102355920|NCT01278784|Antiviral Agents|antiviral agents|mesh-ancestor
102355921|NCT01278784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102355922|NCT01278784|Expectorants|expectorants|mesh-ancestor
102355923|NCT01278784|Respiratory System Agents|respiratory system agents|mesh-ancestor
102355924|NCT01278784|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102355925|NCT01278784|Antioxidants|antioxidants|mesh-ancestor
102355926|NCT01278784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355927|NCT01278784|Protective Agents|protective agents|mesh-ancestor
102355928|NCT01278784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355929|NCT01278784|Antidotes|antidotes|mesh-ancestor
102355930|NCT01278784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102355931|NCT01278784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102355932|NCT01278784|Antimetabolites|antimetabolites|mesh-ancestor
102355933|NCT01278784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102355934|NCT01278784|Chelating Agents|chelating agents|mesh-ancestor
102355935|NCT01278784|Sequestering Agents|sequestering agents|mesh-ancestor
102355936|NCT01278784|Hemostatics|hemostatics|mesh-ancestor
102355937|NCT01278784|Coagulants|coagulants|mesh-ancestor
102355938|NCT01276288|Empagliflozin|empagliflozin|mesh-list
102355939|NCT01276288|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102355940|NCT01276288|Torsemide|torsemide|mesh-list
102355941|NCT01276288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102355942|NCT01276288|Diuretics|diuretics|mesh-ancestor
102355943|NCT01276288|Natriuretic Agents|natriuretic agents|mesh-ancestor
102355944|NCT01276288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355945|NCT01276288|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102355946|NCT01276288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102355947|NCT01276288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355948|NCT01276288|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102355949|NCT01276288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102355950|NCT01276288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102355951|NCT00722566|Bortezomib|bortezomib|mesh-list
102355952|NCT00722566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102355953|NCT00722722|Bortezomib|bortezomib|mesh-list
102355954|NCT00722722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102355955|NCT00723580|Risperidone|risperidone|mesh-list
102355956|NCT00723580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102355957|NCT00723580|Serotonin Agents|serotonin agents|mesh-ancestor
102355958|NCT00723580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102355959|NCT00723580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355960|NCT00723580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102355961|NCT00723580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102355962|NCT00723580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102355963|NCT00723580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102355964|NCT00723580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102355965|NCT00723580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102355966|NCT00723580|Dopamine Agents|dopamine agents|mesh-ancestor
102355967|NCT01273948|Interferons|interferons|mesh-list
102355968|NCT01273948|Bavituximab|bavituximab|mesh-list
102355969|NCT01273948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102355970|NCT01273948|Antiviral Agents|antiviral agents|mesh-ancestor
102355971|NCT01273948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102355972|NCT01273948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102355973|NCT00734344|Tenofovir|tenofovir|mesh-list
102355974|NCT00734344|Efavirenz|efavirenz|mesh-list
102355975|NCT00734344|Raltegravir Potassium|raltegravir potassium|mesh-list
102355976|NCT00734344|Antiviral Agents|antiviral agents|mesh-ancestor
102355977|NCT00734344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102355978|NCT00734344|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102355979|NCT00734344|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102355980|NCT00734344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102355981|NCT00734344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355982|NCT00734344|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102355983|NCT00734344|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102355984|NCT00734344|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102355985|NCT00734344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102355986|NCT00734344|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102355987|NCT00734344|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102355988|NCT00734344|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102355989|NCT00734344|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102355990|NCT00734344|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102355991|NCT00734344|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102355992|NCT04148937|Pembrolizumab|pembrolizumab|mesh-list
102355993|NCT04148937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102355994|NCT04148937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102355995|NCT04148937|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102355996|NCT04148937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102355997|NCT03021057|Pembrolizumab|pembrolizumab|mesh-list
102355998|NCT03021057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102355999|NCT03021057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102356000|NCT03021057|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102356001|NCT03021057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356002|NCT00734500|Anidulafungin|anidulafungin|mesh-list
102356003|NCT00734500|Antifungal Agents|antifungal agents|mesh-ancestor
102356004|NCT00734500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102356005|NCT04143321|Empagliflozin|empagliflozin|mesh-list
102356006|NCT04143321|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102356007|NCT04143321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356008|NCT04143321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101887733|NCT03779191|Growth Inhibitors|growth inhibitors|mesh-ancestor
102356009|NCT04143321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356010|NCT00734968|Nitrofurantoin|nitrofurantoin|mesh-list
102356011|NCT00734968|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102356012|NCT00734968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102356013|NCT00734968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102356014|NCT00735436|Bevacizumab|bevacizumab|mesh-list
102356015|NCT00735436|Irinotecan|irinotecan|mesh-list
102356016|NCT00735436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102356017|NCT00735436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102356018|NCT00735436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102356019|NCT00735436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102356020|NCT00735436|Growth Substances|growth substances|mesh-ancestor
102356021|NCT00735436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356022|NCT00735436|Growth Inhibitors|growth inhibitors|mesh-ancestor
102356023|NCT00735436|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102356024|NCT00735436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102356025|NCT00735436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102356026|NCT00735436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356027|NCT04143165|Lidocaine|lidocaine|mesh-list
102356028|NCT04143165|Anesthetics, Local|anesthetics, local|mesh-ancestor
102356029|NCT04143165|Anesthetics|anesthetics|mesh-ancestor
102356030|NCT04143165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102356031|NCT04143165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356032|NCT04143165|Sensory System Agents|sensory system agents|mesh-ancestor
102356033|NCT04143165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102356034|NCT04143165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102356035|NCT04143165|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102356036|NCT04143165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102356037|NCT04143165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102356038|NCT04143165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356039|NCT00735670|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102356040|NCT00735670|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102356041|NCT00735670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102356042|NCT00735670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102356043|NCT00735670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356044|NCT00735670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102356045|NCT00735670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102612272|NCT00002387|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102356046|NCT00735670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102356047|NCT00735670|Antidepressive Agents|antidepressive agents|mesh-ancestor
102356048|NCT00735670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102356049|NCT00735826|Vorinostat|vorinostat|mesh-list
102356050|NCT00735826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102356051|NCT00735826|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102356052|NCT00735826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102356053|NCT00735826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356054|NCT03916341|Nicotine|nicotine|mesh-list
102356055|NCT03916341|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102356056|NCT03916341|Autonomic Agents|autonomic agents|mesh-ancestor
102356057|NCT03916341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102356058|NCT03916341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356059|NCT03916341|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102356060|NCT03916341|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102356061|NCT03916341|Cholinergic Agents|cholinergic agents|mesh-ancestor
102356062|NCT03916341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102347426|NCT00350272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102347427|NCT00350272|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102347428|NCT00350272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102347429|NCT00350272|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102347430|NCT00350272|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102347431|NCT00350272|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102347432|NCT00350272|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102356063|NCT03916341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356064|NCT01276054|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102356065|NCT01276054|Methylene Blue|methylene blue|mesh-list
102356066|NCT01276054|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
102356067|NCT01276054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102356068|NCT01276054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356069|NCT01276054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102356070|NCT00724594|Acetylcysteine|acetylcysteine|mesh-list
102356071|NCT00724594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102356072|NCT00724594|Antiviral Agents|antiviral agents|mesh-ancestor
102356073|NCT00724594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102356074|NCT00724594|Expectorants|expectorants|mesh-ancestor
102356075|NCT00724594|Respiratory System Agents|respiratory system agents|mesh-ancestor
102356076|NCT00724594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102356077|NCT00724594|Antioxidants|antioxidants|mesh-ancestor
102356078|NCT00724594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356079|NCT00724594|Protective Agents|protective agents|mesh-ancestor
102356080|NCT00724594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356081|NCT00724594|Antidotes|antidotes|mesh-ancestor
102356082|NCT04142931|Nivolumab|nivolumab|mesh-list
102356083|NCT04142931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102356084|NCT04142931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102356085|NCT04142931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102356086|NCT04142931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356087|NCT04143477|Peficitinib|peficitinib|mesh-list
102356088|NCT04143477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102356089|NCT04143477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356090|NCT04143477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102356091|NCT04143477|Immunologic Factors|immunologic factors|mesh-ancestor
102356092|NCT04143477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356093|NCT05586009|Cisplatin|cisplatin|mesh-list
102356094|NCT05586009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102356095|NCT03020979|Apatinib|apatinib|mesh-list
102356096|NCT03020979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102356097|NCT03020979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102356098|NCT03020979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102356099|NCT03020979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356100|NCT04142151|Aspirin|aspirin|mesh-list
102356101|NCT04142151|Clopidogrel|clopidogrel|mesh-list
102356102|NCT04142151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102356103|NCT04142151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102356104|NCT04142151|Analgesics|analgesics|mesh-ancestor
102356105|NCT04142151|Sensory System Agents|sensory system agents|mesh-ancestor
102356106|NCT04142151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102356107|NCT04142151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356108|NCT04142151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102356109|NCT04142151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102356110|NCT04142151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102356111|NCT04142151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102356112|NCT04142151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356113|NCT04142151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102356114|NCT04142151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102356115|NCT04142151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102356116|NCT04142151|Antipyretics|antipyretics|mesh-ancestor
102356117|NCT04142151|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102356118|NCT04142151|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102167816|NCT02123563|Listerine|listerine|mesh-list
102356119|NCT04142151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102356120|NCT04142151|Purinergic Agents|purinergic agents|mesh-ancestor
102356121|NCT04142151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102356122|NCT02985099|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102356123|NCT02985099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102356124|NCT02985099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102356125|NCT02985099|Antimetabolites|antimetabolites|mesh-ancestor
102356126|NCT02985099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356127|NCT02985099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102356128|NCT02985099|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102356129|NCT02985099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102356130|NCT03904329|Anticoagulants|anticoagulants|mesh-list
102356131|NCT04149483|Atorvastatin|atorvastatin|mesh-list
102356132|NCT04149483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102056779|NCT03140956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102056855|NCT03642067|Nivolumab|nivolumab|mesh-list
102356133|NCT04149483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102356134|NCT04149483|Antimetabolites|antimetabolites|mesh-ancestor
102356135|NCT04149483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356136|NCT04149483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102356137|NCT04149483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102356138|NCT04149483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102356139|NCT04149327|Amoxicillin|amoxicillin|mesh-list
102356140|NCT04149327|Metronidazole|metronidazole|mesh-list
102356141|NCT04149327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102356142|NCT04149327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102356143|NCT04149327|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102356144|NCT04149327|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102356145|NCT05582577|Bevacizumab|bevacizumab|mesh-list
102356146|NCT05582577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102356147|NCT05582577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102356148|NCT05582577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102356149|NCT05582577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102356150|NCT05582577|Growth Substances|growth substances|mesh-ancestor
102356151|NCT05582577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356152|NCT05582577|Growth Inhibitors|growth inhibitors|mesh-ancestor
102356153|NCT04149015|Paclitaxel|paclitaxel|mesh-list
102356154|NCT04149015|Fluorouracil|fluorouracil|mesh-list
102356155|NCT04149015|Oxaliplatin|oxaliplatin|mesh-list
102356156|NCT04149015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102356157|NCT04149015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102356158|NCT04149015|Tubulin Modulators|tubulin modulators|mesh-ancestor
102356159|NCT04149015|Antimitotic Agents|antimitotic agents|mesh-ancestor
102356160|NCT04149015|Mitosis Modulators|mitosis modulators|mesh-ancestor
102356161|NCT04149015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356162|NCT04149015|Antimetabolites|antimetabolites|mesh-ancestor
102356163|NCT04149015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102356164|NCT04149015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102356165|NCT04149015|Immunologic Factors|immunologic factors|mesh-ancestor
102356166|NCT04149015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356167|NCT04149171|Tranexamic Acid|tranexamic acid|mesh-list
102356168|NCT04149171|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102356169|NCT04149171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102356170|NCT04149171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356171|NCT04149171|Hemostatics|hemostatics|mesh-ancestor
102356172|NCT04149171|Coagulants|coagulants|mesh-ancestor
102356173|NCT04140591|Propranolol|propranolol|mesh-list
102356174|NCT04140591|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
102356175|NCT04140591|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102356176|NCT04140591|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102356177|NCT04140591|Adrenergic Agents|adrenergic agents|mesh-ancestor
102356178|NCT04140591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102356179|NCT04140591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356180|NCT04140591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356181|NCT04140591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102356182|NCT04140591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102356183|NCT04140591|Vasodilator Agents|vasodilator agents|mesh-ancestor
102356184|NCT04140591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102356185|NCT05582109|Lenvatinib|lenvatinib|mesh-list
102356186|NCT05582109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102356187|NCT05582109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102356188|NCT05582109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102356189|NCT05582109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356190|NCT03020901|Teicoplanin|teicoplanin|mesh-list
102356191|NCT03020901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102356192|NCT03020901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102356193|NCT04140201|Simvastatin|simvastatin|mesh-list
102356194|NCT04140201|Fenofibrate|fenofibrate|mesh-list
102356195|NCT04140201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102356196|NCT04140201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102356197|NCT04140201|Antimetabolites|antimetabolites|mesh-ancestor
102356198|NCT04140201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356199|NCT04140201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102356200|NCT04140201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102356201|NCT04140201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102356202|NCT05581875|Dexamethasone|dexamethasone|mesh-list
102356203|NCT05581875|Daratumumab|daratumumab|mesh-list
102356204|NCT05581875|Pomalidomide|pomalidomide|mesh-list
102356205|NCT05581875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102356206|NCT05581875|Antiemetics|antiemetics|mesh-ancestor
102356207|NCT05581875|Autonomic Agents|autonomic agents|mesh-ancestor
102356208|NCT05581875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102356209|NCT05581875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356210|NCT05581875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102356211|NCT05581875|Glucocorticoids|glucocorticoids|mesh-ancestor
102356212|NCT05581875|Hormones|hormones|mesh-ancestor
102356213|NCT05581875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102356214|NCT05581875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102356215|NCT05581875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102356216|NCT05581875|Immunologic Factors|immunologic factors|mesh-ancestor
102356217|NCT05581875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102356218|NCT05581875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102356219|NCT05581875|Growth Substances|growth substances|mesh-ancestor
102356220|NCT05581875|Growth Inhibitors|growth inhibitors|mesh-ancestor
102356221|NCT04406025|Anesthetics|anesthetics|mesh-list
102356222|NCT04406025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102356223|NCT04406025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356224|NCT05587881|Vaccines|vaccines|mesh-list
102356225|NCT05587881|Immunologic Factors|immunologic factors|mesh-ancestor
102356226|NCT05587881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356227|NCT05582421|Diclofenac|diclofenac|mesh-list
102356228|NCT05582421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102356229|NCT05582421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102356230|NCT05582421|Analgesics|analgesics|mesh-ancestor
102356231|NCT05582421|Sensory System Agents|sensory system agents|mesh-ancestor
102356232|NCT05582421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102356233|NCT05582421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356234|NCT05582421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102356235|NCT05582421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102356236|NCT05582421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102356237|NCT05582421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102356238|NCT05582421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356239|NCT03580473|Moxifloxacin|moxifloxacin|mesh-list
102356240|NCT03580473|Dexamethasone|dexamethasone|mesh-list
102356241|NCT03580473|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102356242|NCT03580473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102356243|NCT03580473|Antiemetics|antiemetics|mesh-ancestor
102356244|NCT03580473|Autonomic Agents|autonomic agents|mesh-ancestor
102356245|NCT03580473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102356246|NCT03580473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356247|NCT03580473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102356248|NCT03580473|Glucocorticoids|glucocorticoids|mesh-ancestor
102356249|NCT03580473|Hormones|hormones|mesh-ancestor
102356250|NCT03580473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102356251|NCT03580473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102356252|NCT03580473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102356253|NCT03580473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102356254|NCT03580473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356255|NCT03580473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102356256|NCT03580473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102356257|NCT03580473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102356258|NCT03580473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102356259|NCT03580473|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102356260|NCT03580473|Contraceptive Agents|contraceptive agents|mesh-ancestor
102356261|NCT03580473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102356262|NCT03580473|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102356263|NCT03580473|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102356264|NCT03580473|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102356265|NCT03897309|Vaccines|vaccines|mesh-list
102356266|NCT03897309|Immunologic Factors|immunologic factors|mesh-ancestor
102356267|NCT03897309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167963|NCT03285087|Dexmedetomidine|dexmedetomidine|mesh-list
102356268|NCT03588429|Sevoflurane|sevoflurane|mesh-list
102356269|NCT03588429|Isoflurane|isoflurane|mesh-list
102356270|NCT03588429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102356271|NCT03588429|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102356272|NCT03588429|Anesthetics, General|anesthetics, general|mesh-ancestor
102356273|NCT03588429|Anesthetics|anesthetics|mesh-ancestor
102356274|NCT03588429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102356275|NCT03588429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057146|NCT05085652|Anesthetics|anesthetics|mesh-list
102356276|NCT03580161|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
102356277|NCT03580161|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
102356278|NCT03580161|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
102356279|NCT03580161|Technetium Tc 99m Dimercaptosuccinic Acid|technetium tc 99m dimercaptosuccinic acid|mesh-list
102356280|NCT03580161|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102356281|NCT03580161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356282|NCT03588351|Chlorhexidine|chlorhexidine|mesh-list
102356283|NCT03588351|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102356284|NCT03588351|Chitosan|chitosan|mesh-list
102356285|NCT03588351|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102356286|NCT03588351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102356287|NCT03588351|Disinfectants|disinfectants|mesh-ancestor
102356288|NCT03588351|Dermatologic Agents|dermatologic agents|mesh-ancestor
102356289|NCT03588351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102356290|NCT03588351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102356291|NCT03588351|Antimetabolites|antimetabolites|mesh-ancestor
102356292|NCT03588351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356293|NCT03588351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102356294|NCT03588351|Chelating Agents|chelating agents|mesh-ancestor
102356295|NCT03588351|Sequestering Agents|sequestering agents|mesh-ancestor
102356296|NCT03588351|Hemostatics|hemostatics|mesh-ancestor
102356297|NCT03588351|Coagulants|coagulants|mesh-ancestor
102356298|NCT03588273|Amoxicillin|amoxicillin|mesh-list
102356299|NCT03588273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102356300|NCT03588273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102356301|NCT02984865|Flurbiprofen|flurbiprofen|mesh-list
102356302|NCT02984865|Sufentanil|sufentanil|mesh-list
102356303|NCT02984865|Nalbuphine|nalbuphine|mesh-list
102356304|NCT02984865|Dsuvia|dsuvia|mesh-list
102356305|NCT02984865|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102356306|NCT02984865|Narcotics|narcotics|mesh-ancestor
102356307|NCT02984865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102356308|NCT02984865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356309|NCT02984865|Analgesics|analgesics|mesh-ancestor
102356310|NCT02984865|Sensory System Agents|sensory system agents|mesh-ancestor
102356311|NCT02984865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102356312|NCT02984865|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102356313|NCT02984865|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102356314|NCT02984865|Anesthetics, General|anesthetics, general|mesh-ancestor
102356315|NCT02984865|Anesthetics|anesthetics|mesh-ancestor
102356316|NCT02984865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102356317|NCT02984865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102356318|NCT02984865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102356319|NCT02984865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102356320|NCT02984865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102356321|NCT02984865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102356322|NCT02984865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356323|NCT01797445|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102356324|NCT01797445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102356325|NCT01797445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102356326|NCT01797445|Antiviral Agents|antiviral agents|mesh-ancestor
102356327|NCT01797445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102356328|NCT03935451|Apixaban|apixaban|mesh-list
102356329|NCT03935451|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102356330|NCT03935451|Antithrombins|antithrombins|mesh-ancestor
102356331|NCT03935451|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102356332|NCT03935451|Protease Inhibitors|protease inhibitors|mesh-ancestor
102356333|NCT03935451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102356334|NCT03935451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356335|NCT03935451|Anticoagulants|anticoagulants|mesh-ancestor
102356336|NCT01611259|Rituximab|rituximab|mesh-list
102356337|NCT01611259|Lenalidomide|lenalidomide|mesh-list
102356338|NCT01611259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102356339|NCT01611259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102356340|NCT01611259|Immunologic Factors|immunologic factors|mesh-ancestor
102356341|NCT01611259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356342|NCT01611259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102356343|NCT01611259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102168062|NCT03078842|Zinc|zinc|mesh-list
102356344|NCT01611259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102356345|NCT01611259|Growth Substances|growth substances|mesh-ancestor
102356346|NCT01611259|Growth Inhibitors|growth inhibitors|mesh-ancestor
102356347|NCT03586869|Leucovorin|leucovorin|mesh-list
102356348|NCT03586869|Paclitaxel|paclitaxel|mesh-list
102356349|NCT03586869|Cyclophosphamide|cyclophosphamide|mesh-list
102356350|NCT03586869|Bevacizumab|bevacizumab|mesh-list
102356351|NCT03586869|Fluorouracil|fluorouracil|mesh-list
102356352|NCT03586869|Capecitabine|capecitabine|mesh-list
102356353|NCT03586869|Oxaliplatin|oxaliplatin|mesh-list
102356354|NCT03586869|Avelumab|avelumab|mesh-list
102356355|NCT03586869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102356356|NCT03586869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102356357|NCT03586869|Tubulin Modulators|tubulin modulators|mesh-ancestor
102356358|NCT03586869|Antimitotic Agents|antimitotic agents|mesh-ancestor
102356359|NCT03586869|Mitosis Modulators|mitosis modulators|mesh-ancestor
102356360|NCT03586869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356361|NCT03586869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102356362|NCT03586869|Immunologic Factors|immunologic factors|mesh-ancestor
102356363|NCT03586869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356364|NCT03586869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102356365|NCT03586869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102356366|NCT03586869|Alkylating Agents|alkylating agents|mesh-ancestor
102356367|NCT03586869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102356368|NCT03586869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102356369|NCT03586869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102356370|NCT03586869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102356371|NCT03586869|Growth Substances|growth substances|mesh-ancestor
102356372|NCT03586869|Growth Inhibitors|growth inhibitors|mesh-ancestor
102356373|NCT03586869|Antimetabolites|antimetabolites|mesh-ancestor
102356374|NCT03586869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102356375|NCT03586869|Antidotes|antidotes|mesh-ancestor
102356376|NCT03586869|Protective Agents|protective agents|mesh-ancestor
102356377|NCT03586869|Vitamin B Complex|vitamin b complex|mesh-ancestor
102356378|NCT03586869|Vitamins|vitamins|mesh-ancestor
102356379|NCT03586869|Micronutrients|micronutrients|mesh-ancestor
102356380|NCT03586791|Anesthetics|anesthetics|mesh-list
102356381|NCT03586791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102356382|NCT03586791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356383|NCT01795495|Magnesium Sulfate|magnesium sulfate|mesh-list
102356384|NCT01795495|Remifentanil|remifentanil|mesh-list
102356385|NCT01795495|Methadone|methadone|mesh-list
102356386|NCT01795495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102356387|NCT01795495|Narcotics|narcotics|mesh-ancestor
102356388|NCT01795495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102356389|NCT01795495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356390|NCT01795495|Analgesics|analgesics|mesh-ancestor
102356391|NCT01795495|Sensory System Agents|sensory system agents|mesh-ancestor
102356392|NCT01795495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102356393|NCT01795495|Anesthetics|anesthetics|mesh-ancestor
102356394|NCT01795495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102356395|NCT01795495|Anticonvulsants|anticonvulsants|mesh-ancestor
102356396|NCT01795495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102356397|NCT01795495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102356398|NCT01795495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356399|NCT01795495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102356400|NCT01795495|Tocolytic Agents|tocolytic agents|mesh-ancestor
102356401|NCT01795495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102356402|NCT01795495|Antitussive Agents|antitussive agents|mesh-ancestor
102356403|NCT01795495|Respiratory System Agents|respiratory system agents|mesh-ancestor
102356404|NCT04765527|Turmeric extract|turmeric extract|mesh-list
102356405|NCT04765527|Antioxidants|antioxidants|mesh-ancestor
102356406|NCT04765527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356407|NCT04765527|Protective Agents|protective agents|mesh-ancestor
102356408|NCT04765527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356409|NCT02947503|Metformin|metformin|mesh-list
102356410|NCT02947503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102356411|NCT02947503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356412|NCT03586323|Lidocaine|lidocaine|mesh-list
102356413|NCT03586323|Anesthetics, Local|anesthetics, local|mesh-ancestor
102356414|NCT03586323|Anesthetics|anesthetics|mesh-ancestor
102356415|NCT03586323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102356416|NCT03586323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356417|NCT03586323|Sensory System Agents|sensory system agents|mesh-ancestor
102356418|NCT03586323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102356419|NCT03586323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102356420|NCT03586323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102356421|NCT03586323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102356422|NCT03586323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102356423|NCT03586323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356424|NCT03586089|Diazepam|diazepam|mesh-list
102356425|NCT03586089|Phenobarbital|phenobarbital|mesh-list
102356426|NCT03586089|Anticonvulsants|anticonvulsants|mesh-ancestor
102356427|NCT03586089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102356428|NCT03586089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102356429|NCT03586089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356430|NCT03586089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102356431|NCT03586089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102356432|NCT03586089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102356433|NCT03586089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356434|NCT03586089|GABA Modulators|gaba modulators|mesh-ancestor
102356435|NCT03586089|GABA Agents|gaba agents|mesh-ancestor
102356436|NCT03586089|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102356437|NCT03586089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102356438|NCT03586089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102356439|NCT03586089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102356440|NCT03586089|Antiemetics|antiemetics|mesh-ancestor
102356441|NCT03586089|Autonomic Agents|autonomic agents|mesh-ancestor
102356442|NCT03586089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102356443|NCT03586089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102356444|NCT03586089|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102356445|NCT03586089|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102356446|NCT03586089|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102356447|NCT03586089|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102356448|NCT03586089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102356449|NCT03586089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102356450|NCT03586089|Anesthetics, General|anesthetics, general|mesh-ancestor
102356451|NCT03586089|Anesthetics|anesthetics|mesh-ancestor
102356452|NCT01986881|Ertugliflozin|ertugliflozin|mesh-list
102356453|NCT01986881|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102356454|NCT01986881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356455|NCT01986881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102356456|NCT01986881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356457|NCT03580395|Paclitaxel|paclitaxel|mesh-list
102356458|NCT03580395|Apatinib|apatinib|mesh-list
102356459|NCT03580395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102356460|NCT03580395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102356461|NCT03580395|Tubulin Modulators|tubulin modulators|mesh-ancestor
102356462|NCT03580395|Antimitotic Agents|antimitotic agents|mesh-ancestor
102356463|NCT03580395|Mitosis Modulators|mitosis modulators|mesh-ancestor
102356464|NCT03580395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356465|NCT03580395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102356466|NCT03580395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102356467|NCT01609543|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102356468|NCT01609543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102356469|NCT01609543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102356470|NCT01609543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102356471|NCT01609543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356472|NCT03580239|Everolimus|everolimus|mesh-list
102356473|NCT03580239|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102356474|NCT03580239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102356475|NCT03580239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102356476|NCT03580239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356477|NCT03580239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102356478|NCT03580239|Immunologic Factors|immunologic factors|mesh-ancestor
102356479|NCT03580239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356480|NCT03580239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102356481|NCT03156153|Bumetanide|bumetanide|mesh-list
102356482|NCT03156153|Diuretics|diuretics|mesh-ancestor
102356483|NCT03156153|Natriuretic Agents|natriuretic agents|mesh-ancestor
102356484|NCT03156153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356485|NCT03156153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102356486|NCT03156153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102356487|NCT03156153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356488|NCT03156231|Acetazolamide|acetazolamide|mesh-list
102356489|NCT03156231|Anticonvulsants|anticonvulsants|mesh-ancestor
102059544|NCT05357989|Phenserine|phenserine|mesh-list
102356490|NCT03156231|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102356491|NCT03156231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102168199|NCT03264651|Anastrozole|anastrozole|mesh-list
102356492|NCT03156231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356493|NCT03156231|Diuretics|diuretics|mesh-ancestor
102356494|NCT03156231|Natriuretic Agents|natriuretic agents|mesh-ancestor
102356495|NCT03156231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356496|NCT05702151|Morphine|morphine|mesh-list
102356497|NCT05702151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102356498|NCT05702151|Narcotics|narcotics|mesh-ancestor
102356499|NCT05702151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102356500|NCT05702151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356501|NCT05702151|Analgesics|analgesics|mesh-ancestor
102356502|NCT05702151|Sensory System Agents|sensory system agents|mesh-ancestor
102356503|NCT05702151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102356504|NCT01985321|Ethanol|ethanol|mesh-list
102356505|NCT01985321|Glycolic acid|glycolic acid|mesh-list
102356506|NCT01985321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102356507|NCT01985321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102356508|NCT01985321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102356509|NCT01985321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356510|NCT01985321|Keratolytic Agents|keratolytic agents|mesh-ancestor
102356511|NCT01985321|Dermatologic Agents|dermatologic agents|mesh-ancestor
102356512|NCT03584919|Doxycycline|doxycycline|mesh-list
102356513|NCT03584919|Cefuroxime|cefuroxime|mesh-list
102356514|NCT03584919|Cefuroxime axetil|cefuroxime axetil|mesh-list
102356515|NCT03584919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102356516|NCT03584919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102356517|NCT03584919|Antimalarials|antimalarials|mesh-ancestor
102356518|NCT03584919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102356519|NCT03584919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102356520|NCT03584841|Pilocarpine|pilocarpine|mesh-list
102356521|NCT03584841|Miotics|miotics|mesh-ancestor
102356522|NCT03584841|Autonomic Agents|autonomic agents|mesh-ancestor
102356523|NCT03584841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102356524|NCT03584841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356525|NCT03584841|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102356526|NCT03584841|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102356527|NCT03584841|Cholinergic Agents|cholinergic agents|mesh-ancestor
102356528|NCT03584841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102356529|NCT03584841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356530|NCT02000921|Nicotine|nicotine|mesh-list
102356531|NCT02000921|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102356532|NCT02000921|Autonomic Agents|autonomic agents|mesh-ancestor
102356533|NCT02000921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102356534|NCT02000921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356535|NCT02000921|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102356536|NCT02000921|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102356537|NCT02000921|Cholinergic Agents|cholinergic agents|mesh-ancestor
102356538|NCT02000921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102356539|NCT02000921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356540|NCT03586947|Vitamin D|vitamin d|mesh-list
102356541|NCT03586947|Ergocalciferols|ergocalciferols|mesh-list
102356542|NCT03586947|Cholecalciferol|cholecalciferol|mesh-list
102356543|NCT03586947|Vitamins|vitamins|mesh-list
102356544|NCT03586947|Micronutrients|micronutrients|mesh-ancestor
102356545|NCT03586947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356546|NCT03586947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102356547|NCT03586947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102356548|NCT03584529|Vitamin D|vitamin d|mesh-list
102356549|NCT03584529|Cholecalciferol|cholecalciferol|mesh-list
102356550|NCT03584529|Vitamins|vitamins|mesh-ancestor
102356551|NCT03584529|Micronutrients|micronutrients|mesh-ancestor
102356552|NCT03584529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356553|NCT03584529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102356554|NCT03584529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102356555|NCT00724984|Abexinostat|abexinostat|mesh-list
102356556|NCT00724984|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102356557|NCT00724984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102356558|NCT00724984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356559|NCT03113253|Tranexamic Acid|tranexamic acid|mesh-list
102356560|NCT03113253|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102356561|NCT03113253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102356562|NCT03113253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356563|NCT03113253|Hemostatics|hemostatics|mesh-ancestor
102356564|NCT03113253|Coagulants|coagulants|mesh-ancestor
102356565|NCT01836523|Liraglutide|liraglutide|mesh-list
102356566|NCT01836523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102356567|NCT01836523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356568|NCT01836523|Incretins|incretins|mesh-ancestor
102168264|NCT02126995|Metadoxine|metadoxine|mesh-list
102356569|NCT01836523|Hormones|hormones|mesh-ancestor
102356570|NCT01836523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102356571|NCT01275196|Imatinib Mesylate|imatinib mesylate|mesh-list
102356572|NCT01275196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102356573|NCT01275196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102356574|NCT01275196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102356575|NCT01275196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356576|NCT03583749|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102356577|NCT03583749|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102356578|NCT03583749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102356579|NCT03583749|Antitubercular Agents|antitubercular agents|mesh-ancestor
102356580|NCT02000531|Cisplatin|cisplatin|mesh-list
102356581|NCT02000531|Gemcitabine|gemcitabine|mesh-list
102356582|NCT02000531|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102356583|NCT02000531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102356584|NCT02000531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102356585|NCT02000531|Antimetabolites|antimetabolites|mesh-ancestor
102356586|NCT02000531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356587|NCT02000531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102356588|NCT02000531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102356589|NCT01609231|Irinotecan|irinotecan|mesh-list
102356590|NCT01609231|Cetuximab|cetuximab|mesh-list
102356591|NCT01609231|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102356592|NCT01609231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102356593|NCT01609231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102356594|NCT01609231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356595|NCT01609231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102356596|NCT01609231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102356597|NCT04438187|Anti-Infective Agents|anti-infective agents|mesh-list
102356598|NCT04438187|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102356599|NCT02092025|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
102356600|NCT02092025|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102356601|NCT02092025|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102356602|NCT02092025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356603|NCT04405011|Entecavir|entecavir|mesh-list
102356604|NCT04405011|Antiviral Agents|antiviral agents|mesh-ancestor
102356605|NCT04405011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102356606|NCT01769443|Bortezomib|bortezomib|mesh-list
102356607|NCT01769443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102356608|NCT03154827|Atezolizumab|atezolizumab|mesh-list
102356609|NCT03154827|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102356610|NCT03154827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356611|NCT03154827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102356612|NCT03154827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102356613|NCT01274182|Rituximab|rituximab|mesh-list
102356614|NCT01274182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102356615|NCT01274182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102356616|NCT01274182|Immunologic Factors|immunologic factors|mesh-ancestor
102356617|NCT01274182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356618|NCT01274182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102356619|NCT01984229|Posaconazole|posaconazole|mesh-list
102356620|NCT01984229|Antifungal Agents|antifungal agents|mesh-ancestor
102356621|NCT01984229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102356622|NCT01984229|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102356623|NCT01984229|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102356624|NCT01984229|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102356625|NCT01984229|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102356626|NCT01984229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102356627|NCT01984229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102356628|NCT01984229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356629|NCT01984229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102356630|NCT01984229|Hormone Antagonists|hormone antagonists|mesh-ancestor
102356631|NCT01984229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102356632|NCT01984229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356633|NCT01274104|Vitamin D|vitamin d|mesh-list
102061954|NCT02155166|Ibuprofen|ibuprofen|mesh-list
102356634|NCT01274104|Cholecalciferol|cholecalciferol|mesh-list
102356635|NCT01274104|Vitamins|vitamins|mesh-ancestor
102356636|NCT01274104|Micronutrients|micronutrients|mesh-ancestor
102356637|NCT01274104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356638|NCT01274104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102356639|NCT01274104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102356640|NCT01279096|Dexamethasone|dexamethasone|mesh-list
102356641|NCT01279096|Etoposide|etoposide|mesh-list
102356642|NCT01279096|Asparaginase|asparaginase|mesh-list
102356643|NCT01279096|Mitoxantrone|mitoxantrone|mesh-list
102356644|NCT01279096|Clofarabine|clofarabine|mesh-list
102356645|NCT01279096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102356646|NCT01279096|Antiemetics|antiemetics|mesh-ancestor
102356647|NCT01279096|Autonomic Agents|autonomic agents|mesh-ancestor
102356648|NCT01279096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102356649|NCT01279096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356650|NCT01279096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102356651|NCT01279096|Glucocorticoids|glucocorticoids|mesh-ancestor
102356652|NCT01279096|Hormones|hormones|mesh-ancestor
102356653|NCT01279096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102356654|NCT01279096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102356655|NCT01279096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102356656|NCT01279096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102356657|NCT01279096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356658|NCT01279096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102356659|NCT01279096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102356660|NCT01279096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102356661|NCT01279096|Analgesics|analgesics|mesh-ancestor
102356662|NCT01279096|Sensory System Agents|sensory system agents|mesh-ancestor
102356663|NCT01279096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102356664|NCT01279096|Antimetabolites|antimetabolites|mesh-ancestor
102356665|NCT01272934|Diclofenac|diclofenac|mesh-list
102356666|NCT01272934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102356667|NCT01272934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102356668|NCT01272934|Analgesics|analgesics|mesh-ancestor
102356669|NCT01272934|Sensory System Agents|sensory system agents|mesh-ancestor
102356670|NCT01272934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102356671|NCT01272934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356672|NCT01272934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102356673|NCT01272934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102356674|NCT01272934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102356675|NCT01272934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102356676|NCT01272934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356677|NCT01279252|Metronidazole|metronidazole|mesh-list
102356678|NCT01279252|Clarithromycin|clarithromycin|mesh-list
102356679|NCT01279252|Ciprofloxacin|ciprofloxacin|mesh-list
102356680|NCT01279252|Lansoprazole|lansoprazole|mesh-list
102356681|NCT01279252|Dexlansoprazole|dexlansoprazole|mesh-list
102356682|NCT01279252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102356683|NCT01279252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102356684|NCT01279252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102356685|NCT01279252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102356686|NCT01279252|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102356687|NCT01279252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102356688|NCT01279252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356689|NCT01279252|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102356690|NCT01279252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101836612|NCT00308620|Filaricides|filaricides|mesh-ancestor
102356691|NCT01279252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102356692|NCT01279252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102356693|NCT01279252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102356694|NCT01279252|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102356695|NCT01279252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102356696|NCT01279252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102356697|NCT01279252|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102356698|NCT04385836|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
102356699|NCT04385836|Protein C Inhibitor|protein c inhibitor|mesh-list
102356700|NCT04385836|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102356701|NCT04385836|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102356702|NCT04385836|Protease Inhibitors|protease inhibitors|mesh-ancestor
102356703|NCT04385836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102356704|NCT04385836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356705|NCT01274260|Methylprednisolone|methylprednisolone|mesh-list
102356706|NCT01274260|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102356707|NCT01274260|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102356708|NCT01274260|Prednisolone|prednisolone|mesh-list
102356709|NCT01274260|Prednisolone acetate|prednisolone acetate|mesh-list
102356710|NCT01274260|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102356711|NCT01274260|Prednisolone phosphate|prednisolone phosphate|mesh-list
102356712|NCT01274260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102356713|NCT01274260|Antiemetics|antiemetics|mesh-ancestor
102356714|NCT01274260|Autonomic Agents|autonomic agents|mesh-ancestor
102356715|NCT01274260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102356716|NCT01274260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356717|NCT01274260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102356718|NCT01274260|Glucocorticoids|glucocorticoids|mesh-ancestor
102356719|NCT01274260|Hormones|hormones|mesh-ancestor
102168413|NCT05075265|Analgesics|analgesics|mesh-ancestor
102356720|NCT01274260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102356721|NCT01274260|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102356722|NCT01274260|Protective Agents|protective agents|mesh-ancestor
102356723|NCT01274260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102356724|NCT01274260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102356725|NCT03154983|Docetaxel|docetaxel|mesh-list
102356726|NCT03154983|Apatinib|apatinib|mesh-list
102356727|NCT03154983|Tegafur|tegafur|mesh-list
102356728|NCT03154983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102356729|NCT03154983|Tubulin Modulators|tubulin modulators|mesh-ancestor
102356730|NCT03154983|Antimitotic Agents|antimitotic agents|mesh-ancestor
102356731|NCT03154983|Mitosis Modulators|mitosis modulators|mesh-ancestor
102356732|NCT03154983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356733|NCT03154983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102356734|NCT03154983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102356735|NCT03154983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102356736|NCT03154983|Antimetabolites|antimetabolites|mesh-ancestor
102356737|NCT01983683|Vancomycin|vancomycin|mesh-list
102356738|NCT01983683|Oxazolidinones|oxazolidinones|mesh-list
102356739|NCT01983683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102356740|NCT01983683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102356741|NCT01983683|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102356742|NCT01983683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102356743|NCT01983683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356744|NCT03154515|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
102356745|NCT03154515|Antiviral Agents|antiviral agents|mesh-ancestor
102356746|NCT03154515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102356747|NCT03158025|Zolpidem|zolpidem|mesh-list
102356748|NCT03158025|Suvorexant|suvorexant|mesh-list
102356749|NCT03158025|Lemborexant|lemborexant|mesh-list
102356750|NCT03158025|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102356751|NCT03158025|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102356752|NCT03158025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102356753|NCT03158025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356754|NCT03158025|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102356755|NCT03158025|GABA Agonists|gaba agonists|mesh-ancestor
102356756|NCT03158025|GABA Agents|gaba agents|mesh-ancestor
102356757|NCT03158025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102356758|NCT03158025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356759|NCT03158025|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102356760|NCT01998893|Rituximab|rituximab|mesh-list
102356761|NCT01998893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102356762|NCT01998893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102356763|NCT01998893|Immunologic Factors|immunologic factors|mesh-ancestor
102356764|NCT01998893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356765|NCT01998893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102356766|NCT01791985|Letrozole|letrozole|mesh-list
102356767|NCT01791985|Anastrozole|anastrozole|mesh-list
102356768|NCT01791985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102356769|NCT01791985|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102356770|NCT01791985|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102356771|NCT01791985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102356772|NCT01791985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356773|NCT01791985|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102356774|NCT01791985|Hormone Antagonists|hormone antagonists|mesh-ancestor
102356775|NCT01791985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102356776|NCT01791985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356777|NCT01791985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102356778|NCT04176497|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102356779|NCT04176497|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102356780|NCT04176497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356781|NCT01791517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102356782|NCT03154281|Everolimus|everolimus|mesh-list
102356783|NCT03154281|Niraparib|niraparib|mesh-list
102356784|NCT03154281|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102356785|NCT03154281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102356786|NCT03154281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102356787|NCT03154281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356788|NCT03154281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102356789|NCT03154281|Immunologic Factors|immunologic factors|mesh-ancestor
102356790|NCT03154281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356791|NCT03154281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102356792|NCT03154281|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102356793|NCT03157791|Simethicone|simethicone|mesh-list
102356794|NCT03157791|Antifoaming Agents|antifoaming agents|mesh-ancestor
102356795|NCT03157791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356796|NCT03157791|Emollients|emollients|mesh-ancestor
102356797|NCT03157791|Dermatologic Agents|dermatologic agents|mesh-ancestor
102356798|NCT05701059|Meloxicam|meloxicam|mesh-list
102356799|NCT05701059|Cimetidine|cimetidine|mesh-list
102356800|NCT05701059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102356801|NCT05701059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102356802|NCT05701059|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102356803|NCT05701059|Histamine Antagonists|histamine antagonists|mesh-ancestor
102356804|NCT05701059|Histamine Agents|histamine agents|mesh-ancestor
102356805|NCT05701059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102356806|NCT05701059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356807|NCT05701059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356808|NCT05701059|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102356809|NCT05701059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102356810|NCT05701059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102356811|NCT05701059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102356812|NCT05701059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102356813|NCT05701059|Analgesics|analgesics|mesh-ancestor
102356814|NCT05701059|Sensory System Agents|sensory system agents|mesh-ancestor
102356815|NCT05701059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102356816|NCT05701059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102356817|NCT05701059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102356818|NCT05701059|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102356819|NCT05701059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102356820|NCT03157479|Anesthetics|anesthetics|mesh-list
102356821|NCT03157479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
102356822|NCT03157479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102356823|NCT03157479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356824|NCT03157479|Anesthetics, General|anesthetics, general|mesh-ancestor
102356825|NCT03013491|Ipilimumab|ipilimumab|mesh-list
102356826|NCT03013491|Vemurafenib|vemurafenib|mesh-list
102356827|NCT03013491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102356828|NCT03013491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102356829|NCT03013491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102356830|NCT03013491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356831|NCT03013491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102356832|NCT03013491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102356833|NCT01272232|Liraglutide|liraglutide|mesh-list
102356834|NCT01272232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102356835|NCT01272232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356836|NCT01272232|Incretins|incretins|mesh-ancestor
102356837|NCT01272232|Hormones|hormones|mesh-ancestor
102356838|NCT01272232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102356839|NCT03157401|Tranexamic Acid|tranexamic acid|mesh-list
102356840|NCT03157401|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102356841|NCT03157401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102356842|NCT03157401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356843|NCT03157401|Hemostatics|hemostatics|mesh-ancestor
102356844|NCT03157401|Coagulants|coagulants|mesh-ancestor
102356845|NCT03153813|Capsaicin|capsaicin|mesh-list
102356846|NCT03153813|Antipruritics|antipruritics|mesh-ancestor
102356847|NCT03153813|Dermatologic Agents|dermatologic agents|mesh-ancestor
102356848|NCT03153813|Sensory System Agents|sensory system agents|mesh-ancestor
102356849|NCT03153813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102356850|NCT03153813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356851|NCT03156855|Bismuth|bismuth|mesh-list
102356852|NCT03156855|Antacids|antacids|mesh-ancestor
102356853|NCT03156855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356854|NCT03156855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102356855|NCT00739960|Abatacept|abatacept|mesh-list
102356856|NCT00739960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102356857|NCT00739960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356858|NCT00739960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102356859|NCT00739960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102356860|NCT00739960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102356861|NCT00739960|Immunologic Factors|immunologic factors|mesh-ancestor
102356862|NCT00739960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356863|NCT00739960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102356864|NCT03153657|Piroxicam|piroxicam|mesh-list
102356865|NCT03153657|Piroxicam-beta-cyclodextrin|piroxicam-beta-cyclodextrin|mesh-list
102356866|NCT03153657|Betadex|betadex|mesh-list
102356867|NCT03153657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102356868|NCT03153657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102356869|NCT03153657|Analgesics|analgesics|mesh-ancestor
102356870|NCT03153657|Sensory System Agents|sensory system agents|mesh-ancestor
102356871|NCT03153657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102356872|NCT03153657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356873|NCT03153657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102356875|NCT03153657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102356876|NCT03153657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102356877|NCT03153657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356878|NCT03153657|Sequestering Agents|sequestering agents|mesh-ancestor
102356879|NCT01670955|Folic Acid|folic acid|mesh-list
102356880|NCT01670955|Hematinics|hematinics|mesh-ancestor
102356881|NCT01670955|Vitamin B Complex|vitamin b complex|mesh-ancestor
102356882|NCT01670955|Vitamins|vitamins|mesh-ancestor
102356883|NCT01670955|Micronutrients|micronutrients|mesh-ancestor
102356884|NCT01670955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356885|NCT01275274|Tretinoin|tretinoin|mesh-list
102356886|NCT01275274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102356887|NCT01275274|Keratolytic Agents|keratolytic agents|mesh-ancestor
102356888|NCT01275274|Dermatologic Agents|dermatologic agents|mesh-ancestor
102356889|NCT01997333|Capecitabine|capecitabine|mesh-list
102356890|NCT01997333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102356891|NCT01997333|Antimetabolites|antimetabolites|mesh-ancestor
102356892|NCT01997333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356893|NCT01997333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102356894|NCT01271920|Trastuzumab|trastuzumab|mesh-list
102356895|NCT01271920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102356896|NCT01271920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102356897|NCT01275352|Eplerenone|eplerenone|mesh-list
102356898|NCT01275352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
102356899|NCT01275352|Hormone Antagonists|hormone antagonists|mesh-ancestor
102356900|NCT01275352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102356901|NCT01275352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356902|NCT01275352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102356903|NCT01275352|Diuretics|diuretics|mesh-ancestor
102356904|NCT01275352|Natriuretic Agents|natriuretic agents|mesh-ancestor
102356905|NCT01275352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102356906|NCT01676259|Paclitaxel|paclitaxel|mesh-list
102356907|NCT01676259|Gemcitabine|gemcitabine|mesh-list
102356908|NCT01676259|Folfirinox|folfirinox|mesh-list
102356909|NCT01676259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102356910|NCT01676259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102356911|NCT01676259|Tubulin Modulators|tubulin modulators|mesh-ancestor
102356912|NCT01676259|Antimitotic Agents|antimitotic agents|mesh-ancestor
102356913|NCT01676259|Mitosis Modulators|mitosis modulators|mesh-ancestor
102356914|NCT01676259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356915|NCT01676259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102356916|NCT01676259|Antimetabolites|antimetabolites|mesh-ancestor
102356917|NCT02662257|Propofol|propofol|mesh-list
102356918|NCT02662257|Sevoflurane|sevoflurane|mesh-list
102356919|NCT02662257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102356920|NCT02662257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102356921|NCT02662257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356922|NCT02662257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102356923|NCT02662257|Anesthetics, General|anesthetics, general|mesh-ancestor
102356924|NCT02662257|Anesthetics|anesthetics|mesh-ancestor
102356925|NCT02662257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102356926|NCT02662257|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102356927|NCT03153267|Doxycycline|doxycycline|mesh-list
102356928|NCT03153267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102356929|NCT03153267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102356930|NCT03153267|Antimalarials|antimalarials|mesh-ancestor
102356931|NCT03153267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102356932|NCT03153267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102356933|NCT00746512|Prednisone|prednisone|mesh-list
102356934|NCT00746512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102356935|NCT00746512|Glucocorticoids|glucocorticoids|mesh-ancestor
102356936|NCT00746512|Hormones|hormones|mesh-ancestor
102356937|NCT00746512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102356938|NCT00746512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356939|NCT00746512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102356940|NCT00746512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102356941|NCT05409027|Cortisone|cortisone|mesh-list
102356942|NCT05409027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102356943|NCT05409027|Glucocorticoids|glucocorticoids|mesh-list
102356944|NCT05409027|Hormones|hormones|mesh-ancestor
102356945|NCT05409027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102356946|NCT05409027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356947|NCT01982435|Ranibizumab|ranibizumab|mesh-list
102356948|NCT01982435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102356949|NCT01982435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102356950|NCT01982435|Growth Substances|growth substances|mesh-ancestor
102356951|NCT01982435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356952|NCT01982435|Growth Inhibitors|growth inhibitors|mesh-ancestor
102356953|NCT01982435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102356954|NCT00747214|Prednisolone|prednisolone|mesh-list
102356955|NCT00747214|Antirheumatic Agents|antirheumatic agents|mesh-list
102356956|NCT00747214|Dipyridamole|dipyridamole|mesh-list
102356957|NCT00747214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102356958|NCT00747214|Glucocorticoids|glucocorticoids|mesh-ancestor
102356960|NCT00747214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102356961|NCT00747214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356962|NCT00747214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102356963|NCT00747214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102356964|NCT00747214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102356965|NCT00747214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102356966|NCT00747214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356967|NCT00747214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102356968|NCT00747214|Vasodilator Agents|vasodilator agents|mesh-ancestor
102356969|NCT00753142|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102356970|NCT00753142|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102356971|NCT00753142|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102356972|NCT00753142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102356973|NCT01279876|Melatonin|melatonin|mesh-list
102356974|NCT01279876|Antioxidants|antioxidants|mesh-ancestor
102356975|NCT01279876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356976|NCT01279876|Protective Agents|protective agents|mesh-ancestor
102356977|NCT01279876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356978|NCT01279876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102356979|NCT01996709|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102068833|NCT01483742|Ritonavir|ritonavir|mesh-list
102356980|NCT01996709|Contact Lens Solutions|contact lens solutions|mesh-list
102356981|NCT01996709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102356982|NCT01996709|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102356983|NCT01996709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102356984|NCT01996709|Disinfectants|disinfectants|mesh-ancestor
102356985|NCT00753220|Cyclophosphamide|cyclophosphamide|mesh-list
102356986|NCT00753220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102356987|NCT00753220|Immunologic Factors|immunologic factors|mesh-ancestor
102356988|NCT00753220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102356989|NCT00753220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102356990|NCT00753220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102356991|NCT00753220|Alkylating Agents|alkylating agents|mesh-ancestor
102356992|NCT00753220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356993|NCT00753220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102356994|NCT00753220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102356995|NCT01279954|Abatacept|abatacept|mesh-list
102356996|NCT01279954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102356997|NCT01279954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102356998|NCT01279954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102356999|NCT01279954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102357000|NCT01279954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102357001|NCT01279954|Immunologic Factors|immunologic factors|mesh-ancestor
102357002|NCT01279954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357003|NCT01279954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102357004|NCT00763048|Triclosan|triclosan|mesh-list
102357005|NCT00763048|Fluorides|fluorides|mesh-list
102357006|NCT00763048|Cariostatic Agents|cariostatic agents|mesh-ancestor
102357007|NCT00763048|Protective Agents|protective agents|mesh-ancestor
102357008|NCT00763048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357009|NCT00763048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102357010|NCT00763048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102357011|NCT00763048|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102357012|NCT00763048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102357013|NCT00763048|Antimetabolites|antimetabolites|mesh-ancestor
102357014|NCT00763048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357015|NCT00763048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102357016|NCT01278394|Tavaborole|tavaborole|mesh-list
102357017|NCT01278394|Antifungal Agents|antifungal agents|mesh-ancestor
102357018|NCT01278394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102357019|NCT00240916|Vaccines|vaccines|mesh-list
102357020|NCT00240916|Immunologic Factors|immunologic factors|mesh-ancestor
102357021|NCT00240916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357022|NCT01278160|Insulin|insulin|mesh-list
102357023|NCT01278160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102357024|NCT01278160|Metformin|metformin|mesh-list
102357025|NCT01278160|Insulin Aspart|insulin aspart|mesh-list
102357026|NCT01278160|Insulin, Long-Acting|insulin, long-acting|mesh-list
102357027|NCT01278160|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102357028|NCT01278160|Biphasic Insulins|biphasic insulins|mesh-list
102357029|NCT01278160|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
102357030|NCT01278160|Insulin, Isophane|insulin, isophane|mesh-list
102357031|NCT01278160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102357032|NCT01278160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357033|NCT00748072|Vasopressins|vasopressins|mesh-list
102357034|NCT00748072|Hemostatics|hemostatics|mesh-ancestor
102357035|NCT00748072|Coagulants|coagulants|mesh-ancestor
102357036|NCT00748072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102357037|NCT00748072|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102357038|NCT00748072|Natriuretic Agents|natriuretic agents|mesh-ancestor
102357039|NCT00748072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357040|NCT01835587|Cc-486|cc-486|mesh-list
102357041|NCT01835587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102357042|NCT01736917|Dexamethasone|dexamethasone|mesh-list
102357043|NCT01736917|Fosaprepitant|fosaprepitant|mesh-list
102357044|NCT01736917|Aprepitant|aprepitant|mesh-list
102357045|NCT01736917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102357046|NCT01736917|Antiemetics|antiemetics|mesh-ancestor
102357047|NCT01736917|Autonomic Agents|autonomic agents|mesh-ancestor
102357048|NCT01736917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102357049|NCT01736917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357050|NCT01736917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102357051|NCT01736917|Glucocorticoids|glucocorticoids|mesh-ancestor
102357052|NCT01736917|Hormones|hormones|mesh-ancestor
102357053|NCT01736917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102357054|NCT01736917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102357055|NCT01736917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102357056|NCT01736917|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102357057|NCT01736917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102357058|NCT01736917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357059|NCT01277302|Ranibizumab|ranibizumab|mesh-list
102357060|NCT01277302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102357061|NCT01277302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102357062|NCT01277302|Growth Substances|growth substances|mesh-ancestor
102357063|NCT01277302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357064|NCT01277302|Growth Inhibitors|growth inhibitors|mesh-ancestor
102357065|NCT01277302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102357066|NCT04414579|Insulin|insulin|mesh-list
102357067|NCT04414579|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102357068|NCT04414579|Insulin Aspart|insulin aspart|mesh-list
102357069|NCT04414579|Insulin, Long-Acting|insulin, long-acting|mesh-list
102357070|NCT04414579|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102357071|NCT04414579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102357072|NCT04414579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357073|NCT01980875|Obinutuzumab|obinutuzumab|mesh-list
102357074|NCT01980875|Idelalisib|idelalisib|mesh-list
102357075|NCT01980875|Chlorambucil|chlorambucil|mesh-list
102357076|NCT01980875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102357077|NCT01980875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102357078|NCT01980875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102357079|NCT01980875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357080|NCT01980875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102357081|NCT01980875|Alkylating Agents|alkylating agents|mesh-ancestor
102357082|NCT01967225|Linezolid|linezolid|mesh-list
102357083|NCT01967225|Tedizolid|tedizolid|mesh-list
102357084|NCT01967225|Tedizolid phosphate|tedizolid phosphate|mesh-list
102357085|NCT01967225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102357086|NCT01967225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102357087|NCT01967225|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102357088|NCT01967225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102357089|NCT01967225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357090|NCT01967147|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102357091|NCT01967147|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102357092|NCT01790503|Temozolomide|temozolomide|mesh-list
102357093|NCT01790503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102357094|NCT01790503|Alkylating Agents|alkylating agents|mesh-ancestor
102357095|NCT01790503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357096|NCT01790503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102357097|NCT01765543|Rifampin|rifampin|mesh-list
102357098|NCT01765543|Vemurafenib|vemurafenib|mesh-list
102357099|NCT01765543|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102357100|NCT01765543|Antitubercular Agents|antitubercular agents|mesh-ancestor
102357101|NCT01765543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102357102|NCT01765543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102357103|NCT01765543|Leprostatic Agents|leprostatic agents|mesh-ancestor
102357104|NCT01765543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102357105|NCT01765543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102357106|NCT01765543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357107|NCT01765543|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102357108|NCT01765543|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102357109|NCT01765543|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102357110|NCT01765543|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102357111|NCT01765543|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102357112|NCT01765543|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102357113|NCT01765543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102357114|NCT01765543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102357115|NCT00248170|Letrozole|letrozole|mesh-list
102357116|NCT00248170|Anastrozole|anastrozole|mesh-list
102357117|NCT00248170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102357118|NCT00248170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102357119|NCT00248170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102357120|NCT00248170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102357121|NCT00248170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357122|NCT00248170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102357123|NCT00248170|Hormone Antagonists|hormone antagonists|mesh-ancestor
102357124|NCT00248170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102357125|NCT00248170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357126|NCT00248170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102357127|NCT01764997|Adalimumab|adalimumab|mesh-list
102357128|NCT01764997|Etanercept|etanercept|mesh-list
102357129|NCT01764997|Methotrexate|methotrexate|mesh-list
102357130|NCT01764997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102357131|NCT01764997|Abortifacient Agents|abortifacient agents|mesh-ancestor
102357132|NCT01764997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102357133|NCT01764997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357134|NCT01764997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102357135|NCT01764997|Antimetabolites|antimetabolites|mesh-ancestor
102357136|NCT01764997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357137|NCT01764997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102357138|NCT01764997|Dermatologic Agents|dermatologic agents|mesh-ancestor
102357139|NCT01764997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102357140|NCT01764997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102357141|NCT01764997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102357142|NCT01764997|Immunologic Factors|immunologic factors|mesh-ancestor
102357143|NCT01764997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102357144|NCT01764997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102357145|NCT01764997|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102357146|NCT01764997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102357147|NCT01764997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102357148|NCT01764997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102357149|NCT01764997|Analgesics|analgesics|mesh-ancestor
102357150|NCT01764997|Sensory System Agents|sensory system agents|mesh-ancestor
102357151|NCT01764997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102357152|NCT01764997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102357153|NCT01276756|Interferons|interferons|mesh-list
102357154|NCT01276756|Ribavirin|ribavirin|mesh-list
102357155|NCT01276756|Interferon-alpha|interferon-alpha|mesh-list
102357156|NCT01276756|Interferon alpha-2|interferon alpha-2|mesh-list
102357157|NCT01276756|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102357158|NCT01276756|Nitazoxanide|nitazoxanide|mesh-list
102357159|NCT01276756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102357160|NCT01276756|Antiviral Agents|antiviral agents|mesh-ancestor
102357161|NCT01276756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102357162|NCT01276756|Antimetabolites|antimetabolites|mesh-ancestor
102357163|NCT01276756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357164|NCT01276756|Immunologic Factors|immunologic factors|mesh-ancestor
102357165|NCT01276756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357166|NCT01276756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102357167|NCT00246376|Niacin|niacin|mesh-list
102357168|NCT00246376|Fenofibrate|fenofibrate|mesh-list
102357169|NCT00246376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102357170|NCT00246376|Antimetabolites|antimetabolites|mesh-ancestor
102357171|NCT00246376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357172|NCT00246376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102357173|NCT00246376|Vasodilator Agents|vasodilator agents|mesh-ancestor
102357174|NCT00246376|Vitamin B Complex|vitamin b complex|mesh-ancestor
102357175|NCT00246376|Vitamins|vitamins|mesh-ancestor
102357176|NCT00246376|Micronutrients|micronutrients|mesh-ancestor
102357177|NCT00246376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357178|NCT03806062|Domperidone|domperidone|mesh-list
102357179|NCT03806062|Antiemetics|antiemetics|mesh-ancestor
102357180|NCT03806062|Autonomic Agents|autonomic agents|mesh-ancestor
102357181|NCT03806062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102357182|NCT03806062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357183|NCT03806062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102357184|NCT03806062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102357185|NCT03806062|Dopamine Agents|dopamine agents|mesh-ancestor
102357186|NCT03806062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102357187|NCT03806062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075704|NCT02125188|Hemostatics|hemostatics|mesh-ancestor
102357188|NCT00754546|Formoterol Fumarate|formoterol fumarate|mesh-list
102357189|NCT00754546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102357190|NCT00754546|Autonomic Agents|autonomic agents|mesh-ancestor
102357191|NCT00754546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102357192|NCT00754546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357193|NCT00754546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102357194|NCT00754546|Respiratory System Agents|respiratory system agents|mesh-ancestor
102357195|NCT00754546|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102357196|NCT00754546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102357197|NCT00754546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102357198|NCT00754546|Adrenergic Agents|adrenergic agents|mesh-ancestor
102357199|NCT00754546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102357200|NCT00754546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357201|NCT01764841|Ciprofloxacin|ciprofloxacin|mesh-list
102357202|NCT01764841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102357203|NCT01764841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102357204|NCT01764841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102357205|NCT01764841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102357206|NCT01764841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102357207|NCT01764841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357208|NCT01764841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102357209|NCT01764841|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102357210|NCT01764841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102357211|NCT00245050|Pyridoxine|pyridoxine|mesh-list
102357212|NCT00245050|Vitamin B 6|vitamin b 6|mesh-list
102357213|NCT00245050|Doxorubicin|doxorubicin|mesh-list
102357214|NCT00245050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102357215|NCT00245050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102357216|NCT00245050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102357217|NCT00245050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102357218|NCT00245050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102357219|NCT00245050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102357220|NCT00245050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357221|NCT00245050|Vitamin B Complex|vitamin b complex|mesh-ancestor
102357222|NCT00245050|Vitamins|vitamins|mesh-ancestor
102357223|NCT00245050|Micronutrients|micronutrients|mesh-ancestor
102357224|NCT00245050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357225|NCT04345588|Dexamethasone|dexamethasone|mesh-list
102357226|NCT04345588|Dexamethasone acetate|dexamethasone acetate|mesh-list
102357227|NCT04345588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102357228|NCT04345588|Antiemetics|antiemetics|mesh-ancestor
102357229|NCT04345588|Autonomic Agents|autonomic agents|mesh-ancestor
102357230|NCT04345588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102357231|NCT04345588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357232|NCT04345588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102357233|NCT04345588|Glucocorticoids|glucocorticoids|mesh-ancestor
102357234|NCT04345588|Hormones|hormones|mesh-ancestor
102357235|NCT04345588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102357236|NCT04345588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102357237|NCT04345588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102357238|NCT03806374|Lidocaine|lidocaine|mesh-list
102357239|NCT03806374|Fentanyl|fentanyl|mesh-list
102357240|NCT03806374|Ketamine|ketamine|mesh-list
102357241|NCT03806374|Propofol|propofol|mesh-list
102357242|NCT03806374|Cisatracurium|cisatracurium|mesh-list
102357243|NCT03806374|Anesthetics, Local|anesthetics, local|mesh-ancestor
102357244|NCT03806374|Anesthetics|anesthetics|mesh-ancestor
102357245|NCT03806374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102357246|NCT03806374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357247|NCT03806374|Sensory System Agents|sensory system agents|mesh-ancestor
102357248|NCT03806374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102357249|NCT03806374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102357250|NCT03806374|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102357251|NCT03806374|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102357252|NCT03806374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102357253|NCT03806374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357254|NCT03806374|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102357255|NCT03806374|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102357256|NCT03806374|Anesthetics, General|anesthetics, general|mesh-ancestor
102357257|NCT03806374|Analgesics|analgesics|mesh-ancestor
102357258|NCT03806374|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102357259|NCT03806374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101836624|NCT00505934|Anticonvulsants|anticonvulsants|mesh-ancestor
102357260|NCT03806374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102357261|NCT03806374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102357262|NCT03806374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102357263|NCT03806374|Narcotics|narcotics|mesh-ancestor
102357264|NCT03806374|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102357265|NCT03806374|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102357266|NCT03806374|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102357267|NCT00763360|Hyaluronic Acid|hyaluronic acid|mesh-list
102357268|NCT00763360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102357269|NCT00763360|Immunologic Factors|immunologic factors|mesh-ancestor
102357270|NCT00763360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357271|NCT00763360|Viscosupplements|viscosupplements|mesh-ancestor
102357272|NCT00763360|Protective Agents|protective agents|mesh-ancestor
102357273|NCT00756106|Temozolomide|temozolomide|mesh-list
102357274|NCT00756106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102357275|NCT00756106|Alkylating Agents|alkylating agents|mesh-ancestor
102357276|NCT00756106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357277|NCT00756106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102357278|NCT00243412|Methylprednisolone|methylprednisolone|mesh-list
102357279|NCT00243412|Rituximab|rituximab|mesh-list
102357280|NCT00243412|Methotrexate|methotrexate|mesh-list
102357281|NCT00243412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102357282|NCT00243412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102357283|NCT00243412|Immunologic Factors|immunologic factors|mesh-ancestor
102357284|NCT00243412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357285|NCT00243412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102357286|NCT00243412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102357287|NCT00243412|Abortifacient Agents|abortifacient agents|mesh-ancestor
102357288|NCT00243412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102357289|NCT00243412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102357290|NCT00243412|Antimetabolites|antimetabolites|mesh-ancestor
102357291|NCT00243412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357292|NCT00243412|Dermatologic Agents|dermatologic agents|mesh-ancestor
102357293|NCT00243412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102357294|NCT00243412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102357295|NCT00243412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102357296|NCT00243412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102357297|NCT00243412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102357298|NCT00243412|Antiemetics|antiemetics|mesh-ancestor
102357299|NCT00243412|Autonomic Agents|autonomic agents|mesh-ancestor
102357300|NCT00243412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102357301|NCT00243412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102357302|NCT00243412|Glucocorticoids|glucocorticoids|mesh-ancestor
102357303|NCT00243412|Hormones|hormones|mesh-ancestor
102357304|NCT00243412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102357305|NCT00243412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102357306|NCT00243412|Protective Agents|protective agents|mesh-ancestor
102357307|NCT00765232|Ketorolac|ketorolac|mesh-list
102357308|NCT00765232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102357309|NCT00765232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102357310|NCT00765232|Analgesics|analgesics|mesh-ancestor
102357311|NCT00765232|Sensory System Agents|sensory system agents|mesh-ancestor
102357312|NCT00765232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102357313|NCT00765232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357314|NCT00765232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102357315|NCT00765232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102357316|NCT00765232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102357317|NCT00765232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102357318|NCT00765232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357319|NCT03805282|Lidocaine|lidocaine|mesh-list
102357320|NCT03805282|Anesthetics, Local|anesthetics, local|mesh-ancestor
102357321|NCT03805282|Anesthetics|anesthetics|mesh-ancestor
102357322|NCT03805282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102357323|NCT03805282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357324|NCT03805282|Sensory System Agents|sensory system agents|mesh-ancestor
102357325|NCT03805282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102357326|NCT03805282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102357327|NCT03805282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102357328|NCT03805282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102077057|NCT00495508|Lumefantrine|lumefantrine|mesh-list
102357329|NCT03805282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102357330|NCT03805282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357331|NCT03805750|Dronabinol|dronabinol|mesh-list
102357332|NCT03805750|Cannabidiol|cannabidiol|mesh-list
102357333|NCT03805750|Anticonvulsants|anticonvulsants|mesh-ancestor
102357334|NCT03805750|Hallucinogens|hallucinogens|mesh-ancestor
102357335|NCT03805750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357336|NCT03805750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102357337|NCT03805750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102357338|NCT03805750|Analgesics|analgesics|mesh-ancestor
102357339|NCT03805750|Sensory System Agents|sensory system agents|mesh-ancestor
102357340|NCT03805750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102357341|NCT03805750|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102357342|NCT03805750|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102357343|NCT03805750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102357344|NCT03805750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357345|NCT03805750|Hormones|hormones|mesh-ancestor
102357346|NCT03805750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102357347|NCT03804268|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102357348|NCT03804268|Pilocarpine|pilocarpine|mesh-list
102357349|NCT03804268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102357350|NCT03804268|Miotics|miotics|mesh-ancestor
102357351|NCT03804268|Autonomic Agents|autonomic agents|mesh-ancestor
102357352|NCT03804268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102357353|NCT03804268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357354|NCT03804268|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102357355|NCT03804268|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102357356|NCT03804268|Cholinergic Agents|cholinergic agents|mesh-ancestor
102357357|NCT03804268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102357358|NCT03804268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357359|NCT00765856|Oxymorphone|oxymorphone|mesh-list
102357360|NCT00765856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102357361|NCT00765856|Narcotics|narcotics|mesh-ancestor
102357362|NCT00765856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102357363|NCT00765856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357364|NCT00765856|Analgesics|analgesics|mesh-ancestor
102357365|NCT00765856|Sensory System Agents|sensory system agents|mesh-ancestor
102357366|NCT00765856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102357367|NCT00765856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102357368|NCT00780208|Methylphenidate|methylphenidate|mesh-list
102357369|NCT00780208|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102357370|NCT00780208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357371|NCT00780208|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102357372|NCT00780208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102357373|NCT00780208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102357374|NCT00780208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357375|NCT00780208|Dopamine Agents|dopamine agents|mesh-ancestor
102357376|NCT00780208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102357377|NCT00243022|Vitamin B 12|vitamin b 12|mesh-list
102357378|NCT00243022|Hydroxocobalamin|hydroxocobalamin|mesh-list
102357379|NCT00243022|Vitamins|vitamins|mesh-ancestor
102357380|NCT00243022|Micronutrients|micronutrients|mesh-ancestor
102357381|NCT00243022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357382|NCT00243022|Vitamin B Complex|vitamin b complex|mesh-ancestor
102357383|NCT00243022|Hematinics|hematinics|mesh-ancestor
102357384|NCT03805360|Ropivacaine|ropivacaine|mesh-list
102357385|NCT03805360|Anesthetics, Local|anesthetics, local|mesh-list
102357386|NCT03805360|Anesthetics|anesthetics|mesh-list
102357387|NCT03805360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102357388|NCT03805360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357389|NCT03805360|Sensory System Agents|sensory system agents|mesh-ancestor
102357390|NCT03805360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102357391|NCT00756964|Rasburicase|rasburicase|mesh-list
102357392|NCT00756964|Gout Suppressants|gout suppressants|mesh-ancestor
102357393|NCT00756964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102357394|NCT00780442|Cycloserine|cycloserine|mesh-list
102169107|NCT03583229|Antipyretics|antipyretics|mesh-ancestor
102357395|NCT00780442|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102357396|NCT00780442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102357397|NCT00780442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102357398|NCT00780442|Antitubercular Agents|antitubercular agents|mesh-ancestor
102357399|NCT00780442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102357400|NCT00780442|Antimetabolites|antimetabolites|mesh-ancestor
102357401|NCT00780442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357402|NCT04384666|Rotigotine|rotigotine|mesh-list
102357403|NCT04384666|Dopamine Agonists|dopamine agonists|mesh-ancestor
102357404|NCT04384666|Dopamine Agents|dopamine agents|mesh-ancestor
102357405|NCT04384666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102357406|NCT04384666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357407|NCT04384666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357408|NCT00767572|Atorvastatin|atorvastatin|mesh-list
102357409|NCT00767572|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102357410|NCT00767572|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102357411|NCT00767572|Antimetabolites|antimetabolites|mesh-ancestor
102357412|NCT00767572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357413|NCT00767572|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102357414|NCT00767572|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102357415|NCT00767572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102357416|NCT00780676|Dasatinib|dasatinib|mesh-list
102357417|NCT00780676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102357418|NCT00780676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102357419|NCT00780676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102357420|NCT00780676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357421|NCT00768118|Curcumin|curcumin|mesh-list
102357422|NCT00768118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102357423|NCT00768118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102357424|NCT00768118|Analgesics|analgesics|mesh-ancestor
102357425|NCT00768118|Sensory System Agents|sensory system agents|mesh-ancestor
102357426|NCT00768118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102357427|NCT00768118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357428|NCT00768118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102357429|NCT00768118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102357430|NCT00768118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102357431|NCT00768118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102357432|NCT00768118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357433|NCT04345432|Gabapentin|gabapentin|mesh-list
102357434|NCT04345432|Analgesics|analgesics|mesh-ancestor
102357435|NCT04345432|Sensory System Agents|sensory system agents|mesh-ancestor
102357436|NCT04345432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102357437|NCT04345432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357438|NCT04345432|Anticonvulsants|anticonvulsants|mesh-ancestor
102357439|NCT04345432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102357440|NCT04345432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102357441|NCT04345432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102357442|NCT04345432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102357443|NCT04345432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102357444|NCT04345432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102357445|NCT04345432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102357446|NCT04345432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357447|NCT04345432|Antimanic Agents|antimanic agents|mesh-ancestor
102357448|NCT00757822|Dronabinol|dronabinol|mesh-list
102357449|NCT00757822|Ondansetron|ondansetron|mesh-list
102357450|NCT00757822|Antiemetics|antiemetics|mesh-ancestor
102357451|NCT00757822|Autonomic Agents|autonomic agents|mesh-ancestor
102357452|NCT00757822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102357453|NCT00757822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357454|NCT00757822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102357455|NCT00757822|Antipruritics|antipruritics|mesh-ancestor
102357456|NCT00757822|Dermatologic Agents|dermatologic agents|mesh-ancestor
102357457|NCT00757822|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102357458|NCT00757822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102357459|NCT00757822|Serotonin Agents|serotonin agents|mesh-ancestor
102357460|NCT00757822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102357461|NCT00757822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357462|NCT00757822|Hallucinogens|hallucinogens|mesh-ancestor
102357463|NCT00757822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102357464|NCT00757822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102357465|NCT00757822|Analgesics|analgesics|mesh-ancestor
102357466|NCT00757822|Sensory System Agents|sensory system agents|mesh-ancestor
102357467|NCT00757822|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102357468|NCT00757822|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102357470|NCT00757822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102357471|NCT00758836|Acetaminophen|acetaminophen|mesh-list
102357472|NCT00758836|Ibuprofen|ibuprofen|mesh-list
102357473|NCT00758836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102357474|NCT00758836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102357475|NCT00758836|Analgesics|analgesics|mesh-ancestor
102357476|NCT00758836|Sensory System Agents|sensory system agents|mesh-ancestor
102357477|NCT00758836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102357478|NCT00758836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357479|NCT00758836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102357480|NCT00758836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102357481|NCT00758836|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102357482|NCT00758836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102357483|NCT00758836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357484|NCT00758836|Antipyretics|antipyretics|mesh-ancestor
102357485|NCT00769600|Itraconazole|itraconazole|mesh-list
102357486|NCT00769600|Pemetrexed|pemetrexed|mesh-list
102357487|NCT00769600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102357488|NCT00769600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102357489|NCT00769600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357490|NCT00769600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102357491|NCT00769600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102357492|NCT00769600|Antifungal Agents|antifungal agents|mesh-ancestor
102357493|NCT00769600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102357494|NCT00769600|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102357495|NCT00769600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102357496|NCT00769600|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102357497|NCT00769600|Hormone Antagonists|hormone antagonists|mesh-ancestor
102357498|NCT00769600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102357499|NCT00769600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357500|NCT00769600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102357501|NCT03809650|Macitentan|macitentan|mesh-list
102357502|NCT03809650|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
102357503|NCT03809650|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102357504|NCT03809650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357505|NCT03809650|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
102357506|NCT03809260|Metformin|metformin|mesh-list
102357507|NCT03809260|Vancomycin|vancomycin|mesh-list
102357508|NCT03809260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102357509|NCT03809260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357510|NCT03809260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102357511|NCT03809260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102357512|NCT01763905|Ezetimibe|ezetimibe|mesh-list
102357513|NCT01763905|Evolocumab|evolocumab|mesh-list
102357514|NCT01763905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102357515|NCT01763905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102357516|NCT01763905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102357517|NCT01763905|Antimetabolites|antimetabolites|mesh-ancestor
102357518|NCT01763905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357519|NCT01763905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102357520|NCT01763905|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102357521|NCT01763905|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102357522|NCT01763905|Protease Inhibitors|protease inhibitors|mesh-ancestor
102357523|NCT01763905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102357524|NCT01763905|Immunologic Factors|immunologic factors|mesh-ancestor
102357525|NCT01763905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357526|NCT05743504|Paclitaxel|paclitaxel|mesh-list
102357527|NCT05743504|Cisplatin|cisplatin|mesh-list
102357528|NCT05743504|Atezolizumab|atezolizumab|mesh-list
102357529|NCT05743504|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102357530|NCT05743504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102357531|NCT05743504|Tubulin Modulators|tubulin modulators|mesh-ancestor
102357532|NCT05743504|Antimitotic Agents|antimitotic agents|mesh-ancestor
102357533|NCT05743504|Mitosis Modulators|mitosis modulators|mesh-ancestor
102357534|NCT05743504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357535|NCT05743504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102357536|NCT05743504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102357537|NCT03803254|Lenvatinib|lenvatinib|mesh-list
102357538|NCT03803254|Antibodies|antibodies|mesh-list
102357539|NCT03803254|Immunologic Factors|immunologic factors|mesh-ancestor
102357540|NCT03803254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357541|NCT03803254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102169250|NCT04989140|Antiemetics|antiemetics|mesh-ancestor
102357542|NCT03803254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102357543|NCT03803254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102357544|NCT03803254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357545|NCT04730999|Bevacizumab|bevacizumab|mesh-list
102357546|NCT04730999|Atezolizumab|atezolizumab|mesh-list
102357547|NCT04730999|Carboplatin|carboplatin|mesh-list
102357548|NCT04730999|Etoposide|etoposide|mesh-list
102357549|NCT04730999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102357550|NCT04730999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102357551|NCT04730999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102357552|NCT04730999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102357553|NCT04730999|Growth Substances|growth substances|mesh-ancestor
102357554|NCT04730999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357555|NCT04730999|Growth Inhibitors|growth inhibitors|mesh-ancestor
102357556|NCT04730999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102357557|NCT04730999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102357558|NCT04730999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102357559|NCT04730999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102357560|NCT04730999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357561|NCT04730999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102357562|NCT00759772|Teriparatide|teriparatide|mesh-list
102357563|NCT00759772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102357564|NCT00759772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357565|NCT00759772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102357566|NCT01977677|Plerixafor|plerixafor|mesh-list
102357567|NCT01977677|Temozolomide|temozolomide|mesh-list
102357568|NCT01977677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102357569|NCT01977677|Alkylating Agents|alkylating agents|mesh-ancestor
102357570|NCT01977677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357571|NCT01977677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102357572|NCT01977677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102357573|NCT01977677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102357574|NCT01977677|Antiviral Agents|antiviral agents|mesh-ancestor
102357575|NCT01977677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102357576|NCT04384744|Hormones|hormones|mesh-list
102357577|NCT04384744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102357578|NCT04384744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357579|NCT01736215|Epoetin Alfa|epoetin alfa|mesh-list
102357580|NCT01736215|Hematinics|hematinics|mesh-ancestor
102357581|NCT01786603|Rasagiline|rasagiline|mesh-list
102357582|NCT01786603|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102357583|NCT01786603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102357584|NCT01786603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357585|NCT01786603|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102357586|NCT01786603|Protective Agents|protective agents|mesh-ancestor
102357587|NCT01786603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357588|NCT00786916|Lidocaine|lidocaine|mesh-list
102357589|NCT00786916|Anesthetics, Local|anesthetics, local|mesh-ancestor
102357590|NCT00786916|Anesthetics|anesthetics|mesh-ancestor
102357591|NCT00786916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102357592|NCT00786916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357593|NCT00786916|Sensory System Agents|sensory system agents|mesh-ancestor
102357594|NCT00786916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102357595|NCT00786916|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102357596|NCT00786916|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102357597|NCT00786916|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102357598|NCT00786916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102357599|NCT00786916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357600|NCT04414267|Vaccines|vaccines|mesh-list
102357601|NCT04414267|BCG Vaccine|bcg vaccine|mesh-list
102357602|NCT04414267|Immunologic Factors|immunologic factors|mesh-ancestor
102357603|NCT04414267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357604|NCT04414267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102357605|NCT01619423|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
102357606|NCT01619423|Edetic Acid|edetic acid|mesh-list
102357607|NCT01619423|Anticoagulants|anticoagulants|mesh-ancestor
102357608|NCT01619423|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102357609|NCT01619423|Chelating Agents|chelating agents|mesh-ancestor
102357610|NCT01619423|Sequestering Agents|sequestering agents|mesh-ancestor
102357611|NCT01619423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357612|NCT01619423|Vitamin B Complex|vitamin b complex|mesh-ancestor
102357613|NCT01619423|Vitamins|vitamins|mesh-ancestor
102357614|NCT01619423|Micronutrients|micronutrients|mesh-ancestor
102357615|NCT01619423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357616|NCT03802552|Cephalexin|cephalexin|mesh-list
102357617|NCT03802552|Cefadroxil|cefadroxil|mesh-list
102084028|NCT02154360|Aprepitant|aprepitant|mesh-list
102357618|NCT03802552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102357619|NCT03802552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102357620|NCT01735279|Mineral Oil|mineral oil|mesh-list
102357621|NCT01735279|Emollients|emollients|mesh-ancestor
102357622|NCT01735279|Dermatologic Agents|dermatologic agents|mesh-ancestor
102357623|NCT03802318|Amoxicillin|amoxicillin|mesh-list
102357624|NCT03802318|Rabeprazole|rabeprazole|mesh-list
102357625|NCT03802318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102357626|NCT03802318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102357627|NCT03802318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102357628|NCT03802318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102357629|NCT03802318|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102357630|NCT03802318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102357631|NCT03802318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357632|NCT01758523|Dutasteride|dutasteride|mesh-list
102357633|NCT01758523|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102357634|NCT01758523|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102357635|NCT01758523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102357636|NCT01758523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357637|NCT01758523|Hormone Antagonists|hormone antagonists|mesh-ancestor
102357638|NCT01758523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102357639|NCT01758523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357640|NCT00773422|Naltrexone|naltrexone|mesh-list
102357641|NCT00773422|Varenicline|varenicline|mesh-list
102357642|NCT00773422|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102357643|NCT00773422|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102357644|NCT00773422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357645|NCT00773422|Sensory System Agents|sensory system agents|mesh-ancestor
102357646|NCT00773422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102357647|NCT00773422|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102357648|NCT00773422|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102357649|NCT00773422|Cholinergic Agents|cholinergic agents|mesh-ancestor
102357650|NCT00773422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102357651|NCT00773422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357652|NCT00786994|Petrolatum|petrolatum|mesh-list
102357653|NCT00786994|Emollients|emollients|mesh-ancestor
102357654|NCT00786994|Dermatologic Agents|dermatologic agents|mesh-ancestor
102357655|NCT00774202|Prednisone|prednisone|mesh-list
102357656|NCT00774202|Cyclophosphamide|cyclophosphamide|mesh-list
102357657|NCT00774202|Rituximab|rituximab|mesh-list
102357658|NCT00774202|Vincristine|vincristine|mesh-list
102357659|NCT00774202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102357660|NCT00774202|Immunologic Factors|immunologic factors|mesh-ancestor
102357661|NCT00774202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357662|NCT00774202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102357663|NCT00774202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102357664|NCT00774202|Alkylating Agents|alkylating agents|mesh-ancestor
102357665|NCT00774202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357666|NCT00774202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102357667|NCT00774202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102357668|NCT00774202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102357669|NCT00774202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102357670|NCT00774202|Glucocorticoids|glucocorticoids|mesh-ancestor
102357671|NCT00774202|Hormones|hormones|mesh-ancestor
102357672|NCT00774202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102357673|NCT00774202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102357674|NCT00774202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102357675|NCT00774202|Tubulin Modulators|tubulin modulators|mesh-ancestor
102357676|NCT00774202|Antimitotic Agents|antimitotic agents|mesh-ancestor
102357677|NCT00774202|Mitosis Modulators|mitosis modulators|mesh-ancestor
102357678|NCT03808168|Nivolumab|nivolumab|mesh-list
102357679|NCT03808168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102357680|NCT03808168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102357681|NCT03808168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102357682|NCT03808168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357683|NCT03802162|Memantine|memantine|mesh-list
102357684|NCT03802162|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102357685|NCT03802162|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102357686|NCT03802162|Dopamine Agents|dopamine agents|mesh-ancestor
102357687|NCT03802162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102357688|NCT03802162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357689|NCT03802162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357690|NCT03802162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102357691|NCT03802162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102357692|NCT01757275|Esomeprazole|esomeprazole|mesh-list
102357694|NCT01757275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102357695|NCT01757275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102357696|NCT01757275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102357697|NCT01757275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102357698|NCT01757275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357699|NCT01757275|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102357700|NCT01757275|Histamine Antagonists|histamine antagonists|mesh-ancestor
102357701|NCT01757275|Histamine Agents|histamine agents|mesh-ancestor
102357702|NCT01757275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102357703|NCT01757275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357704|NCT01757275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102357705|NCT01757275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102357706|NCT00787852|Paclitaxel|paclitaxel|mesh-list
102357707|NCT00787852|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102357708|NCT00787852|Dasatinib|dasatinib|mesh-list
102357709|NCT00787852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102357710|NCT00787852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102357711|NCT00787852|Tubulin Modulators|tubulin modulators|mesh-ancestor
102357712|NCT00787852|Antimitotic Agents|antimitotic agents|mesh-ancestor
102357713|NCT00787852|Mitosis Modulators|mitosis modulators|mesh-ancestor
102357714|NCT00787852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357715|NCT00787852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102357716|NCT00787852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102357717|NCT00788008|Propofol|propofol|mesh-list
102357718|NCT00788008|Isoflurane|isoflurane|mesh-list
102357719|NCT00788008|Anesthetics|anesthetics|mesh-ancestor
102357720|NCT00788008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102357721|NCT00788008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357722|NCT00788008|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102357723|NCT00788008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102357724|NCT00788008|Anesthetics, General|anesthetics, general|mesh-ancestor
102357725|NCT00788008|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102357726|NCT00760006|Ampicillin|ampicillin|mesh-list
102357727|NCT00760006|Sulbactam|sulbactam|mesh-list
102357728|NCT00760006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102357729|NCT00760006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102357730|NCT00760006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102357731|NCT00760006|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102357732|NCT00760006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102357733|NCT00760006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357734|NCT01784965|Liraglutide|liraglutide|mesh-list
102357735|NCT01784965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102357736|NCT01784965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357737|NCT01784965|Incretins|incretins|mesh-ancestor
102357738|NCT01784965|Hormones|hormones|mesh-ancestor
102357739|NCT01784965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102357740|NCT05742724|Dronabinol|dronabinol|mesh-list
102357741|NCT05742724|Nabiximols|nabiximols|mesh-list
102357742|NCT05742724|Cannabidiol|cannabidiol|mesh-list
102357743|NCT05742724|Anticonvulsants|anticonvulsants|mesh-ancestor
102357744|NCT05742724|Hallucinogens|hallucinogens|mesh-ancestor
102357745|NCT05742724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357746|NCT05742724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102357747|NCT05742724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102357748|NCT05742724|Analgesics|analgesics|mesh-ancestor
102357749|NCT05742724|Sensory System Agents|sensory system agents|mesh-ancestor
102357750|NCT05742724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102357751|NCT05742724|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102357752|NCT05742724|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102357753|NCT05742724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102357754|NCT05742724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357755|NCT05742724|Hormones|hormones|mesh-ancestor
102357756|NCT05742724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102357757|NCT01784419|Ivacaftor|ivacaftor|mesh-list
102357758|NCT01784419|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102357759|NCT01784419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102357760|NCT01784419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357761|NCT01784029|Vitamin D|vitamin d|mesh-list
102357762|NCT01784029|Cholecalciferol|cholecalciferol|mesh-list
102357763|NCT01784029|Vitamins|vitamins|mesh-ancestor
102084993|NCT03607149|Pemetrexed|pemetrexed|mesh-list
102357764|NCT01784029|Micronutrients|micronutrients|mesh-ancestor
102357765|NCT01784029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357766|NCT01784029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102169484|NCT03257241|Analgesics|analgesics|mesh-ancestor
102357767|NCT01784029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102357768|NCT00789256|Bortezomib|bortezomib|mesh-list
102357769|NCT00789256|Melphalan|melphalan|mesh-list
102357770|NCT00789256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102357771|NCT00789256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102357772|NCT00789256|Alkylating Agents|alkylating agents|mesh-ancestor
102357773|NCT00789256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357774|NCT00789256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102357775|NCT00789256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102357776|NCT00789256|Immunologic Factors|immunologic factors|mesh-ancestor
102357777|NCT00789256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357778|NCT01733329|Folic Acid|folic acid|mesh-list
102357779|NCT01733329|Misoprostol|misoprostol|mesh-list
102357780|NCT01733329|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102357781|NCT01733329|Abortifacient Agents|abortifacient agents|mesh-ancestor
102357782|NCT01733329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102357783|NCT01733329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357784|NCT01733329|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102357785|NCT01733329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102357786|NCT01733329|Oxytocics|oxytocics|mesh-ancestor
102357787|NCT01733329|Hematinics|hematinics|mesh-ancestor
102357788|NCT01733329|Vitamin B Complex|vitamin b complex|mesh-ancestor
102357789|NCT01733329|Vitamins|vitamins|mesh-ancestor
102357790|NCT01733329|Micronutrients|micronutrients|mesh-ancestor
102357791|NCT02145676|Botulinum Toxins|botulinum toxins|mesh-list
102357792|NCT02145676|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102357793|NCT02145676|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102357794|NCT02145676|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102357795|NCT02145676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102357796|NCT02145676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357797|NCT02145676|Cholinergic Agents|cholinergic agents|mesh-ancestor
102357798|NCT02145676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102357799|NCT02145676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357800|NCT02145676|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102357801|NCT02145676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102357802|NCT05742568|Amoxicillin|amoxicillin|mesh-list
102357803|NCT05742568|Clarithromycin|clarithromycin|mesh-list
102357804|NCT05742568|Esomeprazole|esomeprazole|mesh-list
102357805|NCT05742568|Bismuth|bismuth|mesh-list
102357806|NCT05742568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102357807|NCT05742568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102357808|NCT05742568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102357809|NCT05742568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102357810|NCT05742568|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102357811|NCT05742568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102357812|NCT05742568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357813|NCT05742568|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102357814|NCT05742568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102357815|NCT05742568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102357816|NCT05742568|Antacids|antacids|mesh-ancestor
102357817|NCT01607593|Sertraline|sertraline|mesh-list
102357818|NCT01607593|Antidepressive Agents|antidepressive agents|mesh-ancestor
102357819|NCT01607593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102357820|NCT01607593|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102357821|NCT01607593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102357822|NCT01607593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102357823|NCT01607593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357824|NCT01607593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102357825|NCT01607593|Serotonin Agents|serotonin agents|mesh-ancestor
102357826|NCT01607593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357827|NCT00789724|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102357828|NCT00789724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102357829|NCT01755637|Albendazole|albendazole|mesh-list
102357830|NCT01755637|Anthelmintics|anthelmintics|mesh-ancestor
102357831|NCT01755637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102357832|NCT01755637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102357833|NCT01755637|Anticestodal Agents|anticestodal agents|mesh-ancestor
102357834|NCT01755637|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102357835|NCT01755637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102357836|NCT01755637|Tubulin Modulators|tubulin modulators|mesh-ancestor
102357837|NCT01755637|Antimitotic Agents|antimitotic agents|mesh-ancestor
102357838|NCT01755637|Mitosis Modulators|mitosis modulators|mesh-ancestor
102357839|NCT01755637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357840|NCT01755637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102357841|NCT03801226|Calcium|calcium|mesh-list
102169560|NCT03249519|Cisplatin|cisplatin|mesh-list
102357842|NCT03801226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102357843|NCT03801226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357845|NCT03837808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102357846|NCT03837808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102357847|NCT02148874|Vaccines|vaccines|mesh-list
102357848|NCT02148874|Immunologic Factors|immunologic factors|mesh-ancestor
102357849|NCT02148874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357850|NCT01755091|Dronabinol|dronabinol|mesh-list
102357851|NCT01755091|Hallucinogens|hallucinogens|mesh-ancestor
102357852|NCT01755091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357853|NCT01755091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102357854|NCT01755091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102357855|NCT01755091|Analgesics|analgesics|mesh-ancestor
102357856|NCT01755091|Sensory System Agents|sensory system agents|mesh-ancestor
102357857|NCT01755091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102357858|NCT01755091|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102357859|NCT01755091|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102357860|NCT01755091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102357861|NCT01755091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357862|NCT01755091|Hormones|hormones|mesh-ancestor
102357863|NCT01755091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102357864|NCT00789802|Naproxen|naproxen|mesh-list
102357865|NCT00789802|Estradiol|estradiol|mesh-list
102357866|NCT00789802|Estrogens|estrogens|mesh-ancestor
102357867|NCT00789802|Hormones|hormones|mesh-ancestor
102357868|NCT00789802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102357869|NCT00789802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357870|NCT00789802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102357871|NCT00789802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102357872|NCT00789802|Analgesics|analgesics|mesh-ancestor
102357873|NCT00789802|Sensory System Agents|sensory system agents|mesh-ancestor
102357874|NCT00789802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102357875|NCT00789802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102357876|NCT00789802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102357877|NCT00789802|Gout Suppressants|gout suppressants|mesh-ancestor
102357878|NCT00789802|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102357879|NCT00789802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102357880|NCT00789802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357881|NCT04567225|Insulin Glargine|insulin glargine|mesh-list
102357882|NCT04567225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102357883|NCT04567225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357884|NCT02149342|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
102357885|NCT02149342|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102357886|NCT02149342|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102357887|NCT02149342|Dermatologic Agents|dermatologic agents|mesh-ancestor
102357888|NCT01783015|Etanercept|etanercept|mesh-list
102357889|NCT01783015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102357890|NCT01783015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102357891|NCT01783015|Analgesics|analgesics|mesh-ancestor
102357892|NCT01783015|Sensory System Agents|sensory system agents|mesh-ancestor
102357893|NCT01783015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102357894|NCT01783015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357895|NCT01783015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102357896|NCT01783015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102357897|NCT01783015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102357898|NCT01783015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102357899|NCT01783015|Immunologic Factors|immunologic factors|mesh-ancestor
102357900|NCT01782859|Prednisone|prednisone|mesh-list
102357901|NCT01782859|Hydrocortisone|hydrocortisone|mesh-list
102357902|NCT01782859|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102357903|NCT01782859|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102357904|NCT01782859|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102357905|NCT01782859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102357906|NCT01782859|Glucocorticoids|glucocorticoids|mesh-ancestor
102357907|NCT01782859|Hormones|hormones|mesh-ancestor
102357908|NCT01782859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102357909|NCT01782859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357910|NCT01782859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102357911|NCT01782859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102357912|NCT01782313|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102357913|NCT01782313|Tivozanib|tivozanib|mesh-list
102357914|NCT01782313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102357915|NCT01782313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102357916|NCT01782313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357917|NCT04574947|Lidocaine|lidocaine|mesh-list
102357918|NCT04574947|Anesthetics, Local|anesthetics, local|mesh-ancestor
102357919|NCT04574947|Anesthetics|anesthetics|mesh-ancestor
102357920|NCT04574947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102357921|NCT04574947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357922|NCT04574947|Sensory System Agents|sensory system agents|mesh-ancestor
102357923|NCT04574947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102357924|NCT04574947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102357925|NCT04574947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102357926|NCT04574947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102357927|NCT04574947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102357928|NCT04574947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357929|NCT00790192|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102357930|NCT00790192|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102357931|NCT00790192|Antidepressive Agents|antidepressive agents|mesh-ancestor
102357932|NCT00790192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102357933|NCT00790192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102357934|NCT00790192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102357935|NCT00790192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102357936|NCT00790192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357937|NCT00790192|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102357938|NCT00790192|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102357939|NCT00790192|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102357940|NCT00790192|Adrenergic Agents|adrenergic agents|mesh-ancestor
102357941|NCT00790192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102357942|NCT00790192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357943|NCT00790192|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102357944|NCT00790192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102357945|NCT00790192|Serotonin Agents|serotonin agents|mesh-ancestor
102357946|NCT00790192|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102357947|NCT00790192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102357948|NCT00790192|Dopamine Agents|dopamine agents|mesh-ancestor
102357949|NCT01781611|Aspirin|aspirin|mesh-list
102357950|NCT01781611|Dipyridamole|dipyridamole|mesh-list
102357951|NCT01781611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102357952|NCT01781611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102357953|NCT01781611|Analgesics|analgesics|mesh-ancestor
102357954|NCT01781611|Sensory System Agents|sensory system agents|mesh-ancestor
102357955|NCT01781611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102357956|NCT01781611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357957|NCT01781611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102357958|NCT01781611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102357959|NCT01781611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102357960|NCT01781611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102357961|NCT01781611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357962|NCT01781611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102357963|NCT01781611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102357964|NCT01781611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102357965|NCT01781611|Antipyretics|antipyretics|mesh-ancestor
102357966|NCT01781611|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102357967|NCT01781611|Vasodilator Agents|vasodilator agents|mesh-ancestor
102357968|NCT03802084|Imatinib Mesylate|imatinib mesylate|mesh-list
102357969|NCT03802084|Vactosertib|vactosertib|mesh-list
102357970|NCT03802084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102357971|NCT03802084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102357972|NCT03802084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102357973|NCT03802084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357974|NCT00790270|Ibuprofen|ibuprofen|mesh-list
102357975|NCT00790270|Amitriptyline|amitriptyline|mesh-list
102357976|NCT00790270|Cyclobenzaprine|cyclobenzaprine|mesh-list
102357977|NCT00790270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102357978|NCT00790270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102357979|NCT00790270|Analgesics|analgesics|mesh-ancestor
102357980|NCT00790270|Sensory System Agents|sensory system agents|mesh-ancestor
102357981|NCT00790270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102357982|NCT00790270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102357983|NCT00790270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102357984|NCT00790270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102357985|NCT00790270|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102357986|NCT00790270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102357987|NCT00790270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102357988|NCT00790270|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102357989|NCT00790270|Antidepressive Agents|antidepressive agents|mesh-ancestor
102357990|NCT00790270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102357991|NCT00790270|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102357992|NCT00790270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102357993|NCT00790270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102357994|NCT00790270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102357995|NCT00790270|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102357996|NCT00790270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102357997|NCT00790270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102357998|NCT00790270|Adrenergic Agents|adrenergic agents|mesh-ancestor
102357999|NCT00790270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102358000|NCT01780987|Heparin|heparin|mesh-list
102358001|NCT01780987|Calcium heparin|calcium heparin|mesh-list
102358002|NCT01780987|Warfarin|warfarin|mesh-list
102358003|NCT01780987|Apixaban|apixaban|mesh-list
102358004|NCT01780987|Anticoagulants|anticoagulants|mesh-ancestor
102358005|NCT01780987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102358006|NCT01780987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102358007|NCT01780987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358008|NCT01780987|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102358009|NCT01780987|Antithrombins|antithrombins|mesh-ancestor
102358010|NCT01780987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102358011|NCT01780987|Protease Inhibitors|protease inhibitors|mesh-ancestor
102358012|NCT01780987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102358013|NCT03800290|Clenbuterol|clenbuterol|mesh-list
102358014|NCT03800290|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102358015|NCT03800290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102358016|NCT03800290|Adrenergic Agents|adrenergic agents|mesh-ancestor
102358017|NCT03800290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102358018|NCT03800290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358019|NCT03800290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358020|NCT03800290|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102358021|NCT03800290|Autonomic Agents|autonomic agents|mesh-ancestor
102358022|NCT03800290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102358023|NCT03800290|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102358024|NCT03800290|Respiratory System Agents|respiratory system agents|mesh-ancestor
102358025|NCT03800290|Sympathomimetics|sympathomimetics|mesh-ancestor
102358026|NCT05709184|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102358027|NCT05709184|Vancomycin|vancomycin|mesh-list
102358028|NCT05709184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102358029|NCT03831334|Minoxidil|minoxidil|mesh-list
102358030|NCT03831334|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102358031|NCT03831334|Vasodilator Agents|vasodilator agents|mesh-ancestor
102358032|NCT00809848|Bimatoprost|bimatoprost|mesh-list
102358033|NCT00809848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102358034|NCT00809848|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102358035|NCT00809848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102358036|NCT01730053|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102358037|NCT01730053|Ezetimibe|ezetimibe|mesh-list
102358038|NCT01730053|Alirocumab|alirocumab|mesh-list
102358039|NCT01730053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102358040|NCT01730053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102358041|NCT01730053|Antimetabolites|antimetabolites|mesh-ancestor
102358042|NCT01730053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358043|NCT01730053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102358044|NCT01730053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102358045|NCT01730053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102358046|NCT01730053|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102358047|NCT01730053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102358048|NCT01730053|Protease Inhibitors|protease inhibitors|mesh-ancestor
102358049|NCT01751113|Fluticasone|fluticasone|mesh-list
102358050|NCT01751113|Xhance|xhance|mesh-list
102358051|NCT01751113|Bromides|bromides|mesh-list
102358052|NCT01751113|Tiotropium Bromide|tiotropium bromide|mesh-list
102358053|NCT01751113|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102088342|NCT02683239|Fasinumab|fasinumab|mesh-list
102358054|NCT01751113|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102358055|NCT01751113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102358056|NCT01751113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102358057|NCT01751113|Autonomic Agents|autonomic agents|mesh-ancestor
102358058|NCT01751113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102358059|NCT01751113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358060|NCT01751113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102358061|NCT01751113|Respiratory System Agents|respiratory system agents|mesh-ancestor
102358062|NCT01751113|Dermatologic Agents|dermatologic agents|mesh-ancestor
102358063|NCT01751113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102358064|NCT01751113|Parasympatholytics|parasympatholytics|mesh-ancestor
102358065|NCT01751113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102358066|NCT01751113|Cholinergic Agents|cholinergic agents|mesh-ancestor
102358067|NCT01751113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102358068|NCT01751113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358069|NCT01751113|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102358070|NCT01751113|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102358071|NCT01751113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102358072|NCT01751113|Adrenergic Agents|adrenergic agents|mesh-ancestor
102358073|NCT01751113|Anticonvulsants|anticonvulsants|mesh-ancestor
102358074|NCT01751113|Glucocorticoids|glucocorticoids|mesh-ancestor
102358075|NCT01751113|Hormones|hormones|mesh-ancestor
102358076|NCT01751113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102358077|NCT01751113|Sympathomimetics|sympathomimetics|mesh-ancestor
102358078|NCT04753294|Diazepam|diazepam|mesh-list
102358079|NCT04753294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102358080|NCT04753294|Anticonvulsants|anticonvulsants|mesh-ancestor
102358081|NCT04753294|Antiemetics|antiemetics|mesh-ancestor
102358082|NCT04753294|Autonomic Agents|autonomic agents|mesh-ancestor
102358083|NCT04753294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102358084|NCT04753294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358085|NCT04753294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102358086|NCT04753294|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102358087|NCT04753294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102358088|NCT04753294|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102358089|NCT04753294|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102358090|NCT04753294|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102358091|NCT04753294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102358092|NCT04753294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102358093|NCT04753294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102358094|NCT04753294|Anesthetics, General|anesthetics, general|mesh-ancestor
102358095|NCT04753294|Anesthetics|anesthetics|mesh-ancestor
102358096|NCT04753294|GABA Modulators|gaba modulators|mesh-ancestor
102358097|NCT04753294|GABA Agents|gaba agents|mesh-ancestor
102358098|NCT04753294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102358099|NCT04753294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358100|NCT01719380|Cetuximab|cetuximab|mesh-list
102358101|NCT01719380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102358102|NCT01719380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102358103|NCT00792142|Thalidomide|thalidomide|mesh-list
102358104|NCT00792142|Dexamethasone|dexamethasone|mesh-list
102358105|NCT00792142|Bortezomib|bortezomib|mesh-list
102358106|NCT00792142|Melphalan|melphalan|mesh-list
102358107|NCT00792142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102358108|NCT00792142|Antiemetics|antiemetics|mesh-ancestor
102358109|NCT00792142|Autonomic Agents|autonomic agents|mesh-ancestor
102358110|NCT00792142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102358111|NCT00792142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358112|NCT00792142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102358113|NCT00792142|Glucocorticoids|glucocorticoids|mesh-ancestor
102358114|NCT00792142|Hormones|hormones|mesh-ancestor
102358115|NCT00792142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102358116|NCT00792142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102358117|NCT00792142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102358118|NCT00792142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102358119|NCT00792142|Alkylating Agents|alkylating agents|mesh-ancestor
102358120|NCT00792142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358121|NCT00792142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102358122|NCT00792142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102358123|NCT00792142|Immunologic Factors|immunologic factors|mesh-ancestor
102358124|NCT00792142|Leprostatic Agents|leprostatic agents|mesh-ancestor
102358125|NCT00792142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102358126|NCT00792142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102358127|NCT00792142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102358128|NCT00792142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102358129|NCT00792142|Growth Substances|growth substances|mesh-ancestor
102358130|NCT00792142|Growth Inhibitors|growth inhibitors|mesh-ancestor
102358131|NCT05640778|Cyclophosphamide|cyclophosphamide|mesh-list
102358132|NCT05640778|Taxane|taxane|mesh-list
102358133|NCT05640778|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102358134|NCT05640778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102358135|NCT05640778|Immunologic Factors|immunologic factors|mesh-ancestor
102358136|NCT05640778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358137|NCT05640778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102358138|NCT05640778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102358139|NCT05640778|Alkylating Agents|alkylating agents|mesh-ancestor
102358140|NCT05640778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358141|NCT05640778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102358142|NCT05640778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102358143|NCT05640778|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102358144|NCT05640778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102358145|NCT05640778|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102358146|NCT05640778|Hormone Antagonists|hormone antagonists|mesh-ancestor
102358147|NCT05640778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102358148|NCT01743560|Everolimus|everolimus|mesh-list
102358149|NCT01743560|Exemestane|exemestane|mesh-list
102358150|NCT01743560|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102358151|NCT01743560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102358152|NCT01743560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102358153|NCT01743560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358154|NCT01743560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102358155|NCT01743560|Immunologic Factors|immunologic factors|mesh-ancestor
102358156|NCT01743560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358157|NCT01743560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102358158|NCT01743560|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102358159|NCT01743560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102358160|NCT01743560|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102358161|NCT01743560|Hormone Antagonists|hormone antagonists|mesh-ancestor
102358162|NCT01743560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102358163|NCT00796744|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
102358164|NCT00796744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102358165|NCT00796744|Vasodilator Agents|vasodilator agents|mesh-ancestor
102358166|NCT00792922|Azithromycin|azithromycin|mesh-list
102358167|NCT00792922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102358168|NCT00792922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102358169|NCT01780831|Raltegravir Potassium|raltegravir potassium|mesh-list
102358170|NCT01780831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102358171|NCT01780831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102358172|NCT01780831|Antiviral Agents|antiviral agents|mesh-ancestor
102358173|NCT01780831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102358174|NCT01780831|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102358175|NCT01780831|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102358176|NCT01780831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102358177|NCT01780831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358178|NCT04382170|Dexmedetomidine|dexmedetomidine|mesh-list
102358179|NCT04382170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102358180|NCT04382170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102358181|NCT04382170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358182|NCT04382170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102358183|NCT04382170|Analgesics|analgesics|mesh-ancestor
102358184|NCT04382170|Sensory System Agents|sensory system agents|mesh-ancestor
102358185|NCT04382170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102358186|NCT04382170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102358187|NCT04382170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102358188|NCT04382170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102358189|NCT04382170|Adrenergic Agents|adrenergic agents|mesh-ancestor
102358190|NCT04382170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102358191|NCT04382170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358192|NCT01753297|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102358193|NCT01753297|Luteolytic Agents|luteolytic agents|mesh-ancestor
102358194|NCT01753297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102358195|NCT01753297|Contraceptive Agents|contraceptive agents|mesh-ancestor
102358196|NCT01753297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102358197|NCT01753297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358198|NCT01753297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102358199|NCT01753297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102358200|NCT01753297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102358201|NCT04718350|Simendan|simendan|mesh-list
102358202|NCT04718350|Milrinone|milrinone|mesh-list
102358203|NCT04718350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102358204|NCT04718350|Vasodilator Agents|vasodilator agents|mesh-ancestor
102358205|NCT04718350|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102358206|NCT04718350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102358207|NCT04718350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102358208|NCT04718350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358209|NCT04718350|Protective Agents|protective agents|mesh-ancestor
102358210|NCT04718350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358211|NCT04718350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102358212|NCT01729819|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
102358213|NCT01729819|Tolterodine Tartrate|tolterodine tartrate|mesh-list
102358214|NCT01729819|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102358215|NCT01729819|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102358216|NCT01729819|Cholinergic Agents|cholinergic agents|mesh-ancestor
102358217|NCT01729819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102358218|NCT01729819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358219|NCT01729819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358220|NCT01729819|Urological Agents|urological agents|mesh-ancestor
102358222|NCT01729819|Coagulants|coagulants|mesh-ancestor
102358223|NCT01729819|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102358224|NCT01729819|Natriuretic Agents|natriuretic agents|mesh-ancestor
102358225|NCT00811564|Timolol|timolol|mesh-list
102358226|NCT00811564|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102358227|NCT00811564|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102358228|NCT00811564|Latanoprost|latanoprost|mesh-list
102358229|NCT00811564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102358230|NCT00811564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358231|NCT00811564|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102358232|NCT00811564|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102358233|NCT00811564|Adrenergic Agents|adrenergic agents|mesh-ancestor
102358234|NCT00811564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102358235|NCT00811564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358236|NCT00811564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102358237|NCT00811564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102358238|NCT00811564|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102358239|NCT00811564|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102358240|NCT00811564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102358241|NCT04520776|Meloxicam|meloxicam|mesh-list
102358242|NCT04520776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102358243|NCT04520776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102358244|NCT04520776|Analgesics|analgesics|mesh-ancestor
102358245|NCT04520776|Sensory System Agents|sensory system agents|mesh-ancestor
102358246|NCT04520776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102358247|NCT04520776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358248|NCT04520776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102358249|NCT04520776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102358250|NCT04520776|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102358251|NCT04520776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102358252|NCT04520776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102358253|NCT04520776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358254|NCT01709084|Tenofovir|tenofovir|mesh-list
102358255|NCT01709084|Emtricitabine|emtricitabine|mesh-list
102358256|NCT01709084|Efavirenz|efavirenz|mesh-list
102358257|NCT01709084|Rilpivirine|rilpivirine|mesh-list
102358258|NCT01709084|Antiviral Agents|antiviral agents|mesh-ancestor
102358259|NCT01709084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102358260|NCT01709084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102358261|NCT01709084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102358262|NCT01709084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102358263|NCT01709084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358264|NCT01709084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102358265|NCT01709084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102358266|NCT01709084|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102358267|NCT01709084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102358268|NCT01709084|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102358269|NCT01709084|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102358270|NCT01709084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102358271|NCT01709084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102358272|NCT01776307|Capecitabine|capecitabine|mesh-list
102358273|NCT01776307|Cetuximab|cetuximab|mesh-list
102358274|NCT01776307|Panitumumab|panitumumab|mesh-list
102358275|NCT01776307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102358276|NCT01776307|Antimetabolites|antimetabolites|mesh-ancestor
102358277|NCT01776307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358278|NCT01776307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102358279|NCT01776307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102358280|NCT01741532|Deferiprone|deferiprone|mesh-list
102358281|NCT01741532|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102358282|NCT01741532|Chelating Agents|chelating agents|mesh-ancestor
102358283|NCT01741532|Sequestering Agents|sequestering agents|mesh-ancestor
102358284|NCT01741532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358285|NCT01727713|Aripiprazole|aripiprazole|mesh-list
102358286|NCT01727713|Antidepressive Agents|antidepressive agents|mesh-ancestor
102358287|NCT01727713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102358288|NCT01727713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102358289|NCT01727713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102358290|NCT01727713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102358291|NCT01727713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358292|NCT01727713|Dopamine Agonists|dopamine agonists|mesh-ancestor
102358293|NCT01727713|Dopamine Agents|dopamine agents|mesh-ancestor
102358294|NCT01727713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102358295|NCT01727713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358296|NCT01727713|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102358297|NCT01727713|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102358298|NCT01727713|Serotonin Agents|serotonin agents|mesh-ancestor
102358299|NCT01727713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102358300|NCT01727713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102358301|NCT01727713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102358302|NCT01727713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102358304|NCT04658927|Prednisone|prednisone|mesh-list
102358305|NCT04658927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102358306|NCT04658927|Antiemetics|antiemetics|mesh-ancestor
102358307|NCT04658927|Autonomic Agents|autonomic agents|mesh-ancestor
102358308|NCT04658927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102358309|NCT04658927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358310|NCT04658927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102358311|NCT04658927|Glucocorticoids|glucocorticoids|mesh-ancestor
102358312|NCT04658927|Hormones|hormones|mesh-ancestor
102358313|NCT04658927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102358314|NCT04658927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102358315|NCT04658927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102358316|NCT01965431|Moxifloxacin|moxifloxacin|mesh-list
102358317|NCT01965431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102358318|NCT01965431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102358319|NCT01965431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102358320|NCT01965431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102358321|NCT01965431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102358322|NCT01965431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358323|NCT01965431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102358324|NCT01976507|Dabigatran|dabigatran|mesh-list
102358325|NCT01976507|Antithrombins|antithrombins|mesh-ancestor
102358326|NCT01976507|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102358327|NCT01976507|Protease Inhibitors|protease inhibitors|mesh-ancestor
102358328|NCT01976507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102358329|NCT01976507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358330|NCT01976507|Anticoagulants|anticoagulants|mesh-ancestor
102358331|NCT01964963|Alogliptin|alogliptin|mesh-list
102358332|NCT01964963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102358333|NCT01964963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358334|NCT01964963|Incretins|incretins|mesh-ancestor
102358335|NCT01964963|Hormones|hormones|mesh-ancestor
102358336|NCT01964963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102358337|NCT01964963|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102358338|NCT01964963|Protease Inhibitors|protease inhibitors|mesh-ancestor
102358339|NCT01964963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102358340|NCT01964963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358341|NCT01974323|Dapsone|dapsone|mesh-list
102358342|NCT01974323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102358343|NCT01974323|Antimalarials|antimalarials|mesh-ancestor
102358344|NCT01974323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102358345|NCT01974323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102358346|NCT01974323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102358347|NCT01974323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102358348|NCT01974323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358349|NCT01974323|Leprostatic Agents|leprostatic agents|mesh-ancestor
102358350|NCT01974323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102358351|NCT01973387|Rituximab|rituximab|mesh-list
102358352|NCT01973387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102358353|NCT01973387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102358354|NCT01973387|Immunologic Factors|immunologic factors|mesh-ancestor
102358355|NCT01973387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358356|NCT01973387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102358357|NCT01973231|Liraglutide|liraglutide|mesh-list
102358358|NCT01973231|Lixisenatide|lixisenatide|mesh-list
102358359|NCT01973231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102358360|NCT01973231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358361|NCT01973231|Incretins|incretins|mesh-ancestor
102358362|NCT01973231|Hormones|hormones|mesh-ancestor
102358363|NCT01973231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102358364|NCT02151994|Zamicastat|zamicastat|mesh-list
102358365|NCT02151994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102358366|NCT02151994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358367|NCT04382950|Tretinoin|tretinoin|mesh-list
102358368|NCT04382950|Isotretinoin|isotretinoin|mesh-list
102358369|NCT04382950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102358370|NCT04382950|Keratolytic Agents|keratolytic agents|mesh-ancestor
102358371|NCT04382950|Dermatologic Agents|dermatologic agents|mesh-ancestor
102358372|NCT04383418|Dexmedetomidine|dexmedetomidine|mesh-list
102358373|NCT04383418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102358374|NCT04383418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102358375|NCT04383418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358376|NCT04383418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102358377|NCT04383418|Analgesics|analgesics|mesh-ancestor
102358378|NCT04383418|Sensory System Agents|sensory system agents|mesh-ancestor
102358379|NCT04383418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102358380|NCT04383418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102358381|NCT04383418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102358382|NCT04383418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102358383|NCT04383418|Adrenergic Agents|adrenergic agents|mesh-ancestor
102358384|NCT04383418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102358385|NCT04383418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358386|NCT03414112|Oxytocin|oxytocin|mesh-list
102358387|NCT03414112|Oxytocics|oxytocics|mesh-ancestor
102358388|NCT03414112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102358389|NCT03414112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358390|NCT03839134|Lidocaine|lidocaine|mesh-list
102358391|NCT03839134|Epinephrine|epinephrine|mesh-list
102358392|NCT03839134|Racepinephrine|racepinephrine|mesh-list
102358393|NCT03839134|Epinephryl borate|epinephryl borate|mesh-list
102358394|NCT03839134|Anesthetics, Local|anesthetics, local|mesh-ancestor
102358395|NCT03839134|Anesthetics|anesthetics|mesh-ancestor
102358396|NCT03839134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102358397|NCT03839134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358398|NCT03839134|Sensory System Agents|sensory system agents|mesh-ancestor
102358399|NCT03839134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102358400|NCT03839134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102358401|NCT03839134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102358402|NCT03839134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102358403|NCT03839134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102358404|NCT03839134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358405|NCT03839134|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102358406|NCT03839134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102358407|NCT03839134|Adrenergic Agents|adrenergic agents|mesh-ancestor
102358408|NCT03839134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102358409|NCT03839134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102358410|NCT03839134|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102358411|NCT03839134|Autonomic Agents|autonomic agents|mesh-ancestor
102358412|NCT03839134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102358413|NCT03839134|Respiratory System Agents|respiratory system agents|mesh-ancestor
102358414|NCT03839134|Mydriatics|mydriatics|mesh-ancestor
102358415|NCT03839134|Sympathomimetics|sympathomimetics|mesh-ancestor
102358416|NCT03839134|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102358417|NCT03906526|Nivolumab|nivolumab|mesh-list
102358418|NCT03906526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102358419|NCT03906526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102358420|NCT03906526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102358421|NCT03906526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358422|NCT03088930|Crizotinib|crizotinib|mesh-list
102358423|NCT03088930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102358424|NCT03088930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102358425|NCT03088930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102358426|NCT03088930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358427|NCT02152696|Methotrexate|methotrexate|mesh-list
102154152|NCT00353938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154153|NCT00353938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102154154|NCT00353938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102154155|NCT00353938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102154156|NCT00353938|Adrenergic Agents|adrenergic agents|mesh-ancestor
102154157|NCT00335114|Cyclosporine|cyclosporine|mesh-list
102154158|NCT00335114|Cyclosporins|cyclosporins|mesh-list
102154159|NCT00335114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102154160|NCT00335114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154161|NCT00335114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102154162|NCT00335114|Immunologic Factors|immunologic factors|mesh-ancestor
102154163|NCT00335114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358428|NCT02152696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102358430|NCT02152696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102358431|NCT02152696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358432|NCT02152696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102358433|NCT02152696|Antimetabolites|antimetabolites|mesh-ancestor
102358434|NCT02152696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358435|NCT02152696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102358436|NCT02152696|Dermatologic Agents|dermatologic agents|mesh-ancestor
102358437|NCT02152696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102358438|NCT02152696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102358439|NCT02152696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102358440|NCT02152696|Immunologic Factors|immunologic factors|mesh-ancestor
102358441|NCT02152696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102358442|NCT02152696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102358443|NCT01905436|Ivermectin|ivermectin|mesh-list
102358444|NCT01905436|Albendazole|albendazole|mesh-list
102358445|NCT01905436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102358446|NCT01905436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102358447|NCT01905436|Anthelmintics|anthelmintics|mesh-ancestor
102358448|NCT01905436|Anticestodal Agents|anticestodal agents|mesh-ancestor
102358449|NCT01905436|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102358450|NCT01905436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102358451|NCT01905436|Tubulin Modulators|tubulin modulators|mesh-ancestor
102358452|NCT01905436|Antimitotic Agents|antimitotic agents|mesh-ancestor
102358453|NCT01905436|Mitosis Modulators|mitosis modulators|mesh-ancestor
102358454|NCT01905436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358455|NCT01905436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102358456|NCT01256086|Formoterol Fumarate|formoterol fumarate|mesh-list
102358457|NCT01256086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102358458|NCT01256086|Autonomic Agents|autonomic agents|mesh-ancestor
102358459|NCT01256086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102358460|NCT01256086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358461|NCT01256086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102358462|NCT01256086|Respiratory System Agents|respiratory system agents|mesh-ancestor
102358463|NCT01256086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102358464|NCT01256086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102358465|NCT01256086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102358466|NCT01256086|Adrenergic Agents|adrenergic agents|mesh-ancestor
102358467|NCT01256086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102358468|NCT01256086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358469|NCT01149850|Bevacizumab|bevacizumab|mesh-list
102358470|NCT01149850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102358471|NCT01149850|Temozolomide|temozolomide|mesh-list
102358472|NCT01149850|Antibodies|antibodies|mesh-list
102358473|NCT01149850|Immunoglobulins|immunoglobulins|mesh-list
101890268|NCT03457636|Analgesics|analgesics|mesh-ancestor
102358474|NCT01149850|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102358475|NCT01149850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102358476|NCT01149850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102358477|NCT01149850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102358478|NCT01149850|Growth Substances|growth substances|mesh-ancestor
102358479|NCT01149850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358480|NCT01149850|Growth Inhibitors|growth inhibitors|mesh-ancestor
102358481|NCT01149850|Immunologic Factors|immunologic factors|mesh-ancestor
102358482|NCT01149850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102358483|NCT01149850|Alkylating Agents|alkylating agents|mesh-ancestor
102358484|NCT01149850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358485|NCT01972841|Solifenacin Succinate|solifenacin succinate|mesh-list
102358486|NCT01972841|Mirabegron|mirabegron|mesh-list
102358487|NCT01972841|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102358488|NCT01972841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102358489|NCT01972841|Cholinergic Agents|cholinergic agents|mesh-ancestor
102358490|NCT01972841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102358491|NCT01972841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358492|NCT01972841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358493|NCT01972841|Urological Agents|urological agents|mesh-ancestor
102358494|NCT01972841|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102358495|NCT01972841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102358496|NCT01972841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102358497|NCT01972841|Adrenergic Agents|adrenergic agents|mesh-ancestor
102358498|NCT01774903|Fentanyl|fentanyl|mesh-list
102358499|NCT01774903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102358500|NCT01774903|Narcotics|narcotics|mesh-ancestor
102358501|NCT01774903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102358502|NCT01774903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358503|NCT01774903|Analgesics|analgesics|mesh-ancestor
102358504|NCT01774903|Sensory System Agents|sensory system agents|mesh-ancestor
102358505|NCT01774903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102358506|NCT01774903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102358507|NCT01774903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102358508|NCT01774903|Anesthetics, General|anesthetics, general|mesh-ancestor
102358509|NCT01774903|Anesthetics|anesthetics|mesh-ancestor
102358510|NCT01774591|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
102358511|NCT01774591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102358512|NCT01774591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102358513|NCT01774591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358514|NCT01708915|Nicotinic Acids|nicotinic acids|mesh-list
102358515|NCT01708915|Capsaicin|capsaicin|mesh-list
102358516|NCT01708915|Nonivamide|nonivamide|mesh-list
102358517|NCT01708915|Vitamin B Complex|vitamin b complex|mesh-ancestor
102358518|NCT01708915|Vitamins|vitamins|mesh-ancestor
102358519|NCT01708915|Micronutrients|micronutrients|mesh-ancestor
102358520|NCT01708915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358521|NCT01708915|Sensory System Agents|sensory system agents|mesh-ancestor
102358522|NCT01708915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102358523|NCT01708915|Antipruritics|antipruritics|mesh-ancestor
102358524|NCT01708915|Dermatologic Agents|dermatologic agents|mesh-ancestor
102358525|NCT01708057|Tiotropium Bromide|tiotropium bromide|mesh-list
102358526|NCT01708057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102358527|NCT01708057|Autonomic Agents|autonomic agents|mesh-ancestor
102358528|NCT01708057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102358529|NCT01708057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358530|NCT01708057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102358531|NCT01708057|Respiratory System Agents|respiratory system agents|mesh-ancestor
102358532|NCT01708057|Parasympatholytics|parasympatholytics|mesh-ancestor
102358533|NCT01708057|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102358534|NCT01708057|Cholinergic Agents|cholinergic agents|mesh-ancestor
102358535|NCT01708057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102358536|NCT01708057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358537|NCT01747915|Pregabalin|pregabalin|mesh-list
102358538|NCT01747915|Analgesics|analgesics|mesh-ancestor
102358539|NCT01747915|Sensory System Agents|sensory system agents|mesh-ancestor
102358540|NCT01747915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102358541|NCT01747915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358542|NCT01747915|Anticonvulsants|anticonvulsants|mesh-ancestor
102358543|NCT01747915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102095571|NCT04613453|GABA Modulators|gaba modulators|mesh-ancestor
102358544|NCT01747915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102358545|NCT01747915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358546|NCT01747915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102358547|NCT01747915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102358548|NCT01747915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102358549|NCT01747915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102358550|NCT01747915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102358551|NCT01961297|Sodium Oxybate|sodium oxybate|mesh-list
102358552|NCT01961297|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102358553|NCT01961297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102358554|NCT01961297|Anesthetics, General|anesthetics, general|mesh-ancestor
102358555|NCT01961297|Anesthetics|anesthetics|mesh-ancestor
102358556|NCT01961297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102358557|NCT01961297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358558|NCT04656041|Paclitaxel|paclitaxel|mesh-list
102358559|NCT04656041|Carboplatin|carboplatin|mesh-list
102358560|NCT04656041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102358561|NCT04656041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102358562|NCT04656041|Tubulin Modulators|tubulin modulators|mesh-ancestor
102358563|NCT04656041|Antimitotic Agents|antimitotic agents|mesh-ancestor
102358564|NCT04656041|Mitosis Modulators|mitosis modulators|mesh-ancestor
102358565|NCT04656041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358566|NCT01971203|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102358567|NCT01971203|Antidepressive Agents|antidepressive agents|mesh-ancestor
102358568|NCT01971203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102358569|NCT01971203|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102358570|NCT01971203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102358571|NCT01971203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102358572|NCT01971203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358573|NCT01970501|Metoprolol|metoprolol|mesh-list
102358574|NCT01970501|Bucindolol|bucindolol|mesh-list
102358575|NCT01970501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102358576|NCT01970501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102358577|NCT01970501|Sympatholytics|sympatholytics|mesh-ancestor
102358578|NCT01970501|Autonomic Agents|autonomic agents|mesh-ancestor
102358579|NCT01970501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102358580|NCT01970501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358581|NCT01970501|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102358582|NCT01970501|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102358583|NCT01970501|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102358584|NCT01970501|Adrenergic Agents|adrenergic agents|mesh-ancestor
102358585|NCT01970501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102358586|NCT01970501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358587|NCT01970501|Sympathomimetics|sympathomimetics|mesh-ancestor
102358588|NCT01970501|Vasodilator Agents|vasodilator agents|mesh-ancestor
102358589|NCT01970501|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102358590|NCT01970501|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102358591|NCT01969799|Amikacin|amikacin|mesh-list
102358592|NCT01969799|Fosfomycin|fosfomycin|mesh-list
102358593|NCT01969799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102358594|NCT01969799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102358595|NCT01969721|Fluticasone|fluticasone|mesh-list
102358596|NCT01969721|Xhance|xhance|mesh-list
102358597|NCT01969721|Tiotropium Bromide|tiotropium bromide|mesh-list
102358598|NCT01969721|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102358599|NCT01969721|Olodaterol|olodaterol|mesh-list
102358600|NCT01969721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102358601|NCT01969721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102358602|NCT01969721|Autonomic Agents|autonomic agents|mesh-ancestor
102358603|NCT01969721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102358604|NCT01969721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358605|NCT01969721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102358606|NCT01969721|Respiratory System Agents|respiratory system agents|mesh-ancestor
102358607|NCT01969721|Dermatologic Agents|dermatologic agents|mesh-ancestor
102358608|NCT01969721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102358609|NCT01969721|Parasympatholytics|parasympatholytics|mesh-ancestor
102358610|NCT01969721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102358611|NCT01969721|Cholinergic Agents|cholinergic agents|mesh-ancestor
102358612|NCT01969721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102358613|NCT01969721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358614|NCT01969721|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102358615|NCT01969721|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102358616|NCT01969721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102358617|NCT01969721|Adrenergic Agents|adrenergic agents|mesh-ancestor
102358618|NCT01969565|Dexamethasone|dexamethasone|mesh-list
102358619|NCT01969565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102358620|NCT01969565|Antiemetics|antiemetics|mesh-ancestor
102358621|NCT01969565|Autonomic Agents|autonomic agents|mesh-ancestor
102358622|NCT01969565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102358623|NCT01969565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358624|NCT01969565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102358625|NCT01969565|Glucocorticoids|glucocorticoids|mesh-ancestor
102358626|NCT01969565|Hormones|hormones|mesh-ancestor
102358627|NCT01969565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102358628|NCT01969565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102358629|NCT01969565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102358630|NCT01968707|Ethanol|ethanol|mesh-list
102358631|NCT01968707|Chlorhexidine|chlorhexidine|mesh-list
102358632|NCT01968707|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102358633|NCT01968707|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102358634|NCT01968707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102358635|NCT01968707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102358636|NCT01968707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358637|NCT01968707|Disinfectants|disinfectants|mesh-ancestor
102358638|NCT01968707|Dermatologic Agents|dermatologic agents|mesh-ancestor
102358639|NCT01746901|Naltrexone|naltrexone|mesh-list
102358640|NCT01746901|Oxycodone|oxycodone|mesh-list
102358641|NCT01746901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102358642|NCT01746901|Narcotics|narcotics|mesh-ancestor
102358643|NCT01746901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102358644|NCT01746901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358645|NCT01746901|Analgesics|analgesics|mesh-ancestor
102358646|NCT01746901|Sensory System Agents|sensory system agents|mesh-ancestor
102358647|NCT01746901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102358648|NCT01746901|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102358649|NCT01746901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102358650|NCT01968551|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102358651|NCT01968551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102358652|NCT01968551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102358653|NCT01968551|Antiviral Agents|antiviral agents|mesh-ancestor
102358654|NCT01968551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102358655|NCT01946165|Prednisone|prednisone|mesh-list
102358656|NCT01946165|Abiraterone Acetate|abiraterone acetate|mesh-list
102358657|NCT01946165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102358658|NCT01946165|Glucocorticoids|glucocorticoids|mesh-ancestor
102358659|NCT01946165|Hormones|hormones|mesh-ancestor
102358660|NCT01946165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102358661|NCT01946165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358662|NCT01946165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102358663|NCT01946165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102358664|NCT01946165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102358665|NCT01946165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102358666|NCT01946165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358667|NCT01946165|Hormone Antagonists|hormone antagonists|mesh-ancestor
102358668|NCT01946165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102358669|NCT01707667|Prucalopride|prucalopride|mesh-list
102358670|NCT01707667|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
102358671|NCT01707667|Laxatives|laxatives|mesh-ancestor
102358672|NCT01707667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102358673|NCT01707667|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
102358674|NCT01707667|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102358675|NCT01707667|Serotonin Agents|serotonin agents|mesh-ancestor
102358676|NCT01707667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102358677|NCT01707667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358678|NCT01707667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358679|NCT01959503|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
102358680|NCT01959503|Hemostatics|hemostatics|mesh-ancestor
102358681|NCT01959503|Coagulants|coagulants|mesh-ancestor
102358682|NCT01706575|Interferons|interferons|mesh-list
102358683|NCT01706575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102358684|NCT01706575|Antiviral Agents|antiviral agents|mesh-ancestor
102358685|NCT01706575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102358686|NCT01725529|Ribavirin|ribavirin|mesh-list
102358687|NCT01725529|Simeprevir|simeprevir|mesh-list
102358688|NCT01725529|Antimetabolites|antimetabolites|mesh-ancestor
102358689|NCT01725529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358690|NCT01725529|Antiviral Agents|antiviral agents|mesh-ancestor
102358691|NCT01725529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102358692|NCT01725529|Protease Inhibitors|protease inhibitors|mesh-ancestor
102358693|NCT01725529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102358694|NCT01744093|Doxycycline|doxycycline|mesh-list
102358695|NCT01744093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102358696|NCT01744093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102358697|NCT01744093|Antimalarials|antimalarials|mesh-ancestor
102358698|NCT01744093|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102358699|NCT01744093|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102358700|NCT01725451|Testosterone|testosterone|mesh-list
102358701|NCT01725451|Androgens|androgens|mesh-ancestor
102358702|NCT01725451|Hormones|hormones|mesh-ancestor
102358703|NCT01725451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102358704|NCT01725451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358705|NCT01707290|Ivacaftor|ivacaftor|mesh-list
102358706|NCT01707290|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102358707|NCT01707290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102358708|NCT01707290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358709|NCT01717040|Pioglitazone|pioglitazone|mesh-list
102358710|NCT01717040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102358711|NCT01717040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358712|NCT00803062|Paclitaxel|paclitaxel|mesh-list
102358713|NCT00803062|Bevacizumab|bevacizumab|mesh-list
102358714|NCT00803062|Cisplatin|cisplatin|mesh-list
102358715|NCT00803062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102358716|NCT00803062|Topotecan|topotecan|mesh-list
102358717|NCT00803062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102358718|NCT00803062|Endothelial Growth Factors|endothelial growth factors|mesh-list
102358719|NCT00803062|Antibodies|antibodies|mesh-list
102358720|NCT00803062|Immunoglobulins|immunoglobulins|mesh-list
102358721|NCT00803062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102358722|NCT00803062|Immunoglobulin G|immunoglobulin g|mesh-list
102358723|NCT00803062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102358724|NCT00803062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102358725|NCT00803062|Tubulin Modulators|tubulin modulators|mesh-ancestor
102358726|NCT00803062|Antimitotic Agents|antimitotic agents|mesh-ancestor
102358727|NCT00803062|Mitosis Modulators|mitosis modulators|mesh-ancestor
102358728|NCT00803062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358729|NCT00803062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102358730|NCT00803062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102358731|NCT00803062|Growth Substances|growth substances|mesh-ancestor
102358732|NCT00803062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358733|NCT00803062|Growth Inhibitors|growth inhibitors|mesh-ancestor
102358734|NCT00803062|Immunologic Factors|immunologic factors|mesh-ancestor
102358735|NCT00803062|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102358736|NCT00803062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102358737|NCT00803062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102358738|NCT01743001|Macitentan|macitentan|mesh-list
102358739|NCT01743001|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
102358740|NCT01743001|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102358741|NCT01743001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358742|NCT01743001|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
102358743|NCT01704079|Calcifediol|calcifediol|mesh-list
102358744|NCT01704079|Vitamins|vitamins|mesh-ancestor
102358745|NCT01704079|Micronutrients|micronutrients|mesh-ancestor
102358746|NCT01704079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358747|NCT01704079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102358748|NCT01703845|Tiotropium Bromide|tiotropium bromide|mesh-list
102358749|NCT01703845|Olodaterol|olodaterol|mesh-list
102358750|NCT01703845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102358751|NCT01703845|Autonomic Agents|autonomic agents|mesh-ancestor
102358752|NCT01703845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102358753|NCT01703845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358754|NCT01703845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102358755|NCT01703845|Respiratory System Agents|respiratory system agents|mesh-ancestor
102358756|NCT01703845|Parasympatholytics|parasympatholytics|mesh-ancestor
102358757|NCT01703845|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102358758|NCT01703845|Cholinergic Agents|cholinergic agents|mesh-ancestor
102358759|NCT01703845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102358760|NCT01703845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358761|NCT01724359|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102358762|NCT01724359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102358763|NCT01724359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102358764|NCT01724359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102358765|NCT01724359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358766|NCT01724359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102358767|NCT01724359|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102358768|NCT01724359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102358769|NCT01724359|Serotonin Agents|serotonin agents|mesh-ancestor
102358770|NCT01724359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102358771|NCT01724359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358772|NCT01724359|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102358773|NCT01724359|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102358774|NCT01724359|Dopamine Agents|dopamine agents|mesh-ancestor
102358775|NCT01703221|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102358776|NCT01703221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102358777|NCT01703221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358778|NCT01703221|Incretins|incretins|mesh-ancestor
102358779|NCT01703221|Hormones|hormones|mesh-ancestor
102358780|NCT01703221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102358781|NCT01703221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102358782|NCT01703221|Protease Inhibitors|protease inhibitors|mesh-ancestor
102358783|NCT01703221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102358784|NCT01703221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358785|NCT00803686|Salmon calcitonin|salmon calcitonin|mesh-list
102358786|NCT00803686|Calcitonin|calcitonin|mesh-list
102358787|NCT00803686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102358788|NCT00803686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358789|NCT00803686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102358790|NCT00823966|Delavirdine|delavirdine|mesh-list
102358791|NCT00823966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102358792|NCT00823966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102358793|NCT00823966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102358794|NCT00823966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358795|NCT00823966|Antiviral Agents|antiviral agents|mesh-ancestor
102358796|NCT00823966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102358797|NCT00823966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102358798|NCT00823966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102358799|NCT01702987|Coenzyme Q10|coenzyme q10|mesh-list
102358800|NCT01702987|Atorvastatin|atorvastatin|mesh-list
102358801|NCT01702987|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102358802|NCT01702987|Simvastatin|simvastatin|mesh-list
102358803|NCT01702987|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102358804|NCT01702987|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102358805|NCT01702987|Antimetabolites|antimetabolites|mesh-ancestor
102358806|NCT01702987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358807|NCT01702987|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102358808|NCT01702987|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102358809|NCT01702987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102358810|NCT01702987|Micronutrients|micronutrients|mesh-ancestor
102358811|NCT01702987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358812|NCT01702987|Vitamins|vitamins|mesh-ancestor
102358813|NCT00824044|Escitalopram|escitalopram|mesh-list
102358814|NCT00824044|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102358815|NCT00824044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102358816|NCT00824044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102358817|NCT00824044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358818|NCT00824044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102358819|NCT00824044|Serotonin Agents|serotonin agents|mesh-ancestor
102358820|NCT00824044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358821|NCT01702519|Nicotine|nicotine|mesh-list
102358822|NCT01702519|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102358823|NCT01702519|Autonomic Agents|autonomic agents|mesh-ancestor
102358824|NCT01702519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102358825|NCT01702519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358826|NCT01702519|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102358827|NCT01702519|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102358828|NCT01702519|Cholinergic Agents|cholinergic agents|mesh-ancestor
102358829|NCT01702519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102358830|NCT01702519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358831|NCT01739335|Mifepristone|mifepristone|mesh-list
102358832|NCT01739335|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102358833|NCT01739335|Abortifacient Agents|abortifacient agents|mesh-ancestor
102358834|NCT01739335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102358835|NCT01739335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358836|NCT01739335|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102358837|NCT01739335|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102358838|NCT01739335|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102358839|NCT01739335|Contraceptive Agents|contraceptive agents|mesh-ancestor
102358840|NCT01739335|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102358841|NCT01739335|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102358842|NCT01739335|Hormone Antagonists|hormone antagonists|mesh-ancestor
102358843|NCT01739335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102358844|NCT01739335|Luteolytic Agents|luteolytic agents|mesh-ancestor
102358845|NCT01739335|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102358846|NCT01739335|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102358847|NCT00824746|Gefitinib|gefitinib|mesh-list
102358848|NCT00824746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102358849|NCT00824746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102358850|NCT00824746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102358851|NCT00824746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358852|NCT01722097|Rocuronium|rocuronium|mesh-list
102358853|NCT01722097|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102358854|NCT01722097|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102358855|NCT01722097|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102358856|NCT01722097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102358857|NCT01722097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358858|NCT00824824|Timolol|timolol|mesh-list
102358859|NCT00824824|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102358860|NCT00824824|Dorzolamide|dorzolamide|mesh-list
102358861|NCT00824824|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102358862|NCT00824824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102358863|NCT00824824|Adrenergic Agents|adrenergic agents|mesh-ancestor
102358864|NCT00824824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102358865|NCT00824824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358866|NCT00824824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358867|NCT00824824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102358868|NCT00824824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102358869|NCT00824824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102358870|NCT00824824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102358871|NCT00824824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102358872|NCT00824824|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102358873|NCT00824824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102358874|NCT01701973|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102358875|NCT01701973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102358876|NCT01701973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358877|NCT01701973|Incretins|incretins|mesh-ancestor
102358878|NCT01701973|Hormones|hormones|mesh-ancestor
102358879|NCT01701973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102358880|NCT01701973|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102358881|NCT01701973|Protease Inhibitors|protease inhibitors|mesh-ancestor
102358882|NCT01701973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102358883|NCT01701973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358884|NCT00825370|Hydromorphone|hydromorphone|mesh-list
102358885|NCT00825370|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102358886|NCT00825370|Narcotics|narcotics|mesh-ancestor
102358887|NCT00825370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102358888|NCT00825370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358889|NCT00825370|Analgesics|analgesics|mesh-ancestor
102358890|NCT00825370|Sensory System Agents|sensory system agents|mesh-ancestor
102358891|NCT00825370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102358892|NCT01721317|Ezogabine|ezogabine|mesh-list
102358893|NCT01721317|Anticonvulsants|anticonvulsants|mesh-ancestor
102358894|NCT01721317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102358895|NCT01721317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358896|NCT05014438|Branebrutinib|branebrutinib|mesh-list
102358897|NCT05014438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102358898|NCT05014438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102358899|NCT05014438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358900|NCT00828412|Desonide|desonide|mesh-list
102358901|NCT00828412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102358902|NCT01959035|Aripiprazole|aripiprazole|mesh-list
102358903|NCT01959035|Antidepressive Agents|antidepressive agents|mesh-ancestor
102358904|NCT01959035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102358905|NCT01959035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102358906|NCT01959035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102358907|NCT01959035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102358908|NCT01959035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358909|NCT01959035|Dopamine Agonists|dopamine agonists|mesh-ancestor
102358910|NCT01959035|Dopamine Agents|dopamine agents|mesh-ancestor
102358911|NCT01959035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102358912|NCT01959035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358913|NCT01959035|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102358914|NCT01959035|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102358915|NCT01959035|Serotonin Agents|serotonin agents|mesh-ancestor
102358916|NCT01959035|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102358917|NCT01959035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102358918|NCT01959035|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102358919|NCT01959035|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102358920|NCT01700959|Melatonin|melatonin|mesh-list
102358921|NCT01700959|Antioxidants|antioxidants|mesh-ancestor
102358922|NCT01700959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358923|NCT01700959|Protective Agents|protective agents|mesh-ancestor
102358924|NCT01700959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358925|NCT01700959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102358926|NCT00829738|Pantoprazole|pantoprazole|mesh-list
102358927|NCT00829738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102358928|NCT00829738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102358929|NCT00829738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102358930|NCT00829738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102358931|NCT00829738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358932|NCT01737931|Diphenhydramine|diphenhydramine|mesh-list
102358933|NCT01737931|Promethazine|promethazine|mesh-list
102358934|NCT01737931|Dexamethasone|dexamethasone|mesh-list
102358935|NCT01737931|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
102358936|NCT01737931|Histamine Antagonists|histamine antagonists|mesh-list
102358937|NCT01737931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102358938|NCT01737931|Antiemetics|antiemetics|mesh-ancestor
102358939|NCT01737931|Autonomic Agents|autonomic agents|mesh-ancestor
102358940|NCT01737931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102358941|NCT01737931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358942|NCT01737931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102358943|NCT01737931|Glucocorticoids|glucocorticoids|mesh-ancestor
102358944|NCT01737931|Hormones|hormones|mesh-ancestor
102358945|NCT01737931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102358946|NCT01737931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102358947|NCT01737931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102358948|NCT01737931|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102358949|NCT01737931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102154164|NCT00335114|Antifungal Agents|antifungal agents|mesh-ancestor
102358950|NCT01737931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102358951|NCT01737931|Anesthetics, Local|anesthetics, local|mesh-ancestor
102358952|NCT01737931|Anesthetics|anesthetics|mesh-ancestor
102358953|NCT01737931|Sensory System Agents|sensory system agents|mesh-ancestor
102358954|NCT01737931|Histamine Agents|histamine agents|mesh-ancestor
102358955|NCT01737931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102358956|NCT01737931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358957|NCT01737931|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102358958|NCT01737931|Antipruritics|antipruritics|mesh-ancestor
102358959|NCT01737931|Dermatologic Agents|dermatologic agents|mesh-ancestor
102358960|NCT01958489|Pravastatin|pravastatin|mesh-list
102358961|NCT01958489|Evacetrapib|evacetrapib|mesh-list
102358962|NCT01958489|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102358963|NCT01958489|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102358964|NCT01958489|Antimetabolites|antimetabolites|mesh-ancestor
102358965|NCT01958489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358966|NCT01958489|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102358967|NCT01958489|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102358968|NCT01958489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102358969|NCT00830362|Propranolol|propranolol|mesh-list
102358970|NCT00830362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102358971|NCT00830362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102358972|NCT00830362|Adrenergic Agents|adrenergic agents|mesh-ancestor
102358973|NCT00830362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102358974|NCT00830362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358975|NCT00830362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358976|NCT00830362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102358977|NCT00830362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102358978|NCT00830362|Vasodilator Agents|vasodilator agents|mesh-ancestor
102358979|NCT01944839|Ranibizumab|ranibizumab|mesh-list
102358980|NCT01944839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102358981|NCT01944839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102358982|NCT01944839|Growth Substances|growth substances|mesh-ancestor
102358983|NCT01944839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102358984|NCT01944839|Growth Inhibitors|growth inhibitors|mesh-ancestor
102358985|NCT01944839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102358986|NCT01720225|Azacitidine|azacitidine|mesh-list
102358987|NCT01720225|Decitabine|decitabine|mesh-list
102358988|NCT01720225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102358989|NCT01720225|Antimetabolites|antimetabolites|mesh-ancestor
102358990|NCT01720225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102358991|NCT01720225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102358992|NCT01720225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102358993|NCT01943435|Acetaminophen|acetaminophen|mesh-list
102358994|NCT01943435|Ibuprofen|ibuprofen|mesh-list
102358995|NCT01943435|Celecoxib|celecoxib|mesh-list
102358996|NCT01943435|Diclofenac|diclofenac|mesh-list
102358997|NCT01943435|Gabapentin|gabapentin|mesh-list
102358998|NCT01943435|Tramadol|tramadol|mesh-list
102358999|NCT01943435|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102359000|NCT01943435|Analgesics|analgesics|mesh-list
102359001|NCT01943435|Mirtazapine|mirtazapine|mesh-list
102359002|NCT01943435|Trazodone|trazodone|mesh-list
102359003|NCT01943435|Sertraline|sertraline|mesh-list
102359004|NCT01943435|Nortriptyline|nortriptyline|mesh-list
102359005|NCT01943435|Antidepressive Agents|antidepressive agents|mesh-list
102359006|NCT01943435|Misoprostol|misoprostol|mesh-list
102359007|NCT01943435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102359008|NCT01943435|Sensory System Agents|sensory system agents|mesh-ancestor
102359009|NCT01943435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102359010|NCT01943435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359011|NCT01943435|Antipyretics|antipyretics|mesh-ancestor
102359012|NCT01943435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102359013|NCT01943435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102359014|NCT01943435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102359015|NCT01943435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102359016|NCT01943435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102359017|NCT01943435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359018|NCT01943435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102359019|NCT01943435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102359020|NCT01943435|Abortifacient Agents|abortifacient agents|mesh-ancestor
102359021|NCT01943435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102359022|NCT01943435|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102359023|NCT01943435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102170796|NCT05672524|Tucatinib|tucatinib|mesh-list
102359024|NCT01943435|Oxytocics|oxytocics|mesh-ancestor
102359025|NCT01943435|Anticonvulsants|anticonvulsants|mesh-ancestor
102359026|NCT01943435|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102359027|NCT01943435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102359028|NCT01943435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102359029|NCT01943435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102359030|NCT01943435|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102359031|NCT01943435|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102359032|NCT01943435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102359033|NCT01943435|Antimanic Agents|antimanic agents|mesh-ancestor
102359034|NCT01943435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102359035|NCT01943435|Narcotics|narcotics|mesh-ancestor
102359036|NCT01943435|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102359037|NCT01943435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102359038|NCT01943435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102359039|NCT01943435|Dopamine Agents|dopamine agents|mesh-ancestor
102359040|NCT01943435|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102359041|NCT01943435|Serotonin Agents|serotonin agents|mesh-ancestor
102359042|NCT01943435|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102359043|NCT01943435|Histamine Antagonists|histamine antagonists|mesh-ancestor
102359044|NCT01943435|Histamine Agents|histamine agents|mesh-ancestor
102359045|NCT01943435|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102359046|NCT01943435|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102359047|NCT01943435|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102359048|NCT01943435|Adrenergic Agents|adrenergic agents|mesh-ancestor
102359049|NCT01943435|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102359050|NCT01943435|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102359051|NCT01943435|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102359052|NCT01943435|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102359053|NCT01943435|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102359054|NCT01943435|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102359055|NCT01942733|Brexpiprazole|brexpiprazole|mesh-list
102359056|NCT01942733|Serotonin Agents|serotonin agents|mesh-ancestor
102359057|NCT01942733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102359058|NCT01942733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359059|NCT01942733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359060|NCT01942733|Dopamine Agonists|dopamine agonists|mesh-ancestor
102359061|NCT01942733|Dopamine Agents|dopamine agents|mesh-ancestor
102359062|NCT00807586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102359063|NCT00807586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102359064|NCT00807586|Methylprednisolone|methylprednisolone|mesh-list
102359065|NCT00807586|Prednisolone|prednisolone|mesh-list
102359066|NCT00807586|Prednisolone acetate|prednisolone acetate|mesh-list
102359067|NCT00807586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102359068|NCT00807586|Prednisolone phosphate|prednisolone phosphate|mesh-list
102359069|NCT00807586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102359070|NCT00807586|Glucocorticoids|glucocorticoids|mesh-ancestor
102359071|NCT00807586|Hormones|hormones|mesh-ancestor
102359072|NCT00807586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102359073|NCT00807586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359074|NCT00807586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102359075|NCT00807586|Protective Agents|protective agents|mesh-ancestor
102359076|NCT00807586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102359077|NCT00807586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102359078|NCT00807586|Antiemetics|antiemetics|mesh-ancestor
102359079|NCT00807586|Autonomic Agents|autonomic agents|mesh-ancestor
102359080|NCT00807586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102359081|NCT00807586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102359082|NCT01698775|Glipizide|glipizide|mesh-list
102359083|NCT01698775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102359084|NCT01698775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359085|NCT01941095|Hydroxychloroquine|hydroxychloroquine|mesh-list
102359086|NCT01941095|Chloroquine|chloroquine|mesh-list
102359087|NCT01941095|Sulfasalazine|sulfasalazine|mesh-list
102359088|NCT01941095|Methotrexate|methotrexate|mesh-list
102359089|NCT01941095|Azathioprine|azathioprine|mesh-list
102359090|NCT01941095|Leflunomide|leflunomide|mesh-list
102359091|NCT01941095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102170817|NCT05643170|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102170818|NCT05643170|Cholinergic Agents|cholinergic agents|mesh-ancestor
102170819|NCT05643170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102170820|NCT05643170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170821|NCT05643170|Urological Agents|urological agents|mesh-ancestor
102170822|NCT05643170|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102170823|NCT05643170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102170824|NCT05643170|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102170825|NCT05643170|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102170826|NCT05635916|Bupivacaine|bupivacaine|mesh-list
102359092|NCT01941095|Abortifacient Agents|abortifacient agents|mesh-ancestor
102359093|NCT01941095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102359094|NCT01941095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359095|NCT01941095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102359096|NCT01941095|Antimetabolites|antimetabolites|mesh-ancestor
102359097|NCT01941095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359098|NCT01941095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102359099|NCT01941095|Dermatologic Agents|dermatologic agents|mesh-ancestor
102359100|NCT01941095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102359101|NCT01941095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102359102|NCT01941095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102359103|NCT01941095|Immunologic Factors|immunologic factors|mesh-ancestor
102359104|NCT01941095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102359105|NCT01941095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102359106|NCT01941095|Antimalarials|antimalarials|mesh-ancestor
102359107|NCT01941095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102359108|NCT01941095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102359109|NCT01941095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102359110|NCT01941095|Amebicides|amebicides|mesh-ancestor
102359111|NCT01941095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102359112|NCT01941095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102359113|NCT01941095|Analgesics|analgesics|mesh-ancestor
102359114|NCT01941095|Sensory System Agents|sensory system agents|mesh-ancestor
102359115|NCT01941095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102359116|NCT01941095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102359117|NCT01941095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102359118|NCT00831766|Cytarabine|cytarabine|mesh-list
102359119|NCT00831766|Lenalidomide|lenalidomide|mesh-list
102359120|NCT00831766|Idarubicin|idarubicin|mesh-list
102359121|NCT00831766|Antineoplastic Agents|antineoplastic agents|mesh-list
102359122|NCT00831766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102359123|NCT00831766|Antimetabolites|antimetabolites|mesh-ancestor
102359124|NCT00831766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359125|NCT00831766|Antiviral Agents|antiviral agents|mesh-ancestor
102359126|NCT00831766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102359127|NCT00831766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102359128|NCT00831766|Immunologic Factors|immunologic factors|mesh-ancestor
102359129|NCT00831766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359130|NCT00831766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102359131|NCT00831766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102359132|NCT00831766|Growth Substances|growth substances|mesh-ancestor
102359133|NCT00831766|Growth Inhibitors|growth inhibitors|mesh-ancestor
102359134|NCT00831766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102359135|NCT00831766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102359136|NCT00831766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102359137|NCT00831766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102359138|NCT01957709|Interferons|interferons|mesh-list
102359139|NCT01957709|Interferon-gamma|interferon-gamma|mesh-list
102359140|NCT01957709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102359141|NCT01957709|Antiviral Agents|antiviral agents|mesh-ancestor
102359142|NCT01957709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102359143|NCT00832390|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102359144|NCT00832390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102359145|NCT00832390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359146|NCT00832390|Incretins|incretins|mesh-ancestor
102359147|NCT00832390|Hormones|hormones|mesh-ancestor
102359148|NCT00832390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102359149|NCT00832390|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102359150|NCT00832390|Protease Inhibitors|protease inhibitors|mesh-ancestor
102359151|NCT00832390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102359152|NCT00832390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359153|NCT00844090|Methylphenidate|methylphenidate|mesh-list
102359154|NCT00844090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102359155|NCT00844090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359156|NCT00844090|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102359157|NCT00844090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102359158|NCT00844090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102359159|NCT00844090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359160|NCT00844090|Dopamine Agents|dopamine agents|mesh-ancestor
102359161|NCT00844090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102359162|NCT00844714|Rituximab|rituximab|mesh-list
102359163|NCT00844714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102359164|NCT00844714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102170893|NCT05505825|Chiauranib|chiauranib|mesh-list
102359165|NCT00844714|Immunologic Factors|immunologic factors|mesh-ancestor
102359166|NCT00844714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359167|NCT00844714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102359168|NCT00834652|Metformin|metformin|mesh-list
102359169|NCT00834652|Sertraline|sertraline|mesh-list
102359170|NCT00834652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102359171|NCT00834652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359172|NCT00834652|Antidepressive Agents|antidepressive agents|mesh-ancestor
102359173|NCT00834652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102359174|NCT00834652|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102359175|NCT00834652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102359176|NCT00834652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102359177|NCT00834652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359178|NCT00834652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102359179|NCT00834652|Serotonin Agents|serotonin agents|mesh-ancestor
102359180|NCT00834808|Tramadol|tramadol|mesh-list
102359181|NCT00834808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102359182|NCT00834808|Narcotics|narcotics|mesh-ancestor
102359183|NCT00834808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102359184|NCT00834808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359185|NCT00834808|Analgesics|analgesics|mesh-ancestor
102359186|NCT00834808|Sensory System Agents|sensory system agents|mesh-ancestor
102359187|NCT00834808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102359188|NCT00850096|Insulin|insulin|mesh-list
102359189|NCT00850096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102359190|NCT00850096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359191|NCT00834886|Melatonin|melatonin|mesh-list
102359192|NCT00834886|Antioxidants|antioxidants|mesh-ancestor
102359193|NCT00834886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359194|NCT00834886|Protective Agents|protective agents|mesh-ancestor
102359195|NCT00834886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359196|NCT00834886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102359197|NCT00835198|Dapsone|dapsone|mesh-list
102359198|NCT00835198|Tretinoin|tretinoin|mesh-list
102359199|NCT00835198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102359200|NCT00835198|Keratolytic Agents|keratolytic agents|mesh-ancestor
102359201|NCT00835198|Dermatologic Agents|dermatologic agents|mesh-ancestor
102359202|NCT00835198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102359203|NCT00835198|Antimalarials|antimalarials|mesh-ancestor
102359204|NCT00835198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102359205|NCT00835198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102359206|NCT00835198|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102359207|NCT00835198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102359208|NCT00835198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359209|NCT00835198|Leprostatic Agents|leprostatic agents|mesh-ancestor
102359210|NCT00835198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102359211|NCT00835510|Butenafine|butenafine|mesh-list
102359212|NCT00835510|Clotrimazole|clotrimazole|mesh-list
102359213|NCT00835510|Antifungal Agents|antifungal agents|mesh-ancestor
102359214|NCT00835510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102359215|NCT00835510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102359216|NCT00835510|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102359217|NCT00835510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102359218|NCT00835510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102359219|NCT00835510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359220|NCT00835510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102359221|NCT00835510|Hormone Antagonists|hormone antagonists|mesh-ancestor
102359222|NCT00835510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102359223|NCT00835510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359224|NCT00835900|Varenicline|varenicline|mesh-list
102359225|NCT00835900|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102359226|NCT00835900|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102359227|NCT00835900|Cholinergic Agents|cholinergic agents|mesh-ancestor
102359228|NCT00835900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102359229|NCT00835900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359230|NCT00835900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359231|NCT01954121|Carbamazepine|carbamazepine|mesh-list
102359232|NCT01954121|Levetiracetam|levetiracetam|mesh-list
102359233|NCT01954121|Anticonvulsants|anticonvulsants|mesh-ancestor
102359234|NCT01954121|Nootropic Agents|nootropic agents|mesh-ancestor
102359235|NCT01954121|Antimanic Agents|antimanic agents|mesh-ancestor
102359236|NCT01954121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102359237|NCT01954121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102359238|NCT01954121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359239|NCT01954121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102359240|NCT01954121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102359241|NCT01954121|Analgesics|analgesics|mesh-ancestor
102359242|NCT01954121|Sensory System Agents|sensory system agents|mesh-ancestor
102359243|NCT01954121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102359244|NCT01954121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102359245|NCT01954121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102359246|NCT01954121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359247|NCT01954121|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102359248|NCT01954121|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102359249|NCT03643744|Celecoxib|celecoxib|mesh-list
102359250|NCT03643744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102359251|NCT03643744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102359252|NCT03643744|Analgesics|analgesics|mesh-ancestor
102359253|NCT03643744|Sensory System Agents|sensory system agents|mesh-ancestor
102359254|NCT03643744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102359255|NCT03643744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359256|NCT03643744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102359257|NCT03643744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102359258|NCT03643744|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102359259|NCT03643744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102359260|NCT03643744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102359261|NCT03643744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359262|NCT00838162|Ritonavir|ritonavir|mesh-list
102359263|NCT00838162|TMC-310911|tmc-310911|mesh-list
102359264|NCT00838162|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102359265|NCT00838162|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102359266|NCT00838162|Protease Inhibitors|protease inhibitors|mesh-ancestor
102359267|NCT00838162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102359268|NCT00838162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359269|NCT00838162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102359270|NCT00838162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102359271|NCT00838162|Antiviral Agents|antiviral agents|mesh-ancestor
102359272|NCT00838162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102359273|NCT00838162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102359274|NCT00838162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102359275|NCT00841204|Sulindac|sulindac|mesh-list
102359276|NCT00841204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102359277|NCT00841204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102359278|NCT00841204|Analgesics|analgesics|mesh-ancestor
102359279|NCT00841204|Sensory System Agents|sensory system agents|mesh-ancestor
102359280|NCT00841204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102359281|NCT00841204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359282|NCT00841204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102359283|NCT00841204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102359284|NCT00841204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102359285|NCT00841204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102359286|NCT00841204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102359287|NCT00841204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359288|NCT00853840|Maraviroc|maraviroc|mesh-list
102359289|NCT00853840|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
102359290|NCT00853840|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102359291|NCT00853840|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102359292|NCT00853840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359293|NCT00853840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102359294|NCT00853840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102359295|NCT00853840|Antiviral Agents|antiviral agents|mesh-ancestor
102359296|NCT00853840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102359297|NCT00853840|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102359298|NCT00853840|Vasodilator Agents|vasodilator agents|mesh-ancestor
102359299|NCT00853840|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102359300|NCT00853840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102359301|NCT00853840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102359302|NCT00853840|Urological Agents|urological agents|mesh-ancestor
102359303|NCT00841828|Cyclophosphamide|cyclophosphamide|mesh-list
102359304|NCT00841828|Docetaxel|docetaxel|mesh-list
102359305|NCT00841828|Trastuzumab|trastuzumab|mesh-list
102359306|NCT00841828|Epirubicin|epirubicin|mesh-list
102359307|NCT00841828|Lapatinib|lapatinib|mesh-list
102359308|NCT00841828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102359309|NCT00841828|Immunologic Factors|immunologic factors|mesh-ancestor
102359310|NCT00841828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359311|NCT00841828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102359312|NCT00841828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102359313|NCT00841828|Alkylating Agents|alkylating agents|mesh-ancestor
102359314|NCT00841828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359315|NCT00841828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102359316|NCT00841828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102359317|NCT00841828|Tubulin Modulators|tubulin modulators|mesh-ancestor
102359318|NCT00841828|Antimitotic Agents|antimitotic agents|mesh-ancestor
102359319|NCT00841828|Mitosis Modulators|mitosis modulators|mesh-ancestor
102359320|NCT00841828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102359321|NCT00841828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102359322|NCT00841828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102359323|NCT00841828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102359324|NCT00841828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102359325|NCT00841828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102359326|NCT00855010|Pioglitazone|pioglitazone|mesh-list
102359327|NCT00855010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102359328|NCT00855010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359329|NCT00842608|Haloperidol|haloperidol|mesh-list
102359330|NCT00842608|Haloperidol decanoate|haloperidol decanoate|mesh-list
102359331|NCT00842608|Cholinergic Antagonists|cholinergic antagonists|mesh-list
102359332|NCT00842608|Antiemetics|antiemetics|mesh-ancestor
102359333|NCT00842608|Autonomic Agents|autonomic agents|mesh-ancestor
102359334|NCT00842608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102359335|NCT00842608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359336|NCT00842608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102359337|NCT00842608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102359338|NCT00842608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102359339|NCT00842608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102359340|NCT00842608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102359341|NCT00842608|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102359342|NCT00842608|Dopamine Agents|dopamine agents|mesh-ancestor
102359343|NCT00842608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102359344|NCT00842608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359345|NCT00842608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102359346|NCT00842608|Cholinergic Agents|cholinergic agents|mesh-ancestor
102359347|NCT00856024|Ribavirin|ribavirin|mesh-list
102359348|NCT00856024|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102359349|NCT00856024|Antimetabolites|antimetabolites|mesh-ancestor
102359350|NCT00856024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359351|NCT00856024|Antiviral Agents|antiviral agents|mesh-ancestor
102359352|NCT00856024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102359353|NCT00856414|Botulinum Toxins|botulinum toxins|mesh-list
102359354|NCT00856414|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102359355|NCT00856414|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102359356|NCT00856414|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102359357|NCT00856414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102359358|NCT00856414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359359|NCT00856414|Cholinergic Agents|cholinergic agents|mesh-ancestor
102359360|NCT00856414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102359361|NCT00856414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359362|NCT00856414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102359363|NCT00856414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102359364|NCT00856726|Parathyroid Hormone|parathyroid hormone|mesh-list
102359365|NCT00856726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102359366|NCT00856726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359367|NCT00857272|Bisacodyl|bisacodyl|mesh-list
102359368|NCT00857272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102359369|NCT00857272|Cathartics|cathartics|mesh-ancestor
102359370|NCT00857272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102359371|NCT00857272|Laxatives|laxatives|mesh-ancestor
102359372|NCT03696784|Cyclophosphamide|cyclophosphamide|mesh-list
102359373|NCT03696784|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102359374|NCT03696784|Fludarabine|fludarabine|mesh-list
102359375|NCT03696784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102359376|NCT03696784|Immunologic Factors|immunologic factors|mesh-ancestor
102359377|NCT03696784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359378|NCT03696784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102359379|NCT03696784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102359380|NCT03696784|Alkylating Agents|alkylating agents|mesh-ancestor
102359381|NCT03696784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359382|NCT03696784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102359383|NCT03696784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102359384|NCT01682863|Glycopyrrolate|glycopyrrolate|mesh-list
102359385|NCT01682863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102359386|NCT01682863|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102359387|NCT01682863|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102359388|NCT01682863|Cholinergic Agents|cholinergic agents|mesh-ancestor
102359389|NCT01682863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102359390|NCT01682863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359391|NCT01682863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359393|NCT02453620|Ipilimumab|ipilimumab|mesh-list
102359394|NCT02453620|Entinostat|entinostat|mesh-list
102359395|NCT02453620|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
102359396|NCT02453620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102359397|NCT02453620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102359398|NCT02453620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102359399|NCT02453620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359400|NCT02453620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102359401|NCT04400890|Vitamin D|vitamin d|mesh-list
102359402|NCT04400890|Cholecalciferol|cholecalciferol|mesh-list
102359403|NCT04400890|Resveratrol|resveratrol|mesh-list
102359404|NCT04400890|Vitamins|vitamins|mesh-ancestor
102359405|NCT04400890|Micronutrients|micronutrients|mesh-ancestor
102359406|NCT04400890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359407|NCT04400890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102359408|NCT04400890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102359409|NCT04400890|Antioxidants|antioxidants|mesh-ancestor
102359410|NCT04400890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359411|NCT04400890|Protective Agents|protective agents|mesh-ancestor
102359412|NCT04400890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102359413|NCT04400890|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102359414|NCT01936649|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
102359415|NCT01936649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102359416|NCT01936649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102359417|NCT01936649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359418|NCT01936649|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102359419|NCT04351438|Heparin|heparin|mesh-list
102359420|NCT04351438|Citric Acid|citric acid|mesh-list
102359421|NCT04351438|Sodium Citrate|sodium citrate|mesh-list
102359422|NCT04351438|Anticoagulants|anticoagulants|mesh-ancestor
102359423|NCT04351438|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102359424|NCT04351438|Chelating Agents|chelating agents|mesh-ancestor
102359425|NCT04351438|Sequestering Agents|sequestering agents|mesh-ancestor
102359426|NCT04351438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359427|NCT04351438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102359428|NCT04351438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102359429|NCT00890656|Dexamethasone|dexamethasone|mesh-list
102359430|NCT00890656|Cyclophosphamide|cyclophosphamide|mesh-list
102359431|NCT00890656|Doxorubicin|doxorubicin|mesh-list
102359432|NCT00890656|Methotrexate|methotrexate|mesh-list
102359433|NCT00890656|Vincristine|vincristine|mesh-list
102359434|NCT00890656|Asparaginase|asparaginase|mesh-list
102359435|NCT00890656|Pegaspargase|pegaspargase|mesh-list
102359436|NCT00890656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102359437|NCT00890656|Immunologic Factors|immunologic factors|mesh-ancestor
102359438|NCT00890656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359439|NCT00890656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102359440|NCT00890656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102359441|NCT00890656|Alkylating Agents|alkylating agents|mesh-ancestor
102359442|NCT00890656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359443|NCT00890656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102359444|NCT00890656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102359445|NCT00890656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102359446|NCT00890656|Antiemetics|antiemetics|mesh-ancestor
102359447|NCT00890656|Autonomic Agents|autonomic agents|mesh-ancestor
102359448|NCT00890656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102359449|NCT00890656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102359450|NCT00890656|Glucocorticoids|glucocorticoids|mesh-ancestor
102359451|NCT00890656|Hormones|hormones|mesh-ancestor
102359452|NCT00890656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102359453|NCT00890656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102359454|NCT00890656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102359455|NCT00890656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102359456|NCT00890656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102359457|NCT00890656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102359458|NCT00890656|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102359459|NCT00890656|Abortifacient Agents|abortifacient agents|mesh-ancestor
102359460|NCT00890656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102359461|NCT00890656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102359462|NCT00890656|Antimetabolites|antimetabolites|mesh-ancestor
102359463|NCT00890656|Dermatologic Agents|dermatologic agents|mesh-ancestor
102359464|NCT00890656|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102171210|NCT04675333|Carboplatin|carboplatin|mesh-list
102359465|NCT00890656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102359466|NCT00890656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102359467|NCT00890656|Tubulin Modulators|tubulin modulators|mesh-ancestor
102359468|NCT00890656|Antimitotic Agents|antimitotic agents|mesh-ancestor
102359469|NCT00890656|Mitosis Modulators|mitosis modulators|mesh-ancestor
102359470|NCT00814138|Methotrexate|methotrexate|mesh-list
102359471|NCT00814138|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102359472|NCT00814138|Abortifacient Agents|abortifacient agents|mesh-ancestor
102359473|NCT00814138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102359474|NCT00814138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359475|NCT00814138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102359476|NCT00814138|Antimetabolites|antimetabolites|mesh-ancestor
102359477|NCT00814138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359478|NCT00814138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102359479|NCT00814138|Dermatologic Agents|dermatologic agents|mesh-ancestor
102359480|NCT00814138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102359481|NCT00814138|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102359482|NCT00814138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102359483|NCT00814138|Immunologic Factors|immunologic factors|mesh-ancestor
102359484|NCT00814138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102359485|NCT00814138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102359486|NCT00860938|Budesonide|budesonide|mesh-list
102359487|NCT00860938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102359488|NCT00860938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102359489|NCT00860938|Autonomic Agents|autonomic agents|mesh-ancestor
102359490|NCT00860938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102359491|NCT00860938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359492|NCT00860938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102359493|NCT00860938|Respiratory System Agents|respiratory system agents|mesh-ancestor
102359494|NCT00860938|Glucocorticoids|glucocorticoids|mesh-ancestor
102359495|NCT00860938|Hormones|hormones|mesh-ancestor
102359496|NCT00860938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102359497|NCT01719757|Oxycodone|oxycodone|mesh-list
102359498|NCT01719757|Naloxone|naloxone|mesh-list
102359499|NCT01719757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102359500|NCT01719757|Narcotics|narcotics|mesh-ancestor
102359501|NCT01719757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102359502|NCT01719757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359503|NCT01719757|Analgesics|analgesics|mesh-ancestor
102359504|NCT01719757|Sensory System Agents|sensory system agents|mesh-ancestor
102359505|NCT01719757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102359506|NCT01719757|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102359507|NCT01718509|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102359508|NCT01718509|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102359509|NCT01718509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359510|NCT01718509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102359511|NCT01718509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102359512|NCT01718509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102359513|NCT01718509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359514|NCT01718509|Dopamine Agents|dopamine agents|mesh-ancestor
102359515|NCT01718509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102359516|NCT01857934|Aldesleukin|aldesleukin|mesh-list
102359517|NCT01857934|Cyclophosphamide|cyclophosphamide|mesh-list
102359518|NCT01857934|Melphalan|melphalan|mesh-list
102359519|NCT01857934|Busulfan|busulfan|mesh-list
102359520|NCT01857934|Mechlorethamine|mechlorethamine|mesh-list
102359521|NCT01857934|Doxorubicin|doxorubicin|mesh-list
102359522|NCT01857934|Etoposide|etoposide|mesh-list
102359523|NCT01857934|Vincristine|vincristine|mesh-list
102359524|NCT01857934|Topotecan|topotecan|mesh-list
102359525|NCT01857934|Interleukin-2|interleukin-2|mesh-list
102359526|NCT01857934|Molgramostim|molgramostim|mesh-list
102359527|NCT01857934|Dinutuximab|dinutuximab|mesh-list
102359528|NCT01857934|Levetiracetam|levetiracetam|mesh-list
102359529|NCT01857934|Isotretinoin|isotretinoin|mesh-list
102359530|NCT01857934|Antibodies|antibodies|mesh-list
102359531|NCT01857934|Immunoglobulins|immunoglobulins|mesh-list
102359532|NCT01857934|Sargramostim|sargramostim|mesh-list
102359533|NCT01857934|Lenograstim|lenograstim|mesh-list
102359534|NCT01857934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102359535|NCT01857934|Immunologic Factors|immunologic factors|mesh-ancestor
102359536|NCT01857934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359537|NCT01857934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102359538|NCT01857934|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102359539|NCT01857934|Alkylating Agents|alkylating agents|mesh-ancestor
102359540|NCT01857934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171271|NCT04504734|Antioxidants|antioxidants|mesh-ancestor
102359541|NCT01857934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102359542|NCT01857934|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102359543|NCT01857934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102359544|NCT01857934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102359545|NCT01857934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102359546|NCT01857934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102359547|NCT01857934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102359548|NCT01857934|Tubulin Modulators|tubulin modulators|mesh-ancestor
102359549|NCT01857934|Antimitotic Agents|antimitotic agents|mesh-ancestor
102359550|NCT01857934|Mitosis Modulators|mitosis modulators|mesh-ancestor
102359551|NCT01857934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102359552|NCT01857934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102359553|NCT01857934|Analgesics|analgesics|mesh-ancestor
102359554|NCT01857934|Sensory System Agents|sensory system agents|mesh-ancestor
102359555|NCT01857934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102359556|NCT01857934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102359557|NCT01857934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102359558|NCT01857934|Antiviral Agents|antiviral agents|mesh-ancestor
102359559|NCT01857934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102359560|NCT01857934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102359561|NCT01857934|Anticonvulsants|anticonvulsants|mesh-ancestor
102359562|NCT01857934|Nootropic Agents|nootropic agents|mesh-ancestor
102359563|NCT01857934|Dermatologic Agents|dermatologic agents|mesh-ancestor
102359564|NCT00862810|Vaccines|vaccines|mesh-list
102359565|NCT00862810|Immunologic Factors|immunologic factors|mesh-ancestor
102359566|NCT00862810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359567|NCT00863122|Lapatinib|lapatinib|mesh-list
102359568|NCT00863122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102359569|NCT00863122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102359570|NCT00863122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102359571|NCT00863122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359572|NCT01604785|Dopamine|dopamine|mesh-list
102359573|NCT01604785|Propofol|propofol|mesh-list
102359574|NCT01604785|Dopamine Antagonists|dopamine antagonists|mesh-list
102359575|NCT01604785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102359576|NCT01604785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102359577|NCT01604785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359578|NCT01604785|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102359579|NCT01604785|Anesthetics, General|anesthetics, general|mesh-ancestor
102359580|NCT01604785|Anesthetics|anesthetics|mesh-ancestor
102359581|NCT01604785|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102359582|NCT01604785|Sympathomimetics|sympathomimetics|mesh-ancestor
102359583|NCT01604785|Autonomic Agents|autonomic agents|mesh-ancestor
102359584|NCT01604785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102359585|NCT01604785|Dopamine Agents|dopamine agents|mesh-ancestor
102359586|NCT01604785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102359587|NCT01604785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359588|NCT01604785|Protective Agents|protective agents|mesh-ancestor
102359589|NCT01681849|Paroxetine|paroxetine|mesh-list
102359590|NCT01681849|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102359591|NCT01681849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102359592|NCT01681849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102359593|NCT01681849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359594|NCT01681849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102359595|NCT01681849|Serotonin Agents|serotonin agents|mesh-ancestor
102359596|NCT01681849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359597|NCT01681849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102359598|NCT01681849|Antidepressive Agents|antidepressive agents|mesh-ancestor
102359599|NCT01681849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101567261|NCT01253174|Drospirenone|drospirenone|mesh-list
102359600|NCT01681849|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102359601|NCT01681849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102359602|NCT01681849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102359603|NCT00863356|Hemostatics|hemostatics|mesh-list
102359604|NCT00863356|Chitosan|chitosan|mesh-list
102359605|NCT00863356|Coagulants|coagulants|mesh-ancestor
102359606|NCT00863356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102359607|NCT00863356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102359608|NCT00863356|Antimetabolites|antimetabolites|mesh-ancestor
102359609|NCT00863356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359610|NCT00863356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102359611|NCT00863356|Chelating Agents|chelating agents|mesh-ancestor
102359612|NCT00863356|Sequestering Agents|sequestering agents|mesh-ancestor
102359613|NCT00863434|Cytarabine|cytarabine|mesh-list
102359614|NCT00863434|Clofarabine|clofarabine|mesh-list
102359615|NCT00863434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102359616|NCT00863434|Antimetabolites|antimetabolites|mesh-ancestor
102171343|NCT04274426|Tubulin Modulators|tubulin modulators|mesh-ancestor
102359617|NCT00863434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359618|NCT00863434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102359619|NCT00863434|Antiviral Agents|antiviral agents|mesh-ancestor
102359620|NCT00863434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102359621|NCT00863434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102359622|NCT00863434|Immunologic Factors|immunologic factors|mesh-ancestor
102359623|NCT00863434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359624|NCT04209790|Temozolomide|temozolomide|mesh-list
102359625|NCT04209790|Benzolamide|benzolamide|mesh-list
102359626|NCT04209790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102359627|NCT04209790|Alkylating Agents|alkylating agents|mesh-ancestor
102359628|NCT04209790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359629|NCT04209790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102359630|NCT04209790|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102359631|NCT04209790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102359632|NCT01718353|Prednisone|prednisone|mesh-list
102359633|NCT01718353|Docetaxel|docetaxel|mesh-list
102359634|NCT01718353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102359635|NCT01718353|Tubulin Modulators|tubulin modulators|mesh-ancestor
102359636|NCT01718353|Antimitotic Agents|antimitotic agents|mesh-ancestor
102359637|NCT01718353|Mitosis Modulators|mitosis modulators|mesh-ancestor
102359638|NCT01718353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359639|NCT01718353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102359640|NCT01718353|Glucocorticoids|glucocorticoids|mesh-ancestor
102359641|NCT01718353|Hormones|hormones|mesh-ancestor
102359642|NCT01718353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102359643|NCT01718353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359644|NCT01718353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102359645|NCT01716715|Paclitaxel|paclitaxel|mesh-list
102359646|NCT01716715|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102359647|NCT01716715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102359648|NCT01716715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102359649|NCT01716715|Tubulin Modulators|tubulin modulators|mesh-ancestor
102359650|NCT01716715|Antimitotic Agents|antimitotic agents|mesh-ancestor
102359651|NCT01716715|Mitosis Modulators|mitosis modulators|mesh-ancestor
102359652|NCT01716715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359653|NCT01696279|Calcium Carbonate|calcium carbonate|mesh-list
102359654|NCT01696279|Calcium|calcium|mesh-list
102359655|NCT01696279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102359656|NCT01696279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359657|NCT01696279|Antacids|antacids|mesh-ancestor
102359658|NCT01696279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359659|NCT01696279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102359660|NCT01936181|Infliximab|infliximab|mesh-list
102359661|NCT01936181|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102359662|NCT01936181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102359663|NCT01936181|Dermatologic Agents|dermatologic agents|mesh-ancestor
102359664|NCT01936181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101567267|NCT01253174|Diuretics|diuretics|mesh-ancestor
102359665|NCT01936181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102359666|NCT01696045|Ipilimumab|ipilimumab|mesh-list
102359667|NCT01696045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102359668|NCT01696045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102359669|NCT01696045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102359670|NCT01696045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359671|NCT01935947|Gemcitabine|gemcitabine|mesh-list
102359672|NCT01935947|Azacitidine|azacitidine|mesh-list
102359673|NCT01935947|Docetaxel|docetaxel|mesh-list
102359674|NCT01935947|Irinotecan|irinotecan|mesh-list
102359675|NCT01935947|Pemetrexed|pemetrexed|mesh-list
102359676|NCT01935947|Camptothecin|camptothecin|mesh-list
102359677|NCT01935947|Entinostat|entinostat|mesh-list
102359678|NCT01935947|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
102359679|NCT01935947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102359680|NCT01935947|Antimetabolites|antimetabolites|mesh-ancestor
102359681|NCT01935947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359682|NCT01935947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102359683|NCT01935947|Tubulin Modulators|tubulin modulators|mesh-ancestor
102359684|NCT01935947|Antimitotic Agents|antimitotic agents|mesh-ancestor
102359685|NCT01935947|Mitosis Modulators|mitosis modulators|mesh-ancestor
102359686|NCT01935947|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102359687|NCT01935947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102359688|NCT01935947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102359689|NCT01935947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102359690|NCT01935947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102359691|NCT01935947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102359692|NCT02986321|Budesonide|budesonide|mesh-list
102359693|NCT02986321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102359694|NCT02986321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102359695|NCT02986321|Autonomic Agents|autonomic agents|mesh-ancestor
102359696|NCT02986321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102359697|NCT02986321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359698|NCT02986321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102359699|NCT02986321|Respiratory System Agents|respiratory system agents|mesh-ancestor
102359700|NCT02986321|Glucocorticoids|glucocorticoids|mesh-ancestor
102359701|NCT02986321|Hormones|hormones|mesh-ancestor
102359702|NCT02986321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102359703|NCT01593787|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102359704|NCT01593787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102359705|NCT01593787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359706|NCT01951157|Gemcitabine|gemcitabine|mesh-list
102359707|NCT01951157|Docetaxel|docetaxel|mesh-list
102359708|NCT01951157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102359709|NCT01951157|Antimetabolites|antimetabolites|mesh-ancestor
102359710|NCT01951157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359711|NCT01951157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102359712|NCT01951157|Tubulin Modulators|tubulin modulators|mesh-ancestor
102359713|NCT01951157|Antimitotic Agents|antimitotic agents|mesh-ancestor
102359714|NCT01951157|Mitosis Modulators|mitosis modulators|mesh-ancestor
102359715|NCT01363349|Risperidone|risperidone|mesh-list
102359716|NCT01363349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102359717|NCT01363349|Serotonin Agents|serotonin agents|mesh-ancestor
102359718|NCT01363349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102359719|NCT01363349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359720|NCT01363349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359721|NCT01363349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102359722|NCT01363349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102359723|NCT01363349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102359724|NCT01363349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102359725|NCT01363349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102359726|NCT01363349|Dopamine Agents|dopamine agents|mesh-ancestor
102359727|NCT00818272|Infliximab|infliximab|mesh-list
102359728|NCT00818272|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102359729|NCT00818272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102359730|NCT00818272|Dermatologic Agents|dermatologic agents|mesh-ancestor
102359731|NCT00818272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102359732|NCT00818272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102359733|NCT00868348|Ketorolac|ketorolac|mesh-list
102359734|NCT00868348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102359735|NCT00868348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102359736|NCT00868348|Analgesics|analgesics|mesh-ancestor
102359737|NCT00868348|Sensory System Agents|sensory system agents|mesh-ancestor
102359738|NCT00868348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102359739|NCT00868348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359740|NCT00868348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102359741|NCT00868348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102359742|NCT00868348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102359743|NCT00868348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102359744|NCT00868348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359745|NCT01933919|Fluvoxamine|fluvoxamine|mesh-list
102359746|NCT01933919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102359747|NCT01933919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359748|NCT01933919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102359749|NCT01933919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102359750|NCT01933919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102359751|NCT01933919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359752|NCT01933919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102359753|NCT01933919|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102359754|NCT01933919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102359755|NCT01933919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102359756|NCT01933919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102359757|NCT01933919|Serotonin Agents|serotonin agents|mesh-ancestor
102359758|NCT01933919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102359759|NCT01933919|Antidepressive Agents|antidepressive agents|mesh-ancestor
102359760|NCT01933919|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102359761|NCT01933919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102359762|NCT01933919|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102359763|NCT05317468|Contraceptive Agents|contraceptive agents|mesh-list
102359764|NCT05317468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102359765|NCT05317468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359766|NCT01933217|Methylphenidate|methylphenidate|mesh-list
102359767|NCT01933217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102359768|NCT01933217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359769|NCT01933217|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102359770|NCT01933217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102359771|NCT01933217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102359772|NCT01933217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359773|NCT01933217|Dopamine Agents|dopamine agents|mesh-ancestor
102359774|NCT01933217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102359776|NCT01949051|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102359777|NCT01949051|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102359778|NCT01949051|Histamine Antagonists|histamine antagonists|mesh-ancestor
102359779|NCT01949051|Histamine Agents|histamine agents|mesh-ancestor
102359780|NCT01949051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102359781|NCT01949051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359782|NCT01949051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359783|NCT01692301|Amlodipine|amlodipine|mesh-list
102359784|NCT01692301|Valsartan|valsartan|mesh-list
102359785|NCT01692301|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102359786|NCT01692301|Olmesartan|olmesartan|mesh-list
102359787|NCT01692301|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
102359788|NCT01692301|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102359789|NCT01692301|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102359790|NCT01692301|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102359791|NCT01692301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102359792|NCT01692301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359793|NCT01692301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102359794|NCT01692301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359795|NCT01692301|Vasodilator Agents|vasodilator agents|mesh-ancestor
102359796|NCT01692301|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102359797|NCT01692301|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102359798|NCT01692301|Diuretics|diuretics|mesh-ancestor
102359799|NCT01692301|Natriuretic Agents|natriuretic agents|mesh-ancestor
102359800|NCT01692301|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102359801|NCT01592773|Memantine|memantine|mesh-list
102359802|NCT01592773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102359803|NCT01592773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102359804|NCT01592773|Dopamine Agents|dopamine agents|mesh-ancestor
102359805|NCT01592773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102359806|NCT01592773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359807|NCT01592773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359808|NCT01592773|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102359809|NCT01592773|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102359810|NCT01592695|Ethanol|ethanol|mesh-list
102359811|NCT01592695|Bupropion|bupropion|mesh-list
102359812|NCT01592695|Nicotine|nicotine|mesh-list
102359813|NCT01592695|Varenicline|varenicline|mesh-list
102359814|NCT01592695|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102359815|NCT01592695|Autonomic Agents|autonomic agents|mesh-ancestor
102359816|NCT01592695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102359817|NCT01592695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359818|NCT01592695|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102359819|NCT01592695|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102359820|NCT01592695|Cholinergic Agents|cholinergic agents|mesh-ancestor
102359821|NCT01592695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102359822|NCT01592695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359823|NCT01592695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102359824|NCT01592695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102359825|NCT01592695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102359826|NCT01592695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102359827|NCT01592695|Antidepressive Agents|antidepressive agents|mesh-ancestor
102359828|NCT01592695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102359829|NCT01592695|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102359830|NCT01592695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102359831|NCT01592695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102359832|NCT01592695|Dopamine Agents|dopamine agents|mesh-ancestor
102359833|NCT01592695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102359834|NCT01592695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102359835|NCT01592695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102359836|NCT01929863|Metformin|metformin|mesh-list
102359837|NCT01929863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102359838|NCT01929863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359839|NCT01714609|Sorafenib|sorafenib|mesh-list
102359840|NCT01714609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102359841|NCT01714609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102359842|NCT01714609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102359843|NCT01714609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359844|NCT04553263|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
102359845|NCT04553263|Naltrexone|naltrexone|mesh-list
102359846|NCT04553263|Bupropion|bupropion|mesh-list
102359847|NCT04553263|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102359848|NCT04553263|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102359849|NCT04553263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359850|NCT04553263|Sensory System Agents|sensory system agents|mesh-ancestor
102359851|NCT04553263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102359852|NCT04553263|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102359853|NCT04553263|Antidepressive Agents|antidepressive agents|mesh-ancestor
102359854|NCT04553263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102359855|NCT04553263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102359856|NCT04553263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102359857|NCT04553263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102359858|NCT04553263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359859|NCT04553263|Dopamine Agents|dopamine agents|mesh-ancestor
102359860|NCT04553263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102359861|NCT04553263|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102359862|NCT04553263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102359863|NCT04553263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102359864|NCT04553263|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102359865|NCT01713283|Sofosbuvir|sofosbuvir|mesh-list
102359866|NCT01713283|Antiviral Agents|antiviral agents|mesh-ancestor
102359867|NCT01713283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102359868|NCT04768075|Paclitaxel|paclitaxel|mesh-list
102359869|NCT04768075|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102359870|NCT04768075|Carboplatin|carboplatin|mesh-list
102359871|NCT04768075|Pemetrexed|pemetrexed|mesh-list
102359872|NCT04768075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102359873|NCT04768075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102359874|NCT04768075|Tubulin Modulators|tubulin modulators|mesh-ancestor
102359875|NCT04768075|Antimitotic Agents|antimitotic agents|mesh-ancestor
102359876|NCT04768075|Mitosis Modulators|mitosis modulators|mesh-ancestor
102359877|NCT04768075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359878|NCT04768075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102359879|NCT04768075|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102359880|NCT04768075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102359881|NCT01592383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102359882|NCT01592383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102359883|NCT01592383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102359884|NCT01592383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102359885|NCT01592383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359886|NCT01929317|Ropinirole|ropinirole|mesh-list
102359887|NCT01929317|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102359888|NCT01929317|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102359889|NCT01929317|Dopamine Agonists|dopamine agonists|mesh-ancestor
102359890|NCT01929317|Dopamine Agents|dopamine agents|mesh-ancestor
102359891|NCT01929317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102359892|NCT01929317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359893|NCT01929317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359894|NCT01711879|Aflibercept|aflibercept|mesh-list
102359895|NCT01711879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102359896|NCT01711879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102359897|NCT01711879|Growth Substances|growth substances|mesh-ancestor
102359898|NCT01711879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359899|NCT01711879|Growth Inhibitors|growth inhibitors|mesh-ancestor
102359900|NCT01711879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102359901|NCT00869206|Zoledronic Acid|zoledronic acid|mesh-list
102359902|NCT00869206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102359903|NCT00869206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359904|NCT01689649|Topiramate|topiramate|mesh-list
102171639|NCT03336216|Antimitotic Agents|antimitotic agents|mesh-ancestor
102171640|NCT03336216|Mitosis Modulators|mitosis modulators|mesh-ancestor
102171641|NCT03336216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171642|NCT03336216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102171643|NCT03336216|Antimetabolites|antimetabolites|mesh-ancestor
102171644|NCT03336216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102359905|NCT01689649|Anticonvulsants|anticonvulsants|mesh-ancestor
102359906|NCT01689649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102359907|NCT01689649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359908|NCT01929083|Ibutilide|ibutilide|mesh-list
102359909|NCT01929083|Progesterone|progesterone|mesh-list
102359910|NCT01929083|Progestins|progestins|mesh-ancestor
102359911|NCT01929083|Hormones|hormones|mesh-ancestor
102359912|NCT01929083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102359913|NCT01929083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359914|NCT01929083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102359915|NCT01688635|Insulin Glargine|insulin glargine|mesh-list
102359916|NCT01688635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102359917|NCT01688635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359918|NCT00891436|Fluticasone|fluticasone|mesh-list
102359919|NCT00891436|Xhance|xhance|mesh-list
102359920|NCT00891436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102359921|NCT00891436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102359922|NCT00891436|Autonomic Agents|autonomic agents|mesh-ancestor
102359923|NCT00891436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102359924|NCT00891436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359925|NCT00891436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102359926|NCT00891436|Respiratory System Agents|respiratory system agents|mesh-ancestor
102359927|NCT00891436|Dermatologic Agents|dermatologic agents|mesh-ancestor
102359928|NCT00891436|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102359929|NCT01711645|Aluminum phosphate|aluminum phosphate|mesh-list
102359930|NCT01711645|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102359931|NCT01711645|Immunologic Factors|immunologic factors|mesh-ancestor
102359932|NCT01711645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359933|NCT01711645|Antacids|antacids|mesh-ancestor
102359934|NCT01711645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359935|NCT01711645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102359936|NCT00820534|Penciclovir|penciclovir|mesh-list
102359937|NCT00820534|Antiviral Agents|antiviral agents|mesh-ancestor
102359938|NCT00820534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102359939|NCT01590433|Exenatide|exenatide|mesh-list
102359940|NCT01590433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102359941|NCT01590433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359942|NCT01590433|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102359943|NCT01590433|Incretins|incretins|mesh-ancestor
102359944|NCT01590433|Hormones|hormones|mesh-ancestor
102359945|NCT01590433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102359946|NCT00820612|Indomethacin|indomethacin|mesh-list
102359947|NCT00820612|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102359948|NCT00820612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102359949|NCT00820612|Analgesics|analgesics|mesh-ancestor
102359950|NCT00820612|Sensory System Agents|sensory system agents|mesh-ancestor
102359951|NCT00820612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102359952|NCT00820612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359953|NCT00820612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102359954|NCT00820612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102359955|NCT00820612|Gout Suppressants|gout suppressants|mesh-ancestor
102359956|NCT00820612|Tocolytic Agents|tocolytic agents|mesh-ancestor
102359957|NCT00820612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102359958|NCT00820612|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102359959|NCT00820612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102359960|NCT00820612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359961|NCT01928927|Telmisartan|telmisartan|mesh-list
102359962|NCT01928927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102359963|NCT01928927|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102359964|NCT01928927|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102359965|NCT01928927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359966|NCT00871624|Dexmedetomidine|dexmedetomidine|mesh-list
102359967|NCT00871624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102359968|NCT00871624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102359969|NCT00871624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359970|NCT00871624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102359971|NCT00871624|Analgesics|analgesics|mesh-ancestor
102359972|NCT00871624|Sensory System Agents|sensory system agents|mesh-ancestor
102359973|NCT00871624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102359974|NCT00871624|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102359975|NCT00871624|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102359976|NCT00871624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102359977|NCT00871624|Adrenergic Agents|adrenergic agents|mesh-ancestor
102359978|NCT00871624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102359979|NCT00871624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359980|NCT01710709|Aripiprazole|aripiprazole|mesh-list
102359981|NCT01710709|Antidepressive Agents|antidepressive agents|mesh-ancestor
102359982|NCT01710709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102359983|NCT01710709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102359984|NCT01710709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102359985|NCT01710709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102359986|NCT01710709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102359987|NCT01710709|Dopamine Agonists|dopamine agonists|mesh-ancestor
102359988|NCT01710709|Dopamine Agents|dopamine agents|mesh-ancestor
102359989|NCT01710709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102359990|NCT01710709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102359991|NCT01710709|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102359992|NCT01710709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102359993|NCT01710709|Serotonin Agents|serotonin agents|mesh-ancestor
102359994|NCT01710709|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102359995|NCT01710709|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102359996|NCT01710709|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102359997|NCT01710709|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102359998|NCT05317546|Cannabidiol|cannabidiol|mesh-list
102359999|NCT05317546|Anticonvulsants|anticonvulsants|mesh-ancestor
102360001|NCT01709695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102360002|NCT01709695|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102360003|NCT01709695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102360004|NCT01709695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102360005|NCT01709695|Adrenergic Agents|adrenergic agents|mesh-ancestor
102360006|NCT01709695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101567290|NCT04308525|Analgesics|analgesics|mesh-ancestor
102360007|NCT01709695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360008|NCT01709695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360009|NCT05236504|Melatonin|melatonin|mesh-list
102360010|NCT05236504|Antioxidants|antioxidants|mesh-ancestor
102360011|NCT05236504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360012|NCT05236504|Protective Agents|protective agents|mesh-ancestor
102360013|NCT05236504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360014|NCT05236504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102360015|NCT01685983|Prednisolone|prednisolone|mesh-list
102360016|NCT01685983|Abiraterone Acetate|abiraterone acetate|mesh-list
102360017|NCT01685983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102360018|NCT01685983|Glucocorticoids|glucocorticoids|mesh-ancestor
102360019|NCT01685983|Hormones|hormones|mesh-ancestor
102360020|NCT01685983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102360021|NCT01685983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360022|NCT01685983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102360023|NCT01685983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102360024|NCT01685983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102360025|NCT01685983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102360026|NCT01685983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360027|NCT01685983|Hormone Antagonists|hormone antagonists|mesh-ancestor
102360028|NCT01685983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102360029|NCT02151448|Interferons|interferons|mesh-list
102360030|NCT02151448|Interferon-alpha|interferon-alpha|mesh-list
102360031|NCT02151448|Interferon alpha-2|interferon alpha-2|mesh-list
102360032|NCT02151448|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
102360033|NCT02151448|Celecoxib|celecoxib|mesh-list
102360034|NCT02151448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102360035|NCT02151448|Antiviral Agents|antiviral agents|mesh-ancestor
102360036|NCT02151448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102360037|NCT02151448|Immunologic Factors|immunologic factors|mesh-ancestor
102360038|NCT02151448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360039|NCT02151448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102360040|NCT02151448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102360041|NCT02151448|Analgesics|analgesics|mesh-ancestor
102360042|NCT02151448|Sensory System Agents|sensory system agents|mesh-ancestor
102360043|NCT02151448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102360044|NCT02151448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102360045|NCT02151448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102360046|NCT02151448|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102360047|NCT02151448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102360048|NCT02151448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102360049|NCT02151448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360050|NCT00875212|Calcium|calcium|mesh-list
102360051|NCT00875212|Fluorides|fluorides|mesh-list
102360052|NCT00875212|Sodium Fluoride|sodium fluoride|mesh-list
102360053|NCT00875212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102360054|NCT00875212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360055|NCT00875212|Cariostatic Agents|cariostatic agents|mesh-ancestor
102360056|NCT00875212|Protective Agents|protective agents|mesh-ancestor
102360057|NCT00875836|Buspirone|buspirone|mesh-list
102360058|NCT00875836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102360059|NCT00875836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102360060|NCT00875836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102360061|NCT00875836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360062|NCT00875836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102360063|NCT00875836|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102360064|NCT00875836|Serotonin Agents|serotonin agents|mesh-ancestor
102360065|NCT00875836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102360066|NCT00875836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360067|NCT00891982|Clindamycin, tretinoin drug combination|clindamycin, tretinoin drug combination|mesh-list
102360068|NCT00891982|Dermatologic Agents|dermatologic agents|mesh-ancestor
102360069|NCT05312398|Irinotecan|irinotecan|mesh-list
102360070|NCT05312398|Cetuximab|cetuximab|mesh-list
102360071|NCT05312398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102360072|NCT05312398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102360073|NCT05312398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102360074|NCT05312398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360075|NCT05312398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102360076|NCT05312398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102360077|NCT01685203|Ribavirin|ribavirin|mesh-list
102360078|NCT01685203|Antimetabolites|antimetabolites|mesh-ancestor
102360079|NCT01685203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360080|NCT01685203|Antiviral Agents|antiviral agents|mesh-ancestor
102360081|NCT01685203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102360082|NCT01928771|Benralizumab|benralizumab|mesh-list
102360083|NCT01928771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102360084|NCT01928771|Respiratory System Agents|respiratory system agents|mesh-ancestor
102360085|NCT01589653|Insulin|insulin|mesh-list
102360086|NCT01589653|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102360087|NCT01589653|Insulin Aspart|insulin aspart|mesh-list
102360088|NCT01589653|Insulin, Long-Acting|insulin, long-acting|mesh-list
102360089|NCT01589653|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102360090|NCT01589653|Biphasic Insulins|biphasic insulins|mesh-list
102360091|NCT01589653|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
102360092|NCT01589653|Insulin, Isophane|insulin, isophane|mesh-list
102360093|NCT01589653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102360094|NCT01589653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360095|NCT01928615|Trastuzumab|trastuzumab|mesh-list
102360096|NCT01928615|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102360097|NCT01928615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102360098|NCT01928615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102360099|NCT01589497|Moxifloxacin|moxifloxacin|mesh-list
102360100|NCT01589497|Rifampin|rifampin|mesh-list
102360101|NCT01589497|Isoniazid|isoniazid|mesh-list
102360102|NCT01589497|Pyrazinamide|pyrazinamide|mesh-list
102360103|NCT01589497|Ethambutol|ethambutol|mesh-list
102360104|NCT01589497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102360105|NCT01589497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102360106|NCT01589497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102360107|NCT01589497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102360108|NCT01589497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102360109|NCT01589497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360110|NCT01589497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102360111|NCT01589497|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102360112|NCT01589497|Antitubercular Agents|antitubercular agents|mesh-ancestor
102360113|NCT01589497|Leprostatic Agents|leprostatic agents|mesh-ancestor
102360114|NCT01589497|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102360115|NCT01589497|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102360116|NCT01589497|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102360117|NCT01589497|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102360118|NCT01589497|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102360119|NCT01589497|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102360120|NCT01589497|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102360121|NCT01589497|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102360122|NCT01589497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102360123|NCT01589497|Antimetabolites|antimetabolites|mesh-ancestor
102360124|NCT01589497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102360125|NCT01928381|Pregabalin|pregabalin|mesh-list
102360126|NCT01928381|Analgesics|analgesics|mesh-ancestor
102360127|NCT01928381|Sensory System Agents|sensory system agents|mesh-ancestor
102171867|NCT01871766|Sorafenib|sorafenib|mesh-list
102360128|NCT01928381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102360129|NCT01928381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360130|NCT01928381|Anticonvulsants|anticonvulsants|mesh-ancestor
102360131|NCT01928381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102360132|NCT01928381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102360133|NCT01928381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360134|NCT01928381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102360135|NCT01928381|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102360136|NCT01928381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102360137|NCT01928381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102360138|NCT01928381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102360139|NCT01928225|Vaccines|vaccines|mesh-list
102360140|NCT01928225|Immunologic Factors|immunologic factors|mesh-ancestor
102360141|NCT01928225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360142|NCT01927757|Etanercept|etanercept|mesh-list
102360143|NCT01927757|Methotrexate|methotrexate|mesh-list
102360144|NCT01927757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102360145|NCT01927757|Abortifacient Agents|abortifacient agents|mesh-ancestor
102360146|NCT01927757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102360147|NCT01927757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360148|NCT01927757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102360149|NCT01927757|Antimetabolites|antimetabolites|mesh-ancestor
102360150|NCT01927757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360151|NCT01927757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102360152|NCT01927757|Dermatologic Agents|dermatologic agents|mesh-ancestor
102360153|NCT01927757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102360154|NCT01927757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102360155|NCT01927757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102360156|NCT01927757|Immunologic Factors|immunologic factors|mesh-ancestor
102360157|NCT01927757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102360158|NCT01927757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102360159|NCT01927757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102360160|NCT01927757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102360161|NCT01927757|Analgesics|analgesics|mesh-ancestor
102360162|NCT01927757|Sensory System Agents|sensory system agents|mesh-ancestor
102360163|NCT01927757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102360164|NCT01927757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102360165|NCT01927757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102360166|NCT01913639|Leucovorin|leucovorin|mesh-list
102360167|NCT01913639|Fluorouracil|fluorouracil|mesh-list
102360168|NCT01913639|Oxaliplatin|oxaliplatin|mesh-list
102360169|NCT01913639|Antimetabolites|antimetabolites|mesh-ancestor
102360170|NCT01913639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360171|NCT01913639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102360172|NCT01913639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102360173|NCT01913639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102360174|NCT01913639|Immunologic Factors|immunologic factors|mesh-ancestor
102360175|NCT01913639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360176|NCT01913639|Antidotes|antidotes|mesh-ancestor
102360177|NCT01913639|Protective Agents|protective agents|mesh-ancestor
102360178|NCT01913639|Vitamin B Complex|vitamin b complex|mesh-ancestor
102360179|NCT01913639|Vitamins|vitamins|mesh-ancestor
102360180|NCT01913639|Micronutrients|micronutrients|mesh-ancestor
102360181|NCT01913483|Heparin|heparin|mesh-list
102360182|NCT01913483|Calcium heparin|calcium heparin|mesh-list
102360183|NCT01913483|Bivalirudin|bivalirudin|mesh-list
102360184|NCT01913483|Anticoagulants|anticoagulants|mesh-ancestor
102360185|NCT01913483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102360186|NCT01913483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102360187|NCT01913483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360188|NCT01913483|Antithrombins|antithrombins|mesh-ancestor
102360189|NCT01913483|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102360190|NCT01913483|Protease Inhibitors|protease inhibitors|mesh-ancestor
102360191|NCT01913483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102360192|NCT01913405|Factor VIII|factor viii|mesh-list
102360193|NCT01913405|BAX 855|bax 855|mesh-list
102360194|NCT01913405|Coagulants|coagulants|mesh-ancestor
102360195|NCT01927055|Mannitol|mannitol|mesh-list
102360196|NCT01927055|Droxidopa|droxidopa|mesh-list
102360197|NCT01927055|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102360198|NCT01927055|Diuretics|diuretics|mesh-ancestor
102360199|NCT01927055|Natriuretic Agents|natriuretic agents|mesh-ancestor
102360200|NCT01927055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360201|NCT01927055|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102360202|NCT01927055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102360203|NCT01913327|Risperidone|risperidone|mesh-list
102360204|NCT01913327|Aripiprazole|aripiprazole|mesh-list
102360205|NCT01913327|Modafinil|modafinil|mesh-list
102360206|NCT01913327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102360207|NCT01913327|Serotonin Agents|serotonin agents|mesh-ancestor
102360208|NCT01913327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102360209|NCT01913327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360210|NCT01913327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360211|NCT01913327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102360212|NCT01913327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102360213|NCT01913327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102360214|NCT01913327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102360215|NCT01913327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102360216|NCT01913327|Dopamine Agents|dopamine agents|mesh-ancestor
102360217|NCT01913327|Antidepressive Agents|antidepressive agents|mesh-ancestor
102360218|NCT01913327|Dopamine Agonists|dopamine agonists|mesh-ancestor
102360219|NCT01913327|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102360220|NCT01913327|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102360221|NCT01913327|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102360222|NCT01913327|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102360223|NCT01913327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102360224|NCT01913327|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102360225|NCT01913327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102360226|NCT01913327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102360227|NCT01912781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102360228|NCT01911845|Ribavirin|ribavirin|mesh-list
102360229|NCT01911845|Antimetabolites|antimetabolites|mesh-ancestor
102360230|NCT01911845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360231|NCT01911845|Antiviral Agents|antiviral agents|mesh-ancestor
102360232|NCT01911845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102360233|NCT01925183|Interferons|interferons|mesh-list
102360234|NCT01925183|Ribavirin|ribavirin|mesh-list
102360235|NCT01925183|Interferon-alpha|interferon-alpha|mesh-list
102360236|NCT01925183|Interferon alpha-2|interferon alpha-2|mesh-list
102360237|NCT01925183|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102360238|NCT01925183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102360239|NCT01925183|Antiviral Agents|antiviral agents|mesh-ancestor
102360240|NCT01925183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102360241|NCT01925183|Antimetabolites|antimetabolites|mesh-ancestor
102360242|NCT01925183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360243|NCT01925183|Immunologic Factors|immunologic factors|mesh-ancestor
102360244|NCT01925183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360245|NCT01910519|Vaccines|vaccines|mesh-list
102360246|NCT01910519|Immunologic Factors|immunologic factors|mesh-ancestor
102360247|NCT01910519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360248|NCT01910441|Metformin|metformin|mesh-list
102360249|NCT01910441|Glimepiride|glimepiride|mesh-list
102360250|NCT01910441|Vildagliptin|vildagliptin|mesh-list
102360251|NCT01910441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102360252|NCT01910441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360253|NCT01910441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102360254|NCT01910441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102360255|NCT01910441|Immunologic Factors|immunologic factors|mesh-ancestor
102360256|NCT01910441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102360257|NCT01910441|Protease Inhibitors|protease inhibitors|mesh-ancestor
102360258|NCT01910441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102360259|NCT01910441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360260|NCT01923467|Nicotine|nicotine|mesh-list
102360261|NCT01923467|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102360262|NCT01923467|Autonomic Agents|autonomic agents|mesh-ancestor
102360263|NCT01923467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102360264|NCT01923467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360265|NCT01923467|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102360266|NCT01923467|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102360267|NCT01923467|Cholinergic Agents|cholinergic agents|mesh-ancestor
102360268|NCT01923467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102360269|NCT01923467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360270|NCT01908803|Ciprofloxacin|ciprofloxacin|mesh-list
102360271|NCT01908803|Dexamethasone|dexamethasone|mesh-list
102360272|NCT01908803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102360273|NCT01908803|Antiemetics|antiemetics|mesh-ancestor
102360274|NCT01908803|Autonomic Agents|autonomic agents|mesh-ancestor
102360275|NCT01908803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102360276|NCT01908803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360277|NCT01908803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102360278|NCT01908803|Glucocorticoids|glucocorticoids|mesh-ancestor
102360279|NCT01908803|Hormones|hormones|mesh-ancestor
102612273|NCT00002387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102172015|NCT00539591|Antiviral Agents|antiviral agents|mesh-ancestor
102360280|NCT01908803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102360281|NCT01908803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102360283|NCT01908803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102360284|NCT01908803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102360285|NCT01908803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102360286|NCT01908803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102360287|NCT01908803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102360288|NCT01908803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360289|NCT01908803|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102360290|NCT01908803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102360291|NCT01908101|Halichondrin B|halichondrin b|mesh-list
102360292|NCT01908101|Tubulin Modulators|tubulin modulators|mesh-ancestor
102360293|NCT01908101|Antimitotic Agents|antimitotic agents|mesh-ancestor
102360294|NCT01908101|Mitosis Modulators|mitosis modulators|mesh-ancestor
101567300|NCT01252940|Antiviral Agents|antiviral agents|mesh-ancestor
102360295|NCT01908101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360296|NCT01908101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102360297|NCT01588951|Cytarabine|cytarabine|mesh-list
102360298|NCT01588951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102360299|NCT01588951|Antimetabolites|antimetabolites|mesh-ancestor
102360300|NCT01588951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360301|NCT01588951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102360302|NCT01588951|Antiviral Agents|antiviral agents|mesh-ancestor
102360303|NCT01588951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102360304|NCT01588951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102360305|NCT01588951|Immunologic Factors|immunologic factors|mesh-ancestor
102360306|NCT01588951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360307|NCT01588405|Treprostinil|treprostinil|mesh-list
102360308|NCT01588405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102360309|NCT01923311|Elvitegravir|elvitegravir|mesh-list
102360310|NCT01923311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102360311|NCT01923311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102360312|NCT01923311|Antiviral Agents|antiviral agents|mesh-ancestor
102360313|NCT01923311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102360314|NCT01923311|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102360315|NCT01923311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102360316|NCT01923311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360317|NCT01603615|Botulinum Toxins|botulinum toxins|mesh-list
102360318|NCT01603615|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102360319|NCT01603615|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102360320|NCT01603615|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102360321|NCT01603615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102360322|NCT01603615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360323|NCT01603615|Cholinergic Agents|cholinergic agents|mesh-ancestor
102360324|NCT01603615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102360325|NCT01603615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360326|NCT01603615|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102360327|NCT01603615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102360328|NCT01905683|Botulinum Toxins|botulinum toxins|mesh-list
102360329|NCT01905683|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102360330|NCT01905683|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102360331|NCT01905683|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102360332|NCT01905683|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102360333|NCT01905683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102360334|NCT01905683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360335|NCT01905683|Cholinergic Agents|cholinergic agents|mesh-ancestor
102360336|NCT01905683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102360337|NCT01905683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360338|NCT01905683|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102360339|NCT01905683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102360340|NCT01921829|Diuretics|diuretics|mesh-list
102360341|NCT01921829|Natriuretic Agents|natriuretic agents|mesh-ancestor
102360342|NCT01921829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360343|NCT01904903|Trastuzumab|trastuzumab|mesh-list
102360344|NCT01904903|Pertuzumab|pertuzumab|mesh-list
102360345|NCT01904903|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102360346|NCT01904903|Maytansine|maytansine|mesh-list
102360347|NCT01904903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102360348|NCT01904903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102360349|NCT01904903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102360350|NCT01904903|Tubulin Modulators|tubulin modulators|mesh-ancestor
102360351|NCT01904903|Antimitotic Agents|antimitotic agents|mesh-ancestor
102360352|NCT01904903|Mitosis Modulators|mitosis modulators|mesh-ancestor
102360353|NCT01904903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360354|NCT01904903|Immunotoxins|immunotoxins|mesh-ancestor
102360355|NCT01904903|Immunoconjugates|immunoconjugates|mesh-ancestor
102360356|NCT01904903|Immunologic Factors|immunologic factors|mesh-ancestor
102360357|NCT01904903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360358|NCT01921205|Lacosamide|lacosamide|mesh-list
102360359|NCT01921205|Anticonvulsants|anticonvulsants|mesh-ancestor
102360360|NCT01921205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102360361|NCT01921205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102360362|NCT01921205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102360363|NCT01921205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360364|NCT01920893|Mometasone Furoate|mometasone furoate|mesh-list
102360365|NCT01920893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102360366|NCT01920893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102360367|NCT01920893|Dermatologic Agents|dermatologic agents|mesh-ancestor
102360368|NCT01920893|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102360369|NCT01920893|Immunologic Factors|immunologic factors|mesh-ancestor
102360370|NCT01920893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360371|NCT01709305|Metformin|metformin|mesh-list
102360372|NCT01709305|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102360373|NCT01709305|Glimepiride|glimepiride|mesh-list
102360374|NCT01709305|Acarbose|acarbose|mesh-list
102360375|NCT01709305|Repaglinide|repaglinide|mesh-list
102360376|NCT01709305|Gliclazide|gliclazide|mesh-list
102360377|NCT01709305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102360378|NCT01709305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360379|NCT01709305|Incretins|incretins|mesh-ancestor
102360380|NCT01709305|Hormones|hormones|mesh-ancestor
102360381|NCT01709305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102360382|NCT01709305|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102360383|NCT01709305|Protease Inhibitors|protease inhibitors|mesh-ancestor
102360384|NCT01709305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102360385|NCT01709305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360386|NCT01709305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102360387|NCT01709305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102360388|NCT01709305|Immunologic Factors|immunologic factors|mesh-ancestor
102360389|NCT01709305|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102360390|NCT01684423|Rivaroxaban|rivaroxaban|mesh-list
102360391|NCT01684423|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102360392|NCT01684423|Antithrombins|antithrombins|mesh-ancestor
102360393|NCT01684423|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102360394|NCT01684423|Protease Inhibitors|protease inhibitors|mesh-ancestor
102360395|NCT01684423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102360396|NCT01684423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360397|NCT01684423|Anticoagulants|anticoagulants|mesh-ancestor
102360398|NCT01709227|Furosemide|furosemide|mesh-list
102360399|NCT01709227|Diuretics|diuretics|mesh-ancestor
102360400|NCT01709227|Natriuretic Agents|natriuretic agents|mesh-ancestor
102360401|NCT01709227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360402|NCT01709227|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102360403|NCT01709227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102360404|NCT01709227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360405|NCT00879034|Zoledronic Acid|zoledronic acid|mesh-list
102360406|NCT00879034|Pravastatin|pravastatin|mesh-list
102360407|NCT00879034|Lonafarnib|lonafarnib|mesh-list
102360408|NCT00879034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102360409|NCT00879034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360410|NCT00879034|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102360411|NCT00879034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102360412|NCT00879034|Antimetabolites|antimetabolites|mesh-ancestor
102360413|NCT00879034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360414|NCT00879034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102360415|NCT00879034|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102360416|NCT00879034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102360417|NCT04088890|Cyclophosphamide|cyclophosphamide|mesh-list
102360418|NCT04088890|Fludarabine|fludarabine|mesh-list
102360419|NCT04088890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102360420|NCT04088890|Immunologic Factors|immunologic factors|mesh-ancestor
102360421|NCT04088890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360422|NCT04088890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102360423|NCT04088890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102360424|NCT04088890|Alkylating Agents|alkylating agents|mesh-ancestor
102360425|NCT04088890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360426|NCT04088890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102360427|NCT04088890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102360428|NCT00879190|Gentamicins|gentamicins|mesh-list
102360429|NCT00879190|Ampicillin|ampicillin|mesh-list
102360430|NCT00879190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102360431|NCT00879190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102360432|NCT00879190|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102360433|NCT00879190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102360434|NCT00879190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360435|NCT01903811|Dexamethasone|dexamethasone|mesh-list
102360436|NCT01903811|Dexamethasone acetate|dexamethasone acetate|mesh-list
102360437|NCT01903811|Ichthammol|ichthammol|mesh-list
102360438|NCT01903811|BB 1101|bb 1101|mesh-list
102360439|NCT01903811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102360440|NCT01903811|Antiemetics|antiemetics|mesh-ancestor
102360441|NCT01903811|Autonomic Agents|autonomic agents|mesh-ancestor
102360442|NCT01903811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102360443|NCT01903811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360444|NCT01903811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102360445|NCT01903811|Glucocorticoids|glucocorticoids|mesh-ancestor
102360446|NCT01903811|Hormones|hormones|mesh-ancestor
102360447|NCT01903811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102360448|NCT01903811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102360449|NCT01903811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102360450|NCT01903811|Protease Inhibitors|protease inhibitors|mesh-ancestor
102360451|NCT01903811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102360452|NCT01903811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360453|NCT01903811|Dermatologic Agents|dermatologic agents|mesh-ancestor
102360454|NCT00880360|Denileukin diftitox|denileukin diftitox|mesh-list
102360455|NCT00880360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102360456|NCT01709149|Riluzole|riluzole|mesh-list
102360457|NCT01709149|Anticonvulsants|anticonvulsants|mesh-ancestor
102360458|NCT01709149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102360459|NCT01709149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102360460|NCT01709149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102360461|NCT01709149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360462|NCT01709149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360463|NCT01709149|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102360464|NCT01709149|Protective Agents|protective agents|mesh-ancestor
102360465|NCT05214196|Povidone-Iodine|povidone-iodine|mesh-list
102360466|NCT05214196|Povidone|povidone|mesh-list
102360467|NCT05214196|Plasma Substitutes|plasma substitutes|mesh-ancestor
102360468|NCT05214196|Blood Substitutes|blood substitutes|mesh-ancestor
102360469|NCT05214196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102360470|NCT05214196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102360471|NCT05311228|Azithromycin|azithromycin|mesh-list
102360472|NCT05311228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102360473|NCT05311228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102360474|NCT04382014|Curcumin|curcumin|mesh-list
102360475|NCT04382014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102360476|NCT04382014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102360477|NCT04382014|Analgesics|analgesics|mesh-ancestor
102360478|NCT04382014|Sensory System Agents|sensory system agents|mesh-ancestor
102360479|NCT04382014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102360480|NCT04382014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360481|NCT04382014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102360482|NCT04382014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102360483|NCT04382014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102360484|NCT04382014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102360485|NCT04382014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360486|NCT00892606|Morphine|morphine|mesh-list
102360487|NCT00892606|Methadone|methadone|mesh-list
102360488|NCT00892606|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102360489|NCT00892606|Narcotics|narcotics|mesh-ancestor
102360490|NCT00892606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102360491|NCT00892606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360492|NCT00892606|Analgesics|analgesics|mesh-ancestor
102360493|NCT00892606|Sensory System Agents|sensory system agents|mesh-ancestor
102360494|NCT00892606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102360495|NCT00892606|Antitussive Agents|antitussive agents|mesh-ancestor
102360496|NCT00892606|Respiratory System Agents|respiratory system agents|mesh-ancestor
102360497|NCT04416035|Paclitaxel|paclitaxel|mesh-list
102360498|NCT04416035|Bevacizumab|bevacizumab|mesh-list
102360499|NCT04416035|Carboplatin|carboplatin|mesh-list
102360500|NCT04416035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102360501|NCT04416035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102360502|NCT04416035|Tubulin Modulators|tubulin modulators|mesh-ancestor
102360503|NCT04416035|Antimitotic Agents|antimitotic agents|mesh-ancestor
102360504|NCT04416035|Mitosis Modulators|mitosis modulators|mesh-ancestor
102360505|NCT04416035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360506|NCT04416035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102360507|NCT04416035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102360508|NCT04416035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102360509|NCT04416035|Growth Substances|growth substances|mesh-ancestor
102360510|NCT04416035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360511|NCT04416035|Growth Inhibitors|growth inhibitors|mesh-ancestor
102360512|NCT04381858|Immunoglobulins|immunoglobulins|mesh-list
102360513|NCT04381858|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102360514|NCT04381858|Antibodies|antibodies|mesh-list
102360515|NCT04381858|Immunologic Factors|immunologic factors|mesh-ancestor
102360516|NCT04381858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360517|NCT01903031|Ritonavir|ritonavir|mesh-list
102360518|NCT01903031|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102360519|NCT01903031|Tenofovir|tenofovir|mesh-list
102360520|NCT01903031|Efavirenz|efavirenz|mesh-list
102360521|NCT01903031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
102360522|NCT01903031|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102360523|NCT01903031|Etonogestrel|etonogestrel|mesh-list
102360524|NCT01903031|NuvaRing|nuvaring|mesh-list
102360525|NCT01903031|Estradiol|estradiol|mesh-list
102360526|NCT01903031|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102360527|NCT01903031|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102360528|NCT01903031|Protease Inhibitors|protease inhibitors|mesh-ancestor
102360529|NCT01903031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102360530|NCT01903031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360531|NCT01903031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102360532|NCT01903031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102360533|NCT01903031|Antiviral Agents|antiviral agents|mesh-ancestor
102360534|NCT01903031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102360535|NCT01903031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102360536|NCT01903031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102360537|NCT01903031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102360538|NCT01903031|Estrogens|estrogens|mesh-ancestor
102360539|NCT01903031|Hormones|hormones|mesh-ancestor
102360540|NCT01903031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102360541|NCT01903031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360542|NCT01903031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102360543|NCT01903031|Contraceptive Agents|contraceptive agents|mesh-ancestor
102360544|NCT01903031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102360545|NCT01903031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102360546|NCT01903031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102360547|NCT01903031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102360548|NCT01903031|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102360549|NCT01903031|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102360550|NCT01903031|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102360551|NCT01903031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102360552|NCT01903031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102360553|NCT00883168|Fluticasone|fluticasone|mesh-list
102360554|NCT00883168|Xhance|xhance|mesh-list
102360555|NCT00883168|Azelastine|azelastine|mesh-list
102360556|NCT00883168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102360557|NCT00883168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102360558|NCT00883168|Autonomic Agents|autonomic agents|mesh-ancestor
102360559|NCT00883168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102360560|NCT00883168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360561|NCT00883168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102360562|NCT00883168|Respiratory System Agents|respiratory system agents|mesh-ancestor
102360563|NCT00883168|Dermatologic Agents|dermatologic agents|mesh-ancestor
102360564|NCT00883168|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102360565|NCT00883168|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
102360566|NCT00883168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102360567|NCT00883168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360568|NCT00883168|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102360569|NCT00883168|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102360570|NCT00883168|Histamine Antagonists|histamine antagonists|mesh-ancestor
102360571|NCT00883168|Histamine Agents|histamine agents|mesh-ancestor
102360572|NCT00883168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102360573|NCT01616693|Zinc|zinc|mesh-list
102360574|NCT01616693|Vaccines|vaccines|mesh-list
102360575|NCT01616693|Immunologic Factors|immunologic factors|mesh-ancestor
102360576|NCT01616693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172320|NCT05633420|Antimalarials|antimalarials|mesh-ancestor
102360577|NCT01616693|Trace Elements|trace elements|mesh-ancestor
102360578|NCT01616693|Micronutrients|micronutrients|mesh-ancestor
102360579|NCT00893074|Dronabinol|dronabinol|mesh-list
102360580|NCT00893074|Hallucinogens|hallucinogens|mesh-ancestor
102360581|NCT00893074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360582|NCT00893074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102360583|NCT00893074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102360584|NCT00893074|Analgesics|analgesics|mesh-ancestor
102360585|NCT00893074|Sensory System Agents|sensory system agents|mesh-ancestor
102360586|NCT00893074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102360587|NCT00893074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102360588|NCT00893074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102360589|NCT00893074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102360590|NCT00893074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360591|NCT00893074|Hormones|hormones|mesh-ancestor
102360592|NCT00893074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102360593|NCT00885742|Fibrinolysin|fibrinolysin|mesh-list
102360594|NCT00885742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102360595|NCT00885742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102360596|NCT00885742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360597|NCT00887458|Itraconazole|itraconazole|mesh-list
102360598|NCT00887458|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
102360599|NCT00887458|Antifungal Agents|antifungal agents|mesh-ancestor
102360600|NCT00887458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102360601|NCT00887458|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102360602|NCT00887458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102360603|NCT00887458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102360604|NCT00887458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360605|NCT00887458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102360606|NCT00887458|Hormone Antagonists|hormone antagonists|mesh-ancestor
102360607|NCT00887458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102360608|NCT00887458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360609|NCT00887458|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102360610|NCT03216304|Calcium, Dietary|calcium, dietary|mesh-list
102360611|NCT03216304|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102360612|NCT03216304|Calcium|calcium|mesh-list
102360613|NCT03216304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102360614|NCT03216304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360615|NCT03216304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102360616|NCT03216304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102360617|NCT03216304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102360618|NCT03216304|Antimetabolites|antimetabolites|mesh-ancestor
102360619|NCT03216304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360620|NCT03216304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102360621|NCT03216304|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102360622|NCT03216304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102360623|NCT03216538|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
102360624|NCT03216538|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102360625|NCT03216538|Immunologic Factors|immunologic factors|mesh-ancestor
102360626|NCT03216538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360627|NCT03216538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102360628|NCT03216538|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102360629|NCT03216538|Protective Agents|protective agents|mesh-ancestor
102360630|NCT03216538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102360631|NCT03216538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102360632|NCT03216538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102360633|NCT03216538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360634|NCT03216538|Antiviral Agents|antiviral agents|mesh-ancestor
102360635|NCT03216538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102360636|NCT03218722|Thrombin|thrombin|mesh-list
102360637|NCT03218722|Hemostatics|hemostatics|mesh-ancestor
102360638|NCT03218722|Coagulants|coagulants|mesh-ancestor
102360639|NCT00888628|Etanercept|etanercept|mesh-list
102360640|NCT00888628|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102360641|NCT00888628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102360642|NCT00888628|Analgesics|analgesics|mesh-ancestor
102360643|NCT00888628|Sensory System Agents|sensory system agents|mesh-ancestor
102360644|NCT00888628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102360645|NCT00888628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360646|NCT00888628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102360647|NCT00888628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102360648|NCT00888628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102360649|NCT00888628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102360650|NCT00888628|Immunologic Factors|immunologic factors|mesh-ancestor
102360651|NCT03837886|Calcium Carbonate|calcium carbonate|mesh-list
102360652|NCT03837886|Calcium|calcium|mesh-list
102360653|NCT03837886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102360654|NCT03837886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360655|NCT03837886|Antacids|antacids|mesh-ancestor
102360656|NCT03837886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360657|NCT03837886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102360658|NCT03219970|Osimertinib|osimertinib|mesh-list
102360659|NCT03219970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102360660|NCT03219970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102360661|NCT03219970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102360662|NCT03219970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360663|NCT00889330|Alcaftadine|alcaftadine|mesh-list
102360664|NCT00889330|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102360665|NCT00889330|Histamine Antagonists|histamine antagonists|mesh-ancestor
102360666|NCT00889330|Histamine Agents|histamine agents|mesh-ancestor
102360667|NCT00889330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102360668|NCT00889330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360669|NCT00889330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360670|NCT03219580|Fluorouracil|fluorouracil|mesh-list
102360671|NCT03219580|Antimetabolites|antimetabolites|mesh-ancestor
102360672|NCT03219580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360673|NCT03219580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102360674|NCT03219580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102360675|NCT03219580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102360676|NCT03219580|Immunologic Factors|immunologic factors|mesh-ancestor
102360677|NCT03219580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360678|NCT03215446|Anesthetics|anesthetics|mesh-list
102360679|NCT03215446|Propofol|propofol|mesh-list
102360680|NCT03215446|Sevoflurane|sevoflurane|mesh-list
102360681|NCT03215446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102360682|NCT03215446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360683|NCT03215446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102360684|NCT03215446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102360685|NCT03215446|Anesthetics, General|anesthetics, general|mesh-ancestor
102360686|NCT03215446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102360687|NCT03215446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102360688|NCT00896038|Aprepitant|aprepitant|mesh-list
102360689|NCT00896038|Antiemetics|antiemetics|mesh-ancestor
102360690|NCT00896038|Autonomic Agents|autonomic agents|mesh-ancestor
102360691|NCT00896038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102360692|NCT00896038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360693|NCT00896038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102360694|NCT00896038|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102360695|NCT00896038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102360696|NCT00896038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360697|NCT02804074|Antihypertensive Agents|antihypertensive agents|mesh-list
102360698|NCT04381234|Citric Acid|citric acid|mesh-list
102360699|NCT04381234|Sodium Citrate|sodium citrate|mesh-list
102360700|NCT04381234|Dialysis Solutions|dialysis solutions|mesh-list
102360701|NCT04381234|Anticoagulants|anticoagulants|mesh-ancestor
102360702|NCT04381234|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102360703|NCT04381234|Chelating Agents|chelating agents|mesh-ancestor
102360704|NCT04381234|Sequestering Agents|sequestering agents|mesh-ancestor
102360705|NCT04381234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360706|NCT04381234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102360707|NCT01616459|Vaccines|vaccines|mesh-list
102360708|NCT01616459|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102360709|NCT01616459|Immunologic Factors|immunologic factors|mesh-ancestor
102360710|NCT01616459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360711|NCT03218254|Methylphenidate|methylphenidate|mesh-list
102360712|NCT03218254|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102360713|NCT03218254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360714|NCT03218254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102360715|NCT03218254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102360716|NCT03218254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102360717|NCT03218254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360718|NCT03218254|Dopamine Agents|dopamine agents|mesh-ancestor
102360719|NCT03218254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102360720|NCT03215056|Methoxyflurane|methoxyflurane|mesh-list
102360721|NCT03215056|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102360722|NCT03215056|Anesthetics, General|anesthetics, general|mesh-ancestor
102360723|NCT03215056|Anesthetics|anesthetics|mesh-ancestor
102360724|NCT03215056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102360725|NCT03215056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360726|NCT01919801|Icatibant|icatibant|mesh-list
102360727|NCT01919801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102360728|NCT01919801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102360729|NCT01919801|Analgesics|analgesics|mesh-ancestor
102360730|NCT01919801|Sensory System Agents|sensory system agents|mesh-ancestor
102360731|NCT01919801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102360732|NCT01919801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360733|NCT01919801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102360734|NCT01919801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102360735|NCT01919801|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
102360736|NCT01919801|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
102360737|NCT01919801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360738|NCT01919801|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102360739|NCT01919801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102360740|NCT01919801|Immunologic Factors|immunologic factors|mesh-ancestor
102360741|NCT01919723|Ticagrelor|ticagrelor|mesh-list
102360742|NCT01919723|Eptifibatide|eptifibatide|mesh-list
102360743|NCT01919723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102360744|NCT01919723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102360745|NCT01919723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102360746|NCT01919723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102360747|NCT01919723|Purinergic Agents|purinergic agents|mesh-ancestor
102360748|NCT01919723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102360749|NCT01919723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360750|NCT01919723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360751|NCT01919489|Insulin Glargine|insulin glargine|mesh-list
102360752|NCT01919489|Liraglutide|liraglutide|mesh-list
102360753|NCT01919489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102360754|NCT01919489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360755|NCT01919489|Incretins|incretins|mesh-ancestor
102360756|NCT01919489|Hormones|hormones|mesh-ancestor
102360757|NCT01919489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102360758|NCT01919411|Amoxicillin|amoxicillin|mesh-list
102360759|NCT01919411|Clavulanic Acid|clavulanic acid|mesh-list
102360760|NCT01919411|Clavulanic Acids|clavulanic acids|mesh-list
102360761|NCT01919411|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102360762|NCT01919411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102360763|NCT01919411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102360764|NCT01919411|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102360765|NCT01919411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102360766|NCT01919411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360767|NCT01901393|Ibuprofen|ibuprofen|mesh-list
102360768|NCT01901393|Ketorolac|ketorolac|mesh-list
102360769|NCT01901393|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102360770|NCT01901393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102360771|NCT01901393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102360772|NCT01901393|Analgesics|analgesics|mesh-ancestor
102360773|NCT01901393|Sensory System Agents|sensory system agents|mesh-ancestor
102360774|NCT01901393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102360775|NCT01901393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360776|NCT01901393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102360777|NCT01901393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102360778|NCT01901393|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102360779|NCT01901393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102360780|NCT01901393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360781|NCT01890707|Anesthetics|anesthetics|mesh-list
102360782|NCT01890707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102360783|NCT01890707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360784|NCT01890473|Abatacept|abatacept|mesh-list
102360785|NCT01890473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102360786|NCT01890473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360787|NCT01890473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102360788|NCT01890473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102360789|NCT01890473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102360790|NCT01890473|Immunologic Factors|immunologic factors|mesh-ancestor
102360791|NCT01890473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360792|NCT01890473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102360793|NCT01889069|Prednisone|prednisone|mesh-list
102360794|NCT01889069|Cyclophosphamide|cyclophosphamide|mesh-list
102360795|NCT01889069|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102360796|NCT01889069|Rituximab|rituximab|mesh-list
102360797|NCT01889069|Doxorubicin|doxorubicin|mesh-list
102360798|NCT01889069|Vincristine|vincristine|mesh-list
102360799|NCT01889069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102360801|NCT01889069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360802|NCT01889069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102360803|NCT01889069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102360804|NCT01889069|Alkylating Agents|alkylating agents|mesh-ancestor
102360805|NCT01889069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360806|NCT01889069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102360807|NCT01889069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102360808|NCT01889069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102360809|NCT01889069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102360810|NCT01889069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102360811|NCT01889069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102360812|NCT01889069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102360813|NCT01889069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102360814|NCT01889069|Glucocorticoids|glucocorticoids|mesh-ancestor
102360815|NCT01889069|Hormones|hormones|mesh-ancestor
102360816|NCT01889069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102360817|NCT01889069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102360818|NCT01889069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102360819|NCT01889069|Tubulin Modulators|tubulin modulators|mesh-ancestor
102360820|NCT01889069|Antimitotic Agents|antimitotic agents|mesh-ancestor
102360821|NCT01889069|Mitosis Modulators|mitosis modulators|mesh-ancestor
102360822|NCT00898222|Aspirin|aspirin|mesh-list
102360823|NCT00898222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102360824|NCT00898222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102360825|NCT00898222|Analgesics|analgesics|mesh-ancestor
102360826|NCT00898222|Sensory System Agents|sensory system agents|mesh-ancestor
102360827|NCT00898222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102360828|NCT00898222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360829|NCT00898222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102360830|NCT00898222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102360831|NCT00898222|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102360832|NCT00898222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102360833|NCT00898222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360834|NCT00898222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102360835|NCT00898222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102360836|NCT00898222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102360837|NCT00898222|Antipyretics|antipyretics|mesh-ancestor
102360838|NCT01830556|Cetuximab|cetuximab|mesh-list
102360839|NCT01830556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102360840|NCT01830556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102360841|NCT03214354|Sirolimus|sirolimus|mesh-list
102360842|NCT03214354|Alemtuzumab|alemtuzumab|mesh-list
102360843|NCT03214354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102360844|NCT03214354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102360845|NCT03214354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102360846|NCT03214354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102360847|NCT03214354|Antifungal Agents|antifungal agents|mesh-ancestor
102360848|NCT03214354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102360849|NCT03214354|Immunologic Factors|immunologic factors|mesh-ancestor
102360850|NCT03214354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360851|NCT03214354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102360852|NCT03217942|Mitogens|mitogens|mesh-list
102360853|NCT03217942|Mitosis Modulators|mitosis modulators|mesh-ancestor
102360854|NCT03217942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360855|NCT00903448|Omeprazole|omeprazole|mesh-list
102360856|NCT00903448|Lansoprazole|lansoprazole|mesh-list
102360857|NCT00903448|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102360858|NCT00903448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102360859|NCT00903448|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102360860|NCT00903448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102360861|NCT00903448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360862|NCT00895180|Ramucirumab|ramucirumab|mesh-list
102360863|NCT00895180|Olaratumab|olaratumab|mesh-list
102360864|NCT00895180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102360865|NCT01830868|Zonisamide|zonisamide|mesh-list
102360866|NCT01830868|Anticonvulsants|anticonvulsants|mesh-ancestor
102360867|NCT01830868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102360868|NCT01830868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102360869|NCT01830868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360870|NCT01830868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102360871|NCT01830868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360872|NCT03213964|Interleukin-2|interleukin-2|mesh-list
102172617|NCT04447352|Vitamins|vitamins|mesh-ancestor
102360873|NCT03213964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102360874|NCT03213964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102360875|NCT03213964|Analgesics|analgesics|mesh-ancestor
102360876|NCT03213964|Sensory System Agents|sensory system agents|mesh-ancestor
102360877|NCT03213964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102360878|NCT03213964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360879|NCT03217474|Ganciclovir|ganciclovir|mesh-list
102360880|NCT03217474|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102360881|NCT03217474|Antiviral Agents|antiviral agents|mesh-ancestor
102360882|NCT03217474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102360883|NCT03217474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102360884|NCT03217474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102360885|NCT03217474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360886|NCT01830946|Caseins|caseins|mesh-list
102360887|NCT01830946|Chelating Agents|chelating agents|mesh-ancestor
102360888|NCT01830946|Sequestering Agents|sequestering agents|mesh-ancestor
102360889|NCT01830946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360890|NCT03213886|Vitamin D|vitamin d|mesh-list
102360891|NCT03213886|Calcifediol|calcifediol|mesh-list
102360892|NCT03213886|Vitamins|vitamins|mesh-ancestor
102360893|NCT03213886|Micronutrients|micronutrients|mesh-ancestor
102360894|NCT03213886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360895|NCT03213886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102360896|NCT03217084|Fluorides|fluorides|mesh-list
102360897|NCT03217084|Fluorides, Topical|fluorides, topical|mesh-list
102360898|NCT03217084|Cariostatic Agents|cariostatic agents|mesh-ancestor
102360899|NCT03217084|Protective Agents|protective agents|mesh-ancestor
102360900|NCT03217084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360901|NCT00899470|Metformin|metformin|mesh-list
102360902|NCT00899470|Saxagliptin|saxagliptin|mesh-list
102360903|NCT00899470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102360904|NCT00899470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360905|NCT00899470|Incretins|incretins|mesh-ancestor
102360906|NCT00899470|Hormones|hormones|mesh-ancestor
102360907|NCT00899470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102360908|NCT00899470|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102360909|NCT00899470|Protease Inhibitors|protease inhibitors|mesh-ancestor
102360910|NCT00899470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102360911|NCT00899470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360912|NCT01738646|Bevacizumab|bevacizumab|mesh-list
102360913|NCT01738646|Vorinostat|vorinostat|mesh-list
102360914|NCT01738646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102360915|NCT01738646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102360916|NCT01738646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102360917|NCT01738646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102360918|NCT01738646|Growth Substances|growth substances|mesh-ancestor
102360919|NCT01738646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360920|NCT01738646|Growth Inhibitors|growth inhibitors|mesh-ancestor
102360921|NCT01738646|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102360922|NCT01738646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102360923|NCT01738646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360924|NCT00904618|Lidocaine|lidocaine|mesh-list
102360925|NCT00904618|Anesthetics, Local|anesthetics, local|mesh-ancestor
102360926|NCT00904618|Anesthetics|anesthetics|mesh-ancestor
102360927|NCT00904618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102360928|NCT00904618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360929|NCT00904618|Sensory System Agents|sensory system agents|mesh-ancestor
102360930|NCT00904618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102360931|NCT00904618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102360932|NCT00904618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102360933|NCT00904618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102360934|NCT00904618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102360935|NCT00904618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360936|NCT01839370|Pramlintide|pramlintide|mesh-list
102360937|NCT01839370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102360938|NCT01839370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360939|NCT00907426|Bimatoprost|bimatoprost|mesh-list
102360940|NCT00907426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102360941|NCT00907426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102360942|NCT01832662|Caffeine|caffeine|mesh-list
102360943|NCT01832662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102360944|NCT01832662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360945|NCT01832662|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102360946|NCT01832662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102360947|NCT01832662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360948|NCT01832662|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102360949|NCT01832662|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102360950|NCT01832662|Purinergic Agents|purinergic agents|mesh-ancestor
102360951|NCT01832662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102360953|NCT00909064|Fondaparinux|fondaparinux|mesh-list
102360954|NCT00909064|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102360955|NCT00909064|Antithrombins|antithrombins|mesh-ancestor
102360956|NCT00909064|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102360957|NCT00909064|Protease Inhibitors|protease inhibitors|mesh-ancestor
102360958|NCT00909064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102360959|NCT00909064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360960|NCT00909064|Anticoagulants|anticoagulants|mesh-ancestor
102360961|NCT00909064|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102360962|NCT00909064|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102360963|NCT01832896|Ecallantide|ecallantide|mesh-list
102360964|NCT01832896|Analgesics|analgesics|mesh-ancestor
102360965|NCT01832896|Sensory System Agents|sensory system agents|mesh-ancestor
102360966|NCT01832896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102360967|NCT01832896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360968|NCT01832896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102360969|NCT01832896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102360970|NCT01832896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102360971|NCT01832896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102360972|NCT01830400|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102360973|NCT01830400|Anticonvulsants|anticonvulsants|mesh-ancestor
102360974|NCT01830400|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102360975|NCT01830400|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102360976|NCT01830400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102360977|NCT01830400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360978|NCT01830478|Rituximab|rituximab|mesh-list
102360979|NCT01830478|Lenalidomide|lenalidomide|mesh-list
102360980|NCT01830478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102360981|NCT01830478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102360982|NCT01830478|Immunologic Factors|immunologic factors|mesh-ancestor
102360983|NCT01830478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102360984|NCT01830478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102360985|NCT01830478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102360986|NCT01830478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102360987|NCT01830478|Growth Substances|growth substances|mesh-ancestor
102360988|NCT01830478|Growth Inhibitors|growth inhibitors|mesh-ancestor
102360989|NCT04426695|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
102360990|NCT04426695|Antiviral Agents|antiviral agents|mesh-ancestor
102360991|NCT04426695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102360992|NCT01838200|Isoniazid|isoniazid|mesh-list
102360993|NCT01838200|Ipilimumab|ipilimumab|mesh-list
102360994|NCT01838200|BCG Vaccine|bcg vaccine|mesh-list
102360995|NCT01838200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102360996|NCT01838200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102360997|NCT01838200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102360998|NCT01838200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102360999|NCT01838200|Antitubercular Agents|antitubercular agents|mesh-ancestor
102361000|NCT01838200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102361001|NCT01838200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102361002|NCT01838200|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102361003|NCT01838200|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102361004|NCT01838200|Antimetabolites|antimetabolites|mesh-ancestor
102361005|NCT01838200|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102361006|NCT01838200|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102361007|NCT01838200|Immunologic Factors|immunologic factors|mesh-ancestor
102361008|NCT01838200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361009|NCT01720030|Simendan|simendan|mesh-list
102361010|NCT01720030|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102361011|NCT01720030|Vasodilator Agents|vasodilator agents|mesh-ancestor
102361012|NCT01720030|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102361013|NCT01720030|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102361014|NCT01720030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102361015|NCT01720030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361016|NCT01720030|Protective Agents|protective agents|mesh-ancestor
102361017|NCT01720030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361018|NCT01720108|Rivaroxaban|rivaroxaban|mesh-list
102361019|NCT01720108|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102361020|NCT01720108|Antithrombins|antithrombins|mesh-ancestor
102361021|NCT01720108|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102361022|NCT01720108|Protease Inhibitors|protease inhibitors|mesh-ancestor
102361024|NCT01720108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361025|NCT01720108|Anticoagulants|anticoagulants|mesh-ancestor
102361026|NCT04380220|Protein C|protein c|mesh-list
102361027|NCT04380220|Antithrombins|antithrombins|mesh-list
102361028|NCT04380220|Protein S|protein s|mesh-list
102361029|NCT04380220|Factor VIII|factor viii|mesh-list
102361030|NCT04380220|Complement C3|complement c3|mesh-list
102361031|NCT04380220|Coagulants|coagulants|mesh-ancestor
102361032|NCT04380220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102361033|NCT04380220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361034|NCT04380220|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102361035|NCT04380220|Protease Inhibitors|protease inhibitors|mesh-ancestor
102361036|NCT04380220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102361037|NCT04380220|Anticoagulants|anticoagulants|mesh-ancestor
102361038|NCT04380220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102361039|NCT04380220|Immunologic Factors|immunologic factors|mesh-ancestor
102361040|NCT04380220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361041|NCT01832974|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
102361042|NCT01832974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102361043|NCT01671813|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102361044|NCT01671813|Immunoconjugates|immunoconjugates|mesh-list
102361045|NCT01671813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102361046|NCT01671813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102361047|NCT01671813|Immunotoxins|immunotoxins|mesh-ancestor
102361048|NCT01671813|Immunologic Factors|immunologic factors|mesh-ancestor
102361049|NCT01671813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361050|NCT03830398|Acetaminophen|acetaminophen|mesh-list
102361051|NCT03830398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102361052|NCT03830398|Analgesics|analgesics|mesh-ancestor
102361053|NCT03830398|Sensory System Agents|sensory system agents|mesh-ancestor
102361054|NCT03830398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102361055|NCT03830398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361056|NCT03830398|Antipyretics|antipyretics|mesh-ancestor
102361057|NCT04405323|Itraconazole|itraconazole|mesh-list
102361058|NCT04405323|Antifungal Agents|antifungal agents|mesh-ancestor
102361059|NCT04405323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102361060|NCT04405323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102361061|NCT04405323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102361062|NCT04405323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102361063|NCT04405323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361064|NCT04405323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102361065|NCT04405323|Hormone Antagonists|hormone antagonists|mesh-ancestor
102361066|NCT04405323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102361067|NCT04405323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361068|NCT04405323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102361069|NCT01720498|Remifentanil|remifentanil|mesh-list
102361070|NCT01720498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102361071|NCT01720498|Narcotics|narcotics|mesh-ancestor
102361072|NCT01720498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102361073|NCT01720498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361074|NCT01720498|Analgesics|analgesics|mesh-ancestor
102361075|NCT01720498|Sensory System Agents|sensory system agents|mesh-ancestor
102361076|NCT01720498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102361077|NCT01672047|Vitamin D|vitamin d|mesh-list
102361078|NCT01672047|Ergocalciferols|ergocalciferols|mesh-list
102361079|NCT01672047|Vitamins|vitamins|mesh-ancestor
102361080|NCT01672047|Micronutrients|micronutrients|mesh-ancestor
102361081|NCT01672047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361082|NCT01672047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102361083|NCT01672047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102361084|NCT00911326|Dextrans|dextrans|mesh-list
102361085|NCT00911326|Technetium Tc 99m Pentetate|technetium tc 99m pentetate|mesh-list
102361086|NCT00911326|Anticoagulants|anticoagulants|mesh-ancestor
102361087|NCT00911326|Plasma Substitutes|plasma substitutes|mesh-ancestor
102361088|NCT00911326|Blood Substitutes|blood substitutes|mesh-ancestor
102361089|NCT00911326|Chelating Agents|chelating agents|mesh-ancestor
102361090|NCT00911326|Sequestering Agents|sequestering agents|mesh-ancestor
102361091|NCT00911326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361092|NCT00911326|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102361093|NCT01833676|Sevoflurane|sevoflurane|mesh-list
102361094|NCT01833676|Desflurane|desflurane|mesh-list
102361095|NCT01833676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102361096|NCT01833676|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102361097|NCT01833676|Anesthetics, General|anesthetics, general|mesh-ancestor
102361098|NCT01833676|Anesthetics|anesthetics|mesh-ancestor
102361099|NCT01833676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102361100|NCT01833676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361101|NCT04380376|Melphalan|melphalan|mesh-list
102361102|NCT04380376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102361103|NCT04380376|Alkylating Agents|alkylating agents|mesh-ancestor
102361104|NCT04380376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361105|NCT04380376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102361106|NCT04380376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102361107|NCT04380376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102361108|NCT04380376|Immunologic Factors|immunologic factors|mesh-ancestor
102361109|NCT04380376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361110|NCT04380298|Ketorolac|ketorolac|mesh-list
102361111|NCT04380298|Epinephrine|epinephrine|mesh-list
102361112|NCT04380298|Ropivacaine|ropivacaine|mesh-list
102361113|NCT04380298|Anesthetics, Local|anesthetics, local|mesh-ancestor
102361114|NCT04380298|Anesthetics|anesthetics|mesh-ancestor
102361115|NCT04380298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102361116|NCT04380298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361117|NCT04380298|Sensory System Agents|sensory system agents|mesh-ancestor
102361118|NCT04380298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102361119|NCT04380298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102361120|NCT04380298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102361121|NCT04380298|Adrenergic Agents|adrenergic agents|mesh-ancestor
102361122|NCT04380298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102361123|NCT04380298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361124|NCT04380298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102361125|NCT04380298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102361126|NCT04380298|Autonomic Agents|autonomic agents|mesh-ancestor
102361127|NCT04380298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102361128|NCT04380298|Respiratory System Agents|respiratory system agents|mesh-ancestor
102361129|NCT04380298|Mydriatics|mydriatics|mesh-ancestor
102361130|NCT04380298|Sympathomimetics|sympathomimetics|mesh-ancestor
102361131|NCT04380298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102361132|NCT04380298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102361133|NCT04380298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102361134|NCT04380298|Analgesics|analgesics|mesh-ancestor
102361135|NCT04380298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102361136|NCT04380298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102361137|NCT04380298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102361138|NCT04380298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102361139|NCT04164849|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101567347|NCT02879097|Bevacizumab|bevacizumab|mesh-list
102361140|NCT04164849|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102361141|NCT04164849|Dermatologic Agents|dermatologic agents|mesh-ancestor
102361142|NCT03210610|Colchicine|colchicine|mesh-list
102361143|NCT03210610|Gout Suppressants|gout suppressants|mesh-ancestor
102361144|NCT03210610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102361145|NCT03210610|Tubulin Modulators|tubulin modulators|mesh-ancestor
102361146|NCT03210610|Antimitotic Agents|antimitotic agents|mesh-ancestor
102361147|NCT03210610|Mitosis Modulators|mitosis modulators|mesh-ancestor
102361148|NCT03210610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361149|NCT03210610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102361150|NCT03152955|Sufentanil|sufentanil|mesh-list
102361151|NCT03152955|Ketamine|ketamine|mesh-list
102361152|NCT03152955|Ondansetron|ondansetron|mesh-list
102361153|NCT03152955|Analgesics|analgesics|mesh-ancestor
102361154|NCT03152955|Sensory System Agents|sensory system agents|mesh-ancestor
102361155|NCT03152955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102361156|NCT03152955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361157|NCT03152955|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102361158|NCT03152955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102361159|NCT03152955|Anesthetics, General|anesthetics, general|mesh-ancestor
102361160|NCT03152955|Anesthetics|anesthetics|mesh-ancestor
102361161|NCT03152955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102361162|NCT03152955|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102361163|NCT03152955|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102361164|NCT03152955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102361165|NCT03152955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361166|NCT03152955|Antiemetics|antiemetics|mesh-ancestor
102361167|NCT03152955|Autonomic Agents|autonomic agents|mesh-ancestor
102361168|NCT03152955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102361169|NCT03152955|Antipruritics|antipruritics|mesh-ancestor
102361170|NCT03152955|Dermatologic Agents|dermatologic agents|mesh-ancestor
102361171|NCT03152955|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102361172|NCT03152955|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102361173|NCT03152955|Serotonin Agents|serotonin agents|mesh-ancestor
102361174|NCT03152955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102361175|NCT03152955|Narcotics|narcotics|mesh-ancestor
102361176|NCT03152955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102361177|NCT01676493|Codeine|codeine|mesh-list
102361178|NCT01676493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102361179|NCT01676493|Narcotics|narcotics|mesh-ancestor
102361180|NCT01676493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102361181|NCT01676493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361182|NCT01676493|Analgesics|analgesics|mesh-ancestor
102361183|NCT01676493|Sensory System Agents|sensory system agents|mesh-ancestor
102361184|NCT01676493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102361185|NCT01676493|Antitussive Agents|antitussive agents|mesh-ancestor
102361186|NCT01676493|Respiratory System Agents|respiratory system agents|mesh-ancestor
102361187|NCT01721434|Simendan|simendan|mesh-list
102361188|NCT01721434|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102361189|NCT01721434|Vasodilator Agents|vasodilator agents|mesh-ancestor
102361190|NCT01721434|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102361191|NCT01721434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102361192|NCT01721434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102361193|NCT01721434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361194|NCT01721434|Protective Agents|protective agents|mesh-ancestor
102361195|NCT01721434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361196|NCT03210532|Amlodipine|amlodipine|mesh-list
102361197|NCT03210532|Telmisartan|telmisartan|mesh-list
102361198|NCT03210532|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
102361199|NCT03210532|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102361200|NCT03210532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102361201|NCT03210532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102361202|NCT03210532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102361203|NCT03210532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361204|NCT03210532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102361205|NCT03210532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361206|NCT03210532|Vasodilator Agents|vasodilator agents|mesh-ancestor
102361207|NCT03210532|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102361208|NCT03210532|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102361209|NCT03210532|Antimetabolites|antimetabolites|mesh-ancestor
102361210|NCT03210532|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102361211|NCT03210532|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102361212|NCT03210532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102361213|NCT03210532|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102361214|NCT03210532|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102361215|NCT03152565|Avelumab|avelumab|mesh-list
102361216|NCT03152565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102361217|NCT03152565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102361218|NCT03210064|Fluorouracil|fluorouracil|mesh-list
102361219|NCT03210064|Apatinib|apatinib|mesh-list
102361220|NCT03210064|Antimetabolites|antimetabolites|mesh-ancestor
102361221|NCT03210064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361222|NCT03210064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102361223|NCT03210064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102361224|NCT03210064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102361225|NCT03210064|Immunologic Factors|immunologic factors|mesh-ancestor
102361226|NCT03210064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361227|NCT03210064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102361228|NCT03210064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102361229|NCT05372991|Atropine|atropine|mesh-list
102361230|NCT05372991|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102361231|NCT05372991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102361232|NCT05372991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102361233|NCT05372991|Autonomic Agents|autonomic agents|mesh-ancestor
102361234|NCT05372991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102361235|NCT05372991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361236|NCT05372991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102361237|NCT05372991|Respiratory System Agents|respiratory system agents|mesh-ancestor
102361238|NCT05372991|Mydriatics|mydriatics|mesh-ancestor
102361239|NCT05372991|Parasympatholytics|parasympatholytics|mesh-ancestor
102361240|NCT05372991|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102361241|NCT05372991|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102361242|NCT05372991|Cholinergic Agents|cholinergic agents|mesh-ancestor
102361243|NCT05372991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102361244|NCT05372991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361245|NCT01672593|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102361246|NCT01672593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102361247|NCT01722448|Choline|choline|mesh-list
102361248|NCT01722448|Lipotropic Agents|lipotropic agents|mesh-ancestor
102172993|NCT00002462|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102361249|NCT01722448|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102361250|NCT01722448|Antimetabolites|antimetabolites|mesh-ancestor
102361251|NCT01722448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361252|NCT01722448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102361253|NCT01722448|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102361254|NCT01722448|Nootropic Agents|nootropic agents|mesh-ancestor
102361255|NCT01834768|Eplerenone|eplerenone|mesh-list
102361256|NCT01834768|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102361257|NCT01834768|Hormone Antagonists|hormone antagonists|mesh-ancestor
102361258|NCT01834768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102361259|NCT01834768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361260|NCT01834768|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102361261|NCT01834768|Diuretics|diuretics|mesh-ancestor
102361262|NCT01834768|Natriuretic Agents|natriuretic agents|mesh-ancestor
102361263|NCT01834768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102361264|NCT01672671|Paclitaxel|paclitaxel|mesh-list
102361265|NCT01672671|Doxorubicin|doxorubicin|mesh-list
102361266|NCT01672671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102361267|NCT01672671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102361268|NCT01672671|Tubulin Modulators|tubulin modulators|mesh-ancestor
102361269|NCT01672671|Antimitotic Agents|antimitotic agents|mesh-ancestor
102361270|NCT01672671|Mitosis Modulators|mitosis modulators|mesh-ancestor
102361271|NCT01672671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361272|NCT01672671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102361273|NCT01672671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102361274|NCT01672671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102361275|NCT01672671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102361276|NCT02459457|Paclitaxel|paclitaxel|mesh-list
102361277|NCT02459457|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102361278|NCT02459457|Carboplatin|carboplatin|mesh-list
102361279|NCT02459457|Fluorouracil|fluorouracil|mesh-list
102361280|NCT02459457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102361281|NCT02459457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102361282|NCT02459457|Tubulin Modulators|tubulin modulators|mesh-ancestor
102361283|NCT02459457|Antimitotic Agents|antimitotic agents|mesh-ancestor
102361284|NCT02459457|Mitosis Modulators|mitosis modulators|mesh-ancestor
102361285|NCT02459457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361286|NCT02459457|Antimetabolites|antimetabolites|mesh-ancestor
102361287|NCT02459457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102361288|NCT02459457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102361289|NCT02459457|Immunologic Factors|immunologic factors|mesh-ancestor
102361290|NCT02459457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361291|NCT01835236|Paclitaxel|paclitaxel|mesh-list
102361292|NCT01835236|Vinorelbine|vinorelbine|mesh-list
102361293|NCT01835236|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102361294|NCT01835236|Trastuzumab|trastuzumab|mesh-list
102361295|NCT01835236|Pertuzumab|pertuzumab|mesh-list
102361296|NCT01835236|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102361297|NCT01835236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102361298|NCT01835236|Tubulin Modulators|tubulin modulators|mesh-ancestor
102361299|NCT01835236|Antimitotic Agents|antimitotic agents|mesh-ancestor
102361300|NCT01835236|Mitosis Modulators|mitosis modulators|mesh-ancestor
102361301|NCT01835236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361302|NCT01835236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102361303|NCT01835236|Immunotoxins|immunotoxins|mesh-ancestor
102361304|NCT01835236|Immunoconjugates|immunoconjugates|mesh-ancestor
102361305|NCT01835236|Immunologic Factors|immunologic factors|mesh-ancestor
102361306|NCT01835236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361307|NCT01671891|Capecitabine|capecitabine|mesh-list
102361308|NCT01671891|Oxaliplatin|oxaliplatin|mesh-list
102361309|NCT01671891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102361310|NCT01671891|Antimetabolites|antimetabolites|mesh-ancestor
102361311|NCT01671891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361312|NCT01671891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102361313|NCT03152409|Aspirin|aspirin|mesh-list
102361314|NCT03152409|Salicylic Acid|salicylic acid|mesh-list
102361315|NCT03152409|Salicylates|salicylates|mesh-list
102361316|NCT03152409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102361317|NCT03152409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102361318|NCT03152409|Analgesics|analgesics|mesh-ancestor
102361319|NCT03152409|Sensory System Agents|sensory system agents|mesh-ancestor
102361320|NCT03152409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102361321|NCT03152409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361322|NCT03152409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102361323|NCT03152409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102361324|NCT03152409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102361325|NCT03152409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102361326|NCT03152409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361327|NCT03152409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102361328|NCT03152409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102361329|NCT03152409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102361330|NCT03152409|Antipyretics|antipyretics|mesh-ancestor
102361331|NCT03152409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102361332|NCT03152409|Antifungal Agents|antifungal agents|mesh-ancestor
102361333|NCT03152409|Keratolytic Agents|keratolytic agents|mesh-ancestor
102361334|NCT03152409|Dermatologic Agents|dermatologic agents|mesh-ancestor
102361335|NCT01830322|Gemcitabine|gemcitabine|mesh-list
102361336|NCT01830322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102361337|NCT01830322|Antimetabolites|antimetabolites|mesh-ancestor
102361338|NCT01830322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361339|NCT01830322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102361340|NCT01835314|Stiripentol|stiripentol|mesh-list
102361341|NCT01835314|Anticonvulsants|anticonvulsants|mesh-ancestor
102361342|NCT01706198|Fluticasone|fluticasone|mesh-list
102361343|NCT01706198|Xhance|xhance|mesh-list
102361344|NCT01706198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102361345|NCT01706198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102361346|NCT01706198|Autonomic Agents|autonomic agents|mesh-ancestor
102361347|NCT01706198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102361348|NCT01706198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361349|NCT01706198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102361350|NCT01706198|Respiratory System Agents|respiratory system agents|mesh-ancestor
102361351|NCT01706198|Dermatologic Agents|dermatologic agents|mesh-ancestor
102361352|NCT01706198|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102361353|NCT04378972|Vitamin D|vitamin d|mesh-list
102361354|NCT04378972|Cholecalciferol|cholecalciferol|mesh-list
102361355|NCT04378972|Curcumin|curcumin|mesh-list
102361356|NCT04378972|Tramiprosate|tramiprosate|mesh-list
102361357|NCT04378972|Vitamins|vitamins|mesh-ancestor
102361358|NCT04378972|Micronutrients|micronutrients|mesh-ancestor
102361359|NCT04378972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361360|NCT04378972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101567355|NCT02879097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102361361|NCT04378972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102361362|NCT04378972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102361363|NCT04378972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102361364|NCT04378972|Analgesics|analgesics|mesh-ancestor
102361365|NCT04378972|Sensory System Agents|sensory system agents|mesh-ancestor
102361366|NCT04378972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102361367|NCT04378972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102361368|NCT04378972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102361369|NCT04378972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102361370|NCT04378972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102361371|NCT04378972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361372|NCT04378972|Anticonvulsants|anticonvulsants|mesh-ancestor
102361373|NCT04378972|GABA Agonists|gaba agonists|mesh-ancestor
102361374|NCT04378972|GABA Agents|gaba agents|mesh-ancestor
102361375|NCT04378972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102361376|NCT01723150|Ciprofloxacin|ciprofloxacin|mesh-list
102361377|NCT01723150|Ceftriaxone|ceftriaxone|mesh-list
102361378|NCT01723150|Ertapenem|ertapenem|mesh-list
102361379|NCT01723150|Trimethoprim|trimethoprim|mesh-list
102361380|NCT01723150|Sulfamethoxazole|sulfamethoxazole|mesh-list
102361381|NCT01723150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102361382|NCT01723150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102361383|NCT01723150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102361384|NCT01723150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102361385|NCT01723150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102361386|NCT01723150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361387|NCT01723150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102361388|NCT01723150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102361389|NCT01723150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102361390|NCT01723150|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102361391|NCT01723150|Antimalarials|antimalarials|mesh-ancestor
102361392|NCT01723150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102361393|NCT01723150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102361394|NCT01723150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102361395|NCT01723150|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102361396|NCT01723150|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102361397|NCT01835938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102361398|NCT01835938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102361399|NCT01835938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102154165|NCT00335114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102361400|NCT01835938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102361401|NCT01835938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361402|NCT01836016|Fluticasone|fluticasone|mesh-list
102361403|NCT01836016|Xhance|xhance|mesh-list
102361404|NCT01836016|Albuterol|albuterol|mesh-list
102361405|NCT01836016|Formoterol Fumarate|formoterol fumarate|mesh-list
102361406|NCT01836016|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102361407|NCT01836016|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102361408|NCT01836016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102361409|NCT01836016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102361410|NCT01836016|Autonomic Agents|autonomic agents|mesh-ancestor
102361411|NCT01836016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102361412|NCT01836016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361413|NCT01836016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102361414|NCT01836016|Respiratory System Agents|respiratory system agents|mesh-ancestor
102361415|NCT01836016|Dermatologic Agents|dermatologic agents|mesh-ancestor
102361416|NCT01836016|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102361417|NCT01836016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102361418|NCT01836016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102361419|NCT01836016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102361420|NCT01836016|Adrenergic Agents|adrenergic agents|mesh-ancestor
102361421|NCT01836016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102361422|NCT01836016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361423|NCT01836016|Tocolytic Agents|tocolytic agents|mesh-ancestor
102361424|NCT01836016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102361425|NCT01836016|Glucocorticoids|glucocorticoids|mesh-ancestor
102361426|NCT01836016|Hormones|hormones|mesh-ancestor
102361427|NCT01836016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102361428|NCT01836016|Sympathomimetics|sympathomimetics|mesh-ancestor
102361429|NCT01836094|Methylene Blue|methylene blue|mesh-list
102361430|NCT01836094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102361431|NCT01836094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361432|NCT01726192|Ropivacaine|ropivacaine|mesh-list
102361433|NCT01726192|Anesthetics, Local|anesthetics, local|mesh-ancestor
102361434|NCT01726192|Anesthetics|anesthetics|mesh-ancestor
102361435|NCT01726192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102361436|NCT01726192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361437|NCT01726192|Sensory System Agents|sensory system agents|mesh-ancestor
102361438|NCT01726192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102361439|NCT01836328|Methadone|methadone|mesh-list
102361440|NCT01836328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102361441|NCT01836328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102361442|NCT01836328|Narcotics|narcotics|mesh-ancestor
102361443|NCT01836328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102361444|NCT01836328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361445|NCT01836328|Analgesics|analgesics|mesh-ancestor
102361446|NCT01836328|Sensory System Agents|sensory system agents|mesh-ancestor
102361447|NCT01836328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102361448|NCT01836328|Antitussive Agents|antitussive agents|mesh-ancestor
102361449|NCT01836328|Respiratory System Agents|respiratory system agents|mesh-ancestor
102361450|NCT01836406|Ketorolac|ketorolac|mesh-list
102361451|NCT01836406|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102361452|NCT01836406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102361453|NCT01836406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102361454|NCT01836406|Analgesics|analgesics|mesh-ancestor
102361455|NCT01836406|Sensory System Agents|sensory system agents|mesh-ancestor
102361456|NCT01836406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102361457|NCT01836406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361458|NCT01836406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102361459|NCT01836406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102361460|NCT01836406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102361461|NCT01836406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102361462|NCT01836406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361463|NCT01836484|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102361464|NCT01836484|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102361465|NCT01836484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361466|NCT01726816|Probucol|probucol|mesh-list
102361467|NCT01726816|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102361468|NCT01726816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102361469|NCT01726816|Antimetabolites|antimetabolites|mesh-ancestor
102361470|NCT01726816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361471|NCT01726816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102361472|NCT01726816|Antioxidants|antioxidants|mesh-ancestor
102361473|NCT01726816|Protective Agents|protective agents|mesh-ancestor
102361474|NCT01726816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361475|NCT00915538|Budesonide|budesonide|mesh-list
102361476|NCT00915538|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
102361477|NCT00915538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102361478|NCT00915538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102361479|NCT00915538|Autonomic Agents|autonomic agents|mesh-ancestor
102361480|NCT00915538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102361481|NCT00915538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361482|NCT00915538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102361483|NCT00915538|Respiratory System Agents|respiratory system agents|mesh-ancestor
102361484|NCT00915538|Glucocorticoids|glucocorticoids|mesh-ancestor
102361485|NCT00915538|Hormones|hormones|mesh-ancestor
102361486|NCT00915538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102361487|NCT01724086|Interferons|interferons|mesh-list
102361488|NCT01724086|Ritonavir|ritonavir|mesh-list
102361489|NCT01724086|Ribavirin|ribavirin|mesh-list
102361490|NCT01724086|Interferon-alpha|interferon-alpha|mesh-list
102361491|NCT01724086|Interferon alpha-2|interferon alpha-2|mesh-list
102361492|NCT01724086|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102361493|NCT01724086|Simeprevir|simeprevir|mesh-list
102361494|NCT01724086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102361495|NCT01724086|Antiviral Agents|antiviral agents|mesh-ancestor
102361496|NCT01724086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102361497|NCT01724086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102361498|NCT01724086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102361499|NCT01724086|Protease Inhibitors|protease inhibitors|mesh-ancestor
102361500|NCT01724086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102361501|NCT01724086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361502|NCT01724086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102361503|NCT01724086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102361504|NCT01724086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102361505|NCT01724086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102361506|NCT01724086|Antimetabolites|antimetabolites|mesh-ancestor
102361507|NCT01724086|Immunologic Factors|immunologic factors|mesh-ancestor
102361508|NCT01724086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361509|NCT00913510|Cholinergic Antagonists|cholinergic antagonists|mesh-list
102361510|NCT00913510|Cholinergic Agents|cholinergic agents|mesh-ancestor
102361511|NCT00913510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102361512|NCT00913510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361513|NCT00913510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361514|NCT01727050|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102361515|NCT01727050|Hemostatics|hemostatics|mesh-ancestor
102361516|NCT01727050|Coagulants|coagulants|mesh-ancestor
102361517|NCT03836638|Botulinum Toxins|botulinum toxins|mesh-list
102361518|NCT03836638|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102361519|NCT03836638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102361520|NCT03836638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361521|NCT03836638|Cholinergic Agents|cholinergic agents|mesh-ancestor
102361522|NCT03836638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102361523|NCT03836638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361524|NCT01837108|Eplerenone|eplerenone|mesh-list
102361525|NCT01837108|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102361526|NCT01837108|Hormone Antagonists|hormone antagonists|mesh-ancestor
102361527|NCT01837108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102361528|NCT01837108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361529|NCT01837108|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102361530|NCT01837108|Diuretics|diuretics|mesh-ancestor
102361531|NCT01837108|Natriuretic Agents|natriuretic agents|mesh-ancestor
102361532|NCT01837108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102361533|NCT01724554|Aflibercept|aflibercept|mesh-list
102361534|NCT01724554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102361535|NCT01724554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102361536|NCT01724554|Growth Substances|growth substances|mesh-ancestor
102361537|NCT01724554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361538|NCT01724554|Growth Inhibitors|growth inhibitors|mesh-ancestor
102361539|NCT01724554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102361540|NCT01724788|Furosemide|furosemide|mesh-list
102361541|NCT01724788|Diuretics|diuretics|mesh-ancestor
102361542|NCT01724788|Natriuretic Agents|natriuretic agents|mesh-ancestor
102361543|NCT01724788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361544|NCT01724788|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102361545|NCT01724788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102361546|NCT01724788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361547|NCT01837498|Neostigmine|neostigmine|mesh-list
102361548|NCT01837498|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102154166|NCT00335114|Dermatologic Agents|dermatologic agents|mesh-ancestor
102361549|NCT01837498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102361550|NCT01837498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361551|NCT01837498|Cholinergic Agents|cholinergic agents|mesh-ancestor
102361552|NCT01837498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102361553|NCT01837498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361554|NCT01837498|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102361555|NCT01837498|Autonomic Agents|autonomic agents|mesh-ancestor
102361556|NCT01837498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102361557|NCT01705574|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102361558|NCT01705574|Antiviral Agents|antiviral agents|mesh-ancestor
102361559|NCT01705574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102361560|NCT01705574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102361561|NCT01705574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102361562|NCT01837576|Calcipotriene|calcipotriene|mesh-list
102361563|NCT01837576|Dermatologic Agents|dermatologic agents|mesh-ancestor
102361564|NCT01728298|Immunomodulating Agents|immunomodulating agents|mesh-list
102361565|NCT01728298|Immunologic Factors|immunologic factors|mesh-ancestor
102361566|NCT01728298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361567|NCT01737710|Vaccines|vaccines|mesh-list
102361568|NCT01737710|Immunologic Factors|immunologic factors|mesh-ancestor
102361569|NCT01737710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361570|NCT01837810|Ibuprofen|ibuprofen|mesh-list
102361571|NCT01837810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102361572|NCT01837810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102361573|NCT01837810|Analgesics|analgesics|mesh-ancestor
102361574|NCT01837810|Sensory System Agents|sensory system agents|mesh-ancestor
102361575|NCT01837810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102361576|NCT01837810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361577|NCT01837810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102361578|NCT01837810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102361579|NCT01837810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102361580|NCT01837810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102361581|NCT01837810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361582|NCT01725100|Trametinib|trametinib|mesh-list
102361583|NCT01725100|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
102361584|NCT01725100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102361585|NCT01725100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102361586|NCT01725100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102361587|NCT01725100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361588|NCT01725100|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102361589|NCT01725100|Protective Agents|protective agents|mesh-ancestor
102361590|NCT01725100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361591|NCT01725100|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102361592|NCT01725100|Antioxidants|antioxidants|mesh-ancestor
102361593|NCT01725412|Thiamine|thiamine|mesh-list
102361594|NCT01725412|Vitamin B Complex|vitamin b complex|mesh-ancestor
102361595|NCT01725412|Vitamins|vitamins|mesh-ancestor
102361596|NCT01725412|Micronutrients|micronutrients|mesh-ancestor
102361597|NCT01725412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361598|NCT01725490|Metformin|metformin|mesh-list
102361599|NCT01725490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102361600|NCT01725490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361601|NCT04553666|Vitamins|vitamins|mesh-list
102361602|NCT04553666|Ascorbic Acid|ascorbic acid|mesh-list
102361603|NCT04553666|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
102361604|NCT04553666|Micronutrients|micronutrients|mesh-ancestor
102361605|NCT04553666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361606|NCT04553666|Antioxidants|antioxidants|mesh-ancestor
102361607|NCT04553666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361608|NCT04553666|Protective Agents|protective agents|mesh-ancestor
102361609|NCT04553666|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
102361610|NCT04553666|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102361611|NCT04553666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102361612|NCT04553666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102361613|NCT03834766|Amphetamine|amphetamine|mesh-list
102361614|NCT03834766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102361615|NCT03834766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361616|NCT03834766|Sympathomimetics|sympathomimetics|mesh-ancestor
102361617|NCT03834766|Autonomic Agents|autonomic agents|mesh-ancestor
102361618|NCT03834766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102361619|NCT03834766|Dopamine Agents|dopamine agents|mesh-ancestor
102361620|NCT03834766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102361621|NCT03834766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361622|NCT03834766|Adrenergic Agents|adrenergic agents|mesh-ancestor
102361623|NCT03834766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102361624|NCT03834766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102361625|NCT03834766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102361626|NCT03834766|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102361627|NCT01838434|Lenalidomide|lenalidomide|mesh-list
102361628|NCT01838434|Idelalisib|idelalisib|mesh-list
102361629|NCT01838434|Immunologic Factors|immunologic factors|mesh-ancestor
102361630|NCT01838434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361631|NCT01838434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102361632|NCT01838434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102361633|NCT01838434|Growth Substances|growth substances|mesh-ancestor
102361634|NCT01838434|Growth Inhibitors|growth inhibitors|mesh-ancestor
102361635|NCT01838434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102361636|NCT01838434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102361637|NCT01838434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361638|NCT01838668|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102361639|NCT01838668|Dermatologic Agents|dermatologic agents|mesh-ancestor
102361640|NCT01838668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102361641|NCT01838668|Immunologic Factors|immunologic factors|mesh-ancestor
102361642|NCT01838668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361643|NCT04377646|Zinc|zinc|mesh-list
102361644|NCT04377646|Hydroxychloroquine|hydroxychloroquine|mesh-list
102361645|NCT04377646|Antimalarials|antimalarials|mesh-ancestor
102361646|NCT04377646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102361647|NCT04377646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102361648|NCT04377646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102361649|NCT04377646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102361650|NCT04377646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361651|NCT04377646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101567362|NCT02878863|Antioxidants|antioxidants|mesh-ancestor
102361652|NCT04377646|Trace Elements|trace elements|mesh-ancestor
102361653|NCT04377646|Micronutrients|micronutrients|mesh-ancestor
102361654|NCT04377646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361655|NCT01728922|Vitamin D|vitamin d|mesh-list
102361656|NCT01728922|Ergocalciferols|ergocalciferols|mesh-list
102361657|NCT01728922|Cholecalciferol|cholecalciferol|mesh-list
102361658|NCT01728922|Vitamins|vitamins|mesh-list
102361659|NCT01728922|Micronutrients|micronutrients|mesh-ancestor
102361660|NCT01728922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361661|NCT01728922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102361662|NCT01728922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102361663|NCT01682720|Sofosbuvir|sofosbuvir|mesh-list
102361664|NCT01682720|Antiviral Agents|antiviral agents|mesh-ancestor
102361665|NCT01682720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102361666|NCT01838902|Primaquine|primaquine|mesh-list
102361667|NCT01838902|Antimalarials|antimalarials|mesh-ancestor
102361668|NCT01838902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102361669|NCT01838902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102361670|NCT01838902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102361671|NCT01714544|Clocortolone pivalate|clocortolone pivalate|mesh-list
102361672|NCT01714544|Glucocorticoids|glucocorticoids|mesh-ancestor
102361673|NCT01714544|Hormones|hormones|mesh-ancestor
102361674|NCT01714544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102361675|NCT01714544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361676|NCT03409432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102361677|NCT03409432|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102361678|NCT03409432|Lenalidomide|lenalidomide|mesh-list
102361679|NCT03409432|Antibodies|antibodies|mesh-list
102361680|NCT03409432|Immunoglobulins|immunoglobulins|mesh-list
102361681|NCT03409432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102361682|NCT03409432|Immunoconjugates|immunoconjugates|mesh-list
102361683|NCT03409432|Immunologic Factors|immunologic factors|mesh-ancestor
102361684|NCT03409432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361685|NCT03409432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102361686|NCT03409432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102361687|NCT03409432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102361688|NCT03409432|Growth Substances|growth substances|mesh-ancestor
102361689|NCT03409432|Growth Inhibitors|growth inhibitors|mesh-ancestor
102361690|NCT03409432|Immunotoxins|immunotoxins|mesh-ancestor
102361691|NCT01703858|Pantoprazole|pantoprazole|mesh-list
102361692|NCT01703858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102361693|NCT01703858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102361694|NCT01703858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102361695|NCT01703858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102361696|NCT01703858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361697|NCT01729468|Aspirin|aspirin|mesh-list
102361698|NCT01729468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102361699|NCT01729468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102361700|NCT01729468|Analgesics|analgesics|mesh-ancestor
102361701|NCT01729468|Sensory System Agents|sensory system agents|mesh-ancestor
102361702|NCT01729468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102361703|NCT01729468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361704|NCT01729468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102361705|NCT01729468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102361706|NCT01729468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102361707|NCT01729468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102361708|NCT01729468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361709|NCT01729468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102361710|NCT01729468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102361711|NCT01729468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102361712|NCT01729468|Antipyretics|antipyretics|mesh-ancestor
102361713|NCT04376788|Methylene Blue|methylene blue|mesh-list
102361714|NCT04376788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102361715|NCT04376788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361716|NCT01714310|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102361717|NCT01714310|Fluoxetine|fluoxetine|mesh-list
102361718|NCT01714310|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102361719|NCT01714310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102361720|NCT01714310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102361721|NCT01714310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361722|NCT01714310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102361723|NCT01714310|Serotonin Agents|serotonin agents|mesh-ancestor
102361724|NCT01714310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361725|NCT01714310|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102361726|NCT01714310|Antidepressive Agents|antidepressive agents|mesh-ancestor
102361727|NCT01714310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102361728|NCT01714310|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102361729|NCT01714310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102361730|NCT01714310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102361731|NCT01714310|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102361732|NCT01714310|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102361733|NCT01714310|Dopamine Agents|dopamine agents|mesh-ancestor
102361734|NCT03401788|Belzutifan|belzutifan|mesh-list
102361735|NCT03401788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102361736|NCT01728064|Ubiquinone|ubiquinone|mesh-list
102361737|NCT01728064|Micronutrients|micronutrients|mesh-ancestor
102361738|NCT01728064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361739|NCT03405142|Panitumumab|panitumumab|mesh-list
102361740|NCT03405142|Diethylenetriamine|diethylenetriamine|mesh-list
102361741|NCT03405142|Dextrans|dextrans|mesh-list
102361742|NCT03405142|Edetic Acid|edetic acid|mesh-list
102361743|NCT03405142|Pentetic Acid|pentetic acid|mesh-list
102361744|NCT03405142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102361745|NCT03405142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102361746|NCT03405142|Anticoagulants|anticoagulants|mesh-ancestor
102361747|NCT03405142|Plasma Substitutes|plasma substitutes|mesh-ancestor
102361748|NCT03405142|Blood Substitutes|blood substitutes|mesh-ancestor
102361749|NCT03405142|Antidotes|antidotes|mesh-ancestor
102361750|NCT03405142|Protective Agents|protective agents|mesh-ancestor
102361751|NCT03405142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361752|NCT03405142|Chelating Agents|chelating agents|mesh-ancestor
102361753|NCT03405142|Sequestering Agents|sequestering agents|mesh-ancestor
102361754|NCT03405142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361755|NCT03405142|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102361756|NCT03405142|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102361757|NCT03405142|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102361758|NCT03407872|Esketamine|esketamine|mesh-list
102361759|NCT03407872|Antidepressive Agents|antidepressive agents|mesh-ancestor
102361760|NCT03407872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102361761|NCT03834610|Tadalafil|tadalafil|mesh-list
102361762|NCT03834610|Testosterone|testosterone|mesh-list
102361763|NCT03834610|Androgens|androgens|mesh-ancestor
102361764|NCT03834610|Hormones|hormones|mesh-ancestor
102361765|NCT03834610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102361766|NCT03834610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361767|NCT03834610|Vasodilator Agents|vasodilator agents|mesh-ancestor
102361768|NCT03834610|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102361769|NCT03834610|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102361770|NCT03834610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102361771|NCT03834610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361772|NCT03834610|Urological Agents|urological agents|mesh-ancestor
102361773|NCT01681472|Leucovorin|leucovorin|mesh-list
102173517|NCT02036723|Bevacizumab|bevacizumab|mesh-list
102361774|NCT01681472|Tetrahydrofolates|tetrahydrofolates|mesh-list
102361775|NCT01681472|Levoleucovorin|levoleucovorin|mesh-list
102361776|NCT01681472|Antidotes|antidotes|mesh-ancestor
102361777|NCT01681472|Protective Agents|protective agents|mesh-ancestor
102361778|NCT01681472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361779|NCT01681472|Vitamin B Complex|vitamin b complex|mesh-ancestor
102361780|NCT01681472|Vitamins|vitamins|mesh-ancestor
102361781|NCT01681472|Micronutrients|micronutrients|mesh-ancestor
102361782|NCT00915928|Perindopril|perindopril|mesh-list
102361783|NCT00915928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102361784|NCT00915928|Protease Inhibitors|protease inhibitors|mesh-ancestor
102361785|NCT00915928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102361786|NCT00915928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361787|NCT00915928|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102361788|NCT03407404|Midazolam|midazolam|mesh-list
102361789|NCT03407404|Ketamine|ketamine|mesh-list
102361790|NCT03407404|Morphine|morphine|mesh-list
102361791|NCT03407404|Analgesics|analgesics|mesh-ancestor
102361792|NCT03407404|Sensory System Agents|sensory system agents|mesh-ancestor
102361793|NCT03407404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102361794|NCT03407404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361795|NCT03407404|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102361796|NCT03407404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102361797|NCT03407404|Anesthetics, General|anesthetics, general|mesh-ancestor
102361798|NCT03407404|Anesthetics|anesthetics|mesh-ancestor
102361799|NCT03407404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102361800|NCT03407404|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102361801|NCT03407404|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102361802|NCT03407404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102361803|NCT03407404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361804|NCT03407404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102361805|NCT03407404|Narcotics|narcotics|mesh-ancestor
102361806|NCT03407404|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102361807|NCT03407404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102361808|NCT03407404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102361809|NCT03407404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102361810|NCT03407404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102361811|NCT03407404|GABA Modulators|gaba modulators|mesh-ancestor
102361812|NCT03407404|GABA Agents|gaba agents|mesh-ancestor
102361813|NCT03830086|Midazolam|midazolam|mesh-list
102361814|NCT03830086|Sufentanil|sufentanil|mesh-list
102361815|NCT03830086|Bupivacaine|bupivacaine|mesh-list
102361816|NCT03830086|Propofol|propofol|mesh-list
102361817|NCT03830086|Sevoflurane|sevoflurane|mesh-list
102361818|NCT03830086|Rocuronium|rocuronium|mesh-list
102361819|NCT03830086|Anesthetics, Local|anesthetics, local|mesh-ancestor
102361820|NCT03830086|Anesthetics|anesthetics|mesh-ancestor
102361821|NCT03830086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102361822|NCT03830086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361823|NCT03830086|Sensory System Agents|sensory system agents|mesh-ancestor
102361824|NCT03830086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102361825|NCT03830086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102361826|NCT03830086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102361827|NCT03830086|Anesthetics, General|anesthetics, general|mesh-ancestor
102361828|NCT03830086|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102361829|NCT03830086|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102361830|NCT03830086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102361831|NCT03830086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102361832|NCT03830086|GABA Modulators|gaba modulators|mesh-ancestor
102361833|NCT03830086|GABA Agents|gaba agents|mesh-ancestor
102361834|NCT03830086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102361835|NCT03830086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361836|NCT03830086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102361837|NCT03830086|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102361838|NCT03830086|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102361839|NCT03830086|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102361840|NCT03830086|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102361841|NCT03830086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102361842|NCT03830086|Narcotics|narcotics|mesh-ancestor
102361843|NCT03830086|Analgesics|analgesics|mesh-ancestor
102361844|NCT02240212|Paclitaxel|paclitaxel|mesh-list
102361845|NCT02240212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102361846|NCT02240212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102361847|NCT02240212|Tubulin Modulators|tubulin modulators|mesh-ancestor
102361848|NCT02240212|Antimitotic Agents|antimitotic agents|mesh-ancestor
102361849|NCT02240212|Mitosis Modulators|mitosis modulators|mesh-ancestor
102361850|NCT02240212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361851|NCT01047436|Artemether|artemether|mesh-list
102361852|NCT01047436|Quinine|quinine|mesh-list
102361853|NCT01047436|Antimalarials|antimalarials|mesh-ancestor
102361854|NCT01047436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102361855|NCT01047436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102361856|NCT01047436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102361857|NCT01047436|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102361858|NCT01047436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361859|NCT01047436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102361860|NCT01047436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102361861|NCT01047436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102361862|NCT01047436|Analgesics|analgesics|mesh-ancestor
102361863|NCT01047436|Sensory System Agents|sensory system agents|mesh-ancestor
102361865|NCT03406936|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102361866|NCT03406936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102361867|NCT03406936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102361868|NCT03406936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361869|NCT03406936|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102361870|NCT03406936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102361871|NCT03406936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102361872|NCT03406936|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102361873|NCT03406936|Anesthetics, General|anesthetics, general|mesh-ancestor
102361874|NCT03406936|Anesthetics|anesthetics|mesh-ancestor
102361875|NCT03406936|GABA Modulators|gaba modulators|mesh-ancestor
102361876|NCT03406936|GABA Agents|gaba agents|mesh-ancestor
102361877|NCT03406936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102361878|NCT03406936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361879|NCT02240602|Oxycodone|oxycodone|mesh-list
102361880|NCT02240602|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102361881|NCT02240602|Narcotics|narcotics|mesh-ancestor
102361882|NCT02240602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102361883|NCT02240602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361884|NCT02240602|Analgesics|analgesics|mesh-ancestor
102361885|NCT02240602|Sensory System Agents|sensory system agents|mesh-ancestor
102361886|NCT02240602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102361887|NCT03406546|Dexmedetomidine|dexmedetomidine|mesh-list
102361888|NCT03406546|Remifentanil|remifentanil|mesh-list
102361889|NCT03406546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102361890|NCT03406546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102361891|NCT03406546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361892|NCT03406546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102361893|NCT03406546|Analgesics|analgesics|mesh-ancestor
102361894|NCT03406546|Sensory System Agents|sensory system agents|mesh-ancestor
102361895|NCT03406546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102361896|NCT03406546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102361897|NCT03406546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102361898|NCT03406546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102361899|NCT03406546|Adrenergic Agents|adrenergic agents|mesh-ancestor
102361900|NCT03406546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102361901|NCT03406546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361902|NCT03406546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102361903|NCT03406546|Narcotics|narcotics|mesh-ancestor
102361904|NCT01046110|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102361905|NCT01046110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102361906|NCT01046110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361907|NCT01046110|Incretins|incretins|mesh-ancestor
102361908|NCT01046110|Hormones|hormones|mesh-ancestor
102361909|NCT01046110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102361910|NCT01046110|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102361911|NCT01046110|Protease Inhibitors|protease inhibitors|mesh-ancestor
102361912|NCT01046110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102361913|NCT01046110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361914|NCT01713530|Insulin|insulin|mesh-list
102361915|NCT01713530|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102361916|NCT01713530|Insulin Aspart|insulin aspart|mesh-list
102361917|NCT01713530|Insulin, Long-Acting|insulin, long-acting|mesh-list
102361918|NCT01713530|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102361919|NCT01713530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102361920|NCT01713530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361921|NCT01045798|Caspofungin|caspofungin|mesh-list
102361922|NCT01045798|Antifungal Agents|antifungal agents|mesh-ancestor
102361923|NCT01045798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102361924|NCT01045798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102361925|NCT01045798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361926|NCT02982694|Bevacizumab|bevacizumab|mesh-list
102361927|NCT02982694|Atezolizumab|atezolizumab|mesh-list
102361928|NCT02982694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102361929|NCT02982694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102361930|NCT02982694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102361931|NCT02982694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102361932|NCT02982694|Growth Substances|growth substances|mesh-ancestor
102361933|NCT02982694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361934|NCT02982694|Growth Inhibitors|growth inhibitors|mesh-ancestor
102361935|NCT02982694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102361936|NCT02982694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361937|NCT01712984|Fluconazole|fluconazole|mesh-list
102361938|NCT01712984|Vaccines|vaccines|mesh-list
102361939|NCT01712984|Immunologic Factors|immunologic factors|mesh-ancestor
102361940|NCT01712984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361941|NCT01712984|Antifungal Agents|antifungal agents|mesh-ancestor
102361942|NCT01712984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102361943|NCT01712984|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102361944|NCT01712984|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102361945|NCT01712984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102361946|NCT01712984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361947|NCT01712984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102361948|NCT01712984|Hormone Antagonists|hormone antagonists|mesh-ancestor
102361949|NCT01712984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102361950|NCT01712984|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102361951|NCT01712984|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102361952|NCT00921310|Sirolimus|sirolimus|mesh-list
102361953|NCT00921310|Pemetrexed|pemetrexed|mesh-list
102361954|NCT00921310|Temsirolimus|temsirolimus|mesh-list
102361955|NCT00921310|MTOR Inhibitors|mtor inhibitors|mesh-list
102361956|NCT00921310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102361957|NCT00921310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102361958|NCT00921310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361959|NCT00921310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102361960|NCT00921310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102361961|NCT00921310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102361962|NCT00921310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102361963|NCT00921310|Immunologic Factors|immunologic factors|mesh-ancestor
102361964|NCT00921310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361965|NCT00921310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102361966|NCT00921310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102361967|NCT00921310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102361968|NCT00921310|Antifungal Agents|antifungal agents|mesh-ancestor
102361969|NCT02241148|Acetaminophen|acetaminophen|mesh-list
102361970|NCT02241148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102361971|NCT02241148|Analgesics|analgesics|mesh-ancestor
102361972|NCT02241148|Sensory System Agents|sensory system agents|mesh-ancestor
102361973|NCT02241148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102361974|NCT02241148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361975|NCT02241148|Antipyretics|antipyretics|mesh-ancestor
102361976|NCT01712516|Glycopyrrolate|glycopyrrolate|mesh-list
102361977|NCT01712516|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102361978|NCT01712516|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102361979|NCT01712516|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102361980|NCT01712516|Cholinergic Agents|cholinergic agents|mesh-ancestor
102361981|NCT01712516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102361982|NCT01712516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361983|NCT01712516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361984|NCT01040728|Tiotropium Bromide|tiotropium bromide|mesh-list
102361985|NCT01040728|Olodaterol|olodaterol|mesh-list
102361986|NCT01040728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102361987|NCT01040728|Autonomic Agents|autonomic agents|mesh-ancestor
102361988|NCT01040728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102361989|NCT01040728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102361990|NCT01040728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102361991|NCT01040728|Respiratory System Agents|respiratory system agents|mesh-ancestor
102361992|NCT01040728|Parasympatholytics|parasympatholytics|mesh-ancestor
102361993|NCT01040728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102361994|NCT01040728|Cholinergic Agents|cholinergic agents|mesh-ancestor
102361995|NCT01040728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102361996|NCT01040728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102361997|NCT01593020|Paclitaxel|paclitaxel|mesh-list
102361998|NCT01593020|Cyclophosphamide|cyclophosphamide|mesh-list
102361999|NCT01593020|Doxorubicin|doxorubicin|mesh-list
102362000|NCT01593020|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102362001|NCT01593020|Fluorouracil|fluorouracil|mesh-list
102362002|NCT01593020|Epirubicin|epirubicin|mesh-list
102362003|NCT01593020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102362004|NCT01593020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102362005|NCT01593020|Tubulin Modulators|tubulin modulators|mesh-ancestor
102362006|NCT01593020|Antimitotic Agents|antimitotic agents|mesh-ancestor
102362007|NCT01593020|Mitosis Modulators|mitosis modulators|mesh-ancestor
102362008|NCT01593020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362009|NCT01593020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102362010|NCT01593020|Immunologic Factors|immunologic factors|mesh-ancestor
102362011|NCT01593020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362012|NCT01593020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102362013|NCT01593020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102362014|NCT01593020|Alkylating Agents|alkylating agents|mesh-ancestor
102362015|NCT01593020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102362016|NCT01593020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102362017|NCT01593020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102362018|NCT01593020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102362019|NCT01593020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102362020|NCT01593020|Antimetabolites|antimetabolites|mesh-ancestor
102362021|NCT01593020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102362022|NCT01040260|Nicotine|nicotine|mesh-list
102362023|NCT01040260|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102362024|NCT01040260|Autonomic Agents|autonomic agents|mesh-ancestor
102362025|NCT01040260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102362026|NCT01040260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362027|NCT01040260|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102362028|NCT01040260|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102362029|NCT01040260|Cholinergic Agents|cholinergic agents|mesh-ancestor
102362030|NCT01040260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102362031|NCT01040260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362032|NCT01046422|Metformin|metformin|mesh-list
102362033|NCT01046422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102362034|NCT01046422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362035|NCT03405376|Aflibercept|aflibercept|mesh-list
102362036|NCT03405376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102362037|NCT03405376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102362038|NCT03405376|Growth Substances|growth substances|mesh-ancestor
102362039|NCT03405376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362040|NCT03405376|Growth Inhibitors|growth inhibitors|mesh-ancestor
102362041|NCT03405376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102362042|NCT02241460|Lidocaine|lidocaine|mesh-list
102362043|NCT02241460|Anesthetics, Local|anesthetics, local|mesh-ancestor
102362044|NCT02241460|Anesthetics|anesthetics|mesh-ancestor
102362045|NCT02241460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102362046|NCT02241460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362047|NCT02241460|Sensory System Agents|sensory system agents|mesh-ancestor
102362048|NCT02241460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102362049|NCT02241460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102362050|NCT02241460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102362051|NCT02241460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102362052|NCT02241460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102362053|NCT02241460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362054|NCT01712204|Febuxostat|febuxostat|mesh-list
102362055|NCT01712204|Gout Suppressants|gout suppressants|mesh-ancestor
102362056|NCT01712204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102362057|NCT01592864|Fluorides|fluorides|mesh-list
102362058|NCT01592864|Tin Fluorides|tin fluorides|mesh-list
102362059|NCT01592864|Fluorophosphate|fluorophosphate|mesh-list
102362060|NCT01592864|Cariostatic Agents|cariostatic agents|mesh-ancestor
102362061|NCT01592864|Protective Agents|protective agents|mesh-ancestor
102362062|NCT01592864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362063|NCT01592786|Memantine|memantine|mesh-list
102362064|NCT01592786|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102362065|NCT01592786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102362066|NCT01592786|Dopamine Agents|dopamine agents|mesh-ancestor
102362067|NCT01592786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102362068|NCT01592786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362069|NCT01592786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362070|NCT01592786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102362071|NCT01592786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102362072|NCT01592708|Erythromycin|erythromycin|mesh-list
102362073|NCT01592708|Ibuprofen|ibuprofen|mesh-list
102362074|NCT01592708|Ketorolac|ketorolac|mesh-list
102362075|NCT01592708|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102362076|NCT01592708|Fentanyl|fentanyl|mesh-list
102362077|NCT01592708|Scopolamine|scopolamine|mesh-list
102362078|NCT01592708|Droperidol|droperidol|mesh-list
102362079|NCT01592708|Remifentanil|remifentanil|mesh-list
102362080|NCT01592708|Hydrocodone|hydrocodone|mesh-list
102362081|NCT01592708|Ondansetron|ondansetron|mesh-list
102154167|NCT00335114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102362082|NCT01592708|Antiemetics|antiemetics|mesh-list
102362083|NCT01592708|Propofol|propofol|mesh-list
102362084|NCT01592708|Anesthetics|anesthetics|mesh-ancestor
102362085|NCT01592708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102362086|NCT01592708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362087|NCT01592708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102362088|NCT01592708|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102362089|NCT01592708|Anesthetics, General|anesthetics, general|mesh-ancestor
102362090|NCT01592708|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102362091|NCT01592708|Narcotics|narcotics|mesh-ancestor
102362092|NCT01592708|Analgesics|analgesics|mesh-ancestor
102362093|NCT01592708|Sensory System Agents|sensory system agents|mesh-ancestor
102362094|NCT01592708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102362095|NCT01592708|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102362096|NCT01592708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102362097|NCT01592708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102362098|NCT01592708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102362099|NCT01592708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102362100|NCT01592708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102362101|NCT01592708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102362102|NCT01592708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362103|NCT01592708|Autonomic Agents|autonomic agents|mesh-ancestor
102362104|NCT01592708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102362105|NCT01592708|Antipruritics|antipruritics|mesh-ancestor
102362106|NCT01592708|Dermatologic Agents|dermatologic agents|mesh-ancestor
102362107|NCT01592708|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102362108|NCT01592708|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102362109|NCT01592708|Serotonin Agents|serotonin agents|mesh-ancestor
102362110|NCT01592708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102362111|NCT01592708|Antitussive Agents|antitussive agents|mesh-ancestor
102362112|NCT01592708|Respiratory System Agents|respiratory system agents|mesh-ancestor
102362113|NCT01592708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102362114|NCT01592708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102362115|NCT01592708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102362116|NCT01592708|Mydriatics|mydriatics|mesh-ancestor
102362117|NCT01592708|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102362118|NCT01592708|Cholinergic Agents|cholinergic agents|mesh-ancestor
102362119|NCT01592708|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102362120|NCT01592708|Glucocorticoids|glucocorticoids|mesh-ancestor
102362121|NCT01592708|Hormones|hormones|mesh-ancestor
102362122|NCT01592708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102362123|NCT01592708|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102362124|NCT01592708|Protective Agents|protective agents|mesh-ancestor
102362125|NCT01592708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102362126|NCT01592708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102362127|NCT01592708|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102362128|NCT01592708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102362129|NCT01592708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102362130|NCT01592708|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102362131|NCT01592708|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102362132|NCT01592708|Dopamine Agents|dopamine agents|mesh-ancestor
102362133|NCT01042522|Paclitaxel|paclitaxel|mesh-list
102362134|NCT01042522|Etoposide|etoposide|mesh-list
102362135|NCT01042522|Cisplatin|cisplatin|mesh-list
102362136|NCT01042522|Carboplatin|carboplatin|mesh-list
102362137|NCT01042522|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102362138|NCT01042522|Bleomycin|bleomycin|mesh-list
102362139|NCT01042522|Etoposide phosphate|etoposide phosphate|mesh-list
102362140|NCT01042522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102362141|NCT01042522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102362142|NCT01042522|Tubulin Modulators|tubulin modulators|mesh-ancestor
102362143|NCT01042522|Antimitotic Agents|antimitotic agents|mesh-ancestor
102362144|NCT01042522|Mitosis Modulators|mitosis modulators|mesh-ancestor
102362145|NCT01042522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362146|NCT01042522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102362147|NCT01042522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102362148|NCT01042522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102362149|NCT01042522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102362150|NCT01702844|Paclitaxel|paclitaxel|mesh-list
102362151|NCT01702844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102362152|NCT01702844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102362153|NCT01702844|Tubulin Modulators|tubulin modulators|mesh-ancestor
102362154|NCT01702844|Antimitotic Agents|antimitotic agents|mesh-ancestor
102362155|NCT01702844|Mitosis Modulators|mitosis modulators|mesh-ancestor
102362156|NCT01702844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362157|NCT01702532|Nicotine|nicotine|mesh-list
102362158|NCT01702532|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102362159|NCT01702532|Autonomic Agents|autonomic agents|mesh-ancestor
102362160|NCT01702532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102362161|NCT01702532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362162|NCT01702532|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102362163|NCT01702532|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102362164|NCT01702532|Cholinergic Agents|cholinergic agents|mesh-ancestor
102362165|NCT01702532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102362166|NCT01702532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362167|NCT02241616|Entecavir|entecavir|mesh-list
102362168|NCT02241616|Antiviral Agents|antiviral agents|mesh-ancestor
102362169|NCT02241616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102362170|NCT03400306|Paclitaxel|paclitaxel|mesh-list
102362171|NCT03400306|Carboplatin|carboplatin|mesh-list
102362172|NCT03400306|Veliparib|veliparib|mesh-list
102362173|NCT03400306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102362174|NCT03400306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102362175|NCT03400306|Tubulin Modulators|tubulin modulators|mesh-ancestor
102362176|NCT03400306|Antimitotic Agents|antimitotic agents|mesh-ancestor
102362177|NCT03400306|Mitosis Modulators|mitosis modulators|mesh-ancestor
102362178|NCT03400306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362179|NCT03400306|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102362180|NCT03400306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102362181|NCT03405064|Linezolid|linezolid|mesh-list
102362182|NCT03405064|Levonadifloxacin|levonadifloxacin|mesh-list
102362183|NCT03405064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102362184|NCT03405064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102362185|NCT03405064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102362186|NCT03405064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102362187|NCT03405064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362188|NCT03405064|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102362189|NCT03404908|Acetaminophen|acetaminophen|mesh-list
102362190|NCT03404908|Dipyrone|dipyrone|mesh-list
102362191|NCT03404908|Ketoprofen|ketoprofen|mesh-list
102362192|NCT03404908|Morphine|morphine|mesh-list
102362193|NCT03404908|Ropivacaine|ropivacaine|mesh-list
102362194|NCT03404908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102362195|NCT03404908|Narcotics|narcotics|mesh-ancestor
102362196|NCT03404908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102362197|NCT03404908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362198|NCT03404908|Analgesics|analgesics|mesh-ancestor
102362199|NCT03404908|Sensory System Agents|sensory system agents|mesh-ancestor
102362200|NCT03404908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102362201|NCT03404908|Anesthetics, Local|anesthetics, local|mesh-ancestor
102362202|NCT03404908|Anesthetics|anesthetics|mesh-ancestor
102362203|NCT03404908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102362204|NCT03404908|Antipyretics|antipyretics|mesh-ancestor
102362205|NCT03404908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102362206|NCT03404908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102362207|NCT03404908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102362208|NCT03404908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102362209|NCT03404908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102362210|NCT03404908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362211|NCT01702298|Metformin|metformin|mesh-list
102362212|NCT01702298|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102362213|NCT01702298|Simvastatin|simvastatin|mesh-list
102362214|NCT01702298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102362215|NCT01702298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362216|NCT01702298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102362217|NCT01702298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102362218|NCT01702298|Antimetabolites|antimetabolites|mesh-ancestor
102362219|NCT01702298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362220|NCT01702298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102362221|NCT01702298|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102362222|NCT01702298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102362223|NCT01702298|Incretins|incretins|mesh-ancestor
102362224|NCT01702298|Hormones|hormones|mesh-ancestor
101567397|NCT01097577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362225|NCT01702298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102362226|NCT01702298|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102362227|NCT01702298|Protease Inhibitors|protease inhibitors|mesh-ancestor
102362228|NCT03404752|Lenograstim|lenograstim|mesh-list
102362229|NCT03404752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102362230|NCT03404752|Immunologic Factors|immunologic factors|mesh-ancestor
102362231|NCT03404752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154168|NCT00335114|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102362232|NCT03401710|Epoetin Alfa|epoetin alfa|mesh-list
102362233|NCT03401710|Hematinics|hematinics|mesh-ancestor
102362234|NCT02242084|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102362235|NCT02242084|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102362236|NCT02242084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102362237|NCT02242084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362238|NCT01701362|Pregabalin|pregabalin|mesh-list
102362239|NCT01701362|Analgesics|analgesics|mesh-ancestor
102362240|NCT01701362|Sensory System Agents|sensory system agents|mesh-ancestor
102362241|NCT01701362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102362242|NCT01701362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362243|NCT01701362|Anticonvulsants|anticonvulsants|mesh-ancestor
102362244|NCT01701362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102362245|NCT01701362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102362246|NCT01701362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362247|NCT01701362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102362248|NCT01701362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102362249|NCT01701362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102362250|NCT01701362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102362251|NCT01701362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102362252|NCT00919126|Xenon|xenon|mesh-list
102362253|NCT00919126|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102362254|NCT00919126|Anesthetics, General|anesthetics, general|mesh-ancestor
102362255|NCT00919126|Anesthetics|anesthetics|mesh-ancestor
102362256|NCT00919126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102362257|NCT00919126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362258|NCT01710800|Esomeprazole|esomeprazole|mesh-list
102362259|NCT01710800|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102362260|NCT01710800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102362261|NCT01710800|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102362262|NCT01710800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102362263|NCT01710800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362264|NCT01710020|Tofacitinib|tofacitinib|mesh-list
102362265|NCT01710020|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102362266|NCT01710020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102362267|NCT01710020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102362268|NCT01710020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362269|NCT02982850|Aspirin|aspirin|mesh-list
102362270|NCT02982850|Warfarin|warfarin|mesh-list
102362271|NCT02982850|Dabigatran|dabigatran|mesh-list
102362272|NCT02982850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102362273|NCT02982850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102362274|NCT02982850|Analgesics|analgesics|mesh-ancestor
102362275|NCT02982850|Sensory System Agents|sensory system agents|mesh-ancestor
102362276|NCT02982850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102362277|NCT02982850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362278|NCT02982850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102362279|NCT02982850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102362280|NCT02982850|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102362281|NCT02982850|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102362282|NCT02982850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362283|NCT02982850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102362284|NCT02982850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102362285|NCT02982850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102362286|NCT02982850|Antipyretics|antipyretics|mesh-ancestor
102362287|NCT02982850|Anticoagulants|anticoagulants|mesh-ancestor
102362288|NCT02982850|Antithrombins|antithrombins|mesh-ancestor
102362289|NCT02982850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102362290|NCT02982850|Protease Inhibitors|protease inhibitors|mesh-ancestor
102362291|NCT02242240|Formoterol Fumarate|formoterol fumarate|mesh-list
102362292|NCT02242240|Tiotropium Bromide|tiotropium bromide|mesh-list
102362293|NCT02242240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102362294|NCT02242240|Autonomic Agents|autonomic agents|mesh-ancestor
102362295|NCT02242240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102362296|NCT02242240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362297|NCT02242240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102362298|NCT02242240|Respiratory System Agents|respiratory system agents|mesh-ancestor
102362299|NCT02242240|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102362300|NCT02242240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102362301|NCT02242240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102362302|NCT02242240|Adrenergic Agents|adrenergic agents|mesh-ancestor
102362303|NCT02242240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102362304|NCT02242240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362305|NCT02242240|Parasympatholytics|parasympatholytics|mesh-ancestor
102362306|NCT02242240|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102362307|NCT02242240|Cholinergic Agents|cholinergic agents|mesh-ancestor
102154169|NCT03606577|Dexamethasone|dexamethasone|mesh-list
102362308|NCT03403972|Vancomycin|vancomycin|mesh-list
102362309|NCT03403972|Simvastatin|simvastatin|mesh-list
102362310|NCT03403972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102362311|NCT03403972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102362312|NCT03403972|Antimetabolites|antimetabolites|mesh-ancestor
102362313|NCT03403972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362314|NCT03403972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102362315|NCT03403972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102362316|NCT03403972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102362317|NCT03403972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102362318|NCT03403972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102362319|NCT02242318|Valsartan|valsartan|mesh-list
102362320|NCT02242318|Telmisartan|telmisartan|mesh-list
102362321|NCT02242318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102362322|NCT02242318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102362323|NCT02242318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102362324|NCT02242318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362325|NCT01700192|Mometasone Furoate|mometasone furoate|mesh-list
102362326|NCT01700192|Loratadine|loratadine|mesh-list
102362327|NCT01700192|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
102362328|NCT01700192|Epinephrine|epinephrine|mesh-list
102362329|NCT01700192|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102362330|NCT01700192|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102362331|NCT01700192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102362332|NCT01700192|Adrenergic Agents|adrenergic agents|mesh-ancestor
102362333|NCT01700192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102362334|NCT01700192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362335|NCT01700192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362336|NCT01700192|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102362337|NCT01700192|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102362338|NCT01700192|Autonomic Agents|autonomic agents|mesh-ancestor
102362339|NCT01700192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102362340|NCT01700192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102362341|NCT01700192|Respiratory System Agents|respiratory system agents|mesh-ancestor
102362342|NCT01700192|Mydriatics|mydriatics|mesh-ancestor
102362343|NCT01700192|Sympathomimetics|sympathomimetics|mesh-ancestor
102362344|NCT01700192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102362345|NCT01700192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102362346|NCT01700192|Dermatologic Agents|dermatologic agents|mesh-ancestor
102362347|NCT01700192|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102362348|NCT01700192|Antipruritics|antipruritics|mesh-ancestor
102362349|NCT01700192|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102362350|NCT01700192|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102362351|NCT01700192|Histamine Antagonists|histamine antagonists|mesh-ancestor
102362352|NCT01700192|Histamine Agents|histamine agents|mesh-ancestor
102362353|NCT01700192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102362354|NCT01700192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102362355|NCT01700192|Analgesics|analgesics|mesh-ancestor
102362356|NCT01700192|Sensory System Agents|sensory system agents|mesh-ancestor
102362357|NCT01700192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102362358|NCT01700192|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102362359|NCT02242396|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102362360|NCT02242396|Telmisartan|telmisartan|mesh-list
102362361|NCT02242396|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
102362362|NCT02242396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102362363|NCT02242396|Diuretics|diuretics|mesh-ancestor
102362364|NCT02242396|Natriuretic Agents|natriuretic agents|mesh-ancestor
102362365|NCT02242396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362366|NCT02242396|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101894188|NCT00354107|Methotrexate|methotrexate|mesh-list
102362367|NCT02242396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102362368|NCT02242396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362369|NCT02242396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102362370|NCT02242396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102362371|NCT02242474|Adalimumab|adalimumab|mesh-list
102362372|NCT02242474|Infliximab|infliximab|mesh-list
102362373|NCT02242474|Golimumab|golimumab|mesh-list
102362374|NCT02242474|Certolizumab Pegol|certolizumab pegol|mesh-list
102362375|NCT02242474|Etanercept|etanercept|mesh-list
102362376|NCT02242474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102362377|NCT02242474|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102362378|NCT02242474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102362379|NCT02242474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102362380|NCT02242474|Dermatologic Agents|dermatologic agents|mesh-ancestor
102362381|NCT02242474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102362382|NCT02242474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102362383|NCT02242474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102362384|NCT02242474|Analgesics|analgesics|mesh-ancestor
102362385|NCT02242474|Sensory System Agents|sensory system agents|mesh-ancestor
102362386|NCT02242474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102362387|NCT02242474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362388|NCT02242474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102362389|NCT02242474|Immunologic Factors|immunologic factors|mesh-ancestor
102362390|NCT01709864|Glycopyrrolate|glycopyrrolate|mesh-list
102362391|NCT01709864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102362392|NCT01709864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102362393|NCT01709864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102362394|NCT01709864|Cholinergic Agents|cholinergic agents|mesh-ancestor
102362395|NCT01709864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102362396|NCT01709864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362397|NCT01709864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362398|NCT04878315|Captopril|captopril|mesh-list
102362399|NCT04878315|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102362400|NCT04878315|Protease Inhibitors|protease inhibitors|mesh-ancestor
102362401|NCT04878315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102362402|NCT04878315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362403|NCT04878315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102362404|NCT04374604|Mitogens|mitogens|mesh-list
102362405|NCT04374604|Mitosis Modulators|mitosis modulators|mesh-ancestor
102362406|NCT04374604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362407|NCT02242864|Telmisartan|telmisartan|mesh-list
102362408|NCT02242864|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
102362409|NCT02242864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102362410|NCT02242864|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102362411|NCT02242864|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102362412|NCT02242864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362413|NCT02242864|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102362414|NCT02242864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102362415|NCT02242864|Diuretics|diuretics|mesh-ancestor
102362416|NCT02242864|Natriuretic Agents|natriuretic agents|mesh-ancestor
102362417|NCT02242864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362418|NCT01709708|Bupivacaine|bupivacaine|mesh-list
102362419|NCT01709708|Anesthetics, Local|anesthetics, local|mesh-ancestor
102362420|NCT01709708|Anesthetics|anesthetics|mesh-ancestor
102362421|NCT01709708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102362422|NCT01709708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362423|NCT01709708|Sensory System Agents|sensory system agents|mesh-ancestor
102362424|NCT01709708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102362425|NCT02243098|Digoxin|digoxin|mesh-list
102362426|NCT02243098|Atorvastatin|atorvastatin|mesh-list
102362427|NCT02243098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102362428|NCT02243098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102362429|NCT02243098|Antimetabolites|antimetabolites|mesh-ancestor
102362430|NCT02243098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362431|NCT02243098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102362432|NCT02243098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102362433|NCT02243098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102362434|NCT02243098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102362435|NCT02243098|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102362436|NCT02243098|Protective Agents|protective agents|mesh-ancestor
102362437|NCT02243098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362438|NCT02845323|Nivolumab|nivolumab|mesh-list
102362439|NCT02845323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102362440|NCT02845323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102362441|NCT02845323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102362442|NCT02845323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362443|NCT05289063|Atorvastatin|atorvastatin|mesh-list
102362444|NCT05289063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102362445|NCT05289063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102362446|NCT05289063|Antimetabolites|antimetabolites|mesh-ancestor
102362447|NCT05289063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362448|NCT05289063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102362449|NCT05289063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102362450|NCT05289063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102362451|NCT01709318|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102362452|NCT01709318|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102362453|NCT01709318|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102362454|NCT01709318|Etonogestrel|etonogestrel|mesh-list
102362455|NCT01709318|Estradiol|estradiol|mesh-list
102154170|NCT03606577|Lenalidomide|lenalidomide|mesh-list
102362456|NCT01709318|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102362457|NCT01709318|Estrogens|estrogens|mesh-ancestor
102362459|NCT01709318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102362460|NCT01709318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362461|NCT01709318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102362462|NCT01709318|Contraceptive Agents|contraceptive agents|mesh-ancestor
102362463|NCT01709318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102362464|NCT01709318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102362465|NCT01709318|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102362466|NCT01709318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102362467|NCT02243254|Ibuprofen|ibuprofen|mesh-list
102362468|NCT02243254|Remifentanil|remifentanil|mesh-list
102362469|NCT02243254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102362470|NCT02243254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102362471|NCT02243254|Analgesics|analgesics|mesh-ancestor
102362472|NCT02243254|Sensory System Agents|sensory system agents|mesh-ancestor
102362473|NCT02243254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102362474|NCT02243254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362475|NCT02243254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102362476|NCT02243254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102362477|NCT02243254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102362478|NCT02243254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102362479|NCT02243254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362480|NCT02243254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102362481|NCT02243254|Narcotics|narcotics|mesh-ancestor
102362482|NCT02243254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102362483|NCT03402880|Pembrolizumab|pembrolizumab|mesh-list
102362484|NCT03402880|Immunoglobulins|immunoglobulins|mesh-list
102362485|NCT03402880|Immunoglobulin G|immunoglobulin g|mesh-list
102362486|NCT03402880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102362487|NCT03402880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102362488|NCT03402880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102362489|NCT03402880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362490|NCT03402880|Immunologic Factors|immunologic factors|mesh-ancestor
102362491|NCT03402880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362492|NCT01673997|Metoprolol|metoprolol|mesh-list
102362493|NCT01673997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102362494|NCT01673997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102362495|NCT01673997|Sympatholytics|sympatholytics|mesh-ancestor
102362496|NCT01673997|Autonomic Agents|autonomic agents|mesh-ancestor
102362497|NCT01673997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102362498|NCT01673997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362499|NCT01673997|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102362500|NCT01673997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102362501|NCT01673997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102362502|NCT01673997|Adrenergic Agents|adrenergic agents|mesh-ancestor
102362503|NCT01673997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102362504|NCT01673997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362505|NCT04373824|Ivermectin|ivermectin|mesh-list
102362506|NCT04373824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102362507|NCT04373824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102362508|NCT01676571|Vortioxetine|vortioxetine|mesh-list
102362509|NCT01676571|Antidepressive Agents|antidepressive agents|mesh-ancestor
102362510|NCT01676571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102362511|NCT01676571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102362512|NCT01676571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102362513|NCT01676571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102362514|NCT01676571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362515|NCT01676571|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102362516|NCT01676571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102362517|NCT01676571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102362518|NCT01676571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362519|NCT01676571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102362520|NCT01676571|Serotonin Agents|serotonin agents|mesh-ancestor
102362521|NCT01676571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102362522|NCT01676571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102362523|NCT01676571|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102362524|NCT01676571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102362525|NCT01699178|Methyltestosterone|methyltestosterone|mesh-list
102362526|NCT01699178|Testosterone|testosterone|mesh-list
102362527|NCT01699178|Testosterone undecanoate|testosterone undecanoate|mesh-list
102154171|NCT03606577|Daratumumab|daratumumab|mesh-list
102362528|NCT01699178|Testosterone enanthate|testosterone enanthate|mesh-list
102362529|NCT01699178|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102362530|NCT01699178|Androgens|androgens|mesh-ancestor
102362532|NCT01699178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102362533|NCT01699178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362534|NCT01699178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102362535|NCT01699178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102362536|NCT01699178|Anabolic Agents|anabolic agents|mesh-ancestor
102362537|NCT02077959|Lenalidomide|lenalidomide|mesh-list
102362538|NCT02077959|Pidilizumab|pidilizumab|mesh-list
102362539|NCT02077959|Immunologic Factors|immunologic factors|mesh-ancestor
102362540|NCT02077959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362541|NCT02077959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102362542|NCT02077959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102362543|NCT02077959|Growth Substances|growth substances|mesh-ancestor
102362544|NCT02077959|Growth Inhibitors|growth inhibitors|mesh-ancestor
102362545|NCT02077959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102362546|NCT02077959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102362547|NCT04548518|Vaccines|vaccines|mesh-list
102362548|NCT04548518|Immunologic Factors|immunologic factors|mesh-ancestor
102362549|NCT04548518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362550|NCT01699022|CycloProvera|cycloprovera|mesh-list
102362551|NCT01699022|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102362552|NCT01699022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102362553|NCT01699022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102362554|NCT01699022|Contraceptive Agents|contraceptive agents|mesh-ancestor
102362555|NCT01699022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102362556|NCT01699022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362557|NCT01699022|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102362558|NCT01699022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102362559|NCT01670175|Sirolimus|sirolimus|mesh-list
102362560|NCT01670175|Cyclophosphamide|cyclophosphamide|mesh-list
102362561|NCT01670175|Topotecan|topotecan|mesh-list
102362562|NCT01670175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102362563|NCT01670175|Immunologic Factors|immunologic factors|mesh-ancestor
102362564|NCT01670175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362565|NCT01670175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102362566|NCT01670175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102362567|NCT01670175|Alkylating Agents|alkylating agents|mesh-ancestor
102362568|NCT01670175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362569|NCT01670175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102362570|NCT01670175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102362571|NCT01670175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102362572|NCT01670175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102362573|NCT01670175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102362574|NCT01670175|Antifungal Agents|antifungal agents|mesh-ancestor
102362575|NCT01670175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102362576|NCT01670175|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102362577|NCT01670175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102362578|NCT02243566|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102362579|NCT02243566|Telmisartan|telmisartan|mesh-list
102362580|NCT02243566|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
102362581|NCT02243566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102362582|NCT02243566|Diuretics|diuretics|mesh-ancestor
102362583|NCT02243566|Natriuretic Agents|natriuretic agents|mesh-ancestor
102362584|NCT02243566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362585|NCT02243566|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102362586|NCT02243566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102362587|NCT02243566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362588|NCT02243566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102362589|NCT02243566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102362590|NCT02243644|Albendazole|albendazole|mesh-list
102362591|NCT02243644|Anthelmintics|anthelmintics|mesh-ancestor
102362592|NCT02243644|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102362593|NCT02243644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102362594|NCT02243644|Anticestodal Agents|anticestodal agents|mesh-ancestor
102362595|NCT02243644|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102362596|NCT02243644|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102362597|NCT02243644|Tubulin Modulators|tubulin modulators|mesh-ancestor
102362598|NCT02243644|Antimitotic Agents|antimitotic agents|mesh-ancestor
102362599|NCT02243644|Mitosis Modulators|mitosis modulators|mesh-ancestor
102362600|NCT02243644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174331|NCT02063789|Immunoglobulins|immunoglobulins|mesh-list
102362601|NCT02243644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102362602|NCT01988883|Propranolol|propranolol|mesh-list
102362603|NCT01988883|Modafinil|modafinil|mesh-list
102362604|NCT01988883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102362605|NCT01988883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102362606|NCT01988883|Adrenergic Agents|adrenergic agents|mesh-ancestor
102362607|NCT01988883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102362608|NCT01988883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362609|NCT01988883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362610|NCT01988883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102362611|NCT01988883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102362612|NCT01988883|Vasodilator Agents|vasodilator agents|mesh-ancestor
102362613|NCT01988883|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102362614|NCT01988883|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102362615|NCT01988883|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102362616|NCT01988883|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102362617|NCT04373356|Listerine|listerine|mesh-list
102362618|NCT04373356|Fluorides|fluorides|mesh-list
102362619|NCT04373356|Sodium Fluoride|sodium fluoride|mesh-list
102362620|NCT04373356|Fluorides, Topical|fluorides, topical|mesh-list
102362621|NCT04373356|Cariostatic Agents|cariostatic agents|mesh-ancestor
102362622|NCT04373356|Protective Agents|protective agents|mesh-ancestor
102362623|NCT04373356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362624|NCT04373356|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102362625|NCT04373356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102362626|NCT01745757|Paclitaxel|paclitaxel|mesh-list
102362627|NCT01745757|Bevacizumab|bevacizumab|mesh-list
102362628|NCT01745757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102362629|NCT01745757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102362630|NCT01745757|Tubulin Modulators|tubulin modulators|mesh-ancestor
102362631|NCT01745757|Antimitotic Agents|antimitotic agents|mesh-ancestor
102362632|NCT01745757|Mitosis Modulators|mitosis modulators|mesh-ancestor
102362633|NCT01745757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362634|NCT01745757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102362635|NCT01745757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102362636|NCT01745757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102362637|NCT01745757|Growth Substances|growth substances|mesh-ancestor
102362638|NCT01745757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362639|NCT01745757|Growth Inhibitors|growth inhibitors|mesh-ancestor
102362640|NCT01709162|Ipilimumab|ipilimumab|mesh-list
102362641|NCT01709162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102362642|NCT01709162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102362643|NCT01709162|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102362644|NCT01709162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362645|NCT02243800|Cholecalciferol|cholecalciferol|mesh-list
102362646|NCT02243800|Vitamin D|vitamin d|mesh-list
102362647|NCT02243800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102362648|NCT02243800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362649|NCT02243800|Vitamins|vitamins|mesh-ancestor
102362650|NCT02243800|Micronutrients|micronutrients|mesh-ancestor
102362651|NCT02243800|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102362652|NCT03402100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102362653|NCT03402100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102362654|NCT04764045|Ropivacaine|ropivacaine|mesh-list
102362655|NCT04764045|Anesthetics, Local|anesthetics, local|mesh-ancestor
102362656|NCT04764045|Anesthetics|anesthetics|mesh-ancestor
102362657|NCT04764045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102362658|NCT04764045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362659|NCT04764045|Sensory System Agents|sensory system agents|mesh-ancestor
102362660|NCT04764045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102362661|NCT01698554|Bimatoprost|bimatoprost|mesh-list
102362662|NCT01698554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102362663|NCT01698554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102362664|NCT04404855|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102362665|NCT04404855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102362666|NCT00895791|Umirolimus|umirolimus|mesh-list
102362667|NCT00895791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102362668|NCT00895791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102362669|NCT00895791|Immunologic Factors|immunologic factors|mesh-ancestor
102362670|NCT00895791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362671|NCT01698320|Albuterol|albuterol|mesh-list
102362672|NCT01698320|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102362673|NCT01698320|Autonomic Agents|autonomic agents|mesh-ancestor
102362674|NCT01698320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102362675|NCT01698320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362676|NCT01698320|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102362677|NCT01698320|Respiratory System Agents|respiratory system agents|mesh-ancestor
102362679|NCT01698320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102362680|NCT01698320|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102362681|NCT01698320|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102362682|NCT01698320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102362683|NCT01698320|Adrenergic Agents|adrenergic agents|mesh-ancestor
102362684|NCT01698320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102362685|NCT01698320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362686|NCT03401476|Morphine|morphine|mesh-list
102362687|NCT03401476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102362688|NCT03401476|Narcotics|narcotics|mesh-ancestor
102362689|NCT03401476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102362690|NCT03401476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362691|NCT03401476|Analgesics|analgesics|mesh-ancestor
102362692|NCT03401476|Sensory System Agents|sensory system agents|mesh-ancestor
102362693|NCT03401476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102362694|NCT01674777|Ipragliflozin|ipragliflozin|mesh-list
102362695|NCT01674777|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102362696|NCT01674777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362697|NCT01674777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102362698|NCT01674777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362699|NCT03876717|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
102362700|NCT03876717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102362701|NCT03876717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102362702|NCT03876717|Antimetabolites|antimetabolites|mesh-ancestor
102362703|NCT03876717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362704|NCT03876717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102362705|NCT01674855|Lenograstim|lenograstim|mesh-list
102362706|NCT01674855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102362707|NCT01674855|Immunologic Factors|immunologic factors|mesh-ancestor
102362708|NCT01674855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362709|NCT03854799|Capecitabine|capecitabine|mesh-list
102362710|NCT03854799|Avelumab|avelumab|mesh-list
102362711|NCT03854799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102362712|NCT03854799|Antimetabolites|antimetabolites|mesh-ancestor
102362713|NCT03854799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362714|NCT03854799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102362715|NCT03854799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102362716|NCT00924352|Dasatinib|dasatinib|mesh-list
102362717|NCT00924352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102362718|NCT00924352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102362719|NCT00924352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102362720|NCT00924352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362721|NCT01674933|Listerine|listerine|mesh-list
102362722|NCT01674933|Fluorides|fluorides|mesh-list
102362723|NCT01674933|Fluorides, Topical|fluorides, topical|mesh-list
102362724|NCT01674933|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
102362725|NCT01674933|Sodium Fluoride|sodium fluoride|mesh-list
102362726|NCT01674933|Cariostatic Agents|cariostatic agents|mesh-ancestor
102362727|NCT01674933|Protective Agents|protective agents|mesh-ancestor
102362728|NCT01674933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362729|NCT01674933|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102362730|NCT01674933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102362731|NCT04373044|Hydroxychloroquine|hydroxychloroquine|mesh-list
102362732|NCT04373044|Antimalarials|antimalarials|mesh-ancestor
102362733|NCT04373044|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102362734|NCT04373044|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102362735|NCT04373044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102362736|NCT04373044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102362737|NCT04373044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362738|NCT04373044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102362739|NCT01675089|Zoledronic Acid|zoledronic acid|mesh-list
102362740|NCT01675089|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102362741|NCT01675089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362742|NCT01697696|Glycopyrrolate|glycopyrrolate|mesh-list
102362743|NCT01697696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102362744|NCT01697696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102362745|NCT01697696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102362746|NCT01697696|Cholinergic Agents|cholinergic agents|mesh-ancestor
102362747|NCT01697696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102362748|NCT01697696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362749|NCT01697696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362750|NCT01569152|Methotrexate|methotrexate|mesh-list
102362751|NCT01569152|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102362752|NCT01569152|Abortifacient Agents|abortifacient agents|mesh-ancestor
102362753|NCT01569152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102362754|NCT01569152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362755|NCT01569152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102362756|NCT01569152|Antimetabolites|antimetabolites|mesh-ancestor
102362757|NCT01569152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362758|NCT01569152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102362759|NCT01569152|Dermatologic Agents|dermatologic agents|mesh-ancestor
102362760|NCT01569152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102362761|NCT01569152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102362762|NCT01569152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102362763|NCT01569152|Immunologic Factors|immunologic factors|mesh-ancestor
102362764|NCT01569152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102362765|NCT01569152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102362766|NCT01675557|Vitamin D|vitamin d|mesh-list
102362767|NCT01675557|Ergocalciferols|ergocalciferols|mesh-list
102362768|NCT01675557|Cholecalciferol|cholecalciferol|mesh-list
102362769|NCT01675557|Vitamins|vitamins|mesh-list
102362770|NCT01675557|Micronutrients|micronutrients|mesh-ancestor
102362771|NCT01675557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362772|NCT01675557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102362773|NCT01675557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102362774|NCT01675947|Sirolimus|sirolimus|mesh-list
102362775|NCT01675947|Lidocaine|lidocaine|mesh-list
102362776|NCT01675947|Anesthetics, Local|anesthetics, local|mesh-ancestor
102362777|NCT01675947|Anesthetics|anesthetics|mesh-ancestor
102362778|NCT01675947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102362779|NCT01675947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362780|NCT01675947|Sensory System Agents|sensory system agents|mesh-ancestor
102362781|NCT01675947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102362782|NCT01675947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102362783|NCT01675947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102362784|NCT01675947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102362785|NCT01675947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102362786|NCT01675947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362787|NCT01675947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102362788|NCT01675947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102362789|NCT01675947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102362790|NCT01675947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102362791|NCT01675947|Antifungal Agents|antifungal agents|mesh-ancestor
102362792|NCT01675947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102362793|NCT01675947|Immunologic Factors|immunologic factors|mesh-ancestor
102362794|NCT03748953|Ixazomib|ixazomib|mesh-list
102362795|NCT03748953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102362796|NCT03748953|Protease Inhibitors|protease inhibitors|mesh-ancestor
102362797|NCT03748953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102362798|NCT03748953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362799|NCT01567826|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102362800|NCT01567826|Atorvastatin|atorvastatin|mesh-list
102362801|NCT01567826|Simvastatin|simvastatin|mesh-list
102362802|NCT01567826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102362803|NCT01567826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102362804|NCT01567826|Antimetabolites|antimetabolites|mesh-ancestor
102362805|NCT01567826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362806|NCT01567826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102362807|NCT01567826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102362808|NCT01567826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102362809|NCT03743025|Dulaglutide|dulaglutide|mesh-list
102362810|NCT03743025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102362811|NCT03743025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362812|NCT03742245|Olaparib|olaparib|mesh-list
102362813|NCT03742245|Vorinostat|vorinostat|mesh-list
102362814|NCT03742245|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102362815|NCT03742245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102362816|NCT03742245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362817|NCT03742245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102362818|NCT03742245|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102362819|NCT02083107|Misoprostol|misoprostol|mesh-list
102362820|NCT02083107|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102362821|NCT02083107|Abortifacient Agents|abortifacient agents|mesh-ancestor
102362822|NCT02083107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102362823|NCT02083107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362824|NCT02083107|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102362825|NCT02083107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102362826|NCT02083107|Oxytocics|oxytocics|mesh-ancestor
102362827|NCT02335905|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
102362828|NCT02335905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102362829|NCT02335905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102362830|NCT00925756|Maraviroc|maraviroc|mesh-list
102362831|NCT00925756|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102362832|NCT00925756|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102362833|NCT00925756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362834|NCT00925756|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102362835|NCT00925756|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102362836|NCT00925756|Antiviral Agents|antiviral agents|mesh-ancestor
102362837|NCT00925756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102362838|NCT00925756|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102362839|NCT04372732|Autoantibodies|autoantibodies|mesh-list
102362840|NCT04372732|Immunologic Factors|immunologic factors|mesh-ancestor
102362841|NCT04372732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362842|NCT02245126|Lidocaine|lidocaine|mesh-list
102362843|NCT02245126|Bupivacaine|bupivacaine|mesh-list
102362844|NCT02245126|Anesthetics, Local|anesthetics, local|mesh-ancestor
102362845|NCT02245126|Anesthetics|anesthetics|mesh-ancestor
102362846|NCT02245126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102362847|NCT02245126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362848|NCT02245126|Sensory System Agents|sensory system agents|mesh-ancestor
102362849|NCT02245126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102362850|NCT02245126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102362851|NCT02245126|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102362852|NCT02245126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102362853|NCT02245126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102362854|NCT02245126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362855|NCT04372342|Remifentanil|remifentanil|mesh-list
102362856|NCT04372342|Nalbuphine|nalbuphine|mesh-list
102362857|NCT04372342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102362858|NCT04372342|Narcotics|narcotics|mesh-ancestor
102362859|NCT04372342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102362860|NCT04372342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362861|NCT04372342|Analgesics|analgesics|mesh-ancestor
102362862|NCT04372342|Sensory System Agents|sensory system agents|mesh-ancestor
102362863|NCT04372342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102362864|NCT04372264|Acetaminophen|acetaminophen|mesh-list
102362865|NCT04372264|Ibuprofen|ibuprofen|mesh-list
102362866|NCT04372264|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
102362867|NCT04372264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102362868|NCT04372264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102362869|NCT04372264|Analgesics|analgesics|mesh-ancestor
102362870|NCT04372264|Sensory System Agents|sensory system agents|mesh-ancestor
102362871|NCT04372264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102362872|NCT04372264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362873|NCT04372264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102362874|NCT04372264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102362875|NCT04372264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102362876|NCT04372264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102362877|NCT04372264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362878|NCT04372264|Antipyretics|antipyretics|mesh-ancestor
102362879|NCT02083809|Oxytocin|oxytocin|mesh-list
102362880|NCT02083809|Oxytocics|oxytocics|mesh-ancestor
102362881|NCT02083809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102362882|NCT02083809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362883|NCT02244112|Midazolam|midazolam|mesh-list
102362884|NCT02244112|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102362885|NCT02244112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102362886|NCT02244112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102362887|NCT02244112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362888|NCT02244112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102362889|NCT02244112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102362890|NCT02244112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102362891|NCT02244112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102362892|NCT02244112|Anesthetics, General|anesthetics, general|mesh-ancestor
102362893|NCT02244112|Anesthetics|anesthetics|mesh-ancestor
102362894|NCT02244112|GABA Modulators|gaba modulators|mesh-ancestor
102362895|NCT02244112|GABA Agents|gaba agents|mesh-ancestor
102362896|NCT02244112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102362897|NCT02244112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362898|NCT02244190|Ritonavir|ritonavir|mesh-list
102362899|NCT02244190|Tipranavir|tipranavir|mesh-list
102174620|NCT04964180|Lidocaine|lidocaine|mesh-list
102362900|NCT02244190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102362901|NCT02244190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102362902|NCT02244190|Protease Inhibitors|protease inhibitors|mesh-ancestor
102362903|NCT02244190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102362904|NCT02244190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362905|NCT02244190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102362906|NCT02244190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102362907|NCT02244190|Antiviral Agents|antiviral agents|mesh-ancestor
102362908|NCT02244190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102362909|NCT02244190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102362910|NCT02244190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102362911|NCT00926380|Denosumab|denosumab|mesh-list
102362912|NCT00926380|Teriparatide|teriparatide|mesh-list
102362913|NCT00926380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102362914|NCT00926380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362915|NCT00926380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102362916|NCT02244268|Tamsulosin|tamsulosin|mesh-list
102362917|NCT02244268|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102362918|NCT02244268|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102362919|NCT02244268|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102362920|NCT02244268|Adrenergic Agents|adrenergic agents|mesh-ancestor
102362921|NCT02244268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102362922|NCT02244268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362923|NCT02244268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362924|NCT02244268|Urological Agents|urological agents|mesh-ancestor
102362925|NCT03630315|Bevacizumab|bevacizumab|mesh-list
102362926|NCT03630315|Ranibizumab|ranibizumab|mesh-list
102362927|NCT03630315|Aflibercept|aflibercept|mesh-list
102362928|NCT03630315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102362929|NCT03630315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102362930|NCT03630315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102362931|NCT03630315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102362932|NCT03630315|Growth Substances|growth substances|mesh-ancestor
102362933|NCT03630315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362934|NCT03630315|Growth Inhibitors|growth inhibitors|mesh-ancestor
102362935|NCT00929344|Pregabalin|pregabalin|mesh-list
102362936|NCT00929344|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102362937|NCT00929344|Analgesics|analgesics|mesh-ancestor
102362938|NCT00929344|Sensory System Agents|sensory system agents|mesh-ancestor
102362939|NCT00929344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102362940|NCT00929344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362941|NCT00929344|Anticonvulsants|anticonvulsants|mesh-ancestor
102362942|NCT00929344|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102362943|NCT00929344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102362944|NCT00929344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362945|NCT00929344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102362946|NCT00929344|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102362947|NCT00929344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102362948|NCT00929344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102362949|NCT00929344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102362950|NCT00929344|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102362951|NCT00929344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102362952|NCT00929344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102362953|NCT00929344|Antidepressive Agents|antidepressive agents|mesh-ancestor
102362954|NCT00929344|Dopamine Agents|dopamine agents|mesh-ancestor
102362955|NCT03630159|Pembrolizumab|pembrolizumab|mesh-list
102362956|NCT03630159|Tisagenlecleucel|tisagenlecleucel|mesh-list
102362957|NCT03630159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102362958|NCT03630159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102362959|NCT03630159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102362960|NCT03630159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362961|NCT04371874|Aspirin|aspirin|mesh-list
102362962|NCT04371874|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102362963|NCT04371874|Captopril|captopril|mesh-list
102362964|NCT04371874|Nitrendipine|nitrendipine|mesh-list
102362965|NCT04371874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102362966|NCT04371874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102362967|NCT04371874|Analgesics|analgesics|mesh-ancestor
102362968|NCT04371874|Sensory System Agents|sensory system agents|mesh-ancestor
102362969|NCT04371874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102362970|NCT04371874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362971|NCT04371874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102362972|NCT04371874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102174696|NCT03060044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102362973|NCT04371874|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102362974|NCT04371874|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102362975|NCT04371874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102362976|NCT04371874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102362977|NCT04371874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102362978|NCT04371874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102362980|NCT04371874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102362981|NCT04371874|Diuretics|diuretics|mesh-ancestor
102362982|NCT04371874|Natriuretic Agents|natriuretic agents|mesh-ancestor
102362983|NCT04371874|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102362984|NCT04371874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102362985|NCT04371874|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102362986|NCT04371874|Protease Inhibitors|protease inhibitors|mesh-ancestor
102362987|NCT04371874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102362988|NCT04371874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102362989|NCT04371874|Vasodilator Agents|vasodilator agents|mesh-ancestor
102362990|NCT03629223|Tepotinib|tepotinib|mesh-list
102362991|NCT03629223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102362992|NCT03720717|Baclofen|baclofen|mesh-list
102362993|NCT03720717|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102362994|NCT03720717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102362995|NCT03720717|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102362996|NCT03720717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102362997|NCT03720717|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102362998|NCT03720717|GABA Agonists|gaba agonists|mesh-ancestor
102362999|NCT03720717|GABA Agents|gaba agents|mesh-ancestor
102363000|NCT03720717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102363001|NCT03720717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363002|NCT04376554|Amoxicillin|amoxicillin|mesh-list
102363003|NCT04376554|Clavulanic Acid|clavulanic acid|mesh-list
102363004|NCT04376554|Clavulanic Acids|clavulanic acids|mesh-list
102363005|NCT04376554|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102363006|NCT04376554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102363007|NCT04376554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102363008|NCT04376554|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102363009|NCT04376554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102363010|NCT04376554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363011|NCT03627741|Triamcinolone|triamcinolone|mesh-list
102363012|NCT03627741|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102363013|NCT03627741|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102363014|NCT03627741|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102363015|NCT03627741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102363016|NCT03627741|Glucocorticoids|glucocorticoids|mesh-ancestor
102363017|NCT03627741|Hormones|hormones|mesh-ancestor
102363018|NCT03627741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102363019|NCT03627741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363020|NCT03627741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102363021|NCT03627741|Immunologic Factors|immunologic factors|mesh-ancestor
102363022|NCT03627741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102363023|NCT03627741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363024|NCT03626337|Thiamine|thiamine|mesh-list
102363025|NCT03626337|Vitamin B Complex|vitamin b complex|mesh-ancestor
102363026|NCT03626337|Vitamins|vitamins|mesh-ancestor
102363027|NCT03626337|Micronutrients|micronutrients|mesh-ancestor
102363028|NCT03626337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363029|NCT00929578|Fluphenazine|fluphenazine|mesh-list
102363030|NCT00929578|Fluphenazine depot|fluphenazine depot|mesh-list
102363031|NCT00929578|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
102363032|NCT00929578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102363033|NCT00929578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102363034|NCT00929578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102363035|NCT00929578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363036|NCT00929578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102363037|NCT00929578|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102363038|NCT00929578|Dopamine Agents|dopamine agents|mesh-ancestor
102363039|NCT00929578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102363040|NCT00929578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363041|NCT04371406|Azithromycin|azithromycin|mesh-list
102363042|NCT04371406|Hydroxychloroquine|hydroxychloroquine|mesh-list
102363043|NCT04371406|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102363044|NCT04371406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102363045|NCT04371406|Antimalarials|antimalarials|mesh-ancestor
102363046|NCT04371406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102363047|NCT04371406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102363048|NCT04371406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102363049|NCT04371406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363050|NCT04371406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102363051|NCT03716739|Methyltestosterone|methyltestosterone|mesh-list
102363052|NCT03716739|Testosterone|testosterone|mesh-list
102363053|NCT03716739|Testosterone undecanoate|testosterone undecanoate|mesh-list
102363054|NCT03716739|Testosterone enanthate|testosterone enanthate|mesh-list
102363055|NCT03716739|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102363056|NCT03716739|Androgens|androgens|mesh-ancestor
102363057|NCT03716739|Hormones|hormones|mesh-ancestor
102363058|NCT03716739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102363059|NCT03716739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363060|NCT03716739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102363061|NCT03716739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101894893|NCT01122368|Micafungin|micafungin|mesh-list
102363062|NCT03716739|Anabolic Agents|anabolic agents|mesh-ancestor
102363063|NCT04763265|Botulinum Toxins|botulinum toxins|mesh-list
102363064|NCT04763265|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102363065|NCT04763265|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102363066|NCT04763265|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102363067|NCT04763265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102363068|NCT04763265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363069|NCT04763265|Cholinergic Agents|cholinergic agents|mesh-ancestor
102363070|NCT04763265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102363071|NCT04763265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363072|NCT04763265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102363073|NCT04763265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102363074|NCT00004143|Alemtuzumab|alemtuzumab|mesh-list
102363075|NCT00004143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102363076|NCT00004143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102363077|NCT03705429|Paclitaxel|paclitaxel|mesh-list
102363078|NCT03705429|Docetaxel|docetaxel|mesh-list
102363079|NCT03705429|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102363080|NCT03705429|Cyclophosphamide|cyclophosphamide|mesh-list
102363081|NCT03705429|Trastuzumab|trastuzumab|mesh-list
102363082|NCT03705429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102363083|NCT03705429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102363084|NCT03705429|Tubulin Modulators|tubulin modulators|mesh-ancestor
102363085|NCT03705429|Antimitotic Agents|antimitotic agents|mesh-ancestor
102363086|NCT03705429|Mitosis Modulators|mitosis modulators|mesh-ancestor
102363087|NCT03705429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363088|NCT03705429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102363089|NCT03705429|Immunologic Factors|immunologic factors|mesh-ancestor
102363090|NCT03705429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363091|NCT03705429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102363092|NCT03705429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102363093|NCT03705429|Alkylating Agents|alkylating agents|mesh-ancestor
102363094|NCT03705429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102363095|NCT03705429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102363096|NCT04370782|Azithromycin|azithromycin|mesh-list
102363097|NCT04370782|Doxycycline|doxycycline|mesh-list
102363098|NCT04370782|Hydroxychloroquine|hydroxychloroquine|mesh-list
102363099|NCT04370782|Zinc Sulfate|zinc sulfate|mesh-list
102363100|NCT04370782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102363101|NCT04370782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102363102|NCT04370782|Antimalarials|antimalarials|mesh-ancestor
102363103|NCT04370782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102363104|NCT04370782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102363105|NCT04370782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102363106|NCT04370782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363107|NCT04370782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102363108|NCT04370782|Astringents|astringents|mesh-ancestor
102363109|NCT04370782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363110|NCT04370782|Dermatologic Agents|dermatologic agents|mesh-ancestor
102363111|NCT03604653|Cisplatin|cisplatin|mesh-list
102363112|NCT03604653|Doxorubicin|doxorubicin|mesh-list
102363113|NCT03604653|Mitomycins|mitomycins|mesh-list
102363114|NCT03604653|Mitomycin|mitomycin|mesh-list
102363115|NCT03604653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102363116|NCT03604653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102363117|NCT03604653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102363118|NCT03604653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102363119|NCT03604653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102363120|NCT03604653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363121|NCT03604653|Alkylating Agents|alkylating agents|mesh-ancestor
102363122|NCT03604653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102363123|NCT04376086|Anesthetics|anesthetics|mesh-list
102363124|NCT04376086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102363125|NCT04376086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363126|NCT04375852|Autoantibodies|autoantibodies|mesh-list
102363127|NCT04375852|Immunologic Factors|immunologic factors|mesh-ancestor
102363128|NCT04375852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363129|NCT04364464|Riociguat|riociguat|mesh-list
102363130|NCT04364464|Enzyme Activators|enzyme activators|mesh-ancestor
102363131|NCT04364464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363132|NCT03600441|Abexinostat|abexinostat|mesh-list
102363133|NCT03600441|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102363134|NCT03600441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895000|NCT03710356|Danazol|danazol|mesh-list
102363135|NCT03600441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363136|NCT01592240|Bococizumab|bococizumab|mesh-list
102363137|NCT01592240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102363138|NCT01592240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102363139|NCT01592240|Antimetabolites|antimetabolites|mesh-ancestor
102363140|NCT01592240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363141|NCT01592240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102363142|NCT05620654|Paclitaxel|paclitaxel|mesh-list
102363143|NCT05620654|Cisplatin|cisplatin|mesh-list
102363144|NCT05620654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102363145|NCT05620654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102363146|NCT05620654|Tubulin Modulators|tubulin modulators|mesh-ancestor
102363147|NCT05620654|Antimitotic Agents|antimitotic agents|mesh-ancestor
102363148|NCT05620654|Mitosis Modulators|mitosis modulators|mesh-ancestor
102363149|NCT05620654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363150|NCT03692325|Nivolumab|nivolumab|mesh-list
102363151|NCT03692325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102363152|NCT03692325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102363153|NCT03692325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102363154|NCT03692325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363155|NCT04357522|Vaccines|vaccines|mesh-list
102363156|NCT04357522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102363157|NCT04357522|Immunologic Factors|immunologic factors|mesh-ancestor
102363158|NCT04357522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363159|NCT00005901|Pamidronate|pamidronate|mesh-list
102363160|NCT00005901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102363161|NCT00005901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363162|NCT04369534|Clopidogrel|clopidogrel|mesh-list
102363163|NCT04369534|Ticagrelor|ticagrelor|mesh-list
102363164|NCT04369534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102363165|NCT04369534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102363166|NCT04369534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102363167|NCT04369534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102363168|NCT04369534|Purinergic Agents|purinergic agents|mesh-ancestor
102363169|NCT04369534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102363170|NCT04369534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363171|NCT04369534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363172|NCT04363762|Salicylic Acid|salicylic acid|mesh-list
102363173|NCT04363762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102363174|NCT04363762|Antifungal Agents|antifungal agents|mesh-ancestor
102363175|NCT04363762|Keratolytic Agents|keratolytic agents|mesh-ancestor
102363176|NCT04363762|Dermatologic Agents|dermatologic agents|mesh-ancestor
102363177|NCT04363450|Hydroxychloroquine|hydroxychloroquine|mesh-list
102363178|NCT04363450|Antimalarials|antimalarials|mesh-ancestor
102363179|NCT04363450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102363180|NCT04363450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102363181|NCT04363450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102363182|NCT04363450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102363183|NCT04363450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363184|NCT04363450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102363185|NCT03685149|Flecainide|flecainide|mesh-list
102363186|NCT03685149|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102363187|NCT03685149|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102363188|NCT03685149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102363189|NCT03685149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102363190|NCT03685149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363191|NCT04370080|Fluorides|fluorides|mesh-list
102363192|NCT04370080|Cariostatic Agents|cariostatic agents|mesh-ancestor
102363193|NCT04370080|Protective Agents|protective agents|mesh-ancestor
102363194|NCT04370080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363195|NCT01591616|Lidocaine|lidocaine|mesh-list
102363196|NCT01591616|Prilocaine|prilocaine|mesh-list
102363197|NCT01591616|Anesthetics, Local|anesthetics, local|mesh-ancestor
102363198|NCT01591616|Anesthetics|anesthetics|mesh-ancestor
102363199|NCT01591616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102363204|NCT01591616|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102363205|NCT01591616|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102363206|NCT01591616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102363207|NCT01591616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363208|NCT00938314|Epoetin Alfa|epoetin alfa|mesh-list
102363209|NCT00938314|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102363210|NCT00938314|Hematinics|hematinics|mesh-ancestor
102363211|NCT00938314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102363212|NCT00938314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363217|NCT04370392|Anesthetics|anesthetics|mesh-list
102363218|NCT04370392|Anesthetics, Local|anesthetics, local|mesh-list
102363219|NCT04370392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102363220|NCT04370392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363221|NCT04370392|Sensory System Agents|sensory system agents|mesh-ancestor
102363222|NCT04370392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102363223|NCT04369222|Acetaminophen|acetaminophen|mesh-list
102363224|NCT04369222|Aspirin|aspirin|mesh-list
102363225|NCT04369222|Salicylic Acid|salicylic acid|mesh-list
102363226|NCT04369222|Salicylates|salicylates|mesh-list
102363227|NCT04369222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
102363228|NCT04369222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102363229|NCT04369222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102363230|NCT04369222|Analgesics|analgesics|mesh-ancestor
102363231|NCT04369222|Sensory System Agents|sensory system agents|mesh-ancestor
102363232|NCT04369222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102363233|NCT04369222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363234|NCT04369222|Antipyretics|antipyretics|mesh-ancestor
102363235|NCT04369222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102363236|NCT04369222|Antifungal Agents|antifungal agents|mesh-ancestor
102363237|NCT04369222|Keratolytic Agents|keratolytic agents|mesh-ancestor
102363238|NCT04369222|Dermatologic Agents|dermatologic agents|mesh-ancestor
102363239|NCT04369222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102363240|NCT04369222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102363241|NCT04369222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102363242|NCT04369222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363243|NCT04369222|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102363244|NCT04369222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102363245|NCT04369222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102363246|NCT03584373|Acetaminophen|acetaminophen|mesh-list
102363247|NCT03584373|Ketorolac|ketorolac|mesh-list
102363248|NCT03584373|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102363249|NCT03584373|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
102363250|NCT03584373|Oxycodone|oxycodone|mesh-list
102363251|NCT03584373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102363252|NCT03584373|Analgesics|analgesics|mesh-ancestor
102363253|NCT03584373|Sensory System Agents|sensory system agents|mesh-ancestor
102363254|NCT03584373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102363255|NCT03584373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363256|NCT03584373|Antipyretics|antipyretics|mesh-ancestor
102363257|NCT03584373|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102363258|NCT03584373|Narcotics|narcotics|mesh-ancestor
102363259|NCT03584373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102363260|NCT03584373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102363261|NCT03584373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102363262|NCT03584373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102363263|NCT03584373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102363264|NCT03584373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102363265|NCT03584373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363266|NCT01591460|Ribavirin|ribavirin|mesh-list
102363267|NCT01591460|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102363268|NCT01591460|Interferon-alpha|interferon-alpha|mesh-list
102363269|NCT01591460|Antimetabolites|antimetabolites|mesh-ancestor
102363270|NCT01591460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363271|NCT01591460|Antiviral Agents|antiviral agents|mesh-ancestor
102363272|NCT01591460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102363273|NCT01591460|Immunologic Factors|immunologic factors|mesh-ancestor
102174997|NCT03061136|Clonazepam|clonazepam|mesh-list
102363274|NCT01591460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363275|NCT04363216|Ascorbic Acid|ascorbic acid|mesh-list
102363277|NCT04363216|Micronutrients|micronutrients|mesh-ancestor
102363278|NCT04363216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363279|NCT04363216|Antioxidants|antioxidants|mesh-ancestor
102363280|NCT04363216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363281|NCT04363216|Protective Agents|protective agents|mesh-ancestor
102363282|NCT03678675|Ketorolac|ketorolac|mesh-list
102363283|NCT03678675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102363284|NCT03678675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102363285|NCT03678675|Analgesics|analgesics|mesh-ancestor
102363286|NCT03678675|Sensory System Agents|sensory system agents|mesh-ancestor
102363287|NCT03678675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102363288|NCT03678675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363289|NCT03678675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102363290|NCT03678675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102363291|NCT03678675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102363292|NCT03678675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102363293|NCT03678675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363294|NCT04363060|Amoxicillin|amoxicillin|mesh-list
102363295|NCT04363060|Azithromycin|azithromycin|mesh-list
102363296|NCT04363060|Clavulanic Acid|clavulanic acid|mesh-list
102363297|NCT04363060|Clavulanic Acids|clavulanic acids|mesh-list
102363298|NCT04363060|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102363299|NCT04363060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102363300|NCT04363060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102363301|NCT04363060|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102363302|NCT04363060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102363303|NCT04363060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363304|NCT01591382|Ketamine|ketamine|mesh-list
102363305|NCT01591382|Hydromorphone|hydromorphone|mesh-list
102363306|NCT01591382|Analgesics|analgesics|mesh-ancestor
102363307|NCT01591382|Sensory System Agents|sensory system agents|mesh-ancestor
102363308|NCT01591382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102363309|NCT01591382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363310|NCT01591382|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102363311|NCT01591382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102363312|NCT01591382|Anesthetics, General|anesthetics, general|mesh-ancestor
102363313|NCT01591382|Anesthetics|anesthetics|mesh-ancestor
102363314|NCT01591382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102363315|NCT01591382|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102363316|NCT01591382|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102363317|NCT01591382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102363318|NCT01591382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363319|NCT01591382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102363320|NCT01591382|Narcotics|narcotics|mesh-ancestor
102363321|NCT03677817|Lidocaine|lidocaine|mesh-list
102363322|NCT03677817|Anesthetics, Local|anesthetics, local|mesh-ancestor
102363323|NCT03677817|Anesthetics|anesthetics|mesh-ancestor
102363324|NCT03677817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102363325|NCT03677817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363326|NCT03677817|Sensory System Agents|sensory system agents|mesh-ancestor
102363327|NCT03677817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102363328|NCT03677817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102363329|NCT03677817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102363330|NCT03677817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102363331|NCT03677817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102363332|NCT03677817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363333|NCT00931996|Antipsychotic Agents|antipsychotic agents|mesh-list
102363334|NCT00931996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102363335|NCT00931996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102363336|NCT00931996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363337|NCT00931996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102363338|NCT04348305|Hydrocortisone|hydrocortisone|mesh-list
102363339|NCT04348305|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102363340|NCT04348305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102363341|NCT00928174|Fluorides|fluorides|mesh-list
102363342|NCT00928174|Cariostatic Agents|cariostatic agents|mesh-ancestor
102363343|NCT00928174|Protective Agents|protective agents|mesh-ancestor
102363344|NCT00928174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363345|NCT01696214|Fluticasone|fluticasone|mesh-list
102363346|NCT01696214|Xhance|xhance|mesh-list
102363347|NCT01696214|Theophylline|theophylline|mesh-list
102363348|NCT01696214|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102363349|NCT01696214|Ipratropium|ipratropium|mesh-list
102363350|NCT01696214|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102363351|NCT01696214|Montelukast|montelukast|mesh-list
102363352|NCT01696214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102363353|NCT01696214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102363354|NCT01696214|Autonomic Agents|autonomic agents|mesh-ancestor
102363355|NCT01696214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102363356|NCT01696214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363357|NCT01696214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102363358|NCT01696214|Respiratory System Agents|respiratory system agents|mesh-ancestor
102363359|NCT01696214|Dermatologic Agents|dermatologic agents|mesh-ancestor
102363360|NCT01696214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102363361|NCT01696214|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102363362|NCT01696214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102363363|NCT01696214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102363364|NCT01696214|Adrenergic Agents|adrenergic agents|mesh-ancestor
102363365|NCT01696214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102363366|NCT01696214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363367|NCT01696214|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102363368|NCT01696214|Hormone Antagonists|hormone antagonists|mesh-ancestor
102363369|NCT01696214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102363370|NCT01696214|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102363371|NCT01696214|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102363372|NCT01696214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102363373|NCT01696214|Cholinergic Agents|cholinergic agents|mesh-ancestor
102363374|NCT01696214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102363375|NCT01696214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102363376|NCT01696214|Vasodilator Agents|vasodilator agents|mesh-ancestor
102363377|NCT01696214|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102363378|NCT01696214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102363379|NCT01696214|Purinergic Agents|purinergic agents|mesh-ancestor
102363380|NCT01696214|Glucocorticoids|glucocorticoids|mesh-ancestor
102363381|NCT01696214|Hormones|hormones|mesh-ancestor
102363382|NCT01696214|Sympathomimetics|sympathomimetics|mesh-ancestor
102363383|NCT03794037|Montelukast|montelukast|mesh-list
102363384|NCT03794037|Progesterone|progesterone|mesh-list
102363385|NCT03794037|Progestins|progestins|mesh-ancestor
102363386|NCT03794037|Hormones|hormones|mesh-ancestor
102363387|NCT03794037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102363388|NCT03794037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363389|NCT03794037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102363390|NCT03794037|Respiratory System Agents|respiratory system agents|mesh-ancestor
102363391|NCT03794037|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102363392|NCT03794037|Hormone Antagonists|hormone antagonists|mesh-ancestor
102363393|NCT03794037|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102363394|NCT03794037|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102363395|NCT03794037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363396|NCT04356508|Nivolumab|nivolumab|mesh-list
102363397|NCT04356508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102363398|NCT04356508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102363399|NCT04356508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102363400|NCT04356508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363401|NCT04368598|Acetylcysteine|acetylcysteine|mesh-list
102363402|NCT04368598|Dexamethasone|dexamethasone|mesh-list
102363403|NCT04368598|Dexamethasone acetate|dexamethasone acetate|mesh-list
102363404|NCT04368598|BB 1101|bb 1101|mesh-list
102363405|NCT04368598|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102363406|NCT04368598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102363407|NCT04368598|Antiemetics|antiemetics|mesh-ancestor
102363408|NCT04368598|Autonomic Agents|autonomic agents|mesh-ancestor
102363409|NCT04368598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102363410|NCT04368598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363411|NCT04368598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102363412|NCT04368598|Glucocorticoids|glucocorticoids|mesh-ancestor
102363413|NCT04368598|Hormones|hormones|mesh-ancestor
102363414|NCT04368598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102363415|NCT04368598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102363416|NCT04368598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102363417|NCT04368598|Protease Inhibitors|protease inhibitors|mesh-ancestor
102363418|NCT04368598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102363419|NCT04368598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363420|NCT04368598|Antiviral Agents|antiviral agents|mesh-ancestor
102363421|NCT04368598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102175148|NCT04947566|Ibuprofen|ibuprofen|mesh-list
102363422|NCT04368598|Expectorants|expectorants|mesh-ancestor
102363423|NCT04368598|Respiratory System Agents|respiratory system agents|mesh-ancestor
102363424|NCT04368598|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102363425|NCT04368598|Antioxidants|antioxidants|mesh-ancestor
102363426|NCT04368598|Protective Agents|protective agents|mesh-ancestor
102363427|NCT04368598|Antidotes|antidotes|mesh-ancestor
102363428|NCT05347641|Cytarabine|cytarabine|mesh-list
102363429|NCT05347641|Methotrexate|methotrexate|mesh-list
102363430|NCT05347641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102363431|NCT05347641|Immunologic Factors|immunologic factors|mesh-ancestor
102363432|NCT05347641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363433|NCT05347641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102363434|NCT05347641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102363435|NCT05347641|Abortifacient Agents|abortifacient agents|mesh-ancestor
102363436|NCT05347641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102363437|NCT05347641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102363438|NCT05347641|Antimetabolites|antimetabolites|mesh-ancestor
102363439|NCT05347641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363440|NCT05347641|Dermatologic Agents|dermatologic agents|mesh-ancestor
102363441|NCT05347641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102363442|NCT05347641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102363443|NCT05347641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102363444|NCT05347641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102363445|NCT05347641|Antiviral Agents|antiviral agents|mesh-ancestor
102363446|NCT05347641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102363447|NCT01696058|Tiotropium Bromide|tiotropium bromide|mesh-list
102363448|NCT01696058|Olodaterol|olodaterol|mesh-list
102363449|NCT01696058|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102363450|NCT01696058|Autonomic Agents|autonomic agents|mesh-ancestor
102363451|NCT01696058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102363452|NCT01696058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363453|NCT01696058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102363454|NCT01696058|Respiratory System Agents|respiratory system agents|mesh-ancestor
102363455|NCT01696058|Parasympatholytics|parasympatholytics|mesh-ancestor
102363456|NCT01696058|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102363457|NCT01696058|Cholinergic Agents|cholinergic agents|mesh-ancestor
102363458|NCT01696058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102363459|NCT01696058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363460|NCT04368520|Vitamin D|vitamin d|mesh-list
102363461|NCT04368520|Ergocalciferols|ergocalciferols|mesh-list
102363462|NCT04368520|Cholecalciferol|cholecalciferol|mesh-list
102363463|NCT04368520|Vitamins|vitamins|mesh-list
102363464|NCT04368520|Micronutrients|micronutrients|mesh-ancestor
102363465|NCT04368520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363466|NCT04368520|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102363467|NCT04368520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102363468|NCT03790137|Fenfluramine|fenfluramine|mesh-list
102363469|NCT03790137|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102363470|NCT03790137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102363471|NCT03790137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102363472|NCT03790137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363473|NCT03790137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102363474|NCT03790137|Serotonin Agents|serotonin agents|mesh-ancestor
102363475|NCT03790137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363476|NCT01694420|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102363477|NCT01694420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102363478|NCT01694420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102363479|NCT01694420|Antiviral Agents|antiviral agents|mesh-ancestor
102363480|NCT01694420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102363481|NCT03580317|Carbamazepine|carbamazepine|mesh-list
102363482|NCT03580317|Anticonvulsants|anticonvulsants|mesh-ancestor
102363483|NCT03580317|Antimanic Agents|antimanic agents|mesh-ancestor
102363484|NCT03580317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102363485|NCT03580317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102363486|NCT03580317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363487|NCT03580317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102363488|NCT03580317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102363489|NCT03580317|Analgesics|analgesics|mesh-ancestor
102363490|NCT03580317|Sensory System Agents|sensory system agents|mesh-ancestor
102363491|NCT03580317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102363492|NCT03580317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102363493|NCT03580317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102363494|NCT03580317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363495|NCT03580317|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102363496|NCT03580317|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102363497|NCT04362124|BCG Vaccine|bcg vaccine|mesh-list
102363498|NCT04362124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102363499|NCT04362124|Immunologic Factors|immunologic factors|mesh-ancestor
102363500|NCT04362124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363501|NCT04356118|Methotrexate|methotrexate|mesh-list
102363502|NCT04356118|Endostatins|endostatins|mesh-list
102363503|NCT04356118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102363504|NCT04356118|Abortifacient Agents|abortifacient agents|mesh-ancestor
102363505|NCT04356118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102363506|NCT04356118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363507|NCT04356118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102363508|NCT04356118|Antimetabolites|antimetabolites|mesh-ancestor
102363509|NCT04356118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363510|NCT04356118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102363511|NCT04356118|Dermatologic Agents|dermatologic agents|mesh-ancestor
102363512|NCT04356118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102363513|NCT04356118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102363514|NCT04356118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102363515|NCT04356118|Immunologic Factors|immunologic factors|mesh-ancestor
102363516|NCT04356118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102363517|NCT04356118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102363518|NCT04356118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102363519|NCT04356118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102363520|NCT04356118|Growth Substances|growth substances|mesh-ancestor
102363521|NCT04356118|Growth Inhibitors|growth inhibitors|mesh-ancestor
102363522|NCT04361734|Nitroglycerin|nitroglycerin|mesh-list
102363523|NCT04361734|Vasodilator Agents|vasodilator agents|mesh-ancestor
102363524|NCT04361812|Omalizumab|omalizumab|mesh-list
102363525|NCT04361812|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102363526|NCT04361812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102363527|NCT04361812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102363528|NCT04361812|Respiratory System Agents|respiratory system agents|mesh-ancestor
102363529|NCT04361812|Immunologic Factors|immunologic factors|mesh-ancestor
102363530|NCT04361812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363531|NCT04355962|Sevoflurane|sevoflurane|mesh-list
102363532|NCT04355962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102363533|NCT04355962|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102363534|NCT04355962|Anesthetics, General|anesthetics, general|mesh-ancestor
102363535|NCT04355962|Anesthetics|anesthetics|mesh-ancestor
102363536|NCT04355962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102363537|NCT04355962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363538|NCT00705081|Ezetimibe|ezetimibe|mesh-list
102363539|NCT00705081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102363540|NCT00705081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102363541|NCT00705081|Antimetabolites|antimetabolites|mesh-ancestor
102363542|NCT00705081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363543|NCT00705081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102363544|NCT00704769|Desloratadine|desloratadine|mesh-list
102363545|NCT00704769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102363546|NCT00704769|Cholinergic Agents|cholinergic agents|mesh-ancestor
102363547|NCT00704769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102363548|NCT00704769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363549|NCT00704769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363550|NCT00704769|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102363551|NCT00704769|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102363552|NCT00704769|Histamine Antagonists|histamine antagonists|mesh-ancestor
102363553|NCT00704769|Histamine Agents|histamine agents|mesh-ancestor
102363554|NCT00938548|Pregabalin|pregabalin|mesh-list
102363555|NCT00938548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363556|NCT00938548|Analgesics|analgesics|mesh-ancestor
102363557|NCT00938548|Sensory System Agents|sensory system agents|mesh-ancestor
102363558|NCT00938548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102363559|NCT00938548|Anticonvulsants|anticonvulsants|mesh-ancestor
102363560|NCT00938548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102363561|NCT00938548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102363562|NCT00938548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363563|NCT00938548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102363564|NCT00938548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102363565|NCT00938548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102363566|NCT00938548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102363567|NCT00938548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102363568|NCT00932620|Simvastatin|simvastatin|mesh-list
102363569|NCT00932620|Ezetimibe|ezetimibe|mesh-list
102363570|NCT00932620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102363571|NCT00932620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102175309|NCT04946162|Tadalafil|tadalafil|mesh-list
102363572|NCT00932620|Antimetabolites|antimetabolites|mesh-ancestor
102363573|NCT00932620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363574|NCT00932620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102363575|NCT00932620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102363576|NCT00932620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102363577|NCT04361188|Anesthetics|anesthetics|mesh-list
102363578|NCT04361188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102363579|NCT04361188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363580|NCT04367818|Anesthetics|anesthetics|mesh-list
102363581|NCT04367818|Anesthetics, Local|anesthetics, local|mesh-list
102363582|NCT04367818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102363583|NCT04367818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363584|NCT04367818|Sensory System Agents|sensory system agents|mesh-ancestor
102363585|NCT04367818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102363586|NCT01677273|Caseins|caseins|mesh-list
102363587|NCT01677273|Chelating Agents|chelating agents|mesh-ancestor
102363588|NCT01677273|Sequestering Agents|sequestering agents|mesh-ancestor
102363589|NCT01677273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363590|NCT04355806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102363591|NCT04355806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102363592|NCT04355806|Vaccines|vaccines|mesh-list
102363593|NCT04355806|Antibodies|antibodies|mesh-list
102363594|NCT04355806|Immunoglobulins|immunoglobulins|mesh-list
102363595|NCT04355806|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102363596|NCT04355806|Immunologic Factors|immunologic factors|mesh-ancestor
102363597|NCT04355806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363598|NCT04355806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102363599|NCT04355806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363600|NCT01677351|Clonidine|clonidine|mesh-list
102363601|NCT01677351|Analgesics|analgesics|mesh-ancestor
102363602|NCT01677351|Sensory System Agents|sensory system agents|mesh-ancestor
102363603|NCT01677351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102363604|NCT01677351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363605|NCT01677351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102363606|NCT01677351|Sympatholytics|sympatholytics|mesh-ancestor
102363607|NCT01677351|Autonomic Agents|autonomic agents|mesh-ancestor
102363608|NCT01677351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102363609|NCT01677351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102363610|NCT01677351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102363611|NCT01677351|Adrenergic Agents|adrenergic agents|mesh-ancestor
102363612|NCT01677351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102363613|NCT01677351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363614|NCT00938704|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102363615|NCT00938704|Hyaluronic Acid|hyaluronic acid|mesh-list
102363616|NCT00938704|Glycerol|glycerol|mesh-list
102363617|NCT00938704|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102363618|NCT00938704|Immunologic Factors|immunologic factors|mesh-ancestor
102363619|NCT00938704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363620|NCT00938704|Viscosupplements|viscosupplements|mesh-ancestor
102363621|NCT00938704|Protective Agents|protective agents|mesh-ancestor
102363622|NCT00938704|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102363623|NCT00938704|Laxatives|laxatives|mesh-ancestor
102363624|NCT00938704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102363625|NCT03666351|Losartan|losartan|mesh-list
102363626|NCT03666351|Amlodipine|amlodipine|mesh-list
102363627|NCT03666351|Chlorthalidone|chlorthalidone|mesh-list
102363628|NCT03666351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102363629|NCT03666351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102363630|NCT03666351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102363631|NCT03666351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363632|NCT03666351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102363633|NCT03666351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363634|NCT03666351|Vasodilator Agents|vasodilator agents|mesh-ancestor
102363635|NCT03666351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102363636|NCT03666351|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102363637|NCT03666351|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102363638|NCT03666351|Diuretics|diuretics|mesh-ancestor
102363639|NCT03666351|Natriuretic Agents|natriuretic agents|mesh-ancestor
102363640|NCT03666351|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102363641|NCT00928642|Gemcitabine|gemcitabine|mesh-list
102363642|NCT00928642|Imatinib Mesylate|imatinib mesylate|mesh-list
102363643|NCT00928642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102363644|NCT00928642|Antimetabolites|antimetabolites|mesh-ancestor
102612274|NCT00002387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102175372|NCT02420847|Glycine Agents|glycine agents|mesh-ancestor
102363656|NCT03553875|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102363657|NCT03553875|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102363658|NCT03553875|Dopamine Agents|dopamine agents|mesh-ancestor
102363659|NCT03553875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102363660|NCT03553875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363661|NCT03553875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363662|NCT03553875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102363663|NCT03553875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102363664|NCT04355416|Curcumin|curcumin|mesh-list
102363665|NCT04355416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102363666|NCT04355416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102363667|NCT04355416|Analgesics|analgesics|mesh-ancestor
102363668|NCT04355416|Sensory System Agents|sensory system agents|mesh-ancestor
102363669|NCT04355416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102363670|NCT04355416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363671|NCT04355416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102363672|NCT04355416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102363673|NCT04355416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102363674|NCT04355416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102363675|NCT04355416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363688|NCT04355494|Eculizumab|eculizumab|mesh-list
102363689|NCT04355494|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102363690|NCT04355494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102363691|NCT04355494|Immunologic Factors|immunologic factors|mesh-ancestor
102363692|NCT04355494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363693|NCT00934024|Varenicline|varenicline|mesh-list
102363694|NCT00934024|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102363695|NCT00934024|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102363696|NCT00934024|Cholinergic Agents|cholinergic agents|mesh-ancestor
102363697|NCT00934024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102363698|NCT00934024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363699|NCT00934024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363700|NCT04361032|Deferoxamine|deferoxamine|mesh-list
102363701|NCT04361032|Siderophores|siderophores|mesh-ancestor
102363702|NCT04361032|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102363703|NCT04361032|Chelating Agents|chelating agents|mesh-ancestor
102363704|NCT04361032|Sequestering Agents|sequestering agents|mesh-ancestor
102363705|NCT04361032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363706|NCT00928954|Gabapentin|gabapentin|mesh-list
102363707|NCT00928954|Memantine|memantine|mesh-list
102363708|NCT00928954|Analgesics|analgesics|mesh-ancestor
102363709|NCT00928954|Sensory System Agents|sensory system agents|mesh-ancestor
102363710|NCT00928954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102363711|NCT00928954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363712|NCT00928954|Anticonvulsants|anticonvulsants|mesh-ancestor
102363713|NCT00928954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102363714|NCT00928954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102363715|NCT00928954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102363716|NCT00928954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102363717|NCT00928954|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102363718|NCT00928954|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102363719|NCT00928954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102363720|NCT00928954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363721|NCT00928954|Antimanic Agents|antimanic agents|mesh-ancestor
102363722|NCT00928954|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102363723|NCT00928954|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102363724|NCT00928954|Dopamine Agents|dopamine agents|mesh-ancestor
102363725|NCT04355026|Hydroxychloroquine|hydroxychloroquine|mesh-list
102363726|NCT04355026|Bromhexine|bromhexine|mesh-list
102363727|NCT04355026|Antimalarials|antimalarials|mesh-ancestor
102363728|NCT04355026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102363729|NCT04355026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102363730|NCT04355026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102363731|NCT04355026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102363732|NCT04355026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363733|NCT04355026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102363734|NCT04355026|Expectorants|expectorants|mesh-ancestor
102363735|NCT04355026|Respiratory System Agents|respiratory system agents|mesh-ancestor
102363736|NCT03548571|Temozolomide|temozolomide|mesh-list
102363737|NCT03548571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102363738|NCT03548571|Alkylating Agents|alkylating agents|mesh-ancestor
102363739|NCT03548571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363740|NCT03548571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102363741|NCT00939562|Doxycycline|doxycycline|mesh-list
102363742|NCT00939562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102363743|NCT00939562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102363744|NCT00939562|Antimalarials|antimalarials|mesh-ancestor
102363745|NCT00939562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102363746|NCT00939562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102363747|NCT04359862|Propofol|propofol|mesh-list
102363748|NCT04359862|Sevoflurane|sevoflurane|mesh-list
102363749|NCT04359862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102363750|NCT04359862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102363751|NCT04359862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363752|NCT04359862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102363753|NCT04359862|Anesthetics, General|anesthetics, general|mesh-ancestor
102363754|NCT04359862|Anesthetics|anesthetics|mesh-ancestor
102363755|NCT04359862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102363756|NCT04359862|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102363757|NCT04366726|Abaloparatide|abaloparatide|mesh-list
102363758|NCT04366726|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102363759|NCT04366726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363760|NCT04366960|Enoxaparin|enoxaparin|mesh-list
102363761|NCT04366960|Anticoagulants|anticoagulants|mesh-ancestor
102363762|NCT04366960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102363763|NCT04366960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102363764|NCT04366960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363765|NCT03539445|3-n-butylphthalide|3-n-butylphthalide|mesh-list
102363766|NCT03539445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102363767|NCT03539445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102363768|NCT03539445|Protective Agents|protective agents|mesh-ancestor
102363769|NCT03539445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363770|NCT04360876|Dexamethasone|dexamethasone|mesh-list
102363771|NCT04360876|Dexamethasone acetate|dexamethasone acetate|mesh-list
102363772|NCT04360876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102363773|NCT04360876|Antiemetics|antiemetics|mesh-ancestor
102363774|NCT04360876|Autonomic Agents|autonomic agents|mesh-ancestor
102363775|NCT04360876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102363776|NCT04360876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363777|NCT04360876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102363778|NCT04360876|Glucocorticoids|glucocorticoids|mesh-ancestor
102363779|NCT04360876|Hormones|hormones|mesh-ancestor
102363780|NCT04360876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102363781|NCT04360876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102363782|NCT04360876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102363783|NCT04359550|Antibodies|antibodies|mesh-list
102363784|NCT04359550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102363785|NCT04359550|Immunologic Factors|immunologic factors|mesh-ancestor
102363786|NCT04359550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363787|NCT02084511|Celecoxib|celecoxib|mesh-list
102363788|NCT02084511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102363789|NCT02084511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102363790|NCT02084511|Analgesics|analgesics|mesh-ancestor
102363791|NCT02084511|Sensory System Agents|sensory system agents|mesh-ancestor
102363792|NCT02084511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102363793|NCT02084511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363794|NCT02084511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102363795|NCT02084511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102363796|NCT02084511|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102363797|NCT02084511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102363798|NCT02084511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102363799|NCT02084511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363800|NCT00942448|Diclofenac|diclofenac|mesh-list
102363801|NCT00942448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102363802|NCT00942448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102363803|NCT00942448|Analgesics|analgesics|mesh-ancestor
102363804|NCT00942448|Sensory System Agents|sensory system agents|mesh-ancestor
102363805|NCT00942448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102363806|NCT00942448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363807|NCT00942448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102363808|NCT00942448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102363809|NCT00942448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102363810|NCT00942448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102363811|NCT00942448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363812|NCT03532581|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102363813|NCT02982148|Methylene Blue|methylene blue|mesh-list
102363814|NCT02982148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102363815|NCT02982148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363816|NCT04359316|Azithromycin|azithromycin|mesh-list
102363817|NCT04359316|Hydroxychloroquine|hydroxychloroquine|mesh-list
102363818|NCT04359316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102363819|NCT04359316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102363820|NCT04359316|Antimalarials|antimalarials|mesh-ancestor
102363821|NCT04359316|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102363822|NCT04359316|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102363823|NCT04359316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102363824|NCT04359316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363825|NCT04359316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102363826|NCT00939874|Raltegravir Potassium|raltegravir potassium|mesh-list
102363827|NCT00939874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102363828|NCT00939874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102363829|NCT00939874|Antiviral Agents|antiviral agents|mesh-ancestor
102363830|NCT00939874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102363831|NCT00939874|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102363832|NCT00939874|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102363833|NCT00939874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102363834|NCT00939874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363835|NCT03557385|Adenosine|adenosine|mesh-list
102363836|NCT03557385|Analgesics|analgesics|mesh-ancestor
102363837|NCT03557385|Sensory System Agents|sensory system agents|mesh-ancestor
102363838|NCT03557385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102363839|NCT03557385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363840|NCT03557385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102363841|NCT03557385|Vasodilator Agents|vasodilator agents|mesh-ancestor
102363842|NCT03557385|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102363843|NCT03557385|Purinergic Agonists|purinergic agonists|mesh-ancestor
102363844|NCT03557385|Purinergic Agents|purinergic agents|mesh-ancestor
102363845|NCT03557385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102363846|NCT03557385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363847|NCT04601350|Midazolam|midazolam|mesh-list
102363848|NCT04601350|Anesthetics|anesthetics|mesh-list
102363849|NCT04601350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102363850|NCT04601350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363851|NCT04601350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102363852|NCT04601350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102363853|NCT04601350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102363854|NCT04601350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102363855|NCT04601350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102363856|NCT04601350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102363857|NCT04601350|Anesthetics, General|anesthetics, general|mesh-ancestor
102363858|NCT04601350|GABA Modulators|gaba modulators|mesh-ancestor
102363859|NCT04601350|GABA Agents|gaba agents|mesh-ancestor
102363860|NCT04601350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102363861|NCT04601350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363862|NCT05346861|Trastuzumab|trastuzumab|mesh-list
102363863|NCT05346861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102363864|NCT05346861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102363865|NCT04358614|Ritonavir|ritonavir|mesh-list
102363866|NCT04358614|Lopinavir|lopinavir|mesh-list
102363867|NCT04358614|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102363868|NCT04358614|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102363869|NCT04358614|Protease Inhibitors|protease inhibitors|mesh-ancestor
102363870|NCT04358614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102363871|NCT04358614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175594|NCT02622386|Riboflavin|riboflavin|mesh-list
102363872|NCT04358614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102363873|NCT04358614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102363874|NCT04358614|Antiviral Agents|antiviral agents|mesh-ancestor
102363875|NCT04358614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102363876|NCT04358614|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102363877|NCT04358614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102363878|NCT01670409|Cisplatin|cisplatin|mesh-list
102363879|NCT01670409|Fluorouracil|fluorouracil|mesh-list
102363880|NCT01670409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102363881|NCT01670409|Antimetabolites|antimetabolites|mesh-ancestor
102363882|NCT01670409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363883|NCT01670409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102363884|NCT01670409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102363885|NCT01670409|Immunologic Factors|immunologic factors|mesh-ancestor
102363886|NCT01670409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363887|NCT04761705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102363888|NCT04761705|Latanoprost|latanoprost|mesh-list
102363889|NCT04761705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102363890|NCT04358770|Clocortolone|clocortolone|mesh-list
102363891|NCT04358770|Fluocortolone|fluocortolone|mesh-list
102363892|NCT04358770|Clocortolone pivalate|clocortolone pivalate|mesh-list
102363893|NCT04358770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102363894|NCT04358770|Glucocorticoids|glucocorticoids|mesh-ancestor
102363895|NCT04358770|Hormones|hormones|mesh-ancestor
102363896|NCT04358770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102363897|NCT04358770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363898|NCT03516981|Pembrolizumab|pembrolizumab|mesh-list
102363899|NCT03516981|Lenvatinib|lenvatinib|mesh-list
102363900|NCT03516981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102363901|NCT03516981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102363902|NCT03516981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102363903|NCT03516981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363904|NCT03516981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102363905|NCT03516981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102363906|NCT05618470|Botulinum Toxins|botulinum toxins|mesh-list
102363907|NCT05618470|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102363908|NCT05618470|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102363909|NCT05618470|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102363910|NCT05618470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102363911|NCT05618470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363912|NCT05618470|Cholinergic Agents|cholinergic agents|mesh-ancestor
102363913|NCT05618470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102363914|NCT05618470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363915|NCT05618470|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102363916|NCT05618470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102363917|NCT04358146|Locust bean gum|locust bean gum|mesh-list
102363918|NCT04358146|Antidiarrheals|antidiarrheals|mesh-ancestor
102363919|NCT04358146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102363920|NCT05620498|Lenvatinib|lenvatinib|mesh-list
102363921|NCT05620498|Tislelizumab|tislelizumab|mesh-list
102363922|NCT05620498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102363923|NCT05620498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102363924|NCT05620498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102363925|NCT05620498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363926|NCT05620498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102363927|NCT01670565|Mycophenolic Acid|mycophenolic acid|mesh-list
102363928|NCT01670565|Belimumab|belimumab|mesh-list
102363929|NCT01670565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102363930|NCT01670565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102363931|NCT01670565|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102363932|NCT01670565|Antitubercular Agents|antitubercular agents|mesh-ancestor
102363933|NCT01670565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102363934|NCT01670565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102363935|NCT01670565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102363936|NCT01670565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363937|NCT01670565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102363938|NCT01670565|Immunologic Factors|immunologic factors|mesh-ancestor
102363939|NCT01670565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363940|NCT01670799|Ketorolac|ketorolac|mesh-list
102363941|NCT01670799|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102363942|NCT01670799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102363943|NCT01670799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102363944|NCT01670799|Analgesics|analgesics|mesh-ancestor
102363945|NCT01670799|Sensory System Agents|sensory system agents|mesh-ancestor
102363946|NCT01670799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102363947|NCT01670799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363948|NCT01670799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102363949|NCT01670799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102363950|NCT01670799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102363951|NCT01670799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102363952|NCT01670799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363953|NCT02404935|Cetuximab|cetuximab|mesh-list
102363954|NCT02404935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102363955|NCT02404935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102363956|NCT04320940|Phenobarbital|phenobarbital|mesh-list
102363957|NCT04320940|Anticonvulsants|anticonvulsants|mesh-ancestor
102363958|NCT04320940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102363959|NCT04320940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102363960|NCT04320940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363961|NCT04320940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102363962|NCT04320940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102363963|NCT04320940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102363964|NCT04320940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363965|NCT04320940|GABA Modulators|gaba modulators|mesh-ancestor
102363966|NCT04320940|GABA Agents|gaba agents|mesh-ancestor
102363967|NCT04320940|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102363968|NCT04320940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102363969|NCT04320940|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102363970|NCT03422523|Rituximab|rituximab|mesh-list
102363971|NCT03422523|Atezolizumab|atezolizumab|mesh-list
102363972|NCT03422523|Gemcitabine|gemcitabine|mesh-list
102363973|NCT03422523|Oxaliplatin|oxaliplatin|mesh-list
102363974|NCT03422523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102363975|NCT03422523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102363976|NCT03422523|Immunologic Factors|immunologic factors|mesh-ancestor
102363977|NCT03422523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102363978|NCT03422523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102363979|NCT03422523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102363980|NCT03422523|Antimetabolites|antimetabolites|mesh-ancestor
102363981|NCT03422523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363982|NCT03422523|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102363983|NCT03032536|Tenofovir|tenofovir|mesh-list
102363984|NCT03032536|Entecavir|entecavir|mesh-list
102363985|NCT03032536|Antiviral Agents|antiviral agents|mesh-ancestor
102363986|NCT03032536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102363987|NCT03032536|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102363988|NCT03032536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102363989|NCT03032536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102363990|NCT03032536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102363991|NCT03032536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102363992|NCT03032536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102363993|NCT03420963|Cyclophosphamide|cyclophosphamide|mesh-list
102363994|NCT03420963|Etoposide|etoposide|mesh-list
102363995|NCT03420963|Etoposide phosphate|etoposide phosphate|mesh-list
102363996|NCT03420963|Podophyllotoxin|podophyllotoxin|mesh-list
102363997|NCT03420963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102363998|NCT03420963|Immunologic Factors|immunologic factors|mesh-ancestor
102363999|NCT03420963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364000|NCT03420963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102364001|NCT03420963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102364002|NCT03420963|Alkylating Agents|alkylating agents|mesh-ancestor
102364003|NCT03420963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364004|NCT03420963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102364005|NCT03420963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102364006|NCT03420963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102364007|NCT03420963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102364008|NCT03420963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102364009|NCT03420963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102364010|NCT03420963|Keratolytic Agents|keratolytic agents|mesh-ancestor
102364011|NCT03420963|Dermatologic Agents|dermatologic agents|mesh-ancestor
102364012|NCT03420963|Tubulin Modulators|tubulin modulators|mesh-ancestor
102364013|NCT03420963|Antimitotic Agents|antimitotic agents|mesh-ancestor
102364014|NCT03420963|Mitosis Modulators|mitosis modulators|mesh-ancestor
102364015|NCT03032614|Carboplatin|carboplatin|mesh-list
102364016|NCT03032614|Veliparib|veliparib|mesh-list
102364017|NCT03032614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102364018|NCT03032614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102364019|NCT03032614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102364020|NCT03032614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364021|NCT03032458|Ketorolac|ketorolac|mesh-list
102364022|NCT03032458|Lidocaine|lidocaine|mesh-list
102364024|NCT03032458|Anesthetics, Local|anesthetics, local|mesh-ancestor
102364025|NCT03032458|Anesthetics|anesthetics|mesh-ancestor
102364026|NCT03032458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102364027|NCT03032458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364028|NCT03032458|Sensory System Agents|sensory system agents|mesh-ancestor
102364029|NCT03032458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102364030|NCT03032458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102364031|NCT03032458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102364032|NCT03032458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102364033|NCT03032458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102364034|NCT03032458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364035|NCT03032458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102364036|NCT03032458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102364037|NCT03032458|Analgesics|analgesics|mesh-ancestor
102364038|NCT03032458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102364039|NCT03032458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102364040|NCT03032458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102364041|NCT03032458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102364042|NCT03032458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102364043|NCT03032458|Narcotics|narcotics|mesh-ancestor
102364044|NCT03032458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102364045|NCT02245438|Ritonavir|ritonavir|mesh-list
102364046|NCT02245438|Tipranavir|tipranavir|mesh-list
102364047|NCT02245438|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102364048|NCT02245438|Norethindrone|norethindrone|mesh-list
102364049|NCT02245438|Norethindrone Acetate|norethindrone acetate|mesh-list
102364050|NCT02245438|Norinyl|norinyl|mesh-list
102364051|NCT02245438|Estradiol|estradiol|mesh-list
102364052|NCT02245438|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102364053|NCT02245438|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102364054|NCT02245438|Protease Inhibitors|protease inhibitors|mesh-ancestor
102364055|NCT02245438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102364056|NCT02245438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364057|NCT02245438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102364058|NCT02245438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102364059|NCT02245438|Antiviral Agents|antiviral agents|mesh-ancestor
102364060|NCT02245438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102364061|NCT02245438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102364062|NCT02245438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102364063|NCT02245438|Estrogens|estrogens|mesh-ancestor
102364064|NCT02245438|Hormones|hormones|mesh-ancestor
102364065|NCT02245438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102364066|NCT02245438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364067|NCT02245438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102364068|NCT02245438|Contraceptive Agents|contraceptive agents|mesh-ancestor
102364069|NCT02245438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102364070|NCT02245438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102364071|NCT02245438|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102364072|NCT02245438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102364073|NCT02245438|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102364074|NCT02245438|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102364075|NCT03087669|Norepinephrine|norepinephrine|mesh-list
102364076|NCT03087669|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102364077|NCT03087669|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102364078|NCT03087669|Adrenergic Agents|adrenergic agents|mesh-ancestor
102364079|NCT03087669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102364080|NCT03087669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364081|NCT03087669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364082|NCT03087669|Sympathomimetics|sympathomimetics|mesh-ancestor
102364083|NCT03087669|Autonomic Agents|autonomic agents|mesh-ancestor
102364084|NCT03087669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102364085|NCT03087669|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102364086|NCT00939952|Ertapenem|ertapenem|mesh-list
102364087|NCT00939952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102364088|NCT00939952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102364089|NCT02401815|Sunitinib|sunitinib|mesh-list
102364090|NCT02401815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102364091|NCT02401815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102364092|NCT02401815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102364093|NCT02401815|Growth Substances|growth substances|mesh-ancestor
102364094|NCT02401815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364095|NCT02401815|Growth Inhibitors|growth inhibitors|mesh-ancestor
102364096|NCT02401815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102364097|NCT02401815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102364098|NCT02401815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364099|NCT00947752|Glatiramer Acetate|glatiramer acetate|mesh-list
102364101|NCT00947752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102364102|NCT00947752|Immunologic Factors|immunologic factors|mesh-ancestor
102364103|NCT00947752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364104|NCT00947752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102364105|NCT00947752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102364106|NCT03456687|Exenatide|exenatide|mesh-list
102364107|NCT03456687|Glucagon|glucagon|mesh-list
102364108|NCT03456687|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102364109|NCT03456687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102364110|NCT03456687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364111|NCT03456687|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102364112|NCT03456687|Incretins|incretins|mesh-ancestor
102364113|NCT03456687|Hormones|hormones|mesh-ancestor
102364114|NCT03456687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102364115|NCT03456687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102364116|NCT00948298|Vitamin D|vitamin d|mesh-list
102364117|NCT00948298|Vitamins|vitamins|mesh-ancestor
102364118|NCT00948298|Micronutrients|micronutrients|mesh-ancestor
102364119|NCT00948298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364120|NCT00948298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102364121|NCT00948610|Infliximab|infliximab|mesh-list
102364122|NCT00948610|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102364123|NCT00948610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102364124|NCT00948610|Dermatologic Agents|dermatologic agents|mesh-ancestor
102364125|NCT00948610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102364126|NCT00948610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102364127|NCT03031834|Quinapril|quinapril|mesh-list
102364128|NCT03031834|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102364129|NCT03031834|Protease Inhibitors|protease inhibitors|mesh-ancestor
102364130|NCT03031834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102364131|NCT03031834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364132|NCT03031834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102364133|NCT00944554|Varenicline|varenicline|mesh-list
102364134|NCT00944554|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102364135|NCT00944554|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102364136|NCT00944554|Cholinergic Agents|cholinergic agents|mesh-ancestor
102364137|NCT00944554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102364138|NCT00944554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364139|NCT00944554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364140|NCT03031756|Glycine|glycine|mesh-list
102364141|NCT03031756|Glycine Agents|glycine agents|mesh-ancestor
102364142|NCT03031756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102364143|NCT03031756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364144|NCT03031756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364145|NCT00944710|Atropine|atropine|mesh-list
102364146|NCT00944710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102364147|NCT00944710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102364148|NCT00944710|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102364149|NCT00944710|Autonomic Agents|autonomic agents|mesh-ancestor
102364150|NCT00944710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102364151|NCT00944710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364152|NCT00944710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102364153|NCT00944710|Respiratory System Agents|respiratory system agents|mesh-ancestor
102364154|NCT00944710|Mydriatics|mydriatics|mesh-ancestor
102364155|NCT00944710|Parasympatholytics|parasympatholytics|mesh-ancestor
102364156|NCT00944710|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102364157|NCT00944710|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102364158|NCT00944710|Cholinergic Agents|cholinergic agents|mesh-ancestor
102364159|NCT00944710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102364160|NCT00944710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364161|NCT00949078|Omalizumab|omalizumab|mesh-list
102364162|NCT00949078|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102364163|NCT00949078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102364164|NCT00949078|Respiratory System Agents|respiratory system agents|mesh-ancestor
102364165|NCT00945256|Nitroprusside|nitroprusside|mesh-list
102364166|NCT00945256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102364167|NCT00945256|Vasodilator Agents|vasodilator agents|mesh-ancestor
102364168|NCT00945256|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102364169|NCT00945256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364170|NCT03854032|Nivolumab|nivolumab|mesh-list
102364171|NCT03854032|Linrodostat|linrodostat|mesh-list
102364172|NCT03854032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102364173|NCT03854032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102364174|NCT03854032|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102364175|NCT03854032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364176|NCT03854032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102364177|NCT03031444|Leucovorin|leucovorin|mesh-list
102364178|NCT03031444|Cetuximab|cetuximab|mesh-list
102364179|NCT03031444|Fluorouracil|fluorouracil|mesh-list
102364180|NCT03031444|Oxaliplatin|oxaliplatin|mesh-list
102364181|NCT03031444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102364182|NCT03031444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102364183|NCT03031444|Antimetabolites|antimetabolites|mesh-ancestor
102364184|NCT03031444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364185|NCT03031444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102364186|NCT03031444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102364187|NCT03031444|Immunologic Factors|immunologic factors|mesh-ancestor
102364188|NCT03031444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364189|NCT03031444|Antidotes|antidotes|mesh-ancestor
102364190|NCT03031444|Protective Agents|protective agents|mesh-ancestor
102364191|NCT03031444|Vitamin B Complex|vitamin b complex|mesh-ancestor
102364192|NCT03031444|Vitamins|vitamins|mesh-ancestor
102364193|NCT03031444|Micronutrients|micronutrients|mesh-ancestor
102364194|NCT03031054|Hyaluronic Acid|hyaluronic acid|mesh-list
102364195|NCT03031054|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102364196|NCT03031054|Immunologic Factors|immunologic factors|mesh-ancestor
102364197|NCT03031054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364198|NCT03031054|Viscosupplements|viscosupplements|mesh-ancestor
102364199|NCT03031054|Protective Agents|protective agents|mesh-ancestor
102364200|NCT00945334|Rifaximin|rifaximin|mesh-list
102364201|NCT00945334|Neomycin|neomycin|mesh-list
102364202|NCT00945334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102364203|NCT00945334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102364204|NCT00945334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102364205|NCT00945334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102364206|NCT00945334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102364207|NCT00945334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364208|NCT03559114|Dalteparin|dalteparin|mesh-list
102364209|NCT03559114|Tinzaparin|tinzaparin|mesh-list
102364210|NCT03559114|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102364211|NCT03559114|Anticoagulants|anticoagulants|mesh-ancestor
102364212|NCT03559114|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102364213|NCT03559114|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102364214|NCT03559114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364215|NCT05153590|Liraglutide|liraglutide|mesh-list
102364216|NCT05153590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102364217|NCT05153590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364218|NCT05153590|Incretins|incretins|mesh-ancestor
102364219|NCT05153590|Hormones|hormones|mesh-ancestor
102364220|NCT05153590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102364221|NCT03490864|Melatonin|melatonin|mesh-list
102364222|NCT03490864|Antioxidants|antioxidants|mesh-ancestor
102364223|NCT03490864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364224|NCT03490864|Protective Agents|protective agents|mesh-ancestor
102364225|NCT03490864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364226|NCT03490864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102364227|NCT04402203|Favipiravir|favipiravir|mesh-list
102364228|NCT04402203|Antiviral Agents|antiviral agents|mesh-ancestor
102364229|NCT04402203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102364230|NCT03030976|Cyclophosphamide|cyclophosphamide|mesh-list
102364231|NCT03030976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102364232|NCT03030976|Immunologic Factors|immunologic factors|mesh-ancestor
102364233|NCT03030976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364234|NCT03030976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102364235|NCT03030976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102364236|NCT03030976|Alkylating Agents|alkylating agents|mesh-ancestor
102364237|NCT03030976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567499|NCT00626223|Hematinics|hematinics|mesh-ancestor
102364238|NCT03030976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102364239|NCT03030976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102364240|NCT00949234|Ritonavir|ritonavir|mesh-list
102364241|NCT00949234|Lopinavir|lopinavir|mesh-list
102364242|NCT00949234|Tenofovir|tenofovir|mesh-list
102364243|NCT00949234|Emtricitabine|emtricitabine|mesh-list
102364244|NCT00949234|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102364245|NCT00949234|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102364246|NCT00949234|Protease Inhibitors|protease inhibitors|mesh-ancestor
102364247|NCT00949234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102175972|NCT03234153|Durvalumab|durvalumab|mesh-list
102364248|NCT00949234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364249|NCT00949234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102364250|NCT00949234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102364252|NCT00949234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102364253|NCT00949234|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102364254|NCT00949234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102364255|NCT00949234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102364256|NCT00949234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102364257|NCT03090880|Tinzaparin|tinzaparin|mesh-list
102364258|NCT03090880|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102364259|NCT03090880|Dalteparin|dalteparin|mesh-list
102364260|NCT03090880|Anticoagulants|anticoagulants|mesh-ancestor
102364261|NCT03090880|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102364262|NCT03090880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102364263|NCT03090880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364264|NCT05097976|Methylprednisolone|methylprednisolone|mesh-list
102364265|NCT05097976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102364266|NCT05097976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102364267|NCT05097976|Prednisolone|prednisolone|mesh-list
102364268|NCT05097976|Prednisolone acetate|prednisolone acetate|mesh-list
102364269|NCT05097976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102364270|NCT05097976|Prednisolone phosphate|prednisolone phosphate|mesh-list
102364271|NCT05097976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102364272|NCT05097976|Antiemetics|antiemetics|mesh-ancestor
102364273|NCT05097976|Autonomic Agents|autonomic agents|mesh-ancestor
102364274|NCT05097976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102364275|NCT05097976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364276|NCT05097976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102364277|NCT05097976|Glucocorticoids|glucocorticoids|mesh-ancestor
102364278|NCT05097976|Hormones|hormones|mesh-ancestor
102364279|NCT05097976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102364280|NCT05097976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102364281|NCT05097976|Protective Agents|protective agents|mesh-ancestor
102364282|NCT05097976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102364283|NCT05097976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102364284|NCT03030430|Bevacizumab|bevacizumab|mesh-list
102364285|NCT03030430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102364286|NCT03030430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102364287|NCT03030430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102364288|NCT03030430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102364289|NCT03030430|Growth Substances|growth substances|mesh-ancestor
102364290|NCT03030430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364291|NCT03030430|Growth Inhibitors|growth inhibitors|mesh-ancestor
102364292|NCT00089661|Denosumab|denosumab|mesh-list
102364293|NCT00089661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102364294|NCT00089661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364295|NCT00941668|Triclosan|triclosan|mesh-list
102364296|NCT00941668|Fluorides|fluorides|mesh-list
102364297|NCT00941668|Fluorophosphate|fluorophosphate|mesh-list
102364298|NCT00941668|Cariostatic Agents|cariostatic agents|mesh-ancestor
102364299|NCT00941668|Protective Agents|protective agents|mesh-ancestor
102364300|NCT00941668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364301|NCT00941668|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102364302|NCT00941668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102364303|NCT00941668|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102364304|NCT00941668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102364305|NCT00941668|Antimetabolites|antimetabolites|mesh-ancestor
102364306|NCT00941668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364307|NCT00941668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102364308|NCT01597414|Trastuzumab|trastuzumab|mesh-list
102364309|NCT01597414|Pertuzumab|pertuzumab|mesh-list
101567504|NCT01106157|Thymoglobulin|thymoglobulin|mesh-list
102364310|NCT01597414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102364311|NCT01597414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102364312|NCT04984330|Dexamethasone|dexamethasone|mesh-list
102364313|NCT04984330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102364314|NCT04984330|Antiemetics|antiemetics|mesh-ancestor
102364315|NCT04984330|Autonomic Agents|autonomic agents|mesh-ancestor
102364316|NCT04984330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102364317|NCT04984330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364318|NCT04984330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102364319|NCT04984330|Glucocorticoids|glucocorticoids|mesh-ancestor
102364320|NCT04984330|Hormones|hormones|mesh-ancestor
102364321|NCT04984330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102364322|NCT04984330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102364323|NCT04984330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102364324|NCT03030196|Denosumab|denosumab|mesh-list
102364325|NCT03030196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102364326|NCT03030196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364327|NCT03035578|Morphine|morphine|mesh-list
102364328|NCT03035578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102364329|NCT03035578|Narcotics|narcotics|mesh-ancestor
102364330|NCT03035578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102364331|NCT03035578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364332|NCT03035578|Analgesics|analgesics|mesh-ancestor
102364333|NCT03035578|Sensory System Agents|sensory system agents|mesh-ancestor
102364334|NCT03035578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102364335|NCT04933942|Lomustine|lomustine|mesh-list
102364336|NCT04933942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102364337|NCT04933942|Alkylating Agents|alkylating agents|mesh-ancestor
102364338|NCT04933942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364339|NCT04933942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102364340|NCT00089583|Ritonavir|ritonavir|mesh-list
102364341|NCT00089583|Fosamprenavir|fosamprenavir|mesh-list
102364342|NCT00089583|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102364343|NCT00089583|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102364344|NCT00089583|Protease Inhibitors|protease inhibitors|mesh-ancestor
102364345|NCT00089583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102364346|NCT00089583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364347|NCT00089583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102364348|NCT00089583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102364349|NCT00089583|Antiviral Agents|antiviral agents|mesh-ancestor
102364350|NCT00089583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102364351|NCT00089583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102364352|NCT00089583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102364353|NCT03029494|Ascorbic Acid|ascorbic acid|mesh-list
102364354|NCT03029494|Vitamins|vitamins|mesh-ancestor
102364355|NCT03029494|Micronutrients|micronutrients|mesh-ancestor
102364356|NCT03029494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364357|NCT03029494|Antioxidants|antioxidants|mesh-ancestor
102364358|NCT03029494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364359|NCT03029494|Protective Agents|protective agents|mesh-ancestor
102364360|NCT04402047|Diclofenac|diclofenac|mesh-list
102364361|NCT04402047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102364362|NCT04402047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102364363|NCT04402047|Analgesics|analgesics|mesh-ancestor
102364364|NCT04402047|Sensory System Agents|sensory system agents|mesh-ancestor
102364365|NCT04402047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102364366|NCT04402047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364367|NCT04402047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102364368|NCT04402047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102364369|NCT04402047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102364370|NCT04402047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102364371|NCT04402047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364372|NCT03017248|Ketamine|ketamine|mesh-list
102364373|NCT03017248|Morphine|morphine|mesh-list
102364374|NCT03017248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102364375|NCT03017248|Analgesics|analgesics|mesh-ancestor
102364376|NCT03017248|Sensory System Agents|sensory system agents|mesh-ancestor
102364377|NCT03017248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102364378|NCT03017248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364379|NCT03017248|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102364380|NCT03017248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102364381|NCT03017248|Anesthetics, General|anesthetics, general|mesh-ancestor
102364382|NCT03017248|Anesthetics|anesthetics|mesh-ancestor
102364383|NCT03017248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102364384|NCT03017248|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102364385|NCT03017248|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102364386|NCT03017248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102364387|NCT03017248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364388|NCT03017248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102364389|NCT03017248|Narcotics|narcotics|mesh-ancestor
102364390|NCT00088881|Prednisone|prednisone|mesh-list
102364391|NCT00088881|Cyclophosphamide|cyclophosphamide|mesh-list
102364392|NCT00088881|Rituximab|rituximab|mesh-list
102364393|NCT00088881|Doxorubicin|doxorubicin|mesh-list
102364394|NCT00088881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102364395|NCT00088881|Vincristine|vincristine|mesh-list
102364396|NCT00088881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102364397|NCT00088881|Immunologic Factors|immunologic factors|mesh-ancestor
102364398|NCT00088881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364399|NCT00088881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102364400|NCT00088881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102364401|NCT00088881|Alkylating Agents|alkylating agents|mesh-ancestor
102364402|NCT00088881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364403|NCT00088881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102364404|NCT00088881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102364405|NCT00088881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102364406|NCT00088881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102364407|NCT00088881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102364408|NCT00088881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102364409|NCT00088881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102364410|NCT00088881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102364411|NCT00088881|Glucocorticoids|glucocorticoids|mesh-ancestor
102364412|NCT00088881|Hormones|hormones|mesh-ancestor
102364413|NCT00088881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102364414|NCT00088881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102364415|NCT00088881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102364416|NCT00088881|Tubulin Modulators|tubulin modulators|mesh-ancestor
102364417|NCT00088881|Antimitotic Agents|antimitotic agents|mesh-ancestor
102364418|NCT00088881|Mitosis Modulators|mitosis modulators|mesh-ancestor
102364419|NCT02981914|Pembrolizumab|pembrolizumab|mesh-list
102364420|NCT02981914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102364421|NCT02981914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102364422|NCT02981914|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102364423|NCT02981914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364424|NCT03025750|Vaccines|vaccines|mesh-list
102364425|NCT03025750|Immunologic Factors|immunologic factors|mesh-ancestor
102364426|NCT03025750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364427|NCT03017404|Cyclophosphamide|cyclophosphamide|mesh-list
102364428|NCT03017404|Docetaxel|docetaxel|mesh-list
102364429|NCT03017404|Doxorubicin|doxorubicin|mesh-list
102364430|NCT03017404|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102364431|NCT03017404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102364432|NCT03017404|Immunologic Factors|immunologic factors|mesh-ancestor
102364433|NCT03017404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364434|NCT03017404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102364435|NCT03017404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102364436|NCT03017404|Alkylating Agents|alkylating agents|mesh-ancestor
102364437|NCT03017404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364438|NCT03017404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102364439|NCT03017404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102364440|NCT03017404|Tubulin Modulators|tubulin modulators|mesh-ancestor
102364441|NCT03017404|Antimitotic Agents|antimitotic agents|mesh-ancestor
102364442|NCT03017404|Mitosis Modulators|mitosis modulators|mesh-ancestor
102364443|NCT03017404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102364444|NCT03017404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102364445|NCT03017404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102364446|NCT03017404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102364447|NCT00953212|Ascorbic Acid|ascorbic acid|mesh-list
102364448|NCT00953212|Amiodarone|amiodarone|mesh-list
102364449|NCT00953212|Metoprolol|metoprolol|mesh-list
102364450|NCT00953212|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102364451|NCT00953212|Vitamins|vitamins|mesh-ancestor
102364452|NCT00953212|Micronutrients|micronutrients|mesh-ancestor
102364453|NCT00953212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364454|NCT00953212|Antioxidants|antioxidants|mesh-ancestor
102364455|NCT00953212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364456|NCT00953212|Protective Agents|protective agents|mesh-ancestor
102364457|NCT00953212|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102364458|NCT00953212|Adrenergic Agents|adrenergic agents|mesh-ancestor
102364459|NCT00953212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102364460|NCT00953212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102364461|NCT00953212|Vasodilator Agents|vasodilator agents|mesh-ancestor
102364462|NCT00953212|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102364463|NCT00953212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102364464|NCT00953212|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102364465|NCT00953212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102364466|NCT00953212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102364467|NCT00953212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102364468|NCT00953212|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102364469|NCT00953212|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102364470|NCT00953212|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102364471|NCT00953212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102364472|NCT00953212|Sympatholytics|sympatholytics|mesh-ancestor
102364473|NCT00953212|Autonomic Agents|autonomic agents|mesh-ancestor
102364474|NCT00953212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102176247|NCT04913402|Dsuvia|dsuvia|mesh-list
102364475|NCT00953212|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102364476|NCT03034408|Mannitol|mannitol|mesh-list
102364477|NCT03034408|Baclofen|baclofen|mesh-list
102364478|NCT03034408|Nalmefene|nalmefene|mesh-list
102364479|NCT03034408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102364480|NCT03034408|Diuretics|diuretics|mesh-ancestor
102364481|NCT03034408|Natriuretic Agents|natriuretic agents|mesh-ancestor
102364482|NCT03034408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364483|NCT03034408|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102364484|NCT03034408|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102364485|NCT03034408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102364486|NCT03034408|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102364487|NCT03034408|GABA Agonists|gaba agonists|mesh-ancestor
102364488|NCT03034408|GABA Agents|gaba agents|mesh-ancestor
102364489|NCT03034408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102364490|NCT03034408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364491|NCT03034408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102364492|NCT03034408|Sensory System Agents|sensory system agents|mesh-ancestor
102364493|NCT03023020|Aspirin|aspirin|mesh-list
102364494|NCT03023020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
102364495|NCT03023020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102364496|NCT03023020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102364497|NCT03023020|Analgesics|analgesics|mesh-ancestor
102364498|NCT03023020|Sensory System Agents|sensory system agents|mesh-ancestor
102364499|NCT03023020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102364500|NCT03023020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364501|NCT03023020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102364502|NCT03023020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102364503|NCT03023020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102364504|NCT03023020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102364505|NCT03023020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364506|NCT03023020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102364507|NCT03023020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102364508|NCT03023020|Antipyretics|antipyretics|mesh-ancestor
102364509|NCT00087555|Sodium Oxybate|sodium oxybate|mesh-list
102364510|NCT00087555|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102364511|NCT00087555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102364512|NCT00087555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102364513|NCT00087555|Anesthetics, General|anesthetics, general|mesh-ancestor
102364514|NCT00087555|Anesthetics|anesthetics|mesh-ancestor
102364515|NCT00087555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102364516|NCT00087555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364517|NCT03022318|Levodopa|levodopa|mesh-list
102364518|NCT03022318|Carbidopa|carbidopa|mesh-list
102364519|NCT03022318|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102364520|NCT03022318|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102364521|NCT03022318|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102364522|NCT03022318|Dopamine Agents|dopamine agents|mesh-ancestor
102364523|NCT03022318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102364524|NCT03022318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364525|NCT03022318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364526|NCT03022318|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102364527|NCT03022318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102364528|NCT03022318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102364529|NCT03022318|Immunologic Factors|immunologic factors|mesh-ancestor
102364530|NCT03022318|Dopamine Agonists|dopamine agonists|mesh-ancestor
102364531|NCT01677897|Metformin|metformin|mesh-list
102364532|NCT01677897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102364533|NCT01677897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364534|NCT03483363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102364535|NCT03483363|Bacitracin|bacitracin|mesh-list
102364536|NCT03483363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102364537|NCT03483363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102364538|NCT03483363|Antitubercular Agents|antitubercular agents|mesh-ancestor
102364539|NCT03483363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102364540|NCT03086733|Metformin|metformin|mesh-list
102364541|NCT03086733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102364542|NCT03086733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364543|NCT00086619|Parathyroid Hormone|parathyroid hormone|mesh-list
102364544|NCT00086619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364545|NCT00086619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102364546|NCT00085917|Interferons|interferons|mesh-list
102364547|NCT00085917|Ribavirin|ribavirin|mesh-list
102364548|NCT00085917|Interferon-alpha|interferon-alpha|mesh-list
102364549|NCT00085917|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102364550|NCT00085917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102364551|NCT00085917|Antiviral Agents|antiviral agents|mesh-ancestor
102364553|NCT00085917|Antimetabolites|antimetabolites|mesh-ancestor
102364554|NCT00085917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364555|NCT00085917|Immunologic Factors|immunologic factors|mesh-ancestor
102364556|NCT00085917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364557|NCT00084747|Bortezomib|bortezomib|mesh-list
102364558|NCT00084747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102364559|NCT04402671|Glutaral|glutaral|mesh-list
102364560|NCT04402671|Disinfectants|disinfectants|mesh-ancestor
102364561|NCT04402671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102364562|NCT01678287|Ipragliflozin|ipragliflozin|mesh-list
102364563|NCT01678287|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102364564|NCT01678287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364565|NCT01678287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102364566|NCT01678287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364567|NCT01678365|Metronidazole|metronidazole|mesh-list
102364568|NCT01678365|Gentamicins|gentamicins|mesh-list
102364569|NCT01678365|Ceftriaxone|ceftriaxone|mesh-list
102364570|NCT01678365|Ampicillin|ampicillin|mesh-list
102364571|NCT01678365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102364572|NCT01678365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102364573|NCT01678365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102364574|NCT01678365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102364575|NCT01678365|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102364576|NCT01678365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102364577|NCT01678365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364578|NCT00946270|Thalidomide|thalidomide|mesh-list
102364579|NCT00946270|Prednisone|prednisone|mesh-list
102364580|NCT00946270|Pomalidomide|pomalidomide|mesh-list
102364581|NCT00946270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102364582|NCT00946270|Glucocorticoids|glucocorticoids|mesh-ancestor
102364583|NCT00946270|Hormones|hormones|mesh-ancestor
102364584|NCT00946270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102364585|NCT00946270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364586|NCT00946270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102364587|NCT00946270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102364588|NCT00946270|Immunologic Factors|immunologic factors|mesh-ancestor
102364589|NCT00946270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102364590|NCT00946270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102364591|NCT00946270|Growth Substances|growth substances|mesh-ancestor
102364592|NCT00946270|Growth Inhibitors|growth inhibitors|mesh-ancestor
102364593|NCT00946270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102364594|NCT00946270|Leprostatic Agents|leprostatic agents|mesh-ancestor
102364595|NCT00946270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102364596|NCT00946270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102364597|NCT03021616|Moxifloxacin|moxifloxacin|mesh-list
102364598|NCT03021616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102364599|NCT03021616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102364600|NCT03021616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102364601|NCT03021616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102364602|NCT03021616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102364603|NCT03021616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364604|NCT03021616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102364605|NCT03021694|Caseins|caseins|mesh-list
102364606|NCT03021694|Chelating Agents|chelating agents|mesh-ancestor
102364607|NCT03021694|Sequestering Agents|sequestering agents|mesh-ancestor
102364608|NCT03021694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364609|NCT00956254|Fentanyl|fentanyl|mesh-list
102364610|NCT00956254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102364611|NCT00956254|Narcotics|narcotics|mesh-ancestor
102364612|NCT00956254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102364613|NCT00956254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364614|NCT00956254|Analgesics|analgesics|mesh-ancestor
102364615|NCT00956254|Sensory System Agents|sensory system agents|mesh-ancestor
102364616|NCT00956254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102364617|NCT00956254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102364618|NCT00956254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102364619|NCT00956254|Anesthetics, General|anesthetics, general|mesh-ancestor
102364620|NCT00956254|Anesthetics|anesthetics|mesh-ancestor
102364621|NCT03020680|Ubiquinone|ubiquinone|mesh-list
102364622|NCT03020680|Coenzyme Q10|coenzyme q10|mesh-list
102364623|NCT03020680|Micronutrients|micronutrients|mesh-ancestor
102364624|NCT03020680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364625|NCT03020680|Vitamins|vitamins|mesh-ancestor
102364626|NCT01678599|Benzonidazole|benzonidazole|mesh-list
102364627|NCT01678599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102364628|NCT01678599|Immunologic Factors|immunologic factors|mesh-ancestor
102364629|NCT01678599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364631|NCT01678599|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102364632|NCT01678599|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102364633|NCT01678599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102364634|NCT03019822|Amphetamine|amphetamine|mesh-list
102364635|NCT03019822|Dextroamphetamine|dextroamphetamine|mesh-list
102364636|NCT03019822|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
102364637|NCT03019822|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
102364638|NCT03019822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102364639|NCT03019822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364640|NCT03019822|Sympathomimetics|sympathomimetics|mesh-ancestor
102364641|NCT03019822|Autonomic Agents|autonomic agents|mesh-ancestor
102364642|NCT03019822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102364643|NCT03019822|Dopamine Agents|dopamine agents|mesh-ancestor
102364644|NCT03019822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102364645|NCT03019822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364646|NCT03019822|Adrenergic Agents|adrenergic agents|mesh-ancestor
102364647|NCT03019822|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102364648|NCT03019822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102364649|NCT03019822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102364650|NCT03019822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102364651|NCT03019822|Hallucinogens|hallucinogens|mesh-ancestor
102364652|NCT03019822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102364653|NCT03019822|Serotonin Agents|serotonin agents|mesh-ancestor
102364654|NCT03019822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102364655|NCT03019822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102364656|NCT01678677|Vaccines|vaccines|mesh-list
102364657|NCT01678677|Immunologic Factors|immunologic factors|mesh-ancestor
102364658|NCT01678677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364659|NCT00946348|Dronabinol|dronabinol|mesh-list
102364660|NCT00946348|Hallucinogens|hallucinogens|mesh-ancestor
102364661|NCT00946348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364662|NCT00946348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102364663|NCT00946348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102364664|NCT00946348|Analgesics|analgesics|mesh-ancestor
102364665|NCT00946348|Sensory System Agents|sensory system agents|mesh-ancestor
102364666|NCT00946348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102364667|NCT00946348|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102364668|NCT00946348|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102364669|NCT00946348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101567526|NCT02878161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364670|NCT00946348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364671|NCT00946348|Hormones|hormones|mesh-ancestor
102364672|NCT00946348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102364673|NCT00081159|Zoledronic Acid|zoledronic acid|mesh-list
102364674|NCT00081159|Doxorubicin|doxorubicin|mesh-list
102364675|NCT00081159|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102364676|NCT00081159|Leuprolide|leuprolide|mesh-list
102364677|NCT00081159|Goserelin|goserelin|mesh-list
102364678|NCT00081159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102364679|NCT00081159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102364680|NCT00081159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102364681|NCT00081159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102364682|NCT00081159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102364683|NCT00081159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364684|NCT00081159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102364685|NCT00081159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364686|NCT00081159|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102364687|NCT00081159|Fertility Agents|fertility agents|mesh-ancestor
102364688|NCT00081159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102364689|NCT00081159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102364690|NCT03033472|Clindamycin|clindamycin|mesh-list
102364691|NCT03033472|Clindamycin palmitate|clindamycin palmitate|mesh-list
102364692|NCT03033472|Clindamycin phosphate|clindamycin phosphate|mesh-list
102364693|NCT03033472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102364694|NCT03033472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102364695|NCT03033472|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102364696|NCT03033472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102364697|NCT03033472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364698|NCT02981836|Vaccines|vaccines|mesh-list
102364699|NCT02981836|Immunologic Factors|immunologic factors|mesh-ancestor
102364700|NCT02981836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364701|NCT03033160|Estradiol|estradiol|mesh-list
102364702|NCT03033160|Estrogens|estrogens|mesh-ancestor
102364703|NCT03033160|Hormones|hormones|mesh-ancestor
102364704|NCT03033160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102364705|NCT03033160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364706|NCT00958282|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102364707|NCT00958282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102364708|NCT00958282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364709|NCT00958282|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102364710|NCT00958282|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102364711|NCT00958282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102364712|NCT00958282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364713|NCT00958282|Dopamine Agents|dopamine agents|mesh-ancestor
102364714|NCT00958282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102364715|NCT03033316|Dexamethasone|dexamethasone|mesh-list
102364716|NCT03033316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102364717|NCT03033316|Antiemetics|antiemetics|mesh-ancestor
102364718|NCT03033316|Autonomic Agents|autonomic agents|mesh-ancestor
102364719|NCT03033316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102364720|NCT03033316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364721|NCT03033316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102364722|NCT03033316|Glucocorticoids|glucocorticoids|mesh-ancestor
102364723|NCT03033316|Hormones|hormones|mesh-ancestor
102364724|NCT03033316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102364725|NCT03033316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102364726|NCT03033316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102364727|NCT03032848|Estrogens|estrogens|mesh-list
102364728|NCT03032848|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
102364729|NCT03032848|Hormones|hormones|mesh-ancestor
102364730|NCT03032848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102364731|NCT03032848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364732|NCT00080223|Pirfenidone|pirfenidone|mesh-list
102364733|NCT00080223|Analgesics|analgesics|mesh-ancestor
102364734|NCT00080223|Sensory System Agents|sensory system agents|mesh-ancestor
102364735|NCT00080223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102364736|NCT00080223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364737|NCT00080223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102364738|NCT00080223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102364739|NCT00080223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102364740|NCT00080223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102364741|NCT00080223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102364742|NCT04402359|Meropenem|meropenem|mesh-list
102364743|NCT04402359|Ceftazidime|ceftazidime|mesh-list
102364744|NCT04402359|Avibactam|avibactam|mesh-list
102364745|NCT04402359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102364746|NCT04402359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102364747|NCT04402359|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102364748|NCT04402359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102364749|NCT04402359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364750|NCT00959764|Calcitonin|calcitonin|mesh-list
102364751|NCT00959764|Salmon calcitonin|salmon calcitonin|mesh-list
102364752|NCT00959764|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
102364753|NCT00959764|Katacalcin|katacalcin|mesh-list
102364754|NCT00959764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102364755|NCT00959764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364756|NCT00959764|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102364757|NCT00959764|Vasodilator Agents|vasodilator agents|mesh-ancestor
102364758|NCT01005706|Mycophenolic Acid|mycophenolic acid|mesh-list
102364759|NCT01005706|Sirolimus|sirolimus|mesh-list
102364760|NCT01005706|Temsirolimus|temsirolimus|mesh-list
102364761|NCT01005706|MTOR Inhibitors|mtor inhibitors|mesh-list
102364762|NCT01005706|Tacrolimus|tacrolimus|mesh-list
102364763|NCT01005706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102364764|NCT01005706|Immunologic Factors|immunologic factors|mesh-ancestor
102364765|NCT01005706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364766|NCT01005706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102364767|NCT01005706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102364768|NCT01005706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364769|NCT01005706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102364770|NCT01005706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102364771|NCT01005706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102364772|NCT01005706|Antitubercular Agents|antitubercular agents|mesh-ancestor
102364773|NCT01005706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102364774|NCT01005706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102364775|NCT01005706|Antifungal Agents|antifungal agents|mesh-ancestor
102364776|NCT01005706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102176481|NCT00112957|Vaccines|vaccines|mesh-list
102364777|NCT03085485|Ivacaftor|ivacaftor|mesh-list
102364778|NCT03085485|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102364779|NCT03085485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102364780|NCT03085485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364781|NCT01679691|Anesthetics|anesthetics|mesh-list
102364782|NCT01679691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102364783|NCT01679691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364784|NCT03470805|Olaparib|olaparib|mesh-list
102364785|NCT03470805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102364786|NCT03470805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102364787|NCT03470805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364788|NCT03470805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102364789|NCT03088059|Durvalumab|durvalumab|mesh-list
102364790|NCT03088059|Palbociclib|palbociclib|mesh-list
102364791|NCT03088059|Niraparib|niraparib|mesh-list
102364792|NCT03088059|Afatinib|afatinib|mesh-list
102364793|NCT03088059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102364794|NCT03088059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102364795|NCT03088059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102364796|NCT03088059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102364797|NCT03088059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364798|NCT03088059|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102364799|NCT03084549|Ropivacaine|ropivacaine|mesh-list
102364800|NCT03084549|Anesthetics, Local|anesthetics, local|mesh-ancestor
102364801|NCT03084549|Anesthetics|anesthetics|mesh-ancestor
102364802|NCT03084549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102364803|NCT03084549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364804|NCT03084549|Sensory System Agents|sensory system agents|mesh-ancestor
102364805|NCT03084549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102364806|NCT03082521|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102364807|NCT03082521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102364808|NCT03085719|Pembrolizumab|pembrolizumab|mesh-list
102364809|NCT03085719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102364810|NCT03085719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102364811|NCT03085719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102364812|NCT03085719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364813|NCT03080259|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
102364814|NCT03080259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364815|NCT03084861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102364816|NCT03084861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102364817|NCT01006252|Paclitaxel|paclitaxel|mesh-list
102364818|NCT01006252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102364819|NCT01006252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102364820|NCT01006252|Tubulin Modulators|tubulin modulators|mesh-ancestor
102364821|NCT01006252|Antimitotic Agents|antimitotic agents|mesh-ancestor
102364822|NCT01006252|Mitosis Modulators|mitosis modulators|mesh-ancestor
102364823|NCT01006252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364824|NCT03080805|Capecitabine|capecitabine|mesh-list
102364825|NCT03080805|Lapatinib|lapatinib|mesh-list
102364826|NCT03080805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102364827|NCT03080805|Antimetabolites|antimetabolites|mesh-ancestor
102364828|NCT03080805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364829|NCT03080805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102364830|NCT03080805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102364831|NCT03080805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102364832|NCT03019120|Vitamin D|vitamin d|mesh-list
102364833|NCT03019120|Vitamins|vitamins|mesh-ancestor
102364834|NCT03019120|Micronutrients|micronutrients|mesh-ancestor
102364835|NCT03019120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364836|NCT03019120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102364837|NCT00960622|Tenofovir|tenofovir|mesh-list
102364838|NCT00960622|Lamivudine|lamivudine|mesh-list
102364839|NCT00960622|Emtricitabine|emtricitabine|mesh-list
102364840|NCT00960622|Zidovudine|zidovudine|mesh-list
102364841|NCT00960622|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102364842|NCT00960622|Abacavir|abacavir|mesh-list
102364843|NCT00960622|Dideoxynucleosides|dideoxynucleosides|mesh-list
102364844|NCT00960622|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
102364845|NCT00960622|Antiviral Agents|antiviral agents|mesh-ancestor
102364846|NCT00960622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102364847|NCT00960622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102364848|NCT00960622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102364849|NCT00960622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102364850|NCT00960622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364851|NCT00960622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102364852|NCT00960622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102364853|NCT00960622|Antimetabolites|antimetabolites|mesh-ancestor
102364854|NCT03430947|Vemurafenib|vemurafenib|mesh-list
102364855|NCT03430947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102364856|NCT03430947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102364857|NCT03430947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102364858|NCT03430947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364859|NCT00960778|Nicotine|nicotine|mesh-list
102364860|NCT00960778|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102364861|NCT00960778|Autonomic Agents|autonomic agents|mesh-ancestor
102364862|NCT00960778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102364863|NCT00960778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364864|NCT00960778|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102364865|NCT00960778|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102364866|NCT00960778|Cholinergic Agents|cholinergic agents|mesh-ancestor
102364867|NCT00960778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102364868|NCT00960778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364869|NCT03080181|Pasireotide|pasireotide|mesh-list
102364870|NCT03080181|Hormones|hormones|mesh-ancestor
102364871|NCT03080181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102364872|NCT03080181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364873|NCT03088293|Infliximab|infliximab|mesh-list
102364874|NCT03088293|Cyclophosphamide|cyclophosphamide|mesh-list
102364875|NCT03088293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102364876|NCT03088293|Immunologic Factors|immunologic factors|mesh-ancestor
102364877|NCT03088293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364878|NCT03088293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102364879|NCT03088293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102364880|NCT03088293|Alkylating Agents|alkylating agents|mesh-ancestor
101567533|NCT02878161|Antimetabolites|antimetabolites|mesh-ancestor
102364881|NCT03088293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364882|NCT03088293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102364883|NCT03088293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102364884|NCT03088293|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102364885|NCT03088293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102364886|NCT03088293|Dermatologic Agents|dermatologic agents|mesh-ancestor
102364887|NCT03088293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102364888|NCT01008280|Baclofen|baclofen|mesh-list
102364889|NCT01008280|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102364890|NCT01008280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364891|NCT01008280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102364892|NCT01008280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102364893|NCT01008280|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102364894|NCT01008280|GABA Agonists|gaba agonists|mesh-ancestor
102364895|NCT01008280|GABA Agents|gaba agents|mesh-ancestor
102364896|NCT01008280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102364897|NCT01008280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364898|NCT03089073|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
102364899|NCT03089073|Hemostatics|hemostatics|mesh-ancestor
102364900|NCT03089073|Coagulants|coagulants|mesh-ancestor
102364901|NCT03089073|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102364902|NCT03089073|Natriuretic Agents|natriuretic agents|mesh-ancestor
102364903|NCT03089073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364904|NCT05688813|Anesthetics|anesthetics|mesh-list
102364905|NCT05688813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102364906|NCT05688813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364907|NCT01009918|Carvedilol|carvedilol|mesh-list
102364908|NCT01009918|Lisinopril|lisinopril|mesh-list
102364909|NCT01009918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102364910|NCT01009918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102364911|NCT01009918|Adrenergic Agents|adrenergic agents|mesh-ancestor
102364912|NCT01009918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102364913|NCT01009918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364914|NCT01009918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364915|NCT01009918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102364916|NCT01009918|Antioxidants|antioxidants|mesh-ancestor
102364917|NCT01009918|Protective Agents|protective agents|mesh-ancestor
102364918|NCT01009918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102364919|NCT01009918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102364920|NCT01009918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102364921|NCT01009918|Vasodilator Agents|vasodilator agents|mesh-ancestor
102364922|NCT01009918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102364923|NCT01009918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102364924|NCT01009918|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102364925|NCT01009918|Protease Inhibitors|protease inhibitors|mesh-ancestor
102364926|NCT01009918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102364927|NCT01009918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102364928|NCT04401657|Adenosine|adenosine|mesh-list
102364929|NCT04401657|Analgesics|analgesics|mesh-ancestor
102364930|NCT04401657|Sensory System Agents|sensory system agents|mesh-ancestor
102364931|NCT04401657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102364932|NCT04401657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364933|NCT04401657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102364934|NCT04401657|Vasodilator Agents|vasodilator agents|mesh-ancestor
102364935|NCT04401657|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102364936|NCT04401657|Purinergic Agonists|purinergic agonists|mesh-ancestor
102364937|NCT04401657|Purinergic Agents|purinergic agents|mesh-ancestor
102364938|NCT04401657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102364939|NCT04401657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364940|NCT03019198|Tranexamic Acid|tranexamic acid|mesh-list
102364941|NCT03019198|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102364942|NCT03019198|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102364943|NCT03019198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364944|NCT03019198|Hemostatics|hemostatics|mesh-ancestor
102364945|NCT03019198|Coagulants|coagulants|mesh-ancestor
102364946|NCT03083613|Paclitaxel|paclitaxel|mesh-list
102364947|NCT03083613|Raltitrexed|raltitrexed|mesh-list
102364948|NCT03083613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102364949|NCT03083613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102364950|NCT03083613|Tubulin Modulators|tubulin modulators|mesh-ancestor
102364951|NCT03083613|Antimitotic Agents|antimitotic agents|mesh-ancestor
102364952|NCT03083613|Mitosis Modulators|mitosis modulators|mesh-ancestor
102364953|NCT03083613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364954|NCT03083613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102364955|NCT03083613|Antimetabolites|antimetabolites|mesh-ancestor
102364956|NCT03083613|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102364957|NCT03083613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102364958|NCT00963508|Permethrin|permethrin|mesh-list
102364959|NCT00963508|Malathion|malathion|mesh-list
102364960|NCT00963508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102364961|NCT00963508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364962|NCT00963508|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102364963|NCT00963508|Cholinergic Agents|cholinergic agents|mesh-ancestor
102364964|NCT00963508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102364965|NCT00963508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364966|NCT03088371|Lidocaine|lidocaine|mesh-list
102364967|NCT03088371|Bupivacaine|bupivacaine|mesh-list
102364968|NCT03088371|Anesthetics, Local|anesthetics, local|mesh-ancestor
102364969|NCT03088371|Anesthetics|anesthetics|mesh-ancestor
102364970|NCT03088371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102364971|NCT03088371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364972|NCT03088371|Sensory System Agents|sensory system agents|mesh-ancestor
102364973|NCT03088371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102364974|NCT03088371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102364975|NCT03088371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102364976|NCT03088371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102364977|NCT03088371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102364978|NCT03088371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364979|NCT03083691|Nivolumab|nivolumab|mesh-list
102364980|NCT03083691|Ipilimumab|ipilimumab|mesh-list
102364981|NCT03083691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102364982|NCT03083691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102364983|NCT03083691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102364984|NCT03083691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364985|NCT05685537|Simendan|simendan|mesh-list
102364986|NCT05685537|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102364987|NCT05685537|Vasodilator Agents|vasodilator agents|mesh-ancestor
102364988|NCT05685537|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102364989|NCT05685537|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102364990|NCT05685537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102364991|NCT05685537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102364992|NCT05685537|Protective Agents|protective agents|mesh-ancestor
102364993|NCT05685537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102364994|NCT04400721|Ropivacaine|ropivacaine|mesh-list
102364995|NCT04400721|Anesthetics, Local|anesthetics, local|mesh-ancestor
102364996|NCT04400721|Anesthetics|anesthetics|mesh-ancestor
102364997|NCT04400721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102364998|NCT04400721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176705|NCT03209427|Analgesics|analgesics|mesh-ancestor
102365000|NCT04400721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102365001|NCT01010932|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
102365002|NCT01010932|Chelating Agents|chelating agents|mesh-ancestor
102365003|NCT01010932|Sequestering Agents|sequestering agents|mesh-ancestor
102365004|NCT01010932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365005|NCT03018652|Immunoglobulins|immunoglobulins|mesh-list
102365006|NCT03018652|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102365007|NCT03018652|Antibodies|antibodies|mesh-list
102365008|NCT03018652|gamma-Globulins|gamma-globulins|mesh-list
102365009|NCT03018652|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102365010|NCT03018652|Immunologic Factors|immunologic factors|mesh-ancestor
102365011|NCT03018652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365012|NCT01012336|Dexamethasone|dexamethasone|mesh-list
102365013|NCT01012336|Aprepitant|aprepitant|mesh-list
102365014|NCT01012336|Ramosetron|ramosetron|mesh-list
102365015|NCT01012336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102365016|NCT01012336|Antiemetics|antiemetics|mesh-ancestor
102365017|NCT01012336|Autonomic Agents|autonomic agents|mesh-ancestor
102365018|NCT01012336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102365019|NCT01012336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365020|NCT01012336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102365021|NCT01012336|Glucocorticoids|glucocorticoids|mesh-ancestor
102365022|NCT01012336|Hormones|hormones|mesh-ancestor
102365023|NCT01012336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102365024|NCT01012336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102365025|NCT01012336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365026|NCT01012336|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102365027|NCT01012336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102365028|NCT01012336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365029|NCT01012336|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102365030|NCT01012336|Serotonin Agents|serotonin agents|mesh-ancestor
102365031|NCT03387501|Mitogens|mitogens|mesh-list
102365032|NCT03387501|Mitosis Modulators|mitosis modulators|mesh-ancestor
102365033|NCT03387501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365034|NCT01012492|Abatacept|abatacept|mesh-list
102365035|NCT01012492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102365036|NCT01012492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365037|NCT01012492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102365038|NCT01012492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365039|NCT01012492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102365040|NCT01012492|Immunologic Factors|immunologic factors|mesh-ancestor
102365041|NCT01012492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365042|NCT01012492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102365043|NCT05688345|Dexmedetomidine|dexmedetomidine|mesh-list
102365044|NCT05688345|Propofol|propofol|mesh-list
102365045|NCT05688345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102365046|NCT05688345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102365047|NCT05688345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365048|NCT05688345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102365049|NCT05688345|Analgesics|analgesics|mesh-ancestor
102365050|NCT05688345|Sensory System Agents|sensory system agents|mesh-ancestor
102365051|NCT05688345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102365052|NCT05688345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102365053|NCT05688345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102365054|NCT05688345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102365055|NCT05688345|Adrenergic Agents|adrenergic agents|mesh-ancestor
102365056|NCT05688345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102365057|NCT05688345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365058|NCT05688345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102365059|NCT05688345|Anesthetics, General|anesthetics, general|mesh-ancestor
102365060|NCT05688345|Anesthetics|anesthetics|mesh-ancestor
102365061|NCT03083457|Anesthetics|anesthetics|mesh-list
102365062|NCT03083457|Anesthetics, General|anesthetics, general|mesh-list
102365063|NCT03083457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102365064|NCT03083457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365065|NCT04401345|Glycopyrrolate|glycopyrrolate|mesh-list
102365066|NCT04401345|Bromides|bromides|mesh-list
102365067|NCT04401345|Anticonvulsants|anticonvulsants|mesh-ancestor
102365068|NCT04401345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102365069|NCT04401345|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102365070|NCT04401345|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102365071|NCT04401345|Cholinergic Agents|cholinergic agents|mesh-ancestor
102365072|NCT04401345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102365073|NCT04401345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365074|NCT04401345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365075|NCT01015534|Temozolomide|temozolomide|mesh-list
102365076|NCT01015534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102365077|NCT01015534|Alkylating Agents|alkylating agents|mesh-ancestor
102365078|NCT01015534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365079|NCT01015534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365080|NCT00968890|Vaccines|vaccines|mesh-list
102365081|NCT00968890|Immunologic Factors|immunologic factors|mesh-ancestor
102365082|NCT00968890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365083|NCT00970216|Telbivudine|telbivudine|mesh-list
102365084|NCT00970216|Antiviral Agents|antiviral agents|mesh-ancestor
102365085|NCT00970216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102365086|NCT00970216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102365087|NCT00970216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102365088|NCT00970216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365089|NCT00971620|Botulinum Toxins|botulinum toxins|mesh-list
102365090|NCT00971620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102365091|NCT00971620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102365092|NCT00971620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102365093|NCT00971620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102365094|NCT00971620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365095|NCT00971620|Cholinergic Agents|cholinergic agents|mesh-ancestor
102365096|NCT00971620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102365097|NCT00971620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365098|NCT00971620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102365099|NCT00971620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102365100|NCT03384537|Chlorhexidine|chlorhexidine|mesh-list
102365101|NCT03384537|Listerine|listerine|mesh-list
102365102|NCT03384537|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102365103|NCT03384537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102365104|NCT03384537|Disinfectants|disinfectants|mesh-ancestor
102365105|NCT01884922|Vinblastine|vinblastine|mesh-list
102365106|NCT01884922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102365107|NCT01884922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365108|NCT01884922|Tubulin Modulators|tubulin modulators|mesh-ancestor
102365109|NCT01884922|Antimitotic Agents|antimitotic agents|mesh-ancestor
102365110|NCT01884922|Mitosis Modulators|mitosis modulators|mesh-ancestor
102365111|NCT01884922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365112|NCT05687409|Entecavir|entecavir|mesh-list
102365113|NCT05687409|Lactulose|lactulose|mesh-list
102365114|NCT05687409|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102365115|NCT05687409|Antiviral Agents|antiviral agents|mesh-ancestor
102365116|NCT05687409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102365117|NCT05687409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102365118|NCT02162680|Lidocaine|lidocaine|mesh-list
102365119|NCT02162680|Anesthetics, Local|anesthetics, local|mesh-ancestor
102365120|NCT02162680|Anesthetics|anesthetics|mesh-ancestor
102365121|NCT02162680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102365122|NCT02162680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365123|NCT02162680|Sensory System Agents|sensory system agents|mesh-ancestor
102365124|NCT02162680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102365125|NCT02162680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102365126|NCT02162680|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102365127|NCT02162680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102365128|NCT02162680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102365129|NCT02162680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365130|NCT01017250|Bevacizumab|bevacizumab|mesh-list
102365131|NCT01017250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102365132|NCT01017250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365133|NCT01017250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102365134|NCT01017250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102365135|NCT01017250|Growth Substances|growth substances|mesh-ancestor
102365136|NCT01017250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365137|NCT01017250|Growth Inhibitors|growth inhibitors|mesh-ancestor
102365138|NCT00812032|Aspirin|aspirin|mesh-list
102365139|NCT00812032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102365140|NCT00812032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102365141|NCT00812032|Analgesics|analgesics|mesh-ancestor
102365142|NCT00812032|Sensory System Agents|sensory system agents|mesh-ancestor
102365143|NCT00812032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102365144|NCT00812032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365145|NCT00812032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102365146|NCT00812032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102365147|NCT00812032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102365148|NCT00812032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102365149|NCT00812032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365150|NCT00812032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102365151|NCT00812032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102365152|NCT00812032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102365153|NCT00812032|Antipyretics|antipyretics|mesh-ancestor
102365154|NCT02159872|Homoharringtonine|homoharringtonine|mesh-list
102365155|NCT02159872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102365156|NCT02159872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365157|NCT02159872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102365158|NCT02159872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102365159|NCT02159872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365160|NCT00417664|Midazolam|midazolam|mesh-list
102365161|NCT00417664|Dexmedetomidine|dexmedetomidine|mesh-list
102365162|NCT00417664|Propofol|propofol|mesh-list
102365163|NCT00417664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102365164|NCT00417664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102365165|NCT00417664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365166|NCT00417664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102365167|NCT00417664|Analgesics|analgesics|mesh-ancestor
102365168|NCT00417664|Sensory System Agents|sensory system agents|mesh-ancestor
102365169|NCT00417664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102365170|NCT00417664|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102365171|NCT00417664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102365172|NCT00417664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102365173|NCT00417664|Adrenergic Agents|adrenergic agents|mesh-ancestor
102365174|NCT00417664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102365175|NCT00417664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365176|NCT00417664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102365177|NCT00417664|Anesthetics, General|anesthetics, general|mesh-ancestor
102365178|NCT00417664|Anesthetics|anesthetics|mesh-ancestor
102365179|NCT00417664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102365180|NCT00417664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102365181|NCT00417664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102365182|NCT00417664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102365183|NCT00417664|GABA Modulators|gaba modulators|mesh-ancestor
102365184|NCT00417664|GABA Agents|gaba agents|mesh-ancestor
102365185|NCT01021618|Dipyridamole|dipyridamole|mesh-list
102365186|NCT01021618|Regadenoson|regadenoson|mesh-list
102365187|NCT01021618|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
102365188|NCT01021618|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102365189|NCT01021618|Purinergic Agonists|purinergic agonists|mesh-ancestor
102365190|NCT01021618|Purinergic Agents|purinergic agents|mesh-ancestor
102365191|NCT01021618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102365192|NCT01021618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365193|NCT01021618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365194|NCT01021618|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102365195|NCT01021618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102365196|NCT01021618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102365197|NCT01021618|Vasodilator Agents|vasodilator agents|mesh-ancestor
102365198|NCT03082053|Capecitabine|capecitabine|mesh-list
102365199|NCT03082053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102365200|NCT03082053|Antimetabolites|antimetabolites|mesh-ancestor
102365201|NCT03082053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365202|NCT03082053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365203|NCT03358563|Docetaxel|docetaxel|mesh-list
102365204|NCT03358563|Bicalutamide|bicalutamide|mesh-list
102365205|NCT03358563|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102365206|NCT03358563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365207|NCT03358563|Tubulin Modulators|tubulin modulators|mesh-ancestor
102365208|NCT03358563|Antimitotic Agents|antimitotic agents|mesh-ancestor
102365209|NCT03358563|Mitosis Modulators|mitosis modulators|mesh-ancestor
102365210|NCT03358563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365211|NCT03358563|Androgen Antagonists|androgen antagonists|mesh-ancestor
102365212|NCT03358563|Hormone Antagonists|hormone antagonists|mesh-ancestor
102365213|NCT03358563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102365214|NCT03358563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365215|NCT03358563|Hematinics|hematinics|mesh-ancestor
102365216|NCT03358563|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102365217|NCT03358563|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102365218|NCT01018420|Moxifloxacin|moxifloxacin|mesh-list
102365219|NCT01018420|Colchicine|colchicine|mesh-list
102365220|NCT01018420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102176935|NCT03204669|Micronutrients|micronutrients|mesh-list
102365221|NCT01018420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102365222|NCT01018420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102365223|NCT01018420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102365224|NCT01018420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102365225|NCT01018420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365226|NCT01018420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365227|NCT01018420|Gout Suppressants|gout suppressants|mesh-ancestor
102365228|NCT01018420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102365229|NCT01018420|Tubulin Modulators|tubulin modulators|mesh-ancestor
102365230|NCT01018420|Antimitotic Agents|antimitotic agents|mesh-ancestor
102365231|NCT01018420|Mitosis Modulators|mitosis modulators|mesh-ancestor
102365232|NCT00974350|Bupivacaine|bupivacaine|mesh-list
102365233|NCT00974350|Anesthetics, Local|anesthetics, local|mesh-ancestor
102365234|NCT00974350|Anesthetics|anesthetics|mesh-ancestor
102365235|NCT00974350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102365236|NCT00974350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365237|NCT00974350|Sensory System Agents|sensory system agents|mesh-ancestor
102365238|NCT00974350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102365239|NCT05395702|Interferons|interferons|mesh-list
102365240|NCT05395702|Interferon-gamma|interferon-gamma|mesh-list
102365241|NCT05395702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365242|NCT05395702|Antiviral Agents|antiviral agents|mesh-ancestor
102365243|NCT05395702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102365244|NCT01023178|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102365245|NCT01023178|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102365246|NCT01023178|Estradiol|estradiol|mesh-list
102365247|NCT01023178|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102365248|NCT01023178|Estrogens|estrogens|mesh-list
102365249|NCT01023178|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
102365250|NCT01023178|Progesterone|progesterone|mesh-list
102365251|NCT01023178|Hormones|hormones|mesh-ancestor
102365252|NCT01023178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102365253|NCT01023178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365254|NCT01023178|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102365255|NCT01023178|Contraceptive Agents|contraceptive agents|mesh-ancestor
102365256|NCT01023178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102365257|NCT01023178|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102365258|NCT01023178|Progestins|progestins|mesh-ancestor
102365259|NCT03373851|Sufentanil|sufentanil|mesh-list
102365260|NCT03373851|Dsuvia|dsuvia|mesh-list
102365261|NCT03373851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102365262|NCT03373851|Narcotics|narcotics|mesh-ancestor
102365263|NCT03373851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102365264|NCT03373851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365265|NCT03373851|Analgesics|analgesics|mesh-ancestor
102365266|NCT03373851|Sensory System Agents|sensory system agents|mesh-ancestor
102365267|NCT03373851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102365268|NCT03373851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102365269|NCT03373851|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102365270|NCT03373851|Anesthetics, General|anesthetics, general|mesh-ancestor
102365271|NCT03373851|Anesthetics|anesthetics|mesh-ancestor
102365272|NCT05623995|Evolocumab|evolocumab|mesh-list
102365273|NCT05623995|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
102365274|NCT05623995|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
102365275|NCT05623995|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102365276|NCT05623995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102365277|NCT05623995|Antimetabolites|antimetabolites|mesh-ancestor
102365278|NCT05623995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365279|NCT05623995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102365280|NCT05623995|Protease Inhibitors|protease inhibitors|mesh-ancestor
102365281|NCT05623995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102365282|NCT05623995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102365283|NCT01023724|Ketorolac|ketorolac|mesh-list
102365284|NCT01023724|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102365285|NCT01023724|Bromfenac|bromfenac|mesh-list
102365286|NCT01023724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102365287|NCT01023724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102365288|NCT01023724|Analgesics|analgesics|mesh-ancestor
102365289|NCT01023724|Sensory System Agents|sensory system agents|mesh-ancestor
102365290|NCT01023724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102365291|NCT01023724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365292|NCT01023724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102365293|NCT01023724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102365294|NCT01023724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102365295|NCT01023724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102365296|NCT01023724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365297|NCT00974818|Mitomycins|mitomycins|mesh-list
102365298|NCT00974818|Mitomycin|mitomycin|mesh-list
102365299|NCT00974818|BCG Vaccine|bcg vaccine|mesh-list
102365300|NCT00974818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102365301|NCT00974818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365302|NCT00974818|Alkylating Agents|alkylating agents|mesh-ancestor
102365303|NCT00974818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365304|NCT00974818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102365305|NCT00974818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102365306|NCT00974818|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102365307|NCT00974818|Immunologic Factors|immunologic factors|mesh-ancestor
102365308|NCT00974818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365309|NCT03371667|Methotrexate|methotrexate|mesh-list
102365310|NCT03371667|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102365311|NCT03371667|Abortifacient Agents|abortifacient agents|mesh-ancestor
102365312|NCT03371667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102365313|NCT03371667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365314|NCT03371667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102365315|NCT03371667|Antimetabolites|antimetabolites|mesh-ancestor
102365316|NCT03371667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365317|NCT03371667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365318|NCT03371667|Dermatologic Agents|dermatologic agents|mesh-ancestor
102365319|NCT03371667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102365320|NCT03371667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102365321|NCT03371667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102365322|NCT03371667|Immunologic Factors|immunologic factors|mesh-ancestor
102365323|NCT03371667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102365324|NCT03371667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102365325|NCT01024738|Chlorhexidine|chlorhexidine|mesh-list
102365326|NCT01024738|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102365327|NCT01024738|Triclosan|triclosan|mesh-list
102365328|NCT01024738|Fluorides|fluorides|mesh-list
102365329|NCT01024738|Cariostatic Agents|cariostatic agents|mesh-ancestor
102365330|NCT01024738|Protective Agents|protective agents|mesh-ancestor
102365331|NCT01024738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365332|NCT01024738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102365333|NCT01024738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102365334|NCT01024738|Disinfectants|disinfectants|mesh-ancestor
102365335|NCT01024738|Dermatologic Agents|dermatologic agents|mesh-ancestor
102365336|NCT01024738|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102365337|NCT01024738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102365338|NCT01024738|Antimetabolites|antimetabolites|mesh-ancestor
102365339|NCT01024738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365340|NCT01024738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102365341|NCT05613153|Peppermint oil|peppermint oil|mesh-list
102365342|NCT05613153|Antiemetics|antiemetics|mesh-ancestor
102365343|NCT05613153|Autonomic Agents|autonomic agents|mesh-ancestor
102365344|NCT05613153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102365345|NCT05613153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365346|NCT05613153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102365347|NCT05613153|Parasympatholytics|parasympatholytics|mesh-ancestor
102365348|NCT01024972|Mannitol|mannitol|mesh-list
102365349|NCT01024972|Dantrolene|dantrolene|mesh-list
102365350|NCT01024972|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102365351|NCT01024972|Diuretics|diuretics|mesh-ancestor
102365352|NCT01024972|Natriuretic Agents|natriuretic agents|mesh-ancestor
102365353|NCT01024972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365354|NCT01024972|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102365355|NCT01024972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102365356|NCT01024972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102365357|NCT05686395|Bupivacaine|bupivacaine|mesh-list
102365358|NCT05686395|Anesthetics, Local|anesthetics, local|mesh-ancestor
102365359|NCT05686395|Anesthetics|anesthetics|mesh-ancestor
102365360|NCT05686395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102365361|NCT05686395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365362|NCT05686395|Sensory System Agents|sensory system agents|mesh-ancestor
102365363|NCT05686395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102365364|NCT01025830|Lamivudine|lamivudine|mesh-list
102365365|NCT01025830|Nevirapine|nevirapine|mesh-list
102365366|NCT01025830|Stavudine|stavudine|mesh-list
102365367|NCT01025830|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
102365368|NCT01025830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102365369|NCT01025830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102365370|NCT01025830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102365371|NCT01025830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365372|NCT01025830|Antiviral Agents|antiviral agents|mesh-ancestor
102365373|NCT01025830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102365374|NCT01025830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102365375|NCT01025830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102365376|NCT01025830|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102365377|NCT01025830|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102365378|NCT01025830|Antimetabolites|antimetabolites|mesh-ancestor
102365379|NCT03081039|Carboplatin|carboplatin|mesh-list
102365380|NCT03081039|Gemcitabine|gemcitabine|mesh-list
102365381|NCT03081039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365382|NCT03081039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102365383|NCT03081039|Antimetabolites|antimetabolites|mesh-ancestor
102365384|NCT03081039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365385|NCT01026844|Hydroxychloroquine|hydroxychloroquine|mesh-list
102365386|NCT01026844|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102365387|NCT01026844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365388|NCT01026844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102365389|NCT01026844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102365390|NCT01026844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365391|NCT01026844|Antimalarials|antimalarials|mesh-ancestor
102365392|NCT01026844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102365393|NCT01026844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102365394|NCT01026844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102365395|NCT01026844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102365396|NCT00979732|Grape Seed Extract|grape seed extract|mesh-list
102365397|NCT00979732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102365398|NCT00979732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365399|NCT00979732|Antioxidants|antioxidants|mesh-ancestor
102365400|NCT00979732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365401|NCT00979732|Protective Agents|protective agents|mesh-ancestor
102365402|NCT00979732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365403|NCT03321981|Trastuzumab|trastuzumab|mesh-list
102365404|NCT03321981|Letrozole|letrozole|mesh-list
102365405|NCT03321981|Vinorelbine|vinorelbine|mesh-list
102365406|NCT03321981|Fulvestrant|fulvestrant|mesh-list
102365407|NCT03321981|Exemestane|exemestane|mesh-list
102365408|NCT03321981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102365409|NCT03321981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365410|NCT03321981|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102365411|NCT03321981|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102365412|NCT03321981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102365413|NCT03321981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365414|NCT03321981|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102365415|NCT03321981|Hormone Antagonists|hormone antagonists|mesh-ancestor
102365416|NCT03321981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102365417|NCT03321981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365418|NCT03321981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102365419|NCT03321981|Tubulin Modulators|tubulin modulators|mesh-ancestor
102365420|NCT03321981|Antimitotic Agents|antimitotic agents|mesh-ancestor
102365421|NCT03321981|Mitosis Modulators|mitosis modulators|mesh-ancestor
102365422|NCT03321981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102365423|NCT03321981|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102365424|NCT01027468|Bevacizumab|bevacizumab|mesh-list
102365425|NCT01027468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102365426|NCT01027468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365427|NCT01027468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102365428|NCT01027468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102365429|NCT01027468|Growth Substances|growth substances|mesh-ancestor
102365430|NCT01027468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365431|NCT01027468|Growth Inhibitors|growth inhibitors|mesh-ancestor
102365432|NCT05237349|Oxaliplatin|oxaliplatin|mesh-list
102365433|NCT05237349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365434|NCT04278807|Anesthetics|anesthetics|mesh-list
102365435|NCT04278807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102365436|NCT04278807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365437|NCT03344211|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
102365438|NCT03344211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365439|NCT03274401|Anticoagulants|anticoagulants|mesh-list
102365440|NCT05086107|Rifabutin|rifabutin|mesh-list
102365441|NCT05086107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102365442|NCT05086107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102365443|NCT05086107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102365444|NCT05086107|Antitubercular Agents|antitubercular agents|mesh-ancestor
102365445|NCT01029730|Rituximab|rituximab|mesh-list
102365446|NCT01029730|Bortezomib|bortezomib|mesh-list
102365447|NCT01029730|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102365448|NCT01029730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102177161|NCT03197571|Avelumab|avelumab|mesh-list
102365449|NCT01029730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365450|NCT01029730|Immunologic Factors|immunologic factors|mesh-ancestor
102365451|NCT01029730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365452|NCT01029730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102365453|NCT01029730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102365454|NCT01029730|Alkylating Agents|alkylating agents|mesh-ancestor
102365455|NCT01029730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365456|NCT05066997|Dexamethasone|dexamethasone|mesh-list
102365457|NCT05066997|Dexamethasone acetate|dexamethasone acetate|mesh-list
102365458|NCT05066997|BB 1101|bb 1101|mesh-list
102365459|NCT05066997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102365460|NCT05066997|Antiemetics|antiemetics|mesh-ancestor
102365461|NCT05066997|Autonomic Agents|autonomic agents|mesh-ancestor
102365462|NCT05066997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102365463|NCT05066997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365464|NCT05066997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102365465|NCT05066997|Glucocorticoids|glucocorticoids|mesh-ancestor
102365466|NCT05066997|Hormones|hormones|mesh-ancestor
102365467|NCT05066997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102365468|NCT05066997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102365469|NCT05066997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365470|NCT05066997|Protease Inhibitors|protease inhibitors|mesh-ancestor
102365471|NCT05066997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102365472|NCT05066997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365473|NCT05025033|Paclitaxel|paclitaxel|mesh-list
102365474|NCT05025033|Irinotecan|irinotecan|mesh-list
102365475|NCT05025033|Apatinib|apatinib|mesh-list
102365476|NCT05025033|Antibodies|antibodies|mesh-list
102365477|NCT05025033|Immunoglobulins|immunoglobulins|mesh-list
102365478|NCT05025033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102365479|NCT05025033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365480|NCT05025033|Tubulin Modulators|tubulin modulators|mesh-ancestor
102365481|NCT05025033|Antimitotic Agents|antimitotic agents|mesh-ancestor
102365482|NCT05025033|Mitosis Modulators|mitosis modulators|mesh-ancestor
102365483|NCT05025033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365484|NCT05025033|Immunologic Factors|immunologic factors|mesh-ancestor
102365485|NCT05025033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365486|NCT05025033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102365487|NCT05025033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102365488|NCT05025033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102365489|NCT05025033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102365490|NCT00980746|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102365491|NCT00980746|Anticonvulsants|anticonvulsants|mesh-ancestor
102365492|NCT00980746|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102365493|NCT00980746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102365494|NCT00980746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102365495|NCT00980746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365496|NCT00981214|Pancrelipase|pancrelipase|mesh-list
102365497|NCT00981214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102365498|NCT05415657|Denosumab|denosumab|mesh-list
102365499|NCT05415657|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102365500|NCT05415657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365501|NCT03016234|Propofol|propofol|mesh-list
102365502|NCT03016234|Desflurane|desflurane|mesh-list
102365503|NCT03016234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102365504|NCT03016234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102365505|NCT03016234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365506|NCT03016234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102365507|NCT03016234|Anesthetics, General|anesthetics, general|mesh-ancestor
102365508|NCT03016234|Anesthetics|anesthetics|mesh-ancestor
102365509|NCT03016234|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102365510|NCT02167204|Alovudine|alovudine|mesh-list
102365511|NCT02167204|Antiviral Agents|antiviral agents|mesh-ancestor
102365512|NCT02167204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102365513|NCT00982072|Prednisolone|prednisolone|mesh-list
102365514|NCT00982072|Tacrolimus|tacrolimus|mesh-list
102365515|NCT00982072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102365516|NCT00982072|Immunologic Factors|immunologic factors|mesh-ancestor
102365517|NCT00982072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365518|NCT00982072|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102365519|NCT00982072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102365520|NCT00982072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365521|NCT00982072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102365522|NCT00982072|Glucocorticoids|glucocorticoids|mesh-ancestor
102365523|NCT00982072|Hormones|hormones|mesh-ancestor
102365524|NCT00982072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102365525|NCT00982072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102365526|NCT00982072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365527|NCT01899053|Serabelisib|serabelisib|mesh-list
102365528|NCT01899053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102365529|NCT01899053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365530|NCT01032694|Azithromycin|azithromycin|mesh-list
102365531|NCT01032694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102365532|NCT01032694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102365533|NCT04957095|Levodopa|levodopa|mesh-list
102365534|NCT04957095|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102365535|NCT04957095|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102365536|NCT04957095|Dopamine Agents|dopamine agents|mesh-ancestor
102365537|NCT04957095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102365538|NCT04957095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365539|NCT04957095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365540|NCT01032850|Capecitabine|capecitabine|mesh-list
102365541|NCT01032850|Sorafenib|sorafenib|mesh-list
102365542|NCT01032850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102365543|NCT01032850|Antimetabolites|antimetabolites|mesh-ancestor
102365544|NCT01032850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365545|NCT01032850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365546|NCT01032850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102365547|NCT01032850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102365548|NCT00983242|Colchicine|colchicine|mesh-list
102365549|NCT00983242|Verapamil|verapamil|mesh-list
102365550|NCT00983242|Gout Suppressants|gout suppressants|mesh-ancestor
102365551|NCT00983242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102365552|NCT00983242|Tubulin Modulators|tubulin modulators|mesh-ancestor
102365553|NCT00983242|Antimitotic Agents|antimitotic agents|mesh-ancestor
102365554|NCT00983242|Mitosis Modulators|mitosis modulators|mesh-ancestor
102365555|NCT00983242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365556|NCT00983242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365557|NCT00983242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102365558|NCT00983242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102365559|NCT00983242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102365560|NCT00983242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102365561|NCT00983242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365562|NCT00983242|Vasodilator Agents|vasodilator agents|mesh-ancestor
102365563|NCT00984334|Naloxone|naloxone|mesh-list
102365564|NCT00984334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102365565|NCT00984334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365566|NCT00984334|Sensory System Agents|sensory system agents|mesh-ancestor
102365567|NCT00984334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102365568|NCT02168062|Leuprolide|leuprolide|mesh-list
102365569|NCT02168062|Goserelin|goserelin|mesh-list
102365570|NCT02168062|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102365571|NCT02168062|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102365572|NCT02168062|Fertility Agents|fertility agents|mesh-ancestor
102365573|NCT02168062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102365574|NCT02168062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365575|NCT02168062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102365576|NCT02168062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365577|NCT02168062|Luteolytic Agents|luteolytic agents|mesh-ancestor
102365578|NCT02168062|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102365579|NCT02168062|Contraceptive Agents|contraceptive agents|mesh-ancestor
102365580|NCT02168062|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102365581|NCT01888367|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102365582|NCT01888367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102365583|NCT05343117|Palbociclib|palbociclib|mesh-list
102365584|NCT05343117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365585|NCT05343117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102365586|NCT05343117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102365587|NCT05343117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365588|NCT01898195|Varenicline|varenicline|mesh-list
102365589|NCT01898195|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102365590|NCT01898195|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102365591|NCT01898195|Cholinergic Agents|cholinergic agents|mesh-ancestor
102365592|NCT01898195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102365593|NCT01898195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365594|NCT01898195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365595|NCT01897727|Spironolactone|spironolactone|mesh-list
102365596|NCT01897727|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102365597|NCT01897727|Hormone Antagonists|hormone antagonists|mesh-ancestor
102365598|NCT01897727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102177319|NCT02446431|GABA Agents|gaba agents|mesh-ancestor
102365599|NCT01897727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365600|NCT01897727|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102365601|NCT01897727|Diuretics|diuretics|mesh-ancestor
102365602|NCT01897727|Natriuretic Agents|natriuretic agents|mesh-ancestor
102365603|NCT01897493|Digoxin|digoxin|mesh-list
102365604|NCT01897493|Evacetrapib|evacetrapib|mesh-list
102365605|NCT01897493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102365606|NCT01897493|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102365607|NCT01897493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102365608|NCT01897493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365609|NCT01897493|Protective Agents|protective agents|mesh-ancestor
102365610|NCT01897493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365611|NCT01897493|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102365612|NCT01897493|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102365613|NCT01897493|Antimetabolites|antimetabolites|mesh-ancestor
102365614|NCT01897493|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102365615|NCT01887353|Ranolazine|ranolazine|mesh-list
102365616|NCT01887353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102365617|NCT01887353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102365618|NCT01887353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365619|NCT00988156|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102365620|NCT00988156|Anticonvulsants|anticonvulsants|mesh-ancestor
102365621|NCT00988156|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102365622|NCT00988156|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102365623|NCT00988156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102365624|NCT00988156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365625|NCT02160730|Roscovitine|roscovitine|mesh-list
102365626|NCT02160730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365627|NCT02160730|Antiviral Agents|antiviral agents|mesh-ancestor
102365628|NCT02160730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102365629|NCT02160730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102365630|NCT02160730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102365631|NCT02160730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365632|NCT03329313|Dialysis Solutions|dialysis solutions|mesh-list
102365633|NCT03329313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102365634|NCT01896869|Ipilimumab|ipilimumab|mesh-list
102365635|NCT01896869|Folfirinox|folfirinox|mesh-list
102365636|NCT01896869|Vaccines|vaccines|mesh-list
102365637|NCT01896869|Immunologic Factors|immunologic factors|mesh-ancestor
102365638|NCT01896869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365639|NCT01896869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102365640|NCT01896869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365641|NCT01896869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102365642|NCT01896869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365643|NCT03329001|Niraparib|niraparib|mesh-list
102365644|NCT03329001|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102365645|NCT03329001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102365646|NCT03329001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365647|NCT03329001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365648|NCT01896557|Omeprazole|omeprazole|mesh-list
102365649|NCT01896557|Ranitidine|ranitidine|mesh-list
102365650|NCT01896557|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
102365651|NCT01896557|Clopidogrel|clopidogrel|mesh-list
102365652|NCT01896557|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
102365653|NCT01896557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102365654|NCT01896557|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102365655|NCT01896557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102365656|NCT01896557|Purinergic Agents|purinergic agents|mesh-ancestor
102365657|NCT01896557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102365658|NCT01896557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365659|NCT01896557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365660|NCT01896557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102365661|NCT01896557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102365662|NCT01896557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102365663|NCT01896557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102365664|NCT01896557|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102365665|NCT01896557|Histamine Antagonists|histamine antagonists|mesh-ancestor
102365666|NCT01896557|Histamine Agents|histamine agents|mesh-ancestor
102365667|NCT02160808|Secretin|secretin|mesh-list
102365668|NCT02160808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102365669|NCT02160808|Hormones|hormones|mesh-ancestor
102365670|NCT02160808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102365671|NCT02160808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365672|NCT01886105|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
102365673|NCT01886105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102365675|NCT01886105|Sensory System Agents|sensory system agents|mesh-ancestor
102365676|NCT01886105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102365677|NCT01886105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365678|NCT03262779|Nivolumab|nivolumab|mesh-list
102365679|NCT03262779|Ipilimumab|ipilimumab|mesh-list
102365680|NCT03262779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102365681|NCT03262779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365682|NCT03262779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102365683|NCT03262779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365684|NCT05022394|Nivolumab|nivolumab|mesh-list
102365685|NCT05022394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102365686|NCT05022394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365687|NCT05022394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102365688|NCT05022394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365689|NCT01895777|Dabigatran|dabigatran|mesh-list
102365690|NCT01895777|Antithrombins|antithrombins|mesh-ancestor
102365691|NCT01895777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102365692|NCT01895777|Protease Inhibitors|protease inhibitors|mesh-ancestor
102365693|NCT01895777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102365694|NCT01895777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365695|NCT01895777|Anticoagulants|anticoagulants|mesh-ancestor
102365696|NCT00992602|Cytarabine|cytarabine|mesh-list
102365697|NCT00992602|Methotrexate|methotrexate|mesh-list
102365698|NCT00992602|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102365699|NCT00992602|Abortifacient Agents|abortifacient agents|mesh-ancestor
102365700|NCT00992602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102365701|NCT00992602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365702|NCT00992602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102365703|NCT00992602|Antimetabolites|antimetabolites|mesh-ancestor
102365704|NCT00992602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365705|NCT00992602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365706|NCT00992602|Dermatologic Agents|dermatologic agents|mesh-ancestor
102365707|NCT00992602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102365708|NCT00992602|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102365709|NCT00992602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102365710|NCT00992602|Immunologic Factors|immunologic factors|mesh-ancestor
102365711|NCT00992602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102365712|NCT00992602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102365713|NCT00992602|Antiviral Agents|antiviral agents|mesh-ancestor
102365714|NCT00992602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102365715|NCT00993226|Bupivacaine|bupivacaine|mesh-list
102365716|NCT00993226|Anesthetics, Local|anesthetics, local|mesh-ancestor
102365717|NCT00993226|Anesthetics|anesthetics|mesh-ancestor
102365718|NCT00993226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102365719|NCT00993226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365720|NCT00993226|Sensory System Agents|sensory system agents|mesh-ancestor
102365721|NCT00993226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102365722|NCT01885559|Telmisartan|telmisartan|mesh-list
102365723|NCT01885559|Lisinopril|lisinopril|mesh-list
102365724|NCT01885559|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102365725|NCT01885559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102365726|NCT01885559|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102365727|NCT01885559|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102365728|NCT01885559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365729|NCT01885559|Protease Inhibitors|protease inhibitors|mesh-ancestor
102365730|NCT01885559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102365731|NCT01885559|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102365732|NCT01885559|Protective Agents|protective agents|mesh-ancestor
102365733|NCT01885559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365734|NCT00994318|Ferric Compounds|ferric compounds|mesh-list
102365735|NCT00994318|Hematinics|hematinics|mesh-ancestor
102365736|NCT00995722|Prednisone|prednisone|mesh-list
102365737|NCT00995722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102365738|NCT00995722|Glucocorticoids|glucocorticoids|mesh-ancestor
102365739|NCT00995722|Hormones|hormones|mesh-ancestor
102365740|NCT00995722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102365741|NCT00995722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365742|NCT00995722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102365743|NCT00995722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365744|NCT00996346|Sirolimus|sirolimus|mesh-list
102365745|NCT00996346|Irinotecan|irinotecan|mesh-list
102365746|NCT00996346|Temsirolimus|temsirolimus|mesh-list
102365747|NCT00996346|MTOR Inhibitors|mtor inhibitors|mesh-list
102365748|NCT00996346|Complement Factor H|complement factor h|mesh-list
102365749|NCT00996346|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102365750|NCT00996346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102365751|NCT00996346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102365752|NCT00996346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365753|NCT00996346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365754|NCT00996346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102365755|NCT00996346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102365756|NCT00996346|Immunologic Factors|immunologic factors|mesh-ancestor
102365757|NCT00996346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365758|NCT00996346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102365759|NCT00996346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102365760|NCT00996346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102365761|NCT00996346|Antifungal Agents|antifungal agents|mesh-ancestor
102365762|NCT00996346|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102365764|NCT03016468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102365765|NCT00997204|Icatibant|icatibant|mesh-list
102365766|NCT00997204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102365767|NCT00997204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102365768|NCT00997204|Analgesics|analgesics|mesh-ancestor
102365769|NCT00997204|Sensory System Agents|sensory system agents|mesh-ancestor
102365770|NCT00997204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102365771|NCT00997204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365772|NCT00997204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102365773|NCT00997204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102365774|NCT00997204|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
102365775|NCT00997204|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
102365776|NCT00997204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365777|NCT00997204|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102365778|NCT00997204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102365779|NCT00997204|Immunologic Factors|immunologic factors|mesh-ancestor
102365780|NCT04263610|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102365781|NCT04263610|Dermatologic Agents|dermatologic agents|mesh-ancestor
102365782|NCT04263610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102365783|NCT04263610|Immunologic Factors|immunologic factors|mesh-ancestor
102365784|NCT04263610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365785|NCT04225390|Dacarbazine|dacarbazine|mesh-list
102365786|NCT04225390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102365787|NCT04225390|Alkylating Agents|alkylating agents|mesh-ancestor
102365788|NCT04225390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365789|NCT04225390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365790|NCT00997672|Lithium Carbonate|lithium carbonate|mesh-list
102365791|NCT00997672|Antidepressive Agents|antidepressive agents|mesh-ancestor
102365792|NCT00997672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102365793|NCT00997672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102365794|NCT00997672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365795|NCT00997672|Antimanic Agents|antimanic agents|mesh-ancestor
102365796|NCT00997672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102365797|NCT00997672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102365798|NCT00997672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365799|NCT04606797|Nicotine|nicotine|mesh-list
102365800|NCT04606797|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102365801|NCT04606797|Autonomic Agents|autonomic agents|mesh-ancestor
102365802|NCT04606797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102365803|NCT04606797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365804|NCT04606797|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102365805|NCT04606797|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102365806|NCT04606797|Cholinergic Agents|cholinergic agents|mesh-ancestor
102365807|NCT04606797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102365808|NCT04606797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365809|NCT02164240|Sunitinib|sunitinib|mesh-list
102365810|NCT02164240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365811|NCT02164240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102365812|NCT02164240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102365813|NCT02164240|Growth Substances|growth substances|mesh-ancestor
102365814|NCT02164240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365815|NCT02164240|Growth Inhibitors|growth inhibitors|mesh-ancestor
102365816|NCT02164240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102365817|NCT02164240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102365818|NCT02164240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365819|NCT02169466|Opicapone|opicapone|mesh-list
102177541|NCT03193749|Amiodarone|amiodarone|mesh-list
102365820|NCT02169466|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
102365821|NCT02169466|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102365822|NCT02169466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102365823|NCT02169466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365824|NCT02169466|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102365825|NCT02169466|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102365826|NCT02169466|Dopamine Agents|dopamine agents|mesh-ancestor
102365827|NCT02169466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102365828|NCT02169466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365830|NCT01001806|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102365831|NCT01001806|Nepafenac|nepafenac|mesh-list
102365832|NCT01001806|Bromfenac|bromfenac|mesh-list
102365833|NCT01001806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102365834|NCT01001806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102365835|NCT01001806|Analgesics|analgesics|mesh-ancestor
102365836|NCT01001806|Sensory System Agents|sensory system agents|mesh-ancestor
102365837|NCT01001806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102365838|NCT01001806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365839|NCT01001806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102365840|NCT01001806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102365841|NCT01001806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102365842|NCT01001806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102365843|NCT01001806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365844|NCT04021264|Sufentanil|sufentanil|mesh-list
102365845|NCT04021264|Ropivacaine|ropivacaine|mesh-list
102365846|NCT04021264|Anesthetics, Local|anesthetics, local|mesh-ancestor
102365847|NCT04021264|Anesthetics|anesthetics|mesh-ancestor
102365848|NCT04021264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102365849|NCT04021264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365850|NCT04021264|Sensory System Agents|sensory system agents|mesh-ancestor
102365851|NCT04021264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102365852|NCT04021264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102365853|NCT04021264|Narcotics|narcotics|mesh-ancestor
102365854|NCT04021264|Analgesics|analgesics|mesh-ancestor
102365855|NCT04021264|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102365856|NCT04021264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102365857|NCT04021264|Anesthetics, General|anesthetics, general|mesh-ancestor
102365858|NCT03233139|Paclitaxel|paclitaxel|mesh-list
102365859|NCT03233139|Gemcitabine|gemcitabine|mesh-list
102365860|NCT03233139|Pemetrexed|pemetrexed|mesh-list
102365861|NCT03233139|Ipilimumab|ipilimumab|mesh-list
102365862|NCT03233139|Cemiplimab|cemiplimab|mesh-list
102365863|NCT03233139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102365864|NCT03233139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365865|NCT03233139|Tubulin Modulators|tubulin modulators|mesh-ancestor
102365866|NCT03233139|Antimitotic Agents|antimitotic agents|mesh-ancestor
102365867|NCT03233139|Mitosis Modulators|mitosis modulators|mesh-ancestor
102365868|NCT03233139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365869|NCT03233139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102365870|NCT03233139|Antimetabolites|antimetabolites|mesh-ancestor
102365871|NCT03233139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102365872|NCT03233139|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102365873|NCT03233139|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102365874|NCT03233139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102365875|NCT03233139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102365876|NCT04763343|Ketamine|ketamine|mesh-list
102365877|NCT04763343|Analgesics|analgesics|mesh-ancestor
102365878|NCT04763343|Sensory System Agents|sensory system agents|mesh-ancestor
102365879|NCT04763343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102365880|NCT04763343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365881|NCT04763343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102365882|NCT04763343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102365883|NCT04763343|Anesthetics, General|anesthetics, general|mesh-ancestor
102365884|NCT04763343|Anesthetics|anesthetics|mesh-ancestor
102365885|NCT04763343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102365886|NCT04763343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102365887|NCT04763343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102365888|NCT04763343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102365889|NCT04763343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365890|NCT04757571|Paroxetine|paroxetine|mesh-list
102365891|NCT04757571|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102365892|NCT04757571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102365893|NCT04757571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102177614|NCT02444559|Clonidine|clonidine|mesh-list
102365894|NCT04757571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365895|NCT04757571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102365896|NCT04757571|Serotonin Agents|serotonin agents|mesh-ancestor
102365897|NCT04757571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365898|NCT04757571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102365899|NCT04757571|Antidepressive Agents|antidepressive agents|mesh-ancestor
102365900|NCT04757571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102365901|NCT04757571|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102365902|NCT04757571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102365903|NCT04757571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102365904|NCT03232593|Atezolizumab|atezolizumab|mesh-list
102365905|NCT03232593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102365906|NCT03232593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365907|NCT03232593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102365908|NCT03232593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365909|NCT04746183|Ritonavir|ritonavir|mesh-list
102365910|NCT04746183|Nitazoxanide|nitazoxanide|mesh-list
102365911|NCT04746183|Favipiravir|favipiravir|mesh-list
102365912|NCT04746183|Nirmatrelvir|nirmatrelvir|mesh-list
102365913|NCT04746183|Sotrovimab|sotrovimab|mesh-list
102365914|NCT04746183|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
102365915|NCT04746183|Molnupiravir|molnupiravir|mesh-list
102365916|NCT04746183|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102365917|NCT04746183|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102365918|NCT04746183|Protease Inhibitors|protease inhibitors|mesh-ancestor
102365919|NCT04746183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102365920|NCT04746183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365921|NCT04746183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102365922|NCT04746183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102365923|NCT04746183|Antiviral Agents|antiviral agents|mesh-ancestor
102365924|NCT04746183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102365925|NCT04746183|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102365926|NCT04746183|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102365927|NCT04746183|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102365928|NCT01895309|Etanercept|etanercept|mesh-list
102365929|NCT01895309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102365930|NCT01895309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102365931|NCT01895309|Analgesics|analgesics|mesh-ancestor
102365932|NCT01895309|Sensory System Agents|sensory system agents|mesh-ancestor
102365933|NCT01895309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102365934|NCT01895309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365935|NCT01895309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102365936|NCT01895309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102365937|NCT01895309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102365938|NCT01895309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102365939|NCT01895309|Immunologic Factors|immunologic factors|mesh-ancestor
102365940|NCT04614311|Triamcinolone|triamcinolone|mesh-list
102365941|NCT04614311|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102365942|NCT04614311|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102365943|NCT04614311|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102365944|NCT04614311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102365945|NCT04614311|Glucocorticoids|glucocorticoids|mesh-ancestor
102365946|NCT04614311|Hormones|hormones|mesh-ancestor
102365947|NCT04614311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102365948|NCT04614311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365949|NCT04614311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102365950|NCT04614311|Immunologic Factors|immunologic factors|mesh-ancestor
102365951|NCT04614311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102365952|NCT04614311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365953|NCT03285321|Nivolumab|nivolumab|mesh-list
102365954|NCT03285321|Ipilimumab|ipilimumab|mesh-list
102365955|NCT03285321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102365956|NCT03285321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365957|NCT03285321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102365958|NCT03285321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365959|NCT05066698|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102365960|NCT05066698|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102365961|NCT04323748|Rituximab|rituximab|mesh-list
102365962|NCT04323748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102365963|NCT04323748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365964|NCT04323748|Immunologic Factors|immunologic factors|mesh-ancestor
102365965|NCT04323748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365966|NCT04323748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102177686|NCT02373202|Analgesics|analgesics|mesh-ancestor
102365967|NCT04197310|Nivolumab|nivolumab|mesh-list
102365968|NCT04197310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102365969|NCT04197310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102365970|NCT04197310|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102365971|NCT04197310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365972|NCT05320731|Lidocaine|lidocaine|mesh-list
102365973|NCT05320731|Anesthetics, Local|anesthetics, local|mesh-ancestor
102365974|NCT05320731|Anesthetics|anesthetics|mesh-ancestor
102365975|NCT05320731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102365976|NCT05320731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365977|NCT05320731|Sensory System Agents|sensory system agents|mesh-ancestor
102365978|NCT05320731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102365979|NCT05320731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102365980|NCT05320731|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102365981|NCT05320731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102365982|NCT05320731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102365983|NCT05320731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102365984|NCT02808364|Vaccines|vaccines|mesh-list
102365985|NCT02808364|Immunologic Factors|immunologic factors|mesh-ancestor
102365986|NCT02808364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365987|NCT02709616|Vaccines|vaccines|mesh-list
102365988|NCT02709616|Immunologic Factors|immunologic factors|mesh-ancestor
102365989|NCT02709616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365990|NCT04534881|Progesterone|progesterone|mesh-list
102365991|NCT04534881|Progestins|progestins|mesh-ancestor
102365992|NCT04534881|Hormones|hormones|mesh-ancestor
102365993|NCT04534881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102365994|NCT04534881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102365995|NCT04817956|Trastuzumab|trastuzumab|mesh-list
102365996|NCT04817956|Atezolizumab|atezolizumab|mesh-list
102365997|NCT04817956|Pertuzumab|pertuzumab|mesh-list
102365998|NCT04817956|Vemurafenib|vemurafenib|mesh-list
102365999|NCT04817956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102366000|NCT04817956|Entrectinib|entrectinib|mesh-list
102366001|NCT04817956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102366002|NCT04817956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102366003|NCT04817956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366004|NCT04817956|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102366005|NCT04817956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366006|NCT04817956|Immunologic Factors|immunologic factors|mesh-ancestor
102366007|NCT04817956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102366008|NCT04817956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102366009|NCT01894919|Vaccines|vaccines|mesh-list
102366010|NCT01894919|Immunologic Factors|immunologic factors|mesh-ancestor
102366011|NCT01894919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366012|NCT04130698|Nicotine|nicotine|mesh-list
102366013|NCT04130698|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102366014|NCT04130698|Autonomic Agents|autonomic agents|mesh-ancestor
102366015|NCT04130698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102366016|NCT04130698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366017|NCT04130698|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102366018|NCT04130698|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102366019|NCT04130698|Cholinergic Agents|cholinergic agents|mesh-ancestor
102366020|NCT04130698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101567588|NCT01092507|Vaccines|vaccines|mesh-list
102366021|NCT04130698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366022|NCT05306223|Levofloxacin|levofloxacin|mesh-list
102366023|NCT05306223|Cycloserine|cycloserine|mesh-list
102366024|NCT05306223|Linezolid|linezolid|mesh-list
102366025|NCT05306223|Pyrazinamide|pyrazinamide|mesh-list
102366026|NCT05306223|Bedaquiline|bedaquiline|mesh-list
102366027|NCT05306223|Clofazimine|clofazimine|mesh-list
102366028|NCT05306223|Prothionamide|prothionamide|mesh-list
102366029|NCT05306223|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102366030|NCT05306223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102366031|NCT05306223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102366032|NCT05306223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102366033|NCT05306223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102366034|NCT05306223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102366035|NCT05306223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366036|NCT05306223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102366037|NCT05306223|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102366038|NCT05306223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102366039|NCT05306223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102366040|NCT05306223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102366041|NCT05306223|Antitubercular Agents|antitubercular agents|mesh-ancestor
102177760|NCT02442921|Colchicine|colchicine|mesh-list
102366042|NCT05306223|Antimetabolites|antimetabolites|mesh-ancestor
102366043|NCT05306223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102366044|NCT05306223|Leprostatic Agents|leprostatic agents|mesh-ancestor
102366045|NCT03016000|Thalidomide|thalidomide|mesh-list
102366046|NCT03016000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102366047|NCT03016000|Immunologic Factors|immunologic factors|mesh-ancestor
102366048|NCT03016000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366049|NCT03016000|Leprostatic Agents|leprostatic agents|mesh-ancestor
102366050|NCT03016000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102366051|NCT03016000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102366052|NCT03016000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102366053|NCT03016000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102366054|NCT03016000|Growth Substances|growth substances|mesh-ancestor
102366055|NCT03016000|Growth Inhibitors|growth inhibitors|mesh-ancestor
102366056|NCT03016000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102366057|NCT04130152|Letrozole|letrozole|mesh-list
102366058|NCT04130152|Palbociclib|palbociclib|mesh-list
102366059|NCT04130152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102366060|NCT04130152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102366061|NCT04130152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102366062|NCT04130152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102366063|NCT04130152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366064|NCT04130152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102366065|NCT04130152|Hormone Antagonists|hormone antagonists|mesh-ancestor
102366066|NCT04130152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102366067|NCT04130152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366068|NCT04130152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102366069|NCT03254589|Sulfasalazine|sulfasalazine|mesh-list
102366070|NCT03254589|Methotrexate|methotrexate|mesh-list
102366071|NCT03254589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102366072|NCT03254589|Abortifacient Agents|abortifacient agents|mesh-ancestor
102366073|NCT03254589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102366074|NCT03254589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366075|NCT03254589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102366076|NCT03254589|Antimetabolites|antimetabolites|mesh-ancestor
102366077|NCT03254589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366078|NCT03254589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102366079|NCT03254589|Dermatologic Agents|dermatologic agents|mesh-ancestor
102366080|NCT03254589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102366081|NCT03254589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102366082|NCT03254589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102366083|NCT03254589|Immunologic Factors|immunologic factors|mesh-ancestor
102366084|NCT03254589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102366085|NCT03254589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102366086|NCT03254589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102366087|NCT03254589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102366088|NCT03254589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102366089|NCT03254589|Analgesics|analgesics|mesh-ancestor
102366090|NCT03254589|Sensory System Agents|sensory system agents|mesh-ancestor
102366091|NCT03254589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102366092|NCT03254589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102366093|NCT03254589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102366094|NCT04399395|Naltrexone|naltrexone|mesh-list
102366095|NCT04399395|Bupropion|bupropion|mesh-list
102366096|NCT04399395|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102366097|NCT04399395|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102366098|NCT04399395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366099|NCT04399395|Sensory System Agents|sensory system agents|mesh-ancestor
102366100|NCT04399395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102366101|NCT04399395|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102366102|NCT04399395|Antidepressive Agents|antidepressive agents|mesh-ancestor
102366103|NCT04399395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102366104|NCT04399395|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102366105|NCT04399395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102366106|NCT04399395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102366107|NCT04399395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366108|NCT04399395|Dopamine Agents|dopamine agents|mesh-ancestor
102366109|NCT04399395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102366110|NCT04399395|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102366111|NCT04399395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102366112|NCT04399395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102366113|NCT02000596|Trastuzumab|trastuzumab|mesh-list
102366114|NCT02000596|Pertuzumab|pertuzumab|mesh-list
102177842|NCT04923152|Antimetabolites|antimetabolites|mesh-ancestor
102366115|NCT02000596|Fulvestrant|fulvestrant|mesh-list
102366116|NCT02000596|Anastrozole|anastrozole|mesh-list
102366117|NCT02000596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102366118|NCT02000596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102366119|NCT02000596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102366120|NCT02000596|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102366121|NCT02000596|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102366122|NCT02000596|Hormone Antagonists|hormone antagonists|mesh-ancestor
102366123|NCT02000596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102366124|NCT02000596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366125|NCT02000596|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102366126|NCT02000596|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102366127|NCT02000596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102366128|NCT02000596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366129|NCT03223779|Trifluridine|trifluridine|mesh-list
102366130|NCT03223779|Antimetabolites|antimetabolites|mesh-ancestor
102366131|NCT03223779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366132|NCT03223779|Antiviral Agents|antiviral agents|mesh-ancestor
102366133|NCT03223779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102366134|NCT05168865|Letrozole|letrozole|mesh-list
102366135|NCT05168865|Estradiol|estradiol|mesh-list
102366136|NCT05168865|Progesterone|progesterone|mesh-list
102366137|NCT05168865|Estrogens|estrogens|mesh-ancestor
102366138|NCT05168865|Hormones|hormones|mesh-ancestor
102366139|NCT05168865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102366140|NCT05168865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366141|NCT05168865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102366142|NCT05168865|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102366143|NCT05168865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102366144|NCT05168865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102366145|NCT05168865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366146|NCT05168865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102366147|NCT05168865|Hormone Antagonists|hormone antagonists|mesh-ancestor
102366148|NCT05168865|Progestins|progestins|mesh-ancestor
102366149|NCT01882985|Lycopene|lycopene|mesh-list
102366150|NCT01882985|Docetaxel|docetaxel|mesh-list
102366151|NCT01882985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102366152|NCT01882985|Tubulin Modulators|tubulin modulators|mesh-ancestor
102366153|NCT01882985|Antimitotic Agents|antimitotic agents|mesh-ancestor
102366154|NCT01882985|Mitosis Modulators|mitosis modulators|mesh-ancestor
102366155|NCT01882985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366156|NCT01882985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102366157|NCT01882985|Antioxidants|antioxidants|mesh-ancestor
102366158|NCT01882985|Protective Agents|protective agents|mesh-ancestor
102366159|NCT01882985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366160|NCT01882985|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102366161|NCT01882985|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102366162|NCT02166346|4-Aminopyridine|4-aminopyridine|mesh-list
102366163|NCT02166346|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102366164|NCT02166346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102366165|NCT02166346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366166|NCT04460235|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102366167|NCT04460235|Immunologic Factors|immunologic factors|mesh-ancestor
102366168|NCT04460235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366169|NCT03015922|Lenalidomide|lenalidomide|mesh-list
102366170|NCT03015922|Pomalidomide|pomalidomide|mesh-list
102366171|NCT03015922|Immunologic Factors|immunologic factors|mesh-ancestor
102366172|NCT03015922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366173|NCT03015922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102366174|NCT03015922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102366175|NCT03015922|Growth Substances|growth substances|mesh-ancestor
102366176|NCT03015922|Growth Inhibitors|growth inhibitors|mesh-ancestor
102366177|NCT03015922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102366178|NCT01893827|Naltrexone|naltrexone|mesh-list
102366179|NCT01893827|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102366180|NCT01893827|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102366181|NCT01893827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366182|NCT01893827|Sensory System Agents|sensory system agents|mesh-ancestor
102366183|NCT01893827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102366184|NCT01882907|Pioglitazone|pioglitazone|mesh-list
102366185|NCT01882907|Vildagliptin|vildagliptin|mesh-list
102366186|NCT01882907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102366187|NCT01882907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366188|NCT01882907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102366189|NCT01882907|Protease Inhibitors|protease inhibitors|mesh-ancestor
102366190|NCT01882907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102366191|NCT01882907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366192|NCT01051570|Prednisone|prednisone|mesh-list
102366193|NCT01051570|Carboplatin|carboplatin|mesh-list
102366194|NCT01051570|Everolimus|everolimus|mesh-list
102366195|NCT01051570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102366196|NCT01051570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102366197|NCT01051570|Glucocorticoids|glucocorticoids|mesh-ancestor
102366198|NCT01051570|Hormones|hormones|mesh-ancestor
102366199|NCT01051570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102366200|NCT01051570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366201|NCT01051570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102366202|NCT01051570|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102366203|NCT01051570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102366204|NCT01051570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102366205|NCT01051570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366206|NCT01051570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102366207|NCT01051570|Immunologic Factors|immunologic factors|mesh-ancestor
102366208|NCT01893281|Methyltestosterone|methyltestosterone|mesh-list
102366209|NCT01893281|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102366210|NCT01893281|Testosterone|testosterone|mesh-list
102366211|NCT01893281|Testosterone undecanoate|testosterone undecanoate|mesh-list
102366212|NCT01893281|Testosterone enanthate|testosterone enanthate|mesh-list
102366213|NCT01893281|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102366214|NCT01893281|Androgens|androgens|mesh-ancestor
102366215|NCT01893281|Hormones|hormones|mesh-ancestor
102366216|NCT01893281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102366217|NCT01893281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366218|NCT01893281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102366219|NCT01893281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102366220|NCT01893281|Anabolic Agents|anabolic agents|mesh-ancestor
102366221|NCT02981446|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102366222|NCT02981446|Latanoprost|latanoprost|mesh-list
102366223|NCT02981446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102366224|NCT01893203|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102366225|NCT01893203|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102366226|NCT01893203|Dermatologic Agents|dermatologic agents|mesh-ancestor
102366227|NCT05263947|Bevacizumab|bevacizumab|mesh-list
102366228|NCT05263947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102366229|NCT05263947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102366230|NCT05263947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102366231|NCT05263947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102366232|NCT05263947|Growth Substances|growth substances|mesh-ancestor
102366233|NCT05263947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366234|NCT05263947|Growth Inhibitors|growth inhibitors|mesh-ancestor
102366235|NCT04415567|Lenvatinib|lenvatinib|mesh-list
102366236|NCT04415567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102366237|NCT04415567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102366238|NCT04415567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102366239|NCT04415567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366240|NCT03280251|Methylphenidate|methylphenidate|mesh-list
102366241|NCT03280251|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102366242|NCT03280251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366243|NCT03280251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102366244|NCT03280251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102366245|NCT03280251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102366246|NCT03280251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366247|NCT03280251|Dopamine Agents|dopamine agents|mesh-ancestor
102366248|NCT03280251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102366249|NCT01882829|Quinidine|quinidine|mesh-list
102366250|NCT01882829|Dextromethorphan|dextromethorphan|mesh-list
102366251|NCT01882829|Antitussive Agents|antitussive agents|mesh-ancestor
102366252|NCT01882829|Respiratory System Agents|respiratory system agents|mesh-ancestor
102366253|NCT01882829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102366254|NCT01882829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102366255|NCT01882829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102366256|NCT01882829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366257|NCT01882829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366258|NCT01882829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102366259|NCT01882829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102366260|NCT01882829|Adrenergic Agents|adrenergic agents|mesh-ancestor
102366261|NCT01882829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102366262|NCT01882829|Antimalarials|antimalarials|mesh-ancestor
102177987|NCT03053414|Vitamin D|vitamin d|mesh-list
102366263|NCT01882829|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102366264|NCT01882829|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102366265|NCT01882829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102366266|NCT01882829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102366267|NCT01882829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102366268|NCT01882829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102366269|NCT01882829|Cholinergic Agents|cholinergic agents|mesh-ancestor
102366270|NCT01882829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102366271|NCT01882829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102366272|NCT01882829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102366273|NCT01882829|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102366274|NCT01882829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102366276|NCT04760301|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102366277|NCT04760301|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102366278|NCT04760301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366279|NCT04760301|Hemostatics|hemostatics|mesh-ancestor
102366280|NCT04760301|Coagulants|coagulants|mesh-ancestor
102366281|NCT01054768|Thioctic Acid|thioctic acid|mesh-list
102366282|NCT01054768|Acetylcarnitine|acetylcarnitine|mesh-list
102366283|NCT01054768|Antioxidants|antioxidants|mesh-ancestor
102366284|NCT01054768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366285|NCT01054768|Protective Agents|protective agents|mesh-ancestor
102366286|NCT01054768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366287|NCT01054768|Vitamin B Complex|vitamin b complex|mesh-ancestor
102366288|NCT01054768|Vitamins|vitamins|mesh-ancestor
102366289|NCT01054768|Micronutrients|micronutrients|mesh-ancestor
102366290|NCT01054768|Nootropic Agents|nootropic agents|mesh-ancestor
102366291|NCT04387617|Cannabidiol|cannabidiol|mesh-list
102366292|NCT04387617|Anticonvulsants|anticonvulsants|mesh-ancestor
102366293|NCT03014830|Alirocumab|alirocumab|mesh-list
102366294|NCT03014830|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102366295|NCT03014830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102366296|NCT03014830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102366297|NCT03014830|Antimetabolites|antimetabolites|mesh-ancestor
102366298|NCT03014830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366299|NCT03014830|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102366300|NCT03014830|Protease Inhibitors|protease inhibitors|mesh-ancestor
102366301|NCT03014830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102366302|NCT03014830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102366303|NCT01055704|Naltrexone|naltrexone|mesh-list
102366304|NCT01055704|Codeine|codeine|mesh-list
102366305|NCT01055704|Methylnaltrexone|methylnaltrexone|mesh-list
102366306|NCT01055704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102366307|NCT01055704|Narcotics|narcotics|mesh-ancestor
102366308|NCT01055704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102366309|NCT01055704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366310|NCT01055704|Analgesics|analgesics|mesh-ancestor
102366311|NCT01055704|Sensory System Agents|sensory system agents|mesh-ancestor
102366312|NCT01055704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102366313|NCT01055704|Antitussive Agents|antitussive agents|mesh-ancestor
102366314|NCT01055704|Respiratory System Agents|respiratory system agents|mesh-ancestor
102366315|NCT01055704|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102366316|NCT01055704|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102366317|NCT03280017|Ketamine|ketamine|mesh-list
102366318|NCT03280017|Analgesics|analgesics|mesh-ancestor
102366319|NCT03280017|Sensory System Agents|sensory system agents|mesh-ancestor
102366320|NCT03280017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102366321|NCT03280017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366322|NCT03280017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102366323|NCT03280017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102366324|NCT03280017|Anesthetics, General|anesthetics, general|mesh-ancestor
102366325|NCT03280017|Anesthetics|anesthetics|mesh-ancestor
102366326|NCT03280017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102366327|NCT03280017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102366328|NCT03280017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102366329|NCT03280017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102366330|NCT03280017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366331|NCT01882439|Tofacitinib|tofacitinib|mesh-list
102366332|NCT01882439|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102366333|NCT01882439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102366334|NCT01882439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102178061|NCT04890626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366335|NCT01882439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366336|NCT04400019|Hydroxychloroquine|hydroxychloroquine|mesh-list
102366337|NCT04400019|Antimalarials|antimalarials|mesh-ancestor
102366338|NCT04400019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102366339|NCT04400019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102366340|NCT04400019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102366341|NCT04400019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102366342|NCT04400019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366343|NCT04400019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102366344|NCT05225805|Lefamulin|lefamulin|mesh-list
102366345|NCT05225805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102366346|NCT05225805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102366347|NCT03915405|Avelumab|avelumab|mesh-list
102366348|NCT03915405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102366349|NCT03915405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102366350|NCT04351581|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102366351|NCT04351581|Protease Inhibitors|protease inhibitors|mesh-ancestor
102366352|NCT04351581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102366353|NCT04351581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366354|NCT01109056|Cyclosporine|cyclosporine|mesh-list
102366355|NCT01109056|Cyclosporins|cyclosporins|mesh-list
102366356|NCT01109056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102366357|NCT01109056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366358|NCT01109056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102366359|NCT01109056|Immunologic Factors|immunologic factors|mesh-ancestor
102366360|NCT01109056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366361|NCT01109056|Antifungal Agents|antifungal agents|mesh-ancestor
102366362|NCT01109056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102366363|NCT01109056|Dermatologic Agents|dermatologic agents|mesh-ancestor
102366364|NCT01109056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102366365|NCT01109056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102366366|NCT03870399|Tamoxifen|tamoxifen|mesh-list
102366367|NCT03870399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102366368|NCT03870399|Hormone Antagonists|hormone antagonists|mesh-ancestor
102366369|NCT03870399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102366370|NCT03870399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366371|NCT03870399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102366372|NCT03870399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102366373|NCT03870399|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102366374|NCT03870399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102366375|NCT03870399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102366376|NCT04333407|Aspirin|aspirin|mesh-list
102366377|NCT04333407|Omeprazole|omeprazole|mesh-list
102366378|NCT04333407|Rivaroxaban|rivaroxaban|mesh-list
102366379|NCT04333407|Clopidogrel|clopidogrel|mesh-list
102366380|NCT04333407|Atorvastatin|atorvastatin|mesh-list
102366381|NCT04333407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102366382|NCT04333407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102366383|NCT04333407|Analgesics|analgesics|mesh-ancestor
102366384|NCT04333407|Sensory System Agents|sensory system agents|mesh-ancestor
102366385|NCT04333407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102366386|NCT04333407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366387|NCT04333407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102366388|NCT04333407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102366389|NCT04333407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102366390|NCT04333407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102366391|NCT04333407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366392|NCT04333407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102366393|NCT04333407|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102366394|NCT04333407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102366395|NCT04333407|Antipyretics|antipyretics|mesh-ancestor
102366396|NCT04333407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102366397|NCT04333407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102366398|NCT04333407|Antimetabolites|antimetabolites|mesh-ancestor
102366399|NCT04333407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102366400|NCT04333407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102366401|NCT04333407|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102366402|NCT04333407|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102366403|NCT04333407|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102366404|NCT04333407|Purinergic Agents|purinergic agents|mesh-ancestor
102366405|NCT04333407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102366406|NCT04333407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102366407|NCT04333407|Antithrombins|antithrombins|mesh-ancestor
102366408|NCT04333407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102366409|NCT04333407|Protease Inhibitors|protease inhibitors|mesh-ancestor
102366410|NCT04333407|Anticoagulants|anticoagulants|mesh-ancestor
102366411|NCT04333407|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102366412|NCT04333407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102366413|NCT04333407|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102366414|NCT04398927|Folfirinox|folfirinox|mesh-list
102366415|NCT04398927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102366416|NCT01059682|Dalcetrapib|dalcetrapib|mesh-list
102366417|NCT01059682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102366418|NCT01059682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102366419|NCT01059682|Antimetabolites|antimetabolites|mesh-ancestor
102366420|NCT01059682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366421|NCT01059682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102366422|NCT04399083|Caffeine|caffeine|mesh-list
102366423|NCT04399083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102366424|NCT04399083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366425|NCT04399083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102366426|NCT04399083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102366427|NCT04399083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366428|NCT04399083|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102366429|NCT04399083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102366430|NCT04399083|Purinergic Agents|purinergic agents|mesh-ancestor
102366431|NCT04399083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102366432|NCT01892345|Eculizumab|eculizumab|mesh-list
102366433|NCT01892345|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102366434|NCT01892345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102366435|NCT01892345|Immunologic Factors|immunologic factors|mesh-ancestor
102366436|NCT01892345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366437|NCT01059994|Sildenafil Citrate|sildenafil citrate|mesh-list
102366438|NCT01059994|Vasodilator Agents|vasodilator agents|mesh-ancestor
102366439|NCT01059994|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102366440|NCT01059994|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102366441|NCT01059994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102366442|NCT01059994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366443|NCT01059994|Urological Agents|urological agents|mesh-ancestor
102366444|NCT01111318|Empagliflozin|empagliflozin|mesh-list
102366445|NCT01111318|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102366446|NCT01111318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366447|NCT01111318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102366448|NCT01111318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366449|NCT01892189|Ketamine|ketamine|mesh-list
102366450|NCT01892189|Analgesics|analgesics|mesh-ancestor
102366451|NCT01892189|Sensory System Agents|sensory system agents|mesh-ancestor
102366452|NCT01892189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102366453|NCT01892189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366454|NCT01892189|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102366455|NCT01892189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102366456|NCT01892189|Anesthetics, General|anesthetics, general|mesh-ancestor
102366457|NCT01892189|Anesthetics|anesthetics|mesh-ancestor
102366458|NCT01892189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102366459|NCT01892189|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102366460|NCT01892189|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102366461|NCT01892189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102366462|NCT01892189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366463|NCT01062568|Dexamethasone|dexamethasone|mesh-list
102366464|NCT01062568|Cosyntropin|cosyntropin|mesh-list
102366465|NCT01062568|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102366466|NCT01062568|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
102366467|NCT01062568|beta-Endorphin|beta-endorphin|mesh-list
102366468|NCT01062568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102366469|NCT01062568|Antiemetics|antiemetics|mesh-ancestor
102366470|NCT01062568|Autonomic Agents|autonomic agents|mesh-ancestor
102366471|NCT01062568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102366472|NCT01062568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366473|NCT01062568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102366474|NCT01062568|Glucocorticoids|glucocorticoids|mesh-ancestor
102366475|NCT01062568|Hormones|hormones|mesh-ancestor
102366476|NCT01062568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102366477|NCT01062568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102366478|NCT01062568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102366479|NCT01062568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102366480|NCT01062568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366481|NCT05155137|Amlodipine|amlodipine|mesh-list
102366482|NCT05155137|Valsartan|valsartan|mesh-list
102366483|NCT05155137|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102366484|NCT05155137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102366485|NCT05155137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102178210|NCT04906304|Cyclosporine|cyclosporine|mesh-list
102366486|NCT05155137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102366487|NCT05155137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366488|NCT05155137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102366489|NCT05155137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366490|NCT05155137|Vasodilator Agents|vasodilator agents|mesh-ancestor
102366491|NCT05155137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102366492|NCT05155137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102366493|NCT05155137|Antimetabolites|antimetabolites|mesh-ancestor
102366494|NCT05155137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102366495|NCT05155137|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102366496|NCT05155137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102366497|NCT05155137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102366498|NCT05155137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102366499|NCT01064284|Factor VIII|factor viii|mesh-list
102366500|NCT01064284|Coagulants|coagulants|mesh-ancestor
102366501|NCT01064362|Heparin|heparin|mesh-list
102366502|NCT01064362|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102366503|NCT01064362|Tinzaparin|tinzaparin|mesh-list
102366504|NCT01064362|Dalteparin|dalteparin|mesh-list
102366505|NCT01064362|PENTA|penta|mesh-list
102366506|NCT01064362|Fondaparinux|fondaparinux|mesh-list
102366507|NCT01064362|Anticoagulants|anticoagulants|mesh-ancestor
102366508|NCT01064362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102366509|NCT01064362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102366510|NCT01064362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366511|NCT01064362|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102366512|NCT01064362|Antithrombins|antithrombins|mesh-ancestor
102366513|NCT01064362|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102366514|NCT01064362|Protease Inhibitors|protease inhibitors|mesh-ancestor
102366515|NCT01064362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102366516|NCT03646461|Nivolumab|nivolumab|mesh-list
102366517|NCT03646461|Cetuximab|cetuximab|mesh-list
102366518|NCT03646461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102366519|NCT03646461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102366520|NCT03646461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102366521|NCT03646461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366522|NCT01880957|Lamotrigine|lamotrigine|mesh-list
102366523|NCT01880957|Lithium Carbonate|lithium carbonate|mesh-list
101567684|NCT01198548|Vitamins|vitamins|mesh-ancestor
102366524|NCT01880957|Antidepressive Agents|antidepressive agents|mesh-ancestor
102366525|NCT01880957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101567907|NCT02866396|Pregabalin|pregabalin|mesh-list
102366526|NCT01880957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101568129|NCT00993148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101568203|NCT02555839|Immunologic Factors|immunologic factors|mesh-ancestor
101568285|NCT02850289|Ribavirin|ribavirin|mesh-list
102366527|NCT01880957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568429|NCT01868269|Rituximab|rituximab|mesh-list
102366528|NCT01880957|Antimanic Agents|antimanic agents|mesh-ancestor
102366529|NCT01880957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102366530|NCT01880957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102366531|NCT01880957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366532|NCT01880957|Anticonvulsants|anticonvulsants|mesh-ancestor
102366533|NCT01880957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102366534|NCT01880957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102366535|NCT01880957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102366536|NCT01880957|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102366537|NCT01880957|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101569014|NCT02846857|Glucagon|glucagon|mesh-list
102366538|NCT01064830|Cyclosporine|cyclosporine|mesh-list
102366539|NCT01064830|Cyclosporins|cyclosporins|mesh-list
101569257|NCT05337085|Midazolam|midazolam|mesh-list
102366540|NCT01064830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102366541|NCT01064830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366542|NCT01064830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102366543|NCT01064830|Immunologic Factors|immunologic factors|mesh-ancestor
101569534|NCT01229111|Leucovorin|leucovorin|mesh-list
101569705|NCT00893737|Naproxen|naproxen|mesh-list
101569765|NCT02837965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102366544|NCT01064830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366545|NCT01064830|Antifungal Agents|antifungal agents|mesh-ancestor
102366546|NCT01064830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102366547|NCT01064830|Dermatologic Agents|dermatologic agents|mesh-ancestor
102366548|NCT01064830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101570135|NCT00630214|Calcium, Dietary|calcium, dietary|mesh-list
102366549|NCT01064830|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101570287|NCT04281862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102366550|NCT01890785|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102366551|NCT01890785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101570605|NCT00953680|Losartan|losartan|mesh-list
101570661|NCT02829385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102366552|NCT01890785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570734|NCT02829151|Aspirin|aspirin|mesh-list
101570807|NCT02824315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102366553|NCT01890785|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101570955|NCT00957424|Nicotine|nicotine|mesh-list
102366554|NCT01890785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102366555|NCT01890785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102366556|NCT01890785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366557|NCT01890785|Dopamine Agents|dopamine agents|mesh-ancestor
102366558|NCT01890785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101571260|NCT04237987|Analgesics|analgesics|mesh-ancestor
102366559|NCT01066624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102366561|NCT01066624|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102366562|NCT01066624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366563|NCT04398771|Valsartan|valsartan|mesh-list
101571624|NCT02809573|Prednisone|prednisone|mesh-list
102366564|NCT04398771|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102366565|NCT04398771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102366566|NCT04398771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102366567|NCT04398771|Antimetabolites|antimetabolites|mesh-ancestor
101571997|NCT04301895|Remifentanil|remifentanil|mesh-list
101572070|NCT02806375|Fludarabine|fludarabine|mesh-list
101572146|NCT02800135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101572220|NCT02801305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102366568|NCT04398771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572373|NCT04235569|Enoxaparin sodium|enoxaparin sodium|mesh-list
101572453|NCT04200235|Analgesics|analgesics|mesh-ancestor
102366569|NCT04398771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101572525|NCT01196052|Immunotoxins|immunotoxins|mesh-ancestor
102366570|NCT04398771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102366571|NCT04398771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102366572|NCT04398771|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102366573|NCT04398771|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102366574|NCT04398771|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101572820|NCT02781415|Morphine|morphine|mesh-list
102366575|NCT01863953|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101572968|NCT02780011|Immunotoxins|immunotoxins|mesh-ancestor
102366576|NCT01863953|Bimatoprost|bimatoprost|mesh-list
102366577|NCT01863953|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101573113|NCT01194258|Insulin Lispro|insulin lispro|mesh-list
102366578|NCT01863953|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101573191|NCT02776813|Rituximab|rituximab|mesh-list
102366579|NCT01863953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101573263|NCT04771741|Antidepressive Agents|antidepressive agents|mesh-ancestor
102366580|NCT01863953|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101573413|NCT02771743|Dermatologic Agents|dermatologic agents|mesh-ancestor
102366581|NCT01863953|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102366582|NCT01863953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101573639|NCT00951496|Bevacizumab|bevacizumab|mesh-list
102366583|NCT01863953|Adrenergic Agents|adrenergic agents|mesh-ancestor
101573814|NCT00635323|Antimetabolites|antimetabolites|mesh-ancestor
102366584|NCT01863953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101573902|NCT04529005|Giapreza|giapreza|mesh-list
102154440|NCT05063006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102366585|NCT01863953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366586|NCT01863953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366587|NCT01068964|Timolol|timolol|mesh-list
102366588|NCT01068964|Bimatoprost|bimatoprost|mesh-list
102366589|NCT01068964|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102366590|NCT01068964|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102366591|NCT01068964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102366592|NCT01068964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102154810|NCT04444011|Amoxicillin|amoxicillin|mesh-list
102366593|NCT01068964|Adrenergic Agents|adrenergic agents|mesh-ancestor
102366594|NCT01068964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102154959|NCT05737784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366595|NCT01068964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366596|NCT01068964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366597|NCT01068964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102366598|NCT01068964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102366599|NCT03217162|Pulmonary Surfactants|pulmonary surfactants|mesh-list
102366600|NCT03217162|Respiratory System Agents|respiratory system agents|mesh-ancestor
102366601|NCT02984475|Metformin|metformin|mesh-list
102366602|NCT02984475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102366603|NCT02984475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366604|NCT01069354|Lidocaine|lidocaine|mesh-list
102155034|NCT04508439|Anticoagulants|anticoagulants|mesh-ancestor
102366605|NCT01069354|Anesthetics, Local|anesthetics, local|mesh-ancestor
102366606|NCT01069354|Anesthetics|anesthetics|mesh-ancestor
102155247|NCT03352869|Incretins|incretins|mesh-ancestor
102366607|NCT01069354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102155470|NCT03898154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102366608|NCT01069354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366609|NCT01069354|Sensory System Agents|sensory system agents|mesh-ancestor
102366610|NCT01069354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102155547|NCT05730608|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102366611|NCT01069354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102155616|NCT05083286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366612|NCT01069354|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102155767|NCT03346629|Oxytocics|oxytocics|mesh-ancestor
102155834|NCT03121833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102155835|NCT03121521|Melatonin|melatonin|mesh-list
102155836|NCT03121521|Antioxidants|antioxidants|mesh-ancestor
102155837|NCT03121521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155838|NCT03121521|Protective Agents|protective agents|mesh-ancestor
102155839|NCT03121521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155840|NCT03121521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102155908|NCT03345303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102366613|NCT01069354|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102366614|NCT01069354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102366615|NCT01069354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366616|NCT03080974|Nivolumab|nivolumab|mesh-list
102366617|NCT03080974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102156278|NCT03710876|Antimetabolites|antimetabolites|mesh-ancestor
102366618|NCT03080974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102366619|NCT03080974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102366620|NCT03080974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366621|NCT01069510|Spironolactone|spironolactone|mesh-list
102366622|NCT01069510|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102156580|NCT02508753|Moxifloxacin|moxifloxacin|mesh-list
102366623|NCT01069510|Hormone Antagonists|hormone antagonists|mesh-ancestor
102369687|NCT04450134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369688|NCT04450134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156878|NCT04482686|Antioxidants|antioxidants|mesh-ancestor
102369689|NCT04450134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102157098|NCT02982668|Metoclopramide|metoclopramide|mesh-list
102366624|NCT01069510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102366625|NCT01069510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366626|NCT01069510|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102157322|NCT04595864|Leucovorin|leucovorin|mesh-list
102366627|NCT01069510|Diuretics|diuretics|mesh-ancestor
102157393|NCT05087732|Lidocaine|lidocaine|mesh-list
102366628|NCT01069510|Natriuretic Agents|natriuretic agents|mesh-ancestor
102366629|NCT04278495|Losartan|losartan|mesh-list
102366630|NCT04278495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102366631|NCT04278495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102366632|NCT04278495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102157764|NCT02655224|Relugolix|relugolix|mesh-list
102366633|NCT04278495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102157928|NCT04247750|Sirolimus|sirolimus|mesh-list
102158003|NCT03328533|Nasal Decongestants|nasal decongestants|mesh-ancestor
102158081|NCT03120663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102158153|NCT00706797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102158235|NCT01758614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102366634|NCT04278495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366635|NCT04276545|Midazolam|midazolam|mesh-list
102366636|NCT04276545|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102158317|NCT02492373|Glucocorticoids|glucocorticoids|mesh-ancestor
102366637|NCT04276545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102366638|NCT04276545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102366639|NCT04276545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366640|NCT04276545|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102366641|NCT04276545|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102366642|NCT04276545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102158863|NCT02489019|Fentanyl|fentanyl|mesh-list
102366643|NCT04276545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102366644|NCT04276545|Anesthetics, General|anesthetics, general|mesh-ancestor
102366645|NCT04276545|Anesthetics|anesthetics|mesh-ancestor
102366646|NCT04276545|GABA Modulators|gaba modulators|mesh-ancestor
102366647|NCT04276545|GABA Agents|gaba agents|mesh-ancestor
102366648|NCT04276545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102159285|NCT02485821|Misoprostol|misoprostol|mesh-list
102366649|NCT04276545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366650|NCT01117948|Lornoxicam|lornoxicam|mesh-list
102159431|NCT02484963|GABA Agonists|gaba agonists|mesh-ancestor
102366651|NCT01117948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102366652|NCT01117948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102159587|NCT03563365|Adapalene|adapalene|mesh-list
102366653|NCT01117948|Analgesics|analgesics|mesh-ancestor
102366654|NCT01117948|Sensory System Agents|sensory system agents|mesh-ancestor
102159733|NCT05870917|Growth Substances|growth substances|mesh-ancestor
102366655|NCT01117948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102159807|NCT05870111|Lipotropic Agents|lipotropic agents|mesh-ancestor
102159958|NCT05553522|Antimetabolites|antimetabolites|mesh-ancestor
102366656|NCT01117948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160090|NCT05382338|Mesna|mesna|mesh-list
102160185|NCT05179733|Immunologic Factors|immunologic factors|mesh-ancestor
102160299|NCT04940065|Ofatumumab|ofatumumab|mesh-list
102160337|NCT04908189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160338|NCT04908189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102160339|NCT04908189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102160340|NCT04908189|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102160341|NCT04908189|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102366657|NCT01117948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102366658|NCT01117948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102366659|NCT03602157|Fludarabine|fludarabine|mesh-list
102366660|NCT03602157|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102366661|NCT03602157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102366662|NCT03602157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366663|NCT03602157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102366664|NCT03602157|Alkylating Agents|alkylating agents|mesh-ancestor
102366665|NCT03014440|Cannabidiol|cannabidiol|mesh-list
102366666|NCT03014440|Anticonvulsants|anticonvulsants|mesh-ancestor
102366667|NCT03013036|Fentanyl|fentanyl|mesh-list
102366668|NCT03013036|Midazolam|midazolam|mesh-list
102366669|NCT03013036|Propofol|propofol|mesh-list
102366670|NCT03013036|Sevoflurane|sevoflurane|mesh-list
102366671|NCT03013036|Rocuronium|rocuronium|mesh-list
102160640|NCT04015700|Vaccines|vaccines|mesh-list
102366672|NCT03013036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102366673|NCT03013036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102366674|NCT03013036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366675|NCT03013036|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102366676|NCT03013036|Anesthetics, General|anesthetics, general|mesh-ancestor
102366677|NCT03013036|Anesthetics|anesthetics|mesh-ancestor
102366678|NCT03013036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102366679|NCT03013036|Narcotics|narcotics|mesh-ancestor
102366680|NCT03013036|Analgesics|analgesics|mesh-ancestor
102366681|NCT03013036|Sensory System Agents|sensory system agents|mesh-ancestor
102366682|NCT03013036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102366683|NCT03013036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102366684|NCT03013036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102366685|NCT03013036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102366686|NCT03013036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102366687|NCT03013036|GABA Modulators|gaba modulators|mesh-ancestor
102366688|NCT03013036|GABA Agents|gaba agents|mesh-ancestor
102366689|NCT03013036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102366690|NCT03013036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366691|NCT03013036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102366692|NCT03013036|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102366693|NCT03013036|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102366694|NCT03013036|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102366695|NCT03013036|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102366696|NCT01071538|Buprenorphine|buprenorphine|mesh-list
102366697|NCT01071538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102366698|NCT01071538|Narcotics|narcotics|mesh-ancestor
102366699|NCT01071538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102366700|NCT01071538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366701|NCT01071538|Analgesics|analgesics|mesh-ancestor
102366702|NCT01071538|Sensory System Agents|sensory system agents|mesh-ancestor
102366703|NCT01071538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102366704|NCT01071538|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102366705|NCT04352686|Buspirone|buspirone|mesh-list
102366706|NCT04352686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102366707|NCT04352686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102366708|NCT04352686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102366709|NCT04352686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366710|NCT04352686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102366711|NCT04352686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102366712|NCT04352686|Serotonin Agents|serotonin agents|mesh-ancestor
102366713|NCT04352686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102366714|NCT04352686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366715|NCT03146091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102366716|NCT03146091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102366717|NCT02287311|Cyclophosphamide|cyclophosphamide|mesh-list
102366718|NCT02287311|Fludarabine|fludarabine|mesh-list
102366719|NCT02287311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102366720|NCT02287311|Immunologic Factors|immunologic factors|mesh-ancestor
102366721|NCT02287311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366722|NCT02287311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102366723|NCT02287311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102366724|NCT02287311|Alkylating Agents|alkylating agents|mesh-ancestor
102366725|NCT02287311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366726|NCT02287311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102366727|NCT02287311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102366728|NCT02172742|Digoxin|digoxin|mesh-list
102366729|NCT02172742|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102366730|NCT02172742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102366731|NCT02172742|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102366732|NCT02172742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102366733|NCT02172742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366734|NCT02172742|Protective Agents|protective agents|mesh-ancestor
102366735|NCT02172742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366736|NCT02172742|Anticonvulsants|anticonvulsants|mesh-ancestor
102366737|NCT02172742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102366738|NCT02172742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102366739|NCT02172742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102366740|NCT01075204|Clarithromycin|clarithromycin|mesh-list
102366741|NCT01075204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102366742|NCT01075204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102366743|NCT01075204|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102366744|NCT01075204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102366745|NCT01075204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366746|NCT01075204|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102366747|NCT01075204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102366748|NCT01120834|Azacitidine|azacitidine|mesh-list
102366749|NCT01120834|Vorinostat|vorinostat|mesh-list
102366750|NCT01120834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102366751|NCT01120834|Antimetabolites|antimetabolites|mesh-ancestor
102366752|NCT01120834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366753|NCT01120834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102366754|NCT01120834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102366755|NCT01120834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102366756|NCT01122160|Omeprazole|omeprazole|mesh-list
102366757|NCT01122160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102366758|NCT01122160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102366759|NCT01122160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102366760|NCT01122160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102366761|NCT01122160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366762|NCT02623816|Omeprazole|omeprazole|mesh-list
102366763|NCT02623816|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102366764|NCT02623816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102366765|NCT02623816|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102366766|NCT02623816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102366767|NCT02623816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366768|NCT01122238|Nicotine|nicotine|mesh-list
102366769|NCT01122238|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102366770|NCT01122238|Autonomic Agents|autonomic agents|mesh-ancestor
102366771|NCT01122238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102366772|NCT01122238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366773|NCT01122238|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102366774|NCT01122238|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102366775|NCT01122238|Cholinergic Agents|cholinergic agents|mesh-ancestor
102366776|NCT01122238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102366777|NCT01122238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366778|NCT01122316|Metformin|metformin|mesh-list
102366779|NCT01122316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102366780|NCT01122316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366781|NCT03049449|Cyclophosphamide|cyclophosphamide|mesh-list
102366782|NCT03049449|Fludarabine|fludarabine|mesh-list
102366783|NCT03049449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102366784|NCT03049449|Immunologic Factors|immunologic factors|mesh-ancestor
102366785|NCT03049449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366786|NCT03049449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102366787|NCT03049449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102366788|NCT03049449|Alkylating Agents|alkylating agents|mesh-ancestor
102366789|NCT03049449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366790|NCT03049449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102366791|NCT03049449|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102366792|NCT03186729|Fibrinolytic Agents|fibrinolytic agents|mesh-list
102366793|NCT03186729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102366794|NCT03186729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366796|NCT02399943|Trametinib|trametinib|mesh-list
102366797|NCT02399943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102366798|NCT02399943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102366799|NCT02399943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102366800|NCT02399943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102366801|NCT02399943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366802|NCT03186027|Coenzyme Q10|coenzyme q10|mesh-list
102366803|NCT03186027|Ubiquinone|ubiquinone|mesh-list
102366804|NCT03186027|Vitamins|vitamins|mesh-ancestor
102366805|NCT03186027|Micronutrients|micronutrients|mesh-ancestor
102366806|NCT03186027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366807|NCT04397913|Acetaminophen|acetaminophen|mesh-list
102366808|NCT04397913|Ibuprofen|ibuprofen|mesh-list
102366809|NCT04397913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102366810|NCT04397913|Analgesics|analgesics|mesh-ancestor
102366811|NCT04397913|Sensory System Agents|sensory system agents|mesh-ancestor
102366812|NCT04397913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102366813|NCT04397913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366814|NCT04397913|Antipyretics|antipyretics|mesh-ancestor
102366815|NCT04397913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102366816|NCT04397913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102366817|NCT04397913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102366818|NCT04397913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102366819|NCT04397913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102366820|NCT04397913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366821|NCT02176486|Ixazomib|ixazomib|mesh-list
102366822|NCT02176486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102366823|NCT02176486|Protease Inhibitors|protease inhibitors|mesh-ancestor
102366824|NCT02176486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102366825|NCT02176486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366826|NCT01124188|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102366827|NCT01124188|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102366828|NCT01124188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102366829|NCT01124188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102366830|NCT01124188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366831|NCT01124188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102366832|NCT01124188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366833|NCT01124188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102366834|NCT01124188|Antidepressive Agents|antidepressive agents|mesh-ancestor
102366835|NCT01124188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102366836|NCT03013114|Bortezomib|bortezomib|mesh-list
102366837|NCT03013114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102366838|NCT01077310|Naltrexone|naltrexone|mesh-list
102366839|NCT01077310|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102366840|NCT01077310|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102366841|NCT01077310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366842|NCT01077310|Sensory System Agents|sensory system agents|mesh-ancestor
102366843|NCT01077310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102366844|NCT02989857|Ivosidenib|ivosidenib|mesh-list
102366845|NCT02989857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102366846|NCT02989857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102366847|NCT02989857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366848|NCT02393937|Metronidazole|metronidazole|mesh-list
102366849|NCT02393937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102366850|NCT02393937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102366851|NCT02393937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102366852|NCT02393937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102366853|NCT01877915|Rivaroxaban|rivaroxaban|mesh-list
102366854|NCT01877915|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102366855|NCT01877915|Antithrombins|antithrombins|mesh-ancestor
102366856|NCT01877915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102366857|NCT01877915|Protease Inhibitors|protease inhibitors|mesh-ancestor
102366858|NCT01877915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102366859|NCT01877915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366860|NCT01877915|Anticoagulants|anticoagulants|mesh-ancestor
102366861|NCT04397601|Bevacizumab|bevacizumab|mesh-list
102366862|NCT04397601|Aflibercept|aflibercept|mesh-list
102366863|NCT04397601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102366864|NCT04397601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102366865|NCT04397601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102366866|NCT04397601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102366867|NCT04397601|Growth Substances|growth substances|mesh-ancestor
102366868|NCT04397601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366869|NCT04397601|Growth Inhibitors|growth inhibitors|mesh-ancestor
102366870|NCT02870829|Vitamin K 2|vitamin k 2|mesh-list
102366871|NCT02870829|Vitamin K|vitamin k|mesh-list
102366872|NCT02870829|Menaquinone 7|menaquinone 7|mesh-list
102366873|NCT02870829|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102366874|NCT02870829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102366875|NCT02870829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366876|NCT02870829|Hemostatics|hemostatics|mesh-ancestor
102366877|NCT02870829|Coagulants|coagulants|mesh-ancestor
102366878|NCT02870829|Vitamins|vitamins|mesh-ancestor
102366879|NCT02870829|Micronutrients|micronutrients|mesh-ancestor
102366880|NCT02870829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366881|NCT01876823|Memantine|memantine|mesh-list
102366882|NCT01876823|Citalopram|citalopram|mesh-list
102366883|NCT01876823|Escitalopram|escitalopram|mesh-list
102366884|NCT01876823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102366885|NCT01876823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102366886|NCT01876823|Dopamine Agents|dopamine agents|mesh-ancestor
102366887|NCT01876823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102366888|NCT01876823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366889|NCT01876823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366890|NCT01876823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102366891|NCT01876823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102366892|NCT01876823|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102366893|NCT01876823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102366894|NCT01876823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102366895|NCT01876823|Serotonin Agents|serotonin agents|mesh-ancestor
102366896|NCT01876823|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102366897|NCT01876823|Antidepressive Agents|antidepressive agents|mesh-ancestor
102366898|NCT01876823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102366899|NCT01876511|Pembrolizumab|pembrolizumab|mesh-list
102366900|NCT01876511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102366901|NCT01876511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102366902|NCT01876511|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102366903|NCT01876511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366904|NCT01993719|Vidarabine|vidarabine|mesh-list
102366905|NCT01993719|Aldesleukin|aldesleukin|mesh-list
102366906|NCT01993719|Cyclophosphamide|cyclophosphamide|mesh-list
102366907|NCT01993719|Pembrolizumab|pembrolizumab|mesh-list
102366908|NCT01993719|Fludarabine|fludarabine|mesh-list
102366909|NCT01993719|Fludarabine phosphate|fludarabine phosphate|mesh-list
102366910|NCT01993719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102366911|NCT01993719|Immunologic Factors|immunologic factors|mesh-ancestor
102366912|NCT01993719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366913|NCT01993719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102366914|NCT01993719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102366915|NCT01993719|Alkylating Agents|alkylating agents|mesh-ancestor
102366916|NCT01993719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366917|NCT01993719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102366918|NCT01993719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102366919|NCT01993719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102366920|NCT01993719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102366921|NCT01993719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102366922|NCT01993719|Antimetabolites|antimetabolites|mesh-ancestor
102366923|NCT01993719|Antiviral Agents|antiviral agents|mesh-ancestor
102366924|NCT01993719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102366925|NCT01993719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102366926|NCT01993719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102366927|NCT02758665|Venetoclax|venetoclax|mesh-list
102366928|NCT02758665|Obinutuzumab|obinutuzumab|mesh-list
102366929|NCT02758665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102366930|NCT02758665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102366931|NCT03182673|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102366932|NCT03182673|Fluzoparib|fluzoparib|mesh-list
102366933|NCT03182673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102366934|NCT03182673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366935|NCT03182673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102366936|NCT00638157|Gentamicins|gentamicins|mesh-list
102366937|NCT00638157|Daptomycin|daptomycin|mesh-list
102366938|NCT00638157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102366939|NCT00638157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102366940|NCT00638157|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102366941|NCT00638157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102366942|NCT00638157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366943|NCT00637377|Ranibizumab|ranibizumab|mesh-list
102366944|NCT00637377|Aflibercept|aflibercept|mesh-list
102366945|NCT00637377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102366946|NCT00637377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102366947|NCT00637377|Growth Substances|growth substances|mesh-ancestor
102366948|NCT00637377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366949|NCT00637377|Growth Inhibitors|growth inhibitors|mesh-ancestor
102366950|NCT00637377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102366951|NCT01475110|Imatinib Mesylate|imatinib mesylate|mesh-list
102366952|NCT01475110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102366953|NCT01475110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102366954|NCT01475110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102366955|NCT01475110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366956|NCT05307718|Anticoagulants|anticoagulants|mesh-list
102366957|NCT05307718|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
102366958|NCT05307718|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
102366959|NCT05307718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
102366960|NCT05307718|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
102366961|NCT05307718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102366962|NCT05307718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102366963|NCT05307718|Antimetabolites|antimetabolites|mesh-ancestor
102366964|NCT05307718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366965|NCT05307718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102366966|NCT05307718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102366967|NCT05307718|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102366968|NCT05307718|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102366969|NCT05307718|Purinergic Agents|purinergic agents|mesh-ancestor
102366970|NCT05307718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102366971|NCT05307718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366972|NCT05307718|Antithrombins|antithrombins|mesh-ancestor
102366973|NCT05307718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102366974|NCT05307718|Protease Inhibitors|protease inhibitors|mesh-ancestor
102366975|NCT01033864|Mycophenolic Acid|mycophenolic acid|mesh-list
102366976|NCT01033864|Prednisone|prednisone|mesh-list
102366977|NCT01033864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102366978|NCT01033864|Glucocorticoids|glucocorticoids|mesh-ancestor
102366979|NCT01033864|Hormones|hormones|mesh-ancestor
102366980|NCT01033864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102366981|NCT01033864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102366982|NCT01033864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102366983|NCT01033864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102366984|NCT01033864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102366985|NCT01033864|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102366986|NCT01033864|Antitubercular Agents|antitubercular agents|mesh-ancestor
102366987|NCT01033864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102366988|NCT01033864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102366989|NCT01033864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102366990|NCT01033864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366991|NCT01082380|Crizotinib|crizotinib|mesh-list
102366992|NCT01082380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102366993|NCT01082380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102366994|NCT01082380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102366995|NCT01082380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102366996|NCT01083706|Azacitidine|azacitidine|mesh-list
102366997|NCT01083706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102366998|NCT01083706|Antimetabolites|antimetabolites|mesh-ancestor
102366999|NCT01083706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367000|NCT01083706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102367001|NCT01083706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102367002|NCT01035346|Ibuprofen|ibuprofen|mesh-list
102367003|NCT01035346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102367004|NCT01035346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102367005|NCT01035346|Analgesics|analgesics|mesh-ancestor
102367006|NCT01035346|Sensory System Agents|sensory system agents|mesh-ancestor
102367007|NCT01035346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102367008|NCT01035346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367009|NCT01035346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102367010|NCT01035346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102367011|NCT01035346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102367012|NCT01035346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102367013|NCT01035346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367014|NCT01085344|Factor VIII|factor viii|mesh-list
102367015|NCT01085344|Coagulants|coagulants|mesh-ancestor
102367016|NCT01035658|Doxorubicin|doxorubicin|mesh-list
102367017|NCT01035658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102367018|NCT01035658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102367019|NCT01035658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102367020|NCT01035658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102367021|NCT01035658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102367022|NCT01035658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102367023|NCT01035658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367024|NCT01037452|Calcium, Dietary|calcium, dietary|mesh-list
102367025|NCT01037452|Lansoprazole|lansoprazole|mesh-list
102367026|NCT01037452|Dexlansoprazole|dexlansoprazole|mesh-list
102367027|NCT01037452|Calcium Carbonate|calcium carbonate|mesh-list
102367028|NCT01037452|Magnesium Hydroxide|magnesium hydroxide|mesh-list
102367029|NCT01037452|Calcium|calcium|mesh-list
102367030|NCT01037452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102367031|NCT01037452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367032|NCT01037452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102367033|NCT01037452|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102367034|NCT01037452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102367035|NCT01037452|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102367036|NCT01037452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102367037|NCT01037452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367038|NCT01037452|Antacids|antacids|mesh-ancestor
102367039|NCT03012646|Treprostinil|treprostinil|mesh-list
102367040|NCT03012646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102367041|NCT05289856|Avelumab|avelumab|mesh-list
102367042|NCT05289856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102367043|NCT05289856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102367044|NCT00636441|Cyclophosphamide|cyclophosphamide|mesh-list
102367045|NCT00636441|Docetaxel|docetaxel|mesh-list
102367046|NCT00636441|Doxorubicin|doxorubicin|mesh-list
102367047|NCT00636441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102367048|NCT00636441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102367049|NCT00636441|Immunologic Factors|immunologic factors|mesh-ancestor
102367050|NCT00636441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367051|NCT00636441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102367052|NCT00636441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102367053|NCT00636441|Alkylating Agents|alkylating agents|mesh-ancestor
102367054|NCT00636441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367055|NCT00636441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102367056|NCT00636441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102367057|NCT00636441|Tubulin Modulators|tubulin modulators|mesh-ancestor
102367058|NCT00636441|Antimitotic Agents|antimitotic agents|mesh-ancestor
102367059|NCT00636441|Mitosis Modulators|mitosis modulators|mesh-ancestor
102367060|NCT00636441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102367061|NCT00636441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102367062|NCT00636441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102367063|NCT00636441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102367064|NCT00636363|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102367065|NCT02984397|Ketotifen|ketotifen|mesh-list
102367066|NCT02984397|Antipruritics|antipruritics|mesh-ancestor
102367067|NCT02984397|Dermatologic Agents|dermatologic agents|mesh-ancestor
102367068|NCT02984397|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102367069|NCT02984397|Histamine Antagonists|histamine antagonists|mesh-ancestor
102367070|NCT02984397|Histamine Agents|histamine agents|mesh-ancestor
102367071|NCT02984397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102367072|NCT02984397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367073|NCT02984397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367074|NCT02984397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102367076|NCT01922427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102367077|NCT01922427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102367078|NCT01922427|Analgesics|analgesics|mesh-ancestor
102367079|NCT01922427|Sensory System Agents|sensory system agents|mesh-ancestor
102367080|NCT01922427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102367081|NCT01922427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178813|NCT02086019|Ramipril|ramipril|mesh-list
102367082|NCT01922427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102367083|NCT01922427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102367084|NCT01922427|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102367085|NCT01088464|Necitumumab|necitumumab|mesh-list
102367086|NCT01088464|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102367087|NCT01088464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102367088|NCT01088464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102367089|NCT01088464|Immunologic Factors|immunologic factors|mesh-ancestor
102367090|NCT01088464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367091|NCT01090180|Dexamethasone|dexamethasone|mesh-list
102367092|NCT01090180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102367093|NCT01090180|Antiemetics|antiemetics|mesh-ancestor
102367094|NCT01090180|Autonomic Agents|autonomic agents|mesh-ancestor
102367095|NCT01090180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102367096|NCT01090180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367097|NCT01090180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102367098|NCT01090180|Glucocorticoids|glucocorticoids|mesh-ancestor
102367099|NCT01090180|Hormones|hormones|mesh-ancestor
102367100|NCT01090180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102367101|NCT01090180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102367102|NCT01090180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102367103|NCT00636207|Montelukast|montelukast|mesh-list
102367104|NCT00636207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102367105|NCT00636207|Respiratory System Agents|respiratory system agents|mesh-ancestor
102367106|NCT00636207|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102367107|NCT00636207|Hormone Antagonists|hormone antagonists|mesh-ancestor
102367108|NCT00636207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102367109|NCT00636207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367110|NCT00636207|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102367111|NCT00636207|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102367112|NCT00636207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367113|NCT01091116|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2H-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2h-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|mesh-list
102367114|NCT01091116|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
101573966|NCT02199184|Cortisone|cortisone|mesh-list
102367115|NCT01091116|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
102367116|NCT01091116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367117|NCT01091116|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102367118|NCT01091116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102367119|NCT01091116|Immunologic Factors|immunologic factors|mesh-ancestor
102367120|NCT01091116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367121|NCT03169881|Darbepoetin alfa|darbepoetin alfa|mesh-list
102367122|NCT03169881|Hematinics|hematinics|mesh-ancestor
102367123|NCT01092676|Ibuprofen|ibuprofen|mesh-list
102367124|NCT01092676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102367125|NCT01092676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102367126|NCT01092676|Analgesics|analgesics|mesh-ancestor
102367127|NCT01092676|Sensory System Agents|sensory system agents|mesh-ancestor
102367128|NCT01092676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102367129|NCT01092676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367130|NCT01092676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102367131|NCT01092676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102367132|NCT01092676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102367133|NCT01092676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102367134|NCT01092676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367135|NCT05273320|Dronabinol|dronabinol|mesh-list
102367136|NCT05273320|Nabilone|nabilone|mesh-list
102367137|NCT05273320|Antiemetics|antiemetics|mesh-ancestor
102367138|NCT05273320|Autonomic Agents|autonomic agents|mesh-ancestor
102367139|NCT05273320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102367140|NCT05273320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367141|NCT05273320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102367142|NCT05273320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102367143|NCT05273320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102367144|NCT05273320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102367145|NCT05273320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102367146|NCT05273320|Hallucinogens|hallucinogens|mesh-ancestor
102367147|NCT05273320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102367148|NCT05273320|Analgesics|analgesics|mesh-ancestor
102367149|NCT05273320|Sensory System Agents|sensory system agents|mesh-ancestor
102367150|NCT05273320|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102367151|NCT05273320|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102367152|NCT05273320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102367153|NCT05273320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367154|NCT05273320|Hormones|hormones|mesh-ancestor
102367155|NCT05273320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102367156|NCT01039792|Vitamin B 12|vitamin b 12|mesh-list
102367157|NCT01039792|Vitamins|vitamins|mesh-ancestor
102367158|NCT01039792|Micronutrients|micronutrients|mesh-ancestor
102367159|NCT01039792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367160|NCT01039792|Vitamin B Complex|vitamin b complex|mesh-ancestor
102367161|NCT01041274|Citalopram|citalopram|mesh-list
102367162|NCT01041274|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102367163|NCT01041274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102367164|NCT01041274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102367165|NCT01041274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367166|NCT01041274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102367167|NCT01041274|Serotonin Agents|serotonin agents|mesh-ancestor
102367168|NCT01041274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367169|NCT01041274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102367170|NCT01041274|Antidepressive Agents|antidepressive agents|mesh-ancestor
102367171|NCT01041274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102367172|NCT00635349|Acetaminophen|acetaminophen|mesh-list
102367173|NCT00635349|Meloxicam|meloxicam|mesh-list
102367174|NCT00635349|Aceclofenac|aceclofenac|mesh-list
102367175|NCT00635349|Tramadol|tramadol|mesh-list
102367176|NCT00635349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102367177|NCT00635349|Analgesics|analgesics|mesh-ancestor
102367178|NCT00635349|Sensory System Agents|sensory system agents|mesh-ancestor
102367179|NCT00635349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102367180|NCT00635349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367181|NCT00635349|Antipyretics|antipyretics|mesh-ancestor
102367182|NCT00635349|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102367183|NCT00635349|Narcotics|narcotics|mesh-ancestor
102367184|NCT00635349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102367185|NCT00635349|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102367186|NCT00635349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102367187|NCT00635349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102367188|NCT00635349|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102367189|NCT00635349|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102367190|NCT00635349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102367191|NCT00635349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367192|NCT00634803|Buprenorphine|buprenorphine|mesh-list
102367193|NCT00634803|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102367194|NCT00634803|Narcotics|narcotics|mesh-ancestor
102367195|NCT00634803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102367196|NCT00634803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367197|NCT00634803|Analgesics|analgesics|mesh-ancestor
102367198|NCT00634803|Sensory System Agents|sensory system agents|mesh-ancestor
102367199|NCT00634803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102367200|NCT00634803|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102367201|NCT01042288|Carboplatin|carboplatin|mesh-list
102367202|NCT01042288|Pemetrexed|pemetrexed|mesh-list
102367203|NCT01042288|Panitumumab|panitumumab|mesh-list
102367204|NCT01042288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102367205|NCT01042288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102367206|NCT01042288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367207|NCT01042288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102367208|NCT01042288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102367209|NCT01042288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102367210|NCT01043926|Suvorexant|suvorexant|mesh-list
102367211|NCT01043926|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102367212|NCT01043926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102367213|NCT01043926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102367214|NCT01043926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367215|NCT01043926|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102367216|NCT01043926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102367217|NCT01043926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367218|NCT01044706|Bicalutamide|bicalutamide|mesh-list
102367219|NCT01044706|Androgen Antagonists|androgen antagonists|mesh-ancestor
102367220|NCT01044706|Hormone Antagonists|hormone antagonists|mesh-ancestor
102367221|NCT01044706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102367222|NCT01044706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367223|NCT01044706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102367224|NCT04447534|Hydroxychloroquine|hydroxychloroquine|mesh-list
102367225|NCT04447534|Chloroquine|chloroquine|mesh-list
102367226|NCT04447534|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
102367227|NCT04447534|Antimalarials|antimalarials|mesh-ancestor
102367228|NCT04447534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102367229|NCT04447534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102367230|NCT04447534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102367231|NCT04447534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102367232|NCT04447534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367233|NCT04447534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102367234|NCT04447534|Amebicides|amebicides|mesh-ancestor
102367235|NCT04447534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102367236|NCT04447534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102367237|NCT04447534|Analgesics|analgesics|mesh-ancestor
102367238|NCT04447534|Sensory System Agents|sensory system agents|mesh-ancestor
102367239|NCT04447534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102367240|NCT04447534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367241|NCT04447534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102367242|NCT04447534|Filaricides|filaricides|mesh-ancestor
102367243|NCT04447534|Antinematodal Agents|antinematodal agents|mesh-ancestor
102367244|NCT04447534|Anthelmintics|anthelmintics|mesh-ancestor
102367245|NCT01044862|Letrozole|letrozole|mesh-list
102367246|NCT01044862|Clomiphene|clomiphene|mesh-list
102367247|NCT01044862|Enclomiphene|enclomiphene|mesh-list
102367248|NCT01044862|Zuclomiphene|zuclomiphene|mesh-list
102367249|NCT01044862|Hormones|hormones|mesh-list
102367250|NCT01044862|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102367251|NCT01044862|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102367252|NCT01044862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367253|NCT01044862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102367254|NCT01044862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367255|NCT01044862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102367256|NCT01044862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102367257|NCT01044862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102367258|NCT01044862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102367259|NCT01044862|Hormone Antagonists|hormone antagonists|mesh-ancestor
102367260|NCT01044862|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102367261|NCT01044862|Fertility Agents|fertility agents|mesh-ancestor
102367262|NCT01044862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102367263|NCT01044862|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102367264|NCT01044862|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102367265|NCT04361656|Lubiprostone|lubiprostone|mesh-list
102367266|NCT04361656|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102367267|NCT04361656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102367268|NCT04361656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367269|NCT01047358|Exemestane|exemestane|mesh-list
102367270|NCT01047358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102367271|NCT01047358|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102367272|NCT01047358|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102367273|NCT01047358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102367274|NCT01047358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367275|NCT01047358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102367276|NCT01047358|Hormone Antagonists|hormone antagonists|mesh-ancestor
102367277|NCT01047358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102367278|NCT01047358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367279|NCT01048606|Phytoestrogens|phytoestrogens|mesh-list
102367280|NCT01048606|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102367281|NCT01048606|Estrogens|estrogens|mesh-ancestor
102367282|NCT01048606|Hormones|hormones|mesh-ancestor
102367283|NCT01048606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102367284|NCT01048606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367285|NCT04224766|Bupivacaine|bupivacaine|mesh-list
102367286|NCT04224766|Anesthetics, Local|anesthetics, local|mesh-ancestor
102367287|NCT04224766|Anesthetics|anesthetics|mesh-ancestor
102367288|NCT04224766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102367289|NCT04224766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367290|NCT04224766|Sensory System Agents|sensory system agents|mesh-ancestor
102367291|NCT04224766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102367292|NCT01772004|Avelumab|avelumab|mesh-list
102367293|NCT01772004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102367294|NCT01772004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102367295|NCT02930044|Insulin|insulin|mesh-list
102367296|NCT02930044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102367297|NCT02930044|Insulin Glargine|insulin glargine|mesh-list
102367298|NCT02930044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102367299|NCT02930044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367300|NCT03683524|Dolutegravir|dolutegravir|mesh-list
102367301|NCT03683524|Darunavir|darunavir|mesh-list
102367302|NCT03683524|Cobicistat|cobicistat|mesh-list
102367303|NCT03683524|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
102367304|NCT03683524|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102367305|NCT03683524|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102367306|NCT03683524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102367307|NCT03683524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367309|NCT03683524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102367310|NCT03683524|Antiviral Agents|antiviral agents|mesh-ancestor
102367311|NCT03683524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102367312|NCT03683524|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102367313|NCT03683524|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102367314|NCT03683524|Protease Inhibitors|protease inhibitors|mesh-ancestor
102367315|NCT03683524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102367316|NCT03683524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102367317|NCT02246842|Immunoglobulins|immunoglobulins|mesh-list
102367318|NCT02246842|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102367319|NCT02246842|Antibodies|antibodies|mesh-list
102367320|NCT02246842|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102367321|NCT02246842|gamma-Globulins|gamma-globulins|mesh-list
102367322|NCT02246842|Immunologic Factors|immunologic factors|mesh-ancestor
102367323|NCT02246842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367324|NCT02182492|Clarithromycin|clarithromycin|mesh-list
102367325|NCT02182492|Glucocorticoids|glucocorticoids|mesh-list
102367326|NCT02182492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102367327|NCT02182492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102367328|NCT02182492|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102367329|NCT02182492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102367330|NCT02182492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367331|NCT02182492|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102367332|NCT02182492|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102367333|NCT02182492|Hormones|hormones|mesh-ancestor
102367334|NCT02182492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102367335|NCT02182492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367336|NCT01163656|Cobalt|cobalt|mesh-list
102367337|NCT01163656|Trace Elements|trace elements|mesh-ancestor
102367338|NCT01163656|Micronutrients|micronutrients|mesh-ancestor
102367339|NCT01163656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367340|NCT01165840|Dapsone|dapsone|mesh-list
102367341|NCT01165840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102367342|NCT01165840|Antimalarials|antimalarials|mesh-ancestor
102367343|NCT01165840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102367344|NCT01165840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102367345|NCT01165840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102367346|NCT01165840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102367347|NCT01165840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367348|NCT01165840|Leprostatic Agents|leprostatic agents|mesh-ancestor
102367349|NCT01165840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102367350|NCT00952692|Lapatinib|lapatinib|mesh-list
102367351|NCT00952692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102367352|NCT00952692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102367353|NCT00952692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102367354|NCT00952692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367355|NCT03535506|Palbociclib|palbociclib|mesh-list
102367356|NCT03535506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102367357|NCT03535506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102367358|NCT03535506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102367359|NCT03535506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367360|NCT01170754|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
102367361|NCT01170754|Laxatives|laxatives|mesh-ancestor
102367362|NCT01170754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102367363|NCT01378104|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102367364|NCT01378104|Interferon-alpha|interferon-alpha|mesh-list
102367365|NCT01378104|Antiviral Agents|antiviral agents|mesh-ancestor
102367366|NCT01378104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102367367|NCT01378104|Immunologic Factors|immunologic factors|mesh-ancestor
102367368|NCT01378104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367369|NCT01131052|Insulin|insulin|mesh-list
102367370|NCT01131052|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102367371|NCT01131052|Insulin Glargine|insulin glargine|mesh-list
102367372|NCT01131052|Insulin glulisine|insulin glulisine|mesh-list
102367373|NCT01131052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102367374|NCT01131052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179106|NCT02087579|Aripiprazole|aripiprazole|mesh-list
102367375|NCT01379274|Lenalidomide|lenalidomide|mesh-list
102367376|NCT01379274|Azacitidine|azacitidine|mesh-list
102367377|NCT01379274|Immunologic Factors|immunologic factors|mesh-ancestor
102367378|NCT01379274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367380|NCT01379274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102367381|NCT01379274|Growth Substances|growth substances|mesh-ancestor
102367382|NCT01379274|Growth Inhibitors|growth inhibitors|mesh-ancestor
102367383|NCT01379274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102367384|NCT01379274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102367385|NCT01379274|Antimetabolites|antimetabolites|mesh-ancestor
102367386|NCT01379274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367387|NCT01379274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102367388|NCT01171690|Teriparatide|teriparatide|mesh-list
102367389|NCT01171690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102367390|NCT01171690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367391|NCT01171690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102367392|NCT05396742|Ravulizumab|ravulizumab|mesh-list
102367393|NCT05396742|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102367394|NCT05396742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102367395|NCT05396742|Immunologic Factors|immunologic factors|mesh-ancestor
102367396|NCT05396742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367397|NCT05389176|Esmolol|esmolol|mesh-list
102367398|NCT05389176|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102367399|NCT05389176|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102367400|NCT05389176|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102367401|NCT05389176|Adrenergic Agents|adrenergic agents|mesh-ancestor
102367402|NCT05389176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102367403|NCT05389176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367404|NCT05389176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367405|NCT01132846|Dopamine|dopamine|mesh-list
102367406|NCT01132846|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
102367407|NCT01132846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102367408|NCT01132846|Sympathomimetics|sympathomimetics|mesh-ancestor
102367409|NCT01132846|Autonomic Agents|autonomic agents|mesh-ancestor
102367410|NCT01132846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102367411|NCT01132846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367412|NCT01132846|Dopamine Agents|dopamine agents|mesh-ancestor
102367413|NCT01132846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102367414|NCT01132846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367415|NCT01132846|Protective Agents|protective agents|mesh-ancestor
102367416|NCT01132846|Natriuretic Agents|natriuretic agents|mesh-ancestor
102367417|NCT01133158|Dexamethasone|dexamethasone|mesh-list
102367418|NCT01133158|Rituximab|rituximab|mesh-list
102367419|NCT01133158|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102367420|NCT01133158|Mitoxantrone|mitoxantrone|mesh-list
102367421|NCT01133158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102367422|NCT01133158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102367423|NCT01133158|Immunologic Factors|immunologic factors|mesh-ancestor
102367424|NCT01133158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367425|NCT01133158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102367426|NCT01133158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102367427|NCT01133158|Antiemetics|antiemetics|mesh-ancestor
102367428|NCT01133158|Autonomic Agents|autonomic agents|mesh-ancestor
102367429|NCT01133158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102367430|NCT01133158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102367431|NCT01133158|Glucocorticoids|glucocorticoids|mesh-ancestor
102367432|NCT01133158|Hormones|hormones|mesh-ancestor
102367433|NCT01133158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102367434|NCT01133158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102367435|NCT01133158|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102367436|NCT01133158|Alkylating Agents|alkylating agents|mesh-ancestor
102367437|NCT01133158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367438|NCT01133158|Analgesics|analgesics|mesh-ancestor
102367439|NCT01133158|Sensory System Agents|sensory system agents|mesh-ancestor
102367440|NCT01133158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102367441|NCT01133158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102367442|NCT01133158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102367443|NCT05396118|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102367444|NCT05396118|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102367445|NCT05396118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367446|NCT04092894|Suvorexant|suvorexant|mesh-list
102367447|NCT04092894|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102367448|NCT04092894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102367449|NCT04092894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102367450|NCT04092894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367451|NCT04092894|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102367452|NCT04092894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102367453|NCT04092894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367454|NCT01134952|Mycophenolic Acid|mycophenolic acid|mesh-list
102367455|NCT01134952|Sirolimus|sirolimus|mesh-list
102367456|NCT01134952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102367457|NCT01134952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102367458|NCT01134952|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102367459|NCT01134952|Antitubercular Agents|antitubercular agents|mesh-ancestor
102367460|NCT01134952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102367461|NCT01134952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102367462|NCT01134952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102367463|NCT01134952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367464|NCT01134952|Antifungal Agents|antifungal agents|mesh-ancestor
102367465|NCT01134952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102367466|NCT01134952|Immunologic Factors|immunologic factors|mesh-ancestor
102367467|NCT01134952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367468|NCT01175902|Timolol|timolol|mesh-list
102367469|NCT01175902|Dorzolamide|dorzolamide|mesh-list
102367470|NCT01175902|Latanoprost|latanoprost|mesh-list
102367471|NCT01175902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102367472|NCT01175902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102367473|NCT01175902|Adrenergic Agents|adrenergic agents|mesh-ancestor
102367474|NCT01175902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102367475|NCT01175902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367476|NCT01175902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367477|NCT01175902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102367478|NCT01175902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102367479|NCT01175902|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102367480|NCT01175902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102367481|NCT01175902|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102367482|NCT01175902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102367483|NCT01135186|Verapamil|verapamil|mesh-list
102367484|NCT01135186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102367485|NCT01135186|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102367486|NCT01135186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102367487|NCT01135186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367488|NCT01135186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102367489|NCT01135186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367490|NCT01135186|Vasodilator Agents|vasodilator agents|mesh-ancestor
102367491|NCT05376228|Vancomycin|vancomycin|mesh-list
102367492|NCT05376228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102367493|NCT05376228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102367494|NCT05164848|Afatinib|afatinib|mesh-list
102367495|NCT05164848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102367496|NCT05164848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102367497|NCT05164848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102367498|NCT05164848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367499|NCT05164770|Prednisone|prednisone|mesh-list
102367500|NCT05164770|Zanubrutinib|zanubrutinib|mesh-list
102367501|NCT05164770|Cyclophosphamide|cyclophosphamide|mesh-list
102367502|NCT05164770|Vincristine|vincristine|mesh-list
102367503|NCT05164770|Rituximab|rituximab|mesh-list
102367504|NCT05164770|Doxorubicin|doxorubicin|mesh-list
102367505|NCT05164770|Etoposide|etoposide|mesh-list
102367506|NCT05164770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102367507|NCT05164770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102367508|NCT05164770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102367509|NCT05164770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367510|NCT05164770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102367511|NCT05164770|Immunologic Factors|immunologic factors|mesh-ancestor
102367512|NCT05164770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367513|NCT05164770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102367514|NCT05164770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102367515|NCT05164770|Alkylating Agents|alkylating agents|mesh-ancestor
102367516|NCT05164770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102367517|NCT05164770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102367518|NCT05164770|Glucocorticoids|glucocorticoids|mesh-ancestor
102367519|NCT05164770|Hormones|hormones|mesh-ancestor
102367520|NCT05164770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102367521|NCT05164770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102367522|NCT05164770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102367523|NCT05164770|Tubulin Modulators|tubulin modulators|mesh-ancestor
102367524|NCT05164770|Antimitotic Agents|antimitotic agents|mesh-ancestor
102367525|NCT05164770|Mitosis Modulators|mitosis modulators|mesh-ancestor
102367526|NCT05164770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102367527|NCT05164770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102367528|NCT05164770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102367529|NCT05164770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102367530|NCT00634569|gamma-Globulins|gamma-globulins|mesh-list
102367531|NCT00634569|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102367532|NCT00634569|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102367533|NCT00634569|Immunologic Factors|immunologic factors|mesh-ancestor
102367534|NCT00634569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367535|NCT01175980|Vorinostat|vorinostat|mesh-list
102367536|NCT01175980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102367537|NCT01175980|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102367538|NCT01175980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102367539|NCT01175980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367540|NCT04246554|Acetaminophen|acetaminophen|mesh-list
102367541|NCT04246554|Ketorolac|ketorolac|mesh-list
102367542|NCT04246554|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
102367543|NCT04246554|Oxycodone|oxycodone|mesh-list
102367544|NCT04246554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102367545|NCT04246554|Analgesics|analgesics|mesh-ancestor
102367546|NCT04246554|Sensory System Agents|sensory system agents|mesh-ancestor
102367547|NCT04246554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102367548|NCT04246554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367549|NCT04246554|Antipyretics|antipyretics|mesh-ancestor
102367550|NCT04246554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102367551|NCT04246554|Narcotics|narcotics|mesh-ancestor
102367552|NCT04246554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102367553|NCT04246554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102367554|NCT04246554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102367555|NCT04246554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102367556|NCT04246554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102367557|NCT04246554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102367558|NCT04246554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367559|NCT01922817|Saxagliptin|saxagliptin|mesh-list
102367560|NCT01922817|Incretins|incretins|mesh-ancestor
102367561|NCT01922817|Hormones|hormones|mesh-ancestor
102367562|NCT01922817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102367563|NCT01922817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367564|NCT01922817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102367565|NCT01922817|Protease Inhibitors|protease inhibitors|mesh-ancestor
102367566|NCT01922817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102367567|NCT01922817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367568|NCT01922817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102367569|NCT04397289|Heparin|heparin|mesh-list
102367570|NCT04397289|Rivaroxaban|rivaroxaban|mesh-list
102367571|NCT04397289|Anticoagulants|anticoagulants|mesh-ancestor
102367572|NCT04397289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102367573|NCT04397289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102367574|NCT04397289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367575|NCT04397289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102367576|NCT04397289|Antithrombins|antithrombins|mesh-ancestor
102367577|NCT04397289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102367578|NCT04397289|Protease Inhibitors|protease inhibitors|mesh-ancestor
102367579|NCT04397289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102367580|NCT00634179|Prednisone|prednisone|mesh-list
102367581|NCT00634179|Cyclophosphamide|cyclophosphamide|mesh-list
102367582|NCT00634179|Rituximab|rituximab|mesh-list
102367583|NCT00634179|Doxorubicin|doxorubicin|mesh-list
102367584|NCT00634179|Vincristine|vincristine|mesh-list
102367585|NCT00634179|Bortezomib|bortezomib|mesh-list
102367586|NCT00634179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102367587|NCT00634179|Immunologic Factors|immunologic factors|mesh-ancestor
102367588|NCT00634179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367589|NCT00634179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102367590|NCT00634179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102367591|NCT00634179|Alkylating Agents|alkylating agents|mesh-ancestor
102367592|NCT00634179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367593|NCT00634179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102367594|NCT00634179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102367595|NCT00634179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102367596|NCT00634179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102367597|NCT00634179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102367598|NCT00634179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102367599|NCT00634179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102367600|NCT00634179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102367601|NCT00634179|Glucocorticoids|glucocorticoids|mesh-ancestor
102367603|NCT00634179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102367604|NCT00634179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102367605|NCT00634179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102367606|NCT00634179|Tubulin Modulators|tubulin modulators|mesh-ancestor
102367607|NCT00634179|Antimitotic Agents|antimitotic agents|mesh-ancestor
102367608|NCT00634179|Mitosis Modulators|mitosis modulators|mesh-ancestor
102367609|NCT01178944|Oxaliplatin|oxaliplatin|mesh-list
102367610|NCT01178944|10-deazaaminopterin|10-deazaaminopterin|mesh-list
102367611|NCT01178944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102367612|NCT01178944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102367613|NCT01178944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102367614|NCT01178944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367615|NCT01179490|Prednisolone|prednisolone|mesh-list
102367616|NCT01179490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102367617|NCT01179490|Glucocorticoids|glucocorticoids|mesh-ancestor
102367618|NCT01179490|Hormones|hormones|mesh-ancestor
102367619|NCT01179490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102367620|NCT01179490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367621|NCT01179490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102367622|NCT01179490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102367623|NCT01179568|Citalopram|citalopram|mesh-list
102367624|NCT01179568|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102367625|NCT01179568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102367626|NCT01179568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102367627|NCT01179568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367628|NCT01179568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102367629|NCT01179568|Serotonin Agents|serotonin agents|mesh-ancestor
102367630|NCT01179568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367631|NCT01179568|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102367632|NCT01179568|Antidepressive Agents|antidepressive agents|mesh-ancestor
102367633|NCT01179568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102367634|NCT01180036|Cyclosporine|cyclosporine|mesh-list
102367635|NCT01180036|Rituximab|rituximab|mesh-list
102367636|NCT01180036|Cyclosporins|cyclosporins|mesh-list
102367637|NCT01180036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102367638|NCT01180036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102367639|NCT01180036|Immunologic Factors|immunologic factors|mesh-ancestor
102367640|NCT01180036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367641|NCT01180036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102367642|NCT01180036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102367643|NCT01180036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367644|NCT01180036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102367645|NCT01180036|Antifungal Agents|antifungal agents|mesh-ancestor
102367646|NCT01180036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102367647|NCT01180036|Dermatologic Agents|dermatologic agents|mesh-ancestor
102367648|NCT01180036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102367649|NCT01180894|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102367650|NCT01180894|Hematinics|hematinics|mesh-ancestor
102367651|NCT01181674|Insulin|insulin|mesh-list
102367652|NCT01181674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102367653|NCT01181674|Metformin|metformin|mesh-list
102367654|NCT01181674|Insulin Glargine|insulin glargine|mesh-list
102367655|NCT01181674|Acarbose|acarbose|mesh-list
102367656|NCT01181674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102367657|NCT01181674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367658|NCT01181674|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102367659|NCT01181674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102367660|NCT01181674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367661|NCT01182376|Dronedarone|dronedarone|mesh-list
102367662|NCT01182376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102367663|NCT01183312|Flumazenil|flumazenil|mesh-list
102367664|NCT01183312|Antidotes|antidotes|mesh-ancestor
102367665|NCT01183312|Protective Agents|protective agents|mesh-ancestor
102367666|NCT01183312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367667|NCT01183312|GABA Modulators|gaba modulators|mesh-ancestor
102367668|NCT01183312|GABA Agents|gaba agents|mesh-ancestor
102367669|NCT01183312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102367670|NCT01183312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367671|NCT03188172|Dexamethasone|dexamethasone|mesh-list
102367672|NCT03188172|Cyclophosphamide|cyclophosphamide|mesh-list
102367673|NCT03188172|Melphalan|melphalan|mesh-list
102367674|NCT03188172|Lenalidomide|lenalidomide|mesh-list
102367675|NCT03188172|Bortezomib|bortezomib|mesh-list
102367676|NCT03188172|Daratumumab|daratumumab|mesh-list
102367677|NCT03188172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102367679|NCT03188172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367680|NCT03188172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102367681|NCT03188172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102367682|NCT03188172|Alkylating Agents|alkylating agents|mesh-ancestor
102367683|NCT03188172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367684|NCT03188172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102367685|NCT03188172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102367686|NCT03188172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102367687|NCT03188172|Antiemetics|antiemetics|mesh-ancestor
102367688|NCT03188172|Autonomic Agents|autonomic agents|mesh-ancestor
102367689|NCT03188172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102367690|NCT03188172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102367691|NCT03188172|Glucocorticoids|glucocorticoids|mesh-ancestor
102367692|NCT03188172|Hormones|hormones|mesh-ancestor
102367693|NCT03188172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102367694|NCT03188172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102367695|NCT03188172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102367696|NCT03188172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102367697|NCT03188172|Growth Substances|growth substances|mesh-ancestor
102367698|NCT03188172|Growth Inhibitors|growth inhibitors|mesh-ancestor
102367699|NCT01184014|Insulin|insulin|mesh-list
102367700|NCT01184014|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102367701|NCT01184014|Insulin Glargine|insulin glargine|mesh-list
102367702|NCT01184014|Insulin Lispro|insulin lispro|mesh-list
102367703|NCT01184014|Insulin, Isophane|insulin, isophane|mesh-list
102367704|NCT01184014|Isophane Insulin, Human|isophane insulin, human|mesh-list
102367705|NCT01184014|Isophane insulin, beef|isophane insulin, beef|mesh-list
102367706|NCT01184014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102367707|NCT01184014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367708|NCT05672550|Enoxaparin|enoxaparin|mesh-list
102367709|NCT05672550|Enoxaparin sodium|enoxaparin sodium|mesh-list
102367710|NCT05672550|Anticoagulants|anticoagulants|mesh-ancestor
102367711|NCT05672550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102367712|NCT05672550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102367713|NCT05672550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367714|NCT01185028|Interferons|interferons|mesh-list
102367715|NCT01185028|Ribavirin|ribavirin|mesh-list
102367716|NCT01185028|Nitazoxanide|nitazoxanide|mesh-list
102367717|NCT01185028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102367718|NCT01185028|Antiviral Agents|antiviral agents|mesh-ancestor
102367719|NCT01185028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102367720|NCT01185028|Antimetabolites|antimetabolites|mesh-ancestor
102367721|NCT01185028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367722|NCT01185028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102367723|NCT02187016|Listerine|listerine|mesh-list
102367724|NCT02187016|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102367725|NCT02187016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102367726|NCT05439798|Dexamethasone|dexamethasone|mesh-list
102367727|NCT05439798|Dexamethasone acetate|dexamethasone acetate|mesh-list
102367728|NCT05439798|Ondansetron|ondansetron|mesh-list
102367729|NCT05439798|Palonosetron|palonosetron|mesh-list
102367730|NCT05439798|BB 1101|bb 1101|mesh-list
102367731|NCT05439798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102367732|NCT05439798|Antiemetics|antiemetics|mesh-ancestor
102367733|NCT05439798|Autonomic Agents|autonomic agents|mesh-ancestor
102367734|NCT05439798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102367735|NCT05439798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367736|NCT05439798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102367737|NCT05439798|Glucocorticoids|glucocorticoids|mesh-ancestor
102367738|NCT05439798|Hormones|hormones|mesh-ancestor
102367739|NCT05439798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102367740|NCT05439798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102367741|NCT05439798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102367742|NCT05439798|Protease Inhibitors|protease inhibitors|mesh-ancestor
102367743|NCT05439798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102367744|NCT05439798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367745|NCT05439798|Antipruritics|antipruritics|mesh-ancestor
102367746|NCT05439798|Dermatologic Agents|dermatologic agents|mesh-ancestor
102367747|NCT05439798|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102367748|NCT05439798|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102367749|NCT05439798|Serotonin Agents|serotonin agents|mesh-ancestor
102367750|NCT05439798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102179483|NCT02250599|Paclitaxel|paclitaxel|mesh-list
102367751|NCT02188576|Tranexamic Acid|tranexamic acid|mesh-list
102367752|NCT02188576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102367753|NCT02188576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102367754|NCT02188576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367755|NCT02188576|Hemostatics|hemostatics|mesh-ancestor
102367756|NCT02188576|Coagulants|coagulants|mesh-ancestor
102367757|NCT02189122|Aspirin|aspirin|mesh-list
102367758|NCT02189122|Bradykinin|bradykinin|mesh-list
102367759|NCT02189122|Kininogens|kininogens|mesh-list
102367760|NCT02189122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102367761|NCT02189122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102367762|NCT02189122|Analgesics|analgesics|mesh-ancestor
102367763|NCT02189122|Sensory System Agents|sensory system agents|mesh-ancestor
102367764|NCT02189122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102367765|NCT02189122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367766|NCT02189122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102367767|NCT02189122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102367768|NCT02189122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102367769|NCT02189122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102367770|NCT02189122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367771|NCT02189122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102367772|NCT02189122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102367773|NCT02189122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102367774|NCT02189122|Antipyretics|antipyretics|mesh-ancestor
102367775|NCT02189122|Vasodilator Agents|vasodilator agents|mesh-ancestor
102367776|NCT02189122|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
102367777|NCT02189122|Protease Inhibitors|protease inhibitors|mesh-ancestor
102367778|NCT05309460|Labetalol|labetalol|mesh-list
102367779|NCT05309460|Nifedipine|nifedipine|mesh-list
102367780|NCT05309460|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102367781|NCT05309460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102367782|NCT05309460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367783|NCT05309460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102367784|NCT05309460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367785|NCT05309460|Vasodilator Agents|vasodilator agents|mesh-ancestor
102367786|NCT05309460|Tocolytic Agents|tocolytic agents|mesh-ancestor
102367787|NCT05309460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102367788|NCT05309460|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102367789|NCT05309460|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102367790|NCT05309460|Adrenergic Agents|adrenergic agents|mesh-ancestor
102367791|NCT05309460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102367792|NCT05309460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102367793|NCT05309460|Sympathomimetics|sympathomimetics|mesh-ancestor
102367794|NCT05309460|Autonomic Agents|autonomic agents|mesh-ancestor
102367795|NCT05309460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102367796|NCT05309460|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102367797|NCT05309460|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102367798|NCT01093690|Metoclopramide|metoclopramide|mesh-list
102367799|NCT01093690|Antiemetics|antiemetics|mesh-ancestor
102367800|NCT01093690|Autonomic Agents|autonomic agents|mesh-ancestor
102367801|NCT01093690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102367802|NCT01093690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367803|NCT01093690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102367804|NCT01093690|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102367805|NCT01093690|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102367806|NCT01093690|Dopamine Agents|dopamine agents|mesh-ancestor
102367807|NCT01093690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102367808|NCT01093690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367809|NCT01143688|Albuterol|albuterol|mesh-list
102367810|NCT01143688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102367811|NCT01143688|Autonomic Agents|autonomic agents|mesh-ancestor
102367812|NCT01143688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102367813|NCT01143688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367814|NCT01143688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102367815|NCT01143688|Respiratory System Agents|respiratory system agents|mesh-ancestor
102367816|NCT01143688|Tocolytic Agents|tocolytic agents|mesh-ancestor
102367817|NCT01143688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102367818|NCT01143688|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102367819|NCT01143688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102367820|NCT01143688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102367821|NCT01143688|Adrenergic Agents|adrenergic agents|mesh-ancestor
102367822|NCT01143688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102367823|NCT01143688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367824|NCT04455594|Carboplatin|carboplatin|mesh-list
102367825|NCT04455594|Pemetrexed|pemetrexed|mesh-list
102367826|NCT04455594|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102367827|NCT04455594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102367828|NCT04455594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102367829|NCT04455594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367830|NCT04455594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102367831|NCT04455594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102367832|NCT04455594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102367833|NCT01143766|Gabapentin|gabapentin|mesh-list
102367834|NCT01143766|Analgesics|analgesics|mesh-ancestor
102367835|NCT01143766|Sensory System Agents|sensory system agents|mesh-ancestor
102367836|NCT01143766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102367837|NCT01143766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367838|NCT01143766|Anticonvulsants|anticonvulsants|mesh-ancestor
102367839|NCT01143766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102367840|NCT01143766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102367841|NCT01143766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102367842|NCT01143766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102367843|NCT01143766|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102367844|NCT01143766|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102367845|NCT01143766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102367846|NCT01143766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367847|NCT01143766|Antimanic Agents|antimanic agents|mesh-ancestor
102367848|NCT05439408|Dasatinib|dasatinib|mesh-list
102367849|NCT05439408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102367850|NCT05439408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102367851|NCT05439408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102367852|NCT05439408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367853|NCT03011476|Donepezil|donepezil|mesh-list
102367854|NCT03011476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102367855|NCT03011476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102367856|NCT03011476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367857|NCT03011476|Cholinergic Agents|cholinergic agents|mesh-ancestor
102367858|NCT03011476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102367859|NCT03011476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367860|NCT03011476|Nootropic Agents|nootropic agents|mesh-ancestor
102367861|NCT02522754|Vaccines|vaccines|mesh-list
102367862|NCT02522754|Immunologic Factors|immunologic factors|mesh-ancestor
102367863|NCT02522754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367864|NCT01188694|Methylene Blue|methylene blue|mesh-list
102367865|NCT01188694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102367866|NCT01188694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367867|NCT01188928|Betamethasone|betamethasone|mesh-list
102367868|NCT01188928|Betamethasone Valerate|betamethasone valerate|mesh-list
102367869|NCT01188928|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102367870|NCT01188928|Betamethasone benzoate|betamethasone benzoate|mesh-list
102367871|NCT01188928|Calcipotriene|calcipotriene|mesh-list
102367872|NCT01188928|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102367873|NCT01188928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102367874|NCT01188928|Glucocorticoids|glucocorticoids|mesh-ancestor
102367875|NCT01188928|Hormones|hormones|mesh-ancestor
102367876|NCT01188928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102367877|NCT01188928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367878|NCT01188928|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102367879|NCT01188928|Respiratory System Agents|respiratory system agents|mesh-ancestor
102367880|NCT01188928|Dermatologic Agents|dermatologic agents|mesh-ancestor
102367881|NCT05438706|Carboplatin|carboplatin|mesh-list
102367882|NCT05438706|Capecitabine|capecitabine|mesh-list
102367883|NCT05438706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102367884|NCT05438706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102367885|NCT05438706|Antimetabolites|antimetabolites|mesh-ancestor
102367886|NCT05438706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367887|NCT01189240|Bevacizumab|bevacizumab|mesh-list
102367888|NCT01189240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102367889|NCT01189240|Antibodies|antibodies|mesh-list
102367890|NCT01189240|Immunoglobulins|immunoglobulins|mesh-list
102367891|NCT01189240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102367892|NCT01189240|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
102367893|NCT01189240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102367894|NCT01189240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102367895|NCT01189240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102367896|NCT01189240|Growth Substances|growth substances|mesh-ancestor
102367897|NCT01189240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367898|NCT01189240|Growth Inhibitors|growth inhibitors|mesh-ancestor
102367899|NCT01189240|Immunologic Factors|immunologic factors|mesh-ancestor
102367900|NCT01189240|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
102367901|NCT01189240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102367902|NCT01189240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367903|NCT03467334|Simethicone|simethicone|mesh-list
102367904|NCT03467334|Antifoaming Agents|antifoaming agents|mesh-ancestor
102367905|NCT03467334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367906|NCT03467334|Emollients|emollients|mesh-ancestor
102367907|NCT03467334|Dermatologic Agents|dermatologic agents|mesh-ancestor
102367908|NCT02874144|Mometasone Furoate|mometasone furoate|mesh-list
102367909|NCT02874144|Fluticasone|fluticasone|mesh-list
102367910|NCT02874144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102367911|NCT02874144|Dermatologic Agents|dermatologic agents|mesh-ancestor
102367912|NCT02874144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102367913|NCT02874144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102367914|NCT02874144|Autonomic Agents|autonomic agents|mesh-ancestor
102367915|NCT02874144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102367916|NCT02874144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367917|NCT02874144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102367918|NCT02874144|Respiratory System Agents|respiratory system agents|mesh-ancestor
102367920|NCT03467178|Carboplatin|carboplatin|mesh-list
102367921|NCT03467178|Gemcitabine|gemcitabine|mesh-list
102367922|NCT03467178|Doxorubicin|doxorubicin|mesh-list
102367923|NCT03467178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102367924|NCT03467178|Decitabine|decitabine|mesh-list
102367925|NCT03467178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102367926|NCT03467178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102367927|NCT03467178|Tubulin Modulators|tubulin modulators|mesh-ancestor
102367928|NCT03467178|Antimitotic Agents|antimitotic agents|mesh-ancestor
102367929|NCT03467178|Mitosis Modulators|mitosis modulators|mesh-ancestor
102367930|NCT03467178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367931|NCT03467178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102367932|NCT03467178|Antimetabolites|antimetabolites|mesh-ancestor
102367933|NCT03467178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102367934|NCT03467178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102367935|NCT03467178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102367936|NCT03467178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102367937|NCT02835534|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102367938|NCT02835534|Plasminogen|plasminogen|mesh-list
102367939|NCT02835534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102367940|NCT02835534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102367941|NCT02835534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367942|NCT02722200|Hydrocortisone|hydrocortisone|mesh-list
102367943|NCT02722200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102367944|NCT01094548|Cyclophosphamide|cyclophosphamide|mesh-list
102367945|NCT01094548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102367946|NCT01094548|Immunologic Factors|immunologic factors|mesh-ancestor
102367947|NCT01094548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367948|NCT01094548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102367949|NCT01094548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102367950|NCT01094548|Alkylating Agents|alkylating agents|mesh-ancestor
102367951|NCT01094548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367952|NCT01094548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102367953|NCT01094548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102367954|NCT02611830|Vedolizumab|vedolizumab|mesh-list
102367955|NCT02611830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102367956|NCT03461718|Fentanyl|fentanyl|mesh-list
102367957|NCT03461718|Midazolam|midazolam|mesh-list
102367958|NCT03461718|Ketamine|ketamine|mesh-list
102367959|NCT03461718|Analgesics|analgesics|mesh-ancestor
102367960|NCT03461718|Sensory System Agents|sensory system agents|mesh-ancestor
102367961|NCT03461718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102367962|NCT03461718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367963|NCT03461718|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102367964|NCT03461718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102367965|NCT03461718|Anesthetics, General|anesthetics, general|mesh-ancestor
102367966|NCT03461718|Anesthetics|anesthetics|mesh-ancestor
102367967|NCT03461718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102367968|NCT03461718|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102367969|NCT03461718|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102367970|NCT03461718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102367971|NCT03461718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367972|NCT03461718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102367973|NCT03461718|Narcotics|narcotics|mesh-ancestor
102367974|NCT03461718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102367975|NCT03461718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102367976|NCT03461718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102367977|NCT03461718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102367978|NCT03461718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102367979|NCT03461718|GABA Modulators|gaba modulators|mesh-ancestor
102367980|NCT03461718|GABA Agents|gaba agents|mesh-ancestor
102367981|NCT05431920|Vitamin D|vitamin d|mesh-list
102367982|NCT05431920|Ergocalciferols|ergocalciferols|mesh-list
102367983|NCT05431920|Cholecalciferol|cholecalciferol|mesh-list
102367984|NCT05431920|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
102367985|NCT05431920|Calcifediol|calcifediol|mesh-list
102367986|NCT05431920|Vitamins|vitamins|mesh-list
102367987|NCT05431920|Micronutrients|micronutrients|mesh-ancestor
102367988|NCT05431920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367989|NCT05431920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102367990|NCT05431920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102367991|NCT03467022|Ascorbic Acid|ascorbic acid|mesh-list
102367992|NCT03467022|Vitamins|vitamins|mesh-ancestor
102367993|NCT03467022|Micronutrients|micronutrients|mesh-ancestor
102367994|NCT03467022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102367995|NCT03467022|Antioxidants|antioxidants|mesh-ancestor
102367996|NCT03467022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102367997|NCT03467022|Protective Agents|protective agents|mesh-ancestor
102367998|NCT03129594|Glucagon|glucagon|mesh-list
102367999|NCT03129594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102368000|NCT03129594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102368001|NCT03129594|Hormones|hormones|mesh-ancestor
102160885|NCT03794349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102160975|NCT03387579|SMOFlipid|smoflipid|mesh-list
102369690|NCT04450134|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102161120|NCT03029390|Metformin|metformin|mesh-list
102161205|NCT02822144|Narcotics|narcotics|mesh-ancestor
102368002|NCT03129594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102161422|NCT00656669|Paclitaxel|paclitaxel|mesh-list
102161496|NCT01338415|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102368003|NCT03129594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368004|NCT03129594|Incretins|incretins|mesh-ancestor
102368005|NCT03466632|Dexmedetomidine|dexmedetomidine|mesh-list
102368006|NCT03466632|Propofol|propofol|mesh-list
102161747|NCT05121038|Leucovorin|leucovorin|mesh-list
102368007|NCT03466632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102161817|NCT05689177|Vaccines|vaccines|mesh-list
102368008|NCT03466632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102161946|NCT02475057|Hormones|hormones|mesh-list
102162017|NCT04495088|Leucovorin|leucovorin|mesh-list
102368009|NCT03466632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368010|NCT03466632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102162244|NCT02471547|Mitomycins|mitomycins|mesh-list
102368011|NCT03466632|Analgesics|analgesics|mesh-ancestor
102368012|NCT03466632|Sensory System Agents|sensory system agents|mesh-ancestor
102368013|NCT03466632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102368014|NCT03466632|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102368015|NCT03466632|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102368016|NCT03466632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102368017|NCT03466632|Adrenergic Agents|adrenergic agents|mesh-ancestor
102368018|NCT03466632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102368019|NCT03466632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368020|NCT03466632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102368021|NCT03466632|Anesthetics, General|anesthetics, general|mesh-ancestor
102368022|NCT03466632|Anesthetics|anesthetics|mesh-ancestor
102368023|NCT05339334|Ritonavir|ritonavir|mesh-list
102368024|NCT05339334|Nirmatrelvir|nirmatrelvir|mesh-list
102368025|NCT05339334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102368026|NCT05339334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102368027|NCT05339334|Protease Inhibitors|protease inhibitors|mesh-ancestor
102368028|NCT05339334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102368029|NCT05339334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368030|NCT05339334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102162514|NCT02470923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102368031|NCT05339334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102368032|NCT05339334|Antiviral Agents|antiviral agents|mesh-ancestor
102368033|NCT05339334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102368034|NCT05339334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102368035|NCT05339334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102368036|NCT03461328|Magnesium Sulfate|magnesium sulfate|mesh-list
102368037|NCT03461328|Analgesics|analgesics|mesh-ancestor
102162810|NCT02476929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102368038|NCT03461328|Sensory System Agents|sensory system agents|mesh-ancestor
102368039|NCT03461328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102368040|NCT03461328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368041|NCT03461328|Anesthetics|anesthetics|mesh-ancestor
102368042|NCT03461328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102368043|NCT03461328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102368044|NCT03461328|Anticonvulsants|anticonvulsants|mesh-ancestor
102368045|NCT03461328|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102368046|NCT03461328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102368047|NCT03461328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368048|NCT03461328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102368049|NCT03461328|Tocolytic Agents|tocolytic agents|mesh-ancestor
102368050|NCT03461328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102368051|NCT01145638|Iron|iron|mesh-list
102179781|NCT02103335|Hormones|hormones|mesh-ancestor
102368052|NCT01145638|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
102368053|NCT01145638|Trace Elements|trace elements|mesh-ancestor
102368054|NCT01145638|Micronutrients|micronutrients|mesh-ancestor
102368055|NCT01145638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368056|NCT01145638|Hematinics|hematinics|mesh-ancestor
102368057|NCT03466320|Cyclophosphamide|cyclophosphamide|mesh-list
102368058|NCT03466320|Fludarabine|fludarabine|mesh-list
102368059|NCT03466320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102368060|NCT03466320|Immunologic Factors|immunologic factors|mesh-ancestor
102368061|NCT03466320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368062|NCT03466320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102163542|NCT01362140|Hematinics|hematinics|mesh-ancestor
102368063|NCT03466320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102368064|NCT03466320|Alkylating Agents|alkylating agents|mesh-ancestor
102163839|NCT02809820|Metoprolol|metoprolol|mesh-list
102163983|NCT01187810|Immunologic Factors|immunologic factors|mesh-ancestor
102368065|NCT03466320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368066|NCT03466320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102164281|NCT00779636|Cholinergic Agents|cholinergic agents|mesh-ancestor
102368067|NCT03466320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102368068|NCT03466242|Dexmedetomidine|dexmedetomidine|mesh-list
102368069|NCT03466242|Ketamine|ketamine|mesh-list
102164583|NCT02063425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102368070|NCT03466242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102164733|NCT02461719|Cyclosporine|cyclosporine|mesh-list
102164911|NCT02461329|Polygeline|polygeline|mesh-list
102368071|NCT03466242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102368072|NCT03466242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368073|NCT03466242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102368074|NCT03466242|Analgesics|analgesics|mesh-ancestor
102368075|NCT03466242|Sensory System Agents|sensory system agents|mesh-ancestor
102368076|NCT03466242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102368077|NCT03466242|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102368078|NCT03466242|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102368079|NCT03466242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102368080|NCT03466242|Adrenergic Agents|adrenergic agents|mesh-ancestor
102368081|NCT03466242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102368082|NCT03466242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368083|NCT03466242|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102368084|NCT03466242|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102368085|NCT03466242|Anesthetics, General|anesthetics, general|mesh-ancestor
102368086|NCT03466242|Anesthetics|anesthetics|mesh-ancestor
102368087|NCT03466242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102368088|NCT03466242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102368089|NCT01190878|Bromfenac|bromfenac|mesh-list
102165157|NCT05077917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102368090|NCT01190878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102368091|NCT01190878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102368092|NCT01190878|Analgesics|analgesics|mesh-ancestor
102368093|NCT01190878|Sensory System Agents|sensory system agents|mesh-ancestor
102368094|NCT01190878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102165456|NCT02083315|Morphine|morphine|mesh-list
102165527|NCT02084563|Daunorubicin|daunorubicin|mesh-list
102368095|NCT01190878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165608|NCT02085577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102368096|NCT01190878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102165828|NCT02092597|Exenatide|exenatide|mesh-list
102165907|NCT02094157|Heparin|heparin|mesh-list
102368097|NCT01190878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102368098|NCT01146808|Adefovir|adefovir|mesh-list
102166055|NCT05067530|Paclitaxel|paclitaxel|mesh-list
102368099|NCT01146808|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
102368100|NCT01146808|Antiviral Agents|antiviral agents|mesh-ancestor
102368101|NCT01146808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102166349|NCT03290859|Anesthetics, General|anesthetics, general|mesh-ancestor
102368102|NCT01146808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102166426|NCT02408068|Dexamethasone|dexamethasone|mesh-list
102368103|NCT01146808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102368104|NCT01146808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102368105|NCT01146808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368106|NCT02522130|Naproxen|naproxen|mesh-list
102368107|NCT02522130|Lidocaine|lidocaine|mesh-list
102368108|NCT02522130|Misoprostol|misoprostol|mesh-list
102368109|NCT02522130|Anesthetics, Local|anesthetics, local|mesh-ancestor
102368110|NCT02522130|Anesthetics|anesthetics|mesh-ancestor
102368111|NCT02522130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102368112|NCT02522130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368113|NCT02522130|Sensory System Agents|sensory system agents|mesh-ancestor
102368114|NCT02522130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102167234|NCT03292185|Incretins|incretins|mesh-ancestor
102368115|NCT02522130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102368116|NCT02522130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102368117|NCT02522130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102167535|NCT03553537|Hormones|hormones|mesh-ancestor
102368118|NCT02522130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102368119|NCT02522130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368120|NCT02522130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102368121|NCT02522130|Abortifacient Agents|abortifacient agents|mesh-ancestor
102167601|NCT05027126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102368122|NCT02522130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102368123|NCT02522130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102368124|NCT02522130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102368125|NCT02522130|Oxytocics|oxytocics|mesh-ancestor
102167744|NCT03091868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102167819|NCT02122003|Sorafenib|sorafenib|mesh-list
102368126|NCT02522130|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102368127|NCT02522130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102368128|NCT02522130|Analgesics|analgesics|mesh-ancestor
102368129|NCT02522130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102368130|NCT02522130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102168038|NCT03079076|Bupivacaine|bupivacaine|mesh-list
102368131|NCT02522130|Gout Suppressants|gout suppressants|mesh-ancestor
102168117|NCT03280095|Antipyretics|antipyretics|mesh-ancestor
102368132|NCT02522130|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102368133|NCT02522130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102368134|NCT01148524|Vaccines|vaccines|mesh-list
102368135|NCT01148524|Immunologic Factors|immunologic factors|mesh-ancestor
102168266|NCT04459052|Acetylcysteine|acetylcysteine|mesh-list
102368136|NCT01148524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368137|NCT03460860|Tocopherols|tocopherols|mesh-list
102368138|NCT03460860|Vitamin E|vitamin e|mesh-list
102368139|NCT03460860|Tocotrienols|tocotrienols|mesh-list
102368140|NCT03460860|alpha-Tocopherol|alpha-tocopherol|mesh-list
102368141|NCT03460860|Lycopene|lycopene|mesh-list
102368142|NCT03460860|Antioxidants|antioxidants|mesh-ancestor
102168558|NCT02252341|Antidotes|antidotes|mesh-ancestor
102168708|NCT03072290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102368143|NCT03460860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368144|NCT03460860|Protective Agents|protective agents|mesh-ancestor
102168866|NCT03071822|Hormones|hormones|mesh-ancestor
102368145|NCT03460860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368146|NCT03460860|Vitamins|vitamins|mesh-ancestor
102368147|NCT03460860|Micronutrients|micronutrients|mesh-ancestor
102368148|NCT03460860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102368149|NCT03460860|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102368150|NCT03460860|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102368151|NCT03460860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102368152|NCT03460782|Ipilimumab|ipilimumab|mesh-list
102368153|NCT03460782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102169307|NCT03574649|Alkylating Agents|alkylating agents|mesh-ancestor
102368154|NCT03460782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102368155|NCT03460782|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102169459|NCT03070574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102169534|NCT03245307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102169610|NCT04912856|Ezogabine|ezogabine|mesh-list
102169688|NCT03248427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102169766|NCT03576287|Apremilast|apremilast|mesh-list
102368156|NCT03460782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368157|NCT01099618|Metformin|metformin|mesh-list
102368158|NCT01099618|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102368159|NCT01099618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102170066|NCT05579119|Hormones|hormones|mesh-ancestor
102170126|NCT02138383|Antimitotic Agents|antimitotic agents|mesh-ancestor
102368160|NCT01099618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368161|NCT01099618|Incretins|incretins|mesh-ancestor
102368162|NCT01099618|Hormones|hormones|mesh-ancestor
102369691|NCT04450134|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102368163|NCT01099618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102368164|NCT01099618|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102368165|NCT01099618|Protease Inhibitors|protease inhibitors|mesh-ancestor
102368166|NCT01099618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102369692|NCT01286818|Leucovorin|leucovorin|mesh-list
102369693|NCT01286818|Fluorouracil|fluorouracil|mesh-list
102369694|NCT01286818|Irinotecan|irinotecan|mesh-list
102368167|NCT01099618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368168|NCT01099774|Bimatoprost|bimatoprost|mesh-list
102368169|NCT01099774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102368170|NCT01099774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102368171|NCT01099774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102368172|NCT01100242|Bortezomib|bortezomib|mesh-list
102368173|NCT01100242|Sorafenib|sorafenib|mesh-list
102368174|NCT01100242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102368175|NCT01100242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102368176|NCT01100242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102171254|NCT04560322|Acalabrutinib|acalabrutinib|mesh-list
102369695|NCT01286818|Ramucirumab|ramucirumab|mesh-list
102171394|NCT04102020|Cc-486|cc-486|mesh-list
102369696|NCT01286818|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102368177|NCT01100242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368178|NCT01148836|Ubiquinone|ubiquinone|mesh-list
102368179|NCT01148836|Coenzyme Q10|coenzyme q10|mesh-list
102368180|NCT01148836|Micronutrients|micronutrients|mesh-ancestor
102171713|NCT02706873|Methotrexate|methotrexate|mesh-list
102368181|NCT01148836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368182|NCT01148836|Vitamins|vitamins|mesh-ancestor
102368183|NCT01149616|Dexamethasone|dexamethasone|mesh-list
102368184|NCT01149616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102368185|NCT01149616|Antiemetics|antiemetics|mesh-ancestor
102368186|NCT01149616|Autonomic Agents|autonomic agents|mesh-ancestor
102368187|NCT01149616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102368188|NCT01149616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368189|NCT01149616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102368190|NCT01149616|Glucocorticoids|glucocorticoids|mesh-ancestor
102368191|NCT01149616|Hormones|hormones|mesh-ancestor
102369697|NCT01286818|Levoleucovorin|levoleucovorin|mesh-list
102369698|NCT01286818|Antimetabolites|antimetabolites|mesh-ancestor
102172087|NCT02140489|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102172163|NCT03567395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172164|NCT03567395|Protective Agents|protective agents|mesh-ancestor
102172165|NCT03567395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172166|NCT03567395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102172167|NCT03565133|Quinine|quinine|mesh-list
102172168|NCT03565133|Antimalarials|antimalarials|mesh-ancestor
102172240|NCT05284214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102368192|NCT01149616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102368193|NCT01149616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102368194|NCT01149616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102368195|NCT03460470|Sildenafil Citrate|sildenafil citrate|mesh-list
102368196|NCT03460470|Vasodilator Agents|vasodilator agents|mesh-ancestor
102368197|NCT03460470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102368198|NCT03460470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102172905|NCT00109837|Antimetabolites|antimetabolites|mesh-ancestor
102368199|NCT03460470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102172985|NCT02630186|Atezolizumab|atezolizumab|mesh-list
102368200|NCT03460470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368201|NCT03460470|Urological Agents|urological agents|mesh-ancestor
102368202|NCT01101100|Brodalumab|brodalumab|mesh-list
102368203|NCT01101100|Dermatologic Agents|dermatologic agents|mesh-ancestor
102368204|NCT03460392|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102368205|NCT03460392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102173352|NCT03063788|Copper|copper|mesh-list
102173425|NCT02036489|Antimetabolites|antimetabolites|mesh-ancestor
102368206|NCT01101880|Cytarabine|cytarabine|mesh-list
102368207|NCT01101880|Clofarabine|clofarabine|mesh-list
102368208|NCT01101880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102368209|NCT01101880|Antimetabolites|antimetabolites|mesh-ancestor
102368210|NCT01101880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368211|NCT01101880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102368212|NCT01101880|Antiviral Agents|antiviral agents|mesh-ancestor
102368213|NCT01101880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102173786|NCT02051387|Antidepressive Agents|antidepressive agents|mesh-ancestor
102368214|NCT01101880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102368215|NCT01101880|Immunologic Factors|immunologic factors|mesh-ancestor
102368216|NCT01101880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174156|NCT02058485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102174227|NCT02046590|Anesthetics|anesthetics|mesh-ancestor
102368217|NCT04978038|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102368218|NCT04978038|Immunologic Factors|immunologic factors|mesh-ancestor
102368219|NCT04978038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174449|NCT02793947|Epinephrine|epinephrine|mesh-list
102368220|NCT03011632|Mometasone Furoate|mometasone furoate|mesh-list
102368221|NCT03011632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102174668|NCT02067767|Antiviral Agents|antiviral agents|mesh-ancestor
102368222|NCT03011632|Dermatologic Agents|dermatologic agents|mesh-ancestor
102368223|NCT03011632|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102368224|NCT01102270|Eszopiclone|eszopiclone|mesh-list
102368225|NCT01102270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102368226|NCT01102270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102368227|NCT01102270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368228|NCT01103440|polysaccharide-K|polysaccharide-k|mesh-list
102368229|NCT01103440|Tirofiban|tirofiban|mesh-list
102368230|NCT01103440|Ticlopidine|ticlopidine|mesh-list
102368231|NCT01103440|Abciximab|abciximab|mesh-list
102368232|NCT01103440|Clopidogrel|clopidogrel|mesh-list
102368233|NCT01103440|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102368234|NCT01103440|Cangrelor|cangrelor|mesh-list
102368235|NCT01103440|Eptifibatide|eptifibatide|mesh-list
102368236|NCT01103440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102175180|NCT03241875|Antimanic Agents|antimanic agents|mesh-ancestor
102368237|NCT01103440|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102175328|NCT04945694|Fentanyl|fentanyl|mesh-list
102368238|NCT01103440|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102368239|NCT01103440|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102175518|NCT04933292|Hormones|hormones|mesh-ancestor
102368240|NCT01103440|Purinergic Agents|purinergic agents|mesh-ancestor
102368241|NCT01103440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102368242|NCT01103440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368243|NCT01103440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368244|NCT01103440|Anticoagulants|anticoagulants|mesh-ancestor
102368245|NCT01103440|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102368246|NCT01103440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102368247|NCT01103440|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102368248|NCT01103440|Immunologic Factors|immunologic factors|mesh-ancestor
102368249|NCT01103440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102368250|NCT01103440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102368251|NCT01103440|Antiviral Agents|antiviral agents|mesh-ancestor
102368252|NCT01103440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102368253|NCT01103440|Interferon Inducers|interferon inducers|mesh-ancestor
102175762|NCT03234699|Anticoagulants|anticoagulants|mesh-ancestor
102368254|NCT01103440|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102368255|NCT01103440|Protective Agents|protective agents|mesh-ancestor
102368256|NCT01103440|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102368257|NCT01103440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102368258|NCT01103440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102176267|NCT03232125|Ramosetron|ramosetron|mesh-list
102176353|NCT03220113|Vitamins|vitamins|mesh-ancestor
102368259|NCT01105312|Letrozole|letrozole|mesh-list
102176570|NCT02148913|Melphalan|melphalan|mesh-list
102368260|NCT01105312|Panobinostat|panobinostat|mesh-list
102368261|NCT01105312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102368262|NCT01105312|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102368263|NCT01105312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102368264|NCT01105312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102176792|NCT02452437|Oxycodone|oxycodone|mesh-list
102368265|NCT01105312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368266|NCT01105312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102368267|NCT01105312|Hormone Antagonists|hormone antagonists|mesh-ancestor
102368268|NCT01105312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102177242|NCT03197493|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102368269|NCT01105312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368270|NCT01105312|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102368271|NCT04488978|Amlodipine|amlodipine|mesh-list
102368272|NCT04488978|Irbesartan|irbesartan|mesh-list
102177554|NCT02444013|Folic Acid|folic acid|mesh-list
102368273|NCT04488978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102368274|NCT04488978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102177698|NCT02373202|Antioxidants|antioxidants|mesh-ancestor
102368275|NCT04488978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102177763|NCT02442921|Tubulin Modulators|tubulin modulators|mesh-ancestor
102177913|NCT02441673|Sympathomimetics|sympathomimetics|mesh-ancestor
102368276|NCT04488978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178067|NCT04890626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102178128|NCT04900532|Tocopherols|tocopherols|mesh-list
102178129|NCT04900532|Antioxidants|antioxidants|mesh-ancestor
102178130|NCT04900532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178131|NCT04900532|Protective Agents|protective agents|mesh-ancestor
102178132|NCT04900532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178133|NCT04900532|Vitamins|vitamins|mesh-ancestor
102178204|NCT04898270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102178355|NCT01596062|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102178431|NCT02145715|Antiemetics|antiemetics|mesh-ancestor
102368277|NCT04488978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102368278|NCT04488978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368279|NCT04488978|Vasodilator Agents|vasodilator agents|mesh-ancestor
101887591|NCT03991884|Cortisone|cortisone|mesh-list
102178884|NCT04870502|Fertility Agents|fertility agents|mesh-ancestor
102178952|NCT02086409|Ergocalciferols|ergocalciferols|mesh-list
102180006|NCT02250833|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102179029|NCT02083055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102368280|NCT04488978|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102368281|NCT04488978|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102368282|NCT03460002|Vaccines|vaccines|mesh-list
102368283|NCT03460002|Immunologic Factors|immunologic factors|mesh-ancestor
102179253|NCT02095847|Proflavine|proflavine|mesh-list
102368284|NCT03460002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368285|NCT01105702|Bevacizumab|bevacizumab|mesh-list
102368286|NCT01105702|Temozolomide|temozolomide|mesh-list
102368287|NCT01105702|Lithium Carbonate|lithium carbonate|mesh-list
102179476|NCT02097407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102368288|NCT01105702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102368289|NCT01105702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102179570|NCT02094599|Dronabinol|dronabinol|mesh-list
102368290|NCT01105702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102368291|NCT01105702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102368292|NCT01105702|Growth Substances|growth substances|mesh-ancestor
102368293|NCT01105702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368294|NCT01105702|Growth Inhibitors|growth inhibitors|mesh-ancestor
102368295|NCT01105702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102368296|NCT01105702|Alkylating Agents|alkylating agents|mesh-ancestor
102368297|NCT01105702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368298|NCT01105702|Antidepressive Agents|antidepressive agents|mesh-ancestor
102368299|NCT01105702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102368300|NCT01105702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102368301|NCT01105702|Antimanic Agents|antimanic agents|mesh-ancestor
102368302|NCT01105702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102368303|NCT01105702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102368304|NCT04453332|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102368305|NCT04453332|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102368306|NCT04453332|Hormones|hormones|mesh-list
102368307|NCT04453332|Estradiol|estradiol|mesh-list
102368308|NCT04453332|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102368309|NCT04453332|Progesterone|progesterone|mesh-list
102368310|NCT04453332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102368311|NCT04453332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368312|NCT04453332|Estrogens|estrogens|mesh-ancestor
102368313|NCT04453332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102368314|NCT04453332|Contraceptive Agents|contraceptive agents|mesh-ancestor
102368315|NCT04453332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102368316|NCT04453332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102368317|NCT04453332|Progestins|progestins|mesh-ancestor
102368318|NCT03456570|Dydrogesterone|dydrogesterone|mesh-list
102368319|NCT03456570|Progestins|progestins|mesh-ancestor
102368320|NCT03456570|Hormones|hormones|mesh-ancestor
102369699|NCT01286818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368321|NCT03456570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102368322|NCT03456570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368323|NCT03468348|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102368324|NCT03468348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102180189|NCT03188289|Protective Agents|protective agents|mesh-ancestor
102368325|NCT03468348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102368326|NCT03468348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102369700|NCT01286818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102368327|NCT03468348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368328|NCT03468348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102368329|NCT03468348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368330|NCT03468348|Analgesics|analgesics|mesh-ancestor
102368331|NCT03468348|Sensory System Agents|sensory system agents|mesh-ancestor
102368332|NCT03468348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102368333|NCT03468348|Antidepressive Agents|antidepressive agents|mesh-ancestor
102368334|NCT03468348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102368335|NCT03468348|Dopamine Agents|dopamine agents|mesh-ancestor
102368336|NCT03464682|Atorvastatin|atorvastatin|mesh-list
102368337|NCT03464682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102368338|NCT03464682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102368339|NCT03464682|Antimetabolites|antimetabolites|mesh-ancestor
102368340|NCT03464682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368341|NCT03464682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102368342|NCT03464682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102368343|NCT03464682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102368344|NCT03464058|Rabeprazole|rabeprazole|mesh-list
102368345|NCT03464058|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102368346|NCT03464058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102368347|NCT03464058|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102368348|NCT03464058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102368349|NCT03464058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368350|NCT03451734|Metformin|metformin|mesh-list
102368351|NCT03451734|Antipsychotic Agents|antipsychotic agents|mesh-list
102368352|NCT03451734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102180087|NCT02611778|Ranibizumab|ranibizumab|mesh-list
102368353|NCT03451734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368354|NCT03451734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102368355|NCT03451734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102368356|NCT03451734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102368357|NCT03130218|Peppermint oil|peppermint oil|mesh-list
102368358|NCT03130218|Antiemetics|antiemetics|mesh-ancestor
102368359|NCT03130218|Autonomic Agents|autonomic agents|mesh-ancestor
102368360|NCT03130218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102368361|NCT03130218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368362|NCT03130218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102368363|NCT03130218|Parasympatholytics|parasympatholytics|mesh-ancestor
102181663|NCT02113631|Interferons|interferons|mesh-list
102368364|NCT01199146|Abiraterone Acetate|abiraterone acetate|mesh-list
102181735|NCT03552653|Vitamin D|vitamin d|mesh-list
102368365|NCT01199146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102368366|NCT01199146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102368367|NCT01199146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102369701|NCT01286818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102368368|NCT01199146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368369|NCT01199146|Hormone Antagonists|hormone antagonists|mesh-ancestor
101890993|NCT00005906|Octreotide|octreotide|mesh-list
102369703|NCT01286818|Immunologic Factors|immunologic factors|mesh-ancestor
102368370|NCT01199146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102368371|NCT01199146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368372|NCT01199146|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102368373|NCT01199926|Vitamin D|vitamin d|mesh-list
102368374|NCT01199926|Cholecalciferol|cholecalciferol|mesh-list
102368375|NCT01199926|Vitamins|vitamins|mesh-ancestor
102368376|NCT01199926|Micronutrients|micronutrients|mesh-ancestor
102368377|NCT01199926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368378|NCT01199926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102368379|NCT01199926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102368380|NCT01106950|Cyclophosphamide|cyclophosphamide|mesh-list
102368381|NCT01106950|Fludarabine|fludarabine|mesh-list
102368382|NCT01106950|Interleukin-2|interleukin-2|mesh-list
102368383|NCT01106950|Denileukin diftitox|denileukin diftitox|mesh-list
102368384|NCT01106950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102368385|NCT01106950|Immunologic Factors|immunologic factors|mesh-ancestor
102368386|NCT01106950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368387|NCT01106950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102368388|NCT01106950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102368389|NCT01106950|Alkylating Agents|alkylating agents|mesh-ancestor
102369704|NCT01286818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368390|NCT01106950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368391|NCT01106950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102368392|NCT01106950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102368393|NCT01106950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102368394|NCT01106950|Analgesics|analgesics|mesh-ancestor
102368395|NCT01106950|Sensory System Agents|sensory system agents|mesh-ancestor
102368396|NCT01106950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102368397|NCT03463044|Nangibotide|nangibotide|mesh-list
102368398|NCT03463044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102368399|NCT02522208|Hydralazine|hydralazine|mesh-list
102368400|NCT02522208|Isosorbide|isosorbide|mesh-list
102368401|NCT02522208|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
102368402|NCT02522208|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
102368403|NCT02522208|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102368404|NCT02522208|Diuretics|diuretics|mesh-ancestor
102368405|NCT02522208|Natriuretic Agents|natriuretic agents|mesh-ancestor
102368406|NCT02522208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368407|NCT02522208|Vasodilator Agents|vasodilator agents|mesh-ancestor
102368408|NCT02522208|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102368409|NCT02522208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368410|NCT02522208|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102368411|NCT05684172|Tenecteplase|tenecteplase|mesh-list
102368412|NCT05684172|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102368413|NCT05684172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102368414|NCT05684172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368415|NCT01200160|Niacin|niacin|mesh-list
102368416|NCT01200160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102368417|NCT01200160|Antimetabolites|antimetabolites|mesh-ancestor
102183331|NCT05612984|Sensory System Agents|sensory system agents|mesh-ancestor
102368418|NCT01200160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368419|NCT01200160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102368420|NCT01200160|Vasodilator Agents|vasodilator agents|mesh-ancestor
102368421|NCT01200160|Vitamin B Complex|vitamin b complex|mesh-ancestor
102368422|NCT01200160|Vitamins|vitamins|mesh-ancestor
102368423|NCT01200160|Micronutrients|micronutrients|mesh-ancestor
102183470|NCT05549492|Narcotics|narcotics|mesh-ancestor
102183547|NCT00103285|Alkylating Agents|alkylating agents|mesh-ancestor
102183621|NCT03541603|Protective Agents|protective agents|mesh-ancestor
102368424|NCT01200160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368425|NCT04908228|Obinutuzumab|obinutuzumab|mesh-list
102368426|NCT04908228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102368427|NCT04908228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102180157|NCT04865900|Immunologic Factors|immunologic factors|mesh-ancestor
102368428|NCT01153672|Letrozole|letrozole|mesh-list
102368429|NCT01153672|Anastrozole|anastrozole|mesh-list
102368430|NCT01153672|Vorinostat|vorinostat|mesh-list
102368431|NCT01153672|Exemestane|exemestane|mesh-list
102183919|NCT03185403|Sufentanil|sufentanil|mesh-list
102368432|NCT01153672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102368433|NCT01153672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102368434|NCT01153672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102184070|NCT02161237|Tacrolimus|tacrolimus|mesh-list
102368435|NCT01153672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102368436|NCT01153672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368437|NCT01153672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102368438|NCT01153672|Hormone Antagonists|hormone antagonists|mesh-ancestor
102184203|NCT02410083|Antipyretics|antipyretics|mesh-ancestor
102369705|NCT01286818|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102368439|NCT01153672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102184352|NCT02415777|Thiamine|thiamine|mesh-list
102368440|NCT01153672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368441|NCT01153672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102368442|NCT01153672|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102368443|NCT03010072|Ferric Compounds|ferric compounds|mesh-list
102368444|NCT03010072|Hematinics|hematinics|mesh-ancestor
102368445|NCT03462810|Cabotegravir|cabotegravir|mesh-list
102368446|NCT03462810|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102368447|NCT03462810|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102184724|NCT03173235|Vitamin D|vitamin d|mesh-list
102368448|NCT03462810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102368449|NCT03462810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368450|NCT03462810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102184873|NCT05697614|Oxcarbazepine|oxcarbazepine|mesh-list
102368451|NCT03462810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102368452|NCT03462810|Antiviral Agents|antiviral agents|mesh-ancestor
102368453|NCT03462810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102368454|NCT01219738|Budesonide|budesonide|mesh-list
102185053|NCT02412813|Cobalt|cobalt|mesh-list
102368455|NCT01219738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102368456|NCT01219738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102368457|NCT01219738|Autonomic Agents|autonomic agents|mesh-ancestor
102368458|NCT01219738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102368459|NCT01219738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368460|NCT01219738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102368461|NCT01219738|Respiratory System Agents|respiratory system agents|mesh-ancestor
102368462|NCT01219738|Glucocorticoids|glucocorticoids|mesh-ancestor
102368463|NCT01219738|Hormones|hormones|mesh-ancestor
102368464|NCT01219738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102368465|NCT03848754|Gemtuzumab|gemtuzumab|mesh-list
102185383|NCT02410863|Dabrafenib|dabrafenib|mesh-list
102185459|NCT02400801|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102368466|NCT03848754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102185535|NCT03540199|Antibodies|antibodies|mesh-list
102368467|NCT03848754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102368468|NCT03848754|Immunotoxins|immunotoxins|mesh-ancestor
102368469|NCT03848754|Immunoconjugates|immunoconjugates|mesh-ancestor
102368470|NCT03848754|Immunologic Factors|immunologic factors|mesh-ancestor
102368471|NCT03848754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368472|NCT01155154|Clindamycin|clindamycin|mesh-list
102185822|NCT02170597|Antithrombins|antithrombins|mesh-ancestor
102368473|NCT01155154|Clindamycin palmitate|clindamycin palmitate|mesh-list
102368474|NCT01155154|Clindamycin phosphate|clindamycin phosphate|mesh-list
102368475|NCT01155154|Cephalexin|cephalexin|mesh-list
102368476|NCT01155154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102368477|NCT01155154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102186118|NCT04597268|GABA Agents|gaba agents|mesh-ancestor
102368478|NCT01155154|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102368479|NCT01155154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102368480|NCT01155154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368481|NCT04614714|Niacinamide|niacinamide|mesh-list
102368482|NCT04614714|Niacin|niacin|mesh-list
102368483|NCT04614714|Nicotinic Acids|nicotinic acids|mesh-list
102368484|NCT04614714|Vitamin B Complex|vitamin b complex|mesh-ancestor
102368485|NCT04614714|Vitamins|vitamins|mesh-ancestor
102368486|NCT04614714|Micronutrients|micronutrients|mesh-ancestor
102368487|NCT04614714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368488|NCT04614714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102368489|NCT04614714|Antimetabolites|antimetabolites|mesh-ancestor
102368490|NCT04614714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368491|NCT04614714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102368492|NCT04614714|Vasodilator Agents|vasodilator agents|mesh-ancestor
102368493|NCT01221298|Ritonavir|ritonavir|mesh-list
102368494|NCT01221298|Ribavirin|ribavirin|mesh-list
102368495|NCT01221298|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102368496|NCT01221298|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102368497|NCT01221298|Protease Inhibitors|protease inhibitors|mesh-ancestor
102368498|NCT01221298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102368499|NCT01221298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368500|NCT01221298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102368501|NCT01221298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102368502|NCT01221298|Antiviral Agents|antiviral agents|mesh-ancestor
102368503|NCT01221298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102180259|NCT03189069|Warfarin|warfarin|mesh-list
102368504|NCT01221298|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102368505|NCT01221298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102368507|NCT01222234|Vitamin D|vitamin d|mesh-list
102368508|NCT01222234|Ergocalciferols|ergocalciferols|mesh-list
102186793|NCT05963022|Tirzepatide|tirzepatide|mesh-list
102186794|NCT05963022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102186795|NCT05963022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186796|NCT05963022|Incretins|incretins|mesh-ancestor
102186797|NCT05963022|Hormones|hormones|mesh-ancestor
102368509|NCT01222234|Cholecalciferol|cholecalciferol|mesh-list
102368510|NCT01222234|Calcitriol|calcitriol|mesh-list
102368511|NCT01222234|Vitamins|vitamins|mesh-list
102368512|NCT01222234|Micronutrients|micronutrients|mesh-ancestor
102368513|NCT01222234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186855|NCT05920863|Lenvatinib|lenvatinib|mesh-list
102368514|NCT01222234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102368515|NCT01222234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102368516|NCT01222234|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102368517|NCT01222234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102368518|NCT01222234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368519|NCT01222234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102368520|NCT01203046|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102368521|NCT01203046|Ertapenem|ertapenem|mesh-list
102368522|NCT01203046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102368523|NCT02460588|Prednisolone|prednisolone|mesh-list
102368524|NCT02460588|Cyclophosphamide|cyclophosphamide|mesh-list
102368525|NCT02460588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102368526|NCT02460588|Immunologic Factors|immunologic factors|mesh-ancestor
102368527|NCT02460588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368528|NCT02460588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102368529|NCT02460588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102368530|NCT02460588|Alkylating Agents|alkylating agents|mesh-ancestor
102368531|NCT02460588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368532|NCT02460588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102368533|NCT02460588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102368534|NCT02460588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102368535|NCT02460588|Glucocorticoids|glucocorticoids|mesh-ancestor
102368536|NCT02460588|Hormones|hormones|mesh-ancestor
102368537|NCT02460588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102368538|NCT02460588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102368539|NCT03449082|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102368540|NCT03449082|Hemostatics|hemostatics|mesh-ancestor
102368541|NCT03449082|Coagulants|coagulants|mesh-ancestor
102368542|NCT03413202|3-n-butylphthalide|3-n-butylphthalide|mesh-list
102368543|NCT03413202|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102368544|NCT03413202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102368545|NCT03413202|Protective Agents|protective agents|mesh-ancestor
102368546|NCT03413202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368547|NCT04169100|Prednisone|prednisone|mesh-list
102368548|NCT04169100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102368549|NCT04169100|Glucocorticoids|glucocorticoids|mesh-ancestor
102368550|NCT04169100|Hormones|hormones|mesh-ancestor
102368551|NCT04169100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102368552|NCT04169100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368553|NCT04169100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102368554|NCT04169100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102368555|NCT04155840|Rituximab|rituximab|mesh-list
102368556|NCT04155840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102368557|NCT04155840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102368558|NCT04155840|Antibodies|antibodies|mesh-list
102368559|NCT04155840|Immunoglobulins|immunoglobulins|mesh-list
102368560|NCT04155840|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102368561|NCT04155840|Immunologic Factors|immunologic factors|mesh-ancestor
102368562|NCT04155840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368563|NCT04155840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102368564|NCT04155840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102368565|NCT04155840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102368566|NCT04155840|Alkylating Agents|alkylating agents|mesh-ancestor
102368567|NCT04155840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368568|NCT03448770|Lactulose|lactulose|mesh-list
102368569|NCT03448770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102368570|NCT03443778|Dexamethasone|dexamethasone|mesh-list
102368571|NCT03443778|Bupivacaine|bupivacaine|mesh-list
102368572|NCT03443778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102368573|NCT03443778|Antiemetics|antiemetics|mesh-ancestor
102368574|NCT03443778|Autonomic Agents|autonomic agents|mesh-ancestor
102368575|NCT03443778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102180308|NCT02434029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102368576|NCT03443778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368577|NCT03443778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102368578|NCT03443778|Glucocorticoids|glucocorticoids|mesh-ancestor
102368579|NCT03443778|Hormones|hormones|mesh-ancestor
102368580|NCT03443778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102368581|NCT03443778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102368582|NCT03443778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102368583|NCT03443778|Anesthetics, Local|anesthetics, local|mesh-ancestor
102368584|NCT03443778|Anesthetics|anesthetics|mesh-ancestor
102368585|NCT03443778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102368586|NCT03443778|Sensory System Agents|sensory system agents|mesh-ancestor
102368587|NCT03011008|Liraglutide|liraglutide|mesh-list
102368588|NCT03011008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102368589|NCT03011008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368590|NCT03011008|Incretins|incretins|mesh-ancestor
102368591|NCT03011008|Hormones|hormones|mesh-ancestor
102368592|NCT03011008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102368593|NCT01157416|Cycloserine|cycloserine|mesh-list
102368594|NCT01157416|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102368595|NCT01157416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102368596|NCT01157416|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102368597|NCT01157416|Antitubercular Agents|antitubercular agents|mesh-ancestor
102368598|NCT01157416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102368599|NCT01157416|Antimetabolites|antimetabolites|mesh-ancestor
102368600|NCT01157416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368601|NCT01206478|Megestrol|megestrol|mesh-list
102368602|NCT01206478|Amitriptyline|amitriptyline|mesh-list
102368603|NCT01206478|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102368604|NCT01206478|Antidepressive Agents|antidepressive agents|mesh-ancestor
102368605|NCT01206478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102368606|NCT01206478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102368607|NCT01206478|Analgesics|analgesics|mesh-ancestor
102368608|NCT01206478|Sensory System Agents|sensory system agents|mesh-ancestor
102368609|NCT01206478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102368610|NCT01206478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368611|NCT01206478|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102368612|NCT01206478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102368613|NCT01206478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102368614|NCT01206478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368615|NCT01206478|Adrenergic Agents|adrenergic agents|mesh-ancestor
102368616|NCT01206478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102368617|NCT01206478|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102368618|NCT01206478|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102368619|NCT01206478|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102368620|NCT01206478|Contraceptive Agents|contraceptive agents|mesh-ancestor
102187909|NCT04069156|Aspirin|aspirin|mesh-list
102368621|NCT01206478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102188053|NCT03269669|Vincristine|vincristine|mesh-list
102368622|NCT01206478|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102368623|NCT01206478|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102368624|NCT01206478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102368625|NCT01206478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102368626|NCT04963530|Lithium Carbonate|lithium carbonate|mesh-list
102368627|NCT04963530|Antidepressive Agents|antidepressive agents|mesh-ancestor
102368628|NCT04963530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102368629|NCT04963530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102368630|NCT04963530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368631|NCT04963530|Antimanic Agents|antimanic agents|mesh-ancestor
102368632|NCT04963530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102368633|NCT04963530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102368634|NCT04963530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368635|NCT01158820|Diphenhydramine|diphenhydramine|mesh-list
102368636|NCT01158820|Fentanyl|fentanyl|mesh-list
102368637|NCT01158820|Midazolam|midazolam|mesh-list
102368638|NCT01158820|Dexmedetomidine|dexmedetomidine|mesh-list
102368639|NCT01158820|Ketamine|ketamine|mesh-list
102368640|NCT01158820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102368641|NCT01158820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102368642|NCT01158820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368643|NCT01158820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102368644|NCT01158820|Analgesics|analgesics|mesh-ancestor
102368645|NCT01158820|Sensory System Agents|sensory system agents|mesh-ancestor
102368646|NCT01158820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102368647|NCT01158820|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102188275|NCT01631617|Cephalexin|cephalexin|mesh-list
102188350|NCT00588991|Topotecan|topotecan|mesh-list
102188351|NCT00588991|Veliparib|veliparib|mesh-list
102188352|NCT00588991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188353|NCT00588991|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102188420|NCT00045201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102188421|NCT00045201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102188422|NCT00045201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102188423|NCT00045201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188424|NCT00045201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188433|NCT00001379|Rituximab|rituximab|mesh-list
102368648|NCT01158820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102368649|NCT01158820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102368650|NCT01158820|Adrenergic Agents|adrenergic agents|mesh-ancestor
102188565|NCT02182531|Epinastine|epinastine|mesh-list
102368651|NCT01158820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102612275|NCT00002387|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102180381|NCT04853342|Aflutinib|aflutinib|mesh-list
102368652|NCT01158820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368653|NCT01158820|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102188787|NCT05527340|Dexamethasone|dexamethasone|mesh-list
102368654|NCT01158820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102188860|NCT05522192|Analgesics|analgesics|mesh-ancestor
102368655|NCT01158820|Anesthetics, General|anesthetics, general|mesh-ancestor
102368656|NCT01158820|Anesthetics|anesthetics|mesh-ancestor
102368657|NCT01158820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102368658|NCT01158820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102368659|NCT01158820|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102368660|NCT01158820|Narcotics|narcotics|mesh-ancestor
102368661|NCT01158820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102368662|NCT01158820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102368663|NCT01158820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102368664|NCT01158820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102189077|NCT02184091|Nevirapine|nevirapine|mesh-list
102368665|NCT01158820|GABA Modulators|gaba modulators|mesh-ancestor
102189223|NCT02185261|Interferons|interferons|mesh-list
102368666|NCT01158820|GABA Agents|gaba agents|mesh-ancestor
102189368|NCT02187133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102368667|NCT01158820|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102368668|NCT01158820|Anesthetics, Local|anesthetics, local|mesh-ancestor
102368669|NCT01158820|Antiemetics|antiemetics|mesh-ancestor
102368670|NCT01158820|Autonomic Agents|autonomic agents|mesh-ancestor
102368671|NCT01158820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102189598|NCT02192827|Hormones|hormones|mesh-ancestor
102368672|NCT01158820|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102189711|NCT03534973|Caffeine|caffeine|mesh-list
102189736|NCT03535753|Decitabine|decitabine|mesh-list
102368673|NCT01158820|Histamine Antagonists|histamine antagonists|mesh-ancestor
102368674|NCT01158820|Histamine Agents|histamine agents|mesh-ancestor
102368675|NCT01158820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102368676|NCT03707028|Paclitaxel|paclitaxel|mesh-list
102368677|NCT03707028|Apatinib|apatinib|mesh-list
102368678|NCT03707028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102368679|NCT03707028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102368680|NCT03707028|Tubulin Modulators|tubulin modulators|mesh-ancestor
102368681|NCT03707028|Antimitotic Agents|antimitotic agents|mesh-ancestor
102368682|NCT03707028|Mitosis Modulators|mitosis modulators|mesh-ancestor
102368683|NCT03707028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368684|NCT03707028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102368685|NCT03707028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102368686|NCT03447678|Pembrolizumab|pembrolizumab|mesh-list
102368687|NCT03447678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102368688|NCT03447678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102189952|NCT03533803|Indomethacin|indomethacin|mesh-list
102190031|NCT03533179|Glucagon|glucagon|mesh-list
102368689|NCT03447678|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102368690|NCT03447678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368691|NCT01225354|Calcium|calcium|mesh-list
102368692|NCT01225354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102368693|NCT01225354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368694|NCT02521662|Nicotine|nicotine|mesh-list
102368695|NCT02521662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102190116|NCT02206789|Hormones|hormones|mesh-ancestor
102368696|NCT02521662|Autonomic Agents|autonomic agents|mesh-ancestor
102190166|NCT04058197|Deferoxamine|deferoxamine|mesh-list
102368697|NCT02521662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102368698|NCT02521662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368699|NCT02521662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102368700|NCT02521662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102368701|NCT02521662|Cholinergic Agents|cholinergic agents|mesh-ancestor
102368702|NCT02521662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102368703|NCT02521662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368704|NCT05183880|Vitamins|vitamins|mesh-list
102368705|NCT05183880|Ascorbic Acid|ascorbic acid|mesh-list
102368706|NCT05183880|Micronutrients|micronutrients|mesh-ancestor
102368707|NCT05183880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368708|NCT05183880|Antioxidants|antioxidants|mesh-ancestor
102368709|NCT05183880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368710|NCT05183880|Protective Agents|protective agents|mesh-ancestor
102368711|NCT01159054|Nicotinic Acids|nicotinic acids|mesh-list
102368712|NCT01159054|Niacin|niacin|mesh-list
102368713|NCT01159054|Niacinamide|niacinamide|mesh-list
102368714|NCT01159054|Vitamin B Complex|vitamin b complex|mesh-ancestor
102368715|NCT01159054|Vitamins|vitamins|mesh-ancestor
102368716|NCT01159054|Micronutrients|micronutrients|mesh-ancestor
102368717|NCT01159054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368718|NCT01159054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102368719|NCT01159054|Antimetabolites|antimetabolites|mesh-ancestor
102190459|NCT05969054|Lacosamide|lacosamide|mesh-list
102369706|NCT01286818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102368720|NCT01159054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368721|NCT01159054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102368722|NCT01159054|Vasodilator Agents|vasodilator agents|mesh-ancestor
102368723|NCT01209442|Bevacizumab|bevacizumab|mesh-list
102368724|NCT01209442|Temozolomide|temozolomide|mesh-list
102368725|NCT01209442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102368726|NCT01209442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102368727|NCT01209442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102369707|NCT01286818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102368728|NCT01209442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102368729|NCT01209442|Growth Substances|growth substances|mesh-ancestor
102368730|NCT01209442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368731|NCT01209442|Growth Inhibitors|growth inhibitors|mesh-ancestor
102368732|NCT01209442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102368733|NCT01209442|Alkylating Agents|alkylating agents|mesh-ancestor
102368734|NCT01209442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368735|NCT01160380|Modafinil|modafinil|mesh-list
102368736|NCT01160380|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102368737|NCT01160380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368738|NCT01160380|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102368739|NCT01160380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102368740|NCT01160380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102368741|NCT01160380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368742|NCT04956042|Cytarabine|cytarabine|mesh-list
102368743|NCT04956042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102368744|NCT04956042|Antimetabolites|antimetabolites|mesh-ancestor
102368745|NCT04956042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368746|NCT04956042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102368747|NCT04956042|Antiviral Agents|antiviral agents|mesh-ancestor
102368748|NCT04956042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102368749|NCT04956042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102368750|NCT04956042|Immunologic Factors|immunologic factors|mesh-ancestor
102368751|NCT04956042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368752|NCT01228084|Sulforaphane|sulforaphane|mesh-list
102368753|NCT01228084|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102368754|NCT01228084|Protective Agents|protective agents|mesh-ancestor
102368755|NCT01228084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368756|NCT01228084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102368757|NCT01229410|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102368758|NCT01229410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102368759|NCT01229410|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102368760|NCT01229410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102368761|NCT01229410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102368762|NCT01229410|Adrenergic Agents|adrenergic agents|mesh-ancestor
102368763|NCT01229410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102369708|NCT01286818|Antidotes|antidotes|mesh-ancestor
102369709|NCT01286818|Protective Agents|protective agents|mesh-ancestor
102369710|NCT01286818|Vitamin B Complex|vitamin b complex|mesh-ancestor
102369711|NCT01286818|Vitamins|vitamins|mesh-ancestor
102369712|NCT01286818|Micronutrients|micronutrients|mesh-ancestor
102369713|NCT03428256|Anesthetics|anesthetics|mesh-list
102369714|NCT03428256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102369715|NCT03428256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369716|NCT00635505|Albuterol|albuterol|mesh-list
102369717|NCT00635505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102369718|NCT00635505|Autonomic Agents|autonomic agents|mesh-ancestor
102369719|NCT00635505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102368764|NCT01229410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368765|NCT01229410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368766|NCT01212484|Carbidopa|carbidopa|mesh-list
102368767|NCT01212484|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102368768|NCT01212484|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102368769|NCT01212484|Dopamine Agents|dopamine agents|mesh-ancestor
102368770|NCT01212484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102368771|NCT01212484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368772|NCT01212484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368773|NCT01212484|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102368774|NCT01212484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102368775|NCT03446976|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102368776|NCT03446976|Immunologic Factors|immunologic factors|mesh-ancestor
102368777|NCT03446976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368778|NCT01212874|Nitroglycerin|nitroglycerin|mesh-list
102368779|NCT01212874|Esmolol|esmolol|mesh-list
102368780|NCT01212874|Vasodilator Agents|vasodilator agents|mesh-ancestor
102191717|NCT02781090|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102191792|NCT02689024|Sensory System Agents|sensory system agents|mesh-ancestor
102368781|NCT01212874|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102191872|NCT02337985|Prednisone|prednisone|mesh-list
102368782|NCT01212874|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102368783|NCT01212874|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102368784|NCT01212874|Adrenergic Agents|adrenergic agents|mesh-ancestor
102368785|NCT01212874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102368786|NCT01212874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368787|NCT01212874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368788|NCT01859741|Carboplatin|carboplatin|mesh-list
102368789|NCT01859741|Etoposide|etoposide|mesh-list
102368790|NCT01859741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192016|NCT01708993|Mitosis Modulators|mitosis modulators|mesh-ancestor
102368791|NCT01859741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102368792|NCT01859741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102368793|NCT01859741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102368794|NCT01859741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102368795|NCT01859741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368796|NCT01212952|Dexamethasone|dexamethasone|mesh-list
102368797|NCT01212952|Bortezomib|bortezomib|mesh-list
102368798|NCT01212952|Pomalidomide|pomalidomide|mesh-list
102192230|NCT00387400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102368799|NCT01212952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102368800|NCT01212952|Antiemetics|antiemetics|mesh-ancestor
102368801|NCT01212952|Autonomic Agents|autonomic agents|mesh-ancestor
102180534|NCT02429271|Clopidogrel|clopidogrel|mesh-list
102368802|NCT01212952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102368803|NCT01212952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368804|NCT01212952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102368806|NCT01212952|Hormones|hormones|mesh-ancestor
102368807|NCT01212952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102368808|NCT01212952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102368809|NCT01212952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102368810|NCT01212952|Immunologic Factors|immunologic factors|mesh-ancestor
102368811|NCT01212952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102368812|NCT01212952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102368813|NCT01212952|Growth Substances|growth substances|mesh-ancestor
102368814|NCT01212952|Growth Inhibitors|growth inhibitors|mesh-ancestor
102368815|NCT04609865|Lidocaine|lidocaine|mesh-list
102368816|NCT04609865|Anesthetics, Local|anesthetics, local|mesh-ancestor
102368817|NCT04609865|Anesthetics|anesthetics|mesh-ancestor
102368818|NCT04609865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102368819|NCT04609865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368820|NCT04609865|Sensory System Agents|sensory system agents|mesh-ancestor
102368821|NCT04609865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102368822|NCT04609865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102368823|NCT04609865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102368824|NCT04609865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102368825|NCT04609865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102368826|NCT04609865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368827|NCT01873859|Metformin|metformin|mesh-list
102368828|NCT01873859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102368829|NCT01873859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368830|NCT00493896|Enoxaparin|enoxaparin|mesh-list
102368831|NCT00493896|PENTA|penta|mesh-list
102368832|NCT00493896|Fondaparinux|fondaparinux|mesh-list
102368833|NCT00493896|Anticoagulants|anticoagulants|mesh-ancestor
102368834|NCT00493896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102368835|NCT00493896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102368836|NCT00493896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368837|NCT00493896|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102368838|NCT00493896|Antithrombins|antithrombins|mesh-ancestor
102368839|NCT00493896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102368840|NCT00493896|Protease Inhibitors|protease inhibitors|mesh-ancestor
102368841|NCT00493896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102368842|NCT04597619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
102368843|NCT04597619|Analgesics|analgesics|mesh-ancestor
102368844|NCT04597619|Sensory System Agents|sensory system agents|mesh-ancestor
102368845|NCT04597619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102192565|NCT04714112|Glucocorticoids|glucocorticoids|mesh-ancestor
102192641|NCT02200237|Aluminum phosphate|aluminum phosphate|mesh-list
102192712|NCT02205151|Vasodilator Agents|vasodilator agents|mesh-ancestor
102192798|NCT02525939|Dalcetrapib|dalcetrapib|mesh-list
102368846|NCT04597619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368847|NCT03449940|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102368848|NCT03449940|Ceftriaxone|ceftriaxone|mesh-list
102368849|NCT03449940|Diclofenac|diclofenac|mesh-list
102368850|NCT03449940|Lidocaine|lidocaine|mesh-list
102368851|NCT03449940|Analgesics|analgesics|mesh-list
102368852|NCT03449940|Anesthetics, Local|anesthetics, local|mesh-ancestor
102368853|NCT03449940|Anesthetics|anesthetics|mesh-ancestor
102193082|NCT02231281|Antiviral Agents|antiviral agents|mesh-ancestor
102368854|NCT03449940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102368855|NCT03449940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368856|NCT03449940|Sensory System Agents|sensory system agents|mesh-ancestor
102368857|NCT03449940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102368858|NCT03449940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102193376|NCT05042791|Antimetabolites|antimetabolites|mesh-ancestor
102193448|NCT02145767|Progesterone|progesterone|mesh-list
102368859|NCT03449940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102368860|NCT03449940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102368861|NCT03449940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102368862|NCT03449940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368863|NCT03449940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102368864|NCT03449940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102368865|NCT03449940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102193751|NCT04440267|Hormones|hormones|mesh-ancestor
102368866|NCT03449940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102368867|NCT03449940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102368868|NCT03449940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102368869|NCT03449940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102368870|NCT01230424|Triamcinolone|triamcinolone|mesh-list
102368871|NCT01230424|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102368872|NCT01230424|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102368873|NCT01230424|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102368874|NCT01230424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102368875|NCT01230424|Glucocorticoids|glucocorticoids|mesh-ancestor
102368876|NCT01230424|Hormones|hormones|mesh-ancestor
102368877|NCT01230424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102368878|NCT01230424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368879|NCT01230424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102368880|NCT01230424|Immunologic Factors|immunologic factors|mesh-ancestor
102368881|NCT01230424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102368882|NCT01230424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368883|NCT01230502|Mycophenolic Acid|mycophenolic acid|mesh-list
102368884|NCT01230502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102368885|NCT01230502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102368886|NCT01230502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102368887|NCT01230502|Antitubercular Agents|antitubercular agents|mesh-ancestor
102194013|NCT02259361|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102368888|NCT01230502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102194089|NCT02224105|Hormones|hormones|mesh-ancestor
102368889|NCT01230502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102368890|NCT01230502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102369720|NCT00635505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368891|NCT01230502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368892|NCT03438240|Fentanyl|fentanyl|mesh-list
102368893|NCT03438240|Dexmedetomidine|dexmedetomidine|mesh-list
102368894|NCT03438240|Bupivacaine|bupivacaine|mesh-list
102368895|NCT03438240|Anesthetics, Local|anesthetics, local|mesh-list
102368896|NCT03438240|Anesthetics|anesthetics|mesh-list
102368897|NCT03438240|Sympathomimetics|sympathomimetics|mesh-list
102368898|NCT03438240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102368899|NCT03438240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368900|NCT03438240|Sensory System Agents|sensory system agents|mesh-ancestor
102368901|NCT03438240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102368902|NCT03438240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102368903|NCT03438240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102368904|NCT03438240|Analgesics|analgesics|mesh-ancestor
102368905|NCT03438240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102368906|NCT03438240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102368907|NCT03438240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102368908|NCT03438240|Adrenergic Agents|adrenergic agents|mesh-ancestor
102368909|NCT03438240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102195103|NCT02233777|Pregabalin|pregabalin|mesh-list
102369721|NCT00635505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102369722|NCT00635505|Respiratory System Agents|respiratory system agents|mesh-ancestor
102368910|NCT03438240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368911|NCT03438240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102368912|NCT03438240|Narcotics|narcotics|mesh-ancestor
102368913|NCT03438240|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102368914|NCT03438240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102368915|NCT03438240|Anesthetics, General|anesthetics, general|mesh-ancestor
102368916|NCT03438240|Autonomic Agents|autonomic agents|mesh-ancestor
102368917|NCT01160848|Ethanol|ethanol|mesh-list
102368918|NCT01160848|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102368919|NCT01160848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102195474|NCT02264743|Estradiol|estradiol|mesh-list
102368920|NCT01160848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102368921|NCT01160848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368922|NCT01213576|Ivermectin|ivermectin|mesh-list
102368923|NCT01213576|Albendazole|albendazole|mesh-list
102368924|NCT01213576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102368925|NCT01213576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102368926|NCT01213576|Anthelmintics|anthelmintics|mesh-ancestor
102368927|NCT01213576|Anticestodal Agents|anticestodal agents|mesh-ancestor
102368928|NCT01213576|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102195838|NCT02151305|Propofol|propofol|mesh-list
102368929|NCT01213576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102368930|NCT01213576|Tubulin Modulators|tubulin modulators|mesh-ancestor
102196130|NCT02774681|Trastuzumab|trastuzumab|mesh-list
102368931|NCT01213576|Antimitotic Agents|antimitotic agents|mesh-ancestor
102368932|NCT01213576|Mitosis Modulators|mitosis modulators|mesh-ancestor
102368933|NCT01213576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369723|NCT00635505|Tocolytic Agents|tocolytic agents|mesh-ancestor
102368934|NCT01213576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102196348|NCT01023295|Fosbretabulin|fosbretabulin|mesh-list
102368935|NCT04452318|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
102368936|NCT04452318|Antiviral Agents|antiviral agents|mesh-ancestor
102368937|NCT04452318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102368938|NCT01161862|Glucagon|glucagon|mesh-list
102368939|NCT01161862|Pancrelipase|pancrelipase|mesh-list
102368940|NCT01161862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368941|NCT01161862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102368942|NCT01161862|Hormones|hormones|mesh-ancestor
102196569|NCT02267707|Gemcitabine|gemcitabine|mesh-list
102369724|NCT00635505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102196646|NCT01106989|Lidocaine|lidocaine|mesh-list
102369725|NCT00635505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102369726|NCT00635505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102369727|NCT00635505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102369728|NCT00635505|Adrenergic Agents|adrenergic agents|mesh-ancestor
102369729|NCT00635505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102369730|NCT00635505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369731|NCT01243450|Tretinoin|tretinoin|mesh-list
102369732|NCT01243450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102369733|NCT01243450|Keratolytic Agents|keratolytic agents|mesh-ancestor
102369734|NCT01243450|Dermatologic Agents|dermatologic agents|mesh-ancestor
102369735|NCT05249751|Arginine Vasopressin|arginine vasopressin|mesh-list
102369736|NCT05249751|Hemostatics|hemostatics|mesh-ancestor
102369737|NCT05249751|Coagulants|coagulants|mesh-ancestor
102369738|NCT05249751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102369739|NCT05249751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102369740|NCT05249751|Natriuretic Agents|natriuretic agents|mesh-ancestor
102369741|NCT05249751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369742|NCT00635193|Doxorubicin|doxorubicin|mesh-list
102369743|NCT00635193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102369744|NCT00635193|Volociximab|volociximab|mesh-list
102369745|NCT00635193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102369746|NCT00635193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102369747|NCT00635193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102369748|NCT00635193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102369749|NCT00635193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102369750|NCT00635193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102369751|NCT00635193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369752|NCT00635193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102369753|NCT00635193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102369754|NCT00635193|Growth Substances|growth substances|mesh-ancestor
102369755|NCT00635193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369756|NCT00635193|Growth Inhibitors|growth inhibitors|mesh-ancestor
102196719|NCT00909649|Hemostatics|hemostatics|mesh-ancestor
102368943|NCT01161862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102368944|NCT01214356|Vitamin D|vitamin d|mesh-list
102368945|NCT01214356|Ergocalciferols|ergocalciferols|mesh-list
102368946|NCT01214356|Cholecalciferol|cholecalciferol|mesh-list
102368947|NCT01214356|Vitamins|vitamins|mesh-list
102368948|NCT01214356|Micronutrients|micronutrients|mesh-ancestor
102197019|NCT05430308|Povidone|povidone|mesh-list
102368949|NCT01214356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368950|NCT01214356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102197167|NCT02162537|Pemetrexed|pemetrexed|mesh-list
102369757|NCT00635193|Immunologic Factors|immunologic factors|mesh-ancestor
102368951|NCT01214356|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102368952|NCT01232920|Mycophenolic Acid|mycophenolic acid|mesh-list
102368953|NCT01232920|Methotrexate|methotrexate|mesh-list
102368954|NCT01232920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102368955|NCT01232920|Abortifacient Agents|abortifacient agents|mesh-ancestor
102368956|NCT01232920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102368957|NCT01232920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368958|NCT01232920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102368959|NCT01232920|Antimetabolites|antimetabolites|mesh-ancestor
102368960|NCT01232920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102368961|NCT01232920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102368962|NCT01232920|Dermatologic Agents|dermatologic agents|mesh-ancestor
102368963|NCT01232920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102368964|NCT01232920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102368965|NCT01232920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102368966|NCT01232920|Immunologic Factors|immunologic factors|mesh-ancestor
102197533|NCT03539003|Narcotics|narcotics|mesh-ancestor
102368967|NCT01232920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102368968|NCT01232920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102368969|NCT01232920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102368970|NCT01232920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102368971|NCT01232920|Antitubercular Agents|antitubercular agents|mesh-ancestor
102368972|NCT01232920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102369758|NCT00630201|Buprenorphine|buprenorphine|mesh-list
102368973|NCT01232920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102368974|NCT03445182|Anesthetics|anesthetics|mesh-list
102368975|NCT03445182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102368976|NCT03445182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368977|NCT03010540|Fentanyl|fentanyl|mesh-list
102368978|NCT03010540|Morphine|morphine|mesh-list
102368979|NCT03010540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102368980|NCT03010540|Narcotics|narcotics|mesh-ancestor
102368981|NCT03010540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102368982|NCT03010540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368983|NCT03010540|Analgesics|analgesics|mesh-ancestor
102368984|NCT03010540|Sensory System Agents|sensory system agents|mesh-ancestor
102368985|NCT03010540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102368986|NCT03010540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102368987|NCT03010540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102368988|NCT03010540|Anesthetics, General|anesthetics, general|mesh-ancestor
102368989|NCT03010540|Anesthetics|anesthetics|mesh-ancestor
102368990|NCT03445104|Huperzine A|huperzine a|mesh-list
102198337|NCT01457781|Gasotransmitters|gasotransmitters|mesh-ancestor
102368991|NCT03445104|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102368992|NCT03445104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102369759|NCT00630201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102369760|NCT00630201|Narcotics|narcotics|mesh-ancestor
102198711|NCT02176187|Fenoterol|fenoterol|mesh-list
102368993|NCT03445104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198824|NCT02742649|Timolol|timolol|mesh-list
102368994|NCT03445104|Cholinergic Agents|cholinergic agents|mesh-ancestor
102368995|NCT03445104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102368996|NCT03445104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102368997|NCT03445104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102368998|NCT03445104|Protective Agents|protective agents|mesh-ancestor
102368999|NCT01234714|Liver Extracts|liver extracts|mesh-list
102369000|NCT01234714|Hematinics|hematinics|mesh-ancestor
102369001|NCT03440502|Anesthetics|anesthetics|mesh-list
102369002|NCT03440502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102369003|NCT03440502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369004|NCT01234870|Adenosine|adenosine|mesh-list
102369005|NCT01234870|Analgesics|analgesics|mesh-ancestor
102369006|NCT01234870|Sensory System Agents|sensory system agents|mesh-ancestor
102369007|NCT01234870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102198945|NCT03537287|Hormones|hormones|mesh-ancestor
102369008|NCT01234870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369009|NCT01234870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102369010|NCT01234870|Vasodilator Agents|vasodilator agents|mesh-ancestor
102369011|NCT01234870|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102369012|NCT01234870|Purinergic Agonists|purinergic agonists|mesh-ancestor
102199067|NCT02280265|Factor VIII|factor viii|mesh-list
102369013|NCT01234870|Purinergic Agents|purinergic agents|mesh-ancestor
102369014|NCT01234870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102369761|NCT00630201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102369762|NCT00630201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369763|NCT00630201|Analgesics|analgesics|mesh-ancestor
102369764|NCT00630201|Sensory System Agents|sensory system agents|mesh-ancestor
102369015|NCT01234870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369016|NCT03437460|Ibuprofen|ibuprofen|mesh-list
102369017|NCT03437460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199649|NCT00401011|Hormones|hormones|mesh-ancestor
102369018|NCT03437460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102369019|NCT03437460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102369020|NCT03437460|Analgesics|analgesics|mesh-ancestor
102369021|NCT03437460|Sensory System Agents|sensory system agents|mesh-ancestor
102369022|NCT03437460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102369023|NCT03437460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102369024|NCT03437460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102369025|NCT03437460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102369026|NCT03437460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102369027|NCT03437460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369029|NCT03444636|Bupivacaine|bupivacaine|mesh-list
102369030|NCT03444636|Ropivacaine|ropivacaine|mesh-list
102369031|NCT03444636|Anesthetics, Local|anesthetics, local|mesh-ancestor
102369032|NCT03444636|Anesthetics|anesthetics|mesh-ancestor
102369033|NCT03444636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102369034|NCT03444636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369035|NCT03444636|Sensory System Agents|sensory system agents|mesh-ancestor
102369036|NCT03444636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102369037|NCT03444636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102369038|NCT03444636|Narcotics|narcotics|mesh-ancestor
102369039|NCT03444636|Analgesics|analgesics|mesh-ancestor
102369040|NCT03444636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102369041|NCT03444636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102369042|NCT03444636|Anesthetics, General|anesthetics, general|mesh-ancestor
102369043|NCT01215292|Ketoconazole|ketoconazole|mesh-list
102199929|NCT02187497|Telmisartan|telmisartan|mesh-list
102369044|NCT01215292|Anastrozole|anastrozole|mesh-list
102369045|NCT01215292|Testosterone|testosterone|mesh-list
102200019|NCT00326287|Linezolid|linezolid|mesh-list
102369046|NCT01215292|Dutasteride|dutasteride|mesh-list
102369047|NCT01215292|Acyline|acyline|mesh-list
102369048|NCT01215292|Androgens|androgens|mesh-ancestor
102369049|NCT01215292|Hormones|hormones|mesh-ancestor
102369765|NCT00630201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102200307|NCT03535415|Hormones|hormones|mesh-list
102369050|NCT01215292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102369051|NCT01215292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369052|NCT01215292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102369053|NCT01215292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102369054|NCT01215292|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102369766|NCT00630201|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102369055|NCT01215292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102369056|NCT01215292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102200740|NCT02198261|Minoxidil|minoxidil|mesh-list
102369057|NCT01215292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369058|NCT01215292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102369059|NCT01215292|Hormone Antagonists|hormone antagonists|mesh-ancestor
102200882|NCT02375139|Metformin|metformin|mesh-list
102369060|NCT01215292|Antifungal Agents|antifungal agents|mesh-ancestor
102369061|NCT01215292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102369062|NCT01215292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102369063|NCT01215292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102369767|NCT01925547|Curcumin|curcumin|mesh-list
102369064|NCT01215292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102369065|NCT01215292|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102369066|NCT04796454|Gemcitabine|gemcitabine|mesh-list
102369067|NCT04796454|Oxaliplatin|oxaliplatin|mesh-list
102369068|NCT04796454|Temozolomide|temozolomide|mesh-list
102369069|NCT04796454|Pamiparib|pamiparib|mesh-list
102201481|NCT05442749|Niraparib|niraparib|mesh-list
102369070|NCT04796454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201699|NCT04147546|Antimalarials|antimalarials|mesh-ancestor
102369071|NCT04796454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102369072|NCT04796454|Antimetabolites|antimetabolites|mesh-ancestor
102201847|NCT03105245|GABA Modulators|gaba modulators|mesh-ancestor
102369073|NCT04796454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369074|NCT04796454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102369075|NCT04796454|Alkylating Agents|alkylating agents|mesh-ancestor
102369076|NCT04796454|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102369077|NCT04796454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102369078|NCT02189668|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102369079|NCT02189668|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102369080|NCT02189668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102369081|NCT02189668|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102369082|NCT02189668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102202062|NCT01371630|Alkylating Agents|alkylating agents|mesh-ancestor
102369083|NCT02189668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202137|NCT00783367|Hormones|hormones|mesh-ancestor
102369084|NCT02981290|Mycophenolic Acid|mycophenolic acid|mesh-list
102369085|NCT02981290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102369086|NCT02981290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102369087|NCT02981290|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102202284|NCT01306942|Tubulin Modulators|tubulin modulators|mesh-ancestor
102369088|NCT02981290|Antitubercular Agents|antitubercular agents|mesh-ancestor
102369089|NCT02981290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102369090|NCT02981290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102369091|NCT02981290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102202502|NCT03524833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102202668|NCT04467931|Antioxidants|antioxidants|mesh-ancestor
102369092|NCT02981290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369093|NCT03437226|Simendan|simendan|mesh-list
102369094|NCT03437226|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102369095|NCT03437226|Vasodilator Agents|vasodilator agents|mesh-ancestor
102369096|NCT03437226|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102369097|NCT03437226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102369098|NCT03437226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102369099|NCT03437226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369100|NCT03437226|Protective Agents|protective agents|mesh-ancestor
102203109|NCT02225093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102369101|NCT03437226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369102|NCT04788420|Sorafenib|sorafenib|mesh-list
102369103|NCT04788420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102369104|NCT04788420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102369105|NCT04788420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102369106|NCT04788420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369107|NCT01282138|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
102369108|NCT01282138|Dextrans|dextrans|mesh-list
102369109|NCT01282138|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102369110|NCT01282138|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102369111|NCT01282138|Anticoagulants|anticoagulants|mesh-ancestor
102369112|NCT01282138|Plasma Substitutes|plasma substitutes|mesh-ancestor
102369113|NCT01282138|Blood Substitutes|blood substitutes|mesh-ancestor
102203615|NCT04831619|Deoxyglucose|deoxyglucose|mesh-list
102369114|NCT01282138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102203688|NCT03517033|Vasodilator Agents|vasodilator agents|mesh-ancestor
102369115|NCT01282138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102369116|NCT01282138|Analgesics|analgesics|mesh-ancestor
102369117|NCT01282138|Sensory System Agents|sensory system agents|mesh-ancestor
102203843|NCT02295787|Anesthetics|anesthetics|mesh-ancestor
102369118|NCT01282138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102369119|NCT01282138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369120|NCT01282138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102369121|NCT01282138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102369122|NCT01282138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102369123|NCT01282138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102204223|NCT02298283|Hormones|hormones|mesh-ancestor
102369124|NCT01282138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102369125|NCT01282138|Histamine Antagonists|histamine antagonists|mesh-ancestor
102369126|NCT01282138|Histamine Agents|histamine agents|mesh-ancestor
102369127|NCT01282138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102204355|NCT03949673|Analgesics|analgesics|mesh-ancestor
102204427|NCT03149445|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102204504|NCT02294071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102204579|NCT02342769|Antiviral Agents|antiviral agents|mesh-ancestor
102369128|NCT01282138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369129|NCT03444402|Esomeprazole|esomeprazole|mesh-list
102369130|NCT03444402|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102204806|NCT02349243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102204881|NCT05254899|Tislelizumab|tislelizumab|mesh-list
102369131|NCT03444402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102369132|NCT03444402|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102369133|NCT03444402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102369134|NCT03444402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369135|NCT01238536|Dexamethasone|dexamethasone|mesh-list
102205108|NCT02300701|Omalizumab|omalizumab|mesh-list
102369136|NCT01238536|Betamethasone|betamethasone|mesh-list
102205177|NCT02309437|Oxycodone|oxycodone|mesh-list
102205239|NCT03916419|Tubulin Modulators|tubulin modulators|mesh-ancestor
102205315|NCT02331771|Donepezil|donepezil|mesh-list
102369137|NCT01238536|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102369138|NCT01238536|Lidocaine|lidocaine|mesh-list
102369139|NCT01238536|Anesthetics, Local|anesthetics, local|mesh-list
102369140|NCT01238536|Anesthetics|anesthetics|mesh-list
102369141|NCT01238536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102369142|NCT01238536|Antiemetics|antiemetics|mesh-ancestor
102369143|NCT01238536|Autonomic Agents|autonomic agents|mesh-ancestor
102205529|NCT02292238|Benphothiamine|benphothiamine|mesh-list
102369144|NCT01238536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102369145|NCT01238536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369146|NCT01238536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102369147|NCT01238536|Glucocorticoids|glucocorticoids|mesh-ancestor
102369148|NCT01238536|Hormones|hormones|mesh-ancestor
102205671|NCT02326779|Antipyretics|antipyretics|mesh-ancestor
102205744|NCT02305069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369149|NCT01238536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102369150|NCT01238536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102369151|NCT01238536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205896|NCT02317861|Febuxostat|febuxostat|mesh-list
102205967|NCT02314195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369152|NCT01238536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206120|NCT02319577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102206193|NCT03494257|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102206274|NCT02325583|Midazolam|midazolam|mesh-list
102369153|NCT01238536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102369154|NCT01238536|Sensory System Agents|sensory system agents|mesh-ancestor
102369155|NCT01238536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102369156|NCT01238536|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102369157|NCT01238536|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102206486|NCT02235389|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102206558|NCT03736265|Antioxidants|antioxidants|mesh-ancestor
102369158|NCT01238536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102206708|NCT02262533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102369159|NCT01238536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102369160|NCT01238536|Respiratory System Agents|respiratory system agents|mesh-ancestor
102369161|NCT03437070|Doxorubicin|doxorubicin|mesh-list
102369162|NCT03437070|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102369163|NCT03437070|Trabectedin|trabectedin|mesh-list
102369164|NCT03437070|Olaratumab|olaratumab|mesh-list
102369165|NCT03437070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102369166|NCT03437070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102206970|NCT00156533|GABA Agents|gaba agents|mesh-ancestor
102369167|NCT03437070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102369168|NCT03437070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102369169|NCT03437070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102207040|NCT04476173|Narcotics|narcotics|mesh-ancestor
102369170|NCT03437070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369171|NCT03437070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102369172|NCT03437070|Alkylating Agents|alkylating agents|mesh-ancestor
102369173|NCT03128736|Esomeprazole|esomeprazole|mesh-list
102369174|NCT03128736|Dexlansoprazole|dexlansoprazole|mesh-list
102369175|NCT03128736|Lansoprazole|lansoprazole|mesh-list
102369176|NCT03128736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102369177|NCT03128736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102369178|NCT03128736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102369179|NCT03128736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102369180|NCT03128736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369182|NCT01218958|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102369183|NCT01218958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102369184|NCT01218958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369185|NCT01218958|Sensory System Agents|sensory system agents|mesh-ancestor
102369186|NCT01218958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102369187|NCT03440268|Acetylcysteine|acetylcysteine|mesh-list
102369188|NCT03440268|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101916380|NCT03456843|Docetaxel|docetaxel|mesh-list
102369189|NCT03440268|Antiviral Agents|antiviral agents|mesh-ancestor
102369190|NCT03440268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102369191|NCT03440268|Expectorants|expectorants|mesh-ancestor
102207702|NCT04968938|Hallucinogens|hallucinogens|mesh-ancestor
102207770|NCT05350124|Antioxidants|antioxidants|mesh-ancestor
102369192|NCT03440268|Respiratory System Agents|respiratory system agents|mesh-ancestor
102369193|NCT03440268|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102369194|NCT03440268|Antioxidants|antioxidants|mesh-ancestor
102207920|NCT02328963|Everolimus|everolimus|mesh-list
102369195|NCT03440268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369196|NCT03440268|Protective Agents|protective agents|mesh-ancestor
102369197|NCT03440268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369198|NCT03440268|Antidotes|antidotes|mesh-ancestor
102369199|NCT03444246|Iodine|iodine|mesh-list
102369200|NCT03444246|Cadexomer iodine|cadexomer iodine|mesh-list
102369201|NCT03444246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102208362|NCT05253794|Gout Suppressants|gout suppressants|mesh-ancestor
102369202|NCT03444246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102369203|NCT03444246|Trace Elements|trace elements|mesh-ancestor
102369204|NCT03444246|Micronutrients|micronutrients|mesh-ancestor
102369205|NCT03444246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369206|NCT04369014|Anesthetics|anesthetics|mesh-list
102369207|NCT04369014|Propofol|propofol|mesh-list
102369208|NCT04369014|Etomidate|etomidate|mesh-list
102208687|NCT02566863|Dexmedetomidine|dexmedetomidine|mesh-list
102369209|NCT04369014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102369210|NCT04369014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369211|NCT04369014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102369212|NCT04369014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102369213|NCT04369014|Anesthetics, General|anesthetics, general|mesh-ancestor
102369214|NCT03436836|Lidocaine|lidocaine|mesh-list
102369215|NCT03436836|Nalbuphine|nalbuphine|mesh-list
102369216|NCT03436836|Bupivacaine|bupivacaine|mesh-list
102369217|NCT03436836|Anesthetics, Local|anesthetics, local|mesh-ancestor
102369218|NCT03436836|Anesthetics|anesthetics|mesh-ancestor
102209346|NCT05142254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102369219|NCT03436836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102369220|NCT03436836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369221|NCT03436836|Sensory System Agents|sensory system agents|mesh-ancestor
102369222|NCT03436836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102209743|NCT05026736|Antibodies|antibodies|mesh-list
102369223|NCT03436836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102369224|NCT03436836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102369225|NCT03436836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102369226|NCT03436836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102369227|NCT03436836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369228|NCT03436836|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102369229|NCT03436836|Narcotics|narcotics|mesh-ancestor
102369230|NCT03436836|Analgesics|analgesics|mesh-ancestor
102369231|NCT03444012|Ticagrelor|ticagrelor|mesh-list
102369232|NCT03444012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102369233|NCT03444012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102369234|NCT03444012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102369235|NCT03444012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102369236|NCT03444012|Purinergic Agents|purinergic agents|mesh-ancestor
102369237|NCT03444012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102369238|NCT03444012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369239|NCT03444012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209790|NCT04215848|Budesonide|budesonide|mesh-list
102369240|NCT03440034|Pioglitazone|pioglitazone|mesh-list
102369241|NCT03440034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102369242|NCT03440034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369243|NCT03433326|Grazoprevir|grazoprevir|mesh-list
102369244|NCT03433326|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
102369245|NCT03433326|Antiviral Agents|antiviral agents|mesh-ancestor
102369246|NCT03433326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102369247|NCT00244101|Pulmonary Surfactants|pulmonary surfactants|mesh-list
102369248|NCT00244101|Respiratory System Agents|respiratory system agents|mesh-ancestor
102369249|NCT04451382|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102369250|NCT04451382|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102369251|NCT04451382|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102369252|NCT04451382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102180985|NCT03183843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102369253|NCT04451382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210430|NCT01352507|Vasodilator Agents|vasodilator agents|mesh-ancestor
102210506|NCT00774761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102369254|NCT04451382|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102369255|NCT04451382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102369256|NCT04451382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369257|NCT04451382|Cholinergic Agents|cholinergic agents|mesh-ancestor
102369258|NCT04451382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102369259|NCT04276389|Paclitaxel|paclitaxel|mesh-list
102369260|NCT04276389|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102369261|NCT04276389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102369262|NCT04276389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102369263|NCT04276389|Tubulin Modulators|tubulin modulators|mesh-ancestor
102369264|NCT04276389|Antimitotic Agents|antimitotic agents|mesh-ancestor
102369265|NCT04276389|Mitosis Modulators|mitosis modulators|mesh-ancestor
102369266|NCT04276389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369267|NCT03128619|Letrozole|letrozole|mesh-list
102369268|NCT03128619|Palbociclib|palbociclib|mesh-list
102369269|NCT03128619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102369270|NCT03128619|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102369271|NCT03128619|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102369272|NCT03128619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102369273|NCT03128619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369274|NCT03128619|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102369275|NCT03128619|Hormone Antagonists|hormone antagonists|mesh-ancestor
102369276|NCT03128619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102369277|NCT03128619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369278|NCT03128619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102369279|NCT03433092|Carotenoids|carotenoids|mesh-list
102369280|NCT03433092|Antioxidants|antioxidants|mesh-ancestor
102369281|NCT03433092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369282|NCT03433092|Protective Agents|protective agents|mesh-ancestor
102369283|NCT03433092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210585|NCT00765323|Hormones|hormones|mesh-ancestor
102210659|NCT01641952|Rituximab|rituximab|mesh-list
102369284|NCT03433014|Levobupivacaine|levobupivacaine|mesh-list
102369285|NCT03433014|Anesthetics, Local|anesthetics, local|mesh-ancestor
102369286|NCT03433014|Anesthetics|anesthetics|mesh-ancestor
102210802|NCT02280785|Immunologic Factors|immunologic factors|mesh-ancestor
102210887|NCT05647642|Anesthetics|anesthetics|mesh-ancestor
102369287|NCT03433014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102210953|NCT05984602|Antimetabolites|antimetabolites|mesh-ancestor
102211026|NCT05984173|Antioxidants|antioxidants|mesh-ancestor
102211099|NCT05983276|Carboplatin|carboplatin|mesh-list
102211100|NCT05983276|Decitabine|decitabine|mesh-list
102211101|NCT05983276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102211102|NCT05983276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211103|NCT05983276|Tubulin Modulators|tubulin modulators|mesh-ancestor
102211104|NCT05983276|Antimitotic Agents|antimitotic agents|mesh-ancestor
102211105|NCT05983276|Mitosis Modulators|mitosis modulators|mesh-ancestor
102211106|NCT05983276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211107|NCT05983276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102211108|NCT05983276|Antimetabolites|antimetabolites|mesh-ancestor
102211109|NCT05983276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211110|NCT05983263|Capsaicin|capsaicin|mesh-list
102211111|NCT05983263|Antipruritics|antipruritics|mesh-ancestor
102211112|NCT05983263|Dermatologic Agents|dermatologic agents|mesh-ancestor
102211113|NCT05983263|Sensory System Agents|sensory system agents|mesh-ancestor
102211114|NCT05983263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102211115|NCT05983263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211116|NCT05983198|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102211117|NCT05983198|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102211118|NCT05983198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211119|NCT05983107|Everolimus|everolimus|mesh-list
102211120|NCT05983107|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102211121|NCT05983107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102369288|NCT03433014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369289|NCT03433014|Sensory System Agents|sensory system agents|mesh-ancestor
102211251|NCT05929716|Rituximab|rituximab|mesh-list
102369290|NCT03433014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102369291|NCT01872689|Pirfenidone|pirfenidone|mesh-list
102369292|NCT01872689|Analgesics|analgesics|mesh-ancestor
102369293|NCT01872689|Sensory System Agents|sensory system agents|mesh-ancestor
102369294|NCT01872689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102369295|NCT01872689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211329|NCT05784753|Immunologic Factors|immunologic factors|mesh-ancestor
102369296|NCT01872689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102369297|NCT01872689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102369298|NCT01872689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102369299|NCT01872689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102369300|NCT01872689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102369301|NCT03435900|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102369302|NCT03435900|Metronidazole|metronidazole|mesh-list
102369303|NCT03435900|Fosfomycin|fosfomycin|mesh-list
102369304|NCT03435900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102369305|NCT03435900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102369306|NCT03435900|Antitubercular Agents|antitubercular agents|mesh-ancestor
102369307|NCT03435900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102369308|NCT03435900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102369309|NCT00632931|Vorinostat|vorinostat|mesh-list
102369310|NCT00632931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102369311|NCT00632931|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102369312|NCT00632931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102369313|NCT00632931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369314|NCT01857323|Albuterol|albuterol|mesh-list
102369315|NCT01857323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102369316|NCT01857323|Autonomic Agents|autonomic agents|mesh-ancestor
102211400|NCT05726344|Bisacodyl|bisacodyl|mesh-list
102211401|NCT05726344|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
102211402|NCT05726344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102211403|NCT05726344|Cathartics|cathartics|mesh-ancestor
102211404|NCT05726344|Laxatives|laxatives|mesh-ancestor
102211405|NCT05694260|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
102211406|NCT05694260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102369317|NCT01857323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102369318|NCT01857323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369319|NCT01857323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102369320|NCT01857323|Respiratory System Agents|respiratory system agents|mesh-ancestor
102369321|NCT01857323|Tocolytic Agents|tocolytic agents|mesh-ancestor
102369322|NCT01857323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102211488|NCT05668455|Antiemetics|antiemetics|mesh-ancestor
102369323|NCT01857323|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102211563|NCT05546242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102369324|NCT01857323|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102369325|NCT01857323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102369326|NCT01857323|Adrenergic Agents|adrenergic agents|mesh-ancestor
102211632|NCT05422794|Tubulin Modulators|tubulin modulators|mesh-ancestor
102369327|NCT01857323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102211698|NCT05298202|Capsaicin|capsaicin|mesh-list
102211771|NCT05201248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211845|NCT05156658|Etonogestrel|etonogestrel|mesh-list
102369328|NCT01857323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369329|NCT03104439|Nivolumab|nivolumab|mesh-list
102369330|NCT03104439|Ipilimumab|ipilimumab|mesh-list
102369331|NCT03104439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102369332|NCT03104439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102369333|NCT03104439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102369334|NCT03104439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369335|NCT03432780|Docetaxel|docetaxel|mesh-list
102369336|NCT03432780|Hormones|hormones|mesh-list
102369337|NCT03432780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102369338|NCT03432780|Tubulin Modulators|tubulin modulators|mesh-ancestor
102369339|NCT03432780|Antimitotic Agents|antimitotic agents|mesh-ancestor
102212192|NCT04272242|Pyridoxine|pyridoxine|mesh-list
102369340|NCT03432780|Mitosis Modulators|mitosis modulators|mesh-ancestor
102369341|NCT03432780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369342|NCT03432780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102212273|NCT04231318|Glucocorticoids|glucocorticoids|mesh-ancestor
102369343|NCT03432780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369344|NCT00055731|Aspirin|aspirin|mesh-list
102369345|NCT00055731|Docetaxel|docetaxel|mesh-list
102369346|NCT00055731|Goserelin|goserelin|mesh-list
102369347|NCT00055731|Bicalutamide|bicalutamide|mesh-list
102369348|NCT00055731|Estramustine|estramustine|mesh-list
102369349|NCT00055731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102369350|NCT00055731|Tubulin Modulators|tubulin modulators|mesh-ancestor
102369351|NCT00055731|Antimitotic Agents|antimitotic agents|mesh-ancestor
102369352|NCT00055731|Mitosis Modulators|mitosis modulators|mesh-ancestor
102369353|NCT00055731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369354|NCT00055731|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102369355|NCT00055731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102369356|NCT00055731|Analgesics|analgesics|mesh-ancestor
102369357|NCT00055731|Sensory System Agents|sensory system agents|mesh-ancestor
102369358|NCT00055731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102369359|NCT00055731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369360|NCT00055731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102369361|NCT00055731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102369362|NCT00055731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102369363|NCT00055731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102369364|NCT00055731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102369365|NCT00055731|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102369366|NCT00055731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102369367|NCT00055731|Antipyretics|antipyretics|mesh-ancestor
102369368|NCT00055731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102369369|NCT00055731|Androgen Antagonists|androgen antagonists|mesh-ancestor
102369370|NCT00055731|Hormone Antagonists|hormone antagonists|mesh-ancestor
102369371|NCT00055731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102369372|NCT00055731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102369373|NCT00055731|Alkylating Agents|alkylating agents|mesh-ancestor
102369374|NCT03435744|Simvastatin|simvastatin|mesh-list
102212642|NCT03288545|Carboplatin|carboplatin|mesh-list
102369375|NCT03435744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102369376|NCT03435744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102369377|NCT03435744|Antimetabolites|antimetabolites|mesh-ancestor
102369378|NCT03435744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369379|NCT03435744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102369380|NCT03435744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102369381|NCT03435744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102369382|NCT03435666|Capecitabine|capecitabine|mesh-list
102369383|NCT03435666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102369384|NCT03435666|Antimetabolites|antimetabolites|mesh-ancestor
102369385|NCT03435666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369386|NCT03435666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102369387|NCT00632541|Bevacizumab|bevacizumab|mesh-list
102369388|NCT00632541|Sorafenib|sorafenib|mesh-list
102369389|NCT00632541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102369390|NCT00632541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102369391|NCT00632541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102369392|NCT00632541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102369393|NCT00632541|Growth Substances|growth substances|mesh-ancestor
102369394|NCT00632541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369395|NCT00632541|Growth Inhibitors|growth inhibitors|mesh-ancestor
102369396|NCT00632541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102369397|NCT00632541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102369398|NCT00632541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369399|NCT01872611|Prednisolone|prednisolone|mesh-list
102181136|NCT01648348|Antibodies|antibodies|mesh-list
102369400|NCT01872611|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102369401|NCT01872611|Methylprednisolone|methylprednisolone|mesh-list
102369402|NCT01872611|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102369403|NCT01872611|Prednisolone acetate|prednisolone acetate|mesh-list
102369404|NCT01872611|Nepafenac|nepafenac|mesh-list
102369405|NCT01872611|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102369406|NCT01872611|Prednisolone phosphate|prednisolone phosphate|mesh-list
102369407|NCT01872611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102369408|NCT01872611|Glucocorticoids|glucocorticoids|mesh-ancestor
102369409|NCT01872611|Hormones|hormones|mesh-ancestor
102369410|NCT01872611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102369411|NCT01872611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369412|NCT01872611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102369413|NCT01872611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102369414|NCT01872611|Antiemetics|antiemetics|mesh-ancestor
102369415|NCT01872611|Autonomic Agents|autonomic agents|mesh-ancestor
102369416|NCT01872611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102369417|NCT01872611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102369418|NCT01872611|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102369419|NCT01872611|Protective Agents|protective agents|mesh-ancestor
102369420|NCT01872611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102213437|NCT02356588|Sufentanil|sufentanil|mesh-list
102369421|NCT01872611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102369422|NCT01872611|Analgesics|analgesics|mesh-ancestor
102213589|NCT02353468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102213672|NCT03476941|Clindamycin|clindamycin|mesh-list
102369423|NCT01872611|Sensory System Agents|sensory system agents|mesh-ancestor
102369424|NCT01872611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102369425|NCT03432468|Valsartan|valsartan|mesh-list
102369426|NCT03432468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102369427|NCT03432468|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102214048|NCT05943223|Tazobactam|tazobactam|mesh-list
102214118|NCT05901714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102214193|NCT05768360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102369428|NCT03432468|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102214267|NCT05624528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102369429|NCT03432468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369430|NCT01856543|Mometasone Furoate|mometasone furoate|mesh-list
102369431|NCT01856543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102369432|NCT01856543|Dermatologic Agents|dermatologic agents|mesh-ancestor
102369433|NCT01856543|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102369434|NCT03432312|Nicotine|nicotine|mesh-list
102369435|NCT03432312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102369436|NCT03432312|Autonomic Agents|autonomic agents|mesh-ancestor
102369437|NCT03432312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102369438|NCT03432312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214338|NCT05386888|Paclitaxel|paclitaxel|mesh-list
102214339|NCT05386888|Carboplatin|carboplatin|mesh-list
102214340|NCT05386888|Pemetrexed|pemetrexed|mesh-list
102214341|NCT05386888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102214342|NCT05386888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214343|NCT05386888|Tubulin Modulators|tubulin modulators|mesh-ancestor
102369439|NCT03432312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102369440|NCT03432312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102369441|NCT03432312|Cholinergic Agents|cholinergic agents|mesh-ancestor
102369442|NCT03432312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102369443|NCT03432312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369444|NCT03438942|Folic Acid|folic acid|mesh-list
102369445|NCT03438942|Hematinics|hematinics|mesh-ancestor
102369446|NCT03438942|Vitamin B Complex|vitamin b complex|mesh-ancestor
102369447|NCT03438942|Vitamins|vitamins|mesh-ancestor
102369448|NCT03438942|Micronutrients|micronutrients|mesh-ancestor
102369449|NCT03438942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369450|NCT03432156|Immunomodulating Agents|immunomodulating agents|mesh-list
102369451|NCT03432156|Immunologic Factors|immunologic factors|mesh-ancestor
102369452|NCT03432156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369453|NCT04450680|Lactams|lactams|mesh-list
102369454|NCT04450680|beta-Lactams|beta-lactams|mesh-list
102369455|NCT04450680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102214546|NCT04962022|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102369456|NCT04450680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102369457|NCT03438708|Axitinib|axitinib|mesh-list
102214622|NCT04852224|Leuprolide|leuprolide|mesh-list
102369458|NCT03438708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102369459|NCT03438708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102369460|NCT03438708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102214767|NCT04406272|Growth Inhibitors|growth inhibitors|mesh-ancestor
102214840|NCT04188665|Coagulants|coagulants|mesh-ancestor
102369461|NCT03438708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369462|NCT01923597|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
102369463|NCT01923597|Antioxidants|antioxidants|mesh-ancestor
102215067|NCT03539822|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102369464|NCT01923597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369465|NCT01923597|Protective Agents|protective agents|mesh-ancestor
102369466|NCT01923597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369467|NCT01923597|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
102369468|NCT01923597|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102369469|NCT01923597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102369470|NCT01923597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102369471|NCT00632229|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102215524|NCT00563459|Topiramate|topiramate|mesh-list
102369472|NCT00632229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102369473|NCT00632229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102369474|NCT00632229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102215658|NCT00465803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102369475|NCT00632229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369476|NCT00632229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102369477|NCT00632229|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102215874|NCT00383513|Epratuzumab|epratuzumab|mesh-list
102369478|NCT00632229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102369479|NCT00632229|Serotonin Agents|serotonin agents|mesh-ancestor
102369480|NCT00632229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102369481|NCT00632229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216172|NCT00394121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102369482|NCT00632229|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102369483|NCT00632229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102369484|NCT00632229|Dopamine Agents|dopamine agents|mesh-ancestor
102369485|NCT00631137|Testosterone|testosterone|mesh-list
102369486|NCT00631137|Androgens|androgens|mesh-ancestor
102369487|NCT00631137|Hormones|hormones|mesh-ancestor
102369488|NCT00631137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102369489|NCT00631137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369490|NCT03428880|Morphine|morphine|mesh-list
102369491|NCT03428880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102369492|NCT03428880|Narcotics|narcotics|mesh-ancestor
102216768|NCT05369650|Lidocaine|lidocaine|mesh-list
102369493|NCT03428880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102369494|NCT03428880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369495|NCT03428880|Analgesics|analgesics|mesh-ancestor
102216914|NCT04984798|Vitamin E|vitamin e|mesh-list
102216985|NCT00028301|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102369496|NCT03428880|Sensory System Agents|sensory system agents|mesh-ancestor
102217071|NCT00004169|Etoposide|etoposide|mesh-list
102369497|NCT03428880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102369498|NCT01923831|Dexamethasone|dexamethasone|mesh-list
102369499|NCT01923831|Magnesium Sulfate|magnesium sulfate|mesh-list
102217285|NCT03531359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369500|NCT01923831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102369501|NCT01923831|Antiemetics|antiemetics|mesh-ancestor
102369502|NCT01923831|Autonomic Agents|autonomic agents|mesh-ancestor
102369503|NCT01923831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102369504|NCT01923831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369505|NCT01923831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102369506|NCT01923831|Glucocorticoids|glucocorticoids|mesh-ancestor
102369507|NCT01923831|Hormones|hormones|mesh-ancestor
102217730|NCT04830982|Diazoxide|diazoxide|mesh-list
102369508|NCT01923831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102369509|NCT01923831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102217810|NCT02917096|Vidarabine|vidarabine|mesh-list
102369510|NCT01923831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102369511|NCT01923831|Analgesics|analgesics|mesh-ancestor
102369512|NCT01923831|Sensory System Agents|sensory system agents|mesh-ancestor
102369513|NCT01923831|Anesthetics|anesthetics|mesh-ancestor
102217955|NCT02611024|Irinotecan|irinotecan|mesh-list
102369514|NCT01923831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102218026|NCT05653024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102369515|NCT01923831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102369516|NCT01923831|Anticonvulsants|anticonvulsants|mesh-ancestor
102369517|NCT01923831|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102218170|NCT04596826|Analgesics|analgesics|mesh-ancestor
102369518|NCT01923831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102369519|NCT01923831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369520|NCT01923831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102369521|NCT01923831|Tocolytic Agents|tocolytic agents|mesh-ancestor
102369522|NCT01923831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102369523|NCT01923909|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102369524|NCT01923909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102369525|NCT04892940|Analgesics|analgesics|mesh-list
102369526|NCT04892940|Sensory System Agents|sensory system agents|mesh-ancestor
102369527|NCT04892940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102218538|NCT04699071|Lenvatinib|lenvatinib|mesh-list
102369528|NCT04892940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369529|NCT03085563|Midazolam|midazolam|mesh-list
102369530|NCT03085563|Nitrous Oxide|nitrous oxide|mesh-list
102218680|NCT02294591|Acetylcysteine|acetylcysteine|mesh-list
102369531|NCT03085563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102218758|NCT04465175|Magnesium Sulfate|magnesium sulfate|mesh-list
102369532|NCT03085563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102369533|NCT03085563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102369534|NCT03085563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369535|NCT03085563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102369536|NCT03085563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102369537|NCT03085563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102369538|NCT03085563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102218966|NCT02298335|Prednisone|prednisone|mesh-list
102369539|NCT03085563|Anesthetics, General|anesthetics, general|mesh-ancestor
102369540|NCT03085563|Anesthetics|anesthetics|mesh-ancestor
102369541|NCT03085563|GABA Modulators|gaba modulators|mesh-ancestor
102369542|NCT03085563|GABA Agents|gaba agents|mesh-ancestor
102369543|NCT03085563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102369544|NCT03085563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369545|NCT03085563|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102369546|NCT03085563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102369547|NCT03085563|Analgesics|analgesics|mesh-ancestor
102369548|NCT03085563|Sensory System Agents|sensory system agents|mesh-ancestor
102219335|NCT02322099|Calcium|calcium|mesh-list
102369549|NCT03085563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102369550|NCT03431766|Chlorhexidine|chlorhexidine|mesh-list
102369551|NCT03431766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102369552|NCT03431766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102369553|NCT03431766|Disinfectants|disinfectants|mesh-ancestor
102369554|NCT04450446|Heparin|heparin|mesh-list
102369555|NCT04450446|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102369556|NCT04450446|Tinzaparin|tinzaparin|mesh-list
102369557|NCT04450446|Dalteparin|dalteparin|mesh-list
102369558|NCT04450446|Anticoagulants|anticoagulants|mesh-ancestor
102369559|NCT04450446|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102369560|NCT04450446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102219699|NCT03739099|Pancrelipase|pancrelipase|mesh-list
102219774|NCT02305823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219846|NCT02234596|Nintedanib|nintedanib|mesh-list
102220001|NCT04778176|Levodopa|levodopa|mesh-list
102220066|NCT02307305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102220138|NCT02307695|Hormones|hormones|mesh-ancestor
102220664|NCT02820961|Exemestane|exemestane|mesh-list
102220951|NCT04345887|Diuretics|diuretics|mesh-ancestor
102221336|NCT02322203|Niacin|niacin|mesh-list
102221461|NCT05096143|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102221761|NCT02221648|Cholinergic Agents|cholinergic agents|mesh-ancestor
102221928|NCT05438875|Tretinoin|tretinoin|mesh-list
102222055|NCT03466567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102222279|NCT03489317|Metformin|metformin|mesh-list
102222630|NCT03481517|Anesthetics|anesthetics|mesh-ancestor
102222704|NCT03479879|Estradiol|estradiol|mesh-list
102222981|NCT02523053|Fluorouracil|fluorouracil|mesh-list
102223059|NCT03181529|Psilocybin|psilocybin|mesh-list
102223134|NCT03469271|Vitamins|vitamins|mesh-ancestor
102612475|NCT00002471|Antimetabolites|antimetabolites|mesh-ancestor
102223204|NCT04456829|Protective Agents|protective agents|mesh-ancestor
102223205|NCT04456829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223206|NCT04456829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102223207|NCT04456829|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102223218|NCT02458313|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
102223219|NCT02458313|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102223220|NCT02458313|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102223221|NCT02458313|Cholinergic Agents|cholinergic agents|mesh-ancestor
102223225|NCT02522221|Warfarin|warfarin|mesh-list
102223283|NCT04453189|Histamine Agents|histamine agents|mesh-ancestor
102223354|NCT03464539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102223428|NCT05153135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102223875|NCT05398679|Rifampin|rifampin|mesh-list
102224308|NCT05100303|Analgesics|analgesics|mesh-ancestor
102224811|NCT03690453|Ivermectin|ivermectin|mesh-list
102225292|NCT03797469|Vitamins|vitamins|mesh-ancestor
102225585|NCT02424344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102225656|NCT03434951|Narcotics|narcotics|mesh-ancestor
102225880|NCT03424733|Prednisone|prednisone|mesh-list
102226101|NCT03436303|Hormones|hormones|mesh-ancestor
102226240|NCT03621553|Vitamins|vitamins|mesh-list
102612590|NCT00002159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102226467|NCT03128203|Oxytocin|oxytocin|mesh-list
102226550|NCT01004029|Hormones|hormones|mesh-ancestor
102226607|NCT03420703|Analgesics|analgesics|mesh-ancestor
102226677|NCT03426553|Vitamin B Complex|vitamin b complex|mesh-ancestor
102226826|NCT00950989|Hematinics|hematinics|mesh-ancestor
102227124|NCT03413059|Hormones|hormones|mesh-ancestor
102227125|NCT03413059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102227126|NCT03413059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102227127|NCT03413059|Immunologic Factors|immunologic factors|mesh-ancestor
102227128|NCT03413059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102227129|NCT03413059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227130|NCT05122377|Goserelin|goserelin|mesh-list
102227131|NCT05122377|Leuprolide|leuprolide|mesh-list
102227132|NCT05122377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102227133|NCT05122377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102227134|NCT05122377|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102227135|NCT05122377|Fertility Agents|fertility agents|mesh-ancestor
102227136|NCT05122377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102227137|NCT05122377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227138|NCT03425461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102227139|NCT03425461|Nivolumab|nivolumab|mesh-list
102227140|NCT03425461|Ipilimumab|ipilimumab|mesh-list
102227141|NCT03425461|Antibodies|antibodies|mesh-list
102227142|NCT03425461|Immunoglobulins|immunoglobulins|mesh-list
102227143|NCT03425461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102227206|NCT03412513|Mirabegron|mirabegron|mesh-list
102612608|NCT00002165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102227494|NCT03408847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102227569|NCT03406819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102227796|NCT03397199|Apatinib|apatinib|mesh-list
102227861|NCT03407027|Glucocorticoids|glucocorticoids|mesh-ancestor
102228010|NCT03392623|Niacinamide|niacinamide|mesh-list
102228159|NCT03126097|Natriuretic Agents|natriuretic agents|mesh-ancestor
102228235|NCT03395977|Febuxostat|febuxostat|mesh-list
102228442|NCT03389321|Enzyme Activators|enzyme activators|mesh-ancestor
102228515|NCT03388853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937522|NCT05973747|Calcium|calcium|mesh-list
102228736|NCT03268811|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102612640|NCT00002177|Antimetabolites|antimetabolites|mesh-ancestor
102229110|NCT03381833|Hepcidins|hepcidins|mesh-list
102229182|NCT03460015|Propofol|propofol|mesh-list
102229549|NCT05172115|Dalteparin|dalteparin|mesh-list
102229622|NCT04445857|Katacalcin|katacalcin|mesh-list
102229913|NCT04522297|Norepinephrine|norepinephrine|mesh-list
102229995|NCT02518789|Anesthetics|anesthetics|mesh-ancestor
102230141|NCT03357055|Anesthetics, General|anesthetics, general|mesh-ancestor
102231099|NCT03346837|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102231173|NCT03121963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102231248|NCT05302713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102231328|NCT05135013|Drospirenone|drospirenone|mesh-list
102612704|NCT00002213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101940973|NCT01215669|Vaccines|vaccines|mesh-list
102232302|NCT02502877|Anesthetics|anesthetics|mesh-ancestor
102232457|NCT03341845|Avelumab|avelumab|mesh-list
102232823|NCT03331861|Metformin|metformin|mesh-list
102232970|NCT04492813|Remifentanil|remifentanil|mesh-list
102233165|NCT01876953|Cytarabine|cytarabine|mesh-list
102233194|NCT04493281|Edaravone|edaravone|mesh-list
102233338|NCT03317197|Autonomic Agents|autonomic agents|mesh-ancestor
102233417|NCT05129475|Nirmatrelvir|nirmatrelvir|mesh-list
102233629|NCT02479711|Autonomic Agents|autonomic agents|mesh-ancestor
102234007|NCT05244577|Serotonin Agents|serotonin agents|mesh-ancestor
102234097|NCT03913845|Mydriatics|mydriatics|mesh-ancestor
102234154|NCT05061147|Azacitidine|azacitidine|mesh-list
102234232|NCT05035953|Edaravone|edaravone|mesh-list
102234338|NCT05306431|Eusol|eusol|mesh-list
102612794|NCT00002507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102234526|NCT03309319|Rosiglitazone|rosiglitazone|mesh-list
102234676|NCT03306745|Folic Acid|folic acid|mesh-list
102234816|NCT02916979|Immunologic Factors|immunologic factors|mesh-ancestor
102234889|NCT03299257|Cholinergic Agents|cholinergic agents|mesh-ancestor
102234890|NCT03299257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102234891|NCT03299257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234892|NCT03299257|Nootropic Agents|nootropic agents|mesh-ancestor
102234893|NCT02466373|Clonidine|clonidine|mesh-list
102234894|NCT02466373|Analgesics|analgesics|mesh-ancestor
102234895|NCT02466373|Sensory System Agents|sensory system agents|mesh-ancestor
102612806|NCT00002267|Rifabutin|rifabutin|mesh-list
102235040|NCT02464813|Pregabalin|pregabalin|mesh-list
102235118|NCT02465749|Vitamins|vitamins|mesh-list
102235184|NCT03297073|Analgesics|analgesics|mesh-ancestor
102235275|NCT02460913|Morphine|morphine|mesh-list
102235412|NCT03289429|Analgesics|analgesics|mesh-ancestor
102235491|NCT03370835|Metoprolol|metoprolol|mesh-list
102612813|NCT00002273|Antiviral Agents|antiviral agents|mesh-ancestor
102235705|NCT03375593|Antipyretics|antipyretics|mesh-ancestor
102235852|NCT02519153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102236004|NCT03361397|Lidocaine|lidocaine|mesh-list
102236077|NCT02460055|Antipruritics|antipruritics|mesh-ancestor
102236299|NCT03359837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102236741|NCT03350633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102237402|NCT03254173|Serotonin Agents|serotonin agents|mesh-ancestor
102238089|NCT03235609|Analgesics|analgesics|mesh-ancestor
102238462|NCT03342599|Thioctic Acid|thioctic acid|mesh-list
102238604|NCT02497313|Cholecystokinin|cholecystokinin|mesh-list
102239638|NCT03324503|Hormones|hormones|mesh-ancestor
102612977|NCT00002579|Immunologic Factors|immunologic factors|mesh-ancestor
102240215|NCT02490527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102240300|NCT04485403|Ibuprofen|ibuprofen|mesh-list
102240431|NCT03204331|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102240504|NCT05004207|Lactulose|lactulose|mesh-list
102240800|NCT01374919|Hematinics|hematinics|mesh-ancestor
102241158|NCT05713019|Analgesics|analgesics|mesh-ancestor
102241226|NCT05709353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241301|NCT02481323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241379|NCT02480543|Oxytocics|oxytocics|mesh-ancestor
102241451|NCT02477501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102241524|NCT03196531|Loratadine|loratadine|mesh-list
102241814|NCT04450953|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102613034|NCT00002621|Interferon-alpha|interferon-alpha|mesh-list
102242106|NCT02722967|Aripiprazole|aripiprazole|mesh-list
102242319|NCT02467907|Bevacizumab|bevacizumab|mesh-list
102613064|NCT00002633|Fertility Agents|fertility agents|mesh-ancestor
102242972|NCT05581719|Nivolumab|nivolumab|mesh-list
102243259|NCT04729179|Cannabidiol|cannabidiol|mesh-list
102243325|NCT03719313|Interferons|interferons|mesh-list
102613123|NCT05673785|Prednisone|prednisone|mesh-list
102244268|NCT02458625|Hematinics|hematinics|mesh-ancestor
102244340|NCT03989609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102244486|NCT03267329|Telmisartan|telmisartan|mesh-list
102244564|NCT02458079|Antioxidants|antioxidants|mesh-ancestor
102613146|NCT05673785|Immunotoxins|immunotoxins|mesh-ancestor
102245216|NCT00700817|Metformin|metformin|mesh-list
102245323|NCT04423731|Leucovorin|leucovorin|mesh-list
102245365|NCT04947189|Glucocorticoids|glucocorticoids|mesh-ancestor
102245810|NCT03057015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102246193|NCT04902105|Ecopipam|ecopipam|mesh-list
102246690|NCT03049293|Midazolam|midazolam|mesh-list
102613199|NCT02973113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102247272|NCT03047499|Botulinum Toxins|botulinum toxins|mesh-list
102247273|NCT03047499|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102247274|NCT03047499|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102247286|NCT04867941|Acalabrutinib|acalabrutinib|mesh-list
102613202|NCT00002687|Aldesleukin|aldesleukin|mesh-list
102247421|NCT03043521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102247725|NCT04849845|Insulin|insulin|mesh-list
102247800|NCT01598896|Hormones|hormones|mesh-ancestor
102248014|NCT03040401|Aldesleukin|aldesleukin|mesh-list
102248444|NCT04816461|Artenimol|artenimol|mesh-list
102248592|NCT05619315|Antidotes|antidotes|mesh-ancestor
102248737|NCT04807335|Ketamine|ketamine|mesh-list
102249013|NCT04808895|Antipyretics|antipyretics|mesh-ancestor
102613253|NCT00002735|Immunologic Factors|immunologic factors|mesh-ancestor
102249380|NCT03231215|Autonomic Agents|autonomic agents|mesh-ancestor
102249970|NCT02149108|Nintedanib|nintedanib|mesh-list
102250096|NCT05558319|Dexamethasone|dexamethasone|mesh-list
102250307|NCT02141620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102613318|NCT00002771|Busulfan|busulfan|mesh-list
102613319|NCT00002771|Idarubicin|idarubicin|mesh-list
102613320|NCT00002771|Hydroxyurea|hydroxyurea|mesh-list
102613321|NCT00002771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613322|NCT00002771|Antiviral Agents|antiviral agents|mesh-ancestor
102613323|NCT00002771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102250308|NCT02141620|Expectorants|expectorants|mesh-ancestor
102250309|NCT02141620|Respiratory System Agents|respiratory system agents|mesh-ancestor
102250310|NCT02141620|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102250375|NCT05552391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102613356|NCT00002783|Floxuridine|floxuridine|mesh-list
102251008|NCT02439905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102251277|NCT05530395|Hormones|hormones|mesh-ancestor
102251346|NCT02437721|Folic Acid|folic acid|mesh-list
102251487|NCT03189329|Anesthetics, Local|anesthetics, local|mesh-ancestor
102251643|NCT02433899|Hormones|hormones|mesh-ancestor
102251701|NCT05532111|Alkylating Agents|alkylating agents|mesh-ancestor
102251843|NCT02429531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251922|NCT05518383|Etoposide|etoposide|mesh-list
102251997|NCT03186443|Pregabalin|pregabalin|mesh-list
102252073|NCT03184493|Metformin|metformin|mesh-list
102252143|NCT02430545|Rifampin|rifampin|mesh-list
102252215|NCT02426723|Growth Substances|growth substances|mesh-ancestor
102613431|NCT05749445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102252721|NCT01624090|Plicamycin|plicamycin|mesh-list
102253094|NCT02415179|Glucocorticoids|glucocorticoids|mesh-ancestor
102613455|NCT05545319|Nirmatrelvir|nirmatrelvir|mesh-list
102613467|NCT05523869|Topotecan|topotecan|mesh-list
102254040|NCT05504577|Coagulants|coagulants|mesh-ancestor
102254114|NCT05500677|Sensory System Agents|sensory system agents|mesh-ancestor
102254207|NCT02040766|Hormones|hormones|mesh-ancestor
102613477|NCT05522465|Autonomic Agents|autonomic agents|mesh-ancestor
102254490|NCT02401295|Celecoxib|celecoxib|mesh-list
102254567|NCT02400281|Idarubicin|idarubicin|mesh-list
102254641|NCT02400047|Analgesics|analgesics|mesh-ancestor
102255077|NCT04543071|Antimetabolites|antimetabolites|mesh-ancestor
102255445|NCT02550795|Analgesics|analgesics|mesh-ancestor
102255515|NCT05626439|Alprazolam|alprazolam|mesh-list
102613517|NCT04811339|Antacids|antacids|mesh-ancestor
102256243|NCT03806309|Vitamins|vitamins|mesh-ancestor
102256468|NCT02382029|Anticonvulsants|anticonvulsants|mesh-ancestor
102256544|NCT02384837|Sirolimus|sirolimus|mesh-list
102256691|NCT04688021|Antimetabolites|antimetabolites|mesh-ancestor
102613530|NCT04331093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102256909|NCT02373449|Anesthetics|anesthetics|mesh-ancestor
102257351|NCT02365571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102257429|NCT02361905|Leuprolide|leuprolide|mesh-list
102257520|NCT02357693|Aprepitant|aprepitant|mesh-list
102257573|NCT02359643|Antipyretics|antipyretics|mesh-ancestor
102257745|NCT02355509|Acarbose|acarbose|mesh-list
102258244|NCT02344511|Vancomycin|vancomycin|mesh-list
102258501|NCT02331563|Analgesics|analgesics|mesh-ancestor
102613583|NCT05015621|Calcium|calcium|mesh-list
102258882|NCT03191539|Apremilast|apremilast|mesh-list
102259200|NCT02707861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102259331|NCT02428777|Narcotics|narcotics|mesh-ancestor
102259400|NCT03143465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102259489|NCT01995136|Travoprost|travoprost|mesh-list
102259700|NCT03139409|Chlorhexidine|chlorhexidine|mesh-list
102613652|NCT00382889|Hormones|hormones|mesh-ancestor
102259816|NCT05048069|Rebamipide|rebamipide|mesh-list
102260009|NCT01993186|Glycerol|glycerol|mesh-list
102260048|NCT02420509|Vitamin B Complex|vitamin b complex|mesh-ancestor
102260122|NCT02415829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102260272|NCT05088083|Paclitaxel|paclitaxel|mesh-list
101969468|NCT02286934|Carvedilol|carvedilol|mesh-list
102260714|NCT02423239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102260791|NCT03175939|Immunologic Factors|immunologic factors|mesh-ancestor
102261303|NCT02449187|Metformin|metformin|mesh-list
102261525|NCT02012218|Brexpiprazole|brexpiprazole|mesh-list
102261742|NCT02409199|Docetaxel|docetaxel|mesh-list
102613784|NCT00002921|Hydrocortisone|hydrocortisone|mesh-list
102262414|NCT02396563|Ropivacaine|ropivacaine|mesh-list
102262483|NCT04522739|Diuretics|diuretics|mesh-ancestor
102262778|NCT01984294|Ribavirin|ribavirin|mesh-list
102262937|NCT05120687|Antimetabolites|antimetabolites|mesh-ancestor
102263155|NCT01980706|GABA Agonists|gaba agonists|mesh-ancestor
102263226|NCT04435925|Fentanyl|fentanyl|mesh-list
102613813|NCT00002933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102264102|NCT05323175|Sensory System Agents|sensory system agents|mesh-ancestor
102264103|NCT05323175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102264104|NCT05279963|Amitriptyline|amitriptyline|mesh-list
102264105|NCT05279963|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101973058|NCT03937687|Caffeine|caffeine|mesh-list
102264400|NCT05124431|Everolimus|everolimus|mesh-list
102264468|NCT03114085|Apatinib|apatinib|mesh-list
102264543|NCT02669407|Sensory System Agents|sensory system agents|mesh-ancestor
102613825|NCT00002939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102264818|NCT05899621|Hormones|hormones|mesh-ancestor
102613859|NCT00002945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102264882|NCT05898984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264883|NCT05898984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102264884|NCT05898984|Respiratory System Agents|respiratory system agents|mesh-ancestor
102264885|NCT05898763|Pembrolizumab|pembrolizumab|mesh-list
102264886|NCT05898763|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
102264887|NCT05898763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102265013|NCT05886049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102265014|NCT05886049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102265015|NCT05886049|Immunologic Factors|immunologic factors|mesh-ancestor
102265016|NCT05886049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265025|NCT05861765|Papaverine|papaverine|mesh-list
102265160|NCT05455697|Mitosis Modulators|mitosis modulators|mesh-ancestor
102613881|NCT03058289|Antibodies|antibodies|mesh-list
102613887|NCT03058289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102265676|NCT03653247|Antiviral Agents|antiviral agents|mesh-ancestor
102265970|NCT04489589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101974922|NCT04400110|Amoxicillin|amoxicillin|mesh-list
102266338|NCT05155007|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102266857|NCT01957150|Xhance|xhance|mesh-list
102267004|NCT02369965|Ritonavir|ritonavir|mesh-list
102267144|NCT04157075|Anesthetics|anesthetics|mesh-ancestor
102267216|NCT02368795|Tocolytic Agents|tocolytic agents|mesh-ancestor
102267749|NCT05058755|Pegaspargase|pegaspargase|mesh-list
102613934|NCT03933293|Ezetimibe|ezetimibe|mesh-list
102267959|NCT04499131|Progesterone|progesterone|mesh-list
102268107|NCT01968694|Diphenhydramine|diphenhydramine|mesh-list
102268182|NCT05049473|Alkylating Agents|alkylating agents|mesh-ancestor
102268326|NCT02352025|Equol|equol|mesh-list
102268432|NCT03160651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102268508|NCT03149653|SMOFlipid|smoflipid|mesh-list
102268581|NCT02350387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268655|NCT01939366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102614031|NCT00003035|Mitosis Modulators|mitosis modulators|mesh-ancestor
102269089|NCT03146377|Antimetabolites|antimetabolites|mesh-ancestor
102269308|NCT05991622|Analgesics|analgesics|mesh-ancestor
102269382|NCT05991375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101978265|NCT04462666|Etoricoxib|etoricoxib|mesh-list
102269490|NCT05990387|Urological Agents|urological agents|mesh-ancestor
102269570|NCT05987826|Aflutinib|aflutinib|mesh-list
102614077|NCT00383357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269827|NCT05561387|Ichthammol|ichthammol|mesh-list
102614160|NCT00003119|Sargramostim|sargramostim|mesh-list
102270574|NCT03746106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102614194|NCT00003401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102270647|NCT03678025|Hormone Antagonists|hormone antagonists|mesh-ancestor
102270648|NCT03678025|Luteolytic Agents|luteolytic agents|mesh-ancestor
102270649|NCT03678025|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102270650|NCT03678025|Contraceptive Agents|contraceptive agents|mesh-ancestor
102270651|NCT03678025|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102270656|NCT03644485|Tacrolimus|tacrolimus|mesh-list
102270969|NCT00254384|Cisplatin|cisplatin|mesh-list
102271135|NCT05916066|Niacin|niacin|mesh-list
102271318|NCT05914350|Hormones|hormones|mesh-ancestor
102271421|NCT05913414|Iron|iron|mesh-list
102271529|NCT05911828|Ferroquine|ferroquine|mesh-list
102271602|NCT05907512|Endostar protein|endostar protein|mesh-list
102271676|NCT05867329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102271849|NCT05714553|Leucovorin|leucovorin|mesh-list
102271975|NCT05641051|Autonomic Agents|autonomic agents|mesh-ancestor
102272049|NCT05554237|Ceftibuten|ceftibuten|mesh-list
102272684|NCT04925986|Pembrolizumab|pembrolizumab|mesh-list
101981776|NCT03103100|Lidocaine|lidocaine|mesh-list
102273128|NCT04512430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273203|NCT04438382|Antibodies|antibodies|mesh-list
102273519|NCT04233866|Vitamins|vitamins|mesh-ancestor
102273728|NCT04075292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273729|NCT04075292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102273730|NCT04075292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102273731|NCT04075292|Alkylating Agents|alkylating agents|mesh-ancestor
102273732|NCT04075292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273733|NCT04047472|Aflibercept|aflibercept|mesh-list
102273734|NCT04047472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102273735|NCT04047472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102273736|NCT04047472|Growth Substances|growth substances|mesh-ancestor
102273737|NCT04047472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273738|NCT04047472|Growth Inhibitors|growth inhibitors|mesh-ancestor
102273739|NCT04047472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273740|NCT04047355|Propranolol|propranolol|mesh-list
102273741|NCT04047355|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102273742|NCT04047355|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102273743|NCT04047355|Adrenergic Agents|adrenergic agents|mesh-ancestor
102273744|NCT04047355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102273745|NCT04047355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273746|NCT04047355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273747|NCT04047355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102273748|NCT04047355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102273749|NCT04047355|Vasodilator Agents|vasodilator agents|mesh-ancestor
102273750|NCT04045431|Hylan|hylan|mesh-list
102273751|NCT04045431|Viscosupplements|viscosupplements|mesh-ancestor
102273752|NCT04045431|Protective Agents|protective agents|mesh-ancestor
102273753|NCT04045431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273785|NCT04020341|Nitrofurantoin|nitrofurantoin|mesh-list
102273786|NCT04020341|Gepotidacin|gepotidacin|mesh-list
102274100|NCT03593655|Emtricitabine|emtricitabine|mesh-list
102274622|NCT02628626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102274808|NCT01593254|Dasatinib|dasatinib|mesh-list
102369768|NCT01925547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102369769|NCT01925547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102369770|NCT01925547|Analgesics|analgesics|mesh-ancestor
102369771|NCT01925547|Sensory System Agents|sensory system agents|mesh-ancestor
102369772|NCT01925547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102369773|NCT01925547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369774|NCT01925547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102369775|NCT01925547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102369776|NCT01925547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102369777|NCT01925547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102369778|NCT01925547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369779|NCT03122301|Bupivacaine|bupivacaine|mesh-list
102369780|NCT03122301|Anesthetics, Local|anesthetics, local|mesh-ancestor
102369781|NCT03122301|Anesthetics|anesthetics|mesh-ancestor
102369782|NCT03122301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101893481|NCT03942926|Antifungal Agents|antifungal agents|mesh-ancestor
102369783|NCT03122301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369784|NCT03122301|Sensory System Agents|sensory system agents|mesh-ancestor
102369785|NCT03122301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102369786|NCT01925859|Dexamethasone|dexamethasone|mesh-list
102369787|NCT01925859|Dexamethasone acetate|dexamethasone acetate|mesh-list
102369788|NCT01925859|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102369789|NCT01925859|BB 1101|bb 1101|mesh-list
102369790|NCT01925859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102369791|NCT01925859|Antiemetics|antiemetics|mesh-ancestor
102369792|NCT01925859|Autonomic Agents|autonomic agents|mesh-ancestor
102369793|NCT01925859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102369794|NCT01925859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369795|NCT01925859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102369796|NCT01925859|Glucocorticoids|glucocorticoids|mesh-ancestor
102369797|NCT01925859|Hormones|hormones|mesh-ancestor
102369798|NCT01925859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102369799|NCT01925859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101893683|NCT01109030|Pioglitazone|pioglitazone|mesh-list
102369800|NCT01925859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102369801|NCT01925859|Protease Inhibitors|protease inhibitors|mesh-ancestor
102369802|NCT01925859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102369803|NCT01925859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369804|NCT01920945|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102369805|NCT01920945|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102369806|NCT01920945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101893752|NCT03943784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102369807|NCT01920945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102369808|NCT01920945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369809|NCT01920945|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101893817|NCT01056497|Thioctic Acid|thioctic acid|mesh-list
101893895|NCT03941990|Analgesics|analgesics|mesh-ancestor
102369810|NCT01920945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102369811|NCT01920945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369812|NCT01920945|Cholinergic Agents|cholinergic agents|mesh-ancestor
102369813|NCT01920945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102369814|NCT01926639|Rituximab|rituximab|mesh-list
102369815|NCT01926639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101894047|NCT03942068|Paclitaxel|paclitaxel|mesh-list
102369816|NCT01926639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102369817|NCT01926639|Immunologic Factors|immunologic factors|mesh-ancestor
102369818|NCT01926639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369819|NCT01926639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102369820|NCT02199496|Ustekinumab|ustekinumab|mesh-list
102369821|NCT02199496|Dermatologic Agents|dermatologic agents|mesh-ancestor
102369822|NCT04395417|Hyaluronic Acid|hyaluronic acid|mesh-list
102369823|NCT04395417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102369824|NCT04395417|Immunologic Factors|immunologic factors|mesh-ancestor
101689747|NCT02646774|Micafungin|micafungin|mesh-list
102369825|NCT04395417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369826|NCT04395417|Viscosupplements|viscosupplements|mesh-ancestor
102369827|NCT04395417|Protective Agents|protective agents|mesh-ancestor
102369828|NCT02199574|Bupivacaine|bupivacaine|mesh-list
102369829|NCT02199574|Anesthetics, Local|anesthetics, local|mesh-ancestor
102369830|NCT02199574|Anesthetics|anesthetics|mesh-ancestor
102369831|NCT02199574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102369832|NCT02199574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369833|NCT02199574|Sensory System Agents|sensory system agents|mesh-ancestor
102369834|NCT02199574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102369835|NCT02199652|Prazosin|prazosin|mesh-list
102369836|NCT02199652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102369837|NCT02199652|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102369838|NCT02199652|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102369839|NCT02199652|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102369840|NCT02199652|Adrenergic Agents|adrenergic agents|mesh-ancestor
102369841|NCT02199652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102369842|NCT02199652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369843|NCT02199652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369844|NCT03009916|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
102369845|NCT03009916|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102369846|NCT03009916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102369847|NCT03009916|Antimetabolites|antimetabolites|mesh-ancestor
101894455|NCT03985865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102369848|NCT03009916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369849|NCT03009916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102369850|NCT01927029|Progesterone|progesterone|mesh-list
102181588|NCT02115035|Vemurafenib|vemurafenib|mesh-list
102369851|NCT01927029|Progestins|progestins|mesh-ancestor
102369852|NCT01927029|Hormones|hormones|mesh-ancestor
101894608|NCT01117298|Tadalafil|tadalafil|mesh-list
102369853|NCT01927029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102369854|NCT01927029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369855|NCT01921647|Amoxicillin|amoxicillin|mesh-list
102369856|NCT01921647|Clarithromycin|clarithromycin|mesh-list
102369857|NCT01921647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102369858|NCT01921647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102369859|NCT01921647|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102369860|NCT01921647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102369861|NCT01921647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369862|NCT01921647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102369863|NCT01921647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102369864|NCT01339858|Acetylcysteine|acetylcysteine|mesh-list
102369865|NCT01339858|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102369866|NCT01339858|Antiviral Agents|antiviral agents|mesh-ancestor
102369867|NCT01339858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102369868|NCT01339858|Expectorants|expectorants|mesh-ancestor
102369869|NCT01339858|Respiratory System Agents|respiratory system agents|mesh-ancestor
102369870|NCT01339858|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102369871|NCT01339858|Antioxidants|antioxidants|mesh-ancestor
101894808|NCT01119014|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102369872|NCT01339858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369873|NCT01339858|Protective Agents|protective agents|mesh-ancestor
101894876|NCT01124630|Protective Agents|protective agents|mesh-ancestor
102369874|NCT01339858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369875|NCT01339858|Antidotes|antidotes|mesh-ancestor
102369876|NCT01339936|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102369877|NCT01339936|Glycerol|glycerol|mesh-list
102369878|NCT01339936|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102369879|NCT01339936|Protective Agents|protective agents|mesh-ancestor
101895035|NCT01217450|Cetuximab|cetuximab|mesh-list
102369880|NCT01339936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369881|NCT01339936|Laxatives|laxatives|mesh-ancestor
102369882|NCT01339936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102369883|NCT05246865|Androgens|androgens|mesh-list
102369884|NCT05246865|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
102369885|NCT05246865|Hormones|hormones|mesh-ancestor
102369886|NCT05246865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102369887|NCT05246865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369888|NCT05246865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102369889|NCT05246865|Immunologic Factors|immunologic factors|mesh-ancestor
102369890|NCT03111537|Nicotine|nicotine|mesh-list
102369891|NCT03111537|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102369892|NCT03111537|Autonomic Agents|autonomic agents|mesh-ancestor
101895244|NCT03706300|Sympathomimetics|sympathomimetics|mesh-ancestor
102369893|NCT03111537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102369894|NCT03111537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369895|NCT03111537|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102369896|NCT03111537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102369897|NCT03111537|Cholinergic Agents|cholinergic agents|mesh-ancestor
102369898|NCT03111537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102369899|NCT03111537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369900|NCT05244525|Epinephrine|epinephrine|mesh-list
102369901|NCT05244525|Bupivacaine|bupivacaine|mesh-list
102369902|NCT05244525|Anesthetics, Local|anesthetics, local|mesh-ancestor
102369903|NCT05244525|Anesthetics|anesthetics|mesh-ancestor
101895375|NCT05268562|Sensory System Agents|sensory system agents|mesh-ancestor
102369904|NCT05244525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102369905|NCT05244525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369906|NCT05244525|Sensory System Agents|sensory system agents|mesh-ancestor
102369907|NCT05244525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102369908|NCT05244525|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102369909|NCT05244525|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102369910|NCT05244525|Adrenergic Agents|adrenergic agents|mesh-ancestor
102369911|NCT05244525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102369912|NCT05244525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895585|NCT01224470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102369913|NCT05244525|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102369914|NCT05244525|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102369915|NCT05244525|Autonomic Agents|autonomic agents|mesh-ancestor
102369916|NCT05244525|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102369917|NCT05244525|Respiratory System Agents|respiratory system agents|mesh-ancestor
102369918|NCT05244525|Mydriatics|mydriatics|mesh-ancestor
102369919|NCT05244525|Sympathomimetics|sympathomimetics|mesh-ancestor
101895652|NCT01218620|Hormone Antagonists|hormone antagonists|mesh-ancestor
102369920|NCT05244525|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102369921|NCT01927263|Infliximab|infliximab|mesh-list
102369922|NCT01927263|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102369923|NCT01927263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102369924|NCT01927263|Dermatologic Agents|dermatologic agents|mesh-ancestor
102369925|NCT01927263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102369926|NCT01927263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102369927|NCT01341730|Pioglitazone|pioglitazone|mesh-list
102369928|NCT01341730|Atorvastatin|atorvastatin|mesh-list
102369929|NCT01341730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102369930|NCT01341730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102369931|NCT01341730|Antimetabolites|antimetabolites|mesh-ancestor
102369932|NCT01341730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369933|NCT01341730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102369934|NCT01341730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102369935|NCT01341730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102369936|NCT01341730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102369937|NCT01341730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369938|NCT01247272|Fluoxetine|fluoxetine|mesh-list
102369939|NCT01247272|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102369940|NCT01247272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102369941|NCT01247272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102369942|NCT01247272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369943|NCT01247272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102369944|NCT01247272|Serotonin Agents|serotonin agents|mesh-ancestor
102369945|NCT01247272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369946|NCT01247272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102369947|NCT01247272|Antidepressive Agents|antidepressive agents|mesh-ancestor
102369948|NCT01247272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102369949|NCT01247272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102369950|NCT01247272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102369951|NCT01247272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102369952|NCT01290484|Sildenafil Citrate|sildenafil citrate|mesh-list
102369953|NCT01290484|Vasodilator Agents|vasodilator agents|mesh-ancestor
102369954|NCT01290484|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102369955|NCT01290484|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102369956|NCT01290484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102369957|NCT01290484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369958|NCT01290484|Urological Agents|urological agents|mesh-ancestor
102369959|NCT04396743|Clotrimazole|clotrimazole|mesh-list
102369960|NCT04396743|Miconazole|miconazole|mesh-list
102369961|NCT04396743|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102369962|NCT04396743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102369963|NCT04396743|Antifungal Agents|antifungal agents|mesh-ancestor
102369964|NCT04396743|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102369965|NCT04396743|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102369966|NCT04396743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102369967|NCT04396743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369968|NCT04396743|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101896377|NCT03918590|Nepafenac|nepafenac|mesh-list
102369969|NCT04396743|Hormone Antagonists|hormone antagonists|mesh-ancestor
102369970|NCT04396743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102369971|NCT04396743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369972|NCT04396743|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102369973|NCT04396743|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102369974|NCT01928043|Curcumin|curcumin|mesh-list
102369975|NCT01928043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102369976|NCT01928043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102369977|NCT01928043|Analgesics|analgesics|mesh-ancestor
102369978|NCT01928043|Sensory System Agents|sensory system agents|mesh-ancestor
101896565|NCT01133210|Antiviral Agents|antiviral agents|mesh-ancestor
102369979|NCT01928043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102369980|NCT01928043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896642|NCT00369941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102369981|NCT01928043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102369982|NCT01928043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102369983|NCT01928043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102369984|NCT01928043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102369985|NCT01928043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102369986|NCT02979886|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102369987|NCT02979886|Menotropins|menotropins|mesh-list
102369988|NCT02979886|Luteolytic Agents|luteolytic agents|mesh-ancestor
102369989|NCT02979886|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102369990|NCT02979886|Contraceptive Agents|contraceptive agents|mesh-ancestor
101896715|NCT00369629|Pemetrexed|pemetrexed|mesh-list
102369991|NCT02979886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102369992|NCT02979886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102369993|NCT02979886|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102369994|NCT02979886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102369995|NCT02979886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102369996|NCT02979886|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102369997|NCT02979886|Fertility Agents|fertility agents|mesh-ancestor
102154172|NCT03606577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102369998|NCT01928511|Interferons|interferons|mesh-list
102369999|NCT01928511|Tenofovir|tenofovir|mesh-list
102370000|NCT01928511|Interferon-alpha|interferon-alpha|mesh-list
102370001|NCT01928511|Lamivudine|lamivudine|mesh-list
102370002|NCT01928511|Interferon alpha-2|interferon alpha-2|mesh-list
102370003|NCT01928511|Entecavir|entecavir|mesh-list
102370004|NCT01928511|Adefovir|adefovir|mesh-list
102370005|NCT01928511|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102370006|NCT01928511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102370007|NCT01928511|Antiviral Agents|antiviral agents|mesh-ancestor
102370008|NCT01928511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102370009|NCT01928511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102370010|NCT01928511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101896850|NCT01231490|Naproxen|naproxen|mesh-list
102370011|NCT01928511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102370012|NCT01928511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370013|NCT01928511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102370014|NCT01928511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102370015|NCT01928511|Immunologic Factors|immunologic factors|mesh-ancestor
102370016|NCT01928511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370017|NCT05241249|Paclitaxel|paclitaxel|mesh-list
102370018|NCT05241249|Gemcitabine|gemcitabine|mesh-list
102370019|NCT05241249|Bethanechol|bethanechol|mesh-list
102370020|NCT05241249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102370021|NCT05241249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102370022|NCT05241249|Tubulin Modulators|tubulin modulators|mesh-ancestor
102370023|NCT05241249|Antimitotic Agents|antimitotic agents|mesh-ancestor
102370024|NCT05241249|Mitosis Modulators|mitosis modulators|mesh-ancestor
102370025|NCT05241249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370026|NCT05241249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102370027|NCT05241249|Antimetabolites|antimetabolites|mesh-ancestor
102370028|NCT05241249|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102370029|NCT05241249|Autonomic Agents|autonomic agents|mesh-ancestor
102370030|NCT05241249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102370031|NCT05241249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370032|NCT05241249|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102370033|NCT05241249|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102370034|NCT05241249|Cholinergic Agents|cholinergic agents|mesh-ancestor
102370035|NCT05241249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102370036|NCT01928823|Cycloserine|cycloserine|mesh-list
102370037|NCT01928823|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101897403|NCT04154800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102370038|NCT01928823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102370039|NCT01928823|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102370040|NCT01928823|Antitubercular Agents|antitubercular agents|mesh-ancestor
102370041|NCT01928823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102370042|NCT01928823|Antimetabolites|antimetabolites|mesh-ancestor
102370043|NCT01928823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370044|NCT01290874|Formoterol Fumarate|formoterol fumarate|mesh-list
102370045|NCT01290874|Tiotropium Bromide|tiotropium bromide|mesh-list
102370046|NCT01290874|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102370047|NCT01290874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102370048|NCT01290874|Autonomic Agents|autonomic agents|mesh-ancestor
102370049|NCT01290874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101897617|NCT01240850|Prednisone|prednisone|mesh-list
102370050|NCT01290874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370051|NCT01290874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102370052|NCT01290874|Respiratory System Agents|respiratory system agents|mesh-ancestor
102370053|NCT01290874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102370054|NCT01290874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102370055|NCT01290874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102370056|NCT01290874|Adrenergic Agents|adrenergic agents|mesh-ancestor
102370057|NCT01290874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102370058|NCT01290874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370059|NCT01290874|Parasympatholytics|parasympatholytics|mesh-ancestor
102370060|NCT01290874|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101617652|NCT02838225|Docetaxel|docetaxel|mesh-list
102370061|NCT01290874|Cholinergic Agents|cholinergic agents|mesh-ancestor
102370062|NCT02977494|Dexamethasone|dexamethasone|mesh-list
102370063|NCT02977494|Dexamethasone acetate|dexamethasone acetate|mesh-list
102370064|NCT02977494|Bortezomib|bortezomib|mesh-list
102370065|NCT02977494|Daratumumab|daratumumab|mesh-list
102370066|NCT02977494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102370067|NCT02977494|Antiemetics|antiemetics|mesh-ancestor
102370068|NCT02977494|Autonomic Agents|autonomic agents|mesh-ancestor
102370069|NCT02977494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102370070|NCT02977494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370071|NCT02977494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102370072|NCT02977494|Glucocorticoids|glucocorticoids|mesh-ancestor
102370073|NCT02977494|Hormones|hormones|mesh-ancestor
102370074|NCT02977494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102370075|NCT02977494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102370076|NCT02977494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102370077|NCT01929603|Rifampin|rifampin|mesh-list
102370078|NCT01929603|Olaparib|olaparib|mesh-list
102370079|NCT01929603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102370080|NCT01929603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102370081|NCT01929603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370082|NCT01929603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102370083|NCT01929603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102370084|NCT01929603|Antitubercular Agents|antitubercular agents|mesh-ancestor
102370085|NCT01929603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101898026|NCT03323164|Timolol|timolol|mesh-list
102370086|NCT01929603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102370087|NCT01929603|Leprostatic Agents|leprostatic agents|mesh-ancestor
102370088|NCT01929603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102370089|NCT01929603|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102370090|NCT01929603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102370091|NCT01929603|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102370092|NCT01929603|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102370093|NCT01929603|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101898229|NCT03275350|Naltrexone|naltrexone|mesh-list
102370094|NCT01929603|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102370095|NCT04178460|Niraparib|niraparib|mesh-list
102370096|NCT04178460|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102370097|NCT04178460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102370098|NCT04178460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370099|NCT04178460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102370100|NCT01928901|Thymol|thymol|mesh-list
102370101|NCT01928901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102370102|NCT01928901|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102370103|NCT01928901|Antifungal Agents|antifungal agents|mesh-ancestor
102370104|NCT04395105|Dexamethasone|dexamethasone|mesh-list
102370105|NCT04395105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102370106|NCT04395105|Antiemetics|antiemetics|mesh-ancestor
102370107|NCT04395105|Autonomic Agents|autonomic agents|mesh-ancestor
102370108|NCT04395105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102370109|NCT04395105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370110|NCT04395105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102370111|NCT04395105|Glucocorticoids|glucocorticoids|mesh-ancestor
102370112|NCT04395105|Hormones|hormones|mesh-ancestor
102370113|NCT04395105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102370114|NCT04395105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102370115|NCT04395105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102370116|NCT04072770|Caseins|caseins|mesh-list
102370117|NCT04072770|Chelating Agents|chelating agents|mesh-ancestor
102370118|NCT04072770|Sequestering Agents|sequestering agents|mesh-ancestor
102370119|NCT04072770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370120|NCT01291108|Bimatoprost|bimatoprost|mesh-list
102370121|NCT01291108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102370122|NCT01929213|Bosentan|bosentan|mesh-list
102370123|NCT01929213|Udenafil|udenafil|mesh-list
102370124|NCT01929213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102370125|NCT01929213|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102370126|NCT01929213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898592|NCT00314249|Antidepressive Agents|antidepressive agents|mesh-ancestor
102370127|NCT01929213|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102370128|NCT01929213|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102370129|NCT01929213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102370130|NCT03430518|Durvalumab|durvalumab|mesh-list
101898664|NCT01151696|Histamine Agents|histamine agents|mesh-ancestor
102370131|NCT03430518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102370132|NCT03430518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102370133|NCT05240157|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102370134|NCT05240157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102370135|NCT01925937|Ubiquinone|ubiquinone|mesh-list
102370136|NCT01925937|Coenzyme Q10|coenzyme q10|mesh-list
102370137|NCT01925937|Atorvastatin|atorvastatin|mesh-list
102370138|NCT01925937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102370139|NCT01925937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102370140|NCT01925937|Antimetabolites|antimetabolites|mesh-ancestor
102370141|NCT01925937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370142|NCT01925937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101898873|NCT01259336|Itraconazole|itraconazole|mesh-list
102370143|NCT01925937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102370144|NCT01925937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102370145|NCT01925937|Micronutrients|micronutrients|mesh-ancestor
102370146|NCT01925937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370147|NCT01925937|Vitamins|vitamins|mesh-ancestor
102370148|NCT03430362|Scopolamine|scopolamine|mesh-list
102370149|NCT03430362|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102370150|NCT03430362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102370151|NCT03430362|Antiemetics|antiemetics|mesh-ancestor
102370152|NCT03430362|Autonomic Agents|autonomic agents|mesh-ancestor
102370153|NCT03430362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102370154|NCT03430362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370155|NCT03430362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102370156|NCT03430362|Mydriatics|mydriatics|mesh-ancestor
102370157|NCT03430362|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102370158|NCT03430362|Cholinergic Agents|cholinergic agents|mesh-ancestor
101899224|NCT01260818|Coagulants|coagulants|mesh-ancestor
102370159|NCT03430362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102370160|NCT03430362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370161|NCT03430362|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102370162|NCT03430362|Parasympatholytics|parasympatholytics|mesh-ancestor
102370163|NCT03428022|Apatinib|apatinib|mesh-list
102370164|NCT03428022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102370165|NCT03428022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102370166|NCT03428022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101899365|NCT01263002|Clevudine|clevudine|mesh-list
102370167|NCT03428022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370168|NCT00989781|Dexamethasone|dexamethasone|mesh-list
102370169|NCT00989781|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102370170|NCT00989781|Hormones|hormones|mesh-list
101899445|NCT01265342|Beclomethasone|beclomethasone|mesh-list
102370171|NCT00989781|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102370172|NCT00989781|Cosyntropin|cosyntropin|mesh-list
102370173|NCT00989781|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102370174|NCT00989781|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
102370175|NCT00989781|beta-Endorphin|beta-endorphin|mesh-list
102370176|NCT00989781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102370177|NCT00989781|Antiemetics|antiemetics|mesh-ancestor
102370178|NCT00989781|Autonomic Agents|autonomic agents|mesh-ancestor
102370179|NCT00989781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102370180|NCT00989781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370181|NCT00989781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102370182|NCT00989781|Glucocorticoids|glucocorticoids|mesh-ancestor
101899649|NCT01160276|Mitosis Modulators|mitosis modulators|mesh-ancestor
102370183|NCT00989781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102370184|NCT00989781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102370185|NCT00989781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102370186|NCT00989781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101899798|NCT03877562|Serotonin Agents|serotonin agents|mesh-ancestor
102370187|NCT00989781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102370188|NCT00989781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899857|NCT01269476|Fluorides|fluorides|mesh-list
102370189|NCT03430128|Immunomodulating Agents|immunomodulating agents|mesh-list
102370190|NCT03430128|Immunologic Factors|immunologic factors|mesh-ancestor
102370191|NCT03430128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370192|NCT03427944|Calcium Dobesilate|calcium dobesilate|mesh-list
102370193|NCT03427944|Calcium|calcium|mesh-list
102370194|NCT03427944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102370195|NCT03427944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713665|NCT04378621|Adalimumab|adalimumab|mesh-list
102370196|NCT03427944|Hemostatics|hemostatics|mesh-ancestor
102370197|NCT03427944|Coagulants|coagulants|mesh-ancestor
102370198|NCT01922193|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102370199|NCT01922193|Hormones|hormones|mesh-ancestor
102370200|NCT01922193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101900032|NCT01281566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102370201|NCT01922193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370202|NCT03429972|Paclitaxel|paclitaxel|mesh-list
102370203|NCT03429972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102370204|NCT03429972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102370205|NCT03429972|Tubulin Modulators|tubulin modulators|mesh-ancestor
102370206|NCT03429972|Antimitotic Agents|antimitotic agents|mesh-ancestor
102370207|NCT03429972|Mitosis Modulators|mitosis modulators|mesh-ancestor
101900167|NCT01164488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900227|NCT01164800|Protease Inhibitors|protease inhibitors|mesh-ancestor
102370208|NCT03429972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370209|NCT05601999|Tenecteplase|tenecteplase|mesh-list
102370210|NCT05601999|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102370211|NCT05601999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102370212|NCT05601999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370213|NCT01347034|Immunomodulating Agents|immunomodulating agents|mesh-list
102370214|NCT01347034|Immunologic Factors|immunologic factors|mesh-ancestor
102370215|NCT01347034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370216|NCT03079167|Epoetin Alfa|epoetin alfa|mesh-list
102370217|NCT03079167|Hematinics|hematinics|mesh-ancestor
102370218|NCT03079011|Letrozole|letrozole|mesh-list
102370219|NCT03079011|Fulvestrant|fulvestrant|mesh-list
102370220|NCT03079011|Palbociclib|palbociclib|mesh-list
102370221|NCT03079011|Anastrozole|anastrozole|mesh-list
102370222|NCT03079011|Exemestane|exemestane|mesh-list
102370223|NCT03079011|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102370224|NCT03079011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102370225|NCT03079011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102370226|NCT03079011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102370227|NCT03079011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370228|NCT03079011|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102370229|NCT03079011|Hormone Antagonists|hormone antagonists|mesh-ancestor
101900525|NCT01587326|Serotonin Agents|serotonin agents|mesh-ancestor
102370230|NCT03079011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102370231|NCT03079011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746761|NCT00779649|Cathartics|cathartics|mesh-ancestor
102370232|NCT03079011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102370233|NCT03079011|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102370234|NCT03079011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102370235|NCT03427632|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
102370236|NCT03427632|Vasodilator Agents|vasodilator agents|mesh-ancestor
102370237|NCT03427632|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
102370238|NCT03427632|Protective Agents|protective agents|mesh-ancestor
102370239|NCT03427632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370240|NCT03427554|Tretinoin|tretinoin|mesh-list
102370241|NCT03427554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102370242|NCT03427554|Keratolytic Agents|keratolytic agents|mesh-ancestor
102370243|NCT03427554|Dermatologic Agents|dermatologic agents|mesh-ancestor
102370244|NCT01349920|Infliximab|infliximab|mesh-list
102370245|NCT01349920|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101755884|NCT00879892|Xenon|xenon|mesh-list
102370246|NCT01349920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102370247|NCT01349920|Dermatologic Agents|dermatologic agents|mesh-ancestor
101758303|NCT01034917|Etravirine|etravirine|mesh-list
102370248|NCT01349920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102370249|NCT01349920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102370250|NCT03128346|Aspirin|aspirin|mesh-list
102370251|NCT03128346|Acetaminophen|acetaminophen|mesh-list
102370252|NCT03128346|Fentanyl|fentanyl|mesh-list
102370253|NCT03128346|Hydromorphone|hydromorphone|mesh-list
102370254|NCT03128346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102370255|NCT03128346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102370256|NCT03128346|Analgesics|analgesics|mesh-ancestor
102370257|NCT03128346|Sensory System Agents|sensory system agents|mesh-ancestor
102370258|NCT03128346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101773439|NCT00790998|Ivermectin|ivermectin|mesh-list
102370259|NCT03128346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370260|NCT03128346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102370261|NCT03128346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101774919|NCT05407870|Propofol|propofol|mesh-list
102370262|NCT03128346|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102370263|NCT03128346|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102370264|NCT03128346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370265|NCT03128346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101579623|NCT05272878|Irbesartan|irbesartan|mesh-list
102370266|NCT03128346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102370267|NCT03128346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102370268|NCT03128346|Antipyretics|antipyretics|mesh-ancestor
102370269|NCT03128346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102370270|NCT03128346|Narcotics|narcotics|mesh-ancestor
102370271|NCT03128346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102370272|NCT03128346|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102370273|NCT03128346|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102370274|NCT03128346|Anesthetics, General|anesthetics, general|mesh-ancestor
102370275|NCT03128346|Anesthetics|anesthetics|mesh-ancestor
102370276|NCT03423030|Macozinone|macozinone|mesh-list
102370277|NCT03423030|Antitubercular Agents|antitubercular agents|mesh-ancestor
102370278|NCT03423030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102370279|NCT03423030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102370280|NCT03427242|Apatinib|apatinib|mesh-list
102370281|NCT03427242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102370282|NCT03427242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102370283|NCT03427242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102370284|NCT03427242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370285|NCT01252732|Vancomycin|vancomycin|mesh-list
102370286|NCT01252732|Oritavancin|oritavancin|mesh-list
102370287|NCT01252732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102370288|NCT01252732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102370289|NCT00989235|Abatacept|abatacept|mesh-list
102370290|NCT00989235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102370291|NCT00989235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370292|NCT00989235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102370293|NCT00989235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102370294|NCT00989235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102370295|NCT00989235|Immunologic Factors|immunologic factors|mesh-ancestor
102370296|NCT00989235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370297|NCT00989235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102370298|NCT03422874|Nelfinavir|nelfinavir|mesh-list
102370299|NCT03422874|Ixazomib|ixazomib|mesh-list
102370300|NCT03422874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102182051|NCT02251847|Ezetimibe|ezetimibe|mesh-list
102370301|NCT03422874|Protease Inhibitors|protease inhibitors|mesh-ancestor
102370302|NCT03422874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102370303|NCT03422874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370304|NCT03422874|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102370305|NCT03422874|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102370307|NCT03422874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102370308|NCT03422874|Antiviral Agents|antiviral agents|mesh-ancestor
102370309|NCT03422874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102370310|NCT01253824|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102370311|NCT01253824|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102370312|NCT01253824|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102370313|NCT01253824|Norethindrone|norethindrone|mesh-list
102370314|NCT01253824|Norethindrone Acetate|norethindrone acetate|mesh-list
102370315|NCT01253824|Norinyl|norinyl|mesh-list
102370316|NCT01253824|Mestranol|mestranol|mesh-list
102370317|NCT01253824|Estradiol|estradiol|mesh-list
102370318|NCT01253824|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102370319|NCT01253824|Estrogens|estrogens|mesh-ancestor
102370320|NCT01253824|Hormones|hormones|mesh-ancestor
102370321|NCT01253824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102370322|NCT01253824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370323|NCT01253824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102370324|NCT01253824|Contraceptive Agents|contraceptive agents|mesh-ancestor
101902162|NCT01290458|Vitamins|vitamins|mesh-list
102370325|NCT01253824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102370326|NCT01253824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102370327|NCT01253824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102370328|NCT01253824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102370329|NCT01253824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102370330|NCT01253824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102370331|NCT03422796|Cilostazol|cilostazol|mesh-list
101607633|NCT00655408|Iron|iron|mesh-list
102370332|NCT03422796|Sumatriptan|sumatriptan|mesh-list
102370333|NCT03422796|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102370334|NCT03422796|Autonomic Agents|autonomic agents|mesh-ancestor
102370335|NCT03422796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102370336|NCT03422796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370337|NCT03422796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102370338|NCT03422796|Respiratory System Agents|respiratory system agents|mesh-ancestor
102370339|NCT03422796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102370340|NCT03422796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102370341|NCT03422796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370342|NCT03422796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102370343|NCT03422796|Vasodilator Agents|vasodilator agents|mesh-ancestor
102370344|NCT03422796|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102370345|NCT03422796|Protective Agents|protective agents|mesh-ancestor
102370346|NCT03422796|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102370347|NCT03422796|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101902572|NCT01292408|Antimalarials|antimalarials|mesh-ancestor
102370348|NCT03422796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102370349|NCT03422796|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102370350|NCT03422796|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101902644|NCT01192724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102370351|NCT03422796|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102370352|NCT03422796|Serotonin Agents|serotonin agents|mesh-ancestor
102370353|NCT03422796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102370354|NCT04396977|Histamine|histamine|mesh-list
102370355|NCT04396977|Histamine Agonists|histamine agonists|mesh-ancestor
102370356|NCT04396977|Histamine Agents|histamine agents|mesh-ancestor
102370357|NCT04396977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102370358|NCT04396977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370359|NCT04396977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370360|NCT03429738|Ibuprofen|ibuprofen|mesh-list
102370361|NCT03429738|Pseudoephedrine|pseudoephedrine|mesh-list
102370362|NCT03429738|Ephedrine|ephedrine|mesh-list
102370363|NCT03429738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102370364|NCT03429738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102370365|NCT03429738|Analgesics|analgesics|mesh-ancestor
102370366|NCT03429738|Sensory System Agents|sensory system agents|mesh-ancestor
102370367|NCT03429738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102370368|NCT03429738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370369|NCT03429738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102370370|NCT03429738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102370371|NCT03429738|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102370372|NCT03429738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102370373|NCT03429738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370374|NCT03429738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102182112|NCT02125409|Antipyretics|antipyretics|mesh-ancestor
102370375|NCT03429738|Autonomic Agents|autonomic agents|mesh-ancestor
102370376|NCT03429738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102370377|NCT03429738|Respiratory System Agents|respiratory system agents|mesh-ancestor
102370378|NCT03429738|Nasal Decongestants|nasal decongestants|mesh-ancestor
102370379|NCT03429738|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102370380|NCT03429738|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102370381|NCT03429738|Sympathomimetics|sympathomimetics|mesh-ancestor
102370382|NCT03429738|Adrenergic Agents|adrenergic agents|mesh-ancestor
102370383|NCT03429738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102370384|NCT01253902|Bimatoprost|bimatoprost|mesh-list
102370385|NCT01253902|Travoprost|travoprost|mesh-list
102370386|NCT01253902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102370387|NCT01253902|Latanoprost|latanoprost|mesh-list
102370388|NCT01253902|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102370389|NCT01253902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102370390|NCT01253980|Amoxicillin|amoxicillin|mesh-list
102370391|NCT01253980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102370392|NCT01253980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102370393|NCT00988533|Ivermectin|ivermectin|mesh-list
102370394|NCT00988533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102370395|NCT00988533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102370396|NCT01350388|Febuxostat|febuxostat|mesh-list
102370397|NCT01350388|Gout Suppressants|gout suppressants|mesh-ancestor
102370398|NCT01350388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102370399|NCT03154749|Cyclophosphamide|cyclophosphamide|mesh-list
102370400|NCT03154749|Carboplatin|carboplatin|mesh-list
102370401|NCT03154749|Docetaxel|docetaxel|mesh-list
102370402|NCT03154749|Epirubicin|epirubicin|mesh-list
102370403|NCT03154749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102370404|NCT03154749|Immunologic Factors|immunologic factors|mesh-ancestor
102370405|NCT03154749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370406|NCT03154749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102370407|NCT03154749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102370408|NCT03154749|Alkylating Agents|alkylating agents|mesh-ancestor
102370409|NCT03154749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370410|NCT03154749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102370411|NCT03154749|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102370412|NCT03154749|Tubulin Modulators|tubulin modulators|mesh-ancestor
102370413|NCT03154749|Antimitotic Agents|antimitotic agents|mesh-ancestor
102370414|NCT03154749|Mitosis Modulators|mitosis modulators|mesh-ancestor
102370415|NCT03154749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102370416|NCT03154749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102370417|NCT03154749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102370418|NCT03154749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102370419|NCT03422640|Apremilast|apremilast|mesh-list
102370420|NCT03422640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102370421|NCT03422640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102370422|NCT03422640|Analgesics|analgesics|mesh-ancestor
102370423|NCT03422640|Sensory System Agents|sensory system agents|mesh-ancestor
102370424|NCT03422640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102370425|NCT03422640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370426|NCT03422640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102370427|NCT03422640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102370428|NCT03422640|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102370429|NCT03422640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102370430|NCT03422640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102370431|NCT03422640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370432|NCT01351090|Ketorolac|ketorolac|mesh-list
102370433|NCT01351090|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102370434|NCT01351090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102370435|NCT01351090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102370436|NCT01351090|Analgesics|analgesics|mesh-ancestor
102370437|NCT01351090|Sensory System Agents|sensory system agents|mesh-ancestor
102370438|NCT01351090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102370439|NCT01351090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370440|NCT01351090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102370441|NCT01351090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102370442|NCT01351090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102370443|NCT01351090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102370444|NCT01351090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370445|NCT01918644|Capecitabine|capecitabine|mesh-list
102370446|NCT01918644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102370447|NCT01918644|Antimetabolites|antimetabolites|mesh-ancestor
102370448|NCT01918644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370449|NCT01918644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102370450|NCT00987831|Methylprednisolone|methylprednisolone|mesh-list
102154173|NCT03606577|Antiemetics|antiemetics|mesh-ancestor
102370451|NCT00987831|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102370452|NCT00987831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102370453|NCT00987831|Antiemetics|antiemetics|mesh-ancestor
102370454|NCT00987831|Autonomic Agents|autonomic agents|mesh-ancestor
102370455|NCT00987831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102370456|NCT00987831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370457|NCT00987831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102370458|NCT00987831|Glucocorticoids|glucocorticoids|mesh-ancestor
102370459|NCT00987831|Hormones|hormones|mesh-ancestor
102370460|NCT00987831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102370461|NCT00987831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102370462|NCT00987831|Protective Agents|protective agents|mesh-ancestor
102370463|NCT03608358|Metformin|metformin|mesh-list
102370464|NCT03608358|Dapagliflozin|dapagliflozin|mesh-list
102370465|NCT03608358|Saxagliptin|saxagliptin|mesh-list
102370466|NCT03608358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102370467|NCT03608358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370468|NCT03608358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102370469|NCT03608358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370470|NCT03608358|Incretins|incretins|mesh-ancestor
102370471|NCT03608358|Hormones|hormones|mesh-ancestor
102370472|NCT03608358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101969948|NCT05981365|Furosemide|furosemide|mesh-list
102370473|NCT03608358|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102370474|NCT03608358|Protease Inhibitors|protease inhibitors|mesh-ancestor
102370475|NCT03608358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102370476|NCT04274907|Pembrolizumab|pembrolizumab|mesh-list
102370477|NCT04274907|Venetoclax|venetoclax|mesh-list
102370478|NCT04274907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102370479|NCT04274907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102370480|NCT04274907|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102370481|NCT04274907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370482|NCT01256164|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102370483|NCT01256164|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
102370484|NCT01256164|Hemostatics|hemostatics|mesh-ancestor
102370485|NCT01256164|Coagulants|coagulants|mesh-ancestor
102370486|NCT03427086|Biotin|biotin|mesh-list
102370487|NCT03427086|Vitamins|vitamins|mesh-ancestor
102370488|NCT03427086|Micronutrients|micronutrients|mesh-ancestor
102370489|NCT03427086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370490|NCT03427086|Vitamin B Complex|vitamin b complex|mesh-ancestor
102370491|NCT01887522|Vinblastine|vinblastine|mesh-list
102370492|NCT01887522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102370493|NCT01887522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102370494|NCT01887522|Tubulin Modulators|tubulin modulators|mesh-ancestor
102370495|NCT01887522|Antimitotic Agents|antimitotic agents|mesh-ancestor
102370496|NCT01887522|Mitosis Modulators|mitosis modulators|mesh-ancestor
102370497|NCT01887522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370498|NCT03422406|Iodine|iodine|mesh-list
102370499|NCT03422406|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102370500|NCT03422406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102370501|NCT03422406|Trace Elements|trace elements|mesh-ancestor
102370502|NCT03422406|Micronutrients|micronutrients|mesh-ancestor
102370503|NCT03422406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970008|NCT05981209|Hormones|hormones|mesh-ancestor
101970009|NCT05981209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101970010|NCT05981209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101970011|NCT05981209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102370504|NCT00986427|Cyclosporine|cyclosporine|mesh-list
102370505|NCT00986427|Cyclosporins|cyclosporins|mesh-list
102370506|NCT00986427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102370507|NCT00986427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370508|NCT00986427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102370509|NCT00986427|Immunologic Factors|immunologic factors|mesh-ancestor
102370510|NCT00986427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370511|NCT00986427|Antifungal Agents|antifungal agents|mesh-ancestor
102370512|NCT00986427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101950594|NCT02532257|Rituximab|rituximab|mesh-list
102370513|NCT00986427|Dermatologic Agents|dermatologic agents|mesh-ancestor
102370514|NCT00986427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102370515|NCT00986427|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102370516|NCT03426462|Propofol|propofol|mesh-list
102370517|NCT03426462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102370518|NCT03426462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102370519|NCT03426462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370520|NCT03426462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102370521|NCT03426462|Anesthetics, General|anesthetics, general|mesh-ancestor
102370522|NCT03426462|Anesthetics|anesthetics|mesh-ancestor
102370523|NCT03421860|Phenylephrine|phenylephrine|mesh-list
102370524|NCT03421860|Epinephrine|epinephrine|mesh-list
102370525|NCT03421860|Oxymetazoline|oxymetazoline|mesh-list
102370526|NCT03421860|Ephedrine|ephedrine|mesh-list
102370527|NCT03421860|Norepinephrine|norepinephrine|mesh-list
102370528|NCT03421860|Ondansetron|ondansetron|mesh-list
102370529|NCT03421860|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102370530|NCT03421860|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101970036|NCT05981053|Resveratrol|resveratrol|mesh-list
102370531|NCT03421860|Adrenergic Agents|adrenergic agents|mesh-ancestor
102370532|NCT03421860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102370533|NCT03421860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370534|NCT03421860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370535|NCT03421860|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102370536|NCT03421860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102370537|NCT03421860|Autonomic Agents|autonomic agents|mesh-ancestor
102370538|NCT03421860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102370539|NCT03421860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102370540|NCT03421860|Respiratory System Agents|respiratory system agents|mesh-ancestor
102370541|NCT03421860|Mydriatics|mydriatics|mesh-ancestor
102370542|NCT03421860|Sympathomimetics|sympathomimetics|mesh-ancestor
102370543|NCT03421860|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102370544|NCT03421860|Antiemetics|antiemetics|mesh-ancestor
102370545|NCT03421860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102370546|NCT03421860|Antipruritics|antipruritics|mesh-ancestor
102370547|NCT03421860|Dermatologic Agents|dermatologic agents|mesh-ancestor
102370548|NCT03421860|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102370549|NCT03421860|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101952826|NCT03310268|Listerine|listerine|mesh-list
102370550|NCT03421860|Serotonin Agents|serotonin agents|mesh-ancestor
102370551|NCT03421860|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102370552|NCT03421860|Nasal Decongestants|nasal decongestants|mesh-ancestor
102370553|NCT03421860|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102370554|NCT03421860|Protective Agents|protective agents|mesh-ancestor
102370555|NCT03421860|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102370556|NCT03421314|Selenium|selenium|mesh-list
102370557|NCT03421314|Antioxidants|antioxidants|mesh-ancestor
102370558|NCT03421314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370559|NCT03421314|Protective Agents|protective agents|mesh-ancestor
102370560|NCT03421314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370561|NCT03421314|Trace Elements|trace elements|mesh-ancestor
102370562|NCT03421314|Micronutrients|micronutrients|mesh-ancestor
102370563|NCT03425994|Emtricitabine|emtricitabine|mesh-list
102370564|NCT03425994|Cobicistat|cobicistat|mesh-list
102370565|NCT03425994|Elvitegravir|elvitegravir|mesh-list
102370566|NCT03425994|Antiviral Agents|antiviral agents|mesh-ancestor
102370567|NCT03425994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102370568|NCT03425994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101970062|NCT05981014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102370569|NCT03425994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102370570|NCT03425994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102370571|NCT03425994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370572|NCT03425994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102370573|NCT03425994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102370574|NCT03425994|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102370575|NCT03425994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102370576|NCT03425994|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102370577|NCT03421002|Micafungin|micafungin|mesh-list
102370578|NCT03421002|Antifungal Agents|antifungal agents|mesh-ancestor
102370579|NCT03421002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102370580|NCT00754260|Caffeine|caffeine|mesh-list
102370581|NCT00754260|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101970091|NCT05981001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102370582|NCT00754260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370583|NCT00754260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102370584|NCT00754260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970095|NCT05980871|Doxycycline|doxycycline|mesh-list
102370585|NCT00754260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370586|NCT00754260|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102370587|NCT00754260|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102370588|NCT00754260|Purinergic Agents|purinergic agents|mesh-ancestor
102370589|NCT00754260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102370590|NCT02546232|Paclitaxel|paclitaxel|mesh-list
102370591|NCT02546232|Carboplatin|carboplatin|mesh-list
102370592|NCT02546232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102370593|NCT02546232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102370594|NCT02546232|Tubulin Modulators|tubulin modulators|mesh-ancestor
102370595|NCT02546232|Antimitotic Agents|antimitotic agents|mesh-ancestor
102370596|NCT02546232|Mitosis Modulators|mitosis modulators|mesh-ancestor
102370597|NCT02546232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370598|NCT02521038|Ticagrelor|ticagrelor|mesh-list
102370599|NCT02521038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102370600|NCT02521038|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102370601|NCT02521038|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102370602|NCT02521038|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102370603|NCT02521038|Purinergic Agents|purinergic agents|mesh-ancestor
102370604|NCT02521038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101970117|NCT05980702|Mitosis Modulators|mitosis modulators|mesh-ancestor
102370605|NCT02521038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370606|NCT02521038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370607|NCT00985959|Prednisolone|prednisolone|mesh-list
102370608|NCT00985959|Bortezomib|bortezomib|mesh-list
102370609|NCT00985959|Melphalan|melphalan|mesh-list
102370610|NCT00985959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102370611|NCT00985959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102370612|NCT00985959|Alkylating Agents|alkylating agents|mesh-ancestor
102370613|NCT00985959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971978|NCT01339676|Cholecalciferol|cholecalciferol|mesh-list
102370614|NCT00985959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102370615|NCT00985959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102370616|NCT00985959|Immunologic Factors|immunologic factors|mesh-ancestor
102370617|NCT00985959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370618|NCT00985959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102370619|NCT00985959|Glucocorticoids|glucocorticoids|mesh-ancestor
102370620|NCT00985959|Hormones|hormones|mesh-ancestor
102370621|NCT00985959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101971979|NCT01339676|Vitamins|vitamins|mesh-ancestor
102370622|NCT00985959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102370623|NCT00985725|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102370624|NCT00985725|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102370625|NCT00985725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370626|NCT00985725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102370627|NCT00985725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102370628|NCT00985725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102370629|NCT00985725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954095|NCT01561131|Calcium|calcium|mesh-list
102370630|NCT00985725|Dopamine Agents|dopamine agents|mesh-ancestor
102370631|NCT00985725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102370632|NCT01294306|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102370633|NCT01294306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102370634|NCT01294306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102370635|NCT01294306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102370636|NCT01294306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370637|NCT01351480|Abatacept|abatacept|mesh-list
102370638|NCT01351480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102370639|NCT01351480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370640|NCT01351480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102370641|NCT01351480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102370642|NCT01351480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102370643|NCT01351480|Immunologic Factors|immunologic factors|mesh-ancestor
102370644|NCT01351480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370645|NCT01351480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102370646|NCT01352182|Pioglitazone|pioglitazone|mesh-list
102370647|NCT01352182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102370648|NCT01352182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370649|NCT00984867|Dapagliflozin|dapagliflozin|mesh-list
102370650|NCT00984867|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102370651|NCT00984867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370652|NCT00984867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102370653|NCT00984867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370654|NCT01294384|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102370655|NCT01294384|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102370656|NCT01294384|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102370657|NCT01294384|Laxatives|laxatives|mesh-ancestor
102370658|NCT01294384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102370659|NCT01257802|Leuprolide|leuprolide|mesh-list
102370660|NCT01257802|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102370661|NCT01257802|Fertility Agents|fertility agents|mesh-ancestor
102370662|NCT01257802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101970171|NCT05979597|Hormones|hormones|mesh-ancestor
102370663|NCT01257802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370664|NCT01257802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102370665|NCT01257802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102370666|NCT05607303|Estrogens|estrogens|mesh-list
102370667|NCT05607303|Hormones|hormones|mesh-ancestor
101970176|NCT05979389|Androgen Antagonists|androgen antagonists|mesh-ancestor
102370668|NCT05607303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102370669|NCT05607303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370670|NCT00984009|Colchicine|colchicine|mesh-list
102370671|NCT00984009|Gout Suppressants|gout suppressants|mesh-ancestor
102370672|NCT00984009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102370673|NCT00984009|Tubulin Modulators|tubulin modulators|mesh-ancestor
102370674|NCT00984009|Antimitotic Agents|antimitotic agents|mesh-ancestor
102370675|NCT00984009|Mitosis Modulators|mitosis modulators|mesh-ancestor
102612276|NCT00002387|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102182420|NCT03550781|Prednisone|prednisone|mesh-list
102370676|NCT00984009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370677|NCT00984009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102370678|NCT05606913|Dulaglutide|dulaglutide|mesh-list
102370679|NCT05606913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101970188|NCT05978219|Histamine Antagonists|histamine antagonists|mesh-ancestor
102370680|NCT05606913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370681|NCT00983931|Cyclosporine|cyclosporine|mesh-list
102370682|NCT00983931|Colchicine|colchicine|mesh-list
102370683|NCT00983931|Cyclosporins|cyclosporins|mesh-list
102370684|NCT00983931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102370685|NCT00983931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370686|NCT00983931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102370687|NCT00983931|Immunologic Factors|immunologic factors|mesh-ancestor
102370688|NCT00983931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370689|NCT00983931|Antifungal Agents|antifungal agents|mesh-ancestor
101970199|NCT05978219|Adrenergic Agents|adrenergic agents|mesh-ancestor
102370690|NCT00983931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102370691|NCT00983931|Dermatologic Agents|dermatologic agents|mesh-ancestor
102370692|NCT00983931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102370693|NCT00983931|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102370694|NCT00983931|Gout Suppressants|gout suppressants|mesh-ancestor
102370695|NCT00983931|Tubulin Modulators|tubulin modulators|mesh-ancestor
102370696|NCT00983931|Antimitotic Agents|antimitotic agents|mesh-ancestor
102370697|NCT00983931|Mitosis Modulators|mitosis modulators|mesh-ancestor
102370698|NCT00983931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102370699|NCT00983853|Ribavirin|ribavirin|mesh-list
102370700|NCT00983853|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102370701|NCT00983853|Antimetabolites|antimetabolites|mesh-ancestor
102370702|NCT00983853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370703|NCT00983853|Antiviral Agents|antiviral agents|mesh-ancestor
101970207|NCT05975489|Caffeine|caffeine|mesh-list
102370704|NCT00983853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102370705|NCT05604261|Rabeprazole|rabeprazole|mesh-list
102370706|NCT05604261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102370707|NCT05604261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102370708|NCT05604261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102370709|NCT05604261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102370710|NCT05604261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370711|NCT03032601|Acetylcysteine|acetylcysteine|mesh-list
102370712|NCT03032601|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102370713|NCT03032601|Antiviral Agents|antiviral agents|mesh-ancestor
102370714|NCT03032601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102370715|NCT03032601|Expectorants|expectorants|mesh-ancestor
102370716|NCT03032601|Respiratory System Agents|respiratory system agents|mesh-ancestor
102370717|NCT03032601|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102370718|NCT03032601|Antioxidants|antioxidants|mesh-ancestor
102370719|NCT03032601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370720|NCT03032601|Protective Agents|protective agents|mesh-ancestor
102370721|NCT03032601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370722|NCT03032601|Antidotes|antidotes|mesh-ancestor
102370723|NCT05603013|Vinorelbine|vinorelbine|mesh-list
101523539|NCT02092077|Hormones|hormones|mesh-list
102370724|NCT05603013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102370725|NCT05603013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102370726|NCT05603013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102370727|NCT05603013|Tubulin Modulators|tubulin modulators|mesh-ancestor
102370728|NCT05603013|Antimitotic Agents|antimitotic agents|mesh-ancestor
102370729|NCT05603013|Mitosis Modulators|mitosis modulators|mesh-ancestor
102370730|NCT05603013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383405|NCT00111891|Vitamins|vitamins|mesh-ancestor
102370731|NCT05603013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102370732|NCT00983073|Tapentadol|tapentadol|mesh-list
102370733|NCT00983073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102370734|NCT00983073|Narcotics|narcotics|mesh-ancestor
102370735|NCT00983073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101970234|NCT05965544|Fentanyl|fentanyl|mesh-list
102370736|NCT00983073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370737|NCT00983073|Analgesics|analgesics|mesh-ancestor
101955523|NCT03758079|Gabapentin|gabapentin|mesh-list
102370738|NCT00983073|Sensory System Agents|sensory system agents|mesh-ancestor
102370739|NCT00983073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102370740|NCT00983073|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102370741|NCT00983073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102370742|NCT00983073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101970243|NCT05965544|Narcotics|narcotics|mesh-ancestor
101970245|NCT05965544|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102370743|NCT00983073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370744|NCT00983073|Adrenergic Agents|adrenergic agents|mesh-ancestor
102370745|NCT00983073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102370746|NCT05603715|Bromides|bromides|mesh-list
102370747|NCT05603715|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
102370748|NCT05603715|Anticonvulsants|anticonvulsants|mesh-ancestor
101970250|NCT05954962|Progestins|progestins|mesh-ancestor
102370749|NCT05603715|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102154174|NCT03606577|Autonomic Agents|autonomic agents|mesh-ancestor
102370750|NCT05603715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102370751|NCT05603715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970255|NCT05949684|Epoetin Alfa|epoetin alfa|mesh-list
102370752|NCT05603715|Cholinergic Agents|cholinergic agents|mesh-ancestor
102370753|NCT05603715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102370754|NCT05603715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370755|NCT00981747|Losartan|losartan|mesh-list
102370756|NCT00981747|Sildenafil Citrate|sildenafil citrate|mesh-list
102370757|NCT00981747|Vasodilator Agents|vasodilator agents|mesh-ancestor
102370758|NCT00981747|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102370759|NCT00981747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102370760|NCT00981747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970264|NCT05947201|Mitosis Modulators|mitosis modulators|mesh-ancestor
102370761|NCT00981747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370762|NCT00981747|Urological Agents|urological agents|mesh-ancestor
102370763|NCT00981747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102370764|NCT00981747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102370765|NCT00981747|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101970269|NCT05947201|Immunologic Factors|immunologic factors|mesh-ancestor
102370766|NCT00981747|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102370767|NCT03046251|Natalizumab|natalizumab|mesh-list
102370768|NCT03046251|Immunologic Factors|immunologic factors|mesh-ancestor
102370769|NCT03046251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370770|NCT03029169|Amiodarone|amiodarone|mesh-list
102370771|NCT03029169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
102370772|NCT03029169|Propafenone|propafenone|mesh-list
102370773|NCT03029169|Vasodilator Agents|vasodilator agents|mesh-ancestor
102370774|NCT03029169|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102370775|NCT03029169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102370776|NCT03029169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370777|NCT03029169|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102370778|NCT03029169|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102370779|NCT03029169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102370780|NCT03029169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102370781|NCT03029169|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101956493|NCT03749733|Estradiol|estradiol|mesh-list
102370782|NCT03029169|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102370783|NCT03029169|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102370784|NCT03029169|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102370785|NCT01295710|Immunoglobulins|immunoglobulins|mesh-list
102370786|NCT01295710|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102370787|NCT01295710|Immunologic Factors|immunologic factors|mesh-ancestor
101970290|NCT05944016|Dapagliflozin|dapagliflozin|mesh-list
102370788|NCT01295710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370789|NCT01295710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102370790|NCT01353976|Econazole|econazole|mesh-list
101956707|NCT02087332|Torsemide|torsemide|mesh-list
102370791|NCT01353976|Antifungal Agents|antifungal agents|mesh-ancestor
102370792|NCT01353976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102370793|NCT01353976|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101970298|NCT05914389|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102370794|NCT01353976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102370795|NCT01353976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102370796|NCT01353976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370797|NCT01353976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101956916|NCT05571176|Ketamine|ketamine|mesh-list
102370798|NCT01353976|Hormone Antagonists|hormone antagonists|mesh-ancestor
102370799|NCT01353976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102370800|NCT01353976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370801|NCT01354444|Carvedilol|carvedilol|mesh-list
101970305|NCT05909553|Venetoclax|venetoclax|mesh-list
102370802|NCT01354444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102370803|NCT01354444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102370804|NCT01354444|Adrenergic Agents|adrenergic agents|mesh-ancestor
102370805|NCT01354444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102370806|NCT01354444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370807|NCT01354444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370808|NCT01354444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102370809|NCT01354444|Antioxidants|antioxidants|mesh-ancestor
102370810|NCT01354444|Protective Agents|protective agents|mesh-ancestor
102370811|NCT01354444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102370812|NCT01354444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102370813|NCT01354444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102370814|NCT01354444|Vasodilator Agents|vasodilator agents|mesh-ancestor
102370815|NCT01354444|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102370816|NCT01354444|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102370817|NCT03009526|Pyrimethamine|pyrimethamine|mesh-list
102370818|NCT03009526|Piperaquine|piperaquine|mesh-list
102370819|NCT03009526|Sulfadoxine|sulfadoxine|mesh-list
102370820|NCT03009526|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
102370821|NCT03009526|Artenimol|artenimol|mesh-list
102370822|NCT03009526|Antimalarials|antimalarials|mesh-ancestor
102370823|NCT03009526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102370824|NCT03009526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101957450|NCT02101138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102370825|NCT03009526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102370826|NCT03009526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102370827|NCT03009526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970329|NCT05885074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101970332|NCT05872685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102370828|NCT03009526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370829|NCT03009526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102370830|NCT01354990|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101970334|NCT05870319|Pemetrexed|pemetrexed|mesh-list
102370831|NCT01354990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102370832|NCT01354990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370833|NCT01354990|Incretins|incretins|mesh-ancestor
102370834|NCT01354990|Hormones|hormones|mesh-ancestor
102370835|NCT01354990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102370836|NCT01354990|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102370837|NCT01354990|Protease Inhibitors|protease inhibitors|mesh-ancestor
102370838|NCT01354990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102370839|NCT01354990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370840|NCT01260454|Capsaicin|capsaicin|mesh-list
102370841|NCT01260454|Antipruritics|antipruritics|mesh-ancestor
102370842|NCT01260454|Dermatologic Agents|dermatologic agents|mesh-ancestor
102370843|NCT01260454|Sensory System Agents|sensory system agents|mesh-ancestor
102370844|NCT01260454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102370845|NCT01260454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370846|NCT01296646|Naltrexone|naltrexone|mesh-list
102370847|NCT01296646|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102370848|NCT01296646|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102370849|NCT01296646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970355|NCT05840159|Antimalarials|antimalarials|mesh-ancestor
102370850|NCT01296646|Sensory System Agents|sensory system agents|mesh-ancestor
102370851|NCT01296646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102370852|NCT01297348|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102370853|NCT01297348|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102370854|NCT01297348|Levonorgestrel|levonorgestrel|mesh-list
102370855|NCT01297348|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102370856|NCT01297348|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
102370857|NCT01297348|Norinyl|norinyl|mesh-list
102370858|NCT01297348|Contraceptive Agents|contraceptive agents|mesh-list
102370859|NCT01297348|Contraceptives, Oral|contraceptives, oral|mesh-list
102370860|NCT01297348|Estradiol|estradiol|mesh-list
102370861|NCT01297348|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102370862|NCT01297348|Estrogens|estrogens|mesh-ancestor
102370863|NCT01297348|Hormones|hormones|mesh-ancestor
101958123|NCT03850418|Azacitidine|azacitidine|mesh-list
102370864|NCT01297348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102370865|NCT01297348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370866|NCT01297348|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102370867|NCT01297348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102370868|NCT01297348|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102370869|NCT01297348|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102370870|NCT01297348|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102370871|NCT01297348|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102370872|NCT01297348|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
102370873|NCT01856309|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102370874|NCT01856309|Immunologic Factors|immunologic factors|mesh-ancestor
102370875|NCT01856309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370876|NCT01260688|Dasatinib|dasatinib|mesh-list
102370877|NCT01260688|Cediranib|cediranib|mesh-list
102370878|NCT01260688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102370879|NCT01260688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102370880|NCT01260688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970370|NCT05801172|Anesthetics, Local|anesthetics, local|mesh-ancestor
102370881|NCT01260688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370882|NCT01298128|NuvaRing|nuvaring|mesh-list
102370883|NCT01298128|Desogestrel|desogestrel|mesh-list
102370884|NCT01298128|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101958372|NCT02123056|Metoprolol|metoprolol|mesh-list
102370885|NCT01298128|Contraceptive Agents|contraceptive agents|mesh-ancestor
102370886|NCT01298128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101241418|NCT01628471|Decitabine|decitabine|mesh-list
102370887|NCT01298128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370888|NCT01298128|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102370889|NCT01298128|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102370890|NCT01298128|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101305293|NCT02018601|Analgesics|analgesics|mesh-ancestor
102370891|NCT01298128|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102370892|NCT01298128|Progestins|progestins|mesh-ancestor
102370893|NCT01298128|Hormones|hormones|mesh-ancestor
102370894|NCT01298128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102370895|NCT02199964|Cyclosporine|cyclosporine|mesh-list
102370896|NCT02199964|Lubricant Eye Drops|lubricant eye drops|mesh-list
102370897|NCT02199964|Cyclosporins|cyclosporins|mesh-list
102370898|NCT02199964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102370899|NCT02199964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370900|NCT02199964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101970387|NCT05775289|Paclitaxel|paclitaxel|mesh-list
102370901|NCT02199964|Immunologic Factors|immunologic factors|mesh-ancestor
102370902|NCT02199964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958721|NCT02128204|Lidocaine|lidocaine|mesh-list
102370903|NCT02199964|Antifungal Agents|antifungal agents|mesh-ancestor
102370904|NCT02199964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102370905|NCT02199964|Dermatologic Agents|dermatologic agents|mesh-ancestor
102370906|NCT02199964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102370907|NCT02199964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102370908|NCT02199964|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102370909|NCT02199964|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102370910|NCT02323048|Methamphetamine|methamphetamine|mesh-list
102370911|NCT02323048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102370912|NCT02323048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370913|NCT02323048|Sympathomimetics|sympathomimetics|mesh-ancestor
102370914|NCT02323048|Autonomic Agents|autonomic agents|mesh-ancestor
102370915|NCT02323048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102370916|NCT02323048|Dopamine Agents|dopamine agents|mesh-ancestor
102370917|NCT02323048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102370918|NCT02323048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370919|NCT02323048|Adrenergic Agents|adrenergic agents|mesh-ancestor
101970402|NCT05772871|Levamisole|levamisole|mesh-list
101333846|NCT00041275|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101678848|NCT02778776|Metformin|metformin|mesh-list
102370920|NCT02323048|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102370921|NCT02323048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102370922|NCT02323048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102370923|NCT02323048|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102370924|NCT01265446|Lidocaine|lidocaine|mesh-list
102370925|NCT01265446|Anesthetics, Local|anesthetics, local|mesh-ancestor
102370926|NCT01265446|Anesthetics|anesthetics|mesh-ancestor
102370927|NCT01265446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102370928|NCT01265446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959205|NCT00137111|Hormones|hormones|mesh-ancestor
102370929|NCT01265446|Sensory System Agents|sensory system agents|mesh-ancestor
102370930|NCT01265446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102370931|NCT01265446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102370932|NCT01265446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102370933|NCT01265446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102370934|NCT01265446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102370935|NCT01265446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370936|NCT04352062|Amoxicillin|amoxicillin|mesh-list
102370937|NCT04352062|Levofloxacin|levofloxacin|mesh-list
102370938|NCT04352062|Ofloxacin|ofloxacin|mesh-list
102370939|NCT04352062|Melatonin|melatonin|mesh-list
102370940|NCT04352062|Pantoprazole|pantoprazole|mesh-list
102370941|NCT04352062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102370942|NCT04352062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102370943|NCT04352062|Antioxidants|antioxidants|mesh-ancestor
102370944|NCT04352062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370945|NCT04352062|Protective Agents|protective agents|mesh-ancestor
102370946|NCT04352062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370947|NCT04352062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102370948|NCT04352062|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101959414|NCT02134366|Lorazepam|lorazepam|mesh-list
102370949|NCT04352062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102370950|NCT04352062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102370951|NCT04352062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102370952|NCT04352062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970433|NCT05758818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102370953|NCT04352062|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102370954|NCT04352062|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102370955|NCT04352062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102370956|NCT04352062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102370957|NCT04352062|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102370958|NCT01302808|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102370959|NCT01302808|Romidepsin|romidepsin|mesh-list
102370960|NCT01302808|Antiemetics|antiemetics|mesh-list
102370961|NCT01302808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102370962|NCT01302808|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102370963|NCT01302808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102370964|NCT01302808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370965|NCT01302808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102370966|NCT01302808|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102370967|NCT01302808|Autonomic Agents|autonomic agents|mesh-ancestor
101970448|NCT05696093|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101970449|NCT05696093|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101970450|NCT05696093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101970452|NCT05696093|Antimalarials|antimalarials|mesh-ancestor
102370968|NCT01302808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102370969|NCT01302808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370970|NCT01302808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102370971|NCT01267240|Capecitabine|capecitabine|mesh-list
102370972|NCT01267240|Vorinostat|vorinostat|mesh-list
102370973|NCT01267240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102370974|NCT01267240|Antimetabolites|antimetabolites|mesh-ancestor
102370975|NCT01267240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370976|NCT01267240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102370977|NCT01267240|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102370978|NCT01267240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101305357|NCT02019056|Pyridoxine|pyridoxine|mesh-list
102370979|NCT01855919|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102370980|NCT01855919|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102370981|NCT01855919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102370982|NCT01855919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102370983|NCT01855919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102370984|NCT01855919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102370985|NCT01855919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370986|NCT01855919|Analgesics|analgesics|mesh-ancestor
102370987|NCT01855919|Sensory System Agents|sensory system agents|mesh-ancestor
102370988|NCT01855919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102370989|NCT01855919|Antidepressive Agents|antidepressive agents|mesh-ancestor
102370990|NCT01855919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102370991|NCT01855919|Dopamine Agents|dopamine agents|mesh-ancestor
102370992|NCT01871285|Morphine|morphine|mesh-list
102370993|NCT01871285|Oxycodone|oxycodone|mesh-list
102370994|NCT01871285|Buprenorphine|buprenorphine|mesh-list
102370995|NCT01871285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102370996|NCT01871285|Narcotics|narcotics|mesh-ancestor
102370997|NCT01871285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102370998|NCT01871285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102370999|NCT01871285|Analgesics|analgesics|mesh-ancestor
102371000|NCT01871285|Sensory System Agents|sensory system agents|mesh-ancestor
102371001|NCT01871285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102371002|NCT01871285|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102371003|NCT01358266|Sirolimus|sirolimus|mesh-list
102371004|NCT01358266|Temsirolimus|temsirolimus|mesh-list
102371005|NCT01358266|MTOR Inhibitors|mtor inhibitors|mesh-list
102371006|NCT01358266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102371007|NCT01358266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102371008|NCT01358266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102371009|NCT01358266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102371010|NCT01358266|Antifungal Agents|antifungal agents|mesh-ancestor
102371011|NCT01358266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102371012|NCT01358266|Immunologic Factors|immunologic factors|mesh-ancestor
102371013|NCT01358266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371014|NCT01358266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102371015|NCT01358266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102371016|NCT01358266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371017|NCT01870973|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102371018|NCT01870973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102371019|NCT01870973|Analgesics|analgesics|mesh-list
102371020|NCT01870973|Anesthetics|anesthetics|mesh-list
102371021|NCT01870973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102371022|NCT01870973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371023|NCT01870973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102371024|NCT01870973|Antitubercular Agents|antitubercular agents|mesh-ancestor
101970491|NCT05674877|Anesthetics, General|anesthetics, general|mesh-ancestor
102371025|NCT01870973|Sensory System Agents|sensory system agents|mesh-ancestor
102371026|NCT01870973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102371027|NCT01267864|Ketorolac|ketorolac|mesh-list
102371028|NCT01267864|Valproic Acid|valproic acid|mesh-list
102371029|NCT01267864|Metoclopramide|metoclopramide|mesh-list
102371030|NCT01267864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102371031|NCT01267864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102371032|NCT01267864|Analgesics|analgesics|mesh-ancestor
102371033|NCT01267864|Sensory System Agents|sensory system agents|mesh-ancestor
101970501|NCT05659914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970502|NCT05659914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690266|NCT00650286|Modafinil|modafinil|mesh-list
101305391|NCT02019290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101305392|NCT02019290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101305393|NCT02019290|Anesthetics, General|anesthetics, general|mesh-ancestor
101305394|NCT02019290|Anesthetics|anesthetics|mesh-ancestor
101305395|NCT02019290|GABA Modulators|gaba modulators|mesh-ancestor
101305396|NCT02019290|GABA Agents|gaba agents|mesh-ancestor
101305397|NCT02019290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101305398|NCT02019290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305399|NCT02019329|Risperidone|risperidone|mesh-list
101305400|NCT02019329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101305401|NCT02019329|Serotonin Agents|serotonin agents|mesh-ancestor
101305402|NCT02019329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102371034|NCT01267864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102371035|NCT01267864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371036|NCT01267864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102371037|NCT01267864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102371038|NCT01267864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102371039|NCT01267864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102371040|NCT01267864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371041|NCT01267864|Anticonvulsants|anticonvulsants|mesh-ancestor
102371042|NCT01267864|GABA Agents|gaba agents|mesh-ancestor
102371043|NCT01267864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102371044|NCT01267864|Antimanic Agents|antimanic agents|mesh-ancestor
102371045|NCT01267864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102182786|NCT03962114|Niacinamide|niacinamide|mesh-list
102371046|NCT01267864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102371047|NCT01267864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102371048|NCT01267864|Antiemetics|antiemetics|mesh-ancestor
102371049|NCT01267864|Autonomic Agents|autonomic agents|mesh-ancestor
102371050|NCT01267864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102371051|NCT01267864|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102371052|NCT01267864|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102371053|NCT01267864|Dopamine Agents|dopamine agents|mesh-ancestor
102371054|NCT01854827|Immunoglobulins|immunoglobulins|mesh-list
102371055|NCT01854827|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102371056|NCT01854827|Antibodies|antibodies|mesh-list
102371057|NCT01854827|gamma-Globulins|gamma-globulins|mesh-list
102371058|NCT01854827|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102371059|NCT01854827|Immunologic Factors|immunologic factors|mesh-ancestor
102371060|NCT01854827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371061|NCT01360450|Clonidine|clonidine|mesh-list
102371062|NCT01360450|Analgesics|analgesics|mesh-ancestor
102371063|NCT01360450|Sensory System Agents|sensory system agents|mesh-ancestor
102371064|NCT01360450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102371065|NCT01360450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371066|NCT01360450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102371067|NCT01360450|Sympatholytics|sympatholytics|mesh-ancestor
102371068|NCT01360450|Autonomic Agents|autonomic agents|mesh-ancestor
102371069|NCT01360450|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102371070|NCT01360450|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101970522|NCT05570812|Neurosteroids|neurosteroids|mesh-list
102371071|NCT01360450|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102371072|NCT01360450|Adrenergic Agents|adrenergic agents|mesh-ancestor
102371073|NCT01360450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102371074|NCT01360450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371075|NCT01303744|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
102371076|NCT01303744|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
102371077|NCT01303744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102371078|NCT01303744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371079|NCT01361620|Aspirin|aspirin|mesh-list
102371080|NCT01361620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102371081|NCT01361620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102371082|NCT01361620|Analgesics|analgesics|mesh-ancestor
102371083|NCT01361620|Sensory System Agents|sensory system agents|mesh-ancestor
102371084|NCT01361620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102371085|NCT01361620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371086|NCT01361620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102371087|NCT01361620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102371088|NCT01361620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101970523|NCT05570812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102371089|NCT01361620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102371090|NCT01361620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371091|NCT01361620|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101970542|NCT05534672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102371092|NCT01361620|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102371093|NCT01361620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102371094|NCT01361620|Antipyretics|antipyretics|mesh-ancestor
102371095|NCT01305772|Panitumumab|panitumumab|mesh-list
102371096|NCT01305772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102371097|NCT01305772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101305422|NCT02019355|Emollients|emollients|mesh-ancestor
102371098|NCT01271452|Botulinum Toxins|botulinum toxins|mesh-list
102371099|NCT01271452|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102371100|NCT01271452|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101970550|NCT05498675|Valsartan|valsartan|mesh-list
102371101|NCT01271452|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102371102|NCT01271452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102371103|NCT01271452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371104|NCT01271452|Cholinergic Agents|cholinergic agents|mesh-ancestor
102371105|NCT01271452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102371106|NCT01271452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371107|NCT01271452|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102371108|NCT01271452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102371109|NCT01271686|Bimatoprost|bimatoprost|mesh-list
102371110|NCT01271686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102371111|NCT01854047|Albuterol|albuterol|mesh-list
102371112|NCT01854047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102371113|NCT01854047|Autonomic Agents|autonomic agents|mesh-ancestor
102371114|NCT01854047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102371115|NCT01854047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371116|NCT01854047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102371117|NCT01854047|Respiratory System Agents|respiratory system agents|mesh-ancestor
102371118|NCT01854047|Tocolytic Agents|tocolytic agents|mesh-ancestor
102371119|NCT01854047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102371120|NCT01854047|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102371121|NCT01854047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102371122|NCT01854047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102371123|NCT01854047|Adrenergic Agents|adrenergic agents|mesh-ancestor
102371124|NCT01854047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102371125|NCT01854047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371126|NCT01307956|Calcium, Dietary|calcium, dietary|mesh-list
102371127|NCT01307956|Leucovorin|leucovorin|mesh-list
102371128|NCT01307956|Folic Acid|folic acid|mesh-list
102371129|NCT01307956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102371130|NCT01307956|Panitumumab|panitumumab|mesh-list
102371131|NCT01307956|Fluorouracil|fluorouracil|mesh-list
102371132|NCT01307956|Oxaliplatin|oxaliplatin|mesh-list
102371133|NCT01307956|Antibodies|antibodies|mesh-list
102371134|NCT01307956|Immunoglobulins|immunoglobulins|mesh-list
102371135|NCT01307956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102371136|NCT01307956|Calcium|calcium|mesh-list
102371137|NCT01307956|Levoleucovorin|levoleucovorin|mesh-list
102371138|NCT01307956|Immunologic Factors|immunologic factors|mesh-ancestor
102371139|NCT01307956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371140|NCT01307956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102371141|NCT01307956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102371142|NCT01307956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102371143|NCT01307956|Antimetabolites|antimetabolites|mesh-ancestor
102371144|NCT01307956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371145|NCT01307956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102371146|NCT01307956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102371147|NCT01307956|Antidotes|antidotes|mesh-ancestor
102371148|NCT01307956|Protective Agents|protective agents|mesh-ancestor
102371149|NCT01307956|Vitamin B Complex|vitamin b complex|mesh-ancestor
102371150|NCT01307956|Vitamins|vitamins|mesh-ancestor
102371151|NCT01307956|Micronutrients|micronutrients|mesh-ancestor
102371152|NCT01307956|Hematinics|hematinics|mesh-ancestor
102371153|NCT01870739|Amlodipine|amlodipine|mesh-list
102371154|NCT01870739|Valsartan|valsartan|mesh-list
102371155|NCT01870739|Olmesartan|olmesartan|mesh-list
102371156|NCT01870739|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
102371157|NCT01870739|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102371158|NCT01870739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102371159|NCT01870739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102371160|NCT01870739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102371161|NCT01870739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371162|NCT01870739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102371163|NCT01870739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371164|NCT01870739|Vasodilator Agents|vasodilator agents|mesh-ancestor
102371165|NCT01870739|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102371166|NCT01870739|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102371167|NCT01272388|Tadalafil|tadalafil|mesh-list
102371168|NCT01272388|Vasodilator Agents|vasodilator agents|mesh-ancestor
102371169|NCT01272388|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102371170|NCT01272388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102371171|NCT01272388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102371172|NCT01272388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371173|NCT01272388|Urological Agents|urological agents|mesh-ancestor
102371174|NCT01870583|Iodine|iodine|mesh-list
102371175|NCT01870583|Chlorhexidine|chlorhexidine|mesh-list
102371176|NCT01870583|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102371177|NCT01870583|Cadexomer iodine|cadexomer iodine|mesh-list
102371178|NCT01870583|Povidone|povidone|mesh-list
102371179|NCT01870583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102371180|NCT01870583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102371181|NCT01870583|Disinfectants|disinfectants|mesh-ancestor
102371182|NCT01870583|Dermatologic Agents|dermatologic agents|mesh-ancestor
102371183|NCT01870583|Trace Elements|trace elements|mesh-ancestor
102371184|NCT01870583|Micronutrients|micronutrients|mesh-ancestor
102371185|NCT01870583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371186|NCT01870583|Plasma Substitutes|plasma substitutes|mesh-ancestor
102371187|NCT01870583|Blood Substitutes|blood substitutes|mesh-ancestor
102371188|NCT04351594|Menthol|menthol|mesh-list
102371189|NCT04351594|Antipruritics|antipruritics|mesh-ancestor
102371190|NCT04351594|Dermatologic Agents|dermatologic agents|mesh-ancestor
102371191|NCT01308814|Estradiol|estradiol|mesh-list
102371192|NCT01308814|Estrogens|estrogens|mesh-ancestor
102371193|NCT01308814|Hormones|hormones|mesh-ancestor
102371194|NCT01308814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102371195|NCT01308814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371196|NCT03009604|Simethicone|simethicone|mesh-list
102371197|NCT03009604|Antifoaming Agents|antifoaming agents|mesh-ancestor
101970633|NCT05371093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102371198|NCT03009604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371199|NCT03009604|Emollients|emollients|mesh-ancestor
102371200|NCT03009604|Dermatologic Agents|dermatologic agents|mesh-ancestor
102371201|NCT01275664|Dexamethasone|dexamethasone|mesh-list
101305481|NCT02019797|Desflurane|desflurane|mesh-list
102371202|NCT01275664|Dexamethasone acetate|dexamethasone acetate|mesh-list
102371203|NCT01275664|Cisplatin|cisplatin|mesh-list
102371204|NCT01275664|Carboplatin|carboplatin|mesh-list
102371205|NCT01275664|Aprepitant|aprepitant|mesh-list
102371206|NCT01275664|Granisetron|granisetron|mesh-list
102371207|NCT01275664|Ichthammol|ichthammol|mesh-list
102371208|NCT01275664|BB 1101|bb 1101|mesh-list
102371209|NCT01275664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102371210|NCT01275664|Antiemetics|antiemetics|mesh-ancestor
102371211|NCT01275664|Autonomic Agents|autonomic agents|mesh-ancestor
102371212|NCT01275664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102371213|NCT01275664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371214|NCT01275664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102371215|NCT01275664|Glucocorticoids|glucocorticoids|mesh-ancestor
102371216|NCT01275664|Hormones|hormones|mesh-ancestor
102371217|NCT01275664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102371218|NCT01275664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102371219|NCT01275664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102371220|NCT01275664|Protease Inhibitors|protease inhibitors|mesh-ancestor
102371221|NCT01275664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102371222|NCT01275664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371223|NCT01275664|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102371224|NCT01275664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102371225|NCT01275664|Dermatologic Agents|dermatologic agents|mesh-ancestor
102371226|NCT01275664|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102371227|NCT01275664|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102371228|NCT01275664|Serotonin Agents|serotonin agents|mesh-ancestor
102371229|NCT01613027|Rituximab|rituximab|mesh-list
102371230|NCT01613027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101961841|NCT03521817|Ethanol|ethanol|mesh-list
102371231|NCT01613027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102371232|NCT01613027|Immunologic Factors|immunologic factors|mesh-ancestor
102371233|NCT01613027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371234|NCT01613027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102371235|NCT04595045|Botulinum Toxins|botulinum toxins|mesh-list
102371236|NCT04595045|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102371237|NCT04595045|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102371238|NCT04595045|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102371239|NCT04595045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101970679|NCT05352672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102371240|NCT04595045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371241|NCT04595045|Cholinergic Agents|cholinergic agents|mesh-ancestor
102371242|NCT04595045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102371243|NCT04595045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371244|NCT04595045|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102371245|NCT04595045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102371246|NCT01369732|Epoetin Alfa|epoetin alfa|mesh-list
102371247|NCT01369732|Hematinics|hematinics|mesh-ancestor
102371248|NCT01869725|Octreotide|octreotide|mesh-list
102371249|NCT01869725|Edotreotide|edotreotide|mesh-list
102371250|NCT01869725|Indium-111-octreotide|indium-111-octreotide|mesh-list
102371251|NCT01869725|Somatostatin|somatostatin|mesh-list
102371252|NCT01869725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102371253|NCT01869725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102371254|NCT01869725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102371255|NCT01869725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371256|NCT01869725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371257|NCT01869725|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102371258|NCT01869725|Hormones|hormones|mesh-ancestor
102371259|NCT01869725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102371260|NCT01309360|Midazolam|midazolam|mesh-list
102371261|NCT01309360|Prilocaine|prilocaine|mesh-list
102371262|NCT01309360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102371263|NCT01309360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102371264|NCT01309360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101970697|NCT05345613|Coagulants|coagulants|mesh-ancestor
102371265|NCT01309360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371266|NCT01309360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102371267|NCT01309360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102371268|NCT01309360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102371269|NCT01309360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101970709|NCT05345613|Mydriatics|mydriatics|mesh-ancestor
101970710|NCT05345613|Sympathomimetics|sympathomimetics|mesh-ancestor
101970711|NCT05345613|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101305514|NCT02020005|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101962196|NCT02165644|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101962197|NCT02165644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102371270|NCT01309360|Anesthetics, General|anesthetics, general|mesh-ancestor
102371271|NCT01309360|Anesthetics|anesthetics|mesh-ancestor
102371272|NCT01309360|GABA Modulators|gaba modulators|mesh-ancestor
102371273|NCT01309360|GABA Agents|gaba agents|mesh-ancestor
102371274|NCT01309360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102371275|NCT01309360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371276|NCT01309360|Anesthetics, Local|anesthetics, local|mesh-ancestor
102371277|NCT01309360|Sensory System Agents|sensory system agents|mesh-ancestor
102371278|NCT01309360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102371279|NCT01851863|Flupenthixol|flupenthixol|mesh-list
102371280|NCT01851863|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
102371281|NCT01851863|Omeprazole|omeprazole|mesh-list
102371282|NCT01851863|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102371283|NCT01851863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102371284|NCT01851863|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102371285|NCT01851863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102371286|NCT01851863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371287|NCT01851863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102371288|NCT01851863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102371289|NCT01851863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102371290|NCT01851863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371291|NCT01851863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102371292|NCT01851863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102371293|NCT01851863|Dopamine Agents|dopamine agents|mesh-ancestor
102371294|NCT01851863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102371295|NCT01369888|Cyclophosphamide|cyclophosphamide|mesh-list
102371296|NCT01369888|Fludarabine|fludarabine|mesh-list
102371297|NCT01369888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102371298|NCT01369888|Immunologic Factors|immunologic factors|mesh-ancestor
102371299|NCT01369888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371300|NCT01369888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102371301|NCT01369888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102371302|NCT01369888|Alkylating Agents|alkylating agents|mesh-ancestor
102371303|NCT01369888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371304|NCT01369888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102371305|NCT01369888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102371306|NCT01850615|Insulin|insulin|mesh-list
102371307|NCT01850615|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102371308|NCT01850615|Insulin Aspart|insulin aspart|mesh-list
102371309|NCT01850615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102371310|NCT01850615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371311|NCT04602221|Lamotrigine|lamotrigine|mesh-list
102371312|NCT04602221|BI 425809|bi 425809|mesh-list
102371313|NCT04602221|BI 409306|bi 409306|mesh-list
102371314|NCT04602221|Anticonvulsants|anticonvulsants|mesh-ancestor
102371315|NCT04602221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102371316|NCT04602221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102371317|NCT04602221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371318|NCT04602221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102371319|NCT04602221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371320|NCT04602221|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102371321|NCT04602221|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102371322|NCT04602221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102371323|NCT04602221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101970758|NCT05238831|Niraparib|niraparib|mesh-list
102371324|NCT04602221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102371325|NCT04602221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102371326|NCT04602221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102371327|NCT04602221|Nootropic Agents|nootropic agents|mesh-ancestor
102371328|NCT01280110|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102371329|NCT01280110|Laxatives|laxatives|mesh-ancestor
102371330|NCT01280110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102371331|NCT01374802|Ritonavir|ritonavir|mesh-list
102371332|NCT01374802|Darunavir|darunavir|mesh-list
102371333|NCT01374802|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102371334|NCT01374802|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102371335|NCT01374802|Protease Inhibitors|protease inhibitors|mesh-ancestor
102371336|NCT01374802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102371337|NCT01374802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371338|NCT01374802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102371339|NCT01374802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102371340|NCT01374802|Antiviral Agents|antiviral agents|mesh-ancestor
102371341|NCT01374802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102371342|NCT01374802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102371343|NCT01374802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102371344|NCT01375660|Vitamin D|vitamin d|mesh-list
102371345|NCT01375660|Ergocalciferols|ergocalciferols|mesh-list
102371346|NCT01375660|Vitamins|vitamins|mesh-ancestor
102371347|NCT01375660|Micronutrients|micronutrients|mesh-ancestor
102371348|NCT01375660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371349|NCT01375660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102371350|NCT01375660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102371351|NCT01868477|Epoetin Alfa|epoetin alfa|mesh-list
102371352|NCT01868477|Deferasirox|deferasirox|mesh-list
102371353|NCT01868477|Hematinics|hematinics|mesh-ancestor
101970783|NCT05238831|Antimetabolites|antimetabolites|mesh-ancestor
102371354|NCT01868477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102371355|NCT01868477|Chelating Agents|chelating agents|mesh-ancestor
102371356|NCT01868477|Sequestering Agents|sequestering agents|mesh-ancestor
102371357|NCT01868477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371358|NCT01849289|Insulin|insulin|mesh-list
102371359|NCT01849289|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102371360|NCT01849289|Insulin Glargine|insulin glargine|mesh-list
102371361|NCT01849289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102371362|NCT01849289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371363|NCT01868243|Warfarin|warfarin|mesh-list
102371364|NCT01868243|Dabigatran|dabigatran|mesh-list
102371365|NCT01868243|Anticoagulants|anticoagulants|mesh-ancestor
102371366|NCT01868243|Antithrombins|antithrombins|mesh-ancestor
102371367|NCT01868243|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102371368|NCT01868243|Protease Inhibitors|protease inhibitors|mesh-ancestor
101970797|NCT05238831|Immunotoxins|immunotoxins|mesh-ancestor
102371369|NCT01868243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102371370|NCT01868243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371371|NCT01611935|Vasopressins|vasopressins|mesh-list
102371372|NCT01611935|Arginine Vasopressin|arginine vasopressin|mesh-list
102371373|NCT01611935|Hemostatics|hemostatics|mesh-ancestor
102371374|NCT01611935|Coagulants|coagulants|mesh-ancestor
102371375|NCT01611935|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102371376|NCT01611935|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102371377|NCT01611935|Natriuretic Agents|natriuretic agents|mesh-ancestor
102371378|NCT01611935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371379|NCT02201212|Everolimus|everolimus|mesh-list
102371380|NCT02201212|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102371381|NCT02201212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102371382|NCT02201212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102371383|NCT02201212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371384|NCT02201212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102371385|NCT02201212|Immunologic Factors|immunologic factors|mesh-ancestor
102371386|NCT02201212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371387|NCT02201212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102371388|NCT01376362|Interferons|interferons|mesh-list
102371389|NCT01376362|Interferon-gamma|interferon-gamma|mesh-list
102371390|NCT01376362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102371391|NCT01376362|Antiviral Agents|antiviral agents|mesh-ancestor
102371392|NCT01376362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102371393|NCT03009292|Lenvatinib|lenvatinib|mesh-list
102371394|NCT03009292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970806|NCT05180474|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102371395|NCT03009292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102371396|NCT03009292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102371397|NCT03009292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371398|NCT01962792|Dexamethasone|dexamethasone|mesh-list
102371399|NCT01962792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102371400|NCT01962792|Antiemetics|antiemetics|mesh-ancestor
102371401|NCT01962792|Autonomic Agents|autonomic agents|mesh-ancestor
102371402|NCT01962792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102371403|NCT01962792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371404|NCT01962792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102371405|NCT01962792|Glucocorticoids|glucocorticoids|mesh-ancestor
102371406|NCT01962792|Hormones|hormones|mesh-ancestor
102371407|NCT01962792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102371408|NCT01962792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102371409|NCT01962792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102371410|NCT01849055|Celecoxib|celecoxib|mesh-list
102371411|NCT01849055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102371412|NCT01849055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102371413|NCT01849055|Analgesics|analgesics|mesh-ancestor
102371414|NCT01849055|Sensory System Agents|sensory system agents|mesh-ancestor
102371415|NCT01849055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102371416|NCT01849055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371417|NCT01849055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102371418|NCT01849055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102371419|NCT01849055|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102371420|NCT01849055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102371421|NCT01849055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102371422|NCT01849055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371423|NCT01404832|Lansoprazole|lansoprazole|mesh-list
102371424|NCT01404832|Dexlansoprazole|dexlansoprazole|mesh-list
102371425|NCT01404832|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102183160|NCT03547895|Spironolactone|spironolactone|mesh-list
102371426|NCT01404832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102371427|NCT01404832|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102371428|NCT01404832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102371429|NCT01404832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371430|NCT03420534|Iloperidone|iloperidone|mesh-list
102371431|NCT03420534|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102371432|NCT03420534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102371433|NCT03420534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101970855|NCT05136703|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102371434|NCT03420534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371435|NCT03420534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102371436|NCT01313494|Albuterol|albuterol|mesh-list
102371437|NCT01313494|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102371438|NCT01313494|Autonomic Agents|autonomic agents|mesh-ancestor
101970862|NCT05116293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102371439|NCT01313494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102371440|NCT01313494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371441|NCT01313494|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102371442|NCT01313494|Respiratory System Agents|respiratory system agents|mesh-ancestor
102371443|NCT01313494|Tocolytic Agents|tocolytic agents|mesh-ancestor
102371444|NCT01313494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102371445|NCT01313494|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102371446|NCT01313494|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101964117|NCT02219698|Ibuprofen|ibuprofen|mesh-list
102371447|NCT01313494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102371448|NCT01313494|Adrenergic Agents|adrenergic agents|mesh-ancestor
102371449|NCT01313494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102371450|NCT01313494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371451|NCT01407094|Sertraline|sertraline|mesh-list
102371452|NCT01407094|Antidepressive Agents|antidepressive agents|mesh-ancestor
102371453|NCT01407094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102371454|NCT01407094|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102371455|NCT01407094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102371456|NCT01407094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101970885|NCT05116189|Docetaxel|docetaxel|mesh-list
101964223|NCT02230930|Emetics|emetics|mesh-ancestor
102371457|NCT01407094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371458|NCT01407094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102371459|NCT01407094|Serotonin Agents|serotonin agents|mesh-ancestor
102371460|NCT01407094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371461|NCT01867307|Empagliflozin|empagliflozin|mesh-list
102371462|NCT01867307|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102371463|NCT01867307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371464|NCT01867307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102371465|NCT01867307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371466|NCT01845077|Metformin|metformin|mesh-list
102371467|NCT01845077|Linagliptin|linagliptin|mesh-list
102371468|NCT01845077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102371469|NCT01845077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371470|NCT01845077|Incretins|incretins|mesh-ancestor
102371471|NCT01845077|Hormones|hormones|mesh-ancestor
102371472|NCT01845077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102371473|NCT01845077|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102371474|NCT01845077|Protease Inhibitors|protease inhibitors|mesh-ancestor
101970901|NCT05104567|Pembrolizumab|pembrolizumab|mesh-list
102371475|NCT01845077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102371476|NCT01845077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371477|NCT01866917|Ropivacaine|ropivacaine|mesh-list
102371478|NCT01866917|Anesthetics, Local|anesthetics, local|mesh-ancestor
102371479|NCT01866917|Anesthetics|anesthetics|mesh-ancestor
102371480|NCT01866917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102371481|NCT01866917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371482|NCT01866917|Sensory System Agents|sensory system agents|mesh-ancestor
102371483|NCT01866917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102371484|NCT01316302|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
102371485|NCT01316302|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102371486|NCT01316302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101964841|NCT01085981|Niacin|niacin|mesh-list
102371487|NCT01316302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102371488|NCT01316302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970919|NCT05086224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101970920|NCT05086224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371489|NCT01316302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102371490|NCT01316302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371491|NCT01316302|Antidepressive Agents|antidepressive agents|mesh-ancestor
102371492|NCT01316302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102371493|NCT01410058|Efavirenz|efavirenz|mesh-list
102371494|NCT01410058|Nevirapine|nevirapine|mesh-list
102371495|NCT01410058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102371496|NCT01410058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102371497|NCT01410058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102371498|NCT01410058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371499|NCT01410058|Antiviral Agents|antiviral agents|mesh-ancestor
102371500|NCT01410058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101965039|NCT04981678|Buprenorphine|buprenorphine|mesh-list
102371501|NCT01410058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102371502|NCT01410058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102371503|NCT01410058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102371504|NCT01410058|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102371505|NCT01410058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102371506|NCT01410058|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102371507|NCT01410058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102371508|NCT01410058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102371509|NCT01380106|Lenalidomide|lenalidomide|mesh-list
102371510|NCT01380106|Immunologic Factors|immunologic factors|mesh-ancestor
102371511|NCT01380106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371512|NCT01380106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102371513|NCT01380106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102371514|NCT01380106|Growth Substances|growth substances|mesh-ancestor
102371515|NCT01380106|Growth Inhibitors|growth inhibitors|mesh-ancestor
102371516|NCT01380106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102371517|NCT01381120|Acetaminophen|acetaminophen|mesh-list
102371518|NCT01381120|Oxycodone|oxycodone|mesh-list
102371519|NCT01381120|Solifenacin Succinate|solifenacin succinate|mesh-list
102371520|NCT01381120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102371521|NCT01381120|Analgesics|analgesics|mesh-ancestor
102371522|NCT01381120|Sensory System Agents|sensory system agents|mesh-ancestor
102371523|NCT01381120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102371524|NCT01381120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371525|NCT01381120|Antipyretics|antipyretics|mesh-ancestor
102371526|NCT01381120|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102371527|NCT01381120|Narcotics|narcotics|mesh-ancestor
102371528|NCT01381120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102371529|NCT01381120|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102371530|NCT01381120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102371531|NCT01381120|Cholinergic Agents|cholinergic agents|mesh-ancestor
102371532|NCT01381120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102371533|NCT01381120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371534|NCT01381120|Urological Agents|urological agents|mesh-ancestor
102371535|NCT01316770|Dexamethasone|dexamethasone|mesh-list
102371536|NCT01316770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102371537|NCT01316770|Antiemetics|antiemetics|mesh-ancestor
102371538|NCT01316770|Autonomic Agents|autonomic agents|mesh-ancestor
102371539|NCT01316770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102371540|NCT01316770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371541|NCT01316770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102371542|NCT01316770|Glucocorticoids|glucocorticoids|mesh-ancestor
102371543|NCT01316770|Hormones|hormones|mesh-ancestor
102371544|NCT01316770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102371545|NCT01316770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102371546|NCT01316770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102371547|NCT01318408|Levetiracetam|levetiracetam|mesh-list
102371548|NCT01318408|Anticonvulsants|anticonvulsants|mesh-ancestor
102371549|NCT01318408|Nootropic Agents|nootropic agents|mesh-ancestor
102371550|NCT01319110|Ubiquinone|ubiquinone|mesh-list
102371551|NCT01319110|Coenzyme Q10|coenzyme q10|mesh-list
102371552|NCT01319110|Micronutrients|micronutrients|mesh-ancestor
102371553|NCT01319110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371554|NCT01319110|Vitamins|vitamins|mesh-ancestor
102371555|NCT03008512|Paclitaxel|paclitaxel|mesh-list
102371556|NCT03008512|genexol-PM|genexol-pm|mesh-list
102371557|NCT03008512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102371558|NCT03008512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102371559|NCT03008512|Tubulin Modulators|tubulin modulators|mesh-ancestor
102371560|NCT03008512|Antimitotic Agents|antimitotic agents|mesh-ancestor
102371561|NCT03008512|Mitosis Modulators|mitosis modulators|mesh-ancestor
102371562|NCT03008512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371563|NCT04351516|Hydroxychloroquine|hydroxychloroquine|mesh-list
102371564|NCT04351516|Antimalarials|antimalarials|mesh-ancestor
102371565|NCT04351516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102371566|NCT04351516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102371567|NCT04351516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102371568|NCT04351516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102371569|NCT04351516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371570|NCT04351516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102371571|NCT01411696|Dexamethasone|dexamethasone|mesh-list
102371572|NCT01411696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102371573|NCT01411696|Antiemetics|antiemetics|mesh-ancestor
102371574|NCT01411696|Autonomic Agents|autonomic agents|mesh-ancestor
102371575|NCT01411696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102183321|NCT05612984|Aspirin|aspirin|mesh-list
102371576|NCT01411696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371577|NCT01411696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102371578|NCT01411696|Glucocorticoids|glucocorticoids|mesh-ancestor
102371579|NCT01411696|Hormones|hormones|mesh-ancestor
102371580|NCT01411696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102371581|NCT01411696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102371582|NCT01411696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102371583|NCT01412164|Sirolimus|sirolimus|mesh-list
102371584|NCT01412164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102371585|NCT01412164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102371586|NCT01412164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102371587|NCT01412164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102371588|NCT01412164|Antifungal Agents|antifungal agents|mesh-ancestor
101965463|NCT00049127|Imatinib Mesylate|imatinib mesylate|mesh-list
102371589|NCT01412164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102371590|NCT01412164|Immunologic Factors|immunologic factors|mesh-ancestor
102371591|NCT01412164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371592|NCT01844687|Cannabidiol|cannabidiol|mesh-list
102371593|NCT01844687|Anticonvulsants|anticonvulsants|mesh-ancestor
102371594|NCT01844531|Metformin|metformin|mesh-list
102371595|NCT01844531|Empagliflozin|empagliflozin|mesh-list
102371596|NCT01844531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102371597|NCT01844531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371598|NCT01844531|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102371599|NCT01844531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965731|NCT00043979|Prednisone|prednisone|mesh-list
102371600|NCT02367456|Azacitidine|azacitidine|mesh-list
102371601|NCT02367456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102371602|NCT02367456|Antimetabolites|antimetabolites|mesh-ancestor
102371603|NCT02367456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371604|NCT02367456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102371605|NCT02367456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102371606|NCT03420378|Vitamin D|vitamin d|mesh-list
102371607|NCT03420378|Vitamins|vitamins|mesh-ancestor
102371608|NCT03420378|Micronutrients|micronutrients|mesh-ancestor
102371609|NCT03420378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371610|NCT03420378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102371611|NCT03425448|Heparin|heparin|mesh-list
102371612|NCT03425448|Anticoagulants|anticoagulants|mesh-ancestor
102371613|NCT03425448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102371614|NCT03425448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102371615|NCT03425448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371616|NCT03419910|Cyclosporine|cyclosporine|mesh-list
102371617|NCT03419910|Deucravacitinib|deucravacitinib|mesh-list
102371618|NCT03419910|Cyclosporins|cyclosporins|mesh-list
102371619|NCT03419910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102371620|NCT03419910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371621|NCT03419910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102371622|NCT03419910|Immunologic Factors|immunologic factors|mesh-ancestor
102371623|NCT03419910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371624|NCT03419910|Antifungal Agents|antifungal agents|mesh-ancestor
102371625|NCT03419910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102371626|NCT03419910|Dermatologic Agents|dermatologic agents|mesh-ancestor
102371627|NCT03419910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102371628|NCT03419910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102371629|NCT03419910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102371630|NCT03415386|Anticoagulants|anticoagulants|mesh-list
102371631|NCT03415386|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
102371632|NCT01865747|Everolimus|everolimus|mesh-list
102371633|NCT01865747|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102371634|NCT01865747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102371635|NCT01865747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102371636|NCT01865747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371637|NCT01865747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102371638|NCT01865747|Immunologic Factors|immunologic factors|mesh-ancestor
102371639|NCT01865747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371640|NCT01865747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971049|NCT04935359|Antimetabolites|antimetabolites|mesh-ancestor
102371641|NCT03424980|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102371642|NCT03424980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102371643|NCT03424980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102371644|NCT03424980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371645|NCT03424746|Edetic Acid|edetic acid|mesh-list
102371646|NCT03424746|Pentetic Acid|pentetic acid|mesh-list
102371647|NCT03424746|Anticoagulants|anticoagulants|mesh-ancestor
102371648|NCT03424746|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102371649|NCT03424746|Chelating Agents|chelating agents|mesh-ancestor
102371650|NCT03424746|Sequestering Agents|sequestering agents|mesh-ancestor
102612277|NCT00002387|Protease Inhibitors|protease inhibitors|mesh-ancestor
102371651|NCT03424746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371652|NCT03424746|Antidotes|antidotes|mesh-ancestor
102371653|NCT03424746|Protective Agents|protective agents|mesh-ancestor
102371654|NCT03424746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966317|NCT02236078|Isoniazid|isoniazid|mesh-list
102371655|NCT03424746|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102371656|NCT03414918|Clarithromycin|clarithromycin|mesh-list
102371657|NCT03414918|Roxithromycin|roxithromycin|mesh-list
102371658|NCT03414918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102371659|NCT03414918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102371660|NCT03414918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102371661|NCT03414918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102371662|NCT03414918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371663|NCT03414918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102371664|NCT03414918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102371665|NCT04448496|Dexamethasone|dexamethasone|mesh-list
102371666|NCT04448496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102371667|NCT04448496|Antiemetics|antiemetics|mesh-ancestor
102371668|NCT04448496|Autonomic Agents|autonomic agents|mesh-ancestor
102371669|NCT04448496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102371670|NCT04448496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371671|NCT04448496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102371672|NCT04448496|Glucocorticoids|glucocorticoids|mesh-ancestor
102371673|NCT04448496|Hormones|hormones|mesh-ancestor
102371674|NCT04448496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102371675|NCT04448496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102371676|NCT04448496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102371677|NCT01387672|Nitroglycerin|nitroglycerin|mesh-list
102371678|NCT01387672|Vasodilator Agents|vasodilator agents|mesh-ancestor
102371679|NCT03419442|Docetaxel|docetaxel|mesh-list
102371680|NCT03419442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102371681|NCT03419442|Tubulin Modulators|tubulin modulators|mesh-ancestor
102371682|NCT03419442|Antimitotic Agents|antimitotic agents|mesh-ancestor
102371683|NCT03419442|Mitosis Modulators|mitosis modulators|mesh-ancestor
102371684|NCT03419442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371685|NCT01412710|Vitamin D|vitamin d|mesh-list
102371686|NCT01412710|Cholecalciferol|cholecalciferol|mesh-list
102371687|NCT01412710|Vitamins|vitamins|mesh-ancestor
102371688|NCT01412710|Micronutrients|micronutrients|mesh-ancestor
101971094|NCT04879823|Glucocorticoids|glucocorticoids|mesh-ancestor
102371689|NCT01412710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371690|NCT01412710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102371691|NCT01412710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102371692|NCT01843205|Methamphetamine|methamphetamine|mesh-list
102371693|NCT01843205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102371694|NCT01843205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371695|NCT01843205|Sympathomimetics|sympathomimetics|mesh-ancestor
102371696|NCT01843205|Autonomic Agents|autonomic agents|mesh-ancestor
102371697|NCT01843205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102371698|NCT01843205|Dopamine Agents|dopamine agents|mesh-ancestor
102371699|NCT01843205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102371700|NCT01843205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371701|NCT01843205|Adrenergic Agents|adrenergic agents|mesh-ancestor
102371702|NCT01843205|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102371703|NCT01843205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102371704|NCT01843205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101966786|NCT00978016|GABA Agents|gaba agents|mesh-ancestor
102371705|NCT01843205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102371706|NCT03419130|Pembrolizumab|pembrolizumab|mesh-list
101971112|NCT04879524|Cholinergic Agents|cholinergic agents|mesh-ancestor
102371707|NCT03419130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102371708|NCT03419130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101966944|NCT00078767|Sertraline|sertraline|mesh-list
102371709|NCT03419130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102371710|NCT03419130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371711|NCT03414840|Atorvastatin|atorvastatin|mesh-list
102371712|NCT03414840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102371713|NCT03414840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102371714|NCT03414840|Antimetabolites|antimetabolites|mesh-ancestor
102371715|NCT03414840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371716|NCT03414840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102371717|NCT03414840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102371718|NCT03414840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102371719|NCT03418974|Atorvastatin|atorvastatin|mesh-list
102371720|NCT03418974|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102371721|NCT03418974|Pitavastatin|pitavastatin|mesh-list
102371722|NCT03418974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102371723|NCT03418974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102371724|NCT03418974|Antimetabolites|antimetabolites|mesh-ancestor
102371725|NCT03418974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371726|NCT03418974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102371727|NCT03418974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102371728|NCT03418974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102371730|NCT03424356|Narcotics|narcotics|mesh-list
102371731|NCT03424356|Analgesics|analgesics|mesh-list
102371732|NCT03424356|Bromides|bromides|mesh-list
102371733|NCT03424356|Propofol|propofol|mesh-list
102371734|NCT03424356|Rocuronium|rocuronium|mesh-list
102371735|NCT03424356|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102371736|NCT03424356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102371737|NCT03424356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371738|NCT03424356|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102371739|NCT03424356|Anesthetics, General|anesthetics, general|mesh-ancestor
102371740|NCT03424356|Anesthetics|anesthetics|mesh-ancestor
102371741|NCT03424356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102371742|NCT03424356|Sensory System Agents|sensory system agents|mesh-ancestor
102371743|NCT03424356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102371744|NCT03424356|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102371745|NCT03424356|Anticonvulsants|anticonvulsants|mesh-ancestor
102371746|NCT03424356|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102371747|NCT03424356|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102371748|NCT03424356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102371749|NCT03414450|Dasatinib|dasatinib|mesh-list
102371750|NCT03414450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102371751|NCT03414450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102371752|NCT03414450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102371753|NCT03414450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371754|NCT01389076|Methotrexate|methotrexate|mesh-list
102371755|NCT01389076|Tositumomab I-131|tositumomab i-131|mesh-list
102371756|NCT01389076|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102371757|NCT01389076|Abortifacient Agents|abortifacient agents|mesh-ancestor
102371758|NCT01389076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102371759|NCT01389076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371760|NCT01389076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102371761|NCT01389076|Antimetabolites|antimetabolites|mesh-ancestor
102371762|NCT01389076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371763|NCT01389076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102371764|NCT01389076|Dermatologic Agents|dermatologic agents|mesh-ancestor
102371765|NCT01389076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102371766|NCT01389076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102371767|NCT01389076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102371768|NCT01389076|Immunologic Factors|immunologic factors|mesh-ancestor
102371769|NCT01389076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102371770|NCT01389076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102371771|NCT03127800|Morphine|morphine|mesh-list
102371772|NCT03127800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102371773|NCT03127800|Narcotics|narcotics|mesh-ancestor
102371774|NCT03127800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102371775|NCT03127800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371776|NCT03127800|Analgesics|analgesics|mesh-ancestor
102371777|NCT03127800|Sensory System Agents|sensory system agents|mesh-ancestor
102371778|NCT03127800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102371779|NCT01389856|Bosentan|bosentan|mesh-list
102371780|NCT01389856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102371781|NCT01389856|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102371782|NCT01389856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371783|NCT03418896|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102371784|NCT03418896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102371785|NCT03418896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371786|NCT01323010|Albuterol|albuterol|mesh-list
102371787|NCT01323010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102371788|NCT01323010|Autonomic Agents|autonomic agents|mesh-ancestor
102371789|NCT01323010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102371790|NCT01323010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371791|NCT01323010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102371792|NCT01323010|Respiratory System Agents|respiratory system agents|mesh-ancestor
102371793|NCT01323010|Tocolytic Agents|tocolytic agents|mesh-ancestor
102371794|NCT01323010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102371795|NCT01323010|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102371796|NCT01323010|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102371797|NCT01323010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102371798|NCT01323010|Adrenergic Agents|adrenergic agents|mesh-ancestor
102371799|NCT01323010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102371800|NCT01323010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371801|NCT03423810|Hydralazine|hydralazine|mesh-list
102371802|NCT03423810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102371803|NCT03423810|Vasodilator Agents|vasodilator agents|mesh-ancestor
102371804|NCT01390246|Bupropion|bupropion|mesh-list
102371805|NCT01390246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102371806|NCT01390246|Antidepressive Agents|antidepressive agents|mesh-ancestor
102371807|NCT01390246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102371808|NCT01390246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102371809|NCT01390246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102371810|NCT01390246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102371811|NCT01390246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371812|NCT01390246|Dopamine Agents|dopamine agents|mesh-ancestor
102371813|NCT01390246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102371814|NCT01390246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371815|NCT01390246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102371816|NCT01390246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102371817|NCT01390246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102371818|NCT01390870|Alfuzosin|alfuzosin|mesh-list
102371819|NCT01390870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371820|NCT01390870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371821|NCT01390870|Urological Agents|urological agents|mesh-ancestor
102371822|NCT01390870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102371823|NCT01390870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102371824|NCT01390870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102371825|NCT01390870|Adrenergic Agents|adrenergic agents|mesh-ancestor
102371826|NCT01390870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102371827|NCT03418506|Lobeline|lobeline|mesh-list
102371828|NCT03418506|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102371829|NCT03418506|Autonomic Agents|autonomic agents|mesh-ancestor
102371830|NCT03418506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102371831|NCT03418506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371832|NCT03418506|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102371833|NCT03418506|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102371834|NCT03418506|Cholinergic Agents|cholinergic agents|mesh-ancestor
102371835|NCT03418506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102371836|NCT03418506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371837|NCT03418506|Respiratory System Agents|respiratory system agents|mesh-ancestor
102371838|NCT01842581|Rifaximin|rifaximin|mesh-list
102371839|NCT01842581|Lactulose|lactulose|mesh-list
102371840|NCT01842581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102371841|NCT01842581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102371842|NCT01842581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102371843|NCT04448028|Esomeprazole|esomeprazole|mesh-list
102371844|NCT04448028|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
102371845|NCT04448028|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102371846|NCT04448028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102371847|NCT04448028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102371848|NCT04448028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371849|NCT01833533|Ribavirin|ribavirin|mesh-list
102371850|NCT01833533|Antimetabolites|antimetabolites|mesh-ancestor
102371851|NCT01833533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371852|NCT01833533|Antiviral Agents|antiviral agents|mesh-ancestor
102371853|NCT01833533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102371854|NCT03413436|Cisplatin|cisplatin|mesh-list
102371855|NCT03413436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102371856|NCT01833455|Flecainide|flecainide|mesh-list
102371857|NCT01833455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102371858|NCT01833455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102371859|NCT01833455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102371860|NCT01833455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101971264|NCT04584255|Niraparib|niraparib|mesh-list
102371861|NCT01833455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371862|NCT03413358|Carboplatin|carboplatin|mesh-list
102371863|NCT03413358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102371864|NCT01833143|Acyclovir|acyclovir|mesh-list
102371865|NCT01833143|Bortezomib|bortezomib|mesh-list
102371866|NCT01833143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102371867|NCT01833143|Antiviral Agents|antiviral agents|mesh-ancestor
102371868|NCT01833143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102371869|NCT03411096|Ropivacaine|ropivacaine|mesh-list
102371870|NCT03411096|Anesthetics, Local|anesthetics, local|mesh-ancestor
102371871|NCT03411096|Anesthetics|anesthetics|mesh-ancestor
102371872|NCT03411096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102371873|NCT03411096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371874|NCT03411096|Sensory System Agents|sensory system agents|mesh-ancestor
102371875|NCT03411096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102371876|NCT03417648|Vitamin E|vitamin e|mesh-list
102371877|NCT03417648|Vitamins|vitamins|mesh-ancestor
102371878|NCT03417648|Micronutrients|micronutrients|mesh-ancestor
102371879|NCT03417648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371880|NCT03417648|Antioxidants|antioxidants|mesh-ancestor
102371881|NCT03417648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371882|NCT03417648|Protective Agents|protective agents|mesh-ancestor
102371883|NCT01831817|Calcium, Dietary|calcium, dietary|mesh-list
102371884|NCT01831817|Listerine|listerine|mesh-list
102371885|NCT01831817|Calcium|calcium|mesh-list
102371886|NCT01831817|Fluorides|fluorides|mesh-list
102371887|NCT01831817|Sodium Fluoride|sodium fluoride|mesh-list
102371888|NCT01831817|Fluorophosphate|fluorophosphate|mesh-list
102371889|NCT01831817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102371890|NCT01831817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371891|NCT01831817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102371892|NCT01831817|Cariostatic Agents|cariostatic agents|mesh-ancestor
102371893|NCT01831817|Protective Agents|protective agents|mesh-ancestor
102371894|NCT01831817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102371895|NCT01831817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102371896|NCT03412500|Vancomycin|vancomycin|mesh-list
102371897|NCT03412500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102371898|NCT03412500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102371899|NCT01840943|Topotecan|topotecan|mesh-list
102371900|NCT01840943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102371901|NCT01840943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102371902|NCT01840943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102371903|NCT01840943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371904|NCT01840943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102371905|NCT05171400|Insulin|insulin|mesh-list
102371906|NCT05171400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102371907|NCT05171400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371908|NCT02203630|Phenylephrine|phenylephrine|mesh-list
102371909|NCT02203630|Oxymetazoline|oxymetazoline|mesh-list
102371910|NCT02203630|Norepinephrine|norepinephrine|mesh-list
102371911|NCT02203630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102371912|NCT02203630|Mydriatics|mydriatics|mesh-ancestor
102371913|NCT02203630|Autonomic Agents|autonomic agents|mesh-ancestor
102371914|NCT02203630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101967488|NCT03331562|Ergocalciferols|ergocalciferols|mesh-list
102371915|NCT02203630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371916|NCT02203630|Sympathomimetics|sympathomimetics|mesh-ancestor
102371917|NCT02203630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102371918|NCT02203630|Nasal Decongestants|nasal decongestants|mesh-ancestor
102371919|NCT02203630|Respiratory System Agents|respiratory system agents|mesh-ancestor
102371920|NCT02203630|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102371921|NCT02203630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102371922|NCT02203630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102371923|NCT02203630|Adrenergic Agents|adrenergic agents|mesh-ancestor
101397846|NCT00086333|Docetaxel|docetaxel|mesh-list
102371924|NCT02203630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101971324|NCT04539938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102371925|NCT02203630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371926|NCT02203630|Protective Agents|protective agents|mesh-ancestor
102371927|NCT04593329|Dipyrone|dipyrone|mesh-list
102371928|NCT04593329|Tramadol|tramadol|mesh-list
102371929|NCT04593329|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102371930|NCT04593329|Narcotics|narcotics|mesh-ancestor
102371931|NCT04593329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102371932|NCT04593329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371933|NCT04593329|Analgesics|analgesics|mesh-ancestor
102371934|NCT04593329|Sensory System Agents|sensory system agents|mesh-ancestor
102371935|NCT04593329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102371936|NCT04593329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102371937|NCT04593329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102371938|NCT04593329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102371939|NCT04593329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102371940|NCT04593329|Antipyretics|antipyretics|mesh-ancestor
102371941|NCT03397446|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101306108|NCT02023710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102371942|NCT03397446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102371943|NCT03397446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371944|NCT03397446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102371945|NCT03397446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102371946|NCT03397446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102371947|NCT03397446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371948|NCT03397446|Dopamine Agents|dopamine agents|mesh-ancestor
102371949|NCT03397446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102371950|NCT01393132|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102371951|NCT01393132|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102371952|NCT02520570|Urinastatin|urinastatin|mesh-list
102371953|NCT02520570|Trypsin Inhibitors|trypsin inhibitors|mesh-list
102371954|NCT02520570|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102371955|NCT02520570|Protease Inhibitors|protease inhibitors|mesh-ancestor
102371956|NCT02520570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102371957|NCT02520570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371958|NCT03411798|Hydroxychloroquine|hydroxychloroquine|mesh-list
102371959|NCT03411798|Sulfasalazine|sulfasalazine|mesh-list
102371960|NCT03411798|Methotrexate|methotrexate|mesh-list
102371961|NCT03411798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102371962|NCT03411798|Abortifacient Agents|abortifacient agents|mesh-ancestor
102371963|NCT03411798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102371964|NCT03411798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371965|NCT03411798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102371966|NCT03411798|Antimetabolites|antimetabolites|mesh-ancestor
102371967|NCT03411798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371968|NCT03411798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102371969|NCT03411798|Dermatologic Agents|dermatologic agents|mesh-ancestor
102371970|NCT03411798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102371971|NCT03411798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102371972|NCT03411798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102371973|NCT03411798|Immunologic Factors|immunologic factors|mesh-ancestor
102371974|NCT03411798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102371975|NCT03411798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102371976|NCT03411798|Antimalarials|antimalarials|mesh-ancestor
102371977|NCT03411798|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102371978|NCT03411798|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102371979|NCT03411798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102371980|NCT03411798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102371981|NCT03411798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102371982|NCT03411798|Analgesics|analgesics|mesh-ancestor
102371983|NCT03411798|Sensory System Agents|sensory system agents|mesh-ancestor
102371984|NCT03411798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102371985|NCT03411798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102371986|NCT03411798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102371987|NCT03408756|Methotrexate|methotrexate|mesh-list
101971369|NCT04430738|Antidotes|antidotes|mesh-ancestor
102371988|NCT03408756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102371989|NCT03408756|Abortifacient Agents|abortifacient agents|mesh-ancestor
102371990|NCT03408756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102371991|NCT03408756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102371992|NCT03408756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102371993|NCT03408756|Antimetabolites|antimetabolites|mesh-ancestor
101971386|NCT04415944|Carboplatin|carboplatin|mesh-list
102371994|NCT03408756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102371995|NCT03408756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102371996|NCT03408756|Dermatologic Agents|dermatologic agents|mesh-ancestor
101971390|NCT04398368|Antimetabolites|antimetabolites|mesh-ancestor
101399535|NCT03498261|Gabapentin|gabapentin|mesh-list
102371997|NCT03408756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102371998|NCT03408756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102371999|NCT03408756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102372000|NCT03408756|Immunologic Factors|immunologic factors|mesh-ancestor
102372001|NCT03408756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102372002|NCT03408756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102372003|NCT01394614|Vaccines|vaccines|mesh-list
102372004|NCT01394614|Immunologic Factors|immunologic factors|mesh-ancestor
102372005|NCT01394614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372006|NCT04588818|Adalimumab|adalimumab|mesh-list
102372007|NCT04588818|Methotrexate|methotrexate|mesh-list
101971394|NCT04378959|Anesthetics, Local|anesthetics, local|mesh-ancestor
102372008|NCT04588818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102372009|NCT04588818|Abortifacient Agents|abortifacient agents|mesh-ancestor
102372010|NCT04588818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102372011|NCT04588818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372012|NCT04588818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102372013|NCT04588818|Antimetabolites|antimetabolites|mesh-ancestor
102372014|NCT04588818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372015|NCT04588818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102372016|NCT04588818|Dermatologic Agents|dermatologic agents|mesh-ancestor
102372017|NCT04588818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102372018|NCT04588818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102372019|NCT04588818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102372020|NCT04588818|Immunologic Factors|immunologic factors|mesh-ancestor
102372021|NCT04588818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102372022|NCT04588818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102372023|NCT04588818|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102372024|NCT04588818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102372025|NCT01422226|Alprostadil|alprostadil|mesh-list
102372026|NCT01422226|Misoprostol|misoprostol|mesh-list
102372027|NCT01422226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102372028|NCT01422226|Abortifacient Agents|abortifacient agents|mesh-ancestor
102372029|NCT01422226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102372030|NCT01422226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372031|NCT01422226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102372032|NCT01422226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102372033|NCT01422226|Oxytocics|oxytocics|mesh-ancestor
102372034|NCT01422226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102372035|NCT01422226|Vasodilator Agents|vasodilator agents|mesh-ancestor
102372036|NCT01422226|Urological Agents|urological agents|mesh-ancestor
102372037|NCT01423162|Ascorbic Acid|ascorbic acid|mesh-list
102372038|NCT01423162|Antioxidants|antioxidants|mesh-ancestor
102372039|NCT01423162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372040|NCT01423162|Protective Agents|protective agents|mesh-ancestor
102372041|NCT01423162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372042|NCT01423162|Vitamins|vitamins|mesh-ancestor
102372043|NCT01423162|Micronutrients|micronutrients|mesh-ancestor
102372044|NCT01328782|Acetaminophen|acetaminophen|mesh-list
102372045|NCT01328782|Oxycodone|oxycodone|mesh-list
102372046|NCT01328782|Bupivacaine|bupivacaine|mesh-list
102372047|NCT01328782|Ropivacaine|ropivacaine|mesh-list
102372048|NCT01328782|Anesthetics, Local|anesthetics, local|mesh-ancestor
102372049|NCT01328782|Anesthetics|anesthetics|mesh-ancestor
102372050|NCT01328782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102372051|NCT01328782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372052|NCT01328782|Sensory System Agents|sensory system agents|mesh-ancestor
102372053|NCT01328782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102372054|NCT01328782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102372055|NCT01328782|Analgesics|analgesics|mesh-ancestor
102372056|NCT01328782|Antipyretics|antipyretics|mesh-ancestor
101971449|NCT04204122|Moxifloxacin|moxifloxacin|mesh-list
102372057|NCT01328782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102372058|NCT01328782|Narcotics|narcotics|mesh-ancestor
102372059|NCT04447326|Endostar protein|endostar protein|mesh-list
102372060|NCT04447326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102372061|NCT04447326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102372062|NCT04447326|Growth Substances|growth substances|mesh-ancestor
102372063|NCT04447326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372064|NCT04447326|Growth Inhibitors|growth inhibitors|mesh-ancestor
102372065|NCT04447326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102372066|NCT03411330|Lidocaine|lidocaine|mesh-list
102372067|NCT03411330|Bupivacaine|bupivacaine|mesh-list
102372068|NCT03411330|Anesthetics, Local|anesthetics, local|mesh-ancestor
102372069|NCT03411330|Anesthetics|anesthetics|mesh-ancestor
102372070|NCT03411330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102372071|NCT03411330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372072|NCT03411330|Sensory System Agents|sensory system agents|mesh-ancestor
102372073|NCT03411330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102372074|NCT03411330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102372075|NCT03411330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102372076|NCT03411330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102372077|NCT03411330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102372078|NCT03411330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372079|NCT03411252|Mirabegron|mirabegron|mesh-list
102372080|NCT03411252|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102372081|NCT03411252|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102372082|NCT03411252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102372083|NCT03411252|Adrenergic Agents|adrenergic agents|mesh-ancestor
102372084|NCT03411252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102372085|NCT03411252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372086|NCT03411252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372087|NCT03411252|Urological Agents|urological agents|mesh-ancestor
102372088|NCT01831427|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102372089|NCT01831427|Immunologic Factors|immunologic factors|mesh-ancestor
102372090|NCT01831427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372091|NCT01830881|Ibuprofen|ibuprofen|mesh-list
102372092|NCT01830881|Lidocaine|lidocaine|mesh-list
102372093|NCT01830881|Midazolam|midazolam|mesh-list
102372094|NCT01830881|Anesthetics, Local|anesthetics, local|mesh-ancestor
102372095|NCT01830881|Anesthetics|anesthetics|mesh-ancestor
102372096|NCT01830881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102372097|NCT01830881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372098|NCT01830881|Sensory System Agents|sensory system agents|mesh-ancestor
102372099|NCT01830881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102372100|NCT01830881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102183856|NCT02253953|Ritonavir|ritonavir|mesh-list
102372101|NCT01830881|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102372102|NCT01830881|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102372103|NCT01830881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102372104|NCT01830881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372105|NCT01830881|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102372106|NCT01830881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102372107|NCT01830881|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102372108|NCT01830881|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102372109|NCT01830881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102372110|NCT01830881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102372111|NCT01830881|Anesthetics, General|anesthetics, general|mesh-ancestor
102372112|NCT01830881|GABA Modulators|gaba modulators|mesh-ancestor
102372113|NCT01830881|GABA Agents|gaba agents|mesh-ancestor
102372114|NCT01830881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102372115|NCT01830881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102372116|NCT01830881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102372117|NCT01830881|Analgesics|analgesics|mesh-ancestor
102372118|NCT01830881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102372119|NCT01830881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102372120|NCT01830881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102372121|NCT01830881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102372122|NCT01396486|Inositol|inositol|mesh-list
102372123|NCT01396486|Vitamin B Complex|vitamin b complex|mesh-ancestor
102372124|NCT01396486|Vitamins|vitamins|mesh-ancestor
102372125|NCT01396486|Micronutrients|micronutrients|mesh-ancestor
102372126|NCT01396486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372127|NCT01838681|Brexpiprazole|brexpiprazole|mesh-list
102372128|NCT01838681|Serotonin Agents|serotonin agents|mesh-ancestor
102372129|NCT01838681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101971523|NCT03952403|Immunologic Factors|immunologic factors|mesh-ancestor
102372130|NCT01838681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372131|NCT01838681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372132|NCT01838681|Dopamine Agonists|dopamine agonists|mesh-ancestor
102372133|NCT01838681|Dopamine Agents|dopamine agents|mesh-ancestor
102372134|NCT03404544|Carbetocin|carbetocin|mesh-list
102372135|NCT03404544|Oxytocin|oxytocin|mesh-list
102372136|NCT03404544|Oxytocics|oxytocics|mesh-ancestor
102372137|NCT03404544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102372138|NCT03404544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372139|NCT01398280|Aminocaproic Acid|aminocaproic acid|mesh-list
102372140|NCT01398280|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101971528|NCT03918278|Paclitaxel|paclitaxel|mesh-list
102372141|NCT01398280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102372142|NCT01398280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372143|NCT01398280|Hemostatics|hemostatics|mesh-ancestor
102372144|NCT01398280|Coagulants|coagulants|mesh-ancestor
102372145|NCT03404310|Zinc Sulfate|zinc sulfate|mesh-list
102372146|NCT03404310|Astringents|astringents|mesh-ancestor
102372147|NCT03404310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372148|NCT03404310|Dermatologic Agents|dermatologic agents|mesh-ancestor
102372149|NCT03403842|Sufentanil|sufentanil|mesh-list
102372150|NCT03403842|Morphine|morphine|mesh-list
102372151|NCT03403842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102372152|NCT03403842|Narcotics|narcotics|mesh-ancestor
102372153|NCT03403842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102372154|NCT03403842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372155|NCT03403842|Analgesics|analgesics|mesh-ancestor
102372156|NCT03403842|Sensory System Agents|sensory system agents|mesh-ancestor
102372157|NCT03403842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102372158|NCT03403842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102372159|NCT03403842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102372160|NCT03403842|Anesthetics, General|anesthetics, general|mesh-ancestor
102372161|NCT03403842|Anesthetics|anesthetics|mesh-ancestor
102372162|NCT01398982|Bupivacaine|bupivacaine|mesh-list
102372163|NCT01398982|Anesthetics, Local|anesthetics, local|mesh-ancestor
102372164|NCT01398982|Anesthetics|anesthetics|mesh-ancestor
102372165|NCT01398982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102372166|NCT01398982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971541|NCT03918278|Antimetabolites|antimetabolites|mesh-ancestor
101971561|NCT03904251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101971562|NCT03904251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101971563|NCT03904251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101971564|NCT03904251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101971565|NCT03904251|Immunotoxins|immunotoxins|mesh-ancestor
102372167|NCT01398982|Sensory System Agents|sensory system agents|mesh-ancestor
102372168|NCT01398982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102372169|NCT04447560|Bupivacaine|bupivacaine|mesh-list
102372170|NCT04447560|Anesthetics, Local|anesthetics, local|mesh-ancestor
102372171|NCT04447560|Anesthetics|anesthetics|mesh-ancestor
102372172|NCT04447560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102372173|NCT04447560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372174|NCT04447560|Sensory System Agents|sensory system agents|mesh-ancestor
102372175|NCT04447560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102372176|NCT03401736|Midazolam|midazolam|mesh-list
102372177|NCT03401736|Dexmedetomidine|dexmedetomidine|mesh-list
102372178|NCT03401736|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101971566|NCT03904251|Immunoconjugates|immunoconjugates|mesh-ancestor
102372179|NCT03401736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102372180|NCT03401736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372181|NCT03401736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102372182|NCT03401736|Analgesics|analgesics|mesh-ancestor
102372183|NCT03401736|Sensory System Agents|sensory system agents|mesh-ancestor
102372184|NCT03401736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102372185|NCT03401736|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102372186|NCT03401736|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102372187|NCT03401736|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102372188|NCT03401736|Adrenergic Agents|adrenergic agents|mesh-ancestor
102372189|NCT03401736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102372190|NCT03401736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372191|NCT03401736|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102372192|NCT03401736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102372193|NCT03401736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102372194|NCT03401736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102372195|NCT03401736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102372196|NCT03401736|Anesthetics, General|anesthetics, general|mesh-ancestor
102035403|NCT04707183|Lidocaine|lidocaine|mesh-list
102372197|NCT03401736|Anesthetics|anesthetics|mesh-ancestor
102372198|NCT03401736|GABA Modulators|gaba modulators|mesh-ancestor
102372199|NCT03401736|GABA Agents|gaba agents|mesh-ancestor
102372200|NCT02203786|Haloperidol|haloperidol|mesh-list
102372201|NCT02203786|Haloperidol decanoate|haloperidol decanoate|mesh-list
102372202|NCT02203786|Fluphenazine|fluphenazine|mesh-list
102372203|NCT02203786|Fluphenazine depot|fluphenazine depot|mesh-list
102372204|NCT02203786|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
102372205|NCT02203786|Amphetamine|amphetamine|mesh-list
102372206|NCT02203786|Dextroamphetamine|dextroamphetamine|mesh-list
102372207|NCT02203786|Antiemetics|antiemetics|mesh-ancestor
102372208|NCT02203786|Autonomic Agents|autonomic agents|mesh-ancestor
102372209|NCT02203786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102372210|NCT02203786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372211|NCT02203786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102372212|NCT02203786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102372213|NCT02203786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102372214|NCT02203786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102372215|NCT02203786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102372216|NCT02203786|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102372217|NCT02203786|Dopamine Agents|dopamine agents|mesh-ancestor
102372218|NCT02203786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102035598|NCT05137496|Prednisolone|prednisolone|mesh-list
102372219|NCT02203786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372220|NCT02203786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102372221|NCT02203786|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102372222|NCT02203786|Sympathomimetics|sympathomimetics|mesh-ancestor
102372223|NCT02203786|Adrenergic Agents|adrenergic agents|mesh-ancestor
102372224|NCT02203786|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102372225|NCT02203786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102372226|NCT02203786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102372227|NCT02203786|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102372228|NCT03009058|Leucovorin|leucovorin|mesh-list
102372229|NCT03009058|Folic Acid|folic acid|mesh-list
102372230|NCT03009058|Cyclophosphamide|cyclophosphamide|mesh-list
102372231|NCT03009058|Gemcitabine|gemcitabine|mesh-list
102372232|NCT03009058|Pembrolizumab|pembrolizumab|mesh-list
102372233|NCT03009058|Fluorouracil|fluorouracil|mesh-list
102372234|NCT03009058|Capecitabine|capecitabine|mesh-list
102372235|NCT03009058|Oxaliplatin|oxaliplatin|mesh-list
102372236|NCT03009058|Nivolumab|nivolumab|mesh-list
102372237|NCT03009058|Irinotecan|irinotecan|mesh-list
102372238|NCT03009058|Cetuximab|cetuximab|mesh-list
102372239|NCT03009058|Ipilimumab|ipilimumab|mesh-list
102372240|NCT03009058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102372241|NCT03009058|Levoleucovorin|levoleucovorin|mesh-list
102372242|NCT03009058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102372243|NCT03009058|Immunologic Factors|immunologic factors|mesh-ancestor
102372244|NCT03009058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372245|NCT03009058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102372246|NCT03009058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102372247|NCT03009058|Alkylating Agents|alkylating agents|mesh-ancestor
102372248|NCT03009058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372249|NCT03009058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102372250|NCT03009058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102372251|NCT03009058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102372252|NCT03009058|Antimetabolites|antimetabolites|mesh-ancestor
101971628|NCT03551964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102372253|NCT03009058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102372254|NCT03009058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102372255|NCT03009058|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102183983|NCT05546762|Povidone|povidone|mesh-list
102372256|NCT03009058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102372257|NCT03009058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102372258|NCT03009058|Antidotes|antidotes|mesh-ancestor
102372259|NCT03009058|Protective Agents|protective agents|mesh-ancestor
102372260|NCT03009058|Vitamin B Complex|vitamin b complex|mesh-ancestor
102372261|NCT03009058|Vitamins|vitamins|mesh-ancestor
102372262|NCT03009058|Micronutrients|micronutrients|mesh-ancestor
102372263|NCT03009058|Hematinics|hematinics|mesh-ancestor
102372264|NCT01611857|Leucovorin|leucovorin|mesh-list
102372265|NCT01611857|Fluorouracil|fluorouracil|mesh-list
102372266|NCT01611857|Oxaliplatin|oxaliplatin|mesh-list
102372267|NCT01611857|Levoleucovorin|levoleucovorin|mesh-list
102372268|NCT01611857|Antimetabolites|antimetabolites|mesh-ancestor
102372269|NCT01611857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372270|NCT01611857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102372271|NCT01611857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102372272|NCT01611857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102372273|NCT01611857|Immunologic Factors|immunologic factors|mesh-ancestor
102372274|NCT01611857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372275|NCT01611857|Antidotes|antidotes|mesh-ancestor
102372276|NCT01611857|Protective Agents|protective agents|mesh-ancestor
102372277|NCT01611857|Vitamin B Complex|vitamin b complex|mesh-ancestor
102372278|NCT01611857|Vitamins|vitamins|mesh-ancestor
102372279|NCT01611857|Micronutrients|micronutrients|mesh-ancestor
102372280|NCT03393858|Antibodies|antibodies|mesh-list
102372281|NCT03393858|Immunologic Factors|immunologic factors|mesh-ancestor
102372282|NCT03393858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372283|NCT03393702|Gabapentin|gabapentin|mesh-list
102372284|NCT03393702|Analgesics|analgesics|mesh-ancestor
102372285|NCT03393702|Sensory System Agents|sensory system agents|mesh-ancestor
102372286|NCT03393702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101971666|NCT03448042|Trastuzumab|trastuzumab|mesh-list
102372287|NCT03393702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372288|NCT03393702|Anticonvulsants|anticonvulsants|mesh-ancestor
102372289|NCT03393702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102372290|NCT03393702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102372291|NCT03393702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102372292|NCT03393702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102372293|NCT03393702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102372294|NCT03393702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102372295|NCT03393702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102372296|NCT03393702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372297|NCT03393702|Antimanic Agents|antimanic agents|mesh-ancestor
102372298|NCT01829477|Glimepiride|glimepiride|mesh-list
102372299|NCT01829477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102372300|NCT01829477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101971676|NCT03367741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101306442|NCT02025608|Pramipexole|pramipexole|mesh-list
102372301|NCT01829477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372302|NCT01829477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102372303|NCT01829477|Immunologic Factors|immunologic factors|mesh-ancestor
102372304|NCT03126864|Cyclophosphamide|cyclophosphamide|mesh-list
102372305|NCT03126864|Fludarabine|fludarabine|mesh-list
102372306|NCT03126864|Fludarabine phosphate|fludarabine phosphate|mesh-list
102372307|NCT03126864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102372308|NCT03126864|Immunologic Factors|immunologic factors|mesh-ancestor
102372309|NCT03126864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372310|NCT03126864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102372311|NCT03126864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102372312|NCT03126864|Alkylating Agents|alkylating agents|mesh-ancestor
102372313|NCT03126864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372314|NCT03126864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102372315|NCT03126864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102372316|NCT03126864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102372317|NCT03126864|Antimetabolites|antimetabolites|mesh-ancestor
102372318|NCT03399708|Apremilast|apremilast|mesh-list
102372319|NCT03399708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102372320|NCT03399708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102372321|NCT03399708|Analgesics|analgesics|mesh-ancestor
102372322|NCT03399708|Sensory System Agents|sensory system agents|mesh-ancestor
102372323|NCT03399708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102372324|NCT03399708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372325|NCT03399708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102372326|NCT03399708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102372327|NCT03399708|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102372328|NCT03399708|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102372329|NCT03399708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102372330|NCT03399708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372331|NCT03395730|Oxytocin|oxytocin|mesh-list
102372332|NCT03395730|Oxytocics|oxytocics|mesh-ancestor
102372333|NCT03395730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102372334|NCT03395730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372335|NCT01334086|Aprepitant|aprepitant|mesh-list
102372336|NCT01334086|Antiemetics|antiemetics|mesh-ancestor
102372337|NCT01334086|Autonomic Agents|autonomic agents|mesh-ancestor
102372338|NCT01334086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102372339|NCT01334086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372340|NCT01334086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102372341|NCT01334086|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102372342|NCT01334086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102372343|NCT01334086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372344|NCT03399474|Lidocaine|lidocaine|mesh-list
102372345|NCT03399474|Dexmedetomidine|dexmedetomidine|mesh-list
102372346|NCT03399474|Anesthetics, Local|anesthetics, local|mesh-ancestor
102372347|NCT03399474|Anesthetics|anesthetics|mesh-ancestor
102372348|NCT03399474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102372349|NCT03399474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372350|NCT03399474|Sensory System Agents|sensory system agents|mesh-ancestor
102372351|NCT03399474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102372352|NCT03399474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102372353|NCT03399474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102372354|NCT03399474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102372355|NCT03399474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102372356|NCT03399474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372357|NCT03399474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102372358|NCT03399474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102372359|NCT03399474|Analgesics|analgesics|mesh-ancestor
102372360|NCT03399474|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102372361|NCT03399474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101971731|NCT03083704|Edoxaban|edoxaban|mesh-list
102372362|NCT03399474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102372363|NCT03399474|Adrenergic Agents|adrenergic agents|mesh-ancestor
102372364|NCT03399474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102372365|NCT01611155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102372366|NCT01611155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102372367|NCT01611155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102372368|NCT01611155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102372369|NCT01611155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372370|NCT01611155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102372371|NCT01611155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372372|NCT01611155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102372373|NCT01611155|Antidepressive Agents|antidepressive agents|mesh-ancestor
102372374|NCT01611155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102372375|NCT01430182|Morphine|morphine|mesh-list
102372376|NCT01430182|Methadone|methadone|mesh-list
102372377|NCT01430182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102372378|NCT01430182|Narcotics|narcotics|mesh-ancestor
102372379|NCT01430182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101971759|NCT03033914|Vinblastine|vinblastine|mesh-list
102372380|NCT01430182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372381|NCT01430182|Analgesics|analgesics|mesh-ancestor
102372382|NCT01430182|Sensory System Agents|sensory system agents|mesh-ancestor
102372383|NCT01430182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102372384|NCT01430182|Antitussive Agents|antitussive agents|mesh-ancestor
101971764|NCT03033914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102372385|NCT01430182|Respiratory System Agents|respiratory system agents|mesh-ancestor
102372386|NCT05097768|Dexamethasone|dexamethasone|mesh-list
102372387|NCT05097768|Ibuprofen|ibuprofen|mesh-list
102372388|NCT05097768|Ketorolac|ketorolac|mesh-list
102372389|NCT05097768|Meloxicam|meloxicam|mesh-list
102372390|NCT05097768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102372391|NCT05097768|Antiemetics|antiemetics|mesh-ancestor
102372392|NCT05097768|Autonomic Agents|autonomic agents|mesh-ancestor
102372393|NCT05097768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102372394|NCT05097768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372395|NCT05097768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102372396|NCT05097768|Glucocorticoids|glucocorticoids|mesh-ancestor
102372397|NCT05097768|Hormones|hormones|mesh-ancestor
102372398|NCT05097768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101971774|NCT03010358|Obinutuzumab|obinutuzumab|mesh-list
101306520|NCT02025998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101971776|NCT03010358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971777|NCT02721654|Plasma-lyte 148|plasma-lyte 148|mesh-list
101971778|NCT02721654|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101971779|NCT02721654|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102038908|NCT02251548|Immunologic Factors|immunologic factors|mesh-ancestor
102038909|NCT02251548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372399|NCT05097768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102372400|NCT05097768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102372401|NCT05097768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102372402|NCT05097768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102372403|NCT05097768|Analgesics|analgesics|mesh-ancestor
102372404|NCT05097768|Sensory System Agents|sensory system agents|mesh-ancestor
102372405|NCT05097768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102372406|NCT05097768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102372407|NCT05097768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102372408|NCT05097768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372409|NCT05097768|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102372410|NCT01829243|Milnacipran|milnacipran|mesh-list
102038946|NCT02187198|Naloxone|naloxone|mesh-list
102372411|NCT01829243|Levomilnacipran|levomilnacipran|mesh-list
102372412|NCT01829243|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102372413|NCT01829243|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102372414|NCT01829243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101971788|NCT02596100|Betrixaban|betrixaban|mesh-list
102372415|NCT01829243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372416|NCT01829243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102372417|NCT01829243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372418|NCT01829243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102372419|NCT01829243|Analgesics|analgesics|mesh-ancestor
102372420|NCT01829243|Sensory System Agents|sensory system agents|mesh-ancestor
102372421|NCT01829243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102372422|NCT01829243|Antidepressive Agents|antidepressive agents|mesh-ancestor
102372423|NCT01829243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102372424|NCT01838447|Vitamin D|vitamin d|mesh-list
102372425|NCT01838447|Cholecalciferol|cholecalciferol|mesh-list
102372426|NCT01838447|Vitamins|vitamins|mesh-ancestor
102372427|NCT01838447|Micronutrients|micronutrients|mesh-ancestor
102372428|NCT01838447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372429|NCT01838447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102372430|NCT01838447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102372431|NCT03395574|Terlipressin|terlipressin|mesh-list
102372432|NCT03395574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102372433|NCT03395574|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102372434|NCT04982172|Infliximab|infliximab|mesh-list
102372435|NCT04982172|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102372436|NCT04982172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102372437|NCT04982172|Dermatologic Agents|dermatologic agents|mesh-ancestor
102372438|NCT04982172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102372439|NCT04982172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102372440|NCT01837823|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101971815|NCT01802632|Osimertinib|osimertinib|mesh-list
102372441|NCT01837823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102372442|NCT01837823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102372443|NCT01837823|Antimetabolites|antimetabolites|mesh-ancestor
102372444|NCT01837823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372445|NCT01837823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102372446|NCT01837823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102372447|NCT01837823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102372448|NCT03395262|Caffeine|caffeine|mesh-list
102372449|NCT03395262|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102372450|NCT03395262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372451|NCT03395262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102372452|NCT03395262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102372453|NCT03395262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372454|NCT03395262|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102372455|NCT03395262|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102372456|NCT03395262|Purinergic Agents|purinergic agents|mesh-ancestor
102372457|NCT03395262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102372458|NCT03852888|Methotrexate|methotrexate|mesh-list
102372459|NCT03852888|7-hydroxymethotrexate|7-hydroxymethotrexate|mesh-list
102372460|NCT03852888|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102372461|NCT03852888|Abortifacient Agents|abortifacient agents|mesh-ancestor
102372462|NCT03852888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102372463|NCT03852888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372464|NCT03852888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102372465|NCT03852888|Antimetabolites|antimetabolites|mesh-ancestor
102372466|NCT03852888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306586|NCT02026492|Cholinergic Agents|cholinergic agents|mesh-ancestor
102372467|NCT03852888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102372468|NCT03852888|Dermatologic Agents|dermatologic agents|mesh-ancestor
102372469|NCT03852888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102040324|NCT03659058|Silymarin|silymarin|mesh-list
102372470|NCT03852888|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102372471|NCT03852888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102372472|NCT03852888|Immunologic Factors|immunologic factors|mesh-ancestor
102372473|NCT03852888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102372474|NCT03852888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102372475|NCT04755972|Acetylcysteine|acetylcysteine|mesh-list
102372476|NCT04755972|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102372477|NCT04755972|Antiviral Agents|antiviral agents|mesh-ancestor
102372478|NCT04755972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101971852|NCT00332956|Vaccines|vaccines|mesh-list
102372479|NCT04755972|Expectorants|expectorants|mesh-ancestor
102372480|NCT04755972|Respiratory System Agents|respiratory system agents|mesh-ancestor
102372481|NCT04755972|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102372482|NCT04755972|Antioxidants|antioxidants|mesh-ancestor
101971855|NCT00324220|Mocetinostat|mocetinostat|mesh-list
102372483|NCT04755972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372484|NCT04755972|Protective Agents|protective agents|mesh-ancestor
102372485|NCT04755972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040926|NCT03084315|Nicotine|nicotine|mesh-list
102372486|NCT04755972|Antidotes|antidotes|mesh-ancestor
102372487|NCT01828073|Raltegravir Potassium|raltegravir potassium|mesh-list
102372488|NCT01828073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102372489|NCT01828073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102372490|NCT01828073|Antiviral Agents|antiviral agents|mesh-ancestor
102372491|NCT01828073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102372492|NCT01828073|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102372493|NCT01828073|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102372494|NCT01828073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102372495|NCT01828073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372496|NCT04697693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102372497|NCT04697693|Escitalopram|escitalopram|mesh-list
101971868|NCT00417118|Serotonin Agents|serotonin agents|mesh-ancestor
102372498|NCT04697693|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101971873|NCT02883452|Dermatologic Agents|dermatologic agents|mesh-ancestor
102372499|NCT04697693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102372500|NCT04697693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102372501|NCT04697693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372502|NCT04697693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102372503|NCT04697693|Serotonin Agents|serotonin agents|mesh-ancestor
102372504|NCT04697693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372505|NCT04697693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102372506|NCT04697693|Antidepressive Agents|antidepressive agents|mesh-ancestor
102372507|NCT04697693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102372508|NCT04697693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102372509|NCT04697693|Analgesics|analgesics|mesh-ancestor
102372510|NCT04697693|Sensory System Agents|sensory system agents|mesh-ancestor
102372511|NCT04697693|Dopamine Agents|dopamine agents|mesh-ancestor
102372512|NCT03819114|Levonorgestrel|levonorgestrel|mesh-list
101971889|NCT02207504|Crizotinib|crizotinib|mesh-list
102372513|NCT03819114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102372514|NCT03819114|Contraceptive Agents|contraceptive agents|mesh-ancestor
102372515|NCT03819114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102372516|NCT03819114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372517|NCT03819114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102372518|NCT03819114|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102372519|NCT03819114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102372520|NCT01827839|Vaccines|vaccines|mesh-list
102372521|NCT01827839|Immunologic Factors|immunologic factors|mesh-ancestor
102372522|NCT01827839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372523|NCT04709250|Bupivacaine|bupivacaine|mesh-list
102372524|NCT04709250|Anesthetics, Local|anesthetics, local|mesh-ancestor
102372525|NCT04709250|Anesthetics|anesthetics|mesh-ancestor
101306639|NCT02026856|Selenious Acid|selenious acid|mesh-list
102372526|NCT04709250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102372527|NCT04709250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372528|NCT04709250|Sensory System Agents|sensory system agents|mesh-ancestor
102372529|NCT04709250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102372530|NCT01401166|Trastuzumab|trastuzumab|mesh-list
102372531|NCT01401166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102372532|NCT01401166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102372533|NCT03395028|Lenograstim|lenograstim|mesh-list
102372534|NCT03395028|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102372535|NCT03395028|Immunologic Factors|immunologic factors|mesh-ancestor
102372536|NCT03395028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372537|NCT03394950|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102372538|NCT03394950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101971915|NCT04470310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102372539|NCT03394950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101420128|NCT00163449|Ciclesonide|ciclesonide|mesh-list
102372540|NCT03394950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372541|NCT04567992|Bupivacaine|bupivacaine|mesh-list
102372542|NCT04567992|Anesthetics, Local|anesthetics, local|mesh-ancestor
102372543|NCT04567992|Anesthetics|anesthetics|mesh-ancestor
102372544|NCT04567992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102372545|NCT04567992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372546|NCT04567992|Sensory System Agents|sensory system agents|mesh-ancestor
102372547|NCT04567992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102372548|NCT01335724|Diclofenac|diclofenac|mesh-list
102372549|NCT01335724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102372550|NCT01335724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102372551|NCT01335724|Analgesics|analgesics|mesh-ancestor
102372552|NCT01335724|Sensory System Agents|sensory system agents|mesh-ancestor
102372553|NCT01335724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102372554|NCT01335724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372555|NCT01335724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102372556|NCT01335724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102372557|NCT01335724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102372558|NCT01335724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102372559|NCT01335724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372560|NCT01476202|Nicotine|nicotine|mesh-list
102372561|NCT01476202|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102372562|NCT01476202|Autonomic Agents|autonomic agents|mesh-ancestor
102372563|NCT01476202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102372564|NCT01476202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372565|NCT01476202|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102372566|NCT01476202|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102372567|NCT01476202|Cholinergic Agents|cholinergic agents|mesh-ancestor
101941657|NCT02969356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102372568|NCT01476202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102372569|NCT01476202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372570|NCT01477762|Dexamethasone|dexamethasone|mesh-list
102372571|NCT01477762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102372572|NCT01477762|Antiemetics|antiemetics|mesh-ancestor
102372573|NCT01477762|Autonomic Agents|autonomic agents|mesh-ancestor
102372574|NCT01477762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102372575|NCT01477762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372576|NCT01477762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102372577|NCT01477762|Glucocorticoids|glucocorticoids|mesh-ancestor
102372578|NCT01477762|Hormones|hormones|mesh-ancestor
102372579|NCT01477762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101941666|NCT03854344|Lidocaine|lidocaine|mesh-list
102372580|NCT01477762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102043529|NCT01339741|Vitamin D|vitamin d|mesh-list
102372581|NCT01477762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102372582|NCT01434472|Vidarabine|vidarabine|mesh-list
102372583|NCT01434472|Cyclosporine|cyclosporine|mesh-list
102372584|NCT01434472|Mycophenolic Acid|mycophenolic acid|mesh-list
102372585|NCT01434472|Rituximab|rituximab|mesh-list
102372586|NCT01434472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102372587|NCT01434472|Fludarabine|fludarabine|mesh-list
102372588|NCT01434472|Fludarabine phosphate|fludarabine phosphate|mesh-list
102372589|NCT01434472|Antibodies|antibodies|mesh-list
102372590|NCT01434472|Immunoglobulins|immunoglobulins|mesh-list
102372591|NCT01434472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102372592|NCT01434472|Cyclosporins|cyclosporins|mesh-list
102372593|NCT01434472|Immunologic Factors|immunologic factors|mesh-ancestor
102372594|NCT01434472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372595|NCT01434472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102372596|NCT01434472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102372597|NCT01434472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102372598|NCT01434472|Antimetabolites|antimetabolites|mesh-ancestor
102372599|NCT01434472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372600|NCT01434472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102372601|NCT01434472|Antiviral Agents|antiviral agents|mesh-ancestor
102372602|NCT01434472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102372603|NCT01434472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102372604|NCT01434472|Antifungal Agents|antifungal agents|mesh-ancestor
102372605|NCT01434472|Dermatologic Agents|dermatologic agents|mesh-ancestor
102372606|NCT01434472|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102372607|NCT01434472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101941679|NCT05284318|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102372608|NCT01434472|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102372609|NCT01434472|Antitubercular Agents|antitubercular agents|mesh-ancestor
102372610|NCT01434472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102372611|NCT01435174|Ranolazine|ranolazine|mesh-list
102372612|NCT01435174|Dialysis Solutions|dialysis solutions|mesh-list
102372613|NCT01435174|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102372614|NCT01435174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102372615|NCT01435174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102043962|NCT03571100|Chlorhexidine|chlorhexidine|mesh-list
102372616|NCT01435174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372617|NCT01436266|Folic Acid|folic acid|mesh-list
102372618|NCT01436266|Misoprostol|misoprostol|mesh-list
102372619|NCT01436266|Vitamins|vitamins|mesh-ancestor
102372620|NCT01436266|Micronutrients|micronutrients|mesh-ancestor
102372621|NCT01436266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372622|NCT01436266|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102372623|NCT01436266|Abortifacient Agents|abortifacient agents|mesh-ancestor
101941708|NCT05283850|Calcium|calcium|mesh-list
102372624|NCT01436266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102372625|NCT01436266|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102372626|NCT01436266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102372627|NCT01436266|Oxytocics|oxytocics|mesh-ancestor
102372628|NCT01436266|Hematinics|hematinics|mesh-ancestor
102372629|NCT01436266|Vitamin B Complex|vitamin b complex|mesh-ancestor
102372630|NCT01542502|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102372631|NCT01542502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102372632|NCT01439854|Dapagliflozin|dapagliflozin|mesh-list
102372633|NCT01439854|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102372634|NCT01439854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372635|NCT01439854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102372636|NCT01439854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372637|NCT04409262|Remdesivir|remdesivir|mesh-list
102372638|NCT04409262|Antimetabolites|antimetabolites|mesh-ancestor
102372639|NCT04409262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372640|NCT04409262|Antiviral Agents|antiviral agents|mesh-ancestor
102372641|NCT04409262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102372642|NCT01481740|Phenylephrine|phenylephrine|mesh-list
102372643|NCT01481740|Oxymetazoline|oxymetazoline|mesh-list
102372644|NCT01481740|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102372645|NCT01481740|Mydriatics|mydriatics|mesh-ancestor
102372646|NCT01481740|Autonomic Agents|autonomic agents|mesh-ancestor
102372647|NCT01481740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102372648|NCT01481740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372649|NCT01481740|Sympathomimetics|sympathomimetics|mesh-ancestor
102044709|NCT02250157|Irinotecan|irinotecan|mesh-list
102372650|NCT01481740|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102372651|NCT01481740|Nasal Decongestants|nasal decongestants|mesh-ancestor
102372652|NCT01481740|Respiratory System Agents|respiratory system agents|mesh-ancestor
102372653|NCT01481740|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102372654|NCT01481740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102372655|NCT01481740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102372656|NCT01481740|Adrenergic Agents|adrenergic agents|mesh-ancestor
101941734|NCT05283694|Immunologic Factors|immunologic factors|mesh-ancestor
102372657|NCT01481740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102372658|NCT01481740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372659|NCT01481740|Protective Agents|protective agents|mesh-ancestor
102372660|NCT01544062|Acetaminophen|acetaminophen|mesh-list
102372661|NCT01544062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102372662|NCT01544062|Analgesics|analgesics|mesh-ancestor
102372663|NCT01544062|Sensory System Agents|sensory system agents|mesh-ancestor
102372664|NCT01544062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101941744|NCT01224717|Teriparatide|teriparatide|mesh-list
102372665|NCT01544062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372666|NCT01544062|Antipyretics|antipyretics|mesh-ancestor
102372667|NCT03126084|Acetaminophen|acetaminophen|mesh-list
102372668|NCT03126084|Tramadol|tramadol|mesh-list
102372669|NCT03126084|Bupivacaine|bupivacaine|mesh-list
102372670|NCT03126084|Anesthetics, Local|anesthetics, local|mesh-ancestor
102372671|NCT03126084|Anesthetics|anesthetics|mesh-ancestor
102372672|NCT03126084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102372673|NCT03126084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372674|NCT03126084|Sensory System Agents|sensory system agents|mesh-ancestor
102372675|NCT03126084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102372676|NCT03126084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102372677|NCT03126084|Analgesics|analgesics|mesh-ancestor
102372678|NCT03126084|Antipyretics|antipyretics|mesh-ancestor
102372679|NCT03126084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102372680|NCT03126084|Narcotics|narcotics|mesh-ancestor
102372681|NCT01544998|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
102372682|NCT01544998|Tadalafil|tadalafil|mesh-list
102372683|NCT01544998|Vasodilator Agents|vasodilator agents|mesh-ancestor
102372684|NCT01544998|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102372685|NCT01544998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102372686|NCT01544998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102372687|NCT01544998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372688|NCT01544998|Urological Agents|urological agents|mesh-ancestor
102372689|NCT01544998|Natriuretic Agents|natriuretic agents|mesh-ancestor
102372690|NCT01544998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372691|NCT03391830|Ascorbic Acid|ascorbic acid|mesh-list
102372692|NCT03391830|Atorvastatin|atorvastatin|mesh-list
102372693|NCT03391830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102372694|NCT03391830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102372695|NCT03391830|Antimetabolites|antimetabolites|mesh-ancestor
102372696|NCT03391830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372697|NCT03391830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102372698|NCT03391830|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102372699|NCT03391830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102372700|NCT03391830|Antioxidants|antioxidants|mesh-ancestor
102372701|NCT03391830|Protective Agents|protective agents|mesh-ancestor
102372702|NCT03391830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372703|NCT03391830|Vitamins|vitamins|mesh-ancestor
102372704|NCT03391830|Micronutrients|micronutrients|mesh-ancestor
102372705|NCT01441570|Metoprolol|metoprolol|mesh-list
102372706|NCT01441570|Nebivolol|nebivolol|mesh-list
102372707|NCT01441570|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101306781|NCT02027675|Trace Elements|trace elements|mesh-list
102372708|NCT01441570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102372709|NCT01441570|Sympatholytics|sympatholytics|mesh-ancestor
102372710|NCT01441570|Autonomic Agents|autonomic agents|mesh-ancestor
102372711|NCT01441570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102372712|NCT01441570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046013|NCT02059850|Immunologic Factors|immunologic factors|mesh-ancestor
102372713|NCT01441570|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102372714|NCT01441570|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102372715|NCT01441570|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102372716|NCT01441570|Adrenergic Agents|adrenergic agents|mesh-ancestor
102372717|NCT01441570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102372718|NCT01441570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372719|NCT01441570|Vasodilator Agents|vasodilator agents|mesh-ancestor
102372720|NCT01441570|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102372721|NCT01441570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102372722|NCT01441570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102372723|NCT05238012|Atorvastatin|atorvastatin|mesh-list
102372724|NCT05238012|Calcium|calcium|mesh-list
102372725|NCT05238012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102372726|NCT05238012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372727|NCT05238012|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102372728|NCT05238012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102372729|NCT05238012|Antimetabolites|antimetabolites|mesh-ancestor
102372730|NCT05238012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306789|NCT02027753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102372731|NCT05238012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102372732|NCT05238012|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102372733|NCT05238012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102372734|NCT01441882|Dasatinib|dasatinib|mesh-list
102372735|NCT01441882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102372736|NCT01441882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102372737|NCT01441882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102372738|NCT01441882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372739|NCT01484626|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101424194|NCT03216187|Analgesics|analgesics|mesh-ancestor
102372740|NCT01484626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102372741|NCT01484626|Alkylating Agents|alkylating agents|mesh-ancestor
102372742|NCT01484626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046401|NCT03138967|Rocuronium|rocuronium|mesh-list
102372743|NCT01484626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102372744|NCT01545700|Dexamethasone|dexamethasone|mesh-list
102372745|NCT01545700|Dexamethasone acetate|dexamethasone acetate|mesh-list
102372746|NCT01545700|BB 1101|bb 1101|mesh-list
102372747|NCT01545700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102372748|NCT01545700|Antiemetics|antiemetics|mesh-ancestor
102372749|NCT01545700|Autonomic Agents|autonomic agents|mesh-ancestor
102372750|NCT01545700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102372751|NCT01545700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372752|NCT01545700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102372753|NCT01545700|Glucocorticoids|glucocorticoids|mesh-ancestor
102372754|NCT01545700|Hormones|hormones|mesh-ancestor
102372755|NCT01545700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102372756|NCT01545700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102372757|NCT01545700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102372758|NCT01545700|Protease Inhibitors|protease inhibitors|mesh-ancestor
102372759|NCT01545700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102372760|NCT01545700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306825|NCT02027987|Anticonvulsants|anticonvulsants|mesh-ancestor
102372761|NCT01486810|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102372762|NCT01486810|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102372763|NCT01486810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046651|NCT02797808|Sertraline|sertraline|mesh-list
102372764|NCT01486810|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102046739|NCT03613974|Anesthetics|anesthetics|mesh-ancestor
102372765|NCT01486810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102372766|NCT01486810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102372767|NCT01486810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372768|NCT01486810|Dopamine Agents|dopamine agents|mesh-ancestor
102372769|NCT01486810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102372770|NCT01443442|Loteprednol Etabonate|loteprednol etabonate|mesh-list
102372771|NCT01443442|Bepotastine besilate|bepotastine besilate|mesh-list
102372772|NCT01443442|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102372773|NCT01444924|Bupivacaine|bupivacaine|mesh-list
102047034|NCT03612492|Lidocaine|lidocaine|mesh-list
102372774|NCT01444924|Anesthetics, Local|anesthetics, local|mesh-ancestor
102372775|NCT01444924|Anesthetics|anesthetics|mesh-ancestor
102372776|NCT01444924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102372777|NCT01444924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372778|NCT01444924|Sensory System Agents|sensory system agents|mesh-ancestor
102372779|NCT01444924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102372780|NCT01546402|Dexamethasone|dexamethasone|mesh-list
102372781|NCT01546402|Dexamethasone acetate|dexamethasone acetate|mesh-list
102372782|NCT01546402|BB 1101|bb 1101|mesh-list
102372783|NCT01546402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102372784|NCT01546402|Antiemetics|antiemetics|mesh-ancestor
102372785|NCT01546402|Autonomic Agents|autonomic agents|mesh-ancestor
102372786|NCT01546402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102372787|NCT01546402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372788|NCT01546402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102372789|NCT01546402|Glucocorticoids|glucocorticoids|mesh-ancestor
102372790|NCT01546402|Hormones|hormones|mesh-ancestor
102372791|NCT01546402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102372792|NCT01546402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102372793|NCT01546402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102372794|NCT01546402|Protease Inhibitors|protease inhibitors|mesh-ancestor
102372795|NCT01546402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102372796|NCT01546402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372797|NCT03389490|Insulin|insulin|mesh-list
102372798|NCT03389490|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102372799|NCT03389490|Insulin Glargine|insulin glargine|mesh-list
102372800|NCT03389490|Insulin, Isophane|insulin, isophane|mesh-list
102372801|NCT03389490|Isophane Insulin, Human|isophane insulin, human|mesh-list
102372802|NCT03389490|Isophane insulin, beef|isophane insulin, beef|mesh-list
102372803|NCT03389490|Protamines|protamines|mesh-list
102372804|NCT03389490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102372805|NCT03389490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372806|NCT03389490|Heparin Antagonists|heparin antagonists|mesh-ancestor
101941870|NCT03921645|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102372807|NCT03389490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372808|NCT03389490|Coagulants|coagulants|mesh-ancestor
102372809|NCT01547806|Plerixafor|plerixafor|mesh-list
102372810|NCT01547806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102372811|NCT01547806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102372812|NCT01547806|Antiviral Agents|antiviral agents|mesh-ancestor
102372813|NCT01547806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102372814|NCT01445626|Dexamethasone|dexamethasone|mesh-list
102372815|NCT01445626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102372816|NCT01445626|Antiemetics|antiemetics|mesh-ancestor
102372817|NCT01445626|Autonomic Agents|autonomic agents|mesh-ancestor
102372818|NCT01445626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102372819|NCT01445626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941885|NCT03643666|Analgesics|analgesics|mesh-ancestor
102372820|NCT01445626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102372821|NCT01445626|Glucocorticoids|glucocorticoids|mesh-ancestor
102372822|NCT01445626|Hormones|hormones|mesh-ancestor
102372823|NCT01445626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102372824|NCT01445626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102372825|NCT01445626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102372826|NCT02744742|Cyclophosphamide|cyclophosphamide|mesh-list
102372827|NCT02744742|Busulfan|busulfan|mesh-list
102372828|NCT02744742|Decitabine|decitabine|mesh-list
102372829|NCT02744742|Lenograstim|lenograstim|mesh-list
102372830|NCT02744742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102372831|NCT02744742|Immunologic Factors|immunologic factors|mesh-ancestor
102372832|NCT02744742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372833|NCT02744742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102372834|NCT02744742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102372835|NCT02744742|Alkylating Agents|alkylating agents|mesh-ancestor
102372836|NCT02744742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372837|NCT02744742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102372838|NCT02744742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102372839|NCT02744742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102372840|NCT02744742|Antimetabolites|antimetabolites|mesh-ancestor
102372841|NCT02744742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102372842|NCT02744742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102372843|NCT03125772|Paclitaxel|paclitaxel|mesh-list
102372844|NCT03125772|Everolimus|everolimus|mesh-list
102372845|NCT03125772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102372846|NCT03125772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102372847|NCT03125772|Tubulin Modulators|tubulin modulators|mesh-ancestor
102372848|NCT03125772|Antimitotic Agents|antimitotic agents|mesh-ancestor
102372849|NCT03125772|Mitosis Modulators|mitosis modulators|mesh-ancestor
102372850|NCT03125772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372851|NCT03125772|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102372852|NCT03125772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102372853|NCT03125772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102372854|NCT03125772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102372855|NCT03125772|Immunologic Factors|immunologic factors|mesh-ancestor
102372856|NCT03125772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372857|NCT01447888|Morphine|morphine|mesh-list
102372858|NCT01447888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102372859|NCT01447888|Narcotics|narcotics|mesh-ancestor
102372860|NCT01447888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102372861|NCT01447888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372862|NCT01447888|Analgesics|analgesics|mesh-ancestor
102048681|NCT02084732|Sorafenib|sorafenib|mesh-list
102372863|NCT01447888|Sensory System Agents|sensory system agents|mesh-ancestor
102372864|NCT01447888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102372865|NCT03389256|Apatinib|apatinib|mesh-list
102372866|NCT03389256|Gefitinib|gefitinib|mesh-list
101941925|NCT01131741|Autonomic Agents|autonomic agents|mesh-ancestor
102372867|NCT03389256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102372868|NCT03389256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102372869|NCT03389256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102372870|NCT03389256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372871|NCT01490788|Amitriptyline|amitriptyline|mesh-list
101941929|NCT01131741|Mydriatics|mydriatics|mesh-ancestor
102372872|NCT01490788|Cyclobenzaprine|cyclobenzaprine|mesh-list
102372873|NCT01490788|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102372874|NCT01490788|Antidepressive Agents|antidepressive agents|mesh-ancestor
102372875|NCT01490788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102372876|NCT01490788|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102372877|NCT01490788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372878|NCT01490788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102048974|NCT04431375|Tenofovir|tenofovir|mesh-list
102372879|NCT01490788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102372880|NCT01490788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102372881|NCT01490788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102372882|NCT01490788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102372883|NCT01490788|Analgesics|analgesics|mesh-ancestor
102372884|NCT01490788|Sensory System Agents|sensory system agents|mesh-ancestor
102372885|NCT01490788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102372886|NCT01490788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102372887|NCT01490788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102372888|NCT01490788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372889|NCT01490788|Adrenergic Agents|adrenergic agents|mesh-ancestor
102372890|NCT01490788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102372891|NCT02520180|Everolimus|everolimus|mesh-list
102372892|NCT02520180|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102372893|NCT02520180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102372894|NCT02520180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102372895|NCT02520180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372896|NCT02520180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102372897|NCT02520180|Immunologic Factors|immunologic factors|mesh-ancestor
102372898|NCT02520180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372899|NCT02520180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102372900|NCT03391050|Dabrafenib|dabrafenib|mesh-list
101941950|NCT03921567|Anesthetics, General|anesthetics, general|mesh-ancestor
102372901|NCT03391050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102372902|NCT03391050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102372903|NCT03391050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102372904|NCT03391050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372905|NCT03397992|Dialysis Solutions|dialysis solutions|mesh-list
102372906|NCT03397992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102372907|NCT03390972|Dexmedetomidine|dexmedetomidine|mesh-list
102372908|NCT03390972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102372909|NCT03390972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102372910|NCT03390972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941967|NCT05252884|Antacids|antacids|mesh-ancestor
102372911|NCT03390972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102372912|NCT03390972|Analgesics|analgesics|mesh-ancestor
102372913|NCT03390972|Sensory System Agents|sensory system agents|mesh-ancestor
102372914|NCT03390972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101941969|NCT05252884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102372915|NCT03390972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102372916|NCT03390972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102372917|NCT03390972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102372918|NCT03390972|Adrenergic Agents|adrenergic agents|mesh-ancestor
102372919|NCT03390972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102372920|NCT03390972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372921|NCT01550224|Temozolomide|temozolomide|mesh-list
102372922|NCT01550224|Vorinostat|vorinostat|mesh-list
102372923|NCT01550224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102372924|NCT01550224|Alkylating Agents|alkylating agents|mesh-ancestor
102372925|NCT01550224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372926|NCT01550224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102372927|NCT01550224|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102372928|NCT01550224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102372929|NCT01491022|4-Aminopyridine|4-aminopyridine|mesh-list
102372930|NCT01491022|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102372931|NCT01491022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102372932|NCT01491022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372933|NCT00782184|Atorvastatin|atorvastatin|mesh-list
102372934|NCT00782184|Simvastatin|simvastatin|mesh-list
102372935|NCT00782184|Ezetimibe|ezetimibe|mesh-list
102612278|NCT00002387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101941993|NCT03920631|Nivolumab|nivolumab|mesh-list
102372936|NCT00782184|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
102372937|NCT00782184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102372938|NCT00782184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102372939|NCT00782184|Antimetabolites|antimetabolites|mesh-ancestor
101941996|NCT03920631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102372940|NCT00782184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372941|NCT00782184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102372942|NCT00782184|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102372943|NCT00782184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102372944|NCT03397914|Colistin|colistin|mesh-list
102372945|NCT03397914|Polymyxins|polymyxins|mesh-list
102372946|NCT03397914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102372947|NCT03397914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102050262|NCT02250872|Cisplatin|cisplatin|mesh-list
102372948|NCT01450306|Cycloserine|cycloserine|mesh-list
102372949|NCT01450306|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102372950|NCT01450306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102372951|NCT01450306|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102050350|NCT02108366|Celecoxib|celecoxib|mesh-list
102372952|NCT01450306|Antitubercular Agents|antitubercular agents|mesh-ancestor
102372953|NCT01450306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102372954|NCT01450306|Antimetabolites|antimetabolites|mesh-ancestor
102372955|NCT01450306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372956|NCT03126708|Paclitaxel|paclitaxel|mesh-list
102372957|NCT03126708|Cetuximab|cetuximab|mesh-list
102372958|NCT03126708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102372959|NCT03126708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102050488|NCT02112422|Antiemetics|antiemetics|mesh-ancestor
102372960|NCT03126708|Tubulin Modulators|tubulin modulators|mesh-ancestor
102372961|NCT03126708|Antimitotic Agents|antimitotic agents|mesh-ancestor
102372962|NCT03126708|Mitosis Modulators|mitosis modulators|mesh-ancestor
102372963|NCT03126708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372964|NCT03126708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102372965|NCT03390738|Nivolumab|nivolumab|mesh-list
101942022|NCT01132443|Dermatologic Agents|dermatologic agents|mesh-ancestor
102372966|NCT03390738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102372967|NCT03390738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102372968|NCT03390738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101942029|NCT01132599|Choline|choline|mesh-list
102372969|NCT03390738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102372970|NCT03390582|Methimazole|methimazole|mesh-list
102372971|NCT03390582|Antithyroid Agents|antithyroid agents|mesh-ancestor
102372972|NCT03390582|Hormone Antagonists|hormone antagonists|mesh-ancestor
101942032|NCT01132599|Antimetabolites|antimetabolites|mesh-ancestor
102372973|NCT03390582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102372974|NCT03390582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372975|NCT03385356|Vitamin D|vitamin d|mesh-list
102372976|NCT03385356|Vitamins|vitamins|mesh-ancestor
102372977|NCT03385356|Micronutrients|micronutrients|mesh-ancestor
102372978|NCT03385356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372979|NCT03385356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102372980|NCT03388866|Immunomodulating Agents|immunomodulating agents|mesh-list
102372981|NCT03388866|Immunologic Factors|immunologic factors|mesh-list
102372982|NCT03388866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372983|NCT01873170|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102372984|NCT01873170|Contraceptive Agents|contraceptive agents|mesh-list
102372985|NCT01873170|Levonorgestrel|levonorgestrel|mesh-list
102372986|NCT01873170|Etonogestrel|etonogestrel|mesh-list
102372987|NCT01873170|Desogestrel|desogestrel|mesh-list
102372988|NCT01873170|Contraceptives, Oral|contraceptives, oral|mesh-list
102372989|NCT01873170|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
102372990|NCT01873170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101942050|NCT01132677|Antiemetics|antiemetics|mesh-ancestor
102372991|NCT01873170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102372992|NCT01873170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102372993|NCT01873170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102372994|NCT01873170|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102372995|NCT01873170|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102372996|NCT01873170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102372997|NCT01873170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102372998|NCT01873170|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102372999|NCT01873170|Progestins|progestins|mesh-ancestor
102373000|NCT01873170|Hormones|hormones|mesh-ancestor
102373001|NCT01873170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102373002|NCT03125694|Pioglitazone|pioglitazone|mesh-list
102373003|NCT03125694|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102373004|NCT03125694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102373005|NCT03125694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373006|NCT03125694|Incretins|incretins|mesh-ancestor
102373007|NCT03125694|Hormones|hormones|mesh-ancestor
101942055|NCT01132677|Glucocorticoids|glucocorticoids|mesh-ancestor
102373008|NCT03125694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102373009|NCT03125694|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102373010|NCT03125694|Protease Inhibitors|protease inhibitors|mesh-ancestor
102373011|NCT03125694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102373012|NCT03125694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373014|NCT02731638|Natamycin|natamycin|mesh-list
102373015|NCT02731638|Antifungal Agents|antifungal agents|mesh-ancestor
102373016|NCT02731638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102373017|NCT02731638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102373018|NCT02731638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102373019|NCT02731638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102373020|NCT02731638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373021|NCT02731638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102373022|NCT02731638|Hormone Antagonists|hormone antagonists|mesh-ancestor
101942082|NCT01225341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102373023|NCT02731638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102373024|NCT02731638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373025|NCT02731638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102373026|NCT02731638|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102373027|NCT02731638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102373028|NCT01451632|Irinotecan|irinotecan|mesh-list
102373029|NCT01451632|Cetuximab|cetuximab|mesh-list
101942087|NCT03920553|Hyaluronic Acid|hyaluronic acid|mesh-list
102373030|NCT01451632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102373031|NCT01451632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102373032|NCT01451632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102373033|NCT01451632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373034|NCT01451632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102373035|NCT01451632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102373036|NCT01491958|Methotrexate|methotrexate|mesh-list
102373037|NCT01491958|Atorvastatin|atorvastatin|mesh-list
102373038|NCT01491958|Tacrolimus|tacrolimus|mesh-list
101942095|NCT03643900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102373039|NCT01491958|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102373040|NCT01491958|Abortifacient Agents|abortifacient agents|mesh-ancestor
102373041|NCT01491958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102373042|NCT01491958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373043|NCT01491958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102373044|NCT01491958|Antimetabolites|antimetabolites|mesh-ancestor
102373045|NCT01491958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373046|NCT01491958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102051730|NCT02128100|Leucovorin|leucovorin|mesh-list
102373047|NCT01491958|Dermatologic Agents|dermatologic agents|mesh-ancestor
102373048|NCT01491958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102373049|NCT01491958|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102373050|NCT01491958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102373051|NCT01491958|Immunologic Factors|immunologic factors|mesh-ancestor
102373052|NCT01491958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102373053|NCT01491958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102373054|NCT01491958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102373055|NCT01491958|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102373056|NCT01491958|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102373057|NCT01491958|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102373058|NCT01491958|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102373059|NCT01492582|Vaccines|vaccines|mesh-list
102373060|NCT01492582|Immunologic Factors|immunologic factors|mesh-ancestor
102373061|NCT01492582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373062|NCT02214628|Becaplermin|becaplermin|mesh-list
102373063|NCT02214628|Anticoagulants|anticoagulants|mesh-ancestor
102373064|NCT02214628|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
102373065|NCT02214628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102373066|NCT02214628|Growth Substances|growth substances|mesh-ancestor
101942129|NCT03919461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102373067|NCT02214628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373068|NCT01495858|Naproxen|naproxen|mesh-list
102373069|NCT01495858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101942134|NCT03919461|Analgesics|analgesics|mesh-ancestor
102373070|NCT01495858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102373071|NCT01495858|Analgesics|analgesics|mesh-ancestor
102373072|NCT01495858|Sensory System Agents|sensory system agents|mesh-ancestor
102373073|NCT01495858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102373074|NCT01495858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373075|NCT01495858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102373076|NCT01495858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102373077|NCT01495858|Gout Suppressants|gout suppressants|mesh-ancestor
102373078|NCT01495858|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102373079|NCT01495858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102373080|NCT01495858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373081|NCT01497496|Methylprednisolone|methylprednisolone|mesh-list
102184816|NCT02170909|Dabigatran|dabigatran|mesh-list
102373082|NCT01497496|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101942144|NCT02528877|Fludarabine phosphate|fludarabine phosphate|mesh-list
102373083|NCT01497496|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102373084|NCT01497496|Prednisolone|prednisolone|mesh-list
102373085|NCT01497496|Prednisolone acetate|prednisolone acetate|mesh-list
102373086|NCT01497496|Lenalidomide|lenalidomide|mesh-list
102373087|NCT01497496|Ofatumumab|ofatumumab|mesh-list
102373088|NCT01497496|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102373089|NCT01497496|Prednisolone phosphate|prednisolone phosphate|mesh-list
102373090|NCT01497496|Immunologic Factors|immunologic factors|mesh-ancestor
102373091|NCT01497496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373092|NCT01497496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102373093|NCT01497496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102373094|NCT01497496|Growth Substances|growth substances|mesh-ancestor
102373095|NCT01497496|Growth Inhibitors|growth inhibitors|mesh-ancestor
102373096|NCT01497496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102373097|NCT01497496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102373098|NCT01497496|Antiemetics|antiemetics|mesh-ancestor
102373099|NCT01497496|Autonomic Agents|autonomic agents|mesh-ancestor
102373100|NCT01497496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102373101|NCT01497496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102373102|NCT01497496|Glucocorticoids|glucocorticoids|mesh-ancestor
102373103|NCT01497496|Hormones|hormones|mesh-ancestor
102373104|NCT01497496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102373105|NCT01497496|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102373106|NCT01497496|Protective Agents|protective agents|mesh-ancestor
102373107|NCT01497496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102373108|NCT02208310|Vitamin D|vitamin d|mesh-list
102373109|NCT02208310|Ergocalciferols|ergocalciferols|mesh-list
102373110|NCT02208310|Cholecalciferol|cholecalciferol|mesh-list
102373111|NCT02208310|Vitamins|vitamins|mesh-list
102373112|NCT02208310|Micronutrients|micronutrients|mesh-ancestor
102373113|NCT02208310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373114|NCT02208310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102373115|NCT02208310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102373116|NCT01454362|Nicotine|nicotine|mesh-list
102373117|NCT01454362|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102373118|NCT01454362|Autonomic Agents|autonomic agents|mesh-ancestor
102373119|NCT01454362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102373120|NCT01454362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373121|NCT01454362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102373122|NCT01454362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102373123|NCT01454362|Cholinergic Agents|cholinergic agents|mesh-ancestor
102373124|NCT01454362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102373125|NCT01454362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373126|NCT01497808|Ipilimumab|ipilimumab|mesh-list
102373127|NCT01497808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102373128|NCT01497808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102373129|NCT01497808|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102373130|NCT01497808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373131|NCT01498588|Cyclophosphamide|cyclophosphamide|mesh-list
102373132|NCT01498588|Doxorubicin|doxorubicin|mesh-list
102373133|NCT01498588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102373134|NCT01498588|Immunologic Factors|immunologic factors|mesh-ancestor
102373135|NCT01498588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373136|NCT01498588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102373137|NCT01498588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102373138|NCT01498588|Alkylating Agents|alkylating agents|mesh-ancestor
102373139|NCT01498588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942200|NCT03920397|Vitamin D|vitamin d|mesh-list
102373140|NCT01498588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102373141|NCT01498588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102373142|NCT01498588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101942203|NCT03920397|Vitamins|vitamins|mesh-ancestor
102373143|NCT01498588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102373144|NCT01498588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102053164|NCT03085004|Ethanol|ethanol|mesh-list
102373145|NCT01498588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102373146|NCT01498744|Clindamycin|clindamycin|mesh-list
102373147|NCT01498744|Clindamycin palmitate|clindamycin palmitate|mesh-list
101942207|NCT01131975|Anticonvulsants|anticonvulsants|mesh-ancestor
102373148|NCT01498744|Clindamycin phosphate|clindamycin phosphate|mesh-list
102373149|NCT01498744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102373150|NCT01498744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102373151|NCT01498744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102373152|NCT01498744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102373153|NCT01498744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373154|NCT01498978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102373155|NCT01498978|Ipilimumab|ipilimumab|mesh-list
102373156|NCT01498978|Antibodies|antibodies|mesh-list
102373157|NCT01498978|Immunoglobulins|immunoglobulins|mesh-list
102373158|NCT01498978|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102373159|NCT01498978|Immunologic Factors|immunologic factors|mesh-ancestor
102373160|NCT01498978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373161|NCT01498978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102373162|NCT01498978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102373163|NCT01498978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373165|NCT01458418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102373166|NCT01458418|Respiratory System Agents|respiratory system agents|mesh-ancestor
102373167|NCT01458418|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102053761|NCT02133014|Fluorouracil|fluorouracil|mesh-list
102373168|NCT01458418|Hormone Antagonists|hormone antagonists|mesh-ancestor
102401195|NCT00360399|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102373169|NCT01458418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102373170|NCT01458418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373171|NCT01458418|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102373172|NCT01458418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102373173|NCT01458418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373174|NCT01557322|Etanercept|etanercept|mesh-list
102373175|NCT01557322|Methotrexate|methotrexate|mesh-list
102373176|NCT01557322|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102373177|NCT01557322|Abortifacient Agents|abortifacient agents|mesh-ancestor
102373178|NCT01557322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102373179|NCT01557322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373180|NCT01557322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102373181|NCT01557322|Antimetabolites|antimetabolites|mesh-ancestor
102373182|NCT01557322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373183|NCT01557322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102373184|NCT01557322|Dermatologic Agents|dermatologic agents|mesh-ancestor
102373185|NCT01557322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102373186|NCT01557322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102373187|NCT01557322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102373188|NCT01557322|Immunologic Factors|immunologic factors|mesh-ancestor
102373189|NCT01557322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102373190|NCT01557322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102401196|NCT00360399|Analgesics|analgesics|mesh-ancestor
102373191|NCT01557322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102373192|NCT01557322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102373193|NCT01557322|Analgesics|analgesics|mesh-ancestor
102373194|NCT01557322|Sensory System Agents|sensory system agents|mesh-ancestor
102373195|NCT01557322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102373196|NCT01557322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102373197|NCT01557322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102373198|NCT01459588|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102373199|NCT01459588|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102373200|NCT01459588|Lubricant Eye Drops|lubricant eye drops|mesh-list
102373201|NCT01459588|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102373202|NCT01459588|Laxatives|laxatives|mesh-ancestor
102373203|NCT01459588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102373204|NCT01501162|Ethanol|ethanol|mesh-list
102373205|NCT01501162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102373206|NCT01501162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102373207|NCT01501162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102373208|NCT01501162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373209|NCT01557868|Hyaluronic Acid|hyaluronic acid|mesh-list
102373210|NCT01557868|Hylan|hylan|mesh-list
102373211|NCT01557868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102373212|NCT01557868|Immunologic Factors|immunologic factors|mesh-ancestor
102373213|NCT01557868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373214|NCT01557868|Viscosupplements|viscosupplements|mesh-ancestor
102373215|NCT01557868|Protective Agents|protective agents|mesh-ancestor
102373216|NCT02208466|Fluoxetine|fluoxetine|mesh-list
102373217|NCT02208466|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102373218|NCT02208466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102373219|NCT02208466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102373220|NCT02208466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373221|NCT02208466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102373222|NCT02208466|Serotonin Agents|serotonin agents|mesh-ancestor
102373223|NCT02208466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373224|NCT02208466|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102373225|NCT02208466|Antidepressive Agents|antidepressive agents|mesh-ancestor
102373226|NCT02208466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102373227|NCT02208466|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102373228|NCT02208466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102184973|NCT03171831|Busulfan|busulfan|mesh-list
102373229|NCT02208466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102373230|NCT02209948|Temozolomide|temozolomide|mesh-list
102373231|NCT02209948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102373232|NCT02209948|Alkylating Agents|alkylating agents|mesh-ancestor
102373233|NCT02209948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373234|NCT02209948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102373235|NCT02981212|Mycophenolic Acid|mycophenolic acid|mesh-list
102373236|NCT02981212|Prednisolone|prednisolone|mesh-list
102373237|NCT02981212|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101942298|NCT01233219|Morphine|morphine|mesh-list
102373238|NCT02981212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102373239|NCT02981212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102373240|NCT02981212|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101942303|NCT01233219|Analgesics|analgesics|mesh-ancestor
102373241|NCT02981212|Antitubercular Agents|antitubercular agents|mesh-ancestor
102373242|NCT02981212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102373243|NCT02981212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102373244|NCT02981212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102373245|NCT02981212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373246|NCT02981212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102373247|NCT02981212|Glucocorticoids|glucocorticoids|mesh-ancestor
102373248|NCT02981212|Hormones|hormones|mesh-ancestor
102373249|NCT02981212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102373250|NCT02981212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373251|NCT02981212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102373252|NCT02981212|Protease Inhibitors|protease inhibitors|mesh-ancestor
102373253|NCT01464190|Sevelamer|sevelamer|mesh-list
102373254|NCT01464190|Chelating Agents|chelating agents|mesh-ancestor
102373255|NCT01464190|Sequestering Agents|sequestering agents|mesh-ancestor
102373256|NCT01464190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373257|NCT01466764|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102373258|NCT01466764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102373259|NCT01563406|Ethanol|ethanol|mesh-list
102373260|NCT01563406|Chlorhexidine|chlorhexidine|mesh-list
102373261|NCT01563406|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102373262|NCT01563406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102373263|NCT01563406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102373264|NCT01563406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373265|NCT01563406|Disinfectants|disinfectants|mesh-ancestor
102373266|NCT01468012|Levodopa|levodopa|mesh-list
102373267|NCT01468012|Carbidopa|carbidopa|mesh-list
102373268|NCT01468012|Entacapone|entacapone|mesh-list
102373269|NCT01468012|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102373270|NCT01468012|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102373271|NCT01468012|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102373272|NCT01468012|Dopamine Agents|dopamine agents|mesh-ancestor
102373273|NCT01468012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102373274|NCT01468012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373275|NCT01468012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373276|NCT01468012|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102373277|NCT01468012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102373278|NCT01468012|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102373279|NCT01468012|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102373280|NCT01468012|Immunologic Factors|immunologic factors|mesh-ancestor
102373281|NCT01468012|Dopamine Agonists|dopamine agonists|mesh-ancestor
102373282|NCT01468558|Ketoconazole|ketoconazole|mesh-list
102373283|NCT01468558|Antifungal Agents|antifungal agents|mesh-ancestor
102373284|NCT01468558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102373285|NCT01468558|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102373286|NCT01468558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102373287|NCT01468558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102373288|NCT01468558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373289|NCT01468558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102373290|NCT01468558|Hormone Antagonists|hormone antagonists|mesh-ancestor
102373291|NCT01468558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102373292|NCT01468558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373293|NCT01468558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102373294|NCT03730662|Insulin Glargine|insulin glargine|mesh-list
102373295|NCT03730662|Tirzepatide|tirzepatide|mesh-list
102373296|NCT03730662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102373297|NCT03730662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373298|NCT03730662|Incretins|incretins|mesh-ancestor
102373299|NCT03730662|Hormones|hormones|mesh-ancestor
102373300|NCT03730662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102185045|NCT04723472|Cefuroxime|cefuroxime|mesh-list
102373302|NCT01470118|Dextrans|dextrans|mesh-list
102055629|NCT01810016|Poly I-C|poly i-c|mesh-list
102373303|NCT01470118|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102373304|NCT01470118|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102373305|NCT01470118|Lubricant Eye Drops|lubricant eye drops|mesh-list
102373306|NCT01470118|Alcaftadine|alcaftadine|mesh-list
102373307|NCT01470118|Anticoagulants|anticoagulants|mesh-ancestor
102373308|NCT01470118|Plasma Substitutes|plasma substitutes|mesh-ancestor
102373309|NCT01470118|Blood Substitutes|blood substitutes|mesh-ancestor
102373310|NCT01470118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102373311|NCT01470118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102373312|NCT01470118|Analgesics|analgesics|mesh-ancestor
102373313|NCT01470118|Sensory System Agents|sensory system agents|mesh-ancestor
102373314|NCT01470118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102373315|NCT01470118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373316|NCT01470118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102055876|NCT04753879|Irinotecan|irinotecan|mesh-list
102373317|NCT01470118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102373318|NCT01470118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102401197|NCT00360399|Sensory System Agents|sensory system agents|mesh-ancestor
102373319|NCT01470118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102373320|NCT01470118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102373321|NCT01470118|Histamine Antagonists|histamine antagonists|mesh-ancestor
102373322|NCT01470118|Histamine Agents|histamine agents|mesh-ancestor
102056027|NCT02817347|Tazobactam|tazobactam|mesh-list
102373323|NCT01470118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102373324|NCT01470118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373325|NCT01470196|Dexamethasone|dexamethasone|mesh-list
102373326|NCT01470196|Rituximab|rituximab|mesh-list
102373327|NCT01470196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102373328|NCT01470196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102373329|NCT01470196|Immunologic Factors|immunologic factors|mesh-ancestor
102056116|NCT02140814|Niacin|niacin|mesh-list
102373330|NCT01470196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373331|NCT01470196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102056171|NCT00033293|Prednisone|prednisone|mesh-list
102373332|NCT01470196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102373333|NCT01470196|Antiemetics|antiemetics|mesh-ancestor
102373334|NCT01470196|Autonomic Agents|autonomic agents|mesh-ancestor
102373335|NCT01470196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102373336|NCT01470196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102373337|NCT01470196|Glucocorticoids|glucocorticoids|mesh-ancestor
102373338|NCT01470196|Hormones|hormones|mesh-ancestor
102373339|NCT01470196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102373340|NCT01470196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102373341|NCT03389958|Copper|copper|mesh-list
102373342|NCT03389958|Trace Elements|trace elements|mesh-ancestor
102373343|NCT03389958|Micronutrients|micronutrients|mesh-ancestor
102373344|NCT03389958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373345|NCT04446234|Risperidone|risperidone|mesh-list
102373346|NCT04446234|Aripiprazole|aripiprazole|mesh-list
102373347|NCT04446234|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102373348|NCT04446234|Ziprasidone|ziprasidone|mesh-list
102373349|NCT04446234|Amisulpride|amisulpride|mesh-list
102373350|NCT04446234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102373351|NCT04446234|Serotonin Agents|serotonin agents|mesh-ancestor
102373352|NCT04446234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102373353|NCT04446234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373354|NCT04446234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373355|NCT04446234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102373356|NCT04446234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102401198|NCT00360399|Dopamine Agents|dopamine agents|mesh-ancestor
102373357|NCT04446234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102373358|NCT04446234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102373359|NCT04446234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102373360|NCT04446234|Dopamine Agents|dopamine agents|mesh-ancestor
102373361|NCT04446234|Antidepressive Agents|antidepressive agents|mesh-ancestor
102373362|NCT04446234|Dopamine Agonists|dopamine agonists|mesh-ancestor
102373363|NCT04446234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102373364|NCT04446234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102057850|NCT05707572|Anesthetics|anesthetics|mesh-ancestor
102373365|NCT04446234|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102373366|NCT04446234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102373367|NCT04446234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102373368|NCT03613506|Captopril|captopril|mesh-list
102373369|NCT03613506|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102373370|NCT03613506|Protease Inhibitors|protease inhibitors|mesh-ancestor
102373371|NCT03613506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102373372|NCT03613506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373373|NCT03613506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102373374|NCT01565902|Siponimod|siponimod|mesh-list
102373375|NCT01565902|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102373376|NCT01565902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373377|NCT01565902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102373379|NCT01565902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373380|NCT01566448|Ketamine|ketamine|mesh-list
102373381|NCT01566448|Analgesics|analgesics|mesh-ancestor
102373382|NCT01566448|Sensory System Agents|sensory system agents|mesh-ancestor
102373383|NCT01566448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101942434|NCT01230723|Everolimus|everolimus|mesh-list
102373384|NCT01566448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373385|NCT01566448|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102373386|NCT01566448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102373387|NCT01566448|Anesthetics, General|anesthetics, general|mesh-ancestor
102373388|NCT01566448|Anesthetics|anesthetics|mesh-ancestor
102373389|NCT01566448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102373390|NCT01566448|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102373391|NCT01566448|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102373392|NCT01566448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102373393|NCT01566448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373394|NCT05565976|Aspirin|aspirin|mesh-list
102373395|NCT05565976|Insulin|insulin|mesh-list
102373396|NCT05565976|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102373397|NCT05565976|Insulin Glargine|insulin glargine|mesh-list
102373398|NCT05565976|Dapagliflozin|dapagliflozin|mesh-list
102373399|NCT05565976|Insulin Lispro|insulin lispro|mesh-list
102373400|NCT05565976|Biguanides|biguanides|mesh-list
102373401|NCT05565976|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102373402|NCT05565976|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
102373403|NCT05565976|Meglitinide|meglitinide|mesh-list
102373404|NCT05565976|Clopidogrel|clopidogrel|mesh-list
102373405|NCT05565976|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
102373406|NCT05565976|Atorvastatin|atorvastatin|mesh-list
102373407|NCT05565976|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102373408|NCT05565976|Pravastatin|pravastatin|mesh-list
102401199|NCT02341794|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102373409|NCT05565976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373410|NCT05565976|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102373411|NCT05565976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102373412|NCT05565976|Antimetabolites|antimetabolites|mesh-ancestor
102373413|NCT05565976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373414|NCT05565976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102373415|NCT05565976|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102373416|NCT05565976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102373417|NCT05565976|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101942465|NCT01135953|Antimetabolites|antimetabolites|mesh-ancestor
102373418|NCT05565976|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102373419|NCT05565976|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102373420|NCT05565976|Purinergic Agents|purinergic agents|mesh-ancestor
101942468|NCT01136031|Irinotecan|irinotecan|mesh-list
102373421|NCT05565976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102373422|NCT05565976|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102373423|NCT05565976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102373424|NCT05565976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102373425|NCT05565976|Analgesics|analgesics|mesh-ancestor
102373426|NCT05565976|Sensory System Agents|sensory system agents|mesh-ancestor
102373427|NCT05565976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102373428|NCT05565976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102373429|NCT05565976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102373430|NCT05565976|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102373431|NCT05565976|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102373432|NCT05565976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102373433|NCT05565976|Antipyretics|antipyretics|mesh-ancestor
102373434|NCT01566526|Dexamethasone|dexamethasone|mesh-list
102373435|NCT01566526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102373436|NCT01566526|Antiemetics|antiemetics|mesh-ancestor
102373437|NCT01566526|Autonomic Agents|autonomic agents|mesh-ancestor
102373438|NCT01566526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102373439|NCT01566526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373440|NCT01566526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102373441|NCT01566526|Glucocorticoids|glucocorticoids|mesh-ancestor
102373442|NCT01566526|Hormones|hormones|mesh-ancestor
102373443|NCT01566526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102373444|NCT01566526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102373445|NCT01566526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102373446|NCT01566838|Bupivacaine|bupivacaine|mesh-list
102373447|NCT01566838|Anesthetics, Local|anesthetics, local|mesh-ancestor
102373448|NCT01566838|Anesthetics|anesthetics|mesh-ancestor
102373449|NCT01566838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102373450|NCT01566838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373451|NCT01566838|Sensory System Agents|sensory system agents|mesh-ancestor
102373452|NCT01566838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102373453|NCT05565664|Magnesium Sulfate|magnesium sulfate|mesh-list
102373455|NCT05565664|Analgesics|analgesics|mesh-ancestor
102373456|NCT05565664|Sensory System Agents|sensory system agents|mesh-ancestor
101942483|NCT05400915|Mitosis Modulators|mitosis modulators|mesh-ancestor
102373457|NCT05565664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102373458|NCT05565664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373459|NCT05565664|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102373460|NCT05565664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102373461|NCT05565664|Anesthetics, General|anesthetics, general|mesh-ancestor
102373462|NCT05565664|Anesthetics|anesthetics|mesh-ancestor
102373463|NCT05565664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102373464|NCT05565664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101942514|NCT03739671|Micronutrients|micronutrients|mesh-ancestor
102373465|NCT05565664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102373466|NCT05565664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102373467|NCT05565664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373468|NCT05565664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102373469|NCT05565664|Anticonvulsants|anticonvulsants|mesh-ancestor
102373470|NCT05565664|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102373471|NCT05565664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102373472|NCT05565664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102373473|NCT05565664|Tocolytic Agents|tocolytic agents|mesh-ancestor
102373474|NCT05565664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102373475|NCT03125616|Vaccines|vaccines|mesh-list
102373476|NCT03125616|Immunologic Factors|immunologic factors|mesh-ancestor
102373477|NCT03125616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373478|NCT01568008|Bimatoprost|bimatoprost|mesh-list
102373479|NCT01568008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102373480|NCT01568008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102373481|NCT01568008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102373482|NCT05658120|Epinephrine|epinephrine|mesh-list
102373483|NCT05658120|Racepinephrine|racepinephrine|mesh-list
102373484|NCT05658120|Norepinephrine|norepinephrine|mesh-list
102373485|NCT05658120|Epinephryl borate|epinephryl borate|mesh-list
102373486|NCT05658120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102373487|NCT05658120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102373488|NCT05658120|Adrenergic Agents|adrenergic agents|mesh-ancestor
102373489|NCT05658120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102373490|NCT05658120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373491|NCT05658120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373492|NCT05658120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102373493|NCT05658120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101942518|NCT01233453|Umirolimus|umirolimus|mesh-list
102373494|NCT05658120|Autonomic Agents|autonomic agents|mesh-ancestor
102373495|NCT05658120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102373496|NCT05658120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102373497|NCT05658120|Respiratory System Agents|respiratory system agents|mesh-ancestor
102373498|NCT05658120|Mydriatics|mydriatics|mesh-ancestor
102373499|NCT05658120|Sympathomimetics|sympathomimetics|mesh-ancestor
102373500|NCT05658120|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102373501|NCT01514734|Timolol|timolol|mesh-list
102373502|NCT01514734|Brinzolamide|brinzolamide|mesh-list
102373503|NCT01514734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102401200|NCT02341794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102373504|NCT01514734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373505|NCT01514734|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102373506|NCT01514734|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102373507|NCT01514734|Adrenergic Agents|adrenergic agents|mesh-ancestor
102373508|NCT01514734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102373509|NCT01514734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373510|NCT01514734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102373511|NCT01514734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102373512|NCT01514734|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102373513|NCT01515046|Ascorbic Acid|ascorbic acid|mesh-list
102373514|NCT01515046|Gemcitabine|gemcitabine|mesh-list
102373515|NCT01515046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102373516|NCT01515046|Antimetabolites|antimetabolites|mesh-ancestor
102373517|NCT01515046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373518|NCT01515046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102373519|NCT01515046|Antioxidants|antioxidants|mesh-ancestor
102373520|NCT01515046|Protective Agents|protective agents|mesh-ancestor
102373521|NCT01515046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373522|NCT01515046|Vitamins|vitamins|mesh-ancestor
102373523|NCT01515046|Micronutrients|micronutrients|mesh-ancestor
102373524|NCT01568944|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102373525|NCT01568944|Lansoprazole|lansoprazole|mesh-list
102373526|NCT01568944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102373527|NCT01568944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102373528|NCT01568944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102373529|NCT01568944|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102373530|NCT01568944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102401201|NCT02341794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102373531|NCT01568944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373532|NCT05565274|Pentazocine|pentazocine|mesh-list
102373533|NCT05565274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102373534|NCT05565274|Narcotics|narcotics|mesh-ancestor
102373535|NCT05565274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102373536|NCT05565274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373537|NCT05565274|Analgesics|analgesics|mesh-ancestor
102373538|NCT05565274|Sensory System Agents|sensory system agents|mesh-ancestor
102373539|NCT05565274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102373540|NCT05565274|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102062590|NCT03722849|Capsaicin|capsaicin|mesh-list
102373541|NCT05565274|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102373542|NCT05173584|Albuterol|albuterol|mesh-list
102373543|NCT05173584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102373544|NCT05173584|Autonomic Agents|autonomic agents|mesh-ancestor
102373545|NCT05173584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102373546|NCT05173584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373547|NCT05173584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102062677|NCT03612713|Oxycodone|oxycodone|mesh-list
102373548|NCT05173584|Respiratory System Agents|respiratory system agents|mesh-ancestor
102373549|NCT05173584|Tocolytic Agents|tocolytic agents|mesh-ancestor
102373550|NCT05173584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102373551|NCT05173584|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102373552|NCT05173584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102373553|NCT05173584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102373554|NCT05173584|Adrenergic Agents|adrenergic agents|mesh-ancestor
102373555|NCT05173584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102373556|NCT05173584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373557|NCT04671030|Glycopyrrolate|glycopyrrolate|mesh-list
102373558|NCT04671030|Neostigmine|neostigmine|mesh-list
102373559|NCT04671030|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102373560|NCT04671030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102373561|NCT04671030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373562|NCT04671030|Cholinergic Agents|cholinergic agents|mesh-ancestor
102373563|NCT04671030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102373564|NCT04671030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373565|NCT04671030|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102373566|NCT04671030|Autonomic Agents|autonomic agents|mesh-ancestor
102373567|NCT04671030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102373568|NCT04671030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102373569|NCT04671030|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102373570|NCT04671030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102373571|NCT04660890|Moxifloxacin|moxifloxacin|mesh-list
102373572|NCT04660890|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102373573|NCT04660890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102373574|NCT04660890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102373575|NCT04660890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102373576|NCT04660890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102373577|NCT04660890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102373578|NCT04660890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373579|NCT04660890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102373580|NCT04660890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102063006|NCT03705195|Gliclazide|gliclazide|mesh-list
102373581|NCT04660890|Contraceptive Agents|contraceptive agents|mesh-ancestor
102373582|NCT04660890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102373583|NCT04660890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373584|NCT04660890|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102373585|NCT04660890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102373586|NCT04660890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102373587|NCT04632264|Oxytocin|oxytocin|mesh-list
102373588|NCT04632264|Oxytocics|oxytocics|mesh-ancestor
102373589|NCT04632264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102373590|NCT04632264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942632|NCT01138605|Antiviral Agents|antiviral agents|mesh-ancestor
101942633|NCT01138605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101942634|NCT01138605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101942636|NCT01138683|Diuretics|diuretics|mesh-list
102373591|NCT04607928|Pirfenidone|pirfenidone|mesh-list
102373592|NCT04607928|Analgesics|analgesics|mesh-ancestor
102373593|NCT04607928|Sensory System Agents|sensory system agents|mesh-ancestor
102373594|NCT04607928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101942642|NCT04767243|Sympathomimetics|sympathomimetics|mesh-ancestor
102373595|NCT04607928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373596|NCT04607928|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102373597|NCT04607928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102373598|NCT04607928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102373599|NCT04607928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102373600|NCT04607928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102373601|NCT03380442|Ketamine|ketamine|mesh-list
102373602|NCT03380442|Psilocybin|psilocybin|mesh-list
102373603|NCT03380442|Analgesics|analgesics|mesh-ancestor
102063303|NCT02174900|Artemether|artemether|mesh-list
102373604|NCT03380442|Sensory System Agents|sensory system agents|mesh-ancestor
102373605|NCT03380442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102373606|NCT03380442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373607|NCT03380442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102373608|NCT03380442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102373609|NCT03380442|Anesthetics, General|anesthetics, general|mesh-ancestor
102373610|NCT03380442|Anesthetics|anesthetics|mesh-ancestor
102401202|NCT02341794|Antimetabolites|antimetabolites|mesh-ancestor
102373611|NCT03380442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102373612|NCT03380442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102373613|NCT03380442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102373614|NCT03380442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102373615|NCT03380442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373616|NCT03380442|Hallucinogens|hallucinogens|mesh-ancestor
102373617|NCT03380442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102373618|NCT05172570|Gabapentin|gabapentin|mesh-list
102373619|NCT05172570|Analgesics|analgesics|mesh-ancestor
102373620|NCT05172570|Sensory System Agents|sensory system agents|mesh-ancestor
102373621|NCT05172570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101942667|NCT01234701|Liver Extracts|liver extracts|mesh-list
102373622|NCT05172570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373623|NCT05172570|Anticonvulsants|anticonvulsants|mesh-ancestor
102373624|NCT05172570|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101942672|NCT04721613|Melatonin|melatonin|mesh-list
102373625|NCT05172570|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102373626|NCT05172570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102373627|NCT05172570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102373628|NCT05172570|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102373629|NCT05172570|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102373630|NCT05172570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102373631|NCT05172570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373632|NCT05172570|Antimanic Agents|antimanic agents|mesh-ancestor
102373633|NCT03380130|Nivolumab|nivolumab|mesh-list
102373634|NCT03380130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102373635|NCT03380130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102373636|NCT03380130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102373637|NCT03380130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373638|NCT03386838|Carboplatin|carboplatin|mesh-list
102373639|NCT03386838|Fluorouracil|fluorouracil|mesh-list
102373640|NCT03386838|Nivolumab|nivolumab|mesh-list
102373641|NCT03386838|Cetuximab|cetuximab|mesh-list
102373642|NCT03386838|Linrodostat|linrodostat|mesh-list
102373643|NCT03386838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102373644|NCT03386838|Antimetabolites|antimetabolites|mesh-ancestor
102373645|NCT03386838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373646|NCT03386838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102373647|NCT03386838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102373648|NCT03386838|Immunologic Factors|immunologic factors|mesh-ancestor
102373649|NCT03386838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373650|NCT03386838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102373651|NCT03386838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102373652|NCT03386838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102373653|NCT03379974|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
102373654|NCT03379974|Hemostatics|hemostatics|mesh-ancestor
102373655|NCT03379974|Coagulants|coagulants|mesh-ancestor
102373656|NCT03379974|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102373657|NCT03379974|Natriuretic Agents|natriuretic agents|mesh-ancestor
102373658|NCT03379974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373659|NCT01570036|Trastuzumab|trastuzumab|mesh-list
102373660|NCT01570036|Molgramostim|molgramostim|mesh-list
102373661|NCT01570036|Sargramostim|sargramostim|mesh-list
102373662|NCT01570036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102373663|NCT01570036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102373664|NCT01570036|Immunologic Factors|immunologic factors|mesh-ancestor
102373665|NCT01570036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373666|NCT01516684|Lidocaine|lidocaine|mesh-list
102373667|NCT01516684|Fentanyl|fentanyl|mesh-list
102373668|NCT01516684|Anesthetics, Local|anesthetics, local|mesh-list
102373669|NCT01516684|Prilocaine|prilocaine|mesh-list
102373670|NCT01516684|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
102373671|NCT01516684|Propofol|propofol|mesh-list
102373672|NCT01516684|Anesthetics|anesthetics|mesh-list
102373673|NCT01516684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102373674|NCT01516684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373675|NCT01516684|Sensory System Agents|sensory system agents|mesh-ancestor
102373676|NCT01516684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102373677|NCT01516684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102373678|NCT01516684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102373679|NCT01516684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102373680|NCT01516684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102373681|NCT01516684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373682|NCT01516684|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102373683|NCT01516684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102373684|NCT01516684|Anesthetics, General|anesthetics, general|mesh-ancestor
102373685|NCT01516684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102373686|NCT01516684|Narcotics|narcotics|mesh-ancestor
102373687|NCT01516684|Analgesics|analgesics|mesh-ancestor
102373688|NCT01516684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102373689|NCT01516684|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
102373690|NCT01517074|Sirolimus|sirolimus|mesh-list
102373691|NCT01517074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102373692|NCT01517074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102373693|NCT01517074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102373694|NCT01517074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102373695|NCT01517074|Antifungal Agents|antifungal agents|mesh-ancestor
101942737|NCT03674541|Bromides|bromides|mesh-list
102373696|NCT01517074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102373697|NCT01517074|Immunologic Factors|immunologic factors|mesh-ancestor
102373698|NCT01517074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373699|NCT01570348|Mycophenolic Acid|mycophenolic acid|mesh-list
102373700|NCT01570348|Cyclophosphamide|cyclophosphamide|mesh-list
102373701|NCT01570348|Fludarabine|fludarabine|mesh-list
102373702|NCT01570348|Fludarabine phosphate|fludarabine phosphate|mesh-list
102373703|NCT01570348|Tacrolimus|tacrolimus|mesh-list
102373704|NCT01570348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102373705|NCT01570348|Immunologic Factors|immunologic factors|mesh-ancestor
102373706|NCT01570348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373707|NCT01570348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102373708|NCT01570348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102373709|NCT01570348|Alkylating Agents|alkylating agents|mesh-ancestor
101942743|NCT03674541|Cholinergic Agents|cholinergic agents|mesh-ancestor
102373710|NCT01570348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373711|NCT01570348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102373712|NCT01570348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102373713|NCT01570348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102373714|NCT01570348|Antimetabolites|antimetabolites|mesh-ancestor
102373715|NCT01570348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102373716|NCT01570348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102373717|NCT01570348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102373718|NCT01570348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102373719|NCT01570348|Antitubercular Agents|antitubercular agents|mesh-ancestor
102373720|NCT01570348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102373721|NCT01570348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102373722|NCT03383406|Cytarabine|cytarabine|mesh-list
102373723|NCT03383406|Methotrexate|methotrexate|mesh-list
102373724|NCT03383406|Etoposide|etoposide|mesh-list
102373725|NCT03383406|Ifosfamide|ifosfamide|mesh-list
102373726|NCT03383406|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102373727|NCT03383406|Abortifacient Agents|abortifacient agents|mesh-ancestor
102373728|NCT03383406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102373729|NCT03383406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373730|NCT03383406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101438379|NCT00407459|Pemetrexed|pemetrexed|mesh-list
102373731|NCT03383406|Antimetabolites|antimetabolites|mesh-ancestor
102373732|NCT03383406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373733|NCT03383406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102373734|NCT03383406|Dermatologic Agents|dermatologic agents|mesh-ancestor
102373735|NCT03383406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102373736|NCT03383406|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102373737|NCT03383406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102373738|NCT03383406|Immunologic Factors|immunologic factors|mesh-ancestor
102373739|NCT03383406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102373740|NCT03383406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102373741|NCT03383406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102373742|NCT03383406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102373743|NCT03383406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102373744|NCT03383406|Antiviral Agents|antiviral agents|mesh-ancestor
102373745|NCT03383406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102373746|NCT03383406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102373747|NCT03383406|Alkylating Agents|alkylating agents|mesh-ancestor
102373748|NCT04445922|Anastrozole|anastrozole|mesh-list
102373749|NCT04445922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102373750|NCT04445922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102373751|NCT04445922|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102373752|NCT04445922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102373753|NCT04445922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102373754|NCT04445922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373755|NCT04445922|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102373756|NCT04445922|Hormone Antagonists|hormone antagonists|mesh-ancestor
102065166|NCT02916693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102373757|NCT04445922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102373758|NCT04445922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065249|NCT02195804|Ranitidine|ranitidine|mesh-list
102373759|NCT03383328|Prednisolone|prednisolone|mesh-list
102373760|NCT03383328|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102373761|NCT03383328|Methylprednisolone|methylprednisolone|mesh-list
102373762|NCT03383328|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102373763|NCT03383328|Prednisolone acetate|prednisolone acetate|mesh-list
102373764|NCT03383328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
102373765|NCT03383328|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102373766|NCT03383328|Prednisolone phosphate|prednisolone phosphate|mesh-list
102373767|NCT03383328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102373768|NCT03383328|Glucocorticoids|glucocorticoids|mesh-ancestor
102373769|NCT03383328|Hormones|hormones|mesh-ancestor
102373770|NCT03383328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102373771|NCT03383328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373772|NCT03383328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102373773|NCT03383328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102373774|NCT03383328|Antiemetics|antiemetics|mesh-ancestor
102373775|NCT03383328|Autonomic Agents|autonomic agents|mesh-ancestor
102373776|NCT03383328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102373777|NCT03383328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102373778|NCT03383328|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102373779|NCT03383328|Protective Agents|protective agents|mesh-ancestor
102373780|NCT03383328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102373781|NCT03383328|Analgesics|analgesics|mesh-ancestor
102373782|NCT03383328|Sensory System Agents|sensory system agents|mesh-ancestor
102373783|NCT03383328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102373784|NCT01573702|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102373785|NCT01573702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102373786|NCT01573702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102373787|NCT01573702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102373788|NCT01573702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373789|NCT03093246|Aspirin|aspirin|mesh-list
102373790|NCT03093246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102373791|NCT03093246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102373792|NCT03093246|Analgesics|analgesics|mesh-ancestor
102373793|NCT03093246|Sensory System Agents|sensory system agents|mesh-ancestor
102373794|NCT03093246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102373795|NCT03093246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373796|NCT03093246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102065716|NCT02207348|Hormones|hormones|mesh-ancestor
102373797|NCT03093246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102373798|NCT03093246|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102373799|NCT03093246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101942832|NCT03640390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102373800|NCT03093246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373801|NCT03093246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102373802|NCT03093246|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102373803|NCT03093246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102373804|NCT03093246|Antipyretics|antipyretics|mesh-ancestor
102373805|NCT02969928|Amoxicillin|amoxicillin|mesh-list
102373806|NCT02969928|Metronidazole|metronidazole|mesh-list
102373807|NCT02969928|Clarithromycin|clarithromycin|mesh-list
102373808|NCT02969928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102373809|NCT02969928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102373810|NCT02969928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102373811|NCT02969928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102373812|NCT02969928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102373813|NCT02969928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102373814|NCT02969928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373815|NCT02969928|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102373816|NCT02969928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102373817|NCT02968446|Vitamin D|vitamin d|mesh-list
102373818|NCT02968446|Cholecalciferol|cholecalciferol|mesh-list
102373819|NCT02968446|Mechlorethamine|mechlorethamine|mesh-list
102373820|NCT02968446|Vitamins|vitamins|mesh-ancestor
102373821|NCT02968446|Micronutrients|micronutrients|mesh-ancestor
102373822|NCT02968446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373823|NCT02968446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102373824|NCT02968446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102065900|NCT04374019|Artesunate|artesunate|mesh-list
102185571|NCT05696678|Anesthetics|anesthetics|mesh-ancestor
102373825|NCT02968446|Alkylating Agents|alkylating agents|mesh-ancestor
102373826|NCT02968446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373827|NCT02968446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102373828|NCT02968446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102373830|NCT03378960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102373831|NCT03378960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102373832|NCT03378960|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102373833|NCT03378960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102373834|NCT03378960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373835|NCT02907996|Sofosbuvir|sofosbuvir|mesh-list
102373836|NCT02907996|Antiviral Agents|antiviral agents|mesh-ancestor
102373837|NCT02907996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102373838|NCT03378726|Micronutrients|micronutrients|mesh-list
102373839|NCT03378726|Trace Elements|trace elements|mesh-list
102373840|NCT03378726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373841|NCT03378648|Bromides|bromides|mesh-list
102373842|NCT03378648|Anticonvulsants|anticonvulsants|mesh-ancestor
102373843|NCT01519882|Rotigotine|rotigotine|mesh-list
102373844|NCT01519882|Dopamine Agonists|dopamine agonists|mesh-ancestor
102373845|NCT01519882|Dopamine Agents|dopamine agents|mesh-ancestor
102373846|NCT01519882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102373847|NCT01519882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373848|NCT01519882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373849|NCT01576276|Ketorolac|ketorolac|mesh-list
102373850|NCT01576276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102373851|NCT01576276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102373852|NCT01576276|Analgesics|analgesics|mesh-ancestor
102373853|NCT01576276|Sensory System Agents|sensory system agents|mesh-ancestor
102373854|NCT01576276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102373855|NCT01576276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373856|NCT01576276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102373857|NCT01576276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102373858|NCT01576276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102373859|NCT01576276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101942875|NCT03537508|Vaccines|vaccines|mesh-list
102373860|NCT01576276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373861|NCT01576588|Rituximab|rituximab|mesh-list
102373862|NCT01576588|Glucocorticoids|glucocorticoids|mesh-list
101942894|NCT01236651|Parasympatholytics|parasympatholytics|mesh-ancestor
102373863|NCT01576588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102373864|NCT01576588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102373865|NCT01576588|Immunologic Factors|immunologic factors|mesh-ancestor
102373866|NCT01576588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373867|NCT01576588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102373868|NCT01576588|Hormones|hormones|mesh-ancestor
101942897|NCT04484025|Ebselen|ebselen|mesh-list
102373869|NCT01576588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102373870|NCT01826981|Sofosbuvir|sofosbuvir|mesh-list
102373871|NCT01826981|Antiviral Agents|antiviral agents|mesh-ancestor
102373872|NCT01826981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102373873|NCT02247154|Immunoglobulins|immunoglobulins|mesh-list
102373874|NCT02247154|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102373875|NCT02247154|Antibodies|antibodies|mesh-list
102373876|NCT02247154|Immunologic Factors|immunologic factors|mesh-ancestor
102373877|NCT02247154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373878|NCT02728752|gamma-Globulins|gamma-globulins|mesh-list
102373879|NCT02728752|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102373880|NCT02728752|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102373881|NCT02728752|Immunologic Factors|immunologic factors|mesh-ancestor
102373882|NCT02728752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373883|NCT03007810|Hemay005|hemay005|mesh-list
102373884|NCT03007810|Dermatologic Agents|dermatologic agents|mesh-ancestor
102373885|NCT03007810|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102373886|NCT03007810|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102373887|NCT03007810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102373888|NCT03007810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373889|NCT01578772|Telmisartan|telmisartan|mesh-list
102373890|NCT01578772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102373891|NCT01578772|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101942914|NCT01064518|Botulinum Toxins|botulinum toxins|mesh-list
102373892|NCT01578772|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102373893|NCT01578772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373894|NCT01804049|Metformin|metformin|mesh-list
102373895|NCT01804049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102373896|NCT01804049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942931|NCT02873338|Idarubicin|idarubicin|mesh-list
102373897|NCT02383992|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102373898|NCT02383992|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102373899|NCT02383992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102373900|NCT02346630|Levodopa|levodopa|mesh-list
102373901|NCT02346630|Carbidopa|carbidopa|mesh-list
102373902|NCT02346630|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102373903|NCT02346630|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102373904|NCT02346630|Dopamine Agents|dopamine agents|mesh-ancestor
102373905|NCT02346630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102373906|NCT02346630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942940|NCT02873338|Immunologic Factors|immunologic factors|mesh-ancestor
102373907|NCT02346630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373908|NCT02346630|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102373909|NCT02346630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102373910|NCT03385668|Pirfenidone|pirfenidone|mesh-list
102373911|NCT03385668|Analgesics|analgesics|mesh-ancestor
102373912|NCT03385668|Sensory System Agents|sensory system agents|mesh-ancestor
102373913|NCT03385668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102373914|NCT03385668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373915|NCT03385668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102373916|NCT03385668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102373917|NCT03385668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102373918|NCT03385668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102373919|NCT03385668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102373920|NCT04947072|Anesthetics|anesthetics|mesh-list
102373921|NCT04947072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101942956|NCT03616132|Immunologic Factors|immunologic factors|mesh-ancestor
102373922|NCT04947072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373923|NCT04942158|Eugenol|eugenol|mesh-list
102373924|NCT04942158|Zinc Oxide|zinc oxide|mesh-list
102373925|NCT04942158|Dermatologic Agents|dermatologic agents|mesh-ancestor
102373926|NCT04942158|Sunscreening Agents|sunscreening agents|mesh-ancestor
102373927|NCT04942158|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102373928|NCT04942158|Protective Agents|protective agents|mesh-ancestor
102067328|NCT02258828|Memantine|memantine|mesh-list
102373929|NCT04942158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373930|NCT04942158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102373931|NCT03382470|Anti-Infective Agents|anti-infective agents|mesh-list
102373932|NCT03382470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102373933|NCT03387774|Urinastatin|urinastatin|mesh-list
102373934|NCT03387774|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102373935|NCT03387774|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102373936|NCT03387774|Protease Inhibitors|protease inhibitors|mesh-ancestor
101942970|NCT03617224|Pembrolizumab|pembrolizumab|mesh-list
102373937|NCT03387774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102373938|NCT03387774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373939|NCT03382314|Cholecalciferol|cholecalciferol|mesh-list
102373940|NCT03382314|Vitamin D|vitamin d|mesh-list
102373941|NCT03382314|Bazedoxifene|bazedoxifene|mesh-list
102067550|NCT01050855|Immunologic Factors|immunologic factors|mesh-ancestor
102373942|NCT03382314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102373943|NCT03382314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373944|NCT03382314|Vitamins|vitamins|mesh-ancestor
102373945|NCT03382314|Micronutrients|micronutrients|mesh-ancestor
102373946|NCT03382314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102373947|NCT03382314|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102373948|NCT03382314|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102373949|NCT03382314|Hormone Antagonists|hormone antagonists|mesh-ancestor
102373950|NCT03382314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102373951|NCT03124524|Dienogest|dienogest|mesh-list
102373952|NCT03124524|Drospirenone|drospirenone|mesh-list
102373953|NCT03124524|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102373954|NCT03124524|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102373955|NCT03124524|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102373956|NCT03124524|Estradiol|estradiol|mesh-list
102373957|NCT03124524|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102373958|NCT03124524|Estrogens|estrogens|mesh-ancestor
102373959|NCT03124524|Hormones|hormones|mesh-ancestor
102373960|NCT03124524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102373961|NCT03124524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942987|NCT04837768|Progesterone|progesterone|mesh-list
101942992|NCT02869438|Benralizumab|benralizumab|mesh-list
102373962|NCT03124524|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102373963|NCT03124524|Contraceptive Agents|contraceptive agents|mesh-ancestor
102373964|NCT03124524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102373965|NCT03124524|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101942995|NCT02868892|Pemetrexed|pemetrexed|mesh-list
102373966|NCT03124524|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102373967|NCT03124524|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102373968|NCT03124524|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102373969|NCT03124524|Hormone Antagonists|hormone antagonists|mesh-ancestor
102373970|NCT03124524|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102373971|NCT03124524|Diuretics|diuretics|mesh-ancestor
102373972|NCT03124524|Natriuretic Agents|natriuretic agents|mesh-ancestor
102373973|NCT03124524|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102373974|NCT03124524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102373975|NCT03124524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102373976|NCT03377400|Cisplatin|cisplatin|mesh-list
102373977|NCT03377400|Durvalumab|durvalumab|mesh-list
102373978|NCT03377400|Tremelimumab|tremelimumab|mesh-list
102373979|NCT03377400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102373980|NCT03377400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102373981|NCT01803269|Topotecan|topotecan|mesh-list
102373982|NCT01803269|Camptothecin|camptothecin|mesh-list
102373983|NCT01803269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102373984|NCT01803269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102373985|NCT01803269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102373986|NCT01803269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373987|NCT01803269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102373988|NCT01803269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102373989|NCT01802879|Panobinostat|panobinostat|mesh-list
102373990|NCT01802879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102373991|NCT01802879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102373992|NCT01802879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101943007|NCT03613558|Sensory System Agents|sensory system agents|mesh-ancestor
102373993|NCT01802879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102373994|NCT01825577|Methylphenidate|methylphenidate|mesh-list
102373995|NCT01825577|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101943010|NCT03613558|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102373996|NCT01825577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102373997|NCT01825577|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102373998|NCT01825577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102373999|NCT01825577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101943015|NCT03613168|Trastuzumab|trastuzumab|mesh-list
102374000|NCT01825577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374001|NCT01825577|Dopamine Agents|dopamine agents|mesh-ancestor
102374002|NCT01825577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102374003|NCT03375138|Abatacept|abatacept|mesh-list
102374004|NCT03375138|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102068985|NCT02269514|Nicotine|nicotine|mesh-list
102374005|NCT03375138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374006|NCT03375138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102374007|NCT03375138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102374008|NCT03375138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102374009|NCT03375138|Immunologic Factors|immunologic factors|mesh-ancestor
102374010|NCT03375138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374011|NCT03375138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102374012|NCT03124680|Analgesics, Opioid|analgesics, opioid|mesh-list
102374013|NCT03124680|Narcotics|narcotics|mesh-ancestor
102374014|NCT03124680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102374015|NCT03124680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943033|NCT04707430|Hormones|hormones|mesh-ancestor
102374016|NCT03124680|Analgesics|analgesics|mesh-ancestor
102374017|NCT03124680|Sensory System Agents|sensory system agents|mesh-ancestor
102374018|NCT03124680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102374019|NCT03374670|Aflibercept|aflibercept|mesh-list
102374020|NCT03374670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102069399|NCT02089308|Nicotine|nicotine|mesh-list
102374021|NCT03374670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102374022|NCT03374670|Growth Substances|growth substances|mesh-ancestor
102374023|NCT03374670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374024|NCT03374670|Growth Inhibitors|growth inhibitors|mesh-ancestor
102374025|NCT03374670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102374026|NCT02963610|Pembrolizumab|pembrolizumab|mesh-list
102374027|NCT02963610|Lenalidomide|lenalidomide|mesh-list
102374028|NCT02963610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102374029|NCT02963610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102374030|NCT02963610|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102374031|NCT02963610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374032|NCT02963610|Immunologic Factors|immunologic factors|mesh-ancestor
102374033|NCT02963610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374034|NCT02963610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102374035|NCT02963610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102374036|NCT02963610|Growth Substances|growth substances|mesh-ancestor
102374037|NCT02963610|Growth Inhibitors|growth inhibitors|mesh-ancestor
102374038|NCT03376932|Albuterol|albuterol|mesh-list
102374039|NCT03376932|Tiotropium Bromide|tiotropium bromide|mesh-list
102374040|NCT03376932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102374041|NCT03376932|Autonomic Agents|autonomic agents|mesh-ancestor
102374042|NCT03376932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102374043|NCT03376932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374044|NCT03376932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102374045|NCT03376932|Respiratory System Agents|respiratory system agents|mesh-ancestor
102374046|NCT03376932|Parasympatholytics|parasympatholytics|mesh-ancestor
102374047|NCT03376932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102374048|NCT03376932|Cholinergic Agents|cholinergic agents|mesh-ancestor
102374049|NCT03376932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102374050|NCT03376932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374051|NCT03376932|Tocolytic Agents|tocolytic agents|mesh-ancestor
102374052|NCT03376932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102374053|NCT03376932|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102374054|NCT03376932|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102374055|NCT03376932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102374056|NCT03376932|Adrenergic Agents|adrenergic agents|mesh-ancestor
102374057|NCT03007342|Amoxicillin|amoxicillin|mesh-list
102374058|NCT03007342|Clavulanic Acid|clavulanic acid|mesh-list
102374059|NCT03007342|Clavulanic Acids|clavulanic acids|mesh-list
102374060|NCT03007342|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102374061|NCT03007342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102374062|NCT03007342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102374063|NCT03007342|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102374064|NCT03007342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102374065|NCT03007342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374066|NCT03376854|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
102374067|NCT03376854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101943070|NCT05383534|Anesthetics|anesthetics|mesh-ancestor
102374068|NCT03376854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102374069|NCT03376854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374070|NCT01579162|Cholic Acids|cholic acids|mesh-list
101943071|NCT01235325|Vitamin K|vitamin k|mesh-list
102374071|NCT01579162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102374072|NCT03007654|Chitosan|chitosan|mesh-list
102374073|NCT03007654|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102070207|NCT00991172|Fasinumab|fasinumab|mesh-list
102374074|NCT03007654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102374075|NCT03007654|Antimetabolites|antimetabolites|mesh-ancestor
102374076|NCT03007654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374077|NCT03007654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102374078|NCT03007654|Chelating Agents|chelating agents|mesh-ancestor
102374079|NCT03007654|Sequestering Agents|sequestering agents|mesh-ancestor
102374080|NCT03007654|Hemostatics|hemostatics|mesh-ancestor
102374081|NCT03007654|Coagulants|coagulants|mesh-ancestor
102374082|NCT03374514|Dexamethasone|dexamethasone|mesh-list
102374083|NCT03374514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102374084|NCT03374514|Antiemetics|antiemetics|mesh-ancestor
102374085|NCT03374514|Autonomic Agents|autonomic agents|mesh-ancestor
102374086|NCT03374514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101943090|NCT01235637|Analgesics|analgesics|mesh-ancestor
102374087|NCT03374514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374088|NCT03374514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102374089|NCT03374514|Glucocorticoids|glucocorticoids|mesh-ancestor
102374090|NCT03374514|Hormones|hormones|mesh-ancestor
101943091|NCT01235637|Sensory System Agents|sensory system agents|mesh-ancestor
102374091|NCT03374514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102374092|NCT03374514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102374093|NCT03374514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102374094|NCT01526356|Sirolimus|sirolimus|mesh-list
102374095|NCT01526356|Temsirolimus|temsirolimus|mesh-list
102374096|NCT01526356|MTOR Inhibitors|mtor inhibitors|mesh-list
102374097|NCT01526356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102374098|NCT01526356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101943096|NCT01235637|Anesthetics|anesthetics|mesh-ancestor
102374099|NCT01526356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102374100|NCT01526356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102374101|NCT01526356|Antifungal Agents|antifungal agents|mesh-ancestor
102374102|NCT01526356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102374103|NCT01526356|Immunologic Factors|immunologic factors|mesh-ancestor
102374104|NCT01526356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943108|NCT04966299|Erythritol|erythritol|mesh-list
102374105|NCT01526356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102374106|NCT01526356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102374107|NCT01526356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374108|NCT02903160|Prednisone|prednisone|mesh-list
102374109|NCT02903160|Carboplatin|carboplatin|mesh-list
102374110|NCT02903160|Abiraterone Acetate|abiraterone acetate|mesh-list
102374111|NCT02903160|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
102374112|NCT02903160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102374113|NCT02903160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102374114|NCT02903160|Glucocorticoids|glucocorticoids|mesh-ancestor
102374115|NCT02903160|Hormones|hormones|mesh-ancestor
102374116|NCT02903160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102374117|NCT02903160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374118|NCT02903160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102374119|NCT02903160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102374120|NCT02903160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101943116|NCT01144065|Hydrocortisone|hydrocortisone|mesh-list
102374121|NCT02903160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374122|NCT02903160|Hormone Antagonists|hormone antagonists|mesh-ancestor
102374123|NCT02903160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102374124|NCT03376464|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102374125|NCT03376464|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102374126|NCT03376464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102374127|NCT03376464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374128|NCT03376464|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101444431|NCT00175838|Antipyretics|antipyretics|mesh-ancestor
102374129|NCT03376464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102071200|NCT05762003|Rituximab|rituximab|mesh-list
102374130|NCT03376464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374131|NCT03376464|Cholinergic Agents|cholinergic agents|mesh-ancestor
102374132|NCT03376464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102374133|NCT03374280|Cisplatin|cisplatin|mesh-list
102374134|NCT03374280|Pemetrexed|pemetrexed|mesh-list
102374135|NCT03374280|Gefitinib|gefitinib|mesh-list
102374136|NCT03374280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102374137|NCT03374280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102374138|NCT03374280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374139|NCT03374280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102374140|NCT03374280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102374141|NCT03374280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102374142|NCT03381066|Cisplatin|cisplatin|mesh-list
102374143|NCT03381066|Pemetrexed|pemetrexed|mesh-list
102374144|NCT03381066|Vinorelbine|vinorelbine|mesh-list
102374145|NCT03381066|Gefitinib|gefitinib|mesh-list
102374146|NCT03381066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102374147|NCT03381066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101943147|NCT02908672|Immunologic Factors|immunologic factors|mesh-ancestor
102374148|NCT03381066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374149|NCT03381066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102374150|NCT03381066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102374151|NCT03381066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102374152|NCT03381066|Tubulin Modulators|tubulin modulators|mesh-ancestor
102374153|NCT03381066|Antimitotic Agents|antimitotic agents|mesh-ancestor
102374154|NCT03381066|Mitosis Modulators|mitosis modulators|mesh-ancestor
102374155|NCT03381066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102374156|NCT03375996|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102374157|NCT03375996|Cyclopentolate|cyclopentolate|mesh-list
102374158|NCT03375996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102374159|NCT03375996|Mydriatics|mydriatics|mesh-ancestor
102374160|NCT03375996|Autonomic Agents|autonomic agents|mesh-ancestor
102374161|NCT03375996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101971929|NCT02083250|Busulfan|busulfan|mesh-list
102374162|NCT03375996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374163|NCT03375996|Parasympatholytics|parasympatholytics|mesh-ancestor
102374164|NCT03375996|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102374165|NCT03375996|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102071870|NCT05205317|Metformin|metformin|mesh-list
102374166|NCT03375996|Cholinergic Agents|cholinergic agents|mesh-ancestor
102374167|NCT03375996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102374168|NCT03375996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374169|NCT01580410|Oxaliplatin|oxaliplatin|mesh-list
102374170|NCT01580410|Mitomycins|mitomycins|mesh-list
102374171|NCT01580410|Mitomycin|mitomycin|mesh-list
102374172|NCT01580410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102374173|NCT01580410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102374174|NCT01580410|Alkylating Agents|alkylating agents|mesh-ancestor
102374175|NCT01580410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374176|NCT01580410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102374177|NCT01580410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102374178|NCT02606136|Mitogens|mitogens|mesh-list
102374179|NCT02606136|Mitosis Modulators|mitosis modulators|mesh-ancestor
102374180|NCT02606136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374181|NCT01581658|Empagliflozin|empagliflozin|mesh-list
102374182|NCT01581658|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102374183|NCT01581658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374184|NCT01581658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102374185|NCT01581658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374186|NCT01530178|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102374187|NCT01530178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102374188|NCT01530178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374189|NCT01530178|Incretins|incretins|mesh-ancestor
102374190|NCT01530178|Hormones|hormones|mesh-ancestor
102374191|NCT01530178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102374192|NCT01530178|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102374193|NCT01530178|Protease Inhibitors|protease inhibitors|mesh-ancestor
102374194|NCT01530178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102374195|NCT01530178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374196|NCT03369990|Botulinum Toxins|botulinum toxins|mesh-list
102374197|NCT03369990|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102374198|NCT03369990|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101943197|NCT02410317|Analgesics|analgesics|mesh-ancestor
101943198|NCT02410317|Sensory System Agents|sensory system agents|mesh-ancestor
102374199|NCT03369990|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102374200|NCT03369990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101943200|NCT02410317|Anesthetics, Local|anesthetics, local|mesh-ancestor
102374201|NCT03369990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374202|NCT03369990|Cholinergic Agents|cholinergic agents|mesh-ancestor
102374203|NCT03369990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102374204|NCT03369990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374205|NCT03369990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102374206|NCT03369990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102374207|NCT03006874|Esomeprazole|esomeprazole|mesh-list
102374208|NCT03006874|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102374209|NCT03006874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102374210|NCT03006874|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102374211|NCT03006874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102374212|NCT03006874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374213|NCT01581970|Cyclophosphamide|cyclophosphamide|mesh-list
102374214|NCT01581970|Cetuximab|cetuximab|mesh-list
102374215|NCT01581970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102374216|NCT01581970|Immunologic Factors|immunologic factors|mesh-ancestor
102374217|NCT01581970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374218|NCT01581970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102374219|NCT01581970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102374220|NCT01581970|Alkylating Agents|alkylating agents|mesh-ancestor
102374221|NCT01581970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374222|NCT01581970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102374223|NCT01581970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102374224|NCT01581970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102374225|NCT01583686|Aldesleukin|aldesleukin|mesh-list
102374226|NCT01583686|Cyclophosphamide|cyclophosphamide|mesh-list
102374227|NCT01583686|Fludarabine|fludarabine|mesh-list
101943215|NCT01237275|Sertraline|sertraline|mesh-list
102374228|NCT01583686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102374229|NCT01583686|Immunologic Factors|immunologic factors|mesh-ancestor
102374230|NCT01583686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374231|NCT01583686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101943230|NCT01237275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102374232|NCT01583686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102374233|NCT01583686|Alkylating Agents|alkylating agents|mesh-ancestor
102374234|NCT01583686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374235|NCT01583686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971931|NCT02083250|Clofarabine|clofarabine|mesh-list
102374236|NCT01583686|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102374237|NCT01583686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102073371|NCT00359450|Taxane|taxane|mesh-list
102374238|NCT01583686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102374239|NCT01583686|Antiviral Agents|antiviral agents|mesh-ancestor
102374240|NCT01583686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102374241|NCT01532128|Opicapone|opicapone|mesh-list
102374242|NCT01532128|Rasagiline|rasagiline|mesh-list
101943240|NCT01237977|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102374243|NCT01532128|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102374244|NCT01532128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102374245|NCT01532128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374246|NCT01532128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102374247|NCT01532128|Protective Agents|protective agents|mesh-ancestor
102374248|NCT01532128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374249|NCT01532128|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102374250|NCT01532128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102374251|NCT01532128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102374252|NCT01584388|Rituximab|rituximab|mesh-list
102374253|NCT01584388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102374254|NCT01584388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102374255|NCT01584388|Immunologic Factors|immunologic factors|mesh-ancestor
101971932|NCT02083250|Thymoglobulin|thymoglobulin|mesh-list
102374256|NCT01584388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374257|NCT01584388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102374258|NCT01584544|Capecitabine|capecitabine|mesh-list
102374259|NCT01584544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102374260|NCT01584544|Antimetabolites|antimetabolites|mesh-ancestor
102374261|NCT01584544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374262|NCT01584544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102374263|NCT03006952|Losartan|losartan|mesh-list
102374264|NCT03006952|Pentoxifylline|pentoxifylline|mesh-list
102374265|NCT03006952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102374266|NCT03006952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102374267|NCT03006952|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102374268|NCT03006952|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102374269|NCT03006952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374270|NCT03006952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102374271|NCT03006952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102374272|NCT03006952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102374273|NCT03006952|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102374274|NCT03006952|Protective Agents|protective agents|mesh-ancestor
102374275|NCT03006952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374276|NCT03006952|Vasodilator Agents|vasodilator agents|mesh-ancestor
102374277|NCT03006952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102374278|NCT03006952|Antioxidants|antioxidants|mesh-ancestor
102374279|NCT01802333|Cytarabine|cytarabine|mesh-list
102374280|NCT01802333|Daunorubicin|daunorubicin|mesh-list
102374281|NCT01802333|Vorinostat|vorinostat|mesh-list
102374282|NCT01802333|Idarubicin|idarubicin|mesh-list
102374283|NCT01802333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102374284|NCT01802333|Antimetabolites|antimetabolites|mesh-ancestor
101943276|NCT01982955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102374285|NCT01802333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374286|NCT01802333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102374287|NCT01802333|Antiviral Agents|antiviral agents|mesh-ancestor
102374288|NCT01802333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102374289|NCT01802333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102374290|NCT01802333|Immunologic Factors|immunologic factors|mesh-ancestor
102374291|NCT01802333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374292|NCT01802333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102374293|NCT01802333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102374294|NCT01802333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102374295|NCT01802333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102374296|NCT01802333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102374297|NCT01585324|Ribavirin|ribavirin|mesh-list
101943285|NCT01238055|Docetaxel|docetaxel|mesh-list
102374298|NCT01585324|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102374299|NCT01585324|Antimetabolites|antimetabolites|mesh-ancestor
102374300|NCT01585324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374301|NCT01585324|Antiviral Agents|antiviral agents|mesh-ancestor
102077171|NCT04848584|Vaccines|vaccines|mesh-list
102374302|NCT01585324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102374303|NCT01586962|Acetaminophen|acetaminophen|mesh-list
102374304|NCT01586962|Pseudoephedrine|pseudoephedrine|mesh-list
102374305|NCT01586962|Ephedrine|ephedrine|mesh-list
102374306|NCT01586962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102374307|NCT01586962|Analgesics|analgesics|mesh-ancestor
102374308|NCT01586962|Sensory System Agents|sensory system agents|mesh-ancestor
102077326|NCT05577624|Rifampin|rifampin|mesh-list
102374309|NCT01586962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102374310|NCT01586962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374311|NCT01586962|Antipyretics|antipyretics|mesh-ancestor
102374312|NCT01586962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102374313|NCT01586962|Autonomic Agents|autonomic agents|mesh-ancestor
102374314|NCT01586962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102374315|NCT01586962|Respiratory System Agents|respiratory system agents|mesh-ancestor
102374316|NCT01586962|Nasal Decongestants|nasal decongestants|mesh-ancestor
102374317|NCT01586962|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102374318|NCT01586962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102374319|NCT01586962|Sympathomimetics|sympathomimetics|mesh-ancestor
102374320|NCT01586962|Adrenergic Agents|adrenergic agents|mesh-ancestor
102374321|NCT01586962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102374322|NCT01586962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374323|NCT03006250|Sevoflurane|sevoflurane|mesh-list
102374324|NCT03006250|Desflurane|desflurane|mesh-list
102374325|NCT03006250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102374326|NCT03006250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102374327|NCT03006250|Anesthetics, General|anesthetics, general|mesh-ancestor
102374328|NCT03006250|Anesthetics|anesthetics|mesh-ancestor
102374329|NCT03006250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102374330|NCT03006250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374331|NCT04129437|Ibuprofen|ibuprofen|mesh-list
102374332|NCT04129437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102374333|NCT04129437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102374334|NCT04129437|Analgesics|analgesics|mesh-ancestor
102374335|NCT04129437|Sensory System Agents|sensory system agents|mesh-ancestor
102374336|NCT04129437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102374337|NCT04129437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374338|NCT04129437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102374339|NCT04129437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102374340|NCT04129437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102374341|NCT04129437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102374342|NCT04129437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374343|NCT04588259|Insulin|insulin|mesh-list
102374344|NCT04588259|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102374345|NCT04588259|Insulin Aspart|insulin aspart|mesh-list
101943330|NCT01238133|Paclitaxel|paclitaxel|mesh-list
102374346|NCT04588259|Insulin, Long-Acting|insulin, long-acting|mesh-list
102374347|NCT04588259|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102374348|NCT04588259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102186091|NCT04597268|Dexmedetomidine|dexmedetomidine|mesh-list
102374349|NCT04588259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374350|NCT01801475|Ondansetron|ondansetron|mesh-list
102374351|NCT01801475|Antiemetics|antiemetics|mesh-ancestor
102374352|NCT01801475|Autonomic Agents|autonomic agents|mesh-ancestor
102374353|NCT01801475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102374354|NCT01801475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374355|NCT01801475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102374356|NCT01801475|Antipruritics|antipruritics|mesh-ancestor
102374357|NCT01801475|Dermatologic Agents|dermatologic agents|mesh-ancestor
102374358|NCT01801475|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102374359|NCT01801475|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102374360|NCT01801475|Serotonin Agents|serotonin agents|mesh-ancestor
102374361|NCT01801475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102374362|NCT01801475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374363|NCT03063021|Acetylcysteine|acetylcysteine|mesh-list
102374364|NCT03063021|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102374365|NCT03063021|Antiviral Agents|antiviral agents|mesh-ancestor
102374366|NCT03063021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102374367|NCT03063021|Expectorants|expectorants|mesh-ancestor
102374368|NCT03063021|Respiratory System Agents|respiratory system agents|mesh-ancestor
102374369|NCT03063021|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102374370|NCT03063021|Antioxidants|antioxidants|mesh-ancestor
102374371|NCT03063021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374372|NCT03063021|Protective Agents|protective agents|mesh-ancestor
102374373|NCT03063021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374374|NCT03063021|Antidotes|antidotes|mesh-ancestor
102374375|NCT02337933|Ursolic acid|ursolic acid|mesh-list
102374376|NCT02337933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374377|NCT02337933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102374378|NCT02337933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102374379|NCT02337933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102374380|NCT02337933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102374381|NCT02337933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102374382|NCT02337933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102374383|NCT02337933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102374384|NCT02337933|Analgesics|analgesics|mesh-ancestor
102374385|NCT02337933|Sensory System Agents|sensory system agents|mesh-ancestor
102374386|NCT02337933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102374387|NCT02337933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374388|NCT02337933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102374389|NCT02337933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102374390|NCT03028857|Choline|choline|mesh-list
102374391|NCT03028857|Lipotropic Agents|lipotropic agents|mesh-ancestor
102374392|NCT03028857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102374393|NCT03028857|Antimetabolites|antimetabolites|mesh-ancestor
102374394|NCT03028857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374395|NCT03028857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102374396|NCT03028857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102374397|NCT03028857|Nootropic Agents|nootropic agents|mesh-ancestor
102374398|NCT03062943|Nintedanib|nintedanib|mesh-list
102374399|NCT03062943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102374400|NCT03062943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102374401|NCT03062943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102374402|NCT03062943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374403|NCT01536886|Betamethasone|betamethasone|mesh-list
102374404|NCT01536886|Calcipotriene|calcipotriene|mesh-list
102374405|NCT01536886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102374406|NCT01536886|Glucocorticoids|glucocorticoids|mesh-ancestor
102374407|NCT01536886|Hormones|hormones|mesh-ancestor
102374408|NCT01536886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102374409|NCT01536886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374410|NCT01536886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102374411|NCT01536886|Respiratory System Agents|respiratory system agents|mesh-ancestor
102374412|NCT01536886|Dermatologic Agents|dermatologic agents|mesh-ancestor
102374413|NCT02247310|Interferons|interferons|mesh-list
102374414|NCT02247310|Interferon-beta|interferon-beta|mesh-list
102374415|NCT02247310|Interferon beta-1b|interferon beta-1b|mesh-list
102374416|NCT02247310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102374417|NCT02247310|Antiviral Agents|antiviral agents|mesh-ancestor
102374418|NCT02247310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102374419|NCT02247310|Immunologic Factors|immunologic factors|mesh-ancestor
102374420|NCT02247310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374421|NCT02247310|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102374422|NCT03061539|Nivolumab|nivolumab|mesh-list
102374423|NCT03061539|Ipilimumab|ipilimumab|mesh-list
102374424|NCT03061539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102374425|NCT03061539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102374426|NCT03061539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102374427|NCT03061539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374428|NCT01590550|Dialysis Solutions|dialysis solutions|mesh-list
102374429|NCT01590550|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102374430|NCT05609253|Itraconazole|itraconazole|mesh-list
102374431|NCT05609253|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
102374432|NCT05609253|Antifungal Agents|antifungal agents|mesh-ancestor
102374433|NCT05609253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102374434|NCT05609253|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102374435|NCT05609253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102374436|NCT05609253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102374437|NCT05609253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374438|NCT05609253|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102374439|NCT05609253|Hormone Antagonists|hormone antagonists|mesh-ancestor
102374440|NCT05609253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102374441|NCT05609253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374442|NCT05609253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102374443|NCT01822535|Midodrine|midodrine|mesh-list
102374444|NCT01822535|Sympathomimetics|sympathomimetics|mesh-ancestor
102374445|NCT01822535|Autonomic Agents|autonomic agents|mesh-ancestor
102374446|NCT01822535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102374447|NCT01822535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374448|NCT01822535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102374449|NCT01822535|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102374450|NCT01822535|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102374451|NCT01822535|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102374452|NCT01822535|Adrenergic Agents|adrenergic agents|mesh-ancestor
102374453|NCT01822535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102374454|NCT01822535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374455|NCT01537666|Vancomycin|vancomycin|mesh-list
102374456|NCT01537666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102374457|NCT01537666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102374458|NCT01537900|Grazoprevir|grazoprevir|mesh-list
102374459|NCT01537900|Antiviral Agents|antiviral agents|mesh-ancestor
102374460|NCT01537900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102374461|NCT01799993|Amikacin|amikacin|mesh-list
102374462|NCT01799993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102374463|NCT01799993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102374464|NCT03005860|Fentanyl|fentanyl|mesh-list
102374465|NCT03005860|Propofol|propofol|mesh-list
102374466|NCT03005860|Sevoflurane|sevoflurane|mesh-list
102374467|NCT03005860|Atracurium|atracurium|mesh-list
102374468|NCT03005860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102374469|NCT03005860|Narcotics|narcotics|mesh-ancestor
102374470|NCT03005860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102374471|NCT03005860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374472|NCT03005860|Analgesics|analgesics|mesh-ancestor
102374473|NCT03005860|Sensory System Agents|sensory system agents|mesh-ancestor
102374474|NCT03005860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102374475|NCT03005860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102374476|NCT03005860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102374477|NCT03005860|Anesthetics, General|anesthetics, general|mesh-ancestor
102374478|NCT03005860|Anesthetics|anesthetics|mesh-ancestor
102374479|NCT03005860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078795|NCT04060030|Leucovorin|leucovorin|mesh-list
102374480|NCT03005860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102374481|NCT03005860|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102374482|NCT03005860|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102374483|NCT03005860|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102374484|NCT03005860|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102374485|NCT03005860|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102374486|NCT03005860|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102374487|NCT03005860|Cholinergic Agents|cholinergic agents|mesh-ancestor
102374488|NCT03005860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102374489|NCT03005860|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102374490|NCT01593592|Amoxicillin|amoxicillin|mesh-list
102374491|NCT01593592|Clarithromycin|clarithromycin|mesh-list
102374492|NCT01593592|Omeprazole|omeprazole|mesh-list
102079060|NCT01969578|Paclitaxel|paclitaxel|mesh-list
102374493|NCT01593592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102374494|NCT01593592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102374495|NCT01593592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102374496|NCT01593592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101943467|NCT03403634|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
102374497|NCT01593592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102374498|NCT01593592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102374499|NCT01593592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374500|NCT01593592|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102374501|NCT01593592|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102374502|NCT01593592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102374503|NCT03001960|Clopidogrel|clopidogrel|mesh-list
102374504|NCT03001960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102374505|NCT03001960|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102374506|NCT03001960|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102374507|NCT03001960|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102374508|NCT03001960|Purinergic Agents|purinergic agents|mesh-ancestor
102374509|NCT03001960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101943477|NCT03403634|Analgesics|analgesics|mesh-ancestor
102374510|NCT03001960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374511|NCT03001960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374512|NCT01593670|Decitabine|decitabine|mesh-list
102374513|NCT01593670|Interleukin-2|interleukin-2|mesh-list
102374514|NCT01593670|Vorinostat|vorinostat|mesh-list
102374515|NCT01593670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102374516|NCT01593670|Antimetabolites|antimetabolites|mesh-ancestor
102374517|NCT01593670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943490|NCT02863354|Growth Substances|growth substances|mesh-ancestor
102374518|NCT01593670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102374519|NCT01593670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102374520|NCT01593670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102374521|NCT01593670|Analgesics|analgesics|mesh-ancestor
102374522|NCT01593670|Sensory System Agents|sensory system agents|mesh-ancestor
102374523|NCT01593670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102374524|NCT01593670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374525|NCT01593670|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102374526|NCT01593748|Gemcitabine|gemcitabine|mesh-list
102374527|NCT01593748|Docetaxel|docetaxel|mesh-list
102374528|NCT01593748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102374529|NCT01593748|Antimetabolites|antimetabolites|mesh-ancestor
101450415|NCT00473746|Prednisolone|prednisolone|mesh-list
102374530|NCT01593748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374531|NCT01593748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102374532|NCT01593748|Tubulin Modulators|tubulin modulators|mesh-ancestor
102374533|NCT01593748|Antimitotic Agents|antimitotic agents|mesh-ancestor
102374534|NCT01593748|Mitosis Modulators|mitosis modulators|mesh-ancestor
102374535|NCT01594294|Contact Lens Solutions|contact lens solutions|mesh-list
102374536|NCT01594294|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102374537|NCT01594294|Disinfectants|disinfectants|mesh-ancestor
102080254|NCT04882774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102374538|NCT01594294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102374539|NCT03005704|Aspirin|aspirin|mesh-list
102374540|NCT03005704|Ticagrelor|ticagrelor|mesh-list
102374541|NCT03005704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102374542|NCT03005704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102374543|NCT03005704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102374544|NCT03005704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102374545|NCT03005704|Purinergic Agents|purinergic agents|mesh-ancestor
102374546|NCT03005704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102374547|NCT03005704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080567|NCT03774472|Letrozole|letrozole|mesh-list
102374548|NCT03005704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374549|NCT03005704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102374550|NCT03005704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102374551|NCT03005704|Analgesics|analgesics|mesh-ancestor
102374552|NCT03005704|Sensory System Agents|sensory system agents|mesh-ancestor
102374553|NCT03005704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102374554|NCT03005704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102374555|NCT03005704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102374556|NCT03005704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102374557|NCT03005704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102374558|NCT03005704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102374559|NCT03005704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102374560|NCT03005704|Antipyretics|antipyretics|mesh-ancestor
102374561|NCT01595386|Hydrocortisone|hydrocortisone|mesh-list
102374562|NCT01595386|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102374563|NCT01595386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102374564|NCT01595854|Dabigatran|dabigatran|mesh-list
102374565|NCT01595854|Ticagrelor|ticagrelor|mesh-list
102374566|NCT01595854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102374567|NCT01595854|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102374568|NCT01595854|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102374569|NCT01595854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102374570|NCT01595854|Purinergic Agents|purinergic agents|mesh-ancestor
102374571|NCT01595854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101943522|NCT03610282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102374572|NCT01595854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374573|NCT01595854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374574|NCT01595854|Antithrombins|antithrombins|mesh-ancestor
102374575|NCT01595854|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102374576|NCT01595854|Protease Inhibitors|protease inhibitors|mesh-ancestor
102374577|NCT01595854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102374578|NCT01595854|Anticoagulants|anticoagulants|mesh-ancestor
102374579|NCT01596088|Dexrazoxane|dexrazoxane|mesh-list
102374580|NCT01596088|Razoxane|razoxane|mesh-list
102374581|NCT01596088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102374582|NCT01596088|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102374583|NCT01596088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102374584|NCT01596088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102374585|NCT01596088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102374586|NCT01596088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374587|NCT01596088|Protective Agents|protective agents|mesh-ancestor
102374588|NCT01596088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374589|NCT01596088|Antimitotic Agents|antimitotic agents|mesh-ancestor
102374590|NCT01596088|Mitosis Modulators|mitosis modulators|mesh-ancestor
102374591|NCT02216422|Ritonavir|ritonavir|mesh-list
102374592|NCT02216422|Ribavirin|ribavirin|mesh-list
102374593|NCT02216422|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101943545|NCT03712046|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102374594|NCT02216422|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102374595|NCT02216422|Protease Inhibitors|protease inhibitors|mesh-ancestor
102374596|NCT02216422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102374597|NCT02216422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374598|NCT02216422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102374599|NCT02216422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101943555|NCT03609892|Bismuth|bismuth|mesh-list
102374600|NCT02216422|Antiviral Agents|antiviral agents|mesh-ancestor
102374601|NCT02216422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102374602|NCT02216422|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102374603|NCT02216422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102374604|NCT02216422|Antimetabolites|antimetabolites|mesh-ancestor
102374605|NCT03001570|Cetuximab|cetuximab|mesh-list
102374606|NCT03001570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102374607|NCT03001570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102374608|NCT03005548|Morphine|morphine|mesh-list
102374609|NCT03005548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102374610|NCT03005548|Narcotics|narcotics|mesh-ancestor
102374611|NCT03005548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102374612|NCT03005548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374613|NCT03005548|Analgesics|analgesics|mesh-ancestor
102374614|NCT03005548|Sensory System Agents|sensory system agents|mesh-ancestor
102374615|NCT03005548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102374616|NCT03373266|Anesthetics|anesthetics|mesh-list
102374617|NCT03373266|Sevoflurane|sevoflurane|mesh-list
102374618|NCT03373266|Isoflurane|isoflurane|mesh-list
102374619|NCT03373266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102374620|NCT03373266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374621|NCT03373266|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102374622|NCT03373266|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102374623|NCT03373266|Anesthetics, General|anesthetics, general|mesh-ancestor
102374624|NCT02217904|Islatravir|islatravir|mesh-list
102374625|NCT02217904|Antiviral Agents|antiviral agents|mesh-ancestor
102374626|NCT02217904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102374627|NCT02217904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102374628|NCT02217904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374629|NCT02217904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102374630|NCT02217904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102374631|NCT02217904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102374632|NCT05566834|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
102374633|NCT05566834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102374634|NCT05566834|Alkylating Agents|alkylating agents|mesh-ancestor
102374635|NCT05566834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374636|NCT05566834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102374637|NCT01900002|Sorafenib|sorafenib|mesh-list
102374638|NCT01900002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102374639|NCT01900002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102374640|NCT01900002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102374641|NCT01900002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374642|NCT03005002|Durvalumab|durvalumab|mesh-list
102374643|NCT03005002|Ipilimumab|ipilimumab|mesh-list
102374644|NCT03005002|Tremelimumab|tremelimumab|mesh-list
102374645|NCT03005002|Immunoglobulins|immunoglobulins|mesh-list
102374646|NCT03005002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102374647|NCT03005002|Immunoglobulin G|immunoglobulin g|mesh-list
101943605|NCT03351608|Mydriatics|mydriatics|mesh-ancestor
102374648|NCT03005002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102374649|NCT03005002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102374650|NCT03005002|Immunologic Factors|immunologic factors|mesh-ancestor
102374651|NCT03005002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374652|NCT03005002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102374653|NCT03005002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374654|NCT03001102|Chlorhexidine|chlorhexidine|mesh-list
102374655|NCT03001102|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102374656|NCT03001102|Povidone-Iodine|povidone-iodine|mesh-list
102374657|NCT03001102|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
102374658|NCT03001102|Povidone|povidone|mesh-list
101308499|NCT00005832|Tipifarnib|tipifarnib|mesh-list
102374659|NCT03001102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102374660|NCT03001102|Disinfectants|disinfectants|mesh-ancestor
102374661|NCT03001102|Dermatologic Agents|dermatologic agents|mesh-ancestor
102374662|NCT03001102|Plasma Substitutes|plasma substitutes|mesh-ancestor
102374663|NCT03001102|Blood Substitutes|blood substitutes|mesh-ancestor
102374664|NCT03000946|Octreotide|octreotide|mesh-list
102374665|NCT03000946|Somatostatin|somatostatin|mesh-list
102374666|NCT03000946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102374667|NCT03000946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102374668|NCT03000946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102374669|NCT03000946|Hormones|hormones|mesh-ancestor
102374670|NCT03000946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102374671|NCT03000946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374672|NCT03004768|Deucravacitinib|deucravacitinib|mesh-list
102374673|NCT03004768|Dermatologic Agents|dermatologic agents|mesh-ancestor
102374674|NCT03004768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102374675|NCT03004768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102374676|NCT03004768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374677|NCT03005236|Tacrolimus|tacrolimus|mesh-list
102374678|NCT03005236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102374679|NCT03005236|Immunologic Factors|immunologic factors|mesh-ancestor
102374680|NCT03005236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374681|NCT03005236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102374682|NCT03005236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102374683|NCT03005236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374684|NCT03363204|Salicylic Acid|salicylic acid|mesh-list
102374685|NCT03363204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102374686|NCT03363204|Antifungal Agents|antifungal agents|mesh-ancestor
102374687|NCT03363204|Keratolytic Agents|keratolytic agents|mesh-ancestor
102374688|NCT03363204|Dermatologic Agents|dermatologic agents|mesh-ancestor
102374689|NCT02519010|Amlodipine|amlodipine|mesh-list
102374690|NCT02519010|Valsartan|valsartan|mesh-list
102374691|NCT02519010|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
102374692|NCT02519010|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101943646|NCT02259790|Amlodipine|amlodipine|mesh-list
102374693|NCT02519010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102374694|NCT02519010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102374695|NCT02519010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943647|NCT02259790|Telmisartan|telmisartan|mesh-list
102374696|NCT02519010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102374697|NCT02519010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374698|NCT02519010|Vasodilator Agents|vasodilator agents|mesh-ancestor
102374699|NCT02519010|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102374700|NCT02519010|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102374701|NCT03004612|Metformin|metformin|mesh-list
102374702|NCT03004612|Linagliptin|linagliptin|mesh-list
102374703|NCT03004612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102374704|NCT03004612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374705|NCT03004612|Incretins|incretins|mesh-ancestor
102374706|NCT03004612|Hormones|hormones|mesh-ancestor
102374707|NCT03004612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101943657|NCT02259790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102374708|NCT03004612|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102374709|NCT03004612|Protease Inhibitors|protease inhibitors|mesh-ancestor
102374710|NCT03004612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102374711|NCT03004612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374712|NCT04527042|Rivaroxaban|rivaroxaban|mesh-list
102374713|NCT04527042|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102082489|NCT02319200|Metformin|metformin|mesh-list
102374714|NCT04527042|Antithrombins|antithrombins|mesh-ancestor
102374715|NCT04527042|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102374716|NCT04527042|Protease Inhibitors|protease inhibitors|mesh-ancestor
102374717|NCT04527042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102374718|NCT04527042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374719|NCT04527042|Anticoagulants|anticoagulants|mesh-ancestor
102374720|NCT03372486|Bupivacaine|bupivacaine|mesh-list
102374721|NCT03372486|Naloxone|naloxone|mesh-list
102374722|NCT03372486|Anesthetics, Local|anesthetics, local|mesh-ancestor
102374723|NCT03372486|Anesthetics|anesthetics|mesh-ancestor
102374724|NCT03372486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102374725|NCT03372486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374726|NCT03372486|Sensory System Agents|sensory system agents|mesh-ancestor
102374727|NCT03372486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102374728|NCT03372486|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102374729|NCT05035888|Phenylephrine|phenylephrine|mesh-list
102374730|NCT05035888|Oxymetazoline|oxymetazoline|mesh-list
102374731|NCT05035888|Norepinephrine|norepinephrine|mesh-list
102374732|NCT05035888|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
102374733|NCT05035888|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102374734|NCT05035888|Mydriatics|mydriatics|mesh-ancestor
102374735|NCT05035888|Autonomic Agents|autonomic agents|mesh-ancestor
102374736|NCT05035888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102374737|NCT05035888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374738|NCT05035888|Sympathomimetics|sympathomimetics|mesh-ancestor
102374739|NCT05035888|Nasal Decongestants|nasal decongestants|mesh-ancestor
102374740|NCT05035888|Respiratory System Agents|respiratory system agents|mesh-ancestor
102374741|NCT05035888|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102374742|NCT05035888|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102374743|NCT05035888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102374744|NCT05035888|Adrenergic Agents|adrenergic agents|mesh-ancestor
102374745|NCT05035888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102374746|NCT05035888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374747|NCT05035888|Protective Agents|protective agents|mesh-ancestor
102374748|NCT03362814|Ritonavir|ritonavir|mesh-list
102374749|NCT03362814|Ribavirin|ribavirin|mesh-list
102374750|NCT03362814|Lactams|lactams|mesh-list
102374751|NCT03362814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102374752|NCT03362814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101943698|NCT02856880|Zinc|zinc|mesh-list
102374753|NCT03362814|Protease Inhibitors|protease inhibitors|mesh-ancestor
102374754|NCT03362814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102374755|NCT03362814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374756|NCT03362814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102374757|NCT03362814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102374758|NCT03362814|Antiviral Agents|antiviral agents|mesh-ancestor
102374759|NCT03362814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102083271|NCT02152332|Moxifloxacin|moxifloxacin|mesh-list
102374760|NCT03362814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102374761|NCT03362814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102374762|NCT03362814|Antimetabolites|antimetabolites|mesh-ancestor
102374763|NCT03362814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102374764|NCT03004066|Daptomycin|daptomycin|mesh-list
102374765|NCT03004066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102374766|NCT03004066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102374767|NCT03362736|Ustekinumab|ustekinumab|mesh-list
102374768|NCT03362736|Dermatologic Agents|dermatologic agents|mesh-ancestor
102374769|NCT03004222|Bupivacaine|bupivacaine|mesh-list
102374770|NCT03004222|Anesthetics, Local|anesthetics, local|mesh-ancestor
102374771|NCT03004222|Anesthetics|anesthetics|mesh-ancestor
101943718|NCT02024230|Anticoagulants|anticoagulants|mesh-ancestor
102374772|NCT03004222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102374773|NCT03004222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374774|NCT03004222|Sensory System Agents|sensory system agents|mesh-ancestor
102374775|NCT03004222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102374776|NCT03000634|Dexamethasone|dexamethasone|mesh-list
102374777|NCT03000634|Lenalidomide|lenalidomide|mesh-list
102374778|NCT03000634|Bortezomib|bortezomib|mesh-list
102374779|NCT03000634|Elotuzumab|elotuzumab|mesh-list
102374780|NCT03000634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102374781|NCT03000634|Antiemetics|antiemetics|mesh-ancestor
102374782|NCT03000634|Autonomic Agents|autonomic agents|mesh-ancestor
102374783|NCT03000634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102374784|NCT03000634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374785|NCT03000634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102374786|NCT03000634|Glucocorticoids|glucocorticoids|mesh-ancestor
102374787|NCT03000634|Hormones|hormones|mesh-ancestor
102374788|NCT03000634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102374789|NCT03000634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102374790|NCT03000634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102374791|NCT03000634|Immunologic Factors|immunologic factors|mesh-ancestor
102374792|NCT03000634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102374793|NCT03000634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102374794|NCT03000634|Growth Substances|growth substances|mesh-ancestor
102374795|NCT03000634|Growth Inhibitors|growth inhibitors|mesh-ancestor
102374796|NCT02520102|Sargramostim|sargramostim|mesh-list
102374797|NCT02520102|Immunologic Factors|immunologic factors|mesh-ancestor
102374798|NCT02520102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374799|NCT03000556|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102374800|NCT03000556|Hyaluronic Acid|hyaluronic acid|mesh-list
102374801|NCT03000556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102374802|NCT03000556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102374803|NCT03000556|Immunologic Factors|immunologic factors|mesh-ancestor
102374804|NCT03000556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374805|NCT03000556|Viscosupplements|viscosupplements|mesh-ancestor
102374806|NCT03000556|Protective Agents|protective agents|mesh-ancestor
102374807|NCT03371862|Liraglutide|liraglutide|mesh-list
102374808|NCT03371862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102374809|NCT03371862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374810|NCT03371862|Incretins|incretins|mesh-ancestor
102374811|NCT03371862|Hormones|hormones|mesh-ancestor
101943749|NCT01935778|Mitosis Modulators|mitosis modulators|mesh-ancestor
102374812|NCT03371862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102374813|NCT03368430|Melatonin|melatonin|mesh-list
102374814|NCT03368430|Antioxidants|antioxidants|mesh-ancestor
102374815|NCT03368430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374816|NCT03368430|Protective Agents|protective agents|mesh-ancestor
102084003|NCT05281003|Paclitaxel|paclitaxel|mesh-list
102374817|NCT03368430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374818|NCT03368430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102374819|NCT03371784|Hydrocortisone|hydrocortisone|mesh-list
101943763|NCT02034292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102374820|NCT03371784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102374821|NCT03003832|Analgesics, Opioid|analgesics, opioid|mesh-list
102374822|NCT03003832|Analgesics|analgesics|mesh-list
102374823|NCT03003832|Narcotics|narcotics|mesh-ancestor
102374824|NCT03003832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102374825|NCT03003832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943769|NCT02034292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102374826|NCT03003832|Sensory System Agents|sensory system agents|mesh-ancestor
102374827|NCT03003832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102374828|NCT03368352|Melatonin|melatonin|mesh-list
102374829|NCT03368352|Antioxidants|antioxidants|mesh-ancestor
102374830|NCT03368352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374831|NCT03368352|Protective Agents|protective agents|mesh-ancestor
102374832|NCT03368352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374833|NCT03368352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102374834|NCT02248012|Everolimus|everolimus|mesh-list
102374835|NCT02248012|Temozolomide|temozolomide|mesh-list
102374836|NCT02248012|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102374837|NCT02248012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102374838|NCT02248012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102374839|NCT02248012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374840|NCT02248012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102374841|NCT02248012|Immunologic Factors|immunologic factors|mesh-ancestor
102374842|NCT02248012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374843|NCT02248012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102374844|NCT02248012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102374845|NCT02248012|Alkylating Agents|alkylating agents|mesh-ancestor
102374846|NCT03362268|Omeprazole|omeprazole|mesh-list
102374847|NCT03362268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102374848|NCT03362268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102374849|NCT03362268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102374850|NCT03362268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102374851|NCT03362268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374852|NCT04523844|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102374853|NCT04523844|Brinzolamide|brinzolamide|mesh-list
102374854|NCT04523844|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102374855|NCT04523844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102374856|NCT04523844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102374857|NCT04523844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102374858|NCT04523844|Adrenergic Agents|adrenergic agents|mesh-ancestor
102374859|NCT04523844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102374860|NCT04523844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374861|NCT04523844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374862|NCT04523844|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102374863|NCT04523844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102374864|NCT03361878|Metformin|metformin|mesh-list
102374865|NCT03361878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102374866|NCT03361878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374867|NCT03361800|Entinostat|entinostat|mesh-list
102374868|NCT03361800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102374869|NCT03361800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102374870|NCT03361800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102374871|NCT03361800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374872|NCT02998918|Curcumin|curcumin|mesh-list
102374873|NCT02998918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102374874|NCT02998918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102374875|NCT02998918|Analgesics|analgesics|mesh-ancestor
102374876|NCT02998918|Sensory System Agents|sensory system agents|mesh-ancestor
102374877|NCT02998918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102374878|NCT02998918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186620|NCT06007378|Fentanyl|fentanyl|mesh-list
102374879|NCT02998918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102374880|NCT02998918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102374881|NCT02998918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102374882|NCT02998918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102374883|NCT02998918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374884|NCT02995642|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
102374885|NCT02995642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102374886|NCT02998606|Naloxegol|naloxegol|mesh-list
102374887|NCT02998606|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102374888|NCT02998606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374889|NCT02998606|Sensory System Agents|sensory system agents|mesh-ancestor
102374890|NCT02998606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102374891|NCT05365438|Atorvastatin|atorvastatin|mesh-list
102374892|NCT05365438|Ezetimibe|ezetimibe|mesh-list
102374893|NCT05365438|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102374894|NCT05365438|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102374895|NCT05365438|Antimetabolites|antimetabolites|mesh-ancestor
102374896|NCT05365438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374897|NCT05365438|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102374898|NCT05365438|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102374899|NCT05365438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102374900|NCT05264506|Estradiol|estradiol|mesh-list
102374901|NCT05264506|Estrogens|estrogens|mesh-ancestor
102374902|NCT05264506|Hormones|hormones|mesh-ancestor
102401203|NCT02341794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374903|NCT05264506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102374904|NCT05264506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374905|NCT02248168|Pramipexole|pramipexole|mesh-list
102374906|NCT02248168|Antioxidants|antioxidants|mesh-ancestor
102374907|NCT02248168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374908|NCT02248168|Protective Agents|protective agents|mesh-ancestor
102374909|NCT02248168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374910|NCT02248168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102374911|NCT02248168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102374912|NCT02248168|Dopamine Agonists|dopamine agonists|mesh-ancestor
102374913|NCT02248168|Dopamine Agents|dopamine agents|mesh-ancestor
102374914|NCT02248168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102374915|NCT05672680|Bupivacaine|bupivacaine|mesh-list
102374916|NCT05672680|Anesthetics, Local|anesthetics, local|mesh-ancestor
102374917|NCT05672680|Anesthetics|anesthetics|mesh-ancestor
102374918|NCT05672680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102374919|NCT05672680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374920|NCT05672680|Sensory System Agents|sensory system agents|mesh-ancestor
102374921|NCT05672680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102374922|NCT03002428|Teriparatide|teriparatide|mesh-list
102374923|NCT03002428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102374924|NCT03002428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374925|NCT03002428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102374926|NCT03371550|Docetaxel|docetaxel|mesh-list
102374927|NCT03371550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102374928|NCT03371550|Tubulin Modulators|tubulin modulators|mesh-ancestor
102374929|NCT03371550|Antimitotic Agents|antimitotic agents|mesh-ancestor
102374930|NCT03371550|Mitosis Modulators|mitosis modulators|mesh-ancestor
102374931|NCT03371550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374932|NCT05670028|Antihypertensive Agents|antihypertensive agents|mesh-list
102374933|NCT05669872|Ferric Compounds|ferric compounds|mesh-list
102374934|NCT05669872|Hematinics|hematinics|mesh-ancestor
102374935|NCT04861948|Bevacizumab|bevacizumab|mesh-list
102374936|NCT04861948|Carboplatin|carboplatin|mesh-list
102374937|NCT04861948|Pemetrexed|pemetrexed|mesh-list
102374938|NCT04861948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102374939|NCT04861948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102374940|NCT04861948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102374941|NCT04861948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102374942|NCT04861948|Growth Substances|growth substances|mesh-ancestor
102374943|NCT04861948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374944|NCT04861948|Growth Inhibitors|growth inhibitors|mesh-ancestor
102374945|NCT04861948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102374946|NCT04861948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374947|NCT04861948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102374948|NCT04861948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102374949|NCT04526028|Fulvestrant|fulvestrant|mesh-list
102374950|NCT04526028|Palbociclib|palbociclib|mesh-list
102374951|NCT04526028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102374952|NCT04526028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102374953|NCT04526028|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102374954|NCT04526028|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102374955|NCT04526028|Hormone Antagonists|hormone antagonists|mesh-ancestor
102374956|NCT04526028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102374957|NCT04526028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374958|NCT04526028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102374959|NCT04526028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102374960|NCT04526028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374961|NCT02518698|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
102374962|NCT02518698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102374963|NCT03368274|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
102374964|NCT03368274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102374965|NCT03368274|Glucocorticoids|glucocorticoids|mesh-ancestor
102374966|NCT03368274|Hormones|hormones|mesh-ancestor
102374967|NCT03368274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102374968|NCT03368274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374969|NCT02247544|Trabectedin|trabectedin|mesh-list
102374970|NCT02247544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102374971|NCT02247544|Alkylating Agents|alkylating agents|mesh-ancestor
102374972|NCT02247544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374973|NCT02247544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102374974|NCT03370848|Aspirin|aspirin|mesh-list
102374975|NCT03370848|Psyllium|psyllium|mesh-list
102374976|NCT03370848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102374977|NCT03370848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102374978|NCT03370848|Analgesics|analgesics|mesh-ancestor
102374979|NCT03370848|Sensory System Agents|sensory system agents|mesh-ancestor
102374980|NCT03370848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102374981|NCT03370848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374982|NCT03370848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102374983|NCT03370848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102374984|NCT03370848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102374985|NCT03370848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102374986|NCT03370848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102374987|NCT03370848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102374988|NCT03370848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102374989|NCT03370848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102374990|NCT03370848|Antipyretics|antipyretics|mesh-ancestor
102374991|NCT03370848|Cathartics|cathartics|mesh-ancestor
102374992|NCT03370848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102374993|NCT02248792|Methotrexate|methotrexate|mesh-list
102374994|NCT02248792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102374995|NCT02248792|Abortifacient Agents|abortifacient agents|mesh-ancestor
102374996|NCT02248792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102374997|NCT02248792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102374998|NCT02248792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102374999|NCT02248792|Antimetabolites|antimetabolites|mesh-ancestor
102375000|NCT02248792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375001|NCT02248792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102375002|NCT02248792|Dermatologic Agents|dermatologic agents|mesh-ancestor
102375003|NCT02248792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102375004|NCT02248792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102375005|NCT02248792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102375006|NCT02248792|Immunologic Factors|immunologic factors|mesh-ancestor
102375007|NCT02248792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101943942|NCT03606928|Leucovorin|leucovorin|mesh-list
102375008|NCT02248792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102375009|NCT03367728|Ropivacaine|ropivacaine|mesh-list
102375010|NCT03367728|Anesthetics, Local|anesthetics, local|mesh-ancestor
102375011|NCT03367728|Anesthetics|anesthetics|mesh-ancestor
102375012|NCT03367728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102375013|NCT03367728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375014|NCT03367728|Sensory System Agents|sensory system agents|mesh-ancestor
102375015|NCT03367728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102375016|NCT02248870|Dexamethasone|dexamethasone|mesh-list
102375017|NCT02248870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102375018|NCT02248870|Antiemetics|antiemetics|mesh-ancestor
102375019|NCT02248870|Autonomic Agents|autonomic agents|mesh-ancestor
102375020|NCT02248870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102375021|NCT02248870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943960|NCT03602248|Autonomic Agents|autonomic agents|mesh-ancestor
102375022|NCT02248870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102375023|NCT02248870|Glucocorticoids|glucocorticoids|mesh-ancestor
102375024|NCT02248870|Hormones|hormones|mesh-ancestor
102085630|NCT02167854|Trastuzumab|trastuzumab|mesh-list
102612279|NCT00002387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102186773|NCT05969327|Vitamin D|vitamin d|mesh-list
102375025|NCT02248870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102375026|NCT02248870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102375027|NCT02248870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102375028|NCT04073056|Bupivacaine|bupivacaine|mesh-list
102375029|NCT04073056|Anesthetics, Local|anesthetics, local|mesh-ancestor
102375030|NCT04073056|Anesthetics|anesthetics|mesh-ancestor
102375031|NCT04073056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102375032|NCT04073056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375033|NCT04073056|Sensory System Agents|sensory system agents|mesh-ancestor
102375034|NCT04073056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102375035|NCT03361098|Dapagliflozin|dapagliflozin|mesh-list
102375036|NCT03361098|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102375037|NCT03361098|Exenatide|exenatide|mesh-list
102375038|NCT03361098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375039|NCT03361098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102375040|NCT03361098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375041|NCT03361098|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102375042|NCT03361098|Incretins|incretins|mesh-ancestor
102375043|NCT03361098|Hormones|hormones|mesh-ancestor
102375044|NCT03361098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102375045|NCT03367494|Bromides|bromides|mesh-list
102375046|NCT03367494|Anticonvulsants|anticonvulsants|mesh-ancestor
102375047|NCT05594290|Etoposide|etoposide|mesh-list
102375048|NCT05594290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102375049|NCT05594290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102375050|NCT05594290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102375051|NCT05594290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102375052|NCT05594290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102375053|NCT05594290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375054|NCT03370380|Aflibercept|aflibercept|mesh-list
102375055|NCT03370380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101456403|NCT04664530|Esketamine|esketamine|mesh-list
102375056|NCT03370380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102375057|NCT03370380|Growth Substances|growth substances|mesh-ancestor
102375058|NCT03370380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375059|NCT03370380|Growth Inhibitors|growth inhibitors|mesh-ancestor
102375060|NCT03370380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102375061|NCT04414540|Metformin|metformin|mesh-list
102375062|NCT04414540|Pembrolizumab|pembrolizumab|mesh-list
102375063|NCT04414540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102375064|NCT04414540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375065|NCT04414540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102085934|NCT03486626|Metformin|metformin|mesh-list
102375066|NCT04414540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102375067|NCT04414540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102375068|NCT04414540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375069|NCT05568160|Vasopressins|vasopressins|mesh-list
102375070|NCT05568160|Arginine Vasopressin|arginine vasopressin|mesh-list
102375071|NCT05568160|Norepinephrine|norepinephrine|mesh-list
102375072|NCT05568160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102375073|NCT05568160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102375074|NCT05568160|Adrenergic Agents|adrenergic agents|mesh-ancestor
102375075|NCT05568160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102375076|NCT05568160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375077|NCT05568160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375078|NCT05568160|Sympathomimetics|sympathomimetics|mesh-ancestor
102375079|NCT05568160|Autonomic Agents|autonomic agents|mesh-ancestor
102375080|NCT05568160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102375081|NCT05568160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102375082|NCT05568160|Hemostatics|hemostatics|mesh-ancestor
102375083|NCT05568160|Coagulants|coagulants|mesh-ancestor
102375084|NCT05568160|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102375085|NCT05568160|Natriuretic Agents|natriuretic agents|mesh-ancestor
102375086|NCT03367182|Paclitaxel|paclitaxel|mesh-list
102375087|NCT03367182|Bevacizumab|bevacizumab|mesh-list
102375088|NCT03367182|Doxorubicin|doxorubicin|mesh-list
102375089|NCT03367182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102375090|NCT03367182|Topotecan|topotecan|mesh-list
102375091|NCT03367182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102375092|NCT03367182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102375093|NCT03367182|Tubulin Modulators|tubulin modulators|mesh-ancestor
102375094|NCT03367182|Antimitotic Agents|antimitotic agents|mesh-ancestor
102375095|NCT03367182|Mitosis Modulators|mitosis modulators|mesh-ancestor
102375096|NCT03367182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375097|NCT03367182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102375098|NCT03367182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102375099|NCT03367182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102375100|NCT03367182|Growth Substances|growth substances|mesh-ancestor
102375101|NCT03367182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375102|NCT03367182|Growth Inhibitors|growth inhibitors|mesh-ancestor
102375103|NCT03367182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102375104|NCT03367182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102375105|NCT03367182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102375106|NCT03367182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102375107|NCT03367182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102375108|NCT05561764|Imipenem|imipenem|mesh-list
102375109|NCT05561764|Relebactam|relebactam|mesh-list
102375110|NCT05561764|Cilastatin|cilastatin|mesh-list
102375111|NCT05561764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102086660|NCT00101010|Prednisone|prednisone|mesh-list
102375112|NCT05561764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102375113|NCT05561764|Protease Inhibitors|protease inhibitors|mesh-ancestor
102375114|NCT05561764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102375115|NCT05561764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375116|NCT05561764|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102375117|NCT04119180|Midazolam|midazolam|mesh-list
102375118|NCT04119180|Ketamine|ketamine|mesh-list
102375119|NCT04119180|Analgesics|analgesics|mesh-ancestor
102375120|NCT04119180|Sensory System Agents|sensory system agents|mesh-ancestor
102375121|NCT04119180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102375122|NCT04119180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375123|NCT04119180|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102375124|NCT04119180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102375125|NCT04119180|Anesthetics, General|anesthetics, general|mesh-ancestor
102375126|NCT04119180|Anesthetics|anesthetics|mesh-ancestor
102375127|NCT04119180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102375128|NCT04119180|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102375129|NCT04119180|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102375130|NCT04119180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102375131|NCT04119180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375132|NCT04119180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102375133|NCT04119180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102375134|NCT04119180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102375135|NCT04119180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102375136|NCT04119180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102375137|NCT04119180|GABA Modulators|gaba modulators|mesh-ancestor
102375138|NCT04119180|GABA Agents|gaba agents|mesh-ancestor
102375139|NCT03358212|Denosumab|denosumab|mesh-list
101944062|NCT03594604|Norethindrone|norethindrone|mesh-list
102375140|NCT03358212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102375141|NCT03358212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375142|NCT03109392|Lidocaine|lidocaine|mesh-list
102375143|NCT03109392|Anesthetics, Local|anesthetics, local|mesh-ancestor
102375144|NCT03109392|Anesthetics|anesthetics|mesh-ancestor
102375145|NCT03109392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102375146|NCT03109392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776245|NCT00942435|Darexaban|darexaban|mesh-list
102375147|NCT03109392|Sensory System Agents|sensory system agents|mesh-ancestor
102375148|NCT03109392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102375149|NCT03109392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101944072|NCT02689258|Bupivacaine|bupivacaine|mesh-list
102375150|NCT03109392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102375151|NCT03109392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102375152|NCT03109392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101944075|NCT02689258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102375153|NCT03109392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375154|NCT03357900|Remifentanil|remifentanil|mesh-list
102375155|NCT03357900|Propofol|propofol|mesh-list
102375156|NCT03357900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102375157|NCT03357900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101944079|NCT02238184|Ipratropium|ipratropium|mesh-list
102375158|NCT03357900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375159|NCT03357900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102375160|NCT03357900|Anesthetics, General|anesthetics, general|mesh-ancestor
102375161|NCT03357900|Anesthetics|anesthetics|mesh-ancestor
102375162|NCT03357900|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102375163|NCT03357900|Narcotics|narcotics|mesh-ancestor
102375164|NCT03357900|Analgesics|analgesics|mesh-ancestor
102375165|NCT03357900|Sensory System Agents|sensory system agents|mesh-ancestor
102375166|NCT03357900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102375167|NCT04525326|Bevacizumab|bevacizumab|mesh-list
102375168|NCT04525326|Cetuximab|cetuximab|mesh-list
102375169|NCT04525326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102375170|NCT04525326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102375171|NCT04525326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101944098|NCT03600064|Misoprostol|misoprostol|mesh-list
102375172|NCT04525326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102375173|NCT04525326|Growth Substances|growth substances|mesh-ancestor
102375174|NCT04525326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186917|NCT05846698|Anabolic Agents|anabolic agents|mesh-ancestor
102375175|NCT04525326|Growth Inhibitors|growth inhibitors|mesh-ancestor
102375176|NCT03357822|Interferons|interferons|mesh-list
102375177|NCT03357822|Tenofovir|tenofovir|mesh-list
102375178|NCT03357822|Entecavir|entecavir|mesh-list
102375179|NCT03357822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102375180|NCT03357822|Antiviral Agents|antiviral agents|mesh-ancestor
102375181|NCT03357822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102375182|NCT03357822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102375183|NCT03357822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102375184|NCT03357822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102375185|NCT03357822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375186|NCT03357822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102375187|NCT03357822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102375188|NCT03359694|Docetaxel|docetaxel|mesh-list
102375189|NCT03359694|Doxorubicin|doxorubicin|mesh-list
102375190|NCT03359694|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102375191|NCT03359694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102375192|NCT03359694|Tubulin Modulators|tubulin modulators|mesh-ancestor
102375193|NCT03359694|Antimitotic Agents|antimitotic agents|mesh-ancestor
102375194|NCT03359694|Mitosis Modulators|mitosis modulators|mesh-ancestor
102375195|NCT03359694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375196|NCT03359694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102375197|NCT03359694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102375198|NCT03359694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102375199|NCT03359694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102375200|NCT03123276|Gemcitabine|gemcitabine|mesh-list
102375201|NCT03123276|Pembrolizumab|pembrolizumab|mesh-list
102375202|NCT03123276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102375203|NCT03123276|Antimetabolites|antimetabolites|mesh-ancestor
101944126|NCT02238106|Adrenergic Agents|adrenergic agents|mesh-ancestor
102375204|NCT03123276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375205|NCT03123276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102375206|NCT03123276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102375207|NCT03123276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102375208|NCT03357276|Immunomodulating Agents|immunomodulating agents|mesh-list
102375209|NCT03357276|Immunologic Factors|immunologic factors|mesh-ancestor
101944129|NCT03577912|Anesthetics|anesthetics|mesh-list
102375210|NCT03357276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375211|NCT02249026|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102375212|NCT02249026|Buprenorphine|buprenorphine|mesh-list
102375213|NCT02249026|Opiate Alkaloids|opiate alkaloids|mesh-list
102375214|NCT02249026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102375215|NCT02249026|Narcotics|narcotics|mesh-ancestor
102375216|NCT02249026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102375217|NCT02249026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375218|NCT02249026|Analgesics|analgesics|mesh-ancestor
102375219|NCT02249026|Sensory System Agents|sensory system agents|mesh-ancestor
102375220|NCT02249026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102375221|NCT02249026|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102375222|NCT04521192|Fluzoparib|fluzoparib|mesh-list
102375223|NCT04521192|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102375224|NCT04521192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101944147|NCT03707678|Tocolytic Agents|tocolytic agents|mesh-ancestor
102375225|NCT04521192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375226|NCT04521192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102375227|NCT03359070|Miconazole|miconazole|mesh-list
102375228|NCT03359070|Clotrimazole|clotrimazole|mesh-list
102375229|NCT03359070|Antifungal Agents|antifungal agents|mesh-ancestor
102375230|NCT03359070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102375231|NCT03359070|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102375232|NCT03359070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102375233|NCT03359070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102375234|NCT03359070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375235|NCT03359070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102375236|NCT03359070|Hormone Antagonists|hormone antagonists|mesh-ancestor
101777666|NCT03275818|Paclitaxel|paclitaxel|mesh-list
102375237|NCT03359070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102375238|NCT03359070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088330|NCT03697681|Tranexamic Acid|tranexamic acid|mesh-list
102375239|NCT03359070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102375240|NCT03359070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102375241|NCT03359070|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102375242|NCT03366246|Lidocaine|lidocaine|mesh-list
102375243|NCT03366246|Prilocaine|prilocaine|mesh-list
102375244|NCT03366246|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
102375245|NCT03366246|Anesthetics, Local|anesthetics, local|mesh-ancestor
102375246|NCT03366246|Anesthetics|anesthetics|mesh-ancestor
102375247|NCT03366246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102375248|NCT03366246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375254|NCT03366246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102375255|NCT03366246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375256|NCT03366246|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
102375257|NCT01623466|Contraceptive Agents|contraceptive agents|mesh-list
102375258|NCT01623466|Levonorgestrel|levonorgestrel|mesh-list
102375259|NCT01623466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102375260|NCT01623466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375261|NCT01623466|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102375262|NCT01623466|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102375263|NCT01623466|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102375264|NCT01623466|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102375270|NCT04520646|Empagliflozin|empagliflozin|mesh-list
102088611|NCT03567447|Droxidopa|droxidopa|mesh-list
102375271|NCT04520646|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102375272|NCT04520646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375273|NCT04520646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102375274|NCT04520646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375275|NCT01624948|Mycophenolic Acid|mycophenolic acid|mesh-list
102375276|NCT01624948|Everolimus|everolimus|mesh-list
102375277|NCT01624948|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102375278|NCT01624948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102375279|NCT01624948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102375280|NCT01624948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375281|NCT01624948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102375282|NCT01624948|Immunologic Factors|immunologic factors|mesh-ancestor
102375283|NCT01624948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375284|NCT01624948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102375285|NCT01624948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102375286|NCT01624948|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102375287|NCT01624948|Antitubercular Agents|antitubercular agents|mesh-ancestor
102375288|NCT01624948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102375289|NCT01624948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102375290|NCT04523064|Empagliflozin|empagliflozin|mesh-list
102375291|NCT04523064|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102375292|NCT04523064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375293|NCT04523064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102375294|NCT04523064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375295|NCT04520880|Antibodies|antibodies|mesh-list
102375296|NCT04520880|Immunoglobulins|immunoglobulins|mesh-list
102375297|NCT04520880|Antibodies, Blocking|antibodies, blocking|mesh-list
102375298|NCT04520880|Immunologic Factors|immunologic factors|mesh-ancestor
102375299|NCT04520880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375300|NCT03365466|Aspirin|aspirin|mesh-list
102375301|NCT03365466|Heparin|heparin|mesh-list
102375302|NCT03365466|Calcium heparin|calcium heparin|mesh-list
102375303|NCT03365466|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102375304|NCT03365466|Tinzaparin|tinzaparin|mesh-list
102375305|NCT03365466|Dalteparin|dalteparin|mesh-list
102375306|NCT03365466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102375307|NCT03365466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102375308|NCT03365466|Analgesics|analgesics|mesh-ancestor
102375309|NCT03365466|Sensory System Agents|sensory system agents|mesh-ancestor
102375310|NCT03365466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102375311|NCT03365466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375312|NCT03365466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102375313|NCT03365466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102375314|NCT03365466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102375315|NCT03365466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102375316|NCT03365466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375317|NCT03365466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102375318|NCT03365466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102375319|NCT03365466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102375320|NCT03365466|Antipyretics|antipyretics|mesh-ancestor
102375321|NCT03365466|Anticoagulants|anticoagulants|mesh-ancestor
102187082|NCT05677126|Copper|copper|mesh-list
102375322|NCT03356964|Hormones|hormones|mesh-list
102375323|NCT03356964|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102375324|NCT03356964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102375325|NCT03356964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375326|NCT03346252|Botulinum Toxins|botulinum toxins|mesh-list
102375327|NCT03346252|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102375328|NCT03346252|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102375329|NCT03346252|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102375330|NCT03346252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102375331|NCT03346252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375332|NCT03346252|Cholinergic Agents|cholinergic agents|mesh-ancestor
102375333|NCT03346252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102375334|NCT03346252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375335|NCT03346252|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102375336|NCT03346252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102375337|NCT03365388|Hyaluronic Acid|hyaluronic acid|mesh-list
102375338|NCT03365388|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102375339|NCT03365388|Immunologic Factors|immunologic factors|mesh-ancestor
102375340|NCT03365388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375341|NCT03365388|Viscosupplements|viscosupplements|mesh-ancestor
102375342|NCT03365388|Protective Agents|protective agents|mesh-ancestor
102375343|NCT03123744|Palbociclib|palbociclib|mesh-list
102375344|NCT03123744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102375345|NCT03123744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102375346|NCT03123744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102375347|NCT03123744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375348|NCT03358524|Vitamins|vitamins|mesh-list
102375349|NCT03358524|Vitamin E|vitamin e|mesh-list
102375350|NCT03358524|Tocopherols|tocopherols|mesh-list
102375351|NCT03358524|Tocotrienols|tocotrienols|mesh-list
102375352|NCT03358524|alpha-Tocopherol|alpha-tocopherol|mesh-list
102375353|NCT03358524|Micronutrients|micronutrients|mesh-ancestor
102375354|NCT03358524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375355|NCT03358524|Antioxidants|antioxidants|mesh-ancestor
102375356|NCT03358524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375357|NCT03358524|Protective Agents|protective agents|mesh-ancestor
102375358|NCT04444986|Favipiravir|favipiravir|mesh-list
102375359|NCT04444986|Antiviral Agents|antiviral agents|mesh-ancestor
102375360|NCT04444986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102375361|NCT03356730|Vitamin D|vitamin d|mesh-list
102375362|NCT03356730|Vitamins|vitamins|mesh-ancestor
102375363|NCT03356730|Micronutrients|micronutrients|mesh-ancestor
102375364|NCT03356730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375365|NCT03356730|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102375366|NCT03364998|Factor VIII|factor viii|mesh-list
102375367|NCT03364998|Coagulants|coagulants|mesh-ancestor
102375368|NCT04509102|Adderall|adderall|mesh-list
102375369|NCT04509102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102375370|NCT04509102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375371|NCT04508946|Thiamine|thiamine|mesh-list
102375372|NCT04508946|Hydrocortisone|hydrocortisone|mesh-list
102375373|NCT04508946|Vitamins|vitamins|mesh-ancestor
102375374|NCT04508946|Micronutrients|micronutrients|mesh-ancestor
102375375|NCT04508946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375376|NCT04508946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102375377|NCT04508946|Vitamin B Complex|vitamin b complex|mesh-ancestor
102375378|NCT03364842|Furosemide|furosemide|mesh-list
102375379|NCT03364842|Diuretics|diuretics|mesh-ancestor
102375380|NCT03364842|Natriuretic Agents|natriuretic agents|mesh-ancestor
102375381|NCT03364842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375382|NCT03364842|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102375383|NCT03364842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102375384|NCT03364842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375385|NCT03364764|Sirolimus|sirolimus|mesh-list
102375386|NCT03364764|Temsirolimus|temsirolimus|mesh-list
102375387|NCT03364764|MTOR Inhibitors|mtor inhibitors|mesh-list
102375388|NCT03364764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102375389|NCT03364764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102375390|NCT03364764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102375391|NCT03364764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102375392|NCT03364764|Antifungal Agents|antifungal agents|mesh-ancestor
102375393|NCT03364764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102375394|NCT03364764|Immunologic Factors|immunologic factors|mesh-ancestor
102375395|NCT03364764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187147|NCT05609578|Pemetrexed|pemetrexed|mesh-list
102375396|NCT03364764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102375397|NCT03364764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612280|NCT00002393|Efavirenz|efavirenz|mesh-list
102375398|NCT03364764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375399|NCT02519400|Amitriptyline|amitriptyline|mesh-list
102375400|NCT02519400|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102375401|NCT02519400|Antidepressive Agents|antidepressive agents|mesh-ancestor
102375402|NCT02519400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102375403|NCT02519400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102375404|NCT02519400|Analgesics|analgesics|mesh-ancestor
102375405|NCT02519400|Sensory System Agents|sensory system agents|mesh-ancestor
102375406|NCT02519400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102375407|NCT02519400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375408|NCT02519400|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102375409|NCT02519400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102375410|NCT02519400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102375411|NCT02519400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375412|NCT02519400|Adrenergic Agents|adrenergic agents|mesh-ancestor
102375413|NCT02519400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102375414|NCT04509258|Acetylcarnitine|acetylcarnitine|mesh-list
101944309|NCT02239900|Ipilimumab|ipilimumab|mesh-list
102375415|NCT04509258|Acetylcysteine|acetylcysteine|mesh-list
102375416|NCT04509258|Ondansetron|ondansetron|mesh-list
102375417|NCT04509258|Mineral Oil|mineral oil|mesh-list
102375418|NCT04509258|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102375419|NCT04509258|Antiemetics|antiemetics|mesh-ancestor
102375420|NCT04509258|Autonomic Agents|autonomic agents|mesh-ancestor
102375421|NCT04509258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102375422|NCT04509258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375423|NCT04509258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102375424|NCT04509258|Antipruritics|antipruritics|mesh-ancestor
102375425|NCT04509258|Dermatologic Agents|dermatologic agents|mesh-ancestor
102375426|NCT04509258|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102375427|NCT04509258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102375428|NCT04509258|Serotonin Agents|serotonin agents|mesh-ancestor
102375429|NCT04509258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102375430|NCT04509258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375431|NCT04509258|Antiviral Agents|antiviral agents|mesh-ancestor
102375432|NCT04509258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102375433|NCT04509258|Expectorants|expectorants|mesh-ancestor
102375434|NCT04509258|Respiratory System Agents|respiratory system agents|mesh-ancestor
102375435|NCT04509258|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102375436|NCT04509258|Antioxidants|antioxidants|mesh-ancestor
102375437|NCT04509258|Protective Agents|protective agents|mesh-ancestor
102375438|NCT04509258|Antidotes|antidotes|mesh-ancestor
102375439|NCT04509258|Vitamin B Complex|vitamin b complex|mesh-ancestor
102375440|NCT04509258|Vitamins|vitamins|mesh-ancestor
102375441|NCT04509258|Micronutrients|micronutrients|mesh-ancestor
102375442|NCT04509258|Nootropic Agents|nootropic agents|mesh-ancestor
102375443|NCT04509258|Emollients|emollients|mesh-ancestor
102375444|NCT03354624|Mitogens|mitogens|mesh-list
102375445|NCT03354624|Mitosis Modulators|mitosis modulators|mesh-ancestor
102375446|NCT03354624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375447|NCT03364218|Acetylcysteine|acetylcysteine|mesh-list
102375448|NCT03364218|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102375449|NCT03364218|Antiviral Agents|antiviral agents|mesh-ancestor
102375450|NCT03364218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102375451|NCT03364218|Expectorants|expectorants|mesh-ancestor
102375452|NCT03364218|Respiratory System Agents|respiratory system agents|mesh-ancestor
102375453|NCT03364218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102375454|NCT03364218|Antioxidants|antioxidants|mesh-ancestor
102375455|NCT03364218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375456|NCT03364218|Protective Agents|protective agents|mesh-ancestor
102375457|NCT03364218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375458|NCT03364218|Antidotes|antidotes|mesh-ancestor
102375459|NCT04444284|Vaccines|vaccines|mesh-list
102375460|NCT04444284|Immunologic Factors|immunologic factors|mesh-ancestor
102375461|NCT04444284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375462|NCT03354312|Lidocaine|lidocaine|mesh-list
102375463|NCT03354312|Epinephrine|epinephrine|mesh-list
102375464|NCT03354312|Racepinephrine|racepinephrine|mesh-list
102375465|NCT03354312|Carticaine|carticaine|mesh-list
102375466|NCT03354312|Epinephryl borate|epinephryl borate|mesh-list
102375467|NCT03354312|Anesthetics, Local|anesthetics, local|mesh-ancestor
102375468|NCT03354312|Anesthetics|anesthetics|mesh-ancestor
102375469|NCT03354312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102375470|NCT03354312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375471|NCT03354312|Sensory System Agents|sensory system agents|mesh-ancestor
102375472|NCT03354312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102375473|NCT03354312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102375474|NCT03354312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102375475|NCT03354312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102375476|NCT03354312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102375477|NCT03354312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375478|NCT03354312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102375479|NCT03354312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102375480|NCT03354312|Adrenergic Agents|adrenergic agents|mesh-ancestor
102375481|NCT03354312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102375482|NCT03354312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102375483|NCT03354312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102375484|NCT03354312|Autonomic Agents|autonomic agents|mesh-ancestor
102375485|NCT03354312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102375486|NCT03354312|Respiratory System Agents|respiratory system agents|mesh-ancestor
102375487|NCT03354312|Mydriatics|mydriatics|mesh-ancestor
102375488|NCT03354312|Sympathomimetics|sympathomimetics|mesh-ancestor
102375489|NCT03354312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102375490|NCT03363984|Midazolam|midazolam|mesh-list
102375491|NCT03363984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102375492|NCT03363984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102375493|NCT03363984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102375494|NCT03363984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375495|NCT03363984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102375496|NCT03363984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102375497|NCT03363984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102375498|NCT03363984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102375499|NCT03363984|Anesthetics, General|anesthetics, general|mesh-ancestor
102375500|NCT03363984|Anesthetics|anesthetics|mesh-ancestor
102375501|NCT03363984|GABA Modulators|gaba modulators|mesh-ancestor
102375502|NCT03363984|GABA Agents|gaba agents|mesh-ancestor
102375503|NCT03363984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102375504|NCT03363984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375505|NCT03355716|Fentanyl|fentanyl|mesh-list
102375506|NCT03355716|Ketamine|ketamine|mesh-list
102375507|NCT03355716|Morphine|morphine|mesh-list
102375508|NCT03355716|Bupivacaine|bupivacaine|mesh-list
102375509|NCT03355716|Anesthetics, Local|anesthetics, local|mesh-ancestor
102375510|NCT03355716|Anesthetics|anesthetics|mesh-ancestor
102375511|NCT03355716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102375512|NCT03355716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375513|NCT03355716|Sensory System Agents|sensory system agents|mesh-ancestor
102375514|NCT03355716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102375515|NCT03355716|Analgesics|analgesics|mesh-ancestor
102375516|NCT03355716|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102375517|NCT03355716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102375518|NCT03355716|Anesthetics, General|anesthetics, general|mesh-ancestor
102375519|NCT03355716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102375520|NCT03355716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102375521|NCT03355716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102375522|NCT03355716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375523|NCT03355716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102375524|NCT03355716|Narcotics|narcotics|mesh-ancestor
102375525|NCT03355716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102375526|NCT04508400|Dexamethasone|dexamethasone|mesh-list
102375527|NCT04508400|Dexamethasone acetate|dexamethasone acetate|mesh-list
102375528|NCT04508400|Ondansetron|ondansetron|mesh-list
102375529|NCT04508400|Fosaprepitant|fosaprepitant|mesh-list
102375530|NCT04508400|Aprepitant|aprepitant|mesh-list
102375531|NCT04508400|BB 1101|bb 1101|mesh-list
102375532|NCT04508400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102375533|NCT04508400|Antiemetics|antiemetics|mesh-ancestor
102375534|NCT04508400|Autonomic Agents|autonomic agents|mesh-ancestor
102375535|NCT04508400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102375536|NCT04508400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375537|NCT04508400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102375538|NCT04508400|Glucocorticoids|glucocorticoids|mesh-ancestor
102375539|NCT04508400|Hormones|hormones|mesh-ancestor
102375540|NCT04508400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102375541|NCT04508400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102375542|NCT04508400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102375543|NCT04508400|Protease Inhibitors|protease inhibitors|mesh-ancestor
102375544|NCT04508400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102375545|NCT04508400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375546|NCT04508400|Antipruritics|antipruritics|mesh-ancestor
102375547|NCT04508400|Dermatologic Agents|dermatologic agents|mesh-ancestor
102375548|NCT04508400|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102375549|NCT04508400|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102375550|NCT04508400|Serotonin Agents|serotonin agents|mesh-ancestor
102375551|NCT04508400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102375552|NCT04508400|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102375554|NCT03355638|Aflibercept|aflibercept|mesh-list
102375555|NCT03355638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102375556|NCT03355638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102375557|NCT03355638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102375558|NCT03355638|Growth Substances|growth substances|mesh-ancestor
102375559|NCT03355638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375560|NCT03355638|Growth Inhibitors|growth inhibitors|mesh-ancestor
102375561|NCT03355638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102375562|NCT03355638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102375563|NCT03355638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102375564|NCT03355638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102375565|NCT03355638|Analgesics|analgesics|mesh-ancestor
102375566|NCT03355638|Sensory System Agents|sensory system agents|mesh-ancestor
102375567|NCT03355638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102375568|NCT03355638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102375569|NCT03355638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102375570|NCT03355638|Gout Suppressants|gout suppressants|mesh-ancestor
102375571|NCT01626664|Gemcitabine|gemcitabine|mesh-list
102375572|NCT01626664|Oxaliplatin|oxaliplatin|mesh-list
102375573|NCT01626664|Mogamulizumab|mogamulizumab|mesh-list
102375574|NCT01626664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102375575|NCT01626664|Antimetabolites|antimetabolites|mesh-ancestor
102375576|NCT01626664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375577|NCT01626664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102375578|NCT04515966|Methylprednisolone|methylprednisolone|mesh-list
102375579|NCT04515966|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102375580|NCT04515966|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101944489|NCT03572686|Hormones|hormones|mesh-ancestor
102375581|NCT04515966|Prednisolone|prednisolone|mesh-list
102375582|NCT04515966|Prednisolone acetate|prednisolone acetate|mesh-list
102375583|NCT04515966|Lidocaine|lidocaine|mesh-list
102375584|NCT04515966|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102375585|NCT04515966|Prednisolone phosphate|prednisolone phosphate|mesh-list
102375586|NCT04515966|Anesthetics, Local|anesthetics, local|mesh-ancestor
102375587|NCT04515966|Anesthetics|anesthetics|mesh-ancestor
102375588|NCT04515966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102375589|NCT04515966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375590|NCT04515966|Sensory System Agents|sensory system agents|mesh-ancestor
102375591|NCT04515966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102375592|NCT04515966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102375593|NCT04515966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102375594|NCT04515966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102375595|NCT04515966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102375596|NCT04515966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375597|NCT04515966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102375598|NCT04515966|Antiemetics|antiemetics|mesh-ancestor
102375599|NCT04515966|Autonomic Agents|autonomic agents|mesh-ancestor
102375600|NCT04515966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102375601|NCT04515966|Glucocorticoids|glucocorticoids|mesh-ancestor
102375602|NCT04515966|Hormones|hormones|mesh-ancestor
102375603|NCT04515966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102375604|NCT04515966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102375605|NCT04515966|Protective Agents|protective agents|mesh-ancestor
102375606|NCT04515966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102375607|NCT04515966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102375608|NCT04504110|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102375609|NCT04504110|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102375610|NCT04504110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375611|NCT03355248|Acetaminophen|acetaminophen|mesh-list
102375612|NCT03355248|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
102375613|NCT03355248|Oxycodone|oxycodone|mesh-list
102375614|NCT03355248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102375615|NCT03355248|Analgesics|analgesics|mesh-ancestor
102375616|NCT03355248|Sensory System Agents|sensory system agents|mesh-ancestor
102375617|NCT03355248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102375618|NCT03355248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375619|NCT03355248|Antipyretics|antipyretics|mesh-ancestor
102375620|NCT03355248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102375621|NCT03355248|Narcotics|narcotics|mesh-ancestor
102375622|NCT03355248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102375623|NCT03355248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102375624|NCT03355248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102375625|NCT03355248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102375626|NCT03350334|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102187368|NCT05020236|Dexamethasone|dexamethasone|mesh-list
101779807|NCT05525247|Gemcitabine|gemcitabine|mesh-list
102375627|NCT03350334|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102375628|NCT03350334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102375629|NCT03350334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102375630|NCT03350334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375631|NCT03350334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102375632|NCT03350334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375633|NCT03350334|Analgesics|analgesics|mesh-ancestor
102375634|NCT03350334|Sensory System Agents|sensory system agents|mesh-ancestor
102375635|NCT03350334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102375636|NCT03350334|Antidepressive Agents|antidepressive agents|mesh-ancestor
102375637|NCT03350334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102375638|NCT03350334|Dopamine Agents|dopamine agents|mesh-ancestor
102375639|NCT02230696|Fluticasone|fluticasone|mesh-list
102375640|NCT02230696|Xhance|xhance|mesh-list
102375641|NCT02230696|Azelastine|azelastine|mesh-list
102375642|NCT02230696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102375643|NCT02230696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102375644|NCT02230696|Autonomic Agents|autonomic agents|mesh-ancestor
102375645|NCT02230696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102375646|NCT02230696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375647|NCT02230696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102375648|NCT02230696|Respiratory System Agents|respiratory system agents|mesh-ancestor
102375649|NCT02230696|Dermatologic Agents|dermatologic agents|mesh-ancestor
102375650|NCT02230696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102375651|NCT02230696|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
102375652|NCT02230696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102375653|NCT02230696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375654|NCT02230696|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102375655|NCT02230696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102375656|NCT02230696|Histamine Antagonists|histamine antagonists|mesh-ancestor
102375657|NCT02230696|Histamine Agents|histamine agents|mesh-ancestor
102375658|NCT02230696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102375659|NCT03355014|Metformin|metformin|mesh-list
102375660|NCT03355014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102090409|NCT03677323|Antiemetics|antiemetics|mesh-ancestor
102375661|NCT03355014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375662|NCT02231086|Leucovorin|leucovorin|mesh-list
102375663|NCT02231086|Fluorouracil|fluorouracil|mesh-list
102375664|NCT02231086|Capecitabine|capecitabine|mesh-list
102375665|NCT02231086|Oxaliplatin|oxaliplatin|mesh-list
102375666|NCT02231086|Antimetabolites|antimetabolites|mesh-ancestor
102375667|NCT02231086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375668|NCT02231086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102375669|NCT02231086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102375670|NCT02231086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102375671|NCT02231086|Immunologic Factors|immunologic factors|mesh-ancestor
102375672|NCT02231086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375673|NCT02231086|Antidotes|antidotes|mesh-ancestor
102375674|NCT02231086|Protective Agents|protective agents|mesh-ancestor
102375675|NCT02231086|Vitamin B Complex|vitamin b complex|mesh-ancestor
102375676|NCT02231086|Vitamins|vitamins|mesh-ancestor
102375677|NCT02231086|Micronutrients|micronutrients|mesh-ancestor
102375678|NCT03353298|Allopurinol|allopurinol|mesh-list
102375679|NCT03353298|Antimetabolites|antimetabolites|mesh-ancestor
102375680|NCT03353298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375681|NCT03353298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102375682|NCT03353298|Gout Suppressants|gout suppressants|mesh-ancestor
102375683|NCT03353298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102375684|NCT03353298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102375685|NCT03353298|Antioxidants|antioxidants|mesh-ancestor
102375686|NCT03353298|Protective Agents|protective agents|mesh-ancestor
102375687|NCT03353298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375688|NCT02509546|Adenosine|adenosine|mesh-list
102375689|NCT02509546|Analgesics|analgesics|mesh-ancestor
102375690|NCT02509546|Sensory System Agents|sensory system agents|mesh-ancestor
102375691|NCT02509546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102375692|NCT02509546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375693|NCT02509546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102375694|NCT02509546|Vasodilator Agents|vasodilator agents|mesh-ancestor
102375695|NCT02509546|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102375696|NCT02509546|Purinergic Agonists|purinergic agonists|mesh-ancestor
102375697|NCT02509546|Purinergic Agents|purinergic agents|mesh-ancestor
102375698|NCT02509546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102375699|NCT02509546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375700|NCT03187210|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102375701|NCT03187210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102375702|NCT03187210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102375703|NCT03187210|Immunotoxins|immunotoxins|mesh-ancestor
102375704|NCT03187210|Immunoconjugates|immunoconjugates|mesh-ancestor
102375705|NCT03187210|Immunologic Factors|immunologic factors|mesh-ancestor
102375706|NCT03187210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375707|NCT03349866|Capecitabine|capecitabine|mesh-list
102375708|NCT03349866|Oxaliplatin|oxaliplatin|mesh-list
102375710|NCT03349866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102375711|NCT03349866|Antimetabolites|antimetabolites|mesh-ancestor
102375712|NCT03349866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375713|NCT03349866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102375714|NCT03349866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102375715|NCT03349866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102375716|NCT01631110|Vaccines|vaccines|mesh-list
102375717|NCT01631110|Immunologic Factors|immunologic factors|mesh-ancestor
102375718|NCT01631110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375719|NCT01631656|Azelaic acid|azelaic acid|mesh-list
102375720|NCT01631656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102375721|NCT01631656|Dermatologic Agents|dermatologic agents|mesh-ancestor
102375722|NCT02985190|Azacitidine|azacitidine|mesh-list
102375723|NCT02985190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101780318|NCT03919955|Oxybutynin|oxybutynin|mesh-list
102375724|NCT02985190|Antimetabolites|antimetabolites|mesh-ancestor
102375725|NCT02985190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375726|NCT02985190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102375727|NCT02985190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102375728|NCT01376310|Paclitaxel|paclitaxel|mesh-list
102375729|NCT01376310|Docetaxel|docetaxel|mesh-list
102375730|NCT01376310|Carboplatin|carboplatin|mesh-list
102375731|NCT01376310|Gemcitabine|gemcitabine|mesh-list
102375732|NCT01376310|Pemetrexed|pemetrexed|mesh-list
102375733|NCT01376310|Everolimus|everolimus|mesh-list
102375734|NCT01376310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102375735|NCT01376310|Trametinib|trametinib|mesh-list
102375736|NCT01376310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102375737|NCT01376310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102375738|NCT01376310|Tubulin Modulators|tubulin modulators|mesh-ancestor
102375739|NCT01376310|Antimitotic Agents|antimitotic agents|mesh-ancestor
102375740|NCT01376310|Mitosis Modulators|mitosis modulators|mesh-ancestor
102375741|NCT01376310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375742|NCT01376310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102375743|NCT01376310|Antimetabolites|antimetabolites|mesh-ancestor
102375744|NCT01376310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102375745|NCT01376310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102375746|NCT01376310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102375747|NCT01376310|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102375748|NCT01376310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102375749|NCT01376310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102375750|NCT01376310|Immunologic Factors|immunologic factors|mesh-ancestor
102375751|NCT01376310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375752|NCT01585402|Etidronic Acid|etidronic acid|mesh-list
102375753|NCT01585402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102375754|NCT01585402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375755|NCT01638052|Clonidine|clonidine|mesh-list
102375756|NCT01638052|Bupivacaine|bupivacaine|mesh-list
102375757|NCT01638052|Anesthetics, Local|anesthetics, local|mesh-ancestor
102375758|NCT01638052|Anesthetics|anesthetics|mesh-ancestor
102375759|NCT01638052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102375760|NCT01638052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375761|NCT01638052|Sensory System Agents|sensory system agents|mesh-ancestor
102375762|NCT01638052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102375763|NCT01638052|Analgesics|analgesics|mesh-ancestor
102375764|NCT01638052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102375765|NCT01638052|Sympatholytics|sympatholytics|mesh-ancestor
102375766|NCT01638052|Autonomic Agents|autonomic agents|mesh-ancestor
102375767|NCT01638052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102375768|NCT01638052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102375769|NCT01638052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102375770|NCT01638052|Adrenergic Agents|adrenergic agents|mesh-ancestor
102375771|NCT01638052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102375772|NCT01638052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375773|NCT02518152|Alendronate|alendronate|mesh-list
102375774|NCT02518152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101944655|NCT03565276|Coagulants|coagulants|mesh-ancestor
102375775|NCT02518152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375776|NCT01229878|Vitamin D|vitamin d|mesh-list
102375777|NCT01229878|Cholecalciferol|cholecalciferol|mesh-list
102375778|NCT01229878|Vitamins|vitamins|mesh-ancestor
102375779|NCT01229878|Micronutrients|micronutrients|mesh-ancestor
102375780|NCT01229878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375781|NCT01229878|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102375782|NCT01229878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102375783|NCT03352674|Insulin|insulin|mesh-list
102375784|NCT03352674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102375785|NCT03352674|Insulin Glargine|insulin glargine|mesh-list
102375786|NCT03352674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102375787|NCT03352674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375788|NCT01639222|Calcium, Dietary|calcium, dietary|mesh-list
102375789|NCT01639222|Vitamin D|vitamin d|mesh-list
102375790|NCT01639222|Cholecalciferol|cholecalciferol|mesh-list
102375791|NCT01639222|Calcium|calcium|mesh-list
102375792|NCT01639222|Vitamins|vitamins|mesh-ancestor
102375793|NCT01639222|Micronutrients|micronutrients|mesh-ancestor
102375794|NCT01639222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375795|NCT01639222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102375796|NCT01639222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102375797|NCT04443270|Chloroquine|chloroquine|mesh-list
102375798|NCT04443270|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
102375799|NCT04443270|Amebicides|amebicides|mesh-ancestor
102375800|NCT04443270|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102375801|NCT04443270|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102375802|NCT04443270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102375803|NCT04443270|Antimalarials|antimalarials|mesh-ancestor
102375804|NCT04443270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102375805|NCT04443270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102375806|NCT04443270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102375807|NCT04443270|Analgesics|analgesics|mesh-ancestor
102375808|NCT04443270|Sensory System Agents|sensory system agents|mesh-ancestor
102375809|NCT04443270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102375810|NCT04443270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375811|NCT04443270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102375812|NCT04443270|Filaricides|filaricides|mesh-ancestor
102091519|NCT05126836|Cilostazol|cilostazol|mesh-list
102375813|NCT04443270|Antinematodal Agents|antinematodal agents|mesh-ancestor
102375814|NCT04443270|Anthelmintics|anthelmintics|mesh-ancestor
102375815|NCT03349008|Entecavir|entecavir|mesh-list
102375816|NCT03349008|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
102375817|NCT03349008|Antiviral Agents|antiviral agents|mesh-ancestor
102375818|NCT03349008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102375819|NCT03349008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102375820|NCT03352362|Acetaminophen|acetaminophen|mesh-list
102375821|NCT03352362|Ibuprofen|ibuprofen|mesh-list
102375822|NCT03352362|Propacetamol|propacetamol|mesh-list
101781307|NCT00755417|Analgesics|analgesics|mesh-ancestor
102375823|NCT03352362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102375824|NCT03352362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102375825|NCT03352362|Analgesics|analgesics|mesh-ancestor
102375826|NCT03352362|Sensory System Agents|sensory system agents|mesh-ancestor
102375827|NCT03352362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102375828|NCT03352362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375829|NCT03352362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102375830|NCT03352362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102375831|NCT03352362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102375832|NCT03352362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102375833|NCT03352362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375834|NCT03352362|Antipyretics|antipyretics|mesh-ancestor
102375835|NCT01598740|Spironolactone|spironolactone|mesh-list
102375836|NCT01598740|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102375837|NCT01598740|Hormone Antagonists|hormone antagonists|mesh-ancestor
102375838|NCT01598740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102375839|NCT01598740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375840|NCT01598740|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102375841|NCT01598740|Diuretics|diuretics|mesh-ancestor
102375842|NCT01598740|Natriuretic Agents|natriuretic agents|mesh-ancestor
102375843|NCT00709098|Iloprost|iloprost|mesh-list
102375844|NCT00709098|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102375845|NCT00709098|Vasodilator Agents|vasodilator agents|mesh-ancestor
102375846|NCT03348696|Dexamethasone|dexamethasone|mesh-list
102375847|NCT03348696|Dexamethasone acetate|dexamethasone acetate|mesh-list
102375848|NCT03348696|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102375849|NCT03348696|BB 1101|bb 1101|mesh-list
102375850|NCT03348696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102375851|NCT03348696|Antiemetics|antiemetics|mesh-ancestor
102375852|NCT03348696|Autonomic Agents|autonomic agents|mesh-ancestor
102375853|NCT03348696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102375854|NCT03348696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375855|NCT03348696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102375856|NCT03348696|Glucocorticoids|glucocorticoids|mesh-ancestor
102375857|NCT03348696|Hormones|hormones|mesh-ancestor
101944691|NCT03708848|Respiratory System Agents|respiratory system agents|mesh-ancestor
101944692|NCT03564652|Azithromycin|azithromycin|mesh-list
101944693|NCT03564652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101944694|NCT03564652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101944695|NCT03564574|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101944696|NCT03564574|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101944697|NCT03564574|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102187608|NCT04599634|Venetoclax|venetoclax|mesh-list
102612281|NCT00002393|Indinavir|indinavir|mesh-list
102375858|NCT03348696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102375859|NCT03348696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102375860|NCT03348696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102375861|NCT03348696|Protease Inhibitors|protease inhibitors|mesh-ancestor
102375862|NCT03348696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102375863|NCT03348696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092052|NCT03576547|Rituximab|rituximab|mesh-list
102375864|NCT04506450|Anesthetics|anesthetics|mesh-list
102375865|NCT04506450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102375866|NCT04506450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375867|NCT03352128|Calcium|calcium|mesh-list
102375868|NCT03352128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102375869|NCT03352128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375870|NCT03122730|Epoprostenol|epoprostenol|mesh-list
102375871|NCT03122730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102375872|NCT03122730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102375873|NCT04505904|Oxytocin|oxytocin|mesh-list
102375874|NCT04505904|Oxytocics|oxytocics|mesh-ancestor
102375875|NCT04505904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102375876|NCT04505904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375877|NCT03348462|Anthralin|anthralin|mesh-list
102375878|NCT03348462|Dermatologic Agents|dermatologic agents|mesh-ancestor
102375879|NCT04505514|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
102375880|NCT04505514|Hematinics|hematinics|mesh-ancestor
102375881|NCT04505202|Chlorhexidine|chlorhexidine|mesh-list
102375882|NCT04505202|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102375883|NCT04505202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102375884|NCT04505202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102375885|NCT04505202|Disinfectants|disinfectants|mesh-ancestor
102375886|NCT04505202|Dermatologic Agents|dermatologic agents|mesh-ancestor
102375887|NCT05585346|Prednisolone|prednisolone|mesh-list
102375888|NCT05585346|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102375889|NCT05585346|Methylprednisolone|methylprednisolone|mesh-list
102375890|NCT05585346|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102375891|NCT05585346|Prednisolone acetate|prednisolone acetate|mesh-list
102375892|NCT05585346|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102375893|NCT05585346|Prednisolone phosphate|prednisolone phosphate|mesh-list
101944728|NCT03705884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101944729|NCT03705884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101944730|NCT03359174|Tretinoin|tretinoin|mesh-list
101944731|NCT03359174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101944732|NCT03359174|Keratolytic Agents|keratolytic agents|mesh-ancestor
102375894|NCT05585346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102375895|NCT05585346|Glucocorticoids|glucocorticoids|mesh-ancestor
102375896|NCT05585346|Hormones|hormones|mesh-ancestor
102375897|NCT05585346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101944739|NCT03564106|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102375898|NCT05585346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375899|NCT05585346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102375900|NCT05585346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102375901|NCT05585346|Antiemetics|antiemetics|mesh-ancestor
102375902|NCT05585346|Autonomic Agents|autonomic agents|mesh-ancestor
102375903|NCT05585346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102375904|NCT05585346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102375905|NCT05585346|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102375906|NCT05585346|Protective Agents|protective agents|mesh-ancestor
102375907|NCT05098704|Clopidogrel|clopidogrel|mesh-list
102375908|NCT05098704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102375909|NCT05098704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102375910|NCT05098704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102375911|NCT05098704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102375912|NCT05098704|Purinergic Agents|purinergic agents|mesh-ancestor
102375913|NCT05098704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102375914|NCT05098704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375915|NCT05098704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375916|NCT05584956|Sildenafil Citrate|sildenafil citrate|mesh-list
102375917|NCT05584956|Vasodilator Agents|vasodilator agents|mesh-ancestor
102375918|NCT05584956|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102375919|NCT05584956|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102375920|NCT05584956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101944754|NCT03710174|Salicylic Acid|salicylic acid|mesh-list
102375921|NCT05584956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375922|NCT05584956|Urological Agents|urological agents|mesh-ancestor
102375923|NCT01376700|Factor VIII|factor viii|mesh-list
102375924|NCT01376700|Coagulants|coagulants|mesh-ancestor
102375925|NCT01797965|Daclizumab|daclizumab|mesh-list
102375926|NCT01797965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102375927|NCT01797965|Immunologic Factors|immunologic factors|mesh-ancestor
102375928|NCT01797965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375929|NCT01601236|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102375930|NCT01601236|Hormones|hormones|mesh-ancestor
102092929|NCT02485574|Calcium|calcium|mesh-list
102375931|NCT01601236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102187675|NCT04545736|Metformin|metformin|mesh-list
102375932|NCT01601236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375934|NCT05584878|Calcium|calcium|mesh-list
102375935|NCT05584878|Caseins|caseins|mesh-list
102375936|NCT05584878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102375937|NCT05584878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375938|NCT05584878|Chelating Agents|chelating agents|mesh-ancestor
102375939|NCT05584878|Sequestering Agents|sequestering agents|mesh-ancestor
101944777|NCT05137587|Analgesics|analgesics|mesh-ancestor
102375940|NCT05584878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375941|NCT05584878|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102375942|NCT05584878|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102375943|NCT05584878|Antimetabolites|antimetabolites|mesh-ancestor
102375944|NCT05584878|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102375945|NCT05584878|Hemostatics|hemostatics|mesh-ancestor
102375946|NCT05584878|Coagulants|coagulants|mesh-ancestor
102375947|NCT01643902|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102375948|NCT01643902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102375949|NCT01643902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102375950|NCT01643902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375951|NCT03347994|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
102375952|NCT03347994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102375953|NCT03347994|Alkylating Agents|alkylating agents|mesh-ancestor
102375954|NCT03347994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375955|NCT03347994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102375956|NCT04966338|Ocrelizumab|ocrelizumab|mesh-list
102375957|NCT04966338|Immunologic Factors|immunologic factors|mesh-ancestor
102375958|NCT04966338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375959|NCT03347916|Gabapentin|gabapentin|mesh-list
102375960|NCT03347916|Analgesics|analgesics|mesh-ancestor
102375961|NCT03347916|Sensory System Agents|sensory system agents|mesh-ancestor
102375962|NCT03347916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102375963|NCT03347916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375964|NCT03347916|Anticonvulsants|anticonvulsants|mesh-ancestor
102375965|NCT03347916|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102375966|NCT03347916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102375967|NCT03347916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102375968|NCT03347916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102375969|NCT03347916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102375970|NCT03347916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102375971|NCT03347916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102375972|NCT03347916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375973|NCT03347916|Antimanic Agents|antimanic agents|mesh-ancestor
102375974|NCT05584644|Palbociclib|palbociclib|mesh-list
102375975|NCT05584644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102375976|NCT05584644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101944818|NCT03708536|Antimetabolites|antimetabolites|mesh-ancestor
102375977|NCT05584644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102375978|NCT05584644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944820|NCT03705728|Remifentanil|remifentanil|mesh-list
102375979|NCT04892706|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
102375980|NCT04892706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102375981|NCT04892706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102375982|NCT04892706|Analgesics|analgesics|mesh-ancestor
102375983|NCT04892706|Sensory System Agents|sensory system agents|mesh-ancestor
102375984|NCT04892706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102375985|NCT04892706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944828|NCT03705728|Anesthetics|anesthetics|mesh-ancestor
102375986|NCT04892706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102375987|NCT04892706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102375988|NCT04892706|Dermatologic Agents|dermatologic agents|mesh-ancestor
102375989|NCT01821677|Danazol|danazol|mesh-list
102375990|NCT01821677|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102375991|NCT01821677|Hormone Antagonists|hormone antagonists|mesh-ancestor
101944834|NCT03705728|Sensory System Agents|sensory system agents|mesh-ancestor
102375992|NCT01821677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102375993|NCT01821677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102375994|NCT03347760|Octreotide|octreotide|mesh-list
102375995|NCT03347760|Edotreotide|edotreotide|mesh-list
101944836|NCT01147419|Blood Substitutes|blood substitutes|mesh-list
102375996|NCT03347760|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102375997|NCT03347760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102375998|NCT03347760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102375999|NCT03347760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102376000|NCT03347760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102376001|NCT03062280|Hydrocortisone|hydrocortisone|mesh-list
102376002|NCT03062280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102376003|NCT00709722|Gusperimus|gusperimus|mesh-list
102154175|NCT03606577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102376005|NCT00709722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102376006|NCT00709722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102376007|NCT00709722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376008|NCT00709722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102376009|NCT00709722|Immunologic Factors|immunologic factors|mesh-ancestor
102376010|NCT00709722|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102376011|NCT00709722|Protective Agents|protective agents|mesh-ancestor
102376012|NCT01820585|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102376013|NCT01820585|Anticonvulsants|anticonvulsants|mesh-ancestor
102376014|NCT01820585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102376015|NCT01820585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102376016|NCT01820585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102376017|NCT01820585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376018|NCT02378298|Methylprednisolone|methylprednisolone|mesh-list
102376019|NCT02378298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102376020|NCT02378298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102376021|NCT02378298|Prednisolone|prednisolone|mesh-list
102376022|NCT02378298|Prednisolone acetate|prednisolone acetate|mesh-list
102376023|NCT02378298|Rituximab|rituximab|mesh-list
102376024|NCT02378298|Methotrexate|methotrexate|mesh-list
102376025|NCT02378298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102376026|NCT02378298|Prednisolone phosphate|prednisolone phosphate|mesh-list
102376027|NCT02378298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102376028|NCT02378298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102376029|NCT02378298|Immunologic Factors|immunologic factors|mesh-ancestor
102094519|NCT05773066|Lidocaine|lidocaine|mesh-list
102376030|NCT02378298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376031|NCT02378298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102376032|NCT02378298|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102376033|NCT02378298|Abortifacient Agents|abortifacient agents|mesh-ancestor
101944876|NCT01246323|Analgesics|analgesics|mesh-ancestor
102376034|NCT02378298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102376035|NCT02378298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102376036|NCT02378298|Antimetabolites|antimetabolites|mesh-ancestor
102376037|NCT02378298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376038|NCT02378298|Dermatologic Agents|dermatologic agents|mesh-ancestor
102376039|NCT02378298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102376040|NCT02378298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102376041|NCT02378298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102376042|NCT02378298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102376043|NCT02378298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102376044|NCT02378298|Antiemetics|antiemetics|mesh-ancestor
102376045|NCT02378298|Autonomic Agents|autonomic agents|mesh-ancestor
101944888|NCT05177276|Irinotecan|irinotecan|mesh-list
102376046|NCT02378298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102376047|NCT02378298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102376048|NCT02378298|Glucocorticoids|glucocorticoids|mesh-ancestor
102376049|NCT02378298|Hormones|hormones|mesh-ancestor
102376050|NCT02378298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102376051|NCT02378298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102376052|NCT02378298|Protective Agents|protective agents|mesh-ancestor
102376053|NCT02378298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102376054|NCT02253108|Everolimus|everolimus|mesh-list
102376055|NCT02253108|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102376056|NCT02253108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102376057|NCT02253108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102376058|NCT02253108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376059|NCT02253108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101815013|NCT00399568|Acetaminophen|acetaminophen|mesh-list
102376060|NCT02253108|Immunologic Factors|immunologic factors|mesh-ancestor
102376061|NCT02253108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376062|NCT02253108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102376063|NCT01603420|Ascorbic Acid|ascorbic acid|mesh-list
102376064|NCT01603420|Docetaxel|docetaxel|mesh-list
102376065|NCT01603420|Methyltestosterone|methyltestosterone|mesh-list
102376066|NCT01603420|Hormones|hormones|mesh-list
101944904|NCT03708458|Expectorants|expectorants|mesh-ancestor
102376067|NCT01603420|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
102376068|NCT01603420|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
102376069|NCT01603420|Androgens|androgens|mesh-list
102376070|NCT01603420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102376071|NCT01603420|Tubulin Modulators|tubulin modulators|mesh-ancestor
102376072|NCT01603420|Antimitotic Agents|antimitotic agents|mesh-ancestor
102376073|NCT01603420|Mitosis Modulators|mitosis modulators|mesh-ancestor
102187824|NCT04259255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187825|NCT04259255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102187826|NCT04259255|Protective Agents|protective agents|mesh-ancestor
102187827|NCT04259255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376074|NCT01603420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376075|NCT01603420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101944913|NCT03708458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102376076|NCT01603420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376077|NCT01603420|Antioxidants|antioxidants|mesh-ancestor
102376078|NCT01603420|Protective Agents|protective agents|mesh-ancestor
102376079|NCT01603420|Vitamins|vitamins|mesh-ancestor
102376080|NCT01603420|Micronutrients|micronutrients|mesh-ancestor
102376081|NCT01603420|Estrogens|estrogens|mesh-ancestor
102376082|NCT01603420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102376083|NCT01603420|Anabolic Agents|anabolic agents|mesh-ancestor
102376084|NCT02064036|Leuprolide|leuprolide|mesh-list
102376085|NCT02064036|Goserelin|goserelin|mesh-list
102376086|NCT02064036|Bicalutamide|bicalutamide|mesh-list
102376087|NCT02064036|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102376088|NCT02064036|Fertility Agents|fertility agents|mesh-ancestor
102376089|NCT02064036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102376090|NCT02064036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376091|NCT02064036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102376092|NCT02064036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102376093|NCT02064036|Androgen Antagonists|androgen antagonists|mesh-ancestor
102376094|NCT02064036|Hormone Antagonists|hormone antagonists|mesh-ancestor
102376095|NCT02064036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102376096|NCT05645484|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102376097|NCT05645484|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102376098|NCT05645484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376099|NCT04551300|Sevelamer|sevelamer|mesh-list
102376100|NCT04551300|Chelating Agents|chelating agents|mesh-ancestor
102376101|NCT04551300|Sequestering Agents|sequestering agents|mesh-ancestor
102376102|NCT04551300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376103|NCT04974580|Nicotine|nicotine|mesh-list
102376104|NCT04974580|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102376105|NCT04974580|Autonomic Agents|autonomic agents|mesh-ancestor
102376106|NCT04974580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102376107|NCT04974580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376108|NCT04974580|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101785105|NCT02555852|Antacids|antacids|mesh-ancestor
102376109|NCT04974580|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102376110|NCT04974580|Cholinergic Agents|cholinergic agents|mesh-ancestor
102376111|NCT04974580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102376112|NCT04974580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376113|NCT01691326|Vaccines|vaccines|mesh-list
102376114|NCT01691326|Immunologic Factors|immunologic factors|mesh-ancestor
102376115|NCT01691326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376116|NCT01606852|Dexmedetomidine|dexmedetomidine|mesh-list
102376117|NCT01606852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102376118|NCT01606852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102376119|NCT01606852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376120|NCT01606852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102376121|NCT01606852|Analgesics|analgesics|mesh-ancestor
102376122|NCT01606852|Sensory System Agents|sensory system agents|mesh-ancestor
102376123|NCT01606852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102376124|NCT01606852|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102376125|NCT01606852|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102376126|NCT01606852|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102376127|NCT01606852|Adrenergic Agents|adrenergic agents|mesh-ancestor
102376128|NCT01606852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102376129|NCT01606852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376130|NCT01691560|Calcium, Dietary|calcium, dietary|mesh-list
102376131|NCT01691560|Listerine|listerine|mesh-list
102376132|NCT01691560|Calcium|calcium|mesh-list
102376133|NCT01691560|Fluorides|fluorides|mesh-list
102376134|NCT01691560|Sodium Fluoride|sodium fluoride|mesh-list
102376135|NCT01691560|Fluorophosphate|fluorophosphate|mesh-list
101944967|NCT05631717|Aldesleukin|aldesleukin|mesh-list
102376136|NCT01691560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102376137|NCT01691560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376138|NCT01691560|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102376139|NCT01691560|Cariostatic Agents|cariostatic agents|mesh-ancestor
102376140|NCT01691560|Protective Agents|protective agents|mesh-ancestor
102376141|NCT01691560|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102376142|NCT01691560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102376143|NCT03346200|Tamoxifen|tamoxifen|mesh-list
102376144|NCT03346200|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102376145|NCT03346200|Hormone Antagonists|hormone antagonists|mesh-ancestor
102376146|NCT03346200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102376147|NCT03346200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944983|NCT01147731|Hormones|hormones|mesh-ancestor
102187902|NCT04128748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102376148|NCT03346200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102376149|NCT03346200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102376150|NCT03346200|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102376151|NCT03346200|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102376152|NCT03346200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102376153|NCT01692340|Lycopene|lycopene|mesh-list
102376154|NCT01692340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102376155|NCT01692340|Antioxidants|antioxidants|mesh-ancestor
102376156|NCT01692340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376157|NCT01692340|Protective Agents|protective agents|mesh-ancestor
102376158|NCT01692340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376159|NCT01692340|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102376160|NCT01692340|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102376161|NCT01692340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102376162|NCT02517372|Pemirolast|pemirolast|mesh-list
102376163|NCT02517372|Histamine Antagonists|histamine antagonists|mesh-ancestor
102376164|NCT02517372|Histamine Agents|histamine agents|mesh-ancestor
102376165|NCT02517372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102376166|NCT02517372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376167|NCT02517372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376168|NCT02516826|Olmesartan|olmesartan|mesh-list
101550240|NCT00598169|Rituximab|rituximab|mesh-list
102376169|NCT02516826|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
102376170|NCT02516826|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102376171|NCT02516826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102376172|NCT02516826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102376173|NCT02516826|Antimetabolites|antimetabolites|mesh-ancestor
102376174|NCT02516826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376175|NCT02516826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102376176|NCT02516826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102376177|NCT02516826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102376178|NCT02516826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101550466|NCT00601991|Aflibercept|aflibercept|mesh-list
102376179|NCT02516826|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102376180|NCT02516826|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102376181|NCT01650298|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
102376182|NCT01650298|Thrombin|thrombin|mesh-list
102376183|NCT01650298|Hemostatics|hemostatics|mesh-ancestor
102376184|NCT01650298|Coagulants|coagulants|mesh-ancestor
102376185|NCT01650298|Antithrombins|antithrombins|mesh-ancestor
102376186|NCT01650298|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102376187|NCT01650298|Protease Inhibitors|protease inhibitors|mesh-ancestor
102376188|NCT01650298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102376189|NCT01650298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376190|NCT01650298|Anticoagulants|anticoagulants|mesh-ancestor
102376191|NCT05583006|Tenofovir|tenofovir|mesh-list
102376192|NCT05583006|Antiviral Agents|antiviral agents|mesh-ancestor
102376193|NCT05583006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102376194|NCT05583006|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102376195|NCT05583006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102376196|NCT05583006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102376197|NCT05583006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376198|NCT05583006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102376199|NCT05583006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102376200|NCT01795937|Itraconazole|itraconazole|mesh-list
102376201|NCT01795937|Atorvastatin|atorvastatin|mesh-list
102376202|NCT01795937|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102376203|NCT01795937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102376204|NCT01795937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102376205|NCT01795937|Antimetabolites|antimetabolites|mesh-ancestor
102376206|NCT01795937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376207|NCT01795937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102376208|NCT01795937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102376209|NCT01795937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102376210|NCT01795937|Antifungal Agents|antifungal agents|mesh-ancestor
102376211|NCT01795937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102376212|NCT01795937|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102376213|NCT01795937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102376214|NCT01795937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102376215|NCT01795937|Hormone Antagonists|hormone antagonists|mesh-ancestor
102376216|NCT01795937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102376217|NCT01795937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376218|NCT01795937|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102376219|NCT04501224|Tenofovir|tenofovir|mesh-list
102376220|NCT04501224|Entecavir|entecavir|mesh-list
102376221|NCT04501224|Antiviral Agents|antiviral agents|mesh-ancestor
102376222|NCT04501224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102376223|NCT04501224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102376224|NCT04501224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102376225|NCT04501224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101945060|NCT04865835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102376226|NCT04501224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376227|NCT04501224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102376228|NCT04501224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102376229|NCT01817777|Metformin|metformin|mesh-list
102376230|NCT01817777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102376231|NCT01817777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376232|NCT01795547|Aripiprazole|aripiprazole|mesh-list
102376233|NCT01795547|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102376234|NCT01795547|Antidepressive Agents|antidepressive agents|mesh-ancestor
102376235|NCT01795547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101945071|NCT03911271|Mydriatics|mydriatics|mesh-ancestor
102376236|NCT01795547|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102376237|NCT01795547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102376238|NCT01795547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102376239|NCT01795547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376240|NCT01795547|Dopamine Agonists|dopamine agonists|mesh-ancestor
102376241|NCT01795547|Dopamine Agents|dopamine agents|mesh-ancestor
102376242|NCT01795547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102376243|NCT01795547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376244|NCT01795547|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101945082|NCT01248195|Autonomic Agents|autonomic agents|mesh-ancestor
102376245|NCT01795547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102376246|NCT01795547|Serotonin Agents|serotonin agents|mesh-ancestor
102376247|NCT01795547|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102376248|NCT01795547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102376249|NCT01795547|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102376250|NCT01795547|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102376251|NCT03863184|Rituximab|rituximab|mesh-list
102376252|NCT03863184|Lenalidomide|lenalidomide|mesh-list
102376253|NCT03863184|Acalabrutinib|acalabrutinib|mesh-list
102376254|NCT03863184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102376255|NCT03863184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102376256|NCT03863184|Immunologic Factors|immunologic factors|mesh-ancestor
101945086|NCT01248195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102376257|NCT03863184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376258|NCT03863184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101552006|NCT02871349|Propranolol|propranolol|mesh-list
102376259|NCT03863184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102376260|NCT03863184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102376261|NCT03863184|Growth Substances|growth substances|mesh-ancestor
102376262|NCT03863184|Growth Inhibitors|growth inhibitors|mesh-ancestor
102376263|NCT02516904|Rezafungin|rezafungin|mesh-list
102376264|NCT02516904|Antifungal Agents|antifungal agents|mesh-ancestor
102376265|NCT02516904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102376266|NCT01794845|Docetaxel|docetaxel|mesh-list
102376267|NCT01794845|Cetuximab|cetuximab|mesh-list
102376268|NCT01794845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102376269|NCT01794845|Tubulin Modulators|tubulin modulators|mesh-ancestor
102376270|NCT01794845|Antimitotic Agents|antimitotic agents|mesh-ancestor
102376271|NCT01794845|Mitosis Modulators|mitosis modulators|mesh-ancestor
102376272|NCT01794845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376273|NCT01794845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102376274|NCT01794689|Morphine|morphine|mesh-list
102376275|NCT01794689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102376276|NCT01794689|Narcotics|narcotics|mesh-ancestor
102376277|NCT01794689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102376278|NCT01794689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376279|NCT01794689|Analgesics|analgesics|mesh-ancestor
102376280|NCT01794689|Sensory System Agents|sensory system agents|mesh-ancestor
102376281|NCT01794689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102376282|NCT01817075|Chlorhexidine|chlorhexidine|mesh-list
102376283|NCT01817075|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102376284|NCT01817075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102376285|NCT01817075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102376286|NCT01817075|Disinfectants|disinfectants|mesh-ancestor
102376287|NCT01817075|Dermatologic Agents|dermatologic agents|mesh-ancestor
102376288|NCT00708552|Donepezil|donepezil|mesh-list
102376289|NCT00708552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102376290|NCT00708552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101945121|NCT03341312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102376291|NCT00708552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376292|NCT00708552|Cholinergic Agents|cholinergic agents|mesh-ancestor
102376293|NCT00708552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102376294|NCT00708552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376295|NCT00708552|Nootropic Agents|nootropic agents|mesh-ancestor
102376296|NCT02516436|Buprenorphine|buprenorphine|mesh-list
102376297|NCT02516436|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102376298|NCT02516436|Narcotics|narcotics|mesh-ancestor
102376299|NCT02516436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102376300|NCT02516436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376301|NCT02516436|Analgesics|analgesics|mesh-ancestor
102376302|NCT02516436|Sensory System Agents|sensory system agents|mesh-ancestor
102376303|NCT02516436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102376304|NCT02516436|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102376305|NCT03347526|Vigabatrin|vigabatrin|mesh-list
102376306|NCT03347526|Cosyntropin|cosyntropin|mesh-list
102376307|NCT03347526|Anticonvulsants|anticonvulsants|mesh-ancestor
102376308|NCT03347526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102376309|NCT03347526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376310|NCT03347526|GABA Agents|gaba agents|mesh-ancestor
102376311|NCT03347526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102376312|NCT03347526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376313|NCT03347526|Hormones|hormones|mesh-ancestor
101945143|NCT01239459|Antimetabolites|antimetabolites|mesh-ancestor
102376314|NCT03347526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102376315|NCT03347370|Interferons|interferons|mesh-list
102376316|NCT03347370|Interferon-beta|interferon-beta|mesh-list
102376317|NCT03347370|Interferon beta-1a|interferon beta-1a|mesh-list
102376318|NCT03347370|Interferon beta-1b|interferon beta-1b|mesh-list
102376319|NCT03347370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102376320|NCT03347370|Antiviral Agents|antiviral agents|mesh-ancestor
102376321|NCT03347370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102376322|NCT03347370|Immunologic Factors|immunologic factors|mesh-ancestor
102376323|NCT03347370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376324|NCT03347370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102376325|NCT02515968|Propofol|propofol|mesh-list
102376326|NCT02515968|Desflurane|desflurane|mesh-list
102376327|NCT02515968|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102376328|NCT02515968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102376329|NCT02515968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945159|NCT01148277|Fentanyl|fentanyl|mesh-list
102376330|NCT02515968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102376331|NCT02515968|Anesthetics, General|anesthetics, general|mesh-ancestor
102376332|NCT02515968|Anesthetics|anesthetics|mesh-ancestor
102376333|NCT02515968|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102376334|NCT03345966|Antibodies|antibodies|mesh-list
102376335|NCT03345966|Immunologic Factors|immunologic factors|mesh-ancestor
102376336|NCT03345966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376337|NCT02507700|Bupivacaine|bupivacaine|mesh-list
102376338|NCT02507700|Sevoflurane|sevoflurane|mesh-list
102376339|NCT02507700|Anesthetics, Local|anesthetics, local|mesh-ancestor
102376340|NCT02507700|Anesthetics|anesthetics|mesh-ancestor
102376341|NCT02507700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102376342|NCT02507700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376343|NCT02507700|Sensory System Agents|sensory system agents|mesh-ancestor
102376344|NCT02507700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102376345|NCT02507700|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102376346|NCT02507700|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102376347|NCT02507700|Anesthetics, General|anesthetics, general|mesh-ancestor
102376348|NCT02513004|Clopidogrel|clopidogrel|mesh-list
102376349|NCT02513004|Ticagrelor|ticagrelor|mesh-list
102376350|NCT02513004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102376351|NCT02513004|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102376352|NCT02513004|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102376353|NCT02513004|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102376354|NCT02513004|Purinergic Agents|purinergic agents|mesh-ancestor
102376355|NCT02513004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102376356|NCT02513004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376357|NCT02513004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376358|NCT04500522|Isoniazid|isoniazid|mesh-list
102376359|NCT04500522|Antitubercular Agents|antitubercular agents|mesh-ancestor
102376360|NCT04500522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102376361|NCT04500522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102376362|NCT04500522|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102376363|NCT04500522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102376364|NCT04500522|Antimetabolites|antimetabolites|mesh-ancestor
102376365|NCT04500522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554386|NCT01020526|Analgesics|analgesics|mesh-ancestor
102376366|NCT04500522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102376367|NCT02507232|Temozolomide|temozolomide|mesh-list
102376368|NCT02507232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102376369|NCT02507232|Alkylating Agents|alkylating agents|mesh-ancestor
101554551|NCT04433767|Nicotine|nicotine|mesh-list
102376370|NCT02507232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376371|NCT02507232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102376372|NCT02506998|Histamine|histamine|mesh-list
102376373|NCT02506998|Histamine Antagonists|histamine antagonists|mesh-list
102376374|NCT02506998|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
102376375|NCT02506998|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
102376376|NCT02506998|Histamine Agonists|histamine agonists|mesh-ancestor
102376378|NCT02506998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102376379|NCT02506998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376380|NCT02506998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376381|NCT02507076|Melphalan|melphalan|mesh-list
102376382|NCT02507076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102376383|NCT02507076|Alkylating Agents|alkylating agents|mesh-ancestor
102376384|NCT02507076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376385|NCT02507076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102376386|NCT02507076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102376387|NCT02507076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102376388|NCT02507076|Immunologic Factors|immunologic factors|mesh-ancestor
101945216|NCT03907215|Serotonin Agents|serotonin agents|mesh-ancestor
102376389|NCT02507076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376390|NCT01609348|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102376391|NCT01609348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102376392|NCT01609348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102376393|NCT01609348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101555075|NCT00985621|Oxycodone|oxycodone|mesh-list
102376394|NCT01609348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376395|NCT01609348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102376396|NCT01609348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376397|NCT01609348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102376398|NCT01609348|Antidepressive Agents|antidepressive agents|mesh-ancestor
102376399|NCT01609348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102376400|NCT04500678|Metformin|metformin|mesh-list
102376401|NCT04500678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102376402|NCT04500678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376403|NCT02507154|Cetuximab|cetuximab|mesh-list
102376404|NCT02507154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102376405|NCT02507154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102376406|NCT02515734|Leucovorin|leucovorin|mesh-list
102376407|NCT02515734|Bevacizumab|bevacizumab|mesh-list
102376408|NCT02515734|Cetuximab|cetuximab|mesh-list
102376409|NCT02515734|Fluorouracil|fluorouracil|mesh-list
102376410|NCT02515734|Oxaliplatin|oxaliplatin|mesh-list
102376411|NCT02515734|Irinotecan|irinotecan|mesh-list
102376412|NCT02515734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102376413|NCT02515734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102376414|NCT02515734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102376415|NCT02515734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102376416|NCT02515734|Growth Substances|growth substances|mesh-ancestor
101945241|NCT03902925|Lidocaine|lidocaine|mesh-list
102376417|NCT02515734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376418|NCT02515734|Growth Inhibitors|growth inhibitors|mesh-ancestor
102376419|NCT02515734|Antimetabolites|antimetabolites|mesh-ancestor
102376420|NCT02515734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376421|NCT02515734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102376422|NCT02515734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102376423|NCT02515734|Immunologic Factors|immunologic factors|mesh-ancestor
102376424|NCT02515734|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102376425|NCT02515734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102376426|NCT02515734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102376427|NCT02515734|Antidotes|antidotes|mesh-ancestor
102376428|NCT02515734|Protective Agents|protective agents|mesh-ancestor
102376429|NCT02515734|Vitamin B Complex|vitamin b complex|mesh-ancestor
102376430|NCT02515734|Vitamins|vitamins|mesh-ancestor
102376431|NCT02515734|Micronutrients|micronutrients|mesh-ancestor
102376432|NCT02512536|Botulinum Toxins|botulinum toxins|mesh-list
102376433|NCT02512536|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102376434|NCT02512536|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102376435|NCT02512536|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102376436|NCT02512536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102376437|NCT02512536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376438|NCT02512536|Cholinergic Agents|cholinergic agents|mesh-ancestor
101945265|NCT01250535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102376439|NCT02512536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102376440|NCT02512536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376441|NCT02512536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102376442|NCT02512536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102376443|NCT02506842|Leucovorin|leucovorin|mesh-list
102376444|NCT02506842|Folic Acid|folic acid|mesh-list
102376445|NCT02506842|Gemcitabine|gemcitabine|mesh-list
102376446|NCT02506842|Fluorouracil|fluorouracil|mesh-list
101945271|NCT03906669|Tamoxifen|tamoxifen|mesh-list
102376447|NCT02506842|Oxaliplatin|oxaliplatin|mesh-list
102376448|NCT02506842|Levoleucovorin|levoleucovorin|mesh-list
102376449|NCT02506842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102376450|NCT02506842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376451|NCT02506842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102376452|NCT02506842|Antimetabolites|antimetabolites|mesh-ancestor
102376453|NCT02506842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102376454|NCT02506842|Immunologic Factors|immunologic factors|mesh-ancestor
102376455|NCT02506842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620170|NCT00770653|Metformin|metformin|mesh-list
102376456|NCT02506842|Antidotes|antidotes|mesh-ancestor
102376457|NCT02506842|Protective Agents|protective agents|mesh-ancestor
102376458|NCT02506842|Vitamin B Complex|vitamin b complex|mesh-ancestor
102376460|NCT02506842|Micronutrients|micronutrients|mesh-ancestor
102376461|NCT02506842|Hematinics|hematinics|mesh-ancestor
102376462|NCT02512614|Anti-Infective Agents|anti-infective agents|mesh-list
102376463|NCT02512614|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102376464|NCT03345498|Entecavir|entecavir|mesh-list
102376465|NCT03345498|Antiviral Agents|antiviral agents|mesh-ancestor
102376466|NCT03345498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102376467|NCT02506686|Meropenem|meropenem|mesh-list
102376468|NCT02506686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102376469|NCT02506686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102376470|NCT04499742|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
102376471|NCT04499742|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102376472|NCT04499742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376473|NCT02512380|Docetaxel|docetaxel|mesh-list
102376474|NCT02512380|Oxaliplatin|oxaliplatin|mesh-list
102376475|NCT02512380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102376476|NCT02512380|Tubulin Modulators|tubulin modulators|mesh-ancestor
102376477|NCT02512380|Antimitotic Agents|antimitotic agents|mesh-ancestor
102376478|NCT02512380|Mitosis Modulators|mitosis modulators|mesh-ancestor
102376479|NCT02512380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376480|NCT04497792|Metformin|metformin|mesh-list
102376481|NCT04497792|Empagliflozin|empagliflozin|mesh-list
102376482|NCT04497792|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102376483|NCT04497792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376484|NCT04497792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101620664|NCT05803863|Atropine|atropine|mesh-list
102376485|NCT04497792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376486|NCT03344952|Botulinum Toxins|botulinum toxins|mesh-list
102376487|NCT03344952|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102376488|NCT03344952|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102376489|NCT03344952|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102376490|NCT03344952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102376491|NCT03344952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376492|NCT03344952|Cholinergic Agents|cholinergic agents|mesh-ancestor
102376493|NCT03344952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102376494|NCT03344952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376495|NCT03344952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102376496|NCT03344952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102376497|NCT02515422|Ketamine|ketamine|mesh-list
102376498|NCT02515422|Bupivacaine|bupivacaine|mesh-list
102376499|NCT02515422|Anesthetics, Local|anesthetics, local|mesh-ancestor
102376500|NCT02515422|Anesthetics|anesthetics|mesh-ancestor
102376501|NCT02515422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102376502|NCT02515422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376503|NCT02515422|Sensory System Agents|sensory system agents|mesh-ancestor
102376504|NCT02515422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102376505|NCT02515422|Analgesics|analgesics|mesh-ancestor
102376506|NCT02515422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102376507|NCT02515422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102376508|NCT02515422|Anesthetics, General|anesthetics, general|mesh-ancestor
102376509|NCT02515422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102376510|NCT02515422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102376511|NCT02515422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101945332|NCT03563950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102376512|NCT02515422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376513|NCT02506296|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
102376514|NCT02506296|Protease Inhibitors|protease inhibitors|mesh-ancestor
102376515|NCT02506296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102376516|NCT02506296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376517|NCT02506296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102376518|NCT02506296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376519|NCT02506140|Aspirin|aspirin|mesh-list
102376520|NCT02506140|Clopidogrel|clopidogrel|mesh-list
102376521|NCT02506140|Ticagrelor|ticagrelor|mesh-list
102376522|NCT02506140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102376523|NCT02506140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102376525|NCT02506140|Sensory System Agents|sensory system agents|mesh-ancestor
101945335|NCT03905655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102376526|NCT02506140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102376527|NCT02506140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376528|NCT02506140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102376529|NCT02506140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102376530|NCT02506140|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102376531|NCT02506140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101945353|NCT01254123|Exenatide|exenatide|mesh-list
102376532|NCT02506140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376533|NCT02506140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102376534|NCT02506140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102376535|NCT02506140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102376536|NCT02506140|Antipyretics|antipyretics|mesh-ancestor
102376537|NCT02506140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102376538|NCT02506140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102376539|NCT02506140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102376540|NCT02506140|Purinergic Agents|purinergic agents|mesh-ancestor
102376541|NCT02506140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102376542|NCT02515188|Acetaminophen|acetaminophen|mesh-list
102376543|NCT02515188|Propacetamol|propacetamol|mesh-list
102376544|NCT02515188|Analgesics|analgesics|mesh-ancestor
102376545|NCT02515188|Sensory System Agents|sensory system agents|mesh-ancestor
102376546|NCT02515188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102376547|NCT02515188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376548|NCT02515188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101945359|NCT01254123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101945360|NCT03898635|Linezolid|linezolid|mesh-list
101945361|NCT03898635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101945362|NCT03898635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101945363|NCT03898635|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101945364|NCT03898635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101945366|NCT05116917|Nivolumab|nivolumab|mesh-list
102376549|NCT02515188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102376550|NCT02515188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102376551|NCT02515188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102376552|NCT02515188|Antipyretics|antipyretics|mesh-ancestor
102376553|NCT01696084|Cytarabine|cytarabine|mesh-list
102376554|NCT01696084|Daunorubicin|daunorubicin|mesh-list
102376555|NCT01696084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102376556|NCT01696084|Antimetabolites|antimetabolites|mesh-ancestor
102376557|NCT01696084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376558|NCT01696084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102376559|NCT01696084|Antiviral Agents|antiviral agents|mesh-ancestor
102376560|NCT01696084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102376561|NCT01696084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101621524|NCT03562416|Nintedanib|nintedanib|mesh-list
102376562|NCT01696084|Immunologic Factors|immunologic factors|mesh-ancestor
102376563|NCT01696084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376564|NCT01696084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101945382|NCT01255215|Autonomic Agents|autonomic agents|mesh-ancestor
102376565|NCT01696084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102376566|NCT01696084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102376567|NCT01696084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102376568|NCT02228824|Nicotine|nicotine|mesh-list
102376569|NCT02228824|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102376570|NCT02228824|Autonomic Agents|autonomic agents|mesh-ancestor
102376571|NCT02228824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102376572|NCT02228824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376573|NCT02228824|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102376574|NCT02228824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102376575|NCT02228824|Cholinergic Agents|cholinergic agents|mesh-ancestor
102376576|NCT02228824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102376577|NCT02228824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376578|NCT02511366|Caseins|caseins|mesh-list
102376579|NCT02511366|Chelating Agents|chelating agents|mesh-ancestor
102376580|NCT02511366|Sequestering Agents|sequestering agents|mesh-ancestor
102376581|NCT02511366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376582|NCT02514954|Insulin Lispro|insulin lispro|mesh-list
102376583|NCT02514954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102376584|NCT02514954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376585|NCT04443036|Paclitaxel|paclitaxel|mesh-list
102376586|NCT04443036|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102376587|NCT04443036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102376588|NCT04443036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102376589|NCT04443036|Tubulin Modulators|tubulin modulators|mesh-ancestor
102376590|NCT04443036|Antimitotic Agents|antimitotic agents|mesh-ancestor
102376591|NCT04443036|Mitosis Modulators|mitosis modulators|mesh-ancestor
101945413|NCT03904719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102376592|NCT04443036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376593|NCT01653418|Cytarabine|cytarabine|mesh-list
102376594|NCT01653418|Etoposide|etoposide|mesh-list
102376595|NCT01653418|Bortezomib|bortezomib|mesh-list
102376596|NCT01653418|Melphalan|melphalan|mesh-list
102376597|NCT01653418|Carmustine|carmustine|mesh-list
102188349|NCT00588991|Carboplatin|carboplatin|mesh-list
102376598|NCT01653418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102376599|NCT01653418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102376600|NCT01653418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102376601|NCT01653418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102376602|NCT01653418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102376603|NCT01653418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376604|NCT01653418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102376605|NCT01653418|Antimetabolites|antimetabolites|mesh-ancestor
102376606|NCT01653418|Antiviral Agents|antiviral agents|mesh-ancestor
102376607|NCT01653418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102376608|NCT01653418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102376609|NCT01653418|Immunologic Factors|immunologic factors|mesh-ancestor
102376610|NCT01653418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376611|NCT01653418|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102376612|NCT01653418|Alkylating Agents|alkylating agents|mesh-ancestor
102376613|NCT01653418|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102376614|NCT02514642|Clopidogrel|clopidogrel|mesh-list
102376615|NCT02514642|Ticagrelor|ticagrelor|mesh-list
102376616|NCT02514642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102376617|NCT02514642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102376618|NCT02514642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102376619|NCT02514642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102376620|NCT02514642|Purinergic Agents|purinergic agents|mesh-ancestor
102376621|NCT02514642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102376622|NCT02514642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376623|NCT02514642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376624|NCT02511210|Anesthetics|anesthetics|mesh-list
102376625|NCT02511210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101945437|NCT01256619|Progestins|progestins|mesh-ancestor
102376626|NCT02511210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376627|NCT02237950|Metronidazole|metronidazole|mesh-list
102376628|NCT02237950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102376629|NCT02237950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102376630|NCT02237950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102376631|NCT02237950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102376632|NCT02511054|Chloroquine|chloroquine|mesh-list
102376633|NCT02511054|Pyrimethamine|pyrimethamine|mesh-list
102376634|NCT02511054|Amebicides|amebicides|mesh-ancestor
102376635|NCT02511054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102376636|NCT02511054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102376637|NCT02511054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102376638|NCT02511054|Antimalarials|antimalarials|mesh-ancestor
102376639|NCT02511054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102376640|NCT02511054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102376641|NCT02511054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102376642|NCT02511054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376643|NCT04499118|Paclitaxel|paclitaxel|mesh-list
102376644|NCT04499118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102376645|NCT04499118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102376646|NCT04499118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102376647|NCT04499118|Tubulin Modulators|tubulin modulators|mesh-ancestor
102376648|NCT04499118|Antimitotic Agents|antimitotic agents|mesh-ancestor
102376649|NCT04499118|Mitosis Modulators|mitosis modulators|mesh-ancestor
102376650|NCT04499118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376651|NCT01612546|Camptothecin|camptothecin|mesh-list
102376652|NCT01612546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102376653|NCT01612546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102376654|NCT01612546|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102376655|NCT01612546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102376656|NCT01612546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102376657|NCT01612546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376658|NCT04499898|Carvedilol|carvedilol|mesh-list
102376659|NCT04499898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102376660|NCT04499898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102376661|NCT04499898|Adrenergic Agents|adrenergic agents|mesh-ancestor
102376662|NCT04499898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102376663|NCT04499898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945470|NCT01149993|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102376664|NCT04499898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376665|NCT04499898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102376666|NCT04499898|Antioxidants|antioxidants|mesh-ancestor
102376667|NCT04499898|Protective Agents|protective agents|mesh-ancestor
102376668|NCT04499898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102376669|NCT04499898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102376670|NCT04499898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102376671|NCT04499898|Vasodilator Agents|vasodilator agents|mesh-ancestor
102154176|NCT03606577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376672|NCT04499898|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102376673|NCT04499898|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102376674|NCT02514330|Dihydrotachysterol|dihydrotachysterol|mesh-list
102376675|NCT02514330|Vitamins|vitamins|mesh-ancestor
102376676|NCT02514330|Micronutrients|micronutrients|mesh-ancestor
102376677|NCT02514330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376678|NCT02514330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102376679|NCT02510976|Prucalopride|prucalopride|mesh-list
102376680|NCT02510976|Laxatives|laxatives|mesh-ancestor
102376681|NCT02510976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102376682|NCT02510976|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
102376683|NCT02510976|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102376684|NCT02510976|Serotonin Agents|serotonin agents|mesh-ancestor
102376685|NCT02510976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102376686|NCT02510976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376687|NCT02510976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376688|NCT02505516|Metformin|metformin|mesh-list
102376689|NCT02505516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102376690|NCT02505516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376691|NCT02505360|Hyaluronic Acid|hyaluronic acid|mesh-list
102376692|NCT02505360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102376693|NCT02505360|Immunologic Factors|immunologic factors|mesh-ancestor
102376694|NCT02505360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376695|NCT02505360|Viscosupplements|viscosupplements|mesh-ancestor
102376696|NCT02505360|Protective Agents|protective agents|mesh-ancestor
102376697|NCT04499586|Irinotecan|irinotecan|mesh-list
102376698|NCT04499586|Raltitrexed|raltitrexed|mesh-list
102376699|NCT04499586|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102376700|NCT04499586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102376701|NCT04499586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102376702|NCT04499586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376703|NCT04499586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102376704|NCT04499586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102376705|NCT04499586|Antimetabolites|antimetabolites|mesh-ancestor
102376706|NCT04499586|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102376707|NCT02505282|Vitamin K|vitamin k|mesh-list
102376708|NCT02505282|Vitamins|vitamins|mesh-ancestor
102376709|NCT02505282|Micronutrients|micronutrients|mesh-ancestor
102376710|NCT02505282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376711|NCT02505282|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102376712|NCT02505282|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102376713|NCT02505282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376714|NCT02505282|Hemostatics|hemostatics|mesh-ancestor
102376715|NCT02505282|Coagulants|coagulants|mesh-ancestor
102376716|NCT01816295|Methyltestosterone|methyltestosterone|mesh-list
102376717|NCT01816295|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102376718|NCT01816295|Testosterone|testosterone|mesh-list
102376719|NCT01816295|Testosterone undecanoate|testosterone undecanoate|mesh-list
102376720|NCT01816295|Testosterone enanthate|testosterone enanthate|mesh-list
102376721|NCT01816295|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102376722|NCT01816295|Androgens|androgens|mesh-ancestor
102376723|NCT01816295|Hormones|hormones|mesh-ancestor
102376724|NCT01816295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102376725|NCT01816295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376726|NCT01816295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102376727|NCT01816295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102376728|NCT01816295|Anabolic Agents|anabolic agents|mesh-ancestor
102376729|NCT02514018|Vaccines|vaccines|mesh-list
102376730|NCT02514018|Immunologic Factors|immunologic factors|mesh-ancestor
102376731|NCT02514018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376732|NCT02513862|Heparin|heparin|mesh-list
102376733|NCT02513862|Protamines|protamines|mesh-list
102376734|NCT02513862|Anticoagulants|anticoagulants|mesh-ancestor
101945544|NCT01256775|Aspirin|aspirin|mesh-list
102376735|NCT02513862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102376736|NCT02513862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102376737|NCT02513862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376738|NCT02513862|Heparin Antagonists|heparin antagonists|mesh-ancestor
102376739|NCT02513862|Coagulants|coagulants|mesh-ancestor
102376740|NCT02510586|Sevoflurane|sevoflurane|mesh-list
102376741|NCT02510586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102376742|NCT02510586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102376743|NCT02510586|Anesthetics, General|anesthetics, general|mesh-ancestor
102376744|NCT02510586|Anesthetics|anesthetics|mesh-ancestor
102188495|NCT05450432|Ketamine|ketamine|mesh-list
102376745|NCT02510586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102376746|NCT02510586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376747|NCT01610297|Deferasirox|deferasirox|mesh-list
102376748|NCT01610297|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102376749|NCT01610297|Chelating Agents|chelating agents|mesh-ancestor
102376750|NCT01610297|Sequestering Agents|sequestering agents|mesh-ancestor
102376751|NCT01610297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376752|NCT01660672|Levetiracetam|levetiracetam|mesh-list
102376753|NCT01660672|Anticonvulsants|anticonvulsants|mesh-ancestor
102376754|NCT01660672|Nootropic Agents|nootropic agents|mesh-ancestor
102376755|NCT02505048|Rucaparib|rucaparib|mesh-list
102376756|NCT02505048|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102376757|NCT02505048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102376758|NCT02505048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376759|NCT02505048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102376760|NCT01793051|Minocycline|minocycline|mesh-list
102376761|NCT01793051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102376762|NCT01793051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102376763|NCT01792115|Vitamins|vitamins|mesh-list
102376764|NCT01792115|Vitamin E|vitamin e|mesh-list
102376765|NCT01792115|Tocopherols|tocopherols|mesh-list
102376766|NCT01792115|Tocotrienols|tocotrienols|mesh-list
102376767|NCT01792115|alpha-Tocopherol|alpha-tocopherol|mesh-list
102376768|NCT01792115|Micronutrients|micronutrients|mesh-ancestor
102376769|NCT01792115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376770|NCT01792115|Antioxidants|antioxidants|mesh-ancestor
102376771|NCT01792115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945576|NCT01255527|Bortezomib|bortezomib|mesh-list
102376772|NCT01792115|Protective Agents|protective agents|mesh-ancestor
102376773|NCT01791803|Nicotine|nicotine|mesh-list
102376774|NCT01791803|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102376775|NCT01791803|Autonomic Agents|autonomic agents|mesh-ancestor
102376776|NCT01791803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102376777|NCT01791803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376778|NCT01791803|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102376779|NCT01791803|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102376780|NCT01791803|Cholinergic Agents|cholinergic agents|mesh-ancestor
102376781|NCT01791803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102376782|NCT01791803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376783|NCT01662856|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102376784|NCT01662856|Hemostatics|hemostatics|mesh-ancestor
102376785|NCT01662856|Coagulants|coagulants|mesh-ancestor
102376786|NCT04499976|Misoprostol|misoprostol|mesh-list
102376787|NCT04499976|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102376788|NCT04499976|Abortifacient Agents|abortifacient agents|mesh-ancestor
102376789|NCT04499976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102376790|NCT04499976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376791|NCT04499976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102376792|NCT04499976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102376793|NCT04499976|Oxytocics|oxytocics|mesh-ancestor
102376794|NCT01791413|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102376795|NCT01791413|Medroxyprogesterone|medroxyprogesterone|mesh-list
102376796|NCT01791413|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102376797|NCT01791413|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102376798|NCT01791413|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102376799|NCT01791413|Contraceptive Agents|contraceptive agents|mesh-ancestor
102376800|NCT01791413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102376801|NCT01791413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376802|NCT01791413|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102376803|NCT01791413|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102376804|NCT01791413|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102376805|NCT01791413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102376806|NCT01791413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102376807|NCT02509806|Apatinib|apatinib|mesh-list
102376808|NCT02509806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102376809|NCT02509806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102376810|NCT02509806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102376811|NCT02509806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376812|NCT02509728|Choline|choline|mesh-list
102376813|NCT02509728|Lipotropic Agents|lipotropic agents|mesh-ancestor
102376814|NCT02509728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102376815|NCT02509728|Antimetabolites|antimetabolites|mesh-ancestor
102376816|NCT02509728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376817|NCT02509728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102376818|NCT02509728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102376819|NCT02509728|Nootropic Agents|nootropic agents|mesh-ancestor
102376820|NCT02501616|Metformin|metformin|mesh-list
102376821|NCT02501616|Dapagliflozin|dapagliflozin|mesh-list
102376822|NCT02501616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102376823|NCT02501616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188595|NCT02182765|Nevirapine|nevirapine|mesh-list
102376824|NCT02501616|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102376825|NCT02501616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376826|NCT01788215|Doxycycline|doxycycline|mesh-list
102376827|NCT01788215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102376828|NCT01788215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102376829|NCT01788215|Antimalarials|antimalarials|mesh-ancestor
102376830|NCT01788215|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102376831|NCT01788215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102376832|NCT01812707|Atorvastatin|atorvastatin|mesh-list
102376833|NCT01812707|Alirocumab|alirocumab|mesh-list
102376834|NCT01812707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102376835|NCT01812707|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102376836|NCT01812707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102376837|NCT01812707|Antimetabolites|antimetabolites|mesh-ancestor
102376838|NCT01812707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376839|NCT01812707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102376840|NCT01812707|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102376841|NCT01812707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102376842|NCT01812707|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102376843|NCT01812707|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102376844|NCT01812707|Protease Inhibitors|protease inhibitors|mesh-ancestor
102376845|NCT01812707|Immunologic Factors|immunologic factors|mesh-ancestor
102376846|NCT01812707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376847|NCT01787279|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102376848|NCT01787279|Antiviral Agents|antiviral agents|mesh-ancestor
102376849|NCT01787279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102376850|NCT02728206|Sofosbuvir|sofosbuvir|mesh-list
102376851|NCT02728206|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102376852|NCT02728206|Velpatasvir|velpatasvir|mesh-list
102376853|NCT02728206|Antiviral Agents|antiviral agents|mesh-ancestor
101945673|NCT01259973|Dopamine Agents|dopamine agents|mesh-ancestor
102376854|NCT02728206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102376855|NCT01811225|Progesterone|progesterone|mesh-list
102376856|NCT01811225|Progestins|progestins|mesh-ancestor
102376857|NCT01811225|Hormones|hormones|mesh-ancestor
102376858|NCT01811225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102376859|NCT01811225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376860|NCT01809197|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102376861|NCT02508870|Azacitidine|azacitidine|mesh-list
102376862|NCT02508870|Atezolizumab|atezolizumab|mesh-list
102376863|NCT02508870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102376864|NCT02508870|Antimetabolites|antimetabolites|mesh-ancestor
102376865|NCT02508870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376866|NCT02508870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102376867|NCT02508870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102376868|NCT02508870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102376869|NCT02508870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102376870|NCT01786109|Dronabinol|dronabinol|mesh-list
102376871|NCT01786109|Hallucinogens|hallucinogens|mesh-ancestor
101624610|NCT02760615|GABA Agents|gaba agents|mesh-ancestor
102376872|NCT01786109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376873|NCT01786109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102376874|NCT01786109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102376875|NCT01786109|Analgesics|analgesics|mesh-ancestor
102376876|NCT01786109|Sensory System Agents|sensory system agents|mesh-ancestor
102376877|NCT01786109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102376878|NCT01786109|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102376879|NCT01786109|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102376880|NCT01786109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102376881|NCT01786109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376882|NCT01786109|Hormones|hormones|mesh-ancestor
102376883|NCT01786109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102376884|NCT02509104|Tamsulosin|tamsulosin|mesh-list
102376885|NCT02509104|Dutasteride|dutasteride|mesh-list
102376886|NCT02509104|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102376887|NCT02509104|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102376888|NCT02509104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102376889|NCT02509104|Adrenergic Agents|adrenergic agents|mesh-ancestor
101945718|NCT01153659|Rabeprazole|rabeprazole|mesh-list
102376890|NCT02509104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101795420|NCT00920153|Mitosis Modulators|mitosis modulators|mesh-ancestor
102376891|NCT02509104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945721|NCT01153659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102376892|NCT02509104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376893|NCT02509104|Urological Agents|urological agents|mesh-ancestor
102376894|NCT02509104|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102376895|NCT02509104|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102376896|NCT02509104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102376897|NCT02509104|Hormone Antagonists|hormone antagonists|mesh-ancestor
102154177|NCT03606577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102612282|NCT00002393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102376898|NCT02509104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102376899|NCT02500680|Vaccines|vaccines|mesh-list
102376900|NCT02500680|Immunologic Factors|immunologic factors|mesh-ancestor
101625522|NCT02742675|Leuprolide|leuprolide|mesh-list
102376901|NCT02500680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376902|NCT02500446|Dolutegravir|dolutegravir|mesh-list
102376903|NCT02500446|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102376904|NCT02500446|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102376905|NCT02500446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102376906|NCT02500446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376907|NCT02500446|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102376908|NCT02500446|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102376909|NCT02500446|Antiviral Agents|antiviral agents|mesh-ancestor
102376910|NCT02500446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102376911|NCT02500524|Permethrin|permethrin|mesh-list
102376912|NCT02500524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102376913|NCT02500524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376914|NCT02508402|Dexamethasone|dexamethasone|mesh-list
102376915|NCT02508402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102376916|NCT02508402|Antiemetics|antiemetics|mesh-ancestor
102376917|NCT02508402|Autonomic Agents|autonomic agents|mesh-ancestor
102376918|NCT02508402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102376919|NCT02508402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376920|NCT02508402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102376921|NCT02508402|Glucocorticoids|glucocorticoids|mesh-ancestor
102376922|NCT02508402|Hormones|hormones|mesh-ancestor
102376923|NCT02508402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102376924|NCT02508402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102376925|NCT02508402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102376926|NCT02500212|Tacrolimus|tacrolimus|mesh-list
102376927|NCT02500212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102376928|NCT02500212|Immunologic Factors|immunologic factors|mesh-ancestor
102376929|NCT02500212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376930|NCT02500212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102376931|NCT02500212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101626148|NCT00743119|Dronabinol|dronabinol|mesh-list
101796510|NCT00615056|Antimetabolites|antimetabolites|mesh-ancestor
102376932|NCT02500212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376933|NCT02508168|Metformin|metformin|mesh-list
102376934|NCT02508168|Alogliptin|alogliptin|mesh-list
102376935|NCT02508168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102376936|NCT02508168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376937|NCT02508168|Incretins|incretins|mesh-ancestor
102376938|NCT02508168|Hormones|hormones|mesh-ancestor
102376939|NCT02508168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102376940|NCT02508168|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102376941|NCT02508168|Protease Inhibitors|protease inhibitors|mesh-ancestor
102376942|NCT02508168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102376943|NCT02508168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376944|NCT02503176|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102376945|NCT02503176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102376946|NCT02508246|Cisplatin|cisplatin|mesh-list
102376947|NCT02508246|Docetaxel|docetaxel|mesh-list
102376948|NCT02508246|Adavosertib|adavosertib|mesh-list
101945768|NCT03892161|Rifampin|rifampin|mesh-list
102376949|NCT02508246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102376950|NCT02508246|Tubulin Modulators|tubulin modulators|mesh-ancestor
102376951|NCT02508246|Antimitotic Agents|antimitotic agents|mesh-ancestor
102376952|NCT02508246|Mitosis Modulators|mitosis modulators|mesh-ancestor
101945777|NCT03892161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102376953|NCT02508246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376954|NCT02508246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102376955|NCT01617148|Aflibercept|aflibercept|mesh-list
102376956|NCT01617148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101945781|NCT03892161|Antitubercular Agents|antitubercular agents|mesh-ancestor
102376957|NCT01617148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102376958|NCT01617148|Growth Substances|growth substances|mesh-ancestor
102376959|NCT01617148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376960|NCT01617148|Growth Inhibitors|growth inhibitors|mesh-ancestor
102376961|NCT01617148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101796945|NCT00617084|Everolimus|everolimus|mesh-list
102376962|NCT02499978|Dolutegravir|dolutegravir|mesh-list
102376963|NCT02499978|Darunavir|darunavir|mesh-list
102376964|NCT02499978|Cobicistat|cobicistat|mesh-list
102376965|NCT02499978|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
102376966|NCT02499978|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102376967|NCT02499978|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102376968|NCT02499978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102376969|NCT02499978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376970|NCT02499978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102376971|NCT02499978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102376972|NCT02499978|Antiviral Agents|antiviral agents|mesh-ancestor
102376973|NCT02499978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102376974|NCT02499978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102376975|NCT02499978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101945792|NCT01154361|Icatibant|icatibant|mesh-list
102376976|NCT02499978|Protease Inhibitors|protease inhibitors|mesh-ancestor
102376977|NCT02499978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102376978|NCT02499978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102376979|NCT01620190|Paclitaxel|paclitaxel|mesh-list
102376980|NCT01620190|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102376981|NCT01620190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102376982|NCT01620190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102376983|NCT01620190|Tubulin Modulators|tubulin modulators|mesh-ancestor
102376984|NCT01620190|Antimitotic Agents|antimitotic agents|mesh-ancestor
102376985|NCT01620190|Mitosis Modulators|mitosis modulators|mesh-ancestor
102376986|NCT01620190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102376987|NCT04498884|Insulin|insulin|mesh-list
102376988|NCT04498884|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102376989|NCT04498884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102376990|NCT04498884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102376991|NCT01621672|Lenalidomide|lenalidomide|mesh-list
102376992|NCT01621672|Immunologic Factors|immunologic factors|mesh-ancestor
102376993|NCT01621672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945816|NCT03891615|Niraparib|niraparib|mesh-list
102376994|NCT01621672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102376995|NCT01621672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102376996|NCT01621672|Growth Substances|growth substances|mesh-ancestor
102376997|NCT01621672|Growth Inhibitors|growth inhibitors|mesh-ancestor
102376998|NCT01621672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102376999|NCT03344328|Bortezomib|bortezomib|mesh-list
102377000|NCT03344328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102377001|NCT02499822|Ramipril|ramipril|mesh-list
102377002|NCT02499822|Nifedipine|nifedipine|mesh-list
101945824|NCT02947022|Zinc|zinc|mesh-list
102377003|NCT02499822|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102377004|NCT02499822|Protease Inhibitors|protease inhibitors|mesh-ancestor
102377005|NCT02499822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102377006|NCT02499822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377007|NCT02499822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102377008|NCT02499822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102377009|NCT02499822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102377010|NCT02499822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102377011|NCT02499822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377012|NCT02499822|Vasodilator Agents|vasodilator agents|mesh-ancestor
102377013|NCT02499822|Tocolytic Agents|tocolytic agents|mesh-ancestor
102377014|NCT02499822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102377015|NCT01663012|Etirinotecan pegol|etirinotecan pegol|mesh-list
102377016|NCT01663012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102377017|NCT01663012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102377018|NCT01663012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102377019|NCT01663012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102377020|NCT01663012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377021|NCT03343548|Magnesium Sulfate|magnesium sulfate|mesh-list
102377022|NCT03343548|Analgesics|analgesics|mesh-ancestor
101945845|NCT01259193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102377023|NCT03343548|Sensory System Agents|sensory system agents|mesh-ancestor
102377024|NCT03343548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102377025|NCT03343548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377026|NCT03343548|Anesthetics|anesthetics|mesh-ancestor
102377027|NCT03343548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102377028|NCT03343548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102377029|NCT03343548|Anticonvulsants|anticonvulsants|mesh-ancestor
102377030|NCT03343548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102377031|NCT03343548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102377032|NCT03343548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377033|NCT03343548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102377034|NCT03343548|Tocolytic Agents|tocolytic agents|mesh-ancestor
102377035|NCT03343548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102377036|NCT02507934|Hyaluronic Acid|hyaluronic acid|mesh-list
102377037|NCT02507934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102377038|NCT02507934|Immunologic Factors|immunologic factors|mesh-ancestor
102377039|NCT02507934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945849|NCT05182892|Dopamine|dopamine|mesh-list
102377040|NCT02507934|Viscosupplements|viscosupplements|mesh-ancestor
102377041|NCT02507934|Protective Agents|protective agents|mesh-ancestor
102377042|NCT01622296|Lidocaine|lidocaine|mesh-list
102377043|NCT01622296|Epinephrine|epinephrine|mesh-list
102377044|NCT01622296|Anesthetics, Local|anesthetics, local|mesh-list
102377045|NCT01622296|Anesthetics|anesthetics|mesh-list
102377046|NCT01622296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102377047|NCT01622296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154178|NCT03606577|Glucocorticoids|glucocorticoids|mesh-ancestor
102377048|NCT01622296|Sensory System Agents|sensory system agents|mesh-ancestor
102377049|NCT01622296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102377050|NCT01622296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102377051|NCT01622296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102377052|NCT01622296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102377053|NCT01622296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102377054|NCT01622296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377055|NCT01622296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101945879|NCT01260675|Naloxone|naloxone|mesh-list
102377056|NCT01622296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102377057|NCT01622296|Adrenergic Agents|adrenergic agents|mesh-ancestor
102377058|NCT01622296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102377059|NCT01622296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101945887|NCT01260675|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102377060|NCT01622296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102377061|NCT01622296|Autonomic Agents|autonomic agents|mesh-ancestor
102377062|NCT01622296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102377063|NCT01622296|Respiratory System Agents|respiratory system agents|mesh-ancestor
102377064|NCT01622296|Mydriatics|mydriatics|mesh-ancestor
102377065|NCT01622296|Sympathomimetics|sympathomimetics|mesh-ancestor
102377066|NCT01622296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102377067|NCT02728830|Pembrolizumab|pembrolizumab|mesh-list
102377068|NCT02728830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102377069|NCT02728830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102377070|NCT02728830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102377071|NCT02728830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377072|NCT01705288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101945896|NCT03887871|Urological Agents|urological agents|mesh-ancestor
102377073|NCT01705288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
102377074|NCT01705288|Morphine|morphine|mesh-list
102377075|NCT01705288|Narcotics|narcotics|mesh-list
102377076|NCT01705288|Anesthetics|anesthetics|mesh-list
102377077|NCT01705288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102377078|NCT01705288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377079|NCT01705288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102377080|NCT01705288|Analgesics|analgesics|mesh-ancestor
102377081|NCT01705288|Sensory System Agents|sensory system agents|mesh-ancestor
102377082|NCT01705288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102377083|NCT01705288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102377084|NCT01705288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102377085|NCT03343002|Fentanyl|fentanyl|mesh-list
102377086|NCT03343002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102377087|NCT03343002|Narcotics|narcotics|mesh-ancestor
102377088|NCT03343002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102377089|NCT03343002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377090|NCT03343002|Analgesics|analgesics|mesh-ancestor
102377091|NCT03343002|Sensory System Agents|sensory system agents|mesh-ancestor
102377092|NCT03343002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102377093|NCT03343002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102377094|NCT03343002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102377095|NCT03343002|Anesthetics, General|anesthetics, general|mesh-ancestor
102377096|NCT03343002|Anesthetics|anesthetics|mesh-ancestor
102377097|NCT03120936|Tenofovir|tenofovir|mesh-list
102377098|NCT03120936|Emtricitabine|emtricitabine|mesh-list
102377099|NCT03120936|Antiviral Agents|antiviral agents|mesh-ancestor
102377100|NCT03120936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102377101|NCT03120936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102377102|NCT03120936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102377103|NCT03120936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102377104|NCT03120936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377105|NCT03120936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102377106|NCT03120936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102377107|NCT02234752|Memantine|memantine|mesh-list
102377108|NCT02234752|Galantamine|galantamine|mesh-list
102377109|NCT02234752|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102377110|NCT02234752|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102377111|NCT02234752|Dopamine Agents|dopamine agents|mesh-ancestor
102377112|NCT02234752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102377113|NCT02234752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377114|NCT02234752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377115|NCT02234752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102377116|NCT02234752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102377117|NCT02234752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102377118|NCT02234752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102377119|NCT02234752|Cholinergic Agents|cholinergic agents|mesh-ancestor
102377120|NCT02234752|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102377121|NCT02234752|Autonomic Agents|autonomic agents|mesh-ancestor
102377122|NCT02234752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102377123|NCT02234752|Nootropic Agents|nootropic agents|mesh-ancestor
102377124|NCT01665508|Nebivolol|nebivolol|mesh-list
102377125|NCT01665508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102377126|NCT01665508|Vasodilator Agents|vasodilator agents|mesh-ancestor
102377127|NCT01665508|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102377128|NCT01665508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102377129|NCT01665508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102377130|NCT01665508|Adrenergic Agents|adrenergic agents|mesh-ancestor
102377131|NCT01665508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102377132|NCT01665508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377133|NCT01665508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377134|NCT03344094|Interferons|interferons|mesh-list
102377135|NCT03344094|Interferon-beta|interferon-beta|mesh-list
102377136|NCT03344094|Ocrelizumab|ocrelizumab|mesh-list
102377137|NCT03344094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102377138|NCT03344094|Antiviral Agents|antiviral agents|mesh-ancestor
102377139|NCT03344094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102377140|NCT03344094|Immunologic Factors|immunologic factors|mesh-ancestor
102377141|NCT03344094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377142|NCT02498496|Magnesium Sulfate|magnesium sulfate|mesh-list
102377143|NCT02498496|Analgesics|analgesics|mesh-ancestor
102377144|NCT02498496|Sensory System Agents|sensory system agents|mesh-ancestor
102377145|NCT02498496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102377146|NCT02498496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377147|NCT02498496|Anesthetics|anesthetics|mesh-ancestor
102377148|NCT02498496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102377149|NCT02498496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102377150|NCT02498496|Anticonvulsants|anticonvulsants|mesh-ancestor
102377151|NCT02498496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102377152|NCT02498496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102377153|NCT02498496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377154|NCT02498496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102377155|NCT02498496|Tocolytic Agents|tocolytic agents|mesh-ancestor
101945965|NCT01151397|Vitamin D|vitamin d|mesh-list
102377156|NCT02498496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102377157|NCT02502708|Cyclophosphamide|cyclophosphamide|mesh-list
102377158|NCT02502708|Temozolomide|temozolomide|mesh-list
102377159|NCT02502708|Etoposide|etoposide|mesh-list
102377160|NCT02502708|Tryptophan|tryptophan|mesh-list
102377161|NCT02502708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102377162|NCT02502708|Immunologic Factors|immunologic factors|mesh-ancestor
102377163|NCT02502708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377164|NCT02502708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102377165|NCT02502708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102377166|NCT02502708|Alkylating Agents|alkylating agents|mesh-ancestor
102377167|NCT02502708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377168|NCT02502708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102377169|NCT02502708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102377170|NCT02502708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102377171|NCT02502708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102377172|NCT02502708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102377173|NCT02502708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102377174|NCT02502708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102377175|NCT02502708|Antidepressive Agents|antidepressive agents|mesh-ancestor
102377176|NCT02502708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102377177|NCT01666210|Dexamethasone|dexamethasone|mesh-list
102377178|NCT01666210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102377179|NCT01666210|Antiemetics|antiemetics|mesh-ancestor
102377180|NCT01666210|Autonomic Agents|autonomic agents|mesh-ancestor
102377181|NCT01666210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102377182|NCT01666210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377183|NCT01666210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102377184|NCT01666210|Glucocorticoids|glucocorticoids|mesh-ancestor
102377185|NCT01666210|Hormones|hormones|mesh-ancestor
102377186|NCT01666210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102377187|NCT01666210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102377188|NCT01666210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102377189|NCT01666912|Contraceptive Agents|contraceptive agents|mesh-list
102377190|NCT01666912|Etonogestrel|etonogestrel|mesh-list
102377191|NCT01666912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102377192|NCT01666912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377193|NCT01666912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102377194|NCT01666912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102377195|NCT03341988|Ritonavir|ritonavir|mesh-list
102377196|NCT03341988|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102377197|NCT03341988|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102377198|NCT03341988|Protease Inhibitors|protease inhibitors|mesh-ancestor
102377199|NCT03341988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102377200|NCT03341988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377201|NCT03341988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102377202|NCT03341988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102377203|NCT03341988|Antiviral Agents|antiviral agents|mesh-ancestor
102377204|NCT03341988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102377205|NCT03341988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102377206|NCT03341988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102377207|NCT02501850|Metformin|metformin|mesh-list
102377208|NCT02501850|Liraglutide|liraglutide|mesh-list
102377209|NCT02501850|Exenatide|exenatide|mesh-list
102377210|NCT02501850|Lixisenatide|lixisenatide|mesh-list
102377211|NCT02501850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102377212|NCT02501850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377213|NCT02501850|Incretins|incretins|mesh-ancestor
102377214|NCT02501850|Hormones|hormones|mesh-ancestor
102377215|NCT02501850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102377216|NCT02501850|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102377217|NCT01709032|Deferasirox|deferasirox|mesh-list
102377218|NCT01709032|Deferiprone|deferiprone|mesh-list
102377219|NCT01709032|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102377220|NCT01709032|Chelating Agents|chelating agents|mesh-ancestor
102377221|NCT01709032|Sequestering Agents|sequestering agents|mesh-ancestor
102377222|NCT01709032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377223|NCT02496078|Asunaprevir|asunaprevir|mesh-list
102377224|NCT02496078|Protease Inhibitors|protease inhibitors|mesh-ancestor
102377225|NCT02496078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102377226|NCT02496078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377227|NCT02495922|Dexamethasone|dexamethasone|mesh-list
102377228|NCT02495922|Lenalidomide|lenalidomide|mesh-list
102377229|NCT02495922|Bortezomib|bortezomib|mesh-list
102377230|NCT02495922|Elotuzumab|elotuzumab|mesh-list
102377231|NCT02495922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102377232|NCT02495922|Antiemetics|antiemetics|mesh-ancestor
102377233|NCT02495922|Autonomic Agents|autonomic agents|mesh-ancestor
102377234|NCT02495922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102377235|NCT02495922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377236|NCT02495922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102377237|NCT02495922|Glucocorticoids|glucocorticoids|mesh-ancestor
102377238|NCT02495922|Hormones|hormones|mesh-ancestor
101946065|NCT01261689|Narcotics|narcotics|mesh-ancestor
102377239|NCT02495922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102377240|NCT02495922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102377241|NCT02495922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102377242|NCT02495922|Immunologic Factors|immunologic factors|mesh-ancestor
102377243|NCT02495922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102377244|NCT02495922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102377245|NCT02495922|Growth Substances|growth substances|mesh-ancestor
102377246|NCT02495922|Growth Inhibitors|growth inhibitors|mesh-ancestor
102377247|NCT01709422|Midazolam|midazolam|mesh-list
102377248|NCT01709422|Meperidine|meperidine|mesh-list
102377249|NCT01709422|Propofol|propofol|mesh-list
102377250|NCT01709422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101946077|NCT01157247|Fentanyl|fentanyl|mesh-list
102377251|NCT01709422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102377252|NCT01709422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377253|NCT01709422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102377254|NCT01709422|Anesthetics, General|anesthetics, general|mesh-ancestor
102377255|NCT01709422|Anesthetics|anesthetics|mesh-ancestor
102377256|NCT01709422|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102377257|NCT01709422|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102377258|NCT01709422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102377259|NCT01709422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102377260|NCT01709422|GABA Modulators|gaba modulators|mesh-ancestor
102377261|NCT01709422|GABA Agents|gaba agents|mesh-ancestor
102377262|NCT01709422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102377263|NCT01709422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946090|NCT03881787|Cetuximab|cetuximab|mesh-list
102377264|NCT01709422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102377265|NCT01709422|Narcotics|narcotics|mesh-ancestor
102377266|NCT01709422|Analgesics|analgesics|mesh-ancestor
102377267|NCT01709422|Sensory System Agents|sensory system agents|mesh-ancestor
101946096|NCT03881787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102377268|NCT01709422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102377269|NCT01669642|Ketamine|ketamine|mesh-list
102377270|NCT01669642|Analgesics|analgesics|mesh-ancestor
102377271|NCT01669642|Sensory System Agents|sensory system agents|mesh-ancestor
102377272|NCT01669642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102377273|NCT01669642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377274|NCT01669642|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102377275|NCT01669642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102377276|NCT01669642|Anesthetics, General|anesthetics, general|mesh-ancestor
102377277|NCT01669642|Anesthetics|anesthetics|mesh-ancestor
102377278|NCT01669642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101972969|NCT01115179|Propofol|propofol|mesh-list
102377279|NCT01669642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102377280|NCT01669642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102377281|NCT01669642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102377282|NCT01669642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377283|NCT01669720|Aflibercept|aflibercept|mesh-list
102377284|NCT01669720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101799770|NCT02199665|Hormones|hormones|mesh-ancestor
102377285|NCT01669720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102377286|NCT01669720|Growth Substances|growth substances|mesh-ancestor
102377287|NCT01669720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377288|NCT01669720|Growth Inhibitors|growth inhibitors|mesh-ancestor
102377289|NCT01669720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102377290|NCT01670110|Pasireotide|pasireotide|mesh-list
102377291|NCT01670110|Hormones|hormones|mesh-ancestor
102377292|NCT01670110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102377293|NCT01670110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377294|NCT02245516|Loteprednol Etabonate|loteprednol etabonate|mesh-list
102377295|NCT02245516|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102377296|NCT01677286|Doxycycline|doxycycline|mesh-list
102377297|NCT01677286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102377298|NCT01677286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102377299|NCT01677286|Antimalarials|antimalarials|mesh-ancestor
102377300|NCT01677286|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101973242|NCT04400188|Temozolomide|temozolomide|mesh-list
102377301|NCT01677286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102377302|NCT04498260|Triamcinolone|triamcinolone|mesh-list
102377303|NCT04498260|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102377304|NCT04498260|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102377305|NCT04498260|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102377306|NCT04498260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102377307|NCT04498260|Glucocorticoids|glucocorticoids|mesh-ancestor
102377308|NCT04498260|Hormones|hormones|mesh-ancestor
102377309|NCT04498260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102377310|NCT04498260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377311|NCT04498260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102377312|NCT04498260|Immunologic Factors|immunologic factors|mesh-ancestor
102377313|NCT04498260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102377314|NCT04498260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377315|NCT01680172|Ketamine|ketamine|mesh-list
102377316|NCT01680172|Analgesics|analgesics|mesh-ancestor
102377317|NCT01680172|Sensory System Agents|sensory system agents|mesh-ancestor
102377318|NCT01680172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102377319|NCT01680172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377320|NCT01680172|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102377321|NCT01680172|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102377322|NCT01680172|Anesthetics, General|anesthetics, general|mesh-ancestor
101973676|NCT01218217|Rifampin|rifampin|mesh-list
102377323|NCT01680172|Anesthetics|anesthetics|mesh-ancestor
102377324|NCT01680172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102377325|NCT01680172|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102377326|NCT01680172|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102377327|NCT01680172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101946153|NCT01157559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102377328|NCT01680172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377329|NCT02235064|Sertraline|sertraline|mesh-list
102377330|NCT02235064|Antidepressive Agents|antidepressive agents|mesh-ancestor
102377331|NCT02235064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102377332|NCT02235064|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101946158|NCT01157559|Dopamine Agents|dopamine agents|mesh-ancestor
102377333|NCT02235064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102377334|NCT02235064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102377335|NCT02235064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377336|NCT02235064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102377337|NCT02235064|Serotonin Agents|serotonin agents|mesh-ancestor
101800691|NCT00718757|Hormones|hormones|mesh-ancestor
102377338|NCT02235064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377339|NCT05118490|Isoniazid|isoniazid|mesh-list
102377340|NCT05118490|Rifapentine|rifapentine|mesh-list
102377341|NCT05118490|Rifampin|rifampin|mesh-list
102377342|NCT05118490|Antitubercular Agents|antitubercular agents|mesh-ancestor
101946169|NCT01265433|Molgramostim|molgramostim|mesh-list
102377343|NCT05118490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102377344|NCT05118490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101974206|NCT03525652|Vaccines|vaccines|mesh-list
102377345|NCT05118490|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102377346|NCT05118490|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101974320|NCT03671044|Docetaxel|docetaxel|mesh-list
102377347|NCT05118490|Antimetabolites|antimetabolites|mesh-ancestor
102377348|NCT05118490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189088|NCT02184247|Theophylline|theophylline|mesh-list
102377350|NCT05118490|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102377351|NCT05118490|Leprostatic Agents|leprostatic agents|mesh-ancestor
102377352|NCT05118490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102377353|NCT05118490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102377354|NCT05118490|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101946182|NCT01159587|Factor VIII|factor viii|mesh-list
102377355|NCT05118490|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102377356|NCT05118490|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102377357|NCT05118490|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102377358|NCT05118490|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101974614|NCT05515029|Abatacept|abatacept|mesh-list
102377359|NCT05118490|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102377360|NCT01681030|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102377361|NCT01681030|Hemostatics|hemostatics|mesh-ancestor
102377362|NCT01681030|Coagulants|coagulants|mesh-ancestor
102377363|NCT02249416|Ritonavir|ritonavir|mesh-list
102377364|NCT02249416|Zidovudine|zidovudine|mesh-list
102377365|NCT02249416|Tipranavir|tipranavir|mesh-list
102377366|NCT02249416|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102377367|NCT02249416|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102377368|NCT02249416|Protease Inhibitors|protease inhibitors|mesh-ancestor
102377369|NCT02249416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102377370|NCT02249416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377371|NCT02249416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102377372|NCT02249416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102377373|NCT02249416|Antiviral Agents|antiviral agents|mesh-ancestor
102377374|NCT02249416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102377375|NCT02249416|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102377376|NCT02249416|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102377377|NCT02249416|Antimetabolites|antimetabolites|mesh-ancestor
102377378|NCT02249416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102377379|NCT02249416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102377380|NCT01685242|Cetirizine|cetirizine|mesh-list
102377381|NCT01685242|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102377382|NCT01685242|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102377383|NCT01685242|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102377384|NCT01685242|Histamine Antagonists|histamine antagonists|mesh-ancestor
102377385|NCT01685242|Histamine Agents|histamine agents|mesh-ancestor
102377386|NCT01685242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102377387|NCT01685242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377388|NCT01685242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377389|NCT00708162|Raltegravir Potassium|raltegravir potassium|mesh-list
101975222|NCT03289351|Tazobactam|tazobactam|mesh-list
102377390|NCT00708162|Elvitegravir|elvitegravir|mesh-list
102377391|NCT00708162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102377392|NCT00708162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102377393|NCT00708162|Antiviral Agents|antiviral agents|mesh-ancestor
102377394|NCT00708162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102377395|NCT00708162|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102377396|NCT00708162|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102377397|NCT00708162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102377398|NCT00708162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377399|NCT04930042|Ustekinumab|ustekinumab|mesh-list
102377400|NCT04930042|Dermatologic Agents|dermatologic agents|mesh-ancestor
102377401|NCT04898920|Dexamethasone|dexamethasone|mesh-list
102377402|NCT04898920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102377403|NCT04898920|Antiemetics|antiemetics|mesh-ancestor
102377404|NCT04898920|Autonomic Agents|autonomic agents|mesh-ancestor
102377405|NCT04898920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101946223|NCT01266057|Sirolimus|sirolimus|mesh-list
102377406|NCT04898920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377407|NCT04898920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102377408|NCT04898920|Glucocorticoids|glucocorticoids|mesh-ancestor
102377409|NCT04898920|Hormones|hormones|mesh-ancestor
102377410|NCT04898920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102377411|NCT04898920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102377412|NCT04898920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102377413|NCT02249884|Carbamide Peroxide|carbamide peroxide|mesh-list
102377414|NCT02249884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102377415|NCT02249884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102377416|NCT01686646|Acetaminophen|acetaminophen|mesh-list
102377417|NCT01686646|Caffeine|caffeine|mesh-list
102377418|NCT01686646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102377419|NCT01686646|Analgesics|analgesics|mesh-ancestor
102377420|NCT01686646|Sensory System Agents|sensory system agents|mesh-ancestor
101946238|NCT01266057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102377421|NCT01686646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102377422|NCT01686646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377423|NCT01686646|Antipyretics|antipyretics|mesh-ancestor
102377424|NCT01686646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102377425|NCT01686646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102377426|NCT01686646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102377427|NCT01686646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377428|NCT01686646|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102377429|NCT01686646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102377430|NCT01686646|Purinergic Agents|purinergic agents|mesh-ancestor
102377431|NCT01686646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102377433|NCT02495688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102377434|NCT02495688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377435|NCT01688596|Bupivacaine|bupivacaine|mesh-list
102377436|NCT01688596|Anesthetics, Local|anesthetics, local|mesh-ancestor
102377437|NCT01688596|Anesthetics|anesthetics|mesh-ancestor
102377438|NCT01688596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102377439|NCT01688596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976215|NCT03925285|Bevacizumab|bevacizumab|mesh-list
102377440|NCT01688596|Sensory System Agents|sensory system agents|mesh-ancestor
102377441|NCT01688596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102377442|NCT02495532|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102377443|NCT04869592|Vaccines|vaccines|mesh-list
102377444|NCT04869592|Immunologic Factors|immunologic factors|mesh-ancestor
102377445|NCT04869592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377446|NCT05709652|Ivermectin|ivermectin|mesh-list
102377447|NCT05709652|Selamectin|selamectin|mesh-list
102377448|NCT05709652|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102377449|NCT05709652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102377450|NCT01690000|Melatonin|melatonin|mesh-list
102377451|NCT01690000|Antioxidants|antioxidants|mesh-ancestor
101946266|NCT03880695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102377452|NCT01690000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377453|NCT01690000|Protective Agents|protective agents|mesh-ancestor
102377454|NCT01690000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377455|NCT01690000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102377456|NCT02495220|Dexmedetomidine|dexmedetomidine|mesh-list
102377457|NCT02495220|Bupivacaine|bupivacaine|mesh-list
102377458|NCT02495220|Anesthetics, Local|anesthetics, local|mesh-ancestor
102377459|NCT02495220|Anesthetics|anesthetics|mesh-ancestor
102377460|NCT02495220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102377461|NCT02495220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377462|NCT02495220|Sensory System Agents|sensory system agents|mesh-ancestor
102377463|NCT02495220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102377464|NCT02495220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102377465|NCT02495220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102377466|NCT02495220|Analgesics|analgesics|mesh-ancestor
102377467|NCT02495220|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102377468|NCT02495220|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102377469|NCT02495220|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102377470|NCT02495220|Adrenergic Agents|adrenergic agents|mesh-ancestor
102377471|NCT02495220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102377472|NCT02495220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377473|NCT01690546|Naltrexone|naltrexone|mesh-list
102377474|NCT01690546|Buprenorphine|buprenorphine|mesh-list
102377475|NCT01690546|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102377476|NCT01690546|Naloxone|naloxone|mesh-list
102377477|NCT01690546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102377478|NCT01690546|Narcotics|narcotics|mesh-ancestor
102377479|NCT01690546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102377480|NCT01690546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377481|NCT01690546|Analgesics|analgesics|mesh-ancestor
102377482|NCT01690546|Sensory System Agents|sensory system agents|mesh-ancestor
102377483|NCT01690546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102377484|NCT01690546|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102377485|NCT01690546|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102377486|NCT03336918|Lithium Carbonate|lithium carbonate|mesh-list
102377487|NCT03336918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377488|NCT03336918|Antidepressive Agents|antidepressive agents|mesh-ancestor
102377489|NCT03336918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102377490|NCT03336918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102377491|NCT03336918|Antimanic Agents|antimanic agents|mesh-ancestor
102377492|NCT03336918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102377493|NCT03336918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102377494|NCT03336918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377495|NCT02494830|Ketamine|ketamine|mesh-list
101976666|NCT01356212|Ketorolac|ketorolac|mesh-list
102377496|NCT02494830|Analgesics|analgesics|mesh-ancestor
102377497|NCT02494830|Sensory System Agents|sensory system agents|mesh-ancestor
102377498|NCT02494830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102377499|NCT02494830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377500|NCT02494830|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102377501|NCT02494830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102377502|NCT02494830|Anesthetics, General|anesthetics, general|mesh-ancestor
102377503|NCT02494830|Anesthetics|anesthetics|mesh-ancestor
102377504|NCT02494830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102377505|NCT02494830|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102377506|NCT02494830|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102377507|NCT02494830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102377508|NCT02494830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377509|NCT03336840|Metformin|metformin|mesh-list
102377510|NCT03336840|Promethazine|promethazine|mesh-list
102377511|NCT03336840|Diphenhydramine|diphenhydramine|mesh-list
102377512|NCT03336840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101946326|NCT01155921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102377513|NCT03336840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377514|NCT03336840|Antipruritics|antipruritics|mesh-ancestor
102377515|NCT03336840|Dermatologic Agents|dermatologic agents|mesh-ancestor
102377516|NCT03336840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102377517|NCT03336840|Histamine Antagonists|histamine antagonists|mesh-ancestor
101977010|NCT02298010|Capecitabine|capecitabine|mesh-list
102377518|NCT03336840|Histamine Agents|histamine agents|mesh-ancestor
102377519|NCT03336840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102377520|NCT03336840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377521|NCT03336840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102377522|NCT03336840|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102377523|NCT03336840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102377524|NCT03336840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102377525|NCT03336840|Anesthetics, Local|anesthetics, local|mesh-ancestor
102377526|NCT03336840|Anesthetics|anesthetics|mesh-ancestor
102377527|NCT03336840|Sensory System Agents|sensory system agents|mesh-ancestor
102377528|NCT03336840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102377529|NCT03336840|Antiemetics|antiemetics|mesh-ancestor
102377530|NCT03336840|Autonomic Agents|autonomic agents|mesh-ancestor
102377531|NCT03336840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102377532|NCT02497638|Metformin|metformin|mesh-list
102377533|NCT02497638|Biguanides|biguanides|mesh-list
102377534|NCT02497638|Atorvastatin|atorvastatin|mesh-list
102377535|NCT02497638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102377536|NCT02497638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377537|NCT02497638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102377538|NCT02497638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102377539|NCT02497638|Antimetabolites|antimetabolites|mesh-ancestor
102377540|NCT02497638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377541|NCT02497638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101946350|NCT01158183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102377542|NCT02497638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102377543|NCT02497638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102377544|NCT02495064|Mometasone Furoate|mometasone furoate|mesh-list
102377545|NCT02495064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102377546|NCT02495064|Dermatologic Agents|dermatologic agents|mesh-ancestor
101977271|NCT03507634|Lidocaine|lidocaine|mesh-list
102377547|NCT02495064|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102377548|NCT02493192|Meperidine|meperidine|mesh-list
102377549|NCT02493192|Haloperidol|haloperidol|mesh-list
102377550|NCT02493192|Haloperidol decanoate|haloperidol decanoate|mesh-list
102377551|NCT02493192|Antiemetics|antiemetics|mesh-ancestor
102377552|NCT02493192|Autonomic Agents|autonomic agents|mesh-ancestor
102377553|NCT02493192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102377554|NCT02493192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377555|NCT02493192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102377556|NCT02493192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102377557|NCT02493192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101946373|NCT01264575|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102377558|NCT02493192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102377559|NCT02493192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102377560|NCT02493192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102377561|NCT02493192|Dopamine Agents|dopamine agents|mesh-ancestor
102377562|NCT02493192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102377563|NCT02493192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377564|NCT02493192|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102377565|NCT02493192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102377566|NCT02493192|Narcotics|narcotics|mesh-ancestor
102377567|NCT02493192|Analgesics|analgesics|mesh-ancestor
102377568|NCT02493192|Sensory System Agents|sensory system agents|mesh-ancestor
102377569|NCT02493192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102377570|NCT02497716|Rivaroxaban|rivaroxaban|mesh-list
102377571|NCT02497716|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102377572|NCT02497716|Antithrombins|antithrombins|mesh-ancestor
102377573|NCT02497716|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102377574|NCT02497716|Protease Inhibitors|protease inhibitors|mesh-ancestor
102377575|NCT02497716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102377576|NCT02497716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377578|NCT02238808|Estradiol|estradiol|mesh-list
102377579|NCT02238808|Estrogens|estrogens|mesh-list
102377580|NCT02238808|Hormones|hormones|mesh-ancestor
101946393|NCT03638648|Antimetabolites|antimetabolites|mesh-ancestor
102401205|NCT02341794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102377581|NCT02238808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102377582|NCT02238808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377583|NCT02497326|Heparin|heparin|mesh-list
102377584|NCT02497326|Tramadol|tramadol|mesh-list
102377585|NCT02497326|Anticoagulants|anticoagulants|mesh-ancestor
102377586|NCT02497326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102377587|NCT02497326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102377588|NCT02497326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377589|NCT02497326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102377590|NCT02497326|Narcotics|narcotics|mesh-ancestor
102377591|NCT02497326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102377592|NCT02497326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978187|NCT04462822|Xhance|xhance|mesh-list
102377593|NCT02497326|Analgesics|analgesics|mesh-ancestor
102377594|NCT02497326|Sensory System Agents|sensory system agents|mesh-ancestor
102377595|NCT02497326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102377596|NCT02245672|Fluticasone|fluticasone|mesh-list
102377597|NCT02245672|Xhance|xhance|mesh-list
102377598|NCT02245672|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102377599|NCT02245672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102377600|NCT02245672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102377601|NCT02245672|Autonomic Agents|autonomic agents|mesh-ancestor
102377602|NCT02245672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102377603|NCT02245672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377604|NCT02245672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102377605|NCT02245672|Respiratory System Agents|respiratory system agents|mesh-ancestor
102377606|NCT02245672|Dermatologic Agents|dermatologic agents|mesh-ancestor
102377607|NCT02245672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102401206|NCT02341794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102377608|NCT02245672|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102377609|NCT02245672|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102377610|NCT02245672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102377611|NCT02245672|Adrenergic Agents|adrenergic agents|mesh-ancestor
102377612|NCT02245672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101805161|NCT00950222|Imipenem|imipenem|mesh-list
102377613|NCT02245672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377614|NCT04461418|Glucocorticoids|glucocorticoids|mesh-list
102377615|NCT04461418|Hormones|hormones|mesh-ancestor
102377616|NCT04461418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102377617|NCT04461418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377618|NCT03335904|Losartan|losartan|mesh-list
102377619|NCT03335904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102377620|NCT03335904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102377621|NCT03335904|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101946428|NCT01264653|Epinephrine|epinephrine|mesh-list
102377622|NCT03335904|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102377623|NCT03335904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377624|NCT03335826|Anesthetics|anesthetics|mesh-list
102401207|NCT02344602|Febuxostat|febuxostat|mesh-list
102377625|NCT03335826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102377626|NCT03335826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377627|NCT03340740|Cetirizine|cetirizine|mesh-list
102377628|NCT03340740|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102377629|NCT03340740|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102377630|NCT03340740|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102377631|NCT03340740|Histamine Antagonists|histamine antagonists|mesh-ancestor
102377632|NCT03340740|Histamine Agents|histamine agents|mesh-ancestor
102377633|NCT03340740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102377634|NCT03340740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377635|NCT03340740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377636|NCT03340662|Itraconazole|itraconazole|mesh-list
102377637|NCT03340662|Rifampin|rifampin|mesh-list
102377638|NCT03340662|Fluvoxamine|fluvoxamine|mesh-list
101979214|NCT01693783|Ipilimumab|ipilimumab|mesh-list
102377639|NCT03340662|Antifungal Agents|antifungal agents|mesh-ancestor
102377640|NCT03340662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102377641|NCT03340662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102377642|NCT03340662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101946453|NCT01264731|Imiquimod|imiquimod|mesh-list
102377643|NCT03340662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102377644|NCT03340662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377645|NCT03340662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102377646|NCT03340662|Hormone Antagonists|hormone antagonists|mesh-ancestor
102377647|NCT03340662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102377648|NCT03340662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377649|NCT03340662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102377650|NCT03340662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102377651|NCT03340662|Antitubercular Agents|antitubercular agents|mesh-ancestor
102377652|NCT03340662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102377653|NCT03340662|Leprostatic Agents|leprostatic agents|mesh-ancestor
101979551|NCT01366118|Oxaliplatin|oxaliplatin|mesh-list
102377654|NCT03340662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102377655|NCT03340662|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102377656|NCT03340662|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102377657|NCT03340662|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102377658|NCT03340662|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102377659|NCT03340662|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102377660|NCT03340662|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102377661|NCT03340662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102377662|NCT03340662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102377663|NCT03340662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102377664|NCT03340662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102377665|NCT03340662|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102377666|NCT03340662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102377667|NCT03340662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102377668|NCT03340662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102377669|NCT03340662|Serotonin Agents|serotonin agents|mesh-ancestor
102377670|NCT03340662|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102377671|NCT03340662|Antidepressive Agents|antidepressive agents|mesh-ancestor
102377672|NCT03340662|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102377673|NCT03340662|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102377675|NCT03342300|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102377676|NCT03342300|Pirarubicin|pirarubicin|mesh-list
102377677|NCT03342300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102377678|NCT03342300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102377679|NCT03342300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102377680|NCT03342300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102377681|NCT03342300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102377682|NCT03342300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377683|NCT01711918|Domperidone|domperidone|mesh-list
102377684|NCT01711918|Antiemetics|antiemetics|mesh-ancestor
102377685|NCT01711918|Autonomic Agents|autonomic agents|mesh-ancestor
102377686|NCT01711918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102377687|NCT01711918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377688|NCT01711918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102377689|NCT01711918|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102377690|NCT01711918|Dopamine Agents|dopamine agents|mesh-ancestor
102377691|NCT01711918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102377692|NCT01711918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377693|NCT03120468|Topiramate|topiramate|mesh-list
102377694|NCT03120468|Acetylcysteine|acetylcysteine|mesh-list
102377695|NCT03120468|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102377696|NCT03120468|Anticonvulsants|anticonvulsants|mesh-ancestor
102377697|NCT03120468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102377698|NCT03120468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377699|NCT03120468|Antiviral Agents|antiviral agents|mesh-ancestor
102401208|NCT02344602|Gout Suppressants|gout suppressants|mesh-ancestor
102377700|NCT03120468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102377701|NCT03120468|Expectorants|expectorants|mesh-ancestor
102377702|NCT03120468|Respiratory System Agents|respiratory system agents|mesh-ancestor
101946512|NCT02527083|Narcotics|narcotics|mesh-ancestor
102377703|NCT03120468|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102377704|NCT03120468|Antioxidants|antioxidants|mesh-ancestor
102377705|NCT03120468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377706|NCT03120468|Protective Agents|protective agents|mesh-ancestor
102377707|NCT03120468|Antidotes|antidotes|mesh-ancestor
102377708|NCT01712230|Leuprolide|leuprolide|mesh-list
102377709|NCT01712230|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102377710|NCT01712230|Fertility Agents|fertility agents|mesh-ancestor
102377711|NCT01712230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102377712|NCT01712230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377713|NCT01712230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102377714|NCT01712230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102377715|NCT03335436|Gabapentin|gabapentin|mesh-list
102377716|NCT03335436|Analgesics|analgesics|mesh-ancestor
102377717|NCT03335436|Sensory System Agents|sensory system agents|mesh-ancestor
102377718|NCT03335436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102377719|NCT03335436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377720|NCT03335436|Anticonvulsants|anticonvulsants|mesh-ancestor
102377721|NCT03335436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102189467|NCT04304209|Capecitabine|capecitabine|mesh-list
102377722|NCT03335436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102377723|NCT03335436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102377724|NCT03335436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102377725|NCT03335436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102377726|NCT03335436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102377727|NCT03335436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102401209|NCT02344602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102377728|NCT03335436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377729|NCT03335436|Antimanic Agents|antimanic agents|mesh-ancestor
102377731|NCT02494284|Clopidogrel|clopidogrel|mesh-list
102377732|NCT02494284|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102377733|NCT02494284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102377734|NCT02494284|Analgesics|analgesics|mesh-ancestor
102377735|NCT02494284|Sensory System Agents|sensory system agents|mesh-ancestor
102377736|NCT02494284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102401210|NCT02348268|Analgesics|analgesics|mesh-list
102377737|NCT02494284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377738|NCT02494284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102377739|NCT02494284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102377740|NCT02494284|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102377741|NCT02494284|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102377742|NCT02494284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377743|NCT02494284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102377744|NCT02494284|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102377745|NCT02494284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102377746|NCT02494284|Antipyretics|antipyretics|mesh-ancestor
102377747|NCT02494284|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102377748|NCT02494284|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101980866|NCT04754386|Antibodies|antibodies|mesh-list
102377749|NCT02494284|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102377750|NCT02494284|Purinergic Agents|purinergic agents|mesh-ancestor
102377751|NCT02494284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102377752|NCT01713400|Sirolimus|sirolimus|mesh-list
102377753|NCT01713400|Ustekinumab|ustekinumab|mesh-list
102377754|NCT01713400|Tacrolimus|tacrolimus|mesh-list
102377755|NCT01713400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102377756|NCT01713400|Immunologic Factors|immunologic factors|mesh-ancestor
102377757|NCT01713400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377758|NCT01713400|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102377759|NCT01713400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102377760|NCT01713400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377761|NCT01713400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102377762|NCT01713400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102377763|NCT01713400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102377764|NCT01713400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102377765|NCT01713400|Antifungal Agents|antifungal agents|mesh-ancestor
102377766|NCT01713400|Dermatologic Agents|dermatologic agents|mesh-ancestor
102377767|NCT04494828|Dexmedetomidine|dexmedetomidine|mesh-list
102377768|NCT04494828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102377769|NCT04494828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102377770|NCT04494828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377771|NCT04494828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102377772|NCT04494828|Analgesics|analgesics|mesh-ancestor
102377773|NCT04494828|Sensory System Agents|sensory system agents|mesh-ancestor
102377774|NCT04494828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102377775|NCT04494828|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102377776|NCT04494828|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102377777|NCT04494828|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102377778|NCT04494828|Adrenergic Agents|adrenergic agents|mesh-ancestor
102377779|NCT04494828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102377780|NCT04494828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377781|NCT01714336|Tranexamic Acid|tranexamic acid|mesh-list
102377782|NCT01714336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102377783|NCT01714336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102377784|NCT01714336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377785|NCT01714336|Hemostatics|hemostatics|mesh-ancestor
102377786|NCT01714336|Coagulants|coagulants|mesh-ancestor
102377787|NCT01716208|Ofatumumab|ofatumumab|mesh-list
102377788|NCT01716208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102377789|NCT00706992|Aldesleukin|aldesleukin|mesh-list
102377790|NCT00706992|Vaccines|vaccines|mesh-list
102377791|NCT00706992|Freund's Adjuvant|freund's adjuvant|mesh-list
102377792|NCT00706992|Immunologic Factors|immunologic factors|mesh-ancestor
102377793|NCT00706992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377794|NCT00706992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102377795|NCT00706992|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102189541|NCT05507372|Pimozide|pimozide|mesh-list
102377796|NCT00706992|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102377798|NCT00706992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102377799|NCT00706992|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102377800|NCT03335124|Vitamins|vitamins|mesh-list
102377801|NCT03335124|Ascorbic Acid|ascorbic acid|mesh-list
102377802|NCT03335124|Thiamine|thiamine|mesh-list
102377803|NCT03335124|Hydrocortisone|hydrocortisone|mesh-list
102377804|NCT03335124|Micronutrients|micronutrients|mesh-ancestor
102377805|NCT03335124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377806|NCT03335124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102377807|NCT03335124|Antioxidants|antioxidants|mesh-ancestor
102377808|NCT03335124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946586|NCT01263171|Fluorouracil|fluorouracil|mesh-list
102377809|NCT03335124|Protective Agents|protective agents|mesh-ancestor
102377810|NCT03335124|Vitamin B Complex|vitamin b complex|mesh-ancestor
102377811|NCT03339804|Cyclophosphamide|cyclophosphamide|mesh-list
102377812|NCT03339804|Doxorubicin|doxorubicin|mesh-list
102377813|NCT03339804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102377814|NCT03339804|Immunologic Factors|immunologic factors|mesh-ancestor
102377815|NCT03339804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377816|NCT03339804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102377817|NCT03339804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102377818|NCT03339804|Alkylating Agents|alkylating agents|mesh-ancestor
102377819|NCT03339804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377820|NCT03339804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102377821|NCT03339804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102377822|NCT03339804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102377823|NCT03339804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102377824|NCT03339804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102377825|NCT03339804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102377826|NCT02248636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
102377827|NCT02248636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102377828|NCT02248636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377829|NCT02248636|Cholinergic Agents|cholinergic agents|mesh-ancestor
102377830|NCT02248636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102377831|NCT02248636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377832|NCT02491320|Letrozole|letrozole|mesh-list
102377833|NCT02491320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102377834|NCT02491320|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102377835|NCT02491320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102377836|NCT02491320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102377837|NCT02491320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377838|NCT02491320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102377839|NCT02491320|Hormone Antagonists|hormone antagonists|mesh-ancestor
102401211|NCT02348268|Sensory System Agents|sensory system agents|mesh-ancestor
102377840|NCT02491320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102377841|NCT02491320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377842|NCT02491242|Dolutegravir|dolutegravir|mesh-list
102377843|NCT02491242|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102377844|NCT02491242|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102377845|NCT02491242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102377846|NCT02491242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377847|NCT02491242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102377848|NCT02491242|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102377849|NCT02491242|Antiviral Agents|antiviral agents|mesh-ancestor
102377850|NCT02491242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102377851|NCT03330990|Midazolam|midazolam|mesh-list
102377852|NCT03330990|Entrectinib|entrectinib|mesh-list
102377853|NCT03330990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102377854|NCT03330990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102377855|NCT03330990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102377856|NCT03330990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377857|NCT03330990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102377858|NCT03330990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102377859|NCT03330990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102377860|NCT03330990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102377861|NCT03330990|Anesthetics, General|anesthetics, general|mesh-ancestor
102377862|NCT03330990|Anesthetics|anesthetics|mesh-ancestor
102377863|NCT03330990|GABA Modulators|gaba modulators|mesh-ancestor
102377864|NCT03330990|GABA Agents|gaba agents|mesh-ancestor
102377865|NCT03330990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102377866|NCT03330990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377867|NCT03330990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102377868|NCT03330990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102377869|NCT03339024|Oxytocin|oxytocin|mesh-list
102189619|NCT04535089|Lidocaine|lidocaine|mesh-list
102377870|NCT03339024|Oxytocics|oxytocics|mesh-ancestor
102377871|NCT03339024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102377872|NCT03339024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377873|NCT03330132|Hemagglutinins|hemagglutinins|mesh-list
102377874|NCT03330132|Vaccines|vaccines|mesh-list
102377875|NCT03330132|Immunologic Factors|immunologic factors|mesh-ancestor
102377876|NCT03330132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946692|NCT01161927|Nizatidine|nizatidine|mesh-list
102377877|NCT03330132|Agglutinins|agglutinins|mesh-ancestor
102377878|NCT03330132|Coagulants|coagulants|mesh-ancestor
102377879|NCT02492412|Cyclosporine|cyclosporine|mesh-list
102377880|NCT02492412|Cyclosporins|cyclosporins|mesh-list
102377881|NCT02492412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102377882|NCT02492412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377883|NCT02492412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102377884|NCT02492412|Immunologic Factors|immunologic factors|mesh-ancestor
102377885|NCT02492412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377886|NCT02492412|Antifungal Agents|antifungal agents|mesh-ancestor
102377887|NCT02492412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102377888|NCT02492412|Dermatologic Agents|dermatologic agents|mesh-ancestor
102377889|NCT02492412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102377890|NCT02492412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102377891|NCT03329898|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102377892|NCT03329898|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102377893|NCT03329898|Estradiol|estradiol|mesh-list
102377894|NCT03329898|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102377895|NCT03329898|Dydrogesterone|dydrogesterone|mesh-list
102377896|NCT03329898|Estrogens|estrogens|mesh-ancestor
102377897|NCT03329898|Hormones|hormones|mesh-ancestor
102377898|NCT03329898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102377899|NCT03329898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377900|NCT03329898|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102377901|NCT03329898|Contraceptive Agents|contraceptive agents|mesh-ancestor
102377902|NCT03329898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102377903|NCT03329898|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102377904|NCT03329898|Progestins|progestins|mesh-ancestor
102377905|NCT02492568|Pembrolizumab|pembrolizumab|mesh-list
102377906|NCT02492568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102377907|NCT02492568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102377908|NCT02492568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102377909|NCT02492568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377910|NCT01722292|Carboplatin|carboplatin|mesh-list
102377911|NCT01722292|Etoposide|etoposide|mesh-list
102377912|NCT01722292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102377913|NCT01722292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102377914|NCT01722292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102377915|NCT01722292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102377916|NCT01722292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101946724|NCT03110432|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
102377917|NCT01722292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377918|NCT02493894|Cefazolin|cefazolin|mesh-list
101946733|NCT03110432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102377919|NCT02493894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102377920|NCT02493894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102377921|NCT02493738|Itraconazole|itraconazole|mesh-list
102377922|NCT02493738|Antifungal Agents|antifungal agents|mesh-ancestor
102377923|NCT02493738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102377924|NCT02493738|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102377925|NCT02493738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102377926|NCT02493738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102377927|NCT02493738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377928|NCT02493738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102377929|NCT02493738|Hormone Antagonists|hormone antagonists|mesh-ancestor
102377930|NCT02493738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102377931|NCT02493738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377932|NCT02493738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102377933|NCT03875638|Levetiracetam|levetiracetam|mesh-list
102377934|NCT03875638|Anticonvulsants|anticonvulsants|mesh-ancestor
102377935|NCT03875638|Nootropic Agents|nootropic agents|mesh-ancestor
102377936|NCT02493582|Apatinib|apatinib|mesh-list
102377937|NCT02493582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102377938|NCT02493582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102377939|NCT02493582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102377940|NCT02493582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377941|NCT05560360|Efavirenz|efavirenz|mesh-list
102377942|NCT05560360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102377943|NCT05560360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102377944|NCT05560360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612283|NCT00002393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102377945|NCT05560360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377946|NCT05560360|Antiviral Agents|antiviral agents|mesh-ancestor
102377947|NCT05560360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102377948|NCT05560360|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102377949|NCT05560360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102377950|NCT05560360|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102377951|NCT05560360|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102377952|NCT05560360|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102377953|NCT05560360|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102377954|NCT03329118|Simvastatin|simvastatin|mesh-list
102377955|NCT03329118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102377956|NCT03329118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102377957|NCT03329118|Antimetabolites|antimetabolites|mesh-ancestor
102377958|NCT03329118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377959|NCT03329118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102377960|NCT03329118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102377961|NCT03329118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102377962|NCT01723384|Naltrexone|naltrexone|mesh-list
102377963|NCT01723384|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102377964|NCT01723384|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102377965|NCT01723384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946768|NCT03882489|Chloroprocaine|chloroprocaine|mesh-list
102377966|NCT01723384|Sensory System Agents|sensory system agents|mesh-ancestor
102377967|NCT01723384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102377968|NCT02492490|Basiliximab|basiliximab|mesh-list
102377969|NCT02492490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101946789|NCT04745780|Micronutrients|micronutrients|mesh-ancestor
102377970|NCT02492490|Immunologic Factors|immunologic factors|mesh-ancestor
102377971|NCT02492490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377972|NCT03337932|Doxycycline|doxycycline|mesh-list
102377973|NCT03337932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102377974|NCT03337932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102377975|NCT03337932|Antimalarials|antimalarials|mesh-ancestor
102377976|NCT03337932|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102377977|NCT03337932|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102377978|NCT02493504|Heparin|heparin|mesh-list
102377979|NCT02493504|Anticoagulants|anticoagulants|mesh-ancestor
102377980|NCT02493504|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102377981|NCT02493504|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102377982|NCT02493504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377983|NCT00706914|Formoterol Fumarate|formoterol fumarate|mesh-list
102377984|NCT00706914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102377985|NCT00706914|Autonomic Agents|autonomic agents|mesh-ancestor
102377986|NCT00706914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102377987|NCT00706914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102377988|NCT00706914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102377989|NCT00706914|Respiratory System Agents|respiratory system agents|mesh-ancestor
101946809|NCT02833948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102377990|NCT00706914|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102377991|NCT00706914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102377992|NCT00706914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102377993|NCT00706914|Adrenergic Agents|adrenergic agents|mesh-ancestor
102377994|NCT00706914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102377995|NCT00706914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102377996|NCT03328728|Hylan|hylan|mesh-list
102377997|NCT03328728|Viscosupplements|viscosupplements|mesh-ancestor
102377998|NCT03328728|Protective Agents|protective agents|mesh-ancestor
102377999|NCT03328728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378000|NCT03328494|Paclitaxel|paclitaxel|mesh-list
102378001|NCT03328494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102378002|NCT03328494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102378003|NCT03328494|Tubulin Modulators|tubulin modulators|mesh-ancestor
102378004|NCT03328494|Antimitotic Agents|antimitotic agents|mesh-ancestor
102378005|NCT03328494|Mitosis Modulators|mitosis modulators|mesh-ancestor
102378006|NCT03328494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378007|NCT02491398|Rituximab|rituximab|mesh-list
102378008|NCT02491398|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102378009|NCT02491398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102378010|NCT02491398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102378011|NCT02491398|Immunologic Factors|immunologic factors|mesh-ancestor
102378012|NCT02491398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378013|NCT02491398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102378014|NCT02491398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102378015|NCT02491398|Alkylating Agents|alkylating agents|mesh-ancestor
102378016|NCT02491398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378017|NCT03333018|Bromides|bromides|mesh-list
102154179|NCT03606577|Hormones|hormones|mesh-ancestor
102378018|NCT03333018|Formoterol Fumarate|formoterol fumarate|mesh-list
102378019|NCT03333018|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102378020|NCT03333018|Autonomic Agents|autonomic agents|mesh-ancestor
102378021|NCT03333018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101946837|NCT02404688|Ethanol|ethanol|mesh-list
102378022|NCT03333018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378023|NCT03333018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102378024|NCT03333018|Respiratory System Agents|respiratory system agents|mesh-ancestor
102378025|NCT03333018|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102378026|NCT03333018|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102378027|NCT03333018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102378028|NCT03333018|Adrenergic Agents|adrenergic agents|mesh-ancestor
102378029|NCT03333018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102378030|NCT03333018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378031|NCT03333018|Anticonvulsants|anticonvulsants|mesh-ancestor
102378032|NCT03332940|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
102378033|NCT03332940|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102378034|NCT03332940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378035|NCT01723696|Vitamins|vitamins|mesh-list
102378036|NCT01723696|Ascorbic Acid|ascorbic acid|mesh-list
102378037|NCT01723696|Micronutrients|micronutrients|mesh-ancestor
102378038|NCT01723696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378039|NCT01723696|Antioxidants|antioxidants|mesh-ancestor
102378040|NCT01723696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378041|NCT01723696|Protective Agents|protective agents|mesh-ancestor
102378042|NCT03327558|Mesalamine|mesalamine|mesh-list
102378043|NCT03327558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102378044|NCT03327558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102378045|NCT03327558|Analgesics|analgesics|mesh-ancestor
102378046|NCT03327558|Sensory System Agents|sensory system agents|mesh-ancestor
102378047|NCT03327558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102378048|NCT03327558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378049|NCT03327558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102378050|NCT03327558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102378051|NCT02242630|Methylprednisolone|methylprednisolone|mesh-list
101946863|NCT01162941|Prednisolone|prednisolone|mesh-list
102378052|NCT02242630|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102378053|NCT02242630|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102378054|NCT02242630|Prednisolone|prednisolone|mesh-list
102378055|NCT02242630|Prednisolone acetate|prednisolone acetate|mesh-list
102378056|NCT02242630|Triamcinolone|triamcinolone|mesh-list
102378057|NCT02242630|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102378058|NCT02242630|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102378059|NCT02242630|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102378060|NCT02242630|Prednisolone phosphate|prednisolone phosphate|mesh-list
102378061|NCT02242630|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102378062|NCT02242630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102378063|NCT02242630|Antiemetics|antiemetics|mesh-ancestor
102378064|NCT02242630|Autonomic Agents|autonomic agents|mesh-ancestor
102378065|NCT02242630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102378066|NCT02242630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946873|NCT00161044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102378067|NCT02242630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102378068|NCT02242630|Glucocorticoids|glucocorticoids|mesh-ancestor
102378069|NCT02242630|Hormones|hormones|mesh-ancestor
102378070|NCT02242630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102378071|NCT02242630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102378072|NCT02242630|Protective Agents|protective agents|mesh-ancestor
102378073|NCT02242630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102378074|NCT02242630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102378075|NCT02242630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102378076|NCT02242630|Immunologic Factors|immunologic factors|mesh-ancestor
102378077|NCT02242630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102378078|NCT02242630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378079|NCT03109080|Olaparib|olaparib|mesh-list
102378080|NCT03109080|Adenosine|adenosine|mesh-list
102378081|NCT03109080|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102378082|NCT03109080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102378083|NCT03109080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378084|NCT03109080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102378085|NCT03109080|Analgesics|analgesics|mesh-ancestor
102378086|NCT03109080|Sensory System Agents|sensory system agents|mesh-ancestor
102378087|NCT03109080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102378088|NCT03109080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378089|NCT03109080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102378090|NCT03109080|Vasodilator Agents|vasodilator agents|mesh-ancestor
102378091|NCT03109080|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102189840|NCT02567708|Nemiralisib|nemiralisib|mesh-list
102378092|NCT03109080|Purinergic Agonists|purinergic agonists|mesh-ancestor
102378093|NCT03109080|Purinergic Agents|purinergic agents|mesh-ancestor
102378094|NCT03109080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101946906|NCT01269333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102378096|NCT03109158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102378097|NCT03109158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102378098|NCT03324828|Hydroxyzine|hydroxyzine|mesh-list
102378099|NCT03324828|Antipruritics|antipruritics|mesh-ancestor
102378100|NCT03324828|Dermatologic Agents|dermatologic agents|mesh-ancestor
102378101|NCT03324828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102378102|NCT03324828|Histamine Antagonists|histamine antagonists|mesh-ancestor
102378103|NCT03324828|Histamine Agents|histamine agents|mesh-ancestor
102378104|NCT03324828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102378105|NCT03324828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378106|NCT03324828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983005|NCT01589809|Niacin|niacin|mesh-list
102378107|NCT03332316|Dexamethasone|dexamethasone|mesh-list
102378108|NCT03332316|Dexamethasone acetate|dexamethasone acetate|mesh-list
102378109|NCT03332316|Ropivacaine|ropivacaine|mesh-list
102378110|NCT03332316|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102378111|NCT03332316|BB 1101|bb 1101|mesh-list
102378112|NCT03332316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102378113|NCT03332316|Antiemetics|antiemetics|mesh-ancestor
102378114|NCT03332316|Autonomic Agents|autonomic agents|mesh-ancestor
102378115|NCT03332316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102378116|NCT03332316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378117|NCT03332316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102378118|NCT03332316|Glucocorticoids|glucocorticoids|mesh-ancestor
102378119|NCT03332316|Hormones|hormones|mesh-ancestor
101946932|NCT03882255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102378120|NCT03332316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102378121|NCT03332316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102378122|NCT03332316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102378123|NCT03332316|Anesthetics, Local|anesthetics, local|mesh-ancestor
102378124|NCT03332316|Anesthetics|anesthetics|mesh-ancestor
102378125|NCT03332316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102378126|NCT03332316|Sensory System Agents|sensory system agents|mesh-ancestor
102378127|NCT03332316|Protease Inhibitors|protease inhibitors|mesh-ancestor
102378128|NCT03332316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102378129|NCT03332316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378130|NCT03327168|Adenosine|adenosine|mesh-list
102378131|NCT03327168|Analgesics|analgesics|mesh-ancestor
102378132|NCT03327168|Sensory System Agents|sensory system agents|mesh-ancestor
102378133|NCT03327168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102378134|NCT03327168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378135|NCT03327168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102378136|NCT03327168|Vasodilator Agents|vasodilator agents|mesh-ancestor
102378137|NCT03327168|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102378138|NCT03327168|Purinergic Agonists|purinergic agonists|mesh-ancestor
102378139|NCT03327168|Purinergic Agents|purinergic agents|mesh-ancestor
102378140|NCT03327168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102378141|NCT03327168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378142|NCT01726738|Trametinib|trametinib|mesh-list
102378143|NCT01726738|Dabrafenib|dabrafenib|mesh-list
102378144|NCT01726738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101983522|NCT02526979|Mirabegron|mirabegron|mesh-list
102378145|NCT01726738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102378146|NCT01726738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102378147|NCT01726738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378148|NCT02492178|Artesunate|artesunate|mesh-list
102378149|NCT02492178|Quinine|quinine|mesh-list
102378150|NCT02492178|Antimalarials|antimalarials|mesh-ancestor
102378151|NCT02492178|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102378152|NCT02492178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102378153|NCT02492178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101946961|NCT05430230|Naproxen|naproxen|mesh-list
102378154|NCT02492178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102378155|NCT02492178|Antiviral Agents|antiviral agents|mesh-ancestor
102378156|NCT02492178|Schistosomicides|schistosomicides|mesh-ancestor
102378157|NCT02492178|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102378158|NCT02492178|Anthelmintics|anthelmintics|mesh-ancestor
102378159|NCT02492178|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102378160|NCT02492178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378161|NCT02492178|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102378162|NCT02492178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102378163|NCT02492178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102378164|NCT02492178|Analgesics|analgesics|mesh-ancestor
102378165|NCT02492178|Sensory System Agents|sensory system agents|mesh-ancestor
102378166|NCT03679624|Daratumumab|daratumumab|mesh-list
102378167|NCT03679624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102189908|NCT02562716|Antimetabolites|antimetabolites|mesh-ancestor
102378168|NCT04494126|Tranexamic Acid|tranexamic acid|mesh-list
102378169|NCT04494126|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102378170|NCT04494126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102378171|NCT04494126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378172|NCT04494126|Hemostatics|hemostatics|mesh-ancestor
102378173|NCT04494126|Coagulants|coagulants|mesh-ancestor
102378174|NCT01730872|Prednisolone|prednisolone|mesh-list
102378175|NCT01730872|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102378176|NCT01730872|Methylprednisolone|methylprednisolone|mesh-list
102378177|NCT01730872|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102378178|NCT01730872|Prednisolone acetate|prednisolone acetate|mesh-list
102378179|NCT01730872|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102378180|NCT01730872|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102378181|NCT01730872|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102378182|NCT01730872|Prednisolone phosphate|prednisolone phosphate|mesh-list
102378183|NCT01730872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102378184|NCT01730872|Glucocorticoids|glucocorticoids|mesh-ancestor
102378185|NCT01730872|Hormones|hormones|mesh-ancestor
102378186|NCT01730872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102378187|NCT01730872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378188|NCT01730872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102378189|NCT01730872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102378190|NCT01730872|Antiemetics|antiemetics|mesh-ancestor
102378191|NCT01730872|Autonomic Agents|autonomic agents|mesh-ancestor
102378192|NCT01730872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102378193|NCT01730872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101946974|NCT01268709|Doxepin|doxepin|mesh-list
102378194|NCT01730872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102378195|NCT01730872|Protective Agents|protective agents|mesh-ancestor
102378196|NCT02491086|Nicotine|nicotine|mesh-list
102378197|NCT02491086|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102378198|NCT02491086|Autonomic Agents|autonomic agents|mesh-ancestor
102378199|NCT02491086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102378200|NCT02491086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378201|NCT02491086|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102378202|NCT02491086|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102378203|NCT02491086|Cholinergic Agents|cholinergic agents|mesh-ancestor
102378204|NCT02491086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102378205|NCT02491086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378206|NCT03469492|Insulin|insulin|mesh-list
102378207|NCT03469492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102378208|NCT03469492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378209|NCT03331770|Latanoprost|latanoprost|mesh-list
102378210|NCT03331770|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102378211|NCT03331770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102378212|NCT03331692|Anesthetics|anesthetics|mesh-list
102378213|NCT03331692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102378214|NCT03331692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378215|NCT04826692|Metformin|metformin|mesh-list
102378216|NCT04826692|Biguanides|biguanides|mesh-list
102378217|NCT04826692|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102378218|NCT04826692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378219|NCT02490930|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102378220|NCT02490930|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102378221|NCT02490930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378222|NCT02490930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102378223|NCT02490930|Immunologic Factors|immunologic factors|mesh-ancestor
102378224|NCT02490930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378225|NCT04825990|Pembrolizumab|pembrolizumab|mesh-list
102378226|NCT04825990|Olaparib|olaparib|mesh-list
102378227|NCT04825990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102378228|NCT04825990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102378229|NCT04825990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102378230|NCT04825990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378231|NCT04825990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102378232|NCT04825990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102378234|NCT03331302|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102378235|NCT03331302|Anesthetics, General|anesthetics, general|mesh-ancestor
102378236|NCT03331302|Anesthetics|anesthetics|mesh-ancestor
102378237|NCT03331302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101947042|NCT01584466|Serotonin Agents|serotonin agents|mesh-ancestor
102378238|NCT03331302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378239|NCT01738672|Nitrous Oxide|nitrous oxide|mesh-list
102378240|NCT01738672|Entonox|entonox|mesh-list
102378241|NCT01738672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102189992|NCT03534505|Analgesics|analgesics|mesh-ancestor
102378242|NCT01738672|Anesthetics, General|anesthetics, general|mesh-ancestor
102378243|NCT01738672|Anesthetics|anesthetics|mesh-ancestor
102378244|NCT01738672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101947056|NCT05363384|Protease Inhibitors|protease inhibitors|mesh-ancestor
102378245|NCT01738672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378246|NCT01738672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102378247|NCT01738672|Analgesics|analgesics|mesh-ancestor
102378248|NCT01738672|Sensory System Agents|sensory system agents|mesh-ancestor
102378249|NCT01738672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102378250|NCT01738672|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
102378251|NCT02488512|Edotreotide|edotreotide|mesh-list
102378252|NCT02488512|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102378253|NCT02488512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378254|NCT01808651|Fluoxetine|fluoxetine|mesh-list
102378255|NCT01808651|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102378256|NCT01808651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102378257|NCT01808651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102378258|NCT01808651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378259|NCT01808651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102378260|NCT01808651|Serotonin Agents|serotonin agents|mesh-ancestor
102378261|NCT01808651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378262|NCT01808651|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102378263|NCT01808651|Antidepressive Agents|antidepressive agents|mesh-ancestor
102378264|NCT01808651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102378265|NCT01808651|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102378266|NCT01808651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102378267|NCT01808651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102378268|NCT02488590|Bronchodilator Agents|bronchodilator agents|mesh-list
102378269|NCT02488590|Autonomic Agents|autonomic agents|mesh-ancestor
102378270|NCT02488590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102378271|NCT02488590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378272|NCT02488590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102378273|NCT02488590|Respiratory System Agents|respiratory system agents|mesh-ancestor
102378274|NCT05316376|Paclitaxel|paclitaxel|mesh-list
102378275|NCT05316376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102378276|NCT05316376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102378277|NCT05316376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102378278|NCT05316376|Tubulin Modulators|tubulin modulators|mesh-ancestor
102378279|NCT05316376|Antimitotic Agents|antimitotic agents|mesh-ancestor
102378280|NCT05316376|Mitosis Modulators|mitosis modulators|mesh-ancestor
102378281|NCT05316376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378282|NCT01743976|Donepezil|donepezil|mesh-list
102378283|NCT01743976|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102378284|NCT01743976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102378285|NCT01743976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378286|NCT01743976|Cholinergic Agents|cholinergic agents|mesh-ancestor
102378287|NCT01743976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102378288|NCT01743976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378289|NCT01743976|Nootropic Agents|nootropic agents|mesh-ancestor
102378290|NCT05315830|Vaccines|vaccines|mesh-list
102378291|NCT05315830|Immunologic Factors|immunologic factors|mesh-ancestor
102378292|NCT05315830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378293|NCT05463822|Botulinum Toxins|botulinum toxins|mesh-list
102378294|NCT05463822|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102378295|NCT05463822|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102378296|NCT05463822|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102378297|NCT05463822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102378298|NCT05463822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378299|NCT05463822|Cholinergic Agents|cholinergic agents|mesh-ancestor
102378300|NCT05463822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102378301|NCT05463822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378302|NCT05463822|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102378303|NCT05463822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102378304|NCT04639960|Risperidone|risperidone|mesh-list
102378305|NCT04639960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102378306|NCT04639960|Serotonin Agents|serotonin agents|mesh-ancestor
102378307|NCT04639960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102378308|NCT04639960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378309|NCT04639960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378310|NCT04639960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102378311|NCT04639960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101947125|NCT01583283|Ricolinostat|ricolinostat|mesh-list
102378312|NCT04639960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102378313|NCT04639960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102378314|NCT04639960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102378315|NCT04639960|Dopamine Agents|dopamine agents|mesh-ancestor
102378316|NCT03109314|Donepezil|donepezil|mesh-list
102378317|NCT03109314|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102378318|NCT03109314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102378319|NCT03109314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378320|NCT03109314|Cholinergic Agents|cholinergic agents|mesh-ancestor
102378321|NCT03109314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102378322|NCT03109314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378323|NCT03109314|Nootropic Agents|nootropic agents|mesh-ancestor
102378324|NCT04566016|Anesthetics|anesthetics|mesh-list
102378325|NCT04566016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102378326|NCT04566016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985252|NCT01179529|Omalizumab|omalizumab|mesh-list
102378327|NCT03320538|Rabeprazole|rabeprazole|mesh-list
102378328|NCT03320538|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102378329|NCT03320538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102378330|NCT03320538|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102378331|NCT03320538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102378332|NCT03320538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378333|NCT03322878|Magnesium Sulfate|magnesium sulfate|mesh-list
102378334|NCT03322878|Analgesics|analgesics|mesh-ancestor
102378335|NCT03322878|Sensory System Agents|sensory system agents|mesh-ancestor
102378336|NCT03322878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102378337|NCT03322878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378338|NCT03322878|Anesthetics|anesthetics|mesh-ancestor
102378339|NCT03322878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102378340|NCT03322878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102378341|NCT03322878|Anticonvulsants|anticonvulsants|mesh-ancestor
102378342|NCT03322878|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102378343|NCT03322878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102378344|NCT03322878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378345|NCT03322878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102378346|NCT03322878|Tocolytic Agents|tocolytic agents|mesh-ancestor
102378347|NCT03322878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102378348|NCT03322800|Ziresovir|ziresovir|mesh-list
102378349|NCT03322800|Antiviral Agents|antiviral agents|mesh-ancestor
102378350|NCT03322800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102378351|NCT03320460|Clobetasol|clobetasol|mesh-list
102378352|NCT03320460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102378353|NCT03320460|Glucocorticoids|glucocorticoids|mesh-ancestor
102378354|NCT03320460|Hormones|hormones|mesh-ancestor
102378355|NCT03320460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102378356|NCT03320460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378357|NCT04471714|Baclofen|baclofen|mesh-list
102378358|NCT04471714|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101985848|NCT03720873|Gefitinib|gefitinib|mesh-list
102378359|NCT04471714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378360|NCT04471714|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102378361|NCT04471714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102378362|NCT04471714|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101812570|NCT00972842|Lenalidomide|lenalidomide|mesh-list
102378363|NCT04471714|GABA Agonists|gaba agonists|mesh-ancestor
102378364|NCT04471714|GABA Agents|gaba agents|mesh-ancestor
102378365|NCT04471714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102378366|NCT04471714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378367|NCT05315206|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
102378368|NCT05315206|Nootropic Agents|nootropic agents|mesh-ancestor
102378369|NCT03325686|Vitamin D|vitamin d|mesh-list
102378370|NCT03325686|Vitamins|vitamins|mesh-ancestor
102378371|NCT03325686|Micronutrients|micronutrients|mesh-ancestor
102378372|NCT03325686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378373|NCT03325686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102378374|NCT05315128|Methotrexate|methotrexate|mesh-list
102378375|NCT05315128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102378376|NCT05315128|Abortifacient Agents|abortifacient agents|mesh-ancestor
102378377|NCT05315128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102378378|NCT05315128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378379|NCT05315128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102378380|NCT05315128|Antimetabolites|antimetabolites|mesh-ancestor
102378381|NCT05315128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378382|NCT05315128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102378383|NCT05315128|Dermatologic Agents|dermatologic agents|mesh-ancestor
102378384|NCT05315128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102378385|NCT05315128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102378386|NCT05315128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102378387|NCT05315128|Immunologic Factors|immunologic factors|mesh-ancestor
102378388|NCT05315128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102378389|NCT05315128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102378390|NCT03322488|Metronidazole|metronidazole|mesh-list
102378391|NCT03322488|Doxycycline|doxycycline|mesh-list
102378392|NCT03322488|Ciprofloxacin|ciprofloxacin|mesh-list
102378393|NCT03322488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102378394|NCT03322488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102378395|NCT03322488|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102378396|NCT03322488|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102378397|NCT03322488|Antimalarials|antimalarials|mesh-ancestor
102378398|NCT03322488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102378399|NCT03322488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102378400|NCT03322488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102378401|NCT03322488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378402|NCT03322488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102378403|NCT03322488|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102378404|NCT03322488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102378405|NCT01808573|Capecitabine|capecitabine|mesh-list
102378406|NCT01808573|Lapatinib|lapatinib|mesh-list
102378407|NCT01808573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102378408|NCT01808573|Antimetabolites|antimetabolites|mesh-ancestor
102378409|NCT01808573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378410|NCT01808573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102378411|NCT01808573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102378412|NCT01808573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102378413|NCT01746940|Cocaine|cocaine|mesh-list
102378414|NCT01746940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102378415|NCT01746940|Anesthetics, Local|anesthetics, local|mesh-ancestor
102378416|NCT01746940|Anesthetics|anesthetics|mesh-ancestor
102378417|NCT01746940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102378418|NCT01746940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378419|NCT01746940|Sensory System Agents|sensory system agents|mesh-ancestor
101813110|NCT00977054|Ribavirin|ribavirin|mesh-list
102378420|NCT01746940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102378421|NCT01746940|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101986642|NCT03720249|Vitamins|vitamins|mesh-list
102378422|NCT01746940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102378423|NCT01746940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101947233|NCT01164189|Growth Substances|growth substances|mesh-ancestor
102378424|NCT01746940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102378425|NCT01746940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378426|NCT01746940|Dopamine Agents|dopamine agents|mesh-ancestor
102378427|NCT01746940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102378428|NCT01747330|Pancreatin|pancreatin|mesh-list
102378429|NCT01747330|Pancrelipase|pancrelipase|mesh-list
101947239|NCT01164267|Everolimus|everolimus|mesh-list
102378430|NCT01747330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102378431|NCT02990962|Triamcinolone|triamcinolone|mesh-list
102378432|NCT02990962|Lidocaine|lidocaine|mesh-list
102378433|NCT02990962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102378434|NCT02990962|Glucocorticoids|glucocorticoids|mesh-ancestor
102378435|NCT02990962|Hormones|hormones|mesh-ancestor
102378436|NCT02990962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102378437|NCT02990962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378438|NCT02990962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378439|NCT02990962|Anesthetics, Local|anesthetics, local|mesh-ancestor
102378440|NCT02990962|Anesthetics|anesthetics|mesh-ancestor
102378441|NCT02990962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102378442|NCT02990962|Sensory System Agents|sensory system agents|mesh-ancestor
102378443|NCT02990962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102378444|NCT02990962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102378445|NCT02990962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102378446|NCT02990962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102378447|NCT02990962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102378448|NCT03322098|Atropine|atropine|mesh-list
102378449|NCT03322098|Glycopyrrolate|glycopyrrolate|mesh-list
102378450|NCT03322098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102378451|NCT03322098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102378452|NCT03322098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102378453|NCT03322098|Autonomic Agents|autonomic agents|mesh-ancestor
101947251|NCT01164345|Antiviral Agents|antiviral agents|mesh-ancestor
102378454|NCT03322098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102378455|NCT03322098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987129|NCT03481725|Coal Tar|coal tar|mesh-list
102378456|NCT03322098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102378457|NCT03322098|Respiratory System Agents|respiratory system agents|mesh-ancestor
102378458|NCT03322098|Mydriatics|mydriatics|mesh-ancestor
102378459|NCT03322098|Parasympatholytics|parasympatholytics|mesh-ancestor
102378460|NCT03322098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102378461|NCT03322098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102378462|NCT03322098|Cholinergic Agents|cholinergic agents|mesh-ancestor
102378463|NCT03322098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102612284|NCT00002393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102190210|NCT05977647|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102378464|NCT03322098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378466|NCT03319680|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102378467|NCT01808339|Fluticasone|fluticasone|mesh-list
102378468|NCT01808339|Xhance|xhance|mesh-list
102378469|NCT01808339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102378470|NCT01808339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102378471|NCT01808339|Autonomic Agents|autonomic agents|mesh-ancestor
102378472|NCT01808339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102378473|NCT01808339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378474|NCT01808339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102378475|NCT01808339|Respiratory System Agents|respiratory system agents|mesh-ancestor
102378476|NCT01808339|Dermatologic Agents|dermatologic agents|mesh-ancestor
102378477|NCT01808339|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102378478|NCT01749904|Timolol|timolol|mesh-list
102378479|NCT01749904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102378480|NCT01749904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102378481|NCT01749904|Adrenergic Agents|adrenergic agents|mesh-ancestor
102378482|NCT01749904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102378483|NCT01749904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378484|NCT01749904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378485|NCT01749904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102378486|NCT01749904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102378487|NCT02484768|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
102378488|NCT02484768|Hematinics|hematinics|mesh-ancestor
102378489|NCT03316326|Oxaliplatin|oxaliplatin|mesh-list
102378490|NCT03316326|Irinotecan|irinotecan|mesh-list
102378491|NCT03316326|Tegafur|tegafur|mesh-list
102378492|NCT03316326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102378493|NCT03316326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102378494|NCT03316326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101987757|NCT01110551|Vaccines|vaccines|mesh-list
102378495|NCT03316326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102378496|NCT03316326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947296|NCT00135226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102378497|NCT03316326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102378498|NCT03316326|Antimetabolites|antimetabolites|mesh-ancestor
102378499|NCT02487732|Ticagrelor|ticagrelor|mesh-list
102378500|NCT02487732|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102378501|NCT02487732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101947301|NCT00135226|Antipyretics|antipyretics|mesh-ancestor
102378502|NCT02487732|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102378503|NCT02487732|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102378504|NCT02487732|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102378505|NCT02487732|Purinergic Agents|purinergic agents|mesh-ancestor
102378506|NCT02487732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102378507|NCT02487732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378508|NCT02487732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947310|NCT01269021|Prednisone|prednisone|mesh-list
102378509|NCT03833362|Interferons|interferons|mesh-list
102378510|NCT03833362|Ritonavir|ritonavir|mesh-list
102378511|NCT03833362|Ribavirin|ribavirin|mesh-list
102378512|NCT03833362|Interferon-alpha|interferon-alpha|mesh-list
102378513|NCT03833362|Interferon alpha-2|interferon alpha-2|mesh-list
102378514|NCT03833362|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102378515|NCT03833362|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102378516|NCT03833362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102378517|NCT03833362|Antiviral Agents|antiviral agents|mesh-ancestor
102378518|NCT03833362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102378519|NCT03833362|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102378520|NCT03833362|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102378521|NCT03833362|Protease Inhibitors|protease inhibitors|mesh-ancestor
101988206|NCT01202149|Pimecrolimus|pimecrolimus|mesh-list
102378522|NCT03833362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102378523|NCT03833362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378524|NCT03833362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102378525|NCT03833362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102378526|NCT03833362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102378527|NCT03833362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102378528|NCT03833362|Antimetabolites|antimetabolites|mesh-ancestor
102378529|NCT03833362|Immunologic Factors|immunologic factors|mesh-ancestor
102378530|NCT03833362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378531|NCT05463588|Methamphetamine|methamphetamine|mesh-list
102378532|NCT05463588|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101988434|NCT01199341|Warfarin|warfarin|mesh-list
102378533|NCT05463588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378534|NCT05463588|Sympathomimetics|sympathomimetics|mesh-ancestor
102378535|NCT05463588|Autonomic Agents|autonomic agents|mesh-ancestor
102378536|NCT05463588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101947336|NCT01269099|Anesthetics|anesthetics|mesh-ancestor
102378537|NCT05463588|Dopamine Agents|dopamine agents|mesh-ancestor
102378538|NCT05463588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102378539|NCT05463588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378540|NCT05463588|Adrenergic Agents|adrenergic agents|mesh-ancestor
102378541|NCT05463588|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102378542|NCT05463588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102378543|NCT05463588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102378544|NCT05463588|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102378545|NCT02490774|Levonorgestrel|levonorgestrel|mesh-list
102378546|NCT02490774|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102378547|NCT02490774|Contraceptive Agents|contraceptive agents|mesh-ancestor
102378548|NCT02490774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102378549|NCT02490774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378550|NCT02490774|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102378551|NCT02490774|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102378552|NCT02490774|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102378553|NCT02490540|Sufentanil|sufentanil|mesh-list
102378554|NCT02490540|Dsuvia|dsuvia|mesh-list
101947351|NCT01165905|ON 01910|on 01910|mesh-list
102378555|NCT02490540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102378556|NCT02490540|Narcotics|narcotics|mesh-ancestor
101947355|NCT01165905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102378557|NCT02490540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102378558|NCT02490540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378559|NCT02490540|Analgesics|analgesics|mesh-ancestor
102378560|NCT02490540|Sensory System Agents|sensory system agents|mesh-ancestor
102378561|NCT02490540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102378562|NCT02490540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102378563|NCT02490540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102378564|NCT02490540|Anesthetics, General|anesthetics, general|mesh-ancestor
102378565|NCT02490540|Anesthetics|anesthetics|mesh-ancestor
102378566|NCT02484300|Melatonin|melatonin|mesh-list
102378567|NCT02484300|Antioxidants|antioxidants|mesh-ancestor
102378568|NCT02484300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378569|NCT02484300|Protective Agents|protective agents|mesh-ancestor
102378570|NCT02484300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947369|NCT03563170|Cetuximab|cetuximab|mesh-list
102378571|NCT02484300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102378572|NCT02727660|Budesonide|budesonide|mesh-list
102378573|NCT02727660|Formoterol Fumarate|formoterol fumarate|mesh-list
102378574|NCT02727660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102378575|NCT02727660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102378576|NCT02727660|Autonomic Agents|autonomic agents|mesh-ancestor
102378577|NCT02727660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102378578|NCT02727660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378579|NCT02727660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102378580|NCT02727660|Respiratory System Agents|respiratory system agents|mesh-ancestor
102378581|NCT02727660|Glucocorticoids|glucocorticoids|mesh-ancestor
102378582|NCT02727660|Hormones|hormones|mesh-ancestor
102378583|NCT02727660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102378584|NCT02727660|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102378585|NCT02727660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102378586|NCT02727660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102378587|NCT02727660|Adrenergic Agents|adrenergic agents|mesh-ancestor
102378588|NCT02727660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102378589|NCT02727660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378590|NCT02490072|Dexmedetomidine|dexmedetomidine|mesh-list
102378591|NCT02490072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102378592|NCT02490072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102378593|NCT02490072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378594|NCT02490072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102378595|NCT02490072|Analgesics|analgesics|mesh-ancestor
102378596|NCT02490072|Sensory System Agents|sensory system agents|mesh-ancestor
102378597|NCT02490072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102378598|NCT02490072|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101989502|NCT00890617|Prednisone|prednisone|mesh-list
102378599|NCT02490072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102378600|NCT02490072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102378601|NCT02490072|Adrenergic Agents|adrenergic agents|mesh-ancestor
102378602|NCT02490072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102378603|NCT02490072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378604|NCT02483598|Buspirone|buspirone|mesh-list
102378605|NCT02483598|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102378606|NCT02483598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102378607|NCT02483598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102378608|NCT02483598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947411|NCT01281111|Antipyretics|antipyretics|mesh-ancestor
102378609|NCT02483598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102378610|NCT02483598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102378611|NCT02483598|Serotonin Agents|serotonin agents|mesh-ancestor
102378612|NCT02483598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102378613|NCT02483598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378615|NCT03321318|Vitamin D|vitamin d|mesh-list
102378616|NCT03321318|Bazedoxifene|bazedoxifene|mesh-list
101947417|NCT03869931|Antimetabolites|antimetabolites|mesh-ancestor
102378617|NCT03321318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102378618|NCT03321318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378619|NCT03321318|Vitamins|vitamins|mesh-ancestor
102378620|NCT03321318|Micronutrients|micronutrients|mesh-ancestor
102378621|NCT03321318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102378622|NCT03321318|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102378623|NCT03321318|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101989941|NCT05137678|Glyburide|glyburide|mesh-list
102378624|NCT03321318|Hormone Antagonists|hormone antagonists|mesh-ancestor
102378625|NCT03321318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102378626|NCT01784861|Everolimus|everolimus|mesh-list
102378627|NCT01784861|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102378628|NCT01784861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102378629|NCT01784861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102378630|NCT01784861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378631|NCT01784861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102378632|NCT01784861|Immunologic Factors|immunologic factors|mesh-ancestor
102378633|NCT01784861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378634|NCT01784861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102378635|NCT03318744|Aspirin|aspirin|mesh-list
102378636|NCT03318744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101947434|NCT01169805|Ondansetron|ondansetron|mesh-list
102378637|NCT03318744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102378638|NCT03318744|Analgesics|analgesics|mesh-ancestor
102378639|NCT03318744|Sensory System Agents|sensory system agents|mesh-ancestor
102378640|NCT03318744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102378641|NCT03318744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378642|NCT03318744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102378643|NCT03318744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102378644|NCT03318744|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102378645|NCT03318744|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102378646|NCT03318744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378647|NCT03318744|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102378648|NCT03318744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102378649|NCT03318744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102378650|NCT03318744|Antipyretics|antipyretics|mesh-ancestor
102378651|NCT02489604|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102378652|NCT02489604|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102378653|NCT02489604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378654|NCT01751386|Baclofen|baclofen|mesh-list
102378655|NCT01751386|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102378656|NCT01751386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378657|NCT01751386|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102378658|NCT01751386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102378659|NCT01751386|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102378660|NCT01751386|GABA Agonists|gaba agonists|mesh-ancestor
102378661|NCT01751386|GABA Agents|gaba agents|mesh-ancestor
102378662|NCT01751386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102378663|NCT01751386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378664|NCT02489760|Adalimumab|adalimumab|mesh-list
102378665|NCT02489760|Etanercept|etanercept|mesh-list
102378666|NCT02489760|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102378667|NCT02489760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102378668|NCT02489760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102378669|NCT02489760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102378670|NCT02489760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102378671|NCT02489760|Analgesics|analgesics|mesh-ancestor
102378672|NCT02489760|Sensory System Agents|sensory system agents|mesh-ancestor
102378673|NCT02489760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102378674|NCT02489760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378675|NCT02489760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102378676|NCT02489760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102378677|NCT02489760|Immunologic Factors|immunologic factors|mesh-ancestor
102378678|NCT01752712|Oxytocin|oxytocin|mesh-list
102378679|NCT01752712|Oxytocics|oxytocics|mesh-ancestor
102378680|NCT01752712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101990749|NCT03918551|Febuxostat|febuxostat|mesh-list
102378681|NCT01752712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378682|NCT05127928|Vitamins|vitamins|mesh-list
102378683|NCT05127928|Ascorbic Acid|ascorbic acid|mesh-list
102378684|NCT05127928|Vitamin E|vitamin e|mesh-list
102378685|NCT05127928|Tocopherols|tocopherols|mesh-list
102378686|NCT05127928|Micronutrients|micronutrients|mesh-ancestor
102190436|NCT05975554|Interleukin-2|interleukin-2|mesh-list
102378687|NCT05127928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378688|NCT05127928|Antioxidants|antioxidants|mesh-ancestor
102378689|NCT05127928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947492|NCT01166451|Trace Elements|trace elements|mesh-ancestor
102378690|NCT05127928|Protective Agents|protective agents|mesh-ancestor
102378691|NCT02483130|Acetylcysteine|acetylcysteine|mesh-list
102378692|NCT02483130|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102378693|NCT02483130|Antiviral Agents|antiviral agents|mesh-ancestor
102378694|NCT02483130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102378695|NCT02483130|Expectorants|expectorants|mesh-ancestor
102378696|NCT02483130|Respiratory System Agents|respiratory system agents|mesh-ancestor
102378697|NCT02483130|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102378698|NCT02483130|Antioxidants|antioxidants|mesh-ancestor
102378699|NCT02483130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378700|NCT02483130|Protective Agents|protective agents|mesh-ancestor
102378701|NCT02483130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378702|NCT02483130|Antidotes|antidotes|mesh-ancestor
102378703|NCT03318354|Olmesartan|olmesartan|mesh-list
102378704|NCT03318354|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101991214|NCT03460678|Pemetrexed|pemetrexed|mesh-list
102378705|NCT03318354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102378706|NCT03318354|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102378707|NCT03318354|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102378708|NCT03318354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378709|NCT05113186|Lenvatinib|lenvatinib|mesh-list
102378710|NCT05113186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102378711|NCT05113186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102378712|NCT05113186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102378713|NCT05113186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378714|NCT05093140|Prednisone|prednisone|mesh-list
102378715|NCT05093140|Cyclophosphamide|cyclophosphamide|mesh-list
102378716|NCT05093140|Vincristine|vincristine|mesh-list
102378717|NCT05093140|Doxorubicin|doxorubicin|mesh-list
102378718|NCT05093140|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102378719|NCT05093140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101446659|NCT00583063|Sirolimus|sirolimus|mesh-list
102378720|NCT05093140|Immunologic Factors|immunologic factors|mesh-ancestor
102378721|NCT05093140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378722|NCT05093140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102378723|NCT05093140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102378724|NCT05093140|Alkylating Agents|alkylating agents|mesh-ancestor
102378725|NCT05093140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991679|NCT03792295|Narcotics|narcotics|mesh-ancestor
102378726|NCT05093140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102378727|NCT05093140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102378728|NCT05093140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102378729|NCT05093140|Glucocorticoids|glucocorticoids|mesh-ancestor
102378730|NCT05093140|Hormones|hormones|mesh-ancestor
102378731|NCT05093140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102378732|NCT05093140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102378733|NCT05093140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102378734|NCT05093140|Tubulin Modulators|tubulin modulators|mesh-ancestor
102378735|NCT05093140|Antimitotic Agents|antimitotic agents|mesh-ancestor
102378736|NCT05093140|Mitosis Modulators|mitosis modulators|mesh-ancestor
102378737|NCT05093140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102378738|NCT05093140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102378739|NCT05093140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102378740|NCT05093140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102378741|NCT03315312|Fluorides|fluorides|mesh-list
102378742|NCT03315312|Fluorides, Topical|fluorides, topical|mesh-list
102378743|NCT03315312|Cariostatic Agents|cariostatic agents|mesh-ancestor
102378744|NCT03315312|Protective Agents|protective agents|mesh-ancestor
101947543|NCT02526303|Anticoagulants|anticoagulants|mesh-ancestor
102378745|NCT03315312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378746|NCT00705666|Ribavirin|ribavirin|mesh-list
102378747|NCT00705666|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102378748|NCT00705666|Antimetabolites|antimetabolites|mesh-ancestor
101947547|NCT03869073|Evolocumab|evolocumab|mesh-list
102378749|NCT00705666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378750|NCT00705666|Antiviral Agents|antiviral agents|mesh-ancestor
102378751|NCT00705666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102378752|NCT04955236|Fentanyl|fentanyl|mesh-list
102378753|NCT04955236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102378754|NCT04955236|Narcotics|narcotics|mesh-ancestor
102378755|NCT04955236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101992353|NCT05679765|Anesthetics|anesthetics|mesh-ancestor
102378756|NCT04955236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378757|NCT04955236|Analgesics|analgesics|mesh-ancestor
102378758|NCT04955236|Sensory System Agents|sensory system agents|mesh-ancestor
102378759|NCT04955236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102378760|NCT04955236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102378761|NCT04955236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102378762|NCT04955236|Anesthetics, General|anesthetics, general|mesh-ancestor
102378763|NCT04955236|Anesthetics|anesthetics|mesh-ancestor
102378764|NCT03957304|Dexmedetomidine|dexmedetomidine|mesh-list
102378765|NCT03957304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102378766|NCT03957304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102378767|NCT03957304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378768|NCT03957304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102378769|NCT03957304|Analgesics|analgesics|mesh-ancestor
102378770|NCT03957304|Sensory System Agents|sensory system agents|mesh-ancestor
102378771|NCT03957304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101947557|NCT01587495|Ertapenem|ertapenem|mesh-list
102378772|NCT03957304|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102378773|NCT03957304|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102378774|NCT03957304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102378775|NCT03957304|Adrenergic Agents|adrenergic agents|mesh-ancestor
102378776|NCT03957304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101992494|NCT02522650|Amiloride|amiloride|mesh-list
102378777|NCT03957304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378778|NCT03320928|Methotrexate|methotrexate|mesh-list
102378779|NCT03320928|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102378780|NCT03320928|Abortifacient Agents|abortifacient agents|mesh-ancestor
102378781|NCT03320928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102378782|NCT03320928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378783|NCT03320928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102378784|NCT03320928|Antimetabolites|antimetabolites|mesh-ancestor
102378785|NCT03320928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378786|NCT03320928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102378787|NCT03320928|Dermatologic Agents|dermatologic agents|mesh-ancestor
102378788|NCT03320928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102378789|NCT03320928|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102378790|NCT03320928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102378791|NCT03320928|Immunologic Factors|immunologic factors|mesh-ancestor
102378792|NCT03320928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102378793|NCT03320928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102378794|NCT02488902|Mefloquine|mefloquine|mesh-list
102378795|NCT02488902|Tafenoquine|tafenoquine|mesh-list
102378796|NCT02488902|Antimalarials|antimalarials|mesh-ancestor
102378797|NCT02488902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102378798|NCT02488902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102378799|NCT02488902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102378800|NCT02253160|Lenograstim|lenograstim|mesh-list
102378801|NCT02253160|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101947589|NCT01170507|Vitamins|vitamins|mesh-list
102378802|NCT02253160|Immunologic Factors|immunologic factors|mesh-ancestor
102378803|NCT02253160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378804|NCT02254252|Nicorandil|nicorandil|mesh-list
102378805|NCT02254252|Nitroglycerin|nitroglycerin|mesh-list
102378806|NCT02254252|Vasodilator Agents|vasodilator agents|mesh-ancestor
102378807|NCT02254252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102378808|NCT02254252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101993020|NCT03089216|Calcium|calcium|mesh-list
102378809|NCT02254252|Vitamin B Complex|vitamin b complex|mesh-ancestor
102378810|NCT02254252|Vitamins|vitamins|mesh-ancestor
102378811|NCT02254252|Micronutrients|micronutrients|mesh-ancestor
102378812|NCT02254252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378813|NCT03315078|Busulfan|busulfan|mesh-list
102378814|NCT03315078|Alkylating Agents|alkylating agents|mesh-ancestor
102378815|NCT03315078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993201|NCT01309789|Prednisone|prednisone|mesh-list
102378816|NCT03315078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102378817|NCT03315078|Immunologic Factors|immunologic factors|mesh-ancestor
102378818|NCT03315078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378819|NCT03315078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101947602|NCT01170819|Dinoprostone|dinoprostone|mesh-list
102378820|NCT03315078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102378821|NCT03315078|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102378822|NCT02255110|Doxorubicin|doxorubicin|mesh-list
102378823|NCT02255110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101947606|NCT03868137|Ibuprofen|ibuprofen|mesh-list
102378824|NCT02255110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102378825|NCT02255110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102378826|NCT02255110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102378827|NCT02255110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101819657|NCT01026129|Lidocaine|lidocaine|mesh-list
102378828|NCT02255110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378829|NCT03320694|Insulin|insulin|mesh-list
102378830|NCT03320694|Metformin|metformin|mesh-list
102378831|NCT03320694|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102378832|NCT03320694|Isophane Insulin, Human|isophane insulin, human|mesh-list
102378833|NCT03320694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102378834|NCT03320694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378835|NCT02482740|Tamoxifen|tamoxifen|mesh-list
102378836|NCT02482740|Letrozole|letrozole|mesh-list
102378837|NCT02482740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102378838|NCT02482740|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102378839|NCT02482740|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102378840|NCT02482740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102378841|NCT02482740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378842|NCT02482740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102378843|NCT02482740|Hormone Antagonists|hormone antagonists|mesh-ancestor
102378844|NCT02482740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102378845|NCT02482740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378846|NCT02482740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101947626|NCT01167933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102378847|NCT02482740|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102378848|NCT02482740|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101947632|NCT01168011|ON 01910|on 01910|mesh-list
102378849|NCT02482740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102378850|NCT03315000|Fluticasone|fluticasone|mesh-list
102378851|NCT03315000|Xhance|xhance|mesh-list
102378852|NCT03315000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102378853|NCT03315000|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102378854|NCT03315000|Autonomic Agents|autonomic agents|mesh-ancestor
102378855|NCT03315000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102378856|NCT03315000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378857|NCT03315000|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102378858|NCT03315000|Respiratory System Agents|respiratory system agents|mesh-ancestor
102378859|NCT03315000|Dermatologic Agents|dermatologic agents|mesh-ancestor
102378860|NCT03315000|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102378861|NCT02482818|Pregabalin|pregabalin|mesh-list
102378862|NCT02482818|Analgesics|analgesics|mesh-ancestor
102378863|NCT02482818|Sensory System Agents|sensory system agents|mesh-ancestor
101947637|NCT01171209|Interferons|interferons|mesh-list
102378864|NCT02482818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102378865|NCT02482818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378866|NCT02482818|Anticonvulsants|anticonvulsants|mesh-ancestor
102378867|NCT02482818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102378868|NCT02482818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102378869|NCT02482818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378870|NCT02482818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102378871|NCT02482818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102378872|NCT02482818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102378873|NCT02482818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102378874|NCT02482818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102378875|NCT02989870|Sorafenib|sorafenib|mesh-list
102378876|NCT02989870|Bavituximab|bavituximab|mesh-list
102378877|NCT02989870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102378878|NCT02989870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102378879|NCT02989870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102378880|NCT02989870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378881|NCT02989870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102378882|NCT02480088|Palonosetron|palonosetron|mesh-list
102378883|NCT02480088|Ramosetron|ramosetron|mesh-list
102378884|NCT02480088|Antiemetics|antiemetics|mesh-ancestor
102378885|NCT02480088|Autonomic Agents|autonomic agents|mesh-ancestor
101947668|NCT03872505|Paclitaxel|paclitaxel|mesh-list
102378886|NCT02480088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102378887|NCT02480088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378888|NCT02480088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102378889|NCT02480088|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102378890|NCT02480088|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102378891|NCT02480088|Serotonin Agents|serotonin agents|mesh-ancestor
102378892|NCT02480088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102378893|NCT02480088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378894|NCT01807624|Phenylephrine|phenylephrine|mesh-list
102378895|NCT01807624|Oxymetazoline|oxymetazoline|mesh-list
102378896|NCT01807624|Tetracaine|tetracaine|mesh-list
102378897|NCT01807624|Anesthetics, Local|anesthetics, local|mesh-ancestor
102378898|NCT01807624|Anesthetics|anesthetics|mesh-ancestor
102378899|NCT01807624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102378900|NCT01807624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378901|NCT01807624|Sensory System Agents|sensory system agents|mesh-ancestor
102378902|NCT01807624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102378903|NCT01807624|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102378904|NCT01807624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102378905|NCT01807624|Adrenergic Agents|adrenergic agents|mesh-ancestor
102378906|NCT01807624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102378907|NCT01807624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378908|NCT01807624|Sympathomimetics|sympathomimetics|mesh-ancestor
102378909|NCT01807624|Autonomic Agents|autonomic agents|mesh-ancestor
102378910|NCT01807624|Nasal Decongestants|nasal decongestants|mesh-ancestor
102378911|NCT01807624|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102378912|NCT01807624|Respiratory System Agents|respiratory system agents|mesh-ancestor
102190660|NCT05590598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102378913|NCT01807624|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102378914|NCT01807624|Mydriatics|mydriatics|mesh-ancestor
102378915|NCT01807624|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102378916|NCT01807624|Protective Agents|protective agents|mesh-ancestor
102378917|NCT01808326|Chlorambucil|chlorambucil|mesh-list
102378918|NCT01808326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102378919|NCT01808326|Alkylating Agents|alkylating agents|mesh-ancestor
102378920|NCT01808326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378921|NCT01808326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102378922|NCT03317730|Oxycodone|oxycodone|mesh-list
102378923|NCT03317730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102378924|NCT03317730|Narcotics|narcotics|mesh-ancestor
102378925|NCT03317730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102378926|NCT03317730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378927|NCT03317730|Analgesics|analgesics|mesh-ancestor
102378928|NCT03317730|Sensory System Agents|sensory system agents|mesh-ancestor
102378929|NCT03317730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102378930|NCT02486484|Aflibercept|aflibercept|mesh-list
102378931|NCT02486484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102378932|NCT02486484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102378933|NCT02486484|Growth Substances|growth substances|mesh-ancestor
102378934|NCT02486484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378935|NCT02486484|Growth Inhibitors|growth inhibitors|mesh-ancestor
102378936|NCT02486484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102378937|NCT03317652|Nitroprusside|nitroprusside|mesh-list
102378938|NCT03317652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102378939|NCT03317652|Vasodilator Agents|vasodilator agents|mesh-ancestor
102378940|NCT03317652|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102378941|NCT03317652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378942|NCT02479854|Montelukast|montelukast|mesh-list
102378943|NCT02479854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102378944|NCT02479854|Respiratory System Agents|respiratory system agents|mesh-ancestor
102378945|NCT02479854|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102378946|NCT02479854|Hormone Antagonists|hormone antagonists|mesh-ancestor
102378947|NCT02479854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102378948|NCT02479854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378949|NCT02479854|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102378950|NCT02479854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102401212|NCT02348268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102378951|NCT02479854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378952|NCT01809106|Fentanyl|fentanyl|mesh-list
102378953|NCT01809106|Morphine|morphine|mesh-list
102378954|NCT01809106|Oxycodone|oxycodone|mesh-list
102378955|NCT01809106|Buprenorphine|buprenorphine|mesh-list
102378956|NCT01809106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102378957|NCT01809106|Narcotics|narcotics|mesh-ancestor
102378958|NCT01809106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102378959|NCT01809106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378960|NCT01809106|Analgesics|analgesics|mesh-ancestor
102378961|NCT01809106|Sensory System Agents|sensory system agents|mesh-ancestor
102378962|NCT01809106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102378963|NCT01809106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102378964|NCT01809106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102378965|NCT01809106|Anesthetics, General|anesthetics, general|mesh-ancestor
102378966|NCT01809106|Anesthetics|anesthetics|mesh-ancestor
102378967|NCT01809106|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102378968|NCT03804580|Osimertinib|osimertinib|mesh-list
102378969|NCT03804580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102378970|NCT03804580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102378971|NCT03804580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102378972|NCT03804580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378973|NCT03317574|Botulinum Toxins|botulinum toxins|mesh-list
102378974|NCT03317574|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102378975|NCT03317574|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102378976|NCT03317574|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102378977|NCT03317574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102378978|NCT03317574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378979|NCT03317574|Cholinergic Agents|cholinergic agents|mesh-ancestor
102378980|NCT03317574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102378981|NCT03317574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102378982|NCT03317574|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102378983|NCT03317574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102378984|NCT01810666|Factor VIII|factor viii|mesh-list
102378985|NCT01810666|Coagulants|coagulants|mesh-ancestor
102378986|NCT02482272|Lamivudine|lamivudine|mesh-list
102378987|NCT02482272|Adefovir|adefovir|mesh-list
102190737|NCT05398094|Sotorasib|sotorasib|mesh-list
102378988|NCT02482272|Entecavir|entecavir|mesh-list
102378989|NCT02482272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102378990|NCT02482272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102378991|NCT02482272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102378992|NCT02482272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102378993|NCT02482272|Antiviral Agents|antiviral agents|mesh-ancestor
102378994|NCT02482272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102378995|NCT02482272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102378996|NCT02482272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102378997|NCT01766440|Calcitriol|calcitriol|mesh-list
102378998|NCT01766440|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102378999|NCT01766440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379000|NCT01766440|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102379001|NCT01766440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102379002|NCT01766440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379003|NCT01766440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102379004|NCT01766440|Vitamins|vitamins|mesh-ancestor
102379005|NCT01766440|Micronutrients|micronutrients|mesh-ancestor
102379006|NCT01766440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102379007|NCT02479620|Dexamethasone|dexamethasone|mesh-list
102379008|NCT02479620|Dexamethasone acetate|dexamethasone acetate|mesh-list
102379009|NCT02479620|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102379010|NCT02479620|BB 1101|bb 1101|mesh-list
102379011|NCT02479620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102379012|NCT02479620|Antiemetics|antiemetics|mesh-ancestor
102379013|NCT02479620|Autonomic Agents|autonomic agents|mesh-ancestor
102379014|NCT02479620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102379015|NCT02479620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379016|NCT02479620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102379017|NCT02479620|Glucocorticoids|glucocorticoids|mesh-ancestor
102379018|NCT02479620|Hormones|hormones|mesh-ancestor
102379019|NCT02479620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102379020|NCT02479620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102379021|NCT02479620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102379022|NCT02479620|Protease Inhibitors|protease inhibitors|mesh-ancestor
102379023|NCT02479620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102379024|NCT02479620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379025|NCT02481960|Irinotecan|irinotecan|mesh-list
102379026|NCT02481960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102379027|NCT02481960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102379028|NCT02481960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102379029|NCT02481960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379030|NCT02481960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102379031|NCT02725866|Ritonavir|ritonavir|mesh-list
102379032|NCT02725866|Ribavirin|ribavirin|mesh-list
102379033|NCT02725866|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102379034|NCT02725866|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102379035|NCT02725866|Protease Inhibitors|protease inhibitors|mesh-ancestor
102379036|NCT02725866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101820867|NCT03469713|Nivolumab|nivolumab|mesh-list
102379037|NCT02725866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379038|NCT02725866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102379039|NCT02725866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102379040|NCT02725866|Antiviral Agents|antiviral agents|mesh-ancestor
102379041|NCT02725866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102379042|NCT02725866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102379043|NCT02725866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102379044|NCT02725866|Antimetabolites|antimetabolites|mesh-ancestor
102379045|NCT02481726|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102379046|NCT02481726|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102379047|NCT02481726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379048|NCT03314298|Methyltestosterone|methyltestosterone|mesh-list
102379049|NCT03314298|Anastrozole|anastrozole|mesh-list
102379050|NCT03314298|Testosterone|testosterone|mesh-list
102379051|NCT03314298|Testosterone undecanoate|testosterone undecanoate|mesh-list
102379052|NCT03314298|Testosterone enanthate|testosterone enanthate|mesh-list
102379053|NCT03314298|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102379054|NCT03314298|Androgens|androgens|mesh-ancestor
102379055|NCT03314298|Hormones|hormones|mesh-ancestor
102379056|NCT03314298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102379057|NCT03314298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379058|NCT03314298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102379059|NCT03314298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102379060|NCT03314298|Anabolic Agents|anabolic agents|mesh-ancestor
102379061|NCT03314298|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102190806|NCT05286814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102379062|NCT03314298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102379063|NCT03314298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102379064|NCT03314298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379065|NCT03314298|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102379066|NCT03314298|Hormone Antagonists|hormone antagonists|mesh-ancestor
102379067|NCT02479308|Moxifloxacin|moxifloxacin|mesh-list
102379068|NCT02479308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102379069|NCT02479308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102379070|NCT02479308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102379071|NCT02479308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102379072|NCT02479308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102379073|NCT02479308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379074|NCT02479308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102379075|NCT05461560|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102379076|NCT05713578|Docetaxel|docetaxel|mesh-list
102379077|NCT05713578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102379078|NCT05713578|Tubulin Modulators|tubulin modulators|mesh-ancestor
102379079|NCT05713578|Antimitotic Agents|antimitotic agents|mesh-ancestor
102379080|NCT05713578|Mitosis Modulators|mitosis modulators|mesh-ancestor
102379081|NCT05713578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379082|NCT02485548|Fluorouracil|fluorouracil|mesh-list
102379083|NCT02485548|Raltitrexed|raltitrexed|mesh-list
102379084|NCT02485548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102379085|NCT02485548|Antimetabolites|antimetabolites|mesh-ancestor
102379086|NCT02485548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379087|NCT02485548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102379088|NCT02485548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102379089|NCT02485548|Immunologic Factors|immunologic factors|mesh-ancestor
102379090|NCT02485548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379091|NCT02485548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102379092|NCT02485548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102379093|NCT02479074|Prednisolone|prednisolone|mesh-list
102379094|NCT02479074|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102379095|NCT02479074|Methylprednisolone|methylprednisolone|mesh-list
102379096|NCT02479074|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102379097|NCT02479074|Prednisolone acetate|prednisolone acetate|mesh-list
102379098|NCT02479074|Montelukast|montelukast|mesh-list
102379099|NCT02479074|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102379100|NCT02479074|Prednisolone phosphate|prednisolone phosphate|mesh-list
102379101|NCT02479074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102379102|NCT02479074|Glucocorticoids|glucocorticoids|mesh-ancestor
102379103|NCT02479074|Hormones|hormones|mesh-ancestor
102379104|NCT02479074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102379105|NCT02479074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379106|NCT02479074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102379107|NCT02479074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102379108|NCT02479074|Antiemetics|antiemetics|mesh-ancestor
102379109|NCT02479074|Autonomic Agents|autonomic agents|mesh-ancestor
102379110|NCT02479074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102379111|NCT02479074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102379112|NCT02479074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102379113|NCT02479074|Protective Agents|protective agents|mesh-ancestor
102379114|NCT02479074|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102379115|NCT02479074|Respiratory System Agents|respiratory system agents|mesh-ancestor
102379116|NCT02479074|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102379117|NCT02479074|Hormone Antagonists|hormone antagonists|mesh-ancestor
102379118|NCT02479074|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102379119|NCT02479074|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102379120|NCT02479074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379121|NCT02481180|T0001|t0001|mesh-list
102379122|NCT02481180|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
101994928|NCT03778723|Fentanyl|fentanyl|mesh-list
102379123|NCT02481180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379124|NCT02481180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102379125|NCT02481180|Immunologic Factors|immunologic factors|mesh-ancestor
102379126|NCT02480946|Methotrexate|methotrexate|mesh-list
102379127|NCT02480946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102379128|NCT02480946|Abortifacient Agents|abortifacient agents|mesh-ancestor
102379129|NCT02480946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102379130|NCT02480946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379131|NCT02480946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102379132|NCT02480946|Antimetabolites|antimetabolites|mesh-ancestor
102379133|NCT02480946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379134|NCT02480946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102190884|NCT05157971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379135|NCT02480946|Dermatologic Agents|dermatologic agents|mesh-ancestor
102379136|NCT02480946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102379137|NCT02480946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102379138|NCT02480946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102379139|NCT02480946|Immunologic Factors|immunologic factors|mesh-ancestor
102379140|NCT02480946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102379141|NCT02480946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102379142|NCT01769170|Cidofovir|cidofovir|mesh-list
102379143|NCT01769170|Brincidofovir|brincidofovir|mesh-list
102379144|NCT01769170|Antiviral Agents|antiviral agents|mesh-ancestor
102379145|NCT01769170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102379146|NCT01769170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102379147|NCT01769170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379148|NCT02480634|Zoledronic Acid|zoledronic acid|mesh-list
102379149|NCT02480634|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102379150|NCT02480634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379151|NCT03399292|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102379152|NCT03399292|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102379153|NCT02726022|Ribavirin|ribavirin|mesh-list
102379154|NCT02726022|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102379155|NCT02726022|Antimetabolites|antimetabolites|mesh-ancestor
102379156|NCT02726022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379157|NCT02726022|Antiviral Agents|antiviral agents|mesh-ancestor
102379158|NCT02726022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102379159|NCT02478294|Warfarin|warfarin|mesh-list
102379160|NCT02478294|Anticoagulants|anticoagulants|mesh-list
102379161|NCT01770652|Deferiprone|deferiprone|mesh-list
102379162|NCT01770652|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102379163|NCT01770652|Chelating Agents|chelating agents|mesh-ancestor
102379164|NCT01770652|Sequestering Agents|sequestering agents|mesh-ancestor
102379165|NCT01770652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379166|NCT03316482|Leuprolide|leuprolide|mesh-list
102379167|NCT03316482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102379168|NCT03316482|Fertility Agents|fertility agents|mesh-ancestor
102379169|NCT03316482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101947941|NCT01336634|Trametinib|trametinib|mesh-list
102379170|NCT03316482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379171|NCT03316482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102379172|NCT03316482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102379173|NCT01771666|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
102379174|NCT01771666|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102379175|NCT01771666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379176|NCT01772758|Antioxidants|antioxidants|mesh-list
102379177|NCT01772758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379178|NCT01772758|Protective Agents|protective agents|mesh-ancestor
102379179|NCT01772758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379180|NCT02485080|Sofosbuvir|sofosbuvir|mesh-list
102379181|NCT02485080|Simeprevir|simeprevir|mesh-list
102379182|NCT02485080|Antiviral Agents|antiviral agents|mesh-ancestor
102379183|NCT02485080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102379184|NCT02485080|Protease Inhibitors|protease inhibitors|mesh-ancestor
102379185|NCT02485080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102379186|NCT02485080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379187|NCT02480400|Dexetimide|dexetimide|mesh-list
102379188|NCT02480400|Citalopram|citalopram|mesh-list
102379189|NCT02480400|Escitalopram|escitalopram|mesh-list
102379190|NCT02480400|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102379191|NCT02480400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102379192|NCT02480400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102379193|NCT02480400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379194|NCT02480400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102379195|NCT02480400|Serotonin Agents|serotonin agents|mesh-ancestor
102379196|NCT02480400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379197|NCT02480400|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102379198|NCT02480400|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102379199|NCT02480400|Parasympatholytics|parasympatholytics|mesh-ancestor
102379200|NCT02480400|Autonomic Agents|autonomic agents|mesh-ancestor
102379201|NCT02480400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102379202|NCT02480400|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102379203|NCT02480400|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102379204|NCT02480400|Cholinergic Agents|cholinergic agents|mesh-ancestor
102379205|NCT02480400|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102379206|NCT02480400|Antidepressive Agents|antidepressive agents|mesh-ancestor
102379207|NCT02480400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102379208|NCT02725710|Gabapentin|gabapentin|mesh-list
102379209|NCT02725710|Analgesics|analgesics|mesh-ancestor
102379210|NCT02725710|Sensory System Agents|sensory system agents|mesh-ancestor
102379211|NCT02725710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102379212|NCT02725710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379214|NCT02725710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102379215|NCT02725710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102379216|NCT02725710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102379217|NCT02725710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102379218|NCT02725710|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102379219|NCT02725710|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102379220|NCT02725710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102379221|NCT02725710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379222|NCT02725710|Antimanic Agents|antimanic agents|mesh-ancestor
102379223|NCT02256358|Midazolam|midazolam|mesh-list
102379224|NCT02256358|Ketamine|ketamine|mesh-list
102379225|NCT02256358|Analgesics|analgesics|mesh-ancestor
102379226|NCT02256358|Sensory System Agents|sensory system agents|mesh-ancestor
102379227|NCT02256358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102379228|NCT02256358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379229|NCT02256358|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102379230|NCT02256358|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102379231|NCT02256358|Anesthetics, General|anesthetics, general|mesh-ancestor
102379232|NCT02256358|Anesthetics|anesthetics|mesh-ancestor
102379233|NCT02256358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102379234|NCT02256358|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102379235|NCT02256358|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102379236|NCT02256358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102379237|NCT02256358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379238|NCT02256358|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102379239|NCT02256358|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102379240|NCT02256358|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102379241|NCT02256358|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102379242|NCT02256358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102379243|NCT02256358|GABA Modulators|gaba modulators|mesh-ancestor
102379244|NCT02256358|GABA Agents|gaba agents|mesh-ancestor
102379245|NCT01825408|Azithromycin|azithromycin|mesh-list
102379246|NCT01825408|Doxycycline|doxycycline|mesh-list
102379247|NCT01825408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102379248|NCT01825408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102379249|NCT01825408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102379250|NCT01825408|Antimalarials|antimalarials|mesh-ancestor
102379251|NCT01825408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102379252|NCT01825408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102379253|NCT01825408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102379254|NCT01825408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102379255|NCT01825408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379256|NCT04945824|Dexamethasone|dexamethasone|mesh-list
102379257|NCT04945824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102379258|NCT04945824|Antiemetics|antiemetics|mesh-ancestor
102379259|NCT04945824|Autonomic Agents|autonomic agents|mesh-ancestor
102379260|NCT04945824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102379261|NCT04945824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379262|NCT04945824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102379263|NCT04945824|Glucocorticoids|glucocorticoids|mesh-ancestor
102379264|NCT04945824|Hormones|hormones|mesh-ancestor
102379265|NCT04945824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102379266|NCT04945824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102379267|NCT04945824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102379268|NCT04937634|Melphalan|melphalan|mesh-list
102379269|NCT04937634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102379270|NCT04937634|Alkylating Agents|alkylating agents|mesh-ancestor
102379271|NCT04937634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379272|NCT04937634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102379273|NCT04937634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102379274|NCT04937634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101948054|NCT02822794|Ribavirin|ribavirin|mesh-list
102379275|NCT04937634|Immunologic Factors|immunologic factors|mesh-ancestor
102379276|NCT04937634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379277|NCT02262130|Omalizumab|omalizumab|mesh-list
102379278|NCT02262130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102379279|NCT02262130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102379280|NCT02262130|Respiratory System Agents|respiratory system agents|mesh-ancestor
102379281|NCT04913610|Ivermectin|ivermectin|mesh-list
102379282|NCT04913610|Albendazole|albendazole|mesh-list
102379283|NCT04913610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102379284|NCT04913610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102379285|NCT04913610|Anthelmintics|anthelmintics|mesh-ancestor
102379286|NCT04913610|Anticestodal Agents|anticestodal agents|mesh-ancestor
102379287|NCT04913610|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102379288|NCT04913610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102379289|NCT04913610|Tubulin Modulators|tubulin modulators|mesh-ancestor
102379290|NCT04913610|Antimitotic Agents|antimitotic agents|mesh-ancestor
102379291|NCT04913610|Mitosis Modulators|mitosis modulators|mesh-ancestor
102379292|NCT04913610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379293|NCT04913610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102379294|NCT04887870|Pembrolizumab|pembrolizumab|mesh-list
102379295|NCT04887870|Nivolumab|nivolumab|mesh-list
102379296|NCT04887870|Ipilimumab|ipilimumab|mesh-list
102379297|NCT04887870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102379298|NCT04887870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102379299|NCT04887870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102379300|NCT04887870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379301|NCT01827358|Calcium, Dietary|calcium, dietary|mesh-list
102379302|NCT01827358|Mupirocin|mupirocin|mesh-list
102379303|NCT01827358|Calcium|calcium|mesh-list
102379304|NCT01827358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102379305|NCT01827358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379306|NCT01827358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102379307|NCT01827358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102379308|NCT01827358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102379309|NCT01827358|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102379310|NCT01827358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102379311|NCT01827358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379312|NCT01780324|Lidocaine|lidocaine|mesh-list
102379313|NCT01780324|Anesthetics, Local|anesthetics, local|mesh-ancestor
102379314|NCT01780324|Anesthetics|anesthetics|mesh-ancestor
102379315|NCT01780324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102379316|NCT01780324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379317|NCT01780324|Sensory System Agents|sensory system agents|mesh-ancestor
102379318|NCT01780324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102379319|NCT01780324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102379320|NCT01780324|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102379321|NCT01780324|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102379322|NCT01780324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102379323|NCT01780324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379324|NCT02472600|Colistin|colistin|mesh-list
102379325|NCT02472600|Polymyxins|polymyxins|mesh-list
102379326|NCT02472600|Neomycin|neomycin|mesh-list
102379327|NCT02472600|Omeprazole|omeprazole|mesh-list
102379328|NCT02472600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102379329|NCT02472600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102379330|NCT02472600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102379331|NCT02472600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102379332|NCT02472600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379333|NCT02472600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102379334|NCT02472600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101948089|NCT01169415|Dexamethasone acetate|dexamethasone acetate|mesh-list
102379335|NCT02472600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102379336|NCT04858776|Dexamethasone|dexamethasone|mesh-list
102379337|NCT04858776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102379338|NCT04858776|Antiemetics|antiemetics|mesh-ancestor
102379339|NCT04858776|Autonomic Agents|autonomic agents|mesh-ancestor
102379340|NCT04858776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102379341|NCT04858776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379342|NCT04858776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102379343|NCT04858776|Glucocorticoids|glucocorticoids|mesh-ancestor
102379344|NCT04858776|Hormones|hormones|mesh-ancestor
102379345|NCT04858776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102379346|NCT04858776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102379347|NCT04858776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102379348|NCT01781806|Tenofovir|tenofovir|mesh-list
102379349|NCT01781806|Emtricitabine|emtricitabine|mesh-list
102379350|NCT01781806|Antiviral Agents|antiviral agents|mesh-ancestor
102379351|NCT01781806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102379352|NCT01781806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102379353|NCT01781806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102379354|NCT01781806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102401213|NCT02348268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379355|NCT01781806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379356|NCT01781806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102379357|NCT01781806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102379358|NCT02477514|Tedizolid|tedizolid|mesh-list
102379359|NCT02477514|Tedizolid phosphate|tedizolid phosphate|mesh-list
102379360|NCT02477514|Midazolam|midazolam|mesh-list
102191110|NCT04688320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102379361|NCT02477514|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102379362|NCT02477514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102379363|NCT02477514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102379364|NCT02477514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102379365|NCT02477514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379366|NCT02477514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102379367|NCT02477514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102379368|NCT02477514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102379369|NCT02477514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102379370|NCT02477514|Anesthetics, General|anesthetics, general|mesh-ancestor
102379372|NCT02477514|GABA Modulators|gaba modulators|mesh-ancestor
102379373|NCT02477514|GABA Agents|gaba agents|mesh-ancestor
102379374|NCT02477514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102379375|NCT02477514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379376|NCT02477514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102379377|NCT02477514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102379378|NCT02477514|Antimetabolites|antimetabolites|mesh-ancestor
102379379|NCT02477514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102379380|NCT02477514|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102379381|NCT02477514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102379382|NCT02477514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102379383|NCT02477514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102379384|NCT01746238|Bevacizumab|bevacizumab|mesh-list
102379385|NCT01746238|Doxorubicin|doxorubicin|mesh-list
102379386|NCT01746238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102379387|NCT01746238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102379388|NCT01746238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102379389|NCT01746238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102379390|NCT01746238|Growth Substances|growth substances|mesh-ancestor
102379391|NCT01746238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379392|NCT01746238|Growth Inhibitors|growth inhibitors|mesh-ancestor
102379393|NCT01746238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102379394|NCT01746238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102401214|NCT02348346|Titanium dioxide|titanium dioxide|mesh-list
102379395|NCT01746238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102379396|NCT01746238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102379397|NCT01746238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379398|NCT02472054|Cyclosporine|cyclosporine|mesh-list
102379399|NCT02472054|Prednisolone|prednisolone|mesh-list
102379400|NCT02472054|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102379401|NCT02472054|Methylprednisolone|methylprednisolone|mesh-list
102379402|NCT02472054|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102379403|NCT02472054|Prednisolone acetate|prednisolone acetate|mesh-list
102379404|NCT02472054|Alemtuzumab|alemtuzumab|mesh-list
102379405|NCT02472054|Cyclosporins|cyclosporins|mesh-list
102379406|NCT02472054|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102379407|NCT02472054|Prednisolone phosphate|prednisolone phosphate|mesh-list
102379408|NCT02472054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102379409|NCT02472054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379410|NCT02472054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102379411|NCT02472054|Immunologic Factors|immunologic factors|mesh-ancestor
102379412|NCT02472054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379413|NCT02472054|Antifungal Agents|antifungal agents|mesh-ancestor
102379414|NCT02472054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102379415|NCT02472054|Dermatologic Agents|dermatologic agents|mesh-ancestor
102379416|NCT02472054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102379417|NCT02472054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102379418|NCT02472054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102379419|NCT02472054|Glucocorticoids|glucocorticoids|mesh-ancestor
102379420|NCT02472054|Hormones|hormones|mesh-ancestor
102379421|NCT02472054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102379422|NCT02472054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102379423|NCT02472054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102379424|NCT02472054|Antiemetics|antiemetics|mesh-ancestor
102379425|NCT02472054|Autonomic Agents|autonomic agents|mesh-ancestor
102379426|NCT02472054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102379427|NCT02472054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102379428|NCT02472054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102379429|NCT02472054|Protective Agents|protective agents|mesh-ancestor
102379430|NCT02472054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102379431|NCT01782898|Esmolol|esmolol|mesh-list
102379432|NCT01782898|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102379433|NCT01782898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102379434|NCT01782898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102379435|NCT01782898|Adrenergic Agents|adrenergic agents|mesh-ancestor
102379436|NCT01782898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102379437|NCT01782898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379438|NCT01782898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379439|NCT02475876|Clindamycin|clindamycin|mesh-list
102379440|NCT02475876|Clindamycin palmitate|clindamycin palmitate|mesh-list
102379441|NCT02475876|Clindamycin phosphate|clindamycin phosphate|mesh-list
102379442|NCT02475876|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102379443|NCT02475876|Trimethoprim|trimethoprim|mesh-list
102379444|NCT02475876|Sulfamethoxazole|sulfamethoxazole|mesh-list
102379445|NCT02475876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102379446|NCT02475876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102379447|NCT02475876|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102379448|NCT02475876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102379449|NCT02475876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379450|NCT02475876|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102379451|NCT02475876|Antimalarials|antimalarials|mesh-ancestor
102379452|NCT02475876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102379453|NCT02475876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102379454|NCT02475876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102379455|NCT02475876|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102379456|NCT02475876|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102379457|NCT02475876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102379458|NCT02472210|Botulinum Toxins|botulinum toxins|mesh-list
102379459|NCT02472210|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102379460|NCT02472210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102379461|NCT02472210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996904|NCT03302559|Vitamins|vitamins|mesh-ancestor
102379462|NCT02472210|Cholinergic Agents|cholinergic agents|mesh-ancestor
102379463|NCT02472210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102379464|NCT02472210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379465|NCT01783054|Gemcitabine|gemcitabine|mesh-list
102379466|NCT01783054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102379467|NCT01783054|Antimetabolites|antimetabolites|mesh-ancestor
102379468|NCT01783054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379469|NCT01783054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102379470|NCT05397600|Bimatoprost|bimatoprost|mesh-list
102379471|NCT05397600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102379472|NCT02725008|Dexamethasone|dexamethasone|mesh-list
102379473|NCT02725008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102379474|NCT02725008|Antiemetics|antiemetics|mesh-ancestor
102379475|NCT02725008|Autonomic Agents|autonomic agents|mesh-ancestor
102379476|NCT02725008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102379477|NCT02725008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948253|NCT03862287|Lidocaine|lidocaine|mesh-list
102379478|NCT02725008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102379479|NCT02725008|Glucocorticoids|glucocorticoids|mesh-ancestor
102379480|NCT02725008|Hormones|hormones|mesh-ancestor
102379481|NCT02725008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102379482|NCT02725008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102379483|NCT02725008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102379484|NCT02477436|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
102379485|NCT02477436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102379486|NCT02477436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102379487|NCT02477436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379488|NCT02471820|Dexamethasone|dexamethasone|mesh-list
102379489|NCT02471820|Dexamethasone acetate|dexamethasone acetate|mesh-list
102379490|NCT02471820|Lenalidomide|lenalidomide|mesh-list
102379491|NCT02471820|Doxorubicin|doxorubicin|mesh-list
102379492|NCT02471820|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102379493|NCT02471820|BB 1101|bb 1101|mesh-list
102379494|NCT02471820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102379495|NCT02471820|Antiemetics|antiemetics|mesh-ancestor
102379496|NCT02471820|Autonomic Agents|autonomic agents|mesh-ancestor
102379497|NCT02471820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102379498|NCT02471820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379499|NCT02471820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102379500|NCT02471820|Glucocorticoids|glucocorticoids|mesh-ancestor
102379501|NCT02471820|Hormones|hormones|mesh-ancestor
102379502|NCT02471820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102401215|NCT02348346|Sunscreening Agents|sunscreening agents|mesh-ancestor
102379503|NCT02471820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101824046|NCT00833729|Etanercept|etanercept|mesh-list
102379504|NCT02471820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102379505|NCT02471820|Protease Inhibitors|protease inhibitors|mesh-ancestor
102379506|NCT02471820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102379507|NCT02471820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997693|NCT03171480|Isosorbide|isosorbide|mesh-list
102379508|NCT02471820|Immunologic Factors|immunologic factors|mesh-ancestor
102379509|NCT02471820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102379510|NCT02471820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102379511|NCT02471820|Growth Substances|growth substances|mesh-ancestor
102379512|NCT02471820|Growth Inhibitors|growth inhibitors|mesh-ancestor
101948295|NCT01287507|Lactoferrin|lactoferrin|mesh-list
102379513|NCT02471820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102379514|NCT02471820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102379515|NCT02471820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102379516|NCT01833130|Botulinum Toxins|botulinum toxins|mesh-list
102379517|NCT01833130|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102379518|NCT01833130|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101948303|NCT01176669|Apatinib|apatinib|mesh-list
102379519|NCT01833130|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102379520|NCT01833130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102401216|NCT02348346|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102379521|NCT01833130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379522|NCT01833130|Cholinergic Agents|cholinergic agents|mesh-ancestor
102379523|NCT01833130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102379524|NCT01833130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824476|NCT04043741|Sulfamethazine|sulfamethazine|mesh-list
102379525|NCT01833130|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102379526|NCT01833130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102379527|NCT01783912|Nicotine|nicotine|mesh-list
102379528|NCT01783912|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102379529|NCT01783912|Autonomic Agents|autonomic agents|mesh-ancestor
102379530|NCT01783912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102379531|NCT01783912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379532|NCT01783912|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102379533|NCT01783912|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102379534|NCT01783912|Cholinergic Agents|cholinergic agents|mesh-ancestor
102379535|NCT01783912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102379536|NCT01783912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379537|NCT01783990|Hydroxyurea|hydroxyurea|mesh-list
102379538|NCT01783990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102379539|NCT01783990|Antisickling Agents|antisickling agents|mesh-ancestor
102379540|NCT01783990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102379541|NCT01783990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379542|NCT01783990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102379543|NCT01833988|Pancrelipase|pancrelipase|mesh-list
102379544|NCT01833988|Pancreatin|pancreatin|mesh-list
102379545|NCT01833988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102379546|NCT05363436|Oxycodone|oxycodone|mesh-list
102379547|NCT05363436|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102379548|NCT05363436|Narcotics|narcotics|mesh-ancestor
102379549|NCT05363436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102379550|NCT05363436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379551|NCT05363436|Analgesics|analgesics|mesh-ancestor
102379552|NCT05363436|Sensory System Agents|sensory system agents|mesh-ancestor
102379553|NCT05363436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102379554|NCT01784614|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102379555|NCT02474706|Imipenem|imipenem|mesh-list
102379556|NCT02474706|Cefoxitin|cefoxitin|mesh-list
102379557|NCT02474706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102379558|NCT02474706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102379559|NCT01784770|Azithromycin|azithromycin|mesh-list
102379560|NCT01784770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102379561|NCT01784770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101998634|NCT01147289|Meloxicam|meloxicam|mesh-list
102401217|NCT02348346|Protective Agents|protective agents|mesh-ancestor
101948343|NCT01176903|Parasympatholytics|parasympatholytics|mesh-ancestor
102379562|NCT02471274|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
102379563|NCT02471274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102379564|NCT02471274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379565|NCT02471274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102379566|NCT02471274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379567|NCT04491786|Gabapentin|gabapentin|mesh-list
102379568|NCT04491786|Nefopam|nefopam|mesh-list
102379569|NCT04491786|Analgesics|analgesics|mesh-ancestor
102379570|NCT04491786|Sensory System Agents|sensory system agents|mesh-ancestor
102379571|NCT04491786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102379572|NCT04491786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379573|NCT04491786|Anticonvulsants|anticonvulsants|mesh-ancestor
102379574|NCT04491786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102379575|NCT04491786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102379576|NCT04491786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102379577|NCT04491786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102379578|NCT04491786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102379579|NCT04491786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102379580|NCT04491786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102379581|NCT04491786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379582|NCT04491786|Antimanic Agents|antimanic agents|mesh-ancestor
102379583|NCT04491786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102379584|NCT01786252|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101999072|NCT04549376|Iodine|iodine|mesh-list
102379585|NCT01786252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102379586|NCT01786252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379588|NCT02470026|Mydriatics|mydriatics|mesh-ancestor
102379589|NCT02470026|Autonomic Agents|autonomic agents|mesh-ancestor
102379590|NCT02470026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102379591|NCT02470026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379592|NCT02470026|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102379593|NCT02470026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102379594|NCT02470026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102379595|NCT02470026|Adrenergic Agents|adrenergic agents|mesh-ancestor
102379596|NCT02470026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102379597|NCT02470026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379598|NCT02470026|Urological Agents|urological agents|mesh-ancestor
102379599|NCT01840072|Antihypertensive Agents|antihypertensive agents|mesh-list
102379600|NCT01807949|Ivacaftor|ivacaftor|mesh-list
102379601|NCT01807949|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102379602|NCT01807949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102379603|NCT01807949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379604|NCT02989558|Aspirin|aspirin|mesh-list
102379605|NCT02989558|Clopidogrel|clopidogrel|mesh-list
102379606|NCT02989558|Ticagrelor|ticagrelor|mesh-list
102379607|NCT02989558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102379608|NCT02989558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102379609|NCT02989558|Analgesics|analgesics|mesh-ancestor
102379610|NCT02989558|Sensory System Agents|sensory system agents|mesh-ancestor
102379611|NCT02989558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102379612|NCT02989558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999429|NCT04320745|Hormones|hormones|mesh-ancestor
102379613|NCT02989558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102379614|NCT02989558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102379615|NCT02989558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102379616|NCT02989558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102379617|NCT02989558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379618|NCT02989558|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102379619|NCT02989558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102379620|NCT02989558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102379621|NCT02989558|Antipyretics|antipyretics|mesh-ancestor
102379622|NCT02989558|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102379623|NCT02989558|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102379624|NCT02989558|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102379625|NCT02989558|Purinergic Agents|purinergic agents|mesh-ancestor
101999518|NCT03321188|Paclitaxel|paclitaxel|mesh-list
102379626|NCT02989558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102379627|NCT01806779|Bupropion|bupropion|mesh-list
102379628|NCT01806779|Nicotine|nicotine|mesh-list
102379629|NCT01806779|Varenicline|varenicline|mesh-list
102379630|NCT01806779|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102379631|NCT01806779|Autonomic Agents|autonomic agents|mesh-ancestor
102379632|NCT01806779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102379633|NCT01806779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379634|NCT01806779|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102379635|NCT01806779|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102379636|NCT01806779|Cholinergic Agents|cholinergic agents|mesh-ancestor
102379637|NCT01806779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102379638|NCT01806779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379639|NCT01806779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102379640|NCT01806779|Antidepressive Agents|antidepressive agents|mesh-ancestor
102379641|NCT01806779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102379642|NCT01806779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102379643|NCT01806779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102379644|NCT01806779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102379645|NCT01806779|Dopamine Agents|dopamine agents|mesh-ancestor
102379646|NCT01806779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102379647|NCT01806779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102379648|NCT01806779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102379649|NCT01878526|Domperidone|domperidone|mesh-list
102379650|NCT01878526|Antiemetics|antiemetics|mesh-ancestor
102379651|NCT01878526|Autonomic Agents|autonomic agents|mesh-ancestor
102379652|NCT01878526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102379653|NCT01878526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379654|NCT01878526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101948426|NCT03562468|Vitamins|vitamins|mesh-ancestor
102379655|NCT01878526|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102379656|NCT01878526|Dopamine Agents|dopamine agents|mesh-ancestor
102379657|NCT01878526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101948443|NCT02818036|Naltrexone|naltrexone|mesh-list
102379658|NCT01878526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379659|NCT01878604|Hypolipidemic Agents|hypolipidemic agents|mesh-list
102379660|NCT01878604|Antimetabolites|antimetabolites|mesh-ancestor
102379661|NCT01878604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379662|NCT01878604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102379663|NCT02266810|Mometasone Furoate|mometasone furoate|mesh-list
102379664|NCT02266810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102379665|NCT02266810|Dermatologic Agents|dermatologic agents|mesh-ancestor
102379666|NCT02266810|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102379667|NCT01806623|Fluconazole|fluconazole|mesh-list
102379668|NCT01806623|Antifungal Agents|antifungal agents|mesh-ancestor
102379669|NCT01806623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101948454|NCT01287741|Obinutuzumab|obinutuzumab|mesh-list
102379670|NCT01806623|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102379671|NCT01806623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102379672|NCT01806623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101948460|NCT01287741|Alkylating Agents|alkylating agents|mesh-ancestor
102379673|NCT01806623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379674|NCT01806623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101826577|NCT01005758|Cytarabine|cytarabine|mesh-list
102379675|NCT01806623|Hormone Antagonists|hormone antagonists|mesh-ancestor
102379676|NCT01806623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102379677|NCT01806623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379678|NCT01806623|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102379679|NCT01806623|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102379680|NCT01806545|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
102379681|NCT01806545|Hemostatics|hemostatics|mesh-ancestor
102379682|NCT01806545|Coagulants|coagulants|mesh-ancestor
102379683|NCT01847014|Macitentan|macitentan|mesh-list
102379684|NCT01847014|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
102379685|NCT01847014|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102379686|NCT01847014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379687|NCT01847014|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
102379688|NCT01847638|Nepafenac|nepafenac|mesh-list
102379689|NCT01847638|Bromfenac|bromfenac|mesh-list
102379690|NCT01847638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102379691|NCT01847638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102379692|NCT01847638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102379693|NCT01847638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102379694|NCT01847638|Analgesics|analgesics|mesh-ancestor
102379695|NCT01847638|Sensory System Agents|sensory system agents|mesh-ancestor
102379696|NCT01847638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102379697|NCT01847638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379698|NCT01847638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102379699|NCT01847638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102379700|NCT02474628|Calcium Carbonate|calcium carbonate|mesh-list
102379701|NCT02474628|Calcium|calcium|mesh-list
102379702|NCT02474628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102379703|NCT02474628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379704|NCT02474628|Antacids|antacids|mesh-ancestor
102379705|NCT02474628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379706|NCT02474628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102379707|NCT05211570|Azacitidine|azacitidine|mesh-list
102379708|NCT05211570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102379709|NCT05211570|Antimetabolites|antimetabolites|mesh-ancestor
102379710|NCT05211570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379711|NCT05211570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102379712|NCT05211570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102379713|NCT03099564|Pembrolizumab|pembrolizumab|mesh-list
102379714|NCT03099564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102379715|NCT03099564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102379716|NCT03099564|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102379717|NCT03099564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379718|NCT02469948|Botulinum Toxins|botulinum toxins|mesh-list
102379719|NCT02469948|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102379720|NCT02469948|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102379721|NCT02469948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102379722|NCT02469948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102379723|NCT02469948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379724|NCT02469948|Cholinergic Agents|cholinergic agents|mesh-ancestor
102379725|NCT02469948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102000528|NCT01159301|Entinostat|entinostat|mesh-list
102379726|NCT02469948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379727|NCT02469948|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102379728|NCT02469948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102191491|NCT03480776|Aspirin|aspirin|mesh-list
102379729|NCT05328310|Nebivolol|nebivolol|mesh-list
102379730|NCT05328310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102379731|NCT05328310|Vasodilator Agents|vasodilator agents|mesh-ancestor
102379732|NCT05328310|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102379733|NCT05328310|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102379734|NCT05328310|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102379735|NCT05328310|Adrenergic Agents|adrenergic agents|mesh-ancestor
102379736|NCT05328310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102401218|NCT02348346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379737|NCT05328310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379738|NCT05328310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379739|NCT01797484|Ranolazine|ranolazine|mesh-list
102379740|NCT01797484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102379741|NCT01797484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102379742|NCT01797484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379743|NCT01798264|Exenatide|exenatide|mesh-list
102379744|NCT01798264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102379745|NCT01798264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379746|NCT01798264|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102379747|NCT01798264|Incretins|incretins|mesh-ancestor
102379748|NCT01798264|Hormones|hormones|mesh-ancestor
102379749|NCT01798264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102379750|NCT05326984|Metformin|metformin|mesh-list
102379751|NCT05326984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102379752|NCT05326984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379753|NCT01800838|Silicon|silicon|mesh-list
102379754|NCT01800838|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
102379755|NCT01800838|Trace Elements|trace elements|mesh-ancestor
102379756|NCT01800838|Micronutrients|micronutrients|mesh-ancestor
102379757|NCT01800838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379758|NCT01800838|Antimalarials|antimalarials|mesh-ancestor
102379759|NCT01800838|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101948549|NCT01181193|Temozolomide|temozolomide|mesh-list
102379760|NCT01800838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102379761|NCT01800838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102379762|NCT01800838|Antiviral Agents|antiviral agents|mesh-ancestor
102379763|NCT01800838|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101827472|NCT05667324|Hormones|hormones|mesh-ancestor
102379764|NCT01800838|Dermatologic Agents|dermatologic agents|mesh-ancestor
102379765|NCT01782131|Voriconazole|voriconazole|mesh-list
102379766|NCT01782131|Posaconazole|posaconazole|mesh-list
102379767|NCT01782131|Antifungal Agents|antifungal agents|mesh-ancestor
102379768|NCT01782131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102379769|NCT01782131|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102379770|NCT01782131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102379771|NCT01782131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102379772|NCT01782131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379773|NCT01782131|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102379774|NCT01782131|Hormone Antagonists|hormone antagonists|mesh-ancestor
102379775|NCT01782131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102379776|NCT01782131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379777|NCT01782131|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102379778|NCT01782131|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102379779|NCT01782131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102001261|NCT03935685|Serotonin Agents|serotonin agents|mesh-ancestor
102379780|NCT01782131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102379781|NCT01781975|Imatinib Mesylate|imatinib mesylate|mesh-list
102379782|NCT01781975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102379783|NCT01781975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102379784|NCT01781975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102379785|NCT01781975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379786|NCT01855360|Doxycycline|doxycycline|mesh-list
102379787|NCT01855360|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
102379788|NCT01855360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102379789|NCT01855360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102379790|NCT01855360|Antimalarials|antimalarials|mesh-ancestor
102379791|NCT01855360|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102379792|NCT01855360|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102379793|NCT01855360|Antiviral Agents|antiviral agents|mesh-ancestor
102401219|NCT02348346|Dermatologic Agents|dermatologic agents|mesh-ancestor
102379794|NCT01855360|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102379795|NCT01855360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102379796|NCT04351126|Fludrocortisone|fludrocortisone|mesh-list
102379797|NCT04351126|Bromocriptine|bromocriptine|mesh-list
102379798|NCT04351126|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102379799|NCT04351126|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102379800|NCT04351126|Hormone Antagonists|hormone antagonists|mesh-ancestor
102379801|NCT04351126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102379802|NCT04351126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379803|NCT04351126|Dopamine Agonists|dopamine agonists|mesh-ancestor
102379804|NCT04351126|Dopamine Agents|dopamine agents|mesh-ancestor
102379806|NCT04351126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379807|NCT04351126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102379808|NCT01804673|Fentanyl|fentanyl|mesh-list
102379809|NCT01804673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102379810|NCT01804673|Narcotics|narcotics|mesh-ancestor
102379811|NCT01804673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102379812|NCT01804673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379813|NCT01804673|Analgesics|analgesics|mesh-ancestor
102379814|NCT01804673|Sensory System Agents|sensory system agents|mesh-ancestor
102379815|NCT01804673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102379816|NCT01804673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102379817|NCT01804673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102379818|NCT01804673|Anesthetics, General|anesthetics, general|mesh-ancestor
102379819|NCT01804673|Anesthetics|anesthetics|mesh-ancestor
102379820|NCT01856530|Oxytocin|oxytocin|mesh-list
102379821|NCT01856530|Oxytocics|oxytocics|mesh-ancestor
102379822|NCT01856530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102379823|NCT01856530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379824|NCT05302336|Cyclophosphamide|cyclophosphamide|mesh-list
102379825|NCT05302336|Docetaxel|docetaxel|mesh-list
102379826|NCT05302336|Doxorubicin|doxorubicin|mesh-list
102379827|NCT05302336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102379828|NCT05302336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102379829|NCT05302336|Immunologic Factors|immunologic factors|mesh-ancestor
102379830|NCT05302336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379831|NCT05302336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102379832|NCT05302336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102379833|NCT05302336|Alkylating Agents|alkylating agents|mesh-ancestor
102379834|NCT05302336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379835|NCT05302336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102379836|NCT05302336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102379837|NCT05302336|Tubulin Modulators|tubulin modulators|mesh-ancestor
102379838|NCT05302336|Antimitotic Agents|antimitotic agents|mesh-ancestor
102379839|NCT05302336|Mitosis Modulators|mitosis modulators|mesh-ancestor
102379840|NCT05302336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102379841|NCT05302336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102379842|NCT05302336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102379843|NCT05302336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102379844|NCT01804036|Zolpidem|zolpidem|mesh-list
102379845|NCT01804036|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102379846|NCT01804036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102379847|NCT01804036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102379848|NCT01804036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379849|NCT01804036|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102379850|NCT01804036|GABA Agonists|gaba agonists|mesh-ancestor
102379851|NCT01804036|GABA Agents|gaba agents|mesh-ancestor
102379852|NCT01804036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102379853|NCT01804036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379854|NCT01857232|Dexamethasone|dexamethasone|mesh-list
102379855|NCT01857232|Ondansetron|ondansetron|mesh-list
102379856|NCT01857232|Fosaprepitant|fosaprepitant|mesh-list
102379857|NCT01857232|Aprepitant|aprepitant|mesh-list
102379858|NCT01857232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102379859|NCT01857232|Antiemetics|antiemetics|mesh-ancestor
102379860|NCT01857232|Autonomic Agents|autonomic agents|mesh-ancestor
102379861|NCT01857232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102379862|NCT01857232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379863|NCT01857232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102379864|NCT01857232|Glucocorticoids|glucocorticoids|mesh-ancestor
102379865|NCT01857232|Hormones|hormones|mesh-ancestor
102379866|NCT01857232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102379867|NCT01857232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102379868|NCT01857232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102379869|NCT01857232|Antipruritics|antipruritics|mesh-ancestor
102379870|NCT01857232|Dermatologic Agents|dermatologic agents|mesh-ancestor
102379871|NCT01857232|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102379872|NCT01857232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102379873|NCT01857232|Serotonin Agents|serotonin agents|mesh-ancestor
102379874|NCT01857232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102379875|NCT01857232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379876|NCT01857232|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102379877|NCT01766128|Zonisamide|zonisamide|mesh-list
102379878|NCT01766128|Anticonvulsants|anticonvulsants|mesh-ancestor
102379879|NCT01766128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102191653|NCT02811133|Inositol|inositol|mesh-list
102379880|NCT01766128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102379881|NCT01766128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379882|NCT01766128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102379883|NCT01766128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379885|NCT02859558|Emtricitabine|emtricitabine|mesh-list
102379886|NCT02859558|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102379887|NCT02859558|Cobicistat|cobicistat|mesh-list
102379888|NCT02859558|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
102379889|NCT02859558|Elvitegravir|elvitegravir|mesh-list
102379890|NCT02859558|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102379891|NCT02859558|Antiviral Agents|antiviral agents|mesh-ancestor
102379892|NCT02859558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102379893|NCT02859558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102379894|NCT02859558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102379895|NCT02859558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102379896|NCT02859558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379897|NCT02859558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102379898|NCT02859558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102379899|NCT02859558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102379900|NCT02859558|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102379901|NCT01860586|Bevacizumab|bevacizumab|mesh-list
102379902|NCT01860586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102379903|NCT01860586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102379904|NCT01860586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102379905|NCT01860586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102379906|NCT01860586|Growth Substances|growth substances|mesh-ancestor
102379907|NCT01860586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379908|NCT01860586|Growth Inhibitors|growth inhibitors|mesh-ancestor
102379909|NCT00705432|Ribavirin|ribavirin|mesh-list
102379910|NCT00705432|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102379911|NCT00705432|Antimetabolites|antimetabolites|mesh-ancestor
102379912|NCT00705432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379913|NCT00705432|Antiviral Agents|antiviral agents|mesh-ancestor
102379914|NCT00705432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102379915|NCT00704964|Ribavirin|ribavirin|mesh-list
102379916|NCT00704964|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102379917|NCT00704964|Interferon-alpha|interferon-alpha|mesh-list
102379918|NCT00704964|Antimetabolites|antimetabolites|mesh-ancestor
102379919|NCT00704964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379920|NCT00704964|Antiviral Agents|antiviral agents|mesh-ancestor
102379921|NCT00704964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102379922|NCT00704964|Immunologic Factors|immunologic factors|mesh-ancestor
102379923|NCT00704964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379924|NCT00704808|Temozolomide|temozolomide|mesh-list
102379925|NCT00704808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102379926|NCT00704808|Alkylating Agents|alkylating agents|mesh-ancestor
102379927|NCT00704808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379928|NCT00704808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102379929|NCT05305794|Insulin|insulin|mesh-list
102379930|NCT05305794|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102379931|NCT05305794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102379932|NCT05305794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379933|NCT02474316|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102379934|NCT02474316|Antiviral Agents|antiviral agents|mesh-ancestor
102379935|NCT02474316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102379936|NCT01862536|Tadalafil|tadalafil|mesh-list
102379937|NCT01862536|Vasodilator Agents|vasodilator agents|mesh-ancestor
102379938|NCT01862536|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102379939|NCT01862536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102379940|NCT01862536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102379941|NCT01862536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379942|NCT01862536|Urological Agents|urological agents|mesh-ancestor
102379943|NCT01862614|Epinephrine|epinephrine|mesh-list
102379944|NCT01862614|Racepinephrine|racepinephrine|mesh-list
102379945|NCT01862614|Carticaine|carticaine|mesh-list
102379946|NCT01862614|Epinephryl borate|epinephryl borate|mesh-list
102379947|NCT01862614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102379948|NCT01862614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102379949|NCT01862614|Adrenergic Agents|adrenergic agents|mesh-ancestor
102379950|NCT01862614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102379951|NCT01862614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379952|NCT01862614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191714|NCT02781090|Autonomic Agents|autonomic agents|mesh-ancestor
102379953|NCT01862614|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102379954|NCT01862614|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102379955|NCT01862614|Autonomic Agents|autonomic agents|mesh-ancestor
102379956|NCT01862614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102379957|NCT01862614|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102379958|NCT01862614|Respiratory System Agents|respiratory system agents|mesh-ancestor
102379960|NCT01862614|Sympathomimetics|sympathomimetics|mesh-ancestor
102379961|NCT01862614|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102379962|NCT01862614|Anesthetics, Local|anesthetics, local|mesh-ancestor
102379963|NCT01862614|Anesthetics|anesthetics|mesh-ancestor
102379964|NCT01862614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102379965|NCT01862614|Sensory System Agents|sensory system agents|mesh-ancestor
102379966|NCT05166876|Brequinar|brequinar|mesh-list
102379967|NCT05166876|Dipyridamole|dipyridamole|mesh-list
102379968|NCT05166876|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102379969|NCT05166876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102379970|NCT05166876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379971|NCT05166876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102379972|NCT05166876|Vasodilator Agents|vasodilator agents|mesh-ancestor
102379973|NCT05166876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102379974|NCT05166876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102379975|NCT05166876|Immunologic Factors|immunologic factors|mesh-ancestor
102379976|NCT05166876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102379977|NCT02470650|Ritonavir|ritonavir|mesh-list
102379978|NCT02470650|Darunavir|darunavir|mesh-list
102379979|NCT02470650|Tenofovir|tenofovir|mesh-list
102379980|NCT02470650|Lamivudine|lamivudine|mesh-list
102379981|NCT02470650|Emtricitabine|emtricitabine|mesh-list
102379982|NCT02470650|Abacavir|abacavir|mesh-list
102379983|NCT02470650|Cobicistat|cobicistat|mesh-list
102379984|NCT02470650|Rilpivirine|rilpivirine|mesh-list
102379985|NCT02470650|Elvitegravir|elvitegravir|mesh-list
102379986|NCT02470650|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102379987|NCT02470650|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102379988|NCT02470650|Protease Inhibitors|protease inhibitors|mesh-ancestor
102379989|NCT02470650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102379990|NCT02470650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102379991|NCT02470650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102379992|NCT02470650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102379993|NCT02470650|Antiviral Agents|antiviral agents|mesh-ancestor
102379994|NCT02470650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102379995|NCT02470650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102379996|NCT02470650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102379997|NCT02470650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102379998|NCT02470650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102379999|NCT02470650|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102380000|NCT01866592|Adalimumab|adalimumab|mesh-list
102380001|NCT01866592|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102380002|NCT01866592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102380003|NCT01866592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102380004|NCT01375608|Decitabine|decitabine|mesh-list
102380005|NCT01375608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102380006|NCT01375608|Antimetabolites|antimetabolites|mesh-ancestor
102380007|NCT01375608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380008|NCT01375608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102380009|NCT01375608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102380010|NCT01868776|Lidocaine|lidocaine|mesh-list
102380011|NCT01868776|Anesthetics, Local|anesthetics, local|mesh-ancestor
102380012|NCT01868776|Anesthetics|anesthetics|mesh-ancestor
102380013|NCT01868776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102380014|NCT01868776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380015|NCT01868776|Sensory System Agents|sensory system agents|mesh-ancestor
102380016|NCT01868776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102380017|NCT01868776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102380018|NCT01868776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102380019|NCT01868776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102380020|NCT01868776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102380021|NCT01868776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380022|NCT00704418|Bromfenac|bromfenac|mesh-list
102380023|NCT00704418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102380024|NCT00704418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102380025|NCT00704418|Analgesics|analgesics|mesh-ancestor
102380026|NCT00704418|Sensory System Agents|sensory system agents|mesh-ancestor
102380027|NCT00704418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102380028|NCT00704418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380029|NCT00704418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102380030|NCT00704418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102380031|NCT01869634|Ritonavir|ritonavir|mesh-list
102380032|NCT01869634|Darunavir|darunavir|mesh-list
102380033|NCT01869634|Emtricitabine|emtricitabine|mesh-list
102380034|NCT01869634|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102380035|NCT01869634|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102380036|NCT01869634|Protease Inhibitors|protease inhibitors|mesh-ancestor
102380037|NCT01869634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102380038|NCT01869634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380039|NCT01869634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102380040|NCT01869634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102380041|NCT01869634|Antiviral Agents|antiviral agents|mesh-ancestor
102380042|NCT01869634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102380043|NCT01869634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102380044|NCT01869634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102380045|NCT01869634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101948714|NCT06007846|Memantine|memantine|mesh-list
102380046|NCT01869634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102380047|NCT02047578|Busulfan|busulfan|mesh-list
102380048|NCT02047578|Alkylating Agents|alkylating agents|mesh-ancestor
102380049|NCT02047578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380050|NCT02047578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102380051|NCT02047578|Immunologic Factors|immunologic factors|mesh-ancestor
102380052|NCT02047578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380053|NCT02047578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102380054|NCT02047578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102380055|NCT02047578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102380056|NCT04837066|Imidacloprid|imidacloprid|mesh-list
102380057|NCT04837066|Cholinergic Agents|cholinergic agents|mesh-ancestor
102380058|NCT04837066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102380059|NCT04837066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380060|NCT04837066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380061|NCT04807894|Testosterone|testosterone|mesh-list
102380062|NCT04807894|Androgens|androgens|mesh-ancestor
102380063|NCT04807894|Hormones|hormones|mesh-ancestor
102380064|NCT04807894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102380065|NCT04807894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380066|NCT01874392|Insulin|insulin|mesh-list
102380067|NCT01874392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102380068|NCT01874392|Pancrelipase|pancrelipase|mesh-list
102380069|NCT01874392|Pancreatin|pancreatin|mesh-list
102380070|NCT01874392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101948750|NCT06007352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102380071|NCT01874392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380072|NCT01874392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102380073|NCT00576654|Irinotecan|irinotecan|mesh-list
102380074|NCT00576654|Camptothecin|camptothecin|mesh-list
102380075|NCT00576654|Veliparib|veliparib|mesh-list
102380076|NCT00576654|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102380077|NCT00576654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102380078|NCT00576654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102380079|NCT00576654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380080|NCT00576654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102380081|NCT00576654|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102380082|NCT00576654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102380083|NCT03314064|Dolutegravir|dolutegravir|mesh-list
102380084|NCT03314064|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102380085|NCT03314064|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102380086|NCT03314064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102380087|NCT03314064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380088|NCT03314064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102380089|NCT03314064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102380090|NCT03314064|Antiviral Agents|antiviral agents|mesh-ancestor
102380091|NCT03314064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102380092|NCT00552058|Certolizumab Pegol|certolizumab pegol|mesh-list
102380093|NCT00552058|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102380094|NCT00552058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102380095|NCT00552058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102380096|NCT00552058|Immunologic Factors|immunologic factors|mesh-ancestor
102380097|NCT00552058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380098|NCT00552058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102380099|NCT02473302|Tocopherols|tocopherols|mesh-list
102380100|NCT02473302|Vitamin E|vitamin e|mesh-list
102380101|NCT02473302|Tocotrienols|tocotrienols|mesh-list
102380102|NCT02473302|alpha-Tocopherol|alpha-tocopherol|mesh-list
102380103|NCT02473302|Antioxidants|antioxidants|mesh-ancestor
102380104|NCT02473302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380105|NCT02473302|Protective Agents|protective agents|mesh-ancestor
102380106|NCT02473302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380107|NCT02473302|Vitamins|vitamins|mesh-ancestor
102380108|NCT02473302|Micronutrients|micronutrients|mesh-ancestor
102380109|NCT05747326|Capecitabine|capecitabine|mesh-list
102380110|NCT05747326|Vinorelbine|vinorelbine|mesh-list
102380111|NCT05747326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102380112|NCT05747326|Antimetabolites|antimetabolites|mesh-ancestor
102380113|NCT05747326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380114|NCT05747326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102380115|NCT05747326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102380116|NCT05747326|Tubulin Modulators|tubulin modulators|mesh-ancestor
102380117|NCT05747326|Antimitotic Agents|antimitotic agents|mesh-ancestor
102380118|NCT05747326|Mitosis Modulators|mitosis modulators|mesh-ancestor
102380119|NCT03108300|Doxorubicin|doxorubicin|mesh-list
102380120|NCT03108300|Propranolol|propranolol|mesh-list
102380121|NCT03108300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102380122|NCT03108300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102380123|NCT03108300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102380124|NCT03108300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102380125|NCT03108300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102380126|NCT03108300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380127|NCT03108300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102380128|NCT03108300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102380129|NCT03108300|Adrenergic Agents|adrenergic agents|mesh-ancestor
102380130|NCT03108300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102380131|NCT03108300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380132|NCT03108300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102380133|NCT03108300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102380134|NCT03108300|Vasodilator Agents|vasodilator agents|mesh-ancestor
102380135|NCT03313752|Dapagliflozin|dapagliflozin|mesh-list
102380136|NCT03313752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102380137|NCT03313752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380138|NCT03313752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102380139|NCT03313752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380140|NCT02473146|Gemtuzumab|gemtuzumab|mesh-list
102380141|NCT02473146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102380142|NCT02473146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102380143|NCT02473146|Immunotoxins|immunotoxins|mesh-ancestor
102380144|NCT02473146|Immunoconjugates|immunoconjugates|mesh-ancestor
102380145|NCT02473146|Immunologic Factors|immunologic factors|mesh-ancestor
102380146|NCT02473146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380147|NCT02989012|Oseltamivir|oseltamivir|mesh-list
102380148|NCT02989012|Antiviral Agents|antiviral agents|mesh-ancestor
102380149|NCT02989012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102380150|NCT02989012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102380151|NCT02989012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380152|NCT03832894|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102380153|NCT03832894|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102380154|NCT03832894|Estradiol|estradiol|mesh-list
102380155|NCT03832894|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102380156|NCT03832894|Progesterone|progesterone|mesh-list
102380157|NCT03832894|Estrogens|estrogens|mesh-ancestor
102380158|NCT03832894|Hormones|hormones|mesh-ancestor
102380159|NCT03832894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102380160|NCT03832894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380161|NCT03832894|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102380162|NCT03832894|Contraceptive Agents|contraceptive agents|mesh-ancestor
102380163|NCT03832894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102380164|NCT03832894|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102380165|NCT03832894|Progestins|progestins|mesh-ancestor
102380166|NCT02989324|Misoprostol|misoprostol|mesh-list
102380167|NCT02989324|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102380168|NCT02989324|Abortifacient Agents|abortifacient agents|mesh-ancestor
102380169|NCT02989324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102380170|NCT02989324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380171|NCT02989324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102380172|NCT02989324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102380173|NCT02989324|Oxytocics|oxytocics|mesh-ancestor
102380174|NCT00550732|Posaconazole|posaconazole|mesh-list
102380175|NCT00550732|Antifungal Agents|antifungal agents|mesh-ancestor
102380176|NCT00550732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102380177|NCT00550732|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102380178|NCT00550732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102380179|NCT00550732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101948840|NCT06006598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102380180|NCT00550732|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102380181|NCT00550732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102380182|NCT00550732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102380183|NCT00550732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380184|NCT00550732|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102380185|NCT00550732|Hormone Antagonists|hormone antagonists|mesh-ancestor
102380186|NCT00550732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102380187|NCT00550732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380188|NCT03311022|Nefopam|nefopam|mesh-list
102380189|NCT03311022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102380190|NCT03311022|Analgesics|analgesics|mesh-ancestor
102380191|NCT03311022|Sensory System Agents|sensory system agents|mesh-ancestor
102380192|NCT03311022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102380193|NCT03311022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380194|NCT00550420|Rosiglitazone|rosiglitazone|mesh-list
102380195|NCT00550420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102380196|NCT00550420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380197|NCT00559936|Bevacizumab|bevacizumab|mesh-list
102380198|NCT00559936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102380199|NCT00559936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102380200|NCT00559936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102380201|NCT00559936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102380202|NCT00559936|Growth Substances|growth substances|mesh-ancestor
102380203|NCT00559936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380204|NCT00559936|Growth Inhibitors|growth inhibitors|mesh-ancestor
102380205|NCT05353192|Hormones|hormones|mesh-list
102380206|NCT05353192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102380207|NCT05353192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380208|NCT03310242|Vitamin D|vitamin d|mesh-list
102380209|NCT03310242|Vitamins|vitamins|mesh-ancestor
102380210|NCT03310242|Micronutrients|micronutrients|mesh-ancestor
102380211|NCT03310242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380212|NCT03310242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102380213|NCT00557128|Lisinopril|lisinopril|mesh-list
102380214|NCT00557128|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102380215|NCT00557128|Protease Inhibitors|protease inhibitors|mesh-ancestor
102380216|NCT00557128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102380217|NCT00557128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380218|NCT00557128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102380219|NCT00557128|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102380220|NCT00557128|Protective Agents|protective agents|mesh-ancestor
102380221|NCT00557128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380222|NCT03312582|Metformin|metformin|mesh-list
102380223|NCT03312582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102380224|NCT03312582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380225|NCT04350580|Immunoglobulins|immunoglobulins|mesh-list
102380226|NCT04350580|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102380227|NCT04350580|Antibodies|antibodies|mesh-list
102380228|NCT04350580|Immunologic Factors|immunologic factors|mesh-ancestor
102380229|NCT04350580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380230|NCT00558064|Amlodipine|amlodipine|mesh-list
102380231|NCT00558064|Telmisartan|telmisartan|mesh-list
102380232|NCT00558064|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
102380233|NCT00558064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102380234|NCT00558064|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102380235|NCT00558064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102380236|NCT00558064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380237|NCT00558064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102380238|NCT00558064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380239|NCT00558064|Vasodilator Agents|vasodilator agents|mesh-ancestor
101948896|NCT06006013|Atezolizumab|atezolizumab|mesh-list
102380240|NCT00558064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102380241|NCT00558064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102380242|NCT03312426|Linrodostat|linrodostat|mesh-list
102380243|NCT03312426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102380244|NCT03312426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380245|NCT03309618|Valsartan|valsartan|mesh-list
102380246|NCT03309618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102380247|NCT03309618|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102380248|NCT03309618|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102380249|NCT03309618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380250|NCT03303924|Sulbactam|sulbactam|mesh-list
102380251|NCT03303924|Durlobactam|durlobactam|mesh-list
102380252|NCT03303924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102192021|NCT01656538|Paclitaxel|paclitaxel|mesh-list
102380254|NCT03303924|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102380255|NCT03303924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102380256|NCT03303924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380257|NCT00557830|Sorafenib|sorafenib|mesh-list
102380258|NCT00557830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102380259|NCT00557830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102380260|NCT00557830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102380261|NCT00557830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380262|NCT00557440|Fluticasone|fluticasone|mesh-list
102380263|NCT00557440|Xhance|xhance|mesh-list
102380264|NCT00557440|Mometasone Furoate|mometasone furoate|mesh-list
102380265|NCT00557440|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102380266|NCT00557440|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102380267|NCT00557440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102380268|NCT00557440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102380269|NCT00557440|Autonomic Agents|autonomic agents|mesh-ancestor
102380270|NCT00557440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102380271|NCT00557440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380272|NCT00557440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102380273|NCT00557440|Respiratory System Agents|respiratory system agents|mesh-ancestor
102380274|NCT00557440|Dermatologic Agents|dermatologic agents|mesh-ancestor
102380275|NCT00557440|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102380276|NCT00557440|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102380277|NCT00557440|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102380278|NCT00557440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102380279|NCT00557440|Adrenergic Agents|adrenergic agents|mesh-ancestor
102380280|NCT00557440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102380281|NCT00557440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380282|NCT00557440|Glucocorticoids|glucocorticoids|mesh-ancestor
102380283|NCT00557440|Hormones|hormones|mesh-ancestor
102380284|NCT00557440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102380285|NCT00557440|Sympathomimetics|sympathomimetics|mesh-ancestor
102380286|NCT03311178|Dobutamine|dobutamine|mesh-list
102380287|NCT03311178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102380288|NCT03311178|Sympathomimetics|sympathomimetics|mesh-ancestor
102380289|NCT03311178|Autonomic Agents|autonomic agents|mesh-ancestor
102380290|NCT03311178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102380291|NCT03311178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380292|NCT03311178|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102380293|NCT03311178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101948955|NCT05991401|Rifampin|rifampin|mesh-list
102380294|NCT03311178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102380295|NCT03311178|Adrenergic Agents|adrenergic agents|mesh-ancestor
102380296|NCT03311178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102380297|NCT03311178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380298|NCT03311178|Protective Agents|protective agents|mesh-ancestor
102380299|NCT02469012|Ribavirin|ribavirin|mesh-list
102380300|NCT02469012|Sofosbuvir|sofosbuvir|mesh-list
102380301|NCT02469012|Ledipasvir|ledipasvir|mesh-list
102380302|NCT02469012|Antimetabolites|antimetabolites|mesh-ancestor
102380303|NCT02469012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380304|NCT02469012|Antiviral Agents|antiviral agents|mesh-ancestor
102380305|NCT02469012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102380306|NCT02468856|Modafinil|modafinil|mesh-list
102380307|NCT02468856|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102380308|NCT02468856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003589|NCT01314495|Abatacept|abatacept|mesh-list
102380309|NCT02468856|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102380310|NCT02468856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102380311|NCT02468856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102380312|NCT02468856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380313|NCT05224336|Niacin|niacin|mesh-list
102380314|NCT05224336|Psilocybin|psilocybin|mesh-list
102380315|NCT05224336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102380316|NCT05224336|Antimetabolites|antimetabolites|mesh-ancestor
102380317|NCT05224336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380318|NCT05224336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102380319|NCT05224336|Vasodilator Agents|vasodilator agents|mesh-ancestor
102380320|NCT05224336|Vitamin B Complex|vitamin b complex|mesh-ancestor
102380321|NCT05224336|Vitamins|vitamins|mesh-ancestor
102380322|NCT05224336|Micronutrients|micronutrients|mesh-ancestor
102380323|NCT05224336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380324|NCT05224336|Hallucinogens|hallucinogens|mesh-ancestor
102380325|NCT05224336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102380326|NCT03303378|Melatonin|melatonin|mesh-list
102380327|NCT03303378|Antioxidants|antioxidants|mesh-ancestor
102380328|NCT03303378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380330|NCT03303378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380331|NCT03303378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102380332|NCT04491474|Lidocaine|lidocaine|mesh-list
102380333|NCT04491474|Anesthetics, Local|anesthetics, local|mesh-ancestor
102380334|NCT04491474|Anesthetics|anesthetics|mesh-ancestor
102380335|NCT04491474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102380336|NCT04491474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380337|NCT04491474|Sensory System Agents|sensory system agents|mesh-ancestor
102380338|NCT04491474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102380339|NCT04491474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102380340|NCT04491474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102380341|NCT04491474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102380342|NCT04491474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102380343|NCT04491474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380344|NCT03308682|(177)Lu-DOTA-EB-TATE|(177)lu-dota-eb-tate|mesh-list
102380345|NCT03308682|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102380346|NCT03308682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380347|NCT03308604|Cisplatin|cisplatin|mesh-list
102380348|NCT03308604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102380349|NCT00553306|Aldesleukin|aldesleukin|mesh-list
102380350|NCT00553306|Cyclophosphamide|cyclophosphamide|mesh-list
102380351|NCT00553306|Interleukin-2|interleukin-2|mesh-list
102380352|NCT00553306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102380353|NCT00553306|Immunologic Factors|immunologic factors|mesh-ancestor
102380354|NCT00553306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380355|NCT00553306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102380356|NCT00553306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102380357|NCT00553306|Alkylating Agents|alkylating agents|mesh-ancestor
102380358|NCT00553306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380359|NCT00553306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102380360|NCT00553306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102380361|NCT00553306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102380362|NCT00553306|Analgesics|analgesics|mesh-ancestor
102380363|NCT00553306|Sensory System Agents|sensory system agents|mesh-ancestor
102380364|NCT00553306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101949040|NCT05981573|Sensory System Agents|sensory system agents|mesh-ancestor
101949041|NCT05981573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101949042|NCT05981573|Antitussive Agents|antitussive agents|mesh-ancestor
101949043|NCT05981573|Respiratory System Agents|respiratory system agents|mesh-ancestor
101266304|NCT01780909|Dopamine Agents|dopamine agents|mesh-ancestor
102380365|NCT00553306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102380366|NCT00553306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102380367|NCT00553306|Antiviral Agents|antiviral agents|mesh-ancestor
102380368|NCT00553306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102380369|NCT02722044|Adalimumab|adalimumab|mesh-list
102380370|NCT02722044|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102380371|NCT02722044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102380372|NCT02722044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102380373|NCT05728008|Ustekinumab|ustekinumab|mesh-list
102380374|NCT05728008|Tofacitinib|tofacitinib|mesh-list
102380375|NCT05728008|Dermatologic Agents|dermatologic agents|mesh-ancestor
102004370|NCT01291823|Gefitinib|gefitinib|mesh-list
102004406|NCT04520230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102004407|NCT04520230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102004411|NCT04520230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004413|NCT04520230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102004414|NCT04520230|Cholinergic Agents|cholinergic agents|mesh-ancestor
102004415|NCT03619837|Sofosbuvir|sofosbuvir|mesh-list
102004416|NCT03619837|Velpatasvir|velpatasvir|mesh-list
102004417|NCT03619837|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102004418|NCT03619837|Antiviral Agents|antiviral agents|mesh-ancestor
102004419|NCT03619837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102004420|NCT03852563|Petrolatum|petrolatum|mesh-list
102380376|NCT05728008|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102380377|NCT05728008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102380378|NCT05728008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102380379|NCT05728008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380380|NCT02988700|Bupivacaine|bupivacaine|mesh-list
102380381|NCT02988700|Anesthetics, Local|anesthetics, local|mesh-ancestor
102380382|NCT02988700|Anesthetics|anesthetics|mesh-ancestor
102380383|NCT02988700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102380384|NCT02988700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380385|NCT02988700|Sensory System Agents|sensory system agents|mesh-ancestor
102380386|NCT02988700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102004421|NCT03852563|Emollients|emollients|mesh-ancestor
102380387|NCT03308214|Imipenem|imipenem|mesh-list
102380388|NCT03308214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102380389|NCT03308214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102380390|NCT03308136|Lidocaine|lidocaine|mesh-list
102380391|NCT03308136|Anesthetics, Local|anesthetics, local|mesh-list
102380392|NCT03308136|Anesthetics|anesthetics|mesh-list
102380393|NCT03308136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102380394|NCT03308136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380395|NCT03308136|Sensory System Agents|sensory system agents|mesh-ancestor
102380396|NCT03308136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102004517|NCT03205566|Lamivudine|lamivudine|mesh-list
102380397|NCT03308136|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102380398|NCT03308136|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102380399|NCT03308136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102380400|NCT03308136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102192174|NCT00482755|Sunitinib|sunitinib|mesh-list
102380401|NCT03308136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380402|NCT02466984|Metoclopramide|metoclopramide|mesh-list
102380403|NCT02466984|Antiemetics|antiemetics|mesh-ancestor
102380404|NCT02466984|Autonomic Agents|autonomic agents|mesh-ancestor
102380405|NCT02466984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102380406|NCT02466984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380407|NCT02466984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102380408|NCT02466984|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102380409|NCT02466984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102380410|NCT02466984|Dopamine Agents|dopamine agents|mesh-ancestor
102380411|NCT02466984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102004772|NCT03732703|Thalidomide|thalidomide|mesh-list
102380412|NCT02466984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380413|NCT03302754|Alemtuzumab|alemtuzumab|mesh-list
102380414|NCT03302754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102380415|NCT03302754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102380416|NCT03307902|Imiquimod|imiquimod|mesh-list
102380417|NCT03307902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102380418|NCT03307902|Immunologic Factors|immunologic factors|mesh-ancestor
102380419|NCT03307902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380420|NCT03307902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102380421|NCT03307902|Interferon Inducers|interferon inducers|mesh-ancestor
102380422|NCT03302364|Risperidone|risperidone|mesh-list
102380423|NCT03302364|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102380424|NCT03302364|Serotonin Agents|serotonin agents|mesh-ancestor
102380425|NCT03302364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101949092|NCT05957848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102380426|NCT03302364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380427|NCT03302364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380428|NCT03302364|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102380429|NCT03302364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102380430|NCT03302364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102380431|NCT03302364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102380432|NCT03302364|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102380433|NCT03302364|Dopamine Agents|dopamine agents|mesh-ancestor
102380434|NCT02467920|Exenatide|exenatide|mesh-list
102380435|NCT02467920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102380436|NCT02467920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380437|NCT02467920|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102380438|NCT02467920|Incretins|incretins|mesh-ancestor
102380439|NCT02467920|Hormones|hormones|mesh-ancestor
101949106|NCT05909995|Ipilimumab|ipilimumab|mesh-list
102380440|NCT02467920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102380441|NCT04927312|Metronidazole|metronidazole|mesh-list
102380442|NCT04927312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102380443|NCT04927312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102005509|NCT02729896|Immunoconjugates|immunoconjugates|mesh-ancestor
102380444|NCT04927312|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102380445|NCT04927312|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101949111|NCT05906914|Cytarabine|cytarabine|mesh-list
102380446|NCT03307590|Dexmedetomidine|dexmedetomidine|mesh-list
102380447|NCT03307590|Bupivacaine|bupivacaine|mesh-list
102380448|NCT03307590|Anesthetics, Local|anesthetics, local|mesh-ancestor
102380449|NCT03307590|Anesthetics|anesthetics|mesh-ancestor
102005694|NCT01295099|Hormones|hormones|mesh-ancestor
102380450|NCT03307590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102380451|NCT03307590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380452|NCT03307590|Sensory System Agents|sensory system agents|mesh-ancestor
102380453|NCT03307590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102005748|NCT01190735|Caffeine|caffeine|mesh-list
102380454|NCT03307590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102380455|NCT03307590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102380456|NCT03307590|Analgesics|analgesics|mesh-ancestor
102380457|NCT03307590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102380458|NCT03307590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102380459|NCT03307590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102005816|NCT03845699|Fentanyl|fentanyl|mesh-list
102380460|NCT03307590|Adrenergic Agents|adrenergic agents|mesh-ancestor
102380461|NCT03307590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102380462|NCT03307590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380463|NCT03302208|Pregabalin|pregabalin|mesh-list
102005908|NCT03055988|Xhance|xhance|mesh-list
102380464|NCT03302208|Analgesics|analgesics|mesh-ancestor
102380465|NCT03302208|Sensory System Agents|sensory system agents|mesh-ancestor
102380466|NCT03302208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102380467|NCT03302208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380468|NCT03302208|Anticonvulsants|anticonvulsants|mesh-ancestor
102380469|NCT03302208|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101267941|NCT01800526|Acetylcysteine|acetylcysteine|mesh-list
102380470|NCT03302208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102380471|NCT03302208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380472|NCT03302208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102380473|NCT03302208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102380474|NCT03302208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102380475|NCT03302208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102380476|NCT03302208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102380477|NCT03307512|Insulin|insulin|mesh-list
102380478|NCT03307512|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102380479|NCT03307512|Insulin Lispro|insulin lispro|mesh-list
102380480|NCT03307512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102380481|NCT03307512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380482|NCT02466828|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102380483|NCT02466828|Hematinics|hematinics|mesh-ancestor
102380484|NCT02466828|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102380485|NCT02466828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102380486|NCT02721966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102380487|NCT02721966|Immunologic Factors|immunologic factors|mesh-ancestor
102380488|NCT02721966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380489|NCT00553462|Paclitaxel|paclitaxel|mesh-list
102380490|NCT00553462|Carboplatin|carboplatin|mesh-list
102380491|NCT00553462|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102380492|NCT00553462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102380493|NCT00553462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102380494|NCT00553462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102380495|NCT00553462|Tubulin Modulators|tubulin modulators|mesh-ancestor
102380496|NCT00553462|Antimitotic Agents|antimitotic agents|mesh-ancestor
102380497|NCT00553462|Mitosis Modulators|mitosis modulators|mesh-ancestor
102380498|NCT00553462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380499|NCT00553462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102380500|NCT00553462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102380501|NCT04874038|Lidocaine|lidocaine|mesh-list
102380502|NCT04874038|Anesthetics, Local|anesthetics, local|mesh-ancestor
102380503|NCT04874038|Anesthetics|anesthetics|mesh-ancestor
102380504|NCT04874038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101949160|NCT05864118|Antibodies|antibodies|mesh-list
102380505|NCT04874038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380506|NCT04874038|Sensory System Agents|sensory system agents|mesh-ancestor
102380507|NCT04874038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102380508|NCT04874038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102380509|NCT04874038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102380510|NCT04874038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102380511|NCT04874038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102380512|NCT04874038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380513|NCT03301974|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102380514|NCT03301974|Hemostatics|hemostatics|mesh-ancestor
102380515|NCT03301974|Coagulants|coagulants|mesh-ancestor
102380516|NCT03306732|Thiamine|thiamine|mesh-list
102380517|NCT03306732|Vitamin B Complex|vitamin b complex|mesh-ancestor
102380518|NCT03306732|Vitamins|vitamins|mesh-ancestor
102380519|NCT03306732|Micronutrients|micronutrients|mesh-ancestor
102380520|NCT03306732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380521|NCT00553150|Everolimus|everolimus|mesh-list
102380522|NCT00553150|Temozolomide|temozolomide|mesh-list
102380523|NCT00553150|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102380524|NCT00553150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102380525|NCT00553150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102380526|NCT00553150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380527|NCT00553150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102380528|NCT00553150|Immunologic Factors|immunologic factors|mesh-ancestor
102380529|NCT00553150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380530|NCT00553150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102380531|NCT00553150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102380532|NCT00553150|Alkylating Agents|alkylating agents|mesh-ancestor
102380533|NCT02468232|Enalapril|enalapril|mesh-list
102380534|NCT02468232|Enalaprilat|enalaprilat|mesh-list
102380535|NCT02468232|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102380536|NCT02468232|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102380537|NCT02468232|Protease Inhibitors|protease inhibitors|mesh-ancestor
102380538|NCT02468232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102380539|NCT02468232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380540|NCT02468232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102380541|NCT02468232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102380542|NCT04630834|Acetaminophen|acetaminophen|mesh-list
102380543|NCT04630834|Ibuprofen|ibuprofen|mesh-list
102380544|NCT04630834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102380545|NCT04630834|Analgesics|analgesics|mesh-ancestor
102380546|NCT04630834|Sensory System Agents|sensory system agents|mesh-ancestor
102380547|NCT04630834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102380548|NCT04630834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380549|NCT04630834|Antipyretics|antipyretics|mesh-ancestor
102380550|NCT04630834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102192327|NCT00258388|Hormones|hormones|mesh-ancestor
102380551|NCT04630834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102380552|NCT04630834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102380553|NCT04630834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102380554|NCT04630834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102380555|NCT04630834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380557|NCT03301350|Cyclophosphamide|cyclophosphamide|mesh-list
102380558|NCT03301350|Carboplatin|carboplatin|mesh-list
102380559|NCT03301350|Doxorubicin|doxorubicin|mesh-list
102380560|NCT03301350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102380561|NCT03301350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102380562|NCT03301350|Tubulin Modulators|tubulin modulators|mesh-ancestor
102380563|NCT03301350|Antimitotic Agents|antimitotic agents|mesh-ancestor
102380564|NCT03301350|Mitosis Modulators|mitosis modulators|mesh-ancestor
102380565|NCT03301350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380566|NCT03301350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102380567|NCT03301350|Immunologic Factors|immunologic factors|mesh-ancestor
102380568|NCT03301350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380569|NCT03301350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102380570|NCT03301350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102380571|NCT03301350|Alkylating Agents|alkylating agents|mesh-ancestor
102380572|NCT03301350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102380573|NCT03301350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102380574|NCT03301350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102380575|NCT03301350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102380576|NCT03301350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102380577|NCT05722704|Salicylic Acid|salicylic acid|mesh-list
102380578|NCT05722704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102380579|NCT05722704|Antifungal Agents|antifungal agents|mesh-ancestor
102380580|NCT05722704|Keratolytic Agents|keratolytic agents|mesh-ancestor
102380581|NCT05722704|Dermatologic Agents|dermatologic agents|mesh-ancestor
102380582|NCT02722278|Methyltestosterone|methyltestosterone|mesh-list
102380583|NCT02722278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102380584|NCT02722278|Testosterone|testosterone|mesh-list
102380585|NCT02722278|Testosterone undecanoate|testosterone undecanoate|mesh-list
102380586|NCT02722278|Testosterone enanthate|testosterone enanthate|mesh-list
102380587|NCT02722278|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102380588|NCT02722278|Androgens|androgens|mesh-ancestor
102380589|NCT02722278|Hormones|hormones|mesh-ancestor
102380590|NCT02722278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102380591|NCT02722278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380592|NCT02722278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102380593|NCT02722278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102380594|NCT02722278|Anabolic Agents|anabolic agents|mesh-ancestor
102380595|NCT03300960|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102380596|NCT03300960|Ganirelix|ganirelix|mesh-list
101268896|NCT01810809|Hylan|hylan|mesh-list
102380597|NCT03300960|Hormone Antagonists|hormone antagonists|mesh-ancestor
102380598|NCT03300960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101949258|NCT05773365|Sensory System Agents|sensory system agents|mesh-ancestor
102380599|NCT03300960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380600|NCT03300960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102380601|NCT03300960|Contraceptive Agents|contraceptive agents|mesh-ancestor
102380602|NCT03300960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102380603|NCT03300960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102380604|NCT03300960|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102380605|NCT03300960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102380606|NCT03300960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102380607|NCT02993146|Ropidoxuridine|ropidoxuridine|mesh-list
102380608|NCT02993146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102380609|NCT02485444|Oxytocin|oxytocin|mesh-list
102380610|NCT02485444|Oxytocics|oxytocics|mesh-ancestor
102380611|NCT02485444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102380612|NCT02485444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380613|NCT04443010|Temozolomide|temozolomide|mesh-list
102380614|NCT04443010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102380615|NCT04443010|Alkylating Agents|alkylating agents|mesh-ancestor
102380616|NCT04443010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380617|NCT04443010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102380618|NCT04490694|Lenvatinib|lenvatinib|mesh-list
102380619|NCT04490694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102380620|NCT04490694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102380621|NCT04490694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102380622|NCT04490694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380623|NCT04601584|Antibodies|antibodies|mesh-list
102380624|NCT04601584|Immunoglobulins|immunoglobulins|mesh-list
102380625|NCT04601584|Immunologic Factors|immunologic factors|mesh-ancestor
102380626|NCT04601584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007463|NCT01205087|Omeprazole|omeprazole|mesh-list
102380627|NCT02359474|Trabectedin|trabectedin|mesh-list
102380628|NCT02359474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102380629|NCT02359474|Alkylating Agents|alkylating agents|mesh-ancestor
102380630|NCT02359474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380631|NCT02359474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102380632|NCT02467686|Tamoxifen|tamoxifen|mesh-list
102380633|NCT02467686|Exemestane|exemestane|mesh-list
102380634|NCT02467686|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102380635|NCT02467686|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102380636|NCT02467686|Hormone Antagonists|hormone antagonists|mesh-ancestor
102380637|NCT02467686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102380638|NCT02467686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380639|NCT02467686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102380640|NCT02467686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102380641|NCT02467686|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102380642|NCT02467686|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102380643|NCT02467686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102380644|NCT02467686|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102380645|NCT02467686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102380646|NCT02467686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380647|NCT05707962|Magnesium Sulfate|magnesium sulfate|mesh-list
102380648|NCT05707962|Neuroprotective Agents|neuroprotective agents|mesh-list
102380649|NCT05707962|Analgesics|analgesics|mesh-ancestor
102380650|NCT05707962|Sensory System Agents|sensory system agents|mesh-ancestor
102380651|NCT05707962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102007891|NCT05199324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102380652|NCT05707962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380653|NCT05707962|Anesthetics|anesthetics|mesh-ancestor
102380654|NCT05707962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102380655|NCT05707962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102380656|NCT05707962|Anticonvulsants|anticonvulsants|mesh-ancestor
102380657|NCT05707962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102380658|NCT05707962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102380659|NCT05707962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401220|NCT02348346|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102380660|NCT05707962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102380661|NCT05707962|Tocolytic Agents|tocolytic agents|mesh-ancestor
102380662|NCT05707962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102380663|NCT05707962|Protective Agents|protective agents|mesh-ancestor
102380664|NCT01993810|Paclitaxel|paclitaxel|mesh-list
102380665|NCT01993810|Etoposide|etoposide|mesh-list
102380666|NCT01993810|Podophyllotoxin|podophyllotoxin|mesh-list
102380667|NCT01993810|Cisplatin|cisplatin|mesh-list
102380668|NCT01993810|Carboplatin|carboplatin|mesh-list
102380669|NCT01993810|Pemetrexed|pemetrexed|mesh-list
102008205|NCT03586609|Cytarabine|cytarabine|mesh-list
102380670|NCT01993810|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102380671|NCT01993810|Etoposide phosphate|etoposide phosphate|mesh-list
102380672|NCT01993810|Durvalumab|durvalumab|mesh-list
102380673|NCT01993810|Immunoglobulins|immunoglobulins|mesh-list
102380674|NCT01993810|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101270162|NCT01818908|Hormones|hormones|mesh-ancestor
102380675|NCT01993810|Immunoglobulin G|immunoglobulin g|mesh-list
102380676|NCT01993810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102380677|NCT01993810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102380678|NCT01993810|Tubulin Modulators|tubulin modulators|mesh-ancestor
102380679|NCT01993810|Antimitotic Agents|antimitotic agents|mesh-ancestor
102380680|NCT01993810|Mitosis Modulators|mitosis modulators|mesh-ancestor
102380681|NCT01993810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380682|NCT01993810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102380683|NCT01993810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102380684|NCT01993810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102380685|NCT01993810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102380686|NCT01993810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102380687|NCT01993810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102380688|NCT01993810|Immunologic Factors|immunologic factors|mesh-ancestor
102380689|NCT01993810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380690|NCT01993810|Keratolytic Agents|keratolytic agents|mesh-ancestor
102380691|NCT01993810|Dermatologic Agents|dermatologic agents|mesh-ancestor
102380692|NCT05698680|Prednisolone|prednisolone|mesh-list
102380693|NCT05698680|Colchicine|colchicine|mesh-list
102380694|NCT05698680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102380695|NCT05698680|Glucocorticoids|glucocorticoids|mesh-ancestor
102380696|NCT05698680|Hormones|hormones|mesh-ancestor
102380697|NCT05698680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102380698|NCT05698680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380699|NCT05698680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102380700|NCT05698680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102380701|NCT05698680|Gout Suppressants|gout suppressants|mesh-ancestor
102380702|NCT05698680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102380703|NCT05698680|Tubulin Modulators|tubulin modulators|mesh-ancestor
102380704|NCT05698680|Antimitotic Agents|antimitotic agents|mesh-ancestor
102380705|NCT05698680|Mitosis Modulators|mitosis modulators|mesh-ancestor
102380706|NCT05698680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380707|NCT04058470|Prednisone|prednisone|mesh-list
102380708|NCT04058470|Cyclophosphamide|cyclophosphamide|mesh-list
102380709|NCT04058470|Rituximab|rituximab|mesh-list
102380710|NCT04058470|Doxorubicin|doxorubicin|mesh-list
102380711|NCT04058470|Vincristine|vincristine|mesh-list
102380712|NCT04058470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102380713|NCT04058470|Immunologic Factors|immunologic factors|mesh-ancestor
102380714|NCT04058470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380715|NCT04058470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102380716|NCT04058470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102380717|NCT04058470|Alkylating Agents|alkylating agents|mesh-ancestor
102380718|NCT04058470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380719|NCT04058470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102380720|NCT04058470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102380721|NCT04058470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102380722|NCT04058470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102380723|NCT04058470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102380724|NCT04058470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102380725|NCT04058470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102380726|NCT04058470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102380727|NCT04058470|Glucocorticoids|glucocorticoids|mesh-ancestor
102380728|NCT04058470|Hormones|hormones|mesh-ancestor
102380729|NCT04058470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102380730|NCT04058470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102380731|NCT04058470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102380732|NCT04058470|Tubulin Modulators|tubulin modulators|mesh-ancestor
102380733|NCT04058470|Antimitotic Agents|antimitotic agents|mesh-ancestor
102380734|NCT04058470|Mitosis Modulators|mitosis modulators|mesh-ancestor
102380735|NCT02720484|Nivolumab|nivolumab|mesh-list
102380736|NCT02720484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102380737|NCT02720484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102380738|NCT02720484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102380739|NCT02720484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380740|NCT05447520|Montelukast|montelukast|mesh-list
102380741|NCT05447520|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102380742|NCT05447520|Respiratory System Agents|respiratory system agents|mesh-ancestor
102380743|NCT05447520|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102380744|NCT05447520|Hormone Antagonists|hormone antagonists|mesh-ancestor
102380745|NCT05447520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102380746|NCT05447520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380747|NCT05447520|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102380748|NCT05447520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102380749|NCT05447520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380750|NCT05438550|Amoxicillin|amoxicillin|mesh-list
102380751|NCT05438550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102380752|NCT05438550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102380753|NCT05639946|Brivaracetam|brivaracetam|mesh-list
102380754|NCT05639946|Anticonvulsants|anticonvulsants|mesh-ancestor
102380755|NCT03299712|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
102380756|NCT03299712|Vasodilator Agents|vasodilator agents|mesh-ancestor
102380757|NCT03299712|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
102380758|NCT03299712|Protective Agents|protective agents|mesh-ancestor
102380759|NCT03299712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380760|NCT05327556|Epinephrine|epinephrine|mesh-list
102380761|NCT05327556|Racepinephrine|racepinephrine|mesh-list
102380762|NCT05327556|Epinephryl borate|epinephryl borate|mesh-list
102380763|NCT05327556|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102380764|NCT05327556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102380765|NCT05327556|Adrenergic Agents|adrenergic agents|mesh-ancestor
102380766|NCT05327556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102380767|NCT05327556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380768|NCT05327556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380769|NCT05327556|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101949431|NCT05364190|Empagliflozin|empagliflozin|mesh-list
102380770|NCT05327556|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102380771|NCT05327556|Autonomic Agents|autonomic agents|mesh-ancestor
102380772|NCT05327556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102380773|NCT05327556|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102380774|NCT05327556|Respiratory System Agents|respiratory system agents|mesh-ancestor
102380776|NCT05327556|Sympathomimetics|sympathomimetics|mesh-ancestor
102380777|NCT05327556|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102380778|NCT02466438|Tazobactam|tazobactam|mesh-list
102380779|NCT02466438|Piperacillin|piperacillin|mesh-list
101949439|NCT05359133|Anesthetics|anesthetics|mesh-ancestor
102380780|NCT02466438|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102380781|NCT02466438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102380782|NCT02466438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102008882|NCT05676203|Docetaxel|docetaxel|mesh-list
102380783|NCT02466438|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102380784|NCT02466438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102380785|NCT02466438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380786|NCT05587062|Aflibercept|aflibercept|mesh-list
102380787|NCT05587062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102380788|NCT05587062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102008961|NCT05489796|Ketorolac|ketorolac|mesh-list
102380789|NCT05587062|Growth Substances|growth substances|mesh-ancestor
102380790|NCT05587062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380791|NCT05587062|Growth Inhibitors|growth inhibitors|mesh-ancestor
102380792|NCT05587062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102380793|NCT02463006|Methamphetamine|methamphetamine|mesh-list
102380794|NCT02463006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102380795|NCT02463006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380796|NCT02463006|Sympathomimetics|sympathomimetics|mesh-ancestor
102380797|NCT02463006|Autonomic Agents|autonomic agents|mesh-ancestor
102380798|NCT02463006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102380799|NCT02463006|Dopamine Agents|dopamine agents|mesh-ancestor
102380800|NCT02463006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102380801|NCT02463006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380802|NCT02463006|Adrenergic Agents|adrenergic agents|mesh-ancestor
102380803|NCT02463006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102380804|NCT02463006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102380805|NCT02463006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102380806|NCT02463006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102380807|NCT04779216|Alendronate|alendronate|mesh-list
102380808|NCT04779216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102380809|NCT04779216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380810|NCT02466204|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102380811|NCT02466204|Hormones|hormones|mesh-ancestor
102380812|NCT02466204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102380813|NCT02466204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380814|NCT02715804|Paclitaxel|paclitaxel|mesh-list
102380815|NCT02715804|Gemcitabine|gemcitabine|mesh-list
102380816|NCT02715804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102380817|NCT02715804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102380818|NCT02715804|Tubulin Modulators|tubulin modulators|mesh-ancestor
102380819|NCT02715804|Antimitotic Agents|antimitotic agents|mesh-ancestor
102380820|NCT02715804|Mitosis Modulators|mitosis modulators|mesh-ancestor
102380821|NCT02715804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380822|NCT02715804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102380823|NCT02715804|Antimetabolites|antimetabolites|mesh-ancestor
102380824|NCT04745130|Cetuximab|cetuximab|mesh-list
102380825|NCT04745130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102380826|NCT04745130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102380827|NCT02462304|Bevacizumab|bevacizumab|mesh-list
102380828|NCT02462304|Ranibizumab|ranibizumab|mesh-list
102380829|NCT02462304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102380830|NCT02462304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102380831|NCT02462304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102380832|NCT02462304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102380833|NCT02462304|Growth Substances|growth substances|mesh-ancestor
102380834|NCT02462304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380835|NCT02462304|Growth Inhibitors|growth inhibitors|mesh-ancestor
102380836|NCT03501576|Vaccines|vaccines|mesh-list
102380837|NCT03501576|Immunologic Factors|immunologic factors|mesh-ancestor
102380838|NCT03501576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380839|NCT02465814|Ulipristal acetate|ulipristal acetate|mesh-list
102380840|NCT02465814|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102380841|NCT02465814|Contraceptive Agents|contraceptive agents|mesh-ancestor
102380842|NCT02465814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102380843|NCT02465814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380844|NCT02465814|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102380845|NCT04645212|Aflibercept|aflibercept|mesh-list
102380846|NCT04645212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102380847|NCT04645212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102380848|NCT04645212|Growth Substances|growth substances|mesh-ancestor
102380849|NCT04645212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380850|NCT04645212|Growth Inhibitors|growth inhibitors|mesh-ancestor
102380851|NCT04645212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102380852|NCT04489446|Sildenafil Citrate|sildenafil citrate|mesh-list
102380853|NCT04489446|Vasodilator Agents|vasodilator agents|mesh-ancestor
102380854|NCT04489446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102380855|NCT04489446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102380856|NCT04489446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102380857|NCT04489446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380858|NCT04489446|Urological Agents|urological agents|mesh-ancestor
102380859|NCT02717754|Oseltamivir|oseltamivir|mesh-list
102380860|NCT02717754|Antiviral Agents|antiviral agents|mesh-ancestor
102380861|NCT02717754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102380862|NCT02717754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102380863|NCT02717754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380864|NCT04497168|Citalopram|citalopram|mesh-list
102380865|NCT04497168|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102380866|NCT04497168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102380867|NCT04497168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102380868|NCT04497168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010130|NCT03337672|Midazolam|midazolam|mesh-list
102380869|NCT04497168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102380870|NCT04497168|Serotonin Agents|serotonin agents|mesh-ancestor
102380871|NCT04497168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380872|NCT04497168|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102380873|NCT04497168|Antidepressive Agents|antidepressive agents|mesh-ancestor
102380874|NCT04497168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102380875|NCT02717130|Aripiprazole|aripiprazole|mesh-list
102380876|NCT02717130|Antidepressive Agents|antidepressive agents|mesh-ancestor
102380877|NCT02717130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102380878|NCT02717130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102380879|NCT02717130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102380880|NCT02717130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102380881|NCT02717130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380882|NCT02717130|Dopamine Agonists|dopamine agonists|mesh-ancestor
102380883|NCT02717130|Dopamine Agents|dopamine agents|mesh-ancestor
102380884|NCT02717130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102380885|NCT02717130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380886|NCT02717130|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102380887|NCT02717130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102380888|NCT02717130|Serotonin Agents|serotonin agents|mesh-ancestor
102380889|NCT02717130|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102380890|NCT02717130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102401221|NCT00361257|Minocycline|minocycline|mesh-list
102380891|NCT02717130|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102380892|NCT02717130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102380893|NCT02256696|Rifampin|rifampin|mesh-list
102380894|NCT02256696|Rifabutin|rifabutin|mesh-list
102380895|NCT02256696|Isoniazid|isoniazid|mesh-list
102380896|NCT02256696|Pyrazinamide|pyrazinamide|mesh-list
102380897|NCT02256696|Ethambutol|ethambutol|mesh-list
102380898|NCT02256696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102380899|NCT02256696|Antitubercular Agents|antitubercular agents|mesh-ancestor
102380900|NCT02256696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102010595|NCT03324490|Narcotics|narcotics|mesh-ancestor
102380901|NCT02256696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102380902|NCT02256696|Leprostatic Agents|leprostatic agents|mesh-ancestor
102380903|NCT02256696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102380904|NCT02256696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102380905|NCT02256696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380906|NCT02256696|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102380907|NCT02256696|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102380908|NCT02256696|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102380909|NCT02256696|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102380910|NCT02256696|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102380911|NCT02256696|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102380912|NCT02256696|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102380913|NCT02256696|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102380914|NCT02256696|Antimetabolites|antimetabolites|mesh-ancestor
102380915|NCT02256696|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102380916|NCT01773473|Insulin|insulin|mesh-list
102380917|NCT01773473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102380918|NCT01773473|Insulin Lispro|insulin lispro|mesh-list
102380919|NCT01773473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102380920|NCT01773473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380921|NCT01779869|Regadenoson|regadenoson|mesh-list
102380922|NCT01779869|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
102380923|NCT01779869|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102380924|NCT01779869|Purinergic Agonists|purinergic agonists|mesh-ancestor
102380925|NCT01779869|Purinergic Agents|purinergic agents|mesh-ancestor
102380926|NCT01779869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102401222|NCT00361257|Tetracycline|tetracycline|mesh-list
102380927|NCT01779869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380928|NCT01779869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380930|NCT01772537|Isoflurane|isoflurane|mesh-list
102380931|NCT01772537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102380932|NCT01772537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102380933|NCT01772537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380934|NCT01772537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102380935|NCT01772537|Anesthetics, General|anesthetics, general|mesh-ancestor
102380936|NCT01772537|Anesthetics|anesthetics|mesh-ancestor
102380937|NCT01772537|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102380938|NCT01772147|Fluticasone|fluticasone|mesh-list
102380939|NCT01772147|Xhance|xhance|mesh-list
102380940|NCT01772147|Bromides|bromides|mesh-list
102380941|NCT01772147|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102380942|NCT01772147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102380943|NCT01772147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102380944|NCT01772147|Autonomic Agents|autonomic agents|mesh-ancestor
102380945|NCT01772147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102380946|NCT01772147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380947|NCT01772147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102380948|NCT01772147|Respiratory System Agents|respiratory system agents|mesh-ancestor
102380949|NCT01772147|Dermatologic Agents|dermatologic agents|mesh-ancestor
102380950|NCT01772147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102380951|NCT01772147|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102380952|NCT01772147|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102380953|NCT01772147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102380954|NCT01772147|Adrenergic Agents|adrenergic agents|mesh-ancestor
102011579|NCT03790163|Anesthetics|anesthetics|mesh-ancestor
102380955|NCT01772147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102380956|NCT01772147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380957|NCT01772147|Anticonvulsants|anticonvulsants|mesh-ancestor
102380958|NCT01606787|Mannitol|mannitol|mesh-list
102380959|NCT01606787|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102380960|NCT01606787|Diuretics|diuretics|mesh-ancestor
102380961|NCT01606787|Natriuretic Agents|natriuretic agents|mesh-ancestor
102380962|NCT01606787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380963|NCT01777997|Tenofovir|tenofovir|mesh-list
102380964|NCT01777997|Emtricitabine|emtricitabine|mesh-list
102380965|NCT01777997|Rilpivirine|rilpivirine|mesh-list
102380966|NCT01777997|Antiviral Agents|antiviral agents|mesh-ancestor
102380967|NCT01777997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102380968|NCT01777997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102380969|NCT01777997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102380970|NCT01777997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102401223|NCT00361257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102380971|NCT01777997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380972|NCT01777997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102380973|NCT01777997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102380974|NCT01770353|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102380975|NCT01770353|Hematinics|hematinics|mesh-ancestor
102380976|NCT01770353|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102012006|NCT01308671|Varenicline|varenicline|mesh-list
102380977|NCT01770353|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102380978|NCT01777763|Posaconazole|posaconazole|mesh-list
102380979|NCT01777763|Antifungal Agents|antifungal agents|mesh-ancestor
102380980|NCT01777763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102380981|NCT01777763|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102380982|NCT01777763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102380983|NCT01777763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102380984|NCT01777763|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102380985|NCT01777763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102380986|NCT01777763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101949627|NCT04914741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102380987|NCT01777763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102380988|NCT01777763|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102380989|NCT01777763|Hormone Antagonists|hormone antagonists|mesh-ancestor
102380990|NCT01777763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102380991|NCT01777763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102380992|NCT01769339|Miconazole|miconazole|mesh-list
102380993|NCT01769339|Hydrocortisone|hydrocortisone|mesh-list
102380994|NCT01769339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102380995|NCT01769339|Antifungal Agents|antifungal agents|mesh-ancestor
102380996|NCT01769339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102380997|NCT01769339|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102192789|NCT02220829|Silodosin|silodosin|mesh-list
102380998|NCT01769339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102380999|NCT01769339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102381000|NCT01769339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949649|NCT04862260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102381001|NCT01769339|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102381002|NCT01769339|Hormone Antagonists|hormone antagonists|mesh-ancestor
102381003|NCT01769339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102381004|NCT01769339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381005|NCT01769339|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102381006|NCT01769339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102381007|NCT01777139|Ezogabine|ezogabine|mesh-list
102381008|NCT01777139|Anticonvulsants|anticonvulsants|mesh-ancestor
102381009|NCT01777139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101949657|NCT04862221|Diphenhydramine|diphenhydramine|mesh-list
102381010|NCT01777139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381011|NCT01768637|Aspirin|aspirin|mesh-list
102381012|NCT01768637|Clopidogrel|clopidogrel|mesh-list
101949662|NCT04862221|Prednisolone|prednisolone|mesh-list
102381013|NCT01768637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102381014|NCT01768637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102381015|NCT01768637|Analgesics|analgesics|mesh-ancestor
102381016|NCT01768637|Sensory System Agents|sensory system agents|mesh-ancestor
102381017|NCT01768637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102381018|NCT01768637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381019|NCT01768637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102381020|NCT01768637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102381021|NCT01768637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102381022|NCT01768637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102381023|NCT01768637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381024|NCT01768637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102381025|NCT01768637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102381026|NCT01768637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102381027|NCT01768637|Antipyretics|antipyretics|mesh-ancestor
102381028|NCT01768637|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102381029|NCT01768637|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102381030|NCT01768637|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102381031|NCT01768637|Purinergic Agents|purinergic agents|mesh-ancestor
102381032|NCT01768637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102381033|NCT01768559|Insulin|insulin|mesh-list
102381034|NCT01768559|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102381035|NCT01768559|Metformin|metformin|mesh-list
102012692|NCT05714176|Dextrans|dextrans|mesh-list
102381036|NCT01768559|Insulin Glargine|insulin glargine|mesh-list
102381037|NCT01768559|Insulin glulisine|insulin glulisine|mesh-list
102381038|NCT01768559|Lixisenatide|lixisenatide|mesh-list
101949686|NCT04862221|Anesthetics|anesthetics|mesh-ancestor
102381039|NCT01768559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102381040|NCT01768559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381041|NCT00983619|Rituximab|rituximab|mesh-list
102381042|NCT00983619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102381043|NCT00983619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102381044|NCT00983619|Immunologic Factors|immunologic factors|mesh-ancestor
102381045|NCT00983619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381046|NCT00983619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102381047|NCT00653068|Calcium, Dietary|calcium, dietary|mesh-list
102381048|NCT00653068|Leucovorin|leucovorin|mesh-list
102381049|NCT00653068|Folic Acid|folic acid|mesh-list
102381050|NCT00653068|Cyclophosphamide|cyclophosphamide|mesh-list
102381051|NCT00653068|Thiotepa|thiotepa|mesh-list
102381052|NCT00653068|Cisplatin|cisplatin|mesh-list
102381053|NCT00653068|Carboplatin|carboplatin|mesh-list
102381054|NCT00653068|Methotrexate|methotrexate|mesh-list
102381055|NCT00653068|Etoposide|etoposide|mesh-list
102381056|NCT00653068|Vincristine|vincristine|mesh-list
102381057|NCT00653068|Etoposide phosphate|etoposide phosphate|mesh-list
102381058|NCT00653068|Podophyllotoxin|podophyllotoxin|mesh-list
102381059|NCT00653068|Lenograstim|lenograstim|mesh-list
102381060|NCT00653068|Calcium|calcium|mesh-list
102381061|NCT00653068|Levoleucovorin|levoleucovorin|mesh-list
102381062|NCT00653068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102381063|NCT00653068|Immunologic Factors|immunologic factors|mesh-ancestor
102381064|NCT00653068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381065|NCT00653068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102381066|NCT00653068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102381067|NCT00653068|Alkylating Agents|alkylating agents|mesh-ancestor
102381068|NCT00653068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381069|NCT00653068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102381070|NCT00653068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102381071|NCT00653068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102381072|NCT00653068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102381073|NCT00653068|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102381074|NCT00653068|Abortifacient Agents|abortifacient agents|mesh-ancestor
102381075|NCT00653068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102381076|NCT00653068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102381077|NCT00653068|Antimetabolites|antimetabolites|mesh-ancestor
101274822|NCT01858571|Celecoxib|celecoxib|mesh-list
102381078|NCT00653068|Dermatologic Agents|dermatologic agents|mesh-ancestor
101949728|NCT04799275|Glucocorticoids|glucocorticoids|mesh-ancestor
102381079|NCT00653068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102381080|NCT00653068|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102381081|NCT00653068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102381082|NCT00653068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102381083|NCT00653068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102381084|NCT00653068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102381085|NCT00653068|Antidotes|antidotes|mesh-ancestor
102381086|NCT00653068|Protective Agents|protective agents|mesh-ancestor
102381087|NCT00653068|Vitamin B Complex|vitamin b complex|mesh-ancestor
102381089|NCT00653068|Micronutrients|micronutrients|mesh-ancestor
102381090|NCT00653068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102381091|NCT00653068|Tubulin Modulators|tubulin modulators|mesh-ancestor
102381092|NCT00653068|Antimitotic Agents|antimitotic agents|mesh-ancestor
102381093|NCT00653068|Mitosis Modulators|mitosis modulators|mesh-ancestor
102381094|NCT00653068|Hematinics|hematinics|mesh-ancestor
102381095|NCT00653068|Keratolytic Agents|keratolytic agents|mesh-ancestor
102381096|NCT03028311|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
102381097|NCT03028311|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102381098|NCT03028311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381099|NCT05608785|Capecitabine|capecitabine|mesh-list
102381100|NCT05608785|Oxaliplatin|oxaliplatin|mesh-list
102381101|NCT05608785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102381102|NCT05608785|Antimetabolites|antimetabolites|mesh-ancestor
102401224|NCT00361257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102381103|NCT05608785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381104|NCT05608785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102381105|NCT01775501|Leucovorin|leucovorin|mesh-list
102381106|NCT01775501|Fluorouracil|fluorouracil|mesh-list
102381107|NCT01775501|Oxaliplatin|oxaliplatin|mesh-list
102381108|NCT01775501|Sorafenib|sorafenib|mesh-list
102381109|NCT01775501|Antimetabolites|antimetabolites|mesh-ancestor
102381110|NCT01775501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381111|NCT01775501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102381112|NCT01775501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102381113|NCT01775501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102381114|NCT01775501|Immunologic Factors|immunologic factors|mesh-ancestor
102381115|NCT01775501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381116|NCT01775501|Antidotes|antidotes|mesh-ancestor
102381117|NCT01775501|Protective Agents|protective agents|mesh-ancestor
102381118|NCT01775501|Vitamin B Complex|vitamin b complex|mesh-ancestor
102381119|NCT01775501|Vitamins|vitamins|mesh-ancestor
102381120|NCT01775501|Micronutrients|micronutrients|mesh-ancestor
102381121|NCT01775501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102381122|NCT01775501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102381123|NCT04346667|Hydroxychloroquine|hydroxychloroquine|mesh-list
102381124|NCT04346667|Chloroquine|chloroquine|mesh-list
102381125|NCT04346667|Antimalarials|antimalarials|mesh-ancestor
102381126|NCT04346667|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102381127|NCT04346667|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102381128|NCT04346667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102381129|NCT04346667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102381130|NCT04346667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381131|NCT04346667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102381132|NCT04346667|Amebicides|amebicides|mesh-ancestor
102381133|NCT03024489|Cetuximab|cetuximab|mesh-list
102381134|NCT03024489|Palbociclib|palbociclib|mesh-list
102381135|NCT03024489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102381136|NCT03024489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102381137|NCT03024489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102381138|NCT03024489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102381139|NCT03024489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381140|NCT01775189|Naltrexone|naltrexone|mesh-list
102381141|NCT01775189|Oxycodone|oxycodone|mesh-list
102381142|NCT01775189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102381143|NCT01775189|Narcotics|narcotics|mesh-ancestor
102381144|NCT01775189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102381145|NCT01775189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381146|NCT01775189|Analgesics|analgesics|mesh-ancestor
102381147|NCT01775189|Sensory System Agents|sensory system agents|mesh-ancestor
102381148|NCT01775189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102381149|NCT01775189|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102381150|NCT01775189|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102381151|NCT04551963|Clarithromycin|clarithromycin|mesh-list
102381152|NCT04551963|Fluconazole|fluconazole|mesh-list
102381153|NCT04551963|Voriconazole|voriconazole|mesh-list
102381154|NCT04551963|Zanubrutinib|zanubrutinib|mesh-list
102381155|NCT04551963|Diltiazem|diltiazem|mesh-list
102381156|NCT04551963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102381157|NCT04551963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102381158|NCT04551963|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102381159|NCT04551963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102381160|NCT04551963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381161|NCT04551963|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102381162|NCT04551963|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102381163|NCT04551963|Antifungal Agents|antifungal agents|mesh-ancestor
102381164|NCT04551963|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102381165|NCT04551963|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102381166|NCT04551963|Hormone Antagonists|hormone antagonists|mesh-ancestor
102381167|NCT04551963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102381168|NCT04551963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381169|NCT04551963|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102381170|NCT04551963|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102381171|NCT04551963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102381172|NCT04551963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102381173|NCT04551963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102381174|NCT04551963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102381175|NCT04551963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102381176|NCT04551963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102381177|NCT04551963|Vasodilator Agents|vasodilator agents|mesh-ancestor
102381178|NCT01881412|Fluticasone|fluticasone|mesh-list
102381179|NCT01881412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102381180|NCT01881412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102381181|NCT01881412|Autonomic Agents|autonomic agents|mesh-ancestor
102381182|NCT01881412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102381183|NCT01881412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381184|NCT01881412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102381185|NCT01881412|Respiratory System Agents|respiratory system agents|mesh-ancestor
102381186|NCT01881412|Dermatologic Agents|dermatologic agents|mesh-ancestor
102381187|NCT01881412|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102381188|NCT03832816|Dronabinol|dronabinol|mesh-list
102381189|NCT03832816|Hallucinogens|hallucinogens|mesh-ancestor
102381190|NCT03832816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381191|NCT03832816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102381192|NCT03832816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102381193|NCT03832816|Analgesics|analgesics|mesh-ancestor
102381194|NCT03832816|Sensory System Agents|sensory system agents|mesh-ancestor
102381195|NCT03832816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102381196|NCT03832816|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102381197|NCT03832816|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102381198|NCT03832816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102381199|NCT03832816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381200|NCT03832816|Hormones|hormones|mesh-ancestor
102381201|NCT03832816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102381202|NCT04231084|Epoprostenol|epoprostenol|mesh-list
102381203|NCT04231084|Nitric Oxide|nitric oxide|mesh-list
102381204|NCT04231084|Vasodilator Agents|vasodilator agents|mesh-list
102381205|NCT04231084|Tezosentan|tezosentan|mesh-list
102381206|NCT04231084|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102381207|NCT04231084|Autonomic Agents|autonomic agents|mesh-ancestor
102381208|NCT04231084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102381209|NCT04231084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381210|NCT04231084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102381211|NCT04231084|Respiratory System Agents|respiratory system agents|mesh-ancestor
102381212|NCT04231084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102381213|NCT04231084|Antioxidants|antioxidants|mesh-ancestor
102381214|NCT04231084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381215|NCT04231084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102381216|NCT04231084|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102381217|NCT04231084|Gasotransmitters|gasotransmitters|mesh-ancestor
102381218|NCT04231084|Protective Agents|protective agents|mesh-ancestor
102381219|NCT04231084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102381220|NCT04231084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102381221|NCT01770743|Vaccines|vaccines|mesh-list
102381222|NCT01770743|Immunologic Factors|immunologic factors|mesh-ancestor
102014240|NCT03078192|Xenon|xenon|mesh-list
102381223|NCT01770743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381224|NCT01884844|Vitamin D|vitamin d|mesh-list
102381225|NCT01884844|Cholecalciferol|cholecalciferol|mesh-list
102381226|NCT01884844|Vitamins|vitamins|mesh-ancestor
102381227|NCT01884844|Micronutrients|micronutrients|mesh-ancestor
102381228|NCT01884844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381229|NCT01884844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102381230|NCT01884844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102381231|NCT04123587|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102381232|NCT04123587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381233|NCT04127721|Methotrexate|methotrexate|mesh-list
102381234|NCT04127721|Fludarabine|fludarabine|mesh-list
102381235|NCT04127721|Busulfan|busulfan|mesh-list
102381236|NCT04127721|Tacrolimus|tacrolimus|mesh-list
102381237|NCT04127721|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102381238|NCT04127721|Abortifacient Agents|abortifacient agents|mesh-ancestor
102381239|NCT04127721|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102381240|NCT04127721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381241|NCT04127721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102381242|NCT04127721|Antimetabolites|antimetabolites|mesh-ancestor
102381243|NCT04127721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381244|NCT04127721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102381245|NCT04127721|Dermatologic Agents|dermatologic agents|mesh-ancestor
102381246|NCT04127721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102381247|NCT04127721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102381248|NCT04127721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102381249|NCT04127721|Immunologic Factors|immunologic factors|mesh-ancestor
102381250|NCT04127721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102381251|NCT04127721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102381252|NCT04127721|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102381253|NCT04127721|Alkylating Agents|alkylating agents|mesh-ancestor
102381254|NCT04127721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102381255|NCT04127721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102381256|NCT04123743|Sunscreening Agents|sunscreening agents|mesh-list
102381257|NCT04123743|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102381258|NCT04123743|Protective Agents|protective agents|mesh-ancestor
102381259|NCT04123743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381260|NCT04123743|Dermatologic Agents|dermatologic agents|mesh-ancestor
102381261|NCT02996721|Vitamin D|vitamin d|mesh-list
102381262|NCT02996721|Cholecalciferol|cholecalciferol|mesh-list
102381263|NCT02996721|Vitamins|vitamins|mesh-ancestor
102381264|NCT02996721|Micronutrients|micronutrients|mesh-ancestor
102381265|NCT02996721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381266|NCT02996721|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102381267|NCT02996721|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102381268|NCT04122885|Oxaliplatin|oxaliplatin|mesh-list
102381269|NCT04122885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102381270|NCT03926338|Celecoxib|celecoxib|mesh-list
102381271|NCT03926338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
102014590|NCT03210688|Glucocorticoids|glucocorticoids|mesh-ancestor
102381272|NCT03926338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102381273|NCT03926338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101949923|NCT04628767|Tubulin Modulators|tubulin modulators|mesh-ancestor
102381274|NCT03926338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102381275|NCT03926338|Analgesics|analgesics|mesh-ancestor
102381276|NCT03926338|Sensory System Agents|sensory system agents|mesh-ancestor
102381277|NCT03926338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102381278|NCT03926338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381279|NCT03926338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102381280|NCT03926338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101949930|NCT04576455|Fulvestrant|fulvestrant|mesh-list
102381281|NCT03926338|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102381282|NCT03926338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102381283|NCT03926338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381284|NCT03926338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102381285|NCT03926338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102381286|NCT04126941|Calcium|calcium|mesh-list
102381287|NCT04126941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102014942|NCT01318044|Propofol|propofol|mesh-list
102381288|NCT04126941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381289|NCT02506192|Prednisone|prednisone|mesh-list
102381290|NCT02506192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102381291|NCT02506192|Glucocorticoids|glucocorticoids|mesh-ancestor
102381292|NCT02506192|Hormones|hormones|mesh-ancestor
102381293|NCT02506192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102381294|NCT02506192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949942|NCT04567303|Ranibizumab|ranibizumab|mesh-list
102381295|NCT02506192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102381296|NCT02506192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102381297|NCT04122105|Sildenafil Citrate|sildenafil citrate|mesh-list
102381298|NCT04122105|Vasodilator Agents|vasodilator agents|mesh-ancestor
102381299|NCT04122105|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102381300|NCT04122105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102381302|NCT04122105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381303|NCT04122105|Urological Agents|urological agents|mesh-ancestor
102381304|NCT04127019|Paclitaxel|paclitaxel|mesh-list
102381305|NCT04127019|Docetaxel|docetaxel|mesh-list
102381306|NCT04127019|Cyclophosphamide|cyclophosphamide|mesh-list
102381307|NCT04127019|Fluorouracil|fluorouracil|mesh-list
102381308|NCT04127019|Epirubicin|epirubicin|mesh-list
102381309|NCT04127019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102015226|NCT01350024|Mydriatics|mydriatics|mesh-ancestor
102381310|NCT04127019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102381311|NCT04127019|Tubulin Modulators|tubulin modulators|mesh-ancestor
102381312|NCT04127019|Antimitotic Agents|antimitotic agents|mesh-ancestor
102381313|NCT04127019|Mitosis Modulators|mitosis modulators|mesh-ancestor
102381314|NCT04127019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381315|NCT04127019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102381316|NCT04127019|Immunologic Factors|immunologic factors|mesh-ancestor
102381317|NCT04127019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381318|NCT04127019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102381319|NCT04127019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102381320|NCT04127019|Alkylating Agents|alkylating agents|mesh-ancestor
102381321|NCT04127019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102381322|NCT04127019|Antimetabolites|antimetabolites|mesh-ancestor
102381323|NCT04127019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102381324|NCT04127019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102381325|NCT04127019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102381326|NCT04127019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102381327|NCT04127019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102381328|NCT02076646|Interleukin-2|interleukin-2|mesh-list
102381329|NCT02076646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102381330|NCT02076646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102381331|NCT02076646|Analgesics|analgesics|mesh-ancestor
102381332|NCT02076646|Sensory System Agents|sensory system agents|mesh-ancestor
102381333|NCT02076646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102381334|NCT02076646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381335|NCT04121091|Pramipexole|pramipexole|mesh-list
102381336|NCT04121091|Antioxidants|antioxidants|mesh-ancestor
102381337|NCT04121091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381338|NCT04121091|Protective Agents|protective agents|mesh-ancestor
102381339|NCT04121091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381340|NCT04121091|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102381341|NCT04121091|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102381342|NCT04121091|Dopamine Agonists|dopamine agonists|mesh-ancestor
102381343|NCT04121091|Dopamine Agents|dopamine agents|mesh-ancestor
102381344|NCT04121091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102381345|NCT03283605|Durvalumab|durvalumab|mesh-list
102381346|NCT03283605|Tremelimumab|tremelimumab|mesh-list
102381347|NCT03283605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102381348|NCT03283605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102381349|NCT01896544|Cholecalciferol|cholecalciferol|mesh-list
102381350|NCT01896544|Vitamin D|vitamin d|mesh-list
102381351|NCT01896544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102381352|NCT01896544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381353|NCT01896544|Vitamins|vitamins|mesh-ancestor
102381354|NCT01896544|Micronutrients|micronutrients|mesh-ancestor
102381355|NCT01896544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102381356|NCT04120623|Dapagliflozin|dapagliflozin|mesh-list
102381357|NCT04120623|Insulin Aspart|insulin aspart|mesh-list
102381358|NCT04120623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102381359|NCT04120623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381360|NCT04120623|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102381361|NCT04120623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381362|NCT01931878|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102381363|NCT01931878|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102381364|NCT01931878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102381365|NCT01931878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381366|NCT01931878|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102381367|NCT01931878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102381368|NCT01931878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381369|NCT01931878|Cholinergic Agents|cholinergic agents|mesh-ancestor
102381370|NCT01931878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102381371|NCT01932112|Adenosine|adenosine|mesh-list
102381372|NCT01932112|Analgesics|analgesics|mesh-ancestor
102381373|NCT01932112|Sensory System Agents|sensory system agents|mesh-ancestor
102381374|NCT01932112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102381375|NCT01932112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381376|NCT01932112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102381377|NCT01932112|Vasodilator Agents|vasodilator agents|mesh-ancestor
102381378|NCT01932112|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102381379|NCT01932112|Purinergic Agonists|purinergic agonists|mesh-ancestor
102381380|NCT01932112|Purinergic Agents|purinergic agents|mesh-ancestor
102381381|NCT01932112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102381382|NCT01932112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381383|NCT04120311|Dexamethasone|dexamethasone|mesh-list
102381384|NCT04120311|Dexamethasone acetate|dexamethasone acetate|mesh-list
102381385|NCT04120311|BB 1101|bb 1101|mesh-list
102381386|NCT04120311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102381387|NCT04120311|Antiemetics|antiemetics|mesh-ancestor
102381388|NCT04120311|Autonomic Agents|autonomic agents|mesh-ancestor
102381389|NCT04120311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102381390|NCT04120311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381391|NCT04120311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102381392|NCT04120311|Glucocorticoids|glucocorticoids|mesh-ancestor
102381393|NCT04120311|Hormones|hormones|mesh-ancestor
102381394|NCT04120311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102381395|NCT04120311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102381396|NCT04120311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102381397|NCT04120311|Protease Inhibitors|protease inhibitors|mesh-ancestor
102381398|NCT04120311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102381399|NCT04120311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381400|NCT01897402|Vaccines|vaccines|mesh-list
102381401|NCT01897402|Immunologic Factors|immunologic factors|mesh-ancestor
102381402|NCT01897402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381403|NCT01897792|Vitamins|vitamins|mesh-list
102381404|NCT01897792|Ascorbic Acid|ascorbic acid|mesh-list
102381405|NCT01897792|Vitamin E|vitamin e|mesh-list
102381406|NCT01897792|Tocopherols|tocopherols|mesh-list
102381407|NCT01897792|Tocotrienols|tocotrienols|mesh-list
102381408|NCT01897792|alpha-Tocopherol|alpha-tocopherol|mesh-list
102381409|NCT01897792|Micronutrients|micronutrients|mesh-ancestor
102381410|NCT01897792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381411|NCT01897792|Antioxidants|antioxidants|mesh-ancestor
102381412|NCT01897792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381413|NCT01897792|Protective Agents|protective agents|mesh-ancestor
102381414|NCT01933984|Fluticasone|fluticasone|mesh-list
102381415|NCT01933984|Fenoterol|fenoterol|mesh-list
102381416|NCT01933984|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102381417|NCT01933984|Bronchodilator Agents|bronchodilator agents|mesh-list
102381418|NCT01933984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102381419|NCT01933984|Autonomic Agents|autonomic agents|mesh-ancestor
102381420|NCT01933984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102381421|NCT01933984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381422|NCT01933984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102381423|NCT01933984|Respiratory System Agents|respiratory system agents|mesh-ancestor
102381424|NCT01933984|Dermatologic Agents|dermatologic agents|mesh-ancestor
102381425|NCT01933984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102381426|NCT01933984|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102381427|NCT01933984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102381428|NCT01933984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102381429|NCT01933984|Adrenergic Agents|adrenergic agents|mesh-ancestor
102381430|NCT01933984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102381431|NCT01933984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381432|NCT01933984|Sympathomimetics|sympathomimetics|mesh-ancestor
102381433|NCT01933984|Tocolytic Agents|tocolytic agents|mesh-ancestor
102381434|NCT01933984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102381435|NCT04126083|Lofexidine|lofexidine|mesh-list
102381436|NCT04126083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102381437|NCT04126083|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102381438|NCT04126083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381439|NCT04126083|Sensory System Agents|sensory system agents|mesh-ancestor
102381440|NCT04126083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102381441|NCT04126083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102381442|NCT04126083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102381443|NCT04126083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102381444|NCT04126083|Adrenergic Agents|adrenergic agents|mesh-ancestor
102381445|NCT04126083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102381446|NCT04126083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381447|NCT01935622|Doxycycline|doxycycline|mesh-list
102381448|NCT01935622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102381449|NCT01935622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101950103|NCT04299490|Analgesics|analgesics|mesh-list
102193223|NCT04480593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102381450|NCT01935622|Antimalarials|antimalarials|mesh-ancestor
102381451|NCT01935622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102381452|NCT01935622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102381453|NCT03010917|Ethanol|ethanol|mesh-list
102381454|NCT03010917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102381455|NCT03010917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102381456|NCT03010917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102381457|NCT03010917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381458|NCT02979561|Warfarin|warfarin|mesh-list
102381459|NCT02979561|Dabigatran|dabigatran|mesh-list
102381460|NCT02979561|Anticoagulants|anticoagulants|mesh-ancestor
102381461|NCT02979561|Antithrombins|antithrombins|mesh-ancestor
102381462|NCT02979561|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102381463|NCT02979561|Protease Inhibitors|protease inhibitors|mesh-ancestor
102381464|NCT02979561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102381465|NCT02979561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381466|NCT01937026|Probenecid|probenecid|mesh-list
102381467|NCT01937026|Uricosuric Agents|uricosuric agents|mesh-ancestor
102381468|NCT01937026|Gout Suppressants|gout suppressants|mesh-ancestor
102381469|NCT01937026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102381470|NCT01937260|Brodalumab|brodalumab|mesh-list
102381471|NCT01937260|Dermatologic Agents|dermatologic agents|mesh-ancestor
102381472|NCT01902004|Memantine|memantine|mesh-list
102381473|NCT01902004|Escitalopram|escitalopram|mesh-list
102381474|NCT01902004|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102381475|NCT01902004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102381476|NCT01902004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102381477|NCT01902004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381478|NCT01902004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102381479|NCT01902004|Serotonin Agents|serotonin agents|mesh-ancestor
102381480|NCT01902004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381481|NCT01902004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102381482|NCT01902004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102381483|NCT01902004|Dopamine Agents|dopamine agents|mesh-ancestor
102381484|NCT01902004|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102381485|NCT01902004|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102381486|NCT01938040|Ibuprofen|ibuprofen|mesh-list
102381487|NCT01938040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102381488|NCT01938040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102381489|NCT01938040|Analgesics|analgesics|mesh-ancestor
102381490|NCT01938040|Sensory System Agents|sensory system agents|mesh-ancestor
102381491|NCT01938040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102381492|NCT01938040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381493|NCT01938040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102381494|NCT01938040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102381495|NCT01938040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102381496|NCT01938040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102381497|NCT01938040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381498|NCT03829839|Lorazepam|lorazepam|mesh-list
102381499|NCT03829839|Oxytocin|oxytocin|mesh-list
102381500|NCT03829839|Oxytocics|oxytocics|mesh-ancestor
102381501|NCT03829839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102381502|NCT03829839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381503|NCT03829839|Anticonvulsants|anticonvulsants|mesh-ancestor
102381504|NCT03829839|Antiemetics|antiemetics|mesh-ancestor
102381505|NCT03829839|Autonomic Agents|autonomic agents|mesh-ancestor
102381506|NCT03829839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102381507|NCT03829839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102381508|NCT03829839|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102381509|NCT03829839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102381510|NCT03829839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102381511|NCT03829839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102381512|NCT03829839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102381513|NCT03829839|GABA Modulators|gaba modulators|mesh-ancestor
102381514|NCT03829839|GABA Agents|gaba agents|mesh-ancestor
102381515|NCT03829839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102381516|NCT03829839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381517|NCT01938664|Candesartan|candesartan|mesh-list
102381518|NCT01938664|Candesartan cilexetil|candesartan cilexetil|mesh-list
102381519|NCT01938664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102381520|NCT01938664|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102381521|NCT01938664|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102381522|NCT01938664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381523|NCT03829917|Paromomycin|paromomycin|mesh-list
102381524|NCT03829917|Miltefosine|miltefosine|mesh-list
102381525|NCT03829917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102381526|NCT03829917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102381527|NCT03829917|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102381528|NCT03829917|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102381529|NCT03829917|Antifungal Agents|antifungal agents|mesh-ancestor
102381530|NCT03829917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102381531|NCT02284126|Vancomycin|vancomycin|mesh-list
102381532|NCT02284126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102381533|NCT02284126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102381534|NCT03004833|Nivolumab|nivolumab|mesh-list
102381535|NCT03004833|Doxorubicin|doxorubicin|mesh-list
102381536|NCT03004833|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102381537|NCT03004833|Dacarbazine|dacarbazine|mesh-list
102381538|NCT03004833|Vinblastine|vinblastine|mesh-list
102381539|NCT03004833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102381540|NCT03004833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102381541|NCT03004833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102381542|NCT03004833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381543|NCT03004833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102381544|NCT03004833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102381545|NCT03004833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102381546|NCT03004833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102381547|NCT03004833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102381548|NCT03004833|Alkylating Agents|alkylating agents|mesh-ancestor
102381549|NCT03004833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102381550|NCT03004833|Tubulin Modulators|tubulin modulators|mesh-ancestor
102381551|NCT03004833|Antimitotic Agents|antimitotic agents|mesh-ancestor
102381552|NCT03004833|Mitosis Modulators|mitosis modulators|mesh-ancestor
102381553|NCT01736579|Immunoglobulins|immunoglobulins|mesh-list
102381554|NCT01736579|Antibodies|antibodies|mesh-list
102381555|NCT01736579|gamma-Globulins|gamma-globulins|mesh-list
101950207|NCT04165317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102381556|NCT01736579|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102381557|NCT01736579|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102381558|NCT01736579|Immunologic Factors|immunologic factors|mesh-ancestor
102381559|NCT01736579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381560|NCT04124913|Progesterone|progesterone|mesh-list
102381561|NCT04124913|Dydrogesterone|dydrogesterone|mesh-list
102381562|NCT04124913|Progestins|progestins|mesh-ancestor
102381563|NCT04124913|Hormones|hormones|mesh-ancestor
102381564|NCT04124913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102381565|NCT04124913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381566|NCT03828279|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
101950220|NCT04007224|Oxytocin|oxytocin|mesh-list
102381567|NCT03828279|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102381568|NCT03828279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102381569|NCT03828279|Immunologic Factors|immunologic factors|mesh-ancestor
102381570|NCT03828279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381571|NCT02987920|Acetaminophen|acetaminophen|mesh-list
102381572|NCT02987920|Celecoxib|celecoxib|mesh-list
102381573|NCT02987920|Ketorolac|ketorolac|mesh-list
102381574|NCT02987920|Oxycodone|oxycodone|mesh-list
102381575|NCT02987920|Gabapentin|gabapentin|mesh-list
102381576|NCT02987920|Hydromorphone|hydromorphone|mesh-list
102381577|NCT02987920|Dextromethorphan|dextromethorphan|mesh-list
102381578|NCT02987920|Pantoprazole|pantoprazole|mesh-list
102381579|NCT02987920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102381580|NCT02987920|Analgesics|analgesics|mesh-ancestor
102381581|NCT02987920|Sensory System Agents|sensory system agents|mesh-ancestor
102381582|NCT02987920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102381583|NCT02987920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381584|NCT02987920|Antipyretics|antipyretics|mesh-ancestor
102381585|NCT02987920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102381586|NCT02987920|Narcotics|narcotics|mesh-ancestor
102381587|NCT02987920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102381588|NCT02987920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102381589|NCT02987920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102381590|NCT02987920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102381591|NCT02987920|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102381592|NCT02987920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102381593|NCT02987920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102381594|NCT02987920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381595|NCT02987920|Anticonvulsants|anticonvulsants|mesh-ancestor
102381596|NCT02987920|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102381597|NCT02987920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102381598|NCT02987920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102381599|NCT02987920|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101950240|NCT03952585|Cisplatin|cisplatin|mesh-list
102381600|NCT02987920|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102193374|NCT05042791|Capecitabine|capecitabine|mesh-list
102381601|NCT02987920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102381602|NCT02987920|Antimanic Agents|antimanic agents|mesh-ancestor
102381603|NCT02987920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102381604|NCT02987920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102381605|NCT02987920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102381607|NCT02987920|Respiratory System Agents|respiratory system agents|mesh-ancestor
102381608|NCT02974257|Thiamine|thiamine|mesh-list
102381609|NCT02974257|Vitamins|vitamins|mesh-ancestor
102381610|NCT02974257|Micronutrients|micronutrients|mesh-ancestor
102381611|NCT02974257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381612|NCT02974257|Vitamin B Complex|vitamin b complex|mesh-ancestor
102381613|NCT01736189|Adalimumab|adalimumab|mesh-list
102381614|NCT01736189|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102381615|NCT01736189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102381616|NCT01736189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102381617|NCT02970981|Nivolumab|nivolumab|mesh-list
102381618|NCT02970981|Ipilimumab|ipilimumab|mesh-list
102381619|NCT02970981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102381620|NCT02970981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102381621|NCT02970981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102381622|NCT02970981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381623|NCT02983773|Dronabinol|dronabinol|mesh-list
102381624|NCT02983773|Hallucinogens|hallucinogens|mesh-ancestor
101950278|NCT03816982|Bupivacaine|bupivacaine|mesh-list
102381625|NCT02983773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381626|NCT02983773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102381627|NCT02983773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102381628|NCT02983773|Analgesics|analgesics|mesh-ancestor
101950280|NCT03816982|Anesthetics|anesthetics|mesh-ancestor
102381629|NCT02983773|Sensory System Agents|sensory system agents|mesh-ancestor
102381630|NCT02983773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102381631|NCT02983773|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102381632|NCT02983773|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101950285|NCT03816397|Adalimumab|adalimumab|mesh-list
102381633|NCT02983773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102381634|NCT02983773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381635|NCT02983773|Hormones|hormones|mesh-ancestor
102381636|NCT02983773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102381637|NCT01941628|Rocuronium|rocuronium|mesh-list
102381638|NCT01941628|Succinylcholine|succinylcholine|mesh-list
102381639|NCT01941628|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102381640|NCT01941628|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102381641|NCT01941628|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102381642|NCT01941628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102381643|NCT01941628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381644|NCT01941628|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
102381645|NCT02987218|Propofol|propofol|mesh-list
102381646|NCT02987218|Desflurane|desflurane|mesh-list
102381647|NCT02987218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102381648|NCT02987218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102381649|NCT02987218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381650|NCT02987218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102381651|NCT02987218|Anesthetics, General|anesthetics, general|mesh-ancestor
102381652|NCT02987218|Anesthetics|anesthetics|mesh-ancestor
102381653|NCT02987218|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102381654|NCT01762943|Leuprolide|leuprolide|mesh-list
102381655|NCT01762943|Estradiol|estradiol|mesh-list
102381656|NCT01762943|Progesterone|progesterone|mesh-list
102381657|NCT01762943|Estrogens|estrogens|mesh-ancestor
102381658|NCT01762943|Hormones|hormones|mesh-ancestor
102381659|NCT01762943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101950299|NCT03704363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102381660|NCT01762943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381661|NCT01762943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102381662|NCT01762943|Progestins|progestins|mesh-ancestor
102381663|NCT01762943|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102381664|NCT01762943|Fertility Agents|fertility agents|mesh-ancestor
102381665|NCT01762943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102381666|NCT01762943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102381667|NCT04392063|Melatonin|melatonin|mesh-list
102381668|NCT04392063|Antioxidants|antioxidants|mesh-ancestor
102381669|NCT04392063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381670|NCT04392063|Protective Agents|protective agents|mesh-ancestor
102381671|NCT04392063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381672|NCT04392063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102381673|NCT01903798|Mycophenolic Acid|mycophenolic acid|mesh-list
102381674|NCT01903798|Prednisolone|prednisolone|mesh-list
102381675|NCT01903798|Rilonacept|rilonacept|mesh-list
102381676|NCT01903798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102381677|NCT01903798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102381678|NCT01903798|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102381679|NCT01903798|Antitubercular Agents|antitubercular agents|mesh-ancestor
102381680|NCT01903798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102381681|NCT01903798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102381682|NCT01903798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102381683|NCT01903798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950320|NCT03530683|Dexamethasone|dexamethasone|mesh-list
102381684|NCT01903798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102381685|NCT01903798|Glucocorticoids|glucocorticoids|mesh-ancestor
102381686|NCT01903798|Hormones|hormones|mesh-ancestor
102381687|NCT01903798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102381688|NCT01903798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381689|NCT01903798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102381690|NCT01945138|Insulin|insulin|mesh-list
102381691|NCT01945138|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102381692|NCT01945138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102381693|NCT01945138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381694|NCT01734785|Empagliflozin|empagliflozin|mesh-list
102381695|NCT01734785|Linagliptin|linagliptin|mesh-list
102381696|NCT01734785|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102381697|NCT01734785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381698|NCT01734785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102381699|NCT01734785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381700|NCT01734785|Incretins|incretins|mesh-ancestor
102381701|NCT01734785|Hormones|hormones|mesh-ancestor
102381702|NCT01734785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102381703|NCT01734785|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102381704|NCT01734785|Protease Inhibitors|protease inhibitors|mesh-ancestor
102381705|NCT01734785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102381706|NCT03821415|Estradiol|estradiol|mesh-list
102381707|NCT03821415|Estrogens|estrogens|mesh-ancestor
102381708|NCT03821415|Hormones|hormones|mesh-ancestor
102381709|NCT03821415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102381710|NCT03821415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381711|NCT01734395|Galantamine|galantamine|mesh-list
102381712|NCT01734395|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102381713|NCT01734395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102381714|NCT01734395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381715|NCT01734395|Cholinergic Agents|cholinergic agents|mesh-ancestor
102381716|NCT01734395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102381717|NCT01734395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381718|NCT01734395|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102381719|NCT01734395|Autonomic Agents|autonomic agents|mesh-ancestor
102381720|NCT01734395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102381721|NCT01734395|Nootropic Agents|nootropic agents|mesh-ancestor
102381722|NCT01945294|Interferons|interferons|mesh-list
102381723|NCT01945294|Ribavirin|ribavirin|mesh-list
102381724|NCT01945294|Interferon-alpha|interferon-alpha|mesh-list
102381725|NCT01945294|Interferon alpha-2|interferon alpha-2|mesh-list
102381726|NCT01945294|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102381727|NCT01945294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102381728|NCT01945294|Antiviral Agents|antiviral agents|mesh-ancestor
102381729|NCT01945294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102381730|NCT01945294|Antimetabolites|antimetabolites|mesh-ancestor
102381731|NCT01945294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381732|NCT01945294|Immunologic Factors|immunologic factors|mesh-ancestor
102381733|NCT01945294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381734|NCT04392297|Antibodies|antibodies|mesh-list
102381735|NCT04392297|Immunoglobulin G|immunoglobulin g|mesh-list
102381736|NCT04392297|Immunologic Factors|immunologic factors|mesh-ancestor
102381737|NCT04392297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381738|NCT01947946|Benralizumab|benralizumab|mesh-list
102381739|NCT01947946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102381740|NCT01947946|Respiratory System Agents|respiratory system agents|mesh-ancestor
102381741|NCT02954055|Paclitaxel|paclitaxel|mesh-list
102381742|NCT02954055|Vinorelbine|vinorelbine|mesh-list
102381743|NCT02954055|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102381744|NCT02954055|Cyclophosphamide|cyclophosphamide|mesh-list
102381745|NCT02954055|Capecitabine|capecitabine|mesh-list
101950399|NCT03217201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102381746|NCT02954055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102381747|NCT02954055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102381748|NCT02954055|Tubulin Modulators|tubulin modulators|mesh-ancestor
102381749|NCT02954055|Antimitotic Agents|antimitotic agents|mesh-ancestor
102381750|NCT02954055|Mitosis Modulators|mitosis modulators|mesh-ancestor
102381751|NCT02954055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381752|NCT02954055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102381753|NCT02954055|Immunologic Factors|immunologic factors|mesh-ancestor
102381754|NCT02954055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381755|NCT02954055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102381756|NCT02954055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102381757|NCT02954055|Alkylating Agents|alkylating agents|mesh-ancestor
102381758|NCT02954055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102381759|NCT02954055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102381760|NCT02954055|Antimetabolites|antimetabolites|mesh-ancestor
102381761|NCT03313180|Nintedanib|nintedanib|mesh-list
102381762|NCT03313180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102381763|NCT03313180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102381764|NCT03313180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101950416|NCT03199053|Protease Inhibitors|protease inhibitors|mesh-ancestor
102381765|NCT03313180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381766|NCT03275506|Bevacizumab|bevacizumab|mesh-list
102381767|NCT03275506|Pembrolizumab|pembrolizumab|mesh-list
102381768|NCT03275506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102381769|NCT03275506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102381770|NCT03275506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101670233|NCT03752398|Ipilimumab|ipilimumab|mesh-list
102381771|NCT03275506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102381772|NCT03275506|Growth Substances|growth substances|mesh-ancestor
102381773|NCT03275506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381774|NCT03275506|Growth Inhibitors|growth inhibitors|mesh-ancestor
102381775|NCT03275506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102381776|NCT03275506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381777|NCT03820245|Lycopene|lycopene|mesh-list
102381778|NCT03820245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102381779|NCT03820245|Antioxidants|antioxidants|mesh-ancestor
102401225|NCT00361257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102381780|NCT03820245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381781|NCT03820245|Protective Agents|protective agents|mesh-ancestor
102381782|NCT03820245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381783|NCT03820245|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102381784|NCT03820245|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102381785|NCT03820245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102381786|NCT01597505|Vancomycin|vancomycin|mesh-list
102381787|NCT01597505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102381788|NCT01597505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102381789|NCT03826485|Pranlukast|pranlukast|mesh-list
102381790|NCT03826485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102381791|NCT03826485|Respiratory System Agents|respiratory system agents|mesh-ancestor
102381792|NCT03826485|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102381793|NCT03826485|Hormone Antagonists|hormone antagonists|mesh-ancestor
102381794|NCT03826485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102401226|NCT00361257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102381795|NCT03826485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381796|NCT03823989|Mitomycins|mitomycins|mesh-list
102381797|NCT03823989|Mitomycin|mitomycin|mesh-list
102381798|NCT03823989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102381799|NCT03823989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102381800|NCT03823989|Alkylating Agents|alkylating agents|mesh-ancestor
102381801|NCT03823989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381802|NCT03823989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102381803|NCT03823989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102381804|NCT03826875|Fluoxetine|fluoxetine|mesh-list
102381805|NCT03826875|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102381806|NCT03826875|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102381807|NCT03826875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102381808|NCT03826875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950458|NCT03007147|Cytarabine|cytarabine|mesh-list
102381809|NCT03826875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102381810|NCT03826875|Serotonin Agents|serotonin agents|mesh-ancestor
102381811|NCT03826875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381812|NCT03826875|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102381813|NCT03826875|Antidepressive Agents|antidepressive agents|mesh-ancestor
102381814|NCT03826875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102381815|NCT03826875|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102381816|NCT03826875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102381817|NCT03826875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102381818|NCT01951066|Dexamethasone|dexamethasone|mesh-list
102381819|NCT01951066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102381820|NCT01951066|Antiemetics|antiemetics|mesh-ancestor
102381821|NCT01951066|Autonomic Agents|autonomic agents|mesh-ancestor
102381822|NCT01951066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102381823|NCT01951066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381824|NCT01951066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102381825|NCT01951066|Glucocorticoids|glucocorticoids|mesh-ancestor
102381826|NCT01951066|Hormones|hormones|mesh-ancestor
102381827|NCT01951066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102381828|NCT01951066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102381829|NCT01951066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102381830|NCT05735626|Capsaicin|capsaicin|mesh-list
102381831|NCT05735626|Piperine|piperine|mesh-list
102381832|NCT05735626|Antipruritics|antipruritics|mesh-ancestor
102381833|NCT05735626|Dermatologic Agents|dermatologic agents|mesh-ancestor
102381834|NCT05735626|Sensory System Agents|sensory system agents|mesh-ancestor
102381835|NCT05735626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102381836|NCT05735626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381837|NCT05735626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102381838|NCT05735626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102381839|NCT05735626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381840|NCT01951768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102381841|NCT01951768|Gentamicins|gentamicins|mesh-list
102381842|NCT01951768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102381843|NCT01951768|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102381844|NCT01951768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101950506|NCT03007147|Antiemetics|antiemetics|mesh-ancestor
102381845|NCT01951768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381846|NCT05735470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102381847|NCT05735470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102381848|NCT03825861|Folfirinox|folfirinox|mesh-list
102381849|NCT03825861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102381850|NCT01760447|Metformin|metformin|mesh-list
102381851|NCT01760447|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102381852|NCT01760447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102381853|NCT01760447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381854|NCT01760447|Incretins|incretins|mesh-ancestor
102381855|NCT01760447|Hormones|hormones|mesh-ancestor
102018812|NCT04425863|Glucocorticoids|glucocorticoids|mesh-ancestor
102381856|NCT01760447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102381857|NCT01760447|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102381858|NCT01760447|Protease Inhibitors|protease inhibitors|mesh-ancestor
102381859|NCT01760447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102381860|NCT01760447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381861|NCT01915108|Remifentanil|remifentanil|mesh-list
102381862|NCT01915108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102381863|NCT01915108|Narcotics|narcotics|mesh-ancestor
102381864|NCT01915108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102018956|NCT01372644|Hormones|hormones|mesh-ancestor
102381865|NCT01915108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381866|NCT01915108|Analgesics|analgesics|mesh-ancestor
102381867|NCT01915108|Sensory System Agents|sensory system agents|mesh-ancestor
102381868|NCT01915108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102381869|NCT03825471|Analgesics, Opioid|analgesics, opioid|mesh-list
102381870|NCT03825471|Anesthetics|anesthetics|mesh-list
102381871|NCT03825471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102381872|NCT03825471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381873|NCT03825471|Narcotics|narcotics|mesh-ancestor
102381874|NCT03825471|Analgesics|analgesics|mesh-ancestor
101950535|NCT03007147|Vitamins|vitamins|mesh-ancestor
102381875|NCT03825471|Sensory System Agents|sensory system agents|mesh-ancestor
102381876|NCT03825471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102381877|NCT01917136|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102381878|NCT01917136|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102381879|NCT01917136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381880|NCT01450215|Lenalidomide|lenalidomide|mesh-list
102381881|NCT01450215|Immunologic Factors|immunologic factors|mesh-ancestor
102381882|NCT01450215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950543|NCT03007147|Hematinics|hematinics|mesh-ancestor
102381883|NCT01450215|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102381884|NCT01450215|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102381885|NCT01450215|Growth Substances|growth substances|mesh-ancestor
102381886|NCT01450215|Growth Inhibitors|growth inhibitors|mesh-ancestor
102381887|NCT01450215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102381888|NCT02915523|Avelumab|avelumab|mesh-list
102381889|NCT02915523|Entinostat|entinostat|mesh-list
102381890|NCT02915523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102381891|NCT02915523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102381892|NCT02915523|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102381893|NCT02915523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102381894|NCT02915523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381895|NCT01917214|Sunitinib|sunitinib|mesh-list
102381896|NCT01917214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102381897|NCT01917214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102381898|NCT01917214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102381899|NCT01917214|Growth Substances|growth substances|mesh-ancestor
102381900|NCT01917214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381901|NCT01917214|Growth Inhibitors|growth inhibitors|mesh-ancestor
102381902|NCT01917214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102381903|NCT01917214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102381904|NCT01917214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381905|NCT01955434|Cyclophosphamide|cyclophosphamide|mesh-list
102381906|NCT01955434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102381907|NCT01955434|Immunologic Factors|immunologic factors|mesh-ancestor
102381908|NCT01955434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381909|NCT01955434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102381910|NCT01955434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102381911|NCT01955434|Alkylating Agents|alkylating agents|mesh-ancestor
102381912|NCT01955434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381913|NCT01955434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102381914|NCT01955434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102381915|NCT01732913|Rituximab|rituximab|mesh-list
102381916|NCT01732913|Idelalisib|idelalisib|mesh-list
102381917|NCT01732913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102381918|NCT01732913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102381919|NCT01732913|Immunologic Factors|immunologic factors|mesh-ancestor
102381920|NCT01732913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381921|NCT01732913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102381922|NCT01732913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102381923|NCT01732913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381924|NCT03824925|Zinc|zinc|mesh-list
102381925|NCT03824925|Zinc Sulfate|zinc sulfate|mesh-list
102381926|NCT03824925|Trace Elements|trace elements|mesh-ancestor
102381927|NCT03824925|Micronutrients|micronutrients|mesh-ancestor
102381928|NCT03824925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381929|NCT03824925|Astringents|astringents|mesh-ancestor
102381930|NCT03824925|Dermatologic Agents|dermatologic agents|mesh-ancestor
102381931|NCT03825081|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102381932|NCT03825081|Pilocarpine|pilocarpine|mesh-list
102381933|NCT03825081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102381934|NCT03825081|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102381935|NCT03825081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102381936|NCT03825081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102381937|NCT03825081|Adrenergic Agents|adrenergic agents|mesh-ancestor
102381938|NCT03825081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102381939|NCT03825081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381940|NCT03825081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381941|NCT03825081|Miotics|miotics|mesh-ancestor
102381942|NCT03825081|Autonomic Agents|autonomic agents|mesh-ancestor
102381943|NCT03825081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102381944|NCT03825081|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102381945|NCT03825081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102381946|NCT03825081|Cholinergic Agents|cholinergic agents|mesh-ancestor
102381947|NCT01920802|Olanzapine|olanzapine|mesh-list
102381948|NCT01920802|Iloperidone|iloperidone|mesh-list
102381949|NCT01920802|Antiemetics|antiemetics|mesh-ancestor
102381950|NCT01920802|Autonomic Agents|autonomic agents|mesh-ancestor
102381951|NCT01920802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102381952|NCT01920802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381953|NCT01920802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102381954|NCT01920802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102381955|NCT01920802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102381956|NCT01920802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102381957|NCT01920802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102381958|NCT01920802|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102381959|NCT01920802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102381960|NCT01920802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102381961|NCT01920802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381962|NCT01920802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102381963|NCT01920802|Serotonin Agents|serotonin agents|mesh-ancestor
102381964|NCT01451229|Higenamine|higenamine|mesh-list
102381965|NCT01451229|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102381966|NCT01451229|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102381967|NCT01451229|Adrenergic Agents|adrenergic agents|mesh-ancestor
102381968|NCT01451229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102381969|NCT01451229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102381970|NCT01451229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381971|NCT01451229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102381972|NCT01451229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102381973|NCT01451229|Analgesics|analgesics|mesh-ancestor
102381974|NCT01451229|Sensory System Agents|sensory system agents|mesh-ancestor
102381975|NCT01451229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102381976|NCT01451229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102381977|NCT01451229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102193746|NCT04440267|Antiemetics|antiemetics|mesh-ancestor
102381978|NCT01451229|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102381979|NCT01451229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102381980|NCT01451229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102381981|NCT01451229|Protective Agents|protective agents|mesh-ancestor
102381982|NCT03054519|Metformin|metformin|mesh-list
102381983|NCT03054519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102381984|NCT03054519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381985|NCT01921894|Vitamin D|vitamin d|mesh-list
102381986|NCT01921894|Cholecalciferol|cholecalciferol|mesh-list
102381987|NCT01921894|Vitamins|vitamins|mesh-ancestor
102381988|NCT01921894|Micronutrients|micronutrients|mesh-ancestor
102381989|NCT01921894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102381990|NCT01921894|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102019947|NCT03203356|Hormones|hormones|mesh-list
102381991|NCT01921894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102381992|NCT01452009|Travoprost|travoprost|mesh-list
102020021|NCT02449564|Sirolimus|sirolimus|mesh-list
102381993|NCT01452009|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102381994|NCT01452009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102381995|NCT01452009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102381996|NCT03824379|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102381997|NCT03824379|Magnesium citrate|magnesium citrate|mesh-list
102381998|NCT03824379|Cathartics|cathartics|mesh-ancestor
102381999|NCT03824379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102382000|NCT03824379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382001|NCT01957930|Insulin|insulin|mesh-list
102382002|NCT01957930|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102382003|NCT01957930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102382004|NCT01957930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382005|NCT01732757|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
102382006|NCT01732757|Dextrans|dextrans|mesh-list
102382007|NCT01732757|Alcaftadine|alcaftadine|mesh-list
102382008|NCT01732757|Anticoagulants|anticoagulants|mesh-ancestor
102382009|NCT01732757|Plasma Substitutes|plasma substitutes|mesh-ancestor
102382010|NCT01732757|Blood Substitutes|blood substitutes|mesh-ancestor
102382011|NCT01732757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102382012|NCT01732757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102382013|NCT01732757|Analgesics|analgesics|mesh-ancestor
102382014|NCT01732757|Sensory System Agents|sensory system agents|mesh-ancestor
102382015|NCT01732757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102382016|NCT01732757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382017|NCT01732757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102382018|NCT01732757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102382019|NCT01732757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102382020|NCT01732757|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101950668|NCT00882193|Betaine|betaine|mesh-list
102382021|NCT01732757|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102382022|NCT01732757|Histamine Antagonists|histamine antagonists|mesh-ancestor
102382023|NCT01732757|Histamine Agents|histamine agents|mesh-ancestor
102382024|NCT01732757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102382025|NCT01732757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382026|NCT01758731|Cetuximab|cetuximab|mesh-list
102382027|NCT01758731|Olaparib|olaparib|mesh-list
102382028|NCT01758731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102382029|NCT01758731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102020441|NCT04179461|Vitamins|vitamins|mesh-ancestor
102382030|NCT01758731|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102382031|NCT01758731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102382032|NCT01758731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382033|NCT01452477|Tanshinone|tanshinone|mesh-list
102382034|NCT01452477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102020584|NCT05480150|Serotonin Agents|serotonin agents|mesh-ancestor
102382035|NCT01452477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102382036|NCT01452477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102382037|NCT01452477|Analgesics|analgesics|mesh-ancestor
102382038|NCT01452477|Sensory System Agents|sensory system agents|mesh-ancestor
102382039|NCT01452477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101950702|NCT00233662|Alefacept|alefacept|mesh-list
102382040|NCT01452477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382041|NCT01452477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102382042|NCT01452477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102382043|NCT01452477|Anticoagulants|anticoagulants|mesh-ancestor
102382044|NCT01452477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102382045|NCT01452477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102382046|NCT01452477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102382047|NCT01452477|Immunologic Factors|immunologic factors|mesh-ancestor
102382048|NCT01452633|Bupivacaine|bupivacaine|mesh-list
102382049|NCT01452633|Anesthetics, Local|anesthetics, local|mesh-ancestor
102382050|NCT01452633|Anesthetics|anesthetics|mesh-ancestor
102382051|NCT01452633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102382052|NCT01452633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382053|NCT01452633|Sensory System Agents|sensory system agents|mesh-ancestor
102382054|NCT01452633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102382055|NCT01606319|Acetaminophen|acetaminophen|mesh-list
102382056|NCT01606319|Ibuprofen|ibuprofen|mesh-list
102382057|NCT01606319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
102382058|NCT01606319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102382059|NCT01606319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102382060|NCT01606319|Analgesics|analgesics|mesh-ancestor
102382061|NCT01606319|Sensory System Agents|sensory system agents|mesh-ancestor
102382062|NCT01606319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102382063|NCT01606319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382064|NCT01606319|Antipyretics|antipyretics|mesh-ancestor
102382065|NCT01606319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102382066|NCT01606319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102382067|NCT01606319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102382068|NCT01606319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382069|NCT01452711|Lansoprazole|lansoprazole|mesh-list
102382070|NCT01452711|Dexlansoprazole|dexlansoprazole|mesh-list
102020985|NCT03702140|Teriparatide|teriparatide|mesh-list
102382071|NCT01452711|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102382072|NCT01452711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102382073|NCT01452711|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102382074|NCT01452711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101950735|NCT01289769|Analgesics|analgesics|mesh-ancestor
102382075|NCT01452711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382076|NCT02630121|Phenylephrine|phenylephrine|mesh-list
102382077|NCT02630121|Oxymetazoline|oxymetazoline|mesh-list
102382078|NCT02630121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102382079|NCT02630121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102382080|NCT02630121|Adrenergic Agents|adrenergic agents|mesh-ancestor
102382081|NCT02630121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102382082|NCT02630121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382083|NCT02630121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382084|NCT02630121|Sympathomimetics|sympathomimetics|mesh-ancestor
102382085|NCT02630121|Autonomic Agents|autonomic agents|mesh-ancestor
102382086|NCT02630121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102382087|NCT02630121|Nasal Decongestants|nasal decongestants|mesh-ancestor
102382088|NCT02630121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102382089|NCT02630121|Respiratory System Agents|respiratory system agents|mesh-ancestor
102382090|NCT02630121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102382091|NCT02630121|Mydriatics|mydriatics|mesh-ancestor
102382092|NCT02630121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102382093|NCT02630121|Protective Agents|protective agents|mesh-ancestor
102382094|NCT02956785|Dinoprostone|dinoprostone|mesh-list
102382095|NCT02956785|Oxytocics|oxytocics|mesh-ancestor
102382096|NCT02956785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102382097|NCT02956785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382098|NCT01452867|Chlorhexidine|chlorhexidine|mesh-list
102382099|NCT01452867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102382100|NCT01452867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102382101|NCT01452867|Disinfectants|disinfectants|mesh-ancestor
102382102|NCT02910531|Thioctic Acid|thioctic acid|mesh-list
102382103|NCT02910531|Antioxidants|antioxidants|mesh-ancestor
102382104|NCT02910531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382105|NCT02910531|Protective Agents|protective agents|mesh-ancestor
102382106|NCT02910531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382107|NCT02910531|Vitamin B Complex|vitamin b complex|mesh-ancestor
102382108|NCT02910531|Vitamins|vitamins|mesh-ancestor
102382109|NCT02910531|Micronutrients|micronutrients|mesh-ancestor
102382110|NCT02947581|Albendazole|albendazole|mesh-list
102382111|NCT02947581|Praziquantel|praziquantel|mesh-list
102382112|NCT02947581|Anthelmintics|anthelmintics|mesh-ancestor
102382113|NCT02947581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102382114|NCT02947581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102382115|NCT02947581|Anticestodal Agents|anticestodal agents|mesh-ancestor
102382116|NCT02947581|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102382117|NCT02947581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102382118|NCT02947581|Tubulin Modulators|tubulin modulators|mesh-ancestor
102382119|NCT02947581|Antimitotic Agents|antimitotic agents|mesh-ancestor
102382120|NCT02947581|Mitosis Modulators|mitosis modulators|mesh-ancestor
102382121|NCT02947581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382122|NCT02947581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102382123|NCT05606757|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102382124|NCT05606757|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102382125|NCT05606757|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102382126|NCT05606757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101950787|NCT01290003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102382127|NCT05606757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382128|NCT05606757|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102382129|NCT05606757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102382130|NCT05606757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382131|NCT05606757|Cholinergic Agents|cholinergic agents|mesh-ancestor
102193894|NCT02150291|Vitamins|vitamins|mesh-ancestor
102382132|NCT05606757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102382133|NCT01453881|Beclomethasone|beclomethasone|mesh-list
102382134|NCT01453881|Formoterol Fumarate|formoterol fumarate|mesh-list
102382135|NCT01453881|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102382136|NCT01453881|Autonomic Agents|autonomic agents|mesh-ancestor
102382137|NCT01453881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102382138|NCT01453881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382139|NCT01453881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102382140|NCT01453881|Respiratory System Agents|respiratory system agents|mesh-ancestor
102382141|NCT01453881|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102382142|NCT01453881|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102382143|NCT01453881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102382144|NCT01453881|Adrenergic Agents|adrenergic agents|mesh-ancestor
102382145|NCT01453881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102382146|NCT01453881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382147|NCT01453881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102382148|NCT01453881|Glucocorticoids|glucocorticoids|mesh-ancestor
102382149|NCT01453881|Hormones|hormones|mesh-ancestor
102382150|NCT01453881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102382151|NCT04391361|Atropine|atropine|mesh-list
102382152|NCT04391361|Scopolamine|scopolamine|mesh-list
102382153|NCT04391361|Dexmedetomidine|dexmedetomidine|mesh-list
102382154|NCT04391361|Edaravone|edaravone|mesh-list
102382155|NCT04391361|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102382156|NCT04391361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102382157|NCT04391361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102382158|NCT04391361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382159|NCT04391361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102382160|NCT04391361|Analgesics|analgesics|mesh-ancestor
102382161|NCT04391361|Sensory System Agents|sensory system agents|mesh-ancestor
102382162|NCT04391361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101950826|NCT01587729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102382163|NCT04391361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102382164|NCT04391361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102382165|NCT04391361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102382166|NCT04391361|Adrenergic Agents|adrenergic agents|mesh-ancestor
102382167|NCT04391361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101950831|NCT01587729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382168|NCT04391361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382169|NCT04391361|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102382170|NCT04391361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102382171|NCT04391361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102382172|NCT04391361|Autonomic Agents|autonomic agents|mesh-ancestor
102382173|NCT04391361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102382174|NCT04391361|Respiratory System Agents|respiratory system agents|mesh-ancestor
102382175|NCT04391361|Mydriatics|mydriatics|mesh-ancestor
102382176|NCT04391361|Parasympatholytics|parasympatholytics|mesh-ancestor
102382177|NCT04391361|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102382178|NCT04391361|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102382179|NCT04391361|Cholinergic Agents|cholinergic agents|mesh-ancestor
102382180|NCT04391361|Antiemetics|antiemetics|mesh-ancestor
102382181|NCT04391361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102382182|NCT04391361|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102382183|NCT04391361|Antioxidants|antioxidants|mesh-ancestor
102382184|NCT04391361|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102382185|NCT04391361|Protective Agents|protective agents|mesh-ancestor
102382186|NCT04273191|Brexanolone|brexanolone|mesh-list
102382187|NCT04273191|Neurosteroids|neurosteroids|mesh-ancestor
101284134|NCT01918176|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102382188|NCT04273191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102382189|NCT04273191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382190|NCT04273191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382191|NCT04273191|GABA Modulators|gaba modulators|mesh-ancestor
102382192|NCT04273191|GABA Agents|gaba agents|mesh-ancestor
102382193|NCT04391985|Sofosbuvir|sofosbuvir|mesh-list
102382194|NCT04391985|Antiviral Agents|antiviral agents|mesh-ancestor
102382195|NCT04391985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102382196|NCT01454115|BMS 708163|bms 708163|mesh-list
102382197|NCT01454115|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
102382198|NCT01454115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102382199|NCT01454115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382200|NCT01455597|Estradiol|estradiol|mesh-list
102382201|NCT01455597|Estrogens|estrogens|mesh-ancestor
102382202|NCT01455597|Hormones|hormones|mesh-ancestor
102382203|NCT01455597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102382204|NCT01455597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382205|NCT01453101|Fludarabine|fludarabine|mesh-list
102382206|NCT01453101|Fludarabine phosphate|fludarabine phosphate|mesh-list
102382207|NCT01453101|Bortezomib|bortezomib|mesh-list
102382208|NCT01453101|Melphalan|melphalan|mesh-list
102382209|NCT01453101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102382210|NCT01453101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102382211|NCT01453101|Antimetabolites|antimetabolites|mesh-ancestor
102382212|NCT01453101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382213|NCT01453101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102382214|NCT01453101|Immunologic Factors|immunologic factors|mesh-ancestor
102382215|NCT01453101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382216|NCT01453101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102382217|NCT01453101|Alkylating Agents|alkylating agents|mesh-ancestor
102382218|NCT01453101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102382219|NCT02085447|Haloperidol|haloperidol|mesh-list
102382220|NCT02085447|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102382221|NCT02085447|Haloperidol decanoate|haloperidol decanoate|mesh-list
102382222|NCT02085447|Antipsychotic Agents|antipsychotic agents|mesh-list
102382223|NCT02085447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102382224|NCT02085447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102382225|NCT02085447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382226|NCT02085447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102382227|NCT02085447|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102382228|NCT02085447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102382229|NCT02085447|Serotonin Agents|serotonin agents|mesh-ancestor
102382230|NCT02085447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102382231|NCT02085447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382232|NCT02085447|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102382233|NCT02085447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102382234|NCT02085447|Dopamine Agents|dopamine agents|mesh-ancestor
102382235|NCT02085447|Antiemetics|antiemetics|mesh-ancestor
102382236|NCT02085447|Autonomic Agents|autonomic agents|mesh-ancestor
102382237|NCT02085447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102382238|NCT02085447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102382239|NCT02085447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102382240|NCT04847193|Xanthohumol|xanthohumol|mesh-list
102382241|NCT04847193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102382242|NCT04847193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102382243|NCT04847193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102382244|NCT04847193|Growth Substances|growth substances|mesh-ancestor
102382245|NCT04847193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382246|NCT04847193|Growth Inhibitors|growth inhibitors|mesh-ancestor
102382247|NCT04273035|Midazolam|midazolam|mesh-list
102382248|NCT04273035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102382249|NCT04273035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102382250|NCT04273035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102382251|NCT04273035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382252|NCT04273035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102382253|NCT04273035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102382254|NCT04273035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102382255|NCT04273035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102382256|NCT04273035|Anesthetics, General|anesthetics, general|mesh-ancestor
102382257|NCT04273035|Anesthetics|anesthetics|mesh-ancestor
102382258|NCT04273035|GABA Modulators|gaba modulators|mesh-ancestor
102382259|NCT04273035|GABA Agents|gaba agents|mesh-ancestor
102382260|NCT04273035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102382261|NCT04273035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382262|NCT02836899|Nitric Oxide|nitric oxide|mesh-list
102382263|NCT02836899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102382264|NCT02836899|Autonomic Agents|autonomic agents|mesh-ancestor
102382265|NCT02836899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102382266|NCT02836899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382267|NCT02836899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102382268|NCT02836899|Respiratory System Agents|respiratory system agents|mesh-ancestor
102382269|NCT02836899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102382270|NCT02836899|Antioxidants|antioxidants|mesh-ancestor
102382271|NCT02836899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382272|NCT02836899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102382273|NCT02836899|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102382274|NCT02836899|Vasodilator Agents|vasodilator agents|mesh-ancestor
102382275|NCT02836899|Gasotransmitters|gasotransmitters|mesh-ancestor
102382276|NCT02836899|Protective Agents|protective agents|mesh-ancestor
102382277|NCT02902029|Atezolizumab|atezolizumab|mesh-list
102382278|NCT02902029|Vemurafenib|vemurafenib|mesh-list
102382279|NCT02902029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102382280|NCT02902029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950895|NCT03854409|Aripiprazole|aripiprazole|mesh-list
102382281|NCT02902029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102194052|NCT02150993|Ritonavir|ritonavir|mesh-list
102382282|NCT02902029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102382283|NCT02902029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102382284|NCT02902029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102382286|NCT02933697|Phenprocoumon|phenprocoumon|mesh-list
102382287|NCT02933697|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102382288|NCT02933697|Antithrombins|antithrombins|mesh-ancestor
102382289|NCT02933697|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102382290|NCT02933697|Protease Inhibitors|protease inhibitors|mesh-ancestor
102382291|NCT02933697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102382292|NCT02933697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382293|NCT02933697|Anticoagulants|anticoagulants|mesh-ancestor
102023175|NCT01358253|Hormones|hormones|mesh-ancestor
102382294|NCT01455129|Tiotropium Bromide|tiotropium bromide|mesh-list
102382295|NCT01455129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102382296|NCT01455129|Autonomic Agents|autonomic agents|mesh-ancestor
102382297|NCT01455129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102382298|NCT01455129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382299|NCT01455129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102382300|NCT01455129|Respiratory System Agents|respiratory system agents|mesh-ancestor
102382301|NCT01455129|Parasympatholytics|parasympatholytics|mesh-ancestor
102382302|NCT01455129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102382303|NCT01455129|Cholinergic Agents|cholinergic agents|mesh-ancestor
102382304|NCT01455129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102382305|NCT01455129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382306|NCT01455441|Liraglutide|liraglutide|mesh-list
102382307|NCT01455441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102382308|NCT01455441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382309|NCT01455441|Incretins|incretins|mesh-ancestor
102382310|NCT01455441|Hormones|hormones|mesh-ancestor
102382311|NCT01455441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102382312|NCT01455831|Tinzaparin|tinzaparin|mesh-list
102382313|NCT01455831|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102382314|NCT01455831|Dalteparin|dalteparin|mesh-list
102382315|NCT01455831|Anticoagulants|anticoagulants|mesh-ancestor
102382316|NCT01455831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102382317|NCT01455831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102382318|NCT01455831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382319|NCT04840641|Efavirenz|efavirenz|mesh-list
102382320|NCT04840641|Floxacillin|floxacillin|mesh-list
102382321|NCT04840641|Losartan|losartan|mesh-list
102382322|NCT04840641|Metoprolol|metoprolol|mesh-list
102382323|NCT04840641|Midazolam|midazolam|mesh-list
102382324|NCT04840641|Caffeine|caffeine|mesh-list
102382325|NCT04840641|Omeprazole|omeprazole|mesh-list
102382326|NCT04840641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102382327|NCT04840641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102382328|NCT04840641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102382329|NCT04840641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382330|NCT04840641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102382331|NCT04840641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102382332|NCT04840641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102382333|NCT04840641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101950956|NCT01180413|Losartan|losartan|mesh-list
102382334|NCT04840641|Anesthetics, General|anesthetics, general|mesh-ancestor
102382335|NCT04840641|Anesthetics|anesthetics|mesh-ancestor
102382336|NCT04840641|GABA Modulators|gaba modulators|mesh-ancestor
102382337|NCT04840641|GABA Agents|gaba agents|mesh-ancestor
102382338|NCT04840641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102382339|NCT04840641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382340|NCT04840641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102382341|NCT04840641|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102382342|NCT04840641|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102382343|NCT04840641|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102382344|NCT04840641|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102382345|NCT04840641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102382346|NCT04840641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102382347|NCT04840641|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102382348|NCT04840641|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102382349|NCT04840641|Purinergic Agents|purinergic agents|mesh-ancestor
102382350|NCT04840641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102382351|NCT04840641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102382352|NCT04840641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102382353|NCT04840641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101950961|NCT01180413|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102382354|NCT04840641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102382355|NCT04840641|Antiviral Agents|antiviral agents|mesh-ancestor
102382356|NCT04840641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102382357|NCT04840641|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102382358|NCT04840641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102382359|NCT04840641|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102382360|NCT04840641|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102382361|NCT04840641|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102382362|NCT04840641|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102382363|NCT04840641|Sympatholytics|sympatholytics|mesh-ancestor
102382364|NCT04840641|Autonomic Agents|autonomic agents|mesh-ancestor
102382365|NCT04840641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102382366|NCT04840641|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102382367|NCT04840641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102382368|NCT04840641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102382369|NCT04840641|Adrenergic Agents|adrenergic agents|mesh-ancestor
102382370|NCT04840641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102382371|NCT01455909|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102382372|NCT01455909|Exenatide|exenatide|mesh-list
102382373|NCT01455909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102382374|NCT01455909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382375|NCT01455909|Incretins|incretins|mesh-ancestor
102382376|NCT01455909|Hormones|hormones|mesh-ancestor
102382377|NCT01455909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102382378|NCT01455909|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102382379|NCT01455909|Protease Inhibitors|protease inhibitors|mesh-ancestor
102382380|NCT01455909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102382381|NCT01455909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382382|NCT01455909|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102382383|NCT04844619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102382384|NCT04844619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102382385|NCT02555787|Tacrolimus|tacrolimus|mesh-list
102382386|NCT02555787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102382387|NCT02555787|Immunologic Factors|immunologic factors|mesh-ancestor
102382388|NCT02555787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382389|NCT02555787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102382390|NCT02555787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102382391|NCT02555787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382392|NCT01730729|Cabergoline|cabergoline|mesh-list
102382393|NCT01730729|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102382394|NCT01730729|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102382395|NCT01730729|Dopamine Agonists|dopamine agonists|mesh-ancestor
102382396|NCT01730729|Dopamine Agents|dopamine agents|mesh-ancestor
102382397|NCT01730729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102382398|NCT01730729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382399|NCT01730729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382400|NCT01756157|Complement C1s|complement c1s|mesh-list
102382401|NCT01756157|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
102382402|NCT01756157|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
102382403|NCT01756157|Immunologic Factors|immunologic factors|mesh-ancestor
102382404|NCT01756157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382405|NCT01756157|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102382406|NCT01756157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102382407|NCT01756079|Ribavirin|ribavirin|mesh-list
102382408|NCT01756079|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102382409|NCT01756079|Antimetabolites|antimetabolites|mesh-ancestor
102382410|NCT01756079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382411|NCT01756079|Antiviral Agents|antiviral agents|mesh-ancestor
102382412|NCT01756079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102382413|NCT04272645|Atezolizumab|atezolizumab|mesh-list
102382414|NCT04272645|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102382415|NCT04272645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382416|NCT04272645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102382417|NCT04272645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102382418|NCT04390815|Insulin|insulin|mesh-list
102382419|NCT04390815|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102382420|NCT04390815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102382421|NCT04390815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382422|NCT01456611|Diclofenac|diclofenac|mesh-list
102382423|NCT01456611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102382424|NCT01456611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102382425|NCT01456611|Analgesics|analgesics|mesh-ancestor
102382426|NCT01456611|Sensory System Agents|sensory system agents|mesh-ancestor
102382427|NCT01456611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102382428|NCT01456611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382429|NCT01456611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102382430|NCT01456611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102382431|NCT01456611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102382432|NCT01456611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102382433|NCT01456611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382435|NCT01456689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102382436|NCT01456689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102382437|NCT01456689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102382438|NCT01456689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382439|NCT01456689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102382440|NCT01456689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102382441|NCT01456689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102382442|NCT01456689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102382443|NCT01456689|Anesthetics, General|anesthetics, general|mesh-ancestor
102382444|NCT01456689|Anesthetics|anesthetics|mesh-ancestor
102382445|NCT01456689|GABA Modulators|gaba modulators|mesh-ancestor
102382446|NCT01456689|GABA Agents|gaba agents|mesh-ancestor
102382447|NCT01456689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102382448|NCT01456689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382449|NCT05827159|Naltrexone|naltrexone|mesh-list
102382450|NCT05827159|Gabapentin|gabapentin|mesh-list
102382451|NCT05827159|Analgesics|analgesics|mesh-ancestor
102382452|NCT05827159|Sensory System Agents|sensory system agents|mesh-ancestor
102382453|NCT05827159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102382454|NCT05827159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382455|NCT05827159|Anticonvulsants|anticonvulsants|mesh-ancestor
102382456|NCT05827159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102382457|NCT05827159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102382458|NCT05827159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102382459|NCT05827159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102382460|NCT05827159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102382461|NCT05827159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102382462|NCT05827159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102382463|NCT05827159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382464|NCT05827159|Antimanic Agents|antimanic agents|mesh-ancestor
102382465|NCT05827159|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102382466|NCT05827159|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102382467|NCT05827081|Letrozole|letrozole|mesh-list
102382468|NCT05827081|Leuprolide|leuprolide|mesh-list
102382469|NCT05827081|Goserelin|goserelin|mesh-list
102382470|NCT05827081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102382471|NCT05827081|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102382472|NCT05827081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102382473|NCT05827081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102382474|NCT05827081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382475|NCT05827081|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102382476|NCT05827081|Hormone Antagonists|hormone antagonists|mesh-ancestor
102382477|NCT05827081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102382478|NCT05827081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382479|NCT05827081|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102382480|NCT05827081|Fertility Agents|fertility agents|mesh-ancestor
102382481|NCT05827081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102382482|NCT05827081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102382483|NCT05826990|Cefepime|cefepime|mesh-list
102382484|NCT05826990|Enmetazobactam|enmetazobactam|mesh-list
102382485|NCT05826990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102382486|NCT05826990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102382487|NCT05826990|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102382488|NCT05826990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102382489|NCT05826990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382490|NCT05826821|Pirfenidone|pirfenidone|mesh-list
102382491|NCT05826821|Analgesics|analgesics|mesh-ancestor
102382492|NCT05826821|Sensory System Agents|sensory system agents|mesh-ancestor
102382493|NCT05826821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102382494|NCT05826821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382495|NCT05826821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102382496|NCT05826821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102382497|NCT05826821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102382498|NCT05826821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102382499|NCT05826821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102382500|NCT05826444|Calcium|calcium|mesh-list
102382501|NCT05826444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102382502|NCT05826444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382503|NCT05826249|Ritonavir|ritonavir|mesh-list
102382504|NCT05826249|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102382505|NCT05826249|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102382506|NCT05826249|Protease Inhibitors|protease inhibitors|mesh-ancestor
102382507|NCT05826249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102382508|NCT05826249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382509|NCT05826249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101951128|NCT01184391|Valproic Acid|valproic acid|mesh-list
102382510|NCT05826249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102382511|NCT05826249|Antiviral Agents|antiviral agents|mesh-ancestor
102382512|NCT05826249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102382513|NCT05826249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102382514|NCT05826249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102382515|NCT05825963|Psyllium|psyllium|mesh-list
102382516|NCT05825963|Cathartics|cathartics|mesh-ancestor
102382517|NCT05825963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102382518|NCT05825872|Lidocaine|lidocaine|mesh-list
102382519|NCT05825872|Bupivacaine|bupivacaine|mesh-list
102382520|NCT05825872|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102382521|NCT05825872|Anesthetics, Local|anesthetics, local|mesh-ancestor
102382522|NCT05825872|Anesthetics|anesthetics|mesh-ancestor
102382523|NCT05825872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102382524|NCT05825872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382525|NCT05825872|Sensory System Agents|sensory system agents|mesh-ancestor
102382526|NCT05825872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102382527|NCT05825872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102382528|NCT05825872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102382529|NCT05825872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102382530|NCT05825872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102382531|NCT05825872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382532|NCT05825599|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101951166|NCT01291641|Cilostazol|cilostazol|mesh-list
102382533|NCT05825599|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102382534|NCT05825586|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102382535|NCT05825586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102382536|NCT05825378|Dexamethasone|dexamethasone|mesh-list
102382537|NCT05825378|Ropivacaine|ropivacaine|mesh-list
102382538|NCT05825378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102382539|NCT05825378|Antiemetics|antiemetics|mesh-ancestor
102382540|NCT05825378|Autonomic Agents|autonomic agents|mesh-ancestor
102382541|NCT05825378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102382542|NCT05825378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382543|NCT05825378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102382544|NCT05825378|Glucocorticoids|glucocorticoids|mesh-ancestor
102382545|NCT05825378|Hormones|hormones|mesh-ancestor
102382546|NCT05825378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102382547|NCT05825378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102382548|NCT05825378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102382549|NCT05825378|Anesthetics, Local|anesthetics, local|mesh-ancestor
102382550|NCT05825378|Anesthetics|anesthetics|mesh-ancestor
102382551|NCT05825378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102382552|NCT05825378|Sensory System Agents|sensory system agents|mesh-ancestor
102382553|NCT05825235|Pramipexole|pramipexole|mesh-list
102382554|NCT05825235|Antioxidants|antioxidants|mesh-ancestor
102382555|NCT05825235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382556|NCT05825235|Protective Agents|protective agents|mesh-ancestor
102382557|NCT05825235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382558|NCT05825235|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102382559|NCT05825235|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102382560|NCT05825235|Dopamine Agonists|dopamine agonists|mesh-ancestor
102382561|NCT05825235|Dopamine Agents|dopamine agents|mesh-ancestor
102382562|NCT05825235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102382563|NCT05825092|Methyltestosterone|methyltestosterone|mesh-list
102382564|NCT05825092|Testosterone|testosterone|mesh-list
102382565|NCT05825092|Testosterone undecanoate|testosterone undecanoate|mesh-list
102382566|NCT05825092|Testosterone enanthate|testosterone enanthate|mesh-list
102382567|NCT05825092|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102382568|NCT05825092|Androgens|androgens|mesh-ancestor
102382569|NCT05825092|Hormones|hormones|mesh-ancestor
102382570|NCT05825092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102382571|NCT05825092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382572|NCT05825092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102382573|NCT05825092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102382574|NCT05825092|Anabolic Agents|anabolic agents|mesh-ancestor
102382575|NCT05824897|Vitamin D|vitamin d|mesh-list
102382576|NCT05824897|Vitamins|vitamins|mesh-ancestor
102382577|NCT05824897|Micronutrients|micronutrients|mesh-ancestor
102382578|NCT05824897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382579|NCT05824897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102382580|NCT05824871|Bedaquiline|bedaquiline|mesh-list
102382581|NCT05824871|Antitubercular Agents|antitubercular agents|mesh-ancestor
102382582|NCT05824871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102382583|NCT05824871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102382585|NCT05824832|Dexamethasone acetate|dexamethasone acetate|mesh-list
102382586|NCT05824832|Clonidine|clonidine|mesh-list
102382587|NCT05824832|Buprenorphine|buprenorphine|mesh-list
102382588|NCT05824832|BB 1101|bb 1101|mesh-list
102382589|NCT05824832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102382590|NCT05824832|Antiemetics|antiemetics|mesh-ancestor
102382591|NCT05824832|Autonomic Agents|autonomic agents|mesh-ancestor
102382592|NCT05824832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101951189|NCT01291641|Antioxidants|antioxidants|mesh-ancestor
102382593|NCT05824832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382594|NCT05824832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102382595|NCT05824832|Glucocorticoids|glucocorticoids|mesh-ancestor
102382596|NCT05824832|Hormones|hormones|mesh-ancestor
102382597|NCT05824832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102382598|NCT05824832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102382599|NCT05824832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102382600|NCT05824832|Protease Inhibitors|protease inhibitors|mesh-ancestor
102382601|NCT05824832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102382602|NCT05824832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382603|NCT05824832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102382604|NCT05824832|Narcotics|narcotics|mesh-ancestor
102382605|NCT05824832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102382606|NCT05824832|Analgesics|analgesics|mesh-ancestor
102382607|NCT05824832|Sensory System Agents|sensory system agents|mesh-ancestor
102382608|NCT05824832|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102382609|NCT05824832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102382610|NCT05824832|Sympatholytics|sympatholytics|mesh-ancestor
102382611|NCT05824832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102382612|NCT05824832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102382613|NCT05824832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102382614|NCT05824832|Adrenergic Agents|adrenergic agents|mesh-ancestor
102382615|NCT05824832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102382616|NCT05824806|Hyaluronic Acid|hyaluronic acid|mesh-list
102382617|NCT05824806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102382618|NCT05824806|Immunologic Factors|immunologic factors|mesh-ancestor
102382619|NCT05824806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382620|NCT05824806|Viscosupplements|viscosupplements|mesh-ancestor
102382621|NCT05824806|Protective Agents|protective agents|mesh-ancestor
102382622|NCT05824767|Angiotensin II|angiotensin ii|mesh-list
102382623|NCT05824767|Giapreza|giapreza|mesh-list
102382624|NCT05824767|Angiotensinogen|angiotensinogen|mesh-list
102382625|NCT05824767|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101951223|NCT01293747|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102382626|NCT05824767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102382627|NCT05824767|Protease Inhibitors|protease inhibitors|mesh-ancestor
102382628|NCT05824767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102382629|NCT05824767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382630|NCT05824728|Levetiracetam|levetiracetam|mesh-list
102382631|NCT05824728|Anticonvulsants|anticonvulsants|mesh-ancestor
102382632|NCT05824728|Nootropic Agents|nootropic agents|mesh-ancestor
102382633|NCT05823844|Suvorexant|suvorexant|mesh-list
102382634|NCT05823844|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102382635|NCT05823844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102382636|NCT05823844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102382637|NCT05823844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382638|NCT05823844|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102382639|NCT05823844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102382640|NCT05823844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382641|NCT05823662|Silodosin|silodosin|mesh-list
102382642|NCT05823662|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102382643|NCT05823662|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102382644|NCT05823662|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102382645|NCT05823662|Adrenergic Agents|adrenergic agents|mesh-ancestor
102382646|NCT05823662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102382647|NCT05823662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382648|NCT05823662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382649|NCT05823662|Urological Agents|urological agents|mesh-ancestor
102382650|NCT05823363|Bupivacaine|bupivacaine|mesh-list
102382651|NCT05823363|Anesthetics, Local|anesthetics, local|mesh-ancestor
102382652|NCT05823363|Anesthetics|anesthetics|mesh-ancestor
102382653|NCT05823363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102382654|NCT05823363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382655|NCT05823363|Sensory System Agents|sensory system agents|mesh-ancestor
102382656|NCT05823363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102382657|NCT05822076|Ropivacaine|ropivacaine|mesh-list
102382658|NCT05822076|Anesthetics, Local|anesthetics, local|mesh-ancestor
102382659|NCT05822076|Anesthetics|anesthetics|mesh-ancestor
102382660|NCT05822076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102382661|NCT05822076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382662|NCT05822076|Sensory System Agents|sensory system agents|mesh-ancestor
102382663|NCT05822076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102382664|NCT05821543|Metformin|metformin|mesh-list
102382665|NCT05821543|Sibutramine|sibutramine|mesh-list
102382666|NCT05821543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102382667|NCT05821543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382668|NCT05821543|Antidepressive Agents|antidepressive agents|mesh-ancestor
102382669|NCT05821543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102382670|NCT05821543|Appetite Depressants|appetite depressants|mesh-ancestor
102382671|NCT05821543|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102382672|NCT05811949|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102382673|NCT05811949|Dermatologic Agents|dermatologic agents|mesh-ancestor
102382674|NCT05811949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102382675|NCT05811949|Immunologic Factors|immunologic factors|mesh-ancestor
102382676|NCT05811949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382677|NCT05801978|Vaccines|vaccines|mesh-list
102382678|NCT05801978|Immunologic Factors|immunologic factors|mesh-ancestor
102382679|NCT05801978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382680|NCT05800639|Anesthetics|anesthetics|mesh-list
102382681|NCT05800639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102382682|NCT05800639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382683|NCT05776108|Cabotegravir|cabotegravir|mesh-list
102382684|NCT05776108|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102382685|NCT05776108|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102382686|NCT05776108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102382687|NCT05776108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382688|NCT05776108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102382689|NCT05776108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102382690|NCT05776108|Antiviral Agents|antiviral agents|mesh-ancestor
102382691|NCT05776108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102382692|NCT05753618|Lenograstim|lenograstim|mesh-list
102382693|NCT05753618|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102382694|NCT05753618|Immunologic Factors|immunologic factors|mesh-ancestor
102382695|NCT05753618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382696|NCT05752461|Enoxaparin|enoxaparin|mesh-list
102382697|NCT05752461|Enoxaparin sodium|enoxaparin sodium|mesh-list
102382698|NCT05752461|Anticoagulants|anticoagulants|mesh-ancestor
102382699|NCT05752461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102382700|NCT05752461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102382701|NCT05752461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382702|NCT05733546|Psilocybin|psilocybin|mesh-list
102382703|NCT05733546|Hallucinogens|hallucinogens|mesh-ancestor
102382704|NCT05733546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382705|NCT05733546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102382706|NCT05724550|Neostigmine|neostigmine|mesh-list
102382707|NCT05724550|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102382708|NCT05724550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102382709|NCT05724550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382710|NCT05724550|Cholinergic Agents|cholinergic agents|mesh-ancestor
102382711|NCT05724550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102382712|NCT05724550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382713|NCT05724550|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102382714|NCT05724550|Autonomic Agents|autonomic agents|mesh-ancestor
102382715|NCT05724550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102382716|NCT05659329|Gentamicins|gentamicins|mesh-list
102382717|NCT05659329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102382718|NCT05659329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102382719|NCT05659329|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102382720|NCT05659329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102382721|NCT05659329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382722|NCT05653258|Dasatinib|dasatinib|mesh-list
102382723|NCT05653258|Quercetin|quercetin|mesh-list
102382724|NCT05653258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102382725|NCT05653258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102382726|NCT05653258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102382727|NCT05653258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382728|NCT05653258|Antioxidants|antioxidants|mesh-ancestor
102382729|NCT05653258|Protective Agents|protective agents|mesh-ancestor
102382730|NCT05653258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382731|NCT05632627|Cannabidiol|cannabidiol|mesh-list
102382732|NCT05632627|Anticonvulsants|anticonvulsants|mesh-ancestor
102382733|NCT05586802|Anastrozole|anastrozole|mesh-list
102382734|NCT05586802|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102194492|NCT05497232|Pancrelipase|pancrelipase|mesh-list
102382735|NCT05586802|Testosterone|testosterone|mesh-list
102382736|NCT05586802|Androgens|androgens|mesh-ancestor
102382737|NCT05586802|Hormones|hormones|mesh-ancestor
102382738|NCT05586802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102382739|NCT05586802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382740|NCT05586802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102382741|NCT05586802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102382742|NCT05586802|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102382743|NCT05586802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102382744|NCT05586802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102382745|NCT05586802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382746|NCT05586802|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102382747|NCT05586802|Hormone Antagonists|hormone antagonists|mesh-ancestor
102382748|NCT05586802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102382749|NCT05504291|Carboplatin|carboplatin|mesh-list
102382750|NCT05504291|Etoposide|etoposide|mesh-list
102382751|NCT05504291|Vincristine|vincristine|mesh-list
102382752|NCT05504291|Etoposide phosphate|etoposide phosphate|mesh-list
102382753|NCT05504291|Melphalan|melphalan|mesh-list
102382754|NCT05504291|Mechlorethamine|mechlorethamine|mesh-list
102382755|NCT05504291|Podophyllotoxin|podophyllotoxin|mesh-list
102382756|NCT05504291|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102382757|NCT05504291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102382758|NCT05504291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382759|NCT05504291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102382760|NCT05504291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102382761|NCT05504291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102382762|NCT05504291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102382763|NCT05504291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382764|NCT05504291|Tubulin Modulators|tubulin modulators|mesh-ancestor
102382765|NCT05504291|Antimitotic Agents|antimitotic agents|mesh-ancestor
102382766|NCT05504291|Mitosis Modulators|mitosis modulators|mesh-ancestor
102382767|NCT05504291|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102382768|NCT05504291|Alkylating Agents|alkylating agents|mesh-ancestor
102382769|NCT05504291|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102382770|NCT05504291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102382771|NCT05504291|Immunologic Factors|immunologic factors|mesh-ancestor
102382772|NCT05504291|Keratolytic Agents|keratolytic agents|mesh-ancestor
102382773|NCT05504291|Dermatologic Agents|dermatologic agents|mesh-ancestor
102382774|NCT05496036|Pembrolizumab|pembrolizumab|mesh-list
102382775|NCT05496036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102382776|NCT05496036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102382777|NCT05496036|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102382778|NCT05496036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382779|NCT05487859|Acarbose|acarbose|mesh-list
102382780|NCT05487859|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102382781|NCT05487859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102382782|NCT05487859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382783|NCT05487859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102382784|NCT05487859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382785|NCT05359237|Vincristine|vincristine|mesh-list
102382786|NCT05359237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102382787|NCT05359237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102382788|NCT05359237|Tubulin Modulators|tubulin modulators|mesh-ancestor
102382789|NCT05359237|Antimitotic Agents|antimitotic agents|mesh-ancestor
102382790|NCT05359237|Mitosis Modulators|mitosis modulators|mesh-ancestor
102382791|NCT05359237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382792|NCT05320068|Vancomycin|vancomycin|mesh-list
102382793|NCT05320068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102382794|NCT05320068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102382795|NCT05277402|Pembrolizumab|pembrolizumab|mesh-list
102382796|NCT05277402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102382797|NCT05277402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102382798|NCT05277402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102382799|NCT05277402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382800|NCT05223647|Carboplatin|carboplatin|mesh-list
102382801|NCT05223647|Etoposide|etoposide|mesh-list
102382802|NCT05223647|Durvalumab|durvalumab|mesh-list
102382803|NCT05223647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102382804|NCT05223647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102382805|NCT05223647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102382806|NCT05223647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102382807|NCT05223647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102382808|NCT05223647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382809|NCT05223647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102194564|NCT02234869|Interferon beta-1a|interferon beta-1a|mesh-list
102382810|NCT05204160|Pembrolizumab|pembrolizumab|mesh-list
102382811|NCT05204160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102382812|NCT05204160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102382813|NCT05204160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102382814|NCT05204160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382815|NCT05161637|Bupivacaine|bupivacaine|mesh-list
102382816|NCT05161637|Ropivacaine|ropivacaine|mesh-list
102382817|NCT05161637|Anesthetics, Local|anesthetics, local|mesh-ancestor
102382818|NCT05161637|Anesthetics|anesthetics|mesh-ancestor
102382819|NCT05161637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102382820|NCT05161637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382821|NCT05161637|Sensory System Agents|sensory system agents|mesh-ancestor
102382822|NCT05161637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102382823|NCT05136677|Carboplatin|carboplatin|mesh-list
102382824|NCT05136677|Nivolumab|nivolumab|mesh-list
102382825|NCT05136677|Pemetrexed|pemetrexed|mesh-list
102382826|NCT05136677|Ipilimumab|ipilimumab|mesh-list
102382827|NCT05136677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102382828|NCT05136677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102382829|NCT05136677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102382830|NCT05136677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382831|NCT05136677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102382832|NCT05136677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102382833|NCT05136677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102382834|NCT05080322|Fluticasone|fluticasone|mesh-list
102382835|NCT05080322|Xhance|xhance|mesh-list
102382836|NCT05080322|Azelastine|azelastine|mesh-list
102382837|NCT05080322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102382838|NCT05080322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102382839|NCT05080322|Autonomic Agents|autonomic agents|mesh-ancestor
102382840|NCT05080322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102382841|NCT05080322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382842|NCT05080322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102382843|NCT05080322|Respiratory System Agents|respiratory system agents|mesh-ancestor
102382844|NCT05080322|Dermatologic Agents|dermatologic agents|mesh-ancestor
102382845|NCT05080322|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102382846|NCT05080322|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
102382847|NCT05080322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102382848|NCT05080322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382849|NCT05080322|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102382850|NCT05080322|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102382851|NCT05080322|Histamine Antagonists|histamine antagonists|mesh-ancestor
102382852|NCT05080322|Histamine Agents|histamine agents|mesh-ancestor
102382853|NCT05080322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102382854|NCT05071313|Vaccines|vaccines|mesh-list
102382855|NCT05071313|Immunologic Factors|immunologic factors|mesh-ancestor
102382856|NCT05071313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382857|NCT05041257|Maytansine|maytansine|mesh-list
102382858|NCT05041257|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
102382859|NCT05041257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102382860|NCT05041257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102382861|NCT05041257|Tubulin Modulators|tubulin modulators|mesh-ancestor
102382862|NCT05041257|Antimitotic Agents|antimitotic agents|mesh-ancestor
102382863|NCT05041257|Mitosis Modulators|mitosis modulators|mesh-ancestor
102382864|NCT05041257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382865|NCT05041257|Immunoconjugates|immunoconjugates|mesh-ancestor
102382866|NCT05041257|Immunologic Factors|immunologic factors|mesh-ancestor
102382867|NCT05041257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382868|NCT05015439|Cannabidiol|cannabidiol|mesh-list
102382869|NCT05015439|Anticonvulsants|anticonvulsants|mesh-ancestor
102382870|NCT04922333|Risedronic Acid|risedronic acid|mesh-list
102382871|NCT04922333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102382872|NCT04922333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102382873|NCT04922333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382874|NCT04922333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102382875|NCT04922333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382876|NCT04922333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102382877|NCT04911166|Atezolizumab|atezolizumab|mesh-list
102382878|NCT04911166|Interleukin-12|interleukin-12|mesh-list
102382879|NCT04911166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101951479|NCT01191645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102382880|NCT04911166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382881|NCT04911166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102382882|NCT04911166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102382883|NCT04911166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102382884|NCT04911166|Immunologic Factors|immunologic factors|mesh-ancestor
102382885|NCT04911166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382886|NCT04911166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102382887|NCT04911166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102382888|NCT04911166|Growth Substances|growth substances|mesh-ancestor
102382889|NCT04911166|Growth Inhibitors|growth inhibitors|mesh-ancestor
102382890|NCT04903353|Risperidone|risperidone|mesh-list
102382891|NCT04903353|Aripiprazole|aripiprazole|mesh-list
102382892|NCT04903353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102382893|NCT04903353|Serotonin Agents|serotonin agents|mesh-ancestor
102382894|NCT04903353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102382895|NCT04903353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382896|NCT04903353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382897|NCT04903353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102382898|NCT04903353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102382899|NCT04903353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102382900|NCT04903353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102382901|NCT04903353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102382902|NCT04903353|Dopamine Agents|dopamine agents|mesh-ancestor
102382903|NCT04903353|Antidepressive Agents|antidepressive agents|mesh-ancestor
102382904|NCT04903353|Dopamine Agonists|dopamine agonists|mesh-ancestor
102382905|NCT04903353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102382906|NCT04903353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102382907|NCT04903353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102382908|NCT04903353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102382909|NCT04856904|Trifarotene|trifarotene|mesh-list
102382910|NCT04856904|Dermatologic Agents|dermatologic agents|mesh-ancestor
102382911|NCT04831047|Phenylephrine|phenylephrine|mesh-list
102382912|NCT04831047|Oxymetazoline|oxymetazoline|mesh-list
102382913|NCT04831047|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102382914|NCT04831047|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102382915|NCT04831047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102382916|NCT04831047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102382917|NCT04831047|Adrenergic Agents|adrenergic agents|mesh-ancestor
102382918|NCT04831047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102382919|NCT04831047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286543|NCT01941602|Enoxaparin|enoxaparin|mesh-list
102382920|NCT04831047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382921|NCT04831047|Sympathomimetics|sympathomimetics|mesh-ancestor
102382922|NCT04831047|Autonomic Agents|autonomic agents|mesh-ancestor
102382923|NCT04831047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102382924|NCT04831047|Nasal Decongestants|nasal decongestants|mesh-ancestor
102382925|NCT04831047|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102382926|NCT04831047|Respiratory System Agents|respiratory system agents|mesh-ancestor
102382927|NCT04831047|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102382928|NCT04831047|Mydriatics|mydriatics|mesh-ancestor
102382929|NCT04831047|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102382930|NCT04831047|Protective Agents|protective agents|mesh-ancestor
101286694|NCT01942291|Niacin|niacin|mesh-list
102382932|NCT04775680|Immunologic Factors|immunologic factors|mesh-ancestor
102382933|NCT04775680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382934|NCT04767022|Paclitaxel|paclitaxel|mesh-list
102382935|NCT04767022|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102382936|NCT04767022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102382937|NCT04767022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102382938|NCT04767022|Tubulin Modulators|tubulin modulators|mesh-ancestor
102382939|NCT04767022|Antimitotic Agents|antimitotic agents|mesh-ancestor
102382940|NCT04767022|Mitosis Modulators|mitosis modulators|mesh-ancestor
102382941|NCT04767022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382942|NCT04764162|Choline|choline|mesh-list
102382943|NCT04764162|Lipotropic Agents|lipotropic agents|mesh-ancestor
101286887|NCT01943630|Antiviral Agents|antiviral agents|mesh-ancestor
102382944|NCT04764162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102382945|NCT04764162|Antimetabolites|antimetabolites|mesh-ancestor
102382946|NCT04764162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382947|NCT04764162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102382948|NCT04764162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102382949|NCT04764162|Nootropic Agents|nootropic agents|mesh-ancestor
102382950|NCT04747314|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102382951|NCT04747314|Aripiprazole|aripiprazole|mesh-list
102382952|NCT04747314|Mirtazapine|mirtazapine|mesh-list
102382953|NCT04747314|Bupropion|bupropion|mesh-list
102024730|NCT02700412|Cannabidiol|cannabidiol|mesh-list
102382954|NCT04747314|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102382955|NCT04747314|Sertraline|sertraline|mesh-list
102382956|NCT04747314|Antidepressive Agents|antidepressive agents|mesh-list
102382957|NCT04747314|Escitalopram|escitalopram|mesh-list
102382958|NCT04747314|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101951581|NCT01196481|Vasodilator Agents|vasodilator agents|mesh-ancestor
102382959|NCT04747314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102382960|NCT04747314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102382961|NCT04747314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102382962|NCT04747314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102382963|NCT04747314|Serotonin Agents|serotonin agents|mesh-ancestor
101951587|NCT05283057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102382964|NCT04747314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382965|NCT04747314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102382966|NCT04747314|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102382967|NCT04747314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102382968|NCT04747314|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102382969|NCT04747314|Dopamine Agents|dopamine agents|mesh-ancestor
101951591|NCT01193595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102382970|NCT04747314|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101951598|NCT01196559|Vinorelbine|vinorelbine|mesh-list
102382971|NCT04747314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102382972|NCT04747314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102382973|NCT04747314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102382974|NCT04747314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102382975|NCT04747314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102382976|NCT04747314|Dopamine Agonists|dopamine agonists|mesh-ancestor
102382977|NCT04747314|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102382978|NCT04747314|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102382979|NCT04747314|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102382980|NCT04747314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102382981|NCT04747314|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102382982|NCT04747314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102382983|NCT04747314|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102382984|NCT04747314|Analgesics|analgesics|mesh-ancestor
102382985|NCT04747314|Sensory System Agents|sensory system agents|mesh-ancestor
102382986|NCT04747314|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102382987|NCT04747314|Histamine Antagonists|histamine antagonists|mesh-ancestor
102382988|NCT04747314|Histamine Agents|histamine agents|mesh-ancestor
102382989|NCT04747314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102382990|NCT04747314|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102382991|NCT04747314|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102382992|NCT04747314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102382993|NCT04747314|Adrenergic Agents|adrenergic agents|mesh-ancestor
102382994|NCT04747314|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102382995|NCT04700514|Dexmedetomidine|dexmedetomidine|mesh-list
102382996|NCT04700514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101951602|NCT01196559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102382997|NCT04700514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102382998|NCT04700514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102382999|NCT04700514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102383000|NCT04700514|Analgesics|analgesics|mesh-ancestor
102383001|NCT04700514|Sensory System Agents|sensory system agents|mesh-ancestor
102383002|NCT04700514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102383003|NCT04700514|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102383004|NCT04700514|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102383005|NCT04700514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102383006|NCT04700514|Adrenergic Agents|adrenergic agents|mesh-ancestor
102383007|NCT04700514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102383008|NCT04700514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383009|NCT04669145|Ropivacaine|ropivacaine|mesh-list
102383010|NCT04669145|Anesthetics, Local|anesthetics, local|mesh-ancestor
102383011|NCT04669145|Anesthetics|anesthetics|mesh-ancestor
102383012|NCT04669145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102383013|NCT04669145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951641|NCT01189695|Ritonavir|ritonavir|mesh-list
102383014|NCT04669145|Sensory System Agents|sensory system agents|mesh-ancestor
102383015|NCT04669145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102383016|NCT04650074|Lidocaine|lidocaine|mesh-list
102383017|NCT04650074|Ketamine|ketamine|mesh-list
102383018|NCT04650074|Anesthetics, Local|anesthetics, local|mesh-ancestor
102383019|NCT04650074|Anesthetics|anesthetics|mesh-ancestor
102383020|NCT04650074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102383021|NCT04650074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383022|NCT04650074|Sensory System Agents|sensory system agents|mesh-ancestor
102383023|NCT04650074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102383024|NCT04650074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102383025|NCT04650074|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102383026|NCT04650074|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102383027|NCT04650074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102383028|NCT04650074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383029|NCT04650074|Analgesics|analgesics|mesh-ancestor
102383030|NCT04650074|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102383031|NCT04650074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102194794|NCT02233387|Imidazole|imidazole|mesh-list
102383032|NCT04650074|Anesthetics, General|anesthetics, general|mesh-ancestor
102383033|NCT04650074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102383034|NCT04650074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102383035|NCT04650074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102383036|NCT04620304|UB-421|ub-421|mesh-list
102383037|NCT04620304|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102383038|NCT04620304|Antiviral Agents|antiviral agents|mesh-ancestor
102383039|NCT04620304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102383040|NCT04579380|Trastuzumab|trastuzumab|mesh-list
102383041|NCT04579380|Fulvestrant|fulvestrant|mesh-list
102383042|NCT04579380|Tucatinib|tucatinib|mesh-list
101951672|NCT01189773|Narcotics|narcotics|mesh-ancestor
102383043|NCT04579380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101951676|NCT01189929|Gemcitabine|gemcitabine|mesh-list
102383044|NCT04579380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102383045|NCT04579380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102383046|NCT04579380|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102383047|NCT04579380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102383048|NCT04579380|Hormone Antagonists|hormone antagonists|mesh-ancestor
101951677|NCT01189929|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102383049|NCT04579380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102383050|NCT04579380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383051|NCT04579380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102383052|NCT04579380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102383053|NCT04579380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383054|NCT04578886|Guanfacine|guanfacine|mesh-list
102383055|NCT04578886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102383056|NCT04578886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102383057|NCT04578886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102383058|NCT04578886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102383059|NCT04578886|Adrenergic Agents|adrenergic agents|mesh-ancestor
102383060|NCT04578886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102383061|NCT04578886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383062|NCT04578886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383063|NCT04550585|Insulin|insulin|mesh-list
102383064|NCT04550585|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102383065|NCT04550585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102383066|NCT04550585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383067|NCT04545515|Ivacaftor|ivacaftor|mesh-list
102383068|NCT04545515|Elexacaftor|elexacaftor|mesh-list
102383069|NCT04545515|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102383070|NCT04545515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102383071|NCT04545515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383072|NCT04512066|Risperidone|risperidone|mesh-list
102383073|NCT04512066|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102383074|NCT04512066|Serotonin Agents|serotonin agents|mesh-ancestor
102383075|NCT04512066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102383076|NCT04512066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951712|NCT01190241|Sorafenib|sorafenib|mesh-list
102383077|NCT04512066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383078|NCT04512066|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102383079|NCT04512066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102383080|NCT04512066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102383081|NCT04512066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102383082|NCT04512066|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102383083|NCT04512066|Dopamine Agents|dopamine agents|mesh-ancestor
102383084|NCT04449549|Paclitaxel|paclitaxel|mesh-list
102383085|NCT04449549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102383086|NCT04449549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102383087|NCT04449549|Tubulin Modulators|tubulin modulators|mesh-ancestor
102383088|NCT04449549|Antimitotic Agents|antimitotic agents|mesh-ancestor
102383089|NCT04449549|Mitosis Modulators|mitosis modulators|mesh-ancestor
102383090|NCT04449549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383091|NCT04421092|Lidocaine|lidocaine|mesh-list
102383092|NCT04421092|Anesthetics, Local|anesthetics, local|mesh-ancestor
102383093|NCT04421092|Anesthetics|anesthetics|mesh-ancestor
102383094|NCT04421092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102383095|NCT04421092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383096|NCT04421092|Sensory System Agents|sensory system agents|mesh-ancestor
102383097|NCT04421092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101951733|NCT01197261|Analgesics|analgesics|mesh-ancestor
102383098|NCT04421092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102383099|NCT04421092|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102383100|NCT04421092|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102383101|NCT04421092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102383102|NCT04421092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383103|NCT04406727|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102383104|NCT04406727|UB-421|ub-421|mesh-list
102027001|NCT04058210|Elexacaftor|elexacaftor|mesh-list
102383105|NCT04406727|Antiviral Agents|antiviral agents|mesh-ancestor
102383106|NCT04406727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102383107|NCT04364945|Dexmedetomidine|dexmedetomidine|mesh-list
102383108|NCT04364945|Remifentanil|remifentanil|mesh-list
102383109|NCT04364945|Sevoflurane|sevoflurane|mesh-list
102383110|NCT04364945|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102383111|NCT04364945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102383112|NCT04364945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383113|NCT04364945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102383114|NCT04364945|Analgesics|analgesics|mesh-ancestor
102383115|NCT04364945|Sensory System Agents|sensory system agents|mesh-ancestor
102383116|NCT04364945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102383117|NCT04364945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102383118|NCT04364945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102383119|NCT04364945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102383120|NCT04364945|Adrenergic Agents|adrenergic agents|mesh-ancestor
102383121|NCT04364945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102383122|NCT04364945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383123|NCT04364945|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102383124|NCT04364945|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102383125|NCT04364945|Anesthetics, General|anesthetics, general|mesh-ancestor
102383126|NCT04364945|Anesthetics|anesthetics|mesh-ancestor
102383127|NCT04364945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102383128|NCT04364945|Narcotics|narcotics|mesh-ancestor
102383129|NCT04256941|Letrozole|letrozole|mesh-list
102383130|NCT04256941|Fulvestrant|fulvestrant|mesh-list
102383131|NCT04256941|Palbociclib|palbociclib|mesh-list
102383132|NCT04256941|Anastrozole|anastrozole|mesh-list
102383133|NCT04256941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102383134|NCT04256941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102383135|NCT04256941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102383136|NCT04256941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102383137|NCT04256941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383138|NCT04256941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102383139|NCT04256941|Hormone Antagonists|hormone antagonists|mesh-ancestor
102383140|NCT04256941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102383141|NCT04256941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383142|NCT04256941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102383143|NCT04256941|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102383144|NCT04256941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102383145|NCT04235608|Propofol|propofol|mesh-list
102383146|NCT04235608|Sevoflurane|sevoflurane|mesh-list
102383147|NCT04235608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102383148|NCT04235608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102383149|NCT04235608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951780|NCT03850587|Celecoxib|celecoxib|mesh-list
102383150|NCT04235608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102383151|NCT04235608|Anesthetics, General|anesthetics, general|mesh-ancestor
102383152|NCT04235608|Anesthetics|anesthetics|mesh-ancestor
102383153|NCT04235608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102383154|NCT04235608|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102383155|NCT04232306|Bupivacaine|bupivacaine|mesh-list
102383156|NCT04232306|Anesthetics, Local|anesthetics, local|mesh-ancestor
102383157|NCT04232306|Anesthetics|anesthetics|mesh-ancestor
102383158|NCT04232306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102383159|NCT04232306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383160|NCT04232306|Sensory System Agents|sensory system agents|mesh-ancestor
102383161|NCT04232306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102383162|NCT04161027|Pregabalin|pregabalin|mesh-list
102383163|NCT04161027|Analgesics|analgesics|mesh-ancestor
102383164|NCT04161027|Sensory System Agents|sensory system agents|mesh-ancestor
102383165|NCT04161027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102383166|NCT04161027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383167|NCT04161027|Anticonvulsants|anticonvulsants|mesh-ancestor
102383168|NCT04161027|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102383169|NCT04161027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102383170|NCT04161027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027796|NCT03664622|Anesthetics|anesthetics|mesh-ancestor
102383171|NCT04161027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102383172|NCT04161027|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102383173|NCT04161027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102383174|NCT04161027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102383175|NCT04161027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102383176|NCT04025554|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101290189|NCT05027919|Sympatholytics|sympatholytics|mesh-ancestor
102383177|NCT04025554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102383178|NCT04019964|Nivolumab|nivolumab|mesh-list
102383179|NCT04019964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102383180|NCT04019964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102383181|NCT04019964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102383182|NCT04019964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383183|NCT03990571|Avelumab|avelumab|mesh-list
102383184|NCT03990571|Axitinib|axitinib|mesh-list
102383185|NCT03990571|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102383186|NCT03990571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102383187|NCT03990571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102383188|NCT03990571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102383189|NCT03990571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102383190|NCT03990571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383191|NCT03990571|Immunologic Factors|immunologic factors|mesh-ancestor
102383192|NCT03990571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383193|NCT03936777|Fenfluramine|fenfluramine|mesh-list
102383194|NCT03936777|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102383195|NCT03936777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102383196|NCT03936777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102383197|NCT03936777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383198|NCT03936777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102383199|NCT03936777|Serotonin Agents|serotonin agents|mesh-ancestor
102383200|NCT03936777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383201|NCT03927521|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102383202|NCT03927521|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102383203|NCT03927521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383204|NCT03889756|Midazolam|midazolam|mesh-list
102383205|NCT03889756|Ketamine|ketamine|mesh-list
102383206|NCT03889756|Analgesics|analgesics|mesh-ancestor
102383207|NCT03889756|Sensory System Agents|sensory system agents|mesh-ancestor
102383208|NCT03889756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102383209|NCT03889756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383210|NCT03889756|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102383211|NCT03889756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102383212|NCT03889756|Anesthetics, General|anesthetics, general|mesh-ancestor
102383213|NCT03889756|Anesthetics|anesthetics|mesh-ancestor
102383214|NCT03889756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102383215|NCT03889756|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102383216|NCT03889756|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102383217|NCT03889756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102383218|NCT03889756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383219|NCT03889756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102383220|NCT03889756|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102383221|NCT03889756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102383222|NCT03889756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102383223|NCT03889756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102383224|NCT03889756|GABA Modulators|gaba modulators|mesh-ancestor
102383225|NCT03889756|GABA Agents|gaba agents|mesh-ancestor
102383226|NCT03882580|Antineoplastic Agents|antineoplastic agents|mesh-list
102383227|NCT03881696|Omalizumab|omalizumab|mesh-list
102383228|NCT03881696|Immunomodulating Agents|immunomodulating agents|mesh-list
102383229|NCT03881696|Immunologic Factors|immunologic factors|mesh-list
102383230|NCT03881696|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102383231|NCT03881696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383232|NCT03881696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102383233|NCT03881696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102383234|NCT03881696|Respiratory System Agents|respiratory system agents|mesh-ancestor
102383235|NCT03864406|Darunavir|darunavir|mesh-list
102383236|NCT03864406|Cobicistat|cobicistat|mesh-list
102383237|NCT03864406|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
102383238|NCT03864406|Rivaroxaban|rivaroxaban|mesh-list
102383239|NCT03864406|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102383240|NCT03864406|Antithrombins|antithrombins|mesh-ancestor
102383241|NCT03864406|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102383242|NCT03864406|Protease Inhibitors|protease inhibitors|mesh-ancestor
102383243|NCT03864406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102383244|NCT03864406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383245|NCT03864406|Anticoagulants|anticoagulants|mesh-ancestor
102383246|NCT03864406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102383247|NCT03864406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102383248|NCT03864406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102383249|NCT03864406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102383250|NCT03864406|Antiviral Agents|antiviral agents|mesh-ancestor
102383251|NCT03864406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102383252|NCT03864406|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102383253|NCT03864406|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102383254|NCT03845114|Insulin|insulin|mesh-list
102383255|NCT03845114|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102383256|NCT03845114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102383257|NCT03845114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383258|NCT03778502|Rivaroxaban|rivaroxaban|mesh-list
102383259|NCT03778502|Apixaban|apixaban|mesh-list
102383260|NCT03778502|Edoxaban|edoxaban|mesh-list
102383261|NCT03778502|Dabigatran|dabigatran|mesh-list
102383262|NCT03778502|Anticoagulants|anticoagulants|mesh-list
102383263|NCT03778502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102383264|NCT03778502|Antithrombins|antithrombins|mesh-ancestor
102383265|NCT03778502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102383266|NCT03778502|Protease Inhibitors|protease inhibitors|mesh-ancestor
102383267|NCT03778502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102383268|NCT03778502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383269|NCT03775200|Psilocybin|psilocybin|mesh-list
102383270|NCT03775200|Hallucinogens|hallucinogens|mesh-ancestor
102383271|NCT03775200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383272|NCT03775200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102383273|NCT03698669|Analgesics, Opioid|analgesics, opioid|mesh-list
102383274|NCT03698669|Narcotics|narcotics|mesh-ancestor
102383275|NCT03698669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102383276|NCT03698669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383277|NCT03698669|Analgesics|analgesics|mesh-ancestor
102383278|NCT03698669|Sensory System Agents|sensory system agents|mesh-ancestor
102383279|NCT03698669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102383280|NCT03689855|Atezolizumab|atezolizumab|mesh-list
102383281|NCT03689855|Ramucirumab|ramucirumab|mesh-list
102383282|NCT03689855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102383283|NCT03689855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383284|NCT03689855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102383285|NCT03689855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102383286|NCT03635996|Etripamil|etripamil|mesh-list
102383287|NCT03635996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102383288|NCT03635996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102383289|NCT03635996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383290|NCT03635996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102383291|NCT03635996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383292|NCT03613181|Paclitaxel|paclitaxel|mesh-list
102383293|NCT03613181|Capecitabine|capecitabine|mesh-list
102383294|NCT03613181|Methotrexate|methotrexate|mesh-list
102383295|NCT03613181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102383296|NCT03613181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102383297|NCT03613181|Tubulin Modulators|tubulin modulators|mesh-ancestor
102383298|NCT03613181|Antimitotic Agents|antimitotic agents|mesh-ancestor
102383299|NCT03613181|Mitosis Modulators|mitosis modulators|mesh-ancestor
101951933|NCT01198665|Prednisolone|prednisolone|mesh-list
102383300|NCT03613181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383301|NCT03613181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102383302|NCT03613181|Antimetabolites|antimetabolites|mesh-ancestor
102383303|NCT03613181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102383304|NCT03613181|Abortifacient Agents|abortifacient agents|mesh-ancestor
102383305|NCT03613181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102383306|NCT03613181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383307|NCT03613181|Dermatologic Agents|dermatologic agents|mesh-ancestor
102383308|NCT03613181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102383309|NCT03613181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102383310|NCT03613181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102383311|NCT03613181|Immunologic Factors|immunologic factors|mesh-ancestor
102383312|NCT03613181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102383313|NCT03613181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102383314|NCT03468478|Mycophenolic Acid|mycophenolic acid|mesh-list
102383315|NCT03468478|Sirolimus|sirolimus|mesh-list
102383316|NCT03468478|Everolimus|everolimus|mesh-list
102383317|NCT03468478|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102383318|NCT03468478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102383319|NCT03468478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102383320|NCT03468478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951953|NCT01198665|Glucocorticoids|glucocorticoids|mesh-ancestor
102383321|NCT03468478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102028855|NCT03287635|Hormones|hormones|mesh-ancestor
102383322|NCT03468478|Immunologic Factors|immunologic factors|mesh-ancestor
102383323|NCT03468478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383324|NCT03468478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101951957|NCT05030415|Ixekizumab|ixekizumab|mesh-list
102383325|NCT03468478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102383326|NCT03468478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102383327|NCT03468478|Antitubercular Agents|antitubercular agents|mesh-ancestor
102383328|NCT03468478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102383329|NCT03468478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102383330|NCT03468478|Antifungal Agents|antifungal agents|mesh-ancestor
102195074|NCT02233621|Hormones|hormones|mesh-ancestor
102383331|NCT03409367|Emollients|emollients|mesh-list
102383332|NCT03409367|Petrolatum|petrolatum|mesh-list
102383333|NCT03409367|Dermatologic Agents|dermatologic agents|mesh-ancestor
102383334|NCT03168464|Nivolumab|nivolumab|mesh-list
102383335|NCT03168464|Ipilimumab|ipilimumab|mesh-list
102383336|NCT03168464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102383337|NCT03168464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102383338|NCT03168464|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101951970|NCT01566669|Parecoxib|parecoxib|mesh-list
102383339|NCT03168464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383340|NCT03164447|UB-421|ub-421|mesh-list
102383341|NCT03164447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102383342|NCT03164447|Antiviral Agents|antiviral agents|mesh-ancestor
102383343|NCT03164447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102383344|NCT03054792|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
102383345|NCT03054792|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102383346|NCT03054792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383347|NCT02875262|Deferoxamine|deferoxamine|mesh-list
102383348|NCT02875262|Siderophores|siderophores|mesh-ancestor
102383349|NCT02875262|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102383350|NCT02875262|Chelating Agents|chelating agents|mesh-ancestor
102383351|NCT02875262|Sequestering Agents|sequestering agents|mesh-ancestor
102383352|NCT02875262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383353|NCT02818920|Pembrolizumab|pembrolizumab|mesh-list
102383354|NCT02818920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101951977|NCT01566669|Analgesics|analgesics|mesh-ancestor
102383355|NCT02818920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102383356|NCT02818920|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101951987|NCT03841773|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102383357|NCT02818920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383358|NCT02811510|Dronabinol|dronabinol|mesh-list
102383359|NCT02811510|Hallucinogens|hallucinogens|mesh-ancestor
101951991|NCT03841773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102383360|NCT02811510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383361|NCT02811510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102383362|NCT02811510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102029392|NCT01368783|Tenofovir|tenofovir|mesh-list
102383363|NCT02811510|Analgesics|analgesics|mesh-ancestor
102383364|NCT02811510|Sensory System Agents|sensory system agents|mesh-ancestor
102383365|NCT02811510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102383366|NCT02811510|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102383367|NCT02811510|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102383368|NCT02811510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102383369|NCT02811510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383370|NCT02811510|Hormones|hormones|mesh-ancestor
102029598|NCT02369146|UB-421|ub-421|mesh-list
102383371|NCT02811510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102383372|NCT02786264|Dexmedetomidine|dexmedetomidine|mesh-list
102383373|NCT02786264|Propofol|propofol|mesh-list
102383374|NCT02786264|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102383375|NCT02786264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102383376|NCT02786264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383377|NCT02786264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102383378|NCT02786264|Analgesics|analgesics|mesh-ancestor
102383379|NCT02786264|Sensory System Agents|sensory system agents|mesh-ancestor
102383380|NCT02786264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102383381|NCT02786264|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102383382|NCT02786264|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102383383|NCT02786264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102383384|NCT02786264|Adrenergic Agents|adrenergic agents|mesh-ancestor
102383385|NCT02786264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101952019|NCT01201239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102383386|NCT02786264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383387|NCT02786264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102383388|NCT02786264|Anesthetics, General|anesthetics, general|mesh-ancestor
102383389|NCT02786264|Anesthetics|anesthetics|mesh-ancestor
102383390|NCT02778971|Flutemetamol|flutemetamol|mesh-list
102383391|NCT02778971|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102383392|NCT02778971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383393|NCT02444546|Sargramostim|sargramostim|mesh-list
102383394|NCT02444546|Immunologic Factors|immunologic factors|mesh-ancestor
102383395|NCT02444546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383396|NCT01948505|Acetaminophen|acetaminophen|mesh-list
102383397|NCT01948505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102383398|NCT01948505|Analgesics|analgesics|mesh-ancestor
102383399|NCT01948505|Sensory System Agents|sensory system agents|mesh-ancestor
102383400|NCT01948505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102383401|NCT01948505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383402|NCT01948505|Antipyretics|antipyretics|mesh-ancestor
102383403|NCT01916005|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102383404|NCT01916005|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102383405|NCT01916005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195211|NCT05491928|Tempol|tempol|mesh-list
102383406|NCT01160926|Cediranib|cediranib|mesh-list
102383407|NCT01160926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102383408|NCT01160926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102383409|NCT01160926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101952041|NCT01203735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102383410|NCT01160926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383411|NCT01126957|Fentanyl|fentanyl|mesh-list
102383412|NCT01126957|Ketamine|ketamine|mesh-list
102383413|NCT01126957|Propofol|propofol|mesh-list
102383414|NCT01126957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102383415|NCT01126957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102383416|NCT01126957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383417|NCT01126957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102383418|NCT01126957|Anesthetics, General|anesthetics, general|mesh-ancestor
102383419|NCT01126957|Anesthetics|anesthetics|mesh-ancestor
102383420|NCT01126957|Analgesics|analgesics|mesh-ancestor
102383421|NCT01126957|Sensory System Agents|sensory system agents|mesh-ancestor
102383422|NCT01126957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102383423|NCT01126957|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102383424|NCT01126957|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102383425|NCT01126957|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102383426|NCT01126957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102383427|NCT01126957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383428|NCT01126957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102383429|NCT01126957|Narcotics|narcotics|mesh-ancestor
102383430|NCT01126957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102383431|NCT00811122|Corticosterone|corticosterone|mesh-list
102383432|NCT00811122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102383433|NCT00651885|Treprostinil|treprostinil|mesh-list
102383434|NCT00651885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102383435|NCT01457001|Vitamin D|vitamin d|mesh-list
102383436|NCT01457001|Vitamins|vitamins|mesh-ancestor
102383437|NCT01457001|Micronutrients|micronutrients|mesh-ancestor
102383438|NCT01457001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383439|NCT01457001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102383440|NCT02846883|Plasma-lyte 148|plasma-lyte 148|mesh-list
102383441|NCT02846883|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102383442|NCT02846883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102383443|NCT01457469|Nicotine|nicotine|mesh-list
102383444|NCT01457469|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102383445|NCT01457469|Autonomic Agents|autonomic agents|mesh-ancestor
102383446|NCT01457469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102383447|NCT01457469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383448|NCT01457469|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102383449|NCT01457469|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102383450|NCT01457469|Cholinergic Agents|cholinergic agents|mesh-ancestor
102383451|NCT01457469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101952080|NCT01201551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102383452|NCT01457469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383453|NCT01457547|Edetic Acid|edetic acid|mesh-list
102383454|NCT01457547|Vaccines|vaccines|mesh-list
102383455|NCT01457547|Pentetic Acid|pentetic acid|mesh-list
102383456|NCT01457547|Immunologic Factors|immunologic factors|mesh-ancestor
102383457|NCT01457547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383458|NCT01457547|Antidotes|antidotes|mesh-ancestor
102383459|NCT01457547|Protective Agents|protective agents|mesh-ancestor
102383460|NCT01457547|Chelating Agents|chelating agents|mesh-ancestor
102383461|NCT01457547|Sequestering Agents|sequestering agents|mesh-ancestor
102383462|NCT01457547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383463|NCT01457547|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102383464|NCT01457547|Anticoagulants|anticoagulants|mesh-ancestor
102383465|NCT01457547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102383466|NCT01457859|Triclosan|triclosan|mesh-list
102383467|NCT01457859|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102383468|NCT01457859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102383469|NCT01457859|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102383470|NCT01457859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102383471|NCT01457859|Antimetabolites|antimetabolites|mesh-ancestor
102383472|NCT01457859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383473|NCT01457859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102383474|NCT01890993|Liraglutide|liraglutide|mesh-list
102383475|NCT01890993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102383476|NCT01890993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383477|NCT01890993|Incretins|incretins|mesh-ancestor
102383478|NCT01890993|Hormones|hormones|mesh-ancestor
102383479|NCT01890993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102383480|NCT01457937|Interferons|interferons|mesh-list
102383481|NCT01457937|Ribavirin|ribavirin|mesh-list
102383482|NCT01457937|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102383483|NCT01457937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102383484|NCT01457937|Antiviral Agents|antiviral agents|mesh-ancestor
102383485|NCT01457937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102383486|NCT01457937|Antimetabolites|antimetabolites|mesh-ancestor
102383487|NCT01457937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383488|NCT04272255|Scopolamine|scopolamine|mesh-list
102383489|NCT04272255|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102383490|NCT04272255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102383491|NCT04272255|Antiemetics|antiemetics|mesh-ancestor
102383492|NCT04272255|Autonomic Agents|autonomic agents|mesh-ancestor
102383493|NCT04272255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102383494|NCT04272255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383495|NCT04272255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102383496|NCT04272255|Mydriatics|mydriatics|mesh-ancestor
102383497|NCT04272255|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102383498|NCT04272255|Cholinergic Agents|cholinergic agents|mesh-ancestor
102383499|NCT04272255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102383500|NCT04272255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383501|NCT04272255|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102383502|NCT04272255|Parasympatholytics|parasympatholytics|mesh-ancestor
102383504|NCT01458015|Tapentadol|tapentadol|mesh-list
102383505|NCT01458015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102383506|NCT01458015|Narcotics|narcotics|mesh-ancestor
102383507|NCT01458015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102383508|NCT01458015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383509|NCT01458015|Analgesics|analgesics|mesh-ancestor
102383510|NCT01458015|Sensory System Agents|sensory system agents|mesh-ancestor
102383511|NCT01458015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102383512|NCT01458015|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102383513|NCT01458015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102383514|NCT01458015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102383515|NCT01458015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383516|NCT01458015|Adrenergic Agents|adrenergic agents|mesh-ancestor
102383517|NCT01458015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102383518|NCT05026125|Remifentanil|remifentanil|mesh-list
102383519|NCT05026125|Anesthetics|anesthetics|mesh-list
102383520|NCT05026125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102383521|NCT05026125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383522|NCT05026125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102383523|NCT05026125|Narcotics|narcotics|mesh-ancestor
102383524|NCT05026125|Analgesics|analgesics|mesh-ancestor
102383525|NCT05026125|Sensory System Agents|sensory system agents|mesh-ancestor
102383526|NCT05026125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102383527|NCT01891227|Capecitabine|capecitabine|mesh-list
102383528|NCT01891227|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101952131|NCT03755804|Hormones|hormones|mesh-ancestor
102383529|NCT01891227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102383530|NCT01891227|Antimetabolites|antimetabolites|mesh-ancestor
102383531|NCT01891227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383532|NCT01891227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102383533|NCT01891227|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102383534|NCT01891227|Alkylating Agents|alkylating agents|mesh-ancestor
102383535|NCT04391439|Methylprednisolone|methylprednisolone|mesh-list
102383536|NCT04391439|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102383537|NCT04391439|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102383538|NCT04391439|Prednisolone|prednisolone|mesh-list
102383539|NCT04391439|Prednisolone acetate|prednisolone acetate|mesh-list
102383540|NCT04391439|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102383541|NCT04391439|Prednisolone phosphate|prednisolone phosphate|mesh-list
102383542|NCT04391439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102383543|NCT04391439|Antiemetics|antiemetics|mesh-ancestor
102383544|NCT04391439|Autonomic Agents|autonomic agents|mesh-ancestor
102383545|NCT04391439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101952174|NCT03297398|Antioxidants|antioxidants|mesh-ancestor
102383546|NCT04391439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383547|NCT04391439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102383548|NCT04391439|Glucocorticoids|glucocorticoids|mesh-ancestor
102383549|NCT04391439|Hormones|hormones|mesh-ancestor
102383550|NCT04391439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102383551|NCT04391439|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102383552|NCT04391439|Protective Agents|protective agents|mesh-ancestor
102383553|NCT04391439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102383554|NCT04391439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102383555|NCT02884245|Estrogens|estrogens|mesh-list
102383556|NCT02884245|Hormones|hormones|mesh-ancestor
102195296|NCT02264119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102383557|NCT02884245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102383558|NCT02884245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383559|NCT01891461|Hemostatics|hemostatics|mesh-list
102383560|NCT01891461|Coagulants|coagulants|mesh-ancestor
102383561|NCT04272567|Norepinephrine|norepinephrine|mesh-list
102383562|NCT04272567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102383563|NCT04272567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102383564|NCT04272567|Adrenergic Agents|adrenergic agents|mesh-ancestor
102383565|NCT04272567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102383566|NCT04272567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383567|NCT04272567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383568|NCT04272567|Sympathomimetics|sympathomimetics|mesh-ancestor
102383569|NCT04272567|Autonomic Agents|autonomic agents|mesh-ancestor
102383570|NCT04272567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102383571|NCT04272567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102383572|NCT01891851|Ritonavir|ritonavir|mesh-list
102383573|NCT01891851|Simeprevir|simeprevir|mesh-list
102383574|NCT01891851|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102383575|NCT01891851|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102383576|NCT01891851|Protease Inhibitors|protease inhibitors|mesh-ancestor
102383577|NCT01891851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102383578|NCT01891851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383579|NCT01891851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102383580|NCT01891851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102383581|NCT01891851|Antiviral Agents|antiviral agents|mesh-ancestor
102383582|NCT01891851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102383583|NCT01891851|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102383584|NCT01891851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102383585|NCT01459419|Antibodies|antibodies|mesh-list
102383586|NCT01459419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102383587|NCT01459419|Immunologic Factors|immunologic factors|mesh-ancestor
102383588|NCT01459419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383589|NCT01892241|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102383590|NCT01892241|Entecavir|entecavir|mesh-list
102383591|NCT01892241|Antiviral Agents|antiviral agents|mesh-ancestor
102383592|NCT01892241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102383593|NCT04391127|Hydroxychloroquine|hydroxychloroquine|mesh-list
102383594|NCT04391127|Ivermectin|ivermectin|mesh-list
102383595|NCT04391127|Antimalarials|antimalarials|mesh-ancestor
102383596|NCT04391127|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102383597|NCT04391127|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102383598|NCT04391127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102383599|NCT04391127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102383600|NCT04391127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383601|NCT04391127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102383602|NCT05024253|Tranexamic Acid|tranexamic acid|mesh-list
102383603|NCT05024253|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102383604|NCT05024253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102383605|NCT05024253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383606|NCT05024253|Hemostatics|hemostatics|mesh-ancestor
102383607|NCT05024253|Coagulants|coagulants|mesh-ancestor
102383608|NCT01459809|Metformin|metformin|mesh-list
102383609|NCT01459809|Glimepiride|glimepiride|mesh-list
102383610|NCT01459809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102383611|NCT01459809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383612|NCT01459809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102383613|NCT01459809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102383614|NCT01459809|Immunologic Factors|immunologic factors|mesh-ancestor
102383615|NCT01459887|Prednisone|prednisone|mesh-list
102383616|NCT01459887|Cyclophosphamide|cyclophosphamide|mesh-list
102383617|NCT01459887|Doxorubicin|doxorubicin|mesh-list
102383618|NCT01459887|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102383619|NCT01459887|Vincristine|vincristine|mesh-list
102383620|NCT01459887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102383621|NCT01459887|Immunologic Factors|immunologic factors|mesh-ancestor
102383622|NCT01459887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383623|NCT01459887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102383624|NCT01459887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102383625|NCT01459887|Alkylating Agents|alkylating agents|mesh-ancestor
102383626|NCT01459887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383627|NCT01459887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102383628|NCT01459887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102383629|NCT01459887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102383630|NCT01459887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102383631|NCT01459887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102383632|NCT01459887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102383633|NCT01459887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102383634|NCT01459887|Glucocorticoids|glucocorticoids|mesh-ancestor
102383635|NCT01459887|Hormones|hormones|mesh-ancestor
102383636|NCT01459887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102383637|NCT01459887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102383638|NCT01459887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102383639|NCT01459887|Tubulin Modulators|tubulin modulators|mesh-ancestor
102383640|NCT01459887|Antimitotic Agents|antimitotic agents|mesh-ancestor
102383641|NCT01459887|Mitosis Modulators|mitosis modulators|mesh-ancestor
102383642|NCT02876211|Vitamin D|vitamin d|mesh-list
102383643|NCT02876211|Vitamins|vitamins|mesh-ancestor
102383644|NCT02876211|Micronutrients|micronutrients|mesh-ancestor
102383645|NCT02876211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383646|NCT02876211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102383647|NCT02682147|Sildenafil Citrate|sildenafil citrate|mesh-list
102383648|NCT02682147|Vasodilator Agents|vasodilator agents|mesh-ancestor
102383649|NCT02682147|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102383650|NCT02682147|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102383651|NCT02682147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102383652|NCT02682147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383653|NCT02682147|Urological Agents|urological agents|mesh-ancestor
102383654|NCT01892787|Formoterol Fumarate|formoterol fumarate|mesh-list
102383655|NCT01892787|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102383656|NCT01892787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102383657|NCT01892787|Autonomic Agents|autonomic agents|mesh-ancestor
102383658|NCT01892787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102383659|NCT01892787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383660|NCT01892787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102383661|NCT01892787|Respiratory System Agents|respiratory system agents|mesh-ancestor
102383662|NCT01892787|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102383663|NCT01892787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102383664|NCT01892787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102383665|NCT01892787|Adrenergic Agents|adrenergic agents|mesh-ancestor
102383666|NCT01892787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102383667|NCT01892787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383668|NCT01893723|Remifentanil|remifentanil|mesh-list
102383669|NCT01893723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102383670|NCT01893723|Narcotics|narcotics|mesh-ancestor
102383671|NCT01893723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102383672|NCT01893723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383673|NCT01893723|Analgesics|analgesics|mesh-ancestor
102383674|NCT01893723|Sensory System Agents|sensory system agents|mesh-ancestor
102383675|NCT01893723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102383676|NCT01453959|Fludrocortisone|fludrocortisone|mesh-list
102383677|NCT01453959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102383678|NCT02669901|Naloxone|naloxone|mesh-list
102383679|NCT02669901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102383680|NCT02669901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383681|NCT02669901|Sensory System Agents|sensory system agents|mesh-ancestor
102383682|NCT02669901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102383683|NCT01893099|Sorafenib|sorafenib|mesh-list
102383684|NCT01893099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102383685|NCT01893099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102383686|NCT01893099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102383687|NCT01893099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383688|NCT02327403|Abatacept|abatacept|mesh-list
102383689|NCT02327403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102383690|NCT02327403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383691|NCT02327403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102383692|NCT02327403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101952283|NCT01204437|Alkylating Agents|alkylating agents|mesh-ancestor
102383693|NCT02327403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102383694|NCT02327403|Immunologic Factors|immunologic factors|mesh-ancestor
102383695|NCT02327403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383696|NCT02327403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102383697|NCT01893177|Vaccines|vaccines|mesh-list
102383698|NCT01893177|Immunologic Factors|immunologic factors|mesh-ancestor
102383699|NCT01893177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383700|NCT05740150|Taurolidine|taurolidine|mesh-list
102383701|NCT05740150|Heparin|heparin|mesh-list
102383702|NCT05740150|Calcium heparin|calcium heparin|mesh-list
102383703|NCT05740150|Anticoagulants|anticoagulants|mesh-ancestor
102383704|NCT05740150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383705|NCT05740150|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102383706|NCT05740150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102383707|NCT05740150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102383708|NCT05740150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102383709|NCT05740150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102383710|NCT05734612|Colchicine|colchicine|mesh-list
102383711|NCT05734612|Gout Suppressants|gout suppressants|mesh-ancestor
102383712|NCT05734612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102383713|NCT05734612|Tubulin Modulators|tubulin modulators|mesh-ancestor
102383714|NCT05734612|Antimitotic Agents|antimitotic agents|mesh-ancestor
102383715|NCT05734612|Mitosis Modulators|mitosis modulators|mesh-ancestor
102383716|NCT05734612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383717|NCT05734612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102383718|NCT02349867|Gemcitabine|gemcitabine|mesh-list
102383719|NCT02349867|Sorafenib|sorafenib|mesh-list
102383720|NCT02349867|Vorinostat|vorinostat|mesh-list
102383721|NCT02349867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102383722|NCT02349867|Antimetabolites|antimetabolites|mesh-ancestor
102383723|NCT02349867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383724|NCT02349867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102383725|NCT02349867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102383726|NCT02349867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102383727|NCT02349867|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102383728|NCT02630043|Oxaliplatin|oxaliplatin|mesh-list
102383729|NCT02630043|Tolcapone|tolcapone|mesh-list
102383730|NCT02630043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102383731|NCT02630043|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102383732|NCT02630043|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102383733|NCT02630043|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102383734|NCT02630043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102383735|NCT02630043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383736|NCT02629419|Amphotericin B|amphotericin b|mesh-list
102383737|NCT02629419|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102383738|NCT02629419|Amebicides|amebicides|mesh-ancestor
102383739|NCT02629419|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102383740|NCT02629419|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102383741|NCT02629419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102383742|NCT02629419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102383743|NCT02629419|Antifungal Agents|antifungal agents|mesh-ancestor
102383744|NCT02334735|Vaccines|vaccines|mesh-list
102383745|NCT02334735|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
102383746|NCT02334735|Poly ICLC|poly iclc|mesh-list
102383747|NCT02334735|Immunologic Factors|immunologic factors|mesh-ancestor
102383748|NCT02334735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383749|NCT02334735|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102383750|NCT02334735|Interferon Inducers|interferon inducers|mesh-ancestor
102383751|NCT02329600|Triamcinolone|triamcinolone|mesh-list
102383752|NCT02329600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102383753|NCT02329600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102383754|NCT02329600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102383755|NCT02329600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102383756|NCT02329600|Glucocorticoids|glucocorticoids|mesh-ancestor
102383757|NCT02329600|Hormones|hormones|mesh-ancestor
102383758|NCT02329600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102383759|NCT02329600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383760|NCT02329600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102383761|NCT02329600|Immunologic Factors|immunologic factors|mesh-ancestor
102383762|NCT02329600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101952394|NCT01298505|Terfenadine|terfenadine|mesh-list
102383763|NCT02329600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383764|NCT02620761|Fenoldopam|fenoldopam|mesh-list
102383765|NCT02620761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102383766|NCT02620761|Vasodilator Agents|vasodilator agents|mesh-ancestor
102031015|NCT02343718|Sirolimus|sirolimus|mesh-list
102383767|NCT02620761|Dopamine Agonists|dopamine agonists|mesh-ancestor
102383768|NCT02620761|Dopamine Agents|dopamine agents|mesh-ancestor
101952403|NCT01204593|Insulin|insulin|mesh-list
102383769|NCT02620761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102383770|NCT02620761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383771|NCT02620761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383772|NCT02615691|Factor VIII|factor viii|mesh-list
102383773|NCT02615691|BAX 855|bax 855|mesh-list
102383774|NCT02615691|Coagulants|coagulants|mesh-ancestor
102383775|NCT04758273|Vaccines|vaccines|mesh-list
102383776|NCT04758273|Immunologic Factors|immunologic factors|mesh-ancestor
102383777|NCT04758273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383778|NCT01729871|Vitamin K|vitamin k|mesh-list
102383779|NCT01729871|Rivaroxaban|rivaroxaban|mesh-list
102383780|NCT01729871|Vitamins|vitamins|mesh-ancestor
102383781|NCT01729871|Micronutrients|micronutrients|mesh-ancestor
102383782|NCT01729871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383783|NCT01729871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102383784|NCT01729871|Antithrombins|antithrombins|mesh-ancestor
102383785|NCT01729871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102383786|NCT01729871|Protease Inhibitors|protease inhibitors|mesh-ancestor
102383787|NCT01729871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102383788|NCT01729871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383789|NCT01729871|Anticoagulants|anticoagulants|mesh-ancestor
102383790|NCT01729871|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102383791|NCT01729871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102383792|NCT01729871|Hemostatics|hemostatics|mesh-ancestor
102383793|NCT01729871|Coagulants|coagulants|mesh-ancestor
102383794|NCT02611323|Rituximab|rituximab|mesh-list
102383795|NCT02611323|Obinutuzumab|obinutuzumab|mesh-list
102383796|NCT02611323|Venetoclax|venetoclax|mesh-list
102383797|NCT02611323|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
102383798|NCT02611323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102383799|NCT02611323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102383800|NCT02611323|Immunologic Factors|immunologic factors|mesh-ancestor
102383801|NCT02611323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383802|NCT02611323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102383803|NCT02611323|Immunoconjugates|immunoconjugates|mesh-ancestor
102383804|NCT02608359|Abiraterone Acetate|abiraterone acetate|mesh-list
102383805|NCT02608359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102383806|NCT02608359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102383807|NCT02608359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102383808|NCT02608359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383809|NCT02608359|Hormone Antagonists|hormone antagonists|mesh-ancestor
102383810|NCT02608359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101952432|NCT05281419|Hormones|hormones|mesh-ancestor
102383811|NCT02608359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383812|NCT02608359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102383813|NCT01729559|Heparin|heparin|mesh-list
102383814|NCT01729559|Enoxaparin|enoxaparin|mesh-list
102383815|NCT01729559|Calcium heparin|calcium heparin|mesh-list
102383816|NCT01729559|Enoxaparin sodium|enoxaparin sodium|mesh-list
102383817|NCT01729559|Anticoagulants|anticoagulants|mesh-ancestor
102383818|NCT01729559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102383819|NCT01729559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102383820|NCT01729559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383821|NCT01926496|Imiquimod|imiquimod|mesh-list
102383822|NCT01926496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102383823|NCT01926496|Immunologic Factors|immunologic factors|mesh-ancestor
102383824|NCT01926496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383825|NCT01926496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101952455|NCT02722941|Panobinostat|panobinostat|mesh-list
102383826|NCT01926496|Interferon Inducers|interferon inducers|mesh-ancestor
102383827|NCT01728779|Nelfinavir|nelfinavir|mesh-list
102383828|NCT01728779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102383829|NCT01728779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102383830|NCT01728779|Protease Inhibitors|protease inhibitors|mesh-ancestor
102383831|NCT01728779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102383832|NCT01728779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383833|NCT01728779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102383834|NCT01728779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102383835|NCT01728779|Antiviral Agents|antiviral agents|mesh-ancestor
102383836|NCT01728779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102383837|NCT01927120|Sirolimus|sirolimus|mesh-list
102383838|NCT01927120|Aldesleukin|aldesleukin|mesh-list
102383839|NCT01927120|Tacrolimus|tacrolimus|mesh-list
102383840|NCT01927120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102383841|NCT01927120|Immunologic Factors|immunologic factors|mesh-ancestor
102032032|NCT04407988|Hormone Antagonists|hormone antagonists|mesh-ancestor
102383842|NCT01927120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383843|NCT01927120|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102383844|NCT01927120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102383845|NCT01927120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383846|NCT01927120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102383847|NCT01927120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102383848|NCT01927120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102383849|NCT01927120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102383850|NCT01927120|Antifungal Agents|antifungal agents|mesh-ancestor
102032184|NCT03719261|Eusol|eusol|mesh-list
102383851|NCT01927120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102383852|NCT01927120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102383853|NCT01927120|Antiviral Agents|antiviral agents|mesh-ancestor
102383854|NCT02600949|Pembrolizumab|pembrolizumab|mesh-list
102383855|NCT02600949|Imiquimod|imiquimod|mesh-list
102383856|NCT02600949|Vaccines|vaccines|mesh-list
102383857|NCT02600949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102383858|NCT02600949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102383859|NCT02600949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102383860|NCT02600949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952486|NCT01205139|Rilpivirine|rilpivirine|mesh-list
102383861|NCT02600949|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102195594|NCT01175785|Cyclophosphamide|cyclophosphamide|mesh-list
102383862|NCT02600949|Immunologic Factors|immunologic factors|mesh-ancestor
102383863|NCT02600949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383864|NCT02600949|Interferon Inducers|interferon inducers|mesh-ancestor
102383865|NCT01728623|Lenvatinib|lenvatinib|mesh-list
102383866|NCT01728623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102383867|NCT01728623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101736027|NCT00716859|Timolol|timolol|mesh-list
102383868|NCT01728623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102383869|NCT01728623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383870|NCT02573337|Lidocaine|lidocaine|mesh-list
102383871|NCT02573337|Anesthetics, Local|anesthetics, local|mesh-ancestor
102383872|NCT02573337|Anesthetics|anesthetics|mesh-ancestor
102383873|NCT02573337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102383874|NCT02573337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383875|NCT02573337|Sensory System Agents|sensory system agents|mesh-ancestor
102383876|NCT02573337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102383877|NCT02573337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102383878|NCT02573337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102383879|NCT02573337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102383880|NCT02573337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102383881|NCT02573337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383882|NCT01728077|Brivaracetam|brivaracetam|mesh-list
102383883|NCT01728077|Anticonvulsants|anticonvulsants|mesh-ancestor
102383884|NCT01606007|Metformin|metformin|mesh-list
102383885|NCT01606007|Dapagliflozin|dapagliflozin|mesh-list
102383886|NCT01606007|Saxagliptin|saxagliptin|mesh-list
101736245|NCT04107194|Amoxicillin|amoxicillin|mesh-list
102383887|NCT01606007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102383888|NCT01606007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383889|NCT01606007|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102383890|NCT01606007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383891|NCT01606007|Incretins|incretins|mesh-ancestor
102383892|NCT01606007|Hormones|hormones|mesh-ancestor
101952507|NCT01205217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102383893|NCT01606007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102383894|NCT01606007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102383895|NCT01606007|Protease Inhibitors|protease inhibitors|mesh-ancestor
102383896|NCT01606007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102383897|NCT02304783|Acetaminophen|acetaminophen|mesh-list
102383898|NCT02304783|Piroxicam|piroxicam|mesh-list
102383899|NCT02304783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102383900|NCT02304783|Analgesics|analgesics|mesh-ancestor
102383901|NCT02304783|Sensory System Agents|sensory system agents|mesh-ancestor
102383902|NCT02304783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102383903|NCT02304783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383904|NCT02304783|Antipyretics|antipyretics|mesh-ancestor
101952521|NCT01203267|Carboplatin|carboplatin|mesh-list
102383905|NCT02304783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102383906|NCT02304783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102383907|NCT02304783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102383908|NCT02304783|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102383909|NCT02304783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102383910|NCT02304783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383911|NCT02553447|Vitamin D|vitamin d|mesh-list
102383912|NCT02553447|Cholecalciferol|cholecalciferol|mesh-list
102383913|NCT02553447|Vitamins|vitamins|mesh-ancestor
102383914|NCT02553447|Micronutrients|micronutrients|mesh-ancestor
102383915|NCT02553447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383916|NCT02553447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102383917|NCT02553447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102383918|NCT01928290|Leucovorin|leucovorin|mesh-list
102383919|NCT01928290|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
102383920|NCT01928290|Tetrahydrofolates|tetrahydrofolates|mesh-list
102383921|NCT01928290|Fluorouracil|fluorouracil|mesh-list
102383922|NCT01928290|Oxaliplatin|oxaliplatin|mesh-list
102383923|NCT01928290|Trastuzumab|trastuzumab|mesh-list
101952541|NCT01299597|Atorvastatin|atorvastatin|mesh-list
102383924|NCT01928290|Irinotecan|irinotecan|mesh-list
102383925|NCT01928290|Levoleucovorin|levoleucovorin|mesh-list
102383926|NCT01928290|Antimetabolites|antimetabolites|mesh-ancestor
102383927|NCT01928290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102383928|NCT01928290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102383929|NCT01928290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102383930|NCT01928290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102383931|NCT01928290|Immunologic Factors|immunologic factors|mesh-ancestor
102383932|NCT01928290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102383933|NCT01928290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102383934|NCT01928290|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102383935|NCT01928290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102383936|NCT01928290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102383937|NCT01928290|Antidotes|antidotes|mesh-ancestor
102383938|NCT01928290|Protective Agents|protective agents|mesh-ancestor
102383939|NCT01928290|Vitamin B Complex|vitamin b complex|mesh-ancestor
102383940|NCT01928290|Vitamins|vitamins|mesh-ancestor
102383941|NCT01928290|Micronutrients|micronutrients|mesh-ancestor
102384011|NCT02757885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101952555|NCT03840057|Azithromycin|azithromycin|mesh-list
102384012|NCT02757885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102384013|NCT02757885|Alkylating Agents|alkylating agents|mesh-ancestor
102384014|NCT02757885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384015|NCT02757885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384016|NCT02757885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102384017|NCT02757885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102384018|NCT02757885|Antimetabolites|antimetabolites|mesh-ancestor
102384019|NCT02757885|Antisickling Agents|antisickling agents|mesh-ancestor
102384020|NCT02757885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101574064|NCT05657496|Immunologic Factors|immunologic factors|mesh-ancestor
102384021|NCT02757885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102384022|NCT01928446|Lithium Carbonate|lithium carbonate|mesh-list
102384023|NCT01928446|Antidepressive Agents|antidepressive agents|mesh-ancestor
102384024|NCT01928446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102384025|NCT01928446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101830332|NCT05327010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102384026|NCT01928446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384027|NCT01928446|Antimanic Agents|antimanic agents|mesh-ancestor
102384028|NCT01928446|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102384029|NCT01928446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102384030|NCT01928446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384031|NCT02983383|Anesthetics|anesthetics|mesh-list
102384032|NCT02983383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101574278|NCT01723774|Goserelin|goserelin|mesh-list
102384033|NCT02983383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384034|NCT02748369|Glucagon|glucagon|mesh-list
102384035|NCT02748369|Hormones|hormones|mesh-list
102384036|NCT02748369|Somatostatin|somatostatin|mesh-list
101574348|NCT00602524|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102384037|NCT02748369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102384038|NCT02748369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574416|NCT00604396|Insulin Detemir|insulin detemir|mesh-list
102384039|NCT02748369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102384040|NCT01928680|Capecitabine|capecitabine|mesh-list
102384041|NCT01928680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384042|NCT01928680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102384043|NCT01928680|Antimetabolites|antimetabolites|mesh-ancestor
102384044|NCT01928680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384045|NCT01929460|Ciprofloxacin|ciprofloxacin|mesh-list
102384046|NCT01929460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102384047|NCT01929460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102384048|NCT01929460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102384049|NCT01929460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102384050|NCT01929460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102384051|NCT01929460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384052|NCT01929460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384053|NCT01929460|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102384054|NCT01929460|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102384055|NCT02248701|Methyltestosterone|methyltestosterone|mesh-list
102384056|NCT02248701|Finasteride|finasteride|mesh-list
102384057|NCT02248701|Testosterone|testosterone|mesh-list
101574781|NCT04301583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102384058|NCT02248701|Testosterone undecanoate|testosterone undecanoate|mesh-list
102384059|NCT02248701|Testosterone enanthate|testosterone enanthate|mesh-list
102384060|NCT02248701|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102384061|NCT02248701|Androgens|androgens|mesh-ancestor
102384062|NCT02248701|Hormones|hormones|mesh-ancestor
101574854|NCT02760823|Thioctic Acid|thioctic acid|mesh-list
102384063|NCT02248701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102384064|NCT02248701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384065|NCT02248701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102384066|NCT02248701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384067|NCT02248701|Anabolic Agents|anabolic agents|mesh-ancestor
102384068|NCT02248701|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102384069|NCT02248701|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102384070|NCT02248701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102384071|NCT02248701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384072|NCT02248701|Hormone Antagonists|hormone antagonists|mesh-ancestor
102384073|NCT02248701|Urological Agents|urological agents|mesh-ancestor
102384074|NCT02283814|Topiramate|topiramate|mesh-list
102384075|NCT02283814|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102384076|NCT02283814|Anticonvulsants|anticonvulsants|mesh-ancestor
102384077|NCT02283814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102384078|NCT02283814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384079|NCT02283814|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102384080|NCT02283814|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102384081|NCT02283814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102384082|NCT02283814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384083|NCT05739682|Anti-Infective Agents|anti-infective agents|mesh-list
101830642|NCT04918147|Methylprednisolone|methylprednisolone|mesh-list
102384084|NCT05739682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102384085|NCT05739682|Epinephrine|epinephrine|mesh-list
102384086|NCT05739682|Anesthetics|anesthetics|mesh-list
102384087|NCT05739682|Carticaine|carticaine|mesh-list
102384088|NCT05739682|Anesthetics, Local|anesthetics, local|mesh-list
102384089|NCT05739682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102384090|NCT05739682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384091|NCT05739682|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102384092|NCT05739682|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102384093|NCT05739682|Adrenergic Agents|adrenergic agents|mesh-ancestor
102384094|NCT05739682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102384095|NCT05739682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384096|NCT05739682|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102384097|NCT05739682|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102384098|NCT05739682|Autonomic Agents|autonomic agents|mesh-ancestor
102384099|NCT05739682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102384100|NCT05739682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102384101|NCT05739682|Respiratory System Agents|respiratory system agents|mesh-ancestor
102384102|NCT05739682|Mydriatics|mydriatics|mesh-ancestor
102384103|NCT05739682|Sympathomimetics|sympathomimetics|mesh-ancestor
102384104|NCT05739682|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102384105|NCT05739682|Sensory System Agents|sensory system agents|mesh-ancestor
102384106|NCT02462421|Canagliflozin|canagliflozin|mesh-list
102384107|NCT02462421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102384108|NCT02462421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384109|NCT02462421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101831092|NCT04145440|Felzartamab|felzartamab|mesh-list
102384110|NCT02462421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384111|NCT02727387|Cyclophosphamide|cyclophosphamide|mesh-list
102384112|NCT02727387|Temozolomide|temozolomide|mesh-list
102384113|NCT02727387|Melphalan|melphalan|mesh-list
102384114|NCT02727387|Busulfan|busulfan|mesh-list
102384115|NCT02727387|Ifosfamide|ifosfamide|mesh-list
102384116|NCT02727387|Irinotecan|irinotecan|mesh-list
102384117|NCT02727387|Etoposide|etoposide|mesh-list
102384118|NCT02727387|Vincristine|vincristine|mesh-list
102384119|NCT02727387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102384120|NCT02727387|Immunologic Factors|immunologic factors|mesh-ancestor
102384121|NCT02727387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384122|NCT02727387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102384123|NCT02727387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102384124|NCT02727387|Alkylating Agents|alkylating agents|mesh-ancestor
102384125|NCT02727387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384126|NCT02727387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384127|NCT02727387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102384128|NCT02727387|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102384129|NCT02727387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102384130|NCT02727387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102384131|NCT02727387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102384132|NCT02727387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102384133|NCT02727387|Tubulin Modulators|tubulin modulators|mesh-ancestor
102384134|NCT02727387|Antimitotic Agents|antimitotic agents|mesh-ancestor
102384135|NCT02727387|Mitosis Modulators|mitosis modulators|mesh-ancestor
102384136|NCT01753115|Ciprofloxacin|ciprofloxacin|mesh-list
102384137|NCT01753115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102384138|NCT01753115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102384139|NCT01753115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102384140|NCT01753115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102384141|NCT01753115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102384142|NCT01753115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384143|NCT01753115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384144|NCT01753115|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102384145|NCT01753115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102384146|NCT02445651|Acetylcysteine|acetylcysteine|mesh-list
102384147|NCT02445651|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102384148|NCT02445651|Antiviral Agents|antiviral agents|mesh-ancestor
102384149|NCT02445651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102384150|NCT02445651|Expectorants|expectorants|mesh-ancestor
102384151|NCT02445651|Respiratory System Agents|respiratory system agents|mesh-ancestor
102384152|NCT02445651|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102384153|NCT02445651|Antioxidants|antioxidants|mesh-ancestor
102384154|NCT02445651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384155|NCT02445651|Protective Agents|protective agents|mesh-ancestor
102384156|NCT02445651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384157|NCT02445651|Antidotes|antidotes|mesh-ancestor
102384158|NCT05719714|Dapagliflozin|dapagliflozin|mesh-list
102384159|NCT05719714|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102384160|NCT05719714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384161|NCT05719714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102384162|NCT05719714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384163|NCT02284516|Lifitegrast|lifitegrast|mesh-list
102384164|NCT02284516|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102384165|NCT02284516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102384166|NCT02721537|Niacinamide|niacinamide|mesh-list
102384167|NCT02721537|Niacin|niacin|mesh-list
101831734|NCT02333188|Vitamins|vitamins|mesh-ancestor
102195893|NCT02152475|Sensory System Agents|sensory system agents|mesh-ancestor
102384168|NCT02721537|Nicotinic Acids|nicotinic acids|mesh-list
102384169|NCT02721537|Vitamin B Complex|vitamin b complex|mesh-ancestor
102384170|NCT02721537|Vitamins|vitamins|mesh-ancestor
102384171|NCT02721537|Micronutrients|micronutrients|mesh-ancestor
102384172|NCT02721537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384173|NCT02721537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102384174|NCT02721537|Antimetabolites|antimetabolites|mesh-ancestor
101831869|NCT01409200|Androgens|androgens|mesh-list
102384175|NCT02721537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384176|NCT02721537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102384177|NCT02721537|Vasodilator Agents|vasodilator agents|mesh-ancestor
102384178|NCT02185209|Amoxicillin|amoxicillin|mesh-list
102384179|NCT02185209|Metronidazole|metronidazole|mesh-list
102384180|NCT02185209|Penicillin V|penicillin v|mesh-list
102384181|NCT02185209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102384182|NCT02185209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102384183|NCT02185209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102384184|NCT02185209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102384185|NCT01894035|Iloprost|iloprost|mesh-list
102384186|NCT01894035|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102384187|NCT01894035|Vasodilator Agents|vasodilator agents|mesh-ancestor
102384188|NCT01727141|Glycopyrrolate|glycopyrrolate|mesh-list
102384189|NCT01727141|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102384190|NCT01727141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102384191|NCT01727141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102384192|NCT01727141|Cholinergic Agents|cholinergic agents|mesh-ancestor
102384193|NCT01727141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102384194|NCT01727141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384195|NCT01727141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384196|NCT02716311|Cetuximab|cetuximab|mesh-list
102384197|NCT02716311|Afatinib|afatinib|mesh-list
102384198|NCT02716311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102384199|NCT02716311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384200|NCT02716311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101831960|NCT00833664|Terbinafine|terbinafine|mesh-list
102384201|NCT02716311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102384202|NCT02716311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384203|NCT05439694|Tranexamic Acid|tranexamic acid|mesh-list
102384204|NCT05439694|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102384205|NCT05439694|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102384206|NCT05439694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384207|NCT05439694|Hemostatics|hemostatics|mesh-ancestor
102384208|NCT05439694|Coagulants|coagulants|mesh-ancestor
102384209|NCT02165007|Sirolimus|sirolimus|mesh-list
102384210|NCT02165007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101832086|NCT01008098|Escitalopram|escitalopram|mesh-list
102384211|NCT02165007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102384212|NCT02165007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102384213|NCT02165007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384214|NCT02165007|Antifungal Agents|antifungal agents|mesh-ancestor
102384215|NCT02165007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102384216|NCT02165007|Immunologic Factors|immunologic factors|mesh-ancestor
102384217|NCT02165007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384218|NCT02290444|Hormones|hormones|mesh-list
102384219|NCT02290444|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102384220|NCT02290444|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
102384221|NCT02290444|beta-Endorphin|beta-endorphin|mesh-list
102384222|NCT02290444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102384223|NCT02290444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384224|NCT02290444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102384225|NCT02290444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384226|NCT01726517|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102384227|NCT01726517|Antiviral Agents|antiviral agents|mesh-ancestor
102384228|NCT01726517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102384229|NCT01752023|Itraconazole|itraconazole|mesh-list
102384230|NCT01752023|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
102384231|NCT01752023|Cisplatin|cisplatin|mesh-list
102384232|NCT01752023|Gemcitabine|gemcitabine|mesh-list
102384233|NCT01752023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384234|NCT01752023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102384235|NCT01752023|Antimetabolites|antimetabolites|mesh-ancestor
102384236|NCT01752023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384237|NCT01752023|Antifungal Agents|antifungal agents|mesh-ancestor
102384238|NCT01752023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102384239|NCT01752023|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102384240|NCT01752023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102384241|NCT01752023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102195969|NCT01037179|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102384242|NCT01752023|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102384243|NCT01752023|Hormone Antagonists|hormone antagonists|mesh-ancestor
102384246|NCT01752023|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102384248|NCT02986906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102384249|NCT02986906|Glucocorticoids|glucocorticoids|mesh-ancestor
102384250|NCT02986906|Hormones|hormones|mesh-ancestor
102384251|NCT02986906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101832418|NCT00881855|Cefprozil|cefprozil|mesh-list
102384252|NCT02986906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384256|NCT01726049|Sildenafil Citrate|sildenafil citrate|mesh-list
102384257|NCT01726049|Vasodilator Agents|vasodilator agents|mesh-ancestor
102384258|NCT01726049|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102384259|NCT01726049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102384260|NCT01726049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102384261|NCT01726049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384262|NCT01726049|Urological Agents|urological agents|mesh-ancestor
102384263|NCT02162667|Trastuzumab|trastuzumab|mesh-list
102384264|NCT02162667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102384265|NCT02162667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384266|NCT01605617|Fesoterodine|fesoterodine|mesh-list
102384267|NCT01605617|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101832564|NCT00887003|Hormones|hormones|mesh-ancestor
102384268|NCT01605617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102384269|NCT01605617|Cholinergic Agents|cholinergic agents|mesh-ancestor
102384270|NCT01605617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102384271|NCT01605617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384272|NCT01605617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384273|NCT01605617|Urological Agents|urological agents|mesh-ancestor
102384274|NCT05402020|Tiotropium Bromide|tiotropium bromide|mesh-list
102384275|NCT05402020|Olodaterol|olodaterol|mesh-list
102384276|NCT05402020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102384277|NCT05402020|Autonomic Agents|autonomic agents|mesh-ancestor
101832627|NCT04895306|Androgens|androgens|mesh-ancestor
102384278|NCT05402020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102384279|NCT05402020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384280|NCT05402020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102384281|NCT05402020|Respiratory System Agents|respiratory system agents|mesh-ancestor
102384282|NCT05402020|Parasympatholytics|parasympatholytics|mesh-ancestor
101832769|NCT02542007|Sirolimus|sirolimus|mesh-list
102384283|NCT05402020|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102384284|NCT05402020|Cholinergic Agents|cholinergic agents|mesh-ancestor
102384285|NCT05402020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102384286|NCT05402020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384287|NCT02284828|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102384288|NCT02284828|Anticonvulsants|anticonvulsants|mesh-ancestor
101832911|NCT04017845|Sensory System Agents|sensory system agents|mesh-ancestor
102384289|NCT02284828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102384290|NCT02284828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102384291|NCT02284828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102384292|NCT02284828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384293|NCT01751867|Decitabine|decitabine|mesh-list
102384294|NCT01751867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102384295|NCT01751867|Antimetabolites|antimetabolites|mesh-ancestor
102384296|NCT01751867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384297|NCT01751867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384298|NCT01751867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102384299|NCT02418195|Ketamine|ketamine|mesh-list
102384300|NCT02418195|Analgesics|analgesics|mesh-ancestor
102384301|NCT02418195|Sensory System Agents|sensory system agents|mesh-ancestor
102384302|NCT02418195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102384303|NCT02418195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384304|NCT02418195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102384305|NCT02418195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102384306|NCT02418195|Anesthetics, General|anesthetics, general|mesh-ancestor
102384307|NCT02418195|Anesthetics|anesthetics|mesh-ancestor
101833049|NCT00430677|Prednisone|prednisone|mesh-list
102384308|NCT02418195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102384309|NCT02418195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102384310|NCT02418195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102384311|NCT02418195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102384312|NCT02418195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384313|NCT05633914|Paclitaxel|paclitaxel|mesh-list
101833117|NCT00430521|Immunologic Factors|immunologic factors|mesh-ancestor
102384314|NCT05633914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102384315|NCT05633914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384316|NCT05633914|Tubulin Modulators|tubulin modulators|mesh-ancestor
102384317|NCT05633914|Antimitotic Agents|antimitotic agents|mesh-ancestor
102384318|NCT05633914|Mitosis Modulators|mitosis modulators|mesh-ancestor
102384319|NCT05633914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384320|NCT05383612|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102384321|NCT05383612|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102384322|NCT05382364|Tucatinib|tucatinib|mesh-list
102384323|NCT05382364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384324|NCT05382364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102384325|NCT05382364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102384326|NCT05382364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384327|NCT02712801|Ritonavir|ritonavir|mesh-list
102384328|NCT02712801|Lopinavir|lopinavir|mesh-list
102384329|NCT02712801|Lamivudine|lamivudine|mesh-list
102384330|NCT02712801|Zidovudine|zidovudine|mesh-list
102384331|NCT02712801|Nevirapine|nevirapine|mesh-list
102384332|NCT02712801|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102384333|NCT02712801|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102384334|NCT02712801|Protease Inhibitors|protease inhibitors|mesh-ancestor
102384335|NCT02712801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102384336|NCT02712801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384337|NCT02712801|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102384338|NCT02712801|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102384339|NCT02712801|Antiviral Agents|antiviral agents|mesh-ancestor
102384340|NCT02712801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102384341|NCT02712801|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102384342|NCT02712801|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101833464|NCT03742258|Hormones|hormones|mesh-ancestor
102384343|NCT02712801|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102384344|NCT02712801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102384345|NCT02712801|Antimetabolites|antimetabolites|mesh-ancestor
102384346|NCT02712801|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102384347|NCT02712801|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102384348|NCT02712723|Letrozole|letrozole|mesh-list
102384349|NCT02712723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384350|NCT02712723|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102384351|NCT02712723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102384352|NCT02712723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102384353|NCT02712723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384354|NCT02712723|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102384355|NCT02712723|Hormone Antagonists|hormone antagonists|mesh-ancestor
102384356|NCT02712723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102384357|NCT02712723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384358|NCT02156739|Edetic Acid|edetic acid|mesh-list
102384359|NCT02156739|Pentetic Acid|pentetic acid|mesh-list
102384360|NCT02156739|Antidotes|antidotes|mesh-ancestor
101833756|NCT00514904|Vaccines|vaccines|mesh-list
102384361|NCT02156739|Protective Agents|protective agents|mesh-ancestor
102384362|NCT02156739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384363|NCT02156739|Chelating Agents|chelating agents|mesh-ancestor
102384364|NCT02156739|Sequestering Agents|sequestering agents|mesh-ancestor
102384365|NCT02156739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384366|NCT02156739|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102384367|NCT02156739|Anticoagulants|anticoagulants|mesh-ancestor
102384368|NCT02156739|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102384369|NCT01751087|Vitamins|vitamins|mesh-list
102384370|NCT01751087|Vitamin B 12|vitamin b 12|mesh-list
102384371|NCT01751087|Misoprostol|misoprostol|mesh-list
102384372|NCT01751087|Mifepristone|mifepristone|mesh-list
102384373|NCT01751087|Micronutrients|micronutrients|mesh-ancestor
101833889|NCT00515112|Testosterone|testosterone|mesh-list
102384374|NCT01751087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384375|NCT01751087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102384376|NCT01751087|Abortifacient Agents|abortifacient agents|mesh-ancestor
102384377|NCT01751087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102384378|NCT01751087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102384379|NCT01751087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102384380|NCT01751087|Oxytocics|oxytocics|mesh-ancestor
102384381|NCT01751087|Vitamin B Complex|vitamin b complex|mesh-ancestor
102384382|NCT01751087|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102384383|NCT01751087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102384384|NCT01751087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102384385|NCT01751087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102384386|NCT01751087|Contraceptive Agents|contraceptive agents|mesh-ancestor
102384387|NCT01751087|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101834173|NCT00609167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102384388|NCT01751087|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102384389|NCT01751087|Hormone Antagonists|hormone antagonists|mesh-ancestor
101834244|NCT00514020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102384390|NCT01751087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102384391|NCT01751087|Luteolytic Agents|luteolytic agents|mesh-ancestor
102384392|NCT01751087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102384393|NCT01751087|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102384394|NCT02143401|Sorafenib|sorafenib|mesh-list
102384395|NCT02143401|Navitoclax|navitoclax|mesh-list
102384396|NCT02143401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384397|NCT02143401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102384398|NCT02143401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101834395|NCT00896519|Glucocorticoids|glucocorticoids|mesh-ancestor
102384399|NCT02143401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384400|NCT02401503|Venetoclax|venetoclax|mesh-list
102384401|NCT02401503|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102384402|NCT02401503|Obinutuzumab|obinutuzumab|mesh-list
102384403|NCT02401503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101834533|NCT00337168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384404|NCT02401503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102384405|NCT02401503|Alkylating Agents|alkylating agents|mesh-ancestor
101834605|NCT04017377|Paclitaxel|paclitaxel|mesh-list
102384406|NCT02401503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384407|NCT02401503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102384408|NCT02393157|Carboplatin|carboplatin|mesh-list
102384409|NCT02393157|Etoposide|etoposide|mesh-list
102384410|NCT02393157|Ifosfamide|ifosfamide|mesh-list
102384411|NCT02393157|Obinutuzumab|obinutuzumab|mesh-list
101834762|NCT00902915|Dexamethasone|dexamethasone|mesh-list
102384412|NCT02393157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384413|NCT02393157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102384414|NCT02393157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102384415|NCT02393157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102384416|NCT02393157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102384417|NCT02393157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384418|NCT02393157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102384419|NCT02393157|Alkylating Agents|alkylating agents|mesh-ancestor
102384420|NCT02393157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102384421|NCT01750697|Rituximab|rituximab|mesh-list
102384422|NCT01750697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102384423|NCT01750697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384424|NCT01750697|Immunologic Factors|immunologic factors|mesh-ancestor
102384425|NCT01750697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384426|NCT01750697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102384427|NCT02127723|Hyaluronic Acid|hyaluronic acid|mesh-list
102384428|NCT02127723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102384429|NCT02127723|Immunologic Factors|immunologic factors|mesh-ancestor
102384430|NCT02127723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384431|NCT02127723|Viscosupplements|viscosupplements|mesh-ancestor
102384432|NCT02127723|Protective Agents|protective agents|mesh-ancestor
102384433|NCT05586711|Estradiol|estradiol|mesh-list
102384434|NCT05586711|Estrogens|estrogens|mesh-ancestor
102384435|NCT05586711|Hormones|hormones|mesh-ancestor
102384436|NCT05586711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101834821|NCT00605657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102384437|NCT05586711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384438|NCT05317858|Pembrolizumab|pembrolizumab|mesh-list
102384439|NCT05317858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102384440|NCT05317858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384441|NCT05317858|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102384442|NCT05317858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384443|NCT01724489|Hormones|hormones|mesh-list
102384444|NCT01724489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102384445|NCT01724489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384446|NCT01996293|Lamotrigine|lamotrigine|mesh-list
102384447|NCT01996293|Anticonvulsants|anticonvulsants|mesh-ancestor
101834870|NCT00900887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102384448|NCT01996293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102384449|NCT01996293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102384450|NCT01996293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384451|NCT01996293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102384452|NCT01996293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554706|NCT01224171|Vedolizumab|vedolizumab|mesh-list
102384453|NCT01996293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102384454|NCT01996293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101834997|NCT00603941|Paclitaxel|paclitaxel|mesh-list
102384455|NCT01996293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102384456|NCT01996293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101835068|NCT00907829|Lidocaine|lidocaine|mesh-list
102384457|NCT01996293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102384458|NCT02986750|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102384459|NCT02986750|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102384460|NCT05304364|Naltrexone|naltrexone|mesh-list
102384461|NCT05304364|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102384462|NCT05304364|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102384463|NCT05304364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384464|NCT05304364|Sensory System Agents|sensory system agents|mesh-ancestor
102384465|NCT05304364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102384467|NCT01724177|Immunologic Factors|immunologic factors|mesh-ancestor
102384468|NCT01724177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384469|NCT01724177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102384470|NCT01724177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102384471|NCT01724177|Growth Substances|growth substances|mesh-ancestor
102384472|NCT01724177|Growth Inhibitors|growth inhibitors|mesh-ancestor
101835353|NCT00928655|Diuretics|diuretics|mesh-ancestor
102384473|NCT01724177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384474|NCT01991457|Fludarabine|fludarabine|mesh-list
102384475|NCT01991457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384476|NCT02117817|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102384477|NCT02117817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384478|NCT05529784|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102384479|NCT05529784|Immunologic Factors|immunologic factors|mesh-ancestor
102384480|NCT05529784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384481|NCT05524246|Pravastatin|pravastatin|mesh-list
102384482|NCT05524246|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102384483|NCT05524246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102384484|NCT05524246|Antimetabolites|antimetabolites|mesh-ancestor
102384485|NCT05524246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384486|NCT05524246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102384487|NCT05524246|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102384488|NCT05524246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102384489|NCT02685735|Gabapentin|gabapentin|mesh-list
102384490|NCT02685735|Analgesics|analgesics|mesh-ancestor
102384491|NCT02685735|Sensory System Agents|sensory system agents|mesh-ancestor
102384492|NCT02685735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102384493|NCT02685735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384494|NCT02685735|Anticonvulsants|anticonvulsants|mesh-ancestor
102384495|NCT02685735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102384496|NCT02685735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102384497|NCT02685735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102384498|NCT02685735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102384499|NCT02685735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102384500|NCT02685735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102384501|NCT02685735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102384502|NCT02685735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384503|NCT02685735|Antimanic Agents|antimanic agents|mesh-ancestor
101835853|NCT00930839|Niacin|niacin|mesh-list
102384504|NCT01530009|Amoxicillin|amoxicillin|mesh-list
102384505|NCT01530009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101835913|NCT00935363|Hormone Antagonists|hormone antagonists|mesh-ancestor
102384506|NCT01530009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102384507|NCT04915144|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
102384508|NCT04915144|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102384509|NCT04915144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384510|NCT01724021|Prednisone|prednisone|mesh-list
102384511|NCT01724021|Prednisolone|prednisolone|mesh-list
102384512|NCT01724021|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102384513|NCT01724021|Methylprednisolone|methylprednisolone|mesh-list
102384514|NCT01724021|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102384515|NCT01724021|Prednisolone acetate|prednisolone acetate|mesh-list
102384516|NCT01724021|Cyclophosphamide|cyclophosphamide|mesh-list
102384517|NCT01724021|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102384518|NCT01724021|Rituximab|rituximab|mesh-list
102384519|NCT01724021|Vincristine|vincristine|mesh-list
102384520|NCT01724021|Doxorubicin|doxorubicin|mesh-list
102384521|NCT01724021|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102384522|NCT01724021|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102384523|NCT01724021|Prednisolone phosphate|prednisolone phosphate|mesh-list
102384524|NCT01724021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102384525|NCT01724021|Immunologic Factors|immunologic factors|mesh-ancestor
102384526|NCT01724021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384527|NCT01724021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102384528|NCT01724021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102384529|NCT01724021|Alkylating Agents|alkylating agents|mesh-ancestor
102384530|NCT01724021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384531|NCT01724021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384532|NCT01724021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102384533|NCT01724021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102384534|NCT01724021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102384535|NCT01724021|Glucocorticoids|glucocorticoids|mesh-ancestor
102384536|NCT01724021|Hormones|hormones|mesh-ancestor
102384537|NCT01724021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102196276|NCT02441660|Capsaicin|capsaicin|mesh-list
102384538|NCT01724021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102384539|NCT01724021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102384540|NCT01724021|Tubulin Modulators|tubulin modulators|mesh-ancestor
102384541|NCT01724021|Antimitotic Agents|antimitotic agents|mesh-ancestor
102384542|NCT01724021|Mitosis Modulators|mitosis modulators|mesh-ancestor
102384543|NCT01724021|Antiemetics|antiemetics|mesh-ancestor
102384544|NCT01724021|Autonomic Agents|autonomic agents|mesh-ancestor
102384545|NCT01724021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102384546|NCT01724021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102384547|NCT01724021|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102384548|NCT01724021|Protective Agents|protective agents|mesh-ancestor
102384549|NCT01724021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102384550|NCT01724021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102384551|NCT01724021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102384552|NCT01724021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102384553|NCT05197504|Bevacizumab|bevacizumab|mesh-list
102384554|NCT05197504|Atezolizumab|atezolizumab|mesh-list
102097170|NCT04903678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102384555|NCT05197504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102384556|NCT05197504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384557|NCT05197504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102384558|NCT05197504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102384559|NCT05197504|Growth Substances|growth substances|mesh-ancestor
102384560|NCT05197504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384561|NCT05197504|Growth Inhibitors|growth inhibitors|mesh-ancestor
102384562|NCT05197504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102384563|NCT05197504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384564|NCT02293096|Metoprolol|metoprolol|mesh-list
102384565|NCT02293096|Dextromethorphan|dextromethorphan|mesh-list
102384566|NCT02293096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101550735|NCT04309708|Nimodipine|nimodipine|mesh-list
102384567|NCT02293096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102384568|NCT02293096|Sympatholytics|sympatholytics|mesh-ancestor
102384569|NCT02293096|Autonomic Agents|autonomic agents|mesh-ancestor
102097471|NCT03052348|Ether|ether|mesh-list
102384570|NCT02293096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102384571|NCT02293096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384572|NCT02293096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102384573|NCT02293096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102384574|NCT02293096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102384575|NCT02293096|Adrenergic Agents|adrenergic agents|mesh-ancestor
102384576|NCT02293096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102097597|NCT03161054|Alkylating Agents|alkylating agents|mesh-ancestor
102384577|NCT02293096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384578|NCT02293096|Antitussive Agents|antitussive agents|mesh-ancestor
102384579|NCT02293096|Respiratory System Agents|respiratory system agents|mesh-ancestor
102097666|NCT02809053|Rituximab|rituximab|mesh-list
102384580|NCT02293096|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102384581|NCT02293096|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102384582|NCT01722071|Oxytocin|oxytocin|mesh-list
102384583|NCT01722071|Oxytocics|oxytocics|mesh-ancestor
102384584|NCT01722071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102384585|NCT01722071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384586|NCT04187404|Nivolumab|nivolumab|mesh-list
102384587|NCT04187404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102384588|NCT04187404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384589|NCT04187404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102384590|NCT04187404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384591|NCT04155580|Decitabine|decitabine|mesh-list
102384592|NCT04155580|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
102384593|NCT04155580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102384594|NCT04155580|Antimetabolites|antimetabolites|mesh-ancestor
102384595|NCT04155580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384596|NCT04155580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384597|NCT04155580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102384598|NCT01721759|Nivolumab|nivolumab|mesh-list
102384599|NCT01721759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102384600|NCT01721759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384601|NCT01721759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102384602|NCT01721759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384603|NCT04776850|Mycophenolic Acid|mycophenolic acid|mesh-list
102384604|NCT04776850|Dexamethasone|dexamethasone|mesh-list
102384605|NCT04776850|Dexamethasone acetate|dexamethasone acetate|mesh-list
102384606|NCT04776850|Cyclophosphamide|cyclophosphamide|mesh-list
102384607|NCT04776850|Busulfan|busulfan|mesh-list
102384608|NCT04776850|Rituximab|rituximab|mesh-list
102384609|NCT04776850|Fludarabine|fludarabine|mesh-list
102384610|NCT04776850|Fludarabine phosphate|fludarabine phosphate|mesh-list
102384611|NCT04776850|Bortezomib|bortezomib|mesh-list
102384612|NCT04776850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102196347|NCT02158013|Vasodilator Agents|vasodilator agents|mesh-ancestor
102384613|NCT04776850|Tacrolimus|tacrolimus|mesh-list
102384614|NCT04776850|Thymoglobulin|thymoglobulin|mesh-list
102384615|NCT04776850|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102384616|NCT04776850|Antibodies|antibodies|mesh-list
102384617|NCT04776850|Immunoglobulins|immunoglobulins|mesh-list
102384618|NCT04776850|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102384619|NCT04776850|gamma-Globulins|gamma-globulins|mesh-list
102384620|NCT04776850|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102384621|NCT04776850|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102384622|NCT04776850|BB 1101|bb 1101|mesh-list
102384623|NCT04776850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102384624|NCT04776850|Immunologic Factors|immunologic factors|mesh-ancestor
102384625|NCT04776850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384626|NCT04776850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102384627|NCT04776850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102384628|NCT04776850|Alkylating Agents|alkylating agents|mesh-ancestor
102384629|NCT04776850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384630|NCT04776850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384631|NCT04776850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102384632|NCT04776850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102384633|NCT04776850|Antiemetics|antiemetics|mesh-ancestor
102384634|NCT04776850|Autonomic Agents|autonomic agents|mesh-ancestor
102384635|NCT04776850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102384636|NCT04776850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102384637|NCT04776850|Glucocorticoids|glucocorticoids|mesh-ancestor
102384638|NCT04776850|Hormones|hormones|mesh-ancestor
102384639|NCT04776850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102384640|NCT04776850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102384641|NCT04776850|Protease Inhibitors|protease inhibitors|mesh-ancestor
102384642|NCT04776850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102384643|NCT04776850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102098137|NCT02802345|Nintedanib|nintedanib|mesh-list
102384644|NCT04776850|Antimetabolites|antimetabolites|mesh-ancestor
102384645|NCT04776850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102384646|NCT04776850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102384647|NCT04776850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102384648|NCT04776850|Antitubercular Agents|antitubercular agents|mesh-ancestor
102384649|NCT04776850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102384650|NCT04776850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102384651|NCT04132648|Curcumin|curcumin|mesh-list
102384652|NCT04132648|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102384653|NCT04132648|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102384654|NCT04132648|Analgesics|analgesics|mesh-ancestor
102384655|NCT04132648|Sensory System Agents|sensory system agents|mesh-ancestor
102384656|NCT04132648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102384657|NCT04132648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384658|NCT04132648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102384659|NCT04132648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102384660|NCT04132648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384661|NCT04132648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102384662|NCT04132648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384663|NCT02331940|Tiotropium Bromide|tiotropium bromide|mesh-list
102384664|NCT02331940|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102384665|NCT02331940|Autonomic Agents|autonomic agents|mesh-ancestor
102384666|NCT02331940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102384667|NCT02331940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384668|NCT02331940|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102384669|NCT02331940|Respiratory System Agents|respiratory system agents|mesh-ancestor
102384670|NCT02331940|Parasympatholytics|parasympatholytics|mesh-ancestor
102384671|NCT02331940|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102384672|NCT02331940|Cholinergic Agents|cholinergic agents|mesh-ancestor
102384673|NCT02331940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102384674|NCT02331940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384675|NCT04095208|Nivolumab|nivolumab|mesh-list
102384676|NCT04095208|Relatlimab|relatlimab|mesh-list
102384677|NCT04095208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102384678|NCT04095208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384679|NCT04095208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102384680|NCT04095208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384681|NCT02292082|Cefazolin|cefazolin|mesh-list
102384682|NCT02292082|Dexamethasone|dexamethasone|mesh-list
102384683|NCT02292082|Methylprednisolone|methylprednisolone|mesh-list
102384684|NCT02292082|Midazolam|midazolam|mesh-list
102384685|NCT02292082|Morphine|morphine|mesh-list
102384686|NCT02292082|Bupivacaine|bupivacaine|mesh-list
102384687|NCT02292082|Propofol|propofol|mesh-list
102384688|NCT02292082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102384689|NCT02292082|Antiemetics|antiemetics|mesh-ancestor
102384690|NCT02292082|Autonomic Agents|autonomic agents|mesh-ancestor
102384691|NCT02292082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102384692|NCT02292082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384693|NCT02292082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102384694|NCT02292082|Glucocorticoids|glucocorticoids|mesh-ancestor
102384696|NCT02292082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102384697|NCT02292082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102384698|NCT02292082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384699|NCT02292082|Anesthetics, Local|anesthetics, local|mesh-ancestor
102384700|NCT02292082|Anesthetics|anesthetics|mesh-ancestor
102384701|NCT02292082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102384702|NCT02292082|Sensory System Agents|sensory system agents|mesh-ancestor
102384703|NCT02292082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102384704|NCT02292082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102384705|NCT02292082|Anesthetics, General|anesthetics, general|mesh-ancestor
102384706|NCT02292082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102384707|NCT02292082|Narcotics|narcotics|mesh-ancestor
102384708|NCT02292082|Analgesics|analgesics|mesh-ancestor
102384709|NCT02292082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102384710|NCT02292082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102384711|NCT02292082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102384712|NCT02292082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102384713|NCT02292082|GABA Modulators|gaba modulators|mesh-ancestor
102384714|NCT02292082|GABA Agents|gaba agents|mesh-ancestor
102384715|NCT02292082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102098515|NCT03046108|Mepivacaine|mepivacaine|mesh-list
102384716|NCT02292082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384717|NCT02292082|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102384718|NCT02292082|Protective Agents|protective agents|mesh-ancestor
102384719|NCT02292082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102384720|NCT02292082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102384721|NCT05072704|Sufentanil|sufentanil|mesh-list
102384722|NCT05072704|Dexmedetomidine|dexmedetomidine|mesh-list
102384723|NCT05072704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102384724|NCT05072704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102384725|NCT05072704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384726|NCT05072704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102384727|NCT05072704|Analgesics|analgesics|mesh-ancestor
102384728|NCT05072704|Sensory System Agents|sensory system agents|mesh-ancestor
102384729|NCT05072704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102384730|NCT05072704|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102384731|NCT05072704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102384732|NCT05072704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102384733|NCT05072704|Adrenergic Agents|adrenergic agents|mesh-ancestor
102384734|NCT05072704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102384735|NCT05072704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384736|NCT05072704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102384737|NCT05072704|Narcotics|narcotics|mesh-ancestor
102384738|NCT05072704|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102384739|NCT05072704|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102384740|NCT05072704|Anesthetics, General|anesthetics, general|mesh-ancestor
102384741|NCT05072704|Anesthetics|anesthetics|mesh-ancestor
102384742|NCT04678336|Cyclophosphamide|cyclophosphamide|mesh-list
102384743|NCT04678336|Fludarabine|fludarabine|mesh-list
102384744|NCT04678336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102384745|NCT04678336|Immunologic Factors|immunologic factors|mesh-ancestor
102384746|NCT04678336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384747|NCT04678336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102384748|NCT04678336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102384749|NCT04678336|Alkylating Agents|alkylating agents|mesh-ancestor
102384750|NCT04678336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384751|NCT04678336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384752|NCT04678336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102384753|NCT03195478|Nivolumab|nivolumab|mesh-list
102384754|NCT03195478|Ipilimumab|ipilimumab|mesh-list
102384755|NCT03195478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102384756|NCT03195478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384757|NCT03195478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102384758|NCT03195478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384759|NCT04607122|Landiolol|landiolol|mesh-list
102384760|NCT04607122|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102384761|NCT04607122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102384762|NCT04607122|Adrenergic Agents|adrenergic agents|mesh-ancestor
102384763|NCT04607122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102384764|NCT04607122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384765|NCT04607122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384766|NCT04607122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102384767|NCT03099382|Docetaxel|docetaxel|mesh-list
102384768|NCT03099382|Irinotecan|irinotecan|mesh-list
102384769|NCT03099382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384770|NCT03099382|Tubulin Modulators|tubulin modulators|mesh-ancestor
102384771|NCT03099382|Antimitotic Agents|antimitotic agents|mesh-ancestor
102384772|NCT03099382|Mitosis Modulators|mitosis modulators|mesh-ancestor
102384773|NCT03099382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384774|NCT03099382|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102384775|NCT03099382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102384776|NCT03099382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102384777|NCT04590664|Verteporfin|verteporfin|mesh-list
102384778|NCT04590664|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102384779|NCT04590664|Dermatologic Agents|dermatologic agents|mesh-ancestor
102384780|NCT04494412|Zanamivir|zanamivir|mesh-list
102384781|NCT04494412|Antiviral Agents|antiviral agents|mesh-ancestor
102384782|NCT04494412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102384783|NCT04494412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102384784|NCT04494412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384785|NCT03583528|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102384786|NCT03583528|Edotreotide|edotreotide|mesh-list
102384787|NCT03583528|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102384788|NCT03583528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384789|NCT01949337|Prednisone|prednisone|mesh-list
102384790|NCT01949337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102384791|NCT01949337|Glucocorticoids|glucocorticoids|mesh-ancestor
102384792|NCT01949337|Hormones|hormones|mesh-ancestor
102384793|NCT01949337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102099191|NCT02234466|Dexamethasone|dexamethasone|mesh-list
102384794|NCT01949337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384795|NCT01949337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102384796|NCT01949337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384797|NCT03578146|Rivaroxaban|rivaroxaban|mesh-list
102384798|NCT03578146|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102384799|NCT03578146|Antithrombins|antithrombins|mesh-ancestor
102384800|NCT03578146|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102384801|NCT03578146|Protease Inhibitors|protease inhibitors|mesh-ancestor
102384802|NCT03578146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102384803|NCT03578146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384804|NCT03578146|Anticoagulants|anticoagulants|mesh-ancestor
102384805|NCT04355832|Glucagon|glucagon|mesh-list
102384806|NCT04355832|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102384807|NCT04355832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102384808|NCT04355832|Hormones|hormones|mesh-ancestor
102384809|NCT04355832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102384810|NCT04355832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099410|NCT03041506|Lidocaine|lidocaine|mesh-list
102384811|NCT04355832|Incretins|incretins|mesh-ancestor
102384812|NCT02518594|Progesterone|progesterone|mesh-list
102384813|NCT02518594|Progestins|progestins|mesh-ancestor
102384814|NCT02518594|Hormones|hormones|mesh-ancestor
102384815|NCT02518594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102384816|NCT02518594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384817|NCT01516593|Cytarabine|cytarabine|mesh-list
102384818|NCT01516593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102384819|NCT01516593|Antimetabolites|antimetabolites|mesh-ancestor
102384820|NCT01516593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384821|NCT01516593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384822|NCT01516593|Antiviral Agents|antiviral agents|mesh-ancestor
102384823|NCT01516593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102384824|NCT01516593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102384825|NCT01516593|Immunologic Factors|immunologic factors|mesh-ancestor
102384826|NCT01516593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384827|NCT02042391|Cytarabine|cytarabine|mesh-list
102384828|NCT02042391|Prednisone|prednisone|mesh-list
102384829|NCT02042391|Cyclophosphamide|cyclophosphamide|mesh-list
102384830|NCT02042391|Rituximab|rituximab|mesh-list
102384831|NCT02042391|Oxaliplatin|oxaliplatin|mesh-list
102384832|NCT02042391|Doxorubicin|doxorubicin|mesh-list
102384833|NCT02042391|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102384834|NCT02042391|Vincristine|vincristine|mesh-list
102384835|NCT02042391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102384836|NCT02042391|Immunologic Factors|immunologic factors|mesh-ancestor
102384837|NCT02042391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384838|NCT02042391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102384839|NCT02042391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102384840|NCT02042391|Alkylating Agents|alkylating agents|mesh-ancestor
102384841|NCT02042391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384842|NCT02042391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384843|NCT02042391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102384844|NCT02042391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102384845|NCT02042391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102384846|NCT02042391|Glucocorticoids|glucocorticoids|mesh-ancestor
102384847|NCT02042391|Hormones|hormones|mesh-ancestor
102384848|NCT02042391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102384849|NCT02042391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102384850|NCT02042391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102384851|NCT02042391|Antimetabolites|antimetabolites|mesh-ancestor
102384852|NCT02042391|Antiviral Agents|antiviral agents|mesh-ancestor
102384853|NCT02042391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102384854|NCT02042391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102384855|NCT02042391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102384856|NCT02042391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102384857|NCT02042391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102384858|NCT02042391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102384859|NCT02042391|Tubulin Modulators|tubulin modulators|mesh-ancestor
102384860|NCT02042391|Antimitotic Agents|antimitotic agents|mesh-ancestor
102384861|NCT02042391|Mitosis Modulators|mitosis modulators|mesh-ancestor
102384862|NCT02461836|Gemcitabine|gemcitabine|mesh-list
102384863|NCT02461836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102384864|NCT02461836|Antimetabolites|antimetabolites|mesh-ancestor
102384865|NCT02461836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384866|NCT02461836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384867|NCT02034981|Crizotinib|crizotinib|mesh-list
102384868|NCT02034981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384869|NCT02034981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102384870|NCT02034981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102384871|NCT02034981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384872|NCT01986946|Hydromorphone|hydromorphone|mesh-list
102384873|NCT01986946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102384874|NCT01986946|Narcotics|narcotics|mesh-ancestor
102384875|NCT01986946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102384876|NCT01986946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384877|NCT01986946|Analgesics|analgesics|mesh-ancestor
102384878|NCT01986946|Sensory System Agents|sensory system agents|mesh-ancestor
102384879|NCT01986946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102384880|NCT01921335|Trastuzumab|trastuzumab|mesh-list
102384881|NCT01921335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102384882|NCT01921335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384883|NCT02427724|Lidocaine|lidocaine|mesh-list
102384884|NCT02427724|Tetracaine|tetracaine|mesh-list
102384885|NCT02427724|Prilocaine|prilocaine|mesh-list
102384886|NCT02427724|Anesthetics, Local|anesthetics, local|mesh-list
102384887|NCT02427724|Anesthetics|anesthetics|mesh-list
102384888|NCT02427724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102384889|NCT02427724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384890|NCT02427724|Sensory System Agents|sensory system agents|mesh-ancestor
102384891|NCT02427724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102384892|NCT02427724|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102384893|NCT02427724|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102384894|NCT02427724|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102384895|NCT02427724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102384896|NCT02427724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384897|NCT03437200|Nivolumab|nivolumab|mesh-list
102384898|NCT03437200|Ipilimumab|ipilimumab|mesh-list
102384899|NCT03437200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102384900|NCT03437200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384901|NCT03437200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102384902|NCT03437200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384903|NCT01903473|Sirolimus|sirolimus|mesh-list
102384904|NCT01903473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102384905|NCT01903473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102384906|NCT01903473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102384907|NCT01903473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384908|NCT01903473|Antifungal Agents|antifungal agents|mesh-ancestor
102384909|NCT01903473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102384910|NCT01903473|Immunologic Factors|immunologic factors|mesh-ancestor
102384911|NCT01903473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384912|NCT02715726|Atorvastatin|atorvastatin|mesh-list
102100197|NCT02236182|Bromides|bromides|mesh-list
102384913|NCT02715726|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102384914|NCT02715726|Simvastatin|simvastatin|mesh-list
102384915|NCT02715726|Ezetimibe|ezetimibe|mesh-list
102384916|NCT02715726|Alirocumab|alirocumab|mesh-list
102384917|NCT02715726|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102384918|NCT02715726|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102384920|NCT02715726|Antimetabolites|antimetabolites|mesh-ancestor
102384921|NCT02715726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384922|NCT02715726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102384923|NCT02715726|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102384924|NCT02715726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102384925|NCT02715726|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102384926|NCT02715726|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102384927|NCT02715726|Protease Inhibitors|protease inhibitors|mesh-ancestor
102384928|NCT02715726|Immunologic Factors|immunologic factors|mesh-ancestor
102384929|NCT02715726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384930|NCT01893567|Clobetasol|clobetasol|mesh-list
102384931|NCT01893567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102384932|NCT01893567|Glucocorticoids|glucocorticoids|mesh-ancestor
102384933|NCT01893567|Hormones|hormones|mesh-ancestor
102384934|NCT01893567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102384935|NCT01893567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384936|NCT01485861|Prednisone|prednisone|mesh-list
102100325|NCT02261376|DS-1971a|ds-1971a|mesh-list
102384937|NCT01485861|Prednisolone|prednisolone|mesh-list
102384938|NCT01485861|Ipatasertib|ipatasertib|mesh-list
102384939|NCT01485861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102384940|NCT01485861|Glucocorticoids|glucocorticoids|mesh-ancestor
102384941|NCT01485861|Hormones|hormones|mesh-ancestor
102384942|NCT01485861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102384943|NCT01485861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384944|NCT01485861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102384945|NCT01485861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384946|NCT01485861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102100536|NCT01235754|Anabolic Agents|anabolic agents|mesh-ancestor
102384947|NCT01485861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102384948|NCT01485861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384949|NCT04249596|Tianeptine|tianeptine|mesh-list
102384950|NCT04249596|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102384951|NCT04249596|Antidepressive Agents|antidepressive agents|mesh-ancestor
102384952|NCT04249596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102384953|NCT01476501|Vitamin D|vitamin d|mesh-list
102384954|NCT01476501|Cholecalciferol|cholecalciferol|mesh-list
102384955|NCT01476501|Vitamins|vitamins|mesh-ancestor
102384956|NCT01476501|Micronutrients|micronutrients|mesh-ancestor
102384957|NCT01476501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384958|NCT01476501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102384959|NCT01476501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102384960|NCT03426124|Fibrinolytic Agents|fibrinolytic agents|mesh-list
102384961|NCT03426124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102384962|NCT03426124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384963|NCT02464020|Vancomycin|vancomycin|mesh-list
102384964|NCT02464020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102384965|NCT02464020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102384966|NCT04756089|Oxytocin|oxytocin|mesh-list
102384967|NCT04756089|Oxytocics|oxytocics|mesh-ancestor
102384968|NCT04756089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102384969|NCT04756089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384970|NCT03397888|Betrixaban|betrixaban|mesh-list
102384971|NCT03397888|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102384972|NCT03397888|Antithrombins|antithrombins|mesh-ancestor
102384973|NCT03397888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102384974|NCT03397888|Protease Inhibitors|protease inhibitors|mesh-ancestor
102384975|NCT03397888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102384976|NCT03397888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384977|NCT03397888|Anticoagulants|anticoagulants|mesh-ancestor
102384978|NCT01886859|Lenalidomide|lenalidomide|mesh-list
102384979|NCT01886859|Immunologic Factors|immunologic factors|mesh-ancestor
102384980|NCT01886859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102384981|NCT01886859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102384982|NCT01886859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102384983|NCT01886859|Growth Substances|growth substances|mesh-ancestor
102384984|NCT01886859|Growth Inhibitors|growth inhibitors|mesh-ancestor
102100723|NCT01101594|Doxorubicin|doxorubicin|mesh-list
102384985|NCT01886859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102384986|NCT01989910|Efavirenz|efavirenz|mesh-list
102384987|NCT01989910|Raltegravir Potassium|raltegravir potassium|mesh-list
102384988|NCT01989910|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102384989|NCT01989910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102384990|NCT01989910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102384991|NCT01989910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102384992|NCT01989910|Antiviral Agents|antiviral agents|mesh-ancestor
102384993|NCT01989910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102384994|NCT01989910|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102384995|NCT01989910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102384996|NCT01989910|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102384997|NCT01989910|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102100920|NCT05232734|Caffeine|caffeine|mesh-list
102384998|NCT01989910|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102384999|NCT01989910|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102385000|NCT01989910|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102100971|NCT01016808|Oxycodone|oxycodone|mesh-list
102385001|NCT01989910|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102385002|NCT01989910|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102385003|NCT01989910|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102385004|NCT02464722|Epinephrine|epinephrine|mesh-list
102385005|NCT02464722|Dexmedetomidine|dexmedetomidine|mesh-list
102385006|NCT02464722|Remifentanil|remifentanil|mesh-list
102385007|NCT02464722|Propofol|propofol|mesh-list
102385008|NCT02464722|Rocuronium|rocuronium|mesh-list
102385009|NCT02464722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102101114|NCT01129674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102385010|NCT02464722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102385011|NCT02464722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385012|NCT02464722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102385013|NCT02464722|Analgesics|analgesics|mesh-ancestor
102385014|NCT02464722|Sensory System Agents|sensory system agents|mesh-ancestor
102385015|NCT02464722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102385016|NCT02464722|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102385017|NCT02464722|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102385018|NCT02464722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102385019|NCT02464722|Adrenergic Agents|adrenergic agents|mesh-ancestor
102385020|NCT02464722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102385021|NCT02464722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385022|NCT02464722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102385023|NCT02464722|Anesthetics, General|anesthetics, general|mesh-ancestor
102385024|NCT02464722|Anesthetics|anesthetics|mesh-ancestor
102385025|NCT02464722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102385026|NCT02464722|Narcotics|narcotics|mesh-ancestor
102385027|NCT02464722|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102385028|NCT02464722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102385029|NCT02464722|Autonomic Agents|autonomic agents|mesh-ancestor
102385030|NCT02464722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102101184|NCT03460808|Antioxidants|antioxidants|mesh-ancestor
102385031|NCT02464722|Respiratory System Agents|respiratory system agents|mesh-ancestor
102385032|NCT02464722|Mydriatics|mydriatics|mesh-ancestor
102385033|NCT02464722|Sympathomimetics|sympathomimetics|mesh-ancestor
102385034|NCT02464722|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102101303|NCT04768166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102385035|NCT02464722|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102385036|NCT02464722|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102385037|NCT02464722|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102385038|NCT01991548|Insulin|insulin|mesh-list
102385039|NCT01991548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102385040|NCT01991548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385041|NCT03298854|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
102385042|NCT03298854|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102385043|NCT03298854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385044|NCT02461914|Warfarin|warfarin|mesh-list
102385045|NCT02461914|Anticoagulants|anticoagulants|mesh-ancestor
102385046|NCT01991860|Amisulpride|amisulpride|mesh-list
102385047|NCT01991860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102385048|NCT01991860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102385049|NCT01991860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102385050|NCT01991860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385051|NCT01991860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102101601|NCT00944970|Adenosine|adenosine|mesh-list
102385052|NCT01991860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102385053|NCT01991860|Dopamine Agents|dopamine agents|mesh-ancestor
102385054|NCT01991860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102385055|NCT01991860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385056|NCT01991860|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102385057|NCT01991860|Antidepressive Agents|antidepressive agents|mesh-ancestor
102385058|NCT01873131|Timolol|timolol|mesh-list
102385059|NCT01873131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385060|NCT01873131|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102385061|NCT01873131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102385062|NCT01873131|Adrenergic Agents|adrenergic agents|mesh-ancestor
102101746|NCT00836472|Metformin|metformin|mesh-list
102385063|NCT01873131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102385064|NCT01873131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385065|NCT01873131|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102385066|NCT01873131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102385067|NCT02463552|Naproxen|naproxen|mesh-list
102385068|NCT02463552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102385069|NCT02463552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102385070|NCT02463552|Analgesics|analgesics|mesh-ancestor
102385071|NCT02463552|Sensory System Agents|sensory system agents|mesh-ancestor
102385072|NCT02463552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102385073|NCT02463552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385074|NCT02463552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102385075|NCT02463552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102385076|NCT02463552|Gout Suppressants|gout suppressants|mesh-ancestor
102385077|NCT02463552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102385078|NCT02463552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102385079|NCT02463552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385080|NCT01992016|Ranolazine|ranolazine|mesh-list
102385081|NCT01992016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102385082|NCT01992016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102385083|NCT01992016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385084|NCT01871571|Leucovorin|leucovorin|mesh-list
102385085|NCT01871571|Bevacizumab|bevacizumab|mesh-list
102385086|NCT01871571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102385087|NCT01871571|Fluorouracil|fluorouracil|mesh-list
102385088|NCT01871571|Oxaliplatin|oxaliplatin|mesh-list
102385089|NCT01871571|Antibodies|antibodies|mesh-list
102385090|NCT01871571|Immunoglobulins|immunoglobulins|mesh-list
102385091|NCT01871571|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102385092|NCT01871571|Levoleucovorin|levoleucovorin|mesh-list
102385093|NCT01871571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102385094|NCT01871571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102385095|NCT01871571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102385096|NCT01871571|Growth Substances|growth substances|mesh-ancestor
102385097|NCT01871571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385098|NCT01871571|Growth Inhibitors|growth inhibitors|mesh-ancestor
102385099|NCT01871571|Immunologic Factors|immunologic factors|mesh-ancestor
102385100|NCT01871571|Antimetabolites|antimetabolites|mesh-ancestor
102385101|NCT01871571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385102|NCT01871571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102385103|NCT01871571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102385104|NCT01871571|Antidotes|antidotes|mesh-ancestor
102385105|NCT01871571|Protective Agents|protective agents|mesh-ancestor
102385106|NCT01871571|Vitamin B Complex|vitamin b complex|mesh-ancestor
102385107|NCT01871571|Vitamins|vitamins|mesh-ancestor
102385108|NCT01871571|Micronutrients|micronutrients|mesh-ancestor
102385109|NCT02461368|Triamcinolone|triamcinolone|mesh-list
102385110|NCT02461368|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102385111|NCT02461368|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102385112|NCT02461368|Lidocaine|lidocaine|mesh-list
102385113|NCT02461368|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102385114|NCT02461368|Anesthetics, Local|anesthetics, local|mesh-ancestor
102385115|NCT02461368|Anesthetics|anesthetics|mesh-ancestor
102385116|NCT02461368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102385117|NCT02461368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385118|NCT02461368|Sensory System Agents|sensory system agents|mesh-ancestor
102385119|NCT02461368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102385120|NCT02461368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102385121|NCT02461368|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102385122|NCT02461368|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102385123|NCT02461368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102385124|NCT02461368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385125|NCT02461368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102385126|NCT02461368|Glucocorticoids|glucocorticoids|mesh-ancestor
102385127|NCT02461368|Hormones|hormones|mesh-ancestor
102385128|NCT02461368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102385129|NCT02461368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102385130|NCT02461368|Immunologic Factors|immunologic factors|mesh-ancestor
102385131|NCT02461368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102385132|NCT01422759|Spironolactone|spironolactone|mesh-list
102385133|NCT01422759|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102385134|NCT01422759|Hormone Antagonists|hormone antagonists|mesh-ancestor
102385135|NCT01422759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102385136|NCT01422759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385137|NCT01422759|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102385138|NCT01422759|Diuretics|diuretics|mesh-ancestor
102385139|NCT01422759|Natriuretic Agents|natriuretic agents|mesh-ancestor
102385140|NCT01992172|Sunscreening Agents|sunscreening agents|mesh-list
102385141|NCT01992172|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102385142|NCT01992172|Protective Agents|protective agents|mesh-ancestor
102385143|NCT01992172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385144|NCT01992172|Dermatologic Agents|dermatologic agents|mesh-ancestor
102385145|NCT03296982|Enoxaparin|enoxaparin|mesh-list
102385146|NCT03296982|Edoxaban|edoxaban|mesh-list
102385147|NCT03296982|Anticoagulants|anticoagulants|mesh-ancestor
102385148|NCT03296982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102385149|NCT03296982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102385150|NCT03296982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385151|NCT03296982|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102385152|NCT03296982|Antithrombins|antithrombins|mesh-ancestor
102385153|NCT03296982|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102385154|NCT03296982|Protease Inhibitors|protease inhibitors|mesh-ancestor
102385155|NCT03296982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102385156|NCT01895829|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102385157|NCT01895829|Hematinics|hematinics|mesh-ancestor
102385158|NCT01895829|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102385159|NCT01895829|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102385160|NCT03298698|Prednisone|prednisone|mesh-list
102385161|NCT03298698|Prednisolone|prednisolone|mesh-list
102385162|NCT03298698|Rituximab|rituximab|mesh-list
102385163|NCT03298698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102385164|NCT03298698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102385165|NCT03298698|Immunologic Factors|immunologic factors|mesh-ancestor
102385166|NCT03298698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385167|NCT03298698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102385168|NCT03298698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102385169|NCT03298698|Glucocorticoids|glucocorticoids|mesh-ancestor
102385170|NCT03298698|Hormones|hormones|mesh-ancestor
102385171|NCT03298698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102385172|NCT03298698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102385173|NCT03389620|Dexamethasone|dexamethasone|mesh-list
102385174|NCT03389620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102385175|NCT03389620|Antiemetics|antiemetics|mesh-ancestor
102385176|NCT03389620|Autonomic Agents|autonomic agents|mesh-ancestor
102385177|NCT03389620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102385178|NCT03389620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385179|NCT03389620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102385180|NCT03389620|Glucocorticoids|glucocorticoids|mesh-ancestor
102385181|NCT03389620|Hormones|hormones|mesh-ancestor
102102020|NCT05320874|Immunologic Factors|immunologic factors|mesh-ancestor
102385182|NCT03389620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102385183|NCT03389620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102385184|NCT03389620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102385185|NCT02463942|Doxycycline|doxycycline|mesh-list
102385186|NCT02463942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102385187|NCT02463942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102385188|NCT02463942|Antimalarials|antimalarials|mesh-ancestor
102385189|NCT02463942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102385190|NCT02463942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102385191|NCT03298542|Golimumab|golimumab|mesh-list
102385192|NCT03298542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102385193|NCT03298542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102385194|NCT03298542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102385195|NCT03298542|Immunologic Factors|immunologic factors|mesh-ancestor
102385196|NCT03298542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385197|NCT03296670|Nitroglycerin|nitroglycerin|mesh-list
102385198|NCT03296670|Alprostadil|alprostadil|mesh-list
102385199|NCT03296670|Vasodilator Agents|vasodilator agents|mesh-ancestor
102385200|NCT03296670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102385201|NCT03296670|Urological Agents|urological agents|mesh-ancestor
102385202|NCT03298464|Pioglitazone|pioglitazone|mesh-list
102385203|NCT03298464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102385204|NCT03298464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385205|NCT01852071|Busulfan|busulfan|mesh-list
102385206|NCT01852071|Alkylating Agents|alkylating agents|mesh-ancestor
102385207|NCT01852071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385208|NCT01852071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102102122|NCT00828854|Entinostat|entinostat|mesh-list
102385209|NCT01852071|Immunologic Factors|immunologic factors|mesh-ancestor
102385210|NCT01852071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385211|NCT01852071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102385212|NCT01852071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102385213|NCT01852071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102385214|NCT04084548|Lidocaine|lidocaine|mesh-list
102385215|NCT04084548|Ketamine|ketamine|mesh-list
102385216|NCT04084548|Anesthetics, Local|anesthetics, local|mesh-ancestor
102196954|NCT00794677|Ezetimibe|ezetimibe|mesh-list
102385217|NCT04084548|Anesthetics|anesthetics|mesh-ancestor
102385218|NCT04084548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102385219|NCT04084548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385220|NCT04084548|Sensory System Agents|sensory system agents|mesh-ancestor
102385221|NCT04084548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102385222|NCT04084548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102385223|NCT04084548|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102385224|NCT04084548|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102385225|NCT04084548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102385226|NCT04084548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385228|NCT04084548|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102385229|NCT04084548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102385230|NCT04084548|Anesthetics, General|anesthetics, general|mesh-ancestor
102385231|NCT04084548|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102385232|NCT04084548|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102385233|NCT04084548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102385234|NCT02059642|Metadoxine|metadoxine|mesh-list
102385235|NCT02059642|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102385236|NCT03296358|Dexamethasone|dexamethasone|mesh-list
102102446|NCT00747318|Xhance|xhance|mesh-list
102385237|NCT03296358|Prednisolone|prednisolone|mesh-list
102385238|NCT03296358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102385239|NCT03296358|Antiemetics|antiemetics|mesh-ancestor
102385240|NCT03296358|Autonomic Agents|autonomic agents|mesh-ancestor
102385241|NCT03296358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102385242|NCT03296358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385243|NCT03296358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102385244|NCT03296358|Glucocorticoids|glucocorticoids|mesh-ancestor
102385245|NCT03296358|Hormones|hormones|mesh-ancestor
102385246|NCT03296358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102385247|NCT03296358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102385248|NCT03296358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102385249|NCT04756323|Vaccines|vaccines|mesh-list
102385250|NCT04756323|Immunologic Factors|immunologic factors|mesh-ancestor
102385251|NCT04756323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385252|NCT00469755|Nicotinic Acids|nicotinic acids|mesh-list
102385253|NCT00469755|Adapalene|adapalene|mesh-list
102385254|NCT00469755|Tazarotene|tazarotene|mesh-list
102385255|NCT00469755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102385256|NCT00469755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102385257|NCT00469755|Analgesics|analgesics|mesh-ancestor
102385258|NCT00469755|Sensory System Agents|sensory system agents|mesh-ancestor
102385259|NCT00469755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102385260|NCT00469755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385261|NCT00469755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102385262|NCT00469755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102385263|NCT00469755|Dermatologic Agents|dermatologic agents|mesh-ancestor
102385264|NCT00469755|Keratolytic Agents|keratolytic agents|mesh-ancestor
102385265|NCT00469755|Vitamin B Complex|vitamin b complex|mesh-ancestor
102385266|NCT00469755|Vitamins|vitamins|mesh-ancestor
102385267|NCT00469755|Micronutrients|micronutrients|mesh-ancestor
102385268|NCT00453531|Acetylcholine|acetylcholine|mesh-list
102385269|NCT00453531|Vasodilator Agents|vasodilator agents|mesh-ancestor
102385270|NCT00453531|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102385271|NCT00453531|Cholinergic Agents|cholinergic agents|mesh-ancestor
102385272|NCT00453531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102385273|NCT00453531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385274|NCT00453531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385275|NCT03295968|Ibuprofen|ibuprofen|mesh-list
102385276|NCT03295968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102385277|NCT03295968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102385278|NCT03295968|Analgesics|analgesics|mesh-ancestor
102385279|NCT03295968|Sensory System Agents|sensory system agents|mesh-ancestor
102102710|NCT02065947|Lidocaine|lidocaine|mesh-list
102385280|NCT03295968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102385281|NCT03295968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385282|NCT03295968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102385283|NCT03295968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102385284|NCT03295968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102385285|NCT03295968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102385286|NCT03295968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385287|NCT03298074|Etoposide|etoposide|mesh-list
102385288|NCT03298074|Apatinib|apatinib|mesh-list
102385289|NCT03298074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102385290|NCT03298074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102102926|NCT03435302|Temozolomide|temozolomide|mesh-list
102385291|NCT03298074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102385292|NCT03298074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102385293|NCT03298074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102385294|NCT03298074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385295|NCT03298074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102385296|NCT01992874|Niacinamide|niacinamide|mesh-list
102385297|NCT01992874|Vitamin B Complex|vitamin b complex|mesh-ancestor
102385298|NCT01992874|Vitamins|vitamins|mesh-ancestor
102385299|NCT01992874|Micronutrients|micronutrients|mesh-ancestor
102385300|NCT01992874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385301|NCT04755543|Fluorouracil|fluorouracil|mesh-list
102103076|NCT02281266|Entecavir|entecavir|mesh-list
102385302|NCT04755543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102385303|NCT04755543|Antimetabolites|antimetabolites|mesh-ancestor
102385304|NCT04755543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103134|NCT02071641|Growth Substances|growth substances|mesh-ancestor
102385305|NCT04755543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102385306|NCT04755543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101556598|NCT05645536|Exemestane|exemestane|mesh-list
102385307|NCT04755543|Immunologic Factors|immunologic factors|mesh-ancestor
102385308|NCT04755543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385309|NCT01993108|Naltrexone|naltrexone|mesh-list
102385310|NCT01993108|Methylphenidate|methylphenidate|mesh-list
102385311|NCT01993108|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102103319|NCT02792517|Estradiol|estradiol|mesh-list
102385312|NCT01993108|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102385313|NCT01993108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385314|NCT01993108|Sensory System Agents|sensory system agents|mesh-ancestor
102103392|NCT02072811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102385315|NCT01993108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102385316|NCT01993108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102385317|NCT01993108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102103463|NCT01369485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102385318|NCT01993108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102385319|NCT01993108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102385320|NCT01993108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385321|NCT01993108|Dopamine Agents|dopamine agents|mesh-ancestor
102385322|NCT01993108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102385323|NCT02307526|Bromides|bromides|mesh-list
102385324|NCT02307526|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
102103608|NCT00583830|Paclitaxel|paclitaxel|mesh-list
102385325|NCT02307526|Anticonvulsants|anticonvulsants|mesh-ancestor
102385326|NCT02307526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102385327|NCT02307526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102385328|NCT02307526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385329|NCT02307526|Cholinergic Agents|cholinergic agents|mesh-ancestor
102385330|NCT02307526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102385331|NCT02307526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385332|NCT01371201|Sunitinib|sunitinib|mesh-list
102385333|NCT01371201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102385334|NCT01371201|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102385335|NCT01371201|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102385336|NCT01371201|Growth Substances|growth substances|mesh-ancestor
102385337|NCT01371201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385338|NCT01371201|Growth Inhibitors|growth inhibitors|mesh-ancestor
102385339|NCT01371201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102385340|NCT01371201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102385341|NCT01371201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385342|NCT00436527|Metronidazole|metronidazole|mesh-list
102385343|NCT00436527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102385344|NCT00436527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102385345|NCT00436527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102103874|NCT02081391|Tapentadol|tapentadol|mesh-list
102385346|NCT00436527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102385347|NCT02307916|Mitogens|mitogens|mesh-list
102385348|NCT02307916|Mitosis Modulators|mitosis modulators|mesh-ancestor
102103948|NCT00412932|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102385349|NCT02307916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385350|NCT00419367|Vorinostat|vorinostat|mesh-list
102385351|NCT00419367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102385352|NCT00419367|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102385353|NCT00419367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102385354|NCT00419367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385355|NCT01994746|Glucagon|glucagon|mesh-list
102104020|NCT02282826|Antiviral Agents|antiviral agents|mesh-ancestor
102385356|NCT01994746|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102385357|NCT01994746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102385358|NCT01994746|Hormones|hormones|mesh-ancestor
102385359|NCT01994746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102385360|NCT01994746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385361|NCT01994746|Incretins|incretins|mesh-ancestor
102385362|NCT00291525|Warfarin|warfarin|mesh-list
102385363|NCT00291525|Anticoagulants|anticoagulants|mesh-ancestor
102385364|NCT01337349|Pentoxifylline|pentoxifylline|mesh-list
102385365|NCT01337349|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102385366|NCT01337349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102385367|NCT01337349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385368|NCT01337349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102385369|NCT01337349|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102385370|NCT01337349|Protective Agents|protective agents|mesh-ancestor
102385371|NCT01337349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385372|NCT01337349|Vasodilator Agents|vasodilator agents|mesh-ancestor
102385373|NCT01337349|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102385374|NCT01337349|Antioxidants|antioxidants|mesh-ancestor
102385376|NCT01999348|Bimatoprost|bimatoprost|mesh-list
102385377|NCT01999348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102385378|NCT01999348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102385379|NCT01999348|Adrenergic Agents|adrenergic agents|mesh-ancestor
102385380|NCT01999348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102385381|NCT01999348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385382|NCT01999348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385383|NCT01999348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102385384|NCT01999348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102385385|NCT00280761|Fluorouracil|fluorouracil|mesh-list
102385386|NCT00280761|Capecitabine|capecitabine|mesh-list
102385387|NCT00280761|Antimetabolites|antimetabolites|mesh-ancestor
102385388|NCT00280761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385389|NCT00280761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102385390|NCT00280761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102385391|NCT00280761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102385392|NCT00280761|Immunologic Factors|immunologic factors|mesh-ancestor
102385393|NCT00280761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385394|NCT02463318|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102385395|NCT02463318|Melatonin|melatonin|mesh-list
102385396|NCT02463318|Antioxidants|antioxidants|mesh-ancestor
102385397|NCT02463318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385398|NCT02463318|Protective Agents|protective agents|mesh-ancestor
102385399|NCT02463318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385400|NCT02463318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102104321|NCT02082405|Dexamethasone|dexamethasone|mesh-list
102385401|NCT02463318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102385402|NCT02463318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102385403|NCT01436968|Valacyclovir|valacyclovir|mesh-list
102385404|NCT01436968|Antiviral Agents|antiviral agents|mesh-ancestor
102104407|NCT00345618|Biotin|biotin|mesh-list
102385405|NCT01436968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102385406|NCT02462772|Cabotegravir|cabotegravir|mesh-list
102385407|NCT02462772|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102385408|NCT02462772|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102385409|NCT02462772|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102385410|NCT02462772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102385411|NCT02462772|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102385412|NCT02462772|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102385413|NCT02462772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102385414|NCT02462772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385415|NCT02462772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102385416|NCT02462772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102104534|NCT04792840|Letrozole|letrozole|mesh-list
102385417|NCT02462772|Antiviral Agents|antiviral agents|mesh-ancestor
102385418|NCT02462772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102385419|NCT02716194|Factor VIII|factor viii|mesh-list
102385420|NCT02716194|Coagulants|coagulants|mesh-ancestor
102385421|NCT02461056|Ibuprofen|ibuprofen|mesh-list
102385422|NCT02461056|Hydromorphone|hydromorphone|mesh-list
102104600|NCT02090829|Oxytocin|oxytocin|mesh-list
102385423|NCT02461056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102104670|NCT04801264|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102385424|NCT02461056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102385425|NCT02461056|Analgesics|analgesics|mesh-ancestor
102385426|NCT02461056|Sensory System Agents|sensory system agents|mesh-ancestor
102385427|NCT02461056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102385428|NCT02461056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385429|NCT02461056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102385430|NCT02461056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102385431|NCT02461056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102385432|NCT02461056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102385433|NCT02461056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385434|NCT02461056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102385435|NCT02461056|Narcotics|narcotics|mesh-ancestor
102385436|NCT02461056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102385437|NCT01173172|Boron|boron|mesh-list
102385438|NCT01173172|Trace Elements|trace elements|mesh-ancestor
102385439|NCT01173172|Micronutrients|micronutrients|mesh-ancestor
102385440|NCT01173172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385441|NCT00003270|Cyclosporine|cyclosporine|mesh-list
102385442|NCT00003270|Methylprednisolone|methylprednisolone|mesh-list
102385443|NCT00003270|Cyclophosphamide|cyclophosphamide|mesh-list
102385444|NCT00003270|Busulfan|busulfan|mesh-list
102385445|NCT00003270|Cyclosporins|cyclosporins|mesh-list
102385446|NCT00003270|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102385447|NCT00003270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102385448|NCT00003270|Immunologic Factors|immunologic factors|mesh-ancestor
102385449|NCT00003270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385450|NCT00003270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102385451|NCT00003270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102385452|NCT00003270|Alkylating Agents|alkylating agents|mesh-ancestor
102385453|NCT00003270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385454|NCT00003270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102385455|NCT00003270|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102385456|NCT00003270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102385457|NCT00003270|Antifungal Agents|antifungal agents|mesh-ancestor
102385458|NCT00003270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102385459|NCT00003270|Dermatologic Agents|dermatologic agents|mesh-ancestor
102385460|NCT00003270|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102385461|NCT00003270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102385462|NCT00003270|Antiemetics|antiemetics|mesh-ancestor
102385463|NCT00003270|Autonomic Agents|autonomic agents|mesh-ancestor
102385464|NCT00003270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102385465|NCT00003270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102385466|NCT00003270|Glucocorticoids|glucocorticoids|mesh-ancestor
102385467|NCT00003270|Hormones|hormones|mesh-ancestor
102105383|NCT05809453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102385468|NCT00003270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102385469|NCT00003270|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102385470|NCT00003270|Protective Agents|protective agents|mesh-ancestor
102385471|NCT02005354|Nitrous Oxide|nitrous oxide|mesh-list
102385472|NCT02005354|Anesthetics|anesthetics|mesh-list
102385473|NCT02005354|Anesthetics, Local|anesthetics, local|mesh-list
102385474|NCT02005354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102385475|NCT02005354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385476|NCT02005354|Sensory System Agents|sensory system agents|mesh-ancestor
102385477|NCT02005354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102385478|NCT02005354|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102385479|NCT02005354|Anesthetics, General|anesthetics, general|mesh-ancestor
102385480|NCT02005354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102385481|NCT02005354|Analgesics|analgesics|mesh-ancestor
102385482|NCT03290820|Aspirin|aspirin|mesh-list
102385483|NCT03290820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102385484|NCT03290820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102385485|NCT03290820|Analgesics|analgesics|mesh-ancestor
102385486|NCT03290820|Sensory System Agents|sensory system agents|mesh-ancestor
102385487|NCT03290820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102385488|NCT03290820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385489|NCT03290820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102385490|NCT03290820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102385491|NCT03290820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102385492|NCT03290820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102385493|NCT03290820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385494|NCT03290820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102385495|NCT03290820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102385496|NCT03290820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102385497|NCT03290820|Antipyretics|antipyretics|mesh-ancestor
102385498|NCT03295110|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102385499|NCT03773484|Analgesics, Opioid|analgesics, opioid|mesh-list
102385500|NCT03773484|Narcotics|narcotics|mesh-ancestor
102385501|NCT03773484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102385502|NCT03773484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385503|NCT03773484|Analgesics|analgesics|mesh-ancestor
102385504|NCT03773484|Sensory System Agents|sensory system agents|mesh-ancestor
102105727|NCT05107427|Avelumab|avelumab|mesh-list
102385505|NCT03773484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102385506|NCT03283410|Propofol|propofol|mesh-list
102385507|NCT03283410|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102105804|NCT04866706|Hyaluronic Acid|hyaluronic acid|mesh-list
102385508|NCT03283410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102385509|NCT03283410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385510|NCT03283410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102385511|NCT03283410|Anesthetics, General|anesthetics, general|mesh-ancestor
102385512|NCT03283410|Anesthetics|anesthetics|mesh-ancestor
102385513|NCT04318704|Ifenprodil|ifenprodil|mesh-list
102385514|NCT04318704|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102385515|NCT04318704|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102385516|NCT04318704|Adrenergic Agents|adrenergic agents|mesh-ancestor
102385517|NCT04318704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102385518|NCT04318704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385519|NCT04318704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385520|NCT04318704|Vasodilator Agents|vasodilator agents|mesh-ancestor
102385521|NCT04318704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102385522|NCT04318704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102385523|NCT03283176|Folic Acid|folic acid|mesh-list
102385524|NCT03283176|Vitamin B 12|vitamin b 12|mesh-list
102385525|NCT03283176|Hydroxocobalamin|hydroxocobalamin|mesh-list
102385526|NCT03283176|Vitamins|vitamins|mesh-ancestor
102385527|NCT03283176|Micronutrients|micronutrients|mesh-ancestor
102385528|NCT03283176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385529|NCT03283176|Hematinics|hematinics|mesh-ancestor
102385530|NCT03283176|Vitamin B Complex|vitamin b complex|mesh-ancestor
102385531|NCT03290430|Nicotine|nicotine|mesh-list
102385532|NCT03290430|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102385533|NCT03290430|Autonomic Agents|autonomic agents|mesh-ancestor
102385534|NCT03290430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102385535|NCT03290430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385536|NCT03290430|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102385537|NCT03290430|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102385538|NCT03290430|Cholinergic Agents|cholinergic agents|mesh-ancestor
102385539|NCT03290430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102385540|NCT03290430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385541|NCT03294798|Interferons|interferons|mesh-list
102385542|NCT03294798|Interferon-alpha|interferon-alpha|mesh-list
102385543|NCT03294798|Interferon alpha-2|interferon alpha-2|mesh-list
102385544|NCT03294798|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102385545|NCT03294798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102385546|NCT03294798|Antiviral Agents|antiviral agents|mesh-ancestor
102385547|NCT03294798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102385548|NCT03294798|Immunologic Factors|immunologic factors|mesh-ancestor
102385549|NCT03294798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385550|NCT04488744|Nicotine|nicotine|mesh-list
102385551|NCT04488744|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102385552|NCT04488744|Autonomic Agents|autonomic agents|mesh-ancestor
102385553|NCT04488744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102385554|NCT04488744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106217|NCT03783442|Paclitaxel|paclitaxel|mesh-list
102385555|NCT04488744|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102385556|NCT04488744|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102385557|NCT04488744|Cholinergic Agents|cholinergic agents|mesh-ancestor
102385558|NCT04488744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102385559|NCT04488744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385560|NCT02005666|Clindamycin|clindamycin|mesh-list
102385561|NCT02005666|Clindamycin palmitate|clindamycin palmitate|mesh-list
102385562|NCT02005666|Clindamycin phosphate|clindamycin phosphate|mesh-list
102385563|NCT02005666|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102385564|NCT02005666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102385565|NCT02005666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102385566|NCT02005666|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102106349|NCT03507699|Nivolumab|nivolumab|mesh-list
102385567|NCT02005666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102385568|NCT02005666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385569|NCT02005666|Dermatologic Agents|dermatologic agents|mesh-ancestor
102385570|NCT03283020|Naltrexone|naltrexone|mesh-list
102385571|NCT03283020|Remifentanil|remifentanil|mesh-list
102385572|NCT03283020|Methylnaltrexone|methylnaltrexone|mesh-list
102385573|NCT03283020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102385574|NCT03283020|Narcotics|narcotics|mesh-ancestor
102385575|NCT03283020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102385576|NCT03283020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385577|NCT03283020|Analgesics|analgesics|mesh-ancestor
102385578|NCT03283020|Sensory System Agents|sensory system agents|mesh-ancestor
102385579|NCT03283020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102385580|NCT03283020|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102385581|NCT03283020|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102385582|NCT00494182|Paclitaxel|paclitaxel|mesh-list
102385583|NCT00494182|Carboplatin|carboplatin|mesh-list
102385584|NCT00494182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102385585|NCT00494182|Sorafenib|sorafenib|mesh-list
102385586|NCT00494182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102385587|NCT00494182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102385588|NCT00494182|Tubulin Modulators|tubulin modulators|mesh-ancestor
102385589|NCT00494182|Antimitotic Agents|antimitotic agents|mesh-ancestor
102385590|NCT00494182|Mitosis Modulators|mitosis modulators|mesh-ancestor
102385591|NCT00494182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385592|NCT00494182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102385593|NCT00494182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102385594|NCT02006056|Ondansetron|ondansetron|mesh-list
102385595|NCT02006056|Antiemetics|antiemetics|mesh-ancestor
102385596|NCT02006056|Autonomic Agents|autonomic agents|mesh-ancestor
102385597|NCT02006056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102385598|NCT02006056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385599|NCT02006056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102385600|NCT02006056|Antipruritics|antipruritics|mesh-ancestor
102385601|NCT02006056|Dermatologic Agents|dermatologic agents|mesh-ancestor
102106682|NCT01546987|Bicalutamide|bicalutamide|mesh-list
102385602|NCT02006056|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102385603|NCT02006056|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102385604|NCT02006056|Serotonin Agents|serotonin agents|mesh-ancestor
102385605|NCT02006056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102385606|NCT02006056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106789|NCT00000524|Prednisone|prednisone|mesh-list
102385607|NCT03290196|Bupivacaine|bupivacaine|mesh-list
102385608|NCT03290196|Anesthetics, Local|anesthetics, local|mesh-ancestor
102385609|NCT03290196|Anesthetics|anesthetics|mesh-ancestor
102106824|NCT02097069|Hematinics|hematinics|mesh-ancestor
102385610|NCT03290196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102385611|NCT03290196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385612|NCT03290196|Sensory System Agents|sensory system agents|mesh-ancestor
102385613|NCT03290196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102385614|NCT02006836|Insulin|insulin|mesh-list
102385615|NCT02006836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102385616|NCT02006836|Metformin|metformin|mesh-list
102385617|NCT02006836|Insulin Aspart|insulin aspart|mesh-list
102385618|NCT02006836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102385619|NCT02006836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385620|NCT02068846|Ciprofloxacin|ciprofloxacin|mesh-list
102385621|NCT02068846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102385622|NCT02068846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102385623|NCT02068846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102385624|NCT02068846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102385625|NCT02068846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102385626|NCT02068846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385627|NCT02068846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102385628|NCT02068846|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102385629|NCT02068846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102385630|NCT03294486|Flucytosine|flucytosine|mesh-list
102385631|NCT03294486|Antifungal Agents|antifungal agents|mesh-ancestor
102385632|NCT03294486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102385633|NCT03294486|Antimetabolites|antimetabolites|mesh-ancestor
102107249|NCT05040568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102385634|NCT03294486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385635|NCT03294252|Leucovorin|leucovorin|mesh-list
102385636|NCT03294252|Folic Acid|folic acid|mesh-list
102385637|NCT03294252|Fluorouracil|fluorouracil|mesh-list
102385638|NCT03294252|Oxaliplatin|oxaliplatin|mesh-list
102385639|NCT03294252|Levoleucovorin|levoleucovorin|mesh-list
102385640|NCT03294252|Antimetabolites|antimetabolites|mesh-ancestor
102107391|NCT05166668|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102385641|NCT03294252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385642|NCT03294252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102385643|NCT03294252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102385644|NCT03294252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102385645|NCT03294252|Immunologic Factors|immunologic factors|mesh-ancestor
102385646|NCT03294252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385647|NCT03294252|Antidotes|antidotes|mesh-ancestor
102385648|NCT03294252|Protective Agents|protective agents|mesh-ancestor
102385649|NCT03294252|Vitamin B Complex|vitamin b complex|mesh-ancestor
102385650|NCT03294252|Vitamins|vitamins|mesh-ancestor
102385651|NCT03294252|Micronutrients|micronutrients|mesh-ancestor
102385652|NCT03294252|Hematinics|hematinics|mesh-ancestor
102107688|NCT03126656|Hormones|hormones|mesh-ancestor
102385653|NCT03294174|Ropivacaine|ropivacaine|mesh-list
102385654|NCT03294174|Anesthetics, Local|anesthetics, local|mesh-ancestor
102385655|NCT03294174|Anesthetics|anesthetics|mesh-ancestor
102385656|NCT03294174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102385657|NCT03294174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385658|NCT03294174|Sensory System Agents|sensory system agents|mesh-ancestor
102385659|NCT03294174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102385660|NCT03289338|Zoledronic Acid|zoledronic acid|mesh-list
102385661|NCT03289338|Methylprednisolone|methylprednisolone|mesh-list
102385662|NCT03289338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102385663|NCT03289338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102385664|NCT03289338|Prednisolone|prednisolone|mesh-list
102385665|NCT03289338|Prednisolone acetate|prednisolone acetate|mesh-list
102385666|NCT03289338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102385667|NCT03289338|Prednisolone phosphate|prednisolone phosphate|mesh-list
102385668|NCT03289338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102385669|NCT03289338|Antiemetics|antiemetics|mesh-ancestor
102385670|NCT03289338|Autonomic Agents|autonomic agents|mesh-ancestor
102385671|NCT03289338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102385672|NCT03289338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385673|NCT03289338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102108063|NCT02108301|Tacrolimus|tacrolimus|mesh-list
102385674|NCT03289338|Glucocorticoids|glucocorticoids|mesh-ancestor
102385675|NCT03289338|Hormones|hormones|mesh-ancestor
102385676|NCT03289338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102385677|NCT03289338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102108180|NCT02112903|Serotonin Agents|serotonin agents|mesh-ancestor
102385679|NCT03289338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102385680|NCT03289338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102385681|NCT03289338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102385682|NCT02069704|Leucovorin|leucovorin|mesh-list
102385683|NCT02069704|Folic Acid|folic acid|mesh-list
102385684|NCT02069704|Bevacizumab|bevacizumab|mesh-list
102385685|NCT02069704|Fluorouracil|fluorouracil|mesh-list
102385686|NCT02069704|Oxaliplatin|oxaliplatin|mesh-list
102385687|NCT02069704|Irinotecan|irinotecan|mesh-list
102108255|NCT02118753|Eplerenone|eplerenone|mesh-list
102385688|NCT02069704|Levoleucovorin|levoleucovorin|mesh-list
102385689|NCT02069704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102385690|NCT02069704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102385691|NCT02069704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102108326|NCT01330017|Loratadine|loratadine|mesh-list
102385692|NCT02069704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102385693|NCT02069704|Growth Substances|growth substances|mesh-ancestor
102385694|NCT02069704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385695|NCT02069704|Growth Inhibitors|growth inhibitors|mesh-ancestor
102385696|NCT02069704|Antimetabolites|antimetabolites|mesh-ancestor
102385697|NCT02069704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108392|NCT02986659|Metformin|metformin|mesh-list
102385698|NCT02069704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102385699|NCT02069704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102385700|NCT02069704|Immunologic Factors|immunologic factors|mesh-ancestor
102385701|NCT02069704|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102385702|NCT02069704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102108448|NCT02123589|Anesthetics|anesthetics|mesh-ancestor
102385703|NCT02069704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102385704|NCT02069704|Antidotes|antidotes|mesh-ancestor
102385705|NCT02069704|Protective Agents|protective agents|mesh-ancestor
102385706|NCT02069704|Vitamin B Complex|vitamin b complex|mesh-ancestor
102385707|NCT02069704|Vitamins|vitamins|mesh-ancestor
102385708|NCT02069704|Micronutrients|micronutrients|mesh-ancestor
102385709|NCT02069704|Hematinics|hematinics|mesh-ancestor
102385710|NCT02314546|Lidocaine|lidocaine|mesh-list
102385711|NCT02314546|Midazolam|midazolam|mesh-list
102385712|NCT02314546|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102385713|NCT02314546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102385714|NCT02314546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102385715|NCT02314546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385716|NCT02314546|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102385717|NCT02314546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102385718|NCT02314546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102385719|NCT02314546|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102385720|NCT02314546|Anesthetics, General|anesthetics, general|mesh-ancestor
102385721|NCT02314546|Anesthetics|anesthetics|mesh-ancestor
102108736|NCT01368081|Metformin|metformin|mesh-list
102385722|NCT02314546|GABA Modulators|gaba modulators|mesh-ancestor
102385723|NCT02314546|GABA Agents|gaba agents|mesh-ancestor
102108797|NCT03551067|Anesthetics|anesthetics|mesh-ancestor
102385724|NCT02314546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102385725|NCT02314546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385726|NCT02314546|Anesthetics, Local|anesthetics, local|mesh-ancestor
102385727|NCT02314546|Sensory System Agents|sensory system agents|mesh-ancestor
102385728|NCT02314546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102385729|NCT02314546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102109022|NCT02122809|Chiauranib|chiauranib|mesh-list
102385730|NCT02314546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102385731|NCT02314546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102385732|NCT02314546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102385733|NCT03289260|Imiquimod|imiquimod|mesh-list
102385734|NCT03289260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102385735|NCT03289260|Immunologic Factors|immunologic factors|mesh-ancestor
102385736|NCT03289260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385737|NCT03289260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102385738|NCT03289260|Interferon Inducers|interferon inducers|mesh-ancestor
102385739|NCT03289182|Rituximab|rituximab|mesh-list
102385740|NCT03289182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102385741|NCT03289182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102385742|NCT03289182|Immunologic Factors|immunologic factors|mesh-ancestor
102385743|NCT03289182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385744|NCT03289182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102385745|NCT03289026|Aripiprazole|aripiprazole|mesh-list
102385746|NCT03289026|Antidepressive Agents|antidepressive agents|mesh-ancestor
102385747|NCT03289026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102385748|NCT03289026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102385749|NCT03289026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102385750|NCT03289026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102385751|NCT03289026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385752|NCT03289026|Dopamine Agonists|dopamine agonists|mesh-ancestor
102385753|NCT03289026|Dopamine Agents|dopamine agents|mesh-ancestor
102385754|NCT03289026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102385755|NCT03289026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385756|NCT03289026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102385757|NCT03289026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102385758|NCT03289026|Serotonin Agents|serotonin agents|mesh-ancestor
102385759|NCT03289026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102385760|NCT03289026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102385761|NCT03289026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102385762|NCT03289026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102385763|NCT02460510|Mannitol|mannitol|mesh-list
102385764|NCT02460510|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102385765|NCT02460510|Diuretics|diuretics|mesh-ancestor
102385766|NCT02460510|Natriuretic Agents|natriuretic agents|mesh-ancestor
102385767|NCT02460510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385768|NCT02334436|Botulinum Toxins|botulinum toxins|mesh-list
102109375|NCT02129985|Metformin|metformin|mesh-list
102385769|NCT02334436|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102385770|NCT02334436|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102385771|NCT02334436|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102385772|NCT02334436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102385773|NCT02334436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385774|NCT02334436|Cholinergic Agents|cholinergic agents|mesh-ancestor
102385775|NCT02334436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102385776|NCT02334436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385777|NCT02334436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102385778|NCT02334436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102385779|NCT03288870|Docetaxel|docetaxel|mesh-list
102385780|NCT03288870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102385781|NCT03288870|Tubulin Modulators|tubulin modulators|mesh-ancestor
102109585|NCT04468464|Salicylic Acid|salicylic acid|mesh-list
102385782|NCT03288870|Antimitotic Agents|antimitotic agents|mesh-ancestor
102385783|NCT03288870|Mitosis Modulators|mitosis modulators|mesh-ancestor
102385784|NCT03288870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385785|NCT03282474|Sofosbuvir|sofosbuvir|mesh-list
102385786|NCT03282474|Antiviral Agents|antiviral agents|mesh-ancestor
102109642|NCT02137161|Hormones|hormones|mesh-ancestor
102385787|NCT03282474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102385788|NCT02460354|Metformin|metformin|mesh-list
102385789|NCT02460354|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102385790|NCT02460354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385791|NCT02008942|Aspirin|aspirin|mesh-list
102385792|NCT02008942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102385793|NCT02008942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102385794|NCT02008942|Analgesics|analgesics|mesh-ancestor
102385795|NCT02008942|Sensory System Agents|sensory system agents|mesh-ancestor
102385796|NCT02008942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102385797|NCT02008942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385798|NCT02008942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102385799|NCT02008942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102385800|NCT02008942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102385801|NCT02008942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102385802|NCT02008942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385803|NCT02008942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102385804|NCT02008942|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102109714|NCT04468542|Glucocorticoids|glucocorticoids|mesh-ancestor
102385805|NCT02008942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102385806|NCT02008942|Antipyretics|antipyretics|mesh-ancestor
102385807|NCT03288636|Ritonavir|ritonavir|mesh-list
102385808|NCT03288636|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102109772|NCT05230758|Metformin|metformin|mesh-list
102385809|NCT03288636|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102385810|NCT03288636|Protease Inhibitors|protease inhibitors|mesh-ancestor
102385811|NCT03288636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102385812|NCT03288636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385813|NCT03288636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102385814|NCT03288636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102385815|NCT03288636|Antiviral Agents|antiviral agents|mesh-ancestor
102385816|NCT03288636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102385817|NCT03288636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102385818|NCT03288636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102385819|NCT03293472|Bupivacaine|bupivacaine|mesh-list
102385820|NCT03293472|Ropivacaine|ropivacaine|mesh-list
102385821|NCT03293472|Anesthetics, Local|anesthetics, local|mesh-ancestor
102385822|NCT03293472|Anesthetics|anesthetics|mesh-ancestor
102385823|NCT03293472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102385824|NCT03293472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385825|NCT03293472|Sensory System Agents|sensory system agents|mesh-ancestor
102385826|NCT03293472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102385827|NCT02071810|Opicapone|opicapone|mesh-list
102385828|NCT02071810|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102197557|NCT04265534|Glucocorticoids|glucocorticoids|mesh-ancestor
102385829|NCT02071810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102385830|NCT02071810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385831|NCT02071810|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102385832|NCT02071810|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102385833|NCT02715258|Bexagliflozin|bexagliflozin|mesh-list
102385834|NCT02715258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102385835|NCT02715258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385837|NCT01959490|Docetaxel|docetaxel|mesh-list
102385838|NCT01959490|Cyclophosphamide|cyclophosphamide|mesh-list
102385839|NCT01959490|Bevacizumab|bevacizumab|mesh-list
102385840|NCT01959490|Carboplatin|carboplatin|mesh-list
102385841|NCT01959490|Doxorubicin|doxorubicin|mesh-list
102385842|NCT01959490|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102385843|NCT01959490|Trastuzumab|trastuzumab|mesh-list
102385844|NCT01959490|Pertuzumab|pertuzumab|mesh-list
102385845|NCT01959490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102385846|NCT01959490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102110405|NCT05540470|Chloroquine|chloroquine|mesh-list
102385847|NCT01959490|Tubulin Modulators|tubulin modulators|mesh-ancestor
102385848|NCT01959490|Antimitotic Agents|antimitotic agents|mesh-ancestor
102385849|NCT01959490|Mitosis Modulators|mitosis modulators|mesh-ancestor
102385850|NCT01959490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385851|NCT01959490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102385852|NCT01959490|Immunologic Factors|immunologic factors|mesh-ancestor
102385853|NCT01959490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385854|NCT01959490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102385855|NCT01959490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102385856|NCT01959490|Alkylating Agents|alkylating agents|mesh-ancestor
102385857|NCT01959490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102385858|NCT01959490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102385859|NCT01959490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102385860|NCT01959490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102385861|NCT01959490|Growth Substances|growth substances|mesh-ancestor
102385862|NCT01959490|Growth Inhibitors|growth inhibitors|mesh-ancestor
102385863|NCT01959490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102385864|NCT01959490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102385865|NCT01959490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102385866|NCT01959490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102385867|NCT03288402|Caffeine|caffeine|mesh-list
102385868|NCT03288402|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102385869|NCT03288402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385870|NCT03288402|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102385871|NCT03288402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102385872|NCT03288402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385873|NCT03288402|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102385874|NCT03288402|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102385875|NCT03288402|Purinergic Agents|purinergic agents|mesh-ancestor
102385876|NCT03288402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102385877|NCT02011516|Baclofen|baclofen|mesh-list
102385878|NCT02011516|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102385879|NCT02011516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385880|NCT02011516|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102385881|NCT02011516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102385882|NCT02011516|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102385883|NCT02011516|GABA Agonists|gaba agonists|mesh-ancestor
102385884|NCT02011516|GABA Agents|gaba agents|mesh-ancestor
102385885|NCT02011516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102385886|NCT02011516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385887|NCT04349410|Interferons|interferons|mesh-list
102385888|NCT04349410|Interferon-alpha|interferon-alpha|mesh-list
102385889|NCT04349410|Interferon alpha-2|interferon alpha-2|mesh-list
102385890|NCT04349410|Remdesivir|remdesivir|mesh-list
102385891|NCT04349410|Azithromycin|azithromycin|mesh-list
102385892|NCT04349410|Hydroxychloroquine|hydroxychloroquine|mesh-list
102385893|NCT04349410|Doxycycline|doxycycline|mesh-list
102385894|NCT04349410|Clindamycin|clindamycin|mesh-list
102385895|NCT04349410|Clindamycin palmitate|clindamycin palmitate|mesh-list
102385896|NCT04349410|Clindamycin phosphate|clindamycin phosphate|mesh-list
102385897|NCT04349410|Primaquine|primaquine|mesh-list
102385898|NCT04349410|Methylprednisolone|methylprednisolone|mesh-list
102385899|NCT04349410|Losartan|losartan|mesh-list
102385900|NCT04349410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102385901|NCT04349410|Antiviral Agents|antiviral agents|mesh-ancestor
102385902|NCT04349410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102385903|NCT04349410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102385904|NCT04349410|Antiemetics|antiemetics|mesh-ancestor
102385905|NCT04349410|Autonomic Agents|autonomic agents|mesh-ancestor
102385906|NCT04349410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102385907|NCT04349410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385908|NCT04349410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102385909|NCT04349410|Glucocorticoids|glucocorticoids|mesh-ancestor
102385910|NCT04349410|Hormones|hormones|mesh-ancestor
102385911|NCT04349410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102385912|NCT04349410|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102385913|NCT04349410|Protective Agents|protective agents|mesh-ancestor
102385914|NCT04349410|Immunologic Factors|immunologic factors|mesh-ancestor
102385915|NCT04349410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102385916|NCT04349410|Antimalarials|antimalarials|mesh-ancestor
102385917|NCT04349410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102385918|NCT04349410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102385919|NCT04349410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102385920|NCT04349410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385921|NCT04349410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102385922|NCT04349410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102385923|NCT04349410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102385924|NCT04349410|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102385925|NCT04349410|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102385926|NCT04349410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102385927|NCT04349410|Antimetabolites|antimetabolites|mesh-ancestor
102385928|NCT03287388|Rocuronium|rocuronium|mesh-list
102385929|NCT03287388|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102385930|NCT03287388|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102385931|NCT03287388|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102385932|NCT03287388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102385933|NCT03287388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385934|NCT03293004|Vitamins|vitamins|mesh-list
102385935|NCT03293004|Ascorbic Acid|ascorbic acid|mesh-list
102385936|NCT03293004|Micronutrients|micronutrients|mesh-ancestor
102385937|NCT03293004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385938|NCT03293004|Antioxidants|antioxidants|mesh-ancestor
102385939|NCT03293004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385940|NCT03293004|Protective Agents|protective agents|mesh-ancestor
102385941|NCT03292848|Brexpiprazole|brexpiprazole|mesh-list
102385942|NCT03292848|Serotonin Agents|serotonin agents|mesh-ancestor
102385943|NCT03292848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102385944|NCT03292848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385945|NCT03292848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385946|NCT03292848|Dopamine Agonists|dopamine agonists|mesh-ancestor
102385947|NCT03292848|Dopamine Agents|dopamine agents|mesh-ancestor
102385948|NCT03282162|Oxytocin|oxytocin|mesh-list
102385949|NCT03282162|Oxytocics|oxytocics|mesh-ancestor
102385950|NCT03282162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102385951|NCT03282162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385952|NCT03287076|Exenatide|exenatide|mesh-list
102385953|NCT03287076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102385954|NCT03287076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385955|NCT03287076|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102385956|NCT03287076|Incretins|incretins|mesh-ancestor
102385957|NCT03287076|Hormones|hormones|mesh-ancestor
102385958|NCT03287076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102385959|NCT02460276|Rituximab|rituximab|mesh-list
102385960|NCT02460276|Lenalidomide|lenalidomide|mesh-list
102385961|NCT02460276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102385962|NCT02460276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102385963|NCT02460276|Immunologic Factors|immunologic factors|mesh-ancestor
102385964|NCT02460276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385965|NCT02460276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102385966|NCT02460276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102385967|NCT02460276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102385968|NCT02460276|Growth Substances|growth substances|mesh-ancestor
102385969|NCT02460276|Growth Inhibitors|growth inhibitors|mesh-ancestor
102385970|NCT02460432|Paclitaxel|paclitaxel|mesh-list
102385971|NCT02460432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102385972|NCT02460432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102385973|NCT02460432|Tubulin Modulators|tubulin modulators|mesh-ancestor
102385974|NCT02460432|Antimitotic Agents|antimitotic agents|mesh-ancestor
102385975|NCT02460432|Mitosis Modulators|mitosis modulators|mesh-ancestor
102385976|NCT02460432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102385977|NCT03282006|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
102385978|NCT03282006|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102385979|NCT03282006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102385980|NCT03282006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102385981|NCT03281928|Potassium Citrate|potassium citrate|mesh-list
102385982|NCT03281928|Diuretics|diuretics|mesh-ancestor
102385983|NCT03281928|Natriuretic Agents|natriuretic agents|mesh-ancestor
102385984|NCT03281928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385985|NCT03281928|Expectorants|expectorants|mesh-ancestor
102385986|NCT03281928|Respiratory System Agents|respiratory system agents|mesh-ancestor
102385987|NCT03286764|Peppermint oil|peppermint oil|mesh-list
102385988|NCT03286764|Antiemetics|antiemetics|mesh-ancestor
102385989|NCT03286764|Autonomic Agents|autonomic agents|mesh-ancestor
102385990|NCT03286764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102385991|NCT03286764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385992|NCT03286764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102385993|NCT03286764|Parasympatholytics|parasympatholytics|mesh-ancestor
102385994|NCT03281694|Nicotine|nicotine|mesh-list
102385995|NCT03281694|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102385996|NCT03281694|Autonomic Agents|autonomic agents|mesh-ancestor
102385997|NCT03281694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102385998|NCT03281694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102385999|NCT03281694|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102386000|NCT03281694|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102386001|NCT03281694|Cholinergic Agents|cholinergic agents|mesh-ancestor
102386002|NCT03281694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102386003|NCT03281694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386004|NCT03286452|Anti-Infective Agents|anti-infective agents|mesh-list
102386005|NCT03286452|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102386006|NCT03291054|Pembrolizumab|pembrolizumab|mesh-list
102386007|NCT03291054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102386008|NCT03291054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102386009|NCT03291054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102386010|NCT03291054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386011|NCT03286296|Antibodies|antibodies|mesh-list
102386012|NCT03286296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102386013|NCT03286296|Immunologic Factors|immunologic factors|mesh-ancestor
102386014|NCT03286296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386015|NCT03285906|Apatinib|apatinib|mesh-list
102386016|NCT03285906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102386017|NCT03285906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102386018|NCT03285906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102386019|NCT03285906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386020|NCT01895205|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
102386021|NCT01895205|Hematinics|hematinics|mesh-ancestor
102386022|NCT01748175|Triamcinolone|triamcinolone|mesh-list
102386023|NCT01748175|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102386024|NCT01748175|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102386025|NCT01748175|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102386026|NCT01748175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102386027|NCT01748175|Glucocorticoids|glucocorticoids|mesh-ancestor
102386028|NCT01748175|Hormones|hormones|mesh-ancestor
102386029|NCT01748175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102386030|NCT01748175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386031|NCT01748175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102386032|NCT01748175|Immunologic Factors|immunologic factors|mesh-ancestor
102386033|NCT01748175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102386034|NCT01748175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386035|NCT04755387|Ticagrelor|ticagrelor|mesh-list
102386036|NCT04755387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102386037|NCT04755387|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102386038|NCT04755387|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102386039|NCT04755387|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102386040|NCT04755387|Purinergic Agents|purinergic agents|mesh-ancestor
102386041|NCT04755387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102110710|NCT05537584|Dopamine Agents|dopamine agents|mesh-ancestor
102386042|NCT04755387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386043|NCT04755387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386044|NCT04046328|Cholestyramine Resin|cholestyramine resin|mesh-list
102386045|NCT04046328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102386046|NCT04046328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102386047|NCT04046328|Antimetabolites|antimetabolites|mesh-ancestor
102386048|NCT04046328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386049|NCT04046328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102386050|NCT03285360|Fluorides|fluorides|mesh-list
102386051|NCT03285360|Fluorides, Topical|fluorides, topical|mesh-list
102386052|NCT03285360|Cariostatic Agents|cariostatic agents|mesh-ancestor
102386053|NCT03285360|Protective Agents|protective agents|mesh-ancestor
102386054|NCT03285360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386055|NCT00160173|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102386056|NCT00160173|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102386057|NCT00160173|Estradiol|estradiol|mesh-list
102386059|NCT00160173|Estrogens|estrogens|mesh-ancestor
102386060|NCT00160173|Hormones|hormones|mesh-ancestor
102386061|NCT00160173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102386062|NCT00160173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386063|NCT00160173|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102386064|NCT00160173|Contraceptive Agents|contraceptive agents|mesh-ancestor
102386065|NCT00160173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102386066|NCT00160173|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102386067|NCT00136695|Anastrozole|anastrozole|mesh-list
102386068|NCT00136695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102386069|NCT00136695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102386070|NCT00136695|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102386071|NCT00136695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102386072|NCT00136695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102386073|NCT00136695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386074|NCT00136695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102386075|NCT00136695|Hormone Antagonists|hormone antagonists|mesh-ancestor
102386076|NCT00136695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102386077|NCT00136695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386078|NCT04782375|Antiviral Agents|antiviral agents|mesh-list
102386079|NCT04782375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102386080|NCT02459574|Amiodarone|amiodarone|mesh-list
102386081|NCT02459574|Sotalol|sotalol|mesh-list
102386082|NCT02459574|Flecainide|flecainide|mesh-list
102386083|NCT02459574|Propafenone|propafenone|mesh-list
102386084|NCT02459574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
102386085|NCT02459574|Calcium Channel Blockers|calcium channel blockers|mesh-list
102386086|NCT02459574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102386087|NCT02459574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386088|NCT02459574|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102386089|NCT02459574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102386090|NCT02459574|Adrenergic Agents|adrenergic agents|mesh-ancestor
102386091|NCT02459574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102386092|NCT02459574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386093|NCT02459574|Vasodilator Agents|vasodilator agents|mesh-ancestor
102110737|NCT04459377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102386094|NCT02459574|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102386095|NCT02459574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102386096|NCT02459574|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102386097|NCT02459574|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102386098|NCT02459574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102386099|NCT02459574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102386100|NCT02459574|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102386101|NCT02459574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102386102|NCT02459574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102386103|NCT02459574|Sympatholytics|sympatholytics|mesh-ancestor
102386104|NCT02459574|Autonomic Agents|autonomic agents|mesh-ancestor
102386105|NCT02459574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102386106|NCT02459574|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102386107|NCT04168866|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102386108|NCT04168866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102386109|NCT03280212|Tranexamic Acid|tranexamic acid|mesh-list
102386110|NCT03280212|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102386111|NCT03280212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102386112|NCT03280212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386113|NCT03280212|Hemostatics|hemostatics|mesh-ancestor
102386114|NCT03280212|Coagulants|coagulants|mesh-ancestor
102386115|NCT03536520|Acetazolamide|acetazolamide|mesh-list
102386116|NCT03536520|Anticonvulsants|anticonvulsants|mesh-ancestor
102386117|NCT03536520|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102386118|NCT03536520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102386119|NCT03536520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386120|NCT03536520|Diuretics|diuretics|mesh-ancestor
102386121|NCT03536520|Natriuretic Agents|natriuretic agents|mesh-ancestor
102386122|NCT03536520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386123|NCT01673217|Doxorubicin|doxorubicin|mesh-list
102386124|NCT01673217|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102386125|NCT01673217|Decitabine|decitabine|mesh-list
102386126|NCT01673217|Azacitidine|azacitidine|mesh-list
102386127|NCT01673217|Vaccines|vaccines|mesh-list
102386128|NCT01673217|Sargramostim|sargramostim|mesh-list
102386129|NCT01673217|Freund's Adjuvant|freund's adjuvant|mesh-list
102386130|NCT01673217|Immunologic Factors|immunologic factors|mesh-ancestor
102386131|NCT01673217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386132|NCT01673217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102386133|NCT01673217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102386134|NCT01673217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102386135|NCT01673217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102386136|NCT01673217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102386137|NCT01673217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386138|NCT01673217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102386139|NCT01673217|Antimetabolites|antimetabolites|mesh-ancestor
102386140|NCT01673217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102386141|NCT03475134|Cyclophosphamide|cyclophosphamide|mesh-list
102386143|NCT03475134|Fludarabine|fludarabine|mesh-list
102386144|NCT03475134|Interleukin-2|interleukin-2|mesh-list
102386145|NCT03475134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102386146|NCT03475134|Immunologic Factors|immunologic factors|mesh-ancestor
102386147|NCT03475134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386148|NCT03475134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102386149|NCT03475134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102386150|NCT03475134|Alkylating Agents|alkylating agents|mesh-ancestor
102386151|NCT03475134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386152|NCT03475134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102386153|NCT03475134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102386154|NCT03475134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102386155|NCT03475134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102386156|NCT03475134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102386157|NCT03475134|Analgesics|analgesics|mesh-ancestor
102386158|NCT03475134|Sensory System Agents|sensory system agents|mesh-ancestor
102386159|NCT03475134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102386160|NCT01668849|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
102386161|NCT01668849|Fentanyl|fentanyl|mesh-list
102386162|NCT01668849|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102386163|NCT01668849|Narcotics|narcotics|mesh-ancestor
102386164|NCT01668849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102386165|NCT01668849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386166|NCT01668849|Analgesics|analgesics|mesh-ancestor
102386167|NCT01668849|Sensory System Agents|sensory system agents|mesh-ancestor
102386168|NCT01668849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102386169|NCT01668849|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102386170|NCT01668849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102386171|NCT01668849|Anesthetics, General|anesthetics, general|mesh-ancestor
102386172|NCT01668849|Anesthetics|anesthetics|mesh-ancestor
102386173|NCT01668849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102386174|NCT01668849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102386175|NCT01668849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102386176|NCT01668849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102386177|NCT01252719|Vancomycin|vancomycin|mesh-list
102386178|NCT01252719|Oritavancin|oritavancin|mesh-list
102386179|NCT01252719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102386180|NCT01252719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102386181|NCT01230411|Ibuprofen|ibuprofen|mesh-list
102386182|NCT01230411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102386183|NCT01230411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102386184|NCT01230411|Analgesics|analgesics|mesh-ancestor
102386185|NCT01230411|Sensory System Agents|sensory system agents|mesh-ancestor
102386186|NCT01230411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102386187|NCT01230411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386188|NCT01230411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102386189|NCT01230411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102386190|NCT01230411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102386191|NCT01230411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102386192|NCT01230411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386193|NCT03283800|Copper|copper|mesh-list
102386194|NCT03283800|Trace Elements|trace elements|mesh-ancestor
102386195|NCT03283800|Micronutrients|micronutrients|mesh-ancestor
102386196|NCT03283800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386197|NCT01962688|Diuretics|diuretics|mesh-list
102386198|NCT01962688|Natriuretic Agents|natriuretic agents|mesh-ancestor
102386199|NCT01962688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386200|NCT03274596|Vitamin E|vitamin e|mesh-list
102386201|NCT03274596|Vitamins|vitamins|mesh-ancestor
102386202|NCT03274596|Micronutrients|micronutrients|mesh-ancestor
102386203|NCT03274596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386204|NCT03274596|Antioxidants|antioxidants|mesh-ancestor
102386205|NCT03274596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386206|NCT03274596|Protective Agents|protective agents|mesh-ancestor
102386207|NCT01963078|Oxytocin|oxytocin|mesh-list
102386208|NCT01963078|Oxytocics|oxytocics|mesh-ancestor
102386209|NCT01963078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102386210|NCT01963078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386211|NCT03269760|Zolpidem|zolpidem|mesh-list
102386212|NCT03269760|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102386213|NCT03269760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102386214|NCT03269760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102386215|NCT03269760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386216|NCT03269760|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102386217|NCT03269760|GABA Agonists|gaba agonists|mesh-ancestor
102386218|NCT03269760|GABA Agents|gaba agents|mesh-ancestor
102386219|NCT03269760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102386220|NCT03269760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386221|NCT03269916|Hormones|hormones|mesh-list
102386222|NCT03269916|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102386223|NCT03269916|Estrogens|estrogens|mesh-list
102386224|NCT03269916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102386225|NCT03269916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386226|NCT02346916|Capsaicin|capsaicin|mesh-list
102386227|NCT02346916|Antipruritics|antipruritics|mesh-ancestor
102386228|NCT02346916|Dermatologic Agents|dermatologic agents|mesh-ancestor
102386229|NCT02346916|Sensory System Agents|sensory system agents|mesh-ancestor
102386230|NCT02346916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102386231|NCT02346916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386232|NCT02458482|Albuterol|albuterol|mesh-list
102386233|NCT02458482|Ipratropium|ipratropium|mesh-list
102386234|NCT02458482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102386235|NCT02458482|Autonomic Agents|autonomic agents|mesh-ancestor
102386236|NCT02458482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102386237|NCT02458482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386238|NCT02458482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102386239|NCT02458482|Respiratory System Agents|respiratory system agents|mesh-ancestor
102386240|NCT02458482|Tocolytic Agents|tocolytic agents|mesh-ancestor
102386241|NCT02458482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102386242|NCT02458482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102386243|NCT02458482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102386244|NCT02458482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102386245|NCT02458482|Adrenergic Agents|adrenergic agents|mesh-ancestor
102386246|NCT02458482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102386247|NCT02458482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386248|NCT02458482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102386249|NCT02458482|Cholinergic Agents|cholinergic agents|mesh-ancestor
102386250|NCT03273192|Adalimumab|adalimumab|mesh-list
102386251|NCT03273192|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102386252|NCT03273192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102386253|NCT03273192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102386254|NCT03269604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102386255|NCT03269604|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102386256|NCT03269604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102386257|NCT03269604|Antitubercular Agents|antitubercular agents|mesh-ancestor
102386258|NCT02349178|Cyclophosphamide|cyclophosphamide|mesh-list
102386259|NCT02349178|Etoposide|etoposide|mesh-list
102386260|NCT02349178|Clofarabine|clofarabine|mesh-list
102386261|NCT02349178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102386262|NCT02349178|Immunologic Factors|immunologic factors|mesh-ancestor
102386263|NCT02349178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386264|NCT02349178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102386265|NCT02349178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102386266|NCT02349178|Alkylating Agents|alkylating agents|mesh-ancestor
102110776|NCT05679310|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
102386267|NCT02349178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386268|NCT02349178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102386269|NCT02349178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102386270|NCT02349178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102386271|NCT02349178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102386272|NCT02349178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102386273|NCT02349178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102386274|NCT02349178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102386275|NCT02349178|Antimetabolites|antimetabolites|mesh-ancestor
102110810|NCT05536882|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102110811|NCT05536882|Dermatologic Agents|dermatologic agents|mesh-ancestor
102110812|NCT05536882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102386276|NCT03970356|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102386277|NCT03970356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102386278|NCT05075460|Azacitidine|azacitidine|mesh-list
102386279|NCT05075460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102386280|NCT05075460|Antimetabolites|antimetabolites|mesh-ancestor
102386281|NCT05075460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386282|NCT05075460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102386283|NCT05075460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102386284|NCT01966978|Insulin|insulin|mesh-list
102386285|NCT01966978|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102386286|NCT01966978|Metformin|metformin|mesh-list
102386287|NCT01966978|Insulin Aspart|insulin aspart|mesh-list
102386288|NCT01966978|Insulin, Long-Acting|insulin, long-acting|mesh-list
102386289|NCT01966978|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102386290|NCT01966978|Liraglutide|liraglutide|mesh-list
102386291|NCT01966978|Insulin Detemir|insulin detemir|mesh-list
102386292|NCT01966978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102386293|NCT01966978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386294|NCT01966978|Incretins|incretins|mesh-ancestor
102386295|NCT01966978|Hormones|hormones|mesh-ancestor
102386296|NCT01966978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102386297|NCT03269214|Phenytoin|phenytoin|mesh-list
102386298|NCT03269214|Anticonvulsants|anticonvulsants|mesh-ancestor
102386299|NCT03269214|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102386300|NCT03269214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102386301|NCT03269214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102386302|NCT03269214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386303|NCT03269214|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102386304|NCT03269214|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102386305|NCT03269058|Dapagliflozin|dapagliflozin|mesh-list
102386306|NCT03269058|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102386307|NCT03269058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386308|NCT03269058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102386309|NCT03269058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386310|NCT05074602|Fluconazole|fluconazole|mesh-list
102386311|NCT05074602|Antifungal Agents|antifungal agents|mesh-ancestor
102386312|NCT05074602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102386313|NCT05074602|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102386314|NCT05074602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102386315|NCT05074602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102386316|NCT05074602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386317|NCT05074602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102386318|NCT05074602|Hormone Antagonists|hormone antagonists|mesh-ancestor
102386319|NCT05074602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102386320|NCT05074602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386321|NCT05074602|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102386322|NCT05074602|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102386323|NCT02457312|Letrozole|letrozole|mesh-list
102386324|NCT02457312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102386325|NCT02457312|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102111422|NCT03525912|Analgesics|analgesics|mesh-list
102386326|NCT02457312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102386327|NCT02457312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102386328|NCT02457312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386329|NCT02457312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102386330|NCT02457312|Hormone Antagonists|hormone antagonists|mesh-ancestor
102111491|NCT05631730|Adrenergic Agents|adrenergic agents|mesh-ancestor
102386331|NCT02457312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102386332|NCT02457312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386333|NCT03268902|Niacinamide|niacinamide|mesh-list
102386334|NCT03268902|Niacin|niacin|mesh-list
102386335|NCT03268902|Nicotinic Acids|nicotinic acids|mesh-list
102386336|NCT03268902|Azithromycin|azithromycin|mesh-list
102386337|NCT03268902|Nitazoxanide|nitazoxanide|mesh-list
102386338|NCT03268902|Vitamins|vitamins|mesh-ancestor
102386339|NCT03268902|Micronutrients|micronutrients|mesh-ancestor
102386340|NCT03268902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386341|NCT03268902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102386342|NCT03268902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102386343|NCT03268902|Vitamin B Complex|vitamin b complex|mesh-ancestor
102386344|NCT03268902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102386345|NCT03268902|Antimetabolites|antimetabolites|mesh-ancestor
102111701|NCT03724084|Antimetabolites|antimetabolites|mesh-ancestor
102386346|NCT03268902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386347|NCT03268902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102386348|NCT03268902|Vasodilator Agents|vasodilator agents|mesh-ancestor
102386349|NCT03268902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102386350|NCT02458716|Leuprolide|leuprolide|mesh-list
102386351|NCT02458716|Bicalutamide|bicalutamide|mesh-list
102386352|NCT02458716|Androgens|androgens|mesh-list
102386353|NCT02458716|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
102386354|NCT02458716|Hormones|hormones|mesh-ancestor
102386355|NCT02458716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102386356|NCT02458716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386358|NCT02458716|Fertility Agents|fertility agents|mesh-ancestor
102386359|NCT02458716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102386360|NCT02458716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102386361|NCT02458716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102386362|NCT02458716|Androgen Antagonists|androgen antagonists|mesh-ancestor
102386363|NCT02458716|Hormone Antagonists|hormone antagonists|mesh-ancestor
102386364|NCT03268278|Lidocaine|lidocaine|mesh-list
102386365|NCT03268278|Epinephrine|epinephrine|mesh-list
102386366|NCT03268278|Buprenorphine|buprenorphine|mesh-list
102386367|NCT03268278|Anesthetics, Local|anesthetics, local|mesh-list
102386368|NCT03268278|Anesthetics|anesthetics|mesh-list
102386369|NCT03268278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102386370|NCT03268278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386371|NCT03268278|Sensory System Agents|sensory system agents|mesh-ancestor
102386372|NCT03268278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102386373|NCT03268278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102112045|NCT02145195|Micronutrients|micronutrients|mesh-ancestor
102386374|NCT03268278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102386375|NCT03268278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102386376|NCT03268278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102386377|NCT03268278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386378|NCT03268278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102386379|NCT03268278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102386380|NCT03268278|Adrenergic Agents|adrenergic agents|mesh-ancestor
102386381|NCT03268278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102386382|NCT03268278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102386383|NCT03268278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102386384|NCT03268278|Autonomic Agents|autonomic agents|mesh-ancestor
102386385|NCT03268278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102386386|NCT03268278|Respiratory System Agents|respiratory system agents|mesh-ancestor
102386387|NCT03268278|Mydriatics|mydriatics|mesh-ancestor
102386388|NCT03268278|Sympathomimetics|sympathomimetics|mesh-ancestor
102386389|NCT03268278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102386390|NCT03268278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102386391|NCT03268278|Narcotics|narcotics|mesh-ancestor
102112259|NCT03382886|Nivolumab|nivolumab|mesh-list
102386392|NCT03268278|Analgesics|analgesics|mesh-ancestor
102386393|NCT03268278|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102386394|NCT05045586|Hyaluronic Acid|hyaluronic acid|mesh-list
102112321|NCT02146911|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102386395|NCT05045586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102386396|NCT05045586|Immunologic Factors|immunologic factors|mesh-ancestor
102386397|NCT05045586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386398|NCT05045586|Viscosupplements|viscosupplements|mesh-ancestor
102386399|NCT05045586|Protective Agents|protective agents|mesh-ancestor
102386400|NCT03263520|Nandrolone Decanoate|nandrolone decanoate|mesh-list
102386401|NCT03263520|Dexamethasone|dexamethasone|mesh-list
102386402|NCT03263520|Dexamethasone acetate|dexamethasone acetate|mesh-list
102386403|NCT03263520|Nandrolone|nandrolone|mesh-list
102386404|NCT03263520|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
102386405|NCT03263520|BB 1101|bb 1101|mesh-list
102386406|NCT03263520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102386407|NCT03263520|Antiemetics|antiemetics|mesh-ancestor
102386408|NCT03263520|Autonomic Agents|autonomic agents|mesh-ancestor
102386409|NCT03263520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102386410|NCT03263520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386411|NCT03263520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102386412|NCT03263520|Glucocorticoids|glucocorticoids|mesh-ancestor
102386413|NCT03263520|Hormones|hormones|mesh-ancestor
102386414|NCT03263520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102386415|NCT03263520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102386416|NCT03263520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102386417|NCT03263520|Protease Inhibitors|protease inhibitors|mesh-ancestor
102386418|NCT03263520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102386419|NCT03263520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386420|NCT03263520|Androgens|androgens|mesh-ancestor
102386421|NCT03263520|Anabolic Agents|anabolic agents|mesh-ancestor
102386422|NCT03263520|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102386423|NCT02456844|Leucovorin|leucovorin|mesh-list
102386424|NCT02456844|Flurbiprofen|flurbiprofen|mesh-list
102386425|NCT02456844|Methotrexate|methotrexate|mesh-list
102386426|NCT02456844|Digoxin|digoxin|mesh-list
102386427|NCT02456844|Midazolam|midazolam|mesh-list
102386428|NCT02456844|Pravastatin|pravastatin|mesh-list
102386429|NCT02456844|Montelukast|montelukast|mesh-list
102386430|NCT02456844|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102386431|NCT02456844|Abortifacient Agents|abortifacient agents|mesh-ancestor
102386432|NCT02456844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102386433|NCT02456844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198148|NCT02170571|Dabigatran|dabigatran|mesh-list
102386434|NCT02456844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102386436|NCT02456844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386437|NCT02456844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102386438|NCT02456844|Dermatologic Agents|dermatologic agents|mesh-ancestor
102386439|NCT02456844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102386440|NCT02456844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102386441|NCT02456844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102386442|NCT02456844|Immunologic Factors|immunologic factors|mesh-ancestor
102386443|NCT02456844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102386444|NCT02456844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102386445|NCT02456844|Antidotes|antidotes|mesh-ancestor
102386446|NCT02456844|Protective Agents|protective agents|mesh-ancestor
102386447|NCT02456844|Vitamin B Complex|vitamin b complex|mesh-ancestor
102386448|NCT02456844|Vitamins|vitamins|mesh-ancestor
102386449|NCT02456844|Micronutrients|micronutrients|mesh-ancestor
102386450|NCT02456844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102386451|NCT02456844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102386452|NCT02456844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102113101|NCT02297568|Vitamin D|vitamin d|mesh-list
102386453|NCT02456844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102386454|NCT02456844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102386455|NCT02456844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102386456|NCT02456844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102386457|NCT02456844|Anesthetics, General|anesthetics, general|mesh-ancestor
102386458|NCT02456844|Anesthetics|anesthetics|mesh-ancestor
102386459|NCT02456844|GABA Modulators|gaba modulators|mesh-ancestor
102386460|NCT02456844|GABA Agents|gaba agents|mesh-ancestor
102386461|NCT02456844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102386462|NCT02456844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102386463|NCT02456844|Respiratory System Agents|respiratory system agents|mesh-ancestor
102386464|NCT02456844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102386465|NCT02456844|Hormone Antagonists|hormone antagonists|mesh-ancestor
102386466|NCT02456844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102386467|NCT02456844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102386468|NCT02456844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102386469|NCT02456844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102386470|NCT02456844|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102386471|NCT02456844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102386472|NCT02456844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102386473|NCT02456844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102386474|NCT02456844|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102386475|NCT02456844|Analgesics|analgesics|mesh-ancestor
102386476|NCT02456844|Sensory System Agents|sensory system agents|mesh-ancestor
102386477|NCT02456844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102386478|NCT02456844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102386479|NCT02456844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102386480|NCT02456844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102386481|NCT02456844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102386482|NCT03263208|Cyclophosphamide|cyclophosphamide|mesh-list
102386483|NCT03263208|Fludarabine|fludarabine|mesh-list
102386484|NCT03263208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102386485|NCT03263208|Immunologic Factors|immunologic factors|mesh-ancestor
102386486|NCT03263208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386487|NCT03263208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102386488|NCT03263208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102386489|NCT03263208|Alkylating Agents|alkylating agents|mesh-ancestor
102386490|NCT03263208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386491|NCT03263208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102386492|NCT03263208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102386493|NCT03259542|Itraconazole|itraconazole|mesh-list
102386494|NCT03259542|Mifepristone|mifepristone|mesh-list
102386495|NCT03259542|Antifungal Agents|antifungal agents|mesh-ancestor
102386496|NCT03259542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102386497|NCT03259542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102386498|NCT03259542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102113383|NCT02293824|Caffeine|caffeine|mesh-list
102386499|NCT03259542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102386500|NCT03259542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386501|NCT03259542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102386502|NCT03259542|Hormone Antagonists|hormone antagonists|mesh-ancestor
102386503|NCT03259542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102386504|NCT03259542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386505|NCT03259542|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102198228|NCT00606697|Antiemetics|antiemetics|mesh-ancestor
102386506|NCT03259542|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102386507|NCT03259542|Abortifacient Agents|abortifacient agents|mesh-ancestor
102386508|NCT03259542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102113584|NCT02311764|Carboplatin|carboplatin|mesh-list
102386509|NCT03259542|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102386510|NCT03259542|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102386511|NCT03259542|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102386512|NCT03259542|Contraceptive Agents|contraceptive agents|mesh-ancestor
102386513|NCT03259542|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102386514|NCT03259542|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102386515|NCT03259542|Luteolytic Agents|luteolytic agents|mesh-ancestor
102386516|NCT03259542|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102386517|NCT03259542|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102386518|NCT03267654|Apatinib|apatinib|mesh-list
102386519|NCT03267654|Gefitinib|gefitinib|mesh-list
102386520|NCT03267654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102386521|NCT03267654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102386522|NCT03267654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102386523|NCT03267654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386524|NCT03263052|Tacrolimus|tacrolimus|mesh-list
102386525|NCT03263052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102386526|NCT03263052|Immunologic Factors|immunologic factors|mesh-ancestor
102386527|NCT03263052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386528|NCT03263052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102386529|NCT03263052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102386530|NCT03263052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386531|NCT03267030|Eryaspase|eryaspase|mesh-list
102386532|NCT03267030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102386533|NCT03259152|Denosumab|denosumab|mesh-list
102386534|NCT03259152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102386535|NCT03259152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386536|NCT02456142|Morphine|morphine|mesh-list
102386537|NCT02456142|Bupivacaine|bupivacaine|mesh-list
102386538|NCT02456142|Anesthetics, Local|anesthetics, local|mesh-ancestor
102386539|NCT02456142|Anesthetics|anesthetics|mesh-ancestor
102386540|NCT02456142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102386541|NCT02456142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386542|NCT02456142|Sensory System Agents|sensory system agents|mesh-ancestor
102386543|NCT02456142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102386544|NCT02456142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102386545|NCT02456142|Narcotics|narcotics|mesh-ancestor
102386546|NCT02456142|Analgesics|analgesics|mesh-ancestor
102386547|NCT03262740|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102386548|NCT03262740|Norethindrone|norethindrone|mesh-list
102386549|NCT03262740|Norethindrone Acetate|norethindrone acetate|mesh-list
102386550|NCT03262740|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
102386551|NCT03262740|Estradiol|estradiol|mesh-list
102386552|NCT03262740|Branebrutinib|branebrutinib|mesh-list
102386553|NCT03262740|Estrogens|estrogens|mesh-ancestor
102386554|NCT03262740|Hormones|hormones|mesh-ancestor
102386555|NCT03262740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102386556|NCT03262740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386557|NCT03262740|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101903177|NCT05064020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102386558|NCT03262740|Contraceptive Agents|contraceptive agents|mesh-ancestor
102386559|NCT03262740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102386560|NCT03262740|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102386561|NCT03262740|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102386562|NCT03262740|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102386563|NCT03262740|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102386564|NCT03262740|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102386565|NCT03262740|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
102386566|NCT03262740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102386567|NCT03262740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101903308|NCT01204112|Rifampin|rifampin|mesh-list
102386568|NCT03262740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386569|NCT03266562|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102386570|NCT03266562|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102386571|NCT03266562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386572|NCT03258684|Thiamine|thiamine|mesh-list
102386573|NCT03258684|Hydrocortisone|hydrocortisone|mesh-list
102386574|NCT03258684|Vitamins|vitamins|mesh-ancestor
102386575|NCT03258684|Micronutrients|micronutrients|mesh-ancestor
102386576|NCT03258684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386577|NCT03258684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102386578|NCT03258684|Vitamin B Complex|vitamin b complex|mesh-ancestor
102386579|NCT03266250|Anesthetics|anesthetics|mesh-list
102198301|NCT03170895|Sorafenib|sorafenib|mesh-list
101903449|NCT01200212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102386580|NCT03266250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102386581|NCT03266250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386582|NCT03258372|Rifampin|rifampin|mesh-list
102386583|NCT03258372|Mifepristone|mifepristone|mesh-list
102386584|NCT03258372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102386585|NCT03258372|Antitubercular Agents|antitubercular agents|mesh-ancestor
102386586|NCT03258372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102386587|NCT03258372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102386588|NCT03258372|Leprostatic Agents|leprostatic agents|mesh-ancestor
102386589|NCT03258372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102386590|NCT03258372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101903654|NCT03980249|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102386591|NCT03258372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386592|NCT03258372|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102386593|NCT03258372|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102386594|NCT03258372|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102386595|NCT03258372|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102386596|NCT03258372|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102386597|NCT03258372|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101903739|NCT03902912|Hormones|hormones|mesh-ancestor
102386598|NCT03258372|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102386599|NCT03258372|Abortifacient Agents|abortifacient agents|mesh-ancestor
102386600|NCT03258372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101903792|NCT01205672|Metformin|metformin|mesh-list
102386601|NCT03258372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386602|NCT03258372|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102386603|NCT03258372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101903838|NCT01205984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102386604|NCT03258372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102386605|NCT03258372|Contraceptive Agents|contraceptive agents|mesh-ancestor
102386606|NCT03258372|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102386607|NCT03258372|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102386608|NCT03258372|Hormone Antagonists|hormone antagonists|mesh-ancestor
102386609|NCT03258372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102386610|NCT03258372|Luteolytic Agents|luteolytic agents|mesh-ancestor
102386611|NCT03258372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102386612|NCT03258372|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102386613|NCT02456454|Valproic Acid|valproic acid|mesh-list
102386614|NCT02456454|Risperidone|risperidone|mesh-list
102386615|NCT02456454|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102386616|NCT02456454|Serotonin Agents|serotonin agents|mesh-ancestor
102386617|NCT02456454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102386618|NCT02456454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386619|NCT02456454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386620|NCT02456454|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102386621|NCT02456454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102386622|NCT02456454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102386623|NCT02456454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102386624|NCT02456454|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102386625|NCT02456454|Dopamine Agents|dopamine agents|mesh-ancestor
102386626|NCT02456454|Anticonvulsants|anticonvulsants|mesh-ancestor
102386627|NCT02456454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102386628|NCT02456454|GABA Agents|gaba agents|mesh-ancestor
102386629|NCT02456454|Antimanic Agents|antimanic agents|mesh-ancestor
102386630|NCT03258294|Melatonin|melatonin|mesh-list
102386631|NCT03258294|Antioxidants|antioxidants|mesh-ancestor
102386632|NCT03258294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386633|NCT03258294|Protective Agents|protective agents|mesh-ancestor
102386634|NCT03258294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904117|NCT00303485|Calcium|calcium|mesh-list
102386635|NCT03258294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102386636|NCT03265782|Acetaminophen|acetaminophen|mesh-list
102386637|NCT03265782|Ibuprofen|ibuprofen|mesh-list
102386638|NCT03265782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102386639|NCT03265782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102386640|NCT03265782|Analgesics|analgesics|mesh-ancestor
102386641|NCT03265782|Sensory System Agents|sensory system agents|mesh-ancestor
102386642|NCT03265782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102386643|NCT03265782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386644|NCT03265782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102386645|NCT03265782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102386646|NCT03265782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102386647|NCT03265782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101904315|NCT00329849|Vaccines|vaccines|mesh-list
102386648|NCT03265782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386649|NCT03265782|Antipyretics|antipyretics|mesh-ancestor
102386650|NCT03798054|Insulin|insulin|mesh-list
102386651|NCT03798054|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102386652|NCT03798054|Metformin|metformin|mesh-list
102386653|NCT03798054|Insulin Glargine|insulin glargine|mesh-list
102386654|NCT03798054|Lixisenatide|lixisenatide|mesh-list
102386655|NCT03798054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102386656|NCT03798054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101904517|NCT00300365|Niacin|niacin|mesh-list
102386657|NCT03798054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904530|NCT00300365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102386658|NCT03798054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386659|NCT03265470|Fentanyl|fentanyl|mesh-list
102386660|NCT03265470|Dexmedetomidine|dexmedetomidine|mesh-list
102386661|NCT03265470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102386662|NCT03265470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102386663|NCT03265470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386664|NCT03265470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102386665|NCT03265470|Analgesics|analgesics|mesh-ancestor
101904678|NCT03979469|Anesthetics, General|anesthetics, general|mesh-ancestor
102386666|NCT03265470|Sensory System Agents|sensory system agents|mesh-ancestor
102386667|NCT03265470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102386668|NCT03265470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102386669|NCT03265470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102386670|NCT03265470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102386671|NCT03265470|Adrenergic Agents|adrenergic agents|mesh-ancestor
102386672|NCT03265470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102386673|NCT03265470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386674|NCT03265470|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102386675|NCT03265470|Narcotics|narcotics|mesh-ancestor
102386676|NCT03265470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102386677|NCT03265470|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102386678|NCT03265470|Anesthetics, General|anesthetics, general|mesh-ancestor
101904929|NCT00120952|Cobalt|cobalt|mesh-list
102386679|NCT03265470|Anesthetics|anesthetics|mesh-ancestor
102386680|NCT02019940|Riluzole|riluzole|mesh-list
102386681|NCT02019940|Anticonvulsants|anticonvulsants|mesh-ancestor
102386682|NCT02019940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102386683|NCT02019940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102386684|NCT02019940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102386685|NCT02019940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386686|NCT02019940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386687|NCT02019940|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102386688|NCT02019940|Protective Agents|protective agents|mesh-ancestor
102386689|NCT01229943|Bevacizumab|bevacizumab|mesh-list
102386690|NCT01229943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102386691|NCT01229943|Everolimus|everolimus|mesh-list
102386692|NCT01229943|Octreotide|octreotide|mesh-list
102386693|NCT01229943|Endothelial Growth Factors|endothelial growth factors|mesh-list
102386694|NCT01229943|Antibodies|antibodies|mesh-list
102386695|NCT01229943|Immunoglobulins|immunoglobulins|mesh-list
102386696|NCT01229943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102386697|NCT01229943|Immunoglobulin G|immunoglobulin g|mesh-list
102386698|NCT01229943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102386699|NCT01229943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102386700|NCT01229943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102386701|NCT01229943|Growth Substances|growth substances|mesh-ancestor
102386702|NCT01229943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386703|NCT01229943|Growth Inhibitors|growth inhibitors|mesh-ancestor
102386704|NCT01229943|Immunologic Factors|immunologic factors|mesh-ancestor
102386705|NCT01229943|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101905152|NCT03180736|Autonomic Agents|autonomic agents|mesh-ancestor
102386706|NCT01229943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102386707|NCT01229943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102386708|NCT01229943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386709|NCT01229943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102386710|NCT01229943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102386711|NCT01229943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102386712|NCT02020408|Raclopride|raclopride|mesh-list
102386713|NCT02020408|Amphetamine|amphetamine|mesh-list
102386714|NCT02020408|Dextroamphetamine|dextroamphetamine|mesh-list
102386715|NCT02020408|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102386716|NCT02020408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386717|NCT02020408|Sympathomimetics|sympathomimetics|mesh-ancestor
102386718|NCT02020408|Autonomic Agents|autonomic agents|mesh-ancestor
102386719|NCT02020408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102386720|NCT02020408|Dopamine Agents|dopamine agents|mesh-ancestor
102386721|NCT02020408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102386722|NCT02020408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386723|NCT02020408|Adrenergic Agents|adrenergic agents|mesh-ancestor
102386724|NCT02020408|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102386725|NCT02020408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102386726|NCT02020408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102198449|NCT02178761|Everolimus|everolimus|mesh-list
102386727|NCT02020408|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102386728|NCT02020408|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102386729|NCT02020408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102386730|NCT02020408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102386731|NCT02020408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101905360|NCT01332370|Incretins|incretins|mesh-ancestor
102386732|NCT02020408|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102386733|NCT01219257|Adalimumab|adalimumab|mesh-list
102386734|NCT01219257|Infliximab|infliximab|mesh-list
102386735|NCT01219257|Golimumab|golimumab|mesh-list
102386736|NCT01219257|Etanercept|etanercept|mesh-list
102386737|NCT01219257|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102386738|NCT01219257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102386739|NCT01219257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102386740|NCT01219257|Dermatologic Agents|dermatologic agents|mesh-ancestor
102386741|NCT01219257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102386742|NCT01219257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102386743|NCT01219257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102386744|NCT01219257|Analgesics|analgesics|mesh-ancestor
102386745|NCT01219257|Sensory System Agents|sensory system agents|mesh-ancestor
102386746|NCT01219257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101905426|NCT02818582|Remdesivir|remdesivir|mesh-list
102386747|NCT01219257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386748|NCT01219257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102386749|NCT01219257|Immunologic Factors|immunologic factors|mesh-ancestor
102386750|NCT01615887|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102386751|NCT01615887|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102386752|NCT01615887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386753|NCT01615887|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101905480|NCT01338922|Insulin|insulin|mesh-list
102386754|NCT01615887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102386755|NCT01615887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102386756|NCT01615887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386757|NCT01615887|Dopamine Agents|dopamine agents|mesh-ancestor
102386758|NCT01615887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102386759|NCT04389801|Deferoxamine|deferoxamine|mesh-list
102386760|NCT04389801|Siderophores|siderophores|mesh-ancestor
102386761|NCT04389801|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102386762|NCT04389801|Chelating Agents|chelating agents|mesh-ancestor
102386763|NCT04389801|Sequestering Agents|sequestering agents|mesh-ancestor
102386764|NCT04389801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386765|NCT01606995|Rivaroxaban|rivaroxaban|mesh-list
102386766|NCT01606995|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102386767|NCT01606995|Antithrombins|antithrombins|mesh-ancestor
102386768|NCT01606995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102386769|NCT01606995|Protease Inhibitors|protease inhibitors|mesh-ancestor
102386770|NCT01606995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102386771|NCT01606995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386772|NCT01606995|Anticoagulants|anticoagulants|mesh-ancestor
102386773|NCT03548220|Mitapivat|mitapivat|mesh-list
102386774|NCT03548220|Enzyme Activators|enzyme activators|mesh-ancestor
102386775|NCT03548220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386776|NCT03257670|Lidocaine|lidocaine|mesh-list
102386777|NCT03257670|Anesthetics, Local|anesthetics, local|mesh-ancestor
102386778|NCT03257670|Anesthetics|anesthetics|mesh-ancestor
102386779|NCT03257670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102386780|NCT03257670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386781|NCT03257670|Sensory System Agents|sensory system agents|mesh-ancestor
102386782|NCT03257670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101905609|NCT01341262|Hormones|hormones|mesh-ancestor
102386783|NCT03257670|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102386784|NCT03257670|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102386785|NCT03257670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101905680|NCT01341886|Metformin|metformin|mesh-list
102386786|NCT03257670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102386787|NCT03257670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386788|NCT03265002|Psyllium|psyllium|mesh-list
102386789|NCT03265002|Calcium polycarbophil|calcium polycarbophil|mesh-list
102386790|NCT03265002|Cathartics|cathartics|mesh-ancestor
102386791|NCT03265002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102386792|NCT03265002|Antidiarrheals|antidiarrheals|mesh-ancestor
102386793|NCT03257514|Thioctic Acid|thioctic acid|mesh-list
102386794|NCT03257514|Antioxidants|antioxidants|mesh-ancestor
102386795|NCT03257514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386796|NCT03257514|Protective Agents|protective agents|mesh-ancestor
102386797|NCT03257514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386798|NCT03257514|Vitamin B Complex|vitamin b complex|mesh-ancestor
102386799|NCT03257514|Vitamins|vitamins|mesh-ancestor
102386800|NCT03257514|Micronutrients|micronutrients|mesh-ancestor
102386801|NCT04781751|Insulin|insulin|mesh-list
102386802|NCT04781751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102386803|NCT04781751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386805|NCT04781439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102386806|NCT03261024|Nickel|nickel|mesh-list
102386807|NCT03261024|Trace Elements|trace elements|mesh-ancestor
102386808|NCT03261024|Micronutrients|micronutrients|mesh-ancestor
102386809|NCT03261024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386810|NCT04777383|Atropine|atropine|mesh-list
102386811|NCT04777383|Phenylephrine|phenylephrine|mesh-list
102386812|NCT04777383|Oxymetazoline|oxymetazoline|mesh-list
101905809|NCT02121184|Oxytocin|oxytocin|mesh-list
102386813|NCT04777383|Norepinephrine|norepinephrine|mesh-list
102386814|NCT04777383|Acetylcholine|acetylcholine|mesh-list
102386815|NCT04777383|Neostigmine|neostigmine|mesh-list
102386816|NCT04777383|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102386817|NCT04777383|Mydriatics|mydriatics|mesh-ancestor
102386818|NCT04777383|Autonomic Agents|autonomic agents|mesh-ancestor
102386819|NCT04777383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102386820|NCT04777383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386821|NCT04777383|Sympathomimetics|sympathomimetics|mesh-ancestor
102386822|NCT04777383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102386823|NCT04777383|Nasal Decongestants|nasal decongestants|mesh-ancestor
102386824|NCT04777383|Respiratory System Agents|respiratory system agents|mesh-ancestor
102386825|NCT04777383|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102386826|NCT04777383|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102386827|NCT04777383|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102386828|NCT04777383|Adrenergic Agents|adrenergic agents|mesh-ancestor
102386829|NCT04777383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102386830|NCT04777383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386831|NCT04777383|Protective Agents|protective agents|mesh-ancestor
102386832|NCT04777383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102386833|NCT04777383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102386834|NCT04777383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102386835|NCT04777383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102386836|NCT04777383|Parasympatholytics|parasympatholytics|mesh-ancestor
102386837|NCT04777383|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102386838|NCT04777383|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102386839|NCT04777383|Cholinergic Agents|cholinergic agents|mesh-ancestor
101906145|NCT03974867|Prednisolone|prednisolone|mesh-list
102386840|NCT04777383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102386841|NCT04777383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102386842|NCT04777383|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102386843|NCT04777383|Vasodilator Agents|vasodilator agents|mesh-ancestor
101906223|NCT03816020|Niacin|niacin|mesh-list
102386844|NCT04777383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102386845|NCT03257124|Osimertinib|osimertinib|mesh-list
101906286|NCT03815474|Epirubicin|epirubicin|mesh-list
102386846|NCT03257124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102386847|NCT03257124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102386848|NCT03257124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102386849|NCT03257124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386850|NCT02089113|Dexamethasone|dexamethasone|mesh-list
102386851|NCT02089113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102386852|NCT02089113|Antiemetics|antiemetics|mesh-ancestor
102386853|NCT02089113|Autonomic Agents|autonomic agents|mesh-ancestor
102386854|NCT02089113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102386855|NCT02089113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386856|NCT02089113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102386857|NCT02089113|Glucocorticoids|glucocorticoids|mesh-ancestor
102386858|NCT02089113|Hormones|hormones|mesh-ancestor
102386859|NCT02089113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102386860|NCT02089113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102386861|NCT02089113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102386862|NCT04780659|Vaccines|vaccines|mesh-list
102386863|NCT04780659|Immunologic Factors|immunologic factors|mesh-ancestor
102386864|NCT04780659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386865|NCT03260634|Voriconazole|voriconazole|mesh-list
102386866|NCT03260634|Antifungal Agents|antifungal agents|mesh-ancestor
102386867|NCT03260634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102386868|NCT03260634|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102386869|NCT03260634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102386870|NCT03260634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102386871|NCT03260634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386872|NCT03260634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102386873|NCT03260634|Hormone Antagonists|hormone antagonists|mesh-ancestor
102386874|NCT03260634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102386875|NCT03260634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386876|NCT03260634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102386877|NCT04777227|Lidocaine|lidocaine|mesh-list
102386878|NCT04777227|Anesthetics, Local|anesthetics, local|mesh-ancestor
102386879|NCT04777227|Anesthetics|anesthetics|mesh-ancestor
102386880|NCT04777227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102386881|NCT04777227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386882|NCT04777227|Sensory System Agents|sensory system agents|mesh-ancestor
102386883|NCT04777227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102386884|NCT04777227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102386885|NCT04777227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102386886|NCT04777227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102386887|NCT04777227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101906986|NCT00379288|Xhance|xhance|mesh-list
102386888|NCT04777227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386889|NCT03260556|Pirfenidone|pirfenidone|mesh-list
102386890|NCT03260556|Analgesics|analgesics|mesh-ancestor
102386891|NCT03260556|Sensory System Agents|sensory system agents|mesh-ancestor
102386892|NCT03260556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102386893|NCT03260556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386894|NCT03260556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102386895|NCT03260556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102386896|NCT03260556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102386897|NCT03260556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102386898|NCT03260556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102386899|NCT02712996|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102386900|NCT02712996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102386901|NCT02712996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907141|NCT03620422|Mannitol|mannitol|mesh-list
102386902|NCT02712996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102386903|NCT02712996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102386904|NCT02712996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102386905|NCT02712996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386906|NCT02712996|Dopamine Agents|dopamine agents|mesh-ancestor
102386907|NCT02712996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102386908|NCT03252366|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
102386909|NCT03252366|Hemostatics|hemostatics|mesh-ancestor
102386910|NCT03252366|Coagulants|coagulants|mesh-ancestor
102386911|NCT04346277|Antibodies|antibodies|mesh-list
102386912|NCT04346277|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102386913|NCT04346277|Immunologic Factors|immunologic factors|mesh-ancestor
102386914|NCT04346277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386915|NCT04780347|Paclitaxel|paclitaxel|mesh-list
102386916|NCT04780347|Capecitabine|capecitabine|mesh-list
101907351|NCT03772262|Metformin|metformin|mesh-list
102386917|NCT04780347|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102386918|NCT04780347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102386919|NCT04780347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102386920|NCT04780347|Tubulin Modulators|tubulin modulators|mesh-ancestor
102386921|NCT04780347|Antimitotic Agents|antimitotic agents|mesh-ancestor
102386922|NCT04780347|Mitosis Modulators|mitosis modulators|mesh-ancestor
102386923|NCT04780347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907495|NCT03770936|Ramipril|ramipril|mesh-list
102386924|NCT04780347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102386925|NCT04780347|Antimetabolites|antimetabolites|mesh-ancestor
102386926|NCT02455596|Interferons|interferons|mesh-list
102386927|NCT02455596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102386928|NCT02455596|Antiviral Agents|antiviral agents|mesh-ancestor
102386929|NCT02455596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102386930|NCT02455440|Propofol|propofol|mesh-list
102386931|NCT02455440|Sevoflurane|sevoflurane|mesh-list
102386932|NCT02455440|Esmolol|esmolol|mesh-list
102386933|NCT02455440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102386934|NCT02455440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101907641|NCT01336348|Tirofiban|tirofiban|mesh-list
102386935|NCT02455440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386936|NCT02455440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102386937|NCT02455440|Anesthetics, General|anesthetics, general|mesh-ancestor
102386938|NCT02455440|Anesthetics|anesthetics|mesh-ancestor
102386939|NCT02455440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102386940|NCT02455440|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102386941|NCT02455440|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102386942|NCT02455440|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102386943|NCT02455440|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102386944|NCT02455440|Adrenergic Agents|adrenergic agents|mesh-ancestor
102386945|NCT02455440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102386946|NCT02455440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386947|NCT03260166|Niacinamide|niacinamide|mesh-list
102386948|NCT03260166|Niacin|niacin|mesh-list
102386949|NCT03260166|Nicotinic Acids|nicotinic acids|mesh-list
102386950|NCT03260166|Vitamin B Complex|vitamin b complex|mesh-ancestor
102386951|NCT03260166|Vitamins|vitamins|mesh-ancestor
102386952|NCT03260166|Micronutrients|micronutrients|mesh-ancestor
102386953|NCT03260166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386954|NCT03260166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102386955|NCT03260166|Antimetabolites|antimetabolites|mesh-ancestor
102386956|NCT03260166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386957|NCT03260166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102386958|NCT03260166|Vasodilator Agents|vasodilator agents|mesh-ancestor
102386959|NCT03260010|Fosfomycin|fosfomycin|mesh-list
102386960|NCT03260010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102386961|NCT03260010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102386962|NCT03260088|Immunoglobulins|immunoglobulins|mesh-list
102386963|NCT03260088|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102386964|NCT03260088|Antibodies|antibodies|mesh-list
102386965|NCT03260088|Immunoglobulin G|immunoglobulin g|mesh-list
102386966|NCT03260088|Immunologic Factors|immunologic factors|mesh-ancestor
102386967|NCT03260088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386968|NCT03480672|Pembrolizumab|pembrolizumab|mesh-list
102386969|NCT03480672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102386970|NCT03480672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102386971|NCT03480672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102386972|NCT03480672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386973|NCT04776135|Edaravone|edaravone|mesh-list
101908176|NCT04737278|Niacin|niacin|mesh-list
102386974|NCT04776135|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102386975|NCT04776135|Antioxidants|antioxidants|mesh-ancestor
102386976|NCT04776135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386977|NCT04776135|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102386978|NCT04776135|Protective Agents|protective agents|mesh-ancestor
102386979|NCT04776135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386980|NCT03474276|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102386981|NCT03474276|Azithromycin|azithromycin|mesh-list
102386982|NCT03474276|Albendazole|albendazole|mesh-list
102386983|NCT03474276|Antiparasitic Agents|antiparasitic agents|mesh-list
102386984|NCT03474276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102386985|NCT03474276|Anthelmintics|anthelmintics|mesh-ancestor
102386986|NCT03474276|Anticestodal Agents|anticestodal agents|mesh-ancestor
102386987|NCT03474276|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102386988|NCT03474276|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102386989|NCT03474276|Tubulin Modulators|tubulin modulators|mesh-ancestor
102386990|NCT03474276|Antimitotic Agents|antimitotic agents|mesh-ancestor
102386991|NCT03474276|Mitosis Modulators|mitosis modulators|mesh-ancestor
102386992|NCT03474276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102386993|NCT03474276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102386994|NCT04779255|Acetaminophen|acetaminophen|mesh-list
101908193|NCT03759782|Tenofovir|tenofovir|mesh-list
102386995|NCT04779255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102386996|NCT04779255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102386997|NCT04779255|Analgesics|analgesics|mesh-ancestor
102386998|NCT04779255|Sensory System Agents|sensory system agents|mesh-ancestor
102386999|NCT04779255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102387000|NCT04779255|Antipyretics|antipyretics|mesh-ancestor
102387001|NCT04779567|Acetaminophen|acetaminophen|mesh-list
102387002|NCT04779567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102387003|NCT04779567|Analgesics|analgesics|mesh-ancestor
102387004|NCT04779567|Sensory System Agents|sensory system agents|mesh-ancestor
102387005|NCT04779567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102387006|NCT04779567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387007|NCT04779567|Antipyretics|antipyretics|mesh-ancestor
102387008|NCT02352844|Everolimus|everolimus|mesh-list
102387009|NCT02352844|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102387010|NCT02352844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102387011|NCT02352844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102387012|NCT02352844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387013|NCT02352844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102387014|NCT02352844|Immunologic Factors|immunologic factors|mesh-ancestor
102387015|NCT02352844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387016|NCT02352844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102387017|NCT03255642|Clonazepam|clonazepam|mesh-list
102387018|NCT03255642|Melatonin|melatonin|mesh-list
102387019|NCT03255642|Antioxidants|antioxidants|mesh-ancestor
102387020|NCT03255642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908297|NCT01349452|Ganciclovir|ganciclovir|mesh-list
102387021|NCT03255642|Protective Agents|protective agents|mesh-ancestor
102387022|NCT03255642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387023|NCT03255642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102387024|NCT03255642|Anticonvulsants|anticonvulsants|mesh-ancestor
102387025|NCT03255642|GABA Modulators|gaba modulators|mesh-ancestor
102387026|NCT03255642|GABA Agents|gaba agents|mesh-ancestor
102387027|NCT03255642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102387028|NCT03562377|Vaccines|vaccines|mesh-list
102387029|NCT03562377|Immunologic Factors|immunologic factors|mesh-ancestor
102387030|NCT03562377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387031|NCT02352922|Bupivacaine|bupivacaine|mesh-list
102198753|NCT02403687|Topiramate|topiramate|mesh-list
102387032|NCT02352922|Anesthetics, Local|anesthetics, local|mesh-ancestor
102387033|NCT02352922|Anesthetics|anesthetics|mesh-ancestor
102387034|NCT02352922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102387035|NCT02352922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387036|NCT02352922|Sensory System Agents|sensory system agents|mesh-ancestor
102387037|NCT02352922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102387038|NCT03255330|Dipyrone|dipyrone|mesh-list
102387039|NCT03255330|Gabapentin|gabapentin|mesh-list
102387040|NCT03255330|Tramadol|tramadol|mesh-list
102387041|NCT03255330|Analgesics|analgesics|mesh-ancestor
102387042|NCT03255330|Sensory System Agents|sensory system agents|mesh-ancestor
102387043|NCT03255330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102387044|NCT03255330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387045|NCT03255330|Anticonvulsants|anticonvulsants|mesh-ancestor
102387046|NCT03255330|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102387047|NCT03255330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102387048|NCT03255330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102387049|NCT03255330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102387050|NCT03255330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101908500|NCT02532023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102387051|NCT03255330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102387052|NCT03255330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102387053|NCT03255330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387054|NCT03255330|Antimanic Agents|antimanic agents|mesh-ancestor
102387055|NCT03255330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102387056|NCT03255330|Narcotics|narcotics|mesh-ancestor
102387057|NCT03255330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102387058|NCT03255330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102387059|NCT03255330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102387060|NCT03255330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102387061|NCT03255330|Antipyretics|antipyretics|mesh-ancestor
102387062|NCT02353780|Etanercept|etanercept|mesh-list
102387063|NCT02353780|Infliximab|infliximab|mesh-list
102387064|NCT02353780|Certolizumab Pegol|certolizumab pegol|mesh-list
102387065|NCT02353780|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
102387066|NCT02353780|Abatacept|abatacept|mesh-list
102387067|NCT02353780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102387068|NCT02353780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102387069|NCT02353780|Analgesics|analgesics|mesh-ancestor
102387070|NCT02353780|Sensory System Agents|sensory system agents|mesh-ancestor
102387071|NCT02353780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102387072|NCT02353780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387073|NCT02353780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102387074|NCT02353780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102387075|NCT02353780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102387076|NCT02353780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102387077|NCT02353780|Immunologic Factors|immunologic factors|mesh-ancestor
102387078|NCT02353780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101908767|NCT03951558|Natriuretic Agents|natriuretic agents|mesh-ancestor
102387079|NCT02353780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387080|NCT02353780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102387081|NCT02353780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102387082|NCT02353780|Dermatologic Agents|dermatologic agents|mesh-ancestor
102387083|NCT03176472|Ricolinostat|ricolinostat|mesh-list
101908844|NCT00002766|Cytarabine|cytarabine|mesh-list
102387084|NCT03176472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102387085|NCT03176472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102387086|NCT03176472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102387087|NCT03176472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387088|NCT03246360|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102387089|NCT03246360|Cloxacillin|cloxacillin|mesh-list
102387090|NCT03246360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102387091|NCT02354092|Anesthetics|anesthetics|mesh-list
102387092|NCT02354092|Anesthetics, Local|anesthetics, local|mesh-list
102387093|NCT02354092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102387094|NCT02354092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387095|NCT02354092|Sensory System Agents|sensory system agents|mesh-ancestor
102387096|NCT02354092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102387097|NCT00907101|Adapalene|adapalene|mesh-list
102387098|NCT00907101|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
102387099|NCT00907101|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102387100|NCT00907101|Dermatologic Agents|dermatologic agents|mesh-ancestor
102387101|NCT00907101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102387102|NCT00907101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102387103|NCT00907101|Analgesics|analgesics|mesh-ancestor
102387104|NCT00907101|Sensory System Agents|sensory system agents|mesh-ancestor
102198834|NCT02183051|Ibuprofen|ibuprofen|mesh-list
102387105|NCT00907101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101908975|NCT03950544|Meropenem|meropenem|mesh-list
102387106|NCT00907101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387107|NCT00907101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102387108|NCT00907101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102387109|NCT03245970|Atenolol|atenolol|mesh-list
102387110|NCT03245970|Labetalol|labetalol|mesh-list
102387111|NCT03245970|Nifedipine|nifedipine|mesh-list
102387112|NCT03245970|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102387113|NCT03245970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102387114|NCT03245970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387115|NCT03245970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102387116|NCT03245970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387117|NCT03245970|Vasodilator Agents|vasodilator agents|mesh-ancestor
102387118|NCT03245970|Tocolytic Agents|tocolytic agents|mesh-ancestor
102387119|NCT03245970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102387120|NCT03245970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102387121|NCT03245970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102387122|NCT03245970|Sympatholytics|sympatholytics|mesh-ancestor
102387123|NCT03245970|Autonomic Agents|autonomic agents|mesh-ancestor
102387124|NCT03245970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102387125|NCT03245970|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102387126|NCT03245970|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102387127|NCT03245970|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102387128|NCT03245970|Adrenergic Agents|adrenergic agents|mesh-ancestor
102387129|NCT03245970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102387130|NCT03245970|Sympathomimetics|sympathomimetics|mesh-ancestor
102387131|NCT03245970|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102387132|NCT03245970|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102387133|NCT02454348|Vasopressins|vasopressins|mesh-list
102387134|NCT02454348|Arginine Vasopressin|arginine vasopressin|mesh-list
102387135|NCT02454348|Norepinephrine|norepinephrine|mesh-list
102387136|NCT02454348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102387137|NCT02454348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102387138|NCT02454348|Adrenergic Agents|adrenergic agents|mesh-ancestor
102387139|NCT02454348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102387140|NCT02454348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387141|NCT02454348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387142|NCT02454348|Sympathomimetics|sympathomimetics|mesh-ancestor
102387143|NCT02454348|Autonomic Agents|autonomic agents|mesh-ancestor
102387144|NCT02454348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102387145|NCT02454348|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102387146|NCT02454348|Hemostatics|hemostatics|mesh-ancestor
102387147|NCT02454348|Coagulants|coagulants|mesh-ancestor
101909033|NCT00027378|Serotonin Agents|serotonin agents|mesh-ancestor
102387148|NCT02454348|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102387149|NCT02454348|Natriuretic Agents|natriuretic agents|mesh-ancestor
102387150|NCT02455908|Aldesleukin|aldesleukin|mesh-list
102387151|NCT02455908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102387152|NCT02455908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102387153|NCT02455908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102387154|NCT02455908|Antiviral Agents|antiviral agents|mesh-ancestor
102387155|NCT02455908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102387156|NCT03245424|Ivosidenib|ivosidenib|mesh-list
102387157|NCT03245424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102387158|NCT03245424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102387159|NCT03245424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387160|NCT03251040|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102387161|NCT03251040|Hemostatics|hemostatics|mesh-ancestor
102387162|NCT03251040|Coagulants|coagulants|mesh-ancestor
102387163|NCT04754763|Propolis|propolis|mesh-list
102387164|NCT04754763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102387165|NCT02454894|Lidocaine|lidocaine|mesh-list
102387166|NCT02454894|Anesthetics, Local|anesthetics, local|mesh-ancestor
102387167|NCT02454894|Anesthetics|anesthetics|mesh-ancestor
102387168|NCT02454894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102387169|NCT02454894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387170|NCT02454894|Sensory System Agents|sensory system agents|mesh-ancestor
102387171|NCT02454894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102387172|NCT02454894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102387173|NCT02454894|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102387174|NCT02454894|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102387175|NCT02454894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102387176|NCT02454894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387177|NCT03250962|Decitabine|decitabine|mesh-list
102387178|NCT03250962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102387179|NCT03250962|Antimetabolites|antimetabolites|mesh-ancestor
102387180|NCT03250962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198905|NCT02183363|Hormones|hormones|mesh-ancestor
102387181|NCT03250962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102387182|NCT03250962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102387183|NCT04774029|Lidocaine|lidocaine|mesh-list
102387184|NCT04774029|Anesthetics, Local|anesthetics, local|mesh-ancestor
102387185|NCT04774029|Anesthetics|anesthetics|mesh-ancestor
102387186|NCT04774029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102387187|NCT04774029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387188|NCT04774029|Sensory System Agents|sensory system agents|mesh-ancestor
102387189|NCT04774029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102387190|NCT04774029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102387191|NCT04774029|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102387192|NCT04774029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102387193|NCT04774029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102387194|NCT04774029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387195|NCT03245346|Anesthetics|anesthetics|mesh-list
102387196|NCT03245346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102387197|NCT03245346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387198|NCT03244956|Trametinib|trametinib|mesh-list
102387199|NCT03244956|Dabrafenib|dabrafenib|mesh-list
102387200|NCT03244956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102387201|NCT03244956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102387202|NCT03244956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102387203|NCT03244956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387204|NCT03244488|Mecamylamine|mecamylamine|mesh-list
102387205|NCT03244488|Scopolamine|scopolamine|mesh-list
102387206|NCT03244488|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102387207|NCT03244488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102387208|NCT03244488|Antiemetics|antiemetics|mesh-ancestor
102387209|NCT03244488|Autonomic Agents|autonomic agents|mesh-ancestor
102387210|NCT03244488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102387211|NCT03244488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387212|NCT03244488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102387213|NCT03244488|Mydriatics|mydriatics|mesh-ancestor
102387214|NCT03244488|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102387215|NCT03244488|Cholinergic Agents|cholinergic agents|mesh-ancestor
102387216|NCT03244488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102387217|NCT03244488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387218|NCT03244488|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102387219|NCT03244488|Parasympatholytics|parasympatholytics|mesh-ancestor
102387220|NCT03244488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102387221|NCT03244488|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
102387222|NCT03244488|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102387223|NCT03254784|Deucravacitinib|deucravacitinib|mesh-list
102387224|NCT03254784|Dermatologic Agents|dermatologic agents|mesh-ancestor
102387225|NCT03254784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102387226|NCT03254784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102387227|NCT03254784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387228|NCT03245658|Nabiximols|nabiximols|mesh-list
102387229|NCT03245658|Analgesics|analgesics|mesh-ancestor
102387230|NCT03245658|Sensory System Agents|sensory system agents|mesh-ancestor
102387231|NCT03245658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102387232|NCT03245658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387233|NCT03245190|Chiauranib|chiauranib|mesh-list
102387234|NCT03245190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102387235|NCT03245190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102387236|NCT03245190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102387237|NCT03245190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387238|NCT01969708|Bevacizumab|bevacizumab|mesh-list
102387239|NCT01969708|Aflibercept|aflibercept|mesh-list
102387240|NCT01969708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101909093|NCT00026208|Glucocorticoids|glucocorticoids|mesh-ancestor
102387241|NCT01969708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102387242|NCT01969708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102387243|NCT01969708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102387244|NCT01969708|Growth Substances|growth substances|mesh-ancestor
102387245|NCT01969708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387246|NCT01969708|Growth Inhibitors|growth inhibitors|mesh-ancestor
102387247|NCT03243864|Ceftazidime|ceftazidime|mesh-list
102387248|NCT03243864|Avibactam|avibactam|mesh-list
102387249|NCT03243864|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
102387250|NCT03243864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102387251|NCT03243864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102387252|NCT03243864|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102387253|NCT03243864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102387254|NCT03243864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387255|NCT03250494|Dexamethasone|dexamethasone|mesh-list
102198975|NCT00449605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102387256|NCT03250494|Dexamethasone acetate|dexamethasone acetate|mesh-list
102387257|NCT03250494|BB 1101|bb 1101|mesh-list
102387258|NCT03250494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102387259|NCT03250494|Antiemetics|antiemetics|mesh-ancestor
102387260|NCT03250494|Autonomic Agents|autonomic agents|mesh-ancestor
102387261|NCT03250494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102387262|NCT03250494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387263|NCT03250494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102387264|NCT03250494|Glucocorticoids|glucocorticoids|mesh-ancestor
102387265|NCT03250494|Hormones|hormones|mesh-ancestor
102387266|NCT03250494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102387267|NCT03250494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102387268|NCT03250494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102387269|NCT03250494|Protease Inhibitors|protease inhibitors|mesh-ancestor
102387270|NCT03250494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102387271|NCT03250494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387272|NCT03254628|Misoprostol|misoprostol|mesh-list
102387273|NCT03254628|Oxytocin|oxytocin|mesh-list
102387274|NCT03254628|Oxytocics|oxytocics|mesh-ancestor
102387275|NCT03254628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102387276|NCT03254628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387277|NCT03254628|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102387278|NCT03254628|Abortifacient Agents|abortifacient agents|mesh-ancestor
102387279|NCT03254628|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102387280|NCT03254628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102387281|NCT01970176|Tadalafil|tadalafil|mesh-list
102387282|NCT01970176|Vasodilator Agents|vasodilator agents|mesh-ancestor
102387283|NCT01970176|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102387284|NCT01970176|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102387285|NCT01970176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102387286|NCT01970176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387287|NCT01970176|Urological Agents|urological agents|mesh-ancestor
102387288|NCT02024386|Riociguat|riociguat|mesh-list
102387289|NCT02024386|Enzyme Activators|enzyme activators|mesh-ancestor
102387290|NCT02024386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387291|NCT03250338|Cytarabine|cytarabine|mesh-list
102387292|NCT03250338|Fludarabine|fludarabine|mesh-list
102387293|NCT03250338|Mitoxantrone|mitoxantrone|mesh-list
102387294|NCT03250338|Idarubicin|idarubicin|mesh-list
102387295|NCT03250338|Crenolanib|crenolanib|mesh-list
102387296|NCT03250338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102387297|NCT03250338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102387298|NCT03250338|Antimetabolites|antimetabolites|mesh-ancestor
102387299|NCT03250338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387300|NCT03250338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102387301|NCT03250338|Immunologic Factors|immunologic factors|mesh-ancestor
102387302|NCT03250338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387303|NCT03250338|Antiviral Agents|antiviral agents|mesh-ancestor
102387304|NCT03250338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102387305|NCT03250338|Analgesics|analgesics|mesh-ancestor
102387306|NCT03250338|Sensory System Agents|sensory system agents|mesh-ancestor
102387307|NCT03250338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102387308|NCT03250338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102387309|NCT03250338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102387310|NCT03250338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102387311|NCT03250338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102387312|NCT01971580|Ambrisentan|ambrisentan|mesh-list
102387313|NCT01971580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102387314|NCT00354562|Docetaxel|docetaxel|mesh-list
102387315|NCT00354562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102387316|NCT00354562|Tubulin Modulators|tubulin modulators|mesh-ancestor
102387317|NCT00354562|Antimitotic Agents|antimitotic agents|mesh-ancestor
102387318|NCT00354562|Mitosis Modulators|mitosis modulators|mesh-ancestor
102387319|NCT00354562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387320|NCT03250104|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102387321|NCT03250104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102387322|NCT00838383|Sitaxsentan|sitaxsentan|mesh-list
102387323|NCT00838383|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102387324|NCT00838383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387325|NCT02355886|Gabapentin|gabapentin|mesh-list
102387326|NCT02355886|Analgesics|analgesics|mesh-ancestor
102387327|NCT02355886|Sensory System Agents|sensory system agents|mesh-ancestor
102387328|NCT02355886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102387329|NCT02355886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387330|NCT02355886|Anticonvulsants|anticonvulsants|mesh-ancestor
102387331|NCT02355886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102387332|NCT02355886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102387333|NCT02355886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102387334|NCT02355886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102387335|NCT02355886|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102387336|NCT02355886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102387337|NCT02355886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102387338|NCT02355886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387339|NCT02355886|Antimanic Agents|antimanic agents|mesh-ancestor
102387340|NCT03247413|Dexamethasone|dexamethasone|mesh-list
102387341|NCT03247413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102387342|NCT03247413|Antiemetics|antiemetics|mesh-ancestor
102387343|NCT03247413|Autonomic Agents|autonomic agents|mesh-ancestor
102387344|NCT03247413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102387345|NCT03247413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387346|NCT03247413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102387347|NCT03247413|Glucocorticoids|glucocorticoids|mesh-ancestor
102387348|NCT03247413|Hormones|hormones|mesh-ancestor
102387349|NCT03247413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102387350|NCT03247413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102387351|NCT03247413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102387352|NCT02356198|Hydromorphone|hydromorphone|mesh-list
102387353|NCT02356198|Bupivacaine|bupivacaine|mesh-list
102387354|NCT02356198|Anesthetics, Local|anesthetics, local|mesh-ancestor
102387355|NCT02356198|Anesthetics|anesthetics|mesh-ancestor
102387356|NCT02356198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102387357|NCT02356198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387358|NCT02356198|Sensory System Agents|sensory system agents|mesh-ancestor
102387359|NCT02356198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102387360|NCT02356198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102387361|NCT02356198|Narcotics|narcotics|mesh-ancestor
102387362|NCT02356198|Analgesics|analgesics|mesh-ancestor
102387363|NCT03254004|Pembrolizumab|pembrolizumab|mesh-list
102387364|NCT03254004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102387365|NCT03254004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102387366|NCT03254004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102387367|NCT03254004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387368|NCT04778865|Vitamin D|vitamin d|mesh-list
102387369|NCT04778865|Ergocalciferols|ergocalciferols|mesh-list
102387370|NCT04778865|Cholecalciferol|cholecalciferol|mesh-list
102387371|NCT04778865|Vitamins|vitamins|mesh-list
102387372|NCT04778865|Micronutrients|micronutrients|mesh-ancestor
102387373|NCT04778865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387374|NCT04778865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102387375|NCT04778865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102387376|NCT02025634|Acetaminophen|acetaminophen|mesh-list
102387377|NCT02025634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102387378|NCT02025634|Analgesics|analgesics|mesh-ancestor
102387379|NCT02025634|Sensory System Agents|sensory system agents|mesh-ancestor
102387380|NCT02025634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102387381|NCT02025634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387382|NCT02025634|Antipyretics|antipyretics|mesh-ancestor
102387383|NCT04773951|Antibodies|antibodies|mesh-list
102387384|NCT04773951|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102387385|NCT04773951|Immunologic Factors|immunologic factors|mesh-ancestor
102387386|NCT04773951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387387|NCT04773717|Ascorbic Acid|ascorbic acid|mesh-list
102387388|NCT04773717|Antioxidants|antioxidants|mesh-ancestor
102387389|NCT04773717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387390|NCT04773717|Protective Agents|protective agents|mesh-ancestor
102387391|NCT04773717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387392|NCT04773717|Vitamins|vitamins|mesh-ancestor
102387393|NCT04773717|Micronutrients|micronutrients|mesh-ancestor
102387394|NCT04444167|Lenvatinib|lenvatinib|mesh-list
102387395|NCT04444167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102387396|NCT04444167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102387397|NCT04444167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102387398|NCT04444167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387399|NCT03243006|Acetaminophen|acetaminophen|mesh-list
102387400|NCT03243006|Tramadol|tramadol|mesh-list
102387401|NCT03243006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102387402|NCT03243006|Analgesics|analgesics|mesh-ancestor
102387403|NCT03243006|Sensory System Agents|sensory system agents|mesh-ancestor
102199132|NCT05149365|Cyclosporine|cyclosporine|mesh-list
102387404|NCT03243006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102387405|NCT03243006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387406|NCT03243006|Antipyretics|antipyretics|mesh-ancestor
102387407|NCT03243006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102387408|NCT03243006|Narcotics|narcotics|mesh-ancestor
102387410|NCT03249402|Levonorgestrel|levonorgestrel|mesh-list
102387411|NCT03249402|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102387412|NCT03249402|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
102387413|NCT03249402|Estradiol|estradiol|mesh-list
102387414|NCT03249402|Estrogens|estrogens|mesh-ancestor
102387415|NCT03249402|Hormones|hormones|mesh-ancestor
102387416|NCT03249402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102387417|NCT03249402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387418|NCT03249402|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102387419|NCT03249402|Contraceptive Agents|contraceptive agents|mesh-ancestor
102387420|NCT03249402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102387421|NCT03249402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102387422|NCT03249402|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102387423|NCT03249402|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102387424|NCT03249402|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102387425|NCT03249402|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102387426|NCT03242460|Dexamethasone|dexamethasone|mesh-list
102387427|NCT03242460|Cyclophosphamide|cyclophosphamide|mesh-list
102387428|NCT03242460|Pomalidomide|pomalidomide|mesh-list
102387429|NCT03242460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102387430|NCT03242460|Immunologic Factors|immunologic factors|mesh-ancestor
102387431|NCT03242460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387432|NCT03242460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102387433|NCT03242460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102387434|NCT03242460|Alkylating Agents|alkylating agents|mesh-ancestor
102387435|NCT03242460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387436|NCT03242460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102387437|NCT03242460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102387438|NCT03242460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102387439|NCT03242460|Antiemetics|antiemetics|mesh-ancestor
102387440|NCT03242460|Autonomic Agents|autonomic agents|mesh-ancestor
102387441|NCT03242460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102387442|NCT03242460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102387443|NCT03242460|Glucocorticoids|glucocorticoids|mesh-ancestor
102387444|NCT03242460|Hormones|hormones|mesh-ancestor
102387445|NCT03242460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102387446|NCT03242460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102387447|NCT03242460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102387448|NCT03242460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102387449|NCT03242460|Growth Substances|growth substances|mesh-ancestor
102387450|NCT03242460|Growth Inhibitors|growth inhibitors|mesh-ancestor
102387451|NCT01972516|Tivozanib|tivozanib|mesh-list
102387452|NCT01972516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102387453|NCT01972516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102387454|NCT01972516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387455|NCT03242616|Pemetrexed|pemetrexed|mesh-list
102387456|NCT03242616|Vinorelbine|vinorelbine|mesh-list
102387457|NCT03242616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102387458|NCT03242616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102387459|NCT03242616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387460|NCT03242616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102387461|NCT03242616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102387462|NCT03242616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102387463|NCT03242616|Tubulin Modulators|tubulin modulators|mesh-ancestor
102387464|NCT03242616|Antimitotic Agents|antimitotic agents|mesh-ancestor
102387465|NCT03242616|Mitosis Modulators|mitosis modulators|mesh-ancestor
102387466|NCT01748825|Adavosertib|adavosertib|mesh-list
102387467|NCT01748825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102387468|NCT01748825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387469|NCT03253224|Magnesium Sulfate|magnesium sulfate|mesh-list
102387470|NCT03253224|Analgesics|analgesics|mesh-ancestor
102387471|NCT03253224|Sensory System Agents|sensory system agents|mesh-ancestor
102387472|NCT03253224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102387473|NCT03253224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387474|NCT03253224|Anesthetics|anesthetics|mesh-ancestor
102387475|NCT03253224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102387476|NCT03253224|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102387477|NCT03253224|Anticonvulsants|anticonvulsants|mesh-ancestor
102387478|NCT03253224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102387479|NCT03253224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102387480|NCT03253224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199195|NCT02282371|Cetuximab|cetuximab|mesh-list
102387481|NCT03253224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102387483|NCT03253224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102387484|NCT00789399|PENTA|penta|mesh-list
102387485|NCT00789399|Fondaparinux|fondaparinux|mesh-list
102387486|NCT00789399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102387487|NCT00789399|Antithrombins|antithrombins|mesh-ancestor
102387488|NCT00789399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102387489|NCT00789399|Protease Inhibitors|protease inhibitors|mesh-ancestor
102387490|NCT00789399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102387491|NCT00789399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387492|NCT00789399|Anticoagulants|anticoagulants|mesh-ancestor
102387493|NCT00789399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102387494|NCT00789399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102387495|NCT01720667|Levetiracetam|levetiracetam|mesh-list
102387496|NCT01720667|Phenobarbital|phenobarbital|mesh-list
102387497|NCT01720667|Anticonvulsants|anticonvulsants|mesh-ancestor
102387498|NCT01720667|Nootropic Agents|nootropic agents|mesh-ancestor
102387499|NCT01720667|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102387500|NCT01720667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102387501|NCT01720667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387502|NCT01720667|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102387503|NCT01720667|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102387504|NCT01720667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102387505|NCT01720667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387506|NCT01720667|GABA Modulators|gaba modulators|mesh-ancestor
102387507|NCT01720667|GABA Agents|gaba agents|mesh-ancestor
102387508|NCT01720667|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102387509|NCT01720667|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102387510|NCT01720667|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102387511|NCT04773093|Lidocaine|lidocaine|mesh-list
102387512|NCT04773093|Anesthetics, Local|anesthetics, local|mesh-ancestor
102387513|NCT04773093|Anesthetics|anesthetics|mesh-ancestor
102387514|NCT04773093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102387515|NCT04773093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387516|NCT04773093|Sensory System Agents|sensory system agents|mesh-ancestor
102387517|NCT04773093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102387518|NCT04773093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102387519|NCT04773093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102387520|NCT04773093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102387521|NCT04773093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102387522|NCT04773093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387523|NCT01720043|Bortezomib|bortezomib|mesh-list
102387524|NCT01720043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102387525|NCT02455362|Morphine|morphine|mesh-list
102387526|NCT02455362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102387527|NCT02455362|Narcotics|narcotics|mesh-ancestor
102387528|NCT02455362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102387529|NCT02455362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387530|NCT02455362|Analgesics|analgesics|mesh-ancestor
102387531|NCT02455362|Sensory System Agents|sensory system agents|mesh-ancestor
102387532|NCT02455362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102387533|NCT03242304|Hydrocortisone|hydrocortisone|mesh-list
102387534|NCT03242304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102387535|NCT03253068|Pembrolizumab|pembrolizumab|mesh-list
102387536|NCT03253068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102387537|NCT03253068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102387538|NCT03253068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102387539|NCT03253068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387540|NCT01718483|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102387541|NCT01718483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102387542|NCT01718483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387543|NCT01718483|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102387544|NCT01718483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102387545|NCT01718483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102387546|NCT01718483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387547|NCT01718483|Dopamine Agents|dopamine agents|mesh-ancestor
102387548|NCT01718483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102387549|NCT03249168|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102387550|NCT03249168|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102387551|NCT03249168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101909434|NCT01073111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102387552|NCT03249168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102387553|NCT03249168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387554|NCT03249168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102387555|NCT03249168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387556|NCT03249168|Analgesics|analgesics|mesh-ancestor
102387557|NCT03249168|Sensory System Agents|sensory system agents|mesh-ancestor
102387558|NCT03249168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102387559|NCT03249168|Antidepressive Agents|antidepressive agents|mesh-ancestor
102387560|NCT03249168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102387561|NCT03249168|Dopamine Agents|dopamine agents|mesh-ancestor
102387562|NCT03248856|Triamcinolone|triamcinolone|mesh-list
102387563|NCT03248856|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102387564|NCT03248856|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102387565|NCT03248856|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101909496|NCT02223520|Mupirocin|mupirocin|mesh-list
102387566|NCT03248856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102387567|NCT03248856|Glucocorticoids|glucocorticoids|mesh-ancestor
102387568|NCT03248856|Hormones|hormones|mesh-ancestor
102387569|NCT03248856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102387570|NCT03248856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387571|NCT03248856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102387572|NCT03248856|Immunologic Factors|immunologic factors|mesh-ancestor
102387573|NCT03248856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102387574|NCT03248856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387575|NCT03241602|Lidocaine|lidocaine|mesh-list
102387576|NCT03241602|Anesthetics, Local|anesthetics, local|mesh-ancestor
102387577|NCT03241602|Anesthetics|anesthetics|mesh-ancestor
102387578|NCT03241602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102387579|NCT03241602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387580|NCT03241602|Sensory System Agents|sensory system agents|mesh-ancestor
102387581|NCT03241602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102387582|NCT03241602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102387583|NCT03241602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102387584|NCT03241602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102387585|NCT03241602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102387586|NCT03241602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387587|NCT02357290|Acetylcysteine|acetylcysteine|mesh-list
102387588|NCT02357290|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102387589|NCT02357290|Antiviral Agents|antiviral agents|mesh-ancestor
102387590|NCT02357290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102387591|NCT02357290|Expectorants|expectorants|mesh-ancestor
102387592|NCT02357290|Respiratory System Agents|respiratory system agents|mesh-ancestor
102387593|NCT02357290|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102387594|NCT02357290|Antioxidants|antioxidants|mesh-ancestor
102387595|NCT02357290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387596|NCT02357290|Protective Agents|protective agents|mesh-ancestor
102387597|NCT02357290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387598|NCT02357290|Antidotes|antidotes|mesh-ancestor
102387599|NCT02477202|Levonorgestrel|levonorgestrel|mesh-list
102387600|NCT02477202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102387601|NCT02477202|Contraceptive Agents|contraceptive agents|mesh-ancestor
102387602|NCT02477202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102387603|NCT02477202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387604|NCT02477202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102387605|NCT02477202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102387606|NCT02477202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102387607|NCT00687765|Temozolomide|temozolomide|mesh-list
102387608|NCT00687765|Iniparib|iniparib|mesh-list
102387609|NCT00687765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102387610|NCT00687765|Alkylating Agents|alkylating agents|mesh-ancestor
102387611|NCT00687765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387612|NCT00687765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102387613|NCT00687765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102387614|NCT00687765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102387615|NCT03248544|Vitamin D|vitamin d|mesh-list
102387616|NCT03248544|Cholecalciferol|cholecalciferol|mesh-list
102387617|NCT03248544|Vitamins|vitamins|mesh-ancestor
102387618|NCT03248544|Micronutrients|micronutrients|mesh-ancestor
102387619|NCT03248544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387620|NCT03248544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102387621|NCT03248544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102387622|NCT00984399|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102387623|NCT00984399|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102387624|NCT00984399|Estradiol|estradiol|mesh-list
102387625|NCT00984399|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102387626|NCT00984399|Estrogens|estrogens|mesh-ancestor
102387627|NCT00984399|Hormones|hormones|mesh-ancestor
102387628|NCT00984399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102387629|NCT00984399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387630|NCT00984399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102387631|NCT00984399|Contraceptive Agents|contraceptive agents|mesh-ancestor
102387632|NCT00984399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102387633|NCT00984399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102387634|NCT03248700|Vitamins|vitamins|mesh-list
102387635|NCT03248700|Vitamin A|vitamin a|mesh-list
102387636|NCT03248700|Retinol palmitate|retinol palmitate|mesh-list
102387637|NCT03248700|Retinol acetate|retinol acetate|mesh-list
102387638|NCT03248700|Micronutrients|micronutrients|mesh-ancestor
102387639|NCT03248700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387640|NCT03248700|Antioxidants|antioxidants|mesh-ancestor
102387641|NCT03248700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387642|NCT03248700|Protective Agents|protective agents|mesh-ancestor
102387643|NCT03248700|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102387644|NCT03248700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102387645|NCT03248700|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102387646|NCT03248700|Immunologic Factors|immunologic factors|mesh-ancestor
102387647|NCT03238482|Fluticasone|fluticasone|mesh-list
102387648|NCT03238482|Xhance|xhance|mesh-list
102387649|NCT03238482|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102387650|NCT03238482|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102387651|NCT03238482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102387652|NCT03238482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102387653|NCT03238482|Autonomic Agents|autonomic agents|mesh-ancestor
102387654|NCT03238482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102387655|NCT03238482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387656|NCT03238482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102387657|NCT03238482|Respiratory System Agents|respiratory system agents|mesh-ancestor
102387658|NCT03238482|Dermatologic Agents|dermatologic agents|mesh-ancestor
102387659|NCT03238482|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102387660|NCT03238482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102387661|NCT03238482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102387662|NCT03238482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102387663|NCT03238482|Adrenergic Agents|adrenergic agents|mesh-ancestor
102387664|NCT03238482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102387665|NCT03238482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387666|NCT03238482|Glucocorticoids|glucocorticoids|mesh-ancestor
102387667|NCT03238482|Hormones|hormones|mesh-ancestor
102387668|NCT03238482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102387669|NCT03238482|Sympathomimetics|sympathomimetics|mesh-ancestor
102387670|NCT02454504|Neostigmine|neostigmine|mesh-list
102387671|NCT02454504|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102387672|NCT02454504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102387673|NCT02454504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387674|NCT02454504|Cholinergic Agents|cholinergic agents|mesh-ancestor
102387675|NCT02454504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102387676|NCT02454504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387677|NCT02454504|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102387678|NCT02454504|Autonomic Agents|autonomic agents|mesh-ancestor
102387679|NCT02454504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102387680|NCT03240822|Antibodies|antibodies|mesh-list
102387681|NCT03240822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102387682|NCT03240822|Tacrolimus|tacrolimus|mesh-list
102387683|NCT03240822|Immunologic Factors|immunologic factors|mesh-ancestor
102387684|NCT03240822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387685|NCT03240822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102387686|NCT03240822|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102387687|NCT03240822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102387688|NCT03240822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387689|NCT03238560|Montelukast|montelukast|mesh-list
101909869|NCT01370434|Hormones|hormones|mesh-ancestor
102387690|NCT03238560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102387691|NCT03238560|Respiratory System Agents|respiratory system agents|mesh-ancestor
102387692|NCT03238560|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102387693|NCT03238560|Hormone Antagonists|hormone antagonists|mesh-ancestor
102387694|NCT03238560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102387695|NCT03238560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387696|NCT03238560|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102387697|NCT03238560|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102387698|NCT03238560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387699|NCT04486092|Valproic Acid|valproic acid|mesh-list
102387700|NCT04486092|Anticonvulsants|anticonvulsants|mesh-ancestor
102387701|NCT04486092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102387702|NCT04486092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909882|NCT05190952|Dexamethasone|dexamethasone|mesh-list
102387704|NCT04486092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102387705|NCT04486092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387706|NCT04486092|Antimanic Agents|antimanic agents|mesh-ancestor
102387707|NCT04486092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102387708|NCT04486092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102387709|NCT04486092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102387710|NCT03238638|Pembrolizumab|pembrolizumab|mesh-list
102387711|NCT03238638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102387712|NCT03238638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102387713|NCT03238638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102387714|NCT03238638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387715|NCT00668655|Metronidazole|metronidazole|mesh-list
102387716|NCT00668655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102387717|NCT00668655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102387718|NCT00668655|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102387719|NCT00668655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102387720|NCT02454426|Vortioxetine|vortioxetine|mesh-list
102387721|NCT02454426|Antidepressive Agents|antidepressive agents|mesh-ancestor
102387722|NCT02454426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102387723|NCT02454426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102387724|NCT02454426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102387725|NCT02454426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102387726|NCT02454426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387727|NCT02454426|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102387728|NCT02454426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102387729|NCT02454426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102387730|NCT02454426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387731|NCT02454426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102387732|NCT02454426|Serotonin Agents|serotonin agents|mesh-ancestor
102387733|NCT02454426|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102387734|NCT02454426|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102387735|NCT02454426|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102387736|NCT02454426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102387737|NCT03238092|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102387738|NCT03238092|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102387739|NCT03238092|Estradiol|estradiol|mesh-list
102387740|NCT03238092|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102387741|NCT03238092|Testosterone|testosterone|mesh-list
102387742|NCT03238092|Estrogens|estrogens|mesh-ancestor
102387743|NCT03238092|Hormones|hormones|mesh-ancestor
102387744|NCT03238092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102387745|NCT03238092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387746|NCT03238092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102387747|NCT03238092|Contraceptive Agents|contraceptive agents|mesh-ancestor
102387748|NCT03238092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102387749|NCT03238092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102387750|NCT03238092|Androgens|androgens|mesh-ancestor
102387751|NCT03247998|Remifentanil|remifentanil|mesh-list
102387752|NCT03247998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102387753|NCT03247998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387754|NCT03247998|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102387755|NCT03247998|Narcotics|narcotics|mesh-ancestor
102387756|NCT03247998|Analgesics|analgesics|mesh-ancestor
102387757|NCT03247998|Sensory System Agents|sensory system agents|mesh-ancestor
102387758|NCT03247998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102387759|NCT03248076|Fentanyl|fentanyl|mesh-list
102387760|NCT03248076|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102387761|NCT03248076|Narcotics|narcotics|mesh-ancestor
102387762|NCT03248076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102387763|NCT03248076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387764|NCT03248076|Analgesics|analgesics|mesh-ancestor
102387765|NCT03248076|Sensory System Agents|sensory system agents|mesh-ancestor
102387766|NCT03248076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102387767|NCT03248076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102387768|NCT03248076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102387769|NCT03248076|Anesthetics, General|anesthetics, general|mesh-ancestor
102387770|NCT03248076|Anesthetics|anesthetics|mesh-ancestor
102387771|NCT03240120|Tinzaparin|tinzaparin|mesh-list
102387772|NCT03240120|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102387773|NCT03240120|Dalteparin|dalteparin|mesh-list
102387774|NCT03240120|Dabigatran|dabigatran|mesh-list
102387775|NCT03240120|Antithrombins|antithrombins|mesh-ancestor
102387776|NCT03240120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102387777|NCT03240120|Protease Inhibitors|protease inhibitors|mesh-ancestor
102387778|NCT03240120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102387779|NCT03240120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387780|NCT03240120|Anticoagulants|anticoagulants|mesh-ancestor
102387781|NCT03240120|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102387782|NCT03240120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102387783|NCT03237936|Cyclosporine|cyclosporine|mesh-list
102387784|NCT03237936|Cyclosporins|cyclosporins|mesh-list
102387785|NCT03237936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102387786|NCT03237936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387787|NCT03237936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102387788|NCT03237936|Immunologic Factors|immunologic factors|mesh-ancestor
102387789|NCT03237936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387790|NCT03237936|Antifungal Agents|antifungal agents|mesh-ancestor
102387791|NCT03237936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102387792|NCT03237936|Dermatologic Agents|dermatologic agents|mesh-ancestor
102387793|NCT03237936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102387794|NCT03237936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102387795|NCT03247920|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102387796|NCT03247920|Amoxicillin|amoxicillin|mesh-list
102387797|NCT03247920|Clavulanic Acid|clavulanic acid|mesh-list
102387798|NCT03247920|Clavulanic Acids|clavulanic acids|mesh-list
102387799|NCT03247920|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102387800|NCT03247920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102387801|NCT03247920|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102387802|NCT03247920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102387803|NCT03247920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387804|NCT03239964|Dexamethasone|dexamethasone|mesh-list
102387805|NCT03239964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102387806|NCT03239964|Antiemetics|antiemetics|mesh-ancestor
102387807|NCT03239964|Autonomic Agents|autonomic agents|mesh-ancestor
102387808|NCT03239964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102387809|NCT03239964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387810|NCT03239964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102387811|NCT03239964|Glucocorticoids|glucocorticoids|mesh-ancestor
102387812|NCT03239964|Hormones|hormones|mesh-ancestor
102387813|NCT03239964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102387814|NCT03239964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102387815|NCT03239964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102387816|NCT03239886|Imatinib Mesylate|imatinib mesylate|mesh-list
102387817|NCT03239886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102387818|NCT03239886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102387819|NCT03239886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102387820|NCT03239886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387821|NCT03102723|Cangrelor|cangrelor|mesh-list
102387822|NCT03102723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102387823|NCT03102723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102387824|NCT03102723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102387825|NCT03102723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102387826|NCT03102723|Purinergic Agents|purinergic agents|mesh-ancestor
102387827|NCT03102723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102387828|NCT03102723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387829|NCT03102723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387830|NCT03237312|Hormones|hormones|mesh-list
102387831|NCT03237312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102387832|NCT03237312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387833|NCT03241914|Megestrol|megestrol|mesh-list
102387834|NCT03241914|Megestrol Acetate|megestrol acetate|mesh-list
102387835|NCT03241914|Levonorgestrel|levonorgestrel|mesh-list
102387836|NCT03241914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102387837|NCT03241914|Contraceptive Agents|contraceptive agents|mesh-ancestor
102387838|NCT03241914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102387839|NCT03241914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387840|NCT03241914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102387841|NCT03241914|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102387842|NCT03241914|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102387843|NCT03241914|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102387844|NCT03241914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102387845|NCT03241914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102387846|NCT03241914|Appetite Stimulants|appetite stimulants|mesh-ancestor
102387847|NCT03241914|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102387848|NCT00057681|Valproic Acid|valproic acid|mesh-list
102387849|NCT00057681|Risperidone|risperidone|mesh-list
102387850|NCT00057681|Lithium Carbonate|lithium carbonate|mesh-list
102387851|NCT00057681|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102387852|NCT00057681|Serotonin Agents|serotonin agents|mesh-ancestor
102387853|NCT00057681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102387854|NCT00057681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387855|NCT00057681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387856|NCT00057681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102387857|NCT00057681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102387858|NCT00057681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102387859|NCT00057681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102387860|NCT00057681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102387861|NCT00057681|Dopamine Agents|dopamine agents|mesh-ancestor
102387862|NCT00057681|Antidepressive Agents|antidepressive agents|mesh-ancestor
102387863|NCT00057681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102387864|NCT00057681|Antimanic Agents|antimanic agents|mesh-ancestor
102387865|NCT00057681|Anticonvulsants|anticonvulsants|mesh-ancestor
102387866|NCT00057681|GABA Agents|gaba agents|mesh-ancestor
102387867|NCT03234816|Norepinephrine|norepinephrine|mesh-list
102387868|NCT03234816|Bupivacaine|bupivacaine|mesh-list
102387869|NCT03234816|Anesthetics, Local|anesthetics, local|mesh-ancestor
102387870|NCT03234816|Anesthetics|anesthetics|mesh-ancestor
102387871|NCT03234816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102387872|NCT03234816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387873|NCT03234816|Sensory System Agents|sensory system agents|mesh-ancestor
102387874|NCT03234816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102387875|NCT03234816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102387876|NCT03234816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102387877|NCT03234816|Adrenergic Agents|adrenergic agents|mesh-ancestor
102387878|NCT03234816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102387879|NCT03234816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387880|NCT03234816|Sympathomimetics|sympathomimetics|mesh-ancestor
102387881|NCT03234816|Autonomic Agents|autonomic agents|mesh-ancestor
102387882|NCT03234816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102387883|NCT03247452|Ascorbic Acid|ascorbic acid|mesh-list
102387884|NCT03247452|Antioxidants|antioxidants|mesh-ancestor
102387885|NCT03247452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387886|NCT03247452|Protective Agents|protective agents|mesh-ancestor
102387887|NCT03247452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387888|NCT03247452|Vitamins|vitamins|mesh-ancestor
102387889|NCT03247452|Micronutrients|micronutrients|mesh-ancestor
102387890|NCT03247140|Amlodipine|amlodipine|mesh-list
102387891|NCT03247140|Telmisartan|telmisartan|mesh-list
102387892|NCT03247140|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
102387893|NCT03247140|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102387894|NCT03247140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102387895|NCT03247140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102387896|NCT03247140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102387897|NCT03247140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387898|NCT03247140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101910219|NCT01111656|Antiviral Agents|antiviral agents|mesh-ancestor
102387899|NCT03247140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387900|NCT03247140|Vasodilator Agents|vasodilator agents|mesh-ancestor
102387901|NCT03247140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102387902|NCT03247140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102387903|NCT03247140|Antimetabolites|antimetabolites|mesh-ancestor
102387904|NCT03247140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102387905|NCT03247140|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102387906|NCT03247140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102387907|NCT03247140|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102387908|NCT03247140|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102387909|NCT03237546|Anesthetics|anesthetics|mesh-list
102387910|NCT03237546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102387911|NCT03237546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387912|NCT03247296|Ribavirin|ribavirin|mesh-list
102387913|NCT03247296|Sofosbuvir|sofosbuvir|mesh-list
102387914|NCT03247296|Antimetabolites|antimetabolites|mesh-ancestor
102387915|NCT03247296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387916|NCT03247296|Antiviral Agents|antiviral agents|mesh-ancestor
102387917|NCT03247296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102387918|NCT03247218|Memantine|memantine|mesh-list
102387919|NCT03247218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102387920|NCT03247218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102387921|NCT03247218|Dopamine Agents|dopamine agents|mesh-ancestor
102387922|NCT03247218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102387923|NCT03247218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387924|NCT03247218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387925|NCT03247218|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102387926|NCT03247218|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102387927|NCT03237624|Chitosan|chitosan|mesh-list
102387928|NCT03237624|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102387929|NCT03237624|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102387930|NCT03237624|Antimetabolites|antimetabolites|mesh-ancestor
102387931|NCT03237624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387932|NCT03237624|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102387933|NCT03237624|Chelating Agents|chelating agents|mesh-ancestor
102387934|NCT03237624|Sequestering Agents|sequestering agents|mesh-ancestor
102387935|NCT03237624|Hemostatics|hemostatics|mesh-ancestor
102387936|NCT03237624|Coagulants|coagulants|mesh-ancestor
102387937|NCT03234660|Dexmedetomidine|dexmedetomidine|mesh-list
101910334|NCT01108302|Oxytocics|oxytocics|mesh-ancestor
102387938|NCT03234660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102387939|NCT03234660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102387940|NCT03234660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387941|NCT03234660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102387942|NCT03234660|Analgesics|analgesics|mesh-ancestor
102387943|NCT03234660|Sensory System Agents|sensory system agents|mesh-ancestor
102387944|NCT03234660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102387945|NCT03234660|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102387946|NCT03234660|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102387947|NCT03234660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102387948|NCT03234660|Adrenergic Agents|adrenergic agents|mesh-ancestor
102387949|NCT03234660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102387950|NCT03234660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387951|NCT04485780|Botulinum Toxins|botulinum toxins|mesh-list
102387952|NCT04485780|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102387953|NCT04485780|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102387954|NCT04485780|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102387955|NCT04485780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102387956|NCT04485780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387957|NCT04485780|Cholinergic Agents|cholinergic agents|mesh-ancestor
102387958|NCT04485780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102387959|NCT04485780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387960|NCT04485780|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102387961|NCT04485780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102387962|NCT00059475|polysaccharide-K|polysaccharide-k|mesh-list
102387963|NCT00059475|Interleukin-2|interleukin-2|mesh-list
102387964|NCT00059475|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
102387965|NCT00059475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102387966|NCT00059475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102387967|NCT00059475|Analgesics|analgesics|mesh-ancestor
102387968|NCT00059475|Sensory System Agents|sensory system agents|mesh-ancestor
102387969|NCT00059475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102387970|NCT00059475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102387971|NCT00059475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102387972|NCT00059475|Immunologic Factors|immunologic factors|mesh-ancestor
102387973|NCT00059475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102387974|NCT00059475|Antiviral Agents|antiviral agents|mesh-ancestor
102387975|NCT00059475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102387976|NCT00059475|Interferon Inducers|interferon inducers|mesh-ancestor
102387977|NCT00059475|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102387978|NCT00059475|Protective Agents|protective agents|mesh-ancestor
102387979|NCT02453802|Tranylcypromine|tranylcypromine|mesh-list
102387980|NCT02453802|Rivaroxaban|rivaroxaban|mesh-list
102387981|NCT02453802|Tranexamic Acid|tranexamic acid|mesh-list
102387982|NCT02453802|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102387983|NCT02453802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102387984|NCT02453802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102387985|NCT02453802|Hemostatics|hemostatics|mesh-ancestor
102387986|NCT02453802|Coagulants|coagulants|mesh-ancestor
102387987|NCT02453802|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102387988|NCT02453802|Antithrombins|antithrombins|mesh-ancestor
102387989|NCT02453802|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102387990|NCT02453802|Protease Inhibitors|protease inhibitors|mesh-ancestor
102387991|NCT02453802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102387992|NCT02453802|Anticoagulants|anticoagulants|mesh-ancestor
102387993|NCT02453802|Antidepressive Agents|antidepressive agents|mesh-ancestor
102387994|NCT02453802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102387995|NCT02453802|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102387996|NCT02453802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102387997|NCT02453802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102387998|NCT02453802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102387999|NCT02453802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388000|NCT02028676|Lamivudine|lamivudine|mesh-list
102388001|NCT02028676|Zidovudine|zidovudine|mesh-list
102388002|NCT02028676|Efavirenz|efavirenz|mesh-list
102388003|NCT02028676|Nevirapine|nevirapine|mesh-list
102388004|NCT02028676|Abacavir|abacavir|mesh-list
102388005|NCT02028676|Dideoxynucleosides|dideoxynucleosides|mesh-list
102388006|NCT02028676|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
102388007|NCT02028676|Trimethoprim|trimethoprim|mesh-list
102388008|NCT02028676|Sulfamethoxazole|sulfamethoxazole|mesh-list
102388009|NCT02028676|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102388010|NCT02028676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102388011|NCT02028676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102388012|NCT02028676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102388013|NCT02028676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388014|NCT02028676|Antiviral Agents|antiviral agents|mesh-ancestor
102388015|NCT02028676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102388016|NCT02028676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102388017|NCT02028676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102388018|NCT02028676|Antimetabolites|antimetabolites|mesh-ancestor
102388019|NCT02028676|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102388020|NCT02028676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102388021|NCT02028676|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102388022|NCT02028676|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102388023|NCT02028676|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102388024|NCT02028676|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102388025|NCT02028676|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102388026|NCT02028676|Antimalarials|antimalarials|mesh-ancestor
102388027|NCT02028676|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102388028|NCT02028676|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102388029|NCT02028676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102388030|NCT02028676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102388031|NCT02028676|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102388032|NCT02028676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102388033|NCT03233880|Azithromycin|azithromycin|mesh-list
102388034|NCT03233880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102388035|NCT03233880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102388036|NCT00061893|Celecoxib|celecoxib|mesh-list
102388037|NCT00061893|Cyclophosphamide|cyclophosphamide|mesh-list
102388038|NCT00061893|Ifosfamide|ifosfamide|mesh-list
102388039|NCT00061893|Doxorubicin|doxorubicin|mesh-list
102388040|NCT00061893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102388041|NCT00061893|Etoposide|etoposide|mesh-list
102388042|NCT00061893|Vincristine|vincristine|mesh-list
102388043|NCT00061893|Vinblastine|vinblastine|mesh-list
102388044|NCT00061893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102388045|NCT00061893|Immunologic Factors|immunologic factors|mesh-ancestor
102388046|NCT00061893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388047|NCT00061893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102388048|NCT00061893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102388049|NCT00061893|Alkylating Agents|alkylating agents|mesh-ancestor
102388050|NCT00061893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388051|NCT00061893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102388052|NCT00061893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102388053|NCT00061893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102388054|NCT00061893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102388055|NCT00061893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102388056|NCT00061893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102388057|NCT00061893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102388058|NCT00061893|Tubulin Modulators|tubulin modulators|mesh-ancestor
102388059|NCT00061893|Antimitotic Agents|antimitotic agents|mesh-ancestor
102388060|NCT00061893|Mitosis Modulators|mitosis modulators|mesh-ancestor
102388061|NCT00061893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102388062|NCT00061893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102388063|NCT00061893|Analgesics|analgesics|mesh-ancestor
102388064|NCT00061893|Sensory System Agents|sensory system agents|mesh-ancestor
102388065|NCT00061893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102388066|NCT00061893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102388067|NCT00061893|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102388068|NCT00061893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102388069|NCT02957019|Rituximab|rituximab|mesh-list
102388070|NCT02957019|Interleukin-2|interleukin-2|mesh-list
102388071|NCT02957019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102388072|NCT02957019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102388073|NCT02957019|Immunologic Factors|immunologic factors|mesh-ancestor
102388074|NCT02957019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910588|NCT05192902|Anesthetics|anesthetics|mesh-list
102388075|NCT02957019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102388076|NCT02957019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102388077|NCT02957019|Analgesics|analgesics|mesh-ancestor
102388078|NCT02957019|Sensory System Agents|sensory system agents|mesh-ancestor
102388079|NCT02957019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102388080|NCT02028754|Levofloxacin|levofloxacin|mesh-list
102388081|NCT02028754|Prednisolone|prednisolone|mesh-list
102388082|NCT02028754|Prednisolone acetate|prednisolone acetate|mesh-list
102388083|NCT02028754|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102388084|NCT02028754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102388085|NCT02028754|Glucocorticoids|glucocorticoids|mesh-ancestor
102388087|NCT02028754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102388088|NCT02028754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388089|NCT02028754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102388090|NCT02028754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102388091|NCT02028754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102388092|NCT02028754|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102388093|NCT02028754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102388094|NCT02028754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102388095|NCT02028754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102388096|NCT02028754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102388097|NCT02028754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102388098|NCT02028754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388099|NCT02028754|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102388100|NCT02028754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102388101|NCT02028754|Laxatives|laxatives|mesh-ancestor
102388102|NCT02453490|Fluorouracil|fluorouracil|mesh-list
102388103|NCT02453490|Raltitrexed|raltitrexed|mesh-list
102388104|NCT02453490|Antimetabolites|antimetabolites|mesh-ancestor
102388105|NCT02453490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388106|NCT02453490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102388107|NCT02453490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102388108|NCT02453490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102388109|NCT02453490|Immunologic Factors|immunologic factors|mesh-ancestor
102388110|NCT02453490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388111|NCT02453490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102388112|NCT02453490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102388113|NCT01974700|Levetiracetam|levetiracetam|mesh-list
102388114|NCT01974700|Anticonvulsants|anticonvulsants|mesh-ancestor
102388115|NCT01974700|Nootropic Agents|nootropic agents|mesh-ancestor
102388116|NCT04753203|Capecitabine|capecitabine|mesh-list
102388117|NCT04753203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102388118|NCT04753203|Antimetabolites|antimetabolites|mesh-ancestor
102388119|NCT04753203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388120|NCT04753203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102388121|NCT03236610|Tenofovir|tenofovir|mesh-list
102388122|NCT03236610|Entecavir|entecavir|mesh-list
102388123|NCT03236610|Antiviral Agents|antiviral agents|mesh-ancestor
102388124|NCT03236610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102388125|NCT03236610|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102388126|NCT03236610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102388127|NCT03236610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102388128|NCT03236610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388129|NCT03236610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102388130|NCT03236610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102388131|NCT05287893|Pyronaridine|pyronaridine|mesh-list
102388132|NCT05287893|Antimalarials|antimalarials|mesh-ancestor
102388133|NCT05287893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102388134|NCT05287893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102388135|NCT05287893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102388136|NCT02357758|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102388137|NCT02357758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102388138|NCT02357836|Itraconazole|itraconazole|mesh-list
102388139|NCT02357836|Antifungal Agents|antifungal agents|mesh-ancestor
102388140|NCT02357836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102388141|NCT02357836|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102388142|NCT02357836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102388143|NCT02357836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102388144|NCT02357836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388145|NCT02357836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102388146|NCT02357836|Hormone Antagonists|hormone antagonists|mesh-ancestor
102388147|NCT02357836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102388148|NCT02357836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388149|NCT02357836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102388150|NCT02359006|Minocycline|minocycline|mesh-list
102388151|NCT02359006|Tetracycline|tetracycline|mesh-list
102388152|NCT02359006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102388153|NCT02359006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102388154|NCT02359006|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102388155|NCT02359006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102388156|NCT02359006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388157|NCT04485702|Midazolam|midazolam|mesh-list
102388158|NCT04485702|Ketamine|ketamine|mesh-list
102388159|NCT04485702|Analgesics|analgesics|mesh-ancestor
102388160|NCT04485702|Sensory System Agents|sensory system agents|mesh-ancestor
102388161|NCT04485702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102388162|NCT04485702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388163|NCT04485702|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102388164|NCT04485702|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102388165|NCT04485702|Anesthetics, General|anesthetics, general|mesh-ancestor
102388166|NCT04485702|Anesthetics|anesthetics|mesh-ancestor
102388167|NCT04485702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102388168|NCT04485702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102388169|NCT04485702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102388170|NCT04485702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101910777|NCT01359826|Milnacipran|milnacipran|mesh-list
102388171|NCT04485702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388172|NCT04485702|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102388173|NCT04485702|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102388174|NCT04485702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102388175|NCT04485702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102388176|NCT04485702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102388177|NCT04485702|GABA Modulators|gaba modulators|mesh-ancestor
102388178|NCT04485702|GABA Agents|gaba agents|mesh-ancestor
102388179|NCT00068367|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102388180|NCT00068367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102388181|NCT00068367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102388182|NCT00068367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102388183|NCT00068367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388184|NCT03233412|Imiquimod|imiquimod|mesh-list
102388185|NCT03233412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102388186|NCT03233412|Immunologic Factors|immunologic factors|mesh-ancestor
102388187|NCT03233412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388188|NCT03233412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102388189|NCT03233412|Interferon Inducers|interferon inducers|mesh-ancestor
102388190|NCT01976416|Hydroxyurea|hydroxyurea|mesh-list
102388191|NCT01976416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102388192|NCT01976416|Antisickling Agents|antisickling agents|mesh-ancestor
102388193|NCT01976416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102388194|NCT01976416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388195|NCT01976416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102388196|NCT01976572|Candesartan|candesartan|mesh-list
102388197|NCT01976572|Candesartan cilexetil|candesartan cilexetil|mesh-list
102388198|NCT01976572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102388199|NCT01976572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102388200|NCT01976572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102388201|NCT01976572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388202|NCT01976650|Dexamethasone|dexamethasone|mesh-list
102388203|NCT01976650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102388204|NCT01976650|Antiemetics|antiemetics|mesh-ancestor
102388205|NCT01976650|Autonomic Agents|autonomic agents|mesh-ancestor
102388206|NCT01976650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102388207|NCT01976650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388208|NCT01976650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102388209|NCT01976650|Glucocorticoids|glucocorticoids|mesh-ancestor
102388210|NCT01976650|Hormones|hormones|mesh-ancestor
102388211|NCT01976650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102388212|NCT01976650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102388213|NCT01976650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102388214|NCT01978600|Timolol|timolol|mesh-list
102388215|NCT01978600|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102388216|NCT01978600|Brinzolamide|brinzolamide|mesh-list
102388217|NCT01978600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102388218|NCT01978600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388219|NCT01978600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102388220|NCT01978600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102388221|NCT01978600|Adrenergic Agents|adrenergic agents|mesh-ancestor
102388222|NCT01978600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102388223|NCT01978600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388224|NCT01978600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102388225|NCT01978600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102199938|NCT04195750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102388226|NCT01978600|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102388227|NCT01978600|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102388228|NCT01978600|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101910998|NCT05067166|Ansuvimab|ansuvimab|mesh-list
102388229|NCT01978600|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102388230|NCT03236220|Acetylcysteine|acetylcysteine|mesh-list
102388231|NCT03236220|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102388232|NCT03236220|Antiviral Agents|antiviral agents|mesh-ancestor
102388233|NCT03236220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102388234|NCT03236220|Expectorants|expectorants|mesh-ancestor
102388235|NCT03236220|Respiratory System Agents|respiratory system agents|mesh-ancestor
102388236|NCT03236220|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102388237|NCT03236220|Antioxidants|antioxidants|mesh-ancestor
102388238|NCT03236220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388239|NCT03236220|Protective Agents|protective agents|mesh-ancestor
102388240|NCT03236220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388241|NCT03236220|Antidotes|antidotes|mesh-ancestor
102388242|NCT03232632|Flutemetamol|flutemetamol|mesh-list
102388243|NCT03232632|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102388244|NCT03232632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388245|NCT01747499|Azacitidine|azacitidine|mesh-list
102388246|NCT01747499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102388247|NCT01747499|Antimetabolites|antimetabolites|mesh-ancestor
102388248|NCT01747499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388249|NCT01747499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102388250|NCT01747499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102388251|NCT00071721|Valproic Acid|valproic acid|mesh-list
102388252|NCT00071721|Anticonvulsants|anticonvulsants|mesh-ancestor
102388253|NCT00071721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102388254|NCT00071721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388255|NCT00071721|GABA Agents|gaba agents|mesh-ancestor
102388256|NCT00071721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102388257|NCT00071721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388258|NCT00071721|Antimanic Agents|antimanic agents|mesh-ancestor
102388259|NCT00071721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102388260|NCT00071721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102388261|NCT00071721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102388262|NCT03107208|Insulin Glargine|insulin glargine|mesh-list
102388263|NCT03107208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101911065|NCT01118286|Nifedipine|nifedipine|mesh-list
102388264|NCT03107208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388265|NCT05606055|Tenofovir|tenofovir|mesh-list
102388266|NCT05606055|Emtricitabine|emtricitabine|mesh-list
102388267|NCT05606055|Antiviral Agents|antiviral agents|mesh-ancestor
102388268|NCT05606055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102388269|NCT05606055|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102388270|NCT05606055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102388271|NCT05606055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102388272|NCT05606055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388273|NCT05606055|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101911157|NCT01117116|Xhance|xhance|mesh-list
102388274|NCT05606055|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102388275|NCT01896609|Interferons|interferons|mesh-list
102388276|NCT01896609|Ribavirin|ribavirin|mesh-list
102388277|NCT01896609|Interferon-alpha|interferon-alpha|mesh-list
102388278|NCT01896609|Interferon alpha-2|interferon alpha-2|mesh-list
102388279|NCT01896609|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102388280|NCT01896609|Nitazoxanide|nitazoxanide|mesh-list
102388281|NCT01896609|Complement Factor H|complement factor h|mesh-list
102388282|NCT01896609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102388283|NCT01896609|Antiviral Agents|antiviral agents|mesh-ancestor
102388284|NCT01896609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102388285|NCT01896609|Antimetabolites|antimetabolites|mesh-ancestor
102388286|NCT01896609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388287|NCT01896609|Immunologic Factors|immunologic factors|mesh-ancestor
102388288|NCT01896609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388289|NCT01896609|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102388290|NCT01896609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102388291|NCT01896609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102388292|NCT03232554|Iron|iron|mesh-list
102388293|NCT03232554|Trace Elements|trace elements|mesh-ancestor
102388294|NCT03232554|Micronutrients|micronutrients|mesh-ancestor
102388295|NCT03232554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388296|NCT03232398|Warfarin|warfarin|mesh-list
102388297|NCT03232398|Apixaban|apixaban|mesh-list
102388298|NCT03232398|Anticoagulants|anticoagulants|mesh-ancestor
102388299|NCT03232398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102388300|NCT03232398|Antithrombins|antithrombins|mesh-ancestor
102388301|NCT03232398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102388302|NCT03232398|Protease Inhibitors|protease inhibitors|mesh-ancestor
102388303|NCT03232398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102388304|NCT03232398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388305|NCT02362048|Pembrolizumab|pembrolizumab|mesh-list
102388306|NCT02362048|Acalabrutinib|acalabrutinib|mesh-list
102388307|NCT02362048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102388308|NCT02362048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102388309|NCT02362048|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102388310|NCT02362048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388311|NCT00158223|Pimozide|pimozide|mesh-list
102388312|NCT00158223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102388313|NCT00158223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102388314|NCT00158223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102388315|NCT00158223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388316|NCT00158223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102388317|NCT00158223|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102388318|NCT00158223|Dopamine Agents|dopamine agents|mesh-ancestor
102388319|NCT00158223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102388320|NCT00158223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388321|NCT00158223|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102388322|NCT03228576|Everolimus|everolimus|mesh-list
102388323|NCT03228576|Tacrolimus|tacrolimus|mesh-list
102388324|NCT03228576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102388325|NCT03228576|Immunologic Factors|immunologic factors|mesh-ancestor
102388326|NCT03228576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388327|NCT03228576|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102388328|NCT03228576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102388329|NCT03228576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388330|NCT03228576|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102388331|NCT03228576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102388332|NCT03228576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102388333|NCT00158379|Paclitaxel|paclitaxel|mesh-list
102388334|NCT00158379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102388335|NCT00158379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102388336|NCT00158379|Tubulin Modulators|tubulin modulators|mesh-ancestor
102388337|NCT00158379|Antimitotic Agents|antimitotic agents|mesh-ancestor
102388338|NCT00158379|Mitosis Modulators|mitosis modulators|mesh-ancestor
102388339|NCT00158379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388340|NCT03228498|Choline|choline|mesh-list
102388341|NCT03228498|Lipotropic Agents|lipotropic agents|mesh-ancestor
102388342|NCT03228498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102388343|NCT03228498|Antimetabolites|antimetabolites|mesh-ancestor
102388344|NCT03228498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388345|NCT03228498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102388346|NCT03228498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102388347|NCT03228498|Nootropic Agents|nootropic agents|mesh-ancestor
102388348|NCT03232320|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102388349|NCT03232320|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102388350|NCT03232320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102388351|NCT03232320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388352|NCT03232320|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102388353|NCT03232320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102388354|NCT03232320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388355|NCT03232320|Cholinergic Agents|cholinergic agents|mesh-ancestor
102388356|NCT03232320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102388357|NCT02364076|Pembrolizumab|pembrolizumab|mesh-list
102388358|NCT02364076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102388359|NCT02364076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102388360|NCT02364076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102388361|NCT02364076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388362|NCT02453022|Omeprazole|omeprazole|mesh-list
102388363|NCT02453022|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102388364|NCT02453022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102388365|NCT02453022|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102388366|NCT02453022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102388367|NCT02453022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388368|NCT00163293|Ciclesonide|ciclesonide|mesh-list
102388369|NCT00163293|Glucocorticoids|glucocorticoids|mesh-ancestor
102388370|NCT00163293|Hormones|hormones|mesh-ancestor
102388371|NCT00163293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102388372|NCT00163293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388373|NCT00163293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102388374|NCT02365870|Rotigotine|rotigotine|mesh-list
102388375|NCT02365870|Dopamine Agonists|dopamine agonists|mesh-ancestor
102388376|NCT02365870|Dopamine Agents|dopamine agents|mesh-ancestor
102388377|NCT02365870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102388378|NCT02365870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388379|NCT02365870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388380|NCT03228108|Amoxicillin|amoxicillin|mesh-list
102388381|NCT03228108|Ciprofloxacin|ciprofloxacin|mesh-list
102388382|NCT03228108|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102388383|NCT03228108|Clavulanic Acids|clavulanic acids|mesh-list
102388384|NCT03228108|Clavulanic Acid|clavulanic acid|mesh-list
102388385|NCT03228108|Fosfomycin|fosfomycin|mesh-list
102388386|NCT03228108|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102388387|NCT03228108|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
102388388|NCT03228108|Trimethoprim|trimethoprim|mesh-list
102388389|NCT03228108|Sulfamethoxazole|sulfamethoxazole|mesh-list
102388390|NCT03228108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102388391|NCT03228108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101911233|NCT01216644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102388392|NCT03228108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102388393|NCT03228108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102388394|NCT03228108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101911280|NCT01373398|Apaziquone|apaziquone|mesh-list
102388395|NCT03228108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388396|NCT03228108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102388397|NCT03228108|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102388398|NCT03228108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102388399|NCT03228108|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102388400|NCT03228108|Antimalarials|antimalarials|mesh-ancestor
102388401|NCT03228108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102388402|NCT03228108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102388403|NCT03228108|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102388404|NCT03228108|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102388405|NCT03228108|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102388406|NCT03228108|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102388407|NCT00078897|Selenium|selenium|mesh-list
102388408|NCT00078897|Antioxidants|antioxidants|mesh-ancestor
102388409|NCT00078897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388410|NCT00078897|Protective Agents|protective agents|mesh-ancestor
102388411|NCT00078897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388412|NCT00078897|Trace Elements|trace elements|mesh-ancestor
102388413|NCT00078897|Micronutrients|micronutrients|mesh-ancestor
102388414|NCT03228030|Thiamine|thiamine|mesh-list
102388415|NCT03228030|Vitamin B Complex|vitamin b complex|mesh-ancestor
102388416|NCT03228030|Vitamins|vitamins|mesh-ancestor
102388417|NCT03228030|Micronutrients|micronutrients|mesh-ancestor
102388418|NCT03228030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388419|NCT01717313|Metformin|metformin|mesh-list
102388420|NCT01717313|Glimepiride|glimepiride|mesh-list
102388421|NCT01717313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102388422|NCT01717313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388423|NCT01717313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102388424|NCT01717313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102388425|NCT01717313|Immunologic Factors|immunologic factors|mesh-ancestor
102388426|NCT00081861|Bevacizumab|bevacizumab|mesh-list
102388427|NCT00081861|Rituximab|rituximab|mesh-list
102388428|NCT00081861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101911469|NCT01121016|Montelukast|montelukast|mesh-list
102388429|NCT00081861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102388430|NCT00081861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102388431|NCT00081861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102388432|NCT00081861|Growth Substances|growth substances|mesh-ancestor
102388433|NCT00081861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388434|NCT00081861|Growth Inhibitors|growth inhibitors|mesh-ancestor
102388435|NCT00081861|Immunologic Factors|immunologic factors|mesh-ancestor
102388436|NCT00081861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102388437|NCT03120234|Fentanyl|fentanyl|mesh-list
102388438|NCT03120234|Dexmedetomidine|dexmedetomidine|mesh-list
102388439|NCT03120234|Ketamine|ketamine|mesh-list
102388440|NCT03120234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102388441|NCT03120234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102388442|NCT03120234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388443|NCT03120234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102388444|NCT03120234|Analgesics|analgesics|mesh-ancestor
102388445|NCT03120234|Sensory System Agents|sensory system agents|mesh-ancestor
101911610|NCT01400776|Estradiol|estradiol|mesh-list
102388446|NCT03120234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102388447|NCT03120234|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102388448|NCT03120234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102388449|NCT03120234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102388450|NCT03120234|Adrenergic Agents|adrenergic agents|mesh-ancestor
102388451|NCT03120234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102388452|NCT03120234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200163|NCT02188277|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102388453|NCT03120234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102388454|NCT03120234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102388455|NCT03120234|Anesthetics, General|anesthetics, general|mesh-ancestor
102388456|NCT03120234|Anesthetics|anesthetics|mesh-ancestor
102388457|NCT03120234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102388458|NCT03120234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102388459|NCT03120234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101911832|NCT01073501|Pregabalin|pregabalin|mesh-list
102388460|NCT03120234|Narcotics|narcotics|mesh-ancestor
102388461|NCT03120234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102388462|NCT03230682|Antidepressive Agents|antidepressive agents|mesh-list
102388463|NCT03230682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102388464|NCT03232710|Aripiprazole|aripiprazole|mesh-list
102388465|NCT03232710|Antidepressive Agents|antidepressive agents|mesh-ancestor
102388466|NCT03232710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102388467|NCT03232710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102388468|NCT03232710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101911951|NCT01072097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102388469|NCT03232710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102388470|NCT03232710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388471|NCT03232710|Dopamine Agonists|dopamine agonists|mesh-ancestor
102388472|NCT03232710|Dopamine Agents|dopamine agents|mesh-ancestor
102388473|NCT03232710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101912091|NCT01127100|Anesthetics|anesthetics|mesh-ancestor
102388474|NCT03232710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388475|NCT03232710|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102388476|NCT03232710|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102388477|NCT03232710|Serotonin Agents|serotonin agents|mesh-ancestor
102388478|NCT03232710|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102388479|NCT03232710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102388480|NCT03232710|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102388481|NCT03232710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102388482|NCT03227484|Empagliflozin|empagliflozin|mesh-list
102388483|NCT03227484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102388484|NCT03227484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388485|NCT03227484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101912303|NCT01227408|Paclitaxel|paclitaxel|mesh-list
102388486|NCT03227484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388487|NCT02038894|Propofol|propofol|mesh-list
102388488|NCT02038894|Sevoflurane|sevoflurane|mesh-list
102388489|NCT02038894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101912389|NCT01130298|Hormones|hormones|mesh-ancestor
102388490|NCT02038894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102388491|NCT02038894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388492|NCT02038894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102388493|NCT02038894|Anesthetics, General|anesthetics, general|mesh-ancestor
102388494|NCT02038894|Anesthetics|anesthetics|mesh-ancestor
102388495|NCT02038894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102388496|NCT02038894|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102388497|NCT01375374|Lacosamide|lacosamide|mesh-list
102388498|NCT01375374|Levetiracetam|levetiracetam|mesh-list
102388499|NCT01375374|Anticonvulsants|anticonvulsants|mesh-ancestor
102388500|NCT01375374|Nootropic Agents|nootropic agents|mesh-ancestor
102388501|NCT01375374|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102388502|NCT01375374|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102388503|NCT01375374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101912581|NCT03925662|Growth Substances|growth substances|mesh-ancestor
101912650|NCT01131000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102388504|NCT01375374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388505|NCT04348786|Amoxicillin|amoxicillin|mesh-list
102388506|NCT04348786|Doxycycline|doxycycline|mesh-list
102388507|NCT04348786|Levofloxacin|levofloxacin|mesh-list
102388508|NCT04348786|Esomeprazole|esomeprazole|mesh-list
102388509|NCT04348786|Bismuth|bismuth|mesh-list
102388510|NCT04348786|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
102388511|NCT04348786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102388512|NCT04348786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102388513|NCT04348786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102388514|NCT04348786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102388515|NCT04348786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102388516|NCT04348786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102388517|NCT04348786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388518|NCT04348786|Antimalarials|antimalarials|mesh-ancestor
102388519|NCT04348786|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102388520|NCT04348786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102388521|NCT04348786|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102388522|NCT04348786|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102388523|NCT04348786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102200237|NCT02380131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102388524|NCT04348786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102388525|NCT04348786|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101912969|NCT03917784|Curcumin|curcumin|mesh-list
102388526|NCT04348786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102388527|NCT04348786|Antacids|antacids|mesh-ancestor
102388528|NCT04348786|Antidiarrheals|antidiarrheals|mesh-ancestor
102388529|NCT02369068|Triamcinolone|triamcinolone|mesh-list
102388530|NCT02369068|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102388531|NCT02369068|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102388532|NCT02369068|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102388533|NCT02369068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102388534|NCT02369068|Glucocorticoids|glucocorticoids|mesh-ancestor
102388535|NCT02369068|Hormones|hormones|mesh-ancestor
102388536|NCT02369068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102388537|NCT02369068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388538|NCT02369068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102388539|NCT02369068|Immunologic Factors|immunologic factors|mesh-ancestor
102388540|NCT02369068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388541|NCT02369068|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102388542|NCT02369068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102388543|NCT02369068|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102388544|NCT02369068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102388545|NCT02369068|Cholinergic Agents|cholinergic agents|mesh-ancestor
101913299|NCT04624776|Autonomic Agents|autonomic agents|mesh-ancestor
102388546|NCT02369068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102388547|NCT02452632|Ipragliflozin|ipragliflozin|mesh-list
102388548|NCT02452632|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102388549|NCT02452632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388550|NCT02452632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101913369|NCT01140984|Glucocorticoids|glucocorticoids|mesh-ancestor
102388551|NCT02452632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388552|NCT02371252|Alendronate|alendronate|mesh-list
102388553|NCT02371252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102388554|NCT02371252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388555|NCT03221946|Diclofenac|diclofenac|mesh-list
101913438|NCT05849220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102388556|NCT03221946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101913515|NCT05848531|Clonidine|clonidine|mesh-list
102388557|NCT03221946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102388558|NCT03221946|Analgesics|analgesics|mesh-ancestor
102388559|NCT03221946|Sensory System Agents|sensory system agents|mesh-ancestor
102388560|NCT03221946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102388561|NCT03221946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388562|NCT03221946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102388563|NCT03221946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102388564|NCT03221946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102388565|NCT03221946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102388566|NCT03221946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388567|NCT03229746|Hydroxychloroquine|hydroxychloroquine|mesh-list
102388568|NCT03229746|Vincristine|vincristine|mesh-list
102388569|NCT03229746|Azathioprine|azathioprine|mesh-list
102388570|NCT03229746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102388571|NCT03229746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102388572|NCT03229746|Tubulin Modulators|tubulin modulators|mesh-ancestor
102388573|NCT03229746|Antimitotic Agents|antimitotic agents|mesh-ancestor
102388574|NCT03229746|Mitosis Modulators|mitosis modulators|mesh-ancestor
102388575|NCT03229746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388576|NCT03229746|Antimalarials|antimalarials|mesh-ancestor
102388577|NCT03229746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102388578|NCT03229746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102388579|NCT03229746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102388580|NCT03229746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101913580|NCT05847764|Aflutinib|aflutinib|mesh-list
102388581|NCT03229746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102388582|NCT03229746|Antimetabolites|antimetabolites|mesh-ancestor
102388583|NCT03229746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102388584|NCT03229746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102388585|NCT03229746|Immunologic Factors|immunologic factors|mesh-ancestor
102388586|NCT03229746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388587|NCT02040298|Clemastine|clemastine|mesh-list
102388588|NCT02040298|Antipruritics|antipruritics|mesh-ancestor
102388589|NCT02040298|Dermatologic Agents|dermatologic agents|mesh-ancestor
102388590|NCT02040298|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102388591|NCT02040298|Histamine Antagonists|histamine antagonists|mesh-ancestor
102388592|NCT02040298|Histamine Agents|histamine agents|mesh-ancestor
102388593|NCT02040298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102388594|NCT02040298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388595|NCT02040298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388596|NCT02040298|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102388597|NCT03229668|Pregabalin|pregabalin|mesh-list
102388598|NCT03229668|Analgesics|analgesics|mesh-ancestor
102388599|NCT03229668|Sensory System Agents|sensory system agents|mesh-ancestor
102388600|NCT03229668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102388601|NCT03229668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388602|NCT03229668|Anticonvulsants|anticonvulsants|mesh-ancestor
102388603|NCT03229668|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102388604|NCT03229668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102388605|NCT03229668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388606|NCT03229668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102388607|NCT03229668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102388608|NCT03229668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101913906|NCT05842317|Lenvatinib|lenvatinib|mesh-list
102388609|NCT03229668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102388610|NCT03229668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102388611|NCT03230058|Voriconazole|voriconazole|mesh-list
102388613|NCT03230058|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102388614|NCT03230058|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102388615|NCT03230058|Antifungal Agents|antifungal agents|mesh-ancestor
102388616|NCT03230058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102388617|NCT03230058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102388618|NCT03230058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102388619|NCT03230058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101914068|NCT05817903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102388620|NCT03230058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388621|NCT03230058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102388622|NCT03230058|Hormone Antagonists|hormone antagonists|mesh-ancestor
102388623|NCT03230058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101914146|NCT05804032|Dexamethasone|dexamethasone|mesh-list
102388624|NCT03230058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388625|NCT03230058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102388626|NCT03230058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102388627|NCT03230058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102388628|NCT01985542|Immunomodulating Agents|immunomodulating agents|mesh-list
102388629|NCT01985542|Immunologic Factors|immunologic factors|mesh-ancestor
102388630|NCT01985542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388631|NCT03229824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
102388632|NCT03229824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102388633|NCT00081939|Thalidomide|thalidomide|mesh-list
102388634|NCT00081939|Bortezomib|bortezomib|mesh-list
102388635|NCT00081939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102388636|NCT00081939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102388637|NCT00081939|Immunologic Factors|immunologic factors|mesh-ancestor
102388638|NCT00081939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388639|NCT00081939|Leprostatic Agents|leprostatic agents|mesh-ancestor
102388640|NCT00081939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102388641|NCT00081939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102388642|NCT00081939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102388643|NCT00081939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102388644|NCT00081939|Growth Substances|growth substances|mesh-ancestor
102388645|NCT00081939|Growth Inhibitors|growth inhibitors|mesh-ancestor
102388646|NCT02373124|N-Methylaspartate|n-methylaspartate|mesh-list
102388647|NCT02373124|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
102388648|NCT02373124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102388649|NCT02373124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101914228|NCT05765682|Bupivacaine|bupivacaine|mesh-list
102388650|NCT02373124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388651|NCT02373124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388652|NCT03221634|Pembrolizumab|pembrolizumab|mesh-list
102388653|NCT03221634|Daratumumab|daratumumab|mesh-list
102388654|NCT03221634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102388655|NCT03221634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102388656|NCT03221634|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102388657|NCT03221634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388658|NCT05003037|Carboplatin|carboplatin|mesh-list
102388659|NCT05003037|Pemetrexed|pemetrexed|mesh-list
102388660|NCT05003037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101914450|NCT05523323|Lenvatinib|lenvatinib|mesh-list
102388661|NCT05003037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102388662|NCT05003037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914497|NCT05402111|Olanzapine|olanzapine|mesh-list
102388663|NCT05003037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102388664|NCT05003037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102388665|NCT02374060|Dexamethasone|dexamethasone|mesh-list
102388666|NCT02374060|Triamcinolone|triamcinolone|mesh-list
102388667|NCT02374060|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102388668|NCT02374060|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102388669|NCT02374060|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102388670|NCT02374060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102388671|NCT02374060|Antiemetics|antiemetics|mesh-ancestor
102388672|NCT02374060|Autonomic Agents|autonomic agents|mesh-ancestor
102388673|NCT02374060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102200387|NCT00004897|Antidotes|antidotes|mesh-ancestor
102388674|NCT02374060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388675|NCT02374060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102388676|NCT02374060|Glucocorticoids|glucocorticoids|mesh-ancestor
102388677|NCT02374060|Hormones|hormones|mesh-ancestor
102388678|NCT02374060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102388679|NCT02374060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102388680|NCT02374060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102388681|NCT02374060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102388682|NCT02374060|Immunologic Factors|immunologic factors|mesh-ancestor
102388683|NCT02374060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102388684|NCT02374060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388685|NCT03221166|Thalidomide|thalidomide|mesh-list
102388686|NCT03221166|Infliximab|infliximab|mesh-list
102388687|NCT03221166|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102388688|NCT03221166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102388689|NCT03221166|Dermatologic Agents|dermatologic agents|mesh-ancestor
102388690|NCT03221166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102388691|NCT03221166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102388692|NCT03221166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102388693|NCT03221166|Immunologic Factors|immunologic factors|mesh-ancestor
102388694|NCT03221166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388695|NCT03221166|Leprostatic Agents|leprostatic agents|mesh-ancestor
102388696|NCT03221166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102388697|NCT03221166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102388698|NCT03221166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102388699|NCT03221166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102388700|NCT03221166|Growth Substances|growth substances|mesh-ancestor
102388701|NCT03221166|Growth Inhibitors|growth inhibitors|mesh-ancestor
102388702|NCT03221166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102388703|NCT03220932|Bevacizumab|bevacizumab|mesh-list
102388704|NCT03220932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102388705|NCT03220932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102388706|NCT03220932|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102388707|NCT03220932|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102388708|NCT03220932|Growth Substances|growth substances|mesh-ancestor
101914853|NCT05109611|Nitric Oxide|nitric oxide|mesh-list
102388709|NCT03220932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388710|NCT03220932|Growth Inhibitors|growth inhibitors|mesh-ancestor
102388711|NCT02042872|Zoledronic Acid|zoledronic acid|mesh-list
102388712|NCT02042872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102388713|NCT02042872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388714|NCT04484688|Bisoprolol|bisoprolol|mesh-list
102388715|NCT04484688|Perindopril|perindopril|mesh-list
102388716|NCT04484688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102388717|NCT04484688|Sympatholytics|sympatholytics|mesh-ancestor
102388718|NCT04484688|Autonomic Agents|autonomic agents|mesh-ancestor
102388719|NCT04484688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102388720|NCT04484688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388721|NCT04484688|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102388722|NCT04484688|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102388723|NCT04484688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102388724|NCT04484688|Adrenergic Agents|adrenergic agents|mesh-ancestor
102388725|NCT04484688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102388726|NCT04484688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388727|NCT04484688|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102388728|NCT04484688|Protease Inhibitors|protease inhibitors|mesh-ancestor
102388729|NCT04484688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102388730|NCT00082017|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
102388731|NCT00082017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102388732|NCT00082017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102388733|NCT00082017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102388734|NCT00082017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388735|NCT00082329|Plerixafor|plerixafor|mesh-list
102388736|NCT00082329|Lenograstim|lenograstim|mesh-list
102388737|NCT00082329|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102388738|NCT00082329|Immunologic Factors|immunologic factors|mesh-ancestor
102388739|NCT00082329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388740|NCT00082329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102388741|NCT00082329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102388742|NCT00082329|Antiviral Agents|antiviral agents|mesh-ancestor
102388743|NCT00082329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102388744|NCT02451462|Zoledronic Acid|zoledronic acid|mesh-list
102388745|NCT02451462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102388746|NCT02451462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388747|NCT03207204|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102388748|NCT03207204|Carbamide Peroxide|carbamide peroxide|mesh-list
101915240|NCT04767074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102388749|NCT03207204|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102388750|NCT03207204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102388751|NCT02451306|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102388752|NCT02451306|Antidepressive Agents|antidepressive agents|mesh-ancestor
102388753|NCT02451306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102388754|NCT02451306|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102388755|NCT02451306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102388756|NCT02451306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102388757|NCT02451306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388758|NCT00167661|Alemtuzumab|alemtuzumab|mesh-list
102388759|NCT00167661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102388760|NCT00167661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102388761|NCT03220542|Amoxicillin|amoxicillin|mesh-list
102388762|NCT03220542|Clarithromycin|clarithromycin|mesh-list
102388763|NCT03220542|Sulforaphane|sulforaphane|mesh-list
102388764|NCT03220542|Esomeprazole|esomeprazole|mesh-list
102388765|NCT03220542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102388766|NCT03220542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102388767|NCT03220542|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102388768|NCT03220542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102388769|NCT03220542|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102388770|NCT03220542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102388771|NCT03220542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388772|NCT03220542|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102388773|NCT03220542|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102388774|NCT03220542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102388775|NCT03220542|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102388776|NCT03220542|Protective Agents|protective agents|mesh-ancestor
102388777|NCT03220542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388778|NCT03220542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102388779|NCT03220152|Tenofovir|tenofovir|mesh-list
102388780|NCT03220152|Emtricitabine|emtricitabine|mesh-list
102388781|NCT03220152|Antiviral Agents|antiviral agents|mesh-ancestor
102388782|NCT03220152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102388783|NCT03220152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102388784|NCT03220152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102388785|NCT03220152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102388786|NCT03220152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388787|NCT03220152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102388788|NCT03220152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102388789|NCT03220464|Interferons|interferons|mesh-list
102388790|NCT03220464|Interferon-gamma|interferon-gamma|mesh-list
102388791|NCT03220464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101915743|NCT04315233|Belinostat|belinostat|mesh-list
102388792|NCT03220464|Antiviral Agents|antiviral agents|mesh-ancestor
102388793|NCT03220464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102388794|NCT03206658|Spironolactone|spironolactone|mesh-list
102388795|NCT03206658|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102388796|NCT03206658|Hormone Antagonists|hormone antagonists|mesh-ancestor
102388797|NCT03206658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102388798|NCT03206658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388799|NCT03206658|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102388800|NCT03206658|Diuretics|diuretics|mesh-ancestor
102388801|NCT03206658|Natriuretic Agents|natriuretic agents|mesh-ancestor
102388802|NCT00170157|Ipilimumab|ipilimumab|mesh-list
102388803|NCT00170157|Leuprolide|leuprolide|mesh-list
102388804|NCT00170157|Goserelin|goserelin|mesh-list
102388805|NCT00170157|Bicalutamide|bicalutamide|mesh-list
102388806|NCT00170157|Flutamide|flutamide|mesh-list
102388807|NCT00170157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102388808|NCT00170157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102388809|NCT00170157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102388810|NCT00170157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388811|NCT00170157|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102388812|NCT00170157|Fertility Agents|fertility agents|mesh-ancestor
102388813|NCT00170157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102388814|NCT00170157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388815|NCT00170157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102388816|NCT00170157|Androgen Antagonists|androgen antagonists|mesh-ancestor
102388817|NCT00170157|Hormone Antagonists|hormone antagonists|mesh-ancestor
102388818|NCT00170157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102388819|NCT03206346|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
102388820|NCT03206346|Antiviral Agents|antiviral agents|mesh-ancestor
101915999|NCT03948035|Hormones|hormones|mesh-ancestor
102388821|NCT03206346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102388822|NCT00170625|Topotecan|topotecan|mesh-list
102388823|NCT00170625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102388824|NCT00170625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102388826|NCT00170625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388827|NCT00170625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102388828|NCT02043652|Chloroquine|chloroquine|mesh-list
102388829|NCT02043652|Primaquine|primaquine|mesh-list
102388830|NCT02043652|Amebicides|amebicides|mesh-ancestor
102388831|NCT02043652|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102388832|NCT02043652|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102388833|NCT02043652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102388834|NCT02043652|Antimalarials|antimalarials|mesh-ancestor
102388835|NCT02043652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102388836|NCT01898169|Nicotine|nicotine|mesh-list
101278819|NCT01874574|Hylan|hylan|mesh-list
102388837|NCT01898169|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102388838|NCT01898169|Autonomic Agents|autonomic agents|mesh-ancestor
102388839|NCT01898169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102388840|NCT01898169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388841|NCT01898169|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102388842|NCT01898169|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102388843|NCT01898169|Cholinergic Agents|cholinergic agents|mesh-ancestor
102388844|NCT01898169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102388845|NCT01898169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388846|NCT03227016|Topotecan|topotecan|mesh-list
102388847|NCT03227016|Veliparib|veliparib|mesh-list
102388848|NCT03227016|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102388849|NCT03227016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102388850|NCT03227016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102388851|NCT03227016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102388852|NCT03227016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388853|NCT03227016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102388854|NCT04748991|Amiodarone|amiodarone|mesh-list
102388855|NCT04748991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102388856|NCT04748991|Vasodilator Agents|vasodilator agents|mesh-ancestor
102388857|NCT04748991|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102388858|NCT04748991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101916345|NCT03497975|Nalbuphine|nalbuphine|mesh-list
102388859|NCT04748991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388860|NCT04748991|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102388861|NCT04748991|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102388862|NCT04748991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102388863|NCT04748991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102388864|NCT04748991|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102388865|NCT04748991|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102388866|NCT04748991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102388867|NCT03230136|Anesthetics|anesthetics|mesh-list
102388868|NCT03230136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102388869|NCT03230136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388870|NCT00176865|Cyclosporine|cyclosporine|mesh-list
102388871|NCT00176865|Mycophenolic Acid|mycophenolic acid|mesh-list
102388872|NCT00176865|Fludarabine|fludarabine|mesh-list
102388873|NCT00176865|Melphalan|melphalan|mesh-list
102388874|NCT00176865|Alemtuzumab|alemtuzumab|mesh-list
102388875|NCT00176865|Cyclosporins|cyclosporins|mesh-list
101916487|NCT03310541|Fulvestrant|fulvestrant|mesh-list
102388876|NCT00176865|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102388877|NCT00176865|Immunoglobulins|immunoglobulins|mesh-list
102388878|NCT00176865|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102388879|NCT00176865|gamma-Globulins|gamma-globulins|mesh-list
102388880|NCT00176865|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102388881|NCT00176865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102388882|NCT00176865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388883|NCT00176865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102388884|NCT00176865|Immunologic Factors|immunologic factors|mesh-ancestor
102388885|NCT00176865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388886|NCT00176865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102388887|NCT00176865|Antifungal Agents|antifungal agents|mesh-ancestor
102388888|NCT00176865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102388889|NCT00176865|Dermatologic Agents|dermatologic agents|mesh-ancestor
102388890|NCT00176865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102388891|NCT00176865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102388892|NCT00176865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102388893|NCT00176865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102388894|NCT00176865|Antitubercular Agents|antitubercular agents|mesh-ancestor
102388895|NCT00176865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102388896|NCT00176865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102388897|NCT00176865|Alkylating Agents|alkylating agents|mesh-ancestor
102388898|NCT00176865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102388899|NCT00176865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102388900|NCT02451072|Ketanserin|ketanserin|mesh-list
102388901|NCT02451072|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
102388902|NCT02451072|Hallucinogens|hallucinogens|mesh-ancestor
102388903|NCT02451072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388904|NCT02451072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102388905|NCT02451072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102388906|NCT02451072|Serotonin Agents|serotonin agents|mesh-ancestor
101916909|NCT02519452|Daratumumab|daratumumab|mesh-list
102388907|NCT02451072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102388908|NCT02451072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388909|NCT02451072|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102388910|NCT02451072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102388911|NCT02451072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102388912|NCT03226626|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102388913|NCT03226626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102388914|NCT02450994|Dexamethasone|dexamethasone|mesh-list
102388915|NCT02450994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102388916|NCT02450994|Antiemetics|antiemetics|mesh-ancestor
102388917|NCT02450994|Autonomic Agents|autonomic agents|mesh-ancestor
102388918|NCT02450994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102388919|NCT02450994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388920|NCT02450994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102388921|NCT02450994|Glucocorticoids|glucocorticoids|mesh-ancestor
102388922|NCT02450994|Hormones|hormones|mesh-ancestor
102388923|NCT02450994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102388924|NCT02450994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102388925|NCT02450994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102388926|NCT00177255|Docetaxel|docetaxel|mesh-list
102388927|NCT00177255|Capecitabine|capecitabine|mesh-list
102388928|NCT00177255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102388929|NCT00177255|Tubulin Modulators|tubulin modulators|mesh-ancestor
102388930|NCT00177255|Antimitotic Agents|antimitotic agents|mesh-ancestor
102388931|NCT00177255|Mitosis Modulators|mitosis modulators|mesh-ancestor
102388932|NCT00177255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388933|NCT00177255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102388934|NCT00177255|Antimetabolites|antimetabolites|mesh-ancestor
102388935|NCT02401048|Durvalumab|durvalumab|mesh-list
102388936|NCT02401048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102388937|NCT02401048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102388938|NCT02046382|Acetaminophen|acetaminophen|mesh-list
102388939|NCT02046382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102388940|NCT02046382|Analgesics|analgesics|mesh-ancestor
102388941|NCT02046382|Sensory System Agents|sensory system agents|mesh-ancestor
102388942|NCT02046382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102388943|NCT02046382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388944|NCT02046382|Antipyretics|antipyretics|mesh-ancestor
102388945|NCT03205176|Olaparib|olaparib|mesh-list
102388946|NCT03205176|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102388947|NCT03205176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102388948|NCT03205176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388949|NCT03205176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102388950|NCT02046772|Morphine|morphine|mesh-list
102388951|NCT02046772|Bupivacaine|bupivacaine|mesh-list
102388952|NCT02046772|Anesthetics, Local|anesthetics, local|mesh-ancestor
102388953|NCT02046772|Anesthetics|anesthetics|mesh-ancestor
102388954|NCT02046772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101917325|NCT00841789|Etanercept|etanercept|mesh-list
102388955|NCT02046772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388956|NCT02046772|Sensory System Agents|sensory system agents|mesh-ancestor
102388957|NCT02046772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102388958|NCT02046772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102388959|NCT02046772|Narcotics|narcotics|mesh-ancestor
102388960|NCT02046772|Analgesics|analgesics|mesh-ancestor
102388961|NCT00178503|Methylphenidate|methylphenidate|mesh-list
102388962|NCT00178503|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102388963|NCT00178503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388964|NCT00178503|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102388965|NCT00178503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102388966|NCT00178503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102388967|NCT00178503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388968|NCT00178503|Dopamine Agents|dopamine agents|mesh-ancestor
102388969|NCT00178503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102388970|NCT02376010|Warfarin|warfarin|mesh-list
102388971|NCT02376010|Rivaroxaban|rivaroxaban|mesh-list
102388972|NCT02376010|Anticoagulants|anticoagulants|mesh-ancestor
102388973|NCT02376010|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102388974|NCT02376010|Antithrombins|antithrombins|mesh-ancestor
102388975|NCT02376010|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102388976|NCT02376010|Protease Inhibitors|protease inhibitors|mesh-ancestor
102388977|NCT02376010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102388978|NCT02376010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388979|NCT00085293|Decitabine|decitabine|mesh-list
102388980|NCT00085293|Azacitidine|azacitidine|mesh-list
102388981|NCT00085293|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102388982|NCT00085293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102388983|NCT00085293|Antimetabolites|antimetabolites|mesh-ancestor
102388984|NCT00085293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388985|NCT00085293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102388986|NCT00085293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102388987|NCT00085293|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102388988|NCT02402062|Sunitinib|sunitinib|mesh-list
102388989|NCT02402062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102388990|NCT02402062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102388991|NCT02402062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102388992|NCT02402062|Growth Substances|growth substances|mesh-ancestor
102388993|NCT02402062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102388994|NCT02402062|Growth Inhibitors|growth inhibitors|mesh-ancestor
102388995|NCT02402062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102388996|NCT02402062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102388997|NCT02402062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102388998|NCT02450838|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102388999|NCT02450838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102389000|NCT02450838|Immunologic Factors|immunologic factors|mesh-ancestor
102389001|NCT02450838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389002|NCT02450838|Antacids|antacids|mesh-ancestor
102389003|NCT02450838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389004|NCT02450838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102389005|NCT03214302|Tenofovir|tenofovir|mesh-list
101917893|NCT04316676|Regadenoson|regadenoson|mesh-list
102389006|NCT03214302|Antiviral Agents|antiviral agents|mesh-ancestor
102389007|NCT03214302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102389008|NCT03214302|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102389009|NCT03214302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102389010|NCT03214302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101918024|NCT03673462|Vaccines|vaccines|mesh-list
102389011|NCT03214302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389012|NCT03214302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102389013|NCT03214302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102389014|NCT00085839|Paclitaxel|paclitaxel|mesh-list
102389015|NCT00085839|Carboplatin|carboplatin|mesh-list
102389016|NCT00085839|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102389017|NCT00085839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102389018|NCT00085839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102389019|NCT00085839|Tubulin Modulators|tubulin modulators|mesh-ancestor
102389020|NCT00085839|Antimitotic Agents|antimitotic agents|mesh-ancestor
102389021|NCT00085839|Mitosis Modulators|mitosis modulators|mesh-ancestor
102389022|NCT00085839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389023|NCT00085839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102389024|NCT00085839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102389025|NCT03204474|Lacosamide|lacosamide|mesh-list
102389026|NCT03204474|Anticonvulsants|anticonvulsants|mesh-ancestor
102389027|NCT03204474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102389028|NCT03204474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102389029|NCT03204474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102389030|NCT03204474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389031|NCT03204318|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102389032|NCT03204318|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102389033|NCT03204318|Norethindrone|norethindrone|mesh-list
102389034|NCT03204318|Norethindrone Acetate|norethindrone acetate|mesh-list
102389035|NCT03204318|Estradiol|estradiol|mesh-list
102389036|NCT03204318|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102389037|NCT03204318|Relugolix|relugolix|mesh-list
102389038|NCT03204318|Estrogens|estrogens|mesh-ancestor
102389039|NCT03204318|Hormones|hormones|mesh-ancestor
102389040|NCT03204318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102389041|NCT03204318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389042|NCT03204318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102389043|NCT03204318|Contraceptive Agents|contraceptive agents|mesh-ancestor
102389044|NCT03204318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102389045|NCT03204318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102389046|NCT03204318|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102200763|NCT02200991|Lixisenatide|lixisenatide|mesh-list
102389047|NCT03204318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102389048|NCT03204318|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102389049|NCT03204318|Androgen Antagonists|androgen antagonists|mesh-ancestor
102389050|NCT03204318|Hormone Antagonists|hormone antagonists|mesh-ancestor
102389051|NCT03204006|Dexmedetomidine|dexmedetomidine|mesh-list
101918442|NCT01239498|Mydriatics|mydriatics|mesh-ancestor
102389052|NCT03204006|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102389053|NCT03204006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102389054|NCT03204006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389055|NCT03204006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102389056|NCT03204006|Analgesics|analgesics|mesh-ancestor
101918519|NCT00162773|Omalizumab|omalizumab|mesh-list
102389057|NCT03204006|Sensory System Agents|sensory system agents|mesh-ancestor
102389058|NCT03204006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102389059|NCT03204006|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101918585|NCT00209027|Serotonin Agents|serotonin agents|mesh-ancestor
102389060|NCT03204006|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102389061|NCT03204006|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102389062|NCT03204006|Adrenergic Agents|adrenergic agents|mesh-ancestor
102389063|NCT03204006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101918731|NCT01567930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102389064|NCT03204006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389065|NCT03226080|Rocuronium|rocuronium|mesh-list
102389066|NCT03226080|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102389067|NCT03226080|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102389068|NCT03226080|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102389069|NCT03226080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102389070|NCT03226080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389071|NCT03225924|Prednisone|prednisone|mesh-list
102389072|NCT03225924|Cyclophosphamide|cyclophosphamide|mesh-list
102389073|NCT03225924|Rituximab|rituximab|mesh-list
102389074|NCT03225924|Doxorubicin|doxorubicin|mesh-list
102389075|NCT03225924|Vincristine|vincristine|mesh-list
102389076|NCT03225924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102389077|NCT03225924|Immunologic Factors|immunologic factors|mesh-ancestor
102389078|NCT03225924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389079|NCT03225924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102389080|NCT03225924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102389081|NCT03225924|Alkylating Agents|alkylating agents|mesh-ancestor
102389082|NCT03225924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389083|NCT03225924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102389084|NCT03225924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102389085|NCT03225924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102389086|NCT03225924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102389087|NCT03225924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102389088|NCT03225924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102389089|NCT03225924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102389090|NCT03225924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102389091|NCT03225924|Glucocorticoids|glucocorticoids|mesh-ancestor
102389092|NCT03225924|Hormones|hormones|mesh-ancestor
102389093|NCT03225924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102389094|NCT03225924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102389095|NCT03225924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102389096|NCT03225924|Tubulin Modulators|tubulin modulators|mesh-ancestor
102389097|NCT03225924|Antimitotic Agents|antimitotic agents|mesh-ancestor
101918874|NCT05194852|Anesthetics|anesthetics|mesh-list
102389098|NCT03225924|Mitosis Modulators|mitosis modulators|mesh-ancestor
102389099|NCT03119532|Metronidazole|metronidazole|mesh-list
102389100|NCT03119532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102389101|NCT03119532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102389102|NCT03119532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102389103|NCT03119532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102389104|NCT02404168|Lamotrigine|lamotrigine|mesh-list
102389105|NCT02404168|Anticonvulsants|anticonvulsants|mesh-list
102389106|NCT02404168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102389107|NCT02404168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102389108|NCT02404168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389109|NCT02404168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102389110|NCT02404168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389111|NCT02404168|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102389112|NCT02404168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101919062|NCT03632590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102389113|NCT02404168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102389114|NCT02404168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102389115|NCT02404168|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102389116|NCT04733937|Caseins|caseins|mesh-list
102389117|NCT04733937|Chelating Agents|chelating agents|mesh-ancestor
102389118|NCT04733937|Sequestering Agents|sequestering agents|mesh-ancestor
101919135|NCT01147692|Incretins|incretins|mesh-ancestor
102389119|NCT04733937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389120|NCT02051452|Methylphenidate|methylphenidate|mesh-list
102389121|NCT02051452|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102389122|NCT02051452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389123|NCT02051452|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102389124|NCT02051452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102389125|NCT02051452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102389126|NCT02051452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389127|NCT02051452|Dopamine Agents|dopamine agents|mesh-ancestor
102389128|NCT02051452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102389129|NCT00180687|Bupivacaine|bupivacaine|mesh-list
102389130|NCT00180687|Coal Tar|coal tar|mesh-list
102389131|NCT00180687|Anesthetics, Local|anesthetics, local|mesh-ancestor
102389132|NCT00180687|Anesthetics|anesthetics|mesh-ancestor
102389133|NCT00180687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102389134|NCT00180687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389135|NCT00180687|Sensory System Agents|sensory system agents|mesh-ancestor
101919426|NCT01149174|Mitomycins|mitomycins|mesh-list
102389136|NCT00180687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102389137|NCT00180687|Keratolytic Agents|keratolytic agents|mesh-ancestor
102389138|NCT00180687|Dermatologic Agents|dermatologic agents|mesh-ancestor
102389139|NCT00087633|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102389140|NCT00087633|Antiviral Agents|antiviral agents|mesh-ancestor
102389141|NCT00087633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102389142|NCT02384044|Listerine|listerine|mesh-list
102389143|NCT02384044|Sodium Fluoride|sodium fluoride|mesh-list
102389144|NCT02384044|Cariostatic Agents|cariostatic agents|mesh-ancestor
102389145|NCT02384044|Protective Agents|protective agents|mesh-ancestor
101919556|NCT01149330|Adapalene|adapalene|mesh-list
102389146|NCT02384044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389147|NCT02384044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102389148|NCT02384044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102389149|NCT02384200|Vancomycin|vancomycin|mesh-list
102389150|NCT02384200|Gentamicins|gentamicins|mesh-list
102389151|NCT02384200|Ceftriaxone|ceftriaxone|mesh-list
102389152|NCT02384200|Ampicillin|ampicillin|mesh-list
102389153|NCT02384200|Nitrofurantoin|nitrofurantoin|mesh-list
102389154|NCT02384200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102389155|NCT02384200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102389156|NCT02384200|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101919774|NCT01257048|Glucocorticoids|glucocorticoids|mesh-ancestor
102389157|NCT02384200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102389158|NCT02384200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389159|NCT02384200|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102389160|NCT02051686|Tranexamic Acid|tranexamic acid|mesh-list
102389161|NCT02051686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102389162|NCT02051686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102389163|NCT02051686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389164|NCT02051686|Hemostatics|hemostatics|mesh-ancestor
102389165|NCT02051686|Coagulants|coagulants|mesh-ancestor
102389166|NCT00182793|Cyclophosphamide|cyclophosphamide|mesh-list
102389167|NCT00182793|Melphalan|melphalan|mesh-list
102389168|NCT00182793|Thiotepa|thiotepa|mesh-list
102389169|NCT00182793|Carboplatin|carboplatin|mesh-list
102389170|NCT00182793|Trastuzumab|trastuzumab|mesh-list
102389171|NCT00182793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102389172|NCT00182793|Immunologic Factors|immunologic factors|mesh-ancestor
102389173|NCT00182793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389174|NCT00182793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102389175|NCT00182793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102389176|NCT00182793|Alkylating Agents|alkylating agents|mesh-ancestor
101920060|NCT05941429|Fluorides|fluorides|mesh-list
102389177|NCT00182793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389178|NCT00182793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102389179|NCT00182793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102389180|NCT00182793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102389181|NCT00183339|Fluoxetine|fluoxetine|mesh-list
102389182|NCT00183339|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102389183|NCT00183339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102389184|NCT00183339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102389185|NCT00183339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389186|NCT00183339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101920208|NCT05893797|TEMPO|tempo|mesh-list
102389187|NCT00183339|Serotonin Agents|serotonin agents|mesh-ancestor
102389188|NCT00183339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389189|NCT00183339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102389190|NCT00183339|Antidepressive Agents|antidepressive agents|mesh-ancestor
102389191|NCT00183339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102389192|NCT00183339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101920266|NCT05818826|Hydrocortisone|hydrocortisone|mesh-list
102389193|NCT00183339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102389194|NCT00183339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102389195|NCT00183729|Memantine|memantine|mesh-list
102389196|NCT00183729|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102389197|NCT00183729|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102389198|NCT00183729|Dopamine Agents|dopamine agents|mesh-ancestor
102389199|NCT00183729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101920338|NCT05701241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102389200|NCT00183729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389201|NCT00183729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389202|NCT00183729|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102389203|NCT00183729|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102389204|NCT00186069|Magnesium Sulfate|magnesium sulfate|mesh-list
102389205|NCT00186069|Analgesics|analgesics|mesh-ancestor
102389206|NCT00186069|Sensory System Agents|sensory system agents|mesh-ancestor
102389207|NCT00186069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102389208|NCT00186069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389209|NCT00186069|Anesthetics|anesthetics|mesh-ancestor
102389210|NCT00186069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102389211|NCT00186069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102389212|NCT00186069|Anticonvulsants|anticonvulsants|mesh-ancestor
102389213|NCT00186069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102389214|NCT00186069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102389215|NCT00186069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389216|NCT00186069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102389217|NCT00186069|Tocolytic Agents|tocolytic agents|mesh-ancestor
102389218|NCT00186069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102389219|NCT01742897|Fentanyl|fentanyl|mesh-list
102389220|NCT01742897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102389221|NCT01742897|Narcotics|narcotics|mesh-ancestor
101920639|NCT05123703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102389222|NCT01742897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102389223|NCT01742897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389224|NCT01742897|Analgesics|analgesics|mesh-ancestor
102389225|NCT01742897|Sensory System Agents|sensory system agents|mesh-ancestor
102389226|NCT01742897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102389227|NCT01742897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102389228|NCT01742897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102389229|NCT01742897|Anesthetics, General|anesthetics, general|mesh-ancestor
102389230|NCT01742897|Anesthetics|anesthetics|mesh-ancestor
102389231|NCT04554485|Blinatumomab|blinatumomab|mesh-list
102389232|NCT04554485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102389233|NCT01741259|Meperidine|meperidine|mesh-list
102389234|NCT01741259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102389235|NCT01741259|Narcotics|narcotics|mesh-ancestor
102389236|NCT01741259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102389237|NCT01741259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389238|NCT01741259|Analgesics|analgesics|mesh-ancestor
102389239|NCT01741259|Sensory System Agents|sensory system agents|mesh-ancestor
102389240|NCT01741259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102389241|NCT01741259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102389242|NCT01715129|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102389243|NCT01715129|Luteolytic Agents|luteolytic agents|mesh-ancestor
102389244|NCT01715129|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102389245|NCT01715129|Contraceptive Agents|contraceptive agents|mesh-ancestor
102389246|NCT01715129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102389247|NCT01715129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389248|NCT01715129|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102389249|NCT01715129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102389250|NCT01715129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102389251|NCT02387554|Losartan|losartan|mesh-list
102389252|NCT02387554|Amlodipine|amlodipine|mesh-list
102389253|NCT02387554|Chlorthalidone|chlorthalidone|mesh-list
102389254|NCT02387554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102389255|NCT02387554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102389256|NCT02387554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102389257|NCT02387554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389258|NCT02387554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102389259|NCT02387554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389260|NCT02387554|Vasodilator Agents|vasodilator agents|mesh-ancestor
102389261|NCT02387554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102389262|NCT02387554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102389263|NCT02387554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102389264|NCT02387554|Diuretics|diuretics|mesh-ancestor
102389265|NCT02387554|Natriuretic Agents|natriuretic agents|mesh-ancestor
102389266|NCT02387554|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102389267|NCT02387710|Tiagabine|tiagabine|mesh-list
102389268|NCT02387710|Anticonvulsants|anticonvulsants|mesh-ancestor
102389269|NCT02387710|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
102389270|NCT02387710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102200999|NCT05647291|Methylprednisolone|methylprednisolone|mesh-list
102389271|NCT02387710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102389272|NCT02387710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389273|NCT02387710|GABA Agents|gaba agents|mesh-ancestor
102389274|NCT02387710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102389275|NCT02387710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389276|NCT01740791|Velpatasvir|velpatasvir|mesh-list
102389277|NCT01740791|Antiviral Agents|antiviral agents|mesh-ancestor
102389278|NCT01740791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102389280|NCT01740323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102389281|NCT01740323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102389282|NCT01740323|Analgesics|analgesics|mesh-ancestor
102389283|NCT01740323|Sensory System Agents|sensory system agents|mesh-ancestor
102389284|NCT01740323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102389285|NCT01740323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389286|NCT01740323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102389287|NCT01740323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102389288|NCT01740323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102389289|NCT01740323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102389290|NCT01740323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389291|NCT00090051|Cyclophosphamide|cyclophosphamide|mesh-list
102389292|NCT00090051|Rituximab|rituximab|mesh-list
102389293|NCT00090051|Fludarabine|fludarabine|mesh-list
102389294|NCT00090051|Fludarabine phosphate|fludarabine phosphate|mesh-list
102389295|NCT00090051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102389296|NCT00090051|Immunologic Factors|immunologic factors|mesh-ancestor
102389297|NCT00090051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389298|NCT00090051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102389299|NCT00090051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102389300|NCT00090051|Alkylating Agents|alkylating agents|mesh-ancestor
102389301|NCT00090051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389302|NCT00090051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101921433|NCT02436993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101921434|NCT02436993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101921435|NCT02436993|Growth Substances|growth substances|mesh-ancestor
101921436|NCT02436993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921437|NCT02436993|Growth Inhibitors|growth inhibitors|mesh-ancestor
101921438|NCT02427568|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
101921439|NCT02427568|Hallucinogens|hallucinogens|mesh-ancestor
101921440|NCT02427568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921441|NCT02427568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101921442|NCT02427568|Serotonin Agents|serotonin agents|mesh-ancestor
101921443|NCT02427568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101921444|NCT02427568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921445|NCT02427568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101921446|NCT02427568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101921447|NCT02427568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101921448|NCT02427568|Adrenergic Agents|adrenergic agents|mesh-ancestor
101921481|NCT02193841|Calcium|calcium|mesh-list
101921482|NCT02193841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101921483|NCT02193841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921484|NCT02102802|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
101921485|NCT02102802|Hallucinogens|hallucinogens|mesh-ancestor
101921486|NCT02102802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921487|NCT02102802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101921488|NCT02102802|Serotonin Agents|serotonin agents|mesh-ancestor
101921489|NCT02102802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101921490|NCT02102802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921491|NCT02102802|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102389303|NCT00090051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102389304|NCT00090051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101921497|NCT02011971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102389305|NCT00090051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102389306|NCT00090051|Antimetabolites|antimetabolites|mesh-ancestor
102389307|NCT01740089|Ribavirin|ribavirin|mesh-list
102389308|NCT01740089|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102389309|NCT01740089|Antimetabolites|antimetabolites|mesh-ancestor
102389310|NCT01740089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389311|NCT01740089|Antiviral Agents|antiviral agents|mesh-ancestor
102389312|NCT01740089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102389313|NCT01739933|Dexmedetomidine|dexmedetomidine|mesh-list
102389314|NCT01739933|Propofol|propofol|mesh-list
102389315|NCT01739933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102389316|NCT01739933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102389317|NCT01739933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389318|NCT01739933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102389319|NCT01739933|Analgesics|analgesics|mesh-ancestor
102389320|NCT01739933|Sensory System Agents|sensory system agents|mesh-ancestor
102389321|NCT01739933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102389322|NCT01739933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102389323|NCT01739933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102389324|NCT01739933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102389325|NCT01739933|Adrenergic Agents|adrenergic agents|mesh-ancestor
102389326|NCT01739933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102389327|NCT01739933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389328|NCT01739933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102389329|NCT01739933|Anesthetics, General|anesthetics, general|mesh-ancestor
101921582|NCT01835041|Vitamins|vitamins|mesh-ancestor
102389330|NCT01739933|Anesthetics|anesthetics|mesh-ancestor
102389331|NCT00094497|Doxorubicin|doxorubicin|mesh-list
102389332|NCT00094497|Etoposide|etoposide|mesh-list
102389333|NCT00094497|Mitotane|mitotane|mesh-list
102389334|NCT00094497|Streptozocin|streptozocin|mesh-list
102389335|NCT00094497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101921618|NCT01509586|Lobeline|lobeline|mesh-list
102389336|NCT00094497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102389337|NCT00094497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102389338|NCT00094497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102389339|NCT00094497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102389340|NCT00094497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389341|NCT00094497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102389342|NCT00094497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102389343|NCT00094887|Nitric Oxide|nitric oxide|mesh-list
102389344|NCT00094887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102389345|NCT00094887|Autonomic Agents|autonomic agents|mesh-ancestor
102201063|NCT02202707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101921831|NCT03892902|Zopiclone|zopiclone|mesh-list
102389346|NCT00094887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102389347|NCT00094887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389348|NCT00094887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102389349|NCT00094887|Respiratory System Agents|respiratory system agents|mesh-ancestor
102389350|NCT00094887|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102389352|NCT00094887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389353|NCT00094887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101921984|NCT01152372|Insulin|insulin|mesh-list
102389354|NCT00094887|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102389355|NCT00094887|Vasodilator Agents|vasodilator agents|mesh-ancestor
102389356|NCT00094887|Gasotransmitters|gasotransmitters|mesh-ancestor
102389357|NCT00094887|Protective Agents|protective agents|mesh-ancestor
102389358|NCT01712399|Mavrilimumab|mavrilimumab|mesh-list
102389359|NCT01712399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102389360|NCT00097695|Icatibant|icatibant|mesh-list
102389361|NCT00097695|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102389362|NCT00097695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102389363|NCT00097695|Analgesics|analgesics|mesh-ancestor
102389364|NCT00097695|Sensory System Agents|sensory system agents|mesh-ancestor
102389365|NCT00097695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102389366|NCT00097695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389367|NCT00097695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102389368|NCT00097695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102389369|NCT00097695|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
102389370|NCT00097695|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
101922114|NCT03890406|Rocuronium|rocuronium|mesh-list
102389371|NCT00097695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389372|NCT00097695|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102389373|NCT00097695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102389374|NCT00097695|Immunologic Factors|immunologic factors|mesh-ancestor
102389375|NCT02096679|Osimertinib|osimertinib|mesh-list
102389376|NCT02096679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102389377|NCT02096679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102389378|NCT02096679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102389379|NCT02096679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389380|NCT00195039|Antibodies|antibodies|mesh-list
102389381|NCT00195039|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102389382|NCT00195039|Immunologic Factors|immunologic factors|mesh-ancestor
102389383|NCT00195039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389384|NCT04645719|Magnesium Sulfate|magnesium sulfate|mesh-list
102389385|NCT04645719|Analgesics|analgesics|mesh-ancestor
102389386|NCT04645719|Sensory System Agents|sensory system agents|mesh-ancestor
102389387|NCT04645719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102389388|NCT04645719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389389|NCT04645719|Anesthetics|anesthetics|mesh-ancestor
102389390|NCT04645719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102389391|NCT04645719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102389392|NCT04645719|Anticonvulsants|anticonvulsants|mesh-ancestor
102389393|NCT04645719|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102389394|NCT04645719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102389395|NCT04645719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389396|NCT04645719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102389397|NCT04645719|Tocolytic Agents|tocolytic agents|mesh-ancestor
102389398|NCT04645719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102389399|NCT02054338|Paclitaxel|paclitaxel|mesh-list
102389400|NCT02054338|Gemcitabine|gemcitabine|mesh-list
101922604|NCT01264692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102389401|NCT02054338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102389402|NCT02054338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102389403|NCT02054338|Tubulin Modulators|tubulin modulators|mesh-ancestor
102389404|NCT02054338|Antimitotic Agents|antimitotic agents|mesh-ancestor
102389405|NCT02054338|Mitosis Modulators|mitosis modulators|mesh-ancestor
102389406|NCT02054338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389407|NCT02054338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102389408|NCT02054338|Antimetabolites|antimetabolites|mesh-ancestor
102389409|NCT00198081|Celecoxib|celecoxib|mesh-list
102389410|NCT00198081|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
102389411|NCT00198081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101922740|NCT01268670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102389412|NCT00198081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102389413|NCT00198081|Analgesics|analgesics|mesh-ancestor
102389414|NCT00198081|Sensory System Agents|sensory system agents|mesh-ancestor
102389415|NCT00198081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102389416|NCT00198081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389417|NCT00198081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102201138|NCT02363829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102389418|NCT00198081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102389419|NCT00198081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101922884|NCT01163994|Doxycycline|doxycycline|mesh-list
102389420|NCT00198081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102389421|NCT00198081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389422|NCT00100659|Interferons|interferons|mesh-list
102389423|NCT00100659|Ribavirin|ribavirin|mesh-list
102389424|NCT00100659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102389425|NCT00100659|Antiviral Agents|antiviral agents|mesh-ancestor
102389426|NCT00100659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102389427|NCT00100659|Antimetabolites|antimetabolites|mesh-ancestor
102389428|NCT00100659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389429|NCT00101361|Oxandrolone|oxandrolone|mesh-list
102389430|NCT00101361|Androgens|androgens|mesh-ancestor
102389431|NCT00101361|Hormones|hormones|mesh-ancestor
101923091|NCT03871218|Protective Agents|protective agents|mesh-ancestor
102389432|NCT00101361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102389433|NCT00101361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389434|NCT00101361|Anabolic Agents|anabolic agents|mesh-ancestor
102389435|NCT03225690|Morphine|morphine|mesh-list
102389436|NCT03225690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102389437|NCT03225690|Narcotics|narcotics|mesh-ancestor
102389438|NCT03225690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102389439|NCT03225690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389440|NCT03225690|Analgesics|analgesics|mesh-ancestor
101923231|NCT05834582|Fluzoparib|fluzoparib|mesh-list
102389441|NCT03225690|Sensory System Agents|sensory system agents|mesh-ancestor
102389442|NCT03225690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102389443|NCT02389738|Temozolomide|temozolomide|mesh-list
102389444|NCT02389738|Regadenoson|regadenoson|mesh-list
102389445|NCT02389738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102389446|NCT02389738|Alkylating Agents|alkylating agents|mesh-ancestor
102389447|NCT02389738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389448|NCT02389738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102389449|NCT02389738|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
102389450|NCT02389738|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102389451|NCT02389738|Purinergic Agonists|purinergic agonists|mesh-ancestor
102389452|NCT02389738|Purinergic Agents|purinergic agents|mesh-ancestor
102389453|NCT02389738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102389454|NCT02389738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389455|NCT00200343|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102389456|NCT00200343|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102389457|NCT00200343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102389458|NCT00201123|Interferons|interferons|mesh-list
102389459|NCT00201123|Interferon-gamma|interferon-gamma|mesh-list
102389460|NCT00201123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102389461|NCT00201123|Antiviral Agents|antiviral agents|mesh-ancestor
102389462|NCT00201123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102389463|NCT01712009|Loratadine|loratadine|mesh-list
102389464|NCT01712009|Naproxen|naproxen|mesh-list
102389465|NCT01712009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102389466|NCT01712009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102389467|NCT01712009|Analgesics|analgesics|mesh-ancestor
102389468|NCT01712009|Sensory System Agents|sensory system agents|mesh-ancestor
102389469|NCT01712009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102389470|NCT01712009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389471|NCT01712009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102389472|NCT01712009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102389473|NCT01712009|Gout Suppressants|gout suppressants|mesh-ancestor
102389474|NCT01712009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102389475|NCT01712009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102389476|NCT01712009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389477|NCT01712009|Antipruritics|antipruritics|mesh-ancestor
102389478|NCT01712009|Dermatologic Agents|dermatologic agents|mesh-ancestor
102389479|NCT01712009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102389480|NCT01712009|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102389481|NCT01712009|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102389482|NCT01712009|Histamine Antagonists|histamine antagonists|mesh-ancestor
102389483|NCT01712009|Histamine Agents|histamine agents|mesh-ancestor
102389484|NCT01712009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102389485|NCT03212352|Misoprostol|misoprostol|mesh-list
102389486|NCT03212352|Mifepristone|mifepristone|mesh-list
102389487|NCT03212352|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102389488|NCT03212352|Abortifacient Agents|abortifacient agents|mesh-ancestor
102389489|NCT03212352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102389490|NCT03212352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389491|NCT03212352|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102389492|NCT03212352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102201219|NCT03532919|Cystatins|cystatins|mesh-list
102389493|NCT03212352|Oxytocics|oxytocics|mesh-ancestor
102389494|NCT03212352|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101923571|NCT05557643|Psilocybin|psilocybin|mesh-list
102389495|NCT03212352|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102389496|NCT03212352|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102389497|NCT03212352|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102389498|NCT03212352|Contraceptive Agents|contraceptive agents|mesh-ancestor
101923630|NCT05281614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102389499|NCT03212352|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102389500|NCT03212352|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102389501|NCT03212352|Hormone Antagonists|hormone antagonists|mesh-ancestor
101923699|NCT04872608|Letrozole|letrozole|mesh-list
102389502|NCT03212352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102389503|NCT03212352|Luteolytic Agents|luteolytic agents|mesh-ancestor
102389504|NCT03212352|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102389505|NCT03212352|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102389506|NCT00201825|Docetaxel|docetaxel|mesh-list
102389507|NCT00201825|Capecitabine|capecitabine|mesh-list
102389508|NCT00201825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102389509|NCT00201825|Tubulin Modulators|tubulin modulators|mesh-ancestor
102389510|NCT00201825|Antimitotic Agents|antimitotic agents|mesh-ancestor
102389511|NCT00201825|Mitosis Modulators|mitosis modulators|mesh-ancestor
102389512|NCT00201825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389513|NCT00201825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102389514|NCT00201825|Antimetabolites|antimetabolites|mesh-ancestor
102389515|NCT02390050|Bexagliflozin|bexagliflozin|mesh-list
102389516|NCT02390050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102389517|NCT02390050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389518|NCT01711853|Dabigatran|dabigatran|mesh-list
102389519|NCT01711853|Antithrombins|antithrombins|mesh-ancestor
102389520|NCT01711853|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101923984|NCT03494530|Edoxaban|edoxaban|mesh-list
102389521|NCT01711853|Protease Inhibitors|protease inhibitors|mesh-ancestor
102389522|NCT01711853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102389523|NCT01711853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389524|NCT01711853|Anticoagulants|anticoagulants|mesh-ancestor
102389525|NCT00202449|Prazosin|prazosin|mesh-list
102389526|NCT00202449|Paroxetine|paroxetine|mesh-list
102389527|NCT00202449|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102389528|NCT00202449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101924045|NCT02969837|Elotuzumab|elotuzumab|mesh-list
102389529|NCT00202449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102389530|NCT00202449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389531|NCT00202449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102389532|NCT00202449|Serotonin Agents|serotonin agents|mesh-ancestor
102389533|NCT00202449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389534|NCT00202449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102389535|NCT00202449|Antidepressive Agents|antidepressive agents|mesh-ancestor
102389536|NCT00202449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102389537|NCT00202449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102389538|NCT00202449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102389539|NCT00202449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102389540|NCT00202449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102389541|NCT00202449|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102389542|NCT00202449|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102389543|NCT00202449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102389544|NCT00202449|Adrenergic Agents|adrenergic agents|mesh-ancestor
102389545|NCT03203304|Nivolumab|nivolumab|mesh-list
102389546|NCT03203304|Ipilimumab|ipilimumab|mesh-list
102389547|NCT03203304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102389548|NCT03203304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102389549|NCT03203304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102389550|NCT03203304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389551|NCT03225456|Oxytocin|oxytocin|mesh-list
102389552|NCT03225456|Oxytocics|oxytocics|mesh-ancestor
102389553|NCT03225456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102389554|NCT03225456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389555|NCT00203229|Lamotrigine|lamotrigine|mesh-list
102389556|NCT00203229|Anticonvulsants|anticonvulsants|mesh-ancestor
102389557|NCT00203229|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102389558|NCT00203229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102389559|NCT00203229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389560|NCT00203229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102389561|NCT00203229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924389|NCT00800215|Lacosamide|lacosamide|mesh-list
102389562|NCT00203229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102389563|NCT00203229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102389564|NCT00203229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102389565|NCT00203229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102389566|NCT00203229|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102389567|NCT00203931|Pemetrexed|pemetrexed|mesh-list
102389568|NCT00203931|Cetuximab|cetuximab|mesh-list
102389569|NCT00203931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102389570|NCT00203931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102389571|NCT00203931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389572|NCT00203931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102389573|NCT00203931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102389574|NCT00203931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102389575|NCT02412982|Enoxaparin|enoxaparin|mesh-list
102389576|NCT02412982|Enoxaparin sodium|enoxaparin sodium|mesh-list
102389577|NCT02412982|Anticoagulants|anticoagulants|mesh-ancestor
102389578|NCT02412982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102389579|NCT02412982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102389580|NCT02412982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389581|NCT03203616|Trastuzumab|trastuzumab|mesh-list
102389582|NCT03203616|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102389583|NCT03203616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102389584|NCT03203616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102389585|NCT03203616|Tubulin Modulators|tubulin modulators|mesh-ancestor
102389586|NCT03203616|Antimitotic Agents|antimitotic agents|mesh-ancestor
102389587|NCT03203616|Mitosis Modulators|mitosis modulators|mesh-ancestor
102389588|NCT03203616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389589|NCT03203616|Immunotoxins|immunotoxins|mesh-ancestor
102389590|NCT03203616|Immunoconjugates|immunoconjugates|mesh-ancestor
102389591|NCT03203616|Immunologic Factors|immunologic factors|mesh-ancestor
101924730|NCT01282632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102389592|NCT03203616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389593|NCT02450214|Ketamine|ketamine|mesh-list
102389594|NCT02450214|Analgesics|analgesics|mesh-ancestor
102389595|NCT02450214|Sensory System Agents|sensory system agents|mesh-ancestor
102389596|NCT02450214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102389597|NCT02450214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389598|NCT02450214|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102389599|NCT02450214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102389600|NCT02450214|Anesthetics, General|anesthetics, general|mesh-ancestor
102389601|NCT02450214|Anesthetics|anesthetics|mesh-ancestor
102389602|NCT02450214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102389603|NCT02450214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102389604|NCT02450214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102389605|NCT02450214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102389606|NCT02450214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389607|NCT02450682|Warfarin|warfarin|mesh-list
102389608|NCT02450682|Apixaban|apixaban|mesh-list
102389609|NCT02450682|Anticoagulants|anticoagulants|mesh-ancestor
102389610|NCT02450682|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102389611|NCT02450682|Antithrombins|antithrombins|mesh-ancestor
102389612|NCT02450682|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102389613|NCT02450682|Protease Inhibitors|protease inhibitors|mesh-ancestor
102389614|NCT02450682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102389615|NCT02450682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389616|NCT01740401|Cyclophosphamide|cyclophosphamide|mesh-list
102389617|NCT01740401|Ipilimumab|ipilimumab|mesh-list
102389618|NCT01740401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102389619|NCT01740401|Immunologic Factors|immunologic factors|mesh-ancestor
102389620|NCT01740401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389621|NCT01740401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101924924|NCT01536964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102389622|NCT01740401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102389623|NCT01740401|Alkylating Agents|alkylating agents|mesh-ancestor
102389624|NCT01740401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389625|NCT01740401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102389626|NCT01740401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102389627|NCT01740401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102389628|NCT01740401|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102389629|NCT03202836|Tocolytic Agents|tocolytic agents|mesh-list
102389630|NCT03202836|Progesterone|progesterone|mesh-list
102389631|NCT03202836|Progestins|progestins|mesh-ancestor
102389632|NCT03202836|Hormones|hormones|mesh-ancestor
101925133|NCT02525172|Bortezomib|bortezomib|mesh-list
102389633|NCT03202836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102389634|NCT03202836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389635|NCT03202836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102389636|NCT03203070|Dipyrone|dipyrone|mesh-list
102389637|NCT03203070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102389638|NCT03203070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102389639|NCT03203070|Analgesics|analgesics|mesh-ancestor
102389640|NCT03203070|Sensory System Agents|sensory system agents|mesh-ancestor
102389641|NCT03203070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102389642|NCT03203070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389643|NCT03203070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102389644|NCT03203070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102389645|NCT03203070|Antipyretics|antipyretics|mesh-ancestor
102389646|NCT03209856|Vitamin D|vitamin d|mesh-list
102389647|NCT03209856|Calcitriol|calcitriol|mesh-list
102389648|NCT03209856|Vitamins|vitamins|mesh-ancestor
102389649|NCT03209856|Micronutrients|micronutrients|mesh-ancestor
102389650|NCT03209856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389651|NCT03209856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102389652|NCT03209856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102389653|NCT03209856|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102389654|NCT03209856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102389655|NCT03209856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389656|NCT03209856|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102389657|NCT02413918|Iloperidone|iloperidone|mesh-list
102389658|NCT02413918|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102389659|NCT02413918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102389660|NCT02413918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102389661|NCT02413918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389662|NCT02413918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102389663|NCT03209622|Nicotine|nicotine|mesh-list
102389664|NCT03209622|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102389665|NCT03209622|Autonomic Agents|autonomic agents|mesh-ancestor
102389666|NCT03209622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102389667|NCT03209622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389668|NCT03209622|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102389669|NCT03209622|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102389670|NCT03209622|Cholinergic Agents|cholinergic agents|mesh-ancestor
102389671|NCT03209622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102389672|NCT03209622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389673|NCT00099021|Pioglitazone|pioglitazone|mesh-list
102389674|NCT00099021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102389675|NCT00099021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389676|NCT00354874|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102389677|NCT00354874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101925557|NCT03858270|Memantine|memantine|mesh-list
102389678|NCT00354874|Autonomic Agents|autonomic agents|mesh-ancestor
102389679|NCT00354874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102389680|NCT00354874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389681|NCT00354874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102389682|NCT00354874|Respiratory System Agents|respiratory system agents|mesh-ancestor
102389683|NCT00354874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102389684|NCT00354874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102389685|NCT00354874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102389686|NCT00354874|Adrenergic Agents|adrenergic agents|mesh-ancestor
102389687|NCT00354874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102389688|NCT00354874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389689|NCT03209466|Chlorhexidine|chlorhexidine|mesh-list
102389690|NCT03209466|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102389691|NCT03209466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102389692|NCT03209466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102389693|NCT03209466|Disinfectants|disinfectants|mesh-ancestor
102389694|NCT03209466|Dermatologic Agents|dermatologic agents|mesh-ancestor
102389695|NCT03834688|Rituximab|rituximab|mesh-list
102389696|NCT03834688|Venetoclax|venetoclax|mesh-list
102389697|NCT03834688|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102389698|NCT03834688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102389699|NCT03834688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101925978|NCT01292694|Losartan|losartan|mesh-list
102389700|NCT03834688|Immunologic Factors|immunologic factors|mesh-ancestor
102389701|NCT03834688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389702|NCT03834688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102389703|NCT03834688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101926047|NCT03853200|Pentetic Acid|pentetic acid|mesh-list
102389704|NCT03834688|Alkylating Agents|alkylating agents|mesh-ancestor
102389705|NCT03834688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389706|NCT01710527|Metformin|metformin|mesh-list
102389707|NCT01710527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102389708|NCT01710527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389709|NCT00354952|Azithromycin|azithromycin|mesh-list
102389710|NCT00354952|Clarithromycin|clarithromycin|mesh-list
102389711|NCT00354952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102389712|NCT00354952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102389713|NCT00354952|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102389714|NCT00354952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102389715|NCT00354952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389716|NCT00354952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102389717|NCT00354952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102389719|NCT04943848|Vaccines|vaccines|mesh-list
102389720|NCT04943848|Immunologic Factors|immunologic factors|mesh-ancestor
102389721|NCT04943848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389722|NCT04943848|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102389723|NCT04943848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102389724|NCT04943848|Trace Elements|trace elements|mesh-ancestor
102389725|NCT04943848|Micronutrients|micronutrients|mesh-ancestor
102389726|NCT01706939|Carboplatin|carboplatin|mesh-list
102389727|NCT01706939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102389728|NCT04938232|Nivolumab|nivolumab|mesh-list
102389729|NCT04938232|Ipilimumab|ipilimumab|mesh-list
102389730|NCT04938232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102389731|NCT04938232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102389732|NCT04938232|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102389733|NCT04938232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389734|NCT03209232|Infliximab|infliximab|mesh-list
102389735|NCT03209232|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102389736|NCT03209232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102389737|NCT03209232|Dermatologic Agents|dermatologic agents|mesh-ancestor
102389738|NCT03209232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102389739|NCT03209232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102389740|NCT04485312|Chlorhexidine|chlorhexidine|mesh-list
102389741|NCT04485312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102389742|NCT04485312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102389743|NCT04485312|Disinfectants|disinfectants|mesh-ancestor
102389744|NCT01709903|Fluticasone|fluticasone|mesh-list
102389745|NCT01709903|Xhance|xhance|mesh-list
102389746|NCT01709903|Glycopyrrolate|glycopyrrolate|mesh-list
102389747|NCT01709903|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101926392|NCT05207644|Oxytocics|oxytocics|mesh-ancestor
102389748|NCT01709903|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102389749|NCT01709903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102389750|NCT01709903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101926482|NCT01197144|Adalimumab|adalimumab|mesh-list
102389751|NCT01709903|Autonomic Agents|autonomic agents|mesh-ancestor
102389752|NCT01709903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102389753|NCT01709903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389754|NCT01709903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102389755|NCT01709903|Respiratory System Agents|respiratory system agents|mesh-ancestor
102389756|NCT01709903|Dermatologic Agents|dermatologic agents|mesh-ancestor
102389757|NCT01709903|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102389758|NCT01709903|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102389759|NCT01709903|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102389760|NCT01709903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102389761|NCT01709903|Adrenergic Agents|adrenergic agents|mesh-ancestor
102389762|NCT01709903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102389763|NCT01709903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389764|NCT01709903|Glucocorticoids|glucocorticoids|mesh-ancestor
102389765|NCT01709903|Hormones|hormones|mesh-ancestor
102389766|NCT01709903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102389767|NCT01709903|Sympathomimetics|sympathomimetics|mesh-ancestor
102389768|NCT01709903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102389769|NCT01709903|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101926819|NCT01198860|Antioxidants|antioxidants|mesh-ancestor
102389770|NCT01709903|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102389771|NCT01709903|Cholinergic Agents|cholinergic agents|mesh-ancestor
102389772|NCT03202446|Cyclophosphamide|cyclophosphamide|mesh-list
102389773|NCT03202446|Chitosan|chitosan|mesh-list
102389774|NCT03202446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102389775|NCT03202446|Immunologic Factors|immunologic factors|mesh-ancestor
102389776|NCT03202446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389777|NCT03202446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102389778|NCT03202446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102389779|NCT03202446|Alkylating Agents|alkylating agents|mesh-ancestor
102389780|NCT03202446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389781|NCT03202446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102389782|NCT03202446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102389783|NCT03202446|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102389784|NCT03202446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102389785|NCT03202446|Antimetabolites|antimetabolites|mesh-ancestor
102389786|NCT03202446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102389787|NCT03202446|Chelating Agents|chelating agents|mesh-ancestor
102389788|NCT03202446|Sequestering Agents|sequestering agents|mesh-ancestor
102389789|NCT03202446|Hemostatics|hemostatics|mesh-ancestor
102389790|NCT03202446|Coagulants|coagulants|mesh-ancestor
102389791|NCT05718934|Glycopyrrolate|glycopyrrolate|mesh-list
102389792|NCT05718934|Neostigmine|neostigmine|mesh-list
102389793|NCT05718934|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102389794|NCT05718934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102389795|NCT05718934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389796|NCT05718934|Cholinergic Agents|cholinergic agents|mesh-ancestor
102389797|NCT05718934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102389798|NCT05718934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389799|NCT05718934|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102389800|NCT05718934|Autonomic Agents|autonomic agents|mesh-ancestor
102389801|NCT05718934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102389802|NCT05718934|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102389803|NCT05718934|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102389804|NCT05718934|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102389805|NCT03208764|Nitric Oxide|nitric oxide|mesh-list
102389806|NCT03208764|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102389807|NCT03208764|Autonomic Agents|autonomic agents|mesh-ancestor
102389808|NCT03208764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102389809|NCT03208764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389810|NCT03208764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102389811|NCT03208764|Respiratory System Agents|respiratory system agents|mesh-ancestor
102389812|NCT03208764|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102389813|NCT03208764|Antioxidants|antioxidants|mesh-ancestor
102389814|NCT03208764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389815|NCT03208764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101927156|NCT01204476|Everolimus|everolimus|mesh-list
102389816|NCT03208764|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102389817|NCT03208764|Vasodilator Agents|vasodilator agents|mesh-ancestor
102389818|NCT03208764|Gasotransmitters|gasotransmitters|mesh-ancestor
102389819|NCT03208764|Protective Agents|protective agents|mesh-ancestor
102389820|NCT03208998|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102389821|NCT03208998|Antiviral Agents|antiviral agents|mesh-ancestor
102389822|NCT03208998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102389823|NCT03208452|Magnesium Sulfate|magnesium sulfate|mesh-list
102389824|NCT03208452|Analgesics|analgesics|mesh-ancestor
102389825|NCT03208452|Sensory System Agents|sensory system agents|mesh-ancestor
102389826|NCT03208452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102389827|NCT03208452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389828|NCT03208452|Anesthetics|anesthetics|mesh-ancestor
102389829|NCT03208452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102389830|NCT03208452|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101927369|NCT03719586|Remdesivir|remdesivir|mesh-list
102389831|NCT03208452|Anticonvulsants|anticonvulsants|mesh-ancestor
102389832|NCT03208452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102389833|NCT03208452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101927441|NCT03816306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102389834|NCT03208452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389835|NCT03208452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102389836|NCT03208452|Tocolytic Agents|tocolytic agents|mesh-ancestor
102389837|NCT03208452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102389838|NCT05718310|Nitroglycerin|nitroglycerin|mesh-list
102389839|NCT05718310|Vasodilator Agents|vasodilator agents|mesh-ancestor
102389840|NCT03224208|Vemurafenib|vemurafenib|mesh-list
102389841|NCT03224208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102389842|NCT03224208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102389843|NCT03224208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102389844|NCT03224208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389845|NCT05718232|Lenvatinib|lenvatinib|mesh-list
102389846|NCT05718232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102389847|NCT05718232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102389848|NCT05718232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102389849|NCT05718232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389850|NCT00355966|Misoprostol|misoprostol|mesh-list
102389851|NCT00355966|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102389852|NCT00355966|Abortifacient Agents|abortifacient agents|mesh-ancestor
102389853|NCT00355966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102389854|NCT00355966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389855|NCT00355966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102389856|NCT00355966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102389857|NCT00355966|Oxytocics|oxytocics|mesh-ancestor
102389858|NCT03208218|Lenalidomide|lenalidomide|mesh-list
102389859|NCT03208218|Immunologic Factors|immunologic factors|mesh-ancestor
102389860|NCT03208218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389861|NCT03208218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102389862|NCT03208218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101927709|NCT03353350|Efpeglenatide|efpeglenatide|mesh-list
102389863|NCT03208218|Growth Substances|growth substances|mesh-ancestor
102389864|NCT03208218|Growth Inhibitors|growth inhibitors|mesh-ancestor
102389865|NCT03208218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102389866|NCT05372380|Atorvastatin|atorvastatin|mesh-list
102389867|NCT05372380|Ezetimibe|ezetimibe|mesh-list
102389868|NCT05372380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102389869|NCT05372380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102389870|NCT05372380|Antimetabolites|antimetabolites|mesh-ancestor
102389871|NCT05372380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389872|NCT05372380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102389873|NCT05372380|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102389874|NCT05372380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102389875|NCT02451774|Pentoxifylline|pentoxifylline|mesh-list
102389876|NCT02451774|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102389877|NCT02451774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102389878|NCT02451774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389879|NCT02451774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102389880|NCT02451774|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102389881|NCT02451774|Protective Agents|protective agents|mesh-ancestor
102389882|NCT02451774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389883|NCT02451774|Vasodilator Agents|vasodilator agents|mesh-ancestor
102389884|NCT02451774|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102389885|NCT02451774|Antioxidants|antioxidants|mesh-ancestor
102389886|NCT00355576|Minocycline|minocycline|mesh-list
102389887|NCT00355576|Celecoxib|celecoxib|mesh-list
102389888|NCT00355576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102389889|NCT00355576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102389890|NCT00355576|Analgesics|analgesics|mesh-ancestor
102389891|NCT00355576|Sensory System Agents|sensory system agents|mesh-ancestor
101927990|NCT01303926|Paclitaxel|paclitaxel|mesh-list
102389892|NCT00355576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102389893|NCT00355576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389894|NCT00355576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102389895|NCT00355576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102389896|NCT00355576|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102389897|NCT00355576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102389898|NCT00355576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101928125|NCT03792906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102389899|NCT00355576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389900|NCT00355576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102389901|NCT00355576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102389902|NCT03195582|Chlorhexidine|chlorhexidine|mesh-list
102389903|NCT03195582|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102389904|NCT03195582|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102389905|NCT03195582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102389906|NCT03195582|Disinfectants|disinfectants|mesh-ancestor
102389907|NCT03195582|Dermatologic Agents|dermatologic agents|mesh-ancestor
102389908|NCT02448264|Berotralstat|berotralstat|mesh-list
102389909|NCT02448264|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102389910|NCT02448264|Protease Inhibitors|protease inhibitors|mesh-ancestor
102389911|NCT02448264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102389912|NCT02448264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389913|NCT02451852|Osimertinib|osimertinib|mesh-list
102389914|NCT02451852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102389915|NCT02451852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102389916|NCT02451852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102389917|NCT02451852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389918|NCT00421642|Adalimumab|adalimumab|mesh-list
101928479|NCT01308684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102389919|NCT00421642|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102389920|NCT00421642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102389921|NCT00421642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102389922|NCT03200964|Anesthetics|anesthetics|mesh-list
102389923|NCT03200964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102389924|NCT03200964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389925|NCT04484844|Listerine|listerine|mesh-list
102389926|NCT04484844|Fluorides|fluorides|mesh-list
102389927|NCT04484844|Sodium Fluoride|sodium fluoride|mesh-list
102389928|NCT04484844|Cariostatic Agents|cariostatic agents|mesh-ancestor
102389929|NCT04484844|Protective Agents|protective agents|mesh-ancestor
102389930|NCT04484844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389931|NCT04484844|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102389932|NCT04484844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102389933|NCT03119454|Betamethasone|betamethasone|mesh-list
102389934|NCT03119454|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
101928845|NCT05305560|Ivermectin|ivermectin|mesh-list
102389935|NCT03119454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102389936|NCT03119454|Glucocorticoids|glucocorticoids|mesh-ancestor
102389937|NCT03119454|Hormones|hormones|mesh-ancestor
101928910|NCT05202496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389938|NCT03119454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102389939|NCT03119454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389940|NCT03119454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102201665|NCT04404062|Antibodies|antibodies|mesh-list
102389941|NCT03119454|Respiratory System Agents|respiratory system agents|mesh-ancestor
102389942|NCT04485156|Rifampin|rifampin|mesh-list
102389943|NCT04485156|Isoniazid|isoniazid|mesh-list
102389944|NCT04485156|Pyrazinamide|pyrazinamide|mesh-list
102389945|NCT04485156|Ethambutol|ethambutol|mesh-list
102389946|NCT04485156|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102389947|NCT04485156|Antitubercular Agents|antitubercular agents|mesh-ancestor
102389948|NCT04485156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102389949|NCT04485156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102389950|NCT04485156|Leprostatic Agents|leprostatic agents|mesh-ancestor
102389951|NCT04485156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102389952|NCT04485156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101928985|NCT03775746|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102389953|NCT04485156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389954|NCT04485156|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102389955|NCT04485156|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102389956|NCT04485156|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102389957|NCT04485156|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102389958|NCT04485156|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102389959|NCT04485156|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101929133|NCT04581148|Antibodies|antibodies|mesh-list
102389960|NCT04485156|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101929273|NCT03771222|Decitabine|decitabine|mesh-list
102389961|NCT04485156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102389962|NCT04485156|Antimetabolites|antimetabolites|mesh-ancestor
101929349|NCT03767322|Febuxostat|febuxostat|mesh-list
102389963|NCT04485156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102389964|NCT04637620|Sertraline|sertraline|mesh-list
102389965|NCT04637620|Antidepressive Agents|antidepressive agents|mesh-ancestor
102389966|NCT04637620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102389967|NCT04637620|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102389968|NCT04637620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102389969|NCT04637620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101929482|NCT03769818|Protease Inhibitors|protease inhibitors|mesh-ancestor
102389970|NCT04637620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389971|NCT04637620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102389972|NCT04637620|Serotonin Agents|serotonin agents|mesh-ancestor
102389973|NCT04637620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389974|NCT00355108|Tranexamic Acid|tranexamic acid|mesh-list
102389975|NCT00355108|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102389976|NCT00355108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102389977|NCT00355108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389978|NCT00355108|Hemostatics|hemostatics|mesh-ancestor
102389979|NCT00355108|Coagulants|coagulants|mesh-ancestor
101292115|NCT01960426|Adalimumab|adalimumab|mesh-list
102389980|NCT05271604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102389981|NCT05271604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389982|NCT05271604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102389983|NCT05271604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102389984|NCT04614766|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102389985|NCT04614766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102389986|NCT04614766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102389987|NCT03200886|Triamcinolone|triamcinolone|mesh-list
102389988|NCT03200886|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102389989|NCT03200886|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102389990|NCT03200886|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102389991|NCT03200886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102389992|NCT03200886|Glucocorticoids|glucocorticoids|mesh-ancestor
102389993|NCT03200886|Hormones|hormones|mesh-ancestor
102389994|NCT03200886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102389995|NCT03200886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102389996|NCT03200886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101929834|NCT04451330|Antimalarials|antimalarials|mesh-ancestor
102389997|NCT03200886|Immunologic Factors|immunologic factors|mesh-ancestor
102389998|NCT03200886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102389999|NCT03200886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390000|NCT05717764|Capecitabine|capecitabine|mesh-list
102390001|NCT05717764|Mitoxantrone|mitoxantrone|mesh-list
102390002|NCT05717764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102390003|NCT05717764|Antimetabolites|antimetabolites|mesh-ancestor
102390004|NCT05717764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390005|NCT05717764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102390006|NCT05717764|Analgesics|analgesics|mesh-ancestor
102390007|NCT05717764|Sensory System Agents|sensory system agents|mesh-ancestor
102390008|NCT05717764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102390009|NCT05717764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390010|NCT05717764|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102390011|NCT05717764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102390012|NCT05717764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102390013|NCT03118830|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102390014|NCT03118830|Cetrorelix|cetrorelix|mesh-list
102390015|NCT03118830|Hormones|hormones|mesh-list
102390016|NCT03118830|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102390017|NCT03118830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102390018|NCT03118830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390019|NCT03118830|Luteolytic Agents|luteolytic agents|mesh-ancestor
102390020|NCT03118830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102390021|NCT03118830|Contraceptive Agents|contraceptive agents|mesh-ancestor
102390022|NCT03118830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102390023|NCT03118830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102390024|NCT03118830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102390025|NCT03118830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102390026|NCT03118830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102390027|NCT03118830|Fertility Agents|fertility agents|mesh-ancestor
102390028|NCT03118830|Hormone Antagonists|hormone antagonists|mesh-ancestor
102390029|NCT03223506|Acetaminophen|acetaminophen|mesh-list
102390030|NCT03223506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102390031|NCT03223506|Analgesics|analgesics|mesh-ancestor
102390032|NCT03223506|Sensory System Agents|sensory system agents|mesh-ancestor
102390033|NCT03223506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102390034|NCT03223506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390035|NCT03223506|Antipyretics|antipyretics|mesh-ancestor
102390036|NCT04535362|Nicotine|nicotine|mesh-list
102390037|NCT04535362|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102390038|NCT04535362|Autonomic Agents|autonomic agents|mesh-ancestor
102390039|NCT04535362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102390040|NCT04535362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390041|NCT04535362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102390042|NCT04535362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102390043|NCT04535362|Cholinergic Agents|cholinergic agents|mesh-ancestor
102390044|NCT04535362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102390045|NCT04535362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390046|NCT03223896|Naloxone|naloxone|mesh-list
102390047|NCT03223896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102390048|NCT03223896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930098|NCT03757650|Antacids|antacids|mesh-ancestor
102390049|NCT03223896|Sensory System Agents|sensory system agents|mesh-ancestor
102390050|NCT03223896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102390051|NCT02447796|Dexmedetomidine|dexmedetomidine|mesh-list
102390052|NCT02447796|Propofol|propofol|mesh-list
102390053|NCT02447796|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102390054|NCT02447796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102390055|NCT02447796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930285|NCT03529942|FX006|fx006|mesh-list
102390056|NCT02447796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102390057|NCT02447796|Analgesics|analgesics|mesh-ancestor
102390058|NCT02447796|Sensory System Agents|sensory system agents|mesh-ancestor
102390059|NCT02447796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102390060|NCT02447796|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102390061|NCT02447796|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102390062|NCT02447796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102390063|NCT02447796|Adrenergic Agents|adrenergic agents|mesh-ancestor
101930444|NCT04676412|Pembrolizumab|pembrolizumab|mesh-list
102390064|NCT02447796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101930516|NCT05206318|Cysteamine|cysteamine|mesh-list
102390065|NCT02447796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390066|NCT02447796|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102390067|NCT02447796|Anesthetics, General|anesthetics, general|mesh-ancestor
102390068|NCT02447796|Anesthetics|anesthetics|mesh-ancestor
102390069|NCT05225116|Lenvatinib|lenvatinib|mesh-list
102390070|NCT05225116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102390071|NCT05225116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102390072|NCT05225116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102390073|NCT05225116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390074|NCT03838042|Nivolumab|nivolumab|mesh-list
102390075|NCT03838042|Entinostat|entinostat|mesh-list
102390076|NCT03838042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102390077|NCT03838042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102390078|NCT03838042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102390079|NCT03838042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390080|NCT03838042|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102390081|NCT03838042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102390082|NCT03200184|Sofosbuvir|sofosbuvir|mesh-list
102390083|NCT03200184|Antiviral Agents|antiviral agents|mesh-ancestor
102390084|NCT03200184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102390085|NCT03222960|Propolis|propolis|mesh-list
102390086|NCT03222960|Fluorides|fluorides|mesh-list
102390087|NCT03222960|Cariostatic Agents|cariostatic agents|mesh-ancestor
102390088|NCT03222960|Protective Agents|protective agents|mesh-ancestor
102390089|NCT03222960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390090|NCT03222960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102390091|NCT05681260|Cytarabine|cytarabine|mesh-list
102390092|NCT05681260|Dexamethasone|dexamethasone|mesh-list
102390093|NCT05681260|Dexamethasone acetate|dexamethasone acetate|mesh-list
102390094|NCT05681260|Prednisone|prednisone|mesh-list
102390095|NCT05681260|Cyclophosphamide|cyclophosphamide|mesh-list
102390096|NCT05681260|Ifosfamide|ifosfamide|mesh-list
102390097|NCT05681260|Doxorubicin|doxorubicin|mesh-list
102390098|NCT05681260|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102390099|NCT05681260|Methotrexate|methotrexate|mesh-list
102390100|NCT05681260|Etoposide|etoposide|mesh-list
102390101|NCT05681260|Vincristine|vincristine|mesh-list
102390102|NCT05681260|Bortezomib|bortezomib|mesh-list
102390103|NCT05681260|Daunorubicin|daunorubicin|mesh-list
102390104|NCT05681260|Asparaginase|asparaginase|mesh-list
102390105|NCT05681260|Mercaptopurine|mercaptopurine|mesh-list
102390106|NCT05681260|Vindesine|vindesine|mesh-list
102390107|NCT05681260|Pegaspargase|pegaspargase|mesh-list
102390108|NCT05681260|BB 1101|bb 1101|mesh-list
102390109|NCT05681260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102390110|NCT05681260|Immunologic Factors|immunologic factors|mesh-ancestor
102390111|NCT05681260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390112|NCT05681260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102390113|NCT05681260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102390114|NCT05681260|Alkylating Agents|alkylating agents|mesh-ancestor
102390115|NCT05681260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390116|NCT05681260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102390117|NCT05681260|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102390118|NCT05681260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102390119|NCT05681260|Antiemetics|antiemetics|mesh-ancestor
102390120|NCT05681260|Autonomic Agents|autonomic agents|mesh-ancestor
102390121|NCT05681260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101931163|NCT04399122|Antipyretics|antipyretics|mesh-ancestor
102390122|NCT05681260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102390123|NCT05681260|Glucocorticoids|glucocorticoids|mesh-ancestor
102390124|NCT05681260|Hormones|hormones|mesh-ancestor
101931216|NCT04322682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102390125|NCT05681260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101931290|NCT04249258|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102390126|NCT05681260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102390127|NCT05681260|Protease Inhibitors|protease inhibitors|mesh-ancestor
102390128|NCT05681260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102390129|NCT05681260|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102390130|NCT05681260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102390131|NCT05681260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102390132|NCT05681260|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102390133|NCT05681260|Abortifacient Agents|abortifacient agents|mesh-ancestor
101931515|NCT03745586|Hormones|hormones|mesh-ancestor
102390134|NCT05681260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102390135|NCT05681260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102390136|NCT05681260|Antimetabolites|antimetabolites|mesh-ancestor
102390137|NCT05681260|Dermatologic Agents|dermatologic agents|mesh-ancestor
102390138|NCT05681260|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102390139|NCT05681260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102390140|NCT05681260|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102390141|NCT05681260|Antiviral Agents|antiviral agents|mesh-ancestor
102390142|NCT05681260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102390143|NCT05681260|Tubulin Modulators|tubulin modulators|mesh-ancestor
102390144|NCT05681260|Antimitotic Agents|antimitotic agents|mesh-ancestor
102390145|NCT05681260|Mitosis Modulators|mitosis modulators|mesh-ancestor
102390146|NCT03193086|Alemtuzumab|alemtuzumab|mesh-list
102390147|NCT03193086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102390148|NCT03193086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102390149|NCT03199950|Haloperidol|haloperidol|mesh-list
102390150|NCT03199950|Haloperidol decanoate|haloperidol decanoate|mesh-list
102390151|NCT03199950|Antiemetics|antiemetics|mesh-ancestor
102390152|NCT03199950|Autonomic Agents|autonomic agents|mesh-ancestor
102390153|NCT03199950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101931589|NCT02335060|Hormones|hormones|mesh-ancestor
102390154|NCT03199950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390155|NCT03199950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101931641|NCT01495676|Antimetabolites|antimetabolites|mesh-ancestor
102390156|NCT03199950|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102390157|NCT03199950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102390158|NCT03199950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102390159|NCT03199950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102390160|NCT03199950|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102390161|NCT03199950|Dopamine Agents|dopamine agents|mesh-ancestor
102390162|NCT03199950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102390163|NCT03199950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390164|NCT03199950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102390165|NCT05156632|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102390166|NCT05156632|Vaccines|vaccines|mesh-list
102390167|NCT05156632|Immunologic Factors|immunologic factors|mesh-ancestor
102390168|NCT05156632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390169|NCT05156632|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102390170|NCT05156632|Antacids|antacids|mesh-ancestor
102390171|NCT05156632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390172|NCT05156632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102390173|NCT03118362|Plasma-lyte 148|plasma-lyte 148|mesh-list
102390174|NCT03118362|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102390175|NCT03118362|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102390176|NCT02447016|Tenofovir|tenofovir|mesh-list
102390177|NCT02447016|Emtricitabine|emtricitabine|mesh-list
102390178|NCT02447016|Efavirenz|efavirenz|mesh-list
102390179|NCT02447016|Rilpivirine|rilpivirine|mesh-list
102390180|NCT02447016|Antiviral Agents|antiviral agents|mesh-ancestor
102390181|NCT02447016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102390182|NCT02447016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101931990|NCT05598424|Antiemetics|antiemetics|mesh-ancestor
102390183|NCT02447016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102390184|NCT02447016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102390185|NCT02447016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390186|NCT02447016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102390187|NCT02447016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102390188|NCT02447016|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101932136|NCT04049552|Sirolimus|sirolimus|mesh-list
102390189|NCT02447016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102390190|NCT02447016|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102390191|NCT02447016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102390192|NCT02447016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102390193|NCT02447016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102390194|NCT02447094|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102390195|NCT02447094|Plasminogen|plasminogen|mesh-list
102390196|NCT02447094|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102390197|NCT02447094|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102390198|NCT02447094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390199|NCT02446860|Nivolumab|nivolumab|mesh-list
102390200|NCT02446860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102390201|NCT02446860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102390202|NCT02446860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102390203|NCT02446860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390204|NCT02449746|Immunoglobulins|immunoglobulins|mesh-list
102390205|NCT02449746|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102390206|NCT02449746|Antibodies|antibodies|mesh-list
102390207|NCT02449746|gamma-Globulins|gamma-globulins|mesh-list
102390208|NCT02449746|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102390209|NCT02449746|Immunologic Factors|immunologic factors|mesh-ancestor
102390210|NCT02449746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390211|NCT02446782|Clindamycin|clindamycin|mesh-list
102390212|NCT02446782|Cefazolin|cefazolin|mesh-list
102390213|NCT02446782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102390214|NCT02446782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102390215|NCT02446782|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102390216|NCT02446782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101932571|NCT00745108|Anabolic Agents|anabolic agents|mesh-ancestor
102390217|NCT02446782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390218|NCT04745260|Fentanyl|fentanyl|mesh-list
102390219|NCT04745260|Midazolam|midazolam|mesh-list
102390220|NCT04745260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102390221|NCT04745260|Narcotics|narcotics|mesh-ancestor
102390222|NCT04745260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102390223|NCT04745260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390224|NCT04745260|Analgesics|analgesics|mesh-ancestor
102390225|NCT04745260|Sensory System Agents|sensory system agents|mesh-ancestor
102390226|NCT04745260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102390227|NCT04745260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102390228|NCT04745260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102390229|NCT04745260|Anesthetics, General|anesthetics, general|mesh-ancestor
102390230|NCT04745260|Anesthetics|anesthetics|mesh-ancestor
102390231|NCT04745260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102390232|NCT04745260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102390233|NCT04745260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102390234|NCT04745260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102390235|NCT04745260|GABA Modulators|gaba modulators|mesh-ancestor
102390236|NCT04745260|GABA Agents|gaba agents|mesh-ancestor
102390237|NCT04745260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101932687|NCT03620708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102390238|NCT04745260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390239|NCT03199482|Dexamethasone|dexamethasone|mesh-list
102390240|NCT03199482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102390241|NCT03199482|Antiemetics|antiemetics|mesh-ancestor
102390242|NCT03199482|Autonomic Agents|autonomic agents|mesh-ancestor
102390243|NCT03199482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102390244|NCT03199482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390245|NCT03199482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102390246|NCT03199482|Glucocorticoids|glucocorticoids|mesh-ancestor
102390247|NCT03199482|Hormones|hormones|mesh-ancestor
101932832|NCT04021524|Dermatologic Agents|dermatologic agents|mesh-ancestor
102390248|NCT03199482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102390249|NCT03199482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102390250|NCT03199482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102390251|NCT02446704|Temozolomide|temozolomide|mesh-list
102390252|NCT02446704|Olaparib|olaparib|mesh-list
102390253|NCT02446704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102390254|NCT02446704|Alkylating Agents|alkylating agents|mesh-ancestor
102390255|NCT02446704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390256|NCT02446704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102390257|NCT02446704|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102390258|NCT02446704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102390259|NCT01605227|Prednisone|prednisone|mesh-list
102390260|NCT01605227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102390261|NCT01605227|Glucocorticoids|glucocorticoids|mesh-ancestor
102390262|NCT01605227|Hormones|hormones|mesh-ancestor
102390263|NCT01605227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102390264|NCT01605227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390265|NCT01605227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102390266|NCT01605227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102390267|NCT02446548|Losartan|losartan|mesh-list
102390268|NCT02446548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102390269|NCT02446548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102390270|NCT02446548|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102390271|NCT02446548|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102390272|NCT02446548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390273|NCT04291768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102390274|NCT04291768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102390275|NCT04291768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102390276|NCT04291768|Antitubercular Agents|antitubercular agents|mesh-ancestor
102390277|NCT03199170|Morphine|morphine|mesh-list
102390278|NCT03199170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102390279|NCT03199170|Narcotics|narcotics|mesh-ancestor
102390280|NCT03199170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102390281|NCT03199170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390282|NCT03199170|Analgesics|analgesics|mesh-ancestor
102390283|NCT03199170|Sensory System Agents|sensory system agents|mesh-ancestor
102390284|NCT03199170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102390285|NCT03118128|Metformin|metformin|mesh-list
102390286|NCT03118128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102390287|NCT03118128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390288|NCT05100472|Androgens|androgens|mesh-list
102390289|NCT05100472|Hormones|hormones|mesh-ancestor
101933080|NCT03053362|Serotonin Agents|serotonin agents|mesh-ancestor
102390290|NCT05100472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102390291|NCT05100472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390292|NCT05087914|Naproxen|naproxen|mesh-list
102390293|NCT05087914|Levodopa|levodopa|mesh-list
102390294|NCT05087914|Carbidopa|carbidopa|mesh-list
102390295|NCT05087914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102390296|NCT05087914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102390297|NCT05087914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102390298|NCT05087914|Analgesics|analgesics|mesh-ancestor
102390299|NCT05087914|Sensory System Agents|sensory system agents|mesh-ancestor
102390300|NCT05087914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102390301|NCT05087914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390302|NCT05087914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102390303|NCT05087914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102390304|NCT05087914|Gout Suppressants|gout suppressants|mesh-ancestor
102390305|NCT05087914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102390306|NCT05087914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102390307|NCT05087914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390308|NCT05087914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102390309|NCT05087914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102390310|NCT05087914|Dopamine Agents|dopamine agents|mesh-ancestor
102390311|NCT05087914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102390312|NCT05087914|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102390313|NCT05087914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102390314|NCT05087914|Immunologic Factors|immunologic factors|mesh-ancestor
102390315|NCT05087914|Dopamine Agonists|dopamine agonists|mesh-ancestor
102390316|NCT03194724|Vitamin A|vitamin a|mesh-list
102390317|NCT03194724|Vitamins|vitamins|mesh-ancestor
102390318|NCT03194724|Micronutrients|micronutrients|mesh-ancestor
102202040|NCT01565499|Paclitaxel|paclitaxel|mesh-list
102390319|NCT03194724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390320|NCT03198702|Botulinum Toxins|botulinum toxins|mesh-list
102390321|NCT03198702|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102390322|NCT03198702|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102390323|NCT03198702|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102390324|NCT03198702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102390325|NCT03198702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390326|NCT03198702|Cholinergic Agents|cholinergic agents|mesh-ancestor
102390327|NCT03198702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102390328|NCT03198702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390329|NCT03198702|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102390330|NCT03198702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102390331|NCT01709513|Atorvastatin|atorvastatin|mesh-list
102390332|NCT01709513|Ezetimibe|ezetimibe|mesh-list
102390333|NCT01709513|Alirocumab|alirocumab|mesh-list
102390334|NCT01709513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102390335|NCT01709513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102390336|NCT01709513|Antimetabolites|antimetabolites|mesh-ancestor
102390337|NCT01709513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390338|NCT01709513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102390339|NCT01709513|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102390340|NCT01709513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102390341|NCT01709513|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102390342|NCT01709513|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102390343|NCT01709513|Protease Inhibitors|protease inhibitors|mesh-ancestor
102390344|NCT02446158|Chlorhexidine|chlorhexidine|mesh-list
102390345|NCT02446158|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102390346|NCT02446158|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102390347|NCT02446158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102390348|NCT02446158|Disinfectants|disinfectants|mesh-ancestor
102390349|NCT02446158|Dermatologic Agents|dermatologic agents|mesh-ancestor
102390350|NCT02446002|Lofexidine|lofexidine|mesh-list
102390351|NCT02446002|Clonidine|clonidine|mesh-list
102390352|NCT02446002|Naltrexone|naltrexone|mesh-list
102390353|NCT02446002|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102390354|NCT02446002|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102390355|NCT02446002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933691|NCT01090713|Dopamine Agents|dopamine agents|mesh-ancestor
102390356|NCT02446002|Sensory System Agents|sensory system agents|mesh-ancestor
102390357|NCT02446002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102390358|NCT02446002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102390359|NCT02446002|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102390360|NCT02446002|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102390361|NCT02446002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102390362|NCT02446002|Adrenergic Agents|adrenergic agents|mesh-ancestor
102390363|NCT02446002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102390364|NCT02446002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390365|NCT02446002|Analgesics|analgesics|mesh-ancestor
102390366|NCT02446002|Sympatholytics|sympatholytics|mesh-ancestor
102390367|NCT02446002|Autonomic Agents|autonomic agents|mesh-ancestor
102390368|NCT01605071|Estradiol|estradiol|mesh-list
102390369|NCT01605071|Estrogens|estrogens|mesh-ancestor
102390370|NCT01605071|Hormones|hormones|mesh-ancestor
102390371|NCT01605071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102390372|NCT01605071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390373|NCT04345198|Epinephrine|epinephrine|mesh-list
102390374|NCT04345198|Racepinephrine|racepinephrine|mesh-list
102390375|NCT04345198|Epinephryl borate|epinephryl borate|mesh-list
102390376|NCT04345198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102390377|NCT04345198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102390378|NCT04345198|Adrenergic Agents|adrenergic agents|mesh-ancestor
102390379|NCT04345198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102390380|NCT04345198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390381|NCT04345198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390382|NCT04345198|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102390383|NCT04345198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102390384|NCT04345198|Autonomic Agents|autonomic agents|mesh-ancestor
102390385|NCT04345198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102390386|NCT04345198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102390387|NCT04345198|Respiratory System Agents|respiratory system agents|mesh-ancestor
102390388|NCT04345198|Mydriatics|mydriatics|mesh-ancestor
102390389|NCT04345198|Sympathomimetics|sympathomimetics|mesh-ancestor
102390390|NCT04345198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102390391|NCT03192618|Leucovorin|leucovorin|mesh-list
102390392|NCT03192618|Oxaliplatin|oxaliplatin|mesh-list
102390393|NCT03192618|Calcium|calcium|mesh-list
102390394|NCT03192618|Levoleucovorin|levoleucovorin|mesh-list
101934190|NCT01094535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390395|NCT03192618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102390396|NCT03192618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390397|NCT03192618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102390399|NCT03192618|Protective Agents|protective agents|mesh-ancestor
102390400|NCT03192618|Vitamin B Complex|vitamin b complex|mesh-ancestor
102390401|NCT03192618|Vitamins|vitamins|mesh-ancestor
102390402|NCT03192618|Micronutrients|micronutrients|mesh-ancestor
102390403|NCT04113226|Rituximab|rituximab|mesh-list
102390404|NCT04113226|Lenalidomide|lenalidomide|mesh-list
101934409|NCT01310244|Paclitaxel|paclitaxel|mesh-list
102390405|NCT04113226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102390406|NCT04113226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102390407|NCT04113226|Immunologic Factors|immunologic factors|mesh-ancestor
102390408|NCT04113226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390409|NCT04113226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102390410|NCT04113226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102390411|NCT04113226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102390412|NCT04113226|Growth Substances|growth substances|mesh-ancestor
102390413|NCT04113226|Growth Inhibitors|growth inhibitors|mesh-ancestor
102390414|NCT02444364|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102390415|NCT02444364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102390416|NCT02444364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390417|NCT02444364|Incretins|incretins|mesh-ancestor
102390418|NCT02444364|Hormones|hormones|mesh-ancestor
102390419|NCT02444364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102390420|NCT02444364|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102390421|NCT02444364|Protease Inhibitors|protease inhibitors|mesh-ancestor
102390422|NCT02444364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102390423|NCT02444364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390424|NCT05039476|Vitamin A|vitamin a|mesh-list
102390425|NCT05039476|Vitamins|vitamins|mesh-ancestor
102390426|NCT05039476|Micronutrients|micronutrients|mesh-ancestor
102390427|NCT05039476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390428|NCT00356356|Etanercept|etanercept|mesh-list
102390429|NCT00356356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102390430|NCT00356356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102390431|NCT00356356|Analgesics|analgesics|mesh-ancestor
102390432|NCT00356356|Sensory System Agents|sensory system agents|mesh-ancestor
102390433|NCT00356356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102390434|NCT00356356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390435|NCT00356356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102390436|NCT00356356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102390437|NCT00356356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102390438|NCT00356356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102390439|NCT00356356|Immunologic Factors|immunologic factors|mesh-ancestor
102390440|NCT02443818|Sirolimus|sirolimus|mesh-list
102390441|NCT02443818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102390442|NCT02443818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102390443|NCT02443818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102390444|NCT02443818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102390445|NCT02443818|Antifungal Agents|antifungal agents|mesh-ancestor
101934610|NCT03731286|Caffeine|caffeine|mesh-list
101934678|NCT03428360|Diazepam|diazepam|mesh-list
102390446|NCT02443818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102390447|NCT02443818|Immunologic Factors|immunologic factors|mesh-ancestor
102390448|NCT02443818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390449|NCT01705691|Paclitaxel|paclitaxel|mesh-list
102390450|NCT01705691|Cyclophosphamide|cyclophosphamide|mesh-list
102390451|NCT01705691|Doxorubicin|doxorubicin|mesh-list
102390452|NCT01705691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102390453|NCT01705691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102390454|NCT01705691|Tubulin Modulators|tubulin modulators|mesh-ancestor
102390455|NCT01705691|Antimitotic Agents|antimitotic agents|mesh-ancestor
102390456|NCT01705691|Mitosis Modulators|mitosis modulators|mesh-ancestor
102390457|NCT01705691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390458|NCT01705691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102390459|NCT01705691|Immunologic Factors|immunologic factors|mesh-ancestor
102390460|NCT01705691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390461|NCT01705691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102390462|NCT01705691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102390463|NCT01705691|Alkylating Agents|alkylating agents|mesh-ancestor
101935109|NCT01098201|Certolizumab Pegol|certolizumab pegol|mesh-list
102390464|NCT01705691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102390465|NCT01705691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102390466|NCT01705691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102390467|NCT01705691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101935182|NCT03028012|Dexamethasone|dexamethasone|mesh-list
102390468|NCT01705691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102390469|NCT02450058|Paclitaxel|paclitaxel|mesh-list
102390470|NCT02450058|Cyclophosphamide|cyclophosphamide|mesh-list
102390471|NCT02450058|Fluorouracil|fluorouracil|mesh-list
102390472|NCT02450058|Epirubicin|epirubicin|mesh-list
102390473|NCT02450058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102390474|NCT02450058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102390475|NCT02450058|Tubulin Modulators|tubulin modulators|mesh-ancestor
102390476|NCT02450058|Antimitotic Agents|antimitotic agents|mesh-ancestor
102390477|NCT02450058|Mitosis Modulators|mitosis modulators|mesh-ancestor
102390478|NCT02450058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390479|NCT02450058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102390480|NCT02450058|Immunologic Factors|immunologic factors|mesh-ancestor
101935250|NCT03502070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102390481|NCT02450058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390482|NCT02450058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102390483|NCT02450058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102390484|NCT02450058|Alkylating Agents|alkylating agents|mesh-ancestor
102390485|NCT02450058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102390486|NCT02450058|Antimetabolites|antimetabolites|mesh-ancestor
102390487|NCT02450058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102390488|NCT02450058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102390489|NCT02450058|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102390490|NCT02450058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101935380|NCT03682198|Sympathomimetics|sympathomimetics|mesh-ancestor
102390491|NCT02450058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102390492|NCT02445300|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102390493|NCT02445300|Laxatives|laxatives|mesh-ancestor
102390494|NCT02445300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102390495|NCT02445066|Vitamin D|vitamin d|mesh-list
102390496|NCT02445066|Cholecalciferol|cholecalciferol|mesh-list
102390497|NCT02445066|Vitamins|vitamins|mesh-ancestor
102390498|NCT02445066|Micronutrients|micronutrients|mesh-ancestor
102390499|NCT02445066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390500|NCT02445066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102390501|NCT02445066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102390502|NCT03197298|Clopidogrel|clopidogrel|mesh-list
102390503|NCT03197298|Ticagrelor|ticagrelor|mesh-list
102390504|NCT03197298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101935589|NCT03679780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102390505|NCT03197298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102390506|NCT03197298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102390507|NCT03197298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102390508|NCT03197298|Purinergic Agents|purinergic agents|mesh-ancestor
102390509|NCT03197298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102390510|NCT03197298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390511|NCT03197298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390512|NCT00357448|Interleukin-2|interleukin-2|mesh-list
102390513|NCT00357448|Denileukin diftitox|denileukin diftitox|mesh-list
102390514|NCT00357448|Immunotoxins|immunotoxins|mesh-list
102390515|NCT00357448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102390516|NCT00357448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102390517|NCT00357448|Analgesics|analgesics|mesh-ancestor
102390518|NCT00357448|Sensory System Agents|sensory system agents|mesh-ancestor
102390519|NCT00357448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102390520|NCT00357448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390521|NCT00357448|Immunoconjugates|immunoconjugates|mesh-ancestor
102390522|NCT00357448|Immunologic Factors|immunologic factors|mesh-ancestor
102390523|NCT05715658|Dabigatran|dabigatran|mesh-list
102390524|NCT05715658|Antithrombins|antithrombins|mesh-ancestor
102390525|NCT05715658|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102390526|NCT05715658|Protease Inhibitors|protease inhibitors|mesh-ancestor
102390527|NCT05715658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102390528|NCT05715658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390529|NCT05715658|Anticoagulants|anticoagulants|mesh-ancestor
102390530|NCT02443194|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102390531|NCT02443194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102390532|NCT02443194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102390533|NCT02443194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102390534|NCT02443194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390535|NCT02443194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102390536|NCT02443194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390537|NCT02443194|Analgesics|analgesics|mesh-ancestor
102390538|NCT02443194|Sensory System Agents|sensory system agents|mesh-ancestor
102390539|NCT02443194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102390540|NCT02443194|Antidepressive Agents|antidepressive agents|mesh-ancestor
102390541|NCT02443194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102390542|NCT02443194|Dopamine Agents|dopamine agents|mesh-ancestor
102390543|NCT03193944|Vitamin D|vitamin d|mesh-list
102390544|NCT03193944|Ergocalciferols|ergocalciferols|mesh-list
102390545|NCT03193944|Cholecalciferol|cholecalciferol|mesh-list
102390546|NCT03193944|Vitamins|vitamins|mesh-list
102390547|NCT03193944|Micronutrients|micronutrients|mesh-ancestor
102390548|NCT03193944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390549|NCT03193944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102390550|NCT03193944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102390551|NCT00357604|Ritonavir|ritonavir|mesh-list
102390552|NCT00357604|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101935666|NCT03680404|Tempol|tempol|mesh-list
102390553|NCT00357604|Moxifloxacin|moxifloxacin|mesh-list
102390554|NCT00357604|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102390555|NCT00357604|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102390556|NCT00357604|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102390557|NCT00357604|Norgestimate|norgestimate|mesh-list
102390558|NCT00357604|Norgestrel|norgestrel|mesh-list
102390559|NCT00357604|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102390560|NCT00357604|Estradiol|estradiol|mesh-list
102390561|NCT00357604|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102390562|NCT00357604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102390563|NCT00357604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102390564|NCT00357604|Protease Inhibitors|protease inhibitors|mesh-ancestor
102390565|NCT00357604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102390566|NCT00357604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390567|NCT00357604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102390568|NCT00357604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102390569|NCT00357604|Antiviral Agents|antiviral agents|mesh-ancestor
102390570|NCT00357604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102390571|NCT00357604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102390572|NCT00357604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102390573|NCT00357604|Estrogens|estrogens|mesh-ancestor
102390574|NCT00357604|Hormones|hormones|mesh-ancestor
102390575|NCT00357604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102390576|NCT00357604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390577|NCT00357604|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102390578|NCT00357604|Contraceptive Agents|contraceptive agents|mesh-ancestor
102390579|NCT00357604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102390580|NCT00357604|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102390581|NCT00357604|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102390582|NCT00357604|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102390583|NCT00357604|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102390584|NCT00357604|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102390585|NCT00357604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102390586|NCT00357604|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102390587|NCT00357604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102390588|NCT00357604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102390589|NCT03193788|Folic Acid|folic acid|mesh-list
102390590|NCT03193788|Vitamin B 12|vitamin b 12|mesh-list
102390591|NCT03193788|Dexamethasone|dexamethasone|mesh-list
102390592|NCT03193788|Pemetrexed|pemetrexed|mesh-list
102390593|NCT03193788|Vitamins|vitamins|mesh-ancestor
102390594|NCT03193788|Micronutrients|micronutrients|mesh-ancestor
102390595|NCT03193788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390596|NCT03193788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102390597|NCT03193788|Antiemetics|antiemetics|mesh-ancestor
102390598|NCT03193788|Autonomic Agents|autonomic agents|mesh-ancestor
102390599|NCT03193788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102390600|NCT03193788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102390601|NCT03193788|Glucocorticoids|glucocorticoids|mesh-ancestor
102390602|NCT03193788|Hormones|hormones|mesh-ancestor
102390603|NCT03193788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102390604|NCT03193788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102390605|NCT03193788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102390606|NCT03193788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102390607|NCT03193788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390608|NCT03193788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102390609|NCT03193788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102390610|NCT03193788|Hematinics|hematinics|mesh-ancestor
102390611|NCT03193788|Vitamin B Complex|vitamin b complex|mesh-ancestor
102390612|NCT02442648|Rituximab|rituximab|mesh-list
102390613|NCT02442648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102390614|NCT02442648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102390615|NCT02442648|Immunologic Factors|immunologic factors|mesh-ancestor
102390616|NCT02442648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390617|NCT02442648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102390618|NCT00356824|Artesunate|artesunate|mesh-list
102390619|NCT00356824|Amodiaquine|amodiaquine|mesh-list
102390620|NCT00356824|Antimalarials|antimalarials|mesh-ancestor
102390621|NCT00356824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102390622|NCT00356824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102390623|NCT00356824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102390624|NCT00356824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102390625|NCT00356824|Antiviral Agents|antiviral agents|mesh-ancestor
102390626|NCT00356824|Schistosomicides|schistosomicides|mesh-ancestor
102390627|NCT00356824|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102390628|NCT00356824|Anthelmintics|anthelmintics|mesh-ancestor
102390629|NCT01705145|Ivacaftor|ivacaftor|mesh-list
102390630|NCT01705145|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102390631|NCT01705145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101935926|NCT03675646|Narcotics|narcotics|mesh-ancestor
102390632|NCT01705145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390633|NCT03716934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
102390634|NCT04483830|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
102390635|NCT04483830|Anticoagulants|anticoagulants|mesh-ancestor
102390636|NCT04483830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102390637|NCT04483830|Antimetabolites|antimetabolites|mesh-ancestor
102390638|NCT04483830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390639|NCT04483830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102390640|NCT04483830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102390641|NCT04483830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102390642|NCT04483830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102390643|NCT04483830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390644|NCT02442492|Sildenafil Citrate|sildenafil citrate|mesh-list
102390645|NCT02442492|Vasodilator Agents|vasodilator agents|mesh-ancestor
102390646|NCT02442492|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102390647|NCT02442492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102390648|NCT02442492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102390649|NCT02442492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390650|NCT02442492|Urological Agents|urological agents|mesh-ancestor
102390651|NCT01704755|Ribavirin|ribavirin|mesh-list
102390652|NCT01704755|Antimetabolites|antimetabolites|mesh-ancestor
102390653|NCT01704755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390654|NCT01704755|Antiviral Agents|antiviral agents|mesh-ancestor
102390655|NCT01704755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102390656|NCT05165550|Elsulfavirine|elsulfavirine|mesh-list
102390657|NCT05165550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102390658|NCT05165550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102390659|NCT05165550|Antiviral Agents|antiviral agents|mesh-ancestor
102390660|NCT05165550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102390661|NCT04166669|Itraconazole|itraconazole|mesh-list
102390662|NCT04166669|Rifampin|rifampin|mesh-list
102390663|NCT04166669|Antifungal Agents|antifungal agents|mesh-ancestor
102390664|NCT04166669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102390665|NCT04166669|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102390666|NCT04166669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102390667|NCT04166669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102390668|NCT04166669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390669|NCT04166669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102390670|NCT04166669|Hormone Antagonists|hormone antagonists|mesh-ancestor
102390671|NCT04166669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102390672|NCT04166669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390673|NCT04166669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102390674|NCT04166669|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102390675|NCT04166669|Antitubercular Agents|antitubercular agents|mesh-ancestor
102390676|NCT04166669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102390677|NCT04166669|Leprostatic Agents|leprostatic agents|mesh-ancestor
102390678|NCT04166669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102390679|NCT04166669|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102390680|NCT04166669|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102390681|NCT04166669|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102390682|NCT04166669|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102390683|NCT04166669|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102390684|NCT04166669|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102390685|NCT03193710|Remifentanil|remifentanil|mesh-list
102390686|NCT03193710|Propofol|propofol|mesh-list
102390687|NCT03193710|Sevoflurane|sevoflurane|mesh-list
102390688|NCT03193710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102390689|NCT03193710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102390690|NCT03193710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390691|NCT03193710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102390692|NCT03193710|Anesthetics, General|anesthetics, general|mesh-ancestor
102390693|NCT03193710|Anesthetics|anesthetics|mesh-ancestor
102390694|NCT03193710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102390695|NCT03193710|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102390696|NCT03193710|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102390697|NCT03193710|Narcotics|narcotics|mesh-ancestor
102390698|NCT03193710|Analgesics|analgesics|mesh-ancestor
102390699|NCT03193710|Sensory System Agents|sensory system agents|mesh-ancestor
102390700|NCT03193710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102390701|NCT01704599|Vitamins|vitamins|mesh-list
102390702|NCT01704599|Folic Acid|folic acid|mesh-list
102390703|NCT01704599|Vitamin B 12|vitamin b 12|mesh-list
102390704|NCT01704599|Pyridoxine|pyridoxine|mesh-list
102390705|NCT01704599|Vitamin B 6|vitamin b 6|mesh-list
102390706|NCT01704599|Vitamin B Complex|vitamin b complex|mesh-list
102390707|NCT01704599|Adalimumab|adalimumab|mesh-list
102390708|NCT01704599|Micronutrients|micronutrients|mesh-ancestor
102390709|NCT01704599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390710|NCT01704599|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102390711|NCT01704599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102390712|NCT01704599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102390713|NCT01704599|Hematinics|hematinics|mesh-ancestor
102390714|NCT03196362|Metformin|metformin|mesh-list
102390715|NCT03196362|Pioglitazone|pioglitazone|mesh-list
102390716|NCT03196362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102390717|NCT03196362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390718|NCT02449278|Prednisone|prednisone|mesh-list
102390719|NCT02449278|Cyclophosphamide|cyclophosphamide|mesh-list
102390720|NCT02449278|Doxorubicin|doxorubicin|mesh-list
102390721|NCT02449278|Vincristine|vincristine|mesh-list
102390722|NCT02449278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102390723|NCT02449278|Immunologic Factors|immunologic factors|mesh-ancestor
102390724|NCT02449278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390725|NCT02449278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102390726|NCT02449278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102390727|NCT02449278|Alkylating Agents|alkylating agents|mesh-ancestor
102390728|NCT02449278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390729|NCT02449278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102390730|NCT02449278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102390731|NCT02449278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102390732|NCT02449278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102390733|NCT02449278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102390734|NCT02449278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102390735|NCT02449278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102390736|NCT02449278|Glucocorticoids|glucocorticoids|mesh-ancestor
102390737|NCT02449278|Hormones|hormones|mesh-ancestor
102390738|NCT02449278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101936805|NCT03003676|Pembrolizumab|pembrolizumab|mesh-list
102390739|NCT02449278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102390740|NCT02449278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102390741|NCT02449278|Tubulin Modulators|tubulin modulators|mesh-ancestor
102390742|NCT02449278|Antimitotic Agents|antimitotic agents|mesh-ancestor
102390743|NCT02449278|Mitosis Modulators|mitosis modulators|mesh-ancestor
102390744|NCT03599518|Gefitinib|gefitinib|mesh-list
102390745|NCT03599518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102390746|NCT03599518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102390747|NCT03599518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102390748|NCT03599518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390749|NCT03099486|Leucovorin|leucovorin|mesh-list
102390750|NCT03099486|Antidotes|antidotes|mesh-ancestor
102390751|NCT03099486|Protective Agents|protective agents|mesh-ancestor
102390752|NCT03099486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390753|NCT03099486|Vitamin B Complex|vitamin b complex|mesh-ancestor
102390754|NCT03099486|Vitamins|vitamins|mesh-ancestor
102390755|NCT03099486|Micronutrients|micronutrients|mesh-ancestor
102390756|NCT00358228|Rimonabant|rimonabant|mesh-list
102390757|NCT00358228|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101936873|NCT02911948|Insulin, Long-Acting|insulin, long-acting|mesh-list
102390758|NCT00358228|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
102390759|NCT00358228|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102390760|NCT00358228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102390761|NCT00358228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390762|NCT00358228|Hormones|hormones|mesh-ancestor
102390763|NCT00358228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102390764|NCT00358228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390765|NCT05710198|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
102390766|NCT05710198|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102390767|NCT05710198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102390768|NCT05710198|Nootropic Agents|nootropic agents|mesh-ancestor
102390769|NCT05709028|Fosfomycin|fosfomycin|mesh-list
102390770|NCT05709028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102390771|NCT05709028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102390772|NCT01336530|Oxethazaine|oxethazaine|mesh-list
102390773|NCT01336530|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102390774|NCT01336530|Antacids|antacids|mesh-list
102390775|NCT01336530|Magnesium Hydroxide|magnesium hydroxide|mesh-list
102390776|NCT01336530|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102390777|NCT01336530|Immunologic Factors|immunologic factors|mesh-ancestor
101936929|NCT03367312|Anesthetics|anesthetics|mesh-ancestor
102390778|NCT01336530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390779|NCT01336530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390780|NCT01336530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102390781|NCT01336530|Anesthetics, Local|anesthetics, local|mesh-ancestor
102390783|NCT01336530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102390784|NCT01336530|Sensory System Agents|sensory system agents|mesh-ancestor
102390785|NCT01336530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102390786|NCT00777348|Reproterol|reproterol|mesh-list
102390787|NCT00777348|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102390788|NCT00777348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102390789|NCT00777348|Adrenergic Agents|adrenergic agents|mesh-ancestor
102390790|NCT00777348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102390791|NCT00777348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390792|NCT00777348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390793|NCT00777348|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102390794|NCT00777348|Autonomic Agents|autonomic agents|mesh-ancestor
102390795|NCT00777348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102390796|NCT00777348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102390797|NCT00777348|Respiratory System Agents|respiratory system agents|mesh-ancestor
102390798|NCT03836560|Nicotine|nicotine|mesh-list
102390799|NCT03836560|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102390800|NCT03836560|Autonomic Agents|autonomic agents|mesh-ancestor
102390801|NCT03836560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102390802|NCT03836560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390803|NCT03836560|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102390804|NCT03836560|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102390805|NCT03836560|Cholinergic Agents|cholinergic agents|mesh-ancestor
102390806|NCT03836560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102390807|NCT03836560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390808|NCT04483596|Melatonin|melatonin|mesh-list
102390809|NCT04483596|Antioxidants|antioxidants|mesh-ancestor
102390810|NCT04483596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390811|NCT04483596|Protective Agents|protective agents|mesh-ancestor
102390812|NCT04483596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390813|NCT04483596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102390814|NCT05721586|Listerine|listerine|mesh-list
102390815|NCT05721586|Fluorides|fluorides|mesh-list
102390816|NCT05721586|Fluorides, Topical|fluorides, topical|mesh-list
102390817|NCT05721586|Sodium Fluoride|sodium fluoride|mesh-list
101937058|NCT02994394|Tolvaptan|tolvaptan|mesh-list
101937059|NCT02994394|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101937060|NCT02994394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937061|NCT02994394|Natriuretic Agents|natriuretic agents|mesh-ancestor
101937062|NCT02994394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937063|NCT01063270|Rifampin|rifampin|mesh-list
101937064|NCT01063270|Clindamycin|clindamycin|mesh-list
101937065|NCT01063270|Clindamycin palmitate|clindamycin palmitate|mesh-list
101937066|NCT01063270|Clindamycin phosphate|clindamycin phosphate|mesh-list
101937067|NCT01063270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101937068|NCT01063270|Antitubercular Agents|antitubercular agents|mesh-ancestor
101937069|NCT01063270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101937070|NCT01063270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101937071|NCT01063270|Leprostatic Agents|leprostatic agents|mesh-ancestor
101937072|NCT01063270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102390818|NCT05721586|Cariostatic Agents|cariostatic agents|mesh-ancestor
102390819|NCT05721586|Protective Agents|protective agents|mesh-ancestor
102390820|NCT05721586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390821|NCT05721586|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102390822|NCT05721586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102390823|NCT02978482|Durvalumab|durvalumab|mesh-list
102390824|NCT02978482|Tremelimumab|tremelimumab|mesh-list
102390825|NCT02978482|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102390826|NCT02978482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102390827|NCT02978482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102390828|NCT02978482|Immunologic Factors|immunologic factors|mesh-ancestor
102390829|NCT02978482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390830|NCT00357682|Aspirin|aspirin|mesh-list
102390831|NCT00357682|Esomeprazole|esomeprazole|mesh-list
102390832|NCT00357682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102390833|NCT00357682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102390834|NCT00357682|Analgesics|analgesics|mesh-ancestor
102390835|NCT00357682|Sensory System Agents|sensory system agents|mesh-ancestor
102390836|NCT00357682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102390837|NCT00357682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390838|NCT00357682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102390839|NCT00357682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102390840|NCT00357682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102390841|NCT00357682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102390842|NCT00357682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390843|NCT00357682|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102390844|NCT00357682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102390845|NCT00357682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102390846|NCT00357682|Antipyretics|antipyretics|mesh-ancestor
102390847|NCT00357682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102390848|NCT00357682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102390849|NCT00357682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102390850|NCT00105027|Triamcinolone|triamcinolone|mesh-list
102390851|NCT00105027|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102390852|NCT00105027|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102390853|NCT00105027|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102390854|NCT00105027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102390855|NCT00105027|Glucocorticoids|glucocorticoids|mesh-ancestor
102390856|NCT00105027|Hormones|hormones|mesh-ancestor
102390857|NCT00105027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102390858|NCT00105027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390859|NCT00105027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102390860|NCT00105027|Immunologic Factors|immunologic factors|mesh-ancestor
102390861|NCT00105027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102390862|NCT00105027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390863|NCT03145012|Ranitidine|ranitidine|mesh-list
102390864|NCT03145012|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
102390865|NCT03145012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102390866|NCT03145012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102390867|NCT03145012|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102390868|NCT03145012|Histamine Antagonists|histamine antagonists|mesh-ancestor
101937216|NCT03717662|Nicotine|nicotine|mesh-list
102390869|NCT03145012|Histamine Agents|histamine agents|mesh-ancestor
102390870|NCT03145012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102390871|NCT03145012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390872|NCT03145012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390873|NCT03832660|Valsartan|valsartan|mesh-list
102390874|NCT03832660|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102390875|NCT03832660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102390876|NCT03832660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102390877|NCT03832660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102390878|NCT03832660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390879|NCT00030147|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
102390880|NCT00030147|Estradiol|estradiol|mesh-list
102390881|NCT00030147|Estrogens|estrogens|mesh-ancestor
102390882|NCT00030147|Hormones|hormones|mesh-ancestor
102390883|NCT00030147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102390884|NCT00030147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390885|NCT00030147|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102390886|NCT00030147|Hormone Antagonists|hormone antagonists|mesh-ancestor
102390887|NCT00030147|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102390888|NCT00030147|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102390889|NCT00030147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102390890|NCT02709486|Tanezumab|tanezumab|mesh-list
102390891|NCT02709486|Analgesics|analgesics|mesh-ancestor
102390892|NCT02709486|Sensory System Agents|sensory system agents|mesh-ancestor
102390893|NCT02709486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102390894|NCT02709486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390895|NCT00106431|Romidepsin|romidepsin|mesh-list
102390896|NCT00106431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102390897|NCT00106431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102390898|NCT00106431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102390899|NCT00106431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102390900|NCT00106431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390901|NCT03107416|Bumetanide|bumetanide|mesh-list
102390902|NCT03107416|Diuretics|diuretics|mesh-ancestor
102390903|NCT03107416|Natriuretic Agents|natriuretic agents|mesh-ancestor
102390904|NCT03107416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390905|NCT03107416|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102390906|NCT03107416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102390907|NCT03107416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390908|NCT02439996|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102390909|NCT02439996|gamma-Globulins|gamma-globulins|mesh-list
102390910|NCT02439996|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102390911|NCT02439996|Immunologic Factors|immunologic factors|mesh-ancestor
102390912|NCT02439996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390913|NCT03833596|Prednisone|prednisone|mesh-list
102390914|NCT03833596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102390915|NCT03833596|Glucocorticoids|glucocorticoids|mesh-ancestor
102390916|NCT03833596|Hormones|hormones|mesh-ancestor
102401227|NCT00361257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390917|NCT03833596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102390918|NCT03833596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390919|NCT03833596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102390920|NCT03833596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102390921|NCT02831998|Ethanol|ethanol|mesh-list
102390922|NCT02831998|Chlorhexidine|chlorhexidine|mesh-list
102390923|NCT02831998|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102202659|NCT04467931|Analgesics|analgesics|mesh-ancestor
102390924|NCT02831998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102390925|NCT02831998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102390926|NCT02831998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102390927|NCT02831998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390928|NCT02831998|Disinfectants|disinfectants|mesh-ancestor
102390929|NCT02831998|Dermatologic Agents|dermatologic agents|mesh-ancestor
102390930|NCT02434614|Cisplatin|cisplatin|mesh-list
102390931|NCT02434614|Docetaxel|docetaxel|mesh-list
102390932|NCT02434614|Fluorouracil|fluorouracil|mesh-list
102390933|NCT02434614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102390934|NCT02434614|Tubulin Modulators|tubulin modulators|mesh-ancestor
102390935|NCT02434614|Antimitotic Agents|antimitotic agents|mesh-ancestor
102390936|NCT02434614|Mitosis Modulators|mitosis modulators|mesh-ancestor
102390937|NCT02434614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390938|NCT02434614|Antimetabolites|antimetabolites|mesh-ancestor
102390939|NCT02434614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102390940|NCT02434614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102390941|NCT02434614|Immunologic Factors|immunologic factors|mesh-ancestor
102390942|NCT02434614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390943|NCT05720260|Durvalumab|durvalumab|mesh-list
102390944|NCT05720260|Fulvestrant|fulvestrant|mesh-list
102390945|NCT05720260|Goserelin|goserelin|mesh-list
102390946|NCT05720260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102390947|NCT05720260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102390948|NCT05720260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102390949|NCT05720260|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102390950|NCT05720260|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102390951|NCT05720260|Hormone Antagonists|hormone antagonists|mesh-ancestor
102390952|NCT05720260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102390953|NCT05720260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390954|NCT05720026|Docetaxel|docetaxel|mesh-list
102390955|NCT05720026|Trastuzumab|trastuzumab|mesh-list
102390956|NCT05720026|Pertuzumab|pertuzumab|mesh-list
102390957|NCT05720026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102390958|NCT05720026|Tubulin Modulators|tubulin modulators|mesh-ancestor
102390959|NCT05720026|Antimitotic Agents|antimitotic agents|mesh-ancestor
102390960|NCT05720026|Mitosis Modulators|mitosis modulators|mesh-ancestor
102390961|NCT05720026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390962|NCT05720026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102390963|NCT04483674|Tenofovir|tenofovir|mesh-list
102390964|NCT04483674|Emtricitabine|emtricitabine|mesh-list
102390965|NCT04483674|Antiviral Agents|antiviral agents|mesh-ancestor
101937778|NCT05535764|Interferon-alpha|interferon-alpha|mesh-list
101937779|NCT05535764|Interferon alpha-2|interferon alpha-2|mesh-list
101937780|NCT05535764|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101937781|NCT05535764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937782|NCT05535764|Antiviral Agents|antiviral agents|mesh-ancestor
101937783|NCT05535764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101937784|NCT05535764|Immunologic Factors|immunologic factors|mesh-ancestor
102390966|NCT04483674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102390967|NCT04483674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102390968|NCT04483674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102390969|NCT04483674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102390970|NCT04483674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390971|NCT04483674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102390972|NCT04483674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102390973|NCT02438982|Rituximab|rituximab|mesh-list
102390974|NCT02438982|Tacrolimus|tacrolimus|mesh-list
102390975|NCT02438982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
102390976|NCT02438982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102390977|NCT02438982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102390978|NCT02438982|Immunologic Factors|immunologic factors|mesh-ancestor
102390979|NCT02438982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390980|NCT02438982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102390981|NCT02438982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102390982|NCT02438982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102401228|NCT02341404|Hydroxyflutamide|hydroxyflutamide|mesh-list
102390983|NCT02438982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390984|NCT02425774|Prucalopride|prucalopride|mesh-list
102390985|NCT02425774|Laxatives|laxatives|mesh-ancestor
102390986|NCT02425774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102390987|NCT02425774|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
102390988|NCT02425774|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102390989|NCT02425774|Serotonin Agents|serotonin agents|mesh-ancestor
101937986|NCT04808999|Pembrolizumab|pembrolizumab|mesh-list
102390990|NCT02425774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102390991|NCT02425774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102390992|NCT02425774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390993|NCT02420002|Nitrous Oxide|nitrous oxide|mesh-list
102390994|NCT02420002|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102390995|NCT02420002|Anesthetics, General|anesthetics, general|mesh-ancestor
102390996|NCT02420002|Anesthetics|anesthetics|mesh-ancestor
102390997|NCT02420002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102202735|NCT02366247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102390998|NCT02420002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102390999|NCT02420002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102391001|NCT02420002|Sensory System Agents|sensory system agents|mesh-ancestor
102391002|NCT02420002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102391003|NCT03187626|Botulinum Toxins|botulinum toxins|mesh-list
102391004|NCT03187626|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102391005|NCT03187626|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102391006|NCT03187626|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102391007|NCT03187626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102391008|NCT03187626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391009|NCT03187626|Cholinergic Agents|cholinergic agents|mesh-ancestor
102391010|NCT03187626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102391011|NCT03187626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391012|NCT03187626|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102391013|NCT03187626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102391014|NCT03117894|Acetaminophen|acetaminophen|mesh-list
102391015|NCT03117894|Etoricoxib|etoricoxib|mesh-list
102391016|NCT03117894|Morphine|morphine|mesh-list
102391017|NCT03117894|Remifentanil|remifentanil|mesh-list
102391018|NCT03117894|Ondansetron|ondansetron|mesh-list
102391019|NCT03117894|Propofol|propofol|mesh-list
102391020|NCT03117894|Ropivacaine|ropivacaine|mesh-list
102391021|NCT03117894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102391022|NCT03117894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102391023|NCT03117894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391024|NCT03117894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102391025|NCT03117894|Anesthetics, General|anesthetics, general|mesh-ancestor
102391026|NCT03117894|Anesthetics|anesthetics|mesh-ancestor
102391027|NCT03117894|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102391028|NCT03117894|Narcotics|narcotics|mesh-ancestor
102391029|NCT03117894|Analgesics|analgesics|mesh-ancestor
102391030|NCT03117894|Sensory System Agents|sensory system agents|mesh-ancestor
102391031|NCT03117894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102391032|NCT03117894|Anesthetics, Local|anesthetics, local|mesh-ancestor
102391033|NCT03117894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102391034|NCT03117894|Antipyretics|antipyretics|mesh-ancestor
102391035|NCT03117894|Antiemetics|antiemetics|mesh-ancestor
102391036|NCT03117894|Autonomic Agents|autonomic agents|mesh-ancestor
102391037|NCT03117894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102391038|NCT03117894|Antipruritics|antipruritics|mesh-ancestor
102391039|NCT03117894|Dermatologic Agents|dermatologic agents|mesh-ancestor
102391040|NCT03117894|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102391041|NCT03117894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102391042|NCT03117894|Serotonin Agents|serotonin agents|mesh-ancestor
102391043|NCT03117894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102391044|NCT03117894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391045|NCT03117894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102391046|NCT03117894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102391047|NCT03117894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102391048|NCT03117894|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102391049|NCT03117894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102391050|NCT03117894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102391051|NCT00357292|Azithromycin|azithromycin|mesh-list
102391052|NCT00357292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102391053|NCT00357292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102391054|NCT05625802|Ropivacaine|ropivacaine|mesh-list
102391055|NCT05625802|Anesthetics, Local|anesthetics, local|mesh-ancestor
102391056|NCT05625802|Anesthetics|anesthetics|mesh-ancestor
102391057|NCT05625802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102391058|NCT05625802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391059|NCT05625802|Sensory System Agents|sensory system agents|mesh-ancestor
102391060|NCT05625802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102391061|NCT03187548|Calcium|calcium|mesh-list
102391062|NCT03187548|Caseins|caseins|mesh-list
102391063|NCT03187548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102391064|NCT03187548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391065|NCT03187548|Chelating Agents|chelating agents|mesh-ancestor
102391066|NCT03187548|Sequestering Agents|sequestering agents|mesh-ancestor
102391067|NCT03187548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391068|NCT02042326|Sirolimus|sirolimus|mesh-list
102391069|NCT02042326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102391070|NCT02042326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102391071|NCT02042326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102391072|NCT02042326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938457|NCT03107884|Metformin|metformin|mesh-list
102391073|NCT02042326|Antifungal Agents|antifungal agents|mesh-ancestor
102391074|NCT02042326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102391075|NCT02042326|Immunologic Factors|immunologic factors|mesh-ancestor
102391076|NCT02042326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391077|NCT05718544|Sufentanil|sufentanil|mesh-list
102391078|NCT05718544|Dexmedetomidine|dexmedetomidine|mesh-list
102391079|NCT05718544|Esketamine|esketamine|mesh-list
102391080|NCT05718544|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102391081|NCT05718544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102391082|NCT05718544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391083|NCT05718544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102391084|NCT05718544|Analgesics|analgesics|mesh-ancestor
102391085|NCT05718544|Sensory System Agents|sensory system agents|mesh-ancestor
102391086|NCT05718544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102391087|NCT05718544|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102391088|NCT05718544|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102391089|NCT05718544|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102391090|NCT05718544|Adrenergic Agents|adrenergic agents|mesh-ancestor
102391091|NCT05718544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102391092|NCT05718544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391093|NCT05718544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102391094|NCT05718544|Narcotics|narcotics|mesh-ancestor
101938576|NCT02642965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101938577|NCT02642965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101938578|NCT02595892|Gemcitabine|gemcitabine|mesh-list
101938579|NCT02595892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101938580|NCT02595892|Antimetabolites|antimetabolites|mesh-ancestor
101938581|NCT02595892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938582|NCT02595892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938583|NCT02520362|Denosumab|denosumab|mesh-list
101938584|NCT02520362|Diphosphonates|diphosphonates|mesh-list
101938585|NCT02520362|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101938586|NCT02520362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938587|NCT02461927|Midazolam|midazolam|mesh-list
101938588|NCT02461927|Naltrexone|naltrexone|mesh-list
101938589|NCT02461927|Ketamine|ketamine|mesh-list
101938590|NCT02461927|Analgesics|analgesics|mesh-ancestor
101938591|NCT02461927|Sensory System Agents|sensory system agents|mesh-ancestor
101938592|NCT02461927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101938593|NCT02461927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938594|NCT02461927|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101938595|NCT02461927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101938596|NCT02461927|Anesthetics, General|anesthetics, general|mesh-ancestor
101938597|NCT02461927|Anesthetics|anesthetics|mesh-ancestor
101938598|NCT02461927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101938599|NCT02461927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101938600|NCT02461927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101658471|NCT00851461|Goserelin|goserelin|mesh-list
102391095|NCT05718544|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102391096|NCT05718544|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102391097|NCT05718544|Anesthetics, General|anesthetics, general|mesh-ancestor
102391098|NCT05718544|Anesthetics|anesthetics|mesh-ancestor
102391099|NCT05718544|Antidepressive Agents|antidepressive agents|mesh-ancestor
102391100|NCT05718544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102391101|NCT05616598|Ribavirin|ribavirin|mesh-list
102391102|NCT05616598|Sofosbuvir|sofosbuvir|mesh-list
102391103|NCT05616598|Simeprevir|simeprevir|mesh-list
102391104|NCT05616598|Antimetabolites|antimetabolites|mesh-ancestor
102391105|NCT05616598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391106|NCT05616598|Antiviral Agents|antiviral agents|mesh-ancestor
102391107|NCT05616598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102391108|NCT05616598|Protease Inhibitors|protease inhibitors|mesh-ancestor
102391109|NCT05616598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102391110|NCT03187392|Lidocaine|lidocaine|mesh-list
102391111|NCT03187392|Anesthetics, Local|anesthetics, local|mesh-ancestor
102391112|NCT03187392|Anesthetics|anesthetics|mesh-ancestor
102391113|NCT03187392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102391114|NCT03187392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391115|NCT03187392|Sensory System Agents|sensory system agents|mesh-ancestor
102391116|NCT03187392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102391117|NCT03187392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102391118|NCT03187392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102391119|NCT03187392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102391120|NCT03187392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102391121|NCT03187392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391122|NCT01464268|Riboflavin|riboflavin|mesh-list
101938713|NCT01038778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101938714|NCT01038778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101938715|NCT01038778|Antiviral Agents|antiviral agents|mesh-ancestor
101938716|NCT01038778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101938717|NCT01038778|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101938718|NCT01038778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938719|NCT01038778|Antimetabolites|antimetabolites|mesh-ancestor
101938720|NCT01038778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101938722|NCT00707655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101938723|NCT00707655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938724|NCT00542308|Zalutumumab|zalutumumab|mesh-list
101938725|NCT00542308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102391123|NCT01464268|Dextrans|dextrans|mesh-list
102391124|NCT01464268|Vitamin B Complex|vitamin b complex|mesh-ancestor
102391125|NCT01464268|Vitamins|vitamins|mesh-ancestor
102391126|NCT01464268|Micronutrients|micronutrients|mesh-ancestor
102391127|NCT01464268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391128|NCT01464268|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102391129|NCT01464268|Dermatologic Agents|dermatologic agents|mesh-ancestor
102391130|NCT01464268|Anticoagulants|anticoagulants|mesh-ancestor
102391131|NCT01464268|Plasma Substitutes|plasma substitutes|mesh-ancestor
102391132|NCT01464268|Blood Substitutes|blood substitutes|mesh-ancestor
102391133|NCT00215787|Lansoprazole|lansoprazole|mesh-list
102391134|NCT00215787|Dexlansoprazole|dexlansoprazole|mesh-list
102391135|NCT00215787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102391136|NCT00215787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102391137|NCT00215787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102391138|NCT00215787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102391139|NCT00215787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938785|NCT00006734|Cyclophosphamide|cyclophosphamide|mesh-list
101658612|NCT05578482|Mometasone Furoate|mometasone furoate|mesh-list
101938786|NCT00006734|Ifosfamide|ifosfamide|mesh-list
101938787|NCT00006734|Doxorubicin|doxorubicin|mesh-list
101938788|NCT00006734|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101938789|NCT00006734|Etoposide|etoposide|mesh-list
101938790|NCT00006734|Vincristine|vincristine|mesh-list
101938792|NCT00006734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101938793|NCT00006734|Immunologic Factors|immunologic factors|mesh-ancestor
101938794|NCT00006734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938795|NCT00006734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102391140|NCT05716906|Melatonin|melatonin|mesh-list
102391141|NCT05716906|Antioxidants|antioxidants|mesh-ancestor
102391142|NCT05716906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391143|NCT05716906|Protective Agents|protective agents|mesh-ancestor
102391144|NCT05716906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391145|NCT05716906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102391146|NCT00216099|Folic Acid|folic acid|mesh-list
102391147|NCT00216099|Vitamin B 12|vitamin b 12|mesh-list
101938842|NCT03662620|Amlodipine|amlodipine|mesh-list
102391148|NCT00216099|Hydroxocobalamin|hydroxocobalamin|mesh-list
102391149|NCT00216099|Pemetrexed|pemetrexed|mesh-list
102391150|NCT00216099|Vitamins|vitamins|mesh-ancestor
102391151|NCT00216099|Micronutrients|micronutrients|mesh-ancestor
102391152|NCT00216099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391153|NCT00216099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102391154|NCT00216099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102391155|NCT00216099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391156|NCT00216099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102391157|NCT00216099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102391158|NCT00216099|Hematinics|hematinics|mesh-ancestor
102391159|NCT00216099|Vitamin B Complex|vitamin b complex|mesh-ancestor
102391160|NCT04565925|Sildenafil Citrate|sildenafil citrate|mesh-list
102391161|NCT04565925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391162|NCT04565925|Vasodilator Agents|vasodilator agents|mesh-ancestor
102391163|NCT04565925|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102391164|NCT04565925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102391165|NCT04565925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102391166|NCT04565925|Urological Agents|urological agents|mesh-ancestor
102391167|NCT00039195|Prednisone|prednisone|mesh-list
102391168|NCT00039195|Cyclophosphamide|cyclophosphamide|mesh-list
102391169|NCT00039195|Ifosfamide|ifosfamide|mesh-list
102391170|NCT00039195|Rituximab|rituximab|mesh-list
102391171|NCT00039195|Carboplatin|carboplatin|mesh-list
102391172|NCT00039195|Doxorubicin|doxorubicin|mesh-list
102391173|NCT00039195|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102391174|NCT00039195|Etoposide|etoposide|mesh-list
101939014|NCT04438330|Nickel|nickel|mesh-list
102391175|NCT00039195|Vincristine|vincristine|mesh-list
102391176|NCT00039195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102391177|NCT00039195|Immunologic Factors|immunologic factors|mesh-ancestor
102391178|NCT00039195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391179|NCT00039195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102391180|NCT00039195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102391181|NCT00039195|Alkylating Agents|alkylating agents|mesh-ancestor
102391182|NCT00039195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391183|NCT00039195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101939023|NCT03803475|Anticoagulants|anticoagulants|mesh-ancestor
102391184|NCT00039195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102391185|NCT00039195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102391186|NCT00039195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102391187|NCT00039195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102391188|NCT00039195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102391189|NCT00039195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102391190|NCT00039195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102391191|NCT00039195|Glucocorticoids|glucocorticoids|mesh-ancestor
102391192|NCT00039195|Hormones|hormones|mesh-ancestor
102391193|NCT00039195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102391194|NCT00039195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102391195|NCT00039195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102391196|NCT00039195|Tubulin Modulators|tubulin modulators|mesh-ancestor
102391197|NCT00039195|Antimitotic Agents|antimitotic agents|mesh-ancestor
102391198|NCT00039195|Mitosis Modulators|mitosis modulators|mesh-ancestor
102391199|NCT05591170|Cholecalciferol|cholecalciferol|mesh-list
102391200|NCT05591170|Vitamin D|vitamin d|mesh-list
102391201|NCT05591170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102391202|NCT05591170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391203|NCT05591170|Vitamins|vitamins|mesh-ancestor
102391204|NCT05591170|Micronutrients|micronutrients|mesh-ancestor
102391205|NCT05591170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102391206|NCT00218439|Paroxetine|paroxetine|mesh-list
102391207|NCT00218439|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101939221|NCT01066000|Epoetin Alfa|epoetin alfa|mesh-list
102391208|NCT00218439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102391209|NCT00218439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102391210|NCT00218439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391211|NCT00218439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102391212|NCT00218439|Serotonin Agents|serotonin agents|mesh-ancestor
102391213|NCT00218439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391214|NCT00218439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102391215|NCT00218439|Antidepressive Agents|antidepressive agents|mesh-ancestor
102391216|NCT00218439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102391217|NCT00218439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102391218|NCT00218439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102391219|NCT00218439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102391220|NCT04344730|Dexamethasone|dexamethasone|mesh-list
102391221|NCT04344730|Dexamethasone acetate|dexamethasone acetate|mesh-list
102391222|NCT04344730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102391223|NCT04344730|Antiemetics|antiemetics|mesh-ancestor
102391224|NCT04344730|Autonomic Agents|autonomic agents|mesh-ancestor
102391225|NCT04344730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102391226|NCT04344730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391227|NCT04344730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102391228|NCT04344730|Glucocorticoids|glucocorticoids|mesh-ancestor
102391230|NCT04344730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102391231|NCT04344730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102391232|NCT04344730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102391233|NCT05716672|Lazertinib|lazertinib|mesh-list
102391234|NCT05716672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102391235|NCT05716672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102401229|NCT02341404|Androgen Antagonists|androgen antagonists|mesh-ancestor
102391236|NCT05716672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391237|NCT00358384|Betamethasone|betamethasone|mesh-list
102391238|NCT00358384|Betamethasone Valerate|betamethasone valerate|mesh-list
102391239|NCT00358384|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102391240|NCT00358384|Betamethasone benzoate|betamethasone benzoate|mesh-list
102391241|NCT00358384|Calcipotriene|calcipotriene|mesh-list
102391242|NCT00358384|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102391243|NCT00358384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102391244|NCT00358384|Glucocorticoids|glucocorticoids|mesh-ancestor
102391245|NCT00358384|Hormones|hormones|mesh-ancestor
102391246|NCT00358384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102391247|NCT00358384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391248|NCT00358384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102391249|NCT00358384|Respiratory System Agents|respiratory system agents|mesh-ancestor
102391250|NCT00358384|Dermatologic Agents|dermatologic agents|mesh-ancestor
102391251|NCT02959060|Rifampin|rifampin|mesh-list
102391252|NCT02959060|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102391253|NCT02959060|Antitubercular Agents|antitubercular agents|mesh-ancestor
102391254|NCT02959060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102391255|NCT02959060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102391256|NCT02959060|Leprostatic Agents|leprostatic agents|mesh-ancestor
102391257|NCT02959060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102391258|NCT02959060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102391259|NCT02959060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391260|NCT02959060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102391261|NCT02959060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102391262|NCT02959060|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102391263|NCT02959060|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102391264|NCT02959060|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102391265|NCT02959060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102391266|NCT00109005|Lenalidomide|lenalidomide|mesh-list
102391267|NCT00109005|Immunologic Factors|immunologic factors|mesh-ancestor
102391268|NCT00109005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391269|NCT00109005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102391270|NCT00109005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102391271|NCT00109005|Growth Substances|growth substances|mesh-ancestor
102391272|NCT00109005|Growth Inhibitors|growth inhibitors|mesh-ancestor
102391273|NCT00109005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102391274|NCT05552950|Antiviral Agents|antiviral agents|mesh-list
102391275|NCT05552950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102391276|NCT05547100|Olanzapine|olanzapine|mesh-list
102391277|NCT05547100|Antiemetics|antiemetics|mesh-ancestor
102391278|NCT05547100|Autonomic Agents|autonomic agents|mesh-ancestor
102391279|NCT05547100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102391280|NCT05547100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391281|NCT05547100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102391282|NCT05547100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102391283|NCT05547100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102391284|NCT05547100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102391285|NCT05547100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102391286|NCT05547100|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102391287|NCT05547100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102391288|NCT05547100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102391289|NCT05547100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391290|NCT05547100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102391291|NCT05547100|Serotonin Agents|serotonin agents|mesh-ancestor
102391292|NCT00109473|Prednisone|prednisone|mesh-list
102391293|NCT00109473|Hormones|hormones|mesh-list
102391294|NCT00109473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102391295|NCT00109473|Glucocorticoids|glucocorticoids|mesh-ancestor
102391296|NCT00109473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102391297|NCT00109473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391298|NCT00109473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102391299|NCT00109473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102391300|NCT05136976|Rituximab|rituximab|mesh-list
102203033|NCT02358993|Methenamine mandelate|methenamine mandelate|mesh-list
102391301|NCT05136976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102391302|NCT05136976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102391303|NCT05136976|Immunologic Factors|immunologic factors|mesh-ancestor
102391304|NCT05136976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391305|NCT05136976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102391306|NCT00044655|Olanzapine|olanzapine|mesh-list
102391307|NCT00044655|Risperidone|risperidone|mesh-list
102391308|NCT00044655|Aripiprazole|aripiprazole|mesh-list
102391309|NCT00044655|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102391310|NCT00044655|Ziprasidone|ziprasidone|mesh-list
101940038|NCT03943407|Imiquimod|imiquimod|mesh-list
102391311|NCT00044655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102391312|NCT00044655|Serotonin Agents|serotonin agents|mesh-ancestor
102401230|NCT02341404|Hormone Antagonists|hormone antagonists|mesh-ancestor
102391313|NCT00044655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102391314|NCT00044655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391315|NCT00044655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391316|NCT00044655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102391317|NCT00044655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102391318|NCT00044655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102391319|NCT00044655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102391320|NCT00044655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102391321|NCT00044655|Dopamine Agents|dopamine agents|mesh-ancestor
101940182|NCT01111227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102391322|NCT00044655|Antiemetics|antiemetics|mesh-ancestor
102391323|NCT00044655|Autonomic Agents|autonomic agents|mesh-ancestor
102391324|NCT00044655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102391325|NCT00044655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102391326|NCT00044655|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101940247|NCT01328145|Analgesics|analgesics|mesh-ancestor
102391327|NCT00044655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102391328|NCT00044655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102391329|NCT00044655|Antidepressive Agents|antidepressive agents|mesh-ancestor
102391330|NCT00044655|Dopamine Agonists|dopamine agonists|mesh-ancestor
102391331|NCT00044655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102391332|NCT00044655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102391333|NCT00044655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102391334|NCT00044655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102391335|NCT05130892|Tranilast|tranilast|mesh-list
102391336|NCT05130892|Colchicine|colchicine|mesh-list
102391337|NCT05130892|Gout Suppressants|gout suppressants|mesh-ancestor
102391338|NCT05130892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102391339|NCT05130892|Tubulin Modulators|tubulin modulators|mesh-ancestor
102391340|NCT05130892|Antimitotic Agents|antimitotic agents|mesh-ancestor
102391341|NCT05130892|Mitosis Modulators|mitosis modulators|mesh-ancestor
102391342|NCT05130892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391343|NCT05130892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102391344|NCT05130892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102391345|NCT05130892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102391346|NCT05130892|Analgesics|analgesics|mesh-ancestor
102391347|NCT05130892|Sensory System Agents|sensory system agents|mesh-ancestor
102391348|NCT05130892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102391349|NCT05130892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391350|NCT05130892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102391351|NCT05130892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102391352|NCT05130892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102391353|NCT05130892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102391354|NCT05130892|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102391355|NCT05130892|Histamine Antagonists|histamine antagonists|mesh-ancestor
102391356|NCT05130892|Histamine Agents|histamine agents|mesh-ancestor
102391357|NCT05130892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102391358|NCT05130892|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102391359|NCT05130892|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102391360|NCT00223665|Leuprolide|leuprolide|mesh-list
102391361|NCT00223665|Flutamide|flutamide|mesh-list
102391362|NCT00223665|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102391363|NCT00223665|Fertility Agents|fertility agents|mesh-ancestor
102391364|NCT00223665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102391365|NCT00223665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391366|NCT00223665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102391367|NCT00223665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102391368|NCT00223665|Androgen Antagonists|androgen antagonists|mesh-ancestor
102391369|NCT00223665|Hormone Antagonists|hormone antagonists|mesh-ancestor
102391370|NCT00223665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102391371|NCT05311540|Zinc Sulfate|zinc sulfate|mesh-list
102391372|NCT05311540|Astringents|astringents|mesh-ancestor
102391373|NCT05311540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391374|NCT05311540|Dermatologic Agents|dermatologic agents|mesh-ancestor
102203119|NCT02212535|Plerixafor|plerixafor|mesh-list
102391375|NCT00223821|Oxybutynin|oxybutynin|mesh-list
102391376|NCT00223821|Parasympatholytics|parasympatholytics|mesh-ancestor
102391377|NCT00223821|Autonomic Agents|autonomic agents|mesh-ancestor
102391378|NCT00223821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102391379|NCT00223821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391380|NCT00223821|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102391381|NCT00223821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102391382|NCT00223821|Cholinergic Agents|cholinergic agents|mesh-ancestor
102391383|NCT00223821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102391384|NCT00223821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391385|NCT00223821|Urological Agents|urological agents|mesh-ancestor
102391386|NCT00359164|Bevacizumab|bevacizumab|mesh-list
102391387|NCT00359164|Verteporfin|verteporfin|mesh-list
102391388|NCT00359164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102391389|NCT00359164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102391390|NCT00359164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102391391|NCT00359164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102391392|NCT00359164|Growth Substances|growth substances|mesh-ancestor
102391393|NCT00359164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391394|NCT00359164|Growth Inhibitors|growth inhibitors|mesh-ancestor
102391395|NCT00359164|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102391396|NCT00359164|Dermatologic Agents|dermatologic agents|mesh-ancestor
102391397|NCT00224289|Latanoprost|latanoprost|mesh-list
102391398|NCT00224289|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102391399|NCT00224289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102391400|NCT00045435|Cyclosporine|cyclosporine|mesh-list
102391401|NCT00045435|Mycophenolic Acid|mycophenolic acid|mesh-list
102391402|NCT00045435|Fludarabine|fludarabine|mesh-list
102391403|NCT00045435|Fludarabine phosphate|fludarabine phosphate|mesh-list
102391404|NCT00045435|Cyclosporins|cyclosporins|mesh-list
102391405|NCT00045435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102391406|NCT00045435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102391407|NCT00045435|Antimetabolites|antimetabolites|mesh-ancestor
102391408|NCT00045435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391409|NCT00045435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102391410|NCT00045435|Immunologic Factors|immunologic factors|mesh-ancestor
102391411|NCT00045435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391412|NCT00045435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102391413|NCT00045435|Antifungal Agents|antifungal agents|mesh-ancestor
102391414|NCT00045435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102391415|NCT00045435|Dermatologic Agents|dermatologic agents|mesh-ancestor
102391416|NCT00045435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102391417|NCT00045435|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102391418|NCT00045435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102391419|NCT00045435|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102391420|NCT00045435|Antitubercular Agents|antitubercular agents|mesh-ancestor
102391421|NCT00045435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102391422|NCT00111657|Rasburicase|rasburicase|mesh-list
102391423|NCT00111657|Gout Suppressants|gout suppressants|mesh-ancestor
102391424|NCT00111657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102391425|NCT05292586|Beclomethasone|beclomethasone|mesh-list
102391426|NCT05292586|Formoterol Fumarate|formoterol fumarate|mesh-list
102391427|NCT05292586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102391428|NCT05292586|Autonomic Agents|autonomic agents|mesh-ancestor
102391429|NCT05292586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102391430|NCT05292586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391431|NCT05292586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102391432|NCT05292586|Respiratory System Agents|respiratory system agents|mesh-ancestor
102391433|NCT05292586|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102391434|NCT05292586|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102391435|NCT05292586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102391436|NCT05292586|Adrenergic Agents|adrenergic agents|mesh-ancestor
102391437|NCT05292586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102391438|NCT05292586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391439|NCT05292586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102391440|NCT05292586|Glucocorticoids|glucocorticoids|mesh-ancestor
102391441|NCT05292586|Hormones|hormones|mesh-ancestor
102391442|NCT05292586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102391443|NCT02097303|Prednisone|prednisone|mesh-list
102391444|NCT02097303|Abiraterone Acetate|abiraterone acetate|mesh-list
102391445|NCT02097303|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
102391446|NCT02097303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102391447|NCT02097303|Glucocorticoids|glucocorticoids|mesh-ancestor
102391448|NCT02097303|Hormones|hormones|mesh-ancestor
102391449|NCT02097303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102391450|NCT02097303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391451|NCT02097303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102391452|NCT02097303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102391453|NCT02097303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102391454|NCT02097303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102391455|NCT02097303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391456|NCT02097303|Hormone Antagonists|hormone antagonists|mesh-ancestor
102391457|NCT02097303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102391459|NCT00703326|Ramucirumab|ramucirumab|mesh-list
102391460|NCT00703326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102391461|NCT00703326|Tubulin Modulators|tubulin modulators|mesh-ancestor
102391462|NCT00703326|Antimitotic Agents|antimitotic agents|mesh-ancestor
102391463|NCT00703326|Mitosis Modulators|mitosis modulators|mesh-ancestor
101940886|NCT01121133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102391464|NCT00703326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391465|NCT02097537|Methacholine Chloride|methacholine chloride|mesh-list
102391466|NCT02097537|Miotics|miotics|mesh-ancestor
102391467|NCT02097537|Autonomic Agents|autonomic agents|mesh-ancestor
102391468|NCT02097537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102391469|NCT02097537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391470|NCT02097537|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102391471|NCT02097537|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
102391472|NCT02097537|Respiratory System Agents|respiratory system agents|mesh-ancestor
102391473|NCT02097537|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102391474|NCT02097537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102391475|NCT02097537|Cholinergic Agents|cholinergic agents|mesh-ancestor
102391476|NCT02097537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102391477|NCT02097537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391478|NCT02097849|Interferons|interferons|mesh-list
102391479|NCT02097849|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102391480|NCT02097849|Vaccines|vaccines|mesh-list
102391481|NCT02097849|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102391482|NCT02097849|Immunologic Factors|immunologic factors|mesh-ancestor
102391483|NCT02097849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391484|NCT02097849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102391485|NCT02097849|Antiviral Agents|antiviral agents|mesh-ancestor
102391486|NCT02097849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102391487|NCT02097849|Dermatologic Agents|dermatologic agents|mesh-ancestor
102391488|NCT02097849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102391489|NCT00047697|Donepezil|donepezil|mesh-list
102391490|NCT00047697|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102391491|NCT00047697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102391492|NCT00047697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391493|NCT00047697|Cholinergic Agents|cholinergic agents|mesh-ancestor
102391494|NCT00047697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102391495|NCT00047697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391496|NCT00047697|Nootropic Agents|nootropic agents|mesh-ancestor
102391497|NCT05094154|Penicillins|penicillins|mesh-list
102391498|NCT05094154|Cephalosporins|cephalosporins|mesh-list
102391499|NCT05094154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102391500|NCT05094154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102391501|NCT02437812|Metformin|metformin|mesh-list
102391502|NCT02437812|Paclitaxel|paclitaxel|mesh-list
102391503|NCT02437812|Carboplatin|carboplatin|mesh-list
102391504|NCT02437812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102391505|NCT02437812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102391506|NCT02437812|Tubulin Modulators|tubulin modulators|mesh-ancestor
102391507|NCT02437812|Antimitotic Agents|antimitotic agents|mesh-ancestor
102391508|NCT02437812|Mitosis Modulators|mitosis modulators|mesh-ancestor
102391509|NCT02437812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391510|NCT02437812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102391511|NCT02437812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391512|NCT00112593|Cyclosporine|cyclosporine|mesh-list
102391513|NCT00112593|Mycophenolic Acid|mycophenolic acid|mesh-list
102391514|NCT00112593|Fludarabine|fludarabine|mesh-list
102391515|NCT00112593|Fludarabine phosphate|fludarabine phosphate|mesh-list
102391516|NCT00112593|Cyclosporins|cyclosporins|mesh-list
102391517|NCT00112593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102391518|NCT00112593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102391519|NCT00112593|Antimetabolites|antimetabolites|mesh-ancestor
102391520|NCT00112593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391521|NCT00112593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102391522|NCT00112593|Immunologic Factors|immunologic factors|mesh-ancestor
102203253|NCT02222519|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102391523|NCT00112593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391524|NCT00112593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102391525|NCT00112593|Antifungal Agents|antifungal agents|mesh-ancestor
102391526|NCT00112593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102391527|NCT00112593|Dermatologic Agents|dermatologic agents|mesh-ancestor
102391528|NCT00112593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102391529|NCT00112593|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102391530|NCT00112593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102391531|NCT00112593|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102391532|NCT00112593|Antitubercular Agents|antitubercular agents|mesh-ancestor
102391533|NCT00112593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102391534|NCT05280106|Citric Acid|citric acid|mesh-list
102391535|NCT05280106|Sodium Citrate|sodium citrate|mesh-list
102391536|NCT05280106|Dialysis Solutions|dialysis solutions|mesh-list
102391537|NCT05280106|Anticoagulants|anticoagulants|mesh-ancestor
102391538|NCT05280106|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102391539|NCT05280106|Chelating Agents|chelating agents|mesh-ancestor
102391540|NCT05280106|Sequestering Agents|sequestering agents|mesh-ancestor
102391541|NCT05280106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391542|NCT05280106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102391543|NCT00112671|Sorafenib|sorafenib|mesh-list
102391544|NCT00112671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102391545|NCT00112671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102391546|NCT00112671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102391547|NCT00112671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391548|NCT05279092|Dexamethasone|dexamethasone|mesh-list
102391549|NCT05279092|Methylprednisolone|methylprednisolone|mesh-list
102391550|NCT05279092|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102391551|NCT05279092|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102391552|NCT05279092|Prednisolone|prednisolone|mesh-list
102391553|NCT05279092|Prednisolone acetate|prednisolone acetate|mesh-list
102391554|NCT05279092|Dexamethasone acetate|dexamethasone acetate|mesh-list
102391555|NCT05279092|Bupivacaine|bupivacaine|mesh-list
102391556|NCT05279092|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102391557|NCT05279092|Prednisolone phosphate|prednisolone phosphate|mesh-list
102391558|NCT05279092|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102391559|NCT05279092|BB 1101|bb 1101|mesh-list
102391560|NCT05279092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102391561|NCT05279092|Antiemetics|antiemetics|mesh-ancestor
102391562|NCT05279092|Autonomic Agents|autonomic agents|mesh-ancestor
102391563|NCT05279092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102391564|NCT05279092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391565|NCT05279092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102391566|NCT05279092|Glucocorticoids|glucocorticoids|mesh-ancestor
102391567|NCT05279092|Hormones|hormones|mesh-ancestor
102391568|NCT05279092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102391569|NCT05279092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102391570|NCT05279092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102391571|NCT05279092|Anesthetics, Local|anesthetics, local|mesh-ancestor
102391572|NCT05279092|Anesthetics|anesthetics|mesh-ancestor
102391573|NCT05279092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102391574|NCT05279092|Sensory System Agents|sensory system agents|mesh-ancestor
102391575|NCT05279092|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102391576|NCT05279092|Protective Agents|protective agents|mesh-ancestor
102391577|NCT05279092|Protease Inhibitors|protease inhibitors|mesh-ancestor
102391578|NCT05279092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102391579|NCT05279092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391580|NCT02437656|Metformin|metformin|mesh-list
102391581|NCT02437656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102391582|NCT02437656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391583|NCT05273632|Tranexamic Acid|tranexamic acid|mesh-list
102391584|NCT05273632|Oxytocin|oxytocin|mesh-list
102391585|NCT05273632|Oxytocics|oxytocics|mesh-ancestor
102391586|NCT05273632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102391587|NCT05273632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391588|NCT05273632|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102391589|NCT05273632|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102391590|NCT05273632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391591|NCT05273632|Hemostatics|hemostatics|mesh-ancestor
102391592|NCT05273632|Coagulants|coagulants|mesh-ancestor
102391593|NCT02429622|Paclitaxel|paclitaxel|mesh-list
102391594|NCT02429622|Nedaplatin|nedaplatin|mesh-list
102391595|NCT02429622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102391596|NCT02429622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102391597|NCT02429622|Tubulin Modulators|tubulin modulators|mesh-ancestor
102391598|NCT02429622|Antimitotic Agents|antimitotic agents|mesh-ancestor
102391599|NCT02429622|Mitosis Modulators|mitosis modulators|mesh-ancestor
102391600|NCT02429622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391601|NCT02429466|Guadecitabine|guadecitabine|mesh-list
102391602|NCT02429466|Azacitidine|azacitidine|mesh-list
102391603|NCT02429466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102391605|NCT02429466|Antimetabolites|antimetabolites|mesh-ancestor
102391606|NCT02429466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391607|NCT02429466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101940944|NCT03934047|Hemostatics|hemostatics|mesh-ancestor
102391608|NCT02429388|Sodium Channel Blockers|sodium channel blockers|mesh-list
102391609|NCT02429388|Spironolactone|spironolactone|mesh-list
102391610|NCT02429388|Diuretics|diuretics|mesh-list
102391611|NCT02429388|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-list
102391612|NCT02429388|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102391613|NCT02429388|Hormone Antagonists|hormone antagonists|mesh-ancestor
102391614|NCT02429388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102391615|NCT02429388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391616|NCT02429388|Natriuretic Agents|natriuretic agents|mesh-ancestor
102391617|NCT02429388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102391618|NCT02429388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391619|NCT02429232|Pioglitazone|pioglitazone|mesh-list
102391620|NCT02429232|Linagliptin|linagliptin|mesh-list
102391621|NCT02429232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102391622|NCT02429232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391623|NCT02429232|Incretins|incretins|mesh-ancestor
102391624|NCT02429232|Hormones|hormones|mesh-ancestor
102391625|NCT02429232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102391626|NCT02429232|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102391627|NCT02429232|Protease Inhibitors|protease inhibitors|mesh-ancestor
102391628|NCT02429232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102391629|NCT02429232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391630|NCT03189732|Metformin|metformin|mesh-list
102391631|NCT03189732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102391632|NCT03189732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391633|NCT02437032|Menotropins|menotropins|mesh-list
102391634|NCT02437032|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102391635|NCT02437032|Fertility Agents|fertility agents|mesh-ancestor
102391636|NCT02437032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102391637|NCT02437032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391638|NCT05232994|Metformin|metformin|mesh-list
102391639|NCT05232994|Esomeprazole|esomeprazole|mesh-list
102391640|NCT05232994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102391641|NCT05232994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391642|NCT05232994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102391643|NCT05232994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102391644|NCT05232994|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102391645|NCT05232994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102391646|NCT05232994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391647|NCT02436798|Ondansetron|ondansetron|mesh-list
102391648|NCT02436798|Antiemetics|antiemetics|mesh-ancestor
102391649|NCT02436798|Autonomic Agents|autonomic agents|mesh-ancestor
102391650|NCT02436798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102391651|NCT02436798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391652|NCT02436798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102391653|NCT02436798|Antipruritics|antipruritics|mesh-ancestor
102391654|NCT02436798|Dermatologic Agents|dermatologic agents|mesh-ancestor
102391655|NCT02436798|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102391656|NCT02436798|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102391657|NCT02436798|Serotonin Agents|serotonin agents|mesh-ancestor
102391658|NCT02436798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102391659|NCT02436798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391660|NCT03185130|Diphenhydramine|diphenhydramine|mesh-list
102391661|NCT03185130|Promethazine|promethazine|mesh-list
102391662|NCT03185130|Prochlorperazine|prochlorperazine|mesh-list
102391663|NCT03185130|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102391664|NCT03185130|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102391665|NCT03185130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102391666|NCT03185130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391667|NCT03185130|Anesthetics, Local|anesthetics, local|mesh-ancestor
102391668|NCT03185130|Anesthetics|anesthetics|mesh-ancestor
102391669|NCT03185130|Sensory System Agents|sensory system agents|mesh-ancestor
102391670|NCT03185130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102391671|NCT03185130|Antiemetics|antiemetics|mesh-ancestor
102391672|NCT03185130|Autonomic Agents|autonomic agents|mesh-ancestor
102391673|NCT03185130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102391674|NCT03185130|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102391675|NCT03185130|Histamine Antagonists|histamine antagonists|mesh-ancestor
102391676|NCT03185130|Histamine Agents|histamine agents|mesh-ancestor
102391677|NCT03185130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102391678|NCT03185130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391680|NCT03185130|Antipruritics|antipruritics|mesh-ancestor
102391681|NCT03185130|Dermatologic Agents|dermatologic agents|mesh-ancestor
102391682|NCT03185130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102391683|NCT03185130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102391684|NCT03185130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102391685|NCT03185130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102391686|NCT03185130|Dopamine Agents|dopamine agents|mesh-ancestor
102391687|NCT00358618|Propofol|propofol|mesh-list
102391688|NCT00358618|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102391689|NCT00358618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102391690|NCT00358618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391691|NCT00358618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102391692|NCT00358618|Anesthetics, General|anesthetics, general|mesh-ancestor
102391693|NCT00358618|Anesthetics|anesthetics|mesh-ancestor
102391694|NCT02428764|Carboplatin|carboplatin|mesh-list
102391695|NCT02428764|Gemcitabine|gemcitabine|mesh-list
102391696|NCT02428764|Nimotuzumab|nimotuzumab|mesh-list
102391697|NCT02428764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102391698|NCT02428764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102391699|NCT02428764|Antimetabolites|antimetabolites|mesh-ancestor
102391700|NCT02428764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391701|NCT02428764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102391702|NCT00358696|Tenofovir|tenofovir|mesh-list
102391703|NCT00358696|Antiviral Agents|antiviral agents|mesh-ancestor
102391704|NCT00358696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102391705|NCT00358696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102391706|NCT00358696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102391707|NCT00358696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102391708|NCT00358696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391709|NCT00358696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102391710|NCT00358696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102391711|NCT05429476|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102391712|NCT05429476|Plasminogen|plasminogen|mesh-list
102391713|NCT05429476|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102391714|NCT05429476|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102391715|NCT05429476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391716|NCT00360178|Amlodipine|amlodipine|mesh-list
102391717|NCT00360178|Valsartan|valsartan|mesh-list
102391718|NCT00360178|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102391719|NCT00360178|Candesartan|candesartan|mesh-list
102391720|NCT00360178|Candesartan cilexetil|candesartan cilexetil|mesh-list
102391721|NCT00360178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102391722|NCT00360178|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102391723|NCT00360178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102391724|NCT00360178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391725|NCT00360178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102391726|NCT00360178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391727|NCT00360178|Vasodilator Agents|vasodilator agents|mesh-ancestor
102391728|NCT00360178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102391729|NCT00360178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102391730|NCT00360178|Diuretics|diuretics|mesh-ancestor
102391731|NCT00360178|Natriuretic Agents|natriuretic agents|mesh-ancestor
102391732|NCT00360178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102391733|NCT00421720|Sufentanil|sufentanil|mesh-list
102391734|NCT00421720|Remifentanil|remifentanil|mesh-list
102391735|NCT00421720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102391736|NCT00421720|Narcotics|narcotics|mesh-ancestor
102391737|NCT00421720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102391738|NCT00421720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391739|NCT00421720|Analgesics|analgesics|mesh-ancestor
102391740|NCT00421720|Sensory System Agents|sensory system agents|mesh-ancestor
102391741|NCT00421720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102391742|NCT00421720|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102391743|NCT00421720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102391744|NCT00421720|Anesthetics, General|anesthetics, general|mesh-ancestor
102391745|NCT00421720|Anesthetics|anesthetics|mesh-ancestor
102391746|NCT05008276|Dextrans|dextrans|mesh-list
102391747|NCT05008276|Anticoagulants|anticoagulants|mesh-ancestor
102391748|NCT05008276|Plasma Substitutes|plasma substitutes|mesh-ancestor
102391749|NCT05008276|Blood Substitutes|blood substitutes|mesh-ancestor
102391750|NCT00358930|Beta-lapachone|beta-lapachone|mesh-list
102391751|NCT00358930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102203473|NCT02223299|Tryptophan|tryptophan|mesh-list
102391752|NCT00358930|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102391753|NCT00358930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102391755|NCT00358930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391756|NCT00358930|Antiviral Agents|antiviral agents|mesh-ancestor
102391757|NCT04492306|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
102391758|NCT04492306|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102391759|NCT04492306|Protective Agents|protective agents|mesh-ancestor
102391760|NCT04492306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391761|NCT04492306|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102391762|NCT04492306|Antioxidants|antioxidants|mesh-ancestor
102391763|NCT04492306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391764|NCT04941898|Factor VIII|factor viii|mesh-list
102391765|NCT04941898|BAX 855|bax 855|mesh-list
102391766|NCT04941898|Coagulants|coagulants|mesh-ancestor
102391767|NCT04468360|Pregnanolone|pregnanolone|mesh-list
102391768|NCT04468360|Brexanolone|brexanolone|mesh-list
102391769|NCT04468360|Anesthetics|anesthetics|mesh-ancestor
102391770|NCT04468360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102391771|NCT04468360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391772|NCT04468360|Neurosteroids|neurosteroids|mesh-ancestor
102391773|NCT04468360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102391774|NCT04468360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391775|NCT04468360|GABA Modulators|gaba modulators|mesh-ancestor
102391776|NCT04468360|GABA Agents|gaba agents|mesh-ancestor
102391777|NCT02977312|Imatinib Mesylate|imatinib mesylate|mesh-list
102391778|NCT02977312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102391779|NCT02977312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102391780|NCT02977312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102391781|NCT02977312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391782|NCT04907110|Niacinamide|niacinamide|mesh-list
102391783|NCT04907110|Vitamin B Complex|vitamin b complex|mesh-ancestor
102391784|NCT04907110|Vitamins|vitamins|mesh-ancestor
102391785|NCT04907110|Micronutrients|micronutrients|mesh-ancestor
102391786|NCT04907110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391787|NCT04394416|Imatinib Mesylate|imatinib mesylate|mesh-list
102391788|NCT04394416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102391789|NCT04394416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102391790|NCT04394416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102391791|NCT04394416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391792|NCT04887298|Annamycin|annamycin|mesh-list
102391793|NCT04887298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102391794|NCT04887298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102391795|NCT02977000|Propranolol|propranolol|mesh-list
102391796|NCT02977000|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102391797|NCT02977000|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102391798|NCT02977000|Adrenergic Agents|adrenergic agents|mesh-ancestor
102391799|NCT02977000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102391800|NCT02977000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391801|NCT02977000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391802|NCT02977000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102391803|NCT02977000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102391804|NCT02977000|Vasodilator Agents|vasodilator agents|mesh-ancestor
102391805|NCT02975986|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
102391806|NCT02975986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102391807|NCT02975986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391808|NCT00112827|Cyclophosphamide|cyclophosphamide|mesh-list
102391809|NCT00112827|Melphalan|melphalan|mesh-list
102391810|NCT00112827|Lenalidomide|lenalidomide|mesh-list
102391811|NCT00112827|Lenograstim|lenograstim|mesh-list
102391812|NCT00112827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102391813|NCT00112827|Immunologic Factors|immunologic factors|mesh-ancestor
102391814|NCT00112827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391815|NCT00112827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102391816|NCT00112827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102391817|NCT00112827|Alkylating Agents|alkylating agents|mesh-ancestor
102391818|NCT00112827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391819|NCT00112827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102391820|NCT00112827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102391821|NCT00112827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102391822|NCT00112827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102391823|NCT00112827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102391824|NCT00112827|Growth Substances|growth substances|mesh-ancestor
102391825|NCT00112827|Growth Inhibitors|growth inhibitors|mesh-ancestor
102391826|NCT04752111|Esmolol|esmolol|mesh-list
102391827|NCT04752111|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102391828|NCT04752111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102391829|NCT04752111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102391830|NCT04752111|Adrenergic Agents|adrenergic agents|mesh-ancestor
102391831|NCT04752111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102391832|NCT04752111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391833|NCT04752111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391834|NCT04343170|Folic Acid|folic acid|mesh-list
102391835|NCT04343170|Vitamin B 12|vitamin b 12|mesh-list
102391836|NCT04343170|Hydroxocobalamin|hydroxocobalamin|mesh-list
102391837|NCT04343170|Epoetin Alfa|epoetin alfa|mesh-list
102391838|NCT04343170|Vitamins|vitamins|mesh-ancestor
102391839|NCT04343170|Micronutrients|micronutrients|mesh-ancestor
102391840|NCT04343170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391841|NCT04343170|Hematinics|hematinics|mesh-ancestor
102391842|NCT04343170|Vitamin B Complex|vitamin b complex|mesh-ancestor
102391843|NCT00226239|Docetaxel|docetaxel|mesh-list
102391844|NCT00226239|Cetuximab|cetuximab|mesh-list
102391845|NCT00226239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102391846|NCT00226239|Tubulin Modulators|tubulin modulators|mesh-ancestor
102391847|NCT00226239|Antimitotic Agents|antimitotic agents|mesh-ancestor
102391848|NCT00226239|Mitosis Modulators|mitosis modulators|mesh-ancestor
102391849|NCT00226239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391850|NCT00226239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102391851|NCT00227019|Vitamins|vitamins|mesh-list
102391852|NCT00227019|Folic Acid|folic acid|mesh-list
102391853|NCT00227019|Vitamin B 12|vitamin b 12|mesh-list
102391854|NCT00227019|Vitamin B Complex|vitamin b complex|mesh-list
102391855|NCT00227019|Dexamethasone|dexamethasone|mesh-list
102391856|NCT00227019|Bevacizumab|bevacizumab|mesh-list
102391857|NCT00227019|Pemetrexed|pemetrexed|mesh-list
102391858|NCT00227019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102391859|NCT00227019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102391860|NCT00227019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102391861|NCT00227019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102391862|NCT00227019|Growth Substances|growth substances|mesh-ancestor
102391863|NCT00227019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391864|NCT00227019|Growth Inhibitors|growth inhibitors|mesh-ancestor
102391865|NCT00227019|Micronutrients|micronutrients|mesh-ancestor
102391866|NCT00227019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102391867|NCT00227019|Antiemetics|antiemetics|mesh-ancestor
102391868|NCT00227019|Autonomic Agents|autonomic agents|mesh-ancestor
102391869|NCT00227019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102391870|NCT00227019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102391871|NCT00227019|Glucocorticoids|glucocorticoids|mesh-ancestor
102391872|NCT00227019|Hormones|hormones|mesh-ancestor
102391873|NCT00227019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102391874|NCT00227019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102391875|NCT00227019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102391876|NCT00227019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391877|NCT00227019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102391878|NCT00227019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102391879|NCT00227019|Hematinics|hematinics|mesh-ancestor
102391880|NCT00113217|Bevacizumab|bevacizumab|mesh-list
102391881|NCT00113217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102391882|NCT00113217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102391883|NCT00113217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102391884|NCT00113217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102391885|NCT00113217|Growth Substances|growth substances|mesh-ancestor
102391886|NCT00113217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391887|NCT00113217|Growth Inhibitors|growth inhibitors|mesh-ancestor
102391888|NCT04718116|Tramadol|tramadol|mesh-list
102391889|NCT04718116|Tapentadol|tapentadol|mesh-list
102391890|NCT04718116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102391891|NCT04718116|Narcotics|narcotics|mesh-ancestor
102391892|NCT04718116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102391893|NCT04718116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391894|NCT04718116|Analgesics|analgesics|mesh-ancestor
102391895|NCT04718116|Sensory System Agents|sensory system agents|mesh-ancestor
102391896|NCT04718116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102391897|NCT04718116|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102391898|NCT04718116|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102391899|NCT04718116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102391900|NCT04718116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391901|NCT04718116|Adrenergic Agents|adrenergic agents|mesh-ancestor
102391902|NCT04718116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102391903|NCT04429503|Aflibercept|aflibercept|mesh-list
102391904|NCT04429503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102391905|NCT04429503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102391906|NCT04429503|Growth Substances|growth substances|mesh-ancestor
102391907|NCT04429503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391908|NCT04429503|Growth Inhibitors|growth inhibitors|mesh-ancestor
102391909|NCT04429503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102391910|NCT04276792|Analgesics, Opioid|analgesics, opioid|mesh-list
102391911|NCT04276792|Narcotics|narcotics|mesh-ancestor
102391912|NCT04276792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102391913|NCT04276792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391914|NCT04276792|Analgesics|analgesics|mesh-ancestor
102391915|NCT04276792|Sensory System Agents|sensory system agents|mesh-ancestor
102391916|NCT04276792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102391917|NCT00053703|Olanzapine|olanzapine|mesh-list
102391918|NCT00053703|Risperidone|risperidone|mesh-list
102391919|NCT00053703|Molindone|molindone|mesh-list
102391920|NCT00053703|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102391921|NCT00053703|Serotonin Agents|serotonin agents|mesh-ancestor
102391922|NCT00053703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102391923|NCT00053703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391924|NCT00053703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391925|NCT00053703|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102391926|NCT00053703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102391927|NCT00053703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102391928|NCT00053703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102391929|NCT00053703|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102391930|NCT00053703|Dopamine Agents|dopamine agents|mesh-ancestor
102391931|NCT00053703|Antiemetics|antiemetics|mesh-ancestor
102391932|NCT00053703|Autonomic Agents|autonomic agents|mesh-ancestor
102391933|NCT00053703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102391934|NCT00053703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102391935|NCT00053703|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102391936|NCT00053703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102391937|NCT00053703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102391938|NCT02975440|Rifampin|rifampin|mesh-list
102391939|NCT02975440|Midazolam|midazolam|mesh-list
102391940|NCT02975440|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102391941|NCT02975440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102391942|NCT02975440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102391943|NCT02975440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391944|NCT02975440|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102391945|NCT02975440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102391946|NCT02975440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102391947|NCT02975440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102391948|NCT02975440|Anesthetics, General|anesthetics, general|mesh-ancestor
102391949|NCT02975440|Anesthetics|anesthetics|mesh-ancestor
102391950|NCT02975440|GABA Modulators|gaba modulators|mesh-ancestor
102391951|NCT02975440|GABA Agents|gaba agents|mesh-ancestor
102391952|NCT02975440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102391953|NCT02975440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391954|NCT02975440|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102391955|NCT02975440|Antitubercular Agents|antitubercular agents|mesh-ancestor
102391956|NCT02975440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102391957|NCT02975440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102391958|NCT02975440|Leprostatic Agents|leprostatic agents|mesh-ancestor
102391959|NCT02975440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102391960|NCT02975440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102391961|NCT02975440|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102391962|NCT02975440|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102391963|NCT02975440|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102391964|NCT02975440|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102391965|NCT02975440|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102391966|NCT02975440|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102391967|NCT00231309|Lenograstim|lenograstim|mesh-list
102391968|NCT00231309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102391969|NCT00231309|Immunologic Factors|immunologic factors|mesh-ancestor
102391970|NCT00231309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102391971|NCT04267120|Pembrolizumab|pembrolizumab|mesh-list
102391972|NCT04267120|Lenvatinib|lenvatinib|mesh-list
102391973|NCT04267120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102391974|NCT04267120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102391975|NCT04267120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102391976|NCT04267120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391977|NCT04267120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102391978|NCT04267120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102203697|NCT03516955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102391979|NCT00232479|Carboplatin|carboplatin|mesh-list
102391980|NCT00232479|Docetaxel|docetaxel|mesh-list
102391981|NCT00232479|Trastuzumab|trastuzumab|mesh-list
102391982|NCT00232479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102391983|NCT00232479|Tubulin Modulators|tubulin modulators|mesh-ancestor
102391984|NCT00232479|Antimitotic Agents|antimitotic agents|mesh-ancestor
102391985|NCT00232479|Mitosis Modulators|mitosis modulators|mesh-ancestor
102391986|NCT00232479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391987|NCT00232479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102391988|NCT04710628|Pembrolizumab|pembrolizumab|mesh-list
102391989|NCT04710628|Lenvatinib|lenvatinib|mesh-list
102391990|NCT04710628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102391991|NCT04710628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102391992|NCT04710628|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102391993|NCT04710628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102391994|NCT04710628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102391995|NCT04710628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102391996|NCT00233103|Sertraline|sertraline|mesh-list
102391997|NCT00233103|Antidepressive Agents|antidepressive agents|mesh-ancestor
102391998|NCT00233103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102391999|NCT00233103|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102392000|NCT00233103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102392001|NCT00233103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102392002|NCT00233103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392003|NCT00233103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102392004|NCT00233103|Serotonin Agents|serotonin agents|mesh-ancestor
102392005|NCT00233103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392006|NCT00703014|Progesterone|progesterone|mesh-list
102392007|NCT00703014|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102392008|NCT00703014|Ganirelix|ganirelix|mesh-list
102392009|NCT00703014|Progestins|progestins|mesh-ancestor
102392010|NCT00703014|Hormones|hormones|mesh-ancestor
102392011|NCT00703014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102392012|NCT00703014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392013|NCT00703014|Hormone Antagonists|hormone antagonists|mesh-ancestor
102392014|NCT02433522|Rituximab|rituximab|mesh-list
102392015|NCT02433522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102392016|NCT02433522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102392017|NCT02433522|Immunologic Factors|immunologic factors|mesh-ancestor
102392018|NCT02433522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392019|NCT02433522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102392020|NCT02433912|Acetaminophen|acetaminophen|mesh-list
102392021|NCT02433912|Chlorhexidine|chlorhexidine|mesh-list
102392022|NCT02433912|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102392023|NCT02433912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102392024|NCT02433912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102392025|NCT02433912|Disinfectants|disinfectants|mesh-ancestor
102392026|NCT02433912|Dermatologic Agents|dermatologic agents|mesh-ancestor
102392027|NCT02433912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102392028|NCT02433912|Analgesics|analgesics|mesh-ancestor
102392029|NCT02433912|Sensory System Agents|sensory system agents|mesh-ancestor
102392030|NCT02433912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102392031|NCT02433912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392032|NCT02433912|Antipyretics|antipyretics|mesh-ancestor
102392033|NCT02436486|Moxifloxacin|moxifloxacin|mesh-list
102392034|NCT02436486|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
102392035|NCT02436486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102392036|NCT02436486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102392037|NCT02436486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102392038|NCT02436486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102392039|NCT02436486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102392040|NCT02436486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392041|NCT02436486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102392042|NCT02436486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392043|NCT02436486|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102392044|NCT02436486|Serotonin Agents|serotonin agents|mesh-ancestor
102392045|NCT02436486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102392046|NCT04342858|Listerine|listerine|mesh-list
102392047|NCT04342858|Fluorides|fluorides|mesh-list
102392048|NCT04342858|Sodium Fluoride|sodium fluoride|mesh-list
102392049|NCT04342858|Fluorides, Topical|fluorides, topical|mesh-list
102392050|NCT04342858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392051|NCT04342858|Cariostatic Agents|cariostatic agents|mesh-ancestor
102392052|NCT04342858|Protective Agents|protective agents|mesh-ancestor
102203774|NCT03159741|Glucagon|glucagon|mesh-list
102392053|NCT04342858|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102392054|NCT04342858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102392056|NCT02429076|Sevoflurane|sevoflurane|mesh-list
102392057|NCT02429076|Methylphenidate|methylphenidate|mesh-list
102392058|NCT02429076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102392059|NCT02429076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102392060|NCT02429076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392061|NCT02429076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102392062|NCT02429076|Anesthetics, General|anesthetics, general|mesh-ancestor
102392063|NCT02429076|Anesthetics|anesthetics|mesh-ancestor
102392064|NCT02429076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102392065|NCT02429076|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102392066|NCT02429076|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102392067|NCT02429076|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102392068|NCT02429076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102392069|NCT02429076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102392070|NCT02429076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392071|NCT02429076|Dopamine Agents|dopamine agents|mesh-ancestor
102392072|NCT02429076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102392073|NCT00255177|Mifepristone|mifepristone|mesh-list
102392074|NCT00255177|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102392075|NCT00255177|Abortifacient Agents|abortifacient agents|mesh-ancestor
102392076|NCT00255177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102392077|NCT00255177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392078|NCT00255177|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102392079|NCT00255177|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102392080|NCT00255177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102392081|NCT00255177|Contraceptive Agents|contraceptive agents|mesh-ancestor
102392082|NCT00255177|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102392083|NCT00255177|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102392084|NCT00255177|Hormone Antagonists|hormone antagonists|mesh-ancestor
102392085|NCT00255177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102392086|NCT00255177|Luteolytic Agents|luteolytic agents|mesh-ancestor
102392087|NCT00255177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102392088|NCT00255177|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102392089|NCT04670224|Anesthetics|anesthetics|mesh-list
102392090|NCT04670224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102392091|NCT04670224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392092|NCT00361114|Pyrimethamine|pyrimethamine|mesh-list
102392093|NCT00361114|Sulfadoxine|sulfadoxine|mesh-list
102392094|NCT00361114|Dapsone|dapsone|mesh-list
102392095|NCT00361114|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
102392096|NCT00361114|Chlorproguanil|chlorproguanil|mesh-list
102392097|NCT00361114|Antimalarials|antimalarials|mesh-ancestor
102392098|NCT00361114|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102392099|NCT00361114|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102392100|NCT00361114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102392101|NCT00361114|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102392102|NCT00361114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102392103|NCT00361114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392104|NCT00361114|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102392105|NCT00361114|Leprostatic Agents|leprostatic agents|mesh-ancestor
102392106|NCT00361114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102392107|NCT00702624|Hormones|hormones|mesh-list
102392108|NCT00702624|Progesterone|progesterone|mesh-list
102392109|NCT00702624|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102392110|NCT00702624|Ganirelix|ganirelix|mesh-list
102392111|NCT00702624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102392112|NCT00702624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392113|NCT00702624|Progestins|progestins|mesh-ancestor
102392114|NCT00702624|Hormone Antagonists|hormone antagonists|mesh-ancestor
102392115|NCT03915496|Abrocitinib|abrocitinib|mesh-list
102392116|NCT03915496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101941039|NCT01129323|Fludarabine|fludarabine|mesh-list
102392117|NCT03915496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102392118|NCT03915496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392119|NCT00702546|Hormones|hormones|mesh-list
102392120|NCT00702546|Progesterone|progesterone|mesh-list
102392121|NCT00702546|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102392122|NCT00702546|Ganirelix|ganirelix|mesh-list
102392123|NCT00702546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102392124|NCT00702546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392125|NCT00702546|Progestins|progestins|mesh-ancestor
102392126|NCT00702546|Hormone Antagonists|hormone antagonists|mesh-ancestor
102392127|NCT01372410|Tiotropium Bromide|tiotropium bromide|mesh-list
102392128|NCT01372410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102392129|NCT01372410|Autonomic Agents|autonomic agents|mesh-ancestor
102392130|NCT01372410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102392131|NCT01372410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392132|NCT01372410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102392133|NCT01372410|Respiratory System Agents|respiratory system agents|mesh-ancestor
102392134|NCT01372410|Parasympatholytics|parasympatholytics|mesh-ancestor
102392135|NCT01372410|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102392136|NCT01372410|Cholinergic Agents|cholinergic agents|mesh-ancestor
102392137|NCT01372410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102392138|NCT01372410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392139|NCT02428686|Epoetin Alfa|epoetin alfa|mesh-list
102392140|NCT02428686|Hematinics|hematinics|mesh-ancestor
102392141|NCT02432976|Insulin|insulin|mesh-list
102392142|NCT02432976|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102392143|NCT02432976|Exenatide|exenatide|mesh-list
102392144|NCT02432976|Insulin Lispro|insulin lispro|mesh-list
102392145|NCT02432976|Incretins|incretins|mesh-list
102392146|NCT02432976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102392147|NCT02432976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392148|NCT02432976|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102392149|NCT02432976|Hormones|hormones|mesh-ancestor
102392150|NCT02432976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102392151|NCT02428374|Clopidogrel|clopidogrel|mesh-list
102392152|NCT02428374|Ticagrelor|ticagrelor|mesh-list
102392153|NCT02428374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102392154|NCT02428374|Simvastatin|simvastatin|mesh-list
102392155|NCT02428374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102392156|NCT02428374|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102392157|NCT02428374|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102392158|NCT02428374|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102392159|NCT02428374|Purinergic Agents|purinergic agents|mesh-ancestor
102392160|NCT02428374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102392161|NCT02428374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392162|NCT02428374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392163|NCT02428374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102392164|NCT02428374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102392165|NCT02428374|Antimetabolites|antimetabolites|mesh-ancestor
102392166|NCT02428374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102392167|NCT02428374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102392168|NCT02428374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102392169|NCT02428218|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102392170|NCT02428218|Dermatologic Agents|dermatologic agents|mesh-ancestor
102392171|NCT02428218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102392172|NCT02428218|Immunologic Factors|immunologic factors|mesh-ancestor
102392173|NCT02428218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392174|NCT04606576|Insulin|insulin|mesh-list
102392175|NCT04606576|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102392176|NCT04606576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102392177|NCT04606576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392178|NCT02428062|Phenylephrine|phenylephrine|mesh-list
102392179|NCT02428062|Dopamine|dopamine|mesh-list
102392180|NCT02428062|Epinephrine|epinephrine|mesh-list
102392181|NCT02428062|Oxymetazoline|oxymetazoline|mesh-list
102392182|NCT02428062|Norepinephrine|norepinephrine|mesh-list
102392183|NCT02428062|Ephedrine|ephedrine|mesh-list
102392184|NCT02428062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
102392185|NCT02428062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392186|NCT02428062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102392187|NCT02428062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102392188|NCT02428062|Adrenergic Agents|adrenergic agents|mesh-ancestor
102392189|NCT02428062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102392190|NCT02428062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392191|NCT02428062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102392192|NCT02428062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102392193|NCT02428062|Autonomic Agents|autonomic agents|mesh-ancestor
102392194|NCT02428062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102392195|NCT02428062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102392196|NCT02428062|Respiratory System Agents|respiratory system agents|mesh-ancestor
102392197|NCT02428062|Mydriatics|mydriatics|mesh-ancestor
102392198|NCT02428062|Sympathomimetics|sympathomimetics|mesh-ancestor
102392199|NCT02428062|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102392200|NCT02428062|Nasal Decongestants|nasal decongestants|mesh-ancestor
102392201|NCT02428062|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102392202|NCT02428062|Protective Agents|protective agents|mesh-ancestor
102392203|NCT02428062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102392204|NCT02428062|Dopamine Agents|dopamine agents|mesh-ancestor
102392205|NCT04594798|Prednisone|prednisone|mesh-list
102392206|NCT04594798|Cyclophosphamide|cyclophosphamide|mesh-list
102392208|NCT04594798|Doxorubicin|doxorubicin|mesh-list
102392209|NCT04594798|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
102392210|NCT04594798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102392211|NCT04594798|Immunologic Factors|immunologic factors|mesh-ancestor
102392212|NCT04594798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392213|NCT04594798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102392214|NCT04594798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102392215|NCT04594798|Alkylating Agents|alkylating agents|mesh-ancestor
102392216|NCT04594798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392217|NCT04594798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102392218|NCT04594798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102392219|NCT04594798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102392220|NCT04594798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102392221|NCT04594798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102392222|NCT04594798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102392223|NCT04594798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102392224|NCT04594798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102392225|NCT04594798|Glucocorticoids|glucocorticoids|mesh-ancestor
102392226|NCT04594798|Hormones|hormones|mesh-ancestor
102392227|NCT04594798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102392228|NCT04594798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102392229|NCT04594798|Immunoconjugates|immunoconjugates|mesh-ancestor
102392230|NCT02432664|Midazolam|midazolam|mesh-list
102392231|NCT02432664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102392232|NCT02432664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101941060|NCT01222923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102392233|NCT02432664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102392234|NCT02432664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392235|NCT02432664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102392236|NCT02432664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102392237|NCT02432664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102392238|NCT02432664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102392239|NCT02432664|Anesthetics, General|anesthetics, general|mesh-ancestor
102392240|NCT02432664|Anesthetics|anesthetics|mesh-ancestor
102392241|NCT02432664|GABA Modulators|gaba modulators|mesh-ancestor
102392242|NCT02432664|GABA Agents|gaba agents|mesh-ancestor
102392243|NCT02432664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102392244|NCT02432664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392245|NCT03189186|Pembrolizumab|pembrolizumab|mesh-list
102392246|NCT03189186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102392247|NCT03189186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102392248|NCT03189186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102392249|NCT03189186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392250|NCT00361894|Enoxaparin|enoxaparin|mesh-list
102392251|NCT00361894|Rivaroxaban|rivaroxaban|mesh-list
102392252|NCT00361894|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102392253|NCT00361894|Antithrombins|antithrombins|mesh-ancestor
102392254|NCT00361894|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102392255|NCT00361894|Protease Inhibitors|protease inhibitors|mesh-ancestor
102392256|NCT00361894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102392257|NCT00361894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392258|NCT00361894|Anticoagulants|anticoagulants|mesh-ancestor
102392259|NCT00361894|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102392260|NCT00361894|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102392261|NCT03185988|Trastuzumab|trastuzumab|mesh-list
102392262|NCT03185988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102392263|NCT03185988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102392264|NCT00361348|Heparin|heparin|mesh-list
102392265|NCT00361348|Anticoagulants|anticoagulants|mesh-ancestor
102392266|NCT00361348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102392267|NCT00361348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102392268|NCT00361348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392269|NCT02431728|Melatonin|melatonin|mesh-list
102392270|NCT02431728|Antioxidants|antioxidants|mesh-ancestor
102392271|NCT02431728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392272|NCT02431728|Protective Agents|protective agents|mesh-ancestor
102392273|NCT02431728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392274|NCT02431728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102392275|NCT04343326|Menthol|menthol|mesh-list
102392276|NCT04343326|Antipruritics|antipruritics|mesh-ancestor
102392277|NCT04343326|Dermatologic Agents|dermatologic agents|mesh-ancestor
102392278|NCT00362206|Simvastatin|simvastatin|mesh-list
102392279|NCT00362206|Pravastatin|pravastatin|mesh-list
102392280|NCT00362206|Fenofibrate|fenofibrate|mesh-list
102392281|NCT00362206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102392282|NCT00362206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102392283|NCT00362206|Antimetabolites|antimetabolites|mesh-ancestor
102392284|NCT00362206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392285|NCT00362206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102392286|NCT00362206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102392287|NCT00362206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102392288|NCT02314468|Glycerol|glycerol|mesh-list
102392289|NCT02314468|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102392290|NCT02314468|Protective Agents|protective agents|mesh-ancestor
102392291|NCT02314468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392292|NCT01704287|Paclitaxel|paclitaxel|mesh-list
102392293|NCT01704287|Carboplatin|carboplatin|mesh-list
102392294|NCT01704287|Pembrolizumab|pembrolizumab|mesh-list
102392295|NCT01704287|Temozolomide|temozolomide|mesh-list
102392296|NCT01704287|Dacarbazine|dacarbazine|mesh-list
102392297|NCT01704287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102392298|NCT01704287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102392299|NCT01704287|Tubulin Modulators|tubulin modulators|mesh-ancestor
102392300|NCT01704287|Antimitotic Agents|antimitotic agents|mesh-ancestor
102392301|NCT01704287|Mitosis Modulators|mitosis modulators|mesh-ancestor
102392302|NCT01704287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392303|NCT01704287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102392304|NCT01704287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102392305|NCT01704287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102392306|NCT01704287|Alkylating Agents|alkylating agents|mesh-ancestor
102392307|NCT00362752|Norfloxacin|norfloxacin|mesh-list
102392308|NCT00362752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102392309|NCT00362752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102392310|NCT00362752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102392311|NCT00362752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102392312|NCT00362752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102392313|NCT00362752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392314|NCT00362752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102392315|NCT00362752|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102392316|NCT00362752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102392317|NCT00118209|Prednisone|prednisone|mesh-list
102392318|NCT00118209|Cyclophosphamide|cyclophosphamide|mesh-list
102392319|NCT00118209|Rituximab|rituximab|mesh-list
102392320|NCT00118209|Doxorubicin|doxorubicin|mesh-list
102392321|NCT00118209|Etoposide|etoposide|mesh-list
102392322|NCT00118209|Vincristine|vincristine|mesh-list
102392323|NCT00118209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102392324|NCT00118209|Immunologic Factors|immunologic factors|mesh-ancestor
102392325|NCT00118209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392326|NCT00118209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102392327|NCT00118209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102392328|NCT00118209|Alkylating Agents|alkylating agents|mesh-ancestor
102392329|NCT00118209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392330|NCT00118209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102392331|NCT00118209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102392332|NCT00118209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102392333|NCT00118209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102392334|NCT00118209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102392335|NCT00118209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102392336|NCT00118209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102392337|NCT00118209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102392338|NCT00118209|Glucocorticoids|glucocorticoids|mesh-ancestor
102392339|NCT00118209|Hormones|hormones|mesh-ancestor
102392340|NCT00118209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102392341|NCT00118209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102392342|NCT00118209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102392343|NCT00118209|Tubulin Modulators|tubulin modulators|mesh-ancestor
102392344|NCT00118209|Antimitotic Agents|antimitotic agents|mesh-ancestor
102392345|NCT00118209|Mitosis Modulators|mitosis modulators|mesh-ancestor
102392346|NCT01897779|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
102392347|NCT01897779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102392348|NCT01897779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392349|NCT01897779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102392350|NCT01897779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102392351|NCT04342156|Hydroxychloroquine|hydroxychloroquine|mesh-list
102392352|NCT04342156|Antimalarials|antimalarials|mesh-ancestor
102392353|NCT04342156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102392354|NCT04342156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102392355|NCT04342156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102392356|NCT04342156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102392357|NCT04342156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392358|NCT04342156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102392359|NCT01682837|Potassium Citrate|potassium citrate|mesh-list
102392360|NCT01682837|Magnesium citrate|magnesium citrate|mesh-list
102392361|NCT01682837|Citric Acid|citric acid|mesh-list
102392362|NCT01682837|Sodium Citrate|sodium citrate|mesh-list
102392363|NCT01682837|Anticoagulants|anticoagulants|mesh-ancestor
102392364|NCT01682837|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102392365|NCT01682837|Chelating Agents|chelating agents|mesh-ancestor
102392366|NCT01682837|Sequestering Agents|sequestering agents|mesh-ancestor
102392367|NCT01682837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392368|NCT01682837|Diuretics|diuretics|mesh-ancestor
102392369|NCT01682837|Natriuretic Agents|natriuretic agents|mesh-ancestor
102392370|NCT01682837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392371|NCT01682837|Expectorants|expectorants|mesh-ancestor
102392372|NCT01682837|Respiratory System Agents|respiratory system agents|mesh-ancestor
102392373|NCT01682837|Cathartics|cathartics|mesh-ancestor
102392374|NCT01682837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102392375|NCT02213068|Mycophenolic Acid|mycophenolic acid|mesh-list
102392376|NCT02213068|Abatacept|abatacept|mesh-list
102392377|NCT02213068|Tacrolimus|tacrolimus|mesh-list
102392378|NCT02213068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102392379|NCT02213068|Immunologic Factors|immunologic factors|mesh-ancestor
102392380|NCT02213068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392381|NCT02213068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102392382|NCT02213068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102392383|NCT02213068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392384|NCT02213068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102392385|NCT02213068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102392386|NCT02213068|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102392387|NCT02213068|Antitubercular Agents|antitubercular agents|mesh-ancestor
102392388|NCT02213068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102392389|NCT02213068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102392390|NCT02213068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102392391|NCT02213068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102392392|NCT02213068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102392393|NCT00702234|Progesterone|progesterone|mesh-list
102392394|NCT00702234|Progestins|progestins|mesh-ancestor
102392395|NCT00702234|Hormones|hormones|mesh-ancestor
102392396|NCT00702234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102392397|NCT00702234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392398|NCT04483284|Chlorotrianisene|chlorotrianisene|mesh-list
102392399|NCT04483284|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102392400|NCT04483284|Estrogens|estrogens|mesh-ancestor
102392401|NCT04483284|Hormones|hormones|mesh-ancestor
102392402|NCT04483284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102392403|NCT04483284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392404|NCT04483284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102392405|NCT04483284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102392406|NCT00235833|Adalimumab|adalimumab|mesh-list
102392407|NCT00235833|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102392408|NCT00235833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102392409|NCT00235833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102392410|NCT00255801|Doxorubicin|doxorubicin|mesh-list
102392411|NCT00255801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102392412|NCT00255801|Bexarotene|bexarotene|mesh-list
102392413|NCT00255801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102392414|NCT00255801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102392415|NCT00255801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102392416|NCT00255801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102392417|NCT00255801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102392418|NCT00255801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392419|NCT02431416|Hormones|hormones|mesh-list
102392420|NCT02431416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102392421|NCT02431416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392422|NCT04751955|Capecitabine|capecitabine|mesh-list
102392423|NCT04751955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102392424|NCT04751955|Antimetabolites|antimetabolites|mesh-ancestor
102392425|NCT04751955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392426|NCT04751955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102392427|NCT01682759|Metformin|metformin|mesh-list
102392428|NCT01682759|Insulin Glargine|insulin glargine|mesh-list
102392429|NCT01682759|Glimepiride|glimepiride|mesh-list
102392430|NCT01682759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102392431|NCT01682759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204149|NCT02229773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102392432|NCT01682759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102392433|NCT01682759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102392434|NCT01682759|Immunologic Factors|immunologic factors|mesh-ancestor
102392435|NCT01682681|Topiramate|topiramate|mesh-list
102392436|NCT01682681|Anticonvulsants|anticonvulsants|mesh-ancestor
102392437|NCT01682681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102392438|NCT01682681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392439|NCT01682603|Botulinum Toxins|botulinum toxins|mesh-list
102392440|NCT01682603|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102392441|NCT01682603|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102392442|NCT01682603|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102392443|NCT01682603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102392444|NCT01682603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392445|NCT01682603|Cholinergic Agents|cholinergic agents|mesh-ancestor
102392446|NCT01682603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102392447|NCT01682603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392448|NCT01682603|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102392449|NCT01682603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102392450|NCT03183024|Benralizumab|benralizumab|mesh-list
102392451|NCT03183024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102392452|NCT03183024|Respiratory System Agents|respiratory system agents|mesh-ancestor
102392453|NCT00240981|Testosterone|testosterone|mesh-list
102392454|NCT00240981|Androgens|androgens|mesh-ancestor
102392455|NCT00240981|Hormones|hormones|mesh-ancestor
102392456|NCT00240981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102392457|NCT00240981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392458|NCT01682213|Dabrafenib|dabrafenib|mesh-list
102392459|NCT01682213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102392460|NCT01682213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102392461|NCT01682213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102392462|NCT01682213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392463|NCT04134923|Corticosterone|corticosterone|mesh-list
102392464|NCT04134923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101941125|NCT05284942|Prednisone|prednisone|mesh-list
102392465|NCT02126553|Lenalidomide|lenalidomide|mesh-list
102392466|NCT02126553|Immunologic Factors|immunologic factors|mesh-ancestor
102392467|NCT02126553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392468|NCT02126553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102392469|NCT02126553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102392470|NCT02126553|Growth Substances|growth substances|mesh-ancestor
102392471|NCT02126553|Growth Inhibitors|growth inhibitors|mesh-ancestor
102392472|NCT02126553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102392473|NCT01703741|Testosterone|testosterone|mesh-list
102392474|NCT01703741|Androgens|androgens|mesh-ancestor
102392475|NCT01703741|Hormones|hormones|mesh-ancestor
102392476|NCT01703741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102392477|NCT01703741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392478|NCT02425176|Botulinum Toxins|botulinum toxins|mesh-list
102392479|NCT02425176|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102392480|NCT02425176|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102392481|NCT02425176|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102392482|NCT02425176|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102392483|NCT02425176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102392484|NCT02425176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392485|NCT02425176|Cholinergic Agents|cholinergic agents|mesh-ancestor
102392486|NCT02425176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102392487|NCT02425176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392488|NCT02425176|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102392489|NCT02425176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102392490|NCT02430714|Lenvatinib|lenvatinib|mesh-list
102392491|NCT02430714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102392492|NCT02430714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102392493|NCT02430714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102392494|NCT02430714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392495|NCT02425254|Acetaminophen|acetaminophen|mesh-list
102392496|NCT02425254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102392497|NCT02425254|Analgesics|analgesics|mesh-ancestor
102392498|NCT02425254|Sensory System Agents|sensory system agents|mesh-ancestor
102392499|NCT02425254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102392500|NCT02425254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392501|NCT02425254|Antipyretics|antipyretics|mesh-ancestor
102392502|NCT02426736|Dexamethasone|dexamethasone|mesh-list
102392503|NCT02426736|Bupivacaine|bupivacaine|mesh-list
102392504|NCT02426736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102392505|NCT02426736|Antiemetics|antiemetics|mesh-ancestor
102392506|NCT02426736|Autonomic Agents|autonomic agents|mesh-ancestor
102392507|NCT02426736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102392508|NCT02426736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392509|NCT02426736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102392510|NCT02426736|Glucocorticoids|glucocorticoids|mesh-ancestor
102392511|NCT02426736|Hormones|hormones|mesh-ancestor
102392512|NCT02426736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102392513|NCT02426736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102392514|NCT02426736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102392515|NCT02426736|Anesthetics, Local|anesthetics, local|mesh-ancestor
102392516|NCT02426736|Anesthetics|anesthetics|mesh-ancestor
102392517|NCT02426736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101941161|NCT03647956|Pemetrexed|pemetrexed|mesh-list
102392518|NCT02426736|Sensory System Agents|sensory system agents|mesh-ancestor
102392519|NCT03182634|Fulvestrant|fulvestrant|mesh-list
102392520|NCT03182634|Olaparib|olaparib|mesh-list
102392521|NCT03182634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102392522|NCT03182634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102392523|NCT03182634|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102392524|NCT03182634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102392525|NCT03182634|Hormone Antagonists|hormone antagonists|mesh-ancestor
102392526|NCT03182634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102392527|NCT03182634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392528|NCT03182634|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102392529|NCT03182634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102392530|NCT03182634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392531|NCT03182322|Insulin|insulin|mesh-list
102392532|NCT03182322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102392533|NCT03182322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392534|NCT03185364|Sildenafil Citrate|sildenafil citrate|mesh-list
102392535|NCT03185364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392536|NCT03185364|Vasodilator Agents|vasodilator agents|mesh-ancestor
102392537|NCT03185364|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102392538|NCT03185364|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102392539|NCT03185364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102392540|NCT03185364|Urological Agents|urological agents|mesh-ancestor
102392541|NCT02424552|Vitamin D|vitamin d|mesh-list
102392542|NCT02424552|Cholecalciferol|cholecalciferol|mesh-list
102392543|NCT02424552|Vitamins|vitamins|mesh-ancestor
102392544|NCT02424552|Micronutrients|micronutrients|mesh-ancestor
102392545|NCT02424552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392546|NCT02424552|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102392547|NCT02424552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102392548|NCT03182088|Norepinephrine|norepinephrine|mesh-list
102392549|NCT03182088|Bupivacaine|bupivacaine|mesh-list
102392550|NCT03182088|Anesthetics, Local|anesthetics, local|mesh-ancestor
102392551|NCT03182088|Anesthetics|anesthetics|mesh-ancestor
102392552|NCT03182088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102392553|NCT03182088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392554|NCT03182088|Sensory System Agents|sensory system agents|mesh-ancestor
102392555|NCT03182088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102392556|NCT03182088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102392557|NCT03182088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102392558|NCT03182088|Adrenergic Agents|adrenergic agents|mesh-ancestor
102392559|NCT03182088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102392560|NCT03182088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392561|NCT03182088|Sympathomimetics|sympathomimetics|mesh-ancestor
102392562|NCT03182088|Autonomic Agents|autonomic agents|mesh-ancestor
102392563|NCT03182088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102392564|NCT02425878|Ulipristal acetate|ulipristal acetate|mesh-list
102392565|NCT02425878|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102392566|NCT02425878|Contraceptive Agents|contraceptive agents|mesh-ancestor
102392567|NCT02425878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102392568|NCT02425878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392569|NCT02425878|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102392570|NCT02425722|Linaclotide|linaclotide|mesh-list
102392571|NCT02425722|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102392572|NCT02425722|Enzyme Activators|enzyme activators|mesh-ancestor
102392573|NCT02425722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392574|NCT02425722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102392575|NCT02061514|Propofol|propofol|mesh-list
102392576|NCT02061514|Desflurane|desflurane|mesh-list
102392577|NCT02061514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102392578|NCT02061514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102392579|NCT02061514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392580|NCT02061514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102392581|NCT02061514|Anesthetics, General|anesthetics, general|mesh-ancestor
102392582|NCT02061514|Anesthetics|anesthetics|mesh-ancestor
102392583|NCT02061514|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102392584|NCT03183492|Vaccines|vaccines|mesh-list
102392585|NCT03183492|Immunologic Factors|immunologic factors|mesh-ancestor
102392586|NCT03183492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392587|NCT02424318|Topiramate|topiramate|mesh-list
102392588|NCT02424318|Anticonvulsants|anticonvulsants|mesh-ancestor
102392589|NCT02424318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102392590|NCT02424318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392591|NCT03179280|Insulin|insulin|mesh-list
102392592|NCT03179280|Insulin Aspart|insulin aspart|mesh-list
102392593|NCT03179280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102392594|NCT03179280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392595|NCT01681433|Prednisone|prednisone|mesh-list
102392596|NCT01681433|Abiraterone Acetate|abiraterone acetate|mesh-list
102392597|NCT01681433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102392598|NCT01681433|Glucocorticoids|glucocorticoids|mesh-ancestor
102392599|NCT01681433|Hormones|hormones|mesh-ancestor
102392600|NCT01681433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102392601|NCT01681433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392602|NCT01681433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102392603|NCT01681433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102392604|NCT01681433|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102392605|NCT01681433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102392606|NCT01681433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392607|NCT01681433|Hormone Antagonists|hormone antagonists|mesh-ancestor
102392608|NCT01681433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102392609|NCT01703117|Riluzole|riluzole|mesh-list
102392610|NCT01703117|Anticonvulsants|anticonvulsants|mesh-ancestor
102392611|NCT01703117|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102392612|NCT01703117|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102392613|NCT01703117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102392614|NCT01703117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392615|NCT01703117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392616|NCT01703117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102392617|NCT01703117|Protective Agents|protective agents|mesh-ancestor
102392618|NCT01702961|Cytarabine|cytarabine|mesh-list
102392619|NCT01702961|Etoposide|etoposide|mesh-list
102392620|NCT01702961|Rituximab|rituximab|mesh-list
102392621|NCT01702961|Melphalan|melphalan|mesh-list
102392622|NCT01702961|Carmustine|carmustine|mesh-list
102392623|NCT01702961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102392624|NCT01702961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102392625|NCT01702961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102392626|NCT01702961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102392627|NCT01702961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102392628|NCT01702961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392629|NCT01702961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102392630|NCT01702961|Antimetabolites|antimetabolites|mesh-ancestor
102392631|NCT01702961|Antiviral Agents|antiviral agents|mesh-ancestor
102392632|NCT01702961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102392633|NCT01702961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102392634|NCT01702961|Immunologic Factors|immunologic factors|mesh-ancestor
102392635|NCT01702961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392636|NCT01702961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102392637|NCT01702961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102392638|NCT01702961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102392639|NCT01702961|Alkylating Agents|alkylating agents|mesh-ancestor
102392640|NCT01702961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102392641|NCT01702025|Aminophylline|aminophylline|mesh-list
102392642|NCT01702025|Methazolamide|methazolamide|mesh-list
102392643|NCT01702025|Theophylline|theophylline|mesh-list
101941174|NCT01221675|Antibodies|antibodies|mesh-list
102392644|NCT01702025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102392645|NCT01702025|Autonomic Agents|autonomic agents|mesh-ancestor
102392646|NCT01702025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102392647|NCT01702025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392648|NCT01702025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102392649|NCT01702025|Respiratory System Agents|respiratory system agents|mesh-ancestor
102392650|NCT01702025|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102392651|NCT01702025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102392652|NCT01702025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392653|NCT01702025|Vasodilator Agents|vasodilator agents|mesh-ancestor
102204374|NCT02233205|Antimetabolites|antimetabolites|mesh-ancestor
102392654|NCT01702025|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102392655|NCT01702025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102392656|NCT01702025|Purinergic Agents|purinergic agents|mesh-ancestor
102392657|NCT01702025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102392658|NCT01702025|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102392659|NCT01702025|Protective Agents|protective agents|mesh-ancestor
102392660|NCT01702025|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102392661|NCT01702025|Diuretics|diuretics|mesh-ancestor
102392662|NCT01702025|Natriuretic Agents|natriuretic agents|mesh-ancestor
102392663|NCT01592747|Memantine|memantine|mesh-list
102392664|NCT01592747|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102392665|NCT01592747|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102392666|NCT01592747|Dopamine Agents|dopamine agents|mesh-ancestor
102392667|NCT01592747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102392668|NCT01592747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392669|NCT01592747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392670|NCT01592747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102392671|NCT01592747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102392672|NCT02425488|Coal Tar|coal tar|mesh-list
102392673|NCT02425488|Keratolytic Agents|keratolytic agents|mesh-ancestor
102392674|NCT02425488|Dermatologic Agents|dermatologic agents|mesh-ancestor
102392675|NCT02426112|Azithromycin|azithromycin|mesh-list
102392676|NCT02426112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102392677|NCT02426112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102392678|NCT03117192|Zinc Sulfate|zinc sulfate|mesh-list
102392679|NCT03117192|Astringents|astringents|mesh-ancestor
102392680|NCT03117192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392681|NCT03117192|Dermatologic Agents|dermatologic agents|mesh-ancestor
102392682|NCT04768439|Vitamin D|vitamin d|mesh-list
102392683|NCT04768439|Ergocalciferols|ergocalciferols|mesh-list
102392684|NCT04768439|Cholecalciferol|cholecalciferol|mesh-list
102392685|NCT04768439|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
102392686|NCT04768439|Calcitriol|calcitriol|mesh-list
102392687|NCT04768439|Vitamins|vitamins|mesh-list
102392688|NCT04768439|Micronutrients|micronutrients|mesh-ancestor
102392689|NCT04768439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392690|NCT04768439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102392691|NCT04768439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102392692|NCT04768439|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102392693|NCT04768439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102392694|NCT04768439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392695|NCT04768439|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102392696|NCT02421042|Lenvatinib|lenvatinib|mesh-list
102392697|NCT02421042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102392698|NCT02421042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102392699|NCT02421042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102392700|NCT02421042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392701|NCT03181464|Lidocaine|lidocaine|mesh-list
102392702|NCT03181464|Anesthetics, Local|anesthetics, local|mesh-ancestor
102392703|NCT03181464|Anesthetics|anesthetics|mesh-ancestor
102392704|NCT03181464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102392705|NCT03181464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392706|NCT03181464|Sensory System Agents|sensory system agents|mesh-ancestor
102392707|NCT03181464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101941197|NCT01127217|Losartan|losartan|mesh-list
102392708|NCT03181464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102392709|NCT03181464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102392710|NCT03181464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102392711|NCT03181464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102392712|NCT03181464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392713|NCT02423928|Cyclophosphamide|cyclophosphamide|mesh-list
102392714|NCT02423928|Ipilimumab|ipilimumab|mesh-list
102392715|NCT02423928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102392716|NCT02423928|Immunologic Factors|immunologic factors|mesh-ancestor
102392717|NCT02423928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392718|NCT02423928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102392719|NCT02423928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102392720|NCT02423928|Alkylating Agents|alkylating agents|mesh-ancestor
102392721|NCT02423928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392722|NCT02423928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102392723|NCT02423928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102392724|NCT02423928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102392725|NCT02423928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102392726|NCT02416128|Prednisolone|prednisolone|mesh-list
102392727|NCT02416128|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102392728|NCT02416128|Methylprednisolone|methylprednisolone|mesh-list
102392729|NCT02416128|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102392730|NCT02416128|Prednisolone acetate|prednisolone acetate|mesh-list
102392731|NCT02416128|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102392732|NCT02416128|Prednisolone phosphate|prednisolone phosphate|mesh-list
102392733|NCT02416128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102392734|NCT02416128|Glucocorticoids|glucocorticoids|mesh-ancestor
102392735|NCT02416128|Hormones|hormones|mesh-ancestor
102392736|NCT02416128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102392737|NCT02416128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392738|NCT02416128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102392739|NCT02416128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102392740|NCT02416128|Antiemetics|antiemetics|mesh-ancestor
102392741|NCT02416128|Autonomic Agents|autonomic agents|mesh-ancestor
102392742|NCT02416128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102392743|NCT02416128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102392744|NCT02416128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102392745|NCT02416128|Protective Agents|protective agents|mesh-ancestor
102392746|NCT03106740|Minocycline|minocycline|mesh-list
102392747|NCT03106740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102392748|NCT03106740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102392749|NCT03106818|Ketorolac|ketorolac|mesh-list
102392750|NCT03106818|Magnesium Sulfate|magnesium sulfate|mesh-list
102392751|NCT03106818|Bupivacaine|bupivacaine|mesh-list
102392752|NCT03106818|Anesthetics, Local|anesthetics, local|mesh-list
102392753|NCT03106818|Anesthetics|anesthetics|mesh-list
102392754|NCT03106818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102392755|NCT03106818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392756|NCT03106818|Sensory System Agents|sensory system agents|mesh-ancestor
102392757|NCT03106818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102392758|NCT03106818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102392759|NCT03106818|Analgesics|analgesics|mesh-ancestor
102392760|NCT03106818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102392761|NCT03106818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102392762|NCT03106818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102392763|NCT03106818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102392764|NCT03106818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102392765|NCT03106818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392766|NCT03106818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102392767|NCT03106818|Anticonvulsants|anticonvulsants|mesh-ancestor
102392768|NCT03106818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102392769|NCT03106818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102392770|NCT03106818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102392771|NCT03106818|Tocolytic Agents|tocolytic agents|mesh-ancestor
102392772|NCT03106818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102392773|NCT01592045|Aldesleukin|aldesleukin|mesh-list
102392774|NCT01592045|Molgramostim|molgramostim|mesh-list
102392775|NCT01592045|Dinutuximab|dinutuximab|mesh-list
102392776|NCT01592045|Isotretinoin|isotretinoin|mesh-list
102392777|NCT01592045|Sargramostim|sargramostim|mesh-list
102392778|NCT01592045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102392779|NCT01592045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102392780|NCT01592045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102392781|NCT01592045|Antiviral Agents|antiviral agents|mesh-ancestor
102392782|NCT01592045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102392783|NCT01592045|Dermatologic Agents|dermatologic agents|mesh-ancestor
102392784|NCT01592045|Immunologic Factors|immunologic factors|mesh-ancestor
102392785|NCT01592045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392786|NCT03178656|Sorafenib|sorafenib|mesh-list
102392787|NCT03178656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102392788|NCT03178656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102392789|NCT03178656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102392790|NCT03178656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392791|NCT01590797|Metformin|metformin|mesh-list
102392792|NCT01590797|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102392793|NCT01590797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102392794|NCT01590797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392795|NCT01590797|Incretins|incretins|mesh-ancestor
102392796|NCT01590797|Hormones|hormones|mesh-ancestor
102392797|NCT01590797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102392798|NCT01590797|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102392799|NCT01590797|Protease Inhibitors|protease inhibitors|mesh-ancestor
102392800|NCT01590797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102392801|NCT01590797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392802|NCT02415192|Amlodipine|amlodipine|mesh-list
102392803|NCT02415192|Valsartan|valsartan|mesh-list
102392804|NCT02415192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102392805|NCT02415192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102392806|NCT02415192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102392807|NCT02415192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392808|NCT02415192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102392809|NCT02415192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392810|NCT02415192|Vasodilator Agents|vasodilator agents|mesh-ancestor
102392811|NCT02415192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101941266|NCT01129713|Esomeprazole|esomeprazole|mesh-list
102392812|NCT02415192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102392814|NCT02415270|Nicotine|nicotine|mesh-list
102392815|NCT02415270|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102392816|NCT02415270|Autonomic Agents|autonomic agents|mesh-ancestor
102392817|NCT02415270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102392818|NCT02415270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392819|NCT02415270|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102392820|NCT02415270|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102392821|NCT02415270|Cholinergic Agents|cholinergic agents|mesh-ancestor
102392822|NCT02415270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102392823|NCT02415270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392824|NCT02415270|Antipruritics|antipruritics|mesh-ancestor
102392825|NCT02415270|Dermatologic Agents|dermatologic agents|mesh-ancestor
102392826|NCT02415114|Resveratrol|resveratrol|mesh-list
102392827|NCT02415114|Antioxidants|antioxidants|mesh-ancestor
102392828|NCT02415114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392829|NCT02415114|Protective Agents|protective agents|mesh-ancestor
102392830|NCT02415114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392831|NCT02415114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102392832|NCT02415114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102392833|NCT03178422|Nicotine|nicotine|mesh-list
102392834|NCT03178422|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102392835|NCT03178422|Autonomic Agents|autonomic agents|mesh-ancestor
102392836|NCT03178422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102392837|NCT03178422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392838|NCT03178422|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102392839|NCT03178422|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102392840|NCT03178422|Cholinergic Agents|cholinergic agents|mesh-ancestor
102392841|NCT03178422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102392842|NCT03178422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392843|NCT02420496|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102392844|NCT02420496|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102392845|NCT02420496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102392846|NCT02414880|Rocuronium|rocuronium|mesh-list
102392847|NCT02414880|Neostigmine|neostigmine|mesh-list
102392848|NCT02414880|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102392849|NCT02414880|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102392850|NCT02414880|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102392851|NCT02414880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102392852|NCT02414880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392853|NCT02414880|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102392854|NCT02414880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102392855|NCT02414880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392856|NCT02414880|Cholinergic Agents|cholinergic agents|mesh-ancestor
102392857|NCT02414880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102392858|NCT02414880|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102392859|NCT02414880|Autonomic Agents|autonomic agents|mesh-ancestor
102392860|NCT02423694|Dexetimide|dexetimide|mesh-list
102392861|NCT02423694|Citalopram|citalopram|mesh-list
102392862|NCT02423694|Escitalopram|escitalopram|mesh-list
102392863|NCT02423694|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101941324|NCT03925155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102392864|NCT02423694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102392865|NCT02423694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102392866|NCT02423694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392867|NCT02423694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102392868|NCT02423694|Serotonin Agents|serotonin agents|mesh-ancestor
102392869|NCT02423694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392870|NCT02423694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102392871|NCT02423694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102392872|NCT02423694|Parasympatholytics|parasympatholytics|mesh-ancestor
102392873|NCT02423694|Autonomic Agents|autonomic agents|mesh-ancestor
102392874|NCT02423694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102392875|NCT02423694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102392876|NCT02423694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102392877|NCT02423694|Cholinergic Agents|cholinergic agents|mesh-ancestor
102392878|NCT02423694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102392879|NCT02423694|Antidepressive Agents|antidepressive agents|mesh-ancestor
102392880|NCT02423694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102392881|NCT02420418|Acetylcysteine|acetylcysteine|mesh-list
102392882|NCT02420418|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102392883|NCT02420418|Antiviral Agents|antiviral agents|mesh-ancestor
102392884|NCT02420418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102392885|NCT02420418|Expectorants|expectorants|mesh-ancestor
102392886|NCT02420418|Respiratory System Agents|respiratory system agents|mesh-ancestor
102392887|NCT02420418|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102392888|NCT02420418|Antioxidants|antioxidants|mesh-ancestor
102392889|NCT02420418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392890|NCT02420418|Protective Agents|protective agents|mesh-ancestor
102392891|NCT02420418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392892|NCT02420418|Antidotes|antidotes|mesh-ancestor
102392893|NCT02414802|Calcium, Dietary|calcium, dietary|mesh-list
102392894|NCT02414802|Heparin|heparin|mesh-list
102392895|NCT02414802|Calcium heparin|calcium heparin|mesh-list
102392896|NCT02414802|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102392897|NCT02414802|Tinzaparin|tinzaparin|mesh-list
102392898|NCT02414802|Dalteparin|dalteparin|mesh-list
102392899|NCT02414802|Calcium|calcium|mesh-list
102392900|NCT02414802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102392901|NCT02414802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941349|NCT01131195|Growth Substances|growth substances|mesh-ancestor
102392902|NCT02414802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102392903|NCT02414802|Anticoagulants|anticoagulants|mesh-ancestor
102392904|NCT02414802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102392905|NCT02414802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102392906|NCT02414802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392907|NCT01701401|Sofosbuvir|sofosbuvir|mesh-list
102392908|NCT01701401|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102392909|NCT01701401|Ledipasvir|ledipasvir|mesh-list
102392910|NCT01701401|Antiviral Agents|antiviral agents|mesh-ancestor
102392911|NCT01701401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102392912|NCT04482504|Vitamin D|vitamin d|mesh-list
102392913|NCT04482504|Vitamins|vitamins|mesh-ancestor
102392914|NCT04482504|Micronutrients|micronutrients|mesh-ancestor
102392915|NCT04482504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392916|NCT04482504|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102392917|NCT02414568|Prednisone|prednisone|mesh-list
102392918|NCT02414568|Doxorubicin|doxorubicin|mesh-list
102392919|NCT02414568|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102392920|NCT02414568|Vinblastine|vinblastine|mesh-list
102392921|NCT02414568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102392922|NCT02414568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102392923|NCT02414568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102392924|NCT02414568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102392925|NCT02414568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102392926|NCT02414568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392927|NCT02414568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102392928|NCT02414568|Glucocorticoids|glucocorticoids|mesh-ancestor
102392929|NCT02414568|Hormones|hormones|mesh-ancestor
102392930|NCT02414568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102392931|NCT02414568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392932|NCT02414568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102392933|NCT02414568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102392934|NCT02414568|Alkylating Agents|alkylating agents|mesh-ancestor
102392935|NCT02414568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102392936|NCT02414568|Tubulin Modulators|tubulin modulators|mesh-ancestor
102392937|NCT02414568|Antimitotic Agents|antimitotic agents|mesh-ancestor
102392938|NCT02414568|Mitosis Modulators|mitosis modulators|mesh-ancestor
102392939|NCT04348877|Antibodies|antibodies|mesh-list
102392940|NCT04348877|Immunologic Factors|immunologic factors|mesh-ancestor
102392941|NCT04348877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392942|NCT03176628|Niacinamide|niacinamide|mesh-list
102392943|NCT03176628|Vitamin B Complex|vitamin b complex|mesh-ancestor
102392944|NCT03176628|Vitamins|vitamins|mesh-ancestor
102392945|NCT03176628|Micronutrients|micronutrients|mesh-ancestor
102392946|NCT03176628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392947|NCT02414490|Immunoglobulins|immunoglobulins|mesh-list
102392948|NCT02414490|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102392949|NCT02414490|Antibodies|antibodies|mesh-list
102392950|NCT02414490|gamma-Globulins|gamma-globulins|mesh-list
102392951|NCT02414490|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102392952|NCT02414490|Immunologic Factors|immunologic factors|mesh-ancestor
102392953|NCT02414490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392954|NCT01590017|Cisplatin|cisplatin|mesh-list
102392955|NCT01590017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102392956|NCT01700621|Vaccines|vaccines|mesh-list
102392957|NCT01700621|Immunologic Factors|immunologic factors|mesh-ancestor
102392958|NCT01700621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392959|NCT03178500|Clomiphene|clomiphene|mesh-list
102204675|NCT02306473|Mannitol|mannitol|mesh-list
102392960|NCT03178500|Enclomiphene|enclomiphene|mesh-list
102392961|NCT03178500|Zuclomiphene|zuclomiphene|mesh-list
102392962|NCT03178500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102392963|NCT03178500|Hormone Antagonists|hormone antagonists|mesh-ancestor
102392964|NCT03178500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102392965|NCT03178500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392966|NCT03178500|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102392967|NCT03178500|Fertility Agents|fertility agents|mesh-ancestor
102392968|NCT03178500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101941492|NCT01585623|Metoprolol|metoprolol|mesh-list
102392969|NCT03178500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102392970|NCT03178500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102392971|NCT01700387|Topiramate|topiramate|mesh-list
102392972|NCT01700387|Botulinum Toxins|botulinum toxins|mesh-list
102392973|NCT01700387|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102392974|NCT01700387|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102392975|NCT01700387|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102392976|NCT01700387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102392977|NCT01700387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392978|NCT01700387|Cholinergic Agents|cholinergic agents|mesh-ancestor
102392979|NCT01700387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102392980|NCT01700387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392981|NCT01700387|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102392982|NCT01700387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102392983|NCT01700387|Anticonvulsants|anticonvulsants|mesh-ancestor
102392984|NCT01700387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102392985|NCT01699685|Glycopyrrolate|glycopyrrolate|mesh-list
102392986|NCT01699685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102392987|NCT01699685|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102392988|NCT01699685|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102392989|NCT01699685|Cholinergic Agents|cholinergic agents|mesh-ancestor
102392990|NCT01699685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102392991|NCT01699685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102392992|NCT01699685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392993|NCT01587989|Methotrexate|methotrexate|mesh-list
102392994|NCT01587989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102392995|NCT01587989|Abortifacient Agents|abortifacient agents|mesh-ancestor
102392996|NCT01587989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102392997|NCT01587989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102392998|NCT01587989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102392999|NCT01587989|Antimetabolites|antimetabolites|mesh-ancestor
102393000|NCT01587989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393001|NCT01587989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102393002|NCT01587989|Dermatologic Agents|dermatologic agents|mesh-ancestor
102393003|NCT01587989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102393004|NCT01587989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102393005|NCT01587989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102393006|NCT01587989|Immunologic Factors|immunologic factors|mesh-ancestor
102393007|NCT01587989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102393008|NCT01587989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102393009|NCT01697969|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
102393010|NCT01697969|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102393011|NCT01697969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102393012|NCT01697969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102393013|NCT01697969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102393014|NCT01697969|Analgesics|analgesics|mesh-ancestor
101621356|NCT04413617|Tofacitinib|tofacitinib|mesh-list
102393015|NCT01697969|Sensory System Agents|sensory system agents|mesh-ancestor
102393016|NCT01697969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102393017|NCT01697969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393018|NCT01697969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102393019|NCT01697969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102393020|NCT01697969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102393021|NCT01697969|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102393022|NCT01697969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102393023|NCT01697969|Histamine Antagonists|histamine antagonists|mesh-ancestor
102393024|NCT01697969|Histamine Agents|histamine agents|mesh-ancestor
102393025|NCT01697969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102393026|NCT01697969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393027|NCT01586819|Botulinum Toxins|botulinum toxins|mesh-list
102393028|NCT01586819|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102393029|NCT01586819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102393030|NCT01586819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393031|NCT01586819|Cholinergic Agents|cholinergic agents|mesh-ancestor
102204752|NCT02232581|Alovudine|alovudine|mesh-list
102393032|NCT01586819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102393033|NCT01586819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393034|NCT01697579|Ondansetron|ondansetron|mesh-list
102393035|NCT01697579|Fosaprepitant|fosaprepitant|mesh-list
102393036|NCT01697579|Aprepitant|aprepitant|mesh-list
102393037|NCT01697579|Serotonin|serotonin|mesh-list
102393038|NCT01697579|Antiemetics|antiemetics|mesh-ancestor
102393039|NCT01697579|Autonomic Agents|autonomic agents|mesh-ancestor
102393040|NCT01697579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102393041|NCT01697579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393042|NCT01697579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102393043|NCT01697579|Antipruritics|antipruritics|mesh-ancestor
102393044|NCT01697579|Dermatologic Agents|dermatologic agents|mesh-ancestor
102393045|NCT01697579|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102393046|NCT01697579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102393047|NCT01697579|Serotonin Agents|serotonin agents|mesh-ancestor
102393048|NCT01697579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102393049|NCT01697579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393050|NCT01697579|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102393051|NCT01697579|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102393052|NCT01586195|Vemurafenib|vemurafenib|mesh-list
102393053|NCT01586195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102393054|NCT01586195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102393055|NCT01586195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102393056|NCT01586195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393057|NCT01697345|Testosterone|testosterone|mesh-list
102393058|NCT01697345|Androgens|androgens|mesh-ancestor
102393059|NCT01697345|Hormones|hormones|mesh-ancestor
101637620|NCT00706381|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101637697|NCT04284644|Anesthetics|anesthetics|mesh-ancestor
102393060|NCT01697345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102393061|NCT01697345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393062|NCT03467386|Cyclophosphamide|cyclophosphamide|mesh-list
102393063|NCT03467386|Tacrolimus|tacrolimus|mesh-list
102393064|NCT03467386|Lenograstim|lenograstim|mesh-list
102393065|NCT03467386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102393066|NCT03467386|Immunologic Factors|immunologic factors|mesh-ancestor
102393067|NCT03467386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393068|NCT03467386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102393069|NCT03467386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102393070|NCT03467386|Alkylating Agents|alkylating agents|mesh-ancestor
102393071|NCT03467386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393072|NCT03467386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102393073|NCT03467386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102393074|NCT03467386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102393075|NCT03467386|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102393076|NCT03467386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102393077|NCT03465592|Nivolumab|nivolumab|mesh-list
102393078|NCT03465592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102393079|NCT03465592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102393080|NCT03465592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102393081|NCT03465592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393082|NCT02441062|Edotreotide|edotreotide|mesh-list
102393083|NCT02441062|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102393084|NCT02441062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393085|NCT02442700|Pitavastatin|pitavastatin|mesh-list
102393086|NCT02442700|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102393087|NCT02442700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102393088|NCT02442700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102393089|NCT02442700|Antimetabolites|antimetabolites|mesh-ancestor
101641526|NCT00694369|Ibuprofen|ibuprofen|mesh-list
102393090|NCT02442700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393091|NCT02442700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102393092|NCT02442700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102393093|NCT00619528|Alemtuzumab|alemtuzumab|mesh-list
102393094|NCT00619528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102393095|NCT00619528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102393096|NCT00568672|Olanzapine|olanzapine|mesh-list
102393097|NCT00568672|Antiemetics|antiemetics|mesh-ancestor
102393098|NCT00568672|Autonomic Agents|autonomic agents|mesh-ancestor
102393099|NCT00568672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102393100|NCT00568672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393101|NCT00568672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102393102|NCT00568672|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102393103|NCT00568672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102393104|NCT00568672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102393105|NCT00568672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102393106|NCT00568672|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102393107|NCT00568672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102393108|NCT00568672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102393109|NCT00568672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393110|NCT00568672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102393111|NCT00568672|Serotonin Agents|serotonin agents|mesh-ancestor
102393112|NCT02448862|Fentanyl|fentanyl|mesh-list
102393113|NCT02448862|Analgesics|analgesics|mesh-list
102393114|NCT02448862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102393115|NCT02448862|Narcotics|narcotics|mesh-ancestor
102393116|NCT02448862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102393117|NCT02448862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393118|NCT02448862|Sensory System Agents|sensory system agents|mesh-ancestor
102393119|NCT02448862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102393120|NCT02448862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102393121|NCT02448862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102393122|NCT02448862|Anesthetics, General|anesthetics, general|mesh-ancestor
102393123|NCT02448862|Anesthetics|anesthetics|mesh-ancestor
102393124|NCT01697267|Rituximab|rituximab|mesh-list
102393125|NCT01697267|Azathioprine|azathioprine|mesh-list
102393126|NCT01697267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102393127|NCT01697267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102393128|NCT01697267|Immunologic Factors|immunologic factors|mesh-ancestor
102393129|NCT01697267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393130|NCT01697267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102393131|NCT01697267|Antimetabolites|antimetabolites|mesh-ancestor
102393132|NCT01697267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393133|NCT01697267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102393134|NCT01697267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102393135|NCT00362986|Sunscreening Agents|sunscreening agents|mesh-list
102393136|NCT00362986|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102393137|NCT00362986|Protective Agents|protective agents|mesh-ancestor
102393138|NCT00362986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393139|NCT00362986|Dermatologic Agents|dermatologic agents|mesh-ancestor
102393140|NCT00363376|Zonisamide|zonisamide|mesh-list
102393141|NCT00363376|Olanzapine|olanzapine|mesh-list
102393142|NCT00363376|Antiemetics|antiemetics|mesh-ancestor
102393143|NCT00363376|Autonomic Agents|autonomic agents|mesh-ancestor
102393144|NCT00363376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102393145|NCT00363376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393146|NCT00363376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102393147|NCT00363376|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102393148|NCT00363376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102393149|NCT00363376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102393150|NCT00363376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102393151|NCT00363376|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102393152|NCT00363376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102393153|NCT00363376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102393154|NCT00363376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393155|NCT00363376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102393156|NCT00363376|Serotonin Agents|serotonin agents|mesh-ancestor
102393157|NCT00363376|Anticonvulsants|anticonvulsants|mesh-ancestor
102393158|NCT00363376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102393159|NCT00363376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102393160|NCT02451202|Rocuronium|rocuronium|mesh-list
102393161|NCT02451202|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102393162|NCT02451202|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102393163|NCT02451202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102393164|NCT02451202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102393165|NCT02451202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393166|NCT02452060|Ketamine|ketamine|mesh-list
102393167|NCT02452060|Analgesics|analgesics|mesh-ancestor
102393168|NCT02452060|Sensory System Agents|sensory system agents|mesh-ancestor
102393169|NCT02452060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102393170|NCT02452060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393171|NCT02452060|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102393172|NCT02452060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102393173|NCT02452060|Anesthetics, General|anesthetics, general|mesh-ancestor
102393174|NCT02452060|Anesthetics|anesthetics|mesh-ancestor
102393175|NCT02452060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102393176|NCT02452060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102393177|NCT02452060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102393178|NCT02452060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102393179|NCT02452060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393180|NCT01696955|Cetuximab|cetuximab|mesh-list
102393181|NCT01696955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102393182|NCT01696955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102393183|NCT02452528|Diphenhydramine|diphenhydramine|mesh-list
102393184|NCT02452528|Promethazine|promethazine|mesh-list
102393185|NCT02452528|Tenofovir|tenofovir|mesh-list
102393186|NCT02452528|Entecavir|entecavir|mesh-list
102393187|NCT02452528|Antiviral Agents|antiviral agents|mesh-ancestor
102393188|NCT02452528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102393189|NCT02452528|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102393190|NCT02452528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102393191|NCT02452528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102393192|NCT02452528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393193|NCT02452528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102393194|NCT02452528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102393195|NCT02452528|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102393196|NCT02452528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102393197|NCT02452528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102393198|NCT02452528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941589|NCT03922815|Fentanyl|fentanyl|mesh-list
102393199|NCT02452528|Anesthetics, Local|anesthetics, local|mesh-ancestor
102393200|NCT02452528|Anesthetics|anesthetics|mesh-ancestor
102393201|NCT02452528|Sensory System Agents|sensory system agents|mesh-ancestor
102393202|NCT02452528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102393203|NCT02452528|Antiemetics|antiemetics|mesh-ancestor
102393204|NCT02452528|Autonomic Agents|autonomic agents|mesh-ancestor
102393205|NCT02452528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102393206|NCT02452528|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102393207|NCT02452528|Histamine Antagonists|histamine antagonists|mesh-ancestor
102393208|NCT02452528|Histamine Agents|histamine agents|mesh-ancestor
102393209|NCT02452528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102393210|NCT02452528|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102393211|NCT02452528|Antipruritics|antipruritics|mesh-ancestor
102393212|NCT02452528|Dermatologic Agents|dermatologic agents|mesh-ancestor
102393213|NCT02702388|Lenvatinib|lenvatinib|mesh-list
102393214|NCT02702388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102393215|NCT02702388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102393216|NCT02702388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102393217|NCT02702388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393218|NCT02456896|Oxcarbazepine|oxcarbazepine|mesh-list
102393219|NCT02456896|Anticonvulsants|anticonvulsants|mesh-ancestor
102393220|NCT02456896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102393221|NCT02456896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102393222|NCT02456896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102393223|NCT02456896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393224|NCT02456896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102393225|NCT02456896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102393226|NCT01696877|Cyclophosphamide|cyclophosphamide|mesh-list
102393227|NCT01696877|Molgramostim|molgramostim|mesh-list
102393228|NCT01696877|Sargramostim|sargramostim|mesh-list
102393229|NCT01696877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102393230|NCT01696877|Immunologic Factors|immunologic factors|mesh-ancestor
102393231|NCT01696877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393232|NCT01696877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102393233|NCT01696877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102393234|NCT01696877|Alkylating Agents|alkylating agents|mesh-ancestor
102393235|NCT01696877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393236|NCT01696877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102393237|NCT01696877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102393238|NCT02416102|Losartan|losartan|mesh-list
102393239|NCT02416102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102393240|NCT02416102|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102393241|NCT02416102|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102393242|NCT02416102|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102393243|NCT02416102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393244|NCT02414256|Anesthetics|anesthetics|mesh-list
102393245|NCT02414256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102393246|NCT02414256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393247|NCT02458690|Dopamine|dopamine|mesh-list
102393248|NCT02458690|Norepinephrine|norepinephrine|mesh-list
102393249|NCT02458690|Antidepressive Agents|antidepressive agents|mesh-list
102393250|NCT02458690|Serotonin|serotonin|mesh-list
102393251|NCT02458690|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
102393252|NCT02458690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-list
102393253|NCT02458690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102393254|NCT02458690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102393255|NCT02458690|Adrenergic Agents|adrenergic agents|mesh-ancestor
102393256|NCT02458690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102393257|NCT02458690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393258|NCT02458690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393259|NCT02458690|Sympathomimetics|sympathomimetics|mesh-ancestor
102393260|NCT02458690|Autonomic Agents|autonomic agents|mesh-ancestor
102393261|NCT02458690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102393262|NCT02458690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102393263|NCT02458690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102393264|NCT02458690|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102393265|NCT02458690|Dopamine Agents|dopamine agents|mesh-ancestor
102393266|NCT02458690|Protective Agents|protective agents|mesh-ancestor
102393267|NCT02458690|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102393268|NCT02458690|Serotonin Agents|serotonin agents|mesh-ancestor
102393269|NCT02458690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102393270|NCT02458690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102393271|NCT02458768|Menotropins|menotropins|mesh-list
102393272|NCT02458768|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102393273|NCT02458768|Fertility Agents|fertility agents|mesh-ancestor
102393274|NCT02458768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102393275|NCT02458768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393276|NCT02418676|Insulin|insulin|mesh-list
102393277|NCT02418676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102393278|NCT02418676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393279|NCT02419638|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102393280|NCT02419638|Dermatologic Agents|dermatologic agents|mesh-ancestor
102393281|NCT02419638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102393282|NCT02419638|Immunologic Factors|immunologic factors|mesh-ancestor
102393283|NCT02419638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393284|NCT02422836|Sunscreening Agents|sunscreening agents|mesh-list
102393285|NCT02422836|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102393286|NCT02422836|Protective Agents|protective agents|mesh-ancestor
102393287|NCT02422836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393288|NCT02422836|Dermatologic Agents|dermatologic agents|mesh-ancestor
102393289|NCT03179514|Vasodilator Agents|vasodilator agents|mesh-list
102393290|NCT03179514|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
102393291|NCT03179514|Lipid Regulating Agents|lipid regulating agents|mesh-list
102393292|NCT00707304|Lactoferrin|lactoferrin|mesh-list
102393293|NCT00707304|Talactoferrin alfa|talactoferrin alfa|mesh-list
102393294|NCT00707304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102393295|NCT00707304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102393296|NCT02423980|Glucagon|glucagon|mesh-list
102393297|NCT02423980|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102393298|NCT02423980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102393299|NCT02423980|Hormones|hormones|mesh-ancestor
102393300|NCT02423980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102393301|NCT02423980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393302|NCT02423980|Incretins|incretins|mesh-ancestor
102393303|NCT03176316|Naloxone|naloxone|mesh-list
102393304|NCT03176316|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102393305|NCT03176316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393306|NCT03176316|Sensory System Agents|sensory system agents|mesh-ancestor
102393307|NCT03176316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102393308|NCT02419170|Cyclophosphamide|cyclophosphamide|mesh-list
102393309|NCT02419170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102393310|NCT02419170|Immunologic Factors|immunologic factors|mesh-ancestor
102393311|NCT02419170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393312|NCT02419170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102393313|NCT02419170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102393314|NCT02419170|Alkylating Agents|alkylating agents|mesh-ancestor
102393315|NCT02419170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393316|NCT02419170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102393317|NCT02419170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102393318|NCT02974426|Cisplatin|cisplatin|mesh-list
102393319|NCT02974426|Carboplatin|carboplatin|mesh-list
102393320|NCT02974426|Pemetrexed|pemetrexed|mesh-list
102393321|NCT02974426|Vinorelbine|vinorelbine|mesh-list
102393322|NCT02974426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102393323|NCT02974426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102393324|NCT02974426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393325|NCT02974426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102393326|NCT02974426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102393327|NCT02974426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102393328|NCT02974426|Tubulin Modulators|tubulin modulators|mesh-ancestor
102393329|NCT02974426|Antimitotic Agents|antimitotic agents|mesh-ancestor
102393330|NCT02974426|Mitosis Modulators|mitosis modulators|mesh-ancestor
102393331|NCT02413554|Rivastigmine|rivastigmine|mesh-list
102393332|NCT02413554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102393333|NCT02413554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102393334|NCT02413554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393335|NCT02413554|Cholinergic Agents|cholinergic agents|mesh-ancestor
102393336|NCT02413554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102393337|NCT02413554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393338|NCT02413554|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102393339|NCT02413554|Protective Agents|protective agents|mesh-ancestor
102393340|NCT02422602|Rivaroxaban|rivaroxaban|mesh-list
102393341|NCT02422602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102393342|NCT02422602|Antithrombins|antithrombins|mesh-ancestor
102393343|NCT02422602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102393344|NCT02422602|Protease Inhibitors|protease inhibitors|mesh-ancestor
102393345|NCT02422602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102393346|NCT02422602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393347|NCT02422602|Anticoagulants|anticoagulants|mesh-ancestor
102393348|NCT02465632|Clindamycin|clindamycin|mesh-list
102393349|NCT02465632|Clindamycin palmitate|clindamycin palmitate|mesh-list
102393350|NCT02465632|Clindamycin phosphate|clindamycin phosphate|mesh-list
102393351|NCT02465632|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102393352|NCT02465632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102393353|NCT02465632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102393354|NCT02465632|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102393355|NCT02465632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102393356|NCT02465632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393357|NCT02465632|Dermatologic Agents|dermatologic agents|mesh-ancestor
102393358|NCT02703636|Rivastigmine|rivastigmine|mesh-list
102393359|NCT02703636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102393360|NCT02703636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102393361|NCT02703636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393362|NCT02703636|Cholinergic Agents|cholinergic agents|mesh-ancestor
102393363|NCT02703636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102393364|NCT02703636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393365|NCT02703636|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102393366|NCT02703636|Protective Agents|protective agents|mesh-ancestor
102393367|NCT02422056|Tranexamic Acid|tranexamic acid|mesh-list
102393368|NCT02422056|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102393369|NCT02422056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102393370|NCT02422056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393371|NCT02422056|Hemostatics|hemostatics|mesh-ancestor
102393372|NCT02422056|Coagulants|coagulants|mesh-ancestor
102393373|NCT02466958|Milnacipran|milnacipran|mesh-list
102393374|NCT02466958|Levomilnacipran|levomilnacipran|mesh-list
102393375|NCT02466958|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102393376|NCT02466958|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102393377|NCT02466958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102393378|NCT02466958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393379|NCT02466958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102393380|NCT02466958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393381|NCT02466958|Antidepressive Agents|antidepressive agents|mesh-ancestor
102393382|NCT02466958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102393383|NCT02466958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102393384|NCT02466958|Analgesics|analgesics|mesh-ancestor
102393385|NCT02466958|Sensory System Agents|sensory system agents|mesh-ancestor
102393386|NCT02466958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102393388|NCT02467504|Loxoprofen|loxoprofen|mesh-list
102393389|NCT02467504|Hematinics|hematinics|mesh-ancestor
102393390|NCT02467504|Vitamin B Complex|vitamin b complex|mesh-ancestor
102393391|NCT02467504|Vitamins|vitamins|mesh-ancestor
102393392|NCT02467504|Micronutrients|micronutrients|mesh-ancestor
102393393|NCT02467504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393394|NCT02467504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102393395|NCT02467504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102393396|NCT02467504|Analgesics|analgesics|mesh-ancestor
102393397|NCT02467504|Sensory System Agents|sensory system agents|mesh-ancestor
102393398|NCT02467504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102393399|NCT02467504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102393400|NCT02467504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102393401|NCT02413086|Chitosan|chitosan|mesh-list
102393402|NCT02413086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102393403|NCT02413086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102393404|NCT02413086|Antimetabolites|antimetabolites|mesh-ancestor
102393405|NCT02413086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393406|NCT02413086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102393407|NCT02413086|Chelating Agents|chelating agents|mesh-ancestor
102393408|NCT02413086|Sequestering Agents|sequestering agents|mesh-ancestor
102393409|NCT02413086|Hemostatics|hemostatics|mesh-ancestor
102393410|NCT02413086|Coagulants|coagulants|mesh-ancestor
102393411|NCT02468830|Mirabegron|mirabegron|mesh-list
102393412|NCT02468830|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102393413|NCT02468830|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102393414|NCT02468830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102393415|NCT02468830|Adrenergic Agents|adrenergic agents|mesh-ancestor
102393416|NCT02468830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102393417|NCT02468830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393418|NCT02468830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393419|NCT02468830|Urological Agents|urological agents|mesh-ancestor
101836855|NCT00492284|Dexamethasone|dexamethasone|mesh-list
102393420|NCT02470234|Methylphenidate|methylphenidate|mesh-list
102393421|NCT02470234|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102393422|NCT02470234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393423|NCT02470234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102393424|NCT02470234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102393425|NCT02470234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102393426|NCT02470234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393427|NCT02470234|Dopamine Agents|dopamine agents|mesh-ancestor
102393428|NCT02470234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102393429|NCT02418702|Ketamine|ketamine|mesh-list
102393430|NCT02418702|Analgesics|analgesics|mesh-ancestor
102393431|NCT02418702|Sensory System Agents|sensory system agents|mesh-ancestor
102393432|NCT02418702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102393433|NCT02418702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393434|NCT02418702|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102393435|NCT02418702|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102393436|NCT02418702|Anesthetics, General|anesthetics, general|mesh-ancestor
102393437|NCT02418702|Anesthetics|anesthetics|mesh-ancestor
102393438|NCT02418702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102393439|NCT02418702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102393440|NCT02418702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102393441|NCT02418702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102393442|NCT02418702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393443|NCT02412930|Tramadol|tramadol|mesh-list
102393444|NCT02412930|Bupivacaine|bupivacaine|mesh-list
102393445|NCT02412930|Anesthetics, Local|anesthetics, local|mesh-ancestor
102393446|NCT02412930|Anesthetics|anesthetics|mesh-ancestor
102393447|NCT02412930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102393448|NCT02412930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393449|NCT02412930|Sensory System Agents|sensory system agents|mesh-ancestor
102393450|NCT02412930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102393451|NCT02412930|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102393452|NCT02412930|Narcotics|narcotics|mesh-ancestor
102393453|NCT02412930|Analgesics|analgesics|mesh-ancestor
102393454|NCT02432716|Insulin|insulin|mesh-list
102393455|NCT02432716|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102393456|NCT02432716|Insulin glulisine|insulin glulisine|mesh-list
102393457|NCT02432716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102393458|NCT02432716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393459|NCT02418624|Carboplatin|carboplatin|mesh-list
102393460|NCT02418624|Olaparib|olaparib|mesh-list
102393461|NCT02418624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102393462|NCT02418624|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102393463|NCT02418624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102393464|NCT02418624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393465|NCT02440204|Remifentanil|remifentanil|mesh-list
102393466|NCT02440204|Sevoflurane|sevoflurane|mesh-list
102393467|NCT02440204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102393468|NCT02440204|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102393469|NCT02440204|Anesthetics, General|anesthetics, general|mesh-ancestor
102393470|NCT02440204|Anesthetics|anesthetics|mesh-ancestor
102393471|NCT02440204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102393472|NCT02440204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393473|NCT02440204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102393474|NCT02440204|Narcotics|narcotics|mesh-ancestor
102393475|NCT02440204|Analgesics|analgesics|mesh-ancestor
102393476|NCT02440204|Sensory System Agents|sensory system agents|mesh-ancestor
102393477|NCT02440204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102393478|NCT02410590|Atropine|atropine|mesh-list
102393479|NCT02410590|Rocuronium|rocuronium|mesh-list
102393480|NCT02410590|Cisatracurium|cisatracurium|mesh-list
102393481|NCT02410590|Succinylcholine|succinylcholine|mesh-list
102393482|NCT02410590|Neostigmine|neostigmine|mesh-list
102393483|NCT02410590|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102393484|NCT02410590|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102393485|NCT02410590|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102393486|NCT02410590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102393487|NCT02410590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393488|NCT02410590|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102393489|NCT02410590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102393490|NCT02410590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102393491|NCT02410590|Autonomic Agents|autonomic agents|mesh-ancestor
102393492|NCT02410590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102393493|NCT02410590|Respiratory System Agents|respiratory system agents|mesh-ancestor
102393494|NCT02410590|Mydriatics|mydriatics|mesh-ancestor
102393495|NCT02410590|Parasympatholytics|parasympatholytics|mesh-ancestor
102393496|NCT02410590|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102393497|NCT02410590|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102393498|NCT02410590|Cholinergic Agents|cholinergic agents|mesh-ancestor
102393499|NCT02410590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102393500|NCT02410590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393501|NCT02410590|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102393502|NCT02410590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102393503|NCT02410590|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102393504|NCT02410590|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
102393505|NCT02517580|Vitamin K|vitamin k|mesh-list
102393506|NCT02517580|Vitamin K 2|vitamin k 2|mesh-list
102393507|NCT02517580|Vitamins|vitamins|mesh-ancestor
102393508|NCT02517580|Micronutrients|micronutrients|mesh-ancestor
102393509|NCT02517580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393510|NCT02517580|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102393511|NCT02517580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102393512|NCT02517580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393513|NCT02517580|Hemostatics|hemostatics|mesh-ancestor
102393514|NCT02517580|Coagulants|coagulants|mesh-ancestor
102393515|NCT02522104|Hydroxyurea|hydroxyurea|mesh-list
102393516|NCT02522104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102393517|NCT02522104|Antisickling Agents|antisickling agents|mesh-ancestor
102393518|NCT02522104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102393519|NCT02522104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393520|NCT02522104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102393521|NCT02412150|Dexmedetomidine|dexmedetomidine|mesh-list
102393522|NCT02412150|Remifentanil|remifentanil|mesh-list
102393523|NCT02412150|Desflurane|desflurane|mesh-list
102393524|NCT02412150|Anesthetics|anesthetics|mesh-list
102393525|NCT02412150|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
102393526|NCT02412150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102393527|NCT02412150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102393528|NCT02412150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393529|NCT02412150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102393530|NCT02412150|Analgesics|analgesics|mesh-ancestor
102393531|NCT02412150|Sensory System Agents|sensory system agents|mesh-ancestor
102393532|NCT02412150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102393533|NCT02412150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102393534|NCT02412150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102393535|NCT02412150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102393536|NCT02412150|Adrenergic Agents|adrenergic agents|mesh-ancestor
102393537|NCT02412150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102393538|NCT02412150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393539|NCT02412150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102393540|NCT02412150|Narcotics|narcotics|mesh-ancestor
102393541|NCT02412150|Anesthetics, General|anesthetics, general|mesh-ancestor
102393542|NCT02523196|Cholic Acids|cholic acids|mesh-list
102393543|NCT02523196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102393544|NCT02418078|Anesthetics|anesthetics|mesh-list
102393545|NCT02418078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102393546|NCT02418078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393547|NCT03175926|Budesonide|budesonide|mesh-list
102393548|NCT03175926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102393549|NCT03175926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102393550|NCT03175926|Autonomic Agents|autonomic agents|mesh-ancestor
102393551|NCT03175926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102393552|NCT03175926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393553|NCT03175926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102393554|NCT03175926|Respiratory System Agents|respiratory system agents|mesh-ancestor
101837139|NCT00394251|Paclitaxel|paclitaxel|mesh-list
102393555|NCT03175926|Glucocorticoids|glucocorticoids|mesh-ancestor
102393556|NCT03175926|Hormones|hormones|mesh-ancestor
102393557|NCT03175926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102393558|NCT02524054|Furosemide|furosemide|mesh-list
102393559|NCT02524054|Diuretics|diuretics|mesh-ancestor
102393560|NCT02524054|Natriuretic Agents|natriuretic agents|mesh-ancestor
102393561|NCT02524054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393562|NCT02524054|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102393563|NCT02524054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102393564|NCT02524054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393565|NCT03106662|Cyclophosphamide|cyclophosphamide|mesh-list
102393566|NCT03106662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102393567|NCT03106662|Immunologic Factors|immunologic factors|mesh-ancestor
102393568|NCT03106662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393569|NCT03106662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101837170|NCT00394095|Topiramate|topiramate|mesh-list
102393570|NCT03106662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102393571|NCT03106662|Alkylating Agents|alkylating agents|mesh-ancestor
102393572|NCT03106662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393573|NCT03106662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102393574|NCT03106662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102393575|NCT02417610|Hyaluronic Acid|hyaluronic acid|mesh-list
102393576|NCT02417610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102393577|NCT02417610|Immunologic Factors|immunologic factors|mesh-ancestor
102393578|NCT02417610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393579|NCT02417610|Viscosupplements|viscosupplements|mesh-ancestor
102393580|NCT02417610|Protective Agents|protective agents|mesh-ancestor
102393582|NCT03116490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102393583|NCT03116490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393584|NCT02417298|Ketamine|ketamine|mesh-list
102393585|NCT02417298|Analgesics|analgesics|mesh-ancestor
102393586|NCT02417298|Sensory System Agents|sensory system agents|mesh-ancestor
102393587|NCT02417298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102393588|NCT02417298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393589|NCT02417298|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102393590|NCT02417298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102393591|NCT02417298|Anesthetics, General|anesthetics, general|mesh-ancestor
102393592|NCT02417298|Anesthetics|anesthetics|mesh-ancestor
102393593|NCT02417298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102393594|NCT02417298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102393595|NCT02417298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102393596|NCT02417298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102393597|NCT02417298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393598|NCT02525536|Trebananib|trebananib|mesh-list
102393599|NCT02525536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102393600|NCT02525536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102393601|NCT02525536|Growth Substances|growth substances|mesh-ancestor
102393602|NCT02525536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393603|NCT02525536|Growth Inhibitors|growth inhibitors|mesh-ancestor
102393604|NCT02525536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102393605|NCT02411994|Artesunate|artesunate|mesh-list
102393606|NCT02411994|Lumefantrine|lumefantrine|mesh-list
102393607|NCT02411994|Artemether|artemether|mesh-list
102393608|NCT02411994|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102393609|NCT02411994|Pyronaridine|pyronaridine|mesh-list
102393610|NCT02411994|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
102393611|NCT02411994|Antimalarials|antimalarials|mesh-ancestor
102393612|NCT02411994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102393613|NCT02411994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102393614|NCT02411994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102393615|NCT02411994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102393616|NCT02411994|Antiviral Agents|antiviral agents|mesh-ancestor
102393617|NCT02411994|Schistosomicides|schistosomicides|mesh-ancestor
102393618|NCT02411994|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102393619|NCT02411994|Anthelmintics|anthelmintics|mesh-ancestor
102393620|NCT02530294|Glycopyrrolate|glycopyrrolate|mesh-list
102393621|NCT02530294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102393622|NCT02530294|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102393623|NCT02530294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102393624|NCT02530294|Cholinergic Agents|cholinergic agents|mesh-ancestor
102393625|NCT02530294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102393626|NCT02530294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393627|NCT02530294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393628|NCT03177720|Ciprofloxacin|ciprofloxacin|mesh-list
102393629|NCT03177720|Imipenem|imipenem|mesh-list
102393630|NCT03177720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102393631|NCT03177720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102393632|NCT03177720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102393633|NCT03177720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102393635|NCT03177720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393636|NCT03177720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102393637|NCT03177720|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102393638|NCT03177720|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102393639|NCT02411604|Tacrolimus|tacrolimus|mesh-list
102393640|NCT02411604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101837268|NCT01010516|Niacin|niacin|mesh-list
102393641|NCT02411604|Immunologic Factors|immunologic factors|mesh-ancestor
102393642|NCT02411604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393643|NCT02411604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102393644|NCT02411604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102393645|NCT02411604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393646|NCT03175380|BCG Vaccine|bcg vaccine|mesh-list
102393647|NCT03175380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102393648|NCT03175380|Immunologic Factors|immunologic factors|mesh-ancestor
102393649|NCT03175380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393650|NCT02530528|Chlorhexidine|chlorhexidine|mesh-list
102393651|NCT02530528|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102393652|NCT02530528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102393653|NCT02530528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102393654|NCT02530528|Disinfectants|disinfectants|mesh-ancestor
102393655|NCT02530528|Dermatologic Agents|dermatologic agents|mesh-ancestor
102393656|NCT03174756|Chlorhexidine|chlorhexidine|mesh-list
102393657|NCT03174756|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102393658|NCT03174756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102393659|NCT03174756|Disinfectants|disinfectants|mesh-ancestor
102393660|NCT03174678|Dexmedetomidine|dexmedetomidine|mesh-list
102393661|NCT03174678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102393662|NCT03174678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102393663|NCT03174678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393664|NCT03174678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102393665|NCT03174678|Analgesics|analgesics|mesh-ancestor
102393666|NCT03174678|Sensory System Agents|sensory system agents|mesh-ancestor
102393667|NCT03174678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102393668|NCT03174678|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102393669|NCT03174678|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102393670|NCT03174678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102393671|NCT03174678|Adrenergic Agents|adrenergic agents|mesh-ancestor
102393672|NCT03174678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102393673|NCT03174678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393674|NCT02409498|Bupivacaine|bupivacaine|mesh-list
102393675|NCT02409498|Anesthetics, Local|anesthetics, local|mesh-ancestor
102393676|NCT02409498|Anesthetics|anesthetics|mesh-ancestor
102393677|NCT02409498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102393678|NCT02409498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393679|NCT02409498|Sensory System Agents|sensory system agents|mesh-ancestor
102393680|NCT02409498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102393681|NCT02409186|Paclitaxel|paclitaxel|mesh-list
102393682|NCT02409186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102393683|NCT02409186|Cisplatin|cisplatin|mesh-list
102393684|NCT02409186|Nimotuzumab|nimotuzumab|mesh-list
102393685|NCT02409186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102393686|NCT02409186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102393687|NCT02409186|Tubulin Modulators|tubulin modulators|mesh-ancestor
102393688|NCT02409186|Antimitotic Agents|antimitotic agents|mesh-ancestor
102393689|NCT02409186|Mitosis Modulators|mitosis modulators|mesh-ancestor
102393690|NCT02409186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393691|NCT02409186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102393692|NCT02410746|Ibuprofen|ibuprofen|mesh-list
102393693|NCT02410746|Morphine|morphine|mesh-list
102393694|NCT02410746|Levobupivacaine|levobupivacaine|mesh-list
102393695|NCT02410746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102393696|NCT02410746|Narcotics|narcotics|mesh-ancestor
102393697|NCT02410746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102393698|NCT02410746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393699|NCT02410746|Analgesics|analgesics|mesh-ancestor
102393700|NCT02410746|Sensory System Agents|sensory system agents|mesh-ancestor
102393701|NCT02410746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102393702|NCT02410746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102393703|NCT02410746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102393704|NCT02410746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102393705|NCT02410746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102393706|NCT02410746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102393707|NCT02410746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102393708|NCT02410746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393709|NCT02410746|Anesthetics, Local|anesthetics, local|mesh-ancestor
102393710|NCT02410746|Anesthetics|anesthetics|mesh-ancestor
102393711|NCT03177174|Docetaxel|docetaxel|mesh-list
102393712|NCT03177174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102393713|NCT03177174|Tubulin Modulators|tubulin modulators|mesh-ancestor
102393714|NCT03177174|Antimitotic Agents|antimitotic agents|mesh-ancestor
102393715|NCT03177174|Mitosis Modulators|mitosis modulators|mesh-ancestor
102393716|NCT03177174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393717|NCT03177252|Lidocaine|lidocaine|mesh-list
102393718|NCT03177252|Bupivacaine|bupivacaine|mesh-list
102393719|NCT03177252|Anesthetics, Local|anesthetics, local|mesh-ancestor
102393720|NCT03177252|Anesthetics|anesthetics|mesh-ancestor
102393721|NCT03177252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102393722|NCT03177252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393723|NCT03177252|Sensory System Agents|sensory system agents|mesh-ancestor
102393724|NCT03177252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102393725|NCT03177252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102393726|NCT03177252|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102393727|NCT03177252|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102393728|NCT03177252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102393729|NCT03177252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393730|NCT02703324|Insulin Lispro|insulin lispro|mesh-list
102393731|NCT02703324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102393732|NCT02703324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393733|NCT02408562|Becaplermin|becaplermin|mesh-list
102393734|NCT02408562|Anticoagulants|anticoagulants|mesh-ancestor
102393735|NCT02408562|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
102393736|NCT02408562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102393737|NCT02408562|Growth Substances|growth substances|mesh-ancestor
102393738|NCT02408562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393739|NCT02701764|Pregabalin|pregabalin|mesh-list
102393740|NCT02701764|Analgesics|analgesics|mesh-ancestor
102393741|NCT02701764|Sensory System Agents|sensory system agents|mesh-ancestor
102393742|NCT02701764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102393743|NCT02701764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393744|NCT02701764|Anticonvulsants|anticonvulsants|mesh-ancestor
102393745|NCT02701764|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102393746|NCT02701764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102393747|NCT02701764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393748|NCT02701764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102393749|NCT02701764|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102393750|NCT02701764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102393751|NCT02701764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102393752|NCT02701764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102393753|NCT03174288|Spironolactone|spironolactone|mesh-list
102393754|NCT03174288|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102393755|NCT03174288|Hormone Antagonists|hormone antagonists|mesh-ancestor
102393756|NCT03174288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102393757|NCT03174288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393758|NCT03174288|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102393759|NCT03174288|Diuretics|diuretics|mesh-ancestor
102393760|NCT03174288|Natriuretic Agents|natriuretic agents|mesh-ancestor
102393761|NCT02532010|Cytarabine|cytarabine|mesh-list
102393762|NCT02532010|Decitabine|decitabine|mesh-list
102393763|NCT02532010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102393764|NCT02532010|Antimetabolites|antimetabolites|mesh-ancestor
102393765|NCT02532010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393766|NCT02532010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102393767|NCT02532010|Antiviral Agents|antiviral agents|mesh-ancestor
102393768|NCT02532010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102393769|NCT02532010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102393770|NCT02532010|Immunologic Factors|immunologic factors|mesh-ancestor
102393771|NCT02532010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393772|NCT02532010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102393773|NCT02406300|Bupivacaine|bupivacaine|mesh-list
102393774|NCT02406300|Ropivacaine|ropivacaine|mesh-list
102393775|NCT02406300|Levobupivacaine|levobupivacaine|mesh-list
102393776|NCT02406300|Sevoflurane|sevoflurane|mesh-list
102393777|NCT02406300|Desflurane|desflurane|mesh-list
102393778|NCT02406300|Anesthetics, Local|anesthetics, local|mesh-ancestor
102393779|NCT02406300|Anesthetics|anesthetics|mesh-ancestor
102393780|NCT02406300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102393781|NCT02406300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393782|NCT02406300|Sensory System Agents|sensory system agents|mesh-ancestor
102393783|NCT02406300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102393784|NCT02406300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102393785|NCT02406300|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102393786|NCT02406300|Anesthetics, General|anesthetics, general|mesh-ancestor
102393788|NCT02538016|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102393789|NCT02538016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393790|NCT02538016|Natriuretic Agents|natriuretic agents|mesh-ancestor
102393791|NCT02538016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393792|NCT02406144|Dexamethasone|dexamethasone|mesh-list
102393793|NCT02406144|Lenalidomide|lenalidomide|mesh-list
102393794|NCT02406144|Ixazomib|ixazomib|mesh-list
102393795|NCT02406144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102393796|NCT02406144|Antiemetics|antiemetics|mesh-ancestor
102393797|NCT02406144|Autonomic Agents|autonomic agents|mesh-ancestor
102393798|NCT02406144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102393799|NCT02406144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393800|NCT02406144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102393801|NCT02406144|Glucocorticoids|glucocorticoids|mesh-ancestor
102393802|NCT02406144|Hormones|hormones|mesh-ancestor
102393803|NCT02406144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102393804|NCT02406144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102393805|NCT02406144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102393806|NCT02406144|Immunologic Factors|immunologic factors|mesh-ancestor
102393807|NCT02406144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102393808|NCT02406144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102393809|NCT02406144|Growth Substances|growth substances|mesh-ancestor
102393810|NCT02406144|Growth Inhibitors|growth inhibitors|mesh-ancestor
102393811|NCT02406144|Protease Inhibitors|protease inhibitors|mesh-ancestor
102393812|NCT02406144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102393813|NCT02406144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393814|NCT02416752|Remifentanil|remifentanil|mesh-list
102393815|NCT02416752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102393816|NCT02416752|Narcotics|narcotics|mesh-ancestor
102393817|NCT02416752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102393818|NCT02416752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393819|NCT02416752|Analgesics|analgesics|mesh-ancestor
102393820|NCT02416752|Sensory System Agents|sensory system agents|mesh-ancestor
102393821|NCT02416752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102393822|NCT02405910|Paclitaxel|paclitaxel|mesh-list
102393823|NCT02405910|Gemcitabine|gemcitabine|mesh-list
102393824|NCT02405910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102393825|NCT02405910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102393826|NCT02405910|Tubulin Modulators|tubulin modulators|mesh-ancestor
102393827|NCT02405910|Antimitotic Agents|antimitotic agents|mesh-ancestor
102393828|NCT02405910|Mitosis Modulators|mitosis modulators|mesh-ancestor
102393829|NCT02405910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393830|NCT02405910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102393831|NCT02405910|Antimetabolites|antimetabolites|mesh-ancestor
102393832|NCT02539108|Vaccines|vaccines|mesh-list
102393833|NCT02539108|Immunologic Factors|immunologic factors|mesh-ancestor
102393834|NCT02539108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393835|NCT02406066|Oxazepam|oxazepam|mesh-list
102393836|NCT02406066|Metyrapone|metyrapone|mesh-list
102393837|NCT02406066|Antimetabolites|antimetabolites|mesh-ancestor
102393838|NCT02406066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393839|NCT02406066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102393840|NCT02406066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102393841|NCT02406066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102393842|NCT02406066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393843|NCT02406066|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102393844|NCT02406066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102393845|NCT02406066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102393846|NCT02406066|GABA Modulators|gaba modulators|mesh-ancestor
102393847|NCT02406066|GABA Agents|gaba agents|mesh-ancestor
102393848|NCT02406066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102393849|NCT02408328|Caffeine|caffeine|mesh-list
102393850|NCT02408328|Caffeine citrate|caffeine citrate|mesh-list
102393851|NCT02408328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393852|NCT02408328|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102393853|NCT02408328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393854|NCT02408328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102393855|NCT02408328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102393856|NCT02408328|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102205580|NCT02333799|Linezolid|linezolid|mesh-list
102393857|NCT02408328|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102393858|NCT02408328|Purinergic Agents|purinergic agents|mesh-ancestor
102393859|NCT02408328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102393860|NCT02539342|Calcium|calcium|mesh-list
102393861|NCT02539342|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102393862|NCT02539342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393863|NCT02405988|Remifentanil|remifentanil|mesh-list
102393864|NCT02405988|Naloxone|naloxone|mesh-list
102393865|NCT02405988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102393866|NCT02405988|Narcotics|narcotics|mesh-ancestor
102393867|NCT02405988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102393868|NCT02405988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393869|NCT02405988|Analgesics|analgesics|mesh-ancestor
102393870|NCT02405988|Sensory System Agents|sensory system agents|mesh-ancestor
102393871|NCT02405988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102393872|NCT02405988|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102393873|NCT02542150|Ethanol|ethanol|mesh-list
102393874|NCT02542150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102393875|NCT02542150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102393876|NCT02542150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102393877|NCT02542150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393878|NCT02542462|Vaccines|vaccines|mesh-list
102393879|NCT02542462|Immunologic Factors|immunologic factors|mesh-ancestor
102393880|NCT02542462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393881|NCT03173898|Anesthetics|anesthetics|mesh-list
102393882|NCT03173898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102393883|NCT03173898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393884|NCT02408172|Metoprolol|metoprolol|mesh-list
102393885|NCT02408172|Amlodipine|amlodipine|mesh-list
102393886|NCT02408172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102393887|NCT02408172|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102393888|NCT02408172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102393889|NCT02408172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393890|NCT02408172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102393891|NCT02408172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393892|NCT02408172|Vasodilator Agents|vasodilator agents|mesh-ancestor
102393893|NCT02408172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102393894|NCT02408172|Sympatholytics|sympatholytics|mesh-ancestor
102393895|NCT02408172|Autonomic Agents|autonomic agents|mesh-ancestor
102393896|NCT02408172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102393897|NCT02408172|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102393898|NCT02408172|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102393899|NCT02408172|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102393900|NCT02408172|Adrenergic Agents|adrenergic agents|mesh-ancestor
102393901|NCT02408172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102393902|NCT04481100|Itraconazole|itraconazole|mesh-list
102393903|NCT04481100|Antifungal Agents|antifungal agents|mesh-ancestor
102393904|NCT04481100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102393905|NCT04481100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102393906|NCT04481100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102393907|NCT04481100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102393908|NCT04481100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393909|NCT04481100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102393910|NCT04481100|Hormone Antagonists|hormone antagonists|mesh-ancestor
102393911|NCT04481100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102393912|NCT04481100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393913|NCT04481100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102393914|NCT02405598|Albuterol|albuterol|mesh-list
102393915|NCT02405598|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102393916|NCT02405598|Autonomic Agents|autonomic agents|mesh-ancestor
102393917|NCT02405598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102393918|NCT02405598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393919|NCT02405598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102393920|NCT02405598|Respiratory System Agents|respiratory system agents|mesh-ancestor
102393921|NCT02405598|Tocolytic Agents|tocolytic agents|mesh-ancestor
102393922|NCT02405598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102393923|NCT02405598|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102393924|NCT02405598|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102393925|NCT02405598|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102393926|NCT02405598|Adrenergic Agents|adrenergic agents|mesh-ancestor
102393927|NCT02405598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102393928|NCT02405598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393929|NCT03173508|Acetazolamide|acetazolamide|mesh-list
102205644|NCT02039661|Lidocaine|lidocaine|mesh-list
102393930|NCT03173508|Anticonvulsants|anticonvulsants|mesh-ancestor
102393931|NCT03173508|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102393932|NCT03173508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102393933|NCT03173508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393934|NCT03173508|Diuretics|diuretics|mesh-ancestor
102393935|NCT03173508|Natriuretic Agents|natriuretic agents|mesh-ancestor
102393936|NCT03173508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393937|NCT03173430|Blinatumomab|blinatumomab|mesh-list
102393938|NCT03173430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102393939|NCT02407782|Ivermectin|ivermectin|mesh-list
102393940|NCT02407782|Permethrin|permethrin|mesh-list
102393941|NCT02407782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102393942|NCT02407782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102393943|NCT02407782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102393944|NCT02407782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393945|NCT02405364|Dexamethasone|dexamethasone|mesh-list
102393946|NCT02405364|Lenalidomide|lenalidomide|mesh-list
102393947|NCT02405364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102393948|NCT02405364|Antiemetics|antiemetics|mesh-ancestor
102393949|NCT02405364|Autonomic Agents|autonomic agents|mesh-ancestor
102393950|NCT02405364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102393951|NCT02405364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393952|NCT02405364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102393953|NCT02405364|Glucocorticoids|glucocorticoids|mesh-ancestor
102393954|NCT02405364|Hormones|hormones|mesh-ancestor
102393955|NCT02405364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102393956|NCT02405364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102393957|NCT02405364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102393958|NCT02405364|Immunologic Factors|immunologic factors|mesh-ancestor
102393959|NCT02405364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102393960|NCT02405364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102393961|NCT02405364|Growth Substances|growth substances|mesh-ancestor
102393962|NCT02405364|Growth Inhibitors|growth inhibitors|mesh-ancestor
102393963|NCT02405130|Epinephrine|epinephrine|mesh-list
102393964|NCT02405130|Racepinephrine|racepinephrine|mesh-list
102393965|NCT02405130|Epinephryl borate|epinephryl borate|mesh-list
102393966|NCT02405130|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102393967|NCT02405130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102393968|NCT02405130|Adrenergic Agents|adrenergic agents|mesh-ancestor
102393969|NCT02405130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102393970|NCT02405130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102393971|NCT02405130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393972|NCT02405130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102393973|NCT02405130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102393974|NCT02405130|Autonomic Agents|autonomic agents|mesh-ancestor
102393975|NCT02405130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102393976|NCT02405130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102393977|NCT02405130|Respiratory System Agents|respiratory system agents|mesh-ancestor
102393978|NCT02405130|Mydriatics|mydriatics|mesh-ancestor
102393979|NCT02405130|Sympathomimetics|sympathomimetics|mesh-ancestor
102393980|NCT02405130|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102393981|NCT03171090|Anesthetics|anesthetics|mesh-list
102393982|NCT03171090|Anesthetics, Local|anesthetics, local|mesh-list
102393983|NCT03171090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102393984|NCT03171090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393985|NCT03171090|Sensory System Agents|sensory system agents|mesh-ancestor
102393986|NCT03171090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102393987|NCT02407470|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102393988|NCT02407470|Immunologic Factors|immunologic factors|mesh-ancestor
102393989|NCT02407470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393990|NCT02407470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102393991|NCT02407626|Propofol|propofol|mesh-list
102393992|NCT02407626|Sevoflurane|sevoflurane|mesh-list
102393993|NCT02407626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102393994|NCT02407626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102393995|NCT02407626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102393996|NCT02407626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102393997|NCT02407626|Anesthetics, General|anesthetics, general|mesh-ancestor
102393998|NCT02407626|Anesthetics|anesthetics|mesh-ancestor
102393999|NCT02407626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102394000|NCT02407626|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102394001|NCT02407392|Acetic Acid|acetic acid|mesh-list
102394002|NCT02407392|Retinol acetate|retinol acetate|mesh-list
102394003|NCT02407392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102394004|NCT02407392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102394005|NCT02407392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102394006|NCT02407392|Immunologic Factors|immunologic factors|mesh-ancestor
102394007|NCT02407392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394008|NCT02407392|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102394009|NCT02407392|Protective Agents|protective agents|mesh-ancestor
102394010|NCT02407392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102394011|NCT02551432|Paclitaxel|paclitaxel|mesh-list
102394012|NCT02551432|Pembrolizumab|pembrolizumab|mesh-list
102394013|NCT02551432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102394014|NCT02551432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102394015|NCT02551432|Tubulin Modulators|tubulin modulators|mesh-ancestor
102394016|NCT02551432|Antimitotic Agents|antimitotic agents|mesh-ancestor
102394017|NCT02551432|Mitosis Modulators|mitosis modulators|mesh-ancestor
102394018|NCT02551432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394019|NCT02551432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102394020|NCT02551432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102394021|NCT02407548|Vitamin E|vitamin e|mesh-list
102394022|NCT02407548|Coenzyme Q10|coenzyme q10|mesh-list
102394023|NCT02407548|Ubiquinone|ubiquinone|mesh-list
102394024|NCT02407548|Vitamins|vitamins|mesh-ancestor
102394025|NCT02407548|Micronutrients|micronutrients|mesh-ancestor
102394026|NCT02407548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394027|NCT02407548|Antioxidants|antioxidants|mesh-ancestor
102394028|NCT02407548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394029|NCT02407548|Protective Agents|protective agents|mesh-ancestor
102394030|NCT01695317|Acetylcarnitine|acetylcarnitine|mesh-list
102394031|NCT01695317|Vitamin B Complex|vitamin b complex|mesh-ancestor
102394032|NCT01695317|Vitamins|vitamins|mesh-ancestor
102394033|NCT01695317|Micronutrients|micronutrients|mesh-ancestor
102394034|NCT01695317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394035|NCT01695317|Nootropic Agents|nootropic agents|mesh-ancestor
102394036|NCT02551744|Pantoprazole|pantoprazole|mesh-list
102394037|NCT02551744|Famotidine|famotidine|mesh-list
102394038|NCT02551744|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
102394039|NCT02551744|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
102394040|NCT02551744|Histamine|histamine|mesh-list
102394041|NCT02551744|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102394042|NCT02551744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102394043|NCT02551744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102394044|NCT02551744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394045|NCT02551744|Histamine Antagonists|histamine antagonists|mesh-ancestor
102394046|NCT02551744|Histamine Agents|histamine agents|mesh-ancestor
102394047|NCT02551744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102394048|NCT02551744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394049|NCT02551744|Histamine Agonists|histamine agonists|mesh-ancestor
102394050|NCT04743544|Voriconazole|voriconazole|mesh-list
102394051|NCT04743544|Antifungal Agents|antifungal agents|mesh-ancestor
102394052|NCT04743544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102394053|NCT04743544|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102394054|NCT04743544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102394055|NCT04743544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102394056|NCT04743544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394057|NCT04743544|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102394058|NCT04743544|Hormone Antagonists|hormone antagonists|mesh-ancestor
102394059|NCT04743544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102394060|NCT04743544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394061|NCT04743544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102394062|NCT04481802|Acemannan|acemannan|mesh-list
102394063|NCT04481802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102394064|NCT04481802|Immunologic Factors|immunologic factors|mesh-ancestor
102394065|NCT04481802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837743|NCT01014104|Methylprednisolone|methylprednisolone|mesh-list
102394066|NCT04481802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102394067|NCT04481802|Antiviral Agents|antiviral agents|mesh-ancestor
102394068|NCT04481802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102394069|NCT04481802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102394070|NCT02551822|Neurotransmitter Agents|neurotransmitter agents|mesh-list
102394071|NCT02551822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394072|NCT02551822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394073|NCT02407314|Aspirin|aspirin|mesh-list
102394074|NCT02407314|Ticagrelor|ticagrelor|mesh-list
102394075|NCT02407314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102394076|NCT02407314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102394077|NCT02407314|Analgesics|analgesics|mesh-ancestor
102394078|NCT02407314|Sensory System Agents|sensory system agents|mesh-ancestor
102394079|NCT02407314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102394080|NCT02407314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394081|NCT02407314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102205788|NCT02313103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102394082|NCT02407314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102394083|NCT02407314|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102394084|NCT02407314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102394085|NCT02407314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394086|NCT02407314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102394087|NCT02407314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102394088|NCT02407314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102394089|NCT02407314|Antipyretics|antipyretics|mesh-ancestor
102394090|NCT02407314|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102394091|NCT02407314|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102394092|NCT02407314|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102394093|NCT02407314|Purinergic Agents|purinergic agents|mesh-ancestor
102394094|NCT02407314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102394095|NCT02407080|Interferons|interferons|mesh-list
102394096|NCT02407080|Interferon-alpha|interferon-alpha|mesh-list
102394097|NCT02407080|Interferon alpha-2|interferon alpha-2|mesh-list
102394098|NCT02407080|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102394099|NCT02407080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102394100|NCT02407080|Antiviral Agents|antiviral agents|mesh-ancestor
102394101|NCT02407080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102394102|NCT02407080|Immunologic Factors|immunologic factors|mesh-ancestor
101837770|NCT00402987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102394103|NCT02407080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394104|NCT04743622|Latanoprost|latanoprost|mesh-list
102394105|NCT04743622|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102394106|NCT04743622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102394107|NCT02701296|Epinephrine|epinephrine|mesh-list
102394108|NCT02701296|Ropivacaine|ropivacaine|mesh-list
102394109|NCT02701296|Anesthetics, Local|anesthetics, local|mesh-ancestor
102394110|NCT02701296|Anesthetics|anesthetics|mesh-ancestor
102394111|NCT02701296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102394112|NCT02701296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394113|NCT02701296|Sensory System Agents|sensory system agents|mesh-ancestor
102394114|NCT02701296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102394115|NCT02701296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102394116|NCT02701296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102394117|NCT02701296|Adrenergic Agents|adrenergic agents|mesh-ancestor
102394118|NCT02701296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102394119|NCT02701296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394120|NCT02701296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102394121|NCT02701296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102394122|NCT02701296|Autonomic Agents|autonomic agents|mesh-ancestor
102394123|NCT02701296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102394124|NCT02701296|Respiratory System Agents|respiratory system agents|mesh-ancestor
102394125|NCT02701296|Mydriatics|mydriatics|mesh-ancestor
102394126|NCT02701296|Sympathomimetics|sympathomimetics|mesh-ancestor
102394127|NCT02701296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102394128|NCT02558374|Timolol|timolol|mesh-list
102394129|NCT02558374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102394130|NCT02558374|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102394131|NCT02558374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394132|NCT02558374|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102394133|NCT02558374|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102394134|NCT02558374|Adrenergic Agents|adrenergic agents|mesh-ancestor
102394135|NCT02558374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102394136|NCT02558374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394137|NCT02558374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102394138|NCT02558374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102394139|NCT01582451|Insulin|insulin|mesh-list
102394140|NCT01582451|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102394141|NCT01582451|Insulin Glargine|insulin glargine|mesh-list
102394142|NCT01582451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102394143|NCT01582451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394144|NCT03115320|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102394145|NCT03115320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102394146|NCT03115320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394147|NCT03168828|Trospium chloride|trospium chloride|mesh-list
102394148|NCT03168828|Parasympatholytics|parasympatholytics|mesh-ancestor
102394149|NCT03168828|Autonomic Agents|autonomic agents|mesh-ancestor
102394150|NCT03168828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102394151|NCT03168828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394152|NCT03168828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102394153|NCT03168828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102394154|NCT03168828|Cholinergic Agents|cholinergic agents|mesh-ancestor
102394155|NCT03168828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102394156|NCT03168828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394157|NCT03168828|Urological Agents|urological agents|mesh-ancestor
102394158|NCT02562898|Paclitaxel|paclitaxel|mesh-list
102394159|NCT02562898|Gemcitabine|gemcitabine|mesh-list
102394160|NCT02562898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102394161|NCT02562898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102394162|NCT02562898|Tubulin Modulators|tubulin modulators|mesh-ancestor
102394163|NCT02562898|Antimitotic Agents|antimitotic agents|mesh-ancestor
102394164|NCT02562898|Mitosis Modulators|mitosis modulators|mesh-ancestor
102394165|NCT02562898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394166|NCT02562898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102394167|NCT02562898|Antimetabolites|antimetabolites|mesh-ancestor
102394168|NCT03168594|Cisplatin|cisplatin|mesh-list
102394169|NCT03168594|Irinotecan|irinotecan|mesh-list
102394170|NCT03168594|Etoposide|etoposide|mesh-list
102394171|NCT03168594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102394172|NCT03168594|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102394173|NCT03168594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102394174|NCT03168594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102394175|NCT03168594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394176|NCT03168594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102394177|NCT03168594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102394178|NCT02563834|Insulin|insulin|mesh-list
102394179|NCT02563834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102394180|NCT02563834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394181|NCT02564926|Dapagliflozin|dapagliflozin|mesh-list
102394182|NCT02564926|Glimepiride|glimepiride|mesh-list
102394183|NCT02564926|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102394184|NCT02564926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394185|NCT02564926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102394186|NCT02564926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394187|NCT02564926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102394188|NCT02564926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102394189|NCT02564926|Immunologic Factors|immunologic factors|mesh-ancestor
102394190|NCT02567968|Caffeine|caffeine|mesh-list
102394191|NCT02567968|Caffeine citrate|caffeine citrate|mesh-list
102394192|NCT02567968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394193|NCT02567968|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102394194|NCT02567968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394195|NCT02567968|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102394196|NCT02567968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102394197|NCT02567968|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102394198|NCT02567968|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102394199|NCT02567968|Purinergic Agents|purinergic agents|mesh-ancestor
102394200|NCT02567968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102394201|NCT02571634|Fentanyl|fentanyl|mesh-list
102394202|NCT02571634|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102394203|NCT02571634|Narcotics|narcotics|mesh-ancestor
102394204|NCT02571634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102394205|NCT02571634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394206|NCT02571634|Analgesics|analgesics|mesh-ancestor
102394207|NCT02571634|Sensory System Agents|sensory system agents|mesh-ancestor
102394208|NCT02571634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102394209|NCT02571634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102394210|NCT02571634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102394211|NCT02571634|Anesthetics, General|anesthetics, general|mesh-ancestor
102394212|NCT02571634|Anesthetics|anesthetics|mesh-ancestor
102394213|NCT02404038|NuvaRing|nuvaring|mesh-list
102394214|NCT02404038|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
102394215|NCT02404038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102394216|NCT02404038|Contraceptive Agents|contraceptive agents|mesh-ancestor
102394217|NCT02404038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102394218|NCT02404038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394219|NCT02404038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102394220|NCT02404038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102394221|NCT02404038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102394222|NCT02404038|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102394223|NCT02404038|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102394224|NCT02404038|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
102394225|NCT02404038|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102394226|NCT02404038|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102394227|NCT02574598|Docetaxel|docetaxel|mesh-list
102394228|NCT02574598|Pembrolizumab|pembrolizumab|mesh-list
102394229|NCT02574598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102394230|NCT02574598|Tubulin Modulators|tubulin modulators|mesh-ancestor
102394231|NCT02574598|Antimitotic Agents|antimitotic agents|mesh-ancestor
102205940|NCT02305927|Vitamins|vitamins|mesh-ancestor
102394232|NCT02574598|Mitosis Modulators|mitosis modulators|mesh-ancestor
102394233|NCT02574598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394234|NCT02574598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102394235|NCT02574598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102394236|NCT02574832|Lidocaine|lidocaine|mesh-list
102394237|NCT02574832|Fentanyl|fentanyl|mesh-list
102394238|NCT02574832|Anesthetics, Local|anesthetics, local|mesh-ancestor
102394239|NCT02574832|Anesthetics|anesthetics|mesh-ancestor
102394240|NCT02574832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102394241|NCT02574832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394242|NCT02574832|Sensory System Agents|sensory system agents|mesh-ancestor
102394243|NCT02574832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102394244|NCT02574832|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102394245|NCT02574832|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102394246|NCT02574832|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102394247|NCT02574832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102394248|NCT02574832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394249|NCT02574832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102394250|NCT02574832|Narcotics|narcotics|mesh-ancestor
102394251|NCT02574832|Analgesics|analgesics|mesh-ancestor
102394252|NCT02574832|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102394253|NCT02574832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102394254|NCT02574832|Anesthetics, General|anesthetics, general|mesh-ancestor
102394255|NCT02406690|Leuprolide|leuprolide|mesh-list
102394256|NCT02406690|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102394257|NCT02406690|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102394258|NCT02406690|Estradiol|estradiol|mesh-list
102394259|NCT02406690|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102394260|NCT02406690|Progesterone|progesterone|mesh-list
102394261|NCT02406690|Estrogens|estrogens|mesh-ancestor
102394262|NCT02406690|Hormones|hormones|mesh-ancestor
102394263|NCT02406690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102394264|NCT02406690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394265|NCT02406690|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102394266|NCT02406690|Contraceptive Agents|contraceptive agents|mesh-ancestor
102394267|NCT02406690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102394268|NCT02406690|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102394269|NCT02406690|Progestins|progestins|mesh-ancestor
102394270|NCT02406690|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102394271|NCT02406690|Fertility Agents|fertility agents|mesh-ancestor
102394272|NCT02406690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102394273|NCT02406690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102394274|NCT04440696|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
102394275|NCT04440696|Chelating Agents|chelating agents|mesh-ancestor
102394276|NCT04440696|Sequestering Agents|sequestering agents|mesh-ancestor
102394277|NCT04440696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394278|NCT02974348|Acetaminophen|acetaminophen|mesh-list
102394279|NCT02974348|Amoxicillin|amoxicillin|mesh-list
102394280|NCT02974348|Artesunate|artesunate|mesh-list
102394281|NCT02974348|Lumefantrine|lumefantrine|mesh-list
102394282|NCT02974348|Piperaquine|piperaquine|mesh-list
102394283|NCT02974348|Artenimol|artenimol|mesh-list
102394284|NCT02974348|Mefloquine|mefloquine|mesh-list
102394285|NCT02974348|Quinine|quinine|mesh-list
102394286|NCT02974348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102394287|NCT02974348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102394288|NCT02974348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102394289|NCT02974348|Analgesics|analgesics|mesh-ancestor
102394290|NCT02974348|Sensory System Agents|sensory system agents|mesh-ancestor
102394291|NCT02974348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102394292|NCT02974348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394293|NCT02974348|Antipyretics|antipyretics|mesh-ancestor
102394294|NCT02974348|Antimalarials|antimalarials|mesh-ancestor
102394295|NCT02974348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102394296|NCT02974348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102394297|NCT02974348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102394298|NCT02974348|Antiviral Agents|antiviral agents|mesh-ancestor
102394299|NCT02974348|Schistosomicides|schistosomicides|mesh-ancestor
102394300|NCT02974348|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102394301|NCT02974348|Anthelmintics|anthelmintics|mesh-ancestor
102394302|NCT02974348|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102394303|NCT02974348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102394304|NCT03170310|Apatinib|apatinib|mesh-list
102394305|NCT03170310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102394306|NCT03170310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102394307|NCT03170310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102394308|NCT03170310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394309|NCT00364000|Calcium|calcium|mesh-list
102394310|NCT00364000|Sevelamer|sevelamer|mesh-list
102394311|NCT00364000|Calcium acetate|calcium acetate|mesh-list
102394312|NCT00364000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102394313|NCT00364000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394314|NCT00364000|Chelating Agents|chelating agents|mesh-ancestor
102394315|NCT00364000|Sequestering Agents|sequestering agents|mesh-ancestor
102394316|NCT00364000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394317|NCT00422188|Deoxycholic Acid|deoxycholic acid|mesh-list
102394318|NCT00422188|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102394319|NCT00422188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102394320|NCT02403804|Betaine|betaine|mesh-list
102394321|NCT02403804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102394322|NCT02403804|Lipotropic Agents|lipotropic agents|mesh-ancestor
102394323|NCT02403804|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102394324|NCT02403804|Antimetabolites|antimetabolites|mesh-ancestor
102394325|NCT02403804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394326|NCT02403804|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102394327|NCT03169764|Leucovorin|leucovorin|mesh-list
102394328|NCT03169764|Cyclophosphamide|cyclophosphamide|mesh-list
102394329|NCT03169764|Bevacizumab|bevacizumab|mesh-list
102394330|NCT03169764|Fluorouracil|fluorouracil|mesh-list
102394331|NCT03169764|Capecitabine|capecitabine|mesh-list
102394332|NCT03169764|Nivolumab|nivolumab|mesh-list
102394333|NCT03169764|Cetuximab|cetuximab|mesh-list
102394334|NCT03169764|Fulvestrant|fulvestrant|mesh-list
102394335|NCT03169764|Avelumab|avelumab|mesh-list
102394336|NCT03169764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102394337|NCT03169764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394338|NCT03169764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102394339|NCT03169764|Immunologic Factors|immunologic factors|mesh-ancestor
102394340|NCT03169764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394341|NCT03169764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102394342|NCT03169764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102394343|NCT03169764|Alkylating Agents|alkylating agents|mesh-ancestor
102394344|NCT03169764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102394345|NCT03169764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102394346|NCT03169764|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102394347|NCT03169764|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102394348|NCT03169764|Growth Substances|growth substances|mesh-ancestor
102394349|NCT03169764|Growth Inhibitors|growth inhibitors|mesh-ancestor
102394350|NCT03169764|Antimetabolites|antimetabolites|mesh-ancestor
102394351|NCT03169764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102394352|NCT03169764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102394353|NCT03169764|Antidotes|antidotes|mesh-ancestor
102394354|NCT03169764|Protective Agents|protective agents|mesh-ancestor
102394355|NCT03169764|Vitamin B Complex|vitamin b complex|mesh-ancestor
102394356|NCT03169764|Vitamins|vitamins|mesh-ancestor
102394357|NCT03169764|Micronutrients|micronutrients|mesh-ancestor
102394358|NCT03169764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102394359|NCT03169764|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102394360|NCT03169764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102394361|NCT03169764|Hormone Antagonists|hormone antagonists|mesh-ancestor
102394362|NCT03169764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102394363|NCT03874936|Dexamethasone|dexamethasone|mesh-list
102394364|NCT03874936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102394365|NCT03874936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102394366|NCT03874936|Antiemetics|antiemetics|mesh-ancestor
102394367|NCT03874936|Autonomic Agents|autonomic agents|mesh-ancestor
102394368|NCT03874936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102394369|NCT03874936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394370|NCT03874936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102394371|NCT03874936|Glucocorticoids|glucocorticoids|mesh-ancestor
102394372|NCT03874936|Hormones|hormones|mesh-ancestor
101838243|NCT00402285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102394373|NCT03874936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102394374|NCT03874936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102394375|NCT03874936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102394376|NCT02399592|Bevacizumab|bevacizumab|mesh-list
102394377|NCT02399592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102394378|NCT02399592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102394379|NCT02399592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102394380|NCT02399592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102394381|NCT02399592|Growth Substances|growth substances|mesh-ancestor
102394382|NCT02399592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394383|NCT02399592|Growth Inhibitors|growth inhibitors|mesh-ancestor
102394384|NCT03801304|Atezolizumab|atezolizumab|mesh-list
102394385|NCT03801304|Vinorelbine|vinorelbine|mesh-list
102394386|NCT03801304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102394387|NCT03801304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394388|NCT03801304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102394389|NCT03801304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102394390|NCT03801304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102394391|NCT03801304|Tubulin Modulators|tubulin modulators|mesh-ancestor
102394392|NCT03801304|Antimitotic Agents|antimitotic agents|mesh-ancestor
102394393|NCT03801304|Mitosis Modulators|mitosis modulators|mesh-ancestor
102394394|NCT02696850|Budesonide|budesonide|mesh-list
102394395|NCT02696850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102394396|NCT02696850|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102394397|NCT02696850|Autonomic Agents|autonomic agents|mesh-ancestor
102394398|NCT02696850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102394399|NCT02696850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394400|NCT02696850|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102394401|NCT02696850|Respiratory System Agents|respiratory system agents|mesh-ancestor
102394402|NCT02696850|Glucocorticoids|glucocorticoids|mesh-ancestor
102394403|NCT02696850|Hormones|hormones|mesh-ancestor
102394404|NCT02696850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102394405|NCT00365170|Insulin|insulin|mesh-list
102394406|NCT00365170|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102394407|NCT00365170|Insulin Aspart|insulin aspart|mesh-list
102394408|NCT00365170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102394409|NCT00365170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394410|NCT02403648|Glucagon|glucagon|mesh-list
102394411|NCT02403648|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102394412|NCT02403648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102394413|NCT02403648|Hormones|hormones|mesh-ancestor
102394414|NCT02403648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102394415|NCT02403648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394416|NCT02403648|Incretins|incretins|mesh-ancestor
102394417|NCT02396862|Factor VIII|factor viii|mesh-list
102394418|NCT02396862|Coagulants|coagulants|mesh-ancestor
102394419|NCT02377492|Vasopressins|vasopressins|mesh-list
102394420|NCT02377492|Arginine Vasopressin|arginine vasopressin|mesh-list
102394421|NCT02377492|Hemostatics|hemostatics|mesh-ancestor
102394422|NCT02377492|Coagulants|coagulants|mesh-ancestor
102394423|NCT02377492|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102394424|NCT02377492|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102394425|NCT02377492|Natriuretic Agents|natriuretic agents|mesh-ancestor
102394426|NCT02377492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394427|NCT02594644|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102394428|NCT02594644|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102394429|NCT02594644|Dermatologic Agents|dermatologic agents|mesh-ancestor
102394430|NCT02601976|Ribavirin|ribavirin|mesh-list
102394431|NCT02601976|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102394432|NCT02601976|Antimetabolites|antimetabolites|mesh-ancestor
102394433|NCT02601976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394434|NCT02601976|Antiviral Agents|antiviral agents|mesh-ancestor
102394435|NCT02601976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102394436|NCT02603926|Pregnanolone|pregnanolone|mesh-list
102394437|NCT02603926|Brexanolone|brexanolone|mesh-list
102394438|NCT02603926|Anesthetics|anesthetics|mesh-ancestor
102394439|NCT02603926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102394440|NCT02603926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394441|NCT02603926|Neurosteroids|neurosteroids|mesh-ancestor
102394442|NCT02603926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102394443|NCT02603926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394444|NCT02603926|GABA Modulators|gaba modulators|mesh-ancestor
102394445|NCT02603926|GABA Agents|gaba agents|mesh-ancestor
102394446|NCT00365560|Tiotropium Bromide|tiotropium bromide|mesh-list
102394447|NCT00365560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102394448|NCT00365560|Autonomic Agents|autonomic agents|mesh-ancestor
102394449|NCT00365560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102394450|NCT00365560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394451|NCT00365560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102394452|NCT00365560|Respiratory System Agents|respiratory system agents|mesh-ancestor
102394453|NCT00365560|Parasympatholytics|parasympatholytics|mesh-ancestor
102394454|NCT00365560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102394455|NCT00365560|Cholinergic Agents|cholinergic agents|mesh-ancestor
102394456|NCT00365560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102394457|NCT00365560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394458|NCT02395926|Choline|choline|mesh-list
102394459|NCT02395926|Lipotropic Agents|lipotropic agents|mesh-ancestor
102206177|NCT03498703|Azathioprine|azathioprine|mesh-list
102394460|NCT02395926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102394461|NCT02395926|Antimetabolites|antimetabolites|mesh-ancestor
102394462|NCT02395926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394463|NCT02395926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102394464|NCT02395926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102394465|NCT02395926|Nootropic Agents|nootropic agents|mesh-ancestor
102394466|NCT02402868|Ketamine|ketamine|mesh-list
102394467|NCT02402868|Analgesics|analgesics|mesh-ancestor
102394468|NCT02402868|Sensory System Agents|sensory system agents|mesh-ancestor
102394469|NCT02402868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102394470|NCT02402868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394471|NCT02402868|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102394472|NCT02402868|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102394473|NCT02402868|Anesthetics, General|anesthetics, general|mesh-ancestor
102394474|NCT02402868|Anesthetics|anesthetics|mesh-ancestor
102394475|NCT02402868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102394476|NCT02402868|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102394477|NCT02402868|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102394478|NCT02402868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102394479|NCT02402868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394480|NCT02402712|Docetaxel|docetaxel|mesh-list
102394481|NCT02402712|Trastuzumab|trastuzumab|mesh-list
102394482|NCT02402712|Pertuzumab|pertuzumab|mesh-list
102394483|NCT02402712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102394484|NCT02402712|Tubulin Modulators|tubulin modulators|mesh-ancestor
102394485|NCT02402712|Antimitotic Agents|antimitotic agents|mesh-ancestor
102394486|NCT02402712|Mitosis Modulators|mitosis modulators|mesh-ancestor
102394487|NCT02402712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394488|NCT02402712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102394489|NCT02395458|Amoxicillin|amoxicillin|mesh-list
102394490|NCT02395458|Metronidazole|metronidazole|mesh-list
102394491|NCT02395458|Clarithromycin|clarithromycin|mesh-list
102394492|NCT02395458|Omeprazole|omeprazole|mesh-list
102394493|NCT02395458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102394494|NCT02395458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102394495|NCT02395458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102394496|NCT02395458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102394497|NCT02395458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102394498|NCT02395458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101838379|NCT00468546|Dermatologic Agents|dermatologic agents|mesh-ancestor
102394499|NCT02395458|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102394500|NCT02395458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102394501|NCT02395458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394502|NCT02395458|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102394503|NCT02395458|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102394504|NCT02395458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102394505|NCT02402400|Ticagrelor|ticagrelor|mesh-list
102394506|NCT02402400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102394507|NCT02402400|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102394508|NCT02402400|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102394509|NCT02402400|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102394510|NCT02402400|Purinergic Agents|purinergic agents|mesh-ancestor
102394511|NCT02402400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102394512|NCT02402400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394513|NCT02402400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394514|NCT02610868|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
102394515|NCT02610868|Botulinum Toxins|botulinum toxins|mesh-list
102394516|NCT02610868|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102394517|NCT02610868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102394518|NCT02610868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394519|NCT02610868|Cholinergic Agents|cholinergic agents|mesh-ancestor
102394520|NCT02610868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102394521|NCT02610868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394522|NCT02610868|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102394523|NCT02395068|Irinotecan|irinotecan|mesh-list
102394524|NCT02395068|Nimotuzumab|nimotuzumab|mesh-list
102394525|NCT02395068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102394526|NCT02395068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102394527|NCT02395068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102394528|NCT02395068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394529|NCT02395068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102394530|NCT02395068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102394531|NCT02616250|Ivermectin|ivermectin|mesh-list
102394532|NCT02616250|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102394533|NCT02616250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102394534|NCT02616250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102394535|NCT02616250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102394536|NCT02616250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102394537|NCT02616250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102394538|NCT02616250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101838392|NCT01064986|Epinephrine|epinephrine|mesh-list
102394539|NCT02616250|Adrenergic Agents|adrenergic agents|mesh-ancestor
102394540|NCT02616250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102394541|NCT02616250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394542|NCT02616250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394543|NCT02698410|Temozolomide|temozolomide|mesh-list
102394544|NCT02698410|Lanreotide|lanreotide|mesh-list
102394545|NCT02698410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102394546|NCT02698410|Alkylating Agents|alkylating agents|mesh-ancestor
102394547|NCT02698410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394548|NCT02698410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102394549|NCT00365638|Simvastatin|simvastatin|mesh-list
102394550|NCT00365638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102394551|NCT00365638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102394552|NCT00365638|Antimetabolites|antimetabolites|mesh-ancestor
102394553|NCT00365638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394554|NCT00365638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102394555|NCT00365638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102394556|NCT00365638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102394557|NCT02699892|Rituximab|rituximab|mesh-list
102394558|NCT02699892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102394559|NCT02699892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102394560|NCT02699892|Immunologic Factors|immunologic factors|mesh-ancestor
102394561|NCT02699892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394562|NCT02699892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102394563|NCT05731258|Doxorubicin|doxorubicin|mesh-list
102394564|NCT05731258|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102394565|NCT05731258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102394566|NCT05731258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102394567|NCT05731258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102394568|NCT05731258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102394569|NCT05731258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102394570|NCT05731258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394571|NCT04340908|Dapagliflozin|dapagliflozin|mesh-list
102394572|NCT04340908|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102394573|NCT04340908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394574|NCT04340908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102394575|NCT04340908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394576|NCT05730634|Atorvastatin|atorvastatin|mesh-list
102394577|NCT05730634|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102394578|NCT05730634|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102394579|NCT05730634|Antimetabolites|antimetabolites|mesh-ancestor
102394580|NCT05730634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394581|NCT05730634|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102394582|NCT05730634|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102394583|NCT05730634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102394584|NCT05705830|Serotonin|serotonin|mesh-list
102394585|NCT05705830|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
102394586|NCT05705830|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102394587|NCT05705830|Serotonin Agents|serotonin agents|mesh-ancestor
102394588|NCT05705830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102394589|NCT05705830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394590|NCT05705830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394591|NCT05705830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102394592|NCT05705830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102394593|NCT05745714|Cytarabine|cytarabine|mesh-list
102394594|NCT05745714|Dexamethasone|dexamethasone|mesh-list
102394595|NCT05745714|Cyclophosphamide|cyclophosphamide|mesh-list
102394596|NCT05745714|Venetoclax|venetoclax|mesh-list
102394597|NCT05745714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102394598|NCT05745714|Immunologic Factors|immunologic factors|mesh-ancestor
102394599|NCT05745714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394600|NCT05745714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102394601|NCT05745714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102394602|NCT05745714|Alkylating Agents|alkylating agents|mesh-ancestor
102394603|NCT05745714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394604|NCT05745714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102394605|NCT05745714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102394606|NCT05745714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102394607|NCT05745714|Antiemetics|antiemetics|mesh-ancestor
102394608|NCT05745714|Autonomic Agents|autonomic agents|mesh-ancestor
102394609|NCT05745714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102394610|NCT05745714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102394612|NCT05745714|Hormones|hormones|mesh-ancestor
102394613|NCT05745714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102394614|NCT05745714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102394615|NCT05745714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102394616|NCT05745714|Antimetabolites|antimetabolites|mesh-ancestor
102394617|NCT05745714|Antiviral Agents|antiviral agents|mesh-ancestor
102394618|NCT05745714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102394619|NCT02974270|Leuprolide|leuprolide|mesh-list
102394620|NCT02974270|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102394621|NCT02974270|Fertility Agents|fertility agents|mesh-ancestor
102394622|NCT02974270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102394623|NCT02974270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394624|NCT02974270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102394625|NCT02974270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102394626|NCT03167268|Lycopene|lycopene|mesh-list
102394627|NCT03167268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102394628|NCT03167268|Antioxidants|antioxidants|mesh-ancestor
102394629|NCT03167268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394630|NCT03167268|Protective Agents|protective agents|mesh-ancestor
102394631|NCT03167268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394632|NCT03167268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102394633|NCT03167268|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102394634|NCT03167268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102394635|NCT04544098|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102394636|NCT04544098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101838509|NCT00301834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102394637|NCT04544098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394638|NCT04485052|Azacitidine|azacitidine|mesh-list
102394639|NCT04485052|Decitabine|decitabine|mesh-list
102394640|NCT04485052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102394641|NCT04485052|Antimetabolites|antimetabolites|mesh-ancestor
102394642|NCT04485052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394643|NCT04485052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102394644|NCT04485052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102394645|NCT02393898|Paclitaxel|paclitaxel|mesh-list
102394646|NCT02393898|Bevacizumab|bevacizumab|mesh-list
102394647|NCT02393898|Carboplatin|carboplatin|mesh-list
102394648|NCT02393898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102394649|NCT02393898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102394650|NCT02393898|Tubulin Modulators|tubulin modulators|mesh-ancestor
102394651|NCT02393898|Antimitotic Agents|antimitotic agents|mesh-ancestor
102394652|NCT02393898|Mitosis Modulators|mitosis modulators|mesh-ancestor
102394653|NCT02393898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394654|NCT02393898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102394655|NCT02393898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102394656|NCT02393898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102394657|NCT02393898|Growth Substances|growth substances|mesh-ancestor
102394658|NCT02393898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394659|NCT02393898|Growth Inhibitors|growth inhibitors|mesh-ancestor
102394660|NCT04340128|Meglumine Antimoniate|meglumine antimoniate|mesh-list
102394661|NCT04340128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102394662|NCT04340128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101838549|NCT00465972|Doxepin|doxepin|mesh-list
102394663|NCT04340128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102394664|NCT04258852|Nicotine|nicotine|mesh-list
102394665|NCT04258852|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102394666|NCT04258852|Autonomic Agents|autonomic agents|mesh-ancestor
102394667|NCT04258852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102394668|NCT04258852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394669|NCT04258852|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102394670|NCT04258852|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102394671|NCT04258852|Cholinergic Agents|cholinergic agents|mesh-ancestor
102394672|NCT04258852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102394673|NCT04258852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394674|NCT04145674|Methadone|methadone|mesh-list
102394675|NCT04145674|D-methadone|d-methadone|mesh-list
102394676|NCT04145674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102394677|NCT04145674|Narcotics|narcotics|mesh-ancestor
102394678|NCT04145674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102394679|NCT04145674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394680|NCT04145674|Analgesics|analgesics|mesh-ancestor
102394681|NCT04145674|Sensory System Agents|sensory system agents|mesh-ancestor
102394682|NCT04145674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102394683|NCT04145674|Antitussive Agents|antitussive agents|mesh-ancestor
102394684|NCT04145674|Respiratory System Agents|respiratory system agents|mesh-ancestor
102394685|NCT04145674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102394686|NCT02394054|Vasopressins|vasopressins|mesh-list
102394687|NCT02394054|Arginine Vasopressin|arginine vasopressin|mesh-list
102394688|NCT02394054|Hemostatics|hemostatics|mesh-ancestor
102394689|NCT02394054|Coagulants|coagulants|mesh-ancestor
102394690|NCT02394054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102394691|NCT02394054|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102394692|NCT02394054|Natriuretic Agents|natriuretic agents|mesh-ancestor
102394693|NCT02394054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394694|NCT02393664|Bupivacaine|bupivacaine|mesh-list
102394696|NCT02393664|Sevoflurane|sevoflurane|mesh-list
102394697|NCT02393664|Rocuronium|rocuronium|mesh-list
102394698|NCT02393664|Anesthetics, Local|anesthetics, local|mesh-ancestor
102394699|NCT02393664|Anesthetics|anesthetics|mesh-ancestor
102394700|NCT02393664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102394701|NCT02393664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394702|NCT02393664|Sensory System Agents|sensory system agents|mesh-ancestor
102394703|NCT02393664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102394704|NCT02393664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102394705|NCT02393664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102394706|NCT02393664|Anesthetics, General|anesthetics, general|mesh-ancestor
102394707|NCT02393664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102394708|NCT02393664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102394709|NCT02393664|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102394710|NCT02393664|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102394711|NCT02393664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102394712|NCT02397642|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102394713|NCT02397642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102394714|NCT02397642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394715|NCT02397486|Vitamin E|vitamin e|mesh-list
102394716|NCT02397486|Pentoxifylline|pentoxifylline|mesh-list
102394717|NCT02397486|Vitamins|vitamins|mesh-ancestor
102394718|NCT02397486|Micronutrients|micronutrients|mesh-ancestor
102394719|NCT02397486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394720|NCT02397486|Antioxidants|antioxidants|mesh-ancestor
102394721|NCT02397486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394722|NCT02397486|Protective Agents|protective agents|mesh-ancestor
102394723|NCT02397486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102394724|NCT02397486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102394725|NCT02397486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102394726|NCT02397486|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102394727|NCT02397486|Vasodilator Agents|vasodilator agents|mesh-ancestor
102394728|NCT02397486|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102394729|NCT02393586|Amoxicillin|amoxicillin|mesh-list
102394730|NCT02393586|Rifampin|rifampin|mesh-list
102394731|NCT02393586|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102394732|NCT02393586|Clavulanic Acids|clavulanic acids|mesh-list
102394733|NCT02393586|Clavulanic Acid|clavulanic acid|mesh-list
102394734|NCT02393586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102394735|NCT02393586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102394736|NCT02393586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102394737|NCT02393586|Antitubercular Agents|antitubercular agents|mesh-ancestor
102394738|NCT02393586|Leprostatic Agents|leprostatic agents|mesh-ancestor
102394739|NCT02393586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102394740|NCT02393586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101838682|NCT01042041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102394741|NCT02393586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394742|NCT02393586|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102394743|NCT02393586|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102394744|NCT02393586|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102394745|NCT02393586|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102394746|NCT02393586|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102394747|NCT02393586|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102394748|NCT02393586|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102394749|NCT02393430|Rebamipide|rebamipide|mesh-list
102394750|NCT02393430|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102394751|NCT02393430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102394752|NCT02393430|Antioxidants|antioxidants|mesh-ancestor
102394753|NCT02393430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394754|NCT02393430|Protective Agents|protective agents|mesh-ancestor
102394755|NCT02393430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394756|NCT02393430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102394757|NCT03453892|Pembrolizumab|pembrolizumab|mesh-list
102394758|NCT03453892|Nivolumab|nivolumab|mesh-list
102394759|NCT03453892|Ipilimumab|ipilimumab|mesh-list
102394760|NCT03453892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102394762|NCT03453892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102394763|NCT03453892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394764|NCT00367120|Amoxicillin|amoxicillin|mesh-list
102394765|NCT00367120|Azithromycin|azithromycin|mesh-list
102394766|NCT00367120|Clavulanic Acid|clavulanic acid|mesh-list
102394767|NCT00367120|Clavulanic Acids|clavulanic acids|mesh-list
102394768|NCT00367120|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102394769|NCT00367120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102394770|NCT00367120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102394771|NCT00367120|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102394772|NCT00367120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102394773|NCT00367120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394774|NCT03103750|Calcitriol|calcitriol|mesh-list
102394775|NCT03103750|Amphetamine|amphetamine|mesh-list
102394776|NCT03103750|Dextroamphetamine|dextroamphetamine|mesh-list
102394777|NCT03103750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102394778|NCT03103750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394779|NCT03103750|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102394780|NCT03103750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102394781|NCT03103750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394782|NCT03103750|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102394783|NCT03103750|Vitamins|vitamins|mesh-ancestor
102394784|NCT03103750|Micronutrients|micronutrients|mesh-ancestor
102394785|NCT03103750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102394786|NCT03103750|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102394787|NCT03103750|Sympathomimetics|sympathomimetics|mesh-ancestor
102394788|NCT03103750|Autonomic Agents|autonomic agents|mesh-ancestor
101838746|NCT03992937|Levonorgestrel|levonorgestrel|mesh-list
102394789|NCT03103750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102394790|NCT03103750|Dopamine Agents|dopamine agents|mesh-ancestor
102394791|NCT03103750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102394792|NCT03103750|Adrenergic Agents|adrenergic agents|mesh-ancestor
102394793|NCT03103750|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102394794|NCT03103750|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102394795|NCT03103750|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102394796|NCT02397330|Morphine|morphine|mesh-list
102394797|NCT02397330|Bupivacaine|bupivacaine|mesh-list
102394798|NCT02397330|Anesthetics, Local|anesthetics, local|mesh-ancestor
102394799|NCT02397330|Anesthetics|anesthetics|mesh-ancestor
102394800|NCT02397330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102394801|NCT02397330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394802|NCT02397330|Sensory System Agents|sensory system agents|mesh-ancestor
102394803|NCT02397330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102394804|NCT02397330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102394805|NCT02397330|Narcotics|narcotics|mesh-ancestor
102394806|NCT02397330|Analgesics|analgesics|mesh-ancestor
102394807|NCT03081052|Nitric Oxide|nitric oxide|mesh-list
102394808|NCT03081052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102394809|NCT03081052|Autonomic Agents|autonomic agents|mesh-ancestor
102394810|NCT03081052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102394811|NCT03081052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394812|NCT03081052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102394813|NCT03081052|Respiratory System Agents|respiratory system agents|mesh-ancestor
102394814|NCT03081052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102394815|NCT03081052|Antioxidants|antioxidants|mesh-ancestor
102394816|NCT03081052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394817|NCT03081052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102394818|NCT03081052|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102394819|NCT03081052|Vasodilator Agents|vasodilator agents|mesh-ancestor
102394820|NCT03081052|Gasotransmitters|gasotransmitters|mesh-ancestor
102394821|NCT03081052|Protective Agents|protective agents|mesh-ancestor
102394822|NCT02393196|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
102394823|NCT02393196|Plasma Substitutes|plasma substitutes|mesh-ancestor
102394824|NCT02393196|Blood Substitutes|blood substitutes|mesh-ancestor
102394825|NCT03015610|Lansoprazole|lansoprazole|mesh-list
102394826|NCT03015610|Dexlansoprazole|dexlansoprazole|mesh-list
102394827|NCT03015610|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102394828|NCT03015610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102394829|NCT03015610|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102394830|NCT03015610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102394831|NCT03015610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394832|NCT00422344|Sunitinib|sunitinib|mesh-list
102394833|NCT00422344|Everolimus|everolimus|mesh-list
102394834|NCT00422344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102394835|NCT00422344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102394836|NCT00422344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102394837|NCT00422344|Growth Substances|growth substances|mesh-ancestor
102394838|NCT00422344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394839|NCT00422344|Growth Inhibitors|growth inhibitors|mesh-ancestor
102394840|NCT00422344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102394841|NCT00422344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102394842|NCT00422344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394843|NCT00422344|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102394844|NCT00422344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102394845|NCT00422344|Immunologic Factors|immunologic factors|mesh-ancestor
102394846|NCT02876302|Paclitaxel|paclitaxel|mesh-list
102394847|NCT02876302|Cyclophosphamide|cyclophosphamide|mesh-list
102394848|NCT02876302|Doxorubicin|doxorubicin|mesh-list
102394849|NCT02876302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102394850|NCT02876302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102394851|NCT02876302|Tubulin Modulators|tubulin modulators|mesh-ancestor
102394852|NCT02876302|Antimitotic Agents|antimitotic agents|mesh-ancestor
102394853|NCT02876302|Mitosis Modulators|mitosis modulators|mesh-ancestor
102394854|NCT02876302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394855|NCT02876302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102394856|NCT02876302|Immunologic Factors|immunologic factors|mesh-ancestor
102394857|NCT02876302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394858|NCT02876302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102394859|NCT02876302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102394860|NCT02876302|Alkylating Agents|alkylating agents|mesh-ancestor
102394861|NCT02876302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102394862|NCT02876302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102394863|NCT02876302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102394864|NCT02876302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102394865|NCT02876302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102394866|NCT00367276|Drospirenone|drospirenone|mesh-list
102394867|NCT00367276|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102394868|NCT00367276|Hormone Antagonists|hormone antagonists|mesh-ancestor
102394869|NCT00367276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102394870|NCT00367276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394871|NCT00367276|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102394872|NCT00367276|Diuretics|diuretics|mesh-ancestor
102394873|NCT00367276|Natriuretic Agents|natriuretic agents|mesh-ancestor
102394874|NCT02546986|Pembrolizumab|pembrolizumab|mesh-list
102394875|NCT02546986|Azacitidine|azacitidine|mesh-list
102394876|NCT02546986|Cc-486|cc-486|mesh-list
102394877|NCT02546986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102394878|NCT02546986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102394879|NCT02546986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102394880|NCT02546986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394881|NCT02546986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102394882|NCT02546986|Antimetabolites|antimetabolites|mesh-ancestor
102394883|NCT02546986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102394884|NCT02689206|Glycine|glycine|mesh-list
102394885|NCT02689206|Glycine Agents|glycine agents|mesh-ancestor
102394886|NCT02689206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101838923|NCT00409617|Adalimumab|adalimumab|mesh-list
102394887|NCT02689206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394888|NCT02689206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394889|NCT01695239|Adalimumab|adalimumab|mesh-list
102394890|NCT01695239|Ixekizumab|ixekizumab|mesh-list
102394891|NCT01695239|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102394892|NCT01695239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102394893|NCT01695239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102394894|NCT01695239|Dermatologic Agents|dermatologic agents|mesh-ancestor
102394895|NCT02163694|Paclitaxel|paclitaxel|mesh-list
102394896|NCT02163694|Carboplatin|carboplatin|mesh-list
102394897|NCT02163694|Veliparib|veliparib|mesh-list
102394898|NCT02163694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102394899|NCT02163694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102394900|NCT02163694|Tubulin Modulators|tubulin modulators|mesh-ancestor
102394901|NCT02163694|Antimitotic Agents|antimitotic agents|mesh-ancestor
102394902|NCT02163694|Mitosis Modulators|mitosis modulators|mesh-ancestor
102394903|NCT02163694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394904|NCT02163694|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102394905|NCT02163694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102394906|NCT01587352|Vorinostat|vorinostat|mesh-list
102394907|NCT01587352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102394908|NCT01587352|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102394909|NCT01587352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102394910|NCT01587352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394911|NCT00703222|Interleukin-2|interleukin-2|mesh-list
102394912|NCT00703222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102394913|NCT00703222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102394914|NCT00703222|Analgesics|analgesics|mesh-ancestor
102394915|NCT00703222|Sensory System Agents|sensory system agents|mesh-ancestor
102394916|NCT00703222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102394917|NCT00703222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394918|NCT04449250|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
102394919|NCT04449250|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102394920|NCT04449250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394921|NCT04449250|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102394922|NCT04449250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102394923|NCT04449250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102394924|NCT04449250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394925|NCT04449250|Dopamine Agents|dopamine agents|mesh-ancestor
102394926|NCT04449250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102394927|NCT04317430|Niclosamide|niclosamide|mesh-list
102394928|NCT04317430|Anticestodal Agents|anticestodal agents|mesh-ancestor
102394929|NCT04317430|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102394930|NCT04317430|Anthelmintics|anthelmintics|mesh-ancestor
102394931|NCT04317430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102394932|NCT04317430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102394933|NCT04317430|Antinematodal Agents|antinematodal agents|mesh-ancestor
102394934|NCT04277884|Firibastat|firibastat|mesh-list
102394935|NCT04277884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102394936|NCT00367822|Ropinirole|ropinirole|mesh-list
102394937|NCT00367822|Lisuride|lisuride|mesh-list
102394938|NCT00367822|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102394939|NCT00367822|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102394940|NCT00367822|Dopamine Agonists|dopamine agonists|mesh-ancestor
102394941|NCT00367822|Dopamine Agents|dopamine agents|mesh-ancestor
102394942|NCT00367822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102394943|NCT00367822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394944|NCT00367822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394945|NCT00367822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102394946|NCT00367822|Serotonin Agents|serotonin agents|mesh-ancestor
102394947|NCT03189706|Irinotecan|irinotecan|mesh-list
102394948|NCT03189706|Temozolomide|temozolomide|mesh-list
102394949|NCT03189706|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102394950|NCT03189706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102394951|NCT03189706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102394952|NCT03189706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394953|NCT03189706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102394954|NCT03189706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102394955|NCT03189706|Alkylating Agents|alkylating agents|mesh-ancestor
102394956|NCT02643862|Omalizumab|omalizumab|mesh-list
102394957|NCT02643862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102394958|NCT02643862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102394959|NCT02643862|Respiratory System Agents|respiratory system agents|mesh-ancestor
102394960|NCT01694771|Tiotropium Bromide|tiotropium bromide|mesh-list
102394961|NCT01694771|Olodaterol|olodaterol|mesh-list
102394962|NCT01694771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102394963|NCT01694771|Autonomic Agents|autonomic agents|mesh-ancestor
102394964|NCT01694771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102394965|NCT01694771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394966|NCT01694771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102394967|NCT01694771|Respiratory System Agents|respiratory system agents|mesh-ancestor
102394968|NCT01694771|Parasympatholytics|parasympatholytics|mesh-ancestor
102394969|NCT01694771|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102394970|NCT01694771|Cholinergic Agents|cholinergic agents|mesh-ancestor
102394971|NCT01694771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102394972|NCT01694771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394973|NCT02651272|Macitentan|macitentan|mesh-list
102394974|NCT02651272|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
102394975|NCT02651272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102394976|NCT02651272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394977|NCT02651272|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
102394978|NCT01582061|Pasireotide|pasireotide|mesh-list
102394979|NCT01582061|Hormones|hormones|mesh-ancestor
101839352|NCT00485732|Vaccines|vaccines|mesh-list
102394980|NCT01582061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102394981|NCT01582061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394982|NCT01693523|Minocycline|minocycline|mesh-list
102394983|NCT01693523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102394984|NCT01693523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102394985|NCT03924323|Escitalopram|escitalopram|mesh-list
102394986|NCT03924323|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101839400|NCT00946907|Aspirin|aspirin|mesh-list
102394987|NCT03924323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102394988|NCT03924323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102394989|NCT03924323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102394990|NCT03924323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102394991|NCT03924323|Serotonin Agents|serotonin agents|mesh-ancestor
102394992|NCT03924323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394993|NCT01581281|Topiramate|topiramate|mesh-list
102394994|NCT01581281|Amitriptyline|amitriptyline|mesh-list
102394995|NCT01581281|Anticonvulsants|anticonvulsants|mesh-ancestor
102394996|NCT01581281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102394997|NCT01581281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102394998|NCT01581281|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102394999|NCT01581281|Antidepressive Agents|antidepressive agents|mesh-ancestor
102395000|NCT01581281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101839606|NCT00947843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102395001|NCT01581281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102395002|NCT01581281|Analgesics|analgesics|mesh-ancestor
102395003|NCT01581281|Sensory System Agents|sensory system agents|mesh-ancestor
102395004|NCT01581281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102395005|NCT01581281|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102395006|NCT01581281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102395007|NCT01581281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101839751|NCT00299182|Hormones|hormones|mesh-ancestor
102395008|NCT01581281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395009|NCT01581281|Adrenergic Agents|adrenergic agents|mesh-ancestor
102395010|NCT01581281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102395011|NCT01580969|Minocycline|minocycline|mesh-list
102395012|NCT01580969|Bevacizumab|bevacizumab|mesh-list
102395013|NCT01580969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102395014|NCT01580969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102395015|NCT01580969|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102395016|NCT01580969|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102395017|NCT01580969|Growth Substances|growth substances|mesh-ancestor
102395018|NCT01580969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395019|NCT01580969|Growth Inhibitors|growth inhibitors|mesh-ancestor
102395020|NCT01580969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102395021|NCT01580969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102395022|NCT02696226|Aspirin|aspirin|mesh-list
102395023|NCT02696226|Warfarin|warfarin|mesh-list
102395024|NCT02696226|Clopidogrel|clopidogrel|mesh-list
102395025|NCT02696226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102395026|NCT02696226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102395027|NCT02696226|Analgesics|analgesics|mesh-ancestor
102395028|NCT02696226|Sensory System Agents|sensory system agents|mesh-ancestor
102395029|NCT02696226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102395030|NCT02696226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395031|NCT02696226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102395032|NCT02696226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102395033|NCT02696226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102395034|NCT02696226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102395035|NCT02696226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395036|NCT02696226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102395037|NCT02696226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102395038|NCT02696226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102395039|NCT02696226|Antipyretics|antipyretics|mesh-ancestor
102395040|NCT02696226|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102395041|NCT02696226|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102395042|NCT02696226|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102395043|NCT02696226|Purinergic Agents|purinergic agents|mesh-ancestor
102395044|NCT02696226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102395045|NCT02696226|Anticoagulants|anticoagulants|mesh-ancestor
102395046|NCT04547777|D2C7-(scdsFv)-PE38KDEL|d2c7-(scdsfv)-pe38kdel|mesh-list
102395047|NCT04547777|Immunoconjugates|immunoconjugates|mesh-ancestor
102395048|NCT04547777|Immunologic Factors|immunologic factors|mesh-ancestor
102395049|NCT04547777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395050|NCT03167112|Leucovorin|leucovorin|mesh-list
102395051|NCT03167112|Fluorouracil|fluorouracil|mesh-list
102395052|NCT03167112|Oxaliplatin|oxaliplatin|mesh-list
102395053|NCT03167112|Irinotecan|irinotecan|mesh-list
102395054|NCT03167112|Antimetabolites|antimetabolites|mesh-ancestor
102395055|NCT03167112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395056|NCT03167112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102395057|NCT03167112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102395058|NCT03167112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102395059|NCT03167112|Immunologic Factors|immunologic factors|mesh-ancestor
102395060|NCT03167112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395061|NCT03167112|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102395062|NCT03167112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101840151|NCT01025466|Dopamine Agents|dopamine agents|mesh-ancestor
102395063|NCT03167112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102395064|NCT03167112|Antidotes|antidotes|mesh-ancestor
102395065|NCT03167112|Protective Agents|protective agents|mesh-ancestor
102395066|NCT03167112|Vitamin B Complex|vitamin b complex|mesh-ancestor
102395067|NCT03167112|Vitamins|vitamins|mesh-ancestor
102395068|NCT03167112|Micronutrients|micronutrients|mesh-ancestor
102395069|NCT01578785|Glatiramer Acetate|glatiramer acetate|mesh-list
102395070|NCT01578785|(T,G)-A-L|(t,g)-a-l|mesh-list
102395071|NCT01578785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102395072|NCT01578785|Immunologic Factors|immunologic factors|mesh-ancestor
102395073|NCT01578785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395074|NCT01578785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102395075|NCT01578785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102395076|NCT03167034|Acetazolamide|acetazolamide|mesh-list
102395077|NCT03167034|Anticonvulsants|anticonvulsants|mesh-ancestor
102395078|NCT03167034|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102395079|NCT03167034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102395080|NCT03167034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395081|NCT03167034|Diuretics|diuretics|mesh-ancestor
102395082|NCT03167034|Natriuretic Agents|natriuretic agents|mesh-ancestor
102395083|NCT03167034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395084|NCT01578551|Metformin|metformin|mesh-list
102395085|NCT01578551|Biguanides|biguanides|mesh-list
102395086|NCT01578551|Paclitaxel|paclitaxel|mesh-list
102395087|NCT01578551|Bevacizumab|bevacizumab|mesh-list
102395088|NCT01578551|Carboplatin|carboplatin|mesh-list
102395089|NCT01578551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102395090|NCT01578551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102395091|NCT01578551|Tubulin Modulators|tubulin modulators|mesh-ancestor
102395092|NCT01578551|Antimitotic Agents|antimitotic agents|mesh-ancestor
102395093|NCT01578551|Mitosis Modulators|mitosis modulators|mesh-ancestor
102395094|NCT01578551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395095|NCT01578551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101840456|NCT03996252|Calcitriol|calcitriol|mesh-list
102395096|NCT01578551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102395097|NCT01578551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102395098|NCT01578551|Growth Substances|growth substances|mesh-ancestor
102395099|NCT01578551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395100|NCT01578551|Growth Inhibitors|growth inhibitors|mesh-ancestor
102395101|NCT01578551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102395102|NCT01692197|Cytarabine|cytarabine|mesh-list
102395103|NCT01692197|Dexamethasone|dexamethasone|mesh-list
102395104|NCT01692197|Idarubicin|idarubicin|mesh-list
102395105|NCT01692197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102395106|NCT01692197|Antiemetics|antiemetics|mesh-ancestor
102395107|NCT01692197|Autonomic Agents|autonomic agents|mesh-ancestor
102395108|NCT01692197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102395109|NCT01692197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395110|NCT01692197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102395111|NCT01692197|Glucocorticoids|glucocorticoids|mesh-ancestor
102395112|NCT01692197|Hormones|hormones|mesh-ancestor
102395113|NCT01692197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102395114|NCT01692197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102395115|NCT01692197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102395116|NCT01692197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102395117|NCT01692197|Antimetabolites|antimetabolites|mesh-ancestor
101840703|NCT00547703|Nortriptyline|nortriptyline|mesh-list
102395118|NCT01692197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395119|NCT01692197|Antiviral Agents|antiviral agents|mesh-ancestor
102395120|NCT01692197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102395121|NCT01692197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102395122|NCT01692197|Immunologic Factors|immunologic factors|mesh-ancestor
102395123|NCT01692197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102395124|NCT01692197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102395125|NCT01692197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102395126|NCT01692197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102395127|NCT03166644|Sufentanil|sufentanil|mesh-list
102395128|NCT03166644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102395129|NCT03166644|Narcotics|narcotics|mesh-ancestor
102395130|NCT03166644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102395131|NCT03166644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395132|NCT03166644|Analgesics|analgesics|mesh-ancestor
102395133|NCT03166644|Sensory System Agents|sensory system agents|mesh-ancestor
101840902|NCT01045941|Gemcitabine|gemcitabine|mesh-list
102395134|NCT03166644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102395135|NCT03166644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102395136|NCT03166644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102395137|NCT03166644|Anesthetics, General|anesthetics, general|mesh-ancestor
102395138|NCT03166644|Anesthetics|anesthetics|mesh-ancestor
102395139|NCT01691885|Fluticasone|fluticasone|mesh-list
102395140|NCT01691885|Xhance|xhance|mesh-list
102395141|NCT01691885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102395142|NCT01691885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102395143|NCT01691885|Autonomic Agents|autonomic agents|mesh-ancestor
102395144|NCT01691885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101841117|NCT00959621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102395145|NCT01691885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395146|NCT01691885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102395147|NCT01691885|Respiratory System Agents|respiratory system agents|mesh-ancestor
102395148|NCT01691885|Dermatologic Agents|dermatologic agents|mesh-ancestor
102395149|NCT01691885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102395150|NCT03166800|Ubiquinone|ubiquinone|mesh-list
102395151|NCT03166800|Micronutrients|micronutrients|mesh-ancestor
102395152|NCT03166800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395153|NCT03166254|Pembrolizumab|pembrolizumab|mesh-list
102395154|NCT03166254|Vaccines|vaccines|mesh-list
102395155|NCT03166254|Poly ICLC|poly iclc|mesh-list
102395156|NCT03166254|Immunologic Factors|immunologic factors|mesh-ancestor
102395157|NCT03166254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395158|NCT03166254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102395159|NCT03166254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102395160|NCT03166254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102395161|NCT03166254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395162|NCT03166254|Interferon Inducers|interferon inducers|mesh-ancestor
102395163|NCT02651428|Taurolidine|taurolidine|mesh-list
102395164|NCT02651428|Heparin|heparin|mesh-list
102395165|NCT02651428|Calcium heparin|calcium heparin|mesh-list
102395166|NCT02651428|Anticoagulants|anticoagulants|mesh-ancestor
102395167|NCT02651428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395168|NCT02651428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102395169|NCT02651428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102395170|NCT02651428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102395171|NCT02651428|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102395172|NCT02651428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102395173|NCT02686164|Lenvatinib|lenvatinib|mesh-list
102395174|NCT02686164|Midazolam|midazolam|mesh-list
102395175|NCT02686164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102395176|NCT02686164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102395177|NCT02686164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102395178|NCT02686164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395179|NCT02686164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102395180|NCT02686164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102395181|NCT02686164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102395182|NCT02686164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102395183|NCT02686164|Anesthetics, General|anesthetics, general|mesh-ancestor
102395184|NCT02686164|Anesthetics|anesthetics|mesh-ancestor
102395185|NCT02686164|GABA Modulators|gaba modulators|mesh-ancestor
102395186|NCT02686164|GABA Agents|gaba agents|mesh-ancestor
102395187|NCT02686164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102395188|NCT02686164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395189|NCT02686164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102395190|NCT02686164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102395191|NCT02686164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102395192|NCT02651584|Buprenorphine|buprenorphine|mesh-list
102395193|NCT02651584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102395194|NCT02651584|Narcotics|narcotics|mesh-ancestor
102395195|NCT02651584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102395196|NCT02651584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395197|NCT02651584|Analgesics|analgesics|mesh-ancestor
102395198|NCT02651584|Sensory System Agents|sensory system agents|mesh-ancestor
102395199|NCT02651584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102395200|NCT02651584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102395201|NCT02685072|Progesterone|progesterone|mesh-list
102395202|NCT02685072|Progestins|progestins|mesh-ancestor
102395203|NCT02685072|Hormones|hormones|mesh-ancestor
102395204|NCT02685072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102395205|NCT02685072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395206|NCT02653144|Dexamethasone|dexamethasone|mesh-list
102395207|NCT02653144|Dexmedetomidine|dexmedetomidine|mesh-list
102395208|NCT02653144|Ropivacaine|ropivacaine|mesh-list
102395209|NCT02653144|Anesthetics|anesthetics|mesh-list
102395210|NCT02653144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102395211|NCT02653144|Antiemetics|antiemetics|mesh-ancestor
102206879|NCT02264171|Ketoconazole|ketoconazole|mesh-list
102395212|NCT02653144|Autonomic Agents|autonomic agents|mesh-ancestor
102395213|NCT02653144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101841948|NCT00365547|Topotecan|topotecan|mesh-list
102395214|NCT02653144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395215|NCT02653144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102395216|NCT02653144|Glucocorticoids|glucocorticoids|mesh-ancestor
102395217|NCT02653144|Hormones|hormones|mesh-ancestor
101842015|NCT03923933|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102395218|NCT02653144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102395219|NCT02653144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102395220|NCT02653144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101842087|NCT00273052|Metoprolol|metoprolol|mesh-list
102395221|NCT02653144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102395222|NCT02653144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102395223|NCT02653144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102395224|NCT02653144|Analgesics|analgesics|mesh-ancestor
102395225|NCT02653144|Sensory System Agents|sensory system agents|mesh-ancestor
102395226|NCT02653144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102395227|NCT02653144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102395228|NCT02653144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102395229|NCT02653144|Adrenergic Agents|adrenergic agents|mesh-ancestor
102395230|NCT02653144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102395231|NCT02653144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395232|NCT02653144|Anesthetics, Local|anesthetics, local|mesh-ancestor
102395233|NCT00118365|Eflornithine|eflornithine|mesh-list
102395234|NCT00118365|Sulindac|sulindac|mesh-list
102395235|NCT00118365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102395236|NCT00118365|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102395237|NCT00118365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102395238|NCT00118365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102395239|NCT00118365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102395240|NCT00118365|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
102395241|NCT00118365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102395242|NCT00118365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395243|NCT00118365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102395244|NCT00118365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102395245|NCT00118365|Analgesics|analgesics|mesh-ancestor
102395246|NCT00118365|Sensory System Agents|sensory system agents|mesh-ancestor
102395247|NCT00118365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102395248|NCT00118365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395249|NCT00118365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102395250|NCT00118365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102395251|NCT00118365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102395252|NCT03165240|Eplerenone|eplerenone|mesh-list
102395253|NCT03165240|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102395254|NCT03165240|Hormone Antagonists|hormone antagonists|mesh-ancestor
102395255|NCT03165240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102395256|NCT03165240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395257|NCT03165240|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102395258|NCT03165240|Diuretics|diuretics|mesh-ancestor
102395259|NCT03165240|Natriuretic Agents|natriuretic agents|mesh-ancestor
102395260|NCT03165240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102395261|NCT01587079|Tiotropium Bromide|tiotropium bromide|mesh-list
102395262|NCT01587079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102395263|NCT01587079|Autonomic Agents|autonomic agents|mesh-ancestor
102395264|NCT01587079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102395265|NCT01587079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842711|NCT02534571|Autonomic Agents|autonomic agents|mesh-ancestor
102395266|NCT01587079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102395267|NCT01587079|Respiratory System Agents|respiratory system agents|mesh-ancestor
102395268|NCT01587079|Parasympatholytics|parasympatholytics|mesh-ancestor
102395269|NCT01587079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102395270|NCT01587079|Cholinergic Agents|cholinergic agents|mesh-ancestor
102395271|NCT01587079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101842847|NCT00267748|Sunitinib|sunitinib|mesh-list
102395272|NCT01587079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395273|NCT03028909|Oseltamivir|oseltamivir|mesh-list
102395274|NCT03028909|MEDI8852|medi8852|mesh-list
102395275|NCT03028909|Antiviral Agents|antiviral agents|mesh-ancestor
102395276|NCT03028909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102395277|NCT03028909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102395278|NCT03028909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395279|NCT02654860|Acetaminophen|acetaminophen|mesh-list
102395280|NCT02654860|Bupivacaine|bupivacaine|mesh-list
102395281|NCT02654860|Anesthetics, Local|anesthetics, local|mesh-ancestor
102395282|NCT02654860|Anesthetics|anesthetics|mesh-ancestor
102395283|NCT02654860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102395284|NCT02654860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842983|NCT00286234|Niacin|niacin|mesh-list
102395285|NCT02654860|Sensory System Agents|sensory system agents|mesh-ancestor
102395286|NCT02654860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102395287|NCT02654860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102395288|NCT02654860|Analgesics|analgesics|mesh-ancestor
102395289|NCT02654860|Antipyretics|antipyretics|mesh-ancestor
102395290|NCT01587001|Acetylcysteine|acetylcysteine|mesh-list
102206957|NCT02264873|Decitabine|decitabine|mesh-list
102395291|NCT01587001|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102395292|NCT01587001|Antiviral Agents|antiviral agents|mesh-ancestor
101843129|NCT00483938|Interferons|interferons|mesh-list
102395293|NCT01587001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102395294|NCT01587001|Expectorants|expectorants|mesh-ancestor
102395295|NCT01587001|Respiratory System Agents|respiratory system agents|mesh-ancestor
102395296|NCT01587001|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102395297|NCT01587001|Antioxidants|antioxidants|mesh-ancestor
102395298|NCT01587001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395299|NCT01587001|Protective Agents|protective agents|mesh-ancestor
102395300|NCT01587001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395301|NCT01587001|Antidotes|antidotes|mesh-ancestor
102395302|NCT01568047|Levodopa|levodopa|mesh-list
102395303|NCT01568047|Carbidopa|carbidopa|mesh-list
102395304|NCT01568047|Opicapone|opicapone|mesh-list
102395305|NCT01568047|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102395306|NCT01568047|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102395307|NCT01568047|Dopamine Agents|dopamine agents|mesh-ancestor
102395308|NCT01568047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101843392|NCT00445692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101843393|NCT00445692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843394|NCT00445692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101843395|NCT00445692|Glucocorticoids|glucocorticoids|mesh-ancestor
101843396|NCT00445692|Hormones|hormones|mesh-ancestor
101843397|NCT00445692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101843398|NCT00445692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101843399|NCT00445692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101843400|NCT00445692|Immunologic Factors|immunologic factors|mesh-ancestor
101843401|NCT00445692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101843402|NCT00445692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101843403|NCT00445692|Growth Substances|growth substances|mesh-ancestor
101843404|NCT00445692|Growth Inhibitors|growth inhibitors|mesh-ancestor
101843405|NCT00445692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101843406|NCT00445692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101843407|NCT00445692|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101843408|NCT00445692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101843409|NCT00445692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843412|NCT00445692|Protease Inhibitors|protease inhibitors|mesh-ancestor
102395309|NCT01568047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395310|NCT01568047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395311|NCT01568047|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102395312|NCT01568047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102395313|NCT01568047|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102395314|NCT04782258|Tolvaptan|tolvaptan|mesh-list
102395315|NCT04782258|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102395316|NCT04782258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395317|NCT04782258|Natriuretic Agents|natriuretic agents|mesh-ancestor
101843537|NCT00541385|Antimalarials|antimalarials|mesh-ancestor
102395318|NCT04782258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395319|NCT01688921|Vaccines|vaccines|mesh-list
102395320|NCT01688921|Immunologic Factors|immunologic factors|mesh-ancestor
102395321|NCT01688921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395322|NCT00118755|Bevacizumab|bevacizumab|mesh-list
102395323|NCT00118755|Capecitabine|capecitabine|mesh-list
102395324|NCT00118755|Oxaliplatin|oxaliplatin|mesh-list
102395325|NCT00118755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102395326|NCT00118755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102395327|NCT00118755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102395328|NCT00118755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102395329|NCT00118755|Growth Substances|growth substances|mesh-ancestor
102395330|NCT00118755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395331|NCT00118755|Growth Inhibitors|growth inhibitors|mesh-ancestor
102395332|NCT00118755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102395333|NCT00118755|Antimetabolites|antimetabolites|mesh-ancestor
102395334|NCT00118755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395335|NCT01541371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102395336|NCT01541371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102395337|NCT01541371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102395338|NCT01541371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102395339|NCT01541371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395340|NCT01541371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101843898|NCT00540449|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102395341|NCT01541371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102395342|NCT01541371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102395343|NCT01541371|Serotonin Agents|serotonin agents|mesh-ancestor
101843961|NCT01070290|Antimetabolites|antimetabolites|mesh-ancestor
102395344|NCT01541371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102395345|NCT01541371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395346|NCT01541371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102395347|NCT01541371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102395348|NCT01541371|Dopamine Agents|dopamine agents|mesh-ancestor
102395349|NCT02662036|Bupivacaine|bupivacaine|mesh-list
102395350|NCT02662036|Anesthetics, Local|anesthetics, local|mesh-ancestor
102395351|NCT02662036|Anesthetics|anesthetics|mesh-ancestor
102395352|NCT02662036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102395353|NCT02662036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395354|NCT02662036|Sensory System Agents|sensory system agents|mesh-ancestor
102395355|NCT02662036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102395356|NCT01687673|Sirolimus|sirolimus|mesh-list
102395357|NCT01687673|Sorafenib|sorafenib|mesh-list
102395358|NCT01687673|Temsirolimus|temsirolimus|mesh-list
102395359|NCT01687673|MTOR Inhibitors|mtor inhibitors|mesh-list
102395360|NCT01687673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102395361|NCT01687673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102395362|NCT01687673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102395363|NCT01687673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395364|NCT01687673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102395365|NCT01687673|Immunologic Factors|immunologic factors|mesh-ancestor
102395366|NCT01687673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395367|NCT01687673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102395368|NCT01687673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102395369|NCT01687673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102395370|NCT01687673|Antifungal Agents|antifungal agents|mesh-ancestor
102395371|NCT00121251|Gemcitabine|gemcitabine|mesh-list
102395372|NCT00121251|Capecitabine|capecitabine|mesh-list
102395373|NCT00121251|Sorafenib|sorafenib|mesh-list
102395374|NCT00121251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102395375|NCT00121251|Antimetabolites|antimetabolites|mesh-ancestor
102395376|NCT00121251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395377|NCT00121251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102395378|NCT00121251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102395379|NCT00121251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102395380|NCT02664220|Povidone-Iodine|povidone-iodine|mesh-list
102395381|NCT02664220|Povidone|povidone|mesh-list
102395382|NCT02664220|Plasma Substitutes|plasma substitutes|mesh-ancestor
102395383|NCT02664220|Blood Substitutes|blood substitutes|mesh-ancestor
102395384|NCT02664220|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102395385|NCT02664220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102395386|NCT04339348|Lidocaine|lidocaine|mesh-list
102395387|NCT04339348|Prilocaine|prilocaine|mesh-list
102395388|NCT04339348|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
102395389|NCT04339348|Misoprostol|misoprostol|mesh-list
102395390|NCT04339348|Anesthetics, Local|anesthetics, local|mesh-ancestor
102395391|NCT04339348|Anesthetics|anesthetics|mesh-ancestor
102395392|NCT04339348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102395393|NCT04339348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844671|NCT05590559|Analgesics|analgesics|mesh-ancestor
102395394|NCT04339348|Sensory System Agents|sensory system agents|mesh-ancestor
102395395|NCT04339348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102395396|NCT04339348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102395397|NCT04339348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102395398|NCT04339348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102395399|NCT04339348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101844810|NCT00444600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102395400|NCT04339348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395401|NCT04339348|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102395402|NCT04339348|Abortifacient Agents|abortifacient agents|mesh-ancestor
101844885|NCT01055925|Laxatives|laxatives|mesh-ancestor
102395403|NCT04339348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102395404|NCT04339348|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102395405|NCT04339348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102395406|NCT04339348|Oxytocics|oxytocics|mesh-ancestor
102395407|NCT04339348|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
102395408|NCT02664922|Ketamine|ketamine|mesh-list
102395409|NCT02664922|Remifentanil|remifentanil|mesh-list
102395410|NCT02664922|Propofol|propofol|mesh-list
102395411|NCT02664922|Sevoflurane|sevoflurane|mesh-list
102395412|NCT02664922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102395413|NCT02664922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102395414|NCT02664922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395415|NCT02664922|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102395416|NCT02664922|Anesthetics, General|anesthetics, general|mesh-ancestor
102395417|NCT02664922|Anesthetics|anesthetics|mesh-ancestor
102395418|NCT02664922|Analgesics|analgesics|mesh-ancestor
101845025|NCT04994561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102395419|NCT02664922|Sensory System Agents|sensory system agents|mesh-ancestor
102395420|NCT02664922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102395421|NCT02664922|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102395422|NCT02664922|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102395423|NCT02664922|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102395424|NCT02664922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102395425|NCT02664922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395426|NCT02664922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102395427|NCT02664922|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102395428|NCT02664922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102395429|NCT02664922|Narcotics|narcotics|mesh-ancestor
102395430|NCT02666950|Cytarabine|cytarabine|mesh-list
102395431|NCT02666950|Adavosertib|adavosertib|mesh-list
102395432|NCT02666950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102395433|NCT02666950|Antimetabolites|antimetabolites|mesh-ancestor
102395434|NCT02666950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395435|NCT02666950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102395436|NCT02666950|Antiviral Agents|antiviral agents|mesh-ancestor
102395437|NCT02666950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102395438|NCT02666950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102395439|NCT02666950|Immunologic Factors|immunologic factors|mesh-ancestor
102395440|NCT02666950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395441|NCT02666950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102395443|NCT02668432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102395444|NCT02668432|Vasodilator Agents|vasodilator agents|mesh-ancestor
102395445|NCT02668432|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102395446|NCT02668432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102395447|NCT02668432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395448|NCT02668432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102395449|NCT02668432|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102395450|NCT02668432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102395451|NCT02668432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102395452|NCT02668432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102395453|NCT02668432|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102395454|NCT02668432|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101845485|NCT00345579|PENTA|penta|mesh-list
102395455|NCT01687283|Fluticasone|fluticasone|mesh-list
102395456|NCT01687283|Xhance|xhance|mesh-list
102395457|NCT01687283|Budesonide|budesonide|mesh-list
102395458|NCT01687283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102395459|NCT01687283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102395460|NCT01687283|Autonomic Agents|autonomic agents|mesh-ancestor
102395461|NCT01687283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102395462|NCT01687283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395463|NCT01687283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102395464|NCT01687283|Respiratory System Agents|respiratory system agents|mesh-ancestor
102395465|NCT01687283|Dermatologic Agents|dermatologic agents|mesh-ancestor
102395466|NCT01687283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102395467|NCT01687283|Glucocorticoids|glucocorticoids|mesh-ancestor
102395468|NCT01687283|Hormones|hormones|mesh-ancestor
101845575|NCT05356169|Venetoclax|venetoclax|mesh-list
102395469|NCT01687283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102395470|NCT02684370|Ustekinumab|ustekinumab|mesh-list
102395471|NCT02684370|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102395472|NCT02684370|Dermatologic Agents|dermatologic agents|mesh-ancestor
102395473|NCT02684370|Immunologic Factors|immunologic factors|mesh-ancestor
102395474|NCT02684370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395475|NCT02669914|Durvalumab|durvalumab|mesh-list
102395476|NCT02669914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102395477|NCT02669914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102395478|NCT01686581|Botulinum Toxins|botulinum toxins|mesh-list
102395479|NCT01686581|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102395480|NCT01686581|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102395481|NCT01686581|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102395482|NCT01686581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102395483|NCT01686581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395484|NCT01686581|Cholinergic Agents|cholinergic agents|mesh-ancestor
102395485|NCT01686581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102395486|NCT01686581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395487|NCT01686581|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102395488|NCT01686581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102395489|NCT04739410|Ivermectin|ivermectin|mesh-list
102395490|NCT04739410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102395491|NCT04739410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102395492|NCT02691936|Estrogens|estrogens|mesh-list
102395493|NCT02691936|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
102395494|NCT02691936|Hormones|hormones|mesh-ancestor
102395495|NCT02691936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102395496|NCT02691936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395497|NCT04707742|Povidone-Iodine|povidone-iodine|mesh-list
102395498|NCT04707742|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102395499|NCT04707742|Cetylpyridinium|cetylpyridinium|mesh-list
102395500|NCT04707742|Povidone|povidone|mesh-list
102395501|NCT04707742|Plasma Substitutes|plasma substitutes|mesh-ancestor
102395502|NCT04707742|Blood Substitutes|blood substitutes|mesh-ancestor
102395503|NCT04707742|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102395504|NCT04707742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102395505|NCT02680054|Insulin|insulin|mesh-list
102395506|NCT02680054|Insulin Aspart|insulin aspart|mesh-list
101846016|NCT00337779|(T,G)-A-L|(t,g)-a-l|mesh-list
102395507|NCT02680054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102395508|NCT02680054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395509|NCT00367978|Amlodipine|amlodipine|mesh-list
102395510|NCT00367978|Benazepril|benazepril|mesh-list
102395511|NCT00367978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102395512|NCT00367978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102395513|NCT00367978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102395514|NCT00367978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395515|NCT00367978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102207189|NCT01255709|Epinephrine|epinephrine|mesh-list
102395516|NCT00367978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395517|NCT00367978|Vasodilator Agents|vasodilator agents|mesh-ancestor
102395518|NCT00367978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102395519|NCT00367978|Protease Inhibitors|protease inhibitors|mesh-ancestor
102395520|NCT00367978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102395521|NCT00368056|Eszopiclone|eszopiclone|mesh-list
102395522|NCT00368056|Zopiclone|zopiclone|mesh-list
102395523|NCT00368056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102395524|NCT00368056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102395525|NCT00368056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395526|NCT01685801|Ivacaftor|ivacaftor|mesh-list
102395527|NCT01685801|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102395528|NCT01685801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102395529|NCT01685801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395530|NCT01684943|Insulin|insulin|mesh-list
102395531|NCT01684943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102395532|NCT01684943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395533|NCT04739566|Trametinib|trametinib|mesh-list
102395534|NCT04739566|Dabrafenib|dabrafenib|mesh-list
102395535|NCT04739566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846194|NCT01055379|Rasagiline|rasagiline|mesh-list
102395536|NCT04739566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102395537|NCT04739566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102395538|NCT04739566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395539|NCT05339542|Methylprednisolone|methylprednisolone|mesh-list
102395540|NCT05339542|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102395541|NCT05339542|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102395542|NCT05339542|Prednisolone|prednisolone|mesh-list
102395543|NCT05339542|Prednisolone acetate|prednisolone acetate|mesh-list
102395544|NCT05339542|Lidocaine|lidocaine|mesh-list
102395545|NCT05339542|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102395546|NCT05339542|Prednisolone phosphate|prednisolone phosphate|mesh-list
102395547|NCT05339542|Anesthetics, Local|anesthetics, local|mesh-ancestor
102395548|NCT05339542|Anesthetics|anesthetics|mesh-ancestor
102395549|NCT05339542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102395550|NCT05339542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395551|NCT05339542|Sensory System Agents|sensory system agents|mesh-ancestor
102395552|NCT05339542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102395553|NCT05339542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102395554|NCT05339542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102395555|NCT05339542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102395556|NCT05339542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101846377|NCT00531947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102395557|NCT05339542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395558|NCT05339542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102395559|NCT05339542|Antiemetics|antiemetics|mesh-ancestor
102395560|NCT05339542|Autonomic Agents|autonomic agents|mesh-ancestor
102395561|NCT05339542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102395562|NCT05339542|Glucocorticoids|glucocorticoids|mesh-ancestor
102395563|NCT05339542|Hormones|hormones|mesh-ancestor
102395564|NCT05339542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102395565|NCT05339542|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102395566|NCT05339542|Protective Agents|protective agents|mesh-ancestor
102395567|NCT05339542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102395568|NCT05339542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102395569|NCT03162900|Moxifloxacin|moxifloxacin|mesh-list
102395570|NCT03162900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102395571|NCT03162900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102395572|NCT03162900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102395573|NCT03162900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102395574|NCT03162900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846510|NCT00531479|Voriconazole|voriconazole|mesh-list
102395575|NCT03162900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395576|NCT03162900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102395577|NCT00368602|Timolol|timolol|mesh-list
102395578|NCT00368602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102395579|NCT00368602|Adrenergic Antagonists|adrenergic antagonists|mesh-list
102395580|NCT00368602|Adrenergic Agents|adrenergic agents|mesh-ancestor
102395581|NCT00368602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102395582|NCT00368602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395583|NCT00368602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395584|NCT00368602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102395585|NCT00368602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102395586|NCT01683071|Bupivacaine|bupivacaine|mesh-list
102395587|NCT01683071|Anesthetics, Local|anesthetics, local|mesh-ancestor
102395588|NCT01683071|Anesthetics|anesthetics|mesh-ancestor
102207261|NCT01207115|Naproxen|naproxen|mesh-list
102395589|NCT01683071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102395590|NCT01683071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395592|NCT01683071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102395593|NCT04707508|Metformin|metformin|mesh-list
102395594|NCT04707508|Valsartan|valsartan|mesh-list
102395595|NCT04707508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102395596|NCT04707508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395597|NCT04707508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102395598|NCT04707508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102395599|NCT04707508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102395600|NCT04707508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395601|NCT01567865|Vaccines|vaccines|mesh-list
102395602|NCT01567865|Immunologic Factors|immunologic factors|mesh-ancestor
102395603|NCT01567865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395604|NCT05049226|Vaccines|vaccines|mesh-list
102395605|NCT05049226|Immunologic Factors|immunologic factors|mesh-ancestor
102395606|NCT05049226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395607|NCT01567163|Docetaxel|docetaxel|mesh-list
102395608|NCT01567163|Ramucirumab|ramucirumab|mesh-list
102395609|NCT01567163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102395610|NCT01567163|Tubulin Modulators|tubulin modulators|mesh-ancestor
102395611|NCT01567163|Antimitotic Agents|antimitotic agents|mesh-ancestor
102395612|NCT01567163|Mitosis Modulators|mitosis modulators|mesh-ancestor
102395613|NCT01567163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395614|NCT05002114|Cannabidiol|cannabidiol|mesh-list
102395615|NCT05002114|Anticonvulsants|anticonvulsants|mesh-ancestor
102395616|NCT04338802|Nintedanib|nintedanib|mesh-list
102395617|NCT04338802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102395618|NCT04338802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102395619|NCT04338802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846717|NCT00471146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102395620|NCT04338802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395621|NCT04395508|Trastuzumab|trastuzumab|mesh-list
102395622|NCT04395508|Pertuzumab|pertuzumab|mesh-list
102395623|NCT04395508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102395624|NCT04395508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102395625|NCT00368914|Sirolimus|sirolimus|mesh-list
102395626|NCT00368914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102395627|NCT00368914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102395628|NCT00368914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102395629|NCT00368914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102395630|NCT00368914|Antifungal Agents|antifungal agents|mesh-ancestor
102395631|NCT00368914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102395632|NCT00368914|Immunologic Factors|immunologic factors|mesh-ancestor
102395633|NCT00368914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395634|NCT01567085|Eculizumab|eculizumab|mesh-list
102395635|NCT01567085|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102395636|NCT01567085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102395637|NCT01567085|Immunologic Factors|immunologic factors|mesh-ancestor
102395638|NCT01567085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395639|NCT04344184|Ascorbic Acid|ascorbic acid|mesh-list
102395640|NCT04344184|Vitamins|vitamins|mesh-ancestor
102395641|NCT04344184|Micronutrients|micronutrients|mesh-ancestor
102395642|NCT04344184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395643|NCT04344184|Antioxidants|antioxidants|mesh-ancestor
102395644|NCT04344184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395645|NCT04344184|Protective Agents|protective agents|mesh-ancestor
102395646|NCT01566773|Bromides|bromides|mesh-list
102395647|NCT01566773|Tiotropium Bromide|tiotropium bromide|mesh-list
102395648|NCT01566773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102395649|NCT01566773|Autonomic Agents|autonomic agents|mesh-ancestor
102395650|NCT01566773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102395651|NCT01566773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395652|NCT01566773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102395653|NCT01566773|Respiratory System Agents|respiratory system agents|mesh-ancestor
102395654|NCT01566773|Parasympatholytics|parasympatholytics|mesh-ancestor
102395655|NCT01566773|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102395656|NCT01566773|Cholinergic Agents|cholinergic agents|mesh-ancestor
102395657|NCT01566773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102395658|NCT01566773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395659|NCT01566773|Anticonvulsants|anticonvulsants|mesh-ancestor
102395660|NCT04134442|Bupivacaine|bupivacaine|mesh-list
102395661|NCT04134442|Anesthetics, Local|anesthetics, local|mesh-ancestor
102395662|NCT04134442|Anesthetics|anesthetics|mesh-ancestor
102395663|NCT04134442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102395664|NCT04134442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395665|NCT04134442|Sensory System Agents|sensory system agents|mesh-ancestor
102395666|NCT04134442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102395667|NCT04103476|Bazedoxifene|bazedoxifene|mesh-list
102395668|NCT04103476|Estrogens|estrogens|mesh-list
102395669|NCT04103476|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
102395670|NCT04103476|Hormones|hormones|mesh-ancestor
102395671|NCT04103476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102395672|NCT04103476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395673|NCT04103476|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102395674|NCT04103476|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102395675|NCT04103476|Hormone Antagonists|hormone antagonists|mesh-ancestor
102395676|NCT04103476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102395677|NCT01566149|Mometasone Furoate|mometasone furoate|mesh-list
102395678|NCT01566149|Formoterol Fumarate|formoterol fumarate|mesh-list
102395679|NCT01566149|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
102395680|NCT01566149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102395681|NCT01566149|Autonomic Agents|autonomic agents|mesh-ancestor
102395682|NCT01566149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102395683|NCT01566149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395684|NCT01566149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102395685|NCT01566149|Respiratory System Agents|respiratory system agents|mesh-ancestor
102395686|NCT01566149|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102395687|NCT01566149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102395688|NCT01566149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102395689|NCT01566149|Adrenergic Agents|adrenergic agents|mesh-ancestor
102395690|NCT01566149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102395691|NCT01566149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395692|NCT01566149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102395693|NCT01566149|Dermatologic Agents|dermatologic agents|mesh-ancestor
102395694|NCT01566149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102395695|NCT03417388|Aspirin|aspirin|mesh-list
102395696|NCT03417388|Losartan|losartan|mesh-list
102395697|NCT03417388|Lisinopril|lisinopril|mesh-list
102395698|NCT03417388|Atorvastatin|atorvastatin|mesh-list
102395699|NCT03417388|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102395700|NCT03417388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102395701|NCT03417388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102395702|NCT03417388|Analgesics|analgesics|mesh-ancestor
102395703|NCT03417388|Sensory System Agents|sensory system agents|mesh-ancestor
102395704|NCT03417388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102395705|NCT03417388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395706|NCT03417388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101847235|NCT00467870|Hormones|hormones|mesh-ancestor
102395707|NCT03417388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102395708|NCT03417388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102395709|NCT03417388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102395710|NCT03417388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395711|NCT03417388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102395712|NCT03417388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102395713|NCT03417388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102395714|NCT03417388|Antipyretics|antipyretics|mesh-ancestor
102395715|NCT03417388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102395716|NCT03417388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102395717|NCT03417388|Antimetabolites|antimetabolites|mesh-ancestor
102395718|NCT03417388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102395719|NCT03417388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102395720|NCT03417388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102395721|NCT03417388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102395722|NCT03417388|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102395723|NCT03417388|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102395724|NCT03417388|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102395725|NCT03417388|Protease Inhibitors|protease inhibitors|mesh-ancestor
102395726|NCT03417388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102395727|NCT03417388|Protective Agents|protective agents|mesh-ancestor
102395728|NCT02691702|Melatonin|melatonin|mesh-list
102395729|NCT02691702|Antioxidants|antioxidants|mesh-ancestor
102395730|NCT02691702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395731|NCT02691702|Protective Agents|protective agents|mesh-ancestor
102395732|NCT02691702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395733|NCT02691702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102395734|NCT01564277|Allopurinol|allopurinol|mesh-list
102395735|NCT01564277|Rasburicase|rasburicase|mesh-list
102395736|NCT01564277|Antimetabolites|antimetabolites|mesh-ancestor
101847470|NCT00420342|Hormone Antagonists|hormone antagonists|mesh-ancestor
102395737|NCT01564277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395738|NCT01564277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102395739|NCT01564277|Gout Suppressants|gout suppressants|mesh-ancestor
101847547|NCT01027520|Ionophores|ionophores|mesh-ancestor
102395741|NCT01564277|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102395742|NCT01564277|Antioxidants|antioxidants|mesh-ancestor
102395743|NCT01564277|Protective Agents|protective agents|mesh-ancestor
102395744|NCT01564277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395745|NCT01563185|Ibuprofen|ibuprofen|mesh-list
102395746|NCT01563185|Famotidine|famotidine|mesh-list
102395747|NCT01563185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102395748|NCT01563185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102395749|NCT01563185|Analgesics|analgesics|mesh-ancestor
102395750|NCT01563185|Sensory System Agents|sensory system agents|mesh-ancestor
102395751|NCT01563185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102395752|NCT01563185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847677|NCT00459056|Protease Inhibitors|protease inhibitors|mesh-ancestor
102395753|NCT01563185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102395754|NCT01563185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102395755|NCT01563185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102395756|NCT01563185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102395757|NCT01563185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395758|NCT01563185|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102395759|NCT01563185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102395760|NCT01563185|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102395761|NCT01563185|Histamine Antagonists|histamine antagonists|mesh-ancestor
102395762|NCT01563185|Histamine Agents|histamine agents|mesh-ancestor
102395763|NCT01563185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102395764|NCT02974660|Protamines|protamines|mesh-list
102395765|NCT02974660|Heparin Antagonists|heparin antagonists|mesh-ancestor
102395766|NCT02974660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395767|NCT02974660|Coagulants|coagulants|mesh-ancestor
102395768|NCT03305848|Nitroglycerin|nitroglycerin|mesh-list
102395769|NCT03305848|Vasodilator Agents|vasodilator agents|mesh-ancestor
102395770|NCT01563029|Fluticasone|fluticasone|mesh-list
102395771|NCT01563029|Xhance|xhance|mesh-list
102395772|NCT01563029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102395773|NCT01563029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102395774|NCT01563029|Autonomic Agents|autonomic agents|mesh-ancestor
102395775|NCT01563029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102395776|NCT01563029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395777|NCT01563029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102395778|NCT01563029|Respiratory System Agents|respiratory system agents|mesh-ancestor
102395779|NCT01563029|Dermatologic Agents|dermatologic agents|mesh-ancestor
102395780|NCT01563029|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102395781|NCT03293368|Triamcinolone|triamcinolone|mesh-list
102395782|NCT03293368|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102395783|NCT03293368|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102395784|NCT03293368|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102395785|NCT03293368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102395786|NCT03293368|Glucocorticoids|glucocorticoids|mesh-ancestor
102395787|NCT03293368|Hormones|hormones|mesh-ancestor
102395788|NCT03293368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102395789|NCT03293368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395790|NCT03293368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102395791|NCT03293368|Immunologic Factors|immunologic factors|mesh-ancestor
102395792|NCT03293368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102395793|NCT03293368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395794|NCT03273712|Octreotide|octreotide|mesh-list
102395795|NCT03273712|Edotreotide|edotreotide|mesh-list
102395796|NCT03273712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102395797|NCT03273712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102395798|NCT03273712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102395799|NCT03273712|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102395800|NCT03273712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395801|NCT04113317|Lenograstim|lenograstim|mesh-list
102395802|NCT04113317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102395803|NCT04113317|Immunologic Factors|immunologic factors|mesh-ancestor
102395804|NCT04113317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395805|NCT04341844|Methylene Blue|methylene blue|mesh-list
102395806|NCT04341844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102395807|NCT04341844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395808|NCT01561313|Adalimumab|adalimumab|mesh-list
102395809|NCT01561313|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102395810|NCT01561313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102395811|NCT01561313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102395812|NCT01561079|Buprenorphine|buprenorphine|mesh-list
102395813|NCT01561079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102395814|NCT01561079|Narcotics|narcotics|mesh-ancestor
102395815|NCT01561079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102395816|NCT01561079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395817|NCT01561079|Analgesics|analgesics|mesh-ancestor
102395818|NCT01561079|Sensory System Agents|sensory system agents|mesh-ancestor
102395819|NCT01561079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102395820|NCT01561079|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102395821|NCT01559675|Hydrocortisone|hydrocortisone|mesh-list
102395822|NCT01559675|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102395823|NCT01559675|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102395824|NCT01559675|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102395825|NCT01559675|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102395826|NCT01559675|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102395827|NCT01559675|Methylprednisolone|methylprednisolone|mesh-list
102395828|NCT01559675|Prednisolone|prednisolone|mesh-list
102395829|NCT01559675|Prednisolone acetate|prednisolone acetate|mesh-list
101848443|NCT00439556|Antiviral Agents|antiviral agents|mesh-ancestor
102395830|NCT01559675|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102395831|NCT01559675|Prednisolone phosphate|prednisolone phosphate|mesh-list
102395832|NCT01559675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102395833|NCT01559675|Glucocorticoids|glucocorticoids|mesh-ancestor
102395834|NCT01559675|Hormones|hormones|mesh-ancestor
102395835|NCT01559675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102395836|NCT01559675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395837|NCT01559675|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102395838|NCT01559675|Protective Agents|protective agents|mesh-ancestor
102395839|NCT01559675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102395840|NCT01559675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102395841|NCT01559675|Antiemetics|antiemetics|mesh-ancestor
102395842|NCT01559675|Autonomic Agents|autonomic agents|mesh-ancestor
102395843|NCT01559675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102395844|NCT01559675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102395845|NCT01374906|Pasireotide|pasireotide|mesh-list
102395846|NCT01374906|Hormones|hormones|mesh-ancestor
102395847|NCT01374906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102395848|NCT01374906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395849|NCT00362596|Acyclovir|acyclovir|mesh-list
102395850|NCT00362596|Antiviral Agents|antiviral agents|mesh-ancestor
102395851|NCT00362596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102395852|NCT02974504|Linagliptin|linagliptin|mesh-list
102395853|NCT02974504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102395854|NCT02974504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395855|NCT02974504|Incretins|incretins|mesh-ancestor
102395856|NCT02974504|Hormones|hormones|mesh-ancestor
102395857|NCT02974504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102395858|NCT02974504|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102395859|NCT02974504|Protease Inhibitors|protease inhibitors|mesh-ancestor
102395860|NCT02974504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102395861|NCT02974504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395862|NCT03013504|Cyclophosphamide|cyclophosphamide|mesh-list
102395863|NCT03013504|Docetaxel|docetaxel|mesh-list
102395864|NCT03013504|Trastuzumab|trastuzumab|mesh-list
102395865|NCT03013504|Epirubicin|epirubicin|mesh-list
102395866|NCT03013504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102395867|NCT03013504|Immunologic Factors|immunologic factors|mesh-ancestor
102395868|NCT03013504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395869|NCT03013504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102395870|NCT03013504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102395871|NCT03013504|Alkylating Agents|alkylating agents|mesh-ancestor
102395872|NCT03013504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395873|NCT03013504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102395874|NCT03013504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102395875|NCT03013504|Tubulin Modulators|tubulin modulators|mesh-ancestor
102395876|NCT03013504|Antimitotic Agents|antimitotic agents|mesh-ancestor
102395877|NCT03013504|Mitosis Modulators|mitosis modulators|mesh-ancestor
102395878|NCT03013504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102395879|NCT03013504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102395880|NCT03013504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102395881|NCT03013504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102395882|NCT03013504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102395883|NCT02683746|rGLP-1 protein|rglp-1 protein|mesh-list
102395884|NCT02683746|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102395885|NCT02683746|Incretins|incretins|mesh-ancestor
102395886|NCT02683746|Hormones|hormones|mesh-ancestor
102395887|NCT02683746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102395888|NCT02683746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395889|NCT01559129|Pomalidomide|pomalidomide|mesh-list
102395890|NCT01559129|Immunologic Factors|immunologic factors|mesh-ancestor
102395891|NCT01559129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395892|NCT01559129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102395893|NCT01559129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102395894|NCT01559129|Growth Substances|growth substances|mesh-ancestor
102395895|NCT01559129|Growth Inhibitors|growth inhibitors|mesh-ancestor
102395896|NCT01559129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102395898|NCT02691468|Trace Elements|trace elements|mesh-ancestor
102395899|NCT02691468|Micronutrients|micronutrients|mesh-ancestor
102395900|NCT02691468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395901|NCT03162120|Metoprolol|metoprolol|mesh-list
102395902|NCT03162120|Flecainide|flecainide|mesh-list
102395903|NCT03162120|Ranolazine|ranolazine|mesh-list
102395904|NCT03162120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102395905|NCT03162120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102395906|NCT03162120|Sympatholytics|sympatholytics|mesh-ancestor
102395907|NCT03162120|Autonomic Agents|autonomic agents|mesh-ancestor
102395908|NCT03162120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102395909|NCT03162120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395910|NCT03162120|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102395911|NCT03162120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102395912|NCT03162120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102395913|NCT03162120|Adrenergic Agents|adrenergic agents|mesh-ancestor
102395914|NCT03162120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102395915|NCT03162120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395916|NCT03162120|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102395917|NCT03162120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102395918|NCT03162120|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102395919|NCT02683668|Tiotropium Bromide|tiotropium bromide|mesh-list
102395920|NCT02683668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102395921|NCT02683668|Autonomic Agents|autonomic agents|mesh-ancestor
102395922|NCT02683668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102395923|NCT02683668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395924|NCT02683668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102395925|NCT02683668|Respiratory System Agents|respiratory system agents|mesh-ancestor
102395926|NCT02683668|Parasympatholytics|parasympatholytics|mesh-ancestor
102395927|NCT02683668|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102395928|NCT02683668|Cholinergic Agents|cholinergic agents|mesh-ancestor
101848657|NCT01033994|Mitogens|mitogens|mesh-list
102395929|NCT02683668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102395930|NCT02683668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395931|NCT03114228|Midostaurin|midostaurin|mesh-list
102395932|NCT03114228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102395933|NCT03114228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102395934|NCT03114228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102395935|NCT03114228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395936|NCT02678286|Meloxicam|meloxicam|mesh-list
102395937|NCT02678286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102395938|NCT02678286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102395939|NCT02678286|Analgesics|analgesics|mesh-ancestor
102395940|NCT02678286|Sensory System Agents|sensory system agents|mesh-ancestor
102395941|NCT02678286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102395942|NCT02678286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395943|NCT02678286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102395944|NCT02678286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102395945|NCT02678286|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102395946|NCT02678286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102395947|NCT02678286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102395948|NCT02678286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395949|NCT03164694|Carboplatin|carboplatin|mesh-list
102395950|NCT03164694|Pemetrexed|pemetrexed|mesh-list
102395951|NCT03164694|Apatinib|apatinib|mesh-list
102395952|NCT03164694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102395953|NCT03164694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101848713|NCT00262600|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102395954|NCT03164694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395955|NCT03164694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102395956|NCT03164694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102395957|NCT03164694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102395958|NCT04775550|Dexamethasone|dexamethasone|mesh-list
102395959|NCT04775550|Lenalidomide|lenalidomide|mesh-list
102395960|NCT04775550|Bortezomib|bortezomib|mesh-list
102395961|NCT04775550|Daratumumab|daratumumab|mesh-list
102395962|NCT04775550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102395963|NCT04775550|Antiemetics|antiemetics|mesh-ancestor
102395964|NCT04775550|Autonomic Agents|autonomic agents|mesh-ancestor
102395965|NCT04775550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102395966|NCT04775550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102395967|NCT04775550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102395969|NCT04775550|Hormones|hormones|mesh-ancestor
102395970|NCT04775550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102395971|NCT04775550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102395972|NCT04775550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102395973|NCT04775550|Immunologic Factors|immunologic factors|mesh-ancestor
102395974|NCT04775550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102395975|NCT04775550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102395976|NCT04775550|Growth Substances|growth substances|mesh-ancestor
102395977|NCT04775550|Growth Inhibitors|growth inhibitors|mesh-ancestor
102395978|NCT02930902|Paclitaxel|paclitaxel|mesh-list
102395979|NCT02930902|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102395980|NCT02930902|Gemcitabine|gemcitabine|mesh-list
102395981|NCT02930902|Pembrolizumab|pembrolizumab|mesh-list
102395982|NCT02930902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102395983|NCT02930902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102395984|NCT02930902|Tubulin Modulators|tubulin modulators|mesh-ancestor
102395985|NCT02930902|Antimitotic Agents|antimitotic agents|mesh-ancestor
102395986|NCT02930902|Mitosis Modulators|mitosis modulators|mesh-ancestor
102395987|NCT02930902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395988|NCT02930902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102395989|NCT02930902|Antimetabolites|antimetabolites|mesh-ancestor
102395990|NCT02930902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102395991|NCT02930902|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102395992|NCT02767804|Crizotinib|crizotinib|mesh-list
102395993|NCT02767804|Ensartinib|ensartinib|mesh-list
102395994|NCT02767804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102395995|NCT02767804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102395996|NCT02767804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102395997|NCT02767804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102395998|NCT02741128|Vaccines|vaccines|mesh-list
102395999|NCT02741128|Immunologic Factors|immunologic factors|mesh-ancestor
102396000|NCT02741128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396001|NCT01566721|Trastuzumab|trastuzumab|mesh-list
102396002|NCT01566721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102396003|NCT01566721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102396004|NCT01541215|Metformin|metformin|mesh-list
102396005|NCT01541215|Liraglutide|liraglutide|mesh-list
102396006|NCT01541215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102396007|NCT01541215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396008|NCT01541215|Incretins|incretins|mesh-ancestor
102396009|NCT01541215|Hormones|hormones|mesh-ancestor
102396010|NCT01541215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102396011|NCT01585987|Ipilimumab|ipilimumab|mesh-list
102396012|NCT01585987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102396013|NCT01585987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102396014|NCT01585987|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102396015|NCT01585987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396016|NCT01585831|Testosterone|testosterone|mesh-list
102396017|NCT01585831|Androgens|androgens|mesh-ancestor
102396018|NCT01585831|Hormones|hormones|mesh-ancestor
102396019|NCT01585831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102396020|NCT01585831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396021|NCT01565941|Insulin|insulin|mesh-list
102396022|NCT01565941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102396023|NCT01565941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102396024|NCT01565941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396025|NCT01558271|Liraglutide|liraglutide|mesh-list
102396026|NCT01558271|Dulaglutide|dulaglutide|mesh-list
102396027|NCT01558271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102396028|NCT01558271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396029|NCT01558271|Incretins|incretins|mesh-ancestor
102396030|NCT01558271|Hormones|hormones|mesh-ancestor
102396031|NCT01558271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102396032|NCT01565707|Solifenacin Succinate|solifenacin succinate|mesh-list
102396033|NCT01565707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102396034|NCT01565707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102396035|NCT01565707|Cholinergic Agents|cholinergic agents|mesh-ancestor
102396036|NCT01565707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102396037|NCT01565707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396038|NCT01565707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396039|NCT01565707|Urological Agents|urological agents|mesh-ancestor
102396040|NCT01557569|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102396041|NCT01557569|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102396042|NCT01557569|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102396043|NCT01557569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102396044|NCT01557569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396045|NCT01557569|Adrenergic Agents|adrenergic agents|mesh-ancestor
102396046|NCT01557569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102396047|NCT01557569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396048|NCT04756271|Antibodies|antibodies|mesh-list
102396049|NCT04756271|Antibodies, Blocking|antibodies, blocking|mesh-list
102396050|NCT04756271|Immunologic Factors|immunologic factors|mesh-ancestor
102396051|NCT04756271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396052|NCT01538719|Rilonacept|rilonacept|mesh-list
102396053|NCT01538719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102396054|NCT01537783|Chlorhexidine|chlorhexidine|mesh-list
102396055|NCT01537783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102396056|NCT01537783|Mupirocin|mupirocin|mesh-list
102396057|NCT01537783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102396058|NCT01537783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102396059|NCT01537783|Disinfectants|disinfectants|mesh-ancestor
102396060|NCT01537783|Dermatologic Agents|dermatologic agents|mesh-ancestor
102396061|NCT01537783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102396062|NCT01537783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102396063|NCT01537783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102396064|NCT01537783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396065|NCT01556165|Rasagiline|rasagiline|mesh-list
102396066|NCT01556165|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102396067|NCT01556165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102396068|NCT01556165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396069|NCT01556165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102396070|NCT01556165|Protective Agents|protective agents|mesh-ancestor
102396071|NCT01556165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396072|NCT01537549|Thioctic Acid|thioctic acid|mesh-list
102396073|NCT01537549|Acetylcarnitine|acetylcarnitine|mesh-list
102396074|NCT01537549|Antioxidants|antioxidants|mesh-ancestor
101848907|NCT00434954|Insulin Aspart|insulin aspart|mesh-list
102396075|NCT01537549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396076|NCT01537549|Protective Agents|protective agents|mesh-ancestor
102396077|NCT01537549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396078|NCT01537549|Vitamin B Complex|vitamin b complex|mesh-ancestor
102396079|NCT01537549|Vitamins|vitamins|mesh-ancestor
102396080|NCT01537549|Micronutrients|micronutrients|mesh-ancestor
102396081|NCT01537549|Nootropic Agents|nootropic agents|mesh-ancestor
102396082|NCT01555931|Levonorgestrel|levonorgestrel|mesh-list
102396083|NCT01555931|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102396084|NCT01555931|Contraceptive Agents|contraceptive agents|mesh-ancestor
102396085|NCT01555931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102396086|NCT01555931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396087|NCT01555931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102396088|NCT01555931|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102396089|NCT01555931|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102396090|NCT01583179|Buprenorphine|buprenorphine|mesh-list
102396091|NCT01583179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102396092|NCT01583179|Narcotics|narcotics|mesh-ancestor
102396093|NCT01583179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102396094|NCT01583179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396095|NCT01583179|Analgesics|analgesics|mesh-ancestor
102396096|NCT01583179|Sensory System Agents|sensory system agents|mesh-ancestor
102396097|NCT01583179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102396098|NCT01583179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102396099|NCT01582945|Ketamine|ketamine|mesh-list
102396100|NCT01582945|Analgesics|analgesics|mesh-ancestor
102396101|NCT01582945|Sensory System Agents|sensory system agents|mesh-ancestor
102396102|NCT01582945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102396103|NCT01582945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396104|NCT01582945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102396105|NCT01582945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102396106|NCT01582945|Anesthetics, General|anesthetics, general|mesh-ancestor
102396107|NCT01582945|Anesthetics|anesthetics|mesh-ancestor
102396108|NCT01582945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102396109|NCT01582945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102396110|NCT01582945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102396111|NCT01582945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102396112|NCT01582945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396113|NCT01565083|Trastuzumab|trastuzumab|mesh-list
102396114|NCT01565083|Pertuzumab|pertuzumab|mesh-list
102396115|NCT01565083|Vinorelbine|vinorelbine|mesh-list
102396116|NCT01565083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102396117|NCT01565083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102396118|NCT01565083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101848943|NCT01072318|Letrozole|letrozole|mesh-list
102396119|NCT01565083|Tubulin Modulators|tubulin modulators|mesh-ancestor
102396120|NCT01565083|Antimitotic Agents|antimitotic agents|mesh-ancestor
102396121|NCT01565083|Mitosis Modulators|mitosis modulators|mesh-ancestor
102396122|NCT01565083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396123|NCT01555151|Mometasone Furoate|mometasone furoate|mesh-list
102396124|NCT01555151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102396125|NCT01555151|Dermatologic Agents|dermatologic agents|mesh-ancestor
102396126|NCT01555151|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102396127|NCT01537081|Phenylpropanolamine|phenylpropanolamine|mesh-list
102396128|NCT01537081|Guaifenesin|guaifenesin|mesh-list
102396129|NCT01537081|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
102396130|NCT01537081|Expectorants|expectorants|mesh-ancestor
102396131|NCT01537081|Respiratory System Agents|respiratory system agents|mesh-ancestor
102396132|NCT01537081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102396133|NCT01537081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102396134|NCT01537081|Adrenergic Agents|adrenergic agents|mesh-ancestor
102396135|NCT01537081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102396136|NCT01537081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396137|NCT01537081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396138|NCT01537081|Appetite Depressants|appetite depressants|mesh-ancestor
102396139|NCT01537081|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102396140|NCT01537081|Sympathomimetics|sympathomimetics|mesh-ancestor
102396141|NCT01537081|Autonomic Agents|autonomic agents|mesh-ancestor
102396142|NCT01537081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102396143|NCT01537081|Nasal Decongestants|nasal decongestants|mesh-ancestor
102396144|NCT01537081|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102396145|NCT01555073|Celecoxib|celecoxib|mesh-list
102396146|NCT01555073|Pregabalin|pregabalin|mesh-list
102396147|NCT01555073|Analgesics|analgesics|mesh-ancestor
102396148|NCT01555073|Sensory System Agents|sensory system agents|mesh-ancestor
102396149|NCT01555073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102396150|NCT01555073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396151|NCT01555073|Anticonvulsants|anticonvulsants|mesh-ancestor
102396152|NCT01555073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102396153|NCT01555073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102396154|NCT01555073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396155|NCT01555073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102396156|NCT01555073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102396157|NCT01555073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102396158|NCT01555073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102396159|NCT01555073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102396160|NCT01555073|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102396161|NCT01555073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102396162|NCT01555073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102396163|NCT01555073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102396164|NCT01555073|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102396165|NCT01555073|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102396166|NCT01555073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102396167|NCT01582243|Vildagliptin|vildagliptin|mesh-list
102396168|NCT01582243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102396169|NCT01582243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396170|NCT01582243|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102396171|NCT01582243|Protease Inhibitors|protease inhibitors|mesh-ancestor
102396172|NCT01582243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102396173|NCT01582243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396174|NCT01536535|Prednisone|prednisone|mesh-list
102396175|NCT01536535|Mesalamine|mesalamine|mesh-list
102396176|NCT01536535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102396177|NCT01536535|Glucocorticoids|glucocorticoids|mesh-ancestor
102396178|NCT01536535|Hormones|hormones|mesh-ancestor
102396179|NCT01536535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102396180|NCT01536535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396181|NCT01536535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102396182|NCT01536535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102396183|NCT01536535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102396184|NCT01536535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102396185|NCT01536535|Analgesics|analgesics|mesh-ancestor
102396186|NCT01536535|Sensory System Agents|sensory system agents|mesh-ancestor
102396187|NCT01536535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102396188|NCT01536535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102396189|NCT01553747|Eluxadoline|eluxadoline|mesh-list
102396190|NCT01553747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102207854|NCT04662723|Losartan|losartan|mesh-list
102396191|NCT01536379|Belimumab|belimumab|mesh-list
102396192|NCT01536379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102396193|NCT01536379|Immunologic Factors|immunologic factors|mesh-ancestor
102396194|NCT01536379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396195|NCT01536067|Bortezomib|bortezomib|mesh-list
102396196|NCT01536067|Ofatumumab|ofatumumab|mesh-list
102396197|NCT01536067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102396198|NCT04410211|Midazolam|midazolam|mesh-list
102396199|NCT04410211|Sevoflurane|sevoflurane|mesh-list
102396200|NCT04410211|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102396201|NCT04410211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102396202|NCT04410211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102396203|NCT04410211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396204|NCT04410211|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102396205|NCT04410211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102396206|NCT04410211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102396207|NCT04410211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102396208|NCT04410211|Anesthetics, General|anesthetics, general|mesh-ancestor
102396209|NCT04410211|Anesthetics|anesthetics|mesh-ancestor
102396210|NCT04410211|GABA Modulators|gaba modulators|mesh-ancestor
102396211|NCT04410211|GABA Agents|gaba agents|mesh-ancestor
102396212|NCT04410211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102396213|NCT04410211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396214|NCT04410211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102396215|NCT04410211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102396216|NCT01582009|Everolimus|everolimus|mesh-list
102396217|NCT01582009|Panobinostat|panobinostat|mesh-list
102396218|NCT01582009|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
102396219|NCT01582009|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102396220|NCT01582009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102396221|NCT01582009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102396222|NCT01582009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396223|NCT01582009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102396224|NCT01582009|Immunologic Factors|immunologic factors|mesh-ancestor
102396225|NCT01582009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396226|NCT01582009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102396227|NCT01553591|Eluxadoline|eluxadoline|mesh-list
102396228|NCT01553591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102396229|NCT01581931|Metformin|metformin|mesh-list
102396230|NCT01581931|Linagliptin|linagliptin|mesh-list
102396231|NCT01581931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102396232|NCT01581931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396233|NCT01581931|Incretins|incretins|mesh-ancestor
102396234|NCT01581931|Hormones|hormones|mesh-ancestor
102396235|NCT01581931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102396236|NCT01581931|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102396237|NCT01581931|Protease Inhibitors|protease inhibitors|mesh-ancestor
102396238|NCT01581931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102396239|NCT01581931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396240|NCT01581307|Leucovorin|leucovorin|mesh-list
102396241|NCT01581307|Folic Acid|folic acid|mesh-list
102396242|NCT01581307|Fluorouracil|fluorouracil|mesh-list
102396243|NCT01581307|Oxaliplatin|oxaliplatin|mesh-list
102396244|NCT01581307|Levoleucovorin|levoleucovorin|mesh-list
102396245|NCT01581307|Antimetabolites|antimetabolites|mesh-ancestor
102396246|NCT01581307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396247|NCT01581307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102396248|NCT01581307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102396249|NCT01581307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102396250|NCT01581307|Immunologic Factors|immunologic factors|mesh-ancestor
102396251|NCT01581307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396252|NCT01581307|Antidotes|antidotes|mesh-ancestor
102396253|NCT01581307|Protective Agents|protective agents|mesh-ancestor
102396254|NCT01581307|Vitamin B Complex|vitamin b complex|mesh-ancestor
102396255|NCT01581307|Vitamins|vitamins|mesh-ancestor
102396256|NCT01581307|Micronutrients|micronutrients|mesh-ancestor
102396257|NCT01581307|Hematinics|hematinics|mesh-ancestor
102396258|NCT01580995|Valacyclovir|valacyclovir|mesh-list
102396259|NCT01580995|Antiviral Agents|antiviral agents|mesh-ancestor
102396260|NCT01580995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102396261|NCT01553279|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102396262|NCT01553279|Immunologic Factors|immunologic factors|mesh-ancestor
102396263|NCT01553279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396264|NCT01562743|Rotigotine|rotigotine|mesh-list
102396265|NCT01562743|Dopamine Agonists|dopamine agonists|mesh-ancestor
102207928|NCT02328963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102396266|NCT01562743|Dopamine Agents|dopamine agents|mesh-ancestor
102396267|NCT01562743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102396268|NCT01562743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396269|NCT01562743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396270|NCT03028571|Trimethaphan|trimethaphan|mesh-list
102396271|NCT03028571|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
102396272|NCT03028571|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102396273|NCT03028571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102396274|NCT03028571|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
102396275|NCT03028571|Autonomic Agents|autonomic agents|mesh-ancestor
102396276|NCT03028571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102396277|NCT03028571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396278|NCT03028571|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102396279|NCT03028571|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102396280|NCT03028571|Cholinergic Agents|cholinergic agents|mesh-ancestor
102396281|NCT03028571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101849216|NCT01040286|Chlorhexidine|chlorhexidine|mesh-list
102396282|NCT03028571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396283|NCT03028571|Vasodilator Agents|vasodilator agents|mesh-ancestor
102396284|NCT01535443|Bromfenac|bromfenac|mesh-list
102396285|NCT01535443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102396286|NCT01535443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102396287|NCT01535443|Analgesics|analgesics|mesh-ancestor
102396288|NCT01535443|Sensory System Agents|sensory system agents|mesh-ancestor
102396289|NCT01535443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102396290|NCT01535443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396291|NCT01535443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102396292|NCT01535443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102396293|NCT01535287|Dexmedetomidine|dexmedetomidine|mesh-list
102396294|NCT01535287|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102396295|NCT01535287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102396296|NCT01535287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396297|NCT01535287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102396298|NCT01535287|Analgesics|analgesics|mesh-ancestor
102396299|NCT01535287|Sensory System Agents|sensory system agents|mesh-ancestor
102396300|NCT01535287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102396301|NCT01535287|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102396302|NCT01535287|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102396303|NCT01535287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102396304|NCT01535287|Adrenergic Agents|adrenergic agents|mesh-ancestor
102396305|NCT01535287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102396306|NCT01535287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396307|NCT01549613|Vancomycin|vancomycin|mesh-list
102396308|NCT01549613|Daptomycin|daptomycin|mesh-list
102396309|NCT01549613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102396310|NCT01549613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102396311|NCT04106219|Cyclophosphamide|cyclophosphamide|mesh-list
102396312|NCT04106219|Topotecan|topotecan|mesh-list
101849310|NCT00414440|Everolimus|everolimus|mesh-list
102396313|NCT04106219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102396314|NCT04106219|Immunologic Factors|immunologic factors|mesh-ancestor
102396315|NCT04106219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396316|NCT04106219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101849370|NCT00234052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102396317|NCT04106219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102396318|NCT04106219|Alkylating Agents|alkylating agents|mesh-ancestor
102396319|NCT04106219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396320|NCT04106219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102396321|NCT04106219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102396322|NCT04106219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102396323|NCT04106219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102396324|NCT04106219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102396325|NCT04739189|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
102396326|NCT04739189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102396327|NCT04739189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396328|NCT01546883|Dabigatran|dabigatran|mesh-list
102396329|NCT01546883|Antithrombins|antithrombins|mesh-ancestor
102396330|NCT01546883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102396331|NCT01546883|Protease Inhibitors|protease inhibitors|mesh-ancestor
102396332|NCT01546883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101849577|NCT03982173|Tremelimumab|tremelimumab|mesh-list
102396333|NCT01546883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396334|NCT01546883|Anticoagulants|anticoagulants|mesh-ancestor
102396335|NCT01580293|Factor VIII|factor viii|mesh-list
102396336|NCT01580293|Coagulants|coagulants|mesh-ancestor
102396337|NCT01546649|Leuprolide|leuprolide|mesh-list
102396338|NCT01546649|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102396339|NCT01546649|Fertility Agents|fertility agents|mesh-ancestor
102396340|NCT01546649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102396341|NCT01546649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849732|NCT02532777|Hormones|hormones|mesh-ancestor
102396342|NCT01546649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102396343|NCT01546649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102396344|NCT02985983|Brodalumab|brodalumab|mesh-list
102396345|NCT02985983|Dermatologic Agents|dermatologic agents|mesh-ancestor
102396346|NCT01544309|Atorvastatin|atorvastatin|mesh-list
102396347|NCT01544309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102396348|NCT01544309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102396349|NCT01544309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102396350|NCT01544309|Antimetabolites|antimetabolites|mesh-ancestor
102396351|NCT01544309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396352|NCT01544309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102396353|NCT01544309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101849871|NCT01067235|Modafinil|modafinil|mesh-list
102396354|NCT01544309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102396355|NCT01544153|Nicotine|nicotine|mesh-list
102396356|NCT01544153|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102396357|NCT01544153|Autonomic Agents|autonomic agents|mesh-ancestor
102396358|NCT01544153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102396359|NCT01544153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396360|NCT01544153|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102396361|NCT01544153|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102396362|NCT01544153|Cholinergic Agents|cholinergic agents|mesh-ancestor
102396363|NCT01544153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102396364|NCT01544153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396365|NCT01543685|Celecoxib|celecoxib|mesh-list
102396366|NCT01543685|Indomethacin|indomethacin|mesh-list
101849998|NCT00290433|Glucocorticoids|glucocorticoids|mesh-ancestor
102396367|NCT01543685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102396368|NCT01543685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102396369|NCT01543685|Analgesics|analgesics|mesh-ancestor
102396370|NCT01543685|Sensory System Agents|sensory system agents|mesh-ancestor
102396371|NCT01543685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101850064|NCT00374556|Eszopiclone|eszopiclone|mesh-list
102396372|NCT01543685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396373|NCT01543685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101850138|NCT00390780|Clotrimazole|clotrimazole|mesh-list
102396374|NCT01543685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102396375|NCT01543685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102396376|NCT01543685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102396377|NCT01543685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102396378|NCT01543685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396379|NCT01543685|Gout Suppressants|gout suppressants|mesh-ancestor
102396380|NCT01543685|Tocolytic Agents|tocolytic agents|mesh-ancestor
102396381|NCT01543685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102396382|NCT01540565|Veliparib|veliparib|mesh-list
102396383|NCT01540565|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102396384|NCT01540565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102396385|NCT01540565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396386|NCT01540565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102396387|NCT01540487|Metformin|metformin|mesh-list
102396388|NCT01540487|Linagliptin|linagliptin|mesh-list
102396389|NCT01540487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102396390|NCT01540487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396391|NCT01540487|Incretins|incretins|mesh-ancestor
102396392|NCT01540487|Hormones|hormones|mesh-ancestor
102396393|NCT01540487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101850414|NCT00429416|Cytarabine|cytarabine|mesh-list
102396394|NCT01540487|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102396395|NCT01540487|Protease Inhibitors|protease inhibitors|mesh-ancestor
102396396|NCT01540487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101850483|NCT00301821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102396397|NCT01540487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396398|NCT01539317|Lidocaine|lidocaine|mesh-list
102396399|NCT01539317|Anesthetics, Local|anesthetics, local|mesh-ancestor
102396400|NCT01539317|Anesthetics|anesthetics|mesh-ancestor
102396401|NCT01539317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102396402|NCT01539317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396403|NCT01539317|Sensory System Agents|sensory system agents|mesh-ancestor
102396404|NCT01539317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102396405|NCT01539317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102396406|NCT01539317|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102396407|NCT01539317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102396408|NCT01539317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102396409|NCT01539317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396410|NCT01539083|Thalidomide|thalidomide|mesh-list
102396411|NCT01539083|Dexamethasone|dexamethasone|mesh-list
102396412|NCT01539083|Prednisolone|prednisolone|mesh-list
102396413|NCT01539083|Cyclophosphamide|cyclophosphamide|mesh-list
102396414|NCT01539083|Bortezomib|bortezomib|mesh-list
102396415|NCT01539083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102396416|NCT01539083|Immunologic Factors|immunologic factors|mesh-ancestor
102396417|NCT01539083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396418|NCT01539083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102396419|NCT01539083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102396420|NCT01539083|Alkylating Agents|alkylating agents|mesh-ancestor
102396421|NCT01539083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396422|NCT01539083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102396423|NCT01539083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101850609|NCT01325571|Tacrolimus|tacrolimus|mesh-list
102396424|NCT01539083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102396425|NCT01539083|Antiemetics|antiemetics|mesh-ancestor
102396426|NCT01539083|Autonomic Agents|autonomic agents|mesh-ancestor
102396427|NCT01539083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102396428|NCT01539083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102396429|NCT01539083|Glucocorticoids|glucocorticoids|mesh-ancestor
102396430|NCT01539083|Hormones|hormones|mesh-ancestor
102396431|NCT01539083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102396432|NCT01539083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102396433|NCT01539083|Leprostatic Agents|leprostatic agents|mesh-ancestor
102396434|NCT01539083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102396435|NCT01539083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102396436|NCT01539083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102396437|NCT01539083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102396438|NCT01539083|Growth Substances|growth substances|mesh-ancestor
102396439|NCT01539083|Growth Inhibitors|growth inhibitors|mesh-ancestor
102396440|NCT01537133|Fluticasone|fluticasone|mesh-list
102396441|NCT01537133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102396442|NCT01537133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102396443|NCT01537133|Autonomic Agents|autonomic agents|mesh-ancestor
102396444|NCT01537133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102396445|NCT01537133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396446|NCT01537133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102396447|NCT01537133|Respiratory System Agents|respiratory system agents|mesh-ancestor
102396448|NCT01537133|Dermatologic Agents|dermatologic agents|mesh-ancestor
101850955|NCT00270231|Naltrexone|naltrexone|mesh-list
102396449|NCT01537133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102396450|NCT01536587|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102396451|NCT01536587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102396452|NCT01536587|Autonomic Agents|autonomic agents|mesh-ancestor
102396453|NCT01536587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102396454|NCT01536587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396455|NCT01536587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101851021|NCT00257608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102396456|NCT01536587|Respiratory System Agents|respiratory system agents|mesh-ancestor
102396457|NCT01536587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102396458|NCT01536587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102396459|NCT01536587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102396460|NCT01536587|Adrenergic Agents|adrenergic agents|mesh-ancestor
102396461|NCT01536587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102396462|NCT01536587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396463|NCT02985905|Zinc Sulfate|zinc sulfate|mesh-list
102396464|NCT02985905|Astringents|astringents|mesh-ancestor
102396465|NCT02985905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396466|NCT02985905|Dermatologic Agents|dermatologic agents|mesh-ancestor
102396467|NCT01535261|Ranibizumab|ranibizumab|mesh-list
102396468|NCT01535261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102396469|NCT01535261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102396470|NCT01535261|Growth Substances|growth substances|mesh-ancestor
102396471|NCT01535261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396472|NCT01535261|Growth Inhibitors|growth inhibitors|mesh-ancestor
102396473|NCT01535261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102396474|NCT01534637|Gemcitabine|gemcitabine|mesh-list
102396475|NCT01534637|Fluorouracil|fluorouracil|mesh-list
102396476|NCT01534637|Capecitabine|capecitabine|mesh-list
102396477|NCT01534637|Aprepitant|aprepitant|mesh-list
102396478|NCT01534637|Antiemetics|antiemetics|mesh-list
102396479|NCT01534637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102396480|NCT01534637|Antimetabolites|antimetabolites|mesh-ancestor
101851295|NCT01041170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396481|NCT01534637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396482|NCT01534637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102396483|NCT01534637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102396484|NCT01534637|Immunologic Factors|immunologic factors|mesh-ancestor
102396485|NCT01534637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396486|NCT01534637|Autonomic Agents|autonomic agents|mesh-ancestor
102396487|NCT01534637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102396488|NCT01534637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102396489|NCT01534637|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102396490|NCT01534637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102396491|NCT02655016|Niraparib|niraparib|mesh-list
102396492|NCT02655016|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102396493|NCT02655016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102396494|NCT02655016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396495|NCT02655016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102396496|NCT01533935|Tiotropium Bromide|tiotropium bromide|mesh-list
102396497|NCT01533935|Olodaterol|olodaterol|mesh-list
102396498|NCT01533935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102396499|NCT01533935|Autonomic Agents|autonomic agents|mesh-ancestor
102396500|NCT01533935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102396501|NCT01533935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396502|NCT01533935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102396503|NCT01533935|Respiratory System Agents|respiratory system agents|mesh-ancestor
102396504|NCT01533935|Parasympatholytics|parasympatholytics|mesh-ancestor
102396505|NCT01533935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102396506|NCT01533935|Cholinergic Agents|cholinergic agents|mesh-ancestor
102396507|NCT01533935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102396508|NCT01533935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396509|NCT01532687|Gemcitabine|gemcitabine|mesh-list
102396510|NCT01532687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102396511|NCT01532687|Antimetabolites|antimetabolites|mesh-ancestor
102396512|NCT01532687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396513|NCT01532687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102396514|NCT02677116|Doxorubicin|doxorubicin|mesh-list
102396515|NCT02677116|Irinotecan|irinotecan|mesh-list
102396516|NCT02677116|Vincristine|vincristine|mesh-list
102396517|NCT02677116|Ifosfamide|ifosfamide|mesh-list
102396518|NCT02677116|Olaratumab|olaratumab|mesh-list
101571303|NCT02813863|Metformin|metformin|mesh-list
102396519|NCT02677116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102396520|NCT02677116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102396521|NCT02677116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102396522|NCT02677116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102396523|NCT02677116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102396524|NCT02677116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396525|NCT02677116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102396526|NCT02677116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102396527|NCT02677116|Tubulin Modulators|tubulin modulators|mesh-ancestor
102396528|NCT02677116|Antimitotic Agents|antimitotic agents|mesh-ancestor
102396529|NCT02677116|Mitosis Modulators|mitosis modulators|mesh-ancestor
102396530|NCT02677116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102396531|NCT02677116|Alkylating Agents|alkylating agents|mesh-ancestor
102396532|NCT02689518|Aflibercept|aflibercept|mesh-list
102396533|NCT02689518|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102396534|NCT02689518|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102396535|NCT02689518|Growth Substances|growth substances|mesh-ancestor
102396536|NCT02689518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396537|NCT02689518|Growth Inhibitors|growth inhibitors|mesh-ancestor
102396538|NCT02689518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102396539|NCT02681094|Dapagliflozin|dapagliflozin|mesh-list
102396540|NCT02681094|Saxagliptin|saxagliptin|mesh-list
102396541|NCT02681094|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102396542|NCT02681094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396543|NCT02681094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102396544|NCT02681094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396545|NCT02681094|Incretins|incretins|mesh-ancestor
102396546|NCT02681094|Hormones|hormones|mesh-ancestor
102396547|NCT02681094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102396548|NCT02681094|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102396549|NCT02681094|Protease Inhibitors|protease inhibitors|mesh-ancestor
102396550|NCT02681094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102396551|NCT03164304|Magnesium Sulfate|magnesium sulfate|mesh-list
102396552|NCT03164304|Analgesics|analgesics|mesh-ancestor
102396553|NCT03164304|Sensory System Agents|sensory system agents|mesh-ancestor
102396554|NCT03164304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102396555|NCT03164304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396556|NCT03164304|Anesthetics|anesthetics|mesh-ancestor
102396557|NCT03164304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102396558|NCT03164304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102396559|NCT03164304|Anticonvulsants|anticonvulsants|mesh-ancestor
102396560|NCT03164304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102396561|NCT03164304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102396562|NCT03164304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396563|NCT03164304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102396564|NCT03164304|Tocolytic Agents|tocolytic agents|mesh-ancestor
102396565|NCT03164304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102396566|NCT02689284|Pembrolizumab|pembrolizumab|mesh-list
102396567|NCT02689284|Margetuximab|margetuximab|mesh-list
102208228|NCT05318066|Norepinephrine|norepinephrine|mesh-list
102396569|NCT02689284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102396570|NCT02689284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102396571|NCT02689284|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102396572|NCT02689284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396573|NCT02689284|Immunologic Factors|immunologic factors|mesh-ancestor
102396574|NCT02689284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396575|NCT03165396|Propofol|propofol|mesh-list
102396576|NCT03165396|Sevoflurane|sevoflurane|mesh-list
102396577|NCT03165396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102396578|NCT03165396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102396579|NCT03165396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851944|NCT03993626|Nivolumab|nivolumab|mesh-list
102396580|NCT03165396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102396581|NCT03165396|Anesthetics, General|anesthetics, general|mesh-ancestor
102396582|NCT03165396|Anesthetics|anesthetics|mesh-ancestor
102396583|NCT03165396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102396584|NCT03165396|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102396585|NCT03164382|Sorafenib|sorafenib|mesh-list
102396586|NCT03164382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102396587|NCT03164382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102396588|NCT03164382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102396589|NCT03164382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396590|NCT03161340|Sirolimus|sirolimus|mesh-list
102396591|NCT03161340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102396592|NCT03161340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102396593|NCT03161340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102396594|NCT03161340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102396595|NCT03161340|Antifungal Agents|antifungal agents|mesh-ancestor
102396596|NCT03161340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102396597|NCT03161340|Immunologic Factors|immunologic factors|mesh-ancestor
102396598|NCT03161340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396599|NCT03161574|Fluorouracil|fluorouracil|mesh-list
102396600|NCT03161574|Oxaliplatin|oxaliplatin|mesh-list
102396601|NCT03161574|Irinotecan|irinotecan|mesh-list
102396602|NCT03161574|Antimetabolites|antimetabolites|mesh-ancestor
102396603|NCT03161574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396604|NCT03161574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102396605|NCT03161574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102396606|NCT03161574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102396607|NCT03161574|Immunologic Factors|immunologic factors|mesh-ancestor
102396608|NCT03161574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396609|NCT03161574|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101852068|NCT00418886|Pemetrexed|pemetrexed|mesh-list
102396610|NCT03161574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102396611|NCT03161574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102396612|NCT03163914|Phenylephrine|phenylephrine|mesh-list
102396613|NCT03163914|Epinephrine|epinephrine|mesh-list
102396614|NCT03163914|Oxymetazoline|oxymetazoline|mesh-list
102396615|NCT03163914|Norepinephrine|norepinephrine|mesh-list
102396616|NCT03163914|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102396617|NCT03163914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102396618|NCT03163914|Adrenergic Agents|adrenergic agents|mesh-ancestor
102396619|NCT03163914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102396620|NCT03163914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396621|NCT03163914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396622|NCT03163914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102396623|NCT03163914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102396624|NCT03163914|Autonomic Agents|autonomic agents|mesh-ancestor
102396625|NCT03163914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102396626|NCT03163914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102396627|NCT03163914|Respiratory System Agents|respiratory system agents|mesh-ancestor
102396628|NCT03163914|Mydriatics|mydriatics|mesh-ancestor
102396629|NCT03163914|Sympathomimetics|sympathomimetics|mesh-ancestor
101852352|NCT01071057|Morphine|morphine|mesh-list
102396630|NCT03163914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102396631|NCT03163914|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102396632|NCT03163914|Nasal Decongestants|nasal decongestants|mesh-ancestor
102396633|NCT03163914|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102396634|NCT03163914|Protective Agents|protective agents|mesh-ancestor
102396635|NCT03160872|Hormones|hormones|mesh-list
102396636|NCT03160872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102396637|NCT03160872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396638|NCT03163680|Omeprazole|omeprazole|mesh-list
102396639|NCT03163680|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102396640|NCT03163680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102396641|NCT03163680|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102396642|NCT03163680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102396643|NCT03163680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396644|NCT04574232|Triamcinolone|triamcinolone|mesh-list
102396645|NCT04574232|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102396646|NCT04574232|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102396647|NCT04574232|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102396648|NCT04574232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102396649|NCT04574232|Glucocorticoids|glucocorticoids|mesh-ancestor
102396650|NCT04574232|Hormones|hormones|mesh-ancestor
102396651|NCT04574232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102396652|NCT04574232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396653|NCT04574232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102396654|NCT04574232|Immunologic Factors|immunologic factors|mesh-ancestor
102396655|NCT04574232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102396656|NCT04574232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396657|NCT05071716|Rifaximin|rifaximin|mesh-list
102396658|NCT05071716|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102396659|NCT05071716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102396660|NCT05071716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102396661|NCT02680002|MF59 oil emulsion|mf59 oil emulsion|mesh-list
102396662|NCT02680002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102396663|NCT02680002|Immunologic Factors|immunologic factors|mesh-ancestor
102396664|NCT02680002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396665|NCT04557384|Ramucirumab|ramucirumab|mesh-list
102396666|NCT04557384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102396667|NCT04548648|Isavuconazole|isavuconazole|mesh-list
102396668|NCT04548648|Acalabrutinib|acalabrutinib|mesh-list
102396669|NCT04548648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102396670|NCT04548648|Antifungal Agents|antifungal agents|mesh-ancestor
102396671|NCT04548648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102396672|NCT04443348|Paclitaxel|paclitaxel|mesh-list
102396673|NCT04443348|Cyclophosphamide|cyclophosphamide|mesh-list
102396674|NCT04443348|Carboplatin|carboplatin|mesh-list
102396675|NCT04443348|Doxorubicin|doxorubicin|mesh-list
102396676|NCT04443348|Pembrolizumab|pembrolizumab|mesh-list
102396677|NCT04443348|Capecitabine|capecitabine|mesh-list
101852895|NCT01050036|Immunologic Factors|immunologic factors|mesh-ancestor
102396678|NCT04443348|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102396679|NCT04443348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102396680|NCT04443348|Tubulin Modulators|tubulin modulators|mesh-ancestor
102396681|NCT04443348|Antimitotic Agents|antimitotic agents|mesh-ancestor
102396682|NCT04443348|Mitosis Modulators|mitosis modulators|mesh-ancestor
101852964|NCT00367770|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102396683|NCT04443348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396684|NCT04443348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102396685|NCT04443348|Immunologic Factors|immunologic factors|mesh-ancestor
102396686|NCT04443348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853035|NCT01053390|Vitamins|vitamins|mesh-ancestor
102396687|NCT04443348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102396688|NCT04443348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102396689|NCT04443348|Alkylating Agents|alkylating agents|mesh-ancestor
102396690|NCT04443348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102396691|NCT04443348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102396692|NCT04443348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102396693|NCT04443348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102396694|NCT04443348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102396695|NCT04443348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102396696|NCT04443348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102396697|NCT04443348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102396698|NCT04443348|Antimetabolites|antimetabolites|mesh-ancestor
102396699|NCT03161184|Sulfamethazine|sulfamethazine|mesh-list
102396700|NCT03161184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102396701|NCT05231850|Tislelizumab|tislelizumab|mesh-list
101853170|NCT01054092|Ipragliflozin|ipragliflozin|mesh-list
102396702|NCT05231850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102396703|NCT05231850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102208379|NCT03140943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102208380|NCT03140943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102208381|NCT03140943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102208382|NCT03140943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102208383|NCT03140943|Immunologic Factors|immunologic factors|mesh-ancestor
102208384|NCT03140943|Leprostatic Agents|leprostatic agents|mesh-ancestor
102208385|NCT03140943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102208386|NCT03140943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102208387|NCT03140943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102208388|NCT03140943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102208389|NCT03140943|Growth Substances|growth substances|mesh-ancestor
102208390|NCT03140943|Growth Inhibitors|growth inhibitors|mesh-ancestor
102208391|NCT02038257|Petrolatum|petrolatum|mesh-list
102208392|NCT02038257|Emollients|emollients|mesh-ancestor
102208394|NCT05311436|Iron|iron|mesh-list
102396704|NCT03163212|Lactoferrin|lactoferrin|mesh-list
102396705|NCT03163212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102396706|NCT05007678|Leflunomide|leflunomide|mesh-list
102396707|NCT05007678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102396708|NCT05007678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396709|NCT05007678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102396710|NCT05007678|Immunologic Factors|immunologic factors|mesh-ancestor
102396711|NCT05007678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396712|NCT03161106|Lactulose|lactulose|mesh-list
102396713|NCT03161106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102396714|NCT02671500|Sofosbuvir|sofosbuvir|mesh-list
102396715|NCT02671500|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102396716|NCT02671500|Velpatasvir|velpatasvir|mesh-list
102396717|NCT02671500|Antiviral Agents|antiviral agents|mesh-ancestor
102396718|NCT02671500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102396719|NCT02671266|Oxytocin|oxytocin|mesh-list
102396720|NCT02671266|Oxytocics|oxytocics|mesh-ancestor
102396721|NCT02671266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102396722|NCT02671266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396723|NCT03160404|Zolpidem|zolpidem|mesh-list
101853577|NCT01324544|Narcotics|narcotics|mesh-ancestor
102396724|NCT03160404|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102396725|NCT03160404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102396726|NCT03160404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102396727|NCT03160404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396728|NCT03160404|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102396729|NCT03160404|GABA Agonists|gaba agonists|mesh-ancestor
101853664|NCT00417248|Etoposide|etoposide|mesh-list
102396730|NCT03160404|GABA Agents|gaba agents|mesh-ancestor
102396731|NCT03160404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102396732|NCT03160404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396733|NCT03162588|Epoetin Alfa|epoetin alfa|mesh-list
102396734|NCT03162588|Hematinics|hematinics|mesh-ancestor
102396735|NCT03320070|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102396736|NCT03320070|Hormones|hormones|mesh-ancestor
102396737|NCT03320070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102396738|NCT03320070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396739|NCT04977336|Acetaminophen|acetaminophen|mesh-list
102396740|NCT04977336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102396741|NCT04977336|Analgesics|analgesics|mesh-ancestor
102396742|NCT04977336|Sensory System Agents|sensory system agents|mesh-ancestor
102396743|NCT04977336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102396744|NCT04977336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396745|NCT04977336|Antipyretics|antipyretics|mesh-ancestor
102396746|NCT03284424|Pembrolizumab|pembrolizumab|mesh-list
102396747|NCT03284424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102396748|NCT03284424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102396749|NCT03284424|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101853917|NCT00391586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102396750|NCT03284424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396751|NCT02674854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102396752|NCT02674854|Latanoprost|latanoprost|mesh-list
102396753|NCT02674854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102396754|NCT04036188|Vitamin D|vitamin d|mesh-list
102396755|NCT04036188|Cholecalciferol|cholecalciferol|mesh-list
102396756|NCT04036188|Triamcinolone|triamcinolone|mesh-list
102396757|NCT04036188|Vitamins|vitamins|mesh-ancestor
102396758|NCT04036188|Micronutrients|micronutrients|mesh-ancestor
102396759|NCT04036188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396760|NCT04036188|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102396761|NCT04036188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102396762|NCT04036188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102396763|NCT04036188|Glucocorticoids|glucocorticoids|mesh-ancestor
102396764|NCT04036188|Hormones|hormones|mesh-ancestor
102396765|NCT04036188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102396766|NCT02388516|Vitamin D|vitamin d|mesh-list
102396767|NCT02388516|Cholecalciferol|cholecalciferol|mesh-list
102396768|NCT02388516|Vitamins|vitamins|mesh-ancestor
102396769|NCT02388516|Micronutrients|micronutrients|mesh-ancestor
102396770|NCT02388516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396771|NCT02388516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102396772|NCT02388516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102396773|NCT02669862|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102396774|NCT02135874|Cytarabine|cytarabine|mesh-list
102396775|NCT02135874|Dexamethasone|dexamethasone|mesh-list
102396776|NCT02135874|Dexamethasone acetate|dexamethasone acetate|mesh-list
102396777|NCT02135874|Rituximab|rituximab|mesh-list
102396778|NCT02135874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102396779|NCT02135874|Vincristine|vincristine|mesh-list
102396780|NCT02135874|Sorafenib|sorafenib|mesh-list
102396781|NCT02135874|Idarubicin|idarubicin|mesh-list
102396782|NCT02135874|Clofarabine|clofarabine|mesh-list
102396784|NCT02135874|Immunoglobulins|immunoglobulins|mesh-list
102396785|NCT02135874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102396786|NCT02135874|BB 1101|bb 1101|mesh-list
102396787|NCT02135874|Immunologic Factors|immunologic factors|mesh-ancestor
102396788|NCT02135874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396789|NCT02135874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102396790|NCT02135874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102396791|NCT02135874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102396792|NCT02135874|Antiemetics|antiemetics|mesh-ancestor
102396793|NCT02135874|Autonomic Agents|autonomic agents|mesh-ancestor
101854328|NCT01049672|Alfentanil|alfentanil|mesh-list
102396794|NCT02135874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102396795|NCT02135874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102396796|NCT02135874|Glucocorticoids|glucocorticoids|mesh-ancestor
102396797|NCT02135874|Hormones|hormones|mesh-ancestor
102396798|NCT02135874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102396799|NCT02135874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102396800|NCT02135874|Protease Inhibitors|protease inhibitors|mesh-ancestor
102396801|NCT02135874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854395|NCT00529373|Antacids|antacids|mesh-ancestor
102396802|NCT02135874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396803|NCT02135874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102396804|NCT02135874|Antimetabolites|antimetabolites|mesh-ancestor
102396805|NCT02135874|Antiviral Agents|antiviral agents|mesh-ancestor
102396806|NCT02135874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102396807|NCT02135874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102396808|NCT02135874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102396809|NCT02135874|Tubulin Modulators|tubulin modulators|mesh-ancestor
102396810|NCT02135874|Antimitotic Agents|antimitotic agents|mesh-ancestor
102396811|NCT02135874|Mitosis Modulators|mitosis modulators|mesh-ancestor
102396812|NCT02135874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102396813|NCT02135874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102396814|NCT02135874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102396815|NCT02135874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102396816|NCT01531673|Ivacaftor|ivacaftor|mesh-list
102396817|NCT01531673|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102396818|NCT01531673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102396819|NCT01531673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396820|NCT01531205|Leuprolide|leuprolide|mesh-list
102396821|NCT01531205|Goserelin|goserelin|mesh-list
102396822|NCT01531205|Bicalutamide|bicalutamide|mesh-list
102396823|NCT01531205|Androgens|androgens|mesh-list
102396824|NCT01531205|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102396825|NCT01531205|Fertility Agents|fertility agents|mesh-ancestor
102396826|NCT01531205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102396827|NCT01531205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396828|NCT01531205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102396829|NCT01531205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102396830|NCT01531205|Hormones|hormones|mesh-ancestor
102396831|NCT01531205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102396832|NCT01531205|Androgen Antagonists|androgen antagonists|mesh-ancestor
102396833|NCT01531205|Hormone Antagonists|hormone antagonists|mesh-ancestor
102396834|NCT02985671|Acetaminophen|acetaminophen|mesh-list
102396835|NCT02985671|Diclofenac|diclofenac|mesh-list
102396836|NCT02985671|Orphenadrine|orphenadrine|mesh-list
102396837|NCT02985671|Caffeine|caffeine|mesh-list
102396838|NCT02985671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102396839|NCT02985671|Analgesics|analgesics|mesh-ancestor
102396840|NCT02985671|Sensory System Agents|sensory system agents|mesh-ancestor
102396841|NCT02985671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102396842|NCT02985671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396843|NCT02985671|Antipyretics|antipyretics|mesh-ancestor
102396844|NCT02985671|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102396845|NCT02985671|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102396846|NCT02985671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102396847|NCT02985671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396848|NCT02985671|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101855017|NCT00125164|Mecasermin|mecasermin|mesh-list
102396849|NCT02985671|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102396850|NCT02985671|Purinergic Agents|purinergic agents|mesh-ancestor
102396851|NCT02985671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102396852|NCT02985671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102396853|NCT02985671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102396854|NCT02985671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102396855|NCT02985671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102396856|NCT02985671|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102396857|NCT02985671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102396858|NCT02985671|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102396859|NCT02985671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102396860|NCT02985671|Parasympatholytics|parasympatholytics|mesh-ancestor
102396861|NCT02985671|Autonomic Agents|autonomic agents|mesh-ancestor
102396862|NCT02985671|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102396863|NCT02985671|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102396864|NCT02985671|Cholinergic Agents|cholinergic agents|mesh-ancestor
102396865|NCT02985671|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
102396866|NCT02985671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102396867|NCT01529645|Vaccines|vaccines|mesh-list
102396868|NCT01529645|Immunologic Factors|immunologic factors|mesh-ancestor
102396869|NCT01529645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396870|NCT01528787|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102396871|NCT01528787|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102396872|NCT01528709|Atorvastatin|atorvastatin|mesh-list
102396873|NCT01528709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102396874|NCT01528709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101855232|NCT00363896|Bromides|bromides|mesh-list
102396875|NCT01528709|Antimetabolites|antimetabolites|mesh-ancestor
102396876|NCT01528709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396877|NCT01528709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102396878|NCT01528709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102396879|NCT01528709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102396880|NCT01527383|Vaccines|vaccines|mesh-list
102396881|NCT01527383|Immunologic Factors|immunologic factors|mesh-ancestor
102396882|NCT01527383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396883|NCT01526057|Rituximab|rituximab|mesh-list
101855358|NCT03986268|Micronutrients|micronutrients|mesh-ancestor
102396884|NCT01526057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102396885|NCT01526057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102396886|NCT01526057|Immunologic Factors|immunologic factors|mesh-ancestor
102396887|NCT01526057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396888|NCT01526057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102396889|NCT01525901|Mitogens|mitogens|mesh-list
102396890|NCT01525901|Mecasermin|mecasermin|mesh-list
102396891|NCT01525901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396892|NCT01525901|Mitosis Modulators|mitosis modulators|mesh-ancestor
102396893|NCT01525901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396894|NCT01525901|Growth Substances|growth substances|mesh-ancestor
102396895|NCT00123123|Chlorhexidine|chlorhexidine|mesh-list
102396896|NCT00123123|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102396897|NCT00123123|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102396898|NCT00123123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102396899|NCT00123123|Disinfectants|disinfectants|mesh-ancestor
102396900|NCT00123123|Dermatologic Agents|dermatologic agents|mesh-ancestor
102396901|NCT00242385|Protease Inhibitors|protease inhibitors|mesh-list
102396902|NCT00242385|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
102396903|NCT00242385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102396904|NCT00242385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396905|NCT00242385|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102396906|NCT00242385|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102396907|NCT00242619|Rosiglitazone|rosiglitazone|mesh-list
102396908|NCT00242619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102396909|NCT00242619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396910|NCT01899027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102396911|NCT01899027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102396912|NCT01899027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102396913|NCT01899027|Antimetabolites|antimetabolites|mesh-ancestor
102396914|NCT01899027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396915|NCT01899027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102396916|NCT01899027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102396917|NCT01899027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102396918|NCT00264381|Dalteparin|dalteparin|mesh-list
102396919|NCT00264381|Tinzaparin|tinzaparin|mesh-list
102396920|NCT00264381|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102396921|NCT00264381|Anticoagulants|anticoagulants|mesh-ancestor
102396922|NCT00264381|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102396923|NCT00264381|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102396924|NCT00264381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396925|NCT00246441|Paroxetine|paroxetine|mesh-list
102396926|NCT00246441|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102396927|NCT00246441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102396928|NCT00246441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102396929|NCT00246441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855784|NCT02531451|Antipyretics|antipyretics|mesh-ancestor
102396930|NCT00246441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102396931|NCT00246441|Serotonin Agents|serotonin agents|mesh-ancestor
102396932|NCT00246441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396933|NCT00246441|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102396934|NCT00246441|Antidepressive Agents|antidepressive agents|mesh-ancestor
102396935|NCT00246441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102396936|NCT00246441|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102396937|NCT00246441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102396938|NCT00246441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102396939|NCT00246519|Atenolol|atenolol|mesh-list
102396940|NCT00246519|Metoprolol|metoprolol|mesh-list
102396941|NCT00246519|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102396942|NCT00246519|Trichlormethiazide|trichlormethiazide|mesh-list
102396943|NCT00246519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102396944|NCT00246519|Diuretics|diuretics|mesh-ancestor
102396945|NCT00246519|Natriuretic Agents|natriuretic agents|mesh-ancestor
102396946|NCT00246519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396947|NCT00246519|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102396948|NCT00246519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102396949|NCT00246519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396950|NCT00246519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102396951|NCT00246519|Sympatholytics|sympatholytics|mesh-ancestor
102396952|NCT00246519|Autonomic Agents|autonomic agents|mesh-ancestor
102396953|NCT00246519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102396954|NCT00246519|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102396955|NCT00246519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102396956|NCT00246519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102396957|NCT00246519|Adrenergic Agents|adrenergic agents|mesh-ancestor
102396958|NCT00246519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102396959|NCT00248547|Dexamethasone|dexamethasone|mesh-list
102396960|NCT00248547|Ondansetron|ondansetron|mesh-list
102396961|NCT00248547|Aprepitant|aprepitant|mesh-list
102396962|NCT00248547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102396963|NCT00248547|Antiemetics|antiemetics|mesh-ancestor
102396964|NCT00248547|Autonomic Agents|autonomic agents|mesh-ancestor
102396965|NCT00248547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102396966|NCT00248547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396967|NCT00248547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102396968|NCT00248547|Glucocorticoids|glucocorticoids|mesh-ancestor
102396969|NCT00248547|Hormones|hormones|mesh-ancestor
102396970|NCT00248547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102396971|NCT00248547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102396972|NCT00248547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102396973|NCT00248547|Antipruritics|antipruritics|mesh-ancestor
101856180|NCT00181155|Allopurinol|allopurinol|mesh-list
102396974|NCT00248547|Dermatologic Agents|dermatologic agents|mesh-ancestor
102396975|NCT00248547|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102396976|NCT00248547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102396977|NCT00248547|Serotonin Agents|serotonin agents|mesh-ancestor
102396978|NCT00248547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102396979|NCT00248547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396980|NCT00248547|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102396981|NCT01524887|Immunoglobulins|immunoglobulins|mesh-list
102396982|NCT01524887|Antibodies|antibodies|mesh-list
102396983|NCT01524887|gamma-Globulins|gamma-globulins|mesh-list
102396984|NCT01524887|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102396985|NCT01524887|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102396986|NCT01524887|Immunologic Factors|immunologic factors|mesh-ancestor
102396987|NCT01524887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102396988|NCT00266799|Doxorubicin|doxorubicin|mesh-list
102396989|NCT00266799|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102396990|NCT00266799|Capecitabine|capecitabine|mesh-list
102396991|NCT00266799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102396992|NCT00266799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102396993|NCT00266799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102396994|NCT00266799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102396995|NCT00266799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102396996|NCT00266799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102396997|NCT00266799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102396998|NCT00266799|Antimetabolites|antimetabolites|mesh-ancestor
102396999|NCT00249249|Atorvastatin|atorvastatin|mesh-list
102397000|NCT00249249|Pitavastatin|pitavastatin|mesh-list
101856451|NCT01082926|Aldesleukin|aldesleukin|mesh-list
102397001|NCT00249249|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102397002|NCT00249249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102397003|NCT00249249|Antimetabolites|antimetabolites|mesh-ancestor
102397004|NCT00249249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397005|NCT00249249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101856517|NCT00104572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102397006|NCT00249249|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102397007|NCT00249249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102397008|NCT01522235|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102397009|NCT01522235|gamma-Globulins|gamma-globulins|mesh-list
102397010|NCT01522235|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102397011|NCT01522235|Immunologic Factors|immunologic factors|mesh-ancestor
102397012|NCT01522235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397014|NCT00125931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102397015|NCT00125931|Narcotics|narcotics|mesh-ancestor
102397016|NCT00125931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102397017|NCT00125931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397018|NCT00125931|Analgesics|analgesics|mesh-ancestor
102397019|NCT00125931|Sensory System Agents|sensory system agents|mesh-ancestor
102397020|NCT00125931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102397021|NCT00125931|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102397022|NCT00125931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102397023|NCT00267111|Tetracaine|tetracaine|mesh-list
102397024|NCT00267111|Anesthetics, Local|anesthetics, local|mesh-ancestor
102397025|NCT00267111|Anesthetics|anesthetics|mesh-ancestor
102397026|NCT00267111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102397027|NCT00267111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397028|NCT00267111|Sensory System Agents|sensory system agents|mesh-ancestor
102397029|NCT00267111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102397030|NCT01521923|Certolizumab Pegol|certolizumab pegol|mesh-list
102397031|NCT01521923|Methotrexate|methotrexate|mesh-list
101856792|NCT00513305|Immunologic Factors|immunologic factors|mesh-ancestor
102397032|NCT01521923|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102397033|NCT01521923|Abortifacient Agents|abortifacient agents|mesh-ancestor
102397034|NCT01521923|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102397035|NCT01521923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397036|NCT01521923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102397037|NCT01521923|Antimetabolites|antimetabolites|mesh-ancestor
102397038|NCT01521923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397039|NCT01521923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102397040|NCT01521923|Dermatologic Agents|dermatologic agents|mesh-ancestor
102397041|NCT01521923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102397042|NCT01521923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102397043|NCT01521923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102397044|NCT01521923|Immunologic Factors|immunologic factors|mesh-ancestor
102397045|NCT01521923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102397046|NCT01521923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102397047|NCT01521923|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102397048|NCT01521923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102397049|NCT05240781|Sirolimus|sirolimus|mesh-list
102397050|NCT05240781|Temsirolimus|temsirolimus|mesh-list
102397051|NCT05240781|MTOR Inhibitors|mtor inhibitors|mesh-list
102397052|NCT05240781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102397053|NCT05240781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101857156|NCT03337646|Dopamine Agents|dopamine agents|mesh-ancestor
102397054|NCT05240781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102397055|NCT05240781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102397056|NCT05240781|Antifungal Agents|antifungal agents|mesh-ancestor
102397057|NCT05240781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102397058|NCT05240781|Immunologic Factors|immunologic factors|mesh-ancestor
102397059|NCT05240781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397060|NCT05240781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102397061|NCT05240781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102397062|NCT05240781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397063|NCT01520987|Opicapone|opicapone|mesh-list
102397064|NCT01520987|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102397065|NCT01520987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102397066|NCT01520987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397067|NCT01520987|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102397068|NCT01520987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102397069|NCT00130923|Risperidone|risperidone|mesh-list
102397070|NCT00130923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102397071|NCT00130923|Serotonin Agents|serotonin agents|mesh-ancestor
102397072|NCT00130923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102397073|NCT00130923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397074|NCT00130923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397075|NCT00130923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102397076|NCT00130923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102397077|NCT00130923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102397078|NCT00130923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102397079|NCT00130923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102397080|NCT00130923|Dopamine Agents|dopamine agents|mesh-ancestor
102397081|NCT04117581|Vitamin D|vitamin d|mesh-list
102397082|NCT04117581|Cholecalciferol|cholecalciferol|mesh-list
102397084|NCT04117581|Micronutrients|micronutrients|mesh-ancestor
102397085|NCT04117581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397086|NCT04117581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102397087|NCT04117581|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102397088|NCT00272337|Aspirin|aspirin|mesh-list
102397089|NCT00272337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102397090|NCT00272337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102397091|NCT00272337|Analgesics|analgesics|mesh-ancestor
102397092|NCT00272337|Sensory System Agents|sensory system agents|mesh-ancestor
102397093|NCT00272337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102397094|NCT00272337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397095|NCT00272337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102397096|NCT00272337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101857854|NCT00378014|Everolimus|everolimus|mesh-list
102397097|NCT00272337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102397098|NCT00272337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102397099|NCT00272337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397100|NCT00272337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102397101|NCT00272337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102397102|NCT00272337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102397103|NCT00272337|Antipyretics|antipyretics|mesh-ancestor
102397104|NCT01562275|Ipatasertib|ipatasertib|mesh-list
102397105|NCT01562275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102397106|NCT01562275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102397107|NCT01562275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102397108|NCT01562275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397109|NCT01535053|Calcium, Dietary|calcium, dietary|mesh-list
102397110|NCT01535053|Leucovorin|leucovorin|mesh-list
102397111|NCT01535053|Folic Acid|folic acid|mesh-list
102397112|NCT01535053|Dactinomycin|dactinomycin|mesh-list
102397113|NCT01535053|Methotrexate|methotrexate|mesh-list
102397114|NCT01535053|Calcium|calcium|mesh-list
102397115|NCT01535053|Levoleucovorin|levoleucovorin|mesh-list
102397116|NCT01535053|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102397117|NCT01535053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397118|NCT01535053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102397119|NCT01535053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102397120|NCT01535053|Abortifacient Agents|abortifacient agents|mesh-ancestor
102397121|NCT01535053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102397122|NCT01535053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102397123|NCT01535053|Antimetabolites|antimetabolites|mesh-ancestor
101858197|NCT00331422|Carboplatin|carboplatin|mesh-list
101578064|NCT02701309|Iron|iron|mesh-list
102397124|NCT01535053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397125|NCT01535053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102397126|NCT01535053|Dermatologic Agents|dermatologic agents|mesh-ancestor
102397127|NCT01535053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102397128|NCT01535053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102397129|NCT01535053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102397130|NCT01535053|Immunologic Factors|immunologic factors|mesh-ancestor
102397131|NCT01535053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102397132|NCT01535053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102397133|NCT01535053|Antidotes|antidotes|mesh-ancestor
102397134|NCT01535053|Protective Agents|protective agents|mesh-ancestor
102397135|NCT01535053|Vitamin B Complex|vitamin b complex|mesh-ancestor
102397136|NCT01535053|Vitamins|vitamins|mesh-ancestor
102397137|NCT01535053|Micronutrients|micronutrients|mesh-ancestor
102397138|NCT01535053|Hematinics|hematinics|mesh-ancestor
102397139|NCT01535053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102397140|NCT01535053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102397141|NCT01535053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102397142|NCT01535053|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102397143|NCT03027635|Ciprofloxacin|ciprofloxacin|mesh-list
102397144|NCT03027635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102397145|NCT03027635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102397146|NCT03027635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102397147|NCT03027635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101858560|NCT00352118|Docetaxel|docetaxel|mesh-list
102397148|NCT03027635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102397149|NCT03027635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397150|NCT03027635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102397151|NCT03027635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102397152|NCT03027635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102397153|NCT01520363|Dextromethorphan|dextromethorphan|mesh-list
102397154|NCT01520363|Antitussive Agents|antitussive agents|mesh-ancestor
102397155|NCT01520363|Respiratory System Agents|respiratory system agents|mesh-ancestor
102397156|NCT01520363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102397157|NCT01520363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102397158|NCT01520363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102397159|NCT01520363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397160|NCT01520363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397161|NCT01578499|Methotrexate|methotrexate|mesh-list
102397162|NCT01578499|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102397163|NCT01578499|Bexarotene|bexarotene|mesh-list
102397164|NCT01578499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102397165|NCT01578499|Abortifacient Agents|abortifacient agents|mesh-ancestor
102397166|NCT01578499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102397167|NCT01578499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397168|NCT01578499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102397169|NCT01578499|Antimetabolites|antimetabolites|mesh-ancestor
102397170|NCT01578499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397171|NCT01578499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102397172|NCT01578499|Dermatologic Agents|dermatologic agents|mesh-ancestor
102397173|NCT01578499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102397174|NCT01578499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102397175|NCT01578499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102397176|NCT01578499|Immunologic Factors|immunologic factors|mesh-ancestor
102397177|NCT01578499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102397178|NCT01578499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102397179|NCT01578499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102397180|NCT01578499|Immunotoxins|immunotoxins|mesh-ancestor
102397181|NCT01578499|Immunoconjugates|immunoconjugates|mesh-ancestor
102397182|NCT01561963|Rifampin|rifampin|mesh-list
102397183|NCT01561963|Apremilast|apremilast|mesh-list
102397184|NCT01561963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101859103|NCT01064154|Carvedilol|carvedilol|mesh-list
102397185|NCT01561963|Antitubercular Agents|antitubercular agents|mesh-ancestor
102397186|NCT01561963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102397187|NCT01561963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102397188|NCT01561963|Leprostatic Agents|leprostatic agents|mesh-ancestor
102397189|NCT01561963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102397190|NCT01561963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102397191|NCT01561963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397192|NCT01561963|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101859238|NCT00332462|Cyclosporine|cyclosporine|mesh-list
102397193|NCT01561963|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102397194|NCT01561963|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102397195|NCT01561963|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102397196|NCT01561963|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101859346|NCT00156819|Xhance|xhance|mesh-list
102397197|NCT01561963|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102397198|NCT01561963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102397199|NCT01561963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101859403|NCT01077609|Xhance|xhance|mesh-list
102397200|NCT01561963|Analgesics|analgesics|mesh-ancestor
102397201|NCT01561963|Sensory System Agents|sensory system agents|mesh-ancestor
102397202|NCT01561963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101859464|NCT00323492|Antiviral Agents|antiviral agents|mesh-ancestor
102397203|NCT01561963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397204|NCT01561963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102397205|NCT01561963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102397206|NCT01561963|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102397207|NCT01561963|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102397208|NCT04852003|Morphine|morphine|mesh-list
102397209|NCT04852003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102397210|NCT04852003|Narcotics|narcotics|mesh-ancestor
102397211|NCT04852003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102397212|NCT04852003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397213|NCT04852003|Analgesics|analgesics|mesh-ancestor
102397214|NCT04852003|Sensory System Agents|sensory system agents|mesh-ancestor
102397215|NCT04852003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102397216|NCT01534351|Tamsulosin|tamsulosin|mesh-list
102397217|NCT01534351|Finasteride|finasteride|mesh-list
102397218|NCT01534351|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102397219|NCT01534351|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102397220|NCT01534351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102397221|NCT01534351|Adrenergic Agents|adrenergic agents|mesh-ancestor
102397222|NCT01534351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102397223|NCT01534351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397224|NCT01534351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397225|NCT01534351|Urological Agents|urological agents|mesh-ancestor
102397226|NCT01534351|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102397227|NCT01534351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102397228|NCT01534351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102397229|NCT01534351|Hormone Antagonists|hormone antagonists|mesh-ancestor
101859731|NCT00321932|Vitamins|vitamins|mesh-ancestor
102397230|NCT01534351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102397231|NCT01534195|Prednisolone|prednisolone|mesh-list
102397232|NCT01534195|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102397233|NCT01534195|Methylprednisolone|methylprednisolone|mesh-list
102397234|NCT01534195|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102397235|NCT01534195|Prednisolone acetate|prednisolone acetate|mesh-list
102397236|NCT01534195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102397237|NCT01534195|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102397238|NCT01534195|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102397239|NCT01534195|Prednisolone phosphate|prednisolone phosphate|mesh-list
101859939|NCT00499889|Vidarabine|vidarabine|mesh-list
102397240|NCT01534195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102397241|NCT01534195|Glucocorticoids|glucocorticoids|mesh-ancestor
102397242|NCT01534195|Hormones|hormones|mesh-ancestor
102397243|NCT01534195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102397244|NCT01534195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397245|NCT01534195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102397246|NCT01534195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102397247|NCT01534195|Antiemetics|antiemetics|mesh-ancestor
102397248|NCT01534195|Autonomic Agents|autonomic agents|mesh-ancestor
102397249|NCT01534195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102397250|NCT01534195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102397251|NCT01534195|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102397252|NCT01534195|Protective Agents|protective agents|mesh-ancestor
102397253|NCT01560949|Gemcitabine|gemcitabine|mesh-list
102397254|NCT01560949|Fluorouracil|fluorouracil|mesh-list
102397255|NCT01560949|Oxaliplatin|oxaliplatin|mesh-list
102397256|NCT01560949|Irinotecan|irinotecan|mesh-list
101860228|NCT00290706|Bortezomib|bortezomib|mesh-list
102397257|NCT01560949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102397258|NCT01560949|Antimetabolites|antimetabolites|mesh-ancestor
102397259|NCT01560949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860300|NCT01066572|Lisinopril|lisinopril|mesh-list
102397260|NCT01560949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102397261|NCT01560949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102397262|NCT01560949|Immunologic Factors|immunologic factors|mesh-ancestor
102397263|NCT01560949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397264|NCT01560949|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102397265|NCT01560949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102397266|NCT01560949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102397267|NCT03113448|Capsaicin|capsaicin|mesh-list
102397268|NCT03113448|Antipruritics|antipruritics|mesh-ancestor
102397269|NCT03113448|Dermatologic Agents|dermatologic agents|mesh-ancestor
102397270|NCT03113448|Sensory System Agents|sensory system agents|mesh-ancestor
102397271|NCT03113448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102397272|NCT03113448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397273|NCT01533493|Memantine|memantine|mesh-list
102397274|NCT01533493|Methylphenidate|methylphenidate|mesh-list
102397275|NCT01533493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102397276|NCT01533493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397277|NCT01533493|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101860575|NCT00299130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102397278|NCT01533493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102397279|NCT01533493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102397280|NCT01533493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397281|NCT01533493|Dopamine Agents|dopamine agents|mesh-ancestor
102397282|NCT01533493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102397283|NCT01533493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102397284|NCT01533493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101860794|NCT01065870|Antimitotic Agents|antimitotic agents|mesh-ancestor
102397285|NCT01533493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102397286|NCT01533493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102397287|NCT02388048|Ofatumumab|ofatumumab|mesh-list
102397288|NCT02388048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102397289|NCT02387892|Vitamin D|vitamin d|mesh-list
102397290|NCT02387892|Cholecalciferol|cholecalciferol|mesh-list
102397291|NCT02387892|Vitamins|vitamins|mesh-ancestor
102397292|NCT02387892|Micronutrients|micronutrients|mesh-ancestor
102397293|NCT02387892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861015|NCT00292188|Pregabalin|pregabalin|mesh-list
102397294|NCT02387892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102397295|NCT02387892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102397296|NCT00133575|Vaccines|vaccines|mesh-list
102397297|NCT00133575|Immunologic Factors|immunologic factors|mesh-ancestor
102397298|NCT00133575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397299|NCT00134043|Vorinostat|vorinostat|mesh-list
102397300|NCT00134043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102397301|NCT00134043|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102397302|NCT00134043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102397303|NCT00134043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397304|NCT03715998|Ramipril|ramipril|mesh-list
102397305|NCT03715998|Firibastat|firibastat|mesh-list
102397306|NCT03715998|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102397307|NCT03715998|Protease Inhibitors|protease inhibitors|mesh-ancestor
102397308|NCT03715998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102397309|NCT03715998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397310|NCT03715998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102397311|NCT01790529|Metronidazole|metronidazole|mesh-list
102397312|NCT01790529|Cefuroxime|cefuroxime|mesh-list
102397313|NCT01790529|Cefuroxime axetil|cefuroxime axetil|mesh-list
102397314|NCT01790529|Anesthetics|anesthetics|mesh-list
102397315|NCT01790529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102397316|NCT01790529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397317|NCT01790529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102397318|NCT01790529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102397319|NCT01790529|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102397320|NCT01790529|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102397321|NCT01533181|Topotecan|topotecan|mesh-list
102397322|NCT01533181|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102397323|NCT01533181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102397324|NCT01533181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102397325|NCT01533181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397326|NCT01533181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102397327|NCT04641507|Tadalafil|tadalafil|mesh-list
102397328|NCT04641507|Tamsulosin|tamsulosin|mesh-list
101861589|NCT01581242|Adefovir|adefovir|mesh-list
102397329|NCT04641507|Vasodilator Agents|vasodilator agents|mesh-ancestor
102397330|NCT04641507|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102397331|NCT04641507|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102397332|NCT04641507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101861656|NCT01066988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102397333|NCT04641507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397334|NCT04641507|Urological Agents|urological agents|mesh-ancestor
102397335|NCT04641507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102397336|NCT04641507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102397337|NCT04641507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102397338|NCT04641507|Adrenergic Agents|adrenergic agents|mesh-ancestor
102397339|NCT04641507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102397340|NCT04641507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397341|NCT04489173|Trifluridine|trifluridine|mesh-list
102397342|NCT04489173|Antimetabolites|antimetabolites|mesh-ancestor
102397343|NCT04489173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397344|NCT04489173|Antiviral Agents|antiviral agents|mesh-ancestor
102397345|NCT04489173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102397346|NCT00512070|Olanzapine|olanzapine|mesh-list
102397347|NCT00512070|Melatonin|melatonin|mesh-list
102397348|NCT00512070|Antioxidants|antioxidants|mesh-ancestor
102397349|NCT00512070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397350|NCT00512070|Protective Agents|protective agents|mesh-ancestor
102397351|NCT00512070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397352|NCT00512070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102397353|NCT00512070|Antiemetics|antiemetics|mesh-ancestor
102397354|NCT00512070|Autonomic Agents|autonomic agents|mesh-ancestor
102397355|NCT00512070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102397356|NCT00512070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102397357|NCT00512070|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101862006|NCT00467831|Antioxidants|antioxidants|mesh-ancestor
102397358|NCT00512070|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102397359|NCT00512070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102397360|NCT00512070|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101862075|NCT00115804|Fluoxetine|fluoxetine|mesh-list
102397361|NCT00512070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102397362|NCT00512070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102397363|NCT00512070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102397364|NCT00512070|Serotonin Agents|serotonin agents|mesh-ancestor
102397365|NCT05668026|Venetoclax|venetoclax|mesh-list
102397366|NCT05668026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102397367|NCT05661552|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102397368|NCT05661552|Ezetimibe|ezetimibe|mesh-list
102397369|NCT05661552|Evolocumab|evolocumab|mesh-list
102397370|NCT05661552|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102397371|NCT05661552|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102397372|NCT05661552|Antimetabolites|antimetabolites|mesh-ancestor
102397373|NCT05661552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397374|NCT05661552|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102397375|NCT05661552|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102397376|NCT05661552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102397377|NCT05661552|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102397378|NCT05661552|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102397379|NCT05661552|Protease Inhibitors|protease inhibitors|mesh-ancestor
102397380|NCT03534102|Analgesics, Opioid|analgesics, opioid|mesh-list
102397381|NCT03534102|Narcotics|narcotics|mesh-ancestor
102397382|NCT03534102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102397383|NCT03534102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397384|NCT03534102|Analgesics|analgesics|mesh-ancestor
102397385|NCT03534102|Sensory System Agents|sensory system agents|mesh-ancestor
102397386|NCT03534102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102397387|NCT04051203|Methylprednisolone|methylprednisolone|mesh-list
102397388|NCT04051203|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101862506|NCT00235872|Adalimumab|adalimumab|mesh-list
102397389|NCT04051203|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102397390|NCT04051203|Prednisolone|prednisolone|mesh-list
102397391|NCT04051203|Prednisolone acetate|prednisolone acetate|mesh-list
102397392|NCT04051203|Lidocaine|lidocaine|mesh-list
102397393|NCT04051203|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102397394|NCT04051203|Prednisolone phosphate|prednisolone phosphate|mesh-list
102397395|NCT04051203|Anesthetics, Local|anesthetics, local|mesh-ancestor
102397396|NCT04051203|Anesthetics|anesthetics|mesh-ancestor
102397397|NCT04051203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102397398|NCT04051203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397399|NCT04051203|Sensory System Agents|sensory system agents|mesh-ancestor
102397400|NCT04051203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102397401|NCT04051203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102397402|NCT04051203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102397403|NCT04051203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102397404|NCT04051203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102397405|NCT04051203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397406|NCT04051203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102397407|NCT04051203|Antiemetics|antiemetics|mesh-ancestor
102397408|NCT04051203|Autonomic Agents|autonomic agents|mesh-ancestor
102397409|NCT04051203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102397410|NCT04051203|Glucocorticoids|glucocorticoids|mesh-ancestor
102397411|NCT04051203|Hormones|hormones|mesh-ancestor
102397412|NCT04051203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102397413|NCT04051203|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102397414|NCT04051203|Protective Agents|protective agents|mesh-ancestor
102397415|NCT04051203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102397416|NCT04051203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102397417|NCT00144963|Dexamethasone|dexamethasone|mesh-list
102397418|NCT00144963|Vincristine|vincristine|mesh-list
102397419|NCT00144963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102397420|NCT00144963|Antiemetics|antiemetics|mesh-ancestor
102397421|NCT00144963|Autonomic Agents|autonomic agents|mesh-ancestor
102397422|NCT00144963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102397423|NCT00144963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397424|NCT00144963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102397425|NCT00144963|Glucocorticoids|glucocorticoids|mesh-ancestor
102397426|NCT00144963|Hormones|hormones|mesh-ancestor
101862911|NCT00288626|Prednisone|prednisone|mesh-list
102397427|NCT00144963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102397428|NCT00144963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102397429|NCT00144963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101862984|NCT00288080|Hormone Antagonists|hormone antagonists|mesh-ancestor
102397430|NCT00144963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102397431|NCT00144963|Tubulin Modulators|tubulin modulators|mesh-ancestor
102397432|NCT00144963|Antimitotic Agents|antimitotic agents|mesh-ancestor
102397433|NCT00144963|Mitosis Modulators|mitosis modulators|mesh-ancestor
102397434|NCT00144963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397435|NCT02662764|Sufentanil|sufentanil|mesh-list
102397436|NCT02662764|Dsuvia|dsuvia|mesh-list
102397437|NCT02662764|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102397438|NCT02662764|Narcotics|narcotics|mesh-ancestor
102397439|NCT02662764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102397440|NCT02662764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397441|NCT02662764|Analgesics|analgesics|mesh-ancestor
101863128|NCT03956134|Analgesics|analgesics|mesh-ancestor
102397442|NCT02662764|Sensory System Agents|sensory system agents|mesh-ancestor
102397443|NCT02662764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102397444|NCT02662764|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102397445|NCT02662764|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102397446|NCT02662764|Anesthetics, General|anesthetics, general|mesh-ancestor
102397447|NCT02662764|Anesthetics|anesthetics|mesh-ancestor
102397448|NCT01519817|Vaccines|vaccines|mesh-list
102397449|NCT01519817|Immunologic Factors|immunologic factors|mesh-ancestor
102397450|NCT01519817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397451|NCT05549154|Vitamin D|vitamin d|mesh-list
102397452|NCT05549154|Ergocalciferols|ergocalciferols|mesh-list
102397453|NCT05549154|Cholecalciferol|cholecalciferol|mesh-list
102209121|NCT00950885|Antioxidants|antioxidants|mesh-ancestor
102397454|NCT05549154|Vitamins|vitamins|mesh-list
102397455|NCT05549154|Micronutrients|micronutrients|mesh-ancestor
102397456|NCT05549154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397457|NCT05549154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102397458|NCT05549154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102397459|NCT01518257|Botulinum Toxins|botulinum toxins|mesh-list
102397460|NCT01518257|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102397461|NCT01518257|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102397462|NCT01518257|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102397463|NCT01518257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101863478|NCT01095484|Rotigotine|rotigotine|mesh-list
102397464|NCT01518257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397465|NCT01518257|Cholinergic Agents|cholinergic agents|mesh-ancestor
102397466|NCT01518257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102397467|NCT01518257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397468|NCT01518257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102397469|NCT01518257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102397470|NCT02391636|Oxytocin|oxytocin|mesh-list
102397471|NCT02391636|Carbetocin|carbetocin|mesh-list
102397472|NCT02391636|Oxytocics|oxytocics|mesh-ancestor
102397473|NCT02391636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102397474|NCT02391636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397475|NCT01514357|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
102397476|NCT01514357|Natriuretic Agents|natriuretic agents|mesh-ancestor
102397477|NCT01514357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397478|NCT02383212|Paclitaxel|paclitaxel|mesh-list
102397479|NCT02383212|Docetaxel|docetaxel|mesh-list
102397480|NCT02383212|Cyclophosphamide|cyclophosphamide|mesh-list
102397481|NCT02383212|Carboplatin|carboplatin|mesh-list
102397482|NCT02383212|Pemetrexed|pemetrexed|mesh-list
102397483|NCT02383212|Cemiplimab|cemiplimab|mesh-list
101863757|NCT00283244|Gemcitabine|gemcitabine|mesh-list
102397484|NCT02383212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102397485|NCT02383212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102397486|NCT02383212|Tubulin Modulators|tubulin modulators|mesh-ancestor
102397487|NCT02383212|Antimitotic Agents|antimitotic agents|mesh-ancestor
102397488|NCT02383212|Mitosis Modulators|mitosis modulators|mesh-ancestor
102397489|NCT02383212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397490|NCT02383212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102397491|NCT02383212|Immunologic Factors|immunologic factors|mesh-ancestor
102397492|NCT02383212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397493|NCT02383212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102397494|NCT02383212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102397495|NCT02383212|Alkylating Agents|alkylating agents|mesh-ancestor
102397496|NCT02383212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102397497|NCT02383212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102397498|NCT02383212|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102397499|NCT02383212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102397500|NCT02383212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102397501|NCT01531387|Hydroxyurea|hydroxyurea|mesh-list
102397502|NCT01531387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102397503|NCT01531387|Antisickling Agents|antisickling agents|mesh-ancestor
102397504|NCT01531387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102397505|NCT01531387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864186|NCT00058552|Pertuzumab|pertuzumab|mesh-list
102397506|NCT01531387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102397507|NCT01531153|Galantamine|galantamine|mesh-list
102397508|NCT01531153|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102397509|NCT01531153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101864256|NCT00222729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102397510|NCT01531153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397511|NCT01531153|Cholinergic Agents|cholinergic agents|mesh-ancestor
102397512|NCT01531153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102397513|NCT01531153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397514|NCT01531153|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102397515|NCT01531153|Autonomic Agents|autonomic agents|mesh-ancestor
102397516|NCT01531153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102397517|NCT01531153|Nootropic Agents|nootropic agents|mesh-ancestor
102397518|NCT03027973|Tranexamic Acid|tranexamic acid|mesh-list
102397519|NCT03027973|Ulipristal acetate|ulipristal acetate|mesh-list
102397520|NCT03027973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102397521|NCT03027973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102397522|NCT03027973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397523|NCT03027973|Hemostatics|hemostatics|mesh-ancestor
102397524|NCT03027973|Coagulants|coagulants|mesh-ancestor
102397525|NCT03027973|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101864541|NCT03974984|Anesthetics|anesthetics|mesh-list
102397526|NCT03027973|Contraceptive Agents|contraceptive agents|mesh-ancestor
102397527|NCT03027973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102397528|NCT03027973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397529|NCT03027973|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102397530|NCT01529749|Raltegravir Potassium|raltegravir potassium|mesh-list
102209207|NCT03134651|Propofol|propofol|mesh-list
102397531|NCT01529749|Losartan|losartan|mesh-list
102397532|NCT01529749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102397533|NCT01529749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102397534|NCT01529749|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102397535|NCT01529749|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102397536|NCT01529749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397537|NCT01529749|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102397538|NCT01529749|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102397539|NCT01529749|Antiviral Agents|antiviral agents|mesh-ancestor
102397540|NCT01529749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102397541|NCT01529749|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101864755|NCT01096654|Mydriatics|mydriatics|mesh-ancestor
102397542|NCT01529749|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102397543|NCT01529749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102397544|NCT01529515|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102397545|NCT01529515|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102397546|NCT01529515|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102397547|NCT01529515|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102397548|NCT01528969|Sorbitol|sorbitol|mesh-list
102397549|NCT01528969|Cathartics|cathartics|mesh-ancestor
101864891|NCT01323335|Rasburicase|rasburicase|mesh-list
102397550|NCT01528969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102397551|NCT01514201|Temozolomide|temozolomide|mesh-list
102397552|NCT01514201|Veliparib|veliparib|mesh-list
102397553|NCT01514201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102397554|NCT01514201|Alkylating Agents|alkylating agents|mesh-ancestor
102397555|NCT01514201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397556|NCT01514201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101865036|NCT03995147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102397557|NCT01514201|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102397558|NCT01514201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102397559|NCT02666664|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
102397560|NCT02666664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102397561|NCT02666664|Antimetabolites|antimetabolites|mesh-ancestor
102397562|NCT02666664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397563|NCT02666664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102397564|NCT02666664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102397565|NCT02666664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102397566|NCT02666664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397567|NCT01528735|Ribavirin|ribavirin|mesh-list
102397568|NCT01528735|Antimetabolites|antimetabolites|mesh-ancestor
102397569|NCT01528735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397570|NCT01528735|Antiviral Agents|antiviral agents|mesh-ancestor
102397571|NCT01528735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102397572|NCT02386488|Vortioxetine|vortioxetine|mesh-list
101865244|NCT01029743|Aspirin|aspirin|mesh-list
102397573|NCT02386488|Antidepressive Agents|antidepressive agents|mesh-ancestor
102397574|NCT02386488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102397575|NCT02386488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102397576|NCT02386488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102397577|NCT02386488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102397578|NCT02386488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397579|NCT02386488|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102397580|NCT02386488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102397581|NCT02386488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101865461|NCT01101412|Anticoagulants|anticoagulants|mesh-ancestor
102397582|NCT02386488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397583|NCT02386488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102397584|NCT02386488|Serotonin Agents|serotonin agents|mesh-ancestor
101231782|NCT01468896|Cetuximab|cetuximab|mesh-list
102397585|NCT02386488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102397586|NCT02386488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102397587|NCT02386488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101865611|NCT01037465|Antidotes|antidotes|mesh-ancestor
102397588|NCT02386488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102397589|NCT02661594|Moxifloxacin|moxifloxacin|mesh-list
102397590|NCT02661594|Amisulpride|amisulpride|mesh-list
102397591|NCT02661594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102397592|NCT02661594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102397593|NCT02661594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102397594|NCT02661594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102397595|NCT02661594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102397596|NCT02661594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397597|NCT02661594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102397598|NCT02661594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397599|NCT02661594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102397600|NCT02661594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102397601|NCT02661594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102397602|NCT02661594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102397603|NCT02661594|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102397604|NCT02661594|Dopamine Agents|dopamine agents|mesh-ancestor
102397605|NCT02661594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101865896|NCT00125853|Adrenergic Agents|adrenergic agents|mesh-ancestor
102397606|NCT02661594|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102397607|NCT02661594|Antidepressive Agents|antidepressive agents|mesh-ancestor
102397608|NCT02386566|Natalizumab|natalizumab|mesh-list
102397609|NCT02386566|Immunologic Factors|immunologic factors|mesh-ancestor
102397610|NCT02386566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397611|NCT01528345|Fulvestrant|fulvestrant|mesh-list
102397612|NCT01528345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102397613|NCT01528345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102397614|NCT01528345|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102397615|NCT01528345|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102397616|NCT01528345|Hormone Antagonists|hormone antagonists|mesh-ancestor
102397617|NCT01528345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102397618|NCT01528345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397619|NCT01511939|Diclofenac|diclofenac|mesh-list
102397620|NCT01511939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
102397621|NCT01511939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102397622|NCT01511939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102397623|NCT01511939|Analgesics|analgesics|mesh-ancestor
102397624|NCT01511939|Sensory System Agents|sensory system agents|mesh-ancestor
102397625|NCT01511939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102397626|NCT01511939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397627|NCT01511939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102397628|NCT01511939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102397629|NCT01511939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102397630|NCT01511939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397631|NCT02391480|Venetoclax|venetoclax|mesh-list
102397632|NCT02391480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102397633|NCT01576705|Leucovorin|leucovorin|mesh-list
102397634|NCT01576705|Folic Acid|folic acid|mesh-list
102397635|NCT01576705|Hormones|hormones|mesh-list
102397636|NCT01576705|Levoleucovorin|levoleucovorin|mesh-list
102397637|NCT01576705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102397638|NCT01576705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397639|NCT01576705|Antidotes|antidotes|mesh-ancestor
102397640|NCT01576705|Protective Agents|protective agents|mesh-ancestor
102397641|NCT01576705|Vitamin B Complex|vitamin b complex|mesh-ancestor
102397642|NCT01576705|Vitamins|vitamins|mesh-ancestor
102397643|NCT01576705|Micronutrients|micronutrients|mesh-ancestor
102397644|NCT01576705|Hematinics|hematinics|mesh-ancestor
102397645|NCT02666430|Insulin Glargine|insulin glargine|mesh-list
102397646|NCT02666430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102397647|NCT02666430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397648|NCT02382666|Rolapitant|rolapitant|mesh-list
102397649|NCT02382666|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102397650|NCT02382666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102397651|NCT02382666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397652|NCT02382666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397653|NCT00145041|Vincristine|vincristine|mesh-list
102397654|NCT00145041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102397655|NCT00145041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102397656|NCT00145041|Tubulin Modulators|tubulin modulators|mesh-ancestor
102397657|NCT00145041|Antimitotic Agents|antimitotic agents|mesh-ancestor
102397658|NCT00145041|Mitosis Modulators|mitosis modulators|mesh-ancestor
102397659|NCT00145041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397660|NCT04123561|Dexamethasone|dexamethasone|mesh-list
102397661|NCT04123561|Dexamethasone acetate|dexamethasone acetate|mesh-list
101866234|NCT00262028|Vaccines|vaccines|mesh-list
102397662|NCT04123561|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102397663|NCT04123561|BB 1101|bb 1101|mesh-list
102397664|NCT04123561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102397665|NCT04123561|Antiemetics|antiemetics|mesh-ancestor
101866287|NCT00181844|Lamotrigine|lamotrigine|mesh-list
102397666|NCT04123561|Autonomic Agents|autonomic agents|mesh-ancestor
102397667|NCT04123561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102397668|NCT04123561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397669|NCT04123561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102397670|NCT04123561|Glucocorticoids|glucocorticoids|mesh-ancestor
102397671|NCT04123561|Hormones|hormones|mesh-ancestor
102397672|NCT04123561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102397673|NCT04123561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102397674|NCT04123561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102397675|NCT04123561|Protease Inhibitors|protease inhibitors|mesh-ancestor
102397676|NCT04123561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101687984|NCT02670954|Flurbiprofen|flurbiprofen|mesh-list
102397677|NCT04123561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397678|NCT01510769|Febuxostat|febuxostat|mesh-list
102397679|NCT01510769|Lesinurad|lesinurad|mesh-list
102397680|NCT01510769|Gout Suppressants|gout suppressants|mesh-ancestor
102397681|NCT01510769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102397682|NCT01510769|Uricosuric Agents|uricosuric agents|mesh-ancestor
102397683|NCT02382354|Remifentanil|remifentanil|mesh-list
102397684|NCT02382354|Propofol|propofol|mesh-list
102397685|NCT02382354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102397686|NCT02382354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102397687|NCT02382354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397688|NCT02382354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102397689|NCT02382354|Anesthetics, General|anesthetics, general|mesh-ancestor
102397690|NCT02382354|Anesthetics|anesthetics|mesh-ancestor
102397691|NCT02382354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102397692|NCT02382354|Narcotics|narcotics|mesh-ancestor
102397693|NCT02382354|Analgesics|analgesics|mesh-ancestor
102397694|NCT02382354|Sensory System Agents|sensory system agents|mesh-ancestor
102397695|NCT02382354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102397696|NCT01510145|Travoprost|travoprost|mesh-list
102397697|NCT01510145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102397698|NCT03027167|Aspirin|aspirin|mesh-list
102397699|NCT03027167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102397700|NCT03027167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102397701|NCT03027167|Analgesics|analgesics|mesh-ancestor
101866851|NCT01107808|Metformin|metformin|mesh-list
102397702|NCT03027167|Sensory System Agents|sensory system agents|mesh-ancestor
102397703|NCT03027167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102397704|NCT03027167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397705|NCT03027167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102397706|NCT03027167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102397707|NCT03027167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102397708|NCT03027167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101866995|NCT01208818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102397709|NCT03027167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397710|NCT03027167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102397711|NCT03027167|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102397712|NCT03027167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102397713|NCT03027167|Antipyretics|antipyretics|mesh-ancestor
102397714|NCT02382198|Glycopyrrolate|glycopyrrolate|mesh-list
102397715|NCT02382198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102397716|NCT02382198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102397717|NCT02382198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102397718|NCT02382198|Cholinergic Agents|cholinergic agents|mesh-ancestor
102397719|NCT02382198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102397720|NCT02382198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397721|NCT02382198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397722|NCT02382432|Meperidine|meperidine|mesh-list
102397723|NCT02382432|Dexmedetomidine|dexmedetomidine|mesh-list
102397724|NCT02382432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102397725|NCT02382432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102397726|NCT02382432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397727|NCT02382432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102397728|NCT02382432|Analgesics|analgesics|mesh-ancestor
102397729|NCT02382432|Sensory System Agents|sensory system agents|mesh-ancestor
102397730|NCT02382432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102397731|NCT02382432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102397732|NCT02382432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102397733|NCT02382432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102397734|NCT02382432|Adrenergic Agents|adrenergic agents|mesh-ancestor
102397735|NCT02382432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102397736|NCT02382432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397737|NCT02382432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102397738|NCT02382432|Narcotics|narcotics|mesh-ancestor
102397739|NCT02382432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102397740|NCT00145587|Antibodies|antibodies|mesh-list
102397741|NCT00145587|Immunologic Factors|immunologic factors|mesh-ancestor
102397742|NCT00145587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397743|NCT04298463|Vancomycin|vancomycin|mesh-list
102397744|NCT04298463|Daptomycin|daptomycin|mesh-list
102397745|NCT04298463|Teicoplanin|teicoplanin|mesh-list
102397746|NCT04298463|Dalbavancin|dalbavancin|mesh-list
102397747|NCT04298463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102397748|NCT04298463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102397749|NCT02381964|Coenzyme Q10|coenzyme q10|mesh-list
102397750|NCT02381964|Vitamins|vitamins|mesh-ancestor
102397751|NCT02381964|Micronutrients|micronutrients|mesh-ancestor
102397752|NCT02381964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397753|NCT01509053|Aripiprazole|aripiprazole|mesh-list
102397754|NCT01509053|Antidepressive Agents|antidepressive agents|mesh-ancestor
102397755|NCT01509053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102397756|NCT01509053|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102397757|NCT01509053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102397758|NCT01509053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102397759|NCT01509053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397760|NCT01509053|Dopamine Agonists|dopamine agonists|mesh-ancestor
102397761|NCT01509053|Dopamine Agents|dopamine agents|mesh-ancestor
102397762|NCT01509053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102397763|NCT01509053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397764|NCT01509053|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102397765|NCT01509053|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102397766|NCT01509053|Serotonin Agents|serotonin agents|mesh-ancestor
102397767|NCT01509053|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102397768|NCT01509053|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102397769|NCT01509053|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102397770|NCT01509053|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102397771|NCT01560403|Teduglutide|teduglutide|mesh-list
102397772|NCT01560403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102397773|NCT01560403|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102397774|NCT01560403|Protective Agents|protective agents|mesh-ancestor
102397775|NCT01560403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397776|NCT02100579|Bupivacaine|bupivacaine|mesh-list
102397777|NCT02100579|Anesthetics, Local|anesthetics, local|mesh-ancestor
102397778|NCT02100579|Anesthetics|anesthetics|mesh-ancestor
102397779|NCT02100579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102397780|NCT02100579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397781|NCT02100579|Sensory System Agents|sensory system agents|mesh-ancestor
102397782|NCT02100579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102397783|NCT04251351|Acetaminophen|acetaminophen|mesh-list
102397784|NCT04251351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102397785|NCT04251351|Analgesics|analgesics|mesh-ancestor
102397786|NCT04251351|Sensory System Agents|sensory system agents|mesh-ancestor
102397787|NCT04251351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102397788|NCT04251351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397789|NCT04251351|Antipyretics|antipyretics|mesh-ancestor
102397790|NCT02390700|Golimumab|golimumab|mesh-list
102397791|NCT02390700|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102397792|NCT02390700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102397793|NCT02390700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102397794|NCT02390700|Immunologic Factors|immunologic factors|mesh-ancestor
102397795|NCT02390700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397796|NCT00284739|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102397797|NCT00284739|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102397798|NCT00284739|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101867667|NCT01119430|Serotonin Agents|serotonin agents|mesh-ancestor
102397799|NCT00284739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397800|NCT01527487|Cyclophosphamide|cyclophosphamide|mesh-list
102397801|NCT01527487|Docetaxel|docetaxel|mesh-list
102397802|NCT01527487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102397803|NCT01527487|Immunologic Factors|immunologic factors|mesh-ancestor
102397804|NCT01527487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867728|NCT03933748|Teicoplanin|teicoplanin|mesh-list
102397805|NCT01527487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102397806|NCT01527487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102397807|NCT01527487|Alkylating Agents|alkylating agents|mesh-ancestor
101867799|NCT03933280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102397808|NCT01527487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397809|NCT01527487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102397810|NCT01527487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102397811|NCT01527487|Tubulin Modulators|tubulin modulators|mesh-ancestor
102397812|NCT01527487|Antimitotic Agents|antimitotic agents|mesh-ancestor
102397813|NCT01527487|Mitosis Modulators|mitosis modulators|mesh-ancestor
102397814|NCT01506947|Darbepoetin alfa|darbepoetin alfa|mesh-list
102397815|NCT01506947|Hematinics|hematinics|mesh-ancestor
102397816|NCT00149643|Fluoxetine|fluoxetine|mesh-list
102397817|NCT00149643|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102397818|NCT00149643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102397819|NCT00149643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102397820|NCT00149643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397821|NCT00149643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102397822|NCT00149643|Serotonin Agents|serotonin agents|mesh-ancestor
102397823|NCT00149643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397824|NCT00149643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102397825|NCT00149643|Antidepressive Agents|antidepressive agents|mesh-ancestor
102397826|NCT00149643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102397827|NCT00149643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102397828|NCT00149643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102397829|NCT00149643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102209496|NCT05126342|Niraparib|niraparib|mesh-list
102397830|NCT02381730|Aflibercept|aflibercept|mesh-list
102397831|NCT02381730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102397832|NCT02381730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102397833|NCT02381730|Growth Substances|growth substances|mesh-ancestor
102397834|NCT02381730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397835|NCT02381730|Growth Inhibitors|growth inhibitors|mesh-ancestor
102397836|NCT02381730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102397837|NCT00149799|Escitalopram|escitalopram|mesh-list
102397838|NCT00149799|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102397839|NCT00149799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101868216|NCT01226056|Everolimus|everolimus|mesh-list
102397840|NCT00149799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102397841|NCT00149799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397842|NCT00149799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102397843|NCT00149799|Serotonin Agents|serotonin agents|mesh-ancestor
102397844|NCT00149799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397845|NCT02390544|Melphalan|melphalan|mesh-list
102397846|NCT02390544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102397847|NCT02390544|Alkylating Agents|alkylating agents|mesh-ancestor
101868358|NCT00257660|Botulinum Toxins|botulinum toxins|mesh-list
102397848|NCT02390544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397849|NCT02390544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102397850|NCT02390544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102397851|NCT02390544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102397852|NCT02390544|Immunologic Factors|immunologic factors|mesh-ancestor
102397853|NCT02390544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397854|NCT01790997|Aspirin|aspirin|mesh-list
102397855|NCT01790997|Clopidogrel|clopidogrel|mesh-list
102397856|NCT01790997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102397857|NCT01790997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102397858|NCT01790997|Analgesics|analgesics|mesh-ancestor
101868504|NCT01128322|Vitamins|vitamins|mesh-ancestor
102397859|NCT01790997|Sensory System Agents|sensory system agents|mesh-ancestor
102397860|NCT01790997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102397861|NCT01790997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397862|NCT01790997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102397863|NCT01790997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102397864|NCT01790997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102397865|NCT01790997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102397866|NCT01790997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397867|NCT01790997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101868627|NCT01131364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102397868|NCT01790997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102397869|NCT01790997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102397870|NCT01790997|Antipyretics|antipyretics|mesh-ancestor
102397871|NCT01790997|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102397872|NCT01790997|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102397873|NCT01790997|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102397874|NCT01790997|Purinergic Agents|purinergic agents|mesh-ancestor
102397875|NCT01790997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102397876|NCT02385474|Fluorides|fluorides|mesh-list
102397877|NCT02385474|Cariostatic Agents|cariostatic agents|mesh-ancestor
102397878|NCT02385474|Protective Agents|protective agents|mesh-ancestor
102397879|NCT02385474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397880|NCT02390310|Lidocaine|lidocaine|mesh-list
102397881|NCT02390310|Prilocaine|prilocaine|mesh-list
102397882|NCT02390310|Anesthetics|anesthetics|mesh-list
102397883|NCT02390310|Anesthetics, Local|anesthetics, local|mesh-ancestor
102397884|NCT02390310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102397885|NCT02390310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397886|NCT02390310|Sensory System Agents|sensory system agents|mesh-ancestor
102397887|NCT02390310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102397888|NCT02390310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102397889|NCT02390310|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102397890|NCT02390310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102397891|NCT02390310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102397892|NCT02390310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397893|NCT02381184|Clomiphene|clomiphene|mesh-list
102397894|NCT02381184|Enclomiphene|enclomiphene|mesh-list
102397895|NCT02381184|Zuclomiphene|zuclomiphene|mesh-list
101869060|NCT03921034|Ropivacaine|ropivacaine|mesh-list
102397896|NCT02381184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102397897|NCT02381184|Hormone Antagonists|hormone antagonists|mesh-ancestor
102397898|NCT02381184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102397899|NCT02381184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397900|NCT02381184|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102397901|NCT02381184|Fertility Agents|fertility agents|mesh-ancestor
102397902|NCT02381184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102397903|NCT02381184|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102397904|NCT02381184|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102397905|NCT02381028|Emollients|emollients|mesh-list
102397906|NCT02381028|Dermatologic Agents|dermatologic agents|mesh-ancestor
102397907|NCT00326781|Nicotine|nicotine|mesh-list
102397908|NCT00326781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102397909|NCT00326781|Autonomic Agents|autonomic agents|mesh-ancestor
102397910|NCT00326781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102397911|NCT00326781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397912|NCT00326781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102397913|NCT00326781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102397914|NCT00326781|Cholinergic Agents|cholinergic agents|mesh-ancestor
102397915|NCT00326781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102397916|NCT00326781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397917|NCT02385396|Folic Acid|folic acid|mesh-list
102397918|NCT02385396|Inositol|inositol|mesh-list
102397919|NCT02385396|Hematinics|hematinics|mesh-ancestor
102397920|NCT02385396|Vitamin B Complex|vitamin b complex|mesh-ancestor
102397921|NCT02385396|Vitamins|vitamins|mesh-ancestor
102397922|NCT02385396|Micronutrients|micronutrients|mesh-ancestor
102397923|NCT02385396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397924|NCT05445414|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102397925|NCT05445414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102397926|NCT02979405|Phenylephrine|phenylephrine|mesh-list
102397927|NCT02979405|Oxymetazoline|oxymetazoline|mesh-list
102397928|NCT02979405|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102397929|NCT02979405|Mydriatics|mydriatics|mesh-ancestor
102397930|NCT02979405|Autonomic Agents|autonomic agents|mesh-ancestor
102397931|NCT02979405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102397932|NCT02979405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397933|NCT02979405|Sympathomimetics|sympathomimetics|mesh-ancestor
102397934|NCT02979405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102397935|NCT02979405|Nasal Decongestants|nasal decongestants|mesh-ancestor
102397936|NCT02979405|Respiratory System Agents|respiratory system agents|mesh-ancestor
102397937|NCT02979405|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102397938|NCT02979405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102397939|NCT02979405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102397940|NCT02979405|Adrenergic Agents|adrenergic agents|mesh-ancestor
102397941|NCT02979405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102397942|NCT02979405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397943|NCT02979405|Protective Agents|protective agents|mesh-ancestor
102397944|NCT01791231|Canagliflozin|canagliflozin|mesh-list
102397945|NCT01791231|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101869306|NCT01141036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102397946|NCT01791231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397947|NCT01791231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102397948|NCT01791231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397949|NCT01791309|Panitumumab|panitumumab|mesh-list
102397950|NCT01791309|Vemurafenib|vemurafenib|mesh-list
102397951|NCT01791309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102397952|NCT01791309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102397953|NCT01791309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102397954|NCT01791309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102397955|NCT01791309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397956|NCT00329433|Heparin|heparin|mesh-list
102397957|NCT00329433|Desirudin|desirudin|mesh-list
102397958|NCT00329433|Anticoagulants|anticoagulants|mesh-ancestor
102397959|NCT00329433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102397960|NCT00329433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102397961|NCT00329433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397962|NCT03105960|Chlorhexidine|chlorhexidine|mesh-list
102397963|NCT03105960|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102397964|NCT03105960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102397965|NCT03105960|Disinfectants|disinfectants|mesh-ancestor
102397966|NCT02389842|Palbociclib|palbociclib|mesh-list
102397967|NCT02389842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102397968|NCT02389842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102397969|NCT02389842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102397970|NCT02389842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397971|NCT04932096|Melatonin|melatonin|mesh-list
102397972|NCT04932096|Antioxidants|antioxidants|mesh-ancestor
102397973|NCT04932096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397974|NCT04932096|Protective Agents|protective agents|mesh-ancestor
102397975|NCT04932096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397976|NCT04932096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102397977|NCT00289653|Nicotine|nicotine|mesh-list
102209645|NCT05047094|Pembrolizumab|pembrolizumab|mesh-list
102397978|NCT00289653|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102397979|NCT00289653|Autonomic Agents|autonomic agents|mesh-ancestor
102397980|NCT00289653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102397981|NCT00289653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397982|NCT00289653|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102397983|NCT00289653|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102397984|NCT00289653|Cholinergic Agents|cholinergic agents|mesh-ancestor
102397985|NCT00289653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102397986|NCT00289653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397987|NCT00291135|Letrozole|letrozole|mesh-list
102397988|NCT00291135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102397989|NCT00291135|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102397990|NCT00291135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102397991|NCT00291135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101869505|NCT03965637|Vitamins|vitamins|mesh-ancestor
102397992|NCT00291135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102397993|NCT00291135|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102397994|NCT00291135|Hormone Antagonists|hormone antagonists|mesh-ancestor
102397995|NCT00291135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102397996|NCT00291135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102397997|NCT02103855|Abatacept|abatacept|mesh-list
102397998|NCT02103855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102397999|NCT02103855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398000|NCT02103855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102398001|NCT02103855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102398002|NCT02103855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102398003|NCT02103855|Immunologic Factors|immunologic factors|mesh-ancestor
102398004|NCT02103855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398005|NCT02103855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102398006|NCT03706053|Midodrine|midodrine|mesh-list
102398007|NCT03706053|Sympathomimetics|sympathomimetics|mesh-ancestor
102398008|NCT03706053|Autonomic Agents|autonomic agents|mesh-ancestor
102398009|NCT03706053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102398010|NCT03706053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398011|NCT03706053|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102398012|NCT03706053|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102398013|NCT03706053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102398014|NCT03706053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102398015|NCT03706053|Adrenergic Agents|adrenergic agents|mesh-ancestor
102398016|NCT03706053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102398017|NCT03706053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398018|NCT01504841|Etravirine|etravirine|mesh-list
101869624|NCT00113295|Serotonin Agents|serotonin agents|mesh-ancestor
102398019|NCT01504841|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102398020|NCT01504841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102398021|NCT01504841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102398022|NCT01504841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398023|NCT01504841|Antiviral Agents|antiviral agents|mesh-ancestor
102398024|NCT01504841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102398025|NCT00330915|Pemetrexed|pemetrexed|mesh-list
102398026|NCT00330915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102398027|NCT00330915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102398028|NCT00330915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398029|NCT00330915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102398030|NCT00330915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102398031|NCT03026933|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102398032|NCT03026933|Calcium|calcium|mesh-list
102398033|NCT03026933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102398034|NCT03026933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398035|NCT03026933|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102398036|NCT03026933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102398037|NCT03026933|Antimetabolites|antimetabolites|mesh-ancestor
102398038|NCT03026933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398039|NCT03026933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102398040|NCT03026933|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102398041|NCT03026933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102398042|NCT01502423|Adalimumab|adalimumab|mesh-list
102398043|NCT01502423|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102398044|NCT01502423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102398045|NCT01502423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102398046|NCT04861584|Gemcitabine|gemcitabine|mesh-list
102398047|NCT04861584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102398048|NCT04861584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102398049|NCT04861584|Antimetabolites|antimetabolites|mesh-ancestor
101869726|NCT01588925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102398050|NCT04861584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398051|NCT02388750|Palonosetron|palonosetron|mesh-list
102398052|NCT02388750|Antiemetics|antiemetics|mesh-ancestor
102398053|NCT02388750|Autonomic Agents|autonomic agents|mesh-ancestor
102398054|NCT02388750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102398055|NCT02388750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398056|NCT02388750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101869794|NCT01141972|Vitamin D|vitamin d|mesh-list
102398057|NCT02388750|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102398058|NCT02388750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102398059|NCT02388750|Serotonin Agents|serotonin agents|mesh-ancestor
102398060|NCT02388750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102398061|NCT02388750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398062|NCT02388594|Cyclophosphamide|cyclophosphamide|mesh-list
102398063|NCT02388594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102398064|NCT02388594|Immunologic Factors|immunologic factors|mesh-ancestor
102398065|NCT02388594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398066|NCT02388594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102398067|NCT02388594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102398068|NCT02388594|Alkylating Agents|alkylating agents|mesh-ancestor
102398069|NCT02388594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398070|NCT02388594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102398071|NCT02388594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102398072|NCT01500317|Oxycodone|oxycodone|mesh-list
102398073|NCT01500317|Tapentadol|tapentadol|mesh-list
102398074|NCT01500317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102398075|NCT01500317|Narcotics|narcotics|mesh-ancestor
102398076|NCT01500317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102398077|NCT01500317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398078|NCT01500317|Analgesics|analgesics|mesh-ancestor
102398079|NCT01500317|Sensory System Agents|sensory system agents|mesh-ancestor
102398080|NCT01500317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102398081|NCT01500317|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102398082|NCT01500317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102398083|NCT01500317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102398084|NCT01500317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398085|NCT01500317|Adrenergic Agents|adrenergic agents|mesh-ancestor
102398086|NCT01500317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102398087|NCT02379546|Desflurane|desflurane|mesh-list
102398088|NCT02379546|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102398089|NCT02379546|Anesthetics, General|anesthetics, general|mesh-ancestor
102398090|NCT02379546|Anesthetics|anesthetics|mesh-ancestor
102398091|NCT02379546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102398092|NCT02379546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398093|NCT00332163|Irinotecan|irinotecan|mesh-list
102398094|NCT00332163|Panitumumab|panitumumab|mesh-list
102398095|NCT00332163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102398096|NCT00332163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102398097|NCT00332163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101870125|NCT03530800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102398098|NCT00332163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398099|NCT00332163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102398100|NCT00332163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102398101|NCT02379000|Triamcinolone|triamcinolone|mesh-list
102398102|NCT02379000|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102398103|NCT02379000|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102398104|NCT02379000|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102398105|NCT02379000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102398106|NCT02379000|Glucocorticoids|glucocorticoids|mesh-ancestor
102398107|NCT02379000|Hormones|hormones|mesh-ancestor
102398108|NCT02379000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102398109|NCT02379000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688428|NCT00647634|GABA Agents|gaba agents|mesh-ancestor
102398110|NCT02379000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102398111|NCT02379000|Immunologic Factors|immunologic factors|mesh-ancestor
102398112|NCT02379000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102398113|NCT02379000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398114|NCT00333177|Risperidone|risperidone|mesh-list
102398115|NCT00333177|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102398116|NCT00333177|Serotonin Agents|serotonin agents|mesh-ancestor
102398117|NCT00333177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102398118|NCT00333177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398119|NCT00333177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398120|NCT00333177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102398121|NCT00333177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102398122|NCT00333177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102398123|NCT00333177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102398124|NCT00333177|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102398125|NCT00333177|Dopamine Agents|dopamine agents|mesh-ancestor
102398126|NCT02379156|Midodrine|midodrine|mesh-list
102398127|NCT02379156|Sympathomimetics|sympathomimetics|mesh-ancestor
102398128|NCT02379156|Autonomic Agents|autonomic agents|mesh-ancestor
101870467|NCT01251484|Nintedanib|nintedanib|mesh-list
102398129|NCT02379156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102398130|NCT02379156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398131|NCT02379156|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102398132|NCT02379156|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102398133|NCT02379156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102398134|NCT02379156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102398135|NCT02379156|Adrenergic Agents|adrenergic agents|mesh-ancestor
102398136|NCT02379156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102398137|NCT02379156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398138|NCT00335283|Lansoprazole|lansoprazole|mesh-list
102398139|NCT00335283|Dexlansoprazole|dexlansoprazole|mesh-list
102398140|NCT00335283|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102398141|NCT00335283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102398142|NCT00335283|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102398143|NCT00335283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102398144|NCT00335283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398145|NCT01500083|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102398146|NCT01500083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102398147|NCT01500083|Alkylating Agents|alkylating agents|mesh-ancestor
102398148|NCT01500083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398149|NCT01500083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102398150|NCT02779257|Diazoxide|diazoxide|mesh-list
102398151|NCT02779257|Pasireotide|pasireotide|mesh-list
102398152|NCT02779257|Hormones|hormones|mesh-ancestor
102398153|NCT02779257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102398154|NCT02779257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398155|NCT02779257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101870810|NCT03909646|Fluorouracil|fluorouracil|mesh-list
102398156|NCT02779257|Vasodilator Agents|vasodilator agents|mesh-ancestor
102398157|NCT00295503|Bevacizumab|bevacizumab|mesh-list
102398158|NCT00295503|Pemetrexed|pemetrexed|mesh-list
102398159|NCT00295503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102398160|NCT00295503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102398161|NCT00295503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101870879|NCT03908944|Narcotics|narcotics|mesh-ancestor
102398162|NCT00295503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102398163|NCT00295503|Growth Substances|growth substances|mesh-ancestor
102398164|NCT00295503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398165|NCT00295503|Growth Inhibitors|growth inhibitors|mesh-ancestor
102398166|NCT00295503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102398167|NCT00295503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398168|NCT00295503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101870946|NCT01257490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102398169|NCT00295503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102398170|NCT02371590|Lenalidomide|lenalidomide|mesh-list
102398171|NCT02371590|Obinutuzumab|obinutuzumab|mesh-list
102398172|NCT02371590|Immunologic Factors|immunologic factors|mesh-ancestor
102398173|NCT02371590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398174|NCT02371590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102398175|NCT02371590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101871013|NCT03896074|Bevacizumab|bevacizumab|mesh-list
102398176|NCT02371590|Growth Substances|growth substances|mesh-ancestor
102398177|NCT02371590|Growth Inhibitors|growth inhibitors|mesh-ancestor
102398178|NCT02371590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102398179|NCT02371590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102398180|NCT00298155|Ketoconazole|ketoconazole|mesh-list
102398181|NCT00298155|Goserelin|goserelin|mesh-list
102398182|NCT00298155|Bicalutamide|bicalutamide|mesh-list
102398183|NCT00298155|Dutasteride|dutasteride|mesh-list
102398184|NCT00298155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102398185|NCT00298155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102398186|NCT00298155|Antifungal Agents|antifungal agents|mesh-ancestor
102398187|NCT00298155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102398188|NCT00298155|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102398189|NCT00298155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102398190|NCT00298155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102398191|NCT00298155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398192|NCT00298155|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102398193|NCT00298155|Hormone Antagonists|hormone antagonists|mesh-ancestor
101871298|NCT01152346|Antimetabolites|antimetabolites|mesh-ancestor
102398194|NCT00298155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102398195|NCT00298155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398196|NCT00298155|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102398197|NCT00298155|Androgen Antagonists|androgen antagonists|mesh-ancestor
102398198|NCT00298155|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102398199|NCT01499849|Dexamethasone|dexamethasone|mesh-list
102398200|NCT01499849|Granisetron|granisetron|mesh-list
102398201|NCT01499849|Rolapitant|rolapitant|mesh-list
102398202|NCT01499849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102398203|NCT01499849|Antiemetics|antiemetics|mesh-ancestor
102398204|NCT01499849|Autonomic Agents|autonomic agents|mesh-ancestor
102398205|NCT01499849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102398206|NCT01499849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398207|NCT01499849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102398208|NCT01499849|Glucocorticoids|glucocorticoids|mesh-ancestor
102398209|NCT01499849|Hormones|hormones|mesh-ancestor
102398210|NCT01499849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102398211|NCT01499849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102398212|NCT01499849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102398213|NCT01499849|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102398214|NCT01499849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102398215|NCT01499849|Serotonin Agents|serotonin agents|mesh-ancestor
102398216|NCT01499849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102398217|NCT01499849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398218|NCT01499849|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102398219|NCT00298233|Oseltamivir|oseltamivir|mesh-list
102398220|NCT00298233|Antiviral Agents|antiviral agents|mesh-ancestor
102398221|NCT00298233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102398222|NCT00298233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102398223|NCT00298233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398224|NCT02376972|Rifaximin|rifaximin|mesh-list
102398225|NCT02376972|Metronidazole|metronidazole|mesh-list
102398226|NCT02376972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102398227|NCT02376972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102398228|NCT02376972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102398229|NCT02376972|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102398230|NCT02376972|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102398231|NCT02378532|Chloroquine|chloroquine|mesh-list
102398232|NCT02378532|Temozolomide|temozolomide|mesh-list
102398233|NCT02378532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102398234|NCT02378532|Alkylating Agents|alkylating agents|mesh-ancestor
101871781|NCT01157572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102398235|NCT02378532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398236|NCT02378532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102398237|NCT02378532|Amebicides|amebicides|mesh-ancestor
102398238|NCT02378532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102398239|NCT02378532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102398240|NCT02378532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102398241|NCT02378532|Antimalarials|antimalarials|mesh-ancestor
102398242|NCT02378532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102398243|NCT01498679|Fluticasone|fluticasone|mesh-list
102398244|NCT01498679|Xhance|xhance|mesh-list
102398245|NCT01498679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102398246|NCT01498679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102398247|NCT01498679|Autonomic Agents|autonomic agents|mesh-ancestor
101871920|NCT02527096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102398248|NCT01498679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102398249|NCT01498679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398250|NCT01498679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102398251|NCT01498679|Respiratory System Agents|respiratory system agents|mesh-ancestor
102398252|NCT01498679|Dermatologic Agents|dermatologic agents|mesh-ancestor
102398253|NCT01498679|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102398254|NCT01000467|Probucol|probucol|mesh-list
102398255|NCT01000467|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102398256|NCT01000467|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102398257|NCT01000467|Antimetabolites|antimetabolites|mesh-ancestor
102398258|NCT01000467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398259|NCT01000467|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102398260|NCT01000467|Antioxidants|antioxidants|mesh-ancestor
102398261|NCT01000467|Protective Agents|protective agents|mesh-ancestor
102398262|NCT01000467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398263|NCT00198315|Bleomycin|bleomycin|mesh-list
102398264|NCT00198315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102398265|NCT00198315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102398266|NCT01559389|Solifenacin Succinate|solifenacin succinate|mesh-list
102398267|NCT01559389|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102398268|NCT01559389|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102398269|NCT01559389|Cholinergic Agents|cholinergic agents|mesh-ancestor
102398270|NCT01559389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102398271|NCT01559389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398272|NCT01559389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398273|NCT01559389|Urological Agents|urological agents|mesh-ancestor
102398274|NCT01526551|Vaccines|vaccines|mesh-list
102209944|NCT00730639|Nivolumab|nivolumab|mesh-list
102398275|NCT01526551|Immunologic Factors|immunologic factors|mesh-ancestor
102398276|NCT01526551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398277|NCT04540692|Paclitaxel|paclitaxel|mesh-list
102398278|NCT04540692|Docetaxel|docetaxel|mesh-list
102398279|NCT04540692|Cyclophosphamide|cyclophosphamide|mesh-list
102398280|NCT04540692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102398281|NCT04540692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102398282|NCT04540692|Tubulin Modulators|tubulin modulators|mesh-ancestor
102398283|NCT04540692|Antimitotic Agents|antimitotic agents|mesh-ancestor
102398284|NCT04540692|Mitosis Modulators|mitosis modulators|mesh-ancestor
101872189|NCT01165294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102398285|NCT04540692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398286|NCT04540692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102398287|NCT04540692|Immunologic Factors|immunologic factors|mesh-ancestor
102398288|NCT04540692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398289|NCT04540692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102398290|NCT04540692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102398291|NCT04540692|Alkylating Agents|alkylating agents|mesh-ancestor
101872254|NCT01167478|Caffeine|caffeine|mesh-list
102398292|NCT04540692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102398293|NCT00343083|Paclitaxel|paclitaxel|mesh-list
102398294|NCT00343083|Carboplatin|carboplatin|mesh-list
102398295|NCT00343083|Cetuximab|cetuximab|mesh-list
102398296|NCT00343083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102398297|NCT00343083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102398298|NCT00343083|Tubulin Modulators|tubulin modulators|mesh-ancestor
102398299|NCT00343083|Antimitotic Agents|antimitotic agents|mesh-ancestor
102398300|NCT00343083|Mitosis Modulators|mitosis modulators|mesh-ancestor
102398301|NCT00343083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398302|NCT00343083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101872477|NCT01168492|Ketamine|ketamine|mesh-list
102398303|NCT02376426|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
102398304|NCT02376426|Antiviral Agents|antiviral agents|mesh-ancestor
102398305|NCT02376426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102398306|NCT00343785|Cyclosporine|cyclosporine|mesh-list
102398307|NCT00343785|Cyclophosphamide|cyclophosphamide|mesh-list
102398308|NCT00343785|Methotrexate|methotrexate|mesh-list
102398309|NCT00343785|Cyclosporins|cyclosporins|mesh-list
102398310|NCT00343785|Thymoglobulin|thymoglobulin|mesh-list
102398311|NCT00343785|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102398312|NCT00343785|Immunoglobulins|immunoglobulins|mesh-list
102398313|NCT00343785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102398314|NCT00343785|Immunologic Factors|immunologic factors|mesh-ancestor
102398315|NCT00343785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872601|NCT01169584|Molgramostim|molgramostim|mesh-list
102398316|NCT00343785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102398317|NCT00343785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102398318|NCT00343785|Alkylating Agents|alkylating agents|mesh-ancestor
102398319|NCT00343785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398320|NCT00343785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102398321|NCT00343785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102398322|NCT00343785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102398323|NCT00343785|Abortifacient Agents|abortifacient agents|mesh-ancestor
102398324|NCT00343785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102398325|NCT00343785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102398326|NCT00343785|Antimetabolites|antimetabolites|mesh-ancestor
102398327|NCT00343785|Dermatologic Agents|dermatologic agents|mesh-ancestor
102398328|NCT00343785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102398329|NCT00343785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102398330|NCT00343785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102398331|NCT00343785|Antifungal Agents|antifungal agents|mesh-ancestor
102398332|NCT00343785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102398333|NCT00343785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102398334|NCT00343863|Dexamethasone|dexamethasone|mesh-list
102398335|NCT00343863|Cyclophosphamide|cyclophosphamide|mesh-list
102398336|NCT00343863|Doxorubicin|doxorubicin|mesh-list
101872802|NCT01173562|Piperazine|piperazine|mesh-list
102398337|NCT00343863|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102398338|NCT00343863|Ondansetron|ondansetron|mesh-list
102398339|NCT00343863|Palonosetron|palonosetron|mesh-list
102398340|NCT00343863|Antiemetics|antiemetics|mesh-list
102398341|NCT00343863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102398342|NCT00343863|Immunologic Factors|immunologic factors|mesh-ancestor
102398343|NCT00343863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398344|NCT00343863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102398345|NCT00343863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102398346|NCT00343863|Alkylating Agents|alkylating agents|mesh-ancestor
102398347|NCT00343863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398348|NCT00343863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101872874|NCT01164046|Bemiparin|bemiparin|mesh-list
102398349|NCT00343863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102398350|NCT00343863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102398351|NCT00343863|Autonomic Agents|autonomic agents|mesh-ancestor
102398352|NCT00343863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102398353|NCT00343863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102398354|NCT00343863|Glucocorticoids|glucocorticoids|mesh-ancestor
102398355|NCT00343863|Hormones|hormones|mesh-ancestor
101872944|NCT00158262|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102398356|NCT00343863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102398357|NCT00343863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102398358|NCT00343863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102398359|NCT00343863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102398360|NCT00343863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102398361|NCT00343863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102398362|NCT00343863|Antipruritics|antipruritics|mesh-ancestor
102398363|NCT00343863|Dermatologic Agents|dermatologic agents|mesh-ancestor
102398364|NCT00343863|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102398365|NCT00343863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102398366|NCT00343863|Serotonin Agents|serotonin agents|mesh-ancestor
102398367|NCT00343863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102398368|NCT00344175|Simvastatin|simvastatin|mesh-list
102398369|NCT00344175|Pitavastatin|pitavastatin|mesh-list
102398370|NCT00344175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102398371|NCT00344175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102398372|NCT00344175|Antimetabolites|antimetabolites|mesh-ancestor
102398373|NCT00344175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398374|NCT00344175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102398375|NCT00344175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101873236|NCT01178320|Vitamins|vitamins|mesh-ancestor
102398376|NCT00344175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102398377|NCT00345033|Aripiprazole|aripiprazole|mesh-list
102398378|NCT00345033|Antidepressive Agents|antidepressive agents|mesh-ancestor
102398379|NCT00345033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102398380|NCT00345033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102398381|NCT00345033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102398382|NCT00345033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102398383|NCT00345033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398384|NCT00345033|Dopamine Agonists|dopamine agonists|mesh-ancestor
102398385|NCT00345033|Dopamine Agents|dopamine agents|mesh-ancestor
102398386|NCT00345033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102398387|NCT00345033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398388|NCT00345033|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101873367|NCT01077648|Trastuzumab|trastuzumab|mesh-list
102398389|NCT00345033|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102398390|NCT00345033|Serotonin Agents|serotonin agents|mesh-ancestor
102398391|NCT00345033|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102398392|NCT00345033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102398393|NCT00345033|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101873441|NCT01179412|Iodine|iodine|mesh-list
102398394|NCT00345033|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102398395|NCT00345969|Testosterone|testosterone|mesh-list
102398396|NCT00345969|Androgens|androgens|mesh-ancestor
102398397|NCT00345969|Hormones|hormones|mesh-ancestor
102398398|NCT00345969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102398399|NCT00345969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398400|NCT01498445|Decitabine|decitabine|mesh-list
102398401|NCT01498445|Dasatinib|dasatinib|mesh-list
102398402|NCT01498445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102398403|NCT01498445|Antimetabolites|antimetabolites|mesh-ancestor
102398404|NCT01498445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398405|NCT01498445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102398406|NCT01498445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102398407|NCT01498445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102398408|NCT01525615|Tiotropium Bromide|tiotropium bromide|mesh-list
102398409|NCT01525615|Olodaterol|olodaterol|mesh-list
102398410|NCT01525615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102398411|NCT01525615|Autonomic Agents|autonomic agents|mesh-ancestor
102398412|NCT01525615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102398413|NCT01525615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398414|NCT01525615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102398415|NCT01525615|Respiratory System Agents|respiratory system agents|mesh-ancestor
102398416|NCT01525615|Parasympatholytics|parasympatholytics|mesh-ancestor
102398417|NCT01525615|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102398418|NCT01525615|Cholinergic Agents|cholinergic agents|mesh-ancestor
102398419|NCT01525615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102398420|NCT01525615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398421|NCT00309465|Insulin|insulin|mesh-list
102398422|NCT00309465|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102398423|NCT00309465|Insulin Glargine|insulin glargine|mesh-list
102398424|NCT00309465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102398425|NCT00309465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398426|NCT01791699|Moxonidine|moxonidine|mesh-list
102398427|NCT01791699|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102398429|NCT00302133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102398430|NCT00302133|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102398431|NCT00302133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398432|NCT00302133|Sensory System Agents|sensory system agents|mesh-ancestor
102398433|NCT00302133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102398434|NCT01525225|Metformin|metformin|mesh-list
102398435|NCT01525225|Saxagliptin|saxagliptin|mesh-list
102398436|NCT01525225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102398437|NCT01525225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398438|NCT01525225|Incretins|incretins|mesh-ancestor
102398439|NCT01525225|Hormones|hormones|mesh-ancestor
102398440|NCT01525225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102398441|NCT01525225|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102398442|NCT01525225|Protease Inhibitors|protease inhibitors|mesh-ancestor
102398443|NCT01525225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102398444|NCT01525225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398445|NCT00304161|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102398446|NCT00304161|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102398447|NCT00304161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102398448|NCT00304161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102398449|NCT00304161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398450|NCT00304161|Adrenergic Agents|adrenergic agents|mesh-ancestor
102398451|NCT00304161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102398452|NCT00304161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398453|NCT02660580|Adalimumab|adalimumab|mesh-list
102398454|NCT02660580|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102398455|NCT02660580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102398456|NCT02660580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102398457|NCT01524991|Gemcitabine|gemcitabine|mesh-list
102398458|NCT01524991|Ipilimumab|ipilimumab|mesh-list
102398459|NCT01524991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102398460|NCT01524991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102398461|NCT01524991|Antimetabolites|antimetabolites|mesh-ancestor
102398462|NCT01524991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398463|NCT01524991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102398464|NCT01524991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102398465|NCT04039230|Talazoparib|talazoparib|mesh-list
102398466|NCT04039230|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
102398467|NCT04039230|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102398468|NCT04039230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102398469|NCT04039230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398470|NCT04039230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102398471|NCT04039230|Immunoconjugates|immunoconjugates|mesh-ancestor
102398472|NCT04039230|Immunologic Factors|immunologic factors|mesh-ancestor
102398473|NCT04039230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398474|NCT01524913|Hyaluronic Acid|hyaluronic acid|mesh-list
102398475|NCT01524913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102398476|NCT01524913|Immunologic Factors|immunologic factors|mesh-ancestor
102398477|NCT01524913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398478|NCT01524913|Viscosupplements|viscosupplements|mesh-ancestor
102398479|NCT01524913|Protective Agents|protective agents|mesh-ancestor
102398480|NCT02376192|Phenylephrine|phenylephrine|mesh-list
102398481|NCT02376192|Oxymetazoline|oxymetazoline|mesh-list
102398482|NCT02376192|Ephedrine|ephedrine|mesh-list
102398483|NCT02376192|Bupivacaine|bupivacaine|mesh-list
102398484|NCT02376192|Anesthetics, Local|anesthetics, local|mesh-ancestor
102398485|NCT02376192|Anesthetics|anesthetics|mesh-ancestor
102398486|NCT02376192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102398487|NCT02376192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874474|NCT01296802|Fenfluramine|fenfluramine|mesh-list
102398488|NCT02376192|Sensory System Agents|sensory system agents|mesh-ancestor
102398489|NCT02376192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102398490|NCT02376192|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102398491|NCT02376192|Mydriatics|mydriatics|mesh-ancestor
102398492|NCT02376192|Autonomic Agents|autonomic agents|mesh-ancestor
102398493|NCT02376192|Sympathomimetics|sympathomimetics|mesh-ancestor
102398494|NCT02376192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102398495|NCT02376192|Nasal Decongestants|nasal decongestants|mesh-ancestor
102398496|NCT02376192|Respiratory System Agents|respiratory system agents|mesh-ancestor
102398497|NCT02376192|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102398498|NCT02376192|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102398499|NCT02376192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102398500|NCT02376192|Adrenergic Agents|adrenergic agents|mesh-ancestor
101874699|NCT01193452|Vitamins|vitamins|mesh-ancestor
102210163|NCT00805805|Growth Inhibitors|growth inhibitors|mesh-ancestor
102398501|NCT02376192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102398502|NCT02376192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398503|NCT02376192|Protective Agents|protective agents|mesh-ancestor
102398504|NCT02376192|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102398505|NCT02375880|Gemcitabine|gemcitabine|mesh-list
102398506|NCT02375880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102398507|NCT02375880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102398508|NCT02375880|Antimetabolites|antimetabolites|mesh-ancestor
102398509|NCT02375880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398510|NCT01524679|Interferons|interferons|mesh-list
102398511|NCT01524679|Interferon-alpha|interferon-alpha|mesh-list
102398512|NCT01524679|Interferon alpha-2|interferon alpha-2|mesh-list
102398513|NCT01524679|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102398514|NCT01524679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102398515|NCT01524679|Antiviral Agents|antiviral agents|mesh-ancestor
102398516|NCT01524679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102398517|NCT01524679|Immunologic Factors|immunologic factors|mesh-ancestor
102398518|NCT01524679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398519|NCT02365272|Amikacin|amikacin|mesh-list
102398520|NCT02365272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102398521|NCT02365272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102398522|NCT02369250|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102398523|NCT02369250|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102398524|NCT02369250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102398525|NCT02369250|Antimetabolites|antimetabolites|mesh-ancestor
102398526|NCT02369250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398527|NCT02369250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102398528|NCT02369250|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102398529|NCT02369250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102398530|NCT04645602|Pembrolizumab|pembrolizumab|mesh-list
102398531|NCT04645602|Lenvatinib|lenvatinib|mesh-list
102398532|NCT04645602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101874810|NCT03844360|Imatinib Mesylate|imatinib mesylate|mesh-list
102398533|NCT04645602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102398534|NCT04645602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102398535|NCT04645602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398536|NCT04645602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102398537|NCT04645602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102398538|NCT01880541|Anesthetics|anesthetics|mesh-list
102398539|NCT01880541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102398540|NCT01880541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398541|NCT02368860|Capecitabine|capecitabine|mesh-list
102398542|NCT02368860|Oxaliplatin|oxaliplatin|mesh-list
102398543|NCT02368860|Irinotecan|irinotecan|mesh-list
102398544|NCT02368860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102398545|NCT02368860|Antimetabolites|antimetabolites|mesh-ancestor
102398546|NCT02368860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398547|NCT02368860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102398548|NCT02368860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102398549|NCT02368860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102398550|NCT02368860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102398551|NCT02375646|Heparin|heparin|mesh-list
102398552|NCT02375646|Enoxaparin|enoxaparin|mesh-list
102398553|NCT02375646|Warfarin|warfarin|mesh-list
102398554|NCT02375646|Anticoagulants|anticoagulants|mesh-ancestor
102398555|NCT02375646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102398556|NCT02375646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102398557|NCT02375646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398558|NCT01524289|Anacetrapib|anacetrapib|mesh-list
102398559|NCT01524289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102398560|NCT01524289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102398561|NCT01524289|Antimetabolites|antimetabolites|mesh-ancestor
102398562|NCT01524289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398563|NCT01524289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102398564|NCT01498289|Leucovorin|leucovorin|mesh-list
102398565|NCT01498289|Docetaxel|docetaxel|mesh-list
102398566|NCT01498289|Fluorouracil|fluorouracil|mesh-list
102398567|NCT01498289|Oxaliplatin|oxaliplatin|mesh-list
102398568|NCT01498289|Irinotecan|irinotecan|mesh-list
102398569|NCT01498289|Calcium|calcium|mesh-list
102398570|NCT01498289|Levoleucovorin|levoleucovorin|mesh-list
102398571|NCT01498289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102398572|NCT01498289|Tubulin Modulators|tubulin modulators|mesh-ancestor
102398573|NCT01498289|Antimitotic Agents|antimitotic agents|mesh-ancestor
102398574|NCT01498289|Mitosis Modulators|mitosis modulators|mesh-ancestor
102398575|NCT01498289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398576|NCT01498289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102398577|NCT01498289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398578|NCT01498289|Antimetabolites|antimetabolites|mesh-ancestor
102398579|NCT01498289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102398580|NCT01498289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102398581|NCT01498289|Immunologic Factors|immunologic factors|mesh-ancestor
102398582|NCT01498289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102398583|NCT01498289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102398584|NCT01498289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102398585|NCT01498289|Antidotes|antidotes|mesh-ancestor
102398586|NCT01498289|Protective Agents|protective agents|mesh-ancestor
102398587|NCT01498289|Vitamin B Complex|vitamin b complex|mesh-ancestor
102398588|NCT01498289|Vitamins|vitamins|mesh-ancestor
102398589|NCT01498289|Micronutrients|micronutrients|mesh-ancestor
102398590|NCT02364882|Sildenafil Citrate|sildenafil citrate|mesh-list
102398591|NCT02364882|Vasodilator Agents|vasodilator agents|mesh-ancestor
102398592|NCT02364882|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102398593|NCT02364882|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102398594|NCT02364882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102398595|NCT02364882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398596|NCT02364882|Urological Agents|urological agents|mesh-ancestor
102398597|NCT02364804|Aprepitant|aprepitant|mesh-list
102398598|NCT02364804|Antiemetics|antiemetics|mesh-ancestor
102398599|NCT02364804|Autonomic Agents|autonomic agents|mesh-ancestor
102398600|NCT02364804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102398601|NCT02364804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398602|NCT02364804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101875186|NCT01204138|Apremilast|apremilast|mesh-list
102398603|NCT02364804|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102398604|NCT02364804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102398605|NCT02364804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398606|NCT01524133|Sertraline|sertraline|mesh-list
102398607|NCT01524133|Antidepressive Agents|antidepressive agents|mesh-ancestor
102398608|NCT01524133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102398609|NCT01524133|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102398610|NCT01524133|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102398611|NCT01524133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102398612|NCT01524133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398613|NCT01524133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102398614|NCT01524133|Serotonin Agents|serotonin agents|mesh-ancestor
102398615|NCT01524133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398616|NCT02368470|Gemifloxacin|gemifloxacin|mesh-list
102398617|NCT02368470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102398618|NCT02368470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102398619|NCT02368470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102398620|NCT02368470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398621|NCT02368470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102398622|NCT02368470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102398623|NCT02368470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101875389|NCT05667376|Analgesics|analgesics|mesh-ancestor
102398624|NCT04561206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102398625|NCT04561206|Nivolumab|nivolumab|mesh-list
102398626|NCT04561206|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102398627|NCT04561206|Antibodies|antibodies|mesh-list
102398628|NCT04561206|Immunoglobulins|immunoglobulins|mesh-list
102398629|NCT04561206|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102398630|NCT04561206|Immunoconjugates|immunoconjugates|mesh-list
102398631|NCT04561206|Immunologic Factors|immunologic factors|mesh-ancestor
102398632|NCT04561206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398633|NCT04561206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101875482|NCT03819010|Letrozole|letrozole|mesh-list
102398634|NCT04561206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102398635|NCT04561206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398636|NCT04561206|Immunotoxins|immunotoxins|mesh-ancestor
102398637|NCT04110301|Lenalidomide|lenalidomide|mesh-list
102398638|NCT04110301|Antibodies|antibodies|mesh-list
102398639|NCT04110301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102398640|NCT04110301|Immunologic Factors|immunologic factors|mesh-ancestor
102398641|NCT04110301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398642|NCT04110301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102398643|NCT04110301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102398644|NCT04110301|Growth Substances|growth substances|mesh-ancestor
102398645|NCT04110301|Growth Inhibitors|growth inhibitors|mesh-ancestor
102398646|NCT04110301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102398647|NCT05800587|Paclitaxel|paclitaxel|mesh-list
102398648|NCT05800587|Etoposide|etoposide|mesh-list
102398649|NCT05800587|Docetaxel|docetaxel|mesh-list
102398650|NCT05800587|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102398651|NCT05800587|Carboplatin|carboplatin|mesh-list
102210316|NCT02812667|Nivolumab|nivolumab|mesh-list
102398652|NCT05800587|Gemcitabine|gemcitabine|mesh-list
102398653|NCT05800587|Irinotecan|irinotecan|mesh-list
102398654|NCT05800587|Pemetrexed|pemetrexed|mesh-list
102398655|NCT05800587|Topotecan|topotecan|mesh-list
102398656|NCT05800587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102398657|NCT05800587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102398658|NCT05800587|Tubulin Modulators|tubulin modulators|mesh-ancestor
102398659|NCT05800587|Antimitotic Agents|antimitotic agents|mesh-ancestor
102398660|NCT05800587|Mitosis Modulators|mitosis modulators|mesh-ancestor
102398661|NCT05800587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398662|NCT05800587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102398663|NCT05800587|Antimetabolites|antimetabolites|mesh-ancestor
102398664|NCT05800587|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102398665|NCT05800587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102398666|NCT05800587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102398667|NCT05800587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101875655|NCT01206946|Hormones|hormones|mesh-ancestor
102398668|NCT05800587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102398669|NCT05800587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102398670|NCT05800418|Ramucirumab|ramucirumab|mesh-list
102398671|NCT05800418|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102398672|NCT05800418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102398673|NCT05800418|Immunologic Factors|immunologic factors|mesh-ancestor
102398674|NCT05800418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398675|NCT05800366|Prednisone|prednisone|mesh-list
102398676|NCT05800366|Methylprednisolone|methylprednisolone|mesh-list
102398677|NCT05800366|Prednisolone|prednisolone|mesh-list
102398678|NCT05800366|Cyclophosphamide|cyclophosphamide|mesh-list
102398679|NCT05800366|Rituximab|rituximab|mesh-list
102398680|NCT05800366|Doxorubicin|doxorubicin|mesh-list
102398681|NCT05800366|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102398682|NCT05800366|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
102398683|NCT05800366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102398684|NCT05800366|Immunologic Factors|immunologic factors|mesh-ancestor
102398685|NCT05800366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398686|NCT05800366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102398687|NCT05800366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102398688|NCT05800366|Alkylating Agents|alkylating agents|mesh-ancestor
102398689|NCT05800366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398690|NCT05800366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102398691|NCT05800366|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102398692|NCT05800366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102398693|NCT05800366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102398694|NCT05800366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102398695|NCT05800366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102398696|NCT05800366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102398697|NCT05800366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102398698|NCT05800366|Glucocorticoids|glucocorticoids|mesh-ancestor
102398699|NCT05800366|Hormones|hormones|mesh-ancestor
102398700|NCT05800366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102398701|NCT05800366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102398702|NCT05800366|Antiemetics|antiemetics|mesh-ancestor
102398703|NCT05800366|Autonomic Agents|autonomic agents|mesh-ancestor
102398704|NCT05800366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102398705|NCT05800366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102398706|NCT05800366|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102398707|NCT05800366|Protective Agents|protective agents|mesh-ancestor
102398708|NCT05800366|Immunoconjugates|immunoconjugates|mesh-ancestor
102398709|NCT05800340|Paclitaxel|paclitaxel|mesh-list
102398710|NCT05800340|Carboplatin|carboplatin|mesh-list
102398711|NCT05800340|Pemetrexed|pemetrexed|mesh-list
102398712|NCT05800340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102398713|NCT05800340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102398714|NCT05800340|Tubulin Modulators|tubulin modulators|mesh-ancestor
102398715|NCT05800340|Antimitotic Agents|antimitotic agents|mesh-ancestor
102398716|NCT05800340|Mitosis Modulators|mitosis modulators|mesh-ancestor
102398717|NCT05800340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398718|NCT05800340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102398719|NCT05800340|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102398720|NCT05800340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102398721|NCT05800301|Neurotransmitter Agents|neurotransmitter agents|mesh-list
102398722|NCT05800301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398723|NCT05800301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398724|NCT05800288|Propofol|propofol|mesh-list
102398725|NCT05800288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102398726|NCT05800288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102398727|NCT05800288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398728|NCT05800288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102398729|NCT05800288|Anesthetics, General|anesthetics, general|mesh-ancestor
102398730|NCT05800288|Anesthetics|anesthetics|mesh-ancestor
102398746|NCT05800054|Antimitotic Agents|antimitotic agents|mesh-ancestor
102398747|NCT05800054|Mitosis Modulators|mitosis modulators|mesh-ancestor
102398748|NCT05800054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398749|NCT05800041|Cyclophosphamide|cyclophosphamide|mesh-list
102398750|NCT05800041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102398751|NCT05800041|Immunologic Factors|immunologic factors|mesh-ancestor
102398752|NCT05800041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398753|NCT05800041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102398754|NCT05800041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102398755|NCT05800041|Alkylating Agents|alkylating agents|mesh-ancestor
102398756|NCT05800041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398757|NCT05800041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102398758|NCT05800041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102398759|NCT05799924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101875954|NCT05030818|Aspirin|aspirin|mesh-list
102398760|NCT05799924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
102398761|NCT05799924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102398762|NCT05799924|Analgesics|analgesics|mesh-ancestor
102398763|NCT05799924|Sensory System Agents|sensory system agents|mesh-ancestor
102398764|NCT05799924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102398765|NCT05799924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398766|NCT05799924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102398767|NCT05799729|Ketamine|ketamine|mesh-list
102398768|NCT05799729|Analgesics|analgesics|mesh-ancestor
102398769|NCT05799729|Sensory System Agents|sensory system agents|mesh-ancestor
102398770|NCT05799729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102398771|NCT05799729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398772|NCT05799729|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102398773|NCT05799729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102398774|NCT05799729|Anesthetics, General|anesthetics, general|mesh-ancestor
102398775|NCT05799729|Anesthetics|anesthetics|mesh-ancestor
102398776|NCT05799729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102398777|NCT05799729|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102398778|NCT05799729|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102398779|NCT05799729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102398780|NCT05799729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398796|NCT05799469|Cisplatin|cisplatin|mesh-list
102398797|NCT05799469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102398798|NCT05799443|Irinotecan|irinotecan|mesh-list
102398799|NCT05799443|Cetuximab|cetuximab|mesh-list
102398800|NCT05799443|Tislelizumab|tislelizumab|mesh-list
102398801|NCT05799443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102398802|NCT05799443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102398803|NCT05799443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102398804|NCT05799443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210470|NCT00873275|Vitamins|vitamins|mesh-ancestor
102398805|NCT05799443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102398806|NCT05799443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102398807|NCT05799300|Anesthetics|anesthetics|mesh-list
102398808|NCT05799300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102398809|NCT05799300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398810|NCT05799105|Omeprazole|omeprazole|mesh-list
102398811|NCT05799105|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102398812|NCT05799105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102398813|NCT05799105|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102398814|NCT05799105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102398815|NCT05799105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398816|NCT05799053|Peppermint oil|peppermint oil|mesh-list
102398817|NCT05799053|Antiemetics|antiemetics|mesh-ancestor
102398818|NCT05799053|Autonomic Agents|autonomic agents|mesh-ancestor
102398819|NCT05799053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102398820|NCT05799053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398821|NCT05799053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102398822|NCT05799053|Parasympatholytics|parasympatholytics|mesh-ancestor
102398823|NCT05798936|Ethanol|ethanol|mesh-list
102398824|NCT05798936|Polidocanol|polidocanol|mesh-list
102398825|NCT05798936|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102398826|NCT05798936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102398827|NCT05798936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102398828|NCT05798936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398829|NCT05798936|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102398830|NCT05798936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102398831|NCT05798871|Erythritol|erythritol|mesh-list
102398832|NCT05798871|Vasodilator Agents|vasodilator agents|mesh-ancestor
102398833|NCT05798819|Paclitaxel|paclitaxel|mesh-list
102398834|NCT05798819|Bevacizumab|bevacizumab|mesh-list
102398835|NCT05798819|Carboplatin|carboplatin|mesh-list
102398836|NCT05798819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102398837|NCT05798819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102398838|NCT05798819|Tubulin Modulators|tubulin modulators|mesh-ancestor
102398839|NCT05798819|Antimitotic Agents|antimitotic agents|mesh-ancestor
102398840|NCT05798819|Mitosis Modulators|mitosis modulators|mesh-ancestor
102398841|NCT05798819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398842|NCT05798819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102398843|NCT05798819|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102398844|NCT05798819|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102398845|NCT05798819|Growth Substances|growth substances|mesh-ancestor
102398846|NCT05798819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398847|NCT05798819|Growth Inhibitors|growth inhibitors|mesh-ancestor
102398848|NCT05798728|Misoprostol|misoprostol|mesh-list
102398849|NCT05798728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102398850|NCT05798728|Abortifacient Agents|abortifacient agents|mesh-ancestor
102398851|NCT05798728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102398852|NCT05798728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398853|NCT05798728|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102398854|NCT05798728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102398855|NCT05798728|Oxytocics|oxytocics|mesh-ancestor
102398856|NCT05798715|Metformin|metformin|mesh-list
102398857|NCT05798715|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102398858|NCT05798715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102398859|NCT05798715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398860|NCT05798715|Incretins|incretins|mesh-ancestor
102398861|NCT05798715|Hormones|hormones|mesh-ancestor
102398862|NCT05798715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102398863|NCT05798715|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102398864|NCT05798715|Protease Inhibitors|protease inhibitors|mesh-ancestor
102398865|NCT05798715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102398866|NCT05798715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398867|NCT05796167|Pimavanserin|pimavanserin|mesh-list
102398868|NCT05796167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102398869|NCT05796167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102398870|NCT05796167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102398871|NCT05796167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102398872|NCT05796167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102398873|NCT05796167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398874|NCT05796167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102398875|NCT05796167|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102398876|NCT05796167|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102398877|NCT05796167|Serotonin Agents|serotonin agents|mesh-ancestor
102398878|NCT05796167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102398879|NCT05796167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398881|NCT05795491|Antifungal Agents|antifungal agents|mesh-list
102398882|NCT05795491|Clotrimazole|clotrimazole|mesh-list
102398883|NCT05795491|Miconazole|miconazole|mesh-list
102398884|NCT05795491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102398885|NCT05795491|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101876289|NCT04246762|Midazolam|midazolam|mesh-list
102398886|NCT05795491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102398887|NCT05795491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102398888|NCT05795491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398889|NCT05795491|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102398890|NCT05795491|Hormone Antagonists|hormone antagonists|mesh-ancestor
102398891|NCT05795491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102398892|NCT05795491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398893|NCT05795491|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102398894|NCT05795491|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102398895|NCT05795491|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102398896|NCT05795491|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102398897|NCT05788627|Lactulose|lactulose|mesh-list
102398898|NCT05788627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102398899|NCT05777135|Propofol|propofol|mesh-list
102398900|NCT05777135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102398901|NCT05777135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102398902|NCT05777135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398903|NCT05777135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102398904|NCT05777135|Anesthetics, General|anesthetics, general|mesh-ancestor
102398905|NCT05777135|Anesthetics|anesthetics|mesh-ancestor
102398906|NCT05771883|Lenalidomide|lenalidomide|mesh-list
102398907|NCT05771883|Immunologic Factors|immunologic factors|mesh-ancestor
102398908|NCT05771883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398909|NCT05771883|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102398910|NCT05771883|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102398911|NCT05771883|Growth Substances|growth substances|mesh-ancestor
102398912|NCT05771883|Growth Inhibitors|growth inhibitors|mesh-ancestor
102398913|NCT05771883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102398914|NCT05767892|Carboplatin|carboplatin|mesh-list
102398915|NCT05767892|Pemetrexed|pemetrexed|mesh-list
102398916|NCT05767892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102398917|NCT05767892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102398918|NCT05767892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398919|NCT05767892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102398920|NCT05767892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102398921|NCT05730816|Magnesium Sulfate|magnesium sulfate|mesh-list
102398922|NCT05730816|Analgesics|analgesics|mesh-ancestor
102398923|NCT05730816|Sensory System Agents|sensory system agents|mesh-ancestor
102398924|NCT05730816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102398925|NCT05730816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398926|NCT05730816|Anesthetics|anesthetics|mesh-ancestor
102398927|NCT05730816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102398928|NCT05730816|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102398929|NCT05730816|Anticonvulsants|anticonvulsants|mesh-ancestor
102398930|NCT05730816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102398931|NCT05730816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102398932|NCT05730816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398933|NCT05730816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102398934|NCT05730816|Tocolytic Agents|tocolytic agents|mesh-ancestor
101876547|NCT00143390|Exemestane|exemestane|mesh-list
102398935|NCT05730816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102398936|NCT05702333|Simendan|simendan|mesh-list
102398937|NCT05702333|Dobutamine|dobutamine|mesh-list
102398938|NCT05702333|Dopamine|dopamine|mesh-list
102398939|NCT05702333|Epinephrine|epinephrine|mesh-list
102398940|NCT05702333|Norepinephrine|norepinephrine|mesh-list
102398941|NCT05702333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102398942|NCT05702333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102398943|NCT05702333|Adrenergic Agents|adrenergic agents|mesh-ancestor
102398944|NCT05702333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102398945|NCT05702333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398946|NCT05702333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398947|NCT05702333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102398948|NCT05702333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102398949|NCT05702333|Autonomic Agents|autonomic agents|mesh-ancestor
102398950|NCT05702333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101876600|NCT03789058|Ibuprofen|ibuprofen|mesh-list
102398951|NCT05702333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102398952|NCT05702333|Respiratory System Agents|respiratory system agents|mesh-ancestor
102398953|NCT05702333|Mydriatics|mydriatics|mesh-ancestor
102398954|NCT05702333|Sympathomimetics|sympathomimetics|mesh-ancestor
102398955|NCT05702333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102398956|NCT05702333|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102398957|NCT05702333|Vasodilator Agents|vasodilator agents|mesh-ancestor
102398958|NCT05702333|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102398959|NCT05702333|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102398960|NCT05702333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102398961|NCT05702333|Protective Agents|protective agents|mesh-ancestor
102398962|NCT05702333|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102398963|NCT05702333|Dopamine Agents|dopamine agents|mesh-ancestor
102398964|NCT05671913|Ketamine|ketamine|mesh-list
102398965|NCT05671913|Analgesics|analgesics|mesh-ancestor
102398966|NCT05671913|Sensory System Agents|sensory system agents|mesh-ancestor
102398967|NCT05671913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102398968|NCT05671913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398969|NCT05671913|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102398970|NCT05671913|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102398971|NCT05671913|Anesthetics, General|anesthetics, general|mesh-ancestor
102398972|NCT05671913|Anesthetics|anesthetics|mesh-ancestor
102398973|NCT05671913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102398974|NCT05671913|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102398975|NCT05671913|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102398976|NCT05671913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102398977|NCT05671913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398978|NCT05668936|Moxifloxacin|moxifloxacin|mesh-list
102398979|NCT05668936|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102398980|NCT05668936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102398981|NCT05668936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102398982|NCT05668936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102398983|NCT05668936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102398984|NCT05668936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102398985|NCT05668936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102398986|NCT05668936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102398987|NCT05668936|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102398988|NCT05668936|Contraceptive Agents|contraceptive agents|mesh-ancestor
102398989|NCT05668936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102398990|NCT05668936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102398991|NCT05668936|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102398992|NCT05668936|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102398993|NCT05668936|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102398994|NCT05668676|Prednisone|prednisone|mesh-list
102398995|NCT05668676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102398996|NCT05668676|Glucocorticoids|glucocorticoids|mesh-ancestor
102398997|NCT05668676|Hormones|hormones|mesh-ancestor
102398998|NCT05668676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102398999|NCT05668676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399000|NCT05668676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102399001|NCT05668676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399002|NCT05657990|Tamsulosin|tamsulosin|mesh-list
102399003|NCT05657990|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102399004|NCT05657990|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102399005|NCT05657990|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102399006|NCT05657990|Adrenergic Agents|adrenergic agents|mesh-ancestor
102399007|NCT05657990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102399008|NCT05657990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399009|NCT05657990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399010|NCT05657990|Urological Agents|urological agents|mesh-ancestor
102399011|NCT05627752|Docetaxel|docetaxel|mesh-list
102399012|NCT05627752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399013|NCT05627752|Tubulin Modulators|tubulin modulators|mesh-ancestor
102399014|NCT05627752|Antimitotic Agents|antimitotic agents|mesh-ancestor
102399015|NCT05627752|Mitosis Modulators|mitosis modulators|mesh-ancestor
102399016|NCT05627752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399017|NCT05609942|Azacitidine|azacitidine|mesh-list
102399018|NCT05609942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102399019|NCT05609942|Antimetabolites|antimetabolites|mesh-ancestor
102399020|NCT05609942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399021|NCT05609942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399022|NCT05609942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102399023|NCT05590676|Metformin|metformin|mesh-list
102399024|NCT05590676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102399025|NCT05590676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399026|NCT05559814|Peppermint oil|peppermint oil|mesh-list
102399027|NCT05559814|Antiemetics|antiemetics|mesh-ancestor
102399028|NCT05559814|Autonomic Agents|autonomic agents|mesh-ancestor
102399029|NCT05559814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102399030|NCT05559814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399031|NCT05559814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102399032|NCT05559814|Parasympatholytics|parasympatholytics|mesh-ancestor
102399034|NCT05438420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102399035|NCT05438420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399036|NCT05438420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102399037|NCT05438420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399038|NCT05419466|Melatonin|melatonin|mesh-list
102399039|NCT05419466|Antioxidants|antioxidants|mesh-ancestor
102399040|NCT05419466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399041|NCT05419466|Protective Agents|protective agents|mesh-ancestor
102399042|NCT05419466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399043|NCT05419466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102399044|NCT05382481|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102399045|NCT05382481|Dalteparin|dalteparin|mesh-list
102399046|NCT05382481|Anticoagulants|anticoagulants|mesh-ancestor
102399047|NCT05382481|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102399048|NCT05382481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102399049|NCT05382481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399050|NCT05353283|Tenofovir|tenofovir|mesh-list
102399051|NCT05353283|Antiviral Agents|antiviral agents|mesh-ancestor
102399052|NCT05353283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102399053|NCT05353283|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102399054|NCT05353283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102399055|NCT05353283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102399056|NCT05353283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399057|NCT05353283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102399058|NCT05353283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102399059|NCT05323786|Anesthetics|anesthetics|mesh-list
102399060|NCT05323786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102399061|NCT05323786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399062|NCT05262387|Insulin Lispro|insulin lispro|mesh-list
102399063|NCT05262387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102399064|NCT05262387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399065|NCT05221554|Tacrine|tacrine|mesh-list
102399066|NCT05221554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102399067|NCT05221554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102399068|NCT05221554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399069|NCT05221554|Cholinergic Agents|cholinergic agents|mesh-ancestor
102399070|NCT05221554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102399071|NCT05221554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399072|NCT05221554|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102399073|NCT05221554|Autonomic Agents|autonomic agents|mesh-ancestor
102399074|NCT05221554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102399075|NCT05221554|Nootropic Agents|nootropic agents|mesh-ancestor
102399076|NCT05162937|Antibodies|antibodies|mesh-list
102399077|NCT05162937|Immunologic Factors|immunologic factors|mesh-ancestor
102399078|NCT05162937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399079|NCT04985500|Bupivacaine|bupivacaine|mesh-list
102399080|NCT04985500|Anesthetics, Local|anesthetics, local|mesh-ancestor
102399081|NCT04985500|Anesthetics|anesthetics|mesh-ancestor
102399082|NCT04985500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102399083|NCT04985500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399084|NCT04985500|Sensory System Agents|sensory system agents|mesh-ancestor
102399085|NCT04985500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102399086|NCT04973670|Sivelestat|sivelestat|mesh-list
102399087|NCT04973670|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102399088|NCT04973670|Protease Inhibitors|protease inhibitors|mesh-ancestor
102399089|NCT04973670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102399090|NCT04973670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399091|NCT04967248|Fulvestrant|fulvestrant|mesh-list
102399092|NCT04967248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102399093|NCT04967248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399094|NCT04967248|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102399095|NCT04967248|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102399096|NCT04967248|Hormone Antagonists|hormone antagonists|mesh-ancestor
102399097|NCT04967248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101876903|NCT01307488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102399098|NCT04967248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399099|NCT04929626|Magnesium Sulfate|magnesium sulfate|mesh-list
102399100|NCT04929626|Albuterol|albuterol|mesh-list
102399101|NCT04929626|Analgesics|analgesics|mesh-ancestor
102399102|NCT04929626|Sensory System Agents|sensory system agents|mesh-ancestor
102399103|NCT04929626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102399104|NCT04929626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399105|NCT04929626|Anesthetics|anesthetics|mesh-ancestor
102399106|NCT04929626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102399107|NCT04929626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102399108|NCT04929626|Anticonvulsants|anticonvulsants|mesh-ancestor
101876953|NCT03713320|Vorinostat|vorinostat|mesh-list
102399109|NCT04929626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102399110|NCT04929626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102399111|NCT04929626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399112|NCT04929626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102399113|NCT04929626|Tocolytic Agents|tocolytic agents|mesh-ancestor
102399114|NCT04929626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102399115|NCT04929626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102399116|NCT04929626|Autonomic Agents|autonomic agents|mesh-ancestor
102399117|NCT04929626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102399118|NCT04929626|Respiratory System Agents|respiratory system agents|mesh-ancestor
102399119|NCT04929626|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102399120|NCT04929626|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102399121|NCT04929626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102399122|NCT04929626|Adrenergic Agents|adrenergic agents|mesh-ancestor
102399123|NCT04929626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102399124|NCT04908202|Deucravacitinib|deucravacitinib|mesh-list
102399125|NCT04908202|Dermatologic Agents|dermatologic agents|mesh-ancestor
102399126|NCT04908202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102399127|NCT04908202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102399128|NCT04908202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399129|NCT04905316|Durvalumab|durvalumab|mesh-list
102399130|NCT04905316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102399131|NCT04905316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399132|NCT04879849|Pembrolizumab|pembrolizumab|mesh-list
102399133|NCT04879849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102399134|NCT04879849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399135|NCT04879849|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102399136|NCT04879849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399137|NCT04826198|Olaparib|olaparib|mesh-list
102399138|NCT04826198|Niraparib|niraparib|mesh-list
102399139|NCT04826198|Rucaparib|rucaparib|mesh-list
102399140|NCT04826198|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102399141|NCT04826198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102399142|NCT04826198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399143|NCT04826198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399144|NCT04808934|Rivaroxaban|rivaroxaban|mesh-list
102399145|NCT04808934|Apixaban|apixaban|mesh-list
102399146|NCT04808934|Dabigatran|dabigatran|mesh-list
102399147|NCT04808934|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102399148|NCT04808934|Antithrombins|antithrombins|mesh-ancestor
102399149|NCT04808934|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102399150|NCT04808934|Protease Inhibitors|protease inhibitors|mesh-ancestor
102399151|NCT04808934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102399152|NCT04808934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399153|NCT04808934|Anticoagulants|anticoagulants|mesh-ancestor
102399154|NCT04754230|Tranexamic Acid|tranexamic acid|mesh-list
102399155|NCT04754230|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102399156|NCT04754230|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102399157|NCT04754230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399158|NCT04754230|Hemostatics|hemostatics|mesh-ancestor
102399159|NCT04754230|Coagulants|coagulants|mesh-ancestor
102399160|NCT04733118|Trastuzumab|trastuzumab|mesh-list
102399161|NCT04733118|Pertuzumab|pertuzumab|mesh-list
102399162|NCT04733118|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101877091|NCT05694130|Hormones|hormones|mesh-ancestor
102399163|NCT04733118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102399164|NCT04733118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399165|NCT04733118|Tubulin Modulators|tubulin modulators|mesh-ancestor
102399166|NCT04733118|Antimitotic Agents|antimitotic agents|mesh-ancestor
102399167|NCT04733118|Mitosis Modulators|mitosis modulators|mesh-ancestor
102399168|NCT04733118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399169|NCT04733118|Immunotoxins|immunotoxins|mesh-ancestor
102399170|NCT04733118|Immunoconjugates|immunoconjugates|mesh-ancestor
102399171|NCT04733118|Immunologic Factors|immunologic factors|mesh-ancestor
102399172|NCT04733118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399173|NCT04699461|Idelalisib|idelalisib|mesh-list
102399174|NCT04699461|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
102210840|NCT00728351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102399175|NCT04699461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399176|NCT04699461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102399177|NCT04699461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399178|NCT04699461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102399179|NCT04659928|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102399180|NCT04659928|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102399181|NCT04659928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102399182|NCT04653337|Norepinephrine|norepinephrine|mesh-list
102399183|NCT04653337|Serotonin|serotonin|mesh-list
102399184|NCT04653337|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
102399185|NCT04653337|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102399186|NCT04653337|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102399187|NCT04653337|Adrenergic Agents|adrenergic agents|mesh-ancestor
102399188|NCT04653337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102399189|NCT04653337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399190|NCT04653337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399191|NCT04653337|Sympathomimetics|sympathomimetics|mesh-ancestor
102399192|NCT04653337|Autonomic Agents|autonomic agents|mesh-ancestor
102399193|NCT04653337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102399194|NCT04653337|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102399195|NCT04653337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102399196|NCT04653337|Serotonin Agents|serotonin agents|mesh-ancestor
102399197|NCT04653337|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102399198|NCT04653337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102399199|NCT04561739|Sirolimus|sirolimus|mesh-list
102399200|NCT04561739|Paclitaxel|paclitaxel|mesh-list
102399201|NCT04561739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101877297|NCT03777280|Cobalt|cobalt|mesh-list
102399202|NCT04561739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399203|NCT04561739|Tubulin Modulators|tubulin modulators|mesh-ancestor
102399204|NCT04561739|Antimitotic Agents|antimitotic agents|mesh-ancestor
102399205|NCT04561739|Mitosis Modulators|mitosis modulators|mesh-ancestor
102399206|NCT04561739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399207|NCT04561739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102399208|NCT04561739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102399209|NCT04561739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102399210|NCT04561739|Antifungal Agents|antifungal agents|mesh-ancestor
102399211|NCT04561739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102399212|NCT04561739|Immunologic Factors|immunologic factors|mesh-ancestor
102399213|NCT04561739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399214|NCT04539626|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102399215|NCT04539626|Estradiol|estradiol|mesh-list
102399216|NCT04539626|Estrogens|estrogens|mesh-list
102399217|NCT04539626|Hormones|hormones|mesh-ancestor
102399218|NCT04539626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102399219|NCT04539626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399220|NCT04539626|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102399221|NCT04539626|Contraceptive Agents|contraceptive agents|mesh-ancestor
102399222|NCT04539626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102399223|NCT04539626|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102399224|NCT04539626|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102399225|NCT04539626|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102399226|NCT04521348|Antibodies|antibodies|mesh-list
102399227|NCT04521348|Immunoglobulins|immunoglobulins|mesh-list
102399228|NCT04521348|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102399229|NCT04521348|Immunologic Factors|immunologic factors|mesh-ancestor
102399230|NCT04521348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399231|NCT04521348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102399232|NCT04521348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102399233|NCT04521348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399234|NCT04512534|Antibodies|antibodies|mesh-list
102399235|NCT04512534|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
102399236|NCT04512534|Immunologic Factors|immunologic factors|mesh-ancestor
102399237|NCT04512534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399238|NCT04512534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102399239|NCT04512534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399240|NCT04486118|Lisinopril|lisinopril|mesh-list
102399241|NCT04486118|Benazepril|benazepril|mesh-list
102399242|NCT04486118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102399243|NCT04486118|Protease Inhibitors|protease inhibitors|mesh-ancestor
102399244|NCT04486118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102399245|NCT04486118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399246|NCT04486118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102399247|NCT04486118|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102399248|NCT04486118|Protective Agents|protective agents|mesh-ancestor
102399249|NCT04486118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399250|NCT04442581|Pembrolizumab|pembrolizumab|mesh-list
102399251|NCT04442581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102399252|NCT04442581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399253|NCT04442581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101877488|NCT03776032|Hematinics|hematinics|mesh-ancestor
102399254|NCT04442581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399255|NCT04436731|Phentolamine|phentolamine|mesh-list
102399256|NCT04436731|Phenylephrine|phenylephrine|mesh-list
102399257|NCT04436731|Oxymetazoline|oxymetazoline|mesh-list
102399258|NCT04436731|Norepinephrine|norepinephrine|mesh-list
102399259|NCT04436731|Dexmedetomidine|dexmedetomidine|mesh-list
102399260|NCT04436731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102399261|NCT04436731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102399262|NCT04436731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399263|NCT04436731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102399264|NCT04436731|Analgesics|analgesics|mesh-ancestor
102399265|NCT04436731|Sensory System Agents|sensory system agents|mesh-ancestor
102399266|NCT04436731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102399267|NCT04436731|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102399268|NCT04436731|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102399269|NCT04436731|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102399270|NCT04436731|Adrenergic Agents|adrenergic agents|mesh-ancestor
101877619|NCT03782662|Hormone Antagonists|hormone antagonists|mesh-ancestor
102399271|NCT04436731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102399272|NCT04436731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399273|NCT04436731|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102399274|NCT04436731|Mydriatics|mydriatics|mesh-ancestor
102399275|NCT04436731|Autonomic Agents|autonomic agents|mesh-ancestor
102399276|NCT04436731|Sympathomimetics|sympathomimetics|mesh-ancestor
101877699|NCT03967496|Metformin|metformin|mesh-list
102399277|NCT04436731|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102399278|NCT04436731|Nasal Decongestants|nasal decongestants|mesh-ancestor
102399279|NCT04436731|Respiratory System Agents|respiratory system agents|mesh-ancestor
102399280|NCT04436731|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102399281|NCT04436731|Protective Agents|protective agents|mesh-ancestor
102399282|NCT04436731|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102399283|NCT04436731|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102399284|NCT04436731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102399285|NCT04423068|Contraceptive Agents|contraceptive agents|mesh-list
102399286|NCT04423068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102399287|NCT04423068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399288|NCT04420598|Trastuzumab|trastuzumab|mesh-list
102399289|NCT04420598|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
102399290|NCT04420598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102399291|NCT04420598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399292|NCT04420598|Immunoconjugates|immunoconjugates|mesh-ancestor
102399293|NCT04420598|Immunologic Factors|immunologic factors|mesh-ancestor
102399294|NCT04420598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399295|NCT04411654|Sirolimus|sirolimus|mesh-list
102399296|NCT04411654|Prednisone|prednisone|mesh-list
102399297|NCT04411654|Methylprednisolone|methylprednisolone|mesh-list
102399298|NCT04411654|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102399299|NCT04411654|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102399300|NCT04411654|Prednisolone|prednisolone|mesh-list
102399301|NCT04411654|Prednisolone acetate|prednisolone acetate|mesh-list
102399302|NCT04411654|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102399303|NCT04411654|Prednisolone phosphate|prednisolone phosphate|mesh-list
102399304|NCT04411654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102399305|NCT04411654|Glucocorticoids|glucocorticoids|mesh-ancestor
102399306|NCT04411654|Hormones|hormones|mesh-ancestor
102399307|NCT04411654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102399308|NCT04411654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399309|NCT04411654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102399310|NCT04411654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399311|NCT04411654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102399312|NCT04411654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102399313|NCT04411654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102399314|NCT04411654|Antifungal Agents|antifungal agents|mesh-ancestor
102399315|NCT04411654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102399316|NCT04411654|Immunologic Factors|immunologic factors|mesh-ancestor
102399317|NCT04411654|Antiemetics|antiemetics|mesh-ancestor
102399318|NCT04411654|Autonomic Agents|autonomic agents|mesh-ancestor
102399319|NCT04411654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102399320|NCT04411654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102399321|NCT04411654|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102399322|NCT04411654|Protective Agents|protective agents|mesh-ancestor
102399323|NCT04364230|Poly ICLC|poly iclc|mesh-list
102399324|NCT04364230|Immunologic Factors|immunologic factors|mesh-ancestor
101878024|NCT00137436|Prednisone|prednisone|mesh-list
102399325|NCT04364230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399326|NCT04364230|Interferon Inducers|interferon inducers|mesh-ancestor
102399327|NCT04268706|Fludarabine|fludarabine|mesh-list
102399328|NCT04268706|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102399329|NCT04268706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399330|NCT04268706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399331|NCT04268706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102399332|NCT04268706|Alkylating Agents|alkylating agents|mesh-ancestor
102399333|NCT04223609|Oxycodone|oxycodone|mesh-list
102399334|NCT04223609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102399335|NCT04223609|Narcotics|narcotics|mesh-ancestor
102399336|NCT04223609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102399337|NCT04223609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399338|NCT04223609|Analgesics|analgesics|mesh-ancestor
102399339|NCT04223609|Sensory System Agents|sensory system agents|mesh-ancestor
101878086|NCT03767920|Anesthetics, Local|anesthetics, local|mesh-ancestor
102399340|NCT04223609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102399341|NCT04118920|Insulin|insulin|mesh-list
102399342|NCT04118920|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102399343|NCT04118920|Lubricant Eye Drops|lubricant eye drops|mesh-list
102399344|NCT04118920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102399345|NCT04118920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399346|NCT04118920|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102399347|NCT04118920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102399348|NCT04083144|Varenicline|varenicline|mesh-list
102399349|NCT04083144|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102399350|NCT04083144|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102399351|NCT04083144|Cholinergic Agents|cholinergic agents|mesh-ancestor
102399352|NCT04083144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102399353|NCT04083144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399354|NCT04083144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399355|NCT04055818|Niacinamide|niacinamide|mesh-list
102399356|NCT04055818|Niacin|niacin|mesh-list
102399357|NCT04055818|Nicotinic Acids|nicotinic acids|mesh-list
102399358|NCT04055818|Decitabine|decitabine|mesh-list
102399359|NCT04055818|Tetrahydrouridine|tetrahydrouridine|mesh-list
102399360|NCT04055818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102399361|NCT04055818|Antimetabolites|antimetabolites|mesh-ancestor
102399362|NCT04055818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399363|NCT04055818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399364|NCT04055818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102399365|NCT04055818|Vitamin B Complex|vitamin b complex|mesh-ancestor
102399366|NCT04055818|Vitamins|vitamins|mesh-ancestor
102399367|NCT04055818|Micronutrients|micronutrients|mesh-ancestor
102399368|NCT04055818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399369|NCT04055818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102399370|NCT04055818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102399371|NCT04055818|Vasodilator Agents|vasodilator agents|mesh-ancestor
102399372|NCT04047953|Paclitaxel|paclitaxel|mesh-list
102399373|NCT04047953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102399374|NCT04047953|Oxaliplatin|oxaliplatin|mesh-list
102399375|NCT04047953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102399376|NCT04047953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399377|NCT04047953|Tubulin Modulators|tubulin modulators|mesh-ancestor
102399378|NCT04047953|Antimitotic Agents|antimitotic agents|mesh-ancestor
102399379|NCT04047953|Mitosis Modulators|mitosis modulators|mesh-ancestor
102399380|NCT04047953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399381|NCT03981900|Tofacitinib|tofacitinib|mesh-list
102399382|NCT03981900|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102399383|NCT03981900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102399384|NCT03981900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102399385|NCT03981900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399386|NCT03958877|Interferons|interferons|mesh-list
102399387|NCT03958877|Interferon-beta|interferon-beta|mesh-list
102399388|NCT03958877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399389|NCT03958877|Antiviral Agents|antiviral agents|mesh-ancestor
102399390|NCT03958877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102399391|NCT03958877|Immunologic Factors|immunologic factors|mesh-ancestor
102399392|NCT03958877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399393|NCT03941288|Cannabidiol|cannabidiol|mesh-list
102399394|NCT03941288|Anticonvulsants|anticonvulsants|mesh-ancestor
102399395|NCT03925727|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102399396|NCT03925727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102399397|NCT03864419|Prednisone|prednisone|mesh-list
102399398|NCT03864419|Cyclophosphamide|cyclophosphamide|mesh-list
102399399|NCT03864419|Rituximab|rituximab|mesh-list
102399400|NCT03864419|Doxorubicin|doxorubicin|mesh-list
102399401|NCT03864419|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102399402|NCT03864419|Methotrexate|methotrexate|mesh-list
102399403|NCT03864419|Etoposide|etoposide|mesh-list
102399404|NCT03864419|Vincristine|vincristine|mesh-list
102399405|NCT03864419|Daunorubicin|daunorubicin|mesh-list
101878323|NCT02531724|Simendan|simendan|mesh-list
102399406|NCT03864419|Podophyllotoxin|podophyllotoxin|mesh-list
102399407|NCT03864419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102399408|NCT03864419|Antibodies|antibodies|mesh-list
102399409|NCT03864419|Immunoglobulins|immunoglobulins|mesh-list
102399410|NCT03864419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102399411|NCT03864419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102399412|NCT03864419|Immunologic Factors|immunologic factors|mesh-ancestor
102399413|NCT03864419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399414|NCT03864419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102399415|NCT03864419|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102399416|NCT03864419|Alkylating Agents|alkylating agents|mesh-ancestor
102399417|NCT03864419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399418|NCT03864419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399419|NCT03864419|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102399420|NCT03864419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102399421|NCT03864419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102399422|NCT03864419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102399423|NCT03864419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102399424|NCT03864419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102399425|NCT03864419|Glucocorticoids|glucocorticoids|mesh-ancestor
102399426|NCT03864419|Hormones|hormones|mesh-ancestor
102399427|NCT03864419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102399428|NCT03864419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102399429|NCT03864419|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102399430|NCT03864419|Abortifacient Agents|abortifacient agents|mesh-ancestor
102399431|NCT03864419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102399432|NCT03864419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102399433|NCT03864419|Antimetabolites|antimetabolites|mesh-ancestor
102399434|NCT03864419|Dermatologic Agents|dermatologic agents|mesh-ancestor
102399435|NCT03864419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102399436|NCT03864419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102399437|NCT03864419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102399438|NCT03864419|Tubulin Modulators|tubulin modulators|mesh-ancestor
102399439|NCT03864419|Antimitotic Agents|antimitotic agents|mesh-ancestor
102399440|NCT03864419|Mitosis Modulators|mitosis modulators|mesh-ancestor
102399441|NCT03864419|Keratolytic Agents|keratolytic agents|mesh-ancestor
102399442|NCT03859427|Dexamethasone|dexamethasone|mesh-list
102399443|NCT03859427|Lenalidomide|lenalidomide|mesh-list
102399444|NCT03859427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102399445|NCT03859427|Antiemetics|antiemetics|mesh-ancestor
102399446|NCT03859427|Autonomic Agents|autonomic agents|mesh-ancestor
102399447|NCT03859427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102399448|NCT03859427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399449|NCT03859427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102399450|NCT03859427|Glucocorticoids|glucocorticoids|mesh-ancestor
102399451|NCT03859427|Hormones|hormones|mesh-ancestor
102399452|NCT03859427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102399453|NCT03859427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102399454|NCT03859427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399455|NCT03859427|Immunologic Factors|immunologic factors|mesh-ancestor
102399456|NCT03859427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102399457|NCT03859427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102399458|NCT03859427|Growth Substances|growth substances|mesh-ancestor
102399459|NCT03859427|Growth Inhibitors|growth inhibitors|mesh-ancestor
102399460|NCT03856671|Metronidazole|metronidazole|mesh-list
102399461|NCT03856671|Neomycin|neomycin|mesh-list
102399462|NCT03856671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102399463|NCT03856671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102399464|NCT03856671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102399465|NCT03856671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102399466|NCT03856671|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102399467|NCT03856671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102399468|NCT03856671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399469|NCT03728361|Nivolumab|nivolumab|mesh-list
102399470|NCT03728361|Temozolomide|temozolomide|mesh-list
102399471|NCT03728361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102399472|NCT03728361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399473|NCT03728361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102399474|NCT03728361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399475|NCT03728361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102399476|NCT03728361|Alkylating Agents|alkylating agents|mesh-ancestor
102399477|NCT03662685|Coal Tar|coal tar|mesh-list
101879004|NCT00118716|Fluticasone|fluticasone|mesh-list
102399478|NCT03662685|Keratolytic Agents|keratolytic agents|mesh-ancestor
102399479|NCT03662685|Dermatologic Agents|dermatologic agents|mesh-ancestor
102399480|NCT03617328|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
102399481|NCT03617328|Poly ICLC|poly iclc|mesh-list
102399482|NCT03617328|Immunologic Factors|immunologic factors|mesh-ancestor
102399483|NCT03617328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399484|NCT03617328|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102399485|NCT03617328|Interferon Inducers|interferon inducers|mesh-ancestor
102399486|NCT03391934|Leucovorin|leucovorin|mesh-list
102399487|NCT03391934|Fluorouracil|fluorouracil|mesh-list
102399488|NCT03391934|Irinotecan|irinotecan|mesh-list
102399489|NCT03391934|Cetuximab|cetuximab|mesh-list
102399490|NCT03391934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399491|NCT03391934|Antimetabolites|antimetabolites|mesh-ancestor
102399492|NCT03391934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399493|NCT03391934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102399494|NCT03391934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399495|NCT03391934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102399496|NCT03391934|Immunologic Factors|immunologic factors|mesh-ancestor
102399497|NCT03391934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102399498|NCT03391934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102399499|NCT03391934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102399500|NCT03391934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102399501|NCT03391934|Antidotes|antidotes|mesh-ancestor
102399502|NCT03391934|Protective Agents|protective agents|mesh-ancestor
102399503|NCT03391934|Vitamin B Complex|vitamin b complex|mesh-ancestor
102399504|NCT03391934|Vitamins|vitamins|mesh-ancestor
102399505|NCT03391934|Micronutrients|micronutrients|mesh-ancestor
102399506|NCT03333343|Gefitinib|gefitinib|mesh-list
102399507|NCT03333343|Trametinib|trametinib|mesh-list
102399508|NCT03333343|Nazartinib|nazartinib|mesh-list
102399509|NCT03333343|Naporafenib|naporafenib|mesh-list
102399510|NCT03333343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399511|NCT03333343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102399512|NCT03333343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101879348|NCT04799782|Adrenergic Agents|adrenergic agents|mesh-ancestor
102399513|NCT03333343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399514|NCT03326947|Docetaxel|docetaxel|mesh-list
102399515|NCT03326947|Fluorouracil|fluorouracil|mesh-list
102399516|NCT03326947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399517|NCT03326947|Tubulin Modulators|tubulin modulators|mesh-ancestor
102399518|NCT03326947|Antimitotic Agents|antimitotic agents|mesh-ancestor
102399519|NCT03326947|Mitosis Modulators|mitosis modulators|mesh-ancestor
102399520|NCT03326947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399521|NCT03326947|Antimetabolites|antimetabolites|mesh-ancestor
102399522|NCT03326947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101879494|NCT00128102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102399523|NCT03326947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102399524|NCT03326947|Immunologic Factors|immunologic factors|mesh-ancestor
102399525|NCT03326947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399526|NCT03304639|Pembrolizumab|pembrolizumab|mesh-list
102399527|NCT03304639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102399528|NCT03304639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399529|NCT03304639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102399530|NCT03304639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399531|NCT03289234|Edaravone|edaravone|mesh-list
102399532|NCT03289234|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102399533|NCT03289234|Antioxidants|antioxidants|mesh-ancestor
102399534|NCT03289234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399535|NCT03289234|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102399536|NCT03289234|Protective Agents|protective agents|mesh-ancestor
102399537|NCT03289234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399538|NCT03289208|Edaravone|edaravone|mesh-list
102399539|NCT03289208|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102399540|NCT03289208|Antioxidants|antioxidants|mesh-ancestor
102399541|NCT03289208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399542|NCT03289208|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102399543|NCT03289208|Protective Agents|protective agents|mesh-ancestor
102399544|NCT03289208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399545|NCT03244059|Belimumab|belimumab|mesh-list
102399546|NCT03244059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102399547|NCT03244059|Immunologic Factors|immunologic factors|mesh-ancestor
102399548|NCT03244059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399549|NCT03036566|Lithium Carbonate|lithium carbonate|mesh-list
102399550|NCT03036566|Antidepressive Agents|antidepressive agents|mesh-ancestor
102399551|NCT03036566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102399552|NCT03036566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102399553|NCT03036566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399554|NCT03036566|Antimanic Agents|antimanic agents|mesh-ancestor
102399555|NCT03036566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102399556|NCT03036566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102399557|NCT03036566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399558|NCT03010228|Aluminum sulfate|aluminum sulfate|mesh-list
102399559|NCT03010228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102399560|NCT03010228|Immunologic Factors|immunologic factors|mesh-ancestor
102399561|NCT03010228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399562|NCT03006302|Cyclophosphamide|cyclophosphamide|mesh-list
102399563|NCT03006302|Pembrolizumab|pembrolizumab|mesh-list
102399564|NCT03006302|Immunologic Factors|immunologic factors|mesh-ancestor
102399565|NCT03006302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399566|NCT03006302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101879755|NCT04171414|Adalimumab|adalimumab|mesh-list
102399567|NCT03006302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102399568|NCT03006302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102399569|NCT03006302|Alkylating Agents|alkylating agents|mesh-ancestor
102399570|NCT03006302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399571|NCT03006302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399572|NCT03006302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102399573|NCT03006302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102399574|NCT03006302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102399575|NCT02927249|Aspirin|aspirin|mesh-list
102399576|NCT02927249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102399577|NCT02927249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102399578|NCT02927249|Analgesics|analgesics|mesh-ancestor
102399579|NCT02927249|Sensory System Agents|sensory system agents|mesh-ancestor
102399580|NCT02927249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102399581|NCT02927249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399582|NCT02927249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102399583|NCT02927249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102399584|NCT02927249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102399585|NCT02927249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102399586|NCT02927249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399587|NCT02927249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102399588|NCT02927249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102399589|NCT02927249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102399590|NCT02927249|Antipyretics|antipyretics|mesh-ancestor
102399591|NCT02918864|Oxytocin|oxytocin|mesh-list
102399592|NCT02918864|Oxytocics|oxytocics|mesh-ancestor
102399593|NCT02918864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102399594|NCT02918864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399595|NCT02890368|Interferons|interferons|mesh-list
102399596|NCT02890368|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
102399597|NCT02890368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102399598|NCT02890368|Immunoglobulin G|immunoglobulin g|mesh-list
102399599|NCT02890368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399600|NCT02890368|Antiviral Agents|antiviral agents|mesh-ancestor
102399601|NCT02890368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102399602|NCT02890368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102399603|NCT02890368|Immunologic Factors|immunologic factors|mesh-ancestor
102399604|NCT02890368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399605|NCT02890368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399606|NCT02754141|Nivolumab|nivolumab|mesh-list
102399607|NCT02754141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102399608|NCT02754141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399609|NCT02754141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102399610|NCT02754141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399611|NCT02659059|Paclitaxel|paclitaxel|mesh-list
102399612|NCT02659059|Cisplatin|cisplatin|mesh-list
102399613|NCT02659059|Carboplatin|carboplatin|mesh-list
102399614|NCT02659059|Nivolumab|nivolumab|mesh-list
102399615|NCT02659059|Pemetrexed|pemetrexed|mesh-list
102399616|NCT02659059|Ipilimumab|ipilimumab|mesh-list
102399617|NCT02659059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102399618|NCT02659059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399619|NCT02659059|Tubulin Modulators|tubulin modulators|mesh-ancestor
102399620|NCT02659059|Antimitotic Agents|antimitotic agents|mesh-ancestor
102399621|NCT02659059|Mitosis Modulators|mitosis modulators|mesh-ancestor
102399622|NCT02659059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399623|NCT02659059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102399624|NCT02659059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102399625|NCT02659059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102399626|NCT02659059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102399627|NCT02659059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102399628|NCT01997840|Dexamethasone|dexamethasone|mesh-list
102399629|NCT01997840|Dexamethasone acetate|dexamethasone acetate|mesh-list
102399630|NCT01997840|Pomalidomide|pomalidomide|mesh-list
102211294|NCT05859269|Autonomic Agents|autonomic agents|mesh-ancestor
102211295|NCT05859269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102211297|NCT05859269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102399631|NCT01997840|Ricolinostat|ricolinostat|mesh-list
102399632|NCT01997840|BB 1101|bb 1101|mesh-list
102399633|NCT01997840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102399634|NCT01997840|Antiemetics|antiemetics|mesh-ancestor
102399635|NCT01997840|Autonomic Agents|autonomic agents|mesh-ancestor
102399636|NCT01997840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102399637|NCT01997840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399638|NCT01997840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102399639|NCT01997840|Glucocorticoids|glucocorticoids|mesh-ancestor
102399640|NCT01997840|Hormones|hormones|mesh-ancestor
102399641|NCT01997840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102399642|NCT01997840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102399643|NCT01997840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399644|NCT01997840|Protease Inhibitors|protease inhibitors|mesh-ancestor
102399645|NCT01997840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102399646|NCT01997840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399647|NCT01997840|Immunologic Factors|immunologic factors|mesh-ancestor
102399648|NCT01997840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102399649|NCT01997840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102399650|NCT01997840|Growth Substances|growth substances|mesh-ancestor
102399651|NCT01997840|Growth Inhibitors|growth inhibitors|mesh-ancestor
102399652|NCT01997840|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102399653|NCT01505569|Etoposide|etoposide|mesh-list
102399654|NCT01505569|Carboplatin|carboplatin|mesh-list
102399655|NCT01505569|Melphalan|melphalan|mesh-list
102399656|NCT01505569|Busulfan|busulfan|mesh-list
102399657|NCT01505569|Ifosfamide|ifosfamide|mesh-list
102399658|NCT01505569|Thiotepa|thiotepa|mesh-list
102399659|NCT01505569|Lenograstim|lenograstim|mesh-list
102399660|NCT01505569|Mesna|mesna|mesh-list
101880179|NCT04207840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102399661|NCT01505569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102399662|NCT01505569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399663|NCT01505569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399664|NCT01505569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101880264|NCT03656692|Hormones|hormones|mesh-ancestor
102399665|NCT01505569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102399666|NCT01505569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102399667|NCT01505569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102399668|NCT01505569|Alkylating Agents|alkylating agents|mesh-ancestor
101880322|NCT01084044|Urinastatin|urinastatin|mesh-list
102399669|NCT01505569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102399670|NCT01505569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102399671|NCT01505569|Immunologic Factors|immunologic factors|mesh-ancestor
102399672|NCT01505569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399673|NCT01505569|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102399674|NCT01505569|Protective Agents|protective agents|mesh-ancestor
102399675|NCT02375178|Biguanides|biguanides|mesh-list
102399676|NCT02375178|Chlorhexidine|chlorhexidine|mesh-list
102399677|NCT02375178|Polihexanide|polihexanide|mesh-list
102399678|NCT02375178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102399679|NCT02375178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102399680|NCT02375178|Disinfectants|disinfectants|mesh-ancestor
102399681|NCT02375178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101257346|NCT01715701|Iodine|iodine|mesh-list
102399682|NCT02375178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399683|NCT02375100|Acetaminophen|acetaminophen|mesh-list
102399684|NCT02375100|Tramadol|tramadol|mesh-list
102399685|NCT02375100|Analgesics|analgesics|mesh-list
102399686|NCT02375100|Bupivacaine|bupivacaine|mesh-list
102399687|NCT02375100|Anesthetics, Local|anesthetics, local|mesh-ancestor
102399688|NCT02375100|Anesthetics|anesthetics|mesh-ancestor
102399689|NCT02375100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102399690|NCT02375100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399691|NCT02375100|Sensory System Agents|sensory system agents|mesh-ancestor
102399692|NCT02375100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102399693|NCT02375100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102399694|NCT02375100|Antipyretics|antipyretics|mesh-ancestor
102399695|NCT02375100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102399696|NCT02375100|Narcotics|narcotics|mesh-ancestor
102399697|NCT02364258|Atorvastatin|atorvastatin|mesh-list
102399698|NCT02364258|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102399699|NCT02364258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102399700|NCT02364258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102399701|NCT02364258|Antimetabolites|antimetabolites|mesh-ancestor
102399702|NCT02364258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399703|NCT02364258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102399704|NCT02364258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102399705|NCT02364258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102399706|NCT02375022|Endostar protein|endostar protein|mesh-list
102211377|NCT05736419|Antiemetics|antiemetics|mesh-ancestor
102399707|NCT02375022|Endostatins|endostatins|mesh-list
102399708|NCT02375022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102399712|NCT02375022|Growth Inhibitors|growth inhibitors|mesh-ancestor
101880800|NCT00403481|Olmesartan|olmesartan|mesh-list
102399713|NCT02375022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399714|NCT01497899|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102399715|NCT01497899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102399716|NCT01497899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102399717|NCT01497899|Antiviral Agents|antiviral agents|mesh-ancestor
102399718|NCT01497899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102399719|NCT01497275|Rituximab|rituximab|mesh-list
102399720|NCT01497275|Bortezomib|bortezomib|mesh-list
102399721|NCT01497275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102399722|NCT01497275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399723|NCT01497275|Immunologic Factors|immunologic factors|mesh-ancestor
102399724|NCT01497275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399725|NCT01497275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102399726|NCT01557517|Clobetasol|clobetasol|mesh-list
102399727|NCT01557517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102399728|NCT01557517|Glucocorticoids|glucocorticoids|mesh-ancestor
102399729|NCT01557517|Hormones|hormones|mesh-ancestor
102399730|NCT01557517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101881012|NCT01079078|Acetaminophen|acetaminophen|mesh-list
102399731|NCT01557517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399732|NCT02363556|Misoprostol|misoprostol|mesh-list
102399733|NCT02363556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102399734|NCT02363556|Abortifacient Agents|abortifacient agents|mesh-ancestor
102399735|NCT02363556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102399736|NCT02363556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399737|NCT02363556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102399738|NCT02363556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102399739|NCT02363556|Oxytocics|oxytocics|mesh-ancestor
102399740|NCT01497197|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102399741|NCT01497197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102399742|NCT01497197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399743|NCT01557283|Etanercept|etanercept|mesh-list
102399744|NCT01557283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102399745|NCT01557283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102399746|NCT01557283|Analgesics|analgesics|mesh-ancestor
102399747|NCT01557283|Sensory System Agents|sensory system agents|mesh-ancestor
102399748|NCT01557283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102399749|NCT01557283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399750|NCT01557283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102399751|NCT01557283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102399752|NCT01557283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102399753|NCT01557283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102399754|NCT01557283|Immunologic Factors|immunologic factors|mesh-ancestor
102399755|NCT02374632|Octreotide|octreotide|mesh-list
102399756|NCT02374632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102399757|NCT02374632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102399758|NCT02374632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399759|NCT02363400|Cisplatin|cisplatin|mesh-list
102399760|NCT02363400|Epirubicin|epirubicin|mesh-list
102399761|NCT02363400|Mitomycins|mitomycins|mesh-list
102399762|NCT02363400|Mitomycin|mitomycin|mesh-list
102399763|NCT02363400|Tegafur|tegafur|mesh-list
102399764|NCT02363400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399765|NCT02363400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102399766|NCT02363400|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102399767|NCT02363400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102399768|NCT02363400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211447|NCT05687266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211448|NCT05687266|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102211449|NCT05687266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102211450|NCT05681195|Pemetrexed|pemetrexed|mesh-list
102211451|NCT05681195|Zanubrutinib|zanubrutinib|mesh-list
102211452|NCT05681195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211453|NCT05681195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211454|NCT05681195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211455|NCT05681195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102211456|NCT05681195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102211457|NCT05681195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102211486|NCT05668455|Povidone|povidone|mesh-list
102399769|NCT02363400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399770|NCT02363400|Alkylating Agents|alkylating agents|mesh-ancestor
102399771|NCT02363400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102399772|NCT02363400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102399773|NCT02363400|Antimetabolites|antimetabolites|mesh-ancestor
102399774|NCT00350025|Paclitaxel|paclitaxel|mesh-list
102399775|NCT00350025|Cetuximab|cetuximab|mesh-list
102399776|NCT00350025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102399777|NCT00350025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399778|NCT00350025|Tubulin Modulators|tubulin modulators|mesh-ancestor
102399779|NCT00350025|Antimitotic Agents|antimitotic agents|mesh-ancestor
101881507|NCT00384293|Niacin|niacin|mesh-list
102399780|NCT00350025|Mitosis Modulators|mitosis modulators|mesh-ancestor
102399781|NCT00350025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399782|NCT00350025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102399783|NCT01496807|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102399784|NCT01496807|Ipilimumab|ipilimumab|mesh-list
102399785|NCT01496807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102399786|NCT01496807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399787|NCT01496807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102399788|NCT01496807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399789|NCT01496807|Antiviral Agents|antiviral agents|mesh-ancestor
102399790|NCT01496807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102399791|NCT02374320|Bupivacaine|bupivacaine|mesh-list
101881626|NCT01326858|Ketotifen|ketotifen|mesh-list
102399792|NCT02374320|Anesthetics, Local|anesthetics, local|mesh-ancestor
102399793|NCT02374320|Anesthetics|anesthetics|mesh-ancestor
102399794|NCT02374320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102399795|NCT02374320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399796|NCT02374320|Sensory System Agents|sensory system agents|mesh-ancestor
102399797|NCT02374320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102399798|NCT01496183|Olanzapine|olanzapine|mesh-list
102399799|NCT01496183|Antiemetics|antiemetics|mesh-ancestor
102399800|NCT01496183|Autonomic Agents|autonomic agents|mesh-ancestor
102399801|NCT01496183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102399802|NCT01496183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399803|NCT01496183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102399804|NCT01496183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102399805|NCT01496183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102399806|NCT01496183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102399807|NCT01496183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102399808|NCT01496183|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102399809|NCT01496183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102399810|NCT01496183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102399811|NCT01496183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399812|NCT01496183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102399813|NCT01496183|Serotonin Agents|serotonin agents|mesh-ancestor
102399814|NCT01495793|Rotigotine|rotigotine|mesh-list
102399815|NCT01495793|Dopamine Agonists|dopamine agonists|mesh-ancestor
102399816|NCT01495793|Dopamine Agents|dopamine agents|mesh-ancestor
102399817|NCT01495793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102399818|NCT01495793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399819|NCT01495793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399820|NCT02374008|Dexamethasone|dexamethasone|mesh-list
102399821|NCT02374008|Ketorolac|ketorolac|mesh-list
102399822|NCT02374008|Ropivacaine|ropivacaine|mesh-list
102399823|NCT02374008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102399824|NCT02374008|Antiemetics|antiemetics|mesh-ancestor
102399825|NCT02374008|Autonomic Agents|autonomic agents|mesh-ancestor
102399826|NCT02374008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102399827|NCT02374008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399828|NCT02374008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102399829|NCT02374008|Glucocorticoids|glucocorticoids|mesh-ancestor
102399830|NCT02374008|Hormones|hormones|mesh-ancestor
102399831|NCT02374008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102399832|NCT02374008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102399833|NCT02374008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399834|NCT02374008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102399835|NCT02374008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399836|NCT02374008|Anesthetics, Local|anesthetics, local|mesh-ancestor
102399837|NCT02374008|Anesthetics|anesthetics|mesh-ancestor
102399838|NCT02374008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102399839|NCT02374008|Sensory System Agents|sensory system agents|mesh-ancestor
102399840|NCT02374008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102399841|NCT02374008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102399842|NCT02374008|Analgesics|analgesics|mesh-ancestor
102399843|NCT02374008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102399844|NCT02374008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102399846|NCT04505280|Anesthetics, Local|anesthetics, local|mesh-ancestor
102399847|NCT04505280|Anesthetics|anesthetics|mesh-ancestor
102399848|NCT04505280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102399849|NCT04505280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399850|NCT04505280|Sensory System Agents|sensory system agents|mesh-ancestor
102399851|NCT04505280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102399852|NCT04505280|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102399853|NCT04505280|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102399854|NCT04505280|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102399855|NCT04505280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102399856|NCT04505280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399857|NCT02366676|Hyaluronic Acid|hyaluronic acid|mesh-list
101882248|NCT03615040|Astegolimab|astegolimab|mesh-list
102399858|NCT02366676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102399859|NCT02366676|Immunologic Factors|immunologic factors|mesh-ancestor
102399860|NCT02366676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399861|NCT02366676|Viscosupplements|viscosupplements|mesh-ancestor
102399862|NCT02366676|Protective Agents|protective agents|mesh-ancestor
102399863|NCT02373384|Allopurinol|allopurinol|mesh-list
102399864|NCT02373384|Potassium Citrate|potassium citrate|mesh-list
102399865|NCT02373384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399866|NCT02373384|Antimetabolites|antimetabolites|mesh-ancestor
102399867|NCT02373384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102399868|NCT02373384|Gout Suppressants|gout suppressants|mesh-ancestor
101882378|NCT00130689|Cetuximab|cetuximab|mesh-list
102399869|NCT02373384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102399870|NCT02373384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102399871|NCT02373384|Antioxidants|antioxidants|mesh-ancestor
102399872|NCT02373384|Protective Agents|protective agents|mesh-ancestor
102399873|NCT02373384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399874|NCT02373384|Diuretics|diuretics|mesh-ancestor
102399875|NCT02373384|Natriuretic Agents|natriuretic agents|mesh-ancestor
102399876|NCT02373384|Expectorants|expectorants|mesh-ancestor
102399877|NCT02373384|Respiratory System Agents|respiratory system agents|mesh-ancestor
102399878|NCT01494467|Azelaic acid|azelaic acid|mesh-list
101882451|NCT00096135|Etoposide|etoposide|mesh-list
102399879|NCT01494467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399880|NCT01494467|Dermatologic Agents|dermatologic agents|mesh-ancestor
102399881|NCT02881086|Cytarabine|cytarabine|mesh-list
102399882|NCT02881086|Dexamethasone|dexamethasone|mesh-list
102399883|NCT02881086|Prednisolone|prednisolone|mesh-list
102399884|NCT02881086|Cyclophosphamide|cyclophosphamide|mesh-list
102399885|NCT02881086|Rituximab|rituximab|mesh-list
102399886|NCT02881086|Methotrexate|methotrexate|mesh-list
102399887|NCT02881086|Fludarabine|fludarabine|mesh-list
102399888|NCT02881086|Vincristine|vincristine|mesh-list
102399889|NCT02881086|Doxorubicin|doxorubicin|mesh-list
102399890|NCT02881086|Daunorubicin|daunorubicin|mesh-list
102399891|NCT02881086|Asparaginase|asparaginase|mesh-list
102399892|NCT02881086|Mercaptopurine|mercaptopurine|mesh-list
102399893|NCT02881086|Idarubicin|idarubicin|mesh-list
102399894|NCT02881086|Pegaspargase|pegaspargase|mesh-list
102399895|NCT02881086|Vindesine|vindesine|mesh-list
102399896|NCT02881086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102399897|NCT02881086|Immunologic Factors|immunologic factors|mesh-ancestor
102399898|NCT02881086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399899|NCT02881086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102399900|NCT02881086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102399901|NCT02881086|Alkylating Agents|alkylating agents|mesh-ancestor
102399902|NCT02881086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399903|NCT02881086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399904|NCT02881086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102399905|NCT02881086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102399906|NCT02881086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102399907|NCT02881086|Antiemetics|antiemetics|mesh-ancestor
102399908|NCT02881086|Autonomic Agents|autonomic agents|mesh-ancestor
102399909|NCT02881086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102399910|NCT02881086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101882587|NCT03599362|Nivolumab|nivolumab|mesh-list
102399911|NCT02881086|Glucocorticoids|glucocorticoids|mesh-ancestor
102399912|NCT02881086|Hormones|hormones|mesh-ancestor
102399913|NCT02881086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102399914|NCT02881086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102399915|NCT02881086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102399916|NCT02881086|Abortifacient Agents|abortifacient agents|mesh-ancestor
102399917|NCT02881086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102399918|NCT02881086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102399919|NCT02881086|Antimetabolites|antimetabolites|mesh-ancestor
102399920|NCT02881086|Dermatologic Agents|dermatologic agents|mesh-ancestor
102399921|NCT02881086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102399922|NCT02881086|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102399923|NCT02881086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102399924|NCT02881086|Antiviral Agents|antiviral agents|mesh-ancestor
102399925|NCT02881086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102399926|NCT02881086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102399927|NCT02881086|Tubulin Modulators|tubulin modulators|mesh-ancestor
102399928|NCT02881086|Antimitotic Agents|antimitotic agents|mesh-ancestor
102399929|NCT02881086|Mitosis Modulators|mitosis modulators|mesh-ancestor
102399930|NCT02881086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102399931|NCT02881086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102399932|NCT02881086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102399933|NCT03922542|Riboflavin|riboflavin|mesh-list
102399934|NCT03922542|Vitamin B Complex|vitamin b complex|mesh-ancestor
102399935|NCT03922542|Vitamins|vitamins|mesh-ancestor
102399936|NCT03922542|Micronutrients|micronutrients|mesh-ancestor
102399937|NCT03922542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399938|NCT03922542|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102399939|NCT03922542|Dermatologic Agents|dermatologic agents|mesh-ancestor
102399940|NCT01493687|Azelaic acid|azelaic acid|mesh-list
102399941|NCT01493687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399942|NCT01493687|Dermatologic Agents|dermatologic agents|mesh-ancestor
102399943|NCT02362308|Eplerenone|eplerenone|mesh-list
102399944|NCT02362308|Spironolactone|spironolactone|mesh-list
102399945|NCT02362308|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
102399946|NCT02362308|Mineralocorticoids|mineralocorticoids|mesh-list
102399947|NCT02362308|Hormone Antagonists|hormone antagonists|mesh-ancestor
102399948|NCT02362308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102399949|NCT02362308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882825|NCT00079040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102399950|NCT02362308|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102399951|NCT02362308|Diuretics|diuretics|mesh-ancestor
102399952|NCT02362308|Natriuretic Agents|natriuretic agents|mesh-ancestor
102399953|NCT02362308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102399954|NCT02362308|Hormones|hormones|mesh-ancestor
102399955|NCT02366208|Adefovir|adefovir|mesh-list
102399956|NCT02366208|Thymalfasin|thymalfasin|mesh-list
102399957|NCT02366208|Antiviral Agents|antiviral agents|mesh-ancestor
102399958|NCT02366208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102399959|NCT02366208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102399960|NCT02366208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102399961|NCT02366208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102399962|NCT02366208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399963|NCT02366208|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102399964|NCT02366208|Immunologic Factors|immunologic factors|mesh-ancestor
102399965|NCT02366208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399966|NCT02373462|Olmesartan|olmesartan|mesh-list
102399967|NCT02373462|Antihypertensive Agents|antihypertensive agents|mesh-list
102399968|NCT02373462|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102399969|NCT02373462|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102399970|NCT02373462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399971|NCT01523587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102399972|NCT01523587|Afatinib|afatinib|mesh-list
101883028|NCT03730714|Morphine|morphine|mesh-list
102399973|NCT01523587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102399974|NCT01523587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102399975|NCT01523587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102399976|NCT01523587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399977|NCT00310401|Albuterol|albuterol|mesh-list
102399978|NCT00310401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102399979|NCT00310401|Autonomic Agents|autonomic agents|mesh-ancestor
102399980|NCT00310401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102399981|NCT00310401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102399982|NCT00310401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102399983|NCT00310401|Respiratory System Agents|respiratory system agents|mesh-ancestor
102399984|NCT00310401|Tocolytic Agents|tocolytic agents|mesh-ancestor
102399985|NCT00310401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102399986|NCT00310401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102399987|NCT00310401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102399988|NCT00310401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102399989|NCT00310401|Adrenergic Agents|adrenergic agents|mesh-ancestor
102399990|NCT00310401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102399991|NCT00310401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102399992|NCT00310791|Levonorgestrel|levonorgestrel|mesh-list
102399993|NCT00310791|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102399994|NCT00310791|Hormones|hormones|mesh-list
102399995|NCT00310791|Estradiol|estradiol|mesh-list
102399996|NCT00310791|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
102399997|NCT00310791|Estrogens|estrogens|mesh-list
102399998|NCT00310791|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
102399999|NCT00310791|Progestins|progestins|mesh-list
102400000|NCT00310791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102400001|NCT00310791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400002|NCT00310791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102400003|NCT00310791|Contraceptive Agents|contraceptive agents|mesh-ancestor
101883304|NCT03586726|Natriuretic Agents|natriuretic agents|mesh-ancestor
102400004|NCT00310791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102400005|NCT00310791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102400006|NCT00310791|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102400007|NCT00310791|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102400008|NCT00310791|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102400009|NCT00310791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102400010|NCT00310791|Immunologic Factors|immunologic factors|mesh-ancestor
102400011|NCT02362152|Diclofenac|diclofenac|mesh-list
102400012|NCT02362152|Fluorouracil|fluorouracil|mesh-list
102400013|NCT02362152|Imiquimod|imiquimod|mesh-list
102400014|NCT02362152|Antimetabolites|antimetabolites|mesh-ancestor
102400015|NCT02362152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400016|NCT02362152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102400017|NCT02362152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102400018|NCT02362152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102400019|NCT02362152|Immunologic Factors|immunologic factors|mesh-ancestor
102400020|NCT02362152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400021|NCT02362152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102400022|NCT02362152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102400023|NCT02362152|Analgesics|analgesics|mesh-ancestor
102400024|NCT02362152|Sensory System Agents|sensory system agents|mesh-ancestor
102400025|NCT02362152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102400026|NCT02362152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102400027|NCT02362152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102400028|NCT02362152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102400029|NCT02362152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102400030|NCT02362152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102400031|NCT02362152|Interferon Inducers|interferon inducers|mesh-ancestor
102400032|NCT01493531|Allopurinol|allopurinol|mesh-list
102400033|NCT01493531|Lesinurad|lesinurad|mesh-list
102400034|NCT01493531|Antimetabolites|antimetabolites|mesh-ancestor
102400035|NCT01493531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400036|NCT01493531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101883663|NCT05645900|Vaccines|vaccines|mesh-list
102400037|NCT01493531|Gout Suppressants|gout suppressants|mesh-ancestor
102400038|NCT01493531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102400039|NCT01493531|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102400040|NCT01493531|Antioxidants|antioxidants|mesh-ancestor
102400041|NCT01493531|Protective Agents|protective agents|mesh-ancestor
102400042|NCT01493531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400043|NCT01493531|Uricosuric Agents|uricosuric agents|mesh-ancestor
102400044|NCT02105415|Ketamine|ketamine|mesh-list
102400045|NCT02105415|Propofol|propofol|mesh-list
102400046|NCT02105415|Etomidate|etomidate|mesh-list
102400047|NCT02105415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102400048|NCT02105415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102400049|NCT02105415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400050|NCT02105415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102400051|NCT02105415|Anesthetics, General|anesthetics, general|mesh-ancestor
102400052|NCT02105415|Anesthetics|anesthetics|mesh-ancestor
102400053|NCT02105415|Analgesics|analgesics|mesh-ancestor
102400054|NCT02105415|Sensory System Agents|sensory system agents|mesh-ancestor
102400055|NCT02105415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102400056|NCT02105415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102400057|NCT02105415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102400058|NCT02105415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102400059|NCT02105415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102400060|NCT02105415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400061|NCT01523275|Mitomycins|mitomycins|mesh-list
102400062|NCT01523275|Mitomycin|mitomycin|mesh-list
102400063|NCT01523275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102400064|NCT01523275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101883856|NCT04631601|Androgens|androgens|mesh-list
102400065|NCT01523275|Alkylating Agents|alkylating agents|mesh-ancestor
102400066|NCT01523275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400067|NCT01523275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102400068|NCT01523275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102400069|NCT00304707|Bupropion|bupropion|mesh-list
102400070|NCT00304707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102400071|NCT00304707|Antidepressive Agents|antidepressive agents|mesh-ancestor
102400072|NCT00304707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102400073|NCT00304707|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102400074|NCT00304707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102400075|NCT00304707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102400076|NCT00304707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400078|NCT00304707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102400079|NCT00304707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883981|NCT04175470|Vitamin E|vitamin e|mesh-list
102400080|NCT00304707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102400081|NCT00304707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102400082|NCT00304707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102400083|NCT04409483|Ritonavir|ritonavir|mesh-list
102400084|NCT04409483|Lopinavir|lopinavir|mesh-list
102400085|NCT04409483|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101884044|NCT03878524|Vitamins|vitamins|mesh-list
102400086|NCT04409483|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102400087|NCT04409483|Protease Inhibitors|protease inhibitors|mesh-ancestor
102400088|NCT04409483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102400089|NCT04409483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400090|NCT04409483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102400091|NCT04409483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102400092|NCT04409483|Antiviral Agents|antiviral agents|mesh-ancestor
102400093|NCT04409483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102400094|NCT04409483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102400095|NCT04409483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102400096|NCT02365740|Insulin|insulin|mesh-list
102400097|NCT02365740|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102400098|NCT02365740|Hormones|hormones|mesh-list
102400099|NCT02365740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101884192|NCT03638999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102400100|NCT02365740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400101|NCT02365740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102400102|NCT02437110|Ritonavir|ritonavir|mesh-list
102400103|NCT02437110|Darunavir|darunavir|mesh-list
102400104|NCT02437110|Tenofovir|tenofovir|mesh-list
102400105|NCT02437110|Dolutegravir|dolutegravir|mesh-list
102400106|NCT02437110|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102400107|NCT02437110|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102400108|NCT02437110|Protease Inhibitors|protease inhibitors|mesh-ancestor
102400109|NCT02437110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102400110|NCT02437110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400111|NCT02437110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102400112|NCT02437110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102400113|NCT02437110|Antiviral Agents|antiviral agents|mesh-ancestor
102400114|NCT02437110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102400115|NCT02437110|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102400116|NCT02437110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102400117|NCT02437110|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102400118|NCT02437110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101884396|NCT02989597|Anesthetics|anesthetics|mesh-ancestor
102400119|NCT02437110|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102400120|NCT02437110|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102400121|NCT05267847|Anesthetics|anesthetics|mesh-list
102400122|NCT05267847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102400123|NCT05267847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400124|NCT05267457|Vanadium|vanadium|mesh-list
102400125|NCT05267457|Trace Elements|trace elements|mesh-ancestor
102400126|NCT05267457|Micronutrients|micronutrients|mesh-ancestor
102400127|NCT05267457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400128|NCT00351039|Bevacizumab|bevacizumab|mesh-list
102400129|NCT00351039|Pemetrexed|pemetrexed|mesh-list
102400130|NCT00351039|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102400131|NCT00351039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102400132|NCT00351039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102400133|NCT00351039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101884606|NCT05532358|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102400134|NCT00351039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102400135|NCT00351039|Growth Substances|growth substances|mesh-ancestor
102400136|NCT00351039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400137|NCT00351039|Growth Inhibitors|growth inhibitors|mesh-ancestor
102400138|NCT00351039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102400139|NCT00351039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400140|NCT00351039|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102400141|NCT00351039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102400142|NCT00351039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102400143|NCT02373072|Trimethobenzamide|trimethobenzamide|mesh-list
102400144|NCT02373072|Antiemetics|antiemetics|mesh-ancestor
101884748|NCT05244213|Paclitaxel|paclitaxel|mesh-list
102400145|NCT02373072|Autonomic Agents|autonomic agents|mesh-ancestor
102400146|NCT02373072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102400147|NCT02373072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400148|NCT02373072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102400149|NCT02372916|Ranibizumab|ranibizumab|mesh-list
102400150|NCT02372916|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102400151|NCT02372916|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102400152|NCT02372916|Growth Substances|growth substances|mesh-ancestor
102400153|NCT02372916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400154|NCT02372916|Growth Inhibitors|growth inhibitors|mesh-ancestor
101884947|NCT04652245|Xhance|xhance|mesh-list
102400155|NCT02372916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102400156|NCT02361528|Sargramostim|sargramostim|mesh-list
102400157|NCT02361528|Immunologic Factors|immunologic factors|mesh-ancestor
102400158|NCT02361528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400159|NCT01572727|Paclitaxel|paclitaxel|mesh-list
101884954|NCT04652245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102400160|NCT01572727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102400161|NCT01572727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102400162|NCT01572727|Tubulin Modulators|tubulin modulators|mesh-ancestor
102400163|NCT01572727|Antimitotic Agents|antimitotic agents|mesh-ancestor
102400164|NCT01572727|Mitosis Modulators|mitosis modulators|mesh-ancestor
102400165|NCT01572727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400166|NCT02359266|Vitamin D|vitamin d|mesh-list
102400167|NCT02359266|Cholecalciferol|cholecalciferol|mesh-list
102400168|NCT02359266|Vitamins|vitamins|mesh-ancestor
102400169|NCT02359266|Micronutrients|micronutrients|mesh-ancestor
101885023|NCT04421820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885024|NCT04421820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101885025|NCT04421820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101885026|NCT04421820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102400170|NCT02359266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400171|NCT02359266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102400172|NCT02359266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102400173|NCT02359500|Octreotide|octreotide|mesh-list
102400174|NCT02359500|Edotreotide|edotreotide|mesh-list
102400175|NCT02359500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102400176|NCT02359500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102400177|NCT02359500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102400178|NCT02359500|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102400179|NCT02359500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400180|NCT02372526|Orlistat|orlistat|mesh-list
102400181|NCT02372526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102400182|NCT02372526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400183|NCT02372526|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102400184|NCT02372526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102400185|NCT02985697|Midazolam|midazolam|mesh-list
102400186|NCT02985697|Dexmedetomidine|dexmedetomidine|mesh-list
101885190|NCT05933044|Durvalumab|durvalumab|mesh-list
102400187|NCT02985697|Nitrous Oxide|nitrous oxide|mesh-list
102400188|NCT02985697|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102400189|NCT02985697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102400190|NCT02985697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885259|NCT05932472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102400191|NCT02985697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102400192|NCT02985697|Analgesics|analgesics|mesh-ancestor
102400193|NCT02985697|Sensory System Agents|sensory system agents|mesh-ancestor
102400194|NCT02985697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102400195|NCT02985697|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102400196|NCT02985697|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102400197|NCT02985697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102400198|NCT02985697|Adrenergic Agents|adrenergic agents|mesh-ancestor
102400199|NCT02985697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102400200|NCT02985697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400201|NCT02985697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102400202|NCT02985697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102400203|NCT02985697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102400204|NCT02985697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101885393|NCT05931822|Cariostatic Agents|cariostatic agents|mesh-ancestor
102400205|NCT02985697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102400206|NCT02985697|Anesthetics, General|anesthetics, general|mesh-ancestor
102400207|NCT02985697|Anesthetics|anesthetics|mesh-ancestor
102400208|NCT02985697|GABA Modulators|gaba modulators|mesh-ancestor
102400209|NCT02985697|GABA Agents|gaba agents|mesh-ancestor
102400210|NCT02985697|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102400211|NCT02372760|Lidocaine|lidocaine|mesh-list
102400212|NCT02372760|Anesthetics|anesthetics|mesh-list
102400213|NCT02372760|Anesthetics, Local|anesthetics, local|mesh-ancestor
102400214|NCT02372760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102400215|NCT02372760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400216|NCT02372760|Sensory System Agents|sensory system agents|mesh-ancestor
102400217|NCT02372760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102400218|NCT02372760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102400219|NCT02372760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101885527|NCT05931042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101885528|NCT05931042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101885529|NCT05931029|Ubiquinone|ubiquinone|mesh-list
101885530|NCT05931029|Idebenone|idebenone|mesh-list
101885531|NCT05931029|Antioxidants|antioxidants|mesh-ancestor
101885532|NCT05931029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885533|NCT05931029|Protective Agents|protective agents|mesh-ancestor
101885534|NCT05931029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885535|NCT05931029|Micronutrients|micronutrients|mesh-ancestor
101885536|NCT05930938|Cetuximab|cetuximab|mesh-list
101885537|NCT05930938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101885540|NCT05930912|Sertraline|sertraline|mesh-list
102211888|NCT04952597|Tislelizumab|tislelizumab|mesh-list
102400220|NCT02372760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102400221|NCT02372760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102400222|NCT02372760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400223|NCT00352911|Mifepristone|mifepristone|mesh-list
102400224|NCT00352911|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102400225|NCT00352911|Abortifacient Agents|abortifacient agents|mesh-ancestor
102400226|NCT00352911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102400227|NCT00352911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400228|NCT00352911|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101885597|NCT05930405|Narcotics|narcotics|mesh-ancestor
102400229|NCT00352911|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102400230|NCT00352911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102400231|NCT00352911|Contraceptive Agents|contraceptive agents|mesh-ancestor
102400232|NCT00352911|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102400233|NCT00352911|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102400234|NCT00352911|Hormone Antagonists|hormone antagonists|mesh-ancestor
101885661|NCT05930080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400235|NCT00352911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102400236|NCT00352911|Luteolytic Agents|luteolytic agents|mesh-ancestor
102400237|NCT00352911|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102400238|NCT00352911|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102400239|NCT00353301|Sirolimus|sirolimus|mesh-list
102400240|NCT00353301|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102400241|NCT00353301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102400242|NCT00353301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102400243|NCT00353301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102400244|NCT00353301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400245|NCT00353301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102400246|NCT00353301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102400247|NCT00353301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102400248|NCT00353301|Antifungal Agents|antifungal agents|mesh-ancestor
102400249|NCT00353301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102400250|NCT00353301|Immunologic Factors|immunologic factors|mesh-ancestor
102400251|NCT00353301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400252|NCT02372604|Cetirizine|cetirizine|mesh-list
102400253|NCT02372604|Levocetirizine|levocetirizine|mesh-list
102400254|NCT02372604|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102400255|NCT02372604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102400256|NCT02372604|Histamine Antagonists|histamine antagonists|mesh-ancestor
102400257|NCT02372604|Histamine Agents|histamine agents|mesh-ancestor
102400258|NCT02372604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102400259|NCT02372604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400260|NCT02372604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400261|NCT02372604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102400262|NCT01792323|Insulin Lispro|insulin lispro|mesh-list
102400263|NCT01792323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101885937|NCT05769309|Anesthetics|anesthetics|mesh-ancestor
102400264|NCT01792323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400265|NCT02358642|Lisinopril|lisinopril|mesh-list
102400266|NCT02358642|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102400267|NCT02358642|Enzyme Inhibitors|enzyme inhibitors|mesh-list
102400268|NCT02358642|Protease Inhibitors|protease inhibitors|mesh-ancestor
102400269|NCT02358642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400270|NCT02358642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102400271|NCT02358642|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102400272|NCT02358642|Protective Agents|protective agents|mesh-ancestor
102400273|NCT02358642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400274|NCT03160248|Apremilast|apremilast|mesh-list
101886003|NCT05691491|Alkylating Agents|alkylating agents|mesh-ancestor
101886004|NCT05691491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886005|NCT05691491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101886018|NCT05649722|Treprostinil|treprostinil|mesh-list
101886019|NCT05649722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101886020|NCT05640102|Zanubrutinib|zanubrutinib|mesh-list
101886021|NCT05640102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101886022|NCT05640102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101886023|NCT05640102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101886024|NCT05640102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886025|NCT05636787|Melphalan|melphalan|mesh-list
101886026|NCT05636787|Treosulfan|treosulfan|mesh-list
101886028|NCT05636787|Alkylating Agents|alkylating agents|mesh-ancestor
102400275|NCT03160248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102400276|NCT03160248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102400277|NCT03160248|Analgesics|analgesics|mesh-ancestor
101886067|NCT05627557|Hormones|hormones|mesh-ancestor
102400278|NCT03160248|Sensory System Agents|sensory system agents|mesh-ancestor
102400279|NCT03160248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102400280|NCT03160248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400281|NCT03160248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102400282|NCT03160248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102400283|NCT03160248|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102400284|NCT03160248|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102400285|NCT03160248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102400286|NCT03160248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400287|NCT01522651|Dronedarone|dronedarone|mesh-list
102400288|NCT01522651|Ranolazine|ranolazine|mesh-list
102400289|NCT01522651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102400290|NCT01522651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102400291|NCT01522651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400292|NCT01522651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102400293|NCT02372292|Furosemide|furosemide|mesh-list
102400294|NCT02372292|Diuretics|diuretics|mesh-ancestor
102400295|NCT02372292|Natriuretic Agents|natriuretic agents|mesh-ancestor
102400296|NCT02372292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400297|NCT02372292|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101886137|NCT05594667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102400298|NCT02372292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102400299|NCT02372292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400301|NCT01554241|Cholecalciferol|cholecalciferol|mesh-list
102400302|NCT01554241|Vitamins|vitamins|mesh-ancestor
102400303|NCT01554241|Micronutrients|micronutrients|mesh-ancestor
102400304|NCT01554241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400305|NCT01554241|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102400306|NCT01554241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102400307|NCT02353026|Artesunate|artesunate|mesh-list
102400308|NCT02353026|Antimalarials|antimalarials|mesh-ancestor
102400309|NCT02353026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102400310|NCT02353026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102400311|NCT02353026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102400312|NCT02353026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102400313|NCT02353026|Antiviral Agents|antiviral agents|mesh-ancestor
102400314|NCT02353026|Schistosomicides|schistosomicides|mesh-ancestor
102400315|NCT02353026|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102400316|NCT02353026|Anthelmintics|anthelmintics|mesh-ancestor
102400317|NCT01521559|Aflibercept|aflibercept|mesh-list
102400318|NCT01521559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102400319|NCT01521559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102400320|NCT01521559|Growth Substances|growth substances|mesh-ancestor
102400321|NCT01521559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400322|NCT01521559|Growth Inhibitors|growth inhibitors|mesh-ancestor
102400323|NCT01521559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102400324|NCT04438980|Methylprednisolone|methylprednisolone|mesh-list
102400325|NCT04438980|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102400326|NCT04438980|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102400327|NCT04438980|Prednisolone|prednisolone|mesh-list
102400328|NCT04438980|Prednisolone acetate|prednisolone acetate|mesh-list
102400329|NCT04438980|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102400330|NCT04438980|Prednisolone phosphate|prednisolone phosphate|mesh-list
102400331|NCT04438980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102400332|NCT04438980|Antiemetics|antiemetics|mesh-ancestor
102400333|NCT04438980|Autonomic Agents|autonomic agents|mesh-ancestor
102400334|NCT04438980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102400335|NCT04438980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400336|NCT04438980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102400337|NCT04438980|Glucocorticoids|glucocorticoids|mesh-ancestor
102400338|NCT04438980|Hormones|hormones|mesh-ancestor
102400339|NCT04438980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102400340|NCT04438980|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102400341|NCT04438980|Protective Agents|protective agents|mesh-ancestor
102400342|NCT04438980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102400343|NCT04438980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102400344|NCT03824847|Clarithromycin|clarithromycin|mesh-list
101886262|NCT05488405|Mesalamine|mesalamine|mesh-list
102400345|NCT03824847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102400346|NCT03824847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102400347|NCT03824847|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102400348|NCT03824847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102400349|NCT03824847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400350|NCT03824847|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102400351|NCT03824847|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102400352|NCT01554163|Celecoxib|celecoxib|mesh-list
102400353|NCT01554163|Etoricoxib|etoricoxib|mesh-list
102400354|NCT01554163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102400355|NCT01554163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101886373|NCT05374525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101606196|NCT00600028|Growth Substances|growth substances|mesh-ancestor
101886398|NCT05363553|Caseins|caseins|mesh-list
101886399|NCT05363553|Chelating Agents|chelating agents|mesh-ancestor
101886400|NCT05363553|Sequestering Agents|sequestering agents|mesh-ancestor
101886449|NCT05303935|Antidepressive Agents|antidepressive agents|mesh-ancestor
101886450|NCT05303935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101886451|NCT05303935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101886452|NCT05303935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101886453|NCT05303935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101886454|NCT05303935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886455|NCT05298449|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
101886456|NCT05298449|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101886457|NCT05298449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101886458|NCT05298449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101886459|NCT05298449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886460|NCT05298449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101886461|NCT05298449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101886462|NCT05298449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886463|NCT05298449|Cholinergic Agents|cholinergic agents|mesh-ancestor
101886464|NCT05298449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101606271|NCT02656810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886465|NCT05296837|Doxycycline|doxycycline|mesh-list
101886466|NCT05296837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101886467|NCT05296837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102400356|NCT01554163|Analgesics|analgesics|mesh-ancestor
102400357|NCT01554163|Sensory System Agents|sensory system agents|mesh-ancestor
102400358|NCT01554163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102400359|NCT01554163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400360|NCT01554163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102400361|NCT01554163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102400362|NCT01554163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102400363|NCT01554163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102400364|NCT01554163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101886486|NCT05280769|Cholinergic Agents|cholinergic agents|mesh-ancestor
102400365|NCT01554163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400366|NCT02360826|Simvastatin|simvastatin|mesh-list
102400367|NCT02360826|Pravastatin|pravastatin|mesh-list
102400368|NCT02360826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102212066|NCT04573946|Vitamin D|vitamin d|mesh-list
102400369|NCT02360826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101886567|NCT05166746|Clindamycin|clindamycin|mesh-list
102400370|NCT02360826|Antimetabolites|antimetabolites|mesh-ancestor
101886621|NCT05133297|Tofacitinib|tofacitinib|mesh-list
102400371|NCT02360826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400372|NCT02360826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102400373|NCT02360826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102400374|NCT02360826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102400375|NCT02361060|Atropine|atropine|mesh-list
102400376|NCT02361060|Neostigmine|neostigmine|mesh-list
102400377|NCT02361060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102400378|NCT02361060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102400379|NCT02361060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102400380|NCT02361060|Autonomic Agents|autonomic agents|mesh-ancestor
102400381|NCT02361060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102400382|NCT02361060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400383|NCT02361060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102400384|NCT02361060|Respiratory System Agents|respiratory system agents|mesh-ancestor
102400385|NCT02361060|Mydriatics|mydriatics|mesh-ancestor
101886770|NCT05025423|Venetoclax|venetoclax|mesh-list
102400386|NCT02361060|Parasympatholytics|parasympatholytics|mesh-ancestor
102400387|NCT02361060|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102400388|NCT02361060|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102400389|NCT02361060|Cholinergic Agents|cholinergic agents|mesh-ancestor
102400390|NCT02361060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101886831|NCT04999241|Analgesics|analgesics|mesh-ancestor
102400391|NCT02361060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400392|NCT02361060|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102400393|NCT02361060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102400394|NCT02361060|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102400395|NCT02360982|Fentanyl|fentanyl|mesh-list
102400396|NCT02360982|Propofol|propofol|mesh-list
102400397|NCT02360982|Bupivacaine|bupivacaine|mesh-list
102400398|NCT02360982|Rocuronium|rocuronium|mesh-list
102400399|NCT02360982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102400400|NCT02360982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102400401|NCT02360982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400402|NCT02360982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102400403|NCT02360982|Anesthetics, General|anesthetics, general|mesh-ancestor
102400404|NCT02360982|Anesthetics|anesthetics|mesh-ancestor
102400405|NCT02360982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102400406|NCT02360982|Narcotics|narcotics|mesh-ancestor
102400407|NCT02360982|Analgesics|analgesics|mesh-ancestor
102400408|NCT02360982|Sensory System Agents|sensory system agents|mesh-ancestor
102400409|NCT02360982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102400410|NCT02360982|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102400411|NCT02360982|Anesthetics, Local|anesthetics, local|mesh-ancestor
102400412|NCT02360982|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102400413|NCT02360982|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102400414|NCT02360982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102400415|NCT03786237|ON 01910|on 01910|mesh-list
102400416|NCT03786237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102400417|NCT03786237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102400418|NCT03786237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102400419|NCT03786237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400420|NCT01553851|Trametinib|trametinib|mesh-list
102400421|NCT01553851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102400422|NCT01553851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102400423|NCT01553851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101887193|NCT04418154|Epirubicin|epirubicin|mesh-list
102400424|NCT01553851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400425|NCT02358018|Edotreotide|edotreotide|mesh-list
102400426|NCT02358018|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102400427|NCT02358018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400428|NCT01552915|Methylphenidate|methylphenidate|mesh-list
102400429|NCT01552915|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102400430|NCT01552915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102400431|NCT01552915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400432|NCT01552915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102400433|NCT01552915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102400434|NCT01552915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102400435|NCT01552915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400436|NCT01552915|Dopamine Agents|dopamine agents|mesh-ancestor
102400437|NCT01552915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102400438|NCT02352714|Lidocaine|lidocaine|mesh-list
102400439|NCT02352714|Anesthetics, Local|anesthetics, local|mesh-ancestor
102400440|NCT02352714|Anesthetics|anesthetics|mesh-ancestor
102400441|NCT02352714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102400442|NCT02352714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400443|NCT02352714|Sensory System Agents|sensory system agents|mesh-ancestor
102400444|NCT02352714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102400445|NCT02352714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102400446|NCT02352714|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102400447|NCT02352714|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102400448|NCT02352714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102400449|NCT02352714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400450|NCT03911557|Durvalumab|durvalumab|mesh-list
102400451|NCT03911557|Tremelimumab|tremelimumab|mesh-list
102400452|NCT03911557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102400453|NCT03911557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102400454|NCT00356031|Bevacizumab|bevacizumab|mesh-list
102400455|NCT00356031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102400456|NCT00356031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102400457|NCT00356031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102400458|NCT00356031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102400459|NCT00356031|Growth Substances|growth substances|mesh-ancestor
102400460|NCT00356031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400461|NCT00356031|Growth Inhibitors|growth inhibitors|mesh-ancestor
102400462|NCT02038842|Vaccines|vaccines|mesh-list
102400463|NCT02038842|Immunologic Factors|immunologic factors|mesh-ancestor
102400464|NCT02038842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400465|NCT01790139|Simethicone|simethicone|mesh-list
102400466|NCT01790139|Antifoaming Agents|antifoaming agents|mesh-ancestor
102400467|NCT01790139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400468|NCT01790139|Emollients|emollients|mesh-ancestor
102400469|NCT01790139|Dermatologic Agents|dermatologic agents|mesh-ancestor
102400470|NCT02360592|Interferons|interferons|mesh-list
102400471|NCT02360592|Interferon-alpha|interferon-alpha|mesh-list
102400472|NCT02360592|Interferon alpha-2|interferon alpha-2|mesh-list
102400473|NCT02360592|Entecavir|entecavir|mesh-list
102400474|NCT02360592|Interleukin-2|interleukin-2|mesh-list
102400475|NCT02360592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102400476|NCT02360592|Antiviral Agents|antiviral agents|mesh-ancestor
102400477|NCT02360592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102400478|NCT02360592|Immunologic Factors|immunologic factors|mesh-ancestor
102400479|NCT02360592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400480|NCT02360592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102400481|NCT02360592|Analgesics|analgesics|mesh-ancestor
102400482|NCT02360592|Sensory System Agents|sensory system agents|mesh-ancestor
102400483|NCT02360592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102400484|NCT02360202|Clobetasol|clobetasol|mesh-list
102400485|NCT02360202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102400486|NCT02360202|Glucocorticoids|glucocorticoids|mesh-ancestor
102400487|NCT02360202|Hormones|hormones|mesh-ancestor
101887613|NCT03991884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102400488|NCT02360202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102400489|NCT02360202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400490|NCT00322101|Cyclosporine|cyclosporine|mesh-list
102400491|NCT00322101|Mycophenolic Acid|mycophenolic acid|mesh-list
102400492|NCT00322101|Cyclophosphamide|cyclophosphamide|mesh-list
102400493|NCT00322101|Busulfan|busulfan|mesh-list
102400494|NCT00322101|Methotrexate|methotrexate|mesh-list
102400495|NCT00322101|Fludarabine|fludarabine|mesh-list
102400496|NCT00322101|Fludarabine phosphate|fludarabine phosphate|mesh-list
102400497|NCT00322101|Tacrolimus|tacrolimus|mesh-list
102400498|NCT00322101|Cyclosporins|cyclosporins|mesh-list
102400499|NCT00322101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102400500|NCT00322101|Immunologic Factors|immunologic factors|mesh-ancestor
102400501|NCT00322101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400502|NCT00322101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102400503|NCT00322101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102400504|NCT00322101|Alkylating Agents|alkylating agents|mesh-ancestor
101887835|NCT03641313|Irinotecan|irinotecan|mesh-list
102400505|NCT00322101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400506|NCT00322101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102400507|NCT00322101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102400508|NCT00322101|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102400509|NCT00322101|Abortifacient Agents|abortifacient agents|mesh-ancestor
102400510|NCT00322101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102400511|NCT00322101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102400512|NCT00322101|Antimetabolites|antimetabolites|mesh-ancestor
102400513|NCT00322101|Dermatologic Agents|dermatologic agents|mesh-ancestor
102400514|NCT00322101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102400515|NCT00322101|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102400516|NCT00322101|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102400517|NCT00322101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102400518|NCT00322101|Antifungal Agents|antifungal agents|mesh-ancestor
102400519|NCT00322101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102400520|NCT00322101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102400521|NCT00322101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102400522|NCT00322101|Antitubercular Agents|antitubercular agents|mesh-ancestor
102400523|NCT00322101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102400524|NCT02360046|Hydrocortisone|hydrocortisone|mesh-list
102400525|NCT02360046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102400526|NCT01552681|Immunoglobulins|immunoglobulins|mesh-list
102400527|NCT01552681|Immunologic Factors|immunologic factors|mesh-ancestor
102400528|NCT01552681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400529|NCT02352402|Ticagrelor|ticagrelor|mesh-list
102400530|NCT02352402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102400531|NCT02352402|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102400532|NCT02352402|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102400533|NCT02352402|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102400534|NCT02352402|Purinergic Agents|purinergic agents|mesh-ancestor
102400535|NCT02352402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102400536|NCT02352402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400537|NCT02352402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400538|NCT02357472|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
102400539|NCT02357472|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102400540|NCT02357472|Immunologic Factors|immunologic factors|mesh-ancestor
102400541|NCT02357472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400542|NCT00322335|PENTA|penta|mesh-list
102400543|NCT00322335|Anticoagulants|anticoagulants|mesh-ancestor
102400544|NCT00322335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102400545|NCT00322335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102400546|NCT00322335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400547|NCT03153852|Glycolic acid|glycolic acid|mesh-list
102400548|NCT03153852|Keratolytic Agents|keratolytic agents|mesh-ancestor
101888319|NCT02633059|Dexamethasone|dexamethasone|mesh-list
102400549|NCT03153852|Dermatologic Agents|dermatologic agents|mesh-ancestor
102400550|NCT04751175|Dexamethasone|dexamethasone|mesh-list
102400551|NCT04751175|Ketamine|ketamine|mesh-list
102400552|NCT04751175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102400553|NCT04751175|Antiemetics|antiemetics|mesh-ancestor
102400554|NCT04751175|Autonomic Agents|autonomic agents|mesh-ancestor
102400555|NCT04751175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102400556|NCT04751175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400557|NCT04751175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102400558|NCT04751175|Glucocorticoids|glucocorticoids|mesh-ancestor
102400559|NCT04751175|Hormones|hormones|mesh-ancestor
101888472|NCT02199236|Antimetabolites|antimetabolites|mesh-ancestor
102400560|NCT04751175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102400561|NCT04751175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102400562|NCT04751175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102400563|NCT04751175|Analgesics|analgesics|mesh-ancestor
102400564|NCT04751175|Sensory System Agents|sensory system agents|mesh-ancestor
102400565|NCT04751175|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102400566|NCT04751175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102400567|NCT04751175|Anesthetics, General|anesthetics, general|mesh-ancestor
102400568|NCT04751175|Anesthetics|anesthetics|mesh-ancestor
102400569|NCT04751175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102400570|NCT04751175|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102400571|NCT04751175|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102400572|NCT04751175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102400573|NCT04751175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400574|NCT01792557|Phenol|phenol|mesh-list
102400575|NCT01792557|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102400576|NCT01792557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102400577|NCT01792557|Disinfectants|disinfectants|mesh-ancestor
102400578|NCT01792557|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102400579|NCT01792557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102400580|NCT01792713|Sertaconazole|sertaconazole|mesh-list
102400581|NCT01792713|Antifungal Agents|antifungal agents|mesh-ancestor
102400582|NCT01792713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102400583|NCT02352168|Budesonide|budesonide|mesh-list
102400584|NCT02352168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102400585|NCT02352168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102400586|NCT02352168|Autonomic Agents|autonomic agents|mesh-ancestor
102400587|NCT02352168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102400588|NCT02352168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400589|NCT02352168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102400590|NCT02352168|Respiratory System Agents|respiratory system agents|mesh-ancestor
102400591|NCT02352168|Glucocorticoids|glucocorticoids|mesh-ancestor
102400592|NCT02352168|Hormones|hormones|mesh-ancestor
102400593|NCT02352168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102400594|NCT02357004|Carvedilol|carvedilol|mesh-list
101888906|NCT00046930|Cytarabine|cytarabine|mesh-list
102400595|NCT02357004|Chlorthalidone|chlorthalidone|mesh-list
102400596|NCT02357004|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102400597|NCT02357004|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102400598|NCT02357004|Adrenergic Agents|adrenergic agents|mesh-ancestor
102400599|NCT02357004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102400600|NCT02357004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400601|NCT02357004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400602|NCT02357004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102400603|NCT02357004|Antioxidants|antioxidants|mesh-ancestor
102400604|NCT02357004|Protective Agents|protective agents|mesh-ancestor
102400605|NCT02357004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102400606|NCT02357004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102400607|NCT02357004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101889043|NCT04316013|Lidocaine|lidocaine|mesh-list
102400608|NCT02357004|Vasodilator Agents|vasodilator agents|mesh-ancestor
102400609|NCT02357004|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102400610|NCT02357004|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102400611|NCT02357004|Diuretics|diuretics|mesh-ancestor
102400612|NCT02357004|Natriuretic Agents|natriuretic agents|mesh-ancestor
102400613|NCT02357004|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102400614|NCT01570387|Dexamethasone|dexamethasone|mesh-list
102400615|NCT01570387|Dexamethasone acetate|dexamethasone acetate|mesh-list
102400616|NCT01570387|Pomalidomide|pomalidomide|mesh-list
102400617|NCT01570387|BB 1101|bb 1101|mesh-list
102400618|NCT01570387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102400619|NCT01570387|Antiemetics|antiemetics|mesh-ancestor
102400620|NCT01570387|Autonomic Agents|autonomic agents|mesh-ancestor
102400621|NCT01570387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102400622|NCT01570387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400623|NCT01570387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102400624|NCT01570387|Glucocorticoids|glucocorticoids|mesh-ancestor
102400625|NCT01570387|Hormones|hormones|mesh-ancestor
102400626|NCT01570387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102400627|NCT01570387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102400628|NCT01570387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102400629|NCT01570387|Protease Inhibitors|protease inhibitors|mesh-ancestor
102400630|NCT01570387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102400631|NCT01570387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400632|NCT01570387|Immunologic Factors|immunologic factors|mesh-ancestor
102400633|NCT01570387|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101889473|NCT01233635|Losartan|losartan|mesh-list
102400634|NCT01570387|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102400635|NCT01570387|Growth Substances|growth substances|mesh-ancestor
102400636|NCT01570387|Growth Inhibitors|growth inhibitors|mesh-ancestor
102400637|NCT02348424|Solithromycin|solithromycin|mesh-list
102400638|NCT02348424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101889552|NCT03957668|Lactulose|lactulose|mesh-list
102400639|NCT02348424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102400640|NCT01570309|Ergocalciferols|ergocalciferols|mesh-list
102400641|NCT01570309|Vitamin D|vitamin d|mesh-list
102400642|NCT01570309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102400643|NCT01570309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400644|NCT01570309|Vitamins|vitamins|mesh-ancestor
102400645|NCT01570309|Micronutrients|micronutrients|mesh-ancestor
102400646|NCT01570309|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102400647|NCT02356146|Tacrolimus|tacrolimus|mesh-list
102400648|NCT02356146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102400649|NCT02356146|Immunologic Factors|immunologic factors|mesh-ancestor
102400650|NCT02356146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400651|NCT02356146|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101889675|NCT00072176|Sirolimus|sirolimus|mesh-list
102400652|NCT02356146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102400653|NCT02356146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400654|NCT01519921|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102400655|NCT01519921|Antiviral Agents|antiviral agents|mesh-ancestor
102400656|NCT01519921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102400657|NCT01519765|Misoprostol|misoprostol|mesh-list
102400658|NCT01519765|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102400659|NCT01519765|Abortifacient Agents|abortifacient agents|mesh-ancestor
102400660|NCT01519765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102400661|NCT01519765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400662|NCT01519765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102400663|NCT01519765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102400664|NCT01519765|Oxytocics|oxytocics|mesh-ancestor
102400665|NCT03147066|Flurbiprofen|flurbiprofen|mesh-list
102400666|NCT03147066|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
102400667|NCT03147066|Dezocine|dezocine|mesh-list
102400668|NCT03147066|Analgesics|analgesics|mesh-ancestor
102400669|NCT03147066|Sensory System Agents|sensory system agents|mesh-ancestor
102400670|NCT03147066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102400671|NCT03147066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400672|NCT03147066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102400673|NCT03147066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102400674|NCT03147066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102400675|NCT03147066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102400676|NCT03147066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102400677|NCT03147066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102400678|NCT03147066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400679|NCT03147066|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102400680|NCT03147066|Narcotics|narcotics|mesh-ancestor
102400681|NCT03147066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102400682|NCT02351622|Dexamethasone|dexamethasone|mesh-list
102400683|NCT02351622|Caffeic acid|caffeic acid|mesh-list
102400684|NCT02351622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102400685|NCT02351622|Antiemetics|antiemetics|mesh-ancestor
102400686|NCT02351622|Autonomic Agents|autonomic agents|mesh-ancestor
102400687|NCT02351622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102400688|NCT02351622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400689|NCT02351622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102400690|NCT02351622|Glucocorticoids|glucocorticoids|mesh-ancestor
102400691|NCT02351622|Hormones|hormones|mesh-ancestor
102400692|NCT02351622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102400693|NCT02351622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102400694|NCT02351622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102400695|NCT02351622|Antioxidants|antioxidants|mesh-ancestor
102400696|NCT02351622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400697|NCT02351622|Protective Agents|protective agents|mesh-ancestor
102400698|NCT01552603|Pancrelipase|pancrelipase|mesh-list
102400699|NCT01552603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102400700|NCT02348190|Heparin|heparin|mesh-list
102400701|NCT02348190|Anticoagulants|anticoagulants|mesh-ancestor
102400702|NCT02348190|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102400703|NCT02348190|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102400704|NCT02348190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400705|NCT01552369|Valganciclovir|valganciclovir|mesh-list
102400706|NCT01552369|Antiviral Agents|antiviral agents|mesh-ancestor
102400707|NCT01552369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102400708|NCT02351232|Liraglutide|liraglutide|mesh-list
102400709|NCT02351232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102400710|NCT02351232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400711|NCT02351232|Incretins|incretins|mesh-ancestor
102400712|NCT02351232|Hormones|hormones|mesh-ancestor
102400713|NCT02351232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102400714|NCT02355756|Maxadilan protein, insect|maxadilan protein, insect|mesh-list
102400715|NCT02355756|Vasodilator Agents|vasodilator agents|mesh-ancestor
102400716|NCT03150030|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102400717|NCT03150030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400718|NCT02355678|Acetaminophen|acetaminophen|mesh-list
102400719|NCT02355678|Dexamethasone|dexamethasone|mesh-list
102400720|NCT02355678|Propacetamol|propacetamol|mesh-list
102400721|NCT02355678|Tramadol|tramadol|mesh-list
102400722|NCT02355678|Anesthetics|anesthetics|mesh-list
102400723|NCT02355678|Anesthetics, Local|anesthetics, local|mesh-list
102400724|NCT02355678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102400725|NCT02355678|Antiemetics|antiemetics|mesh-ancestor
102400726|NCT02355678|Autonomic Agents|autonomic agents|mesh-ancestor
102400727|NCT02355678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102400728|NCT02355678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400729|NCT02355678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102400730|NCT02355678|Glucocorticoids|glucocorticoids|mesh-ancestor
102400731|NCT02355678|Hormones|hormones|mesh-ancestor
102400732|NCT02355678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102400733|NCT02355678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102400734|NCT02355678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102400735|NCT02355678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102400736|NCT02355678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102400737|NCT02355678|Analgesics|analgesics|mesh-ancestor
102400738|NCT02355678|Sensory System Agents|sensory system agents|mesh-ancestor
102400739|NCT02355678|Antipyretics|antipyretics|mesh-ancestor
102400740|NCT02355678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102400741|NCT02355678|Narcotics|narcotics|mesh-ancestor
102400742|NCT02355678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102400743|NCT02355678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102400744|NCT02351310|Betamethasone|betamethasone|mesh-list
102400745|NCT02351310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102400746|NCT02351310|Glucocorticoids|glucocorticoids|mesh-ancestor
102400747|NCT02351310|Hormones|hormones|mesh-ancestor
102212395|NCT03907488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102400748|NCT02351310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102400749|NCT02351310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400750|NCT02351310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102400751|NCT02351310|Respiratory System Agents|respiratory system agents|mesh-ancestor
102400752|NCT02347878|Aprepitant|aprepitant|mesh-list
102400753|NCT02347878|Antiemetics|antiemetics|mesh-ancestor
102400754|NCT02347878|Autonomic Agents|autonomic agents|mesh-ancestor
102400755|NCT02347878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102400756|NCT02347878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400757|NCT02347878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101890692|NCT01085721|Expectorants|expectorants|mesh-ancestor
102400758|NCT02347878|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102400759|NCT02347878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101890763|NCT01046981|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102400760|NCT02347878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400761|NCT02355522|Lidocaine|lidocaine|mesh-list
102400762|NCT02355522|Anesthetics, Local|anesthetics, local|mesh-ancestor
102400763|NCT02355522|Anesthetics|anesthetics|mesh-ancestor
101890835|NCT00376961|Bortezomib|bortezomib|mesh-list
102400764|NCT02355522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102400765|NCT02355522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400766|NCT02355522|Sensory System Agents|sensory system agents|mesh-ancestor
102400767|NCT02355522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102400768|NCT02355522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102400769|NCT02355522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102400770|NCT02355522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102400771|NCT02355522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102400772|NCT02355522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400773|NCT02355054|Choline|choline|mesh-list
102400774|NCT02355054|Lipotropic Agents|lipotropic agents|mesh-ancestor
102400775|NCT02355054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102400776|NCT02355054|Antimetabolites|antimetabolites|mesh-ancestor
102400777|NCT02355054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400778|NCT02355054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102400779|NCT02355054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102400780|NCT02355054|Nootropic Agents|nootropic agents|mesh-ancestor
102400781|NCT04478448|Favipiravir|favipiravir|mesh-list
102400782|NCT04478448|Antiviral Agents|antiviral agents|mesh-ancestor
102400783|NCT04478448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102400784|NCT04478526|Norepinephrine|norepinephrine|mesh-list
102400785|NCT04478526|Serotonin|serotonin|mesh-list
102400786|NCT04478526|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
102400787|NCT04478526|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
102400788|NCT04478526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102400789|NCT04478526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102400790|NCT04478526|Adrenergic Agents|adrenergic agents|mesh-ancestor
102400791|NCT04478526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101891102|NCT00078312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102400792|NCT04478526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400793|NCT04478526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400794|NCT04478526|Sympathomimetics|sympathomimetics|mesh-ancestor
102400795|NCT04478526|Autonomic Agents|autonomic agents|mesh-ancestor
102400796|NCT04478526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102400797|NCT04478526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102400798|NCT04478526|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102400799|NCT04478526|Serotonin Agents|serotonin agents|mesh-ancestor
102400800|NCT04478526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102400801|NCT04478526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102400802|NCT01552057|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102400803|NCT01552057|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102400804|NCT01552057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102400805|NCT01552057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102400806|NCT01552057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400807|NCT01552057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102400808|NCT01552057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400809|NCT01552057|Analgesics|analgesics|mesh-ancestor
102400810|NCT01552057|Sensory System Agents|sensory system agents|mesh-ancestor
102400811|NCT01552057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102400812|NCT01552057|Antidepressive Agents|antidepressive agents|mesh-ancestor
102400813|NCT01552057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102400814|NCT01552057|Dopamine Agents|dopamine agents|mesh-ancestor
102400815|NCT02350686|Capecitabine|capecitabine|mesh-list
102400816|NCT02350686|Oxaliplatin|oxaliplatin|mesh-list
102400817|NCT02350686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102400818|NCT02350686|Antimetabolites|antimetabolites|mesh-ancestor
102400819|NCT02350686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400820|NCT02350686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102400821|NCT03159078|Imipenem|imipenem|mesh-list
102400822|NCT03159078|Polymyxins|polymyxins|mesh-list
101891454|NCT05842213|Golimumab|golimumab|mesh-list
102400823|NCT03159078|Polymyxin B|polymyxin b|mesh-list
102400824|NCT03159078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102400825|NCT03159078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102400826|NCT01551745|Bevacizumab|bevacizumab|mesh-list
102400827|NCT01551745|Vaccines|vaccines|mesh-list
102400828|NCT01551745|Immunologic Factors|immunologic factors|mesh-ancestor
102400829|NCT01551745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400830|NCT01551745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102400831|NCT01551745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102400832|NCT01551745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102400833|NCT01551745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102400834|NCT01551745|Growth Substances|growth substances|mesh-ancestor
102400835|NCT01551745|Growth Inhibitors|growth inhibitors|mesh-ancestor
102400836|NCT02350530|Bevacizumab|bevacizumab|mesh-list
102400837|NCT02350530|Fluorouracil|fluorouracil|mesh-list
102400838|NCT02350530|Oxaliplatin|oxaliplatin|mesh-list
102400839|NCT02350530|Irinotecan|irinotecan|mesh-list
102400840|NCT02350530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102400841|NCT02350530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102400842|NCT02350530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102400843|NCT02350530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102400844|NCT02350530|Growth Substances|growth substances|mesh-ancestor
102400845|NCT02350530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400846|NCT02350530|Growth Inhibitors|growth inhibitors|mesh-ancestor
102400847|NCT02350530|Antimetabolites|antimetabolites|mesh-ancestor
102400848|NCT02350530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400849|NCT02350530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102400850|NCT02350530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102400851|NCT02350530|Immunologic Factors|immunologic factors|mesh-ancestor
102400852|NCT02350530|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102400853|NCT02350530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102400854|NCT02350530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102400855|NCT01569841|Insulin|insulin|mesh-list
102400856|NCT01569841|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102400857|NCT01569841|Insulin Glargine|insulin glargine|mesh-list
102400858|NCT01569841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101891525|NCT05841446|Apixaban|apixaban|mesh-list
102400859|NCT01569841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400860|NCT01550965|Adalimumab|adalimumab|mesh-list
102400861|NCT01550965|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102400862|NCT01550965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102400863|NCT01550965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102400864|NCT05265819|Hormones|hormones|mesh-list
102400865|NCT05265819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102400866|NCT05265819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400867|NCT02353494|Piperaquine|piperaquine|mesh-list
102400868|NCT02353494|Artenimol|artenimol|mesh-list
102400869|NCT02353494|Antimalarials|antimalarials|mesh-ancestor
102400870|NCT02353494|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102400871|NCT02353494|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102400872|NCT02353494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102400873|NCT02353260|Docetaxel|docetaxel|mesh-list
102400874|NCT02353260|Fluorouracil|fluorouracil|mesh-list
102400875|NCT02353260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102400876|NCT02353260|Tubulin Modulators|tubulin modulators|mesh-ancestor
102400877|NCT02353260|Antimitotic Agents|antimitotic agents|mesh-ancestor
102400878|NCT02353260|Mitosis Modulators|mitosis modulators|mesh-ancestor
102400879|NCT02353260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400880|NCT02353260|Antimetabolites|antimetabolites|mesh-ancestor
102400881|NCT02353260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102400882|NCT02353260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102400883|NCT02353260|Immunologic Factors|immunologic factors|mesh-ancestor
102400884|NCT02353260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400885|NCT03158610|Capecitabine|capecitabine|mesh-list
102400886|NCT03158610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102400887|NCT03158610|Antimetabolites|antimetabolites|mesh-ancestor
102400888|NCT03158610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400889|NCT03158610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102400890|NCT00323739|Bevacizumab|bevacizumab|mesh-list
102400891|NCT00323739|Everolimus|everolimus|mesh-list
102400892|NCT00323739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102400893|NCT00323739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102400894|NCT00323739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102400895|NCT00323739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102400896|NCT00323739|Growth Substances|growth substances|mesh-ancestor
102400897|NCT00323739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212544|NCT03689244|Selexipag|selexipag|mesh-list
102400898|NCT00323739|Growth Inhibitors|growth inhibitors|mesh-ancestor
102400899|NCT00323739|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102400900|NCT00323739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102400901|NCT00323739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102400902|NCT00323739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400903|NCT00323739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102400904|NCT00323739|Immunologic Factors|immunologic factors|mesh-ancestor
102400905|NCT02350218|Alprostadil|alprostadil|mesh-list
102400906|NCT02350218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102400907|NCT02350218|Vasodilator Agents|vasodilator agents|mesh-ancestor
102400908|NCT02350218|Urological Agents|urological agents|mesh-ancestor
102400909|NCT00390429|Docetaxel|docetaxel|mesh-list
102400910|NCT00390429|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102400911|NCT00390429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102400912|NCT00390429|Tubulin Modulators|tubulin modulators|mesh-ancestor
102400913|NCT00390429|Antimitotic Agents|antimitotic agents|mesh-ancestor
102400914|NCT00390429|Mitosis Modulators|mitosis modulators|mesh-ancestor
102400915|NCT00390429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400916|NCT00390429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102400917|NCT00390429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102400918|NCT02349828|Acyclovir|acyclovir|mesh-list
102400919|NCT02349828|Antiviral Agents|antiviral agents|mesh-ancestor
102400920|NCT02349828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102400921|NCT02353182|Dexmedetomidine|dexmedetomidine|mesh-list
102400922|NCT02353182|Remifentanil|remifentanil|mesh-list
102400923|NCT02353182|Bupivacaine|bupivacaine|mesh-list
102400924|NCT02353182|Ropivacaine|ropivacaine|mesh-list
102400925|NCT02353182|Anesthetics, Local|anesthetics, local|mesh-ancestor
102400926|NCT02353182|Anesthetics|anesthetics|mesh-ancestor
102400927|NCT02353182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102400928|NCT02353182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400929|NCT02353182|Sensory System Agents|sensory system agents|mesh-ancestor
102400930|NCT02353182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102400931|NCT02353182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102400932|NCT02353182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102400933|NCT02353182|Analgesics|analgesics|mesh-ancestor
102400934|NCT02353182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102400935|NCT02353182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102400936|NCT02353182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102400937|NCT02353182|Adrenergic Agents|adrenergic agents|mesh-ancestor
102400938|NCT02353182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102400939|NCT02353182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400940|NCT02353182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102400941|NCT02353182|Narcotics|narcotics|mesh-ancestor
102400942|NCT02349516|Squalamine|squalamine|mesh-list
102400943|NCT02349516|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102400944|NCT02349516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102400945|NCT02349516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102400946|NCT02349516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102400947|NCT02349516|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102400948|NCT02349516|Protective Agents|protective agents|mesh-ancestor
102400949|NCT02349516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400950|NCT02349516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102400951|NCT02349516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102400952|NCT02349516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102400953|NCT02349516|Growth Substances|growth substances|mesh-ancestor
102400954|NCT02349516|Growth Inhibitors|growth inhibitors|mesh-ancestor
102400955|NCT02349594|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102400956|NCT02349594|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102400957|NCT02349594|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102400958|NCT02349594|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102400959|NCT02346084|Maraviroc|maraviroc|mesh-list
102400960|NCT02346084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102400961|NCT02346084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102400962|NCT02346084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400963|NCT02346084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102400964|NCT02346084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102400965|NCT02346084|Antiviral Agents|antiviral agents|mesh-ancestor
102400966|NCT02346084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102400967|NCT02346084|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102400968|NCT03149250|Hemostatics|hemostatics|mesh-list
102400969|NCT03149250|Coagulants|coagulants|mesh-ancestor
102400970|NCT00391443|Bosentan|bosentan|mesh-list
102400971|NCT00391443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102400972|NCT00391443|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102400973|NCT00391443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102400974|NCT02343432|Triamcinolone|triamcinolone|mesh-list
102400975|NCT02343432|Bupivacaine|bupivacaine|mesh-list
102400976|NCT02343432|Anesthetics, Local|anesthetics, local|mesh-ancestor
102400977|NCT02343432|Anesthetics|anesthetics|mesh-ancestor
102400978|NCT02343432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102400979|NCT02343432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400980|NCT02343432|Sensory System Agents|sensory system agents|mesh-ancestor
102400981|NCT02343432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102400982|NCT02343432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102400983|NCT02343432|Glucocorticoids|glucocorticoids|mesh-ancestor
102400984|NCT02343432|Hormones|hormones|mesh-ancestor
102400985|NCT02343432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102400986|NCT02349282|Vitamin D|vitamin d|mesh-list
102400987|NCT02349282|Cholecalciferol|cholecalciferol|mesh-list
102400988|NCT02349282|Calcifediol|calcifediol|mesh-list
102400989|NCT02349282|Vitamins|vitamins|mesh-ancestor
102400990|NCT02349282|Micronutrients|micronutrients|mesh-ancestor
102400991|NCT02349282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400992|NCT02349282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102400993|NCT02349282|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102400994|NCT02349204|Zaleplon|zaleplon|mesh-list
102400995|NCT02349204|Anticonvulsants|anticonvulsants|mesh-ancestor
102400996|NCT02349204|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102400997|NCT02349204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102400998|NCT02349204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102400999|NCT02349204|GABA Modulators|gaba modulators|mesh-ancestor
102401000|NCT02349204|GABA Agents|gaba agents|mesh-ancestor
102401001|NCT02349204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102401002|NCT02349204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401003|NCT02345616|Nitric Oxide|nitric oxide|mesh-list
102401004|NCT02345616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102401005|NCT02345616|Autonomic Agents|autonomic agents|mesh-ancestor
102401006|NCT02345616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102401007|NCT02345616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401008|NCT02345616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102401009|NCT02345616|Respiratory System Agents|respiratory system agents|mesh-ancestor
102401010|NCT02345616|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102401011|NCT02345616|Antioxidants|antioxidants|mesh-ancestor
102401012|NCT02345616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401013|NCT02345616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102401014|NCT02345616|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102401015|NCT02345616|Vasodilator Agents|vasodilator agents|mesh-ancestor
102401016|NCT02345616|Gasotransmitters|gasotransmitters|mesh-ancestor
102401017|NCT02345616|Protective Agents|protective agents|mesh-ancestor
102401018|NCT00391989|Dasatinib|dasatinib|mesh-list
102401019|NCT00391989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102401020|NCT00391989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102401021|NCT00391989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102401022|NCT00391989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401023|NCT03148704|Palonosetron|palonosetron|mesh-list
102401024|NCT03148704|Antiemetics|antiemetics|mesh-ancestor
102401025|NCT03148704|Autonomic Agents|autonomic agents|mesh-ancestor
102401026|NCT03148704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102401027|NCT03148704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401028|NCT03148704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102401029|NCT03148704|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102401030|NCT03148704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102401031|NCT03148704|Serotonin Agents|serotonin agents|mesh-ancestor
102401032|NCT03148704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102401033|NCT03148704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401034|NCT01795287|Anesthetics|anesthetics|mesh-list
102401035|NCT01795287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102401036|NCT01795287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401037|NCT04976283|Pioglitazone|pioglitazone|mesh-list
102401038|NCT04976283|Empagliflozin|empagliflozin|mesh-list
102401039|NCT04976283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102401040|NCT04976283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401041|NCT04976283|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102401042|NCT04976283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401043|NCT02345304|Digoxin|digoxin|mesh-list
102401044|NCT02345304|Midazolam|midazolam|mesh-list
102401045|NCT02345304|Omeprazole|omeprazole|mesh-list
102401046|NCT02345304|Warfarin|warfarin|mesh-list
102401047|NCT02345304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102401048|NCT02345304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102401049|NCT02345304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102401050|NCT02345304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401051|NCT02345304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102401052|NCT02345304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102401053|NCT02345304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102401054|NCT02345304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102401055|NCT02345304|Anesthetics, General|anesthetics, general|mesh-ancestor
102401056|NCT02345304|Anesthetics|anesthetics|mesh-ancestor
102401057|NCT02345304|GABA Modulators|gaba modulators|mesh-ancestor
102401058|NCT02345304|GABA Agents|gaba agents|mesh-ancestor
102401059|NCT02345304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102401060|NCT02345304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401061|NCT02345304|Anticoagulants|anticoagulants|mesh-ancestor
102401062|NCT02345304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102401063|NCT02345304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102401064|NCT02345304|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102401065|NCT02345304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102401066|NCT02345304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102401067|NCT02345304|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102401068|NCT02345304|Protective Agents|protective agents|mesh-ancestor
102401069|NCT01569295|Rituximab|rituximab|mesh-list
102401070|NCT01569295|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102401071|NCT01569295|Idelalisib|idelalisib|mesh-list
101892430|NCT01925131|Tubulin Modulators|tubulin modulators|mesh-ancestor
102401072|NCT01569295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102401073|NCT01569295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102401074|NCT01569295|Immunologic Factors|immunologic factors|mesh-ancestor
102401075|NCT01569295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892505|NCT00840177|Cytarabine|cytarabine|mesh-list
102401076|NCT01569295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102401077|NCT01569295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102401078|NCT01569295|Alkylating Agents|alkylating agents|mesh-ancestor
102401079|NCT01569295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401080|NCT01569295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102401081|NCT03112278|Salicylic Acid|salicylic acid|mesh-list
101892568|NCT00363545|Vaccines|vaccines|mesh-list
102401082|NCT03112278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102401083|NCT03112278|Antifungal Agents|antifungal agents|mesh-ancestor
102401084|NCT03112278|Keratolytic Agents|keratolytic agents|mesh-ancestor
102401085|NCT03112278|Dermatologic Agents|dermatologic agents|mesh-ancestor
102401086|NCT02345148|Esketamine|esketamine|mesh-list
101892645|NCT03957174|Rivastigmine|rivastigmine|mesh-list
102401087|NCT02345148|Antidepressive Agents|antidepressive agents|mesh-ancestor
102401088|NCT02345148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102401089|NCT00394329|Beclomethasone|beclomethasone|mesh-list
102401090|NCT00394329|Albuterol|albuterol|mesh-list
102401091|NCT00394329|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102401092|NCT00394329|Autonomic Agents|autonomic agents|mesh-ancestor
102401093|NCT00394329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102401094|NCT00394329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401095|NCT00394329|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102401096|NCT00394329|Respiratory System Agents|respiratory system agents|mesh-ancestor
102401097|NCT00394329|Tocolytic Agents|tocolytic agents|mesh-ancestor
102401098|NCT00394329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102401099|NCT00394329|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102401100|NCT00394329|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102401101|NCT00394329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102401102|NCT00394329|Adrenergic Agents|adrenergic agents|mesh-ancestor
102401103|NCT00394329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102401104|NCT00394329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401105|NCT00394329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102401106|NCT00394329|Glucocorticoids|glucocorticoids|mesh-ancestor
102401107|NCT00394329|Hormones|hormones|mesh-ancestor
102401108|NCT00394329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102401109|NCT03146052|Simethicone|simethicone|mesh-list
102401110|NCT03146052|Bisacodyl|bisacodyl|mesh-list
102401111|NCT03146052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401112|NCT03146052|Cathartics|cathartics|mesh-ancestor
102401113|NCT03146052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102401114|NCT03146052|Laxatives|laxatives|mesh-ancestor
102401115|NCT03146052|Antifoaming Agents|antifoaming agents|mesh-ancestor
102401116|NCT03146052|Emollients|emollients|mesh-ancestor
102401117|NCT03146052|Dermatologic Agents|dermatologic agents|mesh-ancestor
102401118|NCT01549951|Prednisone|prednisone|mesh-list
102401119|NCT01549951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102401120|NCT01549951|Glucocorticoids|glucocorticoids|mesh-ancestor
102401121|NCT01549951|Hormones|hormones|mesh-ancestor
102401122|NCT01549951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102401123|NCT01549951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401124|NCT01549951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102401125|NCT01549951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102401126|NCT03148314|Misoprostol|misoprostol|mesh-list
102401127|NCT03148314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102401129|NCT03148314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102401130|NCT03148314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401131|NCT03148314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102401132|NCT03148314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102401133|NCT03148314|Oxytocics|oxytocics|mesh-ancestor
102401134|NCT01517893|Simvastatin|simvastatin|mesh-list
102401135|NCT01517893|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102401136|NCT01517893|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102401137|NCT01517893|Antimetabolites|antimetabolites|mesh-ancestor
102401138|NCT01517893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401139|NCT01517893|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102401140|NCT01517893|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102401141|NCT01517893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102401142|NCT02344992|Insulin Lispro|insulin lispro|mesh-list
102401143|NCT02344992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102401144|NCT02344992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401145|NCT01489891|Lidocaine|lidocaine|mesh-list
102401146|NCT01489891|Anesthetics, Local|anesthetics, local|mesh-ancestor
102401147|NCT01489891|Anesthetics|anesthetics|mesh-ancestor
102401148|NCT01489891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102401149|NCT01489891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401150|NCT01489891|Sensory System Agents|sensory system agents|mesh-ancestor
102401151|NCT01489891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102401152|NCT01489891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102401153|NCT01489891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102401154|NCT01489891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102401155|NCT01489891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102401156|NCT01489891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401157|NCT02342574|Olorofim|olorofim|mesh-list
102401158|NCT02342574|Antifungal Agents|antifungal agents|mesh-ancestor
102401159|NCT02342574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102401160|NCT03148002|Lactulose|lactulose|mesh-list
102401161|NCT03148002|Sennosides|sennosides|mesh-list
102401162|NCT03148002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102401163|NCT03148002|Laxatives|laxatives|mesh-ancestor
102401164|NCT02342184|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102401165|NCT02342184|Immunologic Factors|immunologic factors|mesh-ancestor
102401166|NCT02342184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401167|NCT00396201|Plerixafor|plerixafor|mesh-list
102401168|NCT00396201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102401169|NCT00396201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102401170|NCT00396201|Antiviral Agents|antiviral agents|mesh-ancestor
102401171|NCT00396201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102401172|NCT03145896|Vitamin D|vitamin d|mesh-list
102401173|NCT03145896|Vitamins|vitamins|mesh-ancestor
102401174|NCT03145896|Micronutrients|micronutrients|mesh-ancestor
102401175|NCT03145896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401176|NCT03145896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102401177|NCT02341872|Calcium|calcium|mesh-list
102401178|NCT02341872|Fluorides|fluorides|mesh-list
102401179|NCT02341872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102401180|NCT02341872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401181|NCT02341872|Cariostatic Agents|cariostatic agents|mesh-ancestor
102401182|NCT02341872|Protective Agents|protective agents|mesh-ancestor
102401183|NCT00360399|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102401184|NCT00360399|Escitalopram|escitalopram|mesh-list
102401185|NCT00360399|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102401186|NCT00360399|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102401187|NCT00360399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102401188|NCT00360399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401189|NCT00360399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102401190|NCT00360399|Serotonin Agents|serotonin agents|mesh-ancestor
102401191|NCT00360399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893073|NCT00356915|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102401192|NCT00360399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102401193|NCT00360399|Antidepressive Agents|antidepressive agents|mesh-ancestor
102401194|NCT00360399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101893136|NCT01096472|Octenidine|octenidine|mesh-list
102401231|NCT02341404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102401232|NCT02341404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401233|NCT02341638|Aspirin|aspirin|mesh-list
102401234|NCT02341638|Itraconazole|itraconazole|mesh-list
102401235|NCT02341638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102401236|NCT02341638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102401237|NCT02341638|Analgesics|analgesics|mesh-ancestor
102401238|NCT02341638|Sensory System Agents|sensory system agents|mesh-ancestor
102401239|NCT02341638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102401240|NCT02341638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401241|NCT02341638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102401242|NCT02341638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102401243|NCT02341638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102401244|NCT02341638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102401245|NCT02341638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401246|NCT02341638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102401247|NCT02341638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102401248|NCT02341638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102401249|NCT02341638|Antipyretics|antipyretics|mesh-ancestor
102401250|NCT02341638|Antifungal Agents|antifungal agents|mesh-ancestor
102401251|NCT02341638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102401252|NCT02341638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102401253|NCT02341638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102401254|NCT02341638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102401255|NCT02341638|Hormone Antagonists|hormone antagonists|mesh-ancestor
102401256|NCT02341638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102401257|NCT02341638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102401258|NCT02337192|Chlorhexidine|chlorhexidine|mesh-list
102401259|NCT02337192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102401260|NCT02337192|Curcumin|curcumin|mesh-list
102401261|NCT02337192|Pulmonary Surfactants|pulmonary surfactants|mesh-list
102401262|NCT02337192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102401263|NCT02337192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102401264|NCT02337192|Disinfectants|disinfectants|mesh-ancestor
102401265|NCT02337192|Dermatologic Agents|dermatologic agents|mesh-ancestor
102401266|NCT02337192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102401267|NCT02337192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102401268|NCT02337192|Analgesics|analgesics|mesh-ancestor
102401269|NCT02337192|Sensory System Agents|sensory system agents|mesh-ancestor
102401270|NCT02337192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102401271|NCT02337192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401272|NCT02337192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102401273|NCT02337192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102401274|NCT02337192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102401275|NCT02337192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102401276|NCT02337192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401277|NCT02337192|Respiratory System Agents|respiratory system agents|mesh-ancestor
102401278|NCT03111966|Grazoprevir|grazoprevir|mesh-list
102401279|NCT03111966|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
102401280|NCT03111966|Antiviral Agents|antiviral agents|mesh-ancestor
102401281|NCT03111966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102401282|NCT02343666|Plerixafor|plerixafor|mesh-list
102401283|NCT02343666|Carmustine|carmustine|mesh-list
102401284|NCT02343666|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
102401285|NCT02343666|Lenograstim|lenograstim|mesh-list
102401286|NCT02343666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102401287|NCT02343666|Immunologic Factors|immunologic factors|mesh-ancestor
102401288|NCT02343666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401289|NCT02343666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102401290|NCT02343666|Alkylating Agents|alkylating agents|mesh-ancestor
102401291|NCT02343666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401292|NCT02343666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102401293|NCT02343666|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102401294|NCT02343666|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102401295|NCT02343666|Antiviral Agents|antiviral agents|mesh-ancestor
102401296|NCT02343666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102401297|NCT02343666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102401298|NCT02332356|Adalimumab|adalimumab|mesh-list
102401299|NCT02332356|Infliximab|infliximab|mesh-list
102401300|NCT02332356|Azathioprine|azathioprine|mesh-list
102401301|NCT02332356|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102032403|NCT03114969|Tiotropium Bromide|tiotropium bromide|mesh-list
102401302|NCT02332356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102401303|NCT02332356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102401304|NCT02332356|Dermatologic Agents|dermatologic agents|mesh-ancestor
102401305|NCT02332356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102401306|NCT02332356|Antimetabolites|antimetabolites|mesh-ancestor
102401307|NCT02332356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401308|NCT02332356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102401309|NCT02332356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102401310|NCT02332356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102401311|NCT02332356|Immunologic Factors|immunologic factors|mesh-ancestor
102401312|NCT02332356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401313|NCT02340936|Lenalidomide|lenalidomide|mesh-list
102401314|NCT02340936|Immunologic Factors|immunologic factors|mesh-ancestor
102401315|NCT02340936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401316|NCT02340936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102401317|NCT02340936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102401318|NCT02340936|Growth Substances|growth substances|mesh-ancestor
102401319|NCT02340936|Growth Inhibitors|growth inhibitors|mesh-ancestor
102401320|NCT02340936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102401321|NCT02332044|Bepotastine besilate|bepotastine besilate|mesh-list
102401322|NCT02332044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102401323|NCT02337036|Tacrolimus|tacrolimus|mesh-list
102401324|NCT02337036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102401325|NCT02337036|Immunologic Factors|immunologic factors|mesh-ancestor
102032425|NCT03144778|Tremelimumab|tremelimumab|mesh-list
102401326|NCT02337036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401327|NCT02337036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102401328|NCT02337036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102032441|NCT05124678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102401329|NCT02337036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401330|NCT02336568|Oxytocin|oxytocin|mesh-list
102401331|NCT02336568|Oxytocics|oxytocics|mesh-ancestor
102401332|NCT02336568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102401333|NCT02336568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401334|NCT05253768|Glycerol|glycerol|mesh-list
102401335|NCT05253768|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102401336|NCT05253768|Protective Agents|protective agents|mesh-ancestor
102401337|NCT05253768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401338|NCT04630938|Lidocaine|lidocaine|mesh-list
102401339|NCT04630938|Morphine|morphine|mesh-list
102401340|NCT04630938|Anesthetics, Local|anesthetics, local|mesh-ancestor
102401341|NCT04630938|Anesthetics|anesthetics|mesh-ancestor
102401342|NCT04630938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102401343|NCT04630938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401344|NCT04630938|Sensory System Agents|sensory system agents|mesh-ancestor
102401345|NCT04630938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102401346|NCT04630938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102401347|NCT04630938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102401348|NCT04630938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102401349|NCT04630938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102401350|NCT04630938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401351|NCT04630938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102401352|NCT04630938|Narcotics|narcotics|mesh-ancestor
102401353|NCT04630938|Analgesics|analgesics|mesh-ancestor
102401355|NCT04594746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102401356|NCT04594746|Vasodilator Agents|vasodilator agents|mesh-ancestor
102401357|NCT04594746|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102401358|NCT04594746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102401359|NCT04594746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401360|NCT04594746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102401361|NCT04594746|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102401362|NCT04594746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102401363|NCT04594746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102032473|NCT05003076|Methamphetamine|methamphetamine|mesh-list
102401364|NCT04594746|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102401365|NCT04594746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102401366|NCT04594746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102401367|NCT02790138|Ciprofloxacin|ciprofloxacin|mesh-list
102401368|NCT02790138|Vedolizumab|vedolizumab|mesh-list
102401369|NCT02790138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102401370|NCT02790138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102401371|NCT02790138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102401372|NCT02790138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102401373|NCT02790138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102401374|NCT02790138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401375|NCT02790138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102401376|NCT02790138|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102401377|NCT02790138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102401378|NCT02790138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102401379|NCT02339844|Aripiprazole|aripiprazole|mesh-list
102401380|NCT02339844|Antidepressive Agents|antidepressive agents|mesh-ancestor
102401381|NCT02339844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102401382|NCT02339844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102401383|NCT02339844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102401384|NCT02339844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102401385|NCT02339844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401386|NCT02339844|Dopamine Agonists|dopamine agonists|mesh-ancestor
102401387|NCT02339844|Dopamine Agents|dopamine agents|mesh-ancestor
102401388|NCT02339844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102401389|NCT02339844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401390|NCT02339844|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102401391|NCT02339844|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102401392|NCT02339844|Serotonin Agents|serotonin agents|mesh-ancestor
102401393|NCT02339844|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102401394|NCT02339844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102401395|NCT02339844|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102401396|NCT02339844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102401397|NCT00397839|Ibandronic Acid|ibandronic acid|mesh-list
102401398|NCT00397839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102401399|NCT00397839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401400|NCT02331576|Fentanyl|fentanyl|mesh-list
102401401|NCT02331576|Ropivacaine|ropivacaine|mesh-list
102401402|NCT02331576|Anesthetics, Local|anesthetics, local|mesh-ancestor
102401403|NCT02331576|Anesthetics|anesthetics|mesh-ancestor
102401404|NCT02331576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102401405|NCT02331576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401406|NCT02331576|Sensory System Agents|sensory system agents|mesh-ancestor
102401407|NCT02331576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102401408|NCT02331576|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102401409|NCT02331576|Narcotics|narcotics|mesh-ancestor
102401410|NCT02331576|Analgesics|analgesics|mesh-ancestor
102401411|NCT02331576|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102401412|NCT02331576|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102401413|NCT02331576|Anesthetics, General|anesthetics, general|mesh-ancestor
102401414|NCT00400803|Bevacizumab|bevacizumab|mesh-list
102401415|NCT00400803|Carboplatin|carboplatin|mesh-list
102401416|NCT00400803|Gemcitabine|gemcitabine|mesh-list
102401417|NCT00400803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102032516|NCT02327416|Entecavir|entecavir|mesh-list
102401418|NCT00400803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102401419|NCT00400803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102401420|NCT00400803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102401421|NCT00400803|Growth Substances|growth substances|mesh-ancestor
102401422|NCT00400803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401423|NCT00400803|Growth Inhibitors|growth inhibitors|mesh-ancestor
102401424|NCT00400803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102213079|NCT02298959|Pembrolizumab|pembrolizumab|mesh-list
102401425|NCT00400803|Antimetabolites|antimetabolites|mesh-ancestor
102401426|NCT00400803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401427|NCT04681443|Phenol|phenol|mesh-list
102401428|NCT04681443|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102401429|NCT04681443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102401430|NCT04681443|Disinfectants|disinfectants|mesh-ancestor
102401431|NCT04681443|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102401432|NCT04681443|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102401433|NCT02339142|Methylprednisolone|methylprednisolone|mesh-list
102401434|NCT02339142|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102401435|NCT02339142|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102401436|NCT02339142|Prednisolone|prednisolone|mesh-list
102401437|NCT02339142|Prednisolone acetate|prednisolone acetate|mesh-list
102401438|NCT02339142|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102401439|NCT02339142|Prednisolone phosphate|prednisolone phosphate|mesh-list
102401440|NCT02339142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102401441|NCT02339142|Antiemetics|antiemetics|mesh-ancestor
102401442|NCT02339142|Autonomic Agents|autonomic agents|mesh-ancestor
102032538|NCT01064414|Canagliflozin|canagliflozin|mesh-list
102401443|NCT02339142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102401444|NCT02339142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401445|NCT02339142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102401446|NCT02339142|Glucocorticoids|glucocorticoids|mesh-ancestor
102401447|NCT02339142|Hormones|hormones|mesh-ancestor
102401448|NCT02339142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102401449|NCT02339142|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102401450|NCT02339142|Protective Agents|protective agents|mesh-ancestor
102401451|NCT02339142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102401452|NCT02339142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102401453|NCT00362817|Carboplatin|carboplatin|mesh-list
102401454|NCT00362817|Temozolomide|temozolomide|mesh-list
102401455|NCT00362817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102032546|NCT03433703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102401456|NCT00362817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102401457|NCT00362817|Alkylating Agents|alkylating agents|mesh-ancestor
102401458|NCT00362817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401459|NCT02330952|Prednisone|prednisone|mesh-list
102401460|NCT02330952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102401461|NCT02330952|Glucocorticoids|glucocorticoids|mesh-ancestor
102401462|NCT02330952|Hormones|hormones|mesh-ancestor
102401463|NCT02330952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102401464|NCT02330952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401465|NCT02330952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102401466|NCT02330952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102401467|NCT02338830|Progesterone|progesterone|mesh-list
102401468|NCT02338830|Progestins|progestins|mesh-ancestor
102401469|NCT02338830|Hormones|hormones|mesh-ancestor
102401470|NCT02338830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102401471|NCT02338830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401472|NCT00364377|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102401473|NCT00364377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102401474|NCT00364377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401475|NCT00364377|Incretins|incretins|mesh-ancestor
102401476|NCT00364377|Hormones|hormones|mesh-ancestor
102401477|NCT00364377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102401478|NCT00364377|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102401479|NCT00364377|Protease Inhibitors|protease inhibitors|mesh-ancestor
102401480|NCT00364377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102401481|NCT00364377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401482|NCT04175886|Tofacitinib|tofacitinib|mesh-list
102401483|NCT04175886|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102401484|NCT04175886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102401485|NCT04175886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102401486|NCT04175886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401487|NCT02338674|Tenofovir|tenofovir|mesh-list
102401488|NCT02338674|Telbivudine|telbivudine|mesh-list
102401489|NCT02338674|Antiviral Agents|antiviral agents|mesh-ancestor
102401490|NCT02338674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102401491|NCT02338674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102401492|NCT02338674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102401493|NCT02338674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102401494|NCT02338674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401495|NCT02338674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102401496|NCT02338674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102401497|NCT02338518|Oxaliplatin|oxaliplatin|mesh-list
102401498|NCT02338518|Etoposide|etoposide|mesh-list
102401499|NCT02338518|Epirubicin|epirubicin|mesh-list
102213155|NCT01932697|Docetaxel|docetaxel|mesh-list
102401500|NCT02338518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102401501|NCT02338518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102401502|NCT02338518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102401503|NCT02338518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102401504|NCT02338518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102401505|NCT02338518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401506|NCT02338518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102401508|NCT01826838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102401509|NCT01826838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102401510|NCT01826838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102401511|NCT01826838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401512|NCT00365391|Bevacizumab|bevacizumab|mesh-list
102401513|NCT00365391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102401514|NCT00365391|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102401515|NCT00365391|Antibodies|antibodies|mesh-list
102401516|NCT00365391|Immunoglobulins|immunoglobulins|mesh-list
102401517|NCT00365391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102401518|NCT00365391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102401519|NCT00365391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102401520|NCT00365391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102401521|NCT00365391|Growth Substances|growth substances|mesh-ancestor
102401522|NCT00365391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401523|NCT00365391|Growth Inhibitors|growth inhibitors|mesh-ancestor
102401524|NCT00365391|Immunologic Factors|immunologic factors|mesh-ancestor
102032613|NCT04629378|Amoxicillin|amoxicillin|mesh-list
102401525|NCT00365391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102401526|NCT00365391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102401527|NCT00365391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401528|NCT03105180|Mannitol|mannitol|mesh-list
102401529|NCT03105180|Sorbitol|sorbitol|mesh-list
102401530|NCT03105180|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102401531|NCT03105180|Diuretics|diuretics|mesh-ancestor
102401532|NCT03105180|Natriuretic Agents|natriuretic agents|mesh-ancestor
102401533|NCT03105180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401534|NCT03105180|Cathartics|cathartics|mesh-ancestor
102401535|NCT03105180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102401536|NCT02331030|Ropivacaine|ropivacaine|mesh-list
102401537|NCT02331030|Anesthetics, Local|anesthetics, local|mesh-ancestor
102401538|NCT02331030|Anesthetics|anesthetics|mesh-ancestor
102401539|NCT02331030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102401540|NCT02331030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032626|NCT03651674|Olanzapine|olanzapine|mesh-list
102401541|NCT02331030|Sensory System Agents|sensory system agents|mesh-ancestor
102401542|NCT02331030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102401543|NCT04270929|Folfirinox|folfirinox|mesh-list
102401544|NCT04270929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102401545|NCT00401817|Bevacizumab|bevacizumab|mesh-list
102401546|NCT00401817|Rituximab|rituximab|mesh-list
102401547|NCT00401817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102401548|NCT00401817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102401549|NCT00401817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102401550|NCT00401817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101334172|NCT00043069|Hormones|hormones|mesh-ancestor
102401551|NCT00401817|Growth Substances|growth substances|mesh-ancestor
102401552|NCT00401817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401553|NCT00401817|Growth Inhibitors|growth inhibitors|mesh-ancestor
102401554|NCT00401817|Immunologic Factors|immunologic factors|mesh-ancestor
102401555|NCT00401817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102401556|NCT04417179|Bupivacaine|bupivacaine|mesh-list
102401557|NCT04417179|Anesthetics, Local|anesthetics, local|mesh-ancestor
102401558|NCT04417179|Anesthetics|anesthetics|mesh-ancestor
102401559|NCT04417179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102401560|NCT04417179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401561|NCT04417179|Sensory System Agents|sensory system agents|mesh-ancestor
102401562|NCT04417179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102401563|NCT02330796|Bucillamine|bucillamine|mesh-list
102401564|NCT02330796|Colchicine|colchicine|mesh-list
102401565|NCT02330796|Gout Suppressants|gout suppressants|mesh-ancestor
102401566|NCT02330796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102401567|NCT02330796|Tubulin Modulators|tubulin modulators|mesh-ancestor
102401568|NCT02330796|Antimitotic Agents|antimitotic agents|mesh-ancestor
102401569|NCT02330796|Mitosis Modulators|mitosis modulators|mesh-ancestor
102401570|NCT02330796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401571|NCT02330796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102401572|NCT02330796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102401573|NCT02330796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102401574|NCT02330796|Analgesics|analgesics|mesh-ancestor
102213227|NCT00869232|Doxorubicin|doxorubicin|mesh-list
102401575|NCT02330796|Sensory System Agents|sensory system agents|mesh-ancestor
102401576|NCT02330796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102401577|NCT02330796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401578|NCT02330796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102401579|NCT02330796|Antioxidants|antioxidants|mesh-ancestor
102401580|NCT02330796|Protective Agents|protective agents|mesh-ancestor
102401581|NCT02330640|Clopidogrel|clopidogrel|mesh-list
102401582|NCT02330640|Ticagrelor|ticagrelor|mesh-list
102401583|NCT02330640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102401584|NCT02330640|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102401585|NCT02330640|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102401586|NCT02330640|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102401587|NCT02330640|Purinergic Agents|purinergic agents|mesh-ancestor
102401588|NCT02330640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102401589|NCT02330640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401590|NCT02330640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401591|NCT02335398|Methadone|methadone|mesh-list
102401592|NCT02335398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102401593|NCT02335398|Narcotics|narcotics|mesh-ancestor
102401594|NCT02335398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102401595|NCT02335398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401596|NCT02335398|Analgesics|analgesics|mesh-ancestor
102401597|NCT02335398|Sensory System Agents|sensory system agents|mesh-ancestor
102401598|NCT02335398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102401599|NCT02335398|Antitussive Agents|antitussive agents|mesh-ancestor
102401600|NCT02335398|Respiratory System Agents|respiratory system agents|mesh-ancestor
102401601|NCT02338206|Hormones|hormones|mesh-list
102401602|NCT02338206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102401603|NCT02338206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401604|NCT02338050|Immunotoxin HA22|immunotoxin ha22|mesh-list
102401605|NCT02338050|Immunotoxins|immunotoxins|mesh-ancestor
102401606|NCT02338050|Immunoconjugates|immunoconjugates|mesh-ancestor
102401607|NCT02338050|Immunologic Factors|immunologic factors|mesh-ancestor
102401608|NCT02338050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401609|NCT02338050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102401610|NCT02330406|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102401611|NCT02330406|Anagliptin|anagliptin|mesh-list
102401612|NCT02330406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102401613|NCT02330406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401614|NCT02330406|Incretins|incretins|mesh-ancestor
102401615|NCT02330406|Hormones|hormones|mesh-ancestor
102401616|NCT02330406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102401617|NCT02330406|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102401618|NCT02330406|Protease Inhibitors|protease inhibitors|mesh-ancestor
102401619|NCT02330406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102401620|NCT02330406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401621|NCT03906708|Carbon Monoxide|carbon monoxide|mesh-list
102401622|NCT03906708|Antimetabolites|antimetabolites|mesh-ancestor
102401623|NCT03906708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401624|NCT03906708|Gasotransmitters|gasotransmitters|mesh-ancestor
102401625|NCT03906708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102401626|NCT03906708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401627|NCT02337972|Povidone-Iodine|povidone-iodine|mesh-list
102401628|NCT02337972|Povidone|povidone|mesh-list
102401629|NCT02337972|Plasma Substitutes|plasma substitutes|mesh-ancestor
102401630|NCT02337972|Blood Substitutes|blood substitutes|mesh-ancestor
102401631|NCT02337972|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102401632|NCT02337972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102401633|NCT02335164|Hemagglutinins|hemagglutinins|mesh-list
102401634|NCT02335164|Agglutinins|agglutinins|mesh-ancestor
102401635|NCT02335164|Immunologic Factors|immunologic factors|mesh-ancestor
102401636|NCT02335164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401637|NCT02335164|Coagulants|coagulants|mesh-ancestor
102401638|NCT00365859|Aripiprazole|aripiprazole|mesh-list
102401639|NCT00365859|Antidepressive Agents|antidepressive agents|mesh-ancestor
102401640|NCT00365859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102401641|NCT00365859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102401642|NCT00365859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102401643|NCT00365859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102401644|NCT00365859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334265|NCT00043537|Fluoxetine|fluoxetine|mesh-list
102401645|NCT00365859|Dopamine Agonists|dopamine agonists|mesh-ancestor
102401646|NCT00365859|Dopamine Agents|dopamine agents|mesh-ancestor
102401647|NCT00365859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102401648|NCT00365859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401649|NCT00365859|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102401650|NCT00365859|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102401651|NCT00365859|Serotonin Agents|serotonin agents|mesh-ancestor
102401652|NCT00365859|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102401653|NCT00365859|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102401654|NCT00365859|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102401655|NCT00365859|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102401656|NCT02337426|Temozolomide|temozolomide|mesh-list
102401657|NCT02337426|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102401658|NCT02337426|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102401659|NCT02337426|Alkylating Agents|alkylating agents|mesh-ancestor
102401660|NCT02337426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401661|NCT02337426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102032743|NCT05761470|Paclitaxel|paclitaxel|mesh-list
102401662|NCT02337426|Dermatologic Agents|dermatologic agents|mesh-ancestor
102401663|NCT02337426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102401664|NCT02337426|Immunologic Factors|immunologic factors|mesh-ancestor
102401665|NCT02337426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401666|NCT03664830|Plerixafor|plerixafor|mesh-list
102401667|NCT03664830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102401668|NCT03664830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102401669|NCT03664830|Antiviral Agents|antiviral agents|mesh-ancestor
102401670|NCT03664830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102401671|NCT00407355|Ranibizumab|ranibizumab|mesh-list
102401672|NCT00407355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102401673|NCT00407355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102401674|NCT00407355|Growth Substances|growth substances|mesh-ancestor
102401675|NCT00407355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401676|NCT00407355|Growth Inhibitors|growth inhibitors|mesh-ancestor
102401677|NCT00407355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102401678|NCT02334462|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102401679|NCT02334462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102401680|NCT02334462|Immunologic Factors|immunologic factors|mesh-ancestor
102401681|NCT02334462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401682|NCT02334462|Antacids|antacids|mesh-ancestor
102401683|NCT02334462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401684|NCT02334462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102401685|NCT03144882|Curcumin|curcumin|mesh-list
102401686|NCT03144882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102401687|NCT03144882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102401688|NCT03144882|Analgesics|analgesics|mesh-ancestor
102401689|NCT03144882|Sensory System Agents|sensory system agents|mesh-ancestor
102401690|NCT03144882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102401691|NCT03144882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401692|NCT03144882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102401693|NCT03144882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102401694|NCT03144882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102401695|NCT03144882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102401696|NCT03144882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401697|NCT01793259|Methotrexate|methotrexate|mesh-list
102401698|NCT01793259|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102401699|NCT01793259|Abortifacient Agents|abortifacient agents|mesh-ancestor
102401700|NCT01793259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102401701|NCT01793259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401702|NCT01793259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102401703|NCT01793259|Antimetabolites|antimetabolites|mesh-ancestor
102032775|NCT03650270|Anesthetics|anesthetics|mesh-ancestor
102032776|NCT03650270|GABA Modulators|gaba modulators|mesh-ancestor
102401704|NCT01793259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401705|NCT01793259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102401706|NCT01793259|Dermatologic Agents|dermatologic agents|mesh-ancestor
102401707|NCT01793259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102401708|NCT01793259|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102401709|NCT01793259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102401710|NCT01793259|Immunologic Factors|immunologic factors|mesh-ancestor
102401711|NCT01793259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102401712|NCT01793259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102401713|NCT02329626|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102401714|NCT02329626|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102401715|NCT02329626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401716|NCT03111810|Prednisolone|prednisolone|mesh-list
102401717|NCT03111810|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102401718|NCT03111810|Methylprednisolone|methylprednisolone|mesh-list
102401719|NCT03111810|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102401720|NCT03111810|Prednisolone acetate|prednisolone acetate|mesh-list
102401721|NCT03111810|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102401722|NCT03111810|Prednisolone phosphate|prednisolone phosphate|mesh-list
102401723|NCT03111810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102401724|NCT03111810|Glucocorticoids|glucocorticoids|mesh-ancestor
102401725|NCT03111810|Hormones|hormones|mesh-ancestor
102401726|NCT03111810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102401727|NCT03111810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401728|NCT03111810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102401729|NCT03111810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102401730|NCT03111810|Antiemetics|antiemetics|mesh-ancestor
102401731|NCT03111810|Autonomic Agents|autonomic agents|mesh-ancestor
102401732|NCT03111810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102401733|NCT03111810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102401734|NCT03111810|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102401735|NCT03111810|Protective Agents|protective agents|mesh-ancestor
102401736|NCT02334150|Sufentanil|sufentanil|mesh-list
102401737|NCT02334150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102401738|NCT02334150|Narcotics|narcotics|mesh-ancestor
102401739|NCT02334150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102401740|NCT02334150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401741|NCT02334150|Analgesics|analgesics|mesh-ancestor
102401742|NCT02334150|Sensory System Agents|sensory system agents|mesh-ancestor
102401743|NCT02334150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102401744|NCT02334150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102401745|NCT02334150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102401746|NCT02334150|Anesthetics, General|anesthetics, general|mesh-ancestor
102401747|NCT02334150|Anesthetics|anesthetics|mesh-ancestor
102401748|NCT02326428|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102401749|NCT02326428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102032803|NCT05204628|Crizotinib|crizotinib|mesh-list
102032834|NCT03649334|Sensory System Agents|sensory system agents|mesh-ancestor
102032835|NCT03649334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102032836|NCT03649334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401750|NCT02326428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102401751|NCT02326428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401752|NCT04477590|Metformin|metformin|mesh-list
102401753|NCT04477590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102401754|NCT04477590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401755|NCT02333838|Fludarabine|fludarabine|mesh-list
102401756|NCT02333838|Fludarabine phosphate|fludarabine phosphate|mesh-list
102401757|NCT02333838|Busulfan|busulfan|mesh-list
102401758|NCT02333838|Thiotepa|thiotepa|mesh-list
102401759|NCT02333838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102401760|NCT02333838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102401761|NCT02333838|Antimetabolites|antimetabolites|mesh-ancestor
102401762|NCT02333838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401763|NCT02333838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102401764|NCT02333838|Immunologic Factors|immunologic factors|mesh-ancestor
102401765|NCT02333838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401766|NCT02333838|Alkylating Agents|alkylating agents|mesh-ancestor
102401767|NCT02333838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102401768|NCT02333838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102401769|NCT02326584|Cytarabine|cytarabine|mesh-list
102401770|NCT02326584|Daunorubicin|daunorubicin|mesh-list
102401771|NCT02326584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102401772|NCT02326584|Antimetabolites|antimetabolites|mesh-ancestor
102401773|NCT02326584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401774|NCT02326584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102401775|NCT02326584|Antiviral Agents|antiviral agents|mesh-ancestor
102401776|NCT02326584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102401777|NCT02326584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102401778|NCT02326584|Immunologic Factors|immunologic factors|mesh-ancestor
102401779|NCT02326584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401780|NCT02326584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102401781|NCT02326584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102401782|NCT02326584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102401783|NCT02326584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102401784|NCT03111342|Lidocaine|lidocaine|mesh-list
102401785|NCT03111342|Anesthetics, Local|anesthetics, local|mesh-ancestor
102401786|NCT03111342|Anesthetics|anesthetics|mesh-ancestor
102401787|NCT03111342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102401788|NCT03111342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401789|NCT03111342|Sensory System Agents|sensory system agents|mesh-ancestor
102401790|NCT03111342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102401791|NCT03111342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102401792|NCT03111342|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102401793|NCT03111342|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102401794|NCT03111342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102401795|NCT03111342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401796|NCT03111420|Clopidogrel|clopidogrel|mesh-list
102401797|NCT03111420|Ticagrelor|ticagrelor|mesh-list
102401798|NCT03111420|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102401799|NCT03111420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102401800|NCT03111420|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102401801|NCT03111420|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102401802|NCT03111420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102401803|NCT03111420|Purinergic Agents|purinergic agents|mesh-ancestor
102401804|NCT03111420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102401805|NCT03111420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401806|NCT03111420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401807|NCT02333682|Vitamin D|vitamin d|mesh-list
102401808|NCT02333682|Cholecalciferol|cholecalciferol|mesh-list
102401809|NCT02333682|Calcifediol|calcifediol|mesh-list
102401810|NCT02333682|Vitamins|vitamins|mesh-ancestor
102401811|NCT02333682|Micronutrients|micronutrients|mesh-ancestor
102401812|NCT02333682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401813|NCT02333682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102032880|NCT03068754|Hormones|hormones|mesh-ancestor
102401814|NCT02333682|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102401815|NCT02328456|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102401816|NCT02328456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102401817|NCT02326350|Aspirin|aspirin|mesh-list
102401818|NCT02326350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102401819|NCT02326350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102401820|NCT02326350|Analgesics|analgesics|mesh-ancestor
102401821|NCT02326350|Sensory System Agents|sensory system agents|mesh-ancestor
102401822|NCT02326350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102401823|NCT02326350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401824|NCT02326350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102401825|NCT02326350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102401826|NCT02326350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102401827|NCT02326350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102401828|NCT02326350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401829|NCT02326350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102401830|NCT02326350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102401831|NCT02326350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102401832|NCT02326350|Antipyretics|antipyretics|mesh-ancestor
102401833|NCT02326194|Vaccines|vaccines|mesh-list
102401834|NCT02326194|Immunologic Factors|immunologic factors|mesh-ancestor
102401835|NCT02326194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401836|NCT02326038|Methylphenidate|methylphenidate|mesh-list
102401837|NCT02326038|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102032898|NCT03452189|Vancomycin|vancomycin|mesh-list
102401838|NCT02326038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401839|NCT02326038|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102401840|NCT02326038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102401841|NCT02326038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102401842|NCT02326038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401843|NCT02326038|Dopamine Agents|dopamine agents|mesh-ancestor
102401844|NCT02326038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102401845|NCT00970866|Folic Acid|folic acid|mesh-list
102401846|NCT00970866|Micronutrients|micronutrients|mesh-list
102401847|NCT00970866|Trace Elements|trace elements|mesh-list
102401848|NCT00970866|Hematinics|hematinics|mesh-ancestor
102401849|NCT00970866|Vitamin B Complex|vitamin b complex|mesh-ancestor
102401850|NCT00970866|Vitamins|vitamins|mesh-ancestor
102401851|NCT00970866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401852|NCT03145584|Bupivacaine|bupivacaine|mesh-list
102401853|NCT03145584|Anesthetics, Local|anesthetics, local|mesh-ancestor
102401854|NCT03145584|Anesthetics|anesthetics|mesh-ancestor
102401855|NCT03145584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102401856|NCT03145584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401857|NCT03145584|Sensory System Agents|sensory system agents|mesh-ancestor
102401858|NCT03145584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102401859|NCT03145194|Ticagrelor|ticagrelor|mesh-list
102401860|NCT03145194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102401861|NCT03145194|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102401862|NCT03145194|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102401863|NCT03145194|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102401864|NCT03145194|Purinergic Agents|purinergic agents|mesh-ancestor
102401865|NCT03145194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102401866|NCT03145194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213533|NCT02260492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102213534|NCT02260492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102032929|NCT01372371|Vancomycin|vancomycin|mesh-list
102213535|NCT02260492|Autonomic Agents|autonomic agents|mesh-ancestor
102213536|NCT02260492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102213537|NCT02260492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213538|NCT02260492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102401868|NCT03143946|Vitamins|vitamins|mesh-list
102401869|NCT03143946|Micronutrients|micronutrients|mesh-ancestor
102401870|NCT03143946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401871|NCT02039700|Lesinurad|lesinurad|mesh-list
102401872|NCT02039700|Gout Suppressants|gout suppressants|mesh-ancestor
102401873|NCT02039700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102401874|NCT02039700|Uricosuric Agents|uricosuric agents|mesh-ancestor
102401875|NCT05076474|Orlistat|orlistat|mesh-list
102401876|NCT05076474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102401877|NCT05076474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401878|NCT05076474|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102401879|NCT05076474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102401880|NCT02328144|Metronidazole|metronidazole|mesh-list
102401881|NCT02328144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102401882|NCT02328144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102401883|NCT02328144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102401884|NCT02328144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102401885|NCT02327676|Emtricitabine|emtricitabine|mesh-list
102401886|NCT02327676|Antiviral Agents|antiviral agents|mesh-ancestor
102401887|NCT02327676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102401888|NCT02327676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102401889|NCT02327676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102401890|NCT02327676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102401891|NCT02327676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401892|NCT02327676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102401893|NCT02327676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102401894|NCT02333058|Treosulfan|treosulfan|mesh-list
102401895|NCT02333058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102401896|NCT02333058|Alkylating Agents|alkylating agents|mesh-ancestor
102032954|NCT01374789|Panitumumab|panitumumab|mesh-list
102401897|NCT02333058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401898|NCT02333058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101603921|NCT02679820|Copper|copper|mesh-list
102401899|NCT03111186|Acetaminophen|acetaminophen|mesh-list
102401900|NCT03111186|Ibuprofen|ibuprofen|mesh-list
102401901|NCT03111186|Oxycodone|oxycodone|mesh-list
102401902|NCT03111186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102401903|NCT03111186|Analgesics|analgesics|mesh-ancestor
102401904|NCT03111186|Sensory System Agents|sensory system agents|mesh-ancestor
102032987|NCT01376193|Naratriptan|naratriptan|mesh-list
102401905|NCT03111186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102401906|NCT03111186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401907|NCT03111186|Antipyretics|antipyretics|mesh-ancestor
102401908|NCT03111186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102401909|NCT03111186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102401910|NCT03111186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102401911|NCT03111186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102401912|NCT03111186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102401913|NCT03111186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401914|NCT03111186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102401915|NCT03111186|Narcotics|narcotics|mesh-ancestor
102401916|NCT03111186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102401917|NCT02332512|Apatinib|apatinib|mesh-list
102401918|NCT02332512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102401919|NCT02332512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102401920|NCT02332512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102401921|NCT02332512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401922|NCT02327754|FYX-051|fyx-051|mesh-list
102401923|NCT02327754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102401924|NCT02327754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401925|NCT03142620|Vitamin D|vitamin d|mesh-list
102401926|NCT03142620|Cholecalciferol|cholecalciferol|mesh-list
102401927|NCT03142620|Amoxicillin|amoxicillin|mesh-list
102401928|NCT03142620|Clarithromycin|clarithromycin|mesh-list
102401929|NCT03142620|Clavulanic Acid|clavulanic acid|mesh-list
102401930|NCT03142620|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102401931|NCT03142620|Esomeprazole|esomeprazole|mesh-list
102401932|NCT03142620|Vitamins|vitamins|mesh-ancestor
102401933|NCT03142620|Micronutrients|micronutrients|mesh-ancestor
102401934|NCT03142620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401935|NCT03142620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102401936|NCT03142620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102401937|NCT03142620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102401938|NCT03142620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102401939|NCT03142620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102401940|NCT03142620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102401941|NCT03142620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102401942|NCT03142620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102401943|NCT03142620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401944|NCT03142620|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102401945|NCT03142620|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102401946|NCT03142620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102401947|NCT03142620|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102401948|NCT03110952|alpha-Tocopherol|alpha-tocopherol|mesh-list
102401949|NCT03110952|Vaccines|vaccines|mesh-list
102401950|NCT03110952|Immunologic Factors|immunologic factors|mesh-ancestor
102401951|NCT03110952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401952|NCT03110952|Antioxidants|antioxidants|mesh-ancestor
102401953|NCT03110952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401954|NCT03110952|Protective Agents|protective agents|mesh-ancestor
102401955|NCT03110952|Vitamins|vitamins|mesh-ancestor
102401956|NCT03110952|Micronutrients|micronutrients|mesh-ancestor
102401957|NCT03143244|Ketorolac|ketorolac|mesh-list
102401958|NCT03143244|Midazolam|midazolam|mesh-list
102401959|NCT03143244|Dexmedetomidine|dexmedetomidine|mesh-list
102401960|NCT03143244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102401961|NCT03143244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102401962|NCT03143244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102401963|NCT03143244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102401964|NCT03143244|Analgesics|analgesics|mesh-ancestor
102401965|NCT03143244|Sensory System Agents|sensory system agents|mesh-ancestor
102401966|NCT03143244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102401967|NCT03143244|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102401968|NCT03143244|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102401969|NCT03143244|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102401970|NCT03143244|Adrenergic Agents|adrenergic agents|mesh-ancestor
102401971|NCT03143244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102401972|NCT03143244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033035|NCT01376271|Paroxetine|paroxetine|mesh-list
102401973|NCT03143244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102401974|NCT03143244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102401975|NCT03143244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102401976|NCT03143244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102401977|NCT03143244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102401978|NCT03143244|Anesthetics, General|anesthetics, general|mesh-ancestor
102401979|NCT03143244|Anesthetics|anesthetics|mesh-ancestor
102401980|NCT03143244|GABA Modulators|gaba modulators|mesh-ancestor
102401981|NCT03143244|GABA Agents|gaba agents|mesh-ancestor
102401982|NCT03143244|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102401983|NCT03143244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102401984|NCT03143244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102401985|NCT03143244|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102401986|NCT03143244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102401987|NCT03838692|Ponatinib|ponatinib|mesh-list
102401988|NCT03838692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102401989|NCT03838692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102401990|NCT03838692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102401991|NCT03838692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102401992|NCT03774186|Pancrelipase|pancrelipase|mesh-list
102401993|NCT03774186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102401994|NCT03505944|Venetoclax|venetoclax|mesh-list
102401995|NCT03505944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102401996|NCT01489189|Ranibizumab|ranibizumab|mesh-list
102401997|NCT01489189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102401998|NCT01489189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102401999|NCT01489189|Growth Substances|growth substances|mesh-ancestor
102402000|NCT01489189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402001|NCT01489189|Growth Inhibitors|growth inhibitors|mesh-ancestor
102402002|NCT01489189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102402003|NCT01549873|Propofol|propofol|mesh-list
102402004|NCT01549873|Desflurane|desflurane|mesh-list
102402005|NCT01549873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102402006|NCT01549873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102402007|NCT01549873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402008|NCT01549873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102402009|NCT01549873|Anesthetics, General|anesthetics, general|mesh-ancestor
102402010|NCT01549873|Anesthetics|anesthetics|mesh-ancestor
102402011|NCT01549873|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102402012|NCT04106401|Carbon Monoxide|carbon monoxide|mesh-list
102402013|NCT04106401|Antimetabolites|antimetabolites|mesh-ancestor
102402014|NCT04106401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402015|NCT04106401|Gasotransmitters|gasotransmitters|mesh-ancestor
102402016|NCT04106401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102402017|NCT04106401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402018|NCT01488487|Everolimus|everolimus|mesh-list
102402019|NCT01488487|Pasireotide|pasireotide|mesh-list
102402020|NCT01488487|Somatostatin|somatostatin|mesh-list
102402021|NCT01488487|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102402022|NCT01488487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102402023|NCT01488487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102402024|NCT01488487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402025|NCT01488487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102402026|NCT01488487|Immunologic Factors|immunologic factors|mesh-ancestor
102402027|NCT01488487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402028|NCT01488487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102402029|NCT01488487|Hormones|hormones|mesh-ancestor
102402030|NCT01488487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102402031|NCT03027115|Tamsulosin|tamsulosin|mesh-list
102402032|NCT03027115|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102402033|NCT03027115|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102402034|NCT03027115|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102402035|NCT03027115|Adrenergic Agents|adrenergic agents|mesh-ancestor
102402036|NCT03027115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102402037|NCT03027115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402038|NCT03027115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402039|NCT03027115|Urological Agents|urological agents|mesh-ancestor
102402040|NCT03026881|Paclitaxel|paclitaxel|mesh-list
102402041|NCT03026881|Apatinib|apatinib|mesh-list
102402042|NCT03026881|Fluzoparib|fluzoparib|mesh-list
102402043|NCT03026881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102402044|NCT03026881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102402045|NCT03026881|Tubulin Modulators|tubulin modulators|mesh-ancestor
102402046|NCT03026881|Antimitotic Agents|antimitotic agents|mesh-ancestor
102402047|NCT03026881|Mitosis Modulators|mitosis modulators|mesh-ancestor
102133715|NCT02295189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402048|NCT03026881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402049|NCT03026881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102402050|NCT03026881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102402051|NCT03026881|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102402052|NCT01516879|Atorvastatin|atorvastatin|mesh-list
102402053|NCT01516879|Ezetimibe|ezetimibe|mesh-list
102402054|NCT01516879|Evolocumab|evolocumab|mesh-list
102402055|NCT01516879|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102402056|NCT01516879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102402057|NCT01516879|Antimetabolites|antimetabolites|mesh-ancestor
102402058|NCT01516879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402059|NCT01516879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102402060|NCT01516879|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102402061|NCT01516879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102402062|NCT01516879|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102402063|NCT01516879|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102402064|NCT01516879|Protease Inhibitors|protease inhibitors|mesh-ancestor
102402065|NCT01515865|Midodrine|midodrine|mesh-list
102402066|NCT01515865|Sympathomimetics|sympathomimetics|mesh-ancestor
102402067|NCT01515865|Autonomic Agents|autonomic agents|mesh-ancestor
102402068|NCT01515865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102402069|NCT01515865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402070|NCT01515865|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102402071|NCT01515865|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102033150|NCT01373697|Ibuprofen|ibuprofen|mesh-list
102402072|NCT01515865|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102402073|NCT01515865|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102402074|NCT01515865|Adrenergic Agents|adrenergic agents|mesh-ancestor
102402075|NCT01515865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102402076|NCT01515865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402077|NCT01547299|Leuprolide|leuprolide|mesh-list
102402078|NCT01547299|Dutasteride|dutasteride|mesh-list
102402079|NCT01547299|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102402080|NCT01547299|Fertility Agents|fertility agents|mesh-ancestor
102402081|NCT01547299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102402082|NCT01547299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402083|NCT01547299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102402084|NCT01547299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102402085|NCT01547299|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102402086|NCT01547299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102402087|NCT01547299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102402088|NCT01547299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402089|NCT01547299|Hormone Antagonists|hormone antagonists|mesh-ancestor
102402090|NCT01547299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102402091|NCT04072107|Capecitabine|capecitabine|mesh-list
102402092|NCT04072107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102402093|NCT04072107|Antimetabolites|antimetabolites|mesh-ancestor
102402094|NCT04072107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402095|NCT04072107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102402096|NCT00411411|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102402097|NCT00411411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102402098|NCT00411411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402099|NCT00411411|Incretins|incretins|mesh-ancestor
102402100|NCT00411411|Hormones|hormones|mesh-ancestor
102402101|NCT00411411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102402102|NCT00411411|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102402103|NCT00411411|Protease Inhibitors|protease inhibitors|mesh-ancestor
102402104|NCT00411411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102402105|NCT00411411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402106|NCT01794273|Phenylephrine|phenylephrine|mesh-list
102402107|NCT01794273|Oxymetazoline|oxymetazoline|mesh-list
102402108|NCT01794273|Ephedrine|ephedrine|mesh-list
102402109|NCT01794273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102402110|NCT01794273|Mydriatics|mydriatics|mesh-ancestor
102402111|NCT01794273|Autonomic Agents|autonomic agents|mesh-ancestor
102402112|NCT01794273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102402113|NCT01794273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402114|NCT01794273|Sympathomimetics|sympathomimetics|mesh-ancestor
102402115|NCT01794273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102402116|NCT01794273|Nasal Decongestants|nasal decongestants|mesh-ancestor
102402117|NCT01794273|Respiratory System Agents|respiratory system agents|mesh-ancestor
102402118|NCT01794273|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102402119|NCT01794273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102402120|NCT01794273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102402121|NCT01794273|Adrenergic Agents|adrenergic agents|mesh-ancestor
102402122|NCT01794273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102402123|NCT01794273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402124|NCT01794273|Protective Agents|protective agents|mesh-ancestor
102402125|NCT01794273|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102402126|NCT02109939|Psychotropic Drugs|psychotropic drugs|mesh-list
102402127|NCT01795599|Mifepristone|mifepristone|mesh-list
102402128|NCT01795599|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102402129|NCT01795599|Abortifacient Agents|abortifacient agents|mesh-ancestor
102402130|NCT01795599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102402131|NCT01795599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402132|NCT01795599|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102402133|NCT01795599|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102402134|NCT01795599|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102402135|NCT01795599|Contraceptive Agents|contraceptive agents|mesh-ancestor
102402136|NCT01795599|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102402137|NCT01795599|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102402138|NCT01795599|Hormone Antagonists|hormone antagonists|mesh-ancestor
102402139|NCT01795599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102402140|NCT01795599|Luteolytic Agents|luteolytic agents|mesh-ancestor
102402141|NCT01795599|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102402142|NCT01795599|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102402143|NCT01794351|Resveratrol|resveratrol|mesh-list
102402144|NCT01794351|Antioxidants|antioxidants|mesh-ancestor
102402145|NCT01794351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402146|NCT01794351|Protective Agents|protective agents|mesh-ancestor
102402147|NCT01794351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033201|NCT03629262|Analgesics|analgesics|mesh-ancestor
102402148|NCT01794351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102402149|NCT01794351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102402150|NCT04409431|Epinephrine|epinephrine|mesh-list
102402151|NCT04409431|Racepinephrine|racepinephrine|mesh-list
102402152|NCT04409431|Epinephryl borate|epinephryl borate|mesh-list
102402153|NCT04409431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102402154|NCT04409431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102402155|NCT04409431|Adrenergic Agents|adrenergic agents|mesh-ancestor
102402156|NCT04409431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102402157|NCT04409431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402158|NCT04409431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402159|NCT04409431|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102402160|NCT04409431|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102402161|NCT04409431|Autonomic Agents|autonomic agents|mesh-ancestor
102402162|NCT04409431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102402163|NCT04409431|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102402164|NCT04409431|Respiratory System Agents|respiratory system agents|mesh-ancestor
102402165|NCT04409431|Mydriatics|mydriatics|mesh-ancestor
102402166|NCT04409431|Sympathomimetics|sympathomimetics|mesh-ancestor
102402167|NCT04409431|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102402168|NCT01794507|Dexamethasone|dexamethasone|mesh-list
102402169|NCT01794507|Bortezomib|bortezomib|mesh-list
102402170|NCT01794507|Venetoclax|venetoclax|mesh-list
102402171|NCT01794507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102402172|NCT01794507|Antiemetics|antiemetics|mesh-ancestor
102402173|NCT01794507|Autonomic Agents|autonomic agents|mesh-ancestor
102402174|NCT01794507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102402175|NCT01794507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402176|NCT01794507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102402177|NCT01794507|Glucocorticoids|glucocorticoids|mesh-ancestor
102402178|NCT01794507|Hormones|hormones|mesh-ancestor
102402179|NCT01794507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102402180|NCT01794507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102402181|NCT01794507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102402182|NCT00412425|Palonosetron|palonosetron|mesh-list
102402183|NCT00412425|Antiemetics|antiemetics|mesh-ancestor
102402184|NCT00412425|Autonomic Agents|autonomic agents|mesh-ancestor
102402185|NCT00412425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102402186|NCT00412425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402187|NCT00412425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102402188|NCT00412425|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102402189|NCT00412425|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102402190|NCT00412425|Serotonin Agents|serotonin agents|mesh-ancestor
102402191|NCT00412425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102402192|NCT00412425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402193|NCT01492361|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
102402194|NCT01492361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102402195|NCT01492361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102402196|NCT00415857|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102402197|NCT00415857|Imatinib Mesylate|imatinib mesylate|mesh-list
102402198|NCT00415857|Vaccines|vaccines|mesh-list
102402199|NCT00415857|Sargramostim|sargramostim|mesh-list
102402200|NCT00415857|Immunologic Factors|immunologic factors|mesh-ancestor
102402201|NCT00415857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402202|NCT00415857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102402203|NCT00415857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102402204|NCT00415857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102402205|NCT00415857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402206|NCT00415857|Antiviral Agents|antiviral agents|mesh-ancestor
102402207|NCT00415857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102402208|NCT03491631|Apatinib|apatinib|mesh-list
102402209|NCT03491631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102402210|NCT03491631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102402211|NCT03491631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102402212|NCT03491631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033284|NCT03953079|Sunitinib|sunitinib|mesh-list
102402213|NCT04271007|Mometasone Furoate|mometasone furoate|mesh-list
102402214|NCT04271007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102402215|NCT04271007|Dermatologic Agents|dermatologic agents|mesh-ancestor
102402216|NCT04271007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102402217|NCT00416793|Carboplatin|carboplatin|mesh-list
102402218|NCT00416793|Bortezomib|bortezomib|mesh-list
102402219|NCT00416793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102402220|NCT00417417|Rilonacept|rilonacept|mesh-list
102402221|NCT00417417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102402222|NCT00419445|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
102402223|NCT00419445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102402224|NCT00419445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102402225|NCT00419445|Cholinergic Agents|cholinergic agents|mesh-ancestor
102402226|NCT00419445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102402227|NCT00419445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402228|NCT00419445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402229|NCT00420459|Aripiprazole|aripiprazole|mesh-list
102402230|NCT00420459|Antidepressive Agents|antidepressive agents|mesh-ancestor
102402231|NCT00420459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102402232|NCT00420459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102402233|NCT00420459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102402234|NCT00420459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102402235|NCT00420459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402236|NCT00420459|Dopamine Agonists|dopamine agonists|mesh-ancestor
102402237|NCT00420459|Dopamine Agents|dopamine agents|mesh-ancestor
102402238|NCT00420459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102402239|NCT00420459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402240|NCT00420459|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102402241|NCT00420459|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102213907|NCT05944458|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102402242|NCT00420459|Serotonin Agents|serotonin agents|mesh-ancestor
102033301|NCT03357939|Adalimumab|adalimumab|mesh-list
102402243|NCT00420459|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102402244|NCT00420459|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102402245|NCT00420459|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102402246|NCT00420459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102402247|NCT00420771|Gabapentin|gabapentin|mesh-list
102402248|NCT00420771|Analgesics|analgesics|mesh-ancestor
102402249|NCT00420771|Sensory System Agents|sensory system agents|mesh-ancestor
102402250|NCT00420771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102402251|NCT00420771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402252|NCT00420771|Anticonvulsants|anticonvulsants|mesh-ancestor
102402253|NCT00420771|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102402254|NCT00420771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102402255|NCT00420771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102402256|NCT00420771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102402257|NCT00420771|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102402258|NCT00420771|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102402259|NCT00420771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102402260|NCT00420771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402261|NCT00420771|Antimanic Agents|antimanic agents|mesh-ancestor
102402262|NCT00426153|Octreotide|octreotide|mesh-list
102402263|NCT00426153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102402264|NCT00426153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102402265|NCT00426153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102402266|NCT04750317|Tofacitinib|tofacitinib|mesh-list
102402267|NCT04750317|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102402268|NCT04750317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102402269|NCT04750317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102402270|NCT04750317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402271|NCT01996449|Amlodipine|amlodipine|mesh-list
102402272|NCT01996449|Eplerenone|eplerenone|mesh-list
102402273|NCT01996449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102402274|NCT01996449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102402275|NCT01996449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102133716|NCT02295189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102402276|NCT01996449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402277|NCT01996449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102402278|NCT01996449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402279|NCT01996449|Vasodilator Agents|vasodilator agents|mesh-ancestor
102402280|NCT01996449|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102402281|NCT01996449|Hormone Antagonists|hormone antagonists|mesh-ancestor
102402282|NCT01996449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102402283|NCT01996449|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102402284|NCT01996449|Diuretics|diuretics|mesh-ancestor
102402285|NCT01996449|Natriuretic Agents|natriuretic agents|mesh-ancestor
102402286|NCT00426855|Bortezomib|bortezomib|mesh-list
102402287|NCT00426855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102402288|NCT00426855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102402289|NCT00426855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102402290|NCT00426855|Alkylating Agents|alkylating agents|mesh-ancestor
102402291|NCT00426855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402292|NCT01491737|Trastuzumab|trastuzumab|mesh-list
102402293|NCT01491737|Pertuzumab|pertuzumab|mesh-list
102402294|NCT01491737|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102402295|NCT01491737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102402296|NCT01491737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102402297|NCT01491737|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102402298|NCT01491737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102402299|NCT01491737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402300|NCT01491737|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102402301|NCT01491737|Hormone Antagonists|hormone antagonists|mesh-ancestor
102402302|NCT01491737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102402303|NCT01491737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402304|NCT00427557|Rituximab|rituximab|mesh-list
102402305|NCT00427557|Fludarabine|fludarabine|mesh-list
102402306|NCT00427557|Fludarabine phosphate|fludarabine phosphate|mesh-list
102402307|NCT00427557|Melphalan|melphalan|mesh-list
102402308|NCT00427557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102402309|NCT00427557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102402310|NCT00427557|Immunologic Factors|immunologic factors|mesh-ancestor
102402311|NCT00427557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402312|NCT00427557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102402313|NCT00427557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102402314|NCT00427557|Antimetabolites|antimetabolites|mesh-ancestor
102402315|NCT00427557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402316|NCT00427557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102402317|NCT00427557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102402318|NCT00427557|Alkylating Agents|alkylating agents|mesh-ancestor
102402319|NCT00427557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102402320|NCT01487863|Abiraterone Acetate|abiraterone acetate|mesh-list
102402321|NCT01487863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102402322|NCT01487863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102402323|NCT01487863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102402324|NCT01487863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402325|NCT01487863|Hormone Antagonists|hormone antagonists|mesh-ancestor
102402326|NCT01487863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102402327|NCT01487863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402328|NCT01487863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102402329|NCT04088305|Vancomycin|vancomycin|mesh-list
102402330|NCT04088305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102402331|NCT04088305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102402332|NCT00427791|Rituximab|rituximab|mesh-list
102402333|NCT00427791|Etoposide|etoposide|mesh-list
102402334|NCT00427791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102402335|NCT00427791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102402336|NCT00427791|Immunologic Factors|immunologic factors|mesh-ancestor
102402337|NCT00427791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402338|NCT00427791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102402339|NCT00427791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102402340|NCT00427791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102402341|NCT00427791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102402342|NCT00427791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102402343|NCT00427791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402344|NCT01487161|Triamcinolone|triamcinolone|mesh-list
102402345|NCT01487161|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102402346|NCT01487161|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102402347|NCT01487161|FX006|fx006|mesh-list
102402348|NCT01487161|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102402349|NCT01487161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102402350|NCT01487161|Glucocorticoids|glucocorticoids|mesh-ancestor
102402351|NCT01487161|Hormones|hormones|mesh-ancestor
102402352|NCT01487161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102402353|NCT01487161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402354|NCT01487161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102402355|NCT01487161|Immunologic Factors|immunologic factors|mesh-ancestor
102402356|NCT01487161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102402357|NCT01487161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402358|NCT00429507|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
102133717|NCT02295189|Immunologic Factors|immunologic factors|mesh-ancestor
102402359|NCT00429507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102402360|NCT00429507|Analgesics|analgesics|mesh-ancestor
102402361|NCT00429507|Sensory System Agents|sensory system agents|mesh-ancestor
102402362|NCT00429507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102402363|NCT00429507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402364|NCT01794897|Valacyclovir|valacyclovir|mesh-list
102402365|NCT01794897|Antiviral Agents|antiviral agents|mesh-ancestor
102402366|NCT01794897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102402367|NCT01794975|Ketamine|ketamine|mesh-list
102402368|NCT01794975|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102402369|NCT01794975|Analgesics|analgesics|mesh-ancestor
102402370|NCT01794975|Sensory System Agents|sensory system agents|mesh-ancestor
102402371|NCT01794975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102402372|NCT01794975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402373|NCT01794975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102402374|NCT01794975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102402375|NCT01794975|Anesthetics, General|anesthetics, general|mesh-ancestor
102402376|NCT01794975|Anesthetics|anesthetics|mesh-ancestor
102402377|NCT01794975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102402378|NCT01794975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102402379|NCT01794975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102402380|NCT01794975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102402381|NCT01794975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402382|NCT01794975|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102402383|NCT01794975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102402384|NCT01794975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102402385|NCT01794975|Adrenergic Agents|adrenergic agents|mesh-ancestor
102402386|NCT05285787|Menaquinone 7|menaquinone 7|mesh-list
102402387|NCT05285787|Hemostatics|hemostatics|mesh-ancestor
102402388|NCT05285787|Coagulants|coagulants|mesh-ancestor
102214060|NCT05943158|Inositol|inositol|mesh-list
102402390|NCT01491035|Antidepressive Agents|antidepressive agents|mesh-ancestor
102402391|NCT01491035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102402392|NCT01491035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102402393|NCT01491035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102402394|NCT01491035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102402395|NCT01491035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402396|NCT01491035|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102402397|NCT01491035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102402398|NCT01491035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102402399|NCT01491035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402400|NCT01491035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102402401|NCT01491035|Serotonin Agents|serotonin agents|mesh-ancestor
102402402|NCT01491035|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102402403|NCT01491035|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102402404|NCT01491035|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102402405|NCT01491035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102402406|NCT00375999|Docetaxel|docetaxel|mesh-list
102402407|NCT00375999|Epirubicin|epirubicin|mesh-list
102402408|NCT00375999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102402409|NCT00375999|Tubulin Modulators|tubulin modulators|mesh-ancestor
102402410|NCT00375999|Antimitotic Agents|antimitotic agents|mesh-ancestor
102402411|NCT00375999|Mitosis Modulators|mitosis modulators|mesh-ancestor
102402412|NCT00375999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402413|NCT00375999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102402414|NCT00375999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102402415|NCT00375999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102402416|NCT00375999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102402417|NCT04409327|Dactolisib|dactolisib|mesh-list
102402418|NCT04409327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102402419|NCT01488071|Vortioxetine|vortioxetine|mesh-list
102402420|NCT01488071|Agomelatine|agomelatine|mesh-list
102402421|NCT01488071|Antidepressive Agents|antidepressive agents|mesh-ancestor
102402422|NCT01488071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102402423|NCT01488071|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102402424|NCT01488071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102402425|NCT01488071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102402426|NCT01488071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402427|NCT01488071|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102402428|NCT01488071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102402429|NCT01488071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102402430|NCT01488071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402431|NCT01488071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102402432|NCT01488071|Serotonin Agents|serotonin agents|mesh-ancestor
102402433|NCT01488071|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102402434|NCT01488071|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102402435|NCT01488071|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102402436|NCT01488071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102402437|NCT01488071|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102402438|NCT01485887|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102402439|NCT01485887|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102402440|NCT01485887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102402441|NCT01485887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102402442|NCT01485887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753297|NCT00854230|Naltrexone|naltrexone|mesh-list
102402443|NCT01485887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102402444|NCT01485887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402445|NCT01485887|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102402446|NCT01485887|Antidepressive Agents|antidepressive agents|mesh-ancestor
102402447|NCT01485887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102402448|NCT01484951|Timolol|timolol|mesh-list
102402449|NCT01484951|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102402450|NCT01484951|Brinzolamide|brinzolamide|mesh-list
102402451|NCT01484951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102402452|NCT01484951|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102402453|NCT01484951|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102402454|NCT01484951|Adrenergic Agents|adrenergic agents|mesh-ancestor
102402455|NCT01484951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102402456|NCT01484951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402457|NCT01484951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402458|NCT01484951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102214137|NCT05898399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102402459|NCT01484951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102402460|NCT01484951|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102402461|NCT01484951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102402462|NCT01484873|Exenatide|exenatide|mesh-list
102402463|NCT01484873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102402464|NCT01484873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402465|NCT01484873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102402466|NCT01484873|Incretins|incretins|mesh-ancestor
102402467|NCT01484873|Hormones|hormones|mesh-ancestor
102402468|NCT01484873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102402469|NCT01486927|Factor VIII|factor viii|mesh-list
102402470|NCT01486927|Coagulants|coagulants|mesh-ancestor
102402471|NCT00379197|Naltrexone|naltrexone|mesh-list
102402472|NCT00379197|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102402473|NCT00379197|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102402474|NCT00379197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402475|NCT00379197|Sensory System Agents|sensory system agents|mesh-ancestor
102402476|NCT00379197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102402477|NCT01513759|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102402478|NCT01513759|Plasminogen|plasminogen|mesh-list
102402479|NCT01513759|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102402480|NCT01513759|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102402481|NCT01513759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402482|NCT01484561|Tofacitinib|tofacitinib|mesh-list
102402483|NCT01484561|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102402484|NCT01484561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102402485|NCT01484561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102402486|NCT01484561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402487|NCT01483625|Tiotropium Bromide|tiotropium bromide|mesh-list
102402488|NCT01483625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102402489|NCT01483625|Autonomic Agents|autonomic agents|mesh-ancestor
102402490|NCT01483625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102402491|NCT01483625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402492|NCT01483625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102402493|NCT01483625|Respiratory System Agents|respiratory system agents|mesh-ancestor
102402494|NCT01483625|Parasympatholytics|parasympatholytics|mesh-ancestor
102402495|NCT01483625|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102402496|NCT01483625|Cholinergic Agents|cholinergic agents|mesh-ancestor
102402497|NCT01483625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102402498|NCT01483625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402499|NCT01485991|Simeprevir|simeprevir|mesh-list
102402500|NCT01485991|Antiviral Agents|antiviral agents|mesh-ancestor
102402501|NCT01485991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102402502|NCT01485991|Protease Inhibitors|protease inhibitors|mesh-ancestor
102402503|NCT01485991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102402504|NCT01485991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402505|NCT00379821|Azithromycin|azithromycin|mesh-list
102402506|NCT00379821|Artesunate|artesunate|mesh-list
102402507|NCT00379821|Chloroquine|chloroquine|mesh-list
102402508|NCT00379821|Atovaquone|atovaquone|mesh-list
102402509|NCT00379821|Proguanil|proguanil|mesh-list
102402510|NCT00379821|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
102402511|NCT00379821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102402512|NCT00379821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102402513|NCT00379821|Antimalarials|antimalarials|mesh-ancestor
102402514|NCT00379821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102402515|NCT00379821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102402516|NCT00379821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102402517|NCT00379821|Antiviral Agents|antiviral agents|mesh-ancestor
102402518|NCT00379821|Schistosomicides|schistosomicides|mesh-ancestor
102402519|NCT00379821|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102402520|NCT00379821|Anthelmintics|anthelmintics|mesh-ancestor
102402521|NCT00379821|Amebicides|amebicides|mesh-ancestor
102402522|NCT00379821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102402523|NCT00379821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102402524|NCT00379821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402525|NCT00379821|Antimetabolites|antimetabolites|mesh-ancestor
102402526|NCT01482767|Interferons|interferons|mesh-list
102402527|NCT01482767|Ribavirin|ribavirin|mesh-list
102402528|NCT01482767|Interferon-alpha|interferon-alpha|mesh-list
102402529|NCT01482767|Interferon alpha-2|interferon alpha-2|mesh-list
102402530|NCT01482767|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102214211|NCT05737693|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102402531|NCT01482767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102402532|NCT01482767|Antiviral Agents|antiviral agents|mesh-ancestor
102402533|NCT01482767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102402534|NCT01482767|Antimetabolites|antimetabolites|mesh-ancestor
102402535|NCT01482767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402537|NCT01482767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402538|NCT00435591|Conivaptan|conivaptan|mesh-list
102402539|NCT00435591|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102402540|NCT00435591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402541|NCT00435591|Natriuretic Agents|natriuretic agents|mesh-ancestor
102402542|NCT00435591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402543|NCT00439335|Vaccines|vaccines|mesh-list
102402544|NCT00439335|Immunologic Factors|immunologic factors|mesh-ancestor
102402545|NCT00439335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402546|NCT01545817|Everolimus|everolimus|mesh-list
102402547|NCT01545817|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102402548|NCT01545817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102402549|NCT01545817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102402550|NCT01545817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402551|NCT01545817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102402552|NCT01545817|Immunologic Factors|immunologic factors|mesh-ancestor
102402553|NCT01545817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402554|NCT01545817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102402555|NCT01512979|Metformin|metformin|mesh-list
102402556|NCT01512979|Linagliptin|linagliptin|mesh-list
102402557|NCT01512979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102402558|NCT01512979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402559|NCT01512979|Incretins|incretins|mesh-ancestor
102402560|NCT01512979|Hormones|hormones|mesh-ancestor
102402561|NCT01512979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102402562|NCT01512979|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102402563|NCT01512979|Protease Inhibitors|protease inhibitors|mesh-ancestor
102402564|NCT01512979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102402565|NCT01512979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402566|NCT00383565|Romidepsin|romidepsin|mesh-list
102402567|NCT00383565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102402568|NCT00383565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102402569|NCT00383565|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102402570|NCT00383565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102402571|NCT00383565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402572|NCT01512745|Apatinib|apatinib|mesh-list
102402573|NCT01512745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102402574|NCT01512745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102402575|NCT01512745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102402576|NCT01512745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402577|NCT01478321|Bevacizumab|bevacizumab|mesh-list
102402578|NCT01478321|Temozolomide|temozolomide|mesh-list
102402579|NCT01478321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102402580|NCT01478321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102402581|NCT01478321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102402582|NCT01478321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102402583|NCT01478321|Growth Substances|growth substances|mesh-ancestor
102402584|NCT01478321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402585|NCT01478321|Growth Inhibitors|growth inhibitors|mesh-ancestor
102402586|NCT01478321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102402587|NCT01478321|Alkylating Agents|alkylating agents|mesh-ancestor
102402588|NCT01478321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402589|NCT01544491|Everolimus|everolimus|mesh-list
102402590|NCT01544491|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102402591|NCT01544491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102402592|NCT01544491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102402593|NCT01544491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402594|NCT01544491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102402595|NCT01544491|Immunologic Factors|immunologic factors|mesh-ancestor
102402596|NCT01544491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402597|NCT01544491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102402598|NCT00383643|Sodium Oxybate|sodium oxybate|mesh-list
102402599|NCT00383643|Zolpidem|zolpidem|mesh-list
102402600|NCT00383643|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102402601|NCT00383643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102402602|NCT00383643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102402603|NCT00383643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402604|NCT00383643|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102402605|NCT00383643|GABA Agonists|gaba agonists|mesh-ancestor
102402606|NCT00383643|GABA Agents|gaba agents|mesh-ancestor
102402607|NCT00383643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102402608|NCT00383643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402610|NCT00383643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102402611|NCT00383643|Anesthetics, General|anesthetics, general|mesh-ancestor
102402612|NCT00383643|Anesthetics|anesthetics|mesh-ancestor
102402613|NCT00439413|Selegiline|selegiline|mesh-list
102402614|NCT00439413|Antidepressive Agents|antidepressive agents|mesh-ancestor
102402615|NCT00439413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102402616|NCT00439413|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102402617|NCT00439413|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102402618|NCT00439413|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102402619|NCT00439413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102402620|NCT00439413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402621|NCT00439413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102402622|NCT00439413|Protective Agents|protective agents|mesh-ancestor
102402623|NCT00439413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402624|NCT01477853|Metformin|metformin|mesh-list
102402625|NCT01477853|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102402626|NCT01477853|Glimepiride|glimepiride|mesh-list
102402627|NCT01477853|Atorvastatin|atorvastatin|mesh-list
102402628|NCT01477853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102402629|NCT01477853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402630|NCT01477853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102402631|NCT01477853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102402632|NCT01477853|Antimetabolites|antimetabolites|mesh-ancestor
102402633|NCT01477853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402634|NCT01477853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102402635|NCT01477853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102402636|NCT01477853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102402637|NCT01477853|Incretins|incretins|mesh-ancestor
102402638|NCT01477853|Hormones|hormones|mesh-ancestor
102402639|NCT01477853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102402640|NCT01477853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102402641|NCT01477853|Protease Inhibitors|protease inhibitors|mesh-ancestor
102402642|NCT01477853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102402643|NCT01477853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102402644|NCT01477853|Immunologic Factors|immunologic factors|mesh-ancestor
102402645|NCT00440505|Nicotine|nicotine|mesh-list
102402646|NCT00440505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102402647|NCT00440505|Autonomic Agents|autonomic agents|mesh-ancestor
102402648|NCT00440505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102402649|NCT00440505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402650|NCT00440505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102402651|NCT00440505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102402652|NCT00440505|Cholinergic Agents|cholinergic agents|mesh-ancestor
102402653|NCT00440505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102402654|NCT00440505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402655|NCT00441285|Albendazole|albendazole|mesh-list
102402656|NCT00441285|Praziquantel|praziquantel|mesh-list
102402657|NCT00441285|Anthelmintics|anthelmintics|mesh-ancestor
102402658|NCT00441285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102402659|NCT00441285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102402660|NCT00441285|Anticestodal Agents|anticestodal agents|mesh-ancestor
102402661|NCT00441285|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102402662|NCT00441285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102402663|NCT00441285|Tubulin Modulators|tubulin modulators|mesh-ancestor
102402664|NCT00441285|Antimitotic Agents|antimitotic agents|mesh-ancestor
102402665|NCT00441285|Mitosis Modulators|mitosis modulators|mesh-ancestor
102402666|NCT00441285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402667|NCT00441285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102402668|NCT01796613|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102402669|NCT01796613|Desogestrel|desogestrel|mesh-list
102402670|NCT01796613|Etonogestrel|etonogestrel|mesh-list
102402671|NCT01796613|NuvaRing|nuvaring|mesh-list
102402672|NCT01796613|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102402673|NCT01796613|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102402674|NCT01796613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102402675|NCT01796613|Contraceptive Agents|contraceptive agents|mesh-ancestor
102402676|NCT01796613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102402677|NCT01796613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402678|NCT01796613|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102402679|NCT01796613|Estrogens|estrogens|mesh-ancestor
102402680|NCT01796613|Hormones|hormones|mesh-ancestor
102402681|NCT01796613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102402682|NCT01796613|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102402683|NCT01796613|Progestins|progestins|mesh-ancestor
102402684|NCT00442611|Abatacept|abatacept|mesh-list
102402685|NCT00442611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102402686|NCT00442611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402687|NCT00442611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102402688|NCT00442611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102402689|NCT00442611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102402690|NCT00442611|Immunologic Factors|immunologic factors|mesh-ancestor
102402691|NCT00442611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402692|NCT00442611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102402693|NCT01511107|Amoxicillin|amoxicillin|mesh-list
102402694|NCT01511107|Clavulanic Acid|clavulanic acid|mesh-list
102402695|NCT01511107|Clavulanic Acids|clavulanic acids|mesh-list
102402696|NCT01511107|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102402697|NCT01511107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102402698|NCT01511107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102402699|NCT01511107|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102402700|NCT01511107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102402701|NCT01511107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402702|NCT00387621|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
102402703|NCT00387621|Natriuretic Agents|natriuretic agents|mesh-ancestor
102402704|NCT00387621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402705|NCT00442689|Flutamide|flutamide|mesh-list
102402706|NCT00442689|Drospirenone|drospirenone|mesh-list
102402707|NCT00442689|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102402708|NCT00442689|Estradiol|estradiol|mesh-list
102402709|NCT00442689|Estrogens|estrogens|mesh-ancestor
102402710|NCT00442689|Hormones|hormones|mesh-ancestor
102402711|NCT00442689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102402712|NCT00442689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402713|NCT00442689|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102402714|NCT00442689|Contraceptive Agents|contraceptive agents|mesh-ancestor
102402715|NCT00442689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102402716|NCT00442689|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102402717|NCT00442689|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102402718|NCT00442689|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102402719|NCT00442689|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102402720|NCT00442689|Hormone Antagonists|hormone antagonists|mesh-ancestor
102402721|NCT00442689|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102402722|NCT00442689|Diuretics|diuretics|mesh-ancestor
102402723|NCT00442689|Natriuretic Agents|natriuretic agents|mesh-ancestor
102402724|NCT00442689|Androgen Antagonists|androgen antagonists|mesh-ancestor
102402725|NCT00442689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102402726|NCT00442689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102402727|NCT01484977|Lacosamide|lacosamide|mesh-list
102402728|NCT01484977|Anticonvulsants|anticonvulsants|mesh-ancestor
102402729|NCT01484977|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102402730|NCT01484977|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102402731|NCT01484977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102402732|NCT01484977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402733|NCT00442767|Insulin|insulin|mesh-list
102402734|NCT00442767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102402735|NCT00442767|Pramlintide|pramlintide|mesh-list
102402736|NCT00442767|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
102402737|NCT00442767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102402738|NCT00442767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402739|NCT00442767|Appetite Depressants|appetite depressants|mesh-ancestor
102402740|NCT00442767|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102402741|NCT00442767|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
102402742|NCT00442767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402743|NCT00445263|Tirofiban|tirofiban|mesh-list
102402744|NCT00445263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102402745|NCT00445263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102402746|NCT00445263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402747|NCT00445263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102402748|NCT00389493|Risperidone|risperidone|mesh-list
102402749|NCT00389493|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102402750|NCT00389493|Serotonin Agents|serotonin agents|mesh-ancestor
102402751|NCT00389493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102402752|NCT00389493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402753|NCT00389493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402754|NCT00389493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102033835|NCT02675946|Cetuximab|cetuximab|mesh-list
102402755|NCT00389493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102402756|NCT00389493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102402757|NCT00389493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102402758|NCT00389493|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102402759|NCT00389493|Dopamine Agents|dopamine agents|mesh-ancestor
102402760|NCT04388709|Interferons|interferons|mesh-list
102402761|NCT04388709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102402762|NCT04388709|Antiviral Agents|antiviral agents|mesh-ancestor
102402763|NCT04388709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102402764|NCT00389805|Pemetrexed|pemetrexed|mesh-list
102402765|NCT00389805|Bortezomib|bortezomib|mesh-list
102402766|NCT00389805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102402767|NCT00389805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102402768|NCT00389805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402769|NCT00389805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102402770|NCT00389805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102402771|NCT00456807|Vaccines|vaccines|mesh-list
102402772|NCT00456807|Immunologic Factors|immunologic factors|mesh-ancestor
102402773|NCT00456807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402774|NCT00456885|Exenatide|exenatide|mesh-list
102402775|NCT00456885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102402776|NCT00456885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402777|NCT00456885|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102402778|NCT00456885|Incretins|incretins|mesh-ancestor
102402779|NCT00456885|Hormones|hormones|mesh-ancestor
102402780|NCT00456885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102402781|NCT01475825|Mipomersen|mipomersen|mesh-list
102402782|NCT01475825|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102402783|NCT01475825|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102402784|NCT01475825|Antimetabolites|antimetabolites|mesh-ancestor
102402785|NCT01475825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402786|NCT01475825|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102402787|NCT00457197|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102402788|NCT00457197|Antidepressive Agents|antidepressive agents|mesh-ancestor
102402789|NCT00457197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102402790|NCT00457197|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102402791|NCT00457197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102402792|NCT00457197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102402793|NCT00457197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402794|NCT01484431|Tadalafil|tadalafil|mesh-list
102402795|NCT01484431|Vasodilator Agents|vasodilator agents|mesh-ancestor
102402796|NCT01484431|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102402797|NCT01484431|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102402798|NCT01484431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102402799|NCT01484431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402800|NCT01484431|Urological Agents|urological agents|mesh-ancestor
102402801|NCT00445887|Levonorgestrel|levonorgestrel|mesh-list
102402802|NCT00445887|Norgestrel|norgestrel|mesh-list
102402803|NCT00445887|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102402804|NCT00445887|Contraceptive Agents|contraceptive agents|mesh-ancestor
102402805|NCT00445887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102402806|NCT00445887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402807|NCT00445887|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102402808|NCT00445887|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102402809|NCT00445887|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102402810|NCT00445887|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102402811|NCT01473953|Liraglutide|liraglutide|mesh-list
102402812|NCT01473953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102402813|NCT01473953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402814|NCT01473953|Incretins|incretins|mesh-ancestor
102402815|NCT01473953|Hormones|hormones|mesh-ancestor
102402816|NCT01473953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102402817|NCT00457977|Vaccines|vaccines|mesh-list
102402818|NCT00457977|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102402819|NCT00457977|Immunologic Factors|immunologic factors|mesh-ancestor
102402820|NCT00457977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402821|NCT01473563|Pemetrexed|pemetrexed|mesh-list
102402822|NCT01473563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102402823|NCT01473563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102402824|NCT01473563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402825|NCT01473563|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102402826|NCT01473563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102402827|NCT01795209|Ranibizumab|ranibizumab|mesh-list
102402828|NCT01795209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102402829|NCT01795209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102402830|NCT01795209|Growth Substances|growth substances|mesh-ancestor
102402831|NCT01795209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402832|NCT01795209|Growth Inhibitors|growth inhibitors|mesh-ancestor
102402833|NCT01795209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102402834|NCT01484275|Siltuximab|siltuximab|mesh-list
102402835|NCT01484275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102402836|NCT01484197|Maleic acid|maleic acid|mesh-list
102402837|NCT01484197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102402838|NCT01484197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402839|NCT01473407|Epoetin Alfa|epoetin alfa|mesh-list
102402840|NCT01473407|Hematinics|hematinics|mesh-ancestor
102402841|NCT04082897|Atezolizumab|atezolizumab|mesh-list
102402842|NCT04082897|Venetoclax|venetoclax|mesh-list
102402843|NCT04082897|Obinutuzumab|obinutuzumab|mesh-list
102402844|NCT04082897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102133718|NCT02295189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102402845|NCT04082897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402846|NCT04082897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102402847|NCT04082897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102402848|NCT01544179|Pemetrexed|pemetrexed|mesh-list
102402849|NCT01544179|Gefitinib|gefitinib|mesh-list
102402850|NCT01544179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102402851|NCT01544179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102402852|NCT01544179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402853|NCT01544179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102402854|NCT01544179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102402855|NCT01544179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102402856|NCT01483651|Insulin|insulin|mesh-list
102402857|NCT01483651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102402858|NCT01483651|Glucagon|glucagon|mesh-list
102402859|NCT01483651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102402860|NCT01483651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402861|NCT01483651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102402862|NCT01483651|Hormones|hormones|mesh-ancestor
102402863|NCT01483651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102402864|NCT01464307|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102402865|NCT01464307|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102402866|NCT01464307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102402867|NCT01464307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402868|NCT01464307|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102402869|NCT01464307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102402870|NCT01464307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402871|NCT01464307|Cholinergic Agents|cholinergic agents|mesh-ancestor
102402872|NCT01464307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102402873|NCT01482169|Adenosine|adenosine|mesh-list
102402874|NCT01482169|Regadenoson|regadenoson|mesh-list
102402875|NCT01482169|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
102402876|NCT01482169|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102402877|NCT01482169|Purinergic Agonists|purinergic agonists|mesh-ancestor
102402878|NCT01482169|Purinergic Agents|purinergic agents|mesh-ancestor
102402879|NCT01482169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102402880|NCT01482169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402881|NCT01482169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402882|NCT01482169|Analgesics|analgesics|mesh-ancestor
102402883|NCT01482169|Sensory System Agents|sensory system agents|mesh-ancestor
102402884|NCT01482169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102402885|NCT01482169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102402886|NCT01482169|Vasodilator Agents|vasodilator agents|mesh-ancestor
102402887|NCT01481779|Insulin Lispro|insulin lispro|mesh-list
102402888|NCT01481779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102402889|NCT01481779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402890|NCT01509547|Varenicline|varenicline|mesh-list
102402891|NCT01509547|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102402892|NCT01509547|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102402893|NCT01509547|Cholinergic Agents|cholinergic agents|mesh-ancestor
102402894|NCT01509547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102402895|NCT01509547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402896|NCT01509547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402897|NCT01509079|Vitamin D|vitamin d|mesh-list
102402898|NCT01509079|Ergocalciferols|ergocalciferols|mesh-list
102402899|NCT01509079|Cholecalciferol|cholecalciferol|mesh-list
102402900|NCT01509079|Vitamins|vitamins|mesh-list
102402901|NCT01509079|Micronutrients|micronutrients|mesh-ancestor
102402902|NCT01509079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402903|NCT01509079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102402904|NCT01509079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102402905|NCT04650217|Levodopa|levodopa|mesh-list
102402906|NCT04650217|Carbidopa|carbidopa|mesh-list
102402907|NCT04650217|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102402908|NCT04650217|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102402909|NCT04650217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102214583|NCT04929808|Emollients|emollients|mesh-list
102402911|NCT04650217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102402912|NCT04650217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402913|NCT04650217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402914|NCT04650217|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102034001|NCT02896400|Autonomic Agents|autonomic agents|mesh-ancestor
102402915|NCT04650217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102402916|NCT04650217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102402917|NCT04650217|Immunologic Factors|immunologic factors|mesh-ancestor
102402918|NCT04650217|Dopamine Agonists|dopamine agonists|mesh-ancestor
102402919|NCT01462435|Celecoxib|celecoxib|mesh-list
102402920|NCT01462435|Diclofenac|diclofenac|mesh-list
102402921|NCT01462435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102402922|NCT01462435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102402923|NCT01462435|Analgesics|analgesics|mesh-ancestor
102402924|NCT01462435|Sensory System Agents|sensory system agents|mesh-ancestor
102402925|NCT01462435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102402926|NCT01462435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402927|NCT01462435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102402928|NCT01462435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102402929|NCT01462435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102402930|NCT01462435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102402931|NCT01462435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102402932|NCT01462435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402933|NCT01472081|Nivolumab|nivolumab|mesh-list
102402934|NCT01472081|Ipilimumab|ipilimumab|mesh-list
102402935|NCT01472081|Sunitinib|sunitinib|mesh-list
102402936|NCT01472081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102402937|NCT01472081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102402938|NCT01472081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102402939|NCT01472081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402940|NCT01472081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102402941|NCT01472081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102402942|NCT01472081|Growth Substances|growth substances|mesh-ancestor
102402943|NCT01472081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402944|NCT01472081|Growth Inhibitors|growth inhibitors|mesh-ancestor
102402945|NCT01472081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102402946|NCT01472081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102402947|NCT01471691|Ranibizumab|ranibizumab|mesh-list
102402948|NCT01471691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102402949|NCT01471691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102402950|NCT01471691|Growth Substances|growth substances|mesh-ancestor
102402951|NCT01471691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402952|NCT01471691|Growth Inhibitors|growth inhibitors|mesh-ancestor
102402953|NCT01471691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102402954|NCT01471379|Milnacipran|milnacipran|mesh-list
102402955|NCT01471379|Levomilnacipran|levomilnacipran|mesh-list
102402956|NCT01471379|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102402957|NCT01471379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102402958|NCT01471379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102402959|NCT01471379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402960|NCT01471379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102402961|NCT01471379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402962|NCT01471379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102402963|NCT01471379|Analgesics|analgesics|mesh-ancestor
102402964|NCT01471379|Sensory System Agents|sensory system agents|mesh-ancestor
102402965|NCT01471379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102402966|NCT01471379|Antidepressive Agents|antidepressive agents|mesh-ancestor
102402967|NCT01471379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102402968|NCT01470989|Triamcinolone|triamcinolone|mesh-list
102402969|NCT01470989|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102402970|NCT01470989|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102402971|NCT01470989|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102402972|NCT01470989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102402973|NCT01470989|Glucocorticoids|glucocorticoids|mesh-ancestor
102402974|NCT01470989|Hormones|hormones|mesh-ancestor
102402975|NCT01470989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102402976|NCT01470989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102402977|NCT01470989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102034069|NCT03422159|Antioxidants|antioxidants|mesh-ancestor
102402978|NCT01470989|Immunologic Factors|immunologic factors|mesh-ancestor
102402979|NCT01470989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102402980|NCT01470989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402981|NCT01470599|Tofacitinib|tofacitinib|mesh-list
102402982|NCT01470599|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102402983|NCT01470599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102402984|NCT01470599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102402985|NCT01470599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402986|NCT01469819|Lubiprostone|lubiprostone|mesh-list
102402987|NCT01469819|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102402988|NCT01469819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102402989|NCT01469819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102402990|NCT04618523|Artesunate|artesunate|mesh-list
102402991|NCT04618523|Lumefantrine|lumefantrine|mesh-list
102402992|NCT04618523|Artemether|artemether|mesh-list
102402993|NCT04618523|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101606199|NCT02650102|Olanzapine|olanzapine|mesh-list
102402994|NCT04618523|Amodiaquine|amodiaquine|mesh-list
102402995|NCT04618523|Antimalarials|antimalarials|mesh-ancestor
102402996|NCT04618523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102402997|NCT04618523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102402998|NCT04618523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102402999|NCT04618523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102403000|NCT04618523|Antiviral Agents|antiviral agents|mesh-ancestor
102403001|NCT04618523|Schistosomicides|schistosomicides|mesh-ancestor
102403002|NCT04618523|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102403003|NCT04618523|Anthelmintics|anthelmintics|mesh-ancestor
102403004|NCT01507831|Alirocumab|alirocumab|mesh-list
102403005|NCT01507831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102403006|NCT01507831|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102403007|NCT01507831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102403008|NCT01507831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102403009|NCT01507831|Antimetabolites|antimetabolites|mesh-ancestor
102034097|NCT03644576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102403010|NCT01507831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403011|NCT01507831|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102403012|NCT01507831|Protease Inhibitors|protease inhibitors|mesh-ancestor
102403013|NCT01507831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102403014|NCT01507831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102403015|NCT01507831|Immunologic Factors|immunologic factors|mesh-ancestor
102403016|NCT01507831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403017|NCT01479439|Losartan|losartan|mesh-list
102403018|NCT01479439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102403019|NCT01479439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102403020|NCT01479439|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102403021|NCT01479439|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102403022|NCT01479439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403023|NCT01478971|Epoetin Alfa|epoetin alfa|mesh-list
102403024|NCT01478971|Hematinics|hematinics|mesh-ancestor
102403025|NCT01507051|Vitamin K|vitamin k|mesh-list
102403026|NCT01507051|Vitamin K 1|vitamin k 1|mesh-list
102403027|NCT01507051|Warfarin|warfarin|mesh-list
102403028|NCT01507051|Rivaroxaban|rivaroxaban|mesh-list
102403029|NCT01507051|Vitamins|vitamins|mesh-ancestor
102403030|NCT01507051|Micronutrients|micronutrients|mesh-ancestor
102403031|NCT01507051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403032|NCT01507051|Anticoagulants|anticoagulants|mesh-ancestor
102403033|NCT01507051|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102403034|NCT01507051|Antithrombins|antithrombins|mesh-ancestor
102403035|NCT01507051|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102403036|NCT01507051|Protease Inhibitors|protease inhibitors|mesh-ancestor
102403037|NCT01507051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102034120|NCT01180374|Dronabinol|dronabinol|mesh-list
102403038|NCT01507051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403039|NCT01507051|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102403040|NCT01507051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102403041|NCT01507051|Hemostatics|hemostatics|mesh-ancestor
102403042|NCT01507051|Coagulants|coagulants|mesh-ancestor
102403043|NCT04079257|Eculizumab|eculizumab|mesh-list
102403044|NCT04079257|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102403045|NCT04079257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102403046|NCT04079257|Immunologic Factors|immunologic factors|mesh-ancestor
102403047|NCT04079257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403048|NCT01478113|Amphetamine|amphetamine|mesh-list
102403049|NCT01478113|Adderall|adderall|mesh-list
102403050|NCT01478113|Dextroamphetamine|dextroamphetamine|mesh-list
102403051|NCT01478113|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102403052|NCT01478113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403053|NCT01478113|Sympathomimetics|sympathomimetics|mesh-ancestor
102403054|NCT01478113|Autonomic Agents|autonomic agents|mesh-ancestor
102403055|NCT01478113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102403056|NCT01478113|Dopamine Agents|dopamine agents|mesh-ancestor
102403057|NCT01478113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102403058|NCT01478113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403059|NCT01478113|Adrenergic Agents|adrenergic agents|mesh-ancestor
102403060|NCT01478113|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102403061|NCT01478113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102403062|NCT01478113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102403063|NCT01478113|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102403065|NCT01506271|Relebactam|relebactam|mesh-list
102403066|NCT01506271|Cilastatin|cilastatin|mesh-list
102403067|NCT01506271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102403068|NCT01506271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102403069|NCT01506271|Protease Inhibitors|protease inhibitors|mesh-ancestor
102403070|NCT01506271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102403071|NCT01506271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403072|NCT01506271|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102403073|NCT01506193|Vaccines|vaccines|mesh-list
102403074|NCT01506193|Immunologic Factors|immunologic factors|mesh-ancestor
102403075|NCT01506193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403076|NCT01505881|Warfarin|warfarin|mesh-list
102403077|NCT01505881|Dabigatran|dabigatran|mesh-list
102403078|NCT01505881|Anticoagulants|anticoagulants|mesh-ancestor
102403079|NCT01505881|Antithrombins|antithrombins|mesh-ancestor
102403080|NCT01505881|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102403081|NCT01505881|Protease Inhibitors|protease inhibitors|mesh-ancestor
102403082|NCT01505881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102403083|NCT01505881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403084|NCT01505647|Vaccines|vaccines|mesh-list
102403085|NCT01505647|Immunologic Factors|immunologic factors|mesh-ancestor
102403086|NCT01505647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403087|NCT01477333|Treprostinil|treprostinil|mesh-list
102403088|NCT01477333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102403089|NCT01505491|Adalimumab|adalimumab|mesh-list
102403090|NCT01505491|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102034165|NCT03717467|Tocolytic Agents|tocolytic agents|mesh-ancestor
102403091|NCT01505491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102403092|NCT01505491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102403093|NCT01504867|Aspirin|aspirin|mesh-list
102403094|NCT01504867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102403095|NCT01504867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102403096|NCT01504867|Analgesics|analgesics|mesh-ancestor
102403097|NCT01504867|Sensory System Agents|sensory system agents|mesh-ancestor
102403098|NCT01504867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102403099|NCT01504867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403100|NCT01504867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102403101|NCT01504867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102403102|NCT01504867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102403103|NCT01504867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102403104|NCT01504867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403105|NCT01504867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102403106|NCT01504867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102403107|NCT01504867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102403108|NCT01504867|Antipyretics|antipyretics|mesh-ancestor
102403109|NCT01476475|Insulin|insulin|mesh-list
102403110|NCT01476475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102403111|NCT01476475|Metformin|metformin|mesh-list
102403112|NCT01476475|Insulin Glargine|insulin glargine|mesh-list
102403113|NCT01476475|Lixisenatide|lixisenatide|mesh-list
102403114|NCT01476475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102403115|NCT01476475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403116|NCT01460719|Vaccines|vaccines|mesh-list
102403117|NCT01460719|Immunologic Factors|immunologic factors|mesh-ancestor
102403118|NCT01460719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403119|NCT00527943|Vorapaxar|vorapaxar|mesh-list
102403120|NCT00527943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102403121|NCT00448227|Famciclovir|famciclovir|mesh-list
102403122|NCT00448227|Antiviral Agents|antiviral agents|mesh-ancestor
102403123|NCT00448227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102403124|NCT00448227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102403125|NCT00448227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102403126|NCT00448227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403127|NCT00529191|Atorvastatin|atorvastatin|mesh-list
102403128|NCT00529191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102403129|NCT00529191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102403130|NCT00529191|Antimetabolites|antimetabolites|mesh-ancestor
102403131|NCT00529191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403132|NCT00529191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102403133|NCT00529191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102403134|NCT00529191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102403135|NCT00449007|Bupropion|bupropion|mesh-list
102403136|NCT00449007|Fluoxetine|fluoxetine|mesh-list
102403137|NCT00449007|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102403138|NCT00449007|Antidepressive Agents|antidepressive agents|mesh-ancestor
102403139|NCT00449007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102403140|NCT00449007|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102403141|NCT00449007|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102403142|NCT00449007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102403143|NCT00449007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403144|NCT00449007|Dopamine Agents|dopamine agents|mesh-ancestor
102403145|NCT00449007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102403146|NCT00449007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403147|NCT00449007|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102403148|NCT00449007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102403149|NCT00449007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102403150|NCT00449007|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102403151|NCT00449007|Serotonin Agents|serotonin agents|mesh-ancestor
102403152|NCT00460551|Zalutumumab|zalutumumab|mesh-list
102403153|NCT00460551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102403154|NCT00460551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102403155|NCT01468181|Dulaglutide|dulaglutide|mesh-list
102403156|NCT01468181|Biguanides|biguanides|mesh-list
102403157|NCT01468181|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
102403158|NCT01468181|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
102403159|NCT01468181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102034230|NCT03440411|Autonomic Agents|autonomic agents|mesh-ancestor
102403160|NCT01468181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403161|NCT01468181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102403162|NCT01468181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403163|NCT01693562|Durvalumab|durvalumab|mesh-list
102403164|NCT01693562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102403165|NCT01693562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102403166|NCT00461097|Immunomodulating Agents|immunomodulating agents|mesh-list
102403167|NCT00461097|Immunologic Factors|immunologic factors|mesh-ancestor
102403168|NCT00461097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403169|NCT00531453|Thalidomide|thalidomide|mesh-list
102403170|NCT00531453|Dexamethasone|dexamethasone|mesh-list
102403171|NCT00531453|Dexamethasone acetate|dexamethasone acetate|mesh-list
102403172|NCT00531453|Cyclophosphamide|cyclophosphamide|mesh-list
102403173|NCT00531453|Bortezomib|bortezomib|mesh-list
102403174|NCT00531453|BB 1101|bb 1101|mesh-list
102403175|NCT00531453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102403176|NCT00531453|Immunologic Factors|immunologic factors|mesh-ancestor
102403177|NCT00531453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403178|NCT00531453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102403179|NCT00531453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102403180|NCT00531453|Alkylating Agents|alkylating agents|mesh-ancestor
102403181|NCT00531453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403182|NCT00531453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102403183|NCT00531453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102403184|NCT00531453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102403185|NCT00531453|Antiemetics|antiemetics|mesh-ancestor
102403186|NCT00531453|Autonomic Agents|autonomic agents|mesh-ancestor
102403187|NCT00531453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102403188|NCT00531453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102403189|NCT00531453|Glucocorticoids|glucocorticoids|mesh-ancestor
102403190|NCT00531453|Hormones|hormones|mesh-ancestor
102403191|NCT00531453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102403192|NCT00531453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102403193|NCT00531453|Protease Inhibitors|protease inhibitors|mesh-ancestor
102403194|NCT00531453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102403195|NCT00531453|Leprostatic Agents|leprostatic agents|mesh-ancestor
102403196|NCT00531453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102403197|NCT00531453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102403198|NCT00531453|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102403199|NCT00531453|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102403200|NCT00531453|Growth Substances|growth substances|mesh-ancestor
102403201|NCT00531453|Growth Inhibitors|growth inhibitors|mesh-ancestor
102403202|NCT00531843|PENTA|penta|mesh-list
102403203|NCT00531843|Fondaparinux|fondaparinux|mesh-list
102403204|NCT00531843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102403205|NCT00531843|Antithrombins|antithrombins|mesh-ancestor
102403206|NCT00531843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102403207|NCT00531843|Protease Inhibitors|protease inhibitors|mesh-ancestor
102403208|NCT00531843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102403209|NCT00531843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403210|NCT00531843|Anticoagulants|anticoagulants|mesh-ancestor
102034279|NCT03395405|Nitazoxanide|nitazoxanide|mesh-list
102403211|NCT00531843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102403212|NCT00531843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102403213|NCT02073461|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102403214|NCT02073461|Dermatologic Agents|dermatologic agents|mesh-ancestor
102403215|NCT01590758|Pexiganan|pexiganan|mesh-list
102403216|NCT01590758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102403217|NCT01590758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102403218|NCT00534417|Capecitabine|capecitabine|mesh-list
102403219|NCT00534417|Fulvestrant|fulvestrant|mesh-list
102403220|NCT00534417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102403221|NCT00534417|Antimetabolites|antimetabolites|mesh-ancestor
102403222|NCT00534417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403223|NCT00534417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102403224|NCT00534417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102403225|NCT00534417|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102403226|NCT00534417|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102403227|NCT00534417|Hormone Antagonists|hormone antagonists|mesh-ancestor
102403228|NCT00534417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102403229|NCT00534417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403230|NCT01692626|Pimecrolimus|pimecrolimus|mesh-list
102403231|NCT01692626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102403232|NCT01692626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102403233|NCT01692626|Analgesics|analgesics|mesh-ancestor
102403234|NCT01692626|Sensory System Agents|sensory system agents|mesh-ancestor
102403235|NCT01692626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102403236|NCT01692626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403237|NCT01692626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102403238|NCT01692626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102403239|NCT01692626|Dermatologic Agents|dermatologic agents|mesh-ancestor
102403240|NCT01692626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102403241|NCT01692626|Immunologic Factors|immunologic factors|mesh-ancestor
102034311|NCT03414983|Nivolumab|nivolumab|mesh-list
102403242|NCT01692626|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102403243|NCT01692626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102403244|NCT01692626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403245|NCT00535587|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
102403246|NCT00535587|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102403247|NCT00535587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102403248|NCT00535587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403249|NCT00535587|Cholinergic Agents|cholinergic agents|mesh-ancestor
102403250|NCT00535587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102403251|NCT00535587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403252|NCT01475461|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102403253|NCT01475461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102403254|NCT01475461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403255|NCT01475461|Incretins|incretins|mesh-ancestor
102403256|NCT01475461|Hormones|hormones|mesh-ancestor
102403257|NCT01475461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102403258|NCT01475461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102403259|NCT01475461|Protease Inhibitors|protease inhibitors|mesh-ancestor
102403260|NCT01475461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102403261|NCT01475461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403262|NCT01589822|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102403263|NCT01589822|Hemostatics|hemostatics|mesh-ancestor
102403264|NCT01589822|Coagulants|coagulants|mesh-ancestor
102403265|NCT01475071|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
102403266|NCT01475071|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102403267|NCT01475071|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102403268|NCT01475071|Dermatologic Agents|dermatologic agents|mesh-ancestor
102403269|NCT01474993|Sulforaphane|sulforaphane|mesh-list
102403270|NCT01474993|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102403271|NCT01474993|Protective Agents|protective agents|mesh-ancestor
102403272|NCT01474993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403273|NCT01474993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102403274|NCT01691768|Tenofovir|tenofovir|mesh-list
102403275|NCT01691768|Antiviral Agents|antiviral agents|mesh-ancestor
102403276|NCT01691768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102403277|NCT01691768|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102403278|NCT01691768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102403279|NCT01691768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102403280|NCT01691768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403281|NCT01691768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102403282|NCT01691768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102403283|NCT01503229|Prednisone|prednisone|mesh-list
102403284|NCT01503229|Cortisone|cortisone|mesh-list
102403285|NCT01503229|Abiraterone Acetate|abiraterone acetate|mesh-list
102403286|NCT01503229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102403287|NCT01503229|Glucocorticoids|glucocorticoids|mesh-ancestor
102214965|NCT03867201|Erenumab|erenumab|mesh-list
102403289|NCT01503229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102403290|NCT01503229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403291|NCT01503229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102403292|NCT01503229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102403293|NCT01503229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102403294|NCT01503229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102403295|NCT01503229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403296|NCT01503229|Hormone Antagonists|hormone antagonists|mesh-ancestor
102403297|NCT01503229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102403298|NCT01460407|Clarithromycin|clarithromycin|mesh-list
102403299|NCT01460407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102403300|NCT01460407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102403301|NCT01460407|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102403302|NCT01460407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102403303|NCT01460407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403304|NCT01460407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102403305|NCT01460407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102403306|NCT01502371|Mometasone Furoate|mometasone furoate|mesh-list
102403307|NCT01502371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102403308|NCT01502371|Dermatologic Agents|dermatologic agents|mesh-ancestor
102403309|NCT01502371|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102403310|NCT01588496|Evolocumab|evolocumab|mesh-list
102403311|NCT01588496|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102403312|NCT01588496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102403313|NCT01588496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102403314|NCT01588496|Antimetabolites|antimetabolites|mesh-ancestor
102403315|NCT01588496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403316|NCT01588496|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102403317|NCT01588496|Protease Inhibitors|protease inhibitors|mesh-ancestor
102403318|NCT01588496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102403319|NCT01588496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102403320|NCT01502293|Interleukin-12|interleukin-12|mesh-list
102403321|NCT01502293|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102403322|NCT01502293|Immunologic Factors|immunologic factors|mesh-ancestor
102034352|NCT02583048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102403323|NCT01502293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403324|NCT01502293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102403325|NCT01502293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102403326|NCT01502293|Growth Substances|growth substances|mesh-ancestor
102403327|NCT01502293|Growth Inhibitors|growth inhibitors|mesh-ancestor
102403328|NCT01502293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102403329|NCT01588184|Bevacizumab|bevacizumab|mesh-list
102403330|NCT01588184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102403331|NCT01588184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102403332|NCT01588184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102403333|NCT01588184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102403334|NCT01588184|Growth Substances|growth substances|mesh-ancestor
102403335|NCT01588184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403336|NCT01588184|Growth Inhibitors|growth inhibitors|mesh-ancestor
102403337|NCT01564862|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102403338|NCT01564862|Vortioxetine|vortioxetine|mesh-list
102403339|NCT01564862|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102403340|NCT01564862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102403341|NCT01564862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102403342|NCT01564862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403343|NCT01564862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102403344|NCT01564862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403345|NCT01564862|Analgesics|analgesics|mesh-ancestor
102403346|NCT01564862|Sensory System Agents|sensory system agents|mesh-ancestor
102403347|NCT01564862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102403348|NCT01564862|Antidepressive Agents|antidepressive agents|mesh-ancestor
102403349|NCT01564862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102403350|NCT01564862|Dopamine Agents|dopamine agents|mesh-ancestor
102403351|NCT01564862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102403352|NCT01564862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102403353|NCT01564862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102403354|NCT01564862|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102403355|NCT01564862|Serotonin Agents|serotonin agents|mesh-ancestor
102403356|NCT01564862|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102403357|NCT01564862|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102403358|NCT01564862|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102403359|NCT01564862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102403361|NCT04857164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102403362|NCT04857164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102403363|NCT04857164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102403364|NCT04857164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403365|NCT01467479|Interferons|interferons|mesh-list
102403366|NCT01467479|Ribavirin|ribavirin|mesh-list
102403367|NCT01467479|Interferon-alpha|interferon-alpha|mesh-list
102403368|NCT01467479|Interferon alpha-2|interferon alpha-2|mesh-list
102403369|NCT01467479|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102403370|NCT01467479|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102403371|NCT01467479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102403372|NCT01467479|Antiviral Agents|antiviral agents|mesh-ancestor
102403373|NCT01467479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102403374|NCT01467479|Antimetabolites|antimetabolites|mesh-ancestor
102403375|NCT01467479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403376|NCT01467479|Immunologic Factors|immunologic factors|mesh-ancestor
102403377|NCT01467479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403378|NCT01466387|Vaccines|vaccines|mesh-list
102403379|NCT01466387|Immunologic Factors|immunologic factors|mesh-ancestor
102403380|NCT01466387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403381|NCT00535743|Bromides|bromides|mesh-list
102403382|NCT00535743|Rocuronium|rocuronium|mesh-list
102403383|NCT00535743|Anticonvulsants|anticonvulsants|mesh-ancestor
102403384|NCT00535743|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102403385|NCT00535743|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102403386|NCT00535743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102403387|NCT00535743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102403388|NCT00535743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403389|NCT01564784|Cytarabine|cytarabine|mesh-list
102403390|NCT01564784|Fludarabine|fludarabine|mesh-list
102403391|NCT01564784|Mitoxantrone|mitoxantrone|mesh-list
102403392|NCT01564784|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
102403393|NCT01564784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102403394|NCT01564784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102403395|NCT01564784|Antimetabolites|antimetabolites|mesh-ancestor
102403396|NCT01564784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403397|NCT01564784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102403398|NCT01564784|Immunologic Factors|immunologic factors|mesh-ancestor
102403399|NCT01564784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403400|NCT01564784|Antiviral Agents|antiviral agents|mesh-ancestor
102403401|NCT01564784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102403402|NCT01564784|Analgesics|analgesics|mesh-ancestor
102403403|NCT01564784|Sensory System Agents|sensory system agents|mesh-ancestor
102403404|NCT01564784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102403405|NCT01564784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102403406|NCT01564784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102403407|NCT01564784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102403408|NCT01564784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102403409|NCT01564784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102403410|NCT01564784|Immunotoxins|immunotoxins|mesh-ancestor
102403411|NCT01564784|Immunoconjugates|immunoconjugates|mesh-ancestor
102403412|NCT00536601|Cyclophosphamide|cyclophosphamide|mesh-list
102403413|NCT00536601|Melphalan|melphalan|mesh-list
102403414|NCT00536601|Busulfan|busulfan|mesh-list
102403415|NCT00536601|Thiotepa|thiotepa|mesh-list
102403416|NCT00536601|Carmustine|carmustine|mesh-list
102403417|NCT00536601|Carboplatin|carboplatin|mesh-list
102403418|NCT00536601|Etoposide|etoposide|mesh-list
102403419|NCT00536601|Etoposide phosphate|etoposide phosphate|mesh-list
102403420|NCT00536601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102403421|NCT00536601|Immunologic Factors|immunologic factors|mesh-ancestor
102403422|NCT00536601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403423|NCT00536601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102403424|NCT00536601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102403425|NCT00536601|Alkylating Agents|alkylating agents|mesh-ancestor
102403426|NCT00536601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403427|NCT00536601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102403428|NCT00536601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102403429|NCT00536601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102403430|NCT00536601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102403431|NCT00536601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102403432|NCT00536601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102403433|NCT00536913|Budesonide|budesonide|mesh-list
102403434|NCT00536913|Formoterol Fumarate|formoterol fumarate|mesh-list
102403435|NCT00536913|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
102403436|NCT00536913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102403438|NCT00536913|Autonomic Agents|autonomic agents|mesh-ancestor
102403439|NCT00536913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102403440|NCT00536913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403441|NCT00536913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102403442|NCT00536913|Respiratory System Agents|respiratory system agents|mesh-ancestor
102034478|NCT02236572|Everolimus|everolimus|mesh-list
102403443|NCT00536913|Glucocorticoids|glucocorticoids|mesh-ancestor
102403444|NCT00536913|Hormones|hormones|mesh-ancestor
102403445|NCT00536913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102403446|NCT00536913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102403447|NCT00536913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102403448|NCT00536913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102403449|NCT00536913|Adrenergic Agents|adrenergic agents|mesh-ancestor
102403450|NCT00536913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102403451|NCT00536913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403452|NCT00462423|Bevacizumab|bevacizumab|mesh-list
102403453|NCT00462423|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102403454|NCT00462423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102403455|NCT00462423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102403456|NCT00462423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102403457|NCT00462423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102403458|NCT00462423|Growth Substances|growth substances|mesh-ancestor
102403459|NCT00462423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403460|NCT00462423|Growth Inhibitors|growth inhibitors|mesh-ancestor
102403461|NCT00461331|Insulin|insulin|mesh-list
102403462|NCT00461331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102403463|NCT00461331|Insulin Aspart|insulin aspart|mesh-list
102403464|NCT00461331|Insulin, Long-Acting|insulin, long-acting|mesh-list
102403465|NCT00461331|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102403466|NCT00461331|Insulin Lispro|insulin lispro|mesh-list
102403467|NCT00461331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102403468|NCT00461331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403469|NCT00462735|Fluorouracil|fluorouracil|mesh-list
102403470|NCT00462735|Cetuximab|cetuximab|mesh-list
102403471|NCT00462735|Hydroxyurea|hydroxyurea|mesh-list
102403472|NCT00462735|Antimetabolites|antimetabolites|mesh-ancestor
102403473|NCT00462735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403474|NCT00462735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102403475|NCT00462735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102403476|NCT00462735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102403477|NCT00462735|Immunologic Factors|immunologic factors|mesh-ancestor
102403478|NCT00462735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403479|NCT00462735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102403480|NCT00462735|Antisickling Agents|antisickling agents|mesh-ancestor
102403481|NCT00462735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102403482|NCT00462735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102403483|NCT01690988|Ketamine|ketamine|mesh-list
102403484|NCT01690988|Analgesics|analgesics|mesh-ancestor
102403485|NCT01690988|Sensory System Agents|sensory system agents|mesh-ancestor
102403486|NCT01690988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102403487|NCT01690988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403488|NCT01690988|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102403489|NCT01690988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102403490|NCT01690988|Anesthetics, General|anesthetics, general|mesh-ancestor
102403491|NCT01690988|Anesthetics|anesthetics|mesh-ancestor
102403492|NCT01690988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102403493|NCT01690988|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102403494|NCT01690988|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102403495|NCT01690988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102403496|NCT01690988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403497|NCT00463437|Vaccines|vaccines|mesh-list
102403498|NCT00463437|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102403499|NCT00463437|Immunologic Factors|immunologic factors|mesh-ancestor
102403500|NCT00463437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403501|NCT01466153|Rituximab|rituximab|mesh-list
102403502|NCT01466153|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102403503|NCT01466153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102403504|NCT01466153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102403505|NCT01466153|Immunologic Factors|immunologic factors|mesh-ancestor
102403506|NCT01466153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403507|NCT01466153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102403508|NCT01466153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102034526|NCT04465266|Tolperisone|tolperisone|mesh-list
102403509|NCT01466153|Alkylating Agents|alkylating agents|mesh-ancestor
102403510|NCT01466153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403511|NCT00464685|Dexamethasone|dexamethasone|mesh-list
102403512|NCT00464685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102403513|NCT00464685|Antiemetics|antiemetics|mesh-ancestor
102403514|NCT00464685|Autonomic Agents|autonomic agents|mesh-ancestor
102403515|NCT00464685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102403516|NCT00464685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403517|NCT00464685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102403518|NCT00464685|Glucocorticoids|glucocorticoids|mesh-ancestor
102403520|NCT00464685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102403521|NCT00464685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102403522|NCT00464685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102403523|NCT01465997|Lacosamide|lacosamide|mesh-list
102403524|NCT01465997|Carbamazepine|carbamazepine|mesh-list
102403525|NCT01465997|Anticonvulsants|anticonvulsants|mesh-ancestor
102403526|NCT01465997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102403527|NCT01465997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102403528|NCT01465997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102403529|NCT01465997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403530|NCT01465997|Antimanic Agents|antimanic agents|mesh-ancestor
102403531|NCT01465997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102403532|NCT01465997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102403533|NCT01465997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403534|NCT01465997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102403535|NCT01465997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102403536|NCT01465997|Analgesics|analgesics|mesh-ancestor
102403537|NCT01465997|Sensory System Agents|sensory system agents|mesh-ancestor
102403538|NCT01465997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102403539|NCT01465997|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102403540|NCT01465997|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102403541|NCT00538863|Fentanyl|fentanyl|mesh-list
102403542|NCT00538863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102403543|NCT00538863|Narcotics|narcotics|mesh-ancestor
102403544|NCT00538863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102403545|NCT00538863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403546|NCT00538863|Analgesics|analgesics|mesh-ancestor
102403547|NCT00538863|Sensory System Agents|sensory system agents|mesh-ancestor
102403548|NCT00538863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102403549|NCT00538863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102403550|NCT00538863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102403551|NCT00538863|Anesthetics, General|anesthetics, general|mesh-ancestor
102403552|NCT00538863|Anesthetics|anesthetics|mesh-ancestor
102403553|NCT01465763|Tofacitinib|tofacitinib|mesh-list
102403554|NCT01465763|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102403555|NCT01465763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102403556|NCT01465763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102034593|NCT03822780|Hydroxychloroquine|hydroxychloroquine|mesh-list
102403557|NCT01465763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403558|NCT00540579|Gemcitabine|gemcitabine|mesh-list
102403559|NCT00540579|Pomalidomide|pomalidomide|mesh-list
102403560|NCT00540579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102403561|NCT00540579|Antimetabolites|antimetabolites|mesh-ancestor
102403562|NCT00540579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403563|NCT00540579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102403564|NCT00540579|Immunologic Factors|immunologic factors|mesh-ancestor
102403565|NCT00540579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403566|NCT00540579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102403567|NCT00540579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102403568|NCT00540579|Growth Substances|growth substances|mesh-ancestor
102403569|NCT00540579|Growth Inhibitors|growth inhibitors|mesh-ancestor
102403570|NCT01690520|Cyclosporine|cyclosporine|mesh-list
102403571|NCT01690520|Mycophenolic Acid|mycophenolic acid|mesh-list
102403572|NCT01690520|Cyclophosphamide|cyclophosphamide|mesh-list
102403573|NCT01690520|Thiotepa|thiotepa|mesh-list
102403574|NCT01690520|Fludarabine|fludarabine|mesh-list
102403575|NCT01690520|Fludarabine phosphate|fludarabine phosphate|mesh-list
102403576|NCT01690520|Cyclosporins|cyclosporins|mesh-list
102403577|NCT01690520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102403578|NCT01690520|Immunologic Factors|immunologic factors|mesh-ancestor
102403579|NCT01690520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403580|NCT01690520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102403581|NCT01690520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102403582|NCT01690520|Alkylating Agents|alkylating agents|mesh-ancestor
102403583|NCT01690520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403584|NCT01690520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102403586|NCT01690520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102403587|NCT01690520|Antimetabolites|antimetabolites|mesh-ancestor
102403588|NCT01690520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102403589|NCT01690520|Antifungal Agents|antifungal agents|mesh-ancestor
102403590|NCT01690520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102403591|NCT01690520|Dermatologic Agents|dermatologic agents|mesh-ancestor
102403592|NCT01690520|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102403593|NCT01690520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102403594|NCT01690520|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102403595|NCT01690520|Antitubercular Agents|antitubercular agents|mesh-ancestor
102403596|NCT01690520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102403597|NCT04081337|Tirzepatide|tirzepatide|mesh-list
102403598|NCT04081337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102403599|NCT04081337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403600|NCT04081337|Incretins|incretins|mesh-ancestor
102403601|NCT04081337|Hormones|hormones|mesh-ancestor
102403602|NCT04081337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102403603|NCT00541671|Promethazine|promethazine|mesh-list
102403604|NCT00541671|Antipruritics|antipruritics|mesh-ancestor
102403605|NCT00541671|Dermatologic Agents|dermatologic agents|mesh-ancestor
102403606|NCT00541671|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102403607|NCT00541671|Histamine Antagonists|histamine antagonists|mesh-ancestor
102403608|NCT00541671|Histamine Agents|histamine agents|mesh-ancestor
102403609|NCT00541671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102403610|NCT00541671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403611|NCT00541671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403612|NCT00541671|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102403613|NCT01563536|Ritonavir|ritonavir|mesh-list
102403614|NCT01563536|Ribavirin|ribavirin|mesh-list
102403615|NCT01563536|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102403616|NCT01563536|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102403617|NCT01563536|Protease Inhibitors|protease inhibitors|mesh-ancestor
102403618|NCT01563536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102403619|NCT01563536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403620|NCT01563536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102403621|NCT01563536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102403622|NCT01563536|Antiviral Agents|antiviral agents|mesh-ancestor
102403623|NCT01563536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102403624|NCT01563536|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102403625|NCT01563536|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102403626|NCT01563536|Antimetabolites|antimetabolites|mesh-ancestor
102403627|NCT01690052|Pilocarpine|pilocarpine|mesh-list
102403628|NCT01690052|Cevimeline|cevimeline|mesh-list
102403629|NCT01690052|Miotics|miotics|mesh-ancestor
102403630|NCT01690052|Autonomic Agents|autonomic agents|mesh-ancestor
102403631|NCT01690052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102403632|NCT01690052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403633|NCT01690052|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102403634|NCT01690052|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102403635|NCT01690052|Cholinergic Agents|cholinergic agents|mesh-ancestor
102403636|NCT01690052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102403637|NCT01690052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403638|NCT01690052|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102403639|NCT01689974|Ipilimumab|ipilimumab|mesh-list
102403640|NCT01689974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102403641|NCT01689974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102403642|NCT01689974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102403643|NCT01689974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403644|NCT04750083|Carboplatin|carboplatin|mesh-list
102403645|NCT04750083|Pembrolizumab|pembrolizumab|mesh-list
102403646|NCT04750083|Pemetrexed|pemetrexed|mesh-list
102403647|NCT04750083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102403648|NCT04750083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102403649|NCT04750083|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102403650|NCT04750083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403651|NCT04750083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102403652|NCT04750083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102403653|NCT04750083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102403654|NCT02954991|Nivolumab|nivolumab|mesh-list
102403655|NCT02954991|Mocetinostat|mocetinostat|mesh-list
102403656|NCT02954991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102403657|NCT02954991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102403658|NCT02954991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102215338|NCT00644228|Antiemetics|antiemetics|mesh-ancestor
102403659|NCT02954991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403661|NCT02954991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102403662|NCT02892591|Oxycodone|oxycodone|mesh-list
102403663|NCT02892591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102403664|NCT02892591|Narcotics|narcotics|mesh-ancestor
102403665|NCT02892591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102403666|NCT02892591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403667|NCT02892591|Analgesics|analgesics|mesh-ancestor
102403668|NCT02892591|Sensory System Agents|sensory system agents|mesh-ancestor
102403669|NCT02892591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102403670|NCT00470301|Paclitaxel|paclitaxel|mesh-list
102403671|NCT00470301|Cyclophosphamide|cyclophosphamide|mesh-list
102403672|NCT00470301|Doxorubicin|doxorubicin|mesh-list
102403673|NCT00470301|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102403674|NCT00470301|Tipifarnib|tipifarnib|mesh-list
102403675|NCT00470301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102403676|NCT00470301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102403677|NCT00470301|Tubulin Modulators|tubulin modulators|mesh-ancestor
102403678|NCT00470301|Antimitotic Agents|antimitotic agents|mesh-ancestor
102403679|NCT00470301|Mitosis Modulators|mitosis modulators|mesh-ancestor
102403680|NCT00470301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403681|NCT00470301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102403682|NCT00470301|Immunologic Factors|immunologic factors|mesh-ancestor
102403683|NCT00470301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403684|NCT00470301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102403685|NCT00470301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102403686|NCT00470301|Alkylating Agents|alkylating agents|mesh-ancestor
102403687|NCT00470301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102403688|NCT00470301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102403689|NCT00470301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102403690|NCT00470301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102403691|NCT00470301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102403692|NCT00544713|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102403693|NCT00544713|Lubricant Eye Drops|lubricant eye drops|mesh-list
102403694|NCT00544713|Glycerol|glycerol|mesh-list
102403695|NCT00544713|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102403696|NCT00544713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102403697|NCT00544713|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102403698|NCT00544713|Protective Agents|protective agents|mesh-ancestor
102403699|NCT00544713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403700|NCT00544713|Laxatives|laxatives|mesh-ancestor
102403701|NCT00544713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102403702|NCT00545181|Metronidazole|metronidazole|mesh-list
102403703|NCT00545181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102403704|NCT00545181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102403705|NCT00545181|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102403706|NCT00545181|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102403707|NCT01797315|Sirolimus|sirolimus|mesh-list
102403708|NCT01797315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102403709|NCT01797315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102403710|NCT01797315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102403711|NCT01797315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102403712|NCT01797315|Antifungal Agents|antifungal agents|mesh-ancestor
102403713|NCT01797315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102403714|NCT01797315|Immunologic Factors|immunologic factors|mesh-ancestor
102403715|NCT01797315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403716|NCT00471705|Miltefosine|miltefosine|mesh-list
102403717|NCT00471705|Meglumine Antimoniate|meglumine antimoniate|mesh-list
102403718|NCT00471705|Antifungal Agents|antifungal agents|mesh-ancestor
102403719|NCT00471705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102403720|NCT00471705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102403721|NCT00471705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102403722|NCT00471705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102403723|NCT00472797|Interferon beta-1a|interferon beta-1a|mesh-list
102403724|NCT00472797|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102403725|NCT00472797|Immunologic Factors|immunologic factors|mesh-ancestor
102403726|NCT00472797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403727|NCT00472797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102403728|NCT00472797|Antiviral Agents|antiviral agents|mesh-ancestor
102403729|NCT00472797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102403730|NCT01458535|Ritonavir|ritonavir|mesh-list
102403731|NCT01458535|Ribavirin|ribavirin|mesh-list
102403732|NCT01458535|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102403733|NCT01458535|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102403734|NCT01458535|Protease Inhibitors|protease inhibitors|mesh-ancestor
102403735|NCT01458535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102403736|NCT01458535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403737|NCT01458535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102403738|NCT01458535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102403739|NCT01458535|Antiviral Agents|antiviral agents|mesh-ancestor
102403740|NCT01458535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102403741|NCT01458535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102403742|NCT01458535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102403743|NCT01458535|Antimetabolites|antimetabolites|mesh-ancestor
102403744|NCT01464827|Ritonavir|ritonavir|mesh-list
102403745|NCT01464827|Ribavirin|ribavirin|mesh-list
102403746|NCT01464827|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102403747|NCT01464827|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102403748|NCT01464827|Protease Inhibitors|protease inhibitors|mesh-ancestor
102403749|NCT01464827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102403750|NCT01464827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403751|NCT01464827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102403752|NCT01464827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102403753|NCT01464827|Antiviral Agents|antiviral agents|mesh-ancestor
102403754|NCT01464827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102403755|NCT01464827|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102403756|NCT01464827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102403757|NCT01464827|Antimetabolites|antimetabolites|mesh-ancestor
102403758|NCT01463111|Lamotrigine|lamotrigine|mesh-list
102403759|NCT01463111|Valproic Acid|valproic acid|mesh-list
102403760|NCT01463111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102403761|NCT01463111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102403762|NCT01463111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403763|NCT01463111|Antimanic Agents|antimanic agents|mesh-ancestor
102403764|NCT01463111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102403765|NCT01463111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102403766|NCT01463111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403767|NCT01463111|Anticonvulsants|anticonvulsants|mesh-ancestor
102403768|NCT01463111|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102403769|NCT01463111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102403770|NCT01463111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102403771|NCT01463111|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102403772|NCT01463111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102403773|NCT01463111|GABA Agents|gaba agents|mesh-ancestor
102403774|NCT01463111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102403775|NCT01463033|Levetiracetam|levetiracetam|mesh-list
102403776|NCT01463033|Anticonvulsants|anticonvulsants|mesh-ancestor
102403777|NCT01463033|Nootropic Agents|nootropic agents|mesh-ancestor
102403778|NCT01461551|Propofol|propofol|mesh-list
102403779|NCT01461551|Sevoflurane|sevoflurane|mesh-list
102403780|NCT01461551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102403781|NCT01461551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102403782|NCT01461551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403783|NCT01461551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102403784|NCT01461551|Anesthetics, General|anesthetics, general|mesh-ancestor
102403785|NCT01461551|Anesthetics|anesthetics|mesh-ancestor
102403786|NCT01461551|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102403787|NCT01461551|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102403788|NCT01460381|Quinidine|quinidine|mesh-list
102403789|NCT01460381|Quinidine gluconate|quinidine gluconate|mesh-list
102403790|NCT01460381|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102403791|NCT01460381|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102403792|NCT01460381|Adrenergic Agents|adrenergic agents|mesh-ancestor
102403793|NCT01460381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102403794|NCT01460381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403795|NCT01460381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403796|NCT01460381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102403797|NCT01460381|Antimalarials|antimalarials|mesh-ancestor
102403798|NCT01460381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102403799|NCT01460381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102403800|NCT01460381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102403801|NCT01460381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102403802|NCT01460381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102403803|NCT01460381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102403804|NCT01460381|Cholinergic Agents|cholinergic agents|mesh-ancestor
102403805|NCT01460381|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102403806|NCT01460381|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102403807|NCT01460381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102403808|NCT01460381|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102403809|NCT01460381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102403810|NCT00546897|Lenalidomide|lenalidomide|mesh-list
102215498|NCT00489203|Hormones|hormones|mesh-ancestor
102403812|NCT00546897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403813|NCT00546897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102403814|NCT00546897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102403815|NCT00546897|Growth Substances|growth substances|mesh-ancestor
102403816|NCT00546897|Growth Inhibitors|growth inhibitors|mesh-ancestor
102403817|NCT00546897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102403818|NCT00474123|Simvastatin|simvastatin|mesh-list
102403819|NCT00474123|Ezetimibe|ezetimibe|mesh-list
102403820|NCT00474123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102403821|NCT00474123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102403822|NCT00474123|Antimetabolites|antimetabolites|mesh-ancestor
102403823|NCT00474123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403824|NCT00474123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102403825|NCT00474123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102403826|NCT00474123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102403827|NCT00474201|Ritonavir|ritonavir|mesh-list
102403828|NCT00474201|Lopinavir|lopinavir|mesh-list
102403829|NCT00474201|Gemfibrozil|gemfibrozil|mesh-list
102403830|NCT00474201|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102403831|NCT00474201|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102403832|NCT00474201|Protease Inhibitors|protease inhibitors|mesh-ancestor
102403833|NCT00474201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102403834|NCT00474201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403835|NCT00474201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102403836|NCT00474201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102403837|NCT00474201|Antiviral Agents|antiviral agents|mesh-ancestor
102403838|NCT00474201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102403839|NCT00474201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102403840|NCT00474201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102034880|NCT02891915|Cefdinir|cefdinir|mesh-list
102403841|NCT00474201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102403842|NCT00474201|Antimetabolites|antimetabolites|mesh-ancestor
102403843|NCT00474201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102403844|NCT00474201|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102403845|NCT00549393|Chlorhexidine|chlorhexidine|mesh-list
102403846|NCT00549393|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102403847|NCT00549393|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102403848|NCT00549393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102403849|NCT00549393|Disinfectants|disinfectants|mesh-ancestor
102403850|NCT00549393|Dermatologic Agents|dermatologic agents|mesh-ancestor
102403851|NCT00549783|Botulinum Toxins|botulinum toxins|mesh-list
102403852|NCT00549783|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102403853|NCT00549783|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102403854|NCT00549783|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102403855|NCT00549783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102403856|NCT00549783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403857|NCT00549783|Cholinergic Agents|cholinergic agents|mesh-ancestor
102403858|NCT00549783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102403859|NCT00549783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403860|NCT00549783|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102403861|NCT00549783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102403862|NCT00475215|Rocuronium|rocuronium|mesh-list
102403863|NCT00475215|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102403864|NCT00475215|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102403865|NCT00475215|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102403866|NCT00475215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102403867|NCT00475215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403868|NCT02733159|Pembrolizumab|pembrolizumab|mesh-list
102403869|NCT02733159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102403870|NCT02733159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102403871|NCT02733159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102403872|NCT02733159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403873|NCT00477087|Molgramostim|molgramostim|mesh-list
102403874|NCT00477087|Mitoxantrone|mitoxantrone|mesh-list
102403875|NCT00477087|Sargramostim|sargramostim|mesh-list
102403876|NCT00477087|Immunologic Factors|immunologic factors|mesh-ancestor
102403877|NCT00477087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403878|NCT00477087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102403879|NCT00477087|Analgesics|analgesics|mesh-ancestor
102403880|NCT00477087|Sensory System Agents|sensory system agents|mesh-ancestor
102403881|NCT00477087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102403882|NCT00477087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102403883|NCT00477087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102403884|NCT00477087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102403885|NCT00477087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403886|NCT04409912|Sirolimus|sirolimus|mesh-list
102403887|NCT04409912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102403888|NCT04409912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102403889|NCT04409912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102403890|NCT04409912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102403891|NCT04409912|Antifungal Agents|antifungal agents|mesh-ancestor
102403892|NCT04409912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102403893|NCT04409912|Immunologic Factors|immunologic factors|mesh-ancestor
102403894|NCT04409912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403895|NCT01473589|Vitamin D|vitamin d|mesh-list
102403896|NCT01473589|Teriparatide|teriparatide|mesh-list
102403897|NCT01473589|Calcium|calcium|mesh-list
102403898|NCT01473589|Vitamins|vitamins|mesh-ancestor
102403899|NCT01473589|Micronutrients|micronutrients|mesh-ancestor
102403900|NCT01473589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403901|NCT01473589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102403902|NCT01473589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102403903|NCT00478335|Calcitonin|calcitonin|mesh-list
102403904|NCT00478335|Salmon calcitonin|salmon calcitonin|mesh-list
102403905|NCT00478335|Indomethacin|indomethacin|mesh-list
102403906|NCT00478335|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102403907|NCT00478335|Amiloride|amiloride|mesh-list
102403908|NCT00478335|Sildenafil Citrate|sildenafil citrate|mesh-list
102403909|NCT00478335|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
102403910|NCT00478335|Katacalcin|katacalcin|mesh-list
102403911|NCT00478335|Vasodilator Agents|vasodilator agents|mesh-ancestor
102403912|NCT00478335|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102403913|NCT00478335|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102403914|NCT00478335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102403915|NCT00478335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403916|NCT00478335|Urological Agents|urological agents|mesh-ancestor
102403917|NCT00478335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102403918|NCT00478335|Diuretics|diuretics|mesh-ancestor
102403919|NCT00478335|Natriuretic Agents|natriuretic agents|mesh-ancestor
102403920|NCT00478335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403921|NCT00478335|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102403922|NCT00478335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102403923|NCT00478335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102403924|NCT00478335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102403925|NCT00478335|Analgesics|analgesics|mesh-ancestor
102403926|NCT00478335|Sensory System Agents|sensory system agents|mesh-ancestor
102403927|NCT00478335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102403928|NCT00478335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102403929|NCT00478335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102403930|NCT00478335|Gout Suppressants|gout suppressants|mesh-ancestor
102403931|NCT00478335|Tocolytic Agents|tocolytic agents|mesh-ancestor
102403932|NCT00478335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102403933|NCT00478335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102403934|NCT00478335|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
102403935|NCT00478335|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102403936|NCT00478335|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
102403937|NCT00478335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102403938|NCT00478335|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102403939|NCT00478335|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102403940|NCT00478569|Hormones|hormones|mesh-list
102403941|NCT00478569|Parathyroid Hormone|parathyroid hormone|mesh-list
102403942|NCT00478569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102034982|NCT04625088|Parasympatholytics|parasympatholytics|mesh-ancestor
102403943|NCT00478569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403944|NCT00478569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102403945|NCT00479037|Strontium ranelate|strontium ranelate|mesh-list
102403946|NCT00479037|Hormones|hormones|mesh-list
102403947|NCT00479037|Parathyroid Hormone|parathyroid hormone|mesh-list
102403948|NCT00479037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102403949|NCT00479037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403950|NCT00479037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102403951|NCT00479037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102403952|NCT02985229|Misoprostol|misoprostol|mesh-list
102403953|NCT02985229|Mifepristone|mifepristone|mesh-list
102403954|NCT02985229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102403955|NCT02985229|Abortifacient Agents|abortifacient agents|mesh-ancestor
102403956|NCT02985229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102403957|NCT02985229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403958|NCT02985229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102403959|NCT02985229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102403960|NCT02985229|Oxytocics|oxytocics|mesh-ancestor
102403961|NCT02985229|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102403962|NCT02985229|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102403963|NCT02985229|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102403964|NCT02985229|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102403965|NCT02985229|Contraceptive Agents|contraceptive agents|mesh-ancestor
102403966|NCT02985229|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102403967|NCT02985229|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102403968|NCT02985229|Hormone Antagonists|hormone antagonists|mesh-ancestor
102403969|NCT02985229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102403970|NCT02985229|Luteolytic Agents|luteolytic agents|mesh-ancestor
102403971|NCT02985229|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102403972|NCT02985229|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102403973|NCT00479115|Plerixafor|plerixafor|mesh-list
102403974|NCT00479115|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102403975|NCT00479115|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102403976|NCT00479115|Antiviral Agents|antiviral agents|mesh-ancestor
102403977|NCT00479115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102403978|NCT01472965|Ethanol|ethanol|mesh-list
102403979|NCT01472965|Heparin|heparin|mesh-list
102403980|NCT01472965|Calcium heparin|calcium heparin|mesh-list
102403981|NCT01472965|Anticoagulants|anticoagulants|mesh-ancestor
102403982|NCT01472965|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102403983|NCT01472965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102403984|NCT01472965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403985|NCT01472965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102403986|NCT01472965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102403987|NCT01472965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102403988|NCT01472965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102403989|NCT00480987|Cytarabine|cytarabine|mesh-list
102403990|NCT00480987|Oxaliplatin|oxaliplatin|mesh-list
102403991|NCT00480987|Fludarabine|fludarabine|mesh-list
102403992|NCT00480987|Fludarabine phosphate|fludarabine phosphate|mesh-list
102403993|NCT00480987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102403994|NCT00480987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102403995|NCT00480987|Antimetabolites|antimetabolites|mesh-ancestor
102403996|NCT00480987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102403997|NCT00480987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102403998|NCT00480987|Immunologic Factors|immunologic factors|mesh-ancestor
102403999|NCT00480987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404000|NCT00480987|Antiviral Agents|antiviral agents|mesh-ancestor
102404001|NCT00480987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102404002|NCT01457053|Torsemide|torsemide|mesh-list
102404003|NCT01457053|Furosemide|furosemide|mesh-list
102404004|NCT01457053|Bumetanide|bumetanide|mesh-list
102404005|NCT01457053|Diuretics|diuretics|mesh-list
102404006|NCT01457053|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
102404007|NCT01457053|Natriuretic Agents|natriuretic agents|mesh-ancestor
102404008|NCT01457053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404009|NCT01457053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102404010|NCT01457053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404011|NCT01457053|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102404012|NCT04082767|Midazolam|midazolam|mesh-list
102404013|NCT04082767|Dexmedetomidine|dexmedetomidine|mesh-list
102404014|NCT04082767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102404015|NCT04082767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102404016|NCT04082767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404017|NCT04082767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102404018|NCT04082767|Analgesics|analgesics|mesh-ancestor
102404019|NCT04082767|Sensory System Agents|sensory system agents|mesh-ancestor
102404020|NCT04082767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102404021|NCT04082767|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102404022|NCT04082767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102404023|NCT04082767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102404024|NCT04082767|Adrenergic Agents|adrenergic agents|mesh-ancestor
102404025|NCT04082767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102404026|NCT04082767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404027|NCT04082767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102404028|NCT04082767|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102404029|NCT04082767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102404030|NCT04082767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102404031|NCT04082767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102404032|NCT04082767|Anesthetics, General|anesthetics, general|mesh-ancestor
102404033|NCT04082767|Anesthetics|anesthetics|mesh-ancestor
102404034|NCT04082767|GABA Modulators|gaba modulators|mesh-ancestor
102404035|NCT04082767|GABA Agents|gaba agents|mesh-ancestor
102404036|NCT00481845|Anastrozole|anastrozole|mesh-list
102404037|NCT00481845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102404038|NCT00481845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102404039|NCT00481845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102404040|NCT00481845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102404041|NCT00481845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102404042|NCT00481845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404043|NCT00481845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102404044|NCT00481845|Hormone Antagonists|hormone antagonists|mesh-ancestor
102404045|NCT00481845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102404046|NCT00481845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404047|NCT01472185|Ranolazine|ranolazine|mesh-list
102404048|NCT01472185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102404049|NCT01472185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102404050|NCT01472185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404051|NCT00482625|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102404052|NCT00482625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102404053|NCT00482625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102404054|NCT00482625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102404055|NCT00482625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404056|NCT00553839|Ketamine|ketamine|mesh-list
102404057|NCT00553839|Analgesics|analgesics|mesh-ancestor
102404058|NCT00553839|Sensory System Agents|sensory system agents|mesh-ancestor
102404059|NCT00553839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102404060|NCT00553839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404061|NCT00553839|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102404062|NCT00553839|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102404063|NCT00553839|Anesthetics, General|anesthetics, general|mesh-ancestor
102404064|NCT00553839|Anesthetics|anesthetics|mesh-ancestor
102404065|NCT00553839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102404066|NCT00553839|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102404067|NCT00553839|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102404068|NCT00553839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102404069|NCT00553839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404070|NCT00554463|Etoposide|etoposide|mesh-list
102404071|NCT00554463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102404072|NCT00554463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102404073|NCT00554463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102404074|NCT00554463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102404075|NCT00554463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102404076|NCT00554463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404077|NCT00554853|Pioglitazone|pioglitazone|mesh-list
102404078|NCT00554853|Nitroglycerin|nitroglycerin|mesh-list
102404079|NCT00554853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102404080|NCT00554853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404081|NCT00554853|Vasodilator Agents|vasodilator agents|mesh-ancestor
102404082|NCT00556491|Minocycline|minocycline|mesh-list
102404083|NCT00556491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102404084|NCT00556491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102404085|NCT02685969|Flutemetamol|flutemetamol|mesh-list
102404086|NCT02685969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102404087|NCT02685969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404088|NCT00483561|Etoposide|etoposide|mesh-list
102404089|NCT00483561|Gefitinib|gefitinib|mesh-list
102404090|NCT00483561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102404091|NCT00483561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102404092|NCT00483561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102404093|NCT00483561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102404094|NCT00483561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102404095|NCT00483561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404096|NCT00483561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102404097|NCT00485433|Epinephrine|epinephrine|mesh-list
102404098|NCT00485433|Bupivacaine|bupivacaine|mesh-list
102404099|NCT00485433|Anesthetics, Local|anesthetics, local|mesh-ancestor
102404100|NCT00485433|Anesthetics|anesthetics|mesh-ancestor
102404101|NCT00485433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102404102|NCT00485433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404103|NCT00485433|Sensory System Agents|sensory system agents|mesh-ancestor
102404104|NCT00485433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102404105|NCT00485433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102404106|NCT00485433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102404107|NCT00485433|Adrenergic Agents|adrenergic agents|mesh-ancestor
102404108|NCT00485433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102404109|NCT00485433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404110|NCT00485433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102404111|NCT00485433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102404112|NCT00485433|Autonomic Agents|autonomic agents|mesh-ancestor
102035145|NCT03646370|Tenofovir|tenofovir|mesh-list
102404113|NCT00485433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102404114|NCT00485433|Respiratory System Agents|respiratory system agents|mesh-ancestor
102404115|NCT00485433|Mydriatics|mydriatics|mesh-ancestor
102404116|NCT00485433|Sympathomimetics|sympathomimetics|mesh-ancestor
102404117|NCT00485433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102404118|NCT02850081|Atorvastatin|atorvastatin|mesh-list
102404119|NCT02850081|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
102404120|NCT02850081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102404121|NCT02850081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102404122|NCT02850081|Antimetabolites|antimetabolites|mesh-ancestor
102404123|NCT02850081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404124|NCT02850081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102404125|NCT02850081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102404126|NCT01456039|Romidepsin|romidepsin|mesh-list
102404127|NCT01456039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102404128|NCT01456039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102404129|NCT01456039|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102404130|NCT01456039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102404131|NCT01456039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404132|NCT01455415|Pregabalin|pregabalin|mesh-list
102404133|NCT01455415|Analgesics|analgesics|mesh-ancestor
102404134|NCT01455415|Sensory System Agents|sensory system agents|mesh-ancestor
102404135|NCT01455415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102404136|NCT01455415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404137|NCT01455415|Anticonvulsants|anticonvulsants|mesh-ancestor
102404138|NCT01455415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102404139|NCT01455415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102404140|NCT01455415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404141|NCT01455415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102404142|NCT01455415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102404143|NCT01455415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102404144|NCT01455415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102404145|NCT01455415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102404146|NCT01471171|Bromides|bromides|mesh-list
102404147|NCT01471171|Anticonvulsants|anticonvulsants|mesh-ancestor
102404148|NCT01471093|Rebamipide|rebamipide|mesh-list
102404149|NCT01471093|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102404150|NCT01471093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102404151|NCT01471093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102404152|NCT01471093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102404153|NCT01471093|Antioxidants|antioxidants|mesh-ancestor
102404154|NCT01471093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404155|NCT01471093|Protective Agents|protective agents|mesh-ancestor
102404156|NCT01471093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404157|NCT01471093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102404158|NCT01471015|Darbepoetin alfa|darbepoetin alfa|mesh-list
102404159|NCT01471015|Hematinics|hematinics|mesh-ancestor
102404160|NCT01470469|Guanfacine|guanfacine|mesh-list
102404161|NCT01470469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102404162|NCT01470469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102404163|NCT01470469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102404164|NCT01470469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102404165|NCT01470469|Adrenergic Agents|adrenergic agents|mesh-ancestor
102404166|NCT01470469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102404167|NCT01470469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404168|NCT01470469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404169|NCT01470001|Solifenacin Succinate|solifenacin succinate|mesh-list
102404170|NCT01470001|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102404171|NCT01470001|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102404172|NCT01470001|Cholinergic Agents|cholinergic agents|mesh-ancestor
102404173|NCT01470001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102404174|NCT01470001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404175|NCT01470001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404176|NCT01470001|Urological Agents|urological agents|mesh-ancestor
102404177|NCT01469377|Cariprazine|cariprazine|mesh-list
102404178|NCT01469377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102404179|NCT01469377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102404180|NCT01469377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102404181|NCT01469377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215865|NCT04470479|Miotics|miotics|mesh-ancestor
102404182|NCT01469377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102404183|NCT01469221|Apaziquone|apaziquone|mesh-list
102404184|NCT01469221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102404185|NCT01453855|Travoprost|travoprost|mesh-list
102404186|NCT01453855|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102404187|NCT01453855|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102404188|NCT01453855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102404189|NCT01469065|Nicotinic Acids|nicotinic acids|mesh-list
102404190|NCT01469065|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
102404191|NCT01469065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102404192|NCT01469065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404193|NCT01469065|Vitamin B Complex|vitamin b complex|mesh-ancestor
102404194|NCT01469065|Vitamins|vitamins|mesh-ancestor
102404195|NCT01469065|Micronutrients|micronutrients|mesh-ancestor
102404196|NCT01469065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404197|NCT01586156|Carvedilol|carvedilol|mesh-list
102404198|NCT01586156|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102404199|NCT01586156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102404200|NCT01586156|Adrenergic Agents|adrenergic agents|mesh-ancestor
102404201|NCT01586156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102404202|NCT01586156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404203|NCT01586156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404204|NCT01586156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102404205|NCT01586156|Antioxidants|antioxidants|mesh-ancestor
102404206|NCT01586156|Protective Agents|protective agents|mesh-ancestor
102404207|NCT01586156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102404208|NCT01586156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102404209|NCT01586156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102404210|NCT01586156|Vasodilator Agents|vasodilator agents|mesh-ancestor
102404211|NCT01586156|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102404212|NCT01586156|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102404213|NCT01459913|Interferons|interferons|mesh-list
102404214|NCT01459913|Ribavirin|ribavirin|mesh-list
102404215|NCT01459913|Interferon-alpha|interferon-alpha|mesh-list
102404216|NCT01459913|Interferon alpha-2|interferon alpha-2|mesh-list
102404217|NCT01459913|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102404218|NCT01459913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102404219|NCT01459913|Antiviral Agents|antiviral agents|mesh-ancestor
102404220|NCT01459913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102404221|NCT01459913|Antimetabolites|antimetabolites|mesh-ancestor
102404222|NCT01459913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404223|NCT01459913|Immunologic Factors|immunologic factors|mesh-ancestor
102404224|NCT01459913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404225|NCT01458587|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102404226|NCT01458587|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102404227|NCT01458587|Dermatologic Agents|dermatologic agents|mesh-ancestor
102404228|NCT01458275|Ciclesonide|ciclesonide|mesh-list
102404229|NCT01458275|Glucocorticoids|glucocorticoids|mesh-ancestor
102404230|NCT01458275|Hormones|hormones|mesh-ancestor
102404231|NCT01458275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102404232|NCT01458275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404233|NCT01458275|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102404234|NCT02334527|Palbociclib|palbociclib|mesh-list
102404235|NCT02334527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102404236|NCT02334527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102404237|NCT02334527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102404238|NCT02334527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404239|NCT01688726|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102404240|NCT01688726|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102404241|NCT01457339|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102404242|NCT01457339|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102404243|NCT01457339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404244|NCT01457339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102404245|NCT01457339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102404246|NCT01457339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102404247|NCT01457339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404248|NCT01457339|Dopamine Agents|dopamine agents|mesh-ancestor
102404249|NCT01457339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102404250|NCT01456169|Chlorthalidone|chlorthalidone|mesh-list
102404251|NCT01456169|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
102404252|NCT01456169|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102404253|NCT01456169|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102404254|NCT01456169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404255|NCT01456169|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102404257|NCT01456169|Natriuretic Agents|natriuretic agents|mesh-ancestor
102404258|NCT01456169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404259|NCT01456169|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102404260|NCT01456169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102404261|NCT01453595|Dactolisib|dactolisib|mesh-list
102404262|NCT01453595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102404263|NCT01585298|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102404264|NCT01585298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102404265|NCT01585298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404266|NCT01585298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102404267|NCT01585298|Immunologic Factors|immunologic factors|mesh-ancestor
102404268|NCT01585298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404269|NCT04124198|Nimorazole|nimorazole|mesh-list
102404270|NCT04124198|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
102404271|NCT04124198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102404272|NCT04124198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102404273|NCT04124198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102404274|NCT01453205|Rituximab|rituximab|mesh-list
102404275|NCT01453205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102404276|NCT01453205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102404277|NCT01453205|Immunologic Factors|immunologic factors|mesh-ancestor
102404278|NCT01453205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404279|NCT01453205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102404280|NCT01453049|Glimepiride|glimepiride|mesh-list
102404281|NCT01453049|Rosiglitazone|rosiglitazone|mesh-list
102404282|NCT01453049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102404283|NCT01453049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102404284|NCT01453049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404285|NCT01453049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102404286|NCT01453049|Immunologic Factors|immunologic factors|mesh-ancestor
102404287|NCT01452347|Warfarin|warfarin|mesh-list
102404288|NCT01452347|Dabigatran|dabigatran|mesh-list
102404289|NCT01452347|Anticoagulants|anticoagulants|mesh-ancestor
102404290|NCT01452347|Antithrombins|antithrombins|mesh-ancestor
102035300|NCT03371381|Nivolumab|nivolumab|mesh-list
102404291|NCT01452347|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102404292|NCT01452347|Protease Inhibitors|protease inhibitors|mesh-ancestor
102404293|NCT01452347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102404294|NCT01452347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404295|NCT01451723|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
102404296|NCT01451723|Antioxidants|antioxidants|mesh-ancestor
102404297|NCT01451723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404298|NCT01451723|Protective Agents|protective agents|mesh-ancestor
102404299|NCT01451723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404300|NCT01451723|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
102404301|NCT01451723|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102404302|NCT01451723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102404303|NCT01451723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102404304|NCT01451645|Colchicine|colchicine|mesh-list
102404305|NCT01451645|Allopurinol|allopurinol|mesh-list
102404306|NCT01451645|Gout Suppressants|gout suppressants|mesh-ancestor
102404307|NCT01451645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102404308|NCT01451645|Tubulin Modulators|tubulin modulators|mesh-ancestor
102404309|NCT01451645|Antimitotic Agents|antimitotic agents|mesh-ancestor
102404310|NCT01451645|Mitosis Modulators|mitosis modulators|mesh-ancestor
102404311|NCT01451645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404312|NCT01451645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102404313|NCT01451645|Antimetabolites|antimetabolites|mesh-ancestor
102404314|NCT01451645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102404315|NCT01451645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102404316|NCT01451645|Antioxidants|antioxidants|mesh-ancestor
102404317|NCT01451645|Protective Agents|protective agents|mesh-ancestor
102404318|NCT01451645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404319|NCT01450007|Dexamethasone|dexamethasone|mesh-list
102404320|NCT01450007|Dexamethasone acetate|dexamethasone acetate|mesh-list
102404321|NCT01450007|Ropivacaine|ropivacaine|mesh-list
102404322|NCT01450007|BB 1101|bb 1101|mesh-list
102404323|NCT01450007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102404324|NCT01450007|Antiemetics|antiemetics|mesh-ancestor
102404325|NCT01450007|Autonomic Agents|autonomic agents|mesh-ancestor
102404326|NCT01450007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102404327|NCT01450007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404328|NCT01450007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102404329|NCT01450007|Glucocorticoids|glucocorticoids|mesh-ancestor
102404330|NCT01450007|Hormones|hormones|mesh-ancestor
102404331|NCT01450007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102216011|NCT00360035|Obatoclax|obatoclax|mesh-list
102404332|NCT01450007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102404333|NCT01450007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102404334|NCT01450007|Protease Inhibitors|protease inhibitors|mesh-ancestor
102404335|NCT01450007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102404336|NCT01450007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404337|NCT01450007|Anesthetics, Local|anesthetics, local|mesh-ancestor
102404339|NCT01450007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102404340|NCT01450007|Sensory System Agents|sensory system agents|mesh-ancestor
102404341|NCT01496365|Pregabalin|pregabalin|mesh-list
102404342|NCT01496365|Analgesics|analgesics|mesh-ancestor
102404343|NCT01496365|Sensory System Agents|sensory system agents|mesh-ancestor
102404344|NCT01496365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102404345|NCT01496365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404346|NCT01496365|Anticonvulsants|anticonvulsants|mesh-ancestor
102404347|NCT01496365|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102404348|NCT01496365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102404349|NCT01496365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404350|NCT01496365|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102404351|NCT01496365|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102404352|NCT01496365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102404353|NCT01496365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102404354|NCT01496365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102404355|NCT01468987|Insulin|insulin|mesh-list
102404356|NCT01468987|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102404357|NCT01468987|Insulin Glargine|insulin glargine|mesh-list
102404358|NCT01468987|Insulin Lispro|insulin lispro|mesh-list
102404359|NCT01468987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102404360|NCT01468987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404361|NCT01687712|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102404362|NCT01687712|Hormones|hormones|mesh-ancestor
102404363|NCT01687712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102404364|NCT01687712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404365|NCT01603628|Botulinum Toxins|botulinum toxins|mesh-list
102404366|NCT01603628|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102404367|NCT01603628|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102404368|NCT01603628|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102404369|NCT01603628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102404370|NCT01603628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404371|NCT01603628|Cholinergic Agents|cholinergic agents|mesh-ancestor
102404372|NCT01603628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102404373|NCT01603628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404374|NCT01603628|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102404375|NCT01603628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102404376|NCT01453153|Gemcitabine|gemcitabine|mesh-list
102404377|NCT01453153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102404378|NCT01453153|Antimetabolites|antimetabolites|mesh-ancestor
102404379|NCT01453153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404380|NCT01453153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102404381|NCT01584440|Quinidine|quinidine|mesh-list
102404382|NCT01584440|Dextromethorphan|dextromethorphan|mesh-list
102404383|NCT01584440|Antitussive Agents|antitussive agents|mesh-ancestor
102404384|NCT01584440|Respiratory System Agents|respiratory system agents|mesh-ancestor
102404385|NCT01584440|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102404386|NCT01584440|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102404387|NCT01584440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102404388|NCT01584440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404389|NCT01584440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404390|NCT01584440|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102404391|NCT01584440|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102404392|NCT01584440|Adrenergic Agents|adrenergic agents|mesh-ancestor
102404393|NCT01584440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102404394|NCT01584440|Antimalarials|antimalarials|mesh-ancestor
102404395|NCT01584440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102404396|NCT01584440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102404397|NCT01584440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102404398|NCT01584440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102404399|NCT01584440|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102404400|NCT01584440|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102404401|NCT01584440|Cholinergic Agents|cholinergic agents|mesh-ancestor
102404402|NCT01584440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102404403|NCT01584440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102216086|NCT00405743|Cytarabine|cytarabine|mesh-list
102404404|NCT01584440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102404405|NCT01584440|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102404406|NCT01584440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102404407|NCT01687478|Olanzapine|olanzapine|mesh-list
102404408|NCT01687478|Fluoxetine|fluoxetine|mesh-list
102404409|NCT01687478|Antiemetics|antiemetics|mesh-ancestor
102404410|NCT01687478|Autonomic Agents|autonomic agents|mesh-ancestor
102404411|NCT01687478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102404412|NCT01687478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404413|NCT01687478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102404414|NCT01687478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102404415|NCT01687478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102404416|NCT01687478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102404417|NCT01687478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102404418|NCT01687478|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102404419|NCT01687478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102404420|NCT01687478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102404421|NCT01687478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404422|NCT01687478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102404423|NCT01687478|Serotonin Agents|serotonin agents|mesh-ancestor
102404424|NCT01687478|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102404425|NCT01687478|Antidepressive Agents|antidepressive agents|mesh-ancestor
102404426|NCT01687478|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102404427|NCT01687478|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102404428|NCT01687478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102404429|NCT01468909|Paclitaxel|paclitaxel|mesh-list
102404430|NCT01468909|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102404431|NCT01468909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102404432|NCT01468909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102404433|NCT01468909|Tubulin Modulators|tubulin modulators|mesh-ancestor
102404434|NCT01468909|Antimitotic Agents|antimitotic agents|mesh-ancestor
102035462|NCT03708497|Hemostatics|hemostatics|mesh-ancestor
102404435|NCT01468909|Mitosis Modulators|mitosis modulators|mesh-ancestor
102404436|NCT01468909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404437|NCT01687166|Acifluorfen|acifluorfen|mesh-list
102404438|NCT01687166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102404439|NCT01687166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404440|NCT01561976|Metformin|metformin|mesh-list
102404441|NCT01561976|Glimepiride|glimepiride|mesh-list
102404442|NCT01561976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102404443|NCT01561976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404444|NCT01561976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102404445|NCT01561976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102404446|NCT01561976|Immunologic Factors|immunologic factors|mesh-ancestor
102404447|NCT01686932|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102404448|NCT01686932|Vildagliptin|vildagliptin|mesh-list
102404449|NCT01686932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102404450|NCT01686932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404451|NCT01686932|Incretins|incretins|mesh-ancestor
102404452|NCT01686932|Hormones|hormones|mesh-ancestor
102404453|NCT01686932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102404454|NCT01686932|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102404455|NCT01686932|Protease Inhibitors|protease inhibitors|mesh-ancestor
102404456|NCT01686932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102404457|NCT01686932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404458|NCT01468207|Adalimumab|adalimumab|mesh-list
102404459|NCT01468207|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102404460|NCT01468207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102404461|NCT01468207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102404462|NCT03026725|Calcium|calcium|mesh-list
102404463|NCT03026725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102404464|NCT03026725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404465|NCT01686152|Imiquimod|imiquimod|mesh-list
102404466|NCT01686152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102404467|NCT01686152|Immunologic Factors|immunologic factors|mesh-ancestor
102404468|NCT01686152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404469|NCT01686152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102404470|NCT01686152|Interferon Inducers|interferon inducers|mesh-ancestor
102404471|NCT01561898|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102404472|NCT01561898|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102404473|NCT01561898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102404474|NCT01561898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102404475|NCT01561898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404476|NCT01561898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102404477|NCT01561898|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102404478|NCT01561898|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102404479|NCT01561898|Serotonin Agents|serotonin agents|mesh-ancestor
102404480|NCT01561898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102404481|NCT01561898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404482|NCT01561898|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102404483|NCT01561898|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102404484|NCT01561898|Dopamine Agents|dopamine agents|mesh-ancestor
102404485|NCT01452529|Hydrocodone|hydrocodone|mesh-list
102404486|NCT01452529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102404487|NCT01452529|Narcotics|narcotics|mesh-ancestor
102404488|NCT01452529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102404489|NCT01452529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404490|NCT01452529|Analgesics|analgesics|mesh-ancestor
102404491|NCT01452529|Sensory System Agents|sensory system agents|mesh-ancestor
102404492|NCT01452529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102404493|NCT01452529|Antitussive Agents|antitussive agents|mesh-ancestor
102404494|NCT01452529|Respiratory System Agents|respiratory system agents|mesh-ancestor
102404495|NCT01560416|Fulvestrant|fulvestrant|mesh-list
102404496|NCT01560416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102404497|NCT01560416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102404498|NCT01560416|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102404499|NCT01560416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102404500|NCT01560416|Hormone Antagonists|hormone antagonists|mesh-ancestor
102404501|NCT01560416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102404502|NCT01560416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404503|NCT01685606|Immunomodulating Agents|immunomodulating agents|mesh-list
102404504|NCT01685606|Immunologic Factors|immunologic factors|mesh-ancestor
102404505|NCT01685606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404506|NCT01685372|Vaccines|vaccines|mesh-list
102404507|NCT01685372|Immunologic Factors|immunologic factors|mesh-ancestor
102404508|NCT01685372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404509|NCT01685138|Ceritinib|ceritinib|mesh-list
102404510|NCT01685138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102404511|NCT01685138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102404512|NCT01685138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102404513|NCT01685138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404514|NCT01685060|Ceritinib|ceritinib|mesh-list
102404515|NCT01685060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102404516|NCT01685060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102404517|NCT01685060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102404518|NCT01685060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404519|NCT03887936|Testosterone|testosterone|mesh-list
102404520|NCT03887936|Androgens|androgens|mesh-ancestor
102404521|NCT03887936|Hormones|hormones|mesh-ancestor
102404522|NCT03887936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102404523|NCT03887936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404524|NCT01684202|Tolvaptan|tolvaptan|mesh-list
102404525|NCT01684202|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102404526|NCT01684202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404527|NCT01684202|Natriuretic Agents|natriuretic agents|mesh-ancestor
102404528|NCT01684202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404529|NCT01559090|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102404530|NCT01559090|Immunologic Factors|immunologic factors|mesh-ancestor
102404531|NCT01559090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404532|NCT01683266|Insulin|insulin|mesh-list
102404533|NCT01683266|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102404534|NCT01683266|Insulin Glargine|insulin glargine|mesh-list
102404535|NCT01683266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102404536|NCT01683266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404537|NCT01467661|Anagrelide|anagrelide|mesh-list
102404538|NCT01467661|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102404539|NCT01467661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102404540|NCT01467661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404541|NCT01467661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102404542|NCT01577186|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102404543|NCT01577186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102404544|NCT01577186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102404545|NCT01577186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102404546|NCT01577186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404547|NCT01577186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102404548|NCT01577186|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102404549|NCT01577186|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102404550|NCT01577186|Serotonin Agents|serotonin agents|mesh-ancestor
102404551|NCT01577186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102404552|NCT01577186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404553|NCT01577186|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102404554|NCT01577186|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102404555|NCT01577186|Dopamine Agents|dopamine agents|mesh-ancestor
102404557|NCT01559012|Analgesics|analgesics|mesh-ancestor
102404558|NCT01559012|Sensory System Agents|sensory system agents|mesh-ancestor
102404559|NCT01559012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102404560|NCT01559012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404561|NCT01559012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102404562|NCT01559012|Sympatholytics|sympatholytics|mesh-ancestor
102404563|NCT01559012|Autonomic Agents|autonomic agents|mesh-ancestor
102404564|NCT01559012|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102404565|NCT01559012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102404566|NCT01559012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102404567|NCT01559012|Adrenergic Agents|adrenergic agents|mesh-ancestor
102404568|NCT01559012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102404569|NCT01559012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404570|NCT01451827|Tolvaptan|tolvaptan|mesh-list
102404571|NCT01451827|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102404572|NCT01451827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404573|NCT01451827|Natriuretic Agents|natriuretic agents|mesh-ancestor
102404574|NCT01451827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404575|NCT01557920|Propofol|propofol|mesh-list
102404576|NCT01557920|Sevoflurane|sevoflurane|mesh-list
102404577|NCT01557920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102404578|NCT01557920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102404579|NCT01557920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404580|NCT01557920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102404581|NCT01557920|Anesthetics, General|anesthetics, general|mesh-ancestor
102404582|NCT01557920|Anesthetics|anesthetics|mesh-ancestor
102404583|NCT01557920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102404584|NCT01557920|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102404585|NCT01467583|PENTA|penta|mesh-list
102404586|NCT01467583|Fondaparinux|fondaparinux|mesh-list
102404587|NCT01467583|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102404588|NCT01467583|Antithrombins|antithrombins|mesh-ancestor
102404589|NCT01467583|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102404590|NCT01467583|Protease Inhibitors|protease inhibitors|mesh-ancestor
102404591|NCT01467583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102404592|NCT01467583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404593|NCT01467583|Anticoagulants|anticoagulants|mesh-ancestor
102404594|NCT01467583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102404595|NCT01467583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102404596|NCT01576718|Fluticasone|fluticasone|mesh-list
102404597|NCT01576718|Xhance|xhance|mesh-list
102404598|NCT01576718|Albuterol|albuterol|mesh-list
102404599|NCT01576718|Adrenergic Agonists|adrenergic agonists|mesh-list
102404600|NCT01576718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102404601|NCT01576718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102404602|NCT01576718|Autonomic Agents|autonomic agents|mesh-ancestor
102404603|NCT01576718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102404604|NCT01576718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404605|NCT01576718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102404606|NCT01576718|Respiratory System Agents|respiratory system agents|mesh-ancestor
102404607|NCT01576718|Dermatologic Agents|dermatologic agents|mesh-ancestor
102404608|NCT01576718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102404609|NCT01576718|Tocolytic Agents|tocolytic agents|mesh-ancestor
102404610|NCT01576718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102404611|NCT01576718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102404612|NCT01576718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102404613|NCT01576718|Adrenergic Agents|adrenergic agents|mesh-ancestor
102404614|NCT01576718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102404615|NCT01576718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404616|NCT01493557|Pantoprazole|pantoprazole|mesh-list
102404617|NCT01493557|Dabigatran|dabigatran|mesh-list
102404618|NCT01493557|Antithrombins|antithrombins|mesh-ancestor
102404619|NCT01493557|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102404620|NCT01493557|Protease Inhibitors|protease inhibitors|mesh-ancestor
102404621|NCT01493557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102404622|NCT01493557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404623|NCT01493557|Anticoagulants|anticoagulants|mesh-ancestor
102404624|NCT01493557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102404625|NCT01493557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102404626|NCT01493557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102404627|NCT01451749|Donepezil|donepezil|mesh-list
102404628|NCT01451749|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102404629|NCT01451749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102404630|NCT01451749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404631|NCT01451749|Cholinergic Agents|cholinergic agents|mesh-ancestor
102404632|NCT01451749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102404633|NCT01451749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404634|NCT01451749|Nootropic Agents|nootropic agents|mesh-ancestor
102404635|NCT01576484|Alirocumab|alirocumab|mesh-list
102404636|NCT01576484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102404637|NCT01576484|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102404638|NCT01576484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102404639|NCT01576484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102404640|NCT01576484|Antimetabolites|antimetabolites|mesh-ancestor
102404641|NCT01576484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404642|NCT01576484|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102404643|NCT01576484|Protease Inhibitors|protease inhibitors|mesh-ancestor
102404644|NCT01576484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102404645|NCT01576484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102404646|NCT01576484|Immunologic Factors|immunologic factors|mesh-ancestor
102404647|NCT01576484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404648|NCT01467505|Interferons|interferons|mesh-list
102404649|NCT01467505|Ribavirin|ribavirin|mesh-list
102404650|NCT01467505|Interferon-alpha|interferon-alpha|mesh-list
102404651|NCT01467505|Interferon alpha-2|interferon alpha-2|mesh-list
102404652|NCT01467505|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102404653|NCT01467505|Immunosuppressive Agents|immunosuppressive agents|mesh-list
102404654|NCT01467505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102404655|NCT01467505|Antiviral Agents|antiviral agents|mesh-ancestor
102404656|NCT01467505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102404657|NCT01467505|Antimetabolites|antimetabolites|mesh-ancestor
102404658|NCT01467505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404659|NCT01467505|Immunologic Factors|immunologic factors|mesh-ancestor
102404660|NCT01467505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404661|NCT01449929|Ritonavir|ritonavir|mesh-list
102404662|NCT01449929|Darunavir|darunavir|mesh-list
102404663|NCT01449929|Dolutegravir|dolutegravir|mesh-list
102404664|NCT01449929|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102404665|NCT01449929|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102404666|NCT01449929|Protease Inhibitors|protease inhibitors|mesh-ancestor
102404667|NCT01449929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102404668|NCT01449929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404669|NCT01449929|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102404670|NCT01449929|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102404671|NCT01449929|Antiviral Agents|antiviral agents|mesh-ancestor
102404672|NCT01449929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102404673|NCT01449929|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102404674|NCT01449929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102404675|NCT01449929|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102404676|NCT01449929|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102404677|NCT01451515|Cytarabine|cytarabine|mesh-list
102404678|NCT01451515|Dexamethasone|dexamethasone|mesh-list
102404679|NCT01451515|Prednisone|prednisone|mesh-list
102404680|NCT01451515|Prednisolone|prednisolone|mesh-list
102404681|NCT01451515|Hydrocortisone|hydrocortisone|mesh-list
102404682|NCT01451515|Cyclophosphamide|cyclophosphamide|mesh-list
102404683|NCT01451515|Doxorubicin|doxorubicin|mesh-list
102404684|NCT01451515|Methotrexate|methotrexate|mesh-list
102404685|NCT01451515|Etoposide|etoposide|mesh-list
102404686|NCT01451515|Vincristine|vincristine|mesh-list
102404687|NCT01451515|Daunorubicin|daunorubicin|mesh-list
102404688|NCT01451515|Asparaginase|asparaginase|mesh-list
102404689|NCT01451515|Mercaptopurine|mercaptopurine|mesh-list
102404690|NCT01451515|Clofarabine|clofarabine|mesh-list
102404691|NCT01451515|Pegaspargase|pegaspargase|mesh-list
102404692|NCT01451515|Thioguanine|thioguanine|mesh-list
102404693|NCT01451515|Antimetabolites|antimetabolites|mesh-list
102404694|NCT01451515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102404695|NCT01451515|Immunologic Factors|immunologic factors|mesh-ancestor
102404696|NCT01451515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404697|NCT01451515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102404698|NCT01451515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102404699|NCT01451515|Alkylating Agents|alkylating agents|mesh-ancestor
102404700|NCT01451515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404701|NCT01451515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102404702|NCT01451515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102404703|NCT01451515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102404704|NCT01451515|Antiemetics|antiemetics|mesh-ancestor
102404705|NCT01451515|Autonomic Agents|autonomic agents|mesh-ancestor
102404706|NCT01451515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102404707|NCT01451515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102404708|NCT01451515|Glucocorticoids|glucocorticoids|mesh-ancestor
102404709|NCT01451515|Hormones|hormones|mesh-ancestor
102404710|NCT01451515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102404711|NCT01451515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102404712|NCT01451515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102404713|NCT01451515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102404714|NCT01451515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102404715|NCT01451515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102404716|NCT01451515|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102404717|NCT01451515|Abortifacient Agents|abortifacient agents|mesh-ancestor
102404718|NCT01451515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102404719|NCT01451515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102404720|NCT01451515|Dermatologic Agents|dermatologic agents|mesh-ancestor
102404721|NCT01451515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102404722|NCT01451515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102404723|NCT01451515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102404724|NCT01451515|Antiviral Agents|antiviral agents|mesh-ancestor
102404725|NCT01451515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102404726|NCT01451515|Tubulin Modulators|tubulin modulators|mesh-ancestor
102404727|NCT01451515|Antimitotic Agents|antimitotic agents|mesh-ancestor
102404728|NCT01451515|Mitosis Modulators|mitosis modulators|mesh-ancestor
102404729|NCT01576406|Crizotinib|crizotinib|mesh-list
102404730|NCT01576406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102404731|NCT01576406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102404732|NCT01576406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102404733|NCT01576406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404734|NCT01576172|Prednisone|prednisone|mesh-list
102404735|NCT01576172|Cortisone|cortisone|mesh-list
102404736|NCT01576172|Abiraterone Acetate|abiraterone acetate|mesh-list
102404737|NCT01576172|Veliparib|veliparib|mesh-list
102404738|NCT01576172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102404739|NCT01576172|Glucocorticoids|glucocorticoids|mesh-ancestor
102404740|NCT01576172|Hormones|hormones|mesh-ancestor
102404741|NCT01576172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102404742|NCT01576172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404743|NCT01576172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102404744|NCT01576172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102404745|NCT01576172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102404746|NCT01576172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102404747|NCT01576172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404748|NCT01576172|Hormone Antagonists|hormone antagonists|mesh-ancestor
102404749|NCT01576172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102404750|NCT01576172|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102404751|NCT01542788|Sofosbuvir|sofosbuvir|mesh-list
102404752|NCT01542788|Antiviral Agents|antiviral agents|mesh-ancestor
102404753|NCT01542788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102404754|NCT01541930|Metronidazole|metronidazole|mesh-list
102404755|NCT01541930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102404756|NCT01541930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102404757|NCT01541930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102404758|NCT01541930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102404759|NCT03028298|Sildenafil Citrate|sildenafil citrate|mesh-list
102404760|NCT03028298|Citric Acid|citric acid|mesh-list
102404761|NCT03028298|Sodium Citrate|sodium citrate|mesh-list
102404762|NCT03028298|Anticoagulants|anticoagulants|mesh-ancestor
102404763|NCT03028298|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102404764|NCT03028298|Chelating Agents|chelating agents|mesh-ancestor
102404765|NCT03028298|Sequestering Agents|sequestering agents|mesh-ancestor
102404766|NCT03028298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404767|NCT03028298|Vasodilator Agents|vasodilator agents|mesh-ancestor
102404768|NCT03028298|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102404769|NCT03028298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102404770|NCT03028298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102404771|NCT03028298|Urological Agents|urological agents|mesh-ancestor
102404772|NCT01540838|Acetaminophen|acetaminophen|mesh-list
102404773|NCT01540838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102404774|NCT01540838|Analgesics|analgesics|mesh-ancestor
102404775|NCT01540838|Sensory System Agents|sensory system agents|mesh-ancestor
102404776|NCT01540838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102404777|NCT01540838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404778|NCT01540838|Antipyretics|antipyretics|mesh-ancestor
102404779|NCT01451203|Certolizumab Pegol|certolizumab pegol|mesh-list
102404780|NCT01451203|Methotrexate|methotrexate|mesh-list
102216461|NCT05259007|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102404781|NCT01451203|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102404782|NCT01451203|Abortifacient Agents|abortifacient agents|mesh-ancestor
102404783|NCT01451203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102404784|NCT01451203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404785|NCT01451203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102404786|NCT01451203|Antimetabolites|antimetabolites|mesh-ancestor
102404787|NCT01451203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404788|NCT01451203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102404789|NCT01451203|Dermatologic Agents|dermatologic agents|mesh-ancestor
102404790|NCT01451203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102404791|NCT01451203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102404792|NCT01451203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102404793|NCT01451203|Immunologic Factors|immunologic factors|mesh-ancestor
102404794|NCT01451203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102404795|NCT01451203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102404796|NCT01451203|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102404797|NCT01451203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102404798|NCT01556438|Dexamethasone|dexamethasone|mesh-list
102404799|NCT01556438|Bortezomib|bortezomib|mesh-list
102404800|NCT01556438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102404801|NCT01556438|Antiemetics|antiemetics|mesh-ancestor
102404802|NCT01556438|Autonomic Agents|autonomic agents|mesh-ancestor
102404803|NCT01556438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102404804|NCT01556438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404805|NCT01556438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102404806|NCT01556438|Glucocorticoids|glucocorticoids|mesh-ancestor
102404807|NCT01556438|Hormones|hormones|mesh-ancestor
102404808|NCT01556438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102404809|NCT01556438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102404810|NCT01556438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102404811|NCT02073487|Paclitaxel|paclitaxel|mesh-list
102404812|NCT02073487|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102404813|NCT02073487|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102404814|NCT02073487|Trastuzumab|trastuzumab|mesh-list
102404815|NCT02073487|Lapatinib|lapatinib|mesh-list
102404816|NCT02073487|Pertuzumab|pertuzumab|mesh-list
102404817|NCT02073487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102404818|NCT02073487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102404819|NCT02073487|Tubulin Modulators|tubulin modulators|mesh-ancestor
102404820|NCT02073487|Antimitotic Agents|antimitotic agents|mesh-ancestor
102404821|NCT02073487|Mitosis Modulators|mitosis modulators|mesh-ancestor
102404822|NCT02073487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404823|NCT02073487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102404824|NCT02073487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102404825|NCT02073487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102404826|NCT02073487|Immunotoxins|immunotoxins|mesh-ancestor
102404827|NCT02073487|Immunoconjugates|immunoconjugates|mesh-ancestor
102404828|NCT02073487|Immunologic Factors|immunologic factors|mesh-ancestor
102404829|NCT02073487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404830|NCT01466491|Lidocaine|lidocaine|mesh-list
102404831|NCT01466491|Anesthetics, Local|anesthetics, local|mesh-ancestor
102404832|NCT01466491|Anesthetics|anesthetics|mesh-ancestor
102404833|NCT01466491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102404834|NCT01466491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404835|NCT01466491|Sensory System Agents|sensory system agents|mesh-ancestor
102404836|NCT01466491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102404837|NCT01466491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102404838|NCT01466491|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102404839|NCT01466491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102404840|NCT01466491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102404841|NCT01466491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404842|NCT01466179|Blinatumomab|blinatumomab|mesh-list
102404843|NCT01466179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102404844|NCT01493089|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
102404845|NCT01493089|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102404846|NCT01493089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102404847|NCT01493089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404848|NCT01450813|Bromides|bromides|mesh-list
102404849|NCT01450813|Rocuronium|rocuronium|mesh-list
102404850|NCT01450813|Anticonvulsants|anticonvulsants|mesh-ancestor
102404851|NCT01450813|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102404852|NCT01450813|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102404853|NCT01450813|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102404854|NCT01450813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102404855|NCT01450813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404856|NCT01539512|Rituximab|rituximab|mesh-list
102404857|NCT01539512|Idelalisib|idelalisib|mesh-list
102404858|NCT01539512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102404859|NCT01539512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102404860|NCT01539512|Immunologic Factors|immunologic factors|mesh-ancestor
102404861|NCT01539512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404862|NCT01539512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102404863|NCT01539512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102404864|NCT01539512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404865|NCT01449955|Sirolimus|sirolimus|mesh-list
102404866|NCT01449955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102404867|NCT01449955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102404868|NCT01449955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102404869|NCT01449955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102404870|NCT01449955|Antifungal Agents|antifungal agents|mesh-ancestor
102404871|NCT01449955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102404872|NCT01449955|Immunologic Factors|immunologic factors|mesh-ancestor
102404873|NCT01449955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404874|NCT01574612|Acyclovir|acyclovir|mesh-list
102404875|NCT01574612|Hydrocortisone|hydrocortisone|mesh-list
102404876|NCT01574612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102404877|NCT01574612|Antiviral Agents|antiviral agents|mesh-ancestor
102404878|NCT01574612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102404879|NCT01573910|Moxifloxacin|moxifloxacin|mesh-list
102404880|NCT01573910|Ofloxacin|ofloxacin|mesh-list
102404881|NCT01573910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102404882|NCT01573910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102404883|NCT01573910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102404884|NCT01573910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102404885|NCT01573910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102404886|NCT01573910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102404887|NCT01573910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102404888|NCT01573910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404889|NCT01573910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102404890|NCT01573910|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102404891|NCT01573910|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102404892|NCT01573910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102404893|NCT01491919|Lisinopril|lisinopril|mesh-list
102404894|NCT01491919|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102404895|NCT01491919|Protease Inhibitors|protease inhibitors|mesh-ancestor
102404896|NCT01491919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102404897|NCT01491919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404898|NCT01491919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102404899|NCT01491919|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102404900|NCT01491919|Protective Agents|protective agents|mesh-ancestor
102404901|NCT01491919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404902|NCT01573442|Testosterone|testosterone|mesh-list
102404903|NCT01573442|Androgens|androgens|mesh-ancestor
102404904|NCT01573442|Hormones|hormones|mesh-ancestor
102404905|NCT01573442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102404906|NCT01573442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404907|NCT02319369|Azacitidine|azacitidine|mesh-list
102404908|NCT02319369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102404909|NCT02319369|Antimetabolites|antimetabolites|mesh-ancestor
102404910|NCT02319369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404911|NCT02319369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102404912|NCT02319369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102404913|NCT01491841|Rituximab|rituximab|mesh-list
102404914|NCT01491841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102404915|NCT01491841|Pixantrone|pixantrone|mesh-list
102404916|NCT01491841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102404917|NCT01491841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102404918|NCT01491841|Immunologic Factors|immunologic factors|mesh-ancestor
102404919|NCT01491841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404920|NCT01491841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102404921|NCT01491841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102404922|NCT01491841|Alkylating Agents|alkylating agents|mesh-ancestor
102404923|NCT01491841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404924|NCT01491841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102035971|NCT05551949|Estradiol|estradiol|mesh-list
102404925|NCT01491841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102404926|NCT01491841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102404927|NCT00297063|Rosiglitazone|rosiglitazone|mesh-list
102404928|NCT00297063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102404929|NCT00297063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404930|NCT01553318|Ketotifen|ketotifen|mesh-list
102404931|NCT01553318|Antipruritics|antipruritics|mesh-ancestor
102404932|NCT01553318|Dermatologic Agents|dermatologic agents|mesh-ancestor
102404933|NCT01553318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102404934|NCT01553318|Histamine Antagonists|histamine antagonists|mesh-ancestor
102404935|NCT01553318|Histamine Agents|histamine agents|mesh-ancestor
102404936|NCT01553318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102404937|NCT01553318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404938|NCT01553318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404939|NCT01553318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102404940|NCT01572740|Liraglutide|liraglutide|mesh-list
102404941|NCT01572740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102404942|NCT01572740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404943|NCT01572740|Incretins|incretins|mesh-ancestor
102404944|NCT01572740|Hormones|hormones|mesh-ancestor
102404945|NCT01572740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102404946|NCT01491607|Vaccines|vaccines|mesh-list
102404947|NCT01491607|Immunologic Factors|immunologic factors|mesh-ancestor
102404948|NCT01491607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404949|NCT02338713|Calcium Carbonate|calcium carbonate|mesh-list
102404950|NCT02338713|Antacids|antacids|mesh-ancestor
102404951|NCT02338713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404952|NCT02338713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102404953|NCT00557349|Omeprazole|omeprazole|mesh-list
102404954|NCT00557349|Famotidine|famotidine|mesh-list
102404955|NCT00557349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102404956|NCT00557349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102404957|NCT00557349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102404958|NCT00557349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102404959|NCT00557349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404960|NCT00557349|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102404961|NCT00557349|Histamine Antagonists|histamine antagonists|mesh-ancestor
102404962|NCT00557349|Histamine Agents|histamine agents|mesh-ancestor
102404963|NCT00557349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102404964|NCT00557349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404965|NCT01553084|Nicotine|nicotine|mesh-list
102404966|NCT01553084|Varenicline|varenicline|mesh-list
102404967|NCT01553084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102404968|NCT01553084|Autonomic Agents|autonomic agents|mesh-ancestor
102404969|NCT01553084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102404970|NCT01553084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102404971|NCT01553084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102404972|NCT01553084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102404973|NCT01553084|Cholinergic Agents|cholinergic agents|mesh-ancestor
102404974|NCT01553084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102404975|NCT01553084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404976|NCT01552928|Moxifloxacin|moxifloxacin|mesh-list
102404977|NCT01552928|Anagrelide|anagrelide|mesh-list
102404978|NCT01552928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102404979|NCT01552928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102404980|NCT01552928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102404981|NCT01552928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102404982|NCT01552928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102404983|NCT01552928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404984|NCT01552928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102404985|NCT01552928|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102404986|NCT01552928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102404987|NCT01552928|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102404988|NCT01448707|Ritonavir|ritonavir|mesh-list
102404989|NCT01448707|Darunavir|darunavir|mesh-list
102404990|NCT01448707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102404991|NCT01448707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102404992|NCT01448707|Protease Inhibitors|protease inhibitors|mesh-ancestor
102404993|NCT01448707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102404994|NCT01448707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102404995|NCT01448707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102404996|NCT01448707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102404997|NCT01448707|Antiviral Agents|antiviral agents|mesh-ancestor
102404998|NCT01448707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102404999|NCT01448707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102405000|NCT01448707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102405001|NCT01536704|Nicotine|nicotine|mesh-list
102405002|NCT01536704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102405003|NCT01536704|Autonomic Agents|autonomic agents|mesh-ancestor
102405004|NCT01536704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102405005|NCT01536704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405006|NCT01536704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102405007|NCT01536704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102216683|NCT04351243|Gimsilumab|gimsilumab|mesh-list
102405008|NCT01536704|Cholinergic Agents|cholinergic agents|mesh-ancestor
102405009|NCT01536704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102405010|NCT01536704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405012|NCT04108676|Omeprazole|omeprazole|mesh-list
102405013|NCT04108676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102405014|NCT04108676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102405015|NCT04108676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102405016|NCT04108676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102405017|NCT04108676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405018|NCT04108676|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102405019|NCT04108676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405020|NCT01552772|Aripiprazole|aripiprazole|mesh-list
102405021|NCT01552772|Antidepressive Agents|antidepressive agents|mesh-ancestor
102405022|NCT01552772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102405023|NCT01552772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102405024|NCT01552772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102405025|NCT01552772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102405026|NCT01552772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405027|NCT01552772|Dopamine Agonists|dopamine agonists|mesh-ancestor
102405028|NCT01552772|Dopamine Agents|dopamine agents|mesh-ancestor
102405029|NCT01552772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102405030|NCT01552772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405031|NCT01552772|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102405032|NCT01552772|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102405033|NCT01552772|Serotonin Agents|serotonin agents|mesh-ancestor
102405034|NCT01552772|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102405035|NCT01552772|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102405036|NCT01552772|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102405037|NCT01552772|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102405038|NCT01552694|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102405039|NCT01552694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102405040|NCT01552694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405041|NCT01552694|Incretins|incretins|mesh-ancestor
102405042|NCT01552694|Hormones|hormones|mesh-ancestor
102405043|NCT01552694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102405044|NCT01552694|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102405045|NCT01552694|Protease Inhibitors|protease inhibitors|mesh-ancestor
102405046|NCT01552694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102405047|NCT01552694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405048|NCT01464931|Denosumab|denosumab|mesh-list
102405049|NCT01464931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102405050|NCT01464931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405051|NCT01536392|Ondansetron|ondansetron|mesh-list
102405052|NCT01536392|Granisetron|granisetron|mesh-list
102405053|NCT01536392|Antiemetics|antiemetics|mesh-ancestor
102405054|NCT01536392|Autonomic Agents|autonomic agents|mesh-ancestor
102405055|NCT01536392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102405056|NCT01536392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405057|NCT01536392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102405058|NCT01536392|Antipruritics|antipruritics|mesh-ancestor
102405059|NCT01536392|Dermatologic Agents|dermatologic agents|mesh-ancestor
102405060|NCT01536392|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102405061|NCT01536392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102405062|NCT01536392|Serotonin Agents|serotonin agents|mesh-ancestor
102405063|NCT01536392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102405064|NCT01536392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405065|NCT04767295|Paclitaxel|paclitaxel|mesh-list
102405066|NCT04767295|Carboplatin|carboplatin|mesh-list
102405067|NCT04767295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102405068|NCT04767295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405069|NCT04767295|Tubulin Modulators|tubulin modulators|mesh-ancestor
102405070|NCT04767295|Antimitotic Agents|antimitotic agents|mesh-ancestor
102405071|NCT04767295|Mitosis Modulators|mitosis modulators|mesh-ancestor
102405072|NCT04767295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405073|NCT02118831|Bevacizumab|bevacizumab|mesh-list
102405074|NCT02118831|Ranibizumab|ranibizumab|mesh-list
102405075|NCT02118831|Aflibercept|aflibercept|mesh-list
102405076|NCT02118831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102405077|NCT02118831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405078|NCT02118831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102405079|NCT02118831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102405080|NCT02118831|Growth Substances|growth substances|mesh-ancestor
102216760|NCT05650216|Mitosis Modulators|mitosis modulators|mesh-ancestor
102405081|NCT02118831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405082|NCT02118831|Growth Inhibitors|growth inhibitors|mesh-ancestor
102405083|NCT00490269|Dronabinol|dronabinol|mesh-list
102405084|NCT00490269|Hallucinogens|hallucinogens|mesh-ancestor
102405085|NCT00490269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405086|NCT00490269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102405087|NCT00490269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102405088|NCT00490269|Analgesics|analgesics|mesh-ancestor
102405089|NCT00490269|Sensory System Agents|sensory system agents|mesh-ancestor
102405090|NCT00490269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102405091|NCT00490269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102405092|NCT00490269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102405093|NCT00490269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102405094|NCT00490269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405095|NCT00490269|Hormones|hormones|mesh-ancestor
102405096|NCT00490269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102405097|NCT05621499|Lenvatinib|lenvatinib|mesh-list
102405098|NCT05621499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405099|NCT05621499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102405100|NCT05621499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102405101|NCT05621499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405102|NCT01490125|Glycopyrrolate|glycopyrrolate|mesh-list
102405103|NCT01490125|Albuterol|albuterol|mesh-list
102405104|NCT01490125|Tiotropium Bromide|tiotropium bromide|mesh-list
102405105|NCT01490125|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102405106|NCT01490125|Autonomic Agents|autonomic agents|mesh-ancestor
102405107|NCT01490125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102405108|NCT01490125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405109|NCT01490125|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102405110|NCT01490125|Respiratory System Agents|respiratory system agents|mesh-ancestor
102405111|NCT01490125|Parasympatholytics|parasympatholytics|mesh-ancestor
102405112|NCT01490125|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102405113|NCT01490125|Cholinergic Agents|cholinergic agents|mesh-ancestor
102405114|NCT01490125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102405115|NCT01490125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405116|NCT01490125|Tocolytic Agents|tocolytic agents|mesh-ancestor
102405117|NCT01490125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102405118|NCT01490125|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102405119|NCT01490125|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102405120|NCT01490125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102405121|NCT01490125|Adrenergic Agents|adrenergic agents|mesh-ancestor
102405122|NCT01490125|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102405123|NCT01490125|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102405124|NCT00491751|Ascorbic Acid|ascorbic acid|mesh-list
102405125|NCT00491751|Atorvastatin|atorvastatin|mesh-list
102405126|NCT00491751|Vitamins|vitamins|mesh-ancestor
102405127|NCT00491751|Micronutrients|micronutrients|mesh-ancestor
102405128|NCT00491751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405129|NCT00491751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102405130|NCT00491751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102405131|NCT00491751|Antimetabolites|antimetabolites|mesh-ancestor
102405132|NCT00491751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405133|NCT00491751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102405134|NCT00491751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102405135|NCT00491751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102405136|NCT00491751|Antioxidants|antioxidants|mesh-ancestor
102405137|NCT00491751|Protective Agents|protective agents|mesh-ancestor
102405138|NCT01420549|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102405139|NCT01420549|Simvastatin|simvastatin|mesh-list
102405140|NCT01420549|Ezetimibe|ezetimibe|mesh-list
102405141|NCT01420549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102405142|NCT01420549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102405143|NCT01420549|Antimetabolites|antimetabolites|mesh-ancestor
102405144|NCT01420549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405145|NCT01420549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102405146|NCT01420549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102405147|NCT01420549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102405148|NCT01440595|Ribavirin|ribavirin|mesh-list
102405149|NCT01440595|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102405150|NCT01440595|Grazoprevir|grazoprevir|mesh-list
102405151|NCT01440595|Antimetabolites|antimetabolites|mesh-ancestor
102405152|NCT01440595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405153|NCT01440595|Antiviral Agents|antiviral agents|mesh-ancestor
102405154|NCT01440595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102405155|NCT05560035|Lidocaine|lidocaine|mesh-list
102405156|NCT05560035|Anesthetics, Local|anesthetics, local|mesh-ancestor
102405157|NCT05560035|Anesthetics|anesthetics|mesh-ancestor
102405158|NCT05560035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102405159|NCT05560035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405160|NCT05560035|Sensory System Agents|sensory system agents|mesh-ancestor
102405161|NCT05560035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102405162|NCT05560035|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102405163|NCT05560035|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102405164|NCT05560035|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102405165|NCT05560035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102405166|NCT05560035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405167|NCT00497055|Aripiprazole|aripiprazole|mesh-list
102405168|NCT00497055|Antidepressive Agents|antidepressive agents|mesh-ancestor
102405169|NCT00497055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102405170|NCT00497055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102405171|NCT00497055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102405172|NCT00497055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102405173|NCT00497055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405174|NCT00497055|Dopamine Agonists|dopamine agonists|mesh-ancestor
102405175|NCT00497055|Dopamine Agents|dopamine agents|mesh-ancestor
102405176|NCT00497055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102405177|NCT00497055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405178|NCT00497055|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102405179|NCT00497055|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102405180|NCT00497055|Serotonin Agents|serotonin agents|mesh-ancestor
102405181|NCT00497055|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102405182|NCT00497055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102405183|NCT00497055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102405184|NCT00497055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102405185|NCT00498615|Fasudil|fasudil|mesh-list
102405186|NCT00498615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102405187|NCT00498615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102405188|NCT00498615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405189|NCT00498615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102405190|NCT00498615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405191|NCT00498615|Vasodilator Agents|vasodilator agents|mesh-ancestor
102405192|NCT00498615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102405193|NCT00498615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102405194|NCT00498927|Temozolomide|temozolomide|mesh-list
102405195|NCT00498927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102405196|NCT00498927|Alkylating Agents|alkylating agents|mesh-ancestor
102405197|NCT00498927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405198|NCT00498927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405199|NCT00499473|Sunitinib|sunitinib|mesh-list
102405200|NCT00499473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405201|NCT00499473|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102405202|NCT00499473|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102405203|NCT00499473|Growth Substances|growth substances|mesh-ancestor
102405204|NCT00499473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405205|NCT00499473|Growth Inhibitors|growth inhibitors|mesh-ancestor
102405206|NCT00499473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102405207|NCT00499473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102405208|NCT00499473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405209|NCT00501891|Bevacizumab|bevacizumab|mesh-list
102405210|NCT00501891|Temozolomide|temozolomide|mesh-list
102405211|NCT00501891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102405212|NCT00501891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405213|NCT00501891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102405214|NCT00501891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102405215|NCT00501891|Growth Substances|growth substances|mesh-ancestor
102405216|NCT00501891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405217|NCT00501891|Growth Inhibitors|growth inhibitors|mesh-ancestor
102405218|NCT00501891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102405219|NCT00501891|Alkylating Agents|alkylating agents|mesh-ancestor
102405220|NCT00501891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405221|NCT01798017|Misoprostol|misoprostol|mesh-list
102405222|NCT01798017|Mifepristone|mifepristone|mesh-list
102405223|NCT01798017|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102405224|NCT01798017|Abortifacient Agents|abortifacient agents|mesh-ancestor
102405225|NCT01798017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102405226|NCT01798017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405227|NCT01798017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102216910|NCT04988308|Adalimumab|adalimumab|mesh-list
102405228|NCT01798017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102405229|NCT01798017|Oxytocics|oxytocics|mesh-ancestor
102405230|NCT01798017|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102405231|NCT01798017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102405232|NCT01798017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102405233|NCT01798017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102405234|NCT01798017|Contraceptive Agents|contraceptive agents|mesh-ancestor
102405235|NCT01798017|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102405236|NCT01798017|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102405237|NCT01798017|Hormone Antagonists|hormone antagonists|mesh-ancestor
102405238|NCT01798017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102405239|NCT01798017|Luteolytic Agents|luteolytic agents|mesh-ancestor
102405240|NCT01798017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102405241|NCT01798017|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102405242|NCT00502905|Fludarabine|fludarabine|mesh-list
102405243|NCT00502905|Fludarabine phosphate|fludarabine phosphate|mesh-list
102405244|NCT00502905|Busulfan|busulfan|mesh-list
102405245|NCT00502905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405246|NCT00502905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102405247|NCT00502905|Antimetabolites|antimetabolites|mesh-ancestor
102405248|NCT00502905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405249|NCT00502905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102405250|NCT00502905|Immunologic Factors|immunologic factors|mesh-ancestor
102405251|NCT00502905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405252|NCT00502905|Alkylating Agents|alkylating agents|mesh-ancestor
102405253|NCT00502905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102405254|NCT00502905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102405255|NCT05418777|Trimethoprim|trimethoprim|mesh-list
102405256|NCT05418777|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102405257|NCT05418777|Sulfamethoxazole|sulfamethoxazole|mesh-list
102405258|NCT05418777|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102405259|NCT05418777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102405260|NCT05418777|Antimalarials|antimalarials|mesh-ancestor
102405261|NCT05418777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102405262|NCT05418777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102405263|NCT05418777|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102405264|NCT05418777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102405265|NCT05418777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405266|NCT05418777|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102405267|NCT05418777|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102405268|NCT05418777|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102405269|NCT05418777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102405270|NCT00505635|Interferons|interferons|mesh-list
102405271|NCT00505635|Interferon-alpha|interferon-alpha|mesh-list
102405272|NCT00505635|Interferon alpha-2|interferon alpha-2|mesh-list
102405273|NCT00505635|Thalidomide|thalidomide|mesh-list
102405274|NCT00505635|Cisplatin|cisplatin|mesh-list
102405275|NCT00505635|Temozolomide|temozolomide|mesh-list
102405276|NCT00505635|Interleukin-2|interleukin-2|mesh-list
102405277|NCT00505635|Vinblastine|vinblastine|mesh-list
102405278|NCT00505635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405279|NCT00505635|Antiviral Agents|antiviral agents|mesh-ancestor
102405280|NCT00505635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102405281|NCT00505635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102405282|NCT00505635|Alkylating Agents|alkylating agents|mesh-ancestor
102405283|NCT00505635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405284|NCT00505635|Immunologic Factors|immunologic factors|mesh-ancestor
102405285|NCT00505635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405286|NCT00505635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102405287|NCT00505635|Analgesics|analgesics|mesh-ancestor
102405288|NCT00505635|Sensory System Agents|sensory system agents|mesh-ancestor
102405289|NCT00505635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102405290|NCT00505635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102405291|NCT00505635|Leprostatic Agents|leprostatic agents|mesh-ancestor
102405292|NCT00505635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102405293|NCT00505635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102405294|NCT00505635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102405295|NCT00505635|Growth Substances|growth substances|mesh-ancestor
102405296|NCT00505635|Growth Inhibitors|growth inhibitors|mesh-ancestor
102405297|NCT00505635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102405298|NCT00505635|Tubulin Modulators|tubulin modulators|mesh-ancestor
102405299|NCT00505635|Antimitotic Agents|antimitotic agents|mesh-ancestor
102405300|NCT00505635|Mitosis Modulators|mitosis modulators|mesh-ancestor
102405301|NCT01842165|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102405302|NCT01842165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102405303|NCT01842165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405304|NCT04479813|Moxonidine|moxonidine|mesh-list
102405305|NCT04479813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102405306|NCT04474899|Amlodipine|amlodipine|mesh-list
102405307|NCT04474899|Moxonidine|moxonidine|mesh-list
102405308|NCT04474899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102405309|NCT04474899|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102405310|NCT04474899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102405311|NCT04474899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405312|NCT04474899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102405313|NCT04474899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405314|NCT04474899|Vasodilator Agents|vasodilator agents|mesh-ancestor
102405315|NCT00511173|Warfarin|warfarin|mesh-list
102405316|NCT00511173|Anticoagulants|anticoagulants|mesh-ancestor
102405317|NCT01447927|Metformin|metformin|mesh-list
102405318|NCT01447927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102405319|NCT01447927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405320|NCT04037397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
102405321|NCT00513747|Rituximab|rituximab|mesh-list
102405322|NCT00513747|Fludarabine|fludarabine|mesh-list
102405323|NCT00513747|Fludarabine phosphate|fludarabine phosphate|mesh-list
102405324|NCT00513747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102405325|NCT00513747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405326|NCT00513747|Immunologic Factors|immunologic factors|mesh-ancestor
102405327|NCT00513747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405328|NCT00513747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102405329|NCT00513747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102405330|NCT00513747|Antimetabolites|antimetabolites|mesh-ancestor
102405331|NCT00513747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405332|NCT00513747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102405333|NCT00514137|Sunitinib|sunitinib|mesh-list
102405334|NCT00514137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405335|NCT00514137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102405336|NCT00514137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102405337|NCT00514137|Growth Substances|growth substances|mesh-ancestor
102405338|NCT00514137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405339|NCT00514137|Growth Inhibitors|growth inhibitors|mesh-ancestor
102405340|NCT00514137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102405341|NCT00514137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102405342|NCT00514137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405343|NCT00514215|Molgramostim|molgramostim|mesh-list
102405344|NCT00514215|Sargramostim|sargramostim|mesh-list
102405345|NCT00514215|Immunologic Factors|immunologic factors|mesh-ancestor
102405346|NCT00514215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405347|NCT00514215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405348|NCT03912909|Empagliflozin|empagliflozin|mesh-list
102405349|NCT03912909|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102405350|NCT03912909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405351|NCT03912909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102405352|NCT03912909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405353|NCT02130063|Iron|iron|mesh-list
102405354|NCT02130063|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102405355|NCT02130063|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
102405356|NCT02130063|Trace Elements|trace elements|mesh-ancestor
102405357|NCT02130063|Micronutrients|micronutrients|mesh-ancestor
102405358|NCT02130063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405359|NCT02130063|Hematinics|hematinics|mesh-ancestor
102405360|NCT00515697|Ramucirumab|ramucirumab|mesh-list
102405361|NCT00515697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405362|NCT00516165|Everolimus|everolimus|mesh-list
102405363|NCT00516165|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102405364|NCT00516165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102405365|NCT00516165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102405366|NCT00516165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405367|NCT00516165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102405368|NCT00516165|Immunologic Factors|immunologic factors|mesh-ancestor
102405369|NCT00516165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405370|NCT00516165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405371|NCT03631173|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102405372|NCT03631173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102405373|NCT03419481|Pembrolizumab|pembrolizumab|mesh-list
102405374|NCT03419481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102405375|NCT03419481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405376|NCT03419481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102405377|NCT03419481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405378|NCT02132169|Cetirizine|cetirizine|mesh-list
102405379|NCT02132169|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102405380|NCT02132169|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102405381|NCT02132169|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102405382|NCT02132169|Histamine Antagonists|histamine antagonists|mesh-ancestor
102405383|NCT02132169|Histamine Agents|histamine agents|mesh-ancestor
102405384|NCT02132169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102405385|NCT02132169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405386|NCT02132169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405387|NCT03174405|Avelumab|avelumab|mesh-list
102405388|NCT03174405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102405389|NCT03174405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405390|NCT00522795|Paclitaxel|paclitaxel|mesh-list
102405391|NCT00522795|Cisplatin|cisplatin|mesh-list
102405392|NCT00522795|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
102405393|NCT00522795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102405394|NCT00522795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405395|NCT00522795|Tubulin Modulators|tubulin modulators|mesh-ancestor
102405396|NCT00522795|Antimitotic Agents|antimitotic agents|mesh-ancestor
102405397|NCT00522795|Mitosis Modulators|mitosis modulators|mesh-ancestor
102405398|NCT00522795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405399|NCT02871687|Simvastatin|simvastatin|mesh-list
102405400|NCT02871687|Pravastatin|pravastatin|mesh-list
102405401|NCT02871687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102405402|NCT02871687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102405403|NCT02871687|Antimetabolites|antimetabolites|mesh-ancestor
102405404|NCT02871687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405405|NCT02871687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102405406|NCT02871687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102405407|NCT02871687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102405408|NCT00525057|Dalteparin|dalteparin|mesh-list
102405409|NCT00525057|Tinzaparin|tinzaparin|mesh-list
102405410|NCT00525057|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102405411|NCT00525057|Anticoagulants|anticoagulants|mesh-ancestor
102405412|NCT00525057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102405413|NCT00525057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102405414|NCT00525057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405415|NCT00525135|Valproic Acid|valproic acid|mesh-list
102405416|NCT00525135|Anticonvulsants|anticonvulsants|mesh-ancestor
102405417|NCT00525135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102405418|NCT00525135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405419|NCT00525135|GABA Agents|gaba agents|mesh-ancestor
102405420|NCT00525135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102405421|NCT00525135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405422|NCT00525135|Antimanic Agents|antimanic agents|mesh-ancestor
102405423|NCT00525135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102405424|NCT00525135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102405425|NCT00525135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102405426|NCT00525525|Bevacizumab|bevacizumab|mesh-list
102405427|NCT00525525|Temozolomide|temozolomide|mesh-list
102405428|NCT00525525|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102405429|NCT00525525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102405430|NCT00525525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405431|NCT00525525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102405432|NCT00525525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102405433|NCT00525525|Growth Substances|growth substances|mesh-ancestor
102405434|NCT00525525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405435|NCT00525525|Growth Inhibitors|growth inhibitors|mesh-ancestor
102405436|NCT00525525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102405437|NCT00525525|Alkylating Agents|alkylating agents|mesh-ancestor
102405438|NCT00525525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405439|NCT00525525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102405440|NCT00525525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102405441|NCT00525603|Cyclophosphamide|cyclophosphamide|mesh-list
102405442|NCT00525603|Rituximab|rituximab|mesh-list
102405443|NCT00525603|Fludarabine|fludarabine|mesh-list
102405444|NCT00525603|Fludarabine phosphate|fludarabine phosphate|mesh-list
102405445|NCT00525603|Alemtuzumab|alemtuzumab|mesh-list
102405446|NCT00525603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102405447|NCT00525603|Immunologic Factors|immunologic factors|mesh-ancestor
102405448|NCT00525603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405449|NCT00525603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102405450|NCT00525603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102405451|NCT00525603|Alkylating Agents|alkylating agents|mesh-ancestor
102405452|NCT00525603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405453|NCT00525603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405454|NCT00525603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102405455|NCT00525603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102405456|NCT00525603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102405457|NCT00525603|Antimetabolites|antimetabolites|mesh-ancestor
102405459|NCT00398307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405460|NCT00564447|Azithromycin|azithromycin|mesh-list
102405461|NCT00564447|Moxifloxacin|moxifloxacin|mesh-list
102405462|NCT00564447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102405463|NCT00564447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102405464|NCT00564447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102405465|NCT00564447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102405466|NCT00564447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102405467|NCT00564447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405468|NCT00564447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405469|NCT00564681|Botulinum Toxins|botulinum toxins|mesh-list
102405470|NCT00564681|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102405471|NCT00564681|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102405472|NCT00564681|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102405473|NCT00564681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102405474|NCT00564681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405475|NCT00564681|Cholinergic Agents|cholinergic agents|mesh-ancestor
102405476|NCT00564681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102405477|NCT00564681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405478|NCT00564681|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102405479|NCT00564681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102405480|NCT00525837|Varenicline|varenicline|mesh-list
102405481|NCT00525837|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102405482|NCT00525837|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102405483|NCT00525837|Cholinergic Agents|cholinergic agents|mesh-ancestor
102405484|NCT00525837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102405485|NCT00525837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405486|NCT00525837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405487|NCT00527475|Ranibizumab|ranibizumab|mesh-list
102405488|NCT00527475|Verteporfin|verteporfin|mesh-list
102405489|NCT00527475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102405490|NCT00527475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102405491|NCT00527475|Growth Substances|growth substances|mesh-ancestor
102405492|NCT00527475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405493|NCT00527475|Growth Inhibitors|growth inhibitors|mesh-ancestor
102405494|NCT00527475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405495|NCT00527475|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102405496|NCT00527475|Dermatologic Agents|dermatologic agents|mesh-ancestor
102405497|NCT01798251|Capecitabine|capecitabine|mesh-list
102405498|NCT01798251|Oxaliplatin|oxaliplatin|mesh-list
102405499|NCT01798251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102405500|NCT01798251|Antimetabolites|antimetabolites|mesh-ancestor
102405501|NCT01798251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405502|NCT01798251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405503|NCT02121483|Empagliflozin|empagliflozin|mesh-list
102405504|NCT02121483|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102405505|NCT02121483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405506|NCT02121483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102405507|NCT02121483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405508|NCT01572038|Paclitaxel|paclitaxel|mesh-list
102405509|NCT01572038|Docetaxel|docetaxel|mesh-list
102405510|NCT01572038|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102405511|NCT01572038|Trastuzumab|trastuzumab|mesh-list
102405512|NCT01572038|Pertuzumab|pertuzumab|mesh-list
102405513|NCT01572038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102405514|NCT01572038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405515|NCT01572038|Tubulin Modulators|tubulin modulators|mesh-ancestor
102405516|NCT01572038|Antimitotic Agents|antimitotic agents|mesh-ancestor
102405517|NCT01572038|Mitosis Modulators|mitosis modulators|mesh-ancestor
102405518|NCT01572038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405519|NCT01572038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102405520|NCT01448213|Fluorometholone|fluorometholone|mesh-list
102405521|NCT01448213|Prednisolone|prednisolone|mesh-list
102405522|NCT01448213|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102405523|NCT01448213|Methylprednisolone|methylprednisolone|mesh-list
102405524|NCT01448213|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102405525|NCT01448213|Prednisolone acetate|prednisolone acetate|mesh-list
102405526|NCT01448213|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102405527|NCT01448213|Prednisolone phosphate|prednisolone phosphate|mesh-list
102405528|NCT01448213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102405529|NCT01448213|Glucocorticoids|glucocorticoids|mesh-ancestor
102405530|NCT01448213|Hormones|hormones|mesh-ancestor
102405531|NCT01448213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102405532|NCT01448213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405533|NCT01448213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102405534|NCT01448213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405535|NCT01448213|Antiemetics|antiemetics|mesh-ancestor
102405536|NCT01448213|Autonomic Agents|autonomic agents|mesh-ancestor
102405537|NCT01448213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102405538|NCT01448213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102405539|NCT01448213|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102405540|NCT01448213|Protective Agents|protective agents|mesh-ancestor
102405541|NCT01448213|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102405542|NCT01448057|Acetaminophen|acetaminophen|mesh-list
102405543|NCT01448057|Dimethindene|dimethindene|mesh-list
102405544|NCT01448057|Phenylephrine|phenylephrine|mesh-list
102405545|NCT01448057|Oxymetazoline|oxymetazoline|mesh-list
102405546|NCT01448057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102405547|NCT01448057|Analgesics|analgesics|mesh-ancestor
102405548|NCT01448057|Sensory System Agents|sensory system agents|mesh-ancestor
102405549|NCT01448057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102405550|NCT01448057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405551|NCT01448057|Antipyretics|antipyretics|mesh-ancestor
102405552|NCT01448057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405553|NCT01448057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102405554|NCT01448057|Mydriatics|mydriatics|mesh-ancestor
102405555|NCT01448057|Autonomic Agents|autonomic agents|mesh-ancestor
102405556|NCT01448057|Sympathomimetics|sympathomimetics|mesh-ancestor
102405557|NCT01448057|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102405558|NCT01448057|Nasal Decongestants|nasal decongestants|mesh-ancestor
102405559|NCT01448057|Respiratory System Agents|respiratory system agents|mesh-ancestor
102405560|NCT01448057|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102405561|NCT01448057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102405562|NCT01448057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102405563|NCT01448057|Adrenergic Agents|adrenergic agents|mesh-ancestor
102405564|NCT01448057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102405565|NCT01448057|Protective Agents|protective agents|mesh-ancestor
102405566|NCT01448057|Antipruritics|antipruritics|mesh-ancestor
102405567|NCT01448057|Dermatologic Agents|dermatologic agents|mesh-ancestor
102405568|NCT01448057|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102405569|NCT01448057|Histamine Antagonists|histamine antagonists|mesh-ancestor
102405570|NCT01448057|Histamine Agents|histamine agents|mesh-ancestor
102405571|NCT01448057|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102405572|NCT05246631|Dexamethasone|dexamethasone|mesh-list
102405573|NCT05246631|Dexamethasone acetate|dexamethasone acetate|mesh-list
102405574|NCT05246631|Haloperidol|haloperidol|mesh-list
102405575|NCT05246631|Haloperidol decanoate|haloperidol decanoate|mesh-list
102405576|NCT05246631|BB 1101|bb 1101|mesh-list
102405577|NCT05246631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102405578|NCT05246631|Antiemetics|antiemetics|mesh-ancestor
102405579|NCT05246631|Autonomic Agents|autonomic agents|mesh-ancestor
102405580|NCT05246631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102405581|NCT05246631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405582|NCT05246631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102405583|NCT05246631|Glucocorticoids|glucocorticoids|mesh-ancestor
102405584|NCT05246631|Hormones|hormones|mesh-ancestor
102405585|NCT05246631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102405586|NCT05246631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102405587|NCT05246631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405588|NCT05246631|Protease Inhibitors|protease inhibitors|mesh-ancestor
102405589|NCT05246631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102405590|NCT05246631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405591|NCT05246631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102405592|NCT05246631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102405593|NCT05246631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102405594|NCT05246631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102405595|NCT05246631|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102405596|NCT05246631|Dopamine Agents|dopamine agents|mesh-ancestor
102405597|NCT05246631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102405598|NCT05246631|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102405599|NCT01447433|Calcium Carbonate|calcium carbonate|mesh-list
102405600|NCT01447433|Calcium|calcium|mesh-list
102405601|NCT01447433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102405602|NCT01447433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405603|NCT01447433|Antacids|antacids|mesh-ancestor
102405604|NCT01447433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405605|NCT01447433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102405606|NCT01798875|Metformin|metformin|mesh-list
102405607|NCT01798875|Contraceptive Agents|contraceptive agents|mesh-list
102405608|NCT01798875|Contraceptives, Oral|contraceptives, oral|mesh-list
102405609|NCT01798875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102405610|NCT01798875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405611|NCT01798875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102405612|NCT01798875|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102405613|NCT05362851|Celecoxib|celecoxib|mesh-list
102405614|NCT05362851|Tramadol|tramadol|mesh-list
102405615|NCT05362851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102405616|NCT05362851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102405617|NCT05362851|Analgesics|analgesics|mesh-ancestor
102405618|NCT05362851|Sensory System Agents|sensory system agents|mesh-ancestor
102405619|NCT05362851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102405620|NCT05362851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405621|NCT05362851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102405622|NCT05362851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102405623|NCT05362851|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102405624|NCT05362851|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102405625|NCT05362851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102405626|NCT05362851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405627|NCT05362851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102405628|NCT05362851|Narcotics|narcotics|mesh-ancestor
102405629|NCT05362851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102405630|NCT04408235|Enoxaparin|enoxaparin|mesh-list
102405631|NCT04408235|Anticoagulants|anticoagulants|mesh-ancestor
102405632|NCT04408235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102405633|NCT04408235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102036657|NCT03229759|Octenidine|octenidine|mesh-list
102405634|NCT04408235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405635|NCT03517137|Cyclophosphamide|cyclophosphamide|mesh-list
102405636|NCT03517137|Dacarbazine|dacarbazine|mesh-list
102405637|NCT03517137|Etoposide|etoposide|mesh-list
102405638|NCT03517137|Doxorubicin|doxorubicin|mesh-list
102405639|NCT03517137|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102405640|NCT03517137|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102405641|NCT03517137|Vinblastine|vinblastine|mesh-list
102405642|NCT03517137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102405643|NCT03517137|Immunologic Factors|immunologic factors|mesh-ancestor
102405644|NCT03517137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405645|NCT03517137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102405646|NCT03517137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102405647|NCT03517137|Alkylating Agents|alkylating agents|mesh-ancestor
102405648|NCT03517137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405649|NCT03517137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405650|NCT03517137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102405651|NCT03517137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102405652|NCT03517137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102405653|NCT03517137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102405654|NCT03517137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102405655|NCT03517137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102405656|NCT03517137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102405657|NCT03517137|Immunotoxins|immunotoxins|mesh-ancestor
102405658|NCT03517137|Immunoconjugates|immunoconjugates|mesh-ancestor
102405659|NCT03517137|Tubulin Modulators|tubulin modulators|mesh-ancestor
102405660|NCT03517137|Antimitotic Agents|antimitotic agents|mesh-ancestor
102405661|NCT03517137|Mitosis Modulators|mitosis modulators|mesh-ancestor
102405662|NCT01446809|Doxorubicin|doxorubicin|mesh-list
102405663|NCT01446809|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102405664|NCT01446809|Ifosfamide|ifosfamide|mesh-list
102405665|NCT01446809|Isophosphamide mustard|isophosphamide mustard|mesh-list
102405666|NCT01446809|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102405667|NCT01446809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405668|NCT01446809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102405669|NCT01446809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102405670|NCT01446809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102405671|NCT01446809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405672|NCT01446809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102405673|NCT01446809|Alkylating Agents|alkylating agents|mesh-ancestor
102405674|NCT03357159|Cyclophosphamide|cyclophosphamide|mesh-list
102405675|NCT03357159|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102405676|NCT03357159|Immunoglobulins|immunoglobulins|mesh-list
102405677|NCT03357159|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102405678|NCT03357159|Antibodies|antibodies|mesh-list
102405679|NCT03357159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102405680|NCT03357159|Immunologic Factors|immunologic factors|mesh-ancestor
102405681|NCT03357159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405682|NCT03357159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102405683|NCT03357159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102405684|NCT03357159|Alkylating Agents|alkylating agents|mesh-ancestor
102405685|NCT03357159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405686|NCT03357159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405687|NCT03357159|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102405688|NCT04387929|Antibodies|antibodies|mesh-list
102405689|NCT04387929|Immunologic Factors|immunologic factors|mesh-ancestor
102405690|NCT04387929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405691|NCT05361291|Dexamethasone|dexamethasone|mesh-list
102405692|NCT05361291|Lidocaine|lidocaine|mesh-list
102405693|NCT05361291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102405694|NCT05361291|Antiemetics|antiemetics|mesh-ancestor
102405695|NCT05361291|Autonomic Agents|autonomic agents|mesh-ancestor
102405696|NCT05361291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102405697|NCT05361291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405698|NCT05361291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102405699|NCT05361291|Glucocorticoids|glucocorticoids|mesh-ancestor
102405700|NCT05361291|Hormones|hormones|mesh-ancestor
102405701|NCT05361291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102405702|NCT05361291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102405703|NCT05361291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405704|NCT05361291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405705|NCT05361291|Anesthetics, Local|anesthetics, local|mesh-ancestor
102405706|NCT05361291|Anesthetics|anesthetics|mesh-ancestor
102405707|NCT05361291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102405708|NCT05361291|Sensory System Agents|sensory system agents|mesh-ancestor
102405709|NCT05361291|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102405710|NCT05361291|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102405711|NCT05361291|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102405712|NCT05361291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102405713|NCT01445951|Insulin|insulin|mesh-list
102405714|NCT01445951|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102405715|NCT01445951|Insulin Aspart|insulin aspart|mesh-list
102405716|NCT01445951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102405717|NCT01445951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405718|NCT03169101|Nicotine|nicotine|mesh-list
102405719|NCT03169101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102405720|NCT03169101|Autonomic Agents|autonomic agents|mesh-ancestor
102405721|NCT03169101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102405722|NCT03169101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405723|NCT03169101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102405724|NCT03169101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102405725|NCT03169101|Cholinergic Agents|cholinergic agents|mesh-ancestor
102405726|NCT03169101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102405727|NCT03169101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405728|NCT05219877|Levofloxacin|levofloxacin|mesh-list
102405729|NCT05219877|Ofloxacin|ofloxacin|mesh-list
102405730|NCT05219877|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102405731|NCT05219877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102405732|NCT05219877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102405733|NCT05219877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102405734|NCT05219877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102405735|NCT05219877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102405736|NCT05219877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405737|NCT05219877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405738|NCT05219877|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102405739|NCT05219877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102405740|NCT00513435|Saracatinib|saracatinib|mesh-list
102405741|NCT00513435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405742|NCT00513435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102405743|NCT00513435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405744|NCT05214339|Bevacizumab|bevacizumab|mesh-list
102405745|NCT05214339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102405746|NCT05214339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405747|NCT05214339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102405748|NCT05214339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102036773|NCT03665545|Laxatives|laxatives|mesh-ancestor
102405749|NCT05214339|Growth Substances|growth substances|mesh-ancestor
102405750|NCT05214339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405751|NCT05214339|Growth Inhibitors|growth inhibitors|mesh-ancestor
102405752|NCT01444781|Vaccines|vaccines|mesh-list
102405753|NCT01444781|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102405754|NCT01444781|Immunologic Factors|immunologic factors|mesh-ancestor
102405755|NCT01444781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217443|NCT04589819|Teriparatide|teriparatide|mesh-list
102405756|NCT02431845|Fluoxetine|fluoxetine|mesh-list
102405757|NCT02431845|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102405758|NCT02431845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102405759|NCT02431845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102405760|NCT02431845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405761|NCT02431845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102405762|NCT02431845|Serotonin Agents|serotonin agents|mesh-ancestor
102405763|NCT02431845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405764|NCT02431845|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102405765|NCT02431845|Antidepressive Agents|antidepressive agents|mesh-ancestor
102405766|NCT02431845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102405767|NCT02431845|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102405768|NCT02431845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102405769|NCT02431845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102405770|NCT01443923|Interferons|interferons|mesh-list
102405771|NCT01443923|Ribavirin|ribavirin|mesh-list
102405772|NCT01443923|Interferon-alpha|interferon-alpha|mesh-list
102405773|NCT01443923|Interferon alpha-2|interferon alpha-2|mesh-list
102405774|NCT01443923|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102405775|NCT01443923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405776|NCT01443923|Antiviral Agents|antiviral agents|mesh-ancestor
102405777|NCT01443923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102405778|NCT01443923|Antimetabolites|antimetabolites|mesh-ancestor
102405779|NCT01443923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405780|NCT01443923|Immunologic Factors|immunologic factors|mesh-ancestor
102405781|NCT01443923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405782|NCT00569673|Docetaxel|docetaxel|mesh-list
102405783|NCT00569673|Trabectedin|trabectedin|mesh-list
102405784|NCT00569673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405785|NCT00569673|Tubulin Modulators|tubulin modulators|mesh-ancestor
102405786|NCT00569673|Antimitotic Agents|antimitotic agents|mesh-ancestor
102405787|NCT00569673|Mitosis Modulators|mitosis modulators|mesh-ancestor
102405788|NCT00569673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405789|NCT00569673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102405790|NCT00569673|Alkylating Agents|alkylating agents|mesh-ancestor
102405791|NCT01551212|Everolimus|everolimus|mesh-list
102405792|NCT01551212|Tacrolimus|tacrolimus|mesh-list
102405793|NCT01551212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102405794|NCT01551212|Immunologic Factors|immunologic factors|mesh-ancestor
102405795|NCT01551212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405796|NCT01551212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102405797|NCT01551212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102405798|NCT01551212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405799|NCT01551212|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102405800|NCT01551212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102405801|NCT01551212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405802|NCT00573261|Pregabalin|pregabalin|mesh-list
102405803|NCT00573261|Analgesics|analgesics|mesh-ancestor
102405804|NCT00573261|Sensory System Agents|sensory system agents|mesh-ancestor
102405805|NCT00573261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102405806|NCT00573261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405807|NCT00573261|Anticonvulsants|anticonvulsants|mesh-ancestor
102405808|NCT00573261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102405809|NCT00573261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102405810|NCT00573261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405811|NCT00573261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102405812|NCT00573261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102405813|NCT00573261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102405814|NCT00573261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102405815|NCT00573261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102405816|NCT04268199|Bortezomib|bortezomib|mesh-list
102405817|NCT04268199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405818|NCT04514211|Propofol|propofol|mesh-list
102405819|NCT04514211|Sevoflurane|sevoflurane|mesh-list
102405820|NCT04514211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102405821|NCT04514211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102405822|NCT04514211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405823|NCT04514211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102405824|NCT04514211|Anesthetics, General|anesthetics, general|mesh-ancestor
102405825|NCT04514211|Anesthetics|anesthetics|mesh-ancestor
102405826|NCT04514211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102405827|NCT04514211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102405828|NCT00574197|Mycophenolic Acid|mycophenolic acid|mesh-list
102405829|NCT00574197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102405830|NCT00574197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405831|NCT00574197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102405832|NCT00574197|Antitubercular Agents|antitubercular agents|mesh-ancestor
102405833|NCT00574197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102405834|NCT00574197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102405835|NCT00574197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102405836|NCT00574197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405838|NCT00574587|Cyclophosphamide|cyclophosphamide|mesh-list
102405839|NCT00574587|Doxorubicin|doxorubicin|mesh-list
102405840|NCT00574587|Trastuzumab|trastuzumab|mesh-list
102405841|NCT00574587|Vorinostat|vorinostat|mesh-list
102405842|NCT00574587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102405843|NCT00574587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405844|NCT00574587|Tubulin Modulators|tubulin modulators|mesh-ancestor
102405845|NCT00574587|Antimitotic Agents|antimitotic agents|mesh-ancestor
102405846|NCT00574587|Mitosis Modulators|mitosis modulators|mesh-ancestor
102405847|NCT00574587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405848|NCT00574587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102405849|NCT00574587|Immunologic Factors|immunologic factors|mesh-ancestor
102405850|NCT00574587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405851|NCT00574587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102405852|NCT00574587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102405853|NCT00574587|Alkylating Agents|alkylating agents|mesh-ancestor
102405854|NCT00574587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102405855|NCT00574587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102405856|NCT00574587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102405857|NCT00574587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102405858|NCT00574587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102405859|NCT00574587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102405860|NCT00574587|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102405861|NCT00603993|Adalimumab|adalimumab|mesh-list
102405862|NCT00603993|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102405863|NCT00603993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102405864|NCT00603993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102405865|NCT00575367|Azithromycin|azithromycin|mesh-list
102405866|NCT00575367|Moxifloxacin|moxifloxacin|mesh-list
102405867|NCT00575367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102405868|NCT00575367|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102405869|NCT00575367|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102405870|NCT00575367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102405871|NCT00575367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102405872|NCT00575367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102405873|NCT00575367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102405874|NCT00575367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102405875|NCT00575367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405876|NCT00575367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405877|NCT00575367|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102405878|NCT00575367|Contraceptive Agents|contraceptive agents|mesh-ancestor
102405879|NCT00575367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102405880|NCT00575367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405881|NCT00575367|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102405882|NCT00575367|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102405883|NCT00575367|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102405884|NCT00604461|Bevacizumab|bevacizumab|mesh-list
102405885|NCT00604461|Carboplatin|carboplatin|mesh-list
102405886|NCT00604461|Pemetrexed|pemetrexed|mesh-list
102405887|NCT00604461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102405888|NCT00604461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405889|NCT00604461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102405890|NCT00604461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102405891|NCT00604461|Growth Substances|growth substances|mesh-ancestor
102405892|NCT00604461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405893|NCT00604461|Growth Inhibitors|growth inhibitors|mesh-ancestor
102405894|NCT00604461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102405895|NCT00604461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405896|NCT00604461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102405897|NCT00604461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102405898|NCT04417569|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102405899|NCT04417569|Estradiol|estradiol|mesh-list
102405900|NCT04417569|Progesterone|progesterone|mesh-list
102405901|NCT04417569|Hormones|hormones|mesh-ancestor
102405902|NCT04417569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102405903|NCT04417569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405904|NCT04417569|Estrogens|estrogens|mesh-ancestor
102405905|NCT04417569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102405906|NCT04417569|Progestins|progestins|mesh-ancestor
102405907|NCT01550744|Ustekinumab|ustekinumab|mesh-list
102405908|NCT01550744|Dermatologic Agents|dermatologic agents|mesh-ancestor
102405910|NCT00606489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102405911|NCT00606489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102405912|NCT00606489|Analgesics|analgesics|mesh-ancestor
102405913|NCT00606489|Sensory System Agents|sensory system agents|mesh-ancestor
102405914|NCT00606489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102405915|NCT00606489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405916|NCT00606489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102405917|NCT00606489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102405918|NCT00606489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102405919|NCT00606489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102405920|NCT00606489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405921|NCT00578331|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
102405922|NCT00578331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102405923|NCT00578331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102405924|NCT00578331|Analgesics|analgesics|mesh-ancestor
102405925|NCT00578331|Sensory System Agents|sensory system agents|mesh-ancestor
102405926|NCT00578331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102405927|NCT00578331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405928|NCT00578331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102405929|NCT00578331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102405930|NCT00578331|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102405931|NCT00578331|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102405932|NCT00578331|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102405933|NCT00578331|Histamine Antagonists|histamine antagonists|mesh-ancestor
102405934|NCT00578331|Histamine Agents|histamine agents|mesh-ancestor
102405935|NCT00578331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102405936|NCT00578331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405937|NCT00607113|Bevacizumab|bevacizumab|mesh-list
102405938|NCT00607113|Everolimus|everolimus|mesh-list
102405939|NCT00607113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102405940|NCT00607113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405941|NCT00607113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102405942|NCT00607113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102405943|NCT00607113|Growth Substances|growth substances|mesh-ancestor
102405944|NCT00607113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405945|NCT00607113|Growth Inhibitors|growth inhibitors|mesh-ancestor
102405946|NCT00607113|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102405947|NCT00607113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102405948|NCT00607113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102405949|NCT00607113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405950|NCT00607113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102405951|NCT00607113|Immunologic Factors|immunologic factors|mesh-ancestor
102405952|NCT01549964|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102405953|NCT01549964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102405954|NCT01549964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405955|NCT01549964|Incretins|incretins|mesh-ancestor
102405956|NCT01549964|Hormones|hormones|mesh-ancestor
102405957|NCT01549964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102405958|NCT01549964|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102405959|NCT01549964|Protease Inhibitors|protease inhibitors|mesh-ancestor
102405960|NCT01549964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102405961|NCT01549964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405962|NCT00579111|Fludarabine|fludarabine|mesh-list
102405963|NCT00579111|Busulfan|busulfan|mesh-list
102405964|NCT00579111|Alemtuzumab|alemtuzumab|mesh-list
102405965|NCT00579111|Tacrolimus|tacrolimus|mesh-list
102405966|NCT00579111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405967|NCT00579111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405968|NCT00579111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102405969|NCT00579111|Immunologic Factors|immunologic factors|mesh-ancestor
102405970|NCT00579111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405971|NCT00579111|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102405972|NCT00579111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102405973|NCT00579111|Alkylating Agents|alkylating agents|mesh-ancestor
102405974|NCT00579111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102405975|NCT00579111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102405976|NCT00579111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102405977|NCT04363437|Colchicine|colchicine|mesh-list
102405978|NCT04363437|Gout Suppressants|gout suppressants|mesh-ancestor
102405979|NCT04363437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102405980|NCT04363437|Tubulin Modulators|tubulin modulators|mesh-ancestor
102405981|NCT04363437|Antimitotic Agents|antimitotic agents|mesh-ancestor
102405982|NCT04363437|Mitosis Modulators|mitosis modulators|mesh-ancestor
102405983|NCT04363437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102405984|NCT04363437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102405985|NCT01570244|Levonorgestrel|levonorgestrel|mesh-list
102405986|NCT01570244|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102405987|NCT01570244|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102405988|NCT01570244|Contraceptive Agents|contraceptive agents|mesh-ancestor
102405989|NCT01570244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102405990|NCT01570244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102405991|NCT01570244|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102405992|NCT01570244|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102405993|NCT01570244|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102405994|NCT01570244|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102405995|NCT01570244|Estrogens|estrogens|mesh-ancestor
102405996|NCT01570244|Hormones|hormones|mesh-ancestor
102405997|NCT01570244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102405998|NCT00579813|Pioglitazone|pioglitazone|mesh-list
102405999|NCT00579813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102406000|NCT00579813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406001|NCT01549886|Rituximab|rituximab|mesh-list
102406002|NCT01549886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102406003|NCT01549886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102406004|NCT01549886|Immunologic Factors|immunologic factors|mesh-ancestor
102406005|NCT01549886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406006|NCT01549886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102406007|NCT00610311|Aldesleukin|aldesleukin|mesh-list
102406008|NCT00610311|Cyclophosphamide|cyclophosphamide|mesh-list
102406009|NCT00610311|Fludarabine|fludarabine|mesh-list
102406010|NCT00610311|Fludarabine phosphate|fludarabine phosphate|mesh-list
102406011|NCT00610311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102406012|NCT00610311|Immunologic Factors|immunologic factors|mesh-ancestor
102406013|NCT00610311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037021|NCT01965132|Adalimumab|adalimumab|mesh-list
102406014|NCT00610311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102406015|NCT00610311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102406016|NCT00610311|Alkylating Agents|alkylating agents|mesh-ancestor
102406017|NCT00610311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406018|NCT00610311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102406019|NCT00610311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102406020|NCT00610311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102406021|NCT00610311|Antimetabolites|antimetabolites|mesh-ancestor
102406022|NCT00610311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102406023|NCT00610311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102406024|NCT00610311|Antiviral Agents|antiviral agents|mesh-ancestor
102406025|NCT00610311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102406026|NCT04233567|Infigratinib|infigratinib|mesh-list
102406027|NCT04233567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102406028|NCT00581061|Solifenacin Succinate|solifenacin succinate|mesh-list
102406029|NCT00581061|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102406030|NCT00581061|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102406031|NCT00581061|Cholinergic Agents|cholinergic agents|mesh-ancestor
102406032|NCT00581061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102406033|NCT00581061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406034|NCT00581061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406035|NCT00581061|Urological Agents|urological agents|mesh-ancestor
102406036|NCT01549652|Morphine|morphine|mesh-list
102406037|NCT01549652|Ondansetron|ondansetron|mesh-list
102406038|NCT01549652|Naloxone|naloxone|mesh-list
102406039|NCT01549652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102406040|NCT01549652|Narcotics|narcotics|mesh-ancestor
102406041|NCT01549652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102406042|NCT01549652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406043|NCT01549652|Analgesics|analgesics|mesh-ancestor
102406044|NCT01549652|Sensory System Agents|sensory system agents|mesh-ancestor
102406045|NCT01549652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102406046|NCT01549652|Antiemetics|antiemetics|mesh-ancestor
102406047|NCT01549652|Autonomic Agents|autonomic agents|mesh-ancestor
102406048|NCT01549652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102406049|NCT01549652|Antipruritics|antipruritics|mesh-ancestor
102406050|NCT01549652|Dermatologic Agents|dermatologic agents|mesh-ancestor
102406051|NCT01549652|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102406052|NCT01549652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102406053|NCT01549652|Serotonin Agents|serotonin agents|mesh-ancestor
102406054|NCT01549652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102217747|NCT01637272|Pasireotide|pasireotide|mesh-list
102406055|NCT01549652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406056|NCT01549652|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102406058|NCT01569464|Dopamine Agonists|dopamine agonists|mesh-ancestor
102406059|NCT01569464|Dopamine Agents|dopamine agents|mesh-ancestor
102406060|NCT01569464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102406061|NCT01569464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406062|NCT01569464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406063|NCT01534520|Lidocaine|lidocaine|mesh-list
102406064|NCT01534520|Anesthetics, Local|anesthetics, local|mesh-ancestor
102406065|NCT01534520|Anesthetics|anesthetics|mesh-ancestor
102406066|NCT01534520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102406067|NCT01534520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406068|NCT01534520|Sensory System Agents|sensory system agents|mesh-ancestor
102406069|NCT01534520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102406070|NCT01534520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102406071|NCT01534520|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102406072|NCT01534520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102406073|NCT01534520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102406074|NCT01534520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406075|NCT00611325|Bevacizumab|bevacizumab|mesh-list
102406076|NCT00611325|Bortezomib|bortezomib|mesh-list
102406077|NCT00611325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102037097|NCT01498770|GABA Agents|gaba agents|mesh-ancestor
102406078|NCT00611325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102406079|NCT00611325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102406080|NCT00611325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102406081|NCT00611325|Growth Substances|growth substances|mesh-ancestor
102406082|NCT00611325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406083|NCT00611325|Growth Inhibitors|growth inhibitors|mesh-ancestor
102406084|NCT00611403|Cyclosporine|cyclosporine|mesh-list
102406085|NCT00611403|Lubricant Eye Drops|lubricant eye drops|mesh-list
102406086|NCT00611403|Cyclosporins|cyclosporins|mesh-list
102406087|NCT00611403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102406088|NCT00611403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406089|NCT00611403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102406090|NCT00611403|Immunologic Factors|immunologic factors|mesh-ancestor
102406091|NCT00611403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406092|NCT00611403|Antifungal Agents|antifungal agents|mesh-ancestor
102406093|NCT00611403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102406094|NCT00611403|Dermatologic Agents|dermatologic agents|mesh-ancestor
102406095|NCT00611403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102406096|NCT00611403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102406097|NCT00611403|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102406098|NCT00611403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102406099|NCT01534208|Enclomiphene|enclomiphene|mesh-list
102406100|NCT01534208|Clomiphene|clomiphene|mesh-list
102406101|NCT01534208|Zuclomiphene|zuclomiphene|mesh-list
102406102|NCT01534208|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102406103|NCT01534208|Hormone Antagonists|hormone antagonists|mesh-ancestor
102406104|NCT01534208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102406105|NCT01534208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406106|NCT01534208|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102406107|NCT01534208|Fertility Agents|fertility agents|mesh-ancestor
102406108|NCT01534208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102406109|NCT01534208|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102406110|NCT01534208|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102406111|NCT01548638|Galantamine|galantamine|mesh-list
102406112|NCT01548638|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102406113|NCT01548638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102406114|NCT01548638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406115|NCT01548638|Cholinergic Agents|cholinergic agents|mesh-ancestor
102406116|NCT01548638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102406117|NCT01548638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406118|NCT01548638|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102406119|NCT01548638|Autonomic Agents|autonomic agents|mesh-ancestor
102406120|NCT01548638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102406121|NCT01548638|Nootropic Agents|nootropic agents|mesh-ancestor
102406122|NCT00612339|Bevacizumab|bevacizumab|mesh-list
102406123|NCT00612339|Temozolomide|temozolomide|mesh-list
102406124|NCT00612339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102406125|NCT00612339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102406126|NCT00612339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102406127|NCT00612339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102406128|NCT00612339|Growth Substances|growth substances|mesh-ancestor
102406129|NCT00612339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406131|NCT00612339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102406132|NCT00612339|Alkylating Agents|alkylating agents|mesh-ancestor
102406133|NCT00612339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406134|NCT01533428|Capsaicin|capsaicin|mesh-list
102406135|NCT01533428|Antipruritics|antipruritics|mesh-ancestor
102406136|NCT01533428|Dermatologic Agents|dermatologic agents|mesh-ancestor
102406137|NCT01533428|Sensory System Agents|sensory system agents|mesh-ancestor
102406138|NCT01533428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102406139|NCT01533428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406140|NCT04066725|Aspirin|aspirin|mesh-list
102406141|NCT04066725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102406142|NCT04066725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102406143|NCT04066725|Analgesics|analgesics|mesh-ancestor
102406144|NCT04066725|Sensory System Agents|sensory system agents|mesh-ancestor
102406145|NCT04066725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102406146|NCT04066725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406147|NCT04066725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102406148|NCT04066725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102406149|NCT04066725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102406150|NCT04066725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102406151|NCT04066725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406152|NCT04066725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102406153|NCT04066725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102406154|NCT04066725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102406155|NCT04066725|Antipyretics|antipyretics|mesh-ancestor
102406156|NCT01517984|Mycophenolic Acid|mycophenolic acid|mesh-list
102406157|NCT01517984|Prednisone|prednisone|mesh-list
102406158|NCT01517984|Tacrolimus|tacrolimus|mesh-list
102406159|NCT01517984|Thymoglobulin|thymoglobulin|mesh-list
102406160|NCT01517984|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102406161|NCT01517984|Immunosuppressive Agents|immunosuppressive agents|mesh-list
102406162|NCT01517984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
102406163|NCT01517984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102406164|NCT01517984|Glucocorticoids|glucocorticoids|mesh-ancestor
102406165|NCT01517984|Hormones|hormones|mesh-ancestor
102406166|NCT01517984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102406167|NCT01517984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406168|NCT01517984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102406169|NCT01517984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102406170|NCT01517984|Immunologic Factors|immunologic factors|mesh-ancestor
102406171|NCT01517984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102406172|NCT01517984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406173|NCT01517984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102406174|NCT01517984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102406175|NCT01517984|Antitubercular Agents|antitubercular agents|mesh-ancestor
102406176|NCT01517984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102406177|NCT01517984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102406178|NCT00612573|Doxycycline|doxycycline|mesh-list
102406179|NCT00612573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102406180|NCT00612573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102406181|NCT00612573|Antimalarials|antimalarials|mesh-ancestor
102406182|NCT00612573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102406183|NCT00612573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102406184|NCT00614445|Pyridoxine|pyridoxine|mesh-list
102406185|NCT00614445|Vitamin B 6|vitamin b 6|mesh-list
102406186|NCT00614445|Doxylamine|doxylamine|mesh-list
102406187|NCT00614445|Doxylamine succinate|doxylamine succinate|mesh-list
102406188|NCT00614445|Vitamin B Complex|vitamin b complex|mesh-ancestor
102406189|NCT00614445|Vitamins|vitamins|mesh-ancestor
102406190|NCT00614445|Micronutrients|micronutrients|mesh-ancestor
102406191|NCT00614445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406192|NCT00614445|Antiemetics|antiemetics|mesh-ancestor
102406193|NCT00614445|Autonomic Agents|autonomic agents|mesh-ancestor
102406194|NCT00614445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102406195|NCT00614445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102406196|NCT00614445|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102406197|NCT00614445|Histamine Antagonists|histamine antagonists|mesh-ancestor
102406198|NCT00614445|Histamine Agents|histamine agents|mesh-ancestor
102406199|NCT00614445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102406200|NCT00614445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406201|NCT00583011|Anesthetics|anesthetics|mesh-list
102406202|NCT00583011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102406203|NCT00583011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406204|NCT01547390|Aspirin|aspirin|mesh-list
102406205|NCT01547390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102406206|NCT01547390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102406208|NCT01547390|Sensory System Agents|sensory system agents|mesh-ancestor
102406209|NCT01547390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102406210|NCT01547390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406211|NCT01547390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102406212|NCT01547390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102406213|NCT01547390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102406214|NCT01547390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102406215|NCT01547390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406216|NCT01547390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102406217|NCT01547390|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102406218|NCT01547390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102406219|NCT01547390|Antipyretics|antipyretics|mesh-ancestor
102406220|NCT01546922|Hydrocortisone|hydrocortisone|mesh-list
102406221|NCT01546922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102406222|NCT00615927|Imatinib Mesylate|imatinib mesylate|mesh-list
102406223|NCT00615927|Hydroxyurea|hydroxyurea|mesh-list
102406224|NCT00615927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102406225|NCT00615927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102406226|NCT00615927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102406227|NCT00615927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406228|NCT00615927|Antisickling Agents|antisickling agents|mesh-ancestor
102406229|NCT00615927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102406230|NCT01532648|Budesonide|budesonide|mesh-list
102406231|NCT01532648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102406232|NCT01532648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102406233|NCT01532648|Autonomic Agents|autonomic agents|mesh-ancestor
102406234|NCT01532648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102406235|NCT01532648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406236|NCT01532648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102406237|NCT01532648|Respiratory System Agents|respiratory system agents|mesh-ancestor
102406238|NCT01532648|Glucocorticoids|glucocorticoids|mesh-ancestor
102406239|NCT01532648|Hormones|hormones|mesh-ancestor
102406240|NCT01532648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102406241|NCT00617097|Ketorolac|ketorolac|mesh-list
102406242|NCT00617097|Lidocaine|lidocaine|mesh-list
102406243|NCT00617097|Anesthetics, Local|anesthetics, local|mesh-ancestor
102406244|NCT00617097|Anesthetics|anesthetics|mesh-ancestor
102406245|NCT00617097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102406246|NCT00617097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406247|NCT00617097|Sensory System Agents|sensory system agents|mesh-ancestor
102406248|NCT00617097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102406249|NCT00617097|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102406250|NCT00617097|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102406251|NCT00617097|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102406252|NCT00617097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102406253|NCT00617097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406254|NCT00617097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102406255|NCT00617097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102406256|NCT00617097|Analgesics|analgesics|mesh-ancestor
102406257|NCT00617097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102406258|NCT00617097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102406259|NCT00617097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102406260|NCT00617097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102406261|NCT01532414|Enclomiphene|enclomiphene|mesh-list
102406262|NCT01532414|Clomiphene|clomiphene|mesh-list
102406263|NCT01532414|Zuclomiphene|zuclomiphene|mesh-list
102406264|NCT01532414|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102406265|NCT01532414|Hormone Antagonists|hormone antagonists|mesh-ancestor
102406266|NCT01532414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102406267|NCT01532414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406268|NCT01532414|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102406269|NCT01532414|Fertility Agents|fertility agents|mesh-ancestor
102406270|NCT01532414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102406271|NCT01532414|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102406272|NCT01532414|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102406273|NCT01441973|Elotuzumab|elotuzumab|mesh-list
102406274|NCT01441973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102406275|NCT02074709|Bupivacaine|bupivacaine|mesh-list
102406276|NCT02074709|Anesthetics, Local|anesthetics, local|mesh-ancestor
102406277|NCT02074709|Anesthetics|anesthetics|mesh-ancestor
102406278|NCT02074709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102406279|NCT02074709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406280|NCT02074709|Sensory System Agents|sensory system agents|mesh-ancestor
102406281|NCT02074709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102406283|NCT03571191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102406284|NCT03571191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406285|NCT01575899|Amoxicillin|amoxicillin|mesh-list
102406286|NCT01575899|Clarithromycin|clarithromycin|mesh-list
102406287|NCT01575899|Levofloxacin|levofloxacin|mesh-list
102406288|NCT01575899|Ofloxacin|ofloxacin|mesh-list
102406289|NCT01575899|Clavulanic Acid|clavulanic acid|mesh-list
102406290|NCT01575899|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102406291|NCT01575899|Rabeprazole|rabeprazole|mesh-list
102406292|NCT01575899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102406293|NCT01575899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102406294|NCT01575899|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102406295|NCT01575899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102406296|NCT01575899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406297|NCT01575899|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102406298|NCT01575899|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102406299|NCT01575899|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102406300|NCT01575899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102406301|NCT01575899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102406302|NCT01575899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102406303|NCT01575899|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102406304|NCT01575899|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102406305|NCT01575899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102406306|NCT01575899|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102406307|NCT01575899|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102406308|NCT01440881|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
102406309|NCT01440881|Natriuretic Agents|natriuretic agents|mesh-ancestor
102406310|NCT01440881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406311|NCT00620061|Lubiprostone|lubiprostone|mesh-list
102406312|NCT00620061|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102406313|NCT00620061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102406314|NCT00620061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406315|NCT04122443|Acetaminophen|acetaminophen|mesh-list
102406316|NCT04122443|Oxycodone|oxycodone|mesh-list
102406317|NCT04122443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102406318|NCT04122443|Analgesics|analgesics|mesh-ancestor
102406319|NCT04122443|Sensory System Agents|sensory system agents|mesh-ancestor
102406320|NCT04122443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102406321|NCT04122443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406322|NCT04122443|Antipyretics|antipyretics|mesh-ancestor
102406323|NCT04122443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102406324|NCT04122443|Narcotics|narcotics|mesh-ancestor
102406325|NCT04122443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102406326|NCT00587769|Bupropion|bupropion|mesh-list
102406327|NCT00587769|Varenicline|varenicline|mesh-list
102406328|NCT00587769|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102406329|NCT00587769|Antidepressive Agents|antidepressive agents|mesh-ancestor
102406330|NCT00587769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102406331|NCT00587769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102406332|NCT00587769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102406333|NCT00587769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102406334|NCT00587769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406335|NCT00587769|Dopamine Agents|dopamine agents|mesh-ancestor
102406336|NCT00587769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102406337|NCT00587769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406338|NCT00587769|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102406339|NCT00587769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102406340|NCT00587769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102406341|NCT00587769|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102406342|NCT00587769|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102406343|NCT00587769|Cholinergic Agents|cholinergic agents|mesh-ancestor
102406344|NCT00623181|Vaccines|vaccines|mesh-list
102406345|NCT00623181|Immunologic Factors|immunologic factors|mesh-ancestor
102406346|NCT00623181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406347|NCT03433833|Digoxin|digoxin|mesh-list
102406348|NCT03433833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102406349|NCT03433833|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102406350|NCT03433833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102406351|NCT03433833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406352|NCT03433833|Protective Agents|protective agents|mesh-ancestor
102406353|NCT03433833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406354|NCT01574651|Glycopyrrolate|glycopyrrolate|mesh-list
102406355|NCT01574651|Formoterol Fumarate|formoterol fumarate|mesh-list
102406356|NCT01574651|Tiotropium Bromide|tiotropium bromide|mesh-list
102406357|NCT01574651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102406358|NCT01574651|Autonomic Agents|autonomic agents|mesh-ancestor
102406359|NCT01574651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102406360|NCT01574651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406361|NCT01574651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102406362|NCT01574651|Respiratory System Agents|respiratory system agents|mesh-ancestor
102406363|NCT01574651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102406364|NCT01574651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102406365|NCT01574651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102406366|NCT01574651|Adrenergic Agents|adrenergic agents|mesh-ancestor
102406367|NCT01574651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102406368|NCT01574651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406369|NCT01574651|Parasympatholytics|parasympatholytics|mesh-ancestor
102406370|NCT01574651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102406371|NCT01574651|Cholinergic Agents|cholinergic agents|mesh-ancestor
102406372|NCT01574651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102406373|NCT01574651|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102406374|NCT03179163|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102406375|NCT03179163|Enalapril|enalapril|mesh-list
102406376|NCT03179163|Captopril|captopril|mesh-list
102406377|NCT03179163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102406378|NCT03179163|Diuretics|diuretics|mesh-ancestor
102406379|NCT03179163|Natriuretic Agents|natriuretic agents|mesh-ancestor
102406380|NCT03179163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406381|NCT03179163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102406382|NCT03179163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102406383|NCT03179163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406384|NCT03179163|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102406385|NCT03179163|Protease Inhibitors|protease inhibitors|mesh-ancestor
102406386|NCT03179163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102406387|NCT01440803|Teriparatide|teriparatide|mesh-list
102406388|NCT01440803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102406389|NCT01440803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406390|NCT01440803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102406391|NCT05247177|Dexmedetomidine|dexmedetomidine|mesh-list
102406392|NCT05247177|Ketamine|ketamine|mesh-list
102406393|NCT05247177|Anesthetics|anesthetics|mesh-list
102406394|NCT05247177|Sevoflurane|sevoflurane|mesh-list
102406395|NCT05247177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102406396|NCT05247177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406397|NCT05247177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102406398|NCT05247177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102406399|NCT05247177|Analgesics|analgesics|mesh-ancestor
102406400|NCT05247177|Sensory System Agents|sensory system agents|mesh-ancestor
102406401|NCT05247177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102406402|NCT05247177|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102406403|NCT05247177|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102037421|NCT02499120|Cetuximab|cetuximab|mesh-list
102406404|NCT05247177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102406405|NCT05247177|Adrenergic Agents|adrenergic agents|mesh-ancestor
102406406|NCT05247177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102406407|NCT05247177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406408|NCT05247177|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102406409|NCT05247177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102406410|NCT05247177|Anesthetics, General|anesthetics, general|mesh-ancestor
102406411|NCT05247177|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102406412|NCT05247177|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102406413|NCT05247177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102406414|NCT05247177|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102406415|NCT00624195|Etravirine|etravirine|mesh-list
102406416|NCT00624195|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102406417|NCT00624195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102406418|NCT00624195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102406419|NCT00624195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102406420|NCT00624195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406421|NCT00624195|Antiviral Agents|antiviral agents|mesh-ancestor
102406422|NCT00624195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102406423|NCT01516970|Ritonavir|ritonavir|mesh-list
102406424|NCT01516970|Lopinavir|lopinavir|mesh-list
102406425|NCT01516970|Darunavir|darunavir|mesh-list
102406426|NCT01516970|Zidovudine|zidovudine|mesh-list
102406427|NCT01516970|Efavirenz|efavirenz|mesh-list
102406428|NCT01516970|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102406429|NCT01516970|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102406430|NCT01516970|Protease Inhibitors|protease inhibitors|mesh-ancestor
102406431|NCT01516970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102406432|NCT01516970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406433|NCT01516970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102406434|NCT01516970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102406435|NCT01516970|Antiviral Agents|antiviral agents|mesh-ancestor
102406436|NCT01516970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102406437|NCT01516970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102406438|NCT01516970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102406439|NCT01516970|Antimetabolites|antimetabolites|mesh-ancestor
102406440|NCT01516970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102406441|NCT01516970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102406442|NCT01516970|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102406443|NCT01516970|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102406444|NCT01516970|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102406445|NCT01516970|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102406446|NCT01516970|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102406447|NCT02140593|Rocuronium|rocuronium|mesh-list
102406448|NCT02140593|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102406449|NCT02140593|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102406450|NCT02140593|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102406451|NCT02140593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102406452|NCT02140593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406453|NCT01516892|Botulinum Toxins|botulinum toxins|mesh-list
102406454|NCT01516892|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102406455|NCT01516892|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102406456|NCT01516892|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102406457|NCT01516892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102406458|NCT01516892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406459|NCT01516892|Cholinergic Agents|cholinergic agents|mesh-ancestor
102406460|NCT01516892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102406461|NCT01516892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406462|NCT01516892|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102406463|NCT01516892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102406464|NCT00668811|Sunitinib|sunitinib|mesh-list
102406465|NCT00668811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102406466|NCT00668811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102406467|NCT00668811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102406468|NCT00668811|Growth Substances|growth substances|mesh-ancestor
102406469|NCT00668811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406470|NCT00668811|Growth Inhibitors|growth inhibitors|mesh-ancestor
102406471|NCT00668811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102406472|NCT00668811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102406473|NCT00668811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406474|NCT02776605|Prednisone|prednisone|mesh-list
102406475|NCT02776605|Methotrexate|methotrexate|mesh-list
102406476|NCT02776605|Vincristine|vincristine|mesh-list
102406477|NCT02776605|Daunorubicin|daunorubicin|mesh-list
102406478|NCT02776605|Mercaptopurine|mercaptopurine|mesh-list
102406479|NCT02776605|Ponatinib|ponatinib|mesh-list
102406480|NCT02776605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102406481|NCT02776605|Glucocorticoids|glucocorticoids|mesh-ancestor
102406482|NCT02776605|Hormones|hormones|mesh-ancestor
102406483|NCT02776605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102406484|NCT02776605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406485|NCT02776605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102406486|NCT02776605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102406487|NCT02776605|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102406488|NCT02776605|Abortifacient Agents|abortifacient agents|mesh-ancestor
102406489|NCT02776605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102406490|NCT02776605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102406491|NCT02776605|Antimetabolites|antimetabolites|mesh-ancestor
102406492|NCT02776605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406493|NCT02776605|Dermatologic Agents|dermatologic agents|mesh-ancestor
102406494|NCT02776605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102406495|NCT02776605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102406496|NCT02776605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102406497|NCT02776605|Immunologic Factors|immunologic factors|mesh-ancestor
102406498|NCT02776605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102406499|NCT02776605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102218193|NCT02440568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102406500|NCT02776605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102406501|NCT02776605|Tubulin Modulators|tubulin modulators|mesh-ancestor
102406502|NCT02776605|Antimitotic Agents|antimitotic agents|mesh-ancestor
102406503|NCT02776605|Mitosis Modulators|mitosis modulators|mesh-ancestor
102406504|NCT02776605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102406505|NCT02776605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102406506|NCT02776605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102406507|NCT02776605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102406509|NCT00627861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102406510|NCT00627861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102406511|NCT00627861|Sympatholytics|sympatholytics|mesh-ancestor
102406512|NCT00627861|Autonomic Agents|autonomic agents|mesh-ancestor
102406513|NCT00627861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102406514|NCT00627861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406515|NCT00627861|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102406516|NCT00627861|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102406517|NCT00627861|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102406518|NCT00627861|Adrenergic Agents|adrenergic agents|mesh-ancestor
102406519|NCT00627861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102406520|NCT00627861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406521|NCT00669279|Atenolol|atenolol|mesh-list
102406522|NCT00669279|Carvedilol|carvedilol|mesh-list
102406523|NCT00669279|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102406524|NCT00669279|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102406525|NCT00669279|Adrenergic Agents|adrenergic agents|mesh-ancestor
102406526|NCT00669279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102406527|NCT00669279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406528|NCT00669279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406529|NCT00669279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102406530|NCT00669279|Antioxidants|antioxidants|mesh-ancestor
102406531|NCT00669279|Protective Agents|protective agents|mesh-ancestor
102406532|NCT00669279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102406533|NCT00669279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102406534|NCT00669279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102406535|NCT00669279|Vasodilator Agents|vasodilator agents|mesh-ancestor
102406536|NCT00669279|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102406537|NCT00669279|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102406538|NCT00669279|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102406539|NCT00669279|Sympatholytics|sympatholytics|mesh-ancestor
102406540|NCT00669279|Autonomic Agents|autonomic agents|mesh-ancestor
102406541|NCT00669279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102406542|NCT00669279|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102406543|NCT02394795|Calcium, Dietary|calcium, dietary|mesh-list
102406544|NCT02394795|Leucovorin|leucovorin|mesh-list
102406545|NCT02394795|Bevacizumab|bevacizumab|mesh-list
102406546|NCT02394795|Panitumumab|panitumumab|mesh-list
102406547|NCT02394795|Oxaliplatin|oxaliplatin|mesh-list
102406548|NCT02394795|Fluorouracil|fluorouracil|mesh-list
102406549|NCT02394795|Calcium|calcium|mesh-list
102406550|NCT02394795|Levoleucovorin|levoleucovorin|mesh-list
102406551|NCT02394795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102406552|NCT02394795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102406553|NCT02394795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102406554|NCT02394795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102406555|NCT02394795|Growth Substances|growth substances|mesh-ancestor
102406556|NCT02394795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406557|NCT02394795|Growth Inhibitors|growth inhibitors|mesh-ancestor
102406558|NCT02394795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102406559|NCT02394795|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102406560|NCT02394795|Antimetabolites|antimetabolites|mesh-ancestor
102406561|NCT02394795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406562|NCT02394795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102406563|NCT02394795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102406564|NCT02394795|Immunologic Factors|immunologic factors|mesh-ancestor
102406565|NCT02394795|Antidotes|antidotes|mesh-ancestor
102406566|NCT02394795|Protective Agents|protective agents|mesh-ancestor
102406567|NCT02394795|Vitamin B Complex|vitamin b complex|mesh-ancestor
102406568|NCT02394795|Vitamins|vitamins|mesh-ancestor
102406569|NCT02394795|Micronutrients|micronutrients|mesh-ancestor
102406570|NCT01546688|Zonisamide|zonisamide|mesh-list
102406571|NCT01546688|Anticonvulsants|anticonvulsants|mesh-ancestor
102406572|NCT01546688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102406573|NCT01546688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102406574|NCT01546688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406575|NCT01546688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102406576|NCT01546688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406577|NCT04409522|Melatonin|melatonin|mesh-list
102406578|NCT04409522|Antioxidants|antioxidants|mesh-ancestor
102406579|NCT04409522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406580|NCT04409522|Protective Agents|protective agents|mesh-ancestor
102406581|NCT04409522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406582|NCT04409522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102406583|NCT00672243|Sirolimus|sirolimus|mesh-list
102406584|NCT00672243|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102406585|NCT00672243|Temsirolimus|temsirolimus|mesh-list
102406586|NCT00672243|MTOR Inhibitors|mtor inhibitors|mesh-list
102406587|NCT00672243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102406588|NCT00672243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102406589|NCT00672243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102406590|NCT00672243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406591|NCT00672243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102406592|NCT00672243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102406593|NCT00672243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102406594|NCT00672243|Antifungal Agents|antifungal agents|mesh-ancestor
102406595|NCT00672243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102406596|NCT00672243|Immunologic Factors|immunologic factors|mesh-ancestor
102406597|NCT00672243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406598|NCT04105946|Dexmedetomidine|dexmedetomidine|mesh-list
102406599|NCT04105946|Remifentanil|remifentanil|mesh-list
102406600|NCT04105946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102406601|NCT04105946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102406602|NCT04105946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406603|NCT04105946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102406604|NCT04105946|Analgesics|analgesics|mesh-ancestor
102406605|NCT04105946|Sensory System Agents|sensory system agents|mesh-ancestor
102406606|NCT04105946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102406607|NCT04105946|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102406608|NCT04105946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102406609|NCT04105946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102406610|NCT04105946|Adrenergic Agents|adrenergic agents|mesh-ancestor
102406611|NCT04105946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102406612|NCT04105946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406613|NCT04105946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102406614|NCT04105946|Narcotics|narcotics|mesh-ancestor
102406615|NCT01440569|Darunavir|darunavir|mesh-list
102406616|NCT01440569|Cobicistat|cobicistat|mesh-list
102406617|NCT01440569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102406618|NCT01440569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102406619|NCT01440569|Protease Inhibitors|protease inhibitors|mesh-ancestor
102406620|NCT01440569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102406621|NCT01440569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406622|NCT01440569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102406623|NCT01440569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102406624|NCT01440569|Antiviral Agents|antiviral agents|mesh-ancestor
102406625|NCT01440569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102406626|NCT01440569|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102406627|NCT01440569|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102406628|NCT00629499|Paclitaxel|paclitaxel|mesh-list
102406629|NCT00629499|Cyclophosphamide|cyclophosphamide|mesh-list
102406630|NCT00629499|Trastuzumab|trastuzumab|mesh-list
102406631|NCT00629499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102406632|NCT00629499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102406633|NCT00629499|Tubulin Modulators|tubulin modulators|mesh-ancestor
102406634|NCT00629499|Antimitotic Agents|antimitotic agents|mesh-ancestor
102406635|NCT00629499|Mitosis Modulators|mitosis modulators|mesh-ancestor
102406636|NCT00629499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406637|NCT00629499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102406638|NCT00629499|Immunologic Factors|immunologic factors|mesh-ancestor
102406639|NCT00629499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406640|NCT00629499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102406641|NCT00629499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102406642|NCT00629499|Alkylating Agents|alkylating agents|mesh-ancestor
102406643|NCT00629499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102406644|NCT00629499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102406645|NCT00631449|Raltegravir Potassium|raltegravir potassium|mesh-list
102406646|NCT00631449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102406647|NCT00631449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102406648|NCT00631449|Antiviral Agents|antiviral agents|mesh-ancestor
102406649|NCT00631449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102406650|NCT00631449|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102406651|NCT00631449|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102406652|NCT00631449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102406653|NCT00631449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406654|NCT01546142|Deoxycholic Acid|deoxycholic acid|mesh-list
102406655|NCT01546142|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102406656|NCT01546142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102406657|NCT00632619|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
102406658|NCT00632619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406660|NCT01440101|Immunologic Factors|immunologic factors|mesh-ancestor
102406661|NCT01440101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406662|NCT01530464|Ambrisentan|ambrisentan|mesh-list
102406663|NCT01530464|Aminophylline|aminophylline|mesh-list
102406664|NCT01530464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102406665|NCT01530464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102406666|NCT01530464|Autonomic Agents|autonomic agents|mesh-ancestor
102406667|NCT01530464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102406668|NCT01530464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406669|NCT01530464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102406670|NCT01530464|Respiratory System Agents|respiratory system agents|mesh-ancestor
102406671|NCT01530464|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102406672|NCT01530464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102406673|NCT01530464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102406674|NCT01530464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406675|NCT01530464|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102406676|NCT01530464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102406677|NCT01530464|Purinergic Agents|purinergic agents|mesh-ancestor
102406678|NCT01530464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102406679|NCT01530464|Protective Agents|protective agents|mesh-ancestor
102406680|NCT00633399|Ziprasidone|ziprasidone|mesh-list
102406681|NCT00633399|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102406682|NCT00633399|Serotonin Agents|serotonin agents|mesh-ancestor
102406683|NCT00633399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102406684|NCT00633399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406685|NCT00633399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406686|NCT00633399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102406687|NCT00633399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102406688|NCT00633399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102406689|NCT00633399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102406690|NCT00633399|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102406691|NCT00633399|Dopamine Agents|dopamine agents|mesh-ancestor
102406692|NCT01077843|Etoricoxib|etoricoxib|mesh-list
102406693|NCT01077843|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
102406694|NCT01077843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102406695|NCT01077843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102406696|NCT01077843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102406697|NCT01077843|Analgesics|analgesics|mesh-ancestor
102406698|NCT01077843|Sensory System Agents|sensory system agents|mesh-ancestor
102406699|NCT01077843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102406700|NCT01077843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406701|NCT01077843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102406702|NCT01077843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102406703|NCT01077843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102406704|NCT01077843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406705|NCT00673959|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102406706|NCT00673959|Lubricant Eye Drops|lubricant eye drops|mesh-list
102406707|NCT00673959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102406708|NCT00635817|Leuprolide|leuprolide|mesh-list
102406709|NCT00635817|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102406710|NCT00635817|Fertility Agents|fertility agents|mesh-ancestor
102406711|NCT00635817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102406712|NCT00635817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406713|NCT00635817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102406714|NCT00635817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102406715|NCT01439945|Magnesium Oxide|magnesium oxide|mesh-list
102406716|NCT01439945|Antacids|antacids|mesh-ancestor
102406717|NCT01439945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406718|NCT01439945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102406719|NCT00651963|Ezetimibe|ezetimibe|mesh-list
102406720|NCT00651963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102406721|NCT00651963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102406722|NCT00651963|Antimetabolites|antimetabolites|mesh-ancestor
102406723|NCT00651963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406724|NCT00651963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102406725|NCT00674115|Omeprazole|omeprazole|mesh-list
102406726|NCT00674115|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
102406727|NCT00674115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102406728|NCT00674115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102406729|NCT00674115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102406730|NCT00674115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102406731|NCT00674115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406732|NCT02142153|Olorofim|olorofim|mesh-list
102406733|NCT02142153|Antifungal Agents|antifungal agents|mesh-ancestor
102406734|NCT02142153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102406735|NCT00674583|Vaccines|vaccines|mesh-list
102406736|NCT00674583|Immunologic Factors|immunologic factors|mesh-ancestor
102406737|NCT00674583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406738|NCT01420081|Gedatolisib|gedatolisib|mesh-list
102406739|NCT01420081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102406740|NCT01420081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102406741|NCT01420081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406742|NCT01439867|Cinacalcet|cinacalcet|mesh-list
102406743|NCT01439867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102406744|NCT01439867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406745|NCT01439867|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
102406746|NCT01439867|Hormone Antagonists|hormone antagonists|mesh-ancestor
102406747|NCT01439867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102406748|NCT00637923|Ribavirin|ribavirin|mesh-list
102406749|NCT00637923|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102406750|NCT00637923|Nitazoxanide|nitazoxanide|mesh-list
102406751|NCT00637923|Antimetabolites|antimetabolites|mesh-ancestor
102406752|NCT00637923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406753|NCT00637923|Antiviral Agents|antiviral agents|mesh-ancestor
102406754|NCT00637923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102406755|NCT00637923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102406756|NCT01439711|Letrozole|letrozole|mesh-list
102406757|NCT01439711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102406758|NCT01439711|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102406759|NCT01439711|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102406760|NCT01439711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102406761|NCT01439711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406762|NCT01439711|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102406763|NCT01439711|Hormone Antagonists|hormone antagonists|mesh-ancestor
102406764|NCT01439711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102406765|NCT01439711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406766|NCT01439555|Simvastatin|simvastatin|mesh-list
102406767|NCT01439555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102406768|NCT01439555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102406769|NCT01439555|Antimetabolites|antimetabolites|mesh-ancestor
102406770|NCT01439555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406771|NCT01439555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102406772|NCT01439555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102406773|NCT01439555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102406774|NCT00674739|Imiquimod|imiquimod|mesh-list
102406775|NCT00674739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102406776|NCT00674739|Immunologic Factors|immunologic factors|mesh-ancestor
102406777|NCT00674739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406778|NCT00674739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102406779|NCT00674739|Interferon Inducers|interferon inducers|mesh-ancestor
102406780|NCT00675909|Midazolam|midazolam|mesh-list
102406781|NCT00675909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102406782|NCT00675909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102406783|NCT00675909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102406784|NCT00675909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406785|NCT00675909|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102406786|NCT00675909|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102406787|NCT00675909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102406788|NCT00675909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102406789|NCT00675909|Anesthetics, General|anesthetics, general|mesh-ancestor
102406790|NCT00675909|Anesthetics|anesthetics|mesh-ancestor
102406791|NCT00675909|GABA Modulators|gaba modulators|mesh-ancestor
102406792|NCT00675909|GABA Agents|gaba agents|mesh-ancestor
102406793|NCT00675909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102406794|NCT00675909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406795|NCT03027908|Fluorides|fluorides|mesh-list
102406796|NCT03027908|Cariostatic Agents|cariostatic agents|mesh-ancestor
102406797|NCT03027908|Protective Agents|protective agents|mesh-ancestor
102406798|NCT03027908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406799|NCT00638937|Saracatinib|saracatinib|mesh-list
102406800|NCT00638937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102406801|NCT00638937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102406802|NCT00638937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406803|NCT01439009|Tolvaptan|tolvaptan|mesh-list
102406804|NCT01439009|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102406805|NCT01439009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406806|NCT01439009|Natriuretic Agents|natriuretic agents|mesh-ancestor
102406807|NCT01439009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406808|NCT00675987|Losartan|losartan|mesh-list
102406809|NCT00675987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102406810|NCT00675987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102406811|NCT00675987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102406812|NCT00675987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102406813|NCT00675987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406814|NCT00639717|Etanercept|etanercept|mesh-list
102406815|NCT00639717|Methoxsalen|methoxsalen|mesh-list
102406816|NCT00639717|Tacrolimus|tacrolimus|mesh-list
102406817|NCT00639717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102406818|NCT00639717|Immunologic Factors|immunologic factors|mesh-ancestor
102406819|NCT00639717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406820|NCT00639717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102406821|NCT00639717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102406822|NCT00639717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406823|NCT00639717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102406824|NCT00639717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102406825|NCT00639717|Analgesics|analgesics|mesh-ancestor
102406826|NCT00639717|Sensory System Agents|sensory system agents|mesh-ancestor
102406827|NCT00639717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102406828|NCT00639717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102406829|NCT00639717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102406830|NCT00639717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102406831|NCT00639717|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102406832|NCT00639717|Dermatologic Agents|dermatologic agents|mesh-ancestor
102406833|NCT01571453|Vortioxetine|vortioxetine|mesh-list
102406834|NCT01571453|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102406835|NCT01571453|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102406836|NCT01571453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102406837|NCT01571453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102406838|NCT01571453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406839|NCT01571453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102406840|NCT01571453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406841|NCT01571453|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102406842|NCT01571453|Antidepressive Agents|antidepressive agents|mesh-ancestor
102406843|NCT01571453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102406844|NCT01571453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102406845|NCT01571453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102406846|NCT01571453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102406847|NCT01571453|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102406848|NCT01571453|Serotonin Agents|serotonin agents|mesh-ancestor
102406849|NCT01571453|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102406850|NCT01571453|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102406851|NCT01571453|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102406852|NCT01571453|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102406853|NCT04120961|Hirudins|hirudins|mesh-list
102406854|NCT04120961|Bivalirudin|bivalirudin|mesh-list
102406855|NCT04120961|Antithrombins|antithrombins|mesh-ancestor
102406856|NCT04120961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102406857|NCT04120961|Protease Inhibitors|protease inhibitors|mesh-ancestor
102406858|NCT04120961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102406859|NCT04120961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406860|NCT04120961|Anticoagulants|anticoagulants|mesh-ancestor
102406861|NCT04120961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102406862|NCT04120961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102406863|NCT04410263|Dimercaprol|dimercaprol|mesh-list
102406864|NCT04410263|Chelating Agents|chelating agents|mesh-ancestor
102406865|NCT04410263|Sequestering Agents|sequestering agents|mesh-ancestor
102406866|NCT04410263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406867|NCT01444651|Tadalafil|tadalafil|mesh-list
102406868|NCT01444651|Vasodilator Agents|vasodilator agents|mesh-ancestor
102406869|NCT01444651|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102406870|NCT01444651|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102406871|NCT01444651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102406872|NCT01444651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406873|NCT01444651|Urological Agents|urological agents|mesh-ancestor
102406874|NCT01570751|Insulin|insulin|mesh-list
102406875|NCT01570751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102406876|NCT01570751|Insulin Glargine|insulin glargine|mesh-list
102406877|NCT01570751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102406878|NCT01570751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406879|NCT01419535|Mifepristone|mifepristone|mesh-list
102406880|NCT01419535|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102406881|NCT01419535|Abortifacient Agents|abortifacient agents|mesh-ancestor
102406882|NCT01419535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102406883|NCT01419535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406884|NCT01419535|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102406885|NCT01419535|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102406886|NCT01419535|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102406887|NCT01419535|Contraceptive Agents|contraceptive agents|mesh-ancestor
102406888|NCT01419535|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102406889|NCT01419535|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102406890|NCT01419535|Hormone Antagonists|hormone antagonists|mesh-ancestor
102406891|NCT01419535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102406892|NCT01419535|Luteolytic Agents|luteolytic agents|mesh-ancestor
102406893|NCT01419535|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102406894|NCT01419535|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102406895|NCT01438151|Infliximab|infliximab|mesh-list
102406896|NCT01438151|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102406897|NCT01438151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102406898|NCT01438151|Dermatologic Agents|dermatologic agents|mesh-ancestor
102406899|NCT01438151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102406900|NCT01438151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102406901|NCT02141451|Rituximab|rituximab|mesh-list
102406902|NCT02141451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102406903|NCT02141451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102406904|NCT02141451|Immunologic Factors|immunologic factors|mesh-ancestor
102406905|NCT02141451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406906|NCT02141451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102406907|NCT01418365|Metronidazole|metronidazole|mesh-list
102406908|NCT01418365|Mesalamine|mesalamine|mesh-list
102406909|NCT01418365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102406910|NCT01418365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102406911|NCT01418365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102406912|NCT01418365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102406913|NCT01418365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102406914|NCT01418365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102406915|NCT01418365|Analgesics|analgesics|mesh-ancestor
102406916|NCT01418365|Sensory System Agents|sensory system agents|mesh-ancestor
102406917|NCT01418365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102406918|NCT01418365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406919|NCT01418365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102406920|NCT01418365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102406921|NCT02075125|Ticagrelor|ticagrelor|mesh-list
102406922|NCT02075125|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102406923|NCT02075125|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102406924|NCT02075125|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102406925|NCT02075125|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102406926|NCT02075125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102406927|NCT02075125|Purinergic Agents|purinergic agents|mesh-ancestor
102406928|NCT02075125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102406929|NCT02075125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406930|NCT02075125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406931|NCT00678015|Masoprocol|masoprocol|mesh-list
102406932|NCT00678015|Antioxidants|antioxidants|mesh-ancestor
102406933|NCT00678015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406934|NCT00678015|Protective Agents|protective agents|mesh-ancestor
102406935|NCT00678015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406936|NCT00678015|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
102406937|NCT00678015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102406938|NCT00678015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102406939|NCT00678015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102406940|NCT00678015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102406941|NCT00678015|Analgesics|analgesics|mesh-ancestor
102406942|NCT00678015|Sensory System Agents|sensory system agents|mesh-ancestor
102406943|NCT00678015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102406944|NCT00678015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102406945|NCT00678015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102406946|NCT01437995|Fluticasone|fluticasone|mesh-list
102406947|NCT01437995|Xhance|xhance|mesh-list
102406948|NCT01437995|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102406949|NCT01437995|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102406950|NCT01437995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102406951|NCT01437995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102406952|NCT01437995|Autonomic Agents|autonomic agents|mesh-ancestor
102406953|NCT01437995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102406954|NCT01437995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406955|NCT01437995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102406956|NCT01437995|Respiratory System Agents|respiratory system agents|mesh-ancestor
102406957|NCT01437995|Dermatologic Agents|dermatologic agents|mesh-ancestor
102406958|NCT01437995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102406959|NCT01437995|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102406960|NCT01437995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102406961|NCT01437995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102406962|NCT01437995|Adrenergic Agents|adrenergic agents|mesh-ancestor
102406963|NCT01437995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102406964|NCT01437995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406965|NCT01437995|Glucocorticoids|glucocorticoids|mesh-ancestor
102406966|NCT01437995|Hormones|hormones|mesh-ancestor
102406967|NCT01437995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102406968|NCT01437995|Sympathomimetics|sympathomimetics|mesh-ancestor
102406969|NCT00641745|Risperidone|risperidone|mesh-list
102406970|NCT00641745|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102406971|NCT00641745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102406972|NCT00641745|Serotonin Agents|serotonin agents|mesh-ancestor
102406973|NCT00641745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102406974|NCT00641745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102406975|NCT00641745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406976|NCT00641745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102406977|NCT00641745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102406978|NCT00641745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102406979|NCT00641745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102406980|NCT00641745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102406981|NCT00641745|Dopamine Agents|dopamine agents|mesh-ancestor
102406982|NCT00641745|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102406983|NCT00641745|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102406984|NCT00641745|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102406985|NCT00641745|Adrenergic Agents|adrenergic agents|mesh-ancestor
102406986|NCT00641745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102406987|NCT00641745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102406988|NCT01799109|Magnesium Sulfate|magnesium sulfate|mesh-list
102406989|NCT01799109|Albuterol|albuterol|mesh-list
102406990|NCT01799109|Analgesics|analgesics|mesh-ancestor
102406991|NCT01799109|Sensory System Agents|sensory system agents|mesh-ancestor
102406992|NCT01799109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102406993|NCT01799109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102406994|NCT01799109|Anesthetics|anesthetics|mesh-ancestor
102406995|NCT01799109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102406996|NCT01799109|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102406997|NCT01799109|Anticonvulsants|anticonvulsants|mesh-ancestor
102406998|NCT01799109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102406999|NCT01799109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102407000|NCT01799109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407001|NCT01799109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102407002|NCT01799109|Tocolytic Agents|tocolytic agents|mesh-ancestor
102407003|NCT01799109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102407004|NCT01799109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102407005|NCT01799109|Autonomic Agents|autonomic agents|mesh-ancestor
102407006|NCT01799109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102407007|NCT01799109|Respiratory System Agents|respiratory system agents|mesh-ancestor
102407008|NCT01799109|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102407009|NCT01799109|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102407010|NCT01799109|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102407011|NCT01799109|Adrenergic Agents|adrenergic agents|mesh-ancestor
102407012|NCT01799109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102407013|NCT00588159|Diphenhydramine|diphenhydramine|mesh-list
102407014|NCT00588159|Promethazine|promethazine|mesh-list
102407015|NCT00588159|Gabapentin|gabapentin|mesh-list
102407016|NCT00588159|Analgesics|analgesics|mesh-ancestor
102407017|NCT00588159|Sensory System Agents|sensory system agents|mesh-ancestor
102407018|NCT00588159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102218714|NCT03520985|Hormones|hormones|mesh-ancestor
102407019|NCT00588159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407020|NCT00588159|Anticonvulsants|anticonvulsants|mesh-ancestor
102407021|NCT00588159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102407022|NCT00588159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102407023|NCT00588159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102407024|NCT00588159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102407025|NCT00588159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102407026|NCT00588159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102407027|NCT00588159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102407028|NCT00588159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407029|NCT00588159|Antimanic Agents|antimanic agents|mesh-ancestor
102407030|NCT00588159|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102407031|NCT00588159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102407032|NCT00588159|Anesthetics, Local|anesthetics, local|mesh-ancestor
102407033|NCT00588159|Anesthetics|anesthetics|mesh-ancestor
102407034|NCT00588159|Antiemetics|antiemetics|mesh-ancestor
102407035|NCT00588159|Autonomic Agents|autonomic agents|mesh-ancestor
102407036|NCT00588159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102407037|NCT00588159|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102407038|NCT00588159|Histamine Antagonists|histamine antagonists|mesh-ancestor
102407039|NCT00588159|Histamine Agents|histamine agents|mesh-ancestor
102407040|NCT00588159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102407041|NCT00588159|Antipruritics|antipruritics|mesh-ancestor
102407042|NCT00588159|Dermatologic Agents|dermatologic agents|mesh-ancestor
102407043|NCT01439347|Vincristine|vincristine|mesh-list
102407044|NCT01439347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102407045|NCT01439347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102407046|NCT01439347|Tubulin Modulators|tubulin modulators|mesh-ancestor
102407047|NCT01439347|Antimitotic Agents|antimitotic agents|mesh-ancestor
102407048|NCT01439347|Mitosis Modulators|mitosis modulators|mesh-ancestor
102407049|NCT01439347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407050|NCT00680823|Ropivacaine|ropivacaine|mesh-list
102407051|NCT00680823|Anesthetics, Local|anesthetics, local|mesh-ancestor
102407052|NCT00680823|Anesthetics|anesthetics|mesh-ancestor
102407053|NCT00680823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102407054|NCT00680823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407055|NCT00680823|Sensory System Agents|sensory system agents|mesh-ancestor
102407056|NCT00680823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102407057|NCT00589329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102407058|NCT00589329|Metronidazole|metronidazole|mesh-list
102407059|NCT00589329|Erythromycin|erythromycin|mesh-list
102407060|NCT00589329|Erythromycin Estolate|erythromycin estolate|mesh-list
102407061|NCT00589329|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
102407062|NCT00589329|Erythromycin stearate|erythromycin stearate|mesh-list
102407063|NCT00589329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102407064|NCT00589329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102407065|NCT00589329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102407066|NCT00589329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102407067|NCT00589329|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102407068|NCT00589329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102407069|NCT00589329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407070|NCT01438957|Dexmedetomidine|dexmedetomidine|mesh-list
102407071|NCT01438957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102407072|NCT01438957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102407073|NCT01438957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407074|NCT01438957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102407075|NCT01438957|Analgesics|analgesics|mesh-ancestor
102407076|NCT01438957|Sensory System Agents|sensory system agents|mesh-ancestor
102407077|NCT01438957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102407078|NCT01438957|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102407079|NCT01438957|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102407080|NCT01438957|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102407081|NCT01438957|Adrenergic Agents|adrenergic agents|mesh-ancestor
102407082|NCT01438957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102407083|NCT01438957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407084|NCT00589563|Sirolimus|sirolimus|mesh-list
102407085|NCT00589563|Cyclophosphamide|cyclophosphamide|mesh-list
102407086|NCT00589563|Melphalan|melphalan|mesh-list
102407087|NCT00589563|Methotrexate|methotrexate|mesh-list
102407088|NCT00589563|Fludarabine|fludarabine|mesh-list
102407089|NCT00589563|Fludarabine phosphate|fludarabine phosphate|mesh-list
102407090|NCT00589563|Etoposide|etoposide|mesh-list
102407091|NCT00589563|Tacrolimus|tacrolimus|mesh-list
102407092|NCT00589563|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102407093|NCT00589563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102407094|NCT00589563|Immunologic Factors|immunologic factors|mesh-ancestor
102407095|NCT00589563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407096|NCT00589563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102407097|NCT00589563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102407098|NCT00589563|Alkylating Agents|alkylating agents|mesh-ancestor
102407099|NCT00589563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407100|NCT00589563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102407101|NCT00589563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102407102|NCT00589563|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102407103|NCT00589563|Abortifacient Agents|abortifacient agents|mesh-ancestor
102407104|NCT00589563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102407105|NCT00589563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102407106|NCT00589563|Antimetabolites|antimetabolites|mesh-ancestor
102407107|NCT00589563|Dermatologic Agents|dermatologic agents|mesh-ancestor
102407108|NCT00589563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102407109|NCT00589563|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102407110|NCT00589563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102407111|NCT00589563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102407112|NCT00589563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102407113|NCT00589563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102407114|NCT00589563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102407115|NCT00589563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102407116|NCT00589563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102407117|NCT00589563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102407118|NCT00589563|Antifungal Agents|antifungal agents|mesh-ancestor
102407119|NCT00645333|Docetaxel|docetaxel|mesh-list
102407120|NCT00645333|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
102407121|NCT00645333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102407122|NCT00645333|Tubulin Modulators|tubulin modulators|mesh-ancestor
102407123|NCT00645333|Antimitotic Agents|antimitotic agents|mesh-ancestor
102407124|NCT00645333|Mitosis Modulators|mitosis modulators|mesh-ancestor
102407125|NCT00645333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407126|NCT00645333|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
102407127|NCT00645333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102407128|NCT00646581|Insulin|insulin|mesh-list
102407129|NCT00646581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102407130|NCT00646581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102407131|NCT00646581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407132|NCT00648375|Propranolol|propranolol|mesh-list
102407133|NCT00648375|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102407134|NCT00648375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102407135|NCT00648375|Adrenergic Agents|adrenergic agents|mesh-ancestor
102407136|NCT00648375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102407137|NCT00648375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407138|NCT00648375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407139|NCT00648375|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102407140|NCT00648375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102407141|NCT00648375|Vasodilator Agents|vasodilator agents|mesh-ancestor
102407142|NCT00654069|Niacin|niacin|mesh-list
102407143|NCT00654069|Niacinamide|niacinamide|mesh-list
102407144|NCT00654069|Nicotinic Acids|nicotinic acids|mesh-list
102407145|NCT00654069|Oxycodone|oxycodone|mesh-list
102407146|NCT00654069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102407147|NCT00654069|Narcotics|narcotics|mesh-ancestor
102407148|NCT00654069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102407149|NCT00654069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407150|NCT00654069|Analgesics|analgesics|mesh-ancestor
102407151|NCT00654069|Sensory System Agents|sensory system agents|mesh-ancestor
102407152|NCT00654069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102407153|NCT00654069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102407154|NCT00654069|Antimetabolites|antimetabolites|mesh-ancestor
102407155|NCT00654069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407156|NCT00654069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102407157|NCT00654069|Vasodilator Agents|vasodilator agents|mesh-ancestor
102407158|NCT00654069|Vitamin B Complex|vitamin b complex|mesh-ancestor
102407159|NCT00654069|Vitamins|vitamins|mesh-ancestor
102407160|NCT00654069|Micronutrients|micronutrients|mesh-ancestor
102407161|NCT00654147|Ritonavir|ritonavir|mesh-list
102407162|NCT00654147|Lopinavir|lopinavir|mesh-list
102407163|NCT00654147|Tenofovir|tenofovir|mesh-list
102407164|NCT00654147|Emtricitabine|emtricitabine|mesh-list
102407165|NCT00654147|Raltegravir Potassium|raltegravir potassium|mesh-list
102407166|NCT00654147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102407167|NCT00654147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102407168|NCT00654147|Protease Inhibitors|protease inhibitors|mesh-ancestor
102407169|NCT00654147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102407170|NCT00654147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407171|NCT00654147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102407172|NCT00654147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102407173|NCT00654147|Antiviral Agents|antiviral agents|mesh-ancestor
102407174|NCT00654147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102407175|NCT00654147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102407176|NCT00654147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102407177|NCT00654147|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102407178|NCT00654147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102407179|NCT00654147|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102407180|NCT00654147|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102407181|NCT01438489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102407182|NCT01438489|Immunologic Factors|immunologic factors|mesh-ancestor
102407183|NCT01438489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407184|NCT00654927|4-Aminopyridine|4-aminopyridine|mesh-list
102407185|NCT00654927|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102407186|NCT00654927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102407187|NCT00654927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407188|NCT00655083|MEN 11420|men 11420|mesh-list
102407189|NCT00655083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102407190|NCT00655083|Autonomic Agents|autonomic agents|mesh-ancestor
102407191|NCT00655083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102407192|NCT00655083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407193|NCT00655083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102407194|NCT00655083|Respiratory System Agents|respiratory system agents|mesh-ancestor
102407195|NCT01418209|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102407196|NCT01418209|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102407197|NCT01418209|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102407198|NCT01418209|Estradiol|estradiol|mesh-list
102407199|NCT01418209|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102407200|NCT01418209|Progesterone|progesterone|mesh-list
102407201|NCT01418209|Estrogens|estrogens|mesh-ancestor
102407202|NCT01418209|Hormones|hormones|mesh-ancestor
102407203|NCT01418209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102407204|NCT01418209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407205|NCT01418209|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102407206|NCT01418209|Contraceptive Agents|contraceptive agents|mesh-ancestor
102407207|NCT01418209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102407208|NCT01418209|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102407209|NCT01418209|Progestins|progestins|mesh-ancestor
102407210|NCT01418209|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102407211|NCT01418209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102407212|NCT01418209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102407213|NCT01418209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407214|NCT01418209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102407215|NCT01418209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102407216|NCT01418209|Antidepressive Agents|antidepressive agents|mesh-ancestor
102407217|NCT01418209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102407218|NCT00655473|Dalcetrapib|dalcetrapib|mesh-list
102407219|NCT00655473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102407220|NCT00655473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102407221|NCT00655473|Antimetabolites|antimetabolites|mesh-ancestor
102407222|NCT00655473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407223|NCT00655473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102407224|NCT01570361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
102407225|NCT01417195|Menotropins|menotropins|mesh-list
102407226|NCT01417195|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102407227|NCT01417195|Hormones|hormones|mesh-ancestor
102407228|NCT01417195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102407229|NCT01417195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407230|NCT01417195|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102407231|NCT01417195|Fertility Agents|fertility agents|mesh-ancestor
102407232|NCT01417195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102407233|NCT00656487|Rimonabant|rimonabant|mesh-list
102407234|NCT00656487|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102407235|NCT00656487|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
102407236|NCT00656487|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102407237|NCT00656487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102407238|NCT00656487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407239|NCT00656487|Hormones|hormones|mesh-ancestor
102407240|NCT00656487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102407241|NCT00656487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407242|NCT01438411|Cholic Acids|cholic acids|mesh-list
102407243|NCT01438411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102407244|NCT01438177|Chloroquine|chloroquine|mesh-list
102407245|NCT01438177|Cyclophosphamide|cyclophosphamide|mesh-list
102407246|NCT01438177|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102407248|NCT01438177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102407249|NCT01438177|Immunologic Factors|immunologic factors|mesh-ancestor
102407250|NCT01438177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407251|NCT01438177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102407252|NCT01438177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102407253|NCT01438177|Alkylating Agents|alkylating agents|mesh-ancestor
102407254|NCT01438177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407255|NCT01438177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102407256|NCT01438177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102407257|NCT01438177|Amebicides|amebicides|mesh-ancestor
102407258|NCT01438177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102407259|NCT01438177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102407260|NCT01438177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102407261|NCT01438177|Antimalarials|antimalarials|mesh-ancestor
102407262|NCT01442779|Interferons|interferons|mesh-list
102407263|NCT01442779|Interferon-alpha|interferon-alpha|mesh-list
102407264|NCT01442779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102407265|NCT01442779|Antiviral Agents|antiviral agents|mesh-ancestor
102407266|NCT01442779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102407267|NCT01442779|Immunologic Factors|immunologic factors|mesh-ancestor
102407268|NCT01442779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407269|NCT01436201|Dulaglutide|dulaglutide|mesh-list
102407270|NCT01436201|Digoxin|digoxin|mesh-list
102407271|NCT01436201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102407272|NCT01436201|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102407273|NCT01436201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102407274|NCT01436201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407275|NCT01436201|Protective Agents|protective agents|mesh-ancestor
102407276|NCT01436201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407277|NCT01436201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102407278|NCT01437397|Bromides|bromides|mesh-list
102407279|NCT01437397|Formoterol Fumarate|formoterol fumarate|mesh-list
102407280|NCT01437397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102407281|NCT01437397|Autonomic Agents|autonomic agents|mesh-ancestor
102407282|NCT01437397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102407283|NCT01437397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407284|NCT01437397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102407285|NCT01437397|Respiratory System Agents|respiratory system agents|mesh-ancestor
102407286|NCT01437397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102407287|NCT01437397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102407288|NCT01437397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102407289|NCT01437397|Adrenergic Agents|adrenergic agents|mesh-ancestor
102407290|NCT01437397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102407291|NCT01437397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407292|NCT01437397|Anticonvulsants|anticonvulsants|mesh-ancestor
102407293|NCT04070833|Vitamin D|vitamin d|mesh-list
102407294|NCT04070833|Ergocalciferols|ergocalciferols|mesh-list
102407295|NCT04070833|Cholecalciferol|cholecalciferol|mesh-list
102407296|NCT04070833|Vitamins|vitamins|mesh-list
102407297|NCT04070833|Micronutrients|micronutrients|mesh-ancestor
102407298|NCT04070833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407299|NCT04070833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102407300|NCT04070833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102407301|NCT01442155|Capecitabine|capecitabine|mesh-list
102407302|NCT01442155|Oxaliplatin|oxaliplatin|mesh-list
102407303|NCT01442155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102407304|NCT01442155|Antimetabolites|antimetabolites|mesh-ancestor
102407305|NCT01442155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407306|NCT01442155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102407307|NCT01416181|Natalizumab|natalizumab|mesh-list
102407308|NCT01416181|Immunologic Factors|immunologic factors|mesh-ancestor
102407309|NCT01416181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407310|NCT03026023|Ribavirin|ribavirin|mesh-list
102407311|NCT03026023|Grazoprevir|grazoprevir|mesh-list
102407312|NCT03026023|Antimetabolites|antimetabolites|mesh-ancestor
102407313|NCT03026023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407314|NCT03026023|Antiviral Agents|antiviral agents|mesh-ancestor
102407315|NCT03026023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102407316|NCT01441765|Pidilizumab|pidilizumab|mesh-list
102407317|NCT01441765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102407318|NCT01441765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102407319|NCT01419665|Rituximab|rituximab|mesh-list
102407320|NCT01419665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102407321|NCT01419665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102407322|NCT01419665|Immunologic Factors|immunologic factors|mesh-ancestor
102407323|NCT01419665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407324|NCT01419665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102407325|NCT01436305|Mycophenolic Acid|mycophenolic acid|mesh-list
102407326|NCT01436305|Methylprednisolone|methylprednisolone|mesh-list
102407327|NCT01436305|Alemtuzumab|alemtuzumab|mesh-list
102407328|NCT01436305|Abatacept|abatacept|mesh-list
102407329|NCT01436305|Tacrolimus|tacrolimus|mesh-list
102407330|NCT01436305|Basiliximab|basiliximab|mesh-list
102407331|NCT01436305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102407332|NCT01436305|Immunologic Factors|immunologic factors|mesh-ancestor
102407333|NCT01436305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407334|NCT01436305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102407335|NCT01436305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102407336|NCT01436305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407337|NCT01436305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102407338|NCT01436305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102407339|NCT01436305|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102407340|NCT01436305|Antitubercular Agents|antitubercular agents|mesh-ancestor
102407341|NCT01436305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102407342|NCT01436305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102407343|NCT01436305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102407344|NCT01436305|Antiemetics|antiemetics|mesh-ancestor
102407345|NCT01436305|Autonomic Agents|autonomic agents|mesh-ancestor
102407346|NCT01436305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102407347|NCT01436305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102407348|NCT01436305|Glucocorticoids|glucocorticoids|mesh-ancestor
102407349|NCT01436305|Hormones|hormones|mesh-ancestor
102407350|NCT01436305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102407351|NCT01436305|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102407352|NCT01436305|Protective Agents|protective agents|mesh-ancestor
102407353|NCT01436305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102407354|NCT01436305|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102407355|NCT01436305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102407356|NCT01436149|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102407357|NCT01436149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102407358|NCT01436149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407359|NCT01436149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102407360|NCT01436149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102407361|NCT01436149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102407362|NCT01436149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407363|NCT01436149|Dopamine Agents|dopamine agents|mesh-ancestor
102407364|NCT01436149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102407365|NCT01415401|Timolol|timolol|mesh-list
102407366|NCT01415401|Brinzolamide|brinzolamide|mesh-list
102407367|NCT01415401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102407368|NCT01415401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407369|NCT01415401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102407370|NCT01415401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102407371|NCT01415401|Adrenergic Agents|adrenergic agents|mesh-ancestor
102407372|NCT01415401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102407373|NCT01415401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407374|NCT01415401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102038393|NCT05351151|Lidocaine|lidocaine|mesh-list
102407375|NCT01415401|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102407376|NCT01415401|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102407377|NCT01414855|Prednisone|prednisone|mesh-list
102407378|NCT01414855|Cyclophosphamide|cyclophosphamide|mesh-list
102407379|NCT01414855|Doxorubicin|doxorubicin|mesh-list
102407380|NCT01414855|Vincristine|vincristine|mesh-list
102407381|NCT01414855|Obinutuzumab|obinutuzumab|mesh-list
102407382|NCT01414855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102407383|NCT01414855|Immunologic Factors|immunologic factors|mesh-ancestor
102407384|NCT01414855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407385|NCT01414855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102407386|NCT01414855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102407387|NCT01414855|Alkylating Agents|alkylating agents|mesh-ancestor
102407388|NCT01414855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407389|NCT01414855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102407390|NCT01414855|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102407391|NCT01414855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102407392|NCT01414855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102407393|NCT01414855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102407394|NCT01414855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102407395|NCT01414855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102407396|NCT01414855|Glucocorticoids|glucocorticoids|mesh-ancestor
102407398|NCT01414855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102407399|NCT01414855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102407400|NCT01414855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102407401|NCT01414855|Tubulin Modulators|tubulin modulators|mesh-ancestor
102407402|NCT01414855|Antimitotic Agents|antimitotic agents|mesh-ancestor
102407403|NCT01414855|Mitosis Modulators|mitosis modulators|mesh-ancestor
102407404|NCT01414855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102407405|NCT02074735|Choline|choline|mesh-list
102407406|NCT02074735|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
102407407|NCT02074735|Lipotropic Agents|lipotropic agents|mesh-ancestor
102407408|NCT02074735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102407409|NCT02074735|Antimetabolites|antimetabolites|mesh-ancestor
102407410|NCT02074735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407411|NCT02074735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102407412|NCT02074735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102407413|NCT02074735|Nootropic Agents|nootropic agents|mesh-ancestor
102407414|NCT01527110|Zanamivir|zanamivir|mesh-list
102407415|NCT01527110|Antiviral Agents|antiviral agents|mesh-ancestor
102407416|NCT01527110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102407417|NCT01527110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102407418|NCT01527110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407419|NCT01441063|Zidovudine|zidovudine|mesh-list
102407420|NCT01441063|Valganciclovir|valganciclovir|mesh-list
102407421|NCT01441063|Antimetabolites|antimetabolites|mesh-ancestor
102407422|NCT01441063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407423|NCT01441063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102407424|NCT01441063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102407425|NCT01441063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102407426|NCT01441063|Antiviral Agents|antiviral agents|mesh-ancestor
102407427|NCT01441063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102407428|NCT01441063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102407429|NCT01441063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102407430|NCT01436071|Fluticasone|fluticasone|mesh-list
102407431|NCT01436071|Xhance|xhance|mesh-list
102407432|NCT01436071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102407433|NCT01436071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102407434|NCT01436071|Autonomic Agents|autonomic agents|mesh-ancestor
102407435|NCT01436071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102407436|NCT01436071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407437|NCT01436071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102407438|NCT01436071|Respiratory System Agents|respiratory system agents|mesh-ancestor
102407439|NCT01436071|Dermatologic Agents|dermatologic agents|mesh-ancestor
102407440|NCT01436071|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102407441|NCT01514864|Dasatinib|dasatinib|mesh-list
102407442|NCT01514864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102407443|NCT01514864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102407444|NCT01514864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102407445|NCT01514864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407446|NCT01514240|Mesalamine|mesalamine|mesh-list
102407447|NCT01514240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102407448|NCT01514240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102407449|NCT01514240|Analgesics|analgesics|mesh-ancestor
102407450|NCT01514240|Sensory System Agents|sensory system agents|mesh-ancestor
102407451|NCT01514240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102407452|NCT01514240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407453|NCT01514240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102407454|NCT01514240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102407455|NCT01435759|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102407456|NCT01435759|Antidepressive Agents|antidepressive agents|mesh-list
102407457|NCT01435759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102407458|NCT01435759|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102407459|NCT01435759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407460|NCT01435759|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102407461|NCT01435759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102407462|NCT01435759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102407463|NCT01435759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407464|NCT01435759|Dopamine Agents|dopamine agents|mesh-ancestor
102407465|NCT01435759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102407466|NCT04061239|Cytarabine|cytarabine|mesh-list
102407467|NCT04061239|Azacitidine|azacitidine|mesh-list
102407468|NCT04061239|Daunorubicin|daunorubicin|mesh-list
102407469|NCT04061239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102407470|NCT04061239|Antimetabolites|antimetabolites|mesh-ancestor
102407471|NCT04061239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407472|NCT04061239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102407474|NCT04061239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102407475|NCT04061239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102407476|NCT04061239|Immunologic Factors|immunologic factors|mesh-ancestor
102407477|NCT04061239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407478|NCT04061239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102407479|NCT04061239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102407480|NCT04061239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102407481|NCT04061239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102407482|NCT01393405|Methotrexate|methotrexate|mesh-list
102407483|NCT01393405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102407484|NCT01393405|Abortifacient Agents|abortifacient agents|mesh-ancestor
102407485|NCT01393405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102407486|NCT01393405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407487|NCT01393405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102407488|NCT01393405|Antimetabolites|antimetabolites|mesh-ancestor
102407489|NCT01393405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407490|NCT01393405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102407491|NCT01393405|Dermatologic Agents|dermatologic agents|mesh-ancestor
102407492|NCT01393405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102407493|NCT01393405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102407494|NCT01393405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102407495|NCT01393405|Immunologic Factors|immunologic factors|mesh-ancestor
102407496|NCT01393405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102407497|NCT01393405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102407498|NCT01419197|Trastuzumab|trastuzumab|mesh-list
102407499|NCT01419197|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102407500|NCT01419197|Maytansine|maytansine|mesh-list
102407501|NCT01419197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102407502|NCT01419197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102407503|NCT01419197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102407504|NCT01419197|Tubulin Modulators|tubulin modulators|mesh-ancestor
102407505|NCT01419197|Antimitotic Agents|antimitotic agents|mesh-ancestor
102407506|NCT01419197|Mitosis Modulators|mitosis modulators|mesh-ancestor
102407507|NCT01419197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407508|NCT01419197|Immunotoxins|immunotoxins|mesh-ancestor
102407509|NCT01419197|Immunoconjugates|immunoconjugates|mesh-ancestor
102407510|NCT01419197|Immunologic Factors|immunologic factors|mesh-ancestor
102407511|NCT01419197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407512|NCT01414075|Iron|iron|mesh-list
102407513|NCT01414075|Trace Elements|trace elements|mesh-ancestor
102407514|NCT01414075|Micronutrients|micronutrients|mesh-ancestor
102407515|NCT01414075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407516|NCT01513460|Glycopyrrolate|glycopyrrolate|mesh-list
102407517|NCT01513460|Tiotropium Bromide|tiotropium bromide|mesh-list
102407518|NCT01513460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102407519|NCT01513460|Autonomic Agents|autonomic agents|mesh-ancestor
102407520|NCT01513460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102407521|NCT01513460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407522|NCT01513460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102407523|NCT01513460|Respiratory System Agents|respiratory system agents|mesh-ancestor
102407524|NCT01513460|Parasympatholytics|parasympatholytics|mesh-ancestor
102407525|NCT01513460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102407526|NCT01513460|Cholinergic Agents|cholinergic agents|mesh-ancestor
102407527|NCT01513460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102407528|NCT01513460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407529|NCT01513460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102407530|NCT01513460|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102407531|NCT01418339|Aripiprazole|aripiprazole|mesh-list
102407532|NCT01418339|Antidepressive Agents|antidepressive agents|mesh-ancestor
102407533|NCT01418339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102407534|NCT01418339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102407535|NCT01418339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102407536|NCT01418339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102407537|NCT01418339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407538|NCT01418339|Dopamine Agonists|dopamine agonists|mesh-ancestor
102407539|NCT01418339|Dopamine Agents|dopamine agents|mesh-ancestor
102407540|NCT01418339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102407541|NCT01418339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407542|NCT01418339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102407543|NCT01418339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102407544|NCT01418339|Serotonin Agents|serotonin agents|mesh-ancestor
102407545|NCT01418339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102407546|NCT01418339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102407547|NCT01418339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102407548|NCT01418339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102407549|NCT01417481|Glycine|glycine|mesh-list
102407550|NCT01417481|Glycine Agents|glycine agents|mesh-ancestor
102407551|NCT01417481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102407552|NCT01417481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407553|NCT01417481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407554|NCT01392469|Imatinib Mesylate|imatinib mesylate|mesh-list
102407555|NCT01392469|Bosentan|bosentan|mesh-list
102407556|NCT01392469|Sildenafil Citrate|sildenafil citrate|mesh-list
102407557|NCT01392469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102407558|NCT01392469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102407559|NCT01392469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102407560|NCT01392469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407561|NCT01392469|Vasodilator Agents|vasodilator agents|mesh-ancestor
102407562|NCT01392469|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102407563|NCT01392469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102407564|NCT01392469|Urological Agents|urological agents|mesh-ancestor
102407565|NCT01392469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102407566|NCT01392469|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102407567|NCT01435577|Tapentadol|tapentadol|mesh-list
102407568|NCT01435577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102407569|NCT01435577|Narcotics|narcotics|mesh-ancestor
102407570|NCT01435577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102407571|NCT01435577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407572|NCT01435577|Analgesics|analgesics|mesh-ancestor
102407573|NCT01435577|Sensory System Agents|sensory system agents|mesh-ancestor
102407574|NCT01435577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102407575|NCT01435577|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102407576|NCT01435577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102407577|NCT01435577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102407578|NCT01435577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407579|NCT01435577|Adrenergic Agents|adrenergic agents|mesh-ancestor
102407580|NCT01435577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102407581|NCT04039087|Sildenafil Citrate|sildenafil citrate|mesh-list
102407582|NCT04039087|Vasodilator Agents|vasodilator agents|mesh-ancestor
102407583|NCT04039087|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102407584|NCT04039087|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102407585|NCT04039087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102407586|NCT04039087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407587|NCT04039087|Urological Agents|urological agents|mesh-ancestor
102407588|NCT01411891|Chlorhexidine|chlorhexidine|mesh-list
102407589|NCT01411891|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102407590|NCT01411891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102407591|NCT01411891|Disinfectants|disinfectants|mesh-ancestor
102407592|NCT01416389|Lenograstim|lenograstim|mesh-list
102407593|NCT01416389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102407594|NCT01416389|Immunologic Factors|immunologic factors|mesh-ancestor
102407595|NCT01416389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407596|NCT04497155|Norepinephrine|norepinephrine|mesh-list
102407597|NCT04497155|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102407598|NCT04497155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102407599|NCT04497155|Adrenergic Agents|adrenergic agents|mesh-ancestor
102407600|NCT04497155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102407601|NCT04497155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407602|NCT04497155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407603|NCT04497155|Sympathomimetics|sympathomimetics|mesh-ancestor
102407604|NCT04497155|Autonomic Agents|autonomic agents|mesh-ancestor
102407605|NCT04497155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102407606|NCT04497155|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102407607|NCT01544348|Omalizumab|omalizumab|mesh-list
102407608|NCT01544348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102407609|NCT01544348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102407610|NCT01544348|Respiratory System Agents|respiratory system agents|mesh-ancestor
102407611|NCT01416155|Natalizumab|natalizumab|mesh-list
102407612|NCT01416155|Immunologic Factors|immunologic factors|mesh-ancestor
102407613|NCT01416155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407614|NCT01415921|Bromides|bromides|mesh-list
102407615|NCT01415921|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
102407616|NCT01415921|Anticonvulsants|anticonvulsants|mesh-ancestor
102407617|NCT01415921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102407618|NCT01415921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102407619|NCT01415921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407620|NCT01415921|Cholinergic Agents|cholinergic agents|mesh-ancestor
102407621|NCT01415921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102407622|NCT01415921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407623|NCT01415531|Nebivolol|nebivolol|mesh-list
102407624|NCT01415531|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102407625|NCT01415531|Vasodilator Agents|vasodilator agents|mesh-ancestor
102407626|NCT01415531|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102407627|NCT01415531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102407628|NCT01415531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102407629|NCT01415531|Adrenergic Agents|adrenergic agents|mesh-ancestor
102407630|NCT01415531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102407631|NCT01415531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407632|NCT01415531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407633|NCT01544114|Naproxen|naproxen|mesh-list
102407634|NCT01544114|Esomeprazole|esomeprazole|mesh-list
102407635|NCT01544114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102407636|NCT01544114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102407637|NCT01544114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102407638|NCT01544114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102407639|NCT01544114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407640|NCT01544114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102407641|NCT01544114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102407642|NCT01544114|Analgesics|analgesics|mesh-ancestor
102407643|NCT01544114|Sensory System Agents|sensory system agents|mesh-ancestor
102407644|NCT01544114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102407645|NCT01544114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407646|NCT01544114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102407647|NCT01544114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102407648|NCT01544114|Gout Suppressants|gout suppressants|mesh-ancestor
102407649|NCT01544114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102407650|NCT01410799|Hormones|hormones|mesh-list
102407651|NCT01410799|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
102407652|NCT01410799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102407653|NCT01410799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407654|NCT01432171|Lacosamide|lacosamide|mesh-list
102407655|NCT01432171|Anticonvulsants|anticonvulsants|mesh-ancestor
102407656|NCT01432171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102407657|NCT01432171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102407658|NCT01432171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102407659|NCT01432171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407660|NCT04046263|Ferric Compounds|ferric compounds|mesh-list
102407661|NCT04046263|Hematinics|hematinics|mesh-ancestor
102407662|NCT01414205|Obinutuzumab|obinutuzumab|mesh-list
102407663|NCT01414205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102407664|NCT01414205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102407665|NCT01413503|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
102407666|NCT01413503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102407667|NCT01413503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102407668|NCT01413503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407669|NCT01413503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102407670|NCT01413191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102407671|NCT01413191|Immunologic Factors|immunologic factors|mesh-ancestor
102407672|NCT01413191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407673|NCT05021562|Niraparib|niraparib|mesh-list
102407674|NCT05021562|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102407675|NCT05021562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102407676|NCT05021562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407677|NCT05021562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102407678|NCT01412957|Panitumumab|panitumumab|mesh-list
102407679|NCT01412957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102407680|NCT01412957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102407681|NCT04973826|Aztreonam|aztreonam|mesh-list
102407682|NCT04973826|Avibactam|avibactam|mesh-list
102407683|NCT04973826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102407684|NCT04973826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102407685|NCT04973826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102407686|NCT04973826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102407687|NCT04973826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407688|NCT05387616|Obinutuzumab|obinutuzumab|mesh-list
102407689|NCT05387616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102407690|NCT05387616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102407691|NCT03025841|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
102407692|NCT03025841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102407693|NCT03025841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102407694|NCT01432457|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
102407695|NCT01432457|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102407696|NCT01432457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102407697|NCT01432457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102407698|NCT01432457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407699|NCT01432457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102407700|NCT01432457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407701|NCT01432457|Antidepressive Agents|antidepressive agents|mesh-ancestor
102407702|NCT01432457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102407703|NCT05062278|Hydroxyurea|hydroxyurea|mesh-list
102407704|NCT05062278|Vinblastine|vinblastine|mesh-list
102407705|NCT05062278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102407706|NCT05062278|Antisickling Agents|antisickling agents|mesh-ancestor
102407707|NCT05062278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102407708|NCT05062278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407709|NCT05062278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102407710|NCT05062278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102407711|NCT05062278|Tubulin Modulators|tubulin modulators|mesh-ancestor
102407712|NCT05062278|Antimitotic Agents|antimitotic agents|mesh-ancestor
102407713|NCT05062278|Mitosis Modulators|mitosis modulators|mesh-ancestor
102407714|NCT02823990|Nivolumab|nivolumab|mesh-list
102407715|NCT02823990|Interleukin-2|interleukin-2|mesh-list
102407716|NCT02823990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407717|NCT02823990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102407718|NCT02823990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102407719|NCT02823990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102407720|NCT02823990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407721|NCT02823990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102407722|NCT02823990|Analgesics|analgesics|mesh-ancestor
102407723|NCT02823990|Sensory System Agents|sensory system agents|mesh-ancestor
102407724|NCT02823990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102407725|NCT02427126|Aspirin|aspirin|mesh-list
102407726|NCT02427126|Apixaban|apixaban|mesh-list
102407727|NCT02427126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102407728|NCT02427126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102407729|NCT02427126|Analgesics|analgesics|mesh-ancestor
102407730|NCT02427126|Sensory System Agents|sensory system agents|mesh-ancestor
102407731|NCT02427126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102407732|NCT02427126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407733|NCT02427126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102407734|NCT02427126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102407735|NCT02427126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102407736|NCT02427126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102407737|NCT02427126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407738|NCT02427126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102407739|NCT02427126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102407740|NCT02427126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102407741|NCT02427126|Antipyretics|antipyretics|mesh-ancestor
102407742|NCT02427126|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102407743|NCT02427126|Antithrombins|antithrombins|mesh-ancestor
102407744|NCT02427126|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102407745|NCT02427126|Protease Inhibitors|protease inhibitors|mesh-ancestor
102407746|NCT02427126|Anticoagulants|anticoagulants|mesh-ancestor
102407747|NCT04807920|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102407748|NCT04807920|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102407749|NCT04807920|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102407750|NCT04807920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102407751|NCT04807920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407752|NCT04807920|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102407753|NCT04807920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102407754|NCT04807920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407755|NCT04807920|Cholinergic Agents|cholinergic agents|mesh-ancestor
102407756|NCT04807920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102407757|NCT00658515|Dalcetrapib|dalcetrapib|mesh-list
102407758|NCT00658515|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102407759|NCT00658515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102407760|NCT00658515|Antimetabolites|antimetabolites|mesh-ancestor
102407761|NCT00658515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407762|NCT00658515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102407763|NCT04797312|Sufentanil|sufentanil|mesh-list
102407764|NCT04797312|Remifentanil|remifentanil|mesh-list
102407765|NCT04797312|Analgesics, Opioid|analgesics, opioid|mesh-list
102407766|NCT04797312|Anesthetics|anesthetics|mesh-ancestor
102407767|NCT04797312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102407768|NCT04797312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407769|NCT04797312|Narcotics|narcotics|mesh-ancestor
102407770|NCT04797312|Analgesics|analgesics|mesh-ancestor
102407771|NCT04797312|Sensory System Agents|sensory system agents|mesh-ancestor
102407772|NCT04797312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102407773|NCT04797312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102407774|NCT04797312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102407775|NCT04797312|Anesthetics, General|anesthetics, general|mesh-ancestor
102407776|NCT05080140|Ezetimibe|ezetimibe|mesh-list
102407777|NCT05080140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102407778|NCT05080140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102407779|NCT05080140|Antimetabolites|antimetabolites|mesh-ancestor
102038798|NCT03671070|Autonomic Agents|autonomic agents|mesh-ancestor
102407780|NCT05080140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407781|NCT05080140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102407782|NCT01390441|Acetaminophen|acetaminophen|mesh-list
102407783|NCT01390441|Loratadine|loratadine|mesh-list
102407784|NCT01390441|Methylprednisolone|methylprednisolone|mesh-list
102407785|NCT01390441|Rituximab|rituximab|mesh-list
102407786|NCT01390441|Methotrexate|methotrexate|mesh-list
102407787|NCT01390441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102407788|NCT01390441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102407789|NCT01390441|Immunologic Factors|immunologic factors|mesh-ancestor
102407790|NCT01390441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407791|NCT01390441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102407792|NCT01390441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102407793|NCT01390441|Abortifacient Agents|abortifacient agents|mesh-ancestor
102407794|NCT01390441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102407795|NCT01390441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102407796|NCT01390441|Antimetabolites|antimetabolites|mesh-ancestor
102407797|NCT01390441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407798|NCT01390441|Dermatologic Agents|dermatologic agents|mesh-ancestor
102407799|NCT01390441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102407800|NCT01390441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102407801|NCT01390441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102407802|NCT01390441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102407803|NCT01390441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102407804|NCT01390441|Analgesics|analgesics|mesh-ancestor
102407805|NCT01390441|Sensory System Agents|sensory system agents|mesh-ancestor
102407806|NCT01390441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102407807|NCT01390441|Antipyretics|antipyretics|mesh-ancestor
102407808|NCT01390441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102407809|NCT01390441|Antiemetics|antiemetics|mesh-ancestor
102407810|NCT01390441|Autonomic Agents|autonomic agents|mesh-ancestor
102407811|NCT01390441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102407812|NCT01390441|Glucocorticoids|glucocorticoids|mesh-ancestor
102407813|NCT01390441|Hormones|hormones|mesh-ancestor
102407814|NCT01390441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102407815|NCT01390441|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102407816|NCT01390441|Protective Agents|protective agents|mesh-ancestor
102407817|NCT01390441|Antipruritics|antipruritics|mesh-ancestor
102407818|NCT01390441|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102407819|NCT01390441|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102407820|NCT01390441|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102407821|NCT01390441|Histamine Antagonists|histamine antagonists|mesh-ancestor
102407822|NCT01390441|Histamine Agents|histamine agents|mesh-ancestor
102407823|NCT01390441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102407824|NCT03142542|Udenafil|udenafil|mesh-list
102407825|NCT03142542|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102407826|NCT03142542|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102407827|NCT03142542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102407828|NCT03142542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407829|NCT03025867|Niraparib|niraparib|mesh-list
102407830|NCT03025867|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102407831|NCT03025867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102407832|NCT03025867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407833|NCT03025867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102407834|NCT01412879|Leucovorin|leucovorin|mesh-list
102407835|NCT01412879|Cytarabine|cytarabine|mesh-list
102407836|NCT01412879|Dexamethasone|dexamethasone|mesh-list
102407837|NCT01412879|Cyclophosphamide|cyclophosphamide|mesh-list
102407838|NCT01412879|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102407839|NCT01412879|Rituximab|rituximab|mesh-list
102407840|NCT01412879|Doxorubicin|doxorubicin|mesh-list
102407841|NCT01412879|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102407842|NCT01412879|Methotrexate|methotrexate|mesh-list
102219563|NCT04958967|Aflutinib|aflutinib|mesh-list
102407843|NCT01412879|Vincristine|vincristine|mesh-list
102407844|NCT01412879|Levoleucovorin|levoleucovorin|mesh-list
102407845|NCT01412879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102407846|NCT01412879|Immunologic Factors|immunologic factors|mesh-ancestor
102407847|NCT01412879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407848|NCT01412879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102407849|NCT01412879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102407850|NCT01412879|Alkylating Agents|alkylating agents|mesh-ancestor
102407851|NCT01412879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407852|NCT01412879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102407853|NCT01412879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102407854|NCT01412879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102407855|NCT01412879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102407856|NCT01412879|Antiemetics|antiemetics|mesh-ancestor
102407857|NCT01412879|Autonomic Agents|autonomic agents|mesh-ancestor
102407858|NCT01412879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102407859|NCT01412879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102407860|NCT01412879|Glucocorticoids|glucocorticoids|mesh-ancestor
102407861|NCT01412879|Hormones|hormones|mesh-ancestor
102407862|NCT01412879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102407863|NCT01412879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102407864|NCT01412879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102407865|NCT01412879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102407866|NCT01412879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102407867|NCT01412879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102407868|NCT01412879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102407869|NCT01412879|Abortifacient Agents|abortifacient agents|mesh-ancestor
102407870|NCT01412879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102407871|NCT01412879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102407872|NCT01412879|Antimetabolites|antimetabolites|mesh-ancestor
102407873|NCT01412879|Dermatologic Agents|dermatologic agents|mesh-ancestor
102407874|NCT01412879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102407875|NCT01412879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102407876|NCT01412879|Antiviral Agents|antiviral agents|mesh-ancestor
102407877|NCT01412879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102407878|NCT01412879|Antidotes|antidotes|mesh-ancestor
102407879|NCT01412879|Protective Agents|protective agents|mesh-ancestor
102407880|NCT01412879|Vitamin B Complex|vitamin b complex|mesh-ancestor
102407881|NCT01412879|Vitamins|vitamins|mesh-ancestor
102407882|NCT01412879|Micronutrients|micronutrients|mesh-ancestor
102407883|NCT01412879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102407884|NCT01412879|Tubulin Modulators|tubulin modulators|mesh-ancestor
102407885|NCT01412879|Antimitotic Agents|antimitotic agents|mesh-ancestor
102407886|NCT01412879|Mitosis Modulators|mitosis modulators|mesh-ancestor
102407887|NCT03143010|Dexmedetomidine|dexmedetomidine|mesh-list
102407888|NCT03143010|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102407889|NCT03143010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102407890|NCT03143010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407891|NCT03143010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102407892|NCT03143010|Analgesics|analgesics|mesh-ancestor
102407893|NCT03143010|Sensory System Agents|sensory system agents|mesh-ancestor
102407894|NCT03143010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102407895|NCT03143010|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102407896|NCT03143010|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102407897|NCT03143010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102407898|NCT03143010|Adrenergic Agents|adrenergic agents|mesh-ancestor
102407899|NCT03143010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102407900|NCT03143010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407901|NCT03142776|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102407902|NCT03142776|Clarithromycin|clarithromycin|mesh-list
102407903|NCT03142776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102407904|NCT03142776|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102407905|NCT03142776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102407906|NCT03142776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407907|NCT03142776|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102407908|NCT03142776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102407909|NCT01430611|Vaccines|vaccines|mesh-list
102407910|NCT01430611|Immunologic Factors|immunologic factors|mesh-ancestor
102407911|NCT01430611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407912|NCT03140826|Meropenem|meropenem|mesh-list
102407913|NCT03140826|Tazobactam|tazobactam|mesh-list
102407914|NCT03140826|Piperacillin|piperacillin|mesh-list
102407915|NCT03140826|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102407916|NCT03140826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102407917|NCT03140826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102219615|NCT02239120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102407918|NCT03140826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102407919|NCT03140826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102407920|NCT03140826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407921|NCT01389973|Ustekinumab|ustekinumab|mesh-list
102407922|NCT01389973|Dermatologic Agents|dermatologic agents|mesh-ancestor
102407924|NCT04529460|Immunologic Factors|immunologic factors|mesh-ancestor
102407925|NCT04529460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407926|NCT04032067|Finasteride|finasteride|mesh-list
102407927|NCT04032067|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102407928|NCT04032067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102407929|NCT04032067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102407930|NCT04032067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407931|NCT04032067|Hormone Antagonists|hormone antagonists|mesh-ancestor
102407932|NCT04032067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102407933|NCT04032067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407934|NCT04032067|Urological Agents|urological agents|mesh-ancestor
102407935|NCT00659295|Insulin Detemir|insulin detemir|mesh-list
102407936|NCT00659295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102407937|NCT00659295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407938|NCT01430455|Tranylcypromine|tranylcypromine|mesh-list
102407939|NCT01430455|Antidepressive Agents|antidepressive agents|mesh-ancestor
102407940|NCT01430455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102407941|NCT01430455|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102407942|NCT01430455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102407943|NCT01430455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407944|NCT01430455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102407945|NCT01430455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102407946|NCT01430455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102407947|NCT01430455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407948|NCT04051957|Isosorbide|isosorbide|mesh-list
102407949|NCT04051957|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
102407950|NCT04051957|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
102407951|NCT04051957|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102407952|NCT04051957|Diuretics|diuretics|mesh-ancestor
102407953|NCT04051957|Natriuretic Agents|natriuretic agents|mesh-ancestor
102407954|NCT04051957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407955|NCT04051957|Vasodilator Agents|vasodilator agents|mesh-ancestor
102407956|NCT04051957|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102407957|NCT04051957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407958|NCT00591123|Leucovorin|leucovorin|mesh-list
102407959|NCT00591123|Fluorouracil|fluorouracil|mesh-list
102407960|NCT00591123|Oxaliplatin|oxaliplatin|mesh-list
102407961|NCT00591123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102407962|NCT00591123|Levoleucovorin|levoleucovorin|mesh-list
102407963|NCT00591123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407964|NCT00591123|Antimetabolites|antimetabolites|mesh-ancestor
102407965|NCT00591123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407966|NCT00591123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102407967|NCT00591123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102407968|NCT00591123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102407969|NCT00591123|Immunologic Factors|immunologic factors|mesh-ancestor
102407970|NCT00591123|Antidotes|antidotes|mesh-ancestor
102407971|NCT00591123|Protective Agents|protective agents|mesh-ancestor
102407972|NCT00591123|Vitamin B Complex|vitamin b complex|mesh-ancestor
102407973|NCT00591123|Vitamins|vitamins|mesh-ancestor
102407974|NCT00591123|Micronutrients|micronutrients|mesh-ancestor
102407975|NCT00591123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102407976|NCT00591123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102407977|NCT04149990|Valsartan|valsartan|mesh-list
102407978|NCT04149990|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102407979|NCT04149990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102407980|NCT04149990|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102407981|NCT04149990|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102407982|NCT04149990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407983|NCT00591825|Cycloserine|cycloserine|mesh-list
102407984|NCT00591825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102407985|NCT00591825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102407986|NCT00591825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102407987|NCT00591825|Antitubercular Agents|antitubercular agents|mesh-ancestor
102407988|NCT00591825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102407989|NCT00591825|Antimetabolites|antimetabolites|mesh-ancestor
102407990|NCT00591825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102407991|NCT01429285|Hydromorphone|hydromorphone|mesh-list
102407992|NCT01429285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102407993|NCT01429285|Narcotics|narcotics|mesh-ancestor
102407994|NCT01429285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102407995|NCT01429285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102407996|NCT01429285|Analgesics|analgesics|mesh-ancestor
102407997|NCT01429285|Sensory System Agents|sensory system agents|mesh-ancestor
102407998|NCT01429285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102407999|NCT00594945|Clonazepam|clonazepam|mesh-list
102408000|NCT00594945|Anticonvulsants|anticonvulsants|mesh-ancestor
102408001|NCT00594945|GABA Modulators|gaba modulators|mesh-ancestor
102408002|NCT00594945|GABA Agents|gaba agents|mesh-ancestor
102408003|NCT00594945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102408004|NCT00594945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408005|NCT00594945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408006|NCT00595101|Latanoprost|latanoprost|mesh-list
102408007|NCT00595101|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102408008|NCT00595101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102408009|NCT00660075|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102408010|NCT00660075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102408011|NCT00660075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408012|NCT00660075|Incretins|incretins|mesh-ancestor
102408013|NCT00660075|Hormones|hormones|mesh-ancestor
102408014|NCT00660075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102039047|NCT03668262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102408015|NCT00660075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102408016|NCT00660075|Protease Inhibitors|protease inhibitors|mesh-ancestor
102408017|NCT00660075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102408018|NCT00660075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408019|NCT05174052|Dapagliflozin|dapagliflozin|mesh-list
102408020|NCT05174052|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102408021|NCT05174052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408022|NCT05174052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102408023|NCT05174052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408024|NCT01429051|Fentanyl|fentanyl|mesh-list
102408025|NCT01429051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102408026|NCT01429051|Narcotics|narcotics|mesh-ancestor
102408027|NCT01429051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102408028|NCT01429051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408029|NCT01429051|Analgesics|analgesics|mesh-ancestor
102408030|NCT01429051|Sensory System Agents|sensory system agents|mesh-ancestor
102408031|NCT01429051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102408032|NCT01429051|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102408033|NCT01429051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102408034|NCT01429051|Anesthetics, General|anesthetics, general|mesh-ancestor
102408035|NCT01429051|Anesthetics|anesthetics|mesh-ancestor
102408036|NCT03968562|Doxycycline|doxycycline|mesh-list
102408037|NCT03968562|Petrolatum|petrolatum|mesh-list
102408038|NCT03968562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102408039|NCT03968562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102408040|NCT03968562|Antimalarials|antimalarials|mesh-ancestor
102408041|NCT03968562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102408042|NCT03968562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102408043|NCT03968562|Emollients|emollients|mesh-ancestor
102408044|NCT03968562|Dermatologic Agents|dermatologic agents|mesh-ancestor
102408045|NCT03425292|Bevacizumab|bevacizumab|mesh-list
102408046|NCT03425292|Nivolumab|nivolumab|mesh-list
102408047|NCT03425292|Ipilimumab|ipilimumab|mesh-list
102408048|NCT03425292|Temozolomide|temozolomide|mesh-list
102408049|NCT03425292|Lomustine|lomustine|mesh-list
102408050|NCT03425292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102408051|NCT03425292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102408052|NCT03425292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102408053|NCT03425292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102408054|NCT03425292|Growth Substances|growth substances|mesh-ancestor
102408055|NCT03425292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408056|NCT03425292|Growth Inhibitors|growth inhibitors|mesh-ancestor
102408057|NCT03425292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102408058|NCT03425292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408059|NCT03425292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102408060|NCT03425292|Alkylating Agents|alkylating agents|mesh-ancestor
102408061|NCT00596271|Vaccines|vaccines|mesh-list
102408062|NCT00596271|Immunologic Factors|immunologic factors|mesh-ancestor
102408063|NCT00596271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408064|NCT03139422|Tranexamic Acid|tranexamic acid|mesh-list
102408065|NCT03139422|Calcium Dobesilate|calcium dobesilate|mesh-list
102408066|NCT03139422|Calcium|calcium|mesh-list
102408067|NCT03139422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102408068|NCT03139422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408069|NCT03139422|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102408070|NCT03139422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102408071|NCT03139422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408072|NCT03139422|Hemostatics|hemostatics|mesh-ancestor
102408073|NCT03139422|Coagulants|coagulants|mesh-ancestor
102408074|NCT01428583|Naltrexone|naltrexone|mesh-list
102408075|NCT01428583|Oxycodone|oxycodone|mesh-list
102408076|NCT01428583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102408077|NCT01428583|Narcotics|narcotics|mesh-ancestor
102408078|NCT01428583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102408079|NCT01428583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408080|NCT01428583|Analgesics|analgesics|mesh-ancestor
102408081|NCT01428583|Sensory System Agents|sensory system agents|mesh-ancestor
102408082|NCT01428583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102408083|NCT01428583|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102408084|NCT01428583|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102408085|NCT00660543|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102408086|NCT00660543|Hematinics|hematinics|mesh-ancestor
102408087|NCT00660543|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102408088|NCT00660543|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102408089|NCT01428193|Flutamide|flutamide|mesh-list
102408090|NCT01428193|Estradiol|estradiol|mesh-list
102408091|NCT01428193|Progesterone|progesterone|mesh-list
102408092|NCT01428193|Estrogens|estrogens|mesh-ancestor
102408093|NCT01428193|Hormones|hormones|mesh-ancestor
102408094|NCT01428193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102408095|NCT01428193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408096|NCT01428193|Progestins|progestins|mesh-ancestor
102408097|NCT01428193|Androgen Antagonists|androgen antagonists|mesh-ancestor
102408098|NCT01428193|Hormone Antagonists|hormone antagonists|mesh-ancestor
102408099|NCT01428193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102408100|NCT01428193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102408101|NCT03864276|Propofol|propofol|mesh-list
102408102|NCT03864276|Desflurane|desflurane|mesh-list
102408103|NCT03864276|Anesthetics|anesthetics|mesh-ancestor
102408104|NCT03864276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102408105|NCT03864276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408106|NCT03864276|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102408107|NCT03864276|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102408108|NCT03864276|Anesthetics, General|anesthetics, general|mesh-ancestor
102408109|NCT03864276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102408110|NCT05083026|Antibodies|antibodies|mesh-list
102408111|NCT05083026|Antibodies, Blocking|antibodies, blocking|mesh-list
102408112|NCT05083026|Immunologic Factors|immunologic factors|mesh-ancestor
102408113|NCT05083026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408114|NCT03141918|Curcumin|curcumin|mesh-list
102408115|NCT03141918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102408116|NCT03141918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102408117|NCT03141918|Analgesics|analgesics|mesh-ancestor
102408118|NCT03141918|Sensory System Agents|sensory system agents|mesh-ancestor
102408119|NCT03141918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102408120|NCT03141918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408121|NCT03141918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102408122|NCT03141918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102408123|NCT03141918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102408124|NCT03141918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102408125|NCT03141918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408126|NCT01427803|Naproxen|naproxen|mesh-list
102408127|NCT01427803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102408128|NCT01427803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102408129|NCT01427803|Analgesics|analgesics|mesh-ancestor
102408130|NCT01427803|Sensory System Agents|sensory system agents|mesh-ancestor
102408131|NCT01427803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102408132|NCT01427803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408133|NCT01427803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102039175|NCT02924688|Tocolytic Agents|tocolytic agents|mesh-ancestor
102408134|NCT01427803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102408135|NCT01427803|Gout Suppressants|gout suppressants|mesh-ancestor
102408136|NCT01427803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102408137|NCT01427803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102408138|NCT01427803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408139|NCT03139500|Midazolam|midazolam|mesh-list
102408140|NCT03139500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102408141|NCT03139500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102408142|NCT03139500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102408143|NCT03139500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408144|NCT03139500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102408145|NCT03139500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102408146|NCT03139500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102408147|NCT03139500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102408148|NCT03139500|Anesthetics, General|anesthetics, general|mesh-ancestor
102408149|NCT03139500|Anesthetics|anesthetics|mesh-ancestor
102408150|NCT03139500|GABA Modulators|gaba modulators|mesh-ancestor
102408151|NCT03139500|GABA Agents|gaba agents|mesh-ancestor
102408152|NCT03139500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102408153|NCT03139500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408154|NCT00661479|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102408155|NCT00661479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102408156|NCT00661479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102408157|NCT00661479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102408158|NCT00661479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102408159|NCT00661479|Adrenergic Agents|adrenergic agents|mesh-ancestor
102408160|NCT00661479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102408161|NCT00661479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408162|NCT00661479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408163|NCT04476966|Mirabegron|mirabegron|mesh-list
102408164|NCT04476966|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102408165|NCT04476966|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102408166|NCT04476966|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102408167|NCT04476966|Adrenergic Agents|adrenergic agents|mesh-ancestor
102408168|NCT04476966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102408169|NCT04476966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408170|NCT04476966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408171|NCT04476966|Urological Agents|urological agents|mesh-ancestor
102408172|NCT03821610|Cyclophosphamide|cyclophosphamide|mesh-list
102408173|NCT03821610|Melphalan|melphalan|mesh-list
102408174|NCT03821610|Fludarabine|fludarabine|mesh-list
102408175|NCT03821610|Alemtuzumab|alemtuzumab|mesh-list
102408176|NCT03821610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102408177|NCT03821610|Immunologic Factors|immunologic factors|mesh-ancestor
102408178|NCT03821610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408179|NCT03821610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102408180|NCT03821610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102408181|NCT03821610|Alkylating Agents|alkylating agents|mesh-ancestor
102408182|NCT03821610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408183|NCT03821610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102408184|NCT03821610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102408185|NCT03821610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102408186|NCT00683163|Ibandronic Acid|ibandronic acid|mesh-list
102408187|NCT00683163|Parathyroid Hormone|parathyroid hormone|mesh-list
102408188|NCT00683163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102408189|NCT00683163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408190|NCT00683163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102408191|NCT04044001|Isoniazid|isoniazid|mesh-list
102408192|NCT04044001|Pyrazinamide|pyrazinamide|mesh-list
102408193|NCT04044001|Ethambutol|ethambutol|mesh-list
102408194|NCT04044001|Dolutegravir|dolutegravir|mesh-list
102408195|NCT04044001|Antitubercular Agents|antitubercular agents|mesh-ancestor
102408196|NCT04044001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102408197|NCT04044001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102408198|NCT04044001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102408199|NCT04044001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408200|NCT04044001|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102408201|NCT04044001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102408202|NCT04044001|Antimetabolites|antimetabolites|mesh-ancestor
102408203|NCT04044001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102408204|NCT04044001|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102408205|NCT04044001|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102408206|NCT04044001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102408207|NCT04044001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102408208|NCT04044001|Antiviral Agents|antiviral agents|mesh-ancestor
102408209|NCT00684723|Lovastatin|lovastatin|mesh-list
102408210|NCT00684723|L 647318|l 647318|mesh-list
102408211|NCT00684723|Dihydromevinolin|dihydromevinolin|mesh-list
102408212|NCT00684723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102408213|NCT00684723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102408214|NCT00684723|Antimetabolites|antimetabolites|mesh-ancestor
102408215|NCT00684723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408216|NCT00684723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102408217|NCT00684723|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102408218|NCT00684723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102408219|NCT01405027|Interferons|interferons|mesh-list
102408220|NCT01405027|Ribavirin|ribavirin|mesh-list
102408221|NCT01405027|Interferon-alpha|interferon-alpha|mesh-list
102408222|NCT01405027|Interferon alpha-2|interferon alpha-2|mesh-list
102408223|NCT01405027|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102408224|NCT01405027|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102408225|NCT01405027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102408226|NCT01405027|Antiviral Agents|antiviral agents|mesh-ancestor
102408227|NCT01405027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102408228|NCT01405027|Antimetabolites|antimetabolites|mesh-ancestor
102408229|NCT01405027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408230|NCT01405027|Immunologic Factors|immunologic factors|mesh-ancestor
102408231|NCT01405027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408232|NCT00663039|Oxytocin|oxytocin|mesh-list
102408233|NCT00663039|Oxytocics|oxytocics|mesh-ancestor
102408234|NCT00663039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102408235|NCT00663039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408236|NCT04387539|Sofosbuvir|sofosbuvir|mesh-list
102408237|NCT04387539|Simeprevir|simeprevir|mesh-list
102408238|NCT04387539|Antiviral Agents|antiviral agents|mesh-ancestor
102408239|NCT04387539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102408240|NCT04387539|Protease Inhibitors|protease inhibitors|mesh-ancestor
102408241|NCT04387539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102408242|NCT04387539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408243|NCT00664755|Nicotine|nicotine|mesh-list
102408244|NCT00664755|Varenicline|varenicline|mesh-list
102408245|NCT00664755|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102408246|NCT00664755|Autonomic Agents|autonomic agents|mesh-ancestor
102408247|NCT00664755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102408248|NCT00664755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408249|NCT00664755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102408250|NCT00664755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102408251|NCT00664755|Cholinergic Agents|cholinergic agents|mesh-ancestor
102408252|NCT00664755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102408253|NCT00664755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408254|NCT01525628|Tolbutamide|tolbutamide|mesh-list
102408255|NCT01525628|Interferons|interferons|mesh-list
102408256|NCT01525628|Tenofovir|tenofovir|mesh-list
102408257|NCT01525628|Ribavirin|ribavirin|mesh-list
102408258|NCT01525628|Midazolam|midazolam|mesh-list
102408259|NCT01525628|Caffeine|caffeine|mesh-list
102408260|NCT01525628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102408261|NCT01525628|Antiviral Agents|antiviral agents|mesh-ancestor
102408262|NCT01525628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102408263|NCT01525628|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102408264|NCT01525628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102039279|NCT03003000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102408265|NCT01525628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102408266|NCT01525628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408267|NCT01525628|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102408268|NCT01525628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102408269|NCT01525628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102408270|NCT01525628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102408271|NCT01525628|Anesthetics, General|anesthetics, general|mesh-ancestor
102408272|NCT01525628|Anesthetics|anesthetics|mesh-ancestor
102408273|NCT01525628|GABA Modulators|gaba modulators|mesh-ancestor
102408274|NCT01525628|GABA Agents|gaba agents|mesh-ancestor
102408275|NCT01525628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102408276|NCT01525628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408277|NCT01525628|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102408278|NCT01525628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102408279|NCT01525628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102408280|NCT01525628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102408281|NCT01525628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102408282|NCT01525628|Antimetabolites|antimetabolites|mesh-ancestor
102408283|NCT01525628|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102408284|NCT01525628|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102408285|NCT01525628|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102408286|NCT01525628|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102408287|NCT01525628|Purinergic Agents|purinergic agents|mesh-ancestor
102408288|NCT01525628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102408289|NCT00665457|Celecoxib|celecoxib|mesh-list
102408290|NCT00665457|Cyclophosphamide|cyclophosphamide|mesh-list
102408291|NCT00665457|Docetaxel|docetaxel|mesh-list
102408292|NCT00665457|Doxorubicin|doxorubicin|mesh-list
102408293|NCT00665457|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102408294|NCT00665457|Capecitabine|capecitabine|mesh-list
102408295|NCT00665457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102408296|NCT00665457|Immunologic Factors|immunologic factors|mesh-ancestor
102408297|NCT00665457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408298|NCT00665457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102408299|NCT00665457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102408300|NCT00665457|Alkylating Agents|alkylating agents|mesh-ancestor
102408301|NCT00665457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408302|NCT00665457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102408303|NCT00665457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102408304|NCT00665457|Tubulin Modulators|tubulin modulators|mesh-ancestor
102408305|NCT00665457|Antimitotic Agents|antimitotic agents|mesh-ancestor
102408306|NCT00665457|Mitosis Modulators|mitosis modulators|mesh-ancestor
102408307|NCT00665457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102408308|NCT00665457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102408309|NCT00665457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102408310|NCT00665457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102408311|NCT00665457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102408312|NCT00665457|Antimetabolites|antimetabolites|mesh-ancestor
102408313|NCT00665457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102408314|NCT00665457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102408315|NCT00665457|Analgesics|analgesics|mesh-ancestor
102408316|NCT00665457|Sensory System Agents|sensory system agents|mesh-ancestor
102408317|NCT00665457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102408318|NCT00665457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102408319|NCT00665457|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102408320|NCT00665457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102408321|NCT02320695|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102039349|NCT05178953|Zinc|zinc|mesh-list
102408322|NCT02320695|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
102408324|NCT02320695|Neomycin|neomycin|mesh-list
102408325|NCT02320695|Polymyxin B|polymyxin b|mesh-list
102408326|NCT02320695|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102408327|NCT02320695|Ethanol|ethanol|mesh-list
102408328|NCT02320695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102408329|NCT02320695|Antitubercular Agents|antitubercular agents|mesh-ancestor
102408330|NCT02320695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102408331|NCT02320695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102408332|NCT02320695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408333|NCT02320695|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102408334|NCT02320695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102408335|NCT02320695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408336|NCT01426009|Bromides|bromides|mesh-list
102408337|NCT01426009|Tiotropium Bromide|tiotropium bromide|mesh-list
102408338|NCT01426009|Ipratropium|ipratropium|mesh-list
102408339|NCT01426009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102408340|NCT01426009|Autonomic Agents|autonomic agents|mesh-ancestor
102408341|NCT01426009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102408342|NCT01426009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408343|NCT01426009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102408344|NCT01426009|Respiratory System Agents|respiratory system agents|mesh-ancestor
102408345|NCT01426009|Parasympatholytics|parasympatholytics|mesh-ancestor
102408346|NCT01426009|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102408347|NCT01426009|Cholinergic Agents|cholinergic agents|mesh-ancestor
102408348|NCT01426009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102408349|NCT01426009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408350|NCT01426009|Anticonvulsants|anticonvulsants|mesh-ancestor
102408351|NCT01543958|Sevelamer|sevelamer|mesh-list
102408352|NCT01543958|Chelating Agents|chelating agents|mesh-ancestor
102408353|NCT01543958|Sequestering Agents|sequestering agents|mesh-ancestor
102408354|NCT01543958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408355|NCT04880928|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102408356|NCT04880928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102408357|NCT01411085|Risperidone|risperidone|mesh-list
102408358|NCT01411085|Desipramine|desipramine|mesh-list
102408359|NCT01411085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102408360|NCT01411085|Serotonin Agents|serotonin agents|mesh-ancestor
102408361|NCT01411085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102408362|NCT01411085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408363|NCT01411085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408364|NCT01411085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102408365|NCT01411085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102408366|NCT01411085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102408367|NCT01411085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102408368|NCT01411085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102408369|NCT01411085|Dopamine Agents|dopamine agents|mesh-ancestor
102408370|NCT01411085|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102408371|NCT01411085|Antidepressive Agents|antidepressive agents|mesh-ancestor
102408372|NCT01411085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102408373|NCT01411085|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102408374|NCT01411085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102408375|NCT01411085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102408376|NCT01411085|Adrenergic Agents|adrenergic agents|mesh-ancestor
102408377|NCT01404949|Arsenic Trioxide|arsenic trioxide|mesh-list
102408378|NCT01404949|Tretinoin|tretinoin|mesh-list
102408379|NCT01404949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102408380|NCT01404949|Keratolytic Agents|keratolytic agents|mesh-ancestor
102408381|NCT01404949|Dermatologic Agents|dermatologic agents|mesh-ancestor
102408382|NCT01431521|Pioglitazone|pioglitazone|mesh-list
102408383|NCT01431521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102408384|NCT01431521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408385|NCT00601965|Escitalopram|escitalopram|mesh-list
102408386|NCT00601965|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102408387|NCT00601965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102408388|NCT00601965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102408389|NCT00601965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408390|NCT00601965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102408391|NCT00601965|Serotonin Agents|serotonin agents|mesh-ancestor
102408392|NCT00601965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408393|NCT04751994|Sorbitol|sorbitol|mesh-list
102408394|NCT04751994|Cathartics|cathartics|mesh-ancestor
102408395|NCT04751994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102408396|NCT00687453|Insulin Glargine|insulin glargine|mesh-list
102408397|NCT00687453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102408398|NCT00687453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408399|NCT00602043|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102408400|NCT00602043|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102408401|NCT00602043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408402|NCT02998437|Amoxicillin|amoxicillin|mesh-list
102408403|NCT02998437|Clarithromycin|clarithromycin|mesh-list
102408404|NCT02998437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102408405|NCT02998437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102408406|NCT02998437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102408407|NCT02998437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102408408|NCT02998437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408409|NCT02998437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102408410|NCT02998437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102408411|NCT02618148|Estrogens|estrogens|mesh-list
102408412|NCT02618148|Hormones|hormones|mesh-ancestor
102408413|NCT02618148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102408414|NCT02618148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408415|NCT04680936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102408416|NCT01404325|Everolimus|everolimus|mesh-list
102408417|NCT01404325|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102408418|NCT01404325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102408419|NCT01404325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102408420|NCT01404325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408421|NCT01404325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102408422|NCT01404325|Immunologic Factors|immunologic factors|mesh-ancestor
102408423|NCT01404325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408424|NCT01404325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102408425|NCT00602355|Sertraline|sertraline|mesh-list
102408426|NCT00602355|Antidepressive Agents|antidepressive agents|mesh-ancestor
102408427|NCT00602355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102408428|NCT00602355|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102408429|NCT00602355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102408430|NCT00602355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102408431|NCT00602355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408432|NCT00602355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102408433|NCT00602355|Serotonin Agents|serotonin agents|mesh-ancestor
102408434|NCT00602355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408435|NCT01425463|Glycine|glycine|mesh-list
102408436|NCT01425463|Glycine Agents|glycine agents|mesh-ancestor
102408437|NCT01425463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102408438|NCT01425463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408439|NCT01425463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408440|NCT02144259|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102408441|NCT02144259|Medroxyprogesterone|medroxyprogesterone|mesh-list
102408442|NCT02144259|Etonogestrel|etonogestrel|mesh-list
102408443|NCT02144259|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102408444|NCT02144259|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102408445|NCT02144259|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102408446|NCT02144259|Contraceptive Agents|contraceptive agents|mesh-ancestor
102408447|NCT02144259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102220140|NCT02307695|Protease Inhibitors|protease inhibitors|mesh-ancestor
102408448|NCT02144259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408449|NCT02144259|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102408450|NCT02144259|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102408451|NCT02144259|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102408452|NCT02144259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102408453|NCT02144259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102408454|NCT04655586|Heparin|heparin|mesh-list
102408455|NCT04655586|Protein C|protein c|mesh-list
102408456|NCT04655586|Anticoagulants|anticoagulants|mesh-list
102408457|NCT04655586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102408458|NCT04655586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102408459|NCT04655586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408460|NCT01388647|Carboplatin|carboplatin|mesh-list
102408461|NCT01388647|Trastuzumab|trastuzumab|mesh-list
102408462|NCT01388647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102408463|NCT01388647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102408464|NCT03140982|Propofol|propofol|mesh-list
102408465|NCT03140982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102408466|NCT03140982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102408467|NCT03140982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408468|NCT03140982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102408469|NCT03140982|Anesthetics, General|anesthetics, general|mesh-ancestor
102408470|NCT03140982|Anesthetics|anesthetics|mesh-ancestor
102408471|NCT05392686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102408472|NCT05392686|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102408473|NCT05392686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408474|NCT05392686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102408475|NCT05392686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102408476|NCT05392686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102408477|NCT00705003|Melatonin|melatonin|mesh-list
102408478|NCT00705003|Buspirone|buspirone|mesh-list
102408479|NCT00705003|Antioxidants|antioxidants|mesh-ancestor
102408480|NCT00705003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408481|NCT00705003|Protective Agents|protective agents|mesh-ancestor
102408482|NCT00705003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408483|NCT00705003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102408484|NCT00705003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102408485|NCT00705003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102408486|NCT00705003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102408487|NCT00705003|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102408488|NCT00705003|Serotonin Agents|serotonin agents|mesh-ancestor
102408489|NCT00705003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102408490|NCT03110640|Cyclophosphamide|cyclophosphamide|mesh-list
102408491|NCT03110640|Fludarabine|fludarabine|mesh-list
102408492|NCT03110640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102408493|NCT03110640|Immunologic Factors|immunologic factors|mesh-ancestor
102408494|NCT03110640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408495|NCT03110640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102408496|NCT03110640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102408497|NCT03110640|Alkylating Agents|alkylating agents|mesh-ancestor
102408498|NCT03110640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408499|NCT03110640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102408500|NCT03110640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102408501|NCT00690495|Propofol|propofol|mesh-list
102408502|NCT00690495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102408503|NCT00690495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102408504|NCT00690495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408505|NCT00690495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102408506|NCT00690495|Anesthetics, General|anesthetics, general|mesh-ancestor
102408507|NCT00690495|Anesthetics|anesthetics|mesh-ancestor
102408508|NCT00691197|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102408509|NCT00691197|Glycerol|glycerol|mesh-list
102408510|NCT00691197|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102408511|NCT00691197|Protective Agents|protective agents|mesh-ancestor
102408512|NCT00691197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408513|NCT00691197|Laxatives|laxatives|mesh-ancestor
102408514|NCT00691197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102408515|NCT02997969|Vaccines|vaccines|mesh-list
102408516|NCT02997969|MF59 oil emulsion|mf59 oil emulsion|mesh-list
102408517|NCT02997969|Immunologic Factors|immunologic factors|mesh-ancestor
102408518|NCT02997969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408519|NCT02997969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102408520|NCT04351230|Trastuzumab|trastuzumab|mesh-list
102408521|NCT04351230|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102408522|NCT04351230|Maytansine|maytansine|mesh-list
102220219|NCT05108974|Choline|choline|mesh-list
102408523|NCT04351230|Immunoconjugates|immunoconjugates|mesh-list
102408524|NCT04351230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102408525|NCT04351230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102408526|NCT04351230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102408527|NCT04351230|Tubulin Modulators|tubulin modulators|mesh-ancestor
102408528|NCT04351230|Antimitotic Agents|antimitotic agents|mesh-ancestor
102408529|NCT04351230|Mitosis Modulators|mitosis modulators|mesh-ancestor
102408530|NCT04351230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408532|NCT04351230|Immunologic Factors|immunologic factors|mesh-ancestor
102408533|NCT04351230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408534|NCT05392374|TIC10 compound|tic10 compound|mesh-list
102408535|NCT05392374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102408536|NCT04028388|Docetaxel|docetaxel|mesh-list
102408537|NCT04028388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102408538|NCT04028388|Tubulin Modulators|tubulin modulators|mesh-ancestor
102408539|NCT04028388|Antimitotic Agents|antimitotic agents|mesh-ancestor
102408540|NCT04028388|Mitosis Modulators|mitosis modulators|mesh-ancestor
102408541|NCT04028388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408542|NCT01402063|Temozolomide|temozolomide|mesh-list
102408543|NCT01402063|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
102408544|NCT01402063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102408545|NCT01402063|Alkylating Agents|alkylating agents|mesh-ancestor
102408546|NCT01402063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408547|NCT01402063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102408548|NCT01796301|Teriparatide|teriparatide|mesh-list
102408549|NCT01796301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102408550|NCT01796301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408551|NCT01796301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102408552|NCT00868179|Dabigatran|dabigatran|mesh-list
102408553|NCT00868179|Antithrombins|antithrombins|mesh-ancestor
102408554|NCT00868179|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102408555|NCT00868179|Protease Inhibitors|protease inhibitors|mesh-ancestor
102408556|NCT00868179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102408557|NCT00868179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408558|NCT00868179|Anticoagulants|anticoagulants|mesh-ancestor
102408559|NCT01204905|Raltegravir Potassium|raltegravir potassium|mesh-list
102408560|NCT01204905|Maraviroc|maraviroc|mesh-list
102408561|NCT01204905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102408562|NCT01204905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102408563|NCT01204905|Antiviral Agents|antiviral agents|mesh-ancestor
102408564|NCT01204905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102408565|NCT01204905|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102408566|NCT01204905|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102408567|NCT01204905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102408568|NCT01204905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408569|NCT01204905|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102408570|NCT01204905|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102408571|NCT01204905|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102408572|NCT00691665|Fluticasone|fluticasone|mesh-list
102408573|NCT00691665|Xhance|xhance|mesh-list
102408574|NCT00691665|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
102408575|NCT00691665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102408576|NCT00691665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102408577|NCT00691665|Autonomic Agents|autonomic agents|mesh-ancestor
102408578|NCT00691665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102408579|NCT00691665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408580|NCT00691665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102408581|NCT00691665|Respiratory System Agents|respiratory system agents|mesh-ancestor
102408582|NCT00691665|Dermatologic Agents|dermatologic agents|mesh-ancestor
102408583|NCT00691665|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102408584|NCT00691665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102408585|NCT00691665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102408586|NCT00691665|Analgesics|analgesics|mesh-ancestor
102408587|NCT00691665|Sensory System Agents|sensory system agents|mesh-ancestor
102408588|NCT00691665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102408589|NCT00691665|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102408590|NCT00691665|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102408591|NCT00691665|Histamine Antagonists|histamine antagonists|mesh-ancestor
102408592|NCT00691665|Histamine Agents|histamine agents|mesh-ancestor
102408593|NCT00691665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102408594|NCT00691665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408595|NCT01388335|Warfarin|warfarin|mesh-list
102408596|NCT01388335|Anticoagulants|anticoagulants|mesh-ancestor
102408597|NCT00713583|Levodopa|levodopa|mesh-list
102408598|NCT00713583|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102408599|NCT00713583|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102408600|NCT00713583|Dopamine Agents|dopamine agents|mesh-ancestor
102408601|NCT00713583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102408602|NCT00713583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408603|NCT00713583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408604|NCT03359460|Lenalidomide|lenalidomide|mesh-list
102408605|NCT03359460|Immunologic Factors|immunologic factors|mesh-ancestor
102408606|NCT03359460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408607|NCT03359460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102408608|NCT03359460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102408609|NCT03359460|Growth Substances|growth substances|mesh-ancestor
102408610|NCT03359460|Growth Inhibitors|growth inhibitors|mesh-ancestor
102408611|NCT03359460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102408612|NCT03025477|Paclitaxel|paclitaxel|mesh-list
102408613|NCT03025477|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102408614|NCT03025477|Cisplatin|cisplatin|mesh-list
102408615|NCT03025477|Carboplatin|carboplatin|mesh-list
102408616|NCT03025477|Epirubicin|epirubicin|mesh-list
102408617|NCT03025477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102408618|NCT03025477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102408619|NCT03025477|Tubulin Modulators|tubulin modulators|mesh-ancestor
102408620|NCT03025477|Antimitotic Agents|antimitotic agents|mesh-ancestor
102408621|NCT03025477|Mitosis Modulators|mitosis modulators|mesh-ancestor
102408622|NCT03025477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408623|NCT03025477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102408624|NCT03025477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102408625|NCT03025477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102408626|NCT03025477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102408627|NCT03147378|Docetaxel|docetaxel|mesh-list
102408628|NCT03147378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102408629|NCT03147378|Tubulin Modulators|tubulin modulators|mesh-ancestor
102408630|NCT03147378|Antimitotic Agents|antimitotic agents|mesh-ancestor
102408631|NCT03147378|Mitosis Modulators|mitosis modulators|mesh-ancestor
102408632|NCT03147378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408633|NCT00159744|Olanzapine|olanzapine|mesh-list
102408634|NCT00159744|Asenapine|asenapine|mesh-list
102408635|NCT00159744|Antiemetics|antiemetics|mesh-ancestor
102408636|NCT00159744|Autonomic Agents|autonomic agents|mesh-ancestor
102408637|NCT00159744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102408638|NCT00159744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408639|NCT00159744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102408640|NCT00159744|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102408641|NCT00159744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102408642|NCT00159744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102408643|NCT00159744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102408644|NCT00159744|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102408645|NCT00159744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102408646|NCT00159744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102408647|NCT00159744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408648|NCT00159744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102408649|NCT00159744|Serotonin Agents|serotonin agents|mesh-ancestor
102408650|NCT04041973|Lumefantrine|lumefantrine|mesh-list
102408651|NCT04041973|Artemether|artemether|mesh-list
102408652|NCT04041973|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102408653|NCT04041973|Antimalarials|antimalarials|mesh-ancestor
102408654|NCT04041973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102408655|NCT04041973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102408656|NCT04041973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102408657|NCT02914470|Atezolizumab|atezolizumab|mesh-list
102408658|NCT02914470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102408659|NCT02914470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408660|NCT02914470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102408661|NCT02914470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102408662|NCT05088330|Daratumumab|daratumumab|mesh-list
102408663|NCT05088330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102408664|NCT00695097|Rituximab|rituximab|mesh-list
102408665|NCT00695097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102408666|NCT00695097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102408667|NCT00695097|Immunologic Factors|immunologic factors|mesh-ancestor
102408668|NCT00695097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408669|NCT00695097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102408670|NCT01795911|Interferons|interferons|mesh-list
102408671|NCT01795911|Ribavirin|ribavirin|mesh-list
102408672|NCT01795911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102408673|NCT01795911|Antiviral Agents|antiviral agents|mesh-ancestor
102408674|NCT01795911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102408675|NCT01795911|Antimetabolites|antimetabolites|mesh-ancestor
102408676|NCT01795911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408678|NCT03137316|Parathyroid Hormone|parathyroid hormone|mesh-list
102408679|NCT03137316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102408680|NCT03137316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408681|NCT03137316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102408682|NCT03137082|Guanfacine|guanfacine|mesh-list
102408683|NCT03137082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102408684|NCT03137082|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102408685|NCT03137082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102408686|NCT03137082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102408687|NCT03137082|Adrenergic Agents|adrenergic agents|mesh-ancestor
102408688|NCT03137082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102408689|NCT03137082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408690|NCT03137082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408691|NCT05088174|Cyclosporine|cyclosporine|mesh-list
102408692|NCT05088174|Cyclosporins|cyclosporins|mesh-list
102408693|NCT05088174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102408694|NCT05088174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408695|NCT05088174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102408696|NCT05088174|Immunologic Factors|immunologic factors|mesh-ancestor
102408697|NCT05088174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408698|NCT05088174|Antifungal Agents|antifungal agents|mesh-ancestor
102408699|NCT05088174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102408700|NCT05088174|Dermatologic Agents|dermatologic agents|mesh-ancestor
102408701|NCT05088174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102408702|NCT05088174|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102408703|NCT00695409|Cytarabine|cytarabine|mesh-list
102408704|NCT00695409|Rituximab|rituximab|mesh-list
102408705|NCT00695409|Etoposide|etoposide|mesh-list
102408706|NCT00695409|Etoposide phosphate|etoposide phosphate|mesh-list
102408707|NCT00695409|Melphalan|melphalan|mesh-list
102408708|NCT00695409|Carmustine|carmustine|mesh-list
102408709|NCT00695409|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102408710|NCT00695409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102408711|NCT00695409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102408712|NCT00695409|Immunologic Factors|immunologic factors|mesh-ancestor
102408713|NCT00695409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408714|NCT00695409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102408715|NCT00695409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102408716|NCT00695409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102408717|NCT00695409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102408718|NCT00695409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102408719|NCT00695409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408720|NCT00695409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102408721|NCT00695409|Antimetabolites|antimetabolites|mesh-ancestor
102408722|NCT00695409|Antiviral Agents|antiviral agents|mesh-ancestor
102408723|NCT00695409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102408724|NCT00695409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102408725|NCT00695409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102408726|NCT00695409|Alkylating Agents|alkylating agents|mesh-ancestor
102408727|NCT00695409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102408728|NCT03469050|Rifaximin|rifaximin|mesh-list
102408729|NCT03469050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102408730|NCT03469050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102408731|NCT03469050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102408732|NCT05087706|Bicalutamide|bicalutamide|mesh-list
102408733|NCT05087706|Leuprolide|leuprolide|mesh-list
102408734|NCT05087706|Androgen Antagonists|androgen antagonists|mesh-ancestor
102408735|NCT05087706|Hormone Antagonists|hormone antagonists|mesh-ancestor
102408736|NCT05087706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102408737|NCT05087706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408738|NCT05087706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102408739|NCT05087706|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102408740|NCT05087706|Fertility Agents|fertility agents|mesh-ancestor
102408741|NCT05087706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102408742|NCT05087706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102408743|NCT02990403|Aspirin|aspirin|mesh-list
102408744|NCT02990403|Prednisone|prednisone|mesh-list
102408745|NCT02990403|Heparin|heparin|mesh-list
102408746|NCT02990403|Dydrogesterone|dydrogesterone|mesh-list
102408747|NCT02990403|Immunoglobulins|immunoglobulins|mesh-list
102408748|NCT02990403|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102408749|NCT02990403|Antibodies|antibodies|mesh-list
102408750|NCT02990403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102408751|NCT02990403|Glucocorticoids|glucocorticoids|mesh-ancestor
102408752|NCT02990403|Hormones|hormones|mesh-ancestor
102408753|NCT02990403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102408754|NCT02990403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408755|NCT02990403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102408756|NCT02990403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102408757|NCT02990403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102408758|NCT02990403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102408759|NCT02990403|Analgesics|analgesics|mesh-ancestor
102408760|NCT02990403|Sensory System Agents|sensory system agents|mesh-ancestor
102408761|NCT02990403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102408762|NCT02990403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102408763|NCT02990403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102408764|NCT02990403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102408765|NCT02990403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408766|NCT02990403|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102408767|NCT02990403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102408768|NCT02990403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102408769|NCT02990403|Antipyretics|antipyretics|mesh-ancestor
102408770|NCT02990403|Anticoagulants|anticoagulants|mesh-ancestor
102408771|NCT02990403|Immunologic Factors|immunologic factors|mesh-ancestor
102408772|NCT02990403|Progestins|progestins|mesh-ancestor
102408773|NCT00697203|Pravastatin|pravastatin|mesh-list
102408774|NCT00697203|Dalcetrapib|dalcetrapib|mesh-list
102408775|NCT00697203|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102408776|NCT00697203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102408777|NCT00697203|Antimetabolites|antimetabolites|mesh-ancestor
102408778|NCT00697203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408779|NCT00697203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102408780|NCT00697203|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102408781|NCT00697203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102408782|NCT05086848|Leucovorin|leucovorin|mesh-list
102408783|NCT05086848|Fluorouracil|fluorouracil|mesh-list
102408784|NCT05086848|Irinotecan|irinotecan|mesh-list
102408785|NCT05086848|Antimetabolites|antimetabolites|mesh-ancestor
102408786|NCT05086848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408787|NCT05086848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102408788|NCT05086848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102408789|NCT05086848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102408790|NCT05086848|Immunologic Factors|immunologic factors|mesh-ancestor
102408791|NCT05086848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408792|NCT05086848|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102408793|NCT05086848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102408794|NCT05086848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102408795|NCT05086848|Antidotes|antidotes|mesh-ancestor
102408796|NCT05086848|Protective Agents|protective agents|mesh-ancestor
102408797|NCT05086848|Vitamin B Complex|vitamin b complex|mesh-ancestor
102408798|NCT05086848|Vitamins|vitamins|mesh-ancestor
102408799|NCT05086848|Micronutrients|micronutrients|mesh-ancestor
102408800|NCT00830895|Everolimus|everolimus|mesh-list
102408801|NCT00830895|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102408802|NCT00830895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102408803|NCT00830895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102039820|NCT03611504|Hemostatics|hemostatics|mesh-list
102408804|NCT00830895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408805|NCT00830895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102408806|NCT00830895|Immunologic Factors|immunologic factors|mesh-ancestor
102408807|NCT00830895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408808|NCT00830895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102408809|NCT01158417|Resveratrol|resveratrol|mesh-list
102408810|NCT01158417|Antioxidants|antioxidants|mesh-ancestor
102408811|NCT01158417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408812|NCT01158417|Protective Agents|protective agents|mesh-ancestor
102408813|NCT01158417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408814|NCT01158417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102408815|NCT01158417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102408816|NCT05086614|Thymalfasin|thymalfasin|mesh-list
102408817|NCT05086614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102408818|NCT05086614|Immunologic Factors|immunologic factors|mesh-ancestor
102408819|NCT05086614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408820|NCT01795131|Vitamin B 12|vitamin b 12|mesh-list
102408821|NCT01795131|Hydroxocobalamin|hydroxocobalamin|mesh-list
102408822|NCT01795131|Vitamins|vitamins|mesh-ancestor
102408823|NCT01795131|Micronutrients|micronutrients|mesh-ancestor
102408824|NCT01795131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408825|NCT01795131|Vitamin B Complex|vitamin b complex|mesh-ancestor
102408826|NCT01795131|Hematinics|hematinics|mesh-ancestor
102408827|NCT03137004|Docetaxel|docetaxel|mesh-list
102408828|NCT03137004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102408829|NCT03137004|Tubulin Modulators|tubulin modulators|mesh-ancestor
102408830|NCT03137004|Antimitotic Agents|antimitotic agents|mesh-ancestor
102408831|NCT03137004|Mitosis Modulators|mitosis modulators|mesh-ancestor
102408832|NCT03137004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408833|NCT03113994|Calcium, Dietary|calcium, dietary|mesh-list
102408834|NCT03113994|Vitamin D|vitamin d|mesh-list
102408835|NCT03113994|Coenzyme Q10|coenzyme q10|mesh-list
102408836|NCT03113994|Ubiquinone|ubiquinone|mesh-list
102408837|NCT03113994|Calcium Carbonate|calcium carbonate|mesh-list
102408838|NCT03113994|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102408839|NCT03113994|Calcium|calcium|mesh-list
102408840|NCT03113994|Vitamins|vitamins|mesh-ancestor
102408841|NCT03113994|Micronutrients|micronutrients|mesh-ancestor
102408842|NCT03113994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408843|NCT03113994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102408844|NCT03113994|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102408845|NCT03113994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102408846|NCT03113994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102408847|NCT03113994|Antimetabolites|antimetabolites|mesh-ancestor
102408848|NCT03113994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408849|NCT03113994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102408850|NCT03113994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102408851|NCT03113994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102408852|NCT03113994|Antacids|antacids|mesh-ancestor
102408853|NCT03113994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102408854|NCT02003742|Tamsulosin|tamsulosin|mesh-list
102408855|NCT02003742|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102408856|NCT02003742|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102408857|NCT02003742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102408858|NCT02003742|Adrenergic Agents|adrenergic agents|mesh-ancestor
102408859|NCT02003742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102408860|NCT02003742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408861|NCT02003742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408862|NCT02003742|Urological Agents|urological agents|mesh-ancestor
102408863|NCT03134118|Nivolumab|nivolumab|mesh-list
102408864|NCT03134118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102408865|NCT03134118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102408866|NCT03134118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102408867|NCT03134118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408868|NCT05085912|Ethanol|ethanol|mesh-list
102408869|NCT05085912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102408870|NCT05085912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102408871|NCT05085912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102408872|NCT05085912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408873|NCT02339415|Edoxaban|edoxaban|mesh-list
102408874|NCT02339415|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102408875|NCT02339415|Antithrombins|antithrombins|mesh-ancestor
102408876|NCT02339415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102408877|NCT02339415|Protease Inhibitors|protease inhibitors|mesh-ancestor
102408878|NCT02339415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102408879|NCT02339415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408880|NCT02339415|Anticoagulants|anticoagulants|mesh-ancestor
102408881|NCT02998047|Lintuzumab|lintuzumab|mesh-list
102408882|NCT02998047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102408883|NCT02998047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102408884|NCT03110172|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102408885|NCT03110172|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102408886|NCT03110172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102408887|NCT03110172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102408888|NCT03110172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408889|NCT03110172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102408890|NCT03110172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408891|NCT03110172|Analgesics|analgesics|mesh-ancestor
102408892|NCT03110172|Sensory System Agents|sensory system agents|mesh-ancestor
102408893|NCT03110172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102408894|NCT03110172|Antidepressive Agents|antidepressive agents|mesh-ancestor
102408895|NCT03110172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102408896|NCT03110172|Dopamine Agents|dopamine agents|mesh-ancestor
102408897|NCT01400503|Siltuximab|siltuximab|mesh-list
102408898|NCT01400503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102408899|NCT00706719|Enclomiphene|enclomiphene|mesh-list
102408900|NCT00706719|Clomiphene|clomiphene|mesh-list
102408901|NCT00706719|Zuclomiphene|zuclomiphene|mesh-list
102408902|NCT00706719|Testosterone|testosterone|mesh-list
102408903|NCT00706719|Androgens|androgens|mesh-ancestor
102408905|NCT00706719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102408906|NCT00706719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408907|NCT00706719|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102408908|NCT00706719|Hormone Antagonists|hormone antagonists|mesh-ancestor
102408909|NCT00706719|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102408910|NCT00706719|Fertility Agents|fertility agents|mesh-ancestor
102408911|NCT00706719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102408912|NCT00706719|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102408913|NCT00706719|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102408914|NCT05079672|Dexmedetomidine|dexmedetomidine|mesh-list
102408915|NCT05079672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102408916|NCT05079672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102408917|NCT05079672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408918|NCT05079672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102408919|NCT05079672|Analgesics|analgesics|mesh-ancestor
102408920|NCT05079672|Sensory System Agents|sensory system agents|mesh-ancestor
102408921|NCT05079672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102408922|NCT05079672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102408923|NCT05079672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102408924|NCT05079672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102408925|NCT05079672|Adrenergic Agents|adrenergic agents|mesh-ancestor
102408926|NCT05079672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102408927|NCT05079672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408928|NCT04766827|Paclitaxel|paclitaxel|mesh-list
102408929|NCT04766827|Docetaxel|docetaxel|mesh-list
102408930|NCT04766827|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102408931|NCT04766827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102408932|NCT04766827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102408933|NCT04766827|Tubulin Modulators|tubulin modulators|mesh-ancestor
102408934|NCT04766827|Antimitotic Agents|antimitotic agents|mesh-ancestor
102408935|NCT04766827|Mitosis Modulators|mitosis modulators|mesh-ancestor
102408936|NCT04766827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408937|NCT02960568|Primaquine|primaquine|mesh-list
102408938|NCT02960568|Antimalarials|antimalarials|mesh-ancestor
102408939|NCT02960568|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102408940|NCT02960568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102408941|NCT02960568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102408942|NCT02996409|Lidocaine|lidocaine|mesh-list
102408943|NCT02996409|Anesthetics, Local|anesthetics, local|mesh-ancestor
102408944|NCT02996409|Anesthetics|anesthetics|mesh-ancestor
102408945|NCT02996409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102408946|NCT02996409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408947|NCT02996409|Sensory System Agents|sensory system agents|mesh-ancestor
102408948|NCT02996409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102408949|NCT02996409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102408950|NCT02996409|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102408951|NCT02996409|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102408952|NCT02996409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102408953|NCT02996409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408954|NCT02864004|Apomorphine|apomorphine|mesh-list
102408955|NCT02864004|Emetics|emetics|mesh-ancestor
102408956|NCT02864004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408957|NCT02864004|Autonomic Agents|autonomic agents|mesh-ancestor
102408958|NCT02864004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102408959|NCT02864004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102408960|NCT02864004|Dopamine Agonists|dopamine agonists|mesh-ancestor
102408961|NCT02864004|Dopamine Agents|dopamine agents|mesh-ancestor
102408962|NCT02864004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102408963|NCT02864004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408964|NCT01421719|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102408965|NCT01421719|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102408966|NCT01421719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102408967|NCT01421719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408968|NCT01421719|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102040049|NCT01330693|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102040050|NCT01330693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102040051|NCT01330693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102408969|NCT01421719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102408970|NCT01421719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408971|NCT01421719|Cholinergic Agents|cholinergic agents|mesh-ancestor
102408972|NCT01421719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102408973|NCT01421641|Lidocaine|lidocaine|mesh-list
102408974|NCT01421641|Anesthetics, Local|anesthetics, local|mesh-ancestor
102408975|NCT01421641|Anesthetics|anesthetics|mesh-ancestor
102408976|NCT01421641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102408977|NCT01421641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408978|NCT01421641|Sensory System Agents|sensory system agents|mesh-ancestor
102408979|NCT01421641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102408980|NCT01421641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102408981|NCT01421641|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102408982|NCT01421641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102408983|NCT01421641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102408984|NCT01421641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102408986|NCT05068206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102408987|NCT05068206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102408988|NCT05068206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102408989|NCT05068206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102408990|NCT05068206|Growth Substances|growth substances|mesh-ancestor
102408991|NCT05068206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102408992|NCT05068206|Growth Inhibitors|growth inhibitors|mesh-ancestor
102408993|NCT05063370|Simendan|simendan|mesh-list
102408994|NCT05063370|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102408995|NCT05063370|Vasodilator Agents|vasodilator agents|mesh-ancestor
102408996|NCT05063370|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102408997|NCT05063370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102408998|NCT05063370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102408999|NCT05063370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409000|NCT05063370|Protective Agents|protective agents|mesh-ancestor
102409001|NCT05063370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409002|NCT01421017|Cyclophosphamide|cyclophosphamide|mesh-list
102409003|NCT01421017|Imiquimod|imiquimod|mesh-list
102409004|NCT01421017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102409005|NCT01421017|Immunologic Factors|immunologic factors|mesh-ancestor
102409006|NCT01421017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409007|NCT01421017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102409008|NCT01421017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102409009|NCT01421017|Alkylating Agents|alkylating agents|mesh-ancestor
102409010|NCT01421017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409011|NCT01421017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102409012|NCT01421017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102409013|NCT01421017|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102409014|NCT01421017|Interferon Inducers|interferon inducers|mesh-ancestor
102409015|NCT04951050|Sirolimus|sirolimus|mesh-list
102409016|NCT04951050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102409017|NCT04951050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102409018|NCT04951050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102409019|NCT04951050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102409020|NCT04951050|Antifungal Agents|antifungal agents|mesh-ancestor
102409021|NCT04951050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102409022|NCT04951050|Immunologic Factors|immunologic factors|mesh-ancestor
102409023|NCT04951050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409024|NCT05089344|Clomiphene|clomiphene|mesh-list
102409025|NCT05089344|Enclomiphene|enclomiphene|mesh-list
102409026|NCT05089344|Zuclomiphene|zuclomiphene|mesh-list
102409027|NCT05089344|Hormones|hormones|mesh-list
102409028|NCT05089344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102409029|NCT05089344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409030|NCT05089344|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102409031|NCT05089344|Hormone Antagonists|hormone antagonists|mesh-ancestor
102409032|NCT05089344|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102409033|NCT05089344|Fertility Agents|fertility agents|mesh-ancestor
102409034|NCT05089344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102409035|NCT05089344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102409036|NCT05089344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102409037|NCT01400113|Asenapine|asenapine|mesh-list
102409038|NCT01400113|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102409039|NCT01400113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102409040|NCT01400113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102409041|NCT01400113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409042|NCT01400113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102409043|NCT01399723|Amoxicillin|amoxicillin|mesh-list
102409044|NCT01399723|Penicillins|penicillins|mesh-list
102409045|NCT01399723|Penicillin G|penicillin g|mesh-list
102409046|NCT01399723|Penicillin G Benzathine|penicillin g benzathine|mesh-list
102409047|NCT01399723|Penicillin G Procaine|penicillin g procaine|mesh-list
102409048|NCT01399723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102409049|NCT01399723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102409050|NCT04771962|Sevoflurane|sevoflurane|mesh-list
102409051|NCT04771962|Desflurane|desflurane|mesh-list
102409052|NCT04771962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102409053|NCT04771962|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102409054|NCT04771962|Anesthetics, General|anesthetics, general|mesh-ancestor
102409055|NCT04771962|Anesthetics|anesthetics|mesh-ancestor
102409056|NCT04771962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102409057|NCT04771962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409058|NCT04726098|Dexamethasone|dexamethasone|mesh-list
102409059|NCT04726098|Dexamethasone acetate|dexamethasone acetate|mesh-list
102409060|NCT04726098|BB 1101|bb 1101|mesh-list
102409061|NCT04726098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102409062|NCT04726098|Antiemetics|antiemetics|mesh-ancestor
102409063|NCT04726098|Autonomic Agents|autonomic agents|mesh-ancestor
102409064|NCT04726098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102409065|NCT04726098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409066|NCT04726098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102409067|NCT04726098|Glucocorticoids|glucocorticoids|mesh-ancestor
102409068|NCT04726098|Hormones|hormones|mesh-ancestor
102409069|NCT04726098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102409070|NCT04726098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102409071|NCT04726098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102409072|NCT04726098|Protease Inhibitors|protease inhibitors|mesh-ancestor
102409073|NCT04726098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102409074|NCT04726098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409075|NCT05088720|Misoprostol|misoprostol|mesh-list
102409076|NCT05088720|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102409077|NCT05088720|Abortifacient Agents|abortifacient agents|mesh-ancestor
102409078|NCT05088720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102409079|NCT05088720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409080|NCT05088720|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102409081|NCT05088720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102409082|NCT05088720|Oxytocics|oxytocics|mesh-ancestor
102409083|NCT01383499|Bromides|bromides|mesh-list
102409084|NCT01383499|Tiotropium Bromide|tiotropium bromide|mesh-list
102409085|NCT01383499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102409086|NCT01383499|Autonomic Agents|autonomic agents|mesh-ancestor
102409087|NCT01383499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102409088|NCT01383499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409089|NCT01383499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102409090|NCT01383499|Respiratory System Agents|respiratory system agents|mesh-ancestor
102409091|NCT01383499|Parasympatholytics|parasympatholytics|mesh-ancestor
102409092|NCT01383499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102409093|NCT01383499|Cholinergic Agents|cholinergic agents|mesh-ancestor
102409094|NCT01383499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102409095|NCT01383499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409096|NCT01383499|Anticonvulsants|anticonvulsants|mesh-ancestor
102409097|NCT05084118|Landiolol|landiolol|mesh-list
102409098|NCT05084118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102409099|NCT05084118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102409100|NCT05084118|Adrenergic Agents|adrenergic agents|mesh-ancestor
102409101|NCT05084118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102409102|NCT05084118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409103|NCT05084118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409104|NCT05084118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102409105|NCT03025009|Insulin|insulin|mesh-list
102409106|NCT03025009|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102409107|NCT03025009|Insulin Glargine|insulin glargine|mesh-list
102409108|NCT03025009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102409109|NCT03025009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409110|NCT03135912|Terbinafine|terbinafine|mesh-list
102409111|NCT03135912|Antifungal Agents|antifungal agents|mesh-ancestor
102409112|NCT03135912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102409113|NCT03135912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102409114|NCT03135912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409115|NCT01397461|Retapamulin|retapamulin|mesh-list
102409116|NCT01397461|Ozenoxacin|ozenoxacin|mesh-list
102409117|NCT01397461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102409118|NCT01397461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102409119|NCT01397461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102409120|NCT01397461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102409121|NCT01397461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409122|NCT01397461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102409123|NCT04335084|Vitamin D|vitamin d|mesh-list
102409124|NCT04335084|Vitamins|vitamins|mesh-list
102409125|NCT04335084|Hydroxychloroquine|hydroxychloroquine|mesh-list
102409126|NCT04335084|Micronutrients|micronutrients|mesh-ancestor
102409127|NCT04335084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409128|NCT04335084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102409130|NCT04335084|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102409131|NCT04335084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102409132|NCT04335084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102409133|NCT04335084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102409134|NCT04335084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409135|NCT04335084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102409136|NCT02996019|Etrolizumab|etrolizumab|mesh-list
102409137|NCT02996019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102409138|NCT02996019|Immunologic Factors|immunologic factors|mesh-ancestor
102409139|NCT02996019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409140|NCT02997501|Osimertinib|osimertinib|mesh-list
102409141|NCT02997501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102409142|NCT02997501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102409143|NCT02997501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102409144|NCT02997501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409145|NCT02998827|Thalidomide|thalidomide|mesh-list
102409146|NCT02998827|Infliximab|infliximab|mesh-list
102409147|NCT02998827|Azathioprine|azathioprine|mesh-list
102409148|NCT02998827|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102409149|NCT02998827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102409150|NCT02998827|Dermatologic Agents|dermatologic agents|mesh-ancestor
102409151|NCT02998827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102409152|NCT02998827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102409153|NCT02998827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102409154|NCT02998827|Immunologic Factors|immunologic factors|mesh-ancestor
102409155|NCT02998827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409156|NCT02998827|Leprostatic Agents|leprostatic agents|mesh-ancestor
102409157|NCT02998827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102409158|NCT02998827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102409159|NCT02998827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102409160|NCT02998827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102409161|NCT02998827|Growth Substances|growth substances|mesh-ancestor
102409162|NCT02998827|Growth Inhibitors|growth inhibitors|mesh-ancestor
102409163|NCT02998827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102409164|NCT02998827|Antimetabolites|antimetabolites|mesh-ancestor
102409165|NCT02998827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409166|NCT02998827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102409167|NCT02995707|Thalidomide|thalidomide|mesh-list
102409168|NCT02995707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102409169|NCT02995707|Immunologic Factors|immunologic factors|mesh-ancestor
102409170|NCT02995707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409171|NCT02995707|Leprostatic Agents|leprostatic agents|mesh-ancestor
102409172|NCT02995707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102409173|NCT02995707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102409174|NCT02995707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102409175|NCT02995707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102409176|NCT02995707|Growth Substances|growth substances|mesh-ancestor
102409177|NCT02995707|Growth Inhibitors|growth inhibitors|mesh-ancestor
102409178|NCT02995707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102409179|NCT01270035|Adalimumab|adalimumab|mesh-list
102409180|NCT01270035|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102409181|NCT01270035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102409182|NCT01270035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102409183|NCT01396447|Cariprazine|cariprazine|mesh-list
102409184|NCT01396447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102409185|NCT01396447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102409186|NCT01396447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102409187|NCT01396447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409188|NCT01396447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102409189|NCT00704379|Sertraline|sertraline|mesh-list
102409190|NCT00704379|Antidepressive Agents|antidepressive agents|mesh-ancestor
102409191|NCT00704379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102409192|NCT00704379|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102409193|NCT00704379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102409194|NCT00704379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102409195|NCT00704379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409196|NCT00704379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102409197|NCT00704379|Serotonin Agents|serotonin agents|mesh-ancestor
102409198|NCT00704379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409199|NCT02991495|Vaccines|vaccines|mesh-list
102409200|NCT02991495|Immunologic Factors|immunologic factors|mesh-ancestor
102409201|NCT02991495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409202|NCT04449042|Anesthetics|anesthetics|mesh-list
102409203|NCT04449042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102409204|NCT04449042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409205|NCT04341090|Apatinib|apatinib|mesh-list
102409206|NCT04341090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102409207|NCT04341090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102409208|NCT04341090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102409209|NCT04341090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409210|NCT04413396|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102409211|NCT04413396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102409212|NCT04089150|Leucovorin|leucovorin|mesh-list
102409213|NCT04089150|Paclitaxel|paclitaxel|mesh-list
102409214|NCT04089150|Gemcitabine|gemcitabine|mesh-list
102409215|NCT04089150|Fluorouracil|fluorouracil|mesh-list
102409216|NCT04089150|Capecitabine|capecitabine|mesh-list
102409217|NCT04089150|Oxaliplatin|oxaliplatin|mesh-list
102409218|NCT04089150|Irinotecan|irinotecan|mesh-list
102409219|NCT04089150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102409220|NCT04089150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102040249|NCT03203447|Hormones|hormones|mesh-ancestor
102409221|NCT04089150|Tubulin Modulators|tubulin modulators|mesh-ancestor
102409222|NCT04089150|Antimitotic Agents|antimitotic agents|mesh-ancestor
102409223|NCT04089150|Mitosis Modulators|mitosis modulators|mesh-ancestor
102409224|NCT04089150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409225|NCT04089150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102409226|NCT04089150|Antimetabolites|antimetabolites|mesh-ancestor
102409227|NCT04089150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102409228|NCT04089150|Immunologic Factors|immunologic factors|mesh-ancestor
102409229|NCT04089150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409230|NCT04089150|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102409231|NCT04089150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102409232|NCT04089150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102409233|NCT04089150|Antidotes|antidotes|mesh-ancestor
102409234|NCT04089150|Protective Agents|protective agents|mesh-ancestor
102409235|NCT04089150|Vitamin B Complex|vitamin b complex|mesh-ancestor
102409236|NCT04089150|Vitamins|vitamins|mesh-ancestor
102409237|NCT04089150|Micronutrients|micronutrients|mesh-ancestor
102409238|NCT02076919|Acrizanib|acrizanib|mesh-list
102409239|NCT02076919|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102409240|NCT02076919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102409241|NCT02076919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102409242|NCT02076919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102409243|NCT02076919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409244|NCT02076997|Methotrexate|methotrexate|mesh-list
102409245|NCT02076997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102409246|NCT02076997|Abortifacient Agents|abortifacient agents|mesh-ancestor
102409247|NCT02076997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102409248|NCT02076997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409249|NCT02076997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102409250|NCT02076997|Antimetabolites|antimetabolites|mesh-ancestor
102409251|NCT02076997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409252|NCT02076997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102409253|NCT02076997|Dermatologic Agents|dermatologic agents|mesh-ancestor
102409254|NCT02076997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102409255|NCT02076997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102409256|NCT02076997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102409257|NCT02076997|Immunologic Factors|immunologic factors|mesh-ancestor
102409258|NCT02076997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102409259|NCT02076997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102409260|NCT05365165|Sevoflurane|sevoflurane|mesh-list
102409261|NCT05365165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102409262|NCT05365165|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102409263|NCT05365165|Anesthetics, General|anesthetics, general|mesh-ancestor
102409264|NCT05365165|Anesthetics|anesthetics|mesh-ancestor
102409265|NCT05365165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102409266|NCT05365165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409267|NCT03925350|Niraparib|niraparib|mesh-list
102409268|NCT03925350|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102409269|NCT03925350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102409270|NCT03925350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409271|NCT03925350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102409272|NCT00707967|Vaccines|vaccines|mesh-list
102409273|NCT00707967|Immunologic Factors|immunologic factors|mesh-ancestor
102409274|NCT00707967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409275|NCT02994381|Ozanimod|ozanimod|mesh-list
102409276|NCT02994381|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102409277|NCT02994381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409278|NCT02994381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102409280|NCT02994381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409281|NCT00716079|Metoprolol|metoprolol|mesh-list
102409282|NCT00716079|Clonidine|clonidine|mesh-list
102409283|NCT00716079|Labetalol|labetalol|mesh-list
102409284|NCT00716079|Hydralazine|hydralazine|mesh-list
102409285|NCT00716079|Nicardipine|nicardipine|mesh-list
102409286|NCT00716079|Phentolamine|phentolamine|mesh-list
102409287|NCT00716079|Urapidil|urapidil|mesh-list
102409288|NCT00716079|Enalaprilat|enalaprilat|mesh-list
102409289|NCT00716079|Esmolol|esmolol|mesh-list
102409290|NCT00716079|Glycerol|glycerol|mesh-list
102409291|NCT00716079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102409292|NCT00716079|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102409293|NCT00716079|Sympatholytics|sympatholytics|mesh-ancestor
102409294|NCT00716079|Autonomic Agents|autonomic agents|mesh-ancestor
102409295|NCT00716079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102409296|NCT00716079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409297|NCT00716079|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102409298|NCT00716079|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102409299|NCT00716079|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102409300|NCT00716079|Adrenergic Agents|adrenergic agents|mesh-ancestor
102409301|NCT00716079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102409302|NCT00716079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409303|NCT00716079|Analgesics|analgesics|mesh-ancestor
102409304|NCT00716079|Sensory System Agents|sensory system agents|mesh-ancestor
102409305|NCT00716079|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102409306|NCT00716079|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102409307|NCT00716079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102409308|NCT00716079|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102409309|NCT00716079|Protective Agents|protective agents|mesh-ancestor
102409310|NCT00716079|Sympathomimetics|sympathomimetics|mesh-ancestor
102409311|NCT00716079|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102409312|NCT00716079|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102409313|NCT00716079|Vasodilator Agents|vasodilator agents|mesh-ancestor
102409314|NCT00716079|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102409315|NCT00716079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102409316|NCT00716079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102409317|NCT00716079|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102409318|NCT00716079|Serotonin Agents|serotonin agents|mesh-ancestor
102409319|NCT00716079|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102409320|NCT00716079|Protease Inhibitors|protease inhibitors|mesh-ancestor
102409321|NCT00716079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102409322|NCT01270191|Exenatide|exenatide|mesh-list
102409323|NCT01270191|Isophane Insulin, Human|isophane insulin, human|mesh-list
102409324|NCT01270191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102040358|NCT02960113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102409325|NCT01270191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409326|NCT01270191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102409327|NCT01270191|Incretins|incretins|mesh-ancestor
102409328|NCT01270191|Hormones|hormones|mesh-ancestor
102409329|NCT01270191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102409330|NCT02999919|Bupivacaine|bupivacaine|mesh-list
102409331|NCT02999919|Anesthetics, Local|anesthetics, local|mesh-ancestor
102409332|NCT02999919|Anesthetics|anesthetics|mesh-ancestor
102409333|NCT02999919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102409334|NCT02999919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409335|NCT02999919|Sensory System Agents|sensory system agents|mesh-ancestor
102409336|NCT02999919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102409337|NCT04526652|Dexmedetomidine|dexmedetomidine|mesh-list
102409338|NCT04526652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102409339|NCT04526652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102409340|NCT04526652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409341|NCT04526652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102409342|NCT04526652|Analgesics|analgesics|mesh-ancestor
102409343|NCT04526652|Sensory System Agents|sensory system agents|mesh-ancestor
102409344|NCT04526652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102409345|NCT04526652|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102409346|NCT04526652|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102409347|NCT04526652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102409348|NCT04526652|Adrenergic Agents|adrenergic agents|mesh-ancestor
102409349|NCT04526652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102409350|NCT04526652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409351|NCT01381549|Imipenem|imipenem|mesh-list
102409352|NCT01381549|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
102409353|NCT01381549|Cilastatin|cilastatin|mesh-list
102221044|NCT02317601|Prednisolone|prednisolone|mesh-list
102409354|NCT01381549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102409355|NCT01381549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102409356|NCT01381549|Protease Inhibitors|protease inhibitors|mesh-ancestor
102409357|NCT01381549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102409358|NCT01381549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409359|NCT00159432|Bevacizumab|bevacizumab|mesh-list
102409360|NCT00159432|Capecitabine|capecitabine|mesh-list
102409361|NCT00159432|Oxaliplatin|oxaliplatin|mesh-list
102409362|NCT00159432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102409363|NCT00159432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102409364|NCT00159432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102409365|NCT00159432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102409366|NCT00159432|Growth Substances|growth substances|mesh-ancestor
102409367|NCT00159432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409368|NCT00159432|Growth Inhibitors|growth inhibitors|mesh-ancestor
102409369|NCT00159432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102409370|NCT00159432|Antimetabolites|antimetabolites|mesh-ancestor
102409371|NCT00159432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409373|NCT02969850|Calcium|calcium|mesh-list
102409374|NCT02969850|Vitamins|vitamins|mesh-ancestor
102409375|NCT02969850|Micronutrients|micronutrients|mesh-ancestor
102409376|NCT02969850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409377|NCT02969850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102409378|NCT02969850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102409379|NCT02339766|Morphine|morphine|mesh-list
102409380|NCT02339766|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102409381|NCT02339766|Narcotics|narcotics|mesh-ancestor
102409382|NCT02339766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102409383|NCT02339766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409384|NCT02339766|Analgesics|analgesics|mesh-ancestor
102409385|NCT02339766|Sensory System Agents|sensory system agents|mesh-ancestor
102409386|NCT02339766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102409387|NCT04287660|Clarithromycin|clarithromycin|mesh-list
102409388|NCT04287660|Dexamethasone|dexamethasone|mesh-list
102409389|NCT04287660|Lenalidomide|lenalidomide|mesh-list
102409390|NCT04287660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102409391|NCT04287660|Antiemetics|antiemetics|mesh-ancestor
102409392|NCT04287660|Autonomic Agents|autonomic agents|mesh-ancestor
102409393|NCT04287660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102409394|NCT04287660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409395|NCT04287660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102409396|NCT04287660|Glucocorticoids|glucocorticoids|mesh-ancestor
102409397|NCT04287660|Hormones|hormones|mesh-ancestor
102409398|NCT04287660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102409399|NCT04287660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102409400|NCT04287660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102409401|NCT04287660|Immunologic Factors|immunologic factors|mesh-ancestor
102409402|NCT04287660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102409403|NCT04287660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102409404|NCT04287660|Growth Substances|growth substances|mesh-ancestor
102409405|NCT04287660|Growth Inhibitors|growth inhibitors|mesh-ancestor
102409406|NCT04287660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102409407|NCT04287660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102409408|NCT04287660|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102409409|NCT04287660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102409410|NCT04287660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409411|NCT04287660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102409412|NCT04287660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102409413|NCT01396057|Dexamethasone|dexamethasone|mesh-list
102409414|NCT01396057|Ranibizumab|ranibizumab|mesh-list
102409415|NCT01396057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102409416|NCT01396057|Antiemetics|antiemetics|mesh-ancestor
102409417|NCT01396057|Autonomic Agents|autonomic agents|mesh-ancestor
102409418|NCT01396057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102409419|NCT01396057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409420|NCT01396057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102409421|NCT01396057|Glucocorticoids|glucocorticoids|mesh-ancestor
102409422|NCT01396057|Hormones|hormones|mesh-ancestor
102409423|NCT01396057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102409424|NCT01396057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102409425|NCT01396057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102409426|NCT01396057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102409427|NCT01396057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102409428|NCT01396057|Growth Substances|growth substances|mesh-ancestor
102409429|NCT01396057|Growth Inhibitors|growth inhibitors|mesh-ancestor
102409431|NCT02419560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102409432|NCT04011163|Morphine|morphine|mesh-list
102409433|NCT04011163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102409434|NCT04011163|Narcotics|narcotics|mesh-ancestor
102409435|NCT04011163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102409436|NCT04011163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409437|NCT04011163|Analgesics|analgesics|mesh-ancestor
102409438|NCT04011163|Sensory System Agents|sensory system agents|mesh-ancestor
102409439|NCT04011163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102409440|NCT00704847|Calcitonin|calcitonin|mesh-list
102409441|NCT00704847|Salmon calcitonin|salmon calcitonin|mesh-list
102409442|NCT00704847|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
102409443|NCT00704847|Katacalcin|katacalcin|mesh-list
102409444|NCT00704847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102409445|NCT00704847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040467|NCT02981472|Hemostatics|hemostatics|mesh-ancestor
102409446|NCT00704847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102409447|NCT00704847|Vasodilator Agents|vasodilator agents|mesh-ancestor
102409448|NCT03393468|Dapivirine|dapivirine|mesh-list
102409449|NCT03393468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102409450|NCT03393468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102409451|NCT03393468|Antiviral Agents|antiviral agents|mesh-ancestor
102409452|NCT03393468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102409453|NCT05091606|Anesthetics|anesthetics|mesh-list
102409454|NCT05091606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102409455|NCT05091606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409456|NCT01395901|Ondansetron|ondansetron|mesh-list
102409457|NCT01395901|Palonosetron|palonosetron|mesh-list
102409458|NCT01395901|Antiemetics|antiemetics|mesh-ancestor
102409459|NCT01395901|Autonomic Agents|autonomic agents|mesh-ancestor
102409460|NCT01395901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102409461|NCT01395901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409462|NCT01395901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102409463|NCT01395901|Antipruritics|antipruritics|mesh-ancestor
102409464|NCT01395901|Dermatologic Agents|dermatologic agents|mesh-ancestor
102409465|NCT01395901|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102409466|NCT01395901|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102409467|NCT01395901|Serotonin Agents|serotonin agents|mesh-ancestor
102409468|NCT01395901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102409469|NCT01395901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409470|NCT01395823|Vitamin D|vitamin d|mesh-list
102409471|NCT01395823|Ergocalciferols|ergocalciferols|mesh-list
102409472|NCT01395823|Vitamins|vitamins|mesh-ancestor
102409473|NCT01395823|Micronutrients|micronutrients|mesh-ancestor
102409474|NCT01395823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409475|NCT01395823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102409476|NCT01395823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102409477|NCT02993991|Durvalumab|durvalumab|mesh-list
102409478|NCT02993991|Mocetinostat|mocetinostat|mesh-list
102409479|NCT02993991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102409480|NCT02993991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102409481|NCT02993991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102409482|NCT02993991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102409483|NCT02993991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409484|NCT00158184|Oxycodone|oxycodone|mesh-list
102409485|NCT00158184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102409486|NCT00158184|Narcotics|narcotics|mesh-ancestor
102409487|NCT00158184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102409488|NCT00158184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409489|NCT00158184|Analgesics|analgesics|mesh-ancestor
102409490|NCT00158184|Sensory System Agents|sensory system agents|mesh-ancestor
102409491|NCT00158184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102409492|NCT02405520|Vaccines|vaccines|mesh-list
102409493|NCT02405520|Immunologic Factors|immunologic factors|mesh-ancestor
102409494|NCT02405520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409495|NCT02993835|Iron|iron|mesh-list
102409496|NCT02993835|Trace Elements|trace elements|mesh-ancestor
102409497|NCT02993835|Micronutrients|micronutrients|mesh-ancestor
102409498|NCT02993835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409499|NCT05091138|Buprenorphine|buprenorphine|mesh-list
102409500|NCT05091138|Bupivacaine|bupivacaine|mesh-list
102409501|NCT05091138|Anesthetics, Local|anesthetics, local|mesh-ancestor
102409502|NCT05091138|Anesthetics|anesthetics|mesh-ancestor
102409503|NCT05091138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102221194|NCT04454281|Naloxone|naloxone|mesh-list
102409504|NCT05091138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409505|NCT05091138|Sensory System Agents|sensory system agents|mesh-ancestor
102409506|NCT05091138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102409507|NCT05091138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102409508|NCT05091138|Narcotics|narcotics|mesh-ancestor
102409509|NCT05091138|Analgesics|analgesics|mesh-ancestor
102409510|NCT05091138|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102409511|NCT02999295|Nivolumab|nivolumab|mesh-list
102409512|NCT02999295|Ramucirumab|ramucirumab|mesh-list
102409513|NCT02999295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102409514|NCT02999295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102409515|NCT02999295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102409516|NCT02999295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409517|NCT02998905|Aspirin|aspirin|mesh-list
102409518|NCT02998905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102409519|NCT02998905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102409520|NCT02998905|Analgesics|analgesics|mesh-ancestor
102409521|NCT02998905|Sensory System Agents|sensory system agents|mesh-ancestor
102409522|NCT02998905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102409523|NCT02998905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409524|NCT02998905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102409525|NCT02998905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102409526|NCT02998905|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102409527|NCT02998905|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102409528|NCT02998905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409529|NCT02998905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102409530|NCT02998905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102409531|NCT02998905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102409532|NCT02998905|Antipyretics|antipyretics|mesh-ancestor
102409533|NCT02993367|3-n-butylphthalide|3-n-butylphthalide|mesh-list
102409534|NCT02993367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102409535|NCT02993367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102409536|NCT02993367|Protective Agents|protective agents|mesh-ancestor
102409537|NCT02993367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409538|NCT05094492|Fluorides|fluorides|mesh-list
102409539|NCT05094492|Fluorides, Topical|fluorides, topical|mesh-list
102409540|NCT05094492|Cariostatic Agents|cariostatic agents|mesh-ancestor
102409541|NCT05094492|Protective Agents|protective agents|mesh-ancestor
102409542|NCT05094492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409543|NCT01380691|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
102409544|NCT01380691|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102409545|NCT01380691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102409546|NCT01380691|Disinfectants|disinfectants|mesh-ancestor
102409547|NCT05094414|Valacyclovir|valacyclovir|mesh-list
102409548|NCT05094414|Antiviral Agents|antiviral agents|mesh-ancestor
102409549|NCT05094414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102409550|NCT04386447|Oxytocin|oxytocin|mesh-list
102409551|NCT04386447|Oxytocics|oxytocics|mesh-ancestor
102409552|NCT04386447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102409553|NCT04386447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409554|NCT02993133|Mycophenolic Acid|mycophenolic acid|mesh-list
102409555|NCT02993133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102409556|NCT02993133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102409557|NCT02993133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102409558|NCT02993133|Antitubercular Agents|antitubercular agents|mesh-ancestor
102409559|NCT02993133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102409560|NCT02993133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102409561|NCT02993133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102409562|NCT02993133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409563|NCT01380535|Methoxsalen|methoxsalen|mesh-list
102409564|NCT01380535|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102409565|NCT01380535|Dermatologic Agents|dermatologic agents|mesh-ancestor
102409566|NCT00725361|Ambrisentan|ambrisentan|mesh-list
102409567|NCT00725361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102409568|NCT02816424|TEMPO|tempo|mesh-list
102409569|NCT02816424|Antioxidants|antioxidants|mesh-ancestor
102409570|NCT02816424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409571|NCT02816424|Protective Agents|protective agents|mesh-ancestor
102409572|NCT02816424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409573|NCT01275885|Cholecalciferol|cholecalciferol|mesh-list
102409574|NCT01275885|Vitamin D|vitamin d|mesh-list
102409575|NCT01275885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102409576|NCT01275885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409577|NCT01275885|Vitamins|vitamins|mesh-ancestor
102409578|NCT01275885|Micronutrients|micronutrients|mesh-ancestor
102409579|NCT01275885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102221266|NCT01584934|Sodium Oxybate|sodium oxybate|mesh-list
102409580|NCT02794896|Fentanyl|fentanyl|mesh-list
102409581|NCT02794896|Propofol|propofol|mesh-list
102409582|NCT02794896|Sevoflurane|sevoflurane|mesh-list
102409583|NCT02794896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102409584|NCT02794896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102409585|NCT02794896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409586|NCT02794896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102409587|NCT02794896|Anesthetics, General|anesthetics, general|mesh-ancestor
102409588|NCT02794896|Anesthetics|anesthetics|mesh-ancestor
102409589|NCT02794896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102409590|NCT02794896|Narcotics|narcotics|mesh-ancestor
102409591|NCT02794896|Analgesics|analgesics|mesh-ancestor
102409592|NCT02794896|Sensory System Agents|sensory system agents|mesh-ancestor
102409593|NCT02794896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102409594|NCT02794896|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102409595|NCT02794896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102409596|NCT02794896|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102409597|NCT01271283|Lenalidomide|lenalidomide|mesh-list
102409598|NCT01271283|Immunologic Factors|immunologic factors|mesh-ancestor
102409599|NCT01271283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409600|NCT01271283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102409601|NCT01271283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102409602|NCT01271283|Growth Substances|growth substances|mesh-ancestor
102409603|NCT01271283|Growth Inhibitors|growth inhibitors|mesh-ancestor
102409604|NCT01271283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102409605|NCT01271439|Cetuximab|cetuximab|mesh-list
102409606|NCT01271439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102409607|NCT01271439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102409608|NCT01271517|Insulin, Isophane|insulin, isophane|mesh-list
102409609|NCT01271517|Isophane Insulin, Human|isophane insulin, human|mesh-list
102409610|NCT01271517|Isophane insulin, beef|isophane insulin, beef|mesh-list
102409611|NCT01271517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102409612|NCT01271517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409613|NCT05090592|Atropine|atropine|mesh-list
102409614|NCT05090592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102409615|NCT05090592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102409616|NCT05090592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102409617|NCT05090592|Autonomic Agents|autonomic agents|mesh-ancestor
102409618|NCT05090592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102409619|NCT05090592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409620|NCT05090592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102409621|NCT05090592|Respiratory System Agents|respiratory system agents|mesh-ancestor
102409622|NCT05090592|Mydriatics|mydriatics|mesh-ancestor
102409623|NCT05090592|Parasympatholytics|parasympatholytics|mesh-ancestor
102409624|NCT05090592|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102409625|NCT05090592|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102409626|NCT05090592|Cholinergic Agents|cholinergic agents|mesh-ancestor
102409627|NCT05090592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102409628|NCT05090592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409629|NCT02992665|Ionophores|ionophores|mesh-list
102409630|NCT02992665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102409631|NCT02992665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409632|NCT05093478|Lidocaine|lidocaine|mesh-list
102409633|NCT05093478|Capsaicin|capsaicin|mesh-list
102409634|NCT05093478|Anesthetics, Local|anesthetics, local|mesh-ancestor
102409635|NCT05093478|Anesthetics|anesthetics|mesh-ancestor
102409636|NCT05093478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102409637|NCT05093478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409638|NCT05093478|Sensory System Agents|sensory system agents|mesh-ancestor
102409639|NCT05093478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102409640|NCT05093478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102409641|NCT05093478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102409642|NCT05093478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102409643|NCT05093478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102409644|NCT05093478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409645|NCT05093478|Antipruritics|antipruritics|mesh-ancestor
102409646|NCT05093478|Dermatologic Agents|dermatologic agents|mesh-ancestor
102409647|NCT00725751|Interferons|interferons|mesh-list
102409648|NCT00725751|Ribavirin|ribavirin|mesh-list
102409649|NCT00725751|Interferon-alpha|interferon-alpha|mesh-list
102409650|NCT00725751|Interferon alpha-2|interferon alpha-2|mesh-list
102409651|NCT00725751|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102409652|NCT00725751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102409653|NCT00725751|Antiviral Agents|antiviral agents|mesh-ancestor
102409654|NCT00725751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102409655|NCT00725751|Antimetabolites|antimetabolites|mesh-ancestor
102409656|NCT00725751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221345|NCT02322203|Vitamins|vitamins|mesh-ancestor
102409657|NCT00725751|Immunologic Factors|immunologic factors|mesh-ancestor
102409658|NCT00725751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409659|NCT05364385|Budesonide|budesonide|mesh-list
102409660|NCT05364385|Pulmonary Surfactants|pulmonary surfactants|mesh-list
102409661|NCT05364385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102409662|NCT05364385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102409663|NCT05364385|Autonomic Agents|autonomic agents|mesh-ancestor
102409664|NCT05364385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102409665|NCT05364385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409666|NCT05364385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102409667|NCT05364385|Respiratory System Agents|respiratory system agents|mesh-ancestor
102409668|NCT05364385|Glucocorticoids|glucocorticoids|mesh-ancestor
102409669|NCT05364385|Hormones|hormones|mesh-ancestor
102409670|NCT05364385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102409671|NCT00726375|Etanercept|etanercept|mesh-list
102409672|NCT00726375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102409673|NCT00726375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102409674|NCT00726375|Analgesics|analgesics|mesh-ancestor
102409675|NCT00726375|Sensory System Agents|sensory system agents|mesh-ancestor
102409676|NCT00726375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102409677|NCT00726375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409678|NCT00726375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102409679|NCT00726375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102409680|NCT00726375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102409681|NCT00726375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102409682|NCT00726375|Immunologic Factors|immunologic factors|mesh-ancestor
102409683|NCT02693184|Vitamin D|vitamin d|mesh-list
102409684|NCT02693184|Calcium|calcium|mesh-list
102409685|NCT02693184|Vitamins|vitamins|mesh-ancestor
102409686|NCT02693184|Micronutrients|micronutrients|mesh-ancestor
102409687|NCT02693184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409688|NCT02693184|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102409689|NCT02693184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102409690|NCT05363059|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102409691|NCT05363059|Antihypertensive Agents|antihypertensive agents|mesh-list
102409692|NCT05363059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409693|NCT01394185|Dronabinol|dronabinol|mesh-list
102409694|NCT01394185|Hallucinogens|hallucinogens|mesh-ancestor
102409695|NCT01394185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409696|NCT01394185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102409697|NCT01394185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102409698|NCT01394185|Analgesics|analgesics|mesh-ancestor
102409699|NCT01394185|Sensory System Agents|sensory system agents|mesh-ancestor
102409700|NCT01394185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102409701|NCT01394185|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102409702|NCT01394185|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102409703|NCT01394185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102409704|NCT01394185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409705|NCT01394185|Hormones|hormones|mesh-ancestor
102409706|NCT01394185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102409707|NCT04361851|Pembrolizumab|pembrolizumab|mesh-list
102409708|NCT04361851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102409709|NCT04361851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102409710|NCT04361851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102409711|NCT04361851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409712|NCT04407715|Anesthetics|anesthetics|mesh-list
102409713|NCT04407715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102409714|NCT04407715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409715|NCT00727857|Metformin|metformin|mesh-list
102409716|NCT00727857|Pioglitazone|pioglitazone|mesh-list
102409717|NCT00727857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102409718|NCT00727857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409719|NCT05092152|Propofol|propofol|mesh-list
102409720|NCT05092152|Esketamine|esketamine|mesh-list
102409721|NCT05092152|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102409722|NCT05092152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102409723|NCT05092152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409724|NCT05092152|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102409725|NCT05092152|Anesthetics, General|anesthetics, general|mesh-ancestor
102409726|NCT05092152|Anesthetics|anesthetics|mesh-ancestor
102409727|NCT05092152|Antidepressive Agents|antidepressive agents|mesh-ancestor
102409728|NCT05092152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102409729|NCT05081700|Ocrelizumab|ocrelizumab|mesh-list
102409730|NCT05081700|Immunologic Factors|immunologic factors|mesh-ancestor
102409731|NCT05081700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409732|NCT05001360|Nivolumab|nivolumab|mesh-list
102409733|NCT05001360|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102409734|NCT05001360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102409735|NCT05001360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102409736|NCT05001360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409737|NCT05022810|Acetaminophen|acetaminophen|mesh-list
102409738|NCT05022810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102409739|NCT05022810|Analgesics|analgesics|mesh-ancestor
102409740|NCT05022810|Sensory System Agents|sensory system agents|mesh-ancestor
102409741|NCT05022810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102409742|NCT05022810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409743|NCT05022810|Antipyretics|antipyretics|mesh-ancestor
102409744|NCT01525550|Sunitinib|sunitinib|mesh-list
102409745|NCT01525550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102409746|NCT01525550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102409747|NCT01525550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102409748|NCT01525550|Growth Substances|growth substances|mesh-ancestor
102409749|NCT01525550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409750|NCT01525550|Growth Inhibitors|growth inhibitors|mesh-ancestor
102409751|NCT01525550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102409752|NCT01525550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102409753|NCT01525550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409754|NCT04730232|Paclitaxel|paclitaxel|mesh-list
102409755|NCT04730232|Tislelizumab|tislelizumab|mesh-list
102409756|NCT04730232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102409757|NCT04730232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102409758|NCT04730232|Tubulin Modulators|tubulin modulators|mesh-ancestor
102409759|NCT04730232|Antimitotic Agents|antimitotic agents|mesh-ancestor
102409760|NCT04730232|Mitosis Modulators|mitosis modulators|mesh-ancestor
102409761|NCT04730232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409762|NCT04730232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102409763|NCT04701918|Pembrolizumab|pembrolizumab|mesh-list
102409764|NCT04701918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102409765|NCT04701918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102409766|NCT04701918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102409767|NCT04701918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409768|NCT04540848|Bupivacaine|bupivacaine|mesh-list
102409769|NCT04540848|Anesthetics, Local|anesthetics, local|mesh-ancestor
102409770|NCT04540848|Anesthetics|anesthetics|mesh-ancestor
102409771|NCT04540848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102409772|NCT04540848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409773|NCT04540848|Sensory System Agents|sensory system agents|mesh-ancestor
102409774|NCT04540848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102409775|NCT04793100|Aflibercept|aflibercept|mesh-list
102409776|NCT04793100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102409777|NCT04793100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102409778|NCT04793100|Growth Substances|growth substances|mesh-ancestor
102409779|NCT04793100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409780|NCT04793100|Growth Inhibitors|growth inhibitors|mesh-ancestor
102409781|NCT04793100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102409782|NCT04760028|Anesthetics|anesthetics|mesh-list
102409783|NCT04760028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102409784|NCT04760028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409785|NCT05366101|Valsartan|valsartan|mesh-list
102409786|NCT05366101|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102409787|NCT05366101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102409788|NCT05366101|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102409789|NCT05366101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102409790|NCT05366101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409791|NCT04993560|Vaccines|vaccines|mesh-list
102409792|NCT04993560|Immunologic Factors|immunologic factors|mesh-ancestor
102409793|NCT04993560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409794|NCT05365555|Anesthetics|anesthetics|mesh-list
102409795|NCT05365555|Ropivacaine|ropivacaine|mesh-list
102409796|NCT05365555|Anesthetics, Local|anesthetics, local|mesh-list
102409797|NCT05365555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102409798|NCT05365555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409799|NCT05365555|Sensory System Agents|sensory system agents|mesh-ancestor
102409800|NCT05365555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102409801|NCT01525238|Dapagliflozin|dapagliflozin|mesh-list
102409802|NCT01525238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102409803|NCT01525238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409804|NCT01525238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102409805|NCT01525238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409806|NCT05374356|Morphine|morphine|mesh-list
102409807|NCT05374356|Bupivacaine|bupivacaine|mesh-list
102409808|NCT05374356|Anesthetics, Local|anesthetics, local|mesh-ancestor
102409809|NCT05374356|Anesthetics|anesthetics|mesh-ancestor
102409810|NCT05374356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102409811|NCT05374356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409812|NCT05374356|Sensory System Agents|sensory system agents|mesh-ancestor
102409813|NCT05374356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102409814|NCT05374356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102409815|NCT05374356|Narcotics|narcotics|mesh-ancestor
102409816|NCT05374356|Analgesics|analgesics|mesh-ancestor
102409817|NCT00717405|Bevacizumab|bevacizumab|mesh-list
102409818|NCT00717405|Trastuzumab|trastuzumab|mesh-list
102409819|NCT00717405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102409820|NCT00717405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102409821|NCT00717405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102409822|NCT00717405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102409823|NCT00717405|Growth Substances|growth substances|mesh-ancestor
102409824|NCT00717405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409825|NCT00717405|Growth Inhibitors|growth inhibitors|mesh-ancestor
102409826|NCT01276977|Zolmitriptan|zolmitriptan|mesh-list
102409827|NCT01276977|Eletriptan|eletriptan|mesh-list
102409828|NCT01276977|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102409829|NCT01276977|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102409830|NCT01276977|Serotonin Agents|serotonin agents|mesh-ancestor
102409831|NCT01276977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102409832|NCT01276977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409833|NCT01276977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409834|NCT03832699|Dydrogesterone|dydrogesterone|mesh-list
102409835|NCT03832699|Progesterone|progesterone|mesh-list
102409836|NCT03832699|Progestins|progestins|mesh-ancestor
102409837|NCT03832699|Hormones|hormones|mesh-ancestor
102409838|NCT03832699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102409839|NCT03832699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409840|NCT01277289|Dexamethasone|dexamethasone|mesh-list
102409841|NCT01277289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102409842|NCT01277289|Antiemetics|antiemetics|mesh-ancestor
102409843|NCT01277289|Autonomic Agents|autonomic agents|mesh-ancestor
102409844|NCT01277289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102409845|NCT01277289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409846|NCT01277289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102409847|NCT01277289|Glucocorticoids|glucocorticoids|mesh-ancestor
102409848|NCT01277289|Hormones|hormones|mesh-ancestor
102409849|NCT01277289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102409850|NCT01277289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102409851|NCT01277289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102409852|NCT01525082|Bevacizumab|bevacizumab|mesh-list
102409853|NCT01525082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102409854|NCT01525082|Capecitabine|capecitabine|mesh-list
102409855|NCT01525082|Temozolomide|temozolomide|mesh-list
102409856|NCT01525082|Antibodies|antibodies|mesh-list
102409857|NCT01525082|Immunoglobulins|immunoglobulins|mesh-list
102409858|NCT01525082|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102409859|NCT01525082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102409860|NCT01525082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102409861|NCT01525082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102409862|NCT01525082|Growth Substances|growth substances|mesh-ancestor
102409863|NCT01525082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409864|NCT01525082|Growth Inhibitors|growth inhibitors|mesh-ancestor
102409865|NCT01525082|Immunologic Factors|immunologic factors|mesh-ancestor
102409866|NCT01525082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102409867|NCT01525082|Antimetabolites|antimetabolites|mesh-ancestor
102409868|NCT01525082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409869|NCT01525082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102409870|NCT01525082|Alkylating Agents|alkylating agents|mesh-ancestor
102409871|NCT03599791|Fluticasone|fluticasone|mesh-list
102409872|NCT03599791|Xhance|xhance|mesh-list
102409873|NCT03599791|Azelastine|azelastine|mesh-list
102409874|NCT03599791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102409875|NCT03599791|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102409876|NCT03599791|Autonomic Agents|autonomic agents|mesh-ancestor
102409877|NCT03599791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102409878|NCT03599791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409879|NCT03599791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102409880|NCT03599791|Respiratory System Agents|respiratory system agents|mesh-ancestor
102409881|NCT03599791|Dermatologic Agents|dermatologic agents|mesh-ancestor
102221562|NCT02325557|Pembrolizumab|pembrolizumab|mesh-list
102409882|NCT03599791|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102409883|NCT03599791|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
102409884|NCT03599791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102409885|NCT03599791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409886|NCT03599791|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102409887|NCT03599791|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102409888|NCT03599791|Histamine Antagonists|histamine antagonists|mesh-ancestor
102409889|NCT03599791|Histamine Agents|histamine agents|mesh-ancestor
102409890|NCT03599791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102409891|NCT01488578|Tolterodine Tartrate|tolterodine tartrate|mesh-list
102409892|NCT01488578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102409893|NCT01488578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102409894|NCT01488578|Cholinergic Agents|cholinergic agents|mesh-ancestor
102409895|NCT01488578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102409896|NCT01488578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409897|NCT01488578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409898|NCT01488578|Urological Agents|urological agents|mesh-ancestor
102409900|NCT00720369|Coenzyme Q10|coenzyme q10|mesh-list
102409901|NCT00720369|Micronutrients|micronutrients|mesh-ancestor
102409902|NCT00720369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409903|NCT00720369|Vitamins|vitamins|mesh-ancestor
102409904|NCT01524770|Dulaglutide|dulaglutide|mesh-list
102409905|NCT01524770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102409906|NCT01524770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409907|NCT04088864|Cyclophosphamide|cyclophosphamide|mesh-list
102409908|NCT04088864|Fludarabine|fludarabine|mesh-list
102409909|NCT04088864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102409910|NCT04088864|Immunologic Factors|immunologic factors|mesh-ancestor
102409911|NCT04088864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409912|NCT04088864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102409913|NCT04088864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102409914|NCT04088864|Alkylating Agents|alkylating agents|mesh-ancestor
102409915|NCT04088864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409916|NCT04088864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102409917|NCT04088864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102409918|NCT02991339|Dexamethasone|dexamethasone|mesh-list
102409919|NCT02991339|Dexamethasone acetate|dexamethasone acetate|mesh-list
102409920|NCT02991339|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102409921|NCT02991339|BB 1101|bb 1101|mesh-list
102409922|NCT02991339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102409923|NCT02991339|Antiemetics|antiemetics|mesh-ancestor
102409924|NCT02991339|Autonomic Agents|autonomic agents|mesh-ancestor
102409925|NCT02991339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102409926|NCT02991339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409927|NCT02991339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102409928|NCT02991339|Glucocorticoids|glucocorticoids|mesh-ancestor
102409929|NCT02991339|Hormones|hormones|mesh-ancestor
102409930|NCT02991339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102409931|NCT02991339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102409932|NCT02991339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102409933|NCT02991339|Protease Inhibitors|protease inhibitors|mesh-ancestor
102409934|NCT02991339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102409935|NCT02991339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409936|NCT04018105|Metformin|metformin|mesh-list
102409937|NCT04018105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102409938|NCT04018105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409939|NCT05632549|Biotin|biotin|mesh-list
102409940|NCT05632549|Vitamin B Complex|vitamin b complex|mesh-ancestor
102409941|NCT05632549|Vitamins|vitamins|mesh-ancestor
102409942|NCT05632549|Micronutrients|micronutrients|mesh-ancestor
102409943|NCT05632549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409944|NCT00721617|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102409945|NCT00721617|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102409946|NCT00721617|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102409947|NCT00721617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102409948|NCT03597997|Propofol|propofol|mesh-list
102409949|NCT03597997|Sevoflurane|sevoflurane|mesh-list
102409950|NCT03597997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102409951|NCT03597997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102409952|NCT03597997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409953|NCT03597997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102409954|NCT03597997|Anesthetics, General|anesthetics, general|mesh-ancestor
102409955|NCT03597997|Anesthetics|anesthetics|mesh-ancestor
102409956|NCT03597997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102409957|NCT03597997|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102409958|NCT01277835|Lidocaine|lidocaine|mesh-list
102409959|NCT01277835|Anesthetics, Local|anesthetics, local|mesh-ancestor
102409960|NCT01277835|Anesthetics|anesthetics|mesh-ancestor
102409961|NCT01277835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102409962|NCT01277835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409963|NCT01277835|Sensory System Agents|sensory system agents|mesh-ancestor
102409964|NCT01277835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102409965|NCT01277835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102409966|NCT01277835|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102409967|NCT01277835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102409968|NCT01277835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102409969|NCT01277835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409970|NCT01431287|Tiotropium Bromide|tiotropium bromide|mesh-list
102409971|NCT01431287|Olodaterol|olodaterol|mesh-list
102409972|NCT01431287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102409973|NCT01431287|Autonomic Agents|autonomic agents|mesh-ancestor
102409974|NCT01431287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102409975|NCT01431287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409976|NCT01431287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102409977|NCT01431287|Respiratory System Agents|respiratory system agents|mesh-ancestor
102409978|NCT01431287|Parasympatholytics|parasympatholytics|mesh-ancestor
102409979|NCT01431287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102409980|NCT01431287|Cholinergic Agents|cholinergic agents|mesh-ancestor
102409981|NCT01431287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102409982|NCT01431287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409983|NCT05632159|Anesthetics|anesthetics|mesh-list
102409984|NCT05632159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102409985|NCT05632159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409986|NCT04017013|Lidocaine|lidocaine|mesh-list
102409987|NCT04017013|Anesthetics, Local|anesthetics, local|mesh-ancestor
102409988|NCT04017013|Anesthetics|anesthetics|mesh-ancestor
102409989|NCT04017013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102409990|NCT04017013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102409991|NCT04017013|Sensory System Agents|sensory system agents|mesh-ancestor
102409992|NCT04017013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102409993|NCT04017013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102409994|NCT04017013|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102409995|NCT04017013|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102409996|NCT04017013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102409997|NCT04017013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102409998|NCT01277913|Vitamin D|vitamin d|mesh-list
102409999|NCT01277913|Ergocalciferols|ergocalciferols|mesh-list
102410000|NCT01277913|Cholecalciferol|cholecalciferol|mesh-list
102410001|NCT01277913|Vitamins|vitamins|mesh-list
102410002|NCT01277913|Micronutrients|micronutrients|mesh-ancestor
102410003|NCT01277913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410004|NCT01277913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102410005|NCT01277913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102410006|NCT05631847|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102410007|NCT05631847|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102410008|NCT05631847|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102410009|NCT05631847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410010|NCT00729807|Pentamidine|pentamidine|mesh-list
102410011|NCT00729807|Antifungal Agents|antifungal agents|mesh-ancestor
102410012|NCT00729807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102410013|NCT00729807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102410014|NCT00729807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102410015|NCT00729807|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102410016|NCT03590119|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102410017|NCT03590119|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102410018|NCT03590119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410019|NCT03592693|Vitamins|vitamins|mesh-list
102410020|NCT03592693|Hydrocortisone|hydrocortisone|mesh-list
102410021|NCT03592693|Micronutrients|micronutrients|mesh-ancestor
102410022|NCT03592693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410023|NCT03592693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102410024|NCT00730353|Paclitaxel|paclitaxel|mesh-list
102410025|NCT00730353|Sunitinib|sunitinib|mesh-list
102410026|NCT00730353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102410027|NCT00730353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102410028|NCT00730353|Tubulin Modulators|tubulin modulators|mesh-ancestor
102410029|NCT00730353|Antimitotic Agents|antimitotic agents|mesh-ancestor
102410030|NCT00730353|Mitosis Modulators|mitosis modulators|mesh-ancestor
102410031|NCT00730353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410032|NCT00730353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102410033|NCT00730353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102410034|NCT00730353|Growth Substances|growth substances|mesh-ancestor
102410035|NCT00730353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410036|NCT00730353|Growth Inhibitors|growth inhibitors|mesh-ancestor
102410037|NCT00730353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102410038|NCT00730353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102410039|NCT01272531|Valproic Acid|valproic acid|mesh-list
102410040|NCT01272531|Lithium Carbonate|lithium carbonate|mesh-list
102410041|NCT01272531|Anticonvulsants|anticonvulsants|mesh-ancestor
102410042|NCT01272531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102410043|NCT01272531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410044|NCT01272531|GABA Agents|gaba agents|mesh-ancestor
102410045|NCT01272531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102410046|NCT01272531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410047|NCT01272531|Antimanic Agents|antimanic agents|mesh-ancestor
102410048|NCT01272531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102410049|NCT01272531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102410050|NCT01272531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102410051|NCT01272531|Antidepressive Agents|antidepressive agents|mesh-ancestor
102410053|NCT01272609|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102410054|NCT01272609|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102410055|NCT01272609|Adrenergic Agents|adrenergic agents|mesh-ancestor
102410056|NCT01272609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102410057|NCT01272609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410058|NCT01272609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410059|NCT01272609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102410060|NCT01272609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102410061|NCT03595189|Cilastatin|cilastatin|mesh-list
102410062|NCT03595189|Protease Inhibitors|protease inhibitors|mesh-ancestor
102410063|NCT03595189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102041088|NCT03136055|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102410064|NCT03595189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410065|NCT01410227|Factor VIII|factor viii|mesh-list
102410066|NCT01410227|Coagulants|coagulants|mesh-ancestor
102410067|NCT04007029|Cyclophosphamide|cyclophosphamide|mesh-list
102410068|NCT04007029|Fludarabine|fludarabine|mesh-list
102410069|NCT04007029|Fludarabine phosphate|fludarabine phosphate|mesh-list
102410070|NCT04007029|Immunoglobulins|immunoglobulins|mesh-list
102410071|NCT04007029|Immunoglobulin G|immunoglobulin g|mesh-list
102410072|NCT04007029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102410073|NCT04007029|Immunologic Factors|immunologic factors|mesh-ancestor
102410074|NCT04007029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410075|NCT04007029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102410076|NCT04007029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102410077|NCT04007029|Alkylating Agents|alkylating agents|mesh-ancestor
102410078|NCT04007029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410079|NCT04007029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102410080|NCT04007029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102410081|NCT04007029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102410082|NCT04007029|Antimetabolites|antimetabolites|mesh-ancestor
102410083|NCT01274559|Niacin|niacin|mesh-list
102410084|NCT01274559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102410085|NCT01274559|Antimetabolites|antimetabolites|mesh-ancestor
102410086|NCT01274559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410087|NCT01274559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102410088|NCT01274559|Vasodilator Agents|vasodilator agents|mesh-ancestor
102410089|NCT01274559|Vitamin B Complex|vitamin b complex|mesh-ancestor
102410090|NCT01274559|Vitamins|vitamins|mesh-ancestor
102410091|NCT01274559|Micronutrients|micronutrients|mesh-ancestor
102410092|NCT01274559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410093|NCT01409993|Sildenafil Citrate|sildenafil citrate|mesh-list
102410094|NCT01409993|Vasodilator Agents|vasodilator agents|mesh-ancestor
102410095|NCT01409993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102410096|NCT01409993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102410097|NCT01409993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102410098|NCT01409993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410099|NCT01409993|Urological Agents|urological agents|mesh-ancestor
102410100|NCT01409915|Molgramostim|molgramostim|mesh-list
102410101|NCT01409915|Sargramostim|sargramostim|mesh-list
102410102|NCT01409915|Immunologic Factors|immunologic factors|mesh-ancestor
102410103|NCT01409915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410104|NCT01409915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102410105|NCT01272921|Bupivacaine|bupivacaine|mesh-list
102410106|NCT01272921|Ropivacaine|ropivacaine|mesh-list
102221801|NCT04923295|Dapagliflozin|dapagliflozin|mesh-list
102410107|NCT01272921|Anesthetics, Local|anesthetics, local|mesh-ancestor
102410108|NCT01272921|Anesthetics|anesthetics|mesh-ancestor
102410109|NCT01272921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102410110|NCT01272921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410111|NCT01272921|Sensory System Agents|sensory system agents|mesh-ancestor
102410112|NCT01272921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102410113|NCT01409837|Lisinopril|lisinopril|mesh-list
102410114|NCT01409837|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102410115|NCT01409837|Protease Inhibitors|protease inhibitors|mesh-ancestor
102410116|NCT01409837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102410117|NCT01409837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410118|NCT01409837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102410119|NCT01409837|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102410120|NCT01409837|Protective Agents|protective agents|mesh-ancestor
102410121|NCT01409837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410122|NCT01278459|Atorvastatin|atorvastatin|mesh-list
102410123|NCT01278459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102410124|NCT01278459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102410125|NCT01278459|Antimetabolites|antimetabolites|mesh-ancestor
102410126|NCT01278459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410127|NCT01278459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102410128|NCT01278459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102410129|NCT01278459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102410130|NCT00731055|Varenicline|varenicline|mesh-list
102410131|NCT00731055|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102410132|NCT00731055|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102410133|NCT00731055|Cholinergic Agents|cholinergic agents|mesh-ancestor
102410134|NCT00731055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102410135|NCT00731055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410136|NCT00731055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410137|NCT03594565|Fluticasone|fluticasone|mesh-list
102410138|NCT03594565|Xhance|xhance|mesh-list
102410139|NCT03594565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102410140|NCT03594565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102410141|NCT03594565|Autonomic Agents|autonomic agents|mesh-ancestor
102410142|NCT03594565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102410143|NCT03594565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410144|NCT03594565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102410145|NCT03594565|Respiratory System Agents|respiratory system agents|mesh-ancestor
102410146|NCT03594565|Dermatologic Agents|dermatologic agents|mesh-ancestor
102410147|NCT03594565|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102410148|NCT01430585|Letrozole|letrozole|mesh-list
102410149|NCT01430585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102410150|NCT01430585|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102410151|NCT01430585|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102410152|NCT01430585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102410153|NCT01430585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410154|NCT01430585|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102410155|NCT01430585|Hormone Antagonists|hormone antagonists|mesh-ancestor
102410156|NCT01430585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102410157|NCT01430585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410158|NCT04005859|Lidocaine|lidocaine|mesh-list
102410159|NCT04005859|Anesthetics, Local|anesthetics, local|mesh-ancestor
102410160|NCT04005859|Anesthetics|anesthetics|mesh-ancestor
102410161|NCT04005859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102410162|NCT04005859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410163|NCT04005859|Sensory System Agents|sensory system agents|mesh-ancestor
102410164|NCT04005859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102410165|NCT04005859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102410166|NCT04005859|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102410167|NCT04005859|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102410168|NCT04005859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102410169|NCT04005859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410170|NCT05633719|Carboplatin|carboplatin|mesh-list
102410171|NCT05633719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102410172|NCT01408901|Molgramostim|molgramostim|mesh-list
102410173|NCT01408901|Sargramostim|sargramostim|mesh-list
102410174|NCT01408901|Immunologic Factors|immunologic factors|mesh-ancestor
102410175|NCT01408901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410176|NCT01408901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102410177|NCT02080195|Mycophenolic Acid|mycophenolic acid|mesh-list
102410178|NCT02080195|Cyclophosphamide|cyclophosphamide|mesh-list
102410179|NCT02080195|Fludarabine|fludarabine|mesh-list
102410180|NCT02080195|Tacrolimus|tacrolimus|mesh-list
102410181|NCT02080195|Thymoglobulin|thymoglobulin|mesh-list
102410182|NCT02080195|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102410183|NCT02080195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102410184|NCT02080195|Immunologic Factors|immunologic factors|mesh-ancestor
102410185|NCT02080195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410186|NCT02080195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102410187|NCT02080195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102410188|NCT02080195|Alkylating Agents|alkylating agents|mesh-ancestor
102410189|NCT02080195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410190|NCT02080195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102410191|NCT02080195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102410192|NCT02080195|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102410193|NCT02080195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102410194|NCT02080195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102410195|NCT02080195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102410196|NCT02080195|Antitubercular Agents|antitubercular agents|mesh-ancestor
102410197|NCT02080195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102410198|NCT02080195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102410199|NCT04044131|Sorbitol|sorbitol|mesh-list
102410200|NCT04044131|Cathartics|cathartics|mesh-ancestor
102410201|NCT04044131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102410202|NCT01428713|Tranexamic Acid|tranexamic acid|mesh-list
102410203|NCT01428713|Contraceptive Agents|contraceptive agents|mesh-list
102410204|NCT01428713|Contraceptives, Oral|contraceptives, oral|mesh-list
102410205|NCT01428713|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
102410206|NCT01428713|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102410207|NCT01428713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102410208|NCT01428713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410209|NCT01428713|Hemostatics|hemostatics|mesh-ancestor
102410210|NCT01428713|Coagulants|coagulants|mesh-ancestor
102410211|NCT01428713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102410212|NCT01428713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410213|NCT01428713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102410214|NCT01408043|Plerixafor|plerixafor|mesh-list
102410215|NCT01408043|Etoposide|etoposide|mesh-list
102410216|NCT01408043|Etoposide phosphate|etoposide phosphate|mesh-list
102410217|NCT01408043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102410218|NCT01408043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102410219|NCT01408043|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102410220|NCT01408043|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102410221|NCT01408043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102410222|NCT01408043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410223|NCT01408043|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102410224|NCT01408043|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102410225|NCT01408043|Antiviral Agents|antiviral agents|mesh-ancestor
102410226|NCT01408043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102410227|NCT00219349|Escitalopram|escitalopram|mesh-list
102410228|NCT00219349|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102410229|NCT00219349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102410230|NCT00219349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102410231|NCT00219349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410232|NCT00219349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102410233|NCT00219349|Serotonin Agents|serotonin agents|mesh-ancestor
102410234|NCT00219349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410235|NCT00218257|Progesterone|progesterone|mesh-list
102410236|NCT00218257|Progestins|progestins|mesh-ancestor
102410237|NCT00218257|Hormones|hormones|mesh-ancestor
102410238|NCT00218257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102410239|NCT00218257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410240|NCT01523366|Clopidogrel|clopidogrel|mesh-list
102410241|NCT01523366|Ticagrelor|ticagrelor|mesh-list
102410242|NCT01523366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102410243|NCT01523366|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102410244|NCT01523366|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102410245|NCT01523366|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102410246|NCT01523366|Purinergic Agents|purinergic agents|mesh-ancestor
102410247|NCT01523366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102410248|NCT01523366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410249|NCT01523366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410250|NCT03024697|Anesthetics|anesthetics|mesh-list
102410251|NCT03024697|Anesthetics, Local|anesthetics, local|mesh-list
102410252|NCT03024697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102410253|NCT03024697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410254|NCT03024697|Sensory System Agents|sensory system agents|mesh-ancestor
102410255|NCT03024697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102410256|NCT01427933|Ramucirumab|ramucirumab|mesh-list
102410257|NCT01427933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102410259|NCT00217087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102410260|NCT00217087|Dermatologic Agents|dermatologic agents|mesh-ancestor
102410261|NCT00217087|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102410262|NCT03780127|Fenfluramine|fenfluramine|mesh-list
102410263|NCT03780127|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102410264|NCT03780127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102410265|NCT03780127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102410266|NCT03780127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410267|NCT03780127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102410268|NCT03780127|Serotonin Agents|serotonin agents|mesh-ancestor
102410269|NCT03780127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410270|NCT01406873|Mexiletine|mexiletine|mesh-list
102410271|NCT01406873|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102410272|NCT01406873|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102410273|NCT01406873|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102410274|NCT01406873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102410275|NCT01406873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410276|NCT01406795|Heparin|heparin|mesh-list
102410277|NCT01406795|Anticoagulants|anticoagulants|mesh-ancestor
102410278|NCT01406795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102410279|NCT01406795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102410280|NCT01406795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410281|NCT01406015|Spironolactone|spironolactone|mesh-list
102410282|NCT01406015|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102410283|NCT01406015|Hormone Antagonists|hormone antagonists|mesh-ancestor
102410284|NCT01406015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102410285|NCT01406015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410286|NCT01406015|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102410287|NCT01406015|Diuretics|diuretics|mesh-ancestor
102410288|NCT01406015|Natriuretic Agents|natriuretic agents|mesh-ancestor
102410289|NCT00215137|Escitalopram|escitalopram|mesh-list
102410290|NCT00215137|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102410291|NCT00215137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102410292|NCT00215137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102410293|NCT00215137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410294|NCT00215137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102410295|NCT00215137|Serotonin Agents|serotonin agents|mesh-ancestor
102410296|NCT00215137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410297|NCT04406779|Hormones|hormones|mesh-list
102410298|NCT04406779|Autoantibodies|autoantibodies|mesh-list
102410299|NCT04406779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102410300|NCT04406779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410301|NCT04406779|Immunologic Factors|immunologic factors|mesh-ancestor
102410302|NCT00214201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
102410303|NCT00214201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102041322|NCT01335529|Immunologic Factors|immunologic factors|mesh-ancestor
102410304|NCT00214201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410305|NCT03598075|Pramlintide|pramlintide|mesh-list
102410306|NCT03598075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102410307|NCT03598075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410308|NCT03597919|Vaccines|vaccines|mesh-list
102410309|NCT03597919|Immunologic Factors|immunologic factors|mesh-ancestor
102410310|NCT03597919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410311|NCT04001413|Durvalumab|durvalumab|mesh-list
102410312|NCT04001413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102410313|NCT04001413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102410314|NCT01677858|Dexamethasone|dexamethasone|mesh-list
102410315|NCT01677858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102410316|NCT01677858|Antiemetics|antiemetics|mesh-ancestor
102410317|NCT01677858|Autonomic Agents|autonomic agents|mesh-ancestor
102410318|NCT01677858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102410319|NCT01677858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410320|NCT01677858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102410321|NCT01677858|Glucocorticoids|glucocorticoids|mesh-ancestor
102410322|NCT01677858|Hormones|hormones|mesh-ancestor
102410323|NCT01677858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102410324|NCT01677858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102410325|NCT01677858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102410326|NCT03027284|Gemcitabine|gemcitabine|mesh-list
102410327|NCT03027284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102410328|NCT03027284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102410329|NCT03027284|Antimetabolites|antimetabolites|mesh-ancestor
102410330|NCT03027284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410331|NCT03592069|Amoxicillin|amoxicillin|mesh-list
102410332|NCT03592069|Metronidazole|metronidazole|mesh-list
102410333|NCT03592069|Clarithromycin|clarithromycin|mesh-list
102410334|NCT03592069|Esomeprazole|esomeprazole|mesh-list
102410335|NCT03592069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102410336|NCT03592069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102410337|NCT03592069|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102410338|NCT03592069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102410339|NCT03592069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102410340|NCT03592069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102410341|NCT03592069|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102410342|NCT03592069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102410343|NCT03592069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410344|NCT03592069|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102410345|NCT03592069|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102410346|NCT03592069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102410347|NCT03591991|Empagliflozin|empagliflozin|mesh-list
102410348|NCT03591991|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102410349|NCT03591991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410350|NCT03591991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102410351|NCT03591991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410352|NCT03591913|Misoprostol|misoprostol|mesh-list
102410353|NCT03591913|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102410354|NCT03591913|Abortifacient Agents|abortifacient agents|mesh-ancestor
102410355|NCT03591913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102410356|NCT03591913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410357|NCT03591913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102410358|NCT03591913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102410359|NCT03591913|Oxytocics|oxytocics|mesh-ancestor
102410360|NCT04198129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102410361|NCT04198129|Amoxicillin|amoxicillin|mesh-list
102410362|NCT04198129|Clindamycin|clindamycin|mesh-list
102410363|NCT04198129|Clindamycin palmitate|clindamycin palmitate|mesh-list
102410364|NCT04198129|Clindamycin phosphate|clindamycin phosphate|mesh-list
102410365|NCT04198129|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102410366|NCT04198129|Ampicillin|ampicillin|mesh-list
102410367|NCT04198129|Sultamicillin|sultamicillin|mesh-list
102410368|NCT04198129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102410369|NCT04198129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102410370|NCT04198129|Antitubercular Agents|antitubercular agents|mesh-ancestor
102410371|NCT04198129|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102410372|NCT04198129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102410373|NCT04198129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410374|NCT04198129|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102410375|NCT03591757|Tolcapone|tolcapone|mesh-list
102410376|NCT03591757|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102410377|NCT03591757|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102410378|NCT03591757|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102410379|NCT03591757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102410380|NCT03591757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410381|NCT04438434|Chlorhexidine|chlorhexidine|mesh-list
102410382|NCT04438434|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102410383|NCT04438434|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102410384|NCT04438434|Hyaluronic Acid|hyaluronic acid|mesh-list
102410385|NCT04438434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102410386|NCT04438434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102410387|NCT04438434|Disinfectants|disinfectants|mesh-ancestor
102410388|NCT04438434|Dermatologic Agents|dermatologic agents|mesh-ancestor
102410389|NCT04438434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102410390|NCT04438434|Immunologic Factors|immunologic factors|mesh-ancestor
102410391|NCT04438434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410392|NCT04438434|Viscosupplements|viscosupplements|mesh-ancestor
102410393|NCT04438434|Protective Agents|protective agents|mesh-ancestor
102410394|NCT03591679|Oxytocin|oxytocin|mesh-list
102410395|NCT03591679|Oxytocics|oxytocics|mesh-ancestor
102410396|NCT03591679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102410397|NCT03591679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410398|NCT04197817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102410399|NCT04197817|Antibodies|antibodies|mesh-list
102410400|NCT04197817|Immunoglobulins|immunoglobulins|mesh-list
102410401|NCT04197817|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102410402|NCT04197817|Immunologic Factors|immunologic factors|mesh-ancestor
102410403|NCT04197817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410404|NCT04197817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102410405|NCT04585854|Caffeine|caffeine|mesh-list
102410406|NCT04585854|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102410407|NCT04585854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410408|NCT04585854|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102410409|NCT04585854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102410410|NCT04585854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410411|NCT04585854|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102410412|NCT04585854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102410413|NCT04585854|Purinergic Agents|purinergic agents|mesh-ancestor
102410414|NCT04585854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102410415|NCT03481842|Axitinib|axitinib|mesh-list
102410416|NCT03481842|Afatinib|afatinib|mesh-list
102410417|NCT03481842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102410418|NCT03481842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102410419|NCT03481842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102410420|NCT03481842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410421|NCT04197739|Amikacin|amikacin|mesh-list
102410422|NCT04197739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102410423|NCT04197739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102410424|NCT03449706|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102410425|NCT03449706|Antiviral Agents|antiviral agents|mesh-ancestor
102410426|NCT03449706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102410427|NCT04197349|Sumatriptan|sumatriptan|mesh-list
102410428|NCT04197349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102410429|NCT04197349|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102410430|NCT04197349|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102410431|NCT04197349|Serotonin Agents|serotonin agents|mesh-ancestor
102410432|NCT04197349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102410433|NCT04197349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410434|NCT04197349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410435|NCT03422094|Nivolumab|nivolumab|mesh-list
102410436|NCT03422094|Ipilimumab|ipilimumab|mesh-list
102410437|NCT03422094|Poly ICLC|poly iclc|mesh-list
102410438|NCT03422094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102410439|NCT03422094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102410440|NCT03422094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102410441|NCT03422094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410442|NCT03422094|Interferon Inducers|interferon inducers|mesh-ancestor
102410443|NCT03422094|Immunologic Factors|immunologic factors|mesh-ancestor
102410444|NCT03422094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410445|NCT04356534|Antibodies|antibodies|mesh-list
102410446|NCT04356534|Immunologic Factors|immunologic factors|mesh-ancestor
102410447|NCT04356534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410448|NCT03591289|Bromides|bromides|mesh-list
102410449|NCT03591289|Rocuronium|rocuronium|mesh-list
102410450|NCT03591289|Anticonvulsants|anticonvulsants|mesh-ancestor
102410451|NCT03591289|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102410452|NCT03591289|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102410453|NCT03591289|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102410454|NCT03591289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102410455|NCT03591289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410456|NCT05338866|Capecitabine|capecitabine|mesh-list
102410457|NCT05338866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102410458|NCT05338866|Antimetabolites|antimetabolites|mesh-ancestor
102410459|NCT05338866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410460|NCT05338866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102410461|NCT02471118|Adalimumab|adalimumab|mesh-list
102410462|NCT02471118|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102410463|NCT02471118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102410464|NCT02471118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102410465|NCT04197115|Vitamins|vitamins|mesh-list
102410466|NCT04197115|Ascorbic Acid|ascorbic acid|mesh-list
102410467|NCT04197115|Vitamin B Complex|vitamin b complex|mesh-list
102410468|NCT04197115|Hydrocortisone|hydrocortisone|mesh-list
102410469|NCT04197115|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102410470|NCT04197115|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102410471|NCT04197115|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102410472|NCT04197115|Micronutrients|micronutrients|mesh-ancestor
102410473|NCT04197115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410474|NCT04197115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102410475|NCT04197115|Antioxidants|antioxidants|mesh-ancestor
102410476|NCT04197115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222167|NCT03466021|Hormones|hormones|mesh-ancestor
102410477|NCT04197115|Protective Agents|protective agents|mesh-ancestor
102410478|NCT02467452|Tiotropium Bromide|tiotropium bromide|mesh-list
102410479|NCT02467452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102410480|NCT02467452|Autonomic Agents|autonomic agents|mesh-ancestor
102410481|NCT02467452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102410482|NCT02467452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410483|NCT02467452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102410484|NCT02467452|Respiratory System Agents|respiratory system agents|mesh-ancestor
102410485|NCT02467452|Parasympatholytics|parasympatholytics|mesh-ancestor
102410486|NCT02467452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102410487|NCT02467452|Cholinergic Agents|cholinergic agents|mesh-ancestor
102410488|NCT02467452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102410489|NCT02467452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410490|NCT03590587|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
102410491|NCT03590587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102410492|NCT03590587|Glucocorticoids|glucocorticoids|mesh-ancestor
102410493|NCT03590587|Hormones|hormones|mesh-ancestor
102410494|NCT03590587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102410495|NCT03590587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410496|NCT03590431|Iodine|iodine|mesh-list
102410497|NCT03590431|Cadexomer iodine|cadexomer iodine|mesh-list
102410498|NCT03590431|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102410499|NCT03590431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102410500|NCT03590431|Trace Elements|trace elements|mesh-ancestor
102410501|NCT03590431|Micronutrients|micronutrients|mesh-ancestor
102410502|NCT03590431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410503|NCT03980665|Arsenic Trioxide|arsenic trioxide|mesh-list
102410504|NCT03980665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102410505|NCT05102448|Methotrexate|methotrexate|mesh-list
102410506|NCT05102448|Tofacitinib|tofacitinib|mesh-list
102410507|NCT05102448|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102410508|NCT05102448|Abortifacient Agents|abortifacient agents|mesh-ancestor
102410509|NCT05102448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102410510|NCT05102448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410511|NCT05102448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102410512|NCT05102448|Antimetabolites|antimetabolites|mesh-ancestor
102410513|NCT05102448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410514|NCT05102448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102410515|NCT05102448|Dermatologic Agents|dermatologic agents|mesh-ancestor
102410516|NCT05102448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102410517|NCT05102448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102410518|NCT05102448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102410519|NCT05102448|Immunologic Factors|immunologic factors|mesh-ancestor
102410520|NCT05102448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102410521|NCT05102448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102410522|NCT05102448|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102410523|NCT05102448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102410524|NCT03599323|Clotrimazole|clotrimazole|mesh-list
102410525|NCT03599323|Miconazole|miconazole|mesh-list
102410526|NCT03599323|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102410527|NCT03599323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102410528|NCT03599323|Antifungal Agents|antifungal agents|mesh-ancestor
102410529|NCT03599323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102410530|NCT03599323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102410531|NCT03599323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102410532|NCT03599323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410533|NCT03599323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102410534|NCT03599323|Hormone Antagonists|hormone antagonists|mesh-ancestor
102410535|NCT03599323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102410536|NCT03599323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410537|NCT03599323|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102410538|NCT03599323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102410539|NCT04195867|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102410540|NCT04195867|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102410541|NCT04195867|Autonomic Agents|autonomic agents|mesh-ancestor
102410542|NCT04195867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102410543|NCT04195867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410544|NCT04195867|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102410545|NCT04195867|Respiratory System Agents|respiratory system agents|mesh-ancestor
102410546|NCT04195867|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102410547|NCT04195867|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102410548|NCT04195867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102410549|NCT04195867|Adrenergic Agents|adrenergic agents|mesh-ancestor
102410550|NCT04195867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102410551|NCT04195867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410552|NCT05102058|Dexmedetomidine|dexmedetomidine|mesh-list
102410553|NCT05102058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102410554|NCT05102058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102410555|NCT05102058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410556|NCT05102058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102410558|NCT05102058|Sensory System Agents|sensory system agents|mesh-ancestor
102410559|NCT05102058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102410560|NCT05102058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102410561|NCT05102058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102410562|NCT05102058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102410563|NCT05102058|Adrenergic Agents|adrenergic agents|mesh-ancestor
102410564|NCT05102058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102410565|NCT05102058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410566|NCT03956797|Anesthetics|anesthetics|mesh-list
102410567|NCT03956797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102410568|NCT03956797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410569|NCT03598777|Botulinum Toxins|botulinum toxins|mesh-list
102410570|NCT03598777|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102410571|NCT03598777|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102410572|NCT03598777|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102410573|NCT03598777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102410574|NCT03598777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410575|NCT03598777|Cholinergic Agents|cholinergic agents|mesh-ancestor
102410576|NCT03598777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102410577|NCT03598777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410578|NCT03598777|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102410579|NCT03598777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102410580|NCT04195243|Dapagliflozin|dapagliflozin|mesh-list
102410581|NCT04195243|Empagliflozin|empagliflozin|mesh-list
102410582|NCT04195243|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102410583|NCT04195243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410584|NCT04195243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102410585|NCT04195243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410586|NCT04195321|Phenylephrine|phenylephrine|mesh-list
102410587|NCT04195321|Oxymetazoline|oxymetazoline|mesh-list
102410588|NCT04195321|Norepinephrine|norepinephrine|mesh-list
102410589|NCT04195321|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102410590|NCT04195321|Mydriatics|mydriatics|mesh-ancestor
102410591|NCT04195321|Autonomic Agents|autonomic agents|mesh-ancestor
102410592|NCT04195321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102410593|NCT04195321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410594|NCT04195321|Sympathomimetics|sympathomimetics|mesh-ancestor
102410595|NCT04195321|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102410596|NCT04195321|Nasal Decongestants|nasal decongestants|mesh-ancestor
102410597|NCT04195321|Respiratory System Agents|respiratory system agents|mesh-ancestor
102410598|NCT04195321|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102410599|NCT04195321|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102410600|NCT04195321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102410601|NCT04195321|Adrenergic Agents|adrenergic agents|mesh-ancestor
102410602|NCT04195321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102410603|NCT04195321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041620|NCT01379001|Nootropic Agents|nootropic agents|mesh-ancestor
102410604|NCT04195321|Protective Agents|protective agents|mesh-ancestor
102410605|NCT06012760|Epoetin Alfa|epoetin alfa|mesh-list
102410606|NCT06012760|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102410607|NCT06012760|Hematinics|hematinics|mesh-ancestor
102410608|NCT06012734|Atezolizumab|atezolizumab|mesh-list
102410609|NCT06012734|LB100|lb100|mesh-list
102410610|NCT06012734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102410611|NCT06012734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410612|NCT06012734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102410613|NCT06012734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102410614|NCT06012734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102410615|NCT06012695|Temozolomide|temozolomide|mesh-list
102410616|NCT06012695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102410617|NCT06012695|Alkylating Agents|alkylating agents|mesh-ancestor
102410618|NCT06012695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410619|NCT06012695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102410620|NCT06012682|Metformin|metformin|mesh-list
102410621|NCT06012682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102410622|NCT06012682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410623|NCT06012552|Tianeptine|tianeptine|mesh-list
102410624|NCT06012552|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102410625|NCT06012552|Antidepressive Agents|antidepressive agents|mesh-ancestor
102410626|NCT06012552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102410627|NCT06012500|Xenon|xenon|mesh-list
102410632|NCT06012500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410633|NCT06012435|Docetaxel|docetaxel|mesh-list
102410634|NCT06012435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102410635|NCT06012435|Tubulin Modulators|tubulin modulators|mesh-ancestor
102410636|NCT06012435|Antimitotic Agents|antimitotic agents|mesh-ancestor
102410637|NCT06012435|Mitosis Modulators|mitosis modulators|mesh-ancestor
102410638|NCT06012435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410639|NCT06012383|Bortezomib|bortezomib|mesh-list
102410640|NCT06012383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102410641|NCT06012279|Dapagliflozin|dapagliflozin|mesh-list
102410642|NCT06012279|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102410643|NCT06012279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410644|NCT06012279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102410645|NCT06012279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410646|NCT06012266|Dapagliflozin|dapagliflozin|mesh-list
102410647|NCT06012266|Empagliflozin|empagliflozin|mesh-list
102410648|NCT06012266|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102410649|NCT06012266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410650|NCT06012266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102410651|NCT06012266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410652|NCT06012240|Upadacitinib|upadacitinib|mesh-list
102410653|NCT06012240|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102410654|NCT06012240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102410655|NCT06012240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102410656|NCT06012240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410657|NCT06012240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102410658|NCT06012175|Melatonin|melatonin|mesh-list
102410659|NCT06012175|Antioxidants|antioxidants|mesh-ancestor
102410660|NCT06012175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410661|NCT06012175|Protective Agents|protective agents|mesh-ancestor
102410662|NCT06012175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410663|NCT06012175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102410664|NCT06012097|Diclofenac|diclofenac|mesh-list
102410665|NCT06012097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102410666|NCT06012097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102410667|NCT06012097|Analgesics|analgesics|mesh-ancestor
102410668|NCT06012097|Sensory System Agents|sensory system agents|mesh-ancestor
102410669|NCT06012097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102410670|NCT06012097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410671|NCT06012097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102410672|NCT06012097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102410673|NCT06012097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102410674|NCT06012097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102410675|NCT06012097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410676|NCT06011980|Growth Inhibitors|growth inhibitors|mesh-list
102410677|NCT06011980|Growth Substances|growth substances|mesh-ancestor
102410678|NCT06011980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410679|NCT06011889|Etanercept|etanercept|mesh-list
102410680|NCT06011889|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102410681|NCT06011889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102410682|NCT06011889|Analgesics|analgesics|mesh-ancestor
102410683|NCT06011889|Sensory System Agents|sensory system agents|mesh-ancestor
102410684|NCT06011889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102410685|NCT06011889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410686|NCT06011889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102410687|NCT06011889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102410688|NCT06011889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102410689|NCT06011889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102410690|NCT06011889|Immunologic Factors|immunologic factors|mesh-ancestor
102410691|NCT06011798|Aflibercept|aflibercept|mesh-list
102410692|NCT06011798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102410693|NCT06011798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102410694|NCT06011798|Growth Substances|growth substances|mesh-ancestor
102410695|NCT06011798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410696|NCT06011798|Growth Inhibitors|growth inhibitors|mesh-ancestor
102410697|NCT06011798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102410766|NCT06011343|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102410767|NCT06011343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102410768|NCT06011343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102410769|NCT06011343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410770|NCT06011343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102410771|NCT06011343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102410772|NCT06011343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102410773|NCT06011265|Mirabegron|mirabegron|mesh-list
102410774|NCT06011265|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102410775|NCT06011265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102410776|NCT06011265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102410777|NCT06011265|Adrenergic Agents|adrenergic agents|mesh-ancestor
102410778|NCT06011265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102410779|NCT06011265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410780|NCT06011265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410781|NCT06011265|Urological Agents|urological agents|mesh-ancestor
102410782|NCT06011083|Betamethasone|betamethasone|mesh-list
102410783|NCT06011083|Betamethasone Valerate|betamethasone valerate|mesh-list
102410784|NCT06011083|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102410785|NCT06011083|Betamethasone benzoate|betamethasone benzoate|mesh-list
102410786|NCT06011083|Calcipotriene|calcipotriene|mesh-list
102410787|NCT06011083|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102410788|NCT06011083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102410789|NCT06011083|Glucocorticoids|glucocorticoids|mesh-ancestor
102410790|NCT06011083|Hormones|hormones|mesh-ancestor
102410791|NCT06011083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102410792|NCT06011083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410793|NCT06011083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102410794|NCT06011083|Respiratory System Agents|respiratory system agents|mesh-ancestor
102410795|NCT06011083|Dermatologic Agents|dermatologic agents|mesh-ancestor
102410796|NCT06011005|Benzocaine|benzocaine|mesh-list
102410797|NCT06011005|Ethyl Chloride|ethyl chloride|mesh-list
102410798|NCT06011005|Anesthetics, Local|anesthetics, local|mesh-ancestor
102410799|NCT06011005|Anesthetics|anesthetics|mesh-ancestor
102410800|NCT06011005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102410801|NCT06011005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410802|NCT06011005|Sensory System Agents|sensory system agents|mesh-ancestor
102410803|NCT06011005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102410804|NCT06010992|Nitazoxanide|nitazoxanide|mesh-list
102410805|NCT06010992|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102410806|NCT06010992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102410807|NCT06010927|Midazolam|midazolam|mesh-list
102410808|NCT06010927|Ketamine|ketamine|mesh-list
102410809|NCT06010927|Analgesics|analgesics|mesh-ancestor
102410810|NCT06010927|Sensory System Agents|sensory system agents|mesh-ancestor
102410811|NCT06010927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102410812|NCT06010927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410813|NCT06010927|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102410814|NCT06010927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102410815|NCT06010927|Anesthetics, General|anesthetics, general|mesh-ancestor
102410816|NCT06010927|Anesthetics|anesthetics|mesh-ancestor
102410817|NCT06010927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102410818|NCT06010927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102410819|NCT06010927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102410820|NCT06010927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102410821|NCT06010927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410822|NCT06010927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102410823|NCT06010927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102410824|NCT06010927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102410825|NCT06010927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102410826|NCT06010927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102410827|NCT06010927|GABA Modulators|gaba modulators|mesh-ancestor
102410828|NCT06010927|GABA Agents|gaba agents|mesh-ancestor
102410829|NCT06010810|Tranexamic Acid|tranexamic acid|mesh-list
102410830|NCT06010810|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102410831|NCT06010810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102410832|NCT06010810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410833|NCT06010810|Hemostatics|hemostatics|mesh-ancestor
102410834|NCT06010810|Coagulants|coagulants|mesh-ancestor
102410835|NCT06010758|Listerine|listerine|mesh-list
102410836|NCT06010758|Sodium Fluoride|sodium fluoride|mesh-list
102410837|NCT06010758|Cariostatic Agents|cariostatic agents|mesh-ancestor
102410838|NCT06010758|Protective Agents|protective agents|mesh-ancestor
102410839|NCT06010758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410840|NCT06010758|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102410841|NCT06010758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102410842|NCT06010745|Biotin|biotin|mesh-list
102410843|NCT06010745|Silicon|silicon|mesh-list
102410844|NCT06010745|Vitamin B Complex|vitamin b complex|mesh-ancestor
102410845|NCT06010745|Vitamins|vitamins|mesh-ancestor
102410846|NCT06010745|Micronutrients|micronutrients|mesh-ancestor
102410847|NCT06010745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410848|NCT06010745|Trace Elements|trace elements|mesh-ancestor
102410849|NCT06010732|Listerine|listerine|mesh-list
102410850|NCT06010732|Fluorides|fluorides|mesh-list
102410851|NCT06010732|Sodium Fluoride|sodium fluoride|mesh-list
102410852|NCT06010732|Cariostatic Agents|cariostatic agents|mesh-ancestor
102410853|NCT06010732|Protective Agents|protective agents|mesh-ancestor
102410854|NCT06010732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410855|NCT06010732|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102410856|NCT06010732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102410857|NCT06010719|Amoxicillin|amoxicillin|mesh-list
102410858|NCT06010719|Azithromycin|azithromycin|mesh-list
102410859|NCT06010719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102410860|NCT06010719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102410861|NCT06010628|Tenecteplase|tenecteplase|mesh-list
102410862|NCT06010628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102410863|NCT06010628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102410864|NCT06010628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410865|NCT06010368|Tranexamic Acid|tranexamic acid|mesh-list
102410866|NCT06010368|Oxytocin|oxytocin|mesh-list
102410867|NCT06010368|Oxytocics|oxytocics|mesh-ancestor
102410868|NCT06010368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102410869|NCT06010368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410870|NCT06010368|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102410871|NCT06010368|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102410872|NCT06010368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410873|NCT06010368|Hemostatics|hemostatics|mesh-ancestor
102410874|NCT06010368|Coagulants|coagulants|mesh-ancestor
102410875|NCT06010121|Vitamin D|vitamin d|mesh-list
102410876|NCT06010121|Ergocalciferols|ergocalciferols|mesh-list
102410877|NCT06010121|Cholecalciferol|cholecalciferol|mesh-list
102410878|NCT06010121|Vitamins|vitamins|mesh-list
102410879|NCT06010121|Micronutrients|micronutrients|mesh-ancestor
102410880|NCT06010121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410881|NCT06010121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102410882|NCT06010121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102410883|NCT06008990|Buprenorphine|buprenorphine|mesh-list
102410884|NCT06008990|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102410885|NCT06008990|Narcotics|narcotics|mesh-ancestor
102410886|NCT06008990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102410887|NCT06008990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410888|NCT06008990|Analgesics|analgesics|mesh-ancestor
102410889|NCT06008990|Sensory System Agents|sensory system agents|mesh-ancestor
102410890|NCT06008990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102410891|NCT06008990|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102410892|NCT06008002|Tramadol|tramadol|mesh-list
102410893|NCT06008002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102410894|NCT06008002|Narcotics|narcotics|mesh-ancestor
102410895|NCT06008002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102410896|NCT06008002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410897|NCT06008002|Analgesics|analgesics|mesh-ancestor
102410898|NCT06008002|Sensory System Agents|sensory system agents|mesh-ancestor
102410899|NCT06008002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102410900|NCT06006286|Bevacizumab|bevacizumab|mesh-list
102410901|NCT06006286|Atezolizumab|atezolizumab|mesh-list
102410902|NCT06006286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102410903|NCT06006286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102410904|NCT06006286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102410905|NCT06006286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102410906|NCT06006286|Growth Substances|growth substances|mesh-ancestor
102410907|NCT06006286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410908|NCT06006286|Growth Inhibitors|growth inhibitors|mesh-ancestor
102410909|NCT06006286|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102410910|NCT06006286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410911|NCT05996627|Belumosudil|belumosudil|mesh-list
102410912|NCT05996627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102410913|NCT05996627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102410914|NCT05996627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410915|NCT05996133|Dexamethasone|dexamethasone|mesh-list
102410916|NCT05996133|Epinephrine|epinephrine|mesh-list
102410917|NCT05996133|Bupivacaine|bupivacaine|mesh-list
102410918|NCT05996133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102410919|NCT05996133|Antiemetics|antiemetics|mesh-ancestor
102410920|NCT05996133|Autonomic Agents|autonomic agents|mesh-ancestor
102410921|NCT05996133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102410922|NCT05996133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410923|NCT05996133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102410924|NCT05996133|Glucocorticoids|glucocorticoids|mesh-ancestor
102410925|NCT05996133|Hormones|hormones|mesh-ancestor
102410926|NCT05996133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102410927|NCT05996133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102410928|NCT05996133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102410929|NCT05996133|Anesthetics, Local|anesthetics, local|mesh-ancestor
102410930|NCT05996133|Anesthetics|anesthetics|mesh-ancestor
102410931|NCT05996133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102410932|NCT05996133|Sensory System Agents|sensory system agents|mesh-ancestor
102410933|NCT05996133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102410934|NCT05996133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102410935|NCT05996133|Adrenergic Agents|adrenergic agents|mesh-ancestor
102410936|NCT05996133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102410937|NCT05996133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410938|NCT05996133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102410939|NCT05996133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102410940|NCT05996133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102410941|NCT05996133|Respiratory System Agents|respiratory system agents|mesh-ancestor
102410942|NCT05996133|Mydriatics|mydriatics|mesh-ancestor
102410943|NCT05996133|Sympathomimetics|sympathomimetics|mesh-ancestor
102410944|NCT05996133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102410945|NCT05969223|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102410946|NCT05969223|Immunologic Factors|immunologic factors|mesh-ancestor
102410947|NCT05969223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410948|NCT05967286|Olaparib|olaparib|mesh-list
102410949|NCT05967286|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102410950|NCT05967286|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
102410951|NCT05967286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102410952|NCT05967286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410953|NCT05967286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102410954|NCT05965492|Acetaminophen|acetaminophen|mesh-list
102410955|NCT05965492|Celecoxib|celecoxib|mesh-list
102410956|NCT05965492|Oxycodone|oxycodone|mesh-list
102410957|NCT05965492|Gabapentin|gabapentin|mesh-list
102410958|NCT05965492|Famotidine|famotidine|mesh-list
102410959|NCT05965492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102410960|NCT05965492|Analgesics|analgesics|mesh-ancestor
102410961|NCT05965492|Sensory System Agents|sensory system agents|mesh-ancestor
102410962|NCT05965492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102410963|NCT05965492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410964|NCT05965492|Antipyretics|antipyretics|mesh-ancestor
102410965|NCT05965492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102410966|NCT05965492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102410967|NCT05965492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102410968|NCT05965492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102410969|NCT05965492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102410970|NCT05965492|Narcotics|narcotics|mesh-ancestor
102410971|NCT05965492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102410972|NCT05965492|Anticonvulsants|anticonvulsants|mesh-ancestor
102410973|NCT05965492|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102410974|NCT05965492|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102410975|NCT05965492|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102410976|NCT05965492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102410977|NCT05965492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102410978|NCT05965492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102410979|NCT05965492|Antimanic Agents|antimanic agents|mesh-ancestor
102410980|NCT05965492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102410981|NCT05965492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102410982|NCT05965492|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102410983|NCT05965492|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102410984|NCT05965492|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102410985|NCT05965492|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102410986|NCT05965492|Histamine Antagonists|histamine antagonists|mesh-ancestor
102410987|NCT05965492|Histamine Agents|histamine agents|mesh-ancestor
102410988|NCT05941520|Tamoxifen|tamoxifen|mesh-list
102410989|NCT05941520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102410990|NCT05941520|Hormone Antagonists|hormone antagonists|mesh-ancestor
102410991|NCT05941520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102410992|NCT05941520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102410993|NCT05941520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102410994|NCT05941520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102410995|NCT05941520|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102410996|NCT05941520|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102410997|NCT05941520|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102410998|NCT05935774|Atezolizumab|atezolizumab|mesh-list
102410999|NCT05935774|Trabedersen|trabedersen|mesh-list
102411000|NCT05935774|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102411001|NCT05935774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411002|NCT05935774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102411003|NCT05935774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411004|NCT05928806|Nivolumab|nivolumab|mesh-list
102411005|NCT05928806|Ipilimumab|ipilimumab|mesh-list
102411006|NCT05928806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102411007|NCT05928806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411008|NCT05928806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102411009|NCT05928806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411010|NCT05926440|Vaccines|vaccines|mesh-list
102411011|NCT05926440|Somatomedin B|somatomedin b|mesh-list
102411012|NCT05926440|Immunologic Factors|immunologic factors|mesh-ancestor
102411013|NCT05926440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411014|NCT05926440|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102411015|NCT05926440|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102411016|NCT05926440|Protease Inhibitors|protease inhibitors|mesh-ancestor
102411017|NCT05926440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102411018|NCT05926440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411019|NCT05898646|Daratumumab|daratumumab|mesh-list
102411020|NCT05898646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411021|NCT05868525|Aspirin|aspirin|mesh-list
102411022|NCT05868525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102411023|NCT05868525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102411024|NCT05868525|Analgesics|analgesics|mesh-ancestor
102411025|NCT05868525|Sensory System Agents|sensory system agents|mesh-ancestor
102411026|NCT05868525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102411027|NCT05868525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411028|NCT05868525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102411029|NCT05868525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102411030|NCT05868525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102411031|NCT05868525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102411032|NCT05868525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411033|NCT05868525|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102411034|NCT05868525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102411035|NCT05868525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102411036|NCT05868525|Antipyretics|antipyretics|mesh-ancestor
102411037|NCT05864742|Rituximab|rituximab|mesh-list
102411038|NCT05864742|Venetoclax|venetoclax|mesh-list
102411039|NCT05864742|Navitoclax|navitoclax|mesh-list
102411040|NCT05864742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102411041|NCT05864742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411042|NCT05864742|Immunologic Factors|immunologic factors|mesh-ancestor
102411043|NCT05864742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411044|NCT05864742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102411045|NCT05852691|Paclitaxel|paclitaxel|mesh-list
102411046|NCT05852691|Pembrolizumab|pembrolizumab|mesh-list
102411047|NCT05852691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102411048|NCT05852691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411049|NCT05852691|Tubulin Modulators|tubulin modulators|mesh-ancestor
102411050|NCT05852691|Antimitotic Agents|antimitotic agents|mesh-ancestor
102411051|NCT05852691|Mitosis Modulators|mitosis modulators|mesh-ancestor
102411052|NCT05852691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411053|NCT05852691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102411054|NCT05852691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102411055|NCT05846789|Carboplatin|carboplatin|mesh-list
102411056|NCT05846789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411057|NCT05837455|Anastrozole|anastrozole|mesh-list
102411058|NCT05837455|Taxane|taxane|mesh-list
102411059|NCT05837455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102411060|NCT05837455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411061|NCT05837455|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102411062|NCT05837455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102411063|NCT05837455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102411064|NCT05837455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411065|NCT05837455|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102411066|NCT05837455|Hormone Antagonists|hormone antagonists|mesh-ancestor
102411067|NCT05837455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102411068|NCT05837455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411069|NCT05822752|Sorafenib|sorafenib|mesh-list
102411070|NCT05822752|Lenvatinib|lenvatinib|mesh-list
102411071|NCT05822752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411072|NCT05822752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102411073|NCT05822752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102411074|NCT05822752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411075|NCT05822583|Abatacept|abatacept|mesh-list
102411076|NCT05822583|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102411077|NCT05822583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411078|NCT05822583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102411079|NCT05822583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411080|NCT05822583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102411081|NCT05822583|Immunologic Factors|immunologic factors|mesh-ancestor
102222754|NCT03478709|Sympathomimetics|sympathomimetics|mesh-ancestor
102411082|NCT05822583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411083|NCT05822583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102411085|NCT05817851|Thiamine|thiamine|mesh-list
102411086|NCT05817851|Micronutrients|micronutrients|mesh-ancestor
102411087|NCT05817851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411088|NCT05817851|Vitamin B Complex|vitamin b complex|mesh-ancestor
102411089|NCT05802693|Mitogens|mitogens|mesh-list
102411090|NCT05802693|Mitosis Modulators|mitosis modulators|mesh-ancestor
102411091|NCT05802693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411092|NCT05799521|Glycine|glycine|mesh-list
102411093|NCT05799521|Glycine Agents|glycine agents|mesh-ancestor
102411094|NCT05799521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102411095|NCT05799521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411096|NCT05799521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411097|NCT05784870|Ferrous succinate|ferrous succinate|mesh-list
102411098|NCT05784870|Hematinics|hematinics|mesh-ancestor
102411099|NCT05767684|Nivolumab|nivolumab|mesh-list
102411100|NCT05767684|Lenvatinib|lenvatinib|mesh-list
102411101|NCT05767684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102411102|NCT05767684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411103|NCT05767684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102411104|NCT05767684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411105|NCT05767684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102411106|NCT05767684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102411107|NCT05766501|Islatravir|islatravir|mesh-list
102411108|NCT05766501|Antiviral Agents|antiviral agents|mesh-ancestor
102411109|NCT05766501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102411110|NCT05766501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102411111|NCT05766501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411112|NCT05766501|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102411113|NCT05766501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102411114|NCT05766501|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102411115|NCT05740982|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
102411116|NCT05740982|Antiviral Agents|antiviral agents|mesh-ancestor
102411117|NCT05740982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102411118|NCT05734794|Rituximab|rituximab|mesh-list
102411119|NCT05734794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102411120|NCT05734794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411121|NCT05734794|Immunologic Factors|immunologic factors|mesh-ancestor
102411122|NCT05734794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411123|NCT05734794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102411124|NCT05707377|Zanubrutinib|zanubrutinib|mesh-list
102411125|NCT05707377|Tacrolimus|tacrolimus|mesh-list
102411126|NCT05707377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102411127|NCT05707377|Immunologic Factors|immunologic factors|mesh-ancestor
102411128|NCT05707377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411129|NCT05707377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102411130|NCT05707377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102411131|NCT05707377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411132|NCT05707377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411133|NCT05707377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102411134|NCT05706870|Clobetasol|clobetasol|mesh-list
102411135|NCT05706870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102411136|NCT05706870|Glucocorticoids|glucocorticoids|mesh-ancestor
102411137|NCT05706870|Hormones|hormones|mesh-ancestor
102411138|NCT05706870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102411139|NCT05706870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411140|NCT05705349|Islatravir|islatravir|mesh-list
102042087|NCT03163667|Everolimus|everolimus|mesh-list
102411141|NCT05705349|Antiviral Agents|antiviral agents|mesh-ancestor
102411142|NCT05705349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102411143|NCT05705349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102411144|NCT05705349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411145|NCT05705349|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102411146|NCT05705349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102411147|NCT05705349|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102411148|NCT05705128|Dexmedetomidine|dexmedetomidine|mesh-list
102411149|NCT05705128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102411150|NCT05705128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102411151|NCT05705128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411152|NCT05705128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102411153|NCT05705128|Analgesics|analgesics|mesh-ancestor
102411154|NCT05705128|Sensory System Agents|sensory system agents|mesh-ancestor
102411155|NCT05705128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102411156|NCT05705128|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102411162|NCT05704049|Dexamethasone|dexamethasone|mesh-list
102411163|NCT05704049|Dexamethasone acetate|dexamethasone acetate|mesh-list
102411164|NCT05704049|BB 1101|bb 1101|mesh-list
102411165|NCT05704049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102411166|NCT05704049|Antiemetics|antiemetics|mesh-ancestor
102411167|NCT05704049|Autonomic Agents|autonomic agents|mesh-ancestor
102411168|NCT05704049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102411169|NCT05704049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411170|NCT05704049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102411171|NCT05704049|Glucocorticoids|glucocorticoids|mesh-ancestor
102411172|NCT05704049|Hormones|hormones|mesh-ancestor
102411173|NCT05704049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102411174|NCT05704049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102411175|NCT05704049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411176|NCT05704049|Protease Inhibitors|protease inhibitors|mesh-ancestor
102411177|NCT05704049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102411178|NCT05704049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411179|NCT05701995|Deucravacitinib|deucravacitinib|mesh-list
102411180|NCT05701995|Dermatologic Agents|dermatologic agents|mesh-ancestor
102411181|NCT05701995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102411182|NCT05701995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102411183|NCT05701995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411184|NCT05687032|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
102411185|NCT05687032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102411186|NCT05687032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411187|NCT05687032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102411188|NCT05687032|Immunotoxins|immunotoxins|mesh-ancestor
102411189|NCT05687032|Immunoconjugates|immunoconjugates|mesh-ancestor
102411190|NCT05687032|Immunologic Factors|immunologic factors|mesh-ancestor
102411191|NCT05687032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411192|NCT05681481|Prednisone|prednisone|mesh-list
102411193|NCT05681481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102411194|NCT05681481|Glucocorticoids|glucocorticoids|mesh-ancestor
102411195|NCT05681481|Hormones|hormones|mesh-ancestor
102411196|NCT05681481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102411197|NCT05681481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411198|NCT05681481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102411199|NCT05681481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411200|NCT05668650|Pembrolizumab|pembrolizumab|mesh-list
102411201|NCT05668650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102411202|NCT05668650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411203|NCT05668650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102411204|NCT05668650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411205|NCT05667662|Itraconazole|itraconazole|mesh-list
102411206|NCT05667662|Antifungal Agents|antifungal agents|mesh-ancestor
102411207|NCT05667662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102411208|NCT05667662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102042150|NCT02237768|Dirithromycin|dirithromycin|mesh-list
102411209|NCT05667662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102411210|NCT05667662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102411211|NCT05667662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411212|NCT05667662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102411213|NCT05667662|Hormone Antagonists|hormone antagonists|mesh-ancestor
102411214|NCT05667662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102411215|NCT05667662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411216|NCT05667662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102411217|NCT05665595|Pembrolizumab|pembrolizumab|mesh-list
102411218|NCT05665595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102411219|NCT05665595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411220|NCT05665595|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102411221|NCT05665595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411227|NCT05650554|Vaccines|vaccines|mesh-list
102411228|NCT05650554|Immunologic Factors|immunologic factors|mesh-ancestor
102411229|NCT05650554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411230|NCT05646303|Psilocybin|psilocybin|mesh-list
102411231|NCT05646303|Hallucinogens|hallucinogens|mesh-ancestor
102411232|NCT05646303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411233|NCT05646303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102411234|NCT05635708|Paclitaxel|paclitaxel|mesh-list
102411235|NCT05635708|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102411236|NCT05635708|Carboplatin|carboplatin|mesh-list
102411237|NCT05635708|Pemetrexed|pemetrexed|mesh-list
102411238|NCT05635708|Tislelizumab|tislelizumab|mesh-list
102411239|NCT05635708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102411240|NCT05635708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411241|NCT05635708|Tubulin Modulators|tubulin modulators|mesh-ancestor
102411242|NCT05635708|Antimitotic Agents|antimitotic agents|mesh-ancestor
102411243|NCT05635708|Mitosis Modulators|mitosis modulators|mesh-ancestor
102411244|NCT05635708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411245|NCT05635708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102411246|NCT05635708|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102411247|NCT05635708|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102411248|NCT05635708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102411249|NCT05633667|Paclitaxel|paclitaxel|mesh-list
102411250|NCT05633667|Docetaxel|docetaxel|mesh-list
102411251|NCT05633667|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102411252|NCT05633667|Carboplatin|carboplatin|mesh-list
102411253|NCT05633667|Nivolumab|nivolumab|mesh-list
102411254|NCT05633667|Pemetrexed|pemetrexed|mesh-list
102411255|NCT05633667|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
102411256|NCT05633667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102411257|NCT05633667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411258|NCT05633667|Tubulin Modulators|tubulin modulators|mesh-ancestor
102411259|NCT05633667|Antimitotic Agents|antimitotic agents|mesh-ancestor
102411260|NCT05633667|Mitosis Modulators|mitosis modulators|mesh-ancestor
102411261|NCT05633667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411262|NCT05633667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102411263|NCT05633667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102411264|NCT05633667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102411265|NCT05633667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102411266|NCT05633667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102411267|NCT05633667|Immunoconjugates|immunoconjugates|mesh-ancestor
102411268|NCT05633667|Immunologic Factors|immunologic factors|mesh-ancestor
102411269|NCT05633667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411270|NCT05631093|Islatravir|islatravir|mesh-list
102411271|NCT05631093|Antiviral Agents|antiviral agents|mesh-ancestor
102411272|NCT05631093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102411273|NCT05631093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102411274|NCT05631093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411275|NCT05631093|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102411276|NCT05631093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102411277|NCT05631093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102411278|NCT05630859|Vaccines|vaccines|mesh-list
102411279|NCT05630859|Immunologic Factors|immunologic factors|mesh-ancestor
102411280|NCT05630859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411281|NCT05630781|Suvorexant|suvorexant|mesh-list
102411282|NCT05630781|Methylphenidate|methylphenidate|mesh-list
102411283|NCT05630781|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102411284|NCT05630781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411285|NCT05630781|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102411286|NCT05630781|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102411287|NCT05630781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102411288|NCT05630781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411289|NCT05630781|Dopamine Agents|dopamine agents|mesh-ancestor
102411290|NCT05630781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102411291|NCT05630781|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102411292|NCT05630781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102411293|NCT05630781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102411294|NCT05630781|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102411295|NCT05630755|Islatravir|islatravir|mesh-list
102411296|NCT05630755|Antiviral Agents|antiviral agents|mesh-ancestor
102411297|NCT05630755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102411298|NCT05630755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102411299|NCT05630755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411300|NCT05630755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102411301|NCT05630755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102411302|NCT05630755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102222977|NCT05157893|Analgesics|analgesics|mesh-list
102411323|NCT05576077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102411324|NCT05576077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411325|NCT05576077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102411326|NCT05576077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411327|NCT05575518|Rifamycins|rifamycins|mesh-list
102411328|NCT05575518|Fluoroquinolones|fluoroquinolones|mesh-list
102411329|NCT05575518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102411330|NCT05575518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102411331|NCT05575518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102411332|NCT05575518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102411333|NCT05575518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411334|NCT05554341|Paclitaxel|paclitaxel|mesh-list
102411335|NCT05554341|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102411336|NCT05554341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102411337|NCT05554341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411338|NCT05554341|Tubulin Modulators|tubulin modulators|mesh-ancestor
102411339|NCT05554341|Antimitotic Agents|antimitotic agents|mesh-ancestor
102411340|NCT05554341|Mitosis Modulators|mitosis modulators|mesh-ancestor
102411341|NCT05554341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411342|NCT05512949|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
102411343|NCT05512949|Antiviral Agents|antiviral agents|mesh-ancestor
102411344|NCT05512949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102411345|NCT05508867|Gemcitabine|gemcitabine|mesh-list
102411346|NCT05508867|Pembrolizumab|pembrolizumab|mesh-list
102411347|NCT05508867|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102411348|NCT05508867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102411349|NCT05508867|Antimetabolites|antimetabolites|mesh-ancestor
102411350|NCT05508867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411351|NCT05508867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411352|NCT05508867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102411353|NCT05508867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102411354|NCT05508867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102411355|NCT05508867|Alkylating Agents|alkylating agents|mesh-ancestor
102411356|NCT05491226|Pembrolizumab|pembrolizumab|mesh-list
102411357|NCT05491226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102411358|NCT05491226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411359|NCT05491226|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102411360|NCT05491226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411361|NCT05479045|Nivolumab|nivolumab|mesh-list
102411362|NCT05479045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102411363|NCT05479045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411364|NCT05479045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102411365|NCT05479045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411366|NCT05468619|Valacyclovir|valacyclovir|mesh-list
102411367|NCT05468619|Antiviral Agents|antiviral agents|mesh-ancestor
102411368|NCT05468619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102411369|NCT05468320|Prednisone|prednisone|mesh-list
102411370|NCT05468320|Prednisolone|prednisolone|mesh-list
102411371|NCT05468320|Antibodies|antibodies|mesh-list
102411372|NCT05468320|Immunologic Factors|immunologic factors|mesh-ancestor
102411373|NCT05468320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411374|NCT05468320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102223053|NCT04206761|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102411375|NCT05468320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102411376|NCT05468320|Glucocorticoids|glucocorticoids|mesh-ancestor
102411377|NCT05468320|Hormones|hormones|mesh-ancestor
102411378|NCT05468320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102411379|NCT05468320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102411380|NCT05461794|Docetaxel|docetaxel|mesh-list
102411381|NCT05461794|Irinotecan|irinotecan|mesh-list
102411382|NCT05461794|Tislelizumab|tislelizumab|mesh-list
102411383|NCT05461794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411384|NCT05461794|Tubulin Modulators|tubulin modulators|mesh-ancestor
102411385|NCT05461794|Antimitotic Agents|antimitotic agents|mesh-ancestor
102411386|NCT05461794|Mitosis Modulators|mitosis modulators|mesh-ancestor
102411387|NCT05461794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411388|NCT05461794|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102411389|NCT05461794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102411390|NCT05461794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102411391|NCT05461794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102411392|NCT05458765|Tenofovir|tenofovir|mesh-list
102411393|NCT05458765|Emtricitabine|emtricitabine|mesh-list
102411394|NCT05458765|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102411395|NCT05458765|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
102411396|NCT05458765|Antiviral Agents|antiviral agents|mesh-ancestor
102411397|NCT05458765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102411398|NCT05458765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102411399|NCT05458765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102411400|NCT05458765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102411401|NCT05458765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411402|NCT05458765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102411403|NCT05458765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102411404|NCT05442983|Probenecid|probenecid|mesh-list
102411405|NCT05442983|Uricosuric Agents|uricosuric agents|mesh-ancestor
102411406|NCT05442983|Gout Suppressants|gout suppressants|mesh-ancestor
102411407|NCT05442983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102411408|NCT05432804|Temozolomide|temozolomide|mesh-list
102411409|NCT05432804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102411410|NCT05432804|Alkylating Agents|alkylating agents|mesh-ancestor
102411411|NCT05432804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411412|NCT05432804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411413|NCT05426174|Vaccines|vaccines|mesh-list
102411414|NCT05426174|Immunologic Factors|immunologic factors|mesh-ancestor
102411415|NCT05426174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411416|NCT05413304|Temozolomide|temozolomide|mesh-list
102411417|NCT05413304|Dialysis Solutions|dialysis solutions|mesh-list
102411418|NCT05413304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102411419|NCT05413304|Alkylating Agents|alkylating agents|mesh-ancestor
102411420|NCT05413304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411421|NCT05413304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411422|NCT05413304|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102411423|NCT05405114|Decitabine|decitabine|mesh-list
102411424|NCT05405114|Hydroxyurea|hydroxyurea|mesh-list
102411425|NCT05405114|Tetrahydrouridine|tetrahydrouridine|mesh-list
102411426|NCT05405114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102411427|NCT05405114|Antimetabolites|antimetabolites|mesh-ancestor
102411428|NCT05405114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411429|NCT05405114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411430|NCT05405114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102411431|NCT05405114|Antisickling Agents|antisickling agents|mesh-ancestor
102411432|NCT05405114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102411433|NCT05404945|Doxorubicin|doxorubicin|mesh-list
102411434|NCT05404945|Pembrolizumab|pembrolizumab|mesh-list
102411435|NCT05404945|Dacarbazine|dacarbazine|mesh-list
102411436|NCT05404945|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102411437|NCT05404945|Vinblastine|vinblastine|mesh-list
102411438|NCT05404945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102411439|NCT05404945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411440|NCT05404945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102411441|NCT05404945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102411442|NCT05404945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102411443|NCT05404945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411444|NCT05404945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102411445|NCT05404945|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102411446|NCT05404945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102411447|NCT05404945|Alkylating Agents|alkylating agents|mesh-ancestor
102411448|NCT05404945|Immunotoxins|immunotoxins|mesh-ancestor
102411449|NCT05404945|Immunoconjugates|immunoconjugates|mesh-ancestor
102411450|NCT05404945|Immunologic Factors|immunologic factors|mesh-ancestor
102411451|NCT05404945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411452|NCT05404945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102411453|NCT05404945|Tubulin Modulators|tubulin modulators|mesh-ancestor
102411454|NCT05404945|Antimitotic Agents|antimitotic agents|mesh-ancestor
102411455|NCT05404945|Mitosis Modulators|mitosis modulators|mesh-ancestor
102411456|NCT05382559|Cetuximab|cetuximab|mesh-list
102411457|NCT05382559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102411458|NCT05382559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411459|NCT05381909|Paclitaxel|paclitaxel|mesh-list
102411460|NCT05381909|Carboplatin|carboplatin|mesh-list
102411461|NCT05381909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102411462|NCT05381909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411463|NCT05381909|Tubulin Modulators|tubulin modulators|mesh-ancestor
102411464|NCT05381909|Antimitotic Agents|antimitotic agents|mesh-ancestor
102411465|NCT05381909|Mitosis Modulators|mitosis modulators|mesh-ancestor
102411466|NCT05381909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411467|NCT05305989|Belumosudil|belumosudil|mesh-list
102411468|NCT05305989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102411469|NCT05305989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102411470|NCT05305989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411471|NCT05298423|Paclitaxel|paclitaxel|mesh-list
102411472|NCT05298423|Etoposide|etoposide|mesh-list
102411473|NCT05298423|Carboplatin|carboplatin|mesh-list
102411474|NCT05298423|Pembrolizumab|pembrolizumab|mesh-list
102411475|NCT05298423|Pemetrexed|pemetrexed|mesh-list
102411476|NCT05298423|Durvalumab|durvalumab|mesh-list
102411477|NCT05298423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102411478|NCT05298423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411479|NCT05298423|Tubulin Modulators|tubulin modulators|mesh-ancestor
102411480|NCT05298423|Antimitotic Agents|antimitotic agents|mesh-ancestor
102411481|NCT05298423|Mitosis Modulators|mitosis modulators|mesh-ancestor
102411482|NCT05298423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411483|NCT05298423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102411484|NCT05298423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102411485|NCT05298423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102411486|NCT05298423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102411487|NCT05298423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102411488|NCT05298423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102411489|NCT05298423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102411490|NCT05279456|Myeloma Proteins|myeloma proteins|mesh-list
102411491|NCT05279456|Paraproteins|paraproteins|mesh-list
102411492|NCT05279456|Immunologic Factors|immunologic factors|mesh-ancestor
102411493|NCT05279456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411494|NCT05276830|Dexmedetomidine|dexmedetomidine|mesh-list
102411495|NCT05276830|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102411496|NCT05276830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102411497|NCT05276830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411498|NCT05276830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102411499|NCT05276830|Analgesics|analgesics|mesh-ancestor
102411500|NCT05276830|Sensory System Agents|sensory system agents|mesh-ancestor
102411501|NCT05276830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102411502|NCT05276830|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102411503|NCT05276830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102411504|NCT05276830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102411505|NCT05276830|Adrenergic Agents|adrenergic agents|mesh-ancestor
102411506|NCT05276830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102411507|NCT05276830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411508|NCT05262400|Letrozole|letrozole|mesh-list
102411509|NCT05262400|Fulvestrant|fulvestrant|mesh-list
102411510|NCT05262400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411511|NCT05262400|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102411512|NCT05262400|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102411513|NCT05262400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102411514|NCT05262400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411515|NCT05262400|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102411516|NCT05262400|Hormone Antagonists|hormone antagonists|mesh-ancestor
102411517|NCT05262400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102411518|NCT05262400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411519|NCT05262400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102411520|NCT05262400|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102411521|NCT05239728|Pembrolizumab|pembrolizumab|mesh-list
102411522|NCT05239728|Belzutifan|belzutifan|mesh-list
102411523|NCT05239728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102223202|NCT04456829|Antioxidants|antioxidants|mesh-ancestor
102411524|NCT05239728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411525|NCT05239728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102411526|NCT05239728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411527|NCT05200845|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102411528|NCT05194735|Aldesleukin|aldesleukin|mesh-list
102411529|NCT05194735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411530|NCT05194735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102411531|NCT05194735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102411532|NCT05194735|Antiviral Agents|antiviral agents|mesh-ancestor
102411533|NCT05194735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102411534|NCT05176639|Nicotine|nicotine|mesh-list
102411535|NCT05176639|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102411536|NCT05176639|Autonomic Agents|autonomic agents|mesh-ancestor
102411537|NCT05176639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102411538|NCT05176639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411539|NCT05176639|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102411540|NCT05176639|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102411541|NCT05176639|Cholinergic Agents|cholinergic agents|mesh-ancestor
102411542|NCT05176639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102411543|NCT05176639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411544|NCT05172791|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102411545|NCT05172791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102411546|NCT05116085|Tislelizumab|tislelizumab|mesh-list
102411547|NCT05116085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102411548|NCT05116085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411549|NCT05114421|Pembrolizumab|pembrolizumab|mesh-list
102411550|NCT05114421|Lenvatinib|lenvatinib|mesh-list
102411551|NCT05114421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102411552|NCT05114421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411553|NCT05114421|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102411554|NCT05114421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411555|NCT05114421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102411556|NCT05114421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102411557|NCT05100862|Rituximab|rituximab|mesh-list
102411558|NCT05100862|Obinutuzumab|obinutuzumab|mesh-list
102411559|NCT05100862|Lenalidomide|lenalidomide|mesh-list
102411560|NCT05100862|Zanubrutinib|zanubrutinib|mesh-list
102411561|NCT05100862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102411562|NCT05100862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411563|NCT05100862|Immunologic Factors|immunologic factors|mesh-ancestor
102411564|NCT05100862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411565|NCT05100862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102411566|NCT05100862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102411567|NCT05100862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102411568|NCT05100862|Growth Substances|growth substances|mesh-ancestor
102411569|NCT05100862|Growth Inhibitors|growth inhibitors|mesh-ancestor
102411570|NCT05100862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102411571|NCT05100862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102411572|NCT05100862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411573|NCT05083481|Pembrolizumab|pembrolizumab|mesh-list
102411574|NCT05083481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102411575|NCT05083481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411576|NCT05083481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102411577|NCT05083481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411578|NCT05070364|Interferons|interferons|mesh-list
102411579|NCT05070364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411580|NCT05070364|Antiviral Agents|antiviral agents|mesh-ancestor
102411581|NCT05070364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102411582|NCT05060068|Ketamine|ketamine|mesh-list
102411583|NCT05060068|Esketamine|esketamine|mesh-list
102411584|NCT05060068|Analgesics|analgesics|mesh-ancestor
102411585|NCT05060068|Sensory System Agents|sensory system agents|mesh-ancestor
102411586|NCT05060068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102411587|NCT05060068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411588|NCT05060068|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102411589|NCT05060068|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102411590|NCT05060068|Anesthetics, General|anesthetics, general|mesh-ancestor
102411591|NCT05060068|Anesthetics|anesthetics|mesh-ancestor
102411592|NCT05060068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102411593|NCT05060068|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102411594|NCT05060068|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102411595|NCT05060068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102411596|NCT05060068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411597|NCT05060068|Antidepressive Agents|antidepressive agents|mesh-ancestor
102223286|NCT03465085|Heparin|heparin|mesh-list
102411598|NCT05060068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102411599|NCT05058651|Cisplatin|cisplatin|mesh-list
102411600|NCT05058651|Carboplatin|carboplatin|mesh-list
102411601|NCT05058651|Etoposide|etoposide|mesh-list
102411602|NCT05058651|Etoposide phosphate|etoposide phosphate|mesh-list
102411603|NCT05058651|Atezolizumab|atezolizumab|mesh-list
102411604|NCT05058651|Podophyllotoxin|podophyllotoxin|mesh-list
102411605|NCT05058651|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102411606|NCT05058651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411607|NCT05058651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102411608|NCT05058651|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102411609|NCT05058651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102411610|NCT05058651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102411611|NCT05058651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411612|NCT05058651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102411613|NCT05058651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102411614|NCT05058651|Immunologic Factors|immunologic factors|mesh-ancestor
102042563|NCT02737826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102411615|NCT05058651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411616|NCT05058651|Keratolytic Agents|keratolytic agents|mesh-ancestor
102411617|NCT05058651|Dermatologic Agents|dermatologic agents|mesh-ancestor
102411618|NCT05058651|Tubulin Modulators|tubulin modulators|mesh-ancestor
102411619|NCT05058651|Antimitotic Agents|antimitotic agents|mesh-ancestor
102411620|NCT05058651|Mitosis Modulators|mitosis modulators|mesh-ancestor
102411621|NCT05043350|Loratadine|loratadine|mesh-list
102411622|NCT05043350|Famotidine|famotidine|mesh-list
102411623|NCT05043350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102411624|NCT05043350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102411625|NCT05043350|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102411626|NCT05043350|Histamine Antagonists|histamine antagonists|mesh-ancestor
102411627|NCT05043350|Histamine Agents|histamine agents|mesh-ancestor
102411628|NCT05043350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102411629|NCT05043350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411630|NCT05043350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411631|NCT05043350|Antipruritics|antipruritics|mesh-ancestor
102411632|NCT05043350|Dermatologic Agents|dermatologic agents|mesh-ancestor
102411633|NCT05043350|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102411634|NCT05043350|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102411635|NCT05043350|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102411636|NCT05039281|Atezolizumab|atezolizumab|mesh-list
102411637|NCT05039281|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102411638|NCT05039281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102411639|NCT05039281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411640|NCT05039281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102411641|NCT05039281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411642|NCT05039281|Immunologic Factors|immunologic factors|mesh-ancestor
102411643|NCT05039281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411644|NCT05036681|Pembrolizumab|pembrolizumab|mesh-list
102411645|NCT05036681|Futibatinib|futibatinib|mesh-list
102411646|NCT05036681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102411647|NCT05036681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411648|NCT05036681|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102411649|NCT05036681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411650|NCT05018585|Cholecalciferol|cholecalciferol|mesh-list
102411651|NCT05018585|Vitamin D|vitamin d|mesh-list
102411652|NCT05018585|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102411653|NCT05018585|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102411654|NCT05018585|Immunologic Factors|immunologic factors|mesh-ancestor
102411655|NCT05018585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411656|NCT05018585|Antacids|antacids|mesh-ancestor
102411657|NCT05018585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411658|NCT05018585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102411659|NCT05018585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102411660|NCT05018585|Vitamins|vitamins|mesh-ancestor
102411661|NCT05018585|Micronutrients|micronutrients|mesh-ancestor
102411662|NCT05018585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102411663|NCT05010772|Decitabine|decitabine|mesh-list
102411664|NCT05010772|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
102411665|NCT05010772|Venetoclax|venetoclax|mesh-list
102411666|NCT05010772|Ivosidenib|ivosidenib|mesh-list
102411667|NCT05010772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102411668|NCT05010772|Antimetabolites|antimetabolites|mesh-ancestor
102411669|NCT05010772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762329|NCT02562690|Coagulants|coagulants|mesh-ancestor
102411670|NCT05010772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411671|NCT05010772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102411672|NCT05007106|Docetaxel|docetaxel|mesh-list
102411673|NCT05007106|Bevacizumab|bevacizumab|mesh-list
102411674|NCT05007106|Carboplatin|carboplatin|mesh-list
102411675|NCT05007106|Gemcitabine|gemcitabine|mesh-list
102411676|NCT05007106|Pembrolizumab|pembrolizumab|mesh-list
102411677|NCT05007106|Fluorouracil|fluorouracil|mesh-list
102411678|NCT05007106|Capecitabine|capecitabine|mesh-list
102411679|NCT05007106|Oxaliplatin|oxaliplatin|mesh-list
102411680|NCT05007106|Lenvatinib|lenvatinib|mesh-list
102411681|NCT05007106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411682|NCT05007106|Tubulin Modulators|tubulin modulators|mesh-ancestor
102411683|NCT05007106|Antimitotic Agents|antimitotic agents|mesh-ancestor
102411684|NCT05007106|Mitosis Modulators|mitosis modulators|mesh-ancestor
102411685|NCT05007106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411686|NCT05007106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102411687|NCT05007106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102411688|NCT05007106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102411689|NCT05007106|Growth Substances|growth substances|mesh-ancestor
102411690|NCT05007106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411691|NCT05007106|Growth Inhibitors|growth inhibitors|mesh-ancestor
102411692|NCT05007106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102411693|NCT05007106|Antimetabolites|antimetabolites|mesh-ancestor
102411694|NCT05007106|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102411695|NCT05007106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102411696|NCT05007106|Immunologic Factors|immunologic factors|mesh-ancestor
102411697|NCT05007106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102411698|NCT05007106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102411699|NCT05005442|Pembrolizumab|pembrolizumab|mesh-list
102411700|NCT05005442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102411701|NCT05005442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411702|NCT05005442|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102411703|NCT05005442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411704|NCT04985266|Tamoxifen|tamoxifen|mesh-list
102411705|NCT04985266|Letrozole|letrozole|mesh-list
102411706|NCT04985266|Fulvestrant|fulvestrant|mesh-list
102411707|NCT04985266|Palbociclib|palbociclib|mesh-list
102411708|NCT04985266|Anastrozole|anastrozole|mesh-list
102411709|NCT04985266|Exemestane|exemestane|mesh-list
102411710|NCT04985266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411711|NCT04985266|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102411712|NCT04985266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102411713|NCT04985266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102411714|NCT04985266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411715|NCT04985266|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102411716|NCT04985266|Hormone Antagonists|hormone antagonists|mesh-ancestor
102411717|NCT04985266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102411718|NCT04985266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411719|NCT04985266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102411720|NCT04985266|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102411721|NCT04985266|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102411722|NCT04985266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102411723|NCT04985266|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102411724|NCT04985266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102411725|NCT04976634|Pembrolizumab|pembrolizumab|mesh-list
102411726|NCT04976634|Lenvatinib|lenvatinib|mesh-list
102411727|NCT04976634|Belzutifan|belzutifan|mesh-list
102411728|NCT04976634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102042668|NCT03579758|Gemcitabine|gemcitabine|mesh-list
102411729|NCT04976634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411730|NCT04976634|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102411731|NCT04976634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411732|NCT04976634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102411733|NCT04976634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102411734|NCT04973605|Dexamethasone|dexamethasone|mesh-list
102411735|NCT04973605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102411736|NCT04973605|Antiemetics|antiemetics|mesh-ancestor
102411737|NCT04973605|Autonomic Agents|autonomic agents|mesh-ancestor
102411738|NCT04973605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102411739|NCT04973605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411740|NCT04973605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102411741|NCT04973605|Glucocorticoids|glucocorticoids|mesh-ancestor
102411742|NCT04973605|Hormones|hormones|mesh-ancestor
102411743|NCT04973605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102411744|NCT04973605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102411745|NCT04973605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411746|NCT04963153|Immunoconjugates|immunoconjugates|mesh-list
102411747|NCT04963153|Immunologic Factors|immunologic factors|mesh-ancestor
102223431|NCT02616185|Tremelimumab|tremelimumab|mesh-list
102411748|NCT04963153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411749|NCT04947020|Metformin|metformin|mesh-list
102411750|NCT04947020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102411751|NCT04947020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411752|NCT04936685|Vaccines|vaccines|mesh-list
102411753|NCT04936685|Immunologic Factors|immunologic factors|mesh-ancestor
102411754|NCT04936685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411755|NCT04924075|Belzutifan|belzutifan|mesh-list
102411756|NCT04924075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411757|NCT04896697|Atezolizumab|atezolizumab|mesh-list
102411758|NCT04896697|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102411759|NCT04896697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411760|NCT04896697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102411761|NCT04896697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411762|NCT04886531|Trastuzumab|trastuzumab|mesh-list
102411763|NCT04886531|Letrozole|letrozole|mesh-list
102411764|NCT04886531|Anastrozole|anastrozole|mesh-list
102411765|NCT04886531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102411766|NCT04886531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411767|NCT04886531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102411768|NCT04886531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102411769|NCT04886531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102411770|NCT04886531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411771|NCT04886531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102411772|NCT04886531|Hormone Antagonists|hormone antagonists|mesh-ancestor
102411773|NCT04886531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102411774|NCT04886531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411775|NCT04886531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102411776|NCT04862468|Dexamethasone|dexamethasone|mesh-list
102411777|NCT04862468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102411778|NCT04862468|Antiemetics|antiemetics|mesh-ancestor
102411779|NCT04862468|Autonomic Agents|autonomic agents|mesh-ancestor
102411780|NCT04862468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102411781|NCT04862468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411782|NCT04862468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102411783|NCT04862468|Glucocorticoids|glucocorticoids|mesh-ancestor
102411784|NCT04862468|Hormones|hormones|mesh-ancestor
102411785|NCT04862468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102411786|NCT04862468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102411787|NCT04862468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411788|NCT04858334|Olaparib|olaparib|mesh-list
102411789|NCT04858334|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102411790|NCT04858334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102411791|NCT04858334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411792|NCT04858334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411793|NCT04814927|Copper|copper|mesh-list
102411794|NCT04814927|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102411795|NCT04814927|Levonorgestrel|levonorgestrel|mesh-list
102411796|NCT04814927|Medroxyprogesterone|medroxyprogesterone|mesh-list
102411797|NCT04814927|Etonogestrel|etonogestrel|mesh-list
102411798|NCT04814927|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102411799|NCT04814927|Contraceptive Agents|contraceptive agents|mesh-ancestor
102411800|NCT04814927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102411801|NCT04814927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411802|NCT04814927|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102411803|NCT04814927|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102411804|NCT04814927|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102411805|NCT04814927|Trace Elements|trace elements|mesh-ancestor
102411806|NCT04814927|Micronutrients|micronutrients|mesh-ancestor
102411807|NCT04814927|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102411808|NCT04814927|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102411809|NCT04814927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102411810|NCT04814927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411811|NCT04776252|Islatravir|islatravir|mesh-list
102411812|NCT04776252|Antiviral Agents|antiviral agents|mesh-ancestor
102411813|NCT04776252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102411814|NCT04776252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102411815|NCT04776252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411816|NCT04776252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102411817|NCT04776252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102411818|NCT04776252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102411819|NCT04775953|Vancomycin|vancomycin|mesh-list
102411820|NCT04775953|Cefazolin|cefazolin|mesh-list
102411821|NCT04775953|Daptomycin|daptomycin|mesh-list
102411822|NCT04775953|Dalbavancin|dalbavancin|mesh-list
102411823|NCT04775953|Oxacillin|oxacillin|mesh-list
102411824|NCT04775953|Nafcillin|nafcillin|mesh-list
102411825|NCT04775953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102411826|NCT04775953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102411828|NCT04771130|Azacitidine|azacitidine|mesh-list
102411829|NCT04771130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102411830|NCT04771130|Antimetabolites|antimetabolites|mesh-ancestor
102411831|NCT04771130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411832|NCT04771130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411833|NCT04771130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102411834|NCT04771130|Antifungal Agents|antifungal agents|mesh-ancestor
102411835|NCT04771130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102411836|NCT04771130|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102411837|NCT04771130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102411838|NCT04771130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102411839|NCT04771130|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102411840|NCT04771130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102411841|NCT04771130|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102411842|NCT04771130|Hormone Antagonists|hormone antagonists|mesh-ancestor
102411843|NCT04771130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102411844|NCT04771130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411845|NCT04747912|Dexamethasone|dexamethasone|mesh-list
102411846|NCT04747912|Dexamethasone acetate|dexamethasone acetate|mesh-list
102411847|NCT04747912|Methotrexate|methotrexate|mesh-list
102411848|NCT04747912|Vincristine|vincristine|mesh-list
102411849|NCT04747912|Dasatinib|dasatinib|mesh-list
102411850|NCT04747912|Ponatinib|ponatinib|mesh-list
102411851|NCT04747912|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
102411852|NCT04747912|BB 1101|bb 1101|mesh-list
102411853|NCT04747912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102411854|NCT04747912|Antiemetics|antiemetics|mesh-ancestor
102411855|NCT04747912|Autonomic Agents|autonomic agents|mesh-ancestor
102411856|NCT04747912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102411857|NCT04747912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411858|NCT04747912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102411859|NCT04747912|Glucocorticoids|glucocorticoids|mesh-ancestor
102411860|NCT04747912|Hormones|hormones|mesh-ancestor
102411861|NCT04747912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102411862|NCT04747912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102411863|NCT04747912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411864|NCT04747912|Protease Inhibitors|protease inhibitors|mesh-ancestor
102411865|NCT04747912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102411866|NCT04747912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411867|NCT04747912|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102411868|NCT04747912|Abortifacient Agents|abortifacient agents|mesh-ancestor
102411869|NCT04747912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102411870|NCT04747912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102411871|NCT04747912|Antimetabolites|antimetabolites|mesh-ancestor
102411872|NCT04747912|Dermatologic Agents|dermatologic agents|mesh-ancestor
102411873|NCT04747912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102411874|NCT04747912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102411875|NCT04747912|Immunologic Factors|immunologic factors|mesh-ancestor
102411876|NCT04747912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102411877|NCT04747912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102411878|NCT04747912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102411879|NCT04747912|Tubulin Modulators|tubulin modulators|mesh-ancestor
102411880|NCT04747912|Antimitotic Agents|antimitotic agents|mesh-ancestor
102411881|NCT04747912|Mitosis Modulators|mitosis modulators|mesh-ancestor
102411882|NCT04747912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102411883|NCT04747912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102411884|NCT04747912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102411885|NCT04747912|Immunotoxins|immunotoxins|mesh-ancestor
102411886|NCT04747912|Immunoconjugates|immunoconjugates|mesh-ancestor
102411887|NCT04746924|Pembrolizumab|pembrolizumab|mesh-list
102411888|NCT04746924|Tislelizumab|tislelizumab|mesh-list
102411889|NCT04746924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102411890|NCT04746924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411891|NCT04746924|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102411892|NCT04746924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411893|NCT04738487|Pembrolizumab|pembrolizumab|mesh-list
102411894|NCT04738487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102411895|NCT04738487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411896|NCT04738487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102411897|NCT04738487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411898|NCT04736706|Pembrolizumab|pembrolizumab|mesh-list
102411899|NCT04736706|Lenvatinib|lenvatinib|mesh-list
102411900|NCT04736706|Belzutifan|belzutifan|mesh-list
102411906|NCT04736706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102411907|NCT04728230|Carboplatin|carboplatin|mesh-list
102411908|NCT04728230|Etoposide|etoposide|mesh-list
102411909|NCT04728230|Etoposide phosphate|etoposide phosphate|mesh-list
102411910|NCT04728230|Durvalumab|durvalumab|mesh-list
102411911|NCT04728230|Olaparib|olaparib|mesh-list
102411912|NCT04728230|Podophyllotoxin|podophyllotoxin|mesh-list
102411913|NCT04728230|Immunoglobulins|immunoglobulins|mesh-list
102411914|NCT04728230|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102411915|NCT04728230|Immunoglobulin G|immunoglobulin g|mesh-list
102411916|NCT04728230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411917|NCT04728230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102411918|NCT04728230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102411919|NCT04728230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102411920|NCT04728230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102411921|NCT04728230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411922|NCT04728230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102411923|NCT04728230|Immunologic Factors|immunologic factors|mesh-ancestor
102411924|NCT04728230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411925|NCT04728230|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102411926|NCT04728230|Keratolytic Agents|keratolytic agents|mesh-ancestor
102411927|NCT04728230|Dermatologic Agents|dermatologic agents|mesh-ancestor
102411928|NCT04728230|Tubulin Modulators|tubulin modulators|mesh-ancestor
102411929|NCT04728230|Antimitotic Agents|antimitotic agents|mesh-ancestor
102411930|NCT04728230|Mitosis Modulators|mitosis modulators|mesh-ancestor
102411931|NCT04681131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102411932|NCT04681131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411933|NCT04681131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102411934|NCT04681131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411940|NCT04649385|Tislelizumab|tislelizumab|mesh-list
102411941|NCT04649385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102411942|NCT04649385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411943|NCT04643002|Dexamethasone|dexamethasone|mesh-list
102411944|NCT04643002|Pomalidomide|pomalidomide|mesh-list
102411945|NCT04643002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102411946|NCT04643002|Antiemetics|antiemetics|mesh-ancestor
102411947|NCT04643002|Autonomic Agents|autonomic agents|mesh-ancestor
102411948|NCT04643002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102411949|NCT04643002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411950|NCT04643002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102411951|NCT04643002|Glucocorticoids|glucocorticoids|mesh-ancestor
102411952|NCT04643002|Hormones|hormones|mesh-ancestor
102411953|NCT04643002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102411954|NCT04643002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102411955|NCT04643002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411956|NCT04643002|Immunologic Factors|immunologic factors|mesh-ancestor
102411957|NCT04643002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102411958|NCT04643002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102411959|NCT04643002|Growth Substances|growth substances|mesh-ancestor
102411960|NCT04643002|Growth Inhibitors|growth inhibitors|mesh-ancestor
102411961|NCT04606446|Letrozole|letrozole|mesh-list
102411962|NCT04606446|Fulvestrant|fulvestrant|mesh-list
102411963|NCT04606446|Palbociclib|palbociclib|mesh-list
102411964|NCT04606446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411965|NCT04606446|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102411966|NCT04606446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102411967|NCT04606446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102411968|NCT04606446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102411969|NCT04606446|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102411970|NCT04606446|Hormone Antagonists|hormone antagonists|mesh-ancestor
102411971|NCT04606446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102411972|NCT04606446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411973|NCT04606446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102223657|NCT03679091|Ticagrelor|ticagrelor|mesh-list
102411974|NCT04606446|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102411975|NCT04606446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102411976|NCT04603911|Dexamethasone|dexamethasone|mesh-list
102411977|NCT04603911|Clonidine|clonidine|mesh-list
102411978|NCT04603911|Epinephrine|epinephrine|mesh-list
102411979|NCT04603911|Bupivacaine|bupivacaine|mesh-list
102411980|NCT04603911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102411981|NCT04603911|Antiemetics|antiemetics|mesh-ancestor
102411982|NCT04603911|Autonomic Agents|autonomic agents|mesh-ancestor
102411983|NCT04603911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102411984|NCT04603911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102411985|NCT04603911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102411986|NCT04603911|Glucocorticoids|glucocorticoids|mesh-ancestor
102411987|NCT04603911|Hormones|hormones|mesh-ancestor
102411988|NCT04603911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102411989|NCT04603911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102411990|NCT04603911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102411991|NCT04603911|Anesthetics, Local|anesthetics, local|mesh-ancestor
102411992|NCT04603911|Anesthetics|anesthetics|mesh-ancestor
102411993|NCT04603911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102411994|NCT04603911|Sensory System Agents|sensory system agents|mesh-ancestor
102411995|NCT04603911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102411996|NCT04603911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102411997|NCT04603911|Adrenergic Agents|adrenergic agents|mesh-ancestor
102411998|NCT04603911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102411999|NCT04603911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412000|NCT04603911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102412001|NCT04603911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102412002|NCT04603911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102412003|NCT04603911|Respiratory System Agents|respiratory system agents|mesh-ancestor
102412004|NCT04603911|Mydriatics|mydriatics|mesh-ancestor
102412005|NCT04603911|Sympathomimetics|sympathomimetics|mesh-ancestor
102412006|NCT04603911|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102412007|NCT04603911|Analgesics|analgesics|mesh-ancestor
102412008|NCT04603911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102412009|NCT04603911|Sympatholytics|sympatholytics|mesh-ancestor
102412010|NCT04603911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102412011|NCT04597424|Doxycycline|doxycycline|mesh-list
102412012|NCT04597424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102412013|NCT04597424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102412014|NCT04597424|Antimalarials|antimalarials|mesh-ancestor
102412015|NCT04597424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102412016|NCT04597424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102412017|NCT04585958|Trastuzumab|trastuzumab|mesh-list
102412018|NCT04585958|Olaparib|olaparib|mesh-list
102412019|NCT04585958|Camptothecin|camptothecin|mesh-list
102412020|NCT04585958|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102412021|NCT04585958|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
102412022|NCT04585958|Immunoconjugates|immunoconjugates|mesh-list
102412023|NCT04585958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102412024|NCT04585958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412025|NCT04585958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102412026|NCT04585958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412027|NCT04585958|Immunologic Factors|immunologic factors|mesh-ancestor
102412028|NCT04585958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412029|NCT04585958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102412030|NCT04585958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102412031|NCT04585958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102412032|NCT04548661|Povidone-Iodine|povidone-iodine|mesh-list
102412033|NCT04548661|Povidone|povidone|mesh-list
102412034|NCT04548661|Plasma Substitutes|plasma substitutes|mesh-ancestor
102412035|NCT04548661|Blood Substitutes|blood substitutes|mesh-ancestor
102412036|NCT04548661|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102412037|NCT04548661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102412038|NCT04546633|Lumefantrine|lumefantrine|mesh-list
102412039|NCT04546633|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102412040|NCT04546633|Antimalarials|antimalarials|mesh-ancestor
102412041|NCT04546633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102412042|NCT04546633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102412043|NCT04546633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102412044|NCT04503551|Ranibizumab|ranibizumab|mesh-list
102412045|NCT04503551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102412046|NCT04503551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102412047|NCT04503551|Growth Substances|growth substances|mesh-ancestor
102412048|NCT04503551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223728|NCT02193880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102412049|NCT04503551|Growth Inhibitors|growth inhibitors|mesh-ancestor
102412059|NCT04487067|Bevacizumab|bevacizumab|mesh-list
102412060|NCT04487067|Atezolizumab|atezolizumab|mesh-list
102412061|NCT04487067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102412062|NCT04487067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412063|NCT04487067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102412064|NCT04487067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102412065|NCT04487067|Growth Substances|growth substances|mesh-ancestor
102412066|NCT04487067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412067|NCT04487067|Growth Inhibitors|growth inhibitors|mesh-ancestor
102412068|NCT04487067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102412069|NCT04487067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412078|NCT04348747|Pembrolizumab|pembrolizumab|mesh-list
102412079|NCT04348747|Vaccines|vaccines|mesh-list
102412080|NCT04348747|Immunologic Factors|immunologic factors|mesh-ancestor
102412081|NCT04348747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412082|NCT04348747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102412083|NCT04348747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412084|NCT04348747|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102412085|NCT04348747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412086|NCT04342819|Empagliflozin|empagliflozin|mesh-list
102412087|NCT04342819|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102412088|NCT04342819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412089|NCT04342819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102412090|NCT04342819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412091|NCT04318080|Tislelizumab|tislelizumab|mesh-list
102412092|NCT04318080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102412093|NCT04318080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412094|NCT04282018|Tislelizumab|tislelizumab|mesh-list
102412095|NCT04282018|Zanubrutinib|zanubrutinib|mesh-list
102412096|NCT04282018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102412097|NCT04282018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412098|NCT04282018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102412099|NCT04282018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102412100|NCT04282018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412101|NCT04225598|Buprenorphine|buprenorphine|mesh-list
102412102|NCT04225598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102412103|NCT04225598|Narcotics|narcotics|mesh-ancestor
102412104|NCT04225598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102412105|NCT04225598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412106|NCT04225598|Analgesics|analgesics|mesh-ancestor
102412107|NCT04225598|Sensory System Agents|sensory system agents|mesh-ancestor
102412108|NCT04225598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102412109|NCT04225598|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102412118|NCT04187248|Asparaginase|asparaginase|mesh-list
102412119|NCT04187248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412120|NCT04156087|Gemcitabine|gemcitabine|mesh-list
102412121|NCT04156087|Durvalumab|durvalumab|mesh-list
102412122|NCT04156087|Tremelimumab|tremelimumab|mesh-list
102412123|NCT04156087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102412124|NCT04156087|Antimetabolites|antimetabolites|mesh-ancestor
102412125|NCT04156087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412126|NCT04156087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412127|NCT04156087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102412128|NCT04112212|Vedolizumab|vedolizumab|mesh-list
102412129|NCT04112212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102412130|NCT04107077|Mitomycins|mitomycins|mesh-list
102412131|NCT04107077|Mitomycin|mitomycin|mesh-list
102412132|NCT04107077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412133|NCT04107077|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102412134|NCT04107077|Alkylating Agents|alkylating agents|mesh-ancestor
102412135|NCT04107077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412136|NCT04107077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102412137|NCT04107077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102412138|NCT04059484|Tamoxifen|tamoxifen|mesh-list
102412139|NCT04059484|Letrozole|letrozole|mesh-list
102412140|NCT04059484|Fulvestrant|fulvestrant|mesh-list
102412141|NCT04059484|Anastrozole|anastrozole|mesh-list
102412142|NCT04059484|Exemestane|exemestane|mesh-list
102412143|NCT04059484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412144|NCT04059484|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102412145|NCT04059484|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102412146|NCT04059484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102412147|NCT04059484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412148|NCT04059484|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102412149|NCT04059484|Hormone Antagonists|hormone antagonists|mesh-ancestor
102412150|NCT04059484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102412151|NCT04059484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412152|NCT04059484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102412153|NCT04059484|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101762787|NCT00750048|Naloxone|naloxone|mesh-list
102412154|NCT04059484|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102412155|NCT04059484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102412156|NCT04059484|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102412157|NCT04051320|Leuprolide|leuprolide|mesh-list
102412158|NCT04051320|Estradiol|estradiol|mesh-list
102412159|NCT04051320|Progesterone|progesterone|mesh-list
102412160|NCT04051320|Estrogens|estrogens|mesh-ancestor
102412161|NCT04051320|Hormones|hormones|mesh-ancestor
102412162|NCT04051320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102412163|NCT04051320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412164|NCT04051320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102412165|NCT04051320|Progestins|progestins|mesh-ancestor
102412166|NCT04051320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102412167|NCT04051320|Fertility Agents|fertility agents|mesh-ancestor
102412168|NCT04051320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102412169|NCT04051320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412170|NCT04049669|Cyclophosphamide|cyclophosphamide|mesh-list
102412171|NCT04049669|Temozolomide|temozolomide|mesh-list
102412172|NCT04049669|Lomustine|lomustine|mesh-list
102412173|NCT04049669|Etoposide|etoposide|mesh-list
102412174|NCT04049669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102412175|NCT04049669|Immunologic Factors|immunologic factors|mesh-ancestor
102412176|NCT04049669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412177|NCT04049669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102412178|NCT04049669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102412179|NCT04049669|Alkylating Agents|alkylating agents|mesh-ancestor
102412180|NCT04049669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412181|NCT04049669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412182|NCT04049669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102412183|NCT04049669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102412184|NCT04049669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102412185|NCT04049669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102412186|NCT04049669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102412187|NCT04035005|Ocrelizumab|ocrelizumab|mesh-list
102412188|NCT04035005|Immunologic Factors|immunologic factors|mesh-ancestor
102412189|NCT04035005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412190|NCT03990961|Pembrolizumab|pembrolizumab|mesh-list
102412191|NCT03990961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102412192|NCT03990961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412193|NCT03990961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102412194|NCT03990961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412195|NCT03970447|Temozolomide|temozolomide|mesh-list
102412196|NCT03970447|Lomustine|lomustine|mesh-list
102412197|NCT03970447|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
102412198|NCT03970447|GDC-0084|gdc-0084|mesh-list
102412199|NCT03970447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102412200|NCT03970447|Alkylating Agents|alkylating agents|mesh-ancestor
102412207|NCT03878095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412208|NCT03878095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412209|NCT03842228|Durvalumab|durvalumab|mesh-list
102412210|NCT03842228|Olaparib|olaparib|mesh-list
102412211|NCT03842228|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102412212|NCT03842228|Immunoglobulins|immunoglobulins|mesh-list
102412213|NCT03842228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102412214|NCT03842228|Immunoglobulin G|immunoglobulin g|mesh-list
102412215|NCT03842228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102412216|NCT03842228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412217|NCT03842228|Immunologic Factors|immunologic factors|mesh-ancestor
102412218|NCT03842228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412219|NCT03842228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102412220|NCT03842228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412221|NCT03841526|Insulin|insulin|mesh-list
102412222|NCT03841526|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102412223|NCT03841526|Glucagon|glucagon|mesh-list
102412224|NCT03841526|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102412225|NCT03841526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102412226|NCT03841526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412227|NCT03841526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102412228|NCT03841526|Hormones|hormones|mesh-ancestor
102412229|NCT03841526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102412230|NCT03841526|Incretins|incretins|mesh-ancestor
102412231|NCT03834506|Dexamethasone|dexamethasone|mesh-list
102412232|NCT03834506|Prednisone|prednisone|mesh-list
102412233|NCT03834506|Docetaxel|docetaxel|mesh-list
102412234|NCT03834506|Pembrolizumab|pembrolizumab|mesh-list
102412235|NCT03834506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102412236|NCT03834506|Antiemetics|antiemetics|mesh-ancestor
102412237|NCT03834506|Autonomic Agents|autonomic agents|mesh-ancestor
102412238|NCT03834506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102412239|NCT03834506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412240|NCT03834506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102412241|NCT03834506|Glucocorticoids|glucocorticoids|mesh-ancestor
102412242|NCT03834506|Hormones|hormones|mesh-ancestor
102412243|NCT03834506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102412244|NCT03834506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102412245|NCT03834506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412246|NCT03834506|Tubulin Modulators|tubulin modulators|mesh-ancestor
102412247|NCT03834506|Antimitotic Agents|antimitotic agents|mesh-ancestor
102412248|NCT03834506|Mitosis Modulators|mitosis modulators|mesh-ancestor
102412249|NCT03834506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412250|NCT03834506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102412251|NCT03834506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102412252|NCT03799445|Nivolumab|nivolumab|mesh-list
102412253|NCT03799445|Ipilimumab|ipilimumab|mesh-list
102412254|NCT03799445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102412255|NCT03799445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412256|NCT03799445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102412257|NCT03799445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412264|NCT03775265|Cisplatin|cisplatin|mesh-list
102412265|NCT03775265|Gemcitabine|gemcitabine|mesh-list
102412266|NCT03775265|Fluorouracil|fluorouracil|mesh-list
102412267|NCT03775265|Atezolizumab|atezolizumab|mesh-list
102412268|NCT03775265|Mitomycins|mitomycins|mesh-list
102412269|NCT03775265|Mitomycin|mitomycin|mesh-list
102412270|NCT03775265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102412271|NCT03775265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412272|NCT03775265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102412273|NCT03775265|Antimetabolites|antimetabolites|mesh-ancestor
102412274|NCT03775265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412275|NCT03775265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102412276|NCT03775265|Immunologic Factors|immunologic factors|mesh-ancestor
102412283|NCT03775265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102412284|NCT03773107|Dexamethasone|dexamethasone|mesh-list
102412285|NCT03773107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102412286|NCT03773107|Antiemetics|antiemetics|mesh-ancestor
102412287|NCT03773107|Autonomic Agents|autonomic agents|mesh-ancestor
102412288|NCT03773107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102412289|NCT03773107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412290|NCT03773107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102412291|NCT03773107|Glucocorticoids|glucocorticoids|mesh-ancestor
102412292|NCT03773107|Hormones|hormones|mesh-ancestor
102043167|NCT03578354|Atenolol|atenolol|mesh-list
102412293|NCT03773107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102412294|NCT03773107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102412295|NCT03773107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412296|NCT03768063|Atezolizumab|atezolizumab|mesh-list
102412297|NCT03768063|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102412298|NCT03768063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412299|NCT03768063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102412300|NCT03768063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412301|NCT03737643|Paclitaxel|paclitaxel|mesh-list
102412302|NCT03737643|Bevacizumab|bevacizumab|mesh-list
102412303|NCT03737643|Carboplatin|carboplatin|mesh-list
102412304|NCT03737643|Durvalumab|durvalumab|mesh-list
102412305|NCT03737643|Olaparib|olaparib|mesh-list
102412306|NCT03737643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102412307|NCT03737643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102412308|NCT03737643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412309|NCT03737643|Tubulin Modulators|tubulin modulators|mesh-ancestor
102412310|NCT03737643|Antimitotic Agents|antimitotic agents|mesh-ancestor
102412311|NCT03737643|Mitosis Modulators|mitosis modulators|mesh-ancestor
102412312|NCT03737643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412313|NCT03737643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102412314|NCT03737643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102412315|NCT03737643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102412316|NCT03737643|Growth Substances|growth substances|mesh-ancestor
102412317|NCT03737643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412318|NCT03737643|Growth Inhibitors|growth inhibitors|mesh-ancestor
102412319|NCT03737643|Immunologic Factors|immunologic factors|mesh-ancestor
102412320|NCT03737643|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102412321|NCT03737643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102412322|NCT03734016|Zanubrutinib|zanubrutinib|mesh-list
102412323|NCT03734016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412324|NCT03734016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102412325|NCT03734016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102412326|NCT03734016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412332|NCT03709680|Cyclophosphamide|cyclophosphamide|mesh-list
102412333|NCT03709680|Temozolomide|temozolomide|mesh-list
102412334|NCT03709680|Irinotecan|irinotecan|mesh-list
102412335|NCT03709680|Topotecan|topotecan|mesh-list
102412336|NCT03709680|Palbociclib|palbociclib|mesh-list
102412337|NCT03709680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102412338|NCT03709680|Immunologic Factors|immunologic factors|mesh-ancestor
102412339|NCT03709680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412340|NCT03709680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102412341|NCT03709680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102412342|NCT03709680|Alkylating Agents|alkylating agents|mesh-ancestor
102412343|NCT03709680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412344|NCT03709680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412345|NCT03709680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102412346|NCT03709680|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102412347|NCT03709680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102412348|NCT03709680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102412349|NCT03709680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102412364|NCT03539744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102412365|NCT03539744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412366|NCT03539744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102412368|NCT03539744|Hormones|hormones|mesh-ancestor
102412369|NCT03539744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102412370|NCT03539744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102412371|NCT03539744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412372|NCT03539744|Immunologic Factors|immunologic factors|mesh-ancestor
102412373|NCT03539744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102412374|NCT03539744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102412375|NCT03539744|Growth Substances|growth substances|mesh-ancestor
102412376|NCT03539744|Growth Inhibitors|growth inhibitors|mesh-ancestor
102412377|NCT03537196|Ribavirin|ribavirin|mesh-list
102412378|NCT03537196|Sofosbuvir|sofosbuvir|mesh-list
102412379|NCT03537196|Antimetabolites|antimetabolites|mesh-ancestor
102412380|NCT03537196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412381|NCT03537196|Antiviral Agents|antiviral agents|mesh-ancestor
102412382|NCT03537196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102412386|NCT03518060|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
102412387|NCT03518060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102412388|NCT03518060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102412389|NCT03518060|Antiviral Agents|antiviral agents|mesh-ancestor
102412390|NCT03518060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102412391|NCT03504488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102412392|NCT03504488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412393|NCT03504488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102412394|NCT03504488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412395|NCT03504397|Leucovorin|leucovorin|mesh-list
102412396|NCT03504397|Folic Acid|folic acid|mesh-list
102412397|NCT03504397|Fluorouracil|fluorouracil|mesh-list
102412398|NCT03504397|Oxaliplatin|oxaliplatin|mesh-list
102412399|NCT03504397|Levoleucovorin|levoleucovorin|mesh-list
102412400|NCT03504397|Antimetabolites|antimetabolites|mesh-ancestor
102412401|NCT03504397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412402|NCT03504397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102412403|NCT03504397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412404|NCT03504397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102412405|NCT03504397|Immunologic Factors|immunologic factors|mesh-ancestor
102412406|NCT03504397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412407|NCT03504397|Antidotes|antidotes|mesh-ancestor
102412408|NCT03504397|Protective Agents|protective agents|mesh-ancestor
102412409|NCT03504397|Vitamin B Complex|vitamin b complex|mesh-ancestor
102412410|NCT03504397|Vitamins|vitamins|mesh-ancestor
102412411|NCT03504397|Micronutrients|micronutrients|mesh-ancestor
102412412|NCT03504397|Hematinics|hematinics|mesh-ancestor
102412413|NCT03498521|Bevacizumab|bevacizumab|mesh-list
102412414|NCT03498521|Carboplatin|carboplatin|mesh-list
102412415|NCT03498521|Gemcitabine|gemcitabine|mesh-list
102412416|NCT03498521|Trastuzumab|trastuzumab|mesh-list
102412417|NCT03498521|Atezolizumab|atezolizumab|mesh-list
102412418|NCT03498521|Olaparib|olaparib|mesh-list
102412419|NCT03498521|Pertuzumab|pertuzumab|mesh-list
102412420|NCT03498521|Vemurafenib|vemurafenib|mesh-list
102412421|NCT03498521|Ipatasertib|ipatasertib|mesh-list
102412422|NCT03498521|Ivosidenib|ivosidenib|mesh-list
102412423|NCT03498521|Entrectinib|entrectinib|mesh-list
102412424|NCT03498521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412425|NCT03498521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412426|NCT03498521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102412427|NCT03498521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102043277|NCT03621618|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102412428|NCT03498521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102412429|NCT03498521|Growth Substances|growth substances|mesh-ancestor
102412430|NCT03498521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412431|NCT03498521|Growth Inhibitors|growth inhibitors|mesh-ancestor
102412432|NCT03498521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102412433|NCT03498521|Antimetabolites|antimetabolites|mesh-ancestor
102412434|NCT03498521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102412435|NCT03498521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102412436|NCT03498521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102412437|NCT03498521|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102412439|NCT03478865|Retinol palmitate|retinol palmitate|mesh-list
102412440|NCT03478865|Vitamins|vitamins|mesh-ancestor
102412441|NCT03478865|Micronutrients|micronutrients|mesh-ancestor
102412442|NCT03478865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412443|NCT03478865|Antioxidants|antioxidants|mesh-ancestor
102412444|NCT03478865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412445|NCT03478865|Protective Agents|protective agents|mesh-ancestor
102412446|NCT03478865|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102412447|NCT03478865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412448|NCT03474744|Rituximab|rituximab|mesh-list
102412449|NCT03474744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102412450|NCT03474744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412451|NCT03474744|Immunologic Factors|immunologic factors|mesh-ancestor
102412452|NCT03474744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412453|NCT03474744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102412454|NCT03436745|Zolpidem|zolpidem|mesh-list
102412455|NCT03436745|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102412456|NCT03436745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102412457|NCT03436745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102412458|NCT03436745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412459|NCT03436745|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102412460|NCT03436745|GABA Agonists|gaba agonists|mesh-ancestor
102412461|NCT03436745|GABA Agents|gaba agents|mesh-ancestor
102412462|NCT03436745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102412463|NCT03436745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412464|NCT03367871|Paclitaxel|paclitaxel|mesh-list
102412465|NCT03367871|Bevacizumab|bevacizumab|mesh-list
102412466|NCT03367871|Carboplatin|carboplatin|mesh-list
102412467|NCT03367871|Pembrolizumab|pembrolizumab|mesh-list
102412468|NCT03367871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102412469|NCT03367871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412470|NCT03367871|Tubulin Modulators|tubulin modulators|mesh-ancestor
102412471|NCT03367871|Antimitotic Agents|antimitotic agents|mesh-ancestor
102412472|NCT03367871|Mitosis Modulators|mitosis modulators|mesh-ancestor
102412473|NCT03367871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412474|NCT03367871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102412475|NCT03367871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102412476|NCT03367871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102412477|NCT03367871|Growth Substances|growth substances|mesh-ancestor
102412478|NCT03367871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412479|NCT03367871|Growth Inhibitors|growth inhibitors|mesh-ancestor
102412480|NCT03367871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102412481|NCT03340064|Levetiracetam|levetiracetam|mesh-list
102412482|NCT03340064|Anticonvulsants|anticonvulsants|mesh-ancestor
102412483|NCT03340064|Nootropic Agents|nootropic agents|mesh-ancestor
102412484|NCT03312400|Danazol|danazol|mesh-list
102412485|NCT03312400|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102412486|NCT03312400|Hormone Antagonists|hormone antagonists|mesh-ancestor
102412487|NCT03312400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102412488|NCT03312400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412489|NCT03277638|Pembrolizumab|pembrolizumab|mesh-list
102412490|NCT03277638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102412491|NCT03277638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412492|NCT03277638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102412493|NCT03277638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412494|NCT03273023|Chromium|chromium|mesh-list
102412495|NCT03273023|Everolimus|everolimus|mesh-list
102412496|NCT03273023|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102412497|NCT03273023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102412498|NCT03273023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102412499|NCT03273023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412500|NCT03273023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102412501|NCT03273023|Immunologic Factors|immunologic factors|mesh-ancestor
102412502|NCT03273023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412503|NCT03273023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412504|NCT03273023|Trace Elements|trace elements|mesh-ancestor
102412505|NCT03273023|Micronutrients|micronutrients|mesh-ancestor
102412506|NCT03223610|Prednisone|prednisone|mesh-list
102412507|NCT03223610|Lenalidomide|lenalidomide|mesh-list
102412508|NCT03223610|Venetoclax|venetoclax|mesh-list
102412509|NCT03223610|Obinutuzumab|obinutuzumab|mesh-list
102412510|NCT03223610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102412511|NCT03223610|Glucocorticoids|glucocorticoids|mesh-ancestor
102412512|NCT03223610|Hormones|hormones|mesh-ancestor
102412513|NCT03223610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102412514|NCT03223610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412515|NCT03223610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102412516|NCT03223610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412517|NCT03223610|Immunologic Factors|immunologic factors|mesh-ancestor
102412518|NCT03223610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102412519|NCT03223610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102412520|NCT03223610|Growth Substances|growth substances|mesh-ancestor
102412521|NCT03223610|Growth Inhibitors|growth inhibitors|mesh-ancestor
102412522|NCT03223610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102412523|NCT03191786|Gemcitabine|gemcitabine|mesh-list
102412524|NCT03191786|Atezolizumab|atezolizumab|mesh-list
102412525|NCT03191786|Vinorelbine|vinorelbine|mesh-list
102412526|NCT03191786|Antibodies|antibodies|mesh-list
102412527|NCT03191786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102412528|NCT03191786|Immunologic Factors|immunologic factors|mesh-ancestor
102412529|NCT03191786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412530|NCT03191786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102412531|NCT03191786|Antimetabolites|antimetabolites|mesh-ancestor
102412532|NCT03191786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412533|NCT03191786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412534|NCT03191786|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102412535|NCT03191786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102412536|NCT03191786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102412537|NCT03191786|Tubulin Modulators|tubulin modulators|mesh-ancestor
102412538|NCT03191786|Antimitotic Agents|antimitotic agents|mesh-ancestor
102412539|NCT03191786|Mitosis Modulators|mitosis modulators|mesh-ancestor
102412540|NCT03180684|Imiquimod|imiquimod|mesh-list
102412541|NCT03180684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102412542|NCT03180684|Immunologic Factors|immunologic factors|mesh-ancestor
102412543|NCT03180684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412544|NCT03180684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412545|NCT03180684|Interferon Inducers|interferon inducers|mesh-ancestor
102412546|NCT03161652|Ranibizumab|ranibizumab|mesh-list
102412547|NCT03161652|Dopamine|dopamine|mesh-list
102412548|NCT03161652|Sulpiride|sulpiride|mesh-list
102412549|NCT03161652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102412550|NCT03161652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102412551|NCT03161652|Growth Substances|growth substances|mesh-ancestor
102412552|NCT03161652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412553|NCT03161652|Growth Inhibitors|growth inhibitors|mesh-ancestor
102412554|NCT03161652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412555|NCT03161652|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102412556|NCT03161652|Sympathomimetics|sympathomimetics|mesh-ancestor
102412557|NCT03161652|Autonomic Agents|autonomic agents|mesh-ancestor
102412558|NCT03161652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102412559|NCT03161652|Dopamine Agents|dopamine agents|mesh-ancestor
102412560|NCT03161652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102412561|NCT03161652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412562|NCT03161652|Protective Agents|protective agents|mesh-ancestor
102412563|NCT03161652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102412564|NCT03161652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102412565|NCT03161652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102412566|NCT03161652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102412567|NCT03161652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102412568|NCT03161652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102412569|NCT03161652|Antidepressive Agents|antidepressive agents|mesh-ancestor
102412570|NCT03131037|Valacyclovir|valacyclovir|mesh-list
102412571|NCT03131037|Antiviral Agents|antiviral agents|mesh-ancestor
102412572|NCT03131037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102412573|NCT03049462|Mirabegron|mirabegron|mesh-list
102412574|NCT03049462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412575|NCT03049462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412576|NCT03049462|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102412577|NCT03049462|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102412578|NCT03049462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102224264|NCT03463967|Lycopene|lycopene|mesh-list
102412579|NCT03049462|Adrenergic Agents|adrenergic agents|mesh-ancestor
102412587|NCT02992457|Sofosbuvir|sofosbuvir|mesh-list
102412588|NCT02992457|Ledipasvir|ledipasvir|mesh-list
102412589|NCT02992457|Simeprevir|simeprevir|mesh-list
102412590|NCT02992457|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102412591|NCT02992457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412592|NCT02992457|Antiviral Agents|antiviral agents|mesh-ancestor
102412593|NCT02992457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102412594|NCT02992457|Antimetabolites|antimetabolites|mesh-ancestor
102412595|NCT02992457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412596|NCT02992457|Immunologic Factors|immunologic factors|mesh-ancestor
102412597|NCT02992457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412598|NCT02992457|Protease Inhibitors|protease inhibitors|mesh-ancestor
102412599|NCT02992457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102412600|NCT02944071|Paclitaxel|paclitaxel|mesh-list
102412601|NCT02944071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102412602|NCT02944071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412603|NCT02944071|Tubulin Modulators|tubulin modulators|mesh-ancestor
102412604|NCT02944071|Antimitotic Agents|antimitotic agents|mesh-ancestor
102412605|NCT02944071|Mitosis Modulators|mitosis modulators|mesh-ancestor
102412606|NCT02944071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412607|NCT02884648|Bevacizumab|bevacizumab|mesh-list
102412608|NCT02884648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102412609|NCT02884648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412610|NCT02884648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102412611|NCT02884648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102412612|NCT02884648|Growth Substances|growth substances|mesh-ancestor
102412613|NCT02884648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412614|NCT02884648|Growth Inhibitors|growth inhibitors|mesh-ancestor
102412615|NCT02864953|Glyburide|glyburide|mesh-list
102412616|NCT02864953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102043451|NCT01335685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102412617|NCT02864953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412618|NCT02858310|Aldesleukin|aldesleukin|mesh-list
102412619|NCT02858310|Cyclophosphamide|cyclophosphamide|mesh-list
102412620|NCT02858310|Fludarabine|fludarabine|mesh-list
102412621|NCT02858310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102412622|NCT02858310|Immunologic Factors|immunologic factors|mesh-ancestor
102412623|NCT02858310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412624|NCT02858310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102412625|NCT02858310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102412626|NCT02858310|Alkylating Agents|alkylating agents|mesh-ancestor
102412627|NCT02858310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412628|NCT02858310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412629|NCT02858310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102412630|NCT02858310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102412631|NCT02858310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102412632|NCT02858310|Antiviral Agents|antiviral agents|mesh-ancestor
102412633|NCT02858310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102412634|NCT02829424|Methotrexate|methotrexate|mesh-list
102412635|NCT02829424|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102412636|NCT02829424|Abortifacient Agents|abortifacient agents|mesh-ancestor
102412637|NCT02829424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102412638|NCT02829424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412639|NCT02829424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102412640|NCT02829424|Antimetabolites|antimetabolites|mesh-ancestor
102412641|NCT02829424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412642|NCT02829424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412643|NCT02829424|Dermatologic Agents|dermatologic agents|mesh-ancestor
102412644|NCT02829424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102412645|NCT02829424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102412646|NCT02829424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102412647|NCT02829424|Immunologic Factors|immunologic factors|mesh-ancestor
102412648|NCT02829424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102412649|NCT02829424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102412684|NCT02629120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102412686|NCT02629120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412687|NCT02629120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412688|NCT02629120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102412689|NCT02629120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102412690|NCT02629120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102412691|NCT02629120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102412692|NCT02629120|Antifungal Agents|antifungal agents|mesh-ancestor
102412693|NCT02629120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102412694|NCT02627846|Lidocaine|lidocaine|mesh-list
102412695|NCT02627846|Epinephrine|epinephrine|mesh-list
102412696|NCT02627846|Racepinephrine|racepinephrine|mesh-list
102412697|NCT02627846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102412698|NCT02627846|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
102412699|NCT02627846|Epinephryl borate|epinephryl borate|mesh-list
102412700|NCT02627846|Anesthetics, Local|anesthetics, local|mesh-ancestor
102412701|NCT02627846|Anesthetics|anesthetics|mesh-ancestor
102412702|NCT02627846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102412703|NCT02627846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412704|NCT02627846|Sensory System Agents|sensory system agents|mesh-ancestor
102412705|NCT02627846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102412706|NCT02627846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102412707|NCT02627846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102412708|NCT02627846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102412709|NCT02627846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102412710|NCT02627846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412711|NCT02627846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102412712|NCT02627846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102412713|NCT02627846|Adrenergic Agents|adrenergic agents|mesh-ancestor
102412714|NCT02627846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102412715|NCT02627846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102412716|NCT02627846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102412717|NCT02627846|Autonomic Agents|autonomic agents|mesh-ancestor
102412718|NCT02627846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102412719|NCT02627846|Respiratory System Agents|respiratory system agents|mesh-ancestor
102412720|NCT02627846|Mydriatics|mydriatics|mesh-ancestor
102412721|NCT02627846|Sympathomimetics|sympathomimetics|mesh-ancestor
102412722|NCT02627846|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102412723|NCT02627846|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102412724|NCT02543983|Ketamine|ketamine|mesh-list
102412725|NCT02543983|Analgesics|analgesics|mesh-ancestor
102412726|NCT02543983|Sensory System Agents|sensory system agents|mesh-ancestor
102412727|NCT02543983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102412728|NCT02543983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224423|NCT05103501|Cisplatin|cisplatin|mesh-list
102412729|NCT02543983|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102412730|NCT02543983|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102412731|NCT02543983|Anesthetics, General|anesthetics, general|mesh-ancestor
102412732|NCT02543983|Anesthetics|anesthetics|mesh-ancestor
102412733|NCT02543983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102412734|NCT02543983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102412735|NCT02543983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102412736|NCT02543983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102412737|NCT02543983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412738|NCT02535533|Selenium|selenium|mesh-list
102412739|NCT02535533|Axitinib|axitinib|mesh-list
102412740|NCT02535533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412741|NCT02535533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102412742|NCT02535533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102412743|NCT02535533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412744|NCT02535533|Antioxidants|antioxidants|mesh-ancestor
102412745|NCT02535533|Protective Agents|protective agents|mesh-ancestor
102412746|NCT02535533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412747|NCT02535533|Trace Elements|trace elements|mesh-ancestor
102412748|NCT02535533|Micronutrients|micronutrients|mesh-ancestor
102412749|NCT02515227|Pembrolizumab|pembrolizumab|mesh-list
102412750|NCT02515227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102412751|NCT02515227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412752|NCT02515227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102412753|NCT02515227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412754|NCT02502266|Paclitaxel|paclitaxel|mesh-list
102412755|NCT02502266|Doxorubicin|doxorubicin|mesh-list
102412756|NCT02502266|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102412757|NCT02502266|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102412758|NCT02502266|Topotecan|topotecan|mesh-list
102412759|NCT02502266|Olaparib|olaparib|mesh-list
102412760|NCT02502266|Cediranib|cediranib|mesh-list
102412761|NCT02502266|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102412762|NCT02502266|Maleic acid|maleic acid|mesh-list
102412763|NCT02502266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102412764|NCT02502266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412765|NCT02502266|Tubulin Modulators|tubulin modulators|mesh-ancestor
102412766|NCT02502266|Antimitotic Agents|antimitotic agents|mesh-ancestor
102412767|NCT02502266|Mitosis Modulators|mitosis modulators|mesh-ancestor
102412768|NCT02502266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412769|NCT02502266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102412770|NCT02502266|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102412771|NCT02502266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102412772|NCT02502266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102412773|NCT02502266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102412774|NCT02502266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102412775|NCT02404870|Canagliflozin|canagliflozin|mesh-list
102412776|NCT02404870|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102412777|NCT02404870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412778|NCT02404870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102412779|NCT02404870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412780|NCT02369458|Mitomycins|mitomycins|mesh-list
102412781|NCT02369458|Mitomycin|mitomycin|mesh-list
102412782|NCT02369458|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102412783|NCT02369458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412784|NCT02369458|Alkylating Agents|alkylating agents|mesh-ancestor
102412785|NCT02369458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412786|NCT02369458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102412787|NCT02369458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102412788|NCT02225405|Cisplatin|cisplatin|mesh-list
102412789|NCT02225405|Docetaxel|docetaxel|mesh-list
102412790|NCT02225405|Nintedanib|nintedanib|mesh-list
102412791|NCT02225405|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102412792|NCT02225405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412793|NCT02225405|Tubulin Modulators|tubulin modulators|mesh-ancestor
102412794|NCT02225405|Antimitotic Agents|antimitotic agents|mesh-ancestor
102412795|NCT02225405|Mitosis Modulators|mitosis modulators|mesh-ancestor
102412796|NCT02225405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412797|NCT02225405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102412798|NCT02225405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102412799|NCT02122172|Afatinib|afatinib|mesh-list
102412800|NCT02122172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412801|NCT02122172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102412802|NCT02122172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102412803|NCT02122172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412804|NCT02105766|Sirolimus|sirolimus|mesh-list
102412805|NCT02105766|Cyclophosphamide|cyclophosphamide|mesh-list
102412806|NCT02105766|Alemtuzumab|alemtuzumab|mesh-list
102412807|NCT02105766|Pentostatin|pentostatin|mesh-list
102412830|NCT02031939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412831|NCT02031939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412832|NCT02015013|Plerixafor|plerixafor|mesh-list
102412833|NCT02015013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102412834|NCT02015013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102412835|NCT02015013|Antiviral Agents|antiviral agents|mesh-ancestor
102412836|NCT02015013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102412837|NCT01997190|Valacyclovir|valacyclovir|mesh-list
102412838|NCT01997190|Antiviral Agents|antiviral agents|mesh-ancestor
102412839|NCT01997190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102412864|NCT01391962|Sunitinib|sunitinib|mesh-list
102412865|NCT01391962|Cediranib|cediranib|mesh-list
102412866|NCT01391962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412867|NCT01391962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102412868|NCT01391962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102412869|NCT01391962|Growth Substances|growth substances|mesh-ancestor
102412870|NCT01391962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412871|NCT01391962|Growth Inhibitors|growth inhibitors|mesh-ancestor
102412872|NCT01391962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102412873|NCT01391962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102412874|NCT01391962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412875|NCT01327781|Tamoxifen|tamoxifen|mesh-list
102412876|NCT01327781|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102412877|NCT01327781|Hormone Antagonists|hormone antagonists|mesh-ancestor
102412878|NCT01327781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102412879|NCT01327781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412880|NCT01327781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102412881|NCT01327781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412882|NCT01327781|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102224552|NCT05115123|Analgesics|analgesics|mesh-ancestor
102412892|NCT01319565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102412893|NCT01319565|Alkylating Agents|alkylating agents|mesh-ancestor
102412894|NCT01319565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412895|NCT01319565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412896|NCT01319565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102412897|NCT01319565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102412898|NCT01319565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102412899|NCT01319565|Antiviral Agents|antiviral agents|mesh-ancestor
102412900|NCT01319565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102412910|NCT01154920|Paclitaxel|paclitaxel|mesh-list
102412911|NCT01154920|Docetaxel|docetaxel|mesh-list
102412912|NCT01154920|Cisplatin|cisplatin|mesh-list
102412913|NCT01154920|Carboplatin|carboplatin|mesh-list
102412914|NCT01154920|Fluorouracil|fluorouracil|mesh-list
102412915|NCT01154920|Cetuximab|cetuximab|mesh-list
102412916|NCT01154920|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102412917|NCT01154920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412918|NCT01154920|Tubulin Modulators|tubulin modulators|mesh-ancestor
102412919|NCT01154920|Antimitotic Agents|antimitotic agents|mesh-ancestor
102412920|NCT01154920|Mitosis Modulators|mitosis modulators|mesh-ancestor
102412921|NCT01154920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412922|NCT01154920|Antimetabolites|antimetabolites|mesh-ancestor
102412923|NCT01154920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102412924|NCT01154920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102412925|NCT01154920|Immunologic Factors|immunologic factors|mesh-ancestor
102412926|NCT01154920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412927|NCT01154920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102412928|NCT01139970|Temozolomide|temozolomide|mesh-list
102412929|NCT01139970|Veliparib|veliparib|mesh-list
102412930|NCT01139970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102412931|NCT01139970|Alkylating Agents|alkylating agents|mesh-ancestor
102412932|NCT01139970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412933|NCT01139970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412934|NCT01139970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102412935|NCT01139970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102412936|NCT01028963|Pioglitazone|pioglitazone|mesh-list
102412937|NCT01028963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102412938|NCT01028963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412939|NCT00977977|Cyclosporine|cyclosporine|mesh-list
102412940|NCT00977977|Rituximab|rituximab|mesh-list
102412941|NCT00977977|Cyclosporins|cyclosporins|mesh-list
102412942|NCT00977977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102412943|NCT00977977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412944|NCT00977977|Immunologic Factors|immunologic factors|mesh-ancestor
102412945|NCT00977977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412946|NCT00977977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102412947|NCT00977977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102412948|NCT00977977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412949|NCT00977977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102412950|NCT00977977|Antifungal Agents|antifungal agents|mesh-ancestor
102412951|NCT00977977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102412952|NCT00977977|Dermatologic Agents|dermatologic agents|mesh-ancestor
102412953|NCT00977977|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102412954|NCT00967785|Plerixafor|plerixafor|mesh-list
102412955|NCT00967785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102412956|NCT00967785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102412957|NCT00967785|Antiviral Agents|antiviral agents|mesh-ancestor
102224633|NCT03756311|Paclitaxel|paclitaxel|mesh-list
102412958|NCT00967785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102412959|NCT00792948|Calcium, Dietary|calcium, dietary|mesh-list
102412961|NCT00792948|Folic Acid|folic acid|mesh-list
102412962|NCT00792948|Cytarabine|cytarabine|mesh-list
102412963|NCT00792948|Sirolimus|sirolimus|mesh-list
102412964|NCT00792948|Dexamethasone|dexamethasone|mesh-list
102412965|NCT00792948|Dexamethasone acetate|dexamethasone acetate|mesh-list
102412966|NCT00792948|Prednisone|prednisone|mesh-list
102412967|NCT00792948|Methylprednisolone|methylprednisolone|mesh-list
102412968|NCT00792948|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102412969|NCT00792948|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102412970|NCT00792948|Prednisolone|prednisolone|mesh-list
102412971|NCT00792948|Prednisolone acetate|prednisolone acetate|mesh-list
102412972|NCT00792948|Cortisone|cortisone|mesh-list
102412973|NCT00792948|Cyclophosphamide|cyclophosphamide|mesh-list
102412974|NCT00792948|Doxorubicin|doxorubicin|mesh-list
102412975|NCT00792948|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102412976|NCT00792948|Methotrexate|methotrexate|mesh-list
102412977|NCT00792948|Etoposide|etoposide|mesh-list
102412978|NCT00792948|Vincristine|vincristine|mesh-list
102412979|NCT00792948|Etoposide phosphate|etoposide phosphate|mesh-list
102412980|NCT00792948|Dasatinib|dasatinib|mesh-list
102412981|NCT00792948|Podophyllotoxin|podophyllotoxin|mesh-list
102412982|NCT00792948|Tacrolimus|tacrolimus|mesh-list
102412983|NCT00792948|Lenograstim|lenograstim|mesh-list
102412984|NCT00792948|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102412985|NCT00792948|Prednisolone phosphate|prednisolone phosphate|mesh-list
102412986|NCT00792948|BB 1101|bb 1101|mesh-list
102412987|NCT00792948|Calcium|calcium|mesh-list
102412988|NCT00792948|Levoleucovorin|levoleucovorin|mesh-list
102412989|NCT00792948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102412990|NCT00792948|Immunologic Factors|immunologic factors|mesh-ancestor
102412991|NCT00792948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102412992|NCT00792948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102412993|NCT00792948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102412994|NCT00792948|Alkylating Agents|alkylating agents|mesh-ancestor
102412995|NCT00792948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102412996|NCT00792948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102412997|NCT00792948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102412998|NCT00792948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102412999|NCT00792948|Antiemetics|antiemetics|mesh-ancestor
102413000|NCT00792948|Autonomic Agents|autonomic agents|mesh-ancestor
102413001|NCT00792948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102413002|NCT00792948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102413003|NCT00792948|Glucocorticoids|glucocorticoids|mesh-ancestor
102413004|NCT00792948|Hormones|hormones|mesh-ancestor
102413005|NCT00792948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102413006|NCT00792948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102413007|NCT00792948|Protease Inhibitors|protease inhibitors|mesh-ancestor
102413008|NCT00792948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102413009|NCT00792948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102413010|NCT00792948|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102413011|NCT00792948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102413012|NCT00792948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102413013|NCT00792948|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102413014|NCT00792948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102413015|NCT00792948|Abortifacient Agents|abortifacient agents|mesh-ancestor
102413016|NCT00792948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102413017|NCT00792948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102413018|NCT00792948|Antimetabolites|antimetabolites|mesh-ancestor
102413019|NCT00792948|Dermatologic Agents|dermatologic agents|mesh-ancestor
102413020|NCT00792948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102413021|NCT00792948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102413022|NCT00792948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102413023|NCT00792948|Antiviral Agents|antiviral agents|mesh-ancestor
102413024|NCT00792948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102413025|NCT00792948|Antidotes|antidotes|mesh-ancestor
102413026|NCT00792948|Protective Agents|protective agents|mesh-ancestor
102413027|NCT00792948|Vitamin B Complex|vitamin b complex|mesh-ancestor
102413028|NCT00792948|Vitamins|vitamins|mesh-ancestor
102413029|NCT00792948|Micronutrients|micronutrients|mesh-ancestor
102413030|NCT00792948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102413031|NCT00792948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102413032|NCT00792948|Tubulin Modulators|tubulin modulators|mesh-ancestor
102413033|NCT00792948|Antimitotic Agents|antimitotic agents|mesh-ancestor
102413034|NCT00792948|Mitosis Modulators|mitosis modulators|mesh-ancestor
102413035|NCT00792948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102413036|NCT00792948|Antifungal Agents|antifungal agents|mesh-ancestor
102413037|NCT00792948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102413038|NCT00792948|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102413039|NCT00792948|Hematinics|hematinics|mesh-ancestor
102413040|NCT00792948|Keratolytic Agents|keratolytic agents|mesh-ancestor
102413041|NCT00754845|Letrozole|letrozole|mesh-list
102413042|NCT00754845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102413043|NCT00754845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102413044|NCT00754845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102413045|NCT00754845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102413046|NCT00754845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413047|NCT00754845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102413048|NCT00754845|Hormone Antagonists|hormone antagonists|mesh-ancestor
102413049|NCT00754845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102413050|NCT00754845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413051|NCT00751270|Valacyclovir|valacyclovir|mesh-list
102413052|NCT00751270|Antiviral Agents|antiviral agents|mesh-ancestor
102413053|NCT00751270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102413054|NCT00715611|Carboplatin|carboplatin|mesh-list
102413055|NCT00715611|Pemetrexed|pemetrexed|mesh-list
102413056|NCT00715611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102413057|NCT00715611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102413058|NCT00715611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413059|NCT00715611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102413060|NCT00715611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102413061|NCT00638612|Valacyclovir|valacyclovir|mesh-list
102413062|NCT00638612|Antiviral Agents|antiviral agents|mesh-ancestor
102413063|NCT00638612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102413064|NCT00634231|Valacyclovir|valacyclovir|mesh-list
102413065|NCT00634231|Antiviral Agents|antiviral agents|mesh-ancestor
102413066|NCT00634231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102413067|NCT00602641|Thalidomide|thalidomide|mesh-list
102413068|NCT00602641|Prednisone|prednisone|mesh-list
102413069|NCT00602641|Cortisone|cortisone|mesh-list
102413070|NCT00602641|Lenalidomide|lenalidomide|mesh-list
102413071|NCT00602641|Melphalan|melphalan|mesh-list
102413072|NCT00602641|Mechlorethamine|mechlorethamine|mesh-list
102413073|NCT00602641|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102413074|NCT00602641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102413075|NCT00602641|Glucocorticoids|glucocorticoids|mesh-ancestor
102413076|NCT00602641|Hormones|hormones|mesh-ancestor
102413077|NCT00602641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102413078|NCT00602641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413079|NCT00602641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102413080|NCT00602641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102413081|NCT00602641|Immunologic Factors|immunologic factors|mesh-ancestor
102413082|NCT00602641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102413083|NCT00602641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102413084|NCT00602641|Growth Substances|growth substances|mesh-ancestor
102413085|NCT00602641|Growth Inhibitors|growth inhibitors|mesh-ancestor
102413086|NCT00602641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102413087|NCT00602641|Alkylating Agents|alkylating agents|mesh-ancestor
102413088|NCT00602641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413089|NCT00602641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102413090|NCT00602641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102413091|NCT00602641|Leprostatic Agents|leprostatic agents|mesh-ancestor
102413092|NCT00602641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102413093|NCT00602641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102413094|NCT00555555|Factor VIII|factor viii|mesh-list
102413095|NCT00555555|Coagulants|coagulants|mesh-ancestor
102413096|NCT00445627|Metformin|metformin|mesh-list
102413097|NCT00445627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102413098|NCT00445627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413099|NCT00312039|Lamivudine|lamivudine|mesh-list
102413100|NCT00312039|Dexelvucitabine|dexelvucitabine|mesh-list
102413101|NCT00312039|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102413102|NCT00312039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102413103|NCT00312039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102413104|NCT00312039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413105|NCT00312039|Antiviral Agents|antiviral agents|mesh-ancestor
102413106|NCT00312039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102413107|NCT00312039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102413108|NCT00312039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102413109|NCT00268385|Temozolomide|temozolomide|mesh-list
102413110|NCT00268385|Vorinostat|vorinostat|mesh-list
102413111|NCT00268385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102413112|NCT00268385|Alkylating Agents|alkylating agents|mesh-ancestor
102413113|NCT00268385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413114|NCT00268385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102413115|NCT00268385|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102413116|NCT00268385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102413117|NCT00095784|Decitabine|decitabine|mesh-list
102413118|NCT00095784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102413119|NCT00095784|Antimetabolites|antimetabolites|mesh-ancestor
102413120|NCT00095784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413121|NCT00095784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102413122|NCT00095784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102413123|NCT00092222|Interferons|interferons|mesh-list
102413124|NCT00092222|Interferon-alpha|interferon-alpha|mesh-list
102413125|NCT00092222|Zidovudine|zidovudine|mesh-list
102413126|NCT00092222|Valganciclovir|valganciclovir|mesh-list
102413127|NCT00092222|Sirolimus|sirolimus|mesh-list
102413128|NCT00092222|Prednisone|prednisone|mesh-list
102413129|NCT00092222|Cyclophosphamide|cyclophosphamide|mesh-list
102413130|NCT00092222|Rituximab|rituximab|mesh-list
102413131|NCT00092222|Doxorubicin|doxorubicin|mesh-list
102413132|NCT00092222|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102413133|NCT00092222|Etoposide|etoposide|mesh-list
102413134|NCT00092222|Vincristine|vincristine|mesh-list
102413135|NCT00092222|Bortezomib|bortezomib|mesh-list
102413136|NCT00092222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102413137|NCT00092222|Immunologic Factors|immunologic factors|mesh-ancestor
102413138|NCT00092222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413139|NCT00092222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102413140|NCT00092222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102413141|NCT00092222|Alkylating Agents|alkylating agents|mesh-ancestor
102413142|NCT00092222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413143|NCT00092222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102413144|NCT00092222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102413145|NCT00092222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102413146|NCT00092222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102413147|NCT00092222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102413148|NCT00092222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102413149|NCT00092222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102413150|NCT00092222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102413151|NCT00092222|Glucocorticoids|glucocorticoids|mesh-ancestor
102413152|NCT00092222|Hormones|hormones|mesh-ancestor
102413153|NCT00092222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102413154|NCT00092222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102413155|NCT00092222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102413156|NCT00092222|Antiviral Agents|antiviral agents|mesh-ancestor
102413157|NCT00092222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102413158|NCT00092222|Tubulin Modulators|tubulin modulators|mesh-ancestor
102413159|NCT00092222|Antimitotic Agents|antimitotic agents|mesh-ancestor
102413160|NCT00092222|Mitosis Modulators|mitosis modulators|mesh-ancestor
102413161|NCT00092222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102413162|NCT00092222|Antifungal Agents|antifungal agents|mesh-ancestor
102413163|NCT00092222|Antimetabolites|antimetabolites|mesh-ancestor
102413164|NCT00092222|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102413165|NCT00092222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102413166|NCT00092222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102413167|NCT00092222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102413168|NCT00083174|Exemestane|exemestane|mesh-list
102413169|NCT00083174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102413170|NCT00083174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102413171|NCT00083174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102413172|NCT00083174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102413173|NCT00083174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413174|NCT00083174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102413175|NCT00083174|Hormone Antagonists|hormone antagonists|mesh-ancestor
102413176|NCT00083174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102043913|NCT03571490|Anesthetics|anesthetics|mesh-ancestor
102413177|NCT00083174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413178|NCT00070499|Imatinib Mesylate|imatinib mesylate|mesh-list
102413179|NCT00070499|Dasatinib|dasatinib|mesh-list
102413180|NCT00070499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102413181|NCT00070499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102413182|NCT00070499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102413183|NCT00070499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413184|NCT00066573|Anastrozole|anastrozole|mesh-list
102413185|NCT00066573|Exemestane|exemestane|mesh-list
102413186|NCT00066573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102413187|NCT00066573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102413188|NCT00066573|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102413189|NCT00066573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102413190|NCT00066573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102413191|NCT00066573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413192|NCT00066573|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102413240|NCT04766359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102413241|NCT04766359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102413242|NCT04766359|Tubulin Modulators|tubulin modulators|mesh-ancestor
102413243|NCT04766359|Antimitotic Agents|antimitotic agents|mesh-ancestor
102413244|NCT04766359|Mitosis Modulators|mitosis modulators|mesh-ancestor
102413245|NCT04766359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413247|NCT04020601|Anesthetics, Local|anesthetics, local|mesh-ancestor
102413248|NCT04020601|Anesthetics|anesthetics|mesh-ancestor
102413249|NCT04020601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102413250|NCT04020601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413251|NCT04020601|Sensory System Agents|sensory system agents|mesh-ancestor
102413252|NCT04020601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102413253|NCT03964051|Omalizumab|omalizumab|mesh-list
102413254|NCT03964051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102413255|NCT03964051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102413256|NCT03964051|Respiratory System Agents|respiratory system agents|mesh-ancestor
102413257|NCT03973489|Methamphetamine|methamphetamine|mesh-list
102413258|NCT03973489|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102413259|NCT03973489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413260|NCT03973489|Sympathomimetics|sympathomimetics|mesh-ancestor
102413261|NCT03973489|Autonomic Agents|autonomic agents|mesh-ancestor
102413262|NCT03973489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102413263|NCT03973489|Dopamine Agents|dopamine agents|mesh-ancestor
102413264|NCT03973489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102413265|NCT03973489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413266|NCT03973489|Adrenergic Agents|adrenergic agents|mesh-ancestor
102413267|NCT03973489|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102413268|NCT03973489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102413269|NCT03973489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102413270|NCT03973489|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102413271|NCT04193137|Captopril|captopril|mesh-list
102413272|NCT04193137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102413273|NCT04193137|Protease Inhibitors|protease inhibitors|mesh-ancestor
102413274|NCT04193137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102413275|NCT04193137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413276|NCT04193137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102413277|NCT05060484|Vaccines|vaccines|mesh-list
102413278|NCT05060484|Immunologic Factors|immunologic factors|mesh-ancestor
102413279|NCT05060484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413280|NCT04193059|Paclitaxel|paclitaxel|mesh-list
102413281|NCT04193059|Docetaxel|docetaxel|mesh-list
102413282|NCT04193059|Cyclophosphamide|cyclophosphamide|mesh-list
102413283|NCT04193059|Carboplatin|carboplatin|mesh-list
102413284|NCT04193059|Trastuzumab|trastuzumab|mesh-list
102413285|NCT04193059|Epirubicin|epirubicin|mesh-list
102413286|NCT04193059|Pertuzumab|pertuzumab|mesh-list
102413287|NCT04193059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102413288|NCT04193059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102413289|NCT04193059|Tubulin Modulators|tubulin modulators|mesh-ancestor
102413290|NCT04193059|Antimitotic Agents|antimitotic agents|mesh-ancestor
102413291|NCT04193059|Mitosis Modulators|mitosis modulators|mesh-ancestor
102413292|NCT04193059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413293|NCT04193059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102413294|NCT04193059|Immunologic Factors|immunologic factors|mesh-ancestor
102413295|NCT04193059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413296|NCT04193059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102413297|NCT04193059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102413298|NCT04193059|Alkylating Agents|alkylating agents|mesh-ancestor
102413299|NCT04193059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102413300|NCT04193059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102413301|NCT04193059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102413302|NCT04193059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102413303|NCT04193059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102413304|NCT04193059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102413305|NCT04028869|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
102413306|NCT04028869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102413307|NCT05092074|Sofosbuvir|sofosbuvir|mesh-list
102413308|NCT05092074|Velpatasvir|velpatasvir|mesh-list
102413309|NCT05092074|Antiviral Agents|antiviral agents|mesh-ancestor
102413310|NCT05092074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102413311|NCT02080273|Listerine|listerine|mesh-list
102413312|NCT02080273|Sodium Fluoride|sodium fluoride|mesh-list
102413313|NCT02080273|Cariostatic Agents|cariostatic agents|mesh-ancestor
102413314|NCT02080273|Protective Agents|protective agents|mesh-ancestor
102413315|NCT02080273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413316|NCT02080273|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102413317|NCT02080273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102413318|NCT04199143|Nitrous Oxide|nitrous oxide|mesh-list
102413319|NCT04199143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102413320|NCT04199143|Anesthetics, General|anesthetics, general|mesh-ancestor
102413321|NCT04199143|Anesthetics|anesthetics|mesh-ancestor
102413322|NCT04199143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102413323|NCT04199143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413324|NCT04199143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102413325|NCT04199143|Analgesics|analgesics|mesh-ancestor
102413326|NCT04199143|Sensory System Agents|sensory system agents|mesh-ancestor
102413327|NCT04199143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102413328|NCT04616274|Venetoclax|venetoclax|mesh-list
102413329|NCT04616274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102413330|NCT04613622|Venetoclax|venetoclax|mesh-list
102413331|NCT04613622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102413332|NCT04515186|Miltefosine|miltefosine|mesh-list
102413333|NCT04515186|Meglumine Antimoniate|meglumine antimoniate|mesh-list
102413334|NCT04515186|Antifungal Agents|antifungal agents|mesh-ancestor
102413335|NCT04515186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102413336|NCT04515186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102413337|NCT04515186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102413338|NCT04515186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102413339|NCT04021225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102413340|NCT04021225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102413341|NCT05096676|Oxytocin|oxytocin|mesh-list
102225004|NCT02656173|Tamsulosin|tamsulosin|mesh-list
102413342|NCT05096676|Oxytocics|oxytocics|mesh-ancestor
102413343|NCT05096676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102413344|NCT05096676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413345|NCT03948763|Pembrolizumab|pembrolizumab|mesh-list
102413346|NCT03948763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102413347|NCT03948763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102413348|NCT03948763|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102413349|NCT03948763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413350|NCT05096520|Lidocaine|lidocaine|mesh-list
102413351|NCT05096520|Anesthetics, Local|anesthetics, local|mesh-ancestor
102413352|NCT05096520|Anesthetics|anesthetics|mesh-ancestor
102413353|NCT05096520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102413354|NCT05096520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413355|NCT05096520|Sensory System Agents|sensory system agents|mesh-ancestor
102413356|NCT05096520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102413357|NCT05096520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102413358|NCT05096520|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102413359|NCT05096520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102413360|NCT05096520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102413361|NCT05096520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413362|NCT03832465|Levofloxacin|levofloxacin|mesh-list
102413363|NCT03832465|Ofloxacin|ofloxacin|mesh-list
102413364|NCT03832465|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102413365|NCT03832465|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102413366|NCT03832465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102413367|NCT03832465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102413368|NCT03832465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102413369|NCT03832465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102413370|NCT03832465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102413371|NCT03832465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413372|NCT03832465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102413373|NCT03832465|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102413374|NCT03832465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102413375|NCT04190173|Prucalopride|prucalopride|mesh-list
102413376|NCT04190173|Laxatives|laxatives|mesh-ancestor
102413377|NCT04190173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102413378|NCT04190173|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
102413379|NCT04190173|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102413380|NCT04190173|Serotonin Agents|serotonin agents|mesh-ancestor
102413381|NCT04190173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102413382|NCT04190173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413383|NCT04190173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413384|NCT01272219|Liraglutide|liraglutide|mesh-list
102413385|NCT01272219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102413386|NCT01272219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413387|NCT01272219|Incretins|incretins|mesh-ancestor
102413388|NCT01272219|Hormones|hormones|mesh-ancestor
102413389|NCT01272219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102413390|NCT04198363|Amoxicillin|amoxicillin|mesh-list
102413391|NCT04198363|Clarithromycin|clarithromycin|mesh-list
102413392|NCT04198363|Potassium Citrate|potassium citrate|mesh-list
102413393|NCT04198363|Esomeprazole|esomeprazole|mesh-list
102413394|NCT04198363|Bismuth|bismuth|mesh-list
102413395|NCT04198363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413396|NCT04198363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102413397|NCT04198363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102413398|NCT04198363|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102413399|NCT04198363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102413400|NCT04198363|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102413401|NCT04198363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102413402|NCT04198363|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102413403|NCT04198363|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102413404|NCT04198363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102413405|NCT04198363|Antacids|antacids|mesh-ancestor
102413406|NCT04198363|Diuretics|diuretics|mesh-ancestor
102413407|NCT04198363|Natriuretic Agents|natriuretic agents|mesh-ancestor
102413408|NCT04198363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413409|NCT04198363|Expectorants|expectorants|mesh-ancestor
102413410|NCT04198363|Respiratory System Agents|respiratory system agents|mesh-ancestor
102413411|NCT04020133|Epinephrine|epinephrine|mesh-list
102413412|NCT04020133|Bupivacaine|bupivacaine|mesh-list
102413413|NCT04020133|Anesthetics, Local|anesthetics, local|mesh-ancestor
102413414|NCT04020133|Anesthetics|anesthetics|mesh-ancestor
102413415|NCT04020133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102413416|NCT04020133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413417|NCT04020133|Sensory System Agents|sensory system agents|mesh-ancestor
102413418|NCT04020133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102413419|NCT04020133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102413420|NCT04020133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102413421|NCT04020133|Adrenergic Agents|adrenergic agents|mesh-ancestor
102413422|NCT04020133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102413423|NCT04020133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413424|NCT04020133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102413425|NCT04020133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102413426|NCT04020133|Autonomic Agents|autonomic agents|mesh-ancestor
102413427|NCT04020133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102413428|NCT04020133|Respiratory System Agents|respiratory system agents|mesh-ancestor
102413429|NCT04020133|Mydriatics|mydriatics|mesh-ancestor
102413430|NCT04020133|Sympathomimetics|sympathomimetics|mesh-ancestor
102413431|NCT04020133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102413432|NCT04565574|Rifampin|rifampin|mesh-list
102413433|NCT04565574|Rabeprazole|rabeprazole|mesh-list
102413434|NCT04565574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102413435|NCT04565574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102413436|NCT04565574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102413437|NCT04565574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102413438|NCT04565574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413439|NCT04565574|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102413440|NCT04565574|Antitubercular Agents|antitubercular agents|mesh-ancestor
102413441|NCT04565574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102413442|NCT04565574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102413443|NCT04565574|Leprostatic Agents|leprostatic agents|mesh-ancestor
102413444|NCT04565574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102413445|NCT04565574|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102413446|NCT04565574|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102413447|NCT04565574|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102413448|NCT04565574|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102413449|NCT04565574|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102413450|NCT04565574|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102413451|NCT01270971|Tavaborole|tavaborole|mesh-list
102413452|NCT01270971|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102413453|NCT01270971|Antifungal Agents|antifungal agents|mesh-ancestor
102413454|NCT01270971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102413455|NCT04026841|Antibodies|antibodies|mesh-list
102413456|NCT04026841|Immunologic Factors|immunologic factors|mesh-ancestor
102413457|NCT04026841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413458|NCT04128774|Dexamethasone|dexamethasone|mesh-list
102413459|NCT04128774|Dexamethasone acetate|dexamethasone acetate|mesh-list
102413460|NCT04128774|BB 1101|bb 1101|mesh-list
102413461|NCT04128774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102413462|NCT04128774|Antiemetics|antiemetics|mesh-ancestor
102413463|NCT04128774|Autonomic Agents|autonomic agents|mesh-ancestor
102413464|NCT04128774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102413465|NCT04128774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413466|NCT04128774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102413467|NCT04128774|Glucocorticoids|glucocorticoids|mesh-ancestor
102413468|NCT04128774|Hormones|hormones|mesh-ancestor
102413469|NCT04128774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102413470|NCT04128774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102413471|NCT04128774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102413472|NCT04128774|Protease Inhibitors|protease inhibitors|mesh-ancestor
102413473|NCT04128774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102413474|NCT04128774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413475|NCT00732225|Hyaluronic Acid|hyaluronic acid|mesh-list
102413476|NCT00732225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102413477|NCT00732225|Immunologic Factors|immunologic factors|mesh-ancestor
102413478|NCT00732225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413479|NCT00732225|Viscosupplements|viscosupplements|mesh-ancestor
102413480|NCT00732225|Protective Agents|protective agents|mesh-ancestor
102413481|NCT04026685|Phenylephrine|phenylephrine|mesh-list
102413482|NCT04026685|Oxymetazoline|oxymetazoline|mesh-list
102413483|NCT04026685|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102413484|NCT04026685|Mydriatics|mydriatics|mesh-ancestor
102413485|NCT04026685|Autonomic Agents|autonomic agents|mesh-ancestor
102413486|NCT04026685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102413487|NCT04026685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413488|NCT04026685|Sympathomimetics|sympathomimetics|mesh-ancestor
102413489|NCT04026685|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102413490|NCT04026685|Nasal Decongestants|nasal decongestants|mesh-ancestor
102413491|NCT04026685|Respiratory System Agents|respiratory system agents|mesh-ancestor
102413492|NCT04026685|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102225159|NCT03443843|Xhance|xhance|mesh-list
102413493|NCT04026685|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102413494|NCT04026685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102413495|NCT04026685|Adrenergic Agents|adrenergic agents|mesh-ancestor
102413496|NCT04026685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102413497|NCT04026685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413498|NCT04026685|Protective Agents|protective agents|mesh-ancestor
102413499|NCT00751179|Bromides|bromides|mesh-list
102413500|NCT00751179|Rocuronium|rocuronium|mesh-list
102413501|NCT00751179|Succinylcholine|succinylcholine|mesh-list
102413502|NCT00751179|Anticonvulsants|anticonvulsants|mesh-ancestor
102413503|NCT00751179|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102413504|NCT00751179|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102413505|NCT00751179|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102413506|NCT00751179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102413507|NCT00751179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413508|NCT00751179|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
102413509|NCT01273233|Vaccines|vaccines|mesh-list
102413510|NCT01273233|Immunologic Factors|immunologic factors|mesh-ancestor
102413511|NCT01273233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413512|NCT01277211|NuvaRing|nuvaring|mesh-list
102413513|NCT01277211|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102413514|NCT01277211|Contraceptive Agents|contraceptive agents|mesh-ancestor
102413515|NCT01277211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102413516|NCT01277211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413517|NCT04022161|Nitric Oxide|nitric oxide|mesh-list
102413518|NCT04022161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102413519|NCT04022161|Autonomic Agents|autonomic agents|mesh-ancestor
102413520|NCT04022161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102413521|NCT04022161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413522|NCT04022161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102413523|NCT04022161|Respiratory System Agents|respiratory system agents|mesh-ancestor
102413524|NCT04022161|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102413525|NCT04022161|Antioxidants|antioxidants|mesh-ancestor
102413526|NCT04022161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413527|NCT04022161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102413528|NCT04022161|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102413529|NCT04022161|Vasodilator Agents|vasodilator agents|mesh-ancestor
102413530|NCT04022161|Gasotransmitters|gasotransmitters|mesh-ancestor
102413531|NCT04022161|Protective Agents|protective agents|mesh-ancestor
102413532|NCT01676220|Insulin|insulin|mesh-list
102413533|NCT01676220|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102413534|NCT01676220|Insulin Glargine|insulin glargine|mesh-list
102413535|NCT01676220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102413536|NCT01676220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413537|NCT01275105|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102413538|NCT01275105|Phenylephrine|phenylephrine|mesh-list
102413539|NCT01275105|Oxymetazoline|oxymetazoline|mesh-list
102413540|NCT01275105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102413541|NCT01275105|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102413542|NCT01275105|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102413543|NCT01275105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102413544|NCT01275105|Adrenergic Agents|adrenergic agents|mesh-ancestor
102413545|NCT01275105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102413546|NCT01275105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413547|NCT01275105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413548|NCT01275105|Sympathomimetics|sympathomimetics|mesh-ancestor
102413549|NCT01275105|Autonomic Agents|autonomic agents|mesh-ancestor
102413550|NCT01275105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102413551|NCT01275105|Nasal Decongestants|nasal decongestants|mesh-ancestor
102413552|NCT01275105|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102413553|NCT01275105|Respiratory System Agents|respiratory system agents|mesh-ancestor
102413554|NCT01275105|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102413555|NCT01275105|Mydriatics|mydriatics|mesh-ancestor
102413556|NCT01275105|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102413557|NCT01275105|Protective Agents|protective agents|mesh-ancestor
102413558|NCT01270347|Levofloxacin|levofloxacin|mesh-list
102413559|NCT01270347|Ofloxacin|ofloxacin|mesh-list
102413560|NCT01270347|Tobramycin|tobramycin|mesh-list
102413561|NCT01270347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102413562|NCT01270347|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102413563|NCT01270347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102413564|NCT01270347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102413565|NCT01270347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102413566|NCT01270347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102413567|NCT01270347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102413568|NCT01270347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413569|NCT01270347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102413570|NCT01270347|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102413571|NCT01270347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102413573|NCT03608436|Rocuronium|rocuronium|mesh-list
102413574|NCT03608436|Anticonvulsants|anticonvulsants|mesh-ancestor
102413575|NCT03608436|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102413576|NCT03608436|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102413577|NCT03608436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102413578|NCT03608436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102413579|NCT03608436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413580|NCT04025671|Naloxone|naloxone|mesh-list
102413581|NCT04025671|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102413582|NCT04025671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413583|NCT04025671|Sensory System Agents|sensory system agents|mesh-ancestor
102413584|NCT04025671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102413585|NCT03412188|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102413586|NCT03412188|gamma-Globulins|gamma-globulins|mesh-list
102413587|NCT03412188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102413588|NCT03412188|Immunologic Factors|immunologic factors|mesh-ancestor
102413589|NCT03412188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413590|NCT03412188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102413591|NCT03412188|Glucocorticoids|glucocorticoids|mesh-ancestor
102413592|NCT03412188|Hormones|hormones|mesh-ancestor
102413593|NCT03412188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102413594|NCT03412188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102413595|NCT03412188|Protective Agents|protective agents|mesh-ancestor
102413596|NCT03412188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102413597|NCT01278849|Vadimezan|vadimezan|mesh-list
102413598|NCT01278849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102413599|NCT04949412|Vitamin D|vitamin d|mesh-list
102413600|NCT04949412|Vitamins|vitamins|mesh-ancestor
102413601|NCT04949412|Micronutrients|micronutrients|mesh-ancestor
102413602|NCT04949412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413603|NCT04949412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102413604|NCT04022473|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102413605|NCT04022473|Dermatologic Agents|dermatologic agents|mesh-ancestor
102413606|NCT04022473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102413607|NCT04022473|Immunologic Factors|immunologic factors|mesh-ancestor
102413608|NCT04022473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413609|NCT01485614|Metformin|metformin|mesh-list
102413610|NCT01485614|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102413611|NCT01485614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102413612|NCT01485614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413613|NCT01485614|Incretins|incretins|mesh-ancestor
102413614|NCT01485614|Hormones|hormones|mesh-ancestor
102413615|NCT01485614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102413616|NCT01485614|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102413617|NCT01485614|Protease Inhibitors|protease inhibitors|mesh-ancestor
102413618|NCT01485614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102413619|NCT01485614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413620|NCT00722553|Vitamins|vitamins|mesh-list
102413621|NCT00722553|Folic Acid|folic acid|mesh-list
102413622|NCT00722553|Vitamin B 12|vitamin b 12|mesh-list
102413623|NCT00722553|Vitamin B Complex|vitamin b complex|mesh-list
102413624|NCT00722553|10-deazaaminopterin|10-deazaaminopterin|mesh-list
102413625|NCT00722553|Aminopterin|aminopterin|mesh-list
102413626|NCT00722553|Micronutrients|micronutrients|mesh-ancestor
102413627|NCT00722553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413628|NCT00722553|Hematinics|hematinics|mesh-ancestor
102413629|NCT00722553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102413630|NCT00722553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102413631|NCT00722553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413632|NCT00722553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102413633|NCT03022747|Allopurinol|allopurinol|mesh-list
102413634|NCT03022747|Antimetabolites|antimetabolites|mesh-ancestor
102413635|NCT03022747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413636|NCT03022747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102413637|NCT03022747|Gout Suppressants|gout suppressants|mesh-ancestor
102413638|NCT03022747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102413639|NCT03022747|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102413640|NCT03022747|Antioxidants|antioxidants|mesh-ancestor
102413641|NCT03022747|Protective Agents|protective agents|mesh-ancestor
102413642|NCT03022747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413643|NCT03928015|Analgesics|analgesics|mesh-list
102413644|NCT03928015|Dronabinol|dronabinol|mesh-list
102413645|NCT03928015|Sensory System Agents|sensory system agents|mesh-ancestor
102413646|NCT03928015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102413647|NCT03928015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413648|NCT03928015|Hallucinogens|hallucinogens|mesh-ancestor
102413649|NCT03928015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102413650|NCT03928015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102413651|NCT03928015|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102413652|NCT03928015|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102413653|NCT03928015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102413654|NCT03928015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413655|NCT03928015|Hormones|hormones|mesh-ancestor
102413656|NCT03928015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102413657|NCT00735969|Ribavirin|ribavirin|mesh-list
102413658|NCT00735969|Antimetabolites|antimetabolites|mesh-ancestor
102413659|NCT00735969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413660|NCT00735969|Antiviral Agents|antiviral agents|mesh-ancestor
102413661|NCT00735969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102413662|NCT03229512|Sildenafil Citrate|sildenafil citrate|mesh-list
102413663|NCT03229512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413664|NCT03229512|Vasodilator Agents|vasodilator agents|mesh-ancestor
102413665|NCT03229512|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102413666|NCT03229512|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102413667|NCT03229512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102413668|NCT03229512|Urological Agents|urological agents|mesh-ancestor
102413669|NCT01279083|Timolol|timolol|mesh-list
102413670|NCT01279083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102413671|NCT01279083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413672|NCT01279083|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102413673|NCT01279083|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102413674|NCT01279083|Adrenergic Agents|adrenergic agents|mesh-ancestor
102413675|NCT01279083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102413676|NCT01279083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413677|NCT01279083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102413678|NCT01279083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102413679|NCT03022201|Domperidone|domperidone|mesh-list
102413680|NCT03022201|Antiemetics|antiemetics|mesh-ancestor
102413681|NCT03022201|Autonomic Agents|autonomic agents|mesh-ancestor
102413682|NCT03022201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102413683|NCT03022201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413684|NCT03022201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102413685|NCT03022201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102413686|NCT03022201|Dopamine Agents|dopamine agents|mesh-ancestor
102413687|NCT03022201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102413688|NCT03022201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413689|NCT04716114|Cytarabine|cytarabine|mesh-list
102413690|NCT04716114|Fludarabine|fludarabine|mesh-list
102413691|NCT04716114|Azacitidine|azacitidine|mesh-list
102413692|NCT04716114|Homoharringtonine|homoharringtonine|mesh-list
102413693|NCT04716114|Aclarubicin|aclarubicin|mesh-list
102413694|NCT04716114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102413695|NCT04716114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102413696|NCT04716114|Antimetabolites|antimetabolites|mesh-ancestor
102413697|NCT04716114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413698|NCT04716114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102413699|NCT04716114|Immunologic Factors|immunologic factors|mesh-ancestor
102413700|NCT04716114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413701|NCT04716114|Antiviral Agents|antiviral agents|mesh-ancestor
102413702|NCT04716114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102413703|NCT04716114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102413704|NCT04716114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102413705|NCT04716114|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102413706|NCT04716114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102413707|NCT04716114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102413708|NCT04716114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102413709|NCT00752973|Malathion|malathion|mesh-list
102413710|NCT00752973|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102413711|NCT00752973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102413712|NCT00752973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413713|NCT00752973|Cholinergic Agents|cholinergic agents|mesh-ancestor
102413714|NCT00752973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102413715|NCT00752973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413716|NCT04025593|Prednisone|prednisone|mesh-list
102413717|NCT04025593|Cyclophosphamide|cyclophosphamide|mesh-list
102413718|NCT04025593|Rituximab|rituximab|mesh-list
102413719|NCT04025593|Doxorubicin|doxorubicin|mesh-list
102413720|NCT04025593|Vincristine|vincristine|mesh-list
102413725|NCT04025593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413727|NCT04025593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102413728|NCT04025593|Alkylating Agents|alkylating agents|mesh-ancestor
102413729|NCT04025593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413730|NCT04025593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102413731|NCT04025593|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102413732|NCT04025593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102413733|NCT04025593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102413734|NCT04025593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102413735|NCT04025593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102413736|NCT04025593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102413737|NCT04025593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102413738|NCT04025593|Glucocorticoids|glucocorticoids|mesh-ancestor
102413739|NCT04025593|Hormones|hormones|mesh-ancestor
102413740|NCT04025593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102413741|NCT04025593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102413742|NCT04025593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102413743|NCT04025593|Tubulin Modulators|tubulin modulators|mesh-ancestor
102413744|NCT04025593|Antimitotic Agents|antimitotic agents|mesh-ancestor
102413745|NCT04025593|Mitosis Modulators|mitosis modulators|mesh-ancestor
102413746|NCT04025593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102413747|NCT04025593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102413748|NCT04025593|Growth Substances|growth substances|mesh-ancestor
102413749|NCT04025593|Growth Inhibitors|growth inhibitors|mesh-ancestor
102413750|NCT04025593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102413751|NCT04025593|Antimetabolites|antimetabolites|mesh-ancestor
102413752|NCT01279707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102413753|NCT01279707|Epratuzumab|epratuzumab|mesh-list
102413754|NCT01279707|Veltuzumab|veltuzumab|mesh-list
102413755|NCT01279707|Antibodies|antibodies|mesh-list
102413756|NCT01279707|Immunoglobulins|immunoglobulins|mesh-list
102413757|NCT01279707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102413758|NCT01279707|Immunologic Factors|immunologic factors|mesh-ancestor
102413759|NCT01279707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413760|NCT01279707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102413761|NCT02957292|Levonorgestrel|levonorgestrel|mesh-list
102413762|NCT02957292|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102413763|NCT02957292|Contraceptive Agents|contraceptive agents|mesh-ancestor
102413764|NCT02957292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102413765|NCT02957292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413766|NCT02957292|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102413767|NCT02957292|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102413768|NCT02957292|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102413774|NCT01273779|Talactoferrin alfa|talactoferrin alfa|mesh-list
102413775|NCT01273779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102413776|NCT03023124|Doxorubicin|doxorubicin|mesh-list
102413777|NCT03023124|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102413778|NCT03023124|Dacarbazine|dacarbazine|mesh-list
102413779|NCT03023124|Trabectedin|trabectedin|mesh-list
102413780|NCT03023124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102413781|NCT03023124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102413782|NCT03023124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102413783|NCT03023124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102413784|NCT03023124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102413785|NCT03023124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413786|NCT03023124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102413787|NCT03023124|Alkylating Agents|alkylating agents|mesh-ancestor
102413788|NCT03022123|Prednisone|prednisone|mesh-list
102413789|NCT03022123|Cyclophosphamide|cyclophosphamide|mesh-list
102413790|NCT03022123|Doxorubicin|doxorubicin|mesh-list
102413791|NCT03022123|Vincristine|vincristine|mesh-list
102413792|NCT03022123|Epirubicin|epirubicin|mesh-list
102413793|NCT03022123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102413794|NCT03022123|Immunologic Factors|immunologic factors|mesh-ancestor
102413795|NCT03022123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413796|NCT03022123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102413797|NCT03022123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102413798|NCT03022123|Alkylating Agents|alkylating agents|mesh-ancestor
102413799|NCT03022123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413800|NCT03022123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102413801|NCT03022123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102413802|NCT03022123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102413803|NCT03022123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102413804|NCT03022123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102413805|NCT03022123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102413806|NCT03022123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102413807|NCT03022123|Glucocorticoids|glucocorticoids|mesh-ancestor
102413808|NCT03022123|Hormones|hormones|mesh-ancestor
102413809|NCT03022123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102413810|NCT03022123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102413811|NCT03022123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102413812|NCT03022123|Tubulin Modulators|tubulin modulators|mesh-ancestor
102413813|NCT03022123|Antimitotic Agents|antimitotic agents|mesh-ancestor
102413814|NCT03022123|Mitosis Modulators|mitosis modulators|mesh-ancestor
102413815|NCT00722865|Bevacizumab|bevacizumab|mesh-list
102413816|NCT00722865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102413817|NCT00722865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102413818|NCT00722865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102413819|NCT00722865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102413820|NCT00722865|Growth Substances|growth substances|mesh-ancestor
102413821|NCT00722865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413822|NCT00722865|Growth Inhibitors|growth inhibitors|mesh-ancestor
102413823|NCT02700529|Ubenimex|ubenimex|mesh-list
102413824|NCT02700529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102413825|NCT02700529|Immunologic Factors|immunologic factors|mesh-ancestor
102413826|NCT02700529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413827|NCT02700529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102413828|NCT02700529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102413829|NCT02700529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102413830|NCT02700529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102413831|NCT02700529|Protease Inhibitors|protease inhibitors|mesh-ancestor
102413832|NCT02700529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102413833|NCT02700529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413834|NCT02700529|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102413835|NCT02700529|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102413836|NCT02700529|Antiviral Agents|antiviral agents|mesh-ancestor
102413837|NCT04146493|Heparin|heparin|mesh-list
102413838|NCT04146493|Anticoagulants|anticoagulants|mesh-ancestor
102413839|NCT04146493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102413840|NCT04146493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102413841|NCT04146493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413842|NCT00723099|Cyclosporine|cyclosporine|mesh-list
102413843|NCT00723099|Mycophenolic Acid|mycophenolic acid|mesh-list
102413844|NCT00723099|Cyclophosphamide|cyclophosphamide|mesh-list
102413845|NCT00723099|Fludarabine|fludarabine|mesh-list
102413846|NCT00723099|Fludarabine phosphate|fludarabine phosphate|mesh-list
102413847|NCT00723099|Cyclosporins|cyclosporins|mesh-list
102413848|NCT00723099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102413849|NCT00723099|Immunologic Factors|immunologic factors|mesh-ancestor
102413850|NCT00723099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413851|NCT00723099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102413852|NCT00723099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102413853|NCT00723099|Alkylating Agents|alkylating agents|mesh-ancestor
102413854|NCT00723099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413855|NCT00723099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102413856|NCT00723099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102413857|NCT00723099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102413858|NCT00723099|Antimetabolites|antimetabolites|mesh-ancestor
102413859|NCT00723099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102413860|NCT00723099|Antifungal Agents|antifungal agents|mesh-ancestor
102413861|NCT00723099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102413862|NCT00723099|Dermatologic Agents|dermatologic agents|mesh-ancestor
102413863|NCT00723099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102413864|NCT00723099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102413865|NCT00723099|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102413866|NCT00723099|Antitubercular Agents|antitubercular agents|mesh-ancestor
102413867|NCT00723099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102413868|NCT01508936|Reslizumab|reslizumab|mesh-list
102413869|NCT01508936|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102413870|NCT01508936|Respiratory System Agents|respiratory system agents|mesh-ancestor
102413871|NCT04146259|Alfacalcidol|alfacalcidol|mesh-list
102413872|NCT04146259|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
102413873|NCT04146259|Calcium Carbonate|calcium carbonate|mesh-list
102413874|NCT04146259|Calcium|calcium|mesh-list
102413875|NCT04146259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102413876|NCT04146259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413877|NCT04146259|Antacids|antacids|mesh-ancestor
102413878|NCT04146259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413879|NCT04146259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102413880|NCT04146259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102413881|NCT04146259|Vitamins|vitamins|mesh-ancestor
102413882|NCT04146259|Micronutrients|micronutrients|mesh-ancestor
102413883|NCT05100186|Dexamethasone|dexamethasone|mesh-list
102413884|NCT05100186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102413885|NCT05100186|Antiemetics|antiemetics|mesh-ancestor
102413886|NCT05100186|Autonomic Agents|autonomic agents|mesh-ancestor
102413887|NCT05100186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102413888|NCT05100186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413889|NCT05100186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102413890|NCT05100186|Glucocorticoids|glucocorticoids|mesh-ancestor
102413891|NCT05100186|Hormones|hormones|mesh-ancestor
102413892|NCT05100186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102044560|NCT01841177|Milrinone|milrinone|mesh-list
102413893|NCT05100186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102413894|NCT05100186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102413895|NCT04323462|Insulin|insulin|mesh-list
102413896|NCT04323462|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102413897|NCT04323462|Insulin Glargine|insulin glargine|mesh-list
102413898|NCT04323462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102413899|NCT04323462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413900|NCT00723177|Ibudilast|ibudilast|mesh-list
102413901|NCT00723177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102413902|NCT00723177|Autonomic Agents|autonomic agents|mesh-ancestor
102413903|NCT00723177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102413904|NCT00723177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413905|NCT00723177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102413906|NCT00723177|Respiratory System Agents|respiratory system agents|mesh-ancestor
102413907|NCT00723177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102413908|NCT00723177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102413909|NCT00723177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413910|NCT00723177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102413911|NCT00723177|Vasodilator Agents|vasodilator agents|mesh-ancestor
102413912|NCT04318392|Dimercaprol|dimercaprol|mesh-list
102413913|NCT04318392|Chelating Agents|chelating agents|mesh-ancestor
102413914|NCT04318392|Sequestering Agents|sequestering agents|mesh-ancestor
102413915|NCT04318392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413916|NCT04698434|Esketamine|esketamine|mesh-list
102413917|NCT04698434|Antidepressive Agents|antidepressive agents|mesh-ancestor
102413918|NCT04698434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102413919|NCT04142749|Oltipraz|oltipraz|mesh-list
102413920|NCT04142749|Antiviral Agents|antiviral agents|mesh-ancestor
102413921|NCT04142749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102413922|NCT04142749|Schistosomicides|schistosomicides|mesh-ancestor
102413923|NCT04142749|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102413924|NCT04142749|Anthelmintics|anthelmintics|mesh-ancestor
102413925|NCT04142749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102413926|NCT04142749|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102413927|NCT04142749|Protective Agents|protective agents|mesh-ancestor
102413928|NCT04142749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413929|NCT04142749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102413930|NCT04142749|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102413931|NCT04142749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102413932|NCT04142749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102413933|NCT04142749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413934|NCT01508702|Lesinurad|lesinurad|mesh-list
102413935|NCT01508702|Gout Suppressants|gout suppressants|mesh-ancestor
102413936|NCT01508702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102413937|NCT01508702|Uricosuric Agents|uricosuric agents|mesh-ancestor
102413938|NCT04024813|Seladelpar|seladelpar|mesh-list
102413939|NCT04024813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102413940|NCT04024813|Antimetabolites|antimetabolites|mesh-ancestor
102413941|NCT04024813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413942|NCT04024813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102413943|NCT01276041|Paclitaxel|paclitaxel|mesh-list
102413944|NCT01276041|Trastuzumab|trastuzumab|mesh-list
102413945|NCT01276041|Pertuzumab|pertuzumab|mesh-list
102413946|NCT01276041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102413947|NCT01276041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102413948|NCT01276041|Tubulin Modulators|tubulin modulators|mesh-ancestor
102413949|NCT01276041|Antimitotic Agents|antimitotic agents|mesh-ancestor
102413950|NCT01276041|Mitosis Modulators|mitosis modulators|mesh-ancestor
102413951|NCT01276041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413952|NCT01276041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102413953|NCT04150770|Infliximab|infliximab|mesh-list
102413954|NCT04150770|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102413955|NCT04150770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102413956|NCT04150770|Dermatologic Agents|dermatologic agents|mesh-ancestor
102413957|NCT04150770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102413958|NCT04150770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102413959|NCT04026438|Potassium phosphate|potassium phosphate|mesh-list
102413960|NCT04026438|Cariostatic Agents|cariostatic agents|mesh-ancestor
102413961|NCT04026438|Protective Agents|protective agents|mesh-ancestor
102413962|NCT04026438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413963|NCT01275339|Tadalafil|tadalafil|mesh-list
102413964|NCT01275339|Vasodilator Agents|vasodilator agents|mesh-ancestor
102413965|NCT01275339|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102413966|NCT01275339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102413967|NCT01275339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102413968|NCT01275339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413969|NCT01275339|Urological Agents|urological agents|mesh-ancestor
102413970|NCT01520402|Warfarin|warfarin|mesh-list
102413971|NCT01520402|Anticoagulants|anticoagulants|mesh-list
102413972|NCT00738543|Povidone-Iodine|povidone-iodine|mesh-list
102413973|NCT00738543|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102413974|NCT00738543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102413975|NCT05108220|Cannabidiol|cannabidiol|mesh-list
102413976|NCT05108220|Anticonvulsants|anticonvulsants|mesh-ancestor
102413977|NCT03027674|Nifedipine|nifedipine|mesh-list
102413978|NCT03027674|Sildenafil Citrate|sildenafil citrate|mesh-list
102413979|NCT03027674|Vasodilator Agents|vasodilator agents|mesh-ancestor
102413980|NCT03027674|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102413981|NCT03027674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102413982|NCT03027674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102413983|NCT03027674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413984|NCT03027674|Urological Agents|urological agents|mesh-ancestor
102413985|NCT03027674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102413986|NCT03027674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102413987|NCT03027674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102413988|NCT03027674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413989|NCT03027674|Tocolytic Agents|tocolytic agents|mesh-ancestor
102413990|NCT03027674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102413991|NCT04094948|Clenbuterol|clenbuterol|mesh-list
102413992|NCT04094948|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102413993|NCT04094948|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102413994|NCT04094948|Adrenergic Agents|adrenergic agents|mesh-ancestor
102413995|NCT04094948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102413996|NCT04094948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102413997|NCT04094948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102413998|NCT04094948|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102413999|NCT04094948|Autonomic Agents|autonomic agents|mesh-ancestor
102414000|NCT04094948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102414001|NCT04094948|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102414002|NCT04094948|Respiratory System Agents|respiratory system agents|mesh-ancestor
102414003|NCT04094948|Sympathomimetics|sympathomimetics|mesh-ancestor
102414004|NCT04023565|Perindopril|perindopril|mesh-list
102414005|NCT04023565|Moxonidine|moxonidine|mesh-list
102414006|NCT04023565|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102414007|NCT04023565|Protease Inhibitors|protease inhibitors|mesh-ancestor
102414008|NCT04023565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102414009|NCT04023565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414010|NCT04023565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102414011|NCT01506908|Nicotine|nicotine|mesh-list
102414012|NCT01506908|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102414013|NCT01506908|Autonomic Agents|autonomic agents|mesh-ancestor
102414014|NCT01506908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102414015|NCT01506908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414016|NCT01506908|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102414017|NCT01506908|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102414018|NCT01506908|Cholinergic Agents|cholinergic agents|mesh-ancestor
102414019|NCT01506908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102414020|NCT01506908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414021|NCT01519778|Tedizolid|tedizolid|mesh-list
102414022|NCT01519778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102414023|NCT01519778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102414024|NCT04144933|Acetaminophen|acetaminophen|mesh-list
102414025|NCT04144933|Dexamethasone|dexamethasone|mesh-list
102414026|NCT04144933|Lidocaine|lidocaine|mesh-list
102414027|NCT04144933|Magnesium Sulfate|magnesium sulfate|mesh-list
102414029|NCT04144933|Dexmedetomidine|dexmedetomidine|mesh-list
102414030|NCT04144933|Ketamine|ketamine|mesh-list
102414031|NCT04144933|Gabapentin|gabapentin|mesh-list
102414032|NCT04144933|Dsuvia|dsuvia|mesh-list
102414033|NCT04144933|Analgesics, Opioid|analgesics, opioid|mesh-list
102414034|NCT04144933|Ondansetron|ondansetron|mesh-list
102414035|NCT04144933|Sevoflurane|sevoflurane|mesh-list
102414036|NCT04144933|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102414037|NCT04144933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102414038|NCT04144933|Antiemetics|antiemetics|mesh-ancestor
102414039|NCT04144933|Autonomic Agents|autonomic agents|mesh-ancestor
102414040|NCT04144933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102414041|NCT04144933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414042|NCT04144933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102414043|NCT04144933|Glucocorticoids|glucocorticoids|mesh-ancestor
102414044|NCT04144933|Hormones|hormones|mesh-ancestor
102414045|NCT04144933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102414046|NCT04144933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102414047|NCT04144933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102414048|NCT04144933|Anesthetics, Local|anesthetics, local|mesh-ancestor
102414049|NCT04144933|Anesthetics|anesthetics|mesh-ancestor
102414050|NCT04144933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102414051|NCT04144933|Sensory System Agents|sensory system agents|mesh-ancestor
102414052|NCT04144933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102414053|NCT04144933|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102414054|NCT04144933|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102414055|NCT04144933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102044720|NCT03564158|Meropenem|meropenem|mesh-list
102414056|NCT04144933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414057|NCT04144933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102414058|NCT04144933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102414059|NCT04144933|Analgesics|analgesics|mesh-ancestor
102414060|NCT04144933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102414061|NCT04144933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102414062|NCT04144933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102414063|NCT04144933|Adrenergic Agents|adrenergic agents|mesh-ancestor
102414064|NCT04144933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102414065|NCT04144933|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102414066|NCT04144933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102414067|NCT04144933|Anesthetics, General|anesthetics, general|mesh-ancestor
102414068|NCT04144933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102414069|NCT04144933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102414070|NCT04144933|Antipyretics|antipyretics|mesh-ancestor
102414071|NCT04144933|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102414072|NCT04144933|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102414073|NCT04144933|Anticonvulsants|anticonvulsants|mesh-ancestor
102414074|NCT04144933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102414075|NCT04144933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102414076|NCT04144933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102414077|NCT04144933|Antimanic Agents|antimanic agents|mesh-ancestor
102414078|NCT04144933|Narcotics|narcotics|mesh-ancestor
102414079|NCT04144933|Antipruritics|antipruritics|mesh-ancestor
102414080|NCT04144933|Dermatologic Agents|dermatologic agents|mesh-ancestor
102414081|NCT04144933|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102414082|NCT04144933|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102414083|NCT04144933|Serotonin Agents|serotonin agents|mesh-ancestor
102414084|NCT04144933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102414085|NCT04144933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102414086|NCT04144933|Tocolytic Agents|tocolytic agents|mesh-ancestor
102414087|NCT04144933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102414088|NCT04144933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102414089|NCT04149067|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102414090|NCT04149067|Dapagliflozin|dapagliflozin|mesh-list
102414091|NCT04149067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102414092|NCT04149067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414093|NCT04149067|Incretins|incretins|mesh-ancestor
102414094|NCT04149067|Hormones|hormones|mesh-ancestor
102414095|NCT04149067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102414096|NCT04149067|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102414097|NCT04149067|Protease Inhibitors|protease inhibitors|mesh-ancestor
102414098|NCT04149067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102044777|NCT01346137|Analgesics|analgesics|mesh-ancestor
102414099|NCT04149067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414100|NCT04149067|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102414101|NCT04022941|Sodium Benzoate|sodium benzoate|mesh-list
102414102|NCT04022941|Antifungal Agents|antifungal agents|mesh-ancestor
102414103|NCT04022941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102414104|NCT05087862|Anesthetics|anesthetics|mesh-list
102414105|NCT05087862|Anesthetics, Local|anesthetics, local|mesh-list
102414106|NCT05087862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102414107|NCT05087862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414108|NCT05087862|Sensory System Agents|sensory system agents|mesh-ancestor
102414109|NCT05087862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102414110|NCT01519700|Lenograstim|lenograstim|mesh-list
102414111|NCT01519700|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102414112|NCT01519700|Immunologic Factors|immunologic factors|mesh-ancestor
102414113|NCT01519700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414114|NCT04143685|Misoprostol|misoprostol|mesh-list
102414115|NCT04143685|Oxytocin|oxytocin|mesh-list
102414116|NCT04143685|Oxytocics|oxytocics|mesh-ancestor
102414117|NCT04143685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102414118|NCT04143685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414119|NCT04143685|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102414120|NCT04143685|Abortifacient Agents|abortifacient agents|mesh-ancestor
102414121|NCT04143685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102414122|NCT04143685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102414123|NCT04148599|Lidocaine|lidocaine|mesh-list
102414124|NCT04148599|Dexmedetomidine|dexmedetomidine|mesh-list
102414125|NCT04148599|Anesthetics, Local|anesthetics, local|mesh-ancestor
102414126|NCT04148599|Anesthetics|anesthetics|mesh-ancestor
102414127|NCT04148599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102414128|NCT04148599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414129|NCT04148599|Sensory System Agents|sensory system agents|mesh-ancestor
102414130|NCT04148599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102414131|NCT04148599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102414132|NCT04148599|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102414133|NCT04148599|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102414134|NCT04148599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102414135|NCT04148599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414136|NCT04148599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102414137|NCT04148599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102414138|NCT04148599|Analgesics|analgesics|mesh-ancestor
102414139|NCT04148599|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102414140|NCT04148599|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102414141|NCT04148599|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102414142|NCT04148599|Adrenergic Agents|adrenergic agents|mesh-ancestor
102414143|NCT04148599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102414144|NCT04930458|Listerine|listerine|mesh-list
102414145|NCT04930458|Calcium|calcium|mesh-list
102414146|NCT04930458|Fluorides|fluorides|mesh-list
102414147|NCT04930458|Sodium Fluoride|sodium fluoride|mesh-list
102414148|NCT04930458|Fluorides, Topical|fluorides, topical|mesh-list
102414149|NCT04930458|Caseins|caseins|mesh-list
102414150|NCT04930458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102414151|NCT04930458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414152|NCT04930458|Cariostatic Agents|cariostatic agents|mesh-ancestor
102414153|NCT04930458|Protective Agents|protective agents|mesh-ancestor
102414154|NCT04930458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102414155|NCT04930458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102414156|NCT04930458|Chelating Agents|chelating agents|mesh-ancestor
102414157|NCT04930458|Sequestering Agents|sequestering agents|mesh-ancestor
102414158|NCT04930458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414159|NCT04917588|Lidocaine|lidocaine|mesh-list
102414160|NCT04917588|Anesthetics, Local|anesthetics, local|mesh-ancestor
102414161|NCT04917588|Anesthetics|anesthetics|mesh-ancestor
102414162|NCT04917588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102414163|NCT04917588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414164|NCT04917588|Sensory System Agents|sensory system agents|mesh-ancestor
102414165|NCT04917588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102414166|NCT04917588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102414167|NCT04917588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102414168|NCT04917588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102414169|NCT04917588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102414170|NCT04917588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414171|NCT05101356|Antineoplastic Agents|antineoplastic agents|mesh-list
102414172|NCT05101356|Vaccines|vaccines|mesh-list
102414173|NCT05101356|Sargramostim|sargramostim|mesh-list
102414174|NCT05101356|Immunologic Factors|immunologic factors|mesh-ancestor
102414175|NCT05101356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414176|NCT04022317|Insulin|insulin|mesh-list
102414177|NCT04022317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102225823|NCT03426527|Dexmedetomidine|dexmedetomidine|mesh-list
102414178|NCT04022317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414179|NCT05099250|Magnesium Sulfate|magnesium sulfate|mesh-list
102414180|NCT05099250|Bupivacaine|bupivacaine|mesh-list
102414181|NCT05099250|Anesthetics, Local|anesthetics, local|mesh-ancestor
102414182|NCT05099250|Anesthetics|anesthetics|mesh-ancestor
102414183|NCT05099250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102414184|NCT05099250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414185|NCT05099250|Sensory System Agents|sensory system agents|mesh-ancestor
102414186|NCT05099250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102414187|NCT05099250|Analgesics|analgesics|mesh-ancestor
102414188|NCT05099250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102414189|NCT05099250|Anticonvulsants|anticonvulsants|mesh-ancestor
102414190|NCT05099250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102414191|NCT05099250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102414192|NCT05099250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414193|NCT05099250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102414194|NCT05099250|Tocolytic Agents|tocolytic agents|mesh-ancestor
102414195|NCT05099250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102414196|NCT04143451|Imiquimod|imiquimod|mesh-list
102414197|NCT04143451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102414198|NCT04143451|Immunologic Factors|immunologic factors|mesh-ancestor
102414199|NCT04143451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414200|NCT04143451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102414201|NCT04143451|Interferon Inducers|interferon inducers|mesh-ancestor
102414202|NCT05105412|Gemcitabine|gemcitabine|mesh-list
102414203|NCT05105412|Lenalidomide|lenalidomide|mesh-list
102414204|NCT05105412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102414205|NCT05105412|Antimetabolites|antimetabolites|mesh-ancestor
102414206|NCT05105412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414207|NCT05105412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102414208|NCT05105412|Immunologic Factors|immunologic factors|mesh-ancestor
102414209|NCT05105412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414210|NCT05105412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102414211|NCT05105412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102414212|NCT05105412|Growth Substances|growth substances|mesh-ancestor
102414213|NCT05105412|Growth Inhibitors|growth inhibitors|mesh-ancestor
102414214|NCT04766047|Dexmedetomidine|dexmedetomidine|mesh-list
102414215|NCT04766047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102414216|NCT04766047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102044887|NCT01348243|Lidocaine|lidocaine|mesh-list
102414217|NCT04766047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414218|NCT04766047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102414219|NCT04766047|Analgesics|analgesics|mesh-ancestor
102414220|NCT04766047|Sensory System Agents|sensory system agents|mesh-ancestor
102414221|NCT04766047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102414222|NCT04766047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102414223|NCT04766047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102414224|NCT04766047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102414225|NCT04766047|Adrenergic Agents|adrenergic agents|mesh-ancestor
102414226|NCT04766047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102414227|NCT04766047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414228|NCT02080819|Levodopa|levodopa|mesh-list
102414229|NCT02080819|Carbidopa|carbidopa|mesh-list
102414230|NCT02080819|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102414231|NCT02080819|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102414232|NCT02080819|Dopamine Agents|dopamine agents|mesh-ancestor
102414233|NCT02080819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102414234|NCT02080819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414235|NCT02080819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414236|NCT02080819|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102414237|NCT02080819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102414238|NCT05104788|Carboplatin|carboplatin|mesh-list
102414239|NCT05104788|Pemetrexed|pemetrexed|mesh-list
102414240|NCT05104788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102414241|NCT05104788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102414242|NCT05104788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414243|NCT05104788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102414244|NCT05104788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102414245|NCT04405843|Ivermectin|ivermectin|mesh-list
102414246|NCT04405843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102414247|NCT04405843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102414248|NCT04316364|Paclitaxel|paclitaxel|mesh-list
102414249|NCT04316364|Carboplatin|carboplatin|mesh-list
102414250|NCT04316364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102225897|NCT03423797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102414251|NCT04316364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102414252|NCT04316364|Tubulin Modulators|tubulin modulators|mesh-ancestor
102414253|NCT04316364|Antimitotic Agents|antimitotic agents|mesh-ancestor
102414254|NCT04316364|Mitosis Modulators|mitosis modulators|mesh-ancestor
102414255|NCT04316364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414257|NCT03916003|Antimalarials|antimalarials|mesh-ancestor
102414258|NCT03916003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102414259|NCT03916003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102414260|NCT03916003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102414261|NCT04781478|Chlorhexidine|chlorhexidine|mesh-list
102414262|NCT04781478|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102414263|NCT04781478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102414264|NCT04781478|Disinfectants|disinfectants|mesh-ancestor
102414265|NCT04018872|Itraconazole|itraconazole|mesh-list
102414266|NCT04018872|Antifungal Agents|antifungal agents|mesh-ancestor
102414267|NCT04018872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102414268|NCT04018872|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102414269|NCT04018872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102414270|NCT04018872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102414271|NCT04018872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414272|NCT04018872|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102414273|NCT04018872|Hormone Antagonists|hormone antagonists|mesh-ancestor
102044941|NCT01317589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102414274|NCT04018872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102414275|NCT04018872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414276|NCT04018872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102414277|NCT03896737|Thalidomide|thalidomide|mesh-list
102414278|NCT03896737|Dexamethasone|dexamethasone|mesh-list
102414279|NCT03896737|Dexamethasone acetate|dexamethasone acetate|mesh-list
102414280|NCT03896737|Cyclophosphamide|cyclophosphamide|mesh-list
102414281|NCT03896737|Bortezomib|bortezomib|mesh-list
102414282|NCT03896737|Daratumumab|daratumumab|mesh-list
102414283|NCT03896737|BB 1101|bb 1101|mesh-list
102414284|NCT03896737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102414285|NCT03896737|Immunologic Factors|immunologic factors|mesh-ancestor
102414286|NCT03896737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414287|NCT03896737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102414288|NCT03896737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102414289|NCT03896737|Alkylating Agents|alkylating agents|mesh-ancestor
102414290|NCT03896737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414291|NCT03896737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102414292|NCT03896737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102414293|NCT03896737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102414294|NCT03896737|Antiemetics|antiemetics|mesh-ancestor
102414295|NCT03896737|Autonomic Agents|autonomic agents|mesh-ancestor
102414296|NCT03896737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102414297|NCT03896737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102414298|NCT03896737|Glucocorticoids|glucocorticoids|mesh-ancestor
102414299|NCT03896737|Hormones|hormones|mesh-ancestor
102414300|NCT03896737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102414301|NCT03896737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102414302|NCT03896737|Protease Inhibitors|protease inhibitors|mesh-ancestor
102414303|NCT03896737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102414304|NCT03896737|Leprostatic Agents|leprostatic agents|mesh-ancestor
102414305|NCT03896737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102414306|NCT03896737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102414307|NCT03896737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102414308|NCT03896737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102414309|NCT03896737|Growth Substances|growth substances|mesh-ancestor
102414310|NCT03896737|Growth Inhibitors|growth inhibitors|mesh-ancestor
102414311|NCT05076786|Carboplatin|carboplatin|mesh-list
102414312|NCT05076786|Etoposide|etoposide|mesh-list
102414313|NCT05076786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102414314|NCT05076786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102414315|NCT05076786|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102414316|NCT05076786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102414317|NCT05076786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102414318|NCT05076786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414319|NCT03476317|Vancomycin|vancomycin|mesh-list
102414320|NCT03476317|Ciprofloxacin|ciprofloxacin|mesh-list
102414321|NCT03476317|Neomycin|neomycin|mesh-list
102414322|NCT03476317|Fluconazole|fluconazole|mesh-list
102414323|NCT03476317|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
102414324|NCT03476317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102414325|NCT03476317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102414326|NCT03476317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102414327|NCT03476317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102414328|NCT03476317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102414329|NCT03476317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414330|NCT03476317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102414331|NCT03476317|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102414332|NCT03476317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102414333|NCT03476317|Antifungal Agents|antifungal agents|mesh-ancestor
102414334|NCT03476317|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102414335|NCT03476317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102414336|NCT03476317|Hormone Antagonists|hormone antagonists|mesh-ancestor
102414337|NCT03476317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102414338|NCT03476317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414339|NCT03476317|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102414340|NCT03476317|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102414341|NCT03476317|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102414342|NCT03476317|Laxatives|laxatives|mesh-ancestor
102414343|NCT03476317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102414344|NCT02658084|Trastuzumab|trastuzumab|mesh-list
102414345|NCT02658084|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102414346|NCT02658084|Vinorelbine|vinorelbine|mesh-list
102414347|NCT02658084|Maytansine|maytansine|mesh-list
102414348|NCT02658084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102414349|NCT02658084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102414350|NCT02658084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102414351|NCT02658084|Tubulin Modulators|tubulin modulators|mesh-ancestor
102414352|NCT02658084|Antimitotic Agents|antimitotic agents|mesh-ancestor
102414353|NCT02658084|Mitosis Modulators|mitosis modulators|mesh-ancestor
102414354|NCT02658084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414355|NCT02658084|Immunotoxins|immunotoxins|mesh-ancestor
102414356|NCT02658084|Immunoconjugates|immunoconjugates|mesh-ancestor
102414357|NCT02658084|Immunologic Factors|immunologic factors|mesh-ancestor
102414358|NCT02658084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414359|NCT03588871|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102414360|NCT03588871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102414361|NCT03588871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102414362|NCT03588715|Interferons|interferons|mesh-list
102414363|NCT03588715|Interferon-alpha|interferon-alpha|mesh-list
102414364|NCT03588715|Interferon alpha-2|interferon alpha-2|mesh-list
102414365|NCT03588715|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102414366|NCT03588715|Antibodies, Blocking|antibodies, blocking|mesh-list
102414367|NCT03588715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102414368|NCT03588715|Antiviral Agents|antiviral agents|mesh-ancestor
102414369|NCT03588715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102414370|NCT03588715|Immunologic Factors|immunologic factors|mesh-ancestor
102414371|NCT03588715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414372|NCT04528758|Rhodamine 6G|rhodamine 6g|mesh-list
102414373|NCT04528758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102414374|NCT04140409|Octreotide|octreotide|mesh-list
102414375|NCT04140409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102414376|NCT04140409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102414377|NCT04140409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102414378|NCT04527432|Antibodies|antibodies|mesh-list
102414379|NCT04527432|Immunologic Factors|immunologic factors|mesh-ancestor
102414380|NCT04527432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414381|NCT03912805|Botulinum Toxins|botulinum toxins|mesh-list
102414382|NCT03912805|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102414383|NCT03912805|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102414384|NCT03912805|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102414385|NCT03912805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102045054|NCT03562754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102414386|NCT03912805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414387|NCT03912805|Cholinergic Agents|cholinergic agents|mesh-ancestor
102414388|NCT03912805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102414389|NCT03912805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414390|NCT03912805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102414391|NCT03912805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102414392|NCT04642950|Sargramostim|sargramostim|mesh-list
102414393|NCT04642950|Immunologic Factors|immunologic factors|mesh-ancestor
102414394|NCT04642950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414395|NCT04374240|Tretazicar|tretazicar|mesh-list
102414396|NCT04374240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102414397|NCT05109390|Cyclosporine|cyclosporine|mesh-list
102414398|NCT05109390|Simethicone|simethicone|mesh-list
102226045|NCT04451239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414399|NCT05109390|Omeprazole|omeprazole|mesh-list
102414400|NCT05109390|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
102414401|NCT05109390|Calcium Carbonate|calcium carbonate|mesh-list
102414402|NCT05109390|Magnesium Hydroxide|magnesium hydroxide|mesh-list
102414403|NCT05109390|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
102414404|NCT05109390|Antacids|antacids|mesh-list
102414405|NCT05109390|Tacrolimus|tacrolimus|mesh-list
102414406|NCT05109390|Cyclosporins|cyclosporins|mesh-list
102414407|NCT05109390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414408|NCT05109390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102414409|NCT05109390|Immunologic Factors|immunologic factors|mesh-ancestor
102414410|NCT05109390|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102414411|NCT05109390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102414412|NCT05109390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414413|NCT05109390|Antifungal Agents|antifungal agents|mesh-ancestor
102414414|NCT05109390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102414415|NCT05109390|Dermatologic Agents|dermatologic agents|mesh-ancestor
102414416|NCT05109390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102414417|NCT05109390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102414418|NCT05109390|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102414419|NCT05109390|Antifoaming Agents|antifoaming agents|mesh-ancestor
102414420|NCT05109390|Emollients|emollients|mesh-ancestor
102414421|NCT04030182|Vitamin D|vitamin d|mesh-list
102414422|NCT04030182|Vitamins|vitamins|mesh-ancestor
102414423|NCT04030182|Micronutrients|micronutrients|mesh-ancestor
102414424|NCT04030182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414425|NCT04030182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102414426|NCT05109312|Acetaminophen|acetaminophen|mesh-list
102414427|NCT05109312|Ibuprofen|ibuprofen|mesh-list
102414428|NCT05109312|Bupivacaine|bupivacaine|mesh-list
102414429|NCT05109312|Anesthetics, Local|anesthetics, local|mesh-ancestor
102414430|NCT05109312|Anesthetics|anesthetics|mesh-ancestor
102414431|NCT05109312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102414432|NCT05109312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414433|NCT05109312|Sensory System Agents|sensory system agents|mesh-ancestor
102414434|NCT05109312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102414435|NCT05109312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102414436|NCT05109312|Analgesics|analgesics|mesh-ancestor
102414437|NCT05109312|Antipyretics|antipyretics|mesh-ancestor
102414438|NCT05109312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102414439|NCT05109312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102414440|NCT05109312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102414441|NCT05109312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102414442|NCT05109312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102414443|NCT05109312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414444|NCT03661632|Nivolumab|nivolumab|mesh-list
102414445|NCT03661632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102414446|NCT03661632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102414447|NCT03661632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102414448|NCT03661632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414449|NCT04748250|Phytoestrogens|phytoestrogens|mesh-list
102414450|NCT04748250|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102414451|NCT04748250|Estrogens|estrogens|mesh-ancestor
102414452|NCT04748250|Hormones|hormones|mesh-ancestor
102414453|NCT04748250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102414454|NCT04748250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414455|NCT04726878|Acetaminophen|acetaminophen|mesh-list
102414456|NCT04726878|Oxycodone|oxycodone|mesh-list
102414457|NCT04726878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102414458|NCT04726878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414459|NCT04726878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102414460|NCT04726878|Analgesics|analgesics|mesh-ancestor
102414461|NCT04726878|Sensory System Agents|sensory system agents|mesh-ancestor
102414462|NCT04726878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102414463|NCT04726878|Antipyretics|antipyretics|mesh-ancestor
102414464|NCT04726878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102414465|NCT04726878|Narcotics|narcotics|mesh-ancestor
102414466|NCT04525638|Nivolumab|nivolumab|mesh-list
102414467|NCT04525638|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102414468|NCT04525638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102414469|NCT04525638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102414470|NCT04525638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102414471|NCT04525638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414472|NCT04525638|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102414473|NCT01482962|Gemcitabine|gemcitabine|mesh-list
102414474|NCT01482962|Romidepsin|romidepsin|mesh-list
102414475|NCT01482962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102414476|NCT01482962|Antimetabolites|antimetabolites|mesh-ancestor
102414477|NCT01482962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414478|NCT01482962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102414479|NCT01482962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102414480|NCT01482962|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102414482|NCT04701060|Apatinib|apatinib|mesh-list
102414483|NCT04701060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102414484|NCT04701060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102414485|NCT04701060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102414486|NCT04701060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414487|NCT05116098|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
102414488|NCT05116098|Antioxidants|antioxidants|mesh-ancestor
102414489|NCT05116098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414490|NCT05116098|Protective Agents|protective agents|mesh-ancestor
102414491|NCT05116098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414492|NCT05116098|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
102414493|NCT05116098|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102414494|NCT05116098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102414495|NCT05116098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102414496|NCT04464408|Favipiravir|favipiravir|mesh-list
102414497|NCT04464408|Antiviral Agents|antiviral agents|mesh-ancestor
102414498|NCT04464408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102414499|NCT04339218|Carboplatin|carboplatin|mesh-list
102414500|NCT04339218|Pembrolizumab|pembrolizumab|mesh-list
102414501|NCT04339218|Pemetrexed|pemetrexed|mesh-list
102414502|NCT04339218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102414503|NCT04339218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102414504|NCT04339218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102414505|NCT04339218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414506|NCT04339218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102414507|NCT04339218|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102414508|NCT04339218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102414509|NCT03895801|Prednisone|prednisone|mesh-list
102045178|NCT01352611|Baclofen|baclofen|mesh-list
102414510|NCT03895801|Glucocorticoids|glucocorticoids|mesh-list
102414511|NCT03895801|Vilobelimab|vilobelimab|mesh-list
102414512|NCT03895801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102414513|NCT03895801|Hormones|hormones|mesh-ancestor
102414514|NCT03895801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102414515|NCT03895801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414516|NCT03895801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102414517|NCT03895801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102414518|NCT03895801|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102414519|NCT03895801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102414520|NCT03895801|Immunologic Factors|immunologic factors|mesh-ancestor
102414521|NCT03021421|Bupivacaine|bupivacaine|mesh-list
102414522|NCT03021421|Anesthetics, Local|anesthetics, local|mesh-ancestor
102414523|NCT03021421|Anesthetics|anesthetics|mesh-ancestor
102414524|NCT03021421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102414525|NCT03021421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414526|NCT03021421|Sensory System Agents|sensory system agents|mesh-ancestor
102414527|NCT03021421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102414528|NCT04521582|Amlodipine|amlodipine|mesh-list
102414529|NCT04521582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102414530|NCT04521582|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102414531|NCT04521582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102414532|NCT04521582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414533|NCT04521582|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102414534|NCT04521582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414535|NCT04521582|Vasodilator Agents|vasodilator agents|mesh-ancestor
102414536|NCT03588091|Docetaxel|docetaxel|mesh-list
102414537|NCT03588091|Trastuzumab|trastuzumab|mesh-list
102414538|NCT03588091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102414539|NCT03588091|Tubulin Modulators|tubulin modulators|mesh-ancestor
102414540|NCT03588091|Antimitotic Agents|antimitotic agents|mesh-ancestor
102414541|NCT03588091|Mitosis Modulators|mitosis modulators|mesh-ancestor
102414542|NCT03588091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414543|NCT03588091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102414544|NCT05065554|Rituximab|rituximab|mesh-list
102414545|NCT05065554|Acalabrutinib|acalabrutinib|mesh-list
102414546|NCT05065554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102414547|NCT05065554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102414548|NCT05065554|Immunologic Factors|immunologic factors|mesh-ancestor
102414549|NCT05065554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414550|NCT05065554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102414551|NCT04436172|Anesthetics|anesthetics|mesh-list
102414552|NCT04436172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102414553|NCT04436172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414554|NCT03587779|Sevoflurane|sevoflurane|mesh-list
102414555|NCT03587779|Desflurane|desflurane|mesh-list
102414556|NCT03587779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102414557|NCT03587779|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102414558|NCT03587779|Anesthetics, General|anesthetics, general|mesh-ancestor
102414559|NCT03587779|Anesthetics|anesthetics|mesh-ancestor
102414560|NCT03587779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102414561|NCT03587779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414562|NCT04405921|Azithromycin|azithromycin|mesh-list
102414563|NCT04405921|Hydroxychloroquine|hydroxychloroquine|mesh-list
102414564|NCT04405921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102414565|NCT04405921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102414566|NCT04405921|Antimalarials|antimalarials|mesh-ancestor
102414567|NCT04405921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102414568|NCT04405921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102414569|NCT04405921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102414570|NCT04405921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414571|NCT04405921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102414572|NCT04516902|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
102414573|NCT04516902|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
102414574|NCT04516902|Hallucinogens|hallucinogens|mesh-ancestor
102414575|NCT04516902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414576|NCT04516902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102414577|NCT04516902|Serotonin Agents|serotonin agents|mesh-ancestor
102414578|NCT04516902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102414579|NCT04516902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414580|NCT04516902|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102414581|NCT04516902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102414582|NCT04516902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102414583|NCT04516902|Adrenergic Agents|adrenergic agents|mesh-ancestor
102414584|NCT04516902|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102414585|NCT04516902|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102414586|NCT03581149|Ascorbic Acid|ascorbic acid|mesh-list
102414587|NCT03581149|Magnesium citrate|magnesium citrate|mesh-list
102414588|NCT03581149|Picosulfate sodium|picosulfate sodium|mesh-list
102414589|NCT03581149|Laxatives|laxatives|mesh-list
102414590|NCT03581149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414591|NCT03581149|Antioxidants|antioxidants|mesh-ancestor
102414592|NCT03581149|Protective Agents|protective agents|mesh-ancestor
102414593|NCT03581149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414594|NCT03581149|Vitamins|vitamins|mesh-ancestor
102414595|NCT03581149|Micronutrients|micronutrients|mesh-ancestor
102414596|NCT03581149|Cathartics|cathartics|mesh-ancestor
102414597|NCT03581149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102414598|NCT04765267|Vitamin D|vitamin d|mesh-list
102414599|NCT04765267|Cholecalciferol|cholecalciferol|mesh-list
102414600|NCT04765267|Zinc Sulfate|zinc sulfate|mesh-list
102414601|NCT04765267|Vitamins|vitamins|mesh-ancestor
102414602|NCT04765267|Micronutrients|micronutrients|mesh-ancestor
102414603|NCT04765267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414604|NCT04765267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102414605|NCT04765267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102414606|NCT04765267|Astringents|astringents|mesh-ancestor
102414607|NCT04765267|Dermatologic Agents|dermatologic agents|mesh-ancestor
102414608|NCT05583409|Osimertinib|osimertinib|mesh-list
102414609|NCT05583409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102414610|NCT05583409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102414611|NCT05583409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102414612|NCT05583409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414613|NCT03020953|Estrogens|estrogens|mesh-list
102414614|NCT03020953|Hormones|hormones|mesh-ancestor
102414615|NCT03020953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102414616|NCT03020953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414617|NCT05583175|Venetoclax|venetoclax|mesh-list
102414618|NCT05583175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102414619|NCT03891901|Isoniazid|isoniazid|mesh-list
102414620|NCT03891901|Rifabutin|rifabutin|mesh-list
102414621|NCT03891901|Imatinib Mesylate|imatinib mesylate|mesh-list
102414622|NCT03891901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102414623|NCT03891901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102414624|NCT03891901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102414625|NCT03891901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414626|NCT03891901|Antitubercular Agents|antitubercular agents|mesh-ancestor
102414627|NCT03891901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102414628|NCT03891901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102414629|NCT03891901|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102414631|NCT03891901|Antimetabolites|antimetabolites|mesh-ancestor
102414632|NCT03891901|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102414633|NCT03891901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102414634|NCT03580681|Vitamin E|vitamin e|mesh-list
102414635|NCT03580681|Vitamins|vitamins|mesh-ancestor
102414636|NCT03580681|Micronutrients|micronutrients|mesh-ancestor
102414637|NCT03580681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414638|NCT03580681|Antioxidants|antioxidants|mesh-ancestor
102414639|NCT03580681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414640|NCT03580681|Protective Agents|protective agents|mesh-ancestor
102414641|NCT03452826|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102414642|NCT03452826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102414643|NCT03452826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102414644|NCT03452826|Antitubercular Agents|antitubercular agents|mesh-ancestor
102414645|NCT05040126|Linezolid|linezolid|mesh-list
102414646|NCT05040126|Bedaquiline|bedaquiline|mesh-list
102414647|NCT05040126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102414648|NCT05040126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102414649|NCT05040126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102414650|NCT05040126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102414651|NCT05040126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414652|NCT05040126|Antitubercular Agents|antitubercular agents|mesh-ancestor
102414653|NCT03069300|Acetylcysteine|acetylcysteine|mesh-list
102414654|NCT03069300|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102414655|NCT03069300|Antiviral Agents|antiviral agents|mesh-ancestor
102414656|NCT03069300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102414657|NCT03069300|Expectorants|expectorants|mesh-ancestor
102414658|NCT03069300|Respiratory System Agents|respiratory system agents|mesh-ancestor
102414659|NCT03069300|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102414660|NCT03069300|Antioxidants|antioxidants|mesh-ancestor
102414661|NCT03069300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414662|NCT03069300|Protective Agents|protective agents|mesh-ancestor
102414663|NCT03069300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414664|NCT03069300|Antidotes|antidotes|mesh-ancestor
102414665|NCT05582317|Simvastatin|simvastatin|mesh-list
102414666|NCT05582317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102414667|NCT05582317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102414668|NCT05582317|Antimetabolites|antimetabolites|mesh-ancestor
102414669|NCT05582317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414670|NCT05582317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102414671|NCT05582317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102414672|NCT05582317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102414673|NCT03891355|Dexamethasone|dexamethasone|mesh-list
102414674|NCT03891355|Lenalidomide|lenalidomide|mesh-list
102414675|NCT03891355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102414676|NCT03891355|Antiemetics|antiemetics|mesh-ancestor
102414677|NCT03891355|Autonomic Agents|autonomic agents|mesh-ancestor
102414678|NCT03891355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102414679|NCT03891355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414680|NCT03891355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102414681|NCT03891355|Glucocorticoids|glucocorticoids|mesh-ancestor
102414682|NCT03891355|Hormones|hormones|mesh-ancestor
102414683|NCT03891355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102414684|NCT03891355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102414685|NCT03891355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102414686|NCT03891355|Immunologic Factors|immunologic factors|mesh-ancestor
102414687|NCT03891355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102414688|NCT03891355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102414689|NCT03891355|Growth Substances|growth substances|mesh-ancestor
102414690|NCT03891355|Growth Inhibitors|growth inhibitors|mesh-ancestor
102414691|NCT05582083|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
102414692|NCT05582083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102414693|NCT05582083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102414694|NCT05582083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414695|NCT03954132|Cholinergic Agents|cholinergic agents|mesh-list
102414696|NCT03954132|Muscarinic Antagonists|muscarinic antagonists|mesh-list
102414697|NCT03954132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102414698|NCT03954132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414699|NCT03954132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414700|NCT03954132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102414701|NCT03580291|Mycophenolic Acid|mycophenolic acid|mesh-list
102414702|NCT03580291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102414703|NCT03580291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102414704|NCT03580291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102414705|NCT03580291|Antitubercular Agents|antitubercular agents|mesh-ancestor
102414706|NCT03580291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102414707|NCT03580291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102414708|NCT03580291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102414709|NCT03580291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414711|NCT02936388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102414712|NCT03586141|Chrysarobin|chrysarobin|mesh-list
102414713|NCT03586141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102414714|NCT03586141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102414715|NCT03586141|Analgesics|analgesics|mesh-ancestor
102414716|NCT03586141|Sensory System Agents|sensory system agents|mesh-ancestor
102414717|NCT03586141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102414718|NCT03586141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414719|NCT03586141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102414720|NCT03586141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102414721|NCT03020563|Bupivacaine|bupivacaine|mesh-list
102414722|NCT03020563|Anesthetics, Local|anesthetics, local|mesh-ancestor
102414723|NCT03020563|Anesthetics|anesthetics|mesh-ancestor
102414724|NCT03020563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102414725|NCT03020563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414726|NCT03020563|Sensory System Agents|sensory system agents|mesh-ancestor
102414727|NCT03020563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102414728|NCT04591626|Insulin Glargine|insulin glargine|mesh-list
102414729|NCT04591626|Dulaglutide|dulaglutide|mesh-list
102414730|NCT04591626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102414731|NCT04591626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414732|NCT04518306|Amlodipine|amlodipine|mesh-list
102414733|NCT04518306|Telmisartan|telmisartan|mesh-list
102414734|NCT04518306|Indapamide|indapamide|mesh-list
102414735|NCT04518306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102414736|NCT04518306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102414737|NCT04518306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102414738|NCT04518306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414739|NCT04518306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102414740|NCT04518306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414741|NCT04518306|Vasodilator Agents|vasodilator agents|mesh-ancestor
102414742|NCT04518306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102414743|NCT04518306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102414744|NCT04518306|Diuretics|diuretics|mesh-ancestor
102414745|NCT04518306|Natriuretic Agents|natriuretic agents|mesh-ancestor
102414746|NCT04518306|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102414747|NCT03580135|Propolis|propolis|mesh-list
102414748|NCT03580135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102414749|NCT01890252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102414750|NCT03901573|Atezolizumab|atezolizumab|mesh-list
102414751|NCT03901573|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102414752|NCT03901573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414753|NCT03901573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102414754|NCT03901573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102414755|NCT03585829|Prednisolone|prednisolone|mesh-list
102414756|NCT03585829|Hydrocortisone|hydrocortisone|mesh-list
102414757|NCT03585829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102414758|NCT03585829|Glucocorticoids|glucocorticoids|mesh-ancestor
102414759|NCT03585829|Hormones|hormones|mesh-ancestor
102414760|NCT03585829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102414761|NCT03585829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414762|NCT03585829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102414763|NCT03585829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102414764|NCT05701969|Melatonin|melatonin|mesh-list
102414765|NCT05701969|Antioxidants|antioxidants|mesh-ancestor
102414766|NCT05701969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414767|NCT05701969|Protective Agents|protective agents|mesh-ancestor
102414768|NCT05701969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414769|NCT05701969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102414770|NCT03585751|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102414771|NCT03585751|Simvastatin|simvastatin|mesh-list
102414772|NCT03585751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102414773|NCT03585751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102414774|NCT03585751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102414775|NCT03585751|Antimetabolites|antimetabolites|mesh-ancestor
102414776|NCT03585751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414777|NCT03585751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102414778|NCT03585751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102414780|NCT03583333|Linezolid|linezolid|mesh-list
102414781|NCT03583333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102414782|NCT03583333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102414783|NCT03583333|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102414784|NCT03583333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102414785|NCT03583333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414786|NCT03585673|Docetaxel|docetaxel|mesh-list
102414787|NCT03585673|Oxaliplatin|oxaliplatin|mesh-list
102414788|NCT03585673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102414789|NCT03585673|Tubulin Modulators|tubulin modulators|mesh-ancestor
102414790|NCT03585673|Antimitotic Agents|antimitotic agents|mesh-ancestor
102414791|NCT03585673|Mitosis Modulators|mitosis modulators|mesh-ancestor
102414792|NCT03585673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414793|NCT01602510|Lamotrigine|lamotrigine|mesh-list
102414794|NCT01602510|Anticonvulsants|anticonvulsants|mesh-ancestor
102414795|NCT01602510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102414796|NCT01602510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102414797|NCT01602510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414798|NCT01602510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102414799|NCT01602510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414800|NCT01602510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102414801|NCT01602510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102414802|NCT01602510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102414803|NCT01602510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102414804|NCT01602510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102414805|NCT03899467|Androgens|androgens|mesh-list
102414806|NCT03899467|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
102414807|NCT03899467|Hormones|hormones|mesh-ancestor
102414808|NCT03899467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102414809|NCT03899467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414810|NCT03899467|Androgen Antagonists|androgen antagonists|mesh-ancestor
102414811|NCT03899467|Hormone Antagonists|hormone antagonists|mesh-ancestor
102414812|NCT05701813|Inositol|inositol|mesh-list
102414813|NCT05701813|Vitamin B Complex|vitamin b complex|mesh-ancestor
102414814|NCT05701813|Vitamins|vitamins|mesh-ancestor
102414815|NCT05701813|Micronutrients|micronutrients|mesh-ancestor
102414816|NCT05701813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414817|NCT03586219|Analgesics, Opioid|analgesics, opioid|mesh-list
102414818|NCT03586219|Narcotics|narcotics|mesh-ancestor
102414819|NCT03586219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102414820|NCT03586219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414821|NCT03586219|Analgesics|analgesics|mesh-ancestor
102414822|NCT03586219|Sensory System Agents|sensory system agents|mesh-ancestor
102414823|NCT03586219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102414824|NCT05118984|Azithromycin|azithromycin|mesh-list
102414825|NCT05118984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102414826|NCT05118984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102414827|NCT04514328|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102414828|NCT04514328|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102414829|NCT04514328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414830|NCT02802852|Lenograstim|lenograstim|mesh-list
102414831|NCT02802852|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102414832|NCT02802852|Immunologic Factors|immunologic factors|mesh-ancestor
102414833|NCT02802852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414834|NCT03158389|Sirolimus|sirolimus|mesh-list
102414835|NCT03158389|Atezolizumab|atezolizumab|mesh-list
102414836|NCT03158389|Palbociclib|palbociclib|mesh-list
102414837|NCT03158389|Temsirolimus|temsirolimus|mesh-list
102414838|NCT03158389|MTOR Inhibitors|mtor inhibitors|mesh-list
102414839|NCT03158389|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102414840|NCT03158389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414841|NCT03158389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102414842|NCT03158389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102414843|NCT03158389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102414844|NCT03158389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102414845|NCT03158389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102414846|NCT03158389|Immunologic Factors|immunologic factors|mesh-ancestor
102414847|NCT03158389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414848|NCT03158389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102414849|NCT03158389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102414850|NCT03158389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102414851|NCT03158389|Antifungal Agents|antifungal agents|mesh-ancestor
102414852|NCT01236456|Cyclophosphamide|cyclophosphamide|mesh-list
102414853|NCT01236456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102414854|NCT01236456|Immunologic Factors|immunologic factors|mesh-ancestor
102414855|NCT01236456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414856|NCT01236456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102414857|NCT01236456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102414858|NCT01236456|Alkylating Agents|alkylating agents|mesh-ancestor
102414859|NCT01236456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414860|NCT01236456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102414861|NCT01236456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102414862|NCT05118048|Chrysarobin|chrysarobin|mesh-list
102414863|NCT05118048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102414864|NCT05118048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102414865|NCT05118048|Analgesics|analgesics|mesh-ancestor
102414866|NCT05118048|Sensory System Agents|sensory system agents|mesh-ancestor
102414867|NCT05118048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102414868|NCT05118048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414869|NCT05118048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102414870|NCT05118048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102414871|NCT04405375|Dexamethasone|dexamethasone|mesh-list
102414872|NCT04405375|Etoposide|etoposide|mesh-list
102414873|NCT04405375|Pegaspargase|pegaspargase|mesh-list
102414874|NCT04405375|Gemcitabine|gemcitabine|mesh-list
102414875|NCT04405375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102414876|NCT04405375|Antiemetics|antiemetics|mesh-ancestor
102414877|NCT04405375|Autonomic Agents|autonomic agents|mesh-ancestor
102414878|NCT04405375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102414879|NCT04405375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414880|NCT04405375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102414881|NCT04405375|Glucocorticoids|glucocorticoids|mesh-ancestor
102414882|NCT04405375|Hormones|hormones|mesh-ancestor
102414883|NCT04405375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102414884|NCT04405375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102414885|NCT04405375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102414886|NCT04405375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102414887|NCT04405375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102414888|NCT04405375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102414889|NCT04405375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102414890|NCT04405375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414891|NCT04405375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102414892|NCT04405375|Antimetabolites|antimetabolites|mesh-ancestor
102414893|NCT03158857|Sofosbuvir|sofosbuvir|mesh-list
102414894|NCT03158857|Antiviral Agents|antiviral agents|mesh-ancestor
102414895|NCT03158857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102414896|NCT03029611|Paclitaxel|paclitaxel|mesh-list
102414897|NCT03029611|Carboplatin|carboplatin|mesh-list
102414898|NCT03029611|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102414899|NCT03029611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102414900|NCT03029611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102414901|NCT03029611|Tubulin Modulators|tubulin modulators|mesh-ancestor
102414902|NCT03029611|Antimitotic Agents|antimitotic agents|mesh-ancestor
102414903|NCT03029611|Mitosis Modulators|mitosis modulators|mesh-ancestor
102414904|NCT03029611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414905|NCT03589495|Acetylcysteine|acetylcysteine|mesh-list
102414906|NCT03589495|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102414907|NCT03589495|Antiviral Agents|antiviral agents|mesh-ancestor
102414908|NCT03589495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102414909|NCT03589495|Expectorants|expectorants|mesh-ancestor
102414910|NCT03589495|Respiratory System Agents|respiratory system agents|mesh-ancestor
102414911|NCT03589495|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102045585|NCT02053922|Oxytocin|oxytocin|mesh-list
102414912|NCT03589495|Antioxidants|antioxidants|mesh-ancestor
102414913|NCT03589495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414914|NCT03589495|Protective Agents|protective agents|mesh-ancestor
102414915|NCT03589495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414916|NCT03589495|Antidotes|antidotes|mesh-ancestor
102414917|NCT03159559|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102414918|NCT03159559|Alprostadil|alprostadil|mesh-list
102414919|NCT03159559|Clopidogrel|clopidogrel|mesh-list
102414920|NCT03159559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414921|NCT03159559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414922|NCT03159559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102414923|NCT03159559|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102414924|NCT03159559|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102414925|NCT03159559|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102414926|NCT03159559|Purinergic Agents|purinergic agents|mesh-ancestor
102414927|NCT03159559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102414928|NCT03159559|Vasodilator Agents|vasodilator agents|mesh-ancestor
102414929|NCT03159559|Urological Agents|urological agents|mesh-ancestor
102414930|NCT03159403|Oritavancin|oritavancin|mesh-list
102414931|NCT03159403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102414932|NCT03159403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102414933|NCT03583567|Chlorpheniramine|chlorpheniramine|mesh-list
102414934|NCT03583567|Ranitidine|ranitidine|mesh-list
102414935|NCT03583567|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
102414936|NCT03583567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102414937|NCT03583567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102414938|NCT03583567|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102414939|NCT03583567|Histamine Antagonists|histamine antagonists|mesh-ancestor
102414940|NCT03583567|Histamine Agents|histamine agents|mesh-ancestor
102414941|NCT03583567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102414942|NCT03583567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414943|NCT03583567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414944|NCT03583567|Antipruritics|antipruritics|mesh-ancestor
102414945|NCT03583567|Dermatologic Agents|dermatologic agents|mesh-ancestor
102414946|NCT03583567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102414947|NCT03583567|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102414948|NCT03583489|Ondansetron|ondansetron|mesh-list
102414949|NCT03583489|Antiemetics|antiemetics|mesh-ancestor
102414950|NCT03583489|Autonomic Agents|autonomic agents|mesh-ancestor
102414951|NCT03583489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102414952|NCT03583489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414953|NCT03583489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102414954|NCT03583489|Antipruritics|antipruritics|mesh-ancestor
102414955|NCT03583489|Dermatologic Agents|dermatologic agents|mesh-ancestor
102414956|NCT03583489|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102414957|NCT03583489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102414958|NCT03583489|Serotonin Agents|serotonin agents|mesh-ancestor
102414959|NCT03583489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102414960|NCT03583489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414961|NCT03158935|Aldesleukin|aldesleukin|mesh-list
102414962|NCT03158935|Cyclophosphamide|cyclophosphamide|mesh-list
102414963|NCT03158935|Pembrolizumab|pembrolizumab|mesh-list
102414964|NCT03158935|Fludarabine|fludarabine|mesh-list
102414965|NCT03158935|Interleukin-2|interleukin-2|mesh-list
102414966|NCT03158935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102414967|NCT03158935|Immunologic Factors|immunologic factors|mesh-ancestor
102414968|NCT03158935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414969|NCT03158935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102414970|NCT03158935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102414971|NCT03158935|Alkylating Agents|alkylating agents|mesh-ancestor
102414972|NCT03158935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102414973|NCT03158935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102414974|NCT03158935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102414975|NCT03158935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102414976|NCT03158935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102414977|NCT03158935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102414978|NCT03158935|Analgesics|analgesics|mesh-ancestor
102414979|NCT03158935|Sensory System Agents|sensory system agents|mesh-ancestor
102414980|NCT03158935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102414981|NCT03158935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102414982|NCT03158935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102414983|NCT03158935|Antiviral Agents|antiviral agents|mesh-ancestor
102414984|NCT03158935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102414985|NCT04818372|Dexamethasone|dexamethasone|mesh-list
102414986|NCT04818372|Lenalidomide|lenalidomide|mesh-list
102414987|NCT04818372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102414988|NCT04818372|Antiemetics|antiemetics|mesh-ancestor
102414989|NCT04818372|Autonomic Agents|autonomic agents|mesh-ancestor
102414990|NCT04818372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102414991|NCT04818372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102414992|NCT04818372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102414993|NCT04818372|Glucocorticoids|glucocorticoids|mesh-ancestor
102414994|NCT04818372|Hormones|hormones|mesh-ancestor
102414995|NCT04818372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102414996|NCT04818372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102414997|NCT04818372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102414998|NCT04818372|Immunologic Factors|immunologic factors|mesh-ancestor
102414999|NCT04818372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102415000|NCT04818372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102415001|NCT04818372|Growth Substances|growth substances|mesh-ancestor
102415002|NCT04818372|Growth Inhibitors|growth inhibitors|mesh-ancestor
102415003|NCT01462578|Azacitidine|azacitidine|mesh-list
102415004|NCT01462578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102415006|NCT01462578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415007|NCT01462578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102415008|NCT01462578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102415009|NCT03059173|Inositol|inositol|mesh-list
102415010|NCT03059173|Clomiphene|clomiphene|mesh-list
102415011|NCT03059173|Enclomiphene|enclomiphene|mesh-list
102415012|NCT03059173|Zuclomiphene|zuclomiphene|mesh-list
102415013|NCT03059173|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102415014|NCT03059173|Hormone Antagonists|hormone antagonists|mesh-ancestor
102415015|NCT03059173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102415016|NCT03059173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415017|NCT03059173|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102415018|NCT03059173|Fertility Agents|fertility agents|mesh-ancestor
102415019|NCT03059173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102415020|NCT03059173|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102415021|NCT03059173|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102415022|NCT03059173|Vitamin B Complex|vitamin b complex|mesh-ancestor
102415023|NCT03059173|Vitamins|vitamins|mesh-ancestor
102415024|NCT03059173|Micronutrients|micronutrients|mesh-ancestor
102415025|NCT05122338|Lidocaine|lidocaine|mesh-list
102415026|NCT05122338|Ropivacaine|ropivacaine|mesh-list
102415027|NCT05122338|Esketamine|esketamine|mesh-list
102415028|NCT05122338|Anesthetics, Local|anesthetics, local|mesh-ancestor
102415029|NCT05122338|Anesthetics|anesthetics|mesh-ancestor
102415030|NCT05122338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102415031|NCT05122338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415032|NCT05122338|Sensory System Agents|sensory system agents|mesh-ancestor
102415033|NCT05122338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102415034|NCT05122338|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102415035|NCT05122338|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102415036|NCT05122338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102415037|NCT05122338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102415038|NCT05122338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415039|NCT05122338|Antidepressive Agents|antidepressive agents|mesh-ancestor
102415040|NCT05122338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102415041|NCT03157843|Heparin|heparin|mesh-list
102415042|NCT03157843|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102415043|NCT03157843|Tinzaparin|tinzaparin|mesh-list
102415044|NCT03157843|Dalteparin|dalteparin|mesh-list
102415045|NCT03157843|Anticoagulants|anticoagulants|mesh-ancestor
102415046|NCT03157843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102415047|NCT03157843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102415048|NCT03157843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415049|NCT03589027|Ritonavir|ritonavir|mesh-list
102415050|NCT03589027|Darunavir|darunavir|mesh-list
102415051|NCT03589027|Rilpivirine|rilpivirine|mesh-list
102415052|NCT03589027|Levonorgestrel|levonorgestrel|mesh-list
102415053|NCT03589027|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102415054|NCT03589027|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102415055|NCT03589027|Protease Inhibitors|protease inhibitors|mesh-ancestor
102415056|NCT03589027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102415057|NCT03589027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415058|NCT03589027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102415059|NCT03589027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102415060|NCT03589027|Antiviral Agents|antiviral agents|mesh-ancestor
102415061|NCT03589027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102415062|NCT03589027|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102415063|NCT03589027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102415064|NCT03589027|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102415065|NCT03589027|Contraceptive Agents|contraceptive agents|mesh-ancestor
102415066|NCT03589027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102415067|NCT03589027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415068|NCT03589027|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102415069|NCT03589027|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102415070|NCT03589027|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102415071|NCT03589027|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102415072|NCT03589027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102415073|NCT03874494|Aripiprazole|aripiprazole|mesh-list
102415074|NCT03874494|Brexpiprazole|brexpiprazole|mesh-list
102415075|NCT03874494|Antidepressive Agents|antidepressive agents|mesh-ancestor
102415076|NCT03874494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102415077|NCT03874494|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102226715|NCT04448821|Metformin|metformin|mesh-list
102415078|NCT03874494|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102415079|NCT03874494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102415080|NCT03874494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415081|NCT03874494|Dopamine Agonists|dopamine agonists|mesh-ancestor
102415082|NCT03874494|Dopamine Agents|dopamine agents|mesh-ancestor
102415083|NCT03874494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102415084|NCT03874494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415085|NCT03874494|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102415086|NCT03874494|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102415087|NCT03874494|Serotonin Agents|serotonin agents|mesh-ancestor
102415088|NCT03874494|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102415089|NCT03874494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102415090|NCT03874494|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102415091|NCT03874494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102415092|NCT03156439|Huperzine A|huperzine a|mesh-list
102415093|NCT03156439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102415094|NCT03156439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102415095|NCT03156439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415096|NCT03156439|Cholinergic Agents|cholinergic agents|mesh-ancestor
102045768|NCT03635411|Niacin|niacin|mesh-list
102415097|NCT03156439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102415098|NCT03156439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415099|NCT03156439|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102415100|NCT03156439|Protective Agents|protective agents|mesh-ancestor
102415101|NCT04436328|Anti-Infective Agents|anti-infective agents|mesh-list
102415102|NCT04436328|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102415104|NCT03156361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102415105|NCT03156361|Insulin Lispro|insulin lispro|mesh-list
102415106|NCT03156361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102415107|NCT03156361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415108|NCT05690035|Tislelizumab|tislelizumab|mesh-list
102415109|NCT05690035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102415110|NCT05690035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102415111|NCT05002530|Vitamin D|vitamin d|mesh-list
102415112|NCT05002530|Ergocalciferols|ergocalciferols|mesh-list
102415113|NCT05002530|Cholecalciferol|cholecalciferol|mesh-list
102415114|NCT05002530|Vitamins|vitamins|mesh-list
102415115|NCT05002530|Tretinoin|tretinoin|mesh-list
102415116|NCT05002530|Isotretinoin|isotretinoin|mesh-list
102415117|NCT05002530|Micronutrients|micronutrients|mesh-ancestor
102415118|NCT05002530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415119|NCT05002530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102415120|NCT05002530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102415121|NCT05002530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102415122|NCT05002530|Keratolytic Agents|keratolytic agents|mesh-ancestor
102415123|NCT05002530|Dermatologic Agents|dermatologic agents|mesh-ancestor
102415124|NCT03583021|Neostigmine|neostigmine|mesh-list
102415125|NCT03583021|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102415126|NCT03583021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102415127|NCT03583021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415128|NCT03583021|Cholinergic Agents|cholinergic agents|mesh-ancestor
102415129|NCT03583021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102415130|NCT03583021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415131|NCT03583021|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102415132|NCT03583021|Autonomic Agents|autonomic agents|mesh-ancestor
102415133|NCT03583021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102415134|NCT03155971|Paclitaxel|paclitaxel|mesh-list
102415135|NCT03155971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102415136|NCT03155971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102415137|NCT03155971|Tubulin Modulators|tubulin modulators|mesh-ancestor
102415138|NCT03155971|Antimitotic Agents|antimitotic agents|mesh-ancestor
102415139|NCT03155971|Mitosis Modulators|mitosis modulators|mesh-ancestor
102415140|NCT03155971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415141|NCT03582319|Formaldehyde|formaldehyde|mesh-list
102415142|NCT03582319|Disinfectants|disinfectants|mesh-ancestor
102415143|NCT03582319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102415144|NCT00307242|Adefovir|adefovir|mesh-list
102415145|NCT00307242|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
102415146|NCT00307242|Antiviral Agents|antiviral agents|mesh-ancestor
102415147|NCT00307242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102415148|NCT00307242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102415149|NCT00307242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102415150|NCT00307242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102415151|NCT00307242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415152|NCT03582007|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102415153|NCT03582007|Murepavadin|murepavadin|mesh-list
102415154|NCT03582007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102415155|NCT05120622|Tremelimumab|tremelimumab|mesh-list
102415156|NCT05120622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102415157|NCT02895373|Alprostadil|alprostadil|mesh-list
102415158|NCT02895373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102415159|NCT02895373|Vasodilator Agents|vasodilator agents|mesh-ancestor
102415160|NCT02895373|Urological Agents|urological agents|mesh-ancestor
102415161|NCT05698771|Niacinamide|niacinamide|mesh-list
102415162|NCT05698771|Niacin|niacin|mesh-list
102415163|NCT05698771|Nicotinic Acids|nicotinic acids|mesh-list
102415164|NCT05698771|Vitamin B Complex|vitamin b complex|mesh-ancestor
102415165|NCT05698771|Vitamins|vitamins|mesh-ancestor
102415166|NCT05698771|Micronutrients|micronutrients|mesh-ancestor
102415167|NCT05698771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415168|NCT05698771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102415169|NCT05698771|Antimetabolites|antimetabolites|mesh-ancestor
102415170|NCT05698771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415171|NCT05698771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102415172|NCT05698771|Vasodilator Agents|vasodilator agents|mesh-ancestor
102415173|NCT05698147|Rituximab|rituximab|mesh-list
102415174|NCT05698147|Methotrexate|methotrexate|mesh-list
102415175|NCT05698147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102415176|NCT05698147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102415177|NCT05698147|Immunologic Factors|immunologic factors|mesh-ancestor
102415178|NCT05698147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415179|NCT05698147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102415180|NCT05698147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102415181|NCT05698147|Abortifacient Agents|abortifacient agents|mesh-ancestor
102415182|NCT05698147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102415183|NCT05698147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102415184|NCT05698147|Antimetabolites|antimetabolites|mesh-ancestor
102415185|NCT05698147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415186|NCT05698147|Dermatologic Agents|dermatologic agents|mesh-ancestor
102415187|NCT05698147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102415188|NCT05698147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102415189|NCT05698147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102415190|NCT05698147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102415191|NCT03156907|Buprenorphine|buprenorphine|mesh-list
102415192|NCT03156907|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102415193|NCT03156907|Narcotics|narcotics|mesh-ancestor
102415194|NCT03156907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102415195|NCT03156907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415196|NCT03156907|Analgesics|analgesics|mesh-ancestor
102415197|NCT03156907|Sensory System Agents|sensory system agents|mesh-ancestor
102415198|NCT03156907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102415199|NCT03156907|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102415200|NCT03156829|Betamethasone|betamethasone|mesh-list
102415201|NCT03156829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102415202|NCT03156829|Glucocorticoids|glucocorticoids|mesh-ancestor
102415203|NCT03156829|Hormones|hormones|mesh-ancestor
102415204|NCT03156829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102415205|NCT03156829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415206|NCT03156829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102415207|NCT03156829|Respiratory System Agents|respiratory system agents|mesh-ancestor
102415208|NCT05229276|Bone wax|bone wax|mesh-list
102415209|NCT05229276|Hemostatics|hemostatics|mesh-ancestor
102415210|NCT05229276|Coagulants|coagulants|mesh-ancestor
102415211|NCT03581773|Folic Acid|folic acid|mesh-list
102415212|NCT03581773|Hematinics|hematinics|mesh-ancestor
102045873|NCT02800928|Aticaprant|aticaprant|mesh-list
102415213|NCT03581773|Vitamin B Complex|vitamin b complex|mesh-ancestor
102415214|NCT03581773|Vitamins|vitamins|mesh-ancestor
102415215|NCT03581773|Micronutrients|micronutrients|mesh-ancestor
102415216|NCT03581773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415217|NCT04425174|Anesthetics|anesthetics|mesh-list
102415218|NCT04425174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102415219|NCT04425174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415220|NCT05119452|Adalimumab|adalimumab|mesh-list
102415221|NCT05119452|Infliximab|infliximab|mesh-list
102415222|NCT05119452|Golimumab|golimumab|mesh-list
102415223|NCT05119452|Certolizumab Pegol|certolizumab pegol|mesh-list
102415224|NCT05119452|Etanercept|etanercept|mesh-list
102415225|NCT05119452|Antirheumatic Agents|antirheumatic agents|mesh-list
102415226|NCT05119452|Tofacitinib|tofacitinib|mesh-list
102415227|NCT05119452|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102415228|NCT05119452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102415229|NCT05119452|Dermatologic Agents|dermatologic agents|mesh-ancestor
102415230|NCT05119452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102415231|NCT05119452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102415232|NCT05119452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102415233|NCT05119452|Analgesics|analgesics|mesh-ancestor
102415234|NCT05119452|Sensory System Agents|sensory system agents|mesh-ancestor
102415235|NCT05119452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102415236|NCT05119452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415237|NCT05119452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102415238|NCT05119452|Immunologic Factors|immunologic factors|mesh-ancestor
102415239|NCT05119452|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102415240|NCT05119452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102415241|NCT05119452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102415242|NCT05119452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415243|NCT02788591|Esomeprazole|esomeprazole|mesh-list
102415244|NCT02788591|Omeprazole|omeprazole|mesh-list
102415245|NCT02788591|Pantoprazole|pantoprazole|mesh-list
102415246|NCT02788591|Lansoprazole|lansoprazole|mesh-list
102415247|NCT02788591|Sucralfate|sucralfate|mesh-list
102415248|NCT02788591|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
102415249|NCT02788591|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102415250|NCT02788591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102415251|NCT02788591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102415252|NCT02788591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415253|NCT05229042|Ricolinostat|ricolinostat|mesh-list
102415254|NCT05229042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102415255|NCT05229042|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102415256|NCT05229042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102415257|NCT05229042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415258|NCT01670305|Photosensitizing Agents|photosensitizing agents|mesh-list
102415259|NCT01670305|Dermatologic Agents|dermatologic agents|mesh-ancestor
102415260|NCT03076164|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102415261|NCT03076164|Trametinib|trametinib|mesh-list
102415262|NCT03076164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102415263|NCT03076164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102415264|NCT03076164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102415265|NCT03076164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415266|NCT03155893|Moxifloxacin|moxifloxacin|mesh-list
102415267|NCT03155893|Adafosbuvir|adafosbuvir|mesh-list
102415268|NCT03155893|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102415269|NCT03155893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102415270|NCT03155893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102415271|NCT03155893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102415272|NCT03155893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102415273|NCT03155893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102415274|NCT03155893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415275|NCT03155893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102415276|NCT03155893|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102415277|NCT03155893|Contraceptive Agents|contraceptive agents|mesh-ancestor
102045934|NCT02059694|Lidocaine|lidocaine|mesh-list
102415278|NCT03155893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102415279|NCT03155893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415280|NCT03155893|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102415281|NCT03155893|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102415282|NCT03155893|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102415283|NCT03155893|Antiviral Agents|antiviral agents|mesh-ancestor
102415284|NCT01670773|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
102415285|NCT01670773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102415286|NCT01670773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102415287|NCT01670773|Analgesics|analgesics|mesh-ancestor
102415288|NCT01670773|Sensory System Agents|sensory system agents|mesh-ancestor
102415289|NCT01670773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102415290|NCT01670773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415291|NCT01670773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102415292|NCT01670773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102415293|NCT05228418|Naltrexone|naltrexone|mesh-list
102415294|NCT05228418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102415295|NCT05228418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102415296|NCT05228418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415297|NCT05228418|Sensory System Agents|sensory system agents|mesh-ancestor
102415298|NCT05228418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102415299|NCT01676233|Insulin|insulin|mesh-list
102415300|NCT01676233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102415301|NCT01676233|Insulin Glargine|insulin glargine|mesh-list
102415302|NCT01676233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102415303|NCT01676233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415304|NCT01670929|Progesterone|progesterone|mesh-list
102415305|NCT01670929|Progestins|progestins|mesh-ancestor
102415306|NCT01670929|Hormones|hormones|mesh-ancestor
102415307|NCT01670929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102415308|NCT01670929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415309|NCT02673996|Phenylephrine|phenylephrine|mesh-list
102415310|NCT02673996|Isoproterenol|isoproterenol|mesh-list
102415311|NCT02673996|Oxymetazoline|oxymetazoline|mesh-list
102415312|NCT02673996|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102415313|NCT02673996|Mydriatics|mydriatics|mesh-ancestor
102415314|NCT02673996|Autonomic Agents|autonomic agents|mesh-ancestor
102415315|NCT02673996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102415316|NCT02673996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415317|NCT02673996|Sympathomimetics|sympathomimetics|mesh-ancestor
102415318|NCT02673996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102415319|NCT02673996|Nasal Decongestants|nasal decongestants|mesh-ancestor
102415320|NCT02673996|Respiratory System Agents|respiratory system agents|mesh-ancestor
102415321|NCT02673996|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102415322|NCT02673996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102415323|NCT02673996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102415324|NCT02673996|Adrenergic Agents|adrenergic agents|mesh-ancestor
102415325|NCT02673996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102415326|NCT02673996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415327|NCT02673996|Protective Agents|protective agents|mesh-ancestor
102415328|NCT02673996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102415329|NCT02673996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102415330|NCT02673996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102415331|NCT04746937|Nitazoxanide|nitazoxanide|mesh-list
102415332|NCT04746937|Norfloxacin|norfloxacin|mesh-list
102415333|NCT04746937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102415334|NCT04746937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102415335|NCT04746937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102045991|NCT02059772|Growth Substances|growth substances|mesh-ancestor
102415336|NCT04746937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102415337|NCT04746937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102415338|NCT04746937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102415339|NCT04746937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415340|NCT04746937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102415341|NCT04746937|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102415342|NCT04746937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102415343|NCT05220319|Methylprednisolone|methylprednisolone|mesh-list
102415344|NCT05220319|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102415345|NCT05220319|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102415346|NCT05220319|Prednisolone|prednisolone|mesh-list
102415347|NCT05220319|Prednisolone acetate|prednisolone acetate|mesh-list
102415348|NCT05220319|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102415349|NCT05220319|Prednisolone phosphate|prednisolone phosphate|mesh-list
102415350|NCT05220319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102415351|NCT05220319|Antiemetics|antiemetics|mesh-ancestor
102415352|NCT05220319|Autonomic Agents|autonomic agents|mesh-ancestor
102415353|NCT05220319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102415354|NCT05220319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415355|NCT05220319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102415356|NCT05220319|Glucocorticoids|glucocorticoids|mesh-ancestor
102415357|NCT05220319|Hormones|hormones|mesh-ancestor
102415358|NCT05220319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102415359|NCT05220319|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102415360|NCT05220319|Protective Agents|protective agents|mesh-ancestor
102415361|NCT05220319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102415362|NCT05220319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102415363|NCT03155035|Vitamin D|vitamin d|mesh-list
102415364|NCT03155035|Albendazole|albendazole|mesh-list
102415365|NCT03155035|Calcium|calcium|mesh-list
102415366|NCT03155035|Vitamins|vitamins|mesh-ancestor
102415367|NCT03155035|Micronutrients|micronutrients|mesh-ancestor
102415368|NCT03155035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415369|NCT03155035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102415370|NCT03155035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102415371|NCT03155035|Anthelmintics|anthelmintics|mesh-ancestor
102415372|NCT03155035|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102415373|NCT03155035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102415374|NCT03155035|Anticestodal Agents|anticestodal agents|mesh-ancestor
102415375|NCT03155035|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102415376|NCT03155035|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102415377|NCT03155035|Tubulin Modulators|tubulin modulators|mesh-ancestor
102415378|NCT03155035|Antimitotic Agents|antimitotic agents|mesh-ancestor
102415379|NCT03155035|Mitosis Modulators|mitosis modulators|mesh-ancestor
102415380|NCT03155035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415381|NCT03155035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102227026|NCT01328093|Aripiprazole|aripiprazole|mesh-list
102415382|NCT04497870|Peppermint oil|peppermint oil|mesh-list
102415383|NCT04497870|Menthol|menthol|mesh-list
102415384|NCT04497870|Antipruritics|antipruritics|mesh-ancestor
102415385|NCT04497870|Dermatologic Agents|dermatologic agents|mesh-ancestor
102415387|NCT04497870|Autonomic Agents|autonomic agents|mesh-ancestor
102415388|NCT04497870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102415389|NCT04497870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415390|NCT04497870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102415391|NCT04497870|Parasympatholytics|parasympatholytics|mesh-ancestor
102415392|NCT03154723|Vitamin A|vitamin a|mesh-list
102415393|NCT03154723|Vitamins|vitamins|mesh-ancestor
102415394|NCT03154723|Micronutrients|micronutrients|mesh-ancestor
102415395|NCT03154723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415396|NCT04080908|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102415397|NCT04080908|Hematinics|hematinics|mesh-ancestor
102415398|NCT04080908|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102415399|NCT04080908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102415400|NCT02653482|Dapagliflozin|dapagliflozin|mesh-list
102415401|NCT02653482|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102415402|NCT02653482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415403|NCT02653482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102415404|NCT02653482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415405|NCT03154567|Yohimbine|yohimbine|mesh-list
102415406|NCT03154567|Mydriatics|mydriatics|mesh-ancestor
102415407|NCT03154567|Autonomic Agents|autonomic agents|mesh-ancestor
102415408|NCT03154567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102415409|NCT03154567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415410|NCT03154567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102415411|NCT03154567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102415412|NCT03154567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102415413|NCT03154567|Adrenergic Agents|adrenergic agents|mesh-ancestor
102415414|NCT03154567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102415415|NCT03154567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415416|NCT03154567|Urological Agents|urological agents|mesh-ancestor
102415417|NCT04310748|Anesthetics|anesthetics|mesh-list
102415418|NCT04310748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102415419|NCT04310748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415420|NCT03154645|Ibuprofen|ibuprofen|mesh-list
102415421|NCT03154645|Acetazolamide|acetazolamide|mesh-list
102415422|NCT03154645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102415423|NCT03154645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102415424|NCT03154645|Analgesics|analgesics|mesh-ancestor
102415425|NCT03154645|Sensory System Agents|sensory system agents|mesh-ancestor
102415426|NCT03154645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102415427|NCT03154645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415428|NCT03154645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102415429|NCT03154645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102415430|NCT03154645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102415431|NCT03154645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102415432|NCT03154645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415433|NCT03154645|Anticonvulsants|anticonvulsants|mesh-ancestor
102415434|NCT03154645|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102415435|NCT03154645|Diuretics|diuretics|mesh-ancestor
102415436|NCT03154645|Natriuretic Agents|natriuretic agents|mesh-ancestor
102415437|NCT01631292|Vitamin D|vitamin d|mesh-list
102415438|NCT01631292|Ergocalciferols|ergocalciferols|mesh-list
102415439|NCT01631292|Cholecalciferol|cholecalciferol|mesh-list
102415440|NCT01631292|Vitamins|vitamins|mesh-list
102415441|NCT01631292|Micronutrients|micronutrients|mesh-ancestor
102415442|NCT01631292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415443|NCT01631292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102415444|NCT01631292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102415445|NCT01671709|Montelukast|montelukast|mesh-list
102415446|NCT01671709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102415447|NCT01671709|Respiratory System Agents|respiratory system agents|mesh-ancestor
102415448|NCT01671709|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102415449|NCT01671709|Hormone Antagonists|hormone antagonists|mesh-ancestor
102415450|NCT01671709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102415451|NCT01671709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415452|NCT01671709|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102415453|NCT01671709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102415454|NCT01671709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415455|NCT05222256|Simendan|simendan|mesh-list
102415456|NCT05222256|Epinephrine|epinephrine|mesh-list
102415457|NCT05222256|Racepinephrine|racepinephrine|mesh-list
102415458|NCT05222256|Epinephryl borate|epinephryl borate|mesh-list
102415459|NCT05222256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102227094|NCT05122455|Edoxaban|edoxaban|mesh-list
102415460|NCT05222256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102415461|NCT05222256|Adrenergic Agents|adrenergic agents|mesh-ancestor
102415462|NCT05222256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102415463|NCT05222256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415464|NCT05222256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415465|NCT05222256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102415466|NCT05222256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102415467|NCT05222256|Autonomic Agents|autonomic agents|mesh-ancestor
102415468|NCT05222256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102415469|NCT05222256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102415470|NCT05222256|Respiratory System Agents|respiratory system agents|mesh-ancestor
102415472|NCT05222256|Sympathomimetics|sympathomimetics|mesh-ancestor
102415473|NCT05222256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102415474|NCT05222256|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102415475|NCT05222256|Vasodilator Agents|vasodilator agents|mesh-ancestor
102415476|NCT05222256|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102415477|NCT05222256|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102415478|NCT05222256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102415479|NCT05222256|Protective Agents|protective agents|mesh-ancestor
102415480|NCT01671787|Tenofovir|tenofovir|mesh-list
102415481|NCT01671787|Antiviral Agents|antiviral agents|mesh-ancestor
102415482|NCT01671787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102415483|NCT01671787|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102415484|NCT01671787|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102415485|NCT01671787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102415486|NCT01671787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415487|NCT01671787|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102415488|NCT01671787|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102415489|NCT05229510|Ribavirin|ribavirin|mesh-list
102415490|NCT05229510|Antimetabolites|antimetabolites|mesh-ancestor
102415491|NCT05229510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415492|NCT05229510|Antiviral Agents|antiviral agents|mesh-ancestor
102415493|NCT05229510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102415494|NCT01362348|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102415495|NCT01362348|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102415496|NCT03154489|Acenocoumarol|acenocoumarol|mesh-list
102415497|NCT03154489|Anticoagulants|anticoagulants|mesh-ancestor
102415498|NCT00698022|Risperidone|risperidone|mesh-list
102415499|NCT00698022|Mifepristone|mifepristone|mesh-list
102415500|NCT00698022|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102415501|NCT00698022|Serotonin Agents|serotonin agents|mesh-ancestor
102415502|NCT00698022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102415503|NCT00698022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415504|NCT00698022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415505|NCT00698022|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102415506|NCT00698022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102415507|NCT00698022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102415508|NCT00698022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102415509|NCT00698022|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102415510|NCT00698022|Dopamine Agents|dopamine agents|mesh-ancestor
102415511|NCT00698022|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102415512|NCT00698022|Abortifacient Agents|abortifacient agents|mesh-ancestor
102415513|NCT00698022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102415514|NCT00698022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102415515|NCT00698022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102415516|NCT00698022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102415517|NCT00698022|Contraceptive Agents|contraceptive agents|mesh-ancestor
102415518|NCT00698022|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102415519|NCT00698022|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102415520|NCT00698022|Hormone Antagonists|hormone antagonists|mesh-ancestor
102415521|NCT00698022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102415522|NCT00698022|Luteolytic Agents|luteolytic agents|mesh-ancestor
102415523|NCT00698022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102415524|NCT00698022|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102415525|NCT02570503|Ketorolac|ketorolac|mesh-list
102415526|NCT02570503|Clonidine|clonidine|mesh-list
102415527|NCT02570503|Epinephrine|epinephrine|mesh-list
102415528|NCT02570503|Ropivacaine|ropivacaine|mesh-list
102415529|NCT02570503|Anesthetics, Local|anesthetics, local|mesh-ancestor
102415530|NCT02570503|Anesthetics|anesthetics|mesh-ancestor
102415531|NCT02570503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102415532|NCT02570503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415533|NCT02570503|Sensory System Agents|sensory system agents|mesh-ancestor
102415534|NCT02570503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102415535|NCT02570503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102415536|NCT02570503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102415537|NCT02570503|Adrenergic Agents|adrenergic agents|mesh-ancestor
102415538|NCT02570503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102415539|NCT02570503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415540|NCT02570503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102415541|NCT02570503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102415542|NCT02570503|Autonomic Agents|autonomic agents|mesh-ancestor
102415543|NCT02570503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102415544|NCT02570503|Respiratory System Agents|respiratory system agents|mesh-ancestor
102415545|NCT02570503|Mydriatics|mydriatics|mesh-ancestor
102415546|NCT02570503|Sympathomimetics|sympathomimetics|mesh-ancestor
102415547|NCT02570503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102415548|NCT02570503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102415549|NCT02570503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102415550|NCT02570503|Analgesics|analgesics|mesh-ancestor
102415551|NCT02570503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102415552|NCT02570503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102415553|NCT02570503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102415554|NCT02570503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102415555|NCT02570503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102415556|NCT02570503|Sympatholytics|sympatholytics|mesh-ancestor
102415557|NCT02570503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102415558|NCT02492269|Dexmedetomidine|dexmedetomidine|mesh-list
102415559|NCT02492269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102415560|NCT02492269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102415561|NCT02492269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415562|NCT02492269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102415563|NCT02492269|Analgesics|analgesics|mesh-ancestor
102415564|NCT02492269|Sensory System Agents|sensory system agents|mesh-ancestor
102415565|NCT02492269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102415566|NCT02492269|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102415567|NCT02492269|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102415568|NCT02492269|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102415569|NCT02492269|Adrenergic Agents|adrenergic agents|mesh-ancestor
102415570|NCT02492269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102415571|NCT02492269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415572|NCT05561179|Hyaluronic Acid|hyaluronic acid|mesh-list
102415573|NCT05561179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102415574|NCT05561179|Immunologic Factors|immunologic factors|mesh-ancestor
102415575|NCT05561179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415576|NCT05561179|Viscosupplements|viscosupplements|mesh-ancestor
102415577|NCT05561179|Protective Agents|protective agents|mesh-ancestor
102415578|NCT02467153|Vitamin D|vitamin d|mesh-list
102415579|NCT02467153|Cholecalciferol|cholecalciferol|mesh-list
102415580|NCT02467153|Vitamins|vitamins|mesh-ancestor
102415581|NCT02467153|Micronutrients|micronutrients|mesh-ancestor
102415582|NCT02467153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415583|NCT02467153|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102415584|NCT02467153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102415585|NCT04933903|Nivolumab|nivolumab|mesh-list
102415586|NCT04933903|Ipilimumab|ipilimumab|mesh-list
102415587|NCT04933903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102415588|NCT04933903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102415589|NCT04933903|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102415590|NCT04933903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415591|NCT03153163|Trastuzumab|trastuzumab|mesh-list
102415592|NCT03153163|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102415593|NCT03153163|Maytansine|maytansine|mesh-list
102415594|NCT03153163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102415595|NCT03153163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102415596|NCT03153163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102415597|NCT03153163|Tubulin Modulators|tubulin modulators|mesh-ancestor
102415598|NCT03153163|Antimitotic Agents|antimitotic agents|mesh-ancestor
102415599|NCT03153163|Mitosis Modulators|mitosis modulators|mesh-ancestor
102415600|NCT03153163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415601|NCT03153163|Immunotoxins|immunotoxins|mesh-ancestor
102415602|NCT03153163|Immunoconjugates|immunoconjugates|mesh-ancestor
102415603|NCT03153163|Immunologic Factors|immunologic factors|mesh-ancestor
102415604|NCT03153163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415605|NCT03153085|Ipilimumab|ipilimumab|mesh-list
102415606|NCT03153085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102415607|NCT03153085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102415608|NCT03153085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102415609|NCT03153085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415610|NCT03589339|Pembrolizumab|pembrolizumab|mesh-list
102415611|NCT03589339|Nivolumab|nivolumab|mesh-list
102415612|NCT03589339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102415613|NCT03589339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102415614|NCT03589339|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102415615|NCT03589339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415616|NCT03463525|Osimertinib|osimertinib|mesh-list
102415617|NCT03463525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102415618|NCT03463525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102415619|NCT03463525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102415620|NCT03463525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415621|NCT01675128|Irinotecan|irinotecan|mesh-list
102415622|NCT01675128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102415623|NCT01675128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102415624|NCT01675128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102415625|NCT01675128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415626|NCT01675128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102415627|NCT02626507|Fulvestrant|fulvestrant|mesh-list
102415628|NCT02626507|Goserelin|goserelin|mesh-list
102415629|NCT02626507|Palbociclib|palbociclib|mesh-list
102415630|NCT02626507|Gedatolisib|gedatolisib|mesh-list
102415631|NCT02626507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102415632|NCT02626507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102415633|NCT02626507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102415634|NCT02626507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102415635|NCT02626507|Hormone Antagonists|hormone antagonists|mesh-ancestor
102415636|NCT02626507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102415637|NCT02626507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415638|NCT02626507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102415639|NCT02626507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102046293|NCT03618264|Sensory System Agents|sensory system agents|mesh-ancestor
102415640|NCT02626507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415641|NCT03413995|Rucaparib|rucaparib|mesh-list
102415642|NCT03413995|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102415643|NCT03413995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102415644|NCT03413995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415645|NCT03413995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102415646|NCT04508244|Propranolol|propranolol|mesh-list
102415647|NCT04508244|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102415648|NCT04508244|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102415649|NCT04508244|Adrenergic Agents|adrenergic agents|mesh-ancestor
102415650|NCT04508244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102415651|NCT04508244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415652|NCT04508244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415653|NCT04508244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102415654|NCT04508244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102415655|NCT04508244|Vasodilator Agents|vasodilator agents|mesh-ancestor
102415656|NCT03243175|Apixaban|apixaban|mesh-list
102415657|NCT03243175|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102415658|NCT03243175|Antithrombins|antithrombins|mesh-ancestor
102415659|NCT03243175|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102415660|NCT03243175|Protease Inhibitors|protease inhibitors|mesh-ancestor
102415661|NCT03243175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102415662|NCT03243175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415663|NCT03243175|Anticoagulants|anticoagulants|mesh-ancestor
102415664|NCT04764955|Vitamin D|vitamin d|mesh-list
102415665|NCT04764955|Cholecalciferol|cholecalciferol|mesh-list
102415666|NCT04764955|Vitamins|vitamins|mesh-ancestor
102415667|NCT04764955|Micronutrients|micronutrients|mesh-ancestor
102415668|NCT04764955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415669|NCT04764955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102415670|NCT04764955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102415671|NCT03126331|Nivolumab|nivolumab|mesh-list
102415672|NCT03126331|Ipilimumab|ipilimumab|mesh-list
102415673|NCT03126331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102415674|NCT03126331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102415675|NCT03126331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102415676|NCT03126331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415677|NCT01674127|Methyldopa|methyldopa|mesh-list
102415678|NCT01674127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102415679|NCT01674127|Sympatholytics|sympatholytics|mesh-ancestor
102415680|NCT01674127|Autonomic Agents|autonomic agents|mesh-ancestor
102415681|NCT01674127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102415682|NCT01674127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415683|NCT01674127|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102415684|NCT01674127|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102415685|NCT01674127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102415686|NCT01674127|Adrenergic Agents|adrenergic agents|mesh-ancestor
102415687|NCT01674127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102415688|NCT01674127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415690|NCT02081443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102415691|NCT02081443|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102415692|NCT02081443|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102415693|NCT02081443|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102415694|NCT02081443|Purinergic Agents|purinergic agents|mesh-ancestor
102415695|NCT02081443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102415696|NCT02081443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415697|NCT02081443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415698|NCT01674205|Vaccines|vaccines|mesh-list
102415699|NCT01674205|Immunologic Factors|immunologic factors|mesh-ancestor
102415700|NCT01674205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415701|NCT02646475|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
102415702|NCT02646475|Angiotensin II|angiotensin ii|mesh-list
102415703|NCT02646475|Angiotensinogen|angiotensinogen|mesh-list
102415704|NCT02646475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102415705|NCT02646475|Vasodilator Agents|vasodilator agents|mesh-ancestor
102415706|NCT02646475|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102415707|NCT02646475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102415708|NCT02646475|Protease Inhibitors|protease inhibitors|mesh-ancestor
102415709|NCT02646475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102415710|NCT02646475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415711|NCT03151057|Idelalisib|idelalisib|mesh-list
102415712|NCT03151057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102415713|NCT03151057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102415714|NCT03151057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415715|NCT01674283|Glucagon|glucagon|mesh-list
102415716|NCT01674283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102415717|NCT01674283|Hormones|hormones|mesh-ancestor
102415718|NCT01674283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102415719|NCT01674283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415720|NCT04404517|Adalimumab|adalimumab|mesh-list
102415721|NCT04404517|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102415722|NCT04404517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102415723|NCT04404517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102415724|NCT01674517|Montelukast|montelukast|mesh-list
102415725|NCT01674517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102415726|NCT01674517|Respiratory System Agents|respiratory system agents|mesh-ancestor
102415727|NCT01674517|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102415728|NCT01674517|Hormone Antagonists|hormone antagonists|mesh-ancestor
102415729|NCT01674517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102415730|NCT01674517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415731|NCT01674517|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102415732|NCT01674517|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102415733|NCT01674517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415734|NCT01923649|Lanreotide|lanreotide|mesh-list
102415735|NCT01923649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102415736|NCT01670071|Risperidone|risperidone|mesh-list
102415737|NCT01670071|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102415738|NCT01670071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102415739|NCT01670071|Serotonin Agents|serotonin agents|mesh-ancestor
102415740|NCT01670071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102415741|NCT01670071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415742|NCT01670071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415743|NCT01670071|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102415744|NCT01670071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102415745|NCT01670071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102415746|NCT01670071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102415747|NCT01670071|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102415748|NCT01670071|Dopamine Agents|dopamine agents|mesh-ancestor
102415749|NCT01670071|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102415750|NCT01670071|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102415751|NCT01427309|Vaccines|vaccines|mesh-list
102415752|NCT01427309|Immunologic Factors|immunologic factors|mesh-ancestor
102415753|NCT01427309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415754|NCT01426373|Deoxycholic Acid|deoxycholic acid|mesh-list
102415755|NCT01426373|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102227394|NCT03418337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102415756|NCT01426373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102415757|NCT03855007|Hydroxychloroquine|hydroxychloroquine|mesh-list
102415758|NCT03855007|Prednisone|prednisone|mesh-list
102415759|NCT03855007|Methotrexate|methotrexate|mesh-list
102415760|NCT03855007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102415761|NCT03855007|Glucocorticoids|glucocorticoids|mesh-ancestor
102415762|NCT03855007|Hormones|hormones|mesh-ancestor
102415763|NCT03855007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102415764|NCT03855007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415765|NCT03855007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102415766|NCT03855007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102415767|NCT03855007|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102415768|NCT03855007|Abortifacient Agents|abortifacient agents|mesh-ancestor
102415769|NCT03855007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102415770|NCT03855007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102415771|NCT03855007|Antimetabolites|antimetabolites|mesh-ancestor
102415772|NCT03855007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415773|NCT03855007|Dermatologic Agents|dermatologic agents|mesh-ancestor
102415774|NCT03855007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102415775|NCT03855007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102415776|NCT03855007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102415777|NCT03855007|Immunologic Factors|immunologic factors|mesh-ancestor
102415778|NCT03855007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102415779|NCT03855007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102415780|NCT03855007|Antimalarials|antimalarials|mesh-ancestor
102415781|NCT03855007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102415782|NCT03855007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102415783|NCT03855007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102415784|NCT03852901|Empagliflozin|empagliflozin|mesh-list
102415785|NCT03852901|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102415786|NCT03852901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415787|NCT03852901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102415788|NCT03852901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415789|NCT01675999|Leucovorin|leucovorin|mesh-list
102415790|NCT01675999|Cetuximab|cetuximab|mesh-list
102415791|NCT01675999|Fluorouracil|fluorouracil|mesh-list
102415792|NCT01675999|Oxaliplatin|oxaliplatin|mesh-list
102415793|NCT01675999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102415794|NCT01675999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102415795|NCT01675999|Antimetabolites|antimetabolites|mesh-ancestor
102415796|NCT01675999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415797|NCT01675999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102415798|NCT01675999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102415799|NCT01675999|Immunologic Factors|immunologic factors|mesh-ancestor
102415800|NCT01675999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415801|NCT01675999|Antidotes|antidotes|mesh-ancestor
102415802|NCT01675999|Protective Agents|protective agents|mesh-ancestor
102415803|NCT01675999|Vitamin B Complex|vitamin b complex|mesh-ancestor
102415804|NCT01675999|Vitamins|vitamins|mesh-ancestor
102415805|NCT01675999|Micronutrients|micronutrients|mesh-ancestor
102415806|NCT01425359|Ranolazine|ranolazine|mesh-list
102415807|NCT01425359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102415808|NCT01425359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102415809|NCT01425359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415810|NCT04404751|Folic Acid|folic acid|mesh-list
102415811|NCT04404751|Vitamin B 12|vitamin b 12|mesh-list
102415812|NCT04404751|Hydroxocobalamin|hydroxocobalamin|mesh-list
102415813|NCT04404751|Iron|iron|mesh-list
102415814|NCT04404751|Vitamins|vitamins|mesh-ancestor
102415815|NCT04404751|Micronutrients|micronutrients|mesh-ancestor
102415816|NCT04404751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415817|NCT04404751|Trace Elements|trace elements|mesh-ancestor
102415818|NCT04404751|Hematinics|hematinics|mesh-ancestor
102415819|NCT04404751|Vitamin B Complex|vitamin b complex|mesh-ancestor
102415820|NCT01403051|Calcium, Dietary|calcium, dietary|mesh-list
102415821|NCT01403051|Vitamin D|vitamin d|mesh-list
102415822|NCT01403051|Ergocalciferols|ergocalciferols|mesh-list
102415823|NCT01403051|Cholecalciferol|cholecalciferol|mesh-list
102415824|NCT01403051|Vitamins|vitamins|mesh-list
102415825|NCT01403051|Calcium Carbonate|calcium carbonate|mesh-list
102415826|NCT01403051|Calcium|calcium|mesh-list
102415827|NCT01403051|Micronutrients|micronutrients|mesh-ancestor
102415828|NCT01403051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415829|NCT01403051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102415830|NCT01403051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102415831|NCT01403051|Antacids|antacids|mesh-ancestor
102415832|NCT01403051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415833|NCT01403051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102415834|NCT03873337|Nicotine|nicotine|mesh-list
102415835|NCT03873337|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102415836|NCT03873337|Autonomic Agents|autonomic agents|mesh-ancestor
102415837|NCT03873337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102415838|NCT03873337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415839|NCT03873337|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102415840|NCT03873337|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102415841|NCT03873337|Cholinergic Agents|cholinergic agents|mesh-ancestor
102415842|NCT03873337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102415843|NCT03873337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415844|NCT04115748|Adalimumab|adalimumab|mesh-list
102415845|NCT04115748|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102415846|NCT04115748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102415847|NCT04115748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102415848|NCT03838159|Paclitaxel|paclitaxel|mesh-list
102415849|NCT03838159|Carboplatin|carboplatin|mesh-list
102415850|NCT03838159|Nivolumab|nivolumab|mesh-list
102415851|NCT03838159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102415852|NCT03838159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102415853|NCT03838159|Tubulin Modulators|tubulin modulators|mesh-ancestor
102415854|NCT03838159|Antimitotic Agents|antimitotic agents|mesh-ancestor
102415855|NCT03838159|Mitosis Modulators|mitosis modulators|mesh-ancestor
102415856|NCT03838159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415857|NCT03838159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102415858|NCT03838159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102415859|NCT04747015|Oxytocin|oxytocin|mesh-list
102415860|NCT04747015|Oxytocics|oxytocics|mesh-ancestor
102415861|NCT04747015|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102415862|NCT04747015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415863|NCT04747171|Dexmedetomidine|dexmedetomidine|mesh-list
102415864|NCT04747171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102415865|NCT04747171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102415866|NCT04747171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415867|NCT04747171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102415868|NCT04747171|Analgesics|analgesics|mesh-ancestor
102415869|NCT04747171|Sensory System Agents|sensory system agents|mesh-ancestor
102415870|NCT04747171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102415871|NCT04747171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102415872|NCT04747171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102415873|NCT04747171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102415874|NCT04747171|Adrenergic Agents|adrenergic agents|mesh-ancestor
102415875|NCT04747171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102415876|NCT04747171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415877|NCT02082769|Allopurinol|allopurinol|mesh-list
102415878|NCT02082769|Febuxostat|febuxostat|mesh-list
102415879|NCT02082769|Antimetabolites|antimetabolites|mesh-ancestor
102415880|NCT02082769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415881|NCT02082769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102415882|NCT02082769|Gout Suppressants|gout suppressants|mesh-ancestor
102415883|NCT02082769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102415884|NCT02082769|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102415885|NCT02082769|Antioxidants|antioxidants|mesh-ancestor
102415886|NCT02082769|Protective Agents|protective agents|mesh-ancestor
102415887|NCT02082769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415888|NCT03751423|Fentanyl|fentanyl|mesh-list
102415889|NCT03751423|Ketamine|ketamine|mesh-list
102415890|NCT03751423|Morphine|morphine|mesh-list
102415891|NCT03751423|Analgesics|analgesics|mesh-ancestor
102415892|NCT03751423|Sensory System Agents|sensory system agents|mesh-ancestor
102415893|NCT03751423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102415894|NCT03751423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415895|NCT03751423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102415896|NCT03751423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102415897|NCT03751423|Anesthetics, General|anesthetics, general|mesh-ancestor
102415898|NCT03751423|Anesthetics|anesthetics|mesh-ancestor
102415899|NCT03751423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102415900|NCT03751423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102415901|NCT03751423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102415902|NCT03751423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102415903|NCT03751423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415904|NCT03751423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102415905|NCT03751423|Narcotics|narcotics|mesh-ancestor
102415906|NCT03751423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102415907|NCT03745729|Allopurinol|allopurinol|mesh-list
102415908|NCT03745729|Antimetabolites|antimetabolites|mesh-ancestor
102415909|NCT03745729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415910|NCT03745729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102415911|NCT03745729|Gout Suppressants|gout suppressants|mesh-ancestor
102415912|NCT03745729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102415913|NCT03745729|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102415914|NCT03745729|Antioxidants|antioxidants|mesh-ancestor
102415915|NCT03745729|Protective Agents|protective agents|mesh-ancestor
102415916|NCT03745729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415917|NCT04904952|Acetylcysteine|acetylcysteine|mesh-list
102415918|NCT04904952|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102415919|NCT04904952|Antiviral Agents|antiviral agents|mesh-ancestor
102415920|NCT04904952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102415921|NCT04904952|Expectorants|expectorants|mesh-ancestor
102415922|NCT04904952|Respiratory System Agents|respiratory system agents|mesh-ancestor
102415923|NCT04904952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102415924|NCT04904952|Antioxidants|antioxidants|mesh-ancestor
102415925|NCT04904952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415926|NCT04904952|Protective Agents|protective agents|mesh-ancestor
102415927|NCT04904952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415928|NCT04904952|Antidotes|antidotes|mesh-ancestor
102415929|NCT03661411|Aspirin|aspirin|mesh-list
102415930|NCT03661411|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102415931|NCT03661411|Clopidogrel|clopidogrel|mesh-list
102415932|NCT03661411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102415933|NCT03661411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102415934|NCT03661411|Analgesics|analgesics|mesh-ancestor
102415935|NCT03661411|Sensory System Agents|sensory system agents|mesh-ancestor
102415936|NCT03661411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102415937|NCT03661411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415938|NCT03661411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102415939|NCT03661411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102415940|NCT03661411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102415941|NCT03661411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102415942|NCT03661411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415943|NCT03661411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102415944|NCT03661411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102415945|NCT03661411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102415946|NCT03661411|Antipyretics|antipyretics|mesh-ancestor
102415947|NCT03661411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102415948|NCT03661411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102415949|NCT03661411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102415950|NCT03661411|Purinergic Agents|purinergic agents|mesh-ancestor
102415951|NCT03661411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102415952|NCT05048784|Sotorasib|sotorasib|mesh-list
102415953|NCT05048784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102415954|NCT05048784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415955|NCT05048784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102415956|NCT05048784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102415957|NCT03742297|Dexamethasone|dexamethasone|mesh-list
102415958|NCT03742297|Prednisone|prednisone|mesh-list
102415959|NCT03742297|Lenalidomide|lenalidomide|mesh-list
102415960|NCT03742297|Bortezomib|bortezomib|mesh-list
102415961|NCT03742297|Melphalan|melphalan|mesh-list
102415962|NCT03742297|Daratumumab|daratumumab|mesh-list
102415963|NCT03742297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102415964|NCT03742297|Antiemetics|antiemetics|mesh-ancestor
102415965|NCT03742297|Autonomic Agents|autonomic agents|mesh-ancestor
102415966|NCT03742297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102415967|NCT03742297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415968|NCT03742297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102415969|NCT03742297|Glucocorticoids|glucocorticoids|mesh-ancestor
102415970|NCT03742297|Hormones|hormones|mesh-ancestor
102415971|NCT03742297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102415972|NCT03742297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102415973|NCT03742297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102415974|NCT03742297|Immunologic Factors|immunologic factors|mesh-ancestor
102415975|NCT03742297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102415976|NCT03742297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102415977|NCT03742297|Growth Substances|growth substances|mesh-ancestor
102415978|NCT03742297|Growth Inhibitors|growth inhibitors|mesh-ancestor
102415979|NCT03742297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102415980|NCT03742297|Alkylating Agents|alkylating agents|mesh-ancestor
102415981|NCT03742297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415982|NCT03742297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102415983|NCT03742297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102415984|NCT01677403|Tobramycin|tobramycin|mesh-list
102415985|NCT01677403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102415986|NCT01677403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102415987|NCT03742141|Glycopyrrolate|glycopyrrolate|mesh-list
102415988|NCT03742141|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102415989|NCT03742141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102415990|NCT03742141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102415991|NCT03742141|Cholinergic Agents|cholinergic agents|mesh-ancestor
102415992|NCT03742141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102415993|NCT03742141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102415994|NCT03742141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415995|NCT03441750|Metformin|metformin|mesh-list
102415996|NCT03441750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102415997|NCT03441750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102415998|NCT03826693|Nitrous Oxide|nitrous oxide|mesh-list
102415999|NCT03826693|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102416000|NCT03826693|Anesthetics, General|anesthetics, general|mesh-ancestor
102416001|NCT03826693|Anesthetics|anesthetics|mesh-ancestor
102416002|NCT03826693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102416003|NCT03826693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416004|NCT03826693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102416005|NCT03826693|Analgesics|analgesics|mesh-ancestor
102416006|NCT03826693|Sensory System Agents|sensory system agents|mesh-ancestor
102416007|NCT03826693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102416008|NCT03660553|Insulin|insulin|mesh-list
102416009|NCT03660553|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102416010|NCT03660553|Insulin Glargine|insulin glargine|mesh-list
102416011|NCT03660553|Insulin Aspart|insulin aspart|mesh-list
102416012|NCT03660553|Insulin Lispro|insulin lispro|mesh-list
102416013|NCT03660553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102416014|NCT03660553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416015|NCT04527744|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102416016|NCT04527744|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102416017|NCT04527744|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102416018|NCT04527744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102416019|NCT04527744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416020|NCT04527744|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102416021|NCT04527744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102416022|NCT04527744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416023|NCT04527744|Cholinergic Agents|cholinergic agents|mesh-ancestor
102416024|NCT04527744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102416025|NCT03825757|Aspirin|aspirin|mesh-list
102416026|NCT03825757|Salicylic Acid|salicylic acid|mesh-list
102416027|NCT03825757|Salicylates|salicylates|mesh-list
102416028|NCT03825757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102416029|NCT03825757|Antifungal Agents|antifungal agents|mesh-ancestor
102416030|NCT03825757|Keratolytic Agents|keratolytic agents|mesh-ancestor
102416031|NCT03825757|Dermatologic Agents|dermatologic agents|mesh-ancestor
102416032|NCT03825757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102416033|NCT03825757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102416034|NCT03825757|Analgesics|analgesics|mesh-ancestor
102416035|NCT03825757|Sensory System Agents|sensory system agents|mesh-ancestor
102416036|NCT03825757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102416037|NCT03825757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416038|NCT03825757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102416039|NCT03825757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102416040|NCT03825757|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102416041|NCT03825757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102416042|NCT03825757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416043|NCT03825757|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102416044|NCT03825757|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102416045|NCT03825757|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102416046|NCT03825757|Antipyretics|antipyretics|mesh-ancestor
102416047|NCT03657433|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102416048|NCT03657433|Hematinics|hematinics|mesh-ancestor
102416049|NCT03657433|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102416050|NCT03657433|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102416051|NCT04827030|Ropivacaine|ropivacaine|mesh-list
102416052|NCT04827030|Anesthetics, Local|anesthetics, local|mesh-ancestor
102416053|NCT04827030|Anesthetics|anesthetics|mesh-ancestor
102416054|NCT04827030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102416055|NCT04827030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416056|NCT04827030|Sensory System Agents|sensory system agents|mesh-ancestor
102416057|NCT04827030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102416058|NCT03820141|Trastuzumab|trastuzumab|mesh-list
102416059|NCT03820141|Durvalumab|durvalumab|mesh-list
102416060|NCT03820141|Pertuzumab|pertuzumab|mesh-list
102416061|NCT03820141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102416062|NCT03820141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102416063|NCT03651895|Metformin|metformin|mesh-list
102416064|NCT03651895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102416065|NCT03651895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416066|NCT02398656|Tenecteplase|tenecteplase|mesh-list
102416067|NCT02398656|Clopidogrel|clopidogrel|mesh-list
102416068|NCT02398656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102416069|NCT02398656|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102416070|NCT02398656|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102416071|NCT02398656|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102416072|NCT02398656|Purinergic Agents|purinergic agents|mesh-ancestor
102416073|NCT02398656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102416074|NCT02398656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416075|NCT02398656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416076|NCT02398656|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102416077|NCT02398656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102416078|NCT03807037|Tocotrienols|tocotrienols|mesh-list
102416079|NCT03807037|Vitamin E|vitamin e|mesh-list
102416080|NCT03807037|Tocopherols|tocopherols|mesh-list
102416081|NCT03807037|Tocovid|tocovid|mesh-list
102416082|NCT03807037|Antioxidants|antioxidants|mesh-ancestor
102416083|NCT03807037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416084|NCT03807037|Protective Agents|protective agents|mesh-ancestor
102416085|NCT03807037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416086|NCT03807037|Vitamins|vitamins|mesh-ancestor
102416087|NCT03807037|Micronutrients|micronutrients|mesh-ancestor
102416088|NCT03805399|Sirolimus|sirolimus|mesh-list
102416089|NCT03805399|Paclitaxel|paclitaxel|mesh-list
102416090|NCT03805399|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102416091|NCT03805399|Capecitabine|capecitabine|mesh-list
102416092|NCT03805399|Everolimus|everolimus|mesh-list
102416093|NCT03805399|Apatinib|apatinib|mesh-list
102416094|NCT03805399|Temsirolimus|temsirolimus|mesh-list
102416095|NCT03805399|MTOR Inhibitors|mtor inhibitors|mesh-list
102416096|NCT03805399|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102416097|NCT03805399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102416098|NCT03805399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102416099|NCT03805399|Tubulin Modulators|tubulin modulators|mesh-ancestor
102416100|NCT03805399|Antimitotic Agents|antimitotic agents|mesh-ancestor
102416101|NCT03805399|Mitosis Modulators|mitosis modulators|mesh-ancestor
102416102|NCT03805399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416103|NCT03805399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102416104|NCT03805399|Antimetabolites|antimetabolites|mesh-ancestor
102416105|NCT03805399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102416106|NCT03805399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102416107|NCT03805399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102416108|NCT03805399|Immunologic Factors|immunologic factors|mesh-ancestor
102416109|NCT03805399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416110|NCT03805399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102416111|NCT03805399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102416112|NCT03805399|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102416113|NCT03805399|Antifungal Agents|antifungal agents|mesh-ancestor
102416114|NCT03725059|Paclitaxel|paclitaxel|mesh-list
102416115|NCT03725059|Cyclophosphamide|cyclophosphamide|mesh-list
102416116|NCT03725059|Doxorubicin|doxorubicin|mesh-list
102416117|NCT03725059|Pembrolizumab|pembrolizumab|mesh-list
102416118|NCT03725059|Epirubicin|epirubicin|mesh-list
102416119|NCT03725059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102416120|NCT03725059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102416121|NCT03725059|Tubulin Modulators|tubulin modulators|mesh-ancestor
102416122|NCT03725059|Antimitotic Agents|antimitotic agents|mesh-ancestor
102416123|NCT03725059|Mitosis Modulators|mitosis modulators|mesh-ancestor
102416124|NCT03725059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416125|NCT03725059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102416126|NCT03725059|Immunologic Factors|immunologic factors|mesh-ancestor
102416127|NCT03725059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416128|NCT03725059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102416129|NCT03725059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102416130|NCT03725059|Alkylating Agents|alkylating agents|mesh-ancestor
102416131|NCT03725059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102416132|NCT03725059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102416133|NCT03725059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102416134|NCT03725059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102416135|NCT03725059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102416136|NCT03725059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102416137|NCT03725059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102416138|NCT02652624|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102416139|NCT02652624|Antiviral Agents|antiviral agents|mesh-ancestor
102416140|NCT02652624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102416141|NCT02652624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102416142|NCT02652624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102416143|NCT03637075|Insulin|insulin|mesh-list
102416144|NCT03637075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102416145|NCT03637075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416146|NCT04403503|Thrombin|thrombin|mesh-list
102416147|NCT04403503|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
102416148|NCT04403503|Hemostatics|hemostatics|mesh-ancestor
102416149|NCT04403503|Coagulants|coagulants|mesh-ancestor
102416150|NCT00249795|Irbesartan|irbesartan|mesh-list
102416151|NCT00249795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102416152|NCT00249795|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102416153|NCT00249795|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102416154|NCT00249795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416155|NCT04404127|Basiliximab|basiliximab|mesh-list
102416156|NCT04404127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102416157|NCT04404127|Immunologic Factors|immunologic factors|mesh-ancestor
102416158|NCT04404127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416159|NCT02651220|Adapalene|adapalene|mesh-list
102416160|NCT02651220|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
102416161|NCT02651220|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102416162|NCT02651220|Dermatologic Agents|dermatologic agents|mesh-ancestor
102416163|NCT02651220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102416164|NCT02651220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102416165|NCT02651220|Analgesics|analgesics|mesh-ancestor
102416166|NCT02651220|Sensory System Agents|sensory system agents|mesh-ancestor
102416167|NCT02651220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102416168|NCT02651220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416169|NCT02651220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102416170|NCT02651220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102416171|NCT01279551|Lidocaine|lidocaine|mesh-list
102416172|NCT01279551|Nitroglycerin|nitroglycerin|mesh-list
102416173|NCT01279551|Anesthetics, Local|anesthetics, local|mesh-ancestor
102416174|NCT01279551|Anesthetics|anesthetics|mesh-ancestor
102416175|NCT01279551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102416176|NCT01279551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416177|NCT01279551|Sensory System Agents|sensory system agents|mesh-ancestor
102416178|NCT01279551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102416179|NCT01279551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102416180|NCT01279551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102416181|NCT01279551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102416182|NCT01279551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102416183|NCT01279551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416184|NCT01279551|Vasodilator Agents|vasodilator agents|mesh-ancestor
102416185|NCT03738696|Bupivacaine|bupivacaine|mesh-list
102416186|NCT03738696|Ropivacaine|ropivacaine|mesh-list
102416187|NCT03738696|Anesthetics, Local|anesthetics, local|mesh-ancestor
102416188|NCT03738696|Anesthetics|anesthetics|mesh-ancestor
102416189|NCT03738696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102416190|NCT03738696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416191|NCT03738696|Sensory System Agents|sensory system agents|mesh-ancestor
102416192|NCT03738696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102416193|NCT00780403|Cetirizine|cetirizine|mesh-list
102416194|NCT00780403|Desloratadine|desloratadine|mesh-list
102416195|NCT00780403|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102416196|NCT00780403|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102416197|NCT00780403|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102416198|NCT00780403|Histamine Antagonists|histamine antagonists|mesh-ancestor
102416199|NCT00780403|Histamine Agents|histamine agents|mesh-ancestor
102416200|NCT00780403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102416201|NCT00780403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416202|NCT00780403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416203|NCT00780403|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102416204|NCT00780403|Cholinergic Agents|cholinergic agents|mesh-ancestor
102416205|NCT03704610|Infliximab|infliximab|mesh-list
102416206|NCT03704610|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102416207|NCT03704610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102416208|NCT03704610|Dermatologic Agents|dermatologic agents|mesh-ancestor
102416209|NCT03704610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102416210|NCT03704610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102416211|NCT01979796|Nicotine|nicotine|mesh-list
102416212|NCT01979796|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102416213|NCT01979796|Autonomic Agents|autonomic agents|mesh-ancestor
102416214|NCT01979796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102416215|NCT01979796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416216|NCT01979796|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102416217|NCT01979796|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102416218|NCT01979796|Cholinergic Agents|cholinergic agents|mesh-ancestor
102416219|NCT01979796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102416220|NCT01979796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416221|NCT03628339|Tepotinib|tepotinib|mesh-list
102416222|NCT03628339|Midazolam|midazolam|mesh-list
102416223|NCT03628339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102416224|NCT03628339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102416225|NCT03628339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102416226|NCT03628339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416227|NCT03628339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102416228|NCT03628339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102416229|NCT03628339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102416230|NCT03628339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102416231|NCT03628339|Anesthetics, General|anesthetics, general|mesh-ancestor
102416232|NCT03628339|Anesthetics|anesthetics|mesh-ancestor
102416233|NCT03628339|GABA Modulators|gaba modulators|mesh-ancestor
102416234|NCT03628339|GABA Agents|gaba agents|mesh-ancestor
102416235|NCT03628339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102416236|NCT03628339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416237|NCT03628339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102416238|NCT03792763|Denosumab|denosumab|mesh-list
102416239|NCT03792763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102416240|NCT03792763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102416241|NCT03792763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416242|NCT04412694|Dexamethasone|dexamethasone|mesh-list
102416243|NCT04412694|Dexamethasone acetate|dexamethasone acetate|mesh-list
102416244|NCT04412694|BB 1101|bb 1101|mesh-list
102416245|NCT04412694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102416246|NCT04412694|Antiemetics|antiemetics|mesh-ancestor
102416247|NCT04412694|Autonomic Agents|autonomic agents|mesh-ancestor
102416248|NCT04412694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102416249|NCT04412694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416250|NCT04412694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102416251|NCT04412694|Glucocorticoids|glucocorticoids|mesh-ancestor
102416252|NCT04412694|Hormones|hormones|mesh-ancestor
102416253|NCT04412694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102416254|NCT04412694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102416255|NCT04412694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102416256|NCT04412694|Protease Inhibitors|protease inhibitors|mesh-ancestor
102416257|NCT04412694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102416258|NCT04412694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416259|NCT03627715|Propagermanium|propagermanium|mesh-list
102416260|NCT03627715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102416261|NCT03627715|Interferon Inducers|interferon inducers|mesh-ancestor
102416262|NCT03627715|Immunologic Factors|immunologic factors|mesh-ancestor
102416263|NCT03627715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416264|NCT00246753|Lapatinib|lapatinib|mesh-list
102416265|NCT00246753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102416266|NCT00246753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102416267|NCT00246753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102416268|NCT00246753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416269|NCT02083861|Oxymetazoline|oxymetazoline|mesh-list
102416270|NCT02083861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102416271|NCT02083861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102416272|NCT02083861|Adrenergic Agents|adrenergic agents|mesh-ancestor
102416273|NCT02083861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102416274|NCT02083861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416275|NCT02083861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416276|NCT02083861|Sympathomimetics|sympathomimetics|mesh-ancestor
102416277|NCT02083861|Autonomic Agents|autonomic agents|mesh-ancestor
102416278|NCT02083861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102416279|NCT02083861|Nasal Decongestants|nasal decongestants|mesh-ancestor
102416280|NCT02083861|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102416281|NCT02083861|Respiratory System Agents|respiratory system agents|mesh-ancestor
102416282|NCT00246129|Alemtuzumab|alemtuzumab|mesh-list
102416283|NCT00246129|Daclizumab|daclizumab|mesh-list
102416284|NCT00246129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102416285|NCT00246129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102416286|NCT00246129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102416287|NCT00246129|Immunologic Factors|immunologic factors|mesh-ancestor
102416288|NCT00246129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416289|NCT01274247|Benzocaine|benzocaine|mesh-list
102227919|NCT05060991|Antimetabolites|antimetabolites|mesh-list
102416290|NCT01274247|Anesthetics, Local|anesthetics, local|mesh-ancestor
102416292|NCT01274247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102416293|NCT01274247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416294|NCT01274247|Sensory System Agents|sensory system agents|mesh-ancestor
102416295|NCT01274247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102416296|NCT03783715|Ketoprofen|ketoprofen|mesh-list
102416297|NCT03783715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102416298|NCT03783715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102416299|NCT03783715|Analgesics|analgesics|mesh-ancestor
102416300|NCT03783715|Sensory System Agents|sensory system agents|mesh-ancestor
102416301|NCT03783715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102416302|NCT03783715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416303|NCT03783715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102416304|NCT03783715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102416305|NCT03783715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102416306|NCT03783715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102416307|NCT03783715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416308|NCT01279629|Tazarotene|tazarotene|mesh-list
102416309|NCT01279629|Calcipotriene|calcipotriene|mesh-list
102416310|NCT01279629|Dermatologic Agents|dermatologic agents|mesh-ancestor
102416311|NCT01279629|Keratolytic Agents|keratolytic agents|mesh-ancestor
102416312|NCT01274325|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102416313|NCT01274325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102416314|NCT01274325|Autonomic Agents|autonomic agents|mesh-ancestor
102416315|NCT01274325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102416316|NCT01274325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416317|NCT01274325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102416318|NCT01274325|Respiratory System Agents|respiratory system agents|mesh-ancestor
102416319|NCT01274325|Glucocorticoids|glucocorticoids|mesh-ancestor
102416320|NCT01274325|Hormones|hormones|mesh-ancestor
102416321|NCT01274325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102416322|NCT01274325|Sympathomimetics|sympathomimetics|mesh-ancestor
102416323|NCT04502394|Acalabrutinib|acalabrutinib|mesh-list
102416324|NCT04502394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102416325|NCT01274403|Thalidomide|thalidomide|mesh-list
102416326|NCT01274403|Prednisone|prednisone|mesh-list
102416327|NCT01274403|Melphalan|melphalan|mesh-list
102416328|NCT01274403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102416329|NCT01274403|Glucocorticoids|glucocorticoids|mesh-ancestor
102416330|NCT01274403|Hormones|hormones|mesh-ancestor
102416331|NCT01274403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102416332|NCT01274403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416333|NCT01274403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102416334|NCT01274403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102416335|NCT01274403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102416336|NCT01274403|Alkylating Agents|alkylating agents|mesh-ancestor
102416337|NCT01274403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416338|NCT01274403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102416339|NCT01274403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102416340|NCT01274403|Immunologic Factors|immunologic factors|mesh-ancestor
102416341|NCT01274403|Leprostatic Agents|leprostatic agents|mesh-ancestor
102416342|NCT01274403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102416343|NCT01274403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102416344|NCT01274403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102416345|NCT01274403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102416346|NCT01274403|Growth Substances|growth substances|mesh-ancestor
102416347|NCT01274403|Growth Inhibitors|growth inhibitors|mesh-ancestor
102416348|NCT03700099|Docetaxel|docetaxel|mesh-list
102416349|NCT03700099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102416350|NCT03700099|Tubulin Modulators|tubulin modulators|mesh-ancestor
102416351|NCT03700099|Antimitotic Agents|antimitotic agents|mesh-ancestor
102416352|NCT03700099|Mitosis Modulators|mitosis modulators|mesh-ancestor
102416353|NCT03700099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416354|NCT01274481|Iloprost|iloprost|mesh-list
102416355|NCT01274481|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102416356|NCT01274481|Vasodilator Agents|vasodilator agents|mesh-ancestor
102416357|NCT00245583|Topiramate|topiramate|mesh-list
102047014|NCT05095857|Ketamine|ketamine|mesh-list
102416358|NCT00245583|Anticonvulsants|anticonvulsants|mesh-ancestor
102416359|NCT00245583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102416360|NCT00245583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416361|NCT01379989|Carboplatin|carboplatin|mesh-list
102416362|NCT01379989|Doxorubicin|doxorubicin|mesh-list
102416363|NCT01379989|Trabectedin|trabectedin|mesh-list
102416364|NCT01379989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102227996|NCT03396601|Ketamine|ketamine|mesh-list
102416365|NCT01379989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102416366|NCT01379989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102416367|NCT01379989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102416368|NCT01379989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102416369|NCT01379989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416370|NCT01379989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102416371|NCT01379989|Alkylating Agents|alkylating agents|mesh-ancestor
102416372|NCT02652156|Bupivacaine|bupivacaine|mesh-list
102416373|NCT02652156|Ropivacaine|ropivacaine|mesh-list
102416374|NCT02652156|Anesthetics, Local|anesthetics, local|mesh-ancestor
102416375|NCT02652156|Anesthetics|anesthetics|mesh-ancestor
102416376|NCT02652156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102416377|NCT02652156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416378|NCT02652156|Sensory System Agents|sensory system agents|mesh-ancestor
102416379|NCT02652156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102416380|NCT03699865|Nicotine|nicotine|mesh-list
102416381|NCT03699865|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102416382|NCT03699865|Autonomic Agents|autonomic agents|mesh-ancestor
102416383|NCT03699865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102416384|NCT03699865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416385|NCT03699865|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102416386|NCT03699865|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102416387|NCT03699865|Cholinergic Agents|cholinergic agents|mesh-ancestor
102416388|NCT03699865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102416389|NCT03699865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416390|NCT00754923|Sorafenib|sorafenib|mesh-list
102416391|NCT00754923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102416392|NCT00754923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102416393|NCT00754923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102416394|NCT00754923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416395|NCT03696199|Anesthetics|anesthetics|mesh-list
102416396|NCT03696199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102416397|NCT03696199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416398|NCT00746421|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102416399|NCT00746421|Antidepressive Agents|antidepressive agents|mesh-ancestor
102416400|NCT00746421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102416401|NCT00746421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102416402|NCT00746421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102416403|NCT00746421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102416404|NCT00746421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416405|NCT02117076|Gabapentin|gabapentin|mesh-list
102416406|NCT02117076|Analgesics|analgesics|mesh-ancestor
102416407|NCT02117076|Sensory System Agents|sensory system agents|mesh-ancestor
102416408|NCT02117076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102416409|NCT02117076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416410|NCT02117076|Anticonvulsants|anticonvulsants|mesh-ancestor
102416411|NCT02117076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102416412|NCT02117076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102416413|NCT02117076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102416414|NCT02117076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102416415|NCT02117076|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102416416|NCT02117076|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102416417|NCT02117076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102416418|NCT02117076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416419|NCT02117076|Antimanic Agents|antimanic agents|mesh-ancestor
102416420|NCT01274793|Mosapride|mosapride|mesh-list
102416421|NCT01274793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416422|NCT01274793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102416423|NCT01274793|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102416424|NCT01274793|Serotonin Agents|serotonin agents|mesh-ancestor
102416425|NCT01274793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102416426|NCT01274793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416427|NCT00746889|Triamcinolone|triamcinolone|mesh-list
102416428|NCT00746889|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102416429|NCT00746889|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102416430|NCT00746889|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102416431|NCT00746889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102416432|NCT00746889|Glucocorticoids|glucocorticoids|mesh-ancestor
102416433|NCT00746889|Hormones|hormones|mesh-ancestor
102416434|NCT00746889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102416435|NCT00746889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416436|NCT00746889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102416437|NCT00746889|Immunologic Factors|immunologic factors|mesh-ancestor
102416438|NCT00746889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102416439|NCT00746889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416440|NCT01675050|Cyproheptadine|cyproheptadine|mesh-list
102416441|NCT01675050|Antipruritics|antipruritics|mesh-ancestor
102416442|NCT01675050|Dermatologic Agents|dermatologic agents|mesh-ancestor
102416443|NCT01675050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102416444|NCT01675050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102416445|NCT01675050|Histamine Antagonists|histamine antagonists|mesh-ancestor
102416446|NCT01675050|Histamine Agents|histamine agents|mesh-ancestor
102416447|NCT01675050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102416448|NCT01675050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416449|NCT01675050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416450|NCT01675050|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102416451|NCT01675050|Serotonin Agents|serotonin agents|mesh-ancestor
102416452|NCT01675050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102416453|NCT00756093|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102416454|NCT00756093|Lubricant Eye Drops|lubricant eye drops|mesh-list
102416455|NCT00756093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102416456|NCT00816582|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102416457|NCT00816582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102416458|NCT00816582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416459|NCT03771313|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
102416460|NCT03771313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102416461|NCT03771313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102416462|NCT03704688|Trametinib|trametinib|mesh-list
102416463|NCT03704688|Ponatinib|ponatinib|mesh-list
102416464|NCT03704688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102416465|NCT03704688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102416466|NCT03704688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102416467|NCT03704688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416468|NCT03600649|Cyclophosphamide|cyclophosphamide|mesh-list
102416469|NCT03600649|Topotecan|topotecan|mesh-list
102416470|NCT03600649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102416471|NCT03600649|Immunologic Factors|immunologic factors|mesh-ancestor
102416472|NCT03600649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416473|NCT03600649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102416474|NCT03600649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102416475|NCT03600649|Alkylating Agents|alkylating agents|mesh-ancestor
102416476|NCT03600649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416477|NCT03600649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102416478|NCT03600649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102416479|NCT03600649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102416480|NCT03600649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102416481|NCT03600649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102416482|NCT00244881|Cediranib|cediranib|mesh-list
102416483|NCT00244881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102416484|NCT00244881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416485|NCT00244881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102416486|NCT00244881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102416487|NCT00530517|Sumatriptan|sumatriptan|mesh-list
102416488|NCT00530517|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102416489|NCT00530517|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102416490|NCT00530517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102416491|NCT00530517|Serotonin Agents|serotonin agents|mesh-ancestor
102416492|NCT00530517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102416493|NCT00530517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416494|NCT00530517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416495|NCT03765541|Cytarabine|cytarabine|mesh-list
102416496|NCT03765541|Dexamethasone|dexamethasone|mesh-list
102416497|NCT03765541|Azacitidine|azacitidine|mesh-list
102416498|NCT03765541|Amsacrine|amsacrine|mesh-list
102416499|NCT03765541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102416500|NCT03765541|Antiemetics|antiemetics|mesh-ancestor
102416501|NCT03765541|Autonomic Agents|autonomic agents|mesh-ancestor
102416502|NCT03765541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102416503|NCT03765541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416504|NCT03765541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102416505|NCT03765541|Glucocorticoids|glucocorticoids|mesh-ancestor
102416506|NCT03765541|Hormones|hormones|mesh-ancestor
102416507|NCT03765541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102416508|NCT03765541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102416509|NCT03765541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102416510|NCT03765541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102416511|NCT03765541|Antimetabolites|antimetabolites|mesh-ancestor
102416512|NCT03765541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416513|NCT03765541|Antiviral Agents|antiviral agents|mesh-ancestor
102416514|NCT03765541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102416515|NCT03765541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102416516|NCT03765541|Immunologic Factors|immunologic factors|mesh-ancestor
102416517|NCT03765541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102416518|NCT05123976|Olanzapine|olanzapine|mesh-list
102416519|NCT05123976|Antiemetics|antiemetics|mesh-ancestor
102416520|NCT05123976|Autonomic Agents|autonomic agents|mesh-ancestor
102416521|NCT05123976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102416522|NCT05123976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416523|NCT05123976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102416524|NCT05123976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102416525|NCT05123976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102416526|NCT05123976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102416527|NCT05123976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102416528|NCT05123976|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102416529|NCT05123976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102416530|NCT05123976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102416531|NCT05123976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416532|NCT05123976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102416533|NCT05123976|Serotonin Agents|serotonin agents|mesh-ancestor
102416534|NCT00005803|Cytarabine|cytarabine|mesh-list
102416535|NCT00005803|Cyclosporine|cyclosporine|mesh-list
102416536|NCT00005803|Mycophenolic Acid|mycophenolic acid|mesh-list
102416537|NCT00005803|Cyclophosphamide|cyclophosphamide|mesh-list
102416538|NCT00005803|Melphalan|melphalan|mesh-list
102416539|NCT00005803|Mechlorethamine|mechlorethamine|mesh-list
102416540|NCT00005803|Carmustine|carmustine|mesh-list
102416541|NCT00005803|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102416542|NCT00005803|Fludarabine|fludarabine|mesh-list
102416543|NCT00005803|Fludarabine phosphate|fludarabine phosphate|mesh-list
102416544|NCT00005803|Etoposide|etoposide|mesh-list
102416545|NCT00005803|Etoposide phosphate|etoposide phosphate|mesh-list
102416546|NCT00005803|Podophyllotoxin|podophyllotoxin|mesh-list
102416547|NCT00005803|Cyclosporins|cyclosporins|mesh-list
102416548|NCT00005803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102416549|NCT00005803|Immunologic Factors|immunologic factors|mesh-ancestor
102416550|NCT00005803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416551|NCT00005803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102416552|NCT00005803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102416553|NCT00005803|Alkylating Agents|alkylating agents|mesh-ancestor
102416554|NCT00005803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416555|NCT00005803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102416556|NCT00005803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102416557|NCT00005803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102416558|NCT00005803|Antimetabolites|antimetabolites|mesh-ancestor
102416559|NCT00005803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102416560|NCT00005803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102416561|NCT00005803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102416562|NCT00005803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102416563|NCT00005803|Antiviral Agents|antiviral agents|mesh-ancestor
102416564|NCT00005803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102416565|NCT00005803|Antifungal Agents|antifungal agents|mesh-ancestor
102416566|NCT00005803|Dermatologic Agents|dermatologic agents|mesh-ancestor
102416567|NCT00005803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102416568|NCT00005803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102416569|NCT00005803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102416570|NCT00005803|Antitubercular Agents|antitubercular agents|mesh-ancestor
102416571|NCT00005803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102416572|NCT00005803|Keratolytic Agents|keratolytic agents|mesh-ancestor
102416573|NCT00005803|Tubulin Modulators|tubulin modulators|mesh-ancestor
102416574|NCT00005803|Antimitotic Agents|antimitotic agents|mesh-ancestor
102416575|NCT00005803|Mitosis Modulators|mitosis modulators|mesh-ancestor
102416576|NCT00244725|Warfarin|warfarin|mesh-list
102416577|NCT00244725|Anticoagulants|anticoagulants|mesh-ancestor
102416578|NCT02649894|Silver Nitrate|silver nitrate|mesh-list
102416579|NCT02649894|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102416580|NCT02649894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102416581|NCT04185012|Benralizumab|benralizumab|mesh-list
102416582|NCT04185012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102416583|NCT04185012|Respiratory System Agents|respiratory system agents|mesh-ancestor
102416584|NCT01275183|Raltegravir Potassium|raltegravir potassium|mesh-list
102416585|NCT01275183|Cisplatin|cisplatin|mesh-list
102416586|NCT01275183|Docetaxel|docetaxel|mesh-list
102416587|NCT01275183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102416588|NCT01275183|Tubulin Modulators|tubulin modulators|mesh-ancestor
102416589|NCT01275183|Antimitotic Agents|antimitotic agents|mesh-ancestor
102416590|NCT01275183|Mitosis Modulators|mitosis modulators|mesh-ancestor
102416591|NCT01275183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416593|NCT01275183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102416594|NCT01275183|Antiviral Agents|antiviral agents|mesh-ancestor
102416595|NCT01275183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102416596|NCT01275183|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102416597|NCT01275183|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102416598|NCT01275183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102416599|NCT05126004|Acetylcysteine|acetylcysteine|mesh-list
102416600|NCT05126004|Azacitidine|azacitidine|mesh-list
102047269|NCT02304991|Glycerol|glycerol|mesh-list
102416601|NCT05126004|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102416602|NCT05126004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102416603|NCT05126004|Antimetabolites|antimetabolites|mesh-ancestor
102416604|NCT05126004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416605|NCT05126004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102416606|NCT05126004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102416607|NCT05126004|Antiviral Agents|antiviral agents|mesh-ancestor
102416608|NCT05126004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102416609|NCT05126004|Expectorants|expectorants|mesh-ancestor
102416610|NCT05126004|Respiratory System Agents|respiratory system agents|mesh-ancestor
102416611|NCT05126004|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102416612|NCT05126004|Antioxidants|antioxidants|mesh-ancestor
102416613|NCT05126004|Protective Agents|protective agents|mesh-ancestor
102416614|NCT05126004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416615|NCT05126004|Antidotes|antidotes|mesh-ancestor
102416616|NCT03672643|Crizotinib|crizotinib|mesh-list
102416617|NCT03672643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102416618|NCT03672643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102416619|NCT03672643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102416620|NCT03672643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416621|NCT00350701|Methyltestosterone|methyltestosterone|mesh-list
102416622|NCT00350701|Testosterone|testosterone|mesh-list
102416623|NCT00350701|Testosterone undecanoate|testosterone undecanoate|mesh-list
102416624|NCT00350701|Testosterone enanthate|testosterone enanthate|mesh-list
102416625|NCT00350701|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102416626|NCT00350701|Androgens|androgens|mesh-ancestor
102416627|NCT00350701|Hormones|hormones|mesh-ancestor
102416628|NCT00350701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102416629|NCT00350701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416630|NCT00350701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102416631|NCT00350701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102416632|NCT00350701|Anabolic Agents|anabolic agents|mesh-ancestor
102416633|NCT04277247|Botulinum Toxins|botulinum toxins|mesh-list
102416634|NCT04277247|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102416635|NCT04277247|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102416636|NCT04277247|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102416637|NCT04277247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102416638|NCT04277247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416639|NCT04277247|Cholinergic Agents|cholinergic agents|mesh-ancestor
102416640|NCT04277247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102416641|NCT04277247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416642|NCT04277247|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102416643|NCT04277247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102416644|NCT01505114|Tenofovir|tenofovir|mesh-list
102416645|NCT01505114|Emtricitabine|emtricitabine|mesh-list
102416646|NCT01505114|Maraviroc|maraviroc|mesh-list
102416647|NCT01505114|Antiviral Agents|antiviral agents|mesh-ancestor
102416648|NCT01505114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102416649|NCT01505114|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102416650|NCT01505114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102416651|NCT01505114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102416652|NCT01505114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416653|NCT01505114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102416654|NCT01505114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102416655|NCT01505114|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102416656|NCT01505114|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102416657|NCT01505114|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102416658|NCT04761757|Antidepressive Agents|antidepressive agents|mesh-list
102416659|NCT04761757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102416660|NCT04187898|Cyclophosphamide|cyclophosphamide|mesh-list
102416661|NCT04187898|Docetaxel|docetaxel|mesh-list
102416662|NCT04187898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102416663|NCT04187898|Immunologic Factors|immunologic factors|mesh-ancestor
102416664|NCT04187898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416665|NCT04187898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102416666|NCT04187898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102416667|NCT04187898|Alkylating Agents|alkylating agents|mesh-ancestor
102416668|NCT04187898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416669|NCT04187898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102416670|NCT04187898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102416671|NCT04187898|Tubulin Modulators|tubulin modulators|mesh-ancestor
102416672|NCT04187898|Antimitotic Agents|antimitotic agents|mesh-ancestor
102416673|NCT04187898|Mitosis Modulators|mitosis modulators|mesh-ancestor
102416674|NCT00243867|Paclitaxel|paclitaxel|mesh-list
102416675|NCT00243867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102416676|NCT00243867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102416677|NCT00243867|Tubulin Modulators|tubulin modulators|mesh-ancestor
102416678|NCT00243867|Antimitotic Agents|antimitotic agents|mesh-ancestor
102416679|NCT00243867|Mitosis Modulators|mitosis modulators|mesh-ancestor
102416680|NCT00243867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416681|NCT01679899|Vildagliptin|vildagliptin|mesh-list
102416682|NCT01679899|Gliclazide|gliclazide|mesh-list
102416683|NCT01679899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102416684|NCT01679899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416685|NCT01679899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102416686|NCT01679899|Protease Inhibitors|protease inhibitors|mesh-ancestor
102416687|NCT01679899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102416688|NCT01679899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416689|NCT01276821|Epinephrine|epinephrine|mesh-list
102416690|NCT01276821|Racepinephrine|racepinephrine|mesh-list
102416691|NCT01276821|Epinephryl borate|epinephryl borate|mesh-list
102416692|NCT01276821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102416693|NCT01276821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102416694|NCT01276821|Adrenergic Agents|adrenergic agents|mesh-ancestor
102416695|NCT01276821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102416696|NCT01276821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416697|NCT01276821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416698|NCT01276821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102416699|NCT01276821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102416700|NCT01276821|Autonomic Agents|autonomic agents|mesh-ancestor
102416701|NCT01276821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102416702|NCT01276821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102416703|NCT01276821|Respiratory System Agents|respiratory system agents|mesh-ancestor
102416704|NCT01276821|Mydriatics|mydriatics|mesh-ancestor
102416705|NCT01276821|Sympathomimetics|sympathomimetics|mesh-ancestor
102416706|NCT01276821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102416707|NCT00245037|Cyclosporine|cyclosporine|mesh-list
102416708|NCT00245037|Mycophenolic Acid|mycophenolic acid|mesh-list
102416709|NCT00245037|Methotrexate|methotrexate|mesh-list
102416710|NCT00245037|Fludarabine phosphate|fludarabine phosphate|mesh-list
102416711|NCT00245037|Fludarabine|fludarabine|mesh-list
102416712|NCT00245037|Busulfan|busulfan|mesh-list
102416713|NCT00245037|Phenytoin|phenytoin|mesh-list
102416714|NCT00245037|Cyclosporins|cyclosporins|mesh-list
102416715|NCT00245037|Lenograstim|lenograstim|mesh-list
102416716|NCT00245037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102416717|NCT00245037|Abortifacient Agents|abortifacient agents|mesh-ancestor
102416718|NCT00245037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102416719|NCT00245037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416720|NCT00245037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102416721|NCT00245037|Antimetabolites|antimetabolites|mesh-ancestor
102416722|NCT00245037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416723|NCT00245037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102416724|NCT00245037|Dermatologic Agents|dermatologic agents|mesh-ancestor
102416725|NCT00245037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102416726|NCT00245037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102416727|NCT00245037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102416728|NCT00245037|Immunologic Factors|immunologic factors|mesh-ancestor
102416729|NCT00245037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102416730|NCT00245037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102416731|NCT00245037|Antifungal Agents|antifungal agents|mesh-ancestor
102416732|NCT00245037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102416733|NCT00245037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102416734|NCT00245037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102416735|NCT00245037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102416736|NCT00245037|Antitubercular Agents|antitubercular agents|mesh-ancestor
102416737|NCT00245037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102416738|NCT00245037|Alkylating Agents|alkylating agents|mesh-ancestor
102416739|NCT00245037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102416740|NCT00245037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102416741|NCT00245037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102416742|NCT00245037|Anticonvulsants|anticonvulsants|mesh-ancestor
102416743|NCT00245037|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102416744|NCT00245037|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102416745|NCT00245037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102416746|NCT00245037|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102416747|NCT00245037|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102416748|NCT00241839|Allopurinol|allopurinol|mesh-list
102416749|NCT00241839|Chlorthalidone|chlorthalidone|mesh-list
102416750|NCT00241839|Antimetabolites|antimetabolites|mesh-ancestor
102416751|NCT00241839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416752|NCT00241839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102416753|NCT00241839|Gout Suppressants|gout suppressants|mesh-ancestor
102416754|NCT00241839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102047418|NCT01356355|Urological Agents|urological agents|mesh-ancestor
102416755|NCT00241839|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102416756|NCT00241839|Antioxidants|antioxidants|mesh-ancestor
102416757|NCT00241839|Protective Agents|protective agents|mesh-ancestor
102416758|NCT00241839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416759|NCT00241839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102416760|NCT00241839|Diuretics|diuretics|mesh-ancestor
102416761|NCT00241839|Natriuretic Agents|natriuretic agents|mesh-ancestor
102416762|NCT00241839|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102416763|NCT00241839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102416764|NCT05347381|Dexamethasone|dexamethasone|mesh-list
102416765|NCT05347381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102416766|NCT05347381|Antiemetics|antiemetics|mesh-ancestor
102416767|NCT05347381|Autonomic Agents|autonomic agents|mesh-ancestor
102416768|NCT05347381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102416769|NCT05347381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416770|NCT05347381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102416771|NCT05347381|Glucocorticoids|glucocorticoids|mesh-ancestor
102416772|NCT05347381|Hormones|hormones|mesh-ancestor
102416773|NCT05347381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102416774|NCT05347381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102416775|NCT05347381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102416776|NCT02651688|Enclomiphene|enclomiphene|mesh-list
102416777|NCT02651688|Clomiphene|clomiphene|mesh-list
102416778|NCT02651688|Zuclomiphene|zuclomiphene|mesh-list
102416779|NCT02651688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102416780|NCT02651688|Hormone Antagonists|hormone antagonists|mesh-ancestor
102416781|NCT02651688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102416782|NCT02651688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416783|NCT02651688|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102416784|NCT02651688|Fertility Agents|fertility agents|mesh-ancestor
102416785|NCT02651688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102416786|NCT02651688|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102416787|NCT02651688|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102416788|NCT01276353|Donepezil|donepezil|mesh-list
102416789|NCT01276353|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102416790|NCT01276353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102416791|NCT01276353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416792|NCT01276353|Cholinergic Agents|cholinergic agents|mesh-ancestor
102416793|NCT01276353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102416794|NCT01276353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416795|NCT01276353|Nootropic Agents|nootropic agents|mesh-ancestor
102416796|NCT03809013|Trastuzumab|trastuzumab|mesh-list
102416797|NCT03809013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102416798|NCT03809013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102416799|NCT03807921|Aspirin|aspirin|mesh-list
102416800|NCT03807921|Warfarin|warfarin|mesh-list
102416801|NCT03807921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102416802|NCT03807921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102416803|NCT03807921|Analgesics|analgesics|mesh-ancestor
102416804|NCT03807921|Sensory System Agents|sensory system agents|mesh-ancestor
102416805|NCT03807921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102416806|NCT03807921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416807|NCT03807921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102416808|NCT03807921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102416809|NCT03807921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102416810|NCT03807921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102416811|NCT03807921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416812|NCT03807921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102416813|NCT03807921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102416814|NCT03807921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102416815|NCT03807921|Antipyretics|antipyretics|mesh-ancestor
102416816|NCT03807921|Anticoagulants|anticoagulants|mesh-ancestor
102416817|NCT01675609|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102416818|NCT01675609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102416819|NCT01675609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102416820|NCT01675609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102416821|NCT01675609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102416822|NCT01675609|Adrenergic Agents|adrenergic agents|mesh-ancestor
102416823|NCT01675609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102416824|NCT01675609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416825|NCT01675609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416826|NCT01673659|Mometasone Furoate|mometasone furoate|mesh-list
102416827|NCT01673659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102416828|NCT01673659|Dermatologic Agents|dermatologic agents|mesh-ancestor
102416829|NCT01673659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102416830|NCT00762177|Triclosan|triclosan|mesh-list
102416831|NCT00762177|Fluorides|fluorides|mesh-list
102416832|NCT00762177|Tin Fluorides|tin fluorides|mesh-list
102416833|NCT00762177|Cariostatic Agents|cariostatic agents|mesh-ancestor
102416834|NCT00762177|Protective Agents|protective agents|mesh-ancestor
102416835|NCT00762177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416836|NCT00762177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102416837|NCT00762177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102416838|NCT00762177|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102416839|NCT00762177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102416840|NCT00762177|Antimetabolites|antimetabolites|mesh-ancestor
102416841|NCT00762177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416842|NCT00762177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102416843|NCT03458455|Pembrolizumab|pembrolizumab|mesh-list
102416844|NCT03458455|Nivolumab|nivolumab|mesh-list
102416845|NCT03458455|Ipilimumab|ipilimumab|mesh-list
102416846|NCT03458455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102416847|NCT03458455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102416848|NCT03458455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102416849|NCT03458455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416850|NCT02536794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102416851|NCT02536794|Durvalumab|durvalumab|mesh-list
102416852|NCT02536794|Ipilimumab|ipilimumab|mesh-list
102416853|NCT02536794|Tremelimumab|tremelimumab|mesh-list
102416854|NCT02536794|Antibodies|antibodies|mesh-list
102416855|NCT02536794|Immunoglobulins|immunoglobulins|mesh-list
102416856|NCT02536794|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102416857|NCT02536794|Immunologic Factors|immunologic factors|mesh-ancestor
102416858|NCT02536794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416859|NCT02536794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102416860|NCT02536794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102416861|NCT02536794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416862|NCT00777855|Rifampin|rifampin|mesh-list
102416863|NCT00777855|Warfarin|warfarin|mesh-list
102416864|NCT00777855|Anticoagulants|anticoagulants|mesh-ancestor
102416865|NCT00777855|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102416866|NCT00777855|Antitubercular Agents|antitubercular agents|mesh-ancestor
102416867|NCT00777855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102416868|NCT00777855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102416869|NCT00777855|Leprostatic Agents|leprostatic agents|mesh-ancestor
102416870|NCT00777855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102416871|NCT00777855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102416872|NCT00777855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416873|NCT00777855|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102416874|NCT00777855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102416875|NCT00777855|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102416876|NCT00777855|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102416877|NCT00777855|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102416878|NCT00777855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102416879|NCT03523429|Blinatumomab|blinatumomab|mesh-list
102416880|NCT03523429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102416881|NCT05125380|Acetic Acid|acetic acid|mesh-list
102416882|NCT05125380|Retinol acetate|retinol acetate|mesh-list
102416883|NCT05125380|Lugol's solution|lugol's solution|mesh-list
102416884|NCT05125380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102416885|NCT05125380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102416886|NCT05125380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102416887|NCT05125380|Immunologic Factors|immunologic factors|mesh-ancestor
102416888|NCT05125380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416889|NCT05125380|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102416890|NCT05125380|Protective Agents|protective agents|mesh-ancestor
102416891|NCT05125380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102416892|NCT05125380|Hemostatics|hemostatics|mesh-ancestor
102416893|NCT05125380|Coagulants|coagulants|mesh-ancestor
102416894|NCT00762645|Travoprost|travoprost|mesh-list
102416895|NCT00762645|Pilocarpine|pilocarpine|mesh-list
102416896|NCT00762645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102416897|NCT00762645|Miotics|miotics|mesh-ancestor
102416898|NCT00762645|Autonomic Agents|autonomic agents|mesh-ancestor
102416899|NCT00762645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102416900|NCT00762645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416901|NCT00762645|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102416902|NCT00762645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102416903|NCT00762645|Cholinergic Agents|cholinergic agents|mesh-ancestor
102416904|NCT00762645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102416905|NCT00762645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416906|NCT02403193|Spartalizumab|spartalizumab|mesh-list
102416907|NCT02403193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102416908|NCT02403193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416909|NCT02403193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102416910|NCT02403193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102416911|NCT03807297|Dexmedetomidine|dexmedetomidine|mesh-list
102416912|NCT03807297|Nitrous Oxide|nitrous oxide|mesh-list
102416913|NCT03807297|Propofol|propofol|mesh-list
102416914|NCT03807297|Sevoflurane|sevoflurane|mesh-list
102416915|NCT03807297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102416916|NCT03807297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102416917|NCT03807297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416918|NCT03807297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102416919|NCT03807297|Analgesics|analgesics|mesh-ancestor
102416920|NCT03807297|Sensory System Agents|sensory system agents|mesh-ancestor
102416921|NCT03807297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102416922|NCT03807297|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102416923|NCT03807297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102416924|NCT03807297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102416925|NCT03807297|Adrenergic Agents|adrenergic agents|mesh-ancestor
102416926|NCT03807297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102416927|NCT03807297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416928|NCT03807297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102416929|NCT03807297|Anesthetics, General|anesthetics, general|mesh-ancestor
102416930|NCT03807297|Anesthetics|anesthetics|mesh-ancestor
102416931|NCT03807297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102416932|NCT03807297|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102416933|NCT03573349|Ketamine|ketamine|mesh-list
102416934|NCT03573349|Analgesics|analgesics|mesh-ancestor
102416935|NCT03573349|Sensory System Agents|sensory system agents|mesh-ancestor
102416936|NCT03573349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102416937|NCT03573349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416938|NCT03573349|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102416939|NCT03573349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102416940|NCT03573349|Anesthetics, General|anesthetics, general|mesh-ancestor
102416941|NCT03573349|Anesthetics|anesthetics|mesh-ancestor
102416942|NCT03573349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102416943|NCT03573349|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102416944|NCT03573349|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102416945|NCT03573349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102416946|NCT03573349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416947|NCT05387148|Cannabidiol|cannabidiol|mesh-list
102416948|NCT05387148|Anticonvulsants|anticonvulsants|mesh-ancestor
102416949|NCT03809637|Pemetrexed|pemetrexed|mesh-list
102416950|NCT03809637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102416951|NCT03809637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102416952|NCT03809637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416953|NCT03809637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102416954|NCT03809637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102416955|NCT03513445|Epinephrine|epinephrine|mesh-list
102416956|NCT03513445|Morphine|morphine|mesh-list
102416957|NCT03513445|Ropivacaine|ropivacaine|mesh-list
102416958|NCT03513445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102416959|NCT03513445|Narcotics|narcotics|mesh-ancestor
102416960|NCT03513445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102416961|NCT03513445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416962|NCT03513445|Analgesics|analgesics|mesh-ancestor
102416963|NCT03513445|Sensory System Agents|sensory system agents|mesh-ancestor
102416964|NCT03513445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102416965|NCT03513445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102416966|NCT03513445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102416967|NCT03513445|Adrenergic Agents|adrenergic agents|mesh-ancestor
102416968|NCT03513445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102416969|NCT03513445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416970|NCT03513445|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102416971|NCT03513445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102416972|NCT03513445|Autonomic Agents|autonomic agents|mesh-ancestor
102416973|NCT03513445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102416974|NCT03513445|Respiratory System Agents|respiratory system agents|mesh-ancestor
102416975|NCT03513445|Mydriatics|mydriatics|mesh-ancestor
102416976|NCT03513445|Sympathomimetics|sympathomimetics|mesh-ancestor
102416977|NCT03513445|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102416978|NCT03513445|Anesthetics, Local|anesthetics, local|mesh-ancestor
102416979|NCT03513445|Anesthetics|anesthetics|mesh-ancestor
102416980|NCT03802071|Doxorubicin|doxorubicin|mesh-list
102416981|NCT03802071|Durvalumab|durvalumab|mesh-list
102416982|NCT03802071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102416983|NCT03802071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102416984|NCT03802071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102416985|NCT03802071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102416986|NCT03802071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102416987|NCT03802071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416988|NCT03802071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102416989|NCT03809793|Acipimox|acipimox|mesh-list
102416990|NCT03809793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102416991|NCT03809793|Antimetabolites|antimetabolites|mesh-ancestor
102416992|NCT03809793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102416993|NCT03809793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102416994|NCT00758667|Mesna|mesna|mesh-list
102416995|NCT00758667|Protective Agents|protective agents|mesh-ancestor
102416996|NCT00758667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102416997|NCT05041920|Omeprazole|omeprazole|mesh-list
102416998|NCT05041920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102416999|NCT05041920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102417000|NCT05041920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102417001|NCT05041920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102417002|NCT05041920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417003|NCT03508921|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102417004|NCT03508921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102417005|NCT03508921|Trimethoprim|trimethoprim|mesh-list
102417006|NCT03508921|Sulfamethoxazole|sulfamethoxazole|mesh-list
102417007|NCT03508921|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102417008|NCT03508921|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102417009|NCT03508921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102417010|NCT03508921|Antitubercular Agents|antitubercular agents|mesh-ancestor
102417011|NCT03508921|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102417012|NCT03508921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102417013|NCT03508921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417014|NCT03508921|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102417015|NCT03508921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102417016|NCT03508921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417017|NCT03508921|Cholinergic Agents|cholinergic agents|mesh-ancestor
102417018|NCT03508921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102417019|NCT03508921|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102417020|NCT03508921|Antimalarials|antimalarials|mesh-ancestor
102417021|NCT03508921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102417022|NCT03508921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102417023|NCT03508921|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102417024|NCT03508921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102417025|NCT03508921|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102417026|NCT03508921|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102417027|NCT03508921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102417028|NCT03506113|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102417029|NCT03506113|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102417030|NCT03506113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102417031|NCT03506113|Antitubercular Agents|antitubercular agents|mesh-ancestor
102417032|NCT04412850|Magnesium Sulfate|magnesium sulfate|mesh-list
102417033|NCT04412850|Analgesics|analgesics|mesh-ancestor
102417034|NCT04412850|Sensory System Agents|sensory system agents|mesh-ancestor
102417035|NCT04412850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102417036|NCT04412850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417037|NCT04412850|Anesthetics|anesthetics|mesh-ancestor
102417038|NCT04412850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102417039|NCT04412850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102417040|NCT04412850|Anticonvulsants|anticonvulsants|mesh-ancestor
102417041|NCT04412850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102417042|NCT04412850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102417043|NCT04412850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417044|NCT04412850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102228670|NCT04501211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102417045|NCT04412850|Tocolytic Agents|tocolytic agents|mesh-ancestor
102417046|NCT04412850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102417047|NCT00778167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102417048|NCT00778167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102417049|NCT00778167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102417050|NCT00778167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102417051|NCT00778167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102417052|NCT00778167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417053|NCT00778167|Immunologic Factors|immunologic factors|mesh-ancestor
102417054|NCT00778167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417055|NCT00778869|Infliximab|infliximab|mesh-list
102417056|NCT00778869|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102417057|NCT00778869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102417058|NCT00778869|Dermatologic Agents|dermatologic agents|mesh-ancestor
102417059|NCT00778869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102417060|NCT00778869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102417061|NCT05008536|Fludarabine|fludarabine|mesh-list
102417062|NCT05008536|Cyclophosphamide|cyclophosphamide|mesh-list
102417063|NCT05008536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102417064|NCT05008536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417065|NCT05008536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102417066|NCT05008536|Immunologic Factors|immunologic factors|mesh-ancestor
102417067|NCT05008536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417068|NCT05008536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102417069|NCT05008536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102417070|NCT05008536|Alkylating Agents|alkylating agents|mesh-ancestor
102417071|NCT05008536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102417072|NCT04345419|Remdesivir|remdesivir|mesh-list
102417073|NCT04345419|Antimetabolites|antimetabolites|mesh-ancestor
102417074|NCT04345419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417075|NCT04345419|Antiviral Agents|antiviral agents|mesh-ancestor
102417076|NCT04345419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102417077|NCT01480076|4-Aminopyridine|4-aminopyridine|mesh-list
102417078|NCT01480076|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102417079|NCT01480076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102417080|NCT01480076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417081|NCT00759525|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
102417082|NCT00759525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102417083|NCT00759603|Rituximab|rituximab|mesh-list
102417084|NCT00759603|Lenalidomide|lenalidomide|mesh-list
102417085|NCT00759603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102417086|NCT00759603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102417087|NCT00759603|Immunologic Factors|immunologic factors|mesh-ancestor
102417088|NCT00759603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417089|NCT00759603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102417090|NCT00759603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102417091|NCT00759603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102417092|NCT00759603|Growth Substances|growth substances|mesh-ancestor
102417093|NCT00759603|Growth Inhibitors|growth inhibitors|mesh-ancestor
102417094|NCT03809325|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102417095|NCT03809325|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102417096|NCT03809325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102417097|NCT03809325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102417098|NCT03809325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417099|NCT03809325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102417100|NCT03809325|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102417101|NCT03809325|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102417102|NCT03809325|Serotonin Agents|serotonin agents|mesh-ancestor
102417103|NCT03809325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102417104|NCT03809325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417105|NCT03809325|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102417106|NCT03809325|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102417107|NCT03809325|Dopamine Agents|dopamine agents|mesh-ancestor
102417108|NCT03510390|Metformin|metformin|mesh-list
102417109|NCT03510390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102417110|NCT03510390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417111|NCT03806673|Bupivacaine|bupivacaine|mesh-list
102417112|NCT03806673|Anesthetics, Local|anesthetics, local|mesh-ancestor
102417113|NCT03806673|Anesthetics|anesthetics|mesh-ancestor
102417114|NCT03806673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102417115|NCT03806673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417116|NCT03806673|Sensory System Agents|sensory system agents|mesh-ancestor
102417117|NCT03806673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102417118|NCT03291990|Temozolomide|temozolomide|mesh-list
102417119|NCT03291990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102417120|NCT03291990|Alkylating Agents|alkylating agents|mesh-ancestor
102417121|NCT03291990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417122|NCT03291990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102417123|NCT03806595|Lidocaine|lidocaine|mesh-list
102417124|NCT03806595|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102417125|NCT03806595|Anesthetics, Local|anesthetics, local|mesh-ancestor
102417126|NCT03806595|Anesthetics|anesthetics|mesh-ancestor
102417127|NCT03806595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102417128|NCT03806595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417129|NCT03806595|Sensory System Agents|sensory system agents|mesh-ancestor
102417130|NCT03806595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102417131|NCT03806595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102417132|NCT03806595|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102417133|NCT03806595|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102417134|NCT03806595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102417135|NCT03806595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417136|NCT03807999|Paclitaxel|paclitaxel|mesh-list
102417137|NCT03807999|Gemcitabine|gemcitabine|mesh-list
102417138|NCT03807999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102417139|NCT03807999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102417140|NCT03807999|Tubulin Modulators|tubulin modulators|mesh-ancestor
102417141|NCT03807999|Antimitotic Agents|antimitotic agents|mesh-ancestor
102417142|NCT03807999|Mitosis Modulators|mitosis modulators|mesh-ancestor
102417143|NCT03807999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417144|NCT03807999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102417145|NCT03807999|Antimetabolites|antimetabolites|mesh-ancestor
102417146|NCT04762147|Acetaminophen|acetaminophen|mesh-list
102417147|NCT04762147|Fentanyl|fentanyl|mesh-list
102417148|NCT04762147|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102417149|NCT04762147|Narcotics|narcotics|mesh-ancestor
102417150|NCT04762147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102417151|NCT04762147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417152|NCT04762147|Analgesics|analgesics|mesh-ancestor
102417153|NCT04762147|Sensory System Agents|sensory system agents|mesh-ancestor
102417154|NCT04762147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102417155|NCT04762147|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102417156|NCT04762147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102417157|NCT04762147|Anesthetics, General|anesthetics, general|mesh-ancestor
102417158|NCT04762147|Anesthetics|anesthetics|mesh-ancestor
102417159|NCT04762147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102417160|NCT04762147|Antipyretics|antipyretics|mesh-ancestor
102417161|NCT04273737|Amantadine|amantadine|mesh-list
102417162|NCT04273737|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102417163|NCT04273737|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102417164|NCT04273737|Antiviral Agents|antiviral agents|mesh-ancestor
102417165|NCT04273737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102417166|NCT04273737|Dopamine Agents|dopamine agents|mesh-ancestor
102417167|NCT04273737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102417168|NCT04273737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417169|NCT04273737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417170|NCT04273737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102417171|NCT04273737|Analgesics|analgesics|mesh-ancestor
102417172|NCT04273737|Sensory System Agents|sensory system agents|mesh-ancestor
102417173|NCT04273737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102417174|NCT02963064|Antibodies|antibodies|mesh-list
102417175|NCT02963064|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102417176|NCT02963064|Immunologic Factors|immunologic factors|mesh-ancestor
102417177|NCT02963064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417178|NCT04183062|Gemcitabine|gemcitabine|mesh-list
102417179|NCT04183062|Docetaxel|docetaxel|mesh-list
102417180|NCT04183062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102417181|NCT04183062|Antimetabolites|antimetabolites|mesh-ancestor
102417182|NCT04183062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417183|NCT04183062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102417184|NCT04183062|Tubulin Modulators|tubulin modulators|mesh-ancestor
102417185|NCT04183062|Antimitotic Agents|antimitotic agents|mesh-ancestor
102417186|NCT04183062|Mitosis Modulators|mitosis modulators|mesh-ancestor
102417187|NCT04325880|Tamsulosin|tamsulosin|mesh-list
102417188|NCT04325880|Solifenacin Succinate|solifenacin succinate|mesh-list
102417189|NCT04325880|Mirabegron|mirabegron|mesh-list
102417190|NCT04325880|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102417191|NCT04325880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102417192|NCT04325880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102417193|NCT04325880|Adrenergic Agents|adrenergic agents|mesh-ancestor
102417194|NCT04325880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102417195|NCT04325880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047836|NCT04700007|Diphenhydramine|diphenhydramine|mesh-list
102417196|NCT04325880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417197|NCT04325880|Urological Agents|urological agents|mesh-ancestor
102417198|NCT04325880|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102417199|NCT04325880|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102417200|NCT04325880|Cholinergic Agents|cholinergic agents|mesh-ancestor
102417201|NCT04325880|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102417202|NCT04325880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102417203|NCT04325880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102417204|NCT04846218|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102417205|NCT04846218|Progesterone|progesterone|mesh-list
102417206|NCT04846218|Progestins|progestins|mesh-ancestor
102417207|NCT04846218|Hormones|hormones|mesh-ancestor
102417208|NCT04846218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102417209|NCT04846218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417210|NCT04846218|Luteolytic Agents|luteolytic agents|mesh-ancestor
102417211|NCT04846218|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102417212|NCT04846218|Contraceptive Agents|contraceptive agents|mesh-ancestor
102417213|NCT04846218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102417214|NCT04846218|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102417215|NCT04846218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102417216|NCT04846218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102417217|NCT04152486|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
102417218|NCT04152486|Antiviral Agents|antiviral agents|mesh-ancestor
102417219|NCT04152486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102417220|NCT02512692|Gemcitabine|gemcitabine|mesh-list
102417221|NCT02512692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102417222|NCT02512692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102417223|NCT02512692|Antimetabolites|antimetabolites|mesh-ancestor
102417224|NCT02512692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417225|NCT01594398|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102417226|NCT01594398|Exemestane|exemestane|mesh-list
102417227|NCT01594398|Entinostat|entinostat|mesh-list
102417228|NCT01594398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102417229|NCT01594398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102417230|NCT01594398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102417231|NCT01594398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417232|NCT01594398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102417233|NCT01594398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102417234|NCT01594398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102417235|NCT01594398|Hormone Antagonists|hormone antagonists|mesh-ancestor
102417236|NCT01594398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102417237|NCT01594398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417238|NCT01594398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102417239|NCT00782379|Mycophenolic Acid|mycophenolic acid|mesh-list
102417240|NCT00782379|Cyclophosphamide|cyclophosphamide|mesh-list
102417241|NCT00782379|Busulfan|busulfan|mesh-list
102417242|NCT00782379|Fludarabine|fludarabine|mesh-list
102417243|NCT00782379|Fludarabine phosphate|fludarabine phosphate|mesh-list
102417244|NCT00782379|Tacrolimus|tacrolimus|mesh-list
102417245|NCT00782379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102417246|NCT00782379|Immunologic Factors|immunologic factors|mesh-ancestor
102417247|NCT00782379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417248|NCT00782379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102417249|NCT00782379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102417250|NCT00782379|Alkylating Agents|alkylating agents|mesh-ancestor
102417251|NCT00782379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417252|NCT00782379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102417253|NCT00782379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102417254|NCT00782379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102417255|NCT00782379|Antimetabolites|antimetabolites|mesh-ancestor
102417256|NCT00782379|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102417257|NCT00782379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102417258|NCT00782379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102417259|NCT00782379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102417260|NCT00782379|Antitubercular Agents|antitubercular agents|mesh-ancestor
102417261|NCT00782379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102047901|NCT03137303|Tocolytic Agents|tocolytic agents|mesh-ancestor
102417262|NCT00782379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102417263|NCT04572828|Naproxen|naproxen|mesh-list
102417264|NCT04572828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102417265|NCT04572828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102417266|NCT04572828|Analgesics|analgesics|mesh-ancestor
102417267|NCT04572828|Sensory System Agents|sensory system agents|mesh-ancestor
102417268|NCT04572828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102417269|NCT04572828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417270|NCT04572828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102417272|NCT04572828|Gout Suppressants|gout suppressants|mesh-ancestor
102417273|NCT04572828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102417274|NCT04572828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102417275|NCT04572828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417276|NCT05134350|Omeprazole|omeprazole|mesh-list
102417277|NCT05134350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102417278|NCT05134350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102417279|NCT05134350|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102417280|NCT05134350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102417281|NCT05134350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417282|NCT05134194|Gemcitabine|gemcitabine|mesh-list
102417283|NCT05134194|Capecitabine|capecitabine|mesh-list
102417284|NCT05134194|Vinorelbine|vinorelbine|mesh-list
102417285|NCT05134194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102417286|NCT05134194|Antimetabolites|antimetabolites|mesh-ancestor
102417287|NCT05134194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417288|NCT05134194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102417289|NCT05134194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102417290|NCT05134194|Tubulin Modulators|tubulin modulators|mesh-ancestor
102417291|NCT05134194|Antimitotic Agents|antimitotic agents|mesh-ancestor
102417292|NCT05134194|Mitosis Modulators|mitosis modulators|mesh-ancestor
102417293|NCT00761085|Morphine|morphine|mesh-list
102417294|NCT00761085|Methadone|methadone|mesh-list
102417295|NCT00761085|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102417296|NCT00761085|Narcotics|narcotics|mesh-ancestor
102417297|NCT00761085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102417298|NCT00761085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417299|NCT00761085|Analgesics|analgesics|mesh-ancestor
102417300|NCT00761085|Sensory System Agents|sensory system agents|mesh-ancestor
102417301|NCT00761085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102417302|NCT00761085|Antitussive Agents|antitussive agents|mesh-ancestor
102417303|NCT00761085|Respiratory System Agents|respiratory system agents|mesh-ancestor
102417304|NCT02145039|Cyclophosphamide|cyclophosphamide|mesh-list
102417305|NCT02145039|Fludarabine|fludarabine|mesh-list
102417306|NCT02145039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102417307|NCT02145039|Immunologic Factors|immunologic factors|mesh-ancestor
102417308|NCT02145039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417309|NCT02145039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102417310|NCT02145039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102417311|NCT02145039|Alkylating Agents|alkylating agents|mesh-ancestor
102417312|NCT02145039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417313|NCT02145039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102417314|NCT02145039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102417315|NCT03806049|Paclitaxel|paclitaxel|mesh-list
102417316|NCT03806049|Bevacizumab|bevacizumab|mesh-list
102417317|NCT03806049|Carboplatin|carboplatin|mesh-list
102417318|NCT03806049|Niraparib|niraparib|mesh-list
102417319|NCT03806049|Dostarlimab|dostarlimab|mesh-list
102417320|NCT03806049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102417321|NCT03806049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102417322|NCT03806049|Tubulin Modulators|tubulin modulators|mesh-ancestor
102417323|NCT03806049|Antimitotic Agents|antimitotic agents|mesh-ancestor
102417324|NCT03806049|Mitosis Modulators|mitosis modulators|mesh-ancestor
102417325|NCT03806049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417326|NCT03806049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102417327|NCT03806049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102417328|NCT03806049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102417329|NCT03806049|Growth Substances|growth substances|mesh-ancestor
102417330|NCT03806049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417331|NCT03806049|Growth Inhibitors|growth inhibitors|mesh-ancestor
102417332|NCT03806049|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102417333|NCT03806049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102417334|NCT00089479|Capecitabine|capecitabine|mesh-list
102417335|NCT00089479|Docetaxel|docetaxel|mesh-list
102417336|NCT00089479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102417337|NCT00089479|Antimetabolites|antimetabolites|mesh-ancestor
102417338|NCT00089479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417339|NCT00089479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102417340|NCT00089479|Tubulin Modulators|tubulin modulators|mesh-ancestor
102417341|NCT00089479|Antimitotic Agents|antimitotic agents|mesh-ancestor
102417342|NCT00089479|Mitosis Modulators|mitosis modulators|mesh-ancestor
102417343|NCT01463306|Pregabalin|pregabalin|mesh-list
102417344|NCT01463306|Analgesics|analgesics|mesh-ancestor
102417345|NCT01463306|Sensory System Agents|sensory system agents|mesh-ancestor
102417346|NCT01463306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102417347|NCT01463306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417348|NCT01463306|Anticonvulsants|anticonvulsants|mesh-ancestor
102417349|NCT01463306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102417350|NCT01463306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102417351|NCT01463306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417352|NCT01463306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102417353|NCT01463306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102417354|NCT01463306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102417355|NCT01463306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102417356|NCT01463306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102417357|NCT05055726|Benzydamine|benzydamine|mesh-list
102417358|NCT05055726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102417359|NCT00765375|Botulinum Toxins|botulinum toxins|mesh-list
102417360|NCT00765375|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102417361|NCT00765375|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102417362|NCT00765375|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102417363|NCT00765375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102417364|NCT00765375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417365|NCT00765375|Cholinergic Agents|cholinergic agents|mesh-ancestor
102417366|NCT00765375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102417367|NCT00765375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417368|NCT00765375|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102417369|NCT00765375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102417370|NCT03451591|Cilostazol|cilostazol|mesh-list
102417371|NCT03451591|Isosorbide|isosorbide|mesh-list
102417372|NCT03451591|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
102417373|NCT03451591|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
102417374|NCT03451591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102417375|NCT03451591|Autonomic Agents|autonomic agents|mesh-ancestor
102417376|NCT03451591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102417377|NCT03451591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417378|NCT03451591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102417379|NCT03451591|Respiratory System Agents|respiratory system agents|mesh-ancestor
102417380|NCT03451591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102417381|NCT03451591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102417382|NCT03451591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417383|NCT03451591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102417384|NCT03451591|Vasodilator Agents|vasodilator agents|mesh-ancestor
102417385|NCT03451591|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102417386|NCT03451591|Protective Agents|protective agents|mesh-ancestor
102417387|NCT03451591|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102417388|NCT03451591|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102417389|NCT03451591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102417390|NCT03451591|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102417391|NCT03451591|Diuretics|diuretics|mesh-ancestor
102417392|NCT03451591|Natriuretic Agents|natriuretic agents|mesh-ancestor
102417393|NCT03451591|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102417394|NCT05744115|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102417395|NCT05744115|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102417396|NCT05744115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417397|NCT01677559|Paclitaxel|paclitaxel|mesh-list
102417398|NCT01677559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102417399|NCT01677559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102417400|NCT01677559|Tubulin Modulators|tubulin modulators|mesh-ancestor
102417401|NCT01677559|Antimitotic Agents|antimitotic agents|mesh-ancestor
102417402|NCT01677559|Mitosis Modulators|mitosis modulators|mesh-ancestor
102417403|NCT01677559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417404|NCT05132712|Losartan|losartan|mesh-list
102417405|NCT05132712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102417406|NCT05132712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102417407|NCT05132712|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102417408|NCT05132712|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102417409|NCT05132712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417410|NCT02149173|Deoxyglucose|deoxyglucose|mesh-list
102417411|NCT02149173|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102417412|NCT02149173|Fluorides|fluorides|mesh-list
102417413|NCT02149173|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102417414|NCT02149173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417415|NCT02149173|Cariostatic Agents|cariostatic agents|mesh-ancestor
102417416|NCT02149173|Protective Agents|protective agents|mesh-ancestor
102417417|NCT02149173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417418|NCT02149173|Antimetabolites|antimetabolites|mesh-ancestor
102417419|NCT02149173|Antiviral Agents|antiviral agents|mesh-ancestor
102417420|NCT02149173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102417421|NCT04789434|Tislelizumab|tislelizumab|mesh-list
102417422|NCT04789434|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102417423|NCT04789434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102417424|NCT04789434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102417425|NCT04789434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417426|NCT03805503|Chloroprocaine|chloroprocaine|mesh-list
102417427|NCT03805503|Procaine|procaine|mesh-list
102417428|NCT03805503|Anesthetics, Local|anesthetics, local|mesh-ancestor
102417429|NCT03805503|Anesthetics|anesthetics|mesh-ancestor
102417430|NCT03805503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102417431|NCT03805503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417432|NCT03805503|Sensory System Agents|sensory system agents|mesh-ancestor
102417433|NCT03805503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102417434|NCT01504412|Pregabalin|pregabalin|mesh-list
102417435|NCT01504412|Analgesics|analgesics|mesh-ancestor
102417436|NCT01504412|Sensory System Agents|sensory system agents|mesh-ancestor
102417437|NCT01504412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102417438|NCT01504412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417439|NCT01504412|Anticonvulsants|anticonvulsants|mesh-ancestor
102417440|NCT01504412|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102417441|NCT01504412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102417442|NCT01504412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417443|NCT01504412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102417444|NCT01504412|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102417445|NCT01504412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102417446|NCT01504412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102417447|NCT01504412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102417448|NCT04702464|Fluconazole|fluconazole|mesh-list
102417449|NCT04702464|Antifungal Agents|antifungal agents|mesh-ancestor
102417450|NCT04702464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102417451|NCT04702464|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102417452|NCT04702464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102417453|NCT04702464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102048100|NCT02075528|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102417454|NCT04702464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417455|NCT04702464|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102417456|NCT04702464|Hormone Antagonists|hormone antagonists|mesh-ancestor
102417457|NCT04702464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102417458|NCT04702464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417459|NCT04702464|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102417460|NCT04702464|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102417461|NCT00088465|Olanzapine|olanzapine|mesh-list
102417462|NCT00088465|Antiemetics|antiemetics|mesh-ancestor
102417463|NCT00088465|Autonomic Agents|autonomic agents|mesh-ancestor
102417464|NCT00088465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102417465|NCT00088465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417466|NCT00088465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102417467|NCT00088465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102417468|NCT00088465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102417469|NCT00088465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102417470|NCT00088465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102417471|NCT00088465|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102417472|NCT00088465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102417473|NCT00088465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102417474|NCT00088465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417475|NCT00088465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102417476|NCT00088465|Serotonin Agents|serotonin agents|mesh-ancestor
102417477|NCT04405674|Paclitaxel|paclitaxel|mesh-list
102417478|NCT04405674|Bevacizumab|bevacizumab|mesh-list
102417479|NCT04405674|Carboplatin|carboplatin|mesh-list
102417480|NCT04405674|Pemetrexed|pemetrexed|mesh-list
102417481|NCT04405674|Tislelizumab|tislelizumab|mesh-list
102417482|NCT04405674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102417483|NCT04405674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102417484|NCT04405674|Tubulin Modulators|tubulin modulators|mesh-ancestor
102417485|NCT04405674|Antimitotic Agents|antimitotic agents|mesh-ancestor
102417486|NCT04405674|Mitosis Modulators|mitosis modulators|mesh-ancestor
102417487|NCT04405674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417488|NCT04405674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102417489|NCT04405674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102417490|NCT04405674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102417491|NCT04405674|Growth Substances|growth substances|mesh-ancestor
102417492|NCT04405674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417494|NCT04405674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102417495|NCT04405674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102417496|NCT04405674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102417497|NCT00088153|Progesterone|progesterone|mesh-list
102417498|NCT00088153|Estrogens|estrogens|mesh-list
102417499|NCT00088153|Progestins|progestins|mesh-ancestor
102417500|NCT00088153|Hormones|hormones|mesh-ancestor
102417501|NCT00088153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102417502|NCT00088153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417503|NCT02074358|Apixaban|apixaban|mesh-list
102417504|NCT02074358|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102417505|NCT02074358|Antithrombins|antithrombins|mesh-ancestor
102417506|NCT02074358|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102417507|NCT02074358|Protease Inhibitors|protease inhibitors|mesh-ancestor
102417508|NCT02074358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102417509|NCT02074358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417510|NCT02074358|Anticoagulants|anticoagulants|mesh-ancestor
102417511|NCT05743725|Magnesium Sulfate|magnesium sulfate|mesh-list
102417512|NCT05743725|Dexmedetomidine|dexmedetomidine|mesh-list
102417513|NCT05743725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102417514|NCT05743725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102417515|NCT05743725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417516|NCT05743725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102417517|NCT05743725|Analgesics|analgesics|mesh-ancestor
102417518|NCT05743725|Sensory System Agents|sensory system agents|mesh-ancestor
102417519|NCT05743725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102417520|NCT05743725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102417521|NCT05743725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102417522|NCT05743725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102417523|NCT05743725|Adrenergic Agents|adrenergic agents|mesh-ancestor
102417524|NCT05743725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102417525|NCT05743725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417526|NCT05743725|Anesthetics|anesthetics|mesh-ancestor
102417527|NCT05743725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102417528|NCT05743725|Anticonvulsants|anticonvulsants|mesh-ancestor
102417529|NCT05743725|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102417530|NCT05743725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102417531|NCT05743725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102417532|NCT05743725|Tocolytic Agents|tocolytic agents|mesh-ancestor
102417533|NCT05743725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102417534|NCT05547321|Pembrolizumab|pembrolizumab|mesh-list
102417535|NCT05547321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102417536|NCT05547321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102417537|NCT05547321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102417538|NCT05547321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417539|NCT04912518|Dexmedetomidine|dexmedetomidine|mesh-list
102417540|NCT04912518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102417541|NCT04912518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102417542|NCT04912518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417543|NCT04912518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102417544|NCT04912518|Analgesics|analgesics|mesh-ancestor
102417545|NCT04912518|Sensory System Agents|sensory system agents|mesh-ancestor
102417546|NCT04912518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102417547|NCT04912518|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102417548|NCT04912518|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102417549|NCT04912518|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102417550|NCT04912518|Adrenergic Agents|adrenergic agents|mesh-ancestor
102417551|NCT04912518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102417552|NCT04912518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417553|NCT00087685|Everolimus|everolimus|mesh-list
102417554|NCT00087685|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102417555|NCT00087685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102417556|NCT00087685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102417557|NCT00087685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417558|NCT00087685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102417559|NCT00087685|Immunologic Factors|immunologic factors|mesh-ancestor
102417560|NCT00087685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417561|NCT00087685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102417562|NCT04094558|Lactulose|lactulose|mesh-list
102417563|NCT04094558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102417564|NCT01502228|Sunitinib|sunitinib|mesh-list
102417565|NCT01502228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102229199|NCT03375515|Hydromorphone|hydromorphone|mesh-list
102417566|NCT01502228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102417567|NCT01502228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102417568|NCT01502228|Growth Substances|growth substances|mesh-ancestor
102417569|NCT01502228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417570|NCT01502228|Growth Inhibitors|growth inhibitors|mesh-ancestor
102417571|NCT01502228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102417572|NCT01502228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102417573|NCT01502228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417574|NCT05011812|Ritonavir|ritonavir|mesh-list
102417575|NCT05011812|Midazolam|midazolam|mesh-list
102417576|NCT05011812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102417577|NCT05011812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102417578|NCT05011812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102417579|NCT05011812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417580|NCT05011812|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102417581|NCT05011812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102417582|NCT05011812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102417583|NCT05011812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102417584|NCT05011812|Anesthetics, General|anesthetics, general|mesh-ancestor
102417585|NCT05011812|Anesthetics|anesthetics|mesh-ancestor
102417586|NCT05011812|GABA Modulators|gaba modulators|mesh-ancestor
102417587|NCT05011812|GABA Agents|gaba agents|mesh-ancestor
102417588|NCT05011812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102417589|NCT05011812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417590|NCT05011812|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102417591|NCT05011812|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102417592|NCT05011812|Protease Inhibitors|protease inhibitors|mesh-ancestor
102417593|NCT05011812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102417594|NCT05011812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102417595|NCT05011812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102417596|NCT05011812|Antiviral Agents|antiviral agents|mesh-ancestor
102417597|NCT05011812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102417598|NCT05011812|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102417599|NCT05011812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102417600|NCT05535231|Curcumin|curcumin|mesh-list
102417601|NCT05535231|Turmeric extract|turmeric extract|mesh-list
102417602|NCT05535231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102417603|NCT05535231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102417604|NCT05535231|Analgesics|analgesics|mesh-ancestor
102417605|NCT05535231|Sensory System Agents|sensory system agents|mesh-ancestor
102417606|NCT05535231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102417607|NCT05535231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417608|NCT05535231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102417609|NCT05535231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102417610|NCT05535231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102417611|NCT05535231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102417612|NCT05535231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417613|NCT05535231|Antioxidants|antioxidants|mesh-ancestor
102417614|NCT05535231|Protective Agents|protective agents|mesh-ancestor
102417615|NCT01502072|Ribavirin|ribavirin|mesh-list
102417616|NCT01502072|Antimetabolites|antimetabolites|mesh-ancestor
102417617|NCT01502072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417618|NCT01502072|Antiviral Agents|antiviral agents|mesh-ancestor
102417619|NCT01502072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102417620|NCT01462370|Acetaminophen|acetaminophen|mesh-list
102417621|NCT01462370|Ibuprofen|ibuprofen|mesh-list
102417622|NCT01462370|Etoricoxib|etoricoxib|mesh-list
102417623|NCT01462370|Caffeine|caffeine|mesh-list
102417624|NCT01462370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102417625|NCT01462370|Analgesics|analgesics|mesh-ancestor
102417626|NCT01462370|Sensory System Agents|sensory system agents|mesh-ancestor
102417627|NCT01462370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102417628|NCT01462370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417629|NCT01462370|Antipyretics|antipyretics|mesh-ancestor
102417630|NCT01462370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102417631|NCT01462370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102417632|NCT01462370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102417633|NCT01462370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102417634|NCT01462370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102417635|NCT01462370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417636|NCT01462370|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102417637|NCT01462370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102417638|NCT01462370|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102417639|NCT01462370|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102417640|NCT01462370|Purinergic Agents|purinergic agents|mesh-ancestor
102229271|NCT02520505|Fertility Agents|fertility agents|mesh-ancestor
102417641|NCT01462370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102417642|NCT01462370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102417643|NCT05743179|Zoledronic Acid|zoledronic acid|mesh-list
102417644|NCT05743179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102417645|NCT05743179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417646|NCT01479764|Glycopyrrolate|glycopyrrolate|mesh-list
102417647|NCT01479764|Neostigmine|neostigmine|mesh-list
102417648|NCT01479764|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102417649|NCT01479764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102417650|NCT01479764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417651|NCT01479764|Cholinergic Agents|cholinergic agents|mesh-ancestor
102417652|NCT01479764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102417653|NCT01479764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417654|NCT01479764|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102417655|NCT01479764|Autonomic Agents|autonomic agents|mesh-ancestor
102417656|NCT01479764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102417657|NCT01479764|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102417658|NCT01479764|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102417659|NCT01479764|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102417660|NCT01479530|Rasagiline|rasagiline|mesh-list
102417661|NCT01479530|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102417662|NCT01479530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102417663|NCT01479530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417664|NCT01479530|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102417665|NCT01479530|Protective Agents|protective agents|mesh-ancestor
102417666|NCT01479530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417667|NCT01479374|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
102048309|NCT02079506|Candesartan|candesartan|mesh-list
102417668|NCT01479374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102417669|NCT01479374|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102417670|NCT01479374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102417671|NCT01479374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102417672|NCT01479374|Analgesics|analgesics|mesh-ancestor
102417673|NCT01479374|Sensory System Agents|sensory system agents|mesh-ancestor
102417674|NCT01479374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102417675|NCT01479374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417676|NCT01479374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102417677|NCT01479374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102417678|NCT01479374|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102417679|NCT01479374|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102417680|NCT01479374|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102417681|NCT01479374|Histamine Antagonists|histamine antagonists|mesh-ancestor
102417682|NCT01479374|Histamine Agents|histamine agents|mesh-ancestor
102417683|NCT01479374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102417684|NCT01479374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417685|NCT00087529|Rituximab|rituximab|mesh-list
102417686|NCT00087529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102417687|NCT00087529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102417688|NCT00087529|Immunologic Factors|immunologic factors|mesh-ancestor
102417689|NCT00087529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417690|NCT00087529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102417691|NCT00794313|Topiramate|topiramate|mesh-list
102417692|NCT00794313|Amantadine|amantadine|mesh-list
102417693|NCT00794313|Anticonvulsants|anticonvulsants|mesh-ancestor
102417694|NCT00794313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102417695|NCT00794313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417696|NCT00794313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102417697|NCT00794313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102417698|NCT00794313|Antiviral Agents|antiviral agents|mesh-ancestor
102417699|NCT00794313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102417700|NCT00794313|Dopamine Agents|dopamine agents|mesh-ancestor
102417701|NCT00794313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102417702|NCT00794313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417703|NCT00794313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102417704|NCT00794313|Analgesics|analgesics|mesh-ancestor
102417705|NCT00794313|Sensory System Agents|sensory system agents|mesh-ancestor
102417706|NCT00794313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102417707|NCT05743101|Levofloxacin|levofloxacin|mesh-list
102417708|NCT05743101|Ofloxacin|ofloxacin|mesh-list
102417709|NCT05743101|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102417710|NCT05743101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102417711|NCT05743101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102417712|NCT05743101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102417713|NCT05743101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102417714|NCT05743101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102417715|NCT05743101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417716|NCT05743101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102417717|NCT05743101|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102417718|NCT05743101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102417719|NCT01500434|Aspirin|aspirin|mesh-list
102417720|NCT01500434|Ticlopidine|ticlopidine|mesh-list
102417721|NCT01500434|Clopidogrel|clopidogrel|mesh-list
102417722|NCT01500434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102417723|NCT01500434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102417724|NCT01500434|Analgesics|analgesics|mesh-ancestor
102417725|NCT01500434|Sensory System Agents|sensory system agents|mesh-ancestor
102417726|NCT01500434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102417727|NCT01500434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417728|NCT01500434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102417729|NCT01500434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102417730|NCT01500434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102417731|NCT01500434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102417732|NCT01500434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417733|NCT01500434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102417734|NCT01500434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102417735|NCT01500434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102417736|NCT01500434|Antipyretics|antipyretics|mesh-ancestor
102417737|NCT01500434|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102417738|NCT01500434|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102417739|NCT01500434|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102417740|NCT01500434|Purinergic Agents|purinergic agents|mesh-ancestor
102417741|NCT01500434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102417742|NCT01500434|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102417743|NCT01500434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102417744|NCT00087139|Epothilones|epothilones|mesh-list
102417745|NCT00087139|Epothilone B|epothilone b|mesh-list
102417746|NCT00087139|Tubulin Modulators|tubulin modulators|mesh-ancestor
102417747|NCT00087139|Antimitotic Agents|antimitotic agents|mesh-ancestor
102417748|NCT00087139|Mitosis Modulators|mitosis modulators|mesh-ancestor
102417749|NCT00087139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417750|NCT00087139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102417751|NCT00794547|Calcitriol|calcitriol|mesh-list
102417752|NCT00794547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102417753|NCT00794547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417754|NCT00794547|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102417755|NCT00794547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102417756|NCT00794547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417757|NCT00794547|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102417758|NCT00794547|Vitamins|vitamins|mesh-ancestor
102417759|NCT00794547|Micronutrients|micronutrients|mesh-ancestor
102417760|NCT00794547|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102417761|NCT03493165|Everolimus|everolimus|mesh-list
102417762|NCT03493165|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102417763|NCT03493165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102417764|NCT03493165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102417765|NCT03493165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417766|NCT03493165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102417767|NCT03493165|Immunologic Factors|immunologic factors|mesh-ancestor
102417768|NCT03493165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417769|NCT03493165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102417770|NCT00786825|Somatostatin|somatostatin|mesh-list
102417771|NCT00786825|Hormones|hormones|mesh-ancestor
102417772|NCT00786825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102417773|NCT00786825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417774|NCT00768261|Memantine|memantine|mesh-list
102417775|NCT00768261|Donepezil|donepezil|mesh-list
102417776|NCT00768261|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102417777|NCT00768261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102417778|NCT00768261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417779|NCT00768261|Cholinergic Agents|cholinergic agents|mesh-ancestor
102417780|NCT00768261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102417781|NCT00768261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417782|NCT00768261|Nootropic Agents|nootropic agents|mesh-ancestor
102417783|NCT00768261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102417784|NCT00768261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102417785|NCT00768261|Dopamine Agents|dopamine agents|mesh-ancestor
102417786|NCT00768261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102417787|NCT00768261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102417788|NCT03804723|Prednisone|prednisone|mesh-list
102417789|NCT03804723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102417790|NCT03804723|Glucocorticoids|glucocorticoids|mesh-ancestor
102417791|NCT03804723|Hormones|hormones|mesh-ancestor
102417792|NCT03804723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102417793|NCT03804723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417794|NCT03804723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102417795|NCT03804723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102417796|NCT00797277|Lorazepam|lorazepam|mesh-list
102417797|NCT00797277|Haloperidol|haloperidol|mesh-list
102417798|NCT00797277|Olanzapine|olanzapine|mesh-list
102417799|NCT00797277|Haloperidol decanoate|haloperidol decanoate|mesh-list
102417800|NCT00797277|Antiemetics|antiemetics|mesh-ancestor
102417801|NCT00797277|Autonomic Agents|autonomic agents|mesh-ancestor
102417802|NCT00797277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102417803|NCT00797277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417804|NCT00797277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102417805|NCT00797277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102417806|NCT00797277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102417807|NCT00797277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102417808|NCT00797277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102417809|NCT00797277|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102417810|NCT00797277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102417811|NCT00797277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102417812|NCT00797277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417813|NCT00797277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102417814|NCT00797277|Serotonin Agents|serotonin agents|mesh-ancestor
102417815|NCT00797277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102417816|NCT00797277|Dopamine Agents|dopamine agents|mesh-ancestor
102417817|NCT00797277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102417818|NCT00797277|Anticonvulsants|anticonvulsants|mesh-ancestor
102417819|NCT00797277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102417820|NCT00797277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102417821|NCT00797277|GABA Modulators|gaba modulators|mesh-ancestor
102417822|NCT00797277|GABA Agents|gaba agents|mesh-ancestor
102417823|NCT03837015|Estradiol|estradiol|mesh-list
102417824|NCT03837015|Estrogens|estrogens|mesh-ancestor
102417825|NCT03837015|Hormones|hormones|mesh-ancestor
102417826|NCT03837015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102417827|NCT03837015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417828|NCT01500278|Adalimumab|adalimumab|mesh-list
102417829|NCT01500278|Certolizumab Pegol|certolizumab pegol|mesh-list
102417830|NCT01500278|Methotrexate|methotrexate|mesh-list
102417831|NCT01500278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102417832|NCT01500278|Abortifacient Agents|abortifacient agents|mesh-ancestor
102417833|NCT01500278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102417834|NCT01500278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417835|NCT01500278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102417836|NCT01500278|Antimetabolites|antimetabolites|mesh-ancestor
102417837|NCT01500278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417838|NCT01500278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102417839|NCT01500278|Dermatologic Agents|dermatologic agents|mesh-ancestor
102417840|NCT01500278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102417841|NCT01500278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102417842|NCT01500278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102417843|NCT01500278|Immunologic Factors|immunologic factors|mesh-ancestor
102417844|NCT01500278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102417845|NCT01500278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102417846|NCT01500278|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102417847|NCT01500278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102417848|NCT00086281|Zolpidem|zolpidem|mesh-list
102417849|NCT00086281|Modafinil|modafinil|mesh-list
102417850|NCT00086281|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102417851|NCT00086281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417852|NCT00086281|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102417853|NCT00086281|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102417854|NCT00086281|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102417855|NCT00086281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417856|NCT00086281|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102417857|NCT00086281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102417858|NCT00086281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102417859|NCT00086281|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102417860|NCT00086281|GABA Agonists|gaba agonists|mesh-ancestor
102417861|NCT00086281|GABA Agents|gaba agents|mesh-ancestor
102417862|NCT00086281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102417863|NCT00787761|Cyclophosphamide|cyclophosphamide|mesh-list
102417864|NCT00787761|Busulfan|busulfan|mesh-list
102417865|NCT00787761|Methotrexate|methotrexate|mesh-list
102417866|NCT00787761|Fludarabine|fludarabine|mesh-list
102417867|NCT00787761|Fludarabine phosphate|fludarabine phosphate|mesh-list
102417868|NCT00787761|Tacrolimus|tacrolimus|mesh-list
102417869|NCT00787761|Thymoglobulin|thymoglobulin|mesh-list
102417870|NCT00787761|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102417871|NCT00787761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102417872|NCT00787761|Immunologic Factors|immunologic factors|mesh-ancestor
102417873|NCT00787761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417874|NCT00787761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102417875|NCT00787761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102417876|NCT00787761|Alkylating Agents|alkylating agents|mesh-ancestor
102417877|NCT00787761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417878|NCT00787761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102417879|NCT00787761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102417880|NCT00787761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102417881|NCT00787761|Abortifacient Agents|abortifacient agents|mesh-ancestor
102417882|NCT00787761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102417883|NCT00787761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102417884|NCT00787761|Antimetabolites|antimetabolites|mesh-ancestor
102417885|NCT00787761|Dermatologic Agents|dermatologic agents|mesh-ancestor
102417886|NCT00787761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102417887|NCT00787761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102417888|NCT00787761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102417889|NCT00787761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102417890|NCT01478828|Lovastatin|lovastatin|mesh-list
102417891|NCT01478828|L 647318|l 647318|mesh-list
102417892|NCT01478828|Dihydromevinolin|dihydromevinolin|mesh-list
102417893|NCT01478828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102417894|NCT01478828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102417895|NCT01478828|Antimetabolites|antimetabolites|mesh-ancestor
102417896|NCT01478828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417897|NCT01478828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102417898|NCT01478828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102417899|NCT01478828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102417900|NCT00085423|Aldesleukin|aldesleukin|mesh-list
102417901|NCT00085423|Cyclophosphamide|cyclophosphamide|mesh-list
102417902|NCT00085423|Fludarabine|fludarabine|mesh-list
102417903|NCT00085423|Fludarabine phosphate|fludarabine phosphate|mesh-list
102417904|NCT00085423|Interleukin-2|interleukin-2|mesh-list
102417905|NCT00085423|Molgramostim|molgramostim|mesh-list
102417906|NCT00085423|Sargramostim|sargramostim|mesh-list
102417907|NCT00085423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102417908|NCT00085423|Immunologic Factors|immunologic factors|mesh-ancestor
102417909|NCT00085423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417910|NCT00085423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102417911|NCT00085423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102417912|NCT00085423|Alkylating Agents|alkylating agents|mesh-ancestor
102417913|NCT00085423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417914|NCT00085423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102417915|NCT00085423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102417916|NCT00085423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102417917|NCT00085423|Antimetabolites|antimetabolites|mesh-ancestor
102417918|NCT00085423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102417919|NCT00085423|Analgesics|analgesics|mesh-ancestor
102417920|NCT00085423|Sensory System Agents|sensory system agents|mesh-ancestor
102417921|NCT00085423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102417922|NCT00085423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102417923|NCT00085423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102417924|NCT00085423|Antiviral Agents|antiviral agents|mesh-ancestor
102417925|NCT00085423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102417926|NCT04079192|Umirolimus|umirolimus|mesh-list
102417927|NCT04079192|Paclitaxel|paclitaxel|mesh-list
102417928|NCT04079192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102417929|NCT04079192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102417930|NCT04079192|Tubulin Modulators|tubulin modulators|mesh-ancestor
102417931|NCT04079192|Antimitotic Agents|antimitotic agents|mesh-ancestor
102417932|NCT04079192|Mitosis Modulators|mitosis modulators|mesh-ancestor
102417933|NCT04079192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417934|NCT04079192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102417935|NCT04079192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102417936|NCT04079192|Immunologic Factors|immunologic factors|mesh-ancestor
102417937|NCT04079192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417938|NCT03087877|Acetaminophen|acetaminophen|mesh-list
102417939|NCT03087877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102417940|NCT03087877|Analgesics|analgesics|mesh-ancestor
102417941|NCT03087877|Sensory System Agents|sensory system agents|mesh-ancestor
102417942|NCT03087877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102417943|NCT03087877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417944|NCT03087877|Antipyretics|antipyretics|mesh-ancestor
102417945|NCT05742477|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102417946|NCT05742477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102417947|NCT03447379|Aspirin|aspirin|mesh-list
102417948|NCT03447379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102417949|NCT03447379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102417950|NCT03447379|Analgesics|analgesics|mesh-ancestor
102417951|NCT03447379|Sensory System Agents|sensory system agents|mesh-ancestor
102417952|NCT03447379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102417953|NCT03447379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417954|NCT03447379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102417955|NCT03447379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102417956|NCT03447379|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102417957|NCT03447379|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102417958|NCT03447379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417959|NCT03447379|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102417960|NCT03447379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102417961|NCT03447379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102417962|NCT03447379|Antipyretics|antipyretics|mesh-ancestor
102417963|NCT03803553|Fluorouracil|fluorouracil|mesh-list
102417964|NCT03803553|Nivolumab|nivolumab|mesh-list
102417965|NCT03803553|Irinotecan|irinotecan|mesh-list
102417966|NCT03803553|Cetuximab|cetuximab|mesh-list
102417967|NCT03803553|Antimetabolites|antimetabolites|mesh-ancestor
102417968|NCT03803553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417969|NCT03803553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102417970|NCT03803553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102417971|NCT03803553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102417972|NCT03803553|Immunologic Factors|immunologic factors|mesh-ancestor
102417973|NCT03803553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417974|NCT03803553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102417975|NCT03803553|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102417976|NCT03803553|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102417977|NCT03803553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102417978|NCT03803553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102417979|NCT05740449|Decitabine|decitabine|mesh-list
102417980|NCT05740449|Venetoclax|venetoclax|mesh-list
102417981|NCT05740449|Navitoclax|navitoclax|mesh-list
102417982|NCT05740449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102417983|NCT05740449|Antimetabolites|antimetabolites|mesh-ancestor
102417984|NCT05740449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417985|NCT05740449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102417986|NCT05740449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102417987|NCT01677949|Cyclophosphamide|cyclophosphamide|mesh-list
102417988|NCT01677949|Etoposide|etoposide|mesh-list
102417989|NCT01677949|Clofarabine|clofarabine|mesh-list
102417990|NCT01677949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102417991|NCT01677949|Immunologic Factors|immunologic factors|mesh-ancestor
102417992|NCT01677949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102417993|NCT01677949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102417994|NCT01677949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102417995|NCT01677949|Alkylating Agents|alkylating agents|mesh-ancestor
102417996|NCT01677949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102417997|NCT01677949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102417998|NCT01677949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102417999|NCT01677949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102418000|NCT01677949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102418001|NCT01677949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102418002|NCT01677949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102418003|NCT01677949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102418004|NCT01677949|Antimetabolites|antimetabolites|mesh-ancestor
102418005|NCT03483883|Gemcitabine|gemcitabine|mesh-list
102418006|NCT03483883|Avelumab|avelumab|mesh-list
102418007|NCT03483883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102418008|NCT03483883|Antimetabolites|antimetabolites|mesh-ancestor
102418009|NCT03483883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418010|NCT03483883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102418011|NCT03483883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102418012|NCT03482167|Niacinamide|niacinamide|mesh-list
102418013|NCT03482167|Vitamin B Complex|vitamin b complex|mesh-ancestor
102418014|NCT03482167|Vitamins|vitamins|mesh-ancestor
102418015|NCT03482167|Micronutrients|micronutrients|mesh-ancestor
102418016|NCT03482167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418017|NCT00799227|Dexamethasone|dexamethasone|mesh-list
102418018|NCT00799227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102418019|NCT00799227|Antiemetics|antiemetics|mesh-ancestor
102418020|NCT00799227|Autonomic Agents|autonomic agents|mesh-ancestor
102418021|NCT00799227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102418022|NCT00799227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418023|NCT00799227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102418024|NCT00799227|Glucocorticoids|glucocorticoids|mesh-ancestor
102418026|NCT00799227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102418027|NCT00799227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102418028|NCT00799227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102418029|NCT03439267|Calcium|calcium|mesh-list
102418030|NCT03439267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102418031|NCT03439267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418032|NCT00770133|Ketotifen|ketotifen|mesh-list
102418033|NCT00770133|Naphazoline|naphazoline|mesh-list
102418034|NCT00770133|Antipruritics|antipruritics|mesh-ancestor
102418035|NCT00770133|Dermatologic Agents|dermatologic agents|mesh-ancestor
102418036|NCT00770133|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102418037|NCT00770133|Histamine Antagonists|histamine antagonists|mesh-ancestor
102418038|NCT00770133|Histamine Agents|histamine agents|mesh-ancestor
102418039|NCT00770133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102418040|NCT00770133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418041|NCT00770133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418042|NCT00770133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102418043|NCT00770133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102418044|NCT00770133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102418045|NCT00770133|Adrenergic Agents|adrenergic agents|mesh-ancestor
102418046|NCT00770133|Nasal Decongestants|nasal decongestants|mesh-ancestor
102418047|NCT00770133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102418048|NCT00770133|Respiratory System Agents|respiratory system agents|mesh-ancestor
102418049|NCT00770757|Pomalidomide|pomalidomide|mesh-list
102418050|NCT00770757|Immunologic Factors|immunologic factors|mesh-ancestor
102418051|NCT00770757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418052|NCT00770757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102418053|NCT00770757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102418054|NCT00770757|Growth Substances|growth substances|mesh-ancestor
102418055|NCT00770757|Growth Inhibitors|growth inhibitors|mesh-ancestor
102048702|NCT02942277|Antimalarials|antimalarials|mesh-ancestor
102418056|NCT00770757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102418057|NCT01425281|Everolimus|everolimus|mesh-list
102418058|NCT01425281|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102418059|NCT01425281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102418060|NCT01425281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102418061|NCT01425281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418062|NCT01425281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102418063|NCT01425281|Immunologic Factors|immunologic factors|mesh-ancestor
102418064|NCT01425281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418065|NCT01425281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102418066|NCT04384653|Furosemide|furosemide|mesh-list
102418067|NCT04384653|Diuretics|diuretics|mesh-ancestor
102418068|NCT04384653|Natriuretic Agents|natriuretic agents|mesh-ancestor
102418069|NCT04384653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418070|NCT04384653|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102418071|NCT04384653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102418072|NCT04384653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418073|NCT04113720|Dexmedetomidine|dexmedetomidine|mesh-list
102418074|NCT04113720|Levobupivacaine|levobupivacaine|mesh-list
102418075|NCT04113720|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102418076|NCT04113720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102418077|NCT04113720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418078|NCT04113720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102418079|NCT04113720|Analgesics|analgesics|mesh-ancestor
102418080|NCT04113720|Sensory System Agents|sensory system agents|mesh-ancestor
102418081|NCT04113720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102418082|NCT04113720|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102418083|NCT04113720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102418084|NCT04113720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102418085|NCT04113720|Adrenergic Agents|adrenergic agents|mesh-ancestor
102418086|NCT04113720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102418087|NCT04113720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418088|NCT04113720|Anesthetics, Local|anesthetics, local|mesh-ancestor
102418089|NCT04113720|Anesthetics|anesthetics|mesh-ancestor
102418090|NCT01402817|Sunitinib|sunitinib|mesh-list
102418091|NCT01402817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102418092|NCT01402817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102418093|NCT01402817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102418094|NCT01402817|Growth Substances|growth substances|mesh-ancestor
102418095|NCT01402817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418096|NCT01402817|Growth Inhibitors|growth inhibitors|mesh-ancestor
102418097|NCT01402817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102418098|NCT01402817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102418099|NCT01402817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418100|NCT01425203|Ribavirin|ribavirin|mesh-list
102418101|NCT01425203|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102418102|NCT01425203|Antimetabolites|antimetabolites|mesh-ancestor
102418103|NCT01425203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418104|NCT01425203|Antiviral Agents|antiviral agents|mesh-ancestor
102418105|NCT01425203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102418106|NCT04215120|Epoetin Alfa|epoetin alfa|mesh-list
102418107|NCT04215120|Hematinics|hematinics|mesh-ancestor
102418108|NCT00081289|Leucovorin|leucovorin|mesh-list
102418109|NCT00081289|Folic Acid|folic acid|mesh-list
102418110|NCT00081289|Fluorouracil|fluorouracil|mesh-list
102418111|NCT00081289|Capecitabine|capecitabine|mesh-list
102418112|NCT00081289|Oxaliplatin|oxaliplatin|mesh-list
102418113|NCT00081289|Irinotecan|irinotecan|mesh-list
102418114|NCT00081289|Levoleucovorin|levoleucovorin|mesh-list
102418115|NCT00081289|Antimetabolites|antimetabolites|mesh-ancestor
102418116|NCT00081289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418117|NCT00081289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102418118|NCT00081289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102418119|NCT00081289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102418120|NCT00081289|Immunologic Factors|immunologic factors|mesh-ancestor
102418121|NCT00081289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418122|NCT00081289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102418123|NCT00081289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102418124|NCT00081289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102418125|NCT00081289|Antidotes|antidotes|mesh-ancestor
102418126|NCT00081289|Protective Agents|protective agents|mesh-ancestor
102418127|NCT00081289|Vitamin B Complex|vitamin b complex|mesh-ancestor
102418128|NCT00081289|Vitamins|vitamins|mesh-ancestor
102418129|NCT00081289|Micronutrients|micronutrients|mesh-ancestor
102418130|NCT00081289|Hematinics|hematinics|mesh-ancestor
102418131|NCT01478594|Bevacizumab|bevacizumab|mesh-list
102418132|NCT01478594|Tivozanib|tivozanib|mesh-list
102418133|NCT01478594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102418134|NCT01478594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102418135|NCT01478594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102418136|NCT01478594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102418137|NCT01478594|Growth Substances|growth substances|mesh-ancestor
102418138|NCT01478594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418139|NCT01478594|Growth Inhibitors|growth inhibitors|mesh-ancestor
102418140|NCT01478594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102418141|NCT01478594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102418142|NCT01478594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418143|NCT01424813|Albuterol|albuterol|mesh-list
102418144|NCT01424813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102418145|NCT01424813|Autonomic Agents|autonomic agents|mesh-ancestor
102418146|NCT01424813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102418147|NCT01424813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418148|NCT01424813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102418149|NCT01424813|Respiratory System Agents|respiratory system agents|mesh-ancestor
102418150|NCT01424813|Tocolytic Agents|tocolytic agents|mesh-ancestor
102418151|NCT01424813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102418152|NCT01424813|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102418153|NCT01424813|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102418154|NCT01424813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102418155|NCT01424813|Adrenergic Agents|adrenergic agents|mesh-ancestor
102418156|NCT01424813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102418157|NCT01424813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418158|NCT03480061|Dexmedetomidine|dexmedetomidine|mesh-list
102418159|NCT03480061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102418160|NCT03480061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102418161|NCT03480061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418162|NCT03480061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102418163|NCT03480061|Analgesics|analgesics|mesh-ancestor
102418164|NCT03480061|Sensory System Agents|sensory system agents|mesh-ancestor
102418165|NCT03480061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102418166|NCT03480061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102418167|NCT03480061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102229798|NCT03369847|Budesonide|budesonide|mesh-list
102418168|NCT03480061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102418169|NCT03480061|Adrenergic Agents|adrenergic agents|mesh-ancestor
102418170|NCT03480061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102418171|NCT03480061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418172|NCT03389022|Ketamine|ketamine|mesh-list
102418173|NCT03389022|Analgesics|analgesics|mesh-ancestor
102418174|NCT03389022|Sensory System Agents|sensory system agents|mesh-ancestor
102418175|NCT03389022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102418176|NCT03389022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418177|NCT03389022|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102418178|NCT03389022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102418179|NCT03389022|Anesthetics, General|anesthetics, general|mesh-ancestor
102418180|NCT03389022|Anesthetics|anesthetics|mesh-ancestor
102418181|NCT03389022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102418182|NCT03389022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102418183|NCT03389022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102418184|NCT03389022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102418185|NCT03389022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418186|NCT00080899|Fenretinide|fenretinide|mesh-list
102418187|NCT00080899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102418188|NCT00080899|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102418189|NCT00080899|Protective Agents|protective agents|mesh-ancestor
102418190|NCT00080899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418191|NCT03627858|Beclomethasone|beclomethasone|mesh-list
102418192|NCT03627858|Glycopyrrolate|glycopyrrolate|mesh-list
102418193|NCT03627858|Formoterol Fumarate|formoterol fumarate|mesh-list
102418194|NCT03627858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102418195|NCT03627858|Autonomic Agents|autonomic agents|mesh-ancestor
102418196|NCT03627858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102418197|NCT03627858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418198|NCT03627858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102418199|NCT03627858|Respiratory System Agents|respiratory system agents|mesh-ancestor
102418200|NCT03627858|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102418201|NCT03627858|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102418202|NCT03627858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102418203|NCT03627858|Adrenergic Agents|adrenergic agents|mesh-ancestor
102418204|NCT03627858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102418205|NCT03627858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418206|NCT03627858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102418207|NCT03627858|Glucocorticoids|glucocorticoids|mesh-ancestor
102418208|NCT03627858|Hormones|hormones|mesh-ancestor
102418209|NCT03627858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102418210|NCT03627858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102418211|NCT03627858|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102418212|NCT03627858|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102418213|NCT03627858|Cholinergic Agents|cholinergic agents|mesh-ancestor
102418214|NCT03086785|Apatinib|apatinib|mesh-list
102418215|NCT03086785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102418216|NCT03086785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102418217|NCT03086785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102418218|NCT03086785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418219|NCT03259698|Tenofovir|tenofovir|mesh-list
102418220|NCT03259698|Emtricitabine|emtricitabine|mesh-list
102418221|NCT03259698|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
102418222|NCT03259698|Antiviral Agents|antiviral agents|mesh-ancestor
102418223|NCT03259698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102418224|NCT03259698|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102418225|NCT03259698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102418226|NCT03259698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102418227|NCT03259698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418228|NCT03259698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102418229|NCT03259698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102418230|NCT00089635|Panitumumab|panitumumab|mesh-list
102418231|NCT00089635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102418232|NCT00089635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102418233|NCT03445728|Nicorandil|nicorandil|mesh-list
102418234|NCT03445728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102418235|NCT03445728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102418236|NCT03445728|Vasodilator Agents|vasodilator agents|mesh-ancestor
102418237|NCT03445728|Vitamin B Complex|vitamin b complex|mesh-ancestor
102418238|NCT03445728|Vitamins|vitamins|mesh-ancestor
102418239|NCT03445728|Micronutrients|micronutrients|mesh-ancestor
102418240|NCT03445728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418241|NCT02795520|OTS167|ots167|mesh-list
102418242|NCT02795520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102418243|NCT02795520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102229880|NCT03369379|Vitamins|vitamins|mesh-ancestor
102418244|NCT02795520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418245|NCT03159000|Lidocaine|lidocaine|mesh-list
102418246|NCT03159000|Bupivacaine|bupivacaine|mesh-list
102418247|NCT03159000|Anesthetics, Local|anesthetics, local|mesh-ancestor
102418248|NCT03159000|Anesthetics|anesthetics|mesh-ancestor
102418249|NCT03159000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102418250|NCT03159000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418251|NCT03159000|Sensory System Agents|sensory system agents|mesh-ancestor
102418252|NCT03159000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102418253|NCT03159000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102418254|NCT03159000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102418255|NCT03159000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102418256|NCT03159000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102418257|NCT03159000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418258|NCT00086671|Antibodies|antibodies|mesh-list
102418259|NCT00086671|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102418260|NCT00086671|Immunologic Factors|immunologic factors|mesh-ancestor
102418261|NCT00086671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418262|NCT02464878|Etanercept|etanercept|mesh-list
102418263|NCT02464878|Thymoglobulin|thymoglobulin|mesh-list
102418264|NCT02464878|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102418265|NCT02464878|Basiliximab|basiliximab|mesh-list
102418266|NCT02464878|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
102418267|NCT02464878|Protein C Inhibitor|protein c inhibitor|mesh-list
102418268|NCT02464878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102418269|NCT02464878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102418270|NCT02464878|Analgesics|analgesics|mesh-ancestor
102418271|NCT02464878|Sensory System Agents|sensory system agents|mesh-ancestor
102418272|NCT02464878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102418273|NCT02464878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418274|NCT02464878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102418275|NCT02464878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102418276|NCT02464878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102418277|NCT02464878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102418278|NCT02464878|Immunologic Factors|immunologic factors|mesh-ancestor
102418279|NCT02464878|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102418280|NCT02464878|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102418281|NCT02464878|Protease Inhibitors|protease inhibitors|mesh-ancestor
102418282|NCT02464878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102418283|NCT02464878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418284|NCT02010606|Bevacizumab|bevacizumab|mesh-list
102418285|NCT02010606|Temozolomide|temozolomide|mesh-list
102418286|NCT02010606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102418287|NCT02010606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102418288|NCT02010606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102418289|NCT02010606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102418290|NCT02010606|Growth Substances|growth substances|mesh-ancestor
102418291|NCT02010606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418292|NCT02010606|Growth Inhibitors|growth inhibitors|mesh-ancestor
102418293|NCT02010606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102418294|NCT02010606|Alkylating Agents|alkylating agents|mesh-ancestor
102418295|NCT02010606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418296|NCT00084253|Ritonavir|ritonavir|mesh-list
102418297|NCT00084253|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102418298|NCT00084253|Lamivudine|lamivudine|mesh-list
102418299|NCT00084253|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102418300|NCT00084253|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102418301|NCT00084253|Protease Inhibitors|protease inhibitors|mesh-ancestor
102418302|NCT00084253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102418303|NCT00084253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418304|NCT00084253|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102418305|NCT00084253|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102418306|NCT00084253|Antiviral Agents|antiviral agents|mesh-ancestor
102418307|NCT00084253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102418308|NCT00084253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102418309|NCT00084253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102418310|NCT00084253|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102418311|NCT00084253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102418312|NCT02951364|Sofosbuvir|sofosbuvir|mesh-list
102418313|NCT02951364|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102418314|NCT02951364|Ledipasvir|ledipasvir|mesh-list
102418315|NCT02951364|Antiviral Agents|antiviral agents|mesh-ancestor
102418316|NCT02951364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102418317|NCT01678417|Rituximab|rituximab|mesh-list
102418318|NCT01678417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102418319|NCT01678417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102418320|NCT01678417|Immunologic Factors|immunologic factors|mesh-ancestor
102418321|NCT01678417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418322|NCT01678417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102418323|NCT00083941|Interleukin-2|interleukin-2|mesh-list
102418324|NCT00083941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102418325|NCT00083941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102418326|NCT00083941|Analgesics|analgesics|mesh-ancestor
102418327|NCT00083941|Sensory System Agents|sensory system agents|mesh-ancestor
102418328|NCT00083941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102418329|NCT00083941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418330|NCT02856438|Dexamethasone|dexamethasone|mesh-list
102418331|NCT02856438|Lenalidomide|lenalidomide|mesh-list
102418332|NCT02856438|Elotuzumab|elotuzumab|mesh-list
102418333|NCT02856438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102418334|NCT02856438|Antiemetics|antiemetics|mesh-ancestor
102418335|NCT02856438|Autonomic Agents|autonomic agents|mesh-ancestor
102418336|NCT02856438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102418337|NCT02856438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418338|NCT02856438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102418339|NCT02856438|Glucocorticoids|glucocorticoids|mesh-ancestor
102418340|NCT02856438|Hormones|hormones|mesh-ancestor
102418341|NCT02856438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102418342|NCT02856438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102418343|NCT02856438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102418344|NCT02856438|Immunologic Factors|immunologic factors|mesh-ancestor
102418345|NCT02856438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102418346|NCT02856438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102418347|NCT02856438|Growth Substances|growth substances|mesh-ancestor
102418348|NCT02856438|Growth Inhibitors|growth inhibitors|mesh-ancestor
102418349|NCT01678495|Plasminogen|plasminogen|mesh-list
102418350|NCT01678495|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102418351|NCT01678495|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102418352|NCT01678495|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102418353|NCT01678495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418354|NCT01678573|Abiraterone Acetate|abiraterone acetate|mesh-list
102418355|NCT01678573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102418356|NCT01678573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102418357|NCT01678573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102418358|NCT01678573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418359|NCT01678573|Hormone Antagonists|hormone antagonists|mesh-ancestor
102418360|NCT01678573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102418361|NCT01678573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418362|NCT01678573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102418363|NCT01678651|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102418364|NCT01678651|Hormones|hormones|mesh-ancestor
102418365|NCT01678651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102418366|NCT01678651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418367|NCT03084523|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102418368|NCT03084523|Hematinics|hematinics|mesh-ancestor
102418369|NCT03084523|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102418370|NCT03084523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102418371|NCT04094090|Riboflavin|riboflavin|mesh-list
102418372|NCT04094090|Vitamin B Complex|vitamin b complex|mesh-ancestor
102418373|NCT04094090|Vitamins|vitamins|mesh-ancestor
102418374|NCT04094090|Micronutrients|micronutrients|mesh-ancestor
102418375|NCT04094090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418376|NCT04094090|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102418377|NCT04094090|Dermatologic Agents|dermatologic agents|mesh-ancestor
102418378|NCT04670796|Trastuzumab|trastuzumab|mesh-list
102418379|NCT04670796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102418380|NCT04670796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102418381|NCT01019616|Paclitaxel|paclitaxel|mesh-list
102418382|NCT01019616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102418383|NCT01019616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102418384|NCT01019616|Tubulin Modulators|tubulin modulators|mesh-ancestor
102418385|NCT01019616|Antimitotic Agents|antimitotic agents|mesh-ancestor
102418386|NCT01019616|Mitosis Modulators|mitosis modulators|mesh-ancestor
102049027|NCT02087540|Telmisartan|telmisartan|mesh-list
102418387|NCT01019616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418388|NCT03086395|Obinutuzumab|obinutuzumab|mesh-list
102418389|NCT03086395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102418390|NCT03086395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102418391|NCT03083197|Azithromycin|azithromycin|mesh-list
102418392|NCT03083197|Doxycycline|doxycycline|mesh-list
102230020|NCT03357757|Antimanic Agents|antimanic agents|mesh-ancestor
102418393|NCT03083197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102418394|NCT03083197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102418395|NCT03083197|Antimalarials|antimalarials|mesh-ancestor
102418396|NCT03083197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102418397|NCT03083197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102418398|NCT03086239|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
102418399|NCT03086239|Immunoconjugates|immunoconjugates|mesh-ancestor
102418400|NCT03086239|Immunologic Factors|immunologic factors|mesh-ancestor
102418401|NCT03086239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418402|NCT01678963|Squalamine|squalamine|mesh-list
102418403|NCT01678963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102418404|NCT01678963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102418405|NCT01678963|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102418406|NCT01678963|Protective Agents|protective agents|mesh-ancestor
102418407|NCT01678963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418408|NCT01678963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102418409|NCT01678963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102418410|NCT01678963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102418411|NCT01678963|Growth Substances|growth substances|mesh-ancestor
102418412|NCT01678963|Growth Inhibitors|growth inhibitors|mesh-ancestor
102418413|NCT00790335|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102418414|NCT00790335|Plasminogen|plasminogen|mesh-list
102418415|NCT00790335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102418416|NCT00790335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102418417|NCT00790335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418418|NCT05136534|Anesthetics|anesthetics|mesh-list
102418419|NCT05136534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102418420|NCT05136534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418421|NCT05135442|Bortezomib|bortezomib|mesh-list
102418422|NCT05135442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102418423|NCT05130684|Paclitaxel|paclitaxel|mesh-list
102418424|NCT05130684|Cisplatin|cisplatin|mesh-list
102418425|NCT05130684|Nivolumab|nivolumab|mesh-list
102418426|NCT05130684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102418427|NCT05130684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102418428|NCT05130684|Tubulin Modulators|tubulin modulators|mesh-ancestor
102418429|NCT05130684|Antimitotic Agents|antimitotic agents|mesh-ancestor
102418430|NCT05130684|Mitosis Modulators|mitosis modulators|mesh-ancestor
102418431|NCT05130684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418432|NCT05130684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102418433|NCT05130684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102418434|NCT04402411|Analgesics, Opioid|analgesics, opioid|mesh-list
102418435|NCT04402411|Narcotics|narcotics|mesh-ancestor
102418436|NCT04402411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102418437|NCT04402411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418438|NCT04402411|Analgesics|analgesics|mesh-ancestor
102418439|NCT04402411|Sensory System Agents|sensory system agents|mesh-ancestor
102418440|NCT04402411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102418441|NCT05265507|Glycopyrrolate|glycopyrrolate|mesh-list
102418442|NCT05265507|Ondansetron|ondansetron|mesh-list
102418443|NCT05265507|Antiemetics|antiemetics|mesh-ancestor
102418444|NCT05265507|Autonomic Agents|autonomic agents|mesh-ancestor
102418445|NCT05265507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102418446|NCT05265507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418447|NCT05265507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102418448|NCT05265507|Antipruritics|antipruritics|mesh-ancestor
102418449|NCT05265507|Dermatologic Agents|dermatologic agents|mesh-ancestor
102418450|NCT05265507|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102418451|NCT05265507|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102418452|NCT05265507|Serotonin Agents|serotonin agents|mesh-ancestor
102418453|NCT05265507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102418454|NCT05265507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418455|NCT05265507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102418456|NCT05265507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102418457|NCT05265507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102418458|NCT05265507|Cholinergic Agents|cholinergic agents|mesh-ancestor
102418459|NCT05135286|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102418460|NCT05135286|Carbachol|carbachol|mesh-list
102418461|NCT05135286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102418462|NCT05135286|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102418463|NCT05135286|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102418464|NCT05135286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102230101|NCT04521049|Saxagliptin|saxagliptin|mesh-list
102418465|NCT05135286|Adrenergic Agents|adrenergic agents|mesh-ancestor
102418466|NCT05135286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102418467|NCT05135286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418468|NCT05135286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418469|NCT05135286|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102418470|NCT05135286|Miotics|miotics|mesh-ancestor
102418471|NCT05135286|Autonomic Agents|autonomic agents|mesh-ancestor
102418472|NCT05135286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102418473|NCT05135286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102418474|NCT05135286|Cholinergic Agents|cholinergic agents|mesh-ancestor
102418475|NCT05135286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102418476|NCT05135286|Analgesics|analgesics|mesh-ancestor
102418477|NCT05135286|Sensory System Agents|sensory system agents|mesh-ancestor
102418478|NCT05135286|Protective Agents|protective agents|mesh-ancestor
102418479|NCT03089671|Vitamins|vitamins|mesh-list
102418480|NCT03089671|Riboflavin|riboflavin|mesh-list
102418481|NCT03089671|Vitamin B Complex|vitamin b complex|mesh-list
102418482|NCT03089671|Micronutrients|micronutrients|mesh-ancestor
102418483|NCT03089671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418484|NCT03089671|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102418485|NCT03089671|Dermatologic Agents|dermatologic agents|mesh-ancestor
102418486|NCT05136924|Varenicline|varenicline|mesh-list
102418487|NCT05136924|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102418488|NCT05136924|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102418489|NCT05136924|Cholinergic Agents|cholinergic agents|mesh-ancestor
102418490|NCT05136924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102418491|NCT05136924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418492|NCT05136924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418493|NCT00791037|Cyclophosphamide|cyclophosphamide|mesh-list
102418494|NCT00791037|Sargramostim|sargramostim|mesh-list
102418495|NCT00791037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102418496|NCT00791037|Immunologic Factors|immunologic factors|mesh-ancestor
102418497|NCT00791037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418498|NCT00791037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102418499|NCT00791037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102418500|NCT00791037|Alkylating Agents|alkylating agents|mesh-ancestor
102418501|NCT00791037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418502|NCT00791037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102418503|NCT00791037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102049169|NCT02090036|Artemether|artemether|mesh-list
102418504|NCT04403191|Ondansetron|ondansetron|mesh-list
102418505|NCT04403191|Antiemetics|antiemetics|mesh-ancestor
102418506|NCT04403191|Autonomic Agents|autonomic agents|mesh-ancestor
102418507|NCT04403191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102418508|NCT04403191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418509|NCT04403191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102418510|NCT04403191|Antipruritics|antipruritics|mesh-ancestor
102418511|NCT04403191|Dermatologic Agents|dermatologic agents|mesh-ancestor
102418512|NCT04403191|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102418513|NCT04403191|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102418514|NCT04403191|Serotonin Agents|serotonin agents|mesh-ancestor
102418515|NCT04403191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102418516|NCT04403191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418517|NCT04383093|Tadalafil|tadalafil|mesh-list
102418518|NCT04383093|Tamsulosin|tamsulosin|mesh-list
102418519|NCT04383093|Vasodilator Agents|vasodilator agents|mesh-ancestor
102418520|NCT04383093|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102418521|NCT04383093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102418522|NCT04383093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102418523|NCT04383093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418524|NCT04383093|Urological Agents|urological agents|mesh-ancestor
102418525|NCT04383093|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102418526|NCT04383093|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102418527|NCT04383093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102418528|NCT04383093|Adrenergic Agents|adrenergic agents|mesh-ancestor
102418529|NCT04383093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102418530|NCT04383093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418531|NCT05301660|Nicotine|nicotine|mesh-list
102418532|NCT05301660|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102418533|NCT05301660|Autonomic Agents|autonomic agents|mesh-ancestor
102418534|NCT05301660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102418535|NCT05301660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418536|NCT05301660|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102418537|NCT05301660|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102418538|NCT05301660|Cholinergic Agents|cholinergic agents|mesh-ancestor
102418539|NCT05301660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102418540|NCT05301660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418541|NCT01401959|Trastuzumab|trastuzumab|mesh-list
102418542|NCT01401959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102418543|NCT01401959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102418545|NCT04767035|Ketamine|ketamine|mesh-list
102418546|NCT04767035|Analgesics|analgesics|mesh-ancestor
102418547|NCT04767035|Sensory System Agents|sensory system agents|mesh-ancestor
102418548|NCT04767035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102418549|NCT04767035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418550|NCT04767035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102418551|NCT04767035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102418552|NCT04767035|Anesthetics, General|anesthetics, general|mesh-ancestor
102418553|NCT04767035|Anesthetics|anesthetics|mesh-ancestor
102418554|NCT04767035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102418555|NCT04767035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102418556|NCT04767035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102418557|NCT04767035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102418558|NCT04767035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418559|NCT04767035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102418560|NCT04767035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102418561|NCT04767035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102418562|NCT04767035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102418563|NCT04767035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102418564|NCT04767035|GABA Modulators|gaba modulators|mesh-ancestor
102418565|NCT04767035|GABA Agents|gaba agents|mesh-ancestor
102418566|NCT03081169|Heparin|heparin|mesh-list
102418567|NCT03081169|Enoxaparin|enoxaparin|mesh-list
102418568|NCT03081169|Enoxaparin sodium|enoxaparin sodium|mesh-list
102418569|NCT03081169|Anticoagulants|anticoagulants|mesh-ancestor
102418570|NCT03081169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102418571|NCT03081169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102418572|NCT03081169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418573|NCT03803163|Treprostinil|treprostinil|mesh-list
102418574|NCT03803163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102418575|NCT05287308|Paclitaxel|paclitaxel|mesh-list
102418576|NCT05287308|Docetaxel|docetaxel|mesh-list
102418577|NCT05287308|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102418578|NCT05287308|Cyclophosphamide|cyclophosphamide|mesh-list
102418579|NCT05287308|Doxorubicin|doxorubicin|mesh-list
102418580|NCT05287308|Epirubicin|epirubicin|mesh-list
102418581|NCT05287308|Pirarubicin|pirarubicin|mesh-list
102418582|NCT05287308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102418583|NCT05287308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102418584|NCT05287308|Tubulin Modulators|tubulin modulators|mesh-ancestor
102418585|NCT05287308|Antimitotic Agents|antimitotic agents|mesh-ancestor
102418586|NCT05287308|Mitosis Modulators|mitosis modulators|mesh-ancestor
102418587|NCT05287308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418588|NCT05287308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102418589|NCT05287308|Immunologic Factors|immunologic factors|mesh-ancestor
102418590|NCT05287308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418591|NCT05287308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102418592|NCT05287308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102418593|NCT05287308|Alkylating Agents|alkylating agents|mesh-ancestor
102418594|NCT05287308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102418595|NCT05287308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102418596|NCT05287308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102418597|NCT05287308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102418598|NCT05287308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102418599|NCT00801723|Budesonide|budesonide|mesh-list
102418600|NCT00801723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102418601|NCT00801723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102418602|NCT00801723|Autonomic Agents|autonomic agents|mesh-ancestor
102418603|NCT00801723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102418604|NCT00801723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418605|NCT00801723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102418606|NCT00801723|Respiratory System Agents|respiratory system agents|mesh-ancestor
102418607|NCT00801723|Glucocorticoids|glucocorticoids|mesh-ancestor
102418608|NCT00801723|Hormones|hormones|mesh-ancestor
102418609|NCT00801723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102418610|NCT05346211|Curcumin|curcumin|mesh-list
102418611|NCT05346211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102418612|NCT05346211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102418613|NCT05346211|Analgesics|analgesics|mesh-ancestor
102418614|NCT05346211|Sensory System Agents|sensory system agents|mesh-ancestor
102230243|NCT05127369|Fluoxetine|fluoxetine|mesh-list
102418615|NCT05346211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102418616|NCT05346211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418617|NCT05346211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102418618|NCT05346211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102418619|NCT05346211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102418620|NCT05346211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102418621|NCT05346211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418623|NCT05694897|Bupivacaine|bupivacaine|mesh-list
102418624|NCT05694897|Anesthetics, Local|anesthetics, local|mesh-ancestor
102418625|NCT05694897|Anesthetics|anesthetics|mesh-ancestor
102418626|NCT05694897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102418627|NCT05694897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418628|NCT05694897|Sensory System Agents|sensory system agents|mesh-ancestor
102418629|NCT05694897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102418630|NCT05694897|Analgesics|analgesics|mesh-ancestor
102418631|NCT05694897|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102418632|NCT05694897|Anticonvulsants|anticonvulsants|mesh-ancestor
102418633|NCT05694897|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102418634|NCT05694897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102418635|NCT05694897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418636|NCT05694897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102418637|NCT05694897|Tocolytic Agents|tocolytic agents|mesh-ancestor
102418638|NCT05694897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102418639|NCT01478048|Dexamethasone|dexamethasone|mesh-list
102418640|NCT01478048|Dexamethasone acetate|dexamethasone acetate|mesh-list
102418641|NCT01478048|Bortezomib|bortezomib|mesh-list
102418642|NCT01478048|Elotuzumab|elotuzumab|mesh-list
102418643|NCT01478048|BB 1101|bb 1101|mesh-list
102418644|NCT01478048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102418645|NCT01478048|Antiemetics|antiemetics|mesh-ancestor
102418646|NCT01478048|Autonomic Agents|autonomic agents|mesh-ancestor
102418647|NCT01478048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102418648|NCT01478048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418649|NCT01478048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102418650|NCT01478048|Glucocorticoids|glucocorticoids|mesh-ancestor
102418651|NCT01478048|Hormones|hormones|mesh-ancestor
102418652|NCT01478048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102418653|NCT01478048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102418654|NCT01478048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102418655|NCT01478048|Protease Inhibitors|protease inhibitors|mesh-ancestor
102418656|NCT01478048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102418657|NCT01478048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418658|NCT04585776|Insulin|insulin|mesh-list
102418659|NCT04585776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102418660|NCT04585776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418661|NCT01401647|Lidocaine|lidocaine|mesh-list
102418662|NCT01401647|Amiodarone|amiodarone|mesh-list
102418663|NCT01401647|Anesthetics, Local|anesthetics, local|mesh-ancestor
102418664|NCT01401647|Anesthetics|anesthetics|mesh-ancestor
102418665|NCT01401647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102418666|NCT01401647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418667|NCT01401647|Sensory System Agents|sensory system agents|mesh-ancestor
102418668|NCT01401647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102418669|NCT01401647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102418670|NCT01401647|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102418671|NCT01401647|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102418672|NCT01401647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102418673|NCT01401647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418674|NCT01401647|Vasodilator Agents|vasodilator agents|mesh-ancestor
102418675|NCT01401647|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102418676|NCT01401647|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102418677|NCT01401647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102418678|NCT01401647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102418679|NCT01401647|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102418680|NCT01401647|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102418681|NCT01401647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102418682|NCT01423253|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102418683|NCT01423253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102418684|NCT01423253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102418685|NCT01423253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102418686|NCT01423253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418687|NCT01423253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102418688|NCT01423253|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102418689|NCT01423253|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102418690|NCT01423253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102418691|NCT01423253|Adrenergic Agents|adrenergic agents|mesh-ancestor
102230315|NCT04278651|Hematinics|hematinics|mesh-ancestor
102418692|NCT01423253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102418693|NCT01423253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418694|NCT01423253|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102418695|NCT01423253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102418696|NCT01423253|Serotonin Agents|serotonin agents|mesh-ancestor
102418697|NCT01423253|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102418698|NCT01423253|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102418699|NCT01423253|Dopamine Agents|dopamine agents|mesh-ancestor
102418700|NCT03088891|Antioxidants|antioxidants|mesh-list
102418701|NCT03088891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418702|NCT03088891|Protective Agents|protective agents|mesh-ancestor
102418703|NCT03088891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418704|NCT01477892|Remifentanil|remifentanil|mesh-list
102418705|NCT01477892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102418706|NCT01477892|Narcotics|narcotics|mesh-ancestor
102418707|NCT01477892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102418708|NCT01477892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418709|NCT01477892|Analgesics|analgesics|mesh-ancestor
102418710|NCT01477892|Sensory System Agents|sensory system agents|mesh-ancestor
102418711|NCT01477892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102418712|NCT00801801|Docetaxel|docetaxel|mesh-list
102418713|NCT00801801|Sorafenib|sorafenib|mesh-list
102418714|NCT00801801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102418715|NCT00801801|Tubulin Modulators|tubulin modulators|mesh-ancestor
102418716|NCT00801801|Antimitotic Agents|antimitotic agents|mesh-ancestor
102418717|NCT00801801|Mitosis Modulators|mitosis modulators|mesh-ancestor
102049368|NCT02099240|Minocycline|minocycline|mesh-list
102418718|NCT00801801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418719|NCT00801801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102418720|NCT00801801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102418721|NCT01499576|Acetic Acid|acetic acid|mesh-list
102418722|NCT01499576|Retinol acetate|retinol acetate|mesh-list
102418723|NCT01499576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102418724|NCT01499576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102418725|NCT01499576|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102418726|NCT01499576|Immunologic Factors|immunologic factors|mesh-ancestor
102418727|NCT01499576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418728|NCT01499576|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102418729|NCT01499576|Protective Agents|protective agents|mesh-ancestor
102418730|NCT01499576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102418731|NCT04546074|Pembrolizumab|pembrolizumab|mesh-list
102418732|NCT04546074|Imatinib Mesylate|imatinib mesylate|mesh-list
102418733|NCT04546074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102418734|NCT04546074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102418735|NCT04546074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102418736|NCT04546074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418737|NCT04546074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102418738|NCT04546074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102418739|NCT00802113|Fludarabine|fludarabine|mesh-list
102418740|NCT00802113|Busulfan|busulfan|mesh-list
102418741|NCT00802113|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102418742|NCT00802113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102418743|NCT00802113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418744|NCT00802113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102418745|NCT00802113|Immunologic Factors|immunologic factors|mesh-ancestor
102418746|NCT00802113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418747|NCT00802113|Alkylating Agents|alkylating agents|mesh-ancestor
102418748|NCT00802113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102418749|NCT00802113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102418750|NCT03084601|Calcium|calcium|mesh-list
102418751|NCT03084601|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102418752|NCT03084601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418753|NCT00791973|Fluticasone|fluticasone|mesh-list
102418754|NCT00791973|Xhance|xhance|mesh-list
102418755|NCT00791973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102418756|NCT00791973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102418757|NCT00791973|Autonomic Agents|autonomic agents|mesh-ancestor
102418758|NCT00791973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102418759|NCT00791973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418760|NCT00791973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102418761|NCT00791973|Respiratory System Agents|respiratory system agents|mesh-ancestor
102418762|NCT00791973|Dermatologic Agents|dermatologic agents|mesh-ancestor
102418763|NCT00791973|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102418764|NCT00773955|Acetic Acid|acetic acid|mesh-list
102418765|NCT00773955|Retinol acetate|retinol acetate|mesh-list
102418766|NCT00773955|Gossypol acetic acid|gossypol acetic acid|mesh-list
102418767|NCT00773955|Gossypol|gossypol|mesh-list
102418768|NCT00773955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102418769|NCT00773955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102418770|NCT00773955|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102418771|NCT00773955|Immunologic Factors|immunologic factors|mesh-ancestor
102418772|NCT00773955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418773|NCT00773955|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102418774|NCT00773955|Protective Agents|protective agents|mesh-ancestor
102418775|NCT00773955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102418776|NCT00773955|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102418777|NCT00773955|Contraceptive Agents|contraceptive agents|mesh-ancestor
102418778|NCT00773955|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102418779|NCT00773955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102418780|NCT00773955|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102418781|NCT00773955|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
102418782|NCT00773955|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
102418784|NCT01421459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102418785|NCT01421459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418786|NCT01498952|Sorafenib|sorafenib|mesh-list
102418787|NCT01498952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102418788|NCT01498952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102418789|NCT01498952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102418790|NCT01498952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418791|NCT04499196|Glucocorticoids|glucocorticoids|mesh-list
102418792|NCT04499196|Hormones|hormones|mesh-ancestor
102418793|NCT04499196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102418794|NCT04499196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418795|NCT04608266|Camostat|camostat|mesh-list
102418796|NCT04608266|Protease Inhibitors|protease inhibitors|mesh-ancestor
102418797|NCT04608266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102418798|NCT04608266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418799|NCT04608266|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102418800|NCT04608266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102418801|NCT00774267|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
102418802|NCT00774267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102418803|NCT00774267|Hormone Antagonists|hormone antagonists|mesh-ancestor
102418804|NCT00774267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102418805|NCT00774267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418806|NCT00774267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102418807|NCT00774267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102418808|NCT00774267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102418809|NCT04460352|Leucovorin|leucovorin|mesh-list
102418810|NCT04460352|Paclitaxel|paclitaxel|mesh-list
102418811|NCT04460352|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102418812|NCT04460352|Carboplatin|carboplatin|mesh-list
102418813|NCT04460352|Fluorouracil|fluorouracil|mesh-list
102418814|NCT04460352|Oxaliplatin|oxaliplatin|mesh-list
102418815|NCT04460352|Calcium|calcium|mesh-list
102418816|NCT04460352|Levoleucovorin|levoleucovorin|mesh-list
102418817|NCT04460352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102418818|NCT04460352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102418819|NCT04460352|Tubulin Modulators|tubulin modulators|mesh-ancestor
102418820|NCT04460352|Antimitotic Agents|antimitotic agents|mesh-ancestor
102418821|NCT04460352|Mitosis Modulators|mitosis modulators|mesh-ancestor
102418822|NCT04460352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418823|NCT04460352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102418824|NCT04460352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418825|NCT04460352|Antimetabolites|antimetabolites|mesh-ancestor
102418826|NCT04460352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102418827|NCT04460352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102418828|NCT04460352|Immunologic Factors|immunologic factors|mesh-ancestor
102418829|NCT04460352|Antidotes|antidotes|mesh-ancestor
102418830|NCT04460352|Protective Agents|protective agents|mesh-ancestor
102418831|NCT04460352|Vitamin B Complex|vitamin b complex|mesh-ancestor
102418832|NCT04460352|Vitamins|vitamins|mesh-ancestor
102418833|NCT04460352|Micronutrients|micronutrients|mesh-ancestor
102418834|NCT03083353|Isradipine|isradipine|mesh-list
102418835|NCT03083353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102418836|NCT03083353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102418837|NCT03083353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102418838|NCT03083353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418839|NCT03083353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102418840|NCT03083353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230466|NCT02519335|Protective Agents|protective agents|mesh-ancestor
102418841|NCT03083353|Vasodilator Agents|vasodilator agents|mesh-ancestor
102418842|NCT01421303|Etanercept|etanercept|mesh-list
102418843|NCT01421303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102418844|NCT01421303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102418845|NCT01421303|Analgesics|analgesics|mesh-ancestor
102418846|NCT01421303|Sensory System Agents|sensory system agents|mesh-ancestor
102418847|NCT01421303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102418848|NCT01421303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418849|NCT01421303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102418850|NCT01421303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102418851|NCT01421303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102418852|NCT01421303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102418853|NCT01421303|Immunologic Factors|immunologic factors|mesh-ancestor
102418854|NCT03703375|Gemcitabine|gemcitabine|mesh-list
102418855|NCT03703375|Azacitidine|azacitidine|mesh-list
102418856|NCT03703375|Romidepsin|romidepsin|mesh-list
102418857|NCT03703375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102418858|NCT03703375|Antimetabolites|antimetabolites|mesh-ancestor
102418859|NCT03703375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418860|NCT03703375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102418861|NCT03703375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102418862|NCT03703375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102418863|NCT03703375|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102418864|NCT05303688|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
102418865|NCT05303688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102418866|NCT05303688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102418867|NCT05303688|Analgesics|analgesics|mesh-ancestor
102418868|NCT05303688|Sensory System Agents|sensory system agents|mesh-ancestor
102418869|NCT05303688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102418870|NCT05303688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418871|NCT05303688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102418872|NCT05303688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102418873|NCT04383717|Azithromycin|azithromycin|mesh-list
102418874|NCT04383717|Hydroxychloroquine|hydroxychloroquine|mesh-list
102418875|NCT04383717|Levamisole|levamisole|mesh-list
102418876|NCT04383717|Inosine Pranobex|inosine pranobex|mesh-list
102418877|NCT04383717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102418878|NCT04383717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102418879|NCT04383717|Antimalarials|antimalarials|mesh-ancestor
102418880|NCT04383717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102418881|NCT04383717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102418882|NCT04383717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102418883|NCT04383717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418884|NCT04383717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102418885|NCT04383717|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102418886|NCT04383717|Immunologic Factors|immunologic factors|mesh-ancestor
102418887|NCT04383717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418888|NCT04383717|Antinematodal Agents|antinematodal agents|mesh-ancestor
102418889|NCT04383717|Anthelmintics|anthelmintics|mesh-ancestor
102418890|NCT04383717|Antiviral Agents|antiviral agents|mesh-ancestor
102418891|NCT01400243|Nicotine|nicotine|mesh-list
102418892|NCT01400243|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102418893|NCT01400243|Autonomic Agents|autonomic agents|mesh-ancestor
102418894|NCT01400243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102418895|NCT01400243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418896|NCT01400243|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102418897|NCT01400243|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102418898|NCT01400243|Cholinergic Agents|cholinergic agents|mesh-ancestor
102418899|NCT01400243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102418900|NCT01400243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418901|NCT00809055|Caffeine|caffeine|mesh-list
102418902|NCT00809055|Caffeine citrate|caffeine citrate|mesh-list
102418903|NCT00809055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418904|NCT00809055|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102418905|NCT00809055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418906|NCT00809055|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102418907|NCT00809055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102418908|NCT00809055|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102418909|NCT00809055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102418910|NCT00809055|Purinergic Agents|purinergic agents|mesh-ancestor
102418911|NCT00809055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102418912|NCT01421225|Insulin|insulin|mesh-list
102418913|NCT01421225|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102418914|NCT01421225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102230545|NCT03364075|Analgesics|analgesics|mesh-ancestor
102418915|NCT01421225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418916|NCT03082885|Thymalfasin|thymalfasin|mesh-list
102418917|NCT03082885|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102418918|NCT03082885|Immunologic Factors|immunologic factors|mesh-ancestor
102049592|NCT05215743|Siderophores|siderophores|mesh-ancestor
102418919|NCT03082885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418920|NCT04382781|Immunosuppressive Agents|immunosuppressive agents|mesh-list
102418921|NCT04382781|Immunologic Factors|immunologic factors|mesh-ancestor
102418922|NCT04382781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418923|NCT05688631|Antioxidants|antioxidants|mesh-list
102418924|NCT05688631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418925|NCT05688631|Protective Agents|protective agents|mesh-ancestor
102418926|NCT05688631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418927|NCT04348032|Apatinib|apatinib|mesh-list
102418928|NCT04348032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102418929|NCT04348032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102418930|NCT04348032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102418931|NCT04348032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418932|NCT05007873|Decitabine|decitabine|mesh-list
102418933|NCT05007873|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
102418934|NCT05007873|Dasatinib|dasatinib|mesh-list
102418935|NCT05007873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102418936|NCT05007873|Antimetabolites|antimetabolites|mesh-ancestor
102418937|NCT05007873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418938|NCT05007873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102418939|NCT05007873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102418940|NCT05007873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102418941|NCT01474772|Pregabalin|pregabalin|mesh-list
102418942|NCT01474772|Analgesics|analgesics|mesh-ancestor
102418943|NCT01474772|Sensory System Agents|sensory system agents|mesh-ancestor
102418944|NCT01474772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102418945|NCT01474772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418946|NCT01474772|Anticonvulsants|anticonvulsants|mesh-ancestor
102418947|NCT01474772|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102418948|NCT01474772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102418949|NCT01474772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418950|NCT01474772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102418951|NCT01474772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102418952|NCT01474772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102418953|NCT01474772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102418954|NCT01474772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102418955|NCT03082339|Cortisone|cortisone|mesh-list
102418956|NCT03082339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102418957|NCT03801759|Adefovir|adefovir|mesh-list
102418958|NCT03801759|Digoxin|digoxin|mesh-list
102418959|NCT03801759|Furosemide|furosemide|mesh-list
102418960|NCT03801759|Diuretics|diuretics|mesh-ancestor
102418961|NCT03801759|Natriuretic Agents|natriuretic agents|mesh-ancestor
102418962|NCT03801759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418963|NCT03801759|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102418964|NCT03801759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102418965|NCT03801759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418966|NCT03801759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102418967|NCT03801759|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102418968|NCT03801759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102418969|NCT03801759|Protective Agents|protective agents|mesh-ancestor
102418970|NCT03801759|Antiviral Agents|antiviral agents|mesh-ancestor
102418971|NCT03801759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102418972|NCT03801759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102418973|NCT03801759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102418974|NCT01421147|Insulin Lispro|insulin lispro|mesh-list
102418975|NCT01421147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102418976|NCT01421147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418977|NCT03082573|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102418978|NCT03082573|Hormones|hormones|mesh-ancestor
102418979|NCT03082573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102418980|NCT03082573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418981|NCT01497938|Insulin|insulin|mesh-list
102418982|NCT01497938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102418983|NCT01497938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102418984|NCT03092154|Hypolipidemic Agents|hypolipidemic agents|mesh-list
102418985|NCT03092154|Antimetabolites|antimetabolites|mesh-ancestor
102418986|NCT03092154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418987|NCT03092154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102418988|NCT04301310|Rifampin|rifampin|mesh-list
102418989|NCT04301310|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102418990|NCT04301310|Antitubercular Agents|antitubercular agents|mesh-ancestor
102418991|NCT04301310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102418992|NCT04301310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102418993|NCT04301310|Leprostatic Agents|leprostatic agents|mesh-ancestor
102418994|NCT04301310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102418995|NCT04301310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102418996|NCT04301310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102418997|NCT04301310|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102418998|NCT04301310|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102418999|NCT04301310|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102419000|NCT04301310|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102419001|NCT04301310|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102419002|NCT04301310|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102419004|NCT03026894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102419005|NCT03026894|Antifungal Agents|antifungal agents|mesh-ancestor
102419006|NCT03026894|Keratolytic Agents|keratolytic agents|mesh-ancestor
102419007|NCT03026894|Dermatologic Agents|dermatologic agents|mesh-ancestor
102419008|NCT00804609|Lidocaine|lidocaine|mesh-list
102419009|NCT00804609|Morphine|morphine|mesh-list
102419010|NCT00804609|Anesthetics|anesthetics|mesh-list
102419011|NCT00804609|Anesthetics, Local|anesthetics, local|mesh-ancestor
102419012|NCT00804609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102419013|NCT00804609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419014|NCT00804609|Sensory System Agents|sensory system agents|mesh-ancestor
102419015|NCT00804609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102419016|NCT00804609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102419017|NCT00804609|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102419018|NCT00804609|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102419019|NCT00804609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102419020|NCT00804609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419021|NCT00804609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102419022|NCT00804609|Narcotics|narcotics|mesh-ancestor
102419023|NCT00804609|Analgesics|analgesics|mesh-ancestor
102419024|NCT03082183|Rifampin|rifampin|mesh-list
102419025|NCT03082183|BI 425809|bi 425809|mesh-list
102419026|NCT03082183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102419027|NCT03082183|Antitubercular Agents|antitubercular agents|mesh-ancestor
102419028|NCT03082183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102419029|NCT03082183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102419030|NCT03082183|Leprostatic Agents|leprostatic agents|mesh-ancestor
102419031|NCT03082183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102419032|NCT03082183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102419033|NCT03082183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419034|NCT03082183|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102419035|NCT03082183|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102419036|NCT03082183|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102419037|NCT03082183|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102419038|NCT03082183|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102419039|NCT03082183|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102419040|NCT03082183|Nootropic Agents|nootropic agents|mesh-ancestor
102419041|NCT03361735|Leuprolide|leuprolide|mesh-list
102419042|NCT03361735|Goserelin|goserelin|mesh-list
102419043|NCT03361735|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
102419044|NCT03361735|Hormones|hormones|mesh-list
102049739|NCT04964193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419045|NCT03361735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102419046|NCT03361735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419047|NCT03361735|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102419048|NCT03361735|Fertility Agents|fertility agents|mesh-ancestor
102419049|NCT03361735|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102419050|NCT03361735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102419051|NCT03361735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102419052|NCT00804999|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102419053|NCT00804999|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102419054|NCT00804999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102419055|NCT04283604|Methylphenidate|methylphenidate|mesh-list
102419056|NCT04283604|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102419057|NCT04283604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419058|NCT04283604|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102419059|NCT04283604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102419060|NCT04283604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102419061|NCT04283604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419062|NCT04283604|Dopamine Agents|dopamine agents|mesh-ancestor
102419063|NCT04283604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102419064|NCT00810303|Efavirenz|efavirenz|mesh-list
102419065|NCT00810303|Ezetimibe|ezetimibe|mesh-list
102419066|NCT00810303|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102419067|NCT00810303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102419068|NCT00810303|Antimetabolites|antimetabolites|mesh-ancestor
102419069|NCT00810303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419070|NCT00810303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102419071|NCT00810303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102419072|NCT00810303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102419073|NCT00810303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102419074|NCT00810303|Antiviral Agents|antiviral agents|mesh-ancestor
102419075|NCT00810303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102419076|NCT00810303|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102419077|NCT00810303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102419078|NCT00810303|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102419079|NCT00810303|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102419080|NCT00810303|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102419081|NCT00810303|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102419082|NCT04401085|Antibodies|antibodies|mesh-list
102419083|NCT04401085|Immunologic Factors|immunologic factors|mesh-ancestor
102419084|NCT04401085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419085|NCT05645107|Immunoglobulins|immunoglobulins|mesh-list
102419086|NCT05645107|gamma-Globulins|gamma-globulins|mesh-list
102419087|NCT05645107|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102419088|NCT05645107|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102419089|NCT05645107|Immunologic Factors|immunologic factors|mesh-ancestor
102419090|NCT05645107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419091|NCT04227756|Psilocybin|psilocybin|mesh-list
102419092|NCT04227756|Mescaline|mescaline|mesh-list
102419093|NCT04227756|Hallucinogens|hallucinogens|mesh-ancestor
102419094|NCT04227756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419095|NCT04227756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102419096|NCT04227756|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102419097|NCT04227756|Serotonin Agents|serotonin agents|mesh-ancestor
102419098|NCT04227756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102419099|NCT04227756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419100|NCT01460342|Tadalafil|tadalafil|mesh-list
102419101|NCT01460342|Vasodilator Agents|vasodilator agents|mesh-ancestor
102419102|NCT01460342|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102419103|NCT01460342|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102419104|NCT01460342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102419105|NCT01460342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419106|NCT01460342|Urological Agents|urological agents|mesh-ancestor
102419107|NCT00775671|Metoprolol|metoprolol|mesh-list
102419108|NCT00775671|Nebivolol|nebivolol|mesh-list
102419109|NCT00775671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102419110|NCT00775671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102419111|NCT00775671|Sympatholytics|sympatholytics|mesh-ancestor
102419112|NCT00775671|Autonomic Agents|autonomic agents|mesh-ancestor
102419113|NCT00775671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102049799|NCT02098460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102419114|NCT00775671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419115|NCT00775671|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102419116|NCT00775671|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102419117|NCT00775671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102419118|NCT00775671|Adrenergic Agents|adrenergic agents|mesh-ancestor
102419119|NCT00775671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102419120|NCT00775671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419121|NCT00775671|Vasodilator Agents|vasodilator agents|mesh-ancestor
102419122|NCT00775671|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102419123|NCT00775671|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102419124|NCT00775671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102419125|NCT03800745|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
102419126|NCT03800745|Laxatives|laxatives|mesh-ancestor
102419127|NCT03800745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102419128|NCT01459796|Rilonacept|rilonacept|mesh-list
102419129|NCT01459796|Allopurinol|allopurinol|mesh-list
102419130|NCT01459796|Antimetabolites|antimetabolites|mesh-ancestor
102419131|NCT01459796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419132|NCT01459796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102419133|NCT01459796|Gout Suppressants|gout suppressants|mesh-ancestor
102419134|NCT01459796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102419135|NCT01459796|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102419136|NCT01459796|Antioxidants|antioxidants|mesh-ancestor
102419137|NCT01459796|Protective Agents|protective agents|mesh-ancestor
102419138|NCT01459796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419140|NCT04721691|Cannabidiol|cannabidiol|mesh-list
102419141|NCT04721691|Anticonvulsants|anticonvulsants|mesh-ancestor
102419142|NCT04760821|Trimetazidine|trimetazidine|mesh-list
102419143|NCT04760821|Vasodilator Agents|vasodilator agents|mesh-ancestor
102419144|NCT04382079|Propolis|propolis|mesh-list
102419145|NCT04382079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102419146|NCT05688007|Hormones|hormones|mesh-list
102419147|NCT05688007|Parathyroid Hormone|parathyroid hormone|mesh-list
102419148|NCT05688007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102419149|NCT05688007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419150|NCT05688007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102419151|NCT01459718|Deferasirox|deferasirox|mesh-list
102419152|NCT01459718|Deferoxamine|deferoxamine|mesh-list
102419153|NCT01459718|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102419154|NCT01459718|Chelating Agents|chelating agents|mesh-ancestor
102419155|NCT01459718|Sequestering Agents|sequestering agents|mesh-ancestor
102419156|NCT01459718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419157|NCT01459718|Siderophores|siderophores|mesh-ancestor
102419158|NCT04918407|Empagliflozin|empagliflozin|mesh-list
102419159|NCT04918407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102419160|NCT04918407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419161|NCT04918407|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102419162|NCT04918407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419163|NCT04989660|Phenol|phenol|mesh-list
102419164|NCT04989660|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102419165|NCT04989660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102419166|NCT04989660|Disinfectants|disinfectants|mesh-ancestor
102419167|NCT04989660|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102419168|NCT04989660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102419169|NCT02970318|Rituximab|rituximab|mesh-list
102419170|NCT02970318|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102419171|NCT02970318|Acalabrutinib|acalabrutinib|mesh-list
102419172|NCT02970318|Idelalisib|idelalisib|mesh-list
102419173|NCT02970318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102419174|NCT02970318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102419175|NCT02970318|Immunologic Factors|immunologic factors|mesh-ancestor
102419176|NCT02970318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419177|NCT02970318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102419178|NCT02970318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102419179|NCT02970318|Alkylating Agents|alkylating agents|mesh-ancestor
102419180|NCT02970318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419181|NCT02970318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102419182|NCT03081325|Immunomodulating Agents|immunomodulating agents|mesh-list
102419183|NCT03081325|Immunologic Factors|immunologic factors|mesh-ancestor
102419184|NCT03081325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419185|NCT04384731|Poractant alfa|poractant alfa|mesh-list
102419186|NCT04384731|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
102419187|NCT04384731|Respiratory System Agents|respiratory system agents|mesh-ancestor
102419188|NCT05042466|Psilocybin|psilocybin|mesh-list
102419189|NCT05042466|Hallucinogens|hallucinogens|mesh-ancestor
102419190|NCT05042466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419191|NCT05042466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102419192|NCT05615467|Metformin|metformin|mesh-list
102419193|NCT05615467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102419194|NCT05615467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419195|NCT03800433|Pentoxifylline|pentoxifylline|mesh-list
102419196|NCT03800433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102419197|NCT03800433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102419198|NCT03800433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419199|NCT03800433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102419200|NCT03800433|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102419201|NCT03800433|Protective Agents|protective agents|mesh-ancestor
102419202|NCT03800433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419203|NCT03800433|Vasodilator Agents|vasodilator agents|mesh-ancestor
102419204|NCT03800433|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102419205|NCT03800433|Antioxidants|antioxidants|mesh-ancestor
102419206|NCT03395899|Bevacizumab|bevacizumab|mesh-list
102419207|NCT03395899|Atezolizumab|atezolizumab|mesh-list
102419208|NCT03395899|Ipatasertib|ipatasertib|mesh-list
102419209|NCT03395899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102419210|NCT03395899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102419211|NCT03395899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102419212|NCT03395899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102419213|NCT03395899|Growth Substances|growth substances|mesh-ancestor
102419214|NCT03395899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419215|NCT03395899|Growth Inhibitors|growth inhibitors|mesh-ancestor
102419216|NCT03395899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102419217|NCT03395899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419218|NCT03395899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102419219|NCT03395899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102419220|NCT02900976|Rituximab|rituximab|mesh-list
102419221|NCT02900976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102419222|NCT02900976|Antibodies|antibodies|mesh-list
102419223|NCT02900976|Immunoglobulins|immunoglobulins|mesh-list
102419224|NCT02900976|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102419225|NCT02900976|Immunologic Factors|immunologic factors|mesh-ancestor
102419226|NCT02900976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419227|NCT02900976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102419228|NCT02900976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102419229|NCT05602597|Itraconazole|itraconazole|mesh-list
102419230|NCT05602597|Fluconazole|fluconazole|mesh-list
102419231|NCT05602597|Rifampin|rifampin|mesh-list
102419232|NCT05602597|Rabeprazole|rabeprazole|mesh-list
102419233|NCT05602597|Antifungal Agents|antifungal agents|mesh-ancestor
102419234|NCT05602597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102419235|NCT05602597|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102419236|NCT05602597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102419237|NCT05602597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102419238|NCT05602597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419239|NCT05602597|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102419240|NCT05602597|Hormone Antagonists|hormone antagonists|mesh-ancestor
102419241|NCT05602597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102419242|NCT05602597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419243|NCT05602597|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102419244|NCT05602597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102419245|NCT05602597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102419246|NCT05602597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102419247|NCT05602597|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102419248|NCT05602597|Antitubercular Agents|antitubercular agents|mesh-ancestor
102419249|NCT05602597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102419250|NCT05602597|Leprostatic Agents|leprostatic agents|mesh-ancestor
102419251|NCT05602597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102419252|NCT05602597|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102419253|NCT05602597|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102419254|NCT05602597|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102419255|NCT05602597|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102419256|NCT05602597|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102419257|NCT05602597|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102419258|NCT05602597|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102419259|NCT05602597|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102419260|NCT04608201|Nicotine|nicotine|mesh-list
102419261|NCT04608201|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102419262|NCT04608201|Autonomic Agents|autonomic agents|mesh-ancestor
102419263|NCT04608201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102419264|NCT04608201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419265|NCT04608201|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102419266|NCT04608201|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102419267|NCT04608201|Cholinergic Agents|cholinergic agents|mesh-ancestor
102419268|NCT04608201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102419269|NCT04608201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419270|NCT04110444|Sildenafil Citrate|sildenafil citrate|mesh-list
102419271|NCT04110444|Vasodilator Agents|vasodilator agents|mesh-ancestor
102419272|NCT04110444|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102419273|NCT04110444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102419274|NCT04110444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102419275|NCT04110444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419276|NCT04110444|Urological Agents|urological agents|mesh-ancestor
102419277|NCT04951986|Levofloxacin|levofloxacin|mesh-list
102419278|NCT04951986|Rifampin|rifampin|mesh-list
102419279|NCT04951986|Isoniazid|isoniazid|mesh-list
102419280|NCT04951986|Pyrazinamide|pyrazinamide|mesh-list
102419281|NCT04951986|Ethambutol|ethambutol|mesh-list
102419282|NCT04951986|Prednisone|prednisone|mesh-list
102419283|NCT04951986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102419284|NCT04951986|Glucocorticoids|glucocorticoids|mesh-ancestor
102419285|NCT04951986|Hormones|hormones|mesh-ancestor
102419286|NCT04951986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102419287|NCT04951986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419289|NCT04951986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102419290|NCT04951986|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102419291|NCT04951986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102419292|NCT04951986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102419293|NCT04951986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102419294|NCT04951986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102419295|NCT04951986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102419296|NCT04951986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419297|NCT04951986|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102419298|NCT04951986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102419299|NCT04951986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102419300|NCT04951986|Antitubercular Agents|antitubercular agents|mesh-ancestor
102419301|NCT04951986|Leprostatic Agents|leprostatic agents|mesh-ancestor
102419302|NCT04951986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102419303|NCT04951986|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102419304|NCT04951986|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102419305|NCT04951986|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102419306|NCT04951986|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102419307|NCT04951986|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102419308|NCT04951986|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102419309|NCT04951986|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102419310|NCT04951986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102419311|NCT04951986|Antimetabolites|antimetabolites|mesh-ancestor
102419312|NCT04951986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102419313|NCT04278859|Antibodies|antibodies|mesh-list
102419314|NCT04278859|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102419315|NCT04278859|Immunologic Factors|immunologic factors|mesh-ancestor
102419316|NCT04278859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419317|NCT04484337|Cabotegravir|cabotegravir|mesh-list
102419318|NCT04484337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102419319|NCT04484337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
102419320|NCT04484337|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102419321|NCT04484337|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102419322|NCT04484337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102419323|NCT04484337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419324|NCT04484337|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102419325|NCT04484337|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102419326|NCT04484337|Antiviral Agents|antiviral agents|mesh-ancestor
102419327|NCT04484337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102419328|NCT04484337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102419329|NCT04484337|Analgesics|analgesics|mesh-ancestor
102419330|NCT04484337|Sensory System Agents|sensory system agents|mesh-ancestor
102419331|NCT04484337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102419332|NCT04484337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419333|NCT04484337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102419334|NCT01474538|Insulin|insulin|mesh-list
102419335|NCT01474538|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102419336|NCT01474538|Insulin Aspart|insulin aspart|mesh-list
102419337|NCT01474538|Insulin Lispro|insulin lispro|mesh-list
102419338|NCT01474538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102419339|NCT01474538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419340|NCT04278703|Oxycodone|oxycodone|mesh-list
102419341|NCT04278703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102419342|NCT04278703|Narcotics|narcotics|mesh-ancestor
102419343|NCT04278703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102419344|NCT04278703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419345|NCT04278703|Analgesics|analgesics|mesh-ancestor
102419346|NCT04278703|Sensory System Agents|sensory system agents|mesh-ancestor
102419347|NCT04278703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102419348|NCT02647788|Acetaminophen|acetaminophen|mesh-list
102419349|NCT02647788|Ibuprofen|ibuprofen|mesh-list
102419350|NCT02647788|Codeine|codeine|mesh-list
102419351|NCT02647788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102419352|NCT02647788|Analgesics|analgesics|mesh-ancestor
102419353|NCT02647788|Sensory System Agents|sensory system agents|mesh-ancestor
102419354|NCT02647788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102419355|NCT02647788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419356|NCT02647788|Antipyretics|antipyretics|mesh-ancestor
102419357|NCT02647788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102419358|NCT02647788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102419359|NCT02647788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102419360|NCT02647788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102419361|NCT02647788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102419362|NCT02647788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419363|NCT02647788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102419364|NCT02647788|Narcotics|narcotics|mesh-ancestor
102419365|NCT02647788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102419366|NCT02647788|Antitussive Agents|antitussive agents|mesh-ancestor
102419367|NCT02647788|Respiratory System Agents|respiratory system agents|mesh-ancestor
102419368|NCT04382859|Bupivacaine|bupivacaine|mesh-list
102419369|NCT04382859|Anesthetics, Local|anesthetics, local|mesh-ancestor
102419370|NCT04382859|Anesthetics|anesthetics|mesh-ancestor
102419371|NCT04382859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102419372|NCT04382859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050076|NCT03117361|Hormones|hormones|mesh-ancestor
102419373|NCT04382859|Sensory System Agents|sensory system agents|mesh-ancestor
102419374|NCT04382859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102419375|NCT03318133|Anesthetics|anesthetics|mesh-list
102419376|NCT03318133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102419377|NCT03318133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419378|NCT04520217|Imipramine|imipramine|mesh-list
102419379|NCT04520217|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102419380|NCT04520217|Antidepressive Agents|antidepressive agents|mesh-ancestor
102419381|NCT04520217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102419382|NCT04520217|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102419383|NCT04520217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102419384|NCT04520217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102419385|NCT04520217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419386|NCT04520217|Adrenergic Agents|adrenergic agents|mesh-ancestor
102419387|NCT04520217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102419388|NCT04520217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419389|NCT04134663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
102419390|NCT04134663|Oxytocin|oxytocin|mesh-list
102419391|NCT04134663|Oxytocics|oxytocics|mesh-ancestor
102419392|NCT04134663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102419393|NCT04134663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419394|NCT05431764|Gemcitabine|gemcitabine|mesh-list
102419395|NCT05431764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102419396|NCT05431764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102419397|NCT05431764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419398|NCT05431764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102419399|NCT05431764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102419400|NCT05431764|Antimetabolites|antimetabolites|mesh-ancestor
102419401|NCT04311411|Liraglutide|liraglutide|mesh-list
102419402|NCT04311411|Tirzepatide|tirzepatide|mesh-list
102419403|NCT04311411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102419404|NCT04311411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419405|NCT04311411|Incretins|incretins|mesh-ancestor
102419406|NCT04311411|Hormones|hormones|mesh-ancestor
102419407|NCT04311411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102419408|NCT00843531|Everolimus|everolimus|mesh-list
102419409|NCT00843531|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102419410|NCT00843531|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102419411|NCT00843531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102419412|NCT00843531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102419413|NCT00843531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419414|NCT00843531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102419415|NCT00843531|Immunologic Factors|immunologic factors|mesh-ancestor
102419416|NCT00843531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419417|NCT00843531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102419418|NCT00812877|Calcium|calcium|mesh-list
102419419|NCT00812877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102419420|NCT00812877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419421|NCT00813111|Epinephrine|epinephrine|mesh-list
102419422|NCT00813111|Bupivacaine|bupivacaine|mesh-list
102419423|NCT00813111|Anesthetics, Local|anesthetics, local|mesh-ancestor
102419424|NCT00813111|Anesthetics|anesthetics|mesh-ancestor
102419425|NCT00813111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102419426|NCT00813111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419427|NCT00813111|Sensory System Agents|sensory system agents|mesh-ancestor
102419428|NCT00813111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102419429|NCT00813111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102419430|NCT00813111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102419431|NCT00813111|Adrenergic Agents|adrenergic agents|mesh-ancestor
102419432|NCT00813111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102419433|NCT00813111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419434|NCT00813111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102419435|NCT00813111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102419436|NCT00813111|Autonomic Agents|autonomic agents|mesh-ancestor
102419437|NCT00813111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102419438|NCT00813111|Respiratory System Agents|respiratory system agents|mesh-ancestor
102419439|NCT00813111|Mydriatics|mydriatics|mesh-ancestor
102419440|NCT00813111|Sympathomimetics|sympathomimetics|mesh-ancestor
102419441|NCT00813111|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102419443|NCT00845481|Betamethasone|betamethasone|mesh-list
102419444|NCT00845481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102419445|NCT00845481|Glucocorticoids|glucocorticoids|mesh-ancestor
102419446|NCT00845481|Hormones|hormones|mesh-ancestor
102419447|NCT00845481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102419448|NCT00845481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419449|NCT00845481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102419450|NCT00845481|Respiratory System Agents|respiratory system agents|mesh-ancestor
102419451|NCT00845481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102419452|NCT00845481|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102419453|NCT00845481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102419454|NCT00845481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419455|NCT00845481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102419456|NCT00845481|Vitamins|vitamins|mesh-ancestor
102419457|NCT00845481|Micronutrients|micronutrients|mesh-ancestor
102419458|NCT00845481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102419459|NCT03641001|Micronutrients|micronutrients|mesh-list
102419460|NCT03641001|Trace Elements|trace elements|mesh-list
102419461|NCT03641001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419462|NCT01421069|Etanercept|etanercept|mesh-list
102419463|NCT01421069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102419464|NCT01421069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102419465|NCT01421069|Analgesics|analgesics|mesh-ancestor
102419466|NCT01421069|Sensory System Agents|sensory system agents|mesh-ancestor
102419467|NCT01421069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102419468|NCT01421069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419469|NCT01421069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102419470|NCT01421069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102419471|NCT01421069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102419472|NCT01421069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102419473|NCT01421069|Immunologic Factors|immunologic factors|mesh-ancestor
102419474|NCT04276233|Albuterol|albuterol|mesh-list
102419475|NCT04276233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102419476|NCT04276233|Autonomic Agents|autonomic agents|mesh-ancestor
102419477|NCT04276233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102419478|NCT04276233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419479|NCT04276233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102419480|NCT04276233|Respiratory System Agents|respiratory system agents|mesh-ancestor
102419481|NCT04276233|Tocolytic Agents|tocolytic agents|mesh-ancestor
102419482|NCT04276233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102419483|NCT04276233|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102419484|NCT04276233|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102419485|NCT04276233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102419486|NCT04276233|Adrenergic Agents|adrenergic agents|mesh-ancestor
102419487|NCT04276233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102050191|NCT02373241|Losartan|losartan|mesh-list
102050202|NCT02103998|Iodine|iodine|mesh-list
102419488|NCT04276233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419489|NCT04681430|Gabexate|gabexate|mesh-list
102419490|NCT04681430|Camostat|camostat|mesh-list
102419491|NCT04681430|Protease Inhibitors|protease inhibitors|mesh-ancestor
102419492|NCT04681430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102419493|NCT04681430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419494|NCT04681430|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102419495|NCT04681430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102419496|NCT04681430|Anticoagulants|anticoagulants|mesh-ancestor
102419497|NCT03309475|Psychotropic Drugs|psychotropic drugs|mesh-list
102419498|NCT00814671|Rifampin|rifampin|mesh-list
102419499|NCT00814671|Rifapentine|rifapentine|mesh-list
102419500|NCT00814671|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102419501|NCT00814671|Antitubercular Agents|antitubercular agents|mesh-ancestor
102419502|NCT00814671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102419503|NCT00814671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102419504|NCT00814671|Leprostatic Agents|leprostatic agents|mesh-ancestor
102419505|NCT00814671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102419506|NCT00814671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102419507|NCT00814671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419508|NCT00814671|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102419509|NCT00814671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102419510|NCT00814671|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102419511|NCT00814671|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102419512|NCT00814671|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102419513|NCT00814671|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102419514|NCT03379051|Lenalidomide|lenalidomide|mesh-list
102419515|NCT03379051|Venetoclax|venetoclax|mesh-list
102419516|NCT03379051|Immunologic Factors|immunologic factors|mesh-ancestor
102419517|NCT03379051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419518|NCT03379051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102419519|NCT03379051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102419520|NCT03379051|Growth Substances|growth substances|mesh-ancestor
102419521|NCT03379051|Growth Inhibitors|growth inhibitors|mesh-ancestor
102419522|NCT03379051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102419523|NCT01473836|Metronidazole|metronidazole|mesh-list
102419524|NCT01473836|Ceftriaxone|ceftriaxone|mesh-list
102419525|NCT01473836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102419526|NCT01473836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102419527|NCT01473836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102419528|NCT01473836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102419529|NCT03340909|Prednisolone|prednisolone|mesh-list
102419530|NCT03340909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102419531|NCT03340909|Glucocorticoids|glucocorticoids|mesh-ancestor
102419532|NCT03340909|Hormones|hormones|mesh-ancestor
102419533|NCT03340909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102419534|NCT03340909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419535|NCT03340909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102419536|NCT03340909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102419537|NCT05686915|Cobalt|cobalt|mesh-list
102419538|NCT05686915|Chromium|chromium|mesh-list
102419539|NCT05686915|Trace Elements|trace elements|mesh-ancestor
102419540|NCT05686915|Micronutrients|micronutrients|mesh-ancestor
102419541|NCT05686915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419542|NCT03674151|Povidone|povidone|mesh-list
102419543|NCT03674151|Plasma Substitutes|plasma substitutes|mesh-ancestor
102419544|NCT03674151|Blood Substitutes|blood substitutes|mesh-ancestor
102419545|NCT03643965|Budesonide|budesonide|mesh-list
102050250|NCT02107742|Lidocaine|lidocaine|mesh-list
102419546|NCT03643965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102419547|NCT03643965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102419548|NCT03643965|Autonomic Agents|autonomic agents|mesh-ancestor
102419549|NCT03643965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102419550|NCT03643965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419551|NCT03643965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102419552|NCT03643965|Respiratory System Agents|respiratory system agents|mesh-ancestor
102419553|NCT03643965|Glucocorticoids|glucocorticoids|mesh-ancestor
102419554|NCT03643965|Hormones|hormones|mesh-ancestor
102419555|NCT03643965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102419556|NCT02979522|Doxorubicin|doxorubicin|mesh-list
102419557|NCT02979522|Dacarbazine|dacarbazine|mesh-list
102419558|NCT02979522|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102419559|NCT02979522|Vinblastine|vinblastine|mesh-list
102419560|NCT02979522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102419561|NCT02979522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102419562|NCT02979522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102419563|NCT02979522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102419564|NCT02979522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102419565|NCT02979522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419566|NCT02979522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102419567|NCT02979522|Alkylating Agents|alkylating agents|mesh-ancestor
102419568|NCT02979522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102419569|NCT02979522|Immunotoxins|immunotoxins|mesh-ancestor
102419570|NCT02979522|Immunoconjugates|immunoconjugates|mesh-ancestor
102419571|NCT02979522|Immunologic Factors|immunologic factors|mesh-ancestor
102419572|NCT02979522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419573|NCT02979522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102419574|NCT02979522|Tubulin Modulators|tubulin modulators|mesh-ancestor
102419575|NCT02979522|Antimitotic Agents|antimitotic agents|mesh-ancestor
102419576|NCT02979522|Mitosis Modulators|mitosis modulators|mesh-ancestor
102419577|NCT01420679|10-deazaaminopterin|10-deazaaminopterin|mesh-list
102419578|NCT01420679|Aminopterin|aminopterin|mesh-list
102419579|NCT01420679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102419580|NCT01420679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102419581|NCT01420679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419582|NCT01420679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102419583|NCT00851409|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
102419584|NCT00851409|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102231221|NCT04475991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102419585|NCT00851409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102419586|NCT00851409|Immunologic Factors|immunologic factors|mesh-ancestor
102419587|NCT00851409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419589|NCT04401007|Anesthetics, Local|anesthetics, local|mesh-ancestor
102419590|NCT04401007|Anesthetics|anesthetics|mesh-ancestor
102419591|NCT04401007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102419592|NCT04401007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419593|NCT04401007|Sensory System Agents|sensory system agents|mesh-ancestor
102419594|NCT04401007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102419595|NCT04401007|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102419596|NCT04401007|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102419597|NCT04401007|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102419598|NCT04401007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102419599|NCT04401007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419600|NCT01496846|Lidocaine|lidocaine|mesh-list
102419601|NCT01496846|Carticaine|carticaine|mesh-list
102419602|NCT01496846|Anesthetics, Local|anesthetics, local|mesh-ancestor
102419603|NCT01496846|Anesthetics|anesthetics|mesh-ancestor
102419604|NCT01496846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102419605|NCT01496846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419606|NCT01496846|Sensory System Agents|sensory system agents|mesh-ancestor
102419607|NCT01496846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102419608|NCT01496846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102419609|NCT01496846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102419610|NCT01496846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102419611|NCT01496846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102419612|NCT01496846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419613|NCT00964002|Efavirenz|efavirenz|mesh-list
102419614|NCT00964002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102419615|NCT00964002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102419616|NCT00964002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102419617|NCT00964002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419618|NCT00964002|Antiviral Agents|antiviral agents|mesh-ancestor
102419619|NCT00964002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102419620|NCT00964002|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102419621|NCT00964002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102419622|NCT00964002|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102419623|NCT00964002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102419624|NCT00964002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102419625|NCT00964002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102419626|NCT00818337|Aspirin|aspirin|mesh-list
102419627|NCT00818337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102419628|NCT00818337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102419629|NCT00818337|Analgesics|analgesics|mesh-ancestor
102419630|NCT00818337|Sensory System Agents|sensory system agents|mesh-ancestor
102419631|NCT00818337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102419632|NCT00818337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419633|NCT00818337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102419634|NCT00818337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102419635|NCT00818337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102419636|NCT00818337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102419637|NCT00818337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419638|NCT00818337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102419639|NCT00818337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102419640|NCT00818337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102419641|NCT00818337|Antipyretics|antipyretics|mesh-ancestor
102419642|NCT02577120|Decanoic acid|decanoic acid|mesh-list
102419643|NCT02577120|Petrolatum|petrolatum|mesh-list
102419644|NCT02577120|Emollients|emollients|mesh-ancestor
102419645|NCT02577120|Dermatologic Agents|dermatologic agents|mesh-ancestor
102419646|NCT02577120|Antifungal Agents|antifungal agents|mesh-ancestor
102419647|NCT02577120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102419648|NCT01399697|Methotrexate|methotrexate|mesh-list
102419649|NCT01399697|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102419650|NCT01399697|Abortifacient Agents|abortifacient agents|mesh-ancestor
102419651|NCT01399697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102419652|NCT01399697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419653|NCT01399697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102419654|NCT01399697|Antimetabolites|antimetabolites|mesh-ancestor
102419655|NCT01399697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419656|NCT01399697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102419657|NCT01399697|Dermatologic Agents|dermatologic agents|mesh-ancestor
102419658|NCT01399697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102419659|NCT01399697|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102419660|NCT01399697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102419661|NCT01399697|Immunologic Factors|immunologic factors|mesh-ancestor
102419662|NCT01399697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102419663|NCT01399697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102419665|NCT00853671|Analgesics|analgesics|mesh-ancestor
102419666|NCT00853671|Sensory System Agents|sensory system agents|mesh-ancestor
102419667|NCT00853671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102419668|NCT00853671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419669|NCT00853671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102419670|NCT00853671|Vasodilator Agents|vasodilator agents|mesh-ancestor
102419671|NCT00853671|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102419672|NCT00853671|Purinergic Agonists|purinergic agonists|mesh-ancestor
102419673|NCT00853671|Purinergic Agents|purinergic agents|mesh-ancestor
102419674|NCT00853671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102419675|NCT00853671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419676|NCT00818805|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
102419677|NCT00818805|Tranilast|tranilast|mesh-list
102419678|NCT00818805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102419679|NCT00818805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102419680|NCT00818805|Analgesics|analgesics|mesh-ancestor
102419681|NCT00818805|Sensory System Agents|sensory system agents|mesh-ancestor
102419682|NCT00818805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102419683|NCT00818805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419684|NCT00818805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102419685|NCT00818805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102419686|NCT00818805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102419687|NCT00818805|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102419688|NCT00818805|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102419689|NCT00818805|Histamine Antagonists|histamine antagonists|mesh-ancestor
102419690|NCT00818805|Histamine Agents|histamine agents|mesh-ancestor
102419691|NCT00818805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102419692|NCT00818805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419693|NCT00818805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102419694|NCT00818805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102419695|NCT00818805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102419696|NCT00818805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102419697|NCT00854061|Prednisone|prednisone|mesh-list
102419698|NCT00854061|Prednisolone acetate|prednisolone acetate|mesh-list
102419699|NCT00854061|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102419700|NCT00854061|Methylprednisolone|methylprednisolone|mesh-list
102419701|NCT00854061|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102419702|NCT00854061|Prednisolone|prednisolone|mesh-list
102419703|NCT00854061|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102419704|NCT00854061|Prednisolone phosphate|prednisolone phosphate|mesh-list
102419705|NCT00854061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102419706|NCT00854061|Glucocorticoids|glucocorticoids|mesh-ancestor
102419707|NCT00854061|Hormones|hormones|mesh-ancestor
102419708|NCT00854061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102419709|NCT00854061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419710|NCT00854061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102419711|NCT00854061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102419712|NCT00854061|Antiemetics|antiemetics|mesh-ancestor
102419713|NCT00854061|Autonomic Agents|autonomic agents|mesh-ancestor
102419714|NCT00854061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102419715|NCT00854061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102419716|NCT00854061|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102419717|NCT00854061|Protective Agents|protective agents|mesh-ancestor
102419718|NCT01473602|Vitamin D|vitamin d|mesh-list
102419719|NCT01473602|Teriparatide|teriparatide|mesh-list
102419720|NCT01473602|Calcium|calcium|mesh-list
102419721|NCT01473602|Vitamins|vitamins|mesh-ancestor
102419722|NCT01473602|Micronutrients|micronutrients|mesh-ancestor
102419723|NCT01473602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419724|NCT01473602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102419725|NCT01473602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102419726|NCT03336073|Dexamethasone|dexamethasone|mesh-list
102419727|NCT03336073|Cyclophosphamide|cyclophosphamide|mesh-list
102419728|NCT03336073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102419729|NCT03336073|Immunologic Factors|immunologic factors|mesh-ancestor
102419730|NCT03336073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419731|NCT03336073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102419732|NCT03336073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102419733|NCT03336073|Alkylating Agents|alkylating agents|mesh-ancestor
102419734|NCT03336073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419735|NCT03336073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102419736|NCT03336073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102419737|NCT03336073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102419738|NCT03336073|Antiemetics|antiemetics|mesh-ancestor
102419739|NCT03336073|Autonomic Agents|autonomic agents|mesh-ancestor
102419740|NCT03336073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102419741|NCT03336073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102419742|NCT03336073|Glucocorticoids|glucocorticoids|mesh-ancestor
102419743|NCT03336073|Hormones|hormones|mesh-ancestor
102419744|NCT03336073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102419745|NCT03336073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102419746|NCT05334433|Anesthetics|anesthetics|mesh-list
102419747|NCT05334433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102419748|NCT05334433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419749|NCT01496612|Buspirone|buspirone|mesh-list
102419750|NCT01496612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102419751|NCT01496612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102419752|NCT01496612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102419753|NCT01496612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419754|NCT01496612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102419755|NCT01496612|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102419756|NCT01496612|Serotonin Agents|serotonin agents|mesh-ancestor
102419757|NCT01496612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102419758|NCT01496612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419759|NCT00790218|Adenosine|adenosine|mesh-list
102419760|NCT00790218|Analgesics|analgesics|mesh-ancestor
102419761|NCT00790218|Sensory System Agents|sensory system agents|mesh-ancestor
102419762|NCT00790218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102419763|NCT00790218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419764|NCT00790218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102419765|NCT00790218|Vasodilator Agents|vasodilator agents|mesh-ancestor
102419766|NCT00790218|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102419767|NCT00790218|Purinergic Agonists|purinergic agonists|mesh-ancestor
102419768|NCT00790218|Purinergic Agents|purinergic agents|mesh-ancestor
102419769|NCT00790218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102419770|NCT00790218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419771|NCT03300427|Valsartan|valsartan|mesh-list
102419772|NCT03300427|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102419773|NCT03300427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102419774|NCT03300427|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102419775|NCT03300427|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102419776|NCT03300427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419777|NCT00818961|Cyclophosphamide|cyclophosphamide|mesh-list
102419778|NCT00818961|Busulfan|busulfan|mesh-list
102419779|NCT00818961|Rituximab|rituximab|mesh-list
102419780|NCT00818961|Methotrexate|methotrexate|mesh-list
102419781|NCT00818961|Fludarabine|fludarabine|mesh-list
102419782|NCT00818961|Fludarabine phosphate|fludarabine phosphate|mesh-list
102419783|NCT00818961|Alemtuzumab|alemtuzumab|mesh-list
102419784|NCT00818961|Tacrolimus|tacrolimus|mesh-list
102419785|NCT00818961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102419786|NCT00818961|Immunologic Factors|immunologic factors|mesh-ancestor
102419787|NCT00818961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419788|NCT00818961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102419789|NCT00818961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102419790|NCT00818961|Alkylating Agents|alkylating agents|mesh-ancestor
102419791|NCT00818961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419792|NCT00818961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102419793|NCT00818961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102050494|NCT02112422|Hormones|hormones|mesh-ancestor
102419794|NCT00818961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102419795|NCT00818961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102419796|NCT00818961|Abortifacient Agents|abortifacient agents|mesh-ancestor
102419797|NCT00818961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102419798|NCT00818961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102419799|NCT00818961|Antimetabolites|antimetabolites|mesh-ancestor
102419800|NCT00818961|Dermatologic Agents|dermatologic agents|mesh-ancestor
102419801|NCT00818961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102419802|NCT00818961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102419803|NCT00818961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102419804|NCT00818961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102419805|NCT05431218|Cholecalciferol|cholecalciferol|mesh-list
102419806|NCT05431218|Vitamin D|vitamin d|mesh-list
102419807|NCT05431218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102419817|NCT05431062|Sensory System Agents|sensory system agents|mesh-ancestor
102419818|NCT05431062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102419820|NCT00819507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102419821|NCT00819507|Glucocorticoids|glucocorticoids|mesh-ancestor
102419822|NCT00819507|Hormones|hormones|mesh-ancestor
102419823|NCT00819507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102419824|NCT00819507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419825|NCT00819507|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102419826|NCT03696121|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
102419827|NCT03696121|Hemostatics|hemostatics|mesh-ancestor
102419828|NCT03696121|Coagulants|coagulants|mesh-ancestor
102419829|NCT03696121|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102419830|NCT03696121|Natriuretic Agents|natriuretic agents|mesh-ancestor
102419831|NCT03696121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419842|NCT01457924|Ofatumumab|ofatumumab|mesh-list
102419843|NCT01457924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102419844|NCT01457924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102419845|NCT01457924|Immunologic Factors|immunologic factors|mesh-ancestor
102419846|NCT01457924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419847|NCT05237115|Amoxicillin|amoxicillin|mesh-list
102419848|NCT05237115|Clarithromycin|clarithromycin|mesh-list
102419849|NCT05237115|Esomeprazole|esomeprazole|mesh-list
102419850|NCT05237115|Bismuth|bismuth|mesh-list
102419851|NCT05237115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102419852|NCT05237115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102419853|NCT05237115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102419854|NCT05237115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102419855|NCT05237115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102419856|NCT05237115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102419857|NCT05237115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419858|NCT05237115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102419859|NCT05237115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102419860|NCT05237115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102419861|NCT05237115|Antacids|antacids|mesh-ancestor
102419862|NCT04040621|Ceftazidime|ceftazidime|mesh-list
102419863|NCT04040621|Avibactam|avibactam|mesh-list
102419864|NCT04040621|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
102419865|NCT04040621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102419866|NCT04040621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102419867|NCT04040621|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102419868|NCT04040621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102419869|NCT04040621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419870|NCT00856791|ON 01910|on 01910|mesh-list
102419871|NCT00856791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102419872|NCT00856791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102419873|NCT00856791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102419874|NCT00856791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419875|NCT00857493|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
102419876|NCT00857493|Antiviral Agents|antiviral agents|mesh-ancestor
102419877|NCT00857493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102419878|NCT05236569|Tranexamic Acid|tranexamic acid|mesh-list
102419879|NCT05236569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102419880|NCT05236569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102419881|NCT05236569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419882|NCT05236569|Hemostatics|hemostatics|mesh-ancestor
102419883|NCT05236569|Coagulants|coagulants|mesh-ancestor
102419884|NCT00857727|Dexmedetomidine|dexmedetomidine|mesh-list
102419885|NCT00857727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102419886|NCT00857727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102419887|NCT00857727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419888|NCT00857727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102419889|NCT00857727|Analgesics|analgesics|mesh-ancestor
102419890|NCT00857727|Sensory System Agents|sensory system agents|mesh-ancestor
102419891|NCT00857727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102419892|NCT00857727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102419893|NCT00857727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102419894|NCT00857727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102419895|NCT00857727|Adrenergic Agents|adrenergic agents|mesh-ancestor
102419896|NCT00857727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102419897|NCT00857727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419898|NCT00857961|Testosterone|testosterone|mesh-list
102419899|NCT00857961|Androgens|androgens|mesh-ancestor
102419900|NCT00857961|Hormones|hormones|mesh-ancestor
102419901|NCT00857961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102419902|NCT00857961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419903|NCT03839433|Ciclesonide|ciclesonide|mesh-list
102419904|NCT03839433|Glucocorticoids|glucocorticoids|mesh-ancestor
102419905|NCT03839433|Hormones|hormones|mesh-ancestor
102419906|NCT03839433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102419907|NCT03839433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419908|NCT03839433|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102419909|NCT05033041|Metoclopramide|metoclopramide|mesh-list
102419910|NCT05033041|Antiemetics|antiemetics|mesh-ancestor
102419911|NCT05033041|Autonomic Agents|autonomic agents|mesh-ancestor
102419912|NCT05033041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102419913|NCT05033041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419914|NCT05033041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102419915|NCT05033041|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102419916|NCT05033041|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102419917|NCT05033041|Dopamine Agents|dopamine agents|mesh-ancestor
102419918|NCT05033041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102419919|NCT05033041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419920|NCT00823797|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102419921|NCT00823797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102419922|NCT00823797|Alkylating Agents|alkylating agents|mesh-ancestor
102419923|NCT00823797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419924|NCT00823797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102419925|NCT00824733|Trastuzumab|trastuzumab|mesh-list
102419926|NCT00824733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102419927|NCT00824733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102419928|NCT02150499|Albuterol|albuterol|mesh-list
102419929|NCT02150499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102419930|NCT02150499|Autonomic Agents|autonomic agents|mesh-ancestor
102419931|NCT02150499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102419932|NCT02150499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419933|NCT02150499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102419934|NCT02150499|Respiratory System Agents|respiratory system agents|mesh-ancestor
102419935|NCT02150499|Tocolytic Agents|tocolytic agents|mesh-ancestor
102419936|NCT02150499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102419937|NCT02150499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102419938|NCT02150499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102419939|NCT02150499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102419940|NCT02150499|Adrenergic Agents|adrenergic agents|mesh-ancestor
102419941|NCT02150499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102419942|NCT02150499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419943|NCT03287947|Nintedanib|nintedanib|mesh-list
102419944|NCT03287947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102419945|NCT03287947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102419946|NCT03287947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102419947|NCT03287947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419948|NCT05685667|Hyaluronic Acid|hyaluronic acid|mesh-list
102419949|NCT05685667|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102419950|NCT05685667|Immunologic Factors|immunologic factors|mesh-ancestor
102419951|NCT05685667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419952|NCT05685667|Viscosupplements|viscosupplements|mesh-ancestor
102419953|NCT05685667|Protective Agents|protective agents|mesh-ancestor
102419954|NCT00859131|Thymoglobulin|thymoglobulin|mesh-list
102419955|NCT00859131|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102419956|NCT00859131|Daclizumab|daclizumab|mesh-list
102419957|NCT00859131|Immunologic Factors|immunologic factors|mesh-ancestor
102419958|NCT00859131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419959|NCT00859131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102419960|NCT00859833|Adenosine|adenosine|mesh-list
102419961|NCT00859833|Regadenoson|regadenoson|mesh-list
102419962|NCT00859833|Analgesics|analgesics|mesh-ancestor
102419963|NCT00859833|Sensory System Agents|sensory system agents|mesh-ancestor
102419964|NCT00859833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102419965|NCT00859833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419966|NCT00859833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102419967|NCT00859833|Vasodilator Agents|vasodilator agents|mesh-ancestor
102419968|NCT00859833|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102419969|NCT00859833|Purinergic Agonists|purinergic agonists|mesh-ancestor
102419970|NCT00859833|Purinergic Agents|purinergic agents|mesh-ancestor
102419971|NCT00859833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102419972|NCT00859833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419973|NCT00859833|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
102419974|NCT02154477|Insulin|insulin|mesh-list
102419975|NCT02154477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102419976|NCT02154477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419977|NCT00860379|Selenium|selenium|mesh-list
102419978|NCT00860379|Antioxidants|antioxidants|mesh-ancestor
102419979|NCT00860379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102419980|NCT00860379|Protective Agents|protective agents|mesh-ancestor
102419981|NCT00860379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419982|NCT00860379|Trace Elements|trace elements|mesh-ancestor
102419983|NCT00860379|Micronutrients|micronutrients|mesh-ancestor
102419984|NCT00860457|Rituximab|rituximab|mesh-list
102419985|NCT00860457|Fludarabine|fludarabine|mesh-list
102419986|NCT00860457|Lenalidomide|lenalidomide|mesh-list
102419987|NCT00860457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102419988|NCT00860457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102419989|NCT00860457|Immunologic Factors|immunologic factors|mesh-ancestor
102419990|NCT00860457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102419991|NCT00860457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102419992|NCT00860457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102419993|NCT00860457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102419994|NCT00860457|Growth Substances|growth substances|mesh-ancestor
102419995|NCT00860457|Growth Inhibitors|growth inhibitors|mesh-ancestor
102419996|NCT00827073|Lidocaine|lidocaine|mesh-list
102419997|NCT00827073|Tetracaine|tetracaine|mesh-list
102419998|NCT00827073|Anesthetics, Local|anesthetics, local|mesh-ancestor
102419999|NCT00827073|Anesthetics|anesthetics|mesh-ancestor
102050676|NCT05103735|Propofol|propofol|mesh-list
102420000|NCT00827073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102420001|NCT00827073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420002|NCT00827073|Sensory System Agents|sensory system agents|mesh-ancestor
102420003|NCT00827073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102420004|NCT00827073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102420005|NCT00827073|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102420006|NCT00827073|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102420007|NCT00827073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102420008|NCT00827073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420009|NCT00860847|Ubiquinone|ubiquinone|mesh-list
102420010|NCT00860847|Coenzyme Q10|coenzyme q10|mesh-list
102420011|NCT00860847|Micronutrients|micronutrients|mesh-ancestor
102420012|NCT00860847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420013|NCT00860847|Vitamins|vitamins|mesh-ancestor
102420014|NCT04347733|Triamcinolone|triamcinolone|mesh-list
102420015|NCT04347733|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102420016|NCT04347733|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102420017|NCT04347733|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102420018|NCT04347733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102420019|NCT04347733|Glucocorticoids|glucocorticoids|mesh-ancestor
102420020|NCT04347733|Hormones|hormones|mesh-ancestor
102420021|NCT04347733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102420022|NCT04347733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420023|NCT04347733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102420024|NCT04347733|Immunologic Factors|immunologic factors|mesh-ancestor
102420025|NCT04347733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102420026|NCT04347733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420027|NCT02155101|Ritonavir|ritonavir|mesh-list
102420028|NCT02155101|Lopinavir|lopinavir|mesh-list
102420029|NCT02155101|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102420030|NCT02155101|Darunavir|darunavir|mesh-list
102420031|NCT02155101|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102420032|NCT02155101|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102420033|NCT02155101|Protease Inhibitors|protease inhibitors|mesh-ancestor
102420034|NCT02155101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102420035|NCT02155101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420036|NCT02155101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102420037|NCT02155101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102420038|NCT02155101|Antiviral Agents|antiviral agents|mesh-ancestor
102420039|NCT02155101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102420040|NCT02155101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102420041|NCT02155101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102420042|NCT02155257|Gabapentin|gabapentin|mesh-list
102420043|NCT02155257|Modafinil|modafinil|mesh-list
102420044|NCT02155257|Analgesics|analgesics|mesh-ancestor
102420045|NCT02155257|Sensory System Agents|sensory system agents|mesh-ancestor
102420046|NCT02155257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102420047|NCT02155257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420048|NCT02155257|Anticonvulsants|anticonvulsants|mesh-ancestor
102420049|NCT02155257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102420050|NCT02155257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102420051|NCT02155257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102420052|NCT02155257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102420053|NCT02155257|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102420054|NCT02155257|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102420055|NCT02155257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102420056|NCT02155257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420057|NCT02155257|Antimanic Agents|antimanic agents|mesh-ancestor
102420058|NCT02155257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102420059|NCT02155257|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102420060|NCT02155257|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102420061|NCT02155257|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102420062|NCT03243019|Sirolimus|sirolimus|mesh-list
102420063|NCT03243019|Temsirolimus|temsirolimus|mesh-list
102420064|NCT03243019|MTOR Inhibitors|mtor inhibitors|mesh-list
102420065|NCT03243019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102420066|NCT03243019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102420067|NCT03243019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102420068|NCT03243019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102420069|NCT03243019|Antifungal Agents|antifungal agents|mesh-ancestor
102420070|NCT03243019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102420071|NCT03243019|Immunologic Factors|immunologic factors|mesh-ancestor
102420072|NCT03243019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420073|NCT03243019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102420074|NCT03243019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102420075|NCT03243019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420076|NCT04382625|Hydroxychloroquine|hydroxychloroquine|mesh-list
102420077|NCT04382625|Antimalarials|antimalarials|mesh-ancestor
102420078|NCT04382625|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102420079|NCT04382625|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102420080|NCT04382625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102420081|NCT04382625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102420082|NCT04382625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420083|NCT04382625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102420084|NCT01673646|Pasireotide|pasireotide|mesh-list
102420085|NCT01673646|Hormones|hormones|mesh-ancestor
102420086|NCT01673646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102420087|NCT01673646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420088|NCT00862563|Topiramate|topiramate|mesh-list
102420089|NCT00862563|Zonisamide|zonisamide|mesh-list
102420090|NCT00862563|Levetiracetam|levetiracetam|mesh-list
102420091|NCT00862563|Anticonvulsants|anticonvulsants|mesh-ancestor
102420092|NCT00862563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102420093|NCT00862563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420094|NCT00862563|Nootropic Agents|nootropic agents|mesh-ancestor
102420095|NCT00862563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102420096|NCT00862563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102420097|NCT00862563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420098|NCT00862563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102420099|NCT04278937|Azithromycin|azithromycin|mesh-list
102420100|NCT04278937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102420101|NCT04278937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102420102|NCT02647944|Liraglutide|liraglutide|mesh-list
102420103|NCT02647944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102420104|NCT02647944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420105|NCT02647944|Incretins|incretins|mesh-ancestor
102420106|NCT02647944|Hormones|hormones|mesh-ancestor
102420107|NCT02647944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102420108|NCT04278469|Antineoplastic Agents|antineoplastic agents|mesh-list
102420109|NCT04278547|Valganciclovir|valganciclovir|mesh-list
102420110|NCT04278547|Antiviral Agents|antiviral agents|mesh-ancestor
102420111|NCT04278547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102420112|NCT00863109|Ribavirin|ribavirin|mesh-list
102420113|NCT00863109|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102420114|NCT00863109|Antimetabolites|antimetabolites|mesh-ancestor
102420115|NCT00863109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420116|NCT00863109|Antiviral Agents|antiviral agents|mesh-ancestor
102420117|NCT00863109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102420118|NCT03238807|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102420119|NCT03238807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102420120|NCT03238807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420121|NCT05246371|Dexmedetomidine|dexmedetomidine|mesh-list
102420122|NCT05246371|Propofol|propofol|mesh-list
102420123|NCT05246371|Desflurane|desflurane|mesh-list
102420124|NCT05246371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102420125|NCT05246371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102420126|NCT05246371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420127|NCT05246371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102420128|NCT05246371|Analgesics|analgesics|mesh-ancestor
102420129|NCT05246371|Sensory System Agents|sensory system agents|mesh-ancestor
102420130|NCT05246371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102420131|NCT05246371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102420132|NCT05246371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102420133|NCT05246371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102420134|NCT05246371|Adrenergic Agents|adrenergic agents|mesh-ancestor
102420135|NCT05246371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102420136|NCT05246371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420137|NCT05246371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102420138|NCT05246371|Anesthetics, General|anesthetics, general|mesh-ancestor
102420139|NCT05246371|Anesthetics|anesthetics|mesh-ancestor
102420140|NCT05246371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102420141|NCT00863265|Ezetimibe|ezetimibe|mesh-list
102420142|NCT00863265|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102420143|NCT00863265|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102420144|NCT00863265|Antimetabolites|antimetabolites|mesh-ancestor
102420145|NCT00863265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420146|NCT00863265|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102420147|NCT00831675|Vaccines|vaccines|mesh-list
102420148|NCT00831675|Immunologic Factors|immunologic factors|mesh-ancestor
102420149|NCT00831675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420150|NCT01397825|Rituximab|rituximab|mesh-list
102420151|NCT01397825|Vincristine|vincristine|mesh-list
102420152|NCT01397825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102420153|NCT01397825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102420154|NCT01397825|Immunologic Factors|immunologic factors|mesh-ancestor
102420155|NCT01397825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420156|NCT01397825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102420157|NCT01397825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102420158|NCT01397825|Tubulin Modulators|tubulin modulators|mesh-ancestor
102420159|NCT01397825|Antimitotic Agents|antimitotic agents|mesh-ancestor
102420160|NCT01397825|Mitosis Modulators|mitosis modulators|mesh-ancestor
102420161|NCT01397825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420162|NCT05373186|Insulin Lispro|insulin lispro|mesh-list
102420163|NCT05373186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102420164|NCT05373186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420165|NCT05353764|Ropivacaine|ropivacaine|mesh-list
102420166|NCT05353764|Anesthetics, Local|anesthetics, local|mesh-ancestor
102420167|NCT05353764|Anesthetics|anesthetics|mesh-ancestor
102420168|NCT05353764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102420169|NCT05353764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420170|NCT05353764|Sensory System Agents|sensory system agents|mesh-ancestor
102420171|NCT05353764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102420172|NCT00831987|Vaccines|vaccines|mesh-list
102420173|NCT00831987|Immunologic Factors|immunologic factors|mesh-ancestor
102420174|NCT00831987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420175|NCT05239884|Nicotine|nicotine|mesh-list
102420176|NCT05239884|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102420177|NCT05239884|Autonomic Agents|autonomic agents|mesh-ancestor
102420178|NCT05239884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102420179|NCT05239884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420180|NCT05239884|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102420181|NCT05239884|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102420182|NCT05239884|Cholinergic Agents|cholinergic agents|mesh-ancestor
102420183|NCT05239884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102420184|NCT05239884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420185|NCT03836352|Cyclophosphamide|cyclophosphamide|mesh-list
102420187|NCT03836352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102420188|NCT03836352|Immunologic Factors|immunologic factors|mesh-ancestor
102420189|NCT03836352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420190|NCT03836352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102420191|NCT03836352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102420192|NCT03836352|Alkylating Agents|alkylating agents|mesh-ancestor
102420193|NCT03836352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420194|NCT03836352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102420195|NCT03836352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102420196|NCT03836352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102420197|NCT03836352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102420198|NCT01397201|Fluticasone|fluticasone|mesh-list
102420199|NCT01397201|Xhance|xhance|mesh-list
102420200|NCT01397201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102420201|NCT01397201|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102420202|NCT01397201|Autonomic Agents|autonomic agents|mesh-ancestor
102420203|NCT01397201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102420204|NCT01397201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420205|NCT01397201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102420206|NCT01397201|Respiratory System Agents|respiratory system agents|mesh-ancestor
102420207|NCT01397201|Dermatologic Agents|dermatologic agents|mesh-ancestor
102420208|NCT01397201|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102420209|NCT04845919|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102420210|NCT04845919|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102420211|NCT04845919|Dermatologic Agents|dermatologic agents|mesh-ancestor
102420212|NCT00834171|Loteprednol Etabonate|loteprednol etabonate|mesh-list
102420213|NCT00834171|Tobramycin|tobramycin|mesh-list
102420214|NCT00834171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102420215|NCT00834171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102420216|NCT00834171|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102420217|NCT02985437|Pulmonary Surfactants|pulmonary surfactants|mesh-list
102420218|NCT02985437|Respiratory System Agents|respiratory system agents|mesh-ancestor
102420219|NCT05205577|Iodine|iodine|mesh-list
102420220|NCT05205577|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102420221|NCT05205577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102420222|NCT05205577|Trace Elements|trace elements|mesh-ancestor
102420223|NCT05205577|Micronutrients|micronutrients|mesh-ancestor
102420224|NCT05205577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420225|NCT00835185|Leucovorin|leucovorin|mesh-list
102420226|NCT00835185|Folic Acid|folic acid|mesh-list
102420227|NCT00835185|Oxaliplatin|oxaliplatin|mesh-list
102420228|NCT00835185|Necitumumab|necitumumab|mesh-list
102420229|NCT00835185|Levoleucovorin|levoleucovorin|mesh-list
102420230|NCT00835185|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102420231|NCT00835185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102420232|NCT00835185|Antidotes|antidotes|mesh-ancestor
102420233|NCT00835185|Protective Agents|protective agents|mesh-ancestor
102420234|NCT00835185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420235|NCT00835185|Vitamin B Complex|vitamin b complex|mesh-ancestor
102420236|NCT00835185|Vitamins|vitamins|mesh-ancestor
102420237|NCT00835185|Micronutrients|micronutrients|mesh-ancestor
102420238|NCT00835185|Hematinics|hematinics|mesh-ancestor
102420239|NCT00835185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102420240|NCT00835185|Immunologic Factors|immunologic factors|mesh-ancestor
102420241|NCT04399525|Cetirizine|cetirizine|mesh-list
102420242|NCT04399525|Loratadine|loratadine|mesh-list
102420243|NCT04399525|Levocetirizine|levocetirizine|mesh-list
102420244|NCT04399525|Desloratadine|desloratadine|mesh-list
102420245|NCT04399525|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102420246|NCT04399525|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102420247|NCT04399525|Histamine Antagonists|histamine antagonists|mesh-ancestor
102420248|NCT04399525|Histamine Agents|histamine agents|mesh-ancestor
102420249|NCT04399525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102420250|NCT04399525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420251|NCT04399525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420252|NCT04399525|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102420253|NCT04399525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102420254|NCT04399525|Cholinergic Agents|cholinergic agents|mesh-ancestor
102420255|NCT04399525|Antipruritics|antipruritics|mesh-ancestor
102420256|NCT04399525|Dermatologic Agents|dermatologic agents|mesh-ancestor
102420257|NCT00864123|Cycloserine|cycloserine|mesh-list
102420258|NCT00864123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102420259|NCT00864123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102420260|NCT00864123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102231897|NCT02505841|Curare|curare|mesh-list
102420261|NCT00864123|Antitubercular Agents|antitubercular agents|mesh-ancestor
102420262|NCT00864123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102420263|NCT00864123|Antimetabolites|antimetabolites|mesh-ancestor
102420264|NCT00864123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420266|NCT03858465|Oxymetazoline|oxymetazoline|mesh-list
102420267|NCT03858465|Ephedrine|ephedrine|mesh-list
102420268|NCT03858465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102420269|NCT03858465|Mydriatics|mydriatics|mesh-ancestor
102420270|NCT03858465|Autonomic Agents|autonomic agents|mesh-ancestor
102420271|NCT03858465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102420272|NCT03858465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420273|NCT03858465|Sympathomimetics|sympathomimetics|mesh-ancestor
102420274|NCT03858465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102420275|NCT03858465|Nasal Decongestants|nasal decongestants|mesh-ancestor
102420276|NCT03858465|Respiratory System Agents|respiratory system agents|mesh-ancestor
102420277|NCT03858465|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102420278|NCT03858465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102420279|NCT03858465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102420280|NCT03858465|Adrenergic Agents|adrenergic agents|mesh-ancestor
102420281|NCT03858465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102420282|NCT03858465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420283|NCT03858465|Protective Agents|protective agents|mesh-ancestor
102420284|NCT03858465|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102420285|NCT00867789|Trimethoprim|trimethoprim|mesh-list
102420286|NCT00867789|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102420287|NCT00867789|Sulfamethoxazole|sulfamethoxazole|mesh-list
102420288|NCT00867789|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102420289|NCT00867789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102420290|NCT00867789|Antimalarials|antimalarials|mesh-ancestor
102420291|NCT00867789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102420292|NCT00867789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102420293|NCT00867789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102420294|NCT00867789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102420295|NCT00867789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420296|NCT00867789|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102420297|NCT00867789|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102420298|NCT00867789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102420299|NCT00867789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102420300|NCT01396421|Brexpiprazole|brexpiprazole|mesh-list
102420301|NCT01396421|Serotonin Agents|serotonin agents|mesh-ancestor
102420302|NCT01396421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102420303|NCT01396421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050967|NCT03553238|Glucocorticoids|glucocorticoids|mesh-ancestor
102420304|NCT01396421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420305|NCT01396421|Dopamine Agonists|dopamine agonists|mesh-ancestor
102420306|NCT01396421|Dopamine Agents|dopamine agents|mesh-ancestor
102420307|NCT04797013|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102420308|NCT04797013|Plasminogen|plasminogen|mesh-list
102420309|NCT04797013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102420310|NCT04797013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102420311|NCT04797013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420312|NCT00838695|Phenylephrine|phenylephrine|mesh-list
102420313|NCT00838695|Oxymetazoline|oxymetazoline|mesh-list
102420314|NCT00838695|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102420315|NCT00838695|Mydriatics|mydriatics|mesh-ancestor
102420316|NCT00838695|Autonomic Agents|autonomic agents|mesh-ancestor
102420317|NCT00838695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102420318|NCT00838695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420319|NCT00838695|Sympathomimetics|sympathomimetics|mesh-ancestor
102420320|NCT00838695|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102420321|NCT00838695|Nasal Decongestants|nasal decongestants|mesh-ancestor
102420322|NCT00838695|Respiratory System Agents|respiratory system agents|mesh-ancestor
102420323|NCT00838695|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102420324|NCT00838695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102420325|NCT00838695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102420326|NCT00838695|Adrenergic Agents|adrenergic agents|mesh-ancestor
102420327|NCT00838695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102420328|NCT00838695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420329|NCT00838695|Protective Agents|protective agents|mesh-ancestor
102420330|NCT04775173|Sirolimus|sirolimus|mesh-list
102420331|NCT04775173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102420332|NCT04775173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102420333|NCT04775173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102420334|NCT04775173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102420335|NCT04775173|Antifungal Agents|antifungal agents|mesh-ancestor
102420336|NCT04775173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102420337|NCT04775173|Immunologic Factors|immunologic factors|mesh-ancestor
102420338|NCT04775173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420339|NCT01396265|Rifampin|rifampin|mesh-list
102420340|NCT01396265|Afatinib|afatinib|mesh-list
102420341|NCT01396265|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102420342|NCT01396265|Antitubercular Agents|antitubercular agents|mesh-ancestor
102420343|NCT01396265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102420344|NCT01396265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102420345|NCT01396265|Leprostatic Agents|leprostatic agents|mesh-ancestor
102420346|NCT01396265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102420347|NCT01396265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102420348|NCT01396265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420349|NCT01396265|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102420350|NCT01396265|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102420351|NCT01396265|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102420352|NCT01396265|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102420353|NCT01396265|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102420354|NCT01396265|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102420355|NCT01396265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102420356|NCT01396265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102420357|NCT04760431|Paclitaxel|paclitaxel|mesh-list
102420358|NCT04760431|Docetaxel|docetaxel|mesh-list
102420359|NCT04760431|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102420360|NCT04760431|Trastuzumab|trastuzumab|mesh-list
102420361|NCT04760431|Pertuzumab|pertuzumab|mesh-list
102420362|NCT04760431|Taxane|taxane|mesh-list
102420363|NCT04760431|Tucatinib|tucatinib|mesh-list
102420364|NCT04760431|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102420365|NCT04760431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102420366|NCT04760431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102420367|NCT04760431|Tubulin Modulators|tubulin modulators|mesh-ancestor
102420368|NCT04760431|Antimitotic Agents|antimitotic agents|mesh-ancestor
102420369|NCT04760431|Mitosis Modulators|mitosis modulators|mesh-ancestor
102420370|NCT04760431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420371|NCT04760431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102420372|NCT04760431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102420373|NCT04760431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102420374|NCT00839319|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102420375|NCT00839319|Testosterone|testosterone|mesh-list
102420376|NCT00839319|Acyline|acyline|mesh-list
102420377|NCT00839319|Androgens|androgens|mesh-ancestor
102420378|NCT00839319|Hormones|hormones|mesh-ancestor
102420379|NCT00839319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102420380|NCT00839319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420381|NCT00839319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102420382|NCT00839319|Hormone Antagonists|hormone antagonists|mesh-ancestor
102420383|NCT00868959|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102420384|NCT00868959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102420385|NCT00868959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102420386|NCT00868959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102420387|NCT00868959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420388|NCT00868959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102420389|NCT00868959|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102420390|NCT00868959|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102420391|NCT00868959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102420392|NCT00868959|Adrenergic Agents|adrenergic agents|mesh-ancestor
102420393|NCT00868959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102420394|NCT00868959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420395|NCT00868959|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102420396|NCT00868959|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102420397|NCT00868959|Serotonin Agents|serotonin agents|mesh-ancestor
102420398|NCT00868959|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102420399|NCT00868959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102420400|NCT00868959|Dopamine Agents|dopamine agents|mesh-ancestor
102420401|NCT02647866|KHK4083|khk4083|mesh-list
102420402|NCT02647866|Dermatologic Agents|dermatologic agents|mesh-ancestor
102420403|NCT02246127|Everolimus|everolimus|mesh-list
102420404|NCT02246127|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102420405|NCT02246127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102420406|NCT02246127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102420407|NCT02246127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420408|NCT02246127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102420409|NCT02246127|Immunologic Factors|immunologic factors|mesh-ancestor
102420410|NCT02246127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420411|NCT02246127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102420412|NCT04277923|SMOFlipid|smoflipid|mesh-list
102420413|NCT04277923|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102420414|NCT04277923|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102420415|NCT04277923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102420416|NCT00870363|Efavirenz|efavirenz|mesh-list
102420417|NCT00870363|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
102420418|NCT00870363|Raltegravir Potassium|raltegravir potassium|mesh-list
102420419|NCT00870363|Maraviroc|maraviroc|mesh-list
102420420|NCT00870363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102420421|NCT00870363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102420422|NCT00870363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420423|NCT00870363|Antiviral Agents|antiviral agents|mesh-ancestor
102420424|NCT00870363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102420425|NCT00870363|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102420426|NCT00870363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102420427|NCT00870363|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102420428|NCT00870363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102420429|NCT00870363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102420430|NCT00870363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102420431|NCT00870363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102420432|NCT00870363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102420433|NCT00870363|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102420434|NCT00870363|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102420435|NCT00870363|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102420436|NCT00870363|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102420437|NCT00870363|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102420438|NCT03104634|Bromides|bromides|mesh-list
102420439|NCT03104634|Formoterol Fumarate|formoterol fumarate|mesh-list
102420440|NCT03104634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102420441|NCT03104634|Autonomic Agents|autonomic agents|mesh-ancestor
102420442|NCT03104634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102420443|NCT03104634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420444|NCT03104634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102420445|NCT03104634|Respiratory System Agents|respiratory system agents|mesh-ancestor
102420446|NCT03104634|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102420447|NCT03104634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102420448|NCT03104634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102420449|NCT03104634|Adrenergic Agents|adrenergic agents|mesh-ancestor
102420450|NCT03104634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102420451|NCT03104634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420452|NCT03104634|Anticonvulsants|anticonvulsants|mesh-ancestor
102420453|NCT00871689|Aldesleukin|aldesleukin|mesh-list
102420454|NCT00871689|Cyclophosphamide|cyclophosphamide|mesh-list
102420455|NCT00871689|Fludarabine|fludarabine|mesh-list
102420456|NCT00871689|Fludarabine phosphate|fludarabine phosphate|mesh-list
102420457|NCT00871689|Interleukin-2|interleukin-2|mesh-list
102420458|NCT00871689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102420459|NCT00871689|Immunologic Factors|immunologic factors|mesh-ancestor
102420460|NCT00871689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420461|NCT00871689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102420462|NCT00871689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102420463|NCT00871689|Alkylating Agents|alkylating agents|mesh-ancestor
102420464|NCT00871689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420465|NCT00871689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102420466|NCT00871689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102420467|NCT00871689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102420468|NCT00871689|Antimetabolites|antimetabolites|mesh-ancestor
102420469|NCT00871689|Antiviral Agents|antiviral agents|mesh-ancestor
102420470|NCT00871689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102420471|NCT00871689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102420472|NCT00871689|Analgesics|analgesics|mesh-ancestor
102420473|NCT00871689|Sensory System Agents|sensory system agents|mesh-ancestor
102420474|NCT00871689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102420475|NCT00871689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102420476|NCT00871689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102420477|NCT02084797|Vasopressins|vasopressins|mesh-list
102420478|NCT02084797|Arginine Vasopressin|arginine vasopressin|mesh-list
102420479|NCT02084797|Tolvaptan|tolvaptan|mesh-list
102420480|NCT02084797|Hemostatics|hemostatics|mesh-ancestor
102420481|NCT02084797|Coagulants|coagulants|mesh-ancestor
102420482|NCT02084797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102420483|NCT02084797|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102420484|NCT02084797|Natriuretic Agents|natriuretic agents|mesh-ancestor
102420485|NCT02084797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420486|NCT02084797|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102232122|NCT02509429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102420487|NCT02084797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420488|NCT00873327|Tazobactam|tazobactam|mesh-list
102420489|NCT00873327|Piperacillin|piperacillin|mesh-list
102420490|NCT00873327|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102420491|NCT00873327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102420492|NCT00873327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102420493|NCT00873327|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102420494|NCT00873327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102420495|NCT00873327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420496|NCT04816890|Insulin Lispro|insulin lispro|mesh-list
102420497|NCT04816890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102420498|NCT04816890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420499|NCT01392677|Dapagliflozin|dapagliflozin|mesh-list
102420500|NCT01392677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102420501|NCT01392677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420502|NCT01392677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102420503|NCT01392677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420504|NCT00841971|Fluconazole|fluconazole|mesh-list
102420505|NCT00841971|Anidulafungin|anidulafungin|mesh-list
102420506|NCT00841971|Antifungal Agents|antifungal agents|mesh-ancestor
102420507|NCT00841971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102420508|NCT00841971|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102420509|NCT00841971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102420510|NCT00841971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102420511|NCT00841971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420512|NCT00841971|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102420513|NCT00841971|Hormone Antagonists|hormone antagonists|mesh-ancestor
102420514|NCT00841971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102420515|NCT00841971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420516|NCT00841971|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102420517|NCT00841971|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102420518|NCT00842751|Finasteride|finasteride|mesh-list
102420519|NCT00842751|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102420520|NCT00842751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102420521|NCT00842751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102420522|NCT00842751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420523|NCT00842751|Hormone Antagonists|hormone antagonists|mesh-ancestor
102420524|NCT00842751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102420525|NCT00842751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420526|NCT00842751|Urological Agents|urological agents|mesh-ancestor
102420527|NCT03104010|Hormones|hormones|mesh-list
102420528|NCT03104010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102420529|NCT03104010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420530|NCT03907969|AZD7648|azd7648|mesh-list
102420531|NCT03907969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102420532|NCT03907969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102420533|NCT03907969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420534|NCT04399213|Histamine|histamine|mesh-list
102420535|NCT04399213|Histamine phosphate|histamine phosphate|mesh-list
102420536|NCT04399213|Histamine Agonists|histamine agonists|mesh-ancestor
102420537|NCT04399213|Histamine Agents|histamine agents|mesh-ancestor
102420538|NCT04399213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102420539|NCT04399213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420540|NCT04399213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420541|NCT02154243|Midodrine|midodrine|mesh-list
102420542|NCT02154243|Sympathomimetics|sympathomimetics|mesh-ancestor
102420543|NCT02154243|Autonomic Agents|autonomic agents|mesh-ancestor
102420544|NCT02154243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102420545|NCT02154243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420546|NCT02154243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102420547|NCT02154243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102420548|NCT02154243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102420549|NCT02154243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102420550|NCT02154243|Adrenergic Agents|adrenergic agents|mesh-ancestor
102420551|NCT02154243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102420552|NCT02154243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420553|NCT03995004|Dexamethasone|dexamethasone|mesh-list
102420554|NCT03995004|Melatonin|melatonin|mesh-list
102420555|NCT03995004|Sodium sulfate|sodium sulfate|mesh-list
102420556|NCT03995004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102420557|NCT03995004|Antiemetics|antiemetics|mesh-ancestor
102420558|NCT03995004|Autonomic Agents|autonomic agents|mesh-ancestor
102420559|NCT03995004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102420560|NCT03995004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420561|NCT03995004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102420562|NCT03995004|Glucocorticoids|glucocorticoids|mesh-ancestor
102420563|NCT03995004|Hormones|hormones|mesh-ancestor
102420564|NCT03995004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102420565|NCT03995004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102420566|NCT03995004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102420567|NCT03995004|Antioxidants|antioxidants|mesh-ancestor
102420568|NCT03995004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420569|NCT03995004|Protective Agents|protective agents|mesh-ancestor
102420570|NCT03995004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102420571|NCT03995004|Cathartics|cathartics|mesh-ancestor
102420572|NCT03216525|Alvimopan|alvimopan|mesh-list
102420573|NCT03216525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102420574|NCT03249181|Dolutegravir|dolutegravir|mesh-list
102420575|NCT03249181|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102420576|NCT03249181|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102420577|NCT03249181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102420578|NCT03249181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420579|NCT03249181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102420580|NCT03249181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102420581|NCT03249181|Antiviral Agents|antiviral agents|mesh-ancestor
102420582|NCT03249181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102420583|NCT03216447|Tacrolimus|tacrolimus|mesh-list
102420584|NCT03216447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102420585|NCT03216447|Immunologic Factors|immunologic factors|mesh-ancestor
102420586|NCT03216447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420587|NCT03216447|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102420588|NCT03216447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102420589|NCT03216447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420590|NCT04669938|Immunologic Factors|immunologic factors|mesh-list
102420591|NCT04669938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420592|NCT03957876|Cytarabine|cytarabine|mesh-list
102420593|NCT03957876|Daunorubicin|daunorubicin|mesh-list
102420594|NCT03957876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102420595|NCT03957876|Antimetabolites|antimetabolites|mesh-ancestor
102420596|NCT03957876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420597|NCT03957876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102420598|NCT03957876|Antiviral Agents|antiviral agents|mesh-ancestor
102420599|NCT03957876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102420600|NCT03957876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102420601|NCT03957876|Immunologic Factors|immunologic factors|mesh-ancestor
102420602|NCT03957876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420603|NCT03957876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102420604|NCT03957876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102420605|NCT03957876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102420606|NCT03957876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612285|NCT00002393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612286|NCT00002393|Antiviral Agents|antiviral agents|mesh-ancestor
102612287|NCT00002393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102612288|NCT00002393|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102612289|NCT00002393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102612290|NCT00002393|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102612291|NCT00002393|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102612292|NCT00002393|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102612293|NCT00002393|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102612294|NCT00002393|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102612295|NCT00002393|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102612296|NCT00002393|Protease Inhibitors|protease inhibitors|mesh-ancestor
102612297|NCT00002393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102612298|NCT00002393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102612299|NCT00002399|Fluconazole|fluconazole|mesh-list
102612300|NCT00002399|Posaconazole|posaconazole|mesh-list
102612301|NCT00002399|Antifungal Agents|antifungal agents|mesh-ancestor
102612302|NCT00002399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102612303|NCT00002399|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102612304|NCT00002399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102612305|NCT00002399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612306|NCT00002399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612307|NCT00002399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102612308|NCT00002399|Hormone Antagonists|hormone antagonists|mesh-ancestor
102612309|NCT00002399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102420607|NCT03837925|Atorvastatin|atorvastatin|mesh-list
102420608|NCT03837925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102420609|NCT03837925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102420610|NCT03837925|Antimetabolites|antimetabolites|mesh-ancestor
102420611|NCT03837925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420612|NCT03837925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102420613|NCT03837925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102420614|NCT03837925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102420615|NCT04398589|Dexmedetomidine|dexmedetomidine|mesh-list
102420616|NCT04398589|Ropivacaine|ropivacaine|mesh-list
102420617|NCT04398589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102420618|NCT04398589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102420619|NCT04398589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420620|NCT04398589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102420621|NCT04398589|Analgesics|analgesics|mesh-ancestor
102420622|NCT04398589|Sensory System Agents|sensory system agents|mesh-ancestor
102420623|NCT04398589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102420624|NCT04398589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102420625|NCT04398589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102420626|NCT04398589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102420627|NCT04398589|Adrenergic Agents|adrenergic agents|mesh-ancestor
102420628|NCT04398589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102420629|NCT04398589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420630|NCT04398589|Anesthetics, Local|anesthetics, local|mesh-ancestor
102420631|NCT04398589|Anesthetics|anesthetics|mesh-ancestor
102420632|NCT00874887|Moxifloxacin|moxifloxacin|mesh-list
102420633|NCT00874887|Gatifloxacin|gatifloxacin|mesh-list
102420634|NCT00874887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102420635|NCT00874887|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102420636|NCT00874887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102420637|NCT00874887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102420638|NCT00874887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102420639|NCT00874887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102420640|NCT00874887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102420641|NCT00874887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420642|NCT00874887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102420643|NCT03882060|Epoetin Alfa|epoetin alfa|mesh-list
102420644|NCT03882060|Hematinics|hematinics|mesh-ancestor
102420645|NCT01376505|Vaccines|vaccines|mesh-list
102420646|NCT01376505|Immunologic Factors|immunologic factors|mesh-ancestor
102420647|NCT01376505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420648|NCT00875277|Betamethasone|betamethasone|mesh-list
102420649|NCT00875277|Betamethasone Valerate|betamethasone valerate|mesh-list
102420650|NCT00875277|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102420651|NCT00875277|Betamethasone benzoate|betamethasone benzoate|mesh-list
102420652|NCT00875277|Calcipotriene|calcipotriene|mesh-list
102420653|NCT00875277|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102420654|NCT00875277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102420655|NCT00875277|Glucocorticoids|glucocorticoids|mesh-ancestor
102420656|NCT00875277|Hormones|hormones|mesh-ancestor
102420657|NCT00875277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102420658|NCT00875277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420659|NCT00875277|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102420660|NCT00875277|Respiratory System Agents|respiratory system agents|mesh-ancestor
102420661|NCT00875277|Dermatologic Agents|dermatologic agents|mesh-ancestor
102420662|NCT04634539|Paclitaxel|paclitaxel|mesh-list
102420663|NCT04634539|Gemcitabine|gemcitabine|mesh-list
102420664|NCT04634539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102420665|NCT04634539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102420666|NCT04634539|Tubulin Modulators|tubulin modulators|mesh-ancestor
102420667|NCT04634539|Antimitotic Agents|antimitotic agents|mesh-ancestor
102420668|NCT04634539|Mitosis Modulators|mitosis modulators|mesh-ancestor
102420669|NCT04634539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420670|NCT04634539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102420671|NCT04634539|Antimetabolites|antimetabolites|mesh-ancestor
102420672|NCT03750786|Leucovorin|leucovorin|mesh-list
102420673|NCT03750786|Antidotes|antidotes|mesh-ancestor
102420674|NCT03750786|Protective Agents|protective agents|mesh-ancestor
102420675|NCT03750786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420676|NCT03750786|Vitamin B Complex|vitamin b complex|mesh-ancestor
102420677|NCT03750786|Vitamins|vitamins|mesh-ancestor
102420678|NCT03750786|Micronutrients|micronutrients|mesh-ancestor
102420679|NCT04457245|Fluorides|fluorides|mesh-list
102420680|NCT04457245|Cariostatic Agents|cariostatic agents|mesh-ancestor
102420681|NCT04457245|Protective Agents|protective agents|mesh-ancestor
102420682|NCT04457245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420683|NCT01395017|Dasatinib|dasatinib|mesh-list
102420684|NCT01395017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102420685|NCT01395017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102420686|NCT01395017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102420687|NCT01395017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420688|NCT03299088|Pembrolizumab|pembrolizumab|mesh-list
102420689|NCT03299088|Trametinib|trametinib|mesh-list
102420690|NCT03299088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102420691|NCT03299088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102420692|NCT03299088|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102420693|NCT03299088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420694|NCT03299088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102420695|NCT03299088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102420696|NCT03235986|Poractant alfa|poractant alfa|mesh-list
102420697|NCT03235986|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
102420698|NCT03235986|Respiratory System Agents|respiratory system agents|mesh-ancestor
102420699|NCT03657342|Cyclosporine|cyclosporine|mesh-list
102420700|NCT03657342|Cyclosporins|cyclosporins|mesh-list
102420701|NCT03657342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102420702|NCT03657342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420703|NCT03657342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102420704|NCT03657342|Immunologic Factors|immunologic factors|mesh-ancestor
102420705|NCT03657342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420706|NCT03657342|Antifungal Agents|antifungal agents|mesh-ancestor
102420707|NCT03657342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102420708|NCT03657342|Dermatologic Agents|dermatologic agents|mesh-ancestor
102420709|NCT03657342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102420710|NCT03657342|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102420711|NCT03600090|Paclitaxel|paclitaxel|mesh-list
102420712|NCT03600090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102420713|NCT03600090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102420714|NCT03600090|Tubulin Modulators|tubulin modulators|mesh-ancestor
102420715|NCT03600090|Antimitotic Agents|antimitotic agents|mesh-ancestor
102420716|NCT03600090|Mitosis Modulators|mitosis modulators|mesh-ancestor
102420717|NCT03600090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420718|NCT02912988|Letrozole|letrozole|mesh-list
102420719|NCT02912988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102420720|NCT02912988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102420721|NCT02912988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102420722|NCT02912988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102420723|NCT02912988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420724|NCT02912988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102420725|NCT02912988|Hormone Antagonists|hormone antagonists|mesh-ancestor
102420726|NCT02912988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102420727|NCT02912988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420728|NCT03103074|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
102420729|NCT03103074|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102420730|NCT03103074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102420731|NCT03103074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102420732|NCT03103074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420733|NCT03103074|Cholinergic Agents|cholinergic agents|mesh-ancestor
102420734|NCT03103074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102420735|NCT03103074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420736|NCT00876915|Dalteparin|dalteparin|mesh-list
102420737|NCT00876915|Tinzaparin|tinzaparin|mesh-list
102420738|NCT00876915|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102420739|NCT00876915|Anticoagulants|anticoagulants|mesh-ancestor
102420740|NCT00876915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102420741|NCT00876915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102420742|NCT00876915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420743|NCT02854488|Ipilimumab|ipilimumab|mesh-list
102420744|NCT02854488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102420745|NCT02854488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102420746|NCT02854488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102420747|NCT02854488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420748|NCT00896181|Carboplatin|carboplatin|mesh-list
102420749|NCT00896181|Docetaxel|docetaxel|mesh-list
102420750|NCT00896181|Fluorouracil|fluorouracil|mesh-list
102420751|NCT00896181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102420752|NCT00896181|Tubulin Modulators|tubulin modulators|mesh-ancestor
102420753|NCT00896181|Antimitotic Agents|antimitotic agents|mesh-ancestor
102420754|NCT00896181|Mitosis Modulators|mitosis modulators|mesh-ancestor
102420755|NCT00896181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420756|NCT00896181|Antimetabolites|antimetabolites|mesh-ancestor
102420757|NCT00896181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102420758|NCT00896181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102420759|NCT00896181|Immunologic Factors|immunologic factors|mesh-ancestor
102420760|NCT00896181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420761|NCT02647320|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102420763|NCT02647320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102420764|NCT02647320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420765|NCT02647320|Incretins|incretins|mesh-ancestor
102420766|NCT02647320|Hormones|hormones|mesh-ancestor
102420767|NCT02647320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102420768|NCT02647320|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102420769|NCT02647320|Protease Inhibitors|protease inhibitors|mesh-ancestor
102420770|NCT02647320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102420771|NCT02647320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420772|NCT03457896|Trastuzumab|trastuzumab|mesh-list
102420773|NCT03457896|Cetuximab|cetuximab|mesh-list
102420774|NCT03457896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102420775|NCT03457896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102420776|NCT04380597|Betamethasone|betamethasone|mesh-list
102420777|NCT04380597|Betamethasone Valerate|betamethasone valerate|mesh-list
102420778|NCT04380597|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102420779|NCT04380597|Betamethasone benzoate|betamethasone benzoate|mesh-list
102420780|NCT04380597|Calcipotriene|calcipotriene|mesh-list
102420781|NCT04380597|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102420782|NCT04380597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102420783|NCT04380597|Glucocorticoids|glucocorticoids|mesh-ancestor
102420784|NCT04380597|Hormones|hormones|mesh-ancestor
102420785|NCT04380597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102420786|NCT04380597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420787|NCT04380597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102420788|NCT04380597|Respiratory System Agents|respiratory system agents|mesh-ancestor
102420789|NCT04380597|Dermatologic Agents|dermatologic agents|mesh-ancestor
102420790|NCT03214731|Artesunate|artesunate|mesh-list
102420791|NCT03214731|Antimalarials|antimalarials|mesh-ancestor
102420792|NCT03214731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102420793|NCT03214731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102420794|NCT03214731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102420795|NCT03214731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102420796|NCT03214731|Antiviral Agents|antiviral agents|mesh-ancestor
102420797|NCT03214731|Schistosomicides|schistosomicides|mesh-ancestor
102420798|NCT03214731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102420799|NCT03214731|Anthelmintics|anthelmintics|mesh-ancestor
102420800|NCT04424862|Cyclosporine|cyclosporine|mesh-list
102420801|NCT04424862|Mycophenolic Acid|mycophenolic acid|mesh-list
102420802|NCT04424862|Prednisone|prednisone|mesh-list
102420803|NCT04424862|Cyclosporins|cyclosporins|mesh-list
102420804|NCT04424862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102420805|NCT04424862|Glucocorticoids|glucocorticoids|mesh-ancestor
102420806|NCT04424862|Hormones|hormones|mesh-ancestor
102420807|NCT04424862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102420808|NCT04424862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420809|NCT04424862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102420810|NCT04424862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102420811|NCT04424862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102420812|NCT04424862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420813|NCT04424862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102420814|NCT04424862|Immunologic Factors|immunologic factors|mesh-ancestor
102420815|NCT04424862|Antifungal Agents|antifungal agents|mesh-ancestor
102420816|NCT04424862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102420817|NCT04424862|Dermatologic Agents|dermatologic agents|mesh-ancestor
102420818|NCT04424862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102420819|NCT04424862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102420820|NCT04424862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102420821|NCT04424862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102420822|NCT04424862|Antitubercular Agents|antitubercular agents|mesh-ancestor
102420823|NCT04424862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102420824|NCT00882687|Lifitegrast|lifitegrast|mesh-list
102420825|NCT00882687|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102420826|NCT00882687|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102420827|NCT04313166|Copper|copper|mesh-list
102420828|NCT04313166|Trace Elements|trace elements|mesh-ancestor
102420829|NCT04313166|Micronutrients|micronutrients|mesh-ancestor
102420830|NCT04313166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420831|NCT00883233|Adapalene|adapalene|mesh-list
102420832|NCT00883233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102420833|NCT00883233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102420834|NCT00883233|Analgesics|analgesics|mesh-ancestor
102420836|NCT00883233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102420837|NCT00883233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420838|NCT00883233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102420839|NCT00883233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102420840|NCT00883233|Dermatologic Agents|dermatologic agents|mesh-ancestor
102420841|NCT01394939|Irinotecan|irinotecan|mesh-list
102420842|NCT01394939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102420843|NCT01394939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102420844|NCT01394939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102420845|NCT01394939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420846|NCT01394939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102420847|NCT01394627|Eplerenone|eplerenone|mesh-list
102420848|NCT01394627|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102420849|NCT01394627|Hormone Antagonists|hormone antagonists|mesh-ancestor
102420850|NCT01394627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102420851|NCT01394627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420852|NCT01394627|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102420853|NCT01394627|Diuretics|diuretics|mesh-ancestor
102420854|NCT01394627|Natriuretic Agents|natriuretic agents|mesh-ancestor
102420855|NCT01394627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102420856|NCT02288377|Lanreotide|lanreotide|mesh-list
102420857|NCT02288377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102420858|NCT04133532|Metoprolol|metoprolol|mesh-list
102420859|NCT04133532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102420860|NCT04133532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102420861|NCT04133532|Sympatholytics|sympatholytics|mesh-ancestor
102420862|NCT04133532|Autonomic Agents|autonomic agents|mesh-ancestor
102420863|NCT04133532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102420864|NCT04133532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420865|NCT04133532|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102420866|NCT04133532|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102420867|NCT04133532|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102420868|NCT04133532|Adrenergic Agents|adrenergic agents|mesh-ancestor
102420869|NCT04133532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102420870|NCT04133532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420871|NCT01391663|Alogliptin|alogliptin|mesh-list
102420872|NCT01391663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102420873|NCT01391663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420874|NCT01391663|Incretins|incretins|mesh-ancestor
102420875|NCT01391663|Hormones|hormones|mesh-ancestor
102420876|NCT01391663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102420877|NCT01391663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102420878|NCT01391663|Protease Inhibitors|protease inhibitors|mesh-ancestor
102420879|NCT01391663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102420880|NCT01391663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420881|NCT03176173|Immunomodulating Agents|immunomodulating agents|mesh-list
102420882|NCT03176173|Immunologic Factors|immunologic factors|mesh-ancestor
102420883|NCT03176173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420884|NCT05072106|Bosentan|bosentan|mesh-list
102420885|NCT05072106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102420886|NCT05072106|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102420887|NCT05072106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420888|NCT03838497|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102420889|NCT03838497|Immunologic Factors|immunologic factors|mesh-ancestor
102420890|NCT03838497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420891|NCT05071482|Imatinib Mesylate|imatinib mesylate|mesh-list
102420892|NCT05071482|Flumatinib|flumatinib|mesh-list
102420893|NCT05071482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102420894|NCT05071482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102420895|NCT05071482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102420896|NCT05071482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420897|NCT03213249|Gentamicins|gentamicins|mesh-list
102420898|NCT03213249|Cefazolin|cefazolin|mesh-list
102420899|NCT03213249|Bacitracin|bacitracin|mesh-list
102420900|NCT03213249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102420901|NCT03213249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102420902|NCT03213249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102420903|NCT03213249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102420904|NCT03213249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420905|NCT03213249|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102420906|NCT03317067|Dexmedetomidine|dexmedetomidine|mesh-list
102420907|NCT03317067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102420908|NCT03317067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102420909|NCT03317067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420910|NCT03317067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102420911|NCT03317067|Analgesics|analgesics|mesh-ancestor
102420912|NCT03317067|Sensory System Agents|sensory system agents|mesh-ancestor
102420913|NCT03317067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102420914|NCT03317067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102420915|NCT03317067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102420916|NCT03317067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102420917|NCT03317067|Adrenergic Agents|adrenergic agents|mesh-ancestor
102420918|NCT03317067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102420919|NCT03317067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420920|NCT04440007|Abivertinib|abivertinib|mesh-list
102420921|NCT04440007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102420922|NCT04440007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420923|NCT04440007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102420924|NCT00888459|Nicotine|nicotine|mesh-list
102420925|NCT00888459|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102420926|NCT00888459|Autonomic Agents|autonomic agents|mesh-ancestor
102420927|NCT00888459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102420928|NCT00888459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420929|NCT00888459|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102420930|NCT00888459|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102420931|NCT00888459|Cholinergic Agents|cholinergic agents|mesh-ancestor
102420932|NCT00888459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102420933|NCT00888459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420934|NCT05312541|Bupivacaine|bupivacaine|mesh-list
102420935|NCT05312541|Anesthetics, Local|anesthetics, local|mesh-list
102420936|NCT05312541|Anesthetics|anesthetics|mesh-list
102420937|NCT05312541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102420938|NCT05312541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420939|NCT05312541|Sensory System Agents|sensory system agents|mesh-ancestor
102420940|NCT05312541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102420941|NCT04398823|Polidocanol|polidocanol|mesh-list
102420942|NCT04398823|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102420943|NCT04398823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102420944|NCT04410913|Psilocybin|psilocybin|mesh-list
102420945|NCT04410913|Hallucinogens|hallucinogens|mesh-ancestor
102420946|NCT04410913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420947|NCT04410913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102420948|NCT02013336|Cyclophosphamide|cyclophosphamide|mesh-list
102420949|NCT02013336|Irinotecan|irinotecan|mesh-list
102420950|NCT02013336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102420951|NCT02013336|Immunologic Factors|immunologic factors|mesh-ancestor
102420952|NCT02013336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420953|NCT02013336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102420954|NCT02013336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102420955|NCT02013336|Alkylating Agents|alkylating agents|mesh-ancestor
102420956|NCT02013336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420957|NCT02013336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102420958|NCT02013336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102420959|NCT02013336|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102420960|NCT02013336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102420961|NCT02013336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102420962|NCT04397653|Ezetimibe|ezetimibe|mesh-list
102420963|NCT04397653|Evolocumab|evolocumab|mesh-list
102420964|NCT04397653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102420965|NCT04397653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102420966|NCT04397653|Antimetabolites|antimetabolites|mesh-ancestor
102420967|NCT04397653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420968|NCT04397653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102420969|NCT04397653|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102420970|NCT04397653|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102420971|NCT04397653|Protease Inhibitors|protease inhibitors|mesh-ancestor
102420972|NCT04397653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102420973|NCT03212781|Ferrous fumarate|ferrous fumarate|mesh-list
102420974|NCT03212781|Dextrans|dextrans|mesh-list
102420975|NCT03212781|Iron-Dextran Complex|iron-dextran complex|mesh-list
102420976|NCT03212781|Anticoagulants|anticoagulants|mesh-ancestor
102420977|NCT03212781|Plasma Substitutes|plasma substitutes|mesh-ancestor
102420978|NCT03212781|Blood Substitutes|blood substitutes|mesh-ancestor
102420979|NCT03212781|Trace Elements|trace elements|mesh-ancestor
102420980|NCT03212781|Micronutrients|micronutrients|mesh-ancestor
102420981|NCT03212781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420982|NCT03212781|Hematinics|hematinics|mesh-ancestor
102420983|NCT03212937|Carboplatin|carboplatin|mesh-list
102232655|NCT02492503|Paclitaxel|paclitaxel|mesh-list
102420984|NCT03212937|Etoposide|etoposide|mesh-list
102420985|NCT03212937|Ifosfamide|ifosfamide|mesh-list
102420986|NCT03212937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102420987|NCT03212937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102420988|NCT03212937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102420989|NCT03212937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102420990|NCT03212937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102420991|NCT03212937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102420992|NCT03212937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102420993|NCT03212937|Alkylating Agents|alkylating agents|mesh-ancestor
102420994|NCT04397497|Mavrilimumab|mavrilimumab|mesh-list
102420995|NCT04397497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102420996|NCT04412538|Vaccines|vaccines|mesh-list
102420997|NCT04412538|Immunologic Factors|immunologic factors|mesh-ancestor
102420998|NCT04412538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102420999|NCT04397341|Docetaxel|docetaxel|mesh-list
102421000|NCT04397341|Fluorouracil|fluorouracil|mesh-list
102421001|NCT04397341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102421002|NCT04397341|Tubulin Modulators|tubulin modulators|mesh-ancestor
102421003|NCT04397341|Antimitotic Agents|antimitotic agents|mesh-ancestor
102421004|NCT04397341|Mitosis Modulators|mitosis modulators|mesh-ancestor
102421005|NCT04397341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421006|NCT04397341|Antimetabolites|antimetabolites|mesh-ancestor
102421007|NCT04397341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102421008|NCT04397341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102421009|NCT04397341|Immunologic Factors|immunologic factors|mesh-ancestor
102421010|NCT04397341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421011|NCT03940326|Levetiracetam|levetiracetam|mesh-list
102421012|NCT03940326|Valproic Acid|valproic acid|mesh-list
102421013|NCT03940326|Anticonvulsants|anticonvulsants|mesh-ancestor
102421014|NCT03940326|Nootropic Agents|nootropic agents|mesh-ancestor
102421015|NCT03940326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102421016|NCT03940326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421017|NCT03940326|GABA Agents|gaba agents|mesh-ancestor
102421018|NCT03940326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102421019|NCT03940326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421020|NCT03940326|Antimanic Agents|antimanic agents|mesh-ancestor
102421021|NCT03940326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102421022|NCT03940326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102421023|NCT03940326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102421024|NCT04347889|Hydroxychloroquine|hydroxychloroquine|mesh-list
102421025|NCT04347889|Antimalarials|antimalarials|mesh-ancestor
102421026|NCT04347889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102421027|NCT04347889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102421028|NCT04347889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102421029|NCT04347889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102421030|NCT04347889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421031|NCT04347889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102421032|NCT01473524|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
102421033|NCT01473524|Cathartics|cathartics|mesh-ancestor
102421034|NCT01473524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102421035|NCT01390649|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102421036|NCT01390649|Immunologic Factors|immunologic factors|mesh-ancestor
102421037|NCT01390649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421038|NCT03696355|GDC-0084|gdc-0084|mesh-list
102421039|NCT03696355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102421040|NCT03696355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421041|NCT03882996|Atorvastatin|atorvastatin|mesh-list
102421042|NCT03882996|Ezetimibe|ezetimibe|mesh-list
102421043|NCT03882996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102421044|NCT03882996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102421045|NCT03882996|Antimetabolites|antimetabolites|mesh-ancestor
102421046|NCT03882996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421047|NCT03882996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102421048|NCT03882996|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102421049|NCT03882996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102421050|NCT04383691|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102421051|NCT04383691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102421052|NCT04383691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102421053|NCT04383691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102421054|NCT04383691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421055|NCT04383691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102421056|NCT04383691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102421057|NCT04383691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102421058|NCT04383691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102421059|NCT04383691|Adrenergic Agents|adrenergic agents|mesh-ancestor
102421060|NCT04383691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102421061|NCT04383691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421062|NCT04383691|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102421063|NCT04383691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102421064|NCT04383691|Serotonin Agents|serotonin agents|mesh-ancestor
102421065|NCT04383691|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102421066|NCT04383691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102421067|NCT04383691|Dopamine Agents|dopamine agents|mesh-ancestor
102421068|NCT05070468|Dexamethasone|dexamethasone|mesh-list
102421069|NCT05070468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102421070|NCT05070468|Antiemetics|antiemetics|mesh-ancestor
102421071|NCT05070468|Autonomic Agents|autonomic agents|mesh-ancestor
102421072|NCT05070468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102421073|NCT05070468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421074|NCT05070468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102421075|NCT05070468|Glucocorticoids|glucocorticoids|mesh-ancestor
102421076|NCT05070468|Hormones|hormones|mesh-ancestor
102421077|NCT05070468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102421078|NCT05070468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102421079|NCT05070468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102421080|NCT01390181|Losartan|losartan|mesh-list
102421081|NCT01390181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102421082|NCT01390181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102421083|NCT01390181|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102421084|NCT01390181|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102421085|NCT01390181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421086|NCT02641080|Aspirin|aspirin|mesh-list
102421087|NCT02641080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102421088|NCT02641080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102421089|NCT02641080|Analgesics|analgesics|mesh-ancestor
102421090|NCT02641080|Sensory System Agents|sensory system agents|mesh-ancestor
102421091|NCT02641080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102421092|NCT02641080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421093|NCT02641080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102421094|NCT02641080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102421095|NCT02641080|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102421096|NCT02641080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102421097|NCT02641080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421098|NCT02641080|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102421099|NCT02641080|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102421100|NCT02641080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102421101|NCT02641080|Antipyretics|antipyretics|mesh-ancestor
102421102|NCT03101280|Atezolizumab|atezolizumab|mesh-list
102421103|NCT03101280|Rucaparib|rucaparib|mesh-list
102421104|NCT03101280|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102421105|NCT03101280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421106|NCT03101280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102421107|NCT03101280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102421108|NCT03101280|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102421109|NCT03101280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102421110|NCT04015739|Bevacizumab|bevacizumab|mesh-list
102421111|NCT04015739|Durvalumab|durvalumab|mesh-list
102421112|NCT04015739|Olaparib|olaparib|mesh-list
102421113|NCT04015739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102421114|NCT04015739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102421115|NCT04015739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102421116|NCT04015739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102421117|NCT04015739|Growth Substances|growth substances|mesh-ancestor
102421118|NCT04015739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421119|NCT04015739|Growth Inhibitors|growth inhibitors|mesh-ancestor
102421120|NCT04015739|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102421121|NCT04015739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102421122|NCT04015739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421123|NCT03867318|Atorvastatin|atorvastatin|mesh-list
102421124|NCT03867318|Ezetimibe|ezetimibe|mesh-list
102421125|NCT03867318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102421126|NCT03867318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102421127|NCT03867318|Antimetabolites|antimetabolites|mesh-ancestor
102421128|NCT03867318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421129|NCT03867318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102421130|NCT03867318|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102421131|NCT03867318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102232800|NCT03330613|Anesthetics|anesthetics|mesh-list
102421132|NCT01876771|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102421133|NCT01876771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421135|NCT05360615|Empagliflozin|empagliflozin|mesh-list
102421136|NCT05360615|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102421137|NCT05360615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421138|NCT05360615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102421139|NCT05360615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421140|NCT04381377|Bromides|bromides|mesh-list
102421141|NCT04381377|Anticonvulsants|anticonvulsants|mesh-ancestor
102421142|NCT01457846|Paclitaxel|paclitaxel|mesh-list
102421143|NCT01457846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102421144|NCT01457846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102421145|NCT01457846|Tubulin Modulators|tubulin modulators|mesh-ancestor
102421146|NCT01457846|Antimitotic Agents|antimitotic agents|mesh-ancestor
102421147|NCT01457846|Mitosis Modulators|mitosis modulators|mesh-ancestor
102421148|NCT01457846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421149|NCT04032119|Epinephrine|epinephrine|mesh-list
102421150|NCT04032119|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102421151|NCT04032119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102421152|NCT04032119|Adrenergic Agents|adrenergic agents|mesh-ancestor
102421153|NCT04032119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102421154|NCT04032119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421155|NCT04032119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421156|NCT04032119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102421157|NCT04032119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102421158|NCT04032119|Autonomic Agents|autonomic agents|mesh-ancestor
102421159|NCT04032119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102421160|NCT04032119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102421161|NCT04032119|Respiratory System Agents|respiratory system agents|mesh-ancestor
102421162|NCT04032119|Mydriatics|mydriatics|mesh-ancestor
102421163|NCT04032119|Sympathomimetics|sympathomimetics|mesh-ancestor
102421164|NCT04032119|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102421165|NCT03211455|Lidocaine|lidocaine|mesh-list
102421166|NCT03211455|Anesthetics, Local|anesthetics, local|mesh-ancestor
102421167|NCT03211455|Anesthetics|anesthetics|mesh-ancestor
102421168|NCT03211455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102421169|NCT03211455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421170|NCT03211455|Sensory System Agents|sensory system agents|mesh-ancestor
102421171|NCT03211455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102421172|NCT03211455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102421173|NCT03211455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102421174|NCT03211455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102421175|NCT03211455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102421176|NCT03211455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421177|NCT04375033|Buprenorphine|buprenorphine|mesh-list
102421178|NCT04375033|Naloxone|naloxone|mesh-list
102421179|NCT04375033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102421180|NCT04375033|Narcotics|narcotics|mesh-ancestor
102421181|NCT04375033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102421182|NCT04375033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421183|NCT04375033|Analgesics|analgesics|mesh-ancestor
102421184|NCT04375033|Sensory System Agents|sensory system agents|mesh-ancestor
102421185|NCT04375033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102421186|NCT04375033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102421187|NCT03172819|Pembrolizumab|pembrolizumab|mesh-list
102421188|NCT03172819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102421189|NCT03172819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102421190|NCT03172819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102421191|NCT03172819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421192|NCT01389323|Interferons|interferons|mesh-list
102421193|NCT01389323|Ribavirin|ribavirin|mesh-list
102421194|NCT01389323|Interferon-alpha|interferon-alpha|mesh-list
102421195|NCT01389323|Interferon alpha-2|interferon alpha-2|mesh-list
102421196|NCT01389323|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102421197|NCT01389323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102421198|NCT01389323|Antiviral Agents|antiviral agents|mesh-ancestor
102421199|NCT01389323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102421200|NCT01389323|Antimetabolites|antimetabolites|mesh-ancestor
102421201|NCT01389323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421202|NCT01389323|Immunologic Factors|immunologic factors|mesh-ancestor
102421203|NCT01389323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421204|NCT05310591|Nivolumab|nivolumab|mesh-list
102421205|NCT05310591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102421206|NCT05310591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102421207|NCT05310591|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102421208|NCT05310591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421209|NCT05314569|Fentanyl|fentanyl|mesh-list
102421210|NCT05314569|Midazolam|midazolam|mesh-list
102421211|NCT05314569|Dexmedetomidine|dexmedetomidine|mesh-list
102421212|NCT05314569|Ketamine|ketamine|mesh-list
102421213|NCT05314569|Isoflurane|isoflurane|mesh-list
102421214|NCT05314569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102421215|NCT05314569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102421216|NCT05314569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421217|NCT05314569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102421218|NCT05314569|Analgesics|analgesics|mesh-ancestor
102421219|NCT05314569|Sensory System Agents|sensory system agents|mesh-ancestor
102421220|NCT05314569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102421221|NCT05314569|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102421222|NCT05314569|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102421223|NCT05314569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102421224|NCT05314569|Adrenergic Agents|adrenergic agents|mesh-ancestor
102421225|NCT05314569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102421226|NCT05314569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421227|NCT05314569|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102421228|NCT05314569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102421229|NCT05314569|Anesthetics, General|anesthetics, general|mesh-ancestor
102421230|NCT05314569|Anesthetics|anesthetics|mesh-ancestor
102421231|NCT05314569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102421232|NCT05314569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102421233|NCT05314569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102421234|NCT05314569|Narcotics|narcotics|mesh-ancestor
102421235|NCT05314569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102421236|NCT05314569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102421237|NCT05314569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102421238|NCT05314569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102421239|NCT05314569|GABA Modulators|gaba modulators|mesh-ancestor
102421240|NCT05314569|GABA Agents|gaba agents|mesh-ancestor
102421241|NCT05314569|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102421242|NCT01494818|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102421243|NCT01494818|Contact Lens Solutions|contact lens solutions|mesh-list
102421244|NCT01494818|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102421245|NCT01494818|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102421246|NCT01494818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102421247|NCT01494818|Disinfectants|disinfectants|mesh-ancestor
102421248|NCT03167905|Fentanyl|fentanyl|mesh-list
102421249|NCT03167905|Meperidine|meperidine|mesh-list
102421250|NCT03167905|Remifentanil|remifentanil|mesh-list
102421251|NCT03167905|Nitrous Oxide|nitrous oxide|mesh-list
102421252|NCT03167905|Ropivacaine|ropivacaine|mesh-list
102421253|NCT03167905|Entonox|entonox|mesh-list
102421254|NCT03167905|Anesthetics, Local|anesthetics, local|mesh-ancestor
102421255|NCT03167905|Anesthetics|anesthetics|mesh-ancestor
102421256|NCT03167905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102421257|NCT03167905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421258|NCT03167905|Sensory System Agents|sensory system agents|mesh-ancestor
102421259|NCT03167905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102421260|NCT03167905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102421261|NCT03167905|Narcotics|narcotics|mesh-ancestor
102421262|NCT03167905|Analgesics|analgesics|mesh-ancestor
102421263|NCT03167905|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102421264|NCT03167905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102421265|NCT03167905|Anesthetics, General|anesthetics, general|mesh-ancestor
102421266|NCT03167905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102421267|NCT03167905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102421268|NCT03167905|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
102421269|NCT04030169|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
102421270|NCT04030169|Hallucinogens|hallucinogens|mesh-ancestor
102421271|NCT04030169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421272|NCT04030169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102421273|NCT04030169|Serotonin Agents|serotonin agents|mesh-ancestor
102421274|NCT04030169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102421275|NCT04030169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421276|NCT04030169|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102421277|NCT04030169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102421278|NCT04030169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102421279|NCT04030169|Adrenergic Agents|adrenergic agents|mesh-ancestor
102421280|NCT02638389|Sirolimus|sirolimus|mesh-list
102421281|NCT02638389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102421282|NCT02638389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102421283|NCT02638389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102421284|NCT02638389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102421285|NCT02638389|Antifungal Agents|antifungal agents|mesh-ancestor
102421286|NCT02638389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102421287|NCT02638389|Immunologic Factors|immunologic factors|mesh-ancestor
102421288|NCT02638389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421289|NCT01494584|Ezogabine|ezogabine|mesh-list
102421290|NCT01494584|Anticonvulsants|anticonvulsants|mesh-ancestor
102421291|NCT01494584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102421292|NCT01494584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421293|NCT03211143|Esomeprazole|esomeprazole|mesh-list
102421294|NCT03211143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102421295|NCT03211143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102421296|NCT03211143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102421297|NCT03211143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102421298|NCT03211143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421299|NCT01388543|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102421300|NCT01388543|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102421301|NCT01388543|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102421302|NCT01388543|Protease Inhibitors|protease inhibitors|mesh-ancestor
102421303|NCT01388543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102421304|NCT01388543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421305|NCT01388543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102421306|NCT01388543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102421307|NCT01388543|Antiviral Agents|antiviral agents|mesh-ancestor
102421308|NCT01388543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102421309|NCT00882895|Mycophenolic Acid|mycophenolic acid|mesh-list
102421310|NCT00882895|Methylprednisolone|methylprednisolone|mesh-list
102421311|NCT00882895|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102421312|NCT00882895|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102421313|NCT00882895|Prednisolone|prednisolone|mesh-list
102421314|NCT00882895|Prednisolone acetate|prednisolone acetate|mesh-list
102421315|NCT00882895|Tacrolimus|tacrolimus|mesh-list
102421316|NCT00882895|Thymoglobulin|thymoglobulin|mesh-list
102421317|NCT00882895|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102421318|NCT00882895|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102421319|NCT00882895|Prednisolone phosphate|prednisolone phosphate|mesh-list
102421320|NCT00882895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102421321|NCT00882895|Immunologic Factors|immunologic factors|mesh-ancestor
102421322|NCT00882895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421323|NCT00882895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102421324|NCT00882895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102421325|NCT00882895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421326|NCT00882895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102421327|NCT00882895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102421328|NCT00882895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102421329|NCT00882895|Antitubercular Agents|antitubercular agents|mesh-ancestor
102421330|NCT00882895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102421331|NCT00882895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102421332|NCT00882895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102421333|NCT00882895|Antiemetics|antiemetics|mesh-ancestor
102421334|NCT00882895|Autonomic Agents|autonomic agents|mesh-ancestor
102421335|NCT00882895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102421336|NCT00882895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102421337|NCT00882895|Glucocorticoids|glucocorticoids|mesh-ancestor
102421338|NCT00882895|Hormones|hormones|mesh-ancestor
102421339|NCT00882895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102421340|NCT00882895|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102421341|NCT00882895|Protective Agents|protective agents|mesh-ancestor
102421342|NCT00882895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102421343|NCT00900237|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102421344|NCT00900237|Oxcarbazepine|oxcarbazepine|mesh-list
102421345|NCT00900237|Anticonvulsants|anticonvulsants|mesh-ancestor
102421346|NCT00900237|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102421347|NCT00900237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102421348|NCT00900237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102421349|NCT00900237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421350|NCT00900237|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102421351|NCT00900237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102421352|NCT00893997|Vaccines|vaccines|mesh-list
102421353|NCT00893997|Immunologic Factors|immunologic factors|mesh-ancestor
102421354|NCT00893997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421355|NCT00512317|Ganaxolone|ganaxolone|mesh-list
102421356|NCT00512317|Neurosteroids|neurosteroids|mesh-ancestor
102421357|NCT00512317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102421358|NCT00512317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421359|NCT00512317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421360|NCT00512317|GABA Modulators|gaba modulators|mesh-ancestor
102421361|NCT00512317|GABA Agents|gaba agents|mesh-ancestor
102421362|NCT01494506|Leucovorin|leucovorin|mesh-list
102421363|NCT01494506|Fluorouracil|fluorouracil|mesh-list
102421364|NCT01494506|Antimetabolites|antimetabolites|mesh-ancestor
102421365|NCT01494506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421366|NCT01494506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102421367|NCT01494506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102421368|NCT01494506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102421369|NCT01494506|Immunologic Factors|immunologic factors|mesh-ancestor
102421370|NCT01494506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421371|NCT01494506|Antidotes|antidotes|mesh-ancestor
102421372|NCT01494506|Protective Agents|protective agents|mesh-ancestor
102421373|NCT01494506|Vitamin B Complex|vitamin b complex|mesh-ancestor
102421374|NCT01494506|Vitamins|vitamins|mesh-ancestor
102421375|NCT01494506|Micronutrients|micronutrients|mesh-ancestor
102421376|NCT03024905|Misoprostol|misoprostol|mesh-list
102421377|NCT03024905|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102421378|NCT03024905|Abortifacient Agents|abortifacient agents|mesh-ancestor
102421379|NCT03024905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102421380|NCT03024905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421381|NCT03024905|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102421382|NCT03024905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102421383|NCT03024905|Oxytocics|oxytocics|mesh-ancestor
102421384|NCT02643420|Cyclophosphamide|cyclophosphamide|mesh-list
102421385|NCT02643420|Docetaxel|docetaxel|mesh-list
102421386|NCT02643420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102421387|NCT02643420|Immunologic Factors|immunologic factors|mesh-ancestor
102421388|NCT02643420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421389|NCT02643420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102421390|NCT02643420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102421391|NCT02643420|Alkylating Agents|alkylating agents|mesh-ancestor
102421392|NCT02643420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421393|NCT02643420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102421394|NCT02643420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102421395|NCT02643420|Tubulin Modulators|tubulin modulators|mesh-ancestor
102421396|NCT02643420|Antimitotic Agents|antimitotic agents|mesh-ancestor
102421397|NCT02643420|Mitosis Modulators|mitosis modulators|mesh-ancestor
102421398|NCT01830465|Rituximab|rituximab|mesh-list
102421399|NCT01830465|Bortezomib|bortezomib|mesh-list
102421400|NCT01830465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102421401|NCT01830465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102421402|NCT01830465|Immunologic Factors|immunologic factors|mesh-ancestor
102421403|NCT01830465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421404|NCT01830465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102421405|NCT00894465|Midazolam|midazolam|mesh-list
102421406|NCT00894465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102421407|NCT00894465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102421408|NCT00894465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102421409|NCT00894465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421410|NCT00894465|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102421411|NCT00894465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102421412|NCT00894465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102421413|NCT00894465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102421414|NCT00894465|Anesthetics, General|anesthetics, general|mesh-ancestor
102421415|NCT00894465|Anesthetics|anesthetics|mesh-ancestor
102421416|NCT00894465|GABA Modulators|gaba modulators|mesh-ancestor
102421417|NCT00894465|GABA Agents|gaba agents|mesh-ancestor
102421418|NCT00894465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102421419|NCT00894465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421420|NCT01456130|Alogliptin|alogliptin|mesh-list
102421421|NCT01456130|Insulin, Short-Acting|insulin, short-acting|mesh-list
102421422|NCT01456130|Secretagogues|secretagogues|mesh-list
102421423|NCT01456130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102421424|NCT01456130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421425|NCT01456130|Incretins|incretins|mesh-ancestor
102421426|NCT01456130|Hormones|hormones|mesh-ancestor
102421427|NCT01456130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102421428|NCT01456130|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102421429|NCT01456130|Protease Inhibitors|protease inhibitors|mesh-ancestor
102421430|NCT01456130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102421431|NCT01456130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421432|NCT03479671|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102421433|NCT03479671|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102421434|NCT03479671|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102421435|NCT03479671|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102421436|NCT03219645|Aspirin|aspirin|mesh-list
102421437|NCT03219645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102421438|NCT03219645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102421439|NCT03219645|Analgesics|analgesics|mesh-ancestor
102421440|NCT03219645|Sensory System Agents|sensory system agents|mesh-ancestor
102421441|NCT03219645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102421442|NCT03219645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421443|NCT03219645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102421444|NCT03219645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102421445|NCT03219645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102421446|NCT03219645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102421447|NCT03219645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421448|NCT03219645|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102421449|NCT03219645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102421450|NCT03219645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102421451|NCT03219645|Antipyretics|antipyretics|mesh-ancestor
102421452|NCT04435314|Nitazoxanide|nitazoxanide|mesh-list
102421453|NCT04435314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102421454|NCT04435314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102421455|NCT03102450|Benzalkonium Compounds|benzalkonium compounds|mesh-list
102421456|NCT03102450|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102421457|NCT03102450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102421458|NCT01387607|Pregabalin|pregabalin|mesh-list
102421459|NCT01387607|Analgesics|analgesics|mesh-ancestor
102421460|NCT01387607|Sensory System Agents|sensory system agents|mesh-ancestor
102421461|NCT01387607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102421462|NCT01387607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421463|NCT01387607|Anticonvulsants|anticonvulsants|mesh-ancestor
102421464|NCT01387607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102421465|NCT01387607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102421466|NCT01387607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421467|NCT01387607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102421468|NCT01387607|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102052154|NCT05383742|Rifampin|rifampin|mesh-list
102421469|NCT01387607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102421470|NCT01387607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102421471|NCT01387607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102421472|NCT05069454|Vaccines|vaccines|mesh-list
102421473|NCT05069454|Immunologic Factors|immunologic factors|mesh-ancestor
102421474|NCT05069454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421475|NCT05069688|Rifampin|rifampin|mesh-list
102421476|NCT05069688|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102421477|NCT05069688|Antitubercular Agents|antitubercular agents|mesh-ancestor
102421478|NCT05069688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102421479|NCT05069688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102421480|NCT05069688|Leprostatic Agents|leprostatic agents|mesh-ancestor
102421481|NCT05069688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102421482|NCT05069688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102421483|NCT05069688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421484|NCT05069688|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102421485|NCT05069688|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102421486|NCT05069688|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102421487|NCT05069688|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102421488|NCT05069688|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102421489|NCT05069688|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102421490|NCT01830777|Cytarabine|cytarabine|mesh-list
102421491|NCT01830777|Etoposide|etoposide|mesh-list
102421492|NCT01830777|Mitoxantrone|mitoxantrone|mesh-list
102421493|NCT01830777|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102421494|NCT01830777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102421495|NCT01830777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102421496|NCT01830777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102421497|NCT01830777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102421498|NCT01830777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102421499|NCT01830777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421500|NCT01830777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102421501|NCT01830777|Antimetabolites|antimetabolites|mesh-ancestor
102421502|NCT01830777|Antiviral Agents|antiviral agents|mesh-ancestor
102421503|NCT01830777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102421504|NCT01830777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102421505|NCT01830777|Immunologic Factors|immunologic factors|mesh-ancestor
102421506|NCT01830777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421507|NCT01830777|Analgesics|analgesics|mesh-ancestor
102421508|NCT01830777|Sensory System Agents|sensory system agents|mesh-ancestor
102421509|NCT01830777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102421510|NCT01830777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102421511|NCT01830777|Immunotoxins|immunotoxins|mesh-ancestor
102421512|NCT01830777|Immunoconjugates|immunoconjugates|mesh-ancestor
102421513|NCT03218631|Oxandrolone|oxandrolone|mesh-list
102421514|NCT03218631|Androgens|androgens|mesh-ancestor
102421515|NCT03218631|Hormones|hormones|mesh-ancestor
102421516|NCT03218631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102421517|NCT03218631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421518|NCT03218631|Anabolic Agents|anabolic agents|mesh-ancestor
102421519|NCT03451045|Dronabinol|dronabinol|mesh-list
102421520|NCT03451045|Lenabasum|lenabasum|mesh-list
102421521|NCT03451045|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102421522|NCT03451045|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102421523|NCT03451045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102421524|NCT03451045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421525|NCT03451045|Hormones|hormones|mesh-ancestor
102421526|NCT03451045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102421527|NCT03451045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421528|NCT03451045|Hallucinogens|hallucinogens|mesh-ancestor
102421529|NCT03451045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102421530|NCT03451045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102421531|NCT03451045|Analgesics|analgesics|mesh-ancestor
102421532|NCT03451045|Sensory System Agents|sensory system agents|mesh-ancestor
102421533|NCT03451045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102421534|NCT01831011|Aspirin|aspirin|mesh-list
102421535|NCT01831011|Cinepazide|cinepazide|mesh-list
102421536|NCT01831011|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
102052203|NCT05327595|GABA Agents|gaba agents|mesh-ancestor
102421537|NCT01831011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102421538|NCT01831011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102421539|NCT01831011|Analgesics|analgesics|mesh-ancestor
102421540|NCT01831011|Sensory System Agents|sensory system agents|mesh-ancestor
102421541|NCT01831011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102421542|NCT01831011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421543|NCT01831011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102421544|NCT01831011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102421545|NCT01831011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102421546|NCT01831011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102421547|NCT01831011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421548|NCT01831011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102421549|NCT01831011|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102421550|NCT01831011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102421551|NCT01831011|Antipyretics|antipyretics|mesh-ancestor
102421552|NCT01831011|Vasodilator Agents|vasodilator agents|mesh-ancestor
102421553|NCT01831011|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102421554|NCT01831011|Immunologic Factors|immunologic factors|mesh-ancestor
102421555|NCT03218709|Vitamins|vitamins|mesh-list
102421556|NCT03218709|Micronutrients|micronutrients|mesh-ancestor
102421557|NCT03218709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421558|NCT03218553|Dexamethasone|dexamethasone|mesh-list
102421559|NCT03218553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102421560|NCT03218553|Antiemetics|antiemetics|mesh-ancestor
102421561|NCT03218553|Autonomic Agents|autonomic agents|mesh-ancestor
102421562|NCT03218553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102421563|NCT03218553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421564|NCT03218553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102421565|NCT03218553|Glucocorticoids|glucocorticoids|mesh-ancestor
102421566|NCT03218553|Hormones|hormones|mesh-ancestor
102421567|NCT03218553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102421568|NCT03218553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102421569|NCT03218553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102421570|NCT03430843|Paclitaxel|paclitaxel|mesh-list
102421571|NCT03430843|Docetaxel|docetaxel|mesh-list
102421572|NCT03430843|Irinotecan|irinotecan|mesh-list
102421573|NCT03430843|Tislelizumab|tislelizumab|mesh-list
102421574|NCT03430843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102421575|NCT03430843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102421576|NCT03430843|Tubulin Modulators|tubulin modulators|mesh-ancestor
102421577|NCT03430843|Antimitotic Agents|antimitotic agents|mesh-ancestor
102421578|NCT03430843|Mitosis Modulators|mitosis modulators|mesh-ancestor
102421579|NCT03430843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421580|NCT03430843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102421581|NCT03430843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102421582|NCT03430843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102421583|NCT03430843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102421584|NCT01386125|Mometasone Furoate|mometasone furoate|mesh-list
102421585|NCT01386125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102421587|NCT01386125|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102421588|NCT01831323|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102421589|NCT01831323|Rifaximin|rifaximin|mesh-list
102421590|NCT01831323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102421591|NCT01831323|Mesalamine|mesalamine|mesh-list
102421592|NCT01831323|Psyllium|psyllium|mesh-list
102421593|NCT01831323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102421594|NCT01831323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102421595|NCT01831323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102421596|NCT01831323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102421597|NCT01831323|Analgesics|analgesics|mesh-ancestor
102421598|NCT01831323|Sensory System Agents|sensory system agents|mesh-ancestor
102421599|NCT01831323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102421600|NCT01831323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421601|NCT01831323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102421602|NCT01831323|Cathartics|cathartics|mesh-ancestor
102421603|NCT03221400|Leucovorin|leucovorin|mesh-list
102421604|NCT03221400|Folic Acid|folic acid|mesh-list
102421605|NCT03221400|Fluorouracil|fluorouracil|mesh-list
102421606|NCT03221400|Niraparib|niraparib|mesh-list
102421607|NCT03221400|Levoleucovorin|levoleucovorin|mesh-list
102421608|NCT03221400|Antimetabolites|antimetabolites|mesh-ancestor
102421609|NCT03221400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421610|NCT03221400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102421611|NCT03221400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102421612|NCT03221400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102421613|NCT03221400|Immunologic Factors|immunologic factors|mesh-ancestor
102421614|NCT03221400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421615|NCT03221400|Antidotes|antidotes|mesh-ancestor
102421616|NCT03221400|Protective Agents|protective agents|mesh-ancestor
102421617|NCT03221400|Vitamin B Complex|vitamin b complex|mesh-ancestor
102421618|NCT03221400|Vitamins|vitamins|mesh-ancestor
102421619|NCT03221400|Micronutrients|micronutrients|mesh-ancestor
102421620|NCT03221400|Hematinics|hematinics|mesh-ancestor
102421621|NCT03221400|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102421622|NCT03221400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102421623|NCT01384877|Lidocaine|lidocaine|mesh-list
102421624|NCT01384877|Anesthetics, Local|anesthetics, local|mesh-ancestor
102421625|NCT01384877|Anesthetics|anesthetics|mesh-ancestor
102421626|NCT01384877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102421627|NCT01384877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421628|NCT01384877|Sensory System Agents|sensory system agents|mesh-ancestor
102421629|NCT01384877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102421630|NCT01384877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102421631|NCT01384877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102421632|NCT01384877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102421633|NCT01384877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102421634|NCT01384877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421635|NCT00114517|Hormones|hormones|mesh-list
102421636|NCT00114517|Estradiol|estradiol|mesh-list
102421637|NCT00114517|Estrogens|estrogens|mesh-list
102421638|NCT00114517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102421639|NCT00114517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421640|NCT01831479|Olmesartan|olmesartan|mesh-list
102421641|NCT01831479|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
102421642|NCT01831479|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102421643|NCT01831479|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102421644|NCT01831479|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102421645|NCT01831479|Antimetabolites|antimetabolites|mesh-ancestor
102421646|NCT01831479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421647|NCT01831479|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102421648|NCT01831479|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102421649|NCT01831479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102421650|NCT01831479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102421651|NCT01831479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102421652|NCT01831479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102421653|NCT03099720|Ropivacaine|ropivacaine|mesh-list
102421654|NCT03099720|Anesthetics, Local|anesthetics, local|mesh-ancestor
102421655|NCT03099720|Anesthetics|anesthetics|mesh-ancestor
102421656|NCT03099720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102421657|NCT03099720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421658|NCT03099720|Sensory System Agents|sensory system agents|mesh-ancestor
102421659|NCT03099720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102421660|NCT03025295|Dexmedetomidine|dexmedetomidine|mesh-list
102421661|NCT03025295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102421662|NCT03025295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102421663|NCT03025295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421664|NCT03025295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102421665|NCT03025295|Analgesics|analgesics|mesh-ancestor
102421666|NCT03025295|Sensory System Agents|sensory system agents|mesh-ancestor
102421667|NCT03025295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102421668|NCT03025295|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102421669|NCT03025295|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102421670|NCT03025295|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102421671|NCT03025295|Adrenergic Agents|adrenergic agents|mesh-ancestor
102421672|NCT03025295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102421673|NCT03025295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421674|NCT01471574|Interferons|interferons|mesh-list
102421675|NCT01471574|Ribavirin|ribavirin|mesh-list
102421676|NCT01471574|Interferon-alpha|interferon-alpha|mesh-list
102421677|NCT01471574|Interferon alpha-2|interferon alpha-2|mesh-list
102421678|NCT01471574|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102421679|NCT01471574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102421680|NCT01471574|Antiviral Agents|antiviral agents|mesh-ancestor
102421681|NCT01471574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102421682|NCT01471574|Antimetabolites|antimetabolites|mesh-ancestor
102421683|NCT01471574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421684|NCT01471574|Immunologic Factors|immunologic factors|mesh-ancestor
102421685|NCT01471574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421686|NCT01383707|Leucovorin|leucovorin|mesh-list
102421687|NCT01383707|Bevacizumab|bevacizumab|mesh-list
102421688|NCT01383707|Fluorouracil|fluorouracil|mesh-list
102421689|NCT01383707|Oxaliplatin|oxaliplatin|mesh-list
102421690|NCT01383707|Levoleucovorin|levoleucovorin|mesh-list
102421691|NCT01383707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102421692|NCT01383707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102421693|NCT01383707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102421694|NCT01383707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102421695|NCT01383707|Growth Substances|growth substances|mesh-ancestor
102421696|NCT01383707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421697|NCT01383707|Growth Inhibitors|growth inhibitors|mesh-ancestor
102421698|NCT01383707|Antimetabolites|antimetabolites|mesh-ancestor
102421699|NCT01383707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421700|NCT01383707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102421701|NCT01383707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102421702|NCT01383707|Immunologic Factors|immunologic factors|mesh-ancestor
102421703|NCT01383707|Antidotes|antidotes|mesh-ancestor
102421704|NCT01383707|Protective Agents|protective agents|mesh-ancestor
102421705|NCT01383707|Vitamin B Complex|vitamin b complex|mesh-ancestor
102421706|NCT01383707|Vitamins|vitamins|mesh-ancestor
102421707|NCT01383707|Micronutrients|micronutrients|mesh-ancestor
102421708|NCT01839357|Rivaroxaban|rivaroxaban|mesh-list
102421709|NCT01839357|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102421710|NCT01839357|Antithrombins|antithrombins|mesh-ancestor
102421711|NCT01839357|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102421712|NCT01839357|Protease Inhibitors|protease inhibitors|mesh-ancestor
102421713|NCT01839357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102421714|NCT01839357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421715|NCT01839357|Anticoagulants|anticoagulants|mesh-ancestor
102421716|NCT03306901|Fluorouracil|fluorouracil|mesh-list
102421717|NCT03306901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102421718|NCT03306901|Antimetabolites|antimetabolites|mesh-ancestor
102421719|NCT03306901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421720|NCT03306901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102421721|NCT03306901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102421722|NCT03306901|Immunologic Factors|immunologic factors|mesh-ancestor
102421723|NCT03306901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421724|NCT01455428|Pregabalin|pregabalin|mesh-list
102421725|NCT01455428|Analgesics|analgesics|mesh-ancestor
102421726|NCT01455428|Sensory System Agents|sensory system agents|mesh-ancestor
102421727|NCT01455428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102421728|NCT01455428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421729|NCT01455428|Anticonvulsants|anticonvulsants|mesh-ancestor
102421730|NCT01455428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102421731|NCT01455428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102421732|NCT01455428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421733|NCT01455428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102421734|NCT01455428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102421735|NCT01455428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102421736|NCT01455428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102233416|NCT05129475|Ritonavir|ritonavir|mesh-list
102421737|NCT01455428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102421738|NCT01831947|Ranibizumab|ranibizumab|mesh-list
102421739|NCT01831947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102421740|NCT01831947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102421741|NCT01831947|Growth Substances|growth substances|mesh-ancestor
102421742|NCT01831947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421743|NCT01831947|Growth Inhibitors|growth inhibitors|mesh-ancestor
102421744|NCT01831947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102421746|NCT01383161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102421747|NCT01383161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102421748|NCT01383161|Analgesics|analgesics|mesh-ancestor
102421749|NCT01383161|Sensory System Agents|sensory system agents|mesh-ancestor
102421750|NCT01383161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102421751|NCT01383161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421752|NCT01383161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102421753|NCT01383161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102421754|NCT01383161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102421755|NCT01383161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102421756|NCT01383161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421757|NCT00894699|Sufentanil|sufentanil|mesh-list
102421758|NCT00894699|Triazolam|triazolam|mesh-list
102421759|NCT00894699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102421760|NCT00894699|Narcotics|narcotics|mesh-ancestor
102421761|NCT00894699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102421762|NCT00894699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421763|NCT00894699|Analgesics|analgesics|mesh-ancestor
102421764|NCT00894699|Sensory System Agents|sensory system agents|mesh-ancestor
102421765|NCT00894699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102421766|NCT00894699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102421767|NCT00894699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102421768|NCT00894699|Anesthetics, General|anesthetics, general|mesh-ancestor
102421769|NCT00894699|Anesthetics|anesthetics|mesh-ancestor
102421770|NCT00894699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102421771|NCT00894699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102421772|NCT00894699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102421773|NCT00894699|GABA Modulators|gaba modulators|mesh-ancestor
102421774|NCT00894699|GABA Agents|gaba agents|mesh-ancestor
102421775|NCT00894699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102421776|NCT00894699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421777|NCT03087019|Pembrolizumab|pembrolizumab|mesh-list
102421778|NCT03087019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102421779|NCT03087019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102421780|NCT03087019|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102421781|NCT03087019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421782|NCT01382225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102421783|NCT01382225|Hyaluronic Acid|hyaluronic acid|mesh-list
102421784|NCT01382225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102421785|NCT01382225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102421786|NCT01382225|Immunologic Factors|immunologic factors|mesh-ancestor
102421787|NCT01382225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421788|NCT01382225|Viscosupplements|viscosupplements|mesh-ancestor
102421789|NCT01382225|Protective Agents|protective agents|mesh-ancestor
102421790|NCT01381679|Ezetimibe|ezetimibe|mesh-list
102421791|NCT01381679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102421792|NCT01381679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102421793|NCT01381679|Antimetabolites|antimetabolites|mesh-ancestor
102421794|NCT01381679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421795|NCT01381679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102421796|NCT01832415|Bevacizumab|bevacizumab|mesh-list
102421797|NCT01832415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102421798|NCT01832415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102421799|NCT01832415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102421800|NCT01832415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102421801|NCT01832415|Growth Substances|growth substances|mesh-ancestor
102421802|NCT01832415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421803|NCT01832415|Growth Inhibitors|growth inhibitors|mesh-ancestor
102421804|NCT01455194|Ciclesonide|ciclesonide|mesh-list
102421805|NCT01455194|Glucocorticoids|glucocorticoids|mesh-ancestor
102421806|NCT01455194|Hormones|hormones|mesh-ancestor
102421807|NCT01455194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102421808|NCT01455194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421809|NCT01455194|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102421810|NCT03216759|Dexmedetomidine|dexmedetomidine|mesh-list
102421811|NCT03216759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102233553|NCT02476825|Xhance|xhance|mesh-list
102421812|NCT03216759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102421813|NCT03216759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421814|NCT03216759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102421816|NCT03216759|Sensory System Agents|sensory system agents|mesh-ancestor
102421817|NCT03216759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102421818|NCT03216759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102421819|NCT03216759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102421820|NCT03216759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102421821|NCT03216759|Adrenergic Agents|adrenergic agents|mesh-ancestor
102421822|NCT03216759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102421823|NCT03216759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421824|NCT01832571|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102421825|NCT01832571|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102421826|NCT01832571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102421827|NCT01832571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102421828|NCT01832571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421829|NCT01832571|Antiviral Agents|antiviral agents|mesh-ancestor
102421830|NCT01832571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102421831|NCT01832571|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102421832|NCT01832571|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102421833|NCT03216915|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102421834|NCT03216915|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102421835|NCT03216915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421836|NCT03216915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102421837|NCT03216915|Immunologic Factors|immunologic factors|mesh-ancestor
102421838|NCT03216915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421839|NCT04007393|Topiramate|topiramate|mesh-list
102421840|NCT04007393|Phentermine|phentermine|mesh-list
102421841|NCT04007393|Anticonvulsants|anticonvulsants|mesh-ancestor
102421842|NCT04007393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102421843|NCT04007393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421844|NCT04007393|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102421845|NCT04007393|Appetite Depressants|appetite depressants|mesh-ancestor
102421846|NCT04007393|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102421847|NCT04007393|Sympathomimetics|sympathomimetics|mesh-ancestor
102421848|NCT04007393|Autonomic Agents|autonomic agents|mesh-ancestor
102421849|NCT04007393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102421850|NCT04007393|Adrenergic Agents|adrenergic agents|mesh-ancestor
102421851|NCT04007393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102421852|NCT04007393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421853|NCT05368805|Dabigatran|dabigatran|mesh-list
102421854|NCT05368805|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102421855|NCT05368805|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102421856|NCT05368805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102421857|NCT05368805|Antimetabolites|antimetabolites|mesh-ancestor
102421858|NCT05368805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421859|NCT05368805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102421860|NCT05368805|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102421861|NCT05368805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102421862|NCT05368805|Antithrombins|antithrombins|mesh-ancestor
102421863|NCT05368805|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102421864|NCT05368805|Protease Inhibitors|protease inhibitors|mesh-ancestor
102421865|NCT05368805|Anticoagulants|anticoagulants|mesh-ancestor
102421866|NCT03304717|Tenofovir|tenofovir|mesh-list
102421867|NCT03304717|Emtricitabine|emtricitabine|mesh-list
102421868|NCT03304717|Antiviral Agents|antiviral agents|mesh-ancestor
102421869|NCT03304717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102421870|NCT03304717|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102421871|NCT03304717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102421872|NCT03304717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102421873|NCT03304717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421874|NCT03304717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102421875|NCT03304717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102421876|NCT01839981|Thioctic Acid|thioctic acid|mesh-list
102421877|NCT01839981|Antioxidants|antioxidants|mesh-ancestor
102421878|NCT01839981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421879|NCT01839981|Protective Agents|protective agents|mesh-ancestor
102421880|NCT01839981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421881|NCT01839981|Vitamin B Complex|vitamin b complex|mesh-ancestor
102421882|NCT01839981|Vitamins|vitamins|mesh-ancestor
102421883|NCT01839981|Micronutrients|micronutrients|mesh-ancestor
102421884|NCT03081156|Glycopyrrolate|glycopyrrolate|mesh-list
102421885|NCT03081156|Formoterol Fumarate|formoterol fumarate|mesh-list
102421886|NCT03081156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102421887|NCT03081156|Autonomic Agents|autonomic agents|mesh-ancestor
102421888|NCT03081156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102052551|NCT04610320|Daratumumab|daratumumab|mesh-list
102421889|NCT03081156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421890|NCT03081156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102421891|NCT03081156|Respiratory System Agents|respiratory system agents|mesh-ancestor
102421892|NCT03081156|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102421893|NCT03081156|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102421894|NCT03081156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102421895|NCT03081156|Adrenergic Agents|adrenergic agents|mesh-ancestor
102421896|NCT03081156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102421897|NCT03081156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421898|NCT03081156|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102421899|NCT03081156|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102421900|NCT03081156|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102421901|NCT03081156|Cholinergic Agents|cholinergic agents|mesh-ancestor
102421902|NCT01494350|Gentamicins|gentamicins|mesh-list
102421903|NCT01494350|Paromomycin|paromomycin|mesh-list
102421904|NCT01494350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102421905|NCT01494350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102421906|NCT01494350|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102421907|NCT01494350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102421908|NCT01494350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421909|NCT01494350|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102421910|NCT01494350|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102421911|NCT02135484|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
102421912|NCT02135484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102421913|NCT03258385|Vitamin B 12|vitamin b 12|mesh-list
102421914|NCT03258385|Hydroxocobalamin|hydroxocobalamin|mesh-list
102421915|NCT03258385|Vitamins|vitamins|mesh-ancestor
102421916|NCT03258385|Micronutrients|micronutrients|mesh-ancestor
102421917|NCT03258385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421918|NCT03258385|Vitamin B Complex|vitamin b complex|mesh-ancestor
102421919|NCT03258385|Hematinics|hematinics|mesh-ancestor
102421920|NCT03024515|Analgesics, Opioid|analgesics, opioid|mesh-list
102421921|NCT03024515|Narcotics|narcotics|mesh-ancestor
102421922|NCT03024515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102421923|NCT03024515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421924|NCT03024515|Analgesics|analgesics|mesh-ancestor
102421925|NCT03024515|Sensory System Agents|sensory system agents|mesh-ancestor
102421926|NCT03024515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102421927|NCT01834911|Tetrabenazine|tetrabenazine|mesh-list
102421928|NCT01834911|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102421929|NCT01834911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102421930|NCT01834911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102421931|NCT01834911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421932|NCT01834911|Adrenergic Agents|adrenergic agents|mesh-ancestor
102421933|NCT01834911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102421934|NCT01834911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421935|NCT04287829|Pembrolizumab|pembrolizumab|mesh-list
102421936|NCT04287829|Lenvatinib|lenvatinib|mesh-list
102421937|NCT04287829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102421938|NCT04287829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102421939|NCT04287829|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102421940|NCT04287829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421941|NCT04287829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102421942|NCT04287829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102421943|NCT03083821|Entecavir|entecavir|mesh-list
102421944|NCT03083821|Antiviral Agents|antiviral agents|mesh-ancestor
102421945|NCT03083821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102421946|NCT05367869|Methylene Blue|methylene blue|mesh-list
102421947|NCT05367869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102421948|NCT05367869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421949|NCT01720095|Niacin|niacin|mesh-list
102421950|NCT01720095|Nicotinic Acids|nicotinic acids|mesh-list
102421951|NCT01720095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102421952|NCT01720095|Antimetabolites|antimetabolites|mesh-ancestor
102421953|NCT01720095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421954|NCT01720095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102421955|NCT01720095|Vasodilator Agents|vasodilator agents|mesh-ancestor
102421956|NCT01720095|Vitamin B Complex|vitamin b complex|mesh-ancestor
102421957|NCT01720095|Vitamins|vitamins|mesh-ancestor
102233632|NCT02479711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102421958|NCT01720095|Micronutrients|micronutrients|mesh-ancestor
102052624|NCT04546399|Vitamins|vitamins|mesh-ancestor
102421959|NCT01720095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421961|NCT03836157|Maytansine|maytansine|mesh-list
102421962|NCT03836157|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
102421963|NCT03836157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102421964|NCT03836157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102421965|NCT03836157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102421966|NCT03836157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102421967|NCT03836157|Growth Substances|growth substances|mesh-ancestor
102421968|NCT03836157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421969|NCT03836157|Growth Inhibitors|growth inhibitors|mesh-ancestor
102421970|NCT03836157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102421971|NCT03836157|Tubulin Modulators|tubulin modulators|mesh-ancestor
102421972|NCT03836157|Antimitotic Agents|antimitotic agents|mesh-ancestor
102421973|NCT03836157|Mitosis Modulators|mitosis modulators|mesh-ancestor
102421974|NCT03836157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421975|NCT03836157|Immunoconjugates|immunoconjugates|mesh-ancestor
102421976|NCT03836157|Immunologic Factors|immunologic factors|mesh-ancestor
102421977|NCT03080545|Calcitriol|calcitriol|mesh-list
102421978|NCT03080545|Betamethasone|betamethasone|mesh-list
102421979|NCT03080545|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102421980|NCT03080545|Calcipotriene|calcipotriene|mesh-list
102421981|NCT03080545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102421982|NCT03080545|Glucocorticoids|glucocorticoids|mesh-ancestor
102421983|NCT03080545|Hormones|hormones|mesh-ancestor
102421984|NCT03080545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102421985|NCT03080545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102421986|NCT03080545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102421987|NCT03080545|Respiratory System Agents|respiratory system agents|mesh-ancestor
102421988|NCT03080545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102421989|NCT03080545|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102421990|NCT03080545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102421991|NCT03080545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102421992|NCT03080545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102421993|NCT03080545|Vitamins|vitamins|mesh-ancestor
102421994|NCT03080545|Micronutrients|micronutrients|mesh-ancestor
102421995|NCT03080545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102421996|NCT03080545|Dermatologic Agents|dermatologic agents|mesh-ancestor
102421997|NCT03101124|Tranexamic Acid|tranexamic acid|mesh-list
102421998|NCT03101124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102421999|NCT03101124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102422000|NCT03101124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422001|NCT03101124|Hemostatics|hemostatics|mesh-ancestor
102422002|NCT03101124|Coagulants|coagulants|mesh-ancestor
102422003|NCT02985203|Vinorelbine|vinorelbine|mesh-list
102422004|NCT02985203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102422005|NCT02985203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102422006|NCT02985203|Tubulin Modulators|tubulin modulators|mesh-ancestor
102422007|NCT02985203|Antimitotic Agents|antimitotic agents|mesh-ancestor
102422008|NCT02985203|Mitosis Modulators|mitosis modulators|mesh-ancestor
102422009|NCT02985203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422010|NCT04283617|Insulin|insulin|mesh-list
102422011|NCT04283617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102422012|NCT04283617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422013|NCT05247619|Paclitaxel|paclitaxel|mesh-list
102422014|NCT05247619|Bevacizumab|bevacizumab|mesh-list
102422015|NCT05247619|Carboplatin|carboplatin|mesh-list
102422016|NCT05247619|Tislelizumab|tislelizumab|mesh-list
102422017|NCT05247619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102422018|NCT05247619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102422019|NCT05247619|Tubulin Modulators|tubulin modulators|mesh-ancestor
102422020|NCT05247619|Antimitotic Agents|antimitotic agents|mesh-ancestor
102422021|NCT05247619|Mitosis Modulators|mitosis modulators|mesh-ancestor
102052692|NCT04417998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102422022|NCT05247619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422023|NCT05247619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102422024|NCT05247619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102422025|NCT05247619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102422026|NCT05247619|Growth Substances|growth substances|mesh-ancestor
102422027|NCT05247619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422028|NCT05247619|Growth Inhibitors|growth inhibitors|mesh-ancestor
102422029|NCT04018937|Fludarabine|fludarabine|mesh-list
102422030|NCT04018937|Melphalan|melphalan|mesh-list
102422031|NCT04018937|Alemtuzumab|alemtuzumab|mesh-list
102422032|NCT04018937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102422033|NCT04018937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422034|NCT04018937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102422035|NCT04018937|Immunologic Factors|immunologic factors|mesh-ancestor
102422036|NCT04018937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422037|NCT04018937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102422038|NCT04018937|Alkylating Agents|alkylating agents|mesh-ancestor
102422039|NCT04018937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102422040|NCT04018937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102422041|NCT00805584|Desloratadine|desloratadine|mesh-list
102422042|NCT00805584|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102422043|NCT00805584|Cholinergic Agents|cholinergic agents|mesh-ancestor
102422044|NCT00805584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102422045|NCT00805584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422046|NCT00805584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422047|NCT00805584|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102422048|NCT00805584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102422049|NCT00805584|Histamine Antagonists|histamine antagonists|mesh-ancestor
102422050|NCT00805584|Histamine Agents|histamine agents|mesh-ancestor
102422051|NCT01833351|Vitamins|vitamins|mesh-list
102422052|NCT01833351|Ascorbic Acid|ascorbic acid|mesh-list
102422053|NCT01833351|Micronutrients|micronutrients|mesh-ancestor
102422054|NCT01833351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422055|NCT01833351|Antioxidants|antioxidants|mesh-ancestor
102422056|NCT01833351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422057|NCT01833351|Protective Agents|protective agents|mesh-ancestor
102422058|NCT03187405|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102422059|NCT03187405|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102422060|NCT03187405|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102422061|NCT03187405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422062|NCT05066958|Antiviral Agents|antiviral agents|mesh-list
102422063|NCT05066958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102422064|NCT00218543|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102422065|NCT00218543|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102422066|NCT00218543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102422067|NCT00218543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102422068|NCT00218543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422069|NCT00218543|Adrenergic Agents|adrenergic agents|mesh-ancestor
102422070|NCT00218543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102422071|NCT00218543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422072|NCT00795522|Desloratadine|desloratadine|mesh-list
102422073|NCT00795522|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102422074|NCT00795522|Cholinergic Agents|cholinergic agents|mesh-ancestor
102422075|NCT00795522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102422076|NCT00795522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422077|NCT00795522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422078|NCT00795522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102422079|NCT00795522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102422080|NCT00795522|Histamine Antagonists|histamine antagonists|mesh-ancestor
102422081|NCT00795522|Histamine Agents|histamine agents|mesh-ancestor
102422082|NCT00910845|Botulinum Toxins|botulinum toxins|mesh-list
102422083|NCT00910845|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102422084|NCT00910845|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102422085|NCT00910845|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102422086|NCT00910845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102422087|NCT00910845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422088|NCT00910845|Cholinergic Agents|cholinergic agents|mesh-ancestor
102422089|NCT00910845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102422090|NCT00910845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422091|NCT00910845|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102422092|NCT00910845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102422093|NCT05243251|Olanzapine|olanzapine|mesh-list
102422094|NCT05243251|Antiemetics|antiemetics|mesh-ancestor
102422095|NCT05243251|Autonomic Agents|autonomic agents|mesh-ancestor
102422096|NCT05243251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102422097|NCT05243251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422098|NCT05243251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102422099|NCT05243251|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102422100|NCT05243251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102422101|NCT05243251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102422102|NCT05243251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102422103|NCT05243251|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102422104|NCT05243251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102422105|NCT05243251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102233780|NCT03100071|Anticoagulants|anticoagulants|mesh-ancestor
102422106|NCT05243251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422107|NCT05243251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102422108|NCT05243251|Serotonin Agents|serotonin agents|mesh-ancestor
102422109|NCT05242705|Cystatins|cystatins|mesh-list
102422110|NCT05242705|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
102422111|NCT05242705|Protease Inhibitors|protease inhibitors|mesh-ancestor
102422112|NCT05242705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102422113|NCT05242705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422114|NCT00216671|Risperidone|risperidone|mesh-list
102422115|NCT00216671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102422116|NCT00216671|Serotonin Agents|serotonin agents|mesh-ancestor
102422117|NCT00216671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102422118|NCT00216671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422119|NCT00216671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422120|NCT00216671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102422121|NCT00216671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102422122|NCT00216671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102422123|NCT00216671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102422124|NCT00216671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102422125|NCT00216671|Dopamine Agents|dopamine agents|mesh-ancestor
102422126|NCT00783354|Loratadine|loratadine|mesh-list
102422127|NCT00783354|Desloratadine|desloratadine|mesh-list
102422128|NCT00783354|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102422129|NCT00783354|Cholinergic Agents|cholinergic agents|mesh-ancestor
102422130|NCT00783354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102422131|NCT00783354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422132|NCT00783354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422133|NCT00783354|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102422134|NCT00783354|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102422135|NCT00783354|Histamine Antagonists|histamine antagonists|mesh-ancestor
102422136|NCT00783354|Histamine Agents|histamine agents|mesh-ancestor
102422137|NCT00783354|Antipruritics|antipruritics|mesh-ancestor
102422138|NCT00783354|Dermatologic Agents|dermatologic agents|mesh-ancestor
102422139|NCT00783354|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102422140|NCT01833663|Solifenacin Succinate|solifenacin succinate|mesh-list
102422141|NCT01833663|Estrogens|estrogens|mesh-list
102422142|NCT01833663|Hormones|hormones|mesh-ancestor
102422143|NCT01833663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102422144|NCT01833663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422145|NCT01833663|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102422146|NCT01833663|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102422147|NCT01833663|Cholinergic Agents|cholinergic agents|mesh-ancestor
102422148|NCT01833663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102422149|NCT01833663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422150|NCT01833663|Urological Agents|urological agents|mesh-ancestor
102422151|NCT01720875|Dexamethasone|dexamethasone|mesh-list
102422152|NCT01720875|Bortezomib|bortezomib|mesh-list
102422153|NCT01720875|Vorinostat|vorinostat|mesh-list
102422154|NCT01720875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102422155|NCT01720875|Antiemetics|antiemetics|mesh-ancestor
102422156|NCT01720875|Autonomic Agents|autonomic agents|mesh-ancestor
102422157|NCT01720875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102422158|NCT01720875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422159|NCT01720875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102422160|NCT01720875|Glucocorticoids|glucocorticoids|mesh-ancestor
102422161|NCT01720875|Hormones|hormones|mesh-ancestor
102422162|NCT01720875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102422163|NCT01720875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102422164|NCT01720875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102422165|NCT01720875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102422166|NCT01720875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102422167|NCT01720875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422168|NCT04277143|Daptomycin|daptomycin|mesh-list
102422169|NCT04277143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102422170|NCT04277143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102422171|NCT00750750|Mometasone Furoate|mometasone furoate|mesh-list
102422172|NCT00750750|Amoxicillin|amoxicillin|mesh-list
102422173|NCT00750750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102422174|NCT00750750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102422175|NCT00750750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102422176|NCT00750750|Dermatologic Agents|dermatologic agents|mesh-ancestor
102422177|NCT00750750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102422178|NCT05066802|Folfirinox|folfirinox|mesh-list
102422179|NCT05066802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102422180|NCT04379739|Apatinib|apatinib|mesh-list
102233861|NCT02475499|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102422181|NCT04379739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102422182|NCT04379739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102422183|NCT04379739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102422184|NCT04379739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422185|NCT05066568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
102422186|NCT05066568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102422187|NCT05066568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422188|NCT05248633|Dexamethasone|dexamethasone|mesh-list
102422189|NCT05248633|Lenalidomide|lenalidomide|mesh-list
102422190|NCT05248633|Bortezomib|bortezomib|mesh-list
102422191|NCT05248633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102422192|NCT05248633|Antiemetics|antiemetics|mesh-ancestor
102422193|NCT05248633|Autonomic Agents|autonomic agents|mesh-ancestor
102422194|NCT05248633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102422195|NCT05248633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422196|NCT05248633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102422197|NCT05248633|Glucocorticoids|glucocorticoids|mesh-ancestor
102422198|NCT05248633|Hormones|hormones|mesh-ancestor
102422199|NCT05248633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102422200|NCT05248633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102422201|NCT05248633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102422202|NCT05248633|Immunologic Factors|immunologic factors|mesh-ancestor
102422203|NCT05248633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102422204|NCT05248633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102422205|NCT05248633|Growth Substances|growth substances|mesh-ancestor
102422206|NCT05248633|Growth Inhibitors|growth inhibitors|mesh-ancestor
102422207|NCT00216203|Pemetrexed|pemetrexed|mesh-list
102422208|NCT00216203|Cetuximab|cetuximab|mesh-list
102422209|NCT00216203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102422210|NCT00216203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102422211|NCT00216203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422212|NCT00216203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102422213|NCT00216203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102422214|NCT00216203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102422215|NCT01727271|Interferons|interferons|mesh-list
102422216|NCT01727271|Tenofovir|tenofovir|mesh-list
102422217|NCT01727271|Interferon-alpha|interferon-alpha|mesh-list
102422218|NCT01727271|Interferon alpha-2|interferon alpha-2|mesh-list
102422219|NCT01727271|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102422220|NCT01727271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102422221|NCT01727271|Antiviral Agents|antiviral agents|mesh-ancestor
102422222|NCT01727271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102422223|NCT01727271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102422224|NCT01727271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102422225|NCT01727271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102422226|NCT01727271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422227|NCT01727271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102422228|NCT01727271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102422229|NCT01727271|Immunologic Factors|immunologic factors|mesh-ancestor
102422230|NCT01727271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422231|NCT00653796|Atorvastatin|atorvastatin|mesh-list
102422232|NCT00653796|Ezetimibe|ezetimibe|mesh-list
102422233|NCT00653796|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102422234|NCT00653796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102422235|NCT00653796|Antimetabolites|antimetabolites|mesh-ancestor
102422236|NCT00653796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422237|NCT00653796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102422238|NCT00653796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102422239|NCT00653796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102422240|NCT01833819|Lidocaine|lidocaine|mesh-list
102422241|NCT01833819|Dexmedetomidine|dexmedetomidine|mesh-list
102422242|NCT01833819|Remifentanil|remifentanil|mesh-list
102422243|NCT01833819|Anesthetics, Local|anesthetics, local|mesh-ancestor
102422244|NCT01833819|Anesthetics|anesthetics|mesh-ancestor
102422245|NCT01833819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102422246|NCT01833819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422247|NCT01833819|Sensory System Agents|sensory system agents|mesh-ancestor
102422248|NCT01833819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102422249|NCT01833819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102422250|NCT01833819|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102422251|NCT01833819|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102422252|NCT01833819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102422253|NCT01833819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422254|NCT01833819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102422255|NCT01833819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102422257|NCT01833819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102422258|NCT01833819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102422259|NCT01833819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102422260|NCT01833819|Adrenergic Agents|adrenergic agents|mesh-ancestor
102422261|NCT01833819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102422262|NCT01833819|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102422263|NCT01833819|Narcotics|narcotics|mesh-ancestor
102422264|NCT05244109|Antibodies|antibodies|mesh-list
102422265|NCT05244109|Immunoglobulins|immunoglobulins|mesh-list
102422266|NCT05244109|Immunologic Factors|immunologic factors|mesh-ancestor
102422267|NCT05244109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422268|NCT00651144|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102422269|NCT00651144|Ezetimibe|ezetimibe|mesh-list
102422270|NCT00651144|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102422271|NCT00651144|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102422272|NCT00651144|Antimetabolites|antimetabolites|mesh-ancestor
102422273|NCT00651144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422274|NCT00651144|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102422275|NCT00651144|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102422276|NCT00651144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102422277|NCT01721031|Tramadol|tramadol|mesh-list
102422278|NCT01721031|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102422279|NCT01721031|Narcotics|narcotics|mesh-ancestor
102422280|NCT01721031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102422281|NCT01721031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422282|NCT01721031|Analgesics|analgesics|mesh-ancestor
102422283|NCT01721031|Sensory System Agents|sensory system agents|mesh-ancestor
102422284|NCT01721031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102422285|NCT03218683|Venetoclax|venetoclax|mesh-list
102422286|NCT03218683|AZD5991|azd5991|mesh-list
102422287|NCT03218683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102422288|NCT03182491|Anaphylatoxins|anaphylatoxins|mesh-list
102422289|NCT03182491|Immunologic Factors|immunologic factors|mesh-ancestor
102422290|NCT03182491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422291|NCT04378647|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102422292|NCT04378647|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102422293|NCT04378647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102422294|NCT04378647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102422295|NCT04378647|Immunotoxins|immunotoxins|mesh-ancestor
102422296|NCT04378647|Immunoconjugates|immunoconjugates|mesh-ancestor
102422297|NCT04378647|Immunologic Factors|immunologic factors|mesh-ancestor
102422298|NCT04378647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422299|NCT00370890|Gemcitabine|gemcitabine|mesh-list
102422300|NCT00370890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102422301|NCT00370890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102422302|NCT00370890|Antimetabolites|antimetabolites|mesh-ancestor
102422303|NCT00370890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422304|NCT02669953|Aflibercept|aflibercept|mesh-list
102422305|NCT02669953|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102422306|NCT02669953|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102422307|NCT02669953|Growth Substances|growth substances|mesh-ancestor
102422308|NCT02669953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422309|NCT02669953|Growth Inhibitors|growth inhibitors|mesh-ancestor
102422310|NCT02669953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102422311|NCT01721655|Spironolactone|spironolactone|mesh-list
102422312|NCT01721655|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102422313|NCT01721655|Hormone Antagonists|hormone antagonists|mesh-ancestor
102422314|NCT01721655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102422315|NCT01721655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422316|NCT01721655|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102422317|NCT01721655|Diuretics|diuretics|mesh-ancestor
102422318|NCT01721655|Natriuretic Agents|natriuretic agents|mesh-ancestor
102422319|NCT00904995|Voriconazole|voriconazole|mesh-list
102422320|NCT00904995|Antifungal Agents|antifungal agents|mesh-ancestor
102422321|NCT00904995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102422322|NCT00904995|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102422323|NCT00904995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102422324|NCT00904995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102422325|NCT00904995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422326|NCT00904995|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102422327|NCT00904995|Hormone Antagonists|hormone antagonists|mesh-ancestor
102422328|NCT00904995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102422329|NCT00904995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234014|NCT05067153|Heparin|heparin|mesh-list
102422330|NCT00904995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102422331|NCT05249725|Irsogladine|irsogladine|mesh-list
102422332|NCT05249725|Hydrotalcite|hydrotalcite|mesh-list
102422333|NCT05249725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422334|NCT05249725|Antacids|antacids|mesh-ancestor
102422335|NCT05249725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102422336|NCT05249725|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102422337|NCT05249725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102422338|NCT05249725|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102422339|NCT05249725|Protective Agents|protective agents|mesh-ancestor
102422340|NCT05249725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422341|NCT05249725|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102422342|NCT01834209|Prednisone|prednisone|mesh-list
102422343|NCT01834209|Prednisolone|prednisolone|mesh-list
102422344|NCT01834209|Abiraterone Acetate|abiraterone acetate|mesh-list
102422345|NCT01834209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102422346|NCT01834209|Glucocorticoids|glucocorticoids|mesh-ancestor
102422347|NCT01834209|Hormones|hormones|mesh-ancestor
102422348|NCT01834209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102422349|NCT01834209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422350|NCT01834209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102422351|NCT01834209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102422352|NCT01834209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102422353|NCT01834209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102422354|NCT01834209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422355|NCT01834209|Hormone Antagonists|hormone antagonists|mesh-ancestor
102422356|NCT01834209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102422357|NCT05241535|Moxifloxacin|moxifloxacin|mesh-list
102422358|NCT05241535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102422359|NCT05241535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102422360|NCT05241535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102422361|NCT05241535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102422362|NCT05241535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102422363|NCT05241535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422364|NCT05241535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102422365|NCT02488135|Hemostatics|hemostatics|mesh-list
102422366|NCT02488135|Coagulants|coagulants|mesh-ancestor
102422367|NCT01727973|Doxycycline|doxycycline|mesh-list
102422368|NCT01727973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102422369|NCT01727973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102422370|NCT01727973|Antimalarials|antimalarials|mesh-ancestor
102422371|NCT01727973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102422372|NCT01727973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102422373|NCT03100734|Etanercept|etanercept|mesh-list
102422374|NCT03100734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102422375|NCT03100734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102422376|NCT03100734|Analgesics|analgesics|mesh-ancestor
102422377|NCT03100734|Sensory System Agents|sensory system agents|mesh-ancestor
102422378|NCT03100734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102422379|NCT03100734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422380|NCT03100734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102422381|NCT03100734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102422382|NCT03100734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102422383|NCT03100734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102422384|NCT03100734|Immunologic Factors|immunologic factors|mesh-ancestor
102422385|NCT05243706|Loratadine|loratadine|mesh-list
102422386|NCT05243706|Antipruritics|antipruritics|mesh-ancestor
102422387|NCT05243706|Dermatologic Agents|dermatologic agents|mesh-ancestor
102422388|NCT05243706|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102422389|NCT05243706|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102422390|NCT05243706|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102422391|NCT05243706|Histamine Antagonists|histamine antagonists|mesh-ancestor
102422392|NCT05243706|Histamine Agents|histamine agents|mesh-ancestor
102422393|NCT05243706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102422394|NCT05243706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422395|NCT05243706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422396|NCT01728051|Melphalan|melphalan|mesh-list
102422397|NCT01728051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102422398|NCT01728051|Alkylating Agents|alkylating agents|mesh-ancestor
102422399|NCT01728051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422400|NCT01728051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102422401|NCT01728051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102422402|NCT01728051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102422403|NCT01728051|Immunologic Factors|immunologic factors|mesh-ancestor
102422404|NCT01728051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422405|NCT01722201|Risperidone|risperidone|mesh-list
102422406|NCT01722201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102422407|NCT01722201|Serotonin Agents|serotonin agents|mesh-ancestor
102422408|NCT01722201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102422409|NCT01722201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422410|NCT01722201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422411|NCT01722201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102422412|NCT01722201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102422413|NCT01722201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102422414|NCT01722201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102422415|NCT01722201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102422416|NCT01722201|Dopamine Agents|dopamine agents|mesh-ancestor
102422417|NCT01722513|Alprostadil|alprostadil|mesh-list
102422418|NCT01722513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102422419|NCT01722513|Vasodilator Agents|vasodilator agents|mesh-ancestor
102422420|NCT01722513|Urological Agents|urological agents|mesh-ancestor
102422421|NCT03179995|Octreotide|octreotide|mesh-list
102422422|NCT03179995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102422423|NCT03179995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102422424|NCT03179995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102422425|NCT01728441|Paclitaxel|paclitaxel|mesh-list
102422426|NCT01728441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102422427|NCT01728441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102422428|NCT01728441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102422429|NCT01728441|Tubulin Modulators|tubulin modulators|mesh-ancestor
102422430|NCT01728441|Antimitotic Agents|antimitotic agents|mesh-ancestor
102422431|NCT01728441|Mitosis Modulators|mitosis modulators|mesh-ancestor
102422432|NCT01728441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422433|NCT03099408|Metronidazole|metronidazole|mesh-list
102422434|NCT03099408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102422435|NCT03099408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102422436|NCT03099408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102422437|NCT03099408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102422438|NCT04984200|Mydriatics|mydriatics|mesh-list
102422439|NCT04984200|Autonomic Agents|autonomic agents|mesh-ancestor
102422440|NCT04984200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102422441|NCT04984200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422442|NCT00912873|Ropivacaine|ropivacaine|mesh-list
102422443|NCT00912873|Anesthetics, Local|anesthetics, local|mesh-ancestor
102422444|NCT00912873|Anesthetics|anesthetics|mesh-ancestor
102422445|NCT00912873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102422446|NCT00912873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422447|NCT00912873|Sensory System Agents|sensory system agents|mesh-ancestor
102422448|NCT00912873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102422449|NCT01494038|Isoniazid|isoniazid|mesh-list
102422450|NCT01494038|Antitubercular Agents|antitubercular agents|mesh-ancestor
102422451|NCT01494038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102422452|NCT01494038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102422453|NCT01494038|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102422454|NCT01494038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102422455|NCT01494038|Antimetabolites|antimetabolites|mesh-ancestor
102422456|NCT01494038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422457|NCT01494038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102422458|NCT05059782|Coal Tar|coal tar|mesh-list
102422459|NCT05059782|Keratolytic Agents|keratolytic agents|mesh-ancestor
102422460|NCT05059782|Dermatologic Agents|dermatologic agents|mesh-ancestor
102422461|NCT05242081|Sufentanil|sufentanil|mesh-list
102422462|NCT05242081|Ketamine|ketamine|mesh-list
102422463|NCT05242081|Esketamine|esketamine|mesh-list
102422464|NCT05242081|Analgesics|analgesics|mesh-ancestor
102422465|NCT05242081|Sensory System Agents|sensory system agents|mesh-ancestor
102422466|NCT05242081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102422467|NCT05242081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422468|NCT05242081|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102053142|NCT03176498|Antipyretics|antipyretics|mesh-ancestor
102422469|NCT05242081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102422470|NCT05242081|Anesthetics, General|anesthetics, general|mesh-ancestor
102422471|NCT05242081|Anesthetics|anesthetics|mesh-ancestor
102422472|NCT05242081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102422473|NCT05242081|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102422474|NCT05242081|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102422475|NCT05242081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102422476|NCT05242081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422477|NCT05242081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102422478|NCT05242081|Narcotics|narcotics|mesh-ancestor
102422479|NCT05242081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102422480|NCT05242081|Antidepressive Agents|antidepressive agents|mesh-ancestor
102422481|NCT05242081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102422482|NCT03149029|Pembrolizumab|pembrolizumab|mesh-list
102422483|NCT03149029|Trametinib|trametinib|mesh-list
102422484|NCT03149029|Dabrafenib|dabrafenib|mesh-list
102422485|NCT03149029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102422486|NCT03149029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102422487|NCT03149029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102422488|NCT03149029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422489|NCT03149029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102422490|NCT03149029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102422491|NCT04412304|Dalteparin|dalteparin|mesh-list
102422492|NCT04412304|Tinzaparin|tinzaparin|mesh-list
102422493|NCT04412304|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102422494|NCT04412304|Anticoagulants|anticoagulants|mesh-ancestor
102422495|NCT04412304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102422496|NCT04412304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102422497|NCT04412304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422498|NCT00915603|Paclitaxel|paclitaxel|mesh-list
102422499|NCT00915603|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102422500|NCT00915603|Bevacizumab|bevacizumab|mesh-list
102422501|NCT00915603|Everolimus|everolimus|mesh-list
102422502|NCT00915603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102422503|NCT00915603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102422504|NCT00915603|Tubulin Modulators|tubulin modulators|mesh-ancestor
102422505|NCT00915603|Antimitotic Agents|antimitotic agents|mesh-ancestor
102422506|NCT00915603|Mitosis Modulators|mitosis modulators|mesh-ancestor
102422507|NCT00915603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422508|NCT00915603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102422509|NCT00915603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102422510|NCT00915603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102422511|NCT00915603|Growth Substances|growth substances|mesh-ancestor
102422512|NCT00915603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422513|NCT00915603|Growth Inhibitors|growth inhibitors|mesh-ancestor
102422514|NCT00915603|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102422515|NCT00915603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102422516|NCT00915603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102422517|NCT00915603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102422518|NCT00915603|Immunologic Factors|immunologic factors|mesh-ancestor
102422519|NCT01929265|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102422520|NCT01929265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102422521|NCT01929265|Alkylating Agents|alkylating agents|mesh-ancestor
102422522|NCT01929265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422523|NCT01929265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102422524|NCT01929421|Gemcitabine|gemcitabine|mesh-list
102422525|NCT01929421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102422526|NCT01929421|Antimetabolites|antimetabolites|mesh-ancestor
102422527|NCT01929421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422528|NCT01929421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102422529|NCT04474002|Picosulfate sodium|picosulfate sodium|mesh-list
102422530|NCT04474002|Cathartics|cathartics|mesh-ancestor
102422531|NCT04474002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102422532|NCT01929577|Peficitinib|peficitinib|mesh-list
102422533|NCT01929577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102422534|NCT01929577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422535|NCT01929577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102422536|NCT01929577|Immunologic Factors|immunologic factors|mesh-ancestor
102422537|NCT01929577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422538|NCT03142321|Vedolizumab|vedolizumab|mesh-list
102422539|NCT03142321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102422540|NCT01929655|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
102422541|NCT01929655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102422542|NCT03836703|Iron|iron|mesh-list
102422543|NCT03836703|Trace Elements|trace elements|mesh-ancestor
102422544|NCT03836703|Micronutrients|micronutrients|mesh-ancestor
102422545|NCT03836703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422546|NCT02398825|Ponatinib|ponatinib|mesh-list
102422547|NCT02398825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102422548|NCT02398825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102422549|NCT02398825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102422550|NCT02398825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422551|NCT01723059|Amoxicillin|amoxicillin|mesh-list
102422552|NCT01723059|Metronidazole|metronidazole|mesh-list
102422553|NCT01723059|Clarithromycin|clarithromycin|mesh-list
102422554|NCT01723059|Omeprazole|omeprazole|mesh-list
102422555|NCT01723059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102422556|NCT01723059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102422557|NCT01723059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102422558|NCT01723059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102422559|NCT01723059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102422560|NCT01723059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102422561|NCT01723059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102422562|NCT01723059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102422563|NCT01723059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422564|NCT01723059|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102422565|NCT01723059|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102422566|NCT01723059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102422567|NCT04379271|Calcium|calcium|mesh-list
102422568|NCT04379271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102422569|NCT04379271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422570|NCT01728909|Oxytocin|oxytocin|mesh-list
102422571|NCT01728909|Oxytocics|oxytocics|mesh-ancestor
102422572|NCT01728909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102422573|NCT01728909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422574|NCT01922713|Vitamin A|vitamin a|mesh-list
102422575|NCT01922713|Beta Carotene|beta carotene|mesh-list
102422576|NCT01922713|Retinol palmitate|retinol palmitate|mesh-list
102422577|NCT01922713|Vitamins|vitamins|mesh-ancestor
102422578|NCT01922713|Micronutrients|micronutrients|mesh-ancestor
102422579|NCT01922713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422580|NCT01922713|Antioxidants|antioxidants|mesh-ancestor
102422581|NCT01922713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422582|NCT01922713|Protective Agents|protective agents|mesh-ancestor
102422583|NCT01922713|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102422584|NCT01922713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102422585|NCT01922713|Provitamins|provitamins|mesh-ancestor
102422586|NCT05061732|Amoxicillin|amoxicillin|mesh-list
102422587|NCT05061732|Metronidazole|metronidazole|mesh-list
102422588|NCT05061732|Clarithromycin|clarithromycin|mesh-list
102422589|NCT05061732|Doxycycline|doxycycline|mesh-list
102422590|NCT05061732|Levofloxacin|levofloxacin|mesh-list
102422591|NCT05061732|Tetracycline|tetracycline|mesh-list
102422592|NCT05061732|Potassium Citrate|potassium citrate|mesh-list
102422593|NCT05061732|Rabeprazole|rabeprazole|mesh-list
102422594|NCT05061732|Bismuth|bismuth|mesh-list
102422595|NCT05061732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422596|NCT05061732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102422597|NCT05061732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102422598|NCT05061732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102422599|NCT05061732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102422600|NCT05061732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102422601|NCT05061732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102422602|NCT05061732|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102422603|NCT05061732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102422604|NCT05061732|Antimalarials|antimalarials|mesh-ancestor
102422605|NCT05061732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102422606|NCT05061732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102422607|NCT05061732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102422608|NCT05061732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102422609|NCT05061732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102422610|NCT05061732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102422611|NCT05061732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102422612|NCT05061732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102422613|NCT05061732|Antacids|antacids|mesh-ancestor
102422614|NCT05061732|Diuretics|diuretics|mesh-ancestor
102422615|NCT05061732|Natriuretic Agents|natriuretic agents|mesh-ancestor
102422616|NCT05061732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422617|NCT05061732|Expectorants|expectorants|mesh-ancestor
102422618|NCT05061732|Respiratory System Agents|respiratory system agents|mesh-ancestor
102422619|NCT02391571|Naltrexone|naltrexone|mesh-list
102422620|NCT02391571|Oxycodone|oxycodone|mesh-list
102422621|NCT02391571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102422622|NCT02391571|Narcotics|narcotics|mesh-ancestor
102422623|NCT02391571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102422624|NCT02391571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422625|NCT02391571|Analgesics|analgesics|mesh-ancestor
102422626|NCT02391571|Sensory System Agents|sensory system agents|mesh-ancestor
102422627|NCT02391571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102422628|NCT02391571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102422629|NCT02391571|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102422630|NCT01728987|Cholecalciferol|cholecalciferol|mesh-list
102422631|NCT01728987|Vitamin D|vitamin d|mesh-list
102422632|NCT01728987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102422633|NCT01728987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422634|NCT01728987|Vitamins|vitamins|mesh-ancestor
102422635|NCT01728987|Micronutrients|micronutrients|mesh-ancestor
102422636|NCT01728987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102422637|NCT01834989|Mitogens|mitogens|mesh-list
102422638|NCT01834989|Mitosis Modulators|mitosis modulators|mesh-ancestor
102422639|NCT01834989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422640|NCT01835067|Ranibizumab|ranibizumab|mesh-list
102422641|NCT01835067|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102422642|NCT01835067|Plasminogen|plasminogen|mesh-list
102422643|NCT01835067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102422644|NCT01835067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102422645|NCT01835067|Growth Substances|growth substances|mesh-ancestor
102422646|NCT01835067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422647|NCT01835067|Growth Inhibitors|growth inhibitors|mesh-ancestor
102422648|NCT01835067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102422649|NCT01835067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102422650|NCT01835067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102422651|NCT01835067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422652|NCT03100422|Armin|armin|mesh-list
102422653|NCT03100422|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102422654|NCT03100422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102422655|NCT03100422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422656|NCT03100422|Cholinergic Agents|cholinergic agents|mesh-ancestor
102422657|NCT03100422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102422658|NCT03100422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422659|NCT00639769|Cisplatin|cisplatin|mesh-list
102422660|NCT00639769|Irinotecan|irinotecan|mesh-list
102422661|NCT00639769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102422662|NCT00639769|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102422663|NCT00639769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102422664|NCT00639769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102422665|NCT00639769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422666|NCT01723371|Carvedilol|carvedilol|mesh-list
102422667|NCT01723371|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102422668|NCT01723371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102422669|NCT01723371|Adrenergic Agents|adrenergic agents|mesh-ancestor
102422670|NCT01723371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102422671|NCT01723371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422672|NCT01723371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422673|NCT01723371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102422674|NCT01723371|Antioxidants|antioxidants|mesh-ancestor
102422675|NCT01723371|Protective Agents|protective agents|mesh-ancestor
102422676|NCT01723371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102422677|NCT01723371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102422678|NCT01723371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102422679|NCT01723371|Vasodilator Agents|vasodilator agents|mesh-ancestor
102422680|NCT01723371|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102422681|NCT01723371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102422682|NCT00639457|Pioglitazone|pioglitazone|mesh-list
102422683|NCT00639457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102422684|NCT00639457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422685|NCT05057286|Botulinum Toxins|botulinum toxins|mesh-list
102422686|NCT05057286|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102422687|NCT05057286|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102422688|NCT05057286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102422689|NCT05057286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422690|NCT05057286|Cholinergic Agents|cholinergic agents|mesh-ancestor
102422691|NCT05057286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102422692|NCT05057286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422693|NCT05057286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102422694|NCT05057286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102422695|NCT01723527|Buprenorphine|buprenorphine|mesh-list
102422696|NCT01723527|Methadone|methadone|mesh-list
102422697|NCT01723527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102422698|NCT01723527|Narcotics|narcotics|mesh-ancestor
102422699|NCT01723527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102422700|NCT01723527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422701|NCT01723527|Analgesics|analgesics|mesh-ancestor
102422702|NCT01723527|Sensory System Agents|sensory system agents|mesh-ancestor
102422703|NCT01723527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102422704|NCT01723527|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102422705|NCT01723527|Antitussive Agents|antitussive agents|mesh-ancestor
102422706|NCT01723527|Respiratory System Agents|respiratory system agents|mesh-ancestor
102422707|NCT00639223|Pravastatin|pravastatin|mesh-list
102422708|NCT00639223|Red yeast rice|red yeast rice|mesh-list
102422709|NCT00639223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102422710|NCT00639223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102422711|NCT00639223|Antimetabolites|antimetabolites|mesh-ancestor
102053406|NCT01446133|Rituximab|rituximab|mesh-list
102422712|NCT00639223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422713|NCT00639223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102422714|NCT00639223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102422715|NCT00639223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102422716|NCT01723683|Pulmonary Surfactants|pulmonary surfactants|mesh-list
102422717|NCT01723683|Respiratory System Agents|respiratory system agents|mesh-ancestor
102422719|NCT03519984|Vincristine|vincristine|mesh-list
102422720|NCT03519984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102422721|NCT03519984|Antimetabolites|antimetabolites|mesh-ancestor
102422722|NCT03519984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422723|NCT03519984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102422724|NCT03519984|Antiviral Agents|antiviral agents|mesh-ancestor
102422725|NCT03519984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102422726|NCT03519984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102422727|NCT03519984|Immunologic Factors|immunologic factors|mesh-ancestor
102422728|NCT03519984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422729|NCT03519984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102422730|NCT03519984|Tubulin Modulators|tubulin modulators|mesh-ancestor
102422731|NCT03519984|Antimitotic Agents|antimitotic agents|mesh-ancestor
102422732|NCT03519984|Mitosis Modulators|mitosis modulators|mesh-ancestor
102422733|NCT05056896|Aspirin|aspirin|mesh-list
102422734|NCT05056896|Salicylic Acid|salicylic acid|mesh-list
102422735|NCT05056896|Salicylates|salicylates|mesh-list
102422736|NCT05056896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102422737|NCT05056896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102422738|NCT05056896|Analgesics|analgesics|mesh-ancestor
102422739|NCT05056896|Sensory System Agents|sensory system agents|mesh-ancestor
102422740|NCT05056896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102422741|NCT05056896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422742|NCT05056896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102422743|NCT05056896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102422744|NCT05056896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102422745|NCT05056896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102422746|NCT05056896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422747|NCT05056896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102422748|NCT05056896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102422749|NCT05056896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102422750|NCT05056896|Antipyretics|antipyretics|mesh-ancestor
102422751|NCT05056896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102422752|NCT05056896|Antifungal Agents|antifungal agents|mesh-ancestor
102422753|NCT05056896|Keratolytic Agents|keratolytic agents|mesh-ancestor
102422754|NCT05056896|Dermatologic Agents|dermatologic agents|mesh-ancestor
102422755|NCT00638989|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102422756|NCT00638989|Immunologic Factors|immunologic factors|mesh-ancestor
102422757|NCT00638989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422758|NCT01835691|Vitamin D|vitamin d|mesh-list
102422759|NCT01835691|Ergocalciferols|ergocalciferols|mesh-list
102422760|NCT01835691|Cholecalciferol|cholecalciferol|mesh-list
102422761|NCT01835691|Vitamins|vitamins|mesh-list
102422762|NCT01835691|Micronutrients|micronutrients|mesh-ancestor
102422763|NCT01835691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422764|NCT01835691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102422765|NCT01835691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102422766|NCT01729767|Acyclovir|acyclovir|mesh-list
102422767|NCT01729767|Antiviral Agents|antiviral agents|mesh-ancestor
102422768|NCT01729767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102422769|NCT00913263|Flutamide|flutamide|mesh-list
102422770|NCT00913263|Hydroxyflutamide|hydroxyflutamide|mesh-list
102422771|NCT00913263|Androgen Antagonists|androgen antagonists|mesh-ancestor
102422772|NCT00913263|Hormone Antagonists|hormone antagonists|mesh-ancestor
102422773|NCT00913263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102422774|NCT00913263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422775|NCT00913263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102422776|NCT00913263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102422777|NCT04377867|Abatacept|abatacept|mesh-list
102422778|NCT04377867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102422779|NCT04377867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422780|NCT04377867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102422781|NCT04377867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102422782|NCT04377867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102422783|NCT04377867|Immunologic Factors|immunologic factors|mesh-ancestor
102422784|NCT04377867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422785|NCT04377867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102422786|NCT00637273|Pioglitazone|pioglitazone|mesh-list
102422787|NCT00637273|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102422789|NCT00637273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102422790|NCT00637273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422791|NCT00637273|Incretins|incretins|mesh-ancestor
102422792|NCT00637273|Hormones|hormones|mesh-ancestor
102422793|NCT00637273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102422794|NCT00637273|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102422795|NCT00637273|Protease Inhibitors|protease inhibitors|mesh-ancestor
102422796|NCT00637273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102422797|NCT00637273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422798|NCT00637273|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102422799|NCT01923259|Donepezil|donepezil|mesh-list
102422800|NCT01923259|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102422801|NCT01923259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102422802|NCT01923259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422803|NCT01923259|Cholinergic Agents|cholinergic agents|mesh-ancestor
102422804|NCT01923259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102422805|NCT01923259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422806|NCT01923259|Nootropic Agents|nootropic agents|mesh-ancestor
102422807|NCT01923337|Irinotecan|irinotecan|mesh-list
102422808|NCT01923337|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102422809|NCT01923337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102422810|NCT01923337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102422811|NCT01923337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422812|NCT01923337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102422813|NCT03098160|Ipilimumab|ipilimumab|mesh-list
102422814|NCT03098160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102422815|NCT03098160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102422816|NCT03098160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102422817|NCT03098160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422818|NCT01720563|Leucovorin|leucovorin|mesh-list
102422819|NCT01720563|Tegafur|tegafur|mesh-list
102422820|NCT01720563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102422821|NCT01720563|Antidotes|antidotes|mesh-ancestor
102422822|NCT01720563|Protective Agents|protective agents|mesh-ancestor
102422823|NCT01720563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422824|NCT01720563|Vitamin B Complex|vitamin b complex|mesh-ancestor
102422825|NCT01720563|Vitamins|vitamins|mesh-ancestor
102422826|NCT01720563|Micronutrients|micronutrients|mesh-ancestor
102422827|NCT01720563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102422828|NCT01720563|Antimetabolites|antimetabolites|mesh-ancestor
102422829|NCT01720563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422830|NCT01724385|Bevacizumab|bevacizumab|mesh-list
102422831|NCT01724385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102422832|NCT01724385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102422833|NCT01724385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102422834|NCT01724385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102422835|NCT01724385|Growth Substances|growth substances|mesh-ancestor
102422836|NCT01724385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422837|NCT01724385|Growth Inhibitors|growth inhibitors|mesh-ancestor
102422838|NCT04377789|Quercetin|quercetin|mesh-list
102422839|NCT04377789|Antioxidants|antioxidants|mesh-ancestor
102422840|NCT04377789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422841|NCT04377789|Protective Agents|protective agents|mesh-ancestor
102422842|NCT04377789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422843|NCT00988117|Rivastigmine|rivastigmine|mesh-list
102053517|NCT01187199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102422844|NCT00988117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102422845|NCT00988117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102422846|NCT00988117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422847|NCT00988117|Cholinergic Agents|cholinergic agents|mesh-ancestor
102422848|NCT00988117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102422849|NCT00988117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422850|NCT00988117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102422851|NCT00988117|Protective Agents|protective agents|mesh-ancestor
102422852|NCT01728753|Favipiravir|favipiravir|mesh-list
102422853|NCT01728753|Antiviral Agents|antiviral agents|mesh-ancestor
102422854|NCT01728753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102422855|NCT01724619|Dihydrotestosterone|dihydrotestosterone|mesh-list
102422856|NCT01724619|Androgens|androgens|mesh-ancestor
102422857|NCT01724619|Hormones|hormones|mesh-ancestor
102422858|NCT01724619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102422859|NCT01724619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234545|NCT03174847|Mineralocorticoids|mineralocorticoids|mesh-list
102422860|NCT05045508|Varenicline|varenicline|mesh-list
102422861|NCT05045508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102422862|NCT05045508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102422863|NCT05045508|Cholinergic Agents|cholinergic agents|mesh-ancestor
102422864|NCT05045508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102422865|NCT05045508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422866|NCT05045508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422867|NCT00637195|Vaccines|vaccines|mesh-list
102422868|NCT00637195|Immunologic Factors|immunologic factors|mesh-ancestor
102422869|NCT00637195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422870|NCT05045274|Aspirin|aspirin|mesh-list
102422871|NCT05045274|Dapagliflozin|dapagliflozin|mesh-list
102422872|NCT05045274|Angiotensin II|angiotensin ii|mesh-list
102422873|NCT05045274|Giapreza|giapreza|mesh-list
102422874|NCT05045274|Clopidogrel|clopidogrel|mesh-list
102422875|NCT05045274|Ticagrelor|ticagrelor|mesh-list
102422876|NCT05045274|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
102422877|NCT05045274|Enzyme Inhibitors|enzyme inhibitors|mesh-list
102422878|NCT05045274|Angiotensinogen|angiotensinogen|mesh-list
102422879|NCT05045274|Diuretics|diuretics|mesh-list
102422880|NCT05045274|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102422881|NCT05045274|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102422882|NCT05045274|Mineralocorticoids|mineralocorticoids|mesh-list
102422883|NCT05045274|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
102422884|NCT05045274|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
102422885|NCT05045274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102422886|NCT05045274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102422887|NCT05045274|Analgesics|analgesics|mesh-ancestor
102422888|NCT05045274|Sensory System Agents|sensory system agents|mesh-ancestor
102422889|NCT05045274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102422890|NCT05045274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422891|NCT05045274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102422892|NCT05045274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102422893|NCT05045274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102422894|NCT05045274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102422895|NCT05045274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422896|NCT05045274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102422897|NCT05045274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102422898|NCT05045274|Antipyretics|antipyretics|mesh-ancestor
102422899|NCT05045274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102422900|NCT05045274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102422901|NCT05045274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102422902|NCT05045274|Purinergic Agents|purinergic agents|mesh-ancestor
102422903|NCT05045274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102422904|NCT05045274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102422905|NCT05045274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102422906|NCT05045274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102422907|NCT05045274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102422908|NCT05045274|Antimetabolites|antimetabolites|mesh-ancestor
102422909|NCT05045274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102422910|NCT05045274|Natriuretic Agents|natriuretic agents|mesh-ancestor
102422911|NCT05045274|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102053578|NCT03149107|Acetylcysteine|acetylcysteine|mesh-list
102422912|NCT05045274|Adrenergic Agents|adrenergic agents|mesh-ancestor
102422913|NCT05045274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102422914|NCT05045274|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102422915|NCT05045274|Protease Inhibitors|protease inhibitors|mesh-ancestor
102422916|NCT05045274|Hormones|hormones|mesh-ancestor
102422917|NCT05045274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102422918|NCT05045274|Hormone Antagonists|hormone antagonists|mesh-ancestor
102422919|NCT05045274|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102422920|NCT01721733|Ubiquinone|ubiquinone|mesh-list
102422921|NCT01721733|Micronutrients|micronutrients|mesh-ancestor
102422922|NCT01721733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422923|NCT01720485|Prednisolone|prednisolone|mesh-list
102422924|NCT01720485|Betamethasone|betamethasone|mesh-list
102422925|NCT01720485|Desloratadine|desloratadine|mesh-list
102422926|NCT01720485|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
102422927|NCT01720485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102422928|NCT01720485|Glucocorticoids|glucocorticoids|mesh-ancestor
102422929|NCT01720485|Hormones|hormones|mesh-ancestor
102422930|NCT01720485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102422931|NCT01720485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422932|NCT01720485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102422933|NCT01720485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102422934|NCT01720485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102422935|NCT01720485|Respiratory System Agents|respiratory system agents|mesh-ancestor
102422936|NCT01720485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102422937|NCT01720485|Cholinergic Agents|cholinergic agents|mesh-ancestor
102422938|NCT01720485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102422939|NCT01720485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422940|NCT01720485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102422941|NCT01720485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102422942|NCT01720485|Histamine Antagonists|histamine antagonists|mesh-ancestor
102422943|NCT01720485|Histamine Agents|histamine agents|mesh-ancestor
102422944|NCT01726725|Desflurane|desflurane|mesh-list
102422945|NCT01726725|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102422946|NCT01726725|Anesthetics, General|anesthetics, general|mesh-ancestor
102422947|NCT01726725|Anesthetics|anesthetics|mesh-ancestor
102422948|NCT01726725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102422949|NCT01726725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422950|NCT05044728|Paclitaxel|paclitaxel|mesh-list
102422951|NCT05044728|Carboplatin|carboplatin|mesh-list
102422952|NCT05044728|Antibodies|antibodies|mesh-list
102422953|NCT05044728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102422954|NCT05044728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102422955|NCT05044728|Tubulin Modulators|tubulin modulators|mesh-ancestor
102422956|NCT05044728|Antimitotic Agents|antimitotic agents|mesh-ancestor
102422957|NCT05044728|Mitosis Modulators|mitosis modulators|mesh-ancestor
102422958|NCT05044728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422959|NCT05044728|Immunologic Factors|immunologic factors|mesh-ancestor
102422960|NCT05044728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422961|NCT05054478|Daratumumab|daratumumab|mesh-list
102422962|NCT05054478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102422963|NCT01041807|Losartan|losartan|mesh-list
102422964|NCT01041807|Amlodipine|amlodipine|mesh-list
102422965|NCT01041807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102422966|NCT01041807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102422967|NCT01041807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102422968|NCT01041807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422969|NCT01041807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102422970|NCT01041807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422971|NCT01041807|Vasodilator Agents|vasodilator agents|mesh-ancestor
102422972|NCT01041807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102422973|NCT01041807|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102422974|NCT01041807|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102422975|NCT01724931|Aminopterin|aminopterin|mesh-list
102422976|NCT01724931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102422977|NCT01724931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102422978|NCT01724931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422979|NCT00635089|Reslizumab|reslizumab|mesh-list
102422980|NCT00635089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102422981|NCT00635089|Respiratory System Agents|respiratory system agents|mesh-ancestor
102422982|NCT01725009|Levetiracetam|levetiracetam|mesh-list
102422983|NCT01725009|Anticonvulsants|anticonvulsants|mesh-ancestor
102422984|NCT01725009|Nootropic Agents|nootropic agents|mesh-ancestor
102422985|NCT01725087|Tapentadol|tapentadol|mesh-list
102422986|NCT01725087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102422987|NCT01725087|Narcotics|narcotics|mesh-ancestor
102422988|NCT01725087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102422989|NCT01725087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102422990|NCT01725087|Analgesics|analgesics|mesh-ancestor
102422991|NCT01725087|Sensory System Agents|sensory system agents|mesh-ancestor
102422992|NCT01725087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102422993|NCT01725087|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102422994|NCT01725087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102422995|NCT01725087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102422996|NCT01725087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102422997|NCT01725087|Adrenergic Agents|adrenergic agents|mesh-ancestor
102422998|NCT01725087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102422999|NCT00634543|Acetaminophen|acetaminophen|mesh-list
102423000|NCT00634543|Gabapentin|gabapentin|mesh-list
102423001|NCT00634543|Tramadol|tramadol|mesh-list
102423002|NCT00634543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102423003|NCT00634543|Analgesics|analgesics|mesh-ancestor
102423004|NCT00634543|Sensory System Agents|sensory system agents|mesh-ancestor
102423005|NCT00634543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102423006|NCT00634543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423007|NCT00634543|Antipyretics|antipyretics|mesh-ancestor
102423008|NCT00634543|Anticonvulsants|anticonvulsants|mesh-ancestor
102423009|NCT00634543|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102423010|NCT00634543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102423011|NCT00634543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102423012|NCT00634543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102423013|NCT00634543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102423014|NCT00634543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102423015|NCT00634543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102423016|NCT00634543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423017|NCT00634543|Antimanic Agents|antimanic agents|mesh-ancestor
102423018|NCT00634543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102423019|NCT00634543|Narcotics|narcotics|mesh-ancestor
102423020|NCT05054322|Fluticasone|fluticasone|mesh-list
102423021|NCT05054322|Xhance|xhance|mesh-list
102423022|NCT05054322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102423023|NCT05054322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102423024|NCT05054322|Autonomic Agents|autonomic agents|mesh-ancestor
102423025|NCT05054322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102423026|NCT05054322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423027|NCT05054322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102423028|NCT05054322|Respiratory System Agents|respiratory system agents|mesh-ancestor
102423029|NCT05054322|Dermatologic Agents|dermatologic agents|mesh-ancestor
102423030|NCT05054322|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102423031|NCT00985465|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102423032|NCT00985465|Immunologic Factors|immunologic factors|mesh-ancestor
102423033|NCT00985465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423034|NCT03097380|Tiotropium Bromide|tiotropium bromide|mesh-list
102423035|NCT03097380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102423036|NCT03097380|Autonomic Agents|autonomic agents|mesh-ancestor
102423037|NCT03097380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102423038|NCT03097380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423039|NCT03097380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102423040|NCT03097380|Respiratory System Agents|respiratory system agents|mesh-ancestor
102423041|NCT03097380|Parasympatholytics|parasympatholytics|mesh-ancestor
102423042|NCT03097380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102423043|NCT03097380|Cholinergic Agents|cholinergic agents|mesh-ancestor
102423044|NCT03097380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102423045|NCT03097380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423046|NCT04759729|Vitamin D|vitamin d|mesh-list
102423047|NCT04759729|Ergocalciferols|ergocalciferols|mesh-list
102423048|NCT04759729|Cholecalciferol|cholecalciferol|mesh-list
102423049|NCT04759729|Vitamins|vitamins|mesh-list
102423050|NCT04759729|Micronutrients|micronutrients|mesh-ancestor
102423051|NCT04759729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423052|NCT04759729|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102423053|NCT04759729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102423054|NCT05053386|Epirubicin|epirubicin|mesh-list
102423055|NCT05053386|Idarubicin|idarubicin|mesh-list
102423056|NCT05053386|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102423057|NCT05053386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102423058|NCT05053386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102423059|NCT05053386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102423060|NCT05053386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102423061|NCT05053386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423062|NCT01725243|Carbetocin|carbetocin|mesh-list
102423063|NCT01725243|Oxytocics|oxytocics|mesh-ancestor
102423064|NCT01725243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102423065|NCT01725243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423066|NCT01725477|Methylene Blue|methylene blue|mesh-list
102423067|NCT01725477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102423068|NCT01725477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423069|NCT03096990|Apremilast|apremilast|mesh-list
102423070|NCT03096990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102423071|NCT03096990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102423072|NCT03096990|Analgesics|analgesics|mesh-ancestor
102423073|NCT03096990|Sensory System Agents|sensory system agents|mesh-ancestor
102423074|NCT03096990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102423075|NCT03096990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423076|NCT03096990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102423077|NCT03096990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102423078|NCT03096990|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102423079|NCT03096990|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102423080|NCT03096990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102423081|NCT03096990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423082|NCT01725555|Podophyllotoxin|podophyllotoxin|mesh-list
102423083|NCT01725555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102423084|NCT01725555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102423085|NCT01725555|Keratolytic Agents|keratolytic agents|mesh-ancestor
102423086|NCT01725555|Dermatologic Agents|dermatologic agents|mesh-ancestor
102234771|NCT03311425|Prednisolone|prednisolone|mesh-list
102423087|NCT01725555|Tubulin Modulators|tubulin modulators|mesh-ancestor
102423088|NCT01725555|Antimitotic Agents|antimitotic agents|mesh-ancestor
102423089|NCT01725555|Mitosis Modulators|mitosis modulators|mesh-ancestor
102423090|NCT01725555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423091|NCT01048671|Raltegravir Potassium|raltegravir potassium|mesh-list
102423092|NCT01048671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102423093|NCT01048671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102423094|NCT01048671|Antiviral Agents|antiviral agents|mesh-ancestor
102423095|NCT01048671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102423096|NCT01048671|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102423097|NCT01048671|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102423098|NCT01048671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102423099|NCT01048671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423100|NCT03836781|Chlorhexidine|chlorhexidine|mesh-list
102423101|NCT03836781|Ketorolac|ketorolac|mesh-list
102423102|NCT03836781|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102423103|NCT03836781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102423104|NCT03836781|Disinfectants|disinfectants|mesh-ancestor
102423105|NCT03836781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102423106|NCT03836781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102423107|NCT03836781|Analgesics|analgesics|mesh-ancestor
102423108|NCT03836781|Sensory System Agents|sensory system agents|mesh-ancestor
102423109|NCT03836781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102423110|NCT03836781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423111|NCT03836781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102423112|NCT03836781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102423113|NCT03836781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102423114|NCT03836781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102423115|NCT03836781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423116|NCT01360866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102423117|NCT01360866|Fluoxetine|fluoxetine|mesh-list
102423118|NCT01360866|Paroxetine|paroxetine|mesh-list
102423119|NCT01360866|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102423120|NCT01360866|Sertraline|sertraline|mesh-list
102423121|NCT01360866|Escitalopram|escitalopram|mesh-list
102423122|NCT01360866|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102423123|NCT01360866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102423124|NCT01360866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102423125|NCT01360866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423126|NCT01360866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102423127|NCT01360866|Serotonin Agents|serotonin agents|mesh-ancestor
102423128|NCT01360866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423129|NCT01360866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102423130|NCT01360866|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102423131|NCT01360866|Antidepressive Agents|antidepressive agents|mesh-ancestor
102423132|NCT01360866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102423133|NCT01360866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102423134|NCT01360866|Analgesics|analgesics|mesh-ancestor
102423135|NCT01360866|Sensory System Agents|sensory system agents|mesh-ancestor
102423136|NCT01360866|Dopamine Agents|dopamine agents|mesh-ancestor
102423137|NCT01360866|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102423138|NCT01360866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102423139|NCT01360866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102423140|NCT00984061|Clarithromycin|clarithromycin|mesh-list
102423141|NCT00984061|Colchicine|colchicine|mesh-list
102423142|NCT00984061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102423143|NCT00984061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102423144|NCT00984061|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102423145|NCT00984061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102423146|NCT00984061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423147|NCT00984061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102423148|NCT00984061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102423149|NCT00984061|Gout Suppressants|gout suppressants|mesh-ancestor
102423150|NCT00984061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102423151|NCT00984061|Tubulin Modulators|tubulin modulators|mesh-ancestor
102423152|NCT00984061|Antimitotic Agents|antimitotic agents|mesh-ancestor
102423153|NCT00984061|Mitosis Modulators|mitosis modulators|mesh-ancestor
102423154|NCT00984061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102423155|NCT01046643|Estradiol|estradiol|mesh-list
102423156|NCT01046643|Progesterone|progesterone|mesh-list
102423157|NCT01046643|Estrogens|estrogens|mesh-ancestor
102423158|NCT01046643|Hormones|hormones|mesh-ancestor
102423159|NCT01046643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102423160|NCT01046643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423161|NCT01046643|Progestins|progestins|mesh-ancestor
102423162|NCT03096756|Avasopasem manganese|avasopasem manganese|mesh-list
102423163|NCT03096756|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102423165|NCT03096756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423166|NCT03096756|Protective Agents|protective agents|mesh-ancestor
102423167|NCT03096756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423168|NCT00983905|Colchicine|colchicine|mesh-list
102423169|NCT00983905|Theophylline|theophylline|mesh-list
102423170|NCT00983905|Gout Suppressants|gout suppressants|mesh-ancestor
102423171|NCT00983905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102423172|NCT00983905|Tubulin Modulators|tubulin modulators|mesh-ancestor
102423173|NCT00983905|Antimitotic Agents|antimitotic agents|mesh-ancestor
102423174|NCT00983905|Mitosis Modulators|mitosis modulators|mesh-ancestor
102423175|NCT00983905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423176|NCT00983905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102423177|NCT00983905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102423178|NCT00983905|Autonomic Agents|autonomic agents|mesh-ancestor
102423179|NCT00983905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102423180|NCT00983905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423181|NCT00983905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102423182|NCT00983905|Respiratory System Agents|respiratory system agents|mesh-ancestor
102423183|NCT00983905|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102423184|NCT00983905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102423185|NCT00983905|Vasodilator Agents|vasodilator agents|mesh-ancestor
102423186|NCT00983905|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102053852|NCT02137616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102423187|NCT00983905|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102423188|NCT00983905|Purinergic Agents|purinergic agents|mesh-ancestor
102423189|NCT00983905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102423190|NCT01046565|Adapalene|adapalene|mesh-list
102423191|NCT01046565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102423192|NCT01046565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102423193|NCT01046565|Analgesics|analgesics|mesh-ancestor
102423194|NCT01046565|Sensory System Agents|sensory system agents|mesh-ancestor
102423195|NCT01046565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102423196|NCT01046565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423197|NCT01046565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102423198|NCT01046565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102423199|NCT01046565|Dermatologic Agents|dermatologic agents|mesh-ancestor
102423200|NCT01046253|Lansoprazole|lansoprazole|mesh-list
102423201|NCT01046253|Dexlansoprazole|dexlansoprazole|mesh-list
102423202|NCT01046253|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102423203|NCT01046253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102423204|NCT01046253|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102423205|NCT01046253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102423206|NCT01046253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423207|NCT05050656|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102423208|NCT05050656|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102423209|NCT05050656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102423210|NCT05050656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102423211|NCT05050656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423212|NCT05050656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102423213|NCT05050656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423214|NCT05050656|Analgesics|analgesics|mesh-ancestor
102423215|NCT05050656|Sensory System Agents|sensory system agents|mesh-ancestor
102423216|NCT05050656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102423217|NCT05050656|Antidepressive Agents|antidepressive agents|mesh-ancestor
102423218|NCT05050656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102423219|NCT05050656|Dopamine Agents|dopamine agents|mesh-ancestor
102423220|NCT00983515|Ritonavir|ritonavir|mesh-list
102423221|NCT00983515|Colchicine|colchicine|mesh-list
102423222|NCT00983515|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102423223|NCT00983515|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102423224|NCT00983515|Protease Inhibitors|protease inhibitors|mesh-ancestor
102423225|NCT00983515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102423226|NCT00983515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423227|NCT00983515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102423228|NCT00983515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102423229|NCT00983515|Antiviral Agents|antiviral agents|mesh-ancestor
102423230|NCT00983515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102423231|NCT00983515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102423232|NCT00983515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102423233|NCT00983515|Gout Suppressants|gout suppressants|mesh-ancestor
102423234|NCT00983515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102423235|NCT00983515|Tubulin Modulators|tubulin modulators|mesh-ancestor
102423236|NCT00983515|Antimitotic Agents|antimitotic agents|mesh-ancestor
102423237|NCT00983515|Mitosis Modulators|mitosis modulators|mesh-ancestor
102423238|NCT00983515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102423240|NCT05033574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102423241|NCT05033574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423242|NCT04471818|Ketamine|ketamine|mesh-list
102423243|NCT04471818|Analgesics|analgesics|mesh-ancestor
102423244|NCT04471818|Sensory System Agents|sensory system agents|mesh-ancestor
102423245|NCT04471818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102423246|NCT04471818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423247|NCT04471818|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102423248|NCT04471818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102423249|NCT04471818|Anesthetics, General|anesthetics, general|mesh-ancestor
102423250|NCT04471818|Anesthetics|anesthetics|mesh-ancestor
102423251|NCT04471818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102423252|NCT04471818|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102423253|NCT04471818|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102423254|NCT04471818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102423255|NCT04471818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423256|NCT05050188|Lansoprazole|lansoprazole|mesh-list
102423257|NCT05050188|Dexlansoprazole|dexlansoprazole|mesh-list
102423258|NCT05050188|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102423259|NCT05050188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102423260|NCT05050188|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102423261|NCT05050188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102423262|NCT05050188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423263|NCT04434378|Tamsulosin|tamsulosin|mesh-list
102423264|NCT04434378|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102423265|NCT04434378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102423266|NCT04434378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102423267|NCT04434378|Adrenergic Agents|adrenergic agents|mesh-ancestor
102423268|NCT04434378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102423269|NCT04434378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423270|NCT04434378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423271|NCT04434378|Urological Agents|urological agents|mesh-ancestor
102423272|NCT00981799|Cyclophosphamide|cyclophosphamide|mesh-list
102423273|NCT00981799|Methotrexate|methotrexate|mesh-list
102423274|NCT00981799|Etoposide|etoposide|mesh-list
102423275|NCT00981799|Lenograstim|lenograstim|mesh-list
102423276|NCT00981799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102423277|NCT00981799|Immunologic Factors|immunologic factors|mesh-ancestor
102423278|NCT00981799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423279|NCT00981799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102423280|NCT00981799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102423281|NCT00981799|Alkylating Agents|alkylating agents|mesh-ancestor
102423282|NCT00981799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423283|NCT00981799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102423284|NCT00981799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102423285|NCT00981799|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102423286|NCT00981799|Abortifacient Agents|abortifacient agents|mesh-ancestor
102423287|NCT00981799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102423288|NCT00981799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102423289|NCT00981799|Antimetabolites|antimetabolites|mesh-ancestor
102423290|NCT00981799|Dermatologic Agents|dermatologic agents|mesh-ancestor
102423291|NCT00981799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102423292|NCT00981799|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102423293|NCT00981799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102423294|NCT00981799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102423295|NCT00981799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102423296|NCT00981799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102423297|NCT00981799|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102423298|NCT05033106|Bevacizumab|bevacizumab|mesh-list
102423299|NCT05033106|Ranibizumab|ranibizumab|mesh-list
102053968|NCT02828761|Calcium, Dietary|calcium, dietary|mesh-list
102423300|NCT05033106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102423301|NCT05033106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102423302|NCT05033106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102423303|NCT05033106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102423304|NCT05033106|Growth Substances|growth substances|mesh-ancestor
102423305|NCT05033106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423306|NCT05033106|Growth Inhibitors|growth inhibitors|mesh-ancestor
102423307|NCT03095040|Everolimus|everolimus|mesh-list
102423308|NCT03095040|Vorolanib|vorolanib|mesh-list
102423309|NCT03095040|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102423310|NCT03095040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102423311|NCT03095040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102423312|NCT03095040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423313|NCT03095040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102423314|NCT03095040|Immunologic Factors|immunologic factors|mesh-ancestor
102423315|NCT03095040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423316|NCT03095040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102423317|NCT03099499|TIC10 compound|tic10 compound|mesh-list
102423318|NCT03099499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102423320|NCT03096522|Anticonvulsants|anticonvulsants|mesh-ancestor
102423321|NCT03096522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102423322|NCT03096522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102423323|NCT03096522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102423324|NCT03096522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423325|NCT03096522|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102423326|NCT03096522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102423327|NCT01045161|Bromides|bromides|mesh-list
102423328|NCT01045161|Anticonvulsants|anticonvulsants|mesh-ancestor
102423329|NCT05032248|Tacrolimus|tacrolimus|mesh-list
102423330|NCT05032248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102423331|NCT05032248|Immunologic Factors|immunologic factors|mesh-ancestor
102423332|NCT05032248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423333|NCT05032248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102423334|NCT05032248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102423335|NCT05032248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423336|NCT00633217|Fluticasone|fluticasone|mesh-list
102423337|NCT00633217|Xhance|xhance|mesh-list
102423338|NCT00633217|Norflurane|norflurane|mesh-list
102423339|NCT00633217|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102423340|NCT00633217|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102423341|NCT00633217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102423342|NCT00633217|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102423343|NCT00633217|Autonomic Agents|autonomic agents|mesh-ancestor
102423344|NCT00633217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102423345|NCT00633217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423346|NCT00633217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102423347|NCT00633217|Respiratory System Agents|respiratory system agents|mesh-ancestor
102423348|NCT00633217|Dermatologic Agents|dermatologic agents|mesh-ancestor
102423349|NCT00633217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102423350|NCT00633217|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102423351|NCT00633217|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102423352|NCT00633217|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102423353|NCT00633217|Adrenergic Agents|adrenergic agents|mesh-ancestor
102423354|NCT00633217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102423355|NCT00633217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423356|NCT00633217|Glucocorticoids|glucocorticoids|mesh-ancestor
102423357|NCT00633217|Hormones|hormones|mesh-ancestor
102423358|NCT00633217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102423359|NCT00633217|Sympathomimetics|sympathomimetics|mesh-ancestor
102423360|NCT00633217|Anesthetics|anesthetics|mesh-ancestor
102423361|NCT00633217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102423362|NCT01673490|Tamsulosin|tamsulosin|mesh-list
102423363|NCT01673490|Dutasteride|dutasteride|mesh-list
102423364|NCT01673490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102423365|NCT01673490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102423366|NCT01673490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102423367|NCT01673490|Adrenergic Agents|adrenergic agents|mesh-ancestor
102423368|NCT01673490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102423369|NCT01673490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423370|NCT01673490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423371|NCT01673490|Urological Agents|urological agents|mesh-ancestor
102423372|NCT01673490|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102423373|NCT01673490|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102423374|NCT01673490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102423375|NCT01673490|Hormone Antagonists|hormone antagonists|mesh-ancestor
102423376|NCT01673490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102423377|NCT00633061|Enoxaparin|enoxaparin|mesh-list
102423378|NCT00633061|Anticoagulants|anticoagulants|mesh-ancestor
102423379|NCT00633061|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102423380|NCT00633061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102423381|NCT00633061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423382|NCT00632827|Leucovorin|leucovorin|mesh-list
102423383|NCT00632827|Cytarabine|cytarabine|mesh-list
102423384|NCT00632827|Cyclophosphamide|cyclophosphamide|mesh-list
102423385|NCT00632827|Carmustine|carmustine|mesh-list
102423386|NCT00632827|Gemcitabine|gemcitabine|mesh-list
102423387|NCT00632827|Doxorubicin|doxorubicin|mesh-list
102423388|NCT00632827|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102423389|NCT00632827|Methotrexate|methotrexate|mesh-list
102423390|NCT00632827|Etoposide|etoposide|mesh-list
102423391|NCT00632827|Vincristine|vincristine|mesh-list
102423392|NCT00632827|Vinorelbine|vinorelbine|mesh-list
102423393|NCT00632827|Denileukin diftitox|denileukin diftitox|mesh-list
102423394|NCT00632827|Lenograstim|lenograstim|mesh-list
102423395|NCT00632827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102423396|NCT00632827|Immunologic Factors|immunologic factors|mesh-ancestor
102423397|NCT00632827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423398|NCT00632827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102423399|NCT00632827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102423400|NCT00632827|Alkylating Agents|alkylating agents|mesh-ancestor
102423401|NCT00632827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423402|NCT00632827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102423403|NCT00632827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102423404|NCT00632827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102423405|NCT00632827|Antimetabolites|antimetabolites|mesh-ancestor
102423406|NCT00632827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102423407|NCT00632827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102423408|NCT00632827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102423409|NCT00632827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102423410|NCT00632827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102423411|NCT00632827|Abortifacient Agents|abortifacient agents|mesh-ancestor
102423412|NCT00632827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102423413|NCT00632827|Dermatologic Agents|dermatologic agents|mesh-ancestor
102423414|NCT00632827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102423415|NCT00632827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102423416|NCT00632827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102423417|NCT00632827|Antiviral Agents|antiviral agents|mesh-ancestor
102423418|NCT00632827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102423419|NCT00632827|Antidotes|antidotes|mesh-ancestor
102423420|NCT00632827|Protective Agents|protective agents|mesh-ancestor
102423421|NCT00632827|Vitamin B Complex|vitamin b complex|mesh-ancestor
102423422|NCT00632827|Vitamins|vitamins|mesh-ancestor
102423423|NCT00632827|Micronutrients|micronutrients|mesh-ancestor
102423424|NCT00632827|Tubulin Modulators|tubulin modulators|mesh-ancestor
102423425|NCT00632827|Antimitotic Agents|antimitotic agents|mesh-ancestor
102423426|NCT00632827|Mitosis Modulators|mitosis modulators|mesh-ancestor
102423427|NCT00632827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102423428|NCT00214019|Fluticasone|fluticasone|mesh-list
102423429|NCT00214019|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102423430|NCT00214019|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102423431|NCT00214019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102423432|NCT00214019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102423433|NCT00214019|Autonomic Agents|autonomic agents|mesh-ancestor
102423434|NCT00214019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102423435|NCT00214019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423436|NCT00214019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102423437|NCT00214019|Respiratory System Agents|respiratory system agents|mesh-ancestor
102423438|NCT00214019|Dermatologic Agents|dermatologic agents|mesh-ancestor
102423439|NCT00214019|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102423440|NCT00214019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102423441|NCT00214019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102423442|NCT00214019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102423443|NCT00214019|Adrenergic Agents|adrenergic agents|mesh-ancestor
102423444|NCT00214019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102423445|NCT00214019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423446|NCT00214019|Glucocorticoids|glucocorticoids|mesh-ancestor
102423447|NCT00214019|Hormones|hormones|mesh-ancestor
102423448|NCT00214019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102423449|NCT00214019|Sympathomimetics|sympathomimetics|mesh-ancestor
102423450|NCT03097848|Sorafenib|sorafenib|mesh-list
102423451|NCT03097848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102423452|NCT03097848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102423453|NCT03097848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102423454|NCT03097848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423455|NCT05047848|Fulvestrant|fulvestrant|mesh-list
102423456|NCT05047848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102423457|NCT05047848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102423458|NCT05047848|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102423459|NCT05047848|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102423460|NCT05047848|Hormone Antagonists|hormone antagonists|mesh-ancestor
102423461|NCT05047848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102423463|NCT00210119|Imatinib Mesylate|imatinib mesylate|mesh-list
102423464|NCT00210119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102423465|NCT00210119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102423466|NCT00210119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102423467|NCT00210119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423468|NCT01044459|Bromides|bromides|mesh-list
102423469|NCT01044459|Anticonvulsants|anticonvulsants|mesh-ancestor
102423470|NCT01837329|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
102423471|NCT01837329|Chelating Agents|chelating agents|mesh-ancestor
102423472|NCT01837329|Sequestering Agents|sequestering agents|mesh-ancestor
102423473|NCT01837329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423474|NCT01837329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102423475|NCT01837329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102423476|NCT01837329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102423477|NCT01837329|Growth Substances|growth substances|mesh-ancestor
102423478|NCT01837329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423479|NCT01837329|Growth Inhibitors|growth inhibitors|mesh-ancestor
102423480|NCT01837329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102423481|NCT05040906|Rituximab|rituximab|mesh-list
102423482|NCT05040906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102423483|NCT05040906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102423484|NCT05040906|Immunologic Factors|immunologic factors|mesh-ancestor
102423485|NCT05040906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423486|NCT05040906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102423487|NCT01044303|Mycophenolic Acid|mycophenolic acid|mesh-list
102423488|NCT01044303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102423489|NCT01044303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102423490|NCT01044303|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102423491|NCT01044303|Antitubercular Agents|antitubercular agents|mesh-ancestor
102423492|NCT01044303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102423493|NCT01044303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102423494|NCT01044303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102423495|NCT01044303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423496|NCT05040828|Montelukast|montelukast|mesh-list
102423497|NCT05040828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102423498|NCT05040828|Respiratory System Agents|respiratory system agents|mesh-ancestor
102423499|NCT05040828|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102423500|NCT05040828|Hormone Antagonists|hormone antagonists|mesh-ancestor
102423501|NCT05040828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102423502|NCT05040828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423503|NCT05040828|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102423504|NCT05040828|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102423505|NCT05040828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423506|NCT00983437|Modafinil|modafinil|mesh-list
102423507|NCT00983437|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102423508|NCT00983437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423509|NCT00983437|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102423510|NCT00983437|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102423511|NCT00983437|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102423512|NCT00983437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423513|NCT05031234|Morphine|morphine|mesh-list
102423514|NCT05031234|Anesthetics|anesthetics|mesh-list
102423515|NCT05031234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102423516|NCT05031234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423517|NCT05031234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102423518|NCT05031234|Narcotics|narcotics|mesh-ancestor
102423519|NCT05031234|Analgesics|analgesics|mesh-ancestor
102423520|NCT05031234|Sensory System Agents|sensory system agents|mesh-ancestor
102423521|NCT05031234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102423522|NCT03599609|Simvastatin|simvastatin|mesh-list
102423523|NCT03599609|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102423524|NCT03599609|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102423525|NCT03599609|Antimetabolites|antimetabolites|mesh-ancestor
102423526|NCT03599609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423527|NCT03599609|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102423528|NCT03599609|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102423529|NCT03599609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102423530|NCT05040594|Lidocaine|lidocaine|mesh-list
102423531|NCT05040594|Anesthetics, Local|anesthetics, local|mesh-ancestor
102423532|NCT05040594|Anesthetics|anesthetics|mesh-ancestor
102423533|NCT05040594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102423534|NCT05040594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423535|NCT05040594|Sensory System Agents|sensory system agents|mesh-ancestor
102423536|NCT05040594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102423537|NCT05040594|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102423538|NCT05040594|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102423539|NCT05040594|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102423540|NCT05040594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102423541|NCT05040594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423542|NCT01042977|Dapagliflozin|dapagliflozin|mesh-list
102423543|NCT01042977|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102423544|NCT01042977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423545|NCT01042977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102423546|NCT01042977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423547|NCT03598673|Nebivolol|nebivolol|mesh-list
102423548|NCT03598673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102423549|NCT03598673|Vasodilator Agents|vasodilator agents|mesh-ancestor
102423550|NCT03598673|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102423551|NCT03598673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102423552|NCT03598673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102423553|NCT03598673|Adrenergic Agents|adrenergic agents|mesh-ancestor
102423554|NCT03598673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102423555|NCT03598673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423556|NCT03598673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423557|NCT05039580|Dexamethasone|dexamethasone|mesh-list
102423558|NCT05039580|Antibodies|antibodies|mesh-list
102423559|NCT05039580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102423560|NCT05039580|Immunologic Factors|immunologic factors|mesh-ancestor
102423561|NCT05039580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423562|NCT05039580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102423563|NCT05039580|Antiemetics|antiemetics|mesh-ancestor
102423564|NCT05039580|Autonomic Agents|autonomic agents|mesh-ancestor
102423565|NCT05039580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102423566|NCT05039580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102423567|NCT05039580|Glucocorticoids|glucocorticoids|mesh-ancestor
102423568|NCT05039580|Hormones|hormones|mesh-ancestor
102423569|NCT05039580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102423570|NCT05039580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102423571|NCT05039580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102423572|NCT05025228|Acetaminophen|acetaminophen|mesh-list
102423573|NCT05025228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102423574|NCT05025228|Analgesics|analgesics|mesh-ancestor
102423575|NCT05025228|Sensory System Agents|sensory system agents|mesh-ancestor
102423576|NCT05025228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102423577|NCT05025228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423578|NCT05025228|Antipyretics|antipyretics|mesh-ancestor
102423579|NCT05025072|Hydroxyurea|hydroxyurea|mesh-list
102423580|NCT05025072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102423581|NCT05025072|Antisickling Agents|antisickling agents|mesh-ancestor
102423582|NCT05025072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102423583|NCT05025072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423584|NCT05025072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102423585|NCT05024604|Progesterone|progesterone|mesh-list
102423586|NCT05024604|Progestins|progestins|mesh-ancestor
102423587|NCT05024604|Hormones|hormones|mesh-ancestor
102423588|NCT05024604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102423589|NCT05024604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423590|NCT03597893|Oxytocin|oxytocin|mesh-list
102423591|NCT03597893|Oxytocics|oxytocics|mesh-ancestor
102423592|NCT03597893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102423593|NCT03597893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423594|NCT01041573|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102423595|NCT01041573|Immunologic Factors|immunologic factors|mesh-ancestor
102423596|NCT01041573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423597|NCT05024448|Prednisone|prednisone|mesh-list
102423598|NCT05024448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102423599|NCT05024448|Glucocorticoids|glucocorticoids|mesh-ancestor
102423600|NCT05024448|Hormones|hormones|mesh-ancestor
102423601|NCT05024448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102423602|NCT05024448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423603|NCT05024448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102423604|NCT05024448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102235296|NCT03290365|Hyaluronic Acid|hyaluronic acid|mesh-list
102423606|NCT03596957|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102423607|NCT03596957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423608|NCT03596957|Natriuretic Agents|natriuretic agents|mesh-ancestor
102423609|NCT03596957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423610|NCT03408015|Lifitegrast|lifitegrast|mesh-list
102423611|NCT03408015|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102423612|NCT03408015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102423613|NCT01041495|Cyclobenzaprine|cyclobenzaprine|mesh-list
102423614|NCT01041495|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102423615|NCT01041495|Antidepressive Agents|antidepressive agents|mesh-ancestor
102423616|NCT01041495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102423617|NCT01041495|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102423618|NCT01041495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423619|NCT01041495|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102423620|NCT01041495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102423621|NCT01041495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102423622|NCT01041495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102423623|NCT03407937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
102423624|NCT03407937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102423625|NCT03407937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423626|NCT03596099|Acetic Acid|acetic acid|mesh-list
102423627|NCT03596099|Retinol acetate|retinol acetate|mesh-list
102423628|NCT03596099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102423629|NCT03596099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102423630|NCT03596099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102423631|NCT03596099|Immunologic Factors|immunologic factors|mesh-ancestor
102423632|NCT03596099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423633|NCT03596099|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102423634|NCT03596099|Protective Agents|protective agents|mesh-ancestor
102423635|NCT03596099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102423636|NCT01041417|Molgramostim|molgramostim|mesh-list
102423637|NCT01041417|Sargramostim|sargramostim|mesh-list
102423638|NCT01041417|Immunologic Factors|immunologic factors|mesh-ancestor
102423639|NCT01041417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423640|NCT01041417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102423641|NCT03595397|Magnesium Sulfate|magnesium sulfate|mesh-list
102423642|NCT03595397|Fentanyl|fentanyl|mesh-list
102423643|NCT03595397|Bupivacaine|bupivacaine|mesh-list
102423644|NCT03595397|Anesthetics, Local|anesthetics, local|mesh-ancestor
102423645|NCT03595397|Anesthetics|anesthetics|mesh-ancestor
102423646|NCT03595397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102423647|NCT03595397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423648|NCT03595397|Sensory System Agents|sensory system agents|mesh-ancestor
102423649|NCT03595397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102423650|NCT03595397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102423651|NCT03595397|Narcotics|narcotics|mesh-ancestor
102423652|NCT03595397|Analgesics|analgesics|mesh-ancestor
102423653|NCT03595397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102423654|NCT03595397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102423655|NCT03595397|Anesthetics, General|anesthetics, general|mesh-ancestor
102423656|NCT03595397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102423657|NCT03595397|Anticonvulsants|anticonvulsants|mesh-ancestor
102423658|NCT03595397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102423659|NCT03595397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102423660|NCT03595397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423661|NCT03595397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102423662|NCT03595397|Tocolytic Agents|tocolytic agents|mesh-ancestor
102423663|NCT03595397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102423664|NCT03595319|Sevoflurane|sevoflurane|mesh-list
102423665|NCT03595319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102423666|NCT03595319|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102423667|NCT03595319|Anesthetics, General|anesthetics, general|mesh-ancestor
102423668|NCT03595319|Anesthetics|anesthetics|mesh-ancestor
102423669|NCT03595319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102423670|NCT03595319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423671|NCT01040871|Prednisone|prednisone|mesh-list
102423672|NCT01040871|Cyclophosphamide|cyclophosphamide|mesh-list
102423673|NCT01040871|Rituximab|rituximab|mesh-list
102423674|NCT01040871|Doxorubicin|doxorubicin|mesh-list
102423675|NCT01040871|Vincristine|vincristine|mesh-list
102423676|NCT01040871|Bortezomib|bortezomib|mesh-list
102423677|NCT01040871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102423678|NCT01040871|Immunologic Factors|immunologic factors|mesh-ancestor
102423679|NCT01040871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423680|NCT01040871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102423681|NCT01040871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102423682|NCT01040871|Alkylating Agents|alkylating agents|mesh-ancestor
102423683|NCT01040871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423684|NCT01040871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102423685|NCT01040871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102423686|NCT01040871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102423687|NCT01040871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102423688|NCT01040871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102423689|NCT01040871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102423690|NCT01040871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102423691|NCT01040871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102423692|NCT01040871|Glucocorticoids|glucocorticoids|mesh-ancestor
102423693|NCT01040871|Hormones|hormones|mesh-ancestor
102423694|NCT01040871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102423695|NCT01040871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102423696|NCT01040871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102423697|NCT01040871|Tubulin Modulators|tubulin modulators|mesh-ancestor
102423698|NCT01040871|Antimitotic Agents|antimitotic agents|mesh-ancestor
102423699|NCT01040871|Mitosis Modulators|mitosis modulators|mesh-ancestor
102423700|NCT01040169|Calcium Carbonate|calcium carbonate|mesh-list
102423701|NCT01040169|Calcium|calcium|mesh-list
102423702|NCT01040169|Fluorides|fluorides|mesh-list
102423703|NCT01040169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102423704|NCT01040169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423705|NCT01040169|Cariostatic Agents|cariostatic agents|mesh-ancestor
102423706|NCT01040169|Protective Agents|protective agents|mesh-ancestor
102423707|NCT01040169|Antacids|antacids|mesh-ancestor
102423708|NCT01040169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423709|NCT01040169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102423710|NCT01044381|Luliconazole|luliconazole|mesh-list
102423711|NCT01044381|Antifungal Agents|antifungal agents|mesh-ancestor
102423712|NCT01044381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102423713|NCT03594461|Aflibercept|aflibercept|mesh-list
102423714|NCT03594461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102423715|NCT03594461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102423716|NCT03594461|Growth Substances|growth substances|mesh-ancestor
102423717|NCT03594461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423718|NCT03594461|Growth Inhibitors|growth inhibitors|mesh-ancestor
102423719|NCT03594461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102423720|NCT03407703|Grazoprevir|grazoprevir|mesh-list
102423721|NCT03407703|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
102423722|NCT03407703|Antiviral Agents|antiviral agents|mesh-ancestor
102423723|NCT03407703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102423724|NCT03594149|Levofloxacin|levofloxacin|mesh-list
102423725|NCT03594149|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102423726|NCT03594149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102423727|NCT03594149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102423728|NCT03594149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102423729|NCT03594149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102423730|NCT03594149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102423731|NCT03594149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423732|NCT03594149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102423733|NCT03594149|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102423734|NCT03594149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102423735|NCT00916539|Calpastatin|calpastatin|mesh-list
102423736|NCT00916539|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
102423737|NCT00916539|Protease Inhibitors|protease inhibitors|mesh-ancestor
102423738|NCT00916539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102423739|NCT00916539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423740|NCT03593447|Ribavirin|ribavirin|mesh-list
102423741|NCT03593447|Yimitasvir|yimitasvir|mesh-list
102423742|NCT03593447|Antimetabolites|antimetabolites|mesh-ancestor
102423743|NCT03593447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423744|NCT03593447|Antiviral Agents|antiviral agents|mesh-ancestor
102423745|NCT03593447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102423746|NCT03593291|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102423747|NCT03593291|Dalteparin|dalteparin|mesh-list
102423748|NCT03593291|Anticoagulants|anticoagulants|mesh-ancestor
102423749|NCT03593291|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102423750|NCT03593291|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102423751|NCT03593291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423752|NCT03593135|Metformin|metformin|mesh-list
102423753|NCT03593135|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102423754|NCT03593135|Acetic Acid|acetic acid|mesh-list
102423755|NCT03593135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102423756|NCT03593135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423757|NCT03593135|Incretins|incretins|mesh-ancestor
102423758|NCT03593135|Hormones|hormones|mesh-ancestor
102423759|NCT03593135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102423760|NCT03593135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102423761|NCT03593135|Protease Inhibitors|protease inhibitors|mesh-ancestor
102423762|NCT03593135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102423763|NCT03593135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423764|NCT03593135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102423765|NCT03593135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102423766|NCT03592901|Anesthetics|anesthetics|mesh-list
102423767|NCT03592901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102423768|NCT03592901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423769|NCT03830385|Carboplatin|carboplatin|mesh-list
102423770|NCT03830385|Bleomycin|bleomycin|mesh-list
102423771|NCT03830385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102423772|NCT03830385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102423773|NCT03592823|Hydroxychloroquine|hydroxychloroquine|mesh-list
102423774|NCT03592823|Antimalarials|antimalarials|mesh-ancestor
102423775|NCT03592823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102423776|NCT03592823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102423777|NCT03592823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102423778|NCT03592823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102423779|NCT03592823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423780|NCT03592823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102423781|NCT03592667|Dapagliflozin|dapagliflozin|mesh-list
102423782|NCT03592667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102423783|NCT03592667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423784|NCT03592667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102423785|NCT03592667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423786|NCT03406689|Nepafenac|nepafenac|mesh-list
102423787|NCT03406689|Lubricant Eye Drops|lubricant eye drops|mesh-list
102423788|NCT03406689|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102423789|NCT03406689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102423790|NCT03406689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102423791|NCT03406689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102423792|NCT03406689|Analgesics|analgesics|mesh-ancestor
102423793|NCT03406689|Sensory System Agents|sensory system agents|mesh-ancestor
102423794|NCT03406689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102423795|NCT03406689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423796|NCT03406689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102423797|NCT03406689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102423798|NCT03591575|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102423799|NCT03591575|Deferiprone|deferiprone|mesh-list
102423800|NCT03591575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102423801|NCT03591575|Chelating Agents|chelating agents|mesh-ancestor
102423802|NCT03591575|Sequestering Agents|sequestering agents|mesh-ancestor
102423803|NCT03591575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423804|NCT03406533|Fentanyl|fentanyl|mesh-list
102423805|NCT03406533|Midazolam|midazolam|mesh-list
102423806|NCT03406533|Dexmedetomidine|dexmedetomidine|mesh-list
102423807|NCT03406533|Remifentanil|remifentanil|mesh-list
102423808|NCT03406533|Propofol|propofol|mesh-list
102423809|NCT03406533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102423810|NCT03406533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102423811|NCT03406533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423812|NCT03406533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102423813|NCT03406533|Analgesics|analgesics|mesh-ancestor
102423814|NCT03406533|Sensory System Agents|sensory system agents|mesh-ancestor
102423815|NCT03406533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102423816|NCT03406533|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102423817|NCT03406533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102423818|NCT03406533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102423819|NCT03406533|Adrenergic Agents|adrenergic agents|mesh-ancestor
102423820|NCT03406533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102423821|NCT03406533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423822|NCT03406533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102423823|NCT03406533|Anesthetics, General|anesthetics, general|mesh-ancestor
102423824|NCT03406533|Anesthetics|anesthetics|mesh-ancestor
102423825|NCT03406533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102423826|NCT03406533|Narcotics|narcotics|mesh-ancestor
102423827|NCT03406533|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102423828|NCT03406533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102235518|NCT02460367|Mitosis Modulators|mitosis modulators|mesh-ancestor
102423829|NCT03406533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102423830|NCT03406533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102423832|NCT03406533|GABA Agents|gaba agents|mesh-ancestor
102423833|NCT03591341|Melatonin|melatonin|mesh-list
102423834|NCT03591341|Antioxidants|antioxidants|mesh-ancestor
102423835|NCT03591341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423836|NCT03591341|Protective Agents|protective agents|mesh-ancestor
102423837|NCT03591341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423838|NCT03591341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102423839|NCT04377399|Vitamin D|vitamin d|mesh-list
102423840|NCT04377399|Vitamins|vitamins|mesh-ancestor
102423841|NCT04377399|Micronutrients|micronutrients|mesh-ancestor
102423842|NCT04377399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423843|NCT04377399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102423844|NCT03400995|Ziresovir|ziresovir|mesh-list
102423845|NCT03400995|Antiviral Agents|antiviral agents|mesh-ancestor
102423846|NCT03400995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102423847|NCT03590873|Vasopressins|vasopressins|mesh-list
102423848|NCT03590873|Arginine Vasopressin|arginine vasopressin|mesh-list
102423849|NCT03590873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423850|NCT03590873|Hemostatics|hemostatics|mesh-ancestor
102423851|NCT03590873|Coagulants|coagulants|mesh-ancestor
102423852|NCT03590873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102423853|NCT03590873|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102423854|NCT03590873|Natriuretic Agents|natriuretic agents|mesh-ancestor
102423855|NCT02155335|Golimumab|golimumab|mesh-list
102423856|NCT02155335|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102423857|NCT02155335|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102423858|NCT02155335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102423859|NCT02155335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102423860|NCT02155335|Immunologic Factors|immunologic factors|mesh-ancestor
102423861|NCT02155335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423862|NCT05024526|Edaravone|edaravone|mesh-list
102423863|NCT05024526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102423864|NCT05024526|Antioxidants|antioxidants|mesh-ancestor
102423865|NCT05024526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423866|NCT05024526|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102423867|NCT05024526|Protective Agents|protective agents|mesh-ancestor
102423868|NCT05024526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423869|NCT03597035|Spironolactone|spironolactone|mesh-list
102423870|NCT03597035|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102423871|NCT03597035|Hormone Antagonists|hormone antagonists|mesh-ancestor
102423872|NCT03597035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102423873|NCT03597035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423874|NCT03597035|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102423875|NCT03597035|Diuretics|diuretics|mesh-ancestor
102423876|NCT03597035|Natriuretic Agents|natriuretic agents|mesh-ancestor
102423877|NCT03400683|Letrozole|letrozole|mesh-list
102423878|NCT03400683|Misoprostol|misoprostol|mesh-list
102423879|NCT03400683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102423880|NCT03400683|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102423881|NCT03400683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102423882|NCT03400683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102423883|NCT03400683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423884|NCT03400683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102423885|NCT03400683|Hormone Antagonists|hormone antagonists|mesh-ancestor
102423886|NCT03400683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102423887|NCT03400683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423888|NCT03400683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102423889|NCT03400683|Abortifacient Agents|abortifacient agents|mesh-ancestor
102423890|NCT03400683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102423891|NCT03400683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102423892|NCT03400683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102423893|NCT03400683|Oxytocics|oxytocics|mesh-ancestor
102423894|NCT05037240|Quercetin|quercetin|mesh-list
102423895|NCT05037240|Antioxidants|antioxidants|mesh-ancestor
102423896|NCT05037240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423897|NCT05037240|Protective Agents|protective agents|mesh-ancestor
102423898|NCT05037240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423899|NCT05037006|Anesthetics|anesthetics|mesh-list
102423900|NCT05037006|Sevoflurane|sevoflurane|mesh-list
102423901|NCT05037006|Neostigmine|neostigmine|mesh-list
102423902|NCT05037006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102423903|NCT05037006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423904|NCT05037006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102423905|NCT05037006|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102423906|NCT05037006|Anesthetics, General|anesthetics, general|mesh-ancestor
102423907|NCT05037006|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102423908|NCT05037006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102423909|NCT05037006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423910|NCT05037006|Cholinergic Agents|cholinergic agents|mesh-ancestor
102423911|NCT05037006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102423912|NCT05037006|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102423913|NCT05037006|Autonomic Agents|autonomic agents|mesh-ancestor
102423914|NCT05037006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102423915|NCT03093090|Furosemide|furosemide|mesh-list
102423916|NCT03093090|Diuretics|diuretics|mesh-ancestor
102423917|NCT03093090|Natriuretic Agents|natriuretic agents|mesh-ancestor
102423918|NCT03093090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423919|NCT03093090|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102423920|NCT03093090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102423921|NCT03093090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423922|NCT03093168|Cyclophosphamide|cyclophosphamide|mesh-list
102423923|NCT03093168|Fludarabine|fludarabine|mesh-list
102423924|NCT03093168|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
102423925|NCT03093168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102423926|NCT03093168|Immunologic Factors|immunologic factors|mesh-ancestor
102423927|NCT03093168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423928|NCT03093168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102423929|NCT03093168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102423930|NCT03093168|Alkylating Agents|alkylating agents|mesh-ancestor
102423931|NCT03093168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423932|NCT03093168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102423933|NCT03093168|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102423934|NCT03093168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102423935|NCT04377321|Colchicine|colchicine|mesh-list
102423936|NCT04377321|Gout Suppressants|gout suppressants|mesh-ancestor
102423937|NCT04377321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102423938|NCT04377321|Tubulin Modulators|tubulin modulators|mesh-ancestor
102423939|NCT04377321|Antimitotic Agents|antimitotic agents|mesh-ancestor
102423940|NCT04377321|Mitosis Modulators|mitosis modulators|mesh-ancestor
102423941|NCT04377321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423942|NCT04377321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102423943|NCT05018364|Epoetin Alfa|epoetin alfa|mesh-list
102423944|NCT05018364|Hematinics|hematinics|mesh-ancestor
102423945|NCT03593213|Cariprazine|cariprazine|mesh-list
102423946|NCT03593213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102423947|NCT03593213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102423948|NCT03593213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102423949|NCT03593213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423950|NCT03593213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102423951|NCT05023824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
102423952|NCT05023824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102423953|NCT05023824|Adrenergic Agents|adrenergic agents|mesh-ancestor
102423954|NCT05023824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102423955|NCT05023824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423956|NCT05023824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423957|NCT03595163|Folic Acid|folic acid|mesh-list
102423958|NCT03595163|Vitamin B Complex|vitamin b complex|mesh-list
102423959|NCT03595163|Propofol|propofol|mesh-list
102423960|NCT03595163|Sevoflurane|sevoflurane|mesh-list
102423961|NCT03595163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102423962|NCT03595163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102423963|NCT03595163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423964|NCT03595163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102423965|NCT03595163|Anesthetics, General|anesthetics, general|mesh-ancestor
102423966|NCT03595163|Anesthetics|anesthetics|mesh-ancestor
102423967|NCT03595163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102423968|NCT03595163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102423969|NCT03595163|Hematinics|hematinics|mesh-ancestor
102423970|NCT03595163|Vitamins|vitamins|mesh-ancestor
102423971|NCT03595163|Micronutrients|micronutrients|mesh-ancestor
102423972|NCT03404115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102423973|NCT03404115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102423974|NCT04199819|Entecavir|entecavir|mesh-list
102423975|NCT04199819|Antiviral Agents|antiviral agents|mesh-ancestor
102423976|NCT04199819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102423977|NCT00918723|Cyclophosphamide|cyclophosphamide|mesh-list
102423978|NCT00918723|Rituximab|rituximab|mesh-list
102423979|NCT00918723|Fludarabine|fludarabine|mesh-list
102423980|NCT00918723|Fludarabine phosphate|fludarabine phosphate|mesh-list
102423981|NCT00918723|Vorinostat|vorinostat|mesh-list
102423982|NCT00918723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102423983|NCT00918723|Immunologic Factors|immunologic factors|mesh-ancestor
102423984|NCT00918723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102423985|NCT00918723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102423986|NCT00918723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102423987|NCT00918723|Alkylating Agents|alkylating agents|mesh-ancestor
102423988|NCT00918723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102423989|NCT00918723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102423990|NCT00918723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102423991|NCT00918723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102423992|NCT00918723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102423993|NCT00918723|Antimetabolites|antimetabolites|mesh-ancestor
102423994|NCT00918723|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102423995|NCT00918723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102423996|NCT04192331|Paclitaxel|paclitaxel|mesh-list
102423997|NCT04192331|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102423998|NCT04192331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102423999|NCT04192331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102424000|NCT04192331|Tubulin Modulators|tubulin modulators|mesh-ancestor
102424001|NCT04192331|Antimitotic Agents|antimitotic agents|mesh-ancestor
102424002|NCT04192331|Mitosis Modulators|mitosis modulators|mesh-ancestor
102424003|NCT04192331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424004|NCT00919035|Temsirolimus|temsirolimus|mesh-list
102424005|NCT00919035|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102424006|NCT00919035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102424007|NCT00919035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102424008|NCT00919035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424009|NCT00919035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102424010|NCT00919035|Immunologic Factors|immunologic factors|mesh-ancestor
102424011|NCT00919035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424012|NCT00919035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102424013|NCT03969953|Rivaroxaban|rivaroxaban|mesh-list
102424014|NCT03969953|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102424015|NCT03969953|Antithrombins|antithrombins|mesh-ancestor
102424016|NCT03969953|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102424017|NCT03969953|Protease Inhibitors|protease inhibitors|mesh-ancestor
102424018|NCT03969953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102424019|NCT03969953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424020|NCT03969953|Anticoagulants|anticoagulants|mesh-ancestor
102424021|NCT04374981|Celecoxib|celecoxib|mesh-list
102424022|NCT04374981|Montelukast|montelukast|mesh-list
102424023|NCT04374981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102424024|NCT04374981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102424025|NCT04374981|Analgesics|analgesics|mesh-ancestor
102424026|NCT04374981|Sensory System Agents|sensory system agents|mesh-ancestor
102424027|NCT04374981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102424028|NCT04374981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424029|NCT04374981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102424030|NCT04374981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102424031|NCT04374981|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102424032|NCT04374981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102424033|NCT04374981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102424034|NCT04374981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424035|NCT04374981|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102424036|NCT04374981|Respiratory System Agents|respiratory system agents|mesh-ancestor
102424037|NCT04374981|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102424038|NCT04374981|Hormone Antagonists|hormone antagonists|mesh-ancestor
102424039|NCT04374981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102424040|NCT04374981|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102424041|NCT04374981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102424042|NCT03092544|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102424043|NCT03092544|Dermatologic Agents|dermatologic agents|mesh-ancestor
102424044|NCT03092544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102424045|NCT03092544|Immunologic Factors|immunologic factors|mesh-ancestor
102424046|NCT03092544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424047|NCT03090516|Donepezil|donepezil|mesh-list
102424048|NCT03090516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102424049|NCT03090516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102424050|NCT03090516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424051|NCT03090516|Cholinergic Agents|cholinergic agents|mesh-ancestor
102424052|NCT03090516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102424053|NCT03090516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424054|NCT03090516|Nootropic Agents|nootropic agents|mesh-ancestor
102424055|NCT04198571|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
102424056|NCT04198571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102424057|NCT04198571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102424058|NCT03092310|Pancrelipase|pancrelipase|mesh-list
102424059|NCT03092310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102424060|NCT03405207|Vitamin D|vitamin d|mesh-list
102424061|NCT03405207|Cholecalciferol|cholecalciferol|mesh-list
102424062|NCT03405207|Vitamins|vitamins|mesh-ancestor
102424063|NCT03405207|Micronutrients|micronutrients|mesh-ancestor
102424064|NCT03405207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424065|NCT03405207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102424066|NCT03405207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102424067|NCT04197323|Alprostadil|alprostadil|mesh-list
102424068|NCT04197323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102424069|NCT04197323|Vasodilator Agents|vasodilator agents|mesh-ancestor
102424070|NCT04197323|Urological Agents|urological agents|mesh-ancestor
102424071|NCT04196855|Teriparatide|teriparatide|mesh-list
102424072|NCT04196855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102424073|NCT04196855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424074|NCT04196855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102424075|NCT04196621|Lubricant Eye Drops|lubricant eye drops|mesh-list
102424076|NCT04196621|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102424077|NCT04196621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102424078|NCT04196309|Heparin|heparin|mesh-list
102424079|NCT04196309|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102424080|NCT04196309|Tinzaparin|tinzaparin|mesh-list
102424081|NCT04196309|Dalteparin|dalteparin|mesh-list
102424082|NCT04196309|Anticoagulants|anticoagulants|mesh-ancestor
102424083|NCT04196309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102424084|NCT04196309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102424085|NCT04196309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424086|NCT03090048|Vitamin A|vitamin a|mesh-list
102424087|NCT03090048|Azithromycin|azithromycin|mesh-list
102424088|NCT03090048|Retinol palmitate|retinol palmitate|mesh-list
102424089|NCT03090048|Vitamins|vitamins|mesh-ancestor
102424090|NCT03090048|Micronutrients|micronutrients|mesh-ancestor
102424091|NCT03090048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424092|NCT03090048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102424093|NCT03090048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102424094|NCT03090048|Antioxidants|antioxidants|mesh-ancestor
102424095|NCT03090048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424096|NCT03090048|Protective Agents|protective agents|mesh-ancestor
102424097|NCT03090048|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102424098|NCT03090048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102424099|NCT04195997|Heparin|heparin|mesh-list
102424100|NCT04195997|Bivalirudin|bivalirudin|mesh-list
102424101|NCT04195997|Anticoagulants|anticoagulants|mesh-ancestor
102054791|NCT05417893|Sirolimus|sirolimus|mesh-list
102424102|NCT04195997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102424103|NCT04195997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102424104|NCT04195997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424105|NCT04195997|Antithrombins|antithrombins|mesh-ancestor
102424106|NCT04195997|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102424107|NCT04195997|Protease Inhibitors|protease inhibitors|mesh-ancestor
102424108|NCT04195997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102424109|NCT05023122|Vitamin D|vitamin d|mesh-list
102424110|NCT05023122|Cholecalciferol|cholecalciferol|mesh-list
102424111|NCT05023122|Calcium|calcium|mesh-list
102424112|NCT05023122|Vitamins|vitamins|mesh-ancestor
102424113|NCT05023122|Micronutrients|micronutrients|mesh-ancestor
102424114|NCT05023122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424115|NCT05023122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102424116|NCT05023122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102424117|NCT04195373|Flucytosine|flucytosine|mesh-list
102424118|NCT04195373|Antifungal Agents|antifungal agents|mesh-ancestor
102424119|NCT04195373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102424120|NCT04195373|Antimetabolites|antimetabolites|mesh-ancestor
102424121|NCT04195373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424122|NCT04194827|Adalimumab|adalimumab|mesh-list
102424123|NCT04194827|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102424124|NCT04194827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102424125|NCT04194827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102424126|NCT04194905|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102424127|NCT04194905|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102424128|NCT04194905|Levonorgestrel|levonorgestrel|mesh-list
102424129|NCT04194905|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102424130|NCT04194905|Estradiol|estradiol|mesh-list
102424131|NCT04194905|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102424132|NCT04194905|Estrogens|estrogens|mesh-ancestor
102424133|NCT04194905|Hormones|hormones|mesh-ancestor
102424134|NCT04194905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102424135|NCT04194905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424136|NCT04194905|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102424137|NCT04194905|Contraceptive Agents|contraceptive agents|mesh-ancestor
102424138|NCT04194905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102424139|NCT04194905|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102424140|NCT04194905|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102424141|NCT04194905|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102424142|NCT04194905|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102424143|NCT05017428|Niacinamide|niacinamide|mesh-list
102424144|NCT05017428|Niacin|niacin|mesh-list
102424145|NCT05017428|Nicotinic Acids|nicotinic acids|mesh-list
102424146|NCT05017428|Vitamin B Complex|vitamin b complex|mesh-ancestor
102424147|NCT05017428|Vitamins|vitamins|mesh-ancestor
102424148|NCT05017428|Micronutrients|micronutrients|mesh-ancestor
102424149|NCT05017428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424150|NCT05017428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102424151|NCT05017428|Antimetabolites|antimetabolites|mesh-ancestor
102424152|NCT05017428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424153|NCT05017428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102424154|NCT05017428|Vasodilator Agents|vasodilator agents|mesh-ancestor
102424155|NCT04196231|Insulin|insulin|mesh-list
102424156|NCT04196231|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102424157|NCT04196231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102424158|NCT04196231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424159|NCT00013611|Aldesleukin|aldesleukin|mesh-list
102424160|NCT00013611|Interleukin-2|interleukin-2|mesh-list
102424161|NCT00013611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102424162|NCT00013611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102424163|NCT00013611|Analgesics|analgesics|mesh-ancestor
102424164|NCT00013611|Sensory System Agents|sensory system agents|mesh-ancestor
102424165|NCT00013611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102424166|NCT00013611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424167|NCT00013611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102424168|NCT00013611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102424169|NCT00013611|Antiviral Agents|antiviral agents|mesh-ancestor
102424170|NCT00013611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102424171|NCT04194515|Metformin|metformin|mesh-list
102424172|NCT04194515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102424173|NCT04194515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424174|NCT03094182|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
102424175|NCT03094182|Hematinics|hematinics|mesh-ancestor
102424176|NCT05017116|Entecavir|entecavir|mesh-list
102424177|NCT05017116|Antiviral Agents|antiviral agents|mesh-ancestor
102424178|NCT05017116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102424179|NCT05022030|Cetuximab|cetuximab|mesh-list
102424180|NCT05022030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102424181|NCT05022030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102424182|NCT04192643|Tranexamic Acid|tranexamic acid|mesh-list
102424183|NCT04192643|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102424184|NCT04192643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102424185|NCT04192643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424186|NCT04192643|Hemostatics|hemostatics|mesh-ancestor
102424187|NCT04192643|Coagulants|coagulants|mesh-ancestor
102424188|NCT03753659|Pembrolizumab|pembrolizumab|mesh-list
102424189|NCT03753659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102424190|NCT03753659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102424191|NCT03753659|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102424192|NCT03753659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424193|NCT00010257|Paclitaxel|paclitaxel|mesh-list
102424194|NCT00010257|Carboplatin|carboplatin|mesh-list
102424195|NCT00010257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102424196|NCT00010257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102424197|NCT00010257|Tubulin Modulators|tubulin modulators|mesh-ancestor
102424198|NCT00010257|Antimitotic Agents|antimitotic agents|mesh-ancestor
102424199|NCT00010257|Mitosis Modulators|mitosis modulators|mesh-ancestor
102424200|NCT00010257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424201|NCT05022186|Cannabidiol|cannabidiol|mesh-list
102424202|NCT05022186|Tramiprosate|tramiprosate|mesh-list
102424203|NCT05022186|Anticonvulsants|anticonvulsants|mesh-ancestor
102424204|NCT05022186|GABA Agonists|gaba agonists|mesh-ancestor
102424205|NCT05022186|GABA Agents|gaba agents|mesh-ancestor
102424206|NCT05022186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102424207|NCT05022186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424208|NCT05022186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424209|NCT02240043|Hormones|hormones|mesh-list
102424210|NCT02240043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102235898|NCT03285607|Tubulin Modulators|tubulin modulators|mesh-ancestor
102424211|NCT02240043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424212|NCT03404037|Endostatins|endostatins|mesh-list
102424213|NCT03404037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102424214|NCT03404037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102424215|NCT03404037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102424216|NCT03404037|Growth Substances|growth substances|mesh-ancestor
102424217|NCT03404037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424218|NCT03404037|Growth Inhibitors|growth inhibitors|mesh-ancestor
102424219|NCT02240199|Lidocaine|lidocaine|mesh-list
102424220|NCT02240199|Pregabalin|pregabalin|mesh-list
102424221|NCT02240199|Anesthetics, Local|anesthetics, local|mesh-ancestor
102424222|NCT02240199|Anesthetics|anesthetics|mesh-ancestor
102424223|NCT02240199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102424224|NCT02240199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424225|NCT02240199|Sensory System Agents|sensory system agents|mesh-ancestor
102424226|NCT02240199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102424227|NCT02240199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102424228|NCT02240199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102424229|NCT02240199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102424230|NCT02240199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102424231|NCT02240199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424232|NCT02240199|Analgesics|analgesics|mesh-ancestor
102424233|NCT02240199|Anticonvulsants|anticonvulsants|mesh-ancestor
102424234|NCT02240199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102054904|NCT04631471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102424235|NCT02240199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102424236|NCT02240199|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102424237|NCT02240199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102424238|NCT02240199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102424239|NCT04190927|Estradiol|estradiol|mesh-list
102424240|NCT04190927|Progesterone|progesterone|mesh-list
102424241|NCT04190927|Estrogens|estrogens|mesh-ancestor
102424242|NCT04190927|Hormones|hormones|mesh-ancestor
102424243|NCT04190927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102424244|NCT04190927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424245|NCT04190927|Progestins|progestins|mesh-ancestor
102424246|NCT00919191|Adapalene|adapalene|mesh-list
102424247|NCT00919191|Tretinoin|tretinoin|mesh-list
102424248|NCT00919191|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102424249|NCT00919191|Dermatologic Agents|dermatologic agents|mesh-ancestor
102424250|NCT00919191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102424251|NCT00919191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102424252|NCT00919191|Analgesics|analgesics|mesh-ancestor
102424253|NCT00919191|Sensory System Agents|sensory system agents|mesh-ancestor
102424254|NCT00919191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102424255|NCT00919191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424256|NCT00919191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102424257|NCT00919191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102424258|NCT00919191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102424259|NCT00919191|Keratolytic Agents|keratolytic agents|mesh-ancestor
102424260|NCT05021406|Carvedilol|carvedilol|mesh-list
102424261|NCT05021406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102424262|NCT05021406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102424263|NCT05021406|Adrenergic Agents|adrenergic agents|mesh-ancestor
102424264|NCT05021406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102424265|NCT05021406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424266|NCT05021406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424267|NCT05021406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102424268|NCT05021406|Antioxidants|antioxidants|mesh-ancestor
102424269|NCT05021406|Protective Agents|protective agents|mesh-ancestor
102424270|NCT05021406|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102424271|NCT05021406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102424272|NCT05021406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102424273|NCT05021406|Vasodilator Agents|vasodilator agents|mesh-ancestor
102424274|NCT05021406|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102424275|NCT05021406|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102424276|NCT04766177|Bumetanide|bumetanide|mesh-list
102424277|NCT04766177|Diuretics|diuretics|mesh-ancestor
102424278|NCT04766177|Natriuretic Agents|natriuretic agents|mesh-ancestor
102424279|NCT04766177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424280|NCT04766177|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102424281|NCT04766177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102424282|NCT04766177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424283|NCT04466280|Hydroxychloroquine|hydroxychloroquine|mesh-list
102424284|NCT04466280|Antimalarials|antimalarials|mesh-ancestor
102424285|NCT04466280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102424286|NCT04466280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102424287|NCT04466280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102424288|NCT04466280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102424289|NCT04466280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424290|NCT04466280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102424291|NCT05016180|Ropivacaine|ropivacaine|mesh-list
102424292|NCT05016180|Anesthetics, Local|anesthetics, local|mesh-ancestor
102424293|NCT05016180|Anesthetics|anesthetics|mesh-ancestor
102424294|NCT05016180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102424295|NCT05016180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424296|NCT05016180|Sensory System Agents|sensory system agents|mesh-ancestor
102424297|NCT05016180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102424299|NCT03023501|Analgesics|analgesics|mesh-ancestor
102424300|NCT03023501|Sensory System Agents|sensory system agents|mesh-ancestor
102424301|NCT03023501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102424302|NCT03023501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424303|NCT03023501|Anticonvulsants|anticonvulsants|mesh-ancestor
102424304|NCT03023501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102424305|NCT03023501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102424306|NCT03023501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102424307|NCT03023501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102424308|NCT03023501|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102424309|NCT03023501|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102424310|NCT03023501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102424311|NCT03023501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424312|NCT03023501|Antimanic Agents|antimanic agents|mesh-ancestor
102424313|NCT05015322|Methylprednisolone|methylprednisolone|mesh-list
102424314|NCT05015322|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102424315|NCT05015322|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102424316|NCT05015322|Prednisolone|prednisolone|mesh-list
102424317|NCT05015322|Prednisolone acetate|prednisolone acetate|mesh-list
102424318|NCT05015322|Bupivacaine|bupivacaine|mesh-list
102424319|NCT05015322|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102424320|NCT05015322|Prednisolone phosphate|prednisolone phosphate|mesh-list
102424321|NCT05015322|Anesthetics, Local|anesthetics, local|mesh-ancestor
102424322|NCT05015322|Anesthetics|anesthetics|mesh-ancestor
102424323|NCT05015322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102424324|NCT05015322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424325|NCT05015322|Sensory System Agents|sensory system agents|mesh-ancestor
102424326|NCT05015322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102424327|NCT05015322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102424328|NCT05015322|Antiemetics|antiemetics|mesh-ancestor
102424329|NCT05015322|Autonomic Agents|autonomic agents|mesh-ancestor
102424330|NCT05015322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102424331|NCT05015322|Glucocorticoids|glucocorticoids|mesh-ancestor
102424332|NCT05015322|Hormones|hormones|mesh-ancestor
102424333|NCT05015322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102424334|NCT05015322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102424335|NCT05015322|Protective Agents|protective agents|mesh-ancestor
102424336|NCT05015322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102424337|NCT05015322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102424338|NCT05021250|Ethiodized Oil|ethiodized oil|mesh-list
102424339|NCT05021250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102424340|NCT00919503|Cyclosporine|cyclosporine|mesh-list
102424341|NCT00919503|Mycophenolic Acid|mycophenolic acid|mesh-list
102424342|NCT00919503|Methotrexate|methotrexate|mesh-list
102424343|NCT00919503|Fludarabine phosphate|fludarabine phosphate|mesh-list
102424344|NCT00919503|Fludarabine|fludarabine|mesh-list
102424345|NCT00919503|Treosulfan|treosulfan|mesh-list
102424346|NCT00919503|Busulfan|busulfan|mesh-list
102424347|NCT00919503|Tacrolimus|tacrolimus|mesh-list
102424348|NCT00919503|Cyclosporins|cyclosporins|mesh-list
102424349|NCT00919503|Thymoglobulin|thymoglobulin|mesh-list
102424350|NCT00919503|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102424351|NCT00919503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102424352|NCT00919503|Abortifacient Agents|abortifacient agents|mesh-ancestor
102424353|NCT00919503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102424354|NCT00919503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424355|NCT00919503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102424356|NCT00919503|Antimetabolites|antimetabolites|mesh-ancestor
102424357|NCT00919503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424358|NCT00919503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102424359|NCT00919503|Dermatologic Agents|dermatologic agents|mesh-ancestor
102424360|NCT00919503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102424361|NCT00919503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102424362|NCT00919503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102424363|NCT00919503|Immunologic Factors|immunologic factors|mesh-ancestor
102236047|NCT03365999|Coagulants|coagulants|mesh-ancestor
102424364|NCT00919503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102424365|NCT00919503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102424366|NCT00919503|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102424367|NCT00919503|Antifungal Agents|antifungal agents|mesh-ancestor
102424368|NCT00919503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102424369|NCT00919503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102424370|NCT00919503|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102424371|NCT00919503|Antitubercular Agents|antitubercular agents|mesh-ancestor
102424372|NCT00919503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102424373|NCT00919503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102424374|NCT00919503|Alkylating Agents|alkylating agents|mesh-ancestor
102424375|NCT00919503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102424377|NCT05020704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102424378|NCT05020704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424379|NCT05020704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102424380|NCT05020704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424381|NCT02979665|Ranibizumab|ranibizumab|mesh-list
102424382|NCT02979665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102424383|NCT02979665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102424384|NCT02979665|Growth Substances|growth substances|mesh-ancestor
102424385|NCT02979665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424386|NCT02979665|Growth Inhibitors|growth inhibitors|mesh-ancestor
102424387|NCT02979665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102424388|NCT03092076|Ticagrelor|ticagrelor|mesh-list
102424389|NCT03092076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102424390|NCT03092076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102424391|NCT03092076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102424392|NCT03092076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102424393|NCT03092076|Purinergic Agents|purinergic agents|mesh-ancestor
102424394|NCT03092076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102424395|NCT03092076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424396|NCT03092076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424397|NCT04193501|Melatonin|melatonin|mesh-list
102424398|NCT04193501|Antioxidants|antioxidants|mesh-ancestor
102424399|NCT04193501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424400|NCT04193501|Protective Agents|protective agents|mesh-ancestor
102424401|NCT04193501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424402|NCT04193501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102424403|NCT04374279|Bicalutamide|bicalutamide|mesh-list
102424404|NCT04374279|Androgen Antagonists|androgen antagonists|mesh-ancestor
102424405|NCT04374279|Hormone Antagonists|hormone antagonists|mesh-ancestor
102424406|NCT04374279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102424407|NCT04374279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424408|NCT04374279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102424409|NCT02240433|Sorafenib|sorafenib|mesh-list
102424410|NCT02240433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102424411|NCT02240433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102424412|NCT02240433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102424413|NCT02240433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424414|NCT03403647|Vitamin D|vitamin d|mesh-list
102424415|NCT03403647|Vitamins|vitamins|mesh-ancestor
102424416|NCT03403647|Micronutrients|micronutrients|mesh-ancestor
102424417|NCT03403647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424418|NCT03403647|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102424419|NCT05014464|Crizotinib|crizotinib|mesh-list
102424420|NCT05014464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102424421|NCT05014464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102424422|NCT05014464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102424423|NCT05014464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424424|NCT03403101|Oxaliplatin|oxaliplatin|mesh-list
102424425|NCT03403101|Irinotecan|irinotecan|mesh-list
102424426|NCT03403101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102424427|NCT03403101|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102424428|NCT03403101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102424429|NCT03403101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102424430|NCT03403101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424431|NCT00211757|Valproic Acid|valproic acid|mesh-list
102424432|NCT00211757|Anticonvulsants|anticonvulsants|mesh-ancestor
102424433|NCT00211757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102424434|NCT00211757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424435|NCT00211757|GABA Agents|gaba agents|mesh-ancestor
102424436|NCT00211757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102424437|NCT00211757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424438|NCT00211757|Antimanic Agents|antimanic agents|mesh-ancestor
102424439|NCT00211757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102424440|NCT00211757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102424441|NCT00211757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102424442|NCT04373967|Metformin|metformin|mesh-list
102424443|NCT04373967|Liraglutide|liraglutide|mesh-list
102424444|NCT04373967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102424445|NCT04373967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424446|NCT04373967|Incretins|incretins|mesh-ancestor
102424447|NCT04373967|Hormones|hormones|mesh-ancestor
102424448|NCT04373967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102424449|NCT04026191|Hyaluronic Acid|hyaluronic acid|mesh-list
102424450|NCT04026191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102424451|NCT04026191|Immunologic Factors|immunologic factors|mesh-ancestor
102424452|NCT04026191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424453|NCT04026191|Viscosupplements|viscosupplements|mesh-ancestor
102424454|NCT04026191|Protective Agents|protective agents|mesh-ancestor
102424455|NCT04022057|Ropivacaine|ropivacaine|mesh-list
102424456|NCT04022057|Anesthetics, Local|anesthetics, local|mesh-ancestor
102424457|NCT04022057|Anesthetics|anesthetics|mesh-ancestor
102424458|NCT04022057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102424459|NCT04022057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424460|NCT04022057|Sensory System Agents|sensory system agents|mesh-ancestor
102424461|NCT04022057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102424462|NCT00921843|Methadone|methadone|mesh-list
102424463|NCT00921843|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102424464|NCT00921843|Narcotics|narcotics|mesh-ancestor
102424465|NCT00921843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102424466|NCT00921843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424467|NCT00921843|Analgesics|analgesics|mesh-ancestor
102424468|NCT00921843|Sensory System Agents|sensory system agents|mesh-ancestor
102424469|NCT00921843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102424470|NCT00921843|Antitussive Agents|antitussive agents|mesh-ancestor
102424471|NCT00921843|Respiratory System Agents|respiratory system agents|mesh-ancestor
102424472|NCT04020653|Ferrous citrate|ferrous citrate|mesh-list
102424473|NCT04020653|Lumefantrine|lumefantrine|mesh-list
102424474|NCT04020653|Artemether|artemether|mesh-list
102424475|NCT04020653|Artemisinins|artemisinins|mesh-list
102424476|NCT04020653|Artemisinin|artemisinin|mesh-list
102424477|NCT04020653|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102424478|NCT04020653|Citric Acid|citric acid|mesh-list
102424479|NCT04020653|Sodium Citrate|sodium citrate|mesh-list
102424480|NCT04020653|Anticoagulants|anticoagulants|mesh-ancestor
102424481|NCT04020653|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102424482|NCT04020653|Chelating Agents|chelating agents|mesh-ancestor
102424483|NCT04020653|Sequestering Agents|sequestering agents|mesh-ancestor
102424484|NCT04020653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424485|NCT04020653|Antimalarials|antimalarials|mesh-ancestor
102424486|NCT04020653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102424487|NCT04020653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102424488|NCT04020653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102424489|NCT04020653|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102424490|NCT04020653|Dermatologic Agents|dermatologic agents|mesh-ancestor
102424491|NCT04020653|Trace Elements|trace elements|mesh-ancestor
102424492|NCT04020653|Micronutrients|micronutrients|mesh-ancestor
102424493|NCT04020653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424494|NCT05008458|Arginine Vasopressin|arginine vasopressin|mesh-list
102424495|NCT05008458|Hemostatics|hemostatics|mesh-ancestor
102424496|NCT05008458|Coagulants|coagulants|mesh-ancestor
102424497|NCT05008458|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102424498|NCT05008458|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102424499|NCT05008458|Natriuretic Agents|natriuretic agents|mesh-ancestor
102424500|NCT05008458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424501|NCT02080637|Ambrisentan|ambrisentan|mesh-list
102424502|NCT02080637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102424503|NCT05019690|Paclitaxel|paclitaxel|mesh-list
102424504|NCT05019690|Apatinib|apatinib|mesh-list
102424505|NCT05019690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102424506|NCT05019690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102424507|NCT05019690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102424508|NCT05019690|Tubulin Modulators|tubulin modulators|mesh-ancestor
102424509|NCT05019690|Antimitotic Agents|antimitotic agents|mesh-ancestor
102424510|NCT05019690|Mitosis Modulators|mitosis modulators|mesh-ancestor
102236199|NCT03264781|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102424511|NCT05019690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424512|NCT05019690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102424513|NCT05019690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102424514|NCT04029467|Dexmedetomidine|dexmedetomidine|mesh-list
102424515|NCT04029467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102424516|NCT04029467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102424517|NCT04029467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424518|NCT04029467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102424520|NCT04029467|Sensory System Agents|sensory system agents|mesh-ancestor
102424521|NCT04029467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102424522|NCT04029467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102424523|NCT04029467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102424524|NCT04029467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102424525|NCT04029467|Adrenergic Agents|adrenergic agents|mesh-ancestor
102424526|NCT04029467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102424527|NCT04029467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424528|NCT03402321|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
102424529|NCT03402321|Hemostatics|hemostatics|mesh-ancestor
102424530|NCT03402321|Coagulants|coagulants|mesh-ancestor
102424531|NCT03402165|Sofosbuvir|sofosbuvir|mesh-list
102424532|NCT03402165|Ledipasvir|ledipasvir|mesh-list
102424533|NCT03402165|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102424534|NCT03402165|Antiviral Agents|antiviral agents|mesh-ancestor
102424535|NCT03402165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102424536|NCT03402087|Leucovorin|leucovorin|mesh-list
102424537|NCT03402087|Methotrexate|methotrexate|mesh-list
102424538|NCT03402087|Deucravacitinib|deucravacitinib|mesh-list
102424539|NCT03402087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102424540|NCT03402087|Abortifacient Agents|abortifacient agents|mesh-ancestor
102424541|NCT03402087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102424542|NCT03402087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424543|NCT03402087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102424544|NCT03402087|Antimetabolites|antimetabolites|mesh-ancestor
102424545|NCT03402087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424546|NCT03402087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102424547|NCT03402087|Dermatologic Agents|dermatologic agents|mesh-ancestor
102424548|NCT03402087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102424549|NCT03402087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102424550|NCT03402087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102424551|NCT03402087|Immunologic Factors|immunologic factors|mesh-ancestor
102424552|NCT03402087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102424553|NCT03402087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102424554|NCT03402087|Antidotes|antidotes|mesh-ancestor
102424555|NCT03402087|Protective Agents|protective agents|mesh-ancestor
102424556|NCT03402087|Vitamin B Complex|vitamin b complex|mesh-ancestor
102424557|NCT03402087|Vitamins|vitamins|mesh-ancestor
102424558|NCT03402087|Micronutrients|micronutrients|mesh-ancestor
102424559|NCT03402087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102424560|NCT04020263|Simendan|simendan|mesh-list
102424561|NCT04020263|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102424562|NCT04020263|Vasodilator Agents|vasodilator agents|mesh-ancestor
102424563|NCT04020263|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102424564|NCT04020263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102424565|NCT04020263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102424566|NCT04020263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424567|NCT04020263|Protective Agents|protective agents|mesh-ancestor
102424568|NCT04020263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424569|NCT05013060|Butyric Acid|butyric acid|mesh-list
102424570|NCT05013060|Histamine Antagonists|histamine antagonists|mesh-ancestor
102424571|NCT05013060|Histamine Agents|histamine agents|mesh-ancestor
102424572|NCT05013060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102424573|NCT05013060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424574|NCT05013060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424575|NCT05008068|Simvastatin|simvastatin|mesh-list
102424576|NCT05008068|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102424577|NCT05008068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102424578|NCT05008068|Antimetabolites|antimetabolites|mesh-ancestor
102424579|NCT05008068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424580|NCT05008068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102424581|NCT05008068|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102424582|NCT05008068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102424583|NCT00925119|Atenolol|atenolol|mesh-list
102424584|NCT00925119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102424585|NCT00925119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102424586|NCT00925119|Sympatholytics|sympatholytics|mesh-ancestor
102424587|NCT00925119|Autonomic Agents|autonomic agents|mesh-ancestor
102424588|NCT00925119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102424589|NCT00925119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424590|NCT00925119|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102424591|NCT00925119|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102424592|NCT00925119|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102424593|NCT00925119|Adrenergic Agents|adrenergic agents|mesh-ancestor
102424594|NCT00925119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102424595|NCT00925119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424596|NCT04020809|Atezolizumab|atezolizumab|mesh-list
102424597|NCT04020809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102424598|NCT04020809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424599|NCT04020809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102424600|NCT04020809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102424601|NCT04027751|Tropisetron|tropisetron|mesh-list
102424602|NCT04027751|Antiemetics|antiemetics|mesh-ancestor
102424603|NCT04027751|Autonomic Agents|autonomic agents|mesh-ancestor
102424604|NCT04027751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102424605|NCT04027751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424606|NCT04027751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102424607|NCT04027751|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102424608|NCT04027751|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102424609|NCT04027751|Serotonin Agents|serotonin agents|mesh-ancestor
102424610|NCT04027751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102424611|NCT04027751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424612|NCT05018988|Vitamin D|vitamin d|mesh-list
102424613|NCT05018988|Ergocalciferols|ergocalciferols|mesh-list
102424614|NCT05018988|Cholecalciferol|cholecalciferol|mesh-list
102424615|NCT05018988|Vitamins|vitamins|mesh-list
102424616|NCT05018988|Micronutrients|micronutrients|mesh-ancestor
102424617|NCT05018988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424618|NCT05018988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102424619|NCT05018988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102424620|NCT02241759|Moxifloxacin|moxifloxacin|mesh-list
102424621|NCT02241759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102424622|NCT02241759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102424623|NCT02241759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102424624|NCT02241759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102424625|NCT02241759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102424626|NCT02241759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424627|NCT02241759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102424628|NCT04434144|Azithromycin|azithromycin|mesh-list
102424629|NCT04434144|Doxycycline|doxycycline|mesh-list
102424630|NCT04434144|Hydroxychloroquine|hydroxychloroquine|mesh-list
102424631|NCT04434144|Ivermectin|ivermectin|mesh-list
102424632|NCT04434144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102424633|NCT04434144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102424634|NCT04434144|Antimalarials|antimalarials|mesh-ancestor
102424635|NCT04434144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102424636|NCT04434144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102424637|NCT04434144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102424638|NCT04434144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424639|NCT04434144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102424640|NCT04957914|Insulin Glargine|insulin glargine|mesh-list
102424641|NCT04957914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102424642|NCT04957914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424643|NCT04027283|Erythritol|erythritol|mesh-list
102424644|NCT04027283|Vasodilator Agents|vasodilator agents|mesh-ancestor
102424645|NCT04028141|Ketamine|ketamine|mesh-list
102424646|NCT04028141|Propofol|propofol|mesh-list
102424647|NCT04028141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102424648|NCT04028141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102424649|NCT04028141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424650|NCT04028141|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102424651|NCT04028141|Anesthetics, General|anesthetics, general|mesh-ancestor
102424652|NCT04028141|Anesthetics|anesthetics|mesh-ancestor
102424653|NCT04028141|Analgesics|analgesics|mesh-ancestor
102424654|NCT04028141|Sensory System Agents|sensory system agents|mesh-ancestor
102424655|NCT04028141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102424656|NCT04028141|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102424657|NCT04028141|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102424658|NCT04028141|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102424659|NCT04028141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102424660|NCT04028141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424661|NCT03401541|Vitamin D|vitamin d|mesh-list
102424662|NCT03401541|Calcifediol|calcifediol|mesh-list
102424663|NCT03401541|Ergocalciferols|ergocalciferols|mesh-list
102424664|NCT03401541|Vitamins|vitamins|mesh-ancestor
102236350|NCT03359057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102424665|NCT03401541|Micronutrients|micronutrients|mesh-ancestor
102424666|NCT03401541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424667|NCT03401541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102424668|NCT03401541|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102424669|NCT03953261|Curcumin|curcumin|mesh-list
102424670|NCT03953261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102424671|NCT03953261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102424672|NCT03953261|Analgesics|analgesics|mesh-ancestor
102424673|NCT03953261|Sensory System Agents|sensory system agents|mesh-ancestor
102424674|NCT03953261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102424675|NCT03953261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424676|NCT03953261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102424677|NCT03953261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102424678|NCT03953261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102424679|NCT03953261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102424680|NCT03953261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424681|NCT02242149|Diacerein|diacerein|mesh-list
102424682|NCT02242149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102424683|NCT03022565|Vorinostat|vorinostat|mesh-list
102424684|NCT03022565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102424685|NCT03022565|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102424686|NCT03022565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102424687|NCT03022565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424688|NCT03079050|Dexlansoprazole|dexlansoprazole|mesh-list
102424689|NCT03079050|Lansoprazole|lansoprazole|mesh-list
102424690|NCT03079050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102424691|NCT03079050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102424692|NCT03079050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102424693|NCT03079050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102424694|NCT03079050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424695|NCT03834129|Dexmedetomidine|dexmedetomidine|mesh-list
102424696|NCT03834129|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102424697|NCT03834129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102424698|NCT03834129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424699|NCT03834129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102424700|NCT03834129|Analgesics|analgesics|mesh-ancestor
102424701|NCT03834129|Sensory System Agents|sensory system agents|mesh-ancestor
102424702|NCT03834129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102424703|NCT03834129|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102424704|NCT03834129|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102424705|NCT03834129|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102424706|NCT03834129|Adrenergic Agents|adrenergic agents|mesh-ancestor
102424707|NCT03834129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102424708|NCT03834129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424709|NCT05001204|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
102424710|NCT05001204|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102424711|NCT05001204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424712|NCT03022409|Olaparib|olaparib|mesh-list
102424713|NCT03022409|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102424714|NCT03022409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102424715|NCT03022409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424716|NCT03022409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102424717|NCT03833895|Phenylephrine|phenylephrine|mesh-list
102424718|NCT03833895|Oxymetazoline|oxymetazoline|mesh-list
102424719|NCT03833895|Norepinephrine|norepinephrine|mesh-list
102424720|NCT03833895|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102424721|NCT03833895|Mydriatics|mydriatics|mesh-ancestor
102424722|NCT03833895|Autonomic Agents|autonomic agents|mesh-ancestor
102424723|NCT03833895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102424724|NCT03833895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424725|NCT03833895|Sympathomimetics|sympathomimetics|mesh-ancestor
102424726|NCT03833895|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102424727|NCT03833895|Nasal Decongestants|nasal decongestants|mesh-ancestor
102424728|NCT03833895|Respiratory System Agents|respiratory system agents|mesh-ancestor
102424729|NCT03833895|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102424730|NCT03833895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102424731|NCT03833895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102424732|NCT03833895|Adrenergic Agents|adrenergic agents|mesh-ancestor
102424733|NCT03833895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102424734|NCT03833895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424735|NCT03833895|Protective Agents|protective agents|mesh-ancestor
102424736|NCT02242227|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102424737|NCT02242227|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102424738|NCT02242227|Autonomic Agents|autonomic agents|mesh-ancestor
102424739|NCT02242227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102424740|NCT02242227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424741|NCT02242227|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102424742|NCT02242227|Respiratory System Agents|respiratory system agents|mesh-ancestor
102424743|NCT02242227|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102424744|NCT02242227|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102424745|NCT02242227|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102424746|NCT02242227|Adrenergic Agents|adrenergic agents|mesh-ancestor
102424747|NCT02242227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102424748|NCT02242227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424749|NCT05000892|Paclitaxel|paclitaxel|mesh-list
102424750|NCT05000892|Carboplatin|carboplatin|mesh-list
102424751|NCT05000892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102424752|NCT05000892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102424753|NCT05000892|Tubulin Modulators|tubulin modulators|mesh-ancestor
102424754|NCT05000892|Antimitotic Agents|antimitotic agents|mesh-ancestor
102424755|NCT05000892|Mitosis Modulators|mitosis modulators|mesh-ancestor
102424756|NCT05000892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424757|NCT04372407|Itraconazole|itraconazole|mesh-list
102424758|NCT04372407|Antifungal Agents|antifungal agents|mesh-ancestor
102424759|NCT04372407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102424760|NCT04372407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102424761|NCT04372407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102424762|NCT04372407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102424763|NCT04372407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424764|NCT04372407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102424765|NCT04372407|Hormone Antagonists|hormone antagonists|mesh-ancestor
102424766|NCT04372407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102424767|NCT04372407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424768|NCT04372407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102424769|NCT02242383|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102424770|NCT02242383|Telmisartan|telmisartan|mesh-list
102424771|NCT02242383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102424772|NCT02242383|Diuretics|diuretics|mesh-ancestor
102424773|NCT02242383|Natriuretic Agents|natriuretic agents|mesh-ancestor
102424774|NCT02242383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424775|NCT02242383|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102424776|NCT02242383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102424777|NCT02242383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424778|NCT02242383|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102424779|NCT02242383|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102424780|NCT04366089|Azithromycin|azithromycin|mesh-list
102424781|NCT04366089|Hydroxychloroquine|hydroxychloroquine|mesh-list
102424782|NCT04366089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102424783|NCT04366089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102424784|NCT04366089|Antimalarials|antimalarials|mesh-ancestor
102424785|NCT04366089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102424786|NCT04366089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102424787|NCT04366089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102424788|NCT04366089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424789|NCT04366089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102424790|NCT03079830|Pirinitramide|pirinitramide|mesh-list
102424791|NCT03079830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102424792|NCT03079830|Narcotics|narcotics|mesh-ancestor
102424793|NCT03079830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102424794|NCT03079830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424795|NCT03079830|Analgesics|analgesics|mesh-ancestor
102424796|NCT03079830|Sensory System Agents|sensory system agents|mesh-ancestor
102424797|NCT03079830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102424798|NCT02242695|Clotrimazole|clotrimazole|mesh-list
102424799|NCT02242695|Dequalinium|dequalinium|mesh-list
102424800|NCT02242695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102424801|NCT02242695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102424802|NCT02242695|Antifungal Agents|antifungal agents|mesh-ancestor
102424803|NCT02242695|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102424804|NCT02242695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102424805|NCT02242695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102424806|NCT02242695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424807|NCT02242695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102424808|NCT02242695|Hormone Antagonists|hormone antagonists|mesh-ancestor
102424809|NCT02242695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102424810|NCT02242695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424811|NCT04999800|Pembrolizumab|pembrolizumab|mesh-list
102424812|NCT04999800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102424813|NCT04999800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102424814|NCT04999800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102424815|NCT04999800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424816|NCT02242851|Telmisartan|telmisartan|mesh-list
102424817|NCT02242851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102424818|NCT02242851|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102424819|NCT02242851|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102424820|NCT02242851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424821|NCT04999878|Dexamethasone|dexamethasone|mesh-list
102424822|NCT04999878|Gemcitabine|gemcitabine|mesh-list
102424823|NCT04999878|Etoposide|etoposide|mesh-list
102424824|NCT04999878|Cisplatin|cisplatin|mesh-list
102424825|NCT04999878|Pegaspargase|pegaspargase|mesh-list
102424826|NCT04999878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102424827|NCT04999878|Antiemetics|antiemetics|mesh-ancestor
102424828|NCT04999878|Autonomic Agents|autonomic agents|mesh-ancestor
102424829|NCT04999878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102424830|NCT04999878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424831|NCT04999878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102424832|NCT04999878|Glucocorticoids|glucocorticoids|mesh-ancestor
102424833|NCT04999878|Hormones|hormones|mesh-ancestor
102424834|NCT04999878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102424835|NCT04999878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102424836|NCT04999878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102424837|NCT04999878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102424838|NCT04999878|Antimetabolites|antimetabolites|mesh-ancestor
102424839|NCT04999878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424840|NCT04999878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102424841|NCT04999878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102424842|NCT04999878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102424843|NCT04999878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102424844|NCT02242929|Imiquimod|imiquimod|mesh-list
102424845|NCT02242929|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102424846|NCT02242929|Immunologic Factors|immunologic factors|mesh-ancestor
102424847|NCT02242929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424848|NCT02242929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102424849|NCT02242929|Interferon Inducers|interferon inducers|mesh-ancestor
102424850|NCT04457856|Plonmarlimab|plonmarlimab|mesh-list
102424851|NCT04457856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102424852|NCT04457856|Antiviral Agents|antiviral agents|mesh-ancestor
102424853|NCT04457856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102424854|NCT05006898|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102424855|NCT05006898|Oxymetazoline|oxymetazoline|mesh-list
102424856|NCT05006898|Pilocarpine|pilocarpine|mesh-list
102424857|NCT05006898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102424858|NCT05006898|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102424859|NCT05006898|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102424860|NCT05006898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102424861|NCT05006898|Adrenergic Agents|adrenergic agents|mesh-ancestor
102424862|NCT05006898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102424863|NCT05006898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424864|NCT05006898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424865|NCT05006898|Sympathomimetics|sympathomimetics|mesh-ancestor
102424866|NCT05006898|Autonomic Agents|autonomic agents|mesh-ancestor
102424867|NCT05006898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102424868|NCT05006898|Nasal Decongestants|nasal decongestants|mesh-ancestor
102424869|NCT05006898|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102424870|NCT05006898|Respiratory System Agents|respiratory system agents|mesh-ancestor
102424871|NCT05006898|Miotics|miotics|mesh-ancestor
102424872|NCT05006898|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102424873|NCT05006898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102424874|NCT05006898|Cholinergic Agents|cholinergic agents|mesh-ancestor
102424875|NCT02243241|Moxifloxacin|moxifloxacin|mesh-list
102424876|NCT02243241|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102424877|NCT02243241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102424878|NCT02243241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102424879|NCT02243241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102424880|NCT02243241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102424881|NCT02243241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102424882|NCT02243241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424883|NCT02243241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102424884|NCT02243241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102236578|NCT03984955|Mannitol|mannitol|mesh-list
102424885|NCT02243241|Contraceptive Agents|contraceptive agents|mesh-ancestor
102424886|NCT02243241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102424887|NCT02243241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424888|NCT02243241|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102424889|NCT02243241|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102424890|NCT02243241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102424891|NCT04365309|Aspirin|aspirin|mesh-list
102424892|NCT04365309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102424893|NCT04365309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102424894|NCT04365309|Analgesics|analgesics|mesh-ancestor
102424895|NCT04365309|Sensory System Agents|sensory system agents|mesh-ancestor
102424896|NCT04365309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102424897|NCT04365309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424898|NCT04365309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102424899|NCT04365309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102424900|NCT04365309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102424901|NCT04365309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102424902|NCT04365309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424903|NCT04365309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102424904|NCT04365309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102424905|NCT04365309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102424906|NCT04365309|Antipyretics|antipyretics|mesh-ancestor
102424907|NCT02243553|Vitamin K|vitamin k|mesh-list
102424908|NCT02243553|Ritonavir|ritonavir|mesh-list
102424909|NCT02243553|Tipranavir|tipranavir|mesh-list
102424910|NCT02243553|Digoxin|digoxin|mesh-list
102424911|NCT02243553|Midazolam|midazolam|mesh-list
102424912|NCT02243553|Dextromethorphan|dextromethorphan|mesh-list
102424913|NCT02243553|Caffeine|caffeine|mesh-list
102424914|NCT02243553|Omeprazole|omeprazole|mesh-list
102424915|NCT02243553|Warfarin|warfarin|mesh-list
102424916|NCT02243553|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102424917|NCT02243553|Vitamins|vitamins|mesh-ancestor
102424918|NCT02243553|Micronutrients|micronutrients|mesh-ancestor
102424919|NCT02243553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424920|NCT02243553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102424921|NCT02243553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102424922|NCT02243553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102424923|NCT02243553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102424924|NCT02243553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102424925|NCT02243553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102424926|NCT02243553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102424927|NCT02243553|Anesthetics, General|anesthetics, general|mesh-ancestor
102424928|NCT02243553|Anesthetics|anesthetics|mesh-ancestor
102424929|NCT02243553|GABA Modulators|gaba modulators|mesh-ancestor
102424930|NCT02243553|GABA Agents|gaba agents|mesh-ancestor
102424931|NCT02243553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102424932|NCT02243553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424933|NCT02243553|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102424934|NCT02243553|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102424935|NCT02243553|Protease Inhibitors|protease inhibitors|mesh-ancestor
102424936|NCT02243553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102424937|NCT02243553|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102424938|NCT02243553|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102424939|NCT02243553|Antiviral Agents|antiviral agents|mesh-ancestor
102424940|NCT02243553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102424941|NCT02243553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102424942|NCT02243553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102424943|NCT02243553|Anticoagulants|anticoagulants|mesh-ancestor
102424944|NCT02243553|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102424945|NCT02243553|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102424946|NCT02243553|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102424947|NCT02243553|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102424948|NCT02243553|Purinergic Agents|purinergic agents|mesh-ancestor
102424949|NCT02243553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102424950|NCT02243553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102424951|NCT02243553|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102424952|NCT02243553|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102424953|NCT02243553|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102424954|NCT02243553|Protective Agents|protective agents|mesh-ancestor
102424955|NCT02243553|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102424956|NCT02243553|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102424957|NCT02243553|Hemostatics|hemostatics|mesh-ancestor
102424958|NCT02243553|Coagulants|coagulants|mesh-ancestor
102236653|NCT03266731|Antipyretics|antipyretics|mesh-ancestor
102424959|NCT02243553|Antitussive Agents|antitussive agents|mesh-ancestor
102424960|NCT02243553|Respiratory System Agents|respiratory system agents|mesh-ancestor
102424961|NCT02243553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102424962|NCT02243553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102424963|NCT00922233|Levonorgestrel|levonorgestrel|mesh-list
102424964|NCT00922233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102424965|NCT00922233|Contraceptive Agents|contraceptive agents|mesh-ancestor
102424966|NCT00922233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102424967|NCT00922233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424968|NCT00922233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102424969|NCT00922233|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102424970|NCT00922233|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102424971|NCT05006664|Prednisone|prednisone|mesh-list
102424972|NCT05006664|Cyclophosphamide|cyclophosphamide|mesh-list
102424973|NCT05006664|Doxorubicin|doxorubicin|mesh-list
102424974|NCT05006664|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102424975|NCT05006664|Etoposide|etoposide|mesh-list
102424976|NCT05006664|Etoposide phosphate|etoposide phosphate|mesh-list
102424977|NCT05006664|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102424978|NCT05006664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102424979|NCT05006664|Immunologic Factors|immunologic factors|mesh-ancestor
102424980|NCT05006664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102424981|NCT05006664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102424982|NCT05006664|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102424983|NCT05006664|Alkylating Agents|alkylating agents|mesh-ancestor
102424984|NCT05006664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102424985|NCT05006664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102424986|NCT05006664|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102424987|NCT05006664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102424988|NCT05006664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102424989|NCT05006664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102424990|NCT05006664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102424991|NCT05006664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102424992|NCT05006664|Glucocorticoids|glucocorticoids|mesh-ancestor
102424993|NCT05006664|Hormones|hormones|mesh-ancestor
102424994|NCT05006664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102424995|NCT05006664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102424996|NCT05006664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102424997|NCT05006664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102424998|NCT05006664|Immunotoxins|immunotoxins|mesh-ancestor
102424999|NCT05006664|Immunoconjugates|immunoconjugates|mesh-ancestor
102425000|NCT04346901|Methimazole|methimazole|mesh-list
102425001|NCT04346901|Antithyroid Agents|antithyroid agents|mesh-ancestor
102425002|NCT04346901|Hormone Antagonists|hormone antagonists|mesh-ancestor
102425003|NCT04346901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102425004|NCT04346901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425005|NCT02244021|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102425006|NCT02244021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102425007|NCT02244021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102425008|NCT02244021|Immunotoxins|immunotoxins|mesh-ancestor
102425009|NCT02244021|Immunoconjugates|immunoconjugates|mesh-ancestor
102425010|NCT02244021|Immunologic Factors|immunologic factors|mesh-ancestor
102425011|NCT02244021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425012|NCT04364451|Asparaginase|asparaginase|mesh-list
102425013|NCT04364451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102425014|NCT02245269|Ritonavir|ritonavir|mesh-list
102425015|NCT02245269|Tipranavir|tipranavir|mesh-list
102425016|NCT02245269|Atorvastatin|atorvastatin|mesh-list
102425017|NCT02245269|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102425018|NCT02245269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102425019|NCT02245269|Antimetabolites|antimetabolites|mesh-ancestor
102425020|NCT02245269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425021|NCT02245269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102425022|NCT02245269|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102425023|NCT02245269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102425024|NCT02245269|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102425025|NCT02245269|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102425026|NCT02245269|Protease Inhibitors|protease inhibitors|mesh-ancestor
102425027|NCT02245269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102425028|NCT02245269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102425029|NCT02245269|Antiviral Agents|antiviral agents|mesh-ancestor
102425030|NCT02245269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102425031|NCT02245269|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102425032|NCT02245269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102425033|NCT04364139|Metoprolol|metoprolol|mesh-list
102425034|NCT04364139|Amlodipine|amlodipine|mesh-list
102425035|NCT04364139|Ramipril|ramipril|mesh-list
102425036|NCT04364139|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102236723|NCT04506827|Viscosupplements|viscosupplements|mesh-ancestor
102425037|NCT04364139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102425038|NCT04364139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102425039|NCT04364139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425040|NCT04364139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102425041|NCT04364139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425042|NCT04364139|Vasodilator Agents|vasodilator agents|mesh-ancestor
102425043|NCT04364139|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102425044|NCT04364139|Sympatholytics|sympatholytics|mesh-ancestor
102425045|NCT04364139|Autonomic Agents|autonomic agents|mesh-ancestor
102425046|NCT04364139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102425047|NCT04364139|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102425048|NCT04364139|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102425049|NCT04364139|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102425050|NCT04364139|Adrenergic Agents|adrenergic agents|mesh-ancestor
102425051|NCT04364139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102425052|NCT04364139|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102425053|NCT04364139|Protease Inhibitors|protease inhibitors|mesh-ancestor
102425054|NCT04364139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102425055|NCT02244255|Tamsulosin|tamsulosin|mesh-list
102425056|NCT02244255|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102425057|NCT02244255|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102425058|NCT02244255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102425059|NCT02244255|Adrenergic Agents|adrenergic agents|mesh-ancestor
102425060|NCT02244255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102425061|NCT02244255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425062|NCT02244255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425063|NCT02244255|Urological Agents|urological agents|mesh-ancestor
102425064|NCT04363827|Hydroxychloroquine|hydroxychloroquine|mesh-list
102425065|NCT04363827|Antimalarials|antimalarials|mesh-ancestor
102425066|NCT04363827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102425067|NCT04363827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102425068|NCT04363827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102425069|NCT04363827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102425070|NCT04363827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425071|NCT04363827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102425072|NCT00923949|Pioglitazone|pioglitazone|mesh-list
102425073|NCT00923949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102425074|NCT00923949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425075|NCT04376541|Fentanyl|fentanyl|mesh-list
102425076|NCT04376541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102425077|NCT04376541|Narcotics|narcotics|mesh-ancestor
102425078|NCT04376541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102425079|NCT04376541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425080|NCT04376541|Analgesics|analgesics|mesh-ancestor
102425081|NCT04376541|Sensory System Agents|sensory system agents|mesh-ancestor
102425082|NCT04376541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102425083|NCT04376541|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102425084|NCT04376541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102425085|NCT04376541|Anesthetics, General|anesthetics, general|mesh-ancestor
102425086|NCT04376541|Anesthetics|anesthetics|mesh-ancestor
102425087|NCT04376307|Anesthetics|anesthetics|mesh-list
102425088|NCT04376307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102425089|NCT04376307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425090|NCT02244489|Capecitabine|capecitabine|mesh-list
102425091|NCT02244489|Oxaliplatin|oxaliplatin|mesh-list
102425092|NCT02244489|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
102425093|NCT02244489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102425094|NCT02244489|Antimetabolites|antimetabolites|mesh-ancestor
102425095|NCT02244489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425096|NCT02244489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102425097|NCT02244489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102425098|NCT02244489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102425099|NCT02244567|Metformin|metformin|mesh-list
102425100|NCT02244567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425101|NCT02244567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102425102|NCT04376073|Niraparib|niraparib|mesh-list
102425103|NCT04376073|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102425104|NCT04376073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102425105|NCT04376073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425106|NCT04376073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102425107|NCT04999176|Enoxaparin|enoxaparin|mesh-list
102425108|NCT04999176|Rivaroxaban|rivaroxaban|mesh-list
102425109|NCT04999176|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102425110|NCT04999176|Antithrombins|antithrombins|mesh-ancestor
102425111|NCT04999176|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102425112|NCT04999176|Protease Inhibitors|protease inhibitors|mesh-ancestor
102425113|NCT04999176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102425114|NCT04999176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425115|NCT04999176|Anticoagulants|anticoagulants|mesh-ancestor
102425116|NCT04999176|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102425117|NCT04999176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102425118|NCT04363203|Azithromycin|azithromycin|mesh-list
102425119|NCT04363203|Hydroxychloroquine|hydroxychloroquine|mesh-list
102055812|NCT05489211|Vitamins|vitamins|mesh-ancestor
102425120|NCT04363203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102425121|NCT04363203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102425122|NCT04363203|Antimalarials|antimalarials|mesh-ancestor
102425123|NCT04363203|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102425124|NCT04363203|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102425125|NCT04363203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102425126|NCT04363203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425127|NCT04363203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102425128|NCT04363359|Vaccines|vaccines|mesh-list
102425129|NCT04363359|Immunologic Factors|immunologic factors|mesh-ancestor
102425130|NCT04363359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425131|NCT02244879|Resveratrol|resveratrol|mesh-list
102425132|NCT02244879|Antioxidants|antioxidants|mesh-ancestor
102425133|NCT02244879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425134|NCT02244879|Protective Agents|protective agents|mesh-ancestor
102425135|NCT02244879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425136|NCT02244879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102425137|NCT02244879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102425138|NCT04362735|Vedolizumab|vedolizumab|mesh-list
102425139|NCT04362735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102425140|NCT04375995|Nitric Oxide|nitric oxide|mesh-list
102425141|NCT04375995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102425142|NCT04375995|Autonomic Agents|autonomic agents|mesh-ancestor
102425143|NCT04375995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102425144|NCT04375995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425145|NCT04375995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102425146|NCT04375995|Respiratory System Agents|respiratory system agents|mesh-ancestor
102425147|NCT04375995|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102425148|NCT04375995|Antioxidants|antioxidants|mesh-ancestor
102425149|NCT04375995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425150|NCT04375995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102425151|NCT04375995|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102425152|NCT04375995|Vasodilator Agents|vasodilator agents|mesh-ancestor
102425153|NCT04375995|Gasotransmitters|gasotransmitters|mesh-ancestor
102425154|NCT04375995|Protective Agents|protective agents|mesh-ancestor
102425155|NCT04365231|Azithromycin|azithromycin|mesh-list
102425156|NCT04365231|Hydroxychloroquine|hydroxychloroquine|mesh-list
102425157|NCT04365231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102425158|NCT04365231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102425159|NCT04365231|Antimalarials|antimalarials|mesh-ancestor
102425160|NCT04365231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102425161|NCT04365231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102425162|NCT04365231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102425163|NCT04365231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425164|NCT04365231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102425165|NCT04993014|Trastuzumab|trastuzumab|mesh-list
102425166|NCT04993014|Pertuzumab|pertuzumab|mesh-list
102425167|NCT04993014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102425168|NCT04993014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102425169|NCT05005494|Magnesium Sulfate|magnesium sulfate|mesh-list
102425170|NCT05005494|Analgesics|analgesics|mesh-ancestor
102425171|NCT05005494|Sensory System Agents|sensory system agents|mesh-ancestor
102425172|NCT05005494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102425173|NCT05005494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425174|NCT05005494|Anesthetics|anesthetics|mesh-ancestor
102425175|NCT05005494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102425176|NCT05005494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102425177|NCT05005494|Anticonvulsants|anticonvulsants|mesh-ancestor
102425178|NCT05005494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102425179|NCT05005494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102425180|NCT05005494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425181|NCT05005494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102425182|NCT05005494|Tocolytic Agents|tocolytic agents|mesh-ancestor
102425183|NCT05005494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102425184|NCT04025567|Vancomycin|vancomycin|mesh-list
102425185|NCT04025567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102236873|NCT04505657|Analgesics|analgesics|mesh-ancestor
102425186|NCT04025567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102425188|NCT03074994|Anesthetics, Local|anesthetics, local|mesh-list
102425189|NCT03074994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102425190|NCT03074994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425191|NCT03074994|Sensory System Agents|sensory system agents|mesh-ancestor
102055872|NCT04753879|Paclitaxel|paclitaxel|mesh-list
102425192|NCT03074994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102425193|NCT04025177|Indomethacin|indomethacin|mesh-list
102425194|NCT04025177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102425195|NCT04025177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102425196|NCT04025177|Analgesics|analgesics|mesh-ancestor
102425197|NCT04025177|Sensory System Agents|sensory system agents|mesh-ancestor
102425198|NCT04025177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102425199|NCT04025177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425200|NCT04025177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102425201|NCT04025177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102425202|NCT04025177|Gout Suppressants|gout suppressants|mesh-ancestor
102425203|NCT04025177|Tocolytic Agents|tocolytic agents|mesh-ancestor
102425204|NCT04025177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102425205|NCT04025177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102425206|NCT04025177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102425207|NCT04025177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425208|NCT04358055|Hyaluronic Acid|hyaluronic acid|mesh-list
102425209|NCT04358055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102425210|NCT04358055|Immunologic Factors|immunologic factors|mesh-ancestor
102425211|NCT04358055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425212|NCT04358055|Viscosupplements|viscosupplements|mesh-ancestor
102425213|NCT04358055|Protective Agents|protective agents|mesh-ancestor
102425214|NCT04147325|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102425215|NCT04147325|Antiviral Agents|antiviral agents|mesh-ancestor
102425216|NCT04147325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102425217|NCT02985281|Ribavirin|ribavirin|mesh-list
102425218|NCT02985281|Sofosbuvir|sofosbuvir|mesh-list
102425219|NCT02985281|Antimetabolites|antimetabolites|mesh-ancestor
102425220|NCT02985281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425221|NCT02985281|Antiviral Agents|antiviral agents|mesh-ancestor
102425222|NCT02985281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102425223|NCT00927849|Nitroglycerin|nitroglycerin|mesh-list
102425224|NCT00927849|Botulinum Toxins|botulinum toxins|mesh-list
102425225|NCT00927849|Glycerol|glycerol|mesh-list
102425226|NCT00927849|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102425227|NCT00927849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102425228|NCT00927849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425229|NCT00927849|Cholinergic Agents|cholinergic agents|mesh-ancestor
102425230|NCT00927849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102425231|NCT00927849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425232|NCT00927849|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102425233|NCT00927849|Protective Agents|protective agents|mesh-ancestor
102425234|NCT00927849|Vasodilator Agents|vasodilator agents|mesh-ancestor
102425235|NCT04149587|Brodalumab|brodalumab|mesh-list
102425236|NCT04149587|Dermatologic Agents|dermatologic agents|mesh-ancestor
102425237|NCT02985125|Everolimus|everolimus|mesh-list
102425238|NCT02985125|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102425239|NCT02985125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102425240|NCT02985125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102425241|NCT02985125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425242|NCT02985125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102425243|NCT02985125|Immunologic Factors|immunologic factors|mesh-ancestor
102425244|NCT02985125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425245|NCT02985125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102425246|NCT04912596|Albuterol|albuterol|mesh-list
102425247|NCT04912596|Procaterol|procaterol|mesh-list
102425248|NCT04912596|Methacholine Chloride|methacholine chloride|mesh-list
102425249|NCT04912596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102425250|NCT04912596|Autonomic Agents|autonomic agents|mesh-ancestor
102425251|NCT04912596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102425252|NCT04912596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425253|NCT04912596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102425254|NCT04912596|Respiratory System Agents|respiratory system agents|mesh-ancestor
102425255|NCT04912596|Tocolytic Agents|tocolytic agents|mesh-ancestor
102425256|NCT04912596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102425257|NCT04912596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102425258|NCT04912596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102425259|NCT04912596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102425260|NCT04912596|Adrenergic Agents|adrenergic agents|mesh-ancestor
102055944|NCT04704219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102425261|NCT04912596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102425262|NCT04912596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425263|NCT04912596|Miotics|miotics|mesh-ancestor
102425264|NCT04912596|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102425265|NCT04912596|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
102425266|NCT04912596|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102425267|NCT04912596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102425268|NCT04912596|Cholinergic Agents|cholinergic agents|mesh-ancestor
102425269|NCT04912596|Sympathomimetics|sympathomimetics|mesh-ancestor
102425270|NCT00936741|Mifepristone|mifepristone|mesh-list
102425271|NCT00936741|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102425272|NCT00936741|Abortifacient Agents|abortifacient agents|mesh-ancestor
102425273|NCT00936741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102425274|NCT00936741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425275|NCT00936741|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102425276|NCT00936741|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102425277|NCT00936741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102425278|NCT00936741|Contraceptive Agents|contraceptive agents|mesh-ancestor
102425279|NCT00936741|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102425280|NCT00936741|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102425281|NCT00936741|Hormone Antagonists|hormone antagonists|mesh-ancestor
102425282|NCT00936741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102425283|NCT00936741|Luteolytic Agents|luteolytic agents|mesh-ancestor
102425284|NCT00936741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102425285|NCT00936741|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102425286|NCT04024865|Domperidone|domperidone|mesh-list
102425287|NCT04024865|Antiemetics|antiemetics|mesh-ancestor
102425288|NCT04024865|Autonomic Agents|autonomic agents|mesh-ancestor
102425289|NCT04024865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102425290|NCT04024865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425291|NCT04024865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102425292|NCT04024865|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102425293|NCT04024865|Dopamine Agents|dopamine agents|mesh-ancestor
102425294|NCT04024865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102425295|NCT04024865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425296|NCT04024241|Cytarabine|cytarabine|mesh-list
102425297|NCT04024241|Mitoxantrone|mitoxantrone|mesh-list
102425298|NCT04024241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102425299|NCT04024241|Antimetabolites|antimetabolites|mesh-ancestor
102425300|NCT04024241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425301|NCT04024241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102425302|NCT04024241|Antiviral Agents|antiviral agents|mesh-ancestor
102425303|NCT04024241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102425304|NCT04024241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102425305|NCT04024241|Immunologic Factors|immunologic factors|mesh-ancestor
102425306|NCT04024241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425307|NCT04024241|Analgesics|analgesics|mesh-ancestor
102425308|NCT04024241|Sensory System Agents|sensory system agents|mesh-ancestor
102425309|NCT04024241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102425310|NCT04024241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102425311|NCT04024241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102425312|NCT04024241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102425313|NCT04996290|Ropivacaine|ropivacaine|mesh-list
102425314|NCT04996290|Anesthetics, Local|anesthetics, local|mesh-ancestor
102425315|NCT04996290|Anesthetics|anesthetics|mesh-ancestor
102425316|NCT04996290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102425317|NCT04996290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425318|NCT04996290|Sensory System Agents|sensory system agents|mesh-ancestor
102425319|NCT04996290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102425320|NCT04023617|Docetaxel|docetaxel|mesh-list
102425321|NCT04023617|Nivolumab|nivolumab|mesh-list
102425322|NCT04023617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102425323|NCT04023617|Tubulin Modulators|tubulin modulators|mesh-ancestor
102425324|NCT04023617|Antimitotic Agents|antimitotic agents|mesh-ancestor
102425325|NCT04023617|Mitosis Modulators|mitosis modulators|mesh-ancestor
102425326|NCT04023617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425327|NCT04023617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102425328|NCT04023617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102425329|NCT04023149|Aldesleukin|aldesleukin|mesh-list
102425330|NCT04023149|Interleukin-2|interleukin-2|mesh-list
102425331|NCT04023149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102425332|NCT04023149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102425333|NCT04023149|Analgesics|analgesics|mesh-ancestor
102425334|NCT04023149|Sensory System Agents|sensory system agents|mesh-ancestor
102425335|NCT04023149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102425336|NCT04023149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425338|NCT04023149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102425339|NCT04023149|Antiviral Agents|antiviral agents|mesh-ancestor
102425340|NCT04023149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102425341|NCT04023305|Sevoflurane|sevoflurane|mesh-list
102425342|NCT04023305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102425343|NCT04023305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102425344|NCT04023305|Anesthetics, General|anesthetics, general|mesh-ancestor
102425345|NCT04023305|Anesthetics|anesthetics|mesh-ancestor
102425346|NCT04023305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102425347|NCT04023305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425348|NCT04149275|Nivolumab|nivolumab|mesh-list
102425349|NCT04149275|Ipilimumab|ipilimumab|mesh-list
102425350|NCT04149275|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102425351|NCT04149275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102425352|NCT04149275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102425353|NCT04149275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102425354|NCT04149275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425355|NCT04149275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102425356|NCT04149275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102425357|NCT04148963|Loxapine|loxapine|mesh-list
102425358|NCT04148963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102425359|NCT04148963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102425360|NCT04148963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102425361|NCT04148963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425362|NCT04148963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102425363|NCT04148963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102425364|NCT04148963|Dopamine Agents|dopamine agents|mesh-ancestor
102425365|NCT04148963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102425366|NCT04148963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425367|NCT04022837|Pantoprazole|pantoprazole|mesh-list
102425368|NCT04022837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102425369|NCT04022837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102425370|NCT04022837|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102425371|NCT04022837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102425372|NCT04022837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425373|NCT04022993|Insulin Glargine|insulin glargine|mesh-list
102425374|NCT04022993|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102425375|NCT04022993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102425376|NCT04022993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425377|NCT04148885|Paclitaxel|paclitaxel|mesh-list
102425378|NCT04148885|Carboplatin|carboplatin|mesh-list
102425379|NCT04148885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102425380|NCT04148885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102425381|NCT04148885|Tubulin Modulators|tubulin modulators|mesh-ancestor
102425382|NCT04148885|Antimitotic Agents|antimitotic agents|mesh-ancestor
102425383|NCT04148885|Mitosis Modulators|mitosis modulators|mesh-ancestor
102425384|NCT04148885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425385|NCT04022525|Leflunomide|leflunomide|mesh-list
102425386|NCT04022525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102425387|NCT04022525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425388|NCT04022525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102425389|NCT04022525|Immunologic Factors|immunologic factors|mesh-ancestor
102425390|NCT04022525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425391|NCT04022291|Insulin|insulin|mesh-list
102425392|NCT04022291|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102425393|NCT04022291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102425394|NCT04022291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425395|NCT03074448|Picosulfate sodium|picosulfate sodium|mesh-list
102425396|NCT03074448|Cathartics|cathartics|mesh-ancestor
102425397|NCT03074448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102425398|NCT04021433|Ketamine|ketamine|mesh-list
102425399|NCT04021433|Analgesics|analgesics|mesh-ancestor
102425400|NCT04021433|Sensory System Agents|sensory system agents|mesh-ancestor
102425401|NCT04021433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102425402|NCT04021433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425403|NCT04021433|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102425404|NCT04021433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102425405|NCT04021433|Anesthetics, General|anesthetics, general|mesh-ancestor
102425406|NCT04021433|Anesthetics|anesthetics|mesh-ancestor
102425407|NCT04021433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102425408|NCT04021433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102425409|NCT04021433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102425410|NCT04021433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102237097|NCT03246451|Metformin|metformin|mesh-list
102425411|NCT04021433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425412|NCT04147481|Anesthetics|anesthetics|mesh-list
102425413|NCT04147481|Anesthetics, Local|anesthetics, local|mesh-list
102425414|NCT04147481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102425415|NCT04147481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425416|NCT04147481|Sensory System Agents|sensory system agents|mesh-ancestor
102425417|NCT04147481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102425418|NCT04148261|Hydrocortisone|hydrocortisone|mesh-list
102425419|NCT04148261|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102425420|NCT04148261|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102425421|NCT04148261|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102425422|NCT04148261|Epinephrine|epinephrine|mesh-list
102425423|NCT04148261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102425424|NCT04148261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102425425|NCT04148261|Adrenergic Agents|adrenergic agents|mesh-ancestor
102425426|NCT04148261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102425427|NCT04148261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425428|NCT04148261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425429|NCT04148261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102425430|NCT04148261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102425431|NCT04148261|Autonomic Agents|autonomic agents|mesh-ancestor
102425432|NCT04148261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102425433|NCT04148261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102425434|NCT04148261|Respiratory System Agents|respiratory system agents|mesh-ancestor
102425435|NCT04148261|Mydriatics|mydriatics|mesh-ancestor
102425436|NCT04148261|Sympathomimetics|sympathomimetics|mesh-ancestor
102425437|NCT04148261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102425438|NCT04148261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102425440|NCT03072264|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102425441|NCT03072264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102425442|NCT03072264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102425443|NCT03072264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425444|NCT03072264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102425445|NCT03072264|Serotonin Agents|serotonin agents|mesh-ancestor
102425446|NCT03072264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425447|NCT03072264|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102425448|NCT03072264|Antidepressive Agents|antidepressive agents|mesh-ancestor
102425449|NCT03072264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102425450|NCT03072264|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102425451|NCT03072264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102425452|NCT03072264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102425453|NCT04991064|Titanium dioxide|titanium dioxide|mesh-list
102425454|NCT04991064|Sunscreening Agents|sunscreening agents|mesh-ancestor
102425455|NCT04991064|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102425456|NCT04991064|Protective Agents|protective agents|mesh-ancestor
102425457|NCT04991064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425458|NCT04991064|Dermatologic Agents|dermatologic agents|mesh-ancestor
102425459|NCT04991064|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102425460|NCT00928083|Artefenomel|artefenomel|mesh-list
102425461|NCT00928083|Antimalarials|antimalarials|mesh-ancestor
102425462|NCT00928083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102425463|NCT00928083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102425464|NCT00928083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102425465|NCT04996446|Tislelizumab|tislelizumab|mesh-list
102425466|NCT04996446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102425467|NCT04996446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102425468|NCT04361721|Erenumab|erenumab|mesh-list
102425469|NCT04361721|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
102425470|NCT04361721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425471|NCT04361721|Analgesics|analgesics|mesh-ancestor
102425472|NCT04361721|Sensory System Agents|sensory system agents|mesh-ancestor
102425473|NCT04361721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102425474|NCT04361721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425475|NCT04361643|Lenalidomide|lenalidomide|mesh-list
102425476|NCT04361643|Immunologic Factors|immunologic factors|mesh-ancestor
102425477|NCT04361643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425478|NCT04361643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102425479|NCT04361643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102425480|NCT04361643|Growth Substances|growth substances|mesh-ancestor
102425481|NCT04361643|Growth Inhibitors|growth inhibitors|mesh-ancestor
102425482|NCT04361643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102237174|NCT03249259|Choline|choline|mesh-list
102425483|NCT04406051|Norepinephrine|norepinephrine|mesh-list
102425484|NCT04406051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102425485|NCT04406051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102425486|NCT04406051|Adrenergic Agents|adrenergic agents|mesh-ancestor
102425487|NCT04406051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102425488|NCT04406051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425489|NCT04406051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425490|NCT04406051|Sympathomimetics|sympathomimetics|mesh-ancestor
102425491|NCT04406051|Autonomic Agents|autonomic agents|mesh-ancestor
102425492|NCT04406051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102425493|NCT04406051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102425494|NCT04991298|Fentanyl|fentanyl|mesh-list
102425495|NCT04991298|Midazolam|midazolam|mesh-list
102425496|NCT04991298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102425497|NCT04991298|Narcotics|narcotics|mesh-ancestor
102425498|NCT04991298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102425499|NCT04991298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425500|NCT04991298|Analgesics|analgesics|mesh-ancestor
102425501|NCT04991298|Sensory System Agents|sensory system agents|mesh-ancestor
102425502|NCT04991298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102425503|NCT04991298|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102425504|NCT04991298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102425505|NCT04991298|Anesthetics, General|anesthetics, general|mesh-ancestor
102425506|NCT04991298|Anesthetics|anesthetics|mesh-ancestor
102425507|NCT04991298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102425508|NCT04991298|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102425509|NCT04991298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102425510|NCT04991298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102425511|NCT04991298|GABA Modulators|gaba modulators|mesh-ancestor
102425512|NCT04991298|GABA Agents|gaba agents|mesh-ancestor
102425513|NCT04991298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102425514|NCT04991298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425515|NCT04361175|Letrozole|letrozole|mesh-list
102425516|NCT04361175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425517|NCT04361175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102425518|NCT04361175|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102425519|NCT04361175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102425520|NCT04361175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102425521|NCT04361175|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102425522|NCT04361175|Hormone Antagonists|hormone antagonists|mesh-ancestor
102425523|NCT04361175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102425524|NCT04361175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425525|NCT04368819|Allopurinol|allopurinol|mesh-list
102425526|NCT04368819|Antimetabolites|antimetabolites|mesh-ancestor
102425527|NCT04368819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425528|NCT04368819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102425529|NCT04368819|Gout Suppressants|gout suppressants|mesh-ancestor
102425530|NCT04368819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102425531|NCT04368819|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102425532|NCT04368819|Antioxidants|antioxidants|mesh-ancestor
102425533|NCT04368819|Protective Agents|protective agents|mesh-ancestor
102425534|NCT04368819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425535|NCT04368585|Simethicone|simethicone|mesh-list
102425536|NCT04368585|Omeprazole|omeprazole|mesh-list
102425537|NCT04368585|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102425538|NCT04368585|Magnesium Hydroxide|magnesium hydroxide|mesh-list
102425539|NCT04368585|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
102425540|NCT04368585|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
102425542|NCT04368585|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102425543|NCT04368585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102425544|NCT04368585|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102425545|NCT04368585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102425546|NCT04368585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425547|NCT04368585|Antifoaming Agents|antifoaming agents|mesh-ancestor
102425548|NCT04368585|Emollients|emollients|mesh-ancestor
102425549|NCT04368585|Dermatologic Agents|dermatologic agents|mesh-ancestor
102425550|NCT04368585|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102425551|NCT04368585|Immunologic Factors|immunologic factors|mesh-ancestor
102425552|NCT04368585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425553|NCT04368585|Antacids|antacids|mesh-ancestor
102425554|NCT04368585|Antioxidants|antioxidants|mesh-ancestor
102425555|NCT04368585|Protective Agents|protective agents|mesh-ancestor
102425556|NCT04361331|Lenvatinib|lenvatinib|mesh-list
102425557|NCT04361331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102425558|NCT04361331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102425559|NCT04361331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102425560|NCT04361331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425561|NCT04990830|Heparin|heparin|mesh-list
102425562|NCT04990830|Enoxaparin|enoxaparin|mesh-list
102425563|NCT04990830|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102425564|NCT04990830|Tinzaparin|tinzaparin|mesh-list
102425565|NCT04990830|Dalteparin|dalteparin|mesh-list
102425566|NCT04990830|Enoxaparin sodium|enoxaparin sodium|mesh-list
102425567|NCT04990830|Anticoagulants|anticoagulants|mesh-ancestor
102425568|NCT04990830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102425569|NCT04990830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102425570|NCT04990830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425571|NCT04361409|Rituximab|rituximab|mesh-list
102425572|NCT04361409|Gemcitabine|gemcitabine|mesh-list
102425573|NCT04361409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102425574|NCT04361409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102425575|NCT04361409|Immunologic Factors|immunologic factors|mesh-ancestor
102425576|NCT04361409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425577|NCT04361409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102425578|NCT04361409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102425579|NCT04361409|Antimetabolites|antimetabolites|mesh-ancestor
102425580|NCT04361409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425581|NCT04368273|Antibodies|antibodies|mesh-list
102425582|NCT04368273|Immunologic Factors|immunologic factors|mesh-ancestor
102425583|NCT04368273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425584|NCT04995354|Mitogens|mitogens|mesh-list
102425585|NCT04995354|Mitosis Modulators|mitosis modulators|mesh-ancestor
102425586|NCT04995354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425587|NCT04368351|Azithromycin|azithromycin|mesh-list
102425588|NCT04368351|Hydroxychloroquine|hydroxychloroquine|mesh-list
102425589|NCT04368351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102425590|NCT04368351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102425591|NCT04368351|Antimalarials|antimalarials|mesh-ancestor
102425592|NCT04368351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102425593|NCT04368351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102425594|NCT04368351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102425595|NCT04368351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425596|NCT04368351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102425597|NCT04360785|Methotrexate|methotrexate|mesh-list
102425598|NCT04360785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102425599|NCT04360785|Abortifacient Agents|abortifacient agents|mesh-ancestor
102425600|NCT04360785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102425601|NCT04360785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425602|NCT04360785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102425603|NCT04360785|Antimetabolites|antimetabolites|mesh-ancestor
102425604|NCT04360785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425605|NCT04360785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102425606|NCT04360785|Dermatologic Agents|dermatologic agents|mesh-ancestor
102425607|NCT04360785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102425608|NCT04360785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102425609|NCT04360785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102425610|NCT04360785|Immunologic Factors|immunologic factors|mesh-ancestor
102425611|NCT04360785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102425612|NCT04360785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102425613|NCT04360317|Docetaxel|docetaxel|mesh-list
102425614|NCT04360317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102425615|NCT04360317|Tubulin Modulators|tubulin modulators|mesh-ancestor
102425616|NCT04360317|Antimitotic Agents|antimitotic agents|mesh-ancestor
102425617|NCT04360317|Mitosis Modulators|mitosis modulators|mesh-ancestor
102425618|NCT04360317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425619|NCT03074136|Sodium Hypochlorite|sodium hypochlorite|mesh-list
102425620|NCT03074136|Eusol|eusol|mesh-list
102425621|NCT03074136|Disinfectants|disinfectants|mesh-ancestor
102425622|NCT03074136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102425623|NCT04146155|Liraglutide|liraglutide|mesh-list
102425624|NCT04146155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102425625|NCT04146155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425626|NCT04146155|Incretins|incretins|mesh-ancestor
102425627|NCT04146155|Hormones|hormones|mesh-ancestor
102425628|NCT04146155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102425629|NCT04990752|Urinastatin|urinastatin|mesh-list
102425630|NCT04990752|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102425631|NCT04990752|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102425632|NCT04990752|Protease Inhibitors|protease inhibitors|mesh-ancestor
102425633|NCT04990752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102425634|NCT04990752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425635|NCT02245191|Phenylephrine|phenylephrine|mesh-list
102425636|NCT02245191|Oxymetazoline|oxymetazoline|mesh-list
102425637|NCT02245191|Ephedrine|ephedrine|mesh-list
102425638|NCT02245191|Metaraminol|metaraminol|mesh-list
102425639|NCT02245191|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102425640|NCT02245191|Mydriatics|mydriatics|mesh-ancestor
102425641|NCT02245191|Autonomic Agents|autonomic agents|mesh-ancestor
102425642|NCT02245191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102425643|NCT02245191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425644|NCT02245191|Sympathomimetics|sympathomimetics|mesh-ancestor
102425645|NCT02245191|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102425646|NCT02245191|Nasal Decongestants|nasal decongestants|mesh-ancestor
102425647|NCT02245191|Respiratory System Agents|respiratory system agents|mesh-ancestor
102425648|NCT02245191|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102425649|NCT02245191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102425650|NCT02245191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102425651|NCT02245191|Adrenergic Agents|adrenergic agents|mesh-ancestor
102425652|NCT02245191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102425653|NCT02245191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425654|NCT02245191|Protective Agents|protective agents|mesh-ancestor
102425655|NCT02245191|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102425656|NCT04145921|Tacrine|tacrine|mesh-list
102425657|NCT04145921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102425658|NCT04145921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102425659|NCT04145921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425660|NCT04145921|Cholinergic Agents|cholinergic agents|mesh-ancestor
102425661|NCT04145921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102425662|NCT04145921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425663|NCT04145921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102425664|NCT04145921|Autonomic Agents|autonomic agents|mesh-ancestor
102425665|NCT04145921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102425666|NCT04145921|Nootropic Agents|nootropic agents|mesh-ancestor
102425667|NCT04145687|Metformin|metformin|mesh-list
102425668|NCT04145687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102425669|NCT04145687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425670|NCT04359615|Hydroxychloroquine|hydroxychloroquine|mesh-list
102425671|NCT04359615|Favipiravir|favipiravir|mesh-list
102425672|NCT04359615|Antimalarials|antimalarials|mesh-ancestor
102425673|NCT04359615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102425674|NCT04359615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102425675|NCT04359615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102425676|NCT04359615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102425677|NCT04359615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425678|NCT04359615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102425679|NCT04359615|Antiviral Agents|antiviral agents|mesh-ancestor
102425680|NCT02635386|Metformin|metformin|mesh-list
102425681|NCT02635386|Dapagliflozin|dapagliflozin|mesh-list
102425682|NCT02635386|Exenatide|exenatide|mesh-list
102425683|NCT02635386|Topiramate|topiramate|mesh-list
102425684|NCT02635386|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102425685|NCT02635386|Phentermine|phentermine|mesh-list
102425686|NCT02635386|Glucagon|glucagon|mesh-list
102425687|NCT02635386|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102425688|NCT02635386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102425689|NCT02635386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425690|NCT02635386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425691|NCT02635386|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102425692|NCT02635386|Incretins|incretins|mesh-ancestor
102425693|NCT02635386|Hormones|hormones|mesh-ancestor
102425694|NCT02635386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102425695|NCT02635386|Anticonvulsants|anticonvulsants|mesh-ancestor
102425696|NCT02635386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102425697|NCT02635386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102425698|NCT02635386|Appetite Depressants|appetite depressants|mesh-ancestor
102425699|NCT02635386|Sympathomimetics|sympathomimetics|mesh-ancestor
102425700|NCT02635386|Autonomic Agents|autonomic agents|mesh-ancestor
102425701|NCT02635386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102425702|NCT02635386|Adrenergic Agents|adrenergic agents|mesh-ancestor
102425703|NCT02635386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102425704|NCT03924947|Pancrelipase|pancrelipase|mesh-list
102425705|NCT03924947|Pancreatin|pancreatin|mesh-list
102425706|NCT03924947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102425707|NCT00934635|Risperidone|risperidone|mesh-list
102425708|NCT00934635|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102425709|NCT00934635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102425710|NCT00934635|Serotonin Agents|serotonin agents|mesh-ancestor
102425711|NCT00934635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102425712|NCT00934635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425713|NCT00934635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425714|NCT00934635|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102425715|NCT00934635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102425716|NCT00934635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102425717|NCT00934635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102425718|NCT00934635|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102425719|NCT00934635|Dopamine Agents|dopamine agents|mesh-ancestor
102425720|NCT00934635|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102425721|NCT00934635|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102425722|NCT04359537|Hydroxychloroquine|hydroxychloroquine|mesh-list
102425723|NCT04359537|Antimalarials|antimalarials|mesh-ancestor
102425724|NCT04359537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102425725|NCT04359537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102425726|NCT04359537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102425727|NCT04359537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102425728|NCT04359537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425729|NCT04359537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102425730|NCT03922997|Atezolizumab|atezolizumab|mesh-list
102425731|NCT03922997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102425732|NCT03922997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425733|NCT03922997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102425734|NCT03922997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102425735|NCT04356417|Antimalarials|antimalarials|mesh-list
102425736|NCT04356417|Enzyme Inhibitors|enzyme inhibitors|mesh-list
102425737|NCT04356417|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
102425738|NCT04356417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425739|NCT04356417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102425740|NCT04356417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102425741|NCT04356417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102425742|NCT04355949|Vitamin D|vitamin d|mesh-list
102425743|NCT04355949|Ergocalciferols|ergocalciferols|mesh-list
102425744|NCT04355949|Cholecalciferol|cholecalciferol|mesh-list
102425745|NCT04355949|Vitamins|vitamins|mesh-list
102425746|NCT04355949|Folic Acid|folic acid|mesh-list
102425747|NCT04355949|Vitamin B 12|vitamin b 12|mesh-list
102425748|NCT04355949|Hydroxocobalamin|hydroxocobalamin|mesh-list
102425749|NCT04355949|Vitamin B Complex|vitamin b complex|mesh-list
102425750|NCT04355949|Micronutrients|micronutrients|mesh-ancestor
102425751|NCT04355949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425752|NCT04355949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102425753|NCT04355949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102425754|NCT04355949|Hematinics|hematinics|mesh-ancestor
102425755|NCT05580887|Paclitaxel|paclitaxel|mesh-list
102425756|NCT05580887|Cyclophosphamide|cyclophosphamide|mesh-list
102425757|NCT05580887|Carboplatin|carboplatin|mesh-list
102425758|NCT05580887|Doxorubicin|doxorubicin|mesh-list
102425759|NCT05580887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102425760|NCT05580887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102425761|NCT05580887|Tubulin Modulators|tubulin modulators|mesh-ancestor
102425762|NCT05580887|Antimitotic Agents|antimitotic agents|mesh-ancestor
102425763|NCT05580887|Mitosis Modulators|mitosis modulators|mesh-ancestor
102425764|NCT05580887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425765|NCT05580887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102425766|NCT05580887|Immunologic Factors|immunologic factors|mesh-ancestor
102425767|NCT05580887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425768|NCT05580887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102425769|NCT05580887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102425770|NCT05580887|Alkylating Agents|alkylating agents|mesh-ancestor
102425771|NCT05580887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102425772|NCT05580887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102425773|NCT05580887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102425774|NCT05580887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102425775|NCT05580887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102425776|NCT04994262|Menthol|menthol|mesh-list
102425777|NCT04994262|Antipruritics|antipruritics|mesh-ancestor
102425778|NCT04994262|Dermatologic Agents|dermatologic agents|mesh-ancestor
102425779|NCT00939159|Panobinostat|panobinostat|mesh-list
102425780|NCT00939159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102425781|NCT00939159|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102425782|NCT00939159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102425783|NCT00939159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425784|NCT05620641|Gabapentin|gabapentin|mesh-list
102425785|NCT05620641|Ondansetron|ondansetron|mesh-list
102425786|NCT05620641|Analgesics|analgesics|mesh-ancestor
102425787|NCT05620641|Sensory System Agents|sensory system agents|mesh-ancestor
102425788|NCT05620641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102425789|NCT05620641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425790|NCT05620641|Anticonvulsants|anticonvulsants|mesh-ancestor
102425791|NCT05620641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102425792|NCT05620641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102425793|NCT05620641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102425794|NCT05620641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102425795|NCT05620641|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102425796|NCT05620641|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102425797|NCT05620641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102056478|NCT03110848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102425798|NCT05620641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425799|NCT05620641|Antimanic Agents|antimanic agents|mesh-ancestor
102425800|NCT05620641|Antiemetics|antiemetics|mesh-ancestor
102425801|NCT05620641|Autonomic Agents|autonomic agents|mesh-ancestor
102425802|NCT05620641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102425803|NCT05620641|Antipruritics|antipruritics|mesh-ancestor
102425804|NCT05620641|Dermatologic Agents|dermatologic agents|mesh-ancestor
102425805|NCT05620641|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102425806|NCT05620641|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102425807|NCT05620641|Serotonin Agents|serotonin agents|mesh-ancestor
102425808|NCT04144439|Butyric Acid|butyric acid|mesh-list
102425809|NCT04144439|Histamine Antagonists|histamine antagonists|mesh-ancestor
102425810|NCT04144439|Histamine Agents|histamine agents|mesh-ancestor
102425811|NCT04144439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102425812|NCT04144439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425813|NCT04144439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425814|NCT04994574|Tiotropium Bromide|tiotropium bromide|mesh-list
102425815|NCT04994574|Olodaterol|olodaterol|mesh-list
102425816|NCT04994574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102425817|NCT04994574|Autonomic Agents|autonomic agents|mesh-ancestor
102425818|NCT04994574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102425819|NCT04994574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425820|NCT04994574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102425821|NCT04994574|Respiratory System Agents|respiratory system agents|mesh-ancestor
102425822|NCT04994574|Parasympatholytics|parasympatholytics|mesh-ancestor
102425823|NCT04994574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102425824|NCT04994574|Cholinergic Agents|cholinergic agents|mesh-ancestor
102425825|NCT04994574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102425826|NCT04994574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425827|NCT04355637|Budesonide|budesonide|mesh-list
102425828|NCT04355637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102425829|NCT04355637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102425830|NCT04355637|Autonomic Agents|autonomic agents|mesh-ancestor
102425831|NCT04355637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102425832|NCT04355637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425833|NCT04355637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102425834|NCT04355637|Respiratory System Agents|respiratory system agents|mesh-ancestor
102425835|NCT04355637|Glucocorticoids|glucocorticoids|mesh-ancestor
102425836|NCT04355637|Hormones|hormones|mesh-ancestor
102425837|NCT04355637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102425838|NCT04367025|Oxaliplatin|oxaliplatin|mesh-list
102425839|NCT04367025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102425840|NCT03076710|Bupivacaine|bupivacaine|mesh-list
102425841|NCT03076710|Anesthetics, Local|anesthetics, local|mesh-ancestor
102425842|NCT03076710|Anesthetics|anesthetics|mesh-ancestor
102425843|NCT03076710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102425844|NCT03076710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425845|NCT03076710|Sensory System Agents|sensory system agents|mesh-ancestor
102425846|NCT03076710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102425847|NCT04143581|Empagliflozin|empagliflozin|mesh-list
102425848|NCT04143581|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102425849|NCT04143581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425850|NCT04143581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102425851|NCT04143581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425852|NCT03071172|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102425853|NCT03071172|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102425854|NCT03071172|Progesterone|progesterone|mesh-list
102425855|NCT03071172|Hormones|hormones|mesh-ancestor
102425856|NCT03071172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102425857|NCT03071172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425858|NCT03071172|Progestins|progestins|mesh-ancestor
102425859|NCT03071172|Luteolytic Agents|luteolytic agents|mesh-ancestor
102425860|NCT03071172|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102425861|NCT03071172|Contraceptive Agents|contraceptive agents|mesh-ancestor
102425862|NCT03071172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102425863|NCT03071172|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102425864|NCT03071172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102425865|NCT03071172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102425866|NCT03070938|Anti-Infective Agents|anti-infective agents|mesh-list
102425867|NCT03070938|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102425868|NCT04143815|Botulinum Toxins|botulinum toxins|mesh-list
102425869|NCT04143815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102425870|NCT04143815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102425871|NCT04143815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102425872|NCT04143815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102425873|NCT04143815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425874|NCT04143815|Cholinergic Agents|cholinergic agents|mesh-ancestor
102425875|NCT04143815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102425876|NCT04143815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425877|NCT04143815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102425878|NCT04143815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102425879|NCT04355247|Methylprednisolone|methylprednisolone|mesh-list
102425880|NCT04355247|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102425881|NCT04355247|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102425882|NCT04355247|Prednisolone|prednisolone|mesh-list
102425883|NCT04355247|Prednisolone acetate|prednisolone acetate|mesh-list
102425884|NCT04355247|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102425885|NCT04355247|Prednisolone phosphate|prednisolone phosphate|mesh-list
102425886|NCT04355247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102425887|NCT04355247|Antiemetics|antiemetics|mesh-ancestor
102425888|NCT04355247|Autonomic Agents|autonomic agents|mesh-ancestor
102425889|NCT04355247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102425890|NCT04355247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425891|NCT04355247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102425892|NCT04355247|Glucocorticoids|glucocorticoids|mesh-ancestor
102425893|NCT04355247|Hormones|hormones|mesh-ancestor
102425894|NCT04355247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102425895|NCT04355247|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102425896|NCT04355247|Protective Agents|protective agents|mesh-ancestor
102425897|NCT04355247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102425898|NCT04355247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102425899|NCT03903809|Epoetin Alfa|epoetin alfa|mesh-list
102425900|NCT03903809|Hematinics|hematinics|mesh-ancestor
102425901|NCT04987554|Immunoferon|immunoferon|mesh-list
102425902|NCT04987554|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102425903|NCT04987554|Immunologic Factors|immunologic factors|mesh-ancestor
102425904|NCT04987554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425905|NCT04358367|Dexmedetomidine|dexmedetomidine|mesh-list
102425906|NCT04358367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102425907|NCT04358367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102425908|NCT04358367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425909|NCT04358367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102425910|NCT04358367|Analgesics|analgesics|mesh-ancestor
102425911|NCT04358367|Sensory System Agents|sensory system agents|mesh-ancestor
102425912|NCT04358367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102425913|NCT04358367|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102425914|NCT04358367|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102425915|NCT04358367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102425916|NCT04358367|Adrenergic Agents|adrenergic agents|mesh-ancestor
102425917|NCT04358367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102425918|NCT04358367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425919|NCT04358523|Sofosbuvir|sofosbuvir|mesh-list
102425920|NCT04358523|Antiviral Agents|antiviral agents|mesh-ancestor
102425921|NCT04358523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102425922|NCT00936663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102425923|NCT00936663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102425924|NCT00936663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425925|NCT00936663|Incretins|incretins|mesh-ancestor
102425926|NCT00936663|Hormones|hormones|mesh-ancestor
102425927|NCT00936663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102425928|NCT00936663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102425929|NCT00936663|Protease Inhibitors|protease inhibitors|mesh-ancestor
102425930|NCT00936663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102425931|NCT00936663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425932|NCT03917303|Adalimumab|adalimumab|mesh-list
102425933|NCT03917303|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102425934|NCT03917303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102425935|NCT03917303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102425936|NCT03070860|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102425937|NCT03070860|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102425938|NCT03070860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237621|NCT03246685|Pembrolizumab|pembrolizumab|mesh-list
102425939|NCT05583149|Cyclophosphamide|cyclophosphamide|mesh-list
102425940|NCT05583149|Fludarabine|fludarabine|mesh-list
102425941|NCT05583149|Acalabrutinib|acalabrutinib|mesh-list
102425942|NCT05583149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102425943|NCT05583149|Immunologic Factors|immunologic factors|mesh-ancestor
102425944|NCT05583149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425945|NCT05583149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102425946|NCT05583149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102425947|NCT05583149|Alkylating Agents|alkylating agents|mesh-ancestor
102425948|NCT05583149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425949|NCT05583149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102425950|NCT05583149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102425951|NCT04366869|Salicylic Acid|salicylic acid|mesh-list
102425952|NCT04366869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102425953|NCT04366869|Antifungal Agents|antifungal agents|mesh-ancestor
102425954|NCT04366869|Keratolytic Agents|keratolytic agents|mesh-ancestor
102425955|NCT04366869|Dermatologic Agents|dermatologic agents|mesh-ancestor
102425956|NCT04989270|Anesthetics|anesthetics|mesh-list
102425957|NCT04989270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102425958|NCT04989270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425959|NCT04989348|Hormones|hormones|mesh-list
102425960|NCT04989348|Progestins|progestins|mesh-list
102425961|NCT04989348|Hormone Antagonists|hormone antagonists|mesh-list
102425962|NCT04989348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102425963|NCT04989348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425964|NCT04346823|Sevoflurane|sevoflurane|mesh-list
102425965|NCT04346823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102425966|NCT04346823|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102425967|NCT04346823|Anesthetics, General|anesthetics, general|mesh-ancestor
102425968|NCT04346823|Anesthetics|anesthetics|mesh-ancestor
102425969|NCT04346823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102425970|NCT04346823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425971|NCT05582837|Topiramate|topiramate|mesh-list
102425972|NCT05582837|Nortriptyline|nortriptyline|mesh-list
102425973|NCT05582837|Anticonvulsants|anticonvulsants|mesh-ancestor
102425974|NCT05582837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102425975|NCT05582837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102425976|NCT05582837|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102425977|NCT05582837|Antidepressive Agents|antidepressive agents|mesh-ancestor
102425978|NCT05582837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102425979|NCT05582837|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102425980|NCT05582837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102425981|NCT05582837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102425982|NCT05582837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425983|NCT05582837|Adrenergic Agents|adrenergic agents|mesh-ancestor
102425984|NCT05582837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102425985|NCT04728633|Carmustine|carmustine|mesh-list
102425986|NCT04728633|Ethiodized Oil|ethiodized oil|mesh-list
102425987|NCT04728633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102425988|NCT04728633|Alkylating Agents|alkylating agents|mesh-ancestor
102425989|NCT04728633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425990|NCT04728633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102425991|NCT05003700|Lenvatinib|lenvatinib|mesh-list
102425992|NCT05003700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102425993|NCT05003700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102425994|NCT05003700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102425995|NCT05003700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102425996|NCT04143191|Sorafenib|sorafenib|mesh-list
102425997|NCT04143191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102425998|NCT04143191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102425999|NCT04143191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102426000|NCT04143191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426001|NCT03647657|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102426002|NCT03647657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102426003|NCT03647657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426004|NCT04461288|Nicotine|nicotine|mesh-list
102426005|NCT04461288|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102426006|NCT04461288|Autonomic Agents|autonomic agents|mesh-ancestor
102426007|NCT04461288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102426008|NCT04461288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426009|NCT04461288|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102426010|NCT04461288|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102426011|NCT04461288|Cholinergic Agents|cholinergic agents|mesh-ancestor
102237698|NCT03234673|Dermatologic Agents|dermatologic agents|mesh-ancestor
102426012|NCT04461288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102426013|NCT04461288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426014|NCT05582135|Morphine|morphine|mesh-list
102426015|NCT05582135|Esketamine|esketamine|mesh-list
102426016|NCT05582135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102426017|NCT05582135|Narcotics|narcotics|mesh-ancestor
102426018|NCT05582135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102426019|NCT05582135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426020|NCT05582135|Analgesics|analgesics|mesh-ancestor
102426021|NCT05582135|Sensory System Agents|sensory system agents|mesh-ancestor
102426022|NCT05582135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102426023|NCT05582135|Antidepressive Agents|antidepressive agents|mesh-ancestor
102426024|NCT05582135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102426025|NCT03070704|Liraglutide|liraglutide|mesh-list
102426026|NCT03070704|Xultophy|xultophy|mesh-list
102426027|NCT03070704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102426028|NCT03070704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426029|NCT03070704|Incretins|incretins|mesh-ancestor
102426030|NCT03070704|Hormones|hormones|mesh-ancestor
102426031|NCT03070704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102426032|NCT03069768|Varenicline|varenicline|mesh-list
102426033|NCT03069768|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102426034|NCT03069768|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102426035|NCT03069768|Cholinergic Agents|cholinergic agents|mesh-ancestor
102426036|NCT03069768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102426037|NCT03069768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056713|NCT03140332|Sorafenib|sorafenib|mesh-list
102426038|NCT03069768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426039|NCT04141553|Diltiazem|diltiazem|mesh-list
102426040|NCT04141553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102426041|NCT04141553|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102426042|NCT04141553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102426043|NCT04141553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426044|NCT04141553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102426045|NCT04141553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426046|NCT04141553|Vasodilator Agents|vasodilator agents|mesh-ancestor
102426047|NCT04141163|Metformin|metformin|mesh-list
102426048|NCT04141163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102426049|NCT04141163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426050|NCT00942825|Cisplatin|cisplatin|mesh-list
102426051|NCT00942825|Pemetrexed|pemetrexed|mesh-list
102426052|NCT00942825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102426053|NCT00942825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102426054|NCT00942825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426055|NCT00942825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102426056|NCT00942825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102426057|NCT04544943|Gentamicins|gentamicins|mesh-list
102426058|NCT04544943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102426059|NCT04544943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102426060|NCT04544943|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102426061|NCT04544943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102426062|NCT04544943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426063|NCT04140461|Amphotericin B|amphotericin b|mesh-list
102426064|NCT04140461|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102426065|NCT04140461|Flucytosine|flucytosine|mesh-list
102426066|NCT04140461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102426067|NCT04140461|Amebicides|amebicides|mesh-ancestor
102426068|NCT04140461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102426069|NCT04140461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102426070|NCT04140461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102056787|NCT00089245|Iodine|iodine|mesh-list
102426071|NCT04140461|Antifungal Agents|antifungal agents|mesh-ancestor
102426072|NCT04140461|Antimetabolites|antimetabolites|mesh-ancestor
102426073|NCT04140461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426074|NCT03021629|Vitamin D|vitamin d|mesh-list
102426075|NCT03021629|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
102426076|NCT03021629|Vitamins|vitamins|mesh-ancestor
102426077|NCT03021629|Micronutrients|micronutrients|mesh-ancestor
102426078|NCT03021629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426079|NCT03021629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102426080|NCT03021395|Decitabine|decitabine|mesh-list
102426081|NCT03021395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102426082|NCT03021395|Antimetabolites|antimetabolites|mesh-ancestor
102426083|NCT03021395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426084|NCT03021395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102426085|NCT03021395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102426086|NCT03021317|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102426087|NCT03021317|Hormones|hormones|mesh-ancestor
102426088|NCT03021317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102426089|NCT03021317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426090|NCT04987632|Letrozole|letrozole|mesh-list
102426091|NCT04987632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102426092|NCT04987632|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102426093|NCT04987632|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102426094|NCT04987632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102426095|NCT04987632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426096|NCT04987632|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102426097|NCT04987632|Hormone Antagonists|hormone antagonists|mesh-ancestor
102426098|NCT04987632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102426099|NCT04987632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426100|NCT03032367|Bedaquiline|bedaquiline|mesh-list
102426101|NCT03032367|Antitubercular Agents|antitubercular agents|mesh-ancestor
102426102|NCT03032367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102426103|NCT03032367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102426104|NCT02634606|Tocotrienols|tocotrienols|mesh-list
102426105|NCT02634606|Vitamin E|vitamin e|mesh-list
102426106|NCT02634606|Tocopherols|tocopherols|mesh-list
102426107|NCT02634606|Antioxidants|antioxidants|mesh-ancestor
102426108|NCT02634606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426109|NCT02634606|Protective Agents|protective agents|mesh-ancestor
102426110|NCT02634606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426111|NCT02634606|Vitamins|vitamins|mesh-ancestor
102426112|NCT02634606|Micronutrients|micronutrients|mesh-ancestor
102426113|NCT05002686|Paclitaxel|paclitaxel|mesh-list
102426114|NCT05002686|Capecitabine|capecitabine|mesh-list
102426115|NCT05002686|Oxaliplatin|oxaliplatin|mesh-list
102426116|NCT05002686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102426117|NCT05002686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102426118|NCT05002686|Tubulin Modulators|tubulin modulators|mesh-ancestor
102426119|NCT05002686|Antimitotic Agents|antimitotic agents|mesh-ancestor
102426120|NCT05002686|Mitosis Modulators|mitosis modulators|mesh-ancestor
102426121|NCT05002686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426122|NCT05002686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102056820|NCT03632317|Everolimus|everolimus|mesh-list
102426123|NCT05002686|Antimetabolites|antimetabolites|mesh-ancestor
102426124|NCT03588689|Ropivacaine|ropivacaine|mesh-list
102426125|NCT03588689|Anesthetics, Local|anesthetics, local|mesh-ancestor
102426126|NCT03588689|Anesthetics|anesthetics|mesh-ancestor
102426127|NCT03588689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102426128|NCT03588689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426129|NCT03588689|Sensory System Agents|sensory system agents|mesh-ancestor
102426130|NCT03588689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102426131|NCT04985526|Octenidine|octenidine|mesh-list
102426132|NCT04985526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102426133|NCT04985526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102426134|NCT03588611|Hirudins|hirudins|mesh-list
102426135|NCT03588611|Bivalirudin|bivalirudin|mesh-list
102426136|NCT03588611|Antithrombins|antithrombins|mesh-ancestor
102426137|NCT03588611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102426138|NCT03588611|Protease Inhibitors|protease inhibitors|mesh-ancestor
102426139|NCT03588611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102426140|NCT03588611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426141|NCT03588611|Anticoagulants|anticoagulants|mesh-ancestor
102426142|NCT03588611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102426143|NCT03588611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102426144|NCT03588533|Capecitabine|capecitabine|mesh-list
102426145|NCT03588533|Trastuzumab|trastuzumab|mesh-list
102426146|NCT03588533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102426147|NCT03588533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102426148|NCT03588533|Antimetabolites|antimetabolites|mesh-ancestor
102426149|NCT03588533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426150|NCT03588533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102426151|NCT03068442|Flutemetamol|flutemetamol|mesh-list
102426152|NCT03068442|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102426153|NCT03068442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426154|NCT00939705|Topiramate|topiramate|mesh-list
102426155|NCT00939705|Anticonvulsants|anticonvulsants|mesh-ancestor
102426156|NCT00939705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102426157|NCT00939705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426158|NCT05001672|Tenofovir|tenofovir|mesh-list
102426159|NCT05001672|Antiviral Agents|antiviral agents|mesh-ancestor
102426160|NCT05001672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102426161|NCT05001672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102426162|NCT05001672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102426163|NCT05001672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102426164|NCT05001672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426165|NCT05001672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102426166|NCT05001672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102426167|NCT04354545|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102426169|NCT04354545|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102426170|NCT03587285|Goserelin|goserelin|mesh-list
102426171|NCT03587285|Abiraterone Acetate|abiraterone acetate|mesh-list
102426172|NCT03587285|Bicalutamide|bicalutamide|mesh-list
102426173|NCT03587285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102426174|NCT03587285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102426175|NCT03587285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102426176|NCT03587285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102426177|NCT03587285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426178|NCT03587285|Hormone Antagonists|hormone antagonists|mesh-ancestor
102426179|NCT03587285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102426180|NCT03587285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426181|NCT03587285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102426182|NCT03587285|Androgen Antagonists|androgen antagonists|mesh-ancestor
102426183|NCT03587129|Apatinib|apatinib|mesh-list
102426184|NCT03587129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102426185|NCT03587129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102426186|NCT03587129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102426187|NCT03587129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426188|NCT02245503|Tamsulosin|tamsulosin|mesh-list
102426189|NCT02245503|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102426190|NCT02245503|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102426191|NCT02245503|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102426192|NCT02245503|Adrenergic Agents|adrenergic agents|mesh-ancestor
102426193|NCT02245503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102426194|NCT02245503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426195|NCT02245503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426196|NCT02245503|Urological Agents|urological agents|mesh-ancestor
102426197|NCT03586817|Palonosetron|palonosetron|mesh-list
102426198|NCT03586817|Fosaprepitant|fosaprepitant|mesh-list
102426199|NCT03586817|Aprepitant|aprepitant|mesh-list
102426200|NCT03586817|Antiemetics|antiemetics|mesh-ancestor
102426201|NCT03586817|Autonomic Agents|autonomic agents|mesh-ancestor
102426202|NCT03586817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102426203|NCT03586817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426204|NCT03586817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102426205|NCT03586817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102426206|NCT03586817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102426207|NCT03586817|Serotonin Agents|serotonin agents|mesh-ancestor
102426208|NCT03586817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102426209|NCT03586817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426210|NCT03586817|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102426211|NCT03891173|Vinorelbine|vinorelbine|mesh-list
102426212|NCT03891173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102426213|NCT03891173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102426214|NCT03891173|Tubulin Modulators|tubulin modulators|mesh-ancestor
102426215|NCT03891173|Antimitotic Agents|antimitotic agents|mesh-ancestor
102426216|NCT03891173|Mitosis Modulators|mitosis modulators|mesh-ancestor
102426217|NCT03891173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426218|NCT03585725|Ribavirin|ribavirin|mesh-list
102426219|NCT03585725|Antimetabolites|antimetabolites|mesh-ancestor
102426220|NCT03585725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426221|NCT03585725|Antiviral Agents|antiviral agents|mesh-ancestor
102426222|NCT03585725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102426223|NCT03585569|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102426224|NCT03585569|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102426225|NCT03585569|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102426226|NCT03585569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102426227|NCT03585569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426228|NCT03585569|Cholinergic Agents|cholinergic agents|mesh-ancestor
102426229|NCT03585569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102426230|NCT03585569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426231|NCT03585569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102426232|NCT03585569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102426233|NCT03585179|Tranexamic Acid|tranexamic acid|mesh-list
102426234|NCT03585179|Hydroquinone|hydroquinone|mesh-list
102426235|NCT03585179|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102426236|NCT03585179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102426237|NCT03585179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426239|NCT03585179|Coagulants|coagulants|mesh-ancestor
102426240|NCT03585179|Antioxidants|antioxidants|mesh-ancestor
102426241|NCT03585179|Protective Agents|protective agents|mesh-ancestor
102426242|NCT03585179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426243|NCT03585179|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102426244|NCT03585101|Grazoprevir|grazoprevir|mesh-list
102426245|NCT03585101|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
102426246|NCT03585101|Antiviral Agents|antiviral agents|mesh-ancestor
102426247|NCT03585101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102426248|NCT03584087|Terlipressin|terlipressin|mesh-list
102426249|NCT03584087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102426250|NCT03584087|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102426251|NCT03834363|Fentanyl|fentanyl|mesh-list
102426252|NCT03834363|Morphine|morphine|mesh-list
102426253|NCT03834363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102426254|NCT03834363|Narcotics|narcotics|mesh-ancestor
102426255|NCT03834363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102426256|NCT03834363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426257|NCT03834363|Analgesics|analgesics|mesh-ancestor
102426258|NCT03834363|Sensory System Agents|sensory system agents|mesh-ancestor
102426259|NCT03834363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102426260|NCT03834363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102426261|NCT03834363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102426262|NCT03834363|Anesthetics, General|anesthetics, general|mesh-ancestor
102426263|NCT03834363|Anesthetics|anesthetics|mesh-ancestor
102426264|NCT03031353|Misoprostol|misoprostol|mesh-list
102426265|NCT03031353|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102426266|NCT03031353|Abortifacient Agents|abortifacient agents|mesh-ancestor
102426267|NCT03031353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102426268|NCT03031353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426269|NCT03031353|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102426270|NCT03031353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102426271|NCT03031353|Oxytocics|oxytocics|mesh-ancestor
102426272|NCT05702957|Letrozole|letrozole|mesh-list
102426273|NCT05702957|Clomiphene|clomiphene|mesh-list
102426274|NCT05702957|Enclomiphene|enclomiphene|mesh-list
102426275|NCT05702957|Zuclomiphene|zuclomiphene|mesh-list
102426276|NCT05702957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426277|NCT05702957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102426278|NCT05702957|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102426279|NCT05702957|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102426280|NCT05702957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102426281|NCT05702957|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102426282|NCT05702957|Hormone Antagonists|hormone antagonists|mesh-ancestor
102426283|NCT05702957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102426284|NCT05702957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426285|NCT05702957|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102426286|NCT05702957|Fertility Agents|fertility agents|mesh-ancestor
102426287|NCT05702957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102426288|NCT05702957|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102426289|NCT05702957|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102426290|NCT04405505|Paclitaxel|paclitaxel|mesh-list
102426291|NCT04405505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102426292|NCT04405505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102426293|NCT04405505|Tubulin Modulators|tubulin modulators|mesh-ancestor
102426294|NCT04405505|Antimitotic Agents|antimitotic agents|mesh-ancestor
102426295|NCT04405505|Mitosis Modulators|mitosis modulators|mesh-ancestor
102426296|NCT04405505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426297|NCT03580733|Caspofungin|caspofungin|mesh-list
102426298|NCT03580733|Antifungal Agents|antifungal agents|mesh-list
102426299|NCT03580733|Clotrimazole|clotrimazole|mesh-list
102426300|NCT03580733|Miconazole|miconazole|mesh-list
102426301|NCT03580733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102426302|NCT03580733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102426303|NCT03580733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426304|NCT03580733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102426305|NCT03580733|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102426306|NCT03580733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102426307|NCT03580733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102426308|NCT03580733|Hormone Antagonists|hormone antagonists|mesh-ancestor
102426309|NCT03580733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102426310|NCT03580733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426311|NCT03580733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102426312|NCT03580733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102426314|NCT03461445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102426315|NCT03461445|Immunologic Factors|immunologic factors|mesh-ancestor
102426316|NCT03461445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426317|NCT03461445|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102426318|NCT03461445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102426319|NCT03461445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426320|NCT04939662|Bevacizumab|bevacizumab|mesh-list
102426321|NCT04939662|Olaparib|olaparib|mesh-list
102426322|NCT04939662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102426323|NCT04939662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102426324|NCT04939662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102426325|NCT04939662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102426326|NCT04939662|Growth Substances|growth substances|mesh-ancestor
102426327|NCT04939662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426328|NCT04939662|Growth Inhibitors|growth inhibitors|mesh-ancestor
102426329|NCT04939662|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102426330|NCT04939662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102426331|NCT04939662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426332|NCT05581979|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102426333|NCT05581979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102426334|NCT05581979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426335|NCT05331144|Losartan|losartan|mesh-list
102426336|NCT05331144|Amlodipine|amlodipine|mesh-list
102426337|NCT05331144|Calcium Channel Blockers|calcium channel blockers|mesh-list
102426338|NCT05331144|Angiotensin II|angiotensin ii|mesh-list
102426339|NCT05331144|Giapreza|giapreza|mesh-list
102426340|NCT05331144|Calcium|calcium|mesh-list
102426341|NCT05331144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
102426342|NCT05331144|Angiotensinogen|angiotensinogen|mesh-list
102426343|NCT05331144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102426344|NCT05331144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426345|NCT05331144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102426346|NCT05331144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102426347|NCT05331144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426348|NCT05331144|Vasodilator Agents|vasodilator agents|mesh-ancestor
102426349|NCT05331144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102426350|NCT05331144|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102426351|NCT05331144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102426352|NCT05331144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102426353|NCT05331144|Protease Inhibitors|protease inhibitors|mesh-ancestor
102426354|NCT05331144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102426355|NCT00951561|Ibuprofen|ibuprofen|mesh-list
102426356|NCT00951561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102426357|NCT00951561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102426358|NCT00951561|Analgesics|analgesics|mesh-ancestor
102426359|NCT00951561|Sensory System Agents|sensory system agents|mesh-ancestor
102426360|NCT00951561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102426361|NCT00951561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426362|NCT00951561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102426363|NCT00951561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102426364|NCT00951561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102426365|NCT00951561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102426366|NCT00951561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426367|NCT03031119|Atorvastatin|atorvastatin|mesh-list
102426368|NCT03031119|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102426369|NCT03031119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102426370|NCT03031119|Antimetabolites|antimetabolites|mesh-ancestor
102426371|NCT03031119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426372|NCT03031119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102057115|NCT05346874|Oxaliplatin|oxaliplatin|mesh-list
102057116|NCT05346874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101607654|NCT04163536|Protective Agents|protective agents|mesh-ancestor
101607655|NCT04163536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101607656|NCT04163536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101607657|NCT00652288|Insulin|insulin|mesh-list
101607658|NCT00652288|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101607659|NCT00652288|Insulin Glargine|insulin glargine|mesh-list
102426373|NCT03031119|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102426374|NCT03031119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102426375|NCT03076203|Niraparib|niraparib|mesh-list
102426376|NCT03076203|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
102426377|NCT03076203|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102426378|NCT03076203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102426379|NCT03076203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426380|NCT03076203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102426381|NCT02943057|Ganciclovir|ganciclovir|mesh-list
102426382|NCT02943057|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101607660|NCT00652288|Insulin Aspart|insulin aspart|mesh-list
102057131|NCT02123823|Everolimus|everolimus|mesh-list
102057132|NCT02123823|Exemestane|exemestane|mesh-list
102057133|NCT02123823|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102057134|NCT02123823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102057135|NCT02123823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101358729|NCT00205738|Dopamine Agents|dopamine agents|mesh-ancestor
102426383|NCT02943057|Antiviral Agents|antiviral agents|mesh-ancestor
102426384|NCT02943057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102426385|NCT02943057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102426386|NCT02943057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102426387|NCT02943057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426388|NCT03581903|Vaccines|vaccines|mesh-list
102426389|NCT03581903|Immunologic Factors|immunologic factors|mesh-ancestor
102426390|NCT03581903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426391|NCT02783547|Azacitidine|azacitidine|mesh-list
102426392|NCT02783547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102426393|NCT02783547|Antimetabolites|antimetabolites|mesh-ancestor
101607713|NCT02637700|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102426394|NCT02783547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426395|NCT02783547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102426396|NCT02783547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102426397|NCT02555007|Vinorelbine|vinorelbine|mesh-list
102426398|NCT02555007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102426399|NCT02555007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102426400|NCT02555007|Tubulin Modulators|tubulin modulators|mesh-ancestor
102426401|NCT02555007|Antimitotic Agents|antimitotic agents|mesh-ancestor
102426402|NCT02555007|Mitosis Modulators|mitosis modulators|mesh-ancestor
102426403|NCT02555007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426404|NCT03898037|Metformin|metformin|mesh-list
102426405|NCT03898037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102426406|NCT03898037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426407|NCT04982874|Furosemide|furosemide|mesh-list
102426408|NCT04982874|Diuretics|diuretics|mesh-ancestor
102426409|NCT04982874|Natriuretic Agents|natriuretic agents|mesh-ancestor
102426410|NCT04982874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426411|NCT04982874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102426412|NCT04982874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102426413|NCT04982874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426414|NCT03897491|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102426415|NCT03897491|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102426416|NCT03897491|Dermatologic Agents|dermatologic agents|mesh-ancestor
102426417|NCT03068208|Methylene Blue|methylene blue|mesh-list
102426418|NCT03068208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102426419|NCT03068208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426420|NCT03067974|Ketamine|ketamine|mesh-list
102426421|NCT03067974|Analgesics|analgesics|mesh-ancestor
102426422|NCT03067974|Sensory System Agents|sensory system agents|mesh-ancestor
102426423|NCT03067974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102426424|NCT03067974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426425|NCT03067974|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102426426|NCT03067974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102426427|NCT03067974|Anesthetics, General|anesthetics, general|mesh-ancestor
102426428|NCT03067974|Anesthetics|anesthetics|mesh-ancestor
102426429|NCT03067974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102426430|NCT03067974|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102426431|NCT03067974|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102426432|NCT03067974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102426433|NCT03067974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426434|NCT03582137|Cannabidiol|cannabidiol|mesh-list
102426435|NCT03582137|Anticonvulsants|anticonvulsants|mesh-ancestor
102426436|NCT04405193|Acetylcysteine|acetylcysteine|mesh-list
102426437|NCT04405193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102426438|NCT04405193|Antiviral Agents|antiviral agents|mesh-ancestor
102426439|NCT04405193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102426440|NCT04405193|Expectorants|expectorants|mesh-ancestor
102426441|NCT04405193|Respiratory System Agents|respiratory system agents|mesh-ancestor
102426442|NCT04405193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102426443|NCT04405193|Antioxidants|antioxidants|mesh-ancestor
102426444|NCT04405193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426445|NCT04405193|Protective Agents|protective agents|mesh-ancestor
102057151|NCT03136510|Antithrombins|antithrombins|mesh-ancestor
102426446|NCT04405193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426447|NCT04405193|Antidotes|antidotes|mesh-ancestor
102426448|NCT05227833|Pantoprazole|pantoprazole|mesh-list
102426449|NCT05227833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102426450|NCT05227833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102426451|NCT05227833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102426452|NCT05227833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102426453|NCT05227833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426454|NCT05083299|Sarpogrelate|sarpogrelate|mesh-list
102426455|NCT05083299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102426456|NCT05083299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102426457|NCT05083299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426458|NCT05083299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102426459|NCT05083299|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102426460|NCT05083299|Serotonin Agents|serotonin agents|mesh-ancestor
102426461|NCT05083299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102426462|NCT05083299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426463|NCT05701475|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102426464|NCT05701475|Dermatologic Agents|dermatologic agents|mesh-ancestor
102426465|NCT03035253|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102426466|NCT03035253|Immunologic Factors|immunologic factors|mesh-ancestor
102426467|NCT03035253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426468|NCT04405271|Tenofovir|tenofovir|mesh-list
102426469|NCT04405271|Emtricitabine|emtricitabine|mesh-list
102426470|NCT04405271|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
102426471|NCT04405271|Antiviral Agents|antiviral agents|mesh-ancestor
101358805|NCT00039611|Leucovorin|leucovorin|mesh-list
102426472|NCT04405271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102426473|NCT04405271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102426474|NCT04405271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102426475|NCT04405271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102426476|NCT04405271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426477|NCT04405271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102426478|NCT04405271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102426479|NCT03034941|Metformin|metformin|mesh-list
102426480|NCT03034941|Liraglutide|liraglutide|mesh-list
102426481|NCT03034941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102426482|NCT03034941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426483|NCT03034941|Incretins|incretins|mesh-ancestor
102426484|NCT03034941|Hormones|hormones|mesh-ancestor
102426485|NCT03034941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102426486|NCT03030105|Scopolamine|scopolamine|mesh-list
102426487|NCT03030105|Donepezil|donepezil|mesh-list
102426488|NCT03030105|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102426489|NCT03030105|BPN14770|bpn14770|mesh-list
102426490|NCT03030105|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102426491|NCT03030105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102426492|NCT03030105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426493|NCT03030105|Cholinergic Agents|cholinergic agents|mesh-ancestor
102426494|NCT03030105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102426495|NCT03030105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426496|NCT03030105|Nootropic Agents|nootropic agents|mesh-ancestor
102426497|NCT03030105|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102426498|NCT03030105|Antiemetics|antiemetics|mesh-ancestor
102426499|NCT03030105|Autonomic Agents|autonomic agents|mesh-ancestor
102426500|NCT03030105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102426501|NCT03030105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102426502|NCT03030105|Mydriatics|mydriatics|mesh-ancestor
102426503|NCT03030105|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102426504|NCT03030105|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102426505|NCT03030105|Parasympatholytics|parasympatholytics|mesh-ancestor
102426506|NCT03030105|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101608223|NCT02632474|Tenofovir|tenofovir|mesh-list
102426507|NCT03030105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102426508|NCT03067896|Magnesium Sulfate|magnesium sulfate|mesh-list
102426509|NCT03067896|Dexmedetomidine|dexmedetomidine|mesh-list
102426510|NCT03067896|Bupivacaine|bupivacaine|mesh-list
102426511|NCT03067896|Anesthetics, Local|anesthetics, local|mesh-ancestor
102426512|NCT03067896|Anesthetics|anesthetics|mesh-ancestor
102426513|NCT03067896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102426514|NCT03067896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426515|NCT03067896|Sensory System Agents|sensory system agents|mesh-ancestor
102426516|NCT03067896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102426517|NCT03067896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102426518|NCT03067896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102426519|NCT03067896|Analgesics|analgesics|mesh-ancestor
102426520|NCT03067896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102426521|NCT03067896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102426522|NCT03067896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102426523|NCT03067896|Adrenergic Agents|adrenergic agents|mesh-ancestor
102426524|NCT03067896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102426525|NCT03067896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426526|NCT03067896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102426527|NCT03067896|Anticonvulsants|anticonvulsants|mesh-ancestor
102426528|NCT03067896|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102057247|NCT03327844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102426529|NCT03067896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102426530|NCT03067896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102426531|NCT03067896|Tocolytic Agents|tocolytic agents|mesh-ancestor
102426532|NCT03067896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102238221|NCT02500667|Rifampin|rifampin|mesh-list
102426533|NCT03034707|Biotin|biotin|mesh-list
102426534|NCT03034707|Vitamin B Complex|vitamin b complex|mesh-ancestor
102426536|NCT03034707|Micronutrients|micronutrients|mesh-ancestor
102426537|NCT03034707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426538|NCT03067740|Dexmedetomidine|dexmedetomidine|mesh-list
102426539|NCT03067740|Bupivacaine|bupivacaine|mesh-list
102426540|NCT03067740|Anesthetics, Local|anesthetics, local|mesh-ancestor
102426541|NCT03067740|Anesthetics|anesthetics|mesh-ancestor
102426542|NCT03067740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102426543|NCT03067740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426544|NCT03067740|Sensory System Agents|sensory system agents|mesh-ancestor
102426545|NCT03067740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102426546|NCT03067740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102426547|NCT03067740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102426548|NCT03067740|Analgesics|analgesics|mesh-ancestor
102426549|NCT03067740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102426550|NCT03067740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102426551|NCT03067740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102426552|NCT03067740|Adrenergic Agents|adrenergic agents|mesh-ancestor
102426553|NCT03067740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102426554|NCT03067740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426555|NCT05730114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
102426556|NCT03027843|Hormones|hormones|mesh-list
102426557|NCT03027843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102426558|NCT03027843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426559|NCT03068832|Poly I-C|poly i-c|mesh-list
102426560|NCT03068832|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102426561|NCT03068832|Poly ICLC|poly iclc|mesh-list
102426562|NCT03068832|Interferon Inducers|interferon inducers|mesh-ancestor
102426563|NCT03068832|Immunologic Factors|immunologic factors|mesh-ancestor
102426564|NCT03068832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426565|NCT03068832|Laxatives|laxatives|mesh-ancestor
102426566|NCT03068832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102426567|NCT03068832|Antiviral Agents|antiviral agents|mesh-ancestor
102426568|NCT03068832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102426569|NCT04801797|Cytarabine|cytarabine|mesh-list
102426570|NCT04801797|Azacitidine|azacitidine|mesh-list
102426571|NCT04801797|Daunorubicin|daunorubicin|mesh-list
102426572|NCT04801797|Venetoclax|venetoclax|mesh-list
102426573|NCT04801797|Idarubicin|idarubicin|mesh-list
102426574|NCT04801797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102426575|NCT04801797|Antimetabolites|antimetabolites|mesh-ancestor
102426576|NCT04801797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426577|NCT04801797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102426578|NCT04801797|Antiviral Agents|antiviral agents|mesh-ancestor
102426579|NCT04801797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101608577|NCT00878800|Belinostat|belinostat|mesh-list
102426580|NCT04801797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102426581|NCT04801797|Immunologic Factors|immunologic factors|mesh-ancestor
102426582|NCT04801797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426583|NCT04801797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102426584|NCT04801797|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102426585|NCT04801797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102057309|NCT04531059|Esomeprazole|esomeprazole|mesh-list
102426586|NCT04801797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102426587|NCT03033537|Verapamil|verapamil|mesh-list
102426588|NCT03033537|Calcium Channel Blockers|calcium channel blockers|mesh-list
102426589|NCT03033537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102426590|NCT03033537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426591|NCT03033537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102426592|NCT03033537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102426593|NCT03033537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426594|NCT03033537|Vasodilator Agents|vasodilator agents|mesh-ancestor
102426595|NCT01670435|Ciprofloxacin|ciprofloxacin|mesh-list
102426596|NCT01670435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102426597|NCT01670435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102426598|NCT01670435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102426599|NCT01670435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102426600|NCT01670435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102426601|NCT01670435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426602|NCT01670435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102426603|NCT01670435|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102426604|NCT01670435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102426605|NCT03069144|Calcitriol|calcitriol|mesh-list
102426606|NCT03069144|Calcipotriene|calcipotriene|mesh-list
102426607|NCT03069144|Dermatologic Agents|dermatologic agents|mesh-ancestor
102426608|NCT03069144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102426609|NCT03069144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426610|NCT03069144|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102426611|NCT03069144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102426612|NCT03069144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426613|NCT03069144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102426614|NCT03069144|Vitamins|vitamins|mesh-ancestor
102426615|NCT03069144|Micronutrients|micronutrients|mesh-ancestor
102426616|NCT03069144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102426617|NCT03017703|Eplerenone|eplerenone|mesh-list
102426618|NCT03017703|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102426619|NCT03017703|Hormone Antagonists|hormone antagonists|mesh-ancestor
102426620|NCT03017703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102426621|NCT03017703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426622|NCT03017703|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102426623|NCT03017703|Diuretics|diuretics|mesh-ancestor
102426624|NCT03017703|Natriuretic Agents|natriuretic agents|mesh-ancestor
102426625|NCT03017703|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102426626|NCT01670669|Prucalopride|prucalopride|mesh-list
102426627|NCT01670669|Laxatives|laxatives|mesh-ancestor
102426628|NCT01670669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102426629|NCT01670669|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
102426630|NCT01670669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102426631|NCT01670669|Serotonin Agents|serotonin agents|mesh-ancestor
102426632|NCT01670669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102426633|NCT01670669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426634|NCT01670669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426635|NCT00946023|Mycophenolic Acid|mycophenolic acid|mesh-list
102426636|NCT00946023|Cyclophosphamide|cyclophosphamide|mesh-list
102426637|NCT00946023|Rituximab|rituximab|mesh-list
102426638|NCT00946023|Fludarabine|fludarabine|mesh-list
102426639|NCT00946023|Tacrolimus|tacrolimus|mesh-list
102426640|NCT00946023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102426641|NCT00946023|Immunologic Factors|immunologic factors|mesh-ancestor
102426642|NCT00946023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426643|NCT00946023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102426644|NCT00946023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102426645|NCT00946023|Alkylating Agents|alkylating agents|mesh-ancestor
102426646|NCT00946023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426647|NCT00946023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102426648|NCT00946023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102426649|NCT00946023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102426650|NCT00946023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102426651|NCT00946023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102426652|NCT00946023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102426653|NCT00946023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102426654|NCT00946023|Antitubercular Agents|antitubercular agents|mesh-ancestor
102426655|NCT00946023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102426656|NCT00946023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102426657|NCT01672151|Sirolimus|sirolimus|mesh-list
102426658|NCT01672151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102426659|NCT01672151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102426660|NCT01672151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102426661|NCT01672151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102426662|NCT01672151|Antifungal Agents|antifungal agents|mesh-ancestor
102426663|NCT01672151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102426664|NCT01672151|Immunologic Factors|immunologic factors|mesh-ancestor
102426665|NCT01672151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426666|NCT01672229|Bortezomib|bortezomib|mesh-list
102426667|NCT01672229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102426668|NCT01672307|Minoxidil|minoxidil|mesh-list
102426669|NCT01672307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102426670|NCT01672307|Vasodilator Agents|vasodilator agents|mesh-ancestor
102426671|NCT03067194|Celecoxib|celecoxib|mesh-list
102426672|NCT03067194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102426673|NCT03067194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102426674|NCT03067194|Analgesics|analgesics|mesh-ancestor
102426675|NCT03067194|Sensory System Agents|sensory system agents|mesh-ancestor
102426676|NCT03067194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102426677|NCT03067194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426678|NCT03067194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102426679|NCT03067194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102426680|NCT03067194|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102426681|NCT03067194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102426682|NCT03067194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102426683|NCT03067194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426684|NCT05629494|Ibuprofen|ibuprofen|mesh-list
102426685|NCT05629494|Naproxen|naproxen|mesh-list
102426686|NCT05629494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102426687|NCT05629494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102426688|NCT05629494|Analgesics|analgesics|mesh-ancestor
102426689|NCT05629494|Sensory System Agents|sensory system agents|mesh-ancestor
102426690|NCT05629494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102426691|NCT05629494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426692|NCT05629494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102426693|NCT05629494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102426694|NCT05629494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102426695|NCT05629494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102426696|NCT05629494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426697|NCT05629494|Gout Suppressants|gout suppressants|mesh-ancestor
102426698|NCT00952653|Midazolam|midazolam|mesh-list
102426699|NCT00952653|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
102426700|NCT00952653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102426701|NCT00952653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102426702|NCT00952653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102426703|NCT00952653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426704|NCT00952653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102426705|NCT00952653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102426706|NCT00952653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102426707|NCT00952653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102426708|NCT00952653|Anesthetics, General|anesthetics, general|mesh-ancestor
102426709|NCT00952653|Anesthetics|anesthetics|mesh-ancestor
102426710|NCT00952653|GABA Modulators|gaba modulators|mesh-ancestor
102426711|NCT00952653|GABA Agents|gaba agents|mesh-ancestor
102426712|NCT00952653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102426713|NCT00952653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426714|NCT00952653|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102426715|NCT00952653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102426716|NCT00952653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102426717|NCT00952653|Antidepressive Agents|antidepressive agents|mesh-ancestor
102426718|NCT01673087|Dexamethasone|dexamethasone|mesh-list
102426719|NCT01673087|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102426720|NCT01673087|Cosyntropin|cosyntropin|mesh-list
102426721|NCT01673087|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
102426722|NCT01673087|Metyrapone|metyrapone|mesh-list
102426723|NCT01673087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102426724|NCT01673087|Antiemetics|antiemetics|mesh-ancestor
102426725|NCT01673087|Autonomic Agents|autonomic agents|mesh-ancestor
102426726|NCT01673087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102426727|NCT01673087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426728|NCT01673087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102426729|NCT01673087|Glucocorticoids|glucocorticoids|mesh-ancestor
102426730|NCT01673087|Hormones|hormones|mesh-ancestor
102426731|NCT01673087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102426732|NCT01673087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102426733|NCT01673087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102426734|NCT01673087|Antimetabolites|antimetabolites|mesh-ancestor
102426735|NCT01673087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426736|NCT01673087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102426737|NCT02299505|Ceritinib|ceritinib|mesh-list
102426738|NCT02299505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102426739|NCT02299505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102426740|NCT02299505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102426741|NCT02299505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426742|NCT01673399|Atosiban|atosiban|mesh-list
102426743|NCT01673399|Hormone Antagonists|hormone antagonists|mesh-ancestor
102426744|NCT01673399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102426745|NCT01673399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426746|NCT01673399|Tocolytic Agents|tocolytic agents|mesh-ancestor
102426747|NCT01673399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102426748|NCT02235701|Ifosfamide|ifosfamide|mesh-list
102426749|NCT02235701|Doxorubicin|doxorubicin|mesh-list
102426750|NCT02235701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102426751|NCT02235701|Alkylating Agents|alkylating agents|mesh-ancestor
102426752|NCT02235701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426753|NCT02235701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102426754|NCT02235701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102426755|NCT02235701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102426756|NCT02235701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102426757|NCT02235701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102238447|NCT04494659|Rifampin|rifampin|mesh-list
102426758|NCT01674257|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102426759|NCT01674257|Fluorides|fluorides|mesh-list
102426760|NCT01674257|Cariostatic Agents|cariostatic agents|mesh-ancestor
102426761|NCT01674257|Protective Agents|protective agents|mesh-ancestor
102426762|NCT01674257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426763|NCT01674257|Hematinics|hematinics|mesh-ancestor
102426764|NCT01674257|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102426765|NCT01674257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102426766|NCT01674413|Adalimumab|adalimumab|mesh-list
102426767|NCT01674413|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102426768|NCT01674413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102426769|NCT01674413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102426770|NCT00953121|Bevacizumab|bevacizumab|mesh-list
102426771|NCT00953121|Carboplatin|carboplatin|mesh-list
102426772|NCT00953121|Irinotecan|irinotecan|mesh-list
102426773|NCT00953121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102426774|NCT00953121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102426775|NCT00953121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102057489|NCT03563664|Danazol|danazol|mesh-list
102426776|NCT00953121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102426777|NCT00953121|Growth Substances|growth substances|mesh-ancestor
102426778|NCT00953121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426779|NCT00953121|Growth Inhibitors|growth inhibitors|mesh-ancestor
102426780|NCT00953121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102426781|NCT00953121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102426782|NCT00953121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102426783|NCT00953121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426784|NCT03017391|Dexamethasone|dexamethasone|mesh-list
102426785|NCT03017391|Metoclopramide|metoclopramide|mesh-list
102426786|NCT03017391|Granisetron|granisetron|mesh-list
102426787|NCT03017391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102426788|NCT03017391|Antiemetics|antiemetics|mesh-ancestor
102426789|NCT03017391|Autonomic Agents|autonomic agents|mesh-ancestor
102426790|NCT03017391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102426791|NCT03017391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426792|NCT03017391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102426793|NCT03017391|Glucocorticoids|glucocorticoids|mesh-ancestor
102426794|NCT03017391|Hormones|hormones|mesh-ancestor
102057513|NCT01904136|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102426795|NCT03017391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102426796|NCT03017391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102426797|NCT03017391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102426798|NCT03017391|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102426799|NCT03017391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102426800|NCT03017391|Dopamine Agents|dopamine agents|mesh-ancestor
102426801|NCT03017391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102426802|NCT03017391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426803|NCT03017391|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102426804|NCT03017391|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102426805|NCT03017391|Serotonin Agents|serotonin agents|mesh-ancestor
102426806|NCT00953199|Lidocaine|lidocaine|mesh-list
102426807|NCT00953199|Anesthetics, Local|anesthetics, local|mesh-ancestor
102426808|NCT00953199|Anesthetics|anesthetics|mesh-ancestor
102426809|NCT00953199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102426810|NCT00953199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426811|NCT00953199|Sensory System Agents|sensory system agents|mesh-ancestor
102426812|NCT00953199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102426813|NCT00953199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102426814|NCT00953199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102426815|NCT00953199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102426816|NCT00953199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102426817|NCT00953199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426818|NCT03033147|Amoxicillin|amoxicillin|mesh-list
102426819|NCT03033147|Clavulanic Acid|clavulanic acid|mesh-list
102426820|NCT03033147|Clavulanic Acids|clavulanic acids|mesh-list
102426821|NCT03033147|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102426822|NCT03033147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102426823|NCT03033147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102426824|NCT03033147|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102426825|NCT03033147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102426826|NCT03033147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426827|NCT01675895|Lidocaine|lidocaine|mesh-list
102426828|NCT01675895|Levobupivacaine|levobupivacaine|mesh-list
102426829|NCT01675895|Anesthetics|anesthetics|mesh-list
102426830|NCT01675895|Anesthetics, Local|anesthetics, local|mesh-ancestor
102426831|NCT01675895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102426832|NCT01675895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426833|NCT01675895|Sensory System Agents|sensory system agents|mesh-ancestor
102426834|NCT01675895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102426835|NCT01675895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102426836|NCT01675895|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102426837|NCT01675895|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102426838|NCT01675895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102426839|NCT01675895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426840|NCT01675973|Ranolazine|ranolazine|mesh-list
102426841|NCT01675973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102426842|NCT01675973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102426843|NCT01675973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426844|NCT04764851|Ecopipam|ecopipam|mesh-list
102426845|NCT04764851|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102426846|NCT04764851|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102426847|NCT04764851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102426848|NCT04764851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426849|NCT04764851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102426850|NCT04764851|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102057553|NCT04761393|Xenon|xenon|mesh-list
102426851|NCT04764851|Dopamine Agents|dopamine agents|mesh-ancestor
102426852|NCT04764851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102426853|NCT04764851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426854|NCT00956085|Memantine|memantine|mesh-list
102426855|NCT00956085|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102426856|NCT00956085|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102426857|NCT00956085|Dopamine Agents|dopamine agents|mesh-ancestor
102426858|NCT00956085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102426859|NCT00956085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426860|NCT00956085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426861|NCT00956085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102426862|NCT00956085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102426863|NCT01005459|Bupivacaine|bupivacaine|mesh-list
102426864|NCT01005459|Tetracaine|tetracaine|mesh-list
102426865|NCT01005459|Anesthetics, Local|anesthetics, local|mesh-ancestor
102426866|NCT01005459|Anesthetics|anesthetics|mesh-ancestor
102057580|NCT05000736|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102426867|NCT01005459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102426868|NCT01005459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426869|NCT01005459|Sensory System Agents|sensory system agents|mesh-ancestor
102426870|NCT01005459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102426871|NCT01676285|Metoprolol|metoprolol|mesh-list
102426872|NCT01676285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102426873|NCT01676285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102426874|NCT01676285|Sympatholytics|sympatholytics|mesh-ancestor
102426875|NCT01676285|Autonomic Agents|autonomic agents|mesh-ancestor
102426876|NCT01676285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102426877|NCT01676285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426878|NCT01676285|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102426879|NCT01676285|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102426880|NCT01676285|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102426881|NCT01676285|Adrenergic Agents|adrenergic agents|mesh-ancestor
102426882|NCT01676285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102426883|NCT01676285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426884|NCT01676363|Diflunisal|diflunisal|mesh-list
102426885|NCT01676363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102426886|NCT01676363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102426887|NCT01676363|Analgesics|analgesics|mesh-ancestor
102426888|NCT01676363|Sensory System Agents|sensory system agents|mesh-ancestor
102426889|NCT01676363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102426890|NCT01676363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426891|NCT01676363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102426892|NCT01676363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102426893|NCT01676363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102426894|NCT01676363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102057618|NCT01338870|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102426895|NCT01676363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426896|NCT00956709|Ropivacaine|ropivacaine|mesh-list
102426897|NCT00956709|Levobupivacaine|levobupivacaine|mesh-list
102426898|NCT00956709|Anesthetics, Local|anesthetics, local|mesh-ancestor
102426899|NCT00956709|Anesthetics|anesthetics|mesh-ancestor
102426900|NCT00956709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102426901|NCT00956709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426902|NCT00956709|Sensory System Agents|sensory system agents|mesh-ancestor
102057623|NCT01338870|Vitamins|vitamins|mesh-ancestor
102426903|NCT00956709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102426904|NCT00957333|Ketamine|ketamine|mesh-list
102426905|NCT00957333|Analgesics|analgesics|mesh-ancestor
101947491|NCT01166451|Iron|iron|mesh-list
102426906|NCT00957333|Sensory System Agents|sensory system agents|mesh-ancestor
102426907|NCT00957333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102426908|NCT00957333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426909|NCT00957333|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102426910|NCT00957333|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102426911|NCT00957333|Anesthetics, General|anesthetics, general|mesh-ancestor
102426912|NCT00957333|Anesthetics|anesthetics|mesh-ancestor
102426913|NCT00957333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102426914|NCT00957333|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102426915|NCT00957333|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102426916|NCT00957333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102426917|NCT00957333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426918|NCT02159547|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
102426919|NCT02159547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102426920|NCT02159547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102426921|NCT02159547|Analgesics|analgesics|mesh-ancestor
102426922|NCT02159547|Sensory System Agents|sensory system agents|mesh-ancestor
102426923|NCT02159547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102057648|NCT01966471|Maytansine|maytansine|mesh-list
102426924|NCT02159547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426925|NCT02159547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102426926|NCT02159547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102426927|NCT00958035|Bimatoprost|bimatoprost|mesh-list
102426928|NCT00958035|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102426929|NCT00958035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102426931|NCT01011075|Imatinib Mesylate|imatinib mesylate|mesh-list
102426932|NCT01011075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102426933|NCT01011075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102426934|NCT01011075|Tubulin Modulators|tubulin modulators|mesh-ancestor
102426935|NCT01011075|Antimitotic Agents|antimitotic agents|mesh-ancestor
102426936|NCT01011075|Mitosis Modulators|mitosis modulators|mesh-ancestor
102426937|NCT01011075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610774|NCT00663832|Panobinostat|panobinostat|mesh-list
102426938|NCT01011075|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102426939|NCT01011075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102426940|NCT00958581|Tranexamic Acid|tranexamic acid|mesh-list
102426941|NCT00958581|Aminocaproic Acid|aminocaproic acid|mesh-list
102426942|NCT00958581|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102426943|NCT00958581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102426944|NCT00958581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426945|NCT00958581|Hemostatics|hemostatics|mesh-ancestor
102426946|NCT00958581|Coagulants|coagulants|mesh-ancestor
102426947|NCT01012089|Daptomycin|daptomycin|mesh-list
102426948|NCT01012089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102426949|NCT01012089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102426950|NCT04265651|Infigratinib|infigratinib|mesh-list
102426951|NCT04265651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102426952|NCT04055753|Doxorubicin|doxorubicin|mesh-list
102426953|NCT04055753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102057674|NCT01966471|Antimetabolites|antimetabolites|mesh-ancestor
102426954|NCT04055753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102426955|NCT04055753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102426956|NCT04055753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102426957|NCT04055753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102426958|NCT04055753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426959|NCT03871361|Abatacept|abatacept|mesh-list
102426960|NCT03871361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102426961|NCT03871361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426962|NCT03871361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102426963|NCT03871361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102426964|NCT03871361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102426965|NCT03871361|Immunologic Factors|immunologic factors|mesh-ancestor
102426966|NCT03871361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426967|NCT03871361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102426968|NCT03589547|Durvalumab|durvalumab|mesh-list
102426969|NCT03589547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102426970|NCT03589547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102426971|NCT04764383|Histamine|histamine|mesh-list
102426972|NCT04764383|Histamine Agonists|histamine agonists|mesh-ancestor
102426973|NCT04764383|Histamine Agents|histamine agents|mesh-ancestor
102426974|NCT04764383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102426975|NCT04764383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426976|NCT04764383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426977|NCT03016611|Ticagrelor|ticagrelor|mesh-list
102426978|NCT03016611|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102426979|NCT03016611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102426980|NCT03016611|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102426981|NCT03016611|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102426982|NCT03016611|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102426983|NCT03016611|Purinergic Agents|purinergic agents|mesh-ancestor
102426984|NCT03016611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102426985|NCT03016611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102426986|NCT03016611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426987|NCT00961233|Budesonide|budesonide|mesh-list
102426988|NCT00961233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102426989|NCT00961233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102426990|NCT00961233|Autonomic Agents|autonomic agents|mesh-ancestor
102426991|NCT00961233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102426992|NCT00961233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102426993|NCT00961233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102426994|NCT00961233|Respiratory System Agents|respiratory system agents|mesh-ancestor
102426995|NCT00961233|Glucocorticoids|glucocorticoids|mesh-ancestor
102426996|NCT00961233|Hormones|hormones|mesh-ancestor
102426997|NCT00961233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102426998|NCT00962871|Tenofovir|tenofovir|mesh-list
102426999|NCT00962871|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102427000|NCT00962871|Antiviral Agents|antiviral agents|mesh-ancestor
102427001|NCT00962871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102427002|NCT00962871|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102427003|NCT00962871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102427004|NCT00962871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102427005|NCT00962871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427006|NCT00962871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102427007|NCT00962871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102427008|NCT01014351|Paclitaxel|paclitaxel|mesh-list
102427009|NCT01014351|Carboplatin|carboplatin|mesh-list
102427010|NCT01014351|Everolimus|everolimus|mesh-list
102427011|NCT01014351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102427012|NCT01014351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102427013|NCT01014351|Tubulin Modulators|tubulin modulators|mesh-ancestor
102427014|NCT01014351|Antimitotic Agents|antimitotic agents|mesh-ancestor
102427015|NCT01014351|Mitosis Modulators|mitosis modulators|mesh-ancestor
102427016|NCT01014351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427017|NCT01014351|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102427018|NCT01014351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102427019|NCT01014351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102427020|NCT01014351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102427021|NCT01014351|Immunologic Factors|immunologic factors|mesh-ancestor
102427022|NCT01014351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427023|NCT01014741|Ibutilide|ibutilide|mesh-list
102427024|NCT01014741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102427025|NCT01015443|Cyclophosphamide|cyclophosphamide|mesh-list
102427026|NCT01015443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102427027|NCT01015443|Immunologic Factors|immunologic factors|mesh-ancestor
102427028|NCT01015443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427029|NCT01015443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102427030|NCT01015443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102427031|NCT01015443|Alkylating Agents|alkylating agents|mesh-ancestor
102427032|NCT01015443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427033|NCT01015443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102427034|NCT01015443|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102427035|NCT00962949|Angiotensin II|angiotensin ii|mesh-list
102427036|NCT00962949|Giapreza|giapreza|mesh-list
102427037|NCT00962949|Angiotensinogen|angiotensinogen|mesh-list
102427038|NCT00962949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102427039|NCT00962949|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102427040|NCT00962949|Protease Inhibitors|protease inhibitors|mesh-ancestor
102427041|NCT00962949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102427042|NCT00962949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427043|NCT01695941|Rituximab|rituximab|mesh-list
102427044|NCT01695941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102427045|NCT01695941|Bortezomib|bortezomib|mesh-list
102427046|NCT01695941|Antibodies|antibodies|mesh-list
102427047|NCT01695941|Immunoglobulins|immunoglobulins|mesh-list
102427048|NCT01695941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102427049|NCT01695941|Immunologic Factors|immunologic factors|mesh-ancestor
102427050|NCT01695941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427051|NCT01695941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102427052|NCT01695941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102427053|NCT01244789|Paclitaxel|paclitaxel|mesh-list
102427054|NCT01244789|Carboplatin|carboplatin|mesh-list
102427055|NCT01244789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102427056|NCT01244789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102427057|NCT01244789|Tubulin Modulators|tubulin modulators|mesh-ancestor
102427058|NCT01244789|Antimitotic Agents|antimitotic agents|mesh-ancestor
102427059|NCT01244789|Mitosis Modulators|mitosis modulators|mesh-ancestor
102057772|NCT01374581|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102427060|NCT01244789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427061|NCT02631876|Paclitaxel|paclitaxel|mesh-list
102427062|NCT02631876|Maytansine|maytansine|mesh-list
102427063|NCT02631876|Doxorubicin|doxorubicin|mesh-list
102427064|NCT02631876|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102427065|NCT02631876|Topotecan|topotecan|mesh-list
102427066|NCT02631876|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
102427067|NCT02631876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102427068|NCT02631876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102427069|NCT02631876|Tubulin Modulators|tubulin modulators|mesh-ancestor
102427070|NCT02631876|Antimitotic Agents|antimitotic agents|mesh-ancestor
102427071|NCT02631876|Mitosis Modulators|mitosis modulators|mesh-ancestor
102427072|NCT02631876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427073|NCT02631876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102427074|NCT02631876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102427075|NCT02631876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102427076|NCT02631876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102427077|NCT02631876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102427078|NCT02631876|Immunoconjugates|immunoconjugates|mesh-ancestor
102427079|NCT02631876|Immunologic Factors|immunologic factors|mesh-ancestor
102427080|NCT02631876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427081|NCT03156179|Calcium|calcium|mesh-list
102427082|NCT03156179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102427083|NCT03156179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427084|NCT04436796|Pancrelipase|pancrelipase|mesh-list
102427085|NCT04436796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102427086|NCT02081963|Amikacin|amikacin|mesh-list
102427087|NCT02081963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102427088|NCT02081963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102427089|NCT04765085|Aripiprazole|aripiprazole|mesh-list
102427090|NCT04765085|Antidepressive Agents|antidepressive agents|mesh-ancestor
102427091|NCT04765085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102427092|NCT04765085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102427093|NCT04765085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102427094|NCT04765085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102427095|NCT04765085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427096|NCT04765085|Dopamine Agonists|dopamine agonists|mesh-ancestor
102427097|NCT04765085|Dopamine Agents|dopamine agents|mesh-ancestor
102427098|NCT04765085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102427099|NCT04765085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427100|NCT04765085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102427101|NCT04765085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102427102|NCT04765085|Serotonin Agents|serotonin agents|mesh-ancestor
102427103|NCT04765085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102427104|NCT04765085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102427105|NCT04765085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102427106|NCT04765085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102427107|NCT02633046|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102427108|NCT02633046|Hormones|hormones|mesh-ancestor
102427109|NCT02633046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102427110|NCT02633046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427111|NCT03881345|Anticoagulants|anticoagulants|mesh-list
102427112|NCT01676597|Rifaximin|rifaximin|mesh-list
102427113|NCT01676597|Pentoxifylline|pentoxifylline|mesh-list
102427114|NCT01676597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102427115|NCT01676597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102427116|NCT01676597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102427117|NCT01676597|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102427118|NCT01676597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102427119|NCT01676597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427120|NCT01676597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102427121|NCT01676597|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102427122|NCT01676597|Protective Agents|protective agents|mesh-ancestor
102427123|NCT01676597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427124|NCT01676597|Vasodilator Agents|vasodilator agents|mesh-ancestor
102427125|NCT01676597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102427126|NCT01676597|Antioxidants|antioxidants|mesh-ancestor
102427127|NCT05540964|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102427128|NCT05540964|Antiviral Agents|antiviral agents|mesh-ancestor
102427129|NCT05540964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102427130|NCT04364802|Iodine|iodine|mesh-list
102427131|NCT04364802|Cadexomer iodine|cadexomer iodine|mesh-list
102427132|NCT04364802|Povidone-Iodine|povidone-iodine|mesh-list
102427133|NCT04364802|Povidone|povidone|mesh-list
102427134|NCT04364802|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102427135|NCT04364802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102427136|NCT04364802|Trace Elements|trace elements|mesh-ancestor
102427137|NCT04364802|Micronutrients|micronutrients|mesh-ancestor
102427138|NCT04364802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427139|NCT04364802|Plasma Substitutes|plasma substitutes|mesh-ancestor
102427140|NCT04364802|Blood Substitutes|blood substitutes|mesh-ancestor
102427141|NCT03155087|Metformin|metformin|mesh-list
102427142|NCT03155087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102427143|NCT03155087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427144|NCT03867617|Immunosuppressive Agents|immunosuppressive agents|mesh-list
102427145|NCT03867617|Immunologic Factors|immunologic factors|mesh-ancestor
102427146|NCT03867617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427147|NCT00963105|Lenalidomide|lenalidomide|mesh-list
102427148|NCT00963105|Immunologic Factors|immunologic factors|mesh-ancestor
102427149|NCT00963105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427150|NCT00963105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102427151|NCT00963105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102427152|NCT00963105|Growth Substances|growth substances|mesh-ancestor
102427153|NCT00963105|Growth Inhibitors|growth inhibitors|mesh-ancestor
102427154|NCT00963105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102427155|NCT04879992|Amoxicillin|amoxicillin|mesh-list
102427156|NCT04879992|Metronidazole|metronidazole|mesh-list
102427157|NCT04879992|Tetracycline|tetracycline|mesh-list
102427158|NCT04879992|Rifabutin|rifabutin|mesh-list
102427159|NCT04879992|Potassium Citrate|potassium citrate|mesh-list
102427160|NCT04879992|Esomeprazole|esomeprazole|mesh-list
102427161|NCT04879992|Bismuth|bismuth|mesh-list
102427162|NCT04879992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427163|NCT04879992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102427164|NCT04879992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102057865|NCT05707572|Hormones|hormones|mesh-ancestor
102427165|NCT04879992|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102427166|NCT04879992|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102427167|NCT04879992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102427168|NCT04879992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102427169|NCT04879992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102427170|NCT04879992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102427171|NCT04879992|Antacids|antacids|mesh-ancestor
102427172|NCT04879992|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102427173|NCT04879992|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102427174|NCT04879992|Antitubercular Agents|antitubercular agents|mesh-ancestor
102427175|NCT04879992|Diuretics|diuretics|mesh-ancestor
102427176|NCT04879992|Natriuretic Agents|natriuretic agents|mesh-ancestor
102427177|NCT04879992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427178|NCT04879992|Expectorants|expectorants|mesh-ancestor
102427179|NCT04879992|Respiratory System Agents|respiratory system agents|mesh-ancestor
102427180|NCT01016691|Bimatoprost|bimatoprost|mesh-list
102427181|NCT01016691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102427182|NCT04181736|Guanfacine|guanfacine|mesh-list
102427183|NCT04181736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102427184|NCT04181736|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102427185|NCT04181736|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102427186|NCT04181736|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102427187|NCT04181736|Adrenergic Agents|adrenergic agents|mesh-ancestor
102427188|NCT04181736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102427189|NCT04181736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427190|NCT04181736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427191|NCT04404491|Capecitabine|capecitabine|mesh-list
102427192|NCT04404491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102427193|NCT04404491|Antimetabolites|antimetabolites|mesh-ancestor
102427194|NCT04404491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427195|NCT04404491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102427196|NCT03861299|Anesthetics|anesthetics|mesh-list
102427197|NCT03861299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102427198|NCT03861299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427199|NCT05573568|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
102427200|NCT05573568|Hallucinogens|hallucinogens|mesh-ancestor
102427201|NCT05573568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427202|NCT05573568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102427203|NCT05573568|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102427204|NCT05573568|Serotonin Agents|serotonin agents|mesh-ancestor
102427205|NCT05573568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102427206|NCT05573568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427207|NCT05573568|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102238906|NCT05464745|Indapamide|indapamide|mesh-list
102427208|NCT03858491|Cobicistat|cobicistat|mesh-list
102057925|NCT01376765|Antacids|antacids|mesh-ancestor
102427209|NCT03858491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102427210|NCT03858491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102427211|NCT03858491|Antiviral Agents|antiviral agents|mesh-ancestor
102427212|NCT03858491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102427213|NCT03858491|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102427214|NCT03858491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102427215|NCT03858491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102427216|NCT03858491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427217|NCT01672788|Metformin|metformin|mesh-list
102427218|NCT01672788|Empagliflozin|empagliflozin|mesh-list
102427219|NCT01672788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102427220|NCT01672788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427221|NCT01672788|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102427222|NCT01672788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427223|NCT02705963|Trametinib|trametinib|mesh-list
102427224|NCT02705963|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102427225|NCT02705963|Norethindrone|norethindrone|mesh-list
102427226|NCT02705963|Norethindrone Acetate|norethindrone acetate|mesh-list
102427227|NCT02705963|Contraceptive Agents|contraceptive agents|mesh-list
102427228|NCT02705963|Contraceptives, Oral|contraceptives, oral|mesh-list
102427229|NCT02705963|Estradiol|estradiol|mesh-list
102427230|NCT02705963|Estrogens|estrogens|mesh-ancestor
102427231|NCT02705963|Hormones|hormones|mesh-ancestor
102427232|NCT02705963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102427233|NCT02705963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427234|NCT02705963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102427235|NCT02705963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102427236|NCT02705963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102427237|NCT02705963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102427238|NCT02705963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102427239|NCT02705963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102427240|NCT02705963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427241|NCT02705963|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102427242|NCT02705963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102427243|NCT03065868|Clarithromycin|clarithromycin|mesh-list
102427244|NCT03065868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102427245|NCT03065868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102427246|NCT03065868|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102427247|NCT03065868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102427248|NCT03065868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427249|NCT03065868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102427250|NCT03065868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102427251|NCT03840239|Capecitabine|capecitabine|mesh-list
102427252|NCT03840239|Oxaliplatin|oxaliplatin|mesh-list
102427253|NCT03840239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102427254|NCT03840239|Antimetabolites|antimetabolites|mesh-ancestor
102057945|NCT04788563|Antihypertensive Agents|antihypertensive agents|mesh-list
102427255|NCT03840239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427256|NCT03840239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102427257|NCT02632110|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102427258|NCT02632110|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102427259|NCT02632110|Dermatologic Agents|dermatologic agents|mesh-ancestor
102427260|NCT03830723|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102427261|NCT03830723|Hormones|hormones|mesh-ancestor
102427262|NCT03830723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102427263|NCT03830723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611851|NCT01139762|Tadalafil|tadalafil|mesh-list
102427264|NCT03829319|Carboplatin|carboplatin|mesh-list
102427265|NCT03829319|Pembrolizumab|pembrolizumab|mesh-list
102427266|NCT03829319|Pemetrexed|pemetrexed|mesh-list
102427267|NCT03829319|Lenvatinib|lenvatinib|mesh-list
102427268|NCT03829319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102427269|NCT03829319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102427270|NCT03829319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102427271|NCT03829319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427272|NCT03829319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102427273|NCT03829319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102427274|NCT03829319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102427275|NCT03829319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102427276|NCT03814109|Niacin|niacin|mesh-list
102427277|NCT03814109|Indapamide|indapamide|mesh-list
102427278|NCT03814109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102427279|NCT03814109|Diuretics|diuretics|mesh-ancestor
102427280|NCT03814109|Natriuretic Agents|natriuretic agents|mesh-ancestor
102427281|NCT03814109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427282|NCT03814109|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102427283|NCT03814109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102427284|NCT03814109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427285|NCT03814109|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102427286|NCT03814109|Antimetabolites|antimetabolites|mesh-ancestor
102427287|NCT03814109|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102427288|NCT03814109|Vasodilator Agents|vasodilator agents|mesh-ancestor
102427289|NCT03814109|Vitamin B Complex|vitamin b complex|mesh-ancestor
102427290|NCT03814109|Vitamins|vitamins|mesh-ancestor
102427291|NCT03814109|Micronutrients|micronutrients|mesh-ancestor
102427292|NCT01016769|Sirolimus|sirolimus|mesh-list
102427293|NCT01016769|Paclitaxel|paclitaxel|mesh-list
102427294|NCT01016769|Carboplatin|carboplatin|mesh-list
102427295|NCT01016769|Temsirolimus|temsirolimus|mesh-list
102427296|NCT01016769|MTOR Inhibitors|mtor inhibitors|mesh-list
102427297|NCT01016769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102427298|NCT01016769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102427299|NCT01016769|Tubulin Modulators|tubulin modulators|mesh-ancestor
102427300|NCT01016769|Antimitotic Agents|antimitotic agents|mesh-ancestor
102427301|NCT01016769|Mitosis Modulators|mitosis modulators|mesh-ancestor
102427302|NCT01016769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427303|NCT01016769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102427304|NCT01016769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102058016|NCT05392361|Gabapentin|gabapentin|mesh-list
102427305|NCT01016769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102427306|NCT01016769|Immunologic Factors|immunologic factors|mesh-ancestor
102427307|NCT01016769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427308|NCT01016769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102427309|NCT01016769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102427310|NCT01016769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102427311|NCT01016769|Antifungal Agents|antifungal agents|mesh-ancestor
102427312|NCT03807479|Ponatinib|ponatinib|mesh-list
102427313|NCT03807479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102427314|NCT03807479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102427315|NCT03807479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102427316|NCT03807479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427317|NCT03019809|Plerixafor|plerixafor|mesh-list
102427318|NCT03019809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102427319|NCT03019809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102427320|NCT03019809|Antiviral Agents|antiviral agents|mesh-ancestor
102427321|NCT03019809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102427322|NCT00964353|Warfarin|warfarin|mesh-list
102427323|NCT00964353|Anticoagulants|anticoagulants|mesh-ancestor
102427324|NCT00964431|Celecoxib|celecoxib|mesh-list
102427325|NCT00964431|Indomethacin|indomethacin|mesh-list
102427326|NCT00964431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102427327|NCT00964431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102427328|NCT00964431|Analgesics|analgesics|mesh-ancestor
102427329|NCT00964431|Sensory System Agents|sensory system agents|mesh-ancestor
102427330|NCT00964431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102427331|NCT00964431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427332|NCT00964431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102427333|NCT00964431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102427334|NCT00964431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102427335|NCT00964431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102427336|NCT00964431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102058042|NCT05338541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102427337|NCT00964431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427338|NCT00964431|Gout Suppressants|gout suppressants|mesh-ancestor
102427339|NCT00964431|Tocolytic Agents|tocolytic agents|mesh-ancestor
102427340|NCT00964431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102427341|NCT05475054|Liver Extracts|liver extracts|mesh-list
102427342|NCT05475054|Hematinics|hematinics|mesh-ancestor
102427343|NCT01017003|Colchicine|colchicine|mesh-list
102427344|NCT01017003|Gout Suppressants|gout suppressants|mesh-ancestor
102427345|NCT01017003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102427346|NCT01017003|Tubulin Modulators|tubulin modulators|mesh-ancestor
102427347|NCT01017003|Antimitotic Agents|antimitotic agents|mesh-ancestor
102427348|NCT01017003|Mitosis Modulators|mitosis modulators|mesh-ancestor
102427349|NCT01017003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427350|NCT01017003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102427351|NCT01017237|Midazolam|midazolam|mesh-list
102427352|NCT01017237|Dexmedetomidine|dexmedetomidine|mesh-list
102427353|NCT01017237|Ketamine|ketamine|mesh-list
102427354|NCT01017237|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102427355|NCT01017237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102427356|NCT01017237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427357|NCT01017237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102427358|NCT01017237|Analgesics|analgesics|mesh-ancestor
102058071|NCT02821416|Benralizumab|benralizumab|mesh-list
102427359|NCT01017237|Sensory System Agents|sensory system agents|mesh-ancestor
102427360|NCT01017237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102427361|NCT01017237|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102427362|NCT01017237|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102427363|NCT01017237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102427364|NCT01017237|Adrenergic Agents|adrenergic agents|mesh-ancestor
102427365|NCT01017237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102427366|NCT01017237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427367|NCT01017237|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102427368|NCT01017237|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102427369|NCT01017237|Anesthetics, General|anesthetics, general|mesh-ancestor
102427370|NCT01017237|Anesthetics|anesthetics|mesh-ancestor
102427371|NCT01017237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102427372|NCT01017237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102427373|NCT01017237|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102427374|NCT01017237|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102427375|NCT01017237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102427376|NCT01017237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102427377|NCT01017237|GABA Modulators|gaba modulators|mesh-ancestor
102427378|NCT01017237|GABA Agents|gaba agents|mesh-ancestor
102427379|NCT04442412|Vitamin D|vitamin d|mesh-list
102427380|NCT04442412|Cholecalciferol|cholecalciferol|mesh-list
102427381|NCT04442412|Vitamins|vitamins|mesh-ancestor
102058084|NCT04500509|Diclofenac|diclofenac|mesh-list
102427382|NCT04442412|Micronutrients|micronutrients|mesh-ancestor
102427383|NCT04442412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427384|NCT04442412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102427385|NCT04442412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102427386|NCT01018095|Metronidazole|metronidazole|mesh-list
102427387|NCT01018095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102427388|NCT01018095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102427389|NCT01018095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102427390|NCT01018095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102427391|NCT03788759|Thioctic Acid|thioctic acid|mesh-list
102427392|NCT03788759|Antioxidants|antioxidants|mesh-ancestor
102427393|NCT03788759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427394|NCT03788759|Protective Agents|protective agents|mesh-ancestor
102427395|NCT03788759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427396|NCT03788759|Vitamin B Complex|vitamin b complex|mesh-ancestor
102427397|NCT03788759|Vitamins|vitamins|mesh-ancestor
102427398|NCT03788759|Micronutrients|micronutrients|mesh-ancestor
102427399|NCT00967551|Zinc|zinc|mesh-list
102427400|NCT00967551|Trace Elements|trace elements|mesh-list
102427401|NCT00967551|Micronutrients|micronutrients|mesh-list
102427402|NCT00967551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427403|NCT03778073|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102427404|NCT03778073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102058106|NCT05760599|Growth Inhibitors|growth inhibitors|mesh-ancestor
102427405|NCT03778073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102427406|NCT03778073|Alkylating Agents|alkylating agents|mesh-ancestor
102427407|NCT03778073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427408|NCT03778073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102427409|NCT03778073|Immunologic Factors|immunologic factors|mesh-ancestor
102427410|NCT03778073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427411|NCT00970203|Vaccines|vaccines|mesh-list
102427412|NCT00970203|Androgens|androgens|mesh-list
102427413|NCT00970203|Immunologic Factors|immunologic factors|mesh-ancestor
102427414|NCT00970203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427415|NCT00970203|Hormones|hormones|mesh-ancestor
102427416|NCT00970203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102427417|NCT00971295|Metformin|metformin|mesh-list
102427418|NCT00971295|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102427419|NCT00971295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102427420|NCT00971295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427421|NCT00971295|Anticonvulsants|anticonvulsants|mesh-ancestor
102058125|NCT02817828|Diuretics|diuretics|mesh-ancestor
102427422|NCT00971295|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102427423|NCT00971295|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102427424|NCT00971295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102427425|NCT00971295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427426|NCT00954681|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101612870|NCT00949884|Losartan|losartan|mesh-list
102427427|NCT00954681|Antidepressive Agents|antidepressive agents|mesh-ancestor
102427428|NCT00954681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102427429|NCT00954681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102427430|NCT00954681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102427431|NCT00954681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102427432|NCT00954681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427433|NCT00971841|Paclitaxel|paclitaxel|mesh-list
102427434|NCT00971841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102427435|NCT00971841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102427436|NCT00971841|Tubulin Modulators|tubulin modulators|mesh-ancestor
102427439|NCT00971841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427444|NCT05395299|Plant Growth Regulators|plant growth regulators|mesh-ancestor
102427445|NCT05395299|Growth Substances|growth substances|mesh-ancestor
102427446|NCT05395299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427447|NCT02246049|Leucovorin|leucovorin|mesh-list
102427448|NCT02246049|Bevacizumab|bevacizumab|mesh-list
102427449|NCT02246049|Fluorouracil|fluorouracil|mesh-list
102427450|NCT02246049|Oxaliplatin|oxaliplatin|mesh-list
102427451|NCT02246049|Irinotecan|irinotecan|mesh-list
102427452|NCT02246049|Calcium|calcium|mesh-list
102427453|NCT02246049|Levoleucovorin|levoleucovorin|mesh-list
102427454|NCT02246049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102427455|NCT02246049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102427456|NCT02246049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102427457|NCT02246049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102427458|NCT02246049|Growth Substances|growth substances|mesh-ancestor
102427459|NCT02246049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427460|NCT02246049|Growth Inhibitors|growth inhibitors|mesh-ancestor
102427461|NCT02246049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102427462|NCT02246049|Antimetabolites|antimetabolites|mesh-ancestor
102427463|NCT02246049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427464|NCT02246049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102427465|NCT02246049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102427466|NCT02246049|Immunologic Factors|immunologic factors|mesh-ancestor
102427467|NCT02246049|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102427468|NCT02246049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102427469|NCT02246049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102427470|NCT02246049|Antidotes|antidotes|mesh-ancestor
102427471|NCT02246049|Protective Agents|protective agents|mesh-ancestor
102427472|NCT02246049|Vitamin B Complex|vitamin b complex|mesh-ancestor
102427473|NCT02246049|Vitamins|vitamins|mesh-ancestor
102427474|NCT02246049|Micronutrients|micronutrients|mesh-ancestor
102427475|NCT05395143|Zinc Sulfate|zinc sulfate|mesh-list
102427476|NCT05395143|Astringents|astringents|mesh-ancestor
102427477|NCT05395143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427478|NCT05395143|Dermatologic Agents|dermatologic agents|mesh-ancestor
102427479|NCT05394909|Methylprednisolone|methylprednisolone|mesh-list
102058176|NCT03632161|Analgesics|analgesics|mesh-ancestor
102427480|NCT05394909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102427481|NCT05394909|Antiemetics|antiemetics|mesh-ancestor
102427482|NCT05394909|Autonomic Agents|autonomic agents|mesh-ancestor
102427483|NCT05394909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102427484|NCT05394909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427485|NCT05394909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102427486|NCT05394909|Glucocorticoids|glucocorticoids|mesh-ancestor
102427487|NCT05394909|Hormones|hormones|mesh-ancestor
102427488|NCT05394909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102427489|NCT05394909|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102427490|NCT05394909|Protective Agents|protective agents|mesh-ancestor
102427491|NCT05694858|Lidocaine|lidocaine|mesh-list
102427492|NCT05694858|Anesthetics, Local|anesthetics, local|mesh-ancestor
102427493|NCT05694858|Anesthetics|anesthetics|mesh-ancestor
102427494|NCT05694858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102427495|NCT05694858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427496|NCT05694858|Sensory System Agents|sensory system agents|mesh-ancestor
102427497|NCT05694858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102427498|NCT05694858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102427499|NCT05694858|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102427500|NCT05694858|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102427501|NCT05694858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102427502|NCT05694858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427503|NCT02159859|Ertapenem|ertapenem|mesh-list
102427504|NCT02159859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102427505|NCT02159859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102427506|NCT00974493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102427507|NCT00974493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102058198|NCT02810964|Sulforaphane|sulforaphane|mesh-list
102427508|NCT00974493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102427509|NCT00974493|Antitubercular Agents|antitubercular agents|mesh-ancestor
102239201|NCT03327155|Antiviral Agents|antiviral agents|mesh-ancestor
102427510|NCT02083679|Paclitaxel|paclitaxel|mesh-list
102427511|NCT02083679|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102427512|NCT02083679|Cisplatin|cisplatin|mesh-list
102427513|NCT02083679|Carboplatin|carboplatin|mesh-list
102427515|NCT02083679|Pemetrexed|pemetrexed|mesh-list
102427516|NCT02083679|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102427517|NCT02083679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102427518|NCT02083679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102427519|NCT02083679|Tubulin Modulators|tubulin modulators|mesh-ancestor
102427520|NCT02083679|Antimitotic Agents|antimitotic agents|mesh-ancestor
102427521|NCT02083679|Mitosis Modulators|mitosis modulators|mesh-ancestor
102427522|NCT02083679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427523|NCT02083679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102427524|NCT02083679|Antimetabolites|antimetabolites|mesh-ancestor
102427525|NCT02083679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102427526|NCT02083679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102427527|NCT02083679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102427528|NCT02083679|Immunologic Factors|immunologic factors|mesh-ancestor
102427529|NCT02083679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427530|NCT01672710|Niacin|niacin|mesh-list
102427531|NCT01672710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102427532|NCT01672710|Antimetabolites|antimetabolites|mesh-ancestor
102427533|NCT01672710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427534|NCT01672710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102427535|NCT01672710|Vasodilator Agents|vasodilator agents|mesh-ancestor
102427536|NCT01672710|Vitamin B Complex|vitamin b complex|mesh-ancestor
102427537|NCT01672710|Vitamins|vitamins|mesh-ancestor
102427538|NCT01672710|Micronutrients|micronutrients|mesh-ancestor
102427539|NCT01672710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427540|NCT03766763|Venetoclax|venetoclax|mesh-list
102427541|NCT03766763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102427542|NCT04790448|Irinotecan|irinotecan|mesh-list
102427543|NCT04790448|Camptothecin|camptothecin|mesh-list
102427544|NCT04790448|Cetuximab|cetuximab|mesh-list
102427545|NCT04790448|Vemurafenib|vemurafenib|mesh-list
102427546|NCT04790448|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102058238|NCT04011475|Tiotropium Bromide|tiotropium bromide|mesh-list
102427547|NCT04790448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102427548|NCT04790448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102427549|NCT04790448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427550|NCT04790448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102427551|NCT04790448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102427552|NCT04790448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102427553|NCT04790448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102427554|NCT04784052|Cyclophosphamide|cyclophosphamide|mesh-list
102427555|NCT04784052|Rituximab|rituximab|mesh-list
102427556|NCT04784052|Fludarabine|fludarabine|mesh-list
102427557|NCT04784052|Thymoglobulin|thymoglobulin|mesh-list
102427558|NCT04784052|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102427559|NCT04784052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102427560|NCT04784052|Immunologic Factors|immunologic factors|mesh-ancestor
102427561|NCT04784052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427562|NCT04784052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102427563|NCT04784052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102427564|NCT04784052|Alkylating Agents|alkylating agents|mesh-ancestor
102427565|NCT04784052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427566|NCT04784052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102427567|NCT04784052|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102427568|NCT04784052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102427569|NCT00976521|Abciximab|abciximab|mesh-list
102427570|NCT00976521|Anticoagulants|anticoagulants|mesh-ancestor
102427571|NCT00976521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102427572|NCT04410588|Fentanyl|fentanyl|mesh-list
102427573|NCT04410588|Levobupivacaine|levobupivacaine|mesh-list
102427574|NCT04410588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102427575|NCT04410588|Narcotics|narcotics|mesh-ancestor
102427576|NCT04410588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102427577|NCT04410588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427578|NCT04410588|Analgesics|analgesics|mesh-ancestor
102427579|NCT04410588|Sensory System Agents|sensory system agents|mesh-ancestor
102427580|NCT04410588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102427581|NCT04410588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102427582|NCT04410588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102427583|NCT04410588|Anesthetics, General|anesthetics, general|mesh-ancestor
102427584|NCT04410588|Anesthetics|anesthetics|mesh-ancestor
102427585|NCT04410588|Anesthetics, Local|anesthetics, local|mesh-ancestor
101359909|NCT00211354|Anecortave|anecortave|mesh-list
102427586|NCT05303220|Branebrutinib|branebrutinib|mesh-list
102427587|NCT05303220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102427588|NCT05303220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102427589|NCT05303220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427590|NCT04444830|Ketorolac|ketorolac|mesh-list
102427591|NCT04444830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102427592|NCT04444830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102427593|NCT04444830|Analgesics|analgesics|mesh-ancestor
102427594|NCT04444830|Sensory System Agents|sensory system agents|mesh-ancestor
102427595|NCT04444830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102427596|NCT04444830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427597|NCT04444830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102427598|NCT04444830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102427599|NCT04444830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102427600|NCT04444830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102427601|NCT04444830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427602|NCT01273259|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
102427603|NCT01273259|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102427604|NCT01273259|Immunologic Factors|immunologic factors|mesh-ancestor
102427605|NCT01273259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427606|NCT03738917|Bromides|bromides|mesh-list
102427607|NCT03738917|Dextromethorphan|dextromethorphan|mesh-list
102427608|NCT03738917|Ipratropium|ipratropium|mesh-list
102427609|NCT03738917|Cholinergic Antagonists|cholinergic antagonists|mesh-list
102427610|NCT03738917|Anticonvulsants|anticonvulsants|mesh-ancestor
102427611|NCT03738917|Antitussive Agents|antitussive agents|mesh-ancestor
102427612|NCT03738917|Respiratory System Agents|respiratory system agents|mesh-ancestor
102427613|NCT03738917|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102427614|NCT03738917|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102427615|NCT03738917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102427616|NCT03738917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427617|NCT03738917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427618|NCT03738917|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102427619|NCT03738917|Autonomic Agents|autonomic agents|mesh-ancestor
102427620|NCT03738917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102427621|NCT03738917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102427622|NCT03738917|Cholinergic Agents|cholinergic agents|mesh-ancestor
102427623|NCT00976599|Methotrexate|methotrexate|mesh-list
102427624|NCT00976599|Tofacitinib|tofacitinib|mesh-list
102427625|NCT00976599|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102427626|NCT00976599|Abortifacient Agents|abortifacient agents|mesh-ancestor
102427627|NCT00976599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102427628|NCT00976599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427629|NCT00976599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102427630|NCT00976599|Antimetabolites|antimetabolites|mesh-ancestor
102427631|NCT00976599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427632|NCT00976599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102427633|NCT00976599|Dermatologic Agents|dermatologic agents|mesh-ancestor
102427634|NCT00976599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102427635|NCT00976599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102427636|NCT00976599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102427637|NCT00976599|Immunologic Factors|immunologic factors|mesh-ancestor
102427638|NCT00976599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102427639|NCT00976599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102427640|NCT00976599|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102427641|NCT00976599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102427642|NCT02630472|Quinine|quinine|mesh-list
102427643|NCT02630472|Antimalarials|antimalarials|mesh-ancestor
102427644|NCT02630472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102427645|NCT02630472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102427646|NCT02630472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102427647|NCT02630472|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102427648|NCT02630472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427649|NCT02630472|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102427650|NCT02630472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102427651|NCT02630472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102427652|NCT02630472|Analgesics|analgesics|mesh-ancestor
102427653|NCT02630472|Sensory System Agents|sensory system agents|mesh-ancestor
102427654|NCT03729011|Propofol|propofol|mesh-list
102427655|NCT03729011|Sevoflurane|sevoflurane|mesh-list
102427656|NCT03729011|Desflurane|desflurane|mesh-list
102427657|NCT03729011|Isoflurane|isoflurane|mesh-list
102427658|NCT03729011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102427659|NCT03729011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102427660|NCT03729011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427661|NCT03729011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102427662|NCT03729011|Anesthetics, General|anesthetics, general|mesh-ancestor
102427663|NCT03729011|Anesthetics|anesthetics|mesh-ancestor
102427664|NCT03729011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102427665|NCT03729011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102239351|NCT02491697|Antimetabolites|antimetabolites|mesh-ancestor
102427666|NCT05264922|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102427667|NCT05264922|Hemostatics|hemostatics|mesh-ancestor
102427668|NCT05264922|Coagulants|coagulants|mesh-ancestor
102427669|NCT00977769|Oxytocin|oxytocin|mesh-list
102427670|NCT00977769|Carbetocin|carbetocin|mesh-list
102427671|NCT00977769|Oxytocics|oxytocics|mesh-ancestor
102427672|NCT00977769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102427673|NCT00977769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427674|NCT03725501|Ranibizumab|ranibizumab|mesh-list
102427675|NCT03725501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102427676|NCT03725501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102427677|NCT03725501|Growth Substances|growth substances|mesh-ancestor
102427678|NCT03725501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427679|NCT03725501|Growth Inhibitors|growth inhibitors|mesh-ancestor
102427680|NCT03725501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102427681|NCT00979017|Bevacizumab|bevacizumab|mesh-list
102427682|NCT00979017|Irinotecan|irinotecan|mesh-list
102427683|NCT00979017|Temozolomide|temozolomide|mesh-list
102427684|NCT00979017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102427685|NCT00979017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102427686|NCT00979017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102427687|NCT00979017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102427688|NCT00979017|Growth Substances|growth substances|mesh-ancestor
102427689|NCT00979017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427690|NCT00979017|Growth Inhibitors|growth inhibitors|mesh-ancestor
102427691|NCT00979017|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102427692|NCT00979017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102427693|NCT00979017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102427694|NCT00979017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427695|NCT00979017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102427696|NCT00979017|Alkylating Agents|alkylating agents|mesh-ancestor
102427697|NCT01670526|Rivastigmine|rivastigmine|mesh-list
102427698|NCT01670526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
102427699|NCT01670526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102427700|NCT01670526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427701|NCT01670526|Cholinergic Agents|cholinergic agents|mesh-ancestor
102427702|NCT01670526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102427703|NCT01670526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427704|NCT01670526|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102427705|NCT01670526|Protective Agents|protective agents|mesh-ancestor
102427706|NCT00945035|Etoricoxib|etoricoxib|mesh-list
102427707|NCT00945035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102427708|NCT00945035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102427709|NCT00945035|Analgesics|analgesics|mesh-ancestor
102427710|NCT00945035|Sensory System Agents|sensory system agents|mesh-ancestor
102427711|NCT00945035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102427712|NCT00945035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427713|NCT00945035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102427714|NCT00945035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102427715|NCT00945035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102427716|NCT00945035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102427717|NCT00945035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102427718|NCT00945035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427719|NCT03720431|Pembrolizumab|pembrolizumab|mesh-list
102427720|NCT03720431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102427721|NCT03720431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102427722|NCT03720431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102058405|NCT02036736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102427723|NCT03720431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427724|NCT05386953|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102427725|NCT05176548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102427726|NCT05176548|Myeloma Proteins|myeloma proteins|mesh-list
102427727|NCT05176548|Paraproteins|paraproteins|mesh-list
102427728|NCT05176548|Immunologic Factors|immunologic factors|mesh-ancestor
102427729|NCT05176548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427730|NCT03719105|Dexamethasone|dexamethasone|mesh-list
102427731|NCT03719105|Prednisone|prednisone|mesh-list
102427732|NCT03719105|Cyclophosphamide|cyclophosphamide|mesh-list
102427733|NCT03719105|Ifosfamide|ifosfamide|mesh-list
102427734|NCT03719105|Doxorubicin|doxorubicin|mesh-list
102427735|NCT03719105|Methotrexate|methotrexate|mesh-list
102427736|NCT03719105|Etoposide|etoposide|mesh-list
102427737|NCT03719105|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102427738|NCT03719105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102427739|NCT03719105|Immunologic Factors|immunologic factors|mesh-ancestor
102427740|NCT03719105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427741|NCT03719105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102427742|NCT03719105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102427743|NCT03719105|Alkylating Agents|alkylating agents|mesh-ancestor
102427744|NCT03719105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427745|NCT03719105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102427746|NCT03719105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102427747|NCT03719105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102427748|NCT03719105|Antiemetics|antiemetics|mesh-ancestor
102427749|NCT03719105|Autonomic Agents|autonomic agents|mesh-ancestor
102427750|NCT03719105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102427751|NCT03719105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102427752|NCT03719105|Glucocorticoids|glucocorticoids|mesh-ancestor
102427753|NCT03719105|Hormones|hormones|mesh-ancestor
102427754|NCT03719105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102427755|NCT03719105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102427756|NCT03719105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102427757|NCT03719105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102427758|NCT03719105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102427759|NCT03719105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102427760|NCT03719105|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102427761|NCT03719105|Abortifacient Agents|abortifacient agents|mesh-ancestor
102427762|NCT03719105|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102427763|NCT03719105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102427764|NCT03719105|Antimetabolites|antimetabolites|mesh-ancestor
102427765|NCT03719105|Dermatologic Agents|dermatologic agents|mesh-ancestor
102427766|NCT03719105|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102427767|NCT03719105|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102427768|NCT03719105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102427769|NCT03719105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102427770|NCT03719105|Immunotoxins|immunotoxins|mesh-ancestor
102427771|NCT03719105|Immunoconjugates|immunoconjugates|mesh-ancestor
102427772|NCT00979875|Insulin|insulin|mesh-list
102427773|NCT00979875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102427774|NCT00979875|Insulin Aspart|insulin aspart|mesh-list
102427775|NCT00979875|Insulin Lispro|insulin lispro|mesh-list
102427776|NCT00979875|Insulin glulisine|insulin glulisine|mesh-list
102427777|NCT00979875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102427778|NCT00979875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427779|NCT03710603|Dexamethasone|dexamethasone|mesh-list
102427780|NCT03710603|Dexamethasone acetate|dexamethasone acetate|mesh-list
102427781|NCT03710603|Lenalidomide|lenalidomide|mesh-list
102427782|NCT03710603|Bortezomib|bortezomib|mesh-list
102427783|NCT03710603|Daratumumab|daratumumab|mesh-list
102427784|NCT03710603|BB 1101|bb 1101|mesh-list
102427785|NCT03710603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102427786|NCT03710603|Antiemetics|antiemetics|mesh-ancestor
102427787|NCT03710603|Autonomic Agents|autonomic agents|mesh-ancestor
102427788|NCT03710603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102427789|NCT03710603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427790|NCT03710603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102427791|NCT03710603|Glucocorticoids|glucocorticoids|mesh-ancestor
102427792|NCT03710603|Hormones|hormones|mesh-ancestor
102058472|NCT02050152|Nitrous Oxide|nitrous oxide|mesh-list
102427793|NCT03710603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102427794|NCT03710603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102427795|NCT03710603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102427796|NCT03710603|Protease Inhibitors|protease inhibitors|mesh-ancestor
102427797|NCT03710603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102427798|NCT03710603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427799|NCT03710603|Immunologic Factors|immunologic factors|mesh-ancestor
102427800|NCT03710603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102427801|NCT03710603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102427802|NCT03710603|Growth Substances|growth substances|mesh-ancestor
102427803|NCT03710603|Growth Inhibitors|growth inhibitors|mesh-ancestor
102427804|NCT02630706|Metformin|metformin|mesh-list
102427805|NCT02630706|Glimepiride|glimepiride|mesh-list
102427806|NCT02630706|Ertugliflozin|ertugliflozin|mesh-list
102427807|NCT02630706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102427808|NCT02630706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427809|NCT02630706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102427810|NCT02630706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102427811|NCT02630706|Immunologic Factors|immunologic factors|mesh-ancestor
102427812|NCT02630706|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102427813|NCT02630706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427814|NCT04763057|Calcium|calcium|mesh-list
102427815|NCT04763057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102427816|NCT04763057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427817|NCT03702179|Durvalumab|durvalumab|mesh-list
102427818|NCT03702179|Tremelimumab|tremelimumab|mesh-list
102239500|NCT05015361|Anesthetics|anesthetics|mesh-ancestor
102427819|NCT03702179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102427820|NCT03702179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102427821|NCT01677143|Bupivacaine|bupivacaine|mesh-list
102427822|NCT01677143|Anesthetics, Local|anesthetics, local|mesh-ancestor
102427823|NCT01677143|Anesthetics|anesthetics|mesh-ancestor
102427824|NCT01677143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102427825|NCT01677143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427826|NCT01677143|Sensory System Agents|sensory system agents|mesh-ancestor
102427827|NCT01677143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102427828|NCT03692663|Cyclophosphamide|cyclophosphamide|mesh-list
102427829|NCT03692663|Fludarabine|fludarabine|mesh-list
102427830|NCT03692663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102427831|NCT03692663|Immunologic Factors|immunologic factors|mesh-ancestor
102427832|NCT03692663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427833|NCT03692663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102427834|NCT03692663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102427835|NCT03692663|Alkylating Agents|alkylating agents|mesh-ancestor
102427836|NCT03692663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427837|NCT03692663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102427838|NCT03692663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102427839|NCT02084069|Atorvastatin|atorvastatin|mesh-list
102427840|NCT02084069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102427841|NCT02084069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102427842|NCT02084069|Antimetabolites|antimetabolites|mesh-ancestor
102427843|NCT02084069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427844|NCT02084069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102427845|NCT02084069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102427846|NCT02084069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102427847|NCT03685331|Fulvestrant|fulvestrant|mesh-list
102427848|NCT03685331|Olaparib|olaparib|mesh-list
102427849|NCT03685331|Palbociclib|palbociclib|mesh-list
102427850|NCT03685331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102427851|NCT03685331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102427852|NCT03685331|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102427853|NCT03685331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102427854|NCT03685331|Hormone Antagonists|hormone antagonists|mesh-ancestor
102427855|NCT03685331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102058520|NCT05212025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102427856|NCT03685331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427857|NCT03685331|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102427858|NCT03685331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102427859|NCT03685331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427860|NCT03685331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102427861|NCT04626024|Imatinib Mesylate|imatinib mesylate|mesh-list
102427862|NCT04626024|Dasatinib|dasatinib|mesh-list
102058545|NCT02051946|Diuretics|diuretics|mesh-ancestor
102427863|NCT04626024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102427864|NCT04626024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102427865|NCT04626024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102058550|NCT02049606|Nabumetone|nabumetone|mesh-list
102427866|NCT04626024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427867|NCT00981045|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102427868|NCT00981045|Hematinics|hematinics|mesh-ancestor
102427869|NCT00981435|Prednisolone|prednisolone|mesh-list
102427870|NCT00981435|Prednisolone acetate|prednisolone acetate|mesh-list
102427871|NCT00981435|Ketorolac|ketorolac|mesh-list
102427872|NCT00981435|Lubricant Eye Drops|lubricant eye drops|mesh-list
102427873|NCT00981435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102427874|NCT00981435|Glucocorticoids|glucocorticoids|mesh-ancestor
102427875|NCT00981435|Hormones|hormones|mesh-ancestor
102427876|NCT00981435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101616596|NCT00869440|Anesthetics|anesthetics|mesh-ancestor
102427877|NCT00981435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427878|NCT00981435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102427879|NCT00981435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102427880|NCT00981435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102058563|NCT05071703|Carboplatin|carboplatin|mesh-list
102427881|NCT00981435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102427882|NCT00981435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102427883|NCT00981435|Analgesics|analgesics|mesh-ancestor
102427884|NCT00981435|Sensory System Agents|sensory system agents|mesh-ancestor
102427885|NCT00981435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102427886|NCT00981435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102427887|NCT00981435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102427888|NCT00981435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427889|NCT00981435|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102427890|NCT00981435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102427891|NCT04571580|Reteplase|reteplase|mesh-list
102427892|NCT04571580|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102427893|NCT04571580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102427894|NCT04571580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102427895|NCT04571580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427896|NCT00981669|Vaccines|vaccines|mesh-list
102427897|NCT00981669|Immunologic Factors|immunologic factors|mesh-ancestor
102427898|NCT00981669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427899|NCT00981825|Listerine|listerine|mesh-list
102427900|NCT00981825|Triclosan|triclosan|mesh-list
102427901|NCT00981825|Fluorides|fluorides|mesh-list
102427902|NCT00981825|Sodium Fluoride|sodium fluoride|mesh-list
102427903|NCT00981825|Cariostatic Agents|cariostatic agents|mesh-ancestor
102427904|NCT00981825|Protective Agents|protective agents|mesh-ancestor
102427905|NCT00981825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427906|NCT00981825|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102427907|NCT00981825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102427908|NCT00981825|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102427909|NCT00981825|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102427910|NCT00981825|Antimetabolites|antimetabolites|mesh-ancestor
102427911|NCT00981825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427912|NCT00981825|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102427913|NCT00983307|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102427914|NCT00983307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102427915|NCT00983307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102427916|NCT00983307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102427917|NCT00983307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427918|NCT04762745|Thalidomide|thalidomide|mesh-list
102427919|NCT04762745|Dexamethasone|dexamethasone|mesh-list
102427920|NCT04762745|Dexamethasone acetate|dexamethasone acetate|mesh-list
102427921|NCT04762745|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102427922|NCT04762745|Pomalidomide|pomalidomide|mesh-list
102427923|NCT04762745|BB 1101|bb 1101|mesh-list
102427924|NCT04762745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102427925|NCT04762745|Antiemetics|antiemetics|mesh-ancestor
102427926|NCT04762745|Autonomic Agents|autonomic agents|mesh-ancestor
102427927|NCT04762745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102427928|NCT04762745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427929|NCT04762745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102427930|NCT04762745|Glucocorticoids|glucocorticoids|mesh-ancestor
102427931|NCT04762745|Hormones|hormones|mesh-ancestor
102427932|NCT04762745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102427933|NCT04762745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102427934|NCT04762745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102427935|NCT04762745|Protease Inhibitors|protease inhibitors|mesh-ancestor
102427936|NCT04762745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102427937|NCT04762745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427938|NCT04762745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102427939|NCT04762745|Alkylating Agents|alkylating agents|mesh-ancestor
102427940|NCT04762745|Immunologic Factors|immunologic factors|mesh-ancestor
102427941|NCT04762745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102427942|NCT04762745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102427943|NCT04762745|Growth Substances|growth substances|mesh-ancestor
102427944|NCT04762745|Growth Inhibitors|growth inhibitors|mesh-ancestor
102427945|NCT04762745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102427946|NCT04762745|Leprostatic Agents|leprostatic agents|mesh-ancestor
102427947|NCT04762745|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102427948|NCT04762745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102427949|NCT00983541|Gemcitabine|gemcitabine|mesh-list
102427950|NCT00983541|Fluorouracil|fluorouracil|mesh-list
102427951|NCT00983541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102427952|NCT00983541|Antimetabolites|antimetabolites|mesh-ancestor
102427953|NCT00983541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427954|NCT00983541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102427955|NCT00983541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102427956|NCT00983541|Immunologic Factors|immunologic factors|mesh-ancestor
102427957|NCT00983541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427958|NCT03667703|Famotidine|famotidine|mesh-list
102427959|NCT03667703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102427960|NCT03667703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102427961|NCT03667703|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102427962|NCT03667703|Histamine Antagonists|histamine antagonists|mesh-ancestor
102427963|NCT03667703|Histamine Agents|histamine agents|mesh-ancestor
102427964|NCT03667703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102427965|NCT03667703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427966|NCT03667703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427967|NCT05074056|Ketorolac|ketorolac|mesh-list
102427968|NCT05074056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102427969|NCT05074056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102427970|NCT05074056|Analgesics|analgesics|mesh-ancestor
102427971|NCT05074056|Sensory System Agents|sensory system agents|mesh-ancestor
102427972|NCT05074056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102427973|NCT05074056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427974|NCT05074056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102427975|NCT05074056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102427976|NCT05074056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102427977|NCT05074056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102427978|NCT05074056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427979|NCT03656549|Pemetrexed|pemetrexed|mesh-list
102427980|NCT03656549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102427981|NCT03656549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102427982|NCT03656549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427983|NCT03656549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102427984|NCT03656549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102427985|NCT03062904|Methacholine Chloride|methacholine chloride|mesh-list
102427986|NCT03062904|Bronchodilator Agents|bronchodilator agents|mesh-list
102427987|NCT03062904|Miotics|miotics|mesh-ancestor
102427988|NCT03062904|Autonomic Agents|autonomic agents|mesh-ancestor
102427989|NCT03062904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102427990|NCT03062904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102427991|NCT03062904|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102427992|NCT03062904|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
102427993|NCT03062904|Respiratory System Agents|respiratory system agents|mesh-ancestor
102427994|NCT03062904|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102427995|NCT03062904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102427996|NCT03062904|Cholinergic Agents|cholinergic agents|mesh-ancestor
102427997|NCT03062904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102427998|NCT03062904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102427999|NCT03062904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102428000|NCT00986583|Succinylcholine|succinylcholine|mesh-list
102428001|NCT00986583|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
102428002|NCT00986583|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102428003|NCT00986583|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102428004|NCT00986583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102428005|NCT00986583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428007|NCT05056974|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102428008|NCT05056974|Antiviral Agents|antiviral agents|mesh-ancestor
102428009|NCT05056974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102428010|NCT03643913|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
102428011|NCT03643913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102428012|NCT03643913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102428013|NCT03643913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428014|NCT04762511|Vaccines|vaccines|mesh-list
102428015|NCT04762511|Immunologic Factors|immunologic factors|mesh-ancestor
102428016|NCT04762511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428017|NCT04762901|Paclitaxel|paclitaxel|mesh-list
102428018|NCT04762901|Cyclophosphamide|cyclophosphamide|mesh-list
102428019|NCT04762901|Carboplatin|carboplatin|mesh-list
102428020|NCT04762901|Doxorubicin|doxorubicin|mesh-list
102428021|NCT04762901|Niraparib|niraparib|mesh-list
102428022|NCT04762901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102428023|NCT04762901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102428024|NCT04762901|Tubulin Modulators|tubulin modulators|mesh-ancestor
102428025|NCT04762901|Antimitotic Agents|antimitotic agents|mesh-ancestor
102428026|NCT04762901|Mitosis Modulators|mitosis modulators|mesh-ancestor
102428027|NCT04762901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428028|NCT04762901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102428029|NCT04762901|Immunologic Factors|immunologic factors|mesh-ancestor
102428030|NCT04762901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428031|NCT04762901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102428032|NCT04762901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102428033|NCT04762901|Alkylating Agents|alkylating agents|mesh-ancestor
102428034|NCT04762901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102428035|NCT04762901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102428036|NCT04762901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102428037|NCT04762901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102428038|NCT04762901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102428039|NCT04762901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102428040|NCT00988143|Vaccines|vaccines|mesh-list
102428041|NCT00988143|Immunologic Factors|immunologic factors|mesh-ancestor
102428042|NCT00988143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428043|NCT03018171|Clonidine|clonidine|mesh-list
102428045|NCT03018171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102428046|NCT03018171|Narcotics|narcotics|mesh-ancestor
102428047|NCT03018171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102428048|NCT03018171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428049|NCT03018171|Analgesics|analgesics|mesh-ancestor
102428050|NCT03018171|Sensory System Agents|sensory system agents|mesh-ancestor
101366085|NCT00154180|Hormones|hormones|mesh-ancestor
102428051|NCT03018171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102428052|NCT03018171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102428053|NCT03018171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102428054|NCT03018171|Anesthetics, General|anesthetics, general|mesh-ancestor
102428055|NCT03018171|Anesthetics|anesthetics|mesh-ancestor
102428056|NCT03018171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102428057|NCT03018171|Sympatholytics|sympatholytics|mesh-ancestor
102428058|NCT03018171|Autonomic Agents|autonomic agents|mesh-ancestor
102428059|NCT03018171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102428060|NCT03018171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102058730|NCT05051189|Fentanyl|fentanyl|mesh-list
102428061|NCT03018171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102428062|NCT03018171|Adrenergic Agents|adrenergic agents|mesh-ancestor
102428063|NCT03018171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102428064|NCT03018171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428065|NCT03638375|Interferons|interferons|mesh-list
102428066|NCT03638375|Interferon-alpha|interferon-alpha|mesh-list
102428067|NCT03638375|Nivolumab|nivolumab|mesh-list
102428068|NCT03638375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102058741|NCT05051189|Anesthetics|anesthetics|mesh-ancestor
102428069|NCT03638375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102428070|NCT03638375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102428071|NCT03638375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428072|NCT03638375|Antiviral Agents|antiviral agents|mesh-ancestor
102428073|NCT03638375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102428074|NCT03638375|Immunologic Factors|immunologic factors|mesh-ancestor
102058747|NCT04521647|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102428075|NCT03638375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428076|NCT00989157|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102428077|NCT00989157|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102428078|NCT00989157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102428079|NCT00989157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102428080|NCT00989157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428081|NCT00989157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102428082|NCT00989157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428083|NCT00989157|Analgesics|analgesics|mesh-ancestor
102428084|NCT00989157|Sensory System Agents|sensory system agents|mesh-ancestor
102428085|NCT00989157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102428086|NCT00989157|Antidepressive Agents|antidepressive agents|mesh-ancestor
102428087|NCT00989157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102428088|NCT00989157|Dopamine Agents|dopamine agents|mesh-ancestor
102428089|NCT00990561|Clobetasol|clobetasol|mesh-list
102428090|NCT00990561|Halobetasol|halobetasol|mesh-list
102428091|NCT00990561|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102428092|NCT00990561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102428093|NCT00990561|Glucocorticoids|glucocorticoids|mesh-ancestor
102428094|NCT00990561|Hormones|hormones|mesh-ancestor
102428095|NCT00990561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102428096|NCT00990561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428097|NCT03018015|Ibuprofen|ibuprofen|mesh-list
102428098|NCT03018015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102428099|NCT03018015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102428100|NCT03018015|Analgesics|analgesics|mesh-ancestor
102428101|NCT03018015|Sensory System Agents|sensory system agents|mesh-ancestor
102428102|NCT03018015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102428103|NCT03018015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428104|NCT03018015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102428105|NCT03018015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102428106|NCT03018015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102428107|NCT03018015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102428108|NCT03018015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428109|NCT03614741|Tinzaparin|tinzaparin|mesh-list
102428110|NCT03614741|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102428111|NCT03614741|Dalteparin|dalteparin|mesh-list
102428112|NCT03614741|Anticoagulants|anticoagulants|mesh-ancestor
102428113|NCT03614741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102428114|NCT03614741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102058782|NCT03674567|Pembrolizumab|pembrolizumab|mesh-list
102428115|NCT03614741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428116|NCT03609593|Rituximab|rituximab|mesh-list
102428117|NCT03609593|Venetoclax|venetoclax|mesh-list
102239819|NCT02487953|Nicotine|nicotine|mesh-list
102428118|NCT03609593|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102428119|NCT03609593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102428120|NCT03609593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102428122|NCT03609593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058790|NCT04390399|Leucovorin|leucovorin|mesh-list
102428123|NCT03609593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102428124|NCT03609593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102428125|NCT03609593|Alkylating Agents|alkylating agents|mesh-ancestor
102428126|NCT03609593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428127|NCT00004547|Paclitaxel|paclitaxel|mesh-list
102428128|NCT00004547|Cisplatin|cisplatin|mesh-list
102428129|NCT00004547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102428130|NCT00004547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102428131|NCT00004547|Tubulin Modulators|tubulin modulators|mesh-ancestor
102428132|NCT00004547|Antimitotic Agents|antimitotic agents|mesh-ancestor
102428133|NCT00004547|Mitosis Modulators|mitosis modulators|mesh-ancestor
102428134|NCT00004547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428135|NCT00005669|Metformin|metformin|mesh-list
102428136|NCT00005669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102428137|NCT00005669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428138|NCT02089997|Risedronic Acid|risedronic acid|mesh-list
102428139|NCT02089997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102428140|NCT02089997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102428141|NCT02089997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428142|NCT02089997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102428143|NCT02089997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428144|NCT02089997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102428145|NCT01363661|Molsidomine|molsidomine|mesh-list
102428146|NCT01363661|Vasodilator Agents|vasodilator agents|mesh-ancestor
102428147|NCT01363661|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102428148|NCT01363661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428149|NCT02628600|Amikacin|amikacin|mesh-list
102428150|NCT02628600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102428151|NCT02628600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102428152|NCT00006101|Eflornithine|eflornithine|mesh-list
102428153|NCT00006101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102428154|NCT00006101|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102428155|NCT00006101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102428156|NCT00006101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102428157|NCT00006101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102428158|NCT00006101|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
102428159|NCT00006101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102428160|NCT00006101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428161|NCT04294134|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
102428162|NCT04294134|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102428163|NCT04294134|Serotonin Agents|serotonin agents|mesh-ancestor
102428164|NCT04294134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102428165|NCT04294134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428166|NCT04294134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428167|NCT04437888|Ketamine|ketamine|mesh-list
102428168|NCT04437888|Analgesics|analgesics|mesh-ancestor
102428169|NCT04437888|Sensory System Agents|sensory system agents|mesh-ancestor
101367142|NCT00044577|Tenofovir|tenofovir|mesh-list
102428170|NCT04437888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102428171|NCT04437888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428172|NCT04437888|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102428173|NCT04437888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102428174|NCT04437888|Anesthetics, General|anesthetics, general|mesh-ancestor
102428175|NCT04437888|Anesthetics|anesthetics|mesh-ancestor
102428176|NCT04437888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102428177|NCT04437888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102428178|NCT04437888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102428179|NCT04437888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102428180|NCT04437888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428181|NCT00591318|Ceftriaxone|ceftriaxone|mesh-list
102428182|NCT00591318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102428183|NCT00591318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102428184|NCT00991029|Clopidogrel|clopidogrel|mesh-list
102428185|NCT00991029|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102428186|NCT00991029|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102428187|NCT00991029|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102428188|NCT00991029|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102428189|NCT00991029|Purinergic Agents|purinergic agents|mesh-ancestor
102428191|NCT00991029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428192|NCT00991029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428193|NCT00991809|Diphenhydramine|diphenhydramine|mesh-list
102428194|NCT00991809|Promethazine|promethazine|mesh-list
102428195|NCT00991809|Alfentanil|alfentanil|mesh-list
102428196|NCT00991809|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102428197|NCT00991809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102428198|NCT00991809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102428199|NCT00991809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428200|NCT00991809|Anesthetics, Local|anesthetics, local|mesh-ancestor
102428201|NCT00991809|Anesthetics|anesthetics|mesh-ancestor
102428202|NCT00991809|Sensory System Agents|sensory system agents|mesh-ancestor
102428203|NCT00991809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102428204|NCT00991809|Antiemetics|antiemetics|mesh-ancestor
102428205|NCT00991809|Autonomic Agents|autonomic agents|mesh-ancestor
102428206|NCT00991809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102428207|NCT00991809|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102428208|NCT00991809|Histamine Antagonists|histamine antagonists|mesh-ancestor
101367478|NCT00162799|Triflusal|triflusal|mesh-list
102428209|NCT00991809|Histamine Agents|histamine agents|mesh-ancestor
102428210|NCT00991809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102428211|NCT00991809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428212|NCT00991809|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102428213|NCT00991809|Antipruritics|antipruritics|mesh-ancestor
102428214|NCT00991809|Dermatologic Agents|dermatologic agents|mesh-ancestor
102428215|NCT00991809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102428216|NCT00991809|Narcotics|narcotics|mesh-ancestor
102428217|NCT00991809|Analgesics|analgesics|mesh-ancestor
102428218|NCT00991809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102428219|NCT00991809|Anesthetics, General|anesthetics, general|mesh-ancestor
102428220|NCT02627274|Trastuzumab|trastuzumab|mesh-list
102428221|NCT02627274|Cetuximab|cetuximab|mesh-list
102428222|NCT02627274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102428223|NCT02627274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102428224|NCT04982016|Methamphetamine|methamphetamine|mesh-list
102428225|NCT04982016|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102428226|NCT04982016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428227|NCT04982016|Sympathomimetics|sympathomimetics|mesh-ancestor
102428228|NCT04982016|Autonomic Agents|autonomic agents|mesh-ancestor
102428229|NCT04982016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102428230|NCT04982016|Dopamine Agents|dopamine agents|mesh-ancestor
102428231|NCT04982016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102428232|NCT04982016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428233|NCT04982016|Adrenergic Agents|adrenergic agents|mesh-ancestor
102428234|NCT04982016|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102428235|NCT04982016|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102428236|NCT04982016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102428237|NCT04982016|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102428238|NCT04436250|Ketamine|ketamine|mesh-list
102428239|NCT04436250|Esketamine|esketamine|mesh-list
102428240|NCT04436250|Analgesics|analgesics|mesh-ancestor
102428241|NCT04436250|Sensory System Agents|sensory system agents|mesh-ancestor
102428242|NCT04436250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102428243|NCT04436250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428244|NCT04436250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102428245|NCT04436250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102428246|NCT04436250|Anesthetics, General|anesthetics, general|mesh-ancestor
102428247|NCT04436250|Anesthetics|anesthetics|mesh-ancestor
102428248|NCT04436250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102428249|NCT04436250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102428250|NCT04436250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102428251|NCT04436250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102428252|NCT04436250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428253|NCT04436250|Antidepressive Agents|antidepressive agents|mesh-ancestor
102428254|NCT04436250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102428255|NCT00994929|Oprelvekin|oprelvekin|mesh-list
102428256|NCT00994929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102428257|NCT00929253|Buprenorphine|buprenorphine|mesh-list
102428258|NCT00929253|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102428259|NCT00929253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102428260|NCT00929253|Narcotics|narcotics|mesh-ancestor
102428261|NCT00929253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102428262|NCT00929253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428263|NCT00929253|Analgesics|analgesics|mesh-ancestor
102428264|NCT00929253|Sensory System Agents|sensory system agents|mesh-ancestor
102428265|NCT00929253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102428267|NCT00771693|Insulin Aspart|insulin aspart|mesh-list
102428268|NCT00771693|Insulin, Long-Acting|insulin, long-acting|mesh-list
102428269|NCT00771693|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102428270|NCT00771693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102428271|NCT00771693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428272|NCT04374903|Sirolimus|sirolimus|mesh-list
102428273|NCT04374903|Azithromycin|azithromycin|mesh-list
102428274|NCT04374903|Hydroxychloroquine|hydroxychloroquine|mesh-list
102428275|NCT04374903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102428276|NCT04374903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102428277|NCT04374903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102428278|NCT04374903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102428279|NCT04374903|Antifungal Agents|antifungal agents|mesh-ancestor
102428280|NCT04374903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102428281|NCT04374903|Immunologic Factors|immunologic factors|mesh-ancestor
102428282|NCT04374903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428283|NCT04374903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102058936|NCT02419742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102428284|NCT04374903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428285|NCT04374903|Antimalarials|antimalarials|mesh-ancestor
102428286|NCT04374903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102428287|NCT04374903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102428288|NCT04374903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102428289|NCT03062982|Fluzoparib|fluzoparib|mesh-list
102428290|NCT03062982|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102428291|NCT03062982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102058947|NCT02409290|Kanamycin|kanamycin|mesh-list
101360569|NCT00217048|Yohimbine|yohimbine|mesh-list
102428292|NCT03062982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428293|NCT03062982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102428294|NCT03062436|Tin Fluorides|tin fluorides|mesh-list
102428295|NCT03062436|Cariostatic Agents|cariostatic agents|mesh-ancestor
102428296|NCT03062436|Protective Agents|protective agents|mesh-ancestor
102428297|NCT03062436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428298|NCT03500874|Leucovorin|leucovorin|mesh-list
102428299|NCT03500874|Fluorouracil|fluorouracil|mesh-list
102428300|NCT03500874|Floxuridine|floxuridine|mesh-list
102428301|NCT03500874|Oxaliplatin|oxaliplatin|mesh-list
102428302|NCT03500874|Antimetabolites|antimetabolites|mesh-ancestor
102428303|NCT03500874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368346|NCT00168025|Immunologic Factors|immunologic factors|mesh-ancestor
102428304|NCT03500874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102428305|NCT03500874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102428306|NCT03500874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102428307|NCT03500874|Immunologic Factors|immunologic factors|mesh-ancestor
102428308|NCT03500874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428309|NCT03500874|Antidotes|antidotes|mesh-ancestor
102428310|NCT03500874|Protective Agents|protective agents|mesh-ancestor
102428311|NCT03500874|Vitamin B Complex|vitamin b complex|mesh-ancestor
102428312|NCT03500874|Vitamins|vitamins|mesh-ancestor
102428313|NCT03500874|Micronutrients|micronutrients|mesh-ancestor
102428314|NCT00997113|Alfentanil|alfentanil|mesh-list
102428315|NCT00997113|Propofol|propofol|mesh-list
102428316|NCT00997113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102428317|NCT00997113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102428318|NCT00997113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428319|NCT00997113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102428320|NCT00997113|Anesthetics, General|anesthetics, general|mesh-ancestor
102428321|NCT00997113|Anesthetics|anesthetics|mesh-ancestor
102428322|NCT00997113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102428323|NCT00997113|Narcotics|narcotics|mesh-ancestor
102428324|NCT00997113|Analgesics|analgesics|mesh-ancestor
102428325|NCT00997113|Sensory System Agents|sensory system agents|mesh-ancestor
102428326|NCT00997113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102428327|NCT04981704|Itraconazole|itraconazole|mesh-list
102428328|NCT04981704|Phenytoin|phenytoin|mesh-list
102428329|NCT04981704|Paroxetine|paroxetine|mesh-list
102428330|NCT04981704|Antifungal Agents|antifungal agents|mesh-ancestor
102428331|NCT04981704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102428332|NCT04981704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102428333|NCT04981704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102428334|NCT04981704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102428335|NCT04981704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428336|NCT04981704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102428337|NCT04981704|Hormone Antagonists|hormone antagonists|mesh-ancestor
102428338|NCT04981704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102428339|NCT04981704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428340|NCT04981704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102428341|NCT04981704|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102428342|NCT04981704|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102428343|NCT04981704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102428344|NCT04981704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102428345|NCT04981704|Serotonin Agents|serotonin agents|mesh-ancestor
102428346|NCT04981704|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102428347|NCT04981704|Antidepressive Agents|antidepressive agents|mesh-ancestor
102428348|NCT04981704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102428349|NCT04981704|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102428350|NCT04981704|Anticonvulsants|anticonvulsants|mesh-ancestor
102428351|NCT04981704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102428352|NCT04981704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102428353|NCT04981704|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102428354|NCT04981704|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102428355|NCT02163837|Rifaximin|rifaximin|mesh-list
102428356|NCT02163837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102428357|NCT02163837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102428358|NCT02163837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102428359|NCT04974060|Remifentanil|remifentanil|mesh-list
102428360|NCT04974060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102428361|NCT04974060|Narcotics|narcotics|mesh-ancestor
102428362|NCT04974060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102428363|NCT04974060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428364|NCT04974060|Analgesics|analgesics|mesh-ancestor
102428365|NCT04974060|Sensory System Agents|sensory system agents|mesh-ancestor
102428366|NCT04974060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102428367|NCT01021761|Ketorolac|ketorolac|mesh-list
102428368|NCT01021761|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102428369|NCT01021761|Nepafenac|nepafenac|mesh-list
102428370|NCT01021761|Bromfenac|bromfenac|mesh-list
102428371|NCT01021761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102428372|NCT01021761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102428373|NCT01021761|Analgesics|analgesics|mesh-ancestor
102428374|NCT01021761|Sensory System Agents|sensory system agents|mesh-ancestor
102428375|NCT01021761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102428376|NCT01021761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428377|NCT01021761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102428378|NCT01021761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102428379|NCT01021761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102428380|NCT01021761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102428381|NCT01021761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428382|NCT04973904|Paclitaxel|paclitaxel|mesh-list
102428383|NCT04973904|Bevacizumab|bevacizumab|mesh-list
102428384|NCT04973904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102428385|NCT04973904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102428386|NCT04973904|Tubulin Modulators|tubulin modulators|mesh-ancestor
102428387|NCT04973904|Antimitotic Agents|antimitotic agents|mesh-ancestor
102428388|NCT04973904|Mitosis Modulators|mitosis modulators|mesh-ancestor
102428389|NCT04973904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428390|NCT04973904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102428391|NCT04973904|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102428392|NCT04973904|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102428393|NCT04973904|Growth Substances|growth substances|mesh-ancestor
102428394|NCT04973904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059039|NCT02142530|Belinostat|belinostat|mesh-list
102428395|NCT04973904|Growth Inhibitors|growth inhibitors|mesh-ancestor
102428396|NCT00998049|Plerixafor|plerixafor|mesh-list
102428397|NCT00998049|Lenograstim|lenograstim|mesh-list
102428398|NCT00998049|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102428399|NCT00998049|Immunologic Factors|immunologic factors|mesh-ancestor
102428400|NCT00998049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428401|NCT00998049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102428402|NCT00998049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102428403|NCT00998049|Antiviral Agents|antiviral agents|mesh-ancestor
102428404|NCT00998049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102428405|NCT00998205|Atropine|atropine|mesh-list
102428406|NCT00998205|Dobutamine|dobutamine|mesh-list
102428407|NCT00998205|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102428408|NCT00998205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102428409|NCT00998205|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102428410|NCT00998205|Autonomic Agents|autonomic agents|mesh-ancestor
102428411|NCT00998205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102428412|NCT00998205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428413|NCT00998205|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102428414|NCT00998205|Respiratory System Agents|respiratory system agents|mesh-ancestor
102428415|NCT00998205|Mydriatics|mydriatics|mesh-ancestor
102240104|NCT03318419|Cytarabine|cytarabine|mesh-list
102428416|NCT00998205|Parasympatholytics|parasympatholytics|mesh-ancestor
102428417|NCT00998205|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102428418|NCT00998205|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102428419|NCT00998205|Cholinergic Agents|cholinergic agents|mesh-ancestor
102428420|NCT00998205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102428421|NCT00998205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428422|NCT00998205|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102428423|NCT00998205|Sympathomimetics|sympathomimetics|mesh-ancestor
102428424|NCT00998205|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102428425|NCT00998205|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102059068|NCT01383343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102059069|NCT01383343|Antimetabolites|antimetabolites|mesh-ancestor
101360690|NCT00041990|Decitabine|decitabine|mesh-list
102428426|NCT00998205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102428427|NCT00998205|Adrenergic Agents|adrenergic agents|mesh-ancestor
102428428|NCT00998205|Protective Agents|protective agents|mesh-ancestor
102428429|NCT02626182|Sildenafil Citrate|sildenafil citrate|mesh-list
102428430|NCT02626182|Vasodilator Agents|vasodilator agents|mesh-ancestor
102428431|NCT02626182|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102428432|NCT02626182|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102428433|NCT02626182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102428434|NCT02626182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428435|NCT02626182|Urological Agents|urological agents|mesh-ancestor
102428436|NCT01023477|Chloroquine|chloroquine|mesh-list
102059074|NCT01383343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102059075|NCT01383343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102059076|NCT01383343|Antidotes|antidotes|mesh-ancestor
102059077|NCT01383343|Protective Agents|protective agents|mesh-ancestor
102059078|NCT01383343|Vitamin B Complex|vitamin b complex|mesh-ancestor
102059079|NCT01383343|Vitamins|vitamins|mesh-ancestor
102059080|NCT01383343|Micronutrients|micronutrients|mesh-ancestor
102059081|NCT01383343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102059082|NCT01383343|Hematinics|hematinics|mesh-ancestor
102059083|NCT01383343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102059084|NCT03631147|Rifaximin|rifaximin|mesh-list
102059085|NCT03631147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101304497|NCT02013271|Antimitotic Agents|antimitotic agents|mesh-ancestor
101304498|NCT02013271|Mitosis Modulators|mitosis modulators|mesh-ancestor
101304499|NCT02013271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304500|NCT02013362|Folic Acid|folic acid|mesh-list
101304501|NCT02013362|Vitamin B 12|vitamin b 12|mesh-list
101304502|NCT02013362|Hydroxocobalamin|hydroxocobalamin|mesh-list
101304503|NCT02013362|Vitamins|vitamins|mesh-ancestor
101304504|NCT02013362|Micronutrients|micronutrients|mesh-ancestor
101304505|NCT02013362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304506|NCT02013362|Hematinics|hematinics|mesh-ancestor
101304507|NCT02013362|Vitamin B Complex|vitamin b complex|mesh-ancestor
101304508|NCT02013453|Paclitaxel|paclitaxel|mesh-list
101304509|NCT02013453|Carboplatin|carboplatin|mesh-list
101304510|NCT02013453|Fluorouracil|fluorouracil|mesh-list
101304511|NCT02013453|Pemetrexed|pemetrexed|mesh-list
101304512|NCT02013453|Omeprazole|omeprazole|mesh-list
101304513|NCT02013453|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101304514|NCT02013453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102428437|NCT01023477|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
102428438|NCT01023477|Amebicides|amebicides|mesh-ancestor
102428439|NCT01023477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102428440|NCT01023477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102428441|NCT01023477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102428442|NCT01023477|Antimalarials|antimalarials|mesh-ancestor
102428443|NCT01023477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102428444|NCT01023477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102428445|NCT01023477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102428446|NCT01023477|Analgesics|analgesics|mesh-ancestor
102428447|NCT01023477|Sensory System Agents|sensory system agents|mesh-ancestor
102428448|NCT01023477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102059088|NCT02148848|Risedronic Acid|risedronic acid|mesh-list
102428449|NCT01023477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428450|NCT01023477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102428451|NCT01023477|Filaricides|filaricides|mesh-ancestor
102428452|NCT01023477|Antinematodal Agents|antinematodal agents|mesh-ancestor
102428453|NCT01023477|Anthelmintics|anthelmintics|mesh-ancestor
102428454|NCT01023711|Vaccines|vaccines|mesh-list
102428455|NCT01023711|Immunologic Factors|immunologic factors|mesh-ancestor
102428456|NCT01023711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428457|NCT01001403|Nafamostat|nafamostat|mesh-list
102059097|NCT03265145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102428458|NCT01001403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102428459|NCT01001403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102428460|NCT01001403|Analgesics|analgesics|mesh-ancestor
102428461|NCT01001403|Sensory System Agents|sensory system agents|mesh-ancestor
102428462|NCT01001403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102428463|NCT01001403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428464|NCT01001403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102428465|NCT01001403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102428466|NCT01001403|Anticoagulants|anticoagulants|mesh-ancestor
102428467|NCT01001403|Protease Inhibitors|protease inhibitors|mesh-ancestor
102428468|NCT01001403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102428469|NCT01001403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369341|NCT02963779|Apremilast|apremilast|mesh-list
102428470|NCT01001403|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102428471|NCT01001403|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102428472|NCT01001403|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102428473|NCT01001403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102428474|NCT01001403|Immunologic Factors|immunologic factors|mesh-ancestor
102428475|NCT01024335|Naltrexone|naltrexone|mesh-list
102428476|NCT01024335|Dronabinol|dronabinol|mesh-list
102428477|NCT01024335|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102428478|NCT01024335|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102059116|NCT05344495|GABA Modulators|gaba modulators|mesh-ancestor
102428479|NCT01024335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428480|NCT01024335|Sensory System Agents|sensory system agents|mesh-ancestor
102428481|NCT01024335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102428482|NCT01024335|Hallucinogens|hallucinogens|mesh-ancestor
102428483|NCT01024335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102428484|NCT01024335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102428485|NCT01024335|Analgesics|analgesics|mesh-ancestor
102428486|NCT01024335|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102428487|NCT01024335|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102428488|NCT01024335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102428489|NCT01024335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428490|NCT01024335|Hormones|hormones|mesh-ancestor
102240176|NCT05001243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102059124|NCT05960565|Hormones|hormones|mesh-ancestor
102428491|NCT01024335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102428493|NCT01001559|Serotonin|serotonin|mesh-list
102428494|NCT01001559|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
102428495|NCT01001559|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
102428496|NCT01001559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102428497|NCT01001559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102428498|NCT01001559|Adrenergic Agents|adrenergic agents|mesh-ancestor
102428499|NCT01001559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102059138|NCT05959889|Montelukast|montelukast|mesh-list
102428500|NCT01001559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428501|NCT01001559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428502|NCT01001559|Sympathomimetics|sympathomimetics|mesh-ancestor
102428503|NCT01001559|Autonomic Agents|autonomic agents|mesh-ancestor
102428504|NCT01001559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102428505|NCT01001559|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102428506|NCT01001559|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102428507|NCT01001559|Serotonin Agents|serotonin agents|mesh-ancestor
102428508|NCT01001559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102428509|NCT01001559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102428510|NCT01025427|Tenofovir|tenofovir|mesh-list
102428511|NCT01025427|Emtricitabine|emtricitabine|mesh-list
102428512|NCT01025427|Raltegravir Potassium|raltegravir potassium|mesh-list
102428513|NCT01025427|Antiviral Agents|antiviral agents|mesh-ancestor
102428514|NCT01025427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102428515|NCT01025427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102428516|NCT01025427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102428517|NCT01025427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102428518|NCT01025427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428519|NCT01025427|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102059157|NCT05959759|Immunologic Factors|immunologic factors|mesh-ancestor
102428520|NCT01025427|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102428521|NCT01025427|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102428522|NCT01025427|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102428523|NCT02162433|Dexmedetomidine|dexmedetomidine|mesh-list
102428524|NCT02162433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102428525|NCT02162433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102428526|NCT02162433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428527|NCT02162433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102428528|NCT02162433|Analgesics|analgesics|mesh-ancestor
102428529|NCT02162433|Sensory System Agents|sensory system agents|mesh-ancestor
102428530|NCT02162433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102428531|NCT02162433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102428532|NCT02162433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102428533|NCT02162433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102059169|NCT05959603|Vancomycin|vancomycin|mesh-list
102428534|NCT02162433|Adrenergic Agents|adrenergic agents|mesh-ancestor
102428535|NCT02162433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102428536|NCT02162433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428537|NCT01004991|Prednisone|prednisone|mesh-list
102428538|NCT01004991|Cyclophosphamide|cyclophosphamide|mesh-list
102428539|NCT01004991|Rituximab|rituximab|mesh-list
102428540|NCT01004991|Doxorubicin|doxorubicin|mesh-list
102428541|NCT01004991|Vincristine|vincristine|mesh-list
102428542|NCT01004991|Azacitidine|azacitidine|mesh-list
102428543|NCT01004991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102428544|NCT01004991|Immunologic Factors|immunologic factors|mesh-ancestor
102428545|NCT01004991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428546|NCT01004991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102428547|NCT01004991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102428548|NCT01004991|Alkylating Agents|alkylating agents|mesh-ancestor
102428549|NCT01004991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428550|NCT01004991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102428551|NCT01004991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102428552|NCT01004991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102428553|NCT01004991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102428554|NCT01004991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102428555|NCT01004991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102428556|NCT01004991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102428557|NCT01004991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102428558|NCT01004991|Glucocorticoids|glucocorticoids|mesh-ancestor
102428559|NCT01004991|Hormones|hormones|mesh-ancestor
102428560|NCT01004991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102428561|NCT01004991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102428562|NCT01004991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102240263|NCT05004753|Hormones|hormones|mesh-ancestor
102428563|NCT01004991|Tubulin Modulators|tubulin modulators|mesh-ancestor
102428564|NCT01004991|Antimitotic Agents|antimitotic agents|mesh-ancestor
102428565|NCT01004991|Mitosis Modulators|mitosis modulators|mesh-ancestor
102428566|NCT01004991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102428567|NCT01004991|Antimetabolites|antimetabolites|mesh-ancestor
102428569|NCT03063060|Calcium|calcium|mesh-list
102428570|NCT03063060|Vitamins|vitamins|mesh-ancestor
102428571|NCT03063060|Micronutrients|micronutrients|mesh-ancestor
102428572|NCT03063060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428573|NCT03063060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102428574|NCT03063060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102428575|NCT03115047|Meperidine|meperidine|mesh-list
102428576|NCT03115047|Dexmedetomidine|dexmedetomidine|mesh-list
102428577|NCT03115047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102428578|NCT03115047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102059212|NCT05958797|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102428579|NCT03115047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428580|NCT03115047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102428581|NCT03115047|Analgesics|analgesics|mesh-ancestor
102428582|NCT03115047|Sensory System Agents|sensory system agents|mesh-ancestor
102428583|NCT03115047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102428584|NCT03115047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102428585|NCT03115047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102428586|NCT03115047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102428587|NCT03115047|Adrenergic Agents|adrenergic agents|mesh-ancestor
102428588|NCT03115047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102428589|NCT03115047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428590|NCT03115047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102428591|NCT03115047|Narcotics|narcotics|mesh-ancestor
102428592|NCT03115047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102428593|NCT01026909|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102428594|NCT01026909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102428595|NCT03015519|rGLP-1 protein|rglp-1 protein|mesh-list
102428596|NCT03015519|Incretins|incretins|mesh-ancestor
102428597|NCT03015519|Hormones|hormones|mesh-ancestor
102428598|NCT03015519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102059238|NCT05955885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102428599|NCT03015519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428600|NCT01030653|Voriconazole|voriconazole|mesh-list
102428601|NCT01030653|Antifungal Agents|antifungal agents|mesh-ancestor
102428602|NCT01030653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102428603|NCT01030653|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102428604|NCT01030653|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102428605|NCT01030653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102428606|NCT01030653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428607|NCT01030653|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102428608|NCT01030653|Hormone Antagonists|hormone antagonists|mesh-ancestor
102428609|NCT01030653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102428610|NCT01030653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428611|NCT01030653|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102428612|NCT01031043|Bethanechol|bethanechol|mesh-list
102428613|NCT01031043|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102428614|NCT01031043|Autonomic Agents|autonomic agents|mesh-ancestor
102428615|NCT01031043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102428616|NCT01031043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428617|NCT01031043|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102428618|NCT01031043|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102428619|NCT01031043|Cholinergic Agents|cholinergic agents|mesh-ancestor
102428620|NCT01031043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102428621|NCT01031043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428622|NCT01050153|Aspirin|aspirin|mesh-list
102428623|NCT01050153|Dalteparin|dalteparin|mesh-list
102428624|NCT01050153|Tinzaparin|tinzaparin|mesh-list
102428625|NCT01050153|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102428626|NCT01050153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102428627|NCT01050153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102428628|NCT01050153|Analgesics|analgesics|mesh-ancestor
102428629|NCT01050153|Sensory System Agents|sensory system agents|mesh-ancestor
102428630|NCT01050153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102428631|NCT01050153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428632|NCT01050153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102428633|NCT01050153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102428634|NCT01050153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102428635|NCT01050153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102059273|NCT05909696|Rocuronium|rocuronium|mesh-list
102428636|NCT01050153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428637|NCT01050153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102428638|NCT01050153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102428639|NCT01050153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102428640|NCT01050153|Antipyretics|antipyretics|mesh-ancestor
102428641|NCT01050153|Anticoagulants|anticoagulants|mesh-ancestor
102428642|NCT04358133|Morphine|morphine|mesh-list
102428643|NCT04358133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102428644|NCT04358133|Narcotics|narcotics|mesh-ancestor
102059280|NCT05908331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102428645|NCT04358133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102428646|NCT04358133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428647|NCT04358133|Analgesics|analgesics|mesh-ancestor
102428648|NCT04358133|Sensory System Agents|sensory system agents|mesh-ancestor
102428649|NCT04358133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102428650|NCT04291209|Acetylcysteine|acetylcysteine|mesh-list
102428651|NCT04291209|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102428652|NCT04291209|Antiviral Agents|antiviral agents|mesh-ancestor
102428653|NCT04291209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102428654|NCT04291209|Expectorants|expectorants|mesh-ancestor
102428655|NCT04291209|Respiratory System Agents|respiratory system agents|mesh-ancestor
102428656|NCT04291209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102428657|NCT04291209|Antioxidants|antioxidants|mesh-ancestor
102428658|NCT04291209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428659|NCT04291209|Protective Agents|protective agents|mesh-ancestor
102428660|NCT04291209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428661|NCT04291209|Antidotes|antidotes|mesh-ancestor
102428662|NCT01032759|Memantine|memantine|mesh-list
102428663|NCT01032759|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102428664|NCT01032759|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102428665|NCT01032759|Dopamine Agents|dopamine agents|mesh-ancestor
102428666|NCT01032759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102428667|NCT01032759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428668|NCT01032759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428669|NCT01032759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102428670|NCT01032759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102428671|NCT01032993|Ubiquinone|ubiquinone|mesh-list
102428672|NCT01032993|Coenzyme Q10|coenzyme q10|mesh-list
102428673|NCT01032993|Micronutrients|micronutrients|mesh-ancestor
102428674|NCT01032993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428675|NCT01032993|Vitamins|vitamins|mesh-ancestor
102428676|NCT01033773|Metformin|metformin|mesh-list
102428677|NCT01033773|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102428678|NCT01033773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428679|NCT01053507|Naproxen|naproxen|mesh-list
102428680|NCT01053507|Sumatriptan|sumatriptan|mesh-list
102428681|NCT01053507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102428682|NCT01053507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102428683|NCT01053507|Analgesics|analgesics|mesh-ancestor
102428684|NCT01053507|Sensory System Agents|sensory system agents|mesh-ancestor
102428685|NCT01053507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102428686|NCT01053507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428687|NCT01053507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102428688|NCT01053507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102428689|NCT01053507|Gout Suppressants|gout suppressants|mesh-ancestor
102428690|NCT01053507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102428691|NCT01053507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102059326|NCT05891262|Norethindrone|norethindrone|mesh-list
102428692|NCT01053507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428693|NCT01053507|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102428694|NCT01053507|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102428695|NCT01053507|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102428696|NCT01053507|Serotonin Agents|serotonin agents|mesh-ancestor
102428697|NCT01053507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102428698|NCT01053819|Etanercept|etanercept|mesh-list
102428699|NCT01053819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102428700|NCT01053819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102428701|NCT01053819|Analgesics|analgesics|mesh-ancestor
102428702|NCT01053819|Sensory System Agents|sensory system agents|mesh-ancestor
102428703|NCT01053819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102428704|NCT01053819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428705|NCT01053819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102428706|NCT01053819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102428707|NCT01053819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102428708|NCT01053819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102428709|NCT01053819|Immunologic Factors|immunologic factors|mesh-ancestor
102428710|NCT01054911|Sunitinib|sunitinib|mesh-list
102428711|NCT01054911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102428712|NCT01054911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102428713|NCT01054911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102428714|NCT01054911|Growth Substances|growth substances|mesh-ancestor
102428715|NCT01054911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428716|NCT01054911|Growth Inhibitors|growth inhibitors|mesh-ancestor
102428717|NCT01054911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102428718|NCT01054911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102428719|NCT01054911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428720|NCT01055223|Troglitazone|troglitazone|mesh-list
102428721|NCT01055223|Amiloride|amiloride|mesh-list
102428722|NCT01055223|Spironolactone|spironolactone|mesh-list
102428723|NCT01055223|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102428724|NCT01055223|Hormone Antagonists|hormone antagonists|mesh-ancestor
102428725|NCT01055223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102428726|NCT01055223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428727|NCT01055223|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102428728|NCT01055223|Diuretics|diuretics|mesh-ancestor
102059357|NCT05805839|Corticosterone|corticosterone|mesh-list
102428729|NCT01055223|Natriuretic Agents|natriuretic agents|mesh-ancestor
102428730|NCT01055223|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
102428731|NCT01055223|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102428732|NCT01055223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102428733|NCT01055223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428734|NCT01055223|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
102428735|NCT01055223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101371202|NCT02963194|Oxytocin|oxytocin|mesh-list
102428736|NCT02168361|Interferons|interferons|mesh-list
102428737|NCT02168361|Ribavirin|ribavirin|mesh-list
102428738|NCT02168361|Interferon-alpha|interferon-alpha|mesh-list
102428739|NCT02168361|Interferon alpha-2|interferon alpha-2|mesh-list
102428740|NCT02168361|Sofosbuvir|sofosbuvir|mesh-list
102428741|NCT02168361|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102428742|NCT02168361|Simeprevir|simeprevir|mesh-list
102428743|NCT02168361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102428744|NCT02168361|Antiviral Agents|antiviral agents|mesh-ancestor
102428745|NCT02168361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102428746|NCT02168361|Antimetabolites|antimetabolites|mesh-ancestor
102428747|NCT02168361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428748|NCT02168361|Immunologic Factors|immunologic factors|mesh-ancestor
102428749|NCT02168361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428750|NCT02168361|Protease Inhibitors|protease inhibitors|mesh-ancestor
102428751|NCT02168361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102428752|NCT01360554|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102428753|NCT01360554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102428754|NCT01360554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102428755|NCT01360554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102428756|NCT01360554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428757|NCT01055769|Linezolid|linezolid|mesh-list
102428758|NCT01055769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102428759|NCT01055769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102428760|NCT01055769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102428761|NCT01055769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102428762|NCT01055769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428763|NCT01057017|Panitumumab|panitumumab|mesh-list
102428764|NCT01057017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102428765|NCT01057017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102428766|NCT04972032|Estrogens|estrogens|mesh-list
101371608|NCT02922894|Trazodone|trazodone|mesh-list
102428767|NCT04972032|Hyaluronic Acid|hyaluronic acid|mesh-list
102428768|NCT04972032|Hormones|hormones|mesh-ancestor
102428769|NCT04972032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102428770|NCT04972032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428771|NCT04972032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102428772|NCT04972032|Immunologic Factors|immunologic factors|mesh-ancestor
102428773|NCT04972032|Viscosupplements|viscosupplements|mesh-ancestor
102428774|NCT04972032|Protective Agents|protective agents|mesh-ancestor
102428775|NCT04432662|Darbepoetin alfa|darbepoetin alfa|mesh-list
102428776|NCT04432662|Hematinics|hematinics|mesh-ancestor
102428777|NCT04152564|Bupivacaine|bupivacaine|mesh-list
102428778|NCT04152564|Levobupivacaine|levobupivacaine|mesh-list
102428779|NCT04152564|Anesthetics, Local|anesthetics, local|mesh-ancestor
102428780|NCT04152564|Anesthetics|anesthetics|mesh-ancestor
102428781|NCT04152564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102428782|NCT04152564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428783|NCT04152564|Sensory System Agents|sensory system agents|mesh-ancestor
102428784|NCT04152564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102428785|NCT04977960|Canrenone|canrenone|mesh-list
102428786|NCT04977960|Canrenoic Acid|canrenoic acid|mesh-list
102059406|NCT05778760|Vitamins|vitamins|mesh-ancestor
102428787|NCT04977960|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102428788|NCT04977960|Hormone Antagonists|hormone antagonists|mesh-ancestor
102240479|NCT03075657|Haloperidol|haloperidol|mesh-list
102428789|NCT04977960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102428790|NCT04977960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428791|NCT04977960|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102428792|NCT04977960|Diuretics|diuretics|mesh-ancestor
102428793|NCT04977960|Natriuretic Agents|natriuretic agents|mesh-ancestor
102428794|NCT05593809|Technetium Tc 99m Dimercaptosuccinic Acid|technetium tc 99m dimercaptosuccinic acid|mesh-list
102428795|NCT05593809|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102428796|NCT05593809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428797|NCT05593731|Melatonin|melatonin|mesh-list
102428798|NCT05593731|Antioxidants|antioxidants|mesh-ancestor
102428799|NCT05593731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428800|NCT05593731|Protective Agents|protective agents|mesh-ancestor
102428801|NCT05593731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428802|NCT05593731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102428803|NCT01062009|Zinc Sulfate|zinc sulfate|mesh-list
102428804|NCT01062009|Astringents|astringents|mesh-ancestor
102428805|NCT01062009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428806|NCT01062009|Dermatologic Agents|dermatologic agents|mesh-ancestor
102428807|NCT01062165|Caspofungin|caspofungin|mesh-list
102428808|NCT01062165|Antifungal Agents|antifungal agents|mesh-ancestor
102428809|NCT01062165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102428810|NCT01062165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102428811|NCT01062165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428812|NCT05592951|Methamphetamine|methamphetamine|mesh-list
102428813|NCT05592951|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102428814|NCT05592951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428815|NCT05592951|Sympathomimetics|sympathomimetics|mesh-ancestor
102428816|NCT05592951|Autonomic Agents|autonomic agents|mesh-ancestor
102428817|NCT05592951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102428818|NCT05592951|Dopamine Agents|dopamine agents|mesh-ancestor
101372078|NCT00398528|(T,G)-A-L|(t,g)-a-l|mesh-list
102428819|NCT05592951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102428820|NCT05592951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428821|NCT05592951|Adrenergic Agents|adrenergic agents|mesh-ancestor
102428822|NCT05592951|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102428823|NCT05592951|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102428824|NCT05592951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102428825|NCT05592951|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102428826|NCT04041843|Apixaban|apixaban|mesh-list
102428827|NCT04041843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102428828|NCT04041843|Antithrombins|antithrombins|mesh-ancestor
102428829|NCT04041843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102428830|NCT04041843|Protease Inhibitors|protease inhibitors|mesh-ancestor
102428831|NCT04041843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102428832|NCT04041843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428833|NCT04041843|Anticoagulants|anticoagulants|mesh-ancestor
102428834|NCT01068873|Ritonavir|ritonavir|mesh-list
102428835|NCT01068873|Lopinavir|lopinavir|mesh-list
102428836|NCT01068873|Maraviroc|maraviroc|mesh-list
102428837|NCT01068873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102428838|NCT01068873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102428839|NCT01068873|Protease Inhibitors|protease inhibitors|mesh-ancestor
102428840|NCT01068873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102428841|NCT01068873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428842|NCT01068873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102428843|NCT01068873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102428844|NCT01068873|Antiviral Agents|antiviral agents|mesh-ancestor
102428845|NCT01068873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102428846|NCT01068873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102428847|NCT01068873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102428848|NCT01068873|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102428849|NCT01068873|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102428850|NCT01068873|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102428851|NCT01072773|Dexamethasone|dexamethasone|mesh-list
102428852|NCT01072773|Cyclophosphamide|cyclophosphamide|mesh-list
102428853|NCT01072773|Bortezomib|bortezomib|mesh-list
102428854|NCT01072773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102428855|NCT01072773|Immunologic Factors|immunologic factors|mesh-ancestor
102428856|NCT01072773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059474|NCT05664217|Antithrombin III|antithrombin iii|mesh-list
102428857|NCT01072773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102428858|NCT01072773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102428859|NCT01072773|Alkylating Agents|alkylating agents|mesh-ancestor
102428860|NCT01072773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428861|NCT01072773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102428862|NCT01072773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102428863|NCT01072773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102428864|NCT01072773|Antiemetics|antiemetics|mesh-ancestor
102428865|NCT01072773|Autonomic Agents|autonomic agents|mesh-ancestor
102059484|NCT05566795|Antineoplastic Agents|antineoplastic agents|mesh-list
102059485|NCT05557136|Ether|ether|mesh-list
102059486|NCT05557136|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102428866|NCT01072773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102428867|NCT01072773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102428868|NCT01072773|Glucocorticoids|glucocorticoids|mesh-ancestor
102428869|NCT01072773|Hormones|hormones|mesh-ancestor
102428870|NCT01072773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102428871|NCT01072773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102428872|NCT03013647|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102428873|NCT03013647|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
102428874|NCT03013647|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102428875|NCT03013647|Dermatologic Agents|dermatologic agents|mesh-ancestor
102428876|NCT01074177|Afatinib|afatinib|mesh-list
102428877|NCT01074177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102428878|NCT01074177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102428879|NCT01074177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102428880|NCT01074177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428881|NCT01076283|Cyproheptadine|cyproheptadine|mesh-list
102428882|NCT01076283|Baclofen|baclofen|mesh-list
102428883|NCT01076283|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102428884|NCT01076283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428885|NCT01076283|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102428886|NCT01076283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102428887|NCT01076283|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102428888|NCT01076283|GABA Agonists|gaba agonists|mesh-ancestor
102428889|NCT01076283|GABA Agents|gaba agents|mesh-ancestor
102428890|NCT01076283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102428891|NCT01076283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428892|NCT01076283|Antipruritics|antipruritics|mesh-ancestor
102428893|NCT01076283|Dermatologic Agents|dermatologic agents|mesh-ancestor
102428894|NCT01076283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102428895|NCT01076283|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102428896|NCT01076283|Histamine Antagonists|histamine antagonists|mesh-ancestor
102428897|NCT01076283|Histamine Agents|histamine agents|mesh-ancestor
102428898|NCT01076283|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102428899|NCT01076283|Serotonin Agents|serotonin agents|mesh-ancestor
102428900|NCT01076283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102428901|NCT03805581|Defibrotide|defibrotide|mesh-list
102428902|NCT03805581|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102428903|NCT03805581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102428904|NCT03805581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428905|NCT03805581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102428906|NCT01076985|Ritonavir|ritonavir|mesh-list
102428907|NCT01076985|Lopinavir|lopinavir|mesh-list
102428908|NCT01076985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102428909|NCT01076985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102428910|NCT01076985|Protease Inhibitors|protease inhibitors|mesh-ancestor
102428911|NCT01076985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102428912|NCT01076985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428913|NCT01076985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102428914|NCT01076985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102428915|NCT01076985|Antiviral Agents|antiviral agents|mesh-ancestor
102428916|NCT01076985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102428917|NCT01076985|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102428918|NCT01076985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102428919|NCT02176005|Moxifloxacin|moxifloxacin|mesh-list
102428920|NCT02176005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102428921|NCT02176005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102428922|NCT02176005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102428923|NCT02176005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102428924|NCT02176005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102428925|NCT02176005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428926|NCT02176005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102428927|NCT05539911|Fentanyl|fentanyl|mesh-list
102428928|NCT05539911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102428929|NCT05539911|Narcotics|narcotics|mesh-ancestor
102428930|NCT05539911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102428931|NCT05539911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428932|NCT05539911|Analgesics|analgesics|mesh-ancestor
102428933|NCT05539911|Sensory System Agents|sensory system agents|mesh-ancestor
102428934|NCT05539911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102428935|NCT05539911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102428936|NCT05539911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102428937|NCT05539911|Anesthetics, General|anesthetics, general|mesh-ancestor
102428938|NCT05539911|Anesthetics|anesthetics|mesh-ancestor
102428940|NCT03589833|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102428941|NCT03589833|Abortifacient Agents|abortifacient agents|mesh-ancestor
102428942|NCT03589833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102428943|NCT03589833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428944|NCT03589833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102428945|NCT03589833|Antimetabolites|antimetabolites|mesh-ancestor
102059551|NCT05348577|Docetaxel|docetaxel|mesh-list
102428946|NCT03589833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428947|NCT03589833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102428948|NCT03589833|Dermatologic Agents|dermatologic agents|mesh-ancestor
102428949|NCT03589833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102428950|NCT03589833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102428951|NCT03589833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102428952|NCT03589833|Immunologic Factors|immunologic factors|mesh-ancestor
102428953|NCT03589833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102428954|NCT03589833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102428955|NCT01077921|Propranolol|propranolol|mesh-list
102428956|NCT01077921|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102428957|NCT01077921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102428958|NCT01077921|Adrenergic Agents|adrenergic agents|mesh-ancestor
102428959|NCT01077921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102428960|NCT01077921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428961|NCT01077921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428962|NCT01077921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102059559|NCT05304455|Tinzaparin|tinzaparin|mesh-list
102428963|NCT01077921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102428964|NCT01077921|Vasodilator Agents|vasodilator agents|mesh-ancestor
102428965|NCT05498181|Valsartan|valsartan|mesh-list
102428966|NCT05498181|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102428967|NCT05498181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102428968|NCT05498181|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102428969|NCT05498181|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102428970|NCT05498181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428971|NCT04970238|Simendan|simendan|mesh-list
102428972|NCT04970238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102428973|NCT04970238|Vasodilator Agents|vasodilator agents|mesh-ancestor
102428974|NCT04970238|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102428975|NCT04970238|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102428976|NCT04970238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102428977|NCT04970238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428978|NCT04970238|Protective Agents|protective agents|mesh-ancestor
102059583|NCT05232825|Dexamethasone|dexamethasone|mesh-list
102428979|NCT04970238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428980|NCT02169453|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102428981|NCT02169453|Opicapone|opicapone|mesh-list
102428982|NCT02169453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102428983|NCT02169453|Immunologic Factors|immunologic factors|mesh-ancestor
102428984|NCT02169453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102428985|NCT02169453|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102428986|NCT02169453|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102428987|NCT02169453|Dopamine Agonists|dopamine agonists|mesh-ancestor
102428988|NCT02169453|Dopamine Agents|dopamine agents|mesh-ancestor
102428989|NCT02169453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102428990|NCT02169453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102428991|NCT02169453|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102428992|NCT02169453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102428993|NCT01822314|Paclitaxel|paclitaxel|mesh-list
102428994|NCT01822314|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102428995|NCT01822314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102428996|NCT01822314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102428997|NCT01822314|Tubulin Modulators|tubulin modulators|mesh-ancestor
102428998|NCT01822314|Antimitotic Agents|antimitotic agents|mesh-ancestor
102428999|NCT01822314|Mitosis Modulators|mitosis modulators|mesh-ancestor
102429000|NCT01822314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429001|NCT01765296|Celecoxib|celecoxib|mesh-list
102429002|NCT01765296|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102429003|NCT01765296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102429004|NCT01765296|Analgesics|analgesics|mesh-ancestor
102429005|NCT01765296|Sensory System Agents|sensory system agents|mesh-ancestor
102429006|NCT01765296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102429007|NCT01765296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429008|NCT01765296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102429009|NCT01765296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102429010|NCT01765296|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102429011|NCT01765296|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102429012|NCT01765296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102429013|NCT01765296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429014|NCT01081041|Carboplatin|carboplatin|mesh-list
102429015|NCT01081041|Fluorouracil|fluorouracil|mesh-list
102429016|NCT01081041|Cetuximab|cetuximab|mesh-list
102429017|NCT01081041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102429018|NCT01081041|Antimetabolites|antimetabolites|mesh-ancestor
102429019|NCT01081041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429020|NCT01081041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101373357|NCT00222235|Glycine|glycine|mesh-list
102429021|NCT01081041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102429022|NCT01081041|Immunologic Factors|immunologic factors|mesh-ancestor
102429023|NCT01081041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429024|NCT01081041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102429025|NCT03022617|Apremilast|apremilast|mesh-list
102429026|NCT03022617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102429027|NCT03022617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102429028|NCT03022617|Analgesics|analgesics|mesh-ancestor
102429029|NCT03022617|Sensory System Agents|sensory system agents|mesh-ancestor
102429030|NCT03022617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102429031|NCT03022617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429032|NCT03022617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102429033|NCT03022617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102429034|NCT03022617|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102429035|NCT03022617|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102429036|NCT03022617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102429037|NCT03022617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429038|NCT02089685|Pembrolizumab|pembrolizumab|mesh-list
102429039|NCT02089685|Ipilimumab|ipilimumab|mesh-list
102059644|NCT05200208|Nootropic Agents|nootropic agents|mesh-ancestor
102429040|NCT02089685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102429041|NCT02089685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102429042|NCT02089685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102429043|NCT02089685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429044|NCT01088295|Telmisartan|telmisartan|mesh-list
102429045|NCT01088295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102429046|NCT01088295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102429047|NCT01088295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102429048|NCT01088295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429049|NCT04730609|Dexmedetomidine|dexmedetomidine|mesh-list
102429050|NCT04730609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102429051|NCT04730609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102429052|NCT04730609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429053|NCT04730609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102429054|NCT04730609|Analgesics|analgesics|mesh-ancestor
102429055|NCT04730609|Sensory System Agents|sensory system agents|mesh-ancestor
102429056|NCT04730609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102429057|NCT04730609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102429058|NCT04730609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102429059|NCT04730609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102429060|NCT04730609|Adrenergic Agents|adrenergic agents|mesh-ancestor
102429061|NCT04730609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102429062|NCT04730609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429063|NCT03013335|Nivolumab|nivolumab|mesh-list
102429064|NCT03013335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102429065|NCT03013335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102429066|NCT03013335|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102429067|NCT03013335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429068|NCT04730531|Epinephrine|epinephrine|mesh-list
102429069|NCT04730531|Bupivacaine|bupivacaine|mesh-list
102429070|NCT04730531|Anesthetics, Local|anesthetics, local|mesh-ancestor
102429071|NCT04730531|Anesthetics|anesthetics|mesh-ancestor
102429072|NCT04730531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102429073|NCT04730531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429074|NCT04730531|Sensory System Agents|sensory system agents|mesh-ancestor
102059679|NCT05119439|Oxytocics|oxytocics|mesh-ancestor
102429075|NCT04730531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102429076|NCT04730531|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102429077|NCT04730531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102429078|NCT04730531|Adrenergic Agents|adrenergic agents|mesh-ancestor
102429079|NCT04730531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102429080|NCT04730531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429081|NCT04730531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102240781|NCT05353361|Paclitaxel|paclitaxel|mesh-list
102429082|NCT04730531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102429083|NCT04730531|Autonomic Agents|autonomic agents|mesh-ancestor
102429084|NCT04730531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102429085|NCT04730531|Respiratory System Agents|respiratory system agents|mesh-ancestor
102429086|NCT04730531|Mydriatics|mydriatics|mesh-ancestor
102429087|NCT04730531|Sympathomimetics|sympathomimetics|mesh-ancestor
102429088|NCT04730531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102429089|NCT05569733|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102429090|NCT05569733|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102429091|NCT05569733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429092|NCT05853341|Rivastigmine|rivastigmine|mesh-list
102429093|NCT05853341|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102429094|NCT05853341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102429095|NCT05853341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429096|NCT05853341|Cholinergic Agents|cholinergic agents|mesh-ancestor
102429097|NCT05853341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102429098|NCT05853341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373816|NCT00224809|Aspirin|aspirin|mesh-list
102429099|NCT05853341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102429100|NCT05853341|Protective Agents|protective agents|mesh-ancestor
102429101|NCT05853289|Analgesics, Opioid|analgesics, opioid|mesh-list
102429102|NCT05853289|Narcotics|narcotics|mesh-ancestor
102429103|NCT05853289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102429104|NCT05853289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429105|NCT05853289|Analgesics|analgesics|mesh-ancestor
102429106|NCT05853289|Sensory System Agents|sensory system agents|mesh-ancestor
102429107|NCT05853289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102429109|NCT05853224|Hyaluronic Acid|hyaluronic acid|mesh-list
102429110|NCT05853224|Anesthetics, Local|anesthetics, local|mesh-ancestor
102429111|NCT05853224|Anesthetics|anesthetics|mesh-ancestor
102429112|NCT05853224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102429113|NCT05853224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429114|NCT05853224|Sensory System Agents|sensory system agents|mesh-ancestor
102429115|NCT05853224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102059723|NCT04992468|Hormones|hormones|mesh-ancestor
102429116|NCT05853224|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102429117|NCT05853224|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102429118|NCT05853224|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102429119|NCT05853224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102429120|NCT05853224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429121|NCT05853224|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101373999|NCT00225511|Milnacipran|milnacipran|mesh-list
102429122|NCT05853224|Immunologic Factors|immunologic factors|mesh-ancestor
102429123|NCT05853224|Viscosupplements|viscosupplements|mesh-ancestor
102429124|NCT05853224|Protective Agents|protective agents|mesh-ancestor
102429125|NCT05853172|Paclitaxel|paclitaxel|mesh-list
102429126|NCT05853172|Apatinib|apatinib|mesh-list
102429127|NCT05853172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102429128|NCT05853172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102429129|NCT05853172|Tubulin Modulators|tubulin modulators|mesh-ancestor
102429130|NCT05853172|Antimitotic Agents|antimitotic agents|mesh-ancestor
102429131|NCT05853172|Mitosis Modulators|mitosis modulators|mesh-ancestor
102429132|NCT05853172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429133|NCT05853172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102429134|NCT05853172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102429135|NCT05853263|Acetaminophen|acetaminophen|mesh-list
102429136|NCT05853263|Morphine|morphine|mesh-list
102429137|NCT05853263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102429138|NCT05853263|Narcotics|narcotics|mesh-ancestor
102059735|NCT04970342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102429139|NCT05853263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102429140|NCT05853263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429141|NCT05853263|Analgesics|analgesics|mesh-ancestor
102429142|NCT05853263|Sensory System Agents|sensory system agents|mesh-ancestor
102429143|NCT05853263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102429144|NCT05853263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102429145|NCT05853263|Antipyretics|antipyretics|mesh-ancestor
102429146|NCT03001869|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102429147|NCT03001869|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102429148|NCT03001869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429149|NCT05852873|Ritonavir|ritonavir|mesh-list
102429150|NCT05852873|Nirmatrelvir|nirmatrelvir|mesh-list
102429151|NCT05852873|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
102429152|NCT05852873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102429153|NCT05852873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102429154|NCT05852873|Protease Inhibitors|protease inhibitors|mesh-ancestor
102429155|NCT05852873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102429156|NCT05852873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429157|NCT05852873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102429158|NCT05852873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102429159|NCT05852873|Antiviral Agents|antiviral agents|mesh-ancestor
102429160|NCT05852873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102429161|NCT05852873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102429162|NCT05852873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102429163|NCT05852847|Danazol|danazol|mesh-list
102429164|NCT05852847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102429165|NCT05852847|Hormone Antagonists|hormone antagonists|mesh-ancestor
102429166|NCT05852847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102429167|NCT05852847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429168|NCT05852704|Dapagliflozin|dapagliflozin|mesh-list
102429169|NCT05852704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102429170|NCT05852704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429171|NCT05852704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102429172|NCT05852704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429173|NCT05852496|Vitamin D|vitamin d|mesh-list
102429174|NCT05852496|Vitamins|vitamins|mesh-ancestor
102429175|NCT05852496|Micronutrients|micronutrients|mesh-ancestor
102429176|NCT05852496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429177|NCT05852496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102429178|NCT05852223|Pembrolizumab|pembrolizumab|mesh-list
102429179|NCT05852223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102429180|NCT05852223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102429181|NCT05852223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102059774|NCT04881240|Immunologic Factors|immunologic factors|mesh-ancestor
102429182|NCT05852223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429183|NCT05852197|Anticoagulants|anticoagulants|mesh-list
102429184|NCT05852197|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
102429185|NCT05852119|Anticoagulants|anticoagulants|mesh-list
102429186|NCT05852093|Celecoxib|celecoxib|mesh-list
102429187|NCT05852093|Buprenorphine|buprenorphine|mesh-list
102429188|NCT05852093|Tizanidine|tizanidine|mesh-list
102429189|NCT05852093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102429190|NCT05852093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102429191|NCT05852093|Analgesics|analgesics|mesh-ancestor
102429192|NCT05852093|Sensory System Agents|sensory system agents|mesh-ancestor
102429193|NCT05852093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102429194|NCT05852093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429195|NCT05852093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102429196|NCT05852093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102429197|NCT05852093|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102429198|NCT05852093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102429199|NCT05852093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102429200|NCT05852093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429201|NCT05852093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102429202|NCT05852093|Narcotics|narcotics|mesh-ancestor
102059796|NCT04795245|Afatinib|afatinib|mesh-list
102429203|NCT05852093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102429204|NCT05852093|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102429205|NCT05852093|Anticonvulsants|anticonvulsants|mesh-ancestor
102429206|NCT05852093|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102429207|NCT05852093|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102429208|NCT05852093|Parasympatholytics|parasympatholytics|mesh-ancestor
102429209|NCT05852093|Autonomic Agents|autonomic agents|mesh-ancestor
102429210|NCT05852093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102059807|NCT04738422|Glycine|glycine|mesh-list
102429211|NCT05852093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102429212|NCT05852093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102429213|NCT05852093|Adrenergic Agents|adrenergic agents|mesh-ancestor
102429214|NCT05852093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102429215|NCT05852002|Hyaluronic Acid|hyaluronic acid|mesh-list
102429216|NCT05852002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102429217|NCT05852002|Immunologic Factors|immunologic factors|mesh-ancestor
102429218|NCT05852002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429219|NCT05852002|Viscosupplements|viscosupplements|mesh-ancestor
102429220|NCT05852002|Protective Agents|protective agents|mesh-ancestor
102429221|NCT05851976|Naproxen|naproxen|mesh-list
102429222|NCT05851976|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102429223|NCT05851976|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102429224|NCT05851976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102429225|NCT05851976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102429226|NCT05851976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429227|NCT05851976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102429228|NCT05851976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429229|NCT05851976|Analgesics|analgesics|mesh-ancestor
102429230|NCT05851976|Sensory System Agents|sensory system agents|mesh-ancestor
102429231|NCT05851976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102429232|NCT05851976|Antidepressive Agents|antidepressive agents|mesh-ancestor
102429233|NCT05851976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102429234|NCT05851976|Dopamine Agents|dopamine agents|mesh-ancestor
102429235|NCT05851976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102429236|NCT05851976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102429237|NCT05851976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102429238|NCT05851976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102429239|NCT05851976|Gout Suppressants|gout suppressants|mesh-ancestor
102429240|NCT05851976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102429241|NCT05851976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102429242|NCT05849129|Ascorbic Acid|ascorbic acid|mesh-list
102429243|NCT05849129|Vitamins|vitamins|mesh-ancestor
102429244|NCT05849129|Micronutrients|micronutrients|mesh-ancestor
102429245|NCT05849129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429246|NCT05849129|Antioxidants|antioxidants|mesh-ancestor
102429247|NCT05849129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429248|NCT05849129|Protective Agents|protective agents|mesh-ancestor
102429249|NCT05848843|Durvalumab|durvalumab|mesh-list
102429250|NCT05848843|Adagrasib|adagrasib|mesh-list
102429251|NCT05848843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102429252|NCT05848843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102429253|NCT05845762|Obinutuzumab|obinutuzumab|mesh-list
102429254|NCT05845762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102429255|NCT05845762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102429256|NCT05830396|Ambroxol|ambroxol|mesh-list
102429257|NCT05830396|Expectorants|expectorants|mesh-ancestor
102429258|NCT05830396|Respiratory System Agents|respiratory system agents|mesh-ancestor
102429259|NCT05817656|Sucralfate|sucralfate|mesh-list
102429260|NCT05817656|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102429261|NCT05817656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102429262|NCT05810311|Darbepoetin alfa|darbepoetin alfa|mesh-list
102429263|NCT05810311|Hematinics|hematinics|mesh-ancestor
102429264|NCT05809297|Ciclopirox|ciclopirox|mesh-list
102429265|NCT05809297|Chitosan|chitosan|mesh-list
102429266|NCT05809297|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102429267|NCT05809297|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102429268|NCT05809297|Antimetabolites|antimetabolites|mesh-ancestor
102429269|NCT05809297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429270|NCT05809297|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102429271|NCT05809297|Chelating Agents|chelating agents|mesh-ancestor
102429272|NCT05809297|Sequestering Agents|sequestering agents|mesh-ancestor
101476196|NCT00268814|Heroin|heroin|mesh-list
102429273|NCT05809297|Hemostatics|hemostatics|mesh-ancestor
102429274|NCT05809297|Coagulants|coagulants|mesh-ancestor
102429275|NCT05809297|Antifungal Agents|antifungal agents|mesh-ancestor
102429276|NCT05809297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102429277|NCT05807412|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102429278|NCT05807412|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102429279|NCT05807412|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102429280|NCT05807412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102429281|NCT05807412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429282|NCT05807412|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102429283|NCT05807412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102429284|NCT05807412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429285|NCT05807412|Cholinergic Agents|cholinergic agents|mesh-ancestor
102429286|NCT05807412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102429287|NCT05778591|Buprenorphine|buprenorphine|mesh-list
102429288|NCT05778591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102429289|NCT05778591|Narcotics|narcotics|mesh-ancestor
102059876|NCT04645550|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102429290|NCT05778591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102429291|NCT05778591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429292|NCT05778591|Analgesics|analgesics|mesh-ancestor
102429293|NCT05778591|Sensory System Agents|sensory system agents|mesh-ancestor
102429294|NCT05778591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102429295|NCT05778591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102429296|NCT05770375|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
102429297|NCT05770375|Hallucinogens|hallucinogens|mesh-ancestor
102429298|NCT05770375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429299|NCT05770375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102429300|NCT05770375|Serotonin Agents|serotonin agents|mesh-ancestor
102429301|NCT05770375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102429302|NCT05770375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429303|NCT05770375|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102429304|NCT05770375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102429305|NCT05770375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102429306|NCT05770375|Adrenergic Agents|adrenergic agents|mesh-ancestor
102429307|NCT05745987|Vaccines|vaccines|mesh-list
102429308|NCT05745987|Immunologic Factors|immunologic factors|mesh-ancestor
102429309|NCT05745987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429310|NCT05736198|Dexmedetomidine|dexmedetomidine|mesh-list
102429311|NCT05736198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102059896|NCT04645550|Antipyretics|antipyretics|mesh-ancestor
102429312|NCT05736198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102429313|NCT05736198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429314|NCT05736198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102429315|NCT05736198|Analgesics|analgesics|mesh-ancestor
102429316|NCT05736198|Sensory System Agents|sensory system agents|mesh-ancestor
102429317|NCT05736198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102429318|NCT05736198|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102429319|NCT05736198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102429320|NCT05736198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102429321|NCT05736198|Adrenergic Agents|adrenergic agents|mesh-ancestor
102429322|NCT05736198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102429323|NCT05736198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429324|NCT05734495|Venetoclax|venetoclax|mesh-list
102429325|NCT05734495|Pirtobrutinib|pirtobrutinib|mesh-list
102429326|NCT05734495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102429327|NCT05734495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102429328|NCT05734495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102429329|NCT05734495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429330|NCT05729503|Lidocaine|lidocaine|mesh-list
102059921|NCT04627922|Antidotes|antidotes|mesh-ancestor
102429331|NCT05729503|Anesthetics, Local|anesthetics, local|mesh-ancestor
102429332|NCT05729503|Anesthetics|anesthetics|mesh-ancestor
102429333|NCT05729503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102429334|NCT05729503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429335|NCT05729503|Sensory System Agents|sensory system agents|mesh-ancestor
102429336|NCT05729503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102429337|NCT05729503|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102059927|NCT04577716|Listerine|listerine|mesh-list
102429338|NCT05729503|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102429339|NCT05729503|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102429340|NCT05729503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102429341|NCT05729503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429342|NCT05725876|Ustekinumab|ustekinumab|mesh-list
102429343|NCT05725876|Dermatologic Agents|dermatologic agents|mesh-ancestor
102429344|NCT05720390|Quinine|quinine|mesh-list
102429345|NCT05720390|Antimalarials|antimalarials|mesh-ancestor
102429346|NCT05720390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102429347|NCT05720390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102429348|NCT05720390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102429349|NCT05720390|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102429350|NCT05720390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429351|NCT05720390|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102059937|NCT04551131|Etoposide phosphate|etoposide phosphate|mesh-list
102429352|NCT05720390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102429353|NCT05720390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102429354|NCT05720390|Analgesics|analgesics|mesh-ancestor
102429355|NCT05720390|Sensory System Agents|sensory system agents|mesh-ancestor
102429356|NCT05711641|Lidocaine|lidocaine|mesh-list
102429357|NCT05711641|Anesthetics, Local|anesthetics, local|mesh-ancestor
102429358|NCT05711641|Anesthetics|anesthetics|mesh-ancestor
102429359|NCT05711641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102429360|NCT05711641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429361|NCT05711641|Sensory System Agents|sensory system agents|mesh-ancestor
102429362|NCT05711641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102429363|NCT05711641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102429364|NCT05711641|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102429365|NCT05711641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102429366|NCT05711641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102429367|NCT05711641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429368|NCT05702970|Vitamin D|vitamin d|mesh-list
102429369|NCT05702970|Vitamins|vitamins|mesh-ancestor
102429370|NCT05702970|Micronutrients|micronutrients|mesh-ancestor
102059968|NCT04521413|Pembrolizumab|pembrolizumab|mesh-list
102059969|NCT04521413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102059970|NCT04521413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102059971|NCT04521413|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101378811|NCT00255073|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101378853|NCT00255463|Gefitinib|gefitinib|mesh-list
102429371|NCT05702970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429372|NCT05702970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102429373|NCT05693467|Dexamethasone|dexamethasone|mesh-list
102429374|NCT05693467|Ropivacaine|ropivacaine|mesh-list
102429375|NCT05693467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102429376|NCT05693467|Antiemetics|antiemetics|mesh-ancestor
102429377|NCT05693467|Autonomic Agents|autonomic agents|mesh-ancestor
102429378|NCT05693467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102429379|NCT05693467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429380|NCT05693467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102429381|NCT05693467|Glucocorticoids|glucocorticoids|mesh-ancestor
102429382|NCT05693467|Hormones|hormones|mesh-ancestor
102429383|NCT05693467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102429384|NCT05693467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102429385|NCT05693467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102429386|NCT05693467|Anesthetics, Local|anesthetics, local|mesh-ancestor
102429387|NCT05693467|Anesthetics|anesthetics|mesh-ancestor
102429388|NCT05693467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102429389|NCT05693467|Sensory System Agents|sensory system agents|mesh-ancestor
102429390|NCT05682339|Quinine|quinine|mesh-list
102429391|NCT05682339|Antimalarials|antimalarials|mesh-ancestor
102429392|NCT05682339|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102429393|NCT05682339|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102429394|NCT05682339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102429395|NCT05682339|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102429396|NCT05682339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429397|NCT05682339|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102429398|NCT05682339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102429399|NCT05682339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102429400|NCT05682339|Analgesics|analgesics|mesh-ancestor
102429401|NCT05682339|Sensory System Agents|sensory system agents|mesh-ancestor
102429402|NCT05658887|Gabapentin|gabapentin|mesh-list
102429403|NCT05658887|Analgesics|analgesics|mesh-ancestor
102429404|NCT05658887|Sensory System Agents|sensory system agents|mesh-ancestor
102429405|NCT05658887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102429406|NCT05658887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429407|NCT05658887|Anticonvulsants|anticonvulsants|mesh-ancestor
102429408|NCT05658887|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102429409|NCT05658887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102429410|NCT05658887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102429411|NCT05658887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102429412|NCT05658887|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102429413|NCT05658887|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102429414|NCT05658887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102429415|NCT05658887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429416|NCT05658887|Antimanic Agents|antimanic agents|mesh-ancestor
102429417|NCT05652283|Pamiparib|pamiparib|mesh-list
102429418|NCT05652283|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102429419|NCT05652283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102429420|NCT05652283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429421|NCT05652283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102429422|NCT05651282|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102429423|NCT05651282|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102429424|NCT05651282|Contraceptive Agents|contraceptive agents|mesh-ancestor
102429425|NCT05651282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102429426|NCT05651282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429427|NCT05651282|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102429428|NCT05651282|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102429429|NCT05651282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102429430|NCT05651282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102429431|NCT05627115|Tislelizumab|tislelizumab|mesh-list
102429432|NCT05627115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102429433|NCT05627115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102429434|NCT05626920|Disulfiram|disulfiram|mesh-list
102429435|NCT05626920|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102429436|NCT05626920|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
102429437|NCT05626920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102429438|NCT05626920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429439|NCT05605366|Minocycline|minocycline|mesh-list
102429440|NCT05605366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102429441|NCT05605366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102429442|NCT05572255|Cenobamate|cenobamate|mesh-list
102429443|NCT05572255|Anticonvulsants|anticonvulsants|mesh-ancestor
102429444|NCT05531123|Gemcitabine|gemcitabine|mesh-list
102429445|NCT05531123|Tislelizumab|tislelizumab|mesh-list
102429446|NCT05531123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102429447|NCT05531123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102429448|NCT05531123|Antimetabolites|antimetabolites|mesh-ancestor
102429449|NCT05531123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429450|NCT05531123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102429451|NCT05523609|Vitamin D|vitamin d|mesh-list
102429452|NCT05523609|Letrozole|letrozole|mesh-list
102429453|NCT05523609|Vitamins|vitamins|mesh-ancestor
102429454|NCT05523609|Micronutrients|micronutrients|mesh-ancestor
102429455|NCT05523609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429456|NCT05523609|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102241187|NCT03198949|Everolimus|everolimus|mesh-list
102429458|NCT05523609|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102429459|NCT05523609|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102429460|NCT05523609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102429461|NCT05523609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429462|NCT05523609|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102429463|NCT05523609|Hormone Antagonists|hormone antagonists|mesh-ancestor
102429464|NCT05523609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102429465|NCT05483465|Niacinamide|niacinamide|mesh-list
102429466|NCT05483465|Niacin|niacin|mesh-list
102429467|NCT05483465|Nicotinic Acids|nicotinic acids|mesh-list
102429468|NCT05483465|Vitamin B Complex|vitamin b complex|mesh-ancestor
102429469|NCT05483465|Vitamins|vitamins|mesh-ancestor
102429470|NCT05483465|Micronutrients|micronutrients|mesh-ancestor
102429471|NCT05483465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429472|NCT05483465|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102429473|NCT05483465|Antimetabolites|antimetabolites|mesh-ancestor
102429474|NCT05483465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429475|NCT05483465|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102429476|NCT05483465|Vasodilator Agents|vasodilator agents|mesh-ancestor
102429477|NCT05477108|Budesonide|budesonide|mesh-list
102429478|NCT05477108|Formoterol Fumarate|formoterol fumarate|mesh-list
102429479|NCT05477108|Charcoal|charcoal|mesh-list
102429480|NCT05477108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102429481|NCT05477108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102429482|NCT05477108|Autonomic Agents|autonomic agents|mesh-ancestor
102429483|NCT05477108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102429484|NCT05477108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429485|NCT05477108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102429486|NCT05477108|Respiratory System Agents|respiratory system agents|mesh-ancestor
102429487|NCT05477108|Glucocorticoids|glucocorticoids|mesh-ancestor
102429488|NCT05477108|Hormones|hormones|mesh-ancestor
101779788|NCT05554978|Landiolol|landiolol|mesh-list
102429489|NCT05477108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102429490|NCT05477108|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102429491|NCT05477108|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102429492|NCT05477108|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102429493|NCT05477108|Adrenergic Agents|adrenergic agents|mesh-ancestor
102429494|NCT05477108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102429495|NCT05477108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429496|NCT05477108|Antidotes|antidotes|mesh-ancestor
102429497|NCT05477108|Protective Agents|protective agents|mesh-ancestor
102429498|NCT05464979|Fentanyl|fentanyl|mesh-list
102429499|NCT05464979|Midazolam|midazolam|mesh-list
102429500|NCT05464979|Ketamine|ketamine|mesh-list
102429501|NCT05464979|Esketamine|esketamine|mesh-list
102429502|NCT05464979|Analgesics|analgesics|mesh-ancestor
102429503|NCT05464979|Sensory System Agents|sensory system agents|mesh-ancestor
102429504|NCT05464979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102429505|NCT05464979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429506|NCT05464979|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102429507|NCT05464979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102429508|NCT05464979|Anesthetics, General|anesthetics, general|mesh-ancestor
102429509|NCT05464979|Anesthetics|anesthetics|mesh-ancestor
102060088|NCT04081688|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102429510|NCT05464979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102429511|NCT05464979|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102429512|NCT05464979|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102429513|NCT05464979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102429514|NCT05464979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429515|NCT05464979|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102429516|NCT05464979|Narcotics|narcotics|mesh-ancestor
102429517|NCT05464979|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102429518|NCT05464979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102429519|NCT05464979|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102429520|NCT05464979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102429521|NCT05464979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102429522|NCT05464979|GABA Modulators|gaba modulators|mesh-ancestor
102429523|NCT05464979|GABA Agents|gaba agents|mesh-ancestor
102429524|NCT05464979|Antidepressive Agents|antidepressive agents|mesh-ancestor
102429525|NCT05442463|Captopril|captopril|mesh-list
102429526|NCT05442463|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102429527|NCT05442463|Protease Inhibitors|protease inhibitors|mesh-ancestor
102429528|NCT05442463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102429529|NCT05442463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429530|NCT05442463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102429531|NCT05435222|Psychotropic Drugs|psychotropic drugs|mesh-list
102429532|NCT05402319|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102429533|NCT05402319|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102429534|NCT05402319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102429535|NCT05402319|Antitubercular Agents|antitubercular agents|mesh-ancestor
102429536|NCT05398289|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102429537|NCT05398289|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102429538|NCT05398289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102429539|NCT05398289|Antitubercular Agents|antitubercular agents|mesh-ancestor
102429541|NCT05384938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102429542|NCT05384938|Respiratory System Agents|respiratory system agents|mesh-ancestor
102429543|NCT05373108|Macitentan|macitentan|mesh-list
102429544|NCT05373108|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
102429545|NCT05373108|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102429546|NCT05373108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429547|NCT05373108|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
102429548|NCT05368753|Lidocaine|lidocaine|mesh-list
102429549|NCT05368753|Ropivacaine|ropivacaine|mesh-list
102429550|NCT05368753|Anesthetics, Local|anesthetics, local|mesh-ancestor
102429551|NCT05368753|Anesthetics|anesthetics|mesh-ancestor
102429552|NCT05368753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102429553|NCT05368753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060121|NCT03910452|Sirolimus|sirolimus|mesh-list
102429554|NCT05368753|Sensory System Agents|sensory system agents|mesh-ancestor
102429555|NCT05368753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102429556|NCT05368753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102429557|NCT05368753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102429558|NCT05368753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102429559|NCT05368753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102429560|NCT05368753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429561|NCT05363514|Naltrexone|naltrexone|mesh-list
102429562|NCT05363514|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102429563|NCT05363514|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102429564|NCT05363514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429565|NCT05363514|Sensory System Agents|sensory system agents|mesh-ancestor
102429566|NCT05363514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102429567|NCT05359653|Clemastine|clemastine|mesh-list
102429568|NCT05359653|Antipruritics|antipruritics|mesh-ancestor
102429569|NCT05359653|Dermatologic Agents|dermatologic agents|mesh-ancestor
102429570|NCT05359653|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102429571|NCT05359653|Histamine Antagonists|histamine antagonists|mesh-ancestor
102429572|NCT05359653|Histamine Agents|histamine agents|mesh-ancestor
102429573|NCT05359653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102429574|NCT05359653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429575|NCT05359653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429576|NCT05359653|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102429577|NCT05345691|Denosumab|denosumab|mesh-list
102429578|NCT05345691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102429579|NCT05345691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429580|NCT05325073|Epoetin Alfa|epoetin alfa|mesh-list
102429581|NCT05325073|Hematinics|hematinics|mesh-ancestor
102429582|NCT05314998|Leucovorin|leucovorin|mesh-list
102429583|NCT05314998|Folic Acid|folic acid|mesh-list
102429584|NCT05314998|Gemcitabine|gemcitabine|mesh-list
102429585|NCT05314998|Fluorouracil|fluorouracil|mesh-list
102429586|NCT05314998|Capecitabine|capecitabine|mesh-list
102429587|NCT05314998|Oxaliplatin|oxaliplatin|mesh-list
102429588|NCT05314998|Irinotecan|irinotecan|mesh-list
102429589|NCT05314998|Levoleucovorin|levoleucovorin|mesh-list
102429590|NCT05314998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102429591|NCT05314998|Antimetabolites|antimetabolites|mesh-ancestor
102429592|NCT05314998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429593|NCT05314998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102429594|NCT05314998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102429595|NCT05314998|Immunologic Factors|immunologic factors|mesh-ancestor
102429596|NCT05314998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429597|NCT05314998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102429598|NCT05314998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102429599|NCT05314998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102429600|NCT05314998|Antidotes|antidotes|mesh-ancestor
102429601|NCT05314998|Protective Agents|protective agents|mesh-ancestor
102429602|NCT05314998|Vitamin B Complex|vitamin b complex|mesh-ancestor
102429603|NCT05314998|Vitamins|vitamins|mesh-ancestor
102429604|NCT05314998|Micronutrients|micronutrients|mesh-ancestor
102429605|NCT05314998|Hematinics|hematinics|mesh-ancestor
102429606|NCT05284344|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102429607|NCT05284344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429608|NCT05269615|Valsartan|valsartan|mesh-list
102429609|NCT05269615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102429610|NCT05269615|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102429612|NCT05269615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429613|NCT05250895|Misonidazole|misonidazole|mesh-list
102429614|NCT05250895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380300|NCT00102141|Estradiol|estradiol|mesh-list
102429615|NCT05250895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102429616|NCT05250895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102429617|NCT05250895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102429618|NCT05219409|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102429619|NCT05219409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102429620|NCT05219409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429621|NCT05219409|Incretins|incretins|mesh-ancestor
102429622|NCT05219409|Hormones|hormones|mesh-ancestor
102429623|NCT05219409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102429624|NCT05219409|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102429625|NCT05219409|Protease Inhibitors|protease inhibitors|mesh-ancestor
102429626|NCT05219409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102429627|NCT05219409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429628|NCT05196932|Antibodies|antibodies|mesh-list
102429629|NCT05196932|Immunologic Factors|immunologic factors|mesh-ancestor
102429630|NCT05196932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429631|NCT05194111|Valsartan|valsartan|mesh-list
102429632|NCT05194111|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102429633|NCT05194111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102429634|NCT05194111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102429635|NCT05194111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102429636|NCT05194111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429637|NCT05189756|Aprepitant|aprepitant|mesh-list
102429638|NCT05189756|Fosaprepitant|fosaprepitant|mesh-list
102429639|NCT05189756|Antiemetics|antiemetics|mesh-ancestor
102429640|NCT05189756|Autonomic Agents|autonomic agents|mesh-ancestor
102429641|NCT05189756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102429642|NCT05189756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429643|NCT05189756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102429644|NCT05189756|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102429645|NCT05189756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102429646|NCT05189756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429647|NCT05181150|Glucagon|glucagon|mesh-list
102429648|NCT05181150|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102429649|NCT05181150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102429650|NCT05181150|Hormones|hormones|mesh-ancestor
102429651|NCT05181150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102429652|NCT05181150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429653|NCT05181150|Incretins|incretins|mesh-ancestor
102429654|NCT05174637|Immunoconjugates|immunoconjugates|mesh-list
102429655|NCT05174637|Immunologic Factors|immunologic factors|mesh-ancestor
102429656|NCT05174637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429657|NCT05151159|Antibodies|antibodies|mesh-list
102429658|NCT05151159|Immunologic Factors|immunologic factors|mesh-ancestor
102429659|NCT05151159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380809|NCT00269542|Iron|iron|mesh-list
102429660|NCT05144529|Nivolumab|nivolumab|mesh-list
102429661|NCT05144529|Ipilimumab|ipilimumab|mesh-list
102429662|NCT05144529|Evolocumab|evolocumab|mesh-list
102429663|NCT05144529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102429664|NCT05144529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101305015|NCT02016443|Adrenergic Agents|adrenergic agents|mesh-ancestor
102429665|NCT05144529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102429666|NCT05144529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429667|NCT05144529|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102429668|NCT05144529|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102429669|NCT05144529|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102429670|NCT05144529|Antimetabolites|antimetabolites|mesh-ancestor
102429671|NCT05144529|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102429672|NCT05144529|Protease Inhibitors|protease inhibitors|mesh-ancestor
102429673|NCT05144529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102429674|NCT05144529|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102429675|NCT05132920|Dexamethasone|dexamethasone|mesh-list
102429676|NCT05132920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102429677|NCT05132920|Antiemetics|antiemetics|mesh-ancestor
102429678|NCT05132920|Autonomic Agents|autonomic agents|mesh-ancestor
102429679|NCT05132920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102429680|NCT05132920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429681|NCT05132920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102429682|NCT05132920|Glucocorticoids|glucocorticoids|mesh-ancestor
102429683|NCT05132920|Hormones|hormones|mesh-ancestor
102429688|NCT05129085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102429689|NCT05129085|Antiemetics|antiemetics|mesh-ancestor
102429690|NCT05129085|Autonomic Agents|autonomic agents|mesh-ancestor
102429691|NCT05129085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102429692|NCT05129085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429693|NCT05129085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102429694|NCT05129085|Glucocorticoids|glucocorticoids|mesh-ancestor
102429695|NCT05129085|Hormones|hormones|mesh-ancestor
102429696|NCT05129085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102429697|NCT05129085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102429698|NCT05129085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102429703|NCT05099471|Dexamethasone|dexamethasone|mesh-list
102429704|NCT05099471|Cyclophosphamide|cyclophosphamide|mesh-list
102429705|NCT05099471|Rituximab|rituximab|mesh-list
102429706|NCT05099471|Venetoclax|venetoclax|mesh-list
102429707|NCT05099471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102060249|NCT03457701|Iron|iron|mesh-list
102429708|NCT05099471|Immunologic Factors|immunologic factors|mesh-ancestor
102429709|NCT05099471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429710|NCT05099471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102429711|NCT05099471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102429712|NCT05099471|Alkylating Agents|alkylating agents|mesh-ancestor
102429713|NCT05099471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429714|NCT05099471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102429715|NCT05099471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102429716|NCT05099471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102429717|NCT05099471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102429718|NCT05099471|Antiemetics|antiemetics|mesh-ancestor
102429719|NCT05099471|Autonomic Agents|autonomic agents|mesh-ancestor
102429720|NCT05099471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102060262|NCT03457142|Autonomic Agents|autonomic agents|mesh-ancestor
102429721|NCT05099471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102429722|NCT05099471|Glucocorticoids|glucocorticoids|mesh-ancestor
102429723|NCT05099471|Hormones|hormones|mesh-ancestor
102429724|NCT05099471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102429725|NCT05099471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102429726|NCT05087693|Albuterol|albuterol|mesh-list
102429727|NCT05087693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102429728|NCT05087693|Autonomic Agents|autonomic agents|mesh-ancestor
102429729|NCT05087693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102429730|NCT05087693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429731|NCT05087693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102429732|NCT05087693|Respiratory System Agents|respiratory system agents|mesh-ancestor
102429733|NCT05087693|Tocolytic Agents|tocolytic agents|mesh-ancestor
102429734|NCT05087693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102429735|NCT05087693|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102429736|NCT05087693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102429737|NCT05087693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102429738|NCT05087693|Adrenergic Agents|adrenergic agents|mesh-ancestor
102429739|NCT05087693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102429740|NCT05087693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429741|NCT05081583|Midazolam|midazolam|mesh-list
102429742|NCT05081583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102429743|NCT05081583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102429744|NCT05081583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102429745|NCT05081583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429746|NCT05081583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102429747|NCT05081583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102429748|NCT05081583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102429749|NCT05081583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102429750|NCT05081583|Anesthetics, General|anesthetics, general|mesh-ancestor
102429751|NCT05081583|Anesthetics|anesthetics|mesh-ancestor
102429752|NCT05081583|GABA Modulators|gaba modulators|mesh-ancestor
102429753|NCT05081583|GABA Agents|gaba agents|mesh-ancestor
102429754|NCT05081583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102429755|NCT05081583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429756|NCT05070754|Cantharidin|cantharidin|mesh-list
102429757|NCT05070754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102429763|NCT05067387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102429765|NCT05067387|Sensory System Agents|sensory system agents|mesh-ancestor
102429766|NCT05067387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102429767|NCT05067387|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102429768|NCT05067387|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102429769|NCT05067387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102429770|NCT05067387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429771|NCT05067387|Hormones|hormones|mesh-ancestor
102429772|NCT05067387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102429773|NCT05060731|Iron|iron|mesh-list
102429774|NCT05060731|Trace Elements|trace elements|mesh-ancestor
102429775|NCT05060731|Micronutrients|micronutrients|mesh-ancestor
102429776|NCT05060731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429782|NCT05052099|Bevacizumab|bevacizumab|mesh-list
102429783|NCT05052099|Atezolizumab|atezolizumab|mesh-list
102429784|NCT05052099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102429785|NCT05052099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102429786|NCT05052099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102429787|NCT05052099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102429788|NCT05052099|Growth Substances|growth substances|mesh-ancestor
102060315|NCT03182426|Alemtuzumab|alemtuzumab|mesh-list
102429789|NCT05052099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429790|NCT05052099|Growth Inhibitors|growth inhibitors|mesh-ancestor
102429791|NCT05052099|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102429792|NCT05052099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429793|NCT05050253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102429794|NCT05037487|Dronabinol|dronabinol|mesh-list
102429795|NCT05037487|Hallucinogens|hallucinogens|mesh-ancestor
102429796|NCT05037487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429797|NCT05037487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102429798|NCT05037487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102429799|NCT05037487|Analgesics|analgesics|mesh-ancestor
102429800|NCT05037487|Sensory System Agents|sensory system agents|mesh-ancestor
102429801|NCT05037487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102429802|NCT05037487|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102060322|NCT03182426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102429803|NCT05037487|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102429804|NCT05037487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102429805|NCT05037487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429806|NCT05037487|Hormones|hormones|mesh-ancestor
102429807|NCT05037487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102429808|NCT05030441|Ivosidenib|ivosidenib|mesh-list
102429809|NCT05030441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102060327|NCT03182426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102429810|NCT05030441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102429811|NCT05030441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429812|NCT05001074|Tacrolimus|tacrolimus|mesh-list
102429813|NCT05001074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102429814|NCT05001074|Immunologic Factors|immunologic factors|mesh-ancestor
102429815|NCT05001074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429816|NCT05001074|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102060335|NCT03182426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102429817|NCT05001074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102429818|NCT05001074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429819|NCT04985890|UB-421|ub-421|mesh-list
102429820|NCT04985890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102429821|NCT04985890|Antiviral Agents|antiviral agents|mesh-ancestor
102429822|NCT04985890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102429823|NCT04977453|Pembrolizumab|pembrolizumab|mesh-list
102429824|NCT04977453|Lenvatinib|lenvatinib|mesh-list
102429825|NCT04977453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102429826|NCT04977453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102429827|NCT04977453|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102429828|NCT04977453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429829|NCT04977453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102429830|NCT04977453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102429831|NCT04946461|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102429832|NCT04946461|Dextroamphetamine|dextroamphetamine|mesh-list
102429833|NCT04946461|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102429834|NCT04946461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429835|NCT04946461|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102429836|NCT04946461|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102060350|NCT03161379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102429837|NCT04946461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102429838|NCT04946461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429839|NCT04946461|Dopamine Agents|dopamine agents|mesh-ancestor
102429840|NCT04946461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102429841|NCT04928664|Bupivacaine|bupivacaine|mesh-list
102429842|NCT04928664|Anesthetics, Local|anesthetics, local|mesh-ancestor
102429843|NCT04928664|Anesthetics|anesthetics|mesh-ancestor
102429844|NCT04928664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102429845|NCT04928664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429846|NCT04928664|Sensory System Agents|sensory system agents|mesh-ancestor
102429847|NCT04928664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102429848|NCT04916392|Bupivacaine|bupivacaine|mesh-list
102429849|NCT04916392|Anesthetics, Local|anesthetics, local|mesh-ancestor
102429850|NCT04916392|Anesthetics|anesthetics|mesh-ancestor
102060370|NCT03078946|Dexmedetomidine|dexmedetomidine|mesh-list
102429851|NCT04916392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102429852|NCT04916392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429853|NCT04916392|Sensory System Agents|sensory system agents|mesh-ancestor
102429854|NCT04916392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102429855|NCT04903119|Trametinib|trametinib|mesh-list
102429856|NCT04903119|Dabrafenib|dabrafenib|mesh-list
102429857|NCT04903119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102429858|NCT04903119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102429859|NCT04903119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102429860|NCT04903119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429861|NCT04899115|Vancomycin|vancomycin|mesh-list
102429862|NCT04899115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102429863|NCT04899115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102429864|NCT04892875|Cisplatin|cisplatin|mesh-list
102429865|NCT04892875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102429866|NCT04871594|Nivolumab|nivolumab|mesh-list
102429867|NCT04871594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102429868|NCT04871594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102429869|NCT04871594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102429870|NCT04871594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429871|NCT04868903|Vitamin D|vitamin d|mesh-list
102060387|NCT03078946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102429872|NCT04868903|Cholecalciferol|cholecalciferol|mesh-list
102429873|NCT04868903|Vitamins|vitamins|mesh-ancestor
102429874|NCT04868903|Micronutrients|micronutrients|mesh-ancestor
102429875|NCT04868903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429876|NCT04868903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102429877|NCT04868903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102429878|NCT04859530|Lugol's solution|lugol's solution|mesh-list
102429879|NCT04859530|Hemostatics|hemostatics|mesh-ancestor
102429880|NCT04859530|Coagulants|coagulants|mesh-ancestor
102429881|NCT04851301|Naloxone|naloxone|mesh-list
102429882|NCT04851301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102429883|NCT04851301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429884|NCT04851301|Sensory System Agents|sensory system agents|mesh-ancestor
102429885|NCT04851301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102429886|NCT04843982|Esketamine|esketamine|mesh-list
102429887|NCT04843982|Antidepressive Agents|antidepressive agents|mesh-ancestor
102429888|NCT04843982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102429889|NCT04801966|Pembrolizumab|pembrolizumab|mesh-list
102429890|NCT04801966|Nivolumab|nivolumab|mesh-list
102429891|NCT04801966|Atezolizumab|atezolizumab|mesh-list
102429892|NCT04801966|Olaparib|olaparib|mesh-list
102429893|NCT04801966|Palbociclib|palbociclib|mesh-list
102429894|NCT04801966|Trametinib|trametinib|mesh-list
102429895|NCT04801966|Vemurafenib|vemurafenib|mesh-list
102429896|NCT04801966|Dabrafenib|dabrafenib|mesh-list
102429897|NCT04801966|Talazoparib|talazoparib|mesh-list
102429898|NCT04801966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102429899|NCT04801966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102429900|NCT04801966|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102429901|NCT04801966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429902|NCT04801966|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102429903|NCT04801966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102429904|NCT04801966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102429905|NCT04789915|Memantine|memantine|mesh-list
102241611|NCT04433559|Tadalafil|tadalafil|mesh-list
102429906|NCT04789915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102429907|NCT04789915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102429909|NCT04789915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102060423|NCT02970448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102429910|NCT04789915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429911|NCT04789915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429912|NCT04789915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102429913|NCT04789915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102429914|NCT04771299|Cariprazine|cariprazine|mesh-list
102429915|NCT04771299|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102429916|NCT04771299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102429917|NCT04771299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102429918|NCT04771299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429919|NCT04771299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102429920|NCT04725656|Nicotine|nicotine|mesh-list
101362042|NCT00399477|Levodopa|levodopa|mesh-list
102429921|NCT04725656|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102429922|NCT04725656|Autonomic Agents|autonomic agents|mesh-ancestor
102429923|NCT04725656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102429924|NCT04725656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429925|NCT04725656|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102429926|NCT04725656|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102429927|NCT04725656|Cholinergic Agents|cholinergic agents|mesh-ancestor
102429928|NCT04725656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102429929|NCT04725656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429930|NCT04704063|Vitamin E|vitamin e|mesh-list
102429931|NCT04704063|Tocopherols|tocopherols|mesh-list
102429932|NCT04704063|Tocotrienols|tocotrienols|mesh-list
102429933|NCT04704063|Tocovid|tocovid|mesh-list
102429934|NCT04704063|Vitamins|vitamins|mesh-ancestor
102429935|NCT04704063|Micronutrients|micronutrients|mesh-ancestor
102429936|NCT04704063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429937|NCT04704063|Antioxidants|antioxidants|mesh-ancestor
102429938|NCT04704063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429939|NCT04704063|Protective Agents|protective agents|mesh-ancestor
102429940|NCT04703036|Acetylcysteine|acetylcysteine|mesh-list
102429941|NCT04703036|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102429942|NCT04703036|Glycine|glycine|mesh-list
102429943|NCT04703036|Antiviral Agents|antiviral agents|mesh-ancestor
102429944|NCT04703036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102429945|NCT04703036|Expectorants|expectorants|mesh-ancestor
102429946|NCT04703036|Respiratory System Agents|respiratory system agents|mesh-ancestor
102429947|NCT04703036|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102429948|NCT04703036|Antioxidants|antioxidants|mesh-ancestor
102429949|NCT04703036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429950|NCT04703036|Protective Agents|protective agents|mesh-ancestor
102429951|NCT04703036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429952|NCT04703036|Antidotes|antidotes|mesh-ancestor
102429953|NCT04703036|Glycine Agents|glycine agents|mesh-ancestor
102429954|NCT04703036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102429955|NCT04636255|Calcium|calcium|mesh-list
102429956|NCT04636255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102429957|NCT04636255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429958|NCT04635176|Dexamethasone|dexamethasone|mesh-list
102429959|NCT04635176|Epinephrine|epinephrine|mesh-list
102429960|NCT04635176|Bupivacaine|bupivacaine|mesh-list
102429961|NCT04635176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102429962|NCT04635176|Antiemetics|antiemetics|mesh-ancestor
102429963|NCT04635176|Autonomic Agents|autonomic agents|mesh-ancestor
102429964|NCT04635176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102429965|NCT04635176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429966|NCT04635176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102429967|NCT04635176|Glucocorticoids|glucocorticoids|mesh-ancestor
102429968|NCT04635176|Hormones|hormones|mesh-ancestor
102429969|NCT04635176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102429970|NCT04635176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102429971|NCT04635176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102429972|NCT04635176|Anesthetics, Local|anesthetics, local|mesh-ancestor
102429973|NCT04635176|Anesthetics|anesthetics|mesh-ancestor
102429974|NCT04635176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102429975|NCT04635176|Sensory System Agents|sensory system agents|mesh-ancestor
102429976|NCT04635176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102429977|NCT04635176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102429978|NCT04635176|Adrenergic Agents|adrenergic agents|mesh-ancestor
102429979|NCT04635176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102429980|NCT04635176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102429981|NCT04635176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102429982|NCT04635176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102429983|NCT04635176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102429984|NCT04635176|Respiratory System Agents|respiratory system agents|mesh-ancestor
102429985|NCT04635176|Mydriatics|mydriatics|mesh-ancestor
102429986|NCT04635176|Sympathomimetics|sympathomimetics|mesh-ancestor
102429987|NCT04635176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102429988|NCT04625907|Dactinomycin|dactinomycin|mesh-list
102429989|NCT04625907|Cyclophosphamide|cyclophosphamide|mesh-list
102429990|NCT04625907|Temozolomide|temozolomide|mesh-list
102429991|NCT04625907|Ifosfamide|ifosfamide|mesh-list
102429992|NCT04625907|Doxorubicin|doxorubicin|mesh-list
102429993|NCT04625907|Irinotecan|irinotecan|mesh-list
102429994|NCT04625907|Vincristine|vincristine|mesh-list
102429995|NCT04625907|Vinorelbine|vinorelbine|mesh-list
102429996|NCT04625907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102429997|NCT04625907|Immunologic Factors|immunologic factors|mesh-ancestor
102429998|NCT04625907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102429999|NCT04625907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102430000|NCT04625907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102430001|NCT04625907|Alkylating Agents|alkylating agents|mesh-ancestor
102430002|NCT04625907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430003|NCT04625907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430004|NCT04625907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102430005|NCT04625907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102430006|NCT04625907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102430007|NCT04625907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102430008|NCT04625907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102430009|NCT04625907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102430010|NCT04625907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102430011|NCT04625907|Tubulin Modulators|tubulin modulators|mesh-ancestor
102430012|NCT04625907|Antimitotic Agents|antimitotic agents|mesh-ancestor
102430013|NCT04625907|Mitosis Modulators|mitosis modulators|mesh-ancestor
102430014|NCT04625907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102430015|NCT04625907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102430016|NCT04625907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102430017|NCT04625907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102430018|NCT04623086|Insulin|insulin|mesh-list
102430019|NCT04623086|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102430020|NCT04623086|Insulin Glargine|insulin glargine|mesh-list
102430021|NCT04623086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102430022|NCT04623086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430023|NCT04574713|Candesartan|candesartan|mesh-list
102430024|NCT04574713|Candesartan cilexetil|candesartan cilexetil|mesh-list
101481516|NCT00298454|Furosemide|furosemide|mesh-list
102430025|NCT04574713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102430026|NCT04574713|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102430027|NCT04574713|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102430028|NCT04574713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430029|NCT04569877|Molgramostim|molgramostim|mesh-list
102430030|NCT04569877|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102430031|NCT04569877|Sargramostim|sargramostim|mesh-list
102430032|NCT04569877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430033|NCT04569877|Immunologic Factors|immunologic factors|mesh-ancestor
102430034|NCT04569877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430035|NCT04550234|Allopurinol|allopurinol|mesh-list
102430036|NCT04550234|Verinurad|verinurad|mesh-list
102430037|NCT04550234|Antimetabolites|antimetabolites|mesh-ancestor
102430038|NCT04550234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430039|NCT04550234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102060536|NCT02207439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102430040|NCT04550234|Gout Suppressants|gout suppressants|mesh-ancestor
102430041|NCT04550234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102430042|NCT04550234|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102430043|NCT04550234|Antioxidants|antioxidants|mesh-ancestor
102430044|NCT04550234|Protective Agents|protective agents|mesh-ancestor
102430045|NCT04550234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430046|NCT04542070|Rilpivirine|rilpivirine|mesh-list
102430047|NCT04542070|Cabotegravir|cabotegravir|mesh-list
102430048|NCT04542070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102430049|NCT04542070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102430050|NCT04542070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102430051|NCT04542070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430052|NCT04542070|Antiviral Agents|antiviral agents|mesh-ancestor
102430053|NCT04542070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102430054|NCT04542070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102430055|NCT04542070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102430056|NCT04542070|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102430057|NCT04542070|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102430058|NCT04541797|Empagliflozin|empagliflozin|mesh-list
102430059|NCT04541797|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102430060|NCT04541797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430061|NCT04541797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102430062|NCT04541797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430063|NCT04540666|Propofol|propofol|mesh-list
102430064|NCT04540666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102430065|NCT04540666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102430066|NCT04540666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430067|NCT04540666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102430068|NCT04540666|Anesthetics, General|anesthetics, general|mesh-ancestor
102430069|NCT04540666|Anesthetics|anesthetics|mesh-ancestor
102430070|NCT04530383|Metformin|metformin|mesh-list
102430071|NCT04530383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102430072|NCT04530383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430073|NCT04507555|Antidepressive Agents|antidepressive agents|mesh-list
102430074|NCT04507555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102430075|NCT04485130|Disulfiram|disulfiram|mesh-list
102430076|NCT04485130|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102430077|NCT04485130|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
102430078|NCT04485130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102430079|NCT04485130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430080|NCT04469491|Interferons|interferons|mesh-list
102430081|NCT04469491|Interferon Type I|interferon type i|mesh-list
102430082|NCT04469491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430083|NCT04469491|Antiviral Agents|antiviral agents|mesh-ancestor
102430084|NCT04469491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102430085|NCT04431245|Entecavir|entecavir|mesh-list
102430086|NCT04431245|Antiviral Agents|antiviral agents|mesh-ancestor
102430087|NCT04431245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102430088|NCT04421248|Methylphenidate|methylphenidate|mesh-list
102430089|NCT04421248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102430090|NCT04421248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430091|NCT04421248|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102430092|NCT04421248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102430093|NCT04421248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102430094|NCT04421248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430095|NCT04421248|Dopamine Agents|dopamine agents|mesh-ancestor
102430096|NCT04421248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102430097|NCT04355572|Vitamin D|vitamin d|mesh-list
102430098|NCT04355572|Vitamins|vitamins|mesh-ancestor
102430099|NCT04355572|Micronutrients|micronutrients|mesh-ancestor
102430100|NCT04355572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430101|NCT04355572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102430102|NCT04310059|Folic Acid|folic acid|mesh-list
102430103|NCT04310059|Hematinics|hematinics|mesh-ancestor
102430104|NCT04310059|Vitamin B Complex|vitamin b complex|mesh-ancestor
102430105|NCT04310059|Vitamins|vitamins|mesh-ancestor
102430106|NCT04310059|Micronutrients|micronutrients|mesh-ancestor
102430107|NCT04310059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430108|NCT04303780|Docetaxel|docetaxel|mesh-list
102430109|NCT04303780|Sotorasib|sotorasib|mesh-list
102430110|NCT04303780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430111|NCT04303780|Tubulin Modulators|tubulin modulators|mesh-ancestor
102430112|NCT04303780|Antimitotic Agents|antimitotic agents|mesh-ancestor
102430113|NCT04303780|Mitosis Modulators|mitosis modulators|mesh-ancestor
102430114|NCT04303780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430115|NCT04303780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102430116|NCT04303780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102430117|NCT04303689|Colchicine|colchicine|mesh-list
102430118|NCT04303689|Gout Suppressants|gout suppressants|mesh-ancestor
102430119|NCT04303689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102430120|NCT04303689|Tubulin Modulators|tubulin modulators|mesh-ancestor
102430121|NCT04303689|Antimitotic Agents|antimitotic agents|mesh-ancestor
102430122|NCT04303689|Mitosis Modulators|mitosis modulators|mesh-ancestor
102430123|NCT04303689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430124|NCT04303689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430125|NCT04217278|Cytarabine|cytarabine|mesh-list
102430126|NCT04217278|Fludarabine|fludarabine|mesh-list
102430127|NCT04217278|Busulfan|busulfan|mesh-list
102430128|NCT04217278|Thiotepa|thiotepa|mesh-list
102430129|NCT04217278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430130|NCT04217278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102430131|NCT04217278|Antimetabolites|antimetabolites|mesh-ancestor
102430132|NCT04217278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430133|NCT04217278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102430134|NCT04217278|Immunologic Factors|immunologic factors|mesh-ancestor
102430135|NCT04217278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430136|NCT04217278|Antiviral Agents|antiviral agents|mesh-ancestor
102430137|NCT04217278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102430138|NCT04217278|Alkylating Agents|alkylating agents|mesh-ancestor
102430139|NCT04217278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102430140|NCT04217278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102430141|NCT04202809|Durvalumab|durvalumab|mesh-list
102430142|NCT04202809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102430143|NCT04202809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430144|NCT04177953|Carboplatin|carboplatin|mesh-list
102430145|NCT04177953|Nivolumab|nivolumab|mesh-list
102430146|NCT04177953|Pemetrexed|pemetrexed|mesh-list
102430147|NCT04177953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430148|NCT04177953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102430149|NCT04177953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102060600|NCT01796197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430150|NCT04177953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430151|NCT04177953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102430152|NCT04177953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102430153|NCT04177953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102430154|NCT04063579|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
102430155|NCT04063579|Natriuretic Agents|natriuretic agents|mesh-ancestor
102430156|NCT04063579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430157|NCT04061512|Dexamethasone|dexamethasone|mesh-list
102430158|NCT04061512|Cyclophosphamide|cyclophosphamide|mesh-list
102430159|NCT04061512|Rituximab|rituximab|mesh-list
102430160|NCT04061512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102430161|NCT04061512|Immunologic Factors|immunologic factors|mesh-ancestor
102430162|NCT04061512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430163|NCT04061512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102430164|NCT04061512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102430165|NCT04061512|Alkylating Agents|alkylating agents|mesh-ancestor
102430166|NCT04061512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430167|NCT04061512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430168|NCT04061512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102430169|NCT04061512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102430170|NCT04061512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102430171|NCT04061512|Antiemetics|antiemetics|mesh-ancestor
102430172|NCT04061512|Autonomic Agents|autonomic agents|mesh-ancestor
102430173|NCT04061512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102430174|NCT04061512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102430175|NCT04061512|Glucocorticoids|glucocorticoids|mesh-ancestor
102430176|NCT04061512|Hormones|hormones|mesh-ancestor
102430177|NCT04061512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102430178|NCT04061512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102430179|NCT04036461|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
102430180|NCT04036461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102430181|NCT04036461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430182|NCT04019548|Cisplatin|cisplatin|mesh-list
102430183|NCT04019548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430184|NCT04006925|Sodium Oxybate|sodium oxybate|mesh-list
102430185|NCT04006925|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102430186|NCT04006925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102430187|NCT04006925|Anesthetics, General|anesthetics, general|mesh-ancestor
102430188|NCT04006925|Anesthetics|anesthetics|mesh-ancestor
102430189|NCT04006925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102430190|NCT04006925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430191|NCT04002271|Propofol|propofol|mesh-list
102430192|NCT04002271|Sevoflurane|sevoflurane|mesh-list
102430193|NCT04002271|Anesthetics|anesthetics|mesh-ancestor
102430194|NCT04002271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102430195|NCT04002271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430196|NCT04002271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102430197|NCT04002271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102430198|NCT04002271|Anesthetics, General|anesthetics, general|mesh-ancestor
102430199|NCT04002271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102430200|NCT04002271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102430201|NCT03972592|Sirolimus|sirolimus|mesh-list
102430202|NCT03972592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102430203|NCT03972592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102430204|NCT03972592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102430205|NCT03972592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430206|NCT03972592|Antifungal Agents|antifungal agents|mesh-ancestor
102430207|NCT03972592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102430208|NCT03972592|Immunologic Factors|immunologic factors|mesh-ancestor
102430209|NCT03972592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430210|NCT03889743|Dexamethasone|dexamethasone|mesh-list
102430211|NCT03889743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102430212|NCT03889743|Antiemetics|antiemetics|mesh-ancestor
102430213|NCT03889743|Autonomic Agents|autonomic agents|mesh-ancestor
102241902|NCT02473211|Sofosbuvir|sofosbuvir|mesh-list
102430214|NCT03889743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102430215|NCT03889743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430216|NCT03889743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102430218|NCT03889743|Hormones|hormones|mesh-ancestor
102430219|NCT03889743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102430220|NCT03889743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102430221|NCT03889743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430222|NCT03875872|Propofol|propofol|mesh-list
102430223|NCT03875872|Anesthetics|anesthetics|mesh-list
102430224|NCT03875872|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
102430225|NCT03875872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102430226|NCT03875872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102430227|NCT03875872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430228|NCT03875872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102430229|NCT03875872|Anesthetics, General|anesthetics, general|mesh-ancestor
102430230|NCT03871036|Paclitaxel|paclitaxel|mesh-list
102430231|NCT03871036|Durvalumab|durvalumab|mesh-list
102430232|NCT03871036|Tremelimumab|tremelimumab|mesh-list
102430233|NCT03871036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102430234|NCT03871036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430235|NCT03871036|Tubulin Modulators|tubulin modulators|mesh-ancestor
102430236|NCT03871036|Antimitotic Agents|antimitotic agents|mesh-ancestor
102430237|NCT03871036|Mitosis Modulators|mitosis modulators|mesh-ancestor
102430238|NCT03871036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430239|NCT03871036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102430240|NCT03859908|Ethanol|ethanol|mesh-list
102430241|NCT03859908|Chlorhexidine|chlorhexidine|mesh-list
102430242|NCT03859908|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102430243|NCT03859908|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102430244|NCT03859908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102430245|NCT03859908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102430246|NCT03859908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430247|NCT03859908|Disinfectants|disinfectants|mesh-ancestor
102430248|NCT03859908|Dermatologic Agents|dermatologic agents|mesh-ancestor
102430249|NCT03825536|Methamphetamine|methamphetamine|mesh-list
102430250|NCT03825536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102430251|NCT03825536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430252|NCT03825536|Sympathomimetics|sympathomimetics|mesh-ancestor
102430253|NCT03825536|Autonomic Agents|autonomic agents|mesh-ancestor
102430254|NCT03825536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102430255|NCT03825536|Dopamine Agents|dopamine agents|mesh-ancestor
102430256|NCT03825536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102430257|NCT03825536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430258|NCT03825536|Adrenergic Agents|adrenergic agents|mesh-ancestor
102430259|NCT03825536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102430260|NCT03825536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102430261|NCT03825536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102430262|NCT03825536|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102430263|NCT03797196|Mycophenolic Acid|mycophenolic acid|mesh-list
102430264|NCT03797196|Everolimus|everolimus|mesh-list
102430265|NCT03797196|Tacrolimus|tacrolimus|mesh-list
102430266|NCT03797196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102430267|NCT03797196|Immunologic Factors|immunologic factors|mesh-ancestor
102430268|NCT03797196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430269|NCT03797196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102430270|NCT03797196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102430271|NCT03797196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430272|NCT03797196|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102430273|NCT03797196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102430274|NCT03797196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430275|NCT03797196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102430276|NCT03797196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102430277|NCT03797196|Antitubercular Agents|antitubercular agents|mesh-ancestor
102430278|NCT03797196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102430279|NCT03797196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102430280|NCT03775382|Ascorbic Acid|ascorbic acid|mesh-list
102430281|NCT03775382|Vitamins|vitamins|mesh-ancestor
102430282|NCT03775382|Micronutrients|micronutrients|mesh-ancestor
102430283|NCT03775382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430284|NCT03775382|Antioxidants|antioxidants|mesh-ancestor
102430285|NCT03775382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430286|NCT03775382|Protective Agents|protective agents|mesh-ancestor
102430287|NCT03747432|Dexmedetomidine|dexmedetomidine|mesh-list
102430288|NCT03747432|Propofol|propofol|mesh-list
102430289|NCT03747432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102430290|NCT03747432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102430291|NCT03747432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430292|NCT03747432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102430293|NCT03747432|Analgesics|analgesics|mesh-ancestor
102430294|NCT03747432|Sensory System Agents|sensory system agents|mesh-ancestor
102430295|NCT03747432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102430296|NCT03747432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102430297|NCT03747432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102430298|NCT03747432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102430299|NCT03747432|Adrenergic Agents|adrenergic agents|mesh-ancestor
102430300|NCT03747432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102430301|NCT03747432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430302|NCT03747432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102430303|NCT03747432|Anesthetics, General|anesthetics, general|mesh-ancestor
102430304|NCT03747432|Anesthetics|anesthetics|mesh-ancestor
102430305|NCT03724019|Ketamine|ketamine|mesh-list
102430306|NCT03724019|Analgesics|analgesics|mesh-ancestor
102430307|NCT03724019|Sensory System Agents|sensory system agents|mesh-ancestor
102430308|NCT03724019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102430309|NCT03724019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430310|NCT03724019|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102430311|NCT03724019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102430312|NCT03724019|Anesthetics, General|anesthetics, general|mesh-ancestor
102430313|NCT03724019|Anesthetics|anesthetics|mesh-ancestor
102430314|NCT03724019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102430315|NCT03724019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102430316|NCT03724019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102430317|NCT03724019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102430318|NCT03724019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430319|NCT03697512|Rituximab|rituximab|mesh-list
102430320|NCT03697512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102430321|NCT03697512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430322|NCT03697512|Immunologic Factors|immunologic factors|mesh-ancestor
102430323|NCT03697512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430324|NCT03697512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102430325|NCT03686332|Atezolizumab|atezolizumab|mesh-list
102430326|NCT03686332|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102430327|NCT03686332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102430328|NCT03686332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430329|NCT03686332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102430330|NCT03686332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430331|NCT03686332|Immunologic Factors|immunologic factors|mesh-ancestor
102430332|NCT03686332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430333|NCT03683069|Amlodipine|amlodipine|mesh-list
102430334|NCT03683069|Eplerenone|eplerenone|mesh-list
102430335|NCT03683069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102430336|NCT03683069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102430337|NCT03683069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102430338|NCT03683069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430339|NCT03683069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102430340|NCT03683069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430341|NCT03683069|Vasodilator Agents|vasodilator agents|mesh-ancestor
102430342|NCT03683069|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102430343|NCT03683069|Hormone Antagonists|hormone antagonists|mesh-ancestor
102430344|NCT03683069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102430345|NCT03683069|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102430346|NCT03683069|Diuretics|diuretics|mesh-ancestor
102430347|NCT03683069|Natriuretic Agents|natriuretic agents|mesh-ancestor
102430348|NCT03667651|Decanoic acid|decanoic acid|mesh-list
102430349|NCT03667651|Antifungal Agents|antifungal agents|mesh-ancestor
102430350|NCT03667651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102430351|NCT03649633|Vitamins|vitamins|mesh-list
102430352|NCT03649633|Hydrocortisone|hydrocortisone|mesh-list
102430353|NCT03649633|Micronutrients|micronutrients|mesh-ancestor
102430354|NCT03649633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430355|NCT03649633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102430356|NCT03620903|Rituximab|rituximab|mesh-list
102430357|NCT03620903|Bortezomib|bortezomib|mesh-list
102430358|NCT03620903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102430359|NCT03620903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430360|NCT03620903|Immunologic Factors|immunologic factors|mesh-ancestor
102430361|NCT03620903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430362|NCT03620903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102430363|NCT03497156|Lercanidipine|lercanidipine|mesh-list
102430364|NCT03497156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102430365|NCT03497156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102430366|NCT03497156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102430367|NCT03497156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430368|NCT03497156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102430369|NCT03497156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430370|NCT03471117|Pioglitazone|pioglitazone|mesh-list
102430371|NCT03471117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102430372|NCT03471117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430373|NCT03464292|Capsaicin|capsaicin|mesh-list
102430374|NCT03464292|Antipruritics|antipruritics|mesh-ancestor
102430375|NCT03464292|Dermatologic Agents|dermatologic agents|mesh-ancestor
102430376|NCT03464292|Sensory System Agents|sensory system agents|mesh-ancestor
102430377|NCT03464292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102430378|NCT03464292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430379|NCT03448718|Olaparib|olaparib|mesh-list
102430380|NCT03448718|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102430381|NCT03448718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102430382|NCT03448718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430383|NCT03448718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430384|NCT03435939|Losartan|losartan|mesh-list
102430385|NCT03435939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102430386|NCT03435939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102430387|NCT03435939|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102430388|NCT03435939|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102430389|NCT03435939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430390|NCT03422393|Venetoclax|venetoclax|mesh-list
102430391|NCT03422393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430392|NCT03385226|Pembrolizumab|pembrolizumab|mesh-list
102430393|NCT03385226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102430394|NCT03385226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430395|NCT03385226|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102430396|NCT03385226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430397|NCT03377543|Aspirin|aspirin|mesh-list
102430398|NCT03377543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
102430399|NCT03377543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102430400|NCT03377543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102430401|NCT03377543|Analgesics|analgesics|mesh-ancestor
102430402|NCT03377543|Sensory System Agents|sensory system agents|mesh-ancestor
102430403|NCT03377543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102430404|NCT03377543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430405|NCT03377543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102430406|NCT03377543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102430407|NCT03377543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102430408|NCT03377543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430409|NCT03377543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102430410|NCT03377543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102430411|NCT03377543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102430412|NCT03377543|Antipyretics|antipyretics|mesh-ancestor
102430413|NCT03365908|Ropivacaine|ropivacaine|mesh-list
102430414|NCT03365908|Anesthetics, Local|anesthetics, local|mesh-ancestor
102430415|NCT03365908|Anesthetics|anesthetics|mesh-ancestor
102430416|NCT03365908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102430417|NCT03365908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430418|NCT03365908|Sensory System Agents|sensory system agents|mesh-ancestor
102430419|NCT03365908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102430420|NCT03362047|Macitentan|macitentan|mesh-list
102430421|NCT03362047|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
102430422|NCT03362047|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102430423|NCT03362047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430424|NCT03362047|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
102430425|NCT03337919|Nivolumab|nivolumab|mesh-list
102430426|NCT03337919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102430427|NCT03337919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430428|NCT03337919|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102430429|NCT03337919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430430|NCT03334305|Vaccines|vaccines|mesh-list
102430431|NCT03334305|Immunologic Factors|immunologic factors|mesh-ancestor
102430432|NCT03334305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430433|NCT03236324|Epinephrine|epinephrine|mesh-list
102430434|NCT03236324|Bupivacaine|bupivacaine|mesh-list
102430435|NCT03236324|Anesthetics, Local|anesthetics, local|mesh-ancestor
102430436|NCT03236324|Anesthetics|anesthetics|mesh-ancestor
102430437|NCT03236324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102430438|NCT03236324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430439|NCT03236324|Sensory System Agents|sensory system agents|mesh-ancestor
102430440|NCT03236324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102430441|NCT03236324|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102430442|NCT03236324|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102430443|NCT03236324|Adrenergic Agents|adrenergic agents|mesh-ancestor
102430444|NCT03236324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102430445|NCT03236324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430446|NCT03236324|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102430447|NCT03236324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102430448|NCT03236324|Autonomic Agents|autonomic agents|mesh-ancestor
102430449|NCT03236324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102430450|NCT03236324|Respiratory System Agents|respiratory system agents|mesh-ancestor
102430451|NCT03236324|Mydriatics|mydriatics|mesh-ancestor
102430452|NCT03236324|Sympathomimetics|sympathomimetics|mesh-ancestor
102430453|NCT03236324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102430454|NCT03229850|Insulin Lispro|insulin lispro|mesh-list
102430455|NCT03229850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102430456|NCT03229850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430457|NCT03229538|Methylprednisolone|methylprednisolone|mesh-list
102430458|NCT03229538|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102430459|NCT03229538|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102430460|NCT03229538|Prednisolone|prednisolone|mesh-list
102430461|NCT03229538|Prednisolone acetate|prednisolone acetate|mesh-list
102430462|NCT03229538|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102430463|NCT03229538|Prednisolone phosphate|prednisolone phosphate|mesh-list
102430464|NCT03229538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102430465|NCT03229538|Antiemetics|antiemetics|mesh-ancestor
102430466|NCT03229538|Autonomic Agents|autonomic agents|mesh-ancestor
102430467|NCT03229538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102430468|NCT03229538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430469|NCT03229538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102430470|NCT03229538|Glucocorticoids|glucocorticoids|mesh-ancestor
102430471|NCT03229538|Hormones|hormones|mesh-ancestor
102430472|NCT03229538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102430473|NCT03229538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102430474|NCT03229538|Protective Agents|protective agents|mesh-ancestor
102430475|NCT03229538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102430476|NCT03229538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430477|NCT03148795|Talazoparib|talazoparib|mesh-list
102430478|NCT03148795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102430479|NCT03148795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102430480|NCT03148795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430481|NCT03148795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430482|NCT03070054|Epinephrine|epinephrine|mesh-list
102430483|NCT03070054|Bupivacaine|bupivacaine|mesh-list
102430484|NCT03070054|Anesthetics, Local|anesthetics, local|mesh-ancestor
102430485|NCT03070054|Anesthetics|anesthetics|mesh-ancestor
102430486|NCT03070054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102430487|NCT03070054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430488|NCT03070054|Sensory System Agents|sensory system agents|mesh-ancestor
102430489|NCT03070054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102430490|NCT03070054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102430491|NCT03070054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102430492|NCT03070054|Adrenergic Agents|adrenergic agents|mesh-ancestor
102430493|NCT03070054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102430494|NCT03070054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430495|NCT03070054|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102430496|NCT03070054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102430497|NCT03070054|Autonomic Agents|autonomic agents|mesh-ancestor
102430498|NCT03070054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102430499|NCT03070054|Respiratory System Agents|respiratory system agents|mesh-ancestor
102430500|NCT03070054|Mydriatics|mydriatics|mesh-ancestor
102430501|NCT03070054|Sympathomimetics|sympathomimetics|mesh-ancestor
102430502|NCT03070054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102430503|NCT03040778|Vitamin E|vitamin e|mesh-list
102430504|NCT03040778|Tocopherols|tocopherols|mesh-list
102430505|NCT03040778|Tocotrienols|tocotrienols|mesh-list
102430506|NCT03040778|alpha-Tocopherol|alpha-tocopherol|mesh-list
102430507|NCT03040778|Pentoxifylline|pentoxifylline|mesh-list
102430508|NCT03040778|Vitamins|vitamins|mesh-ancestor
102430509|NCT03040778|Micronutrients|micronutrients|mesh-ancestor
102242209|NCT03304457|Olanzapine|olanzapine|mesh-list
102430510|NCT03040778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430511|NCT03040778|Antioxidants|antioxidants|mesh-ancestor
102430512|NCT03040778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430513|NCT03040778|Protective Agents|protective agents|mesh-ancestor
102430514|NCT03040778|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102430515|NCT03040778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102430516|NCT03040778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102430517|NCT03040778|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102430518|NCT03040778|Vasodilator Agents|vasodilator agents|mesh-ancestor
102430519|NCT03040778|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102430520|NCT02962414|Everolimus|everolimus|mesh-list
102430521|NCT02962414|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102430522|NCT02962414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102430523|NCT02962414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102430524|NCT02962414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430525|NCT02962414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102430526|NCT02962414|Immunologic Factors|immunologic factors|mesh-ancestor
102430527|NCT02962414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430528|NCT02962414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430529|NCT02959047|Alirocumab|alirocumab|mesh-list
102430530|NCT02959047|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102430531|NCT02959047|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102430532|NCT02959047|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102430533|NCT02959047|Antimetabolites|antimetabolites|mesh-ancestor
102430534|NCT02959047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430535|NCT02959047|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102430536|NCT02959047|Protease Inhibitors|protease inhibitors|mesh-ancestor
102430537|NCT02959047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102430538|NCT02959047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102430539|NCT02895750|Metformin|metformin|mesh-list
102430540|NCT02895750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102430541|NCT02895750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430542|NCT02895360|Lisavanbulin|lisavanbulin|mesh-list
102430543|NCT02895360|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102430544|NCT02895360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430545|NCT02895360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102430546|NCT02895360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430547|NCT02890784|Dasatinib|dasatinib|mesh-list
102430548|NCT02890784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430549|NCT02890784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102430550|NCT02890784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102430551|NCT02890784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430552|NCT02863809|Riboflavin|riboflavin|mesh-list
102430553|NCT02863809|Dextrans|dextrans|mesh-list
102430554|NCT02863809|Vitamins|vitamins|mesh-ancestor
102430555|NCT02863809|Micronutrients|micronutrients|mesh-ancestor
102430556|NCT02863809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430557|NCT02863809|Vitamin B Complex|vitamin b complex|mesh-ancestor
102430558|NCT02863809|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102430559|NCT02863809|Dermatologic Agents|dermatologic agents|mesh-ancestor
102430560|NCT02863809|Anticoagulants|anticoagulants|mesh-ancestor
102430561|NCT02863809|Plasma Substitutes|plasma substitutes|mesh-ancestor
102430562|NCT02863809|Blood Substitutes|blood substitutes|mesh-ancestor
102430563|NCT02829957|Rivaroxaban|rivaroxaban|mesh-list
102430564|NCT02829957|Apixaban|apixaban|mesh-list
102430565|NCT02829957|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102430566|NCT02829957|Antithrombins|antithrombins|mesh-ancestor
102430567|NCT02829957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102430568|NCT02829957|Protease Inhibitors|protease inhibitors|mesh-ancestor
102430569|NCT02829957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102430570|NCT02829957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430571|NCT02829957|Anticoagulants|anticoagulants|mesh-ancestor
102430572|NCT02823028|Nicotine|nicotine|mesh-list
102430573|NCT02823028|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102430574|NCT02823028|Autonomic Agents|autonomic agents|mesh-ancestor
102430575|NCT02823028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102430576|NCT02823028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430577|NCT02823028|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102430578|NCT02823028|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102430579|NCT02823028|Cholinergic Agents|cholinergic agents|mesh-ancestor
102430580|NCT02823028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102430581|NCT02823028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430582|NCT02785224|Vasopressins|vasopressins|mesh-list
102430583|NCT02785224|Arginine Vasopressin|arginine vasopressin|mesh-list
102430584|NCT02785224|Epinephrine|epinephrine|mesh-list
102430585|NCT02785224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102430586|NCT02785224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102430587|NCT02785224|Adrenergic Agents|adrenergic agents|mesh-ancestor
102430588|NCT02785224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102430589|NCT02785224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430590|NCT02785224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430591|NCT02785224|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102430592|NCT02785224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102430594|NCT02785224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102430595|NCT02785224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102430596|NCT02785224|Respiratory System Agents|respiratory system agents|mesh-ancestor
102430597|NCT02785224|Mydriatics|mydriatics|mesh-ancestor
102430598|NCT02785224|Sympathomimetics|sympathomimetics|mesh-ancestor
102430599|NCT02785224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102430600|NCT02785224|Hemostatics|hemostatics|mesh-ancestor
102430601|NCT02785224|Coagulants|coagulants|mesh-ancestor
102430602|NCT02785224|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102430603|NCT02785224|Natriuretic Agents|natriuretic agents|mesh-ancestor
102430604|NCT02768363|Valacyclovir|valacyclovir|mesh-list
102430605|NCT02768363|Antiviral Agents|antiviral agents|mesh-ancestor
102430606|NCT02768363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102430607|NCT02729805|Ketamine|ketamine|mesh-list
102430608|NCT02729805|Analgesics|analgesics|mesh-ancestor
102430609|NCT02729805|Sensory System Agents|sensory system agents|mesh-ancestor
102430610|NCT02729805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102430611|NCT02729805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430612|NCT02729805|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102430613|NCT02729805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102430614|NCT02729805|Anesthetics, General|anesthetics, general|mesh-ancestor
102430615|NCT02729805|Anesthetics|anesthetics|mesh-ancestor
102430616|NCT02729805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102430617|NCT02729805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102430618|NCT02729805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102430619|NCT02729805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102430620|NCT02729805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430621|NCT02616666|Dapagliflozin|dapagliflozin|mesh-list
102430622|NCT02616666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102430623|NCT02616666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430624|NCT02616666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102430625|NCT02616666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430626|NCT02521311|Clemastine|clemastine|mesh-list
102430627|NCT02521311|Antipruritics|antipruritics|mesh-ancestor
102430628|NCT02521311|Dermatologic Agents|dermatologic agents|mesh-ancestor
102430629|NCT02521311|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102430630|NCT02521311|Histamine Antagonists|histamine antagonists|mesh-ancestor
102430631|NCT02521311|Histamine Agents|histamine agents|mesh-ancestor
102430632|NCT02521311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102430633|NCT02521311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430634|NCT02521311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430635|NCT02521311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102430636|NCT02508038|Zoledronic Acid|zoledronic acid|mesh-list
102430637|NCT02508038|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102430638|NCT02508038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430639|NCT02437045|Meropenem|meropenem|mesh-list
102430640|NCT02437045|Tazobactam|tazobactam|mesh-list
102430641|NCT02437045|Piperacillin|piperacillin|mesh-list
102430642|NCT02437045|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102430643|NCT02437045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102430644|NCT02437045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102430645|NCT02437045|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102430646|NCT02437045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102430647|NCT02437045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430648|NCT02308527|Cyclophosphamide|cyclophosphamide|mesh-list
102430649|NCT02308527|Temozolomide|temozolomide|mesh-list
102430650|NCT02308527|Bevacizumab|bevacizumab|mesh-list
102430651|NCT02308527|Irinotecan|irinotecan|mesh-list
102430652|NCT02308527|Topotecan|topotecan|mesh-list
102430653|NCT02308527|Dinutuximab|dinutuximab|mesh-list
102430654|NCT02308527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102430655|NCT02308527|Immunologic Factors|immunologic factors|mesh-ancestor
102430656|NCT02308527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430657|NCT02308527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102430658|NCT02308527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102430659|NCT02308527|Alkylating Agents|alkylating agents|mesh-ancestor
102430660|NCT02308527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430661|NCT02308527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430662|NCT02308527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102430663|NCT02308527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102430664|NCT02308527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102430665|NCT02308527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102430666|NCT02308527|Growth Substances|growth substances|mesh-ancestor
102430667|NCT02308527|Growth Inhibitors|growth inhibitors|mesh-ancestor
102430668|NCT02308527|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102430669|NCT02308527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102430670|NCT02308527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102430671|NCT02308072|Olaparib|olaparib|mesh-list
102430672|NCT02308072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430673|NCT02308072|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102430674|NCT02308072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102430675|NCT02308072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430676|NCT02289079|Bupivacaine|bupivacaine|mesh-list
102430677|NCT02289079|Anesthetics, Local|anesthetics, local|mesh-ancestor
102430678|NCT02289079|Anesthetics|anesthetics|mesh-ancestor
102430679|NCT02289079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102430680|NCT02289079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430681|NCT02289079|Sensory System Agents|sensory system agents|mesh-ancestor
102430682|NCT02289079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102430683|NCT02131753|Cladribine|cladribine|mesh-list
102430684|NCT02131753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430685|NCT02131753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102430686|NCT02131753|Immunologic Factors|immunologic factors|mesh-ancestor
102430687|NCT02131753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430688|NCT02101788|Tamoxifen|tamoxifen|mesh-list
102430689|NCT02101788|Paclitaxel|paclitaxel|mesh-list
102430690|NCT02101788|Doxorubicin|doxorubicin|mesh-list
102430691|NCT02101788|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102430692|NCT02101788|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102430693|NCT02101788|Letrozole|letrozole|mesh-list
102430694|NCT02101788|Topotecan|topotecan|mesh-list
102430695|NCT02101788|Trametinib|trametinib|mesh-list
102430696|NCT02101788|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
102430697|NCT02101788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102430698|NCT02101788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430699|NCT02101788|Tubulin Modulators|tubulin modulators|mesh-ancestor
102430700|NCT02101788|Antimitotic Agents|antimitotic agents|mesh-ancestor
102430701|NCT02101788|Mitosis Modulators|mitosis modulators|mesh-ancestor
102430702|NCT02101788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430703|NCT02101788|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102430704|NCT02101788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102430705|NCT02101788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102430706|NCT02101788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102430707|NCT02101788|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102430708|NCT02101788|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102430709|NCT02101788|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102430710|NCT02101788|Hormone Antagonists|hormone antagonists|mesh-ancestor
102430711|NCT02101788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102430712|NCT02101788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430713|NCT02101788|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102430714|NCT02101788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102430715|NCT02101788|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102430716|NCT02101788|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102430717|NCT02101788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102430718|NCT02101788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102430719|NCT02101788|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102430720|NCT02101788|Protective Agents|protective agents|mesh-ancestor
102430721|NCT02101788|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102430722|NCT02101788|Antioxidants|antioxidants|mesh-ancestor
102430723|NCT02095132|Irinotecan|irinotecan|mesh-list
102430724|NCT02095132|Camptothecin|camptothecin|mesh-list
102430725|NCT02095132|Adavosertib|adavosertib|mesh-list
102430726|NCT02095132|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102430727|NCT02095132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102430728|NCT02095132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102430729|NCT02095132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430730|NCT02095132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430731|NCT02095132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102430732|NCT02079740|Trametinib|trametinib|mesh-list
102430733|NCT02079740|Navitoclax|navitoclax|mesh-list
102430734|NCT02079740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430735|NCT02079740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102430736|NCT02079740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102430737|NCT02079740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430738|NCT02058706|Leuprolide|leuprolide|mesh-list
102430739|NCT02058706|Goserelin|goserelin|mesh-list
102430740|NCT02058706|Bicalutamide|bicalutamide|mesh-list
102430741|NCT02058706|Androgens|androgens|mesh-list
102430742|NCT02058706|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102430743|NCT02058706|Fertility Agents|fertility agents|mesh-ancestor
102061178|NCT04687631|Cetuximab|cetuximab|mesh-list
102430744|NCT02058706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102430745|NCT02058706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430746|NCT02058706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102430747|NCT02058706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430748|NCT02058706|Hormones|hormones|mesh-ancestor
102430749|NCT02058706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102430750|NCT02058706|Androgen Antagonists|androgen antagonists|mesh-ancestor
102430751|NCT02058706|Hormone Antagonists|hormone antagonists|mesh-ancestor
102430752|NCT02015117|Trametinib|trametinib|mesh-list
102430753|NCT02015117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430754|NCT02015117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102430755|NCT02015117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102430756|NCT02015117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430757|NCT01644110|Pomalidomide|pomalidomide|mesh-list
102430758|NCT01644110|Immunologic Factors|immunologic factors|mesh-ancestor
102430759|NCT01644110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430760|NCT01644110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102430761|NCT01644110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102430762|NCT01644110|Growth Substances|growth substances|mesh-ancestor
102430763|NCT01644110|Growth Inhibitors|growth inhibitors|mesh-ancestor
102430764|NCT01644110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430765|NCT01478542|Rituximab|rituximab|mesh-list
102430766|NCT01478542|Vincristine|vincristine|mesh-list
102430767|NCT01478542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102430768|NCT01478542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430769|NCT01478542|Immunologic Factors|immunologic factors|mesh-ancestor
102430770|NCT01478542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430771|NCT01478542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102430772|NCT01478542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102430773|NCT01478542|Tubulin Modulators|tubulin modulators|mesh-ancestor
102430774|NCT01478542|Antimitotic Agents|antimitotic agents|mesh-ancestor
102430775|NCT01478542|Mitosis Modulators|mitosis modulators|mesh-ancestor
102430776|NCT01478542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430777|NCT01406678|Sufentanil|sufentanil|mesh-list
102430778|NCT01406678|Dsuvia|dsuvia|mesh-list
102430779|NCT01406678|Isoflurane|isoflurane|mesh-list
102430780|NCT01406678|Anesthetics|anesthetics|mesh-ancestor
102430781|NCT01406678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102430782|NCT01406678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430783|NCT01406678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102430784|NCT01406678|Narcotics|narcotics|mesh-ancestor
102430785|NCT01406678|Analgesics|analgesics|mesh-ancestor
102430786|NCT01406678|Sensory System Agents|sensory system agents|mesh-ancestor
102430787|NCT01406678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102430788|NCT01406678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102430789|NCT01406678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102430790|NCT01406678|Anesthetics, General|anesthetics, general|mesh-ancestor
102430791|NCT01406678|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102430792|NCT01397929|Lisavanbulin|lisavanbulin|mesh-list
102430793|NCT01397929|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102430794|NCT01397929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430795|NCT01397929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102430796|NCT01397929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430797|NCT01370330|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
102061251|NCT01382147|Analgesics|analgesics|mesh-ancestor
102430798|NCT01370330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430799|NCT01370330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102430800|NCT01370330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430801|NCT01370330|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102430802|NCT00843323|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
102430803|NCT00843323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102430804|NCT00843323|Dermatologic Agents|dermatologic agents|mesh-ancestor
102430805|NCT00695214|Propofol|propofol|mesh-list
102430806|NCT00695214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102430807|NCT00695214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102430808|NCT00695214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430809|NCT00695214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102430810|NCT00695214|Anesthetics, General|anesthetics, general|mesh-ancestor
102430811|NCT00695214|Anesthetics|anesthetics|mesh-ancestor
102430812|NCT00678327|Prednisolone|prednisolone|mesh-list
102430813|NCT00678327|Cyclophosphamide|cyclophosphamide|mesh-list
102430814|NCT00678327|Dacarbazine|dacarbazine|mesh-list
102430815|NCT00678327|Doxorubicin|doxorubicin|mesh-list
102430816|NCT00678327|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102430818|NCT00678327|Vincristine|vincristine|mesh-list
102430819|NCT00678327|Bleomycin|bleomycin|mesh-list
102430820|NCT00678327|Vinblastine|vinblastine|mesh-list
102430821|NCT00678327|Procarbazine|procarbazine|mesh-list
102430822|NCT00678327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102430823|NCT00678327|Immunologic Factors|immunologic factors|mesh-ancestor
102430824|NCT00678327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430825|NCT00678327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102430826|NCT00678327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102430827|NCT00678327|Alkylating Agents|alkylating agents|mesh-ancestor
102430828|NCT00678327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430829|NCT00678327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430830|NCT00678327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102430831|NCT00678327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102430832|NCT00678327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102430833|NCT00678327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102430834|NCT00678327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102430835|NCT00678327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102430836|NCT00678327|Tubulin Modulators|tubulin modulators|mesh-ancestor
102430837|NCT00678327|Antimitotic Agents|antimitotic agents|mesh-ancestor
102430838|NCT00678327|Mitosis Modulators|mitosis modulators|mesh-ancestor
102430839|NCT00678327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102430840|NCT00678327|Glucocorticoids|glucocorticoids|mesh-ancestor
102430841|NCT00678327|Hormones|hormones|mesh-ancestor
102430842|NCT00678327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102430843|NCT00678327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102430844|NCT00602667|Cyclophosphamide|cyclophosphamide|mesh-list
102430845|NCT00602667|Cisplatin|cisplatin|mesh-list
102430846|NCT00602667|Carboplatin|carboplatin|mesh-list
102430847|NCT00602667|Methotrexate|methotrexate|mesh-list
102430848|NCT00602667|Etoposide|etoposide|mesh-list
102430849|NCT00602667|Etoposide phosphate|etoposide phosphate|mesh-list
102430850|NCT00602667|Vincristine|vincristine|mesh-list
102430851|NCT00602667|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102430852|NCT00602667|Topotecan|topotecan|mesh-list
102430853|NCT00602667|Vinblastine|vinblastine|mesh-list
102430854|NCT00602667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102430855|NCT00602667|Immunologic Factors|immunologic factors|mesh-ancestor
102430856|NCT00602667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430857|NCT00602667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102430858|NCT00602667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102430859|NCT00602667|Alkylating Agents|alkylating agents|mesh-ancestor
102430860|NCT00602667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430861|NCT00602667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102061302|NCT04509193|Antithrombins|antithrombins|mesh-ancestor
102430862|NCT00602667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102430863|NCT00602667|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102430864|NCT00602667|Abortifacient Agents|abortifacient agents|mesh-ancestor
102430865|NCT00602667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102430866|NCT00602667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102430867|NCT00602667|Antimetabolites|antimetabolites|mesh-ancestor
102430868|NCT00602667|Dermatologic Agents|dermatologic agents|mesh-ancestor
102430869|NCT00602667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102430870|NCT00602667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102430871|NCT00602667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102430872|NCT00602667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102430873|NCT00602667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102430874|NCT00602667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102430875|NCT00602667|Tubulin Modulators|tubulin modulators|mesh-ancestor
102430876|NCT00602667|Antimitotic Agents|antimitotic agents|mesh-ancestor
102430877|NCT00602667|Mitosis Modulators|mitosis modulators|mesh-ancestor
102430878|NCT00602667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102430879|NCT00602667|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102430880|NCT00544466|Fludarabine|fludarabine|mesh-list
102430881|NCT00544466|Fludarabine phosphate|fludarabine phosphate|mesh-list
102430882|NCT00544466|Melphalan|melphalan|mesh-list
102430883|NCT00544466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430884|NCT00544466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102430885|NCT00544466|Antimetabolites|antimetabolites|mesh-ancestor
102430886|NCT00544466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430887|NCT00544466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102430888|NCT00544466|Immunologic Factors|immunologic factors|mesh-ancestor
102430889|NCT00544466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430890|NCT00544466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102430891|NCT00544466|Alkylating Agents|alkylating agents|mesh-ancestor
102430892|NCT00544466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102430893|NCT00519675|Alitretinoin|alitretinoin|mesh-list
102430894|NCT00519675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430895|NCT00519675|Dermatologic Agents|dermatologic agents|mesh-ancestor
102430896|NCT00492999|Leucovorin|leucovorin|mesh-list
102430897|NCT00492999|Dexamethasone|dexamethasone|mesh-list
102430898|NCT00492999|Fluorouracil|fluorouracil|mesh-list
102430899|NCT00492999|Oxaliplatin|oxaliplatin|mesh-list
102430900|NCT00492999|Irinotecan|irinotecan|mesh-list
102430901|NCT00492999|Floxuridine|floxuridine|mesh-list
102430902|NCT00492999|Calcium|calcium|mesh-list
102430903|NCT00492999|Levoleucovorin|levoleucovorin|mesh-list
102430904|NCT00492999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102430905|NCT00492999|Antiemetics|antiemetics|mesh-ancestor
102430906|NCT00492999|Autonomic Agents|autonomic agents|mesh-ancestor
102430907|NCT00492999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102430908|NCT00492999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430909|NCT00492999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102430910|NCT00492999|Glucocorticoids|glucocorticoids|mesh-ancestor
102430911|NCT00492999|Hormones|hormones|mesh-ancestor
102430912|NCT00492999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102430913|NCT00492999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102430914|NCT00492999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430915|NCT00492999|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102430916|NCT00492999|Antimetabolites|antimetabolites|mesh-ancestor
102430917|NCT00492999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430918|NCT00492999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102430919|NCT00492999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102430920|NCT00492999|Immunologic Factors|immunologic factors|mesh-ancestor
102430921|NCT00492999|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102430922|NCT00492999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102430923|NCT00492999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102430924|NCT00492999|Antidotes|antidotes|mesh-ancestor
102430925|NCT00492999|Protective Agents|protective agents|mesh-ancestor
102430926|NCT00492999|Vitamin B Complex|vitamin b complex|mesh-ancestor
102430927|NCT00492999|Vitamins|vitamins|mesh-ancestor
102430928|NCT00492999|Micronutrients|micronutrients|mesh-ancestor
102430929|NCT00413439|Isavuconazole|isavuconazole|mesh-list
102430930|NCT00413439|Antifungal Agents|antifungal agents|mesh-ancestor
102430931|NCT00413439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102430932|NCT00374075|Valproic Acid|valproic acid|mesh-list
102430933|NCT00374075|Anticonvulsants|anticonvulsants|mesh-ancestor
102430934|NCT00374075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102430935|NCT00374075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430936|NCT00374075|GABA Agents|gaba agents|mesh-ancestor
102430937|NCT00374075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102430938|NCT00374075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430939|NCT00374075|Antimanic Agents|antimanic agents|mesh-ancestor
102430940|NCT00374075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102430941|NCT00374075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102430942|NCT00374075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102430943|NCT00309621|Alitretinoin|alitretinoin|mesh-list
102430944|NCT00309621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430945|NCT00309621|Dermatologic Agents|dermatologic agents|mesh-ancestor
102430946|NCT00124475|Alitretinoin|alitretinoin|mesh-list
102430947|NCT00124475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430948|NCT00124475|Dermatologic Agents|dermatologic agents|mesh-ancestor
102430949|NCT00124436|Alitretinoin|alitretinoin|mesh-list
102430950|NCT00124436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430951|NCT00124436|Dermatologic Agents|dermatologic agents|mesh-ancestor
102430952|NCT00112931|Rituximab|rituximab|mesh-list
102430953|NCT00112931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102430954|NCT00112931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430955|NCT00112931|Immunologic Factors|immunologic factors|mesh-ancestor
102430956|NCT00112931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430957|NCT00112931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102430958|NCT00110110|Cyclosporine|cyclosporine|mesh-list
102430959|NCT00110110|Carboplatin|carboplatin|mesh-list
102430960|NCT00110110|Etoposide|etoposide|mesh-list
102430961|NCT00110110|Vincristine|vincristine|mesh-list
102430962|NCT00110110|Cyclosporins|cyclosporins|mesh-list
102430963|NCT00110110|Lenograstim|lenograstim|mesh-list
102430964|NCT00110110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102430965|NCT00110110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102430966|NCT00110110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102430967|NCT00110110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102242651|NCT04782687|Antiemetics|antiemetics|mesh-ancestor
102430968|NCT00110110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102430969|NCT00110110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430970|NCT00110110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102430971|NCT00110110|Immunologic Factors|immunologic factors|mesh-ancestor
102430972|NCT00110110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430973|NCT00110110|Tubulin Modulators|tubulin modulators|mesh-ancestor
102430974|NCT00110110|Antimitotic Agents|antimitotic agents|mesh-ancestor
102430975|NCT00110110|Mitosis Modulators|mitosis modulators|mesh-ancestor
102430976|NCT00110110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102430977|NCT00110110|Antifungal Agents|antifungal agents|mesh-ancestor
102430978|NCT00110110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102430979|NCT00110110|Dermatologic Agents|dermatologic agents|mesh-ancestor
102430980|NCT00110110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102430981|NCT00110110|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102430982|NCT05307003|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102430983|NCT05307003|Trazodone|trazodone|mesh-list
102430984|NCT05307003|Antidepressive Agents|antidepressive agents|mesh-ancestor
102430985|NCT05307003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102430986|NCT05307003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102430987|NCT05307003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102430988|NCT05307003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102430989|NCT05307003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102430990|NCT05307003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102430991|NCT05307003|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102430992|NCT05307003|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102430993|NCT05307003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102430994|NCT05307003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102430995|NCT05307003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102430996|NCT05307003|Serotonin Agents|serotonin agents|mesh-ancestor
102430997|NCT05307003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102430998|NCT03153917|Hydrocortisone|hydrocortisone|mesh-list
102430999|NCT03153917|Melatonin|melatonin|mesh-list
102431000|NCT03153917|Antioxidants|antioxidants|mesh-ancestor
102431001|NCT03153917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061428|NCT01381289|Ivacaftor|ivacaftor|mesh-list
102431002|NCT03153917|Protective Agents|protective agents|mesh-ancestor
102431003|NCT03153917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431004|NCT03153917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102431005|NCT03153917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102431006|NCT01096875|Atorvastatin|atorvastatin|mesh-list
102431007|NCT01096875|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102431008|NCT01096875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102431009|NCT01096875|Antimetabolites|antimetabolites|mesh-ancestor
102431010|NCT01096875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431011|NCT01096875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102431012|NCT01096875|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102431013|NCT01096875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102431014|NCT01097343|Clopidogrel|clopidogrel|mesh-list
102431015|NCT01097343|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102431016|NCT01097343|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102431017|NCT01097343|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102431018|NCT01097343|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102431019|NCT01097343|Purinergic Agents|purinergic agents|mesh-ancestor
102431020|NCT01097343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102431021|NCT01097343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431022|NCT01097343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431023|NCT03580187|Morphine|morphine|mesh-list
102431024|NCT03580187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102431025|NCT03580187|Narcotics|narcotics|mesh-ancestor
102431026|NCT03580187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102431027|NCT03580187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431028|NCT03580187|Analgesics|analgesics|mesh-ancestor
102431029|NCT03580187|Sensory System Agents|sensory system agents|mesh-ancestor
102431030|NCT03580187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102431031|NCT01098747|Ibuprofen|ibuprofen|mesh-list
102431032|NCT01098747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102431033|NCT01098747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102431034|NCT01098747|Analgesics|analgesics|mesh-ancestor
102431035|NCT01098747|Sensory System Agents|sensory system agents|mesh-ancestor
102431036|NCT01098747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102431037|NCT01098747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431038|NCT01098747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102431039|NCT01098747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102431040|NCT01098747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102431041|NCT01098747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102431042|NCT01098747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431043|NCT02085161|Tiotropium Bromide|tiotropium bromide|mesh-list
102431044|NCT02085161|Olodaterol|olodaterol|mesh-list
102431045|NCT02085161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102431047|NCT02085161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102431048|NCT02085161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431049|NCT02085161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102431050|NCT02085161|Respiratory System Agents|respiratory system agents|mesh-ancestor
102431051|NCT02085161|Parasympatholytics|parasympatholytics|mesh-ancestor
102431052|NCT02085161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102431053|NCT02085161|Cholinergic Agents|cholinergic agents|mesh-ancestor
102431054|NCT02085161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102431055|NCT02085161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431056|NCT01034553|Bortezomib|bortezomib|mesh-list
102431057|NCT01034553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102431058|NCT01035333|Orlistat|orlistat|mesh-list
102431059|NCT01035333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102061504|NCT01382407|Cetuximab|cetuximab|mesh-list
102431060|NCT01035333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431061|NCT01035333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102431062|NCT01035333|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102431063|NCT05073549|Anti-Infective Agents|anti-infective agents|mesh-list
102431064|NCT05073549|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102431065|NCT03152981|Remifentanil|remifentanil|mesh-list
102431066|NCT03152981|Propofol|propofol|mesh-list
102431067|NCT03152981|Desflurane|desflurane|mesh-list
102431068|NCT03152981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102431069|NCT03152981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102431070|NCT03152981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431071|NCT03152981|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102431072|NCT03152981|Anesthetics, General|anesthetics, general|mesh-ancestor
102431073|NCT03152981|Anesthetics|anesthetics|mesh-ancestor
102431074|NCT03152981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102431075|NCT03152981|Narcotics|narcotics|mesh-ancestor
102431076|NCT03152981|Analgesics|analgesics|mesh-ancestor
102431077|NCT03152981|Sensory System Agents|sensory system agents|mesh-ancestor
102431078|NCT03152981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102431079|NCT03152981|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102431080|NCT05384015|Carboplatin|carboplatin|mesh-list
102431081|NCT05384015|Pembrolizumab|pembrolizumab|mesh-list
102431082|NCT05384015|Etoposide|etoposide|mesh-list
102431083|NCT05384015|Etoposide phosphate|etoposide phosphate|mesh-list
102431084|NCT05384015|Lenvatinib|lenvatinib|mesh-list
102431085|NCT05384015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102431086|NCT05384015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102431087|NCT05384015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102431088|NCT05384015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431089|NCT05384015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102431090|NCT05384015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102431091|NCT05384015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102431092|NCT05384015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102431093|NCT05384015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102431094|NCT03572387|Azacitidine|azacitidine|mesh-list
102431095|NCT03572387|Tretinoin|tretinoin|mesh-list
102431096|NCT03572387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102431097|NCT03572387|Antimetabolites|antimetabolites|mesh-ancestor
102431098|NCT03572387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431099|NCT03572387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102431100|NCT03572387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102431101|NCT03572387|Keratolytic Agents|keratolytic agents|mesh-ancestor
102431102|NCT03572387|Dermatologic Agents|dermatologic agents|mesh-ancestor
102431103|NCT04728971|Caspofungin|caspofungin|mesh-list
102431104|NCT04728971|Micafungin|micafungin|mesh-list
102431105|NCT04728971|Antifungal Agents|antifungal agents|mesh-ancestor
102431106|NCT04728971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102431107|NCT04728971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102431108|NCT04728971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431109|NCT03568643|Amoxicillin|amoxicillin|mesh-list
102431110|NCT03568643|Azithromycin|azithromycin|mesh-list
102431111|NCT03568643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102431112|NCT03568643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102431113|NCT01100931|Paclitaxel|paclitaxel|mesh-list
102431114|NCT01100931|Carboplatin|carboplatin|mesh-list
102431115|NCT01100931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102431116|NCT01100931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102431117|NCT01100931|Tubulin Modulators|tubulin modulators|mesh-ancestor
102431118|NCT01100931|Antimitotic Agents|antimitotic agents|mesh-ancestor
102431119|NCT01100931|Mitosis Modulators|mitosis modulators|mesh-ancestor
102431120|NCT01100931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431121|NCT01101867|Insulin Aspart|insulin aspart|mesh-list
102431122|NCT01101867|Insulin, Long-Acting|insulin, long-acting|mesh-list
102431123|NCT01101867|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102431125|NCT01101867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431126|NCT03013959|Pyranoprofen|pyranoprofen|mesh-list
102431127|NCT03013959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102431128|NCT03013959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102431129|NCT03013959|Analgesics|analgesics|mesh-ancestor
102431130|NCT03013959|Sensory System Agents|sensory system agents|mesh-ancestor
102431131|NCT03013959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102431132|NCT03013959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431133|NCT03013959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102431134|NCT03013959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102431135|NCT03013959|Gout Suppressants|gout suppressants|mesh-ancestor
102431136|NCT02246595|Vilobelimab|vilobelimab|mesh-list
102431137|NCT02246595|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102431138|NCT02246595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102431139|NCT02246595|Immunologic Factors|immunologic factors|mesh-ancestor
102431140|NCT02246595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431141|NCT01106859|Zolpidem|zolpidem|mesh-list
102431142|NCT01106859|Zopiclone|zopiclone|mesh-list
102431143|NCT01106859|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102431144|NCT01106859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102431145|NCT01106859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102431146|NCT01106859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431147|NCT01106859|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102431148|NCT01106859|GABA Agonists|gaba agonists|mesh-ancestor
102431149|NCT01106859|GABA Agents|gaba agents|mesh-ancestor
102431150|NCT01106859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102431151|NCT01106859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431152|NCT01042509|Rituximab|rituximab|mesh-list
102431153|NCT01042509|Alemtuzumab|alemtuzumab|mesh-list
102431154|NCT01042509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102431155|NCT01042509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102431156|NCT01042509|Immunologic Factors|immunologic factors|mesh-ancestor
102431157|NCT01042509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431158|NCT01042509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102431159|NCT04814355|Celecoxib|celecoxib|mesh-list
102431160|NCT04814355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102431161|NCT04814355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102431162|NCT04814355|Analgesics|analgesics|mesh-ancestor
102431163|NCT04814355|Sensory System Agents|sensory system agents|mesh-ancestor
102431164|NCT04814355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102431165|NCT04814355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431166|NCT04814355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102431167|NCT04814355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102431168|NCT04814355|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102431169|NCT04814355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102431170|NCT04814355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102431171|NCT04814355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431172|NCT02179671|Docetaxel|docetaxel|mesh-list
102431173|NCT02179671|Gefitinib|gefitinib|mesh-list
102431174|NCT02179671|Tremelimumab|tremelimumab|mesh-list
102431175|NCT02179671|Osimertinib|osimertinib|mesh-list
102431176|NCT02179671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102431177|NCT02179671|Tubulin Modulators|tubulin modulators|mesh-ancestor
102431178|NCT02179671|Antimitotic Agents|antimitotic agents|mesh-ancestor
102431179|NCT02179671|Mitosis Modulators|mitosis modulators|mesh-ancestor
102431180|NCT02179671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431181|NCT02179671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102431182|NCT02179671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102431183|NCT01110135|Dexamethasone|dexamethasone|mesh-list
102431184|NCT01110135|Etoposide|etoposide|mesh-list
102431185|NCT01110135|Etoposide phosphate|etoposide phosphate|mesh-list
102431186|NCT01110135|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102431187|NCT01110135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102431188|NCT01110135|Antiemetics|antiemetics|mesh-ancestor
102431189|NCT01110135|Autonomic Agents|autonomic agents|mesh-ancestor
102431190|NCT01110135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102431191|NCT01110135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431192|NCT01110135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102431193|NCT01110135|Glucocorticoids|glucocorticoids|mesh-ancestor
102431194|NCT01110135|Hormones|hormones|mesh-ancestor
102431195|NCT01110135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102431196|NCT01110135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102431197|NCT01110135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102431198|NCT01110135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102431199|NCT01110135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102431200|NCT01110135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102431201|NCT01110135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102061625|NCT00943683|Montelukast|montelukast|mesh-list
102431202|NCT01110135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431203|NCT01110135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102431204|NCT01110135|Alkylating Agents|alkylating agents|mesh-ancestor
102431205|NCT01112241|Albuterol|albuterol|mesh-list
102431206|NCT01112241|Tiotropium Bromide|tiotropium bromide|mesh-list
102431207|NCT01112241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102431208|NCT01112241|Autonomic Agents|autonomic agents|mesh-ancestor
102431209|NCT01112241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102431210|NCT01112241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431211|NCT01112241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102431212|NCT01112241|Respiratory System Agents|respiratory system agents|mesh-ancestor
102431213|NCT01112241|Parasympatholytics|parasympatholytics|mesh-ancestor
102431214|NCT01112241|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102431215|NCT01112241|Cholinergic Agents|cholinergic agents|mesh-ancestor
102431216|NCT01112241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102431217|NCT01112241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431218|NCT01112241|Tocolytic Agents|tocolytic agents|mesh-ancestor
102431219|NCT01112241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102431220|NCT01112241|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102431221|NCT01112241|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102431222|NCT01112241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102431223|NCT01112241|Adrenergic Agents|adrenergic agents|mesh-ancestor
102431224|NCT03013881|Trastuzumab|trastuzumab|mesh-list
102431225|NCT03013881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102431226|NCT03013881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102431227|NCT02174913|Fentanyl|fentanyl|mesh-list
102431228|NCT02174913|Propofol|propofol|mesh-list
102431229|NCT02174913|Atracurium|atracurium|mesh-list
102431230|NCT02174913|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102431231|NCT02174913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102431232|NCT02174913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431233|NCT02174913|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102431234|NCT02174913|Anesthetics, General|anesthetics, general|mesh-ancestor
102431235|NCT02174913|Anesthetics|anesthetics|mesh-ancestor
102431236|NCT02174913|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102431237|NCT02174913|Narcotics|narcotics|mesh-ancestor
102431238|NCT02174913|Analgesics|analgesics|mesh-ancestor
102431239|NCT02174913|Sensory System Agents|sensory system agents|mesh-ancestor
102431240|NCT02174913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102431241|NCT02174913|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102431242|NCT02174913|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102431243|NCT02174913|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102431244|NCT02174913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102431245|NCT02174913|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102431246|NCT02174913|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102431247|NCT02174913|Cholinergic Agents|cholinergic agents|mesh-ancestor
102431248|NCT02174913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102431249|NCT02174913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431250|NCT01114503|Methylprednisolone|methylprednisolone|mesh-list
102431251|NCT01114503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102431252|NCT01114503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102431253|NCT01114503|Prednisolone|prednisolone|mesh-list
102431254|NCT01114503|Prednisolone acetate|prednisolone acetate|mesh-list
102431255|NCT01114503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102431256|NCT01114503|Prednisolone phosphate|prednisolone phosphate|mesh-list
102431257|NCT01114503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102431258|NCT01114503|Antiemetics|antiemetics|mesh-ancestor
102431259|NCT01114503|Autonomic Agents|autonomic agents|mesh-ancestor
102431260|NCT01114503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102431261|NCT01114503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431262|NCT01114503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102431263|NCT01114503|Glucocorticoids|glucocorticoids|mesh-ancestor
102431264|NCT01114503|Hormones|hormones|mesh-ancestor
102431265|NCT01114503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102431266|NCT01114503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102431267|NCT01114503|Protective Agents|protective agents|mesh-ancestor
102431268|NCT01114503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102431269|NCT01114503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102431270|NCT03015831|Colchicine|colchicine|mesh-list
102431271|NCT03015831|Gout Suppressants|gout suppressants|mesh-ancestor
102431272|NCT03015831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102431273|NCT03015831|Tubulin Modulators|tubulin modulators|mesh-ancestor
102431274|NCT03015831|Antimitotic Agents|antimitotic agents|mesh-ancestor
102431275|NCT03015831|Mitosis Modulators|mitosis modulators|mesh-ancestor
102431276|NCT03015831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431277|NCT03015831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102431278|NCT01114581|Phenylpropanolamine|phenylpropanolamine|mesh-list
102431279|NCT01114581|Guaifenesin|guaifenesin|mesh-list
102431280|NCT01114581|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
102431281|NCT01114581|Expectorants|expectorants|mesh-ancestor
102431282|NCT01114581|Respiratory System Agents|respiratory system agents|mesh-ancestor
102431283|NCT01114581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102431284|NCT01114581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102431285|NCT01114581|Adrenergic Agents|adrenergic agents|mesh-ancestor
102431286|NCT01114581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102431287|NCT01114581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431288|NCT01114581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431289|NCT01114581|Appetite Depressants|appetite depressants|mesh-ancestor
102431290|NCT01114581|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102431291|NCT01114581|Sympathomimetics|sympathomimetics|mesh-ancestor
102431292|NCT01114581|Autonomic Agents|autonomic agents|mesh-ancestor
102431293|NCT01114581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102431294|NCT01114581|Nasal Decongestants|nasal decongestants|mesh-ancestor
102431295|NCT01114581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102431296|NCT01114893|Travoprost|travoprost|mesh-list
102431297|NCT01114893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102431298|NCT01114971|Labetalol|labetalol|mesh-list
102431299|NCT01114971|Fentanyl|fentanyl|mesh-list
102431300|NCT01114971|Esmolol|esmolol|mesh-list
102431301|NCT01114971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102431302|NCT01114971|Narcotics|narcotics|mesh-ancestor
102431303|NCT01114971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102431304|NCT01114971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431305|NCT01114971|Analgesics|analgesics|mesh-ancestor
102431306|NCT01114971|Sensory System Agents|sensory system agents|mesh-ancestor
102431307|NCT01114971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102431308|NCT01114971|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102431309|NCT01114971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102431310|NCT01114971|Anesthetics, General|anesthetics, general|mesh-ancestor
102431311|NCT01114971|Anesthetics|anesthetics|mesh-ancestor
102431312|NCT01114971|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102431313|NCT01114971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102431314|NCT01114971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102431315|NCT01114971|Adrenergic Agents|adrenergic agents|mesh-ancestor
102431316|NCT01114971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102431317|NCT01114971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431318|NCT01114971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102431319|NCT01114971|Sympathomimetics|sympathomimetics|mesh-ancestor
102431320|NCT01114971|Autonomic Agents|autonomic agents|mesh-ancestor
102431321|NCT01114971|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102431322|NCT01114971|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102431323|NCT01044693|Metoprolol|metoprolol|mesh-list
102431324|NCT01044693|Nebivolol|nebivolol|mesh-list
102431325|NCT01044693|Sildenafil Citrate|sildenafil citrate|mesh-list
102061752|NCT00145795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102431326|NCT01044693|Vasodilator Agents|vasodilator agents|mesh-ancestor
102431327|NCT01044693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102431328|NCT01044693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102431329|NCT01044693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102431330|NCT01044693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431331|NCT01044693|Urological Agents|urological agents|mesh-ancestor
102431332|NCT01044693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102431333|NCT01044693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102431334|NCT01044693|Sympatholytics|sympatholytics|mesh-ancestor
102431335|NCT01044693|Autonomic Agents|autonomic agents|mesh-ancestor
102431336|NCT01044693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102431337|NCT01044693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431338|NCT01044693|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102431339|NCT01044693|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102431340|NCT01044693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102431341|NCT01044693|Adrenergic Agents|adrenergic agents|mesh-ancestor
102431342|NCT01044693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102431343|NCT01044693|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102431344|NCT01044693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102431345|NCT01044693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102431346|NCT01115517|Bevacizumab|bevacizumab|mesh-list
102431347|NCT01115517|Mitomycins|mitomycins|mesh-list
102431348|NCT01115517|Mitomycin|mitomycin|mesh-list
102431349|NCT01115517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102431350|NCT01115517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102431351|NCT01115517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102431352|NCT01115517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102431353|NCT01115517|Growth Substances|growth substances|mesh-ancestor
102431354|NCT01115517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431355|NCT01115517|Growth Inhibitors|growth inhibitors|mesh-ancestor
102431356|NCT01115517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102431357|NCT01115517|Alkylating Agents|alkylating agents|mesh-ancestor
102431358|NCT01115517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431359|NCT01115517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102431360|NCT01115517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102431361|NCT03015675|Ascorbic Acid|ascorbic acid|mesh-list
102431362|NCT03015675|Vitamins|vitamins|mesh-ancestor
102431363|NCT03015675|Micronutrients|micronutrients|mesh-ancestor
102431364|NCT03015675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431365|NCT03015675|Antioxidants|antioxidants|mesh-ancestor
102431366|NCT03015675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431367|NCT03015675|Protective Agents|protective agents|mesh-ancestor
102431368|NCT01044771|Tenofovir|tenofovir|mesh-list
102431369|NCT01044771|Raltegravir Potassium|raltegravir potassium|mesh-list
102431370|NCT01044771|Antiviral Agents|antiviral agents|mesh-ancestor
102431371|NCT01044771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102431372|NCT01044771|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102431373|NCT01044771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102431374|NCT01044771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102431375|NCT01044771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431376|NCT01044771|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102431377|NCT01044771|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102431378|NCT01044771|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102431379|NCT01044771|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102431380|NCT01115673|Acetaminophen|acetaminophen|mesh-list
102431381|NCT01115673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102431382|NCT01115673|Analgesics|analgesics|mesh-ancestor
102431383|NCT01115673|Sensory System Agents|sensory system agents|mesh-ancestor
102431384|NCT01115673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102431385|NCT01115673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431386|NCT01115673|Antipyretics|antipyretics|mesh-ancestor
102431387|NCT01116921|Pulmonary Surfactants|pulmonary surfactants|mesh-list
102431388|NCT01116921|Respiratory System Agents|respiratory system agents|mesh-ancestor
102431389|NCT04582383|Doxycycline|doxycycline|mesh-list
102431390|NCT04582383|Spironolactone|spironolactone|mesh-list
102431391|NCT04582383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102431392|NCT04582383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102431393|NCT04582383|Antimalarials|antimalarials|mesh-ancestor
102431394|NCT04582383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102431395|NCT04582383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102431396|NCT04582383|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102061817|NCT05422183|Lenvatinib|lenvatinib|mesh-list
102431397|NCT04582383|Hormone Antagonists|hormone antagonists|mesh-ancestor
102431398|NCT04582383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102431399|NCT04582383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431400|NCT04582383|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102431401|NCT04582383|Diuretics|diuretics|mesh-ancestor
102431402|NCT04582383|Natriuretic Agents|natriuretic agents|mesh-ancestor
102431403|NCT01118091|Aldesleukin|aldesleukin|mesh-list
102431404|NCT01118091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102431405|NCT01118091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102431406|NCT01118091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102431407|NCT01118091|Antiviral Agents|antiviral agents|mesh-ancestor
102431408|NCT01118091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102431409|NCT01045551|Apremilast|apremilast|mesh-list
102431410|NCT01045551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102431411|NCT01045551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102431412|NCT01045551|Analgesics|analgesics|mesh-ancestor
102431413|NCT01045551|Sensory System Agents|sensory system agents|mesh-ancestor
102431414|NCT01045551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102431415|NCT01045551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431416|NCT01045551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102431417|NCT01045551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102431418|NCT01045551|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102431419|NCT01045551|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102431420|NCT01045551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102431421|NCT01045551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431422|NCT01047189|Clindamycin|clindamycin|mesh-list
102431423|NCT01047189|Clindamycin palmitate|clindamycin palmitate|mesh-list
102431424|NCT01047189|Clindamycin phosphate|clindamycin phosphate|mesh-list
102243106|NCT05505123|Propofol|propofol|mesh-list
102431425|NCT01047189|Tretinoin|tretinoin|mesh-list
102431426|NCT01047189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102431427|NCT01047189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102431428|NCT01047189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102431429|NCT01047189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102431430|NCT01047189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431431|NCT01047189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102431432|NCT01047189|Keratolytic Agents|keratolytic agents|mesh-ancestor
102431433|NCT01047189|Dermatologic Agents|dermatologic agents|mesh-ancestor
102431434|NCT03380559|Botulinum Toxins|botulinum toxins|mesh-list
102431435|NCT03380559|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102431436|NCT03380559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102431437|NCT03380559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431438|NCT03380559|Cholinergic Agents|cholinergic agents|mesh-ancestor
102431439|NCT03380559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102431440|NCT03380559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431441|NCT03012945|Anesthetics|anesthetics|mesh-list
102431442|NCT03012945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102431443|NCT03012945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431444|NCT01121211|Testosterone|testosterone|mesh-list
102431445|NCT01121211|Androgens|androgens|mesh-ancestor
102431446|NCT01121211|Hormones|hormones|mesh-ancestor
102431447|NCT01121211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102431448|NCT01121211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431449|NCT01162551|Sirolimus|sirolimus|mesh-list
102431450|NCT01162551|Methotrexate|methotrexate|mesh-list
102431451|NCT01162551|Temsirolimus|temsirolimus|mesh-list
102431452|NCT01162551|MTOR Inhibitors|mtor inhibitors|mesh-list
102431453|NCT01162551|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102431454|NCT01162551|Abortifacient Agents|abortifacient agents|mesh-ancestor
102431455|NCT01162551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102431456|NCT01162551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431457|NCT01162551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102431458|NCT01162551|Antimetabolites|antimetabolites|mesh-ancestor
102431459|NCT01162551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431460|NCT01162551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102431461|NCT01162551|Dermatologic Agents|dermatologic agents|mesh-ancestor
102431462|NCT01162551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102431463|NCT01162551|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102431464|NCT01162551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102431465|NCT01162551|Immunologic Factors|immunologic factors|mesh-ancestor
102431466|NCT01162551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102431467|NCT01162551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102431468|NCT01162551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102431469|NCT01162551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102431470|NCT01162551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102431471|NCT01162551|Antifungal Agents|antifungal agents|mesh-ancestor
102431472|NCT01162551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102431473|NCT01163097|Heparin|heparin|mesh-list
102431474|NCT01163097|Anticoagulants|anticoagulants|mesh-ancestor
102431475|NCT01163097|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102431476|NCT01163097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102431477|NCT01163097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431478|NCT03013101|Antibodies|antibodies|mesh-list
102431479|NCT03013101|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102431480|NCT03013101|Immunologic Factors|immunologic factors|mesh-ancestor
102431481|NCT03013101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431482|NCT03088137|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102431483|NCT03088137|Hormones|hormones|mesh-ancestor
102431484|NCT03088137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102431485|NCT03088137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431486|NCT01165047|Nitric Oxide|nitric oxide|mesh-list
102431487|NCT01165047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102431488|NCT01165047|Autonomic Agents|autonomic agents|mesh-ancestor
102431489|NCT01165047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102431490|NCT01165047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431491|NCT01165047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102431492|NCT01165047|Respiratory System Agents|respiratory system agents|mesh-ancestor
102431493|NCT01165047|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102431494|NCT01165047|Antioxidants|antioxidants|mesh-ancestor
102431495|NCT01165047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431496|NCT01165047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102431497|NCT01165047|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102431498|NCT01165047|Vasodilator Agents|vasodilator agents|mesh-ancestor
102431499|NCT01165047|Gasotransmitters|gasotransmitters|mesh-ancestor
102431500|NCT01165047|Protective Agents|protective agents|mesh-ancestor
102431501|NCT01166997|Heparin|heparin|mesh-list
102431502|NCT01166997|Calcium heparin|calcium heparin|mesh-list
102431503|NCT01166997|Anticoagulants|anticoagulants|mesh-ancestor
102431504|NCT01166997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102431505|NCT01166997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102431506|NCT01166997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431507|NCT02802969|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
102431508|NCT02802969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102431509|NCT02802969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431510|NCT01170117|Olanzapine|olanzapine|mesh-list
102431511|NCT01170117|Antiemetics|antiemetics|mesh-ancestor
102431512|NCT01170117|Autonomic Agents|autonomic agents|mesh-ancestor
102431513|NCT01170117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102431514|NCT01170117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431515|NCT01170117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102431516|NCT01170117|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102431517|NCT01170117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102431518|NCT01170117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102431519|NCT01170117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102431520|NCT01170117|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102431521|NCT01170117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102431522|NCT01170117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102431523|NCT01170117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431524|NCT01170117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102431525|NCT01170117|Serotonin Agents|serotonin agents|mesh-ancestor
102431526|NCT01172145|Modafinil|modafinil|mesh-list
102431527|NCT01172145|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102431528|NCT01172145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431529|NCT01172145|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102431530|NCT01172145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102431531|NCT01172145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102431532|NCT01172145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431533|NCT01175343|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
102431534|NCT01175343|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
102431535|NCT01175343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102431536|NCT01175343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431537|NCT01176435|Levodopa|levodopa|mesh-list
102431538|NCT01176435|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102431539|NCT01176435|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102431540|NCT01176435|Dopamine Agents|dopamine agents|mesh-ancestor
102431541|NCT01176435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102431542|NCT01176435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431543|NCT01176435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431544|NCT01176591|Aprepitant|aprepitant|mesh-list
102431545|NCT01176591|Fosaprepitant|fosaprepitant|mesh-list
102431546|NCT01176591|Antiemetics|antiemetics|mesh-ancestor
102431547|NCT01176591|Autonomic Agents|autonomic agents|mesh-ancestor
102431548|NCT01176591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102431549|NCT01176591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431550|NCT01176591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102431551|NCT01176591|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102431552|NCT01176591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102431553|NCT01176591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431554|NCT01176981|Methotrexate|methotrexate|mesh-list
102431555|NCT01176981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102431556|NCT01176981|Abortifacient Agents|abortifacient agents|mesh-ancestor
102431557|NCT01176981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102431558|NCT01176981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431559|NCT01176981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102431560|NCT01176981|Antimetabolites|antimetabolites|mesh-ancestor
102431561|NCT01176981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431562|NCT01176981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102431563|NCT01176981|Dermatologic Agents|dermatologic agents|mesh-ancestor
102431564|NCT01176981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102431565|NCT01176981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102431566|NCT01176981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102431567|NCT01176981|Immunologic Factors|immunologic factors|mesh-ancestor
102431568|NCT01176981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102243250|NCT03922139|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102431569|NCT01176981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102431571|NCT01126593|Anesthetics, Local|anesthetics, local|mesh-ancestor
102431572|NCT01126593|Anesthetics|anesthetics|mesh-ancestor
102431573|NCT01126593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102431574|NCT01126593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431575|NCT01126593|Sensory System Agents|sensory system agents|mesh-ancestor
102431576|NCT01126593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102431577|NCT01181349|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
102431578|NCT01181349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102431579|NCT01181349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102431580|NCT01181349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431581|NCT01126671|Vitamin D|vitamin d|mesh-list
102431582|NCT01126671|Vitamins|vitamins|mesh-ancestor
102431583|NCT01126671|Micronutrients|micronutrients|mesh-ancestor
102431584|NCT01126671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431585|NCT01126671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102431586|NCT01182675|Plerixafor|plerixafor|mesh-list
102431587|NCT01182675|Alemtuzumab|alemtuzumab|mesh-list
102431588|NCT01182675|Lenograstim|lenograstim|mesh-list
102431589|NCT01182675|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102431590|NCT01182675|Immunologic Factors|immunologic factors|mesh-ancestor
102431591|NCT01182675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431592|NCT01182675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102431593|NCT01182675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102431594|NCT01182675|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102431595|NCT01182675|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102431596|NCT01182675|Antiviral Agents|antiviral agents|mesh-ancestor
102431597|NCT01182675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102431598|NCT01129245|Celecoxib|celecoxib|mesh-list
102431599|NCT01129245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102431600|NCT01129245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102431601|NCT01129245|Analgesics|analgesics|mesh-ancestor
102431602|NCT01129245|Sensory System Agents|sensory system agents|mesh-ancestor
102431603|NCT01129245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102431604|NCT01129245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431605|NCT01129245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102431606|NCT01129245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102431607|NCT01129245|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102431608|NCT01129245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102431609|NCT01129245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102431610|NCT01129245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431611|NCT01183533|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102431612|NCT01183533|Plasminogen|plasminogen|mesh-list
102431613|NCT01183533|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102431614|NCT01183533|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102431615|NCT01183533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431616|NCT01187355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102431617|NCT01188369|Simendan|simendan|mesh-list
102431618|NCT01188369|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102431619|NCT01188369|Vasodilator Agents|vasodilator agents|mesh-ancestor
102431620|NCT01188369|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102431621|NCT01188369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102431622|NCT01188369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102431623|NCT01188369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431624|NCT01188369|Protective Agents|protective agents|mesh-ancestor
102431625|NCT01188369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431626|NCT01135329|Mycophenolic Acid|mycophenolic acid|mesh-list
102431627|NCT01135329|Cyclophosphamide|cyclophosphamide|mesh-list
102431628|NCT01135329|Busulfan|busulfan|mesh-list
102431629|NCT01135329|Fludarabine|fludarabine|mesh-list
102431630|NCT01135329|Tacrolimus|tacrolimus|mesh-list
102431631|NCT01135329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102431632|NCT01135329|Immunologic Factors|immunologic factors|mesh-ancestor
102431633|NCT01135329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431634|NCT01135329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102431635|NCT01135329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102431636|NCT01135329|Alkylating Agents|alkylating agents|mesh-ancestor
102431637|NCT01135329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431638|NCT01135329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102431639|NCT01135329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102431640|NCT01135329|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102431641|NCT01135329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102431642|NCT01135329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102431643|NCT01135329|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102431644|NCT01135329|Antitubercular Agents|antitubercular agents|mesh-ancestor
102431645|NCT01135329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102431646|NCT01135329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102431647|NCT03012009|Lidocaine|lidocaine|mesh-list
102431648|NCT03012009|Epinephrine|epinephrine|mesh-list
102431649|NCT03012009|Racepinephrine|racepinephrine|mesh-list
102431650|NCT03012009|Anesthetics, Local|anesthetics, local|mesh-list
102431651|NCT03012009|Anesthetics|anesthetics|mesh-list
102431652|NCT03012009|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
102431653|NCT03012009|Epinephryl borate|epinephryl borate|mesh-list
102431654|NCT03012009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102431655|NCT03012009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431656|NCT03012009|Sensory System Agents|sensory system agents|mesh-ancestor
102431657|NCT03012009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102431658|NCT03012009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102431659|NCT03012009|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102431660|NCT03012009|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102431661|NCT03012009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102431662|NCT03012009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431663|NCT03012009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102431664|NCT03012009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102431665|NCT03012009|Adrenergic Agents|adrenergic agents|mesh-ancestor
102431666|NCT03012009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102431667|NCT03012009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102431668|NCT03012009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102431669|NCT03012009|Autonomic Agents|autonomic agents|mesh-ancestor
102431670|NCT03012009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102431671|NCT03012009|Respiratory System Agents|respiratory system agents|mesh-ancestor
102431672|NCT03012009|Mydriatics|mydriatics|mesh-ancestor
102431673|NCT03012009|Sympathomimetics|sympathomimetics|mesh-ancestor
102431674|NCT03012009|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102431675|NCT03012009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102431676|NCT03012009|Dermatologic Agents|dermatologic agents|mesh-ancestor
102431677|NCT04403555|Ivermectin|ivermectin|mesh-list
102431678|NCT04403555|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102431679|NCT04403555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102431680|NCT03565835|Prednisone|prednisone|mesh-list
102431681|NCT03565835|Abiraterone Acetate|abiraterone acetate|mesh-list
102431682|NCT03565835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102431683|NCT03565835|Glucocorticoids|glucocorticoids|mesh-ancestor
102431684|NCT03565835|Hormones|hormones|mesh-ancestor
102431685|NCT03565835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102431686|NCT03565835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431687|NCT03565835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102431688|NCT03565835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102431689|NCT03565835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102431690|NCT03565835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102431691|NCT03565835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431692|NCT03565835|Hormone Antagonists|hormone antagonists|mesh-ancestor
102431693|NCT03565835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102431694|NCT01624259|Metformin|metformin|mesh-list
102431695|NCT01624259|Liraglutide|liraglutide|mesh-list
102431696|NCT01624259|Dulaglutide|dulaglutide|mesh-list
102431697|NCT01624259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102431698|NCT01624259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431699|NCT01624259|Incretins|incretins|mesh-ancestor
102431700|NCT01624259|Hormones|hormones|mesh-ancestor
102431701|NCT01624259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102431702|NCT02081183|Mycophenolic Acid|mycophenolic acid|mesh-list
102431703|NCT02081183|Prednisone|prednisone|mesh-list
102431704|NCT02081183|Cyclophosphamide|cyclophosphamide|mesh-list
102431705|NCT02081183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102431706|NCT02081183|Immunologic Factors|immunologic factors|mesh-ancestor
102431707|NCT02081183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431708|NCT02081183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102431709|NCT02081183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102431710|NCT02081183|Alkylating Agents|alkylating agents|mesh-ancestor
102431711|NCT02081183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431712|NCT02081183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102431713|NCT02081183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102431714|NCT02081183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102431715|NCT02081183|Glucocorticoids|glucocorticoids|mesh-ancestor
102431716|NCT02081183|Hormones|hormones|mesh-ancestor
102431717|NCT02081183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102431718|NCT02081183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102431719|NCT02081183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102431720|NCT02081183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102431721|NCT02081183|Antitubercular Agents|antitubercular agents|mesh-ancestor
102431722|NCT02081183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102431723|NCT02081183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102431724|NCT02081183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102431725|NCT02080403|Chlorhexidine|chlorhexidine|mesh-list
102431726|NCT02080403|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102431727|NCT02080403|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102431728|NCT02080403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102431729|NCT02080403|Disinfectants|disinfectants|mesh-ancestor
102431730|NCT02080403|Dermatologic Agents|dermatologic agents|mesh-ancestor
102431731|NCT02079077|Aspirin|aspirin|mesh-list
102431732|NCT02079077|Hydroxychloroquine|hydroxychloroquine|mesh-list
102431733|NCT02079077|Antimalarials|antimalarials|mesh-ancestor
102431734|NCT02079077|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102431735|NCT02079077|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102431736|NCT02079077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102431737|NCT02079077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102431738|NCT02079077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431739|NCT02079077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102431740|NCT02079077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102431741|NCT02079077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102431742|NCT02079077|Analgesics|analgesics|mesh-ancestor
102431743|NCT02079077|Sensory System Agents|sensory system agents|mesh-ancestor
102431744|NCT02079077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102431745|NCT02079077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154180|NCT03606577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102154181|NCT03606577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102154182|NCT03606577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102154183|NCT03606577|Immunologic Factors|immunologic factors|mesh-ancestor
102154184|NCT03606577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102154185|NCT03606577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102154186|NCT03606577|Growth Substances|growth substances|mesh-ancestor
102154187|NCT03606577|Growth Inhibitors|growth inhibitors|mesh-ancestor
102154188|NCT03601975|Gemcitabine|gemcitabine|mesh-list
102154189|NCT03601975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102154190|NCT03601975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102154191|NCT03601975|Antimetabolites|antimetabolites|mesh-ancestor
102154192|NCT03601975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154193|NCT03602911|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102154194|NCT03602911|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102154195|NCT03602911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154196|NCT03137186|Metformin|metformin|mesh-list
102154197|NCT03137186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101863086|NCT01091896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102154198|NCT03137186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154199|NCT03601897|Paclitaxel|paclitaxel|mesh-list
102154200|NCT03601897|Rebastinib|rebastinib|mesh-list
102154201|NCT03601897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102154202|NCT03601897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102154203|NCT03601897|Tubulin Modulators|tubulin modulators|mesh-ancestor
102154204|NCT03601897|Antimitotic Agents|antimitotic agents|mesh-ancestor
102154205|NCT03601897|Mitosis Modulators|mitosis modulators|mesh-ancestor
102154206|NCT03601897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154207|NCT03601897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102154208|NCT03601897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102154209|NCT03137030|Acetaminophen|acetaminophen|mesh-list
102154210|NCT03137030|Hydrocodone|hydrocodone|mesh-list
102154211|NCT03137030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102154212|NCT03137030|Analgesics|analgesics|mesh-ancestor
102154213|NCT03137030|Sensory System Agents|sensory system agents|mesh-ancestor
102154214|NCT03137030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102154215|NCT03137030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154216|NCT03137030|Antipyretics|antipyretics|mesh-ancestor
102154217|NCT03137030|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102154218|NCT03137030|Narcotics|narcotics|mesh-ancestor
102154219|NCT03137030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102154220|NCT03137030|Antitussive Agents|antitussive agents|mesh-ancestor
102154221|NCT03137030|Respiratory System Agents|respiratory system agents|mesh-ancestor
102154222|NCT03596749|Sevelamer|sevelamer|mesh-list
102154223|NCT03596749|Chelating Agents|chelating agents|mesh-ancestor
102154224|NCT03596749|Sequestering Agents|sequestering agents|mesh-ancestor
102154225|NCT03596749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154226|NCT01595061|Cisplatin|cisplatin|mesh-list
102154227|NCT01595061|Gemcitabine|gemcitabine|mesh-list
102431746|NCT02079077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102431747|NCT02079077|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102431748|NCT02079077|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102431749|NCT02079077|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102431750|NCT02079077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102431751|NCT02079077|Antipyretics|antipyretics|mesh-ancestor
102431752|NCT03547271|Vaccines|vaccines|mesh-list
102431753|NCT03547271|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102431754|NCT03547271|Immunologic Factors|immunologic factors|mesh-ancestor
102431755|NCT03547271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431756|NCT01191255|Sevelamer|sevelamer|mesh-list
102431757|NCT01191255|Chelating Agents|chelating agents|mesh-ancestor
102431758|NCT01191255|Sequestering Agents|sequestering agents|mesh-ancestor
102431759|NCT01191255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431760|NCT02078219|Allopurinol|allopurinol|mesh-list
102431761|NCT02078219|Verinurad|verinurad|mesh-list
102431762|NCT02078219|Antimetabolites|antimetabolites|mesh-ancestor
102431763|NCT02078219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431764|NCT02078219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102431765|NCT02078219|Gout Suppressants|gout suppressants|mesh-ancestor
102431766|NCT02078219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102431767|NCT02078219|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102431768|NCT02078219|Antioxidants|antioxidants|mesh-ancestor
102431769|NCT02078219|Protective Agents|protective agents|mesh-ancestor
102431770|NCT02078219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431771|NCT03536039|Prednisone|prednisone|mesh-list
102431772|NCT03536039|Cyclophosphamide|cyclophosphamide|mesh-list
102431773|NCT03536039|Rituximab|rituximab|mesh-list
102431774|NCT03536039|Doxorubicin|doxorubicin|mesh-list
102431775|NCT03536039|Vincristine|vincristine|mesh-list
102431776|NCT03536039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102431777|NCT03536039|Immunologic Factors|immunologic factors|mesh-ancestor
102431778|NCT03536039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431779|NCT03536039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102431780|NCT03536039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102431781|NCT03536039|Alkylating Agents|alkylating agents|mesh-ancestor
102431782|NCT03536039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431783|NCT03536039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102431784|NCT03536039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102431785|NCT03536039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102431786|NCT03536039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102431787|NCT03536039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102431788|NCT03536039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102431789|NCT03536039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102431790|NCT03536039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102431791|NCT03536039|Glucocorticoids|glucocorticoids|mesh-ancestor
102431792|NCT03536039|Hormones|hormones|mesh-ancestor
102431793|NCT03536039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102431794|NCT03536039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102431795|NCT03536039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102431796|NCT03536039|Tubulin Modulators|tubulin modulators|mesh-ancestor
102431797|NCT03536039|Antimitotic Agents|antimitotic agents|mesh-ancestor
102431798|NCT03536039|Mitosis Modulators|mitosis modulators|mesh-ancestor
102431799|NCT02075255|Benralizumab|benralizumab|mesh-list
102431800|NCT02075255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102431801|NCT02075255|Respiratory System Agents|respiratory system agents|mesh-ancestor
102431802|NCT03532217|Nivolumab|nivolumab|mesh-list
102431803|NCT03532217|Ipilimumab|ipilimumab|mesh-list
102431804|NCT03532217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102431805|NCT03532217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102431806|NCT03532217|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102431807|NCT03532217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431808|NCT03529487|Phenylephrine|phenylephrine|mesh-list
102431809|NCT03529487|Oxymetazoline|oxymetazoline|mesh-list
102431810|NCT03529487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102431811|NCT03529487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102431812|NCT03529487|Adrenergic Agents|adrenergic agents|mesh-ancestor
102431813|NCT03529487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102431814|NCT03529487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431815|NCT03529487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431816|NCT03529487|Sympathomimetics|sympathomimetics|mesh-ancestor
102431817|NCT03529487|Autonomic Agents|autonomic agents|mesh-ancestor
102431818|NCT03529487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102431819|NCT03529487|Nasal Decongestants|nasal decongestants|mesh-ancestor
102431820|NCT03529487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102431821|NCT03529487|Respiratory System Agents|respiratory system agents|mesh-ancestor
102431822|NCT03529487|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102431823|NCT03529487|Mydriatics|mydriatics|mesh-ancestor
102431824|NCT03529487|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102431825|NCT03529487|Protective Agents|protective agents|mesh-ancestor
102431826|NCT03527927|Muscarinic Antagonists|muscarinic antagonists|mesh-list
102431827|NCT03527927|Cholinergic Agents|cholinergic agents|mesh-ancestor
102431828|NCT03527927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102431829|NCT03527927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431830|NCT03527927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431831|NCT03527927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102431832|NCT03527147|Rituximab|rituximab|mesh-list
102431833|NCT03527147|Magrolimab|magrolimab|mesh-list
102431834|NCT03527147|Acalabrutinib|acalabrutinib|mesh-list
102431835|NCT03527147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102431836|NCT03527147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102431837|NCT03527147|Immunologic Factors|immunologic factors|mesh-ancestor
102431838|NCT03527147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431839|NCT03527147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102431840|NCT03527069|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102431841|NCT03527069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102431842|NCT03527069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102431843|NCT03527069|Antimetabolites|antimetabolites|mesh-ancestor
102431844|NCT03527069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431845|NCT03527069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102431846|NCT03527069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102431847|NCT03527069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102431848|NCT01677611|Resveratrol|resveratrol|mesh-list
102431849|NCT01677611|Antioxidants|antioxidants|mesh-ancestor
102431850|NCT01677611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431851|NCT01677611|Protective Agents|protective agents|mesh-ancestor
102431852|NCT01677611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431853|NCT01677611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102431854|NCT01677611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102431855|NCT03518801|Cannabidiol|cannabidiol|mesh-list
102431856|NCT03518801|Anticonvulsants|anticonvulsants|mesh-ancestor
102431857|NCT01191723|Moxifloxacin|moxifloxacin|mesh-list
102431858|NCT01191723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102431859|NCT01191723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102431860|NCT01191723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102431861|NCT01191723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102431862|NCT01191723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102431863|NCT01191723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431864|NCT01191723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102431865|NCT01193049|Prednisone|prednisone|mesh-list
102431866|NCT01193049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102431867|NCT01193049|Glucocorticoids|glucocorticoids|mesh-ancestor
102431868|NCT01193049|Hormones|hormones|mesh-ancestor
102431869|NCT01193049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102431870|NCT01193049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431871|NCT01193049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102431872|NCT01193049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102431873|NCT01679951|Methotrexate|methotrexate|mesh-list
102431874|NCT01679951|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102431875|NCT01679951|Abortifacient Agents|abortifacient agents|mesh-ancestor
102431876|NCT01679951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102431877|NCT01679951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431878|NCT01679951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102431879|NCT01679951|Antimetabolites|antimetabolites|mesh-ancestor
102062350|NCT03700749|Povidone-Iodine|povidone-iodine|mesh-list
102431880|NCT01679951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431881|NCT01679951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102431882|NCT01679951|Dermatologic Agents|dermatologic agents|mesh-ancestor
102431883|NCT01679951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102431884|NCT01679951|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102431885|NCT01679951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102431886|NCT01679951|Immunologic Factors|immunologic factors|mesh-ancestor
102431887|NCT01679951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102431888|NCT01679951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102431889|NCT03514589|Cosyntropin|cosyntropin|mesh-list
102431890|NCT03514589|Hormones|hormones|mesh-ancestor
102431891|NCT03514589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102431892|NCT03514589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431893|NCT01194297|Vaccines|vaccines|mesh-list
102431894|NCT01194297|Immunologic Factors|immunologic factors|mesh-ancestor
102431895|NCT01194297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431896|NCT01194453|Folic Acid|folic acid|mesh-list
102431897|NCT01194453|Vitamin B 12|vitamin b 12|mesh-list
102431899|NCT01194453|Cisplatin|cisplatin|mesh-list
102431900|NCT01194453|Gemcitabine|gemcitabine|mesh-list
102431901|NCT01194453|Vitamins|vitamins|mesh-ancestor
102431902|NCT01194453|Micronutrients|micronutrients|mesh-ancestor
102431903|NCT01194453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431904|NCT01194453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102431905|NCT01194453|Antiemetics|antiemetics|mesh-ancestor
102431906|NCT01194453|Autonomic Agents|autonomic agents|mesh-ancestor
102431907|NCT01194453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102431908|NCT01194453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102431909|NCT01194453|Glucocorticoids|glucocorticoids|mesh-ancestor
102431910|NCT01194453|Hormones|hormones|mesh-ancestor
102431911|NCT01194453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102431912|NCT01194453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102431913|NCT01194453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102431914|NCT01194453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102431915|NCT01194453|Antimetabolites|antimetabolites|mesh-ancestor
102431916|NCT01194453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431917|NCT01194453|Hematinics|hematinics|mesh-ancestor
102431918|NCT01194453|Vitamin B Complex|vitamin b complex|mesh-ancestor
102431919|NCT03507413|Metformin|metformin|mesh-list
102431920|NCT03507413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102431921|NCT03507413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431922|NCT01195467|Tenofovir|tenofovir|mesh-list
102431923|NCT01195467|Emtricitabine|emtricitabine|mesh-list
102431924|NCT01195467|Efavirenz|efavirenz|mesh-list
102431925|NCT01195467|Raltegravir Potassium|raltegravir potassium|mesh-list
102431926|NCT01195467|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102431927|NCT01195467|Antiviral Agents|antiviral agents|mesh-ancestor
102431928|NCT01195467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102431929|NCT01195467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102431930|NCT01195467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102431931|NCT01195467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102431932|NCT01195467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431933|NCT01195467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102431934|NCT01195467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102431935|NCT01195467|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102431936|NCT01195467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102431937|NCT01195467|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102431938|NCT01195467|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102431939|NCT01195467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102431940|NCT01195467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102431941|NCT01195467|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102431942|NCT01195467|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102431943|NCT01677221|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102431944|NCT01677221|Dermatologic Agents|dermatologic agents|mesh-ancestor
102431945|NCT01195779|Vaccines|vaccines|mesh-list
102431946|NCT01195779|Immunologic Factors|immunologic factors|mesh-ancestor
102431947|NCT01195779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431948|NCT02405585|Leucovorin|leucovorin|mesh-list
102431949|NCT02405585|Gemcitabine|gemcitabine|mesh-list
102431950|NCT02405585|Fluorouracil|fluorouracil|mesh-list
102431951|NCT02405585|Oxaliplatin|oxaliplatin|mesh-list
102431952|NCT02405585|Irinotecan|irinotecan|mesh-list
102431953|NCT02405585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102431954|NCT02405585|Antimetabolites|antimetabolites|mesh-ancestor
102431955|NCT02405585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431956|NCT02405585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102431957|NCT02405585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102431958|NCT02405585|Immunologic Factors|immunologic factors|mesh-ancestor
102431959|NCT02405585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431960|NCT02405585|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102431961|NCT02405585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102431962|NCT02405585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102431963|NCT02405585|Antidotes|antidotes|mesh-ancestor
102431964|NCT02405585|Protective Agents|protective agents|mesh-ancestor
102431965|NCT02405585|Vitamin B Complex|vitamin b complex|mesh-ancestor
102431966|NCT02405585|Vitamins|vitamins|mesh-ancestor
102431967|NCT02405585|Micronutrients|micronutrients|mesh-ancestor
102431968|NCT03491345|Avelumab|avelumab|mesh-list
102431969|NCT03491345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102431970|NCT03491345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102431971|NCT00089999|Lapatinib|lapatinib|mesh-list
102431972|NCT00089999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102431973|NCT00089999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102431974|NCT00089999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102431975|NCT00089999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431976|NCT03454451|Pembrolizumab|pembrolizumab|mesh-list
102431977|NCT03454451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102431978|NCT03454451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102431979|NCT03454451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102431980|NCT03454451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431981|NCT00089843|Risedronic Acid|risedronic acid|mesh-list
102431982|NCT00089843|Etidronic Acid|etidronic acid|mesh-list
102431983|NCT00089843|Methyltestosterone|methyltestosterone|mesh-list
102431984|NCT00089843|Testosterone|testosterone|mesh-list
102431985|NCT00089843|Testosterone undecanoate|testosterone undecanoate|mesh-list
102431986|NCT00089843|Testosterone enanthate|testosterone enanthate|mesh-list
102431987|NCT00089843|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102431988|NCT00089843|Androgens|androgens|mesh-ancestor
102431989|NCT00089843|Hormones|hormones|mesh-ancestor
102431990|NCT00089843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102431991|NCT00089843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102431992|NCT00089843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102431993|NCT00089843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102431994|NCT00089843|Anabolic Agents|anabolic agents|mesh-ancestor
102431995|NCT00089843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102431996|NCT00089843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102431997|NCT00089843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102431998|NCT00089843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102431999|NCT00089843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102432000|NCT01677923|Metformin|metformin|mesh-list
102432001|NCT01677923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102432002|NCT01677923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432003|NCT00089297|Paclitaxel|paclitaxel|mesh-list
102432004|NCT00089297|Carboplatin|carboplatin|mesh-list
102432005|NCT00089297|Cetuximab|cetuximab|mesh-list
102432006|NCT00089297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102432007|NCT00089297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102432008|NCT00089297|Tubulin Modulators|tubulin modulators|mesh-ancestor
102432009|NCT00089297|Antimitotic Agents|antimitotic agents|mesh-ancestor
102432010|NCT00089297|Mitosis Modulators|mitosis modulators|mesh-ancestor
102432011|NCT00089297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432012|NCT00089297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102432013|NCT01678001|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102432014|NCT01678001|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102432015|NCT01678001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102432016|NCT01678001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432017|NCT01678001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102432018|NCT01678001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102062493|NCT02255396|Estradiol|estradiol|mesh-list
102432019|NCT01678001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432020|NCT01678001|Cholinergic Agents|cholinergic agents|mesh-ancestor
102432021|NCT01678001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102432022|NCT03482297|Midodrine|midodrine|mesh-list
102432023|NCT03482297|Sympathomimetics|sympathomimetics|mesh-ancestor
102432024|NCT03482297|Autonomic Agents|autonomic agents|mesh-ancestor
102432025|NCT03482297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102432026|NCT03482297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432027|NCT03482297|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102432028|NCT03482297|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102432029|NCT03482297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102432030|NCT03482297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102432031|NCT03482297|Adrenergic Agents|adrenergic agents|mesh-ancestor
102432032|NCT03482297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102432033|NCT03482297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432034|NCT00088907|Docetaxel|docetaxel|mesh-list
102432035|NCT00088907|Gefitinib|gefitinib|mesh-list
102432036|NCT00088907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102432037|NCT00088907|Tubulin Modulators|tubulin modulators|mesh-ancestor
102432038|NCT00088907|Antimitotic Agents|antimitotic agents|mesh-ancestor
102432039|NCT00088907|Mitosis Modulators|mitosis modulators|mesh-ancestor
102432040|NCT00088907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432041|NCT00088907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102432042|NCT00088907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102432043|NCT00088829|Paclitaxel|paclitaxel|mesh-list
102432044|NCT00088829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102432045|NCT00088829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102432046|NCT00088829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102432047|NCT00088829|Tubulin Modulators|tubulin modulators|mesh-ancestor
102432048|NCT00088829|Antimitotic Agents|antimitotic agents|mesh-ancestor
102432049|NCT00088829|Mitosis Modulators|mitosis modulators|mesh-ancestor
102432050|NCT00088829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432051|NCT00088595|Pasireotide|pasireotide|mesh-list
102432053|NCT00088595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102432054|NCT00088595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432055|NCT01678079|Calcium, Dietary|calcium, dietary|mesh-list
102432056|NCT01678079|Calcium|calcium|mesh-list
102432057|NCT01678079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102432058|NCT01678079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432059|NCT01678079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102432060|NCT01678235|Insulin|insulin|mesh-list
102432061|NCT01678235|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102432062|NCT01678235|Insulin Aspart|insulin aspart|mesh-list
102432063|NCT01678235|Insulin glulisine|insulin glulisine|mesh-list
102432064|NCT01678235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102432065|NCT01678235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432066|NCT01197495|Hyaluronic Acid|hyaluronic acid|mesh-list
102432067|NCT01197495|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102432068|NCT01197495|Immunologic Factors|immunologic factors|mesh-ancestor
102432069|NCT01197495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432070|NCT01197495|Viscosupplements|viscosupplements|mesh-ancestor
102432071|NCT01197495|Protective Agents|protective agents|mesh-ancestor
102432072|NCT01197573|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102432073|NCT01197573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102432074|NCT01197573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102432075|NCT01197573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432076|NCT03011931|Simvastatin|simvastatin|mesh-list
102432077|NCT03011931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102432078|NCT03011931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102432079|NCT03011931|Antimetabolites|antimetabolites|mesh-ancestor
102432080|NCT03011931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432081|NCT03011931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102432082|NCT03011931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102432083|NCT03011931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102432084|NCT02185131|Mirtazapine|mirtazapine|mesh-list
102432085|NCT02185131|Antidepressive Agents|antidepressive agents|mesh-ancestor
102432086|NCT02185131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102432087|NCT02185131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102062567|NCT01595321|Antimetabolites|antimetabolites|mesh-ancestor
102432088|NCT02185131|Histamine Antagonists|histamine antagonists|mesh-ancestor
102432089|NCT02185131|Histamine Agents|histamine agents|mesh-ancestor
102432090|NCT02185131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102432091|NCT02185131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432092|NCT02185131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432093|NCT02185131|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102432094|NCT02185131|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102432095|NCT02185131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102432096|NCT02185131|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102432097|NCT02185131|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102432098|NCT02185131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102432099|NCT02185131|Adrenergic Agents|adrenergic agents|mesh-ancestor
102432100|NCT02185131|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102432101|NCT02185131|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102432102|NCT02185131|Serotonin Agents|serotonin agents|mesh-ancestor
102432103|NCT02185131|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102432104|NCT00085709|Cytarabine|cytarabine|mesh-list
102432105|NCT00085709|Daunorubicin|daunorubicin|mesh-list
102432106|NCT00085709|Gemtuzumab|gemtuzumab|mesh-list
102432107|NCT00085709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102432108|NCT00085709|Antimetabolites|antimetabolites|mesh-ancestor
102432109|NCT00085709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432110|NCT00085709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102432111|NCT00085709|Antiviral Agents|antiviral agents|mesh-ancestor
102432112|NCT00085709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102432113|NCT00085709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102432114|NCT00085709|Immunologic Factors|immunologic factors|mesh-ancestor
102432115|NCT00085709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432116|NCT00085709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102432117|NCT00085709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102432118|NCT00085709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102432119|NCT00085709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102432120|NCT00085709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102432121|NCT00085709|Immunotoxins|immunotoxins|mesh-ancestor
102432122|NCT00085709|Immunoconjugates|immunoconjugates|mesh-ancestor
102432123|NCT01201863|Testosterone|testosterone|mesh-list
102432124|NCT01201863|Androgens|androgens|mesh-ancestor
102432126|NCT01201863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102432127|NCT01201863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432128|NCT01202253|Anidulafungin|anidulafungin|mesh-list
102432129|NCT01202253|Antifungal Agents|antifungal agents|mesh-ancestor
102432130|NCT01202253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102432131|NCT01678703|Misoprostol|misoprostol|mesh-list
102432132|NCT01678703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102432133|NCT01678703|Abortifacient Agents|abortifacient agents|mesh-ancestor
102432134|NCT01678703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102432135|NCT01678703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432136|NCT01678703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102432137|NCT01678703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102432138|NCT01678703|Oxytocics|oxytocics|mesh-ancestor
102432139|NCT00085631|Cisplatin|cisplatin|mesh-list
102432140|NCT00085631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102432141|NCT01141491|Vaccines|vaccines|mesh-list
102432142|NCT01141491|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
102432143|NCT01141491|Immunologic Factors|immunologic factors|mesh-ancestor
102432144|NCT01141491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432145|NCT01141569|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
102432146|NCT01141569|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
102432147|NCT01141569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102432148|NCT01141569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432149|NCT01141725|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102432150|NCT01141725|Idarubicin|idarubicin|mesh-list
102432151|NCT01141725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102062642|NCT01384331|Progestins|progestins|mesh-ancestor
102432152|NCT01141725|Alkylating Agents|alkylating agents|mesh-ancestor
102432153|NCT01141725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432154|NCT01141725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102432155|NCT01141725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102432156|NCT01141725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102432157|NCT01141725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102432158|NCT01141725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102432159|NCT01202721|Atenolol|atenolol|mesh-list
102432160|NCT01202721|Telmisartan|telmisartan|mesh-list
102432161|NCT01202721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102432162|NCT01202721|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102432163|NCT01202721|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102432164|NCT01202721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432165|NCT01202721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102432166|NCT01202721|Sympatholytics|sympatholytics|mesh-ancestor
102432167|NCT01202721|Autonomic Agents|autonomic agents|mesh-ancestor
102432168|NCT01202721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102432169|NCT01202721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432170|NCT01202721|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102432171|NCT01202721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102432172|NCT01202721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102432173|NCT01202721|Adrenergic Agents|adrenergic agents|mesh-ancestor
102432174|NCT01202721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102432175|NCT00084617|Capecitabine|capecitabine|mesh-list
102432176|NCT00084617|Oxaliplatin|oxaliplatin|mesh-list
102432177|NCT00084617|Irinotecan|irinotecan|mesh-list
102432178|NCT00084617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102432179|NCT00084617|Antimetabolites|antimetabolites|mesh-ancestor
102432180|NCT00084617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432181|NCT00084617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102432182|NCT00084617|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102432183|NCT00084617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102432184|NCT00084617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102432185|NCT01203189|Ketoconazole|ketoconazole|mesh-list
102432186|NCT01203189|Antifungal Agents|antifungal agents|mesh-ancestor
102432187|NCT01203189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102432188|NCT01203189|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102432189|NCT01203189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102432190|NCT01203189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102432191|NCT01203189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432192|NCT01203189|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102432193|NCT01203189|Hormone Antagonists|hormone antagonists|mesh-ancestor
102432194|NCT01203189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102432195|NCT01203189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432196|NCT01203189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102432197|NCT01204203|Zoledronic Acid|zoledronic acid|mesh-list
102432198|NCT01204203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102432199|NCT01204203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432200|NCT01679327|Calcium, Dietary|calcium, dietary|mesh-list
102432201|NCT01679327|Leucovorin|leucovorin|mesh-list
102432202|NCT01679327|Bevacizumab|bevacizumab|mesh-list
102432203|NCT01679327|Oxaliplatin|oxaliplatin|mesh-list
102432204|NCT01679327|Calcium|calcium|mesh-list
102432205|NCT01679327|Levoleucovorin|levoleucovorin|mesh-list
102432206|NCT01679327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102432207|NCT01679327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102432208|NCT01679327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102432209|NCT01679327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102432210|NCT01679327|Growth Substances|growth substances|mesh-ancestor
102432211|NCT01679327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432212|NCT01679327|Growth Inhibitors|growth inhibitors|mesh-ancestor
102432213|NCT01679327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102432214|NCT01679327|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102432215|NCT01679327|Antidotes|antidotes|mesh-ancestor
102432216|NCT01679327|Protective Agents|protective agents|mesh-ancestor
102432217|NCT01679327|Vitamin B Complex|vitamin b complex|mesh-ancestor
102432218|NCT01679327|Vitamins|vitamins|mesh-ancestor
102432219|NCT01679327|Micronutrients|micronutrients|mesh-ancestor
102432220|NCT01206387|Desoximetasone|desoximetasone|mesh-list
102432221|NCT01206387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102432222|NCT01206387|Glucocorticoids|glucocorticoids|mesh-ancestor
102432223|NCT01206387|Hormones|hormones|mesh-ancestor
102432224|NCT01206387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102432225|NCT01206387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432226|NCT01679561|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102432227|NCT01679561|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102432228|NCT01679561|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102432229|NCT01679561|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102432230|NCT01679639|Rifampin|rifampin|mesh-list
102432231|NCT01679639|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102432232|NCT01679639|Antitubercular Agents|antitubercular agents|mesh-ancestor
102432233|NCT01679639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102432234|NCT01679639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102432235|NCT01679639|Leprostatic Agents|leprostatic agents|mesh-ancestor
102432236|NCT01679639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102432237|NCT01679639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102432238|NCT01679639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432239|NCT01679639|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102432240|NCT01679639|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102432241|NCT01679639|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102432242|NCT01679639|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102432243|NCT01679639|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102432244|NCT01679639|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102432245|NCT01679795|Tibolone|tibolone|mesh-list
102432246|NCT01679795|Androgen Antagonists|androgen antagonists|mesh-ancestor
102432247|NCT01679795|Hormone Antagonists|hormone antagonists|mesh-ancestor
102432248|NCT01679795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102432249|NCT01679795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432250|NCT01679795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102432251|NCT01679795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102432252|NCT01679795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102432253|NCT01679795|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102432254|NCT01679795|Anabolic Agents|anabolic agents|mesh-ancestor
102432255|NCT01679795|Hormones|hormones|mesh-ancestor
102432256|NCT01206465|Fluorouracil|fluorouracil|mesh-list
102432257|NCT01206465|Antimetabolites|antimetabolites|mesh-ancestor
102432258|NCT01206465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432259|NCT01206465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102432260|NCT01206465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102432261|NCT01206465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102432262|NCT01206465|Immunologic Factors|immunologic factors|mesh-ancestor
102432263|NCT01206465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432264|NCT01207401|Lidocaine|lidocaine|mesh-list
102432265|NCT01207401|Anesthetics, Local|anesthetics, local|mesh-ancestor
102432266|NCT01207401|Anesthetics|anesthetics|mesh-ancestor
102432267|NCT01207401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102432268|NCT01207401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432269|NCT01207401|Sensory System Agents|sensory system agents|mesh-ancestor
102432270|NCT01207401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102432271|NCT01207401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102432272|NCT01207401|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102432273|NCT01207401|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102432274|NCT01207401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102432275|NCT01207401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432276|NCT04761731|Tacrolimus|tacrolimus|mesh-list
102432277|NCT04761731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102432278|NCT04761731|Immunologic Factors|immunologic factors|mesh-ancestor
102432279|NCT04761731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432280|NCT04761731|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102432281|NCT04761731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102432282|NCT04761731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432283|NCT03087539|Abciximab|abciximab|mesh-list
102432284|NCT03087539|Anticoagulants|anticoagulants|mesh-ancestor
102432285|NCT03087539|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102432286|NCT03087149|Vitamin D|vitamin d|mesh-list
102432287|NCT03087149|Vitamins|vitamins|mesh-ancestor
102432288|NCT03087149|Micronutrients|micronutrients|mesh-ancestor
102432289|NCT03087149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432290|NCT03087149|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102432291|NCT03086681|Cisplatin|cisplatin|mesh-list
102432292|NCT03086681|Endostar protein|endostar protein|mesh-list
102432293|NCT03086681|Endostatins|endostatins|mesh-list
102432294|NCT03086681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102432295|NCT03086681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102432296|NCT03086681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102432297|NCT03086681|Growth Substances|growth substances|mesh-ancestor
102432298|NCT03086681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432299|NCT03086681|Growth Inhibitors|growth inhibitors|mesh-ancestor
102432300|NCT03086759|Triamcinolone|triamcinolone|mesh-list
102432301|NCT03086759|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102432302|NCT03086759|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102432303|NCT03086759|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102432304|NCT03086759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102432305|NCT03086759|Glucocorticoids|glucocorticoids|mesh-ancestor
102432306|NCT03086759|Hormones|hormones|mesh-ancestor
102432307|NCT03086759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102432308|NCT03086759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432309|NCT03086759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102432310|NCT03086759|Immunologic Factors|immunologic factors|mesh-ancestor
102432311|NCT03086759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102432312|NCT03086759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432313|NCT03086291|Simvastatin|simvastatin|mesh-list
102432314|NCT03086291|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102432315|NCT03086291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102432316|NCT03086291|Antimetabolites|antimetabolites|mesh-ancestor
102432317|NCT03086291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432318|NCT03086291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102432319|NCT03086291|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102432320|NCT03086291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102432321|NCT03086915|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
102432322|NCT03086915|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102432323|NCT03086915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102432324|NCT03086915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432325|NCT01209195|Paclitaxel|paclitaxel|mesh-list
102432326|NCT01209195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102432327|NCT01209195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102432328|NCT01209195|Tubulin Modulators|tubulin modulators|mesh-ancestor
102432329|NCT01209195|Antimitotic Agents|antimitotic agents|mesh-ancestor
102432330|NCT01209195|Mitosis Modulators|mitosis modulators|mesh-ancestor
102432331|NCT01209195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432332|NCT03084809|Leucovorin|leucovorin|mesh-list
102432333|NCT03084809|Oxaliplatin|oxaliplatin|mesh-list
102432334|NCT03084809|Fluorouracil|fluorouracil|mesh-list
102432335|NCT03084809|Levoleucovorin|levoleucovorin|mesh-list
102432336|NCT03084809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102432337|NCT03084809|Antidotes|antidotes|mesh-ancestor
102432338|NCT03084809|Protective Agents|protective agents|mesh-ancestor
102432339|NCT03084809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432340|NCT03084809|Vitamin B Complex|vitamin b complex|mesh-ancestor
102244033|NCT02448901|Edoxaban|edoxaban|mesh-list
102432341|NCT03084809|Vitamins|vitamins|mesh-ancestor
102432342|NCT03084809|Micronutrients|micronutrients|mesh-ancestor
102432343|NCT03084809|Antimetabolites|antimetabolites|mesh-ancestor
102432344|NCT03084809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432345|NCT03084809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102432346|NCT03084809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102432347|NCT03084809|Immunologic Factors|immunologic factors|mesh-ancestor
102432348|NCT01144143|Methylprednisolone|methylprednisolone|mesh-list
102432349|NCT01144143|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102432350|NCT01144143|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102432351|NCT01144143|Prednisolone|prednisolone|mesh-list
102432352|NCT01144143|Prednisolone acetate|prednisolone acetate|mesh-list
102432354|NCT01144143|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102432355|NCT01144143|Prednisolone phosphate|prednisolone phosphate|mesh-list
102432356|NCT01144143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102432357|NCT01144143|Antiemetics|antiemetics|mesh-ancestor
102432358|NCT01144143|Autonomic Agents|autonomic agents|mesh-ancestor
102432359|NCT01144143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102432360|NCT01144143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432361|NCT01144143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102432362|NCT01144143|Glucocorticoids|glucocorticoids|mesh-ancestor
102432363|NCT01144143|Hormones|hormones|mesh-ancestor
102432364|NCT01144143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102432365|NCT01144143|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102432366|NCT01144143|Protective Agents|protective agents|mesh-ancestor
102432367|NCT01144143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102432368|NCT01144143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102432369|NCT01144143|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102432370|NCT01144143|Dermatologic Agents|dermatologic agents|mesh-ancestor
102432371|NCT01144143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102432372|NCT03084575|Glycerol|glycerol|mesh-list
102432373|NCT03084575|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102432374|NCT03084575|Protective Agents|protective agents|mesh-ancestor
102432375|NCT03084575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432376|NCT01212471|Bromfenac|bromfenac|mesh-list
102432377|NCT01212471|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102432378|NCT01212471|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102432379|NCT01212471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102432380|NCT01212471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102432381|NCT01212471|Analgesics|analgesics|mesh-ancestor
102432382|NCT01212471|Sensory System Agents|sensory system agents|mesh-ancestor
102432383|NCT01212471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102432384|NCT01212471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432385|NCT01212471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102432386|NCT01212471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102432387|NCT03084419|Abatacept|abatacept|mesh-list
102432388|NCT03084419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102432389|NCT03084419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432390|NCT03084419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102432391|NCT03084419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102432392|NCT03084419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102432393|NCT03084419|Immunologic Factors|immunologic factors|mesh-ancestor
102432394|NCT03084419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432395|NCT03084419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102432396|NCT03084029|Oxytocin|oxytocin|mesh-list
102432397|NCT03084029|Oxytocics|oxytocics|mesh-ancestor
102432398|NCT03084029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102432399|NCT03084029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432400|NCT04278053|Inositol|inositol|mesh-list
102432401|NCT04278053|Vitamin B Complex|vitamin b complex|mesh-ancestor
102432402|NCT04278053|Vitamins|vitamins|mesh-ancestor
102432403|NCT04278053|Micronutrients|micronutrients|mesh-ancestor
102432404|NCT04278053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432405|NCT05346107|Paclitaxel|paclitaxel|mesh-list
102432406|NCT05346107|Cyclophosphamide|cyclophosphamide|mesh-list
102432407|NCT05346107|Doxorubicin|doxorubicin|mesh-list
102432408|NCT05346107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102432409|NCT05346107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102432410|NCT05346107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102432411|NCT05346107|Tubulin Modulators|tubulin modulators|mesh-ancestor
102432412|NCT05346107|Antimitotic Agents|antimitotic agents|mesh-ancestor
102432413|NCT05346107|Mitosis Modulators|mitosis modulators|mesh-ancestor
102432414|NCT05346107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432415|NCT05346107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102432416|NCT05346107|Immunologic Factors|immunologic factors|mesh-ancestor
102154228|NCT01595061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102432417|NCT05346107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432418|NCT05346107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102432419|NCT05346107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102432420|NCT05346107|Alkylating Agents|alkylating agents|mesh-ancestor
102432421|NCT05346107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102432422|NCT05346107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102432423|NCT05346107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102432424|NCT05346107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102432425|NCT05346107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102432426|NCT03082001|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102432427|NCT00083915|Thalidomide|thalidomide|mesh-list
102432428|NCT00083915|Dexamethasone|dexamethasone|mesh-list
102432429|NCT00083915|Cyclophosphamide|cyclophosphamide|mesh-list
102432431|NCT00083915|Cisplatin|cisplatin|mesh-list
102432432|NCT00083915|Doxorubicin|doxorubicin|mesh-list
102432433|NCT00083915|Etoposide|etoposide|mesh-list
102432434|NCT00083915|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102432435|NCT00083915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102432436|NCT00083915|Immunologic Factors|immunologic factors|mesh-ancestor
102432437|NCT00083915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432438|NCT00083915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102432439|NCT00083915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102432440|NCT00083915|Alkylating Agents|alkylating agents|mesh-ancestor
102432441|NCT00083915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432442|NCT00083915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102432443|NCT00083915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102432444|NCT00083915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102432445|NCT00083915|Antiemetics|antiemetics|mesh-ancestor
102432446|NCT00083915|Autonomic Agents|autonomic agents|mesh-ancestor
102432447|NCT00083915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102432448|NCT00083915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102432449|NCT00083915|Glucocorticoids|glucocorticoids|mesh-ancestor
102432450|NCT00083915|Hormones|hormones|mesh-ancestor
102432451|NCT00083915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102432452|NCT00083915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102432453|NCT00083915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102432454|NCT00083915|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102432455|NCT00083915|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102432456|NCT00083915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102432457|NCT00083915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102432458|NCT00083915|Leprostatic Agents|leprostatic agents|mesh-ancestor
102432459|NCT00083915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102432460|NCT00083915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102432461|NCT00083915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102432462|NCT00083915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102432463|NCT00083915|Growth Substances|growth substances|mesh-ancestor
102432464|NCT00083915|Growth Inhibitors|growth inhibitors|mesh-ancestor
102432465|NCT04401839|Oxytocin|oxytocin|mesh-list
102432466|NCT04401839|Oxytocics|oxytocics|mesh-ancestor
102432467|NCT04401839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102432468|NCT04401839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432469|NCT04761185|Raltitrexed|raltitrexed|mesh-list
102432470|NCT04761185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102432471|NCT04761185|Antimetabolites|antimetabolites|mesh-ancestor
102432472|NCT04761185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432473|NCT04761185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102432474|NCT04761185|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102432475|NCT04761185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102432476|NCT01144455|Gemcitabine|gemcitabine|mesh-list
102432477|NCT01144455|Phosphoramide Mustards|phosphoramide mustards|mesh-list
102432478|NCT01144455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102432479|NCT01144455|Antimetabolites|antimetabolites|mesh-ancestor
102432480|NCT01144455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432481|NCT01144455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102432482|NCT01144455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102432483|NCT01144455|Alkylating Agents|alkylating agents|mesh-ancestor
102432484|NCT03080675|Vitamins|vitamins|mesh-list
102432485|NCT03080675|Micronutrients|micronutrients|mesh-ancestor
102432486|NCT03080675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432487|NCT03080363|Lidocaine|lidocaine|mesh-list
102432488|NCT03080363|Bupivacaine|bupivacaine|mesh-list
102432489|NCT03080363|Anesthetics, Local|anesthetics, local|mesh-ancestor
102432490|NCT03080363|Anesthetics|anesthetics|mesh-ancestor
102432491|NCT03080363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102432492|NCT03080363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432493|NCT03080363|Sensory System Agents|sensory system agents|mesh-ancestor
102432494|NCT03080363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102432495|NCT03080363|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102432496|NCT03080363|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102432497|NCT03080363|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102432498|NCT03080363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102432499|NCT03080363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432500|NCT01145001|Nicotine|nicotine|mesh-list
102432501|NCT01145001|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102432502|NCT01145001|Autonomic Agents|autonomic agents|mesh-ancestor
102432503|NCT01145001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102432504|NCT01145001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432505|NCT01145001|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102432506|NCT01145001|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102432507|NCT01145001|Cholinergic Agents|cholinergic agents|mesh-ancestor
102432508|NCT01145001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102432509|NCT01145001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432510|NCT03011463|Clarithromycin|clarithromycin|mesh-list
102432511|NCT03011463|Ranitidine|ranitidine|mesh-list
102432512|NCT03011463|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
102432513|NCT03011463|Trospium chloride|trospium chloride|mesh-list
102432514|NCT03011463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102432515|NCT03011463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102432516|NCT03011463|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102432517|NCT03011463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102432518|NCT03011463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432519|NCT03011463|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102432520|NCT03011463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102432521|NCT03011463|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102432522|NCT03011463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102432523|NCT03011463|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102432524|NCT03011463|Histamine Antagonists|histamine antagonists|mesh-ancestor
102432525|NCT03011463|Histamine Agents|histamine agents|mesh-ancestor
102432526|NCT03011463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102432527|NCT03011463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432528|NCT03011463|Parasympatholytics|parasympatholytics|mesh-ancestor
102432529|NCT03011463|Autonomic Agents|autonomic agents|mesh-ancestor
102432530|NCT03011463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102432531|NCT03011463|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102432532|NCT03011463|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102432533|NCT03011463|Cholinergic Agents|cholinergic agents|mesh-ancestor
102432534|NCT03011463|Urological Agents|urological agents|mesh-ancestor
102432535|NCT01214109|Pramipexole|pramipexole|mesh-list
102432536|NCT01214109|Antioxidants|antioxidants|mesh-ancestor
102432537|NCT01214109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432538|NCT01214109|Protective Agents|protective agents|mesh-ancestor
102432539|NCT01214109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432540|NCT01214109|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102432541|NCT01214109|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102432542|NCT01214109|Dopamine Agonists|dopamine agonists|mesh-ancestor
102432543|NCT01214109|Dopamine Agents|dopamine agents|mesh-ancestor
102432544|NCT01214109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102432545|NCT05688761|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
102432546|NCT05688761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102432547|NCT05688761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432548|NCT01215123|Bevacizumab|bevacizumab|mesh-list
102432549|NCT01215123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102432550|NCT01215123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102432551|NCT01215123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102432552|NCT01215123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102432553|NCT01215123|Growth Substances|growth substances|mesh-ancestor
102432554|NCT01215123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432555|NCT01215123|Growth Inhibitors|growth inhibitors|mesh-ancestor
102432556|NCT05688449|Fentanyl|fentanyl|mesh-list
102432557|NCT05688449|Bupivacaine|bupivacaine|mesh-list
102432558|NCT05688449|Anesthetics, Local|anesthetics, local|mesh-ancestor
102432559|NCT05688449|Anesthetics|anesthetics|mesh-ancestor
102432560|NCT05688449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102432561|NCT05688449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432562|NCT05688449|Sensory System Agents|sensory system agents|mesh-ancestor
102432563|NCT05688449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102432564|NCT05688449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102432565|NCT05688449|Narcotics|narcotics|mesh-ancestor
102432566|NCT05688449|Analgesics|analgesics|mesh-ancestor
102432567|NCT05688449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102432568|NCT05688449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102432569|NCT05688449|Anesthetics, General|anesthetics, general|mesh-ancestor
102432571|NCT04401137|Anticonvulsants|anticonvulsants|mesh-ancestor
102432572|NCT04401137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102432573|NCT04401137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432574|NCT02189889|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102432575|NCT02189889|Hematinics|hematinics|mesh-ancestor
102432576|NCT02189889|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102432577|NCT02189889|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102432578|NCT01148745|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102432579|NCT01148745|Hematinics|hematinics|mesh-ancestor
102432580|NCT01148745|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102432581|NCT01148745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102432582|NCT04761029|Tramadol|tramadol|mesh-list
102432583|NCT04761029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102432584|NCT04761029|Narcotics|narcotics|mesh-ancestor
102432585|NCT04761029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102432586|NCT04761029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432587|NCT04761029|Analgesics|analgesics|mesh-ancestor
102432588|NCT04761029|Sensory System Agents|sensory system agents|mesh-ancestor
102432589|NCT04761029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102432590|NCT05687981|Dexamethasone|dexamethasone|mesh-list
102432591|NCT05687981|Bupivacaine|bupivacaine|mesh-list
102432592|NCT05687981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102432593|NCT05687981|Antiemetics|antiemetics|mesh-ancestor
102432594|NCT05687981|Autonomic Agents|autonomic agents|mesh-ancestor
102432595|NCT05687981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102432596|NCT05687981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432597|NCT05687981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102432598|NCT05687981|Glucocorticoids|glucocorticoids|mesh-ancestor
102432599|NCT05687981|Hormones|hormones|mesh-ancestor
102432600|NCT05687981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102432601|NCT05687981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102432602|NCT05687981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102432603|NCT05687981|Anesthetics, Local|anesthetics, local|mesh-ancestor
102432604|NCT05687981|Anesthetics|anesthetics|mesh-ancestor
102432605|NCT05687981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102432606|NCT05687981|Sensory System Agents|sensory system agents|mesh-ancestor
102432607|NCT05687747|FAPI-46|fapi-46|mesh-list
102432608|NCT05687747|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102432609|NCT05687747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432610|NCT05687669|Phentolamine|phentolamine|mesh-list
102432611|NCT05687669|Nitroglycerin|nitroglycerin|mesh-list
102432612|NCT05687669|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102432613|NCT05687669|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102432614|NCT05687669|Adrenergic Agents|adrenergic agents|mesh-ancestor
102432615|NCT05687669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102432616|NCT05687669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432617|NCT05687669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432618|NCT05687669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102432619|NCT05687669|Vasodilator Agents|vasodilator agents|mesh-ancestor
102432620|NCT04400747|Vitamin D|vitamin d|mesh-list
102432621|NCT04400747|Cholecalciferol|cholecalciferol|mesh-list
102432622|NCT04400747|Vitamins|vitamins|mesh-ancestor
102432623|NCT04400747|Micronutrients|micronutrients|mesh-ancestor
102432624|NCT04400747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432625|NCT04400747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102432626|NCT04400747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102432627|NCT02190903|Anesthetics|anesthetics|mesh-list
102432628|NCT02190903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102432629|NCT02190903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432630|NCT03369041|Irinotecan|irinotecan|mesh-list
102432631|NCT03369041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102432632|NCT03369041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102432633|NCT03369041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102063117|NCT03624309|Docetaxel|docetaxel|mesh-list
102432634|NCT03369041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432635|NCT03369041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102432636|NCT01149759|Cyclosporine|cyclosporine|mesh-list
102432637|NCT01149759|Cyclosporins|cyclosporins|mesh-list
102432638|NCT01149759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102432639|NCT01149759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432640|NCT01149759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102432641|NCT01149759|Immunologic Factors|immunologic factors|mesh-ancestor
102432642|NCT01149759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432643|NCT01149759|Antifungal Agents|antifungal agents|mesh-ancestor
102432644|NCT01149759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102432645|NCT01149759|Dermatologic Agents|dermatologic agents|mesh-ancestor
102432646|NCT01149759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102432647|NCT01149759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102432648|NCT01216761|Iodine|iodine|mesh-list
102432649|NCT01216761|Chlorhexidine|chlorhexidine|mesh-list
102432650|NCT01216761|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102432651|NCT01216761|Cadexomer iodine|cadexomer iodine|mesh-list
102432652|NCT01216761|Povidone-Iodine|povidone-iodine|mesh-list
102432653|NCT01216761|Povidone|povidone|mesh-list
102432654|NCT01216761|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102432655|NCT01216761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102432656|NCT01216761|Disinfectants|disinfectants|mesh-ancestor
102432657|NCT01216761|Dermatologic Agents|dermatologic agents|mesh-ancestor
102432658|NCT01216761|Trace Elements|trace elements|mesh-ancestor
102432659|NCT01216761|Micronutrients|micronutrients|mesh-ancestor
102432660|NCT01216761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432661|NCT01216761|Plasma Substitutes|plasma substitutes|mesh-ancestor
102432662|NCT01216761|Blood Substitutes|blood substitutes|mesh-ancestor
102432663|NCT04279379|Decitabine|decitabine|mesh-list
102432664|NCT04279379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102432665|NCT04279379|Antimetabolites|antimetabolites|mesh-ancestor
102432666|NCT04279379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432667|NCT04279379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102432668|NCT04279379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102432669|NCT01150461|Losartan|losartan|mesh-list
102432670|NCT01150461|Angiotensin II|angiotensin ii|mesh-list
102432671|NCT01150461|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
102432672|NCT01150461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102432673|NCT01150461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102432674|NCT01150461|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102432675|NCT01150461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432676|NCT01150461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102432677|NCT01218399|Budesonide|budesonide|mesh-list
102432678|NCT01218399|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
102432679|NCT01218399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102432680|NCT01218399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102432681|NCT01218399|Autonomic Agents|autonomic agents|mesh-ancestor
102432682|NCT01218399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102432683|NCT01218399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432684|NCT01218399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102432685|NCT01218399|Respiratory System Agents|respiratory system agents|mesh-ancestor
102432686|NCT01218399|Glucocorticoids|glucocorticoids|mesh-ancestor
102432687|NCT01218399|Hormones|hormones|mesh-ancestor
102432688|NCT01218399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102432689|NCT01219881|Sevoflurane|sevoflurane|mesh-list
102432690|NCT01219881|Desflurane|desflurane|mesh-list
102432691|NCT01219881|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102432692|NCT01219881|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102432693|NCT01219881|Anesthetics, General|anesthetics, general|mesh-ancestor
102432694|NCT01219881|Anesthetics|anesthetics|mesh-ancestor
102432695|NCT01219881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102432696|NCT01219881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432697|NCT01220973|Celecoxib|celecoxib|mesh-list
102432698|NCT01220973|Atorvastatin|atorvastatin|mesh-list
102432699|NCT01220973|Calcium|calcium|mesh-list
102432700|NCT01220973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102432701|NCT01220973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432702|NCT01220973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102432703|NCT01220973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102432704|NCT01220973|Antimetabolites|antimetabolites|mesh-ancestor
102432705|NCT01220973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432706|NCT01220973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102432707|NCT01220973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102432708|NCT01220973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102432709|NCT01220973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102432710|NCT01220973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102432711|NCT01220973|Analgesics|analgesics|mesh-ancestor
102432712|NCT01220973|Sensory System Agents|sensory system agents|mesh-ancestor
102432713|NCT01220973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102432714|NCT01220973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102432715|NCT01220973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102432716|NCT01220973|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102432717|NCT01220973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102432718|NCT05375747|Propofol|propofol|mesh-list
102432719|NCT05375747|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102432720|NCT05375747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102432721|NCT05375747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432722|NCT05375747|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102432723|NCT05375747|Anesthetics, General|anesthetics, general|mesh-ancestor
102432724|NCT05375747|Anesthetics|anesthetics|mesh-ancestor
102432725|NCT01221207|Calpastatin|calpastatin|mesh-list
102432726|NCT01221207|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
102432727|NCT01221207|Protease Inhibitors|protease inhibitors|mesh-ancestor
102432728|NCT01221207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102432729|NCT01221207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432730|NCT03296813|Torsemide|torsemide|mesh-list
102432731|NCT03296813|Furosemide|furosemide|mesh-list
102432732|NCT03296813|Diuretics|diuretics|mesh-ancestor
102432733|NCT03296813|Natriuretic Agents|natriuretic agents|mesh-ancestor
102432734|NCT03296813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432735|NCT03296813|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102432736|NCT03296813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102432737|NCT03296813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432738|NCT03296813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102432739|NCT05338619|Lazertinib|lazertinib|mesh-list
102432740|NCT05338619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102432741|NCT05338619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102432742|NCT05338619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432743|NCT03289949|Ketanserin|ketanserin|mesh-list
102432744|NCT03289949|Psilocybin|psilocybin|mesh-list
102432745|NCT03289949|Hallucinogens|hallucinogens|mesh-ancestor
102432746|NCT03289949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432747|NCT03289949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102432748|NCT03289949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102432749|NCT03289949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102432750|NCT03289949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102432751|NCT03289949|Serotonin Agents|serotonin agents|mesh-ancestor
102432752|NCT03289949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102432753|NCT03289949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432754|NCT01222299|Bepotastine besilate|bepotastine besilate|mesh-list
102432755|NCT01222299|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102432756|NCT04400045|Treosulfan|treosulfan|mesh-list
102432757|NCT04400045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102432758|NCT04400045|Alkylating Agents|alkylating agents|mesh-ancestor
102432759|NCT04400045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432760|NCT04400045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102432761|NCT01222689|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102432762|NCT01222689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102063245|NCT00106808|Pioglitazone|pioglitazone|mesh-list
102432763|NCT01222689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102432764|NCT01222689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102432765|NCT01222689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432766|NCT01153581|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102432767|NCT01153581|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102432768|NCT01153581|Estradiol|estradiol|mesh-list
102432769|NCT01153581|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102432770|NCT01153581|Progesterone|progesterone|mesh-list
102432771|NCT01153581|Ganirelix|ganirelix|mesh-list
102432772|NCT01153581|Estrogens|estrogens|mesh-ancestor
102432773|NCT01153581|Hormones|hormones|mesh-ancestor
102432774|NCT01153581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102432775|NCT01153581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432776|NCT01153581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102432777|NCT01153581|Contraceptive Agents|contraceptive agents|mesh-ancestor
102432778|NCT01153581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102432779|NCT01153581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102432780|NCT01153581|Progestins|progestins|mesh-ancestor
102432781|NCT01153581|Hormone Antagonists|hormone antagonists|mesh-ancestor
102432782|NCT04278599|Zinc|zinc|mesh-list
102432783|NCT04278599|Trace Elements|trace elements|mesh-ancestor
102432784|NCT04278599|Micronutrients|micronutrients|mesh-ancestor
102432785|NCT04278599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432786|NCT05277623|Mannitol|mannitol|mesh-list
102432787|NCT05277623|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102432788|NCT05277623|Diuretics|diuretics|mesh-ancestor
102432789|NCT05277623|Natriuretic Agents|natriuretic agents|mesh-ancestor
102432790|NCT05277623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432791|NCT01224015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102244480|NCT03267407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102432792|NCT01224015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102432793|NCT01224015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102432794|NCT01224015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102432795|NCT01224015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432796|NCT01224015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102432797|NCT01224015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102432798|NCT01224015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432799|NCT01224015|Cholinergic Agents|cholinergic agents|mesh-ancestor
102432800|NCT01224015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102432801|NCT04760327|Cisplatin|cisplatin|mesh-list
102432802|NCT04760327|Bleomycin|bleomycin|mesh-list
102432803|NCT04760327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102432804|NCT04760327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102432805|NCT01225263|Vitamin D|vitamin d|mesh-list
102432806|NCT01225263|Simvastatin|simvastatin|mesh-list
102432807|NCT01225263|Vitamins|vitamins|mesh-ancestor
102432808|NCT01225263|Micronutrients|micronutrients|mesh-ancestor
102432809|NCT01225263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432810|NCT01225263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102432811|NCT01225263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102432812|NCT01225263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102432813|NCT01225263|Antimetabolites|antimetabolites|mesh-ancestor
102432814|NCT01225263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432815|NCT01225263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102432816|NCT01225263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102432817|NCT01225263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102432818|NCT04278287|Paclitaxel|paclitaxel|mesh-list
102432819|NCT04278287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102432820|NCT04278287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102432821|NCT04278287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102432822|NCT04278287|Tubulin Modulators|tubulin modulators|mesh-ancestor
102432823|NCT04278287|Antimitotic Agents|antimitotic agents|mesh-ancestor
102432824|NCT04278287|Mitosis Modulators|mitosis modulators|mesh-ancestor
102432825|NCT04278287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432826|NCT05162027|Erenumab|erenumab|mesh-list
102432827|NCT05162027|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
102432828|NCT05162027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432829|NCT05162027|Analgesics|analgesics|mesh-ancestor
102432830|NCT05162027|Sensory System Agents|sensory system agents|mesh-ancestor
102432831|NCT05162027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102432832|NCT05162027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432833|NCT03278717|Olaparib|olaparib|mesh-list
102432834|NCT03278717|Cediranib|cediranib|mesh-list
102432835|NCT03278717|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102432836|NCT03278717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102432837|NCT03278717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432838|NCT03278717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102432839|NCT03278717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102432840|NCT01227993|Finasteride|finasteride|mesh-list
102432841|NCT01227993|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102432842|NCT01227993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102432843|NCT01227993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102432844|NCT01227993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432845|NCT01227993|Hormone Antagonists|hormone antagonists|mesh-ancestor
102432846|NCT01227993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102432847|NCT01227993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432848|NCT01227993|Urological Agents|urological agents|mesh-ancestor
102432849|NCT01155999|Tobramycin|tobramycin|mesh-list
102432850|NCT01155999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102432851|NCT01155999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102432852|NCT03275597|Durvalumab|durvalumab|mesh-list
102432853|NCT03275597|Tremelimumab|tremelimumab|mesh-list
102432854|NCT03275597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102432855|NCT03275597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102432856|NCT01228149|Acetazolamide|acetazolamide|mesh-list
102432857|NCT01228149|Anticonvulsants|anticonvulsants|mesh-ancestor
102432858|NCT01228149|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102432859|NCT01228149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102432860|NCT01228149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432861|NCT01228149|Diuretics|diuretics|mesh-ancestor
102432862|NCT01228149|Natriuretic Agents|natriuretic agents|mesh-ancestor
102432863|NCT01228149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432864|NCT04989413|Dronabinol|dronabinol|mesh-list
102432865|NCT04989413|Cannabidiol|cannabidiol|mesh-list
102432866|NCT04989413|Anticonvulsants|anticonvulsants|mesh-ancestor
102432867|NCT04989413|Hallucinogens|hallucinogens|mesh-ancestor
102432868|NCT04989413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432869|NCT04989413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102432870|NCT04989413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102432871|NCT04989413|Analgesics|analgesics|mesh-ancestor
102432872|NCT04989413|Sensory System Agents|sensory system agents|mesh-ancestor
102432873|NCT04989413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102432874|NCT04989413|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102432875|NCT04989413|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102432876|NCT04989413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102432877|NCT04989413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432878|NCT04989413|Hormones|hormones|mesh-ancestor
102432879|NCT04989413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102432880|NCT04986839|Acetaminophen|acetaminophen|mesh-list
102432881|NCT04986839|Ibuprofen|ibuprofen|mesh-list
102432882|NCT04986839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102432883|NCT04986839|Analgesics|analgesics|mesh-ancestor
102432884|NCT04986839|Sensory System Agents|sensory system agents|mesh-ancestor
102432885|NCT04986839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102432886|NCT04986839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432887|NCT04986839|Antipyretics|antipyretics|mesh-ancestor
102432888|NCT04986839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102432889|NCT04986839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102432890|NCT04986839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102432891|NCT04986839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102432892|NCT04986839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102432893|NCT04986839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432894|NCT04968587|Dialysis Solutions|dialysis solutions|mesh-list
102432895|NCT04968587|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102432896|NCT02192541|Aflibercept|aflibercept|mesh-list
102432897|NCT02192541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102432898|NCT02192541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102432899|NCT02192541|Growth Substances|growth substances|mesh-ancestor
102063381|NCT02175056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102432900|NCT02192541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432901|NCT02192541|Growth Inhibitors|growth inhibitors|mesh-ancestor
102432902|NCT02192541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102432903|NCT01156701|Zanamivir|zanamivir|mesh-list
102432904|NCT01156701|Antiviral Agents|antiviral agents|mesh-ancestor
102432905|NCT01156701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102432906|NCT01156701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102432907|NCT01156701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432908|NCT04937153|Pembrolizumab|pembrolizumab|mesh-list
102432909|NCT04937153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102432910|NCT04937153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102432911|NCT04937153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102432912|NCT04937153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432913|NCT03266081|Bupivacaine|bupivacaine|mesh-list
102432914|NCT03266081|Anesthetics, Local|anesthetics, local|mesh-ancestor
102432915|NCT03266081|Anesthetics|anesthetics|mesh-ancestor
102432916|NCT03266081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102432917|NCT03266081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432918|NCT03266081|Sensory System Agents|sensory system agents|mesh-ancestor
102432919|NCT03266081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102432920|NCT03010995|Prazosin|prazosin|mesh-list
102432921|NCT03010995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102432922|NCT03010995|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102432923|NCT03010995|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102432924|NCT03010995|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102432925|NCT03010995|Adrenergic Agents|adrenergic agents|mesh-ancestor
102432926|NCT03010995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102432927|NCT03010995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432928|NCT03010995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432929|NCT01230177|Etanercept|etanercept|mesh-list
102432930|NCT01230177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102432931|NCT01230177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102432932|NCT01230177|Analgesics|analgesics|mesh-ancestor
102432933|NCT01230177|Sensory System Agents|sensory system agents|mesh-ancestor
102432934|NCT01230177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102432935|NCT01230177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432936|NCT01230177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102432937|NCT01230177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102432938|NCT01230177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102432939|NCT01230177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102432940|NCT01230177|Immunologic Factors|immunologic factors|mesh-ancestor
102432941|NCT02984657|Anesthetics|anesthetics|mesh-list
102432942|NCT02984657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102432943|NCT02984657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432944|NCT01158651|Everolimus|everolimus|mesh-list
102432945|NCT01158651|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102432946|NCT01158651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102432947|NCT01158651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102432948|NCT01158651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432949|NCT01158651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102432950|NCT01158651|Immunologic Factors|immunologic factors|mesh-ancestor
102432951|NCT01158651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432952|NCT01158651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102432953|NCT04852679|Lanreotide|lanreotide|mesh-list
102432954|NCT04852679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102432955|NCT03262103|Poly I-C|poly i-c|mesh-list
102432956|NCT03262103|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102432957|NCT03262103|Poly ICLC|poly iclc|mesh-list
102432958|NCT03262103|Interferon Inducers|interferon inducers|mesh-ancestor
102432959|NCT03262103|Immunologic Factors|immunologic factors|mesh-ancestor
102432960|NCT03262103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432961|NCT03262103|Laxatives|laxatives|mesh-ancestor
102432962|NCT03262103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102432963|NCT03262103|Antiviral Agents|antiviral agents|mesh-ancestor
102432964|NCT03262103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102432965|NCT04777643|Cannabidiol|cannabidiol|mesh-list
102432966|NCT04777643|Anticonvulsants|anticonvulsants|mesh-ancestor
102432967|NCT04775225|Lidocaine|lidocaine|mesh-list
102432968|NCT04775225|Anesthetics, Local|anesthetics, local|mesh-ancestor
102432969|NCT04775225|Anesthetics|anesthetics|mesh-ancestor
102432970|NCT04775225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102432971|NCT04775225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432972|NCT04775225|Sensory System Agents|sensory system agents|mesh-ancestor
102432973|NCT04775225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102432974|NCT04775225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102432975|NCT04775225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102432976|NCT04775225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102432977|NCT04775225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102432978|NCT04775225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432979|NCT04731467|Paclitaxel|paclitaxel|mesh-list
102432980|NCT04731467|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102432981|NCT04731467|Gemcitabine|gemcitabine|mesh-list
102432982|NCT04731467|Nivolumab|nivolumab|mesh-list
102432983|NCT04731467|Fluorouracil|fluorouracil|mesh-list
102432984|NCT04731467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102432985|NCT04731467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102432986|NCT04731467|Tubulin Modulators|tubulin modulators|mesh-ancestor
102432987|NCT04731467|Antimitotic Agents|antimitotic agents|mesh-ancestor
102432988|NCT04731467|Mitosis Modulators|mitosis modulators|mesh-ancestor
102432989|NCT04731467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102432990|NCT04731467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102432991|NCT04731467|Antimetabolites|antimetabolites|mesh-ancestor
102432992|NCT04731467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102432993|NCT04731467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102432994|NCT04731467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102432995|NCT04731467|Immunologic Factors|immunologic factors|mesh-ancestor
102432996|NCT04731467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102432997|NCT04685915|Acalabrutinib|acalabrutinib|mesh-list
102432998|NCT04685915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102432999|NCT04399187|Sodium Hypochlorite|sodium hypochlorite|mesh-list
102433000|NCT04399187|Eusol|eusol|mesh-list
102433001|NCT04399187|Disinfectants|disinfectants|mesh-ancestor
102433002|NCT04399187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102433003|NCT03239561|JNJ-64326067|jnj-64326067|mesh-list
102433004|NCT03239561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102433005|NCT03239561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433006|NCT04746365|Hydroxychloroquine|hydroxychloroquine|mesh-list
102433007|NCT04746365|Ivermectin|ivermectin|mesh-list
102433008|NCT04746365|Antimalarials|antimalarials|mesh-ancestor
102433009|NCT04746365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102433010|NCT04746365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102433011|NCT04746365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102433012|NCT04746365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102433013|NCT04746365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433014|NCT04746365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102433015|NCT04399343|Dexmedetomidine|dexmedetomidine|mesh-list
102433016|NCT04399343|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102433017|NCT04399343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102433018|NCT04399343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433019|NCT04399343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102433020|NCT04399343|Analgesics|analgesics|mesh-ancestor
102433021|NCT04399343|Sensory System Agents|sensory system agents|mesh-ancestor
102433022|NCT04399343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102433023|NCT04399343|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102433024|NCT04399343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102433025|NCT04399343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102433026|NCT04399343|Adrenergic Agents|adrenergic agents|mesh-ancestor
102433027|NCT04399343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102433028|NCT04399343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433029|NCT03676049|Cannabidiol|cannabidiol|mesh-list
102433030|NCT03676049|Anticonvulsants|anticonvulsants|mesh-ancestor
102433031|NCT03233633|Cannabidiol|cannabidiol|mesh-list
102433032|NCT03233633|Anticonvulsants|anticonvulsants|mesh-ancestor
102433033|NCT02984345|Caseins|caseins|mesh-list
102433034|NCT02984345|Chelating Agents|chelating agents|mesh-ancestor
102433035|NCT02984345|Sequestering Agents|sequestering agents|mesh-ancestor
102433036|NCT02984345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433037|NCT01232205|Micronutrients|micronutrients|mesh-list
102433038|NCT01232205|Trace Elements|trace elements|mesh-list
102433039|NCT01232205|Antioxidants|antioxidants|mesh-list
102433040|NCT01232205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433041|NCT01232205|Protective Agents|protective agents|mesh-ancestor
102433042|NCT01232205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433043|NCT04584125|Riboflavin|riboflavin|mesh-list
102433044|NCT04584125|Flavin Mononucleotide|flavin mononucleotide|mesh-list
102433045|NCT04584125|Dextrans|dextrans|mesh-list
102433046|NCT04584125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102433047|NCT04584125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102433048|NCT04584125|Vitamin B Complex|vitamin b complex|mesh-ancestor
102433049|NCT04584125|Vitamins|vitamins|mesh-ancestor
102433050|NCT04584125|Micronutrients|micronutrients|mesh-ancestor
102433051|NCT04584125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433052|NCT04584125|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102433053|NCT04584125|Dermatologic Agents|dermatologic agents|mesh-ancestor
102433054|NCT04584125|Anticoagulants|anticoagulants|mesh-ancestor
102433055|NCT04584125|Plasma Substitutes|plasma substitutes|mesh-ancestor
102433056|NCT04584125|Blood Substitutes|blood substitutes|mesh-ancestor
102433057|NCT04348409|Nitazoxanide|nitazoxanide|mesh-list
102433058|NCT04348409|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102433059|NCT04348409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102433060|NCT01158885|Cytarabine|cytarabine|mesh-list
102433061|NCT01158885|Methotrexate|methotrexate|mesh-list
102433062|NCT01158885|Clofarabine|clofarabine|mesh-list
102433063|NCT01158885|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102433064|NCT01158885|Abortifacient Agents|abortifacient agents|mesh-ancestor
102433065|NCT01158885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102433066|NCT01158885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433067|NCT01158885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102433068|NCT01158885|Antimetabolites|antimetabolites|mesh-ancestor
102433069|NCT01158885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433070|NCT01158885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102433071|NCT01158885|Dermatologic Agents|dermatologic agents|mesh-ancestor
102433072|NCT01158885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102433073|NCT01158885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102433074|NCT01158885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102433075|NCT01158885|Immunologic Factors|immunologic factors|mesh-ancestor
102433076|NCT01158885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102433077|NCT01158885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102433078|NCT01158885|Antiviral Agents|antiviral agents|mesh-ancestor
102433079|NCT01158885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102433080|NCT01232829|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
102433081|NCT01232829|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
102433082|NCT01232829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102433083|NCT01232829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433084|NCT01233921|Mitogens|mitogens|mesh-list
102433085|NCT01233921|Mitosis Modulators|mitosis modulators|mesh-ancestor
102433086|NCT01233921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433087|NCT03226301|Venetoclax|venetoclax|mesh-list
102433088|NCT03226301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102433089|NCT01236105|Charcoal|charcoal|mesh-list
102433090|NCT01236105|Antidotes|antidotes|mesh-ancestor
102433091|NCT01236105|Protective Agents|protective agents|mesh-ancestor
102433092|NCT01236105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433093|NCT04533347|Tafenoquine|tafenoquine|mesh-list
102433094|NCT04533347|Antimalarials|antimalarials|mesh-ancestor
102433095|NCT04533347|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102433096|NCT04533347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102433097|NCT04533347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102433098|NCT01160445|Aldesleukin|aldesleukin|mesh-list
102433099|NCT01160445|Zanolimumab|zanolimumab|mesh-list
102433100|NCT01160445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102433101|NCT01160445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102433102|NCT01160445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102433103|NCT01160445|Antiviral Agents|antiviral agents|mesh-ancestor
102433104|NCT01160445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102433105|NCT01160445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102433106|NCT01237041|Niacin|niacin|mesh-list
102433107|NCT01237041|Niacinamide|niacinamide|mesh-list
102433108|NCT01237041|Nicotinic Acids|nicotinic acids|mesh-list
102433109|NCT01237041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102433110|NCT01237041|Antimetabolites|antimetabolites|mesh-ancestor
102433111|NCT01237041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433112|NCT01237041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102433113|NCT01237041|Vasodilator Agents|vasodilator agents|mesh-ancestor
102433114|NCT01237041|Vitamin B Complex|vitamin b complex|mesh-ancestor
102433115|NCT01237041|Vitamins|vitamins|mesh-ancestor
102433116|NCT01237041|Micronutrients|micronutrients|mesh-ancestor
102433117|NCT01237041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433118|NCT01237197|Exenatide|exenatide|mesh-list
102433119|NCT01237197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102433120|NCT01237197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433121|NCT01237197|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102433122|NCT01237197|Incretins|incretins|mesh-ancestor
102433123|NCT01237197|Hormones|hormones|mesh-ancestor
102433124|NCT01237197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102433125|NCT01237353|Rabeprazole|rabeprazole|mesh-list
102433126|NCT01237353|Betaine|betaine|mesh-list
102433127|NCT01237353|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102433128|NCT01237353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102433129|NCT01237353|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102433130|NCT01237353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102433131|NCT01237353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433132|NCT01237353|Lipotropic Agents|lipotropic agents|mesh-ancestor
102433133|NCT01237353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102433134|NCT01237353|Antimetabolites|antimetabolites|mesh-ancestor
102433135|NCT01237353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102433136|NCT04410341|Vildagliptin|vildagliptin|mesh-list
102433137|NCT04410341|Escitalopram|escitalopram|mesh-list
102433138|NCT04410341|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102433139|NCT04410341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102433140|NCT04410341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102433141|NCT04410341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433142|NCT04410341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102433143|NCT04410341|Serotonin Agents|serotonin agents|mesh-ancestor
102433144|NCT04410341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433145|NCT04410341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102433146|NCT04410341|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102433147|NCT04410341|Protease Inhibitors|protease inhibitors|mesh-ancestor
102433148|NCT04410341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102433149|NCT03010761|Moclobemide|moclobemide|mesh-list
102433150|NCT03010761|Escitalopram|escitalopram|mesh-list
102433151|NCT03010761|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102433152|NCT03010761|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102433153|NCT03010761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102433154|NCT03010761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433155|NCT03010761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102433156|NCT03010761|Serotonin Agents|serotonin agents|mesh-ancestor
102433157|NCT03010761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433158|NCT03010761|Antidepressive Agents|antidepressive agents|mesh-ancestor
102433159|NCT03010761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102433160|NCT03010761|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102433161|NCT03010761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102433162|NCT01243593|Anesthetics|anesthetics|mesh-list
102433163|NCT01243593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102433164|NCT01243593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433165|NCT04362761|Ivacaftor|ivacaftor|mesh-list
102433166|NCT04362761|Elexacaftor|elexacaftor|mesh-list
102433167|NCT04362761|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102433168|NCT04362761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102433169|NCT04362761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433170|NCT01162005|Tacrolimus|tacrolimus|mesh-list
102433171|NCT01162005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102433172|NCT01162005|Immunologic Factors|immunologic factors|mesh-ancestor
102433173|NCT01162005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433174|NCT01162005|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102433175|NCT01162005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102433176|NCT01162005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433177|NCT04596995|Rozanolixizumab|rozanolixizumab|mesh-list
102433178|NCT04596995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102433179|NCT04596995|Immunologic Factors|immunologic factors|mesh-ancestor
102433180|NCT04596995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433181|NCT04354649|Hydroxychloroquine|hydroxychloroquine|mesh-list
102433182|NCT04354649|Antimalarials|antimalarials|mesh-ancestor
102433183|NCT04354649|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102433184|NCT04354649|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102433185|NCT04354649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102433186|NCT04354649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102433187|NCT04354649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433188|NCT04354649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102433189|NCT01244451|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102433191|NCT01244451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102433192|NCT01244451|Alkylating Agents|alkylating agents|mesh-ancestor
102433193|NCT01244451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433194|NCT01244451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102433195|NCT01246401|Naltrexone|naltrexone|mesh-list
102433196|NCT01246401|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102433197|NCT01246401|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102433198|NCT01246401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433199|NCT01246401|Sensory System Agents|sensory system agents|mesh-ancestor
102433200|NCT01246401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102433201|NCT05627375|Anticoagulants|anticoagulants|mesh-list
102433202|NCT01281501|Scopolamine|scopolamine|mesh-list
102433203|NCT01281501|Pantoprazole|pantoprazole|mesh-list
102433204|NCT01281501|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
102433205|NCT01281501|Antacids|antacids|mesh-list
102433206|NCT01281501|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102433207|NCT01281501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102433208|NCT01281501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102433209|NCT01281501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102433210|NCT01281501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433211|NCT01281501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102433212|NCT01281501|Antiemetics|antiemetics|mesh-ancestor
102433213|NCT01281501|Autonomic Agents|autonomic agents|mesh-ancestor
102433214|NCT01281501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102433215|NCT01281501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433216|NCT01281501|Mydriatics|mydriatics|mesh-ancestor
102433217|NCT01281501|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102433218|NCT01281501|Cholinergic Agents|cholinergic agents|mesh-ancestor
102433219|NCT01281501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102433220|NCT01281501|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102433221|NCT01281501|Parasympatholytics|parasympatholytics|mesh-ancestor
102433222|NCT03353831|Bevacizumab|bevacizumab|mesh-list
102433223|NCT03353831|Atezolizumab|atezolizumab|mesh-list
102433224|NCT03353831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102433225|NCT03353831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102433226|NCT03353831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102433227|NCT03353831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102433228|NCT03353831|Growth Substances|growth substances|mesh-ancestor
102433229|NCT03353831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433230|NCT03353831|Growth Inhibitors|growth inhibitors|mesh-ancestor
102063713|NCT02182544|Epinastine|epinastine|mesh-list
102433231|NCT03353831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102433232|NCT03353831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433233|NCT01246713|Acetaminophen|acetaminophen|mesh-list
102433234|NCT01246713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102433235|NCT01246713|Analgesics|analgesics|mesh-ancestor
102433236|NCT01246713|Sensory System Agents|sensory system agents|mesh-ancestor
102433237|NCT01246713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102433238|NCT01246713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433239|NCT01246713|Antipyretics|antipyretics|mesh-ancestor
102433240|NCT01246791|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102433241|NCT01246791|Norethindrone|norethindrone|mesh-list
102433242|NCT01246791|Norinyl|norinyl|mesh-list
102433243|NCT01246791|Estradiol|estradiol|mesh-list
102433244|NCT01246791|Estrogens|estrogens|mesh-ancestor
102433245|NCT01246791|Hormones|hormones|mesh-ancestor
102433246|NCT01246791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102433247|NCT01246791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433248|NCT01246791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102433249|NCT01246791|Contraceptive Agents|contraceptive agents|mesh-ancestor
102433250|NCT01246791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102433251|NCT01246791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102433252|NCT01246791|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102433253|NCT01246791|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102433254|NCT01246791|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102433255|NCT01246791|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102433256|NCT04319081|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
102433257|NCT04319081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102433258|NCT04319081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102433259|NCT04319081|Antimetabolites|antimetabolites|mesh-ancestor
102433260|NCT04319081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433261|NCT04319081|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102433262|NCT04319081|Protease Inhibitors|protease inhibitors|mesh-ancestor
102433263|NCT04319081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102433264|NCT04319081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102433265|NCT05345639|Ropivacaine|ropivacaine|mesh-list
102433266|NCT05345639|Anesthetics|anesthetics|mesh-ancestor
102433267|NCT05345639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102433268|NCT05345639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433269|NCT05345639|Anesthetics, Local|anesthetics, local|mesh-ancestor
102433270|NCT05345639|Sensory System Agents|sensory system agents|mesh-ancestor
102433271|NCT05345639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102433273|NCT04303325|Antidepressive Agents|antidepressive agents|mesh-ancestor
102433274|NCT04303325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102433275|NCT04248335|Midazolam|midazolam|mesh-list
102433276|NCT04248335|Pantoprazole|pantoprazole|mesh-list
102433277|NCT04248335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102433278|NCT04248335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102433279|NCT04248335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102433280|NCT04248335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433281|NCT04248335|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102433282|NCT04248335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102433283|NCT04248335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102433284|NCT04248335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102433285|NCT04248335|Anesthetics, General|anesthetics, general|mesh-ancestor
102433286|NCT04248335|Anesthetics|anesthetics|mesh-ancestor
102433287|NCT04248335|GABA Modulators|gaba modulators|mesh-ancestor
102433288|NCT04248335|GABA Agents|gaba agents|mesh-ancestor
102433289|NCT04248335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102433290|NCT04248335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433291|NCT04248335|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102433292|NCT04248335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102433293|NCT04248335|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102433294|NCT04248335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102433295|NCT04746209|Blinatumomab|blinatumomab|mesh-list
102433296|NCT04746209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102433297|NCT04176419|Acetaminophen|acetaminophen|mesh-list
102433298|NCT04176419|Celecoxib|celecoxib|mesh-list
102433299|NCT04176419|Lidocaine|lidocaine|mesh-list
102433300|NCT04176419|Ketamine|ketamine|mesh-list
102433301|NCT04176419|Gabapentin|gabapentin|mesh-list
102433302|NCT04176419|Anesthetics, Local|anesthetics, local|mesh-ancestor
102433303|NCT04176419|Anesthetics|anesthetics|mesh-ancestor
102433304|NCT04176419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102433305|NCT04176419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433306|NCT04176419|Sensory System Agents|sensory system agents|mesh-ancestor
102433307|NCT04176419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102433308|NCT04176419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102433309|NCT04176419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102433310|NCT04176419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102433311|NCT04176419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102433312|NCT04176419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433313|NCT04176419|Analgesics|analgesics|mesh-ancestor
102433314|NCT04176419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102433315|NCT04176419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102433316|NCT04176419|Anesthetics, General|anesthetics, general|mesh-ancestor
102433317|NCT04176419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102433318|NCT04176419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102433319|NCT04176419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102433320|NCT04176419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102433321|NCT04176419|Antipyretics|antipyretics|mesh-ancestor
102433322|NCT04176419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102433323|NCT04176419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102433324|NCT04176419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102433325|NCT04176419|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102433326|NCT04176419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102433327|NCT04176419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102433328|NCT04176419|Anticonvulsants|anticonvulsants|mesh-ancestor
102433329|NCT04176419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102433330|NCT04176419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102433331|NCT04176419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102433332|NCT04176419|Antimanic Agents|antimanic agents|mesh-ancestor
102433333|NCT04168931|Trastuzumab|trastuzumab|mesh-list
102433334|NCT04168931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102433335|NCT04168931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102433336|NCT03211949|Mepivacaine|mepivacaine|mesh-list
102433337|NCT03211949|Anesthetics, Local|anesthetics, local|mesh-ancestor
102433338|NCT03211949|Anesthetics|anesthetics|mesh-ancestor
102433339|NCT03211949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102433340|NCT03211949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433341|NCT03211949|Sensory System Agents|sensory system agents|mesh-ancestor
102433342|NCT03211949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102433343|NCT01285635|Docetaxel|docetaxel|mesh-list
102433344|NCT01285635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102433345|NCT01285635|Tubulin Modulators|tubulin modulators|mesh-ancestor
102433346|NCT01285635|Antimitotic Agents|antimitotic agents|mesh-ancestor
102433347|NCT01285635|Mitosis Modulators|mitosis modulators|mesh-ancestor
102433348|NCT01285635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433349|NCT01286259|Disulfiram|disulfiram|mesh-list
102433350|NCT01286259|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102433351|NCT01286259|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
102433352|NCT01286259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102433353|NCT01286259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433354|NCT01286805|Bupivacaine|bupivacaine|mesh-list
102433355|NCT01286805|Anesthetics, Local|anesthetics, local|mesh-ancestor
102433356|NCT01286805|Anesthetics|anesthetics|mesh-ancestor
102433357|NCT01286805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102433358|NCT01286805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433359|NCT01286805|Sensory System Agents|sensory system agents|mesh-ancestor
102433360|NCT01286805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102433361|NCT01288521|Ketoconazole|ketoconazole|mesh-list
102433362|NCT01288521|Tacrolimus|tacrolimus|mesh-list
102433363|NCT01288521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102433364|NCT01288521|Immunologic Factors|immunologic factors|mesh-ancestor
102433365|NCT01288521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433366|NCT01288521|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102433367|NCT01288521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102433368|NCT01288521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433369|NCT01288521|Antifungal Agents|antifungal agents|mesh-ancestor
102433370|NCT01288521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102433371|NCT01288521|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102433372|NCT01288521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102433373|NCT01288521|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102433374|NCT01288521|Hormone Antagonists|hormone antagonists|mesh-ancestor
102433375|NCT01288521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102433376|NCT01288521|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102433377|NCT00632749|Cytarabine|cytarabine|mesh-list
102433378|NCT00632749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102433379|NCT00632749|Antimetabolites|antimetabolites|mesh-ancestor
102433380|NCT00632749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433381|NCT00632749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102433382|NCT00632749|Antiviral Agents|antiviral agents|mesh-ancestor
102433383|NCT00632749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102433384|NCT00632749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102433385|NCT00632749|Immunologic Factors|immunologic factors|mesh-ancestor
102433386|NCT00632749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433387|NCT01289067|Satraplatin|satraplatin|mesh-list
102433388|NCT01289067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102433389|NCT00632359|Lenalidomide|lenalidomide|mesh-list
102433390|NCT00632359|Immunologic Factors|immunologic factors|mesh-ancestor
102433391|NCT00632359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433392|NCT00632359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102433393|NCT00632359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102433394|NCT00632359|Growth Substances|growth substances|mesh-ancestor
102433395|NCT00632359|Growth Inhibitors|growth inhibitors|mesh-ancestor
102433396|NCT00632359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102433397|NCT03954899|Melatonin|melatonin|mesh-list
102433398|NCT03954899|Antioxidants|antioxidants|mesh-ancestor
102433399|NCT03954899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433400|NCT03954899|Protective Agents|protective agents|mesh-ancestor
102433401|NCT03954899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245072|NCT04965051|Insulin|insulin|mesh-list
102433402|NCT03954899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102433403|NCT03934307|Irbesartan|irbesartan|mesh-list
102433404|NCT03934307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102433405|NCT03934307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102433406|NCT03934307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102433407|NCT03934307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433408|NCT03924635|Budesonide|budesonide|mesh-list
102433409|NCT03924635|Albuterol|albuterol|mesh-list
102433410|NCT03924635|Formoterol Fumarate|formoterol fumarate|mesh-list
102433411|NCT03924635|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
102433412|NCT03924635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102433413|NCT03924635|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102433414|NCT03924635|Autonomic Agents|autonomic agents|mesh-ancestor
102433415|NCT03924635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102433416|NCT03924635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433417|NCT03924635|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102433418|NCT03924635|Respiratory System Agents|respiratory system agents|mesh-ancestor
102433419|NCT03924635|Glucocorticoids|glucocorticoids|mesh-ancestor
102433420|NCT03924635|Hormones|hormones|mesh-ancestor
102433421|NCT03924635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102433422|NCT03924635|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102433423|NCT03924635|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102433424|NCT03924635|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102433425|NCT03924635|Adrenergic Agents|adrenergic agents|mesh-ancestor
102433426|NCT03924635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102433427|NCT03924635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433428|NCT03924635|Tocolytic Agents|tocolytic agents|mesh-ancestor
102433429|NCT03924635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102433430|NCT04398251|Febuxostat|febuxostat|mesh-list
102433431|NCT04398251|Gout Suppressants|gout suppressants|mesh-ancestor
102433432|NCT04398251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102433433|NCT00632203|Temozolomide|temozolomide|mesh-list
102433434|NCT00632203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102433435|NCT00632203|Alkylating Agents|alkylating agents|mesh-ancestor
102433436|NCT00632203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433437|NCT00632203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102433438|NCT01289457|Cytarabine|cytarabine|mesh-list
102433439|NCT01289457|Fludarabine|fludarabine|mesh-list
102433440|NCT01289457|Idarubicin|idarubicin|mesh-list
102433441|NCT01289457|Clofarabine|clofarabine|mesh-list
102433442|NCT01289457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102433443|NCT01289457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102433444|NCT01289457|Antimetabolites|antimetabolites|mesh-ancestor
102433445|NCT01289457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433446|NCT01289457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102433447|NCT01289457|Immunologic Factors|immunologic factors|mesh-ancestor
102433448|NCT01289457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433449|NCT01289457|Antiviral Agents|antiviral agents|mesh-ancestor
102433450|NCT01289457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102433451|NCT01289457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102433452|NCT01289457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102433453|NCT01289457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102433454|NCT01289457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102433455|NCT03830333|Metronidazole|metronidazole|mesh-list
102433456|NCT03830333|Meropenem|meropenem|mesh-list
102433457|NCT03830333|Tazobactam|tazobactam|mesh-list
102433458|NCT03830333|Ceftolozane|ceftolozane|mesh-list
102433459|NCT03830333|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
102433460|NCT03830333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102433461|NCT03830333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102433462|NCT03830333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102433463|NCT03830333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102433464|NCT03830333|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102433465|NCT03830333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102433466|NCT03830333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433467|NCT03830333|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102433468|NCT01251315|Acetylcysteine|acetylcysteine|mesh-list
102433469|NCT01251315|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102433470|NCT01251315|Antiviral Agents|antiviral agents|mesh-ancestor
102433471|NCT01251315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102433472|NCT01251315|Expectorants|expectorants|mesh-ancestor
102433473|NCT01251315|Respiratory System Agents|respiratory system agents|mesh-ancestor
102433474|NCT01251315|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102433475|NCT01251315|Antioxidants|antioxidants|mesh-ancestor
102433476|NCT01251315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433477|NCT01251315|Protective Agents|protective agents|mesh-ancestor
102433478|NCT01251315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433479|NCT01251315|Antidotes|antidotes|mesh-ancestor
102433480|NCT03810287|Domperidone|domperidone|mesh-list
102433481|NCT03810287|Antiemetics|antiemetics|mesh-ancestor
102433482|NCT03810287|Autonomic Agents|autonomic agents|mesh-ancestor
102433483|NCT03810287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102433484|NCT03810287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433485|NCT03810287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102433486|NCT03810287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102433487|NCT03810287|Dopamine Agents|dopamine agents|mesh-ancestor
102433488|NCT03810287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102433489|NCT03810287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433490|NCT03749057|Rivaroxaban|rivaroxaban|mesh-list
102433491|NCT03749057|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102433492|NCT03749057|Antithrombins|antithrombins|mesh-ancestor
102433493|NCT03749057|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102433494|NCT03749057|Protease Inhibitors|protease inhibitors|mesh-ancestor
102433495|NCT03749057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102433496|NCT03749057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433497|NCT03749057|Anticoagulants|anticoagulants|mesh-ancestor
102433498|NCT01290237|Vancomycin|vancomycin|mesh-list
102433499|NCT01290237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102063981|NCT02183480|Linagliptin|linagliptin|mesh-list
102433500|NCT01290237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102433501|NCT03613727|Ascorbic Acid|ascorbic acid|mesh-list
102433502|NCT03613727|Vitamins|vitamins|mesh-ancestor
102433503|NCT03613727|Micronutrients|micronutrients|mesh-ancestor
102433504|NCT03613727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433505|NCT03613727|Antioxidants|antioxidants|mesh-ancestor
102433506|NCT03613727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433507|NCT03613727|Protective Agents|protective agents|mesh-ancestor
102433508|NCT01251393|Biperiden|biperiden|mesh-list
102433509|NCT01251393|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102433510|NCT01251393|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102433511|NCT01251393|Parasympatholytics|parasympatholytics|mesh-ancestor
102433512|NCT01251393|Autonomic Agents|autonomic agents|mesh-ancestor
102433513|NCT01251393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102433514|NCT01251393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433515|NCT01251393|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102433516|NCT01251393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102433517|NCT01251393|Cholinergic Agents|cholinergic agents|mesh-ancestor
102433518|NCT01251393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102433519|NCT01251393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433520|NCT00631969|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
102433521|NCT00631969|Vasodilator Agents|vasodilator agents|mesh-ancestor
102433522|NCT00631969|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102433523|NCT00631969|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102433524|NCT00631969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102433525|NCT00631969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433526|NCT00631969|Urological Agents|urological agents|mesh-ancestor
102433527|NCT01255137|Axitinib|axitinib|mesh-list
102433528|NCT01255137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102433529|NCT01255137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102433530|NCT01255137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102433531|NCT01255137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433532|NCT01255449|Albuterol|albuterol|mesh-list
102433533|NCT01255449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102433534|NCT01255449|Autonomic Agents|autonomic agents|mesh-ancestor
102433535|NCT01255449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102433536|NCT01255449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433537|NCT01255449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102433538|NCT01255449|Respiratory System Agents|respiratory system agents|mesh-ancestor
102433539|NCT01255449|Tocolytic Agents|tocolytic agents|mesh-ancestor
102433540|NCT01255449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102433541|NCT01255449|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102433542|NCT01255449|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102433543|NCT01255449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102433544|NCT01255449|Adrenergic Agents|adrenergic agents|mesh-ancestor
102433545|NCT01255449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102433546|NCT01255449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433547|NCT00631657|Mirtazapine|mirtazapine|mesh-list
102433548|NCT00631657|Antidepressive Agents|antidepressive agents|mesh-ancestor
102433549|NCT00631657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102433550|NCT00631657|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102433551|NCT00631657|Histamine Antagonists|histamine antagonists|mesh-ancestor
102245221|NCT00700817|Incretins|incretins|mesh-ancestor
102433552|NCT00631657|Histamine Agents|histamine agents|mesh-ancestor
102433553|NCT00631657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102433554|NCT00631657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433555|NCT00631657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433556|NCT00631657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102433557|NCT00631657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102433558|NCT00631657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102433559|NCT00631657|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102433560|NCT00631657|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102433561|NCT00631657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102433562|NCT00631657|Adrenergic Agents|adrenergic agents|mesh-ancestor
102433563|NCT00631657|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102064045|NCT02184260|Analgesics|analgesics|mesh-ancestor
102433564|NCT00631657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102433565|NCT00631657|Serotonin Agents|serotonin agents|mesh-ancestor
102433566|NCT00631657|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102433567|NCT01257087|Insulin|insulin|mesh-list
102433568|NCT01257087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102433569|NCT01257087|Insulin Glargine|insulin glargine|mesh-list
102433570|NCT01257087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102433571|NCT01257087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433572|NCT00631189|Atorvastatin|atorvastatin|mesh-list
102433573|NCT00631189|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102433574|NCT00631189|Pravastatin|pravastatin|mesh-list
102433575|NCT00631189|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102433576|NCT00631189|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102433577|NCT00631189|Antimetabolites|antimetabolites|mesh-ancestor
102433578|NCT00631189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433579|NCT00631189|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102433580|NCT00631189|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102433581|NCT00631189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102433582|NCT00630877|Aspirin|aspirin|mesh-list
102433583|NCT00630877|Niacin|niacin|mesh-list
102433584|NCT00630877|Niacinamide|niacinamide|mesh-list
102433585|NCT00630877|Nicotinic Acids|nicotinic acids|mesh-list
102433586|NCT00630877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102433587|NCT00630877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102433588|NCT00630877|Analgesics|analgesics|mesh-ancestor
102433589|NCT00630877|Sensory System Agents|sensory system agents|mesh-ancestor
102433590|NCT00630877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102433591|NCT00630877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433592|NCT00630877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102433593|NCT00630877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102433594|NCT00630877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102433595|NCT00630877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102433596|NCT00630877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433597|NCT00630877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102433598|NCT00630877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102433599|NCT00630877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102433600|NCT00630877|Antipyretics|antipyretics|mesh-ancestor
102433601|NCT00630877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102433602|NCT00630877|Antimetabolites|antimetabolites|mesh-ancestor
102433603|NCT00630877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102433604|NCT00630877|Vasodilator Agents|vasodilator agents|mesh-ancestor
102433605|NCT00630877|Vitamin B Complex|vitamin b complex|mesh-ancestor
102433606|NCT00630877|Vitamins|vitamins|mesh-ancestor
102433607|NCT00630877|Micronutrients|micronutrients|mesh-ancestor
102433608|NCT04557163|Itraconazole|itraconazole|mesh-list
102433609|NCT04557163|Antifungal Agents|antifungal agents|mesh-ancestor
102433610|NCT04557163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102433611|NCT04557163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102433612|NCT04557163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102433613|NCT04557163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102433614|NCT04557163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433615|NCT04557163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102433616|NCT04557163|Hormone Antagonists|hormone antagonists|mesh-ancestor
102433617|NCT04557163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102433618|NCT04557163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433619|NCT04557163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102433620|NCT02915783|Everolimus|everolimus|mesh-list
102433621|NCT02915783|Lenvatinib|lenvatinib|mesh-list
102433622|NCT02915783|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102433623|NCT02915783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102433624|NCT02915783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102433625|NCT02915783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433626|NCT02915783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102433627|NCT02915783|Immunologic Factors|immunologic factors|mesh-ancestor
102433628|NCT02915783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433629|NCT02915783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102433630|NCT02736149|Ubenimex|ubenimex|mesh-list
102433631|NCT02736149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102433632|NCT02736149|Immunologic Factors|immunologic factors|mesh-ancestor
102433633|NCT02736149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433634|NCT02736149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102433635|NCT02736149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102433636|NCT02736149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102064111|NCT02181218|Gemcitabine|gemcitabine|mesh-list
102433637|NCT02736149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102433638|NCT02736149|Protease Inhibitors|protease inhibitors|mesh-ancestor
102433639|NCT02736149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102433640|NCT02736149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433641|NCT02736149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102433642|NCT02736149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102433643|NCT02736149|Antiviral Agents|antiviral agents|mesh-ancestor
102433644|NCT02307149|Ipilimumab|ipilimumab|mesh-list
102433645|NCT02307149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102433646|NCT02307149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102433647|NCT02307149|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102433648|NCT02307149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433649|NCT02134301|Oritavancin|oritavancin|mesh-list
102433650|NCT02134301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102433651|NCT02134301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102433652|NCT04397393|Midazolam|midazolam|mesh-list
102433653|NCT04397393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102433654|NCT04397393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102433655|NCT04397393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102433656|NCT04397393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433657|NCT04397393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102433658|NCT04397393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102433659|NCT04397393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102433660|NCT04397393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102433661|NCT04397393|Anesthetics, General|anesthetics, general|mesh-ancestor
102433662|NCT04397393|Anesthetics|anesthetics|mesh-ancestor
102433663|NCT04397393|GABA Modulators|gaba modulators|mesh-ancestor
102433664|NCT04397393|GABA Agents|gaba agents|mesh-ancestor
102433665|NCT04397393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102433666|NCT04397393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433667|NCT03168737|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
102433668|NCT03168737|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102433669|NCT03168737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433670|NCT01176461|Nivolumab|nivolumab|mesh-list
102433671|NCT01176461|Vaccines|vaccines|mesh-list
102433672|NCT01176461|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
102433673|NCT01176461|Immunologic Factors|immunologic factors|mesh-ancestor
102433674|NCT01176461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433675|NCT01176461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102433676|NCT01176461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102433677|NCT01176461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102433678|NCT01176461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433679|NCT01176461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102433680|NCT00630331|Vaccines|vaccines|mesh-list
102433681|NCT00630331|Immunologic Factors|immunologic factors|mesh-ancestor
102433682|NCT00630331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433683|NCT04555291|Ropivacaine|ropivacaine|mesh-list
102433684|NCT04555291|Anesthetics, Local|anesthetics, local|mesh-ancestor
102433685|NCT04555291|Anesthetics|anesthetics|mesh-ancestor
102433686|NCT04555291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102433687|NCT04555291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433688|NCT04555291|Sensory System Agents|sensory system agents|mesh-ancestor
102433689|NCT04555291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102433690|NCT04275115|Midazolam|midazolam|mesh-list
102433691|NCT04275115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102433692|NCT04275115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102433693|NCT04275115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102433694|NCT04275115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433695|NCT04275115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102433696|NCT04275115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102433697|NCT04275115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102433698|NCT04275115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102433699|NCT04275115|Anesthetics, General|anesthetics, general|mesh-ancestor
102433700|NCT04275115|Anesthetics|anesthetics|mesh-ancestor
102433701|NCT04275115|GABA Modulators|gaba modulators|mesh-ancestor
102433702|NCT04275115|GABA Agents|gaba agents|mesh-ancestor
102433703|NCT04275115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102433704|NCT04275115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433705|NCT00633997|Vildagliptin|vildagliptin|mesh-list
102433706|NCT00633997|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102433707|NCT00633997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433708|NCT00633997|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102433709|NCT00633997|Protease Inhibitors|protease inhibitors|mesh-ancestor
102433710|NCT00633997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102433711|NCT00633997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433712|NCT04559347|Bupivacaine|bupivacaine|mesh-list
102433713|NCT04559347|Ropivacaine|ropivacaine|mesh-list
102433714|NCT04559347|Anesthetics, Local|anesthetics, local|mesh-ancestor
102433715|NCT04559347|Anesthetics|anesthetics|mesh-ancestor
102433716|NCT04559347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102433717|NCT04559347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433718|NCT04559347|Sensory System Agents|sensory system agents|mesh-ancestor
102433719|NCT04559347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102433720|NCT00631111|Aspirin|aspirin|mesh-list
102433721|NCT00631111|Ibuprofen|ibuprofen|mesh-list
102433722|NCT00631111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433723|NCT00631111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102433724|NCT00631111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102433725|NCT00631111|Analgesics|analgesics|mesh-ancestor
102433726|NCT00631111|Sensory System Agents|sensory system agents|mesh-ancestor
102433727|NCT00631111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102433728|NCT00631111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102433729|NCT00631111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102433730|NCT00631111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102433731|NCT00631111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102433732|NCT00631111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433733|NCT00631111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102433734|NCT00631111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102433735|NCT00631111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102433736|NCT00631111|Antipyretics|antipyretics|mesh-ancestor
102433737|NCT00630799|Leuprolide|leuprolide|mesh-list
102433738|NCT00630799|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102433739|NCT00630799|Fertility Agents|fertility agents|mesh-ancestor
102433740|NCT00630799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102433741|NCT00630799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433742|NCT00630799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102433743|NCT00630799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102433744|NCT01925287|Curcumin|curcumin|mesh-list
102433745|NCT01925287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102433746|NCT01925287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102433747|NCT01925287|Analgesics|analgesics|mesh-ancestor
102433748|NCT01925287|Sensory System Agents|sensory system agents|mesh-ancestor
102433749|NCT01925287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102433750|NCT01925287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433751|NCT01925287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102433752|NCT01925287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102433753|NCT01925287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102433754|NCT01925287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102433755|NCT01925287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433756|NCT01924273|Talaporfin|talaporfin|mesh-list
102433757|NCT01924273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102433758|NCT01924273|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102433759|NCT01924273|Dermatologic Agents|dermatologic agents|mesh-ancestor
102433760|NCT00667121|Tamoxifen|tamoxifen|mesh-list
102433761|NCT00667121|Gabapentin|gabapentin|mesh-list
102433762|NCT00667121|Dexetimide|dexetimide|mesh-list
102433763|NCT00667121|Citalopram|citalopram|mesh-list
102433764|NCT00667121|Sertraline|sertraline|mesh-list
102433765|NCT00667121|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102433766|NCT00667121|Escitalopram|escitalopram|mesh-list
102433767|NCT00667121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433768|NCT00667121|Analgesics|analgesics|mesh-ancestor
102433769|NCT00667121|Sensory System Agents|sensory system agents|mesh-ancestor
102433770|NCT00667121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102433771|NCT00667121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433772|NCT00667121|Anticonvulsants|anticonvulsants|mesh-ancestor
102433773|NCT00667121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102433774|NCT00667121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102433775|NCT00667121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102433776|NCT00667121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102433777|NCT00667121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102245450|NCT04937907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102433778|NCT00667121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102433779|NCT00667121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102433780|NCT00667121|Antimanic Agents|antimanic agents|mesh-ancestor
102433781|NCT00667121|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102433782|NCT00667121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102433783|NCT00667121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102433784|NCT00667121|Serotonin Agents|serotonin agents|mesh-ancestor
102433785|NCT00667121|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102433786|NCT00667121|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102433787|NCT00667121|Parasympatholytics|parasympatholytics|mesh-ancestor
102433788|NCT00667121|Autonomic Agents|autonomic agents|mesh-ancestor
102433789|NCT00667121|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102433790|NCT00667121|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102433791|NCT00667121|Cholinergic Agents|cholinergic agents|mesh-ancestor
102433792|NCT00667121|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102433793|NCT00667121|Antidepressive Agents|antidepressive agents|mesh-ancestor
102433794|NCT00667121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102433795|NCT00667121|Hormone Antagonists|hormone antagonists|mesh-ancestor
102433796|NCT00667121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102433797|NCT00667121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102433798|NCT00667121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102433799|NCT00667121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102433800|NCT00667121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102433801|NCT00667121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102433802|NCT00667121|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102433803|NCT04828343|Rozanolixizumab|rozanolixizumab|mesh-list
102433804|NCT04828343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102433805|NCT04828343|Immunologic Factors|immunologic factors|mesh-ancestor
102433806|NCT04828343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433807|NCT04276649|Calcium Carbonate|calcium carbonate|mesh-list
102433808|NCT04276649|Antacids|antacids|mesh-ancestor
102433809|NCT04276649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433810|NCT04276649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102433811|NCT04553419|Cephalexin|cephalexin|mesh-list
102433812|NCT04553419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102433813|NCT04553419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102433814|NCT03097783|Lidocaine|lidocaine|mesh-list
102433815|NCT03097783|Anesthetics, Local|anesthetics, local|mesh-ancestor
102433816|NCT03097783|Anesthetics|anesthetics|mesh-ancestor
102433817|NCT03097783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102433818|NCT03097783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433819|NCT03097783|Sensory System Agents|sensory system agents|mesh-ancestor
102433820|NCT03097783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102433821|NCT03097783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102433822|NCT03097783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102433823|NCT03097783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102433824|NCT03097783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102433825|NCT03097783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433826|NCT04346407|Dronabinol|dronabinol|mesh-list
102433827|NCT04346407|Hallucinogens|hallucinogens|mesh-ancestor
102433828|NCT04346407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433829|NCT04346407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102433830|NCT04346407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102433831|NCT04346407|Analgesics|analgesics|mesh-ancestor
102433832|NCT04346407|Sensory System Agents|sensory system agents|mesh-ancestor
102433833|NCT04346407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102433834|NCT04346407|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102433835|NCT04346407|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102433836|NCT04346407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102433837|NCT04346407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433838|NCT04346407|Hormones|hormones|mesh-ancestor
102433839|NCT04346407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102433840|NCT04397549|Morphine|morphine|mesh-list
102433841|NCT04397549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102433842|NCT04397549|Narcotics|narcotics|mesh-ancestor
102433843|NCT04397549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102433844|NCT04397549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433845|NCT04397549|Analgesics|analgesics|mesh-ancestor
102433846|NCT04397549|Sensory System Agents|sensory system agents|mesh-ancestor
102433847|NCT04397549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102433848|NCT03080441|Midodrine|midodrine|mesh-list
102433849|NCT03080441|Sympathomimetics|sympathomimetics|mesh-ancestor
102433850|NCT03080441|Autonomic Agents|autonomic agents|mesh-ancestor
102433851|NCT03080441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102433852|NCT03080441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433853|NCT03080441|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102433854|NCT03080441|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102433855|NCT03080441|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102433856|NCT03080441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102433857|NCT03080441|Adrenergic Agents|adrenergic agents|mesh-ancestor
102433858|NCT03080441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102433859|NCT03080441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433860|NCT01925755|Rivaroxaban|rivaroxaban|mesh-list
102433861|NCT01925755|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102433862|NCT01925755|Antithrombins|antithrombins|mesh-ancestor
102433863|NCT01925755|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102433864|NCT01925755|Protease Inhibitors|protease inhibitors|mesh-ancestor
102433865|NCT01925755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102433866|NCT01925755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433867|NCT01925755|Anticoagulants|anticoagulants|mesh-ancestor
102433868|NCT01920919|Dexamethasone|dexamethasone|mesh-list
102433869|NCT01920919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102433870|NCT01920919|Antiemetics|antiemetics|mesh-ancestor
102433871|NCT01920919|Autonomic Agents|autonomic agents|mesh-ancestor
102433872|NCT01920919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102433873|NCT01920919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433874|NCT01920919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102433875|NCT01920919|Glucocorticoids|glucocorticoids|mesh-ancestor
102433876|NCT01920919|Hormones|hormones|mesh-ancestor
102433877|NCT01920919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102433878|NCT01920919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102433879|NCT01920919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102433880|NCT01925911|Midazolam|midazolam|mesh-list
102433881|NCT01925911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102433882|NCT01925911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102433883|NCT01925911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102433884|NCT01925911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433885|NCT01925911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102433886|NCT01925911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102433887|NCT01925911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102433888|NCT01925911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102433889|NCT01925911|Anesthetics, General|anesthetics, general|mesh-ancestor
102433890|NCT01925911|Anesthetics|anesthetics|mesh-ancestor
102433891|NCT01925911|GABA Modulators|gaba modulators|mesh-ancestor
102433892|NCT01925911|GABA Agents|gaba agents|mesh-ancestor
102433893|NCT01925911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102433894|NCT01925911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433895|NCT05241431|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102433896|NCT05241431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433897|NCT05241431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102433898|NCT05241431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433899|NCT01921231|Bupivacaine|bupivacaine|mesh-list
102433900|NCT01921231|Prilocaine|prilocaine|mesh-list
102433901|NCT01921231|Anesthetics, Local|anesthetics, local|mesh-ancestor
102433902|NCT01921231|Anesthetics|anesthetics|mesh-ancestor
102433903|NCT01921231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102433904|NCT01921231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433905|NCT01921231|Sensory System Agents|sensory system agents|mesh-ancestor
102433906|NCT01921231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102433907|NCT03056833|Paclitaxel|paclitaxel|mesh-list
102433908|NCT03056833|Carboplatin|carboplatin|mesh-list
102433909|NCT03056833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102433910|NCT03056833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102433911|NCT03056833|Tubulin Modulators|tubulin modulators|mesh-ancestor
102433912|NCT03056833|Antimitotic Agents|antimitotic agents|mesh-ancestor
102433913|NCT03056833|Mitosis Modulators|mitosis modulators|mesh-ancestor
102433914|NCT03056833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433915|NCT05240261|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102433916|NCT05240261|Antidepressive Agents|antidepressive agents|mesh-ancestor
102433917|NCT05240261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102433918|NCT05240261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102433919|NCT05240261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102433920|NCT05240261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102433921|NCT05240261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433922|NCT03148457|Rivaroxaban|rivaroxaban|mesh-list
102433923|NCT03148457|Apixaban|apixaban|mesh-list
102433924|NCT03148457|Edoxaban|edoxaban|mesh-list
102433925|NCT03148457|Dabigatran|dabigatran|mesh-list
102245602|NCT03241199|Imatinib Mesylate|imatinib mesylate|mesh-list
102433926|NCT03148457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102433927|NCT03148457|Antithrombins|antithrombins|mesh-ancestor
102433928|NCT03148457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102433929|NCT03148457|Protease Inhibitors|protease inhibitors|mesh-ancestor
102433930|NCT03148457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102433931|NCT03148457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433932|NCT03148457|Anticoagulants|anticoagulants|mesh-ancestor
102433933|NCT01926379|Isoniazid|isoniazid|mesh-list
102433934|NCT01926379|Antitubercular Agents|antitubercular agents|mesh-ancestor
102433935|NCT01926379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102433936|NCT01926379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102433937|NCT01926379|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102433938|NCT01926379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102433939|NCT01926379|Antimetabolites|antimetabolites|mesh-ancestor
102433940|NCT01926379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433941|NCT01926379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102433942|NCT05249309|Ketamine|ketamine|mesh-list
102433943|NCT05249309|Analgesics|analgesics|mesh-ancestor
102433944|NCT05249309|Sensory System Agents|sensory system agents|mesh-ancestor
102433945|NCT05249309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102433946|NCT05249309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433947|NCT05249309|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102433948|NCT05249309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102433949|NCT05249309|Anesthetics, General|anesthetics, general|mesh-ancestor
102433950|NCT05249309|Anesthetics|anesthetics|mesh-ancestor
102433951|NCT05249309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102433952|NCT05249309|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102433953|NCT05249309|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102433954|NCT05249309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102433955|NCT05249309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433956|NCT02393183|Selenium|selenium|mesh-list
102433957|NCT02393183|Antioxidants|antioxidants|mesh-list
102433958|NCT02393183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433959|NCT02393183|Protective Agents|protective agents|mesh-ancestor
102433960|NCT02393183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433961|NCT02393183|Trace Elements|trace elements|mesh-ancestor
102433962|NCT02393183|Micronutrients|micronutrients|mesh-ancestor
102433963|NCT05599295|Oritavancin|oritavancin|mesh-list
102433964|NCT05599295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102433965|NCT05599295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102433966|NCT03351647|Ustekinumab|ustekinumab|mesh-list
102433967|NCT03351647|Dermatologic Agents|dermatologic agents|mesh-ancestor
102433968|NCT02392637|Paclitaxel|paclitaxel|mesh-list
102433969|NCT02392637|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102433970|NCT02392637|Cisplatin|cisplatin|mesh-list
102433971|NCT02392637|Gemcitabine|gemcitabine|mesh-list
102433972|NCT02392637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102433973|NCT02392637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102433974|NCT02392637|Tubulin Modulators|tubulin modulators|mesh-ancestor
102433975|NCT02392637|Antimitotic Agents|antimitotic agents|mesh-ancestor
102433976|NCT02392637|Mitosis Modulators|mitosis modulators|mesh-ancestor
102433977|NCT02392637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064450|NCT02256722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102433978|NCT02392637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102433979|NCT02392637|Antimetabolites|antimetabolites|mesh-ancestor
102433980|NCT05600881|Methylphenidate|methylphenidate|mesh-list
102433981|NCT05600881|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102433982|NCT05600881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433983|NCT05600881|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102433984|NCT05600881|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102433985|NCT05600881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102433986|NCT05600881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102433987|NCT05600881|Dopamine Agents|dopamine agents|mesh-ancestor
102433988|NCT05600881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102433989|NCT01926769|Metformin|metformin|mesh-list
102433990|NCT01926769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102433991|NCT01926769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433992|NCT04394143|Mannitol|mannitol|mesh-list
102433993|NCT04394143|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102433994|NCT04394143|Diuretics|diuretics|mesh-ancestor
102433995|NCT04394143|Natriuretic Agents|natriuretic agents|mesh-ancestor
102433996|NCT04394143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102433997|NCT00639509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102433998|NCT00639509|Immunologic Factors|immunologic factors|mesh-ancestor
102433999|NCT00639509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434000|NCT01926847|Riociguat|riociguat|mesh-list
102434001|NCT01926847|Enzyme Activators|enzyme activators|mesh-ancestor
102434002|NCT01926847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434003|NCT05586815|Minocycline|minocycline|mesh-list
102434004|NCT05586815|Colistin|colistin|mesh-list
102434005|NCT05586815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102434006|NCT05586815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102434007|NCT05607901|Hydrocortisone|hydrocortisone|mesh-list
102434008|NCT05607901|Tacrolimus|tacrolimus|mesh-list
102434009|NCT05607901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102434010|NCT05607901|Immunologic Factors|immunologic factors|mesh-ancestor
102434011|NCT05607901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434012|NCT05607901|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102434013|NCT05607901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102434014|NCT05607901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434015|NCT05607901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102434016|NCT03133325|Lidocaine|lidocaine|mesh-list
102434017|NCT03133325|Anesthetics, Local|anesthetics, local|mesh-ancestor
102434018|NCT03133325|Anesthetics|anesthetics|mesh-ancestor
102434019|NCT03133325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102434020|NCT03133325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434021|NCT03133325|Sensory System Agents|sensory system agents|mesh-ancestor
102434022|NCT03133325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102434023|NCT03133325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102434024|NCT03133325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102434025|NCT03133325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102434026|NCT03133325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102434027|NCT03133325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434028|NCT00638963|Temozolomide|temozolomide|mesh-list
102434029|NCT00638963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102434030|NCT00638963|Alkylating Agents|alkylating agents|mesh-ancestor
102434031|NCT00638963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434032|NCT00638963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102434033|NCT04278677|Melatonin|melatonin|mesh-list
102434034|NCT04278677|Antioxidants|antioxidants|mesh-ancestor
102434035|NCT04278677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434036|NCT04278677|Protective Agents|protective agents|mesh-ancestor
102434037|NCT04278677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434038|NCT04278677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102434039|NCT00638027|Memantine|memantine|mesh-list
102064523|NCT02193698|Dexamethasone|dexamethasone|mesh-list
102434040|NCT00638027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102434041|NCT00638027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102434042|NCT00638027|Dopamine Agents|dopamine agents|mesh-ancestor
102434043|NCT00638027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102434044|NCT00638027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434045|NCT00638027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434046|NCT00638027|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102434047|NCT00638027|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102434048|NCT03342911|Paclitaxel|paclitaxel|mesh-list
102434049|NCT03342911|Carboplatin|carboplatin|mesh-list
102434050|NCT03342911|Nivolumab|nivolumab|mesh-list
102434051|NCT03342911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102434052|NCT03342911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102434053|NCT03342911|Tubulin Modulators|tubulin modulators|mesh-ancestor
102434054|NCT03342911|Antimitotic Agents|antimitotic agents|mesh-ancestor
102434055|NCT03342911|Mitosis Modulators|mitosis modulators|mesh-ancestor
102434056|NCT03342911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434057|NCT03342911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102434058|NCT03342911|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102434059|NCT05607199|Calcium|calcium|mesh-list
102434060|NCT05607199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102434061|NCT05607199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434062|NCT01927315|Fenofibrate|fenofibrate|mesh-list
102434063|NCT01927315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102434064|NCT01927315|Antimetabolites|antimetabolites|mesh-ancestor
102434065|NCT01927315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434066|NCT01927315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102434067|NCT00636155|Cyclophosphamide|cyclophosphamide|mesh-list
102434068|NCT00636155|Rituximab|rituximab|mesh-list
102434069|NCT00636155|Fludarabine|fludarabine|mesh-list
102434070|NCT00636155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102434071|NCT00636155|Immunologic Factors|immunologic factors|mesh-ancestor
102434072|NCT00636155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434073|NCT00636155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102434074|NCT00636155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102434075|NCT00636155|Alkylating Agents|alkylating agents|mesh-ancestor
102434076|NCT00636155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434077|NCT00636155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102434078|NCT00636155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102434079|NCT00636155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102434080|NCT00634907|Warfarin|warfarin|mesh-list
102434081|NCT00634907|Anticoagulants|anticoagulants|mesh-ancestor
102434082|NCT04124497|Dexamethasone|dexamethasone|mesh-list
102434083|NCT04124497|Daratumumab|daratumumab|mesh-list
102434084|NCT04124497|Pomalidomide|pomalidomide|mesh-list
102434085|NCT04124497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102434086|NCT04124497|Antiemetics|antiemetics|mesh-ancestor
102434087|NCT04124497|Autonomic Agents|autonomic agents|mesh-ancestor
102434088|NCT04124497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102434089|NCT04124497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434090|NCT04124497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102434091|NCT04124497|Glucocorticoids|glucocorticoids|mesh-ancestor
102434092|NCT04124497|Hormones|hormones|mesh-ancestor
102434093|NCT04124497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102434094|NCT04124497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102434095|NCT04124497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102434096|NCT04124497|Immunologic Factors|immunologic factors|mesh-ancestor
102434097|NCT04124497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102434098|NCT04124497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102434099|NCT04124497|Growth Substances|growth substances|mesh-ancestor
102434100|NCT04124497|Growth Inhibitors|growth inhibitors|mesh-ancestor
102434101|NCT04127851|Cyclosporine|cyclosporine|mesh-list
102434102|NCT04127851|Cyclosporins|cyclosporins|mesh-list
102434103|NCT04127851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102434104|NCT04127851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434105|NCT04127851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102434106|NCT04127851|Immunologic Factors|immunologic factors|mesh-ancestor
102434107|NCT04127851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434108|NCT04127851|Antifungal Agents|antifungal agents|mesh-ancestor
102434109|NCT04127851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102434110|NCT04127851|Dermatologic Agents|dermatologic agents|mesh-ancestor
102434111|NCT04127851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102434112|NCT04127851|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102434113|NCT04394533|Bupivacaine|bupivacaine|mesh-list
102434114|NCT04394533|Prilocaine|prilocaine|mesh-list
102434115|NCT04394533|Anesthetics, Local|anesthetics, local|mesh-ancestor
102434116|NCT04394533|Anesthetics|anesthetics|mesh-ancestor
102434117|NCT04394533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102434118|NCT04394533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434119|NCT04394533|Sensory System Agents|sensory system agents|mesh-ancestor
102434120|NCT04394533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102434121|NCT05602129|Heparin|heparin|mesh-list
102434122|NCT05602129|Calcium heparin|calcium heparin|mesh-list
102434123|NCT05602129|Anticoagulants|anticoagulants|mesh-ancestor
102434124|NCT05602129|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102434125|NCT05602129|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102434126|NCT05602129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434127|NCT05609929|Omeprazole|omeprazole|mesh-list
102434128|NCT05609929|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102434129|NCT05609929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102434130|NCT05609929|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102434131|NCT05609929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102434132|NCT05609929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434133|NCT01928563|Udenafil|udenafil|mesh-list
102434134|NCT01928563|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102434135|NCT01928563|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102434136|NCT01928563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102434137|NCT01928563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434138|NCT04129255|Octreotide|octreotide|mesh-list
102434139|NCT04129255|Somatostatin|somatostatin|mesh-list
102434140|NCT04129255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102434141|NCT04129255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102434142|NCT04129255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102434143|NCT04129255|Hormones|hormones|mesh-ancestor
102434144|NCT04129255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102434145|NCT04129255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434146|NCT03422731|Alovudine|alovudine|mesh-list
102434147|NCT03422731|Antiviral Agents|antiviral agents|mesh-ancestor
102434148|NCT03422731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102434149|NCT04129489|Cannabidiol|cannabidiol|mesh-list
102434150|NCT04129489|Anticonvulsants|anticonvulsants|mesh-ancestor
102434151|NCT04128787|Omeprazole|omeprazole|mesh-list
102434152|NCT04128787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102434153|NCT04128787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102434154|NCT04128787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102434155|NCT04128787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102434156|NCT04128787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434157|NCT04394377|Heparin|heparin|mesh-list
102434158|NCT04394377|Enoxaparin|enoxaparin|mesh-list
102434159|NCT04394377|Calcium heparin|calcium heparin|mesh-list
102434160|NCT04394377|Rivaroxaban|rivaroxaban|mesh-list
102434161|NCT04394377|Enoxaparin sodium|enoxaparin sodium|mesh-list
102434162|NCT04394377|Anticoagulants|anticoagulants|mesh-ancestor
102434163|NCT04394377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102434164|NCT04394377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102434165|NCT04394377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434166|NCT04394377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102434167|NCT04394377|Antithrombins|antithrombins|mesh-ancestor
102434168|NCT04394377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102434169|NCT04394377|Protease Inhibitors|protease inhibitors|mesh-ancestor
102434170|NCT04394377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102434171|NCT02984293|Atorvastatin|atorvastatin|mesh-list
102434172|NCT02984293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102434173|NCT02984293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102434174|NCT02984293|Antimetabolites|antimetabolites|mesh-ancestor
102434175|NCT02984293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434176|NCT02984293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102434177|NCT02984293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102434178|NCT02984293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102434179|NCT01929187|Amorolfine|amorolfine|mesh-list
102434180|NCT01929187|Antifungal Agents|antifungal agents|mesh-ancestor
102434181|NCT01929187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102434182|NCT00634751|Capecitabine|capecitabine|mesh-list
102434183|NCT00634751|Oxaliplatin|oxaliplatin|mesh-list
102434184|NCT00634751|Sorafenib|sorafenib|mesh-list
102434185|NCT00634751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102434186|NCT00634751|Antimetabolites|antimetabolites|mesh-ancestor
102434187|NCT00634751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434188|NCT00634751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102434189|NCT00634751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102434190|NCT00634751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102434191|NCT04396223|Methotrexate|methotrexate|mesh-list
102434192|NCT04396223|Avelumab|avelumab|mesh-list
102434193|NCT04396223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102434194|NCT04396223|Abortifacient Agents|abortifacient agents|mesh-ancestor
102434195|NCT04396223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102434196|NCT04396223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434197|NCT04396223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102434198|NCT04396223|Antimetabolites|antimetabolites|mesh-ancestor
102434199|NCT04396223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434200|NCT04396223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102434201|NCT04396223|Dermatologic Agents|dermatologic agents|mesh-ancestor
102434202|NCT04396223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102434203|NCT04396223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102434204|NCT04396223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102434205|NCT04396223|Immunologic Factors|immunologic factors|mesh-ancestor
102434206|NCT04396223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102434207|NCT04396223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102434208|NCT04396223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102434209|NCT04396067|Tretinoin|tretinoin|mesh-list
102434210|NCT04396067|Isotretinoin|isotretinoin|mesh-list
102434211|NCT04396067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102434212|NCT04396067|Keratolytic Agents|keratolytic agents|mesh-ancestor
102434213|NCT04396067|Dermatologic Agents|dermatologic agents|mesh-ancestor
102434214|NCT05608213|Lenvatinib|lenvatinib|mesh-list
102434215|NCT05608213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102434216|NCT05608213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102434217|NCT05608213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102434218|NCT05608213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434219|NCT04124107|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102434220|NCT04124107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102434221|NCT04124107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434222|NCT03015259|Budesonide|budesonide|mesh-list
102434223|NCT03015259|Formoterol Fumarate|formoterol fumarate|mesh-list
102434224|NCT03015259|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
102434225|NCT03015259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102434226|NCT03015259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102434227|NCT03015259|Autonomic Agents|autonomic agents|mesh-ancestor
102434228|NCT03015259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102434229|NCT03015259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434230|NCT03015259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102434231|NCT03015259|Respiratory System Agents|respiratory system agents|mesh-ancestor
102434232|NCT03015259|Glucocorticoids|glucocorticoids|mesh-ancestor
102434233|NCT03015259|Hormones|hormones|mesh-ancestor
102434234|NCT03015259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102434235|NCT03015259|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102434236|NCT03015259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102434237|NCT03015259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102434238|NCT03015259|Adrenergic Agents|adrenergic agents|mesh-ancestor
102434239|NCT03015259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102434240|NCT03015259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434241|NCT03236545|Estradiol|estradiol|mesh-list
102434242|NCT03236545|Estrogens|estrogens|mesh-list
102434243|NCT03236545|Hormones|hormones|mesh-ancestor
102434244|NCT03236545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102434245|NCT03236545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434246|NCT04126993|Apatinib|apatinib|mesh-list
102434247|NCT04126993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102434248|NCT04126993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102434249|NCT04126993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102434250|NCT04126993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434251|NCT04127227|Gemcitabine|gemcitabine|mesh-list
102434252|NCT04127227|Oxaliplatin|oxaliplatin|mesh-list
102434253|NCT04127227|Pegaspargase|pegaspargase|mesh-list
102434254|NCT04127227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102434255|NCT04127227|Antimetabolites|antimetabolites|mesh-ancestor
102434256|NCT04127227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434257|NCT04127227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102434258|NCT04274803|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102434259|NCT04274803|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102434260|NCT04274803|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102434261|NCT04274803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102434262|NCT03292861|Mycophenolic Acid|mycophenolic acid|mesh-list
102434263|NCT03292861|Sirolimus|sirolimus|mesh-list
102434264|NCT03292861|Tacrolimus|tacrolimus|mesh-list
102434265|NCT03292861|Thymoglobulin|thymoglobulin|mesh-list
102434266|NCT03292861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102434267|NCT03292861|Immunologic Factors|immunologic factors|mesh-ancestor
102434268|NCT03292861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434269|NCT03292861|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102434270|NCT03292861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102434271|NCT03292861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434272|NCT03292861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102434273|NCT03292861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102434274|NCT03292861|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102434275|NCT03292861|Antitubercular Agents|antitubercular agents|mesh-ancestor
102434276|NCT03292861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102434277|NCT03292861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102434278|NCT03292861|Antifungal Agents|antifungal agents|mesh-ancestor
102434279|NCT03828175|Anesthetics|anesthetics|mesh-list
102434280|NCT03828175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102434281|NCT03828175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434282|NCT04392973|Hydroxychloroquine|hydroxychloroquine|mesh-list
102434283|NCT04392973|Favipiravir|favipiravir|mesh-list
102434284|NCT04392973|Antimalarials|antimalarials|mesh-ancestor
102434285|NCT04392973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102434286|NCT04392973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102434287|NCT04392973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102434288|NCT04392973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102434289|NCT04392973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434290|NCT04392973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102434291|NCT04392973|Antiviral Agents|antiviral agents|mesh-ancestor
102434292|NCT03267277|Sodium thiosulfate|sodium thiosulfate|mesh-list
102434293|NCT03267277|Antidotes|antidotes|mesh-ancestor
102434294|NCT03267277|Protective Agents|protective agents|mesh-ancestor
102434295|NCT03267277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434296|NCT03267277|Antioxidants|antioxidants|mesh-ancestor
102434297|NCT03267277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434298|NCT03267277|Antitubercular Agents|antitubercular agents|mesh-ancestor
102434299|NCT03267277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102434300|NCT03267277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102434301|NCT03267277|Chelating Agents|chelating agents|mesh-ancestor
102434302|NCT03267277|Sequestering Agents|sequestering agents|mesh-ancestor
102434303|NCT00634049|Isavuconazole|isavuconazole|mesh-list
102434304|NCT00634049|Antifungal Agents|antifungal agents|mesh-ancestor
102434305|NCT00634049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102434307|NCT04123249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
102434308|NCT04123249|Anesthetics|anesthetics|mesh-list
102434309|NCT04123249|Sevoflurane|sevoflurane|mesh-list
102434310|NCT04123249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102434311|NCT04123249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102434312|NCT04123249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434313|NCT04123249|Anesthetics, General|anesthetics, general|mesh-ancestor
102434314|NCT04123249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102434315|NCT04123249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102434316|NCT04758871|Progesterone|progesterone|mesh-list
102434317|NCT04758871|Dydrogesterone|dydrogesterone|mesh-list
102434318|NCT04758871|Progestins|progestins|mesh-ancestor
102434319|NCT04758871|Hormones|hormones|mesh-ancestor
102434320|NCT04758871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102434321|NCT04758871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434322|NCT03336203|Allopurinol|allopurinol|mesh-list
102434323|NCT03336203|Febuxostat|febuxostat|mesh-list
102434324|NCT03336203|Antimetabolites|antimetabolites|mesh-ancestor
102434325|NCT03336203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434326|NCT03336203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102434327|NCT03336203|Gout Suppressants|gout suppressants|mesh-ancestor
102434328|NCT03336203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102434329|NCT03336203|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102434330|NCT03336203|Antioxidants|antioxidants|mesh-ancestor
102434331|NCT03336203|Protective Agents|protective agents|mesh-ancestor
102434332|NCT03336203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434333|NCT04274413|Adrenergic Agents|adrenergic agents|mesh-list
102434334|NCT04274413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102434335|NCT04274413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434336|NCT04274413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434337|NCT04274257|Rituximab|rituximab|mesh-list
102434338|NCT04274257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102434339|NCT04274257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102434340|NCT04274257|Immunologic Factors|immunologic factors|mesh-ancestor
102434341|NCT04274257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434342|NCT04274257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102434343|NCT03128879|Venetoclax|venetoclax|mesh-list
102434344|NCT03128879|Acalabrutinib|acalabrutinib|mesh-list
102434345|NCT03128879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102434346|NCT03831815|Rocuronium|rocuronium|mesh-list
102434347|NCT03831815|Cisatracurium|cisatracurium|mesh-list
102434348|NCT03831815|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102434349|NCT03831815|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102434350|NCT03831815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102434351|NCT03831815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102434352|NCT03831815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434353|NCT00632099|Progesterone|progesterone|mesh-list
102434354|NCT00632099|Progestins|progestins|mesh-ancestor
102434355|NCT00632099|Hormones|hormones|mesh-ancestor
102434356|NCT00632099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102434357|NCT00632099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434358|NCT03827629|Naloxone|naloxone|mesh-list
102434359|NCT03827629|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102434360|NCT03827629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434361|NCT03827629|Sensory System Agents|sensory system agents|mesh-ancestor
102434362|NCT03827629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102434363|NCT00631475|Bosentan|bosentan|mesh-list
102434364|NCT00631475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102434365|NCT00631475|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102434366|NCT00631475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434367|NCT03826615|Gabapentin|gabapentin|mesh-list
102434368|NCT03826615|Analgesics|analgesics|mesh-ancestor
102434369|NCT03826615|Sensory System Agents|sensory system agents|mesh-ancestor
102434370|NCT03826615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102434371|NCT03826615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434372|NCT03826615|Anticonvulsants|anticonvulsants|mesh-ancestor
102434373|NCT03826615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102434374|NCT03826615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102434375|NCT03826615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102434376|NCT03826615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102246054|NCT03054207|Clopidogrel|clopidogrel|mesh-list
102434377|NCT03826615|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102434378|NCT03826615|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102434379|NCT03826615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102434380|NCT03826615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434381|NCT03826615|Antimanic Agents|antimanic agents|mesh-ancestor
102434382|NCT04124887|Calcium, Dietary|calcium, dietary|mesh-list
102434383|NCT04124887|Listerine|listerine|mesh-list
102434384|NCT04124887|Calcium|calcium|mesh-list
102434385|NCT04124887|Fluorides|fluorides|mesh-list
102434386|NCT04124887|Sodium Fluoride|sodium fluoride|mesh-list
102434387|NCT04124887|Caseins|caseins|mesh-list
102434388|NCT04124887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102434389|NCT04124887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434390|NCT04124887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102434391|NCT04124887|Cariostatic Agents|cariostatic agents|mesh-ancestor
102434392|NCT04124887|Protective Agents|protective agents|mesh-ancestor
102434393|NCT04124887|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102434394|NCT04124887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102434395|NCT04124887|Chelating Agents|chelating agents|mesh-ancestor
102434396|NCT04124887|Sequestering Agents|sequestering agents|mesh-ancestor
102434397|NCT04124887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434398|NCT04121767|Warfarin|warfarin|mesh-list
102434399|NCT04121767|Edoxaban|edoxaban|mesh-list
102434400|NCT04121767|Anticoagulants|anticoagulants|mesh-ancestor
102434401|NCT04121767|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102434402|NCT04121767|Antithrombins|antithrombins|mesh-ancestor
102434403|NCT04121767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102434404|NCT04121767|Protease Inhibitors|protease inhibitors|mesh-ancestor
102434405|NCT04121767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102434406|NCT04121767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434407|NCT04121689|Caseins|caseins|mesh-list
102434408|NCT04121689|Chelating Agents|chelating agents|mesh-ancestor
102434409|NCT04121689|Sequestering Agents|sequestering agents|mesh-ancestor
102434410|NCT04121689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434411|NCT03830827|Vortioxetine|vortioxetine|mesh-list
102434412|NCT03830827|Antidepressive Agents|antidepressive agents|mesh-ancestor
102434413|NCT03830827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102434414|NCT03830827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102434415|NCT03830827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102434416|NCT03830827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102434417|NCT03830827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434418|NCT03830827|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102434419|NCT03830827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102434420|NCT03830827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102434421|NCT03830827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434422|NCT03830827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102434423|NCT03830827|Serotonin Agents|serotonin agents|mesh-ancestor
102434424|NCT03830827|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102434425|NCT03830827|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102434426|NCT03830827|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102434427|NCT03830827|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102434428|NCT03098563|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
102434429|NCT03098563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434430|NCT03098485|Azithromycin|azithromycin|mesh-list
102434431|NCT03098485|Levofloxacin|levofloxacin|mesh-list
102434432|NCT03098485|Cefpodoxime|cefpodoxime|mesh-list
102434433|NCT03098485|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
102434434|NCT03098485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102434435|NCT03098485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102064905|NCT02058576|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102434436|NCT03098485|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102434437|NCT03098485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102434438|NCT03098485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102434439|NCT03098485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102434440|NCT03098485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434441|NCT03098485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102434442|NCT03098485|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102434443|NCT03098485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102434444|NCT04121533|Vitamin D|vitamin d|mesh-list
102434445|NCT04121533|Cholecalciferol|cholecalciferol|mesh-list
102434446|NCT04121533|Vitamins|vitamins|mesh-ancestor
102434447|NCT04121533|Micronutrients|micronutrients|mesh-ancestor
102434448|NCT04121533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434449|NCT04121533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102434450|NCT04121533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102434451|NCT03822169|Choline|choline|mesh-list
102434452|NCT03822169|Lipotropic Agents|lipotropic agents|mesh-ancestor
102434453|NCT03822169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102434454|NCT03822169|Antimetabolites|antimetabolites|mesh-ancestor
102434455|NCT03822169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434456|NCT03822169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102434457|NCT03822169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102434458|NCT03822169|Nootropic Agents|nootropic agents|mesh-ancestor
102434459|NCT03825601|Flumazenil|flumazenil|mesh-list
102434460|NCT03825601|Antidotes|antidotes|mesh-ancestor
102434461|NCT03825601|Protective Agents|protective agents|mesh-ancestor
102434462|NCT03825601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434463|NCT03825601|GABA Modulators|gaba modulators|mesh-ancestor
102434464|NCT03825601|GABA Agents|gaba agents|mesh-ancestor
102434465|NCT03825601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102434466|NCT03825601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434467|NCT03821701|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102434468|NCT03821701|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102434469|NCT03821701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434470|NCT03825445|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102434471|NCT03825445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102434472|NCT03825445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434473|NCT03064867|Rituximab|rituximab|mesh-list
102434474|NCT03064867|Carboplatin|carboplatin|mesh-list
102434475|NCT03064867|Etoposide|etoposide|mesh-list
102434476|NCT03064867|Venetoclax|venetoclax|mesh-list
102434477|NCT03064867|Ifosfamide|ifosfamide|mesh-list
102434478|NCT03064867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102434479|NCT03064867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102434480|NCT03064867|Immunologic Factors|immunologic factors|mesh-ancestor
102434481|NCT03064867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434482|NCT03064867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102434483|NCT03064867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102434484|NCT03064867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102434485|NCT03064867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102434486|NCT03064867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102434487|NCT03064867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434488|NCT03064867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102434489|NCT03064867|Alkylating Agents|alkylating agents|mesh-ancestor
102434490|NCT03824743|Plasma-lyte 148|plasma-lyte 148|mesh-list
102434491|NCT03824743|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102434492|NCT03824743|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102434493|NCT03824665|Fentanyl|fentanyl|mesh-list
102434494|NCT03824665|Nalbuphine|nalbuphine|mesh-list
102434495|NCT03824665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102434496|NCT03824665|Narcotics|narcotics|mesh-ancestor
102434497|NCT03824665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102434498|NCT03824665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434499|NCT03824665|Analgesics|analgesics|mesh-ancestor
102434500|NCT03824665|Sensory System Agents|sensory system agents|mesh-ancestor
102064964|NCT03675555|Serotonin Agents|serotonin agents|mesh-ancestor
102434501|NCT03824665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102434502|NCT03824665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102434503|NCT03824665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102434504|NCT03824665|Anesthetics, General|anesthetics, general|mesh-ancestor
102434505|NCT03824665|Anesthetics|anesthetics|mesh-ancestor
102434506|NCT04120831|Abatacept|abatacept|mesh-list
102434507|NCT04120831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102434508|NCT04120831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102434509|NCT04120831|Immunologic Factors|immunologic factors|mesh-ancestor
102434510|NCT04120831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434511|NCT04120831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102434512|NCT04120831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102434513|NCT04120831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434514|NCT04120831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102434515|NCT00631163|Deferasirox|deferasirox|mesh-list
102434516|NCT00631163|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102434517|NCT00631163|Chelating Agents|chelating agents|mesh-ancestor
102434518|NCT00631163|Sequestering Agents|sequestering agents|mesh-ancestor
102434519|NCT00631163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434520|NCT04120519|Thalidomide|thalidomide|mesh-list
102434521|NCT04120519|Dexamethasone|dexamethasone|mesh-list
102434522|NCT04120519|Cyclophosphamide|cyclophosphamide|mesh-list
102434523|NCT04120519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102434524|NCT04120519|Immunologic Factors|immunologic factors|mesh-ancestor
102434525|NCT04120519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434526|NCT04120519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102434527|NCT04120519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102434528|NCT04120519|Alkylating Agents|alkylating agents|mesh-ancestor
102434529|NCT04120519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434530|NCT04120519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102434531|NCT04120519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102434532|NCT04120519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102434533|NCT04120519|Antiemetics|antiemetics|mesh-ancestor
102434534|NCT04120519|Autonomic Agents|autonomic agents|mesh-ancestor
102434535|NCT04120519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102434536|NCT04120519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102434537|NCT04120519|Glucocorticoids|glucocorticoids|mesh-ancestor
102434538|NCT04120519|Hormones|hormones|mesh-ancestor
102434539|NCT04120519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102434540|NCT04120519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102434541|NCT04120519|Leprostatic Agents|leprostatic agents|mesh-ancestor
102434542|NCT04120519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102434543|NCT04120519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102434544|NCT04120519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102434545|NCT04120519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102434546|NCT04120519|Growth Substances|growth substances|mesh-ancestor
102434547|NCT04120519|Growth Inhibitors|growth inhibitors|mesh-ancestor
102434548|NCT00631007|Pioglitazone|pioglitazone|mesh-list
102434549|NCT00631007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102434550|NCT00631007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434551|NCT03014167|Albendazole|albendazole|mesh-list
102434552|NCT03014167|Anthelmintics|anthelmintics|mesh-ancestor
102434553|NCT03014167|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102434554|NCT03014167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102434555|NCT03014167|Anticestodal Agents|anticestodal agents|mesh-ancestor
102434556|NCT03014167|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102434557|NCT03014167|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102434558|NCT03014167|Tubulin Modulators|tubulin modulators|mesh-ancestor
102434559|NCT03014167|Antimitotic Agents|antimitotic agents|mesh-ancestor
102434560|NCT03014167|Mitosis Modulators|mitosis modulators|mesh-ancestor
102434561|NCT03014167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434562|NCT03014167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102434563|NCT00630539|Tamoxifen|tamoxifen|mesh-list
102434564|NCT00630539|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102434565|NCT00630539|Hormone Antagonists|hormone antagonists|mesh-ancestor
102434566|NCT00630539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102434567|NCT00630539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434568|NCT00630539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102434569|NCT00630539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102434570|NCT00630539|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102434571|NCT00630539|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102434572|NCT00630539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102434573|NCT00634829|Albuterol|albuterol|mesh-list
102434574|NCT00634829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102434575|NCT00634829|Autonomic Agents|autonomic agents|mesh-ancestor
102434576|NCT00634829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102434577|NCT00634829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434578|NCT00634829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102434579|NCT00634829|Respiratory System Agents|respiratory system agents|mesh-ancestor
102434580|NCT00634829|Tocolytic Agents|tocolytic agents|mesh-ancestor
102434581|NCT00634829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102434582|NCT00634829|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102434583|NCT00634829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102434584|NCT00634829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102434585|NCT00634829|Adrenergic Agents|adrenergic agents|mesh-ancestor
102434586|NCT00634829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102434587|NCT00634829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434588|NCT00634517|Albuterol|albuterol|mesh-list
102434589|NCT00634517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102434590|NCT00634517|Autonomic Agents|autonomic agents|mesh-ancestor
102434591|NCT00634517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102434592|NCT00634517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434593|NCT00634517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102434594|NCT00634517|Respiratory System Agents|respiratory system agents|mesh-ancestor
102434595|NCT00634517|Tocolytic Agents|tocolytic agents|mesh-ancestor
102434596|NCT00634517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102434597|NCT00634517|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102434598|NCT00634517|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102434599|NCT00634517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102434600|NCT00634517|Adrenergic Agents|adrenergic agents|mesh-ancestor
102434601|NCT00634517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102434602|NCT00634517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434603|NCT01920113|Dexmedetomidine|dexmedetomidine|mesh-list
102434604|NCT01920113|Remifentanil|remifentanil|mesh-list
102434605|NCT01920113|Propofol|propofol|mesh-list
102434606|NCT01920113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102434607|NCT01920113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102434608|NCT01920113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434609|NCT01920113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102434610|NCT01920113|Analgesics|analgesics|mesh-ancestor
102434611|NCT01920113|Sensory System Agents|sensory system agents|mesh-ancestor
102434612|NCT01920113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102434613|NCT01920113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102434614|NCT01920113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102434615|NCT01920113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102434616|NCT01920113|Adrenergic Agents|adrenergic agents|mesh-ancestor
102434617|NCT01920113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102434618|NCT01920113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434619|NCT01920113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102434620|NCT01920113|Anesthetics, General|anesthetics, general|mesh-ancestor
102434621|NCT01920113|Anesthetics|anesthetics|mesh-ancestor
102434622|NCT01920113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102434623|NCT01920113|Narcotics|narcotics|mesh-ancestor
102434624|NCT01920191|Poly ICLC|poly iclc|mesh-list
102434625|NCT01920191|Interferon Inducers|interferon inducers|mesh-ancestor
102434626|NCT01920191|Immunologic Factors|immunologic factors|mesh-ancestor
102065101|NCT02063334|Vitamin D|vitamin d|mesh-list
102434627|NCT01920191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434628|NCT01920269|Mitomycins|mitomycins|mesh-list
102434629|NCT01920269|Mitomycin|mitomycin|mesh-list
102434630|NCT01920269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102434631|NCT01920269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102434632|NCT01920269|Alkylating Agents|alkylating agents|mesh-ancestor
102434633|NCT01920269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434634|NCT01920269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102434635|NCT01920269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102434636|NCT02921893|Dexamethasone|dexamethasone|mesh-list
102434637|NCT02921893|Dexamethasone acetate|dexamethasone acetate|mesh-list
102434638|NCT02921893|Lenalidomide|lenalidomide|mesh-list
102434639|NCT02921893|Ixazomib|ixazomib|mesh-list
102434640|NCT02921893|Ichthammol|ichthammol|mesh-list
102434641|NCT02921893|BB 1101|bb 1101|mesh-list
102434642|NCT02921893|Glycine|glycine|mesh-list
102434643|NCT02921893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102434644|NCT02921893|Antiemetics|antiemetics|mesh-ancestor
102434645|NCT02921893|Autonomic Agents|autonomic agents|mesh-ancestor
102434646|NCT02921893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102434647|NCT02921893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434648|NCT02921893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102434649|NCT02921893|Glucocorticoids|glucocorticoids|mesh-ancestor
102434650|NCT02921893|Hormones|hormones|mesh-ancestor
102434651|NCT02921893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102434652|NCT02921893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102434653|NCT02921893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102434654|NCT02921893|Protease Inhibitors|protease inhibitors|mesh-ancestor
102434655|NCT02921893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102434656|NCT02921893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434657|NCT02921893|Immunologic Factors|immunologic factors|mesh-ancestor
102434658|NCT02921893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102434659|NCT02921893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102434660|NCT02921893|Growth Substances|growth substances|mesh-ancestor
102434661|NCT02921893|Growth Inhibitors|growth inhibitors|mesh-ancestor
102434662|NCT02921893|Dermatologic Agents|dermatologic agents|mesh-ancestor
102434663|NCT02921893|Glycine Agents|glycine agents|mesh-ancestor
102434664|NCT02921893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102434665|NCT01920503|Doxorubicin|doxorubicin|mesh-list
102434666|NCT01920503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102434667|NCT01920503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102434668|NCT01920503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102434669|NCT01920503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102434670|NCT01920503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102434671|NCT01920503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434672|NCT01293825|Ziprasidone|ziprasidone|mesh-list
102434673|NCT01293825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102434674|NCT01293825|Serotonin Agents|serotonin agents|mesh-ancestor
102434675|NCT01293825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102434676|NCT01293825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434677|NCT01293825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434678|NCT01293825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102434679|NCT01293825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102434680|NCT01293825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102434682|NCT01293825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102434683|NCT01293825|Dopamine Agents|dopamine agents|mesh-ancestor
102434684|NCT03009513|Glimepiride|glimepiride|mesh-list
102434685|NCT03009513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102434686|NCT03009513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102434687|NCT03009513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434688|NCT03009513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102434689|NCT03009513|Immunologic Factors|immunologic factors|mesh-ancestor
102434690|NCT02983591|Misoprostol|misoprostol|mesh-list
102434691|NCT02983591|Oxytocin|oxytocin|mesh-list
102434692|NCT02983591|Oxytocics|oxytocics|mesh-ancestor
102434693|NCT02983591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102434694|NCT02983591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434695|NCT02983591|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102434696|NCT02983591|Abortifacient Agents|abortifacient agents|mesh-ancestor
102434697|NCT02983591|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102065161|NCT02197676|Guadecitabine|guadecitabine|mesh-list
102434698|NCT02983591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102434699|NCT03829891|Insulin Glargine|insulin glargine|mesh-list
102434700|NCT03829891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102434701|NCT03829891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434702|NCT03115151|Fentanyl|fentanyl|mesh-list
102434703|NCT03115151|Hydromorphone|hydromorphone|mesh-list
102434704|NCT03115151|Bupivacaine|bupivacaine|mesh-list
102434705|NCT03115151|Anesthetics, Local|anesthetics, local|mesh-ancestor
102434706|NCT03115151|Anesthetics|anesthetics|mesh-ancestor
102434707|NCT03115151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102434708|NCT03115151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434709|NCT03115151|Sensory System Agents|sensory system agents|mesh-ancestor
102434710|NCT03115151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102434711|NCT03115151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102434712|NCT03115151|Narcotics|narcotics|mesh-ancestor
102434713|NCT03115151|Analgesics|analgesics|mesh-ancestor
102434714|NCT03115151|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102434715|NCT03115151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102434716|NCT03115151|Anesthetics, General|anesthetics, general|mesh-ancestor
102434717|NCT01263717|Hormones|hormones|mesh-list
102434718|NCT01263717|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
102434719|NCT01263717|Tesamorelin|tesamorelin|mesh-list
102434720|NCT01263717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102434721|NCT01263717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434722|NCT01263717|Growth Substances|growth substances|mesh-ancestor
102434723|NCT04120753|Amlodipine|amlodipine|mesh-list
102434724|NCT04120753|Olmesartan|olmesartan|mesh-list
102434725|NCT04120753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102434726|NCT04120753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102434727|NCT04120753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102434728|NCT04120753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434729|NCT04120753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102434730|NCT04120753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434731|NCT04120753|Vasodilator Agents|vasodilator agents|mesh-ancestor
102434732|NCT04120753|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102434733|NCT04120753|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102434734|NCT01921361|Dexmedetomidine|dexmedetomidine|mesh-list
102434735|NCT01921361|Levobupivacaine|levobupivacaine|mesh-list
102434736|NCT01921361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102434737|NCT01921361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102434738|NCT01921361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434739|NCT01921361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102434740|NCT01921361|Analgesics|analgesics|mesh-ancestor
102434741|NCT01921361|Sensory System Agents|sensory system agents|mesh-ancestor
102434742|NCT01921361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102434743|NCT01921361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102434744|NCT01921361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102434745|NCT01921361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102434746|NCT01921361|Adrenergic Agents|adrenergic agents|mesh-ancestor
102434747|NCT01921361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102434748|NCT01921361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434749|NCT01921361|Anesthetics, Local|anesthetics, local|mesh-ancestor
102434750|NCT01921361|Anesthetics|anesthetics|mesh-ancestor
102434751|NCT01921673|Docetaxel|docetaxel|mesh-list
102434752|NCT01921673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102434753|NCT01921673|Tubulin Modulators|tubulin modulators|mesh-ancestor
102434754|NCT01921673|Antimitotic Agents|antimitotic agents|mesh-ancestor
102434755|NCT01921673|Mitosis Modulators|mitosis modulators|mesh-ancestor
102246431|NCT04906317|Anesthetics, General|anesthetics, general|mesh-ancestor
102434756|NCT01921673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434757|NCT01921985|Terlipressin|terlipressin|mesh-list
102434758|NCT01921985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102434759|NCT01921985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102434760|NCT02943733|Temozolomide|temozolomide|mesh-list
102434761|NCT02943733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102434762|NCT02943733|Alkylating Agents|alkylating agents|mesh-ancestor
102434763|NCT02943733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434764|NCT02943733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102434765|NCT01922141|Amlodipine|amlodipine|mesh-list
102434766|NCT01922141|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102434767|NCT01922141|Ramipril|ramipril|mesh-list
102434768|NCT01922141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102434769|NCT01922141|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102434770|NCT01922141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102434771|NCT01922141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434772|NCT01922141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102434773|NCT01922141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434774|NCT01922141|Vasodilator Agents|vasodilator agents|mesh-ancestor
102434775|NCT01922141|Diuretics|diuretics|mesh-ancestor
102434776|NCT01922141|Natriuretic Agents|natriuretic agents|mesh-ancestor
102434777|NCT01922141|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102434778|NCT01922141|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102434779|NCT01922141|Protease Inhibitors|protease inhibitors|mesh-ancestor
102434780|NCT01922141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102434781|NCT03828019|Cyclosporine|cyclosporine|mesh-list
102434782|NCT03828019|Adalimumab|adalimumab|mesh-list
102434783|NCT03828019|Methotrexate|methotrexate|mesh-list
102434784|NCT03828019|Azathioprine|azathioprine|mesh-list
102434785|NCT03828019|Tacrolimus|tacrolimus|mesh-list
102434786|NCT03828019|Cyclosporins|cyclosporins|mesh-list
102434787|NCT03828019|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102434788|NCT03828019|Abortifacient Agents|abortifacient agents|mesh-ancestor
102434789|NCT03828019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102434790|NCT03828019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434791|NCT03828019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102434792|NCT03828019|Antimetabolites|antimetabolites|mesh-ancestor
102434793|NCT03828019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434794|NCT03828019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102434795|NCT03828019|Dermatologic Agents|dermatologic agents|mesh-ancestor
102434796|NCT03828019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102434797|NCT03828019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102434798|NCT03828019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102434799|NCT03828019|Immunologic Factors|immunologic factors|mesh-ancestor
102434800|NCT03828019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102434801|NCT03828019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102434802|NCT03828019|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102434803|NCT03828019|Antifungal Agents|antifungal agents|mesh-ancestor
102434804|NCT03828019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102434805|NCT03828019|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102434806|NCT03828019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102434807|NCT03111485|Levodopa|levodopa|mesh-list
102434808|NCT03111485|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102434809|NCT03111485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102434810|NCT03111485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102434811|NCT03111485|Dopamine Agents|dopamine agents|mesh-ancestor
102434812|NCT03111485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102434813|NCT03111485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434814|NCT03111485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434815|NCT03111485|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102065285|NCT03674385|Fertility Agents|fertility agents|mesh-ancestor
102434816|NCT03111485|Immunologic Factors|immunologic factors|mesh-ancestor
102434817|NCT03111485|Dopamine Agonists|dopamine agonists|mesh-ancestor
102434818|NCT02856295|Enoxaparin|enoxaparin|mesh-list
102434819|NCT02856295|Anticoagulants|anticoagulants|mesh-ancestor
102434820|NCT02856295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102434821|NCT02856295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102434822|NCT02856295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434823|NCT01266447|Topotecan|topotecan|mesh-list
102434824|NCT01266447|Veliparib|veliparib|mesh-list
102434825|NCT01266447|Lenograstim|lenograstim|mesh-list
102434826|NCT01266447|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102434827|NCT01266447|Immunologic Factors|immunologic factors|mesh-ancestor
102434828|NCT01266447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434829|NCT01266447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102434830|NCT01266447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102434831|NCT01266447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102434832|NCT01266447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434833|NCT01266447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102434834|NCT01266447|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102434835|NCT01922375|Naftopidil|naftopidil|mesh-list
102434836|NCT01922375|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102434837|NCT01922375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102434838|NCT01922375|Adrenergic Agents|adrenergic agents|mesh-ancestor
102434839|NCT01922375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102434840|NCT01922375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434841|NCT01922375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434842|NCT01922375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102434843|NCT01922375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102434844|NCT01922375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102434845|NCT01922375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102434846|NCT01922375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102434847|NCT03823339|Liraglutide|liraglutide|mesh-list
102434848|NCT03823339|Xultophy|xultophy|mesh-list
102434849|NCT03823339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102434850|NCT03823339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434851|NCT03823339|Incretins|incretins|mesh-ancestor
102434852|NCT03823339|Hormones|hormones|mesh-ancestor
102434853|NCT03823339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102434854|NCT01922687|Amlodipine|amlodipine|mesh-list
102434855|NCT01922687|Atorvastatin|atorvastatin|mesh-list
102434856|NCT01922687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102434857|NCT01922687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102434858|NCT01922687|Antimetabolites|antimetabolites|mesh-ancestor
102434859|NCT01922687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434860|NCT01922687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102434861|NCT01922687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102434862|NCT01922687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102434863|NCT01922687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102434864|NCT01922687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102434865|NCT01922687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102434866|NCT01922687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102434867|NCT01922687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434868|NCT01922687|Vasodilator Agents|vasodilator agents|mesh-ancestor
102434869|NCT01268553|Treprostinil|treprostinil|mesh-list
102434870|NCT01268553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102434871|NCT01922999|Melatonin|melatonin|mesh-list
102434872|NCT01922999|Antioxidants|antioxidants|mesh-ancestor
102434873|NCT01922999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434874|NCT01922999|Protective Agents|protective agents|mesh-ancestor
102434875|NCT01922999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434876|NCT01922999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102434877|NCT01268943|Capecitabine|capecitabine|mesh-list
102434878|NCT01268943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102434879|NCT01268943|Antimetabolites|antimetabolites|mesh-ancestor
102065347|NCT01378091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102434880|NCT01268943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434881|NCT01268943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102434882|NCT01923077|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102434883|NCT01923077|Simvastatin|simvastatin|mesh-list
102434884|NCT01923077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102434885|NCT01923077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102434886|NCT01923077|Antimetabolites|antimetabolites|mesh-ancestor
102434887|NCT01923077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434888|NCT01923077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102434889|NCT01923077|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102434890|NCT01923077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102434891|NCT01269801|Botulinum Toxins|botulinum toxins|mesh-list
102434892|NCT01269801|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102434893|NCT01269801|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102434894|NCT01269801|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102434895|NCT01269801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102434896|NCT01269801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434897|NCT01269801|Cholinergic Agents|cholinergic agents|mesh-ancestor
102434898|NCT01269801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102434899|NCT01269801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434900|NCT01269801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102434901|NCT01269801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102434902|NCT01297335|Clonidine|clonidine|mesh-list
102434903|NCT01297335|Analgesics|analgesics|mesh-ancestor
102434904|NCT01297335|Sensory System Agents|sensory system agents|mesh-ancestor
102434905|NCT01297335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102434906|NCT01297335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434908|NCT01297335|Sympatholytics|sympatholytics|mesh-ancestor
102434909|NCT01297335|Autonomic Agents|autonomic agents|mesh-ancestor
102434910|NCT01297335|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102434911|NCT01297335|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102434912|NCT01297335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102434913|NCT01297335|Adrenergic Agents|adrenergic agents|mesh-ancestor
102434914|NCT01297335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102434915|NCT01297335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434916|NCT05498129|Micronutrients|micronutrients|mesh-list
102434917|NCT05498129|Trace Elements|trace elements|mesh-list
102434918|NCT05498129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434919|NCT01270659|Acetaminophen|acetaminophen|mesh-list
102434920|NCT01270659|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
102434921|NCT01270659|Fentanyl|fentanyl|mesh-list
102434922|NCT01270659|Oxycodone|oxycodone|mesh-list
102434923|NCT01270659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102434924|NCT01270659|Narcotics|narcotics|mesh-ancestor
102434925|NCT01270659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102434926|NCT01270659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434927|NCT01270659|Analgesics|analgesics|mesh-ancestor
102434928|NCT01270659|Sensory System Agents|sensory system agents|mesh-ancestor
102434929|NCT01270659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102434930|NCT01270659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102434931|NCT01270659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102434932|NCT01270659|Anesthetics, General|anesthetics, general|mesh-ancestor
102434933|NCT01270659|Anesthetics|anesthetics|mesh-ancestor
102434934|NCT01270659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102434935|NCT01270659|Antipyretics|antipyretics|mesh-ancestor
102434936|NCT01270659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102434937|NCT01270659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102065416|NCT02201576|Bortezomib|bortezomib|mesh-list
102434938|NCT01270659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102434939|NCT01271907|Aldesleukin|aldesleukin|mesh-list
102434940|NCT01271907|Cyclophosphamide|cyclophosphamide|mesh-list
102434941|NCT01271907|Fludarabine|fludarabine|mesh-list
102434942|NCT01271907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102434943|NCT01271907|Immunologic Factors|immunologic factors|mesh-ancestor
102434944|NCT01271907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434945|NCT01271907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102434946|NCT01271907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102434947|NCT01271907|Alkylating Agents|alkylating agents|mesh-ancestor
102434948|NCT01271907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434949|NCT01271907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102434950|NCT01271907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102434951|NCT01271907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102434952|NCT01271907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102434953|NCT01271907|Antiviral Agents|antiviral agents|mesh-ancestor
102434954|NCT01271907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102434955|NCT01929941|Paclitaxel|paclitaxel|mesh-list
102434956|NCT01929941|Gemcitabine|gemcitabine|mesh-list
102434957|NCT01929941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102434958|NCT01929941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102434959|NCT01929941|Tubulin Modulators|tubulin modulators|mesh-ancestor
102434960|NCT01929941|Antimitotic Agents|antimitotic agents|mesh-ancestor
102434961|NCT01929941|Mitosis Modulators|mitosis modulators|mesh-ancestor
102434962|NCT01929941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434963|NCT01929941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102434964|NCT01929941|Antimetabolites|antimetabolites|mesh-ancestor
102434965|NCT01920737|Leucovorin|leucovorin|mesh-list
102434966|NCT01920737|Cytarabine|cytarabine|mesh-list
102434967|NCT01920737|Dexamethasone|dexamethasone|mesh-list
102434968|NCT01920737|Prednisone|prednisone|mesh-list
102434969|NCT01920737|Cyclophosphamide|cyclophosphamide|mesh-list
102434970|NCT01920737|Methotrexate|methotrexate|mesh-list
102434971|NCT01920737|Vincristine|vincristine|mesh-list
102434972|NCT01920737|Daunorubicin|daunorubicin|mesh-list
102434973|NCT01920737|Asparaginase|asparaginase|mesh-list
102434974|NCT01920737|Mercaptopurine|mercaptopurine|mesh-list
102434975|NCT01920737|Pegaspargase|pegaspargase|mesh-list
102434976|NCT01920737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102434977|NCT01920737|Immunologic Factors|immunologic factors|mesh-ancestor
102434978|NCT01920737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102434979|NCT01920737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102434980|NCT01920737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102434981|NCT01920737|Alkylating Agents|alkylating agents|mesh-ancestor
102246655|NCT04886193|Antidotes|antidotes|mesh-ancestor
102434982|NCT01920737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102434983|NCT01920737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102434984|NCT01920737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102434985|NCT01920737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102434987|NCT01920737|Autonomic Agents|autonomic agents|mesh-ancestor
102434988|NCT01920737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102434989|NCT01920737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102434990|NCT01920737|Glucocorticoids|glucocorticoids|mesh-ancestor
102434991|NCT01920737|Hormones|hormones|mesh-ancestor
102434992|NCT01920737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102434993|NCT01920737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102434994|NCT01920737|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102434995|NCT01920737|Abortifacient Agents|abortifacient agents|mesh-ancestor
102434996|NCT01920737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102434997|NCT01920737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102434998|NCT01920737|Antimetabolites|antimetabolites|mesh-ancestor
102434999|NCT01920737|Dermatologic Agents|dermatologic agents|mesh-ancestor
102435000|NCT01920737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102435001|NCT01920737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102435002|NCT01920737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102435003|NCT01920737|Antiviral Agents|antiviral agents|mesh-ancestor
102435004|NCT01920737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102435005|NCT01920737|Antidotes|antidotes|mesh-ancestor
102435006|NCT01920737|Protective Agents|protective agents|mesh-ancestor
102435007|NCT01920737|Vitamin B Complex|vitamin b complex|mesh-ancestor
102435008|NCT01920737|Vitamins|vitamins|mesh-ancestor
102435009|NCT01920737|Micronutrients|micronutrients|mesh-ancestor
102435010|NCT01920737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102435011|NCT01920737|Tubulin Modulators|tubulin modulators|mesh-ancestor
102435012|NCT01920737|Antimitotic Agents|antimitotic agents|mesh-ancestor
102435013|NCT01920737|Mitosis Modulators|mitosis modulators|mesh-ancestor
102435014|NCT01920737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102435015|NCT01920737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102435016|NCT01920737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102435017|NCT01922843|Calcitriol|calcitriol|mesh-list
102435018|NCT01922843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102435019|NCT01922843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435020|NCT01922843|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102435021|NCT01922843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102435022|NCT01922843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435023|NCT01922843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102435024|NCT01922843|Vitamins|vitamins|mesh-ancestor
102435025|NCT01922843|Micronutrients|micronutrients|mesh-ancestor
102435026|NCT01922843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102435027|NCT01302483|Lidocaine|lidocaine|mesh-list
102435028|NCT01302483|Phenylephrine|phenylephrine|mesh-list
102435029|NCT01302483|Oxymetazoline|oxymetazoline|mesh-list
102435030|NCT01302483|Tetracaine|tetracaine|mesh-list
102435031|NCT01302483|Anesthetics, Local|anesthetics, local|mesh-ancestor
102435032|NCT01302483|Anesthetics|anesthetics|mesh-ancestor
102435033|NCT01302483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102435034|NCT01302483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435035|NCT01302483|Sensory System Agents|sensory system agents|mesh-ancestor
102435036|NCT01302483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102435037|NCT01302483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102435038|NCT01302483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102435039|NCT01302483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102435040|NCT01302483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102435041|NCT01302483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435042|NCT01302483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102435043|NCT01302483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102435044|NCT01302483|Adrenergic Agents|adrenergic agents|mesh-ancestor
102435045|NCT01302483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102435046|NCT01302483|Sympathomimetics|sympathomimetics|mesh-ancestor
102435047|NCT01302483|Autonomic Agents|autonomic agents|mesh-ancestor
102435048|NCT01302483|Nasal Decongestants|nasal decongestants|mesh-ancestor
102435049|NCT01302483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102435050|NCT01302483|Respiratory System Agents|respiratory system agents|mesh-ancestor
102435051|NCT01302483|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102435052|NCT01302483|Mydriatics|mydriatics|mesh-ancestor
102435053|NCT01302483|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102435054|NCT01302483|Protective Agents|protective agents|mesh-ancestor
102246728|NCT05257395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102435055|NCT04769583|Metronidazole|metronidazole|mesh-list
102435056|NCT04769583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102435057|NCT04769583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102435058|NCT04769583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102435059|NCT04769583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102435061|NCT01279317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102435062|NCT01279317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102435063|NCT01304589|Milnacipran|milnacipran|mesh-list
102435064|NCT01304589|Levomilnacipran|levomilnacipran|mesh-list
102435065|NCT01304589|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102435066|NCT01304589|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102435067|NCT01304589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102435068|NCT01304589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435069|NCT01304589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102435070|NCT01304589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435071|NCT01304589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102435072|NCT01304589|Analgesics|analgesics|mesh-ancestor
102435073|NCT01304589|Sensory System Agents|sensory system agents|mesh-ancestor
102435074|NCT01304589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102435075|NCT01304589|Antidepressive Agents|antidepressive agents|mesh-ancestor
102435076|NCT01304589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102435077|NCT01280409|Metformin|metformin|mesh-list
102435078|NCT01280409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102435079|NCT01280409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435080|NCT01926197|Leucovorin|leucovorin|mesh-list
102435081|NCT01926197|Fluorouracil|fluorouracil|mesh-list
102435082|NCT01926197|Oxaliplatin|oxaliplatin|mesh-list
102435083|NCT01926197|Irinotecan|irinotecan|mesh-list
102435084|NCT01926197|Camptothecin|camptothecin|mesh-list
102435085|NCT01926197|Antimetabolites|antimetabolites|mesh-ancestor
102435086|NCT01926197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435087|NCT01926197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102435088|NCT01926197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102435089|NCT01926197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102435090|NCT01926197|Immunologic Factors|immunologic factors|mesh-ancestor
102435091|NCT01926197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435092|NCT01926197|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102435093|NCT01926197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102435094|NCT01926197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102435095|NCT01926197|Antidotes|antidotes|mesh-ancestor
102435096|NCT01926197|Protective Agents|protective agents|mesh-ancestor
102435097|NCT01926197|Vitamin B Complex|vitamin b complex|mesh-ancestor
102435098|NCT01926197|Vitamins|vitamins|mesh-ancestor
102435099|NCT01926197|Micronutrients|micronutrients|mesh-ancestor
102435100|NCT01926197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102435101|NCT01923545|Lenograstim|lenograstim|mesh-list
102435102|NCT01923545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102435103|NCT01923545|Immunologic Factors|immunologic factors|mesh-ancestor
102435104|NCT01923545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435105|NCT01925027|Sirolimus|sirolimus|mesh-list
102435106|NCT01925027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102435107|NCT01925027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102435108|NCT01925027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102435109|NCT01925027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102435110|NCT01925027|Antifungal Agents|antifungal agents|mesh-ancestor
102435111|NCT01925027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102435112|NCT01925027|Immunologic Factors|immunologic factors|mesh-ancestor
102435113|NCT01925027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435114|NCT01305213|Bevacizumab|bevacizumab|mesh-list
102435115|NCT01305213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102435116|NCT01305213|Fosbretabulin|fosbretabulin|mesh-list
102435117|NCT01305213|Endothelial Growth Factors|endothelial growth factors|mesh-list
102435118|NCT01305213|Antibodies|antibodies|mesh-list
102435119|NCT01305213|Immunoglobulins|immunoglobulins|mesh-list
102435120|NCT01305213|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102435121|NCT01305213|Immunoglobulin G|immunoglobulin g|mesh-list
102435122|NCT01305213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102435123|NCT01305213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102435124|NCT01305213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102435125|NCT01305213|Growth Substances|growth substances|mesh-ancestor
102435126|NCT01305213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435127|NCT01305213|Growth Inhibitors|growth inhibitors|mesh-ancestor
102435128|NCT01305213|Immunologic Factors|immunologic factors|mesh-ancestor
102435129|NCT01305213|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102435130|NCT00989963|Beraprost|beraprost|mesh-list
102435131|NCT00989963|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102435132|NCT00989963|Vasodilator Agents|vasodilator agents|mesh-ancestor
102435133|NCT01339299|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102435134|NCT01339299|Hormones|hormones|mesh-list
102435135|NCT01339299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102435136|NCT01339299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435137|NCT01339299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102435138|NCT01307007|Dextrans|dextrans|mesh-list
102435139|NCT01307007|Iron-Dextran Complex|iron-dextran complex|mesh-list
102435140|NCT01307007|Anticoagulants|anticoagulants|mesh-ancestor
102435141|NCT01307007|Plasma Substitutes|plasma substitutes|mesh-ancestor
102435142|NCT01307007|Blood Substitutes|blood substitutes|mesh-ancestor
102435143|NCT01307007|Hematinics|hematinics|mesh-ancestor
102435144|NCT02197455|Tofacitinib|tofacitinib|mesh-list
102435145|NCT02197455|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102435146|NCT02197455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102435147|NCT02197455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102435148|NCT02197455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435149|NCT03101501|Mitomycins|mitomycins|mesh-list
102435150|NCT03101501|Mitomycin|mitomycin|mesh-list
102435151|NCT03101501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102435152|NCT03101501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102435153|NCT03101501|Alkylating Agents|alkylating agents|mesh-ancestor
102435154|NCT03101501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435155|NCT03101501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102435156|NCT03101501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102435157|NCT01923623|Ropivacaine|ropivacaine|mesh-list
102435158|NCT01923623|Anesthetics, Local|anesthetics, local|mesh-ancestor
102435159|NCT01923623|Anesthetics|anesthetics|mesh-ancestor
102435160|NCT01923623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102435161|NCT01923623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435162|NCT01923623|Sensory System Agents|sensory system agents|mesh-ancestor
102435163|NCT01923623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102435164|NCT01923857|Enclomiphene|enclomiphene|mesh-list
102435165|NCT01923857|Clomiphene|clomiphene|mesh-list
102435166|NCT01923857|Zuclomiphene|zuclomiphene|mesh-list
102435167|NCT01923857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102435168|NCT01923857|Hormone Antagonists|hormone antagonists|mesh-ancestor
102435169|NCT01923857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102435170|NCT01923857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435171|NCT01923857|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102435172|NCT01923857|Fertility Agents|fertility agents|mesh-ancestor
102435173|NCT01923857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102435174|NCT01923857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102435175|NCT01923857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102435176|NCT03100253|Adalimumab|adalimumab|mesh-list
102435177|NCT03100253|Infliximab|infliximab|mesh-list
102435178|NCT03100253|Golimumab|golimumab|mesh-list
102435179|NCT03100253|Certolizumab Pegol|certolizumab pegol|mesh-list
102435180|NCT03100253|Etanercept|etanercept|mesh-list
102435181|NCT03100253|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102435182|NCT03100253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102435183|NCT03100253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102435184|NCT03100253|Dermatologic Agents|dermatologic agents|mesh-ancestor
102435185|NCT03100253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102435186|NCT03100253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102435187|NCT03100253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102435188|NCT03100253|Analgesics|analgesics|mesh-ancestor
102435189|NCT03100253|Sensory System Agents|sensory system agents|mesh-ancestor
102435190|NCT03100253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102435191|NCT03100253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435192|NCT03100253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102435193|NCT03100253|Immunologic Factors|immunologic factors|mesh-ancestor
102435194|NCT01924091|Dapivirine|dapivirine|mesh-list
102435195|NCT01924091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102435196|NCT01924091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102435197|NCT01924091|Antiviral Agents|antiviral agents|mesh-ancestor
102435198|NCT01924091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102435199|NCT03485729|TIC10 compound|tic10 compound|mesh-list
102435200|NCT03485729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102435201|NCT01924325|Aspirin|aspirin|mesh-list
102435202|NCT01924325|Apixaban|apixaban|mesh-list
102435203|NCT01924325|Clopidogrel|clopidogrel|mesh-list
102435204|NCT01924325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102435205|NCT01924325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102435206|NCT01924325|Analgesics|analgesics|mesh-ancestor
102435207|NCT01924325|Sensory System Agents|sensory system agents|mesh-ancestor
102435208|NCT01924325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102435209|NCT01924325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435210|NCT01924325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102435211|NCT01924325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102435212|NCT01924325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102065677|NCT02068560|Coagulants|coagulants|mesh-ancestor
102435213|NCT01924325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102435214|NCT01924325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435215|NCT01924325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102435216|NCT01924325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102435217|NCT01924325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102435218|NCT01924325|Antipyretics|antipyretics|mesh-ancestor
102435219|NCT01924325|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102435220|NCT01924325|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102435221|NCT01924325|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102435222|NCT01924325|Purinergic Agents|purinergic agents|mesh-ancestor
102435223|NCT01924325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102435224|NCT01924325|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102435225|NCT01924325|Antithrombins|antithrombins|mesh-ancestor
102435226|NCT01924325|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102435227|NCT01924325|Protease Inhibitors|protease inhibitors|mesh-ancestor
102435228|NCT01924325|Anticoagulants|anticoagulants|mesh-ancestor
102435229|NCT01924481|Theobromine|theobromine|mesh-list
102435230|NCT01924481|Caffeine|caffeine|mesh-list
102435231|NCT01924481|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102435232|NCT01924481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435233|NCT01924481|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102435234|NCT01924481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102435235|NCT01924481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435236|NCT01924481|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102435237|NCT01924481|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102435238|NCT01924481|Purinergic Agents|purinergic agents|mesh-ancestor
102435239|NCT01924481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102435240|NCT01924481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102435241|NCT01924481|Autonomic Agents|autonomic agents|mesh-ancestor
102435242|NCT01924481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102435243|NCT01924481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102435244|NCT01924481|Respiratory System Agents|respiratory system agents|mesh-ancestor
102435245|NCT01924481|Vasodilator Agents|vasodilator agents|mesh-ancestor
102435246|NCT01924637|Insulin|insulin|mesh-list
102435247|NCT01924637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102435248|NCT01924637|Insulin Aspart|insulin aspart|mesh-list
102435249|NCT01924637|Insulin, Long-Acting|insulin, long-acting|mesh-list
102435250|NCT01924637|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102435251|NCT01924637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102435252|NCT01924637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435253|NCT01925729|Phenylephrine|phenylephrine|mesh-list
102435254|NCT01925729|Pseudoephedrine|pseudoephedrine|mesh-list
102435255|NCT01925729|Oxymetazoline|oxymetazoline|mesh-list
102435256|NCT01925729|Ephedrine|ephedrine|mesh-list
102435257|NCT01925729|Histamine|histamine|mesh-list
102435258|NCT01925729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102435259|NCT01925729|Autonomic Agents|autonomic agents|mesh-ancestor
102435260|NCT01925729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102435261|NCT01925729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435262|NCT01925729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102435263|NCT01925729|Respiratory System Agents|respiratory system agents|mesh-ancestor
102435264|NCT01925729|Nasal Decongestants|nasal decongestants|mesh-ancestor
102435265|NCT01925729|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102435266|NCT01925729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102435267|NCT01925729|Sympathomimetics|sympathomimetics|mesh-ancestor
102435268|NCT01925729|Adrenergic Agents|adrenergic agents|mesh-ancestor
102435269|NCT01925729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102435270|NCT01925729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435271|NCT01925729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102435272|NCT01925729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102435273|NCT01925729|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102435274|NCT01925729|Mydriatics|mydriatics|mesh-ancestor
102435275|NCT01925729|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102435276|NCT01925729|Protective Agents|protective agents|mesh-ancestor
102435277|NCT01925729|Histamine Agonists|histamine agonists|mesh-ancestor
102435278|NCT01925729|Histamine Agents|histamine agents|mesh-ancestor
102435279|NCT01926587|Azacitidine|azacitidine|mesh-list
102435280|NCT01926587|ON 01910|on 01910|mesh-list
102435281|NCT01926587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102435282|NCT01926587|Antimetabolites|antimetabolites|mesh-ancestor
102435283|NCT01926587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435284|NCT01926587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102435285|NCT01926587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102435286|NCT01926587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102435288|NCT01922765|Metronidazole|metronidazole|mesh-list
102435289|NCT01922765|Clarithromycin|clarithromycin|mesh-list
102435290|NCT01922765|Rabeprazole|rabeprazole|mesh-list
102435291|NCT01922765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102435292|NCT01922765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102435293|NCT01922765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102435294|NCT01922765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102435295|NCT01922765|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102435296|NCT01922765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102435297|NCT01922765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435298|NCT01922765|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102435299|NCT01922765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102435300|NCT01922765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102435301|NCT01922765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102435302|NCT01922765|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102435303|NCT01926665|Dexamethasone|dexamethasone|mesh-list
102435304|NCT01926665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102435305|NCT01926665|Antiemetics|antiemetics|mesh-ancestor
102435306|NCT01926665|Autonomic Agents|autonomic agents|mesh-ancestor
102435307|NCT01926665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102435308|NCT01926665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435309|NCT01926665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102435310|NCT01926665|Glucocorticoids|glucocorticoids|mesh-ancestor
102435311|NCT01926665|Hormones|hormones|mesh-ancestor
102435312|NCT01926665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102435313|NCT01926665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102435314|NCT01926665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102435315|NCT01926821|Sizofiran|sizofiran|mesh-list
102435316|NCT01926821|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102435317|NCT01926821|Immunologic Factors|immunologic factors|mesh-ancestor
102435318|NCT01926821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435319|NCT01926821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102435320|NCT01926821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102435321|NCT01926899|Bortezomib|bortezomib|mesh-list
102435322|NCT01926899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102435323|NCT03430661|Clopidogrel|clopidogrel|mesh-list
102435324|NCT03430661|Ticagrelor|ticagrelor|mesh-list
102435325|NCT03430661|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102435326|NCT03430661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102435327|NCT03430661|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102435328|NCT03430661|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102435329|NCT03430661|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102435330|NCT03430661|Purinergic Agents|purinergic agents|mesh-ancestor
102435331|NCT03430661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102435332|NCT03430661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435333|NCT03430661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435334|NCT01927835|Vaccines|vaccines|mesh-list
102435335|NCT01927835|Immunologic Factors|immunologic factors|mesh-ancestor
102435336|NCT01927835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435337|NCT01927913|Deferasirox|deferasirox|mesh-list
102435338|NCT01927913|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102435339|NCT01927913|Chelating Agents|chelating agents|mesh-ancestor
102435340|NCT01927913|Sequestering Agents|sequestering agents|mesh-ancestor
102435341|NCT01927913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435342|NCT01928069|Montelukast|montelukast|mesh-list
102435343|NCT01928069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102435344|NCT01928069|Respiratory System Agents|respiratory system agents|mesh-ancestor
102435345|NCT01928069|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102435346|NCT01928069|Hormone Antagonists|hormone antagonists|mesh-ancestor
102435347|NCT01928069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102435348|NCT01928069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435349|NCT01928069|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102435350|NCT01928069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102435351|NCT01928069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435352|NCT01928459|Infigratinib|infigratinib|mesh-list
102435353|NCT01928459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102435354|NCT01928537|ON 01910|on 01910|mesh-list
102435355|NCT01928537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102435356|NCT01928537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102435357|NCT01928537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102435358|NCT01928537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435359|NCT01307397|Vemurafenib|vemurafenib|mesh-list
102435360|NCT01307397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102435361|NCT01307397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102435362|NCT01307397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102435363|NCT01307397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435364|NCT01929161|Oxytocin|oxytocin|mesh-list
102435365|NCT01929161|Oxytocics|oxytocics|mesh-ancestor
102435366|NCT01929161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102435367|NCT01929161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435368|NCT03373877|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
102435369|NCT03373877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102435370|NCT04552535|Afatinib|afatinib|mesh-list
102435371|NCT04552535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102435372|NCT04552535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102435373|NCT04552535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102435374|NCT04552535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435375|NCT02197767|Rituximab|rituximab|mesh-list
102435376|NCT02197767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102435377|NCT02197767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102435378|NCT02197767|Immunologic Factors|immunologic factors|mesh-ancestor
102435379|NCT02197767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435380|NCT02197767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102435381|NCT01342029|Ranolazine|ranolazine|mesh-list
102435382|NCT01342029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102435383|NCT01342029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102435384|NCT01342029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435385|NCT01342107|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102435386|NCT05601479|Acetylcarnitine|acetylcarnitine|mesh-list
102435387|NCT05601479|Vitamin B Complex|vitamin b complex|mesh-ancestor
102435388|NCT05601479|Vitamins|vitamins|mesh-ancestor
102435389|NCT05601479|Micronutrients|micronutrients|mesh-ancestor
102435390|NCT05601479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435391|NCT05601479|Nootropic Agents|nootropic agents|mesh-ancestor
102435392|NCT04275245|Meplazumab|meplazumab|mesh-list
102435393|NCT04275245|Antiviral Agents|antiviral agents|mesh-ancestor
102435394|NCT04275245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102435395|NCT01346085|Thymoglobulin|thymoglobulin|mesh-list
102435396|NCT01346085|Immunologic Factors|immunologic factors|mesh-ancestor
102435397|NCT01346085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435398|NCT01346085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102435399|NCT04394897|Remifentanil|remifentanil|mesh-list
102435400|NCT04394897|Propofol|propofol|mesh-list
102435401|NCT04394897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102435402|NCT04394897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102435403|NCT04394897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435404|NCT04394897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102435405|NCT04394897|Anesthetics, General|anesthetics, general|mesh-ancestor
102435406|NCT04394897|Anesthetics|anesthetics|mesh-ancestor
102435407|NCT04394897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102435408|NCT04394897|Narcotics|narcotics|mesh-ancestor
102435409|NCT04394897|Analgesics|analgesics|mesh-ancestor
102435410|NCT04394897|Sensory System Agents|sensory system agents|mesh-ancestor
102435411|NCT04394897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102435412|NCT05607641|Ketorolac|ketorolac|mesh-list
102435413|NCT05607641|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102435414|NCT05607641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102435415|NCT05607641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102435416|NCT05607641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102435417|NCT05607641|Analgesics|analgesics|mesh-ancestor
102435418|NCT05607641|Sensory System Agents|sensory system agents|mesh-ancestor
102435419|NCT05607641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102435420|NCT05607641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435421|NCT05607641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102435422|NCT05607641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102435423|NCT05607641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102435424|NCT05607641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102435425|NCT05607641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435426|NCT05607017|Losartan|losartan|mesh-list
102435427|NCT05607017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102435428|NCT05607017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102435429|NCT05607017|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102435430|NCT05607017|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102435431|NCT05607017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435432|NCT05603039|Bevacizumab|bevacizumab|mesh-list
102435433|NCT05603039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102435434|NCT05603039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102435435|NCT05603039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102435436|NCT05603039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102435437|NCT05603039|Growth Substances|growth substances|mesh-ancestor
102435438|NCT05603039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435439|NCT05603039|Growth Inhibitors|growth inhibitors|mesh-ancestor
102435440|NCT05609903|Paclitaxel|paclitaxel|mesh-list
102435441|NCT05609903|Atezolizumab|atezolizumab|mesh-list
102435442|NCT05609903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102435443|NCT05609903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102435444|NCT05609903|Tubulin Modulators|tubulin modulators|mesh-ancestor
102435445|NCT05609903|Antimitotic Agents|antimitotic agents|mesh-ancestor
102435446|NCT05609903|Mitosis Modulators|mitosis modulators|mesh-ancestor
102435447|NCT05609903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435448|NCT05609903|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102435449|NCT05609903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102435450|NCT04161599|Metronidazole|metronidazole|mesh-list
102435451|NCT04161599|Cefuroxime|cefuroxime|mesh-list
102435452|NCT04161599|Cefuroxime axetil|cefuroxime axetil|mesh-list
102435453|NCT04161599|Picosulfate sodium|picosulfate sodium|mesh-list
102435454|NCT04161599|Magnesium Oxide|magnesium oxide|mesh-list
102435455|NCT04161599|Citric Acid|citric acid|mesh-list
102435456|NCT04161599|Sodium Citrate|sodium citrate|mesh-list
102435457|NCT04161599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102435458|NCT04161599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102435459|NCT04161599|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102435460|NCT04161599|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102435461|NCT04161599|Cathartics|cathartics|mesh-ancestor
102435462|NCT04161599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102435463|NCT04161599|Anticoagulants|anticoagulants|mesh-ancestor
102435464|NCT04161599|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102435465|NCT04161599|Chelating Agents|chelating agents|mesh-ancestor
102435466|NCT04161599|Sequestering Agents|sequestering agents|mesh-ancestor
102435467|NCT04161599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435468|NCT04161599|Antacids|antacids|mesh-ancestor
102435469|NCT04759235|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102435470|NCT04759235|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102435471|NCT04759235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435472|NCT05608499|Clobetasol|clobetasol|mesh-list
102435473|NCT05608499|Halobetasol|halobetasol|mesh-list
102435474|NCT05608499|Tazarotene|tazarotene|mesh-list
102435475|NCT05608499|Dermatologic Agents|dermatologic agents|mesh-ancestor
102435476|NCT05608499|Keratolytic Agents|keratolytic agents|mesh-ancestor
102435477|NCT05608499|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102435478|NCT05608499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102435479|NCT05608499|Glucocorticoids|glucocorticoids|mesh-ancestor
102435480|NCT05608499|Hormones|hormones|mesh-ancestor
102435481|NCT05608499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102435482|NCT05608499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435483|NCT05601167|Ritonavir|ritonavir|mesh-list
102435484|NCT05601167|Nirmatrelvir|nirmatrelvir|mesh-list
102435485|NCT05601167|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
102435486|NCT05601167|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102435487|NCT05601167|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102435488|NCT05601167|Protease Inhibitors|protease inhibitors|mesh-ancestor
102435489|NCT05601167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102435490|NCT05601167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435491|NCT05601167|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102435492|NCT05601167|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102435493|NCT05601167|Antiviral Agents|antiviral agents|mesh-ancestor
102435494|NCT05601167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102435495|NCT05601167|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102435496|NCT05601167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102435497|NCT05605613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102435498|NCT05605613|Antibodies|antibodies|mesh-list
102435499|NCT05605613|Immunologic Factors|immunologic factors|mesh-ancestor
102435500|NCT05605613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435501|NCT05605613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435502|NCT05605613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102435503|NCT05605613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102435504|NCT05602259|Dimercaprol|dimercaprol|mesh-list
102435505|NCT05602259|Chelating Agents|chelating agents|mesh-ancestor
102435506|NCT05602259|Sequestering Agents|sequestering agents|mesh-ancestor
102435507|NCT05602259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435508|NCT04393883|Pembrolizumab|pembrolizumab|mesh-list
102435509|NCT04393883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102435510|NCT04393883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102435511|NCT04393883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102435512|NCT04393883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435513|NCT05603975|Esketamine|esketamine|mesh-list
102435514|NCT05603975|Antidepressive Agents|antidepressive agents|mesh-ancestor
102435515|NCT05603975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102435516|NCT04120363|Methyltestosterone|methyltestosterone|mesh-list
102435517|NCT04120363|Testosterone|testosterone|mesh-list
102435518|NCT04120363|Testosterone undecanoate|testosterone undecanoate|mesh-list
102435519|NCT04120363|Testosterone enanthate|testosterone enanthate|mesh-list
102435520|NCT04120363|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102435521|NCT04120363|Androgens|androgens|mesh-ancestor
102435522|NCT04120363|Hormones|hormones|mesh-ancestor
102435523|NCT04120363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102435524|NCT04120363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435525|NCT04120363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102435526|NCT04120363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102435527|NCT04120363|Anabolic Agents|anabolic agents|mesh-ancestor
102435528|NCT04125745|CXA-10|cxa-10|mesh-list
102435529|NCT04125745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102435530|NCT04393805|Heparin|heparin|mesh-list
102435531|NCT04393805|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102435532|NCT04393805|Tinzaparin|tinzaparin|mesh-list
102435533|NCT04393805|Dalteparin|dalteparin|mesh-list
102435534|NCT04393805|Anticoagulants|anticoagulants|mesh-ancestor
102435535|NCT04393805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102435536|NCT04393805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102435537|NCT04393805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435538|NCT04122755|Buprenorphine|buprenorphine|mesh-list
102435539|NCT04122755|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102435540|NCT04122755|Narcotics|narcotics|mesh-ancestor
102435541|NCT04122755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102435542|NCT04122755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435543|NCT04122755|Analgesics|analgesics|mesh-ancestor
102435544|NCT04122755|Sensory System Agents|sensory system agents|mesh-ancestor
102435545|NCT04122755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102435546|NCT04122755|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102435547|NCT04129697|Dexamethasone|dexamethasone|mesh-list
102435548|NCT04129697|Methylprednisolone|methylprednisolone|mesh-list
102435549|NCT04129697|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102435550|NCT04129697|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102435551|NCT04129697|Prednisolone|prednisolone|mesh-list
102435552|NCT04129697|Prednisolone acetate|prednisolone acetate|mesh-list
102435553|NCT04129697|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102435554|NCT04129697|Prednisolone phosphate|prednisolone phosphate|mesh-list
102435555|NCT04129697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102435556|NCT04129697|Antiemetics|antiemetics|mesh-ancestor
102435557|NCT04129697|Autonomic Agents|autonomic agents|mesh-ancestor
102435558|NCT04129697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102435559|NCT04129697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435560|NCT04129697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102435561|NCT04129697|Glucocorticoids|glucocorticoids|mesh-ancestor
102435562|NCT04129697|Hormones|hormones|mesh-ancestor
102435563|NCT04129697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102435564|NCT04129697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102435565|NCT04129697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102435566|NCT04129697|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102435567|NCT04129697|Protective Agents|protective agents|mesh-ancestor
102435568|NCT04128137|Fludrocortisone|fludrocortisone|mesh-list
102435569|NCT04128137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102435570|NCT05793892|Lidocaine|lidocaine|mesh-list
102435571|NCT05793892|Tetracaine|tetracaine|mesh-list
102435572|NCT05793892|Anesthetics, Local|anesthetics, local|mesh-ancestor
102435573|NCT05793892|Anesthetics|anesthetics|mesh-ancestor
102435574|NCT05793892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102435575|NCT05793892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435576|NCT05793892|Sensory System Agents|sensory system agents|mesh-ancestor
102435577|NCT05793892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102435578|NCT05793892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102435579|NCT05793892|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102435580|NCT05793892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102435581|NCT05793892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102435582|NCT05793892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435583|NCT05793359|Methylprednisolone|methylprednisolone|mesh-list
102435584|NCT05793359|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102435585|NCT05793359|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102247255|NCT03045471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102435586|NCT05793359|Prednisolone|prednisolone|mesh-list
102435587|NCT05793359|Prednisolone acetate|prednisolone acetate|mesh-list
102435588|NCT05793359|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102435589|NCT05793359|Prednisolone phosphate|prednisolone phosphate|mesh-list
102435590|NCT05793359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102435592|NCT05793359|Autonomic Agents|autonomic agents|mesh-ancestor
102435593|NCT05793359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102435594|NCT05793359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435595|NCT05793359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102435596|NCT05793359|Glucocorticoids|glucocorticoids|mesh-ancestor
102435597|NCT05793359|Hormones|hormones|mesh-ancestor
102435598|NCT05793359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102435599|NCT05793359|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102435600|NCT05793359|Protective Agents|protective agents|mesh-ancestor
102435601|NCT05793359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102435602|NCT05793359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102435603|NCT05793268|Tenofovir|tenofovir|mesh-list
102435604|NCT05793268|Entecavir|entecavir|mesh-list
102435605|NCT05793268|Antiviral Agents|antiviral agents|mesh-ancestor
102435606|NCT05793268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102435607|NCT05793268|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102435608|NCT05793268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102435609|NCT05793268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102435610|NCT05793268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435611|NCT05793268|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102435612|NCT05793268|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102435613|NCT05793099|Propolis|propolis|mesh-list
102435614|NCT05793099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102435615|NCT05792995|Pembrolizumab|pembrolizumab|mesh-list
102435616|NCT05792995|Nivolumab|nivolumab|mesh-list
102435617|NCT05792995|Durvalumab|durvalumab|mesh-list
102435618|NCT05792995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102435619|NCT05792995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102435620|NCT05792995|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102435621|NCT05792995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435622|NCT05792878|Interferons|interferons|mesh-list
102435623|NCT05792878|Interferon-alpha|interferon-alpha|mesh-list
102435624|NCT05792878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102435625|NCT05792878|Antiviral Agents|antiviral agents|mesh-ancestor
102435626|NCT05792878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102435627|NCT05792878|Immunologic Factors|immunologic factors|mesh-ancestor
102435628|NCT05792878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435629|NCT05792865|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
102435630|NCT05792865|Antiviral Agents|antiviral agents|mesh-ancestor
102435631|NCT05792865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102435632|NCT05792761|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102435633|NCT05792761|Antiviral Agents|antiviral agents|mesh-ancestor
102435634|NCT05792761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102435635|NCT05792748|Hemostatics|hemostatics|mesh-list
102435636|NCT05792748|Coagulants|coagulants|mesh-ancestor
102435637|NCT05792644|Crizotinib|crizotinib|mesh-list
102435638|NCT05792644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102435639|NCT05792644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102435640|NCT05792644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102435641|NCT05792644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435642|NCT05792410|Bevacizumab|bevacizumab|mesh-list
102435643|NCT05792410|Fulvestrant|fulvestrant|mesh-list
102435644|NCT05792410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102435645|NCT05792410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102435646|NCT05792410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102435647|NCT05792410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102435648|NCT05792410|Growth Substances|growth substances|mesh-ancestor
102435649|NCT05792410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435650|NCT05792410|Growth Inhibitors|growth inhibitors|mesh-ancestor
102435651|NCT05792410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102435652|NCT05792410|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102435653|NCT05792410|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102435654|NCT05792410|Hormone Antagonists|hormone antagonists|mesh-ancestor
102435655|NCT05792410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102435656|NCT05792111|Triamcinolone|triamcinolone|mesh-list
102435657|NCT05792111|Lidocaine|lidocaine|mesh-list
102435658|NCT05792111|Bupivacaine|bupivacaine|mesh-list
102435659|NCT05792111|Anesthetics, Local|anesthetics, local|mesh-ancestor
102435660|NCT05792111|Anesthetics|anesthetics|mesh-ancestor
102435661|NCT05792111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102435662|NCT05792111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435663|NCT05792111|Sensory System Agents|sensory system agents|mesh-ancestor
102435664|NCT05792111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102435665|NCT05792111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102435666|NCT05792111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102435667|NCT05792111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102435668|NCT05792111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102435669|NCT05792111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435670|NCT05792111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102435671|NCT05792111|Glucocorticoids|glucocorticoids|mesh-ancestor
102435672|NCT05792111|Hormones|hormones|mesh-ancestor
102435673|NCT05792111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102435674|NCT05789732|Tadalafil|tadalafil|mesh-list
102435675|NCT05789732|Silodosin|silodosin|mesh-list
102435676|NCT05789732|Vasodilator Agents|vasodilator agents|mesh-ancestor
102435677|NCT05789732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102435678|NCT05789732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102435679|NCT05789732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102435680|NCT05789732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435681|NCT05789732|Urological Agents|urological agents|mesh-ancestor
102435682|NCT05789732|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102435683|NCT05789732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102435684|NCT05789732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102435685|NCT05789732|Adrenergic Agents|adrenergic agents|mesh-ancestor
102435686|NCT05789732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102435687|NCT05789732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435688|NCT05789615|Letermovir|letermovir|mesh-list
102435689|NCT05789615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102435690|NCT05789615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102435691|NCT05789615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435692|NCT05789615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102435693|NCT05789615|Antiviral Agents|antiviral agents|mesh-ancestor
102435694|NCT05789615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102435695|NCT05783817|Methamphetamine|methamphetamine|mesh-list
102435696|NCT05783817|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102435697|NCT05783817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435698|NCT05783817|Sympathomimetics|sympathomimetics|mesh-ancestor
102435699|NCT05783817|Autonomic Agents|autonomic agents|mesh-ancestor
102435700|NCT05783817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102435701|NCT05783817|Dopamine Agents|dopamine agents|mesh-ancestor
102435702|NCT05783817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102435703|NCT05783817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435704|NCT05783817|Adrenergic Agents|adrenergic agents|mesh-ancestor
102435705|NCT05783817|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102435706|NCT05783817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102435707|NCT05783817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102435708|NCT05783817|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102435709|NCT05761080|Amoxicillin|amoxicillin|mesh-list
102435710|NCT05761080|Clavulanic Acids|clavulanic acids|mesh-list
102435711|NCT05761080|Clavulanic Acid|clavulanic acid|mesh-list
102435712|NCT05761080|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102435713|NCT05761080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102435714|NCT05761080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102435715|NCT05761080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102435716|NCT05761080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435717|NCT05761080|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102435718|NCT05743764|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102435719|NCT05743764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102435720|NCT05737186|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102435721|NCT05737186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435722|NCT05737186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102435723|NCT05737186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435724|NCT05700669|Olaparib|olaparib|mesh-list
102435725|NCT05700669|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102435726|NCT05700669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102435727|NCT05700669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435728|NCT05700669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102435729|NCT05652660|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102435730|NCT05652660|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102435731|NCT05652660|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102435732|NCT05652660|Antimetabolites|antimetabolites|mesh-ancestor
102435733|NCT05652660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435734|NCT05652660|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102435735|NCT05652660|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102435736|NCT05652660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102435737|NCT05617742|FAPI-46|fapi-46|mesh-list
102435738|NCT05617742|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102435739|NCT05617742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435740|NCT05593575|Valsartan|valsartan|mesh-list
102435741|NCT05593575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102435742|NCT05593575|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102435743|NCT05593575|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102435744|NCT05593575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435745|NCT05558137|Mivacurium|mivacurium|mesh-list
102435746|NCT05558137|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102435747|NCT05558137|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102435748|NCT05558137|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102435749|NCT05558137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102435750|NCT05558137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435751|NCT05505214|Mometasone Furoate|mometasone furoate|mesh-list
102435752|NCT05505214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102435753|NCT05505214|Dermatologic Agents|dermatologic agents|mesh-ancestor
102435754|NCT05505214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102435755|NCT05501769|Everolimus|everolimus|mesh-list
102435756|NCT05501769|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102435757|NCT05501769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102435758|NCT05501769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102435759|NCT05501769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435760|NCT05501769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102435761|NCT05501769|Immunologic Factors|immunologic factors|mesh-ancestor
102435762|NCT05501769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435763|NCT05501769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102435764|NCT05463224|Lazertinib|lazertinib|mesh-list
102435765|NCT05463224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102435766|NCT05463224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102435767|NCT05463224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435768|NCT05456932|Iron|iron|mesh-list
102435769|NCT05456932|Ferrous fumarate|ferrous fumarate|mesh-list
102435770|NCT05456932|Ferric maltol|ferric maltol|mesh-list
102435771|NCT05456932|Trace Elements|trace elements|mesh-ancestor
102435772|NCT05456932|Micronutrients|micronutrients|mesh-ancestor
102435773|NCT05456932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435774|NCT05456932|Hematinics|hematinics|mesh-ancestor
102435775|NCT05447780|Anesthetics|anesthetics|mesh-list
102435776|NCT05447780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102435777|NCT05447780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435778|NCT05437289|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
102435779|NCT05437289|Antiviral Agents|antiviral agents|mesh-ancestor
102435780|NCT05437289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102435781|NCT05389930|Ethanol|ethanol|mesh-list
102435782|NCT05389930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102435783|NCT05389930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102435784|NCT05389930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102435785|NCT05389930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435786|NCT05382546|Ketorolac|ketorolac|mesh-list
102435787|NCT05382546|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102435788|NCT05382546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102435789|NCT05382546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102435790|NCT05382546|Analgesics|analgesics|mesh-ancestor
102435791|NCT05382546|Sensory System Agents|sensory system agents|mesh-ancestor
102435792|NCT05382546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102435793|NCT05382546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435794|NCT05382546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102435795|NCT05382546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102435796|NCT05382546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102435797|NCT05382546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102435798|NCT05382546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435799|NCT05351554|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102435800|NCT05351554|Immunologic Factors|immunologic factors|mesh-ancestor
102435801|NCT05351554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435802|NCT05292664|Leucovorin|leucovorin|mesh-list
102435803|NCT05292664|Cytarabine|cytarabine|mesh-list
102435804|NCT05292664|Dexamethasone|dexamethasone|mesh-list
102435805|NCT05292664|Dexamethasone acetate|dexamethasone acetate|mesh-list
102435806|NCT05292664|Hydrocortisone|hydrocortisone|mesh-list
102435807|NCT05292664|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102435808|NCT05292664|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102435809|NCT05292664|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102435810|NCT05292664|Cortisone|cortisone|mesh-list
102435811|NCT05292664|Doxorubicin|doxorubicin|mesh-list
102435812|NCT05292664|Methotrexate|methotrexate|mesh-list
102435813|NCT05292664|Vincristine|vincristine|mesh-list
102435814|NCT05292664|Azacitidine|azacitidine|mesh-list
102435815|NCT05292664|Venetoclax|venetoclax|mesh-list
102435816|NCT05292664|Dexrazoxane|dexrazoxane|mesh-list
102435817|NCT05292664|Razoxane|razoxane|mesh-list
102435818|NCT05292664|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102435819|NCT05292664|BB 1101|bb 1101|mesh-list
102435820|NCT05292664|Levoleucovorin|levoleucovorin|mesh-list
102435821|NCT05292664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102435822|NCT05292664|Antiemetics|antiemetics|mesh-ancestor
102435823|NCT05292664|Autonomic Agents|autonomic agents|mesh-ancestor
102435824|NCT05292664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102435825|NCT05292664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435826|NCT05292664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102435827|NCT05292664|Glucocorticoids|glucocorticoids|mesh-ancestor
102435828|NCT05292664|Hormones|hormones|mesh-ancestor
102435829|NCT05292664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102435830|NCT05292664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102435831|NCT05292664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102435832|NCT05292664|Protease Inhibitors|protease inhibitors|mesh-ancestor
102435833|NCT05292664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102435834|NCT05292664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435835|NCT05292664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102435836|NCT05292664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102435837|NCT05292664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102435838|NCT05292664|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102435839|NCT05292664|Abortifacient Agents|abortifacient agents|mesh-ancestor
102435840|NCT05292664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102435841|NCT05292664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102435842|NCT05292664|Antimetabolites|antimetabolites|mesh-ancestor
102435843|NCT05292664|Dermatologic Agents|dermatologic agents|mesh-ancestor
102435844|NCT05292664|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102435845|NCT05292664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102435846|NCT05292664|Immunologic Factors|immunologic factors|mesh-ancestor
102435847|NCT05292664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102435848|NCT05292664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102435849|NCT05292664|Antiviral Agents|antiviral agents|mesh-ancestor
102435850|NCT05292664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102435851|NCT05292664|Antidotes|antidotes|mesh-ancestor
102435852|NCT05292664|Protective Agents|protective agents|mesh-ancestor
102435853|NCT05292664|Vitamin B Complex|vitamin b complex|mesh-ancestor
102435854|NCT05292664|Vitamins|vitamins|mesh-ancestor
102435855|NCT05292664|Micronutrients|micronutrients|mesh-ancestor
102435856|NCT05292664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102435857|NCT05292664|Tubulin Modulators|tubulin modulators|mesh-ancestor
102435858|NCT05292664|Antimitotic Agents|antimitotic agents|mesh-ancestor
102435859|NCT05292664|Mitosis Modulators|mitosis modulators|mesh-ancestor
102435860|NCT05292664|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102435861|NCT05283109|Vaccines|vaccines|mesh-list
102435862|NCT05283109|Poly ICLC|poly iclc|mesh-list
102435863|NCT05283109|Immunologic Factors|immunologic factors|mesh-ancestor
102435864|NCT05283109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435865|NCT05283109|Interferon Inducers|interferon inducers|mesh-ancestor
102435866|NCT05278975|Thiostrepton|thiostrepton|mesh-list
102435867|NCT05278975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102435868|NCT05278975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102435869|NCT05278351|Irinotecan|irinotecan|mesh-list
102435870|NCT05278351|Cetuximab|cetuximab|mesh-list
102435871|NCT05278351|Tislelizumab|tislelizumab|mesh-list
102435872|NCT05278351|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102435873|NCT05278351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102435874|NCT05278351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102435875|NCT05278351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435876|NCT05278351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102435877|NCT05278351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102435878|NCT05275907|Amlodipine|amlodipine|mesh-list
102435879|NCT05275907|Chlorthalidone|chlorthalidone|mesh-list
102435880|NCT05275907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102435881|NCT05275907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102435882|NCT05275907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102435883|NCT05275907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435884|NCT05275907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102247559|NCT03213743|Analgesics|analgesics|mesh-ancestor
102435885|NCT05275907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435886|NCT05275907|Vasodilator Agents|vasodilator agents|mesh-ancestor
102435887|NCT05275907|Diuretics|diuretics|mesh-ancestor
102435888|NCT05275907|Natriuretic Agents|natriuretic agents|mesh-ancestor
102435889|NCT05275907|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102435891|NCT05269628|Cannabidiol|cannabidiol|mesh-list
102435892|NCT05269628|Anticonvulsants|anticonvulsants|mesh-ancestor
102435893|NCT05269628|Hallucinogens|hallucinogens|mesh-ancestor
102435894|NCT05269628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435895|NCT05269628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102435896|NCT05269628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102435897|NCT05269628|Analgesics|analgesics|mesh-ancestor
102435898|NCT05269628|Sensory System Agents|sensory system agents|mesh-ancestor
102435899|NCT05269628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102435900|NCT05269628|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102435901|NCT05269628|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102435902|NCT05269628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102435903|NCT05269628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435904|NCT05269628|Hormones|hormones|mesh-ancestor
102435905|NCT05269628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102435906|NCT05263700|FAPI-46|fapi-46|mesh-list
102435907|NCT05263700|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102435908|NCT05263700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435909|NCT05257447|Baclofen|baclofen|mesh-list
102435910|NCT05257447|Chlorzoxazone|chlorzoxazone|mesh-list
102435911|NCT05257447|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102435912|NCT05257447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435913|NCT05257447|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102435914|NCT05257447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102435915|NCT05257447|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102435916|NCT05257447|GABA Agonists|gaba agonists|mesh-ancestor
102066416|NCT01380457|Hormones|hormones|mesh-ancestor
102435917|NCT05257447|GABA Agents|gaba agents|mesh-ancestor
102435918|NCT05257447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102435919|NCT05257447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435920|NCT05211154|Diclofenac|diclofenac|mesh-list
102435921|NCT05211154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102435922|NCT05211154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102435923|NCT05211154|Analgesics|analgesics|mesh-ancestor
102435924|NCT05211154|Sensory System Agents|sensory system agents|mesh-ancestor
102435925|NCT05211154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102435926|NCT05211154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435927|NCT05211154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102435928|NCT05211154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102435929|NCT05211154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102435930|NCT05211154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102435931|NCT05211154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435932|NCT05128344|Vigabatrin|vigabatrin|mesh-list
102435933|NCT05128344|Anticonvulsants|anticonvulsants|mesh-ancestor
102435934|NCT05128344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102435935|NCT05128344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435936|NCT05128344|GABA Agents|gaba agents|mesh-ancestor
102435937|NCT05128344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102435938|NCT05128344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435939|NCT05093296|Naltrexone|naltrexone|mesh-list
102435940|NCT05093296|Oxytocin|oxytocin|mesh-list
102435941|NCT05093296|Oxytocics|oxytocics|mesh-ancestor
102435942|NCT05093296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102435943|NCT05093296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435944|NCT05093296|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102435945|NCT05093296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102435946|NCT05093296|Sensory System Agents|sensory system agents|mesh-ancestor
102435947|NCT05093296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102435948|NCT05071833|Peppermint oil|peppermint oil|mesh-list
102435949|NCT05071833|Antiemetics|antiemetics|mesh-ancestor
102435950|NCT05071833|Autonomic Agents|autonomic agents|mesh-ancestor
102435951|NCT05071833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102435952|NCT05071833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435953|NCT05071833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102435954|NCT05071833|Parasympatholytics|parasympatholytics|mesh-ancestor
102435955|NCT05023369|Dexamethasone|dexamethasone|mesh-list
102435956|NCT05023369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102435957|NCT05023369|Antiemetics|antiemetics|mesh-ancestor
102435958|NCT05023369|Autonomic Agents|autonomic agents|mesh-ancestor
102435959|NCT05023369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102435960|NCT05023369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435961|NCT05023369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102435962|NCT05023369|Glucocorticoids|glucocorticoids|mesh-ancestor
102435963|NCT05023369|Hormones|hormones|mesh-ancestor
102435964|NCT05023369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102435965|NCT05023369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102435966|NCT05023369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102435967|NCT04818632|Everolimus|everolimus|mesh-list
102435968|NCT04818632|Palbociclib|palbociclib|mesh-list
102435969|NCT04818632|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102435970|NCT04818632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102435971|NCT04818632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102435972|NCT04818632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435973|NCT04818632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102435974|NCT04818632|Immunologic Factors|immunologic factors|mesh-ancestor
102435975|NCT04818632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435976|NCT04818632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102435977|NCT04729101|Lansoprazole|lansoprazole|mesh-list
102435978|NCT04729101|Dexlansoprazole|dexlansoprazole|mesh-list
102435979|NCT04729101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102435980|NCT04729101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102435981|NCT04729101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102435982|NCT04729101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102435983|NCT04729101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435984|NCT04713969|Pantoprazole|pantoprazole|mesh-list
102435985|NCT04713969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102435986|NCT04713969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102066437|NCT02221154|Folic Acid|folic acid|mesh-list
102435987|NCT04713969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102435988|NCT04713969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102435989|NCT04713969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102435990|NCT04707872|Antibodies|antibodies|mesh-list
102435991|NCT04707872|Immunologic Factors|immunologic factors|mesh-ancestor
102435992|NCT04707872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435993|NCT04673448|Niraparib|niraparib|mesh-list
102435994|NCT04673448|Dostarlimab|dostarlimab|mesh-list
102435995|NCT04673448|Immunoglobulins|immunoglobulins|mesh-list
102435996|NCT04673448|Immunoglobulin G|immunoglobulin g|mesh-list
102435997|NCT04673448|Immunologic Factors|immunologic factors|mesh-ancestor
102435998|NCT04673448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102435999|NCT04673448|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102436000|NCT04673448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102436001|NCT04673448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436002|NCT04673448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436003|NCT04670081|Niacinamide|niacinamide|mesh-list
102436004|NCT04670081|Niacin|niacin|mesh-list
102436005|NCT04670081|Nicotinic Acids|nicotinic acids|mesh-list
102436006|NCT04670081|Psilocybin|psilocybin|mesh-list
102436007|NCT04670081|Vitamin B Complex|vitamin b complex|mesh-ancestor
102436008|NCT04670081|Vitamins|vitamins|mesh-ancestor
102436009|NCT04670081|Micronutrients|micronutrients|mesh-ancestor
102436010|NCT04670081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436011|NCT04670081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102436012|NCT04670081|Antimetabolites|antimetabolites|mesh-ancestor
102436013|NCT04670081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436014|NCT04670081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102436015|NCT04670081|Vasodilator Agents|vasodilator agents|mesh-ancestor
102436016|NCT04670081|Hallucinogens|hallucinogens|mesh-ancestor
102436017|NCT04670081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102436018|NCT04648280|Fostemsavir|fostemsavir|mesh-list
102436019|NCT04648280|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102436020|NCT04648280|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102436021|NCT04648280|Antiviral Agents|antiviral agents|mesh-ancestor
102436022|NCT04648280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102436023|NCT04648280|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102436024|NCT04648280|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102436025|NCT04648280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436026|NCT04602377|Pembrolizumab|pembrolizumab|mesh-list
102436027|NCT04602377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102436028|NCT04602377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436029|NCT04602377|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102436030|NCT04602377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436031|NCT04601961|Propofol|propofol|mesh-list
102436032|NCT04601961|Sevoflurane|sevoflurane|mesh-list
102436033|NCT04601961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102436034|NCT04601961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102436035|NCT04601961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436036|NCT04601961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102436037|NCT04601961|Anesthetics, General|anesthetics, general|mesh-ancestor
102436038|NCT04601961|Anesthetics|anesthetics|mesh-ancestor
102436039|NCT04601961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102436041|NCT04551430|Nivolumab|nivolumab|mesh-list
102436042|NCT04551430|Ipilimumab|ipilimumab|mesh-list
102436043|NCT04551430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102436044|NCT04551430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436045|NCT04551430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102436046|NCT04551430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436047|NCT04513314|Valproic Acid|valproic acid|mesh-list
102436048|NCT04513314|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102436049|NCT04513314|Antidepressive Agents|antidepressive agents|mesh-ancestor
102436050|NCT04513314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102436051|NCT04513314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102436052|NCT04513314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102436053|NCT04513314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102436054|NCT04513314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436055|NCT04513314|Anticonvulsants|anticonvulsants|mesh-ancestor
102436056|NCT04513314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102436057|NCT04513314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436058|NCT04513314|GABA Agents|gaba agents|mesh-ancestor
102436059|NCT04513314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102436060|NCT04513314|Antimanic Agents|antimanic agents|mesh-ancestor
102436061|NCT04469868|Analgesics, Opioid|analgesics, opioid|mesh-list
102436062|NCT04469868|Narcotics|narcotics|mesh-ancestor
102436063|NCT04469868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102436064|NCT04469868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436065|NCT04469868|Analgesics|analgesics|mesh-ancestor
102436066|NCT04469868|Sensory System Agents|sensory system agents|mesh-ancestor
102436067|NCT04469868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102436068|NCT04451187|Zopiclone|zopiclone|mesh-list
102436069|NCT04451187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102436070|NCT04451187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102436071|NCT04451187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436072|NCT04363697|Dapagliflozin|dapagliflozin|mesh-list
102436073|NCT04363697|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102436074|NCT04363697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436075|NCT04363697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102436076|NCT04363697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436077|NCT04301778|Durvalumab|durvalumab|mesh-list
102436078|NCT04301778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102436079|NCT04301778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436080|NCT04287049|Azithromycin|azithromycin|mesh-list
102436081|NCT04287049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102436082|NCT04287049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102436083|NCT04282629|Milrinone|milrinone|mesh-list
102436084|NCT04282629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102436085|NCT04282629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102436086|NCT04282629|Vasodilator Agents|vasodilator agents|mesh-ancestor
102436087|NCT04282629|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102436088|NCT04282629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102436089|NCT04282629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102436090|NCT04282629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436091|NCT04282629|Protective Agents|protective agents|mesh-ancestor
102436092|NCT04282629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436093|NCT04275492|Pramipexole|pramipexole|mesh-list
102436094|NCT04275492|Antioxidants|antioxidants|mesh-ancestor
102436095|NCT04275492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436096|NCT04275492|Protective Agents|protective agents|mesh-ancestor
102436097|NCT04275492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436098|NCT04275492|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102436099|NCT04275492|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102436100|NCT04275492|Dopamine Agonists|dopamine agonists|mesh-ancestor
102436101|NCT04275492|Dopamine Agents|dopamine agents|mesh-ancestor
102436102|NCT04275492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102436103|NCT04265105|Fluticasone|fluticasone|mesh-list
102436104|NCT04265105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102436105|NCT04265105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102436106|NCT04265105|Autonomic Agents|autonomic agents|mesh-ancestor
102436107|NCT04265105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102436108|NCT04265105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436109|NCT04265105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102436110|NCT04265105|Respiratory System Agents|respiratory system agents|mesh-ancestor
102436111|NCT04265105|Dermatologic Agents|dermatologic agents|mesh-ancestor
102436112|NCT04265105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102436113|NCT04246229|Bilirubin|bilirubin|mesh-list
102436114|NCT04246229|Antioxidants|antioxidants|mesh-ancestor
102436115|NCT04246229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436117|NCT04246229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436118|NCT04239703|Antibodies|antibodies|mesh-list
102436119|NCT04239703|Immunologic Factors|immunologic factors|mesh-ancestor
102436120|NCT04239703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436121|NCT04031833|Amphotericin B|amphotericin b|mesh-list
102436122|NCT04031833|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102436123|NCT04031833|Amebicides|amebicides|mesh-ancestor
102436124|NCT04031833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102436125|NCT04031833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102436126|NCT04031833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102436127|NCT04031833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102436128|NCT04031833|Antifungal Agents|antifungal agents|mesh-ancestor
102436129|NCT03943875|Vaccines|vaccines|mesh-list
102436130|NCT03943875|Immunologic Factors|immunologic factors|mesh-ancestor
102436131|NCT03943875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436132|NCT03933202|Cladribine|cladribine|mesh-list
102436133|NCT03933202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436134|NCT03933202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102436135|NCT03933202|Immunologic Factors|immunologic factors|mesh-ancestor
102436136|NCT03933202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436137|NCT03908307|Dexamethasone|dexamethasone|mesh-list
102436138|NCT03908307|Dexamethasone acetate|dexamethasone acetate|mesh-list
102436139|NCT03908307|BB 1101|bb 1101|mesh-list
102436140|NCT03908307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102436141|NCT03908307|Antiemetics|antiemetics|mesh-ancestor
102436142|NCT03908307|Autonomic Agents|autonomic agents|mesh-ancestor
102436143|NCT03908307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102436144|NCT03908307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436145|NCT03908307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102436146|NCT03908307|Glucocorticoids|glucocorticoids|mesh-ancestor
102436147|NCT03908307|Hormones|hormones|mesh-ancestor
102436148|NCT03908307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102436149|NCT03908307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102436150|NCT03908307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436151|NCT03908307|Protease Inhibitors|protease inhibitors|mesh-ancestor
102436152|NCT03908307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102436153|NCT03908307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436154|NCT03841058|Abaloparatide|abaloparatide|mesh-list
102436155|NCT03841058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102436156|NCT03841058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436157|NCT03723564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102436158|NCT03688789|Hydrocortisone|hydrocortisone|mesh-list
102436159|NCT03688789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102436160|NCT03684590|Analgesics, Opioid|analgesics, opioid|mesh-list
102436161|NCT03684590|Narcotics|narcotics|mesh-ancestor
102436162|NCT03684590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102436163|NCT03684590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436164|NCT03684590|Analgesics|analgesics|mesh-ancestor
102436165|NCT03684590|Sensory System Agents|sensory system agents|mesh-ancestor
102436166|NCT03684590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102436167|NCT03492775|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102436168|NCT03492775|Obinutuzumab|obinutuzumab|mesh-list
102436169|NCT03492775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102436170|NCT03492775|Alkylating Agents|alkylating agents|mesh-ancestor
102436171|NCT03492775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436172|NCT03492775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436173|NCT03492775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102436174|NCT03385304|Iodine|iodine|mesh-list
102436175|NCT03385304|Chlorhexidine|chlorhexidine|mesh-list
102436176|NCT03385304|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102436177|NCT03385304|Povidone-Iodine|povidone-iodine|mesh-list
102436178|NCT03385304|Povidone|povidone|mesh-list
102436179|NCT03385304|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102436180|NCT03385304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102436181|NCT03385304|Disinfectants|disinfectants|mesh-ancestor
102436182|NCT03385304|Dermatologic Agents|dermatologic agents|mesh-ancestor
102436183|NCT03385304|Trace Elements|trace elements|mesh-ancestor
102436184|NCT03385304|Micronutrients|micronutrients|mesh-ancestor
102436185|NCT03385304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436186|NCT03385304|Plasma Substitutes|plasma substitutes|mesh-ancestor
102436187|NCT03385304|Blood Substitutes|blood substitutes|mesh-ancestor
102436188|NCT03351998|Atorvastatin|atorvastatin|mesh-list
102436189|NCT03351998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102436190|NCT03351998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102436191|NCT03351998|Antimetabolites|antimetabolites|mesh-ancestor
102436192|NCT03351998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436193|NCT03351998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102436194|NCT03351998|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102436195|NCT03351998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102436196|NCT03285568|Palbociclib|palbociclib|mesh-list
102436197|NCT03285568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436198|NCT03285568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102436199|NCT03285568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102436200|NCT03285568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436201|NCT03117816|Interferons|interferons|mesh-list
102436202|NCT03117816|Interferon-alpha|interferon-alpha|mesh-list
102436203|NCT03117816|Interferon alpha-2|interferon alpha-2|mesh-list
102436204|NCT03117816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436205|NCT03117816|Antiviral Agents|antiviral agents|mesh-ancestor
102436206|NCT03117816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102436207|NCT03117816|Immunologic Factors|immunologic factors|mesh-ancestor
102436208|NCT03117816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436209|NCT03038802|Vaccines|vaccines|mesh-list
102436210|NCT03038802|Immunologic Factors|immunologic factors|mesh-ancestor
102436211|NCT03038802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436212|NCT02938793|Durvalumab|durvalumab|mesh-list
102436213|NCT02938793|Tremelimumab|tremelimumab|mesh-list
102436214|NCT02938793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102436215|NCT02938793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436216|NCT02837094|Insulin|insulin|mesh-list
102436217|NCT02837094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102436218|NCT02837094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436219|NCT02836925|Sofosbuvir|sofosbuvir|mesh-list
102436220|NCT02836925|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102436221|NCT02836925|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102436222|NCT02836925|Ledipasvir|ledipasvir|mesh-list
102436223|NCT02836925|Velpatasvir|velpatasvir|mesh-list
102436224|NCT02836925|Antiviral Agents|antiviral agents|mesh-ancestor
102436225|NCT02836925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102436226|NCT02756962|Cytarabine|cytarabine|mesh-list
102436227|NCT02756962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102436228|NCT02756962|Antimetabolites|antimetabolites|mesh-ancestor
102436229|NCT02756962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436230|NCT02756962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436231|NCT02756962|Antiviral Agents|antiviral agents|mesh-ancestor
102436232|NCT02756962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102436233|NCT02756962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102436234|NCT02756962|Immunologic Factors|immunologic factors|mesh-ancestor
102436235|NCT02756962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436236|NCT02728037|Lidocaine|lidocaine|mesh-list
102436237|NCT02728037|Magnesium Sulfate|magnesium sulfate|mesh-list
102436238|NCT02728037|Anesthetics, Local|anesthetics, local|mesh-ancestor
102436239|NCT02728037|Anesthetics|anesthetics|mesh-ancestor
102436240|NCT02728037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102436241|NCT02728037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436242|NCT02728037|Sensory System Agents|sensory system agents|mesh-ancestor
102436243|NCT02728037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102436244|NCT02728037|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102436245|NCT02728037|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102436246|NCT02728037|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102436247|NCT02728037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102436248|NCT02728037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436249|NCT02728037|Analgesics|analgesics|mesh-ancestor
102436250|NCT02728037|Anticonvulsants|anticonvulsants|mesh-ancestor
102436251|NCT02728037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102436252|NCT02728037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102436253|NCT02728037|Tocolytic Agents|tocolytic agents|mesh-ancestor
102436254|NCT02728037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102436255|NCT02546440|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102436256|NCT02546440|Dermatologic Agents|dermatologic agents|mesh-ancestor
102436257|NCT02546440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102436258|NCT02546440|Immunologic Factors|immunologic factors|mesh-ancestor
102436259|NCT02546440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436260|NCT02392572|TIC10 compound|tic10 compound|mesh-list
102436261|NCT02392572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436262|NCT02275780|Ritonavir|ritonavir|mesh-list
102436263|NCT02275780|Darunavir|darunavir|mesh-list
102436264|NCT02275780|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102436265|NCT02275780|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102436266|NCT02275780|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102436267|NCT02275780|Protease Inhibitors|protease inhibitors|mesh-ancestor
102436268|NCT02275780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102436269|NCT02275780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436270|NCT02275780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102436271|NCT02275780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102436272|NCT02275780|Antiviral Agents|antiviral agents|mesh-ancestor
102436273|NCT02275780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102436274|NCT02275780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102436275|NCT02275780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102436276|NCT02275780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102436277|NCT02275780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102436278|NCT02158091|Cyclophosphamide|cyclophosphamide|mesh-list
102436279|NCT02158091|Rituximab|rituximab|mesh-list
102436280|NCT02158091|Fludarabine|fludarabine|mesh-list
102436281|NCT02158091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102436282|NCT02158091|Immunologic Factors|immunologic factors|mesh-ancestor
102436283|NCT02158091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436284|NCT02158091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102436285|NCT02158091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102436286|NCT02158091|Alkylating Agents|alkylating agents|mesh-ancestor
102436287|NCT02158091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436288|NCT02158091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436289|NCT02158091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102436290|NCT02158091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102436291|NCT00545077|Bevacizumab|bevacizumab|mesh-list
102436292|NCT00545077|Letrozole|letrozole|mesh-list
102436293|NCT00545077|Fulvestrant|fulvestrant|mesh-list
102436294|NCT00545077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102436295|NCT00545077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436296|NCT00545077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102436297|NCT00545077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102436298|NCT00545077|Growth Substances|growth substances|mesh-ancestor
102436299|NCT00545077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436300|NCT00545077|Growth Inhibitors|growth inhibitors|mesh-ancestor
102436301|NCT00545077|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102436302|NCT00545077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102436303|NCT00545077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102436304|NCT00545077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436305|NCT00545077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102436306|NCT00545077|Hormone Antagonists|hormone antagonists|mesh-ancestor
102436307|NCT00545077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102436308|NCT00545077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102436309|NCT00545077|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102436310|NCT00251433|Docetaxel|docetaxel|mesh-list
102436311|NCT00251433|Trastuzumab|trastuzumab|mesh-list
102436312|NCT00251433|Lapatinib|lapatinib|mesh-list
102436313|NCT00251433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436314|NCT00251433|Tubulin Modulators|tubulin modulators|mesh-ancestor
102436315|NCT00251433|Antimitotic Agents|antimitotic agents|mesh-ancestor
102436316|NCT00251433|Mitosis Modulators|mitosis modulators|mesh-ancestor
102436317|NCT00251433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436318|NCT00251433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102436319|NCT00251433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102436320|NCT00251433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102436321|NCT00130533|Capecitabine|capecitabine|mesh-list
102436322|NCT00130533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102436323|NCT00130533|Antimetabolites|antimetabolites|mesh-ancestor
102436324|NCT00130533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436325|NCT00130533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436326|NCT00129935|Cyclophosphamide|cyclophosphamide|mesh-list
102436327|NCT00129935|Docetaxel|docetaxel|mesh-list
102436328|NCT00129935|Capecitabine|capecitabine|mesh-list
102436329|NCT00129935|Epirubicin|epirubicin|mesh-list
102436330|NCT00129935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102436331|NCT00129935|Immunologic Factors|immunologic factors|mesh-ancestor
102436332|NCT00129935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436333|NCT00129935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102436334|NCT00129935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102436335|NCT00129935|Alkylating Agents|alkylating agents|mesh-ancestor
102436336|NCT00129935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436337|NCT00129935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436338|NCT00129935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102436339|NCT00129935|Tubulin Modulators|tubulin modulators|mesh-ancestor
102436340|NCT00129935|Antimitotic Agents|antimitotic agents|mesh-ancestor
102436341|NCT00129935|Mitosis Modulators|mitosis modulators|mesh-ancestor
102436342|NCT00129935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102436343|NCT00129935|Antimetabolites|antimetabolites|mesh-ancestor
102436344|NCT00129935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102436345|NCT00129935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102436346|NCT00129935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102436347|NCT00129935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102436349|NCT02760667|Carboplatin|carboplatin|mesh-list
102436350|NCT02760667|Docetaxel|docetaxel|mesh-list
102436351|NCT02760667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436352|NCT02760667|Tubulin Modulators|tubulin modulators|mesh-ancestor
102436353|NCT02760667|Antimitotic Agents|antimitotic agents|mesh-ancestor
102436354|NCT02760667|Mitosis Modulators|mitosis modulators|mesh-ancestor
102436355|NCT02760667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436356|NCT04127357|Fluorides|fluorides|mesh-list
102436357|NCT04127357|Cariostatic Agents|cariostatic agents|mesh-ancestor
102436358|NCT04127357|Protective Agents|protective agents|mesh-ancestor
102436359|NCT04127357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436360|NCT01450111|Lacosamide|lacosamide|mesh-list
102436361|NCT01450111|Anticonvulsants|anticonvulsants|mesh-ancestor
102436362|NCT01450111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102436363|NCT01450111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102436364|NCT01450111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102436365|NCT01450111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436366|NCT02697253|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102436367|NCT02697253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102436368|NCT02697253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436369|NCT02697253|Incretins|incretins|mesh-ancestor
102436370|NCT02697253|Hormones|hormones|mesh-ancestor
102436371|NCT02697253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102436372|NCT02697253|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102436373|NCT02697253|Protease Inhibitors|protease inhibitors|mesh-ancestor
102436374|NCT02697253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102436375|NCT02697253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436376|NCT02660905|Tenofovir|tenofovir|mesh-list
102436377|NCT02660905|Emtricitabine|emtricitabine|mesh-list
102436378|NCT02660905|Sofosbuvir|sofosbuvir|mesh-list
102436379|NCT02660905|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102436380|NCT02660905|Rilpivirine|rilpivirine|mesh-list
102436381|NCT02660905|Ledipasvir|ledipasvir|mesh-list
102436382|NCT02660905|Antiviral Agents|antiviral agents|mesh-ancestor
102436383|NCT02660905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102436384|NCT02660905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102436385|NCT02660905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102436386|NCT02660905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102436387|NCT02660905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436388|NCT02660905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102436389|NCT02660905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102436390|NCT03822715|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102436391|NCT03822715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102436392|NCT03822715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102436393|NCT03822715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436394|NCT03822715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102436395|NCT03822715|Hormone Antagonists|hormone antagonists|mesh-ancestor
102436396|NCT03822715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102436397|NCT03822715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436398|NCT01450345|Pregabalin|pregabalin|mesh-list
102436399|NCT01450345|Analgesics|analgesics|mesh-ancestor
102436400|NCT01450345|Sensory System Agents|sensory system agents|mesh-ancestor
102436401|NCT01450345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102436402|NCT01450345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436403|NCT01450345|Anticonvulsants|anticonvulsants|mesh-ancestor
102436404|NCT01450345|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102436405|NCT01450345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102436406|NCT01450345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436407|NCT01450345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102436408|NCT01450345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102436409|NCT01450345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102436410|NCT01450345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102436411|NCT01450345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102436412|NCT03822559|Timolol|timolol|mesh-list
102436413|NCT03822559|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102436414|NCT03822559|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102436415|NCT03822559|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102436416|NCT03822559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102436417|NCT03822559|Adrenergic Agents|adrenergic agents|mesh-ancestor
102436418|NCT03822559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102436419|NCT03822559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436420|NCT03822559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436421|NCT03822559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102436422|NCT03822559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102436423|NCT01647828|Paclitaxel|paclitaxel|mesh-list
102436424|NCT01647828|Gemcitabine|gemcitabine|mesh-list
102436425|NCT01647828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102436426|NCT01647828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436427|NCT01647828|Tubulin Modulators|tubulin modulators|mesh-ancestor
102436428|NCT01647828|Antimitotic Agents|antimitotic agents|mesh-ancestor
102436429|NCT01647828|Mitosis Modulators|mitosis modulators|mesh-ancestor
102436430|NCT01647828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436431|NCT01647828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102436432|NCT01647828|Antimetabolites|antimetabolites|mesh-ancestor
102436433|NCT03825367|Nivolumab|nivolumab|mesh-list
102436434|NCT03825367|Azacitidine|azacitidine|mesh-list
102436435|NCT03825367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102436436|NCT03825367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436437|NCT03825367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102436438|NCT03825367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436439|NCT03825367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102436440|NCT03825367|Antimetabolites|antimetabolites|mesh-ancestor
102436441|NCT03825367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102436442|NCT04273321|Methylprednisolone|methylprednisolone|mesh-list
102436443|NCT04273321|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102436444|NCT04273321|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102436445|NCT04273321|Prednisolone|prednisolone|mesh-list
102436446|NCT04273321|Prednisolone acetate|prednisolone acetate|mesh-list
102436447|NCT04273321|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102436448|NCT04273321|Prednisolone phosphate|prednisolone phosphate|mesh-list
102436449|NCT04273321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102436450|NCT04273321|Antiemetics|antiemetics|mesh-ancestor
102436451|NCT04273321|Autonomic Agents|autonomic agents|mesh-ancestor
102436452|NCT04273321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102436453|NCT04273321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436454|NCT04273321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102436455|NCT04273321|Glucocorticoids|glucocorticoids|mesh-ancestor
102436456|NCT04273321|Hormones|hormones|mesh-ancestor
102436457|NCT04273321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102436458|NCT04273321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102436459|NCT04273321|Protective Agents|protective agents|mesh-ancestor
102436460|NCT04273321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102436461|NCT04273321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436462|NCT01243476|Lenalidomide|lenalidomide|mesh-list
102436463|NCT01243476|Immunologic Factors|immunologic factors|mesh-ancestor
102436464|NCT01243476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436465|NCT01243476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102436466|NCT01243476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102436467|NCT01243476|Growth Substances|growth substances|mesh-ancestor
102436468|NCT01243476|Growth Inhibitors|growth inhibitors|mesh-ancestor
102436469|NCT01243476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436470|NCT01453933|Raltegravir Potassium|raltegravir potassium|mesh-list
102436471|NCT01453933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102436472|NCT01453933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102436473|NCT01453933|Antiviral Agents|antiviral agents|mesh-ancestor
102436474|NCT01453933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102436475|NCT01453933|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102436476|NCT01453933|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102436477|NCT01453933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102436478|NCT01453933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436479|NCT04976478|Nimotuzumab|nimotuzumab|mesh-list
102436480|NCT04976478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102436481|NCT04976478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436482|NCT01454011|Methyltestosterone|methyltestosterone|mesh-list
102436483|NCT01454011|Testosterone|testosterone|mesh-list
102436484|NCT01454011|Testosterone undecanoate|testosterone undecanoate|mesh-list
102436485|NCT01454011|Testosterone enanthate|testosterone enanthate|mesh-list
102436486|NCT01454011|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102436487|NCT01454011|Androgens|androgens|mesh-ancestor
102436488|NCT01454011|Hormones|hormones|mesh-ancestor
102436489|NCT01454011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102436490|NCT01454011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436491|NCT01454011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102436492|NCT01454011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436493|NCT01454011|Anabolic Agents|anabolic agents|mesh-ancestor
102436495|NCT03060018|Parasympatholytics|parasympatholytics|mesh-ancestor
102436496|NCT03060018|Autonomic Agents|autonomic agents|mesh-ancestor
102436497|NCT03060018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102436498|NCT03060018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436499|NCT04976088|Diclofenac|diclofenac|mesh-list
102436500|NCT04976088|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
102436501|NCT04976088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102436502|NCT04976088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102436503|NCT04976088|Analgesics|analgesics|mesh-ancestor
102436504|NCT04976088|Sensory System Agents|sensory system agents|mesh-ancestor
102436505|NCT04976088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102436506|NCT04976088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436507|NCT04976088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102436508|NCT04976088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102436509|NCT04976088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102436510|NCT04976088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102436511|NCT04976088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436512|NCT04975932|Chlorotrianisene|chlorotrianisene|mesh-list
102436513|NCT04975932|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102436514|NCT04975932|Estrogens|estrogens|mesh-ancestor
102436515|NCT04975932|Hormones|hormones|mesh-ancestor
102436516|NCT04975932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102436517|NCT04975932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436518|NCT04975932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102436519|NCT04975932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436520|NCT04968132|Analgesics, Opioid|analgesics, opioid|mesh-list
102436521|NCT04968132|Narcotics|narcotics|mesh-ancestor
102436522|NCT04968132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102436523|NCT04968132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436524|NCT04968132|Analgesics|analgesics|mesh-ancestor
102436525|NCT04968132|Sensory System Agents|sensory system agents|mesh-ancestor
102436526|NCT04968132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102436527|NCT03829111|Nivolumab|nivolumab|mesh-list
102436528|NCT03829111|Ipilimumab|ipilimumab|mesh-list
102436529|NCT03829111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102436530|NCT03829111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436531|NCT03829111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102436532|NCT03829111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436533|NCT01454479|Lapatinib|lapatinib|mesh-list
102436534|NCT01454479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436535|NCT01454479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102436536|NCT01454479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102436537|NCT01454479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436538|NCT03061032|Ribavirin|ribavirin|mesh-list
102436539|NCT03061032|Sofosbuvir|sofosbuvir|mesh-list
102436540|NCT03061032|Ledipasvir|ledipasvir|mesh-list
102436541|NCT03061032|Antimetabolites|antimetabolites|mesh-ancestor
102436542|NCT03061032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436543|NCT03061032|Antiviral Agents|antiviral agents|mesh-ancestor
102436544|NCT03061032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102436545|NCT02911831|Tranexamic Acid|tranexamic acid|mesh-list
102436546|NCT02911831|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102436547|NCT02911831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102436548|NCT02911831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436549|NCT02911831|Hemostatics|hemostatics|mesh-ancestor
102436550|NCT02911831|Coagulants|coagulants|mesh-ancestor
102436551|NCT03061734|Acetaminophen|acetaminophen|mesh-list
102436552|NCT03061734|Naltrexone|naltrexone|mesh-list
102436553|NCT03061734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102436554|NCT03061734|Analgesics|analgesics|mesh-ancestor
102436555|NCT03061734|Sensory System Agents|sensory system agents|mesh-ancestor
102436556|NCT03061734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102436557|NCT03061734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436558|NCT03061734|Antipyretics|antipyretics|mesh-ancestor
102436559|NCT03061734|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102436560|NCT03061734|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102436561|NCT03061656|Cyclophosphamide|cyclophosphamide|mesh-list
102248232|NCT04836819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102436562|NCT03061656|Melphalan|melphalan|mesh-list
102436563|NCT03061656|Thiotepa|thiotepa|mesh-list
102436564|NCT03061656|Carboplatin|carboplatin|mesh-list
102436565|NCT03061656|Etoposide|etoposide|mesh-list
102436566|NCT03061656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102436567|NCT03061656|Immunologic Factors|immunologic factors|mesh-ancestor
102436568|NCT03061656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436569|NCT03061656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102436570|NCT03061656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102436571|NCT03061656|Alkylating Agents|alkylating agents|mesh-ancestor
102067020|NCT04058145|Plerixafor|plerixafor|mesh-list
102436572|NCT03061656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436573|NCT03061656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436574|NCT03061656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102436575|NCT03061656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102436576|NCT03061656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102436577|NCT03061656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102436578|NCT03061656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102436579|NCT02906761|Aspirin|aspirin|mesh-list
102436580|NCT02906761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102436581|NCT02906761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102436582|NCT02906761|Analgesics|analgesics|mesh-ancestor
102436583|NCT02906761|Sensory System Agents|sensory system agents|mesh-ancestor
102436584|NCT02906761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102436585|NCT02906761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436586|NCT02906761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102436587|NCT02906761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102436588|NCT02906761|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102436589|NCT02906761|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102436590|NCT02906761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436591|NCT02906761|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102436592|NCT02906761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102436593|NCT02906761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102436594|NCT02906761|Antipyretics|antipyretics|mesh-ancestor
102436595|NCT01455025|Plerixafor|plerixafor|mesh-list
102436596|NCT01455025|Lenograstim|lenograstim|mesh-list
102436597|NCT01455025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102436598|NCT01455025|Immunologic Factors|immunologic factors|mesh-ancestor
102436599|NCT01455025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436600|NCT01455025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102436601|NCT01455025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102436602|NCT01455025|Antiviral Agents|antiviral agents|mesh-ancestor
102436603|NCT01455025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102436604|NCT03060798|Desflurane|desflurane|mesh-list
102436605|NCT03060798|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102436606|NCT03060798|Anesthetics, General|anesthetics, general|mesh-ancestor
102436607|NCT03060798|Anesthetics|anesthetics|mesh-ancestor
102436608|NCT03060798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102436609|NCT03060798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436610|NCT01451593|Phenytoin|phenytoin|mesh-list
102436611|NCT01451593|Anticonvulsants|anticonvulsants|mesh-ancestor
102436612|NCT01451593|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102436613|NCT01451593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102436614|NCT01451593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102436615|NCT01451593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436616|NCT01451593|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102436617|NCT01451593|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102436618|NCT01455103|BMS-936559|bms-936559|mesh-list
102436619|NCT01455103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102436620|NCT01455103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102436621|NCT01455103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436622|NCT01455103|Immunologic Factors|immunologic factors|mesh-ancestor
102436623|NCT01455103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436624|NCT04975074|Iron|iron|mesh-list
102436625|NCT04975074|Ferrous succinate|ferrous succinate|mesh-list
102436626|NCT04975074|Trace Elements|trace elements|mesh-ancestor
102436627|NCT04975074|Micronutrients|micronutrients|mesh-ancestor
102436628|NCT04975074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436629|NCT04975074|Hematinics|hematinics|mesh-ancestor
102436630|NCT04963998|Copper|copper|mesh-list
102436631|NCT04963998|Trace Elements|trace elements|mesh-ancestor
102436632|NCT04963998|Micronutrients|micronutrients|mesh-ancestor
102436633|NCT04963998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436634|NCT01451905|Liraglutide|liraglutide|mesh-list
102436635|NCT01451905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102436636|NCT01451905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436637|NCT01451905|Incretins|incretins|mesh-ancestor
102436638|NCT01451905|Hormones|hormones|mesh-ancestor
102436639|NCT01451905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102436640|NCT01455649|Cyclosporine|cyclosporine|mesh-list
102436641|NCT01455649|Everolimus|everolimus|mesh-list
102436642|NCT01455649|Tacrolimus|tacrolimus|mesh-list
102436643|NCT01455649|Cyclosporins|cyclosporins|mesh-list
102436644|NCT01455649|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
102436645|NCT01455649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102436646|NCT01455649|Immunologic Factors|immunologic factors|mesh-ancestor
102436647|NCT01455649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436648|NCT01455649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102436649|NCT01455649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436650|NCT01455649|Antifungal Agents|antifungal agents|mesh-ancestor
102436651|NCT01455649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102436652|NCT01455649|Dermatologic Agents|dermatologic agents|mesh-ancestor
102436653|NCT01455649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102436655|NCT01455649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102436656|NCT01455649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436657|NCT04974294|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102436658|NCT04974294|Immunologic Factors|immunologic factors|mesh-ancestor
102436659|NCT04974294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436660|NCT01452139|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102436661|NCT01452139|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102436662|NCT04852458|Hydrocortisone|hydrocortisone|mesh-list
102436663|NCT04852458|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102436664|NCT04852458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102436665|NCT01455883|Glimepiride|glimepiride|mesh-list
102436666|NCT01455883|Exenatide|exenatide|mesh-list
102436667|NCT01455883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102436668|NCT01455883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102436669|NCT01455883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436670|NCT01455883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102436671|NCT01455883|Immunologic Factors|immunologic factors|mesh-ancestor
102436672|NCT01455883|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102436673|NCT01455883|Incretins|incretins|mesh-ancestor
102436674|NCT01455883|Hormones|hormones|mesh-ancestor
102436675|NCT01455883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102436676|NCT01452217|Secretin|secretin|mesh-list
102436677|NCT01452217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102436678|NCT01452217|Hormones|hormones|mesh-ancestor
102436679|NCT01452217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102436680|NCT01452217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436681|NCT04966884|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
102436682|NCT04966884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102436683|NCT04966884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102436684|NCT04966884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436685|NCT02637583|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102436686|NCT02637583|Immunologic Factors|immunologic factors|mesh-ancestor
102436687|NCT02637583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436688|NCT04954560|Losartan|losartan|mesh-list
102436689|NCT04954560|Eprosartan|eprosartan|mesh-list
102436690|NCT04954560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102436691|NCT04954560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102067140|NCT02226926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102436692|NCT04954560|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102436693|NCT04954560|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102436694|NCT04954560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436695|NCT04954560|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
102436696|NCT01456117|Pioglitazone|pioglitazone|mesh-list
102436697|NCT01456117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102436698|NCT01456117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436699|NCT03829345|Olaparib|olaparib|mesh-list
102436700|NCT03829345|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102436701|NCT03829345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102436702|NCT03829345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436703|NCT03829345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436704|NCT01456351|Rituximab|rituximab|mesh-list
102436705|NCT01456351|Fludarabine|fludarabine|mesh-list
102436706|NCT01456351|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102436707|NCT01456351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102436708|NCT01456351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436709|NCT01456351|Immunologic Factors|immunologic factors|mesh-ancestor
102436710|NCT01456351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436711|NCT01456351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102436712|NCT01456351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436713|NCT01456351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102436714|NCT01456351|Alkylating Agents|alkylating agents|mesh-ancestor
102436715|NCT02541955|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102436716|NCT02541955|Hormones|hormones|mesh-ancestor
102436717|NCT02541955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102436718|NCT02541955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436719|NCT01452685|Leuprolide|leuprolide|mesh-list
102436720|NCT01452685|Relugolix|relugolix|mesh-list
102436721|NCT01452685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102436722|NCT01452685|Fertility Agents|fertility agents|mesh-ancestor
102436723|NCT01452685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102436724|NCT01452685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436725|NCT01452685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102436726|NCT01452685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436727|NCT01452685|Androgen Antagonists|androgen antagonists|mesh-ancestor
102436728|NCT01452685|Hormone Antagonists|hormone antagonists|mesh-ancestor
102436729|NCT01452685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102436730|NCT01452763|Lansoprazole|lansoprazole|mesh-list
102436731|NCT01452763|Dexlansoprazole|dexlansoprazole|mesh-list
102436732|NCT01452763|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102436733|NCT01452763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102436734|NCT01452763|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102436735|NCT01452763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102436736|NCT01452763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436737|NCT04954014|Bevacizumab|bevacizumab|mesh-list
102436738|NCT04954014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102436739|NCT04954014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436740|NCT04954014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102436741|NCT04954014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102436742|NCT04954014|Growth Substances|growth substances|mesh-ancestor
102436743|NCT04954014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436744|NCT04954014|Growth Inhibitors|growth inhibitors|mesh-ancestor
102436745|NCT00988559|Imiquimod|imiquimod|mesh-list
102436746|NCT00988559|Vaccines|vaccines|mesh-list
102436747|NCT00988559|Immunologic Factors|immunologic factors|mesh-ancestor
102436748|NCT00988559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436749|NCT00988559|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102436750|NCT00988559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436751|NCT00988559|Interferon Inducers|interferon inducers|mesh-ancestor
102436752|NCT02967289|Irinotecan|irinotecan|mesh-list
102436753|NCT02967289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102436754|NCT02967289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102436755|NCT02967289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102436756|NCT02967289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436757|NCT02967289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436758|NCT00988169|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102436759|NCT00988169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436760|NCT00988169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102436761|NCT00988169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102436762|NCT00988169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436763|NCT02967133|Paclitaxel|paclitaxel|mesh-list
102436764|NCT02967133|Nivolumab|nivolumab|mesh-list
102436765|NCT02967133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102436766|NCT02967133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436767|NCT02967133|Tubulin Modulators|tubulin modulators|mesh-ancestor
102436768|NCT02967133|Antimitotic Agents|antimitotic agents|mesh-ancestor
102436769|NCT02967133|Mitosis Modulators|mitosis modulators|mesh-ancestor
102436770|NCT02967133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436771|NCT02967133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102436772|NCT02967133|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102436773|NCT04961970|Leucovorin|leucovorin|mesh-list
102436774|NCT04961970|Gemcitabine|gemcitabine|mesh-list
102436775|NCT04961970|Fluorouracil|fluorouracil|mesh-list
102436776|NCT04961970|Oxaliplatin|oxaliplatin|mesh-list
102436777|NCT04961970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436778|NCT04961970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102436779|NCT04961970|Antimetabolites|antimetabolites|mesh-ancestor
102436780|NCT04961970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436781|NCT04961970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102436782|NCT04961970|Immunologic Factors|immunologic factors|mesh-ancestor
102436783|NCT04961970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436784|NCT04961970|Antidotes|antidotes|mesh-ancestor
102436785|NCT04961970|Protective Agents|protective agents|mesh-ancestor
102436786|NCT04961970|Vitamin B Complex|vitamin b complex|mesh-ancestor
102436787|NCT04961970|Vitamins|vitamins|mesh-ancestor
102436788|NCT04961970|Micronutrients|micronutrients|mesh-ancestor
102436789|NCT01311687|Dexamethasone|dexamethasone|mesh-list
102436790|NCT01311687|Pomalidomide|pomalidomide|mesh-list
102436791|NCT01311687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102436792|NCT01311687|Antiemetics|antiemetics|mesh-ancestor
102436793|NCT01311687|Autonomic Agents|autonomic agents|mesh-ancestor
102436794|NCT01311687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102436795|NCT01311687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436796|NCT01311687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102436797|NCT01311687|Glucocorticoids|glucocorticoids|mesh-ancestor
102436799|NCT01311687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102436800|NCT01311687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102436801|NCT01311687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436802|NCT01311687|Immunologic Factors|immunologic factors|mesh-ancestor
102436803|NCT01311687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102436804|NCT01311687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102436805|NCT01311687|Growth Substances|growth substances|mesh-ancestor
102436806|NCT01311687|Growth Inhibitors|growth inhibitors|mesh-ancestor
102436807|NCT00988091|Hyaluronic Acid|hyaluronic acid|mesh-list
102436808|NCT00988091|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102436809|NCT00988091|Immunologic Factors|immunologic factors|mesh-ancestor
102436810|NCT00988091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436811|NCT00988091|Viscosupplements|viscosupplements|mesh-ancestor
102436812|NCT00988091|Protective Agents|protective agents|mesh-ancestor
102436813|NCT04965324|Anesthetics|anesthetics|mesh-list
102436814|NCT04965324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102436815|NCT04965324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436816|NCT04961268|Acetaminophen|acetaminophen|mesh-list
102436817|NCT04961268|Ibuprofen|ibuprofen|mesh-list
102436818|NCT04961268|Tramadol|tramadol|mesh-list
102436819|NCT04961268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102436820|NCT04961268|Analgesics|analgesics|mesh-ancestor
102436821|NCT04961268|Sensory System Agents|sensory system agents|mesh-ancestor
102436822|NCT04961268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102436823|NCT04961268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436824|NCT04961268|Antipyretics|antipyretics|mesh-ancestor
102436825|NCT04961268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102436826|NCT04961268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102067274|NCT02231606|Methamphetamine|methamphetamine|mesh-list
102436827|NCT04961268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102436828|NCT04961268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102436829|NCT04961268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102436830|NCT04961268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436831|NCT04961268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102436832|NCT04961268|Narcotics|narcotics|mesh-ancestor
102436833|NCT04961268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102436834|NCT03828643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102436835|NCT03828643|Immunologic Factors|immunologic factors|mesh-ancestor
102436836|NCT03828643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436837|NCT01346397|Cyclosporine|cyclosporine|mesh-list
102436838|NCT01346397|Tacrolimus|tacrolimus|mesh-list
102436839|NCT01346397|Cyclosporins|cyclosporins|mesh-list
102436840|NCT01346397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102436841|NCT01346397|Immunologic Factors|immunologic factors|mesh-ancestor
102436842|NCT01346397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436843|NCT01346397|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102436844|NCT01346397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102436845|NCT01346397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436846|NCT01346397|Antifungal Agents|antifungal agents|mesh-ancestor
102436847|NCT01346397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102436848|NCT01346397|Dermatologic Agents|dermatologic agents|mesh-ancestor
102436849|NCT01346397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102436850|NCT01347255|Betamethasone|betamethasone|mesh-list
102436851|NCT01347255|Betamethasone Valerate|betamethasone valerate|mesh-list
102436852|NCT01347255|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102436853|NCT01347255|Betamethasone benzoate|betamethasone benzoate|mesh-list
102436854|NCT01347255|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102436855|NCT01347255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102436856|NCT01347255|Glucocorticoids|glucocorticoids|mesh-ancestor
102436857|NCT01347255|Hormones|hormones|mesh-ancestor
102436858|NCT01347255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102436859|NCT01347255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436860|NCT01347255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102436861|NCT01347255|Respiratory System Agents|respiratory system agents|mesh-ancestor
102436862|NCT04392427|Ribavirin|ribavirin|mesh-list
102436863|NCT04392427|Ivermectin|ivermectin|mesh-list
102436864|NCT04392427|Nitazoxanide|nitazoxanide|mesh-list
102436865|NCT04392427|Antimetabolites|antimetabolites|mesh-ancestor
102436866|NCT04392427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436867|NCT04392427|Antiviral Agents|antiviral agents|mesh-ancestor
102436868|NCT04392427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102436869|NCT04392427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102436870|NCT01457131|Cyclophosphamide|cyclophosphamide|mesh-list
102436871|NCT01457131|Fludarabine|fludarabine|mesh-list
102436872|NCT01457131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102436873|NCT01457131|Immunologic Factors|immunologic factors|mesh-ancestor
102436874|NCT01457131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436875|NCT01457131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102436876|NCT01457131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102436877|NCT01457131|Alkylating Agents|alkylating agents|mesh-ancestor
102436878|NCT01457131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436879|NCT01457131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436880|NCT01457131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102436881|NCT03057990|Pyrimethamine|pyrimethamine|mesh-list
102436882|NCT03057990|Antimalarials|antimalarials|mesh-ancestor
102436883|NCT03057990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102436884|NCT03057990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102436885|NCT03057990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102436886|NCT03057990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102436887|NCT03057990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102436888|NCT03057990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436889|NCT01455337|Prednisolone|prednisolone|mesh-list
102436890|NCT01455337|Pentoxifylline|pentoxifylline|mesh-list
102436891|NCT01455337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102436892|NCT01455337|Glucocorticoids|glucocorticoids|mesh-ancestor
102436893|NCT01455337|Hormones|hormones|mesh-ancestor
102436894|NCT01455337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102436895|NCT01455337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436896|NCT01455337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102436897|NCT01455337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436898|NCT01455337|Protective Agents|protective agents|mesh-ancestor
102436899|NCT01455337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102436900|NCT01455337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102436901|NCT01455337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436902|NCT01455337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102436903|NCT01455337|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102436904|NCT01455337|Vasodilator Agents|vasodilator agents|mesh-ancestor
102436905|NCT01455337|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102436906|NCT01455337|Antioxidants|antioxidants|mesh-ancestor
102436907|NCT03059316|Labetalol|labetalol|mesh-list
102436908|NCT03059316|Nitroglycerin|nitroglycerin|mesh-list
102436909|NCT03059316|Vasodilator Agents|vasodilator agents|mesh-ancestor
102436910|NCT03059316|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102436911|NCT03059316|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102436912|NCT03059316|Adrenergic Agents|adrenergic agents|mesh-ancestor
102436913|NCT03059316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102436914|NCT03059316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436915|NCT03059316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436916|NCT03059316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102436917|NCT03059316|Sympathomimetics|sympathomimetics|mesh-ancestor
102436918|NCT03059316|Autonomic Agents|autonomic agents|mesh-ancestor
102436919|NCT03059316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102436920|NCT03059316|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102436921|NCT03059316|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102436922|NCT01312389|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
102436923|NCT01312389|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
102436924|NCT01312389|Immunologic Factors|immunologic factors|mesh-ancestor
102436925|NCT01312389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436926|NCT01312389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102436927|NCT01312389|Antiviral Agents|antiviral agents|mesh-ancestor
102436928|NCT01312389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102436929|NCT04943952|Asparaginase|asparaginase|mesh-list
102436930|NCT04943952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436931|NCT01352637|Cycloserine|cycloserine|mesh-list
102436932|NCT01352637|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102436933|NCT01352637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102436934|NCT01352637|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102436935|NCT01352637|Antitubercular Agents|antitubercular agents|mesh-ancestor
102436936|NCT01352637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102436937|NCT01352637|Antimetabolites|antimetabolites|mesh-ancestor
102436938|NCT01352637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436939|NCT03058536|Progesterone|progesterone|mesh-list
102436940|NCT03058536|Progestins|progestins|mesh-ancestor
102436941|NCT03058536|Hormones|hormones|mesh-ancestor
102436942|NCT03058536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102248604|NCT04814589|Ezetimibe|ezetimibe|mesh-list
102436943|NCT03058536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436944|NCT01314417|Methotrexate|methotrexate|mesh-list
102436945|NCT01314417|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102436946|NCT01314417|Abortifacient Agents|abortifacient agents|mesh-ancestor
102436947|NCT01314417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102436948|NCT01314417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436949|NCT01314417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102436950|NCT01314417|Antimetabolites|antimetabolites|mesh-ancestor
102436951|NCT01314417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436952|NCT01314417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102436953|NCT01314417|Dermatologic Agents|dermatologic agents|mesh-ancestor
102436954|NCT01314417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102436955|NCT01314417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102436956|NCT01314417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102436957|NCT01314417|Immunologic Factors|immunologic factors|mesh-ancestor
102436958|NCT01314417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102436959|NCT01314417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102436960|NCT01457911|Metformin|metformin|mesh-list
102436961|NCT01457911|Glimepiride|glimepiride|mesh-list
102436962|NCT01457911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102436963|NCT01457911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436964|NCT01457911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102436965|NCT01457911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102436966|NCT01457911|Immunologic Factors|immunologic factors|mesh-ancestor
102436967|NCT02893423|Ropivacaine|ropivacaine|mesh-list
102436968|NCT02893423|Anesthetics, Local|anesthetics, local|mesh-ancestor
102436969|NCT02893423|Anesthetics|anesthetics|mesh-ancestor
102436970|NCT02893423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102436971|NCT02893423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436972|NCT02893423|Sensory System Agents|sensory system agents|mesh-ancestor
102436973|NCT02893423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102436974|NCT05586919|Ethanol|ethanol|mesh-list
102436975|NCT05586919|Polidocanol|polidocanol|mesh-list
102436976|NCT05586919|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102436977|NCT05586919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102436978|NCT05586919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102436979|NCT05586919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436980|NCT05586919|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102436981|NCT05586919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102436982|NCT01890889|Ezetimibe|ezetimibe|mesh-list
102436983|NCT01890889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102436984|NCT01890889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102436985|NCT01890889|Antimetabolites|antimetabolites|mesh-ancestor
102436986|NCT01890889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102436987|NCT01890889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102436988|NCT04951752|Ropivacaine|ropivacaine|mesh-list
102436989|NCT04951752|Anesthetics, Local|anesthetics, local|mesh-ancestor
102436990|NCT04951752|Anesthetics|anesthetics|mesh-ancestor
102436991|NCT04951752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102436992|NCT04951752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436993|NCT04951752|Sensory System Agents|sensory system agents|mesh-ancestor
102436994|NCT04951752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102436995|NCT01315665|Sulforaphane|sulforaphane|mesh-list
102436996|NCT01315665|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102436997|NCT01315665|Protective Agents|protective agents|mesh-ancestor
102436998|NCT01315665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102436999|NCT01315665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102437000|NCT01454089|Carboplatin|carboplatin|mesh-list
102437001|NCT01454089|Gemcitabine|gemcitabine|mesh-list
102437002|NCT01454089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102437003|NCT01454089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102437004|NCT01454089|Antimetabolites|antimetabolites|mesh-ancestor
102437005|NCT01454089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437006|NCT01457989|Ezogabine|ezogabine|mesh-list
102437007|NCT01457989|Anticonvulsants|anticonvulsants|mesh-ancestor
102437008|NCT01457989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102437009|NCT01457989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437010|NCT01458067|GSK2636771|gsk2636771|mesh-list
102437011|NCT01458067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102437012|NCT01458067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102437013|NCT01458067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102437014|NCT01458067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437015|NCT04942860|Methotrexate|methotrexate|mesh-list
102437016|NCT04942860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102437017|NCT04942860|Abortifacient Agents|abortifacient agents|mesh-ancestor
102437018|NCT04942860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102437019|NCT04942860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437020|NCT04942860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102437021|NCT04942860|Antimetabolites|antimetabolites|mesh-ancestor
102437022|NCT04942860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437023|NCT04942860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102437024|NCT04942860|Dermatologic Agents|dermatologic agents|mesh-ancestor
102437025|NCT04942860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102437026|NCT04942860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102437027|NCT04942860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102437028|NCT04942860|Immunologic Factors|immunologic factors|mesh-ancestor
102437029|NCT04942860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102437030|NCT04942860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102437031|NCT01458223|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102437032|NCT01458223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102437033|NCT01458223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102437034|NCT01458223|Antitubercular Agents|antitubercular agents|mesh-ancestor
102437035|NCT04959786|Ribavirin|ribavirin|mesh-list
102437036|NCT04959786|Ivermectin|ivermectin|mesh-list
102437037|NCT04959786|Nitazoxanide|nitazoxanide|mesh-list
102437038|NCT04959786|Antimetabolites|antimetabolites|mesh-ancestor
102437039|NCT04959786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437040|NCT04959786|Antiviral Agents|antiviral agents|mesh-ancestor
102437041|NCT04959786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102437042|NCT04959786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102437043|NCT01452451|Exenatide|exenatide|mesh-list
102437044|NCT01452451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102437045|NCT01452451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437046|NCT01452451|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102437047|NCT01452451|Incretins|incretins|mesh-ancestor
102437048|NCT01452451|Hormones|hormones|mesh-ancestor
102437049|NCT01452451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102437050|NCT04951128|Anesthetics|anesthetics|mesh-list
102437051|NCT04951128|Anesthetics, Local|anesthetics, local|mesh-list
102437052|NCT04951128|Tranexamic Acid|tranexamic acid|mesh-list
102437053|NCT04951128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102437054|NCT04951128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437055|NCT04951128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102437056|NCT04951128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102437057|NCT04951128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437058|NCT04951128|Hemostatics|hemostatics|mesh-ancestor
102437059|NCT04951128|Coagulants|coagulants|mesh-ancestor
102437060|NCT04951128|Sensory System Agents|sensory system agents|mesh-ancestor
102437061|NCT04951128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102437062|NCT01458301|Leuprolide|leuprolide|mesh-list
102437063|NCT01458301|Relugolix|relugolix|mesh-list
102437064|NCT01458301|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102437065|NCT01458301|Fertility Agents|fertility agents|mesh-ancestor
102437066|NCT01458301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102437067|NCT01458301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437068|NCT01458301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102437069|NCT01458301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102437070|NCT01458301|Androgen Antagonists|androgen antagonists|mesh-ancestor
102437071|NCT01458301|Hormone Antagonists|hormone antagonists|mesh-ancestor
102437072|NCT01458301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102437073|NCT03059238|Celecoxib|celecoxib|mesh-list
102437074|NCT03059238|Parecoxib|parecoxib|mesh-list
102437075|NCT03059238|Oxycodone|oxycodone|mesh-list
102437076|NCT03059238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102437077|NCT03059238|Narcotics|narcotics|mesh-ancestor
102437078|NCT03059238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102437079|NCT03059238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437080|NCT03059238|Analgesics|analgesics|mesh-ancestor
102437081|NCT03059238|Sensory System Agents|sensory system agents|mesh-ancestor
102437082|NCT03059238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102437083|NCT03059238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102437084|NCT03059238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102437085|NCT03059238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102437086|NCT03059238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102437087|NCT03059238|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102437088|NCT03059238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102437089|NCT03059238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102437090|NCT03059238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437091|NCT01891201|Oxytocin|oxytocin|mesh-list
102437092|NCT01891201|Oxytocics|oxytocics|mesh-ancestor
102437093|NCT01891201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102437094|NCT01891201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437095|NCT04942002|Methylprednisolone|methylprednisolone|mesh-list
102437096|NCT04942002|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102437097|NCT04942002|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102437098|NCT04942002|Prednisolone|prednisolone|mesh-list
102437099|NCT04942002|Prednisolone acetate|prednisolone acetate|mesh-list
102437100|NCT04942002|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102437101|NCT04942002|Prednisolone phosphate|prednisolone phosphate|mesh-list
102437102|NCT04942002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102437103|NCT04942002|Antiemetics|antiemetics|mesh-ancestor
102437104|NCT04942002|Autonomic Agents|autonomic agents|mesh-ancestor
102437105|NCT04942002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102437106|NCT04942002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437107|NCT04942002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102437108|NCT04942002|Glucocorticoids|glucocorticoids|mesh-ancestor
102437109|NCT04942002|Hormones|hormones|mesh-ancestor
102437110|NCT04942002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102437111|NCT04942002|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102437112|NCT04942002|Protective Agents|protective agents|mesh-ancestor
102437113|NCT04942002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102437114|NCT04942002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102437115|NCT01891435|Acetaminophen|acetaminophen|mesh-list
102437116|NCT01891435|Diclofenac|diclofenac|mesh-list
102437117|NCT01891435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102437118|NCT01891435|Analgesics|analgesics|mesh-ancestor
102437119|NCT01891435|Sensory System Agents|sensory system agents|mesh-ancestor
102437120|NCT01891435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102437121|NCT01891435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437122|NCT01891435|Antipyretics|antipyretics|mesh-ancestor
102437123|NCT01891435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102437124|NCT01891435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102437125|NCT01891435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102437126|NCT01891435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102437127|NCT01891435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102437128|NCT01891435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437129|NCT01458769|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102437130|NCT01458769|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102437131|NCT01458769|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102437132|NCT01458769|Protease Inhibitors|protease inhibitors|mesh-ancestor
102437133|NCT01458769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102437134|NCT01458769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437135|NCT01458769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102437136|NCT01458769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102437137|NCT01458769|Antiviral Agents|antiviral agents|mesh-ancestor
102437138|NCT01458769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102437139|NCT01458847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102437140|NCT04941846|Nimodipine|nimodipine|mesh-list
102437141|NCT04941846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102437142|NCT04941846|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102437143|NCT04941846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102437144|NCT04941846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437145|NCT04941846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102437146|NCT04941846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437147|NCT04941846|Vasodilator Agents|vasodilator agents|mesh-ancestor
102437148|NCT01891513|Losartan|losartan|mesh-list
102437149|NCT01891513|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102437150|NCT01891513|Perindopril|perindopril|mesh-list
102437151|NCT01891513|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
102437152|NCT01891513|Diuretics|diuretics|mesh-list
102437153|NCT01891513|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
102437154|NCT01891513|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102437155|NCT01891513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102437156|NCT01891513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102437157|NCT01891513|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102437158|NCT01891513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437159|NCT01891513|Natriuretic Agents|natriuretic agents|mesh-ancestor
102437160|NCT01891513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437161|NCT01891513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102437162|NCT01891513|Protease Inhibitors|protease inhibitors|mesh-ancestor
102437163|NCT01891513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102437164|NCT04843423|Cariprazine|cariprazine|mesh-list
102437165|NCT04843423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102437166|NCT04843423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102437167|NCT04843423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102437168|NCT04843423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437169|NCT04843423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102437171|NCT01459081|Antiviral Agents|antiviral agents|mesh-ancestor
102437172|NCT01459081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102437173|NCT01459081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102437174|NCT01459081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437175|NCT04421196|Analgesics, Opioid|analgesics, opioid|mesh-list
102437176|NCT04421196|Analgesics|analgesics|mesh-list
102437177|NCT04421196|Narcotics|narcotics|mesh-ancestor
102437178|NCT04421196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102437179|NCT04421196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437180|NCT04421196|Sensory System Agents|sensory system agents|mesh-ancestor
102437181|NCT04421196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102437182|NCT01459315|Dolutegravir|dolutegravir|mesh-list
102437183|NCT01459315|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102437184|NCT01459315|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102437185|NCT01459315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102437186|NCT01459315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437187|NCT01459315|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102437188|NCT01459315|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102437189|NCT01459315|Antiviral Agents|antiviral agents|mesh-ancestor
102437190|NCT01459315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102437191|NCT04948788|Gemcitabine|gemcitabine|mesh-list
102437192|NCT04948788|Oxaliplatin|oxaliplatin|mesh-list
102437193|NCT04948788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102437194|NCT04948788|Antimetabolites|antimetabolites|mesh-ancestor
102437195|NCT04948788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437196|NCT04948788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102437197|NCT02865811|Doxorubicin|doxorubicin|mesh-list
102437198|NCT02865811|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102437199|NCT02865811|Pembrolizumab|pembrolizumab|mesh-list
102437200|NCT02865811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102437201|NCT02865811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102437202|NCT02865811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102437203|NCT02865811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102437204|NCT02865811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102437205|NCT02865811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437206|NCT02865811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102437207|NCT02865811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102437208|NCT03058224|Acetaminophen|acetaminophen|mesh-list
102437209|NCT03058224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102437210|NCT03058224|Analgesics|analgesics|mesh-ancestor
102437211|NCT03058224|Sensory System Agents|sensory system agents|mesh-ancestor
102437212|NCT03058224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102437213|NCT03058224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437214|NCT03058224|Antipyretics|antipyretics|mesh-ancestor
102437215|NCT04957212|Carboplatin|carboplatin|mesh-list
102437216|NCT04957212|Docetaxel|docetaxel|mesh-list
102437217|NCT04957212|Trastuzumab|trastuzumab|mesh-list
102437218|NCT04957212|Pertuzumab|pertuzumab|mesh-list
102437219|NCT04957212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102437220|NCT04957212|Tubulin Modulators|tubulin modulators|mesh-ancestor
102437221|NCT04957212|Antimitotic Agents|antimitotic agents|mesh-ancestor
102437222|NCT04957212|Mitosis Modulators|mitosis modulators|mesh-ancestor
102437223|NCT04957212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437224|NCT04957212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102437225|NCT02879617|Durvalumab|durvalumab|mesh-list
102437226|NCT02879617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102437227|NCT02879617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102437228|NCT04390789|Calcium|calcium|mesh-list
102437229|NCT04390789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102437230|NCT04390789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437231|NCT04947774|Immunomodulating Agents|immunomodulating agents|mesh-list
102437232|NCT04947774|Immunologic Factors|immunologic factors|mesh-ancestor
102437233|NCT04947774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437234|NCT04948164|Naproxen|naproxen|mesh-list
102437235|NCT04948164|Sumatriptan|sumatriptan|mesh-list
102437236|NCT04948164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102437237|NCT04948164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102437238|NCT04948164|Analgesics|analgesics|mesh-ancestor
102437239|NCT04948164|Sensory System Agents|sensory system agents|mesh-ancestor
102437240|NCT04948164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102437241|NCT04948164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437242|NCT04948164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102437243|NCT04948164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102437244|NCT04948164|Gout Suppressants|gout suppressants|mesh-ancestor
102437245|NCT04948164|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102437246|NCT04948164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102437247|NCT04948164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437248|NCT04948164|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102437249|NCT04948164|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102437250|NCT04948164|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102437251|NCT04948164|Serotonin Agents|serotonin agents|mesh-ancestor
102437252|NCT04948164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102437253|NCT02808871|Pirfenidone|pirfenidone|mesh-list
102437254|NCT02808871|Analgesics|analgesics|mesh-ancestor
102437255|NCT02808871|Sensory System Agents|sensory system agents|mesh-ancestor
102437256|NCT02808871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102437257|NCT02808871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437258|NCT02808871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102437259|NCT02808871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102437260|NCT02808871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102437261|NCT02808871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102437262|NCT02808871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102437263|NCT01892683|Propofol|propofol|mesh-list
102437264|NCT01892683|Anesthetics|anesthetics|mesh-ancestor
102437265|NCT01892683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102437266|NCT01892683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437267|NCT01892683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102437268|NCT01892683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102437269|NCT01892683|Anesthetics, General|anesthetics, general|mesh-ancestor
102437270|NCT01459627|Ticagrelor|ticagrelor|mesh-list
102437271|NCT01459627|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102437272|NCT01459627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102437273|NCT01459627|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102437274|NCT01459627|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102437275|NCT01459627|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102437276|NCT01459627|Purinergic Agents|purinergic agents|mesh-ancestor
102437277|NCT01459627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102437278|NCT01459627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437279|NCT01459627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437280|NCT02467621|Pantoprazole|pantoprazole|mesh-list
102437281|NCT02467621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102437282|NCT02467621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102437283|NCT02467621|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102437284|NCT02467621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102437285|NCT02467621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437286|NCT04937946|Fentanyl|fentanyl|mesh-list
102437287|NCT04937946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102437288|NCT04937946|Narcotics|narcotics|mesh-ancestor
102437289|NCT04937946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102437290|NCT04937946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437291|NCT04937946|Analgesics|analgesics|mesh-ancestor
102437292|NCT04937946|Sensory System Agents|sensory system agents|mesh-ancestor
102437293|NCT04937946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102437294|NCT04937946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102437295|NCT04937946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102437296|NCT04937946|Anesthetics, General|anesthetics, general|mesh-ancestor
102437297|NCT04937946|Anesthetics|anesthetics|mesh-ancestor
102437298|NCT05160987|Midazolam|midazolam|mesh-list
102437299|NCT05160987|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102437300|NCT05160987|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102437301|NCT05160987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102437302|NCT05160987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437303|NCT05160987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102437304|NCT05160987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102437305|NCT05160987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102437306|NCT05160987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102437307|NCT05160987|Anesthetics, General|anesthetics, general|mesh-ancestor
102437308|NCT05160987|Anesthetics|anesthetics|mesh-ancestor
102437309|NCT05160987|GABA Modulators|gaba modulators|mesh-ancestor
102437310|NCT05160987|GABA Agents|gaba agents|mesh-ancestor
102437311|NCT05160987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102437312|NCT05160987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437313|NCT01892995|Ketamine|ketamine|mesh-list
102437314|NCT01892995|Analgesics|analgesics|mesh-ancestor
102437315|NCT01892995|Sensory System Agents|sensory system agents|mesh-ancestor
102437316|NCT01892995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102437317|NCT01892995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437318|NCT01892995|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102437319|NCT01892995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102437320|NCT01892995|Anesthetics, General|anesthetics, general|mesh-ancestor
102437321|NCT01892995|Anesthetics|anesthetics|mesh-ancestor
102437322|NCT01892995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102437323|NCT01892995|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102437324|NCT01892995|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102437325|NCT01892995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102437326|NCT01892995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437327|NCT04938102|Botulinum Toxins|botulinum toxins|mesh-list
102437328|NCT04938102|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102437329|NCT04938102|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102437330|NCT04938102|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102437331|NCT04938102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102437332|NCT04938102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437333|NCT04938102|Cholinergic Agents|cholinergic agents|mesh-ancestor
102437334|NCT04938102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102437335|NCT04938102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437336|NCT04938102|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102437337|NCT04938102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102437338|NCT02181075|Doxorubicin|doxorubicin|mesh-list
102437339|NCT02181075|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102437340|NCT02181075|Liver Extracts|liver extracts|mesh-list
102437341|NCT02181075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102437342|NCT02181075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102437343|NCT02181075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102437344|NCT02181075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102437345|NCT02181075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102437346|NCT02181075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437347|NCT02181075|Hematinics|hematinics|mesh-ancestor
102437348|NCT01359735|Bacitracin|bacitracin|mesh-list
102437349|NCT01359735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102437350|NCT01359735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102437351|NCT01359735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102437352|NCT01361217|Midazolam|midazolam|mesh-list
102437353|NCT01361217|Dextromethorphan|dextromethorphan|mesh-list
102437354|NCT01361217|Caffeine|caffeine|mesh-list
102437355|NCT01361217|Fluoxetine|fluoxetine|mesh-list
102437356|NCT01361217|Omeprazole|omeprazole|mesh-list
102437357|NCT01361217|Lovastatin|lovastatin|mesh-list
102437358|NCT01361217|L 647318|l 647318|mesh-list
102437359|NCT01361217|Dihydromevinolin|dihydromevinolin|mesh-list
102437360|NCT01361217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102437361|NCT01361217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102437362|NCT01361217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102437363|NCT01361217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437364|NCT01361217|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102437365|NCT01361217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102437366|NCT01361217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102437367|NCT01361217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102437368|NCT01361217|Anesthetics, General|anesthetics, general|mesh-ancestor
102437369|NCT01361217|Anesthetics|anesthetics|mesh-ancestor
102437370|NCT01361217|GABA Modulators|gaba modulators|mesh-ancestor
102437371|NCT01361217|GABA Agents|gaba agents|mesh-ancestor
102437372|NCT01361217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102437373|NCT01361217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437374|NCT01361217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102437375|NCT01361217|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102437376|NCT01361217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102437377|NCT01361217|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102437378|NCT01361217|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102437379|NCT01361217|Purinergic Agents|purinergic agents|mesh-ancestor
102437380|NCT01361217|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102437381|NCT01361217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102437382|NCT01361217|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102437383|NCT01361217|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102437384|NCT01361217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102437385|NCT01361217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102437386|NCT01361217|Serotonin Agents|serotonin agents|mesh-ancestor
102437387|NCT01361217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102437388|NCT01361217|Antidepressive Agents|antidepressive agents|mesh-ancestor
102437389|NCT01361217|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102437390|NCT01361217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102437391|NCT01361217|Antitussive Agents|antitussive agents|mesh-ancestor
102437392|NCT01361217|Respiratory System Agents|respiratory system agents|mesh-ancestor
102437393|NCT01361217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102437394|NCT01361217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102437395|NCT01361217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102437396|NCT01361217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102437397|NCT01361217|Antimetabolites|antimetabolites|mesh-ancestor
102437398|NCT01361217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102437399|NCT01361217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102437400|NCT04271839|Fluticasone|fluticasone|mesh-list
102437401|NCT04271839|Formoterol Fumarate|formoterol fumarate|mesh-list
102437402|NCT04271839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102437403|NCT04271839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102437404|NCT04271839|Autonomic Agents|autonomic agents|mesh-ancestor
102437405|NCT04271839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102437406|NCT04271839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437407|NCT04271839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102437408|NCT04271839|Respiratory System Agents|respiratory system agents|mesh-ancestor
102437409|NCT04271839|Dermatologic Agents|dermatologic agents|mesh-ancestor
102437410|NCT04271839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102437411|NCT04271839|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102437412|NCT04271839|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102437413|NCT04271839|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102437414|NCT04271839|Adrenergic Agents|adrenergic agents|mesh-ancestor
102437415|NCT04271839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102437416|NCT04271839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437417|NCT04945434|Methamphetamine|methamphetamine|mesh-list
102437418|NCT04945434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102437419|NCT04945434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437420|NCT04945434|Sympathomimetics|sympathomimetics|mesh-ancestor
102437421|NCT04945434|Autonomic Agents|autonomic agents|mesh-ancestor
102437422|NCT04945434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102437423|NCT04945434|Dopamine Agents|dopamine agents|mesh-ancestor
102437424|NCT04945434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102437425|NCT04945434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437426|NCT04945434|Adrenergic Agents|adrenergic agents|mesh-ancestor
102437427|NCT04945434|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102437428|NCT04945434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102437429|NCT04945434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102437430|NCT04945434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102437431|NCT04411758|Propolis|propolis|mesh-list
102437432|NCT04411758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102437433|NCT04408560|Acetaminophen|acetaminophen|mesh-list
102437434|NCT04408560|Analgesics|analgesics|mesh-list
102437435|NCT04408560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102437436|NCT04408560|Sensory System Agents|sensory system agents|mesh-ancestor
102437437|NCT04408560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102437438|NCT04408560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437439|NCT04408560|Antipyretics|antipyretics|mesh-ancestor
102437440|NCT04844905|Ivermectin|ivermectin|mesh-list
102437441|NCT04844905|Piperaquine|piperaquine|mesh-list
102437442|NCT04844905|Artenimol|artenimol|mesh-list
102437443|NCT04844905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102437444|NCT04844905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102437445|NCT04844905|Antimalarials|antimalarials|mesh-ancestor
102437446|NCT04844905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102437447|NCT04418856|Methamphetamine|methamphetamine|mesh-list
102437448|NCT04418856|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102437449|NCT04418856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437450|NCT04418856|Sympathomimetics|sympathomimetics|mesh-ancestor
102437451|NCT04418856|Autonomic Agents|autonomic agents|mesh-ancestor
102437452|NCT04418856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102437453|NCT04418856|Dopamine Agents|dopamine agents|mesh-ancestor
102437454|NCT04418856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102437455|NCT04418856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437456|NCT04418856|Adrenergic Agents|adrenergic agents|mesh-ancestor
102437457|NCT04418856|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102437458|NCT04418856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102437459|NCT04418856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102437460|NCT04418856|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102437461|NCT01454635|Sertraline|sertraline|mesh-list
102437462|NCT01454635|Antidepressive Agents|antidepressive agents|mesh-ancestor
102437463|NCT01454635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102437464|NCT01454635|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102437465|NCT01454635|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102437466|NCT01454635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102437467|NCT01454635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437468|NCT01454635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102437469|NCT01454635|Serotonin Agents|serotonin agents|mesh-ancestor
102437470|NCT01454635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437471|NCT02196831|Tesamorelin|tesamorelin|mesh-list
102437472|NCT02196831|Growth Substances|growth substances|mesh-ancestor
102437473|NCT02196831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437474|NCT04944966|Lumefantrine|lumefantrine|mesh-list
102437475|NCT04944966|Artemether|artemether|mesh-list
102437476|NCT04944966|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102437477|NCT04944966|Antimalarials|antimalarials|mesh-ancestor
102437478|NCT04944966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102437479|NCT04944966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102437480|NCT04944966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102437481|NCT04955262|Nivolumab|nivolumab|mesh-list
102437482|NCT04955262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102437483|NCT04955262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102437484|NCT04955262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102437485|NCT04955262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437486|NCT01363479|Dexamethasone|dexamethasone|mesh-list
102437487|NCT01363479|Palonosetron|palonosetron|mesh-list
102437488|NCT01363479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102437489|NCT01363479|Antiemetics|antiemetics|mesh-ancestor
102437490|NCT01363479|Autonomic Agents|autonomic agents|mesh-ancestor
102437491|NCT01363479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102067932|NCT02235428|Ipratropium|ipratropium|mesh-list
102437492|NCT01363479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437493|NCT01363479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102437494|NCT01363479|Glucocorticoids|glucocorticoids|mesh-ancestor
102437495|NCT01363479|Hormones|hormones|mesh-ancestor
102437496|NCT01363479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102437497|NCT01363479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102437498|NCT01363479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102437499|NCT01363479|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102437500|NCT01363479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102437501|NCT01363479|Serotonin Agents|serotonin agents|mesh-ancestor
102437502|NCT01363479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102437503|NCT01363479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437504|NCT01893385|Vitamin D|vitamin d|mesh-list
102437505|NCT01893385|Vitamins|vitamins|mesh-ancestor
102437506|NCT01893385|Micronutrients|micronutrients|mesh-ancestor
102437507|NCT01893385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437508|NCT01893385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102437509|NCT04935450|Dimercaprol|dimercaprol|mesh-list
102437510|NCT04935450|Chelating Agents|chelating agents|mesh-ancestor
102437511|NCT04935450|Sequestering Agents|sequestering agents|mesh-ancestor
102437512|NCT04935450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437513|NCT02181231|Buprenorphine|buprenorphine|mesh-list
102437514|NCT02181231|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102437515|NCT02181231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102437516|NCT02181231|Narcotics|narcotics|mesh-ancestor
102437517|NCT02181231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102437518|NCT02181231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437519|NCT02181231|Analgesics|analgesics|mesh-ancestor
102437520|NCT02181231|Sensory System Agents|sensory system agents|mesh-ancestor
102437521|NCT02181231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102437522|NCT02181231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102437523|NCT02181231|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102437524|NCT02181231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102437525|NCT02181231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102437526|NCT02181231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437527|NCT02181231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102437528|NCT02181231|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102437529|NCT02181231|Antidepressive Agents|antidepressive agents|mesh-ancestor
102437530|NCT02181231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102437531|NCT04922034|Amoxicillin|amoxicillin|mesh-list
102437532|NCT04922034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102437533|NCT04922034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102437534|NCT01364259|Amifostine|amifostine|mesh-list
102437535|NCT01364259|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102437536|NCT01364259|Protective Agents|protective agents|mesh-ancestor
102437537|NCT01364259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437538|NCT01321437|Axitinib|axitinib|mesh-list
102437539|NCT01321437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102437540|NCT01321437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102437541|NCT01321437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102437542|NCT01321437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437543|NCT01365585|Sildenafil Citrate|sildenafil citrate|mesh-list
102437544|NCT01365585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437545|NCT01365585|Vasodilator Agents|vasodilator agents|mesh-ancestor
102437546|NCT01365585|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102437547|NCT01365585|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102437548|NCT01365585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102437549|NCT01365585|Urological Agents|urological agents|mesh-ancestor
102437550|NCT02664181|Nivolumab|nivolumab|mesh-list
102437551|NCT02664181|Decitabine|decitabine|mesh-list
102437552|NCT02664181|Tetrahydrouridine|tetrahydrouridine|mesh-list
102437553|NCT02664181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102437554|NCT02664181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102437555|NCT02664181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102437556|NCT02664181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437557|NCT02664181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102437558|NCT02664181|Antimetabolites|antimetabolites|mesh-ancestor
102437559|NCT02664181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102437560|NCT04407390|Niacinamide|niacinamide|mesh-list
102437561|NCT04407390|Niacin|niacin|mesh-list
102437562|NCT04407390|Nicotinic Acids|nicotinic acids|mesh-list
102437563|NCT04407390|Vitamin B Complex|vitamin b complex|mesh-ancestor
102437564|NCT04407390|Vitamins|vitamins|mesh-ancestor
102437565|NCT04407390|Micronutrients|micronutrients|mesh-ancestor
102437566|NCT04407390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437567|NCT04407390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102437568|NCT04407390|Antimetabolites|antimetabolites|mesh-ancestor
102437569|NCT04407390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437570|NCT04407390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102437571|NCT04407390|Vasodilator Agents|vasodilator agents|mesh-ancestor
102437572|NCT02181387|Acetaminophen|acetaminophen|mesh-list
102437573|NCT02181387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102437574|NCT02181387|Analgesics|analgesics|mesh-ancestor
102437575|NCT02181387|Sensory System Agents|sensory system agents|mesh-ancestor
102437576|NCT02181387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102437577|NCT02181387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437578|NCT02181387|Antipyretics|antipyretics|mesh-ancestor
102437579|NCT04921878|Mitoxantrone|mitoxantrone|mesh-list
102437580|NCT04921878|Analgesics|analgesics|mesh-ancestor
102437581|NCT04921878|Sensory System Agents|sensory system agents|mesh-ancestor
102437582|NCT04921878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102437583|NCT04921878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437584|NCT04921878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102437585|NCT04921878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102437586|NCT04921878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102437587|NCT04921878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102437588|NCT04921878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437589|NCT04351347|Ivermectin|ivermectin|mesh-list
102437590|NCT04351347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102437591|NCT04351347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102437592|NCT04932564|Leflunomide|leflunomide|mesh-list
102437593|NCT04932564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102437594|NCT04932564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437595|NCT04932564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102437596|NCT04932564|Immunologic Factors|immunologic factors|mesh-ancestor
102437597|NCT04932564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437598|NCT04921566|Torsemide|torsemide|mesh-list
102437599|NCT04921566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102437600|NCT04921566|Diuretics|diuretics|mesh-ancestor
102437601|NCT04921566|Natriuretic Agents|natriuretic agents|mesh-ancestor
102437602|NCT04921566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437603|NCT04921566|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102437604|NCT04921566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102437605|NCT04921566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437606|NCT02655601|Manganese|manganese|mesh-list
102437607|NCT02655601|Temozolomide|temozolomide|mesh-list
102437608|NCT02655601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102437609|NCT02655601|Alkylating Agents|alkylating agents|mesh-ancestor
102437610|NCT02655601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437611|NCT02655601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102437612|NCT02655601|Trace Elements|trace elements|mesh-ancestor
102437613|NCT02655601|Micronutrients|micronutrients|mesh-ancestor
102437614|NCT02655601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437615|NCT02652247|Dimercaprol|dimercaprol|mesh-list
102437616|NCT02652247|Chelating Agents|chelating agents|mesh-ancestor
102437617|NCT02652247|Sequestering Agents|sequestering agents|mesh-ancestor
102249275|NCT03195257|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102437618|NCT02652247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437619|NCT01365819|Varenicline|varenicline|mesh-list
102437620|NCT01365819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102437621|NCT01365819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102437622|NCT01365819|Cholinergic Agents|cholinergic agents|mesh-ancestor
102437623|NCT01365819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102437624|NCT01365819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437625|NCT01365819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437626|NCT02635555|Phenylephrine|phenylephrine|mesh-list
102437627|NCT02635555|Oxymetazoline|oxymetazoline|mesh-list
102437628|NCT02635555|Ephedrine|ephedrine|mesh-list
102437629|NCT02635555|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102437630|NCT02635555|Mydriatics|mydriatics|mesh-ancestor
102437631|NCT02635555|Autonomic Agents|autonomic agents|mesh-ancestor
102437632|NCT02635555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102437633|NCT02635555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437634|NCT02635555|Sympathomimetics|sympathomimetics|mesh-ancestor
102437635|NCT02635555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102437636|NCT02635555|Nasal Decongestants|nasal decongestants|mesh-ancestor
102437637|NCT02635555|Respiratory System Agents|respiratory system agents|mesh-ancestor
102437638|NCT02635555|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102437639|NCT02635555|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102437640|NCT02635555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102437641|NCT02635555|Adrenergic Agents|adrenergic agents|mesh-ancestor
102437642|NCT02635555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102437643|NCT02635555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437644|NCT02635555|Protective Agents|protective agents|mesh-ancestor
102437645|NCT02635555|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102437646|NCT01893541|Propranolol|propranolol|mesh-list
102437647|NCT01893541|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102437648|NCT01893541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102437649|NCT01893541|Adrenergic Agents|adrenergic agents|mesh-ancestor
102437650|NCT01893541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102437651|NCT01893541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437652|NCT01893541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437653|NCT01893541|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102437654|NCT01893541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102437655|NCT01893541|Vasodilator Agents|vasodilator agents|mesh-ancestor
102437656|NCT02849899|Vildagliptin|vildagliptin|mesh-list
102437657|NCT02849899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102437658|NCT02849899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437659|NCT02849899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102437660|NCT02849899|Protease Inhibitors|protease inhibitors|mesh-ancestor
102437661|NCT02849899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102437662|NCT02849899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437663|NCT02771197|Pembrolizumab|pembrolizumab|mesh-list
102437664|NCT02771197|Fludarabine|fludarabine|mesh-list
102437665|NCT02771197|Melphalan|melphalan|mesh-list
102437666|NCT02771197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102437667|NCT02771197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102437668|NCT02771197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102437669|NCT02771197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437670|NCT02771197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102437671|NCT02771197|Immunologic Factors|immunologic factors|mesh-ancestor
102437672|NCT02771197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437673|NCT02771197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102437674|NCT02771197|Alkylating Agents|alkylating agents|mesh-ancestor
102437675|NCT02771197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102437676|NCT01369875|Aldesleukin|aldesleukin|mesh-list
102437677|NCT01369875|Cyclophosphamide|cyclophosphamide|mesh-list
102437678|NCT01369875|Fludarabine|fludarabine|mesh-list
102437679|NCT01369875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102437680|NCT01369875|Immunologic Factors|immunologic factors|mesh-ancestor
102437681|NCT01369875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437682|NCT01369875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102437683|NCT01369875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102437684|NCT01369875|Alkylating Agents|alkylating agents|mesh-ancestor
102437685|NCT01369875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437686|NCT01369875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102437687|NCT01369875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102437688|NCT01369875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102437689|NCT01369875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102437690|NCT01369875|Antiviral Agents|antiviral agents|mesh-ancestor
102437691|NCT01369875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102437692|NCT02620189|Adalimumab|adalimumab|mesh-list
102437693|NCT02620189|Certolizumab Pegol|certolizumab pegol|mesh-list
102437694|NCT02620189|Etanercept|etanercept|mesh-list
102437695|NCT02620189|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102437696|NCT02620189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102437697|NCT02620189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102437698|NCT02620189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102437699|NCT02620189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102437700|NCT02620189|Analgesics|analgesics|mesh-ancestor
102437701|NCT02620189|Sensory System Agents|sensory system agents|mesh-ancestor
102437702|NCT02620189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102437703|NCT02620189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437704|NCT02620189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102437705|NCT02620189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102437706|NCT02620189|Immunologic Factors|immunologic factors|mesh-ancestor
102437707|NCT02763319|Rituximab|rituximab|mesh-list
102437708|NCT02763319|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102437709|NCT02763319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102437710|NCT02763319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102437711|NCT02763319|Immunologic Factors|immunologic factors|mesh-ancestor
102437712|NCT02763319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437713|NCT02763319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102437714|NCT02763319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102437715|NCT02763319|Alkylating Agents|alkylating agents|mesh-ancestor
102437716|NCT02763319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437717|NCT01323153|Dalcetrapib|dalcetrapib|mesh-list
102437718|NCT01323153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102437719|NCT01323153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102437720|NCT01323153|Antimetabolites|antimetabolites|mesh-ancestor
102437721|NCT01323153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437722|NCT01323153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102437723|NCT02594371|Paclitaxel|paclitaxel|mesh-list
102437724|NCT02594371|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102437725|NCT02594371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102437726|NCT02594371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102437727|NCT02594371|Tubulin Modulators|tubulin modulators|mesh-ancestor
102437728|NCT02594371|Antimitotic Agents|antimitotic agents|mesh-ancestor
102437729|NCT02594371|Mitosis Modulators|mitosis modulators|mesh-ancestor
102437730|NCT02594371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437731|NCT02197065|Atorvastatin|atorvastatin|mesh-list
102437732|NCT02197065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102437733|NCT02197065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102437734|NCT02197065|Antimetabolites|antimetabolites|mesh-ancestor
102437735|NCT02197065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437736|NCT02197065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102437737|NCT02197065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102437738|NCT02197065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102437739|NCT04405596|Ambroxol|ambroxol|mesh-list
102437740|NCT04405596|Expectorants|expectorants|mesh-ancestor
102437741|NCT04405596|Respiratory System Agents|respiratory system agents|mesh-ancestor
102437742|NCT01375491|Doxycycline|doxycycline|mesh-list
102437743|NCT01375491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102437744|NCT01375491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102437745|NCT01375491|Antimalarials|antimalarials|mesh-ancestor
102437746|NCT01375491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102437747|NCT01375491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102437748|NCT02591251|Povidone-Iodine|povidone-iodine|mesh-list
102437749|NCT02591251|Povidone|povidone|mesh-list
102437750|NCT02591251|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102437751|NCT02591251|Plasma Substitutes|plasma substitutes|mesh-ancestor
102437752|NCT02591251|Blood Substitutes|blood substitutes|mesh-ancestor
102437753|NCT02591251|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102437754|NCT02591251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102437755|NCT01325181|Ranibizumab|ranibizumab|mesh-list
102437756|NCT01325181|Verteporfin|verteporfin|mesh-list
102437757|NCT01325181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102437758|NCT01325181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102437759|NCT01325181|Growth Substances|growth substances|mesh-ancestor
102437760|NCT01325181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437761|NCT01325181|Growth Inhibitors|growth inhibitors|mesh-ancestor
102437762|NCT01325181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102437763|NCT01325181|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102437764|NCT01325181|Dermatologic Agents|dermatologic agents|mesh-ancestor
102437765|NCT02754037|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102437766|NCT02754037|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102437767|NCT02754037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249430|NCT02445599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102437768|NCT04238637|Durvalumab|durvalumab|mesh-list
102437769|NCT04238637|Tremelimumab|tremelimumab|mesh-list
102437770|NCT04238637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102437771|NCT04238637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102437772|NCT02588443|Paclitaxel|paclitaxel|mesh-list
102437773|NCT02588443|Gemcitabine|gemcitabine|mesh-list
102437774|NCT02588443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102437775|NCT02588443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102437776|NCT02588443|Tubulin Modulators|tubulin modulators|mesh-ancestor
102437777|NCT02588443|Antimitotic Agents|antimitotic agents|mesh-ancestor
102437778|NCT02588443|Mitosis Modulators|mitosis modulators|mesh-ancestor
102437779|NCT02588443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437780|NCT02588443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102437781|NCT02588443|Antimetabolites|antimetabolites|mesh-ancestor
102437782|NCT02582359|Cytarabine|cytarabine|mesh-list
102437783|NCT02582359|Daunorubicin|daunorubicin|mesh-list
102437784|NCT02582359|Ixazomib|ixazomib|mesh-list
102437785|NCT02582359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102437786|NCT02582359|Antimetabolites|antimetabolites|mesh-ancestor
102437787|NCT02582359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437788|NCT02582359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102437789|NCT02582359|Antiviral Agents|antiviral agents|mesh-ancestor
102437790|NCT02582359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102437791|NCT02582359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102437792|NCT02582359|Immunologic Factors|immunologic factors|mesh-ancestor
102437793|NCT02582359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437794|NCT02582359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102437795|NCT02582359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102437796|NCT02582359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102437797|NCT02582359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102437798|NCT02582359|Protease Inhibitors|protease inhibitors|mesh-ancestor
102437799|NCT00227253|Hormones|hormones|mesh-list
102437800|NCT00227253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102437801|NCT00227253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437802|NCT05021809|Calcium|calcium|mesh-list
102437803|NCT05021809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102437804|NCT05021809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437805|NCT02730715|Thymoglobulin|thymoglobulin|mesh-list
102437806|NCT02730715|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102437807|NCT02730715|Basiliximab|basiliximab|mesh-list
102437808|NCT02730715|Immunologic Factors|immunologic factors|mesh-ancestor
102437809|NCT02730715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437810|NCT02730715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102437811|NCT04919460|Tolonium Chloride|tolonium chloride|mesh-list
102437812|NCT04919460|Hemostatics|hemostatics|mesh-ancestor
102437813|NCT04919460|Coagulants|coagulants|mesh-ancestor
102437814|NCT04919460|Heparin Antagonists|heparin antagonists|mesh-ancestor
102437815|NCT04919460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437816|NCT04037241|Leucovorin|leucovorin|mesh-list
102437817|NCT04037241|Paclitaxel|paclitaxel|mesh-list
102437818|NCT04037241|Gemcitabine|gemcitabine|mesh-list
102437819|NCT04037241|Capecitabine|capecitabine|mesh-list
102068272|NCT01625234|Ensartinib|ensartinib|mesh-list
102437820|NCT04037241|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102437821|NCT04037241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102437822|NCT04037241|Tubulin Modulators|tubulin modulators|mesh-ancestor
102437823|NCT04037241|Antimitotic Agents|antimitotic agents|mesh-ancestor
102437824|NCT04037241|Mitosis Modulators|mitosis modulators|mesh-ancestor
102437825|NCT04037241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437826|NCT04037241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102437827|NCT04037241|Antimetabolites|antimetabolites|mesh-ancestor
102437828|NCT04037241|Antidotes|antidotes|mesh-ancestor
102437829|NCT04037241|Protective Agents|protective agents|mesh-ancestor
102437830|NCT04037241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437831|NCT04037241|Vitamin B Complex|vitamin b complex|mesh-ancestor
102437832|NCT04037241|Vitamins|vitamins|mesh-ancestor
102437833|NCT04037241|Micronutrients|micronutrients|mesh-ancestor
102437834|NCT04912128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
102437835|NCT04912128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102437836|NCT04912128|Growth Substances|growth substances|mesh-ancestor
102437837|NCT04912128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437838|NCT04912128|Growth Inhibitors|growth inhibitors|mesh-ancestor
102437839|NCT04912128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102437840|NCT01327677|Fentanyl|fentanyl|mesh-list
102437841|NCT01327677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102437842|NCT01327677|Narcotics|narcotics|mesh-ancestor
102437843|NCT01327677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102249504|NCT02444897|Fentanyl|fentanyl|mesh-list
102437844|NCT01327677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437845|NCT01327677|Analgesics|analgesics|mesh-ancestor
102437846|NCT01327677|Sensory System Agents|sensory system agents|mesh-ancestor
102437847|NCT01327677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102437848|NCT01327677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102437849|NCT01327677|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102437850|NCT01327677|Anesthetics, General|anesthetics, general|mesh-ancestor
102437851|NCT01327677|Anesthetics|anesthetics|mesh-ancestor
102437852|NCT03054480|Botulinum Toxins|botulinum toxins|mesh-list
102437853|NCT03054480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102437854|NCT03054480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102437855|NCT03054480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102437856|NCT03054480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102437857|NCT03054480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437858|NCT03054480|Cholinergic Agents|cholinergic agents|mesh-ancestor
102437859|NCT03054480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102437860|NCT03054480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437861|NCT03054480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102437862|NCT03054480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102437863|NCT04918914|Dapsone|dapsone|mesh-list
102437864|NCT04918914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102437865|NCT04918914|Antimalarials|antimalarials|mesh-ancestor
102437866|NCT04918914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102437867|NCT04918914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102437868|NCT04918914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102437869|NCT04918914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102437870|NCT04918914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437871|NCT04918914|Leprostatic Agents|leprostatic agents|mesh-ancestor
102437872|NCT04918914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102437873|NCT04918524|Aspirin|aspirin|mesh-list
102437874|NCT04918524|Hydroxychloroquine|hydroxychloroquine|mesh-list
102437875|NCT04918524|Prednisone|prednisone|mesh-list
102437876|NCT04918524|Heparin|heparin|mesh-list
102437877|NCT04918524|Enoxaparin|enoxaparin|mesh-list
102437878|NCT04918524|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102437879|NCT04918524|Tinzaparin|tinzaparin|mesh-list
102437880|NCT04918524|Dalteparin|dalteparin|mesh-list
102437881|NCT04918524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102437882|NCT04918524|Glucocorticoids|glucocorticoids|mesh-ancestor
102437883|NCT04918524|Hormones|hormones|mesh-ancestor
102437884|NCT04918524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102437885|NCT04918524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437886|NCT04918524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102437887|NCT04918524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102437888|NCT04918524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102437889|NCT04918524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102437890|NCT04918524|Analgesics|analgesics|mesh-ancestor
102437891|NCT04918524|Sensory System Agents|sensory system agents|mesh-ancestor
102437892|NCT04918524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102437893|NCT04918524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102437894|NCT04918524|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102437895|NCT04918524|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102437896|NCT04918524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437897|NCT04918524|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102437898|NCT04918524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102437899|NCT04918524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102437900|NCT04918524|Antipyretics|antipyretics|mesh-ancestor
102437901|NCT04918524|Anticoagulants|anticoagulants|mesh-ancestor
102437902|NCT04918524|Antimalarials|antimalarials|mesh-ancestor
102437903|NCT04918524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102437904|NCT04918524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102437905|NCT04918524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102437906|NCT01328379|4-Aminopyridine|4-aminopyridine|mesh-list
102437907|NCT01328379|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102437908|NCT01328379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102437909|NCT01328379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437910|NCT05586763|Promethazine|promethazine|mesh-list
102437911|NCT05586763|Diphenhydramine|diphenhydramine|mesh-list
102437912|NCT05586763|Metoclopramide|metoclopramide|mesh-list
102437913|NCT05586763|Antiemetics|antiemetics|mesh-ancestor
102437914|NCT05586763|Autonomic Agents|autonomic agents|mesh-ancestor
102437915|NCT05586763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102437916|NCT05586763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437917|NCT05586763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102437918|NCT05586763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102437919|NCT05586763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102437920|NCT05586763|Dopamine Agents|dopamine agents|mesh-ancestor
102437921|NCT05586763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102437922|NCT05586763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437923|NCT05586763|Antipruritics|antipruritics|mesh-ancestor
102437924|NCT05586763|Dermatologic Agents|dermatologic agents|mesh-ancestor
102437925|NCT05586763|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102437926|NCT05586763|Histamine Antagonists|histamine antagonists|mesh-ancestor
102437927|NCT05586763|Histamine Agents|histamine agents|mesh-ancestor
102437928|NCT05586763|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102437929|NCT05586763|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102437930|NCT05586763|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102437931|NCT05586763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102437932|NCT05586763|Anesthetics, Local|anesthetics, local|mesh-ancestor
102437933|NCT05586763|Anesthetics|anesthetics|mesh-ancestor
102437934|NCT05586763|Sensory System Agents|sensory system agents|mesh-ancestor
102437935|NCT01328769|Febuxostat|febuxostat|mesh-list
102437936|NCT01328769|Gout Suppressants|gout suppressants|mesh-ancestor
102437937|NCT01328769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102437938|NCT02552641|Amoxicillin|amoxicillin|mesh-list
102437939|NCT02552641|Clarithromycin|clarithromycin|mesh-list
102437940|NCT02552641|Esomeprazole|esomeprazole|mesh-list
102437941|NCT02552641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102437942|NCT02552641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102437943|NCT02552641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102437944|NCT02552641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102437945|NCT02552641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102437946|NCT02552641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102437947|NCT02552641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437948|NCT02552641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102437949|NCT02552641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102437950|NCT02552641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102437951|NCT02620020|Fasinumab|fasinumab|mesh-list
102437952|NCT02620020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102437953|NCT02620020|Analgesics|analgesics|mesh-ancestor
102437954|NCT02620020|Sensory System Agents|sensory system agents|mesh-ancestor
102437955|NCT02620020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102437956|NCT02620020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437957|NCT02551237|Capecitabine|capecitabine|mesh-list
102437958|NCT02551237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102437959|NCT02551237|Antimetabolites|antimetabolites|mesh-ancestor
102437960|NCT02551237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437961|NCT02551237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102437962|NCT01378299|Methyltestosterone|methyltestosterone|mesh-list
102437963|NCT01378299|Testosterone|testosterone|mesh-list
102437964|NCT01378299|Testosterone undecanoate|testosterone undecanoate|mesh-list
102437965|NCT01378299|Testosterone enanthate|testosterone enanthate|mesh-list
102437966|NCT01378299|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102437967|NCT01378299|Androgens|androgens|mesh-ancestor
102437968|NCT01378299|Hormones|hormones|mesh-ancestor
102437969|NCT01378299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102437970|NCT01378299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437971|NCT01378299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102437972|NCT01378299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102437973|NCT01378299|Anabolic Agents|anabolic agents|mesh-ancestor
102437974|NCT04929522|Anesthetics|anesthetics|mesh-list
102437975|NCT04929522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102437976|NCT04929522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437977|NCT02549833|Poly I-C|poly i-c|mesh-list
102437978|NCT02549833|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102437979|NCT02549833|Poly ICLC|poly iclc|mesh-list
102437980|NCT02549833|Interferon Inducers|interferon inducers|mesh-ancestor
102437981|NCT02549833|Immunologic Factors|immunologic factors|mesh-ancestor
102437982|NCT02549833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102437983|NCT02549833|Laxatives|laxatives|mesh-ancestor
102437984|NCT02549833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102437985|NCT02549833|Antiviral Agents|antiviral agents|mesh-ancestor
102437986|NCT02549833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102437987|NCT02542969|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102437988|NCT02542969|Simvastatin|simvastatin|mesh-list
102437989|NCT02542969|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102437990|NCT02542969|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102437991|NCT02542969|Antimetabolites|antimetabolites|mesh-ancestor
102437992|NCT02542969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102437993|NCT02542969|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102437994|NCT02542969|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102437995|NCT02542969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102437996|NCT04928586|Pirfenidone|pirfenidone|mesh-list
102437997|NCT04928586|Analgesics|analgesics|mesh-ancestor
102249659|NCT05474937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102437998|NCT04928586|Sensory System Agents|sensory system agents|mesh-ancestor
102437999|NCT04928586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102438000|NCT04928586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438001|NCT04928586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102438002|NCT04928586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102438003|NCT04928586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102438004|NCT04928586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102438005|NCT04928586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438007|NCT03054168|Testosterone|testosterone|mesh-list
102438008|NCT03054168|Hormones|hormones|mesh-ancestor
102438009|NCT03054168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102438010|NCT03054168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438011|NCT03054168|Androgens|androgens|mesh-ancestor
102438012|NCT03054168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102438013|NCT03054168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438014|NCT02518945|Dapagliflozin|dapagliflozin|mesh-list
102438015|NCT02518945|Liraglutide|liraglutide|mesh-list
102438016|NCT02518945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102438017|NCT02518945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438018|NCT02518945|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102438019|NCT02518945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438020|NCT02518945|Incretins|incretins|mesh-ancestor
102438021|NCT02518945|Hormones|hormones|mesh-ancestor
102438022|NCT02518945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102438023|NCT02390869|Rituximab|rituximab|mesh-list
102438024|NCT02390869|Lenalidomide|lenalidomide|mesh-list
102438025|NCT02390869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102438026|NCT02390869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438027|NCT02390869|Immunologic Factors|immunologic factors|mesh-ancestor
102438028|NCT02390869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438029|NCT02390869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102438030|NCT02390869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102438031|NCT02390869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102438032|NCT02390869|Growth Substances|growth substances|mesh-ancestor
102438033|NCT02390869|Growth Inhibitors|growth inhibitors|mesh-ancestor
102438034|NCT04757779|Docetaxel|docetaxel|mesh-list
102438035|NCT04757779|Irinotecan|irinotecan|mesh-list
102438036|NCT04757779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438037|NCT04757779|Tubulin Modulators|tubulin modulators|mesh-ancestor
102438038|NCT04757779|Antimitotic Agents|antimitotic agents|mesh-ancestor
102438039|NCT04757779|Mitosis Modulators|mitosis modulators|mesh-ancestor
102438040|NCT04757779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438041|NCT04757779|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102438042|NCT04757779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102438043|NCT04757779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102438044|NCT03053856|Paclitaxel|paclitaxel|mesh-list
102438045|NCT03053856|Pembrolizumab|pembrolizumab|mesh-list
102438046|NCT03053856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102438047|NCT03053856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438048|NCT03053856|Tubulin Modulators|tubulin modulators|mesh-ancestor
102438049|NCT03053856|Antimitotic Agents|antimitotic agents|mesh-ancestor
102438050|NCT03053856|Mitosis Modulators|mitosis modulators|mesh-ancestor
102438051|NCT03053856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438052|NCT03053856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102438053|NCT03053856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102438054|NCT02389309|Sirolimus|sirolimus|mesh-list
102438055|NCT02389309|Cyclophosphamide|cyclophosphamide|mesh-list
102438056|NCT02389309|Temsirolimus|temsirolimus|mesh-list
102438057|NCT02389309|Dasatinib|dasatinib|mesh-list
102438058|NCT02389309|MTOR Inhibitors|mtor inhibitors|mesh-list
102438059|NCT02389309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102438060|NCT02389309|Immunologic Factors|immunologic factors|mesh-ancestor
102438061|NCT02389309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438062|NCT02389309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102438063|NCT02389309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102438064|NCT02389309|Alkylating Agents|alkylating agents|mesh-ancestor
102438065|NCT02389309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438066|NCT02389309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438067|NCT02389309|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102438068|NCT02389309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102438069|NCT02389309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102438070|NCT02389309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102438071|NCT02389309|Antifungal Agents|antifungal agents|mesh-ancestor
102438072|NCT02389309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102438073|NCT02389309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102438075|NCT02489695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438076|NCT02489695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102438077|NCT02489695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102068532|NCT01569919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438078|NCT02489695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438079|NCT03053388|Nitric Oxide|nitric oxide|mesh-list
102438080|NCT03053388|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102438081|NCT03053388|Autonomic Agents|autonomic agents|mesh-ancestor
102438082|NCT03053388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102438083|NCT03053388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438084|NCT03053388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102438085|NCT03053388|Respiratory System Agents|respiratory system agents|mesh-ancestor
102438086|NCT03053388|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102438087|NCT03053388|Antioxidants|antioxidants|mesh-ancestor
102438088|NCT03053388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438089|NCT03053388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102438090|NCT03053388|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102438091|NCT03053388|Vasodilator Agents|vasodilator agents|mesh-ancestor
102438092|NCT03053388|Gasotransmitters|gasotransmitters|mesh-ancestor
102438093|NCT03053388|Protective Agents|protective agents|mesh-ancestor
102438094|NCT03053544|Metformin|metformin|mesh-list
102438095|NCT03053544|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102438096|NCT03053544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438097|NCT02384083|Dexamethasone|dexamethasone|mesh-list
102438098|NCT02384083|Pomalidomide|pomalidomide|mesh-list
102438099|NCT02384083|Filanesib|filanesib|mesh-list
102438100|NCT02384083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102438101|NCT02384083|Antiemetics|antiemetics|mesh-ancestor
102438102|NCT02384083|Autonomic Agents|autonomic agents|mesh-ancestor
102438103|NCT02384083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102438104|NCT02384083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438105|NCT02384083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102438106|NCT02384083|Glucocorticoids|glucocorticoids|mesh-ancestor
102438107|NCT02384083|Hormones|hormones|mesh-ancestor
102438108|NCT02384083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102438109|NCT02384083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102438110|NCT02384083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438111|NCT02384083|Immunologic Factors|immunologic factors|mesh-ancestor
102438112|NCT02384083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102438113|NCT02384083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102438114|NCT02384083|Growth Substances|growth substances|mesh-ancestor
102438115|NCT02384083|Growth Inhibitors|growth inhibitors|mesh-ancestor
102438116|NCT02384083|Antimitotic Agents|antimitotic agents|mesh-ancestor
102438117|NCT02384083|Mitosis Modulators|mitosis modulators|mesh-ancestor
102438118|NCT02384083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438119|NCT04926480|Anesthetics|anesthetics|mesh-list
102438120|NCT04926480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102438121|NCT04926480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438122|NCT03053622|Mirikizumab|mirikizumab|mesh-list
102438123|NCT03053622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102438124|NCT03053622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102438125|NCT03053622|Analgesics|analgesics|mesh-ancestor
102438126|NCT03053622|Sensory System Agents|sensory system agents|mesh-ancestor
102438127|NCT03053622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102438128|NCT03053622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438129|NCT03053622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102438130|NCT03053622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102438131|NCT03053622|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102438132|NCT03053622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102438133|NCT02380573|Methylene Blue|methylene blue|mesh-list
102438134|NCT02380573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102438135|NCT02380573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438136|NCT02461537|Mitoxantrone|mitoxantrone|mesh-list
102438137|NCT02461537|Analgesics|analgesics|mesh-ancestor
102438138|NCT02461537|Sensory System Agents|sensory system agents|mesh-ancestor
102438139|NCT02461537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102438140|NCT02461537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438141|NCT02461537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438142|NCT02461537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102438143|NCT02461537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102438144|NCT02461537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102438145|NCT02461537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438146|NCT05028673|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102438147|NCT05028673|Antacids|antacids|mesh-list
102438148|NCT05028673|Magnesium Hydroxide|magnesium hydroxide|mesh-list
102438149|NCT05028673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102438150|NCT05028673|Immunologic Factors|immunologic factors|mesh-ancestor
102438151|NCT05028673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438152|NCT05028673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438153|NCT05028673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102438154|NCT04916574|Antibodies|antibodies|mesh-list
102438155|NCT04916574|Immunologic Factors|immunologic factors|mesh-ancestor
102438156|NCT04916574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438157|NCT02460445|Cyproterone Acetate|cyproterone acetate|mesh-list
102438158|NCT02460445|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102438159|NCT02460445|Cyproterone|cyproterone|mesh-list
102438160|NCT02460445|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102438161|NCT02460445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102438162|NCT02460445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102438163|NCT02460445|Contraceptive Agents|contraceptive agents|mesh-ancestor
102438164|NCT02460445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102438165|NCT02460445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438166|NCT02460445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102438167|NCT02460445|Estrogens|estrogens|mesh-ancestor
102438168|NCT02460445|Hormones|hormones|mesh-ancestor
102438169|NCT02460445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102438170|NCT02460445|Androgen Antagonists|androgen antagonists|mesh-ancestor
102438171|NCT02460445|Hormone Antagonists|hormone antagonists|mesh-ancestor
102438172|NCT02460445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438173|NCT02460445|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102438174|NCT02455687|Budesonide|budesonide|mesh-list
102438175|NCT02455687|Magnesium Sulfate|magnesium sulfate|mesh-list
102438176|NCT02455687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102438177|NCT02455687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102438178|NCT02455687|Autonomic Agents|autonomic agents|mesh-ancestor
102438179|NCT02455687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102438180|NCT02455687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438181|NCT02455687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102438182|NCT02455687|Respiratory System Agents|respiratory system agents|mesh-ancestor
102438183|NCT02455687|Glucocorticoids|glucocorticoids|mesh-ancestor
102438184|NCT02455687|Hormones|hormones|mesh-ancestor
102438185|NCT02455687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102438186|NCT02455687|Analgesics|analgesics|mesh-ancestor
102438187|NCT02455687|Sensory System Agents|sensory system agents|mesh-ancestor
102438188|NCT02455687|Anesthetics|anesthetics|mesh-ancestor
102438189|NCT02455687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102438190|NCT02455687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102438191|NCT02455687|Anticonvulsants|anticonvulsants|mesh-ancestor
102438192|NCT02455687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102438193|NCT02455687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102438194|NCT02455687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438195|NCT02455687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102438196|NCT02455687|Tocolytic Agents|tocolytic agents|mesh-ancestor
102438197|NCT02455687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102438198|NCT05023837|Pembrolizumab|pembrolizumab|mesh-list
102438199|NCT05023837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102438200|NCT05023837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438201|NCT05023837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102438202|NCT05023837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438203|NCT02358967|Vitamin E|vitamin e|mesh-list
102438204|NCT02358967|Tocopherols|tocopherols|mesh-list
102438205|NCT02358967|Tocotrienols|tocotrienols|mesh-list
102438206|NCT02358967|Vitamins|vitamins|mesh-ancestor
102438207|NCT02358967|Micronutrients|micronutrients|mesh-ancestor
102438208|NCT02358967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438209|NCT02358967|Antioxidants|antioxidants|mesh-ancestor
102438210|NCT02358967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438211|NCT02358967|Protective Agents|protective agents|mesh-ancestor
102438212|NCT03052998|Ivermectin|ivermectin|mesh-list
102438213|NCT03052998|Anticonvulsants|anticonvulsants|mesh-list
102438214|NCT03052998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102438215|NCT03052998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102438216|NCT05586061|Tislelizumab|tislelizumab|mesh-list
102438217|NCT05586061|Disitamab vedotin|disitamab vedotin|mesh-list
102438218|NCT05586061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102438219|NCT05586061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438220|NCT05586061|Immunoconjugates|immunoconjugates|mesh-ancestor
102438221|NCT05586061|Immunologic Factors|immunologic factors|mesh-ancestor
102438222|NCT05586061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438223|NCT02354131|Bevacizumab|bevacizumab|mesh-list
102438224|NCT02354131|Niraparib|niraparib|mesh-list
102438225|NCT02354131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102438226|NCT02354131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438227|NCT02354131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102438228|NCT02354131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102438229|NCT02354131|Growth Substances|growth substances|mesh-ancestor
102438230|NCT02354131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438231|NCT02354131|Growth Inhibitors|growth inhibitors|mesh-ancestor
102438232|NCT02354131|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102438233|NCT02354131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102438234|NCT02354131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438235|NCT02352337|Gemcitabine|gemcitabine|mesh-list
102438236|NCT02352337|Folfirinox|folfirinox|mesh-list
102438237|NCT02352337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102438238|NCT02352337|Antimetabolites|antimetabolites|mesh-ancestor
102438239|NCT02352337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438240|NCT02352337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438241|NCT02349217|Hydrocortisone|hydrocortisone|mesh-list
102438242|NCT02349217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102438243|NCT02827201|Paclitaxel|paclitaxel|mesh-list
102438244|NCT02827201|Gemcitabine|gemcitabine|mesh-list
102438245|NCT02827201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102438246|NCT02827201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438247|NCT02827201|Tubulin Modulators|tubulin modulators|mesh-ancestor
102438248|NCT02827201|Antimitotic Agents|antimitotic agents|mesh-ancestor
102438249|NCT02827201|Mitosis Modulators|mitosis modulators|mesh-ancestor
102438250|NCT02827201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438251|NCT02827201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102438252|NCT02827201|Antimetabolites|antimetabolites|mesh-ancestor
102438253|NCT02346253|Leuprolide|leuprolide|mesh-list
102438254|NCT02346253|Goserelin|goserelin|mesh-list
102438255|NCT02346253|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102438256|NCT02346253|Bicalutamide|bicalutamide|mesh-list
102438257|NCT02346253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102438258|NCT02346253|Fertility Agents|fertility agents|mesh-ancestor
102438259|NCT02346253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102438260|NCT02346253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438261|NCT02346253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102438262|NCT02346253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438263|NCT02346253|Androgen Antagonists|androgen antagonists|mesh-ancestor
102438264|NCT02346253|Hormone Antagonists|hormone antagonists|mesh-ancestor
102438265|NCT02346253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102438266|NCT02346253|Luteolytic Agents|luteolytic agents|mesh-ancestor
102438267|NCT02346253|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102438268|NCT02346253|Contraceptive Agents|contraceptive agents|mesh-ancestor
102438269|NCT02346253|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102438270|NCT01378377|Niacinamide|niacinamide|mesh-list
102438271|NCT01378377|Sirolimus|sirolimus|mesh-list
102438272|NCT01378377|Temsirolimus|temsirolimus|mesh-list
102438273|NCT01378377|MTOR Inhibitors|mtor inhibitors|mesh-list
102438274|NCT01378377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102438275|NCT01378377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102438276|NCT01378377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438277|NCT01378377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102438278|NCT01378377|Immunologic Factors|immunologic factors|mesh-ancestor
102438279|NCT01378377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438280|NCT01378377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438281|NCT01378377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102438282|NCT01378377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102438283|NCT01378377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102438284|NCT01378377|Antifungal Agents|antifungal agents|mesh-ancestor
102438285|NCT01378377|Vitamin B Complex|vitamin b complex|mesh-ancestor
102438286|NCT01378377|Vitamins|vitamins|mesh-ancestor
102438287|NCT01378377|Micronutrients|micronutrients|mesh-ancestor
102438288|NCT03009045|Tedizolid|tedizolid|mesh-list
102438289|NCT03009045|Tedizolid phosphate|tedizolid phosphate|mesh-list
102438290|NCT03009045|Oxazolidinones|oxazolidinones|mesh-list
102438291|NCT03009045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102438292|NCT03009045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102438293|NCT03009045|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102438294|NCT03009045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102438295|NCT03009045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438296|NCT04907838|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
102438298|NCT04907838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102438299|NCT04907838|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102438300|NCT04907838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438301|NCT04907838|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
102438302|NCT03056274|Metformin|metformin|mesh-list
102438303|NCT03056274|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102438304|NCT03056274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102438305|NCT03056274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438306|NCT03056274|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102438307|NCT03056274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102438308|NCT03056118|Aspirin|aspirin|mesh-list
102438309|NCT03056118|Clopidogrel|clopidogrel|mesh-list
102438310|NCT03056118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102438311|NCT03056118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102438312|NCT03056118|Analgesics|analgesics|mesh-ancestor
102438313|NCT03056118|Sensory System Agents|sensory system agents|mesh-ancestor
102438314|NCT03056118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102438315|NCT03056118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438316|NCT03056118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102438317|NCT03056118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102438318|NCT03056118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102438319|NCT03056118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102438320|NCT03056118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438321|NCT03056118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102438322|NCT03056118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102438323|NCT03056118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102438324|NCT03056118|Antipyretics|antipyretics|mesh-ancestor
102438325|NCT03056118|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102438326|NCT03056118|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102438327|NCT03056118|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102438328|NCT03056118|Purinergic Agents|purinergic agents|mesh-ancestor
102438329|NCT03056118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102438330|NCT04923516|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102438331|NCT04923516|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102438332|NCT04923516|Dermatologic Agents|dermatologic agents|mesh-ancestor
102438333|NCT00987935|Sorafenib|sorafenib|mesh-list
102438334|NCT00987935|Nintedanib|nintedanib|mesh-list
102438335|NCT00987935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438336|NCT00987935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102438337|NCT00987935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102438338|NCT00987935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438339|NCT00987467|Cyclosporine|cyclosporine|mesh-list
102438340|NCT00987467|Cyclosporins|cyclosporins|mesh-list
102438341|NCT00987467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102438342|NCT00987467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438343|NCT00987467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102438344|NCT00987467|Immunologic Factors|immunologic factors|mesh-ancestor
102438345|NCT00987467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438346|NCT00987467|Antifungal Agents|antifungal agents|mesh-ancestor
102438347|NCT00987467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102438348|NCT00987467|Dermatologic Agents|dermatologic agents|mesh-ancestor
102438349|NCT00987467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102438350|NCT00987467|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102438351|NCT05874440|Tenofovir|tenofovir|mesh-list
102438352|NCT05874440|Antiviral Agents|antiviral agents|mesh-ancestor
102438353|NCT05874440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102438354|NCT05874440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102438355|NCT05874440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102438356|NCT05874440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102438357|NCT05874440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438358|NCT05874440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102438359|NCT05874440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102438360|NCT05874180|Metformin|metformin|mesh-list
102438361|NCT05874180|Linagliptin|linagliptin|mesh-list
102438362|NCT05874180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102438363|NCT05874180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438364|NCT05874180|Incretins|incretins|mesh-ancestor
102438365|NCT05874180|Hormones|hormones|mesh-ancestor
102438366|NCT05874180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102438367|NCT05874180|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102438368|NCT05874180|Protease Inhibitors|protease inhibitors|mesh-ancestor
102438369|NCT05874180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102438370|NCT05874180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438371|NCT05874167|Metformin|metformin|mesh-list
102438372|NCT05874167|Linagliptin|linagliptin|mesh-list
102438373|NCT05874167|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102438374|NCT05874167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438375|NCT05874167|Incretins|incretins|mesh-ancestor
102438376|NCT05874167|Hormones|hormones|mesh-ancestor
102438377|NCT05874167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102438378|NCT05874167|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102438379|NCT05874167|Protease Inhibitors|protease inhibitors|mesh-ancestor
102438380|NCT05874167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102438381|NCT05874167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438382|NCT05874141|Hormones|hormones|mesh-list
102438383|NCT05874141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102438384|NCT05874141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438385|NCT05873972|Cetuximab|cetuximab|mesh-list
102438386|NCT05873972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102438387|NCT05873972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438388|NCT05873881|Thiamine|thiamine|mesh-list
102438389|NCT05873881|Colchicine|colchicine|mesh-list
102438390|NCT05873881|Gout Suppressants|gout suppressants|mesh-ancestor
102438391|NCT05873881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102438392|NCT05873881|Tubulin Modulators|tubulin modulators|mesh-ancestor
102438393|NCT05873881|Antimitotic Agents|antimitotic agents|mesh-ancestor
102438394|NCT05873881|Mitosis Modulators|mitosis modulators|mesh-ancestor
102438395|NCT05873881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438396|NCT05873881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438397|NCT05873881|Vitamin B Complex|vitamin b complex|mesh-ancestor
102438398|NCT05873881|Vitamins|vitamins|mesh-ancestor
102438399|NCT05873881|Micronutrients|micronutrients|mesh-ancestor
102438400|NCT05873881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438401|NCT05873751|Vaccines|vaccines|mesh-list
102438402|NCT05873751|Immunologic Factors|immunologic factors|mesh-ancestor
102438403|NCT05873751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438404|NCT05873738|Nicotine|nicotine|mesh-list
102438405|NCT05873738|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102438406|NCT05873738|Autonomic Agents|autonomic agents|mesh-ancestor
102438407|NCT05873738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102438408|NCT05873738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438409|NCT05873738|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102438410|NCT05873738|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102438411|NCT05873738|Cholinergic Agents|cholinergic agents|mesh-ancestor
102438412|NCT05873738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102438413|NCT05873738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438414|NCT05873673|Ubiquinone|ubiquinone|mesh-list
102438415|NCT05873673|Coenzyme Q10|coenzyme q10|mesh-list
102438416|NCT05873673|Micronutrients|micronutrients|mesh-ancestor
102438417|NCT05873673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438418|NCT05873673|Vitamins|vitamins|mesh-ancestor
102438419|NCT05873465|Fentanyl|fentanyl|mesh-list
102438420|NCT05873465|Midazolam|midazolam|mesh-list
102438421|NCT05873465|Propofol|propofol|mesh-list
102438422|NCT05873465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102438423|NCT05873465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102438424|NCT05873465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438425|NCT05873465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102438426|NCT05873465|Anesthetics, General|anesthetics, general|mesh-ancestor
102438427|NCT05873465|Anesthetics|anesthetics|mesh-ancestor
102438428|NCT05873465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102438429|NCT05873465|Narcotics|narcotics|mesh-ancestor
102438430|NCT05873465|Analgesics|analgesics|mesh-ancestor
102438431|NCT05873465|Sensory System Agents|sensory system agents|mesh-ancestor
102438432|NCT05873465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102438433|NCT05873465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102438434|NCT05873465|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102438435|NCT05873465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102438436|NCT05873465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102438437|NCT05873465|GABA Modulators|gaba modulators|mesh-ancestor
102438438|NCT05873465|GABA Agents|gaba agents|mesh-ancestor
102438439|NCT05873465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102438440|NCT05873465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438441|NCT05873192|Talazoparib|talazoparib|mesh-list
102438442|NCT05873192|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102438443|NCT05873192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102438444|NCT05873192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438445|NCT05873192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438446|NCT05872932|Botulinum Toxins|botulinum toxins|mesh-list
102438447|NCT05872932|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102438448|NCT05872932|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102438449|NCT05872932|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102438450|NCT05872932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102612310|NCT00002399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438451|NCT05872932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438452|NCT05872932|Cholinergic Agents|cholinergic agents|mesh-ancestor
102438453|NCT05872932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102438454|NCT05872932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438455|NCT05872932|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102438456|NCT05872932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102438457|NCT05872867|Pembrolizumab|pembrolizumab|mesh-list
102438458|NCT05872867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102438459|NCT05872867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438460|NCT05872867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102438461|NCT05872867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438462|NCT05872698|Carvedilol|carvedilol|mesh-list
102438463|NCT05872698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102438464|NCT05872698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102438465|NCT05872698|Adrenergic Agents|adrenergic agents|mesh-ancestor
102438466|NCT05872698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102438467|NCT05872698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438468|NCT05872698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438469|NCT05872698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102438470|NCT05872698|Antioxidants|antioxidants|mesh-ancestor
102438471|NCT05872698|Protective Agents|protective agents|mesh-ancestor
102438472|NCT05872698|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102438473|NCT05872698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102438474|NCT05872698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102438475|NCT05872698|Vasodilator Agents|vasodilator agents|mesh-ancestor
102438476|NCT05872698|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102438477|NCT05872698|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102438478|NCT05872568|Mycophenolic Acid|mycophenolic acid|mesh-list
102438479|NCT05872568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102438480|NCT05872568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438481|NCT05872568|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102438482|NCT05872568|Antitubercular Agents|antitubercular agents|mesh-ancestor
102438483|NCT05872568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102438484|NCT05872568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102438485|NCT05872568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102438486|NCT05872568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438487|NCT05872555|Antipsychotic Agents|antipsychotic agents|mesh-list
102438488|NCT05872555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102438489|NCT05872555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102438490|NCT05872555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438491|NCT05872555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102438492|NCT05872386|Buprenorphine|buprenorphine|mesh-list
102438493|NCT05872386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102438494|NCT05872386|Narcotics|narcotics|mesh-ancestor
102438495|NCT05872386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102438496|NCT05872386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438497|NCT05872386|Analgesics|analgesics|mesh-ancestor
102438498|NCT05872386|Sensory System Agents|sensory system agents|mesh-ancestor
102438499|NCT05872386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102438500|NCT05872386|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102438501|NCT05872256|Halobetasol|halobetasol|mesh-list
102438502|NCT05872256|Tazarotene|tazarotene|mesh-list
102438503|NCT05872256|Dermatologic Agents|dermatologic agents|mesh-ancestor
102438504|NCT05872256|Keratolytic Agents|keratolytic agents|mesh-ancestor
102438505|NCT05872256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102438506|NCT05872087|Midazolam|midazolam|mesh-list
102438507|NCT05872087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102438508|NCT05872087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102438509|NCT05872087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102438510|NCT05872087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438511|NCT05872087|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102438512|NCT05872087|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102438513|NCT05872087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102438514|NCT05872087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102438515|NCT05872087|Anesthetics, General|anesthetics, general|mesh-ancestor
102438516|NCT05872087|Anesthetics|anesthetics|mesh-ancestor
102438517|NCT05872087|GABA Modulators|gaba modulators|mesh-ancestor
102438518|NCT05872087|GABA Agents|gaba agents|mesh-ancestor
102438519|NCT05872087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102438520|NCT05872087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438521|NCT05871619|Fluorides|fluorides|mesh-list
102438522|NCT05871619|Fluorides, Topical|fluorides, topical|mesh-list
102438523|NCT05871619|Cariostatic Agents|cariostatic agents|mesh-ancestor
102438524|NCT05871619|Protective Agents|protective agents|mesh-ancestor
102250185|NCT02112448|Ketorolac|ketorolac|mesh-list
102438525|NCT05871619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438526|NCT05871177|Hyaluronic Acid|hyaluronic acid|mesh-list
102438527|NCT05871177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102438528|NCT05871177|Immunologic Factors|immunologic factors|mesh-ancestor
102438529|NCT05871177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438530|NCT05871177|Viscosupplements|viscosupplements|mesh-ancestor
102438531|NCT05871177|Protective Agents|protective agents|mesh-ancestor
102438532|NCT05870800|Leucovorin|leucovorin|mesh-list
102438533|NCT05870800|Fluorouracil|fluorouracil|mesh-list
102438534|NCT05870800|Capecitabine|capecitabine|mesh-list
102438535|NCT05870800|Oxaliplatin|oxaliplatin|mesh-list
102438536|NCT05870800|Atezolizumab|atezolizumab|mesh-list
102438537|NCT05870800|Antimetabolites|antimetabolites|mesh-ancestor
102438538|NCT05870800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438539|NCT05870800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102438540|NCT05870800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438541|NCT05870800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102438542|NCT05870800|Immunologic Factors|immunologic factors|mesh-ancestor
102438543|NCT05870800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438544|NCT05870800|Antidotes|antidotes|mesh-ancestor
102438545|NCT05870800|Protective Agents|protective agents|mesh-ancestor
102438546|NCT05870800|Vitamin B Complex|vitamin b complex|mesh-ancestor
102438547|NCT05870800|Vitamins|vitamins|mesh-ancestor
102438548|NCT05870800|Micronutrients|micronutrients|mesh-ancestor
102438549|NCT05870800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102438550|NCT05870800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102438551|NCT05869357|Turmeric extract|turmeric extract|mesh-list
102438552|NCT05869357|Antioxidants|antioxidants|mesh-ancestor
102438553|NCT05869357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438554|NCT05869357|Protective Agents|protective agents|mesh-ancestor
102438555|NCT05869357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438556|NCT05869188|Isotretinoin|isotretinoin|mesh-list
102438557|NCT05869188|Dermatologic Agents|dermatologic agents|mesh-ancestor
102438558|NCT05868889|Trabectedin|trabectedin|mesh-list
102438559|NCT05868889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102438560|NCT05868889|Alkylating Agents|alkylating agents|mesh-ancestor
102438561|NCT05868889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438562|NCT05868889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438563|NCT05868174|Peposertib|peposertib|mesh-list
102438564|NCT05868174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102438565|NCT05868174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102438566|NCT05868174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438567|NCT05865457|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102438568|NCT05865457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102438569|NCT05865379|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102438570|NCT05865379|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102438571|NCT05849740|Daratumumab|daratumumab|mesh-list
102438572|NCT05849740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438573|NCT05813587|Meplazumab|meplazumab|mesh-list
102438574|NCT05813587|Antiviral Agents|antiviral agents|mesh-ancestor
102438575|NCT05813587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102438576|NCT05811676|Tranexamic Acid|tranexamic acid|mesh-list
102438577|NCT05811676|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102438578|NCT05811676|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102438579|NCT05811676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438580|NCT05811676|Hemostatics|hemostatics|mesh-ancestor
102438581|NCT05811676|Coagulants|coagulants|mesh-ancestor
102438582|NCT05799326|Levofloxacin|levofloxacin|mesh-list
102438583|NCT05799326|Ofloxacin|ofloxacin|mesh-list
102438584|NCT05799326|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102438585|NCT05799326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102438586|NCT05799326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102438587|NCT05799326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102438588|NCT05799326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102438589|NCT05799326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102438590|NCT05799326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438591|NCT05799326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438592|NCT05799326|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102438593|NCT05799326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102438594|NCT05797467|Bevacizumab|bevacizumab|mesh-list
102438595|NCT05797467|Cetuximab|cetuximab|mesh-list
102438596|NCT05797467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102438597|NCT05797467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438598|NCT05797467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102438599|NCT05797467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102438600|NCT05797467|Growth Substances|growth substances|mesh-ancestor
102438601|NCT05797467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438602|NCT05797467|Growth Inhibitors|growth inhibitors|mesh-ancestor
102438603|NCT05796973|Atorvastatin|atorvastatin|mesh-list
102438604|NCT05796973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102438605|NCT05796973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102438606|NCT05796973|Antimetabolites|antimetabolites|mesh-ancestor
102438607|NCT05796973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438608|NCT05796973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102438609|NCT05796973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102438610|NCT05796973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102438611|NCT05741905|Levofloxacin|levofloxacin|mesh-list
102438612|NCT05741905|Ofloxacin|ofloxacin|mesh-list
102438613|NCT05741905|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102438614|NCT05741905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102438615|NCT05741905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102069076|NCT02084784|Methylene Blue|methylene blue|mesh-list
102438616|NCT05741905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102438617|NCT05741905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102438618|NCT05741905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102438619|NCT05741905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438620|NCT05741905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438621|NCT05741905|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102438622|NCT05741905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102438623|NCT05739123|Relugolix|relugolix|mesh-list
102438624|NCT05739123|Androgen Antagonists|androgen antagonists|mesh-ancestor
102438625|NCT05739123|Hormone Antagonists|hormone antagonists|mesh-ancestor
102438626|NCT05739123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102438627|NCT05739123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438628|NCT05733923|Sodium Hypochlorite|sodium hypochlorite|mesh-list
102438629|NCT05733923|Eusol|eusol|mesh-list
102438630|NCT05733923|Disinfectants|disinfectants|mesh-ancestor
102438631|NCT05733923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102438632|NCT05733741|Benoxinate|benoxinate|mesh-list
102438633|NCT05733741|Hyaluronic Acid|hyaluronic acid|mesh-list
102438634|NCT05733741|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102438635|NCT05733741|Immunologic Factors|immunologic factors|mesh-ancestor
102438636|NCT05733741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438637|NCT05733741|Viscosupplements|viscosupplements|mesh-ancestor
102438638|NCT05733741|Protective Agents|protective agents|mesh-ancestor
102438639|NCT05733741|Anesthetics, Local|anesthetics, local|mesh-ancestor
102438640|NCT05733741|Anesthetics|anesthetics|mesh-ancestor
102438641|NCT05733741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102438642|NCT05733741|Sensory System Agents|sensory system agents|mesh-ancestor
102438643|NCT05733741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102438644|NCT05711082|Dopamine|dopamine|mesh-list
102438645|NCT05711082|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102438646|NCT05711082|Sympathomimetics|sympathomimetics|mesh-ancestor
102438647|NCT05711082|Autonomic Agents|autonomic agents|mesh-ancestor
102438648|NCT05711082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102438649|NCT05711082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438650|NCT05711082|Dopamine Agents|dopamine agents|mesh-ancestor
102438651|NCT05711082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102438652|NCT05711082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438653|NCT05711082|Protective Agents|protective agents|mesh-ancestor
102438654|NCT05689463|Immunoglobulins|immunoglobulins|mesh-list
102438655|NCT05689463|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102438656|NCT05689463|Antibodies|antibodies|mesh-list
102438657|NCT05689463|Immunologic Factors|immunologic factors|mesh-ancestor
102438658|NCT05689463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438659|NCT05686993|Nifedipine|nifedipine|mesh-list
102438660|NCT05686993|Cinnarizine|cinnarizine|mesh-list
102438661|NCT05686993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102438662|NCT05686993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102438663|NCT05686993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438664|NCT05686993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102438665|NCT05686993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438666|NCT05686993|Vasodilator Agents|vasodilator agents|mesh-ancestor
102438667|NCT05686993|Tocolytic Agents|tocolytic agents|mesh-ancestor
102438668|NCT05686993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102438669|NCT05686993|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102438670|NCT05686993|Histamine Antagonists|histamine antagonists|mesh-ancestor
102438671|NCT05686993|Histamine Agents|histamine agents|mesh-ancestor
102438672|NCT05686993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102438673|NCT05673577|Cetuximab|cetuximab|mesh-list
102438674|NCT05673577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102438675|NCT05673577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438676|NCT05658146|Sulconazole|sulconazole|mesh-list
102438677|NCT05658146|Antifungal Agents|antifungal agents|mesh-ancestor
102438678|NCT05658146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102438680|NCT05591755|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102438681|NCT05591755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102438682|NCT05591755|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102438683|NCT05591755|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102438684|NCT05591755|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102069126|NCT04475042|Dapagliflozin|dapagliflozin|mesh-list
102438685|NCT05591755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102438686|NCT05591755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102438687|NCT05591755|Adrenergic Agents|adrenergic agents|mesh-ancestor
102438688|NCT05591755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102438689|NCT05591755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438690|NCT05591755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438691|NCT05591755|Antipruritics|antipruritics|mesh-ancestor
102438692|NCT05591755|Dermatologic Agents|dermatologic agents|mesh-ancestor
102438693|NCT05591755|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102438694|NCT05591755|Histamine Antagonists|histamine antagonists|mesh-ancestor
102438695|NCT05591755|Histamine Agents|histamine agents|mesh-ancestor
102438696|NCT05591755|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102438697|NCT05579730|Ketotifen|ketotifen|mesh-list
102438698|NCT05579730|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102438699|NCT05579730|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102438700|NCT05579730|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102438701|NCT05579730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102438702|NCT05579730|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102438703|NCT05579730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102438704|NCT05579730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102438705|NCT05579730|Adrenergic Agents|adrenergic agents|mesh-ancestor
102438706|NCT05579730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102438707|NCT05579730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438708|NCT05579730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438709|NCT05579730|Antipruritics|antipruritics|mesh-ancestor
102438710|NCT05579730|Dermatologic Agents|dermatologic agents|mesh-ancestor
102438711|NCT05579730|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102438712|NCT05579730|Histamine Antagonists|histamine antagonists|mesh-ancestor
102438713|NCT05579730|Histamine Agents|histamine agents|mesh-ancestor
102438714|NCT05579730|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102438715|NCT05533164|Rituximab|rituximab|mesh-list
102438716|NCT05533164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102438717|NCT05533164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438718|NCT05533164|Immunologic Factors|immunologic factors|mesh-ancestor
102438719|NCT05533164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438720|NCT05533164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102438721|NCT05533125|Rituximab|rituximab|mesh-list
102438722|NCT05533125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102438723|NCT05533125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438724|NCT05533125|Immunologic Factors|immunologic factors|mesh-ancestor
102438725|NCT05533125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438726|NCT05533125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102438727|NCT05407584|Paclitaxel|paclitaxel|mesh-list
102438728|NCT05407584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102438729|NCT05407584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438730|NCT05407584|Tubulin Modulators|tubulin modulators|mesh-ancestor
102438731|NCT05407584|Antimitotic Agents|antimitotic agents|mesh-ancestor
102438732|NCT05407584|Mitosis Modulators|mitosis modulators|mesh-ancestor
102438733|NCT05407584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438734|NCT05335122|Bimatoprost|bimatoprost|mesh-list
102438735|NCT05335122|Travoprost|travoprost|mesh-list
102438736|NCT05335122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102438737|NCT05321251|Insulin|insulin|mesh-list
102438738|NCT05321251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102438739|NCT05321251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438740|NCT05294588|Ciprofloxacin|ciprofloxacin|mesh-list
102438741|NCT05294588|Ceftriaxone|ceftriaxone|mesh-list
102438742|NCT05294588|Cefixime|cefixime|mesh-list
102438743|NCT05294588|Vaccines|vaccines|mesh-list
102438744|NCT05294588|Immunologic Factors|immunologic factors|mesh-ancestor
102438745|NCT05294588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438746|NCT05294588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102438747|NCT05294588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102438748|NCT05294588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102438749|NCT05294588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102438750|NCT05294588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102438751|NCT05294588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438752|NCT05294588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438753|NCT05294588|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102438754|NCT05294588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102438756|NCT05188508|Temozolomide|temozolomide|mesh-list
102438757|NCT05188508|Olaparib|olaparib|mesh-list
102438758|NCT05188508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102438759|NCT05188508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438760|NCT05188508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102438761|NCT05188508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438762|NCT05188508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102438763|NCT05188508|Alkylating Agents|alkylating agents|mesh-ancestor
102438764|NCT05188508|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102438765|NCT05188508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102438766|NCT05170139|Caffeine|caffeine|mesh-list
102438767|NCT05170139|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102438768|NCT05170139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438769|NCT05170139|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102438770|NCT05170139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102438771|NCT05170139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438772|NCT05170139|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102438773|NCT05170139|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102438774|NCT05170139|Purinergic Agents|purinergic agents|mesh-ancestor
102438775|NCT05170139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102438776|NCT05140811|Azacitidine|azacitidine|mesh-list
102438777|NCT05140811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102438778|NCT05140811|Antimetabolites|antimetabolites|mesh-ancestor
102438779|NCT05140811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438780|NCT05140811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438781|NCT05140811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102438782|NCT05117398|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102438783|NCT05117398|Dalbavancin|dalbavancin|mesh-list
102438784|NCT05117398|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102438785|NCT05117398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102438786|NCT05117398|Antitubercular Agents|antitubercular agents|mesh-ancestor
102438787|NCT05096169|Citric Acid|citric acid|mesh-list
102438788|NCT05096169|Sodium Citrate|sodium citrate|mesh-list
102438789|NCT05096169|Clomiphene|clomiphene|mesh-list
102438790|NCT05096169|Enclomiphene|enclomiphene|mesh-list
102438791|NCT05096169|Zuclomiphene|zuclomiphene|mesh-list
102438792|NCT05096169|Anticoagulants|anticoagulants|mesh-ancestor
102438793|NCT05096169|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102438794|NCT05096169|Chelating Agents|chelating agents|mesh-ancestor
102438795|NCT05096169|Sequestering Agents|sequestering agents|mesh-ancestor
102438796|NCT05096169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438797|NCT05096169|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102438798|NCT05096169|Hormone Antagonists|hormone antagonists|mesh-ancestor
102438799|NCT05096169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102438800|NCT05096169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438801|NCT05096169|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102438802|NCT05096169|Fertility Agents|fertility agents|mesh-ancestor
102438803|NCT05096169|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102438804|NCT05096169|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102438805|NCT05096169|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102438806|NCT05079841|Oxytocin|oxytocin|mesh-list
102438807|NCT05079841|Oxytocics|oxytocics|mesh-ancestor
102438808|NCT05079841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102438809|NCT05079841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438810|NCT05046184|Midazolam|midazolam|mesh-list
102438811|NCT05046184|Ketamine|ketamine|mesh-list
102438812|NCT05046184|Analgesics|analgesics|mesh-ancestor
102438813|NCT05046184|Sensory System Agents|sensory system agents|mesh-ancestor
102438814|NCT05046184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102438815|NCT05046184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438816|NCT05046184|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102438817|NCT05046184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102438818|NCT05046184|Anesthetics, General|anesthetics, general|mesh-ancestor
102438819|NCT05046184|Anesthetics|anesthetics|mesh-ancestor
102438820|NCT05046184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102438821|NCT05046184|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102438822|NCT05046184|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102438823|NCT05046184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102438824|NCT05046184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438825|NCT05046184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102438826|NCT05046184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102438827|NCT05046184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102438828|NCT05046184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102438829|NCT05046184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102438830|NCT05046184|GABA Modulators|gaba modulators|mesh-ancestor
102438831|NCT05046184|GABA Agents|gaba agents|mesh-ancestor
102438832|NCT05033522|Sorafenib|sorafenib|mesh-list
102438833|NCT05033522|Lenvatinib|lenvatinib|mesh-list
102438834|NCT05033522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438835|NCT05033522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102438836|NCT05033522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102438837|NCT05033522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438838|NCT05020028|Cannabidiol|cannabidiol|mesh-list
102438839|NCT05020028|Anticonvulsants|anticonvulsants|mesh-ancestor
102438840|NCT04976868|Pimecrolimus|pimecrolimus|mesh-list
102438841|NCT04976868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102438842|NCT04976868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102438843|NCT04976868|Analgesics|analgesics|mesh-ancestor
102438844|NCT04976868|Sensory System Agents|sensory system agents|mesh-ancestor
102438845|NCT04976868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102438846|NCT04976868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438847|NCT04976868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102438848|NCT04976868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102438849|NCT04976868|Dermatologic Agents|dermatologic agents|mesh-ancestor
102438850|NCT04976868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102438851|NCT04976868|Immunologic Factors|immunologic factors|mesh-ancestor
102438852|NCT04976868|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102438853|NCT04976868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102438854|NCT04976868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438855|NCT04944654|Emtricitabine|emtricitabine|mesh-list
102438856|NCT04944654|Antiviral Agents|antiviral agents|mesh-ancestor
102438857|NCT04944654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102438858|NCT04944654|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102438859|NCT04944654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102438860|NCT04944654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102438861|NCT04944654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438862|NCT04944654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102438863|NCT04944654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102438864|NCT04939623|Benzoic Acid|benzoic acid|mesh-list
102438865|NCT04939623|Probenecid|probenecid|mesh-list
102438866|NCT04939623|Uricosuric Agents|uricosuric agents|mesh-ancestor
102438867|NCT04939623|Gout Suppressants|gout suppressants|mesh-ancestor
102438868|NCT04939623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102438869|NCT04939623|Antifungal Agents|antifungal agents|mesh-ancestor
102438870|NCT04939623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102438871|NCT04939597|Memantine|memantine|mesh-list
102438872|NCT04939597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102438873|NCT04939597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102438874|NCT04939597|Dopamine Agents|dopamine agents|mesh-ancestor
102069313|NCT02092506|Amoxicillin|amoxicillin|mesh-list
102438875|NCT04939597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102438876|NCT04939597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438877|NCT04939597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438878|NCT04939597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102438879|NCT04939597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102438880|NCT04886232|Lidocaine|lidocaine|mesh-list
102438881|NCT04886232|Anesthetics, Local|anesthetics, local|mesh-ancestor
102438882|NCT04886232|Anesthetics|anesthetics|mesh-ancestor
102438883|NCT04886232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102438884|NCT04886232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438885|NCT04886232|Sensory System Agents|sensory system agents|mesh-ancestor
102438886|NCT04886232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102438887|NCT04886232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102438888|NCT04886232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102438889|NCT04886232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102438890|NCT04886232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102438891|NCT04886232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438892|NCT04885712|Metformin|metformin|mesh-list
102438893|NCT04885712|Pioglitazone|pioglitazone|mesh-list
102438894|NCT04885712|Dapagliflozin|dapagliflozin|mesh-list
102438895|NCT04885712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102438896|NCT04885712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438897|NCT04885712|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102438898|NCT04885712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438899|NCT04843046|Pioglitazone|pioglitazone|mesh-list
102438900|NCT04843046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102438901|NCT04843046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438902|NCT04789499|Theophylline|theophylline|mesh-list
102438903|NCT04789499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102438904|NCT04789499|Autonomic Agents|autonomic agents|mesh-ancestor
102438905|NCT04789499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102438906|NCT04789499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438907|NCT04789499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102438908|NCT04789499|Respiratory System Agents|respiratory system agents|mesh-ancestor
102438909|NCT04789499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102438910|NCT04789499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102438911|NCT04789499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438912|NCT04789499|Vasodilator Agents|vasodilator agents|mesh-ancestor
102438913|NCT04789499|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102438914|NCT04789499|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102438915|NCT04789499|Purinergic Agents|purinergic agents|mesh-ancestor
102438916|NCT04789499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102438917|NCT04774380|Carboplatin|carboplatin|mesh-list
102438918|NCT04774380|Etoposide|etoposide|mesh-list
102438919|NCT04774380|Durvalumab|durvalumab|mesh-list
102438920|NCT04774380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438921|NCT04774380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102438922|NCT04774380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102438923|NCT04774380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102438924|NCT04774380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102438925|NCT04774380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438926|NCT04774380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102438927|NCT04706130|Artesunate|artesunate|mesh-list
102438928|NCT04706130|Primaquine|primaquine|mesh-list
102438929|NCT04706130|Antimalarials|antimalarials|mesh-ancestor
102438930|NCT04706130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102438931|NCT04706130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102438932|NCT04706130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102438933|NCT04706130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438934|NCT04706130|Antiviral Agents|antiviral agents|mesh-ancestor
102438935|NCT04706130|Schistosomicides|schistosomicides|mesh-ancestor
102438936|NCT04706130|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102438937|NCT04706130|Anthelmintics|anthelmintics|mesh-ancestor
102438938|NCT04697823|Hyaluronic Acid|hyaluronic acid|mesh-list
102438939|NCT04697823|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102438940|NCT04697823|Immunologic Factors|immunologic factors|mesh-ancestor
102438941|NCT04697823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438942|NCT04697823|Viscosupplements|viscosupplements|mesh-ancestor
102438943|NCT04697823|Protective Agents|protective agents|mesh-ancestor
102438944|NCT04675827|Trastuzumab|trastuzumab|mesh-list
102438945|NCT04675827|Pertuzumab|pertuzumab|mesh-list
102438946|NCT04675827|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102438947|NCT04675827|Maytansine|maytansine|mesh-list
102438948|NCT04675827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102438949|NCT04675827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438950|NCT04675827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102438951|NCT04675827|Tubulin Modulators|tubulin modulators|mesh-ancestor
102438952|NCT04675827|Antimitotic Agents|antimitotic agents|mesh-ancestor
102438953|NCT04675827|Mitosis Modulators|mitosis modulators|mesh-ancestor
102438954|NCT04675827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438955|NCT04675827|Immunotoxins|immunotoxins|mesh-ancestor
102438956|NCT04675827|Immunoconjugates|immunoconjugates|mesh-ancestor
102438957|NCT04675827|Immunologic Factors|immunologic factors|mesh-ancestor
102438958|NCT04675827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438959|NCT04674462|Vaccines|vaccines|mesh-list
102438960|NCT04674462|Immunologic Factors|immunologic factors|mesh-ancestor
102438961|NCT04674462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438962|NCT04657016|Tirzepatide|tirzepatide|mesh-list
102438963|NCT04657016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102438964|NCT04657016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438965|NCT04657016|Incretins|incretins|mesh-ancestor
102438966|NCT04657016|Hormones|hormones|mesh-ancestor
102438967|NCT04657016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102438968|NCT04641871|Irinotecan|irinotecan|mesh-list
102438969|NCT04641871|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102438970|NCT04641871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102438971|NCT04641871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102438972|NCT04641871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438973|NCT04641871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438974|NCT04638036|Cetuximab|cetuximab|mesh-list
102438975|NCT04638036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102438976|NCT04638036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102438977|NCT04598074|Analgesics, Opioid|analgesics, opioid|mesh-list
102438978|NCT04598074|Narcotics|narcotics|mesh-ancestor
102438979|NCT04598074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102438980|NCT04598074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102438981|NCT04598074|Analgesics|analgesics|mesh-ancestor
102438982|NCT04598074|Sensory System Agents|sensory system agents|mesh-ancestor
102438983|NCT04598074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102438984|NCT04593758|Hydroxychloroquine|hydroxychloroquine|mesh-list
102438985|NCT04593758|Antimalarials|antimalarials|mesh-ancestor
102438986|NCT04593758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102438987|NCT04593758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102438988|NCT04593758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102438989|NCT04593758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102438990|NCT04593758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438991|NCT04593758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102438992|NCT04560010|Tranexamic Acid|tranexamic acid|mesh-list
102438993|NCT04560010|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102438994|NCT04560010|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102438995|NCT04560010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102438996|NCT04560010|Hemostatics|hemostatics|mesh-ancestor
102438997|NCT04560010|Coagulants|coagulants|mesh-ancestor
102438998|NCT04558866|Methyltestosterone|methyltestosterone|mesh-list
102438999|NCT04558866|Testosterone|testosterone|mesh-list
102439000|NCT04558866|Testosterone undecanoate|testosterone undecanoate|mesh-list
102439001|NCT04558866|Testosterone enanthate|testosterone enanthate|mesh-list
102439002|NCT04558866|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102439003|NCT04558866|Androgens|androgens|mesh-ancestor
102439005|NCT04558866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102439006|NCT04558866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439007|NCT04558866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102439008|NCT04558866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439009|NCT04558866|Anabolic Agents|anabolic agents|mesh-ancestor
102439010|NCT04397679|Chloroquine|chloroquine|mesh-list
102439011|NCT04397679|Temozolomide|temozolomide|mesh-list
102439012|NCT04397679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102439013|NCT04397679|Alkylating Agents|alkylating agents|mesh-ancestor
102439014|NCT04397679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439015|NCT04397679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439016|NCT04397679|Amebicides|amebicides|mesh-ancestor
102439017|NCT04397679|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102439018|NCT04397679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102439019|NCT04397679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102439020|NCT04397679|Antimalarials|antimalarials|mesh-ancestor
102439021|NCT04397679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102439022|NCT04363164|Methyltestosterone|methyltestosterone|mesh-list
102439023|NCT04363164|Testosterone|testosterone|mesh-list
102439024|NCT04363164|Testosterone undecanoate|testosterone undecanoate|mesh-list
102439025|NCT04363164|Testosterone enanthate|testosterone enanthate|mesh-list
102439026|NCT04363164|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102439027|NCT04363164|Androgens|androgens|mesh-ancestor
102439028|NCT04363164|Hormones|hormones|mesh-ancestor
102439029|NCT04363164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102439030|NCT04363164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439031|NCT04363164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102439032|NCT04363164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439033|NCT04363164|Anabolic Agents|anabolic agents|mesh-ancestor
102439034|NCT04258423|Everolimus|everolimus|mesh-list
102439035|NCT04258423|Tacrolimus|tacrolimus|mesh-list
102439036|NCT04258423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102439037|NCT04258423|Immunologic Factors|immunologic factors|mesh-ancestor
102439038|NCT04258423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439039|NCT04258423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102439040|NCT04258423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102439041|NCT04258423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439042|NCT04258423|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102439043|NCT04258423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102439044|NCT04258423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439045|NCT04211987|Cytarabine|cytarabine|mesh-list
102439046|NCT04211987|Methotrexate|methotrexate|mesh-list
102439047|NCT04211987|Etoposide|etoposide|mesh-list
102439048|NCT04211987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102439049|NCT04211987|Antimetabolites|antimetabolites|mesh-ancestor
102439050|NCT04211987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439051|NCT04211987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439052|NCT04211987|Antiviral Agents|antiviral agents|mesh-ancestor
102439053|NCT04211987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102439054|NCT04211987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102439055|NCT04211987|Immunologic Factors|immunologic factors|mesh-ancestor
102250711|NCT02584257|Miotics|miotics|mesh-ancestor
102439056|NCT04211987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439057|NCT04211987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102439058|NCT04211987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102439059|NCT04211987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102439061|NCT04211987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102439062|NCT04211987|Abortifacient Agents|abortifacient agents|mesh-ancestor
102439063|NCT04211987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102439064|NCT04211987|Dermatologic Agents|dermatologic agents|mesh-ancestor
102439065|NCT04211987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102439066|NCT04211987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102439067|NCT04211987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102439068|NCT04190433|Carvedilol|carvedilol|mesh-list
102439069|NCT04190433|Lisinopril|lisinopril|mesh-list
102439070|NCT04190433|Spironolactone|spironolactone|mesh-list
102439071|NCT04190433|Pravastatin|pravastatin|mesh-list
102439072|NCT04190433|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102439073|NCT04190433|Hormone Antagonists|hormone antagonists|mesh-ancestor
102439074|NCT04190433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102439075|NCT04190433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439076|NCT04190433|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102439077|NCT04190433|Diuretics|diuretics|mesh-ancestor
102439078|NCT04190433|Natriuretic Agents|natriuretic agents|mesh-ancestor
102439079|NCT04190433|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102439080|NCT04190433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102439081|NCT04190433|Adrenergic Agents|adrenergic agents|mesh-ancestor
102439082|NCT04190433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102439083|NCT04190433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439084|NCT04190433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102439085|NCT04190433|Antioxidants|antioxidants|mesh-ancestor
102439086|NCT04190433|Protective Agents|protective agents|mesh-ancestor
102069524|NCT02093598|Antifungal Agents|antifungal agents|mesh-ancestor
102439087|NCT04190433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102439088|NCT04190433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102439089|NCT04190433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102439090|NCT04190433|Vasodilator Agents|vasodilator agents|mesh-ancestor
102439091|NCT04190433|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102439092|NCT04190433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102439093|NCT04190433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102439094|NCT04190433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102439095|NCT04190433|Antimetabolites|antimetabolites|mesh-ancestor
102439096|NCT04190433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102439097|NCT04190433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102439098|NCT04190433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102439099|NCT04190433|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102439100|NCT04190433|Protease Inhibitors|protease inhibitors|mesh-ancestor
102439101|NCT04190433|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102439102|NCT04177810|Plerixafor|plerixafor|mesh-list
102439103|NCT04177810|Cemiplimab|cemiplimab|mesh-list
102439104|NCT04177810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102439105|NCT04177810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102439106|NCT04177810|Antiviral Agents|antiviral agents|mesh-ancestor
102439107|NCT04177810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102439108|NCT04177810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102439109|NCT04177810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439110|NCT04163900|Gemcitabine|gemcitabine|mesh-list
102439111|NCT04163900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439112|NCT04163900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102439113|NCT04163900|Antimetabolites|antimetabolites|mesh-ancestor
102439114|NCT04163900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439115|NCT04146038|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
102439116|NCT04146038|Sodium Salicylate|sodium salicylate|mesh-list
102439117|NCT04146038|Azacitidine|azacitidine|mesh-list
102439118|NCT04146038|Decitabine|decitabine|mesh-list
102439119|NCT04146038|Venetoclax|venetoclax|mesh-list
102439120|NCT04146038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102439121|NCT04146038|Antimetabolites|antimetabolites|mesh-ancestor
102439122|NCT04146038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439123|NCT04146038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439124|NCT04146038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102439125|NCT04146038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102439126|NCT04146038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102439127|NCT04146038|Analgesics|analgesics|mesh-ancestor
102439128|NCT04146038|Sensory System Agents|sensory system agents|mesh-ancestor
102439129|NCT04146038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102439130|NCT04146038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439131|NCT04146038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102439132|NCT04146038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102439133|NCT04146038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102439134|NCT04109885|Diphenhydramine|diphenhydramine|mesh-list
102439135|NCT04109885|Promethazine|promethazine|mesh-list
102439136|NCT04109885|Prochlorperazine|prochlorperazine|mesh-list
102439137|NCT04109885|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102439138|NCT04109885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102439139|NCT04109885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102439140|NCT04109885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439141|NCT04109885|Anesthetics, Local|anesthetics, local|mesh-ancestor
102439142|NCT04109885|Anesthetics|anesthetics|mesh-ancestor
102439143|NCT04109885|Sensory System Agents|sensory system agents|mesh-ancestor
102439144|NCT04109885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102439145|NCT04109885|Antiemetics|antiemetics|mesh-ancestor
102439146|NCT04109885|Autonomic Agents|autonomic agents|mesh-ancestor
102439147|NCT04109885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102439148|NCT04109885|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102439149|NCT04109885|Histamine Antagonists|histamine antagonists|mesh-ancestor
102439150|NCT04109885|Histamine Agents|histamine agents|mesh-ancestor
102439151|NCT04109885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102439152|NCT04109885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439153|NCT04109885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102439154|NCT04109885|Antipruritics|antipruritics|mesh-ancestor
102439155|NCT04109885|Dermatologic Agents|dermatologic agents|mesh-ancestor
102439156|NCT04109885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102439157|NCT04109885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102439158|NCT04109885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102439159|NCT04109885|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102439160|NCT04109885|Dopamine Agents|dopamine agents|mesh-ancestor
102439161|NCT04098068|Pembrolizumab|pembrolizumab|mesh-list
102439162|NCT04098068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102439163|NCT04098068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439164|NCT04098068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102439165|NCT04098068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439166|NCT04087668|Anesthetics|anesthetics|mesh-list
102439167|NCT04087668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102439168|NCT04087668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439169|NCT04025372|Bicalutamide|bicalutamide|mesh-list
102439170|NCT04025372|Androgen Antagonists|androgen antagonists|mesh-ancestor
102439171|NCT04025372|Hormone Antagonists|hormone antagonists|mesh-ancestor
102439172|NCT04025372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102439173|NCT04025372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439174|NCT04025372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439175|NCT04006873|Ivacaftor|ivacaftor|mesh-list
102439176|NCT04006873|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102439177|NCT04006873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102439178|NCT04006873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439179|NCT03942419|Atropine|atropine|mesh-list
102439180|NCT03942419|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102439181|NCT03942419|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102439182|NCT03942419|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102439183|NCT03942419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102439184|NCT03942419|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102439185|NCT03942419|Autonomic Agents|autonomic agents|mesh-ancestor
102439186|NCT03942419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102439187|NCT03942419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439188|NCT03942419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102439189|NCT03942419|Respiratory System Agents|respiratory system agents|mesh-ancestor
102439190|NCT03942419|Mydriatics|mydriatics|mesh-ancestor
102439191|NCT03942419|Parasympatholytics|parasympatholytics|mesh-ancestor
102439192|NCT03942419|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102439193|NCT03942419|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102439194|NCT03942419|Cholinergic Agents|cholinergic agents|mesh-ancestor
102439195|NCT03942419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102439196|NCT03942419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439197|NCT03820310|Immunomodulating Agents|immunomodulating agents|mesh-list
102439198|NCT03820310|Immunologic Factors|immunologic factors|mesh-ancestor
102439199|NCT03820310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439200|NCT03780673|Rifaximin|rifaximin|mesh-list
102439201|NCT03780673|Simvastatin|simvastatin|mesh-list
102439202|NCT03780673|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102439203|NCT03780673|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102439204|NCT03780673|Antimetabolites|antimetabolites|mesh-ancestor
102439205|NCT03780673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439206|NCT03780673|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102439207|NCT03780673|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102439208|NCT03780673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102439209|NCT03780673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102439210|NCT03780673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102439211|NCT03780673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102439213|NCT03769311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102439214|NCT03769311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439215|NCT03767335|Trastuzumab|trastuzumab|mesh-list
102439216|NCT03767335|Fulvestrant|fulvestrant|mesh-list
102439217|NCT03767335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102439218|NCT03767335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439219|NCT03767335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102439220|NCT03767335|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102439221|NCT03767335|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102439222|NCT03767335|Hormone Antagonists|hormone antagonists|mesh-ancestor
102439223|NCT03767335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102439224|NCT03767335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439225|NCT03745430|Ramucirumab|ramucirumab|mesh-list
102439226|NCT03745430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439227|NCT03692052|Mitapivat|mitapivat|mesh-list
102439228|NCT03692052|Enzyme Activators|enzyme activators|mesh-ancestor
102439229|NCT03692052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439230|NCT03651882|Oxytocin|oxytocin|mesh-list
102439231|NCT03651882|Carbetocin|carbetocin|mesh-list
102439232|NCT03651882|Oxytocics|oxytocics|mesh-ancestor
102439233|NCT03651882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102439234|NCT03651882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439235|NCT03636932|Acetylcysteine|acetylcysteine|mesh-list
102439236|NCT03636932|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102439237|NCT03636932|Antiviral Agents|antiviral agents|mesh-ancestor
102439238|NCT03636932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102439239|NCT03636932|Expectorants|expectorants|mesh-ancestor
102439240|NCT03636932|Respiratory System Agents|respiratory system agents|mesh-ancestor
102439241|NCT03636932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102439242|NCT03636932|Antioxidants|antioxidants|mesh-ancestor
102439243|NCT03636932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439244|NCT03636932|Protective Agents|protective agents|mesh-ancestor
102439245|NCT03636932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439246|NCT03636932|Antidotes|antidotes|mesh-ancestor
102439247|NCT05910554|Metformin|metformin|mesh-list
102439248|NCT05910554|Glyburide|glyburide|mesh-list
102439249|NCT05910554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102439250|NCT05910554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439251|NCT05910476|Ezetimibe|ezetimibe|mesh-list
102439252|NCT05910476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102439253|NCT05910476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102439254|NCT05910476|Antimetabolites|antimetabolites|mesh-ancestor
102439255|NCT05910476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439256|NCT05910476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102439257|NCT05910450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102439258|NCT05910177|Etoposide|etoposide|mesh-list
102439259|NCT05910177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439260|NCT05910177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102439261|NCT05910177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102439262|NCT05910177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102439263|NCT05910177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102439264|NCT05910177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439265|NCT05910125|Aspirin|aspirin|mesh-list
102439266|NCT05910125|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102439267|NCT05910125|Clopidogrel|clopidogrel|mesh-list
102439268|NCT05910125|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102439269|NCT05910125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102439270|NCT05910125|Analgesics|analgesics|mesh-ancestor
102439271|NCT05910125|Sensory System Agents|sensory system agents|mesh-ancestor
102439272|NCT05910125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102439273|NCT05910125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439274|NCT05910125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102439275|NCT05910125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102439276|NCT05910125|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102439277|NCT05910125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102439278|NCT05910125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439279|NCT05910125|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102439280|NCT05910125|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102439281|NCT05910125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102439282|NCT05910125|Antipyretics|antipyretics|mesh-ancestor
102439283|NCT05910125|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102439284|NCT05910125|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102439285|NCT05910125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102439286|NCT05910125|Purinergic Agents|purinergic agents|mesh-ancestor
102439287|NCT05910125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102439288|NCT05910034|Docetaxel|docetaxel|mesh-list
102439289|NCT05910034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439290|NCT05910034|Tubulin Modulators|tubulin modulators|mesh-ancestor
102439291|NCT05910034|Antimitotic Agents|antimitotic agents|mesh-ancestor
102439292|NCT05910034|Mitosis Modulators|mitosis modulators|mesh-ancestor
102439293|NCT05910034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439294|NCT05909852|Adalimumab|adalimumab|mesh-list
102439295|NCT05909852|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102439296|NCT05909852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102439297|NCT05909852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102439298|NCT05909826|Dexamethasone|dexamethasone|mesh-list
102439299|NCT05909826|Cyclophosphamide|cyclophosphamide|mesh-list
102439300|NCT05909826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102439301|NCT05909826|Immunologic Factors|immunologic factors|mesh-ancestor
102439302|NCT05909826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439303|NCT05909826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102439304|NCT05909826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102439305|NCT05909826|Alkylating Agents|alkylating agents|mesh-ancestor
102439306|NCT05909826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439307|NCT05909826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439308|NCT05909826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102439309|NCT05909826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102439310|NCT05909826|Antiemetics|antiemetics|mesh-ancestor
102439311|NCT05909826|Autonomic Agents|autonomic agents|mesh-ancestor
102439312|NCT05909826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102439313|NCT05909826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102439314|NCT05909826|Glucocorticoids|glucocorticoids|mesh-ancestor
102439315|NCT05909826|Hormones|hormones|mesh-ancestor
102439316|NCT05909826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102439317|NCT05909826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102439318|NCT05909800|Fenofibrate|fenofibrate|mesh-list
102439319|NCT05909800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102439320|NCT05909800|Antimetabolites|antimetabolites|mesh-ancestor
102439321|NCT05909800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439322|NCT05909800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102439323|NCT05909462|Triamcinolone|triamcinolone|mesh-list
102439324|NCT05909462|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102439325|NCT05909462|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102439326|NCT05909462|Lidocaine|lidocaine|mesh-list
102439327|NCT05909462|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102439328|NCT05909462|Anesthetics, Local|anesthetics, local|mesh-ancestor
102439329|NCT05909462|Anesthetics|anesthetics|mesh-ancestor
102439330|NCT05909462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102439331|NCT05909462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439332|NCT05909462|Sensory System Agents|sensory system agents|mesh-ancestor
102439333|NCT05909462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102439334|NCT05909462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102439335|NCT05909462|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102439336|NCT05909462|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102439337|NCT05909462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102439338|NCT05909462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439339|NCT05909462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102439340|NCT05909462|Glucocorticoids|glucocorticoids|mesh-ancestor
102439341|NCT05909462|Hormones|hormones|mesh-ancestor
102439342|NCT05909462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102439343|NCT05909462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102439344|NCT05909462|Immunologic Factors|immunologic factors|mesh-ancestor
102439345|NCT05909462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102439346|NCT05909423|Pembrolizumab|pembrolizumab|mesh-list
102439347|NCT05909423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102439348|NCT05909423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439349|NCT05909423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102439350|NCT05909423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439351|NCT05909293|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102439352|NCT05909293|Venetoclax|venetoclax|mesh-list
102439353|NCT05909293|Antiemetics|antiemetics|mesh-list
102439354|NCT05909293|Lenograstim|lenograstim|mesh-list
102251005|NCT00977483|Vitamins|vitamins|mesh-ancestor
102439355|NCT05909293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102439356|NCT05909293|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102439357|NCT05909293|Immunologic Factors|immunologic factors|mesh-ancestor
102439358|NCT05909293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439359|NCT05909293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439360|NCT05909293|Autonomic Agents|autonomic agents|mesh-ancestor
102439361|NCT05909293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102069795|NCT05627414|Antimetabolites|antimetabolites|mesh-ancestor
102439362|NCT05909293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102439363|NCT05909215|Dexmedetomidine|dexmedetomidine|mesh-list
102439364|NCT05909215|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102439365|NCT05909215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102439366|NCT05909215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439367|NCT05909215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102439368|NCT05909215|Analgesics|analgesics|mesh-ancestor
102439369|NCT05909215|Sensory System Agents|sensory system agents|mesh-ancestor
102439370|NCT05909215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102439371|NCT05909215|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102439372|NCT05909215|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102439373|NCT05909215|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102439374|NCT05909215|Adrenergic Agents|adrenergic agents|mesh-ancestor
102439375|NCT05909215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102439376|NCT05909215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439377|NCT05909137|Immunomodulating Agents|immunomodulating agents|mesh-list
102439378|NCT05909137|Immunologic Factors|immunologic factors|mesh-ancestor
102439379|NCT05909137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439380|NCT05909072|Tranexamic Acid|tranexamic acid|mesh-list
102439381|NCT05909072|Hyaluronic Acid|hyaluronic acid|mesh-list
102439382|NCT05909072|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102439383|NCT05909072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102439384|NCT05909072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439385|NCT05909072|Hemostatics|hemostatics|mesh-ancestor
102439386|NCT05909072|Coagulants|coagulants|mesh-ancestor
102439387|NCT05909072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102439388|NCT05909072|Immunologic Factors|immunologic factors|mesh-ancestor
102439389|NCT05909072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439390|NCT05909072|Viscosupplements|viscosupplements|mesh-ancestor
102439391|NCT05909072|Protective Agents|protective agents|mesh-ancestor
102439392|NCT05909059|Cyclophosphamide|cyclophosphamide|mesh-list
102439393|NCT05909059|Fludarabine|fludarabine|mesh-list
102439394|NCT05909059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102439395|NCT05909059|Immunologic Factors|immunologic factors|mesh-ancestor
102439396|NCT05909059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439397|NCT05909059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102439398|NCT05909059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102439399|NCT05909059|Alkylating Agents|alkylating agents|mesh-ancestor
102439400|NCT05909059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439401|NCT05909059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439402|NCT05909059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102439403|NCT05908864|Magnesium Sulfate|magnesium sulfate|mesh-list
102439404|NCT05908864|Analgesics|analgesics|mesh-ancestor
102439405|NCT05908864|Sensory System Agents|sensory system agents|mesh-ancestor
102439406|NCT05908864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102439407|NCT05908864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439408|NCT05908864|Anesthetics|anesthetics|mesh-ancestor
102439409|NCT05908864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102439410|NCT05908864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102439411|NCT05908864|Anticonvulsants|anticonvulsants|mesh-ancestor
102439412|NCT05908864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102439413|NCT05908864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102439414|NCT05908864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439415|NCT05908864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102439416|NCT05908864|Tocolytic Agents|tocolytic agents|mesh-ancestor
102439417|NCT05908864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102439418|NCT05908851|Ketorolac|ketorolac|mesh-list
102439419|NCT05908851|Epinephrine|epinephrine|mesh-list
102439420|NCT05908851|Morphine|morphine|mesh-list
102439421|NCT05908851|Ropivacaine|ropivacaine|mesh-list
102439422|NCT05908851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102439423|NCT05908851|Narcotics|narcotics|mesh-ancestor
102439424|NCT05908851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102439425|NCT05908851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439426|NCT05908851|Analgesics|analgesics|mesh-ancestor
102439427|NCT05908851|Sensory System Agents|sensory system agents|mesh-ancestor
102439428|NCT05908851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102439429|NCT05908851|Anesthetics, Local|anesthetics, local|mesh-ancestor
102439430|NCT05908851|Anesthetics|anesthetics|mesh-ancestor
102439431|NCT05908851|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102439432|NCT05908851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102439433|NCT05908851|Adrenergic Agents|adrenergic agents|mesh-ancestor
102439434|NCT05908851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102439435|NCT05908851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439436|NCT05908851|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102439437|NCT05908851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102439438|NCT05908851|Autonomic Agents|autonomic agents|mesh-ancestor
102439439|NCT05908851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102439440|NCT05908851|Respiratory System Agents|respiratory system agents|mesh-ancestor
102439441|NCT05908851|Mydriatics|mydriatics|mesh-ancestor
102439442|NCT05908851|Sympathomimetics|sympathomimetics|mesh-ancestor
102439443|NCT05908851|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102439444|NCT05908851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102439445|NCT05908851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102439446|NCT05908851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102439447|NCT05908851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102439448|NCT05908851|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102439449|NCT05908851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102439450|NCT05906732|Dofetilide|dofetilide|mesh-list
102439451|NCT05906732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102439452|NCT05906732|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102439453|NCT05906732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102439454|NCT05906732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439455|NCT05906121|Lidocaine|lidocaine|mesh-list
102439456|NCT05906121|Ketamine|ketamine|mesh-list
102439457|NCT05906121|Anesthetics, Local|anesthetics, local|mesh-ancestor
102439458|NCT05906121|Anesthetics|anesthetics|mesh-ancestor
102439459|NCT05906121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102439460|NCT05906121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439461|NCT05906121|Sensory System Agents|sensory system agents|mesh-ancestor
102439462|NCT05906121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102439463|NCT05906121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102439464|NCT05906121|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102439465|NCT05906121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102439466|NCT05906121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102439467|NCT05906121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439468|NCT05906121|Analgesics|analgesics|mesh-ancestor
102439469|NCT05906121|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102439470|NCT05906121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102439471|NCT05906121|Anesthetics, General|anesthetics, general|mesh-ancestor
102439472|NCT05906121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102439473|NCT05906121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102439474|NCT05906121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102439475|NCT05904587|Imidacloprid|imidacloprid|mesh-list
102069974|NCT04976374|Antimanic Agents|antimanic agents|mesh-ancestor
102439476|NCT05904587|Cholinergic Agents|cholinergic agents|mesh-ancestor
102439477|NCT05904587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102439478|NCT05904587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439479|NCT05904587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439480|NCT05904457|Bevacizumab|bevacizumab|mesh-list
102439481|NCT05904457|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102439482|NCT05904457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102439483|NCT05904457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439484|NCT05904457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102439485|NCT05904457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102439486|NCT05904457|Growth Substances|growth substances|mesh-ancestor
102439487|NCT05904457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439488|NCT05904457|Growth Inhibitors|growth inhibitors|mesh-ancestor
102439489|NCT05904457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102439490|NCT05904457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102439491|NCT05904457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439492|NCT05904275|Dexamethasone|dexamethasone|mesh-list
102439493|NCT05904275|Ropivacaine|ropivacaine|mesh-list
102439494|NCT05904275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102439495|NCT05904275|Antiemetics|antiemetics|mesh-ancestor
102439496|NCT05904275|Autonomic Agents|autonomic agents|mesh-ancestor
102439497|NCT05904275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102439498|NCT05904275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439499|NCT05904275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102439500|NCT05904275|Glucocorticoids|glucocorticoids|mesh-ancestor
102439501|NCT05904275|Hormones|hormones|mesh-ancestor
102439502|NCT05904275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102251152|NCT02441465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102439503|NCT05904275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102439504|NCT05904275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439505|NCT05904275|Anesthetics, Local|anesthetics, local|mesh-ancestor
102439506|NCT05904275|Anesthetics|anesthetics|mesh-ancestor
102439507|NCT05904275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102439508|NCT05904275|Sensory System Agents|sensory system agents|mesh-ancestor
102439509|NCT05904184|Calcium, Dietary|calcium, dietary|mesh-list
102439510|NCT05904184|Calcium|calcium|mesh-list
102439511|NCT05904184|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102439512|NCT05904184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439513|NCT05904184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102439514|NCT05904119|Lomustine|lomustine|mesh-list
102439515|NCT05904119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102439516|NCT05904119|Alkylating Agents|alkylating agents|mesh-ancestor
102439517|NCT05904119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439518|NCT05904119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439519|NCT05904080|Nivolumab|nivolumab|mesh-list
102439520|NCT05904080|Ipilimumab|ipilimumab|mesh-list
102439521|NCT05904080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102439522|NCT05904080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439523|NCT05904080|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102439524|NCT05904080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439525|NCT05904028|Faricimab|faricimab|mesh-list
102439526|NCT05904028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102439527|NCT05904028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102439528|NCT05904028|Growth Substances|growth substances|mesh-ancestor
102439529|NCT05904028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439530|NCT05904028|Growth Inhibitors|growth inhibitors|mesh-ancestor
102439531|NCT05904028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439532|NCT05904002|Budesonide|budesonide|mesh-list
102439533|NCT05904002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102439534|NCT05904002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102439535|NCT05904002|Autonomic Agents|autonomic agents|mesh-ancestor
102439536|NCT05904002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102439537|NCT05904002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439538|NCT05904002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102439539|NCT05904002|Respiratory System Agents|respiratory system agents|mesh-ancestor
102439540|NCT05904002|Glucocorticoids|glucocorticoids|mesh-ancestor
102439541|NCT05904002|Hormones|hormones|mesh-ancestor
102439542|NCT05904002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102439543|NCT05903963|Midazolam|midazolam|mesh-list
102439544|NCT05903963|Dexmedetomidine|dexmedetomidine|mesh-list
102439545|NCT05903963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102439546|NCT05903963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102439547|NCT05903963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439548|NCT05903963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102439549|NCT05903963|Analgesics|analgesics|mesh-ancestor
102439550|NCT05903963|Sensory System Agents|sensory system agents|mesh-ancestor
102439551|NCT05903963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102439552|NCT05903963|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102439553|NCT05903963|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102439554|NCT05903963|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102439555|NCT05903963|Adrenergic Agents|adrenergic agents|mesh-ancestor
102439556|NCT05903963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102439557|NCT05903963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439558|NCT05903963|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102439559|NCT05903963|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102439560|NCT05903963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102439561|NCT05903963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102439562|NCT05903963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102439563|NCT05903963|Anesthetics, General|anesthetics, general|mesh-ancestor
102439564|NCT05903963|Anesthetics|anesthetics|mesh-ancestor
102439565|NCT05903963|GABA Modulators|gaba modulators|mesh-ancestor
102439566|NCT05903963|GABA Agents|gaba agents|mesh-ancestor
102439567|NCT05903937|Melphalan|melphalan|mesh-list
102439568|NCT05903937|Interleukin-2|interleukin-2|mesh-list
102439569|NCT05903937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102439570|NCT05903937|Alkylating Agents|alkylating agents|mesh-ancestor
102439571|NCT05903937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439572|NCT05903937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439573|NCT05903937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102439574|NCT05903937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102439575|NCT05903937|Immunologic Factors|immunologic factors|mesh-ancestor
102439576|NCT05903937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439577|NCT05903937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102439578|NCT05903937|Analgesics|analgesics|mesh-ancestor
102439579|NCT05903937|Sensory System Agents|sensory system agents|mesh-ancestor
102439580|NCT05903937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102439581|NCT05903833|Pembrolizumab|pembrolizumab|mesh-list
102439582|NCT05903833|Lenvatinib|lenvatinib|mesh-list
102439583|NCT05903833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102439584|NCT05903833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439585|NCT05903833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102439586|NCT05903833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439587|NCT05903833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102439588|NCT05903833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102439589|NCT05903807|FAPI-46|fapi-46|mesh-list
102439590|NCT05903807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102439591|NCT05903807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439592|NCT05903755|Methamphetamine|methamphetamine|mesh-list
102439593|NCT05903755|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102439594|NCT05903755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439595|NCT05903755|Sympathomimetics|sympathomimetics|mesh-ancestor
102439596|NCT05903755|Autonomic Agents|autonomic agents|mesh-ancestor
102439597|NCT05903755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102439598|NCT05903755|Dopamine Agents|dopamine agents|mesh-ancestor
102439599|NCT05903755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102439600|NCT05903755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439601|NCT05903755|Adrenergic Agents|adrenergic agents|mesh-ancestor
102439602|NCT05903755|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102439603|NCT05903755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102439604|NCT05903755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102439605|NCT05903755|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102439606|NCT05903716|Isotretinoin|isotretinoin|mesh-list
102439607|NCT05903716|Hormones|hormones|mesh-list
102439608|NCT05903716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102439609|NCT05903716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439610|NCT05903716|Dermatologic Agents|dermatologic agents|mesh-ancestor
102439611|NCT05903703|Canagliflozin|canagliflozin|mesh-list
102439612|NCT05903703|Gemcitabine|gemcitabine|mesh-list
102439613|NCT05903703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102439614|NCT05903703|Antimetabolites|antimetabolites|mesh-ancestor
102439615|NCT05903703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439616|NCT05903703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439617|NCT05903703|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102439618|NCT05903703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102439619|NCT05903703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439620|NCT05903456|Lenvatinib|lenvatinib|mesh-list
102439621|NCT05903456|Immunologic Factors|immunologic factors|mesh-list
102439622|NCT05903456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439623|NCT05903456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102439624|NCT05903456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102439625|NCT05903456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439626|NCT05903456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439627|NCT05903339|MEDI9197|medi9197|mesh-list
102439628|NCT05903339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102439629|NCT05903339|Immunologic Factors|immunologic factors|mesh-ancestor
102439630|NCT05903339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439631|NCT05903326|Dexmedetomidine|dexmedetomidine|mesh-list
102439632|NCT05903326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102439633|NCT05903326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102439634|NCT05903326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439635|NCT05903326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102439636|NCT05903326|Analgesics|analgesics|mesh-ancestor
102439637|NCT05903326|Sensory System Agents|sensory system agents|mesh-ancestor
102439638|NCT05903326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102439639|NCT05903326|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102439640|NCT05903326|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102439641|NCT05903326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102439642|NCT05903326|Adrenergic Agents|adrenergic agents|mesh-ancestor
102439643|NCT05903326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102439644|NCT05903326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439645|NCT05903131|Levonorgestrel|levonorgestrel|mesh-list
102439646|NCT05903131|Progestins|progestins|mesh-list
102439647|NCT05903131|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102439648|NCT05903131|Contraceptive Agents|contraceptive agents|mesh-ancestor
102439649|NCT05903131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102439650|NCT05903131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439651|NCT05903131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102439652|NCT05903131|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102439653|NCT05903131|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102439654|NCT05903131|Hormones|hormones|mesh-ancestor
102439655|NCT05903131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102439656|NCT05903040|Lasmiditan|lasmiditan|mesh-list
102439657|NCT05903040|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102439658|NCT05903040|Serotonin Agents|serotonin agents|mesh-ancestor
102439659|NCT05903040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102439660|NCT05903040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439661|NCT05903040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439662|NCT05902819|Minocycline|minocycline|mesh-list
102439663|NCT05902819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102439664|NCT05902819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102439665|NCT05902754|Sulforaphane|sulforaphane|mesh-list
102439666|NCT05902754|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102439667|NCT05902754|Protective Agents|protective agents|mesh-ancestor
102439668|NCT05902754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439669|NCT05902754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439670|NCT05902728|Itraconazole|itraconazole|mesh-list
102439671|NCT05902728|Rifampin|rifampin|mesh-list
102439672|NCT05902728|Antifungal Agents|antifungal agents|mesh-ancestor
102439673|NCT05902728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102439674|NCT05902728|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102439675|NCT05902728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102439676|NCT05902728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102439677|NCT05902728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439678|NCT05902728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102439679|NCT05902728|Hormone Antagonists|hormone antagonists|mesh-ancestor
102439680|NCT05902728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102439681|NCT05902728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439682|NCT05902728|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102439683|NCT05902728|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102439684|NCT05902728|Antitubercular Agents|antitubercular agents|mesh-ancestor
102439685|NCT05902728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102439686|NCT05902728|Leprostatic Agents|leprostatic agents|mesh-ancestor
102439687|NCT05902728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102439688|NCT05902728|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102439689|NCT05902728|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102439690|NCT05902728|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102439691|NCT05902728|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102439692|NCT05902728|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102439693|NCT05902728|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102439694|NCT05902468|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102439695|NCT05902468|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102439696|NCT05902468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102439697|NCT05902429|Cladribine|cladribine|mesh-list
102439698|NCT05902429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439699|NCT05902429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102439700|NCT05902429|Immunologic Factors|immunologic factors|mesh-ancestor
102439701|NCT05902429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439702|NCT05901428|Cyclophosphamide|cyclophosphamide|mesh-list
102439703|NCT05901428|Carboplatin|carboplatin|mesh-list
102439704|NCT05901428|Docetaxel|docetaxel|mesh-list
102439705|NCT05901428|Epirubicin|epirubicin|mesh-list
102439706|NCT05901428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102439707|NCT05901428|Immunologic Factors|immunologic factors|mesh-ancestor
102439708|NCT05901428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439709|NCT05901428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102439710|NCT05901428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102439711|NCT05901428|Alkylating Agents|alkylating agents|mesh-ancestor
102439712|NCT05901428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439713|NCT05901428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439714|NCT05901428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102439715|NCT05901428|Tubulin Modulators|tubulin modulators|mesh-ancestor
102439716|NCT05901428|Antimitotic Agents|antimitotic agents|mesh-ancestor
102439717|NCT05901428|Mitosis Modulators|mitosis modulators|mesh-ancestor
102439718|NCT05901428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102439719|NCT05901428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102439720|NCT05901428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102439721|NCT05901428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102439722|NCT05899140|Clindamycin|clindamycin|mesh-list
102439723|NCT05899140|Clindamycin palmitate|clindamycin palmitate|mesh-list
102439724|NCT05899140|Clindamycin phosphate|clindamycin phosphate|mesh-list
102439725|NCT05899140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102439726|NCT05899140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102439727|NCT05899140|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102439728|NCT05899140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102439729|NCT05899140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439731|NCT05895838|Olanzapine|olanzapine|mesh-list
102439732|NCT05895838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102439733|NCT05895838|Antiemetics|antiemetics|mesh-ancestor
102439734|NCT05895838|Autonomic Agents|autonomic agents|mesh-ancestor
102439735|NCT05895838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102439736|NCT05895838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439737|NCT05895838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102439738|NCT05895838|Glucocorticoids|glucocorticoids|mesh-ancestor
102439739|NCT05895838|Hormones|hormones|mesh-ancestor
102439740|NCT05895838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102439741|NCT05895838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102439742|NCT05895838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439743|NCT05895838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102439744|NCT05895838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102439745|NCT05895838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102439746|NCT05895838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102439747|NCT05895838|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102439748|NCT05895838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102439749|NCT05895838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102439750|NCT05895838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439751|NCT05895838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102439752|NCT05895838|Serotonin Agents|serotonin agents|mesh-ancestor
102439753|NCT05895383|Nitrous Oxide|nitrous oxide|mesh-list
102439754|NCT05895383|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102439755|NCT05895383|Anesthetics, General|anesthetics, general|mesh-ancestor
102439756|NCT05895383|Anesthetics|anesthetics|mesh-ancestor
102439757|NCT05895383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102439758|NCT05895383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439759|NCT05895383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102439760|NCT05895383|Analgesics|analgesics|mesh-ancestor
102070218|NCT00882440|Losartan|losartan|mesh-list
102439761|NCT05895383|Sensory System Agents|sensory system agents|mesh-ancestor
102439762|NCT05895383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102439763|NCT05893030|Anesthetics|anesthetics|mesh-list
102439764|NCT05893030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102439765|NCT05893030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439766|NCT05885685|Nabilone|nabilone|mesh-list
102439767|NCT05885685|Antiemetics|antiemetics|mesh-ancestor
102439768|NCT05885685|Autonomic Agents|autonomic agents|mesh-ancestor
102439769|NCT05885685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102439770|NCT05885685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439771|NCT05885685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102439772|NCT05885685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102439773|NCT05885685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102439774|NCT05885685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102439775|NCT05885685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102439776|NCT05880394|Copper|copper|mesh-list
102439777|NCT05880394|Trace Elements|trace elements|mesh-ancestor
102439778|NCT05880394|Micronutrients|micronutrients|mesh-ancestor
102439779|NCT05880394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439780|NCT05866471|Psilocybin|psilocybin|mesh-list
102439781|NCT05866471|Hallucinogens|hallucinogens|mesh-ancestor
102439782|NCT05866471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439783|NCT05866471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102439784|NCT05861570|Triamcinolone|triamcinolone|mesh-list
102439785|NCT05861570|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102439786|NCT05861570|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102439787|NCT05861570|Lidocaine|lidocaine|mesh-list
102439788|NCT05861570|Hyaluronic Acid|hyaluronic acid|mesh-list
102439789|NCT05861570|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102439790|NCT05861570|Anesthetics, Local|anesthetics, local|mesh-ancestor
102439791|NCT05861570|Anesthetics|anesthetics|mesh-ancestor
102439792|NCT05861570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102439793|NCT05861570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439794|NCT05861570|Sensory System Agents|sensory system agents|mesh-ancestor
102439795|NCT05861570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102439796|NCT05861570|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102439797|NCT05861570|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102439798|NCT05861570|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102439799|NCT05861570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102439800|NCT05861570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439801|NCT05861570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102439802|NCT05861570|Glucocorticoids|glucocorticoids|mesh-ancestor
102439804|NCT05861570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102439805|NCT05861570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102439806|NCT05861570|Immunologic Factors|immunologic factors|mesh-ancestor
102439807|NCT05861570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102439808|NCT05861570|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102439809|NCT05861570|Viscosupplements|viscosupplements|mesh-ancestor
102439810|NCT05861570|Protective Agents|protective agents|mesh-ancestor
102439811|NCT05857163|Amoxicillin|amoxicillin|mesh-list
102439812|NCT05857163|Clarithromycin|clarithromycin|mesh-list
102439813|NCT05857163|Potassium Citrate|potassium citrate|mesh-list
102439814|NCT05857163|Rabeprazole|rabeprazole|mesh-list
102439815|NCT05857163|Bismuth|bismuth|mesh-list
102439816|NCT05857163|Citric Acid|citric acid|mesh-list
102439817|NCT05857163|Sodium Citrate|sodium citrate|mesh-list
102439818|NCT05857163|Anticoagulants|anticoagulants|mesh-ancestor
102439819|NCT05857163|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102439820|NCT05857163|Chelating Agents|chelating agents|mesh-ancestor
102439821|NCT05857163|Sequestering Agents|sequestering agents|mesh-ancestor
102439822|NCT05857163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439823|NCT05857163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102439824|NCT05857163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102439825|NCT05857163|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102439826|NCT05857163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102439827|NCT05857163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102439828|NCT05857163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102439829|NCT05857163|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102439830|NCT05857163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102439831|NCT05857163|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102439832|NCT05857163|Antacids|antacids|mesh-ancestor
102439833|NCT05857163|Diuretics|diuretics|mesh-ancestor
102439834|NCT05857163|Natriuretic Agents|natriuretic agents|mesh-ancestor
102439835|NCT05857163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439836|NCT05857163|Expectorants|expectorants|mesh-ancestor
102439837|NCT05857163|Respiratory System Agents|respiratory system agents|mesh-ancestor
102439838|NCT05840510|Sirolimus|sirolimus|mesh-list
102439839|NCT05840510|Adagrasib|adagrasib|mesh-list
102439840|NCT05840510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102439841|NCT05840510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102439842|NCT05840510|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102439843|NCT05840510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439844|NCT05840510|Antifungal Agents|antifungal agents|mesh-ancestor
102439845|NCT05840510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102439846|NCT05840510|Immunologic Factors|immunologic factors|mesh-ancestor
102439847|NCT05840510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439848|NCT05839301|Vaccines|vaccines|mesh-list
102439849|NCT05839301|Immunologic Factors|immunologic factors|mesh-ancestor
102439850|NCT05839301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439851|NCT05821556|Paclitaxel|paclitaxel|mesh-list
102439852|NCT05821556|Gemcitabine|gemcitabine|mesh-list
102439853|NCT05821556|Capecitabine|capecitabine|mesh-list
102439854|NCT05821556|Valproic Acid|valproic acid|mesh-list
102439855|NCT05821556|Simvastatin|simvastatin|mesh-list
102439856|NCT05821556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102439857|NCT05821556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439858|NCT05821556|Tubulin Modulators|tubulin modulators|mesh-ancestor
102439859|NCT05821556|Antimitotic Agents|antimitotic agents|mesh-ancestor
102439860|NCT05821556|Mitosis Modulators|mitosis modulators|mesh-ancestor
102439861|NCT05821556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439862|NCT05821556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102439863|NCT05821556|Antimetabolites|antimetabolites|mesh-ancestor
102439864|NCT05821556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102439865|NCT05821556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102439866|NCT05821556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102439867|NCT05821556|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102439868|NCT05821556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102439869|NCT05821556|Anticonvulsants|anticonvulsants|mesh-ancestor
102439870|NCT05821556|GABA Agents|gaba agents|mesh-ancestor
102439871|NCT05821556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102439872|NCT05821556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439873|NCT05821556|Antimanic Agents|antimanic agents|mesh-ancestor
102439874|NCT05821556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102439875|NCT05821556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102439876|NCT05821556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102439877|NCT05797376|Rivaroxaban|rivaroxaban|mesh-list
102439878|NCT05797376|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102439879|NCT05797376|Antithrombins|antithrombins|mesh-ancestor
102439880|NCT05797376|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102439881|NCT05797376|Protease Inhibitors|protease inhibitors|mesh-ancestor
102439882|NCT05797376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102439883|NCT05797376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439884|NCT05797376|Anticoagulants|anticoagulants|mesh-ancestor
102439885|NCT05774717|Tranexamic Acid|tranexamic acid|mesh-list
102439886|NCT05774717|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102070317|NCT05101954|Mitogens|mitogens|mesh-list
102439887|NCT05774717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102439888|NCT05774717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439889|NCT05774717|Hemostatics|hemostatics|mesh-ancestor
102439890|NCT05774717|Coagulants|coagulants|mesh-ancestor
102439891|NCT05767359|Cyclophosphamide|cyclophosphamide|mesh-list
102439892|NCT05767359|Fludarabine|fludarabine|mesh-list
102439893|NCT05767359|Fludarabine phosphate|fludarabine phosphate|mesh-list
102439894|NCT05767359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102439895|NCT05767359|Immunologic Factors|immunologic factors|mesh-ancestor
102439896|NCT05767359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439897|NCT05767359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102439898|NCT05767359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102439899|NCT05767359|Alkylating Agents|alkylating agents|mesh-ancestor
102439900|NCT05767359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439901|NCT05767359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439902|NCT05767359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102439903|NCT05767359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102439904|NCT05767359|Antimetabolites|antimetabolites|mesh-ancestor
102439906|NCT05733286|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102439907|NCT05733286|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102439908|NCT05733286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102439909|NCT05733286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439910|NCT05733286|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102439911|NCT05733286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102439912|NCT05733286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439913|NCT05722327|Irinotecan|irinotecan|mesh-list
102439914|NCT05722327|Cetuximab|cetuximab|mesh-list
102439915|NCT05722327|Adagrasib|adagrasib|mesh-list
102439916|NCT05722327|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102439917|NCT05722327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102439918|NCT05722327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102439919|NCT05722327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439920|NCT05722327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439921|NCT05722327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102439922|NCT05708755|Valganciclovir|valganciclovir|mesh-list
102439923|NCT05708755|Antiviral Agents|antiviral agents|mesh-ancestor
102439924|NCT05708755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102439925|NCT05704647|Nivolumab|nivolumab|mesh-list
102439926|NCT05704647|Relatlimab|relatlimab|mesh-list
102439927|NCT05704647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102439928|NCT05704647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439929|NCT05704647|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102439930|NCT05704647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439931|NCT05689424|Insulin Lispro|insulin lispro|mesh-list
102439932|NCT05689424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102439933|NCT05689424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439934|NCT05683171|Rituximab|rituximab|mesh-list
102439935|NCT05683171|Lenalidomide|lenalidomide|mesh-list
102439936|NCT05683171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102439937|NCT05683171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439938|NCT05683171|Immunologic Factors|immunologic factors|mesh-ancestor
102439939|NCT05683171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439940|NCT05683171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102439941|NCT05683171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102439942|NCT05683171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102439943|NCT05683171|Growth Substances|growth substances|mesh-ancestor
102439944|NCT05683171|Growth Inhibitors|growth inhibitors|mesh-ancestor
102439945|NCT05678257|Leucovorin|leucovorin|mesh-list
102439946|NCT05678257|Bevacizumab|bevacizumab|mesh-list
102439947|NCT05678257|Fluorouracil|fluorouracil|mesh-list
102439948|NCT05678257|Irinotecan|irinotecan|mesh-list
102439949|NCT05678257|Levoleucovorin|levoleucovorin|mesh-list
102439950|NCT05678257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102439951|NCT05678257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439952|NCT05678257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102439953|NCT05678257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102070390|NCT05283382|Cannabidiol|cannabidiol|mesh-list
102439954|NCT05678257|Growth Substances|growth substances|mesh-ancestor
102439955|NCT05678257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439956|NCT05678257|Growth Inhibitors|growth inhibitors|mesh-ancestor
102439957|NCT05678257|Antimetabolites|antimetabolites|mesh-ancestor
102439958|NCT05678257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439959|NCT05678257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102439960|NCT05678257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102439961|NCT05678257|Immunologic Factors|immunologic factors|mesh-ancestor
102439962|NCT05678257|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102439963|NCT05678257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102439964|NCT05678257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102439965|NCT05678257|Antidotes|antidotes|mesh-ancestor
102439966|NCT05678257|Protective Agents|protective agents|mesh-ancestor
102439967|NCT05678257|Vitamin B Complex|vitamin b complex|mesh-ancestor
102439968|NCT05678257|Vitamins|vitamins|mesh-ancestor
102439969|NCT05678257|Micronutrients|micronutrients|mesh-ancestor
102439970|NCT05677633|Sargramostim|sargramostim|mesh-list
102439971|NCT05677633|Immunologic Factors|immunologic factors|mesh-ancestor
102439972|NCT05677633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439973|NCT05669625|Vaccines|vaccines|mesh-list
102439974|NCT05669625|Immunologic Factors|immunologic factors|mesh-ancestor
102439975|NCT05669625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439976|NCT05669339|Irinotecan|irinotecan|mesh-list
102439977|NCT05669339|Sorafenib|sorafenib|mesh-list
102439978|NCT05669339|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102439979|NCT05669339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102439980|NCT05669339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102439981|NCT05669339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102439982|NCT05669339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102439983|NCT05669339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102439984|NCT05663411|Cinacalcet|cinacalcet|mesh-list
102439985|NCT05663411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102439986|NCT05663411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439987|NCT05663411|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
102439988|NCT05663411|Hormone Antagonists|hormone antagonists|mesh-ancestor
102439989|NCT05663411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102439990|NCT05640674|Acetaminophen|acetaminophen|mesh-list
102439991|NCT05640674|Ibuprofen|ibuprofen|mesh-list
102439992|NCT05640674|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
102439993|NCT05640674|Hydrocodone|hydrocodone|mesh-list
102439994|NCT05640674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102439995|NCT05640674|Analgesics|analgesics|mesh-ancestor
102439996|NCT05640674|Sensory System Agents|sensory system agents|mesh-ancestor
102439997|NCT05640674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102439998|NCT05640674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102439999|NCT05640674|Antipyretics|antipyretics|mesh-ancestor
102440000|NCT05640674|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102440001|NCT05640674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102440002|NCT05640674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102440003|NCT05640674|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102440004|NCT05640674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102440005|NCT05640674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440006|NCT05640674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102440007|NCT05640674|Narcotics|narcotics|mesh-ancestor
102440008|NCT05640674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102440009|NCT05640674|Antitussive Agents|antitussive agents|mesh-ancestor
102440010|NCT05640674|Respiratory System Agents|respiratory system agents|mesh-ancestor
102440011|NCT05634785|Cyclophosphamide|cyclophosphamide|mesh-list
102440012|NCT05634785|Fludarabine|fludarabine|mesh-list
102440013|NCT05634785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102440014|NCT05634785|Immunologic Factors|immunologic factors|mesh-ancestor
102440015|NCT05634785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440016|NCT05634785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102440017|NCT05634785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102440018|NCT05634785|Alkylating Agents|alkylating agents|mesh-ancestor
102440019|NCT05634785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440020|NCT05634785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440021|NCT05634785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102440022|NCT05600231|Listerine|listerine|mesh-list
102440023|NCT05600231|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
102440024|NCT05600231|Sodium Fluoride|sodium fluoride|mesh-list
102440025|NCT05600231|Cariostatic Agents|cariostatic agents|mesh-ancestor
102440026|NCT05600231|Protective Agents|protective agents|mesh-ancestor
102440027|NCT05600231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440028|NCT05600231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102440029|NCT05554627|Aripiprazole|aripiprazole|mesh-list
102440030|NCT05554627|Esketamine|esketamine|mesh-list
102440031|NCT05554627|Antidepressive Agents|antidepressive agents|mesh-ancestor
102440032|NCT05554627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102440033|NCT05554627|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102440034|NCT05554627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102440035|NCT05554627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102440036|NCT05554627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440037|NCT05554627|Dopamine Agonists|dopamine agonists|mesh-ancestor
102440038|NCT05554627|Dopamine Agents|dopamine agents|mesh-ancestor
102440039|NCT05554627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102440040|NCT05554627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440041|NCT05554627|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102440042|NCT05554627|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102440043|NCT05554627|Serotonin Agents|serotonin agents|mesh-ancestor
102440044|NCT05554627|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102440045|NCT05554627|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102440046|NCT05554627|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102440047|NCT05554627|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102440048|NCT05542381|Loteprednol Etabonate|loteprednol etabonate|mesh-list
102440049|NCT05542381|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102440050|NCT05542381|Lubricant Eye Drops|lubricant eye drops|mesh-list
102440051|NCT05542381|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102440052|NCT05542381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102440053|NCT05510895|Cetuximab|cetuximab|mesh-list
102440054|NCT05510895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102440055|NCT05510895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440056|NCT05489731|Osimertinib|osimertinib|mesh-list
102440057|NCT05489731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440058|NCT05489731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102440059|NCT05489731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102440060|NCT05489731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440061|NCT05478291|Vitamin D|vitamin d|mesh-list
102440062|NCT05478291|Vitamins|vitamins|mesh-ancestor
102440063|NCT05478291|Micronutrients|micronutrients|mesh-ancestor
102440064|NCT05478291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440065|NCT05478291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102440066|NCT05472792|Tamoxifen|tamoxifen|mesh-list
102440067|NCT05472792|Toremifene|toremifene|mesh-list
102440068|NCT05472792|Letrozole|letrozole|mesh-list
102440069|NCT05472792|Fulvestrant|fulvestrant|mesh-list
102440070|NCT05472792|Anastrozole|anastrozole|mesh-list
102440071|NCT05472792|Exemestane|exemestane|mesh-list
102440072|NCT05472792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440073|NCT05472792|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102440074|NCT05472792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102440075|NCT05472792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102440076|NCT05472792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440077|NCT05472792|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102440078|NCT05472792|Hormone Antagonists|hormone antagonists|mesh-ancestor
102440079|NCT05472792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102440080|NCT05472792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440081|NCT05472792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102440082|NCT05472792|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102440083|NCT05472792|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102440084|NCT05472792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102440085|NCT05472792|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102440086|NCT05467293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102440087|NCT05467293|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102440088|NCT05464836|Venetoclax|venetoclax|mesh-list
102440089|NCT05464836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440090|NCT05463367|Acetaminophen|acetaminophen|mesh-list
102440091|NCT05463367|Naproxen|naproxen|mesh-list
102440092|NCT05463367|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
102440093|NCT05463367|Oxymorphone|oxymorphone|mesh-list
102440094|NCT05463367|Morphine|morphine|mesh-list
102440095|NCT05463367|Oxycodone|oxycodone|mesh-list
102440096|NCT05463367|Tramadol|tramadol|mesh-list
102440097|NCT05463367|Hydrocodone|hydrocodone|mesh-list
102440098|NCT05463367|Codeine|codeine|mesh-list
102440099|NCT05463367|Levodopa|levodopa|mesh-list
102440100|NCT05463367|Carbidopa|carbidopa|mesh-list
102440101|NCT05463367|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102440102|NCT05463367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102440103|NCT05463367|Narcotics|narcotics|mesh-ancestor
102440104|NCT05463367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102440105|NCT05463367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440106|NCT05463367|Analgesics|analgesics|mesh-ancestor
102440107|NCT05463367|Sensory System Agents|sensory system agents|mesh-ancestor
102440108|NCT05463367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102440109|NCT05463367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102440110|NCT05463367|Antipyretics|antipyretics|mesh-ancestor
102440111|NCT05463367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102440112|NCT05463367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102440113|NCT05463367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102440114|NCT05463367|Gout Suppressants|gout suppressants|mesh-ancestor
102440115|NCT05463367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102440116|NCT05463367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102440117|NCT05463367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440118|NCT05463367|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102440119|NCT05463367|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102440120|NCT05463367|Dopamine Agents|dopamine agents|mesh-ancestor
102440121|NCT05463367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102440122|NCT05463367|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102440123|NCT05463367|Antitussive Agents|antitussive agents|mesh-ancestor
102440124|NCT05463367|Respiratory System Agents|respiratory system agents|mesh-ancestor
102440125|NCT05463367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102440126|NCT05463367|Immunologic Factors|immunologic factors|mesh-ancestor
102440127|NCT05463367|Dopamine Agonists|dopamine agonists|mesh-ancestor
102440128|NCT05463367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102440129|NCT05436535|Triamcinolone|triamcinolone|mesh-list
102440130|NCT05436535|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102440131|NCT05436535|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102440132|NCT05436535|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102440133|NCT05436535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102440134|NCT05436535|Glucocorticoids|glucocorticoids|mesh-ancestor
102440135|NCT05436535|Hormones|hormones|mesh-ancestor
102440136|NCT05436535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102440137|NCT05436535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440138|NCT05436535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102440139|NCT05436535|Immunologic Factors|immunologic factors|mesh-ancestor
102440140|NCT05436535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102440141|NCT05436535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440142|NCT05401097|Azacitidine|azacitidine|mesh-list
102440143|NCT05401097|Venetoclax|venetoclax|mesh-list
102440144|NCT05401097|Ivosidenib|ivosidenib|mesh-list
102440145|NCT05401097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102440146|NCT05401097|Antimetabolites|antimetabolites|mesh-ancestor
102440147|NCT05401097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440148|NCT05401097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440149|NCT05401097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102440150|NCT05395091|Denosumab|denosumab|mesh-list
102440151|NCT05395091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102440152|NCT05395091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440153|NCT05391828|Cimetidine|cimetidine|mesh-list
102440154|NCT05391828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102440155|NCT05391828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102440156|NCT05391828|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102440157|NCT05391828|Histamine Antagonists|histamine antagonists|mesh-ancestor
102440158|NCT05391828|Histamine Agents|histamine agents|mesh-ancestor
102440159|NCT05391828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102440160|NCT05391828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440161|NCT05391828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440162|NCT05391828|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102440163|NCT05391828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102440164|NCT05391828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102440165|NCT05382871|Vaccines|vaccines|mesh-list
102440166|NCT05382871|Immunologic Factors|immunologic factors|mesh-ancestor
102070590|NCT00765830|Vildagliptin|vildagliptin|mesh-list
102440167|NCT05382871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440168|NCT05377242|Curcumin|curcumin|mesh-list
102440169|NCT05377242|Resveratrol|resveratrol|mesh-list
102440170|NCT05377242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102440171|NCT05377242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102440172|NCT05377242|Analgesics|analgesics|mesh-ancestor
102440173|NCT05377242|Sensory System Agents|sensory system agents|mesh-ancestor
102440174|NCT05377242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102440175|NCT05377242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440176|NCT05377242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102440177|NCT05377242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102440178|NCT05377242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440179|NCT05377242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102440180|NCT05377242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440181|NCT05377242|Antioxidants|antioxidants|mesh-ancestor
102440182|NCT05377242|Protective Agents|protective agents|mesh-ancestor
102440183|NCT05377242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102440184|NCT05374954|Vaccines|vaccines|mesh-list
102440185|NCT05374954|Immunologic Factors|immunologic factors|mesh-ancestor
102440186|NCT05374954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440187|NCT05363007|Leucovorin|leucovorin|mesh-list
102440188|NCT05363007|Irinotecan|irinotecan|mesh-list
102440189|NCT05363007|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102440190|NCT05363007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102440191|NCT05363007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102440192|NCT05363007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440193|NCT05363007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440194|NCT05363007|Antidotes|antidotes|mesh-ancestor
102440195|NCT05363007|Protective Agents|protective agents|mesh-ancestor
102440196|NCT05363007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440197|NCT05363007|Vitamin B Complex|vitamin b complex|mesh-ancestor
102440198|NCT05363007|Vitamins|vitamins|mesh-ancestor
102440199|NCT05363007|Micronutrients|micronutrients|mesh-ancestor
102440200|NCT05360160|Venetoclax|venetoclax|mesh-list
102440201|NCT05360160|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
102440202|NCT05360160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440203|NCT05360160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102440204|NCT05360160|Antimetabolites|antimetabolites|mesh-ancestor
102440205|NCT05360160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440206|NCT05351606|Bupropion|bupropion|mesh-list
102440207|NCT05351606|Nicotine|nicotine|mesh-list
102440208|NCT05351606|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102440209|NCT05351606|Autonomic Agents|autonomic agents|mesh-ancestor
102440210|NCT05351606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102440211|NCT05351606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440212|NCT05351606|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102440213|NCT05351606|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102440214|NCT05351606|Cholinergic Agents|cholinergic agents|mesh-ancestor
102440215|NCT05351606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102440216|NCT05351606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440217|NCT05351606|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102440218|NCT05351606|Antidepressive Agents|antidepressive agents|mesh-ancestor
102440219|NCT05351606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102440220|NCT05351606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102440221|NCT05351606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102440222|NCT05351606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102440223|NCT05351606|Dopamine Agents|dopamine agents|mesh-ancestor
102440224|NCT05351606|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102440225|NCT05351606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102440226|NCT05351606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102440227|NCT05346159|Androgens|androgens|mesh-list
102440228|NCT05346159|Hormones|hormones|mesh-ancestor
102440229|NCT05346159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102440230|NCT05346159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440231|NCT05338723|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102440232|NCT05338723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102440233|NCT05338723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102440234|NCT05338723|Antimetabolites|antimetabolites|mesh-ancestor
102440235|NCT05338723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440236|NCT05338723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102440237|NCT05338723|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102440238|NCT05338723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102440239|NCT05329545|Immunoconjugates|immunoconjugates|mesh-list
102440240|NCT05329545|Immunologic Factors|immunologic factors|mesh-ancestor
102440241|NCT05329545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440242|NCT05329090|Rituximab|rituximab|mesh-list
102440243|NCT05329090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102440244|NCT05329090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440245|NCT05329090|Immunologic Factors|immunologic factors|mesh-ancestor
102440246|NCT05329090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440247|NCT05329090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102440248|NCT05328154|Diphosphonates|diphosphonates|mesh-list
102440249|NCT05328154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102440250|NCT05328154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440251|NCT05324059|Pregabalin|pregabalin|mesh-list
102440252|NCT05324059|Tramadol|tramadol|mesh-list
102440253|NCT05324059|Analgesics|analgesics|mesh-ancestor
102440254|NCT05324059|Sensory System Agents|sensory system agents|mesh-ancestor
102440255|NCT05324059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102440256|NCT05324059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440257|NCT05324059|Anticonvulsants|anticonvulsants|mesh-ancestor
102440259|NCT05324059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102440260|NCT05324059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440261|NCT05324059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102440262|NCT05324059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102440263|NCT05324059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102440264|NCT05324059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102440265|NCT05324059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102440266|NCT05324059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102440267|NCT05324059|Narcotics|narcotics|mesh-ancestor
102440268|NCT05319353|Maribavir|maribavir|mesh-list
102440269|NCT05319353|Antiviral Agents|antiviral agents|mesh-ancestor
102440270|NCT05319353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102440271|NCT05303636|Drospirenone|drospirenone|mesh-list
102440272|NCT05303636|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102440273|NCT05303636|Hormone Antagonists|hormone antagonists|mesh-ancestor
102440274|NCT05303636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102440275|NCT05303636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440276|NCT05303636|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102440277|NCT05303636|Diuretics|diuretics|mesh-ancestor
102440278|NCT05303636|Natriuretic Agents|natriuretic agents|mesh-ancestor
102440279|NCT05268003|Venetoclax|venetoclax|mesh-list
102440280|NCT05268003|Ponatinib|ponatinib|mesh-list
102440281|NCT05268003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440282|NCT05268003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102440283|NCT05268003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102440284|NCT05268003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440285|NCT05238142|Insulin|insulin|mesh-list
102440286|NCT05238142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102440287|NCT05238142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440288|NCT05226429|Vaccines|vaccines|mesh-list
102440289|NCT05226429|Immunologic Factors|immunologic factors|mesh-ancestor
102440290|NCT05226429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440291|NCT05217446|Pembrolizumab|pembrolizumab|mesh-list
102440292|NCT05217446|Cetuximab|cetuximab|mesh-list
102440293|NCT05217446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102440294|NCT05217446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440295|NCT05217446|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102440296|NCT05217446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440297|NCT05212012|Methadone|methadone|mesh-list
102440298|NCT05212012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102440299|NCT05212012|Narcotics|narcotics|mesh-ancestor
102440300|NCT05212012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102440301|NCT05212012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440302|NCT05212012|Analgesics|analgesics|mesh-ancestor
102440303|NCT05212012|Sensory System Agents|sensory system agents|mesh-ancestor
102440304|NCT05212012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102440305|NCT05212012|Antitussive Agents|antitussive agents|mesh-ancestor
102440306|NCT05212012|Respiratory System Agents|respiratory system agents|mesh-ancestor
102440307|NCT05198804|Niraparib|niraparib|mesh-list
102440308|NCT05198804|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102440309|NCT05198804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102440310|NCT05198804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440311|NCT05198804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440312|NCT05197439|Dexmedetomidine|dexmedetomidine|mesh-list
102440313|NCT05197439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102440314|NCT05197439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102440315|NCT05197439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440316|NCT05197439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102440317|NCT05197439|Analgesics|analgesics|mesh-ancestor
102440318|NCT05197439|Sensory System Agents|sensory system agents|mesh-ancestor
102440319|NCT05197439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102440320|NCT05197439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102440321|NCT05197439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102440322|NCT05197439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102440323|NCT05197439|Adrenergic Agents|adrenergic agents|mesh-ancestor
102440324|NCT05197439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102440325|NCT05197439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440326|NCT05195918|Pirfenidone|pirfenidone|mesh-list
102440327|NCT05195918|Nintedanib|nintedanib|mesh-list
102440328|NCT05195918|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
102440329|NCT05195918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440330|NCT05195918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102440331|NCT05195918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102440332|NCT05195918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440334|NCT05195918|Sensory System Agents|sensory system agents|mesh-ancestor
102440335|NCT05195918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102440336|NCT05195918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440337|NCT05195918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102440338|NCT05195918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102440339|NCT05195918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102440340|NCT05195918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102440341|NCT05195918|Antioxidants|antioxidants|mesh-ancestor
102440342|NCT05195918|Protective Agents|protective agents|mesh-ancestor
102440343|NCT05195918|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
102440344|NCT05195918|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102440345|NCT05195918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102440346|NCT05169372|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102440347|NCT05169372|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102440348|NCT05169372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440349|NCT05169060|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
102440350|NCT05169060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102440351|NCT05169060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102440352|NCT05169060|Analgesics|analgesics|mesh-ancestor
102440353|NCT05169060|Sensory System Agents|sensory system agents|mesh-ancestor
102440354|NCT05169060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102440355|NCT05169060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440356|NCT05169060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102440357|NCT05169060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102440358|NCT05153408|Carboplatin|carboplatin|mesh-list
102440359|NCT05153408|Pemetrexed|pemetrexed|mesh-list
102440360|NCT05153408|Osimertinib|osimertinib|mesh-list
102440361|NCT05153408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440362|NCT05153408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102440363|NCT05153408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440364|NCT05153408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102440365|NCT05153408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102440366|NCT05153408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102440367|NCT05114980|Parathyroid Hormone|parathyroid hormone|mesh-list
102440368|NCT05114980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102440369|NCT05114980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440370|NCT05100628|Doxorubicin|doxorubicin|mesh-list
102440371|NCT05100628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102440372|NCT05100628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440373|NCT05100628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102440374|NCT05100628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102440375|NCT05100628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102440376|NCT05100628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440377|NCT05093959|Metformin|metformin|mesh-list
102440378|NCT05093959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102440379|NCT05093959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440380|NCT05091619|Vaccines|vaccines|mesh-list
102440381|NCT05091619|Immunologic Factors|immunologic factors|mesh-ancestor
102440382|NCT05091619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440383|NCT05089916|Osimertinib|osimertinib|mesh-list
102440384|NCT05089916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440385|NCT05089916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102440386|NCT05089916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102440387|NCT05089916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440388|NCT05089370|Nivolumab|nivolumab|mesh-list
102440389|NCT05089370|Decitabine|decitabine|mesh-list
102440390|NCT05089370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102440391|NCT05089370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440392|NCT05089370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102440393|NCT05089370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440394|NCT05089370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102440395|NCT05089370|Antimetabolites|antimetabolites|mesh-ancestor
102440396|NCT05089370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102440397|NCT05086250|Ketamine|ketamine|mesh-list
102440398|NCT05086250|Analgesics|analgesics|mesh-ancestor
102440399|NCT05086250|Sensory System Agents|sensory system agents|mesh-ancestor
102440400|NCT05086250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102440401|NCT05086250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440402|NCT05086250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102440403|NCT05086250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102440404|NCT05086250|Anesthetics, General|anesthetics, general|mesh-ancestor
102440405|NCT05086250|Anesthetics|anesthetics|mesh-ancestor
102440406|NCT05086250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102440407|NCT05086250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102440408|NCT05086250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102440409|NCT05086250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102440410|NCT05086250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440411|NCT05084911|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
102440412|NCT05084911|Antiviral Agents|antiviral agents|mesh-ancestor
102440413|NCT05084911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102440414|NCT05081388|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
102440415|NCT05081388|Antiviral Agents|antiviral agents|mesh-ancestor
102440416|NCT05081388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102440417|NCT05076149|Ivacaftor|ivacaftor|mesh-list
102440418|NCT05076149|Elexacaftor|elexacaftor|mesh-list
102440419|NCT05076149|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102440420|NCT05076149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102440421|NCT05076149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440422|NCT05075993|Paclitaxel|paclitaxel|mesh-list
102440423|NCT05075993|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102440424|NCT05075993|Cyclophosphamide|cyclophosphamide|mesh-list
102440425|NCT05075993|Bevacizumab|bevacizumab|mesh-list
102440426|NCT05075993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102440427|NCT05075993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440428|NCT05075993|Tubulin Modulators|tubulin modulators|mesh-ancestor
102440429|NCT05075993|Antimitotic Agents|antimitotic agents|mesh-ancestor
102440430|NCT05075993|Mitosis Modulators|mitosis modulators|mesh-ancestor
102440431|NCT05075993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440432|NCT05075993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102440433|NCT05075993|Immunologic Factors|immunologic factors|mesh-ancestor
102440434|NCT05075993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440435|NCT05075993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102440436|NCT05075993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102440437|NCT05075993|Alkylating Agents|alkylating agents|mesh-ancestor
102440438|NCT05075993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102070861|NCT05083000|Topotecan|topotecan|mesh-list
102440439|NCT05075993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102440440|NCT05075993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102440441|NCT05075993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102440442|NCT05075993|Growth Substances|growth substances|mesh-ancestor
102440443|NCT05075993|Growth Inhibitors|growth inhibitors|mesh-ancestor
102440444|NCT05054374|Fulvestrant|fulvestrant|mesh-list
102440445|NCT05054374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102440446|NCT05054374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440447|NCT05054374|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102440448|NCT05054374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102440449|NCT05054374|Hormone Antagonists|hormone antagonists|mesh-ancestor
102440450|NCT05054374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102440451|NCT05054374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440452|NCT05039177|Cetuximab|cetuximab|mesh-list
102440453|NCT05039177|Palbociclib|palbociclib|mesh-list
102440454|NCT05039177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102440455|NCT05039177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440456|NCT05039177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102440457|NCT05039177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102440458|NCT05039177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440459|NCT05027308|Teduglutide|teduglutide|mesh-list
102440460|NCT05027308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102440461|NCT05027308|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102440462|NCT05027308|Protective Agents|protective agents|mesh-ancestor
102440463|NCT05027308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440464|NCT05025800|Rituximab|rituximab|mesh-list
102440465|NCT05025800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102440466|NCT05025800|Lenalidomide|lenalidomide|mesh-list
102440467|NCT05025800|Antibodies|antibodies|mesh-list
102440468|NCT05025800|Immunoglobulins|immunoglobulins|mesh-list
102440469|NCT05025800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102440470|NCT05025800|Immunologic Factors|immunologic factors|mesh-ancestor
102440471|NCT05025800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440472|NCT05025800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440473|NCT05025800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102440474|NCT05025800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102440475|NCT05025800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102440476|NCT05025800|Growth Substances|growth substances|mesh-ancestor
102440477|NCT05025800|Growth Inhibitors|growth inhibitors|mesh-ancestor
102440478|NCT05017246|Lidocaine|lidocaine|mesh-list
102252130|NCT02431013|Protective Agents|protective agents|mesh-ancestor
102440479|NCT05017246|Morphine|morphine|mesh-list
102440480|NCT05017246|Bupivacaine|bupivacaine|mesh-list
102440481|NCT05017246|Anesthetics, Local|anesthetics, local|mesh-ancestor
102440482|NCT05017246|Anesthetics|anesthetics|mesh-ancestor
102440483|NCT05017246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102440484|NCT05017246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440485|NCT05017246|Sensory System Agents|sensory system agents|mesh-ancestor
102440486|NCT05017246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102440487|NCT05017246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102440488|NCT05017246|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102440489|NCT05017246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102440490|NCT05017246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102440491|NCT05017246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440492|NCT05017246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102440493|NCT05017246|Narcotics|narcotics|mesh-ancestor
102440494|NCT05017246|Analgesics|analgesics|mesh-ancestor
102440495|NCT05017025|Osimertinib|osimertinib|mesh-list
102440496|NCT05017025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440497|NCT05017025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102070927|NCT00745316|Adenosine|adenosine|mesh-list
102440498|NCT05017025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102440499|NCT05017025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440500|NCT05007041|Vaccines|vaccines|mesh-list
102440501|NCT05007041|Immunologic Factors|immunologic factors|mesh-ancestor
102440502|NCT05007041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440503|NCT05001555|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
102440504|NCT05001555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440505|NCT05001555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102440506|NCT05001555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102440507|NCT05001555|Analgesics|analgesics|mesh-ancestor
102440508|NCT05001555|Sensory System Agents|sensory system agents|mesh-ancestor
102440509|NCT05001555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102440510|NCT05001555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102440511|NCT05001555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102440512|NCT04995003|Pembrolizumab|pembrolizumab|mesh-list
102440513|NCT04995003|Nivolumab|nivolumab|mesh-list
102440514|NCT04995003|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102440515|NCT04995003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102440516|NCT04995003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440517|NCT04995003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440518|NCT04983888|Obinutuzumab|obinutuzumab|mesh-list
102440519|NCT04983888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102440520|NCT04983888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440521|NCT04978675|Fluorides|fluorides|mesh-list
102440522|NCT04978675|Cariostatic Agents|cariostatic agents|mesh-ancestor
102440523|NCT04978675|Protective Agents|protective agents|mesh-ancestor
102440524|NCT04978675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440525|NCT04977024|Vaccines|vaccines|mesh-list
102440526|NCT04977024|Immunologic Factors|immunologic factors|mesh-ancestor
102440527|NCT04977024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440528|NCT04935177|Antibodies|antibodies|mesh-list
102440529|NCT04935177|Immunoglobulins|immunoglobulins|mesh-list
102440530|NCT04935177|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102440531|NCT04935177|gamma-Globulins|gamma-globulins|mesh-list
102440532|NCT04935177|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102440533|NCT04935177|Eculizumab|eculizumab|mesh-list
102440534|NCT04935177|Immunologic Factors|immunologic factors|mesh-ancestor
102440535|NCT04935177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440536|NCT04935177|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102440537|NCT04935177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102440538|NCT04883255|Dronabinol|dronabinol|mesh-list
102440539|NCT04883255|Cannabidiol|cannabidiol|mesh-list
102440540|NCT04883255|Anticonvulsants|anticonvulsants|mesh-ancestor
102440541|NCT04883255|Hallucinogens|hallucinogens|mesh-ancestor
102440542|NCT04883255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440543|NCT04883255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102440544|NCT04883255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102440545|NCT04883255|Analgesics|analgesics|mesh-ancestor
102440546|NCT04883255|Sensory System Agents|sensory system agents|mesh-ancestor
102440547|NCT04883255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102440548|NCT04883255|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102440549|NCT04883255|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102440550|NCT04883255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102440551|NCT04883255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440552|NCT04883255|Hormones|hormones|mesh-ancestor
102440553|NCT04883255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102440554|NCT04880850|Insulin|insulin|mesh-list
102440555|NCT04880850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102440556|NCT04880850|Insulin Glargine|insulin glargine|mesh-list
102440557|NCT04880850|Insulin Aspart|insulin aspart|mesh-list
102440558|NCT04880850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102440559|NCT04880850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440560|NCT04874194|Venetoclax|venetoclax|mesh-list
102440561|NCT04874194|Homoharringtonine|homoharringtonine|mesh-list
102440562|NCT04874194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440563|NCT04874194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102440564|NCT04874194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102440565|NCT04874194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102440566|NCT04874194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440567|NCT04868838|Daratumumab|daratumumab|mesh-list
102440568|NCT04868838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440569|NCT04863638|Vaccines|vaccines|mesh-list
102440570|NCT04863638|Immunologic Factors|immunologic factors|mesh-ancestor
102440571|NCT04863638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440572|NCT04855617|Ocrelizumab|ocrelizumab|mesh-list
102440573|NCT04855617|Immunologic Factors|immunologic factors|mesh-ancestor
102440574|NCT04855617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440575|NCT04790786|Sotrovimab|sotrovimab|mesh-list
102440576|NCT04790786|Bamlanivimab|bamlanivimab|mesh-list
102440577|NCT04790786|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
102440578|NCT04790786|Antiviral Agents|antiviral agents|mesh-ancestor
102440579|NCT04790786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102440580|NCT04786210|Triamcinolone|triamcinolone|mesh-list
102440581|NCT04786210|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102440582|NCT04786210|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102440583|NCT04786210|Fluorouracil|fluorouracil|mesh-list
102440584|NCT04786210|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102440585|NCT04786210|Antimetabolites|antimetabolites|mesh-ancestor
102440586|NCT04786210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440587|NCT04786210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102440588|NCT04786210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440589|NCT04786210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102440590|NCT04786210|Immunologic Factors|immunologic factors|mesh-ancestor
102440591|NCT04786210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440592|NCT04786210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102440593|NCT04786210|Glucocorticoids|glucocorticoids|mesh-ancestor
102440594|NCT04786210|Hormones|hormones|mesh-ancestor
102440595|NCT04786210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102440596|NCT04786210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102440597|NCT04785950|Levonorgestrel|levonorgestrel|mesh-list
102440598|NCT04785950|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102440599|NCT04785950|Contraceptive Agents|contraceptive agents|mesh-ancestor
102440600|NCT04785950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102440601|NCT04785950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440602|NCT04785950|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102440603|NCT04785950|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102440604|NCT04785950|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102440605|NCT04743505|Osimertinib|osimertinib|mesh-list
102440606|NCT04743505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440607|NCT04743505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102440608|NCT04743505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102440609|NCT04743505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440610|NCT04729322|Metronidazole|metronidazole|mesh-list
102440611|NCT04729322|Vancomycin|vancomycin|mesh-list
102440612|NCT04729322|Neomycin|neomycin|mesh-list
102440613|NCT04729322|Pembrolizumab|pembrolizumab|mesh-list
102440614|NCT04729322|Nivolumab|nivolumab|mesh-list
102440615|NCT04729322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102440616|NCT04729322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440617|NCT04729322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102440618|NCT04729322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440619|NCT04729322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102440620|NCT04729322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102440621|NCT04729322|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102440622|NCT04729322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102440623|NCT04729322|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102440624|NCT04729322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102440625|NCT04724252|Gabapentin|gabapentin|mesh-list
102440626|NCT04724252|Analgesics|analgesics|mesh-ancestor
102440627|NCT04724252|Sensory System Agents|sensory system agents|mesh-ancestor
102252275|NCT02426099|Natriuretic Agents|natriuretic agents|mesh-ancestor
102440628|NCT04724252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102440629|NCT04724252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440630|NCT04724252|Anticonvulsants|anticonvulsants|mesh-ancestor
102440631|NCT04724252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102440632|NCT04724252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102440633|NCT04724252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102440634|NCT04724252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102440635|NCT04724252|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102440636|NCT04724252|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102440637|NCT04724252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102440638|NCT04724252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440639|NCT04724252|Antimanic Agents|antimanic agents|mesh-ancestor
102440640|NCT04670068|Cyclophosphamide|cyclophosphamide|mesh-list
102440641|NCT04670068|Fludarabine|fludarabine|mesh-list
102440642|NCT04670068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102440643|NCT04670068|Immunologic Factors|immunologic factors|mesh-ancestor
102440644|NCT04670068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440645|NCT04670068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102440646|NCT04670068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102440647|NCT04670068|Alkylating Agents|alkylating agents|mesh-ancestor
102440648|NCT04670068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440649|NCT04670068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440650|NCT04670068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102440651|NCT04622267|Anti-Infective Agents|anti-infective agents|mesh-list
102440652|NCT04622267|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102440654|NCT04618289|Cholecalciferol|cholecalciferol|mesh-list
102440655|NCT04618289|Vitamins|vitamins|mesh-ancestor
102440656|NCT04618289|Micronutrients|micronutrients|mesh-ancestor
102440657|NCT04618289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440658|NCT04618289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102440659|NCT04618289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102440660|NCT04617795|Insulin|insulin|mesh-list
102440661|NCT04617795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102440662|NCT04617795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440663|NCT04592237|Carboplatin|carboplatin|mesh-list
102440664|NCT04592237|Niraparib|niraparib|mesh-list
102440665|NCT04592237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440666|NCT04592237|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102440667|NCT04592237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102440668|NCT04592237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440669|NCT04588441|Adenosine|adenosine|mesh-list
102440670|NCT04588441|Analgesics|analgesics|mesh-ancestor
102440671|NCT04588441|Sensory System Agents|sensory system agents|mesh-ancestor
102440672|NCT04588441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102440673|NCT04588441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440674|NCT04588441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102440675|NCT04588441|Vasodilator Agents|vasodilator agents|mesh-ancestor
102440676|NCT04588441|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102440677|NCT04588441|Purinergic Agonists|purinergic agonists|mesh-ancestor
102440678|NCT04588441|Purinergic Agents|purinergic agents|mesh-ancestor
102440679|NCT04588441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102440680|NCT04588441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440681|NCT04578015|Metronidazole|metronidazole|mesh-list
102440682|NCT04578015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102440683|NCT04578015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102440684|NCT04578015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102440685|NCT04578015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102440686|NCT04555044|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102440687|NCT04555044|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102440688|NCT04555044|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102440689|NCT04555044|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102440690|NCT04534205|Pembrolizumab|pembrolizumab|mesh-list
102440691|NCT04534205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102440692|NCT04534205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440693|NCT04534205|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102440694|NCT04534205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440695|NCT04510207|Vaccines|vaccines|mesh-list
102440696|NCT04510207|Immunologic Factors|immunologic factors|mesh-ancestor
102440697|NCT04510207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440698|NCT04445519|Latanoprost|latanoprost|mesh-list
102440699|NCT04445519|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102440700|NCT04445519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102440701|NCT04420585|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
102440702|NCT04420585|Hemostatics|hemostatics|mesh-ancestor
102440703|NCT04420585|Coagulants|coagulants|mesh-ancestor
102440704|NCT04420585|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102440705|NCT04420585|Natriuretic Agents|natriuretic agents|mesh-ancestor
102440706|NCT04420585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440708|NCT04396496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440709|NCT04354103|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102440710|NCT04354103|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102440711|NCT04354103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102440712|NCT04354103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102440713|NCT04354103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440714|NCT04354103|Adrenergic Agents|adrenergic agents|mesh-ancestor
102440715|NCT04354103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102440716|NCT04354103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440717|NCT04338204|Tofacitinib|tofacitinib|mesh-list
102440718|NCT04338204|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102440719|NCT04338204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102440720|NCT04338204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102440721|NCT04338204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440722|NCT04294225|Letrozole|letrozole|mesh-list
102440723|NCT04294225|Anastrozole|anastrozole|mesh-list
102440724|NCT04294225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440725|NCT04294225|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102440726|NCT04294225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102440727|NCT04294225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102440728|NCT04294225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440729|NCT04294225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102440730|NCT04294225|Hormone Antagonists|hormone antagonists|mesh-ancestor
102440731|NCT04294225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102440732|NCT04294225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440733|NCT04294225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102440734|NCT04279392|Zoledronic Acid|zoledronic acid|mesh-list
102440735|NCT04279392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102440736|NCT04279392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440737|NCT04268303|Dexmedetomidine|dexmedetomidine|mesh-list
102440738|NCT04268303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102440739|NCT04268303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102440740|NCT04268303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440741|NCT04268303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102440742|NCT04268303|Analgesics|analgesics|mesh-ancestor
102440743|NCT04268303|Sensory System Agents|sensory system agents|mesh-ancestor
102440744|NCT04268303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102440745|NCT04268303|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102440746|NCT04268303|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102440747|NCT04268303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102440748|NCT04268303|Adrenergic Agents|adrenergic agents|mesh-ancestor
102440749|NCT04268303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102440750|NCT04268303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440751|NCT04267497|Amphotericin B|amphotericin b|mesh-list
102440752|NCT04267497|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102440753|NCT04267497|Amebicides|amebicides|mesh-ancestor
102440754|NCT04267497|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102440755|NCT04267497|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102440756|NCT04267497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102440757|NCT04267497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102440758|NCT04267497|Antifungal Agents|antifungal agents|mesh-ancestor
102440759|NCT04266730|Pembrolizumab|pembrolizumab|mesh-list
102440760|NCT04266730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102440761|NCT04266730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440762|NCT04266730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102440763|NCT04266730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440764|NCT04263831|Aldesleukin|aldesleukin|mesh-list
102440765|NCT04263831|Interleukin-2|interleukin-2|mesh-list
102440766|NCT04263831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440767|NCT04263831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102440768|NCT04263831|Analgesics|analgesics|mesh-ancestor
102440769|NCT04263831|Sensory System Agents|sensory system agents|mesh-ancestor
102440770|NCT04263831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102440771|NCT04263831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440772|NCT04263831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102440773|NCT04263831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102440774|NCT04263831|Antiviral Agents|antiviral agents|mesh-ancestor
102440775|NCT04263831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102440776|NCT04260529|Pembrolizumab|pembrolizumab|mesh-list
102440777|NCT04260529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102440778|NCT04260529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440780|NCT04260529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440781|NCT04249687|Botulinum Toxins|botulinum toxins|mesh-list
102440782|NCT04249687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102440783|NCT04249687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102440784|NCT04249687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440785|NCT04249687|Cholinergic Agents|cholinergic agents|mesh-ancestor
102440786|NCT04249687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102440787|NCT04249687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440788|NCT04249583|Botulinum Toxins|botulinum toxins|mesh-list
102440789|NCT04249583|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102440790|NCT04249583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102440791|NCT04249583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440792|NCT04249583|Cholinergic Agents|cholinergic agents|mesh-ancestor
102440793|NCT04249583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102440794|NCT04249583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440795|NCT04239092|Cyclophosphamide|cyclophosphamide|mesh-list
102440796|NCT04239092|Temozolomide|temozolomide|mesh-list
102440797|NCT04239092|Irinotecan|irinotecan|mesh-list
102440798|NCT04239092|Topotecan|topotecan|mesh-list
102440799|NCT04239092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102440800|NCT04239092|Immunologic Factors|immunologic factors|mesh-ancestor
102440801|NCT04239092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440802|NCT04239092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102440803|NCT04239092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102440804|NCT04239092|Alkylating Agents|alkylating agents|mesh-ancestor
102440805|NCT04239092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440806|NCT04239092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440807|NCT04239092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102440808|NCT04239092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102440809|NCT04239092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102440810|NCT04239092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102440811|NCT04225260|Botulinum Toxins|botulinum toxins|mesh-list
102440812|NCT04225260|Neurotransmitter Agents|neurotransmitter agents|mesh-list
102440813|NCT04225260|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102440814|NCT04225260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102440815|NCT04225260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440816|NCT04225260|Cholinergic Agents|cholinergic agents|mesh-ancestor
102440817|NCT04225260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440818|NCT04224740|Cisplatin|cisplatin|mesh-list
102440819|NCT04224740|Carboplatin|carboplatin|mesh-list
102440820|NCT04224740|Pembrolizumab|pembrolizumab|mesh-list
102440821|NCT04224740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440822|NCT04224740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102440823|NCT04224740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102440824|NCT04224740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440825|NCT04223765|Cyclophosphamide|cyclophosphamide|mesh-list
102440826|NCT04223765|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102440827|NCT04223765|Fludarabine|fludarabine|mesh-list
102440828|NCT04223765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102440829|NCT04223765|Immunologic Factors|immunologic factors|mesh-ancestor
102440830|NCT04223765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440831|NCT04223765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102440832|NCT04223765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102440833|NCT04223765|Alkylating Agents|alkylating agents|mesh-ancestor
102440834|NCT04223765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440835|NCT04223765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440836|NCT04223765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102440837|NCT04205227|Pembrolizumab|pembrolizumab|mesh-list
102440838|NCT04205227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102440839|NCT04205227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440840|NCT04205227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102440841|NCT04205227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440842|NCT04159155|Paclitaxel|paclitaxel|mesh-list
102440843|NCT04159155|Carboplatin|carboplatin|mesh-list
102440844|NCT04159155|Niraparib|niraparib|mesh-list
102440845|NCT04159155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102440846|NCT04159155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440847|NCT04159155|Tubulin Modulators|tubulin modulators|mesh-ancestor
102440848|NCT04159155|Antimitotic Agents|antimitotic agents|mesh-ancestor
102440849|NCT04159155|Mitosis Modulators|mitosis modulators|mesh-ancestor
102440850|NCT04159155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440851|NCT04159155|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102440853|NCT04141696|Midazolam|midazolam|mesh-list
102440854|NCT04141696|Ketamine|ketamine|mesh-list
102440855|NCT04141696|Analgesics|analgesics|mesh-ancestor
102440856|NCT04141696|Sensory System Agents|sensory system agents|mesh-ancestor
102440857|NCT04141696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102440858|NCT04141696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440859|NCT04141696|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102440860|NCT04141696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102440861|NCT04141696|Anesthetics, General|anesthetics, general|mesh-ancestor
102440862|NCT04141696|Anesthetics|anesthetics|mesh-ancestor
102440863|NCT04141696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102440864|NCT04141696|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102440865|NCT04141696|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102440866|NCT04141696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102440867|NCT04141696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440868|NCT04141696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102440869|NCT04141696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102440870|NCT04141696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102440871|NCT04141696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102440872|NCT04141696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102440873|NCT04141696|GABA Modulators|gaba modulators|mesh-ancestor
102440874|NCT04141696|GABA Agents|gaba agents|mesh-ancestor
102440875|NCT04117074|Bupivacaine|bupivacaine|mesh-list
102440876|NCT04117074|Anesthetics, Local|anesthetics, local|mesh-ancestor
102440877|NCT04117074|Anesthetics|anesthetics|mesh-ancestor
102440878|NCT04117074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102440879|NCT04117074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440880|NCT04117074|Sensory System Agents|sensory system agents|mesh-ancestor
102440881|NCT04117074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102440882|NCT04108858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102440883|NCT04108858|Trastuzumab|trastuzumab|mesh-list
102440884|NCT04108858|Pertuzumab|pertuzumab|mesh-list
102440885|NCT04108858|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
102440886|NCT04108858|Antibodies|antibodies|mesh-list
102440887|NCT04108858|Immunoglobulins|immunoglobulins|mesh-list
102440888|NCT04108858|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102440889|NCT04108858|Immunologic Factors|immunologic factors|mesh-ancestor
102440890|NCT04108858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440891|NCT04108858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440892|NCT04094675|Sirolimus|sirolimus|mesh-list
102440893|NCT04094675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102440894|NCT04094675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102440895|NCT04094675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102440896|NCT04094675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440897|NCT04094675|Antifungal Agents|antifungal agents|mesh-ancestor
102440898|NCT04094675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102440899|NCT04094675|Immunologic Factors|immunologic factors|mesh-ancestor
102440900|NCT04094675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440901|NCT04092452|PF-06700841|pf-06700841|mesh-list
102440902|NCT04092452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102440903|NCT04092452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102440904|NCT04092452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440905|NCT04074746|Vidarabine|vidarabine|mesh-list
102440906|NCT04074746|Cyclophosphamide|cyclophosphamide|mesh-list
102440907|NCT04074746|Fludarabine|fludarabine|mesh-list
102440908|NCT04074746|Fludarabine phosphate|fludarabine phosphate|mesh-list
102440909|NCT04074746|Antibodies|antibodies|mesh-list
102440910|NCT04074746|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102440911|NCT04074746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102440912|NCT04074746|Immunologic Factors|immunologic factors|mesh-ancestor
102440913|NCT04074746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440914|NCT04074746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102440915|NCT04074746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102440916|NCT04074746|Alkylating Agents|alkylating agents|mesh-ancestor
102440917|NCT04074746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440918|NCT04074746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440919|NCT04074746|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102440920|NCT04074746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102440921|NCT04074746|Antimetabolites|antimetabolites|mesh-ancestor
102440922|NCT04074746|Antiviral Agents|antiviral agents|mesh-ancestor
102440923|NCT04074746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102440924|NCT04047641|Cytarabine|cytarabine|mesh-list
102440925|NCT04047641|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
102440926|NCT04047641|Idarubicin|idarubicin|mesh-list
102440927|NCT04047641|Cladribine|cladribine|mesh-list
102440928|NCT04047641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102440929|NCT04047641|Antimetabolites|antimetabolites|mesh-ancestor
102440930|NCT04047641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440931|NCT04047641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440932|NCT04047641|Antiviral Agents|antiviral agents|mesh-ancestor
102440933|NCT04047641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102440934|NCT04047641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102440935|NCT04047641|Immunologic Factors|immunologic factors|mesh-ancestor
102440936|NCT04047641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440937|NCT04047641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102440938|NCT04047641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102440939|NCT04047641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102440940|NCT04047641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102440941|NCT04046614|Nivolumab|nivolumab|mesh-list
102440942|NCT04046614|Nintedanib|nintedanib|mesh-list
102440943|NCT04046614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102440944|NCT04046614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440945|NCT04046614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102440946|NCT04046614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440947|NCT04046614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102440948|NCT04046614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102440949|NCT04029116|Fluconazole|fluconazole|mesh-list
102440950|NCT04029116|Ibrexafungerp|ibrexafungerp|mesh-list
102440951|NCT04029116|Antifungal Agents|antifungal agents|mesh-ancestor
102440952|NCT04029116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102440953|NCT04029116|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102440954|NCT04029116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102440955|NCT04029116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102440956|NCT04029116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440957|NCT04029116|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102440958|NCT04029116|Hormone Antagonists|hormone antagonists|mesh-ancestor
102440959|NCT04029116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102440960|NCT04029116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440961|NCT04029116|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102440962|NCT04029116|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102440963|NCT04025489|Vitamin D|vitamin d|mesh-list
102440964|NCT04025489|Vitamins|vitamins|mesh-ancestor
102440965|NCT04025489|Micronutrients|micronutrients|mesh-ancestor
102440966|NCT04025489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440967|NCT04025489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102440968|NCT04002947|Rituximab|rituximab|mesh-list
102440969|NCT04002947|Acalabrutinib|acalabrutinib|mesh-list
102440970|NCT04002947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102440971|NCT04002947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440972|NCT04002947|Immunologic Factors|immunologic factors|mesh-ancestor
102440973|NCT04002947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440974|NCT04002947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102440975|NCT03998839|Pyrimethamine|pyrimethamine|mesh-list
102440976|NCT03998839|Sulfadoxine|sulfadoxine|mesh-list
102440977|NCT03998839|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
102440978|NCT03998839|Antimalarials|antimalarials|mesh-ancestor
102440979|NCT03998839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102440980|NCT03998839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102440981|NCT03998839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102440982|NCT03998839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102440983|NCT03998839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102440984|NCT03998839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102440985|NCT03998839|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102440986|NCT03962894|Prednisolone|prednisolone|mesh-list
102440987|NCT03962894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102440988|NCT03962894|Glucocorticoids|glucocorticoids|mesh-ancestor
102440989|NCT03962894|Hormones|hormones|mesh-ancestor
102440990|NCT03962894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102440991|NCT03962894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102440992|NCT03962894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102440993|NCT03962894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102440994|NCT03959488|Palivizumab|palivizumab|mesh-list
102440995|NCT03959488|Antiviral Agents|antiviral agents|mesh-ancestor
102440996|NCT03959488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102440997|NCT03926026|Fluticasone|fluticasone|mesh-list
102440998|NCT03926026|Xhance|xhance|mesh-list
102440999|NCT03926026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102441000|NCT03926026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102441001|NCT03926026|Autonomic Agents|autonomic agents|mesh-ancestor
102441002|NCT03926026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102441003|NCT03926026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102441004|NCT03926026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102441005|NCT03926026|Respiratory System Agents|respiratory system agents|mesh-ancestor
102441006|NCT03926026|Dermatologic Agents|dermatologic agents|mesh-ancestor
102441007|NCT03926026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102441008|NCT03917082|Tamoxifen|tamoxifen|mesh-list
102441009|NCT03917082|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102441010|NCT03917082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441011|NCT03917082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102441012|NCT03917082|Hormone Antagonists|hormone antagonists|mesh-ancestor
102441013|NCT03917082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102441014|NCT03917082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102441015|NCT03917082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102441016|NCT03917082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441017|NCT03917082|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102441018|NCT03917082|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102441019|NCT03917082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102441020|NCT03917082|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102441021|NCT03917082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102441022|NCT03875690|Methylprednisolone|methylprednisolone|mesh-list
102441023|NCT03875690|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102441024|NCT03875690|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102441025|NCT03875690|Prednisolone|prednisolone|mesh-list
102441026|NCT03875690|Prednisolone acetate|prednisolone acetate|mesh-list
102441027|NCT03875690|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102441028|NCT03875690|Prednisolone phosphate|prednisolone phosphate|mesh-list
102441029|NCT03875690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102441030|NCT03875690|Antiemetics|antiemetics|mesh-ancestor
102441031|NCT03875690|Autonomic Agents|autonomic agents|mesh-ancestor
102441032|NCT03875690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102441033|NCT03875690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102441034|NCT03875690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102441035|NCT03875690|Glucocorticoids|glucocorticoids|mesh-ancestor
102441036|NCT03875690|Hormones|hormones|mesh-ancestor
102441037|NCT03875690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102441038|NCT03875690|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102441039|NCT03875690|Protective Agents|protective agents|mesh-ancestor
102441040|NCT03875690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102441041|NCT03875690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441042|NCT03856216|Rituximab|rituximab|mesh-list
102441043|NCT03856216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102441044|NCT03856216|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
102441045|NCT03856216|Methotrexate|methotrexate|mesh-list
102441046|NCT03856216|Fludarabine|fludarabine|mesh-list
102441047|NCT03856216|Melphalan|melphalan|mesh-list
102441048|NCT03856216|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102441049|NCT03856216|Mechlorethamine|mechlorethamine|mesh-list
102441050|NCT03856216|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102441051|NCT03856216|Antibodies|antibodies|mesh-list
102441052|NCT03856216|Immunoglobulins|immunoglobulins|mesh-list
102441053|NCT03856216|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102441054|NCT03856216|Lenograstim|lenograstim|mesh-list
102441055|NCT03856216|Tacrolimus|tacrolimus|mesh-list
102441056|NCT03856216|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102441057|NCT03856216|Immunologic Factors|immunologic factors|mesh-ancestor
102441058|NCT03856216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102441059|NCT03856216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441060|NCT03856216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102441061|NCT03856216|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102441062|NCT03856216|Abortifacient Agents|abortifacient agents|mesh-ancestor
102441063|NCT03856216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102441064|NCT03856216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102441065|NCT03856216|Antimetabolites|antimetabolites|mesh-ancestor
102441066|NCT03856216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441067|NCT03856216|Dermatologic Agents|dermatologic agents|mesh-ancestor
102441068|NCT03856216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102441069|NCT03856216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102441070|NCT03856216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102441071|NCT03856216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102441072|NCT03856216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102441073|NCT03856216|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102441074|NCT03856216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102441075|NCT03856216|Alkylating Agents|alkylating agents|mesh-ancestor
102441076|NCT03856216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102441077|NCT03856216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102441079|NCT03856216|Immunoconjugates|immunoconjugates|mesh-ancestor
102441080|NCT03834493|Pembrolizumab|pembrolizumab|mesh-list
102441081|NCT03834493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102441082|NCT03834493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441083|NCT03834493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102441084|NCT03834493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441085|NCT03829254|Pembrolizumab|pembrolizumab|mesh-list
102441086|NCT03829254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102441087|NCT03829254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441088|NCT03829254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102441089|NCT03829254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441090|NCT03808610|Cytarabine|cytarabine|mesh-list
102441091|NCT03808610|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
102441092|NCT03808610|Dexamethasone|dexamethasone|mesh-list
102441093|NCT03808610|Dexamethasone acetate|dexamethasone acetate|mesh-list
102441094|NCT03808610|Prednisone|prednisone|mesh-list
102441095|NCT03808610|Cortisone|cortisone|mesh-list
102441096|NCT03808610|Cyclophosphamide|cyclophosphamide|mesh-list
102441097|NCT03808610|Rituximab|rituximab|mesh-list
102441098|NCT03808610|Methotrexate|methotrexate|mesh-list
102441099|NCT03808610|Vincristine|vincristine|mesh-list
102441100|NCT03808610|Venetoclax|venetoclax|mesh-list
102441101|NCT03808610|Asparaginase|asparaginase|mesh-list
102441102|NCT03808610|Pegaspargase|pegaspargase|mesh-list
102441103|NCT03808610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102441104|NCT03808610|Antibodies|antibodies|mesh-list
102441105|NCT03808610|Immunoglobulins|immunoglobulins|mesh-list
102441106|NCT03808610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102441107|NCT03808610|BB 1101|bb 1101|mesh-list
102441108|NCT03808610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102441109|NCT03808610|Immunologic Factors|immunologic factors|mesh-ancestor
102441110|NCT03808610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102441111|NCT03808610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102071524|NCT02283476|Antimetabolites|antimetabolites|mesh-ancestor
102441112|NCT03808610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102441113|NCT03808610|Alkylating Agents|alkylating agents|mesh-ancestor
102441114|NCT03808610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441115|NCT03808610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441116|NCT03808610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102441117|NCT03808610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102441118|NCT03808610|Antiemetics|antiemetics|mesh-ancestor
102441119|NCT03808610|Autonomic Agents|autonomic agents|mesh-ancestor
102441120|NCT03808610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102441121|NCT03808610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102441122|NCT03808610|Glucocorticoids|glucocorticoids|mesh-ancestor
102441123|NCT03808610|Hormones|hormones|mesh-ancestor
102441124|NCT03808610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102441125|NCT03808610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102441126|NCT03808610|Protease Inhibitors|protease inhibitors|mesh-ancestor
102441127|NCT03808610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102441128|NCT03808610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102441129|NCT03808610|Abortifacient Agents|abortifacient agents|mesh-ancestor
102441130|NCT03808610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102441131|NCT03808610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102441132|NCT03808610|Antimetabolites|antimetabolites|mesh-ancestor
102441133|NCT03808610|Dermatologic Agents|dermatologic agents|mesh-ancestor
102441134|NCT03808610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102441135|NCT03808610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102441136|NCT03808610|Antiviral Agents|antiviral agents|mesh-ancestor
102441137|NCT03808610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102441138|NCT03808610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102441139|NCT03808610|Tubulin Modulators|tubulin modulators|mesh-ancestor
102441140|NCT03808610|Antimitotic Agents|antimitotic agents|mesh-ancestor
102441141|NCT03808610|Mitosis Modulators|mitosis modulators|mesh-ancestor
102441142|NCT03774446|Roscovitine|roscovitine|mesh-list
102441143|NCT03774446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441144|NCT03774446|Antiviral Agents|antiviral agents|mesh-ancestor
102441145|NCT03774446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102441146|NCT03774446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102441147|NCT03774446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102441148|NCT03774446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441149|NCT03739996|Cabotegravir|cabotegravir|mesh-list
102441150|NCT03739996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
102441151|NCT03739996|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102252800|NCT02423759|Ciprofloxacin|ciprofloxacin|mesh-list
102441152|NCT03739996|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102441153|NCT03739996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102441154|NCT03739996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441155|NCT03739996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102441156|NCT03739996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102441157|NCT03739996|Antiviral Agents|antiviral agents|mesh-ancestor
102441158|NCT03739996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102441159|NCT03739996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102441160|NCT03734029|Paclitaxel|paclitaxel|mesh-list
102441161|NCT03734029|Camptothecin|camptothecin|mesh-list
102441162|NCT03734029|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102441163|NCT03734029|Gemcitabine|gemcitabine|mesh-list
102441164|NCT03734029|Capecitabine|capecitabine|mesh-list
102441165|NCT03734029|Trastuzumab|trastuzumab|mesh-list
102441166|NCT03734029|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
102441167|NCT03734029|Immunoconjugates|immunoconjugates|mesh-list
102441168|NCT03734029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102441169|NCT03734029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441170|NCT03734029|Tubulin Modulators|tubulin modulators|mesh-ancestor
102441171|NCT03734029|Antimitotic Agents|antimitotic agents|mesh-ancestor
102441172|NCT03734029|Mitosis Modulators|mitosis modulators|mesh-ancestor
102441173|NCT03734029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441174|NCT03734029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102441175|NCT03734029|Antimetabolites|antimetabolites|mesh-ancestor
102441176|NCT03734029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102441177|NCT03734029|Immunologic Factors|immunologic factors|mesh-ancestor
102441178|NCT03734029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102441179|NCT03734029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102441180|NCT03734029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102441181|NCT03734029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102441182|NCT03732820|Olaparib|olaparib|mesh-list
102441183|NCT03732820|Abiraterone Acetate|abiraterone acetate|mesh-list
102441184|NCT03732820|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102441185|NCT03732820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102441186|NCT03732820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441187|NCT03732820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441188|NCT03732820|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102441189|NCT03732820|Hormone Antagonists|hormone antagonists|mesh-ancestor
102441190|NCT03732820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102441191|NCT03732820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102441192|NCT03732820|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102441193|NCT03732677|Gemcitabine|gemcitabine|mesh-list
102441194|NCT03732677|Durvalumab|durvalumab|mesh-list
102441195|NCT03732677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441196|NCT03732677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102441197|NCT03732677|Antimetabolites|antimetabolites|mesh-ancestor
102441198|NCT03732677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441199|NCT03732677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102441200|NCT03721068|Cyclophosphamide|cyclophosphamide|mesh-list
102441201|NCT03721068|Fludarabine|fludarabine|mesh-list
102441202|NCT03721068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102441203|NCT03721068|Immunologic Factors|immunologic factors|mesh-ancestor
102441204|NCT03721068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102441205|NCT03721068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102441206|NCT03721068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102441207|NCT03721068|Alkylating Agents|alkylating agents|mesh-ancestor
102441208|NCT03721068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441209|NCT03721068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441210|NCT03721068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102441211|NCT03711058|Nivolumab|nivolumab|mesh-list
102441212|NCT03711058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102441213|NCT03711058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441214|NCT03711058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102441215|NCT03711058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441216|NCT03710772|Cytarabine|cytarabine|mesh-list
102441217|NCT03710772|Dexamethasone|dexamethasone|mesh-list
102441218|NCT03710772|Dexamethasone acetate|dexamethasone acetate|mesh-list
102441219|NCT03710772|Cyclophosphamide|cyclophosphamide|mesh-list
102441220|NCT03710772|Rituximab|rituximab|mesh-list
102441221|NCT03710772|Doxorubicin|doxorubicin|mesh-list
102441222|NCT03710772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102441223|NCT03710772|Methotrexate|methotrexate|mesh-list
102441224|NCT03710772|Vincristine|vincristine|mesh-list
102441225|NCT03710772|Venetoclax|venetoclax|mesh-list
102441226|NCT03710772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102441227|NCT03710772|Antibodies|antibodies|mesh-list
102441228|NCT03710772|Immunoglobulins|immunoglobulins|mesh-list
102441229|NCT03710772|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102441231|NCT03710772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102441232|NCT03710772|Immunologic Factors|immunologic factors|mesh-ancestor
102441233|NCT03710772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102441234|NCT03710772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102441235|NCT03710772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102441236|NCT03710772|Alkylating Agents|alkylating agents|mesh-ancestor
102441237|NCT03710772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441238|NCT03710772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441239|NCT03710772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102441240|NCT03710772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102441241|NCT03710772|Antiemetics|antiemetics|mesh-ancestor
102441242|NCT03710772|Autonomic Agents|autonomic agents|mesh-ancestor
102441243|NCT03710772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102441244|NCT03710772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102441245|NCT03710772|Glucocorticoids|glucocorticoids|mesh-ancestor
102441246|NCT03710772|Hormones|hormones|mesh-ancestor
102441247|NCT03710772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102441248|NCT03710772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102441249|NCT03710772|Protease Inhibitors|protease inhibitors|mesh-ancestor
102441250|NCT03710772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102441251|NCT03710772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102441252|NCT03710772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102441253|NCT03710772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102441254|NCT03710772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102441255|NCT03710772|Abortifacient Agents|abortifacient agents|mesh-ancestor
102441256|NCT03710772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102441257|NCT03710772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102441258|NCT03710772|Antimetabolites|antimetabolites|mesh-ancestor
102441259|NCT03710772|Dermatologic Agents|dermatologic agents|mesh-ancestor
102441260|NCT03710772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102441261|NCT03710772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102441262|NCT03710772|Antiviral Agents|antiviral agents|mesh-ancestor
102441263|NCT03710772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102441264|NCT03710772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102441265|NCT03710772|Tubulin Modulators|tubulin modulators|mesh-ancestor
102441266|NCT03710772|Antimitotic Agents|antimitotic agents|mesh-ancestor
102441267|NCT03710772|Mitosis Modulators|mitosis modulators|mesh-ancestor
102441268|NCT03705962|Tobramycin|tobramycin|mesh-list
102441269|NCT03705962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102441270|NCT03705962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102441271|NCT03693183|Ketorolac|ketorolac|mesh-list
102441272|NCT03693183|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102441273|NCT03693183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102441274|NCT03693183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102441275|NCT03693183|Analgesics|analgesics|mesh-ancestor
102441276|NCT03693183|Sensory System Agents|sensory system agents|mesh-ancestor
102441277|NCT03693183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102441278|NCT03693183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102441279|NCT03693183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102441280|NCT03693183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102441281|NCT03693183|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102441282|NCT03693183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102441283|NCT03693183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441284|NCT03679650|Decitabine|decitabine|mesh-list
102441285|NCT03679650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102441286|NCT03679650|Antimetabolites|antimetabolites|mesh-ancestor
102441287|NCT03679650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441288|NCT03679650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441289|NCT03679650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102441290|NCT03661307|Decitabine|decitabine|mesh-list
102441291|NCT03661307|Venetoclax|venetoclax|mesh-list
102441292|NCT03661307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102441293|NCT03661307|Antimetabolites|antimetabolites|mesh-ancestor
102441294|NCT03661307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441295|NCT03661307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441296|NCT03661307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102441297|NCT03657797|Latanoprost|latanoprost|mesh-list
102441298|NCT03657797|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102441299|NCT03657797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102441300|NCT03631043|Lenalidomide|lenalidomide|mesh-list
102441301|NCT03631043|Vaccines|vaccines|mesh-list
102441302|NCT03631043|Immunologic Factors|immunologic factors|mesh-ancestor
102441303|NCT03631043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252950|NCT02422199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441304|NCT03631043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102441305|NCT03631043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102441306|NCT03631043|Growth Substances|growth substances|mesh-ancestor
102441307|NCT03631043|Growth Inhibitors|growth inhibitors|mesh-ancestor
102441308|NCT03631043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441309|NCT03616886|Paclitaxel|paclitaxel|mesh-list
102441310|NCT03616886|Carboplatin|carboplatin|mesh-list
102441311|NCT03616886|Durvalumab|durvalumab|mesh-list
102441312|NCT03616886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102441313|NCT03616886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441314|NCT03616886|Tubulin Modulators|tubulin modulators|mesh-ancestor
102441315|NCT03616886|Antimitotic Agents|antimitotic agents|mesh-ancestor
102441316|NCT03616886|Mitosis Modulators|mitosis modulators|mesh-ancestor
102441317|NCT03616886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441318|NCT03616886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102441319|NCT03610711|Nivolumab|nivolumab|mesh-list
102441320|NCT03610711|Relatlimab|relatlimab|mesh-list
102441321|NCT03610711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102441322|NCT03610711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441323|NCT03610711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102441324|NCT03610711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441325|NCT03595124|Nivolumab|nivolumab|mesh-list
102441326|NCT03595124|Axitinib|axitinib|mesh-list
102441327|NCT03595124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102441328|NCT03595124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441329|NCT03595124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102441330|NCT03595124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441331|NCT03595124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102441332|NCT03595124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102441333|NCT03579446|Oxymorphone|oxymorphone|mesh-list
102441334|NCT03579446|Morphine|morphine|mesh-list
102441335|NCT03579446|Oxycodone|oxycodone|mesh-list
102441336|NCT03579446|Hydromorphone|hydromorphone|mesh-list
102441337|NCT03579446|Hydrocodone|hydrocodone|mesh-list
102441338|NCT03579446|Levorphanol|levorphanol|mesh-list
102441339|NCT03579446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102441340|NCT03579446|Narcotics|narcotics|mesh-ancestor
102441341|NCT03579446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102441342|NCT03579446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102441343|NCT03579446|Analgesics|analgesics|mesh-ancestor
102441344|NCT03579446|Sensory System Agents|sensory system agents|mesh-ancestor
102441345|NCT03579446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102441346|NCT03579446|Antitussive Agents|antitussive agents|mesh-ancestor
102441347|NCT03579446|Respiratory System Agents|respiratory system agents|mesh-ancestor
102441348|NCT03579446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102441349|NCT03546361|Pembrolizumab|pembrolizumab|mesh-list
102441350|NCT03546361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102441351|NCT03546361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441352|NCT03546361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102441353|NCT03546361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441354|NCT03473574|Gemcitabine|gemcitabine|mesh-list
102441355|NCT03473574|Durvalumab|durvalumab|mesh-list
102441356|NCT03473574|Tremelimumab|tremelimumab|mesh-list
102441357|NCT03473574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441358|NCT03473574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102441359|NCT03473574|Antimetabolites|antimetabolites|mesh-ancestor
102441360|NCT03473574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441361|NCT03473574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102441362|NCT03472040|Berotralstat|berotralstat|mesh-list
102441363|NCT03472040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102441364|NCT03472040|Protease Inhibitors|protease inhibitors|mesh-ancestor
102441365|NCT03472040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102441366|NCT03472040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441367|NCT03452137|Atezolizumab|atezolizumab|mesh-list
102441368|NCT03452137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102441369|NCT03452137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441370|NCT03452137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102441371|NCT03452137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441372|NCT03428126|Durvalumab|durvalumab|mesh-list
102441373|NCT03428126|Trametinib|trametinib|mesh-list
102441374|NCT03428126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102441375|NCT03428126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441376|NCT03428126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102441377|NCT03428126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612311|NCT00002399|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102253026|NCT04482881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102441378|NCT03428126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441379|NCT03424018|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
102441380|NCT03424018|Natriuretic Agents|natriuretic agents|mesh-ancestor
102441381|NCT03424018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102441382|NCT03416530|TIC10 compound|tic10 compound|mesh-list
102441383|NCT03416530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441384|NCT03345810|Paclitaxel|paclitaxel|mesh-list
102441385|NCT03345810|Vinorelbine|vinorelbine|mesh-list
102441386|NCT03345810|Carboplatin|carboplatin|mesh-list
102441387|NCT03345810|Gemcitabine|gemcitabine|mesh-list
102441388|NCT03345810|Durvalumab|durvalumab|mesh-list
102441389|NCT03345810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102441390|NCT03345810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441391|NCT03345810|Tubulin Modulators|tubulin modulators|mesh-ancestor
102441392|NCT03345810|Antimitotic Agents|antimitotic agents|mesh-ancestor
102441393|NCT03345810|Mitosis Modulators|mitosis modulators|mesh-ancestor
102441394|NCT03345810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441395|NCT03345810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102441396|NCT03345810|Antimetabolites|antimetabolites|mesh-ancestor
102441397|NCT03345810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102441398|NCT03344965|Olaparib|olaparib|mesh-list
102441399|NCT03344965|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102441400|NCT03344965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102441401|NCT03344965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441402|NCT03344965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441403|NCT03323385|Meloxicam|meloxicam|mesh-list
102441404|NCT03323385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102441405|NCT03323385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102441406|NCT03323385|Analgesics|analgesics|mesh-ancestor
102441407|NCT03323385|Sensory System Agents|sensory system agents|mesh-ancestor
102441408|NCT03323385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102441409|NCT03323385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102441410|NCT03323385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102441411|NCT03323385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102441412|NCT03323385|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102441413|NCT03323385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102441414|NCT03323385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102441415|NCT03323385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441416|NCT03298451|Sorafenib|sorafenib|mesh-list
102441417|NCT03298451|Durvalumab|durvalumab|mesh-list
102441418|NCT03298451|Tremelimumab|tremelimumab|mesh-list
102441419|NCT03298451|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102441420|NCT03298451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441421|NCT03298451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102441422|NCT03298451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102071842|NCT04517110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102441423|NCT03298451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441424|NCT03298451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102441425|NCT03298451|Immunologic Factors|immunologic factors|mesh-ancestor
102441426|NCT03298451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102441427|NCT03295396|TIC10 compound|tic10 compound|mesh-list
102441428|NCT03295396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441429|NCT03248479|Azacitidine|azacitidine|mesh-list
102441430|NCT03248479|Magrolimab|magrolimab|mesh-list
102441431|NCT03248479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102441432|NCT03248479|Antimetabolites|antimetabolites|mesh-ancestor
102441433|NCT03248479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441434|NCT03248479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441435|NCT03248479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102441436|NCT03248479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102441437|NCT03217747|Avelumab|avelumab|mesh-list
102441438|NCT03217747|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102441439|NCT03217747|Immunoglobulin G|immunoglobulin g|mesh-list
102441440|NCT03217747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102441441|NCT03217747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441442|NCT03217747|Immunologic Factors|immunologic factors|mesh-ancestor
102441443|NCT03217747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102441444|NCT03215719|Cisplatin|cisplatin|mesh-list
102441445|NCT03215719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441446|NCT03197467|Pembrolizumab|pembrolizumab|mesh-list
102441447|NCT03197467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102441448|NCT03197467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441449|NCT03197467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102441450|NCT03197467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441451|NCT03181867|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102253106|NCT02414945|Cyclophosphamide|cyclophosphamide|mesh-list
102441452|NCT03181867|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102441453|NCT03181867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441455|NCT03172299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102441456|NCT03172299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102441457|NCT03172299|Growth Substances|growth substances|mesh-ancestor
102441458|NCT03172299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102441459|NCT03172299|Growth Inhibitors|growth inhibitors|mesh-ancestor
102441460|NCT03172299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441461|NCT03164616|Cisplatin|cisplatin|mesh-list
102441462|NCT03164616|Carboplatin|carboplatin|mesh-list
102441463|NCT03164616|Gemcitabine|gemcitabine|mesh-list
102441464|NCT03164616|Pemetrexed|pemetrexed|mesh-list
102441465|NCT03164616|Durvalumab|durvalumab|mesh-list
102441466|NCT03164616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102441467|NCT03164616|Tremelimumab|tremelimumab|mesh-list
102441468|NCT03164616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441469|NCT03164616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102441470|NCT03164616|Antimetabolites|antimetabolites|mesh-ancestor
102441471|NCT03164616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441472|NCT03164616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102441473|NCT03164616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102441474|NCT03164616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102441475|NCT03164616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102441476|NCT03132636|Cemiplimab|cemiplimab|mesh-list
102441477|NCT03132636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102441478|NCT03132636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441479|NCT03089983|Isoniazid|isoniazid|mesh-list
102441480|NCT03089983|Rifapentine|rifapentine|mesh-list
102441481|NCT03089983|Buprenorphine|buprenorphine|mesh-list
102441482|NCT03089983|Methadone|methadone|mesh-list
102441483|NCT03089983|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102441484|NCT03089983|Naloxone|naloxone|mesh-list
102441485|NCT03089983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102441486|NCT03089983|Narcotics|narcotics|mesh-ancestor
102441487|NCT03089983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102441488|NCT03089983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102441489|NCT03089983|Analgesics|analgesics|mesh-ancestor
102441490|NCT03089983|Sensory System Agents|sensory system agents|mesh-ancestor
102441491|NCT03089983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102441492|NCT03089983|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102441493|NCT03089983|Antitussive Agents|antitussive agents|mesh-ancestor
102441494|NCT03089983|Respiratory System Agents|respiratory system agents|mesh-ancestor
102441495|NCT03089983|Antitubercular Agents|antitubercular agents|mesh-ancestor
102441496|NCT03089983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102441497|NCT03089983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102441498|NCT03089983|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102441499|NCT03089983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102441500|NCT03089983|Antimetabolites|antimetabolites|mesh-ancestor
102441501|NCT03089983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441502|NCT03089983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102441503|NCT03089983|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102441504|NCT03089983|Leprostatic Agents|leprostatic agents|mesh-ancestor
102441505|NCT03079999|Aspirin|aspirin|mesh-list
102441506|NCT03079999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102441507|NCT03079999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102441508|NCT03079999|Analgesics|analgesics|mesh-ancestor
102441509|NCT03079999|Sensory System Agents|sensory system agents|mesh-ancestor
102441510|NCT03079999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102441511|NCT03079999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102441512|NCT03079999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102441513|NCT03079999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102441514|NCT03079999|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102441515|NCT03079999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102441516|NCT03079999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441517|NCT03079999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102441518|NCT03079999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102441519|NCT03079999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102441520|NCT03079999|Antipyretics|antipyretics|mesh-ancestor
102441521|NCT03070184|Metoprolol|metoprolol|mesh-list
102441522|NCT03070184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102441523|NCT03070184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102441524|NCT03070184|Sympatholytics|sympatholytics|mesh-ancestor
102441525|NCT03070184|Autonomic Agents|autonomic agents|mesh-ancestor
102441526|NCT03070184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102441527|NCT03070184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102441528|NCT03070184|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102441529|NCT03070184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102441530|NCT03070184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102441531|NCT03070184|Adrenergic Agents|adrenergic agents|mesh-ancestor
102441532|NCT03070184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102441533|NCT03070184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441535|NCT03047993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102441536|NCT03047993|Antimetabolites|antimetabolites|mesh-ancestor
102441537|NCT03047993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441538|NCT03047993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441539|NCT03047993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102441540|NCT03044587|Leucovorin|leucovorin|mesh-list
102441541|NCT03044587|Gemcitabine|gemcitabine|mesh-list
102441542|NCT03044587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441543|NCT03044587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102441544|NCT03044587|Antimetabolites|antimetabolites|mesh-ancestor
102441545|NCT03044587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441546|NCT03044587|Antidotes|antidotes|mesh-ancestor
102441547|NCT03044587|Protective Agents|protective agents|mesh-ancestor
102441548|NCT03044587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102441549|NCT03044587|Vitamin B Complex|vitamin b complex|mesh-ancestor
102441550|NCT03044587|Vitamins|vitamins|mesh-ancestor
102441551|NCT03044587|Micronutrients|micronutrients|mesh-ancestor
102441552|NCT03029403|Cyclophosphamide|cyclophosphamide|mesh-list
102441553|NCT03029403|Pembrolizumab|pembrolizumab|mesh-list
102441554|NCT03029403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102441555|NCT03029403|Immunologic Factors|immunologic factors|mesh-ancestor
102441556|NCT03029403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102441557|NCT03029403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102441558|NCT03029403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102441559|NCT03029403|Alkylating Agents|alkylating agents|mesh-ancestor
102441560|NCT03029403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441561|NCT03029403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441562|NCT03029403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102441563|NCT03029403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102441564|NCT03029403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102441565|NCT03016377|Cyclophosphamide|cyclophosphamide|mesh-list
102441566|NCT03016377|Fludarabine|fludarabine|mesh-list
102441567|NCT03016377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102441568|NCT03016377|Immunologic Factors|immunologic factors|mesh-ancestor
102441569|NCT03016377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102441570|NCT03016377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102441571|NCT03016377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102441572|NCT03016377|Alkylating Agents|alkylating agents|mesh-ancestor
102441573|NCT03016377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441574|NCT03016377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441575|NCT03016377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102441576|NCT03003962|Paclitaxel|paclitaxel|mesh-list
102441577|NCT03003962|Cisplatin|cisplatin|mesh-list
102441578|NCT03003962|Carboplatin|carboplatin|mesh-list
102441579|NCT03003962|Gemcitabine|gemcitabine|mesh-list
102441580|NCT03003962|Pemetrexed|pemetrexed|mesh-list
102441581|NCT03003962|Durvalumab|durvalumab|mesh-list
102441582|NCT03003962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102441583|NCT03003962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441584|NCT03003962|Tubulin Modulators|tubulin modulators|mesh-ancestor
102441585|NCT03003962|Antimitotic Agents|antimitotic agents|mesh-ancestor
102441586|NCT03003962|Mitosis Modulators|mitosis modulators|mesh-ancestor
102441587|NCT03003962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441588|NCT03003962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102441589|NCT03003962|Antimetabolites|antimetabolites|mesh-ancestor
102441590|NCT03003962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102441591|NCT03003962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102441592|NCT03003962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102441593|NCT03003962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102441594|NCT02947620|Metformin|metformin|mesh-list
102441595|NCT02947620|Atorvastatin|atorvastatin|mesh-list
102441596|NCT02947620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102441597|NCT02947620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102441598|NCT02947620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102441599|NCT02947620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102441600|NCT02947620|Antimetabolites|antimetabolites|mesh-ancestor
102441601|NCT02947620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441602|NCT02947620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102441603|NCT02947620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102441604|NCT02947620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102441605|NCT02877303|Cytarabine|cytarabine|mesh-list
102441606|NCT02877303|Dexamethasone|dexamethasone|mesh-list
102441607|NCT02877303|Dexamethasone acetate|dexamethasone acetate|mesh-list
102441608|NCT02877303|Prednisone|prednisone|mesh-list
102441609|NCT02877303|Cortisone|cortisone|mesh-list
102441610|NCT02877303|Cyclophosphamide|cyclophosphamide|mesh-list
102441611|NCT02877303|Rituximab|rituximab|mesh-list
102441612|NCT02877303|Doxorubicin|doxorubicin|mesh-list
102441613|NCT02877303|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102441614|NCT02877303|Methotrexate|methotrexate|mesh-list
102441615|NCT02877303|Vincristine|vincristine|mesh-list
102441616|NCT02877303|Mercaptopurine|mercaptopurine|mesh-list
102441617|NCT02877303|Ofatumumab|ofatumumab|mesh-list
102441618|NCT02877303|Blinatumomab|blinatumomab|mesh-list
102441619|NCT02877303|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
102441620|NCT02877303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102441621|NCT02877303|Muromonab-CD3|muromonab-cd3|mesh-list
102441622|NCT02877303|Antibodies|antibodies|mesh-list
102441623|NCT02877303|Immunoglobulins|immunoglobulins|mesh-list
102441624|NCT02877303|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102441625|NCT02877303|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102441626|NCT02877303|BB 1101|bb 1101|mesh-list
102441627|NCT02877303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102441628|NCT02877303|Immunologic Factors|immunologic factors|mesh-ancestor
102441629|NCT02877303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102441630|NCT02877303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102441631|NCT02877303|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102441632|NCT02877303|Alkylating Agents|alkylating agents|mesh-ancestor
102441633|NCT02877303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441634|NCT02877303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441635|NCT02877303|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102441636|NCT02877303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102441637|NCT02877303|Antiemetics|antiemetics|mesh-ancestor
102441638|NCT02877303|Autonomic Agents|autonomic agents|mesh-ancestor
102441639|NCT02877303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102441640|NCT02877303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102441641|NCT02877303|Glucocorticoids|glucocorticoids|mesh-ancestor
102441642|NCT02877303|Hormones|hormones|mesh-ancestor
102441643|NCT02877303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102441644|NCT02877303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102441645|NCT02877303|Protease Inhibitors|protease inhibitors|mesh-ancestor
102441646|NCT02877303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102441647|NCT02877303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102441648|NCT02877303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102441649|NCT02877303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102441650|NCT02877303|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102441651|NCT02877303|Abortifacient Agents|abortifacient agents|mesh-ancestor
102441652|NCT02877303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102441653|NCT02877303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102441654|NCT02877303|Antimetabolites|antimetabolites|mesh-ancestor
102441655|NCT02877303|Dermatologic Agents|dermatologic agents|mesh-ancestor
102441656|NCT02877303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102441657|NCT02877303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102441658|NCT02877303|Antiviral Agents|antiviral agents|mesh-ancestor
102441659|NCT02877303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102441660|NCT02877303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102441661|NCT02877303|Tubulin Modulators|tubulin modulators|mesh-ancestor
102441662|NCT02877303|Antimitotic Agents|antimitotic agents|mesh-ancestor
102441663|NCT02877303|Mitosis Modulators|mitosis modulators|mesh-ancestor
102441664|NCT02877303|Immunotoxins|immunotoxins|mesh-ancestor
102441665|NCT02877303|Immunoconjugates|immunoconjugates|mesh-ancestor
102441666|NCT02869789|Nivolumab|nivolumab|mesh-list
102441667|NCT02869789|Ipilimumab|ipilimumab|mesh-list
102441668|NCT02869789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102441669|NCT02869789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441670|NCT02869789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102441671|NCT02869789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441672|NCT02863445|Levonorgestrel|levonorgestrel|mesh-list
102441673|NCT02863445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102441674|NCT02863445|Contraceptive Agents|contraceptive agents|mesh-ancestor
102441675|NCT02863445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102441676|NCT02863445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102441677|NCT02863445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102441678|NCT02863445|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102441679|NCT02863445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102441680|NCT02696993|Nivolumab|nivolumab|mesh-list
102441681|NCT02696993|Ipilimumab|ipilimumab|mesh-list
102441682|NCT02696993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102441683|NCT02696993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441684|NCT02696993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102441685|NCT02696993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441687|NCT02671890|Disulfiram|disulfiram|mesh-list
102441688|NCT02671890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102441689|NCT02671890|Antimetabolites|antimetabolites|mesh-ancestor
102441690|NCT02671890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441691|NCT02671890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441692|NCT02671890|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102441693|NCT02671890|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
102441694|NCT02671890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102441695|NCT02661282|Temozolomide|temozolomide|mesh-list
102441696|NCT02661282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102441697|NCT02661282|Alkylating Agents|alkylating agents|mesh-ancestor
102441698|NCT02661282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441699|NCT02661282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441700|NCT02659527|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102441701|NCT02659527|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102441702|NCT02659527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441703|NCT02634333|Aflibercept|aflibercept|mesh-list
102441704|NCT02634333|Endothelial Growth Factors|endothelial growth factors|mesh-list
102441705|NCT02634333|Mitogens|mitogens|mesh-list
102441706|NCT02634333|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102441707|NCT02634333|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102441708|NCT02634333|Growth Substances|growth substances|mesh-ancestor
102441709|NCT02634333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102441710|NCT02634333|Growth Inhibitors|growth inhibitors|mesh-ancestor
102441711|NCT02634333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441712|NCT02634333|Mitosis Modulators|mitosis modulators|mesh-ancestor
102441713|NCT02634333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441714|NCT02586857|Acalabrutinib|acalabrutinib|mesh-list
102441715|NCT02586857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441716|NCT02515630|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
102441717|NCT02515630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102441718|NCT02515630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102441719|NCT02515630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441720|NCT02450331|Atezolizumab|atezolizumab|mesh-list
102441721|NCT02450331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102441722|NCT02450331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441723|NCT02450331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102441724|NCT02450331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441725|NCT02443077|Cytarabine|cytarabine|mesh-list
102441726|NCT02443077|Cyclophosphamide|cyclophosphamide|mesh-list
102441727|NCT02443077|Melphalan|melphalan|mesh-list
102441728|NCT02443077|Mechlorethamine|mechlorethamine|mesh-list
102441729|NCT02443077|Carmustine|carmustine|mesh-list
102441730|NCT02443077|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102441731|NCT02443077|Etoposide|etoposide|mesh-list
102441732|NCT02443077|Etoposide phosphate|etoposide phosphate|mesh-list
102441733|NCT02443077|Podophyllotoxin|podophyllotoxin|mesh-list
102441734|NCT02443077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102441735|NCT02443077|Immunologic Factors|immunologic factors|mesh-ancestor
102441736|NCT02443077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102441737|NCT02443077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102441738|NCT02443077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102441739|NCT02443077|Alkylating Agents|alkylating agents|mesh-ancestor
102441740|NCT02443077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441741|NCT02443077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441742|NCT02443077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102441743|NCT02443077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102441744|NCT02443077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102441745|NCT02443077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102441746|NCT02443077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102441747|NCT02443077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102441748|NCT02443077|Antimetabolites|antimetabolites|mesh-ancestor
102441749|NCT02443077|Antiviral Agents|antiviral agents|mesh-ancestor
102441750|NCT02443077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102441751|NCT02443077|Keratolytic Agents|keratolytic agents|mesh-ancestor
102441752|NCT02443077|Dermatologic Agents|dermatologic agents|mesh-ancestor
102441753|NCT02443077|Tubulin Modulators|tubulin modulators|mesh-ancestor
102441754|NCT02443077|Antimitotic Agents|antimitotic agents|mesh-ancestor
102441755|NCT02443077|Mitosis Modulators|mitosis modulators|mesh-ancestor
102441756|NCT02411656|Pembrolizumab|pembrolizumab|mesh-list
102441757|NCT02411656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102441758|NCT02411656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441759|NCT02411656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102441760|NCT02411656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441761|NCT02397720|Nivolumab|nivolumab|mesh-list
102441762|NCT02397720|Ipilimumab|ipilimumab|mesh-list
102441763|NCT02397720|Azacitidine|azacitidine|mesh-list
102441764|NCT02397720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102441765|NCT02397720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441766|NCT02397720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102441767|NCT02397720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441768|NCT02397720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102441769|NCT02397720|Antimetabolites|antimetabolites|mesh-ancestor
102441770|NCT02397720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102441771|NCT02391025|Citric Acid|citric acid|mesh-list
102441772|NCT02391025|Sodium Citrate|sodium citrate|mesh-list
102441773|NCT02391025|Anticoagulants|anticoagulants|mesh-ancestor
102441774|NCT02391025|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102441775|NCT02391025|Chelating Agents|chelating agents|mesh-ancestor
102441776|NCT02391025|Sequestering Agents|sequestering agents|mesh-ancestor
102441777|NCT02391025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441778|NCT02386800|Panobinostat|panobinostat|mesh-list
102441779|NCT02386800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441780|NCT02386800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102441781|NCT02386800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102441782|NCT02386800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441783|NCT02335944|Nazartinib|nazartinib|mesh-list
102441784|NCT02335944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441785|NCT02326974|Pertuzumab|pertuzumab|mesh-list
102441786|NCT02326974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102441787|NCT02326974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441788|NCT02299518|Cytarabine|cytarabine|mesh-list
102441789|NCT02299518|Etoposide|etoposide|mesh-list
102441790|NCT02299518|Mitoxantrone|mitoxantrone|mesh-list
102441791|NCT02299518|Etoposide phosphate|etoposide phosphate|mesh-list
102441792|NCT02299518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102441793|NCT02299518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441794|NCT02299518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102441795|NCT02299518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102441796|NCT02299518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102441797|NCT02299518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441798|NCT02299518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102441799|NCT02299518|Antimetabolites|antimetabolites|mesh-ancestor
102441800|NCT02299518|Antiviral Agents|antiviral agents|mesh-ancestor
102441801|NCT02299518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102441802|NCT02299518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102441803|NCT02299518|Immunologic Factors|immunologic factors|mesh-ancestor
102441804|NCT02299518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102441805|NCT02299518|Analgesics|analgesics|mesh-ancestor
102441806|NCT02299518|Sensory System Agents|sensory system agents|mesh-ancestor
102441807|NCT02299518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102441808|NCT02257138|Decitabine|decitabine|mesh-list
102441809|NCT02257138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102441810|NCT02257138|Antimetabolites|antimetabolites|mesh-ancestor
102441811|NCT02257138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441812|NCT02257138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441813|NCT02257138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102441814|NCT02246621|Letrozole|letrozole|mesh-list
102441815|NCT02246621|Anastrozole|anastrozole|mesh-list
102441816|NCT02246621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441817|NCT02246621|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102441818|NCT02246621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102441819|NCT02246621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102441820|NCT02246621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441821|NCT02246621|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102441822|NCT02246621|Hormone Antagonists|hormone antagonists|mesh-ancestor
102441823|NCT02246621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102441824|NCT02246621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102441825|NCT02246621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102441826|NCT02214550|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
102441827|NCT02214550|Norinyl|norinyl|mesh-list
102441828|NCT02214550|Mestranol|mestranol|mesh-list
102441829|NCT02214550|Norethindrone|norethindrone|mesh-list
102441830|NCT02214550|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102441831|NCT02214550|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102441832|NCT02214550|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102441833|NCT02214550|Contraceptive Agents|contraceptive agents|mesh-ancestor
102441834|NCT02214550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102441835|NCT02214550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102441836|NCT02214550|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102441837|NCT02214550|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102441838|NCT02214550|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
102441839|NCT02214550|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102441840|NCT02214550|Estrogens|estrogens|mesh-ancestor
102441841|NCT02214550|Hormones|hormones|mesh-ancestor
102441842|NCT02214550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102441843|NCT02200445|Aldesleukin|aldesleukin|mesh-list
102441844|NCT02200445|Interleukin-2|interleukin-2|mesh-list
102441845|NCT02200445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441846|NCT02200445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102441847|NCT02200445|Analgesics|analgesics|mesh-ancestor
102441848|NCT02200445|Sensory System Agents|sensory system agents|mesh-ancestor
102441849|NCT02200445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102441850|NCT02200445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102441851|NCT02200445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102441852|NCT02200445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102441853|NCT02200445|Antiviral Agents|antiviral agents|mesh-ancestor
102441854|NCT02200445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102441855|NCT02180711|Rituximab|rituximab|mesh-list
102441856|NCT02180711|Lenalidomide|lenalidomide|mesh-list
102441857|NCT02180711|Acalabrutinib|acalabrutinib|mesh-list
102441858|NCT02180711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102441859|NCT02180711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441860|NCT02180711|Immunologic Factors|immunologic factors|mesh-ancestor
102441861|NCT02180711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102441862|NCT02180711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102441863|NCT02180711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102441864|NCT02180711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102441865|NCT02180711|Growth Substances|growth substances|mesh-ancestor
102441866|NCT02180711|Growth Inhibitors|growth inhibitors|mesh-ancestor
102441867|NCT02152982|Temozolomide|temozolomide|mesh-list
102441868|NCT02152982|Veliparib|veliparib|mesh-list
102441869|NCT02152982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102441870|NCT02152982|Alkylating Agents|alkylating agents|mesh-ancestor
102441871|NCT02152982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441872|NCT02152982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441873|NCT02152982|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102441874|NCT02152982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102441875|NCT02151084|Gemcitabine|gemcitabine|mesh-list
102441876|NCT02151084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441877|NCT02151084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102441878|NCT02151084|Antimetabolites|antimetabolites|mesh-ancestor
102441879|NCT02151084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441880|NCT02120352|Rilpivirine|rilpivirine|mesh-list
102441881|NCT02120352|Cabotegravir|cabotegravir|mesh-list
102441882|NCT02120352|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102441883|NCT02120352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102441884|NCT02120352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102441885|NCT02120352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441886|NCT02120352|Antiviral Agents|antiviral agents|mesh-ancestor
102441887|NCT02120352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102441888|NCT02120352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102441889|NCT02120352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102441890|NCT02120352|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102441891|NCT02120352|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102441892|NCT02058693|Amphetamine|amphetamine|mesh-list
102441893|NCT02058693|Adderall|adderall|mesh-list
102441894|NCT02058693|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102441895|NCT02058693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102441896|NCT02058693|Sympathomimetics|sympathomimetics|mesh-ancestor
102441897|NCT02058693|Autonomic Agents|autonomic agents|mesh-ancestor
102441898|NCT02058693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102441899|NCT02058693|Dopamine Agents|dopamine agents|mesh-ancestor
102441900|NCT02058693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102441901|NCT02058693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441902|NCT02058693|Adrenergic Agents|adrenergic agents|mesh-ancestor
102441903|NCT02058693|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102441904|NCT02058693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102441905|NCT02058693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102441906|NCT02058693|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102441907|NCT02047513|Paclitaxel|paclitaxel|mesh-list
102441908|NCT02047513|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102441909|NCT02047513|Gemcitabine|gemcitabine|mesh-list
102441910|NCT02047513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102441911|NCT02047513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441912|NCT02047513|Tubulin Modulators|tubulin modulators|mesh-ancestor
102441913|NCT02047513|Antimitotic Agents|antimitotic agents|mesh-ancestor
102441914|NCT02047513|Mitosis Modulators|mitosis modulators|mesh-ancestor
102441915|NCT02047513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441916|NCT02047513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102441917|NCT02047513|Antimetabolites|antimetabolites|mesh-ancestor
102441918|NCT02007044|Rituximab|rituximab|mesh-list
102441919|NCT02007044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102441920|NCT02007044|Antibodies|antibodies|mesh-list
102441921|NCT02007044|Immunoglobulins|immunoglobulins|mesh-list
102441922|NCT02007044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102441923|NCT02007044|Immunologic Factors|immunologic factors|mesh-ancestor
102441924|NCT02007044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102441925|NCT02007044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441926|NCT02007044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102441927|NCT01991873|Leucovorin|leucovorin|mesh-list
102441928|NCT01991873|Folic Acid|folic acid|mesh-list
102441929|NCT01991873|Fluorouracil|fluorouracil|mesh-list
102441930|NCT01991873|Oxaliplatin|oxaliplatin|mesh-list
102441931|NCT01991873|Panitumumab|panitumumab|mesh-list
102441932|NCT01991873|Levoleucovorin|levoleucovorin|mesh-list
102441933|NCT01991873|Antimetabolites|antimetabolites|mesh-ancestor
102441934|NCT01991873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441935|NCT01991873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102441936|NCT01991873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441937|NCT01991873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102441938|NCT01991873|Immunologic Factors|immunologic factors|mesh-ancestor
102441939|NCT01991873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102441940|NCT01991873|Antidotes|antidotes|mesh-ancestor
102441941|NCT01991873|Protective Agents|protective agents|mesh-ancestor
102441942|NCT01991873|Vitamin B Complex|vitamin b complex|mesh-ancestor
102441943|NCT01991873|Vitamins|vitamins|mesh-ancestor
102441944|NCT01991873|Micronutrients|micronutrients|mesh-ancestor
102441945|NCT01991873|Hematinics|hematinics|mesh-ancestor
102441946|NCT01991873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102441947|NCT01927744|Docetaxel|docetaxel|mesh-list
102441948|NCT01927744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102441949|NCT01927744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441950|NCT01927744|Tubulin Modulators|tubulin modulators|mesh-ancestor
102441951|NCT01927744|Antimitotic Agents|antimitotic agents|mesh-ancestor
102441952|NCT01927744|Mitosis Modulators|mitosis modulators|mesh-ancestor
102441953|NCT01927744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441954|NCT01927744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102441955|NCT01927744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102441956|NCT01878617|Cyclophosphamide|cyclophosphamide|mesh-list
102441957|NCT01878617|Gemcitabine|gemcitabine|mesh-list
102441958|NCT01878617|Vincristine|vincristine|mesh-list
102441959|NCT01878617|Pemetrexed|pemetrexed|mesh-list
102441960|NCT01878617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102441961|NCT01878617|Immunologic Factors|immunologic factors|mesh-ancestor
102441962|NCT01878617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102441963|NCT01878617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102441964|NCT01878617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102441965|NCT01878617|Alkylating Agents|alkylating agents|mesh-ancestor
102441966|NCT01878617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441967|NCT01878617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441968|NCT01878617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102441969|NCT01878617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102441970|NCT01878617|Antimetabolites|antimetabolites|mesh-ancestor
102441971|NCT01878617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102441972|NCT01878617|Tubulin Modulators|tubulin modulators|mesh-ancestor
102441973|NCT01878617|Antimitotic Agents|antimitotic agents|mesh-ancestor
102441974|NCT01878617|Mitosis Modulators|mitosis modulators|mesh-ancestor
102441975|NCT01878617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102441976|NCT01878617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102441977|NCT01878617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102441978|NCT01843556|Donepezil|donepezil|mesh-list
102441979|NCT01843556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102441980|NCT01843556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102441981|NCT01843556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441982|NCT01843556|Cholinergic Agents|cholinergic agents|mesh-ancestor
102441983|NCT01843556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102441984|NCT01843556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102441985|NCT01843556|Nootropic Agents|nootropic agents|mesh-ancestor
102441986|NCT01787487|Azacitidine|azacitidine|mesh-list
102441987|NCT01787487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102441988|NCT01787487|Antimetabolites|antimetabolites|mesh-ancestor
102441989|NCT01787487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441990|NCT01787487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441991|NCT01787487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102441992|NCT01751425|Imatinib Mesylate|imatinib mesylate|mesh-list
102441993|NCT01751425|Dasatinib|dasatinib|mesh-list
102441994|NCT01751425|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
102441995|NCT01751425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102441996|NCT01751425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102441997|NCT01751425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102441998|NCT01751425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102441999|NCT01618136|Paclitaxel|paclitaxel|mesh-list
102442000|NCT01618136|Carboplatin|carboplatin|mesh-list
102442001|NCT01618136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102442002|NCT01618136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102442003|NCT01618136|Tubulin Modulators|tubulin modulators|mesh-ancestor
102442004|NCT01618136|Antimitotic Agents|antimitotic agents|mesh-ancestor
102442005|NCT01618136|Mitosis Modulators|mitosis modulators|mesh-ancestor
102442006|NCT01618136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442007|NCT01539031|Donepezil|donepezil|mesh-list
102442008|NCT01539031|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102442009|NCT01539031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102442010|NCT01539031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442011|NCT01539031|Cholinergic Agents|cholinergic agents|mesh-ancestor
102442012|NCT01539031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102442013|NCT01539031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442014|NCT01539031|Nootropic Agents|nootropic agents|mesh-ancestor
102442015|NCT01508312|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102442016|NCT01508312|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102442017|NCT01508312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102442018|NCT01508312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102442019|NCT01508312|Immunotoxins|immunotoxins|mesh-ancestor
102442020|NCT01508312|Immunoconjugates|immunoconjugates|mesh-ancestor
102442021|NCT01508312|Immunologic Factors|immunologic factors|mesh-ancestor
102442022|NCT01508312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442023|NCT01375140|Prednisone|prednisone|mesh-list
102442024|NCT01375140|Lenalidomide|lenalidomide|mesh-list
102442025|NCT01375140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102442026|NCT01375140|Glucocorticoids|glucocorticoids|mesh-ancestor
102442027|NCT01375140|Hormones|hormones|mesh-ancestor
102442028|NCT01375140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102442029|NCT01375140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442030|NCT01375140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102442031|NCT01375140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102442032|NCT01375140|Immunologic Factors|immunologic factors|mesh-ancestor
102442033|NCT01375140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102442034|NCT01375140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102442035|NCT01375140|Growth Substances|growth substances|mesh-ancestor
102442036|NCT01375140|Growth Inhibitors|growth inhibitors|mesh-ancestor
102442037|NCT01328171|Folic Acid|folic acid|mesh-list
102442038|NCT01328171|Vitamin B Complex|vitamin b complex|mesh-list
102442039|NCT01328171|Oxaliplatin|oxaliplatin|mesh-list
102442040|NCT01328171|Irinotecan|irinotecan|mesh-list
102442041|NCT01328171|Panitumumab|panitumumab|mesh-list
102442042|NCT01328171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102442043|NCT01328171|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102442044|NCT01328171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102442045|NCT01328171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102442046|NCT01328171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442047|NCT01328171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442048|NCT01328171|Hematinics|hematinics|mesh-ancestor
102442049|NCT01328171|Vitamins|vitamins|mesh-ancestor
102442050|NCT01328171|Micronutrients|micronutrients|mesh-ancestor
102442051|NCT01328171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102442052|NCT01288963|Aldesleukin|aldesleukin|mesh-list
102442053|NCT01288963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102442054|NCT01288963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102442055|NCT01288963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102442056|NCT01288963|Antiviral Agents|antiviral agents|mesh-ancestor
102442057|NCT01288963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102442058|NCT01269190|Proflavine|proflavine|mesh-list
102442059|NCT01269190|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102442060|NCT01269190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102442062|NCT01248715|Antiviral Agents|antiviral agents|mesh-ancestor
102442063|NCT01248715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102442064|NCT01248715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102442065|NCT01248715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442066|NCT00963040|Oxytocin|oxytocin|mesh-list
102442067|NCT00963040|Oxytocics|oxytocics|mesh-ancestor
102442068|NCT00963040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102442069|NCT00963040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442070|NCT00941109|Decitabine|decitabine|mesh-list
102442071|NCT00941109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102442072|NCT00941109|Antimetabolites|antimetabolites|mesh-ancestor
102442073|NCT00941109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442074|NCT00941109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102442075|NCT00941109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102442076|NCT00908050|Botulinum Toxins|botulinum toxins|mesh-list
102442077|NCT00908050|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102442078|NCT00908050|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102442079|NCT00908050|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102442080|NCT00908050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102442081|NCT00908050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442082|NCT00908050|Cholinergic Agents|cholinergic agents|mesh-ancestor
102442083|NCT00908050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102442084|NCT00908050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442085|NCT00908050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102442086|NCT00908050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102442087|NCT00812214|Eszopiclone|eszopiclone|mesh-list
102442088|NCT00812214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102442089|NCT00812214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102072492|NCT04221880|Lidocaine|lidocaine|mesh-list
102442090|NCT00812214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442091|NCT00658814|Azacitidine|azacitidine|mesh-list
102442092|NCT00658814|Gemtuzumab|gemtuzumab|mesh-list
102442093|NCT00658814|Calicheamicins|calicheamicins|mesh-list
102442094|NCT00658814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102442095|NCT00658814|Antimetabolites|antimetabolites|mesh-ancestor
102442096|NCT00658814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442097|NCT00658814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102442098|NCT00658814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102442099|NCT00658814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102442100|NCT00658814|Immunotoxins|immunotoxins|mesh-ancestor
102442101|NCT00658814|Immunoconjugates|immunoconjugates|mesh-ancestor
102442102|NCT00658814|Immunologic Factors|immunologic factors|mesh-ancestor
102442103|NCT00658814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442104|NCT00658814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102442105|NCT00601900|Tamoxifen|tamoxifen|mesh-list
102442106|NCT00601900|Bevacizumab|bevacizumab|mesh-list
102442107|NCT00601900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102442108|NCT00601900|Letrozole|letrozole|mesh-list
102442109|NCT00601900|Endothelial Growth Factors|endothelial growth factors|mesh-list
102442110|NCT00601900|Antibodies|antibodies|mesh-list
102442111|NCT00601900|Immunoglobulins|immunoglobulins|mesh-list
102442112|NCT00601900|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102442113|NCT00601900|Immunoglobulin G|immunoglobulin g|mesh-list
102442114|NCT00601900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102442115|NCT00601900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102442116|NCT00601900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102442117|NCT00601900|Growth Substances|growth substances|mesh-ancestor
102442118|NCT00601900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442119|NCT00601900|Growth Inhibitors|growth inhibitors|mesh-ancestor
102442120|NCT00601900|Immunologic Factors|immunologic factors|mesh-ancestor
102442121|NCT00601900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442122|NCT00601900|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102442123|NCT00601900|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102442124|NCT00601900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102442125|NCT00601900|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102442126|NCT00601900|Hormone Antagonists|hormone antagonists|mesh-ancestor
102442127|NCT00601900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102442128|NCT00601900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102442129|NCT00601900|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102442130|NCT00601900|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102442131|NCT00601900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102442132|NCT00444613|Vitamin B 12|vitamin b 12|mesh-list
102442133|NCT00444613|Vitamin B Complex|vitamin b complex|mesh-ancestor
102442134|NCT00444613|Vitamins|vitamins|mesh-ancestor
102442135|NCT00444613|Micronutrients|micronutrients|mesh-ancestor
102442136|NCT00444613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442138|NCT00217425|Cyclophosphamide|cyclophosphamide|mesh-list
102442139|NCT00217425|Bevacizumab|bevacizumab|mesh-list
102442140|NCT00217425|Doxorubicin|doxorubicin|mesh-list
102442141|NCT00217425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102442142|NCT00217425|Vincristine|vincristine|mesh-list
102442143|NCT00217425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102442144|NCT00217425|Immunologic Factors|immunologic factors|mesh-ancestor
102442145|NCT00217425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442146|NCT00217425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102442147|NCT00217425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102442148|NCT00217425|Alkylating Agents|alkylating agents|mesh-ancestor
102442149|NCT00217425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442150|NCT00217425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102442151|NCT00217425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102442152|NCT00217425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102442153|NCT00217425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102442154|NCT00217425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102442155|NCT00217425|Growth Substances|growth substances|mesh-ancestor
102442156|NCT00217425|Growth Inhibitors|growth inhibitors|mesh-ancestor
102442157|NCT00217425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102442158|NCT00217425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102442159|NCT00217425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102442160|NCT00217425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102442161|NCT00217425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102442162|NCT00217425|Glucocorticoids|glucocorticoids|mesh-ancestor
102442163|NCT00217425|Hormones|hormones|mesh-ancestor
102442164|NCT00217425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102442165|NCT00217425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102442166|NCT00217425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102442167|NCT00217425|Tubulin Modulators|tubulin modulators|mesh-ancestor
102442168|NCT00217425|Antimitotic Agents|antimitotic agents|mesh-ancestor
102442169|NCT00217425|Mitosis Modulators|mitosis modulators|mesh-ancestor
102442170|NCT00209599|Fospropofol|fospropofol|mesh-list
102442171|NCT00209599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102442172|NCT00209599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102442173|NCT00209599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442174|NCT00060567|Irinotecan|irinotecan|mesh-list
102442175|NCT00060567|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
102442176|NCT00060567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102442177|NCT00060567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102442178|NCT00060567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102442179|NCT00060567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442180|NCT00060567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102442181|NCT00060567|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102442182|NCT00049348|Gemcitabine|gemcitabine|mesh-list
102442183|NCT00049348|Fluorouracil|fluorouracil|mesh-list
102442184|NCT00049348|Epoetin Alfa|epoetin alfa|mesh-list
102442185|NCT00049348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102442186|NCT00049348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102442187|NCT00049348|Antimetabolites|antimetabolites|mesh-ancestor
102442188|NCT00049348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442189|NCT00049348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102442190|NCT00049348|Immunologic Factors|immunologic factors|mesh-ancestor
102442191|NCT00049348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442192|NCT00049348|Hematinics|hematinics|mesh-ancestor
102442193|NCT00004125|Tamoxifen|tamoxifen|mesh-list
102442194|NCT00004125|Paclitaxel|paclitaxel|mesh-list
102442195|NCT00004125|Docetaxel|docetaxel|mesh-list
102442196|NCT00004125|Cyclophosphamide|cyclophosphamide|mesh-list
102442197|NCT00004125|Doxorubicin|doxorubicin|mesh-list
102442198|NCT00004125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102442199|NCT00004125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102442200|NCT00004125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102442201|NCT00004125|Tubulin Modulators|tubulin modulators|mesh-ancestor
102442202|NCT00004125|Antimitotic Agents|antimitotic agents|mesh-ancestor
102442203|NCT00004125|Mitosis Modulators|mitosis modulators|mesh-ancestor
102442204|NCT00004125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442205|NCT00004125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102442206|NCT00004125|Immunologic Factors|immunologic factors|mesh-ancestor
102442207|NCT00004125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442208|NCT00004125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102442209|NCT00004125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102442210|NCT00004125|Alkylating Agents|alkylating agents|mesh-ancestor
102442211|NCT00004125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102442212|NCT00004125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102442213|NCT00004125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102442214|NCT00004125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102442215|NCT00004125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102442216|NCT00004125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102442217|NCT00004125|Hormone Antagonists|hormone antagonists|mesh-ancestor
102442218|NCT00004125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102442219|NCT00004125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102442220|NCT00004125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102442221|NCT00004125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102442222|NCT00004125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102442223|NCT00002981|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102442224|NCT00002981|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102442225|NCT00002981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442226|NCT03452865|Esomeprazole|esomeprazole|mesh-list
102442227|NCT03452865|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102442228|NCT03452865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102442229|NCT03452865|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102442230|NCT03452865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102442231|NCT03452865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442232|NCT03446001|Methylene Blue|methylene blue|mesh-list
102442233|NCT03446001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102442234|NCT03446001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442235|NCT03390296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102442236|NCT03390296|Avelumab|avelumab|mesh-list
102442237|NCT03390296|Gemtuzumab|gemtuzumab|mesh-list
102442238|NCT03390296|Azacitidine|azacitidine|mesh-list
102442239|NCT03390296|Venetoclax|venetoclax|mesh-list
102442240|NCT03390296|Calicheamicins|calicheamicins|mesh-list
102442241|NCT03390296|Antibodies|antibodies|mesh-list
102442242|NCT03390296|Immunoglobulins|immunoglobulins|mesh-list
102442243|NCT03390296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102442244|NCT03390296|Maleic acid|maleic acid|mesh-list
102442245|NCT03390296|Immunologic Factors|immunologic factors|mesh-ancestor
102442246|NCT03390296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442247|NCT03390296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102442248|NCT03390296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102442249|NCT03390296|Antimetabolites|antimetabolites|mesh-ancestor
102442250|NCT03390296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442251|NCT03390296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102442252|NCT03390296|Immunotoxins|immunotoxins|mesh-ancestor
102442253|NCT03390296|Immunoconjugates|immunoconjugates|mesh-ancestor
102442254|NCT03390296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102442255|NCT03345095|Temozolomide|temozolomide|mesh-list
102442256|NCT03345095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102442257|NCT03345095|Alkylating Agents|alkylating agents|mesh-ancestor
102442258|NCT03345095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442259|NCT03345095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102442260|NCT03315910|Nicotine|nicotine|mesh-list
102442261|NCT03315910|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102442262|NCT03315910|Autonomic Agents|autonomic agents|mesh-ancestor
102442263|NCT03315910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102442264|NCT03315910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442265|NCT03315910|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102442266|NCT03315910|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102442267|NCT03315910|Cholinergic Agents|cholinergic agents|mesh-ancestor
102442268|NCT03315910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102442269|NCT03315910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442270|NCT03248570|Pembrolizumab|pembrolizumab|mesh-list
102442271|NCT03248570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102442272|NCT03248570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102442273|NCT03248570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102442274|NCT03248570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442275|NCT03208231|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102442276|NCT03208231|Antiviral Agents|antiviral agents|mesh-ancestor
102442277|NCT03208231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102442278|NCT03198000|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102442279|NCT03198000|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102442280|NCT03152058|Certolizumab Pegol|certolizumab pegol|mesh-list
102442281|NCT03152058|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102442282|NCT03152058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102442283|NCT03152058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102442284|NCT03152058|Immunologic Factors|immunologic factors|mesh-ancestor
102442285|NCT03152058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442286|NCT03152058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102442287|NCT03113617|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
102442288|NCT03113617|Bombesin|bombesin|mesh-list
102442289|NCT03113617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442290|NCT03113617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102442291|NCT03113617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442292|NCT03113617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102442293|NCT03102242|Atezolizumab|atezolizumab|mesh-list
102442294|NCT03102242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102442295|NCT03102242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442296|NCT03102242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102442297|NCT03102242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102442298|NCT03090776|Ketamine|ketamine|mesh-list
102442299|NCT03090776|Analgesics|analgesics|mesh-ancestor
102442300|NCT03090776|Sensory System Agents|sensory system agents|mesh-ancestor
102442301|NCT03090776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102442302|NCT03090776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442303|NCT03090776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102442304|NCT03090776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102442305|NCT03090776|Anesthetics, General|anesthetics, general|mesh-ancestor
102442306|NCT03090776|Anesthetics|anesthetics|mesh-ancestor
102442307|NCT03090776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102442308|NCT03090776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102442309|NCT03090776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102442310|NCT03090776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102442311|NCT03090776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442312|NCT02994784|Melphalan|melphalan|mesh-list
102442313|NCT02994784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102442314|NCT02994784|Alkylating Agents|alkylating agents|mesh-ancestor
102442315|NCT02994784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442316|NCT02994784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102442317|NCT02994784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102442318|NCT02994784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102442319|NCT02994784|Immunologic Factors|immunologic factors|mesh-ancestor
102442320|NCT02994784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442321|NCT02966847|Anesthetics|anesthetics|mesh-list
102442322|NCT02966847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102442323|NCT02966847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442324|NCT02884440|Ropivacaine|ropivacaine|mesh-list
102442325|NCT02884440|Anesthetics|anesthetics|mesh-ancestor
102442326|NCT02884440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102442327|NCT02884440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442328|NCT02884440|Anesthetics, Local|anesthetics, local|mesh-ancestor
102442329|NCT02884440|Sensory System Agents|sensory system agents|mesh-ancestor
102442330|NCT02884440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102442331|NCT02851303|Morphine|morphine|mesh-list
102442332|NCT02851303|Methadone|methadone|mesh-list
102442333|NCT02851303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102442334|NCT02851303|Narcotics|narcotics|mesh-ancestor
102442335|NCT02851303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102442336|NCT02851303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442337|NCT02851303|Analgesics|analgesics|mesh-ancestor
102442338|NCT02851303|Sensory System Agents|sensory system agents|mesh-ancestor
102442339|NCT02851303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102442340|NCT02851303|Antitussive Agents|antitussive agents|mesh-ancestor
102442341|NCT02851303|Respiratory System Agents|respiratory system agents|mesh-ancestor
102442342|NCT02775500|Apremilast|apremilast|mesh-list
102442343|NCT02775500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102442344|NCT02775500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102442345|NCT02775500|Analgesics|analgesics|mesh-ancestor
102442346|NCT02775500|Sensory System Agents|sensory system agents|mesh-ancestor
102442347|NCT02775500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102442348|NCT02775500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442349|NCT02775500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102442350|NCT02775500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102442351|NCT02775500|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102442352|NCT02775500|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102442353|NCT02775500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102442354|NCT02775500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442355|NCT02689440|Venetoclax|venetoclax|mesh-list
102442356|NCT02689440|Dasatinib|dasatinib|mesh-list
102442357|NCT02689440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102254004|NCT04664361|Niacin|niacin|mesh-list
102442358|NCT02689440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102442359|NCT02689440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102442360|NCT02689440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442361|NCT02549170|Immunoglobulins|immunoglobulins|mesh-list
102442362|NCT02549170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102442363|NCT02549170|Antibodies|antibodies|mesh-list
102442364|NCT02549170|Immunoglobulin G|immunoglobulin g|mesh-list
102442365|NCT02549170|gamma-Globulins|gamma-globulins|mesh-list
102442366|NCT02549170|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102442367|NCT02549170|Immunologic Factors|immunologic factors|mesh-ancestor
102442368|NCT02549170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442369|NCT02476916|Mitapivat|mitapivat|mesh-list
102442370|NCT02476916|Enzyme Activators|enzyme activators|mesh-ancestor
102442371|NCT02476916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442372|NCT02384122|Octreotide|octreotide|mesh-list
102442373|NCT02384122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102442374|NCT02384122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102442375|NCT02384122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102442376|NCT02363335|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102442377|NCT02363335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102442378|NCT02363335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442379|NCT02363335|Incretins|incretins|mesh-ancestor
102442380|NCT02363335|Hormones|hormones|mesh-ancestor
102442381|NCT02363335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102442382|NCT02363335|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102442383|NCT02363335|Protease Inhibitors|protease inhibitors|mesh-ancestor
102442384|NCT02363335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102442385|NCT02363335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442386|NCT02271919|Nicotine|nicotine|mesh-list
102442387|NCT02271919|Varenicline|varenicline|mesh-list
102442388|NCT02271919|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102442389|NCT02271919|Autonomic Agents|autonomic agents|mesh-ancestor
102442390|NCT02271919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102442391|NCT02271919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442392|NCT02271919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102442393|NCT02271919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102442394|NCT02271919|Cholinergic Agents|cholinergic agents|mesh-ancestor
102442395|NCT02271919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102442396|NCT02271919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442397|NCT02103361|Ustekinumab|ustekinumab|mesh-list
102442398|NCT02103361|Dermatologic Agents|dermatologic agents|mesh-ancestor
102442399|NCT01918397|Levofloxacin|levofloxacin|mesh-list
102442400|NCT01918397|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102442401|NCT01918397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102442402|NCT01918397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102442403|NCT01918397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102442404|NCT01918397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102442405|NCT01918397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102442406|NCT01918397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442407|NCT01918397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102442408|NCT01918397|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102442409|NCT01918397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102442410|NCT01883024|Insulin|insulin|mesh-list
102442411|NCT01883024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102442412|NCT01883024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442413|NCT01611116|Sirolimus|sirolimus|mesh-list
102442414|NCT01611116|Temsirolimus|temsirolimus|mesh-list
102442415|NCT01611116|MTOR Inhibitors|mtor inhibitors|mesh-list
102442416|NCT01611116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102442417|NCT01611116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102442418|NCT01611116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442419|NCT01611116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102442420|NCT01611116|Immunologic Factors|immunologic factors|mesh-ancestor
102442421|NCT01611116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442422|NCT01611116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102442423|NCT01611116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102442424|NCT01611116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102442425|NCT01611116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102442426|NCT01611116|Antifungal Agents|antifungal agents|mesh-ancestor
102442427|NCT01576315|Itraconazole|itraconazole|mesh-list
102442428|NCT01576315|Voriconazole|voriconazole|mesh-list
102442429|NCT01576315|Antifungal Agents|antifungal agents|mesh-ancestor
102442430|NCT01576315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102442431|NCT01576315|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102442432|NCT01576315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102442433|NCT01576315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102442434|NCT01576315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442435|NCT01576315|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102442436|NCT01576315|Hormone Antagonists|hormone antagonists|mesh-ancestor
102442437|NCT01576315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102442438|NCT01576315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072858|NCT04450498|Vaccines|vaccines|mesh-list
102442439|NCT01576315|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102442440|NCT01388387|Tacrolimus|tacrolimus|mesh-list
102442441|NCT01388387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102442442|NCT01388387|Immunologic Factors|immunologic factors|mesh-ancestor
102442443|NCT01388387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442444|NCT01388387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102442445|NCT01388387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102442446|NCT01388387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442447|NCT01039090|Dopamine|dopamine|mesh-list
102442448|NCT01039090|Apomorphine|apomorphine|mesh-list
102442449|NCT01039090|Dopamine Agonists|dopamine agonists|mesh-list
102442450|NCT01039090|Emetics|emetics|mesh-ancestor
102442451|NCT01039090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442452|NCT01039090|Autonomic Agents|autonomic agents|mesh-ancestor
102442453|NCT01039090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102442454|NCT01039090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102442455|NCT01039090|Dopamine Agents|dopamine agents|mesh-ancestor
102442456|NCT01039090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102442457|NCT01039090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442458|NCT01039090|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102442459|NCT01039090|Sympathomimetics|sympathomimetics|mesh-ancestor
102442460|NCT01039090|Protective Agents|protective agents|mesh-ancestor
102442461|NCT00819637|Albuterol|albuterol|mesh-list
102442462|NCT00819637|Formoterol Fumarate|formoterol fumarate|mesh-list
102442463|NCT00819637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102442464|NCT00819637|Autonomic Agents|autonomic agents|mesh-ancestor
102442465|NCT00819637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102442466|NCT00819637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442467|NCT00819637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102442468|NCT00819637|Respiratory System Agents|respiratory system agents|mesh-ancestor
102442469|NCT00819637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102442470|NCT00819637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102442471|NCT00819637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102442472|NCT00819637|Adrenergic Agents|adrenergic agents|mesh-ancestor
102442473|NCT00819637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102442474|NCT00819637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442475|NCT00819637|Tocolytic Agents|tocolytic agents|mesh-ancestor
102442476|NCT00819637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102442477|NCT00593060|Sirolimus|sirolimus|mesh-list
102442478|NCT00593060|Cetuximab|cetuximab|mesh-list
102442479|NCT00593060|Temsirolimus|temsirolimus|mesh-list
102442480|NCT00593060|MTOR Inhibitors|mtor inhibitors|mesh-list
102442481|NCT00593060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102442482|NCT00593060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102442483|NCT00593060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102442484|NCT00593060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102442485|NCT00593060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442486|NCT00593060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102442487|NCT00593060|Immunologic Factors|immunologic factors|mesh-ancestor
102442488|NCT00593060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442489|NCT00593060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102442490|NCT00593060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102442491|NCT00593060|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102442492|NCT00593060|Antifungal Agents|antifungal agents|mesh-ancestor
102442493|NCT00287105|Imatinib Mesylate|imatinib mesylate|mesh-list
102442494|NCT00287105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102442495|NCT00287105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102442496|NCT00287105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102442497|NCT00287105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442498|NCT01332357|Fluticasone|fluticasone|mesh-list
102442499|NCT01332357|Xhance|xhance|mesh-list
102442500|NCT01332357|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102442501|NCT01332357|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102442502|NCT01332357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102442503|NCT01332357|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102442504|NCT01332357|Autonomic Agents|autonomic agents|mesh-ancestor
102442505|NCT01332357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102442506|NCT01332357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254159|NCT02093026|Vitamins|vitamins|mesh-ancestor
102442507|NCT01332357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102442508|NCT01332357|Respiratory System Agents|respiratory system agents|mesh-ancestor
102442509|NCT01332357|Dermatologic Agents|dermatologic agents|mesh-ancestor
102442510|NCT01332357|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102442511|NCT01332357|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102442512|NCT01332357|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102442513|NCT01332357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102442514|NCT01332357|Adrenergic Agents|adrenergic agents|mesh-ancestor
102442515|NCT01332357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102442516|NCT01332357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442517|NCT01332357|Glucocorticoids|glucocorticoids|mesh-ancestor
102442518|NCT01332357|Hormones|hormones|mesh-ancestor
102442519|NCT01332357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102442520|NCT01332357|Sympathomimetics|sympathomimetics|mesh-ancestor
102442521|NCT04914936|Rifampin|rifampin|mesh-list
102442522|NCT04914936|Acalabrutinib|acalabrutinib|mesh-list
102442523|NCT04914936|Omeprazole|omeprazole|mesh-list
102442524|NCT04914936|Calcium Carbonate|calcium carbonate|mesh-list
102442525|NCT04914936|Calcium|calcium|mesh-list
102442526|NCT04914936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102442527|NCT04914936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442528|NCT04914936|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102442529|NCT04914936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102442530|NCT04914936|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102442531|NCT04914936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102442532|NCT04914936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442533|NCT04914936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102442534|NCT04914936|Antitubercular Agents|antitubercular agents|mesh-ancestor
102442535|NCT04914936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102442536|NCT04914936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102442537|NCT04914936|Leprostatic Agents|leprostatic agents|mesh-ancestor
102442538|NCT04914936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102442539|NCT04914936|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102442540|NCT04914936|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102442541|NCT04914936|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102442542|NCT04914936|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102442543|NCT04914936|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102442544|NCT04914936|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102442545|NCT04914936|Antacids|antacids|mesh-ancestor
102442546|NCT04914936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102442547|NCT04914390|Paclitaxel|paclitaxel|mesh-list
102442548|NCT04914390|Tislelizumab|tislelizumab|mesh-list
102442549|NCT04914390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102442550|NCT04914390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102442551|NCT04914390|Tubulin Modulators|tubulin modulators|mesh-ancestor
102442552|NCT04914390|Antimitotic Agents|antimitotic agents|mesh-ancestor
102442553|NCT04914390|Mitosis Modulators|mitosis modulators|mesh-ancestor
102442554|NCT04914390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442555|NCT04914390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102442556|NCT03054948|SMOFlipid|smoflipid|mesh-list
102442557|NCT03054948|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102442558|NCT03054948|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102442559|NCT03054948|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102442560|NCT00986921|Mifepristone|mifepristone|mesh-list
102442561|NCT00986921|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102442562|NCT00986921|Abortifacient Agents|abortifacient agents|mesh-ancestor
102442563|NCT00986921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102442564|NCT00986921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442565|NCT00986921|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102442566|NCT00986921|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102442567|NCT00986921|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102442568|NCT00986921|Contraceptive Agents|contraceptive agents|mesh-ancestor
102442569|NCT00986921|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102442570|NCT00986921|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102442571|NCT00986921|Hormone Antagonists|hormone antagonists|mesh-ancestor
102442572|NCT00986921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102442573|NCT00986921|Luteolytic Agents|luteolytic agents|mesh-ancestor
102442574|NCT00986921|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102442575|NCT00986921|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102442576|NCT01383759|Dexamethasone|dexamethasone|mesh-list
102442577|NCT01383759|Dexamethasone acetate|dexamethasone acetate|mesh-list
102442578|NCT01383759|Bortezomib|bortezomib|mesh-list
102442579|NCT01383759|BB 1101|bb 1101|mesh-list
102254231|NCT02039908|Dopamine Agents|dopamine agents|mesh-ancestor
102442580|NCT01383759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102442581|NCT01383759|Antiemetics|antiemetics|mesh-ancestor
102442582|NCT01383759|Autonomic Agents|autonomic agents|mesh-ancestor
102442583|NCT01383759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102442584|NCT01383759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442585|NCT01383759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102442586|NCT01383759|Glucocorticoids|glucocorticoids|mesh-ancestor
102442587|NCT01383759|Hormones|hormones|mesh-ancestor
102442588|NCT01383759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102442589|NCT01383759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102442590|NCT01383759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102442591|NCT01383759|Protease Inhibitors|protease inhibitors|mesh-ancestor
102442592|NCT01383759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102442593|NCT01383759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442594|NCT01384539|Cholecalciferol|cholecalciferol|mesh-list
102442595|NCT01384539|Vitamin D|vitamin d|mesh-list
102442596|NCT01384539|Calcitriol|calcitriol|mesh-list
102442597|NCT01384539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102442598|NCT01384539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442599|NCT01384539|Vitamins|vitamins|mesh-ancestor
102442600|NCT01384539|Micronutrients|micronutrients|mesh-ancestor
102442601|NCT01384539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102442602|NCT01384539|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102442603|NCT01384539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102442604|NCT01384539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442605|NCT01384539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102442606|NCT04902222|Morphine|morphine|mesh-list
102442607|NCT04902222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102442608|NCT04902222|Narcotics|narcotics|mesh-ancestor
102442609|NCT04902222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102442610|NCT04902222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442611|NCT04902222|Analgesics|analgesics|mesh-ancestor
102442612|NCT04902222|Sensory System Agents|sensory system agents|mesh-ancestor
102442613|NCT04902222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102442614|NCT04904406|Lamivudine|lamivudine|mesh-list
102442615|NCT04904406|Abacavir|abacavir|mesh-list
102442616|NCT04904406|Dolutegravir|dolutegravir|mesh-list
102442617|NCT04904406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102442618|NCT04904406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102442619|NCT04904406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102442620|NCT04904406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442621|NCT04904406|Antiviral Agents|antiviral agents|mesh-ancestor
102442622|NCT04904406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102442623|NCT04904406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102442624|NCT04904406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102442625|NCT04904406|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102442626|NCT04904406|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102442627|NCT00985751|Vaccines|vaccines|mesh-list
102442628|NCT00985751|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102442629|NCT00985751|Immunologic Factors|immunologic factors|mesh-ancestor
102442630|NCT00985751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442631|NCT02429557|Midodrine|midodrine|mesh-list
102442632|NCT02429557|Sympathomimetics|sympathomimetics|mesh-ancestor
102442633|NCT02429557|Autonomic Agents|autonomic agents|mesh-ancestor
102073037|NCT02285972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102442634|NCT02429557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102442635|NCT02429557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442636|NCT02429557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102442637|NCT02429557|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102442638|NCT02429557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102442639|NCT02429557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102442640|NCT02429557|Adrenergic Agents|adrenergic agents|mesh-ancestor
102442641|NCT02429557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102442642|NCT02429557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442643|NCT03052140|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102442644|NCT03052140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102442645|NCT04884516|Vitamin A|vitamin a|mesh-list
102442646|NCT04884516|Vitamins|vitamins|mesh-ancestor
102442647|NCT04884516|Micronutrients|micronutrients|mesh-ancestor
102442648|NCT04884516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442649|NCT04884282|Docetaxel|docetaxel|mesh-list
102442650|NCT04884282|Nivolumab|nivolumab|mesh-list
102442651|NCT04884282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102442652|NCT04884282|Tubulin Modulators|tubulin modulators|mesh-ancestor
102442653|NCT04884282|Antimitotic Agents|antimitotic agents|mesh-ancestor
102442654|NCT04884282|Mitosis Modulators|mitosis modulators|mesh-ancestor
102442655|NCT04884282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442656|NCT04884282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102442657|NCT04884282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102442658|NCT04346329|Hydroxychloroquine|hydroxychloroquine|mesh-list
102442659|NCT04346329|Antimalarials|antimalarials|mesh-ancestor
102442660|NCT04346329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102442661|NCT04346329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102442662|NCT04346329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102442663|NCT04346329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102442664|NCT04346329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442665|NCT04346329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102442666|NCT02422381|Gemcitabine|gemcitabine|mesh-list
102442667|NCT02422381|Pembrolizumab|pembrolizumab|mesh-list
102442668|NCT02422381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102442669|NCT02422381|Antimetabolites|antimetabolites|mesh-ancestor
102442670|NCT02422381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442671|NCT02422381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102442672|NCT02422381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102442673|NCT02422381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102442674|NCT04883736|Tretinoin|tretinoin|mesh-list
102442675|NCT04883736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102442676|NCT04883736|Keratolytic Agents|keratolytic agents|mesh-ancestor
102442677|NCT04883736|Dermatologic Agents|dermatologic agents|mesh-ancestor
102442678|NCT02312557|Pembrolizumab|pembrolizumab|mesh-list
102442679|NCT02312557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102442680|NCT02312557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102442681|NCT02312557|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102442682|NCT02312557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442683|NCT01387815|Adalimumab|adalimumab|mesh-list
102442684|NCT01387815|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102442685|NCT01387815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102442686|NCT01387815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102442687|NCT04883034|Analgesics|analgesics|mesh-list
102442688|NCT04883034|Sensory System Agents|sensory system agents|mesh-ancestor
102442689|NCT04883034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102442690|NCT04883034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442691|NCT01596504|Metformin|metformin|mesh-list
102442692|NCT01596504|Insulin Glargine|insulin glargine|mesh-list
102442693|NCT01596504|Liraglutide|liraglutide|mesh-list
102442694|NCT01596504|Lixisenatide|lixisenatide|mesh-list
102442695|NCT01596504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102442696|NCT01596504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442697|NCT01596504|Incretins|incretins|mesh-ancestor
102442698|NCT01596504|Hormones|hormones|mesh-ancestor
102442699|NCT01596504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102442700|NCT02394769|Aspirin|aspirin|mesh-list
102442701|NCT02394769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102442702|NCT02394769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102442703|NCT02394769|Analgesics|analgesics|mesh-ancestor
102442704|NCT02394769|Sensory System Agents|sensory system agents|mesh-ancestor
102442705|NCT02394769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102073106|NCT02286206|Clozapine|clozapine|mesh-list
102442706|NCT02394769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442707|NCT02394769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102442708|NCT02394769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102442709|NCT02394769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102442710|NCT02394769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102442711|NCT02394769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442712|NCT02394769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102442713|NCT02394769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102442714|NCT02394769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102442715|NCT02394769|Antipyretics|antipyretics|mesh-ancestor
102442716|NCT01334229|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102442717|NCT01334229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102442718|NCT01334229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442719|NCT01334229|Incretins|incretins|mesh-ancestor
102442720|NCT01334229|Hormones|hormones|mesh-ancestor
102442721|NCT01334229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102442722|NCT01334229|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102442723|NCT01334229|Protease Inhibitors|protease inhibitors|mesh-ancestor
102442724|NCT01334229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102442725|NCT01334229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442726|NCT01390077|Nitisinone|nitisinone|mesh-list
102442727|NCT01390077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102442728|NCT01390077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442729|NCT02292979|Doxorubicin|doxorubicin|mesh-list
102442730|NCT02292979|Bleomycin|bleomycin|mesh-list
102442732|NCT02292979|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102442733|NCT02292979|Vinblastine|vinblastine|mesh-list
102442734|NCT02292979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102442735|NCT02292979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102442736|NCT02292979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102442737|NCT02292979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102442738|NCT02292979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102442739|NCT02292979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442740|NCT02292979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102442741|NCT02292979|Alkylating Agents|alkylating agents|mesh-ancestor
102442742|NCT02292979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102442743|NCT02292979|Immunotoxins|immunotoxins|mesh-ancestor
102442744|NCT02292979|Immunoconjugates|immunoconjugates|mesh-ancestor
102442745|NCT02292979|Immunologic Factors|immunologic factors|mesh-ancestor
102442746|NCT02292979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442747|NCT02292979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102442748|NCT02292979|Tubulin Modulators|tubulin modulators|mesh-ancestor
102442749|NCT02292979|Antimitotic Agents|antimitotic agents|mesh-ancestor
102442750|NCT02292979|Mitosis Modulators|mitosis modulators|mesh-ancestor
102442751|NCT02394535|Paclitaxel|paclitaxel|mesh-list
102442752|NCT02394535|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102442753|NCT02394535|Capecitabine|capecitabine|mesh-list
102442754|NCT02394535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102442755|NCT02394535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102442756|NCT02394535|Tubulin Modulators|tubulin modulators|mesh-ancestor
102442757|NCT02394535|Antimitotic Agents|antimitotic agents|mesh-ancestor
102442758|NCT02394535|Mitosis Modulators|mitosis modulators|mesh-ancestor
102442759|NCT02394535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442760|NCT02394535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102442761|NCT02394535|Antimetabolites|antimetabolites|mesh-ancestor
102442762|NCT02285959|Bevacizumab|bevacizumab|mesh-list
102442763|NCT02285959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102442764|NCT02285959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102442765|NCT02285959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102442766|NCT02285959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102442767|NCT02285959|Growth Substances|growth substances|mesh-ancestor
102442768|NCT02285959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442769|NCT02285959|Growth Inhibitors|growth inhibitors|mesh-ancestor
102442770|NCT01404429|Methotrexate|methotrexate|mesh-list
102442771|NCT01404429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102442772|NCT01404429|Abortifacient Agents|abortifacient agents|mesh-ancestor
102442773|NCT01404429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102442774|NCT01404429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442775|NCT01404429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102442776|NCT01404429|Antimetabolites|antimetabolites|mesh-ancestor
102442777|NCT01404429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442778|NCT01404429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102442779|NCT01404429|Dermatologic Agents|dermatologic agents|mesh-ancestor
102442780|NCT01404429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102442781|NCT01404429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102442782|NCT01404429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102442783|NCT01404429|Immunologic Factors|immunologic factors|mesh-ancestor
102442784|NCT01404429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102442785|NCT01404429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102442786|NCT03051906|Cetuximab|cetuximab|mesh-list
102442787|NCT03051906|Durvalumab|durvalumab|mesh-list
102442788|NCT03051906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102442789|NCT03051906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102442790|NCT01390233|Dinoprostone|dinoprostone|mesh-list
102442791|NCT01390233|Oxytocics|oxytocics|mesh-ancestor
102442792|NCT01390233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102442793|NCT01390233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442794|NCT03051360|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
102442795|NCT03051360|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102442796|NCT03051360|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102442797|NCT03051360|Antimetabolites|antimetabolites|mesh-ancestor
102442798|NCT03051360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442799|NCT03051360|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102442800|NCT03051360|Protease Inhibitors|protease inhibitors|mesh-ancestor
102442801|NCT03051360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102442802|NCT03051360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102442803|NCT05026567|Midazolam|midazolam|mesh-list
102442804|NCT05026567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102442805|NCT05026567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102442806|NCT05026567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102442807|NCT05026567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442808|NCT05026567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102442809|NCT05026567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102442810|NCT05026567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102442811|NCT05026567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102442812|NCT05026567|Anesthetics, General|anesthetics, general|mesh-ancestor
102442813|NCT05026567|Anesthetics|anesthetics|mesh-ancestor
102442814|NCT05026567|GABA Modulators|gaba modulators|mesh-ancestor
102442815|NCT05026567|GABA Agents|gaba agents|mesh-ancestor
102442816|NCT05026567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102442817|NCT05026567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442818|NCT01391013|Ritonavir|ritonavir|mesh-list
102442819|NCT01391013|Darunavir|darunavir|mesh-list
102442820|NCT01391013|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
102442821|NCT01391013|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102442822|NCT01391013|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102442823|NCT01391013|Protease Inhibitors|protease inhibitors|mesh-ancestor
102442824|NCT01391013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102442825|NCT01391013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442826|NCT01391013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102442827|NCT01391013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102442828|NCT01391013|Antiviral Agents|antiviral agents|mesh-ancestor
102442829|NCT01391013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102442830|NCT01391013|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102442831|NCT01391013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102442832|NCT01391013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102442833|NCT01891747|Bevacizumab|bevacizumab|mesh-list
102442834|NCT01891747|Temozolomide|temozolomide|mesh-list
102442835|NCT01891747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102442836|NCT01891747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102442837|NCT01891747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102442838|NCT01891747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102442839|NCT01891747|Growth Substances|growth substances|mesh-ancestor
102442840|NCT01891747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442841|NCT01891747|Growth Inhibitors|growth inhibitors|mesh-ancestor
102442842|NCT01891747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102442843|NCT01891747|Alkylating Agents|alkylating agents|mesh-ancestor
102442844|NCT01891747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442845|NCT04899570|Prednisone|prednisone|mesh-list
102442846|NCT04899570|Cyclophosphamide|cyclophosphamide|mesh-list
102442847|NCT04899570|Rituximab|rituximab|mesh-list
102442848|NCT04899570|Epirubicin|epirubicin|mesh-list
102442849|NCT04899570|Zanubrutinib|zanubrutinib|mesh-list
102442850|NCT04899570|Vindesine|vindesine|mesh-list
102442851|NCT04899570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102442852|NCT04899570|Immunologic Factors|immunologic factors|mesh-ancestor
102442853|NCT04899570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442854|NCT04899570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102442855|NCT04899570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102442856|NCT04899570|Alkylating Agents|alkylating agents|mesh-ancestor
102442857|NCT04899570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442858|NCT04899570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102442859|NCT04899570|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102442860|NCT04899570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102442861|NCT04899570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102442862|NCT04899570|Glucocorticoids|glucocorticoids|mesh-ancestor
102442863|NCT04899570|Hormones|hormones|mesh-ancestor
102442864|NCT04899570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102442865|NCT04899570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102442866|NCT04899570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102442867|NCT04899570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102442868|NCT04899570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102442869|NCT04899570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102442870|NCT04899570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102442871|NCT04899570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102442872|NCT04899570|Tubulin Modulators|tubulin modulators|mesh-ancestor
102442873|NCT04899570|Antimitotic Agents|antimitotic agents|mesh-ancestor
102442874|NCT04899570|Mitosis Modulators|mitosis modulators|mesh-ancestor
102442875|NCT02274415|Vaccines|vaccines|mesh-list
102442876|NCT02274415|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102442877|NCT02274415|Immunologic Factors|immunologic factors|mesh-ancestor
102442878|NCT02274415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442879|NCT03049878|Acetaminophen|acetaminophen|mesh-list
102254545|NCT02418533|Hormones|hormones|mesh-list
102442880|NCT03049878|Codeine|codeine|mesh-list
102442881|NCT03049878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102442882|NCT03049878|Analgesics|analgesics|mesh-ancestor
102442883|NCT03049878|Sensory System Agents|sensory system agents|mesh-ancestor
102442884|NCT03049878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102442885|NCT03049878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442886|NCT03049878|Antipyretics|antipyretics|mesh-ancestor
102442887|NCT03049878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102442888|NCT03049878|Narcotics|narcotics|mesh-ancestor
102442889|NCT03049878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102442890|NCT03049878|Antitussive Agents|antitussive agents|mesh-ancestor
102442891|NCT03049878|Respiratory System Agents|respiratory system agents|mesh-ancestor
102442892|NCT01391325|Allopurinol|allopurinol|mesh-list
102442893|NCT01391325|Antimetabolites|antimetabolites|mesh-ancestor
102442894|NCT01391325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442895|NCT01391325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102442896|NCT01391325|Gout Suppressants|gout suppressants|mesh-ancestor
102442897|NCT01391325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102442898|NCT01391325|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102442899|NCT01391325|Antioxidants|antioxidants|mesh-ancestor
102442900|NCT01391325|Protective Agents|protective agents|mesh-ancestor
102442901|NCT01391325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442902|NCT01976065|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102442903|NCT01976065|Metronidazole|metronidazole|mesh-list
102442904|NCT01976065|Ciprofloxacin|ciprofloxacin|mesh-list
102442905|NCT01976065|Minocycline|minocycline|mesh-list
102442906|NCT01976065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102442907|NCT01976065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102442908|NCT01976065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102442909|NCT01976065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102442910|NCT01976065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102442911|NCT01976065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102442912|NCT01976065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442913|NCT01976065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102442914|NCT01976065|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102442915|NCT01976065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102442916|NCT04891458|Dexmedetomidine|dexmedetomidine|mesh-list
102442917|NCT04891458|Anesthetics|anesthetics|mesh-list
102442918|NCT04891458|Propofol|propofol|mesh-list
102442919|NCT04891458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102442920|NCT04891458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442921|NCT04891458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102442922|NCT04891458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102442923|NCT04891458|Analgesics|analgesics|mesh-ancestor
102442924|NCT04891458|Sensory System Agents|sensory system agents|mesh-ancestor
102442925|NCT04891458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102442926|NCT04891458|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102442927|NCT04891458|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102442928|NCT04891458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102442929|NCT04891458|Adrenergic Agents|adrenergic agents|mesh-ancestor
102442930|NCT04891458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102442931|NCT04891458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442932|NCT04891458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102442933|NCT04891458|Anesthetics, General|anesthetics, general|mesh-ancestor
102442934|NCT04899414|Dexamethasone|dexamethasone|mesh-list
102442935|NCT04899414|Azacitidine|azacitidine|mesh-list
102442936|NCT04899414|Tislelizumab|tislelizumab|mesh-list
102442937|NCT04899414|Pegaspargase|pegaspargase|mesh-list
102442938|NCT04899414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102442939|NCT04899414|Antiemetics|antiemetics|mesh-ancestor
102442940|NCT04899414|Autonomic Agents|autonomic agents|mesh-ancestor
102442941|NCT04899414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102442942|NCT04899414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442943|NCT04899414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102442944|NCT04899414|Glucocorticoids|glucocorticoids|mesh-ancestor
102442945|NCT04899414|Hormones|hormones|mesh-ancestor
102442946|NCT04899414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102442947|NCT04899414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102442948|NCT04899414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102442949|NCT04899414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102442950|NCT04899414|Antimetabolites|antimetabolites|mesh-ancestor
102442951|NCT04899414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442952|NCT04899414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102442953|NCT04899414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102442954|NCT03008655|Tranexamic Acid|tranexamic acid|mesh-list
102442955|NCT03008655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102442956|NCT03008655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102442957|NCT03008655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442959|NCT03008655|Coagulants|coagulants|mesh-ancestor
102442960|NCT01894633|Chloroquine|chloroquine|mesh-list
102442961|NCT01894633|Amebicides|amebicides|mesh-ancestor
102442962|NCT01894633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102442963|NCT01894633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102442964|NCT01894633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102442965|NCT01894633|Antimalarials|antimalarials|mesh-ancestor
102442966|NCT01894633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102442967|NCT05585671|Belimumab|belimumab|mesh-list
102442968|NCT05585671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102442969|NCT05585671|Immunologic Factors|immunologic factors|mesh-ancestor
102442970|NCT05585671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442971|NCT01391559|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102442972|NCT01391559|Formoterol Fumarate|formoterol fumarate|mesh-list
102442973|NCT01391559|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102442974|NCT01391559|Autonomic Agents|autonomic agents|mesh-ancestor
102442975|NCT01391559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102442976|NCT01391559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442977|NCT01391559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102442978|NCT01391559|Respiratory System Agents|respiratory system agents|mesh-ancestor
102442979|NCT01391559|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102442980|NCT01391559|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102442981|NCT01391559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102442982|NCT01391559|Adrenergic Agents|adrenergic agents|mesh-ancestor
102442983|NCT01391559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102442984|NCT01391559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442985|NCT01335789|Oxytocin|oxytocin|mesh-list
102442986|NCT01335789|Oxytocics|oxytocics|mesh-ancestor
102442987|NCT01335789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102442988|NCT01335789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102442989|NCT02202135|Vancomycin|vancomycin|mesh-list
102442990|NCT02202135|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
102442991|NCT02202135|Aztreonam|aztreonam|mesh-list
102442992|NCT02202135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102442993|NCT02202135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102442994|NCT05585281|Fluzoparib|fluzoparib|mesh-list
102442995|NCT05585281|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102442996|NCT05585281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102442997|NCT05585281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102442998|NCT05585281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102442999|NCT01335867|Vigabatrin|vigabatrin|mesh-list
102443000|NCT01335867|Anticonvulsants|anticonvulsants|mesh-ancestor
102443001|NCT01335867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102443002|NCT01335867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443003|NCT01335867|GABA Agents|gaba agents|mesh-ancestor
102443004|NCT01335867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102443005|NCT01335867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443006|NCT01894711|Trastuzumab|trastuzumab|mesh-list
102443007|NCT01894711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102443008|NCT01894711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443009|NCT00985439|Celecoxib|celecoxib|mesh-list
102443010|NCT00985439|Diclofenac|diclofenac|mesh-list
102443011|NCT00985439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102443012|NCT00985439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102443013|NCT00985439|Analgesics|analgesics|mesh-ancestor
102443014|NCT00985439|Sensory System Agents|sensory system agents|mesh-ancestor
102443015|NCT00985439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102443016|NCT00985439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443017|NCT00985439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102443018|NCT00985439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102443019|NCT00985439|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102443020|NCT00985439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102443021|NCT00985439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102443022|NCT00985439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443023|NCT02984111|Epoetin Alfa|epoetin alfa|mesh-list
102443024|NCT02984111|Hematinics|hematinics|mesh-ancestor
102443025|NCT04412148|Triamcinolone|triamcinolone|mesh-list
102443026|NCT04412148|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102443027|NCT04412148|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102443028|NCT04412148|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102443029|NCT04412148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102443030|NCT04412148|Glucocorticoids|glucocorticoids|mesh-ancestor
102254684|NCT03177317|Dexamethasone|dexamethasone|mesh-list
102443031|NCT04412148|Hormones|hormones|mesh-ancestor
102443032|NCT04412148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102443033|NCT04412148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443034|NCT04412148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102443035|NCT04412148|Immunologic Factors|immunologic factors|mesh-ancestor
102443036|NCT04412148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102443037|NCT04412148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443038|NCT04890522|Gemcitabine|gemcitabine|mesh-list
102443039|NCT04890522|Fluorouracil|fluorouracil|mesh-list
102443040|NCT04890522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443041|NCT04890522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102443042|NCT04890522|Antimetabolites|antimetabolites|mesh-ancestor
102443043|NCT04890522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443044|NCT04890522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102443045|NCT04890522|Immunologic Factors|immunologic factors|mesh-ancestor
102443046|NCT04890522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443047|NCT01525069|Dexamethasone|dexamethasone|mesh-list
102443048|NCT01525069|Gemcitabine|gemcitabine|mesh-list
102443049|NCT01525069|Oxaliplatin|oxaliplatin|mesh-list
102443050|NCT01525069|Floxuridine|floxuridine|mesh-list
102443051|NCT01525069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102443052|NCT01525069|Antiemetics|antiemetics|mesh-ancestor
102443053|NCT01525069|Autonomic Agents|autonomic agents|mesh-ancestor
102443054|NCT01525069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102443055|NCT01525069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443056|NCT01525069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102443057|NCT01525069|Glucocorticoids|glucocorticoids|mesh-ancestor
102443058|NCT01525069|Hormones|hormones|mesh-ancestor
102443059|NCT01525069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102443060|NCT01525069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102443061|NCT01525069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443062|NCT01525069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102443063|NCT01525069|Antimetabolites|antimetabolites|mesh-ancestor
102443064|NCT01525069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443065|NCT04898946|Vaccines|vaccines|mesh-list
102443066|NCT04898946|Immunologic Factors|immunologic factors|mesh-ancestor
102443067|NCT04898946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443068|NCT02249065|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102443069|NCT02249065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102443070|NCT02249065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102443071|NCT02249065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102443072|NCT02249065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102443073|NCT02249065|Adrenergic Agents|adrenergic agents|mesh-ancestor
102443074|NCT02249065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102443075|NCT02249065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443076|NCT02249065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443077|NCT00983957|Moxifloxacin|moxifloxacin|mesh-list
102443078|NCT00983957|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102443079|NCT00983957|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102443080|NCT00983957|Contraceptive Agents|contraceptive agents|mesh-ancestor
102443081|NCT00983957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102443082|NCT00983957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443083|NCT00983957|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102443084|NCT00983957|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102443085|NCT00983957|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102443086|NCT00983957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102443087|NCT00983957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102443088|NCT00983957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102443089|NCT00983957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102443090|NCT00983957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102443091|NCT00983957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443092|NCT00983957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443093|NCT01894867|Magnesium Oxide|magnesium oxide|mesh-list
102443094|NCT01894867|Antacids|antacids|mesh-ancestor
102443095|NCT01894867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443096|NCT01894867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102443097|NCT01521403|Metronidazole|metronidazole|mesh-list
102443098|NCT01521403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102443099|NCT01521403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102443100|NCT01521403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102443101|NCT01521403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102443102|NCT04881942|Menthol|menthol|mesh-list
102443103|NCT04881942|Nicotine|nicotine|mesh-list
102443104|NCT04881942|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102443105|NCT04881942|Autonomic Agents|autonomic agents|mesh-ancestor
102443106|NCT04881942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102443107|NCT04881942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443108|NCT04881942|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102443109|NCT04881942|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102443110|NCT04881942|Cholinergic Agents|cholinergic agents|mesh-ancestor
102443111|NCT04881942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102443112|NCT04881942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443113|NCT04881942|Antipruritics|antipruritics|mesh-ancestor
102443114|NCT04881942|Dermatologic Agents|dermatologic agents|mesh-ancestor
102443115|NCT04882020|Hydrocortisone|hydrocortisone|mesh-list
102443116|NCT04882020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102443117|NCT04126811|Apatinib|apatinib|mesh-list
102443118|NCT04126811|Ifosfamide|ifosfamide|mesh-list
102443119|NCT04126811|Isophosphamide mustard|isophosphamide mustard|mesh-list
102443120|NCT04126811|Pirarubicin|pirarubicin|mesh-list
102443121|NCT04126811|Doxorubicin|doxorubicin|mesh-list
102443122|NCT04126811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443123|NCT04126811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102443124|NCT04126811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102443125|NCT04126811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443126|NCT04126811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102443127|NCT04126811|Alkylating Agents|alkylating agents|mesh-ancestor
102443128|NCT04126811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102443129|NCT04126811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102443130|NCT04126811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102443131|NCT01406223|Bupropion|bupropion|mesh-list
102443132|NCT01406223|Nicotine|nicotine|mesh-list
102443133|NCT01406223|Varenicline|varenicline|mesh-list
102443134|NCT01406223|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102443135|NCT01406223|Autonomic Agents|autonomic agents|mesh-ancestor
102443136|NCT01406223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102443137|NCT01406223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443138|NCT01406223|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102443139|NCT01406223|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102443140|NCT01406223|Cholinergic Agents|cholinergic agents|mesh-ancestor
102443141|NCT01406223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102443142|NCT01406223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443143|NCT01406223|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102443144|NCT01406223|Antidepressive Agents|antidepressive agents|mesh-ancestor
102443145|NCT01406223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102443146|NCT01406223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102443147|NCT01406223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102443148|NCT01406223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102443149|NCT01406223|Dopamine Agents|dopamine agents|mesh-ancestor
102443150|NCT01406223|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102443151|NCT01406223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102443152|NCT01406223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102443153|NCT02230969|Interferons|interferons|mesh-list
102443154|NCT02230969|Interferon-beta|interferon-beta|mesh-list
102443155|NCT02230969|Interferon beta-1a|interferon beta-1a|mesh-list
102443156|NCT02230969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443157|NCT02230969|Antiviral Agents|antiviral agents|mesh-ancestor
102443158|NCT02230969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102443159|NCT02230969|Immunologic Factors|immunologic factors|mesh-ancestor
102443160|NCT02230969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443161|NCT02230969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102443162|NCT04881474|Ibuprofen|ibuprofen|mesh-list
102443163|NCT04881474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102443164|NCT04881474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102443165|NCT04881474|Analgesics|analgesics|mesh-ancestor
102443166|NCT04881474|Sensory System Agents|sensory system agents|mesh-ancestor
102443167|NCT04881474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102443168|NCT04881474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443169|NCT04881474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102443170|NCT04881474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102443171|NCT04881474|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102443172|NCT04881474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102443173|NCT04881474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443174|NCT00981149|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102443175|NCT00981149|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102443176|NCT00981149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102443177|NCT00981149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102443178|NCT00981149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443179|NCT00981149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102443180|NCT00981149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443181|NCT00981149|Analgesics|analgesics|mesh-ancestor
102443182|NCT00981149|Sensory System Agents|sensory system agents|mesh-ancestor
102443183|NCT00981149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102443184|NCT00981149|Antidepressive Agents|antidepressive agents|mesh-ancestor
102443185|NCT00981149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102443186|NCT00981149|Dopamine Agents|dopamine agents|mesh-ancestor
102443187|NCT04881006|Dapagliflozin|dapagliflozin|mesh-list
102443188|NCT04881006|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102443189|NCT04881006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443190|NCT04881006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102443191|NCT04881006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443192|NCT01595646|Insulin|insulin|mesh-list
102443193|NCT01595646|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102443194|NCT01595646|Insulin Detemir|insulin detemir|mesh-list
102443195|NCT01595646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102443196|NCT01595646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443197|NCT01907191|Bupivacaine|bupivacaine|mesh-list
102443198|NCT01907191|Anesthetics, Local|anesthetics, local|mesh-ancestor
102443199|NCT01907191|Anesthetics|anesthetics|mesh-ancestor
102443200|NCT01907191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102443201|NCT01907191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443202|NCT01907191|Sensory System Agents|sensory system agents|mesh-ancestor
102443203|NCT01907191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102443204|NCT01395537|Paclitaxel|paclitaxel|mesh-list
102443205|NCT01395537|Carboplatin|carboplatin|mesh-list
102443206|NCT01395537|Lapatinib|lapatinib|mesh-list
102073632|NCT02788773|Tremelimumab|tremelimumab|mesh-list
102443207|NCT01395537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102443208|NCT01395537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443209|NCT01395537|Tubulin Modulators|tubulin modulators|mesh-ancestor
102443210|NCT01395537|Antimitotic Agents|antimitotic agents|mesh-ancestor
102443211|NCT01395537|Mitosis Modulators|mitosis modulators|mesh-ancestor
102443212|NCT01395537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443213|NCT01395537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102443214|NCT01395537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102443215|NCT04898712|Tranexamic Acid|tranexamic acid|mesh-list
102073682|NCT04385667|Levonorgestrel|levonorgestrel|mesh-list
102443216|NCT04898712|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102443217|NCT04898712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102443218|NCT04898712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443219|NCT04898712|Hemostatics|hemostatics|mesh-ancestor
102443220|NCT04898712|Coagulants|coagulants|mesh-ancestor
102443221|NCT04898556|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
102443222|NCT04898556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102443223|NCT04898556|Immunologic Factors|immunologic factors|mesh-ancestor
102443224|NCT04898556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443225|NCT02317549|Tranexamic Acid|tranexamic acid|mesh-list
102443226|NCT02317549|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102443227|NCT02317549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102443228|NCT02317549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443229|NCT02317549|Hemostatics|hemostatics|mesh-ancestor
102443230|NCT02317549|Coagulants|coagulants|mesh-ancestor
102443231|NCT05583643|Calcium, Dietary|calcium, dietary|mesh-list
102443232|NCT05583643|Atorvastatin|atorvastatin|mesh-list
102443233|NCT05583643|Calcium|calcium|mesh-list
102443234|NCT05583643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102443235|NCT05583643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443236|NCT05583643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102443237|NCT05583643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102443238|NCT05583643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102443239|NCT05583643|Antimetabolites|antimetabolites|mesh-ancestor
102443240|NCT05583643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443241|NCT05583643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102443242|NCT05583643|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102443243|NCT05583643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102073699|NCT04441424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102443244|NCT02225275|Lenalidomide|lenalidomide|mesh-list
102443245|NCT02225275|Obinutuzumab|obinutuzumab|mesh-list
102443246|NCT02225275|Immunologic Factors|immunologic factors|mesh-ancestor
102443247|NCT02225275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443248|NCT02225275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102443249|NCT02225275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102443250|NCT02225275|Growth Substances|growth substances|mesh-ancestor
102443251|NCT02225275|Growth Inhibitors|growth inhibitors|mesh-ancestor
102443252|NCT02225275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443253|NCT02225275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102443254|NCT01897441|Paclitaxel|paclitaxel|mesh-list
102443255|NCT01897441|Cyclophosphamide|cyclophosphamide|mesh-list
102443256|NCT01897441|Doxorubicin|doxorubicin|mesh-list
102443257|NCT01897441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102443258|NCT01897441|Trastuzumab|trastuzumab|mesh-list
102443259|NCT01897441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102443260|NCT01897441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102443262|NCT01897441|Immunoglobulins|immunoglobulins|mesh-list
102443263|NCT01897441|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102443264|NCT01897441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102443265|NCT01897441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443266|NCT01897441|Tubulin Modulators|tubulin modulators|mesh-ancestor
102443267|NCT01897441|Antimitotic Agents|antimitotic agents|mesh-ancestor
102443268|NCT01897441|Mitosis Modulators|mitosis modulators|mesh-ancestor
102443269|NCT01897441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443270|NCT01897441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102443271|NCT01897441|Immunologic Factors|immunologic factors|mesh-ancestor
102443272|NCT01897441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443273|NCT01897441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102443274|NCT01897441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102443275|NCT01897441|Alkylating Agents|alkylating agents|mesh-ancestor
102443276|NCT01897441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102443277|NCT01897441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102443278|NCT01897441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102443279|NCT01897441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102443280|NCT01897441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102443281|NCT01411137|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102443282|NCT01411137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102443283|NCT01411137|Immunologic Factors|immunologic factors|mesh-ancestor
102443284|NCT01411137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443285|NCT01411137|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102443286|NCT01411137|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102443287|NCT01411137|Dopamine Agonists|dopamine agonists|mesh-ancestor
102443288|NCT01411137|Dopamine Agents|dopamine agents|mesh-ancestor
102443289|NCT01411137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102443290|NCT01411137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443291|NCT04430556|Sertraline|sertraline|mesh-list
102443292|NCT04430556|Antidepressive Agents|antidepressive agents|mesh-ancestor
102443293|NCT04430556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102443294|NCT04430556|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101482043|NCT00302822|Lopinavir|lopinavir|mesh-list
102443295|NCT04430556|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102443296|NCT04430556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102443297|NCT04430556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443298|NCT04430556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102443299|NCT04430556|Serotonin Agents|serotonin agents|mesh-ancestor
102443300|NCT04430556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443301|NCT04897854|Folfirinox|folfirinox|mesh-list
102443302|NCT04897854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443303|NCT01892527|Cetuximab|cetuximab|mesh-list
102443304|NCT01892527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102443305|NCT01892527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443306|NCT01399827|Methylphenidate|methylphenidate|mesh-list
102443307|NCT01399827|Amphetamine|amphetamine|mesh-list
102443308|NCT01399827|Adderall|adderall|mesh-list
102443309|NCT01399827|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
102443310|NCT01399827|Dextroamphetamine|dextroamphetamine|mesh-list
102443311|NCT01399827|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102443312|NCT01399827|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102443313|NCT01399827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443314|NCT01399827|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102443315|NCT01399827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102443316|NCT01399827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102443317|NCT01399827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443318|NCT01399827|Dopamine Agents|dopamine agents|mesh-ancestor
102443319|NCT01399827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102443320|NCT01399827|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102443321|NCT01399827|Adrenergic Agents|adrenergic agents|mesh-ancestor
102443322|NCT01399827|Sympathomimetics|sympathomimetics|mesh-ancestor
102443323|NCT01399827|Autonomic Agents|autonomic agents|mesh-ancestor
102443324|NCT01399827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102443325|NCT04897386|Pemetrexed|pemetrexed|mesh-list
102443326|NCT04897386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443327|NCT04897386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102443328|NCT04897386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255021|NCT05488899|Iodine|iodine|mesh-list
102443329|NCT04897386|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102443330|NCT04897386|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102443332|NCT04879446|Mitosis Modulators|mitosis modulators|mesh-ancestor
102443333|NCT04879446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443334|NCT02618382|Tranexamic Acid|tranexamic acid|mesh-list
102443335|NCT02618382|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102443336|NCT02618382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102073799|NCT02104128|Antidepressive Agents|antidepressive agents|mesh-ancestor
102443337|NCT02618382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443338|NCT02618382|Hemostatics|hemostatics|mesh-ancestor
102443339|NCT02618382|Coagulants|coagulants|mesh-ancestor
102443340|NCT02196961|Nivolumab|nivolumab|mesh-list
102443341|NCT02196961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102443342|NCT02196961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102073810|NCT02104128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102443343|NCT02196961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102443344|NCT02196961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443345|NCT02177071|Infliximab|infliximab|mesh-list
102443346|NCT02177071|Methotrexate|methotrexate|mesh-list
102443347|NCT02177071|Mercaptopurine|mercaptopurine|mesh-list
102443348|NCT02177071|Azathioprine|azathioprine|mesh-list
102443349|NCT02177071|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102443350|NCT02177071|Abortifacient Agents|abortifacient agents|mesh-ancestor
102443351|NCT02177071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102443352|NCT02177071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073812|NCT00004916|Ifosfamide|ifosfamide|mesh-list
102443353|NCT02177071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102443354|NCT02177071|Antimetabolites|antimetabolites|mesh-ancestor
102443355|NCT02177071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443356|NCT02177071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443357|NCT02177071|Dermatologic Agents|dermatologic agents|mesh-ancestor
102443358|NCT02177071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102443359|NCT02177071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102443360|NCT02177071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102443361|NCT02177071|Immunologic Factors|immunologic factors|mesh-ancestor
102443362|NCT02177071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102073825|NCT02101632|Petrolatum|petrolatum|mesh-list
102443363|NCT02177071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102443364|NCT02177071|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102443365|NCT02177071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102443366|NCT02177071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102443367|NCT04889196|Fluorides|fluorides|mesh-list
102443368|NCT04889196|Cariostatic Agents|cariostatic agents|mesh-ancestor
102443369|NCT04889196|Protective Agents|protective agents|mesh-ancestor
102073830|NCT02101710|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
102073831|NCT02101710|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102443370|NCT04889196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443371|NCT03049176|Tenofovir|tenofovir|mesh-list
102443372|NCT03049176|Emtricitabine|emtricitabine|mesh-list
102443373|NCT03049176|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102443374|NCT03049176|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102443375|NCT03049176|Antiviral Agents|antiviral agents|mesh-ancestor
102443376|NCT03049176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102443377|NCT03049176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102443378|NCT03049176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102443379|NCT03049176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102443380|NCT03049176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443381|NCT03049176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102443382|NCT01895023|Midazolam|midazolam|mesh-list
102443383|NCT01895023|Dexmedetomidine|dexmedetomidine|mesh-list
102443384|NCT01895023|GABA Modulators|gaba modulators|mesh-list
102443385|NCT01895023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102443386|NCT01895023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102443387|NCT01895023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443388|NCT01895023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102443389|NCT01895023|Analgesics|analgesics|mesh-ancestor
102443390|NCT01895023|Sensory System Agents|sensory system agents|mesh-ancestor
102443391|NCT01895023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102443392|NCT01895023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102443393|NCT01895023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102443394|NCT01895023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102443395|NCT01895023|Adrenergic Agents|adrenergic agents|mesh-ancestor
102443396|NCT01895023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102443397|NCT01895023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443398|NCT01895023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102443399|NCT01895023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102443400|NCT01895023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102443401|NCT01895023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102443402|NCT01895023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102443404|NCT01895023|Anesthetics|anesthetics|mesh-ancestor
102443405|NCT01895023|GABA Agents|gaba agents|mesh-ancestor
102443406|NCT04888728|Nebivolol|nebivolol|mesh-list
102443407|NCT04888728|Paroxetine|paroxetine|mesh-list
102443408|NCT04888728|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102443409|NCT04888728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102443410|NCT04888728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102443411|NCT04888728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443412|NCT04888728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102443413|NCT04888728|Serotonin Agents|serotonin agents|mesh-ancestor
102443414|NCT04888728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443415|NCT04888728|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102443416|NCT04888728|Antidepressive Agents|antidepressive agents|mesh-ancestor
102443417|NCT04888728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102443418|NCT04888728|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102443419|NCT04888728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102443420|NCT04888728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102073875|NCT00337532|Paclitaxel|paclitaxel|mesh-list
102443421|NCT04888728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102443422|NCT04888728|Vasodilator Agents|vasodilator agents|mesh-ancestor
102443423|NCT04888728|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102443424|NCT04888728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102443425|NCT04888728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102443426|NCT04888728|Adrenergic Agents|adrenergic agents|mesh-ancestor
102443427|NCT04125719|Nivolumab|nivolumab|mesh-list
102443428|NCT04125719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102443429|NCT04125719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443430|NCT04125719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102443431|NCT04125719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443432|NCT01428973|Mycophenolic Acid|mycophenolic acid|mesh-list
102443433|NCT01428973|Sirolimus|sirolimus|mesh-list
102443434|NCT01428973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102443435|NCT01428973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443436|NCT01428973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102443437|NCT01428973|Antitubercular Agents|antitubercular agents|mesh-ancestor
102443438|NCT01428973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102443439|NCT01428973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102443440|NCT01428973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102443441|NCT01428973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443442|NCT01428973|Antifungal Agents|antifungal agents|mesh-ancestor
102443443|NCT01428973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102443444|NCT01428973|Immunologic Factors|immunologic factors|mesh-ancestor
102443445|NCT01428973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073899|NCT02361801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102443446|NCT01421797|Dexamethasone|dexamethasone|mesh-list
102443447|NCT01421797|Cosyntropin|cosyntropin|mesh-list
102443448|NCT01421797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102443449|NCT01421797|Antiemetics|antiemetics|mesh-ancestor
102443450|NCT01421797|Autonomic Agents|autonomic agents|mesh-ancestor
102443451|NCT01421797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102443452|NCT01421797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443453|NCT01421797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102443454|NCT01421797|Glucocorticoids|glucocorticoids|mesh-ancestor
102443455|NCT01421797|Hormones|hormones|mesh-ancestor
102443456|NCT01421797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102443457|NCT01421797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102443458|NCT01421797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443459|NCT01475643|Loteprednol Etabonate|loteprednol etabonate|mesh-list
102443460|NCT01475643|Prednisolone|prednisolone|mesh-list
102443461|NCT01475643|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102443462|NCT01475643|Methylprednisolone|methylprednisolone|mesh-list
102443463|NCT01475643|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102443464|NCT01475643|Prednisolone acetate|prednisolone acetate|mesh-list
102443465|NCT01475643|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102443466|NCT01475643|Prednisolone phosphate|prednisolone phosphate|mesh-list
102443467|NCT01475643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102443468|NCT01475643|Glucocorticoids|glucocorticoids|mesh-ancestor
102443469|NCT01475643|Hormones|hormones|mesh-ancestor
102443470|NCT01475643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102443471|NCT01475643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443472|NCT01475643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102443473|NCT01475643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443474|NCT01475643|Antiemetics|antiemetics|mesh-ancestor
102443475|NCT01475643|Autonomic Agents|autonomic agents|mesh-ancestor
102443476|NCT01475643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102443477|NCT01475643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102443478|NCT01475643|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102443479|NCT01475643|Protective Agents|protective agents|mesh-ancestor
102443480|NCT01475643|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102443481|NCT01846663|Rifaximin|rifaximin|mesh-list
102443482|NCT01846663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102443483|NCT01846663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102443484|NCT01846663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102443485|NCT03004001|Atorvastatin|atorvastatin|mesh-list
102443486|NCT03004001|Alirocumab|alirocumab|mesh-list
102443487|NCT03004001|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102443488|NCT03004001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102443489|NCT03004001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102443490|NCT03004001|Antimetabolites|antimetabolites|mesh-ancestor
102443491|NCT03004001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443492|NCT03004001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102443493|NCT03004001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102443494|NCT03004001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102443495|NCT03004001|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102443496|NCT03004001|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102443497|NCT03004001|Protease Inhibitors|protease inhibitors|mesh-ancestor
102443498|NCT03004001|Immunologic Factors|immunologic factors|mesh-ancestor
102443499|NCT03004001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443500|NCT04395222|Fludarabine|fludarabine|mesh-list
102443501|NCT04395222|Melphalan|melphalan|mesh-list
102443502|NCT04395222|Thymoglobulin|thymoglobulin|mesh-list
102443503|NCT04395222|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102443504|NCT04395222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443505|NCT04395222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443506|NCT04395222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102443507|NCT04395222|Immunologic Factors|immunologic factors|mesh-ancestor
102443508|NCT04395222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443509|NCT04395222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102443510|NCT04395222|Alkylating Agents|alkylating agents|mesh-ancestor
102443511|NCT04395222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102443512|NCT04124003|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102443513|NCT04124003|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102443514|NCT04124003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102443515|NCT04124003|Antimetabolites|antimetabolites|mesh-ancestor
102443516|NCT04124003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443517|NCT04124003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102443518|NCT04124003|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102443519|NCT04124003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102443520|NCT03237377|Durvalumab|durvalumab|mesh-list
102443521|NCT03237377|Tremelimumab|tremelimumab|mesh-list
102443522|NCT03237377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102443523|NCT03237377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443524|NCT04124081|Entecavir|entecavir|mesh-list
102443525|NCT04124081|Antiviral Agents|antiviral agents|mesh-ancestor
102073963|NCT00004898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102443526|NCT04124081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102443527|NCT04123925|Nivolumab|nivolumab|mesh-list
102443528|NCT04123925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102443529|NCT04123925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443530|NCT04123925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102443531|NCT04123925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443532|NCT04759079|Antiemetics|antiemetics|mesh-list
102443533|NCT04759079|Autonomic Agents|autonomic agents|mesh-ancestor
102443534|NCT04759079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102443535|NCT04759079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443536|NCT04759079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102443537|NCT03048942|Paclitaxel|paclitaxel|mesh-list
102443538|NCT03048942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102443539|NCT03048942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443540|NCT03048942|Tubulin Modulators|tubulin modulators|mesh-ancestor
102443541|NCT03048942|Antimitotic Agents|antimitotic agents|mesh-ancestor
102443542|NCT03048942|Mitosis Modulators|mitosis modulators|mesh-ancestor
102073978|NCT00325364|Insulin|insulin|mesh-list
102443543|NCT03048942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443544|NCT04393025|Clopidogrel|clopidogrel|mesh-list
102443545|NCT04393025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443546|NCT04393025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443547|NCT04393025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102443548|NCT04393025|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102443549|NCT04393025|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102443550|NCT04393025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102443551|NCT04393025|Purinergic Agents|purinergic agents|mesh-ancestor
102443552|NCT04393025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102443553|NCT01419067|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102443554|NCT01419067|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102443555|NCT01419067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443557|NCT05580445|Conteltinib|conteltinib|mesh-list
101375675|NCT00234871|Verapamil|verapamil|mesh-list
102443558|NCT05580445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102443559|NCT05580445|Antimetabolites|antimetabolites|mesh-ancestor
101386323|NCT00310141|Autonomic Agents|autonomic agents|mesh-ancestor
102443560|NCT05580445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443561|NCT05580445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443562|NCT05580445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102443563|NCT05580445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102443564|NCT05257902|Choline|choline|mesh-list
102443565|NCT05257902|Lipotropic Agents|lipotropic agents|mesh-ancestor
102443566|NCT05257902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102443567|NCT05257902|Antimetabolites|antimetabolites|mesh-ancestor
102443568|NCT05257902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443569|NCT05257902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102443570|NCT05257902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102443571|NCT05257902|Nootropic Agents|nootropic agents|mesh-ancestor
102443572|NCT02143219|Leucovorin|leucovorin|mesh-list
102443573|NCT02143219|Folic Acid|folic acid|mesh-list
102443574|NCT02143219|Irinotecan|irinotecan|mesh-list
102443575|NCT02143219|Oxaliplatin|oxaliplatin|mesh-list
102443576|NCT02143219|Levoleucovorin|levoleucovorin|mesh-list
102443577|NCT02143219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102443578|NCT02143219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102443579|NCT02143219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102443580|NCT02143219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443581|NCT02143219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443582|NCT02143219|Antidotes|antidotes|mesh-ancestor
102443583|NCT02143219|Protective Agents|protective agents|mesh-ancestor
102443584|NCT02143219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443585|NCT02143219|Vitamin B Complex|vitamin b complex|mesh-ancestor
102443586|NCT02143219|Vitamins|vitamins|mesh-ancestor
102443587|NCT02143219|Micronutrients|micronutrients|mesh-ancestor
102443588|NCT02143219|Hematinics|hematinics|mesh-ancestor
102443589|NCT04122911|Temozolomide|temozolomide|mesh-list
102443590|NCT04122911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102443591|NCT04122911|Alkylating Agents|alkylating agents|mesh-ancestor
102443592|NCT04122911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443593|NCT04122911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443594|NCT04122599|Melatonin|melatonin|mesh-list
102443595|NCT04122599|Antioxidants|antioxidants|mesh-ancestor
102443596|NCT04122599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443597|NCT04122599|Protective Agents|protective agents|mesh-ancestor
102443598|NCT04122599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443599|NCT04122599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102443600|NCT01475955|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102443601|NCT01475955|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102443602|NCT01475955|Dermatologic Agents|dermatologic agents|mesh-ancestor
102443603|NCT03048474|Nivolumab|nivolumab|mesh-list
102443604|NCT03048474|Ipilimumab|ipilimumab|mesh-list
102443605|NCT03048474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102443606|NCT03048474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443607|NCT03048474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102443608|NCT03048474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443609|NCT04121975|Endostar protein|endostar protein|mesh-list
102443610|NCT04121975|Endostatins|endostatins|mesh-list
102074040|NCT00004166|Amifostine|amifostine|mesh-list
102443611|NCT04121975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443612|NCT04121975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102443613|NCT04121975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102443614|NCT04121975|Growth Substances|growth substances|mesh-ancestor
102443615|NCT04121975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443616|NCT04121975|Growth Inhibitors|growth inhibitors|mesh-ancestor
102443617|NCT02139319|Botulinum Toxins|botulinum toxins|mesh-list
102443618|NCT02139319|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102443619|NCT02139319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102443620|NCT02139319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443621|NCT02139319|Cholinergic Agents|cholinergic agents|mesh-ancestor
102443622|NCT02139319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102443623|NCT02139319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443624|NCT03830957|Metoprolol|metoprolol|mesh-list
102443625|NCT03830957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102443626|NCT03830957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102443627|NCT03830957|Sympatholytics|sympatholytics|mesh-ancestor
102443628|NCT03830957|Autonomic Agents|autonomic agents|mesh-ancestor
102443629|NCT03830957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102443630|NCT03830957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443631|NCT03830957|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102443632|NCT03830957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102443633|NCT03830957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102443634|NCT03830957|Adrenergic Agents|adrenergic agents|mesh-ancestor
102443635|NCT03830957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102074059|NCT00002240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102443636|NCT03830957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443637|NCT04121819|Cytarabine|cytarabine|mesh-list
102443638|NCT04121819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102443639|NCT04121819|Antimetabolites|antimetabolites|mesh-ancestor
102443640|NCT04121819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443641|NCT04121819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443642|NCT04121819|Antiviral Agents|antiviral agents|mesh-ancestor
102443643|NCT04121819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102443644|NCT04121819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102443645|NCT04121819|Immunologic Factors|immunologic factors|mesh-ancestor
102443646|NCT04121819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443647|NCT01476267|Dalcetrapib|dalcetrapib|mesh-list
102074075|NCT02250924|Caffeine|caffeine|mesh-list
102443648|NCT01476267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102443649|NCT01476267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102443650|NCT01476267|Antimetabolites|antimetabolites|mesh-ancestor
102443651|NCT01476267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443652|NCT01476267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102443653|NCT05189730|Paclitaxel|paclitaxel|mesh-list
102443654|NCT05189730|Carboplatin|carboplatin|mesh-list
102443655|NCT05189730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102443656|NCT05189730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443657|NCT05189730|Tubulin Modulators|tubulin modulators|mesh-ancestor
102443658|NCT05189730|Antimitotic Agents|antimitotic agents|mesh-ancestor
102443659|NCT05189730|Mitosis Modulators|mitosis modulators|mesh-ancestor
102443660|NCT05189730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443661|NCT04121273|Immunomodulating Agents|immunomodulating agents|mesh-list
102443662|NCT04121273|Immunologic Factors|immunologic factors|mesh-ancestor
102443663|NCT04121273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443664|NCT01476345|Insulin Glargine|insulin glargine|mesh-list
102443665|NCT01476345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102443666|NCT01476345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443667|NCT04121039|Apatinib|apatinib|mesh-list
102443668|NCT04121039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102074092|NCT04082728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102443669|NCT04121039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102443670|NCT04121039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102443671|NCT04121039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443672|NCT01401543|Tadalafil|tadalafil|mesh-list
102443673|NCT01401543|Vasodilator Agents|vasodilator agents|mesh-ancestor
102443674|NCT01401543|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102443675|NCT01401543|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102443676|NCT01401543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102443677|NCT01401543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443678|NCT01401543|Urological Agents|urological agents|mesh-ancestor
102443679|NCT04120259|Metformin|metformin|mesh-list
102443680|NCT04120259|Acetic Acid|acetic acid|mesh-list
102443681|NCT04120259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102074098|NCT04082728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102443682|NCT04120259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443683|NCT04120259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102443684|NCT04120259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102443685|NCT04392102|Niraparib|niraparib|mesh-list
102443686|NCT04392102|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102443687|NCT04392102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102443688|NCT04392102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443689|NCT04392102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443690|NCT05256342|Etoricoxib|etoricoxib|mesh-list
102443691|NCT05256342|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102443692|NCT05256342|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102074112|NCT02110134|Protective Agents|protective agents|mesh-ancestor
102443693|NCT05256342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102443694|NCT05256342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102443695|NCT05256342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443696|NCT05256342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102443697|NCT05256342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443698|NCT05256342|Analgesics|analgesics|mesh-ancestor
102443699|NCT05256342|Sensory System Agents|sensory system agents|mesh-ancestor
102443700|NCT05256342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102443701|NCT05256342|Antidepressive Agents|antidepressive agents|mesh-ancestor
102443702|NCT05256342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102443703|NCT05256342|Dopamine Agents|dopamine agents|mesh-ancestor
102443704|NCT05256342|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102443705|NCT05256342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102443706|NCT05256342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102443707|NCT05256342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102443708|NCT05256342|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102443709|NCT05256342|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102443710|NCT05256342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102443711|NCT02117167|Pemetrexed|pemetrexed|mesh-list
102443712|NCT02117167|Durvalumab|durvalumab|mesh-list
102443713|NCT02117167|Olaparib|olaparib|mesh-list
102443714|NCT02117167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443715|NCT02117167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102443716|NCT02117167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443717|NCT02117167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102443718|NCT02117167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102443719|NCT02117167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102443720|NCT02117167|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102443721|NCT04123379|Nivolumab|nivolumab|mesh-list
102443722|NCT04123379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102074154|NCT03656679|Iodine|iodine|mesh-list
102443723|NCT04123379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443724|NCT04123379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102443725|NCT04123379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443726|NCT01895881|Estradiol|estradiol|mesh-list
102443727|NCT01895881|Estrogens|estrogens|mesh-ancestor
102443728|NCT01895881|Hormones|hormones|mesh-ancestor
102443729|NCT01895881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102443730|NCT01895881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443731|NCT04537962|Listerine|listerine|mesh-list
102443732|NCT04537962|Cetylpyridinium|cetylpyridinium|mesh-list
102443733|NCT04537962|Fluorides|fluorides|mesh-list
102443734|NCT04537962|Sodium Fluoride|sodium fluoride|mesh-list
102443735|NCT04537962|Fluorophosphate|fluorophosphate|mesh-list
102443736|NCT04537962|Tin Fluorides|tin fluorides|mesh-list
102443737|NCT04537962|Cariostatic Agents|cariostatic agents|mesh-ancestor
102443738|NCT04537962|Protective Agents|protective agents|mesh-ancestor
102443739|NCT04537962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443740|NCT04537962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102443741|NCT04537962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102443742|NCT04126733|Nivolumab|nivolumab|mesh-list
102443743|NCT04126733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102443744|NCT04126733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443745|NCT04126733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102443746|NCT04126733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443747|NCT04387734|Ocrelizumab|ocrelizumab|mesh-list
102443748|NCT04387734|Immunologic Factors|immunologic factors|mesh-ancestor
102443749|NCT04387734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443750|NCT04885764|Vaccines|vaccines|mesh-list
102074172|NCT03554304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102443751|NCT04885764|Immunologic Factors|immunologic factors|mesh-ancestor
102443752|NCT04885764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443753|NCT04311606|Aflibercept|aflibercept|mesh-list
102443754|NCT04311606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102443755|NCT04311606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102443756|NCT04311606|Growth Substances|growth substances|mesh-ancestor
102443757|NCT04311606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443758|NCT04311606|Growth Inhibitors|growth inhibitors|mesh-ancestor
102443759|NCT04311606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443760|NCT02980835|Dexamethasone|dexamethasone|mesh-list
102443761|NCT02980835|Epinephrine|epinephrine|mesh-list
102443762|NCT02980835|Ropivacaine|ropivacaine|mesh-list
102443763|NCT02980835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102443764|NCT02980835|Antiemetics|antiemetics|mesh-ancestor
102443765|NCT02980835|Autonomic Agents|autonomic agents|mesh-ancestor
102074186|NCT02107716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102443766|NCT02980835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102443767|NCT02980835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443768|NCT02980835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102443769|NCT02980835|Glucocorticoids|glucocorticoids|mesh-ancestor
102443770|NCT02980835|Hormones|hormones|mesh-ancestor
102443771|NCT02980835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102443772|NCT02980835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102443773|NCT02980835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443774|NCT02980835|Anesthetics, Local|anesthetics, local|mesh-ancestor
102074192|NCT02107716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102074193|NCT02107716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102074194|NCT02107716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074195|NCT02110992|Docetaxel|docetaxel|mesh-list
102443775|NCT02980835|Anesthetics|anesthetics|mesh-ancestor
102443776|NCT02980835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102443777|NCT02980835|Sensory System Agents|sensory system agents|mesh-ancestor
102443778|NCT02980835|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102443779|NCT02980835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102443780|NCT02980835|Adrenergic Agents|adrenergic agents|mesh-ancestor
102443781|NCT02980835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102443782|NCT02980835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443783|NCT02980835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102443784|NCT02980835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102443785|NCT02980835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102443786|NCT02980835|Respiratory System Agents|respiratory system agents|mesh-ancestor
102443787|NCT02980835|Mydriatics|mydriatics|mesh-ancestor
102443788|NCT02980835|Sympathomimetics|sympathomimetics|mesh-ancestor
102443789|NCT02980835|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102443790|NCT03824327|Papaverine|papaverine|mesh-list
102443791|NCT03824327|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102443792|NCT03824327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102443793|NCT03824327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443794|NCT03824327|Vasodilator Agents|vasodilator agents|mesh-ancestor
102443795|NCT03824327|Urological Agents|urological agents|mesh-ancestor
102443796|NCT04871724|Fluconazole|fluconazole|mesh-list
102443797|NCT04871724|Antifungal Agents|antifungal agents|mesh-ancestor
102074214|NCT00311090|Idraparinux|idraparinux|mesh-list
102443798|NCT04871724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102443799|NCT04871724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102443800|NCT04871724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102443801|NCT04871724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102443802|NCT04871724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443803|NCT04871724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102443804|NCT04871724|Hormone Antagonists|hormone antagonists|mesh-ancestor
102443805|NCT04871724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102443806|NCT04871724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443807|NCT04871724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102443808|NCT04871724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102443809|NCT04871802|Taxifolin|taxifolin|mesh-list
102443810|NCT04871802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102443811|NCT04871802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102443812|NCT04871802|Analgesics|analgesics|mesh-ancestor
102443813|NCT04871802|Sensory System Agents|sensory system agents|mesh-ancestor
102443814|NCT04871802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102443815|NCT04871802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443816|NCT04871802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102443817|NCT04871802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102443818|NCT04871646|Nafamostat|nafamostat|mesh-list
102443819|NCT04871646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102443820|NCT04871646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102443821|NCT04871646|Analgesics|analgesics|mesh-ancestor
102443822|NCT04871646|Sensory System Agents|sensory system agents|mesh-ancestor
102443823|NCT04871646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102443824|NCT04871646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074241|NCT02254941|Antibodies|antibodies|mesh-list
102443825|NCT04871646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102443826|NCT04871646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102443827|NCT04871646|Anticoagulants|anticoagulants|mesh-ancestor
102443828|NCT04871646|Protease Inhibitors|protease inhibitors|mesh-ancestor
102443829|NCT04871646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102443830|NCT04871646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443831|NCT04871646|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102443832|NCT04871646|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102443833|NCT04871646|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102443834|NCT04871646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102443835|NCT04871646|Immunologic Factors|immunologic factors|mesh-ancestor
102443836|NCT03748680|Oxaliplatin|oxaliplatin|mesh-list
102443837|NCT03748680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443838|NCT03589014|Propranolol|propranolol|mesh-list
102443839|NCT03589014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102443840|NCT03589014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102443841|NCT03589014|Adrenergic Agents|adrenergic agents|mesh-ancestor
102443842|NCT03589014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102443843|NCT03589014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443844|NCT03589014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375943|NCT00236626|Topiramate|topiramate|mesh-list
102443845|NCT03589014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102443846|NCT03589014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102443847|NCT03589014|Vasodilator Agents|vasodilator agents|mesh-ancestor
102443848|NCT04884906|Paclitaxel|paclitaxel|mesh-list
102443849|NCT04884906|Cisplatin|cisplatin|mesh-list
102443850|NCT04884906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102443851|NCT04884906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443852|NCT04884906|Tubulin Modulators|tubulin modulators|mesh-ancestor
102443853|NCT04884906|Antimitotic Agents|antimitotic agents|mesh-ancestor
102443854|NCT04884906|Mitosis Modulators|mitosis modulators|mesh-ancestor
102443855|NCT04884906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443856|NCT03826589|Avelumab|avelumab|mesh-list
102443857|NCT03826589|Axitinib|axitinib|mesh-list
102443858|NCT03826589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102443859|NCT03826589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443860|NCT03826589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102443861|NCT03826589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102443862|NCT03826589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443863|NCT03046758|Metronidazole|metronidazole|mesh-list
102443864|NCT03046758|Fosfomycin|fosfomycin|mesh-list
102443865|NCT03046758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102443866|NCT03046758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102443867|NCT03046758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102443868|NCT03046758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102443869|NCT04382664|Nivolumab|nivolumab|mesh-list
102443870|NCT04382664|Ipilimumab|ipilimumab|mesh-list
102443871|NCT04382664|Sargramostim|sargramostim|mesh-list
102443872|NCT04382664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102443873|NCT04382664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443874|NCT04382664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102443875|NCT04382664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443876|NCT04382664|Immunologic Factors|immunologic factors|mesh-ancestor
102443877|NCT04382664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443878|NCT04392479|Aflibercept|aflibercept|mesh-list
102443879|NCT04392479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102443880|NCT04392479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102443881|NCT04392479|Growth Substances|growth substances|mesh-ancestor
102443882|NCT04392479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443883|NCT04392479|Growth Inhibitors|growth inhibitors|mesh-ancestor
102443884|NCT04392479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443885|NCT03825887|Morphine|morphine|mesh-list
102443886|NCT03825887|Nalbuphine|nalbuphine|mesh-list
102443887|NCT03825887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102443888|NCT03825887|Narcotics|narcotics|mesh-ancestor
102443889|NCT03825887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102443890|NCT03825887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443891|NCT03825887|Analgesics|analgesics|mesh-ancestor
102443892|NCT03825887|Sensory System Agents|sensory system agents|mesh-ancestor
102443893|NCT03825887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102443894|NCT03825809|Acetaminophen|acetaminophen|mesh-list
102443895|NCT03825809|Celecoxib|celecoxib|mesh-list
102443896|NCT03825809|Ketorolac|ketorolac|mesh-list
102443897|NCT03825809|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
102443898|NCT03825809|Diazepam|diazepam|mesh-list
102443899|NCT03825809|Gabapentin|gabapentin|mesh-list
102443900|NCT03825809|Hydrocodone|hydrocodone|mesh-list
102443901|NCT03825809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102443902|NCT03825809|Analgesics|analgesics|mesh-ancestor
102443903|NCT03825809|Sensory System Agents|sensory system agents|mesh-ancestor
102443904|NCT03825809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102443905|NCT03825809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443906|NCT03825809|Antipyretics|antipyretics|mesh-ancestor
102443907|NCT03825809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102443908|NCT03825809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102443909|NCT03825809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102443910|NCT03825809|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102443911|NCT03825809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102443912|NCT03825809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102443913|NCT03825809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443914|NCT03825809|Anticonvulsants|anticonvulsants|mesh-ancestor
102443915|NCT03825809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102443916|NCT03825809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101389068|NCT05971251|Acalabrutinib|acalabrutinib|mesh-list
102443917|NCT03825809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102443918|NCT03825809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102443919|NCT03825809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102443920|NCT03825809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102443921|NCT03825809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102443922|NCT03825809|Antimanic Agents|antimanic agents|mesh-ancestor
102443923|NCT03825809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102443924|NCT03825809|Narcotics|narcotics|mesh-ancestor
102443925|NCT03825809|Antitussive Agents|antitussive agents|mesh-ancestor
102443926|NCT03825809|Respiratory System Agents|respiratory system agents|mesh-ancestor
102443927|NCT03825809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102443929|NCT03825809|Autonomic Agents|autonomic agents|mesh-ancestor
102443930|NCT03825809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102074318|NCT02107950|Carboplatin|carboplatin|mesh-list
102443931|NCT03825809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102443932|NCT03825809|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102443933|NCT03825809|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102443934|NCT03825809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102443935|NCT03825809|Anesthetics, General|anesthetics, general|mesh-ancestor
102443936|NCT03825809|Anesthetics|anesthetics|mesh-ancestor
102443937|NCT03825809|GABA Modulators|gaba modulators|mesh-ancestor
102443938|NCT03825809|GABA Agents|gaba agents|mesh-ancestor
102443939|NCT03824717|Ropivacaine|ropivacaine|mesh-list
102443940|NCT03824717|Anesthetics, Local|anesthetics, local|mesh-ancestor
102443941|NCT03824717|Anesthetics|anesthetics|mesh-ancestor
102443942|NCT03824717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102443943|NCT03824717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443944|NCT03824717|Sensory System Agents|sensory system agents|mesh-ancestor
102443945|NCT03824717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102443946|NCT04392557|Metformin|metformin|mesh-list
102443947|NCT04392557|Pioglitazone|pioglitazone|mesh-list
102443948|NCT04392557|Alogliptin|alogliptin|mesh-list
102443949|NCT04392557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102443950|NCT04392557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443951|NCT04392557|Incretins|incretins|mesh-ancestor
102443952|NCT04392557|Hormones|hormones|mesh-ancestor
102443953|NCT04392557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102443954|NCT04392557|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102443955|NCT04392557|Protease Inhibitors|protease inhibitors|mesh-ancestor
102443956|NCT04392557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102443957|NCT04392557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443958|NCT02115373|Tepotinib|tepotinib|mesh-list
102443959|NCT02115373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102443960|NCT03824171|Cholecalciferol|cholecalciferol|mesh-list
102443961|NCT03824171|Vitamin D|vitamin d|mesh-list
102443962|NCT03824171|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
102443963|NCT03824171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102443964|NCT03824171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443965|NCT03824171|Vitamins|vitamins|mesh-ancestor
102443966|NCT03824171|Micronutrients|micronutrients|mesh-ancestor
102443967|NCT03824171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102443968|NCT03824171|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102443969|NCT03824171|Hormone Antagonists|hormone antagonists|mesh-ancestor
102443970|NCT03824171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102443971|NCT03824171|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102443972|NCT03824171|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102443973|NCT02946125|Phenylephrine|phenylephrine|mesh-list
102443974|NCT02946125|Oxymetazoline|oxymetazoline|mesh-list
102443975|NCT02946125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102443976|NCT02946125|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102443977|NCT02946125|Mydriatics|mydriatics|mesh-ancestor
102443978|NCT02946125|Autonomic Agents|autonomic agents|mesh-ancestor
102443979|NCT02946125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102443980|NCT02946125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443981|NCT02946125|Sympathomimetics|sympathomimetics|mesh-ancestor
102443982|NCT02946125|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102443983|NCT02946125|Nasal Decongestants|nasal decongestants|mesh-ancestor
102443984|NCT02946125|Respiratory System Agents|respiratory system agents|mesh-ancestor
102074353|NCT02251158|Tipranavir|tipranavir|mesh-list
102443985|NCT02946125|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102443986|NCT02946125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102443987|NCT02946125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102443988|NCT02946125|Adrenergic Agents|adrenergic agents|mesh-ancestor
102443989|NCT02946125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102443990|NCT02946125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102443991|NCT02946125|Protective Agents|protective agents|mesh-ancestor
102443992|NCT02946125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102443993|NCT01895257|Leucovorin|leucovorin|mesh-list
102443994|NCT01895257|Fluorouracil|fluorouracil|mesh-list
102443995|NCT01895257|Levoleucovorin|levoleucovorin|mesh-list
102443996|NCT01895257|Antidotes|antidotes|mesh-ancestor
102443997|NCT01895257|Protective Agents|protective agents|mesh-ancestor
102443998|NCT01895257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102443999|NCT01895257|Vitamin B Complex|vitamin b complex|mesh-ancestor
102444000|NCT01895257|Vitamins|vitamins|mesh-ancestor
102444001|NCT01895257|Micronutrients|micronutrients|mesh-ancestor
102444002|NCT01895257|Antimetabolites|antimetabolites|mesh-ancestor
101376065|NCT00237289|Topiramate|topiramate|mesh-list
102074374|NCT05404516|Antimetabolites|antimetabolites|mesh-ancestor
102074375|NCT05404516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444003|NCT01895257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444004|NCT01895257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102444005|NCT01895257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102444006|NCT01895257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102444007|NCT01895257|Immunologic Factors|immunologic factors|mesh-ancestor
102444008|NCT02064673|Curcumin|curcumin|mesh-list
102444009|NCT02064673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102444010|NCT02064673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102444011|NCT02064673|Analgesics|analgesics|mesh-ancestor
102444012|NCT02064673|Sensory System Agents|sensory system agents|mesh-ancestor
102074390|NCT02114346|Antimetabolites|antimetabolites|mesh-ancestor
102074391|NCT02114346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074392|NCT02114346|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102074393|NCT02114346|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102074394|NCT02114346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102444013|NCT02064673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102444014|NCT02064673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444015|NCT02064673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102444016|NCT02064673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102444017|NCT02064673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102444018|NCT02064673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102444019|NCT02064673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444020|NCT04392713|Ivermectin|ivermectin|mesh-list
102444021|NCT04392713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102444022|NCT04392713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102074403|NCT02108808|Ticagrelor|ticagrelor|mesh-list
102444023|NCT03823625|Nivolumab|nivolumab|mesh-list
102444024|NCT03823625|Ipilimumab|ipilimumab|mesh-list
102444025|NCT03823625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102444026|NCT03823625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102444027|NCT03823625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102444028|NCT03823625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444029|NCT02053909|Aspirin|aspirin|mesh-list
102444030|NCT02053909|Ticagrelor|ticagrelor|mesh-list
102444031|NCT02053909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102074410|NCT02108808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102074411|NCT02108808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444032|NCT02053909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102444033|NCT02053909|Analgesics|analgesics|mesh-ancestor
102444034|NCT02053909|Sensory System Agents|sensory system agents|mesh-ancestor
102444035|NCT02053909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102444036|NCT02053909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444037|NCT02053909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102444038|NCT02053909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102444039|NCT02053909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102444040|NCT02053909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102074418|NCT02108886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102074419|NCT02108886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074420|NCT02108886|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102074421|NCT02108886|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102074422|NCT02108886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074423|NCT02114502|Pyridoxine|pyridoxine|mesh-list
102074424|NCT02114502|Dexamethasone|dexamethasone|mesh-list
101389992|NCT05686863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101389993|NCT05681884|Faricimab|faricimab|mesh-list
101389994|NCT05681884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101389995|NCT05681884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101389996|NCT05681884|Growth Substances|growth substances|mesh-ancestor
101389997|NCT05681884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389998|NCT05681884|Growth Inhibitors|growth inhibitors|mesh-ancestor
101389999|NCT05681884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390000|NCT05681715|Rozanolixizumab|rozanolixizumab|mesh-list
101390001|NCT05681715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101390002|NCT05681715|Immunologic Factors|immunologic factors|mesh-ancestor
101390003|NCT05681715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305438|NCT02019446|Antifungal Agents|antifungal agents|mesh-ancestor
101305439|NCT02019446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101305440|NCT02019446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101177207|NCT05714670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101390033|NCT05677373|Trametinib|trametinib|mesh-list
101390034|NCT05677373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390035|NCT05677373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102444041|NCT02053909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444042|NCT02053909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102444043|NCT02053909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102444044|NCT02053909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102444045|NCT02053909|Antipyretics|antipyretics|mesh-ancestor
102444046|NCT02053909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102444047|NCT02053909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101487815|NCT00328718|Xhance|xhance|mesh-list
102444048|NCT02053909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102444049|NCT02053909|Purinergic Agents|purinergic agents|mesh-ancestor
102444050|NCT02053909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102444051|NCT02863991|TIC10 compound|tic10 compound|mesh-list
102444052|NCT02863991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102444053|NCT02860091|Ropivacaine|ropivacaine|mesh-list
102444054|NCT02860091|Anesthetics, Local|anesthetics, local|mesh-ancestor
102444055|NCT02860091|Anesthetics|anesthetics|mesh-ancestor
102444056|NCT02860091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102444057|NCT02860091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444058|NCT02860091|Sensory System Agents|sensory system agents|mesh-ancestor
102444059|NCT02860091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102444060|NCT02858219|Botulinum Toxins|botulinum toxins|mesh-list
102444061|NCT02858219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102444062|NCT02858219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102444063|NCT02858219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102444064|NCT02858219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102444065|NCT02858219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444066|NCT02858219|Cholinergic Agents|cholinergic agents|mesh-ancestor
102444067|NCT02858219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102444068|NCT02858219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444069|NCT02858219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102444070|NCT02858219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102444071|NCT03823781|Milrinone|milrinone|mesh-list
102444072|NCT03823781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102444073|NCT03823781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102444074|NCT03823781|Vasodilator Agents|vasodilator agents|mesh-ancestor
102444075|NCT03823781|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102444076|NCT03823781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102444077|NCT03823781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101376122|NCT00237484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102444078|NCT03823781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444079|NCT03823781|Protective Agents|protective agents|mesh-ancestor
102444080|NCT03823781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444081|NCT03823079|Irinotecan|irinotecan|mesh-list
102444082|NCT03823079|Raltitrexed|raltitrexed|mesh-list
102444083|NCT03823079|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102444084|NCT03823079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102444085|NCT03823079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102444086|NCT03823079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444087|NCT03823079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102444088|NCT03823079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102444089|NCT03823079|Antimetabolites|antimetabolites|mesh-ancestor
102444090|NCT03823079|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102444091|NCT02839265|Flt3 ligand protein|flt3 ligand protein|mesh-list
102444092|NCT02839265|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102444093|NCT02839265|Immunologic Factors|immunologic factors|mesh-ancestor
102444094|NCT02839265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444095|NCT02839265|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102444096|NCT02839265|Protective Agents|protective agents|mesh-ancestor
102444097|NCT00988247|Beclomethasone|beclomethasone|mesh-list
102444098|NCT00988247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102444099|NCT00988247|Glucocorticoids|glucocorticoids|mesh-ancestor
102444100|NCT00988247|Hormones|hormones|mesh-ancestor
102444101|NCT00988247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102444102|NCT00988247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444103|NCT00988247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102074472|NCT02114736|Botulinum Toxins|botulinum toxins|mesh-list
102074473|NCT02114736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102074474|NCT02114736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101390272|NCT05576662|Ritonavir|ritonavir|mesh-list
102444104|NCT00988247|Respiratory System Agents|respiratory system agents|mesh-ancestor
102444105|NCT02832401|Caffeine|caffeine|mesh-list
102444106|NCT02832401|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102444107|NCT02832401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444108|NCT02832401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102444109|NCT02832401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102444110|NCT02832401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444111|NCT02832401|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102444112|NCT02832401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102444113|NCT02832401|Purinergic Agents|purinergic agents|mesh-ancestor
102074480|NCT02114736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102444114|NCT02832401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102444115|NCT03044808|Lidocaine|lidocaine|mesh-list
102444116|NCT03044808|Anesthetics, Local|anesthetics, local|mesh-ancestor
102444117|NCT03044808|Anesthetics|anesthetics|mesh-ancestor
102444118|NCT03044808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102444119|NCT03044808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444120|NCT03044808|Sensory System Agents|sensory system agents|mesh-ancestor
102444121|NCT03044808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102444122|NCT03044808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102444123|NCT03044808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102444124|NCT03044808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102444125|NCT03044808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102444126|NCT03044808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444127|NCT04430166|Antibodies|antibodies|mesh-list
102074487|NCT02112552|Antimitotic Agents|antimitotic agents|mesh-ancestor
102074488|NCT02112552|Mitosis Modulators|mitosis modulators|mesh-ancestor
102074489|NCT02112552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074490|NCT02109354|Vaccines|vaccines|mesh-list
102074491|NCT02109354|Immunologic Factors|immunologic factors|mesh-ancestor
102444128|NCT04430166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102444129|NCT04430166|Immunologic Factors|immunologic factors|mesh-ancestor
102444130|NCT04430166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444131|NCT04877106|Metformin|metformin|mesh-list
102444132|NCT04877106|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102444133|NCT04877106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102444134|NCT04877106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444135|NCT04877106|Incretins|incretins|mesh-ancestor
102444136|NCT04877106|Hormones|hormones|mesh-ancestor
102444137|NCT04877106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102444138|NCT04877106|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102444139|NCT04877106|Protease Inhibitors|protease inhibitors|mesh-ancestor
102444140|NCT04877106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102074503|NCT02109510|Ketamine|ketamine|mesh-list
102444141|NCT04877106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444142|NCT00981617|ALKS-33|alks-33|mesh-list
102444143|NCT00981617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102444144|NCT00981617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444145|NCT00981617|Sensory System Agents|sensory system agents|mesh-ancestor
102444146|NCT00981617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102444147|NCT04876716|Voriconazole|voriconazole|mesh-list
102444148|NCT04876716|Posaconazole|posaconazole|mesh-list
102444149|NCT04876716|Isavuconazole|isavuconazole|mesh-list
102444150|NCT04876716|Anidulafungin|anidulafungin|mesh-list
102444151|NCT04876716|Antifungal Agents|antifungal agents|mesh-ancestor
102444152|NCT04876716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102255810|NCT02532855|Metformin|metformin|mesh-list
102444153|NCT04876716|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102444154|NCT04876716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102444155|NCT04876716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102444156|NCT04876716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444157|NCT04876716|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102444158|NCT04876716|Hormone Antagonists|hormone antagonists|mesh-ancestor
102444159|NCT04876716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102444160|NCT04876716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444161|NCT04876716|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102444162|NCT04876716|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102444163|NCT04876716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102444164|NCT04876716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102444165|NCT04865250|Paclitaxel|paclitaxel|mesh-list
102444166|NCT04865250|Carboplatin|carboplatin|mesh-list
102444167|NCT04865250|Atezolizumab|atezolizumab|mesh-list
102444168|NCT04865250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102444169|NCT04865250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102444170|NCT04865250|Tubulin Modulators|tubulin modulators|mesh-ancestor
102444171|NCT04865250|Antimitotic Agents|antimitotic agents|mesh-ancestor
102444172|NCT04865250|Mitosis Modulators|mitosis modulators|mesh-ancestor
102444173|NCT04865250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444174|NCT04865250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102444175|NCT04865250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102444176|NCT04865562|Methyltestosterone|methyltestosterone|mesh-list
102444177|NCT04865562|Testosterone|testosterone|mesh-list
102444178|NCT04865562|Testosterone undecanoate|testosterone undecanoate|mesh-list
102444179|NCT04865562|Testosterone enanthate|testosterone enanthate|mesh-list
101376219|NCT00237913|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102444180|NCT04865562|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102444181|NCT04865562|Androgens|androgens|mesh-ancestor
102444182|NCT04865562|Hormones|hormones|mesh-ancestor
102444183|NCT04865562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102444184|NCT04865562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444185|NCT04865562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102444186|NCT04865562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102444187|NCT04865562|Anabolic Agents|anabolic agents|mesh-ancestor
102444188|NCT04864782|Paclitaxel|paclitaxel|mesh-list
101488785|NCT00333632|Midazolam|midazolam|mesh-list
102444189|NCT04864782|Carboplatin|carboplatin|mesh-list
102444190|NCT04864782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102444191|NCT04864782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102444192|NCT04864782|Tubulin Modulators|tubulin modulators|mesh-ancestor
102444193|NCT04864782|Antimitotic Agents|antimitotic agents|mesh-ancestor
102444194|NCT04864782|Mitosis Modulators|mitosis modulators|mesh-ancestor
102444195|NCT04864782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444196|NCT04875858|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102444197|NCT04875858|Immunologic Factors|immunologic factors|mesh-ancestor
102444198|NCT04875858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444199|NCT04385940|Vitamin D|vitamin d|mesh-list
102444200|NCT04385940|Cholecalciferol|cholecalciferol|mesh-list
102444201|NCT04385940|Vitamins|vitamins|mesh-ancestor
102444202|NCT04385940|Micronutrients|micronutrients|mesh-ancestor
102444203|NCT04385940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444204|NCT04385940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102444205|NCT04385940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102444206|NCT00984659|Fluticasone|fluticasone|mesh-list
102074561|NCT02112630|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102074562|NCT02112630|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
102074563|NCT02112630|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102074564|NCT02112630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102074565|NCT02112630|Antiviral Agents|antiviral agents|mesh-ancestor
102074566|NCT02112630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102074567|NCT02112630|Antimetabolites|antimetabolites|mesh-ancestor
101376244|NCT00098241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101393331|NCT04113018|Immunologic Factors|immunologic factors|mesh-ancestor
101393332|NCT04113018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101393333|NCT04113018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101393334|NCT04113018|Growth Substances|growth substances|mesh-ancestor
101393335|NCT04113018|Growth Inhibitors|growth inhibitors|mesh-ancestor
101305626|NCT02020681|Cariostatic Agents|cariostatic agents|mesh-ancestor
102444208|NCT00984659|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102444209|NCT00984659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102444210|NCT00984659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102444211|NCT00984659|Autonomic Agents|autonomic agents|mesh-ancestor
102444212|NCT00984659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102444213|NCT00984659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444214|NCT00984659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102444215|NCT00984659|Respiratory System Agents|respiratory system agents|mesh-ancestor
102444216|NCT00984659|Dermatologic Agents|dermatologic agents|mesh-ancestor
102444217|NCT00984659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102444218|NCT00984659|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102444219|NCT00984659|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102444220|NCT00984659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102444221|NCT00984659|Adrenergic Agents|adrenergic agents|mesh-ancestor
102444222|NCT00984659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102074577|NCT05125588|Analgesics|analgesics|mesh-ancestor
102444223|NCT00984659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444224|NCT04864314|Superoxide Dismutase|superoxide dismutase|mesh-list
102444225|NCT04864314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102444226|NCT04864314|Antioxidants|antioxidants|mesh-ancestor
102444227|NCT04864314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444228|NCT04864314|Protective Agents|protective agents|mesh-ancestor
102444229|NCT04864314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444230|NCT04874844|Antibodies|antibodies|mesh-list
102444231|NCT04874844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102444232|NCT04874844|Immunologic Factors|immunologic factors|mesh-ancestor
102074581|NCT05125588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102074582|NCT05125588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102074583|NCT05125588|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102074584|NCT05125588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102074585|NCT05125588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102074591|NCT02115204|Epirubicin|epirubicin|mesh-list
102444233|NCT04874844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444234|NCT03046290|Lidocaine|lidocaine|mesh-list
102444235|NCT03046290|Ropivacaine|ropivacaine|mesh-list
102444236|NCT03046290|Anesthetics, Local|anesthetics, local|mesh-ancestor
102444237|NCT03046290|Anesthetics|anesthetics|mesh-ancestor
102444238|NCT03046290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102444239|NCT03046290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444240|NCT03046290|Sensory System Agents|sensory system agents|mesh-ancestor
102444241|NCT03046290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102444242|NCT03046290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101376275|NCT00238225|Antiemetics|antiemetics|mesh-ancestor
101376281|NCT00238225|Hormones|hormones|mesh-ancestor
102444243|NCT03046290|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102444244|NCT03046290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102444245|NCT03046290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102444246|NCT03046290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444247|NCT04874688|Provitamins|provitamins|mesh-list
102444248|NCT04874688|Beta Carotene|beta carotene|mesh-list
102444249|NCT04874688|Vitamins|vitamins|mesh-ancestor
102444250|NCT04874688|Micronutrients|micronutrients|mesh-ancestor
102444251|NCT04874688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444252|NCT02612064|Fluorides|fluorides|mesh-list
102444253|NCT02612064|Tin Fluorides|tin fluorides|mesh-list
102444254|NCT02612064|Fluorophosphate|fluorophosphate|mesh-list
102444255|NCT02612064|Cariostatic Agents|cariostatic agents|mesh-ancestor
102444256|NCT02612064|Protective Agents|protective agents|mesh-ancestor
101489411|NCT00336245|Copper|copper|mesh-list
102444257|NCT02612064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444258|NCT04553003|Prednisone|prednisone|mesh-list
102444259|NCT04553003|Methylprednisolone|methylprednisolone|mesh-list
102444260|NCT04553003|Choline|choline|mesh-list
102444261|NCT04553003|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
102444262|NCT04553003|Glucocorticoids|glucocorticoids|mesh-list
102444263|NCT04553003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102444264|NCT04553003|Hormones|hormones|mesh-ancestor
102444265|NCT04553003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102444266|NCT04553003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444267|NCT04553003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102444268|NCT04553003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102444269|NCT04553003|Antiemetics|antiemetics|mesh-ancestor
102444270|NCT04553003|Autonomic Agents|autonomic agents|mesh-ancestor
102444271|NCT04553003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102444272|NCT04553003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102444273|NCT04553003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102444274|NCT04553003|Protective Agents|protective agents|mesh-ancestor
102444275|NCT04553003|Lipotropic Agents|lipotropic agents|mesh-ancestor
102444276|NCT04553003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102444277|NCT04553003|Antimetabolites|antimetabolites|mesh-ancestor
102444278|NCT04553003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444279|NCT04553003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102444280|NCT04553003|Nootropic Agents|nootropic agents|mesh-ancestor
102444281|NCT03044184|Tranylcypromine|tranylcypromine|mesh-list
102444282|NCT03044184|Tranexamic Acid|tranexamic acid|mesh-list
102444283|NCT03044184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102444284|NCT03044184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102444285|NCT03044184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444286|NCT03044184|Hemostatics|hemostatics|mesh-ancestor
102444287|NCT03044184|Coagulants|coagulants|mesh-ancestor
102444288|NCT03044184|Antidepressive Agents|antidepressive agents|mesh-ancestor
102444289|NCT03044184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102444290|NCT03044184|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102444291|NCT03044184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102444292|NCT03044184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102444293|NCT03044184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102444294|NCT03044184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102444295|NCT03044184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444296|NCT03047772|Atorvastatin|atorvastatin|mesh-list
102444297|NCT03047772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102444298|NCT03047772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102444299|NCT03047772|Antimetabolites|antimetabolites|mesh-ancestor
102444300|NCT03047772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444301|NCT03047772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102444302|NCT03047772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102444303|NCT03047772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102444304|NCT03047538|Amlodipine|amlodipine|mesh-list
102444305|NCT03047538|Perindopril|perindopril|mesh-list
102444306|NCT03047538|Atorvastatin|atorvastatin|mesh-list
102444307|NCT03047538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102444308|NCT03047538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102444309|NCT03047538|Antimetabolites|antimetabolites|mesh-ancestor
102444310|NCT03047538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444311|NCT03047538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102444312|NCT03047538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102444313|NCT03047538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102444314|NCT03047538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102444315|NCT03047538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102444316|NCT03047538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102444317|NCT03047538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102444318|NCT03047538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444319|NCT03047538|Vasodilator Agents|vasodilator agents|mesh-ancestor
102444320|NCT03047538|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102444321|NCT03047538|Protease Inhibitors|protease inhibitors|mesh-ancestor
102444322|NCT01728805|Vorinostat|vorinostat|mesh-list
102444323|NCT01728805|Mogamulizumab|mogamulizumab|mesh-list
102444324|NCT01728805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102444325|NCT01728805|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102444326|NCT01728805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102444327|NCT01728805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444328|NCT03822065|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
102444329|NCT03822065|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102444330|NCT03822065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102444331|NCT03822065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102444332|NCT03822065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444333|NCT03822065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102444334|NCT03822065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444335|NCT03822065|Antidepressive Agents|antidepressive agents|mesh-ancestor
102444336|NCT03822065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102444337|NCT03821987|Cyclophosphamide|cyclophosphamide|mesh-list
102444338|NCT03821987|Busulfan|busulfan|mesh-list
102444339|NCT03821987|Fludarabine|fludarabine|mesh-list
102444340|NCT03821987|Thymoglobulin|thymoglobulin|mesh-list
102444341|NCT03821987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101376357|NCT00238849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102074673|NCT03552666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102074674|NCT02115594|Fulvestrant|fulvestrant|mesh-list
102074675|NCT02115594|Entinostat|entinostat|mesh-list
102074676|NCT02115594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102074677|NCT02115594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102074678|NCT02115594|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102074679|NCT02115594|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102074680|NCT02115594|Hormone Antagonists|hormone antagonists|mesh-ancestor
102074681|NCT02115594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102074682|NCT02115594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074683|NCT02115594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102074684|NCT02115594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102074685|NCT02115594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444342|NCT03821987|Immunologic Factors|immunologic factors|mesh-ancestor
102444343|NCT03821987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444344|NCT03821987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102444345|NCT03821987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102444346|NCT03821987|Alkylating Agents|alkylating agents|mesh-ancestor
102444347|NCT03821987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444348|NCT03821987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102444349|NCT03821987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102444350|NCT04273763|Interferons|interferons|mesh-list
102444351|NCT04273763|Bromhexine|bromhexine|mesh-list
102444352|NCT04273763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102444353|NCT04273763|Antiviral Agents|antiviral agents|mesh-ancestor
102074693|NCT05125042|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102074694|NCT05125042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102074695|NCT05125042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102074696|NCT05125042|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102074697|NCT05125042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102074698|NCT05125042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102074699|NCT02113332|Liraglutide|liraglutide|mesh-list
102074700|NCT02113332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102074701|NCT02113332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074702|NCT02113332|Incretins|incretins|mesh-ancestor
102074703|NCT02113332|Hormones|hormones|mesh-ancestor
101394368|NCT03126214|Warfarin|warfarin|mesh-list
101394369|NCT03126214|Anticoagulants|anticoagulants|mesh-list
101394370|NCT03121586|Pimavanserin|pimavanserin|mesh-list
101394371|NCT03121586|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101394372|NCT03121586|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101394373|NCT03121586|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101394374|NCT03121586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101394375|NCT03121586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101394376|NCT03121586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394377|NCT03121586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102444354|NCT04273763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102444355|NCT04273763|Expectorants|expectorants|mesh-ancestor
102444356|NCT04273763|Respiratory System Agents|respiratory system agents|mesh-ancestor
102444357|NCT03820193|Acetaminophen|acetaminophen|mesh-list
102444358|NCT03820193|Celecoxib|celecoxib|mesh-list
102444359|NCT03820193|Ketorolac|ketorolac|mesh-list
102444360|NCT03820193|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
102444361|NCT03820193|Diazepam|diazepam|mesh-list
102444362|NCT03820193|Gabapentin|gabapentin|mesh-list
102444363|NCT03820193|Hydrocodone|hydrocodone|mesh-list
102444364|NCT03820193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102444365|NCT03820193|Analgesics|analgesics|mesh-ancestor
102444366|NCT03820193|Sensory System Agents|sensory system agents|mesh-ancestor
101376390|NCT00239044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102074704|NCT02113332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102074705|NCT02119338|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102074706|NCT02119338|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102074707|NCT02119338|Dermatologic Agents|dermatologic agents|mesh-ancestor
102074708|NCT02918877|Propofol|propofol|mesh-list
102074709|NCT02918877|Sevoflurane|sevoflurane|mesh-list
102074710|NCT02918877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102074711|NCT02918877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102074712|NCT02918877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376392|NCT00239044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101394438|NCT02973789|Antimitotic Agents|antimitotic agents|mesh-ancestor
102444367|NCT03820193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102444368|NCT03820193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444369|NCT03820193|Antipyretics|antipyretics|mesh-ancestor
102444370|NCT03820193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102444371|NCT03820193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102444372|NCT03820193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102444373|NCT03820193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102444374|NCT03820193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102444375|NCT03820193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102444376|NCT03820193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256034|NCT02679755|Letrozole|letrozole|mesh-list
102444377|NCT03820193|Anticonvulsants|anticonvulsants|mesh-ancestor
102444378|NCT03820193|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102444379|NCT03820193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102444380|NCT03820193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102444381|NCT03820193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102444382|NCT03820193|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102444383|NCT03820193|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102444384|NCT03820193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102444385|NCT03820193|Antimanic Agents|antimanic agents|mesh-ancestor
102444386|NCT03820193|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102444387|NCT03820193|Narcotics|narcotics|mesh-ancestor
102444388|NCT03820193|Antitussive Agents|antitussive agents|mesh-ancestor
102444389|NCT03820193|Respiratory System Agents|respiratory system agents|mesh-ancestor
102444390|NCT03820193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102444391|NCT03820193|Antiemetics|antiemetics|mesh-ancestor
102444392|NCT03820193|Autonomic Agents|autonomic agents|mesh-ancestor
102444393|NCT03820193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102444394|NCT03820193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102444395|NCT03820193|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102444396|NCT03820193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102444397|NCT03820193|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102444398|NCT03820193|Anesthetics, General|anesthetics, general|mesh-ancestor
102444399|NCT03820193|Anesthetics|anesthetics|mesh-ancestor
102444400|NCT03820193|GABA Modulators|gaba modulators|mesh-ancestor
102444401|NCT03820193|GABA Agents|gaba agents|mesh-ancestor
102444402|NCT03820037|Opicapone|opicapone|mesh-list
102444403|NCT03820037|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102444404|NCT03820037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102444405|NCT03820037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444406|NCT03820037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102444407|NCT03820037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102444408|NCT03829007|Durvalumab|durvalumab|mesh-list
102444409|NCT03829007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102444410|NCT03829007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102444411|NCT03829007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102444412|NCT03829007|Immunologic Factors|immunologic factors|mesh-ancestor
102444413|NCT03829007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444414|NCT02614560|Fludarabine|fludarabine|mesh-list
102444415|NCT02614560|Melphalan|melphalan|mesh-list
102444416|NCT02614560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102444417|NCT02614560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444418|NCT02614560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102444419|NCT02614560|Immunologic Factors|immunologic factors|mesh-ancestor
102444420|NCT02614560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444421|NCT02614560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102444422|NCT02614560|Alkylating Agents|alkylating agents|mesh-ancestor
102444423|NCT02614560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102444424|NCT03828929|Thiamine|thiamine|mesh-list
102444425|NCT03828929|Vitamins|vitamins|mesh-ancestor
102444426|NCT03828929|Micronutrients|micronutrients|mesh-ancestor
102444427|NCT03828929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444428|NCT03828929|Vitamin B Complex|vitamin b complex|mesh-ancestor
102444429|NCT04873440|Manganese|manganese|mesh-list
102444430|NCT04873440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444431|NCT04873440|Trace Elements|trace elements|mesh-ancestor
102444432|NCT04873440|Micronutrients|micronutrients|mesh-ancestor
102444433|NCT04867980|Moxifloxacin|moxifloxacin|mesh-list
102444434|NCT04867980|Acalabrutinib|acalabrutinib|mesh-list
102444435|NCT04867980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102444436|NCT04867980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102444437|NCT04867980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102444438|NCT04867980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102444439|NCT04867980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102444440|NCT04867980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444441|NCT04867980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102444442|NCT01450241|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102444443|NCT01450241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102444444|NCT04391621|Triamcinolone|triamcinolone|mesh-list
102444445|NCT04391621|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102444446|NCT04391621|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102444447|NCT04391621|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102444448|NCT04391621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102444449|NCT04391621|Glucocorticoids|glucocorticoids|mesh-ancestor
102444450|NCT04391621|Hormones|hormones|mesh-ancestor
102444451|NCT04391621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102444452|NCT04391621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444453|NCT04391621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102444454|NCT04391621|Immunologic Factors|immunologic factors|mesh-ancestor
102444455|NCT04391621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102444456|NCT04391621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444457|NCT01669122|Nicotine|nicotine|mesh-list
102444458|NCT01669122|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102444459|NCT01669122|Autonomic Agents|autonomic agents|mesh-ancestor
102444460|NCT01669122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102444461|NCT01669122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444462|NCT01669122|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102444463|NCT01669122|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102444464|NCT01669122|Cholinergic Agents|cholinergic agents|mesh-ancestor
102444465|NCT01669122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102444466|NCT01669122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444467|NCT03629483|Dexmedetomidine|dexmedetomidine|mesh-list
102444468|NCT03629483|Ropivacaine|ropivacaine|mesh-list
102444469|NCT03629483|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102444470|NCT03629483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102444471|NCT03629483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444472|NCT03629483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102444473|NCT03629483|Analgesics|analgesics|mesh-ancestor
102444474|NCT03629483|Sensory System Agents|sensory system agents|mesh-ancestor
102444475|NCT03629483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102444476|NCT03629483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102444477|NCT03629483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102444478|NCT03629483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102444479|NCT03629483|Adrenergic Agents|adrenergic agents|mesh-ancestor
102444480|NCT03629483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102444481|NCT03629483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444482|NCT03629483|Anesthetics, Local|anesthetics, local|mesh-ancestor
102444483|NCT03629483|Anesthetics|anesthetics|mesh-ancestor
102444484|NCT04873284|Dexamethasone|dexamethasone|mesh-list
102444485|NCT04873284|Aprepitant|aprepitant|mesh-list
102444486|NCT04873284|Fosaprepitant|fosaprepitant|mesh-list
102444487|NCT04873284|Granisetron|granisetron|mesh-list
102444488|NCT04873284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102444489|NCT04873284|Antiemetics|antiemetics|mesh-ancestor
102444490|NCT04873284|Autonomic Agents|autonomic agents|mesh-ancestor
102444491|NCT04873284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102444492|NCT04873284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444493|NCT04873284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102444494|NCT04873284|Glucocorticoids|glucocorticoids|mesh-ancestor
102444495|NCT04873284|Hormones|hormones|mesh-ancestor
102444496|NCT04873284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102444497|NCT04873284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102444498|NCT04873284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102444499|NCT04873284|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102444500|NCT04873284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102444501|NCT04873284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444502|NCT04873284|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102444503|NCT04873284|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102444504|NCT04873284|Serotonin Agents|serotonin agents|mesh-ancestor
102444505|NCT01450865|Flupirtine|flupirtine|mesh-list
102444506|NCT01450865|Analgesics|analgesics|mesh-ancestor
102444507|NCT01450865|Sensory System Agents|sensory system agents|mesh-ancestor
102444508|NCT01450865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102444509|NCT01450865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444510|NCT01308619|Doxycycline|doxycycline|mesh-list
102444511|NCT01308619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102444512|NCT01308619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102444513|NCT01308619|Antimalarials|antimalarials|mesh-ancestor
102444514|NCT01308619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102444515|NCT01308619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102444516|NCT02611752|Buprenorphine|buprenorphine|mesh-list
102444517|NCT02611752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102444518|NCT02611752|Narcotics|narcotics|mesh-ancestor
102444519|NCT02611752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102444520|NCT02611752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444521|NCT02611752|Analgesics|analgesics|mesh-ancestor
102444522|NCT02611752|Sensory System Agents|sensory system agents|mesh-ancestor
102444523|NCT02611752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102444524|NCT02611752|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102444525|NCT01307605|Rituximab|rituximab|mesh-list
102444526|NCT01307605|Lenalidomide|lenalidomide|mesh-list
102444527|NCT01307605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102444528|NCT01307605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102444529|NCT01307605|Immunologic Factors|immunologic factors|mesh-ancestor
102444530|NCT01307605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444531|NCT01307605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102444532|NCT01307605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102444533|NCT01307605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102444534|NCT01307605|Growth Substances|growth substances|mesh-ancestor
102444535|NCT01307605|Growth Inhibitors|growth inhibitors|mesh-ancestor
102444536|NCT04758689|Methotrexate|methotrexate|mesh-list
102444537|NCT04758689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102444538|NCT04758689|Abortifacient Agents|abortifacient agents|mesh-ancestor
102444539|NCT04758689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102444540|NCT04758689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444541|NCT04758689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102444542|NCT04758689|Antimetabolites|antimetabolites|mesh-ancestor
102444543|NCT04758689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444544|NCT04758689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102444545|NCT04758689|Dermatologic Agents|dermatologic agents|mesh-ancestor
102444546|NCT04758689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102444547|NCT04758689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102444548|NCT04758689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102444549|NCT04758689|Immunologic Factors|immunologic factors|mesh-ancestor
102444550|NCT04758689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102444551|NCT04758689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102444552|NCT01451333|Efavirenz|efavirenz|mesh-list
102444553|NCT01451333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102444554|NCT01451333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102444555|NCT01451333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102444556|NCT01451333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444557|NCT01451333|Antiviral Agents|antiviral agents|mesh-ancestor
102444558|NCT01451333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102444559|NCT01451333|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102444560|NCT01451333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102444561|NCT01451333|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102444562|NCT01451333|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102444563|NCT01451333|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102444564|NCT01451333|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102444565|NCT01702831|Lenalidomide|lenalidomide|mesh-list
102444566|NCT01702831|Melphalan|melphalan|mesh-list
102444567|NCT01702831|Busulfan|busulfan|mesh-list
102444568|NCT01702831|Immunologic Factors|immunologic factors|mesh-ancestor
102444569|NCT01702831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444570|NCT01702831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102444571|NCT01702831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102444572|NCT01702831|Growth Substances|growth substances|mesh-ancestor
102444573|NCT01702831|Growth Inhibitors|growth inhibitors|mesh-ancestor
102444574|NCT01702831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102444575|NCT01702831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102444576|NCT01702831|Alkylating Agents|alkylating agents|mesh-ancestor
102444577|NCT01702831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444578|NCT01702831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102444579|NCT01702831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102444580|NCT03045510|Decitabine|decitabine|mesh-list
102074898|NCT03622047|Analgesics|analgesics|mesh-ancestor
102444581|NCT03045510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102444582|NCT03045510|Antimetabolites|antimetabolites|mesh-ancestor
102444583|NCT03045510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444584|NCT03045510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102444585|NCT03045510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102444586|NCT01451879|Miglustat|miglustat|mesh-list
102444587|NCT01451879|Rituximab|rituximab|mesh-list
102444588|NCT01451879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102444589|NCT01451879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102444590|NCT01451879|Immunologic Factors|immunologic factors|mesh-ancestor
102074916|NCT05128630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102444591|NCT01451879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444592|NCT01451879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102444593|NCT01451879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102444594|NCT01451879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444595|NCT01451879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102444596|NCT01451879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102444597|NCT01451879|Antiviral Agents|antiviral agents|mesh-ancestor
102444598|NCT01451879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102444599|NCT01451879|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102444600|NCT01451879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102444601|NCT03045198|Azithromycin|azithromycin|mesh-list
102444602|NCT03045198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102444603|NCT03045198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102444604|NCT01452113|Vildagliptin|vildagliptin|mesh-list
102444605|NCT01452113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102444606|NCT01452113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444607|NCT01452113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102444608|NCT01452113|Protease Inhibitors|protease inhibitors|mesh-ancestor
102444609|NCT01452113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102444610|NCT01452113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444611|NCT02022709|Fluvoxamine|fluvoxamine|mesh-list
102444612|NCT02022709|Sertraline|sertraline|mesh-list
102444613|NCT02022709|Fluoxetine|fluoxetine|mesh-list
102444614|NCT02022709|Paroxetine|paroxetine|mesh-list
102444615|NCT02022709|Citalopram|citalopram|mesh-list
102444616|NCT02022709|Antidepressive Agents|antidepressive agents|mesh-ancestor
102444617|NCT02022709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102444618|NCT02022709|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102444619|NCT02022709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102444620|NCT02022709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102444621|NCT02022709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444622|NCT02022709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102444623|NCT02022709|Serotonin Agents|serotonin agents|mesh-ancestor
102444624|NCT02022709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444625|NCT02022709|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102444626|NCT02022709|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102444627|NCT02022709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102444628|NCT02022709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102444629|NCT02022709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102444630|NCT02022709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102444631|NCT02022709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102074953|NCT02116842|Narcotics|narcotics|mesh-ancestor
102444632|NCT02022709|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102444633|NCT02022709|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102444634|NCT02635841|Deferiprone|deferiprone|mesh-list
102444635|NCT02635841|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102444636|NCT02635841|Chelating Agents|chelating agents|mesh-ancestor
102444637|NCT02635841|Sequestering Agents|sequestering agents|mesh-ancestor
102444638|NCT02635841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074970|NCT04054089|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102074971|NCT04054089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102074972|NCT04054089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102074973|NCT04054089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074974|NCT04054089|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102074975|NCT04054089|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102074976|NCT04054089|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102444639|NCT00608725|Propranolol|propranolol|mesh-list
102444640|NCT00608725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102444641|NCT00608725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102444642|NCT00608725|Adrenergic Agents|adrenergic agents|mesh-ancestor
102444643|NCT00608725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102444644|NCT00608725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444645|NCT00608725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074978|NCT02120196|Rifaximin|rifaximin|mesh-list
102444646|NCT00608725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102444647|NCT00608725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102444648|NCT00608725|Vasodilator Agents|vasodilator agents|mesh-ancestor
102444649|NCT01452659|Relugolix|relugolix|mesh-list
102444650|NCT01452659|Androgen Antagonists|androgen antagonists|mesh-ancestor
102444651|NCT01452659|Hormone Antagonists|hormone antagonists|mesh-ancestor
102444652|NCT01452659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102074990|NCT05001802|Ropivacaine|ropivacaine|mesh-list
102444653|NCT01452659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444654|NCT01896349|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102444655|NCT01896349|Amitriptyline|amitriptyline|mesh-list
102444656|NCT01896349|Risperidone|risperidone|mesh-list
102444657|NCT01896349|Sulpiride|sulpiride|mesh-list
102444658|NCT01896349|Mirtazapine|mirtazapine|mesh-list
101395389|NCT00425152|Leucovorin|leucovorin|mesh-list
102444659|NCT01896349|Fluvoxamine|fluvoxamine|mesh-list
102444660|NCT01896349|Trazodone|trazodone|mesh-list
102444661|NCT01896349|Tranylcypromine|tranylcypromine|mesh-list
102444662|NCT01896349|Citalopram|citalopram|mesh-list
102444663|NCT01896349|Bupropion|bupropion|mesh-list
102444664|NCT01896349|Sertraline|sertraline|mesh-list
102444665|NCT01896349|Fluoxetine|fluoxetine|mesh-list
102444666|NCT01896349|Paroxetine|paroxetine|mesh-list
102444667|NCT01896349|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102444668|NCT01896349|Nortriptyline|nortriptyline|mesh-list
102444669|NCT01896349|Imipramine|imipramine|mesh-list
102444670|NCT01896349|Clomipramine|clomipramine|mesh-list
102444671|NCT01896349|Antidepressive Agents|antidepressive agents|mesh-list
102444672|NCT01896349|Escitalopram|escitalopram|mesh-list
102444673|NCT01896349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102444674|NCT01896349|Serotonin Agents|serotonin agents|mesh-ancestor
102444675|NCT01896349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102444676|NCT01896349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444677|NCT01896349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256338|NCT02387567|Lidocaine|lidocaine|mesh-list
102444678|NCT01896349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102444679|NCT01896349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102444680|NCT01896349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102444681|NCT01896349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102444682|NCT01896349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102444683|NCT01896349|Dopamine Agents|dopamine agents|mesh-ancestor
102444684|NCT01896349|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102444685|NCT01896349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102444686|NCT01896349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102444687|NCT01896349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102444688|NCT01896349|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102444689|NCT01896349|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102444690|NCT01896349|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102444691|NCT01896349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102444692|NCT01896349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102444693|NCT01896349|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102444694|NCT01896349|Analgesics|analgesics|mesh-ancestor
102444695|NCT01896349|Sensory System Agents|sensory system agents|mesh-ancestor
102444696|NCT01896349|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102444697|NCT01896349|Histamine Antagonists|histamine antagonists|mesh-ancestor
102444698|NCT01896349|Histamine Agents|histamine agents|mesh-ancestor
102444699|NCT01896349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102444700|NCT01896349|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102444701|NCT01896349|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102444702|NCT01896349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102444703|NCT01896349|Adrenergic Agents|adrenergic agents|mesh-ancestor
102444704|NCT01896349|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102444705|NCT01896349|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102444706|NCT01896349|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102444707|NCT01896349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102444708|NCT01896349|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102444709|NCT01896349|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102444710|NCT01896349|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102444711|NCT01896349|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102444712|NCT01452737|Bisacodyl|bisacodyl|mesh-list
102444713|NCT01452737|Cathartics|cathartics|mesh-ancestor
102075041|NCT02123628|Doxycycline|doxycycline|mesh-list
102444714|NCT01452737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102444715|NCT01452737|Laxatives|laxatives|mesh-ancestor
102444716|NCT00595933|Muramidase|muramidase|mesh-list
102444717|NCT00595933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102444718|NCT00580489|Fentanyl|fentanyl|mesh-list
102444719|NCT00580489|Morphine|morphine|mesh-list
102444720|NCT00580489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102444721|NCT00580489|Narcotics|narcotics|mesh-ancestor
102444722|NCT00580489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102075052|NCT02123628|Sulfamethoxazole|sulfamethoxazole|mesh-list
102444723|NCT00580489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444724|NCT00580489|Analgesics|analgesics|mesh-ancestor
102444725|NCT00580489|Sensory System Agents|sensory system agents|mesh-ancestor
102444726|NCT00580489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102444727|NCT00580489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102444728|NCT00580489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102444729|NCT00580489|Anesthetics, General|anesthetics, general|mesh-ancestor
102444730|NCT00580489|Anesthetics|anesthetics|mesh-ancestor
102444731|NCT01659307|Aspirin|aspirin|mesh-list
102444732|NCT01659307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102444733|NCT01659307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102444734|NCT01659307|Analgesics|analgesics|mesh-ancestor
102444735|NCT01659307|Sensory System Agents|sensory system agents|mesh-ancestor
102444736|NCT01659307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102444737|NCT01659307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396078|NCT00327769|Fulvestrant|fulvestrant|mesh-list
102444738|NCT01659307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102444739|NCT01659307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102444740|NCT01659307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102444741|NCT01659307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102444742|NCT01659307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444743|NCT01659307|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102444744|NCT01659307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102444745|NCT01659307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102444746|NCT01659307|Antipyretics|antipyretics|mesh-ancestor
102444747|NCT01594476|Levonorgestrel|levonorgestrel|mesh-list
102444748|NCT01594476|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102444749|NCT01594476|Contraceptive Agents|contraceptive agents|mesh-ancestor
102075079|NCT02651116|Dextromethorphan|dextromethorphan|mesh-list
102444750|NCT01594476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102444751|NCT01594476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444752|NCT01594476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102444753|NCT01594476|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102256409|NCT04787471|Dermatologic Agents|dermatologic agents|mesh-ancestor
102444754|NCT01594476|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102444755|NCT04391231|Pentoxifylline|pentoxifylline|mesh-list
102444756|NCT04391231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102444757|NCT04391231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102444758|NCT04391231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444759|NCT04391231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102444760|NCT04391231|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102444761|NCT04391231|Protective Agents|protective agents|mesh-ancestor
102444762|NCT04391231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444763|NCT04391231|Vasodilator Agents|vasodilator agents|mesh-ancestor
102444764|NCT04391231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102444765|NCT04391231|Antioxidants|antioxidants|mesh-ancestor
102444766|NCT04872270|Caffeine|caffeine|mesh-list
102444767|NCT04872270|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102075091|NCT03652467|Hormones|hormones|mesh-ancestor
102444768|NCT04872270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444769|NCT04872270|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102444770|NCT04872270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102444771|NCT04872270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444772|NCT04872270|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102444773|NCT04872270|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102444774|NCT04872270|Purinergic Agents|purinergic agents|mesh-ancestor
102444775|NCT04872270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102444776|NCT04872192|Anesthetics|anesthetics|mesh-list
102444777|NCT04872192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102444778|NCT04872192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444779|NCT01624285|Sorafenib|sorafenib|mesh-list
102444780|NCT01624285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102444781|NCT01624285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102444782|NCT01624285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102444783|NCT01624285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444784|NCT01454609|Clonidine|clonidine|mesh-list
102444785|NCT01454609|Bupivacaine|bupivacaine|mesh-list
102444786|NCT01454609|Anesthetics, Local|anesthetics, local|mesh-ancestor
102444787|NCT01454609|Anesthetics|anesthetics|mesh-ancestor
102444788|NCT01454609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102444789|NCT01454609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444790|NCT01454609|Sensory System Agents|sensory system agents|mesh-ancestor
102444791|NCT01454609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102444792|NCT01454609|Analgesics|analgesics|mesh-ancestor
102444793|NCT01454609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102444794|NCT01454609|Sympatholytics|sympatholytics|mesh-ancestor
102444795|NCT01454609|Autonomic Agents|autonomic agents|mesh-ancestor
102444796|NCT01454609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102444797|NCT01454609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102444798|NCT01454609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102444799|NCT01454609|Adrenergic Agents|adrenergic agents|mesh-ancestor
102444800|NCT01454609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102444801|NCT01454609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444802|NCT03042234|Insulin|insulin|mesh-list
102444803|NCT03042234|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102444804|NCT03042234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102444805|NCT03042234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444806|NCT02905799|Resveratrol|resveratrol|mesh-list
102444807|NCT02905799|Antioxidants|antioxidants|mesh-ancestor
102444808|NCT02905799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444809|NCT02905799|Protective Agents|protective agents|mesh-ancestor
102444810|NCT02905799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444811|NCT02905799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102075130|NCT03552432|Protease Inhibitors|protease inhibitors|mesh-ancestor
102444812|NCT02905799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102444813|NCT00469183|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
102444814|NCT00469183|Tretinoin|tretinoin|mesh-list
102444815|NCT00469183|Hydroquinone|hydroquinone|mesh-list
102444816|NCT00469183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102444817|NCT00469183|Keratolytic Agents|keratolytic agents|mesh-ancestor
102444818|NCT00469183|Dermatologic Agents|dermatologic agents|mesh-ancestor
102444819|NCT00469183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102444820|NCT00469183|Glucocorticoids|glucocorticoids|mesh-ancestor
102444821|NCT00469183|Hormones|hormones|mesh-ancestor
102444822|NCT00469183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102444823|NCT00469183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444824|NCT00469183|Antioxidants|antioxidants|mesh-ancestor
102444825|NCT00469183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444826|NCT00469183|Protective Agents|protective agents|mesh-ancestor
102444827|NCT00469183|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102444828|NCT01455935|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102444829|NCT01455935|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102444830|NCT01455935|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102444831|NCT01455935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444832|NCT00468715|Bicalutamide|bicalutamide|mesh-list
102444833|NCT00468715|Androgen Antagonists|androgen antagonists|mesh-ancestor
102444834|NCT00468715|Hormone Antagonists|hormone antagonists|mesh-ancestor
102444835|NCT00468715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102444836|NCT00468715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444837|NCT00468715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102444838|NCT01456247|Lansoprazole|lansoprazole|mesh-list
102444839|NCT01456247|Dexlansoprazole|dexlansoprazole|mesh-list
102444840|NCT01456247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102444841|NCT01456247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102444842|NCT01456247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102444843|NCT01456247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102444844|NCT01456247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444845|NCT01456325|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102444846|NCT01456325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102444847|NCT01456325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102075168|NCT02788656|Valsartan|valsartan|mesh-list
102444848|NCT01456325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102444849|NCT01456325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444851|NCT04866498|Sensory System Agents|sensory system agents|mesh-ancestor
102444852|NCT04866498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102444853|NCT04866498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444854|NCT04866654|Nivolumab|nivolumab|mesh-list
102444855|NCT04866654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102444856|NCT04866654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102444857|NCT04866654|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102444858|NCT04866654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444859|NCT01456715|Vaccines|vaccines|mesh-list
102444860|NCT01456715|Immunologic Factors|immunologic factors|mesh-ancestor
102075174|NCT02788656|Enzyme Inhibitors|enzyme inhibitors|mesh-list
102444861|NCT01456715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444862|NCT01895569|Metformin|metformin|mesh-list
102444863|NCT01895569|Pioglitazone|pioglitazone|mesh-list
102444864|NCT01895569|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102444865|NCT01895569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102444866|NCT01895569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444867|NCT01895569|Incretins|incretins|mesh-ancestor
102444868|NCT01895569|Hormones|hormones|mesh-ancestor
102444869|NCT01895569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102444870|NCT01895569|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102444871|NCT01895569|Protease Inhibitors|protease inhibitors|mesh-ancestor
102444872|NCT01895569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102444873|NCT01895569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444874|NCT01457261|Albuterol|albuterol|mesh-list
102444875|NCT01457261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102444876|NCT01457261|Autonomic Agents|autonomic agents|mesh-ancestor
102444877|NCT01457261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102444878|NCT01457261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444879|NCT01457261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102444880|NCT01457261|Respiratory System Agents|respiratory system agents|mesh-ancestor
102444881|NCT01457261|Tocolytic Agents|tocolytic agents|mesh-ancestor
102444882|NCT01457261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102444883|NCT01457261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102444884|NCT01457261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102444885|NCT01457261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102444886|NCT01457261|Adrenergic Agents|adrenergic agents|mesh-ancestor
102444887|NCT01457261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102444888|NCT01457261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444889|NCT01457495|Edetic Acid|edetic acid|mesh-list
102444890|NCT01457495|Pentetic Acid|pentetic acid|mesh-list
102444891|NCT01457495|Antidotes|antidotes|mesh-ancestor
102444892|NCT01457495|Protective Agents|protective agents|mesh-ancestor
102075207|NCT02117466|Cetuximab|cetuximab|mesh-list
102444893|NCT01457495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444894|NCT01457495|Chelating Agents|chelating agents|mesh-ancestor
102444895|NCT01457495|Sequestering Agents|sequestering agents|mesh-ancestor
102444896|NCT01457495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444897|NCT01457495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102444898|NCT01457495|Anticoagulants|anticoagulants|mesh-ancestor
102444899|NCT01457495|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102444900|NCT04778137|Omalizumab|omalizumab|mesh-list
102444901|NCT04778137|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102444902|NCT04778137|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102444903|NCT04778137|Respiratory System Agents|respiratory system agents|mesh-ancestor
102444904|NCT03815929|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102444905|NCT03815929|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102444907|NCT03815929|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102444908|NCT03815929|Estrogens|estrogens|mesh-ancestor
102444909|NCT03815929|Hormones|hormones|mesh-ancestor
102444910|NCT03815929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102444911|NCT03815929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444912|NCT03815929|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102444913|NCT03815929|Contraceptive Agents|contraceptive agents|mesh-ancestor
102444914|NCT03815929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102444915|NCT03815929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102444916|NCT00394147|Gemcitabine|gemcitabine|mesh-list
102444917|NCT00394147|Pemetrexed|pemetrexed|mesh-list
102444918|NCT00394147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102444919|NCT00394147|Antimetabolites|antimetabolites|mesh-ancestor
102444920|NCT00394147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444921|NCT00394147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102444922|NCT00394147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102444923|NCT00394147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102444924|NCT00394147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102444925|NCT01458041|Iloprost|iloprost|mesh-list
102075243|NCT02288078|Hormones|hormones|mesh-ancestor
102444926|NCT01458041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102444927|NCT01458041|Vasodilator Agents|vasodilator agents|mesh-ancestor
102444928|NCT02610816|Fluticasone|fluticasone|mesh-list
102444929|NCT02610816|Xhance|xhance|mesh-list
102444930|NCT02610816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102444931|NCT02610816|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102444932|NCT02610816|Autonomic Agents|autonomic agents|mesh-ancestor
102444933|NCT02610816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102444934|NCT02610816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444935|NCT02610816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102444936|NCT02610816|Respiratory System Agents|respiratory system agents|mesh-ancestor
102444937|NCT02610816|Dermatologic Agents|dermatologic agents|mesh-ancestor
102444938|NCT02610816|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102444939|NCT00332605|Acetylcysteine|acetylcysteine|mesh-list
102444940|NCT00332605|Naltrexone|naltrexone|mesh-list
102444941|NCT00332605|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102444942|NCT00332605|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102444943|NCT00332605|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102444944|NCT00332605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444945|NCT00332605|Sensory System Agents|sensory system agents|mesh-ancestor
102444946|NCT00332605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102444947|NCT00332605|Antiviral Agents|antiviral agents|mesh-ancestor
102444948|NCT00332605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102444949|NCT00332605|Expectorants|expectorants|mesh-ancestor
102444950|NCT00332605|Respiratory System Agents|respiratory system agents|mesh-ancestor
102444951|NCT00332605|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102444952|NCT00332605|Antioxidants|antioxidants|mesh-ancestor
102444953|NCT00332605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444954|NCT00332605|Protective Agents|protective agents|mesh-ancestor
102444955|NCT00332605|Antidotes|antidotes|mesh-ancestor
102444956|NCT01458743|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
102444957|NCT01458743|Cephalosporins|cephalosporins|mesh-list
102444958|NCT01458743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102444959|NCT01458743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102444960|NCT01415583|Dexamethasone|dexamethasone|mesh-list
102444961|NCT01415583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102444962|NCT01415583|Antiemetics|antiemetics|mesh-ancestor
102444963|NCT01415583|Autonomic Agents|autonomic agents|mesh-ancestor
102444964|NCT01415583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102444965|NCT01415583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444966|NCT01415583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102444967|NCT01415583|Glucocorticoids|glucocorticoids|mesh-ancestor
102444968|NCT01415583|Hormones|hormones|mesh-ancestor
102444969|NCT01415583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102444970|NCT01415583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102444971|NCT01415583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102444972|NCT01458977|Tenofovir|tenofovir|mesh-list
102444973|NCT01458977|Emtricitabine|emtricitabine|mesh-list
102444974|NCT01458977|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102444975|NCT01458977|Antiviral Agents|antiviral agents|mesh-ancestor
102444976|NCT01458977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102444977|NCT01458977|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102444978|NCT01458977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102444979|NCT01458977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102444980|NCT01458977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444981|NCT01458977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102444982|NCT01458977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102444983|NCT02508311|Albuterol|albuterol|mesh-list
102444984|NCT02508311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102444985|NCT02508311|Autonomic Agents|autonomic agents|mesh-ancestor
102444986|NCT02508311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102444987|NCT02508311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102444988|NCT02508311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102444989|NCT02508311|Respiratory System Agents|respiratory system agents|mesh-ancestor
102444990|NCT02508311|Tocolytic Agents|tocolytic agents|mesh-ancestor
102444991|NCT02508311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102444992|NCT02508311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102444993|NCT02508311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102444994|NCT02508311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102444995|NCT02508311|Adrenergic Agents|adrenergic agents|mesh-ancestor
102444996|NCT02508311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102444997|NCT02508311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102444998|NCT00256399|Alfuzosin|alfuzosin|mesh-list
102444999|NCT00256399|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102445000|NCT00256399|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102445001|NCT00256399|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102445002|NCT00256399|Adrenergic Agents|adrenergic agents|mesh-ancestor
102445003|NCT00256399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102445004|NCT00256399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445005|NCT00256399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445006|NCT00256399|Urological Agents|urological agents|mesh-ancestor
102445007|NCT01459133|Insulin|insulin|mesh-list
102445008|NCT01459133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102445009|NCT01459133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445010|NCT01459211|Dexamethasone|dexamethasone|mesh-list
102445011|NCT01459211|Lenalidomide|lenalidomide|mesh-list
102445012|NCT01459211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102445013|NCT01459211|Antiemetics|antiemetics|mesh-ancestor
102445014|NCT01459211|Autonomic Agents|autonomic agents|mesh-ancestor
102445015|NCT01459211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102445016|NCT01459211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445017|NCT01459211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102445018|NCT01459211|Glucocorticoids|glucocorticoids|mesh-ancestor
102445019|NCT01459211|Hormones|hormones|mesh-ancestor
102445020|NCT01459211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102445021|NCT01459211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102445022|NCT01459211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102445023|NCT01459211|Immunologic Factors|immunologic factors|mesh-ancestor
102445024|NCT01459211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102445025|NCT01459211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102445026|NCT01459211|Growth Substances|growth substances|mesh-ancestor
102445027|NCT01459211|Growth Inhibitors|growth inhibitors|mesh-ancestor
102445028|NCT00198991|Cytarabine|cytarabine|mesh-list
102445029|NCT00198991|Dexamethasone|dexamethasone|mesh-list
102445030|NCT00198991|Prednisolone|prednisolone|mesh-list
102445031|NCT00198991|Cyclophosphamide|cyclophosphamide|mesh-list
102445032|NCT00198991|Methotrexate|methotrexate|mesh-list
102445033|NCT00198991|Fludarabine|fludarabine|mesh-list
102445034|NCT00198991|Etoposide|etoposide|mesh-list
102445035|NCT00198991|Etoposide phosphate|etoposide phosphate|mesh-list
102445036|NCT00198991|Vincristine|vincristine|mesh-list
102445037|NCT00198991|Doxorubicin|doxorubicin|mesh-list
102445038|NCT00198991|Daunorubicin|daunorubicin|mesh-list
102075341|NCT04053543|CXA-10|cxa-10|mesh-list
102445039|NCT00198991|Asparaginase|asparaginase|mesh-list
102445040|NCT00198991|Mercaptopurine|mercaptopurine|mesh-list
102445041|NCT00198991|Idarubicin|idarubicin|mesh-list
102445042|NCT00198991|Cladribine|cladribine|mesh-list
102445043|NCT00198991|Thioguanine|thioguanine|mesh-list
102445044|NCT00198991|Vindesine|vindesine|mesh-list
102445045|NCT00198991|Pegaspargase|pegaspargase|mesh-list
102445046|NCT00198991|Teniposide|teniposide|mesh-list
102445047|NCT00198991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102445048|NCT00198991|Immunologic Factors|immunologic factors|mesh-ancestor
102445049|NCT00198991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445050|NCT00198991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102445051|NCT00198991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102445052|NCT00198991|Alkylating Agents|alkylating agents|mesh-ancestor
102445053|NCT00198991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445054|NCT00198991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102445055|NCT00198991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102445056|NCT00198991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102445057|NCT00198991|Antiemetics|antiemetics|mesh-ancestor
102445058|NCT00198991|Autonomic Agents|autonomic agents|mesh-ancestor
102445059|NCT00198991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102445060|NCT00198991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102445061|NCT00198991|Glucocorticoids|glucocorticoids|mesh-ancestor
102445063|NCT00198991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102445064|NCT00198991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102445065|NCT00198991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102445066|NCT00198991|Abortifacient Agents|abortifacient agents|mesh-ancestor
102445067|NCT00198991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102445068|NCT00198991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102445069|NCT00198991|Antimetabolites|antimetabolites|mesh-ancestor
102445070|NCT00198991|Dermatologic Agents|dermatologic agents|mesh-ancestor
102445071|NCT00198991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102445072|NCT00198991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102445073|NCT00198991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102445074|NCT00198991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102445075|NCT00198991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102445076|NCT00198991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102445077|NCT00198991|Antiviral Agents|antiviral agents|mesh-ancestor
102445078|NCT00198991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102445079|NCT00198991|Tubulin Modulators|tubulin modulators|mesh-ancestor
102445080|NCT00198991|Antimitotic Agents|antimitotic agents|mesh-ancestor
102445081|NCT00198991|Mitosis Modulators|mitosis modulators|mesh-ancestor
102445082|NCT00198991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102445083|NCT01459367|Lansoprazole|lansoprazole|mesh-list
102445084|NCT01459367|Dexlansoprazole|dexlansoprazole|mesh-list
102445085|NCT01459367|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102445086|NCT01459367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102445087|NCT01459367|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102445088|NCT01459367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102445089|NCT01459367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445090|NCT04777591|Bupivacaine|bupivacaine|mesh-list
102445091|NCT04777591|Anesthetics, Local|anesthetics, local|mesh-ancestor
102445092|NCT04777591|Anesthetics|anesthetics|mesh-ancestor
102445093|NCT04777591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102445094|NCT04777591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445095|NCT04777591|Sensory System Agents|sensory system agents|mesh-ancestor
102445096|NCT04777591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102445097|NCT01459601|Cabergoline|cabergoline|mesh-list
102445098|NCT01459601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102445099|NCT01459601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102445100|NCT01459601|Dopamine Agonists|dopamine agonists|mesh-ancestor
102445101|NCT01459601|Dopamine Agents|dopamine agents|mesh-ancestor
102445102|NCT01459601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102075399|NCT03318874|Immunologic Factors|immunologic factors|mesh-ancestor
102445103|NCT01459601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445104|NCT01459601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445105|NCT01418001|Gemcitabine|gemcitabine|mesh-list
102445106|NCT01418001|Docetaxel|docetaxel|mesh-list
102445107|NCT01418001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102445108|NCT01418001|Antimetabolites|antimetabolites|mesh-ancestor
102445109|NCT01418001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075406|NCT03551652|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102445110|NCT01418001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102445111|NCT01418001|Tubulin Modulators|tubulin modulators|mesh-ancestor
102445112|NCT01418001|Antimitotic Agents|antimitotic agents|mesh-ancestor
102445113|NCT01418001|Mitosis Modulators|mitosis modulators|mesh-ancestor
102445114|NCT04776889|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102445115|NCT04776889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102445116|NCT04776889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102445117|NCT04776889|Antimetabolites|antimetabolites|mesh-ancestor
102445118|NCT04776889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445119|NCT04776889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102445120|NCT04776889|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102445121|NCT04776889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102445122|NCT01542255|Cyclophosphamide|cyclophosphamide|mesh-list
102445123|NCT01542255|Dacarbazine|dacarbazine|mesh-list
102445124|NCT01542255|Vinblastine|vinblastine|mesh-list
102445125|NCT01542255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102445126|NCT01542255|Immunologic Factors|immunologic factors|mesh-ancestor
102445127|NCT01542255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445128|NCT01542255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102445129|NCT01542255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102445130|NCT01542255|Alkylating Agents|alkylating agents|mesh-ancestor
102445131|NCT01542255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445132|NCT01542255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102445133|NCT01542255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102445134|NCT01542255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102445135|NCT01542255|Tubulin Modulators|tubulin modulators|mesh-ancestor
102445136|NCT01542255|Antimitotic Agents|antimitotic agents|mesh-ancestor
102445137|NCT01542255|Mitosis Modulators|mitosis modulators|mesh-ancestor
102445138|NCT01456481|Midodrine|midodrine|mesh-list
102445139|NCT01456481|Sympathomimetics|sympathomimetics|mesh-ancestor
102445140|NCT01456481|Autonomic Agents|autonomic agents|mesh-ancestor
102445141|NCT01456481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102445142|NCT01456481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445143|NCT01456481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102445144|NCT01456481|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102445145|NCT01456481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102445146|NCT01456481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102445147|NCT01456481|Adrenergic Agents|adrenergic agents|mesh-ancestor
102445148|NCT01456481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102445149|NCT01456481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445150|NCT02872259|Pembrolizumab|pembrolizumab|mesh-list
102445151|NCT02872259|Trametinib|trametinib|mesh-list
102445152|NCT02872259|Dabrafenib|dabrafenib|mesh-list
102445153|NCT02872259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102445154|NCT02872259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102445155|NCT02872259|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102445156|NCT02872259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445157|NCT02872259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102445158|NCT02872259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102445159|NCT04776655|Leucovorin|leucovorin|mesh-list
102445160|NCT04776655|Bevacizumab|bevacizumab|mesh-list
102445161|NCT04776655|Cetuximab|cetuximab|mesh-list
102445162|NCT04776655|Fluorouracil|fluorouracil|mesh-list
102445163|NCT04776655|Irinotecan|irinotecan|mesh-list
102445164|NCT04776655|Calcium|calcium|mesh-list
102445165|NCT04776655|Levoleucovorin|levoleucovorin|mesh-list
102445166|NCT04776655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102445167|NCT04776655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102445168|NCT04776655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102445169|NCT04776655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102445170|NCT04776655|Growth Substances|growth substances|mesh-ancestor
102445171|NCT04776655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445172|NCT04776655|Growth Inhibitors|growth inhibitors|mesh-ancestor
102445173|NCT04776655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102445174|NCT04776655|Antimetabolites|antimetabolites|mesh-ancestor
102445175|NCT04776655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445176|NCT04776655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102075455|NCT05724446|Antiemetics|antiemetics|mesh-ancestor
102445177|NCT04776655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102445178|NCT04776655|Immunologic Factors|immunologic factors|mesh-ancestor
102445179|NCT04776655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102445180|NCT04776655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102445181|NCT04776655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102445182|NCT04776655|Antidotes|antidotes|mesh-ancestor
102445183|NCT04776655|Protective Agents|protective agents|mesh-ancestor
102445184|NCT04776655|Vitamin B Complex|vitamin b complex|mesh-ancestor
102445185|NCT04776655|Vitamins|vitamins|mesh-ancestor
102445186|NCT04776655|Micronutrients|micronutrients|mesh-ancestor
102445187|NCT01455233|Moxifloxacin|moxifloxacin|mesh-list
102445188|NCT01455233|Besifloxacin|besifloxacin|mesh-list
102445189|NCT01455233|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102445190|NCT01455233|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102445191|NCT01455233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102445192|NCT01455233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102445193|NCT01455233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102445194|NCT01455233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102445195|NCT01455233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102445196|NCT01455233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102445197|NCT01455233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445198|NCT01455233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102445199|NCT01455233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102445200|NCT01455233|Contraceptive Agents|contraceptive agents|mesh-ancestor
102445201|NCT01455233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102445202|NCT01455233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075493|NCT04367103|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102445203|NCT01455233|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102445204|NCT01455233|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102445205|NCT01455233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102445206|NCT01459679|Riboflavin|riboflavin|mesh-list
102445207|NCT01459679|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102445208|NCT01459679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102445209|NCT01459679|Vitamin B Complex|vitamin b complex|mesh-ancestor
102445210|NCT01459679|Vitamins|vitamins|mesh-ancestor
102445211|NCT01459679|Micronutrients|micronutrients|mesh-ancestor
102445212|NCT01459679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445213|NCT01459679|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102445214|NCT01459679|Dermatologic Agents|dermatologic agents|mesh-ancestor
102445215|NCT00048295|Alicaforsen|alicaforsen|mesh-list
102445216|NCT00048295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102445217|NCT00048295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102445218|NCT00048295|Immunologic Factors|immunologic factors|mesh-ancestor
102445219|NCT00048295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445220|NCT01455857|Exenatide|exenatide|mesh-list
102445221|NCT01455857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102445222|NCT01455857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445223|NCT01455857|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102445224|NCT01455857|Incretins|incretins|mesh-ancestor
102445225|NCT01455857|Hormones|hormones|mesh-ancestor
102445226|NCT01455857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102445227|NCT03043248|Digoxin|digoxin|mesh-list
102445228|NCT03043248|Midazolam|midazolam|mesh-list
102445229|NCT03043248|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102445230|NCT03043248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102445231|NCT03043248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102445232|NCT03043248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445233|NCT03043248|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102445234|NCT03043248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102445235|NCT03043248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102445236|NCT03043248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102445237|NCT03043248|Anesthetics, General|anesthetics, general|mesh-ancestor
102445238|NCT03043248|Anesthetics|anesthetics|mesh-ancestor
102445239|NCT03043248|GABA Modulators|gaba modulators|mesh-ancestor
102445240|NCT03043248|GABA Agents|gaba agents|mesh-ancestor
102445241|NCT03043248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102445242|NCT03043248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445243|NCT03043248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102445244|NCT03043248|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102445245|NCT03043248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102445246|NCT03043248|Protective Agents|protective agents|mesh-ancestor
102445247|NCT04843631|Ustekinumab|ustekinumab|mesh-list
102445248|NCT04843631|Dermatologic Agents|dermatologic agents|mesh-ancestor
102445249|NCT03043326|Tenofovir|tenofovir|mesh-list
102445250|NCT03043326|Emtricitabine|emtricitabine|mesh-list
102445251|NCT03043326|Antiviral Agents|antiviral agents|mesh-ancestor
102445252|NCT03043326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102445253|NCT03043326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102445254|NCT03043326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102445255|NCT03043326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102445256|NCT03043326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445257|NCT03043326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102445258|NCT03043326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102445259|NCT04845737|Vitamin D|vitamin d|mesh-list
102445260|NCT04845737|Vitamins|vitamins|mesh-ancestor
102445261|NCT04845737|Micronutrients|micronutrients|mesh-ancestor
102445262|NCT04845737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445263|NCT04845737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102445264|NCT04849715|Rituximab|rituximab|mesh-list
102445265|NCT04849715|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102445266|NCT04849715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102445267|NCT04849715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102445268|NCT04849715|Immunologic Factors|immunologic factors|mesh-ancestor
102445269|NCT04849715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445270|NCT04849715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102445271|NCT04849715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101399191|NCT04800393|Propofol|propofol|mesh-list
102445272|NCT04849715|Alkylating Agents|alkylating agents|mesh-ancestor
102445273|NCT04849715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445274|NCT03044964|Ranolazine|ranolazine|mesh-list
102445275|NCT03044964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102445276|NCT03044964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102445277|NCT03044964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445278|NCT01419639|Everolimus|everolimus|mesh-list
102445279|NCT01419639|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102445280|NCT01419639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102445281|NCT01419639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102445282|NCT01419639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445283|NCT01419639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102445284|NCT01419639|Immunologic Factors|immunologic factors|mesh-ancestor
102445285|NCT01419639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445286|NCT01419639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102445288|NCT02856893|Osimertinib|osimertinib|mesh-list
102445289|NCT02856893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102445290|NCT02856893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102445291|NCT02856893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102445292|NCT02856893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445293|NCT01419795|Rituximab|rituximab|mesh-list
102445294|NCT01419795|Lenalidomide|lenalidomide|mesh-list
102445295|NCT01419795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102445296|NCT01419795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102445297|NCT01419795|Immunologic Factors|immunologic factors|mesh-ancestor
102445298|NCT01419795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445299|NCT01419795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102445300|NCT01419795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102445301|NCT01419795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102445302|NCT01419795|Growth Substances|growth substances|mesh-ancestor
102445303|NCT01419795|Growth Inhibitors|growth inhibitors|mesh-ancestor
102445304|NCT04783753|Itraconazole|itraconazole|mesh-list
102445305|NCT04783753|Quinidine|quinidine|mesh-list
102445306|NCT04783753|Carbamazepine|carbamazepine|mesh-list
102445307|NCT04783753|Antifungal Agents|antifungal agents|mesh-ancestor
102445308|NCT04783753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102445309|NCT04783753|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102445310|NCT04783753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102445311|NCT04783753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102445312|NCT04783753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445313|NCT04783753|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102445314|NCT04783753|Hormone Antagonists|hormone antagonists|mesh-ancestor
102133719|NCT02295189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445315|NCT04783753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102445316|NCT04783753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445317|NCT04783753|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102445318|NCT04783753|Anticonvulsants|anticonvulsants|mesh-ancestor
102445319|NCT04783753|Antimanic Agents|antimanic agents|mesh-ancestor
102445320|NCT04783753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102445321|NCT04783753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102445322|NCT04783753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102445323|NCT04783753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102445324|NCT04783753|Analgesics|analgesics|mesh-ancestor
102445325|NCT04783753|Sensory System Agents|sensory system agents|mesh-ancestor
102445326|NCT04783753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102445327|NCT04783753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102445328|NCT04783753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102445329|NCT04783753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102445330|NCT04783753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102445331|NCT04783753|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102445332|NCT04783753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102445333|NCT04783753|Adrenergic Agents|adrenergic agents|mesh-ancestor
102445334|NCT04783753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102445335|NCT04783753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102445336|NCT04783753|Antimalarials|antimalarials|mesh-ancestor
102445337|NCT04783753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102445338|NCT04783753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102075610|NCT04410874|Vaccines|vaccines|mesh-list
102445339|NCT04783753|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102445340|NCT04783753|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102445341|NCT04783753|Cholinergic Agents|cholinergic agents|mesh-ancestor
102445342|NCT04783753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102445343|NCT04783753|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102445344|NCT02856581|Varenicline|varenicline|mesh-list
102445345|NCT02856581|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102445346|NCT02856581|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102445347|NCT02856581|Cholinergic Agents|cholinergic agents|mesh-ancestor
102445348|NCT02856581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102445349|NCT02856581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445350|NCT02856581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445351|NCT03042000|Capecitabine|capecitabine|mesh-list
102445352|NCT03042000|Oxaliplatin|oxaliplatin|mesh-list
102445353|NCT03042000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102445354|NCT03042000|Antimetabolites|antimetabolites|mesh-ancestor
101377307|NCT00099450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102075625|NCT02124954|Anesthetics, General|anesthetics, general|mesh-ancestor
102075626|NCT02124954|Anesthetics|anesthetics|mesh-ancestor
102075627|NCT02124954|GABA Modulators|gaba modulators|mesh-ancestor
102075628|NCT02124954|GABA Agents|gaba agents|mesh-ancestor
102075629|NCT02124954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102075630|NCT02124954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075631|NCT02124954|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102075632|NCT02124954|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102075633|NCT02124954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102075634|NCT02124954|Protective Agents|protective agents|mesh-ancestor
102075635|NCT04441112|Triamcinolone|triamcinolone|mesh-list
102075636|NCT04441112|Ketorolac|ketorolac|mesh-list
102075637|NCT04441112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102075638|NCT04441112|Glucocorticoids|glucocorticoids|mesh-ancestor
102075639|NCT04441112|Hormones|hormones|mesh-ancestor
102075640|NCT04441112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101399716|NCT02682485|Neomycin|neomycin|mesh-list
102445355|NCT03042000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445356|NCT03042000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102445357|NCT01039285|Poractant alfa|poractant alfa|mesh-list
102445358|NCT01039285|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
102445359|NCT01039285|Respiratory System Agents|respiratory system agents|mesh-ancestor
102445360|NCT03043482|Calcitriol|calcitriol|mesh-list
102075642|NCT04441112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102445361|NCT03043482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102445362|NCT03043482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445363|NCT03043482|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102445364|NCT03043482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102445365|NCT03043482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445366|NCT03043482|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102445367|NCT03043482|Vitamins|vitamins|mesh-ancestor
102445368|NCT03043482|Micronutrients|micronutrients|mesh-ancestor
102445369|NCT03043482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102445370|NCT04775563|Vaccines|vaccines|mesh-list
102445371|NCT04775563|Immunologic Factors|immunologic factors|mesh-ancestor
102445372|NCT04775563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445373|NCT01480089|Ropivacaine|ropivacaine|mesh-list
102445374|NCT01480089|Anesthetics, Local|anesthetics, local|mesh-ancestor
102445375|NCT01480089|Anesthetics|anesthetics|mesh-ancestor
102445376|NCT01480089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102445377|NCT01480089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445378|NCT01480089|Sensory System Agents|sensory system agents|mesh-ancestor
101399882|NCT02187224|Progesterone|progesterone|mesh-list
102445379|NCT01480089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102445380|NCT03523975|Rituximab|rituximab|mesh-list
102445381|NCT03523975|Lenalidomide|lenalidomide|mesh-list
102445382|NCT03523975|Venetoclax|venetoclax|mesh-list
102445383|NCT03523975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102445384|NCT03523975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102445385|NCT03523975|Immunologic Factors|immunologic factors|mesh-ancestor
102445386|NCT03523975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445387|NCT03523975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102445388|NCT03523975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102445389|NCT03523975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102445390|NCT03523975|Growth Substances|growth substances|mesh-ancestor
102445391|NCT03523975|Growth Inhibitors|growth inhibitors|mesh-ancestor
102445392|NCT01542645|Fentanyl|fentanyl|mesh-list
102445393|NCT01542645|Analgesics, Opioid|analgesics, opioid|mesh-list
102445394|NCT01542645|Methadone|methadone|mesh-list
102445395|NCT01542645|Narcotics|narcotics|mesh-ancestor
102445396|NCT01542645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102445397|NCT01542645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445398|NCT01542645|Analgesics|analgesics|mesh-ancestor
102445399|NCT01542645|Sensory System Agents|sensory system agents|mesh-ancestor
102445400|NCT01542645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102445401|NCT01542645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102445402|NCT01542645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102445403|NCT01542645|Anesthetics, General|anesthetics, general|mesh-ancestor
102445404|NCT01542645|Anesthetics|anesthetics|mesh-ancestor
102445405|NCT01542645|Antitussive Agents|antitussive agents|mesh-ancestor
102445406|NCT01542645|Respiratory System Agents|respiratory system agents|mesh-ancestor
102445407|NCT04857450|Ketamine|ketamine|mesh-list
102445408|NCT04857450|Etomidate|etomidate|mesh-list
102445409|NCT04857450|Analgesics|analgesics|mesh-ancestor
102445410|NCT04857450|Sensory System Agents|sensory system agents|mesh-ancestor
102445411|NCT04857450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102445412|NCT04857450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445413|NCT04857450|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102445414|NCT04857450|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102445415|NCT04857450|Anesthetics, General|anesthetics, general|mesh-ancestor
102445416|NCT04857450|Anesthetics|anesthetics|mesh-ancestor
102445417|NCT04857450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102445418|NCT04857450|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102445419|NCT04857450|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102445420|NCT04857450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102075692|NCT04318015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102445421|NCT04857450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445422|NCT04857450|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102445423|NCT01420653|Acetaminophen|acetaminophen|mesh-list
102445424|NCT01420653|Ibuprofen|ibuprofen|mesh-list
102445425|NCT01420653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102445426|NCT01420653|Analgesics|analgesics|mesh-ancestor
102445427|NCT01420653|Sensory System Agents|sensory system agents|mesh-ancestor
102445428|NCT01420653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102445429|NCT01420653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445430|NCT01420653|Antipyretics|antipyretics|mesh-ancestor
102445431|NCT01420653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102445432|NCT01420653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102445433|NCT01420653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102445434|NCT01420653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102445435|NCT01420653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102445436|NCT01420653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445437|NCT03042936|Insulin|insulin|mesh-list
102445438|NCT03042936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102445439|NCT03042936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445440|NCT01421355|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102445441|NCT01421355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102445442|NCT01421355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102445443|NCT01421355|Protease Inhibitors|protease inhibitors|mesh-ancestor
102445444|NCT01421355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102445445|NCT01421355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445446|NCT01421355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102445447|NCT01421355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102445448|NCT01421355|Antiviral Agents|antiviral agents|mesh-ancestor
102445449|NCT01421355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102445450|NCT04844957|Vitamin D|vitamin d|mesh-list
102445451|NCT04844957|Ergocalciferols|ergocalciferols|mesh-list
102445452|NCT04844957|Cholecalciferol|cholecalciferol|mesh-list
102445453|NCT04844957|Vitamins|vitamins|mesh-list
102445454|NCT04844957|Micronutrients|micronutrients|mesh-ancestor
102445455|NCT04844957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445456|NCT04844957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102445457|NCT04844957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102445458|NCT04782115|RC28-E protein|rc28-e protein|mesh-list
102445459|NCT04782115|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102445460|NCT04782115|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102445461|NCT04782115|Growth Substances|growth substances|mesh-ancestor
102445462|NCT04782115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445463|NCT04782115|Growth Inhibitors|growth inhibitors|mesh-ancestor
102445464|NCT04782115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102445465|NCT01421589|Hormones|hormones|mesh-list
102445466|NCT01421589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102075738|NCT05468840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102075739|NCT05468840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075740|NCT05468840|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102075741|NCT05468840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102075742|NCT05468840|Anesthetics, General|anesthetics, general|mesh-ancestor
102075743|NCT05468840|Anesthetics|anesthetics|mesh-ancestor
102075744|NCT05468840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101400640|NCT05457855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101197368|NCT01391052|Norethindrone|norethindrone|mesh-list
102445467|NCT01421589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445468|NCT01422135|Contraceptive Agents|contraceptive agents|mesh-list
102445469|NCT01422135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102445470|NCT01422135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445471|NCT00962845|Hydroxychloroquine|hydroxychloroquine|mesh-list
102445472|NCT00962845|Antimalarials|antimalarials|mesh-ancestor
102445473|NCT00962845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102445474|NCT00962845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102445475|NCT00962845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102445476|NCT00962845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102445477|NCT00962845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445478|NCT00962845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102445479|NCT04390685|Tacrolimus|tacrolimus|mesh-list
102445480|NCT04390685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102445481|NCT04390685|Immunologic Factors|immunologic factors|mesh-ancestor
102445482|NCT04390685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445483|NCT04390685|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102445484|NCT04390685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102445485|NCT04390685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445486|NCT04848246|Bupropion|bupropion|mesh-list
102075761|NCT03651531|Metformin|metformin|mesh-list
102445487|NCT04848246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102445488|NCT04848246|Antidepressive Agents|antidepressive agents|mesh-ancestor
102445489|NCT04848246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102445490|NCT04848246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102445491|NCT04848246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102445492|NCT04848246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102075769|NCT05325528|Tegafur|tegafur|mesh-list
102445493|NCT04848246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445494|NCT04848246|Dopamine Agents|dopamine agents|mesh-ancestor
102445495|NCT04848246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102445496|NCT04848246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445497|NCT04848246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102445498|NCT04848246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102445499|NCT04848246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102445500|NCT04842071|Listerine|listerine|mesh-list
102445501|NCT04842071|Fluorides|fluorides|mesh-list
102445502|NCT04842071|Sodium Fluoride|sodium fluoride|mesh-list
102445503|NCT04842071|Cariostatic Agents|cariostatic agents|mesh-ancestor
102445504|NCT04842071|Protective Agents|protective agents|mesh-ancestor
102445505|NCT04842071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445506|NCT04842071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102445507|NCT04842071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102445508|NCT04038619|Loperamide|loperamide|mesh-list
102445509|NCT04038619|Antidiarrheals|antidiarrheals|mesh-list
102445510|NCT04038619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102445511|NCT04774627|Olaparib|olaparib|mesh-list
102445512|NCT04774627|Niraparib|niraparib|mesh-list
102445513|NCT04774627|Talazoparib|talazoparib|mesh-list
102445514|NCT04774627|Veliparib|veliparib|mesh-list
102445515|NCT04774627|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102445516|NCT04774627|Rucaparib|rucaparib|mesh-list
102445517|NCT04774627|Pamiparib|pamiparib|mesh-list
102445518|NCT04774627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102445519|NCT04774627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445520|NCT04774627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102445521|NCT01545141|Interferons|interferons|mesh-list
102445522|NCT01545141|Interferon-alpha|interferon-alpha|mesh-list
102445523|NCT01545141|Interferon alpha-2|interferon alpha-2|mesh-list
102445524|NCT01545141|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
102445525|NCT01545141|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
102445526|NCT01545141|Poly I-C|poly i-c|mesh-list
102445527|NCT01545141|Celecoxib|celecoxib|mesh-list
102445528|NCT01545141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102445529|NCT01545141|Antiviral Agents|antiviral agents|mesh-ancestor
102445530|NCT01545141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102445531|NCT01545141|Immunologic Factors|immunologic factors|mesh-ancestor
102445532|NCT01545141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445533|NCT01545141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102445534|NCT01545141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102445535|NCT01545141|Analgesics|analgesics|mesh-ancestor
102445536|NCT01545141|Sensory System Agents|sensory system agents|mesh-ancestor
102445537|NCT01545141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102075800|NCT05606965|Immunologic Factors|immunologic factors|mesh-ancestor
102445538|NCT01545141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102445539|NCT01545141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102445540|NCT01545141|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102445541|NCT01545141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102445542|NCT01545141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102445543|NCT01545141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445544|NCT01545141|Interferon Inducers|interferon inducers|mesh-ancestor
102445545|NCT04855968|Analgesics|analgesics|mesh-list
102445546|NCT04855968|Sensory System Agents|sensory system agents|mesh-ancestor
102445547|NCT04855968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102445548|NCT04855968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445549|NCT01545765|Lidocaine|lidocaine|mesh-list
102445550|NCT01545765|Tetracaine|tetracaine|mesh-list
102445551|NCT01545765|Anesthetics, Local|anesthetics, local|mesh-ancestor
102445552|NCT01545765|Anesthetics|anesthetics|mesh-ancestor
102445553|NCT01545765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102445554|NCT01545765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445555|NCT01545765|Sensory System Agents|sensory system agents|mesh-ancestor
102445556|NCT01545765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102445557|NCT01545765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102445558|NCT01545765|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102445559|NCT01545765|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102445560|NCT01545765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102445561|NCT01545765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445562|NCT04856124|Ketamine|ketamine|mesh-list
102445563|NCT04856124|Esketamine|esketamine|mesh-list
102445564|NCT04856124|Analgesics|analgesics|mesh-ancestor
102445565|NCT04856124|Sensory System Agents|sensory system agents|mesh-ancestor
102445566|NCT04856124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102445567|NCT04856124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445568|NCT04856124|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102445569|NCT04856124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102445570|NCT04856124|Anesthetics, General|anesthetics, general|mesh-ancestor
102445571|NCT04856124|Anesthetics|anesthetics|mesh-ancestor
102445572|NCT04856124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102445573|NCT04856124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102445574|NCT04856124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102445575|NCT04856124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102445576|NCT04856124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445577|NCT04856124|Antidepressive Agents|antidepressive agents|mesh-ancestor
102445578|NCT04856124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102445579|NCT04028479|Immunomodulating Agents|immunomodulating agents|mesh-list
102445580|NCT04028479|Immunologic Factors|immunologic factors|mesh-ancestor
102445581|NCT04028479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445582|NCT02208297|Loteprednol Etabonate|loteprednol etabonate|mesh-list
102445583|NCT02208297|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102445584|NCT04847622|Remdesivir|remdesivir|mesh-list
102445585|NCT04847622|Antimetabolites|antimetabolites|mesh-ancestor
102257231|NCT04417114|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102612312|NCT00002399|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102075847|NCT05287984|Rituximab|rituximab|mesh-list
102445586|NCT04847622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445587|NCT04847622|Antiviral Agents|antiviral agents|mesh-ancestor
102445588|NCT04847622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102445590|NCT04781803|Cyclosporins|cyclosporins|mesh-list
102445591|NCT04781803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102445592|NCT04781803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445593|NCT04781803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102445594|NCT04781803|Immunologic Factors|immunologic factors|mesh-ancestor
102445595|NCT04781803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445596|NCT04781803|Antifungal Agents|antifungal agents|mesh-ancestor
102445597|NCT04781803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102445598|NCT04781803|Dermatologic Agents|dermatologic agents|mesh-ancestor
102445599|NCT04781803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102445600|NCT04781803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102445601|NCT01422369|Ritonavir|ritonavir|mesh-list
102445602|NCT01422369|Darunavir|darunavir|mesh-list
102445603|NCT01422369|Pitavastatin|pitavastatin|mesh-list
102445604|NCT01422369|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102445605|NCT01422369|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102445606|NCT01422369|Protease Inhibitors|protease inhibitors|mesh-ancestor
102445607|NCT01422369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102445608|NCT01422369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445609|NCT01422369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102445610|NCT01422369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102445611|NCT01422369|Antiviral Agents|antiviral agents|mesh-ancestor
102445612|NCT01422369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102445613|NCT01422369|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102445614|NCT01422369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102075857|NCT05287984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102445615|NCT01422369|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102445616|NCT01422369|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102445617|NCT01422369|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102445618|NCT01422369|Antimetabolites|antimetabolites|mesh-ancestor
102445619|NCT01422369|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102445620|NCT05023343|Ropivacaine|ropivacaine|mesh-list
102445621|NCT05023343|Anesthetics, Local|anesthetics, local|mesh-ancestor
102445622|NCT05023343|Anesthetics|anesthetics|mesh-ancestor
102445623|NCT05023343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102445624|NCT05023343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445625|NCT05023343|Sensory System Agents|sensory system agents|mesh-ancestor
102445626|NCT05023343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102445627|NCT04859556|Dipivefrin|dipivefrin|mesh-list
102445628|NCT04859556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102445629|NCT04859556|Adrenergic Agents|adrenergic agents|mesh-ancestor
102445630|NCT04859556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102445631|NCT04859556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445632|NCT04859556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445633|NCT04781335|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102445634|NCT04781335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102445635|NCT04781335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102445636|NCT04781335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102445637|NCT04773301|Ropivacaine|ropivacaine|mesh-list
102445638|NCT04773301|Levobupivacaine|levobupivacaine|mesh-list
102445639|NCT04773301|Anesthetics, Local|anesthetics, local|mesh-ancestor
102445640|NCT04773301|Anesthetics|anesthetics|mesh-ancestor
102445641|NCT04773301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102445642|NCT04773301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445643|NCT04773301|Sensory System Agents|sensory system agents|mesh-ancestor
102445644|NCT04773301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102445645|NCT04780945|Olaparib|olaparib|mesh-list
102445646|NCT04780945|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102445647|NCT04780945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102075900|NCT05284474|Mitogens|mitogens|mesh-list
102445648|NCT04780945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445649|NCT04780945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102445650|NCT05021315|Povidone-Iodine|povidone-iodine|mesh-list
102445651|NCT05021315|Povidone|povidone|mesh-list
102445652|NCT05021315|Plasma Substitutes|plasma substitutes|mesh-ancestor
101401689|NCT00125229|Mannitol|mannitol|mesh-list
102445653|NCT05021315|Blood Substitutes|blood substitutes|mesh-ancestor
102445654|NCT05021315|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102445655|NCT05021315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102445656|NCT01427517|Acetylcysteine|acetylcysteine|mesh-list
102445657|NCT01427517|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102445658|NCT01427517|Antiviral Agents|antiviral agents|mesh-ancestor
102257325|NCT02769689|Prednisolone|prednisolone|mesh-list
102445659|NCT01427517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102445660|NCT01427517|Expectorants|expectorants|mesh-ancestor
102445661|NCT01427517|Respiratory System Agents|respiratory system agents|mesh-ancestor
102445662|NCT01427517|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102445663|NCT01427517|Antioxidants|antioxidants|mesh-ancestor
101401761|NCT00332995|Dapivirine|dapivirine|mesh-list
102445664|NCT01427517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445665|NCT01427517|Protective Agents|protective agents|mesh-ancestor
102445666|NCT01427517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445667|NCT01427517|Antidotes|antidotes|mesh-ancestor
102445668|NCT02835131|Pasireotide|pasireotide|mesh-list
102445670|NCT02835131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102445671|NCT02835131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445672|NCT04846452|Paclitaxel|paclitaxel|mesh-list
102445673|NCT04846452|Carboplatin|carboplatin|mesh-list
102445674|NCT04846452|Pemetrexed|pemetrexed|mesh-list
102445675|NCT04846452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102445676|NCT04846452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102445677|NCT04846452|Tubulin Modulators|tubulin modulators|mesh-ancestor
102445678|NCT04846452|Antimitotic Agents|antimitotic agents|mesh-ancestor
102445679|NCT04846452|Mitosis Modulators|mitosis modulators|mesh-ancestor
102445680|NCT04846452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445681|NCT04846452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102445682|NCT04846452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102075934|NCT02126358|Antimetabolites|antimetabolites|mesh-ancestor
102445683|NCT04846452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102445684|NCT04859244|Remdesivir|remdesivir|mesh-list
102445685|NCT04859244|GS-441524|gs-441524|mesh-list
102445686|NCT04859244|Antimetabolites|antimetabolites|mesh-ancestor
102445687|NCT04859244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445688|NCT04859244|Antiviral Agents|antiviral agents|mesh-ancestor
102445689|NCT04859244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102445690|NCT05028725|Lugol's solution|lugol's solution|mesh-list
102445691|NCT05028725|Hemostatics|hemostatics|mesh-ancestor
102445692|NCT05028725|Coagulants|coagulants|mesh-ancestor
102445693|NCT04779853|Antibodies|antibodies|mesh-list
102445694|NCT04779853|Immunologic Factors|immunologic factors|mesh-ancestor
102075943|NCT02127840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102445695|NCT04779853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445696|NCT04855110|Warfarin|warfarin|mesh-list
102445697|NCT04855110|Anticoagulants|anticoagulants|mesh-ancestor
102445698|NCT01485393|Dexmedetomidine|dexmedetomidine|mesh-list
102445699|NCT01485393|Zolpidem|zolpidem|mesh-list
102445700|NCT01485393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102445701|NCT01485393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102445702|NCT01485393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445703|NCT01485393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102445704|NCT01485393|Analgesics|analgesics|mesh-ancestor
102445705|NCT01485393|Sensory System Agents|sensory system agents|mesh-ancestor
102445706|NCT01485393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102445707|NCT01485393|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102445708|NCT01485393|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102445709|NCT01485393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102445710|NCT01485393|Adrenergic Agents|adrenergic agents|mesh-ancestor
102445711|NCT01485393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102445712|NCT01485393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445713|NCT01485393|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102445714|NCT01485393|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102445715|NCT01485393|GABA Agonists|gaba agonists|mesh-ancestor
102445716|NCT01485393|GABA Agents|gaba agents|mesh-ancestor
102445717|NCT04772521|Nicotine|nicotine|mesh-list
102445718|NCT04772521|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102445719|NCT04772521|Autonomic Agents|autonomic agents|mesh-ancestor
102445720|NCT04772521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102445721|NCT04772521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445722|NCT04772521|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102445723|NCT04772521|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102445724|NCT04772521|Cholinergic Agents|cholinergic agents|mesh-ancestor
102445725|NCT04772521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102445726|NCT04772521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445727|NCT04772287|Paclitaxel|paclitaxel|mesh-list
102445728|NCT04772287|Vinorelbine|vinorelbine|mesh-list
102445729|NCT04772287|Docetaxel|docetaxel|mesh-list
102445730|NCT04772287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102445731|NCT04772287|Cisplatin|cisplatin|mesh-list
102445732|NCT04772287|Carboplatin|carboplatin|mesh-list
102445733|NCT04772287|Gemcitabine|gemcitabine|mesh-list
102445734|NCT04772287|Pemetrexed|pemetrexed|mesh-list
102445735|NCT04772287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102445736|NCT04772287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102445737|NCT04772287|Tubulin Modulators|tubulin modulators|mesh-ancestor
102445738|NCT04772287|Antimitotic Agents|antimitotic agents|mesh-ancestor
102445739|NCT04772287|Mitosis Modulators|mitosis modulators|mesh-ancestor
101402254|NCT00343096|GABA Modulators|gaba modulators|mesh-ancestor
102445740|NCT04772287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445741|NCT04772287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102445742|NCT04772287|Antimetabolites|antimetabolites|mesh-ancestor
102445743|NCT04772287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102445744|NCT04772287|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102445745|NCT04772287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102445746|NCT01890005|Aspirin|aspirin|mesh-list
102445747|NCT01890005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102445748|NCT01890005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102445749|NCT01890005|Analgesics|analgesics|mesh-ancestor
102445750|NCT01890005|Sensory System Agents|sensory system agents|mesh-ancestor
102445751|NCT01890005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102445752|NCT01890005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445753|NCT01890005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102445754|NCT01890005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102445755|NCT01890005|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102445756|NCT01890005|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102445757|NCT01890005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445758|NCT01890005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102445759|NCT01890005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102445760|NCT01890005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102445761|NCT01890005|Antipyretics|antipyretics|mesh-ancestor
102445762|NCT02822573|Donepezil|donepezil|mesh-list
102445763|NCT02822573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102445764|NCT02822573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102445765|NCT02822573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445766|NCT02822573|Cholinergic Agents|cholinergic agents|mesh-ancestor
102445767|NCT02822573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102445768|NCT02822573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445769|NCT02822573|Nootropic Agents|nootropic agents|mesh-ancestor
102445770|NCT04854252|Fentanyl|fentanyl|mesh-list
102445771|NCT04854252|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102445772|NCT04854252|Narcotics|narcotics|mesh-ancestor
102445773|NCT04854252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102445774|NCT04854252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445775|NCT04854252|Analgesics|analgesics|mesh-ancestor
102445776|NCT04854252|Sensory System Agents|sensory system agents|mesh-ancestor
102445777|NCT04854252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102445778|NCT04854252|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102445779|NCT04854252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102445780|NCT04854252|Anesthetics, General|anesthetics, general|mesh-ancestor
102445781|NCT04854252|Anesthetics|anesthetics|mesh-ancestor
102445782|NCT03040830|Progesterone|progesterone|mesh-list
102445783|NCT03040830|Progestins|progestins|mesh-ancestor
102445784|NCT03040830|Hormones|hormones|mesh-ancestor
102076028|NCT02131506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102445785|NCT03040830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102445786|NCT03040830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445787|NCT04390295|Metformin|metformin|mesh-list
102445788|NCT04390295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102445789|NCT04390295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445790|NCT03030235|Dapagliflozin|dapagliflozin|mesh-list
102445791|NCT03030235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102445792|NCT03030235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445793|NCT03030235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102445794|NCT03030235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445795|NCT04845672|Chlorhexidine|chlorhexidine|mesh-list
102445796|NCT04845672|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102445797|NCT04845672|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102445798|NCT04845672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102445799|NCT04845672|Disinfectants|disinfectants|mesh-ancestor
102445800|NCT04845672|Dermatologic Agents|dermatologic agents|mesh-ancestor
102445801|NCT01890629|Metformin|metformin|mesh-list
102445802|NCT01890629|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102445803|NCT01890629|Glimepiride|glimepiride|mesh-list
102445804|NCT01890629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102445805|NCT01890629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445806|NCT01890629|Incretins|incretins|mesh-ancestor
102445807|NCT01890629|Hormones|hormones|mesh-ancestor
102445808|NCT01890629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102076052|NCT01674010|Vitamins|vitamins|mesh-ancestor
102445809|NCT01890629|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102445810|NCT01890629|Protease Inhibitors|protease inhibitors|mesh-ancestor
102445811|NCT01890629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102257457|NCT02358707|Analgesics|analgesics|mesh-ancestor
102445812|NCT01890629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445813|NCT01890629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102445814|NCT01890629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102445815|NCT01890629|Immunologic Factors|immunologic factors|mesh-ancestor
102445816|NCT01890863|Fluticasone|fluticasone|mesh-list
102445817|NCT01890863|Xhance|xhance|mesh-list
102445818|NCT01890863|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102445819|NCT01890863|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102445820|NCT01890863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102445821|NCT01890863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102445822|NCT01890863|Autonomic Agents|autonomic agents|mesh-ancestor
102445823|NCT01890863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102445824|NCT01890863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445825|NCT01890863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102445826|NCT01890863|Respiratory System Agents|respiratory system agents|mesh-ancestor
102445827|NCT01890863|Dermatologic Agents|dermatologic agents|mesh-ancestor
102445828|NCT01890863|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102445829|NCT01890863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102445830|NCT01890863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102445831|NCT01890863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102445832|NCT01890863|Adrenergic Agents|adrenergic agents|mesh-ancestor
102445833|NCT01890863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102445834|NCT01890863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445835|NCT01890863|Glucocorticoids|glucocorticoids|mesh-ancestor
102445836|NCT01890863|Hormones|hormones|mesh-ancestor
102445837|NCT01890863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102445838|NCT01890863|Sympathomimetics|sympathomimetics|mesh-ancestor
102445839|NCT02955511|Pyrithione zinc|pyrithione zinc|mesh-list
102445840|NCT02955511|Keratolytic Agents|keratolytic agents|mesh-ancestor
102445841|NCT02955511|Dermatologic Agents|dermatologic agents|mesh-ancestor
102445842|NCT01890941|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102445843|NCT01890941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102445844|NCT01891019|Thalidomide|thalidomide|mesh-list
102445845|NCT01891019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102445846|NCT01891019|Immunologic Factors|immunologic factors|mesh-ancestor
102445847|NCT01891019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445848|NCT01891019|Leprostatic Agents|leprostatic agents|mesh-ancestor
102076089|NCT02131818|Amoxicillin|amoxicillin|mesh-list
102445849|NCT01891019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102445850|NCT01891019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102445851|NCT01891019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102445852|NCT01891019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102445853|NCT01891019|Growth Substances|growth substances|mesh-ancestor
102445854|NCT01891019|Growth Inhibitors|growth inhibitors|mesh-ancestor
102445855|NCT01891019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102445856|NCT04374474|Budesonide|budesonide|mesh-list
102445857|NCT04374474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102445858|NCT04374474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102445859|NCT04374474|Autonomic Agents|autonomic agents|mesh-ancestor
102445860|NCT04374474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102445861|NCT04374474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445862|NCT04374474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102445863|NCT04374474|Respiratory System Agents|respiratory system agents|mesh-ancestor
102445864|NCT04374474|Glucocorticoids|glucocorticoids|mesh-ancestor
102445865|NCT04374474|Hormones|hormones|mesh-ancestor
102445866|NCT04374474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102445867|NCT02983097|Cytarabine|cytarabine|mesh-list
102445868|NCT02983097|Dexamethasone|dexamethasone|mesh-list
102445869|NCT02983097|Rituximab|rituximab|mesh-list
102445870|NCT02983097|Carboplatin|carboplatin|mesh-list
102445871|NCT02983097|Lenalidomide|lenalidomide|mesh-list
102445872|NCT02983097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102445873|NCT02983097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102445874|NCT02983097|Immunologic Factors|immunologic factors|mesh-ancestor
102445875|NCT02983097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445876|NCT02983097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102445877|NCT02983097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102445878|NCT02983097|Antiemetics|antiemetics|mesh-ancestor
102445879|NCT02983097|Autonomic Agents|autonomic agents|mesh-ancestor
102445880|NCT02983097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102445881|NCT02983097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102445882|NCT02983097|Glucocorticoids|glucocorticoids|mesh-ancestor
102445883|NCT02983097|Hormones|hormones|mesh-ancestor
102445884|NCT02983097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102445885|NCT02983097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102445886|NCT02983097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102445887|NCT02983097|Antimetabolites|antimetabolites|mesh-ancestor
102257530|NCT02357615|Nifedipine|nifedipine|mesh-list
102612313|NCT00002399|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102445888|NCT02983097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445889|NCT02983097|Antiviral Agents|antiviral agents|mesh-ancestor
102445890|NCT02983097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102445891|NCT02983097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102445892|NCT02983097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102445893|NCT02983097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102445894|NCT02983097|Growth Substances|growth substances|mesh-ancestor
102445895|NCT02983097|Growth Inhibitors|growth inhibitors|mesh-ancestor
102445896|NCT01891175|Anesthetics|anesthetics|mesh-list
102445897|NCT01891175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102445898|NCT01891175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445899|NCT02347865|Denosumab|denosumab|mesh-list
102445900|NCT02347865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102445901|NCT02347865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076143|NCT01673854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102076144|NCT01673854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102076145|NCT03549702|Povidone-Iodine|povidone-iodine|mesh-list
102076146|NCT03549702|Povidone|povidone|mesh-list
102445902|NCT01550367|Hydroxychloroquine|hydroxychloroquine|mesh-list
102445903|NCT01550367|Aldesleukin|aldesleukin|mesh-list
102445904|NCT01550367|Antimalarials|antimalarials|mesh-ancestor
102445905|NCT01550367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102445906|NCT01550367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102445907|NCT01550367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102445908|NCT01550367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102445909|NCT01550367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445910|NCT01550367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102445911|NCT01550367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102445912|NCT01550367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102445913|NCT01550367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102445914|NCT01550367|Antiviral Agents|antiviral agents|mesh-ancestor
102445915|NCT01427595|Metformin|metformin|mesh-list
101377824|NCT00248209|Dopamine Agents|dopamine agents|mesh-ancestor
101403559|NCT00428428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101403560|NCT00428428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101403561|NCT00428428|Adrenergic Agents|adrenergic agents|mesh-ancestor
101403562|NCT00428428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101403563|NCT00428428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403564|NCT00428428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445916|NCT01427595|Progesterone|progesterone|mesh-list
102445917|NCT01427595|Estradiol|estradiol|mesh-list
102445918|NCT01427595|Estrogens|estrogens|mesh-list
102445919|NCT01427595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102445920|NCT01427595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445921|NCT01427595|Progestins|progestins|mesh-ancestor
102445922|NCT01427595|Hormones|hormones|mesh-ancestor
102445923|NCT01427595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102445924|NCT04390061|Hydroxychloroquine|hydroxychloroquine|mesh-list
102445925|NCT04390061|Tofacitinib|tofacitinib|mesh-list
101403573|NCT00092339|Valdecoxib|valdecoxib|mesh-list
101377829|NCT00248209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102076169|NCT01367886|Fesoterodine|fesoterodine|mesh-list
102076170|NCT01367886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102076171|NCT01367886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102445926|NCT04390061|Antimalarials|antimalarials|mesh-ancestor
102445927|NCT04390061|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102445928|NCT04390061|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102445929|NCT04390061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102445930|NCT04390061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102445931|NCT04390061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445932|NCT04390061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102445933|NCT04390061|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102445934|NCT04390061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102445935|NCT01892813|Bupropion|bupropion|mesh-list
102445936|NCT01892813|Nicotine|nicotine|mesh-list
102445937|NCT01892813|Varenicline|varenicline|mesh-list
102445938|NCT01892813|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102445939|NCT01892813|Autonomic Agents|autonomic agents|mesh-ancestor
102445940|NCT01892813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102445941|NCT01892813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445942|NCT01892813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102445943|NCT01892813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102445944|NCT01892813|Cholinergic Agents|cholinergic agents|mesh-ancestor
102076177|NCT05706337|Propofol|propofol|mesh-list
102445945|NCT01892813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102445946|NCT01892813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445947|NCT01892813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102445948|NCT01892813|Antidepressive Agents|antidepressive agents|mesh-ancestor
102445949|NCT01892813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102445950|NCT01892813|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102076182|NCT05706337|Anesthetics, General|anesthetics, general|mesh-ancestor
102445951|NCT01892813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102445952|NCT01892813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102445953|NCT01892813|Dopamine Agents|dopamine agents|mesh-ancestor
102445954|NCT01892813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102445955|NCT01892813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102445956|NCT01892813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102445957|NCT00716443|Lidocaine|lidocaine|mesh-list
102445958|NCT00716443|Tetracaine|tetracaine|mesh-list
102445959|NCT00716443|Benzocaine|benzocaine|mesh-list
102445960|NCT00716443|Anesthetics, Local|anesthetics, local|mesh-ancestor
102445961|NCT00716443|Anesthetics|anesthetics|mesh-ancestor
102445962|NCT00716443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102445963|NCT00716443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445964|NCT00716443|Sensory System Agents|sensory system agents|mesh-ancestor
102445965|NCT00716443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102445966|NCT00716443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102445967|NCT00716443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102445968|NCT00716443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102445969|NCT00716443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102445970|NCT00716443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445971|NCT00650143|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102445972|NCT00650143|Lenograstim|lenograstim|mesh-list
102445973|NCT00650143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102445974|NCT00650143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445975|NCT00650143|Incretins|incretins|mesh-ancestor
102445976|NCT00650143|Hormones|hormones|mesh-ancestor
102445977|NCT00650143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102445978|NCT00650143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102445979|NCT00650143|Protease Inhibitors|protease inhibitors|mesh-ancestor
102445980|NCT00650143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102445981|NCT00650143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445982|NCT00650143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101377867|NCT00103272|Bortezomib|bortezomib|mesh-list
102445983|NCT00650143|Immunologic Factors|immunologic factors|mesh-ancestor
102445984|NCT04770961|Ropivacaine|ropivacaine|mesh-list
102445985|NCT04770961|Anesthetics, Local|anesthetics, local|mesh-ancestor
102445986|NCT04770961|Anesthetics|anesthetics|mesh-ancestor
102445987|NCT04770961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102445988|NCT04770961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102445989|NCT04770961|Sensory System Agents|sensory system agents|mesh-ancestor
102445990|NCT04770961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102445991|NCT04753489|Rivaroxaban|rivaroxaban|mesh-list
102445992|NCT04753489|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102445993|NCT04753489|Antithrombins|antithrombins|mesh-ancestor
102445994|NCT04753489|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102445995|NCT04753489|Protease Inhibitors|protease inhibitors|mesh-ancestor
102445996|NCT04753489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102445997|NCT04753489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102445998|NCT04753489|Anticoagulants|anticoagulants|mesh-ancestor
102445999|NCT04769557|Acetaminophen|acetaminophen|mesh-list
102446000|NCT04769557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102446001|NCT04769557|Analgesics|analgesics|mesh-ancestor
102446002|NCT04769557|Sensory System Agents|sensory system agents|mesh-ancestor
102446003|NCT04769557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102446004|NCT04769557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446005|NCT04769557|Antipyretics|antipyretics|mesh-ancestor
102446006|NCT05606497|Dexamethasone|dexamethasone|mesh-list
102446007|NCT05606497|Betamethasone|betamethasone|mesh-list
102446008|NCT05606497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102446009|NCT05606497|Antiemetics|antiemetics|mesh-ancestor
102446010|NCT05606497|Autonomic Agents|autonomic agents|mesh-ancestor
102446011|NCT05606497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102446012|NCT05606497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446013|NCT05606497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102446014|NCT05606497|Glucocorticoids|glucocorticoids|mesh-ancestor
102446015|NCT05606497|Hormones|hormones|mesh-ancestor
102446016|NCT05606497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102446017|NCT05606497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102446018|NCT05606497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102446019|NCT05606497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102446020|NCT05606497|Respiratory System Agents|respiratory system agents|mesh-ancestor
102446021|NCT04778917|Heparin|heparin|mesh-list
102446022|NCT04778917|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102446023|NCT04778917|Tinzaparin|tinzaparin|mesh-list
102446024|NCT04778917|Dalteparin|dalteparin|mesh-list
102446025|NCT04778917|Calcium heparin|calcium heparin|mesh-list
102446026|NCT04778917|Calcium|calcium|mesh-list
102446027|NCT04778917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102076247|NCT05252754|Tocolytic Agents|tocolytic agents|mesh-ancestor
102446028|NCT04778917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446029|NCT04778917|Anticoagulants|anticoagulants|mesh-ancestor
102446030|NCT04778917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102446031|NCT04778917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102446032|NCT04778917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446033|NCT02213289|Nivolumab|nivolumab|mesh-list
102446034|NCT02213289|Trastuzumab|trastuzumab|mesh-list
102446035|NCT02213289|Bemarituzumab|bemarituzumab|mesh-list
102446036|NCT02213289|Ramucirumab|ramucirumab|mesh-list
102446037|NCT02213289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102446038|NCT02213289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102446039|NCT02213289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102612314|NCT00002399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102446040|NCT02213289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446041|NCT02779751|Pembrolizumab|pembrolizumab|mesh-list
102446042|NCT02779751|Anastrozole|anastrozole|mesh-list
102076262|NCT02132442|Vitamin D|vitamin d|mesh-list
102446043|NCT02779751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102446044|NCT02779751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102446045|NCT02779751|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102446046|NCT02779751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446047|NCT02779751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102446048|NCT02779751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102446049|NCT02779751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102446050|NCT02779751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102446051|NCT02779751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102446052|NCT02779751|Hormone Antagonists|hormone antagonists|mesh-ancestor
102446053|NCT02779751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102446054|NCT02779751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446055|NCT05606107|Tofacitinib|tofacitinib|mesh-list
102446056|NCT05606107|Glucocorticoids|glucocorticoids|mesh-list
102446057|NCT05606107|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102446058|NCT05606107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102446059|NCT05606107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102446060|NCT05606107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446061|NCT05606107|Hormones|hormones|mesh-ancestor
102446062|NCT05606107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102446063|NCT05606107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446064|NCT00053989|Mycophenolic Acid|mycophenolic acid|mesh-list
102446065|NCT00053989|Methylprednisolone|methylprednisolone|mesh-list
102446066|NCT00053989|Cyclophosphamide|cyclophosphamide|mesh-list
102446067|NCT00053989|Fludarabine|fludarabine|mesh-list
102446068|NCT00053989|Fludarabine phosphate|fludarabine phosphate|mesh-list
102446069|NCT00053989|Tacrolimus|tacrolimus|mesh-list
102446070|NCT00053989|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102446071|NCT00053989|Sargramostim|sargramostim|mesh-list
102446072|NCT00053989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102446073|NCT00053989|Immunologic Factors|immunologic factors|mesh-ancestor
102446074|NCT00053989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446075|NCT00053989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102446076|NCT00053989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102446077|NCT00053989|Alkylating Agents|alkylating agents|mesh-ancestor
102446078|NCT00053989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446079|NCT00053989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102446080|NCT00053989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102446081|NCT00053989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102446082|NCT00053989|Antimetabolites|antimetabolites|mesh-ancestor
102076294|NCT03450772|Pancrelipase|pancrelipase|mesh-list
102446083|NCT00053989|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102446084|NCT00053989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102446085|NCT00053989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102446086|NCT00053989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102446087|NCT00053989|Antitubercular Agents|antitubercular agents|mesh-ancestor
102446088|NCT00053989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102446089|NCT00053989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102446090|NCT00053989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102446091|NCT00053989|Antiemetics|antiemetics|mesh-ancestor
102446092|NCT00053989|Autonomic Agents|autonomic agents|mesh-ancestor
102446093|NCT00053989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102446094|NCT00053989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102446095|NCT00053989|Glucocorticoids|glucocorticoids|mesh-ancestor
102446096|NCT00053989|Hormones|hormones|mesh-ancestor
102446097|NCT00053989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102446098|NCT00053989|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102446099|NCT00053989|Protective Agents|protective agents|mesh-ancestor
102446100|NCT02740595|Nicotine|nicotine|mesh-list
102446101|NCT02740595|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102446102|NCT02740595|Autonomic Agents|autonomic agents|mesh-ancestor
102446103|NCT02740595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102446104|NCT02740595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446105|NCT02740595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102446106|NCT02740595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102446107|NCT02740595|Cholinergic Agents|cholinergic agents|mesh-ancestor
102446108|NCT02740595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102076321|NCT02129166|Dasatinib|dasatinib|mesh-list
102446109|NCT02740595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446110|NCT02214615|Carbamazepine|carbamazepine|mesh-list
102446111|NCT02214615|Anticonvulsants|anticonvulsants|mesh-ancestor
102446112|NCT02214615|Antimanic Agents|antimanic agents|mesh-ancestor
102446113|NCT02214615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102257751|NCT02355197|Ascorbic Acid|ascorbic acid|mesh-list
102446114|NCT02214615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102446115|NCT02214615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446116|NCT02214615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102446117|NCT02214615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102446118|NCT02214615|Analgesics|analgesics|mesh-ancestor
102446119|NCT02214615|Sensory System Agents|sensory system agents|mesh-ancestor
102446120|NCT02214615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102446121|NCT02214615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102446122|NCT02214615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102446123|NCT02214615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446124|NCT02214615|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102446125|NCT02214615|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102446126|NCT02661503|Dexamethasone|dexamethasone|mesh-list
102446127|NCT02661503|Prednisone|prednisone|mesh-list
102446128|NCT02661503|Cyclophosphamide|cyclophosphamide|mesh-list
102446129|NCT02661503|Dacarbazine|dacarbazine|mesh-list
102446130|NCT02661503|Doxorubicin|doxorubicin|mesh-list
102446131|NCT02661503|Etoposide|etoposide|mesh-list
102446132|NCT02661503|Vincristine|vincristine|mesh-list
102446133|NCT02661503|Bleomycin|bleomycin|mesh-list
102446134|NCT02661503|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102446135|NCT02661503|Procarbazine|procarbazine|mesh-list
102446136|NCT02661503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102446137|NCT02661503|Immunologic Factors|immunologic factors|mesh-ancestor
102446138|NCT02661503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446139|NCT02661503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102446140|NCT02661503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102446141|NCT02661503|Alkylating Agents|alkylating agents|mesh-ancestor
102446142|NCT02661503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446143|NCT02661503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102446144|NCT02661503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102446145|NCT02661503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102446146|NCT02661503|Antiemetics|antiemetics|mesh-ancestor
102446147|NCT02661503|Autonomic Agents|autonomic agents|mesh-ancestor
102446148|NCT02661503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102446149|NCT02661503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102446150|NCT02661503|Glucocorticoids|glucocorticoids|mesh-ancestor
102446151|NCT02661503|Hormones|hormones|mesh-ancestor
102446152|NCT02661503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102446153|NCT02661503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102446154|NCT02661503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102446155|NCT02661503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102446156|NCT02661503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102446157|NCT02661503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102446158|NCT02661503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102446159|NCT02661503|Tubulin Modulators|tubulin modulators|mesh-ancestor
102446160|NCT02661503|Antimitotic Agents|antimitotic agents|mesh-ancestor
102446161|NCT02661503|Mitosis Modulators|mitosis modulators|mesh-ancestor
102446162|NCT02661503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102446163|NCT02661503|Immunotoxins|immunotoxins|mesh-ancestor
102446164|NCT02661503|Immunoconjugates|immunoconjugates|mesh-ancestor
102446165|NCT01430091|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102446166|NCT01430091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102446167|NCT02647385|Lidocaine|lidocaine|mesh-list
102446168|NCT02647385|Anesthetics, Local|anesthetics, local|mesh-ancestor
102446169|NCT02647385|Anesthetics|anesthetics|mesh-ancestor
102446170|NCT02647385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102446171|NCT02647385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446172|NCT02647385|Sensory System Agents|sensory system agents|mesh-ancestor
102446173|NCT02647385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102446174|NCT02647385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102446175|NCT02647385|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102446176|NCT02647385|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102446177|NCT02647385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102446178|NCT02647385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446179|NCT03040752|Nifedipine|nifedipine|mesh-list
102446180|NCT03040752|Ritodrine|ritodrine|mesh-list
102446181|NCT03040752|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102446182|NCT03040752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102257830|NCT02350985|Vasodilator Agents|vasodilator agents|mesh-ancestor
102446183|NCT03040752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446184|NCT03040752|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102446185|NCT03040752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446186|NCT03040752|Vasodilator Agents|vasodilator agents|mesh-ancestor
102446187|NCT03040752|Tocolytic Agents|tocolytic agents|mesh-ancestor
102446188|NCT03040752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102446189|NCT03040752|Sympathomimetics|sympathomimetics|mesh-ancestor
102446190|NCT03040752|Autonomic Agents|autonomic agents|mesh-ancestor
102446191|NCT03040752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102446192|NCT03040752|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102446193|NCT03040752|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102446194|NCT03040752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102446195|NCT03040752|Adrenergic Agents|adrenergic agents|mesh-ancestor
102446196|NCT03040752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102446197|NCT01668654|Ezogabine|ezogabine|mesh-list
102446198|NCT01668654|Anticonvulsants|anticonvulsants|mesh-ancestor
102446199|NCT01668654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102446200|NCT01668654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446201|NCT01431105|Atorvastatin|atorvastatin|mesh-list
102446202|NCT01431105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102446203|NCT01431105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102446204|NCT01431105|Antimetabolites|antimetabolites|mesh-ancestor
102446205|NCT01431105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446206|NCT01431105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102446207|NCT01431105|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102446208|NCT01431105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102446209|NCT03038958|Prilocaine|prilocaine|mesh-list
102446210|NCT03038958|Chloroprocaine|chloroprocaine|mesh-list
102446211|NCT03038958|Anesthetics, Local|anesthetics, local|mesh-ancestor
102446212|NCT03038958|Anesthetics|anesthetics|mesh-ancestor
102446213|NCT03038958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102446214|NCT03038958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446215|NCT03038958|Sensory System Agents|sensory system agents|mesh-ancestor
102446216|NCT03038958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102446217|NCT04840290|Paclitaxel|paclitaxel|mesh-list
102446218|NCT04840290|Carboplatin|carboplatin|mesh-list
102446219|NCT04840290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102446220|NCT04840290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102446221|NCT04840290|Tubulin Modulators|tubulin modulators|mesh-ancestor
102446222|NCT04840290|Antimitotic Agents|antimitotic agents|mesh-ancestor
102446223|NCT04840290|Mitosis Modulators|mitosis modulators|mesh-ancestor
102446224|NCT04840290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446225|NCT02630069|Choline|choline|mesh-list
102446226|NCT02630069|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
102446227|NCT02630069|Lipotropic Agents|lipotropic agents|mesh-ancestor
102446228|NCT02630069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102446229|NCT02630069|Antimetabolites|antimetabolites|mesh-ancestor
102446230|NCT02630069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446231|NCT02630069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102446232|NCT02630069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102446233|NCT02630069|Nootropic Agents|nootropic agents|mesh-ancestor
102446234|NCT01431339|Vancomycin|vancomycin|mesh-list
102446235|NCT01431339|Linezolid|linezolid|mesh-list
102446236|NCT01431339|Dalbavancin|dalbavancin|mesh-list
102446237|NCT01431339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102446238|NCT01431339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102446239|NCT01431339|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102446240|NCT01431339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102446241|NCT01431339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446242|NCT02596685|Nicotine|nicotine|mesh-list
102446243|NCT02596685|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102446244|NCT02596685|Autonomic Agents|autonomic agents|mesh-ancestor
102446245|NCT02596685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102446246|NCT02596685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446247|NCT02596685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102446248|NCT02596685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102446249|NCT02596685|Cholinergic Agents|cholinergic agents|mesh-ancestor
102446250|NCT02596685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102446251|NCT02596685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446252|NCT01431573|Lithium Carbonate|lithium carbonate|mesh-list
102446253|NCT01431573|Antidepressive Agents|antidepressive agents|mesh-ancestor
102446254|NCT01431573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102446255|NCT01431573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102446256|NCT01431573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446257|NCT01431573|Antimanic Agents|antimanic agents|mesh-ancestor
102446258|NCT01431573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102446259|NCT01431573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102446260|NCT01431573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446261|NCT04843644|Propolis|propolis|mesh-list
102446262|NCT04843644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102446263|NCT02588105|Leucovorin|leucovorin|mesh-list
102446265|NCT02588105|Fluorouracil|fluorouracil|mesh-list
102446266|NCT02588105|Irinotecan|irinotecan|mesh-list
102446267|NCT02588105|Olaparib|olaparib|mesh-list
102446268|NCT02588105|AZD0156|azd0156|mesh-list
102446269|NCT02588105|Levoleucovorin|levoleucovorin|mesh-list
102446270|NCT02588105|Antimetabolites|antimetabolites|mesh-ancestor
102446271|NCT02588105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446272|NCT02588105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102446273|NCT02588105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102446274|NCT02588105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102446275|NCT02588105|Immunologic Factors|immunologic factors|mesh-ancestor
102446276|NCT02588105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446277|NCT02588105|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102446278|NCT02588105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102446279|NCT02588105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102446280|NCT02588105|Antidotes|antidotes|mesh-ancestor
102446281|NCT02588105|Protective Agents|protective agents|mesh-ancestor
102446282|NCT02588105|Vitamin B Complex|vitamin b complex|mesh-ancestor
102446283|NCT02588105|Vitamins|vitamins|mesh-ancestor
102446284|NCT02588105|Micronutrients|micronutrients|mesh-ancestor
102446285|NCT02588105|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102446286|NCT02588105|Hematinics|hematinics|mesh-ancestor
102446287|NCT02588105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102446288|NCT01488279|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102446289|NCT01488279|Dexamethasone|dexamethasone|mesh-list
102446290|NCT01488279|Dexamethasone acetate|dexamethasone acetate|mesh-list
102446291|NCT01488279|BB 1101|bb 1101|mesh-list
102446292|NCT01488279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102446293|NCT01488279|Antiemetics|antiemetics|mesh-ancestor
102446294|NCT01488279|Autonomic Agents|autonomic agents|mesh-ancestor
102446295|NCT01488279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102446296|NCT01488279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446297|NCT01488279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102446298|NCT01488279|Glucocorticoids|glucocorticoids|mesh-ancestor
102446299|NCT01488279|Hormones|hormones|mesh-ancestor
102446300|NCT01488279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102446301|NCT01488279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102446302|NCT01488279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102446303|NCT01488279|Protease Inhibitors|protease inhibitors|mesh-ancestor
102446304|NCT01488279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102446305|NCT01488279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446306|NCT01488279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102446307|NCT01488279|Incretins|incretins|mesh-ancestor
102446308|NCT01488279|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102446309|NCT01490073|Nitroglycerin|nitroglycerin|mesh-list
102446310|NCT01490073|Vasodilator Agents|vasodilator agents|mesh-ancestor
102446311|NCT03008109|Endostatins|endostatins|mesh-list
102446312|NCT03008109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102446313|NCT03008109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102446314|NCT03008109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102446315|NCT03008109|Growth Substances|growth substances|mesh-ancestor
102446316|NCT03008109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446317|NCT03008109|Growth Inhibitors|growth inhibitors|mesh-ancestor
102446318|NCT02562443|ON 01910|on 01910|mesh-list
102446319|NCT02562443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102446320|NCT02562443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102446321|NCT02562443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102446322|NCT02562443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446323|NCT04843098|Paclitaxel|paclitaxel|mesh-list
102446324|NCT04843098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102446325|NCT04843098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102446326|NCT04843098|Tubulin Modulators|tubulin modulators|mesh-ancestor
102446327|NCT04843098|Antimitotic Agents|antimitotic agents|mesh-ancestor
102446328|NCT04843098|Mitosis Modulators|mitosis modulators|mesh-ancestor
102446329|NCT04843098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446330|NCT01490931|Ketorolac|ketorolac|mesh-list
102446331|NCT01490931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102446332|NCT01490931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102446333|NCT01490931|Analgesics|analgesics|mesh-ancestor
102446334|NCT01490931|Sensory System Agents|sensory system agents|mesh-ancestor
102446335|NCT01490931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102446336|NCT01490931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446337|NCT01490931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102446338|NCT01490931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102446339|NCT01490931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102446340|NCT01490931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102446341|NCT01490931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446342|NCT02562365|Cyclophosphamide|cyclophosphamide|mesh-list
102446343|NCT02562365|Carboplatin|carboplatin|mesh-list
102446344|NCT02562365|Etoposide|etoposide|mesh-list
102446345|NCT02562365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102446346|NCT02562365|Immunologic Factors|immunologic factors|mesh-ancestor
102446347|NCT02562365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446348|NCT02562365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102446349|NCT02562365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102446350|NCT02562365|Alkylating Agents|alkylating agents|mesh-ancestor
102446351|NCT02562365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446352|NCT02562365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102446353|NCT02562365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102446354|NCT02562365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102446355|NCT02562365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102446356|NCT02562365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102446357|NCT02562365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102446358|NCT01491633|Dasatinib|dasatinib|mesh-list
102446359|NCT01491633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102446360|NCT01491633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102446361|NCT01491633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102446362|NCT01491633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446363|NCT01433913|Metformin|metformin|mesh-list
102446364|NCT01433913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102446365|NCT01433913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446366|NCT04839198|Nicotine|nicotine|mesh-list
102446367|NCT04839198|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102446368|NCT04839198|Autonomic Agents|autonomic agents|mesh-ancestor
102446369|NCT04839198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102446370|NCT04839198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446371|NCT04839198|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102446372|NCT04839198|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102446373|NCT04839198|Cholinergic Agents|cholinergic agents|mesh-ancestor
102446374|NCT04839198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102446375|NCT04839198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446376|NCT02509793|Tetrabenazine|tetrabenazine|mesh-list
102446377|NCT02509793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102446378|NCT02509793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102446379|NCT02509793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102446380|NCT02509793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446381|NCT02509793|Adrenergic Agents|adrenergic agents|mesh-ancestor
102446382|NCT02509793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102446383|NCT02509793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446384|NCT02508467|Fisogatinib|fisogatinib|mesh-list
102446385|NCT02508467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102446386|NCT05586347|Nicardipine|nicardipine|mesh-list
102446387|NCT05586347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102446388|NCT05586347|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102446389|NCT05586347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102446390|NCT05586347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446391|NCT05586347|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102446392|NCT05586347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446393|NCT05586347|Vasodilator Agents|vasodilator agents|mesh-ancestor
102446394|NCT01436799|Alfentanil|alfentanil|mesh-list
102446395|NCT01436799|Propofol|propofol|mesh-list
102446396|NCT01436799|Desflurane|desflurane|mesh-list
102446397|NCT01436799|Rocuronium|rocuronium|mesh-list
102446398|NCT01436799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102446399|NCT01436799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102446400|NCT01436799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446401|NCT01436799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102446402|NCT01436799|Anesthetics, General|anesthetics, general|mesh-ancestor
102446403|NCT01436799|Anesthetics|anesthetics|mesh-ancestor
102446404|NCT01436799|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102446405|NCT01436799|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102446406|NCT01436799|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102446407|NCT01436799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102446408|NCT01436799|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102446409|NCT01436799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102446410|NCT01436799|Narcotics|narcotics|mesh-ancestor
102446411|NCT01436799|Analgesics|analgesics|mesh-ancestor
102446412|NCT01436799|Sensory System Agents|sensory system agents|mesh-ancestor
102446413|NCT04851132|Durvalumab|durvalumab|mesh-list
102446414|NCT04851132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102446415|NCT04851132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102446417|NCT02504489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102446418|NCT02504489|Tubulin Modulators|tubulin modulators|mesh-ancestor
102446419|NCT02504489|Antimitotic Agents|antimitotic agents|mesh-ancestor
102446420|NCT02504489|Mitosis Modulators|mitosis modulators|mesh-ancestor
102446421|NCT02504489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446422|NCT02479451|Theophylline|theophylline|mesh-list
102446423|NCT02479451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102446424|NCT02479451|Autonomic Agents|autonomic agents|mesh-ancestor
102446425|NCT02479451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102446426|NCT02479451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446427|NCT02479451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102446428|NCT02479451|Respiratory System Agents|respiratory system agents|mesh-ancestor
102446429|NCT02479451|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102446430|NCT02479451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102446431|NCT02479451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446432|NCT02479451|Vasodilator Agents|vasodilator agents|mesh-ancestor
102446433|NCT02479451|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102446434|NCT02479451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102446435|NCT02479451|Purinergic Agents|purinergic agents|mesh-ancestor
102446436|NCT02479451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102446437|NCT02424617|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102446438|NCT02424617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102446439|NCT02424617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102446440|NCT02424617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102446441|NCT02424617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446442|NCT02415413|Dexamethasone|dexamethasone|mesh-list
102446443|NCT02415413|Lenalidomide|lenalidomide|mesh-list
102446444|NCT02415413|Melphalan|melphalan|mesh-list
102446445|NCT02415413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102446446|NCT02415413|Antiemetics|antiemetics|mesh-ancestor
102446447|NCT02415413|Autonomic Agents|autonomic agents|mesh-ancestor
102446448|NCT02415413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102446449|NCT02415413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446450|NCT02415413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102446451|NCT02415413|Glucocorticoids|glucocorticoids|mesh-ancestor
102446452|NCT02415413|Hormones|hormones|mesh-ancestor
102446453|NCT02415413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102446454|NCT02415413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102446455|NCT02415413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102446456|NCT02415413|Immunologic Factors|immunologic factors|mesh-ancestor
102446457|NCT02415413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102446458|NCT02415413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102446459|NCT02415413|Growth Substances|growth substances|mesh-ancestor
102446460|NCT02415413|Growth Inhibitors|growth inhibitors|mesh-ancestor
102446461|NCT02415413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102446462|NCT02415413|Alkylating Agents|alkylating agents|mesh-ancestor
102446463|NCT02415413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446464|NCT02415413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102446465|NCT02415413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102446466|NCT02379377|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102446467|NCT02379377|Fluorides|fluorides|mesh-list
102446468|NCT02379377|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102446469|NCT02379377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446470|NCT02379377|Cariostatic Agents|cariostatic agents|mesh-ancestor
102446471|NCT02379377|Protective Agents|protective agents|mesh-ancestor
102446472|NCT02379377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446473|NCT01894061|Bevacizumab|bevacizumab|mesh-list
102446474|NCT01894061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102446475|NCT01894061|Antibodies|antibodies|mesh-list
102446476|NCT01894061|Immunoglobulins|immunoglobulins|mesh-list
102446477|NCT01894061|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102446478|NCT01894061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102446479|NCT01894061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102446480|NCT01894061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102446481|NCT01894061|Growth Substances|growth substances|mesh-ancestor
102446482|NCT01894061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446483|NCT01894061|Growth Inhibitors|growth inhibitors|mesh-ancestor
102446484|NCT01894061|Immunologic Factors|immunologic factors|mesh-ancestor
102446485|NCT01561053|Immunoglobulins|immunoglobulins|mesh-list
102446486|NCT01561053|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102446487|NCT01561053|Antibodies|antibodies|mesh-list
102446488|NCT01561053|Immunologic Factors|immunologic factors|mesh-ancestor
102446489|NCT01561053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446490|NCT01561833|Sorafenib|sorafenib|mesh-list
102446491|NCT01561833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102446492|NCT01561833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102446493|NCT01561833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102446494|NCT01561833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446495|NCT02607306|Insulin|insulin|mesh-list
102446496|NCT02607306|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102446497|NCT02607306|Liraglutide|liraglutide|mesh-list
102446498|NCT02607306|Insulin, Long-Acting|insulin, long-acting|mesh-list
102446499|NCT02607306|Xultophy|xultophy|mesh-list
102446500|NCT02607306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102446501|NCT02607306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446502|NCT02607306|Incretins|incretins|mesh-ancestor
102446503|NCT02607306|Hormones|hormones|mesh-ancestor
102446504|NCT02607306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102446505|NCT03040128|Minocycline|minocycline|mesh-list
102446506|NCT03040128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102446507|NCT03040128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102446508|NCT04850040|Oxaliplatin|oxaliplatin|mesh-list
102446509|NCT04850040|Apatinib|apatinib|mesh-list
102446510|NCT04850040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102446511|NCT04850040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102446512|NCT04850040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102446513|NCT04850040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446514|NCT03038334|Magnesium Sulfate|magnesium sulfate|mesh-list
102446515|NCT03038334|Analgesics|analgesics|mesh-ancestor
102446516|NCT03038334|Sensory System Agents|sensory system agents|mesh-ancestor
102446517|NCT03038334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102446518|NCT03038334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446519|NCT03038334|Anesthetics|anesthetics|mesh-ancestor
102446520|NCT03038334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102446521|NCT03038334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102446522|NCT03038334|Anticonvulsants|anticonvulsants|mesh-ancestor
102446523|NCT03038334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102446524|NCT03038334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102446525|NCT03038334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446526|NCT03038334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102446527|NCT03038334|Tocolytic Agents|tocolytic agents|mesh-ancestor
102446528|NCT03038334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102446529|NCT01441245|Furosemide|furosemide|mesh-list
102446530|NCT01441245|Diuretics|diuretics|mesh-ancestor
102446531|NCT01441245|Natriuretic Agents|natriuretic agents|mesh-ancestor
102446532|NCT01441245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446533|NCT01441245|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102446534|NCT01441245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102446535|NCT01441245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446536|NCT02298257|Doxorubicin|doxorubicin|mesh-list
102446537|NCT02298257|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102446538|NCT02298257|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102446539|NCT02298257|Dacarbazine|dacarbazine|mesh-list
102446540|NCT02298257|Vinblastine|vinblastine|mesh-list
102446541|NCT02298257|Antibodies|antibodies|mesh-list
102446542|NCT02298257|Immunoglobulins|immunoglobulins|mesh-list
102446543|NCT02298257|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102446544|NCT02298257|Immunoconjugates|immunoconjugates|mesh-list
102446545|NCT02298257|Immunologic Factors|immunologic factors|mesh-ancestor
102446546|NCT02298257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446547|NCT02298257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102446548|NCT02298257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102446549|NCT02298257|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102446550|NCT02298257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102446551|NCT02298257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102446552|NCT02298257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446553|NCT02298257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102446554|NCT02298257|Immunotoxins|immunotoxins|mesh-ancestor
102446555|NCT02298257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102446556|NCT02298257|Alkylating Agents|alkylating agents|mesh-ancestor
102446557|NCT02298257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102446558|NCT02298257|Tubulin Modulators|tubulin modulators|mesh-ancestor
102446559|NCT02298257|Antimitotic Agents|antimitotic agents|mesh-ancestor
102446560|NCT02298257|Mitosis Modulators|mitosis modulators|mesh-ancestor
102446561|NCT01563081|Cetirizine|cetirizine|mesh-list
102446562|NCT01563081|Levocetirizine|levocetirizine|mesh-list
102446563|NCT01563081|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102446564|NCT01563081|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102446565|NCT01563081|Histamine Antagonists|histamine antagonists|mesh-ancestor
102446566|NCT01563081|Histamine Agents|histamine agents|mesh-ancestor
102446567|NCT01563081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102446568|NCT01563081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446569|NCT01563081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446570|NCT01563081|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102446571|NCT02278601|Fentanyl|fentanyl|mesh-list
102446572|NCT02278601|Ropivacaine|ropivacaine|mesh-list
102446573|NCT02278601|Anesthetics, Local|anesthetics, local|mesh-list
102446574|NCT02278601|Anesthetics|anesthetics|mesh-list
102446575|NCT02278601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102446576|NCT02278601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446577|NCT02278601|Sensory System Agents|sensory system agents|mesh-ancestor
102446578|NCT02278601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102446579|NCT02278601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102446580|NCT02278601|Narcotics|narcotics|mesh-ancestor
102446581|NCT02278601|Analgesics|analgesics|mesh-ancestor
102446582|NCT02278601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102446583|NCT02278601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102446584|NCT02278601|Anesthetics, General|anesthetics, general|mesh-ancestor
102446585|NCT04833738|Triamcinolone|triamcinolone|mesh-list
102446586|NCT04833738|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102446587|NCT04833738|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102446588|NCT04833738|Hyaluronic Acid|hyaluronic acid|mesh-list
102446589|NCT04833738|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102446590|NCT04833738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102446591|NCT04833738|Glucocorticoids|glucocorticoids|mesh-ancestor
102446592|NCT04833738|Hormones|hormones|mesh-ancestor
102446593|NCT04833738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102446594|NCT04833738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446595|NCT04833738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102446596|NCT04833738|Immunologic Factors|immunologic factors|mesh-ancestor
102446597|NCT04833738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102446598|NCT04833738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446599|NCT04833738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102446600|NCT04833738|Viscosupplements|viscosupplements|mesh-ancestor
102446601|NCT04833738|Protective Agents|protective agents|mesh-ancestor
102446602|NCT01441401|Gabapentin|gabapentin|mesh-list
102446603|NCT01441401|Analgesics|analgesics|mesh-ancestor
102446604|NCT01441401|Sensory System Agents|sensory system agents|mesh-ancestor
102446605|NCT01441401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102446606|NCT01441401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446607|NCT01441401|Anticonvulsants|anticonvulsants|mesh-ancestor
102446608|NCT01441401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102446609|NCT01441401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102446610|NCT01441401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102446611|NCT01441401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102446612|NCT01441401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102446613|NCT01441401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102446614|NCT01441401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102446615|NCT01441401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446616|NCT01441401|Antimanic Agents|antimanic agents|mesh-ancestor
102446617|NCT02268695|Docetaxel|docetaxel|mesh-list
102446618|NCT02268695|Cetuximab|cetuximab|mesh-list
102446619|NCT02268695|Lenograstim|lenograstim|mesh-list
102446620|NCT02268695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102446621|NCT02268695|Tubulin Modulators|tubulin modulators|mesh-ancestor
102446622|NCT02268695|Antimitotic Agents|antimitotic agents|mesh-ancestor
102446623|NCT02268695|Mitosis Modulators|mitosis modulators|mesh-ancestor
102446624|NCT02268695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446625|NCT02268695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102446626|NCT02268695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102446627|NCT02268695|Immunologic Factors|immunologic factors|mesh-ancestor
102446628|NCT02268695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446629|NCT01495923|Gabapentin|gabapentin|mesh-list
102446630|NCT01495923|Analgesics|analgesics|mesh-ancestor
102446631|NCT01495923|Sensory System Agents|sensory system agents|mesh-ancestor
102446632|NCT01495923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102446633|NCT01495923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446634|NCT01495923|Anticonvulsants|anticonvulsants|mesh-ancestor
102446635|NCT01495923|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102446636|NCT01495923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102446637|NCT01495923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102446638|NCT01495923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102446639|NCT01495923|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102446640|NCT01495923|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102446641|NCT01495923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102612315|NCT00002399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102446642|NCT01495923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446643|NCT01495923|Antimanic Agents|antimanic agents|mesh-ancestor
102446644|NCT03037944|Drospirenone|drospirenone|mesh-list
102446645|NCT03037944|Levonorgestrel|levonorgestrel|mesh-list
102446646|NCT03037944|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102446647|NCT03037944|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
102446648|NCT03037944|Estradiol|estradiol|mesh-list
102446649|NCT03037944|Estrogens|estrogens|mesh-ancestor
102446650|NCT03037944|Hormones|hormones|mesh-ancestor
102446651|NCT03037944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102446652|NCT03037944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446653|NCT03037944|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102446654|NCT03037944|Contraceptive Agents|contraceptive agents|mesh-ancestor
102446655|NCT03037944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102446656|NCT03037944|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102446657|NCT03037944|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102446658|NCT03037944|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102446659|NCT03037944|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102446660|NCT03037944|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102446661|NCT03037944|Hormone Antagonists|hormone antagonists|mesh-ancestor
102446662|NCT03037944|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102446663|NCT03037944|Diuretics|diuretics|mesh-ancestor
102446664|NCT03037944|Natriuretic Agents|natriuretic agents|mesh-ancestor
102446665|NCT03060473|Amoxicillin|amoxicillin|mesh-list
102446666|NCT03060473|Azithromycin|azithromycin|mesh-list
102446667|NCT03060473|Erythromycin|erythromycin|mesh-list
102446668|NCT03060473|Erythromycin Estolate|erythromycin estolate|mesh-list
102446669|NCT03060473|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
102446670|NCT03060473|Erythromycin stearate|erythromycin stearate|mesh-list
102446671|NCT03060473|Ampicillin|ampicillin|mesh-list
102446672|NCT03060473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102446673|NCT03060473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102446674|NCT03060473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102446675|NCT03060473|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102446676|NCT03060473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102446677|NCT03060473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446678|NCT03039426|Diclofenac|diclofenac|mesh-list
102446679|NCT03039426|Bupivacaine|bupivacaine|mesh-list
102446680|NCT03039426|Anesthetics, Local|anesthetics, local|mesh-ancestor
102446681|NCT03039426|Anesthetics|anesthetics|mesh-ancestor
102446682|NCT03039426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102446683|NCT03039426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446684|NCT03039426|Sensory System Agents|sensory system agents|mesh-ancestor
102446685|NCT03039426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102446686|NCT03039426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102446687|NCT03039426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102446688|NCT03039426|Analgesics|analgesics|mesh-ancestor
102446689|NCT03039426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102446690|NCT03039426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102446691|NCT03039426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102446692|NCT03039426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102446693|NCT03039426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446694|NCT02205515|Everolimus|everolimus|mesh-list
102446695|NCT02205515|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102446696|NCT02205515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102446697|NCT02205515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102446698|NCT02205515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446699|NCT02205515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102446700|NCT02205515|Immunologic Factors|immunologic factors|mesh-ancestor
102446701|NCT02205515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446702|NCT02205515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102446703|NCT04833036|Irinotecan|irinotecan|mesh-list
102446704|NCT04833036|Cetuximab|cetuximab|mesh-list
102446705|NCT04833036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102446706|NCT04833036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102446707|NCT04833036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102446708|NCT04833036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446709|NCT04833036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102446710|NCT04833036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102446711|NCT04832880|Remdesivir|remdesivir|mesh-list
102446712|NCT04832880|Dexamethasone|dexamethasone|mesh-list
102446713|NCT04832880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102446714|NCT04832880|Antiemetics|antiemetics|mesh-ancestor
102446715|NCT04832880|Autonomic Agents|autonomic agents|mesh-ancestor
102446716|NCT04832880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102446717|NCT04832880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446718|NCT04832880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102446720|NCT04832880|Hormones|hormones|mesh-ancestor
102076898|NCT03549312|Elvitegravir|elvitegravir|mesh-list
102446721|NCT04832880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102446722|NCT04832880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102446723|NCT04832880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102446724|NCT04832880|Antimetabolites|antimetabolites|mesh-ancestor
102446725|NCT04832880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446726|NCT04832880|Antiviral Agents|antiviral agents|mesh-ancestor
102446727|NCT04832880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102446728|NCT01447017|Carbamide Peroxide|carbamide peroxide|mesh-list
102446729|NCT01447017|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102446730|NCT01447017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102446731|NCT01894295|Vitamin D|vitamin d|mesh-list
102446732|NCT01894295|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
102446733|NCT01894295|Vitamins|vitamins|mesh-ancestor
102446734|NCT01894295|Micronutrients|micronutrients|mesh-ancestor
102446735|NCT01894295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446736|NCT01894295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102446737|NCT04788186|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102446738|NCT04788186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102446739|NCT04788186|Adrenergic Agents|adrenergic agents|mesh-ancestor
102446740|NCT04788186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102446741|NCT04788186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446742|NCT04788186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446743|NCT01498419|Moxifloxacin|moxifloxacin|mesh-list
102446744|NCT01498419|Pyrazinamide|pyrazinamide|mesh-list
102446745|NCT01498419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102446746|NCT01498419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102446747|NCT01498419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102446748|NCT01498419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102446749|NCT01498419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102446750|NCT01498419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446751|NCT01498419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102446752|NCT01498419|Antitubercular Agents|antitubercular agents|mesh-ancestor
102446753|NCT04824924|Venetoclax|venetoclax|mesh-list
102446754|NCT04824924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102446755|NCT04553705|Quinine|quinine|mesh-list
102446756|NCT04553705|Antimalarials|antimalarials|mesh-ancestor
102446757|NCT04553705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102446758|NCT04553705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102446759|NCT04553705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102446760|NCT04553705|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102446761|NCT04553705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446762|NCT04553705|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102446763|NCT04553705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102446764|NCT04553705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102446765|NCT04553705|Analgesics|analgesics|mesh-ancestor
102446766|NCT04553705|Sensory System Agents|sensory system agents|mesh-ancestor
102446767|NCT02140151|Ranibizumab|ranibizumab|mesh-list
102446768|NCT02140151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102446769|NCT02140151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102446770|NCT02140151|Growth Substances|growth substances|mesh-ancestor
102446771|NCT02140151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446772|NCT02140151|Growth Inhibitors|growth inhibitors|mesh-ancestor
102446773|NCT02140151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102446774|NCT02135315|Isosorbide|isosorbide|mesh-list
102446775|NCT02135315|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
102446776|NCT02135315|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
102446777|NCT02135315|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102446778|NCT02135315|Diuretics|diuretics|mesh-ancestor
102446779|NCT02135315|Natriuretic Agents|natriuretic agents|mesh-ancestor
102446780|NCT02135315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446781|NCT02135315|Vasodilator Agents|vasodilator agents|mesh-ancestor
102446782|NCT02135315|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102446783|NCT02135315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446784|NCT01894373|Immunomodulating Agents|immunomodulating agents|mesh-list
102446785|NCT01894373|Immunologic Factors|immunologic factors|mesh-ancestor
102446786|NCT01894373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446787|NCT02117297|Gemtuzumab|gemtuzumab|mesh-list
102446788|NCT02117297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102446789|NCT02117297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102446790|NCT02117297|Immunotoxins|immunotoxins|mesh-ancestor
102258421|NCT02711995|Botulinum Toxins|botulinum toxins|mesh-list
102446791|NCT02117297|Immunoconjugates|immunoconjugates|mesh-ancestor
102446792|NCT02117297|Immunologic Factors|immunologic factors|mesh-ancestor
102446793|NCT02117297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446794|NCT04837170|Ketamine|ketamine|mesh-list
102446795|NCT04837170|Esketamine|esketamine|mesh-list
102446796|NCT04837170|Analgesics|analgesics|mesh-ancestor
102446797|NCT04837170|Sensory System Agents|sensory system agents|mesh-ancestor
102446798|NCT04837170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102446799|NCT04837170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446800|NCT04837170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102446801|NCT04837170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102446802|NCT04837170|Anesthetics, General|anesthetics, general|mesh-ancestor
102446803|NCT04837170|Anesthetics|anesthetics|mesh-ancestor
102446804|NCT04837170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102446805|NCT04837170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102446806|NCT04837170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102446807|NCT04837170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102446808|NCT04837170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446809|NCT04837170|Antidepressive Agents|antidepressive agents|mesh-ancestor
102446810|NCT04837170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102446811|NCT04824612|Triamcinolone|triamcinolone|mesh-list
102446812|NCT04824612|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102446813|NCT04824612|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102446814|NCT04824612|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102446815|NCT04824612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102446816|NCT04824612|Glucocorticoids|glucocorticoids|mesh-ancestor
102446817|NCT04824612|Hormones|hormones|mesh-ancestor
102446818|NCT04824612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102446819|NCT04824612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446820|NCT04824612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102446821|NCT04824612|Immunologic Factors|immunologic factors|mesh-ancestor
102446822|NCT04824612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102446823|NCT04824612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446824|NCT02113553|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102446825|NCT02113553|Luteolytic Agents|luteolytic agents|mesh-ancestor
102446826|NCT02113553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102446827|NCT02113553|Contraceptive Agents|contraceptive agents|mesh-ancestor
102446828|NCT02113553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102446829|NCT02113553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446830|NCT02113553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102446831|NCT02113553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102446832|NCT02113553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102446833|NCT02101775|Gemcitabine|gemcitabine|mesh-list
102446834|NCT02101775|Adavosertib|adavosertib|mesh-list
102446835|NCT02101775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102446836|NCT02101775|Antimetabolites|antimetabolites|mesh-ancestor
102446837|NCT02101775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446838|NCT02101775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102446839|NCT02101775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102446840|NCT02099591|Naloxegol|naloxegol|mesh-list
102446841|NCT02099591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102446842|NCT02099591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446843|NCT02099591|Sensory System Agents|sensory system agents|mesh-ancestor
102446844|NCT02099591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102446845|NCT01568073|Levodopa|levodopa|mesh-list
102446846|NCT01568073|Carbidopa|carbidopa|mesh-list
102446847|NCT01568073|Opicapone|opicapone|mesh-list
102446848|NCT01568073|Entacapone|entacapone|mesh-list
102446849|NCT01568073|Benserazide|benserazide|mesh-list
102446850|NCT01568073|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102446851|NCT01568073|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102446852|NCT01568073|Dopamine Agents|dopamine agents|mesh-ancestor
102446853|NCT01568073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102446854|NCT01568073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446855|NCT01568073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446856|NCT01568073|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102446857|NCT01568073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102446858|NCT01568073|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102446859|NCT04274933|Capecitabine|capecitabine|mesh-list
102446860|NCT04274933|Venetoclax|venetoclax|mesh-list
102446861|NCT04274933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102446862|NCT04274933|Antimetabolites|antimetabolites|mesh-ancestor
102446863|NCT04274933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446864|NCT04274933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102446865|NCT02603952|Oseltamivir|oseltamivir|mesh-list
102446866|NCT02603952|MEDI8852|medi8852|mesh-list
102446867|NCT02603952|Antiviral Agents|antiviral agents|mesh-ancestor
102612316|NCT00002405|Amprenavir|amprenavir|mesh-list
102446868|NCT02603952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102446869|NCT02603952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102446870|NCT02603952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446872|NCT02062463|Formoterol Fumarate|formoterol fumarate|mesh-list
102446873|NCT02062463|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
102446874|NCT02062463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102446875|NCT02062463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102446876|NCT02062463|Autonomic Agents|autonomic agents|mesh-ancestor
102446877|NCT02062463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102446878|NCT02062463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446879|NCT02062463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102446880|NCT02062463|Respiratory System Agents|respiratory system agents|mesh-ancestor
102446881|NCT02062463|Glucocorticoids|glucocorticoids|mesh-ancestor
102446882|NCT02062463|Hormones|hormones|mesh-ancestor
102446883|NCT02062463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102446884|NCT02062463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102446885|NCT02062463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102446886|NCT02062463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102446887|NCT02062463|Adrenergic Agents|adrenergic agents|mesh-ancestor
102446888|NCT02062463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102446889|NCT02062463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446890|NCT01501929|Metoprolol|metoprolol|mesh-list
102446891|NCT01501929|Nebivolol|nebivolol|mesh-list
102446892|NCT01501929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102446893|NCT01501929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102446894|NCT01501929|Sympatholytics|sympatholytics|mesh-ancestor
102446895|NCT01501929|Autonomic Agents|autonomic agents|mesh-ancestor
102446896|NCT01501929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102446897|NCT01501929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446898|NCT01501929|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102446899|NCT01501929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102446900|NCT01501929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102446901|NCT01501929|Adrenergic Agents|adrenergic agents|mesh-ancestor
102446902|NCT01501929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102446903|NCT01501929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446904|NCT01501929|Vasodilator Agents|vasodilator agents|mesh-ancestor
102446905|NCT01501929|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102446906|NCT01501929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102446907|NCT01501929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102446908|NCT05618496|Hyaluronic Acid|hyaluronic acid|mesh-list
102446909|NCT05618496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102446910|NCT05618496|Immunologic Factors|immunologic factors|mesh-ancestor
102446911|NCT05618496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446912|NCT05618496|Viscosupplements|viscosupplements|mesh-ancestor
102446913|NCT05618496|Protective Agents|protective agents|mesh-ancestor
102446914|NCT02049593|Irinotecan|irinotecan|mesh-list
102446915|NCT02049593|Temozolomide|temozolomide|mesh-list
102446916|NCT02049593|Talazoparib|talazoparib|mesh-list
102446917|NCT02049593|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102446918|NCT02049593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102446919|NCT02049593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102446920|NCT02049593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102446921|NCT02049593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446922|NCT02049593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102446923|NCT02049593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102446924|NCT02049593|Alkylating Agents|alkylating agents|mesh-ancestor
102446925|NCT02049047|Everolimus|everolimus|mesh-list
102446926|NCT02049047|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102446927|NCT02049047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102446928|NCT02049047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102446929|NCT02049047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446930|NCT02049047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102446931|NCT02049047|Immunologic Factors|immunologic factors|mesh-ancestor
102446932|NCT02049047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446933|NCT02049047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102077085|NCT03049735|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102446934|NCT04778358|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102446935|NCT04778358|Hormones|hormones|mesh-ancestor
102446936|NCT04778358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102446937|NCT04778358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446938|NCT01449747|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102446939|NCT01449747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102446940|NCT01449747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446941|NCT01449747|Incretins|incretins|mesh-ancestor
102446942|NCT01449747|Hormones|hormones|mesh-ancestor
102446943|NCT01449747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102446944|NCT01449747|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102446945|NCT01449747|Protease Inhibitors|protease inhibitors|mesh-ancestor
102446946|NCT01449747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102446947|NCT01449747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446948|NCT03035838|Fosaprepitant|fosaprepitant|mesh-list
102446949|NCT03035838|Aprepitant|aprepitant|mesh-list
102446950|NCT03035838|Antiemetics|antiemetics|mesh-ancestor
102446951|NCT03035838|Autonomic Agents|autonomic agents|mesh-ancestor
102446952|NCT03035838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102446953|NCT03035838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446954|NCT03035838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102446955|NCT03035838|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102446956|NCT03035838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102446957|NCT03035838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446958|NCT01569087|Lenograstim|lenograstim|mesh-list
102446959|NCT01569087|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102446960|NCT01569087|Immunologic Factors|immunologic factors|mesh-ancestor
102446961|NCT01569087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446962|NCT02024087|Sorafenib|sorafenib|mesh-list
102446963|NCT02024087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102446964|NCT02024087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102446965|NCT02024087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102446966|NCT02024087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446967|NCT01895621|Thioctic Acid|thioctic acid|mesh-list
102446968|NCT01895621|Antioxidants|antioxidants|mesh-ancestor
102446969|NCT01895621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446970|NCT01895621|Protective Agents|protective agents|mesh-ancestor
102446971|NCT01895621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446972|NCT01895621|Vitamin B Complex|vitamin b complex|mesh-ancestor
102446973|NCT01895621|Vitamins|vitamins|mesh-ancestor
102446974|NCT01895621|Micronutrients|micronutrients|mesh-ancestor
102446975|NCT01517711|Tramadol|tramadol|mesh-list
102446976|NCT01517711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102446977|NCT01517711|Narcotics|narcotics|mesh-ancestor
102446978|NCT01517711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102446979|NCT01517711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102446980|NCT01517711|Analgesics|analgesics|mesh-ancestor
102446981|NCT01517711|Sensory System Agents|sensory system agents|mesh-ancestor
102446982|NCT01517711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102446983|NCT04836078|Chitosan|chitosan|mesh-list
102446984|NCT04836078|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102446985|NCT04836078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102446986|NCT04836078|Antimetabolites|antimetabolites|mesh-ancestor
102446987|NCT04836078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102446988|NCT04836078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102446989|NCT04836078|Chelating Agents|chelating agents|mesh-ancestor
102446990|NCT04836078|Sequestering Agents|sequestering agents|mesh-ancestor
102446991|NCT04836078|Hemostatics|hemostatics|mesh-ancestor
102446992|NCT04836078|Coagulants|coagulants|mesh-ancestor
102446993|NCT01517243|Sirolimus|sirolimus|mesh-list
102446994|NCT01517243|Sunitinib|sunitinib|mesh-list
102446995|NCT01517243|Temsirolimus|temsirolimus|mesh-list
102446996|NCT01517243|MTOR Inhibitors|mtor inhibitors|mesh-list
102446997|NCT01517243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102446998|NCT01517243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102446999|NCT01517243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102447000|NCT01517243|Growth Substances|growth substances|mesh-ancestor
102447001|NCT01517243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447002|NCT01517243|Growth Inhibitors|growth inhibitors|mesh-ancestor
102447003|NCT01517243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102447004|NCT01517243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102447005|NCT01517243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447006|NCT01517243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102447007|NCT01517243|Immunologic Factors|immunologic factors|mesh-ancestor
102447008|NCT01517243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102447009|NCT01517243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102447010|NCT01517243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102447011|NCT01517243|Antifungal Agents|antifungal agents|mesh-ancestor
102447012|NCT00055237|Bevacizumab|bevacizumab|mesh-list
102447013|NCT00055237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102447014|NCT00055237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102258649|NCT02334605|Capsaicin|capsaicin|mesh-list
102447015|NCT00055237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102447016|NCT00055237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102447017|NCT00055237|Growth Substances|growth substances|mesh-ancestor
102447018|NCT00055237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447019|NCT00055237|Growth Inhibitors|growth inhibitors|mesh-ancestor
102447020|NCT04836156|Cyclophosphamide|cyclophosphamide|mesh-list
102447021|NCT04836156|Carboplatin|carboplatin|mesh-list
102447022|NCT04836156|Docetaxel|docetaxel|mesh-list
102447023|NCT04836156|Epirubicin|epirubicin|mesh-list
102447024|NCT04836156|Phenobarbital|phenobarbital|mesh-list
102447025|NCT04836156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102447026|NCT04836156|Immunologic Factors|immunologic factors|mesh-ancestor
102447027|NCT04836156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447028|NCT04836156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102447029|NCT04836156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102447030|NCT04836156|Alkylating Agents|alkylating agents|mesh-ancestor
102447031|NCT04836156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447032|NCT04836156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102447033|NCT04836156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102447034|NCT04836156|Tubulin Modulators|tubulin modulators|mesh-ancestor
102447035|NCT04836156|Antimitotic Agents|antimitotic agents|mesh-ancestor
102447036|NCT04836156|Mitosis Modulators|mitosis modulators|mesh-ancestor
102447037|NCT04836156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102447038|NCT04836156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102447039|NCT04836156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102447040|NCT04836156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102447041|NCT04836156|Anticonvulsants|anticonvulsants|mesh-ancestor
102447042|NCT04836156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102447043|NCT04836156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102447044|NCT04836156|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102447045|NCT04836156|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102447046|NCT04836156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102447047|NCT04836156|GABA Modulators|gaba modulators|mesh-ancestor
102447048|NCT04836156|GABA Agents|gaba agents|mesh-ancestor
102447049|NCT04836156|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102447050|NCT04836156|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102447051|NCT04836156|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102447052|NCT01502787|Metoprolol|metoprolol|mesh-list
102447053|NCT01502787|Nebivolol|nebivolol|mesh-list
102447054|NCT01502787|Angiotensin II|angiotensin ii|mesh-list
102447055|NCT01502787|Giapreza|giapreza|mesh-list
102447056|NCT01502787|Angiotensinogen|angiotensinogen|mesh-list
102447057|NCT01502787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102447058|NCT01502787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102447059|NCT01502787|Sympatholytics|sympatholytics|mesh-ancestor
102447060|NCT01502787|Autonomic Agents|autonomic agents|mesh-ancestor
102447061|NCT01502787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102447062|NCT01502787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447063|NCT01502787|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102447064|NCT01502787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102447065|NCT01502787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102447066|NCT01502787|Adrenergic Agents|adrenergic agents|mesh-ancestor
102447067|NCT01502787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102447068|NCT01502787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447069|NCT01502787|Vasodilator Agents|vasodilator agents|mesh-ancestor
102447070|NCT01502787|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102447071|NCT01502787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102447072|NCT01502787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102447073|NCT01502787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102447074|NCT01502787|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102447075|NCT01502787|Protease Inhibitors|protease inhibitors|mesh-ancestor
102447076|NCT01502787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102447077|NCT04829916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102447078|NCT04835922|Anesthetics|anesthetics|mesh-list
102447079|NCT04835922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102447080|NCT04835922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447081|NCT00153985|Fludarabine|fludarabine|mesh-list
102447082|NCT00153985|Alemtuzumab|alemtuzumab|mesh-list
102447083|NCT00153985|Busulfan|busulfan|mesh-list
102447084|NCT00153985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102447085|NCT00153985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447086|NCT00153985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102447087|NCT00153985|Immunologic Factors|immunologic factors|mesh-ancestor
102447088|NCT00153985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447089|NCT00153985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102447090|NCT00153985|Alkylating Agents|alkylating agents|mesh-ancestor
102447091|NCT00153985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102447092|NCT00153985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102447093|NCT02318303|Mometasone Furoate|mometasone furoate|mesh-list
102447094|NCT02318303|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
102447095|NCT02318303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102447096|NCT02318303|Dermatologic Agents|dermatologic agents|mesh-ancestor
102447097|NCT02318303|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102447098|NCT02318303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102447099|NCT02318303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102447100|NCT02318303|Analgesics|analgesics|mesh-ancestor
102447101|NCT02318303|Sensory System Agents|sensory system agents|mesh-ancestor
102447102|NCT02318303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102447103|NCT02318303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447104|NCT02318303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102447105|NCT02318303|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102447106|NCT02318303|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102447107|NCT02318303|Histamine Antagonists|histamine antagonists|mesh-ancestor
102447108|NCT02318303|Histamine Agents|histamine agents|mesh-ancestor
102447109|NCT02318303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102447110|NCT02318303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447111|NCT01451775|Empagliflozin|empagliflozin|mesh-list
102447112|NCT01451775|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102447113|NCT01451775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447114|NCT01451775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102447115|NCT01451775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447116|NCT04304040|Antibodies|antibodies|mesh-list
102447117|NCT04304040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102447118|NCT04304040|Immunologic Factors|immunologic factors|mesh-ancestor
102447119|NCT04304040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447120|NCT00156013|Clofarabine|clofarabine|mesh-list
102447121|NCT00156013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102447122|NCT00156013|Antimetabolites|antimetabolites|mesh-ancestor
102447123|NCT00156013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447124|NCT00156013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102447125|NCT01358669|Denosumab|denosumab|mesh-list
102447126|NCT01358669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102447127|NCT01358669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447128|NCT00156247|Acitretin|acitretin|mesh-list
102447129|NCT00156247|Keratolytic Agents|keratolytic agents|mesh-ancestor
102447130|NCT00156247|Dermatologic Agents|dermatologic agents|mesh-ancestor
102447131|NCT00156715|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102447132|NCT00156715|Antidepressive Agents|antidepressive agents|mesh-ancestor
102447133|NCT00156715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102447134|NCT00156715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102447135|NCT00156715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102447136|NCT00156715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102447137|NCT00156715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447138|NCT01573533|Rituximab|rituximab|mesh-list
102447139|NCT01573533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102447140|NCT01573533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102447141|NCT01573533|Immunologic Factors|immunologic factors|mesh-ancestor
102447142|NCT01573533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447143|NCT01573533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102447144|NCT01455519|Hydromorphone|hydromorphone|mesh-list
102447145|NCT01455519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102447146|NCT01455519|Narcotics|narcotics|mesh-ancestor
102447147|NCT01455519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102447148|NCT01455519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447149|NCT01455519|Analgesics|analgesics|mesh-ancestor
102447150|NCT01455519|Sensory System Agents|sensory system agents|mesh-ancestor
102447151|NCT01455519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102447152|NCT00157573|Sargramostim|sargramostim|mesh-list
102447153|NCT00157573|Immunologic Factors|immunologic factors|mesh-ancestor
102447154|NCT00157573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447155|NCT04822038|Vitamin D|vitamin d|mesh-list
102447156|NCT04822038|Cholecalciferol|cholecalciferol|mesh-list
102447157|NCT04822038|Vitamins|vitamins|mesh-ancestor
102447158|NCT04822038|Micronutrients|micronutrients|mesh-ancestor
102447159|NCT04822038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447160|NCT04822038|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102447161|NCT04822038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102447162|NCT01576809|Acetaminophen|acetaminophen|mesh-list
102447163|NCT01576809|Phenylpropanolamine|phenylpropanolamine|mesh-list
102447164|NCT01576809|Phenylephrine|phenylephrine|mesh-list
102447165|NCT01576809|Oxymetazoline|oxymetazoline|mesh-list
102447166|NCT01576809|Guaifenesin|guaifenesin|mesh-list
102447167|NCT01576809|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
102447168|NCT01576809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102447169|NCT01576809|Analgesics|analgesics|mesh-ancestor
102447170|NCT01576809|Sensory System Agents|sensory system agents|mesh-ancestor
102447171|NCT01576809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102447172|NCT01576809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447173|NCT01576809|Antipyretics|antipyretics|mesh-ancestor
102447174|NCT01576809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102447175|NCT01576809|Mydriatics|mydriatics|mesh-ancestor
102447176|NCT01576809|Autonomic Agents|autonomic agents|mesh-ancestor
102447177|NCT01576809|Sympathomimetics|sympathomimetics|mesh-ancestor
102447178|NCT01576809|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102447179|NCT01576809|Nasal Decongestants|nasal decongestants|mesh-ancestor
102447180|NCT01576809|Respiratory System Agents|respiratory system agents|mesh-ancestor
102447181|NCT01576809|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102447182|NCT01576809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102447183|NCT01576809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102447184|NCT01576809|Adrenergic Agents|adrenergic agents|mesh-ancestor
102447185|NCT01576809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102447186|NCT01576809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447187|NCT01576809|Protective Agents|protective agents|mesh-ancestor
102447188|NCT01576809|Expectorants|expectorants|mesh-ancestor
102447189|NCT01576809|Appetite Depressants|appetite depressants|mesh-ancestor
102447190|NCT01576809|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102447191|NCT01456143|Proflavine|proflavine|mesh-list
102447192|NCT01456143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102447193|NCT01456143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102447194|NCT01456299|Remifentanil|remifentanil|mesh-list
102447195|NCT01456299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102447196|NCT01456299|Narcotics|narcotics|mesh-ancestor
102447197|NCT01456299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102447198|NCT01456299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447199|NCT01456299|Analgesics|analgesics|mesh-ancestor
102447200|NCT01456299|Sensory System Agents|sensory system agents|mesh-ancestor
102447201|NCT01456299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102447202|NCT00158743|Digoxin|digoxin|mesh-list
102447203|NCT00158743|Antibodies|antibodies|mesh-list
102447204|NCT00158743|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
102447205|NCT00158743|Immunologic Factors|immunologic factors|mesh-ancestor
102447206|NCT00158743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447207|NCT00158743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102447208|NCT00158743|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102447209|NCT00158743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102447210|NCT00158743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447211|NCT00158743|Protective Agents|protective agents|mesh-ancestor
102447212|NCT00161473|Prazosin|prazosin|mesh-list
102447213|NCT00161473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102447214|NCT00161473|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102447215|NCT00161473|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102447216|NCT00161473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102447217|NCT00161473|Adrenergic Agents|adrenergic agents|mesh-ancestor
102447218|NCT00161473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102447219|NCT00161473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447220|NCT00161473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447221|NCT01319981|Cytarabine|cytarabine|mesh-list
102447222|NCT01319981|Dexamethasone|dexamethasone|mesh-list
102447223|NCT01319981|Methylprednisolone|methylprednisolone|mesh-list
102447224|NCT01319981|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102447225|NCT01319981|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102447226|NCT01319981|Prednisolone|prednisolone|mesh-list
102447227|NCT01319981|Prednisolone acetate|prednisolone acetate|mesh-list
102447228|NCT01319981|Cyclophosphamide|cyclophosphamide|mesh-list
102447229|NCT01319981|Rituximab|rituximab|mesh-list
102447230|NCT01319981|Doxorubicin|doxorubicin|mesh-list
102447231|NCT01319981|Methotrexate|methotrexate|mesh-list
102447232|NCT01319981|Vincristine|vincristine|mesh-list
102447233|NCT01319981|Imatinib Mesylate|imatinib mesylate|mesh-list
102447234|NCT01319981|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102447235|NCT01319981|Prednisolone phosphate|prednisolone phosphate|mesh-list
102447236|NCT01319981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102447237|NCT01319981|Immunologic Factors|immunologic factors|mesh-ancestor
102447238|NCT01319981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447239|NCT01319981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102447240|NCT01319981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102447241|NCT01319981|Alkylating Agents|alkylating agents|mesh-ancestor
102447242|NCT01319981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447243|NCT01319981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102447244|NCT01319981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102447245|NCT01319981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102447246|NCT01319981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102447247|NCT01319981|Antiemetics|antiemetics|mesh-ancestor
102447248|NCT01319981|Autonomic Agents|autonomic agents|mesh-ancestor
102447249|NCT01319981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102447250|NCT01319981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102447251|NCT01319981|Glucocorticoids|glucocorticoids|mesh-ancestor
102447252|NCT01319981|Hormones|hormones|mesh-ancestor
102447253|NCT01319981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102447254|NCT01319981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102447255|NCT01319981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102447256|NCT01319981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102447257|NCT01319981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102447258|NCT01319981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102447259|NCT01319981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102447260|NCT01319981|Abortifacient Agents|abortifacient agents|mesh-ancestor
102447261|NCT01319981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102447262|NCT01319981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102447263|NCT01319981|Antimetabolites|antimetabolites|mesh-ancestor
102447264|NCT01319981|Dermatologic Agents|dermatologic agents|mesh-ancestor
102447265|NCT01319981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102447266|NCT01319981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102447267|NCT01319981|Antiviral Agents|antiviral agents|mesh-ancestor
102447268|NCT01319981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102447269|NCT01319981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102447270|NCT01319981|Tubulin Modulators|tubulin modulators|mesh-ancestor
102447271|NCT01319981|Antimitotic Agents|antimitotic agents|mesh-ancestor
102447272|NCT01319981|Mitosis Modulators|mitosis modulators|mesh-ancestor
102447273|NCT01319981|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102447274|NCT01319981|Protective Agents|protective agents|mesh-ancestor
102447275|NCT01319981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102447276|NCT01458561|Thrombin|thrombin|mesh-list
102447277|NCT01458561|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
102447278|NCT01458561|Hemostatics|hemostatics|mesh-ancestor
102447279|NCT01458561|Coagulants|coagulants|mesh-ancestor
102447280|NCT00065611|Dexamethasone|dexamethasone|mesh-list
102447281|NCT00065611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102447282|NCT00065611|Antiemetics|antiemetics|mesh-ancestor
102447283|NCT00065611|Autonomic Agents|autonomic agents|mesh-ancestor
102447284|NCT00065611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102447285|NCT00065611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447286|NCT00065611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102447287|NCT00065611|Glucocorticoids|glucocorticoids|mesh-ancestor
102447288|NCT00065611|Hormones|hormones|mesh-ancestor
102447289|NCT00065611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102447290|NCT00065611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102447291|NCT00065611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102447292|NCT00066781|Gemcitabine|gemcitabine|mesh-list
102447293|NCT00066781|Irinotecan|irinotecan|mesh-list
102447294|NCT00066781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102447295|NCT00066781|Antimetabolites|antimetabolites|mesh-ancestor
102447296|NCT00066781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447297|NCT00066781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102447298|NCT00066781|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102447299|NCT00066781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102447300|NCT00066781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102447301|NCT01189643|Bevacizumab|bevacizumab|mesh-list
102447302|NCT01189643|Irinotecan|irinotecan|mesh-list
102447303|NCT01189643|Temozolomide|temozolomide|mesh-list
102447304|NCT01189643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102447305|NCT01189643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102447306|NCT01189643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102447307|NCT01189643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102447308|NCT01189643|Growth Substances|growth substances|mesh-ancestor
102447309|NCT01189643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447310|NCT01189643|Growth Inhibitors|growth inhibitors|mesh-ancestor
102447311|NCT01189643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102447312|NCT01189643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102447313|NCT01189643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102447314|NCT01189643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447315|NCT01189643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102447316|NCT01189643|Alkylating Agents|alkylating agents|mesh-ancestor
102447317|NCT01431755|Lidocaine|lidocaine|mesh-list
102447318|NCT01431755|Hyaluronic Acid|hyaluronic acid|mesh-list
102447319|NCT01431755|Anesthetics, Local|anesthetics, local|mesh-ancestor
102447320|NCT01431755|Anesthetics|anesthetics|mesh-ancestor
102447321|NCT01431755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102447322|NCT01431755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447324|NCT01431755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102447325|NCT01431755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102447326|NCT01431755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102447327|NCT01431755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102447328|NCT01431755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102447329|NCT01431755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447330|NCT01431755|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102447331|NCT01431755|Immunologic Factors|immunologic factors|mesh-ancestor
102447332|NCT01431755|Viscosupplements|viscosupplements|mesh-ancestor
102447333|NCT01431755|Protective Agents|protective agents|mesh-ancestor
102447334|NCT00066937|Benztropine|benztropine|mesh-list
102447335|NCT00066937|Nortriptyline|nortriptyline|mesh-list
102447336|NCT00066937|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102447337|NCT00066937|Antidepressive Agents|antidepressive agents|mesh-ancestor
102447338|NCT00066937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102447339|NCT00066937|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102447340|NCT00066937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102447341|NCT00066937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102447342|NCT00066937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447343|NCT00066937|Adrenergic Agents|adrenergic agents|mesh-ancestor
102447344|NCT00066937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102447345|NCT00066937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447346|NCT00066937|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102447347|NCT00066937|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102447348|NCT00066937|Parasympatholytics|parasympatholytics|mesh-ancestor
102447349|NCT00066937|Autonomic Agents|autonomic agents|mesh-ancestor
102447350|NCT00066937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102447351|NCT00066937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102447352|NCT00066937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102447353|NCT00066937|Cholinergic Agents|cholinergic agents|mesh-ancestor
102447354|NCT00066937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102447355|NCT00066937|Dopamine Agents|dopamine agents|mesh-ancestor
102447356|NCT01064375|Cyclophosphamide|cyclophosphamide|mesh-list
102447357|NCT01064375|Molgramostim|molgramostim|mesh-list
102447358|NCT01064375|Sargramostim|sargramostim|mesh-list
102447359|NCT01064375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102447360|NCT01064375|Immunologic Factors|immunologic factors|mesh-ancestor
102447361|NCT01064375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447362|NCT01064375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102447363|NCT01064375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102447364|NCT01064375|Alkylating Agents|alkylating agents|mesh-ancestor
102447365|NCT01064375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447366|NCT01064375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102447367|NCT01064375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102447368|NCT01061411|Sunitinib|sunitinib|mesh-list
102447369|NCT01061411|Dalteparin|dalteparin|mesh-list
102447370|NCT01061411|Tinzaparin|tinzaparin|mesh-list
102447371|NCT01061411|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102447372|NCT01061411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102447373|NCT01061411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102447374|NCT01061411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102447375|NCT01061411|Growth Substances|growth substances|mesh-ancestor
102447376|NCT01061411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447377|NCT01061411|Growth Inhibitors|growth inhibitors|mesh-ancestor
102447378|NCT01061411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102447379|NCT01061411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102447380|NCT01061411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447381|NCT01061411|Anticoagulants|anticoagulants|mesh-ancestor
102447382|NCT01061411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102447383|NCT01061411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102447384|NCT01505673|Liraglutide|liraglutide|mesh-list
102447385|NCT01505673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102447386|NCT01505673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447387|NCT01505673|Incretins|incretins|mesh-ancestor
102447388|NCT01505673|Hormones|hormones|mesh-ancestor
102447389|NCT01505673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102447390|NCT04834986|Lenvatinib|lenvatinib|mesh-list
102447391|NCT04834986|Tislelizumab|tislelizumab|mesh-list
102447392|NCT04834986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102447393|NCT04834986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102447394|NCT04834986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102447395|NCT04834986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447396|NCT04834986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102447397|NCT04827966|Calcium, Dietary|calcium, dietary|mesh-list
102447398|NCT04827966|Listerine|listerine|mesh-list
102447399|NCT04827966|Calcium|calcium|mesh-list
102447400|NCT04827966|Fluorides|fluorides|mesh-list
102447401|NCT04827966|Sodium Fluoride|sodium fluoride|mesh-list
102447402|NCT04827966|Caseins|caseins|mesh-list
102447403|NCT04827966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102447404|NCT04827966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447405|NCT04827966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102447406|NCT04827966|Cariostatic Agents|cariostatic agents|mesh-ancestor
102447407|NCT04827966|Protective Agents|protective agents|mesh-ancestor
102447408|NCT04827966|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102447409|NCT04827966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102447410|NCT04827966|Chelating Agents|chelating agents|mesh-ancestor
102447411|NCT04827966|Sequestering Agents|sequestering agents|mesh-ancestor
102447412|NCT04827966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447413|NCT02247141|Immunoglobulins|immunoglobulins|mesh-list
102447414|NCT02247141|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102447415|NCT02247141|Antibodies|antibodies|mesh-list
102447416|NCT02247141|Immunologic Factors|immunologic factors|mesh-ancestor
102447417|NCT02247141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447418|NCT01896245|Sevoflurane|sevoflurane|mesh-list
102447419|NCT01896245|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102447420|NCT01896245|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102447421|NCT01896245|Anesthetics, General|anesthetics, general|mesh-ancestor
102447422|NCT01896245|Anesthetics|anesthetics|mesh-ancestor
102447423|NCT01896245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102447424|NCT01896245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447425|NCT04821804|Hyaluronic Acid|hyaluronic acid|mesh-list
102447426|NCT04821804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102447427|NCT04821804|Immunologic Factors|immunologic factors|mesh-ancestor
102447428|NCT04821804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447429|NCT04821804|Viscosupplements|viscosupplements|mesh-ancestor
102447430|NCT04821804|Protective Agents|protective agents|mesh-ancestor
102447431|NCT04835064|Paclitaxel|paclitaxel|mesh-list
102447432|NCT04835064|Gemcitabine|gemcitabine|mesh-list
102447433|NCT04835064|Folfirinox|folfirinox|mesh-list
102447434|NCT04835064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102447435|NCT04835064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102447436|NCT04835064|Tubulin Modulators|tubulin modulators|mesh-ancestor
102447437|NCT04835064|Antimitotic Agents|antimitotic agents|mesh-ancestor
102447438|NCT04835064|Mitosis Modulators|mitosis modulators|mesh-ancestor
102447439|NCT04835064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447440|NCT04835064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102447441|NCT04835064|Antimetabolites|antimetabolites|mesh-ancestor
102447442|NCT00819221|Doxorubicin|doxorubicin|mesh-list
102447443|NCT00819221|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102447444|NCT00819221|Olaparib|olaparib|mesh-list
102447445|NCT00819221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102447446|NCT00819221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102447447|NCT00819221|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102447448|NCT00819221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102447449|NCT00819221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102447450|NCT00819221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447451|NCT00819221|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102447452|NCT01507779|Vaccines|vaccines|mesh-list
102447453|NCT01507779|Immunologic Factors|immunologic factors|mesh-ancestor
102447454|NCT01507779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447455|NCT01896323|Ketoconazole|ketoconazole|mesh-list
102447456|NCT01896323|Antifungal Agents|antifungal agents|mesh-ancestor
102447457|NCT01896323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102447458|NCT01896323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102447459|NCT01896323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102447460|NCT01896323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102447461|NCT01896323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447462|NCT01896323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102447463|NCT01896323|Hormone Antagonists|hormone antagonists|mesh-ancestor
102447464|NCT01896323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102447465|NCT01896323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447466|NCT01896323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102447467|NCT00068341|Carboplatin|carboplatin|mesh-list
102447468|NCT00068341|Docetaxel|docetaxel|mesh-list
102447469|NCT00068341|Trastuzumab|trastuzumab|mesh-list
102447470|NCT00068341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102447471|NCT00068341|Tubulin Modulators|tubulin modulators|mesh-ancestor
102447472|NCT00068341|Antimitotic Agents|antimitotic agents|mesh-ancestor
102447473|NCT00068341|Mitosis Modulators|mitosis modulators|mesh-ancestor
102447474|NCT00068341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447475|NCT00068341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102447476|NCT02605824|Acetylcysteine|acetylcysteine|mesh-list
102447477|NCT02605824|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102447478|NCT02605824|Antiviral Agents|antiviral agents|mesh-ancestor
102447479|NCT02605824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102447480|NCT02605824|Expectorants|expectorants|mesh-ancestor
102447481|NCT02605824|Respiratory System Agents|respiratory system agents|mesh-ancestor
102447482|NCT02605824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102447483|NCT02605824|Antioxidants|antioxidants|mesh-ancestor
102447484|NCT02605824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447485|NCT02605824|Protective Agents|protective agents|mesh-ancestor
102447486|NCT02605824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447487|NCT02605824|Antidotes|antidotes|mesh-ancestor
102447488|NCT01896661|Amlodipine|amlodipine|mesh-list
102447489|NCT01896661|Chlorthalidone|chlorthalidone|mesh-list
102447490|NCT01896661|Calcium Channel Blockers|calcium channel blockers|mesh-list
102447491|NCT01896661|Amiloride|amiloride|mesh-list
102447492|NCT01896661|Calcium|calcium|mesh-list
102447493|NCT01896661|Diuretics|diuretics|mesh-list
102447494|NCT01896661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102447495|NCT01896661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447496|NCT01896661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102447497|NCT01896661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102447498|NCT01896661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447499|NCT01896661|Vasodilator Agents|vasodilator agents|mesh-ancestor
102447500|NCT01896661|Natriuretic Agents|natriuretic agents|mesh-ancestor
102447501|NCT01896661|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102447502|NCT01896661|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
102447503|NCT01896661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102447504|NCT01896661|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
102447505|NCT01896661|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102447506|NCT01462773|Interferons|interferons|mesh-list
102447507|NCT01462773|Interferon-alpha|interferon-alpha|mesh-list
102447508|NCT01462773|Interferon alpha-2|interferon alpha-2|mesh-list
102447509|NCT01462773|Bortezomib|bortezomib|mesh-list
102447510|NCT01462773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102447511|NCT01462773|Antiviral Agents|antiviral agents|mesh-ancestor
102447512|NCT01462773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102447513|NCT01462773|Immunologic Factors|immunologic factors|mesh-ancestor
102447514|NCT01462773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447515|NCT02096029|Nicotine|nicotine|mesh-list
102447516|NCT02096029|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102447517|NCT02096029|Autonomic Agents|autonomic agents|mesh-ancestor
102447518|NCT02096029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102447519|NCT02096029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447520|NCT02096029|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102447521|NCT02096029|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102447522|NCT02096029|Cholinergic Agents|cholinergic agents|mesh-ancestor
102447523|NCT02096029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102447524|NCT02096029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447525|NCT02205801|Bupivacaine|bupivacaine|mesh-list
102447526|NCT02205801|Anesthetics, Local|anesthetics, local|mesh-ancestor
102447527|NCT02205801|Anesthetics|anesthetics|mesh-ancestor
102447528|NCT02205801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102447529|NCT02205801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447530|NCT02205801|Sensory System Agents|sensory system agents|mesh-ancestor
102447531|NCT02205801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102447532|NCT02096107|Everolimus|everolimus|mesh-list
102447533|NCT02096107|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102447534|NCT02096107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102447535|NCT02096107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102447536|NCT02096107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447537|NCT02096107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102447538|NCT02096107|Immunologic Factors|immunologic factors|mesh-ancestor
102447539|NCT02096107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447540|NCT02096107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102447541|NCT04834440|Ropivacaine|ropivacaine|mesh-list
102447542|NCT04834440|Anesthetics, Local|anesthetics, local|mesh-ancestor
102447543|NCT04834440|Anesthetics|anesthetics|mesh-ancestor
102447544|NCT04834440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102447545|NCT04834440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447546|NCT04834440|Sensory System Agents|sensory system agents|mesh-ancestor
102447547|NCT04834440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102447549|NCT00068575|Interferon-alpha|interferon-alpha|mesh-list
102447550|NCT00068575|Interferon alpha-2|interferon alpha-2|mesh-list
102447551|NCT00068575|Cisplatin|cisplatin|mesh-list
102447552|NCT00068575|Fluorouracil|fluorouracil|mesh-list
102447553|NCT00068575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102447554|NCT00068575|Antimetabolites|antimetabolites|mesh-ancestor
102447555|NCT00068575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447556|NCT00068575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102447557|NCT00068575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102447558|NCT00068575|Immunologic Factors|immunologic factors|mesh-ancestor
102447559|NCT00068575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447560|NCT00068575|Antiviral Agents|antiviral agents|mesh-ancestor
102447561|NCT00068575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102447562|NCT00784823|Bortezomib|bortezomib|mesh-list
102447563|NCT00784823|Melphalan|melphalan|mesh-list
102447564|NCT00784823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102447565|NCT00784823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102447566|NCT00784823|Alkylating Agents|alkylating agents|mesh-ancestor
102447567|NCT00784823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447568|NCT00784823|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102447569|NCT00784823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102447570|NCT00784823|Immunologic Factors|immunologic factors|mesh-ancestor
102447571|NCT00784823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447572|NCT04428684|Goserelin|goserelin|mesh-list
102447573|NCT04428684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102447574|NCT04428684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102447575|NCT01509105|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102447576|NCT01509105|Immunologic Factors|immunologic factors|mesh-ancestor
102447577|NCT01509105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447578|NCT00773357|Guanfacine|guanfacine|mesh-list
102447579|NCT00773357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102447580|NCT00773357|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102447581|NCT00773357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102447582|NCT00773357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102447583|NCT00773357|Adrenergic Agents|adrenergic agents|mesh-ancestor
102447584|NCT00773357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102447585|NCT00773357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447586|NCT00773357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447587|NCT05617950|Salicylic Acid|salicylic acid|mesh-list
102447588|NCT05617950|Salicylates|salicylates|mesh-list
102447589|NCT05617950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102447590|NCT05617950|Antifungal Agents|antifungal agents|mesh-ancestor
102447591|NCT05617950|Keratolytic Agents|keratolytic agents|mesh-ancestor
102447592|NCT05617950|Dermatologic Agents|dermatologic agents|mesh-ancestor
102447593|NCT05617950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102447594|NCT05617950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102447595|NCT05617950|Analgesics|analgesics|mesh-ancestor
102447596|NCT05617950|Sensory System Agents|sensory system agents|mesh-ancestor
102447597|NCT05617950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102447598|NCT05617950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447599|NCT05617950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102447600|NCT05617950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102447601|NCT05617950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102447602|NCT05617950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102447603|NCT05617950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447604|NCT04834752|Esomeprazole|esomeprazole|mesh-list
102447605|NCT04834752|Omeprazole|omeprazole|mesh-list
102447606|NCT04834752|Rabeprazole|rabeprazole|mesh-list
102447607|NCT04834752|Pantoprazole|pantoprazole|mesh-list
102447608|NCT04834752|Lansoprazole|lansoprazole|mesh-list
102447609|NCT04834752|Dexlansoprazole|dexlansoprazole|mesh-list
102447610|NCT04834752|Famotidine|famotidine|mesh-list
102447611|NCT04834752|Ranitidine|ranitidine|mesh-list
102447612|NCT04834752|Cimetidine|cimetidine|mesh-list
102447613|NCT04834752|Nizatidine|nizatidine|mesh-list
102447614|NCT04834752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102447615|NCT04834752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102447616|NCT04834752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102447617|NCT04834752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102447618|NCT04834752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447619|NCT04834752|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102447620|NCT04834752|Histamine Antagonists|histamine antagonists|mesh-ancestor
102447621|NCT04834752|Histamine Agents|histamine agents|mesh-ancestor
102447622|NCT04834752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102447623|NCT04834752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259253|NCT02432365|Paclitaxel|paclitaxel|mesh-list
102447624|NCT04834752|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102447625|NCT04834752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102447627|NCT04834674|Antibodies|antibodies|mesh-list
102447628|NCT04834674|Immunologic Factors|immunologic factors|mesh-ancestor
102447629|NCT04834674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447630|NCT04834674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102447631|NCT04834674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102447632|NCT04834674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102447633|NCT04834674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447634|NCT04826406|Apatinib|apatinib|mesh-list
102447635|NCT04826406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102447636|NCT04826406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102447637|NCT04826406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102447638|NCT04826406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447639|NCT05617872|Acetic Acid|acetic acid|mesh-list
102447640|NCT05617872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102447641|NCT05617872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102447642|NCT04198727|Capecitabine|capecitabine|mesh-list
102447643|NCT04198727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102447644|NCT04198727|Antimetabolites|antimetabolites|mesh-ancestor
102447645|NCT04198727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447646|NCT04198727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102447647|NCT00437255|Betamethasone|betamethasone|mesh-list
102447648|NCT00437255|Betamethasone Valerate|betamethasone valerate|mesh-list
102447649|NCT00437255|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102447650|NCT00437255|Betamethasone benzoate|betamethasone benzoate|mesh-list
102447651|NCT00437255|Clobetasol|clobetasol|mesh-list
102447652|NCT00437255|Calcipotriene|calcipotriene|mesh-list
102447653|NCT00437255|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102447654|NCT00437255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102447655|NCT00437255|Glucocorticoids|glucocorticoids|mesh-ancestor
102447656|NCT00437255|Hormones|hormones|mesh-ancestor
102447657|NCT00437255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102447658|NCT00437255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447659|NCT00437255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102447660|NCT00437255|Respiratory System Agents|respiratory system agents|mesh-ancestor
102447661|NCT00437255|Dermatologic Agents|dermatologic agents|mesh-ancestor
102447662|NCT02324673|Cannabidiol|cannabidiol|mesh-list
102447663|NCT02324673|Anticonvulsants|anticonvulsants|mesh-ancestor
102447664|NCT00373217|Paclitaxel|paclitaxel|mesh-list
102447665|NCT00373217|Carboplatin|carboplatin|mesh-list
102447666|NCT00373217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102447667|NCT00373217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102447668|NCT00373217|Tubulin Modulators|tubulin modulators|mesh-ancestor
102447669|NCT00373217|Antimitotic Agents|antimitotic agents|mesh-ancestor
102447670|NCT00373217|Mitosis Modulators|mitosis modulators|mesh-ancestor
102447671|NCT00373217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447672|NCT02605122|Amoxicillin|amoxicillin|mesh-list
102447673|NCT02605122|Azithromycin|azithromycin|mesh-list
102447674|NCT02605122|Ceftriaxone|ceftriaxone|mesh-list
102447675|NCT02605122|Erythromycin|erythromycin|mesh-list
102447676|NCT02605122|Erythromycin Estolate|erythromycin estolate|mesh-list
102447677|NCT02605122|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
102447678|NCT02605122|Erythromycin stearate|erythromycin stearate|mesh-list
102447679|NCT02605122|Clavulanic Acids|clavulanic acids|mesh-list
102447680|NCT02605122|Clavulanic Acid|clavulanic acid|mesh-list
102447681|NCT02605122|Ampicillin|ampicillin|mesh-list
102447682|NCT02605122|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102447683|NCT02605122|Solithromycin|solithromycin|mesh-list
102447684|NCT02605122|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
102447685|NCT02605122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102447686|NCT02605122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102447687|NCT02605122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102077824|NCT02291666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102447688|NCT02605122|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102447689|NCT02605122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102447690|NCT02605122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447691|NCT02605122|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102447692|NCT01579305|Lidocaine|lidocaine|mesh-list
102447693|NCT01579305|Anesthetics, Local|anesthetics, local|mesh-ancestor
102447694|NCT01579305|Anesthetics|anesthetics|mesh-ancestor
102447695|NCT01579305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102447696|NCT01579305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447697|NCT01579305|Sensory System Agents|sensory system agents|mesh-ancestor
102447698|NCT01579305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102447699|NCT01579305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102447700|NCT01579305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102447701|NCT01579305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102447702|NCT01579305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102447703|NCT01579305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447705|NCT00212147|Anesthetics|anesthetics|mesh-list
102447706|NCT00212147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102447707|NCT00212147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447708|NCT00212147|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102447709|NCT00212147|Anesthetics, General|anesthetics, general|mesh-ancestor
102447710|NCT00212147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102447711|NCT00212147|Analgesics|analgesics|mesh-ancestor
102447712|NCT00212147|Sensory System Agents|sensory system agents|mesh-ancestor
102447713|NCT00212147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102447714|NCT04820010|Insulin|insulin|mesh-list
102447715|NCT04820010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102447716|NCT04820010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447717|NCT04819776|Iloperidone|iloperidone|mesh-list
102447718|NCT04819776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102447719|NCT04819776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102447720|NCT04819776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102447721|NCT04819776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447722|NCT04819776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102447723|NCT01454102|Paclitaxel|paclitaxel|mesh-list
102447724|NCT01454102|Bevacizumab|bevacizumab|mesh-list
102447725|NCT01454102|Carboplatin|carboplatin|mesh-list
102447726|NCT01454102|Gemcitabine|gemcitabine|mesh-list
102447727|NCT01454102|Nivolumab|nivolumab|mesh-list
102447728|NCT01454102|Pemetrexed|pemetrexed|mesh-list
102447729|NCT01454102|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102447730|NCT01454102|Ipilimumab|ipilimumab|mesh-list
102447731|NCT01454102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102447732|NCT01454102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102447733|NCT01454102|Tubulin Modulators|tubulin modulators|mesh-ancestor
102447734|NCT01454102|Antimitotic Agents|antimitotic agents|mesh-ancestor
102447735|NCT01454102|Mitosis Modulators|mitosis modulators|mesh-ancestor
102447736|NCT01454102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447737|NCT01454102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102447738|NCT01454102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102447739|NCT01454102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102447740|NCT01454102|Growth Substances|growth substances|mesh-ancestor
102447741|NCT01454102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447742|NCT01454102|Growth Inhibitors|growth inhibitors|mesh-ancestor
102447743|NCT01454102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102447744|NCT01454102|Antimetabolites|antimetabolites|mesh-ancestor
102447745|NCT01454102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102447746|NCT01454102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102447747|NCT01454102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102447748|NCT01454102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102447749|NCT01454102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102447750|NCT04192253|Paclitaxel|paclitaxel|mesh-list
102447751|NCT04192253|Carboplatin|carboplatin|mesh-list
102447752|NCT04192253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102447753|NCT04192253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102447754|NCT04192253|Tubulin Modulators|tubulin modulators|mesh-ancestor
102447755|NCT04192253|Antimitotic Agents|antimitotic agents|mesh-ancestor
102447756|NCT04192253|Mitosis Modulators|mitosis modulators|mesh-ancestor
102447757|NCT04192253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447758|NCT04825938|Paclitaxel|paclitaxel|mesh-list
102447759|NCT04825938|Carboplatin|carboplatin|mesh-list
102447760|NCT04825938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102077890|NCT05574036|Antioxidants|antioxidants|mesh-ancestor
102447761|NCT04825938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102447762|NCT04825938|Tubulin Modulators|tubulin modulators|mesh-ancestor
102447763|NCT04825938|Antimitotic Agents|antimitotic agents|mesh-ancestor
102447764|NCT04825938|Mitosis Modulators|mitosis modulators|mesh-ancestor
102447765|NCT04825938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447766|NCT04826016|Paclitaxel|paclitaxel|mesh-list
102447767|NCT04826016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102447768|NCT04826016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102447769|NCT04826016|Tubulin Modulators|tubulin modulators|mesh-ancestor
102447770|NCT04826016|Antimitotic Agents|antimitotic agents|mesh-ancestor
102447771|NCT04826016|Mitosis Modulators|mitosis modulators|mesh-ancestor
102447772|NCT04826016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447773|NCT01509807|Morphine|morphine|mesh-list
102259392|NCT03143465|Calcitonin|calcitonin|mesh-list
102447774|NCT01509807|Bupivacaine|bupivacaine|mesh-list
102447775|NCT01509807|Anesthetics, Local|anesthetics, local|mesh-ancestor
102447776|NCT01509807|Anesthetics|anesthetics|mesh-ancestor
102447777|NCT01509807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102447778|NCT01509807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447779|NCT01509807|Sensory System Agents|sensory system agents|mesh-ancestor
102447780|NCT01509807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102447781|NCT01509807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102447782|NCT01509807|Narcotics|narcotics|mesh-ancestor
102447783|NCT01509807|Analgesics|analgesics|mesh-ancestor
102447784|NCT00070135|Methotrexate|methotrexate|mesh-list
102447785|NCT00070135|Fludarabine phosphate|fludarabine phosphate|mesh-list
102447786|NCT00070135|Fludarabine|fludarabine|mesh-list
102447787|NCT00070135|Busulfan|busulfan|mesh-list
102447788|NCT00070135|Tacrolimus|tacrolimus|mesh-list
102447789|NCT00070135|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102447790|NCT00070135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102447791|NCT00070135|Abortifacient Agents|abortifacient agents|mesh-ancestor
102447792|NCT00070135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102447793|NCT00070135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447794|NCT00070135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102447795|NCT00070135|Antimetabolites|antimetabolites|mesh-ancestor
102447796|NCT00070135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447797|NCT00070135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102447798|NCT00070135|Dermatologic Agents|dermatologic agents|mesh-ancestor
102447799|NCT00070135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102447800|NCT00070135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102447801|NCT00070135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102447802|NCT00070135|Immunologic Factors|immunologic factors|mesh-ancestor
102447803|NCT00070135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102447804|NCT00070135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102447805|NCT00070135|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102447806|NCT00070135|Alkylating Agents|alkylating agents|mesh-ancestor
102447807|NCT00070135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102447808|NCT00070135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102447809|NCT01583985|Analgesics, Opioid|analgesics, opioid|mesh-list
102447810|NCT01583985|Narcotics|narcotics|mesh-ancestor
102447811|NCT01583985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102447812|NCT01583985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447813|NCT01583985|Analgesics|analgesics|mesh-ancestor
102447814|NCT01583985|Sensory System Agents|sensory system agents|mesh-ancestor
102447815|NCT01583985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102447816|NCT04816344|Anesthetics|anesthetics|mesh-list
102447817|NCT04816344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102447818|NCT04816344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447819|NCT01467999|Guanfacine|guanfacine|mesh-list
102447820|NCT01467999|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102447821|NCT01467999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102447822|NCT01467999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102447823|NCT01467999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102447824|NCT01467999|Adrenergic Agents|adrenergic agents|mesh-ancestor
102447825|NCT01467999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102447826|NCT01467999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447827|NCT01467999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447828|NCT05617482|Anesthetics|anesthetics|mesh-list
102447829|NCT05617482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102447830|NCT05617482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447831|NCT01470027|Acetylcysteine|acetylcysteine|mesh-list
102447832|NCT01470027|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102447833|NCT01470027|Antiviral Agents|antiviral agents|mesh-ancestor
102447834|NCT01470027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102447835|NCT01470027|Expectorants|expectorants|mesh-ancestor
102447836|NCT01470027|Respiratory System Agents|respiratory system agents|mesh-ancestor
102447837|NCT01470027|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102447838|NCT01470027|Antioxidants|antioxidants|mesh-ancestor
102447839|NCT01470027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447840|NCT01470027|Protective Agents|protective agents|mesh-ancestor
102447841|NCT01470027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447842|NCT01470027|Antidotes|antidotes|mesh-ancestor
102447843|NCT01470651|Modafinil|modafinil|mesh-list
102447844|NCT01470651|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102447845|NCT01470651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447846|NCT01470651|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102447847|NCT01470651|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102447848|NCT01470651|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102447849|NCT01470651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447850|NCT01512225|Domperidone|domperidone|mesh-list
102447851|NCT01512225|Maleic acid|maleic acid|mesh-list
102447852|NCT01512225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102447853|NCT01512225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447854|NCT01512225|Antiemetics|antiemetics|mesh-ancestor
102447855|NCT01512225|Autonomic Agents|autonomic agents|mesh-ancestor
102447856|NCT01512225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102447857|NCT01512225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447858|NCT01512225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102447859|NCT01512225|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102447860|NCT01512225|Dopamine Agents|dopamine agents|mesh-ancestor
102447861|NCT01512225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102447862|NCT01472445|Vitamin D|vitamin d|mesh-list
102447863|NCT01472445|Cholecalciferol|cholecalciferol|mesh-list
102447864|NCT01472445|Vitamins|vitamins|mesh-ancestor
102447865|NCT01472445|Micronutrients|micronutrients|mesh-ancestor
102447866|NCT01472445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447867|NCT01472445|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102447868|NCT01472445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102447869|NCT04782089|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102447870|NCT04782089|Fluzoparib|fluzoparib|mesh-list
102447871|NCT04782089|Antibodies|antibodies|mesh-list
102447872|NCT04782089|Immunologic Factors|immunologic factors|mesh-ancestor
102447873|NCT04782089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447874|NCT04782089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102447875|NCT04782089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447876|NCT04782089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102447877|NCT02604342|Docetaxel|docetaxel|mesh-list
102447878|NCT02604342|Pemetrexed|pemetrexed|mesh-list
102447879|NCT02604342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102447880|NCT02604342|Tubulin Modulators|tubulin modulators|mesh-ancestor
102447881|NCT02604342|Antimitotic Agents|antimitotic agents|mesh-ancestor
102447882|NCT02604342|Mitosis Modulators|mitosis modulators|mesh-ancestor
102447883|NCT02604342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447884|NCT02604342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102447885|NCT02604342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102447886|NCT02604342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102447887|NCT04781777|Insulin|insulin|mesh-list
102447888|NCT04781777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102447889|NCT04781777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447890|NCT04781075|Bupivacaine|bupivacaine|mesh-list
102447891|NCT04781075|Anesthetics, Local|anesthetics, local|mesh-ancestor
102447892|NCT04781075|Anesthetics|anesthetics|mesh-ancestor
102447893|NCT04781075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102447894|NCT04781075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447895|NCT04781075|Sensory System Agents|sensory system agents|mesh-ancestor
102447896|NCT04781075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102447897|NCT01586091|Fexofenadine|fexofenadine|mesh-list
102447898|NCT01586091|Levocetirizine|levocetirizine|mesh-list
102447899|NCT01586091|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102447900|NCT01586091|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102447901|NCT01586091|Histamine Antagonists|histamine antagonists|mesh-ancestor
102447902|NCT01586091|Histamine Agents|histamine agents|mesh-ancestor
102447903|NCT01586091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102447904|NCT01586091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447905|NCT01586091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447906|NCT01586091|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102447907|NCT05565573|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102447908|NCT05565573|Levonorgestrel|levonorgestrel|mesh-list
102447909|NCT05565573|Medroxyprogesterone|medroxyprogesterone|mesh-list
102447910|NCT05565573|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102447911|NCT05565573|Contraceptive Agents|contraceptive agents|mesh-ancestor
102447912|NCT05565573|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102447913|NCT05565573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447914|NCT05565573|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102447915|NCT05565573|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102447916|NCT05565573|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102447917|NCT05565573|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102447918|NCT05565573|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102447919|NCT05565573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102447920|NCT05565573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102447921|NCT04389359|Hydroxychloroquine|hydroxychloroquine|mesh-list
102447922|NCT04389359|Antimalarials|antimalarials|mesh-ancestor
102447923|NCT04389359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102447924|NCT04389359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102447925|NCT04389359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102447926|NCT04389359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102447927|NCT04389359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447928|NCT04389359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102447929|NCT01587027|Aminophylline|aminophylline|mesh-list
102447930|NCT01587027|Methazolamide|methazolamide|mesh-list
102447931|NCT01587027|Theophylline|theophylline|mesh-list
102447932|NCT01587027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102447933|NCT01587027|Autonomic Agents|autonomic agents|mesh-ancestor
102447934|NCT01587027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102447935|NCT01587027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447936|NCT01587027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102447937|NCT01587027|Respiratory System Agents|respiratory system agents|mesh-ancestor
102447938|NCT01587027|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102447939|NCT01587027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102447940|NCT01587027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447941|NCT01587027|Vasodilator Agents|vasodilator agents|mesh-ancestor
102447942|NCT01587027|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102447943|NCT01587027|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102447944|NCT01587027|Purinergic Agents|purinergic agents|mesh-ancestor
102447945|NCT01587027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102447946|NCT01587027|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102447947|NCT01587027|Protective Agents|protective agents|mesh-ancestor
102447948|NCT01587027|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102447949|NCT01587027|Diuretics|diuretics|mesh-ancestor
102447950|NCT01587027|Natriuretic Agents|natriuretic agents|mesh-ancestor
102447951|NCT01471340|Mometasone Furoate|mometasone furoate|mesh-list
102447952|NCT01471340|Prednisone|prednisone|mesh-list
102447953|NCT01471340|Prednisolone|prednisolone|mesh-list
102447954|NCT01471340|Albuterol|albuterol|mesh-list
102447955|NCT01471340|Formoterol Fumarate|formoterol fumarate|mesh-list
102447956|NCT01471340|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
102447957|NCT01471340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102447958|NCT01471340|Glucocorticoids|glucocorticoids|mesh-ancestor
102447959|NCT01471340|Hormones|hormones|mesh-ancestor
102447960|NCT01471340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102078112|NCT05885269|Hormones|hormones|mesh-ancestor
102447961|NCT01471340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447962|NCT01471340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102447963|NCT01471340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102447964|NCT01471340|Autonomic Agents|autonomic agents|mesh-ancestor
102447965|NCT01471340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102447966|NCT01471340|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102447967|NCT01471340|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102447968|NCT01471340|Respiratory System Agents|respiratory system agents|mesh-ancestor
102447969|NCT01471340|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102447970|NCT01471340|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102447971|NCT01471340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102447972|NCT01471340|Adrenergic Agents|adrenergic agents|mesh-ancestor
102447973|NCT01471340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102447974|NCT01471340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447975|NCT01471340|Tocolytic Agents|tocolytic agents|mesh-ancestor
102447976|NCT01471340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102447977|NCT01471340|Dermatologic Agents|dermatologic agents|mesh-ancestor
102447978|NCT01471340|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102447979|NCT04754789|Aspirin|aspirin|mesh-list
102447980|NCT04754789|Ticagrelor|ticagrelor|mesh-list
102447981|NCT04754789|Atorvastatin|atorvastatin|mesh-list
102447982|NCT04754789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102447983|NCT04754789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102447984|NCT04754789|Analgesics|analgesics|mesh-ancestor
102447985|NCT04754789|Sensory System Agents|sensory system agents|mesh-ancestor
102447986|NCT04754789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102447987|NCT04754789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102447988|NCT04754789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102447989|NCT04754789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102447990|NCT04754789|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102447991|NCT04754789|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102447992|NCT04754789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102447993|NCT04754789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102447994|NCT04754789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102447995|NCT04754789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102447996|NCT04754789|Antipyretics|antipyretics|mesh-ancestor
102447997|NCT04754789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102447998|NCT04754789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102447999|NCT04754789|Antimetabolites|antimetabolites|mesh-ancestor
102448000|NCT04754789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102448001|NCT04754789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102448002|NCT04754789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102448003|NCT04754789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102448004|NCT04754789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102448005|NCT04754789|Purinergic Agents|purinergic agents|mesh-ancestor
102448006|NCT04754789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102448007|NCT04817904|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102448008|NCT04817904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102448009|NCT04817904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102448010|NCT04817904|Antimetabolites|antimetabolites|mesh-ancestor
102448011|NCT04817904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448012|NCT04817904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102448013|NCT04817904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102448014|NCT04817904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102448015|NCT04815408|Paclitaxel|paclitaxel|mesh-list
102448016|NCT04815408|Carboplatin|carboplatin|mesh-list
102448017|NCT04815408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102448018|NCT04815408|Tislelizumab|tislelizumab|mesh-list
102448019|NCT04815408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102448020|NCT04815408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102448021|NCT04815408|Tubulin Modulators|tubulin modulators|mesh-ancestor
102448022|NCT04815408|Antimitotic Agents|antimitotic agents|mesh-ancestor
102448023|NCT04815408|Mitosis Modulators|mitosis modulators|mesh-ancestor
102448024|NCT04815408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448025|NCT04815408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102448026|NCT04778813|Artesunate|artesunate|mesh-list
102448027|NCT04778813|Lumefantrine|lumefantrine|mesh-list
102448028|NCT04778813|Artemether|artemether|mesh-list
102448029|NCT04778813|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102448030|NCT04778813|Artenimol|artenimol|mesh-list
102448031|NCT04778813|Pyronaridine|pyronaridine|mesh-list
102448032|NCT04778813|Antimalarials|antimalarials|mesh-ancestor
102448033|NCT04778813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102448034|NCT04778813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102448035|NCT04778813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102448036|NCT04778813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102448037|NCT04778813|Antiviral Agents|antiviral agents|mesh-ancestor
102448038|NCT04778813|Schistosomicides|schistosomicides|mesh-ancestor
102448039|NCT04778813|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102448040|NCT04778813|Anthelmintics|anthelmintics|mesh-ancestor
102448041|NCT04817982|Dexamethasone|dexamethasone|mesh-list
102448042|NCT04817982|Dexamethasone acetate|dexamethasone acetate|mesh-list
102448043|NCT04817982|Lidocaine|lidocaine|mesh-list
102448044|NCT04817982|BB 1101|bb 1101|mesh-list
102448045|NCT04817982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102448046|NCT04817982|Antiemetics|antiemetics|mesh-ancestor
102448047|NCT04817982|Autonomic Agents|autonomic agents|mesh-ancestor
102448048|NCT04817982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102448049|NCT04817982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448050|NCT04817982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102448051|NCT04817982|Glucocorticoids|glucocorticoids|mesh-ancestor
102448052|NCT04817982|Hormones|hormones|mesh-ancestor
102448053|NCT04817982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102448054|NCT04817982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102448055|NCT04817982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102448056|NCT04817982|Protease Inhibitors|protease inhibitors|mesh-ancestor
102448057|NCT04817982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102448058|NCT04817982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448059|NCT04817982|Anesthetics, Local|anesthetics, local|mesh-ancestor
102448060|NCT04817982|Anesthetics|anesthetics|mesh-ancestor
102448061|NCT04817982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102448062|NCT04817982|Sensory System Agents|sensory system agents|mesh-ancestor
102448063|NCT04817982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102448064|NCT04817982|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102448065|NCT04817982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102448066|NCT04817982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102448067|NCT04779047|Ritonavir|ritonavir|mesh-list
102448068|NCT04779047|Lopinavir|lopinavir|mesh-list
102448069|NCT04779047|Hydroxychloroquine|hydroxychloroquine|mesh-list
102448070|NCT04779047|Ivermectin|ivermectin|mesh-list
102448071|NCT04779047|Remdesivir|remdesivir|mesh-list
102448072|NCT04779047|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102448073|NCT04779047|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102448074|NCT04779047|Protease Inhibitors|protease inhibitors|mesh-ancestor
102448075|NCT04779047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102448076|NCT04779047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448077|NCT04779047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102448078|NCT04779047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102448079|NCT04779047|Antiviral Agents|antiviral agents|mesh-ancestor
102448080|NCT04779047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102448081|NCT04779047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102448082|NCT04779047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102448083|NCT04779047|Antimalarials|antimalarials|mesh-ancestor
102448084|NCT04779047|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102448085|NCT04779047|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102448086|NCT04779047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102448087|NCT04779047|Antimetabolites|antimetabolites|mesh-ancestor
102448089|NCT04427826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102448090|NCT04427826|Narcotics|narcotics|mesh-ancestor
102448091|NCT04427826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102448092|NCT04427826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448093|NCT04427826|Analgesics|analgesics|mesh-ancestor
102448094|NCT04427826|Sensory System Agents|sensory system agents|mesh-ancestor
102448095|NCT04427826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102448096|NCT01515345|Clopidogrel|clopidogrel|mesh-list
102448097|NCT01515345|Ticagrelor|ticagrelor|mesh-list
102448098|NCT01515345|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102448099|NCT01515345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102448100|NCT01515345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102448101|NCT01515345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102448102|NCT01515345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102448103|NCT01515345|Purinergic Agents|purinergic agents|mesh-ancestor
102448104|NCT01515345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102448105|NCT01515345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448106|NCT01515345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448107|NCT01492400|Dexamethasone|dexamethasone|mesh-list
102448108|NCT01492400|Ranibizumab|ranibizumab|mesh-list
102448109|NCT01492400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102448110|NCT01492400|Antiemetics|antiemetics|mesh-ancestor
102448111|NCT01492400|Autonomic Agents|autonomic agents|mesh-ancestor
102448112|NCT01492400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102448113|NCT01492400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448114|NCT01492400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102448115|NCT01492400|Glucocorticoids|glucocorticoids|mesh-ancestor
102448116|NCT01492400|Hormones|hormones|mesh-ancestor
102448117|NCT01492400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102448118|NCT01492400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102448119|NCT01492400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102448120|NCT01492400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102448121|NCT01492400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102448122|NCT01492400|Growth Substances|growth substances|mesh-ancestor
102448123|NCT01492400|Growth Inhibitors|growth inhibitors|mesh-ancestor
102448124|NCT00168337|Dexamethasone|dexamethasone|mesh-list
102448125|NCT00168337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102448126|NCT00168337|Antiemetics|antiemetics|mesh-ancestor
102448127|NCT00168337|Autonomic Agents|autonomic agents|mesh-ancestor
102448128|NCT00168337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102448129|NCT00168337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448130|NCT00168337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102448131|NCT00168337|Glucocorticoids|glucocorticoids|mesh-ancestor
102448132|NCT00168337|Hormones|hormones|mesh-ancestor
102448133|NCT00168337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102448134|NCT00168337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102448135|NCT00168337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102448136|NCT01515657|Aspirin|aspirin|mesh-list
102448137|NCT01515657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102448138|NCT01515657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102448139|NCT01515657|Analgesics|analgesics|mesh-ancestor
102448140|NCT01515657|Sensory System Agents|sensory system agents|mesh-ancestor
102448141|NCT01515657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102448142|NCT01515657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448143|NCT01515657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102448144|NCT01515657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102448145|NCT01515657|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102448146|NCT01515657|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102448147|NCT01515657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448148|NCT01515657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102448149|NCT01515657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102448150|NCT01515657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102448151|NCT01515657|Antipyretics|antipyretics|mesh-ancestor
102448152|NCT01515891|Opicapone|opicapone|mesh-list
102448153|NCT01515891|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102448154|NCT01515891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102448155|NCT01515891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448156|NCT01515891|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102448157|NCT01515891|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102448158|NCT00073957|Cytarabine|cytarabine|mesh-list
102448159|NCT00073957|Rituximab|rituximab|mesh-list
102448160|NCT00073957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102448161|NCT00073957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102448162|NCT00073957|Immunologic Factors|immunologic factors|mesh-ancestor
102448163|NCT00073957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448164|NCT00073957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102448165|NCT00073957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102448166|NCT00073957|Antimetabolites|antimetabolites|mesh-ancestor
102448167|NCT00073957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448168|NCT00073957|Antiviral Agents|antiviral agents|mesh-ancestor
102448169|NCT00073957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102448170|NCT00073957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102448171|NCT04354428|Folic Acid|folic acid|mesh-list
102448172|NCT04354428|Ascorbic Acid|ascorbic acid|mesh-list
102448173|NCT04354428|Ritonavir|ritonavir|mesh-list
102448174|NCT04354428|Lopinavir|lopinavir|mesh-list
102448175|NCT04354428|Azithromycin|azithromycin|mesh-list
102078293|NCT05830799|Midazolam|midazolam|mesh-list
102448176|NCT04354428|Hydroxychloroquine|hydroxychloroquine|mesh-list
102448177|NCT04354428|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102448178|NCT04354428|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102448179|NCT04354428|Protease Inhibitors|protease inhibitors|mesh-ancestor
102448180|NCT04354428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102448181|NCT04354428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448182|NCT04354428|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102448183|NCT04354428|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102448184|NCT04354428|Antiviral Agents|antiviral agents|mesh-ancestor
102448185|NCT04354428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102448186|NCT04354428|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102448187|NCT04354428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102448188|NCT04354428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102448189|NCT04354428|Antimalarials|antimalarials|mesh-ancestor
102448190|NCT04354428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102448191|NCT04354428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102448192|NCT04354428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102448193|NCT04354428|Hematinics|hematinics|mesh-ancestor
102448194|NCT04354428|Vitamin B Complex|vitamin b complex|mesh-ancestor
102448195|NCT04354428|Vitamins|vitamins|mesh-ancestor
102448196|NCT04354428|Micronutrients|micronutrients|mesh-ancestor
102448197|NCT04354428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448198|NCT04354428|Antioxidants|antioxidants|mesh-ancestor
102448199|NCT04354428|Protective Agents|protective agents|mesh-ancestor
102448200|NCT02090075|Warfarin|warfarin|mesh-list
102448201|NCT02090075|Apixaban|apixaban|mesh-list
102448202|NCT02090075|Anticoagulants|anticoagulants|mesh-ancestor
102448203|NCT02090075|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102448204|NCT02090075|Antithrombins|antithrombins|mesh-ancestor
102448205|NCT02090075|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102448206|NCT02090075|Protease Inhibitors|protease inhibitors|mesh-ancestor
102448207|NCT02090075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102448208|NCT02090075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448209|NCT04817202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102448210|NCT04817202|Antibodies|antibodies|mesh-list
102448211|NCT04817202|Immunoglobulins|immunoglobulins|mesh-list
102448212|NCT04817202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102448213|NCT04817202|Immunologic Factors|immunologic factors|mesh-ancestor
102448214|NCT04817202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448215|NCT04817202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102448216|NCT04775303|Cyclosporine|cyclosporine|mesh-list
102448217|NCT04775303|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102448218|NCT04775303|Cyclosporins|cyclosporins|mesh-list
102448219|NCT04775303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102448220|NCT04775303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448221|NCT04775303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102448222|NCT04775303|Immunologic Factors|immunologic factors|mesh-ancestor
102448223|NCT04775303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448224|NCT04775303|Antifungal Agents|antifungal agents|mesh-ancestor
102448225|NCT04775303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102448226|NCT04775303|Dermatologic Agents|dermatologic agents|mesh-ancestor
102448227|NCT04775303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102448228|NCT04775303|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102448229|NCT04775303|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102448230|NCT04816968|Vancomycin|vancomycin|mesh-list
102448231|NCT04816968|Meropenem|meropenem|mesh-list
102448232|NCT04816968|Tazobactam|tazobactam|mesh-list
102448233|NCT04816968|Piperacillin|piperacillin|mesh-list
102448234|NCT04816968|Cefepime|cefepime|mesh-list
102448235|NCT04816968|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102448236|NCT04816968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102448237|NCT04816968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102448238|NCT04816968|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102448239|NCT04816968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102448240|NCT04816968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448241|NCT02210247|Bupivacaine|bupivacaine|mesh-list
102448242|NCT02210247|Anesthetics, Local|anesthetics, local|mesh-ancestor
102448243|NCT02210247|Anesthetics|anesthetics|mesh-ancestor
102448244|NCT02210247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102448245|NCT02210247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448246|NCT02210247|Sensory System Agents|sensory system agents|mesh-ancestor
102448247|NCT02210247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102448248|NCT04775459|Pulmonary Surfactants|pulmonary surfactants|mesh-list
102448249|NCT04775459|Respiratory System Agents|respiratory system agents|mesh-ancestor
102448250|NCT04806438|Lidocaine|lidocaine|mesh-list
102448251|NCT04806438|Anesthetics, Local|anesthetics, local|mesh-ancestor
102448252|NCT04806438|Anesthetics|anesthetics|mesh-ancestor
102448253|NCT04806438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102448254|NCT04806438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448255|NCT04806438|Sensory System Agents|sensory system agents|mesh-ancestor
102448256|NCT04806438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102448257|NCT04806438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102448258|NCT04806438|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102448259|NCT04806438|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102448260|NCT04806438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102448261|NCT04806438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448262|NCT00074035|Pentostatin|pentostatin|mesh-list
102448263|NCT00074035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102448264|NCT00074035|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
102448265|NCT00074035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102448266|NCT00074035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448267|NCT01591317|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102448268|NCT01591317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102448269|NCT00074815|Fluvoxamine|fluvoxamine|mesh-list
102448270|NCT00074815|Citalopram|citalopram|mesh-list
102448271|NCT00074815|Fluoxetine|fluoxetine|mesh-list
102448272|NCT00074815|Paroxetine|paroxetine|mesh-list
102448273|NCT00074815|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102448274|NCT00074815|Sertraline|sertraline|mesh-list
102448275|NCT00074815|Clomipramine|clomipramine|mesh-list
102448276|NCT00074815|Escitalopram|escitalopram|mesh-list
102448277|NCT00074815|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
102448278|NCT00074815|Serotonin|serotonin|mesh-list
102448279|NCT00074815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102448280|NCT00074815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102448281|NCT00074815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448282|NCT00074815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102448283|NCT00074815|Serotonin Agents|serotonin agents|mesh-ancestor
102448284|NCT00074815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448285|NCT00074815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102448286|NCT00074815|Antidepressive Agents|antidepressive agents|mesh-ancestor
102448287|NCT00074815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102448288|NCT00074815|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102448289|NCT00074815|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102448290|NCT00074815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102448291|NCT00074815|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102448292|NCT00074815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102448293|NCT00074815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102448294|NCT00074815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102448295|NCT00074815|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102448296|NCT00074815|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102448297|NCT00074815|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102448298|NCT00074815|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102448299|NCT04772729|Insulin|insulin|mesh-list
102448300|NCT04772729|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102448301|NCT04772729|Insulin Aspart|insulin aspart|mesh-list
102448302|NCT04772729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102448303|NCT04772729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448304|NCT05562375|Tolonium Chloride|tolonium chloride|mesh-list
102259906|NCT03106831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448305|NCT05562375|Hemostatics|hemostatics|mesh-ancestor
102448306|NCT05562375|Coagulants|coagulants|mesh-ancestor
102448307|NCT05562375|Heparin Antagonists|heparin antagonists|mesh-ancestor
102448308|NCT05562375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448309|NCT00075829|Thalidomide|thalidomide|mesh-list
102448310|NCT00075829|Dexamethasone|dexamethasone|mesh-list
102448311|NCT00075829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102448312|NCT00075829|Antiemetics|antiemetics|mesh-ancestor
102448313|NCT00075829|Autonomic Agents|autonomic agents|mesh-ancestor
102078444|NCT05334056|Cocaine|cocaine|mesh-list
102448314|NCT00075829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102448315|NCT00075829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448316|NCT00075829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102448317|NCT00075829|Glucocorticoids|glucocorticoids|mesh-ancestor
102448318|NCT00075829|Hormones|hormones|mesh-ancestor
102448319|NCT00075829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102448320|NCT00075829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102448321|NCT00075829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102448322|NCT00075829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102448323|NCT00075829|Immunologic Factors|immunologic factors|mesh-ancestor
102448324|NCT00075829|Leprostatic Agents|leprostatic agents|mesh-ancestor
102448325|NCT00075829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102448326|NCT00075829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102448327|NCT00075829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102448328|NCT00075829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102448329|NCT00075829|Growth Substances|growth substances|mesh-ancestor
102448330|NCT00075829|Growth Inhibitors|growth inhibitors|mesh-ancestor
102448331|NCT02218203|Lidocaine|lidocaine|mesh-list
102448332|NCT02218203|Dextromethorphan|dextromethorphan|mesh-list
102448333|NCT02218203|Anesthetics, Local|anesthetics, local|mesh-ancestor
102448334|NCT02218203|Anesthetics|anesthetics|mesh-ancestor
102448335|NCT02218203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102448336|NCT02218203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448337|NCT02218203|Sensory System Agents|sensory system agents|mesh-ancestor
102448338|NCT02218203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102448339|NCT02218203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102448340|NCT02218203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102448341|NCT02218203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102448342|NCT02218203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102448343|NCT02218203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448344|NCT02218203|Antitussive Agents|antitussive agents|mesh-ancestor
102448345|NCT02218203|Respiratory System Agents|respiratory system agents|mesh-ancestor
102448346|NCT02218203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102448347|NCT02218203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102448348|NCT02218203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102448349|NCT04771715|Pembrolizumab|pembrolizumab|mesh-list
102448350|NCT04771715|Nivolumab|nivolumab|mesh-list
102448351|NCT04771715|Tislelizumab|tislelizumab|mesh-list
102448352|NCT04771715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102448353|NCT04771715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102448354|NCT04771715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102448355|NCT04771715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448356|NCT04771559|Antibodies|antibodies|mesh-list
102448357|NCT04771559|Immunologic Factors|immunologic factors|mesh-ancestor
102448358|NCT04771559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448359|NCT02592876|Rituximab|rituximab|mesh-list
102448360|NCT02592876|Carboplatin|carboplatin|mesh-list
102448361|NCT02592876|Etoposide|etoposide|mesh-list
102448362|NCT02592876|Ifosfamide|ifosfamide|mesh-list
102448363|NCT02592876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102448364|NCT02592876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102448365|NCT02592876|Immunologic Factors|immunologic factors|mesh-ancestor
102448366|NCT02592876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448367|NCT02592876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102448368|NCT02592876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102448369|NCT02592876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102448370|NCT02592876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102448371|NCT02592876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102448372|NCT02592876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448373|NCT02592876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102448374|NCT02592876|Alkylating Agents|alkylating agents|mesh-ancestor
102448375|NCT00585559|Acetaminophen|acetaminophen|mesh-list
102448376|NCT00585559|Acetylcysteine|acetylcysteine|mesh-list
102448377|NCT00585559|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102448378|NCT00585559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102448379|NCT00585559|Analgesics|analgesics|mesh-ancestor
102448380|NCT00585559|Sensory System Agents|sensory system agents|mesh-ancestor
102448381|NCT00585559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102448382|NCT00585559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448384|NCT00585559|Antiviral Agents|antiviral agents|mesh-ancestor
102448385|NCT00585559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102448386|NCT00585559|Expectorants|expectorants|mesh-ancestor
102448387|NCT00585559|Respiratory System Agents|respiratory system agents|mesh-ancestor
102448388|NCT00585559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102448389|NCT00585559|Antioxidants|antioxidants|mesh-ancestor
102448390|NCT00585559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448391|NCT00585559|Protective Agents|protective agents|mesh-ancestor
102448392|NCT00585559|Antidotes|antidotes|mesh-ancestor
102448393|NCT02763137|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102448394|NCT02763137|Carbidopa|carbidopa|mesh-list
102448395|NCT02763137|Levodopa|levodopa|mesh-list
102448396|NCT02763137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102448397|NCT02763137|Immunologic Factors|immunologic factors|mesh-ancestor
102448398|NCT02763137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448399|NCT02763137|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102448400|NCT02763137|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102448401|NCT02763137|Dopamine Agonists|dopamine agonists|mesh-ancestor
102448402|NCT02763137|Dopamine Agents|dopamine agents|mesh-ancestor
102448403|NCT02763137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102448404|NCT02763137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448405|NCT02763137|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102448406|NCT02763137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102448407|NCT01896739|Vaccines|vaccines|mesh-list
102448408|NCT01896739|Immunologic Factors|immunologic factors|mesh-ancestor
102448409|NCT01896739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448410|NCT00176839|Cyclophosphamide|cyclophosphamide|mesh-list
102448411|NCT00176839|Melphalan|melphalan|mesh-list
102448412|NCT00176839|Busulfan|busulfan|mesh-list
102448413|NCT00176839|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102448414|NCT00176839|Lenograstim|lenograstim|mesh-list
102448415|NCT00176839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102448416|NCT00176839|Immunologic Factors|immunologic factors|mesh-ancestor
102448417|NCT00176839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448418|NCT00176839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102448419|NCT00176839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102448420|NCT00176839|Alkylating Agents|alkylating agents|mesh-ancestor
102448421|NCT00176839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448422|NCT00176839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102448423|NCT00176839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102448424|NCT00176839|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102448425|NCT00176917|Cyclophosphamide|cyclophosphamide|mesh-list
102448426|NCT00176917|Busulfan|busulfan|mesh-list
102448427|NCT00176917|Thymoglobulin|thymoglobulin|mesh-list
102448428|NCT00176917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102448429|NCT00176917|Immunologic Factors|immunologic factors|mesh-ancestor
102448430|NCT00176917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448431|NCT00176917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102448432|NCT00176917|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102448433|NCT00176917|Alkylating Agents|alkylating agents|mesh-ancestor
102448434|NCT00176917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448435|NCT00176917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102448436|NCT00176917|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102448437|NCT02664155|Vitamin K|vitamin k|mesh-list
102448438|NCT02664155|Heparin|heparin|mesh-list
102448439|NCT02664155|Rivaroxaban|rivaroxaban|mesh-list
102448440|NCT02664155|Apixaban|apixaban|mesh-list
102448441|NCT02664155|Vitamins|vitamins|mesh-ancestor
102448442|NCT02664155|Micronutrients|micronutrients|mesh-ancestor
102448443|NCT02664155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448444|NCT02664155|Anticoagulants|anticoagulants|mesh-ancestor
102448445|NCT02664155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102448446|NCT02664155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102448447|NCT02664155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448448|NCT02664155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102448449|NCT02664155|Antithrombins|antithrombins|mesh-ancestor
102448450|NCT02664155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102448451|NCT02664155|Protease Inhibitors|protease inhibitors|mesh-ancestor
102448452|NCT02664155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102448453|NCT02664155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102448454|NCT02664155|Hemostatics|hemostatics|mesh-ancestor
102448455|NCT02664155|Coagulants|coagulants|mesh-ancestor
102448456|NCT04770389|Ezetimibe|ezetimibe|mesh-list
102448457|NCT04770389|Hypolipidemic Agents|hypolipidemic agents|mesh-list
102448458|NCT04770389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102448459|NCT04770389|Antimetabolites|antimetabolites|mesh-ancestor
102448460|NCT04770389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448461|NCT04770389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102448462|NCT04753619|Niclosamide|niclosamide|mesh-list
102448463|NCT04753619|Anticestodal Agents|anticestodal agents|mesh-ancestor
102448464|NCT04753619|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102448465|NCT04753619|Anthelmintics|anthelmintics|mesh-ancestor
102448466|NCT04753619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102448467|NCT04753619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102448468|NCT04753619|Antinematodal Agents|antinematodal agents|mesh-ancestor
102448469|NCT01492088|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102448470|NCT01492088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102448471|NCT01492088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102448472|NCT01492088|Immunotoxins|immunotoxins|mesh-ancestor
102448473|NCT01492088|Immunoconjugates|immunoconjugates|mesh-ancestor
102448474|NCT01492088|Immunologic Factors|immunologic factors|mesh-ancestor
102448475|NCT01492088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448476|NCT04753151|Tranexamic Acid|tranexamic acid|mesh-list
102448477|NCT04753151|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102448478|NCT04753151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102448479|NCT04753151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448480|NCT04753151|Hemostatics|hemostatics|mesh-ancestor
102448481|NCT04753151|Coagulants|coagulants|mesh-ancestor
102448483|NCT05606315|Propofol|propofol|mesh-list
102448484|NCT05606315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102448485|NCT05606315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102448486|NCT05606315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448487|NCT05606315|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102448488|NCT05606315|Anesthetics, General|anesthetics, general|mesh-ancestor
102448489|NCT05606315|Anesthetics|anesthetics|mesh-ancestor
102448490|NCT05606315|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102448491|NCT05606315|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102448492|NCT05606315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102448493|NCT05606315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102448494|NCT05606315|GABA Modulators|gaba modulators|mesh-ancestor
102448495|NCT05606315|GABA Agents|gaba agents|mesh-ancestor
102448496|NCT05606315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102448497|NCT05606315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448498|NCT05605925|Ivermectin|ivermectin|mesh-list
102448499|NCT05605925|Lumefantrine|lumefantrine|mesh-list
102448500|NCT05605925|Artemether|artemether|mesh-list
102448501|NCT05605925|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102448502|NCT05605925|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102448503|NCT05605925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102448504|NCT05605925|Antimalarials|antimalarials|mesh-ancestor
102448505|NCT05605925|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102448506|NCT01520727|Opicapone|opicapone|mesh-list
102448507|NCT01520727|Entacapone|entacapone|mesh-list
102448508|NCT01520727|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102448509|NCT01520727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102448510|NCT01520727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448511|NCT01520727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102448512|NCT01520727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102448513|NCT02503709|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
102448514|NCT02503709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102448515|NCT02503709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102448516|NCT02503709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448517|NCT01855607|Menthol|menthol|mesh-list
102448518|NCT01855607|Antipruritics|antipruritics|mesh-ancestor
102448519|NCT01855607|Dermatologic Agents|dermatologic agents|mesh-ancestor
102448520|NCT01596699|Fludarabine|fludarabine|mesh-list
102448521|NCT01596699|Busulfan|busulfan|mesh-list
102448522|NCT01596699|Alemtuzumab|alemtuzumab|mesh-list
102448523|NCT01596699|Clofarabine|clofarabine|mesh-list
102448524|NCT01596699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102448525|NCT01596699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102448526|NCT01596699|Antimetabolites|antimetabolites|mesh-ancestor
102448527|NCT01596699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448528|NCT01596699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102448529|NCT01596699|Immunologic Factors|immunologic factors|mesh-ancestor
102448530|NCT01596699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448531|NCT01596699|Alkylating Agents|alkylating agents|mesh-ancestor
102448532|NCT01596699|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102448533|NCT01596699|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102448534|NCT01596699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102448535|NCT01148849|Margetuximab|margetuximab|mesh-list
102448536|NCT01148849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102448537|NCT05605301|Deoxyglucose|deoxyglucose|mesh-list
102448538|NCT05605301|Antimetabolites|antimetabolites|mesh-ancestor
102448539|NCT05605301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448540|NCT05605301|Antiviral Agents|antiviral agents|mesh-ancestor
102448541|NCT05605301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102448542|NCT05566743|Capecitabine|capecitabine|mesh-list
102448543|NCT05566743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102448544|NCT05566743|Antimetabolites|antimetabolites|mesh-ancestor
102448545|NCT05566743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448546|NCT05566743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102448547|NCT05596721|Azithromycin|azithromycin|mesh-list
102448548|NCT05596721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102448549|NCT05596721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102448550|NCT00076687|Botulinum Toxins|botulinum toxins|mesh-list
102448551|NCT00076687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102448552|NCT00076687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102448553|NCT00076687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102448554|NCT00076687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102448555|NCT00076687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448556|NCT00076687|Cholinergic Agents|cholinergic agents|mesh-ancestor
102448557|NCT00076687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102448558|NCT00076687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448559|NCT00076687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102448560|NCT00076687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102448561|NCT01525173|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102448562|NCT01525173|Bimatoprost|bimatoprost|mesh-list
102448563|NCT01525173|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102448564|NCT01525173|Latanoprost|latanoprost|mesh-list
102448565|NCT01525173|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102448566|NCT01525173|Lubricant Eye Drops|lubricant eye drops|mesh-list
102448567|NCT01525173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102448568|NCT01525173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102448569|NCT01525173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102448570|NCT01525173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102448571|NCT01525173|Adrenergic Agents|adrenergic agents|mesh-ancestor
102448572|NCT01525173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102448573|NCT01525173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448574|NCT01525173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448576|NCT03007563|Antioxidants|antioxidants|mesh-ancestor
102448577|NCT03007563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448578|NCT03007563|Protective Agents|protective agents|mesh-ancestor
102448579|NCT03007563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448580|NCT05331131|Ketamine|ketamine|mesh-list
102448581|NCT05331131|Analgesics|analgesics|mesh-ancestor
102448582|NCT05331131|Sensory System Agents|sensory system agents|mesh-ancestor
102448583|NCT05331131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102448584|NCT05331131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448585|NCT05331131|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102448586|NCT05331131|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102448587|NCT05331131|Anesthetics, General|anesthetics, general|mesh-ancestor
102448588|NCT05331131|Anesthetics|anesthetics|mesh-ancestor
102448589|NCT05331131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102448590|NCT05331131|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102448591|NCT05331131|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102448592|NCT05331131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102448593|NCT05331131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448594|NCT01526577|Ticagrelor|ticagrelor|mesh-list
102448595|NCT01526577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
102448596|NCT01526577|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102448597|NCT01526577|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102448598|NCT01526577|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102448599|NCT01526577|Purinergic Agents|purinergic agents|mesh-ancestor
102448600|NCT01526577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102448601|NCT01526577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448602|NCT01526577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448603|NCT01894451|Bevacizumab|bevacizumab|mesh-list
102448604|NCT01894451|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
102448605|NCT01894451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102448606|NCT01894451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102448607|NCT01894451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102448608|NCT01894451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102448610|NCT01894451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448611|NCT01894451|Growth Inhibitors|growth inhibitors|mesh-ancestor
102448612|NCT01894451|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102448613|NCT01894451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448614|NCT01527045|Calcium, Dietary|calcium, dietary|mesh-list
102448615|NCT01527045|Cyclosporine|cyclosporine|mesh-list
102448616|NCT01527045|Mycophenolic Acid|mycophenolic acid|mesh-list
102448617|NCT01527045|Fludarabine|fludarabine|mesh-list
102448618|NCT01527045|Fludarabine phosphate|fludarabine phosphate|mesh-list
102448619|NCT01527045|Atorvastatin|atorvastatin|mesh-list
102448620|NCT01527045|Calcium|calcium|mesh-list
102448621|NCT01527045|Cyclosporins|cyclosporins|mesh-list
102448622|NCT01527045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102448623|NCT01527045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448624|NCT01527045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102448625|NCT01527045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102448626|NCT01527045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102448627|NCT01527045|Antimetabolites|antimetabolites|mesh-ancestor
102448628|NCT01527045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448629|NCT01527045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102448630|NCT01527045|Immunologic Factors|immunologic factors|mesh-ancestor
102448631|NCT01527045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102448632|NCT01527045|Antifungal Agents|antifungal agents|mesh-ancestor
102448633|NCT01527045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102448634|NCT01527045|Dermatologic Agents|dermatologic agents|mesh-ancestor
102448635|NCT01527045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102448636|NCT01527045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102448637|NCT01527045|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102448638|NCT01527045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102448639|NCT01527045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102448640|NCT01527045|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102448641|NCT01527045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102448642|NCT01527045|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102448643|NCT01527045|Antitubercular Agents|antitubercular agents|mesh-ancestor
102448644|NCT01527045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102448645|NCT00078403|Ribavirin|ribavirin|mesh-list
102448646|NCT00078403|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102448647|NCT00078403|Antimetabolites|antimetabolites|mesh-ancestor
102448648|NCT00078403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448649|NCT00078403|Antiviral Agents|antiviral agents|mesh-ancestor
102448650|NCT00078403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102448651|NCT01976585|Poly ICLC|poly iclc|mesh-list
102448652|NCT01976585|Interferon Inducers|interferon inducers|mesh-ancestor
102448653|NCT01976585|Immunologic Factors|immunologic factors|mesh-ancestor
102448654|NCT01976585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448655|NCT01527513|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102448656|NCT01527513|Anticonvulsants|anticonvulsants|mesh-ancestor
102448657|NCT01527513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102448658|NCT01527513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102448659|NCT01527513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102448660|NCT01527513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448661|NCT03001635|Oxytocin|oxytocin|mesh-list
102448662|NCT03001635|Oxytocics|oxytocics|mesh-ancestor
102448663|NCT03001635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102448664|NCT03001635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448665|NCT02592798|Abatacept|abatacept|mesh-list
102448666|NCT02592798|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102448667|NCT02592798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448668|NCT02592798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102448669|NCT02592798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102448670|NCT02592798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102448671|NCT02592798|Immunologic Factors|immunologic factors|mesh-ancestor
102448672|NCT02592798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448673|NCT02592798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102448674|NCT01530243|Tolterodine Tartrate|tolterodine tartrate|mesh-list
102448675|NCT01530243|Terazosin|terazosin|mesh-list
102448676|NCT01530243|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102448677|NCT01530243|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102448678|NCT01530243|Cholinergic Agents|cholinergic agents|mesh-ancestor
102448679|NCT01530243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102448680|NCT01530243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448681|NCT01530243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448682|NCT01530243|Urological Agents|urological agents|mesh-ancestor
102448683|NCT01530243|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102448684|NCT01530243|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102448685|NCT01530243|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102448686|NCT01530243|Adrenergic Agents|adrenergic agents|mesh-ancestor
102448687|NCT04797546|Morphine|morphine|mesh-list
102448688|NCT04797546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102448689|NCT04797546|Narcotics|narcotics|mesh-ancestor
102448690|NCT04797546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102448691|NCT04797546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448692|NCT04797546|Analgesics|analgesics|mesh-ancestor
102448693|NCT04797546|Sensory System Agents|sensory system agents|mesh-ancestor
102448694|NCT04797546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102448695|NCT02980809|Apatinib|apatinib|mesh-list
102448696|NCT02980809|Topotecan|topotecan|mesh-list
102448697|NCT02980809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102448698|NCT02980809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102448699|NCT02980809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102448700|NCT02980809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448701|NCT02980809|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102448702|NCT02980809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102448703|NCT00078559|Acetaminophen|acetaminophen|mesh-list
102448704|NCT00078559|Diphenhydramine|diphenhydramine|mesh-list
102448705|NCT00078559|Promethazine|promethazine|mesh-list
102448706|NCT00078559|Sirolimus|sirolimus|mesh-list
102448707|NCT00078559|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102448708|NCT00078559|Nystatin|nystatin|mesh-list
102448709|NCT00078559|Clotrimazole|clotrimazole|mesh-list
102448710|NCT00078559|Miconazole|miconazole|mesh-list
102448711|NCT00078559|Pentamidine|pentamidine|mesh-list
102448712|NCT00078559|Trimethoprim|trimethoprim|mesh-list
102448713|NCT00078559|Valganciclovir|valganciclovir|mesh-list
102448714|NCT00078559|Acyclovir|acyclovir|mesh-list
102448715|NCT00078559|Methylprednisolone|methylprednisolone|mesh-list
102448716|NCT00078559|Alemtuzumab|alemtuzumab|mesh-list
102448717|NCT00078559|Tacrolimus|tacrolimus|mesh-list
102078849|NCT03567720|Gemcitabine|gemcitabine|mesh-list
102448718|NCT00078559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102448719|NCT00078559|Immunologic Factors|immunologic factors|mesh-ancestor
102448720|NCT00078559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448721|NCT00078559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102448722|NCT00078559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102448723|NCT00078559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448724|NCT00078559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102448725|NCT00078559|Analgesics|analgesics|mesh-ancestor
102448726|NCT00078559|Sensory System Agents|sensory system agents|mesh-ancestor
102448727|NCT00078559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102448728|NCT00078559|Antipyretics|antipyretics|mesh-ancestor
102448729|NCT00078559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102448730|NCT00078559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102448731|NCT00078559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102448732|NCT00078559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102448733|NCT00078559|Antifungal Agents|antifungal agents|mesh-ancestor
102448734|NCT00078559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102448735|NCT00078559|Antiemetics|antiemetics|mesh-ancestor
102448736|NCT00078559|Autonomic Agents|autonomic agents|mesh-ancestor
102448737|NCT00078559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102448738|NCT00078559|Glucocorticoids|glucocorticoids|mesh-ancestor
102448739|NCT00078559|Hormones|hormones|mesh-ancestor
102448740|NCT00078559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102448741|NCT00078559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102448742|NCT00078559|Protective Agents|protective agents|mesh-ancestor
102448743|NCT00078559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102448744|NCT00078559|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102448745|NCT00078559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102448746|NCT00078559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102448747|NCT00078559|Anesthetics, Local|anesthetics, local|mesh-ancestor
102448748|NCT00078559|Anesthetics|anesthetics|mesh-ancestor
102448749|NCT00078559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102448750|NCT00078559|Histamine Antagonists|histamine antagonists|mesh-ancestor
102448751|NCT00078559|Histamine Agents|histamine agents|mesh-ancestor
102448752|NCT00078559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102448753|NCT00078559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102448754|NCT00078559|Antipruritics|antipruritics|mesh-ancestor
102448755|NCT00078559|Dermatologic Agents|dermatologic agents|mesh-ancestor
102448756|NCT00078559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102448757|NCT00078559|Antimalarials|antimalarials|mesh-ancestor
102448758|NCT00078559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102448759|NCT00078559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102448760|NCT00078559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102448761|NCT00078559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102448762|NCT00078559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102448763|NCT00078559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102448765|NCT00078559|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102448766|NCT00078559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102448767|NCT00078559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102448768|NCT00078559|Hormone Antagonists|hormone antagonists|mesh-ancestor
102448769|NCT00078559|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102448770|NCT00078559|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102448771|NCT00078559|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102448772|NCT00078559|Ionophores|ionophores|mesh-ancestor
102448773|NCT00078559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102448774|NCT00081653|Ibandronic Acid|ibandronic acid|mesh-list
102448775|NCT00081653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102448776|NCT00081653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448777|NCT00078715|Yohimbine|yohimbine|mesh-list
102448778|NCT00078715|Mydriatics|mydriatics|mesh-ancestor
102448779|NCT00078715|Autonomic Agents|autonomic agents|mesh-ancestor
102448780|NCT00078715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102448781|NCT00078715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448782|NCT00078715|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102448783|NCT00078715|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102448784|NCT00078715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102448785|NCT00078715|Adrenergic Agents|adrenergic agents|mesh-ancestor
102448786|NCT00078715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102448787|NCT00078715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448788|NCT00078715|Urological Agents|urological agents|mesh-ancestor
102448789|NCT04805034|Antiviral Agents|antiviral agents|mesh-list
102448790|NCT04805034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102448791|NCT01530399|Tranexamic Acid|tranexamic acid|mesh-list
102448792|NCT01530399|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102448793|NCT01530399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102448794|NCT01530399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448795|NCT01530399|Hemostatics|hemostatics|mesh-ancestor
102448796|NCT01530399|Coagulants|coagulants|mesh-ancestor
102448797|NCT01531803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102448798|NCT02596620|Amoxicillin|amoxicillin|mesh-list
102448799|NCT02596620|Metronidazole|metronidazole|mesh-list
102448800|NCT02596620|Levofloxacin|levofloxacin|mesh-list
102448801|NCT02596620|Esomeprazole|esomeprazole|mesh-list
102448802|NCT02596620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102448803|NCT02596620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102448804|NCT02596620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102448805|NCT02596620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102448806|NCT02596620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102448807|NCT02596620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102448808|NCT02596620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102448809|NCT02596620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102448810|NCT02596620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448811|NCT02596620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102448812|NCT02596620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102448813|NCT02596620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102448814|NCT02596620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102448815|NCT02596620|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102448816|NCT02596620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102448817|NCT01531959|Midodrine|midodrine|mesh-list
102448818|NCT01531959|Sympathomimetics|sympathomimetics|mesh-ancestor
102448819|NCT01531959|Autonomic Agents|autonomic agents|mesh-ancestor
102448820|NCT01531959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102448821|NCT01531959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448822|NCT01531959|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102448823|NCT01531959|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102448824|NCT01531959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102448825|NCT01531959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102448826|NCT01531959|Adrenergic Agents|adrenergic agents|mesh-ancestor
102448827|NCT01531959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102448828|NCT01531959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448829|NCT01532349|Cholecalciferol|cholecalciferol|mesh-list
102448830|NCT01532349|Vitamin D|vitamin d|mesh-list
102448831|NCT01532349|Vitamins|vitamins|mesh-ancestor
102448832|NCT01532349|Micronutrients|micronutrients|mesh-ancestor
102448833|NCT01532349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448834|NCT01532349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102260430|NCT02419105|Androgens|androgens|mesh-ancestor
102448835|NCT01532349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102448836|NCT03001089|Fludrocortisone|fludrocortisone|mesh-list
102448837|NCT03001089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102448838|NCT01533207|Gemcitabine|gemcitabine|mesh-list
102448839|NCT01533207|Docetaxel|docetaxel|mesh-list
102448840|NCT01533207|Doxorubicin|doxorubicin|mesh-list
102448841|NCT01533207|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102448842|NCT01533207|Lenograstim|lenograstim|mesh-list
102448843|NCT01533207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102448844|NCT01533207|Antimetabolites|antimetabolites|mesh-ancestor
102448845|NCT01533207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448846|NCT01533207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102448847|NCT01533207|Tubulin Modulators|tubulin modulators|mesh-ancestor
102448848|NCT01533207|Antimitotic Agents|antimitotic agents|mesh-ancestor
102448849|NCT01533207|Mitosis Modulators|mitosis modulators|mesh-ancestor
102448850|NCT01533207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102448851|NCT01533207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102448852|NCT01533207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102448853|NCT01533207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102448854|NCT01533207|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102448855|NCT01533207|Immunologic Factors|immunologic factors|mesh-ancestor
102448856|NCT01533207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448857|NCT00182767|Doxorubicin|doxorubicin|mesh-list
102448858|NCT00182767|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102448859|NCT00182767|Epothilone B|epothilone b|mesh-list
102448860|NCT00182767|Epothilones|epothilones|mesh-list
102448861|NCT00182767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102448862|NCT00182767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102448863|NCT00182767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102448864|NCT00182767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102448865|NCT00182767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102448866|NCT00182767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448867|NCT00182767|Tubulin Modulators|tubulin modulators|mesh-ancestor
102448868|NCT00182767|Antimitotic Agents|antimitotic agents|mesh-ancestor
102448869|NCT00182767|Mitosis Modulators|mitosis modulators|mesh-ancestor
102448870|NCT01533597|Tamsulosin|tamsulosin|mesh-list
102448871|NCT01533597|Solifenacin Succinate|solifenacin succinate|mesh-list
102448872|NCT01533597|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102448873|NCT01533597|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102448874|NCT01533597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102448875|NCT01533597|Adrenergic Agents|adrenergic agents|mesh-ancestor
102448876|NCT01533597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102448877|NCT01533597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448878|NCT01533597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448879|NCT01533597|Urological Agents|urological agents|mesh-ancestor
102448880|NCT01533597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102448881|NCT01533597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102448882|NCT01533597|Cholinergic Agents|cholinergic agents|mesh-ancestor
102448883|NCT03006627|Morphine|morphine|mesh-list
102448884|NCT03006627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102448885|NCT03006627|Narcotics|narcotics|mesh-ancestor
102448886|NCT03006627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102448887|NCT03006627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448888|NCT03006627|Analgesics|analgesics|mesh-ancestor
102448889|NCT03006627|Sensory System Agents|sensory system agents|mesh-ancestor
102448890|NCT03006627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102448891|NCT04796688|Cyclophosphamide|cyclophosphamide|mesh-list
102448892|NCT04796688|Fludarabine|fludarabine|mesh-list
102448893|NCT04796688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102448894|NCT04796688|Immunologic Factors|immunologic factors|mesh-ancestor
102448895|NCT04796688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448896|NCT04796688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102448897|NCT04796688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102448898|NCT04796688|Alkylating Agents|alkylating agents|mesh-ancestor
102448899|NCT04796688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448900|NCT04796688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102448901|NCT04796688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102448902|NCT01535001|Acetaminophen|acetaminophen|mesh-list
102448903|NCT01535001|Pantoprazole|pantoprazole|mesh-list
102448904|NCT01535001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102448905|NCT01535001|Analgesics|analgesics|mesh-ancestor
102448906|NCT01535001|Sensory System Agents|sensory system agents|mesh-ancestor
102448907|NCT01535001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102448908|NCT01535001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448909|NCT01535001|Antipyretics|antipyretics|mesh-ancestor
102448910|NCT01535001|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102448911|NCT01535001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102448912|NCT01535001|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102448914|NCT01535001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448915|NCT03000777|Melatonin|melatonin|mesh-list
102079039|NCT02027935|Ipilimumab|ipilimumab|mesh-list
102448916|NCT03000777|Antioxidants|antioxidants|mesh-ancestor
102448917|NCT03000777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448918|NCT03000777|Protective Agents|protective agents|mesh-ancestor
102448919|NCT03000777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448920|NCT03000777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102448921|NCT03006003|Alendronate|alendronate|mesh-list
102448922|NCT03006003|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
102448923|NCT03006003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102448924|NCT03006003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448925|NCT03006003|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102448926|NCT03006003|Hormone Antagonists|hormone antagonists|mesh-ancestor
102448927|NCT03006003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102448928|NCT03006003|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102448929|NCT03006003|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102448930|NCT04426734|Dexamethasone|dexamethasone|mesh-list
102448931|NCT04426734|Prednisolone|prednisolone|mesh-list
102448932|NCT04426734|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102448933|NCT04426734|Methylprednisolone|methylprednisolone|mesh-list
102448934|NCT04426734|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102448935|NCT04426734|Prednisolone acetate|prednisolone acetate|mesh-list
102448936|NCT04426734|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102448937|NCT04426734|Prednisolone phosphate|prednisolone phosphate|mesh-list
102448938|NCT04426734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102448939|NCT04426734|Antiemetics|antiemetics|mesh-ancestor
102448940|NCT04426734|Autonomic Agents|autonomic agents|mesh-ancestor
102448941|NCT04426734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102448942|NCT04426734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448943|NCT04426734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102448944|NCT04426734|Glucocorticoids|glucocorticoids|mesh-ancestor
102448945|NCT04426734|Hormones|hormones|mesh-ancestor
102448946|NCT04426734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102448947|NCT04426734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102448948|NCT04426734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102448949|NCT04426734|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102448950|NCT04426734|Protective Agents|protective agents|mesh-ancestor
102448951|NCT03006081|Aflibercept|aflibercept|mesh-list
102448952|NCT03006081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102448953|NCT03006081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102448954|NCT03006081|Growth Substances|growth substances|mesh-ancestor
102448955|NCT03006081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448956|NCT03006081|Growth Inhibitors|growth inhibitors|mesh-ancestor
102448957|NCT03006081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102448958|NCT01535937|Midazolam|midazolam|mesh-list
102448959|NCT01535937|Ketamine|ketamine|mesh-list
102448960|NCT01535937|Analgesics|analgesics|mesh-ancestor
102448961|NCT01535937|Sensory System Agents|sensory system agents|mesh-ancestor
102448962|NCT01535937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102448963|NCT01535937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448964|NCT01535937|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102448965|NCT01535937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102448966|NCT01535937|Anesthetics, General|anesthetics, general|mesh-ancestor
102448967|NCT01535937|Anesthetics|anesthetics|mesh-ancestor
102448968|NCT01535937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102448969|NCT01535937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102448970|NCT01535937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102448971|NCT01535937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102448972|NCT01535937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079102|NCT01716806|Nivolumab|nivolumab|mesh-list
102448973|NCT01535937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102448974|NCT01535937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102448975|NCT01535937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102448976|NCT01535937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102448977|NCT01535937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102448978|NCT01535937|GABA Modulators|gaba modulators|mesh-ancestor
102448979|NCT01535937|GABA Agents|gaba agents|mesh-ancestor
102448980|NCT04813848|Fluorides|fluorides|mesh-list
102448981|NCT04813848|Cariostatic Agents|cariostatic agents|mesh-ancestor
102448982|NCT04813848|Protective Agents|protective agents|mesh-ancestor
102448983|NCT04813848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448984|NCT02999841|Vildagliptin|vildagliptin|mesh-list
102448985|NCT02999841|Acarbose|acarbose|mesh-list
102448986|NCT02999841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102448987|NCT02999841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448988|NCT02999841|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102448989|NCT02999841|Protease Inhibitors|protease inhibitors|mesh-ancestor
102448990|NCT02999841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102448991|NCT02999841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102448992|NCT02999841|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102448993|NCT01537029|Cyclophosphamide|cyclophosphamide|mesh-list
102448994|NCT01537029|Doxorubicin|doxorubicin|mesh-list
102448995|NCT01537029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102448996|NCT01537029|Immunologic Factors|immunologic factors|mesh-ancestor
102448997|NCT01537029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102448998|NCT01537029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102448999|NCT01537029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102449000|NCT01537029|Alkylating Agents|alkylating agents|mesh-ancestor
102449001|NCT01537029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449002|NCT01537029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102449003|NCT01537029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102449004|NCT01537029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102449005|NCT01537029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102449006|NCT01537029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102449007|NCT01537029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102449008|NCT01667562|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102449009|NCT01667562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102449010|NCT01667562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102449011|NCT01667562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102449012|NCT01667562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449013|NCT04803318|Everolimus|everolimus|mesh-list
102449014|NCT04803318|Lenvatinib|lenvatinib|mesh-list
102449015|NCT04803318|Trametinib|trametinib|mesh-list
102449016|NCT04803318|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102449017|NCT04803318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102449018|NCT04803318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102449019|NCT04803318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449020|NCT04803318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102449021|NCT04803318|Immunologic Factors|immunologic factors|mesh-ancestor
102449022|NCT04803318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449023|NCT04803318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102449024|NCT01537185|Aluminum sulfate|aluminum sulfate|mesh-list
102449025|NCT01537185|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102449026|NCT01537185|Immunologic Factors|immunologic factors|mesh-ancestor
102449027|NCT01537185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449028|NCT04803162|Omeprazole|omeprazole|mesh-list
102449029|NCT04803162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102449030|NCT04803162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102449031|NCT04803162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102449032|NCT04803162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102449033|NCT04803162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449034|NCT02999217|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
102449035|NCT02999217|Hematinics|hematinics|mesh-ancestor
102449036|NCT02595528|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102449037|NCT02595528|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102449038|NCT02980965|Cyclophosphamide|cyclophosphamide|mesh-list
102449039|NCT02980965|Docetaxel|docetaxel|mesh-list
102449040|NCT02980965|Fluorouracil|fluorouracil|mesh-list
102449041|NCT02980965|Letrozole|letrozole|mesh-list
102449042|NCT02980965|Epirubicin|epirubicin|mesh-list
102449043|NCT02980965|Leuprolide|leuprolide|mesh-list
102449044|NCT02980965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102449045|NCT02980965|Immunologic Factors|immunologic factors|mesh-ancestor
102449046|NCT02980965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449047|NCT02980965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102449048|NCT02980965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102449049|NCT02980965|Alkylating Agents|alkylating agents|mesh-ancestor
102449050|NCT02980965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449051|NCT02980965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102449052|NCT02980965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102449053|NCT02980965|Tubulin Modulators|tubulin modulators|mesh-ancestor
102449054|NCT02980965|Antimitotic Agents|antimitotic agents|mesh-ancestor
102449055|NCT02980965|Mitosis Modulators|mitosis modulators|mesh-ancestor
102449056|NCT02980965|Antimetabolites|antimetabolites|mesh-ancestor
102449057|NCT02980965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102449058|NCT02980965|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102449059|NCT02980965|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102449060|NCT02980965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102449061|NCT02980965|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102449062|NCT02980965|Hormone Antagonists|hormone antagonists|mesh-ancestor
102449063|NCT02980965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102449064|NCT02980965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102449065|NCT02980965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102449066|NCT02980965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102449067|NCT02980965|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102449068|NCT02980965|Fertility Agents|fertility agents|mesh-ancestor
102449069|NCT02980965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102449070|NCT02980965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102449071|NCT01538745|Ketamine|ketamine|mesh-list
102449072|NCT01538745|Morphine|morphine|mesh-list
102449073|NCT01538745|Analgesics|analgesics|mesh-ancestor
102449074|NCT01538745|Sensory System Agents|sensory system agents|mesh-ancestor
102449075|NCT01538745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102449076|NCT01538745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449077|NCT01538745|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102449078|NCT01538745|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102449079|NCT01538745|Anesthetics, General|anesthetics, general|mesh-ancestor
102449080|NCT01538745|Anesthetics|anesthetics|mesh-ancestor
102449081|NCT01538745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102449082|NCT01538745|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102449083|NCT01538745|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102449084|NCT01538745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102449085|NCT01538745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449086|NCT01538745|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102449087|NCT01538745|Narcotics|narcotics|mesh-ancestor
102449088|NCT04803240|Hyaluronic Acid|hyaluronic acid|mesh-list
102449089|NCT04803240|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102449090|NCT04803240|Immunologic Factors|immunologic factors|mesh-ancestor
102449091|NCT04803240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449092|NCT04803240|Viscosupplements|viscosupplements|mesh-ancestor
102449093|NCT04803240|Protective Agents|protective agents|mesh-ancestor
102449094|NCT04803474|Hormones|hormones|mesh-list
102449095|NCT04803474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102449096|NCT04803474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449097|NCT01539135|Methylene Blue|methylene blue|mesh-list
102449098|NCT01539135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102449099|NCT01539135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449100|NCT04426578|Perhexiline|perhexiline|mesh-list
102449101|NCT04426578|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102449102|NCT04426578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102449103|NCT04426578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449104|NCT04426578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102449105|NCT04426578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449106|NCT04426578|Vasodilator Agents|vasodilator agents|mesh-ancestor
102449107|NCT04802928|Isoniazid|isoniazid|mesh-list
102449108|NCT04802928|Antitubercular Agents|antitubercular agents|mesh-ancestor
102449109|NCT04802928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102449110|NCT04802928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102449111|NCT04802928|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102449112|NCT04802928|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102449113|NCT04802928|Antimetabolites|antimetabolites|mesh-ancestor
102449114|NCT04802928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449115|NCT04802928|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102449116|NCT05365425|Choline|choline|mesh-list
102449117|NCT05365425|Policosanol|policosanol|mesh-list
102449118|NCT05365425|Fenofibrate|fenofibrate|mesh-list
102449119|NCT05365425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102449120|NCT05365425|Antimetabolites|antimetabolites|mesh-ancestor
102449121|NCT05365425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449122|NCT05365425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102449123|NCT05365425|Lipotropic Agents|lipotropic agents|mesh-ancestor
102449124|NCT05365425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102449125|NCT05365425|Nootropic Agents|nootropic agents|mesh-ancestor
102449126|NCT05365425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102449127|NCT05365425|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102449128|NCT02595450|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102449129|NCT02595450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102449130|NCT02595450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102449131|NCT02595450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102449132|NCT02595450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449133|NCT04794738|Morphine|morphine|mesh-list
102449134|NCT04794738|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102449135|NCT04794738|Narcotics|narcotics|mesh-ancestor
102449136|NCT04794738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102449137|NCT04794738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449139|NCT04794738|Sensory System Agents|sensory system agents|mesh-ancestor
102449140|NCT04794738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102449141|NCT04794426|Fluorides|fluorides|mesh-list
102449142|NCT04794426|Cariostatic Agents|cariostatic agents|mesh-ancestor
102449143|NCT04794426|Protective Agents|protective agents|mesh-ancestor
102449144|NCT04794426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449145|NCT04794504|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102449146|NCT04794504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102449147|NCT04794504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102449148|NCT04794504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449149|NCT04794504|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102449150|NCT04794504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102449151|NCT04794504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449152|NCT04794504|Cholinergic Agents|cholinergic agents|mesh-ancestor
102449153|NCT04794504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102449154|NCT05073315|Adalimumab|adalimumab|mesh-list
102449155|NCT05073315|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102449156|NCT05073315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102449157|NCT05073315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102449158|NCT02591238|Melatonin|melatonin|mesh-list
102449159|NCT02591238|Antioxidants|antioxidants|mesh-ancestor
102449160|NCT02591238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449161|NCT02591238|Protective Agents|protective agents|mesh-ancestor
102449162|NCT02591238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449163|NCT02591238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102449164|NCT02221947|Bryostatin 1|bryostatin 1|mesh-list
102449165|NCT02221947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102449166|NCT02221947|Immunologic Factors|immunologic factors|mesh-ancestor
102449167|NCT02221947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449168|NCT02221947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102449169|NCT04793256|Listerine|listerine|mesh-list
102449170|NCT04793256|Fluorides|fluorides|mesh-list
102449171|NCT04793256|Sodium Fluoride|sodium fluoride|mesh-list
102449172|NCT04793256|Fluorides, Topical|fluorides, topical|mesh-list
102449173|NCT04793256|Cariostatic Agents|cariostatic agents|mesh-ancestor
102449174|NCT04793256|Protective Agents|protective agents|mesh-ancestor
102449175|NCT04793256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449176|NCT04793256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102449177|NCT04793256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102449178|NCT03004521|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102449179|NCT03004521|Antidepressive Agents|antidepressive agents|mesh-ancestor
102449180|NCT03004521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102449181|NCT03004521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102449182|NCT03004521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102449183|NCT03004521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102449184|NCT03004521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449185|NCT04792710|Metronidazole|metronidazole|mesh-list
102449186|NCT04792710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102449187|NCT04792710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102449188|NCT04792710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102449189|NCT04792710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102449190|NCT04792398|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102449191|NCT04792398|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102449192|NCT04792398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102449193|NCT04792398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449194|NCT04792398|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102449195|NCT04792398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102449196|NCT04792398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449197|NCT04792398|Cholinergic Agents|cholinergic agents|mesh-ancestor
102449198|NCT04792398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102449199|NCT04814433|Lidocaine|lidocaine|mesh-list
102449200|NCT04814433|Epinephrine|epinephrine|mesh-list
102449201|NCT04814433|Racepinephrine|racepinephrine|mesh-list
102449202|NCT04814433|Bupivacaine|bupivacaine|mesh-list
102449203|NCT04814433|Tranexamic Acid|tranexamic acid|mesh-list
102449204|NCT04814433|Aminocaproic Acid|aminocaproic acid|mesh-list
102449205|NCT04814433|Thrombin|thrombin|mesh-list
102449206|NCT04814433|Epinephryl borate|epinephryl borate|mesh-list
102449207|NCT04814433|Anesthetics, Local|anesthetics, local|mesh-ancestor
102449208|NCT04814433|Anesthetics|anesthetics|mesh-ancestor
102449209|NCT04814433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102449210|NCT04814433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449211|NCT04814433|Sensory System Agents|sensory system agents|mesh-ancestor
102449212|NCT04814433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102449213|NCT04814433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102449214|NCT04814433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102449215|NCT04814433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102449216|NCT04814433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102449217|NCT04814433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449218|NCT04814433|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102449219|NCT04814433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102449220|NCT04814433|Hemostatics|hemostatics|mesh-ancestor
102449221|NCT04814433|Coagulants|coagulants|mesh-ancestor
102449222|NCT04814433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102449223|NCT04814433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102449224|NCT04814433|Adrenergic Agents|adrenergic agents|mesh-ancestor
102449225|NCT04814433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102449226|NCT04814433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102449227|NCT04814433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102449228|NCT04814433|Autonomic Agents|autonomic agents|mesh-ancestor
102449229|NCT04814433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102449230|NCT04814433|Respiratory System Agents|respiratory system agents|mesh-ancestor
102449231|NCT04814433|Mydriatics|mydriatics|mesh-ancestor
102449232|NCT04814433|Sympathomimetics|sympathomimetics|mesh-ancestor
102449233|NCT04814433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102449234|NCT03004209|Epoetin Alfa|epoetin alfa|mesh-list
102449235|NCT03004209|Hematinics|hematinics|mesh-ancestor
102449236|NCT04800978|Durvalumab|durvalumab|mesh-list
102449237|NCT04800978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102449238|NCT04800978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102449239|NCT04791774|Caseins|caseins|mesh-list
102449240|NCT04791774|Chelating Agents|chelating agents|mesh-ancestor
102449241|NCT04791774|Sequestering Agents|sequestering agents|mesh-ancestor
102449242|NCT04791774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449243|NCT00183469|Lamotrigine|lamotrigine|mesh-list
102449244|NCT00183469|Valproic Acid|valproic acid|mesh-list
102449245|NCT00183469|Anticonvulsants|anticonvulsants|mesh-ancestor
102449246|NCT00183469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102449247|NCT00183469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102449248|NCT00183469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449249|NCT00183469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102449250|NCT00183469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449251|NCT00183469|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102449252|NCT00183469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102449253|NCT00183469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102449254|NCT00183469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102449255|NCT00183469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102449256|NCT00183469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102449257|NCT00183469|GABA Agents|gaba agents|mesh-ancestor
102449258|NCT00183469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102449259|NCT00183469|Antimanic Agents|antimanic agents|mesh-ancestor
102449260|NCT02248155|Pramipexole|pramipexole|mesh-list
102449261|NCT02248155|Antioxidants|antioxidants|mesh-ancestor
102449262|NCT02248155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449263|NCT02248155|Protective Agents|protective agents|mesh-ancestor
102449264|NCT02248155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449265|NCT02248155|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102449266|NCT02248155|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102449267|NCT02248155|Dopamine Agonists|dopamine agonists|mesh-ancestor
102449268|NCT02248155|Dopamine Agents|dopamine agents|mesh-ancestor
102449269|NCT02248155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102449270|NCT02597946|Paclitaxel|paclitaxel|mesh-list
102449271|NCT02597946|Afatinib|afatinib|mesh-list
102449272|NCT02597946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102449273|NCT02597946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102449274|NCT02597946|Tubulin Modulators|tubulin modulators|mesh-ancestor
102449275|NCT02597946|Antimitotic Agents|antimitotic agents|mesh-ancestor
102449276|NCT02597946|Mitosis Modulators|mitosis modulators|mesh-ancestor
102449277|NCT02597946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449278|NCT02597946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102449279|NCT02597946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102449280|NCT02248233|Nimodipine|nimodipine|mesh-list
102449281|NCT02248233|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
102449282|NCT02248233|Nootropic Agents|nootropic agents|mesh-ancestor
102449283|NCT02248233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102449284|NCT02248233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102449285|NCT02248233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102449286|NCT02248233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449287|NCT02248233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102449288|NCT02248233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449289|NCT02248233|Vasodilator Agents|vasodilator agents|mesh-ancestor
102449290|NCT04790838|Fluticasone|fluticasone|mesh-list
102449291|NCT04790838|Xhance|xhance|mesh-list
102449292|NCT04790838|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102449293|NCT04790838|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102449294|NCT04790838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102449295|NCT04790838|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102449296|NCT04790838|Autonomic Agents|autonomic agents|mesh-ancestor
102449297|NCT04790838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102449298|NCT04790838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449299|NCT04790838|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102449300|NCT04790838|Respiratory System Agents|respiratory system agents|mesh-ancestor
102449301|NCT04790838|Dermatologic Agents|dermatologic agents|mesh-ancestor
102449302|NCT04790838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102449303|NCT04790838|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102449304|NCT04790838|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102449305|NCT04790838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102449306|NCT04790838|Adrenergic Agents|adrenergic agents|mesh-ancestor
102449307|NCT04790838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102449308|NCT04790838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449309|NCT04790838|Glucocorticoids|glucocorticoids|mesh-ancestor
102449310|NCT04790838|Hormones|hormones|mesh-ancestor
102449311|NCT04790838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102449312|NCT04790838|Sympathomimetics|sympathomimetics|mesh-ancestor
102449313|NCT03003273|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102449314|NCT03003273|Amoxicillin|amoxicillin|mesh-list
102449315|NCT03003273|Levofloxacin|levofloxacin|mesh-list
102449316|NCT03003273|Clavulanic Acids|clavulanic acids|mesh-list
102449317|NCT03003273|Clavulanic Acid|clavulanic acid|mesh-list
102449318|NCT03003273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102449319|NCT03003273|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102449320|NCT03003273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102449321|NCT03003273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102449322|NCT03003273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102449323|NCT03003273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449324|NCT03003273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102449325|NCT03003273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102449326|NCT03003273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102449327|NCT03003273|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102449328|NCT05571345|Oxycodone|oxycodone|mesh-list
102449329|NCT05571345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102449330|NCT05571345|Narcotics|narcotics|mesh-ancestor
102449331|NCT05571345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102449332|NCT05571345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449333|NCT05571345|Analgesics|analgesics|mesh-ancestor
102449334|NCT05571345|Sensory System Agents|sensory system agents|mesh-ancestor
102449335|NCT05571345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102449336|NCT02981121|Metformin|metformin|mesh-list
102449337|NCT02981121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102449338|NCT02981121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449339|NCT02597478|Fentanyl|fentanyl|mesh-list
102449340|NCT02597478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102449341|NCT02597478|Narcotics|narcotics|mesh-ancestor
102449342|NCT02597478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102449343|NCT02597478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449344|NCT02597478|Analgesics|analgesics|mesh-ancestor
102449345|NCT02597478|Sensory System Agents|sensory system agents|mesh-ancestor
102449346|NCT02597478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102449347|NCT02597478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102449348|NCT02597478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102449349|NCT02597478|Anesthetics, General|anesthetics, general|mesh-ancestor
102449350|NCT02597478|Anesthetics|anesthetics|mesh-ancestor
102449351|NCT04811274|Dimercaprol|dimercaprol|mesh-list
102449352|NCT04811274|Chelating Agents|chelating agents|mesh-ancestor
102449353|NCT04811274|Sequestering Agents|sequestering agents|mesh-ancestor
102449354|NCT04811274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449355|NCT04799184|Epinephrine|epinephrine|mesh-list
102449356|NCT04799184|Racepinephrine|racepinephrine|mesh-list
102449357|NCT04799184|Bupivacaine|bupivacaine|mesh-list
102449358|NCT04799184|Levobupivacaine|levobupivacaine|mesh-list
102449359|NCT04799184|Epinephryl borate|epinephryl borate|mesh-list
102449360|NCT04799184|Anesthetics, Local|anesthetics, local|mesh-ancestor
102449361|NCT04799184|Anesthetics|anesthetics|mesh-ancestor
102449362|NCT04799184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102449363|NCT04799184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449364|NCT04799184|Sensory System Agents|sensory system agents|mesh-ancestor
102449365|NCT04799184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102449366|NCT04799184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102449368|NCT04799184|Adrenergic Agents|adrenergic agents|mesh-ancestor
102449369|NCT04799184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102449370|NCT04799184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449371|NCT04799184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102449372|NCT04799184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102449373|NCT04799184|Autonomic Agents|autonomic agents|mesh-ancestor
102449374|NCT04799184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102449375|NCT04799184|Respiratory System Agents|respiratory system agents|mesh-ancestor
102449376|NCT04799184|Mydriatics|mydriatics|mesh-ancestor
102449377|NCT04799184|Sympathomimetics|sympathomimetics|mesh-ancestor
102449378|NCT04799184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102449379|NCT05562297|Paclitaxel|paclitaxel|mesh-list
102449380|NCT05562297|Gemcitabine|gemcitabine|mesh-list
102449381|NCT05562297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102449382|NCT05562297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102449383|NCT05562297|Tubulin Modulators|tubulin modulators|mesh-ancestor
102449384|NCT05562297|Antimitotic Agents|antimitotic agents|mesh-ancestor
102449385|NCT05562297|Mitosis Modulators|mitosis modulators|mesh-ancestor
102449386|NCT05562297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449387|NCT05562297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102449388|NCT05562297|Antimetabolites|antimetabolites|mesh-ancestor
102449389|NCT03003195|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
102449390|NCT03003195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102449391|NCT03003195|Immunologic Factors|immunologic factors|mesh-ancestor
102449392|NCT03003195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449393|NCT04790136|Cannabidiol|cannabidiol|mesh-list
102449394|NCT04790136|Anticonvulsants|anticonvulsants|mesh-ancestor
102449395|NCT04339101|Sirolimus|sirolimus|mesh-list
102449396|NCT04339101|Fludarabine|fludarabine|mesh-list
102449397|NCT04339101|Melphalan|melphalan|mesh-list
102449398|NCT04339101|Mechlorethamine|mechlorethamine|mesh-list
102449399|NCT04339101|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102449400|NCT04339101|Tacrolimus|tacrolimus|mesh-list
102449401|NCT04339101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102449402|NCT04339101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449403|NCT04339101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102449404|NCT04339101|Immunologic Factors|immunologic factors|mesh-ancestor
102449405|NCT04339101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449406|NCT04339101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102449407|NCT04339101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102449408|NCT04339101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102449409|NCT04339101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102449410|NCT04339101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102449411|NCT04339101|Antifungal Agents|antifungal agents|mesh-ancestor
102449412|NCT04339101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102449413|NCT04339101|Alkylating Agents|alkylating agents|mesh-ancestor
102449414|NCT04339101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102449415|NCT03003039|Rituximab|rituximab|mesh-list
102449416|NCT03003039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102449417|NCT03003039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102449418|NCT03003039|Immunologic Factors|immunologic factors|mesh-ancestor
102449419|NCT03003039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449420|NCT03003039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102449421|NCT03002961|Buprenorphine|buprenorphine|mesh-list
102449422|NCT03002961|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102449423|NCT03002961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102449424|NCT03002961|Narcotics|narcotics|mesh-ancestor
102449425|NCT03002961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102449426|NCT03002961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449427|NCT03002961|Analgesics|analgesics|mesh-ancestor
102449428|NCT03002961|Sensory System Agents|sensory system agents|mesh-ancestor
102449429|NCT03002961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102449430|NCT03002961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102449431|NCT03002805|Doxorubicin|doxorubicin|mesh-list
102449432|NCT03002805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102449433|NCT03002805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102449434|NCT03002805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102449435|NCT03002805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102449436|NCT03002805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102449437|NCT03002805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449438|NCT04214691|Acetaminophen|acetaminophen|mesh-list
102449439|NCT04214691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102449440|NCT04214691|Analgesics|analgesics|mesh-ancestor
102449441|NCT04214691|Sensory System Agents|sensory system agents|mesh-ancestor
102449442|NCT04214691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102449443|NCT04214691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449444|NCT04214691|Antipyretics|antipyretics|mesh-ancestor
102449445|NCT04786158|Apomorphine|apomorphine|mesh-list
102449446|NCT04786158|Emetics|emetics|mesh-ancestor
102449447|NCT04786158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449448|NCT04786158|Autonomic Agents|autonomic agents|mesh-ancestor
102449449|NCT04786158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102449450|NCT04786158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102449451|NCT04786158|Dopamine Agonists|dopamine agonists|mesh-ancestor
102449452|NCT04786158|Dopamine Agents|dopamine agents|mesh-ancestor
102449453|NCT04786158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102449454|NCT04786158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449455|NCT03002493|Rifampin|rifampin|mesh-list
102449456|NCT03002493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102449457|NCT03002493|Antitubercular Agents|antitubercular agents|mesh-ancestor
102449458|NCT03002493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102449459|NCT03002493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102449460|NCT03002493|Leprostatic Agents|leprostatic agents|mesh-ancestor
102449461|NCT03002493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102449462|NCT03002493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102449463|NCT03002493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449464|NCT03002493|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102449465|NCT03002493|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102449466|NCT03002493|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102449467|NCT03002493|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102449468|NCT03002493|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102449469|NCT03002493|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102449470|NCT04786470|Ropivacaine|ropivacaine|mesh-list
102449471|NCT04786470|Anesthetics, Local|anesthetics, local|mesh-ancestor
102449472|NCT04786470|Anesthetics|anesthetics|mesh-ancestor
102449473|NCT04786470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102449474|NCT04786470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449475|NCT04786470|Sensory System Agents|sensory system agents|mesh-ancestor
102449476|NCT04786470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102449477|NCT02219997|Methamphetamine|methamphetamine|mesh-list
102449478|NCT02219997|beta-Endorphin|beta-endorphin|mesh-list
102449479|NCT02219997|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102449480|NCT02219997|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
102449481|NCT02219997|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102449482|NCT02219997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449483|NCT02219997|Sympathomimetics|sympathomimetics|mesh-ancestor
102449484|NCT02219997|Autonomic Agents|autonomic agents|mesh-ancestor
102449485|NCT02219997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102449486|NCT02219997|Dopamine Agents|dopamine agents|mesh-ancestor
102449487|NCT02219997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102449488|NCT02219997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449489|NCT02219997|Adrenergic Agents|adrenergic agents|mesh-ancestor
102449490|NCT02219997|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102449491|NCT02219997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102449492|NCT02219997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102449493|NCT02219997|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102449494|NCT02219997|Hormones|hormones|mesh-ancestor
102449495|NCT02219997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102449496|NCT04786002|Busulfan|busulfan|mesh-list
102449497|NCT04786002|Alkylating Agents|alkylating agents|mesh-ancestor
102449498|NCT04786002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449499|NCT04786002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102449500|NCT04786002|Immunologic Factors|immunologic factors|mesh-ancestor
102449501|NCT04786002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449502|NCT04786002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102449503|NCT04786002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102449504|NCT04786002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102449505|NCT04788654|Acetaminophen|acetaminophen|mesh-list
102449506|NCT04788654|Dexamethasone|dexamethasone|mesh-list
102449507|NCT04788654|Celecoxib|celecoxib|mesh-list
102449508|NCT04788654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102449509|NCT04788654|Antiemetics|antiemetics|mesh-ancestor
102449510|NCT04788654|Autonomic Agents|autonomic agents|mesh-ancestor
102449511|NCT04788654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102449512|NCT04788654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449513|NCT04788654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102449514|NCT04788654|Glucocorticoids|glucocorticoids|mesh-ancestor
102449515|NCT04788654|Hormones|hormones|mesh-ancestor
102449516|NCT04788654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102449517|NCT04788654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102449518|NCT04788654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102449519|NCT04788654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102449520|NCT04788654|Analgesics|analgesics|mesh-ancestor
102449521|NCT04788654|Sensory System Agents|sensory system agents|mesh-ancestor
102449522|NCT04788654|Antipyretics|antipyretics|mesh-ancestor
102449523|NCT04788654|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102449524|NCT04788654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102449525|NCT04788654|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102449526|NCT04788654|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102449527|NCT04788654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102449528|NCT04788654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449529|NCT04785768|Morphine|morphine|mesh-list
102449530|NCT04785768|Hydromorphone|hydromorphone|mesh-list
102449531|NCT04785768|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102449532|NCT04785768|Narcotics|narcotics|mesh-ancestor
102449533|NCT04785768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102449534|NCT04785768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449535|NCT04785768|Analgesics|analgesics|mesh-ancestor
102449536|NCT04785768|Sensory System Agents|sensory system agents|mesh-ancestor
102449537|NCT04785768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102449538|NCT02223351|Ritonavir|ritonavir|mesh-list
102449539|NCT02223351|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102449540|NCT02223351|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102449541|NCT02223351|Protease Inhibitors|protease inhibitors|mesh-ancestor
102449542|NCT02223351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102449543|NCT02223351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449544|NCT02223351|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102449545|NCT02223351|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102449546|NCT02223351|Antiviral Agents|antiviral agents|mesh-ancestor
102449547|NCT02223351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102449548|NCT02223351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102449549|NCT02223351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102449550|NCT02223429|Vasopressins|vasopressins|mesh-list
102449551|NCT02223429|Arginine Vasopressin|arginine vasopressin|mesh-list
102449552|NCT02223429|Oxytocin|oxytocin|mesh-list
102449553|NCT02223429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449554|NCT02223429|Oxytocics|oxytocics|mesh-ancestor
102449555|NCT02223429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102449556|NCT02223429|Hemostatics|hemostatics|mesh-ancestor
102449557|NCT02223429|Coagulants|coagulants|mesh-ancestor
102449558|NCT02223429|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102449559|NCT02223429|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102449560|NCT02223429|Natriuretic Agents|natriuretic agents|mesh-ancestor
102449561|NCT03002649|Tofacitinib|tofacitinib|mesh-list
102449562|NCT03002649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449563|NCT03002649|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102449564|NCT03002649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102449565|NCT03002649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102449566|NCT04785222|Dexmedetomidine|dexmedetomidine|mesh-list
102449567|NCT04785222|Bupivacaine|bupivacaine|mesh-list
102449568|NCT04785222|Anesthetics, Local|anesthetics, local|mesh-ancestor
102449569|NCT04785222|Anesthetics|anesthetics|mesh-ancestor
102449570|NCT04785222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102449571|NCT04785222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449572|NCT04785222|Sensory System Agents|sensory system agents|mesh-ancestor
102449573|NCT04785222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102449574|NCT04785222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102449575|NCT04785222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102449576|NCT04785222|Analgesics|analgesics|mesh-ancestor
102449577|NCT04785222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102449578|NCT04785222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102449579|NCT04785222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102449580|NCT04785222|Adrenergic Agents|adrenergic agents|mesh-ancestor
102449581|NCT04785222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102449582|NCT04785222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449583|NCT04808856|Methylprednisolone|methylprednisolone|mesh-list
102449584|NCT04808856|Hormones|hormones|mesh-list
102449585|NCT04808856|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102449586|NCT04808856|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
102449587|NCT04808856|beta-Endorphin|beta-endorphin|mesh-list
102449588|NCT04808856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102449589|NCT04808856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449590|NCT04808856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102449591|NCT04808856|Antiemetics|antiemetics|mesh-ancestor
102449592|NCT04808856|Autonomic Agents|autonomic agents|mesh-ancestor
102449593|NCT04808856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102449594|NCT04808856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102449595|NCT04808856|Glucocorticoids|glucocorticoids|mesh-ancestor
102449596|NCT04808856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102449597|NCT04808856|Protective Agents|protective agents|mesh-ancestor
102449598|NCT04808856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102449599|NCT04808856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449600|NCT02247687|Raltegravir Potassium|raltegravir potassium|mesh-list
102449601|NCT02247687|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
102449602|NCT02247687|Protease Inhibitors|protease inhibitors|mesh-list
102449603|NCT02247687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102449604|NCT02247687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102449605|NCT02247687|Antiviral Agents|antiviral agents|mesh-ancestor
102449606|NCT02247687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102449607|NCT02247687|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102449608|NCT02247687|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102449609|NCT02247687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102449610|NCT02247687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449611|NCT02247687|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102449612|NCT04784988|BAX 855|bax 855|mesh-list
102449613|NCT04784988|Coagulants|coagulants|mesh-ancestor
102449614|NCT04784910|Lansoprazole|lansoprazole|mesh-list
102449615|NCT04784910|Dexlansoprazole|dexlansoprazole|mesh-list
102449616|NCT04784910|Fexuprazan|fexuprazan|mesh-list
102449617|NCT04784910|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102449618|NCT04784910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102449619|NCT04784910|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102449620|NCT04784910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102449621|NCT04784910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449622|NCT01625013|Hylan|hylan|mesh-list
102449623|NCT01625013|Viscosupplements|viscosupplements|mesh-ancestor
102449624|NCT01625013|Protective Agents|protective agents|mesh-ancestor
102449625|NCT01625013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449626|NCT00083551|Interferons|interferons|mesh-list
102449627|NCT00083551|Cytarabine|cytarabine|mesh-list
102449628|NCT00083551|Interferon-alpha|interferon-alpha|mesh-list
102449629|NCT00083551|Interferon alpha-2|interferon alpha-2|mesh-list
102449630|NCT00083551|Thalidomide|thalidomide|mesh-list
102449631|NCT00083551|Dexamethasone|dexamethasone|mesh-list
102449632|NCT00083551|Cyclophosphamide|cyclophosphamide|mesh-list
102449633|NCT00083551|Melphalan|melphalan|mesh-list
102449634|NCT00083551|Carmustine|carmustine|mesh-list
102449635|NCT00083551|Cisplatin|cisplatin|mesh-list
102449636|NCT00083551|Doxorubicin|doxorubicin|mesh-list
102449637|NCT00083551|Etoposide|etoposide|mesh-list
102449638|NCT00083551|Vincristine|vincristine|mesh-list
102449639|NCT00083551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102449640|NCT00083551|Immunologic Factors|immunologic factors|mesh-ancestor
102449641|NCT00083551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449642|NCT00083551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102449643|NCT00083551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102449644|NCT00083551|Alkylating Agents|alkylating agents|mesh-ancestor
102449645|NCT00083551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449646|NCT00083551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102449647|NCT00083551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102449648|NCT00083551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102449649|NCT00083551|Antiemetics|antiemetics|mesh-ancestor
102449650|NCT00083551|Autonomic Agents|autonomic agents|mesh-ancestor
102449651|NCT00083551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102449652|NCT00083551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102449653|NCT00083551|Glucocorticoids|glucocorticoids|mesh-ancestor
102449654|NCT00083551|Hormones|hormones|mesh-ancestor
102079756|NCT05891132|Sensory System Agents|sensory system agents|mesh-ancestor
102449655|NCT00083551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102449656|NCT00083551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102449657|NCT00083551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102449658|NCT00083551|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102449659|NCT00083551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102449660|NCT00083551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102449661|NCT00083551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102449662|NCT00083551|Antiviral Agents|antiviral agents|mesh-ancestor
102449663|NCT00083551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102449664|NCT00083551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102449665|NCT00083551|Antimetabolites|antimetabolites|mesh-ancestor
102449666|NCT00083551|Tubulin Modulators|tubulin modulators|mesh-ancestor
102449667|NCT00083551|Antimitotic Agents|antimitotic agents|mesh-ancestor
102449668|NCT00083551|Mitosis Modulators|mitosis modulators|mesh-ancestor
102449669|NCT00083551|Leprostatic Agents|leprostatic agents|mesh-ancestor
102449670|NCT00083551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102449671|NCT00083551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102449672|NCT00083551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102449673|NCT00083551|Growth Substances|growth substances|mesh-ancestor
102449674|NCT00083551|Growth Inhibitors|growth inhibitors|mesh-ancestor
102449676|NCT01625169|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102449677|NCT01625169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102449678|NCT01625169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102449679|NCT01625169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449680|NCT01625169|Antiviral Agents|antiviral agents|mesh-ancestor
102449681|NCT01625169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102449682|NCT03933813|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102449683|NCT03933813|Hematinics|hematinics|mesh-ancestor
102449684|NCT01628601|Timolol|timolol|mesh-list
102449685|NCT01628601|Bimatoprost|bimatoprost|mesh-list
102449686|NCT01628601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102449687|NCT01628601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102449688|NCT01628601|Adrenergic Agents|adrenergic agents|mesh-ancestor
102449689|NCT01628601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102449690|NCT01628601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449691|NCT01628601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449692|NCT01628601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102449693|NCT01628601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102449694|NCT01470248|Arsenic Trioxide|arsenic trioxide|mesh-list
102449695|NCT01470248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102449696|NCT04091022|Eflornithine|eflornithine|mesh-list
102449697|NCT04091022|Diclofenac|diclofenac|mesh-list
102449698|NCT04091022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102449699|NCT04091022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102449700|NCT04091022|Analgesics|analgesics|mesh-ancestor
102449701|NCT04091022|Sensory System Agents|sensory system agents|mesh-ancestor
102449702|NCT04091022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102449703|NCT04091022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449704|NCT04091022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102449705|NCT04091022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102449706|NCT04091022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102449707|NCT04091022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102449708|NCT04091022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449709|NCT04091022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102449710|NCT04091022|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102449711|NCT04091022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102449712|NCT04091022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102449713|NCT04091022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102449714|NCT04091022|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
102449715|NCT01490918|Metformin|metformin|mesh-list
102449716|NCT01490918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102449717|NCT01490918|Acarbose|acarbose|mesh-list
102449718|NCT01490918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102449719|NCT01490918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449720|NCT01490918|Incretins|incretins|mesh-ancestor
102449721|NCT01490918|Hormones|hormones|mesh-ancestor
102449722|NCT01490918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102449723|NCT01490918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102449724|NCT01490918|Protease Inhibitors|protease inhibitors|mesh-ancestor
102449725|NCT01490918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102449726|NCT01490918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449727|NCT01490918|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102449728|NCT02230995|Metformin|metformin|mesh-list
102449729|NCT02230995|Empagliflozin|empagliflozin|mesh-list
102449730|NCT02230995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102449731|NCT02230995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449732|NCT02230995|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102449733|NCT02230995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449734|NCT02995083|Methylprednisolone|methylprednisolone|mesh-list
102449735|NCT02995083|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102449736|NCT02995083|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102449737|NCT02995083|Prednisolone|prednisolone|mesh-list
102449738|NCT02995083|Prednisolone acetate|prednisolone acetate|mesh-list
102449739|NCT02995083|Lidocaine|lidocaine|mesh-list
102449740|NCT02995083|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102449741|NCT02995083|Prednisolone phosphate|prednisolone phosphate|mesh-list
102449742|NCT02995083|Anesthetics, Local|anesthetics, local|mesh-ancestor
102449743|NCT02995083|Anesthetics|anesthetics|mesh-ancestor
102449744|NCT02995083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102449745|NCT02995083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449746|NCT02995083|Sensory System Agents|sensory system agents|mesh-ancestor
102449747|NCT02995083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102449748|NCT02995083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102449749|NCT02995083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102449750|NCT02995083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102449751|NCT02995083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102449752|NCT02995083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449753|NCT02995083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102449754|NCT02995083|Antiemetics|antiemetics|mesh-ancestor
102449755|NCT02995083|Autonomic Agents|autonomic agents|mesh-ancestor
102449756|NCT02995083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102449757|NCT02995083|Glucocorticoids|glucocorticoids|mesh-ancestor
102449758|NCT02995083|Hormones|hormones|mesh-ancestor
102449759|NCT02995083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102449760|NCT02995083|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102449761|NCT02995083|Protective Agents|protective agents|mesh-ancestor
102449762|NCT02995083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102449763|NCT02995083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102449764|NCT04426422|Metformin|metformin|mesh-list
102449765|NCT04426422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102449766|NCT04426422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449767|NCT05471700|Azacitidine|azacitidine|mesh-list
102449768|NCT05471700|Venetoclax|venetoclax|mesh-list
102449769|NCT05471700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102449770|NCT05471700|Antimetabolites|antimetabolites|mesh-ancestor
102449771|NCT05471700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449772|NCT05471700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102449773|NCT05471700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102449774|NCT01632423|Bimatoprost|bimatoprost|mesh-list
102449775|NCT01632423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102449776|NCT05466318|Cytarabine|cytarabine|mesh-list
102449777|NCT05466318|Gemcitabine|gemcitabine|mesh-list
102449778|NCT05466318|Etoposide|etoposide|mesh-list
102449779|NCT05466318|Melphalan|melphalan|mesh-list
102449780|NCT05466318|Busulfan|busulfan|mesh-list
102449781|NCT05466318|Carmustine|carmustine|mesh-list
102449782|NCT05466318|Cladribine|cladribine|mesh-list
102449783|NCT05466318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102449784|NCT05466318|Antimetabolites|antimetabolites|mesh-ancestor
102449785|NCT05466318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449786|NCT05466318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102449787|NCT05466318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102449788|NCT05466318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102449789|NCT05466318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102449790|NCT05466318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102449791|NCT05466318|Antiviral Agents|antiviral agents|mesh-ancestor
102079897|NCT05890287|Tamoxifen|tamoxifen|mesh-list
102449792|NCT05466318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102449793|NCT05466318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102449794|NCT05466318|Immunologic Factors|immunologic factors|mesh-ancestor
102449795|NCT05466318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449796|NCT05466318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102449797|NCT05466318|Alkylating Agents|alkylating agents|mesh-ancestor
102449798|NCT05466318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102449799|NCT01633827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
102449800|NCT01633827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102449801|NCT01633827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449802|NCT01469546|Axitinib|axitinib|mesh-list
102449803|NCT01469546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102449804|NCT01469546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102449805|NCT01469546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102449806|NCT01469546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449807|NCT03281811|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102449808|NCT03281811|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102449809|NCT03281811|Dermatologic Agents|dermatologic agents|mesh-ancestor
102449810|NCT05613894|177Lu-PSMA-617|177lu-psma-617|mesh-list
102449811|NCT05613894|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102449812|NCT05613894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449813|NCT00081263|Celecoxib|celecoxib|mesh-list
102449814|NCT00081263|Benzenesulfonamide|benzenesulfonamide|mesh-list
102449815|NCT00081263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102449816|NCT00081263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102449817|NCT00081263|Analgesics|analgesics|mesh-ancestor
102449818|NCT00081263|Sensory System Agents|sensory system agents|mesh-ancestor
102449819|NCT00081263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102261407|NCT05099081|Ethanolamine oleate|ethanolamine oleate|mesh-list
102449820|NCT00081263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449821|NCT00081263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102449822|NCT00081263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102449823|NCT00081263|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102449824|NCT00081263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102449825|NCT00081263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102449826|NCT00081263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449827|NCT00081263|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102449829|NCT03138603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102449830|NCT03138603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102449831|NCT03138603|Sympatholytics|sympatholytics|mesh-ancestor
102449832|NCT03138603|Autonomic Agents|autonomic agents|mesh-ancestor
102449833|NCT03138603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102449834|NCT03138603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449835|NCT03138603|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102449836|NCT03138603|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102449837|NCT03138603|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102449838|NCT03138603|Adrenergic Agents|adrenergic agents|mesh-ancestor
102449839|NCT03138603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102449840|NCT03138603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449841|NCT05087381|Cyproheptadine|cyproheptadine|mesh-list
102449842|NCT05087381|Niclosamide|niclosamide|mesh-list
102449843|NCT05087381|Fluvoxamine|fluvoxamine|mesh-list
102449844|NCT05087381|Bromhexine|bromhexine|mesh-list
102449845|NCT05087381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102449846|NCT05087381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449847|NCT05087381|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102449848|NCT05087381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102449849|NCT05087381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102449850|NCT05087381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449851|NCT05087381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102449852|NCT05087381|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102449853|NCT05087381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102449854|NCT05087381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102449855|NCT05087381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102449856|NCT05087381|Serotonin Agents|serotonin agents|mesh-ancestor
102449857|NCT05087381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102449858|NCT05087381|Antidepressive Agents|antidepressive agents|mesh-ancestor
102449859|NCT05087381|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102449860|NCT05087381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102079964|NCT05874570|Antimalarials|antimalarials|mesh-ancestor
102449861|NCT05087381|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102449862|NCT05087381|Anticestodal Agents|anticestodal agents|mesh-ancestor
102449863|NCT05087381|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102449864|NCT05087381|Anthelmintics|anthelmintics|mesh-ancestor
102449865|NCT05087381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102449866|NCT05087381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102449867|NCT05087381|Antinematodal Agents|antinematodal agents|mesh-ancestor
102449868|NCT05087381|Antipruritics|antipruritics|mesh-ancestor
102449869|NCT05087381|Dermatologic Agents|dermatologic agents|mesh-ancestor
102449870|NCT05087381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102449871|NCT05087381|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102449872|NCT05087381|Histamine Antagonists|histamine antagonists|mesh-ancestor
102449873|NCT05087381|Histamine Agents|histamine agents|mesh-ancestor
102449874|NCT05087381|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102449875|NCT05087381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102449876|NCT05087381|Expectorants|expectorants|mesh-ancestor
102449877|NCT05087381|Respiratory System Agents|respiratory system agents|mesh-ancestor
102449878|NCT00080483|Methyltestosterone|methyltestosterone|mesh-list
102449879|NCT00080483|Testosterone|testosterone|mesh-list
102449880|NCT00080483|Testosterone undecanoate|testosterone undecanoate|mesh-list
102449881|NCT00080483|Testosterone enanthate|testosterone enanthate|mesh-list
102449882|NCT00080483|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102449883|NCT00080483|Androgens|androgens|mesh-ancestor
102449884|NCT00080483|Hormones|hormones|mesh-ancestor
102449885|NCT00080483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102449886|NCT00080483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449887|NCT00080483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102449888|NCT00080483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102449889|NCT00080483|Anabolic Agents|anabolic agents|mesh-ancestor
102449890|NCT05248620|Amoxicillin|amoxicillin|mesh-list
102449891|NCT05248620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102449892|NCT05248620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102449893|NCT01639599|Dexamethasone|dexamethasone|mesh-list
102449894|NCT01639599|Dexamethasone acetate|dexamethasone acetate|mesh-list
102449895|NCT01639599|Haloperidol|haloperidol|mesh-list
102449896|NCT01639599|Haloperidol decanoate|haloperidol decanoate|mesh-list
102449897|NCT01639599|BB 1101|bb 1101|mesh-list
102449898|NCT01639599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102449899|NCT01639599|Antiemetics|antiemetics|mesh-ancestor
102449900|NCT01639599|Autonomic Agents|autonomic agents|mesh-ancestor
102449901|NCT01639599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102449902|NCT01639599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449903|NCT01639599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102449904|NCT01639599|Glucocorticoids|glucocorticoids|mesh-ancestor
102449905|NCT01639599|Hormones|hormones|mesh-ancestor
102449906|NCT01639599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102449907|NCT01639599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102449908|NCT01639599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102449909|NCT01639599|Protease Inhibitors|protease inhibitors|mesh-ancestor
102449910|NCT01639599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102449911|NCT01639599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449912|NCT01639599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102449913|NCT01639599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102449914|NCT01639599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102449915|NCT01639599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102449916|NCT01639599|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102449917|NCT01639599|Dopamine Agents|dopamine agents|mesh-ancestor
102449918|NCT01639599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102449919|NCT01639599|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102449920|NCT00089141|Mycophenolic Acid|mycophenolic acid|mesh-list
102449921|NCT00089141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102449922|NCT00089141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102449923|NCT00089141|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102449924|NCT00089141|Antitubercular Agents|antitubercular agents|mesh-ancestor
102449925|NCT00089141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102449926|NCT00089141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102449927|NCT00089141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102449928|NCT00089141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449929|NCT02227329|Ethanol|ethanol|mesh-list
102449930|NCT02227329|Heparin|heparin|mesh-list
102449931|NCT02227329|Calcium heparin|calcium heparin|mesh-list
102449932|NCT02227329|Anticoagulants|anticoagulants|mesh-ancestor
102449933|NCT02227329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102449934|NCT02227329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102449935|NCT02227329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449936|NCT02227329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102449937|NCT02227329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102449938|NCT02227329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102449939|NCT02227329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449940|NCT05611242|Cangrelor|cangrelor|mesh-list
102449941|NCT05611242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
102449942|NCT05611242|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102449943|NCT05611242|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102449944|NCT05611242|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102449945|NCT05611242|Purinergic Agents|purinergic agents|mesh-ancestor
102449946|NCT05611242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102080092|NCT05466799|Oxaliplatin|oxaliplatin|mesh-list
102449947|NCT05611242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449948|NCT05611242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449949|NCT05615142|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102449950|NCT05615142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449951|NCT05615142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102449952|NCT05615142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102449953|NCT02227485|Chlorhexidine|chlorhexidine|mesh-list
102449954|NCT02227485|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102449955|NCT02227485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102449956|NCT02227485|Disinfectants|disinfectants|mesh-ancestor
102449957|NCT03172897|Dexmedetomidine|dexmedetomidine|mesh-list
102449958|NCT03172897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102449959|NCT03172897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102449960|NCT03172897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449961|NCT03172897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102449962|NCT03172897|Analgesics|analgesics|mesh-ancestor
102449963|NCT03172897|Sensory System Agents|sensory system agents|mesh-ancestor
102449964|NCT03172897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102449965|NCT03172897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102449966|NCT03172897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102261562|NCT05097911|Bevacizumab|bevacizumab|mesh-list
102449967|NCT03172897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102449968|NCT03172897|Adrenergic Agents|adrenergic agents|mesh-ancestor
102449969|NCT03172897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102449970|NCT03172897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449971|NCT00086723|Captopril|captopril|mesh-list
102449972|NCT00086723|Plasminogen|plasminogen|mesh-list
102449973|NCT00086723|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102449974|NCT00086723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102449975|NCT00086723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102449976|NCT00086723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449977|NCT00086723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102449978|NCT00086723|Protease Inhibitors|protease inhibitors|mesh-ancestor
102449979|NCT00086723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102449980|NCT00086723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102449981|NCT03849534|Salicylic Acid|salicylic acid|mesh-list
102449982|NCT03849534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102449983|NCT03849534|Antifungal Agents|antifungal agents|mesh-ancestor
102449984|NCT03849534|Keratolytic Agents|keratolytic agents|mesh-ancestor
102449985|NCT03849534|Dermatologic Agents|dermatologic agents|mesh-ancestor
102449986|NCT05346419|Vitamin D|vitamin d|mesh-list
102449987|NCT05346419|Risedronic Acid|risedronic acid|mesh-list
102449988|NCT05346419|Vitamins|vitamins|mesh-ancestor
102449989|NCT05346419|Micronutrients|micronutrients|mesh-ancestor
102449990|NCT05346419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102449991|NCT05346419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102449992|NCT05346419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102449993|NCT05346419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102449994|NCT05346419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102449995|NCT05346419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102449996|NCT00084409|Iloprost|iloprost|mesh-list
102449997|NCT00084409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102449998|NCT00084409|Vasodilator Agents|vasodilator agents|mesh-ancestor
102449999|NCT03831165|Acyclovir|acyclovir|mesh-list
102450000|NCT03831165|Melatonin|melatonin|mesh-list
102450001|NCT03831165|Antioxidants|antioxidants|mesh-ancestor
102450002|NCT03831165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450003|NCT03831165|Protective Agents|protective agents|mesh-ancestor
102450004|NCT03831165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450005|NCT03831165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102450006|NCT03831165|Antiviral Agents|antiviral agents|mesh-ancestor
102450007|NCT03831165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102450008|NCT00088621|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102450009|NCT00088621|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102450010|NCT00088621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102450011|NCT00088621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102450012|NCT00088621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450013|NCT00088621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102450014|NCT00088621|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102450015|NCT00088621|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102450016|NCT00088621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102450017|NCT00088621|Adrenergic Agents|adrenergic agents|mesh-ancestor
102450018|NCT00088621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102450019|NCT00088621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450020|NCT00088621|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102450021|NCT00088621|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102450022|NCT00088621|Serotonin Agents|serotonin agents|mesh-ancestor
102450023|NCT00088621|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102450024|NCT00088621|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102450025|NCT00088621|Dopamine Agents|dopamine agents|mesh-ancestor
102450026|NCT03849651|Cyclophosphamide|cyclophosphamide|mesh-list
102450027|NCT03849651|Melphalan|melphalan|mesh-list
102450028|NCT03849651|Thiotepa|thiotepa|mesh-list
102450029|NCT03849651|Fludarabine|fludarabine|mesh-list
102450030|NCT03849651|Blinatumomab|blinatumomab|mesh-list
102450031|NCT03849651|Thymoglobulin|thymoglobulin|mesh-list
102450032|NCT03849651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102450033|NCT03849651|Immunologic Factors|immunologic factors|mesh-ancestor
102450034|NCT03849651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450035|NCT03849651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102450036|NCT03849651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102450037|NCT03849651|Alkylating Agents|alkylating agents|mesh-ancestor
102450038|NCT03849651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450039|NCT03849651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102450040|NCT03849651|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102450041|NCT05574985|Vaccines|vaccines|mesh-list
102450042|NCT05574985|Immunologic Factors|immunologic factors|mesh-ancestor
102450043|NCT05574985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450044|NCT01642485|Moxifloxacin|moxifloxacin|mesh-list
102450045|NCT01642485|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102450046|NCT01642485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450047|NCT01642485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102450048|NCT01642485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102450049|NCT01642485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102450050|NCT01642485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102450051|NCT01642485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102450052|NCT01642485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450053|NCT01642485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102450054|NCT01642485|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102450055|NCT01642485|Contraceptive Agents|contraceptive agents|mesh-ancestor
102450056|NCT01642485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102450057|NCT01642485|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102450058|NCT01642485|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102450059|NCT01642485|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102450060|NCT04773366|Cytarabine|cytarabine|mesh-list
102450061|NCT04773366|Prednisone|prednisone|mesh-list
102450062|NCT04773366|Vincristine|vincristine|mesh-list
102450063|NCT04773366|Mercaptopurine|mercaptopurine|mesh-list
102450064|NCT04773366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102450065|NCT04773366|Glucocorticoids|glucocorticoids|mesh-ancestor
102450066|NCT04773366|Hormones|hormones|mesh-ancestor
102450067|NCT04773366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102450068|NCT04773366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450069|NCT04773366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102450070|NCT04773366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102450071|NCT04773366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102450072|NCT04773366|Antimetabolites|antimetabolites|mesh-ancestor
102450073|NCT04773366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450074|NCT04773366|Antiviral Agents|antiviral agents|mesh-ancestor
102450075|NCT04773366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102450076|NCT04773366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102450077|NCT04773366|Immunologic Factors|immunologic factors|mesh-ancestor
102450078|NCT04773366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102450079|NCT04773366|Tubulin Modulators|tubulin modulators|mesh-ancestor
102450080|NCT04773366|Antimitotic Agents|antimitotic agents|mesh-ancestor
102450081|NCT04773366|Mitosis Modulators|mitosis modulators|mesh-ancestor
102450082|NCT04773366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102450083|NCT04773366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102450084|NCT04714541|Ketamine|ketamine|mesh-list
102450085|NCT04714541|Analgesics|analgesics|mesh-ancestor
102450086|NCT04714541|Sensory System Agents|sensory system agents|mesh-ancestor
102450087|NCT04714541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102450088|NCT04714541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450089|NCT04714541|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102450090|NCT04714541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102450091|NCT04714541|Anesthetics, General|anesthetics, general|mesh-ancestor
102450092|NCT04714541|Anesthetics|anesthetics|mesh-ancestor
102450093|NCT04714541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102450094|NCT04714541|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102450095|NCT04714541|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102450096|NCT04714541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102450097|NCT04714541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450098|NCT02414724|Gemcitabine|gemcitabine|mesh-list
102450099|NCT02414724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102450100|NCT02414724|Antimetabolites|antimetabolites|mesh-ancestor
102450101|NCT02414724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450102|NCT02414724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102450103|NCT00187681|Metformin|metformin|mesh-list
102450104|NCT00187681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102450105|NCT00187681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450106|NCT00083759|Natalizumab|natalizumab|mesh-list
102450107|NCT00083759|Immunologic Factors|immunologic factors|mesh-ancestor
102450108|NCT00083759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450109|NCT02412228|Dexamethasone|dexamethasone|mesh-list
102450110|NCT02412228|Cyclophosphamide|cyclophosphamide|mesh-list
102450111|NCT02412228|Ixazomib|ixazomib|mesh-list
102450112|NCT02412228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102450113|NCT02412228|Immunologic Factors|immunologic factors|mesh-ancestor
102450114|NCT02412228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450115|NCT02412228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102450116|NCT02412228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102450117|NCT02412228|Alkylating Agents|alkylating agents|mesh-ancestor
102450118|NCT02412228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450119|NCT02412228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102450120|NCT02412228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102450121|NCT02412228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102450122|NCT02412228|Antiemetics|antiemetics|mesh-ancestor
102450123|NCT02412228|Autonomic Agents|autonomic agents|mesh-ancestor
102450124|NCT02412228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102450125|NCT02412228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102450126|NCT02412228|Glucocorticoids|glucocorticoids|mesh-ancestor
102450127|NCT02412228|Hormones|hormones|mesh-ancestor
102450128|NCT02412228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102450129|NCT02412228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102450130|NCT02412228|Protease Inhibitors|protease inhibitors|mesh-ancestor
102450131|NCT02412228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102450132|NCT03693807|Gemcitabine|gemcitabine|mesh-list
102450133|NCT03693807|Fluorouracil|fluorouracil|mesh-list
102450134|NCT03693807|Floxuridine|floxuridine|mesh-list
102450135|NCT03693807|Oxaliplatin|oxaliplatin|mesh-list
102450136|NCT03693807|Irinotecan|irinotecan|mesh-list
102450137|NCT03693807|Cetuximab|cetuximab|mesh-list
102450138|NCT03693807|Panitumumab|panitumumab|mesh-list
102450139|NCT03693807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102450140|NCT03693807|Antimetabolites|antimetabolites|mesh-ancestor
102450141|NCT03693807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450142|NCT03693807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102450143|NCT03693807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102450144|NCT03693807|Immunologic Factors|immunologic factors|mesh-ancestor
102450145|NCT03693807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450146|NCT03693807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102450147|NCT03693807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102450148|NCT03693807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102450149|NCT03693807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102450150|NCT01646151|Bimatoprost|bimatoprost|mesh-list
102450151|NCT01646151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102450152|NCT03692481|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102450153|NCT03692481|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102450154|NCT03692481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450155|NCT01828710|Folic Acid|folic acid|mesh-list
102450156|NCT01828710|Inositol|inositol|mesh-list
102450157|NCT01828710|Hematinics|hematinics|mesh-ancestor
102450158|NCT01828710|Vitamin B Complex|vitamin b complex|mesh-ancestor
102450159|NCT01828710|Vitamins|vitamins|mesh-ancestor
102450160|NCT01828710|Micronutrients|micronutrients|mesh-ancestor
102450161|NCT01828710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450162|NCT00088699|Ketamine|ketamine|mesh-list
102450163|NCT00088699|Analgesics|analgesics|mesh-ancestor
102450164|NCT00088699|Sensory System Agents|sensory system agents|mesh-ancestor
102450165|NCT00088699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102450166|NCT00088699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450167|NCT00088699|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102450168|NCT00088699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102450169|NCT00088699|Anesthetics, General|anesthetics, general|mesh-ancestor
102450170|NCT00088699|Anesthetics|anesthetics|mesh-ancestor
102450171|NCT00088699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102450172|NCT00088699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102450173|NCT00088699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102450174|NCT00088699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102450175|NCT00088699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450176|NCT00089011|Mycophenolic Acid|mycophenolic acid|mesh-list
102450177|NCT00089011|Fludarabine|fludarabine|mesh-list
102450178|NCT00089011|Fludarabine phosphate|fludarabine phosphate|mesh-list
102450179|NCT00089011|Tacrolimus|tacrolimus|mesh-list
102450180|NCT00089011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102450181|NCT00089011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102450182|NCT00089011|Antimetabolites|antimetabolites|mesh-ancestor
102450183|NCT00089011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450184|NCT00089011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102450185|NCT00089011|Immunologic Factors|immunologic factors|mesh-ancestor
102450186|NCT00089011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450187|NCT00089011|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102450188|NCT00089011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102450189|NCT00089011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102450190|NCT00089011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102450191|NCT00089011|Antitubercular Agents|antitubercular agents|mesh-ancestor
102261790|NCT03116269|Aspirin|aspirin|mesh-list
102450192|NCT00089011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102450193|NCT00089011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102450194|NCT01898377|Mycophenolic Acid|mycophenolic acid|mesh-list
102450195|NCT01898377|Imatinib Mesylate|imatinib mesylate|mesh-list
102450196|NCT01898377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102450197|NCT01898377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102450198|NCT01898377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102450199|NCT01898377|Antitubercular Agents|antitubercular agents|mesh-ancestor
102450200|NCT01898377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102450201|NCT01898377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102450202|NCT01898377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102450203|NCT01898377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450204|NCT01898377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102450206|NCT00347412|Carboplatin|carboplatin|mesh-list
102450207|NCT00347412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102450208|NCT00347412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102450209|NCT00347412|Tubulin Modulators|tubulin modulators|mesh-ancestor
102450210|NCT00347412|Antimitotic Agents|antimitotic agents|mesh-ancestor
102450211|NCT00347412|Mitosis Modulators|mitosis modulators|mesh-ancestor
102450212|NCT00347412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450213|NCT00189475|Montelukast|montelukast|mesh-list
102450214|NCT00189475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102450215|NCT00189475|Respiratory System Agents|respiratory system agents|mesh-ancestor
102450216|NCT00189475|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102450217|NCT00189475|Hormone Antagonists|hormone antagonists|mesh-ancestor
102450218|NCT00189475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102450219|NCT00189475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450220|NCT00189475|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102450221|NCT00189475|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102450222|NCT00189475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450223|NCT00091273|Sargramostim|sargramostim|mesh-list
102450224|NCT00091273|Freund's Adjuvant|freund's adjuvant|mesh-list
102450225|NCT00091273|Immunologic Factors|immunologic factors|mesh-ancestor
102450226|NCT00091273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450227|NCT00091273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102450228|NCT00193375|Bevacizumab|bevacizumab|mesh-list
102450229|NCT00193375|Carboplatin|carboplatin|mesh-list
102450230|NCT00193375|Irinotecan|irinotecan|mesh-list
102450231|NCT00193375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102450232|NCT00193375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102450233|NCT00193375|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102450234|NCT00193375|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102450235|NCT00193375|Growth Substances|growth substances|mesh-ancestor
102450236|NCT00193375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450237|NCT00193375|Growth Inhibitors|growth inhibitors|mesh-ancestor
102450238|NCT00193375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102450239|NCT00193375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102450240|NCT00193375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102450241|NCT00193375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450242|NCT00193453|Gemcitabine|gemcitabine|mesh-list
102450243|NCT00193453|Docetaxel|docetaxel|mesh-list
102450244|NCT00193453|Cetuximab|cetuximab|mesh-list
102450245|NCT00193453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102450246|NCT00193453|Antimetabolites|antimetabolites|mesh-ancestor
102450247|NCT00193453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450248|NCT00193453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102450249|NCT00193453|Tubulin Modulators|tubulin modulators|mesh-ancestor
102450250|NCT00193453|Antimitotic Agents|antimitotic agents|mesh-ancestor
102450251|NCT00193453|Mitosis Modulators|mitosis modulators|mesh-ancestor
102450252|NCT00193453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102450253|NCT05614518|Methylene diphosphonate|methylene diphosphonate|mesh-list
102450254|NCT05614518|Listerine|listerine|mesh-list
102450255|NCT05614518|Fluorides|fluorides|mesh-list
102450256|NCT05614518|Sodium Fluoride|sodium fluoride|mesh-list
102450257|NCT05614518|Cariostatic Agents|cariostatic agents|mesh-ancestor
102450258|NCT05614518|Protective Agents|protective agents|mesh-ancestor
102450259|NCT05614518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450260|NCT05614518|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102450261|NCT05614518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102450262|NCT05614518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102450263|NCT00091507|Insulin|insulin|mesh-list
102450264|NCT00091507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102450265|NCT00091507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450266|NCT05611086|Acetylcysteine|acetylcysteine|mesh-list
102450267|NCT05611086|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102450268|NCT05611086|Antiviral Agents|antiviral agents|mesh-ancestor
102450269|NCT05611086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102450270|NCT05611086|Expectorants|expectorants|mesh-ancestor
102450271|NCT05611086|Respiratory System Agents|respiratory system agents|mesh-ancestor
102450272|NCT05611086|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102450273|NCT05611086|Antioxidants|antioxidants|mesh-ancestor
102450274|NCT05611086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450275|NCT05611086|Protective Agents|protective agents|mesh-ancestor
102450276|NCT05611086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450277|NCT05611086|Antidotes|antidotes|mesh-ancestor
102450278|NCT05614440|Tramadol|tramadol|mesh-list
102450279|NCT05614440|Anesthetics|anesthetics|mesh-list
102450280|NCT05614440|Anesthetics, Local|anesthetics, local|mesh-list
102450281|NCT05614440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102450282|NCT05614440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450283|NCT05614440|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102450284|NCT05614440|Narcotics|narcotics|mesh-ancestor
102450285|NCT05614440|Analgesics|analgesics|mesh-ancestor
102450286|NCT05614440|Sensory System Agents|sensory system agents|mesh-ancestor
102450287|NCT05614440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102450288|NCT05613192|Vitamin D|vitamin d|mesh-list
102450289|NCT05613192|Cholecalciferol|cholecalciferol|mesh-list
102450290|NCT05613192|Vitamins|vitamins|mesh-ancestor
102450291|NCT05613192|Micronutrients|micronutrients|mesh-ancestor
102450292|NCT05613192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450293|NCT05613192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102450294|NCT05613192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102450295|NCT00194779|Tamoxifen|tamoxifen|mesh-list
102450296|NCT00194779|Vinorelbine|vinorelbine|mesh-list
102450297|NCT00194779|Cyclophosphamide|cyclophosphamide|mesh-list
102450298|NCT00194779|Doxorubicin|doxorubicin|mesh-list
102450299|NCT00194779|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102450300|NCT00194779|Capecitabine|capecitabine|mesh-list
102450301|NCT00194779|Methotrexate|methotrexate|mesh-list
102450302|NCT00194779|Trastuzumab|trastuzumab|mesh-list
102450303|NCT00194779|Letrozole|letrozole|mesh-list
102450304|NCT00194779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102450305|NCT00194779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102450306|NCT00194779|Tubulin Modulators|tubulin modulators|mesh-ancestor
102450307|NCT00194779|Antimitotic Agents|antimitotic agents|mesh-ancestor
102450308|NCT00194779|Mitosis Modulators|mitosis modulators|mesh-ancestor
102450309|NCT00194779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450310|NCT00194779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102450311|NCT00194779|Immunologic Factors|immunologic factors|mesh-ancestor
102450312|NCT00194779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450313|NCT00194779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102450314|NCT00194779|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102450315|NCT00194779|Alkylating Agents|alkylating agents|mesh-ancestor
102450316|NCT00194779|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102450317|NCT00194779|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102450318|NCT00194779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102450319|NCT00194779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102450320|NCT00194779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102450321|NCT00194779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102450322|NCT00194779|Antimetabolites|antimetabolites|mesh-ancestor
102450323|NCT00194779|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102450324|NCT00194779|Abortifacient Agents|abortifacient agents|mesh-ancestor
102450325|NCT00194779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102450326|NCT00194779|Dermatologic Agents|dermatologic agents|mesh-ancestor
102450327|NCT00194779|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102450328|NCT00194779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102450329|NCT00194779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102450330|NCT00194779|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102450331|NCT00194779|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102450332|NCT00194779|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102450333|NCT00194779|Hormone Antagonists|hormone antagonists|mesh-ancestor
102450334|NCT00194779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102450335|NCT00194779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102450336|NCT00194779|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102450337|NCT00194779|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102450338|NCT00194779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102450339|NCT05474664|Camostat|camostat|mesh-list
102450340|NCT05474664|Protease Inhibitors|protease inhibitors|mesh-ancestor
102450341|NCT05474664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102450342|NCT05474664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450343|NCT05474664|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102450344|NCT05474664|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102450345|NCT02096575|Nitrous Oxide|nitrous oxide|mesh-list
102450346|NCT02096575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102450347|NCT02096575|Anesthetics, General|anesthetics, general|mesh-ancestor
102450348|NCT02096575|Anesthetics|anesthetics|mesh-ancestor
102450349|NCT02096575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102450350|NCT02096575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450351|NCT02096575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102450352|NCT02096575|Analgesics|analgesics|mesh-ancestor
102450353|NCT02096575|Sensory System Agents|sensory system agents|mesh-ancestor
102450354|NCT02096575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102450355|NCT04338984|Fentanyl|fentanyl|mesh-list
102450356|NCT04338984|Ropivacaine|ropivacaine|mesh-list
102450357|NCT04338984|Anesthetics|anesthetics|mesh-list
102450358|NCT04338984|Anesthetics, General|anesthetics, general|mesh-list
102450359|NCT04338984|Anesthetics, Local|anesthetics, local|mesh-ancestor
102450360|NCT04338984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102450361|NCT04338984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450362|NCT04338984|Sensory System Agents|sensory system agents|mesh-ancestor
102450363|NCT04338984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102450364|NCT04338984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102450365|NCT04338984|Narcotics|narcotics|mesh-ancestor
102450366|NCT04338984|Analgesics|analgesics|mesh-ancestor
102450367|NCT04338984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102450368|NCT04338984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102450369|NCT00095563|Lapatinib|lapatinib|mesh-list
102450370|NCT00095563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102450371|NCT00095563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102450372|NCT00095563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102450373|NCT00095563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450374|NCT05473806|Pioglitazone|pioglitazone|mesh-list
102450375|NCT05473806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102450376|NCT05473806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450377|NCT00089609|Thalidomide|thalidomide|mesh-list
102450378|NCT00089609|Prednisone|prednisone|mesh-list
102450379|NCT00089609|Bevacizumab|bevacizumab|mesh-list
102450380|NCT00089609|Docetaxel|docetaxel|mesh-list
102450381|NCT00089609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102450382|NCT00089609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102450383|NCT00089609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102450384|NCT00089609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102450385|NCT00089609|Growth Substances|growth substances|mesh-ancestor
102450386|NCT00089609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450387|NCT00089609|Growth Inhibitors|growth inhibitors|mesh-ancestor
102450388|NCT00089609|Tubulin Modulators|tubulin modulators|mesh-ancestor
102450389|NCT00089609|Antimitotic Agents|antimitotic agents|mesh-ancestor
102450390|NCT00089609|Mitosis Modulators|mitosis modulators|mesh-ancestor
102450391|NCT00089609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450392|NCT00089609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102450393|NCT00089609|Glucocorticoids|glucocorticoids|mesh-ancestor
102450394|NCT00089609|Hormones|hormones|mesh-ancestor
102450395|NCT00089609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102450396|NCT00089609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102450397|NCT00089609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102450398|NCT00089609|Immunologic Factors|immunologic factors|mesh-ancestor
102450399|NCT00089609|Leprostatic Agents|leprostatic agents|mesh-ancestor
102450400|NCT00089609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102450401|NCT00089609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102450402|NCT04661514|Psilocybin|psilocybin|mesh-list
102450403|NCT04661514|Hallucinogens|hallucinogens|mesh-ancestor
102450404|NCT04661514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450405|NCT04661514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102450406|NCT00195403|Etanercept|etanercept|mesh-list
102450407|NCT00195403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102450408|NCT00195403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102450409|NCT00195403|Analgesics|analgesics|mesh-ancestor
102450410|NCT00195403|Sensory System Agents|sensory system agents|mesh-ancestor
102450411|NCT00195403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102450412|NCT00195403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450413|NCT00195403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102450414|NCT00195403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102450415|NCT00195403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102450416|NCT00195403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102450417|NCT00195403|Immunologic Factors|immunologic factors|mesh-ancestor
102450418|NCT04643327|Levetiracetam|levetiracetam|mesh-list
102450419|NCT04643327|Anticonvulsants|anticonvulsants|mesh-ancestor
102450420|NCT04643327|Nootropic Agents|nootropic agents|mesh-ancestor
102450421|NCT00095875|Carboplatin|carboplatin|mesh-list
102450423|NCT00095875|Fluorouracil|fluorouracil|mesh-list
102450424|NCT00095875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102450425|NCT00095875|Tubulin Modulators|tubulin modulators|mesh-ancestor
102450426|NCT00095875|Antimitotic Agents|antimitotic agents|mesh-ancestor
102450427|NCT00095875|Mitosis Modulators|mitosis modulators|mesh-ancestor
102450428|NCT00095875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450429|NCT00095875|Antimetabolites|antimetabolites|mesh-ancestor
102450430|NCT00095875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102450431|NCT00095875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102450432|NCT00095875|Immunologic Factors|immunologic factors|mesh-ancestor
102450433|NCT00095875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450434|NCT03086993|Gemcitabine|gemcitabine|mesh-list
102450435|NCT03086993|Melphalan|melphalan|mesh-list
102450436|NCT03086993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102450437|NCT03086993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102450438|NCT03086993|Antimetabolites|antimetabolites|mesh-ancestor
102450439|NCT03086993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450440|NCT03086993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102450441|NCT03086993|Alkylating Agents|alkylating agents|mesh-ancestor
102450442|NCT03086993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102450443|NCT03086993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102450444|NCT03086993|Immunologic Factors|immunologic factors|mesh-ancestor
102450445|NCT03086993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450446|NCT04089072|Phenylephrine|phenylephrine|mesh-list
102450447|NCT04089072|Oxymetazoline|oxymetazoline|mesh-list
102450448|NCT04089072|Methylene Blue|methylene blue|mesh-list
102450449|NCT04089072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102450450|NCT04089072|Mydriatics|mydriatics|mesh-ancestor
102450451|NCT04089072|Autonomic Agents|autonomic agents|mesh-ancestor
102450452|NCT04089072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102450453|NCT04089072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450454|NCT04089072|Sympathomimetics|sympathomimetics|mesh-ancestor
102450455|NCT04089072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102450456|NCT04089072|Nasal Decongestants|nasal decongestants|mesh-ancestor
102450457|NCT04089072|Respiratory System Agents|respiratory system agents|mesh-ancestor
102450458|NCT04089072|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102450459|NCT04089072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102450460|NCT04089072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102450461|NCT04089072|Adrenergic Agents|adrenergic agents|mesh-ancestor
102450462|NCT04089072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102450463|NCT04089072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450464|NCT04089072|Protective Agents|protective agents|mesh-ancestor
102450465|NCT04089072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102450466|NCT00006227|Paclitaxel|paclitaxel|mesh-list
102450467|NCT00006227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102450468|NCT00006227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102450469|NCT00006227|Tubulin Modulators|tubulin modulators|mesh-ancestor
102450470|NCT00006227|Antimitotic Agents|antimitotic agents|mesh-ancestor
102450471|NCT00006227|Mitosis Modulators|mitosis modulators|mesh-ancestor
102450472|NCT00006227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450473|NCT00097669|Folic Acid|folic acid|mesh-list
102450474|NCT00097669|Hematinics|hematinics|mesh-ancestor
102450475|NCT00097669|Vitamin B Complex|vitamin b complex|mesh-ancestor
102450476|NCT00097669|Vitamins|vitamins|mesh-ancestor
102450477|NCT00097669|Micronutrients|micronutrients|mesh-ancestor
102450478|NCT00097669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450479|NCT05612880|Androgens|androgens|mesh-list
102450480|NCT05612880|Hormones|hormones|mesh-ancestor
102450481|NCT05612880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102450482|NCT05612880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450483|NCT00010439|Alendronate|alendronate|mesh-list
102450484|NCT00010439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102450485|NCT00010439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450486|NCT05468892|Trifluridine|trifluridine|mesh-list
102450487|NCT05468892|Panitumumab|panitumumab|mesh-list
102450488|NCT05468892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102450489|NCT05468892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102450490|NCT05468892|Antimetabolites|antimetabolites|mesh-ancestor
102450491|NCT05468892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450492|NCT05468892|Antiviral Agents|antiviral agents|mesh-ancestor
102450493|NCT05468892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102450494|NCT00200161|Temozolomide|temozolomide|mesh-list
102450495|NCT00200161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102080670|NCT03237780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080671|NCT03237780|Tubulin Modulators|tubulin modulators|mesh-ancestor
102080672|NCT03237780|Antimitotic Agents|antimitotic agents|mesh-ancestor
102080673|NCT03237780|Mitosis Modulators|mitosis modulators|mesh-ancestor
102080698|NCT03100786|Hormones|hormones|mesh-ancestor
102262101|NCT02398357|Nadroparin|nadroparin|mesh-list
102450496|NCT00200161|Alkylating Agents|alkylating agents|mesh-ancestor
102450497|NCT00200161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450498|NCT00200161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102450499|NCT00016913|Paclitaxel|paclitaxel|mesh-list
102450500|NCT00016913|Carboplatin|carboplatin|mesh-list
102450501|NCT00016913|Leuprolide|leuprolide|mesh-list
102450502|NCT00016913|Goserelin|goserelin|mesh-list
102450503|NCT00016913|Estramustine|estramustine|mesh-list
102450504|NCT00016913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102450505|NCT00016913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102450506|NCT00016913|Tubulin Modulators|tubulin modulators|mesh-ancestor
102450507|NCT00016913|Antimitotic Agents|antimitotic agents|mesh-ancestor
102450508|NCT00016913|Mitosis Modulators|mitosis modulators|mesh-ancestor
102450509|NCT00016913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450510|NCT00016913|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102450511|NCT00016913|Fertility Agents|fertility agents|mesh-ancestor
102450512|NCT00016913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102450513|NCT00016913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450514|NCT00016913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102450515|NCT00016913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102450516|NCT00016913|Alkylating Agents|alkylating agents|mesh-ancestor
102450517|NCT00023309|Lamivudine|lamivudine|mesh-list
102450518|NCT00023309|Adefovir|adefovir|mesh-list
102450519|NCT00023309|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
102450520|NCT00023309|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102450521|NCT00023309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102450522|NCT00023309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102450523|NCT00023309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450524|NCT00023309|Antiviral Agents|antiviral agents|mesh-ancestor
102450525|NCT00023309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102450526|NCT00023309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102450527|NCT00023309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102450528|NCT02233101|Tranexamic Acid|tranexamic acid|mesh-list
102450529|NCT02233101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102450530|NCT02233101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102450531|NCT02233101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450532|NCT02233101|Hemostatics|hemostatics|mesh-ancestor
102450533|NCT02233101|Coagulants|coagulants|mesh-ancestor
102450534|NCT00098059|Famciclovir|famciclovir|mesh-list
102450535|NCT00098059|Antiviral Agents|antiviral agents|mesh-ancestor
102450536|NCT00098059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102450537|NCT00098059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102450538|NCT00098059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102450539|NCT00098059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450540|NCT02440581|Alendronate|alendronate|mesh-list
102450541|NCT02440581|Teriparatide|teriparatide|mesh-list
102450542|NCT02440581|Cinacalcet|cinacalcet|mesh-list
102450543|NCT02440581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102450544|NCT02440581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450545|NCT02440581|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102450546|NCT02440581|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
102450547|NCT02440581|Hormone Antagonists|hormone antagonists|mesh-ancestor
102450548|NCT02440581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102450549|NCT01359150|Tofacitinib|tofacitinib|mesh-list
102450550|NCT01359150|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102450551|NCT01359150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102450552|NCT01359150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102450553|NCT01359150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450554|NCT00098371|Alvocidib|alvocidib|mesh-list
102450555|NCT00098371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102450556|NCT00098371|Growth Inhibitors|growth inhibitors|mesh-ancestor
102450557|NCT00098371|Growth Substances|growth substances|mesh-ancestor
102450558|NCT00098371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450559|NCT00098371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102450560|NCT00098371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102450561|NCT00098371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450562|NCT04745988|Leucovorin|leucovorin|mesh-list
102450563|NCT04745988|Docetaxel|docetaxel|mesh-list
102450564|NCT04745988|Pembrolizumab|pembrolizumab|mesh-list
102450565|NCT04745988|Fluorouracil|fluorouracil|mesh-list
102450566|NCT04745988|Oxaliplatin|oxaliplatin|mesh-list
102450567|NCT04745988|Lenvatinib|lenvatinib|mesh-list
102450568|NCT04745988|Levoleucovorin|levoleucovorin|mesh-list
102450569|NCT04745988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102450570|NCT04745988|Tubulin Modulators|tubulin modulators|mesh-ancestor
102450571|NCT04745988|Antimitotic Agents|antimitotic agents|mesh-ancestor
102450572|NCT04745988|Mitosis Modulators|mitosis modulators|mesh-ancestor
102262168|NCT02404363|Purinergic Agents|purinergic agents|mesh-ancestor
102450573|NCT04745988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450574|NCT04745988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102450575|NCT04745988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102450576|NCT04745988|Antimetabolites|antimetabolites|mesh-ancestor
102450577|NCT04745988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102450578|NCT04745988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102450579|NCT04745988|Immunologic Factors|immunologic factors|mesh-ancestor
102450580|NCT04745988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450581|NCT04745988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102450582|NCT04745988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102450583|NCT04745988|Antidotes|antidotes|mesh-ancestor
102450584|NCT04745988|Protective Agents|protective agents|mesh-ancestor
102450585|NCT04745988|Vitamin B Complex|vitamin b complex|mesh-ancestor
102450586|NCT04745988|Vitamins|vitamins|mesh-ancestor
102450587|NCT04745988|Micronutrients|micronutrients|mesh-ancestor
102450588|NCT01647945|Tacrolimus|tacrolimus|mesh-list
102450589|NCT01647945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102450590|NCT01647945|Immunologic Factors|immunologic factors|mesh-ancestor
102450591|NCT01647945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450592|NCT01647945|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102450593|NCT01647945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102450594|NCT01647945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450595|NCT00100165|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
102450596|NCT00100165|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102450597|NCT00100165|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102450598|NCT00100165|Cholinergic Agents|cholinergic agents|mesh-ancestor
102450599|NCT00100165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102450600|NCT00100165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450601|NCT00100165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450602|NCT04351191|Hydroxychloroquine|hydroxychloroquine|mesh-list
102450603|NCT04351191|Chloroquine|chloroquine|mesh-list
102450604|NCT04351191|Antimalarials|antimalarials|mesh-ancestor
102450605|NCT04351191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102450606|NCT04351191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102450607|NCT04351191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102450608|NCT04351191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102450609|NCT04351191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450610|NCT04351191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102450611|NCT04351191|Amebicides|amebicides|mesh-ancestor
102450612|NCT01469000|Pemetrexed|pemetrexed|mesh-list
102450613|NCT01469000|Gefitinib|gefitinib|mesh-list
102450614|NCT01469000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102450615|NCT01469000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102450616|NCT01469000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450617|NCT01469000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102450618|NCT01469000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102450619|NCT01469000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102450620|NCT05557578|Gemcitabine|gemcitabine|mesh-list
102450621|NCT05557578|Oxaliplatin|oxaliplatin|mesh-list
102450622|NCT05557578|Tislelizumab|tislelizumab|mesh-list
102450623|NCT05557578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102450624|NCT05557578|Antimetabolites|antimetabolites|mesh-ancestor
102450625|NCT05557578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450626|NCT05557578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102450627|NCT05557578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102450628|NCT00201877|Rituximab|rituximab|mesh-list
102450629|NCT00201877|Bortezomib|bortezomib|mesh-list
102450630|NCT00201877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102450631|NCT00201877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102450632|NCT00201877|Immunologic Factors|immunologic factors|mesh-ancestor
102450633|NCT00201877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450634|NCT00201877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102450635|NCT05399628|Pulmonary Surfactants|pulmonary surfactants|mesh-list
102450636|NCT05399628|Respiratory System Agents|respiratory system agents|mesh-ancestor
102450637|NCT01490060|Dexamethasone|dexamethasone|mesh-list
102450638|NCT01490060|Dexamethasone acetate|dexamethasone acetate|mesh-list
102450639|NCT01490060|Doxorubicin|doxorubicin|mesh-list
102450640|NCT01490060|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102450641|NCT01490060|Vincristine|vincristine|mesh-list
102450642|NCT01490060|Ifosfamide|ifosfamide|mesh-list
102450643|NCT01490060|Isophosphamide mustard|isophosphamide mustard|mesh-list
102450644|NCT01490060|Fosaprepitant|fosaprepitant|mesh-list
102450645|NCT01490060|Aprepitant|aprepitant|mesh-list
102450646|NCT01490060|BB 1101|bb 1101|mesh-list
102450647|NCT01490060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102450648|NCT01490060|Antiemetics|antiemetics|mesh-ancestor
102450649|NCT01490060|Autonomic Agents|autonomic agents|mesh-ancestor
102450650|NCT01490060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102450651|NCT01490060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450652|NCT01490060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102450653|NCT01490060|Glucocorticoids|glucocorticoids|mesh-ancestor
102450655|NCT01490060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102450656|NCT01490060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102450657|NCT01490060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102450658|NCT01490060|Protease Inhibitors|protease inhibitors|mesh-ancestor
102450659|NCT01490060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102450660|NCT01490060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450661|NCT01490060|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102450662|NCT01490060|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102450663|NCT01490060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102450664|NCT01490060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102450665|NCT01490060|Tubulin Modulators|tubulin modulators|mesh-ancestor
102450666|NCT01490060|Antimitotic Agents|antimitotic agents|mesh-ancestor
102450667|NCT01490060|Mitosis Modulators|mitosis modulators|mesh-ancestor
102450668|NCT01490060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102450669|NCT01490060|Alkylating Agents|alkylating agents|mesh-ancestor
102450670|NCT01490060|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102450671|NCT01490060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102450672|NCT04090736|Azacitidine|azacitidine|mesh-list
102450673|NCT04090736|Pevonedistat|pevonedistat|mesh-list
102450674|NCT04090736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102450675|NCT04090736|Antimetabolites|antimetabolites|mesh-ancestor
102450676|NCT04090736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450677|NCT04090736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102450678|NCT04090736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102450679|NCT05557344|Acetaminophen|acetaminophen|mesh-list
102450680|NCT05557344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102450681|NCT05557344|Analgesics|analgesics|mesh-ancestor
102450682|NCT05557344|Sensory System Agents|sensory system agents|mesh-ancestor
102450683|NCT05557344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102450684|NCT05557344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450685|NCT05557344|Antipyretics|antipyretics|mesh-ancestor
102450686|NCT00101413|Sorafenib|sorafenib|mesh-list
102450687|NCT00101413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102450688|NCT00101413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102450689|NCT00101413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102450690|NCT00101413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450691|NCT01246869|Deoxyglucose|deoxyglucose|mesh-list
102450692|NCT01246869|Imidazole|imidazole|mesh-list
102450693|NCT01246869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102450694|NCT01246869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450695|NCT01246869|Antimetabolites|antimetabolites|mesh-ancestor
102450696|NCT01246869|Antiviral Agents|antiviral agents|mesh-ancestor
102450697|NCT01246869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102450698|NCT01452152|Clopidogrel|clopidogrel|mesh-list
102450699|NCT01452152|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102450700|NCT01452152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102450701|NCT01452152|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102450702|NCT01452152|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102450703|NCT01452152|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102450704|NCT01452152|Purinergic Agents|purinergic agents|mesh-ancestor
102450705|NCT01452152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102450706|NCT01452152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450707|NCT01452152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450708|NCT01451762|Diphenhydramine|diphenhydramine|mesh-list
102450709|NCT01451762|Promethazine|promethazine|mesh-list
102450710|NCT01451762|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102450711|NCT01451762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102450712|NCT01451762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102450713|NCT01451762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450714|NCT01451762|Anesthetics, Local|anesthetics, local|mesh-ancestor
102450715|NCT01451762|Anesthetics|anesthetics|mesh-ancestor
102450716|NCT01451762|Sensory System Agents|sensory system agents|mesh-ancestor
102450717|NCT01451762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102450718|NCT01451762|Antiemetics|antiemetics|mesh-ancestor
102450719|NCT01451762|Autonomic Agents|autonomic agents|mesh-ancestor
102450720|NCT01451762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102450721|NCT01451762|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102450722|NCT01451762|Histamine Antagonists|histamine antagonists|mesh-ancestor
102450723|NCT01451762|Histamine Agents|histamine agents|mesh-ancestor
102450724|NCT01451762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102450725|NCT01451762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450726|NCT01451762|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102450727|NCT01451762|Antipruritics|antipruritics|mesh-ancestor
102450728|NCT01451762|Dermatologic Agents|dermatologic agents|mesh-ancestor
102450729|NCT01654107|Nicotine|nicotine|mesh-list
102450730|NCT01654107|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102450731|NCT01654107|Autonomic Agents|autonomic agents|mesh-ancestor
102450732|NCT01654107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102450733|NCT01654107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450734|NCT01654107|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102450735|NCT01654107|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102450736|NCT01654107|Cholinergic Agents|cholinergic agents|mesh-ancestor
102450737|NCT01654107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102450738|NCT01654107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450739|NCT03085680|Curcumin|curcumin|mesh-list
102450740|NCT03085680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102450741|NCT03085680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102450742|NCT03085680|Analgesics|analgesics|mesh-ancestor
102450743|NCT03085680|Sensory System Agents|sensory system agents|mesh-ancestor
102450744|NCT03085680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102450745|NCT03085680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450746|NCT03085680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102450747|NCT03085680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102450748|NCT03085680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102450749|NCT03085680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102450750|NCT03085680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450751|NCT01468844|Minocycline|minocycline|mesh-list
102450752|NCT01468844|Bevacizumab|bevacizumab|mesh-list
102450753|NCT01468844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102450754|NCT01468844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102450755|NCT01468844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102450756|NCT01468844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102450757|NCT01468844|Growth Substances|growth substances|mesh-ancestor
102450758|NCT01468844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450759|NCT01468844|Growth Inhibitors|growth inhibitors|mesh-ancestor
102450760|NCT01468844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102450761|NCT01468844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102450762|NCT03029598|Carboplatin|carboplatin|mesh-list
102450763|NCT03029598|Pembrolizumab|pembrolizumab|mesh-list
102450764|NCT03029598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102450765|NCT03029598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102450766|NCT03029598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102450767|NCT03029598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450768|NCT01451606|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102450769|NCT01451606|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102450770|NCT01451606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102450771|NCT01451606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102450772|NCT01451606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450773|NCT01451606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102450774|NCT01451606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450775|NCT01451606|Analgesics|analgesics|mesh-ancestor
102450776|NCT01451606|Sensory System Agents|sensory system agents|mesh-ancestor
102450777|NCT01451606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102450778|NCT01451606|Antidepressive Agents|antidepressive agents|mesh-ancestor
102450779|NCT01451606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102450780|NCT01451606|Dopamine Agents|dopamine agents|mesh-ancestor
102450781|NCT00204373|Lansoprazole|lansoprazole|mesh-list
102450782|NCT00204373|Dexlansoprazole|dexlansoprazole|mesh-list
102450783|NCT00204373|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102450784|NCT00204373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102450785|NCT00204373|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102450786|NCT00204373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102450787|NCT00204373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450788|NCT01655043|Regadenoson|regadenoson|mesh-list
102450789|NCT01655043|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
102450790|NCT01655043|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102450791|NCT01655043|Purinergic Agonists|purinergic agonists|mesh-ancestor
102450792|NCT01655043|Purinergic Agents|purinergic agents|mesh-ancestor
102450793|NCT01655043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102450794|NCT01655043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450795|NCT01655043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450796|NCT00473343|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
102450797|NCT00473343|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102450798|NCT00473343|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102450799|NCT00473343|Dermatologic Agents|dermatologic agents|mesh-ancestor
102450800|NCT00032591|Thrombin|thrombin|mesh-list
102450801|NCT00032591|Hemostatics|hemostatics|mesh-ancestor
102450802|NCT00032591|Coagulants|coagulants|mesh-ancestor
102450803|NCT01660191|Atorvastatin|atorvastatin|mesh-list
102450804|NCT01660191|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102450805|NCT01660191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102450806|NCT01660191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102450807|NCT01660191|Antimetabolites|antimetabolites|mesh-ancestor
102450808|NCT01660191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450809|NCT01660191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102450810|NCT01660191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102450811|NCT01660191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102450812|NCT00033917|Indomethacin|indomethacin|mesh-list
102450813|NCT00033917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102450814|NCT00033917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102450815|NCT00033917|Analgesics|analgesics|mesh-ancestor
102450816|NCT00033917|Sensory System Agents|sensory system agents|mesh-ancestor
102450817|NCT00033917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102450818|NCT00033917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450819|NCT00033917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102450820|NCT00033917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102450821|NCT00033917|Gout Suppressants|gout suppressants|mesh-ancestor
102450822|NCT00033917|Tocolytic Agents|tocolytic agents|mesh-ancestor
102450823|NCT00033917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102450824|NCT00033917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102450825|NCT00033917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102450826|NCT00033917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450827|NCT00036569|Interferons|interferons|mesh-list
102450828|NCT00036569|Interferon-alpha|interferon-alpha|mesh-list
102450829|NCT00036569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102450830|NCT00036569|Antiviral Agents|antiviral agents|mesh-ancestor
102450831|NCT00036569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102450832|NCT00036569|Immunologic Factors|immunologic factors|mesh-ancestor
102450833|NCT00036569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450834|NCT01660893|Phenylephrine|phenylephrine|mesh-list
102450835|NCT01660893|Oxymetazoline|oxymetazoline|mesh-list
102450836|NCT01660893|Tetracaine|tetracaine|mesh-list
102450837|NCT01660893|Anesthetics, Local|anesthetics, local|mesh-ancestor
102450838|NCT01660893|Anesthetics|anesthetics|mesh-ancestor
102450839|NCT01660893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102450840|NCT01660893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450841|NCT01660893|Sensory System Agents|sensory system agents|mesh-ancestor
102450842|NCT01660893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102450843|NCT01660893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102450844|NCT01660893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102450845|NCT01660893|Adrenergic Agents|adrenergic agents|mesh-ancestor
102450846|NCT01660893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102450847|NCT01660893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450848|NCT01660893|Sympathomimetics|sympathomimetics|mesh-ancestor
102450849|NCT01660893|Autonomic Agents|autonomic agents|mesh-ancestor
102450850|NCT01660893|Nasal Decongestants|nasal decongestants|mesh-ancestor
102450851|NCT01660893|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102450852|NCT01660893|Respiratory System Agents|respiratory system agents|mesh-ancestor
102450853|NCT01660893|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102450854|NCT01660893|Mydriatics|mydriatics|mesh-ancestor
102450855|NCT01660893|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102450856|NCT01660893|Protective Agents|protective agents|mesh-ancestor
102450857|NCT01661283|Bevacizumab|bevacizumab|mesh-list
102450858|NCT01661283|Everolimus|everolimus|mesh-list
102450859|NCT01661283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102450860|NCT01661283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102450861|NCT01661283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102450862|NCT01661283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102450863|NCT01661283|Growth Substances|growth substances|mesh-ancestor
102450864|NCT01661283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450865|NCT01661283|Growth Inhibitors|growth inhibitors|mesh-ancestor
102450866|NCT01661283|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102450867|NCT01661283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102450868|NCT01661283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102450869|NCT01661283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450870|NCT01661283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102450871|NCT01661283|Immunologic Factors|immunologic factors|mesh-ancestor
102450872|NCT01946373|Cyclophosphamide|cyclophosphamide|mesh-list
102450873|NCT01946373|Fludarabine|fludarabine|mesh-list
102450874|NCT01946373|Fludarabine phosphate|fludarabine phosphate|mesh-list
102450875|NCT01946373|Interleukin-2|interleukin-2|mesh-list
102450876|NCT01946373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102450877|NCT01946373|Immunologic Factors|immunologic factors|mesh-ancestor
102450878|NCT01946373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450879|NCT01946373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102450880|NCT01946373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102450881|NCT01946373|Alkylating Agents|alkylating agents|mesh-ancestor
102450882|NCT01946373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450883|NCT01946373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102450884|NCT01946373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102450885|NCT01946373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102450886|NCT01946373|Antimetabolites|antimetabolites|mesh-ancestor
102450887|NCT01946373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102450888|NCT01946373|Analgesics|analgesics|mesh-ancestor
102450889|NCT01946373|Sensory System Agents|sensory system agents|mesh-ancestor
102450890|NCT01946373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102450891|NCT01662297|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102450892|NCT01662297|Trazodone|trazodone|mesh-list
102450893|NCT01662297|Antidepressive Agents|antidepressive agents|mesh-ancestor
102450894|NCT01662297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102450895|NCT01662297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102450896|NCT01662297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102450897|NCT01662297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102450898|NCT01662297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450899|NCT01662297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102450900|NCT01662297|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102450901|NCT01662297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102450902|NCT01662297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102450903|NCT01662297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450904|NCT01662297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102450905|NCT01662297|Serotonin Agents|serotonin agents|mesh-ancestor
102450906|NCT01662297|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102450907|NCT01600287|Propofol|propofol|mesh-list
102450908|NCT01600287|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102450909|NCT01600287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102450910|NCT01600287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450911|NCT01600287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102450912|NCT01600287|Anesthetics, General|anesthetics, general|mesh-ancestor
102450913|NCT01600287|Anesthetics|anesthetics|mesh-ancestor
102450914|NCT00040937|Thalidomide|thalidomide|mesh-list
102450915|NCT00040937|Dexamethasone|dexamethasone|mesh-list
102450916|NCT00040937|Prednisone|prednisone|mesh-list
102450917|NCT00040937|Cyclophosphamide|cyclophosphamide|mesh-list
102450918|NCT00040937|Melphalan|melphalan|mesh-list
102450919|NCT00040937|Sargramostim|sargramostim|mesh-list
102450920|NCT00040937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102450921|NCT00040937|Immunologic Factors|immunologic factors|mesh-ancestor
102450922|NCT00040937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450923|NCT00040937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102450924|NCT00040937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102450925|NCT00040937|Alkylating Agents|alkylating agents|mesh-ancestor
102450926|NCT00040937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450927|NCT00040937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102450928|NCT00040937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102450929|NCT00040937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102450930|NCT00040937|Antiemetics|antiemetics|mesh-ancestor
102450931|NCT00040937|Autonomic Agents|autonomic agents|mesh-ancestor
102450932|NCT00040937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102450933|NCT00040937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102450934|NCT00040937|Glucocorticoids|glucocorticoids|mesh-ancestor
102450935|NCT00040937|Hormones|hormones|mesh-ancestor
102450936|NCT00040937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102450937|NCT00040937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102450938|NCT00040937|Leprostatic Agents|leprostatic agents|mesh-ancestor
102450939|NCT00040937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102450940|NCT00040937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102450941|NCT00040937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102450942|NCT00040937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102450943|NCT00040937|Growth Substances|growth substances|mesh-ancestor
102450944|NCT00040937|Growth Inhibitors|growth inhibitors|mesh-ancestor
102450945|NCT04756895|Vancomycin|vancomycin|mesh-list
102450946|NCT04756895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102450947|NCT04756895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102262536|NCT03863483|Mitosis Modulators|mitosis modulators|mesh-ancestor
102450948|NCT02234115|Leuprolide|leuprolide|mesh-list
102450949|NCT02234115|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102450950|NCT02234115|Fertility Agents|fertility agents|mesh-ancestor
102450951|NCT02234115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102450952|NCT02234115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450953|NCT02234115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102450954|NCT02234115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102450955|NCT02234427|Aspirin|aspirin|mesh-list
102450956|NCT02234427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102450957|NCT02234427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102450958|NCT02234427|Analgesics|analgesics|mesh-ancestor
102450959|NCT02234427|Sensory System Agents|sensory system agents|mesh-ancestor
102450960|NCT02234427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102450961|NCT02234427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450962|NCT02234427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102450963|NCT02234427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102450964|NCT02234427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102450965|NCT02234427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102450966|NCT02234427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450967|NCT02234427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102450968|NCT02234427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102450969|NCT02234427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102450970|NCT02234427|Antipyretics|antipyretics|mesh-ancestor
102450971|NCT00041717|4-Aminopyridine|4-aminopyridine|mesh-list
102450972|NCT00041717|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102450973|NCT00041717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102450974|NCT00041717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450975|NCT01663935|Levodopa|levodopa|mesh-list
102450976|NCT01663935|Carbidopa|carbidopa|mesh-list
102450977|NCT01663935|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102450978|NCT01663935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102450979|NCT01663935|Dopamine Agents|dopamine agents|mesh-ancestor
102450980|NCT01663935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102450981|NCT01663935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450982|NCT01663935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450983|NCT01663935|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102450984|NCT01663935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102450985|NCT01664559|Ketorolac|ketorolac|mesh-list
102450986|NCT01664559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102450987|NCT01664559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102450988|NCT01664559|Analgesics|analgesics|mesh-ancestor
102450989|NCT01664559|Sensory System Agents|sensory system agents|mesh-ancestor
102450990|NCT01664559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102450991|NCT01664559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102450992|NCT01664559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102450993|NCT01664559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102450994|NCT01664559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102450995|NCT01664559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102450996|NCT01664559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102450997|NCT00046475|Midodrine|midodrine|mesh-list
102450998|NCT00046475|Sympathomimetics|sympathomimetics|mesh-ancestor
102450999|NCT00046475|Autonomic Agents|autonomic agents|mesh-ancestor
102451000|NCT00046475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102451001|NCT00046475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451002|NCT00046475|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102451003|NCT00046475|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102451004|NCT00046475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102451005|NCT00046475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102451006|NCT00046475|Adrenergic Agents|adrenergic agents|mesh-ancestor
102451007|NCT00046475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102451008|NCT00046475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451009|NCT01894685|Mesalamine|mesalamine|mesh-list
102451010|NCT01894685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102451011|NCT01894685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102451012|NCT01894685|Analgesics|analgesics|mesh-ancestor
102451013|NCT01894685|Sensory System Agents|sensory system agents|mesh-ancestor
102451014|NCT01894685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102451015|NCT01894685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451016|NCT01894685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102451017|NCT01894685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102451018|NCT01695291|Minocycline|minocycline|mesh-list
102451019|NCT01695291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102451020|NCT01695291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102451021|NCT00048737|Cyclophosphamide|cyclophosphamide|mesh-list
102451022|NCT00048737|Rituximab|rituximab|mesh-list
102451023|NCT00048737|Fludarabine|fludarabine|mesh-list
102451024|NCT00048737|Fludarabine phosphate|fludarabine phosphate|mesh-list
102451025|NCT00048737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102451026|NCT00048737|Immunologic Factors|immunologic factors|mesh-ancestor
102451027|NCT00048737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451028|NCT00048737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102451029|NCT00048737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102451030|NCT00048737|Alkylating Agents|alkylating agents|mesh-ancestor
102451031|NCT00048737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451032|NCT00048737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102451033|NCT00048737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102451034|NCT00048737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102081158|NCT03581734|Vaccines|vaccines|mesh-list
102451035|NCT00048737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102451036|NCT00048737|Antimetabolites|antimetabolites|mesh-ancestor
102451037|NCT01604109|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
102451039|NCT01604109|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102451040|NCT01604109|Serotonin Agents|serotonin agents|mesh-ancestor
102451041|NCT01604109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102451042|NCT01604109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451043|NCT01604109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451044|NCT01604109|Chelating Agents|chelating agents|mesh-ancestor
102451045|NCT01604109|Sequestering Agents|sequestering agents|mesh-ancestor
102451046|NCT01666197|Diclofenac|diclofenac|mesh-list
102451047|NCT01666197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102451048|NCT01666197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102451049|NCT01666197|Analgesics|analgesics|mesh-ancestor
102451050|NCT01666197|Sensory System Agents|sensory system agents|mesh-ancestor
102451051|NCT01666197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102451052|NCT01666197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451053|NCT01666197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102451054|NCT01666197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102451055|NCT01666197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102451056|NCT01666197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102451057|NCT01666197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451058|NCT01697709|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102451059|NCT01697709|Antidepressive Agents|antidepressive agents|mesh-ancestor
102451060|NCT01697709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102451061|NCT01697709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102451062|NCT01697709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102451063|NCT01697709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102451064|NCT01697709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451065|NCT00048815|Citalopram|citalopram|mesh-list
102451066|NCT00048815|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102451067|NCT00048815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102451068|NCT00048815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102451069|NCT00048815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451070|NCT00048815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102451071|NCT00048815|Serotonin Agents|serotonin agents|mesh-ancestor
102451072|NCT00048815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451073|NCT00048815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102451074|NCT00048815|Antidepressive Agents|antidepressive agents|mesh-ancestor
102451075|NCT00048815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102451076|NCT01605903|Acetaminophen|acetaminophen|mesh-list
102451077|NCT01605903|Ibuprofen|ibuprofen|mesh-list
102451078|NCT01605903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102451079|NCT01605903|Analgesics|analgesics|mesh-ancestor
102451080|NCT01605903|Sensory System Agents|sensory system agents|mesh-ancestor
102451081|NCT01605903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102451082|NCT01605903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451083|NCT01605903|Antipyretics|antipyretics|mesh-ancestor
102451084|NCT01605903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102451085|NCT01605903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102451086|NCT01605903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102451087|NCT01605903|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102451088|NCT01605903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102451089|NCT01605903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451090|NCT00048893|Metronidazole|metronidazole|mesh-list
102451091|NCT00048893|Paclitaxel|paclitaxel|mesh-list
102451092|NCT00048893|Cyclophosphamide|cyclophosphamide|mesh-list
102451093|NCT00048893|Doxorubicin|doxorubicin|mesh-list
102451094|NCT00048893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102451095|NCT00048893|Fludarabine|fludarabine|mesh-list
102451096|NCT00048893|Fludarabine phosphate|fludarabine phosphate|mesh-list
102451097|NCT00048893|Vaccines|vaccines|mesh-list
102451098|NCT00048893|Sargramostim|sargramostim|mesh-list
102451099|NCT00048893|Immunologic Factors|immunologic factors|mesh-ancestor
102451100|NCT00048893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451101|NCT00048893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102451102|NCT00048893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102451103|NCT00048893|Tubulin Modulators|tubulin modulators|mesh-ancestor
102451104|NCT00048893|Antimitotic Agents|antimitotic agents|mesh-ancestor
102451105|NCT00048893|Mitosis Modulators|mitosis modulators|mesh-ancestor
102451106|NCT00048893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451107|NCT00048893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102451108|NCT00048893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102451109|NCT00048893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102451110|NCT00048893|Alkylating Agents|alkylating agents|mesh-ancestor
102451111|NCT00048893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102451112|NCT00048893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102451113|NCT00048893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102451114|NCT00048893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102451115|NCT00048893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102451116|NCT00048893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102451117|NCT00048893|Antimetabolites|antimetabolites|mesh-ancestor
102451118|NCT00048893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102451119|NCT00048893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102451120|NCT00048893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102451121|NCT00048893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102451122|NCT01607853|Calcitriol|calcitriol|mesh-list
102451123|NCT01607853|Betamethasone|betamethasone|mesh-list
102451124|NCT01607853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102451125|NCT01607853|Glucocorticoids|glucocorticoids|mesh-ancestor
102451126|NCT01607853|Hormones|hormones|mesh-ancestor
102451127|NCT01607853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102451128|NCT01607853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451129|NCT01607853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102451130|NCT01607853|Respiratory System Agents|respiratory system agents|mesh-ancestor
102451131|NCT01607853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102451132|NCT01607853|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102451133|NCT01607853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102451134|NCT01607853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451135|NCT01607853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102451136|NCT01607853|Vitamins|vitamins|mesh-ancestor
102451137|NCT01607853|Micronutrients|micronutrients|mesh-ancestor
102451138|NCT01607853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102451139|NCT03089723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102451140|NCT01700517|Anesthetics|anesthetics|mesh-list
102451141|NCT01700517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102451142|NCT01700517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451143|NCT00101647|Dasatinib|dasatinib|mesh-list
102451144|NCT00101647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102451145|NCT00101647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102451146|NCT00101647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102451147|NCT00101647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451148|NCT01669785|Listerine|listerine|mesh-list
102451149|NCT01669785|Fluorides|fluorides|mesh-list
102451150|NCT01669785|Sodium Fluoride|sodium fluoride|mesh-list
102451151|NCT01669785|Cariostatic Agents|cariostatic agents|mesh-ancestor
102451152|NCT01669785|Protective Agents|protective agents|mesh-ancestor
102451153|NCT01669785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451154|NCT01669785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102451155|NCT01669785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102451156|NCT05327491|Sotorasib|sotorasib|mesh-list
102451157|NCT05327491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102451158|NCT05327491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451159|NCT05327491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102451160|NCT05327491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102451161|NCT03089645|Docetaxel|docetaxel|mesh-list
102451162|NCT03089645|Durvalumab|durvalumab|mesh-list
102451163|NCT03089645|Tremelimumab|tremelimumab|mesh-list
102451164|NCT03089645|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102451165|NCT03089645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102451166|NCT03089645|Tubulin Modulators|tubulin modulators|mesh-ancestor
102451167|NCT03089645|Antimitotic Agents|antimitotic agents|mesh-ancestor
102451168|NCT03089645|Mitosis Modulators|mitosis modulators|mesh-ancestor
102451169|NCT03089645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451170|NCT03089645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102451171|NCT03089645|Immunologic Factors|immunologic factors|mesh-ancestor
102451172|NCT03089645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451174|NCT02587962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102451175|NCT02587962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102451176|NCT02587962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102451177|NCT02587962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451178|NCT01931033|Oxytocin|oxytocin|mesh-list
102451179|NCT01931033|Oxytocics|oxytocics|mesh-ancestor
102451180|NCT01931033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102451181|NCT01931033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451182|NCT01671423|Prednisone|prednisone|mesh-list
102451183|NCT01671423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102451184|NCT01671423|Glucocorticoids|glucocorticoids|mesh-ancestor
102451185|NCT01671423|Hormones|hormones|mesh-ancestor
102451186|NCT01671423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102451187|NCT01671423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451188|NCT01671423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102451189|NCT01671423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102451190|NCT02092181|Mirabegron|mirabegron|mesh-list
102451191|NCT02092181|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102451192|NCT02092181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102451193|NCT02092181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102451194|NCT02092181|Adrenergic Agents|adrenergic agents|mesh-ancestor
102451195|NCT02092181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102451196|NCT02092181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451197|NCT02092181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451198|NCT02092181|Urological Agents|urological agents|mesh-ancestor
102451199|NCT01672827|Flutemetamol|flutemetamol|mesh-list
102451200|NCT01672827|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102451201|NCT01672827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451202|NCT01700907|Sevoflurane|sevoflurane|mesh-list
102451203|NCT01700907|Desflurane|desflurane|mesh-list
102451204|NCT01700907|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102451205|NCT01700907|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102451206|NCT01700907|Anesthetics, General|anesthetics, general|mesh-ancestor
102451207|NCT01700907|Anesthetics|anesthetics|mesh-ancestor
102451208|NCT01700907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102451209|NCT01700907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451210|NCT03089567|Listerine|listerine|mesh-list
102451211|NCT03089567|Fluorides|fluorides|mesh-list
102451212|NCT03089567|Sodium Fluoride|sodium fluoride|mesh-list
102451213|NCT03089567|Cariostatic Agents|cariostatic agents|mesh-ancestor
102451214|NCT03089567|Protective Agents|protective agents|mesh-ancestor
102451215|NCT03089567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451216|NCT03089567|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102451217|NCT03089567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102451218|NCT03431987|Ethanol|ethanol|mesh-list
102451219|NCT03431987|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102451220|NCT03431987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102451221|NCT03431987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102451222|NCT03431987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451223|NCT01612221|Acetylcysteine|acetylcysteine|mesh-list
102451224|NCT01612221|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102451225|NCT01612221|Antiviral Agents|antiviral agents|mesh-ancestor
102451226|NCT01612221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102451227|NCT01612221|Expectorants|expectorants|mesh-ancestor
102451228|NCT01612221|Respiratory System Agents|respiratory system agents|mesh-ancestor
102451229|NCT01612221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102451230|NCT01612221|Antioxidants|antioxidants|mesh-ancestor
102451231|NCT01612221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451232|NCT01612221|Protective Agents|protective agents|mesh-ancestor
102451233|NCT01612221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451234|NCT01612221|Antidotes|antidotes|mesh-ancestor
102451235|NCT00105001|Mycophenolic Acid|mycophenolic acid|mesh-list
102451236|NCT00105001|Sirolimus|sirolimus|mesh-list
102451237|NCT00105001|Fludarabine|fludarabine|mesh-list
102451238|NCT00105001|Fludarabine phosphate|fludarabine phosphate|mesh-list
102451239|NCT00105001|Tacrolimus|tacrolimus|mesh-list
102451240|NCT00105001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102451241|NCT00105001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102451242|NCT00105001|Antimetabolites|antimetabolites|mesh-ancestor
102451243|NCT00105001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451244|NCT00105001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102451245|NCT00105001|Immunologic Factors|immunologic factors|mesh-ancestor
102451246|NCT00105001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262837|NCT04735822|Belumosudil|belumosudil|mesh-list
102451247|NCT00105001|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102451248|NCT00105001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102451249|NCT00105001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102451250|NCT00105001|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102451251|NCT00105001|Antitubercular Agents|antitubercular agents|mesh-ancestor
102451252|NCT00105001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102451253|NCT00105001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102451254|NCT00105001|Antifungal Agents|antifungal agents|mesh-ancestor
102451255|NCT02642640|Melatonin|melatonin|mesh-list
102451256|NCT02642640|Antioxidants|antioxidants|mesh-ancestor
102451257|NCT02642640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451258|NCT02642640|Protective Agents|protective agents|mesh-ancestor
102451259|NCT02642640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451260|NCT02642640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102451261|NCT01701375|Palbociclib|palbociclib|mesh-list
102451262|NCT01701375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102451263|NCT01701375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102451264|NCT01701375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102451265|NCT01701375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451266|NCT05556408|Propofol|propofol|mesh-list
102451267|NCT05556408|Succinylcholine|succinylcholine|mesh-list
102451268|NCT05556408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102451269|NCT05556408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102451270|NCT05556408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451271|NCT05556408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102451272|NCT05556408|Anesthetics, General|anesthetics, general|mesh-ancestor
102451273|NCT05556408|Anesthetics|anesthetics|mesh-ancestor
102451274|NCT05556408|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
102451275|NCT05556408|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102451276|NCT05556408|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102451277|NCT05556408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102451278|NCT00054353|Cyclosporine|cyclosporine|mesh-list
102451279|NCT00054353|Mycophenolic Acid|mycophenolic acid|mesh-list
102451280|NCT00054353|Fludarabine|fludarabine|mesh-list
102451281|NCT00054353|Fludarabine phosphate|fludarabine phosphate|mesh-list
102451282|NCT00054353|Melphalan|melphalan|mesh-list
102451283|NCT00054353|Cyclosporins|cyclosporins|mesh-list
102451284|NCT00054353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102451285|NCT00054353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102451286|NCT00054353|Antimetabolites|antimetabolites|mesh-ancestor
102451287|NCT00054353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451288|NCT00054353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102451289|NCT00054353|Immunologic Factors|immunologic factors|mesh-ancestor
102451290|NCT00054353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451291|NCT00054353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102451292|NCT00054353|Antifungal Agents|antifungal agents|mesh-ancestor
102451293|NCT00054353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102451294|NCT00054353|Dermatologic Agents|dermatologic agents|mesh-ancestor
102451295|NCT00054353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102451296|NCT00054353|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102451297|NCT00054353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102451298|NCT00054353|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102451299|NCT00054353|Antitubercular Agents|antitubercular agents|mesh-ancestor
102451300|NCT00054353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102451301|NCT00054353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102451302|NCT00054353|Alkylating Agents|alkylating agents|mesh-ancestor
102451303|NCT00054353|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102451304|NCT00208975|Cyclophosphamide|cyclophosphamide|mesh-list
102451305|NCT00208975|Rituximab|rituximab|mesh-list
102451306|NCT00208975|Fludarabine|fludarabine|mesh-list
102451307|NCT00208975|Mitoxantrone|mitoxantrone|mesh-list
102451308|NCT00208975|Sargramostim|sargramostim|mesh-list
102451309|NCT00208975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102451310|NCT00208975|Immunologic Factors|immunologic factors|mesh-ancestor
102451311|NCT00208975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451312|NCT00208975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102451313|NCT00208975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102451314|NCT00208975|Alkylating Agents|alkylating agents|mesh-ancestor
102451315|NCT00208975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451316|NCT00208975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102451317|NCT00208975|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102451318|NCT00208975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102451319|NCT00208975|Analgesics|analgesics|mesh-ancestor
102451320|NCT00208975|Sensory System Agents|sensory system agents|mesh-ancestor
102451321|NCT00208975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102451322|NCT00208975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102451323|NCT00208975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102451324|NCT00208975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102451325|NCT01702233|Dexamethasone|dexamethasone|mesh-list
102451326|NCT01702233|Dexamethasone acetate|dexamethasone acetate|mesh-list
102451327|NCT01702233|BB 1101|bb 1101|mesh-list
102451328|NCT01702233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102451329|NCT01702233|Antiemetics|antiemetics|mesh-ancestor
102451330|NCT01702233|Autonomic Agents|autonomic agents|mesh-ancestor
102451331|NCT01702233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102451332|NCT01702233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451333|NCT01702233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102451334|NCT01702233|Glucocorticoids|glucocorticoids|mesh-ancestor
102451335|NCT01702233|Hormones|hormones|mesh-ancestor
102451336|NCT01702233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102451337|NCT01702233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102451338|NCT01702233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102451339|NCT01702233|Protease Inhibitors|protease inhibitors|mesh-ancestor
102451340|NCT01702233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102451341|NCT01702233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451342|NCT01852890|Ascorbic Acid|ascorbic acid|mesh-list
102451343|NCT01852890|Gemcitabine|gemcitabine|mesh-list
102451344|NCT01852890|Vitamins|vitamins|mesh-ancestor
102451345|NCT01852890|Micronutrients|micronutrients|mesh-ancestor
102451346|NCT01852890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451347|NCT01852890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102451348|NCT01852890|Antimetabolites|antimetabolites|mesh-ancestor
102451349|NCT01852890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451350|NCT01852890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102451351|NCT01852890|Antioxidants|antioxidants|mesh-ancestor
102451352|NCT01852890|Protective Agents|protective agents|mesh-ancestor
102451353|NCT05555628|Salicylic Acid|salicylic acid|mesh-list
102451354|NCT05555628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102451355|NCT05555628|Antifungal Agents|antifungal agents|mesh-ancestor
102451356|NCT05555628|Keratolytic Agents|keratolytic agents|mesh-ancestor
102451357|NCT05555628|Dermatologic Agents|dermatologic agents|mesh-ancestor
102451358|NCT00217399|Sorafenib|sorafenib|mesh-list
102451359|NCT00217399|Anastrozole|anastrozole|mesh-list
102451360|NCT00217399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102451361|NCT00217399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102451362|NCT00217399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102451363|NCT00217399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451364|NCT00217399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102451365|NCT00217399|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102451366|NCT00217399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102451367|NCT00217399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102451368|NCT00217399|Hormone Antagonists|hormone antagonists|mesh-ancestor
102451369|NCT00217399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102451370|NCT00217399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451371|NCT04739670|Bevacizumab|bevacizumab|mesh-list
102451372|NCT04739670|Atezolizumab|atezolizumab|mesh-list
102451373|NCT04739670|Carboplatin|carboplatin|mesh-list
102451374|NCT04739670|Gemcitabine|gemcitabine|mesh-list
102451375|NCT04739670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102451376|NCT04739670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102451377|NCT04739670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102451378|NCT04739670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102451379|NCT04739670|Growth Substances|growth substances|mesh-ancestor
102451380|NCT04739670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451381|NCT04739670|Growth Inhibitors|growth inhibitors|mesh-ancestor
102451382|NCT04739670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102451383|NCT04739670|Antimetabolites|antimetabolites|mesh-ancestor
102451384|NCT04739670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451385|NCT04739670|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102451386|NCT05286619|Carboplatin|carboplatin|mesh-list
102451387|NCT05286619|Gemcitabine|gemcitabine|mesh-list
102451388|NCT05286619|Pembrolizumab|pembrolizumab|mesh-list
102451389|NCT05286619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102451390|NCT05286619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102451391|NCT05286619|Antimetabolites|antimetabolites|mesh-ancestor
102451392|NCT05286619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451393|NCT05286619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102451394|NCT05286619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102451395|NCT04329624|Simendan|simendan|mesh-list
102451396|NCT04329624|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102451397|NCT04329624|Vasodilator Agents|vasodilator agents|mesh-ancestor
102451398|NCT04329624|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102262986|NCT02893241|Theodrenaline|theodrenaline|mesh-list
102451399|NCT04329624|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102451400|NCT04329624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102451401|NCT04329624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451402|NCT04329624|Protective Agents|protective agents|mesh-ancestor
102451403|NCT04329624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451404|NCT00559182|Omeprazole|omeprazole|mesh-list
102451405|NCT00559182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102451406|NCT00559182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102451407|NCT00559182|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102451408|NCT00559182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102451409|NCT00559182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451410|NCT00218023|Naltrexone|naltrexone|mesh-list
102451411|NCT00218023|Levodopa|levodopa|mesh-list
102451412|NCT00218023|Carbidopa|carbidopa|mesh-list
102451413|NCT00218023|Modafinil|modafinil|mesh-list
102451414|NCT00218023|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102451415|NCT00218023|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102451416|NCT00218023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451417|NCT00218023|Sensory System Agents|sensory system agents|mesh-ancestor
102451418|NCT00218023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102451419|NCT00218023|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102451420|NCT00218023|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102451421|NCT00218023|Dopamine Agents|dopamine agents|mesh-ancestor
102451422|NCT00218023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102451423|NCT00218023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451424|NCT00218023|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102451425|NCT00218023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102451426|NCT00218023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102451427|NCT00218023|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102451428|NCT00218023|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102451429|NCT00218023|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102451430|NCT00054665|Prednisone|prednisone|mesh-list
102451431|NCT00054665|Cyclophosphamide|cyclophosphamide|mesh-list
102451432|NCT00054665|Doxorubicin|doxorubicin|mesh-list
102451433|NCT00054665|Etoposide|etoposide|mesh-list
102451434|NCT00054665|Vincristine|vincristine|mesh-list
102451435|NCT00054665|Bortezomib|bortezomib|mesh-list
102451436|NCT00054665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102451437|NCT00054665|Immunologic Factors|immunologic factors|mesh-ancestor
102451438|NCT00054665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451439|NCT00054665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102451440|NCT00054665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102451441|NCT00054665|Alkylating Agents|alkylating agents|mesh-ancestor
102451442|NCT00054665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451443|NCT00054665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102451444|NCT00054665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102451445|NCT00054665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102451446|NCT00054665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102451447|NCT00054665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102451448|NCT00054665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102451449|NCT00054665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102451450|NCT00054665|Glucocorticoids|glucocorticoids|mesh-ancestor
102451451|NCT00054665|Hormones|hormones|mesh-ancestor
102451452|NCT00054665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102451453|NCT00054665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102451454|NCT00054665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102451455|NCT00054665|Tubulin Modulators|tubulin modulators|mesh-ancestor
102451456|NCT00054665|Antimitotic Agents|antimitotic agents|mesh-ancestor
102451457|NCT00054665|Mitosis Modulators|mitosis modulators|mesh-ancestor
102451458|NCT00476190|Cytarabine|cytarabine|mesh-list
102451459|NCT00476190|Dexamethasone|dexamethasone|mesh-list
102451460|NCT00476190|Hydrocortisone|hydrocortisone|mesh-list
102451461|NCT00476190|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102451462|NCT00476190|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102451463|NCT00476190|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102451464|NCT00476190|Cyclophosphamide|cyclophosphamide|mesh-list
102451465|NCT00476190|Doxorubicin|doxorubicin|mesh-list
102451466|NCT00476190|Methotrexate|methotrexate|mesh-list
102451467|NCT00476190|Etoposide|etoposide|mesh-list
102451468|NCT00476190|Vincristine|vincristine|mesh-list
102451469|NCT00476190|Asparaginase|asparaginase|mesh-list
102451470|NCT00476190|Pegaspargase|pegaspargase|mesh-list
102451471|NCT00476190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102451472|NCT00476190|Immunologic Factors|immunologic factors|mesh-ancestor
102451473|NCT00476190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451474|NCT00476190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102451475|NCT00476190|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102451476|NCT00476190|Alkylating Agents|alkylating agents|mesh-ancestor
102451477|NCT00476190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451478|NCT00476190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102451479|NCT00476190|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102451480|NCT00476190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102451481|NCT00476190|Antiemetics|antiemetics|mesh-ancestor
102451482|NCT00476190|Autonomic Agents|autonomic agents|mesh-ancestor
102451483|NCT00476190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102451484|NCT00476190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102451485|NCT00476190|Glucocorticoids|glucocorticoids|mesh-ancestor
102451487|NCT00476190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102451488|NCT00476190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102451489|NCT00476190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102451490|NCT00476190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102451491|NCT00476190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102451492|NCT00476190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102451493|NCT00476190|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102451494|NCT00476190|Abortifacient Agents|abortifacient agents|mesh-ancestor
102451495|NCT00476190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102451496|NCT00476190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102451497|NCT00476190|Antimetabolites|antimetabolites|mesh-ancestor
102451498|NCT00476190|Dermatologic Agents|dermatologic agents|mesh-ancestor
102451499|NCT00476190|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102451500|NCT00476190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102451501|NCT00476190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102451502|NCT00476190|Antiviral Agents|antiviral agents|mesh-ancestor
102451503|NCT00476190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102451504|NCT00476190|Tubulin Modulators|tubulin modulators|mesh-ancestor
102451505|NCT00476190|Antimitotic Agents|antimitotic agents|mesh-ancestor
102451506|NCT00476190|Mitosis Modulators|mitosis modulators|mesh-ancestor
102451507|NCT00057551|Antidepressive Agents|antidepressive agents|mesh-list
102451508|NCT00057551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102451509|NCT05555316|Lenvatinib|lenvatinib|mesh-list
102451510|NCT05555316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102451511|NCT05555316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102451512|NCT05555316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102081615|NCT04463966|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102451513|NCT05555316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451514|NCT00218491|Acetylcysteine|acetylcysteine|mesh-list
102451515|NCT00218491|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102451516|NCT00218491|Antiviral Agents|antiviral agents|mesh-ancestor
102451517|NCT00218491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102451518|NCT00218491|Expectorants|expectorants|mesh-ancestor
102451519|NCT00218491|Respiratory System Agents|respiratory system agents|mesh-ancestor
102451520|NCT00218491|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102451521|NCT00218491|Antioxidants|antioxidants|mesh-ancestor
102451522|NCT00218491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451523|NCT00218491|Protective Agents|protective agents|mesh-ancestor
102451524|NCT00218491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451525|NCT00218491|Antidotes|antidotes|mesh-ancestor
102451526|NCT05700864|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102451527|NCT05700864|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102451528|NCT00221299|Risedronic Acid|risedronic acid|mesh-list
102451529|NCT00221299|Hormones|hormones|mesh-list
102451530|NCT00221299|Parathyroid Hormone|parathyroid hormone|mesh-list
102451531|NCT00221299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102451532|NCT00221299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451533|NCT00221299|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102451534|NCT00221299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102451535|NCT00221299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451536|NCT00221299|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102451537|NCT00221299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102451538|NCT05554848|Magnesium Sulfate|magnesium sulfate|mesh-list
102451539|NCT05554848|Dexmedetomidine|dexmedetomidine|mesh-list
102451540|NCT05554848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102451541|NCT05554848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102451542|NCT05554848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451543|NCT05554848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102451544|NCT05554848|Analgesics|analgesics|mesh-ancestor
102451545|NCT05554848|Sensory System Agents|sensory system agents|mesh-ancestor
102451546|NCT05554848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102451547|NCT05554848|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102154229|NCT01595061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102451548|NCT05554848|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102451550|NCT05554848|Adrenergic Agents|adrenergic agents|mesh-ancestor
102451551|NCT05554848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102451552|NCT05554848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451553|NCT05554848|Anesthetics|anesthetics|mesh-ancestor
102451554|NCT05554848|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102451555|NCT05554848|Anticonvulsants|anticonvulsants|mesh-ancestor
102451556|NCT05554848|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102451557|NCT05554848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102451558|NCT05554848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102451559|NCT05554848|Tocolytic Agents|tocolytic agents|mesh-ancestor
102451560|NCT05554848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102451561|NCT00057785|Fluorouracil|fluorouracil|mesh-list
102451562|NCT00057785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102451563|NCT00057785|Antimetabolites|antimetabolites|mesh-ancestor
102451564|NCT00057785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451565|NCT00057785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102451566|NCT00057785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102451567|NCT00057785|Immunologic Factors|immunologic factors|mesh-ancestor
102451568|NCT00057785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451569|NCT05554224|Liver Extracts|liver extracts|mesh-list
102451570|NCT05554224|Hematinics|hematinics|mesh-ancestor
102451571|NCT05548998|Anesthetics|anesthetics|mesh-list
102451572|NCT05548998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102451573|NCT05548998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451574|NCT01666782|Vaccines|vaccines|mesh-list
102451575|NCT01666782|Immunologic Factors|immunologic factors|mesh-ancestor
102451576|NCT01666782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451577|NCT00058019|Epothilones|epothilones|mesh-list
102451578|NCT00058019|Epothilone B|epothilone b|mesh-list
102451579|NCT00058019|Tubulin Modulators|tubulin modulators|mesh-ancestor
102451580|NCT00058019|Antimitotic Agents|antimitotic agents|mesh-ancestor
102451581|NCT00058019|Mitosis Modulators|mitosis modulators|mesh-ancestor
102451582|NCT00058019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451583|NCT00058019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102451584|NCT01439360|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102451585|NCT01439360|Immunologic Factors|immunologic factors|mesh-ancestor
102451586|NCT01439360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451587|NCT00110461|Aripiprazole|aripiprazole|mesh-list
102451588|NCT00110461|Antidepressive Agents|antidepressive agents|mesh-ancestor
102451589|NCT00110461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102451590|NCT00110461|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102451591|NCT00110461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102451592|NCT00110461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102451593|NCT00110461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451594|NCT00110461|Dopamine Agonists|dopamine agonists|mesh-ancestor
102451595|NCT00110461|Dopamine Agents|dopamine agents|mesh-ancestor
102451596|NCT00110461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102451597|NCT00110461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451598|NCT00110461|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102451599|NCT00110461|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102451600|NCT00110461|Serotonin Agents|serotonin agents|mesh-ancestor
102451601|NCT00110461|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102451602|NCT00110461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102451603|NCT00110461|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102451604|NCT00110461|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102451605|NCT00061373|Aspirin|aspirin|mesh-list
102451606|NCT00061373|Tinzaparin|tinzaparin|mesh-list
102451607|NCT00061373|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102451608|NCT00061373|Dalteparin|dalteparin|mesh-list
102451609|NCT00061373|Eptifibatide|eptifibatide|mesh-list
102451610|NCT00061373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102451611|NCT00061373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102451612|NCT00061373|Analgesics|analgesics|mesh-ancestor
102451613|NCT00061373|Sensory System Agents|sensory system agents|mesh-ancestor
102451614|NCT00061373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102451615|NCT00061373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451616|NCT00061373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102451617|NCT00061373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102451618|NCT00061373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102451619|NCT00061373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102451620|NCT00061373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451621|NCT00061373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102451622|NCT00061373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102451623|NCT00061373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102451624|NCT00061373|Antipyretics|antipyretics|mesh-ancestor
102451625|NCT00061373|Anticoagulants|anticoagulants|mesh-ancestor
102451626|NCT01897337|Aprepitant|aprepitant|mesh-list
102451627|NCT01897337|Antiemetics|antiemetics|mesh-ancestor
102451628|NCT01897337|Autonomic Agents|autonomic agents|mesh-ancestor
102451629|NCT01897337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102451630|NCT01897337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451631|NCT01897337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102451632|NCT01897337|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102451633|NCT01897337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102451634|NCT01897337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451635|NCT03089333|Dapagliflozin|dapagliflozin|mesh-list
102451636|NCT03089333|Glyburide|glyburide|mesh-list
102451637|NCT03089333|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102451638|NCT03089333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451639|NCT03089333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102451640|NCT03089333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451641|NCT00112723|Alvocidib|alvocidib|mesh-list
102451642|NCT00112723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102451643|NCT00112723|Growth Inhibitors|growth inhibitors|mesh-ancestor
102451644|NCT00112723|Growth Substances|growth substances|mesh-ancestor
102451645|NCT00112723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451646|NCT00112723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102451647|NCT00112723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102451648|NCT00112723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451649|NCT04327206|Vaccines|vaccines|mesh-list
102451650|NCT04327206|BCG Vaccine|bcg vaccine|mesh-list
102451651|NCT04327206|Immunologic Factors|immunologic factors|mesh-ancestor
102451652|NCT04327206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451653|NCT04327206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102451654|NCT05700006|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102451655|NCT05700006|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102451656|NCT05700006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102451657|NCT05700006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451658|NCT05700006|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102451659|NCT05700006|Hormone Antagonists|hormone antagonists|mesh-ancestor
102451660|NCT05700006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102451661|NCT05700006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451662|NCT00115297|Montelukast|montelukast|mesh-list
102451663|NCT00115297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102451664|NCT00115297|Respiratory System Agents|respiratory system agents|mesh-ancestor
102451665|NCT00115297|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102451666|NCT00115297|Hormone Antagonists|hormone antagonists|mesh-ancestor
102451667|NCT00115297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102451668|NCT00115297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451669|NCT00115297|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102451670|NCT00115297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102451671|NCT00115297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451672|NCT00116857|Sertraline|sertraline|mesh-list
102451673|NCT00116857|Antidepressive Agents|antidepressive agents|mesh-ancestor
102451674|NCT00116857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102451675|NCT00116857|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102451676|NCT00116857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102451677|NCT00116857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102451678|NCT00116857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451679|NCT00116857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102451680|NCT00116857|Serotonin Agents|serotonin agents|mesh-ancestor
102451681|NCT00116857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451682|NCT05547828|Tislelizumab|tislelizumab|mesh-list
102451683|NCT05547828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102451684|NCT05547828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102451685|NCT01672983|Ritonavir|ritonavir|mesh-list
102451686|NCT01672983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102451687|NCT01672983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102451688|NCT01672983|Protease Inhibitors|protease inhibitors|mesh-ancestor
102451689|NCT01672983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102451690|NCT01672983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451691|NCT01672983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102451692|NCT01672983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102451693|NCT01672983|Antiviral Agents|antiviral agents|mesh-ancestor
102154230|NCT01595061|Antimetabolites|antimetabolites|mesh-ancestor
102451695|NCT01672983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102451696|NCT01672983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102451697|NCT00117715|Dextromethorphan|dextromethorphan|mesh-list
102451698|NCT00117715|Caffeine|caffeine|mesh-list
102081817|NCT03098680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102451699|NCT00117715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102451700|NCT00117715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451701|NCT00117715|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102451702|NCT00117715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102451703|NCT00117715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451704|NCT00117715|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102451705|NCT00117715|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102451706|NCT00117715|Purinergic Agents|purinergic agents|mesh-ancestor
102451707|NCT00117715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102451708|NCT00117715|Antitussive Agents|antitussive agents|mesh-ancestor
102451709|NCT00117715|Respiratory System Agents|respiratory system agents|mesh-ancestor
102451710|NCT00117715|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102451711|NCT00117715|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102451712|NCT00228943|Tryptophan|tryptophan|mesh-list
102451713|NCT00228943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102451714|NCT00228943|Antidepressive Agents|antidepressive agents|mesh-ancestor
102451715|NCT00228943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102451716|NCT01879085|Gemcitabine|gemcitabine|mesh-list
102451717|NCT01879085|Docetaxel|docetaxel|mesh-list
102451718|NCT01879085|Vorinostat|vorinostat|mesh-list
102451719|NCT01879085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102451720|NCT01879085|Antimetabolites|antimetabolites|mesh-ancestor
102451721|NCT01879085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451722|NCT01879085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102451723|NCT01879085|Tubulin Modulators|tubulin modulators|mesh-ancestor
102451724|NCT01879085|Antimitotic Agents|antimitotic agents|mesh-ancestor
102451725|NCT01879085|Mitosis Modulators|mitosis modulators|mesh-ancestor
102451726|NCT01879085|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102451727|NCT01879085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102451728|NCT01439204|Abatacept|abatacept|mesh-list
102451729|NCT01439204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102451730|NCT01439204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451731|NCT01439204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102451732|NCT01439204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102451733|NCT01439204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102451734|NCT01439204|Immunologic Factors|immunologic factors|mesh-ancestor
102451735|NCT01439204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451736|NCT01439204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102451737|NCT00063635|Vitamin E|vitamin e|mesh-list
102451738|NCT00063635|Metformin|metformin|mesh-list
102451739|NCT00063635|Vitamins|vitamins|mesh-ancestor
102451740|NCT00063635|Micronutrients|micronutrients|mesh-ancestor
102451741|NCT00063635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451742|NCT00063635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102451743|NCT00063635|Antioxidants|antioxidants|mesh-ancestor
102451744|NCT00063635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451745|NCT00063635|Protective Agents|protective agents|mesh-ancestor
102451746|NCT01439126|Clonidine|clonidine|mesh-list
102451747|NCT01439126|Analgesics|analgesics|mesh-ancestor
102451748|NCT01439126|Sensory System Agents|sensory system agents|mesh-ancestor
102451749|NCT01439126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102451750|NCT01439126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451751|NCT01439126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102451752|NCT01439126|Sympatholytics|sympatholytics|mesh-ancestor
102451753|NCT01439126|Autonomic Agents|autonomic agents|mesh-ancestor
102451754|NCT01439126|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102451755|NCT01439126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102451756|NCT01439126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102451757|NCT01439126|Adrenergic Agents|adrenergic agents|mesh-ancestor
102451758|NCT01439126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102451759|NCT01439126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451760|NCT00066677|Docetaxel|docetaxel|mesh-list
102451761|NCT00066677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102451762|NCT00066677|Tubulin Modulators|tubulin modulators|mesh-ancestor
102451763|NCT00066677|Antimitotic Agents|antimitotic agents|mesh-ancestor
102451764|NCT00066677|Mitosis Modulators|mitosis modulators|mesh-ancestor
102451765|NCT00066677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451766|NCT01615731|Digoxin|digoxin|mesh-list
102451767|NCT01615731|Misoprostol|misoprostol|mesh-list
102451768|NCT01615731|Mifepristone|mifepristone|mesh-list
102451769|NCT01615731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102451770|NCT01615731|Abortifacient Agents|abortifacient agents|mesh-ancestor
102451771|NCT01615731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102451772|NCT01615731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451773|NCT01615731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102451774|NCT01615731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102451775|NCT01615731|Oxytocics|oxytocics|mesh-ancestor
102451776|NCT01615731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102451777|NCT01615731|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102451778|NCT01615731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102451779|NCT01615731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451780|NCT01615731|Protective Agents|protective agents|mesh-ancestor
102451781|NCT01615731|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102451782|NCT01615731|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102451783|NCT01615731|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102451784|NCT01615731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102451785|NCT01615731|Contraceptive Agents|contraceptive agents|mesh-ancestor
102451786|NCT01615731|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102451787|NCT01615731|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102451788|NCT01615731|Hormone Antagonists|hormone antagonists|mesh-ancestor
102451789|NCT01615731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102451790|NCT01615731|Luteolytic Agents|luteolytic agents|mesh-ancestor
102451791|NCT01615731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102451792|NCT01615731|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102451793|NCT02334800|Palbociclib|palbociclib|mesh-list
102451794|NCT02334800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102451795|NCT02334800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102451796|NCT02334800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102451797|NCT02334800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451798|NCT01665144|Siponimod|siponimod|mesh-list
102451799|NCT01665144|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102451800|NCT01665144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451801|NCT01665144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102451802|NCT01665144|Immunologic Factors|immunologic factors|mesh-ancestor
102451803|NCT01665144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451804|NCT01675635|Morphine|morphine|mesh-list
102451805|NCT01675635|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102451806|NCT01675635|Narcotics|narcotics|mesh-ancestor
102451807|NCT01675635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102451808|NCT01675635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451809|NCT01675635|Analgesics|analgesics|mesh-ancestor
102451810|NCT01675635|Sensory System Agents|sensory system agents|mesh-ancestor
102451811|NCT01675635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102451812|NCT01615809|Amphotericin B|amphotericin b|mesh-list
102451813|NCT01615809|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102451814|NCT01615809|Amebicides|amebicides|mesh-ancestor
102451815|NCT01615809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102451816|NCT01615809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102451817|NCT01615809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102451818|NCT01615809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102451819|NCT01615809|Antifungal Agents|antifungal agents|mesh-ancestor
102451820|NCT01676415|Mometasone Furoate|mometasone furoate|mesh-list
102451821|NCT01676415|Prednisone|prednisone|mesh-list
102451822|NCT01676415|Glucocorticoids|glucocorticoids|mesh-list
102451823|NCT01676415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102451824|NCT01676415|Hormones|hormones|mesh-ancestor
102451825|NCT01676415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102451826|NCT01676415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451827|NCT01676415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102451828|NCT01676415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102451829|NCT01676415|Dermatologic Agents|dermatologic agents|mesh-ancestor
102451830|NCT01676415|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102451831|NCT05547516|Gemcitabine|gemcitabine|mesh-list
102451832|NCT05547516|Epirubicin|epirubicin|mesh-list
102451833|NCT05547516|Mitomycins|mitomycins|mesh-list
102451834|NCT05547516|Mitomycin|mitomycin|mesh-list
102451835|NCT05547516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102451836|NCT05547516|Antimetabolites|antimetabolites|mesh-ancestor
102451837|NCT05547516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451838|NCT05547516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102451839|NCT05547516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102451840|NCT05547516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102451841|NCT05547516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102451842|NCT05547516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102451843|NCT05547516|Alkylating Agents|alkylating agents|mesh-ancestor
102451844|NCT05547516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102451845|NCT01678443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102451846|NCT01678443|Antibodies|antibodies|mesh-list
102451847|NCT01678443|Immunoglobulins|immunoglobulins|mesh-list
102451848|NCT01678443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102451849|NCT01678443|Immunologic Factors|immunologic factors|mesh-ancestor
102451850|NCT01678443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451851|NCT01678443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102451852|NCT01707225|Octreotide|octreotide|mesh-list
102451853|NCT01707225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102451854|NCT01707225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102451855|NCT01707225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102451856|NCT01707381|Timolol|timolol|mesh-list
102451857|NCT01707381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451858|NCT01707381|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102451859|NCT01707381|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102451860|NCT01707381|Adrenergic Agents|adrenergic agents|mesh-ancestor
102451861|NCT01707381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102451862|NCT01707381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451863|NCT01707381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102451864|NCT01707381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102451865|NCT05552586|Melatonin|melatonin|mesh-list
102451866|NCT05552586|Antioxidants|antioxidants|mesh-ancestor
102451867|NCT05552586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451868|NCT05552586|Protective Agents|protective agents|mesh-ancestor
102451869|NCT05552586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451870|NCT05552586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102451871|NCT00069329|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102451872|NCT00069329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102451873|NCT00072449|Rituximab|rituximab|mesh-list
102451874|NCT00072449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102451875|NCT00072449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102451876|NCT00072449|Immunologic Factors|immunologic factors|mesh-ancestor
102451877|NCT00072449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451878|NCT00072449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102451879|NCT04756661|Misoprostol|misoprostol|mesh-list
102451880|NCT04756661|Oxytocin|oxytocin|mesh-list
102451881|NCT04756661|Carbetocin|carbetocin|mesh-list
102451882|NCT04756661|Oxytocics|oxytocics|mesh-ancestor
102451883|NCT04756661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102451884|NCT04756661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451885|NCT04756661|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102451886|NCT04756661|Abortifacient Agents|abortifacient agents|mesh-ancestor
102451887|NCT04756661|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102451888|NCT04756661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102451889|NCT01708629|Ustekinumab|ustekinumab|mesh-list
102451890|NCT01708629|Brodalumab|brodalumab|mesh-list
102451891|NCT01708629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102451892|NCT01708629|Dermatologic Agents|dermatologic agents|mesh-ancestor
102451893|NCT01708629|Immunologic Factors|immunologic factors|mesh-ancestor
102451894|NCT01708629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451895|NCT00073073|Vitamin D|vitamin d|mesh-list
102451896|NCT00073073|Exemestane|exemestane|mesh-list
102451897|NCT00073073|Calcium Carbonate|calcium carbonate|mesh-list
102451898|NCT00073073|Calcium|calcium|mesh-list
102451899|NCT00073073|Vitamins|vitamins|mesh-ancestor
102451900|NCT00073073|Micronutrients|micronutrients|mesh-ancestor
102451901|NCT00073073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451902|NCT00073073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102451903|NCT00073073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102451904|NCT00073073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102451905|NCT00073073|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102451906|NCT00073073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102451907|NCT00073073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102451908|NCT00073073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451909|NCT00073073|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102451910|NCT00073073|Hormone Antagonists|hormone antagonists|mesh-ancestor
102451911|NCT00073073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102451912|NCT00073073|Antacids|antacids|mesh-ancestor
102451913|NCT00073073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102451914|NCT01466660|Gefitinib|gefitinib|mesh-list
102451915|NCT01466660|Afatinib|afatinib|mesh-list
102451916|NCT01466660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102082021|NCT05046262|Calcium|calcium|mesh-list
102451917|NCT01466660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102451918|NCT01466660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102451919|NCT01466660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263521|NCT04210349|Vaccines|vaccines|mesh-list
102451920|NCT00075335|Plerixafor|plerixafor|mesh-list
102451921|NCT00075335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102451922|NCT00075335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102451923|NCT00075335|Antiviral Agents|antiviral agents|mesh-ancestor
102451924|NCT00075335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102451925|NCT01680549|Gabapentin|gabapentin|mesh-list
102451926|NCT01680549|Analgesics|analgesics|mesh-ancestor
102451927|NCT01680549|Sensory System Agents|sensory system agents|mesh-ancestor
102451928|NCT01680549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102451929|NCT01680549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451930|NCT01680549|Anticonvulsants|anticonvulsants|mesh-ancestor
102451931|NCT01680549|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102451932|NCT01680549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102451933|NCT01680549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102451934|NCT01680549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102451935|NCT01680549|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102451936|NCT01680549|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102451937|NCT01680549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102451938|NCT01680549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451939|NCT01680549|Antimanic Agents|antimanic agents|mesh-ancestor
102451940|NCT01466348|Acetaminophen|acetaminophen|mesh-list
102451941|NCT01466348|Caffeine|caffeine|mesh-list
102451942|NCT01466348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102451943|NCT01466348|Analgesics|analgesics|mesh-ancestor
102451944|NCT01466348|Sensory System Agents|sensory system agents|mesh-ancestor
102451945|NCT01466348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102451946|NCT01466348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451947|NCT01466348|Antipyretics|antipyretics|mesh-ancestor
102451948|NCT01466348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102451949|NCT01466348|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102451950|NCT01466348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102451951|NCT01466348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451952|NCT01466348|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102451953|NCT01466348|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102451954|NCT01466348|Purinergic Agents|purinergic agents|mesh-ancestor
102451955|NCT01466348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102451956|NCT01466270|Donepezil|donepezil|mesh-list
102451957|NCT01466270|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102451958|NCT01466270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102451959|NCT01466270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451960|NCT01466270|Cholinergic Agents|cholinergic agents|mesh-ancestor
102451961|NCT01466270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102451962|NCT01466270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451963|NCT01466270|Nootropic Agents|nootropic agents|mesh-ancestor
102451964|NCT02235987|Octreotide|octreotide|mesh-list
102451965|NCT02235987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102451966|NCT02235987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102451967|NCT02235987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102451968|NCT01466192|Ribavirin|ribavirin|mesh-list
102451969|NCT01466192|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102451970|NCT01466192|Antimetabolites|antimetabolites|mesh-ancestor
102451971|NCT01466192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451972|NCT01466192|Antiviral Agents|antiviral agents|mesh-ancestor
102451973|NCT01466192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102451974|NCT00120523|Pimecrolimus|pimecrolimus|mesh-list
102451975|NCT00120523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102451976|NCT00120523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102451977|NCT00120523|Analgesics|analgesics|mesh-ancestor
102451978|NCT00120523|Sensory System Agents|sensory system agents|mesh-ancestor
102451979|NCT00120523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102451980|NCT00120523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451981|NCT00120523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102451982|NCT00120523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102451983|NCT00120523|Dermatologic Agents|dermatologic agents|mesh-ancestor
102451984|NCT00120523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102451985|NCT00120523|Immunologic Factors|immunologic factors|mesh-ancestor
102451986|NCT00120523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102451987|NCT00120523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102451988|NCT00120523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102451989|NCT01438814|Metformin|metformin|mesh-list
102451990|NCT01438814|Linagliptin|linagliptin|mesh-list
102451991|NCT01438814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102451992|NCT01438814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102451993|NCT01438814|Incretins|incretins|mesh-ancestor
102451994|NCT01438814|Hormones|hormones|mesh-ancestor
102451995|NCT01438814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102451996|NCT01438814|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102451997|NCT01438814|Protease Inhibitors|protease inhibitors|mesh-ancestor
102451998|NCT01438814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102451999|NCT01438814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452001|NCT04425876|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102452002|NCT04425876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102452003|NCT04425876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452004|NCT04425876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102452005|NCT01681095|Tryptophan|tryptophan|mesh-list
102452006|NCT01681095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102452007|NCT01681095|Antidepressive Agents|antidepressive agents|mesh-ancestor
102452008|NCT01681095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102452009|NCT00121225|Vorinostat|vorinostat|mesh-list
102452010|NCT00121225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102452011|NCT00121225|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102452012|NCT00121225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102452013|NCT00121225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452014|NCT05134987|Insulin Detemir|insulin detemir|mesh-list
102452015|NCT05134987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102452016|NCT05134987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452017|NCT05545800|Insulin|insulin|mesh-list
102452018|NCT05545800|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102452019|NCT05545800|Metformin|metformin|mesh-list
102452020|NCT05545800|Insulin Glargine|insulin glargine|mesh-list
102452021|NCT05545800|Empagliflozin|empagliflozin|mesh-list
102452022|NCT05545800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102452023|NCT05545800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452024|NCT05545800|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102452025|NCT05545800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452026|NCT00230737|Melatonin|melatonin|mesh-list
102452027|NCT00230737|Antioxidants|antioxidants|mesh-ancestor
102452028|NCT00230737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452029|NCT00230737|Protective Agents|protective agents|mesh-ancestor
102452030|NCT00230737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452031|NCT00230737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102452032|NCT04425564|Capecitabine|capecitabine|mesh-list
102452033|NCT04425564|Oxaliplatin|oxaliplatin|mesh-list
102452034|NCT04425564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102452035|NCT04425564|Antimetabolites|antimetabolites|mesh-ancestor
102452036|NCT04425564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452037|NCT04425564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102452038|NCT01686165|Rituximab|rituximab|mesh-list
102452039|NCT01686165|Belinostat|belinostat|mesh-list
102452040|NCT01686165|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102452041|NCT01686165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102452042|NCT01686165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102452043|NCT01686165|Immunologic Factors|immunologic factors|mesh-ancestor
102452044|NCT01686165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452045|NCT01686165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102452046|NCT01686165|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102452047|NCT01686165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102452048|NCT01686165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452049|NCT00123643|Rosiglitazone|rosiglitazone|mesh-list
102452050|NCT00123643|Glyburide|glyburide|mesh-list
102452051|NCT00123643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102452052|NCT00123643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452053|NCT00235573|Vitamin B 12|vitamin b 12|mesh-list
102452054|NCT00235573|Hydroxocobalamin|hydroxocobalamin|mesh-list
102452055|NCT00235573|Vitamins|vitamins|mesh-ancestor
102452056|NCT00235573|Micronutrients|micronutrients|mesh-ancestor
102452057|NCT00235573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452058|NCT00235573|Vitamin B Complex|vitamin b complex|mesh-ancestor
102452059|NCT00235573|Hematinics|hematinics|mesh-ancestor
102452060|NCT01687179|Sirolimus|sirolimus|mesh-list
102452061|NCT01687179|Hydroxychloroquine|hydroxychloroquine|mesh-list
102452062|NCT01687179|Temsirolimus|temsirolimus|mesh-list
102452063|NCT01687179|MTOR Inhibitors|mtor inhibitors|mesh-list
102452064|NCT01687179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102452065|NCT01687179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102452066|NCT01687179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102452067|NCT01687179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102452068|NCT01687179|Antifungal Agents|antifungal agents|mesh-ancestor
102452069|NCT01687179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102452070|NCT01687179|Immunologic Factors|immunologic factors|mesh-ancestor
102452071|NCT01687179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452072|NCT01687179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102452074|NCT01687179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452075|NCT01687179|Antimalarials|antimalarials|mesh-ancestor
102452076|NCT01687179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102452077|NCT01687179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102452078|NCT01687179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102452079|NCT00124579|Thalidomide|thalidomide|mesh-list
102452080|NCT00124579|Dexamethasone|dexamethasone|mesh-list
102452081|NCT00124579|Bortezomib|bortezomib|mesh-list
102452082|NCT00124579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102452083|NCT00124579|Antiemetics|antiemetics|mesh-ancestor
102452084|NCT00124579|Autonomic Agents|autonomic agents|mesh-ancestor
102452085|NCT00124579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102452086|NCT00124579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452087|NCT00124579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102452088|NCT00124579|Glucocorticoids|glucocorticoids|mesh-ancestor
102452089|NCT00124579|Hormones|hormones|mesh-ancestor
102452090|NCT00124579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102452091|NCT00124579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102452092|NCT00124579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102452093|NCT00124579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102452094|NCT00124579|Immunologic Factors|immunologic factors|mesh-ancestor
102452095|NCT00124579|Leprostatic Agents|leprostatic agents|mesh-ancestor
102452096|NCT00124579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102452097|NCT00124579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102452098|NCT00124579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102452099|NCT00124579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102452100|NCT00124579|Growth Substances|growth substances|mesh-ancestor
102452101|NCT00124579|Growth Inhibitors|growth inhibitors|mesh-ancestor
102452102|NCT05550090|Immunomodulating Agents|immunomodulating agents|mesh-list
102452103|NCT05550090|Immunologic Factors|immunologic factors|mesh-ancestor
102452104|NCT05550090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452105|NCT00124735|Rocuronium|rocuronium|mesh-list
102452106|NCT00124735|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102452107|NCT00124735|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102452108|NCT00124735|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102452109|NCT00124735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102452110|NCT00124735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452111|NCT05340309|Atezolizumab|atezolizumab|mesh-list
102452112|NCT05340309|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102452113|NCT05340309|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102452114|NCT05340309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452115|NCT05340309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102452116|NCT05340309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102452117|NCT05340309|Immunologic Factors|immunologic factors|mesh-ancestor
102452118|NCT05340309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452119|NCT00125515|Naltrexone|naltrexone|mesh-list
102452120|NCT00125515|Memantine|memantine|mesh-list
102452121|NCT00125515|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102452122|NCT00125515|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102452123|NCT00125515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452124|NCT00125515|Sensory System Agents|sensory system agents|mesh-ancestor
102452125|NCT00125515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102452126|NCT00125515|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102452127|NCT00125515|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102452128|NCT00125515|Dopamine Agents|dopamine agents|mesh-ancestor
102452129|NCT00125515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102452130|NCT00125515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452131|NCT00125515|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102452132|NCT00125515|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102452133|NCT00125593|Simvastatin|simvastatin|mesh-list
102452134|NCT00125593|Ezetimibe|ezetimibe|mesh-list
102452135|NCT00125593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102452136|NCT00125593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102452137|NCT00125593|Antimetabolites|antimetabolites|mesh-ancestor
102082236|NCT03497702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102452138|NCT00125593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452139|NCT00125593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102452140|NCT00125593|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102452141|NCT00125593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102452142|NCT01689441|Calcitriol|calcitriol|mesh-list
102452143|NCT01689441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102452144|NCT01689441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452145|NCT01689441|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102452146|NCT01689441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102452147|NCT01689441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452148|NCT01689441|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102452149|NCT01689441|Vitamins|vitamins|mesh-ancestor
102452150|NCT01689441|Micronutrients|micronutrients|mesh-ancestor
102452151|NCT01689441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102452152|NCT00236977|Iron|iron|mesh-list
102452153|NCT00236977|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102452154|NCT00236977|Trace Elements|trace elements|mesh-ancestor
102452155|NCT00236977|Micronutrients|micronutrients|mesh-ancestor
102452156|NCT00236977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452157|NCT00236977|Hematinics|hematinics|mesh-ancestor
102452158|NCT04753177|Paclitaxel|paclitaxel|mesh-list
102452159|NCT04753177|Cyclophosphamide|cyclophosphamide|mesh-list
102452160|NCT04753177|Doxorubicin|doxorubicin|mesh-list
102452161|NCT04753177|Fulvestrant|fulvestrant|mesh-list
102452162|NCT04753177|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102452163|NCT04753177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102452164|NCT04753177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102452165|NCT04753177|Tubulin Modulators|tubulin modulators|mesh-ancestor
102452166|NCT04753177|Antimitotic Agents|antimitotic agents|mesh-ancestor
102452167|NCT04753177|Mitosis Modulators|mitosis modulators|mesh-ancestor
102452168|NCT04753177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452169|NCT04753177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102452170|NCT04753177|Immunologic Factors|immunologic factors|mesh-ancestor
102452171|NCT04753177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452172|NCT04753177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102452173|NCT04753177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102452174|NCT04753177|Alkylating Agents|alkylating agents|mesh-ancestor
102452175|NCT04753177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102452176|NCT04753177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102452177|NCT04753177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102452178|NCT04753177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102452179|NCT04753177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102452180|NCT04753177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102452181|NCT04753177|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102452182|NCT04753177|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102452183|NCT04753177|Hormone Antagonists|hormone antagonists|mesh-ancestor
102452184|NCT04753177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102452185|NCT04753177|Luteolytic Agents|luteolytic agents|mesh-ancestor
102452186|NCT04753177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102452187|NCT04753177|Contraceptive Agents|contraceptive agents|mesh-ancestor
102452188|NCT04753177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102452189|NCT04753177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102452190|NCT01691313|Vanoxerine|vanoxerine|mesh-list
102452191|NCT01691313|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102452192|NCT01691313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102452193|NCT01691313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102452194|NCT01691313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452195|NCT01691313|Dopamine Agents|dopamine agents|mesh-ancestor
102452196|NCT01691313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102452197|NCT01691313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452198|NCT00079001|Vitamin D|vitamin d|mesh-list
102452199|NCT00079001|Zoledronic Acid|zoledronic acid|mesh-list
102452200|NCT00079001|Calcium|calcium|mesh-list
102452201|NCT00079001|Androgens|androgens|mesh-list
102452202|NCT00079001|Vitamins|vitamins|mesh-ancestor
102452203|NCT00079001|Micronutrients|micronutrients|mesh-ancestor
102452204|NCT00079001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452205|NCT00079001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102452206|NCT00079001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102452207|NCT00079001|Hormones|hormones|mesh-ancestor
102452208|NCT00079001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102452209|NCT05234307|Nivolumab|nivolumab|mesh-list
102452210|NCT05234307|Adenosine|adenosine|mesh-list
102452211|NCT05234307|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-list
102452212|NCT05234307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102452213|NCT05234307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102452214|NCT05234307|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102452215|NCT05234307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452216|NCT05234307|Analgesics|analgesics|mesh-ancestor
102452217|NCT05234307|Sensory System Agents|sensory system agents|mesh-ancestor
102452218|NCT05234307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102452219|NCT05234307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452220|NCT05234307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102452221|NCT05234307|Vasodilator Agents|vasodilator agents|mesh-ancestor
102452222|NCT05234307|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102452223|NCT05234307|Purinergic Agonists|purinergic agonists|mesh-ancestor
102452224|NCT05234307|Purinergic Agents|purinergic agents|mesh-ancestor
102452225|NCT05234307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102452226|NCT05234307|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102452227|NCT05234307|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102452228|NCT00238615|Carboplatin|carboplatin|mesh-list
102452229|NCT00238615|Docetaxel|docetaxel|mesh-list
102452230|NCT00238615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102452231|NCT00238615|Tubulin Modulators|tubulin modulators|mesh-ancestor
102452232|NCT00238615|Antimitotic Agents|antimitotic agents|mesh-ancestor
102452233|NCT00238615|Mitosis Modulators|mitosis modulators|mesh-ancestor
102452234|NCT00238615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452235|NCT02243943|Neostigmine|neostigmine|mesh-list
102452236|NCT02243943|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102452237|NCT02243943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102452238|NCT02243943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452239|NCT02243943|Cholinergic Agents|cholinergic agents|mesh-ancestor
102452240|NCT02243943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102452241|NCT02243943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452242|NCT02243943|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102452243|NCT02243943|Autonomic Agents|autonomic agents|mesh-ancestor
102452244|NCT02243943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102452245|NCT03088631|Metformin|metformin|mesh-list
102452246|NCT03088631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102452247|NCT03088631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452248|NCT00131677|Tenofovir|tenofovir|mesh-list
102452249|NCT00131677|Antiviral Agents|antiviral agents|mesh-ancestor
102452250|NCT00131677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102452251|NCT00131677|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102452252|NCT00131677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102452253|NCT00131677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102452254|NCT00131677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452255|NCT00131677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102452256|NCT00131677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102452257|NCT00240487|Nitric Oxide|nitric oxide|mesh-list
102452258|NCT00240487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102452259|NCT00240487|Autonomic Agents|autonomic agents|mesh-ancestor
102452260|NCT00240487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102452261|NCT00240487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452262|NCT00240487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102082371|NCT02318810|Rocuronium|rocuronium|mesh-list
102452263|NCT00240487|Respiratory System Agents|respiratory system agents|mesh-ancestor
102452264|NCT00240487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102452265|NCT00240487|Antioxidants|antioxidants|mesh-ancestor
102452266|NCT00240487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452267|NCT00240487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102452268|NCT00240487|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102452269|NCT00240487|Vasodilator Agents|vasodilator agents|mesh-ancestor
102452270|NCT00240487|Gasotransmitters|gasotransmitters|mesh-ancestor
102452271|NCT00240487|Protective Agents|protective agents|mesh-ancestor
102452272|NCT02126917|Ethanol|ethanol|mesh-list
102452273|NCT02126917|Hydrocodone|hydrocodone|mesh-list
102452274|NCT02126917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102452275|NCT02126917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102452276|NCT02126917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102452277|NCT02126917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452278|NCT02126917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102452279|NCT02126917|Narcotics|narcotics|mesh-ancestor
102452280|NCT02126917|Analgesics|analgesics|mesh-ancestor
102452281|NCT02126917|Sensory System Agents|sensory system agents|mesh-ancestor
102452282|NCT02126917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102452283|NCT02126917|Antitussive Agents|antitussive agents|mesh-ancestor
102452284|NCT02126917|Respiratory System Agents|respiratory system agents|mesh-ancestor
102452285|NCT01895075|Budesonide|budesonide|mesh-list
102452286|NCT01895075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102452287|NCT01895075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102452288|NCT01895075|Autonomic Agents|autonomic agents|mesh-ancestor
102452289|NCT01895075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102452290|NCT01895075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452291|NCT01895075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102452292|NCT01895075|Respiratory System Agents|respiratory system agents|mesh-ancestor
102452293|NCT01895075|Glucocorticoids|glucocorticoids|mesh-ancestor
102452294|NCT01895075|Hormones|hormones|mesh-ancestor
102452295|NCT01895075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102263894|NCT04500275|Vancomycin|vancomycin|mesh-list
102452297|NCT05168475|Rituximab|rituximab|mesh-list
102452298|NCT05168475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102452299|NCT05168475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102452300|NCT05168475|Immunologic Factors|immunologic factors|mesh-ancestor
102452301|NCT05168475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452302|NCT05168475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102452303|NCT05168475|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102452304|NCT05168475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102452305|NCT05168475|Dermatologic Agents|dermatologic agents|mesh-ancestor
102452306|NCT05168475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102452307|NCT03088709|Mycophenolic Acid|mycophenolic acid|mesh-list
102452308|NCT03088709|Cyclophosphamide|cyclophosphamide|mesh-list
102452309|NCT03088709|Tacrolimus|tacrolimus|mesh-list
102452310|NCT03088709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102452311|NCT03088709|Immunologic Factors|immunologic factors|mesh-ancestor
102452312|NCT03088709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452313|NCT03088709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102452314|NCT03088709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102452315|NCT03088709|Alkylating Agents|alkylating agents|mesh-ancestor
102452316|NCT03088709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452317|NCT03088709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102452318|NCT03088709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102452319|NCT03088709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102452320|NCT03088709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102452321|NCT03088709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102452322|NCT03088709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102452323|NCT03088709|Antitubercular Agents|antitubercular agents|mesh-ancestor
102452324|NCT03088709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102452325|NCT03088709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102452326|NCT03139305|Glucagon|glucagon|mesh-list
102452327|NCT03139305|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102452328|NCT03139305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102452329|NCT03139305|Hormones|hormones|mesh-ancestor
102452330|NCT03139305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102452331|NCT03139305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452332|NCT03139305|Incretins|incretins|mesh-ancestor
102452333|NCT00084149|Ritonavir|ritonavir|mesh-list
102452334|NCT00084149|Lopinavir|lopinavir|mesh-list
102452335|NCT00084149|Lamivudine|lamivudine|mesh-list
102452336|NCT00084149|Zidovudine|zidovudine|mesh-list
102452337|NCT00084149|Abacavir|abacavir|mesh-list
102452338|NCT00084149|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102452339|NCT00084149|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102452340|NCT00084149|Protease Inhibitors|protease inhibitors|mesh-ancestor
102452341|NCT00084149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102452342|NCT00084149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452343|NCT00084149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102452344|NCT00084149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102452345|NCT00084149|Antiviral Agents|antiviral agents|mesh-ancestor
102452346|NCT00084149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102452347|NCT00084149|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102452348|NCT00084149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102452349|NCT00084149|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102452350|NCT00084149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102452351|NCT00084149|Antimetabolites|antimetabolites|mesh-ancestor
102452352|NCT02959905|Cyclophosphamide|cyclophosphamide|mesh-list
102452353|NCT02959905|Fludarabine|fludarabine|mesh-list
102452354|NCT02959905|Fludarabine phosphate|fludarabine phosphate|mesh-list
102452355|NCT02959905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102452356|NCT02959905|Immunologic Factors|immunologic factors|mesh-ancestor
102452357|NCT02959905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452358|NCT02959905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102452359|NCT02959905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102452360|NCT02959905|Alkylating Agents|alkylating agents|mesh-ancestor
102452361|NCT02959905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452362|NCT02959905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102452363|NCT02959905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102452364|NCT02959905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102452365|NCT02959905|Antimetabolites|antimetabolites|mesh-ancestor
102452366|NCT00134017|Cyclophosphamide|cyclophosphamide|mesh-list
102452367|NCT00134017|Busulfan|busulfan|mesh-list
102452368|NCT00134017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102452369|NCT00134017|Immunologic Factors|immunologic factors|mesh-ancestor
102452370|NCT00134017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452371|NCT00134017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102452372|NCT00134017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102452373|NCT00134017|Alkylating Agents|alkylating agents|mesh-ancestor
102452374|NCT00134017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452375|NCT00134017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102452376|NCT00134017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102452377|NCT04783051|Pyrimethamine|pyrimethamine|mesh-list
102452378|NCT04783051|Sulfadoxine|sulfadoxine|mesh-list
102452379|NCT04783051|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
102452380|NCT04783051|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
102452381|NCT04783051|Antimalarials|antimalarials|mesh-ancestor
102452382|NCT04783051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102452383|NCT04783051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102452384|NCT04783051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102452385|NCT04783051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102452386|NCT04783051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102452387|NCT04783051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452388|NCT04783051|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102452389|NCT04783051|Antiviral Agents|antiviral agents|mesh-ancestor
102452390|NCT00243061|Cediranib|cediranib|mesh-list
102452391|NCT00243061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102452392|NCT00243061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452393|NCT00243061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102452394|NCT00243061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102452395|NCT00245557|Sertraline|sertraline|mesh-list
102452396|NCT00245557|Antidepressive Agents|antidepressive agents|mesh-ancestor
102452397|NCT00245557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102452398|NCT00245557|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102452399|NCT00245557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102452400|NCT00245557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102452401|NCT00245557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452402|NCT00245557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102452403|NCT00245557|Serotonin Agents|serotonin agents|mesh-ancestor
102452404|NCT00245557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452405|NCT00245635|Fluoxetine|fluoxetine|mesh-list
102452406|NCT00245635|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102452407|NCT00245635|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102452408|NCT00245635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102452409|NCT00245635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452410|NCT00245635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102452411|NCT00245635|Serotonin Agents|serotonin agents|mesh-ancestor
102452412|NCT00245635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452413|NCT00245635|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102452414|NCT00245635|Antidepressive Agents|antidepressive agents|mesh-ancestor
102452415|NCT00245635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102452416|NCT00245635|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102452417|NCT00245635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102452418|NCT00245635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102452419|NCT00141115|Levetiracetam|levetiracetam|mesh-list
102452420|NCT00141115|Anticonvulsants|anticonvulsants|mesh-ancestor
102452421|NCT00141115|Nootropic Agents|nootropic agents|mesh-ancestor
102452422|NCT00249379|Acamprosate|acamprosate|mesh-list
102452423|NCT00249379|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102452424|NCT00141739|Etanercept|etanercept|mesh-list
102452425|NCT00141739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102452426|NCT00141739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102452427|NCT00141739|Analgesics|analgesics|mesh-ancestor
102452428|NCT00141739|Sensory System Agents|sensory system agents|mesh-ancestor
102452429|NCT00141739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102452430|NCT00141739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452431|NCT00141739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102452432|NCT00141739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102452433|NCT00141739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102452434|NCT00141739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102452435|NCT00141739|Immunologic Factors|immunologic factors|mesh-ancestor
102452436|NCT00143845|Immunosuppressive Agents|immunosuppressive agents|mesh-list
102452437|NCT00143845|Immunologic Factors|immunologic factors|mesh-ancestor
102452438|NCT00143845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452439|NCT00086957|Docetaxel|docetaxel|mesh-list
102452440|NCT00086957|Trastuzumab|trastuzumab|mesh-list
102452441|NCT00086957|Gefitinib|gefitinib|mesh-list
102452442|NCT00086957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102452443|NCT00086957|Tubulin Modulators|tubulin modulators|mesh-ancestor
102452444|NCT00086957|Antimitotic Agents|antimitotic agents|mesh-ancestor
102452445|NCT00086957|Mitosis Modulators|mitosis modulators|mesh-ancestor
102452446|NCT00086957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452447|NCT00086957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102452448|NCT00086957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102452449|NCT00086957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102452450|NCT00144391|Testosterone|testosterone|mesh-list
102452451|NCT00144391|Androgens|androgens|mesh-ancestor
102452452|NCT00144391|Hormones|hormones|mesh-ancestor
102452453|NCT00144391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102452454|NCT00144391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452455|NCT00145249|Fluconazole|fluconazole|mesh-list
102452456|NCT00145249|Amphotericin B|amphotericin b|mesh-list
102452457|NCT00145249|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102452458|NCT00145249|Antifungal Agents|antifungal agents|mesh-ancestor
102452459|NCT00145249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102452460|NCT00145249|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102452461|NCT00145249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102452462|NCT00145249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102452463|NCT00145249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452464|NCT00145249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102452465|NCT00145249|Hormone Antagonists|hormone antagonists|mesh-ancestor
102452466|NCT00145249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102452467|NCT00145249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452468|NCT00145249|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102452469|NCT00145249|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102452470|NCT00145249|Amebicides|amebicides|mesh-ancestor
102452471|NCT00145249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102452472|NCT00145249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102452473|NCT00145249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102452474|NCT00153803|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102452475|NCT00153803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102452476|NCT00153803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102452477|NCT00153803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102452478|NCT00153803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452479|NCT00252967|Atorvastatin|atorvastatin|mesh-list
102452480|NCT00252967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102452481|NCT00252967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102452482|NCT00252967|Antimetabolites|antimetabolites|mesh-ancestor
102452483|NCT00252967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452484|NCT00252967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102452485|NCT00252967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102452486|NCT00252967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102452487|NCT00088985|Trastuzumab|trastuzumab|mesh-list
102452488|NCT00088985|Vinorelbine|vinorelbine|mesh-list
102452489|NCT00088985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102452490|NCT00088985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102452491|NCT00088985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102452492|NCT00088985|Tubulin Modulators|tubulin modulators|mesh-ancestor
102452493|NCT00088985|Antimitotic Agents|antimitotic agents|mesh-ancestor
102452494|NCT00088985|Mitosis Modulators|mitosis modulators|mesh-ancestor
102452495|NCT00088985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452496|NCT00156923|Naltrexone|naltrexone|mesh-list
102452497|NCT00156923|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102452498|NCT00156923|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102452499|NCT00156923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452500|NCT00156923|Sensory System Agents|sensory system agents|mesh-ancestor
102452501|NCT00156923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102452502|NCT00093041|Zalutumumab|zalutumumab|mesh-list
102452503|NCT00093041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102452504|NCT00093041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102452505|NCT00158249|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
102452506|NCT00158249|Nootropic Agents|nootropic agents|mesh-ancestor
102452507|NCT01769885|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102452508|NCT01769885|Tivozanib|tivozanib|mesh-list
102452509|NCT01769885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102452510|NCT01769885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102452511|NCT01769885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452512|NCT01895231|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
102452513|NCT01895231|Hematinics|hematinics|mesh-ancestor
102452514|NCT04745663|Iodine|iodine|mesh-list
102452515|NCT04745663|Cadexomer iodine|cadexomer iodine|mesh-list
102452516|NCT04745663|Povidone-Iodine|povidone-iodine|mesh-list
102452517|NCT04745663|Povidone|povidone|mesh-list
102452518|NCT04745663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102452519|NCT04745663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102452520|NCT04745663|Trace Elements|trace elements|mesh-ancestor
102452521|NCT04745663|Micronutrients|micronutrients|mesh-ancestor
102452522|NCT04745663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452523|NCT04745663|Plasma Substitutes|plasma substitutes|mesh-ancestor
102452524|NCT04745663|Blood Substitutes|blood substitutes|mesh-ancestor
102452525|NCT01747577|Solifenacin Succinate|solifenacin succinate|mesh-list
102452526|NCT01747577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102452527|NCT01747577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102452528|NCT01747577|Cholinergic Agents|cholinergic agents|mesh-ancestor
102452529|NCT01747577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102452530|NCT01747577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452531|NCT01747577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452532|NCT01747577|Urological Agents|urological agents|mesh-ancestor
102452533|NCT00159263|Budesonide|budesonide|mesh-list
102452534|NCT00159263|Formoterol Fumarate|formoterol fumarate|mesh-list
102452535|NCT00159263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102452536|NCT00159263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102452537|NCT00159263|Autonomic Agents|autonomic agents|mesh-ancestor
102452538|NCT00159263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102452539|NCT00159263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452540|NCT00159263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102452541|NCT00159263|Respiratory System Agents|respiratory system agents|mesh-ancestor
102452542|NCT00159263|Glucocorticoids|glucocorticoids|mesh-ancestor
102452543|NCT00159263|Hormones|hormones|mesh-ancestor
102452544|NCT00159263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102452545|NCT00159263|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102452546|NCT00159263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102452547|NCT00159263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102452548|NCT00159263|Adrenergic Agents|adrenergic agents|mesh-ancestor
102452549|NCT00159263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102452550|NCT00159263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452551|NCT00159419|Alendronate|alendronate|mesh-list
102452552|NCT00159419|Pamidronate|pamidronate|mesh-list
102452553|NCT00159419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102452554|NCT00159419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452555|NCT00159965|Sertraline|sertraline|mesh-list
102452556|NCT00159965|Antidepressive Agents|antidepressive agents|mesh-ancestor
102452557|NCT00159965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102452558|NCT00159965|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102452559|NCT00159965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102082678|NCT03493568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102452560|NCT00159965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102452561|NCT00159965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452562|NCT00159965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102452563|NCT00159965|Serotonin Agents|serotonin agents|mesh-ancestor
102452564|NCT00159965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452565|NCT02926833|Cyclophosphamide|cyclophosphamide|mesh-list
102452566|NCT02926833|Fludarabine|fludarabine|mesh-list
102452567|NCT02926833|Atezolizumab|atezolizumab|mesh-list
102452568|NCT02926833|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
102452569|NCT02926833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102452570|NCT02926833|Immunologic Factors|immunologic factors|mesh-ancestor
102452571|NCT02926833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452572|NCT02926833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102452573|NCT02926833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102452574|NCT02926833|Alkylating Agents|alkylating agents|mesh-ancestor
102452575|NCT02926833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452576|NCT02926833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102452577|NCT02926833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102452578|NCT02926833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102452579|NCT02926833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102452580|NCT00096161|Cyclosporine|cyclosporine|mesh-list
102452581|NCT00096161|Mycophenolic Acid|mycophenolic acid|mesh-list
102452582|NCT00096161|Vidarabine|vidarabine|mesh-list
102452583|NCT00096161|Pentostatin|pentostatin|mesh-list
102452584|NCT00096161|Cyclosporins|cyclosporins|mesh-list
102452585|NCT00096161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102452586|NCT00096161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452587|NCT00096161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102452588|NCT00096161|Immunologic Factors|immunologic factors|mesh-ancestor
102452589|NCT00096161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452590|NCT00096161|Antifungal Agents|antifungal agents|mesh-ancestor
102452591|NCT00096161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102452592|NCT00096161|Dermatologic Agents|dermatologic agents|mesh-ancestor
102452593|NCT00096161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102452594|NCT00096161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102452595|NCT00096161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102452596|NCT00096161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102452597|NCT00096161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102452598|NCT00096161|Antitubercular Agents|antitubercular agents|mesh-ancestor
102452599|NCT00096161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102452600|NCT00096161|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
102452602|NCT00096161|Antiviral Agents|antiviral agents|mesh-ancestor
102452603|NCT00097253|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
102452604|NCT00097253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452605|NCT01898039|Cyclophosphamide|cyclophosphamide|mesh-list
102452606|NCT01898039|Vaccines|vaccines|mesh-list
102452607|NCT01898039|Immunologic Factors|immunologic factors|mesh-ancestor
102452608|NCT01898039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452609|NCT01898039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102452610|NCT01898039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102452611|NCT01898039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102452612|NCT01898039|Alkylating Agents|alkylating agents|mesh-ancestor
102452613|NCT01898039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452614|NCT01898039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102452615|NCT01898039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102452616|NCT00099047|Celecoxib|celecoxib|mesh-list
102452617|NCT00099047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102452618|NCT00099047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102452619|NCT00099047|Analgesics|analgesics|mesh-ancestor
102452620|NCT00099047|Sensory System Agents|sensory system agents|mesh-ancestor
102452621|NCT00099047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102452622|NCT00099047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452623|NCT00099047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102452624|NCT00099047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102452625|NCT00099047|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102452626|NCT00099047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102452627|NCT00099047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102452628|NCT00099047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452629|NCT02851797|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
102452630|NCT02851797|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102452631|NCT02851797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102452632|NCT02851797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452633|NCT00253435|Carboplatin|carboplatin|mesh-list
102452634|NCT00253435|Etoposide|etoposide|mesh-list
102452635|NCT00253435|Melphalan|melphalan|mesh-list
102452636|NCT00253435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102452637|NCT00253435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102452638|NCT00253435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102452639|NCT00253435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102452640|NCT00253435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102452641|NCT00253435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452642|NCT00253435|Immunologic Factors|immunologic factors|mesh-ancestor
102452643|NCT00253435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452644|NCT00253435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102452645|NCT00253435|Alkylating Agents|alkylating agents|mesh-ancestor
102452646|NCT00253435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102452647|NCT00253435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102452648|NCT00253513|Fludarabine|fludarabine|mesh-list
102452649|NCT00253513|Treosulfan|treosulfan|mesh-list
102452650|NCT00253513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102452651|NCT00253513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452652|NCT00253513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102452653|NCT00253513|Alkylating Agents|alkylating agents|mesh-ancestor
102452654|NCT05033847|Vaccines|vaccines|mesh-list
102452655|NCT05033847|Immunologic Factors|immunologic factors|mesh-ancestor
102452656|NCT05033847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452657|NCT04963725|Ustekinumab|ustekinumab|mesh-list
102452658|NCT04963725|Dermatologic Agents|dermatologic agents|mesh-ancestor
102452659|NCT02098993|Heparin|heparin|mesh-list
102452660|NCT02098993|Calcium heparin|calcium heparin|mesh-list
102452661|NCT02098993|Anticoagulants|anticoagulants|mesh-ancestor
102452662|NCT02098993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102452663|NCT02098993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102452664|NCT02098993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452665|NCT04930107|Fluconazole|fluconazole|mesh-list
102452666|NCT04930107|Antifungal Agents|antifungal agents|mesh-ancestor
102452667|NCT04930107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102452668|NCT04930107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102452669|NCT04930107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102452670|NCT04930107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102452671|NCT04930107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452672|NCT04930107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102452673|NCT04930107|Hormone Antagonists|hormone antagonists|mesh-ancestor
102452674|NCT04930107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102452675|NCT04930107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452676|NCT04930107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102452677|NCT04930107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102452678|NCT00100841|Leucovorin|leucovorin|mesh-list
102452679|NCT00100841|Bevacizumab|bevacizumab|mesh-list
102452680|NCT00100841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102452681|NCT00100841|Cetuximab|cetuximab|mesh-list
102452682|NCT00100841|Fluorouracil|fluorouracil|mesh-list
102452683|NCT00100841|Oxaliplatin|oxaliplatin|mesh-list
102452684|NCT00100841|Antibodies|antibodies|mesh-list
102452685|NCT00100841|Immunoglobulins|immunoglobulins|mesh-list
102452686|NCT00100841|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102452687|NCT00100841|Levoleucovorin|levoleucovorin|mesh-list
102452688|NCT00100841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102452689|NCT00100841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102452690|NCT00100841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102452691|NCT00100841|Growth Substances|growth substances|mesh-ancestor
102452692|NCT00100841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452693|NCT00100841|Growth Inhibitors|growth inhibitors|mesh-ancestor
102452694|NCT00100841|Immunologic Factors|immunologic factors|mesh-ancestor
102452695|NCT00100841|Antimetabolites|antimetabolites|mesh-ancestor
102452696|NCT00100841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452697|NCT00100841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102452698|NCT00100841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102452699|NCT00100841|Antidotes|antidotes|mesh-ancestor
102452700|NCT00100841|Protective Agents|protective agents|mesh-ancestor
102452701|NCT00100841|Vitamin B Complex|vitamin b complex|mesh-ancestor
102452702|NCT00100841|Vitamins|vitamins|mesh-ancestor
102452703|NCT00100841|Micronutrients|micronutrients|mesh-ancestor
102452704|NCT00147199|Treprostinil|treprostinil|mesh-list
102452705|NCT00147199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102452706|NCT05709171|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102452707|NCT05709171|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102452708|NCT05709171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452709|NCT00149227|Valsartan|valsartan|mesh-list
102452710|NCT00149227|Antihypertensive Agents|antihypertensive agents|mesh-list
102452711|NCT00149227|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102452712|NCT00149227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102452713|NCT00149227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452714|NCT00445965|Antibodies|antibodies|mesh-list
102452715|NCT00445965|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102452716|NCT00445965|Immunologic Factors|immunologic factors|mesh-ancestor
102452717|NCT00445965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452718|NCT02096081|Botulinum Toxins|botulinum toxins|mesh-list
102452719|NCT02096081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102452720|NCT02096081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102452721|NCT02096081|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102452722|NCT02096081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102452723|NCT02096081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102452724|NCT02096081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452725|NCT02096081|Cholinergic Agents|cholinergic agents|mesh-ancestor
102452726|NCT02096081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102452727|NCT02096081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452728|NCT02096081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102452729|NCT02096081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102452730|NCT05708235|Inavolisib|inavolisib|mesh-list
102452731|NCT05708235|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
102452732|NCT05708235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102452733|NCT05708235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452734|NCT02240589|Memantine|memantine|mesh-list
102452735|NCT02240589|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102452736|NCT02240589|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102452737|NCT02240589|Dopamine Agents|dopamine agents|mesh-ancestor
102452738|NCT02240589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102452739|NCT02240589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452740|NCT02240589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452741|NCT02240589|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102452742|NCT02240589|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102452743|NCT00258349|Trastuzumab|trastuzumab|mesh-list
102452744|NCT00258349|Vorinostat|vorinostat|mesh-list
102452745|NCT00258349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102452746|NCT00258349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102452747|NCT00258349|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102452748|NCT00258349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102452749|NCT00258349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452750|NCT01713621|Artefenomel|artefenomel|mesh-list
102452751|NCT01713621|Antimalarials|antimalarials|mesh-ancestor
102452752|NCT01713621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102452753|NCT01713621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102452754|NCT01713621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102452755|NCT05165485|Tiotropium Bromide|tiotropium bromide|mesh-list
102452756|NCT05165485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102452757|NCT05165485|Autonomic Agents|autonomic agents|mesh-ancestor
102452758|NCT05165485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102452759|NCT05165485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452760|NCT05165485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102452761|NCT05165485|Respiratory System Agents|respiratory system agents|mesh-ancestor
102452762|NCT05165485|Parasympatholytics|parasympatholytics|mesh-ancestor
102452763|NCT05165485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102452764|NCT05165485|Cholinergic Agents|cholinergic agents|mesh-ancestor
102452765|NCT05165485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102452766|NCT05165485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452767|NCT00258817|Vaccines|vaccines|mesh-list
102452768|NCT00258817|Immunologic Factors|immunologic factors|mesh-ancestor
102452769|NCT00258817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452770|NCT00259285|Pemetrexed|pemetrexed|mesh-list
102452771|NCT00259285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102452772|NCT00259285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102452773|NCT00259285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452774|NCT00259285|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102452775|NCT00259285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102452776|NCT01716039|Adalimumab|adalimumab|mesh-list
102452777|NCT01716039|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102452778|NCT01716039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102452779|NCT01716039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102452780|NCT01716195|Paclitaxel|paclitaxel|mesh-list
102452781|NCT01716195|Carboplatin|carboplatin|mesh-list
102452782|NCT01716195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102452783|NCT01716195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102452784|NCT01716195|Tubulin Modulators|tubulin modulators|mesh-ancestor
102452785|NCT01716195|Antimitotic Agents|antimitotic agents|mesh-ancestor
102452786|NCT01716195|Mitosis Modulators|mitosis modulators|mesh-ancestor
102452787|NCT01716195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452788|NCT02249481|Bupivacaine|bupivacaine|mesh-list
102452789|NCT02249481|Anesthetics, Local|anesthetics, local|mesh-ancestor
102452790|NCT02249481|Anesthetics|anesthetics|mesh-ancestor
102452791|NCT02249481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102452792|NCT02249481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452793|NCT02249481|Sensory System Agents|sensory system agents|mesh-ancestor
102452794|NCT02249481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102452795|NCT01717053|Prednisone|prednisone|mesh-list
102452796|NCT01717053|Abiraterone Acetate|abiraterone acetate|mesh-list
102452797|NCT01717053|Androgens|androgens|mesh-list
102452798|NCT01717053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102452799|NCT01717053|Glucocorticoids|glucocorticoids|mesh-ancestor
102452800|NCT01717053|Hormones|hormones|mesh-ancestor
102452801|NCT01717053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102452802|NCT01717053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452803|NCT01717053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102452804|NCT01717053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102452805|NCT01717053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102452806|NCT01717053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102452807|NCT01717053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452808|NCT01717053|Hormone Antagonists|hormone antagonists|mesh-ancestor
102452809|NCT01717053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102452810|NCT01666314|Prednisone|prednisone|mesh-list
102452811|NCT01666314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102452812|NCT01666314|Glucocorticoids|glucocorticoids|mesh-ancestor
102452813|NCT01666314|Hormones|hormones|mesh-ancestor
102452814|NCT01666314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102452815|NCT01666314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452816|NCT01666314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102452817|NCT01666314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102452819|NCT01717209|Nitric Oxide|nitric oxide|mesh-list
102452820|NCT01717209|Tezosentan|tezosentan|mesh-list
102452821|NCT01717209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102452822|NCT01717209|Autonomic Agents|autonomic agents|mesh-ancestor
102452823|NCT01717209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102452824|NCT01717209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452825|NCT01717209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102452826|NCT01717209|Respiratory System Agents|respiratory system agents|mesh-ancestor
102452827|NCT01717209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102452828|NCT01717209|Antioxidants|antioxidants|mesh-ancestor
102452829|NCT01717209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452830|NCT01717209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102452831|NCT01717209|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102452832|NCT01717209|Vasodilator Agents|vasodilator agents|mesh-ancestor
102452833|NCT01717209|Gasotransmitters|gasotransmitters|mesh-ancestor
102452834|NCT01717209|Protective Agents|protective agents|mesh-ancestor
102452835|NCT01717209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102452836|NCT01717209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102452837|NCT00260689|Cyclosporine|cyclosporine|mesh-list
102452838|NCT00260689|Alemtuzumab|alemtuzumab|mesh-list
102452839|NCT00260689|Cyclosporins|cyclosporins|mesh-list
102452840|NCT00260689|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102452841|NCT00260689|Thymoglobulin|thymoglobulin|mesh-list
102452842|NCT00260689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102452843|NCT00260689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452844|NCT00260689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102452845|NCT00260689|Immunologic Factors|immunologic factors|mesh-ancestor
102452846|NCT00260689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452847|NCT00260689|Antifungal Agents|antifungal agents|mesh-ancestor
102452848|NCT00260689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102452849|NCT00260689|Dermatologic Agents|dermatologic agents|mesh-ancestor
102452850|NCT00260689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102452851|NCT00260689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102452852|NCT00260689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102452853|NCT00260689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102452854|NCT00262639|Gabapentin|gabapentin|mesh-list
102452855|NCT00262639|Flumazenil|flumazenil|mesh-list
102452856|NCT00262639|Analgesics|analgesics|mesh-ancestor
102452857|NCT00262639|Sensory System Agents|sensory system agents|mesh-ancestor
102452858|NCT00262639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102452859|NCT00262639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452860|NCT00262639|Anticonvulsants|anticonvulsants|mesh-ancestor
102452861|NCT00262639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102452862|NCT00262639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102452863|NCT00262639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102452864|NCT00262639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102452865|NCT00262639|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102452866|NCT00262639|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102452867|NCT00262639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102452868|NCT00262639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452869|NCT00262639|Antimanic Agents|antimanic agents|mesh-ancestor
102452870|NCT00262639|Antidotes|antidotes|mesh-ancestor
102452871|NCT00262639|Protective Agents|protective agents|mesh-ancestor
102452872|NCT00262639|GABA Modulators|gaba modulators|mesh-ancestor
102452873|NCT00262639|GABA Agents|gaba agents|mesh-ancestor
102452874|NCT01062451|Candesartan|candesartan|mesh-list
102452875|NCT01062451|Candesartan cilexetil|candesartan cilexetil|mesh-list
102452876|NCT01062451|Perindopril|perindopril|mesh-list
102452877|NCT01062451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102452878|NCT01062451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102452879|NCT01062451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102452880|NCT01062451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452881|NCT01062451|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102452882|NCT01062451|Protease Inhibitors|protease inhibitors|mesh-ancestor
102452883|NCT01062451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102452884|NCT04639843|Doxorubicin|doxorubicin|mesh-list
102452885|NCT04639843|Romidepsin|romidepsin|mesh-list
102452886|NCT04639843|Azacitidine|azacitidine|mesh-list
102452887|NCT04639843|Cc-486|cc-486|mesh-list
102452888|NCT04639843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102452889|NCT04639843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102452890|NCT04639843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102452891|NCT04639843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102452892|NCT04639843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102452893|NCT04639843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452894|NCT04639843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102452895|NCT04639843|Antimetabolites|antimetabolites|mesh-ancestor
102452896|NCT04639843|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102452897|NCT01718691|Rituximab|rituximab|mesh-list
102452898|NCT01718691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102452899|NCT01718691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102452900|NCT01718691|Immunologic Factors|immunologic factors|mesh-ancestor
102452901|NCT01718691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452902|NCT01718691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102452903|NCT05699148|Ivacaftor|ivacaftor|mesh-list
102452904|NCT05699148|Elexacaftor|elexacaftor|mesh-list
102452905|NCT05699148|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102452906|NCT05699148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102452907|NCT05699148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452908|NCT04638517|Danazol|danazol|mesh-list
102452909|NCT04638517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102452910|NCT04638517|Hormone Antagonists|hormone antagonists|mesh-ancestor
102452911|NCT04638517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102452912|NCT04638517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452913|NCT04467723|Pirfenidone|pirfenidone|mesh-list
102452914|NCT04467723|Atezolizumab|atezolizumab|mesh-list
102452915|NCT04467723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102452916|NCT04467723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452917|NCT04467723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102452918|NCT04467723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102452919|NCT04467723|Analgesics|analgesics|mesh-ancestor
102452920|NCT04467723|Sensory System Agents|sensory system agents|mesh-ancestor
102452921|NCT04467723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102452922|NCT04467723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452923|NCT04467723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102452924|NCT04467723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102452925|NCT04467723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102452926|NCT04467723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102452927|NCT04425642|Methamphetamine|methamphetamine|mesh-list
102452928|NCT04425642|SMOFlipid|smoflipid|mesh-list
102452929|NCT04425642|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102452930|NCT04425642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452931|NCT04425642|Sympathomimetics|sympathomimetics|mesh-ancestor
102452932|NCT04425642|Autonomic Agents|autonomic agents|mesh-ancestor
102452933|NCT04425642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102452934|NCT04425642|Dopamine Agents|dopamine agents|mesh-ancestor
102452935|NCT04425642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102452936|NCT04425642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452937|NCT04425642|Adrenergic Agents|adrenergic agents|mesh-ancestor
102452938|NCT04425642|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102452939|NCT04425642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102452940|NCT04425642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102452941|NCT04425642|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102452942|NCT04425642|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102452943|NCT04425642|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102452944|NCT04425642|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102452945|NCT00266851|Azithromycin|azithromycin|mesh-list
102452946|NCT00266851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102452947|NCT00266851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102452948|NCT00015847|Interferons|interferons|mesh-list
102452949|NCT00015847|Interferon-alpha|interferon-alpha|mesh-list
102452950|NCT00015847|Imatinib Mesylate|imatinib mesylate|mesh-list
102452951|NCT00015847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102452952|NCT00015847|Antiviral Agents|antiviral agents|mesh-ancestor
102452953|NCT00015847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102452954|NCT00015847|Immunologic Factors|immunologic factors|mesh-ancestor
102452955|NCT00015847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452956|NCT00015847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102452957|NCT00015847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102452958|NCT00015847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452959|NCT01665768|Rituximab|rituximab|mesh-list
102452960|NCT01665768|Everolimus|everolimus|mesh-list
102452961|NCT01665768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102452962|NCT01665768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102452963|NCT01665768|Immunologic Factors|immunologic factors|mesh-ancestor
102452964|NCT01665768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452965|NCT01665768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102452966|NCT01665768|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102452967|NCT01665768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102452968|NCT01665768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102452969|NCT01665768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452970|NCT01665768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102452971|NCT01720173|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
102452972|NCT01720173|Immunologic Factors|immunologic factors|mesh-ancestor
102452973|NCT01720173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452974|NCT04617457|Leucovorin|leucovorin|mesh-list
102452975|NCT04617457|Folic Acid|folic acid|mesh-list
102452976|NCT04617457|Oxaliplatin|oxaliplatin|mesh-list
102452977|NCT04617457|Irinotecan|irinotecan|mesh-list
102452978|NCT04617457|Fluorouracil|fluorouracil|mesh-list
102452979|NCT04617457|Levoleucovorin|levoleucovorin|mesh-list
102452980|NCT04617457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102452981|NCT04617457|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102452982|NCT04617457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102452983|NCT04617457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102452984|NCT04617457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102452985|NCT04617457|Antidotes|antidotes|mesh-ancestor
102452986|NCT04617457|Protective Agents|protective agents|mesh-ancestor
102452987|NCT04617457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102452988|NCT04617457|Vitamin B Complex|vitamin b complex|mesh-ancestor
102452989|NCT04617457|Vitamins|vitamins|mesh-ancestor
102452990|NCT04617457|Micronutrients|micronutrients|mesh-ancestor
102452991|NCT04617457|Hematinics|hematinics|mesh-ancestor
102452992|NCT04617457|Antimetabolites|antimetabolites|mesh-ancestor
102452993|NCT04617457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102452994|NCT04617457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102452995|NCT04617457|Immunologic Factors|immunologic factors|mesh-ancestor
102452996|NCT00017563|Docetaxel|docetaxel|mesh-list
102452997|NCT00017563|Mitoxantrone|mitoxantrone|mesh-list
102452998|NCT00017563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102452999|NCT00017563|Tubulin Modulators|tubulin modulators|mesh-ancestor
102453000|NCT00017563|Antimitotic Agents|antimitotic agents|mesh-ancestor
102453001|NCT00017563|Mitosis Modulators|mitosis modulators|mesh-ancestor
102453002|NCT00017563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453003|NCT00017563|Analgesics|analgesics|mesh-ancestor
102453004|NCT00017563|Sensory System Agents|sensory system agents|mesh-ancestor
102453005|NCT00017563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102453006|NCT00017563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453007|NCT00017563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102453008|NCT00017563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102453009|NCT00017563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102453010|NCT00018031|Ribavirin|ribavirin|mesh-list
102453011|NCT00018031|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102453012|NCT00018031|Interferon-alpha|interferon-alpha|mesh-list
102453013|NCT00018031|Antimetabolites|antimetabolites|mesh-ancestor
102453014|NCT00018031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453015|NCT00018031|Antiviral Agents|antiviral agents|mesh-ancestor
102453016|NCT00018031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102453017|NCT00018031|Immunologic Factors|immunologic factors|mesh-ancestor
102453018|NCT00018031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453019|NCT04734210|Betamethasone|betamethasone|mesh-list
102453020|NCT04734210|Betamethasone Valerate|betamethasone valerate|mesh-list
102453021|NCT04734210|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102453022|NCT04734210|Betamethasone benzoate|betamethasone benzoate|mesh-list
102453023|NCT04734210|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102453024|NCT04734210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102453025|NCT04734210|Glucocorticoids|glucocorticoids|mesh-ancestor
102453026|NCT04734210|Hormones|hormones|mesh-ancestor
102453027|NCT04734210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102453028|NCT04734210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453029|NCT04734210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102453030|NCT04734210|Respiratory System Agents|respiratory system agents|mesh-ancestor
102453031|NCT00267085|Imatinib Mesylate|imatinib mesylate|mesh-list
102453032|NCT00267085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102453033|NCT00267085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102453034|NCT00267085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102453035|NCT00267085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453036|NCT04221451|Venglustat|venglustat|mesh-list
102453037|NCT04221451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102453038|NCT04221451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453039|NCT04476511|Cholecalciferol|cholecalciferol|mesh-list
102453040|NCT04476511|Vitamin D|vitamin d|mesh-list
102453041|NCT04476511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102453042|NCT04476511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453043|NCT04476511|Vitamins|vitamins|mesh-ancestor
102453044|NCT04476511|Micronutrients|micronutrients|mesh-ancestor
102453045|NCT04476511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102453046|NCT00026221|Interferons|interferons|mesh-list
102453047|NCT00026221|Interferon-alpha|interferon-alpha|mesh-list
102453048|NCT00026221|Bevacizumab|bevacizumab|mesh-list
102453049|NCT00026221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102453050|NCT00026221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102453051|NCT00026221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102453052|NCT00026221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102453053|NCT00026221|Growth Substances|growth substances|mesh-ancestor
102453054|NCT00026221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453055|NCT00026221|Growth Inhibitors|growth inhibitors|mesh-ancestor
102453056|NCT00026221|Antiviral Agents|antiviral agents|mesh-ancestor
102453057|NCT00026221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102453058|NCT00026221|Immunologic Factors|immunologic factors|mesh-ancestor
102453059|NCT00028093|Ribavirin|ribavirin|mesh-list
102453060|NCT00028093|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102453061|NCT00028093|Interferon-alpha|interferon-alpha|mesh-list
102453062|NCT00028093|Antimetabolites|antimetabolites|mesh-ancestor
102453063|NCT00028093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453064|NCT00028093|Antiviral Agents|antiviral agents|mesh-ancestor
102453065|NCT00028093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102453066|NCT00028093|Immunologic Factors|immunologic factors|mesh-ancestor
102453067|NCT00028093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453068|NCT01721967|Ranolazine|ranolazine|mesh-list
102453069|NCT01721967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102453070|NCT01721967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102453071|NCT01721967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453072|NCT04026451|Propofol|propofol|mesh-list
102453073|NCT04026451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102453074|NCT04026451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102453075|NCT04026451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453076|NCT04026451|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102453077|NCT04026451|Anesthetics, General|anesthetics, general|mesh-ancestor
102453078|NCT04026451|Anesthetics|anesthetics|mesh-ancestor
102453079|NCT01722435|Opiate Alkaloids|opiate alkaloids|mesh-list
102453080|NCT01722435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102453081|NCT01722435|Narcotics|narcotics|mesh-ancestor
102453082|NCT01722435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102453083|NCT01722435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453084|NCT01722435|Analgesics|analgesics|mesh-ancestor
102453085|NCT01722435|Sensory System Agents|sensory system agents|mesh-ancestor
102453086|NCT01722435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102453087|NCT00029107|Rituximab|rituximab|mesh-list
102453088|NCT00029107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102453089|NCT00029107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102453090|NCT00029107|Immunologic Factors|immunologic factors|mesh-ancestor
102453091|NCT00029107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453092|NCT00029107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102453093|NCT04389229|Aldesleukin|aldesleukin|mesh-list
102453094|NCT04389229|Cyclophosphamide|cyclophosphamide|mesh-list
102453095|NCT04389229|Fludarabine|fludarabine|mesh-list
102453096|NCT04389229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102453097|NCT04389229|Immunologic Factors|immunologic factors|mesh-ancestor
102453098|NCT04389229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453099|NCT04389229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102453100|NCT04389229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102453101|NCT04389229|Alkylating Agents|alkylating agents|mesh-ancestor
102453102|NCT04389229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453103|NCT04389229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102453104|NCT04389229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102453105|NCT04389229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102453106|NCT04389229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102453107|NCT04389229|Antiviral Agents|antiviral agents|mesh-ancestor
102453108|NCT04389229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102453109|NCT03723252|Dapagliflozin|dapagliflozin|mesh-list
102453110|NCT03723252|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102453111|NCT03723252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453112|NCT03723252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102453113|NCT03723252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453114|NCT05538702|Menthol|menthol|mesh-list
102453115|NCT05538702|Antipruritics|antipruritics|mesh-ancestor
102453116|NCT05538702|Dermatologic Agents|dermatologic agents|mesh-ancestor
102453117|NCT00271219|Buprenorphine|buprenorphine|mesh-list
102453118|NCT00271219|Methadone|methadone|mesh-list
102453119|NCT00271219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102453120|NCT00271219|Narcotics|narcotics|mesh-ancestor
102453121|NCT00271219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102453122|NCT00271219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453123|NCT00271219|Analgesics|analgesics|mesh-ancestor
102453124|NCT00271219|Sensory System Agents|sensory system agents|mesh-ancestor
102453125|NCT00271219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102453126|NCT00271219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102453127|NCT00271219|Antitussive Agents|antitussive agents|mesh-ancestor
102453128|NCT00271219|Respiratory System Agents|respiratory system agents|mesh-ancestor
102453129|NCT02240667|Vitamin K|vitamin k|mesh-list
102453130|NCT02240667|Dabigatran|dabigatran|mesh-list
102453131|NCT02240667|Phenprocoumon|phenprocoumon|mesh-list
102453132|NCT02240667|Vitamins|vitamins|mesh-ancestor
102453133|NCT02240667|Micronutrients|micronutrients|mesh-ancestor
102453134|NCT02240667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453135|NCT02240667|Antithrombins|antithrombins|mesh-ancestor
102453136|NCT02240667|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102453137|NCT02240667|Protease Inhibitors|protease inhibitors|mesh-ancestor
102453138|NCT02240667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102453139|NCT02240667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453140|NCT02240667|Anticoagulants|anticoagulants|mesh-ancestor
102453141|NCT02240667|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102453142|NCT02240667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102453143|NCT02240667|Hemostatics|hemostatics|mesh-ancestor
102453144|NCT02240667|Coagulants|coagulants|mesh-ancestor
102453145|NCT00272311|Aspirin|aspirin|mesh-list
102453146|NCT00272311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102453147|NCT00272311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102453148|NCT00272311|Analgesics|analgesics|mesh-ancestor
102453149|NCT00272311|Sensory System Agents|sensory system agents|mesh-ancestor
102453150|NCT00272311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102453151|NCT00272311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453152|NCT00272311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102453153|NCT00272311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102453154|NCT00272311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102453155|NCT00272311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102453156|NCT00272311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453157|NCT00272311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102453158|NCT00272311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102453159|NCT00272311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102453160|NCT00272311|Antipyretics|antipyretics|mesh-ancestor
102453161|NCT00038857|Fludarabine|fludarabine|mesh-list
102453162|NCT00038857|Fludarabine phosphate|fludarabine phosphate|mesh-list
102453163|NCT00038857|Melphalan|melphalan|mesh-list
102453164|NCT00038857|Thiotepa|thiotepa|mesh-list
102453165|NCT00038857|Thymoglobulin|thymoglobulin|mesh-list
102453166|NCT00038857|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102453167|NCT00038857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102453168|NCT00038857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102453169|NCT00038857|Antimetabolites|antimetabolites|mesh-ancestor
102453170|NCT00038857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453171|NCT00038857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102453172|NCT00038857|Immunologic Factors|immunologic factors|mesh-ancestor
102453173|NCT00038857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453174|NCT00038857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102453175|NCT00038857|Alkylating Agents|alkylating agents|mesh-ancestor
102453176|NCT00038857|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102453177|NCT03097068|Ranibizumab|ranibizumab|mesh-list
102453178|NCT03097068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102453179|NCT03097068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102453180|NCT03097068|Growth Substances|growth substances|mesh-ancestor
102453181|NCT03097068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453182|NCT03097068|Growth Inhibitors|growth inhibitors|mesh-ancestor
102453183|NCT03097068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102453184|NCT01729845|Cytarabine|cytarabine|mesh-list
102453185|NCT01729845|Etoposide|etoposide|mesh-list
102453186|NCT01729845|Podophyllotoxin|podophyllotoxin|mesh-list
102453187|NCT01729845|Mitoxantrone|mitoxantrone|mesh-list
102453188|NCT01729845|Etoposide phosphate|etoposide phosphate|mesh-list
102453189|NCT01729845|Decitabine|decitabine|mesh-list
102453190|NCT01729845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102453191|NCT01729845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102453192|NCT01729845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102453193|NCT01729845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102453194|NCT01729845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102453195|NCT01729845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453196|NCT01729845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102453197|NCT01729845|Antimetabolites|antimetabolites|mesh-ancestor
102264843|NCT05899127|Dsuvia|dsuvia|mesh-list
102453198|NCT01729845|Antiviral Agents|antiviral agents|mesh-ancestor
102453199|NCT01729845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102453200|NCT01729845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102453201|NCT01729845|Immunologic Factors|immunologic factors|mesh-ancestor
102453202|NCT01729845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453203|NCT01729845|Analgesics|analgesics|mesh-ancestor
102453204|NCT01729845|Sensory System Agents|sensory system agents|mesh-ancestor
102453205|NCT01729845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102453206|NCT01729845|Keratolytic Agents|keratolytic agents|mesh-ancestor
102453207|NCT01729845|Dermatologic Agents|dermatologic agents|mesh-ancestor
102453208|NCT01729845|Tubulin Modulators|tubulin modulators|mesh-ancestor
102453209|NCT01729845|Antimitotic Agents|antimitotic agents|mesh-ancestor
102453210|NCT01729845|Mitosis Modulators|mitosis modulators|mesh-ancestor
102453211|NCT01729923|Celecoxib|celecoxib|mesh-list
102453212|NCT01729923|Capecitabine|capecitabine|mesh-list
102453213|NCT01729923|Benzenesulfonamide|benzenesulfonamide|mesh-list
102453214|NCT01729923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102453215|NCT01729923|Antimetabolites|antimetabolites|mesh-ancestor
102453216|NCT01729923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453217|NCT01729923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102453218|NCT01729923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102453219|NCT01729923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102453220|NCT01729923|Analgesics|analgesics|mesh-ancestor
102453221|NCT01729923|Sensory System Agents|sensory system agents|mesh-ancestor
102453222|NCT01729923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102453223|NCT01729923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453224|NCT01729923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102453225|NCT01729923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102453226|NCT01729923|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102453227|NCT01729923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102453228|NCT01729923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102453229|NCT01729923|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102453230|NCT02584452|Dexamethasone|dexamethasone|mesh-list
102453231|NCT02584452|Fentanyl|fentanyl|mesh-list
102453232|NCT02584452|Bupivacaine|bupivacaine|mesh-list
102453233|NCT02584452|Ropivacaine|ropivacaine|mesh-list
102453234|NCT02584452|Mepivacaine|mepivacaine|mesh-list
102453235|NCT02584452|Propofol|propofol|mesh-list
102453236|NCT02584452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102453237|NCT02584452|Antiemetics|antiemetics|mesh-ancestor
102453238|NCT02584452|Autonomic Agents|autonomic agents|mesh-ancestor
102453239|NCT02584452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102453240|NCT02584452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453241|NCT02584452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102453242|NCT02584452|Glucocorticoids|glucocorticoids|mesh-ancestor
102453243|NCT02584452|Hormones|hormones|mesh-ancestor
102453244|NCT02584452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102453245|NCT02584452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102453246|NCT02584452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102453247|NCT02584452|Anesthetics, Local|anesthetics, local|mesh-ancestor
102453248|NCT02584452|Anesthetics|anesthetics|mesh-ancestor
102453249|NCT02584452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102453250|NCT02584452|Sensory System Agents|sensory system agents|mesh-ancestor
102453251|NCT02584452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102453252|NCT02584452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102453253|NCT02584452|Anesthetics, General|anesthetics, general|mesh-ancestor
102453254|NCT02584452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102453255|NCT02584452|Narcotics|narcotics|mesh-ancestor
102453256|NCT02584452|Analgesics|analgesics|mesh-ancestor
102453257|NCT02584452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102453258|NCT02502006|Celecoxib|celecoxib|mesh-list
102453259|NCT02502006|Naproxen|naproxen|mesh-list
102453260|NCT02502006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102453261|NCT02502006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102453262|NCT02502006|Analgesics|analgesics|mesh-ancestor
102453263|NCT02502006|Sensory System Agents|sensory system agents|mesh-ancestor
102453264|NCT02502006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102453265|NCT02502006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453266|NCT02502006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102453267|NCT02502006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102453268|NCT02502006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102453269|NCT02502006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102453270|NCT02502006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102453271|NCT02502006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453272|NCT02502006|Gout Suppressants|gout suppressants|mesh-ancestor
102453273|NCT05679102|Amlodipine|amlodipine|mesh-list
102453274|NCT05679102|Atorvastatin|atorvastatin|mesh-list
102453275|NCT05679102|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102453276|NCT05679102|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102453277|NCT05679102|Antimetabolites|antimetabolites|mesh-ancestor
102453278|NCT05679102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453279|NCT05679102|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102453280|NCT05679102|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102453281|NCT05679102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102453282|NCT05679102|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102453283|NCT05679102|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102453284|NCT05679102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102453285|NCT05679102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102453286|NCT05679102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453287|NCT05679102|Vasodilator Agents|vasodilator agents|mesh-ancestor
102453288|NCT03520491|Nivolumab|nivolumab|mesh-list
102453289|NCT03520491|Ipilimumab|ipilimumab|mesh-list
102453290|NCT03520491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102453291|NCT03520491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102453292|NCT03520491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102453293|NCT03520491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453294|NCT05588934|Caffeine|caffeine|mesh-list
102453295|NCT05588934|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102453296|NCT05588934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453297|NCT05588934|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102453298|NCT05588934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102453299|NCT05588934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453300|NCT05588934|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102453301|NCT05588934|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102453302|NCT05588934|Purinergic Agents|purinergic agents|mesh-ancestor
102453303|NCT05588934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102453304|NCT02243007|Paclitaxel|paclitaxel|mesh-list
102453305|NCT02243007|Gemcitabine|gemcitabine|mesh-list
102453306|NCT02243007|Capecitabine|capecitabine|mesh-list
102453307|NCT02243007|Folfirinox|folfirinox|mesh-list
102453308|NCT02243007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102453309|NCT02243007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102453310|NCT02243007|Tubulin Modulators|tubulin modulators|mesh-ancestor
102453311|NCT02243007|Antimitotic Agents|antimitotic agents|mesh-ancestor
102453312|NCT02243007|Mitosis Modulators|mitosis modulators|mesh-ancestor
102453313|NCT02243007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453314|NCT02243007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102453315|NCT02243007|Antimetabolites|antimetabolites|mesh-ancestor
102453316|NCT05536596|Hydroxocobalamin|hydroxocobalamin|mesh-list
102453317|NCT05536596|Vitamin B 12|vitamin b 12|mesh-list
102453318|NCT05536596|Melatonin|melatonin|mesh-list
102453319|NCT05536596|Antioxidants|antioxidants|mesh-ancestor
102453320|NCT05536596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453321|NCT05536596|Protective Agents|protective agents|mesh-ancestor
102453322|NCT05536596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453323|NCT05536596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102453324|NCT05536596|Hematinics|hematinics|mesh-ancestor
102453325|NCT05536596|Vitamin B Complex|vitamin b complex|mesh-ancestor
102453326|NCT05536596|Vitamins|vitamins|mesh-ancestor
102453327|NCT05536596|Micronutrients|micronutrients|mesh-ancestor
102453328|NCT03469011|Imatinib Mesylate|imatinib mesylate|mesh-list
102453329|NCT03469011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102083431|NCT02259777|Vasodilator Agents|vasodilator agents|mesh-ancestor
102453330|NCT03469011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102453331|NCT03469011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102453332|NCT03469011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453333|NCT05488626|Immunomodulating Agents|immunomodulating agents|mesh-list
102453334|NCT05488626|Immunologic Factors|immunologic factors|mesh-ancestor
102453335|NCT05488626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453336|NCT03430791|Nivolumab|nivolumab|mesh-list
102453337|NCT03430791|Ipilimumab|ipilimumab|mesh-list
102453338|NCT03430791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102453339|NCT03430791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102453340|NCT03430791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102453341|NCT03430791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453342|NCT05536128|Fulvestrant|fulvestrant|mesh-list
102453343|NCT05536128|Olaparib|olaparib|mesh-list
102453344|NCT05536128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102453345|NCT05536128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102453346|NCT05536128|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102453347|NCT05536128|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102453348|NCT05536128|Hormone Antagonists|hormone antagonists|mesh-ancestor
102453349|NCT05536128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102453350|NCT05536128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453351|NCT05536128|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102453352|NCT05536128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102453353|NCT05536128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453354|NCT04790175|Tolvaptan|tolvaptan|mesh-list
102453355|NCT04790175|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102453356|NCT04790175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453357|NCT04790175|Natriuretic Agents|natriuretic agents|mesh-ancestor
102453358|NCT04790175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453359|NCT05316675|Isotretinoin|isotretinoin|mesh-list
102453360|NCT05316675|Dermatologic Agents|dermatologic agents|mesh-ancestor
102453361|NCT02582814|Dapagliflozin|dapagliflozin|mesh-list
102453362|NCT02582814|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102453363|NCT02582814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453364|NCT02582814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102453365|NCT02582814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453366|NCT01736865|Cholecalciferol|cholecalciferol|mesh-list
102453367|NCT01736865|Vitamin D|vitamin d|mesh-list
102453368|NCT01736865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102453369|NCT01736865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453370|NCT01736865|Vitamins|vitamins|mesh-ancestor
102453371|NCT01736865|Micronutrients|micronutrients|mesh-ancestor
102453372|NCT01736865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102453373|NCT01736943|Doxorubicin|doxorubicin|mesh-list
102453374|NCT01736943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102453375|NCT01736943|Bortezomib|bortezomib|mesh-list
102453376|NCT01736943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102453377|NCT01736943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102453378|NCT01736943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102453379|NCT01736943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102453380|NCT01736943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102453381|NCT01736943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453382|NCT01739361|Acetaminophen|acetaminophen|mesh-list
102453383|NCT01739361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102453384|NCT01739361|Analgesics|analgesics|mesh-ancestor
102453385|NCT01739361|Sensory System Agents|sensory system agents|mesh-ancestor
102453386|NCT01739361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102453387|NCT01739361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453388|NCT01739361|Antipyretics|antipyretics|mesh-ancestor
102453389|NCT01743729|Lifitegrast|lifitegrast|mesh-list
102453390|NCT01743729|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102453391|NCT01743729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102453392|NCT01744353|Oxaliplatin|oxaliplatin|mesh-list
102453393|NCT01744353|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102453394|NCT01744353|Paclitaxel|paclitaxel|mesh-list
102453395|NCT01744353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102453396|NCT01744353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453397|NCT01744353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102453398|NCT01744353|Tubulin Modulators|tubulin modulators|mesh-ancestor
102453399|NCT01744353|Antimitotic Agents|antimitotic agents|mesh-ancestor
102453400|NCT01744353|Mitosis Modulators|mitosis modulators|mesh-ancestor
102453401|NCT01744821|Vitamin D|vitamin d|mesh-list
102453402|NCT01744821|Cholecalciferol|cholecalciferol|mesh-list
102453403|NCT01744821|Vitamins|vitamins|mesh-ancestor
102453404|NCT01744821|Micronutrients|micronutrients|mesh-ancestor
102453405|NCT01744821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453406|NCT01744821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102453407|NCT01744821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102453408|NCT04369365|Azithromycin|azithromycin|mesh-list
102453409|NCT04369365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102453410|NCT04369365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102453411|NCT01745055|Methotrexate|methotrexate|mesh-list
102453412|NCT01745055|Tofacitinib|tofacitinib|mesh-list
102453413|NCT01745055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102453414|NCT01745055|Abortifacient Agents|abortifacient agents|mesh-ancestor
102453415|NCT01745055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102453416|NCT01745055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453417|NCT01745055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102453418|NCT01745055|Antimetabolites|antimetabolites|mesh-ancestor
102453419|NCT01745055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453420|NCT01745055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102453421|NCT01745055|Dermatologic Agents|dermatologic agents|mesh-ancestor
102453422|NCT01745055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102453423|NCT01745055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102453424|NCT01745055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102453425|NCT01745055|Immunologic Factors|immunologic factors|mesh-ancestor
102453427|NCT01745055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102453428|NCT01745055|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102453429|NCT01745055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102453430|NCT01745133|Calcitriol|calcitriol|mesh-list
102453431|NCT01745133|Clobetasol|clobetasol|mesh-list
102453432|NCT01745133|Calcipotriene|calcipotriene|mesh-list
102453433|NCT01745133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102453434|NCT01745133|Glucocorticoids|glucocorticoids|mesh-ancestor
102453435|NCT01745133|Hormones|hormones|mesh-ancestor
102453436|NCT01745133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102453437|NCT01745133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453438|NCT01745133|Dermatologic Agents|dermatologic agents|mesh-ancestor
102453439|NCT01745133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102453440|NCT01745133|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102453441|NCT01745133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102453442|NCT01745133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453443|NCT01745133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102453444|NCT01745133|Vitamins|vitamins|mesh-ancestor
102453445|NCT01745133|Micronutrients|micronutrients|mesh-ancestor
102453446|NCT01745133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102453447|NCT05302011|Carboplatin|carboplatin|mesh-list
102453448|NCT05302011|Docetaxel|docetaxel|mesh-list
102453449|NCT05302011|Pembrolizumab|pembrolizumab|mesh-list
102453450|NCT05302011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102453451|NCT05302011|Tubulin Modulators|tubulin modulators|mesh-ancestor
102453452|NCT05302011|Antimitotic Agents|antimitotic agents|mesh-ancestor
102453453|NCT05302011|Mitosis Modulators|mitosis modulators|mesh-ancestor
102453454|NCT05302011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453455|NCT05302011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102453456|NCT05302011|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102453457|NCT04769271|Tea Tree Oil|tea tree oil|mesh-list
102453458|NCT04769271|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102453459|NCT04769271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102453460|NCT04246359|Interferons|interferons|mesh-list
102453461|NCT04246359|Rituximab|rituximab|mesh-list
102453462|NCT04246359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102453463|NCT04246359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102453464|NCT04246359|Immunologic Factors|immunologic factors|mesh-ancestor
102453465|NCT04246359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453466|NCT04246359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102453467|NCT04246359|Antiviral Agents|antiviral agents|mesh-ancestor
102453468|NCT04246359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102453469|NCT05213169|Apomorphine|apomorphine|mesh-list
102453470|NCT05213169|Emetics|emetics|mesh-ancestor
102453471|NCT05213169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453472|NCT05213169|Autonomic Agents|autonomic agents|mesh-ancestor
102453473|NCT05213169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102453474|NCT05213169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102453475|NCT05213169|Dopamine Agonists|dopamine agonists|mesh-ancestor
102453476|NCT05213169|Dopamine Agents|dopamine agents|mesh-ancestor
102453477|NCT05213169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102453478|NCT05213169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453479|NCT05192265|Artesunate|artesunate|mesh-list
102453480|NCT05192265|Lumefantrine|lumefantrine|mesh-list
102453481|NCT05192265|Artemether|artemether|mesh-list
102453482|NCT05192265|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102453483|NCT05192265|Pyronaridine|pyronaridine|mesh-list
102453484|NCT05192265|Antimalarials|antimalarials|mesh-list
102453485|NCT05192265|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
102453486|NCT05192265|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102453487|NCT05192265|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102453488|NCT05192265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102453489|NCT05192265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102453490|NCT05192265|Antiviral Agents|antiviral agents|mesh-ancestor
102453491|NCT05192265|Schistosomicides|schistosomicides|mesh-ancestor
102453492|NCT05192265|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102453493|NCT05192265|Anthelmintics|anthelmintics|mesh-ancestor
102453494|NCT01748643|Glycopyrrolate|glycopyrrolate|mesh-list
102453495|NCT01748643|Rocuronium|rocuronium|mesh-list
102453496|NCT01748643|Neostigmine|neostigmine|mesh-list
102453497|NCT01748643|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102453498|NCT01748643|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102453499|NCT01748643|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102453500|NCT01748643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102154231|NCT01595061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453501|NCT01748643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453502|NCT01748643|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102453503|NCT01748643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102453504|NCT01748643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453505|NCT01748643|Cholinergic Agents|cholinergic agents|mesh-ancestor
102453506|NCT01748643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102453507|NCT01748643|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102453508|NCT01748643|Autonomic Agents|autonomic agents|mesh-ancestor
102453509|NCT01748643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102453510|NCT01748643|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102453511|NCT01748643|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102453512|NCT00106535|Methotrexate|methotrexate|mesh-list
102453513|NCT00106535|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102453514|NCT00106535|Abortifacient Agents|abortifacient agents|mesh-ancestor
102453515|NCT00106535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102453516|NCT00106535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453517|NCT00106535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102453518|NCT00106535|Antimetabolites|antimetabolites|mesh-ancestor
102453519|NCT00106535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453520|NCT00106535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102453521|NCT00106535|Dermatologic Agents|dermatologic agents|mesh-ancestor
102453522|NCT00106535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102453523|NCT00106535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102453524|NCT00106535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102453525|NCT00106535|Immunologic Factors|immunologic factors|mesh-ancestor
102453526|NCT00106535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102453527|NCT00106535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102453528|NCT01748799|Ethanol|ethanol|mesh-list
102453529|NCT01748799|Nabiximols|nabiximols|mesh-list
102453530|NCT01748799|Dronabinol|dronabinol|mesh-list
102453531|NCT01748799|Cannabidiol|cannabidiol|mesh-list
102453532|NCT01748799|Peppermint oil|peppermint oil|mesh-list
102453533|NCT01748799|Anticonvulsants|anticonvulsants|mesh-ancestor
102453534|NCT01748799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102453535|NCT01748799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102453536|NCT01748799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102453537|NCT01748799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453538|NCT01748799|Analgesics|analgesics|mesh-ancestor
102453539|NCT01748799|Sensory System Agents|sensory system agents|mesh-ancestor
102453540|NCT01748799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102453541|NCT01748799|Hallucinogens|hallucinogens|mesh-ancestor
102453542|NCT01748799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102453543|NCT01748799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102453544|NCT01748799|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102453545|NCT01748799|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102453546|NCT01748799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102453547|NCT01748799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453548|NCT01748799|Hormones|hormones|mesh-ancestor
102453549|NCT01748799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102453550|NCT01748799|Antiemetics|antiemetics|mesh-ancestor
102453551|NCT01748799|Autonomic Agents|autonomic agents|mesh-ancestor
102453552|NCT01748799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102453553|NCT01748799|Parasympatholytics|parasympatholytics|mesh-ancestor
102453554|NCT04107051|Nalmefene|nalmefene|mesh-list
102453555|NCT04107051|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102453556|NCT04107051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453557|NCT04107051|Sensory System Agents|sensory system agents|mesh-ancestor
102453558|NCT04107051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102453559|NCT05696886|Meperidine|meperidine|mesh-list
102453560|NCT05696886|Tramadol|tramadol|mesh-list
102453561|NCT05696886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102453562|NCT05696886|Narcotics|narcotics|mesh-ancestor
102453563|NCT05696886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102453564|NCT05696886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453565|NCT05696886|Analgesics|analgesics|mesh-ancestor
102453566|NCT05696886|Sensory System Agents|sensory system agents|mesh-ancestor
102453567|NCT05696886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102453568|NCT05696886|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102453569|NCT01748955|Bupropion|bupropion|mesh-list
102453570|NCT01748955|Paroxetine|paroxetine|mesh-list
102453571|NCT01748955|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102453572|NCT01748955|Antidepressive Agents|antidepressive agents|mesh-ancestor
102453573|NCT01748955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102453574|NCT01748955|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102453575|NCT01748955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102453576|NCT01748955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102453577|NCT01748955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453578|NCT01748955|Dopamine Agents|dopamine agents|mesh-ancestor
102453579|NCT01748955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102453580|NCT01748955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453581|NCT01748955|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102453582|NCT01748955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102453583|NCT01748955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102453584|NCT01748955|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102453585|NCT01748955|Serotonin Agents|serotonin agents|mesh-ancestor
102453586|NCT05687448|Warfarin|warfarin|mesh-list
102453587|NCT05687448|Apixaban|apixaban|mesh-list
102453588|NCT05687448|Anticoagulants|anticoagulants|mesh-ancestor
102453589|NCT05687448|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102453590|NCT05687448|Antithrombins|antithrombins|mesh-ancestor
102453591|NCT05687448|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102453592|NCT05687448|Protease Inhibitors|protease inhibitors|mesh-ancestor
102453593|NCT05687448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102453594|NCT05687448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453595|NCT01749501|Rocuronium|rocuronium|mesh-list
102453596|NCT01749501|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102453597|NCT01749501|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102453598|NCT01749501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102453599|NCT01749501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102453600|NCT01749501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453601|NCT02255175|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102453602|NCT02255175|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102453603|NCT02255175|Estradiol|estradiol|mesh-list
102453604|NCT02255175|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102453605|NCT02255175|Progesterone|progesterone|mesh-list
102453606|NCT02255175|Estrogens|estrogens|mesh-ancestor
102453607|NCT02255175|Hormones|hormones|mesh-ancestor
102453608|NCT02255175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102453609|NCT02255175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453610|NCT02255175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102453611|NCT02255175|Contraceptive Agents|contraceptive agents|mesh-ancestor
102453612|NCT02255175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102453613|NCT02255175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102453614|NCT02255175|Progestins|progestins|mesh-ancestor
102453615|NCT02585778|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102453616|NCT02585778|Alirocumab|alirocumab|mesh-list
102453617|NCT02585778|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102453618|NCT02585778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102453619|NCT02585778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102453620|NCT02585778|Antimetabolites|antimetabolites|mesh-ancestor
102453621|NCT02585778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453622|NCT02585778|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102453623|NCT02585778|Protease Inhibitors|protease inhibitors|mesh-ancestor
102453624|NCT02585778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102453625|NCT02585778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102453626|NCT02585778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453627|NCT03899103|Mycophenolic Acid|mycophenolic acid|mesh-list
102453628|NCT03899103|Rituximab|rituximab|mesh-list
102453629|NCT03899103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102453630|NCT03899103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102453631|NCT03899103|Immunologic Factors|immunologic factors|mesh-ancestor
102453632|NCT03899103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453633|NCT03899103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102453634|NCT03899103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102453635|NCT03899103|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102453636|NCT03899103|Antitubercular Agents|antitubercular agents|mesh-ancestor
102453637|NCT03899103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102453638|NCT03899103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102453639|NCT03899103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102453640|NCT03899103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453641|NCT01751451|Abiraterone Acetate|abiraterone acetate|mesh-list
102453642|NCT01751451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102453643|NCT01751451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102453644|NCT01751451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102453645|NCT01751451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453646|NCT01751451|Hormone Antagonists|hormone antagonists|mesh-ancestor
102453647|NCT01751451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102453648|NCT01751451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453649|NCT01751451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102453650|NCT01438424|Lamivudine|lamivudine|mesh-list
102453651|NCT01438424|Entecavir|entecavir|mesh-list
102453652|NCT01438424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102453653|NCT01438424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102453654|NCT01438424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083752|NCT04434430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102453655|NCT01438424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453656|NCT01438424|Antiviral Agents|antiviral agents|mesh-ancestor
102453657|NCT01438424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102453658|NCT01438424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102453659|NCT01438424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102453660|NCT02580240|Hydrocortisone|hydrocortisone|mesh-list
102453661|NCT02580240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102453662|NCT01465958|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102453663|NCT01465958|gamma-Globulins|gamma-globulins|mesh-list
102453664|NCT01465958|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102453665|NCT01465958|Immunoglobulin G|immunoglobulin g|mesh-list
102453666|NCT01465958|Immunologic Factors|immunologic factors|mesh-ancestor
102453667|NCT01465958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453668|NCT05299866|Ketamine|ketamine|mesh-list
102453669|NCT05299866|Esketamine|esketamine|mesh-list
102453670|NCT05299866|Analgesics|analgesics|mesh-ancestor
102453671|NCT05299866|Sensory System Agents|sensory system agents|mesh-ancestor
102453672|NCT05299866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102453673|NCT05299866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453674|NCT05299866|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102453675|NCT05299866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102453676|NCT05299866|Anesthetics, General|anesthetics, general|mesh-ancestor
102453677|NCT05299866|Anesthetics|anesthetics|mesh-ancestor
102453678|NCT05299866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102453679|NCT05299866|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102453680|NCT05299866|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102453681|NCT05299866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102453682|NCT05299866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453683|NCT05299866|Antidepressive Agents|antidepressive agents|mesh-ancestor
102453684|NCT05299866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102453685|NCT04133376|Nicotine|nicotine|mesh-list
102453686|NCT04133376|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102453687|NCT04133376|Autonomic Agents|autonomic agents|mesh-ancestor
102453688|NCT04133376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102453689|NCT04133376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453690|NCT04133376|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102453691|NCT04133376|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102453692|NCT04133376|Cholinergic Agents|cholinergic agents|mesh-ancestor
102453693|NCT04133376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102453694|NCT04133376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453695|NCT01753557|Interferon alpha-2|interferon alpha-2|mesh-list
102453696|NCT01753557|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102453697|NCT01753557|Antiviral Agents|antiviral agents|mesh-ancestor
102453698|NCT01753557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102453699|NCT01753557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102453700|NCT05267886|Dobutamine|dobutamine|mesh-list
102453701|NCT05267886|Milrinone|milrinone|mesh-list
102453702|NCT05267886|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102453703|NCT05267886|Sympathomimetics|sympathomimetics|mesh-ancestor
102453704|NCT05267886|Autonomic Agents|autonomic agents|mesh-ancestor
102453705|NCT05267886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102453706|NCT05267886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453707|NCT05267886|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102453708|NCT05267886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102453709|NCT05267886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102453710|NCT05267886|Adrenergic Agents|adrenergic agents|mesh-ancestor
102453711|NCT05267886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102453712|NCT05267886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453713|NCT05267886|Protective Agents|protective agents|mesh-ancestor
102453714|NCT05267886|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102453715|NCT05267886|Vasodilator Agents|vasodilator agents|mesh-ancestor
102453716|NCT05267886|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102453717|NCT05267886|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102453718|NCT05267886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102453719|NCT02250807|Sofosbuvir|sofosbuvir|mesh-list
102453720|NCT02250807|Simeprevir|simeprevir|mesh-list
102453721|NCT02250807|Antiviral Agents|antiviral agents|mesh-ancestor
102453722|NCT02250807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102453723|NCT02250807|Protease Inhibitors|protease inhibitors|mesh-ancestor
102453724|NCT02250807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102453725|NCT02250807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453726|NCT05694936|Cetuximab|cetuximab|mesh-list
102453727|NCT05694936|Panitumumab|panitumumab|mesh-list
102453728|NCT05694936|Valproic Acid|valproic acid|mesh-list
102453729|NCT05694936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102453730|NCT05694936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102453731|NCT05694936|Anticonvulsants|anticonvulsants|mesh-ancestor
102453732|NCT05694936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102453733|NCT05694936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453734|NCT05694936|GABA Agents|gaba agents|mesh-ancestor
102453735|NCT05694936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102453736|NCT05694936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453737|NCT05694936|Antimanic Agents|antimanic agents|mesh-ancestor
102453738|NCT05694936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102453739|NCT05694936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102453740|NCT05694936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102453741|NCT00168389|Dexamethasone|dexamethasone|mesh-list
102453742|NCT00168389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102453743|NCT00168389|Antiemetics|antiemetics|mesh-ancestor
102453744|NCT00168389|Autonomic Agents|autonomic agents|mesh-ancestor
102453745|NCT00168389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102453746|NCT00168389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453747|NCT00168389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102453748|NCT00168389|Glucocorticoids|glucocorticoids|mesh-ancestor
102453749|NCT00168389|Hormones|hormones|mesh-ancestor
102453750|NCT00168389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102453751|NCT00168389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102453752|NCT00168389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102453753|NCT02252445|Propofol|propofol|mesh-list
102453754|NCT02252445|Sevoflurane|sevoflurane|mesh-list
102453755|NCT02252445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102453756|NCT02252445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102453757|NCT02252445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453758|NCT02252445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102453759|NCT02252445|Anesthetics, General|anesthetics, general|mesh-ancestor
102453760|NCT02252445|Anesthetics|anesthetics|mesh-ancestor
102453761|NCT02252445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102453762|NCT02252445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102453763|NCT04592952|Calcitonin|calcitonin|mesh-list
102453764|NCT04592952|Salmon calcitonin|salmon calcitonin|mesh-list
102453765|NCT04592952|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
102453766|NCT04592952|Erenumab|erenumab|mesh-list
102453767|NCT04592952|Katacalcin|katacalcin|mesh-list
102453768|NCT04592952|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
102453769|NCT04592952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453770|NCT04592952|Analgesics|analgesics|mesh-ancestor
102453771|NCT04592952|Sensory System Agents|sensory system agents|mesh-ancestor
102453772|NCT04592952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102453773|NCT04592952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453774|NCT04592952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102453775|NCT04592952|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102453776|NCT04592952|Vasodilator Agents|vasodilator agents|mesh-ancestor
102453777|NCT00176423|Galantamine|galantamine|mesh-list
102453778|NCT00176423|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102453779|NCT00176423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102453780|NCT00176423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453781|NCT00176423|Cholinergic Agents|cholinergic agents|mesh-ancestor
102453782|NCT00176423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102453783|NCT00176423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453784|NCT00176423|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102453785|NCT00176423|Autonomic Agents|autonomic agents|mesh-ancestor
102453786|NCT00176423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102453787|NCT00176423|Nootropic Agents|nootropic agents|mesh-ancestor
102453788|NCT02094443|Ribavirin|ribavirin|mesh-list
102453789|NCT02094443|Antimetabolites|antimetabolites|mesh-ancestor
102453790|NCT02094443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453791|NCT02094443|Antiviral Agents|antiviral agents|mesh-ancestor
102453792|NCT02094443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102453793|NCT00110513|Antithrombins|antithrombins|mesh-list
102453794|NCT00110513|Antithrombin III|antithrombin iii|mesh-list
102453795|NCT00110513|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102453796|NCT00110513|Protease Inhibitors|protease inhibitors|mesh-ancestor
102453797|NCT00110513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102453798|NCT00110513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453799|NCT00110513|Anticoagulants|anticoagulants|mesh-ancestor
102453800|NCT05691426|Nitric Oxide|nitric oxide|mesh-list
102453801|NCT05691426|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102154232|NCT03367143|Carboplatin|carboplatin|mesh-list
102265438|NCT04281108|Xhance|xhance|mesh-list
102453802|NCT05691426|Autonomic Agents|autonomic agents|mesh-ancestor
102453803|NCT05691426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102453804|NCT05691426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453805|NCT05691426|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102453806|NCT05691426|Respiratory System Agents|respiratory system agents|mesh-ancestor
102453807|NCT05691426|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102453808|NCT05691426|Antioxidants|antioxidants|mesh-ancestor
102453809|NCT05691426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453810|NCT05691426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102453811|NCT05691426|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102453812|NCT05691426|Vasodilator Agents|vasodilator agents|mesh-ancestor
102453813|NCT05691426|Gasotransmitters|gasotransmitters|mesh-ancestor
102453814|NCT05691426|Protective Agents|protective agents|mesh-ancestor
102453815|NCT05696574|Misoprostol|misoprostol|mesh-list
102453816|NCT05696574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102453817|NCT05696574|Abortifacient Agents|abortifacient agents|mesh-ancestor
102453818|NCT05696574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102453819|NCT05696574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453820|NCT05696574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102453821|NCT05696574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102453822|NCT05696574|Oxytocics|oxytocics|mesh-ancestor
102453823|NCT00112151|Methyltestosterone|methyltestosterone|mesh-list
102453824|NCT00112151|Testosterone|testosterone|mesh-list
102453825|NCT00112151|Testosterone undecanoate|testosterone undecanoate|mesh-list
102453826|NCT00112151|Testosterone enanthate|testosterone enanthate|mesh-list
102453827|NCT00112151|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102453828|NCT00112151|Androgens|androgens|mesh-ancestor
102453829|NCT00112151|Hormones|hormones|mesh-ancestor
102453830|NCT00112151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102453831|NCT00112151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453832|NCT00112151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102453833|NCT00112151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102453834|NCT00112151|Anabolic Agents|anabolic agents|mesh-ancestor
102453835|NCT05162742|Colchicine|colchicine|mesh-list
102453836|NCT05162742|Gout Suppressants|gout suppressants|mesh-ancestor
102453837|NCT05162742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102453838|NCT05162742|Tubulin Modulators|tubulin modulators|mesh-ancestor
102453839|NCT05162742|Antimitotic Agents|antimitotic agents|mesh-ancestor
102453840|NCT05162742|Mitosis Modulators|mitosis modulators|mesh-ancestor
102453841|NCT05162742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453842|NCT05162742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102453843|NCT04303026|Zoledronic Acid|zoledronic acid|mesh-list
102453844|NCT04303026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102453845|NCT04303026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453846|NCT00113321|Decitabine|decitabine|mesh-list
102453847|NCT00113321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102453848|NCT00113321|Antimetabolites|antimetabolites|mesh-ancestor
102453849|NCT00113321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453850|NCT00113321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102453851|NCT00113321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102453852|NCT05669742|Empagliflozin|empagliflozin|mesh-list
102453853|NCT05669742|Olanzapine|olanzapine|mesh-list
102453854|NCT05669742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102453855|NCT05669742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453856|NCT05669742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102453857|NCT05669742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453858|NCT05669742|Antiemetics|antiemetics|mesh-ancestor
102453859|NCT05669742|Autonomic Agents|autonomic agents|mesh-ancestor
102453860|NCT05669742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102453861|NCT05669742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102453862|NCT05669742|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102453863|NCT05669742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102453864|NCT05669742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102453865|NCT05669742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102453866|NCT05669742|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102453867|NCT05669742|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102453868|NCT05669742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102453869|NCT05669742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102453870|NCT05669742|Serotonin Agents|serotonin agents|mesh-ancestor
102453871|NCT00177047|Cyclophosphamide|cyclophosphamide|mesh-list
102453872|NCT00177047|Melphalan|melphalan|mesh-list
102453873|NCT00177047|Lenograstim|lenograstim|mesh-list
102453874|NCT00177047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102453875|NCT00177047|Immunologic Factors|immunologic factors|mesh-ancestor
102453876|NCT00177047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453877|NCT00177047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102453878|NCT00177047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102453879|NCT00177047|Alkylating Agents|alkylating agents|mesh-ancestor
102453880|NCT00177047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453881|NCT00177047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102453882|NCT00177047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102453883|NCT00177047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102453884|NCT03573921|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102453885|NCT00178841|Rosiglitazone|rosiglitazone|mesh-list
102453886|NCT00178841|Bexarotene|bexarotene|mesh-list
102453887|NCT00178841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102453888|NCT00178841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453889|NCT00178841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102453890|NCT01756209|Acetaminophen|acetaminophen|mesh-list
102453891|NCT01756209|Ibuprofen|ibuprofen|mesh-list
102453892|NCT01756209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102453893|NCT01756209|Analgesics|analgesics|mesh-ancestor
102453894|NCT01756209|Sensory System Agents|sensory system agents|mesh-ancestor
102453895|NCT01756209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102453896|NCT01756209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453897|NCT01756209|Antipyretics|antipyretics|mesh-ancestor
102453898|NCT01756209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102453899|NCT01756209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102453900|NCT01756209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102453901|NCT01756209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102453902|NCT01756209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102453903|NCT01756209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453904|NCT00116207|Niacinamide|niacinamide|mesh-list
102453905|NCT00116207|Allopurinol|allopurinol|mesh-list
102453906|NCT00116207|Antioxidants|antioxidants|mesh-list
102453907|NCT00116207|Antimetabolites|antimetabolites|mesh-ancestor
102453908|NCT00116207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453909|NCT00116207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102453910|NCT00116207|Gout Suppressants|gout suppressants|mesh-ancestor
102453911|NCT00116207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102453912|NCT00116207|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102453913|NCT00116207|Protective Agents|protective agents|mesh-ancestor
102453914|NCT00116207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453915|NCT00116207|Vitamin B Complex|vitamin b complex|mesh-ancestor
102453916|NCT00116207|Vitamins|vitamins|mesh-ancestor
102453917|NCT00116207|Micronutrients|micronutrients|mesh-ancestor
102453918|NCT04129398|Letermovir|letermovir|mesh-list
102453919|NCT04129398|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102453920|NCT04129398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102453921|NCT04129398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453922|NCT04129398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102453923|NCT04129398|Antiviral Agents|antiviral agents|mesh-ancestor
102453924|NCT04129398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102453925|NCT00178919|Trimethaphan|trimethaphan|mesh-list
102453926|NCT00178919|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
102453927|NCT00178919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453928|NCT00178919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102453929|NCT00178919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102453930|NCT00178919|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
102453931|NCT00178919|Autonomic Agents|autonomic agents|mesh-ancestor
102453932|NCT00178919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102453933|NCT00178919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453934|NCT00178919|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102453935|NCT00178919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102453936|NCT00178919|Cholinergic Agents|cholinergic agents|mesh-ancestor
102453937|NCT00178919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102453938|NCT00178919|Vasodilator Agents|vasodilator agents|mesh-ancestor
102453939|NCT05609682|Gabapentin|gabapentin|mesh-list
102453940|NCT05609682|Analgesics|analgesics|mesh-ancestor
102453941|NCT05609682|Sensory System Agents|sensory system agents|mesh-ancestor
102453942|NCT05609682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102453943|NCT05609682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453944|NCT05609682|Anticonvulsants|anticonvulsants|mesh-ancestor
102453945|NCT05609682|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102453946|NCT05609682|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102453947|NCT05609682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102453948|NCT05609682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102453949|NCT05609682|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102265531|NCT04057898|Ibudilast|ibudilast|mesh-list
102453950|NCT05609682|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102453951|NCT05609682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102453952|NCT05609682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453954|NCT04284839|Warfarin|warfarin|mesh-list
102453955|NCT04284839|Rivaroxaban|rivaroxaban|mesh-list
102453956|NCT04284839|Dabigatran|dabigatran|mesh-list
102453957|NCT04284839|Apixaban|apixaban|mesh-list
102453958|NCT04284839|Edoxaban|edoxaban|mesh-list
102453959|NCT04284839|Anticoagulants|anticoagulants|mesh-ancestor
102453960|NCT04284839|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102453961|NCT04284839|Antithrombins|antithrombins|mesh-ancestor
102453962|NCT04284839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102453963|NCT04284839|Protease Inhibitors|protease inhibitors|mesh-ancestor
102453964|NCT04284839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102453965|NCT04284839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453966|NCT05577000|Cyclophosphamide|cyclophosphamide|mesh-list
102453967|NCT05577000|Fludarabine|fludarabine|mesh-list
102453968|NCT05577000|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
102453969|NCT05577000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102453970|NCT05577000|Immunologic Factors|immunologic factors|mesh-ancestor
102453971|NCT05577000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453972|NCT05577000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102453973|NCT05577000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102453974|NCT05577000|Alkylating Agents|alkylating agents|mesh-ancestor
102453975|NCT05577000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453976|NCT05577000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102453977|NCT05577000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102453978|NCT05577000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102453979|NCT00122369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
102453980|NCT00122369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102453981|NCT00122369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453982|NCT00122447|Aspirin|aspirin|mesh-list
102453983|NCT00122447|Thioctic Acid|thioctic acid|mesh-list
102453984|NCT00122447|Olmesartan|olmesartan|mesh-list
102453985|NCT00122447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102453986|NCT00122447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102453987|NCT00122447|Analgesics|analgesics|mesh-ancestor
102453988|NCT00122447|Sensory System Agents|sensory system agents|mesh-ancestor
102453989|NCT00122447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102453990|NCT00122447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102453991|NCT00122447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102453992|NCT00122447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102453993|NCT00122447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102453994|NCT00122447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102453995|NCT00122447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102453996|NCT00122447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102453997|NCT00122447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102453998|NCT00122447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102453999|NCT00122447|Antipyretics|antipyretics|mesh-ancestor
102454000|NCT00122447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102454001|NCT00122447|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102454002|NCT00122447|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102454003|NCT00122447|Antioxidants|antioxidants|mesh-ancestor
102454004|NCT00122447|Protective Agents|protective agents|mesh-ancestor
102454005|NCT00122447|Vitamin B Complex|vitamin b complex|mesh-ancestor
102454006|NCT00122447|Vitamins|vitamins|mesh-ancestor
102454007|NCT00122447|Micronutrients|micronutrients|mesh-ancestor
102454008|NCT00125957|Bupropion|bupropion|mesh-list
102454009|NCT00125957|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102454010|NCT00125957|Antidepressive Agents|antidepressive agents|mesh-ancestor
102454011|NCT00125957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102454012|NCT00125957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102454013|NCT00125957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102454014|NCT00125957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102454015|NCT00125957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454016|NCT00125957|Dopamine Agents|dopamine agents|mesh-ancestor
102454017|NCT00125957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102454018|NCT00125957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454019|NCT00125957|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102454020|NCT00125957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102454021|NCT00125957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102454022|NCT00183443|Valproic Acid|valproic acid|mesh-list
102454023|NCT00183443|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102454024|NCT00183443|Antidepressive Agents|antidepressive agents|mesh-ancestor
102454025|NCT00183443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102454026|NCT00183443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102454027|NCT00183443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102454028|NCT00183443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102454029|NCT00183443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454030|NCT00183443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102454031|NCT00183443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454032|NCT00183443|Antimanic Agents|antimanic agents|mesh-ancestor
102454033|NCT00183443|Anticonvulsants|anticonvulsants|mesh-ancestor
102454034|NCT00183443|GABA Agents|gaba agents|mesh-ancestor
102454035|NCT00183443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102454036|NCT02579928|Midazolam|midazolam|mesh-list
102454037|NCT02579928|Ketamine|ketamine|mesh-list
102454038|NCT02579928|Analgesics|analgesics|mesh-ancestor
102454039|NCT02579928|Sensory System Agents|sensory system agents|mesh-ancestor
102454040|NCT02579928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102454041|NCT02579928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454042|NCT02579928|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102454043|NCT02579928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102454044|NCT02579928|Anesthetics, General|anesthetics, general|mesh-ancestor
102454045|NCT02579928|Anesthetics|anesthetics|mesh-ancestor
102454046|NCT02579928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102454047|NCT02579928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102454048|NCT02579928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102454049|NCT02579928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102454050|NCT02579928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454051|NCT02579928|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102454052|NCT02579928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102454053|NCT02579928|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102454054|NCT02579928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102454055|NCT02579928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102454056|NCT02579928|GABA Modulators|gaba modulators|mesh-ancestor
102454057|NCT02579928|GABA Agents|gaba agents|mesh-ancestor
102454058|NCT00183677|Escitalopram|escitalopram|mesh-list
102454059|NCT00183677|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102454060|NCT00183677|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102454061|NCT00183677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102454062|NCT00183677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454063|NCT00183677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102454064|NCT00183677|Serotonin Agents|serotonin agents|mesh-ancestor
102454065|NCT00183677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454066|NCT00186017|Olanzapine|olanzapine|mesh-list
102454067|NCT00186017|Antiemetics|antiemetics|mesh-ancestor
102454068|NCT00186017|Autonomic Agents|autonomic agents|mesh-ancestor
102454069|NCT00186017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102454070|NCT00186017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454071|NCT00186017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102454072|NCT00186017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102454073|NCT00186017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102454074|NCT00186017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102454075|NCT00186017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102454076|NCT00186017|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102454077|NCT00186017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102454078|NCT00186017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102454079|NCT00186017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454080|NCT00186017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102454081|NCT00186017|Serotonin Agents|serotonin agents|mesh-ancestor
102454082|NCT00041119|Paclitaxel|paclitaxel|mesh-list
102454083|NCT00041119|Cyclophosphamide|cyclophosphamide|mesh-list
102454084|NCT00041119|Doxorubicin|doxorubicin|mesh-list
102454085|NCT00041119|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102454086|NCT00041119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102454087|NCT00041119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102454088|NCT00041119|Tubulin Modulators|tubulin modulators|mesh-ancestor
102454089|NCT00041119|Antimitotic Agents|antimitotic agents|mesh-ancestor
102454090|NCT00041119|Mitosis Modulators|mitosis modulators|mesh-ancestor
102454091|NCT00041119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454092|NCT00041119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102454093|NCT00041119|Immunologic Factors|immunologic factors|mesh-ancestor
102454094|NCT00041119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454095|NCT00041119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102454096|NCT00041119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102454097|NCT00041119|Alkylating Agents|alkylating agents|mesh-ancestor
102454098|NCT00041119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102454099|NCT00041119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102154233|NCT03367143|Etoposide|etoposide|mesh-list
102454100|NCT00041119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102454102|NCT00041119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102454103|NCT00186875|Cytarabine|cytarabine|mesh-list
102454104|NCT00186875|Dexamethasone|dexamethasone|mesh-list
102454105|NCT00186875|Dexamethasone acetate|dexamethasone acetate|mesh-list
102454106|NCT00186875|Cyclophosphamide|cyclophosphamide|mesh-list
102454107|NCT00186875|Methotrexate|methotrexate|mesh-list
102454108|NCT00186875|Etoposide|etoposide|mesh-list
102454109|NCT00186875|Etoposide phosphate|etoposide phosphate|mesh-list
102454110|NCT00186875|Vincristine|vincristine|mesh-list
102454111|NCT00186875|Asparaginase|asparaginase|mesh-list
102454112|NCT00186875|Mitoxantrone|mitoxantrone|mesh-list
102454113|NCT00186875|Mercaptopurine|mercaptopurine|mesh-list
102454114|NCT00186875|Vinblastine|vinblastine|mesh-list
102454115|NCT00186875|Pegaspargase|pegaspargase|mesh-list
102454116|NCT00186875|Teniposide|teniposide|mesh-list
102454117|NCT00186875|BB 1101|bb 1101|mesh-list
102454118|NCT00186875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102454119|NCT00186875|Immunologic Factors|immunologic factors|mesh-ancestor
102454120|NCT00186875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454121|NCT00186875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102454122|NCT00186875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102454123|NCT00186875|Alkylating Agents|alkylating agents|mesh-ancestor
102454124|NCT00186875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454125|NCT00186875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102454126|NCT00186875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102454127|NCT00186875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102454128|NCT00186875|Antiemetics|antiemetics|mesh-ancestor
102454129|NCT00186875|Autonomic Agents|autonomic agents|mesh-ancestor
102454130|NCT00186875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102454131|NCT00186875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102454132|NCT00186875|Glucocorticoids|glucocorticoids|mesh-ancestor
102454133|NCT00186875|Hormones|hormones|mesh-ancestor
102454134|NCT00186875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102454135|NCT00186875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102454136|NCT00186875|Protease Inhibitors|protease inhibitors|mesh-ancestor
102454137|NCT00186875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102454138|NCT00186875|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102454139|NCT00186875|Abortifacient Agents|abortifacient agents|mesh-ancestor
102454140|NCT00186875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102454141|NCT00186875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102454142|NCT00186875|Antimetabolites|antimetabolites|mesh-ancestor
102454143|NCT00186875|Dermatologic Agents|dermatologic agents|mesh-ancestor
102454144|NCT00186875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102454145|NCT00186875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102454146|NCT00186875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102454147|NCT00186875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102454148|NCT00186875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102454149|NCT00186875|Antiviral Agents|antiviral agents|mesh-ancestor
102454150|NCT00186875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102454151|NCT00186875|Tubulin Modulators|tubulin modulators|mesh-ancestor
102454152|NCT00186875|Antimitotic Agents|antimitotic agents|mesh-ancestor
102454153|NCT00186875|Mitosis Modulators|mitosis modulators|mesh-ancestor
102454154|NCT00186875|Analgesics|analgesics|mesh-ancestor
102454155|NCT00186875|Sensory System Agents|sensory system agents|mesh-ancestor
102454156|NCT00551460|Methotrexate|methotrexate|mesh-list
102454157|NCT00551460|Mercaptopurine|mercaptopurine|mesh-list
102454158|NCT00551460|Arsenic Trioxide|arsenic trioxide|mesh-list
102454159|NCT00551460|Tretinoin|tretinoin|mesh-list
102454160|NCT00551460|Gemtuzumab|gemtuzumab|mesh-list
102454161|NCT00551460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102454162|NCT00551460|Abortifacient Agents|abortifacient agents|mesh-ancestor
102454163|NCT00551460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102454164|NCT00551460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454165|NCT00551460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102454166|NCT00551460|Antimetabolites|antimetabolites|mesh-ancestor
102454167|NCT00551460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454168|NCT00551460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102454169|NCT00551460|Dermatologic Agents|dermatologic agents|mesh-ancestor
102454170|NCT00551460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102454171|NCT00551460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102454172|NCT00551460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102454173|NCT00551460|Immunologic Factors|immunologic factors|mesh-ancestor
102265757|NCT03064490|Pembrolizumab|pembrolizumab|mesh-list
102454174|NCT00551460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102454175|NCT00551460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102454176|NCT00551460|Keratolytic Agents|keratolytic agents|mesh-ancestor
102454177|NCT00551460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102454179|NCT00551460|Immunoconjugates|immunoconjugates|mesh-ancestor
102454180|NCT04751227|Modafinil|modafinil|mesh-list
102454181|NCT04751227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102454182|NCT04751227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454183|NCT04751227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102454184|NCT04751227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102454185|NCT04751227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102454186|NCT04751227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454187|NCT02579772|Acetylcysteine|acetylcysteine|mesh-list
102454188|NCT02579772|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102454189|NCT02579772|Antiviral Agents|antiviral agents|mesh-ancestor
102454190|NCT02579772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102454191|NCT02579772|Expectorants|expectorants|mesh-ancestor
102454192|NCT02579772|Respiratory System Agents|respiratory system agents|mesh-ancestor
102454193|NCT02579772|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102454194|NCT02579772|Antioxidants|antioxidants|mesh-ancestor
102454195|NCT02579772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454196|NCT02579772|Protective Agents|protective agents|mesh-ancestor
102454197|NCT02579772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454198|NCT02579772|Antidotes|antidotes|mesh-ancestor
102454199|NCT05535036|Dexamethasone|dexamethasone|mesh-list
102454200|NCT05535036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102454201|NCT05535036|Antiemetics|antiemetics|mesh-ancestor
102454202|NCT05535036|Autonomic Agents|autonomic agents|mesh-ancestor
102454203|NCT05535036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102454204|NCT05535036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454205|NCT05535036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102454206|NCT05535036|Glucocorticoids|glucocorticoids|mesh-ancestor
102454207|NCT05535036|Hormones|hormones|mesh-ancestor
102454208|NCT05535036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102454209|NCT05535036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102454210|NCT05535036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102454211|NCT00044005|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102454212|NCT00044005|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102454213|NCT00044005|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102454214|NCT00044005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102454215|NCT00044005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454216|NCT00044005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102454217|NCT00044005|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102454218|NCT00044005|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102454219|NCT00044005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102454220|NCT00044005|Adrenergic Agents|adrenergic agents|mesh-ancestor
102454221|NCT00044005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102454222|NCT00044005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454223|NCT00044005|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102454224|NCT00044005|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102454225|NCT00044005|Serotonin Agents|serotonin agents|mesh-ancestor
102454226|NCT00044005|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102454227|NCT00044005|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102454228|NCT00044005|Dopamine Agents|dopamine agents|mesh-ancestor
102454229|NCT02989701|Plerixafor|plerixafor|mesh-list
102454230|NCT02989701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102454231|NCT02989701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102454232|NCT02989701|Antiviral Agents|antiviral agents|mesh-ancestor
102454233|NCT02989701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102454234|NCT01790737|Cyclophosphamide|cyclophosphamide|mesh-list
102454235|NCT01790737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102454236|NCT01790737|Immunologic Factors|immunologic factors|mesh-ancestor
102454237|NCT01790737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454238|NCT01790737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102454239|NCT01790737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102454240|NCT01790737|Alkylating Agents|alkylating agents|mesh-ancestor
102454241|NCT01790737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454242|NCT01790737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102454243|NCT01790737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102454244|NCT04953156|Nitroglycerin|nitroglycerin|mesh-list
102454245|NCT04953156|Dexmedetomidine|dexmedetomidine|mesh-list
102454246|NCT04953156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102454247|NCT04953156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102454248|NCT04953156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454249|NCT04953156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102454250|NCT04953156|Analgesics|analgesics|mesh-ancestor
102454251|NCT04953156|Sensory System Agents|sensory system agents|mesh-ancestor
102454252|NCT04953156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102454253|NCT04953156|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102454254|NCT04953156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102454255|NCT04953156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102454256|NCT04953156|Adrenergic Agents|adrenergic agents|mesh-ancestor
102454257|NCT04953156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102454258|NCT04953156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454259|NCT04953156|Vasodilator Agents|vasodilator agents|mesh-ancestor
102454261|NCT01761747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102454262|NCT01761747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102454263|NCT01761747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102454264|NCT01761747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454265|NCT00045487|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102454266|NCT00045487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102454267|NCT00045487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102454268|NCT00045487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102454269|NCT00045487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454270|NCT00278863|Capecitabine|capecitabine|mesh-list
102454271|NCT00278863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102454272|NCT00278863|Antimetabolites|antimetabolites|mesh-ancestor
102454273|NCT00278863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454274|NCT00278863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102454275|NCT01762059|Pancrelipase|pancrelipase|mesh-list
102454276|NCT01762059|Pancreatin|pancreatin|mesh-list
102454277|NCT01762059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102454278|NCT04938024|Ascorbic Acid|ascorbic acid|mesh-list
102454279|NCT04938024|Vitamins|vitamins|mesh-ancestor
102454280|NCT04938024|Micronutrients|micronutrients|mesh-ancestor
102454281|NCT04938024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454282|NCT04938024|Antioxidants|antioxidants|mesh-ancestor
102454283|NCT04938024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454284|NCT04938024|Protective Agents|protective agents|mesh-ancestor
102454285|NCT01808547|Bromfenac|bromfenac|mesh-list
102454286|NCT01808547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102454287|NCT01808547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102454288|NCT01808547|Analgesics|analgesics|mesh-ancestor
102454289|NCT01808547|Sensory System Agents|sensory system agents|mesh-ancestor
102454290|NCT01808547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102454291|NCT01808547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454292|NCT01808547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102454293|NCT01808547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102454294|NCT00187655|Cefotaxime|cefotaxime|mesh-list
102454295|NCT00187655|Cefoxitin|cefoxitin|mesh-list
102454296|NCT00187655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102454297|NCT00187655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102454298|NCT02991651|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102454299|NCT02991651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102454300|NCT02991651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102454301|NCT02991651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102454302|NCT02991651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454303|NCT02579616|Lenvatinib|lenvatinib|mesh-list
102454304|NCT02579616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102454305|NCT02579616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102454306|NCT02579616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102454307|NCT02579616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454308|NCT00131885|Levonorgestrel|levonorgestrel|mesh-list
102454309|NCT00131885|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102454310|NCT00131885|Contraceptive Agents|contraceptive agents|mesh-ancestor
102454311|NCT00131885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102454312|NCT00131885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454313|NCT00131885|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102454314|NCT00131885|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102454315|NCT00131885|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102454316|NCT05534802|Urinastatin|urinastatin|mesh-list
102454317|NCT05534802|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102454318|NCT05534802|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102454319|NCT05534802|Protease Inhibitors|protease inhibitors|mesh-ancestor
102454320|NCT05534802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102454321|NCT05534802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454322|NCT01899703|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102454323|NCT01899703|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102454324|NCT01899703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102454325|NCT01899781|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102454326|NCT01899781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102454327|NCT01790893|Aflibercept|aflibercept|mesh-list
102454328|NCT01790893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102454329|NCT01790893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102454330|NCT01790893|Growth Substances|growth substances|mesh-ancestor
102454331|NCT01790893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454332|NCT01790893|Growth Inhibitors|growth inhibitors|mesh-ancestor
102454333|NCT01790893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102454334|NCT02256111|Androgens|androgens|mesh-list
102454335|NCT02256111|Hormones|hormones|mesh-ancestor
102454336|NCT02256111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102454337|NCT02256111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454338|NCT01790971|Morphine|morphine|mesh-list
102454339|NCT01790971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102454340|NCT01790971|Narcotics|narcotics|mesh-ancestor
102454341|NCT01790971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102454342|NCT01790971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454343|NCT01790971|Analgesics|analgesics|mesh-ancestor
102454344|NCT01790971|Sensory System Agents|sensory system agents|mesh-ancestor
102454345|NCT01790971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102454346|NCT00189137|Gemcitabine|gemcitabine|mesh-list
102454347|NCT00189137|Docetaxel|docetaxel|mesh-list
102454348|NCT00189137|Doxorubicin|doxorubicin|mesh-list
102454349|NCT00189137|Ifosfamide|ifosfamide|mesh-list
102454350|NCT00189137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102454351|NCT00189137|Antimetabolites|antimetabolites|mesh-ancestor
102454352|NCT00189137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454353|NCT00189137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102454354|NCT00189137|Tubulin Modulators|tubulin modulators|mesh-ancestor
102454355|NCT00189137|Antimitotic Agents|antimitotic agents|mesh-ancestor
102454356|NCT00189137|Mitosis Modulators|mitosis modulators|mesh-ancestor
102454357|NCT00189137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102454358|NCT00189137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102454359|NCT00189137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102454360|NCT00189137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102454361|NCT00189137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102454362|NCT00189137|Alkylating Agents|alkylating agents|mesh-ancestor
102454363|NCT02099461|Denosumab|denosumab|mesh-list
102454364|NCT02099461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102454365|NCT02099461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454366|NCT02256189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102454367|NCT02256189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102454368|NCT02256189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454369|NCT02256189|Incretins|incretins|mesh-ancestor
102454370|NCT02256189|Hormones|hormones|mesh-ancestor
102454371|NCT02256189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102454372|NCT02256189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102454373|NCT02256189|Protease Inhibitors|protease inhibitors|mesh-ancestor
102454374|NCT02256189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102454375|NCT02256189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454376|NCT00193037|Docetaxel|docetaxel|mesh-list
102454377|NCT00193037|Doxorubicin|doxorubicin|mesh-list
102454378|NCT00193037|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102454379|NCT00193037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102454380|NCT00193037|Tubulin Modulators|tubulin modulators|mesh-ancestor
102454381|NCT00193037|Antimitotic Agents|antimitotic agents|mesh-ancestor
102454382|NCT00193037|Mitosis Modulators|mitosis modulators|mesh-ancestor
102454383|NCT00193037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454384|NCT00193037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102454385|NCT00193037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102454386|NCT00193037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102454387|NCT00193037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102454388|NCT02100007|Topotecan|topotecan|mesh-list
102454389|NCT02100007|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102454390|NCT02100007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102454391|NCT02100007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102454392|NCT02100007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454393|NCT02100007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102454394|NCT05392764|Empagliflozin|empagliflozin|mesh-list
102454395|NCT05392764|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102454396|NCT05392764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454397|NCT05392764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102454398|NCT05392764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154234|NCT03367143|Lenalidomide|lenalidomide|mesh-list
102454399|NCT02866383|Nivolumab|nivolumab|mesh-list
102454400|NCT02866383|Ipilimumab|ipilimumab|mesh-list
102454401|NCT02866383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102454402|NCT02866383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102454403|NCT02866383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102454404|NCT02866383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454405|NCT01809639|Progesterone|progesterone|mesh-list
102454406|NCT01809639|Progestins|progestins|mesh-ancestor
102454407|NCT01809639|Hormones|hormones|mesh-ancestor
102454408|NCT01809639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102454409|NCT01809639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454410|NCT05391750|Venetoclax|venetoclax|mesh-list
102454411|NCT05391750|Immunoglobulins|immunoglobulins|mesh-list
102454412|NCT05391750|Immunoglobulin G|immunoglobulin g|mesh-list
102454413|NCT05391750|Immunologic Factors|immunologic factors|mesh-ancestor
102454414|NCT05391750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454415|NCT05391750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102454416|NCT01763931|Digoxin|digoxin|mesh-list
102454417|NCT01763931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102454418|NCT01763931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102454419|NCT01763931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102454420|NCT01763931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454421|NCT01763931|Protective Agents|protective agents|mesh-ancestor
102454422|NCT01763931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454423|NCT02822625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
102454424|NCT02822625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102454425|NCT02822625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454426|NCT04677114|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102454427|NCT04677114|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102454428|NCT04677114|Buprenorphine|buprenorphine|mesh-list
102454429|NCT04677114|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102454430|NCT04677114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102454431|NCT04677114|Antitubercular Agents|antitubercular agents|mesh-ancestor
102454432|NCT04677114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102454433|NCT04677114|Narcotics|narcotics|mesh-ancestor
102454434|NCT04677114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102454435|NCT04677114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454436|NCT04677114|Analgesics|analgesics|mesh-ancestor
102454437|NCT04677114|Sensory System Agents|sensory system agents|mesh-ancestor
102454438|NCT04677114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102454439|NCT04677114|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102454440|NCT02783859|Amoxicillin|amoxicillin|mesh-list
102454441|NCT02783859|Clavulanic Acids|clavulanic acids|mesh-list
102454442|NCT02783859|Clavulanic Acid|clavulanic acid|mesh-list
102454443|NCT02783859|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102454444|NCT02783859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102454445|NCT02783859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102454446|NCT02783859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102454447|NCT02783859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454448|NCT02783859|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102454449|NCT01765803|Thioridazine|thioridazine|mesh-list
102454450|NCT01765803|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102454451|NCT01765803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102454452|NCT01765803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102454453|NCT01765803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454454|NCT01765803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102454455|NCT01765803|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102454456|NCT01765803|Dopamine Agents|dopamine agents|mesh-ancestor
102454457|NCT01765803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102454458|NCT01765803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454459|NCT02566395|Cyclophosphamide|cyclophosphamide|mesh-list
102454460|NCT02566395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102454461|NCT02566395|Immunologic Factors|immunologic factors|mesh-ancestor
102454462|NCT02566395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454463|NCT02566395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102454464|NCT02566395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102454465|NCT02566395|Alkylating Agents|alkylating agents|mesh-ancestor
102454466|NCT02566395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454467|NCT02566395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102454468|NCT02566395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102454469|NCT01811355|Mexiletine|mexiletine|mesh-list
102454470|NCT01811355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102454471|NCT01811355|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102454472|NCT01811355|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102454473|NCT01811355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102454474|NCT01811355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454475|NCT05534334|Hydrocortisone|hydrocortisone|mesh-list
102454476|NCT05534334|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102454477|NCT05534334|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102454478|NCT05534334|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102454479|NCT05534334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102454480|NCT01767285|Etonogestrel|etonogestrel|mesh-list
102454481|NCT01767285|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102454482|NCT01767285|Contraceptive Agents|contraceptive agents|mesh-ancestor
102454483|NCT01767285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102454484|NCT01767285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454485|NCT01767285|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102454486|NCT02100891|Immunomodulating Agents|immunomodulating agents|mesh-list
102454487|NCT02100891|Immunologic Factors|immunologic factors|mesh-ancestor
102454488|NCT02100891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454489|NCT01465802|Doxycycline|doxycycline|mesh-list
102454490|NCT01465802|Alclometasone dipropionate|alclometasone dipropionate|mesh-list
102454491|NCT01465802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102454492|NCT01465802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102454493|NCT01465802|Antimalarials|antimalarials|mesh-ancestor
102454494|NCT01465802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102454495|NCT01465802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102454496|NCT01465802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102454497|NCT01465802|Glucocorticoids|glucocorticoids|mesh-ancestor
102454498|NCT01465802|Hormones|hormones|mesh-ancestor
102454499|NCT01465802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102454500|NCT01465802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454501|NCT01813149|Clonidine|clonidine|mesh-list
102454502|NCT01813149|Phenylephrine|phenylephrine|mesh-list
102454503|NCT01813149|Oxymetazoline|oxymetazoline|mesh-list
102454504|NCT01813149|Anesthetics|anesthetics|mesh-list
102454505|NCT01813149|Anesthetics, Local|anesthetics, local|mesh-list
102454506|NCT01813149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102454507|NCT01813149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454508|NCT01813149|Sensory System Agents|sensory system agents|mesh-ancestor
102454509|NCT01813149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102454510|NCT01813149|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102454511|NCT01813149|Mydriatics|mydriatics|mesh-ancestor
102454512|NCT01813149|Autonomic Agents|autonomic agents|mesh-ancestor
102454513|NCT01813149|Sympathomimetics|sympathomimetics|mesh-ancestor
102454514|NCT01813149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102454515|NCT01813149|Nasal Decongestants|nasal decongestants|mesh-ancestor
102454516|NCT01813149|Respiratory System Agents|respiratory system agents|mesh-ancestor
102454517|NCT01813149|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102454518|NCT01813149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102454519|NCT01813149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102454520|NCT01813149|Adrenergic Agents|adrenergic agents|mesh-ancestor
102454521|NCT01813149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102454522|NCT01813149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454523|NCT01813149|Protective Agents|protective agents|mesh-ancestor
102454524|NCT01813149|Analgesics|analgesics|mesh-ancestor
102454525|NCT01813149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102454526|NCT01813149|Sympatholytics|sympatholytics|mesh-ancestor
102454527|NCT01813149|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102454528|NCT00137969|Acetaminophen|acetaminophen|mesh-list
102454529|NCT00137969|Diphenhydramine|diphenhydramine|mesh-list
102454530|NCT00137969|Promethazine|promethazine|mesh-list
102454531|NCT00137969|Prednisone|prednisone|mesh-list
102454532|NCT00137969|Rituximab|rituximab|mesh-list
102454533|NCT00137969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102454534|NCT00137969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102454535|NCT00137969|Immunologic Factors|immunologic factors|mesh-ancestor
102454536|NCT00137969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454537|NCT00137969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102454538|NCT00137969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102454539|NCT00137969|Glucocorticoids|glucocorticoids|mesh-ancestor
102454540|NCT00137969|Hormones|hormones|mesh-ancestor
102454541|NCT00137969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102454542|NCT00137969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102454543|NCT00137969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102454544|NCT00137969|Analgesics|analgesics|mesh-ancestor
102454545|NCT00137969|Sensory System Agents|sensory system agents|mesh-ancestor
102454546|NCT00137969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102454547|NCT00137969|Antipyretics|antipyretics|mesh-ancestor
102454548|NCT00137969|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102454549|NCT00137969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102454550|NCT00137969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102454551|NCT00137969|Anesthetics, Local|anesthetics, local|mesh-ancestor
102454552|NCT00137969|Anesthetics|anesthetics|mesh-ancestor
102454553|NCT00137969|Antiemetics|antiemetics|mesh-ancestor
102454554|NCT00137969|Autonomic Agents|autonomic agents|mesh-ancestor
102454555|NCT00137969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102454556|NCT00137969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102454557|NCT00137969|Histamine Antagonists|histamine antagonists|mesh-ancestor
102454558|NCT00137969|Histamine Agents|histamine agents|mesh-ancestor
102454559|NCT00137969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102454560|NCT00137969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454561|NCT00137969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102454562|NCT00137969|Antipruritics|antipruritics|mesh-ancestor
102454563|NCT00137969|Dermatologic Agents|dermatologic agents|mesh-ancestor
102454564|NCT01437878|Iloprost|iloprost|mesh-list
102454565|NCT01437878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102454566|NCT01437878|Vasodilator Agents|vasodilator agents|mesh-ancestor
102454567|NCT04767308|Cyclophosphamide|cyclophosphamide|mesh-list
102454568|NCT04767308|Fludarabine|fludarabine|mesh-list
102454569|NCT04767308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102454570|NCT04767308|Immunologic Factors|immunologic factors|mesh-ancestor
102454571|NCT04767308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454572|NCT04767308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102454573|NCT04767308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102454574|NCT04767308|Alkylating Agents|alkylating agents|mesh-ancestor
102454575|NCT04767308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454576|NCT04767308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102454577|NCT04767308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102454578|NCT00138125|Trastuzumab|trastuzumab|mesh-list
102454579|NCT00138125|Fulvestrant|fulvestrant|mesh-list
102454580|NCT00138125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102454581|NCT00138125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102454582|NCT00138125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102454583|NCT00138125|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102454584|NCT00138125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102454585|NCT00138125|Hormone Antagonists|hormone antagonists|mesh-ancestor
102454586|NCT00138125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102454587|NCT00138125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454588|NCT01815333|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102454589|NCT01815333|Hematinics|hematinics|mesh-ancestor
102454590|NCT01815333|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102454591|NCT01815333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102454592|NCT01465178|Cholecalciferol|cholecalciferol|mesh-list
102454593|NCT01465178|Vitamin D|vitamin d|mesh-list
102454594|NCT01465178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102454595|NCT01465178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454596|NCT01465178|Vitamins|vitamins|mesh-ancestor
102454597|NCT01465178|Micronutrients|micronutrients|mesh-ancestor
102454598|NCT01465178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102454599|NCT00138203|Vorinostat|vorinostat|mesh-list
102454600|NCT00138203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102454601|NCT00138203|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102454602|NCT00138203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102454603|NCT00138203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454604|NCT01732809|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102454605|NCT01732809|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102454606|NCT01732809|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102454607|NCT01732809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102454608|NCT01732809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454609|NCT01732809|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102454610|NCT01732809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102454611|NCT01732809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454612|NCT01732809|Cholinergic Agents|cholinergic agents|mesh-ancestor
102454613|NCT01732809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102454614|NCT00194129|Valproic Acid|valproic acid|mesh-list
102454615|NCT00194129|Lithium Carbonate|lithium carbonate|mesh-list
102454616|NCT00194129|Antidepressive Agents|antidepressive agents|mesh-ancestor
102454617|NCT00194129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102454618|NCT00194129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102454619|NCT00194129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454620|NCT00194129|Antimanic Agents|antimanic agents|mesh-ancestor
102266202|NCT02102477|Hormones|hormones|mesh-ancestor
102454621|NCT00194129|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102454622|NCT00194129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102454623|NCT00194129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454624|NCT00194129|Anticonvulsants|anticonvulsants|mesh-ancestor
102454625|NCT00194129|GABA Agents|gaba agents|mesh-ancestor
102454626|NCT00194129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102454627|NCT01817907|Trazodone|trazodone|mesh-list
102454628|NCT01817907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102454629|NCT01817907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102454630|NCT01817907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102454631|NCT01817907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454632|NCT01817907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102454633|NCT01817907|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102454634|NCT01817907|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102454635|NCT01817907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102454636|NCT01817907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454637|NCT01817907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102454638|NCT01817907|Serotonin Agents|serotonin agents|mesh-ancestor
102454639|NCT01817907|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102454640|NCT01817907|Antidepressive Agents|antidepressive agents|mesh-ancestor
102454641|NCT01445678|Metronidazole|metronidazole|mesh-list
102454642|NCT01445678|Meropenem|meropenem|mesh-list
102454643|NCT01445678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102454644|NCT01445678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102454645|NCT01445678|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102454646|NCT01445678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102454647|NCT01818063|Paclitaxel|paclitaxel|mesh-list
102454648|NCT01818063|Cyclophosphamide|cyclophosphamide|mesh-list
102454649|NCT01818063|Carboplatin|carboplatin|mesh-list
102454650|NCT01818063|Doxorubicin|doxorubicin|mesh-list
102454651|NCT01818063|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102454652|NCT01818063|Veliparib|veliparib|mesh-list
102454653|NCT01818063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102454654|NCT01818063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102454655|NCT01818063|Tubulin Modulators|tubulin modulators|mesh-ancestor
102454656|NCT01818063|Antimitotic Agents|antimitotic agents|mesh-ancestor
102454657|NCT01818063|Mitosis Modulators|mitosis modulators|mesh-ancestor
102454658|NCT01818063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454659|NCT01818063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102454660|NCT01818063|Immunologic Factors|immunologic factors|mesh-ancestor
102454661|NCT01818063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454662|NCT01818063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102454663|NCT01818063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102454664|NCT01818063|Alkylating Agents|alkylating agents|mesh-ancestor
102454665|NCT01818063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102454666|NCT01818063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102454667|NCT01818063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102454668|NCT01818063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102454669|NCT01818063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102454670|NCT01818063|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102454671|NCT01465022|Estrogens|estrogens|mesh-list
102454672|NCT01465022|Progestins|progestins|mesh-list
102454673|NCT01465022|Hormones|hormones|mesh-ancestor
102454674|NCT01465022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102454675|NCT01465022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454676|NCT02258217|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102454677|NCT02258217|Hormones|hormones|mesh-ancestor
102454678|NCT02258217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102454679|NCT02258217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454680|NCT01464788|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102454681|NCT01464788|Argatroban|argatroban|mesh-list
102454682|NCT01464788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102454683|NCT01464788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102454684|NCT01464788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454685|NCT01464788|Antithrombins|antithrombins|mesh-ancestor
102454686|NCT01464788|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102454687|NCT01464788|Protease Inhibitors|protease inhibitors|mesh-ancestor
102454688|NCT01464788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102454689|NCT01464788|Anticoagulants|anticoagulants|mesh-ancestor
102454690|NCT01464788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102454691|NCT01444898|Exenatide|exenatide|mesh-list
102454692|NCT01444898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102454693|NCT01444898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454694|NCT01444898|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102454695|NCT01444898|Incretins|incretins|mesh-ancestor
102454696|NCT01444898|Hormones|hormones|mesh-ancestor
102454697|NCT01444898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102454699|NCT00201773|Exemestane|exemestane|mesh-list
102454700|NCT00201773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102454701|NCT00201773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102454702|NCT00201773|Analgesics|analgesics|mesh-ancestor
102454703|NCT00201773|Sensory System Agents|sensory system agents|mesh-ancestor
102454704|NCT00201773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102454705|NCT00201773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454706|NCT00201773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102454707|NCT00201773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102454708|NCT00201773|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102454709|NCT00201773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102454710|NCT00201773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102454711|NCT00201773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454712|NCT00201773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102454713|NCT00201773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102454714|NCT00201773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102454715|NCT00201773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102454716|NCT00201773|Hormone Antagonists|hormone antagonists|mesh-ancestor
102454717|NCT00201773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102454718|NCT00256217|Anastrozole|anastrozole|mesh-list
102454719|NCT00256217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102454720|NCT00256217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102454721|NCT00256217|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102454722|NCT00256217|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102454723|NCT00256217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102454724|NCT00256217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454725|NCT00256217|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102454726|NCT00256217|Hormone Antagonists|hormone antagonists|mesh-ancestor
102454727|NCT00256217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102454728|NCT00256217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454729|NCT05643066|Ketamine|ketamine|mesh-list
102454730|NCT05643066|Propofol|propofol|mesh-list
102454731|NCT05643066|Esketamine|esketamine|mesh-list
102454732|NCT05643066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102454733|NCT05643066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102454734|NCT05643066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454735|NCT05643066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102454736|NCT05643066|Anesthetics, General|anesthetics, general|mesh-ancestor
102454737|NCT05643066|Anesthetics|anesthetics|mesh-ancestor
102454738|NCT05643066|Analgesics|analgesics|mesh-ancestor
102454739|NCT05643066|Sensory System Agents|sensory system agents|mesh-ancestor
102454740|NCT05643066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102454741|NCT05643066|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102454742|NCT05643066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102454743|NCT05643066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102454744|NCT05643066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102454745|NCT05643066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454746|NCT05643066|Antidepressive Agents|antidepressive agents|mesh-ancestor
102454747|NCT05643066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102454748|NCT00256451|Ethanol|ethanol|mesh-list
102454749|NCT00256451|Naltrexone|naltrexone|mesh-list
102454750|NCT00256451|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102454751|NCT00256451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102454752|NCT00256451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102454753|NCT00256451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454754|NCT00256451|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102454755|NCT00256451|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102454756|NCT00256451|Sensory System Agents|sensory system agents|mesh-ancestor
102454757|NCT00256451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102454758|NCT03582618|Sorafenib|sorafenib|mesh-list
102454759|NCT03582618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102454760|NCT03582618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102454761|NCT03582618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102454762|NCT03582618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454763|NCT00257309|Tenecteplase|tenecteplase|mesh-list
102454764|NCT00257309|Clopidogrel|clopidogrel|mesh-list
102454765|NCT00257309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102454766|NCT00257309|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102454767|NCT00257309|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102454768|NCT00257309|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102454769|NCT00257309|Purinergic Agents|purinergic agents|mesh-ancestor
102454770|NCT00257309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102454771|NCT00257309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454772|NCT00257309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454773|NCT00257309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102454774|NCT00257309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102454775|NCT01444742|Cytarabine|cytarabine|mesh-list
102454776|NCT01444742|Clofarabine|clofarabine|mesh-list
102454777|NCT01444742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102454778|NCT01444742|Antimetabolites|antimetabolites|mesh-ancestor
102454779|NCT01444742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454780|NCT01444742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102454781|NCT01444742|Antiviral Agents|antiviral agents|mesh-ancestor
102454782|NCT01444742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102454783|NCT01444742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102454784|NCT01444742|Immunologic Factors|immunologic factors|mesh-ancestor
102454785|NCT01444742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454786|NCT01770483|Interferons|interferons|mesh-list
102454787|NCT01770483|Ribavirin|ribavirin|mesh-list
102454788|NCT01770483|Interferon-alpha|interferon-alpha|mesh-list
102454789|NCT01770483|Nitazoxanide|nitazoxanide|mesh-list
102454790|NCT01770483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102454791|NCT01770483|Antiviral Agents|antiviral agents|mesh-ancestor
102454792|NCT01770483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102454793|NCT01770483|Antimetabolites|antimetabolites|mesh-ancestor
102454794|NCT01770483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454795|NCT01770483|Immunologic Factors|immunologic factors|mesh-ancestor
102454796|NCT01770483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454797|NCT01770483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102454798|NCT00257933|Prednisolone|prednisolone|mesh-list
102454799|NCT00257933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102454800|NCT00257933|Methylprednisolone|methylprednisolone|mesh-list
102454801|NCT00257933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102454802|NCT00257933|Prednisolone acetate|prednisolone acetate|mesh-list
102454803|NCT00257933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102454804|NCT00257933|Prednisolone phosphate|prednisolone phosphate|mesh-list
102454805|NCT00257933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102454806|NCT00257933|Glucocorticoids|glucocorticoids|mesh-ancestor
102454807|NCT00257933|Hormones|hormones|mesh-ancestor
102454808|NCT00257933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102454809|NCT00257933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454810|NCT00257933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102454811|NCT00257933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102454812|NCT00257933|Antiemetics|antiemetics|mesh-ancestor
102454813|NCT00257933|Autonomic Agents|autonomic agents|mesh-ancestor
102454814|NCT00257933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102454815|NCT00257933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102454816|NCT00257933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102454817|NCT00257933|Protective Agents|protective agents|mesh-ancestor
102454818|NCT01734525|Anidulafungin|anidulafungin|mesh-list
102454819|NCT01734525|Antifungal Agents|antifungal agents|mesh-ancestor
102454820|NCT01734525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102454821|NCT01819935|Vancomycin|vancomycin|mesh-list
102454822|NCT01819935|Linezolid|linezolid|mesh-list
102454823|NCT01819935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102454824|NCT01819935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102454825|NCT01819935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102454826|NCT01819935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102454827|NCT01819935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454828|NCT01821105|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102454829|NCT01821105|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102454830|NCT01821105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454831|NCT00264641|Insulin|insulin|mesh-list
102454832|NCT00264641|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102454833|NCT00264641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102454834|NCT00264641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454835|NCT01735617|Hydrocortisone|hydrocortisone|mesh-list
102454836|NCT01735617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102454837|NCT00208091|Botulinum Toxins|botulinum toxins|mesh-list
102454838|NCT00208091|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102454839|NCT00208091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102454840|NCT00208091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454841|NCT00208091|Cholinergic Agents|cholinergic agents|mesh-ancestor
102454842|NCT00208091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102454843|NCT00208091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454844|NCT00266279|Capecitabine|capecitabine|mesh-list
102454845|NCT00266279|Oxaliplatin|oxaliplatin|mesh-list
102454846|NCT00266279|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102454847|NCT00266279|Antimetabolites|antimetabolites|mesh-ancestor
102454848|NCT00266279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454849|NCT00266279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102454850|NCT01736085|Nicotine|nicotine|mesh-list
102454851|NCT01736085|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102454852|NCT01736085|Autonomic Agents|autonomic agents|mesh-ancestor
102454853|NCT01736085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102454854|NCT01736085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454855|NCT01736085|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102454856|NCT01736085|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102454857|NCT01736085|Cholinergic Agents|cholinergic agents|mesh-ancestor
102454858|NCT01736085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102454859|NCT01736085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454860|NCT00210353|Rituximab|rituximab|mesh-list
102454861|NCT00210353|Chlorambucil|chlorambucil|mesh-list
102454862|NCT00210353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102454863|NCT00210353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102454864|NCT00210353|Immunologic Factors|immunologic factors|mesh-ancestor
102454865|NCT00210353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454866|NCT00210353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102454867|NCT00210353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102454868|NCT00210353|Alkylating Agents|alkylating agents|mesh-ancestor
102454869|NCT00210353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454870|NCT00267059|Lenalidomide|lenalidomide|mesh-list
102454871|NCT00267059|Immunologic Factors|immunologic factors|mesh-ancestor
102454872|NCT00267059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454873|NCT00267059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102454874|NCT00267059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102454875|NCT00267059|Growth Substances|growth substances|mesh-ancestor
102454876|NCT00267059|Growth Inhibitors|growth inhibitors|mesh-ancestor
102454877|NCT00267059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102454878|NCT00213239|Remifentanil|remifentanil|mesh-list
102454879|NCT00213239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102454880|NCT00213239|Narcotics|narcotics|mesh-ancestor
102454881|NCT00213239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102454882|NCT00213239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454883|NCT00213239|Analgesics|analgesics|mesh-ancestor
102454884|NCT00213239|Sensory System Agents|sensory system agents|mesh-ancestor
102454885|NCT00213239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102454886|NCT01444430|Budesonide|budesonide|mesh-list
102454887|NCT01444430|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
102454888|NCT01444430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102454889|NCT01444430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102454890|NCT01444430|Autonomic Agents|autonomic agents|mesh-ancestor
102454891|NCT01444430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102454892|NCT01444430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454893|NCT01444430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102454894|NCT01444430|Respiratory System Agents|respiratory system agents|mesh-ancestor
102454895|NCT01444430|Glucocorticoids|glucocorticoids|mesh-ancestor
102454896|NCT01444430|Hormones|hormones|mesh-ancestor
102454897|NCT01444430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102454898|NCT01774149|Diazepam|diazepam|mesh-list
102454899|NCT01774149|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102454900|NCT01774149|Anticonvulsants|anticonvulsants|mesh-ancestor
102454901|NCT01774149|Antiemetics|antiemetics|mesh-ancestor
102454902|NCT01774149|Autonomic Agents|autonomic agents|mesh-ancestor
102454903|NCT01774149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102454904|NCT01774149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454905|NCT01774149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102454906|NCT01774149|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102454907|NCT01774149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102454908|NCT01774149|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102454909|NCT01774149|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102454910|NCT01774149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102454911|NCT01774149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102454912|NCT01774149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102454913|NCT01774149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102454914|NCT01774149|Anesthetics, General|anesthetics, general|mesh-ancestor
102454915|NCT01774149|Anesthetics|anesthetics|mesh-ancestor
102454916|NCT01774149|GABA Modulators|gaba modulators|mesh-ancestor
102454917|NCT01774149|GABA Agents|gaba agents|mesh-ancestor
102454918|NCT01774149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102454919|NCT01774149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454920|NCT01898507|Nicotine|nicotine|mesh-list
102454921|NCT01898507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102454922|NCT01898507|Autonomic Agents|autonomic agents|mesh-ancestor
102454923|NCT01898507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102454924|NCT01898507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454925|NCT01898507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102454926|NCT01898507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102454927|NCT01898507|Cholinergic Agents|cholinergic agents|mesh-ancestor
102454928|NCT01898507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102454929|NCT01898507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454930|NCT00267293|Acetaminophen|acetaminophen|mesh-list
102454931|NCT00267293|Ibuprofen|ibuprofen|mesh-list
102454932|NCT00267293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102454933|NCT00267293|Analgesics|analgesics|mesh-ancestor
102454934|NCT00267293|Sensory System Agents|sensory system agents|mesh-ancestor
102454935|NCT00267293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102454936|NCT00267293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454937|NCT00267293|Antipyretics|antipyretics|mesh-ancestor
102454938|NCT00267293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102454939|NCT00267293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102454940|NCT00267293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102454941|NCT00267293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102454942|NCT00267293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102454943|NCT00267293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454944|NCT01436162|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102454945|NCT01436162|Antidepressive Agents|antidepressive agents|mesh-list
102454946|NCT01436162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102454947|NCT01436162|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102454948|NCT01436162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454949|NCT01436162|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102454950|NCT01436162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102454951|NCT01436162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102454952|NCT01436162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454953|NCT01436162|Dopamine Agents|dopamine agents|mesh-ancestor
102454954|NCT01436162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102454955|NCT02579382|Vesatolimod|vesatolimod|mesh-list
102454956|NCT02579382|Antiviral Agents|antiviral agents|mesh-ancestor
102454957|NCT02579382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102454958|NCT01774851|Paclitaxel|paclitaxel|mesh-list
102454959|NCT01774851|Trastuzumab|trastuzumab|mesh-list
102454960|NCT01774851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102454961|NCT01774851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102454962|NCT01774851|Tubulin Modulators|tubulin modulators|mesh-ancestor
102454963|NCT01774851|Antimitotic Agents|antimitotic agents|mesh-ancestor
102454964|NCT01774851|Mitosis Modulators|mitosis modulators|mesh-ancestor
102454965|NCT01774851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454966|NCT01774851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102454967|NCT02990013|Chlorhexidine|chlorhexidine|mesh-list
102454968|NCT02990013|Povidone-Iodine|povidone-iodine|mesh-list
102454969|NCT02990013|Povidone|povidone|mesh-list
102454970|NCT02990013|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102454971|NCT02990013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102454972|NCT02990013|Disinfectants|disinfectants|mesh-ancestor
102454973|NCT02990013|Plasma Substitutes|plasma substitutes|mesh-ancestor
102454974|NCT02990013|Blood Substitutes|blood substitutes|mesh-ancestor
102454975|NCT03440112|Clarithromycin|clarithromycin|mesh-list
102454976|NCT03440112|Flumazenil|flumazenil|mesh-list
102454977|NCT03440112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102454978|NCT03440112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102454979|NCT03440112|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102454980|NCT03440112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102454981|NCT03440112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102454982|NCT03440112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102454983|NCT03440112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102454984|NCT03440112|Antidotes|antidotes|mesh-ancestor
102454985|NCT03440112|Protective Agents|protective agents|mesh-ancestor
102454986|NCT03440112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454987|NCT03440112|GABA Modulators|gaba modulators|mesh-ancestor
102454988|NCT03440112|GABA Agents|gaba agents|mesh-ancestor
102454989|NCT03440112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102454990|NCT01775865|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
102454991|NCT01775865|Sodium Salicylate|sodium salicylate|mesh-list
102085085|NCT04991896|Sympatholytics|sympatholytics|mesh-ancestor
102454992|NCT01775865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102454993|NCT01775865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102454994|NCT01775865|Analgesics|analgesics|mesh-ancestor
102454995|NCT01775865|Sensory System Agents|sensory system agents|mesh-ancestor
102266575|NCT03105661|Atenolol|atenolol|mesh-list
102454996|NCT01775865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102454997|NCT01775865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102454998|NCT01775865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102454999|NCT01775865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102455000|NCT01775865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102455001|NCT01775865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102455002|NCT01775865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455003|NCT01419236|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102455004|NCT01419236|Testosterone|testosterone|mesh-list
102455005|NCT01419236|Androgens|androgens|mesh-ancestor
102455006|NCT01419236|Hormones|hormones|mesh-ancestor
102455007|NCT01419236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102455008|NCT01419236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455009|NCT03323658|Bexarotene|bexarotene|mesh-list
102455010|NCT03323658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455011|NCT01443026|Lycopene|lycopene|mesh-list
102455012|NCT01443026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102455013|NCT01443026|Antioxidants|antioxidants|mesh-ancestor
102455014|NCT01443026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455015|NCT01443026|Protective Agents|protective agents|mesh-ancestor
102455016|NCT01443026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455017|NCT01443026|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102455018|NCT01443026|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102455019|NCT01443026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455020|NCT01879371|Ibuprofen|ibuprofen|mesh-list
102455021|NCT01879371|Caffeine|caffeine|mesh-list
102455022|NCT01879371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102455023|NCT01879371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102455024|NCT01879371|Analgesics|analgesics|mesh-ancestor
102455025|NCT01879371|Sensory System Agents|sensory system agents|mesh-ancestor
102455026|NCT01879371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102455027|NCT01879371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455028|NCT01879371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102455029|NCT01879371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102455030|NCT01879371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102455031|NCT01879371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102455032|NCT01879371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455033|NCT01879371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102455034|NCT01879371|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102455035|NCT01879371|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102455036|NCT01879371|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102455037|NCT01879371|Purinergic Agents|purinergic agents|mesh-ancestor
102455038|NCT01879371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102455039|NCT01733745|Vitamins|vitamins|mesh-list
102455040|NCT01733745|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102455041|NCT01733745|Micronutrients|micronutrients|mesh-ancestor
102455042|NCT01733745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455043|NCT01733745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102455044|NCT03276468|Atezolizumab|atezolizumab|mesh-list
102455045|NCT03276468|Venetoclax|venetoclax|mesh-list
102455046|NCT03276468|Obinutuzumab|obinutuzumab|mesh-list
102455047|NCT03276468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102455048|NCT03276468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455049|NCT03276468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102455050|NCT03276468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455051|NCT01442714|Lenalidomide|lenalidomide|mesh-list
102455052|NCT01442714|Azacitidine|azacitidine|mesh-list
102455053|NCT01442714|Immunologic Factors|immunologic factors|mesh-ancestor
102455054|NCT01442714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455055|NCT01442714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102455056|NCT01442714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102455057|NCT01442714|Growth Substances|growth substances|mesh-ancestor
102455058|NCT01442714|Growth Inhibitors|growth inhibitors|mesh-ancestor
102455059|NCT01442714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102085153|NCT03072082|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102455060|NCT01442714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102455061|NCT01442714|Antimetabolites|antimetabolites|mesh-ancestor
102455062|NCT01442714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455063|NCT01442714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102455064|NCT05328921|Antihypertensive Agents|antihypertensive agents|mesh-list
102455065|NCT05532852|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
102455066|NCT05532852|Antiviral Agents|antiviral agents|mesh-ancestor
102455067|NCT05532852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102455068|NCT05532618|Levobupivacaine|levobupivacaine|mesh-list
102455069|NCT05532618|Anesthetics, Local|anesthetics, local|mesh-ancestor
102455070|NCT05532618|Anesthetics|anesthetics|mesh-ancestor
102455071|NCT05532618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102455072|NCT05532618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455073|NCT05532618|Sensory System Agents|sensory system agents|mesh-ancestor
102455074|NCT05532618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102455075|NCT05501574|Tacrolimus|tacrolimus|mesh-list
102455076|NCT05501574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102455077|NCT05501574|Immunologic Factors|immunologic factors|mesh-ancestor
102455078|NCT05501574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455079|NCT05501574|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102455080|NCT05501574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102455081|NCT05501574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455082|NCT01435928|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102455083|NCT01435928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102455084|NCT01435928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102455085|NCT01435928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102455086|NCT01435928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455087|NCT01435928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102455088|NCT01435928|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102455089|NCT01435928|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102455090|NCT01435928|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102455091|NCT01435928|Adrenergic Agents|adrenergic agents|mesh-ancestor
102455092|NCT01435928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102455093|NCT01435928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455094|NCT01435928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102455095|NCT01435928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102455096|NCT01435928|Serotonin Agents|serotonin agents|mesh-ancestor
102455097|NCT01435928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102455098|NCT01435928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102455099|NCT01435928|Dopamine Agents|dopamine agents|mesh-ancestor
102455100|NCT01828515|Hydrocortisone|hydrocortisone|mesh-list
102455101|NCT01828515|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
102455102|NCT01828515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102455103|NCT01828515|Antidepressive Agents|antidepressive agents|mesh-ancestor
102455104|NCT01828515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102455105|NCT01828515|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102455106|NCT01828515|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102455107|NCT01828515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102455108|NCT01828515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455109|NCT01828515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102455110|NCT01828515|Serotonin Agents|serotonin agents|mesh-ancestor
102455111|NCT01828515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455112|NCT01828515|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102455113|NCT01828515|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102455114|NCT01828593|Immunoglobulins|immunoglobulins|mesh-list
102455115|NCT01828593|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102455116|NCT01828593|Antibodies|antibodies|mesh-list
102455117|NCT01828593|Immunologic Factors|immunologic factors|mesh-ancestor
102455118|NCT01828593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455119|NCT01781169|Vitamin D|vitamin d|mesh-list
102455120|NCT01781169|Vitamins|vitamins|mesh-ancestor
102455121|NCT01781169|Micronutrients|micronutrients|mesh-ancestor
102455122|NCT01781169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455123|NCT01781169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102455124|NCT00216125|Docetaxel|docetaxel|mesh-list
102455125|NCT00216125|Etoposide|etoposide|mesh-list
102455126|NCT00216125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455127|NCT00216125|Tubulin Modulators|tubulin modulators|mesh-ancestor
102455128|NCT00216125|Antimitotic Agents|antimitotic agents|mesh-ancestor
102455129|NCT00216125|Mitosis Modulators|mitosis modulators|mesh-ancestor
102455130|NCT00216125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455131|NCT00216125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102455132|NCT00216125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102455133|NCT00216125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102455134|NCT00216125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102455135|NCT01781403|Capecitabine|capecitabine|mesh-list
102455136|NCT01781403|Temozolomide|temozolomide|mesh-list
102455137|NCT01781403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102455138|NCT01781403|Antimetabolites|antimetabolites|mesh-ancestor
102455139|NCT01781403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455140|NCT01781403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455141|NCT01781403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102455142|NCT01781403|Alkylating Agents|alkylating agents|mesh-ancestor
102455143|NCT00218387|Modafinil|modafinil|mesh-list
102455144|NCT00218387|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102154235|NCT03367143|Ifosfamide|ifosfamide|mesh-list
102455145|NCT00218387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455146|NCT00218387|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102455147|NCT00218387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102455148|NCT00218387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102455149|NCT00218387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455150|NCT00218465|Glycine|glycine|mesh-list
102455151|NCT00218465|Glycine Agents|glycine agents|mesh-ancestor
102455152|NCT00218465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102455153|NCT00218465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455154|NCT00218465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455155|NCT01898585|Vemurafenib|vemurafenib|mesh-list
102455156|NCT01898585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455157|NCT01898585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102455158|NCT01898585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102455159|NCT01898585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455160|NCT00220961|Pioglitazone|pioglitazone|mesh-list
102455161|NCT00220961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102455162|NCT00220961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455163|NCT00222131|Esomeprazole|esomeprazole|mesh-list
102455164|NCT00222131|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102455165|NCT00222131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102455166|NCT00222131|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102455167|NCT00222131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102455168|NCT00222131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455169|NCT00225017|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102455170|NCT00225017|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102455171|NCT00225017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102455172|NCT00225017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102455173|NCT00225017|Protease Inhibitors|protease inhibitors|mesh-ancestor
102455174|NCT00225017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102455175|NCT00225017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455176|NCT00225017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102455177|NCT00225017|Antiviral Agents|antiviral agents|mesh-ancestor
102455178|NCT00225017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102455179|NCT01782963|Dexamethasone|dexamethasone|mesh-list
102455180|NCT01782963|Lenalidomide|lenalidomide|mesh-list
102455181|NCT01782963|Bortezomib|bortezomib|mesh-list
102455182|NCT01782963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102455183|NCT01782963|Antiemetics|antiemetics|mesh-ancestor
102455184|NCT01782963|Autonomic Agents|autonomic agents|mesh-ancestor
102455185|NCT01782963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102455186|NCT01782963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455187|NCT01782963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102455188|NCT01782963|Glucocorticoids|glucocorticoids|mesh-ancestor
102455189|NCT01782963|Hormones|hormones|mesh-ancestor
102455190|NCT01782963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102455191|NCT01782963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102455192|NCT01782963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455193|NCT01782963|Immunologic Factors|immunologic factors|mesh-ancestor
102455194|NCT01782963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102455195|NCT01782963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102455196|NCT01782963|Growth Substances|growth substances|mesh-ancestor
102455197|NCT01782963|Growth Inhibitors|growth inhibitors|mesh-ancestor
102455198|NCT01829217|Sunitinib|sunitinib|mesh-list
102455199|NCT01829217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455200|NCT01829217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102455201|NCT01829217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102455202|NCT01829217|Growth Substances|growth substances|mesh-ancestor
102455203|NCT01829217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455204|NCT01829217|Growth Inhibitors|growth inhibitors|mesh-ancestor
102455205|NCT01829217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102455206|NCT01829217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102455207|NCT01829217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455208|NCT05327751|Celecoxib|celecoxib|mesh-list
102455209|NCT05327751|Capecitabine|capecitabine|mesh-list
102455210|NCT05327751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102455211|NCT05327751|Antimetabolites|antimetabolites|mesh-ancestor
102455212|NCT05327751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455213|NCT05327751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455214|NCT05327751|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102455215|NCT05327751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102455216|NCT05327751|Analgesics|analgesics|mesh-ancestor
102455217|NCT05327751|Sensory System Agents|sensory system agents|mesh-ancestor
102455218|NCT05327751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102455219|NCT05327751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455220|NCT05327751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102455221|NCT05327751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102455222|NCT05327751|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102455223|NCT05327751|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102455224|NCT05327751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102455225|NCT02096861|Infliximab|infliximab|mesh-list
102455226|NCT02096861|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102455227|NCT02096861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102455228|NCT02096861|Dermatologic Agents|dermatologic agents|mesh-ancestor
102455229|NCT02096861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102455230|NCT02096861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102455231|NCT01829919|Paroxetine|paroxetine|mesh-list
102455232|NCT01829919|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102455233|NCT01829919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102455234|NCT01829919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102455235|NCT01829919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455236|NCT01829919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102455237|NCT01829919|Serotonin Agents|serotonin agents|mesh-ancestor
102455238|NCT01829919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455239|NCT01829919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102455240|NCT01829919|Antidepressive Agents|antidepressive agents|mesh-ancestor
102455241|NCT01829919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102455242|NCT01829919|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102455243|NCT01829919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102455244|NCT01829919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102455245|NCT02097641|Plasma-lyte 148|plasma-lyte 148|mesh-list
102455246|NCT02097641|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102455247|NCT02097641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102455248|NCT00274781|Arsenic Trioxide|arsenic trioxide|mesh-list
102455249|NCT00274781|Gemtuzumab|gemtuzumab|mesh-list
102455250|NCT00274781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455251|NCT00274781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102455252|NCT00274781|Immunotoxins|immunotoxins|mesh-ancestor
102455253|NCT00274781|Immunoconjugates|immunoconjugates|mesh-ancestor
102455254|NCT00274781|Immunologic Factors|immunologic factors|mesh-ancestor
102455255|NCT00274781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455256|NCT00226577|Gemcitabine|gemcitabine|mesh-list
102455257|NCT00226577|Pemetrexed|pemetrexed|mesh-list
102455258|NCT00226577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102455259|NCT00226577|Antimetabolites|antimetabolites|mesh-ancestor
102455260|NCT00226577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455261|NCT00226577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455262|NCT00226577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102455263|NCT00226577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102455264|NCT00226577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102455265|NCT01830699|Triamcinolone|triamcinolone|mesh-list
102455266|NCT01830699|Rilonacept|rilonacept|mesh-list
102455267|NCT01830699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102455268|NCT01830699|Glucocorticoids|glucocorticoids|mesh-ancestor
102455269|NCT01830699|Hormones|hormones|mesh-ancestor
102455270|NCT01830699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102455271|NCT01830699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455272|NCT00280241|Cyclophosphamide|cyclophosphamide|mesh-list
102455273|NCT00280241|Rituximab|rituximab|mesh-list
102455274|NCT00280241|Fludarabine|fludarabine|mesh-list
102455275|NCT00280241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102455276|NCT00280241|Immunologic Factors|immunologic factors|mesh-ancestor
102455277|NCT00280241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455278|NCT00280241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102455279|NCT00280241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102455280|NCT00280241|Alkylating Agents|alkylating agents|mesh-ancestor
102455281|NCT00280241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455282|NCT00280241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455283|NCT00280241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102455284|NCT00280241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102455285|NCT01899755|Adalimumab|adalimumab|mesh-list
102455286|NCT01899755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102455287|NCT01899755|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102455288|NCT01899755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102455289|NCT01899755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102455290|NCT01899833|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
102455291|NCT01899833|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102455292|NCT01899833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455293|NCT00229619|Rituximab|rituximab|mesh-list
102455294|NCT00229619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102455296|NCT00229619|Immunologic Factors|immunologic factors|mesh-ancestor
102455297|NCT00229619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455298|NCT00229619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102455299|NCT00281021|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102455300|NCT00281021|Digoxin|digoxin|mesh-list
102455301|NCT00281021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455302|NCT00281021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102455303|NCT00281021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102455304|NCT00281021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455305|NCT00281021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102455306|NCT00281021|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102455307|NCT00281021|Protective Agents|protective agents|mesh-ancestor
102455308|NCT00281021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455309|NCT01786161|Vancomycin|vancomycin|mesh-list
102455310|NCT01786161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102455311|NCT01786161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102455312|NCT01786239|Risperidone|risperidone|mesh-list
102455313|NCT01786239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102455314|NCT01786239|Serotonin Agents|serotonin agents|mesh-ancestor
102455315|NCT01786239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102455316|NCT01786239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455317|NCT01786239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455318|NCT01786239|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102455319|NCT01786239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102455320|NCT01786239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102455321|NCT01786239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102455322|NCT01786239|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102455323|NCT01786239|Dopamine Agents|dopamine agents|mesh-ancestor
102455324|NCT01832961|Bronchodilator Agents|bronchodilator agents|mesh-list
102455325|NCT01832961|Autonomic Agents|autonomic agents|mesh-ancestor
102455326|NCT01832961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102455327|NCT01832961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455328|NCT01832961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102455329|NCT01832961|Respiratory System Agents|respiratory system agents|mesh-ancestor
102455330|NCT01833741|Bimatoprost|bimatoprost|mesh-list
102455331|NCT01833741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102455332|NCT02261727|Prednisone|prednisone|mesh-list
102455333|NCT02261727|Cortisone|cortisone|mesh-list
102455334|NCT02261727|Theophylline|theophylline|mesh-list
102455335|NCT02261727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102455336|NCT02261727|Glucocorticoids|glucocorticoids|mesh-ancestor
102455337|NCT02261727|Hormones|hormones|mesh-ancestor
102455338|NCT02261727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102455339|NCT02261727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455340|NCT02261727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102455341|NCT02261727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455342|NCT02261727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102455343|NCT02261727|Autonomic Agents|autonomic agents|mesh-ancestor
102455344|NCT02261727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102455345|NCT02261727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102455346|NCT02261727|Respiratory System Agents|respiratory system agents|mesh-ancestor
102455347|NCT02261727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102455348|NCT02261727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102455349|NCT02261727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455350|NCT02261727|Vasodilator Agents|vasodilator agents|mesh-ancestor
102455351|NCT02261727|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102455352|NCT02261727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102455353|NCT02261727|Purinergic Agents|purinergic agents|mesh-ancestor
102455354|NCT02261727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102455355|NCT02261805|Doxorubicin|doxorubicin|mesh-list
102455356|NCT02261805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102455357|NCT02261805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455358|NCT02261805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102455359|NCT02261805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102455360|NCT02261805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102455361|NCT02261805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455362|NCT05300841|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102455363|NCT05300841|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102455364|NCT05300841|Estradiol|estradiol|mesh-list
102455365|NCT05300841|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102455366|NCT05300841|Dydrogesterone|dydrogesterone|mesh-list
102455367|NCT05300841|Estrogens|estrogens|mesh-ancestor
102455368|NCT05300841|Hormones|hormones|mesh-ancestor
102455369|NCT05300841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102455370|NCT05300841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455371|NCT05300841|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102455372|NCT05300841|Contraceptive Agents|contraceptive agents|mesh-ancestor
102455373|NCT05300841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102455374|NCT05300841|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102455375|NCT05300841|Progestins|progestins|mesh-ancestor
102455376|NCT00232505|Carboplatin|carboplatin|mesh-list
102455377|NCT00232505|Cetuximab|cetuximab|mesh-list
102455378|NCT00232505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455379|NCT00232505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102455380|NCT00232583|Metformin|metformin|mesh-list
102455381|NCT00232583|Pioglitazone|pioglitazone|mesh-list
102455382|NCT00232583|Glyburide|glyburide|mesh-list
102455383|NCT00232583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102455384|NCT00232583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455385|NCT00232739|Sirolimus|sirolimus|mesh-list
102455386|NCT00232739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102455387|NCT00232739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102455388|NCT00232739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102455389|NCT00232739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455390|NCT00232739|Antifungal Agents|antifungal agents|mesh-ancestor
102455391|NCT00232739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102455392|NCT00232739|Immunologic Factors|immunologic factors|mesh-ancestor
102455393|NCT00232739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455394|NCT01789905|Tigecycline|tigecycline|mesh-list
102455395|NCT01789905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102455396|NCT01789905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102455397|NCT01789905|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102455398|NCT01789905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102455399|NCT01789905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455400|NCT01790685|Dexamethasone|dexamethasone|mesh-list
102455401|NCT01790685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102455402|NCT01790685|Antiemetics|antiemetics|mesh-ancestor
102455403|NCT01790685|Autonomic Agents|autonomic agents|mesh-ancestor
102455404|NCT01790685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102455405|NCT01790685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455406|NCT01790685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102455407|NCT01790685|Glucocorticoids|glucocorticoids|mesh-ancestor
102455408|NCT01790685|Hormones|hormones|mesh-ancestor
102455409|NCT01790685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102455410|NCT01790685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102455411|NCT01790685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455412|NCT01838655|Nitisinone|nitisinone|mesh-list
102455413|NCT01838655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102455414|NCT01838655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455415|NCT00050089|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102455416|NCT00050089|Antiviral Agents|antiviral agents|mesh-ancestor
102455417|NCT00050089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102455418|NCT00282971|Insulin|insulin|mesh-list
102455419|NCT00282971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102455420|NCT00282971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455421|NCT01791465|Exenatide|exenatide|mesh-list
102455422|NCT01791465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102455423|NCT01791465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455424|NCT01791465|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102455425|NCT01791465|Incretins|incretins|mesh-ancestor
102455426|NCT01791465|Hormones|hormones|mesh-ancestor
102455427|NCT01791465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102455428|NCT04484701|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102455429|NCT04484701|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102455430|NCT04484701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455431|NCT00285467|Vitamin D|vitamin d|mesh-list
102455432|NCT00285467|Cholecalciferol|cholecalciferol|mesh-list
102455433|NCT00285467|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
102455434|NCT00285467|Vitamins|vitamins|mesh-ancestor
102455435|NCT00285467|Micronutrients|micronutrients|mesh-ancestor
102455436|NCT00285467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455437|NCT00285467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102455438|NCT00285467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102455439|NCT00281671|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
102455440|NCT00281671|Natriuretic Agents|natriuretic agents|mesh-ancestor
102455441|NCT00281671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455442|NCT05261321|Dronabinol|dronabinol|mesh-list
102267035|NCT04400539|Nivolumab|nivolumab|mesh-list
102455443|NCT05261321|Hallucinogens|hallucinogens|mesh-ancestor
102455444|NCT05261321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455445|NCT05261321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102455446|NCT05261321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102455447|NCT05261321|Analgesics|analgesics|mesh-ancestor
102455448|NCT05261321|Sensory System Agents|sensory system agents|mesh-ancestor
102455449|NCT05261321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102455450|NCT05261321|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102455451|NCT05261321|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102455452|NCT05261321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102455453|NCT05261321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455454|NCT05261321|Hormones|hormones|mesh-ancestor
102455455|NCT05261321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102455456|NCT01676753|Pembrolizumab|pembrolizumab|mesh-list
102455457|NCT01676753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102455458|NCT01676753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455459|NCT01676753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102455460|NCT01676753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455461|NCT01794039|Dexamethasone|dexamethasone|mesh-list
102455462|NCT01794039|Dexamethasone acetate|dexamethasone acetate|mesh-list
102455463|NCT01794039|Lenalidomide|lenalidomide|mesh-list
102455464|NCT01794039|Pomalidomide|pomalidomide|mesh-list
102455465|NCT01794039|Ichthammol|ichthammol|mesh-list
102455466|NCT01794039|BB 1101|bb 1101|mesh-list
102455467|NCT01794039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102455468|NCT01794039|Antiemetics|antiemetics|mesh-ancestor
102455469|NCT01794039|Autonomic Agents|autonomic agents|mesh-ancestor
102455470|NCT01794039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102455471|NCT01794039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455472|NCT01794039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102455473|NCT01794039|Glucocorticoids|glucocorticoids|mesh-ancestor
102455474|NCT01794039|Hormones|hormones|mesh-ancestor
102455475|NCT01794039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102455476|NCT01794039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102455477|NCT01794039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455478|NCT01794039|Immunologic Factors|immunologic factors|mesh-ancestor
102455479|NCT01794039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102085575|NCT02164734|Analgesics|analgesics|mesh-ancestor
102455480|NCT01794039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102455481|NCT01794039|Growth Substances|growth substances|mesh-ancestor
102455482|NCT01794039|Growth Inhibitors|growth inhibitors|mesh-ancestor
102455483|NCT01794039|Protease Inhibitors|protease inhibitors|mesh-ancestor
102455484|NCT01794039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102455485|NCT01794039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455486|NCT01794039|Dermatologic Agents|dermatologic agents|mesh-ancestor
102455487|NCT00281827|Thalidomide|thalidomide|mesh-list
102455488|NCT00281827|Carboplatin|carboplatin|mesh-list
102455489|NCT00281827|Gemcitabine|gemcitabine|mesh-list
102455490|NCT00281827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455491|NCT00281827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102455492|NCT00281827|Antimetabolites|antimetabolites|mesh-ancestor
102455493|NCT00281827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455494|NCT00281827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102455495|NCT00281827|Immunologic Factors|immunologic factors|mesh-ancestor
102455496|NCT00281827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455497|NCT00281827|Leprostatic Agents|leprostatic agents|mesh-ancestor
102455498|NCT00281827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102455499|NCT00281827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102455500|NCT00281827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102455501|NCT00281827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102455502|NCT00281827|Growth Substances|growth substances|mesh-ancestor
102455503|NCT00281827|Growth Inhibitors|growth inhibitors|mesh-ancestor
102455504|NCT01898819|Dexmedetomidine|dexmedetomidine|mesh-list
102455505|NCT01898819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102455506|NCT01898819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102455507|NCT01898819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455508|NCT01898819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102455509|NCT01898819|Analgesics|analgesics|mesh-ancestor
102455510|NCT01898819|Sensory System Agents|sensory system agents|mesh-ancestor
102455511|NCT01898819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102455512|NCT01898819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102455513|NCT01898819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102455514|NCT01898819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102455515|NCT01898819|Adrenergic Agents|adrenergic agents|mesh-ancestor
102455516|NCT01898819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102455517|NCT01898819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455518|NCT01794741|Fluticasone|fluticasone|mesh-list
102455519|NCT01794741|Xhance|xhance|mesh-list
102455520|NCT01794741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102455521|NCT01794741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102455522|NCT01794741|Autonomic Agents|autonomic agents|mesh-ancestor
102455523|NCT01794741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102455524|NCT01794741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455525|NCT01794741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102455526|NCT01794741|Respiratory System Agents|respiratory system agents|mesh-ancestor
102455527|NCT01794741|Dermatologic Agents|dermatologic agents|mesh-ancestor
102455528|NCT01794741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102455529|NCT04446871|Methylene Blue|methylene blue|mesh-list
102455530|NCT04446871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102455531|NCT04446871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455532|NCT04085419|Zoledronic Acid|zoledronic acid|mesh-list
102455533|NCT04085419|Denosumab|denosumab|mesh-list
102455534|NCT04085419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102455535|NCT04085419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455537|NCT02989623|Trace Elements|trace elements|mesh-ancestor
102455538|NCT02989623|Micronutrients|micronutrients|mesh-ancestor
102455539|NCT02989623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455540|NCT00052429|Fluorouracil|fluorouracil|mesh-list
102455541|NCT00052429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455542|NCT00052429|Antimetabolites|antimetabolites|mesh-ancestor
102455543|NCT00052429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455544|NCT00052429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102455545|NCT00052429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102455546|NCT00052429|Immunologic Factors|immunologic factors|mesh-ancestor
102455547|NCT00052429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455548|NCT01435616|Insulin Glargine|insulin glargine|mesh-list
102455549|NCT01435616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102455550|NCT01435616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455551|NCT03972397|Bupivacaine|bupivacaine|mesh-list
102455552|NCT03972397|Anesthetics, Local|anesthetics, local|mesh-ancestor
102455553|NCT03972397|Anesthetics|anesthetics|mesh-ancestor
102455554|NCT03972397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102455555|NCT03972397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455556|NCT03972397|Sensory System Agents|sensory system agents|mesh-ancestor
102455557|NCT03972397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102455558|NCT00287053|Valproic Acid|valproic acid|mesh-list
102455559|NCT00287053|Anticonvulsants|anticonvulsants|mesh-ancestor
102455560|NCT00287053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102455561|NCT00287053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455562|NCT00287053|GABA Agents|gaba agents|mesh-ancestor
102455563|NCT00287053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102455564|NCT00287053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455565|NCT00287053|Antimanic Agents|antimanic agents|mesh-ancestor
102455566|NCT00287053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102455567|NCT00287053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102455568|NCT00287053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102455569|NCT01435460|Loteprednol Etabonate|loteprednol etabonate|mesh-list
102455570|NCT01435460|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
102455571|NCT01435460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102455572|NCT01435460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102455573|NCT01435460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102455574|NCT01435460|Analgesics|analgesics|mesh-ancestor
102455575|NCT01435460|Sensory System Agents|sensory system agents|mesh-ancestor
102455576|NCT01435460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102455577|NCT01435460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455578|NCT01435460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102455579|NCT01435460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102455580|NCT01435460|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102455581|NCT01435460|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102455582|NCT01435460|Histamine Antagonists|histamine antagonists|mesh-ancestor
102455583|NCT01435460|Histamine Agents|histamine agents|mesh-ancestor
102455584|NCT01435460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102455585|NCT01435460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455586|NCT00236951|Epoetin Alfa|epoetin alfa|mesh-list
102455587|NCT00236951|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102455588|NCT00236951|Hematinics|hematinics|mesh-ancestor
102455589|NCT00287287|Lenalidomide|lenalidomide|mesh-list
102455590|NCT00287287|Immunologic Factors|immunologic factors|mesh-ancestor
102455591|NCT00287287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455592|NCT00287287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102455593|NCT00287287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102154236|NCT03367143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455594|NCT00287287|Growth Substances|growth substances|mesh-ancestor
102455595|NCT00287287|Growth Inhibitors|growth inhibitors|mesh-ancestor
102455596|NCT00287287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455597|NCT04871061|Fentanyl|fentanyl|mesh-list
102455598|NCT04871061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102455599|NCT04871061|Narcotics|narcotics|mesh-ancestor
102455600|NCT04871061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102455601|NCT04871061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455602|NCT04871061|Analgesics|analgesics|mesh-ancestor
102455603|NCT04871061|Sensory System Agents|sensory system agents|mesh-ancestor
102455604|NCT04871061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102455605|NCT04871061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102455606|NCT04871061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102455607|NCT04871061|Anesthetics, General|anesthetics, general|mesh-ancestor
102455608|NCT04871061|Anesthetics|anesthetics|mesh-ancestor
102455609|NCT00287989|Paclitaxel|paclitaxel|mesh-list
102455610|NCT00287989|Carboplatin|carboplatin|mesh-list
102455611|NCT00287989|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102455612|NCT00287989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102455613|NCT00287989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455614|NCT00287989|Tubulin Modulators|tubulin modulators|mesh-ancestor
102455615|NCT00287989|Antimitotic Agents|antimitotic agents|mesh-ancestor
102455616|NCT00287989|Mitosis Modulators|mitosis modulators|mesh-ancestor
102455617|NCT00287989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455618|NCT00287989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102455619|NCT00287989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102455620|NCT00288067|Rituximab|rituximab|mesh-list
102455621|NCT00288067|Fenretinide|fenretinide|mesh-list
102455622|NCT00288067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102455623|NCT00288067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455624|NCT00288067|Immunologic Factors|immunologic factors|mesh-ancestor
102455625|NCT00288067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455626|NCT00288067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102455627|NCT00288067|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102455628|NCT00288067|Protective Agents|protective agents|mesh-ancestor
102455629|NCT00285779|Etanercept|etanercept|mesh-list
102455630|NCT00285779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102455631|NCT00285779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102455632|NCT00285779|Analgesics|analgesics|mesh-ancestor
102455633|NCT00285779|Sensory System Agents|sensory system agents|mesh-ancestor
102455634|NCT00285779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102455635|NCT00285779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455636|NCT00285779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102455637|NCT00285779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102455638|NCT00285779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102455639|NCT00285779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102455640|NCT00285779|Immunologic Factors|immunologic factors|mesh-ancestor
102455641|NCT04827537|Metronidazole|metronidazole|mesh-list
102455642|NCT04827537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102455643|NCT04827537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102455644|NCT04827537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102455645|NCT04827537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102455646|NCT01435382|Bococizumab|bococizumab|mesh-list
102455647|NCT01435382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102455648|NCT01435382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102455649|NCT01435382|Antimetabolites|antimetabolites|mesh-ancestor
102455650|NCT01435382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455651|NCT01435382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102455652|NCT01801449|Rilonacept|rilonacept|mesh-list
102455653|NCT01801449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102455654|NCT00286325|Rituximab|rituximab|mesh-list
102455655|NCT00286325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102455656|NCT00286325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455657|NCT00286325|Immunologic Factors|immunologic factors|mesh-ancestor
102455658|NCT00286325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455659|NCT00286325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102455660|NCT00238355|Voriconazole|voriconazole|mesh-list
102455661|NCT00238355|Caspofungin|caspofungin|mesh-list
102455662|NCT00238355|Antifungal Agents|antifungal agents|mesh-ancestor
102455663|NCT00238355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102455664|NCT00238355|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102455665|NCT00238355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102455666|NCT00238355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102455667|NCT00238355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455668|NCT00238355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102455669|NCT00238355|Hormone Antagonists|hormone antagonists|mesh-ancestor
102612317|NCT00002405|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102455670|NCT00238355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102455671|NCT00238355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455672|NCT00238355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102455673|NCT01791439|Lidocaine|lidocaine|mesh-list
102455674|NCT01791439|Anesthetics, Local|anesthetics, local|mesh-ancestor
102455675|NCT01791439|Anesthetics|anesthetics|mesh-ancestor
102455676|NCT01791439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102455677|NCT01791439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455678|NCT01791439|Sensory System Agents|sensory system agents|mesh-ancestor
102455679|NCT01791439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102455680|NCT01791439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102455681|NCT01791439|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102455682|NCT01791439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102455683|NCT01791439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102455684|NCT01791439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455685|NCT01650701|Rituximab|rituximab|mesh-list
102455686|NCT01650701|Lenalidomide|lenalidomide|mesh-list
102455687|NCT01650701|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102455688|NCT01650701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102455689|NCT01650701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455690|NCT01650701|Immunologic Factors|immunologic factors|mesh-ancestor
102455691|NCT01650701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455692|NCT01650701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102455693|NCT01650701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102455694|NCT01650701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102455695|NCT01650701|Growth Substances|growth substances|mesh-ancestor
102455696|NCT01650701|Growth Inhibitors|growth inhibitors|mesh-ancestor
102455697|NCT01650701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102455698|NCT01650701|Alkylating Agents|alkylating agents|mesh-ancestor
102455699|NCT01650701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455700|NCT00290329|Vaccines|vaccines|mesh-list
102455701|NCT00290329|Immunologic Factors|immunologic factors|mesh-ancestor
102455702|NCT00290329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455703|NCT04058678|Danazol|danazol|mesh-list
102455704|NCT04058678|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102455705|NCT04058678|Hormone Antagonists|hormone antagonists|mesh-ancestor
102455706|NCT04058678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102455707|NCT04058678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455708|NCT00286949|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102455709|NCT00286949|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102455710|NCT00286949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102455711|NCT00286949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102455712|NCT00286949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455713|NCT00286949|Adrenergic Agents|adrenergic agents|mesh-ancestor
102455714|NCT00286949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102455715|NCT00286949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455716|NCT00287339|Esomeprazole|esomeprazole|mesh-list
102455717|NCT00287339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102455718|NCT00287339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102455719|NCT00287339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102455720|NCT00287339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102455721|NCT00287339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455722|NCT00291655|Levetiracetam|levetiracetam|mesh-list
102455723|NCT00291655|Anticonvulsants|anticonvulsants|mesh-ancestor
102455724|NCT00291655|Nootropic Agents|nootropic agents|mesh-ancestor
102455725|NCT01846455|Promethazine|promethazine|mesh-list
102455726|NCT01846455|Diphenhydramine|diphenhydramine|mesh-list
102455727|NCT01846455|Buprenorphine|buprenorphine|mesh-list
102455728|NCT01846455|Naloxone|naloxone|mesh-list
102455729|NCT01846455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102455730|NCT01846455|Narcotics|narcotics|mesh-ancestor
102455731|NCT01846455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102455732|NCT01846455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455733|NCT01846455|Analgesics|analgesics|mesh-ancestor
102455734|NCT01846455|Sensory System Agents|sensory system agents|mesh-ancestor
102455735|NCT01846455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102455736|NCT01846455|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102455737|NCT01846455|Antipruritics|antipruritics|mesh-ancestor
102455738|NCT01846455|Dermatologic Agents|dermatologic agents|mesh-ancestor
102455739|NCT01846455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102455740|NCT01846455|Histamine Antagonists|histamine antagonists|mesh-ancestor
102455741|NCT01846455|Histamine Agents|histamine agents|mesh-ancestor
102455742|NCT01846455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102612318|NCT00002405|Antitubercular Agents|antitubercular agents|mesh-ancestor
102455743|NCT01846455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455744|NCT01846455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102455745|NCT01846455|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102455746|NCT01846455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102455747|NCT01846455|Anesthetics, Local|anesthetics, local|mesh-ancestor
102455748|NCT01846455|Anesthetics|anesthetics|mesh-ancestor
102455749|NCT01846455|Antiemetics|antiemetics|mesh-ancestor
102455750|NCT01846455|Autonomic Agents|autonomic agents|mesh-ancestor
102455751|NCT01846455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102455752|NCT03366415|Cisplatin|cisplatin|mesh-list
102455753|NCT03366415|Gemcitabine|gemcitabine|mesh-list
102455754|NCT03366415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455755|NCT03366415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102455756|NCT03366415|Antimetabolites|antimetabolites|mesh-ancestor
102455757|NCT03366415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455758|NCT00292591|Vitamin D|vitamin d|mesh-list
102455759|NCT00292591|Ergocalciferols|ergocalciferols|mesh-list
102455760|NCT00292591|Cholecalciferol|cholecalciferol|mesh-list
102455761|NCT00292591|Vitamins|vitamins|mesh-list
102455762|NCT00292591|Micronutrients|micronutrients|mesh-ancestor
102455763|NCT00292591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455764|NCT00292591|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102455765|NCT00292591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102455766|NCT01847001|Paclitaxel|paclitaxel|mesh-list
102455767|NCT01847001|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102455768|NCT01847001|Cyclophosphamide|cyclophosphamide|mesh-list
102455769|NCT01847001|Doxorubicin|doxorubicin|mesh-list
102455770|NCT01847001|Trastuzumab|trastuzumab|mesh-list
102455771|NCT01847001|Pertuzumab|pertuzumab|mesh-list
102455772|NCT01847001|Propranolol|propranolol|mesh-list
102455773|NCT01847001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102455774|NCT01847001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455775|NCT01847001|Tubulin Modulators|tubulin modulators|mesh-ancestor
102455776|NCT01847001|Antimitotic Agents|antimitotic agents|mesh-ancestor
102455777|NCT01847001|Mitosis Modulators|mitosis modulators|mesh-ancestor
102455778|NCT01847001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455779|NCT01847001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102455780|NCT01847001|Immunologic Factors|immunologic factors|mesh-ancestor
102455781|NCT01847001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455782|NCT01847001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102455783|NCT01847001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102455784|NCT01847001|Alkylating Agents|alkylating agents|mesh-ancestor
102455785|NCT01847001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102455786|NCT01847001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102455787|NCT01847001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102455788|NCT01847001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102455789|NCT01847001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102455790|NCT01847001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102455791|NCT01847001|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102455792|NCT01847001|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102455793|NCT01847001|Adrenergic Agents|adrenergic agents|mesh-ancestor
102455794|NCT01847001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102455795|NCT01847001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102455796|NCT01847001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102455797|NCT01847001|Vasodilator Agents|vasodilator agents|mesh-ancestor
102455798|NCT01847469|Zonisamide|zonisamide|mesh-list
102455799|NCT01847469|Anticonvulsants|anticonvulsants|mesh-ancestor
102455800|NCT01847469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102455801|NCT01847469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102455802|NCT01847469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455803|NCT01847469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102455804|NCT01847469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455805|NCT01804101|Cytarabine|cytarabine|mesh-list
102455806|NCT01804101|Daunorubicin|daunorubicin|mesh-list
102455807|NCT01804101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102455808|NCT01804101|Antimetabolites|antimetabolites|mesh-ancestor
102455809|NCT01804101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455810|NCT01804101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455811|NCT01804101|Antiviral Agents|antiviral agents|mesh-ancestor
102455812|NCT01804101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102455813|NCT01804101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102455814|NCT01804101|Immunologic Factors|immunologic factors|mesh-ancestor
102455815|NCT01804101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455816|NCT01804101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102455817|NCT01804101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102455818|NCT01804101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102455819|NCT01804101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102455820|NCT00287729|Pirfenidone|pirfenidone|mesh-list
102455821|NCT00287729|Analgesics|analgesics|mesh-ancestor
102455822|NCT00287729|Sensory System Agents|sensory system agents|mesh-ancestor
102455823|NCT00287729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102455824|NCT00287729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455825|NCT00287729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102455826|NCT00287729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102455827|NCT00287729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102455828|NCT00287729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102455829|NCT00287729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455830|NCT01433978|Maleic acid|maleic acid|mesh-list
102455831|NCT01433978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102455832|NCT01433978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455833|NCT00289211|Complement C1s|complement c1s|mesh-list
102455834|NCT00289211|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
102455835|NCT00289211|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
102455836|NCT00289211|Immunologic Factors|immunologic factors|mesh-ancestor
102455837|NCT00289211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455838|NCT00289211|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102455839|NCT00289211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102455840|NCT01619111|Lapatinib|lapatinib|mesh-list
102455841|NCT01619111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455842|NCT01619111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102455843|NCT01619111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102455844|NCT01619111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455845|NCT01727193|Azathioprine|azathioprine|mesh-list
102455846|NCT01727193|Leflunomide|leflunomide|mesh-list
102455847|NCT01727193|Antimetabolites|antimetabolites|mesh-ancestor
102455848|NCT01727193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455849|NCT01727193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102455850|NCT01727193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455851|NCT01727193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102455852|NCT01727193|Immunologic Factors|immunologic factors|mesh-ancestor
102455853|NCT01727193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455854|NCT01727193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102455855|NCT01727193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102455856|NCT00181701|Paclitaxel|paclitaxel|mesh-list
102455857|NCT00181701|Carboplatin|carboplatin|mesh-list
102455858|NCT00181701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102455859|NCT00181701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455860|NCT00181701|Tubulin Modulators|tubulin modulators|mesh-ancestor
102455861|NCT00181701|Antimitotic Agents|antimitotic agents|mesh-ancestor
102455862|NCT00181701|Mitosis Modulators|mitosis modulators|mesh-ancestor
102455863|NCT00181701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455864|NCT01849419|Oxytocin|oxytocin|mesh-list
102455865|NCT01849419|Oxytocics|oxytocics|mesh-ancestor
102455866|NCT01849419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102455867|NCT01849419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455868|NCT00295867|Zoledronic Acid|zoledronic acid|mesh-list
102455869|NCT00295867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102455870|NCT00295867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455871|NCT05098067|Ondansetron|ondansetron|mesh-list
102455872|NCT05098067|Metoclopramide|metoclopramide|mesh-list
102455873|NCT05098067|Capsaicin|capsaicin|mesh-list
102455874|NCT05098067|Antiemetics|antiemetics|mesh-ancestor
102455875|NCT05098067|Autonomic Agents|autonomic agents|mesh-ancestor
102455876|NCT05098067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102455877|NCT05098067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455878|NCT05098067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102455879|NCT05098067|Antipruritics|antipruritics|mesh-ancestor
102455880|NCT05098067|Dermatologic Agents|dermatologic agents|mesh-ancestor
102455881|NCT05098067|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102455882|NCT05098067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102455883|NCT05098067|Serotonin Agents|serotonin agents|mesh-ancestor
102455884|NCT05098067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102455885|NCT05098067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455886|NCT05098067|Sensory System Agents|sensory system agents|mesh-ancestor
102455887|NCT05098067|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102455888|NCT05098067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102455889|NCT05098067|Dopamine Agents|dopamine agents|mesh-ancestor
102455890|NCT01852383|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102455891|NCT01852383|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102455892|NCT01852383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102267503|NCT03965741|Rivaroxaban|rivaroxaban|mesh-list
102455893|NCT01852383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102455894|NCT01852383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455895|NCT01852383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102455896|NCT01852383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455897|NCT01852383|Analgesics|analgesics|mesh-ancestor
102455898|NCT01852383|Sensory System Agents|sensory system agents|mesh-ancestor
102455899|NCT01852383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102455900|NCT01852383|Antidepressive Agents|antidepressive agents|mesh-ancestor
102455901|NCT01852383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102455902|NCT01852383|Dopamine Agents|dopamine agents|mesh-ancestor
102455903|NCT04272333|Nivolumab|nivolumab|mesh-list
102455904|NCT04272333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102455905|NCT04272333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455906|NCT04272333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102455907|NCT04272333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455908|NCT02273115|Oxytocin|oxytocin|mesh-list
102455909|NCT02273115|Oxytocics|oxytocics|mesh-ancestor
102455910|NCT02273115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102455911|NCT02273115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455912|NCT01853085|Bimatoprost|bimatoprost|mesh-list
102455913|NCT01853085|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102455914|NCT01853085|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102455915|NCT01853085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102455916|NCT02989467|Aprepitant|aprepitant|mesh-list
102455917|NCT02989467|Antiemetics|antiemetics|mesh-ancestor
102455918|NCT02989467|Autonomic Agents|autonomic agents|mesh-ancestor
102455919|NCT02989467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102455920|NCT02989467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455921|NCT02989467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102455922|NCT02989467|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102455923|NCT02989467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102455924|NCT02989467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455925|NCT01853553|Spironolactone|spironolactone|mesh-list
102455926|NCT01853553|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102455927|NCT01853553|Hormone Antagonists|hormone antagonists|mesh-ancestor
102455928|NCT01853553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102455929|NCT01853553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455930|NCT01853553|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102455931|NCT01853553|Diuretics|diuretics|mesh-ancestor
102455932|NCT01853553|Natriuretic Agents|natriuretic agents|mesh-ancestor
102455933|NCT05748561|Methylprednisolone|methylprednisolone|mesh-list
102455934|NCT05748561|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102455935|NCT05748561|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102455936|NCT05748561|Prednisolone|prednisolone|mesh-list
102455937|NCT05748561|Prednisolone acetate|prednisolone acetate|mesh-list
102455938|NCT05748561|Epoetin Alfa|epoetin alfa|mesh-list
102455939|NCT05748561|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102455940|NCT05748561|Prednisolone phosphate|prednisolone phosphate|mesh-list
102455941|NCT05748561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102455942|NCT05748561|Antiemetics|antiemetics|mesh-ancestor
102455943|NCT05748561|Autonomic Agents|autonomic agents|mesh-ancestor
102455944|NCT05748561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102455945|NCT05748561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455946|NCT05748561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102455947|NCT05748561|Glucocorticoids|glucocorticoids|mesh-ancestor
102455948|NCT05748561|Hormones|hormones|mesh-ancestor
102455949|NCT05748561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102455950|NCT05748561|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102455951|NCT05748561|Protective Agents|protective agents|mesh-ancestor
102455952|NCT05748561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102455953|NCT05748561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455954|NCT05748561|Hematinics|hematinics|mesh-ancestor
102455955|NCT00290537|Paclitaxel|paclitaxel|mesh-list
102455956|NCT00290537|Carboplatin|carboplatin|mesh-list
102455957|NCT00290537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102455958|NCT00290537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455959|NCT00290537|Tubulin Modulators|tubulin modulators|mesh-ancestor
102455960|NCT00290537|Antimitotic Agents|antimitotic agents|mesh-ancestor
102455961|NCT00290537|Mitosis Modulators|mitosis modulators|mesh-ancestor
102455962|NCT00290537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455963|NCT00290615|Bevacizumab|bevacizumab|mesh-list
102455964|NCT00290615|Cetuximab|cetuximab|mesh-list
102455965|NCT00290615|Capecitabine|capecitabine|mesh-list
102455966|NCT00290615|Oxaliplatin|oxaliplatin|mesh-list
102455967|NCT00290615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102455968|NCT00290615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455969|NCT00290615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102455970|NCT00290615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102455971|NCT00290615|Growth Substances|growth substances|mesh-ancestor
102455972|NCT00290615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455973|NCT00290615|Growth Inhibitors|growth inhibitors|mesh-ancestor
102455974|NCT00290615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102455975|NCT00290615|Antimetabolites|antimetabolites|mesh-ancestor
102455976|NCT00290615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455977|NCT01854177|Aprepitant|aprepitant|mesh-list
102455978|NCT01854177|Fosaprepitant|fosaprepitant|mesh-list
102455979|NCT01854177|Antiemetics|antiemetics|mesh-ancestor
102455980|NCT01854177|Autonomic Agents|autonomic agents|mesh-ancestor
102455981|NCT01854177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102455982|NCT01854177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455983|NCT01854177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102455984|NCT01854177|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102455985|NCT01854177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102455986|NCT01854177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455987|NCT00243191|Imatinib Mesylate|imatinib mesylate|mesh-list
102455988|NCT00243191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102455989|NCT00243191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102455990|NCT00243191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102455991|NCT00243191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102455992|NCT00299221|Mycophenolic Acid|mycophenolic acid|mesh-list
102455993|NCT00299221|Tacrolimus|tacrolimus|mesh-list
102455994|NCT00299221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102455995|NCT00299221|Immunologic Factors|immunologic factors|mesh-ancestor
102455996|NCT00299221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102455997|NCT00299221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102455998|NCT00299221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102455999|NCT00299221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456000|NCT00299221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102456001|NCT00299221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456002|NCT00299221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102456003|NCT00299221|Antitubercular Agents|antitubercular agents|mesh-ancestor
102456004|NCT00299221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102456005|NCT00299221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102456006|NCT03799731|Trifluridine|trifluridine|mesh-list
102456007|NCT03799731|Antimetabolites|antimetabolites|mesh-ancestor
102456008|NCT03799731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456009|NCT03799731|Antiviral Agents|antiviral agents|mesh-ancestor
102456010|NCT03799731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102456011|NCT00299689|Denileukin diftitox|denileukin diftitox|mesh-list
102456012|NCT00299689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456013|NCT00244985|Rituximab|rituximab|mesh-list
102456014|NCT00244985|Doxorubicin|doxorubicin|mesh-list
102456015|NCT00244985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102456016|NCT00244985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102456017|NCT00244985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456018|NCT00244985|Immunologic Factors|immunologic factors|mesh-ancestor
102456019|NCT00244985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456020|NCT00244985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102456021|NCT00244985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102456022|NCT00244985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102456023|NCT00244985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102456024|NCT00244985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102456025|NCT00244985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456026|NCT01857297|Vaccines|vaccines|mesh-list
102456027|NCT01857297|Immunologic Factors|immunologic factors|mesh-ancestor
102456028|NCT01857297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456029|NCT00300391|Haloperidol|haloperidol|mesh-list
102456030|NCT00300391|Haloperidol decanoate|haloperidol decanoate|mesh-list
102456031|NCT00300391|Antiemetics|antiemetics|mesh-ancestor
102456032|NCT00300391|Autonomic Agents|autonomic agents|mesh-ancestor
102456033|NCT00300391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102456034|NCT00300391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456035|NCT00300391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102456036|NCT00300391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102456037|NCT00300391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102456038|NCT00300391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102456039|NCT00300391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102456040|NCT00300391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102456041|NCT00300391|Dopamine Agents|dopamine agents|mesh-ancestor
102456042|NCT00300391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102612319|NCT00002405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102456043|NCT00300391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456045|NCT01859013|Topiramate|topiramate|mesh-list
102456046|NCT01859013|Anticonvulsants|anticonvulsants|mesh-ancestor
102456047|NCT01859013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102456048|NCT01859013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456049|NCT00294515|Valganciclovir|valganciclovir|mesh-list
102456050|NCT00294515|Antiviral Agents|antiviral agents|mesh-ancestor
102456051|NCT00294515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102456052|NCT00300469|Atorvastatin|atorvastatin|mesh-list
102456053|NCT00300469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102456054|NCT00300469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102456055|NCT00300469|Antimetabolites|antimetabolites|mesh-ancestor
102456056|NCT00300469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456057|NCT00300469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102456058|NCT00300469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102456059|NCT00300469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102456060|NCT01859637|Lenograstim|lenograstim|mesh-list
102456061|NCT01859637|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102456062|NCT01859637|Immunologic Factors|immunologic factors|mesh-ancestor
102456063|NCT01859637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456064|NCT00295061|Protease Inhibitors|protease inhibitors|mesh-list
102456065|NCT00295061|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
102456066|NCT00295061|Protein C Inhibitor|protein c inhibitor|mesh-list
102456067|NCT00295061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102456068|NCT00295061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456069|NCT00295061|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102456070|NCT00295061|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102456071|NCT02117141|Hydrocodone|hydrocodone|mesh-list
102456072|NCT02117141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102456073|NCT02117141|Narcotics|narcotics|mesh-ancestor
102456074|NCT02117141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102456075|NCT02117141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456076|NCT02117141|Analgesics|analgesics|mesh-ancestor
102456077|NCT02117141|Sensory System Agents|sensory system agents|mesh-ancestor
102456078|NCT02117141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102456079|NCT02117141|Antitussive Agents|antitussive agents|mesh-ancestor
102456080|NCT02117141|Respiratory System Agents|respiratory system agents|mesh-ancestor
102456081|NCT00299741|Sunitinib|sunitinib|mesh-list
102456082|NCT00299741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456083|NCT00299741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102456084|NCT00299741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102456085|NCT00299741|Growth Substances|growth substances|mesh-ancestor
102456086|NCT00299741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456087|NCT00299741|Growth Inhibitors|growth inhibitors|mesh-ancestor
102456088|NCT00299741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102456089|NCT00299741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102456090|NCT00299741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456091|NCT00328861|Aldesleukin|aldesleukin|mesh-list
102456092|NCT00328861|Cyclophosphamide|cyclophosphamide|mesh-list
102456093|NCT00328861|Fludarabine|fludarabine|mesh-list
102456094|NCT00328861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102456095|NCT00328861|Immunologic Factors|immunologic factors|mesh-ancestor
102456096|NCT00328861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456097|NCT00328861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102456098|NCT00328861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102456099|NCT00328861|Alkylating Agents|alkylating agents|mesh-ancestor
102456100|NCT00328861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456101|NCT00328861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456102|NCT00328861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102456103|NCT00328861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102456104|NCT00328861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102456105|NCT00328861|Antiviral Agents|antiviral agents|mesh-ancestor
102456106|NCT00328861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102456107|NCT00248807|Enalaprilat|enalaprilat|mesh-list
102456108|NCT00248807|Enalapril|enalapril|mesh-list
102456109|NCT00248807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102456110|NCT00248807|Protease Inhibitors|protease inhibitors|mesh-ancestor
102456111|NCT00248807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102456112|NCT00248807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456113|NCT00248807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102456114|NCT01860807|Ibudilast|ibudilast|mesh-list
102456115|NCT01860807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102456116|NCT01860807|Autonomic Agents|autonomic agents|mesh-ancestor
102267721|NCT05058677|Sensory System Agents|sensory system agents|mesh-ancestor
102456117|NCT01860807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102456118|NCT01860807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456120|NCT01860807|Respiratory System Agents|respiratory system agents|mesh-ancestor
102456121|NCT01860807|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102456122|NCT01860807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102456123|NCT01860807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456124|NCT01860807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102456125|NCT01860807|Vasodilator Agents|vasodilator agents|mesh-ancestor
102456126|NCT00330421|Sorafenib|sorafenib|mesh-list
102456127|NCT00330421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456128|NCT00330421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102456129|NCT00330421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102456130|NCT00330421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456131|NCT04350645|Tranexamic Acid|tranexamic acid|mesh-list
102456132|NCT04350645|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102456133|NCT04350645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102456134|NCT04350645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456135|NCT04350645|Hemostatics|hemostatics|mesh-ancestor
102456136|NCT04350645|Coagulants|coagulants|mesh-ancestor
102456137|NCT00330733|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
102456138|NCT00330733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102456139|NCT00330733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102456140|NCT00330733|Analgesics|analgesics|mesh-ancestor
102456141|NCT00330733|Sensory System Agents|sensory system agents|mesh-ancestor
102456142|NCT00330733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102456143|NCT00330733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456144|NCT00330733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102456145|NCT00330733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102456146|NCT05192369|Moxifloxacin|moxifloxacin|mesh-list
102456147|NCT05192369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102456148|NCT05192369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102456149|NCT05192369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102456150|NCT05192369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102456151|NCT05192369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102456152|NCT05192369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456153|NCT05192369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456154|NCT05185973|Micronutrients|micronutrients|mesh-list
102456155|NCT05185973|Trace Elements|trace elements|mesh-list
102456156|NCT05185973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456157|NCT00301873|Zoledronic Acid|zoledronic acid|mesh-list
102456158|NCT00301873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102456159|NCT00301873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456160|NCT01892839|Dialysis Solutions|dialysis solutions|mesh-list
102456161|NCT01892839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102456162|NCT00251225|Docetaxel|docetaxel|mesh-list
102456163|NCT00251225|Imatinib Mesylate|imatinib mesylate|mesh-list
102456164|NCT00251225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456165|NCT00251225|Tubulin Modulators|tubulin modulators|mesh-ancestor
102456166|NCT00251225|Antimitotic Agents|antimitotic agents|mesh-ancestor
102456167|NCT00251225|Mitosis Modulators|mitosis modulators|mesh-ancestor
102456168|NCT00251225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456169|NCT00251225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102456170|NCT00251225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102456171|NCT02979327|Adderall|adderall|mesh-list
102456172|NCT02979327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102456173|NCT02979327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456174|NCT05951075|Vitamins|vitamins|mesh-list
102456175|NCT05951075|Micronutrients|micronutrients|mesh-ancestor
102456176|NCT05951075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456177|NCT05951062|Antihypertensive Agents|antihypertensive agents|mesh-list
102456178|NCT05951023|Eszopiclone|eszopiclone|mesh-list
102456179|NCT05951023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102456180|NCT05951023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102456181|NCT05951023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456182|NCT05950997|Obinutuzumab|obinutuzumab|mesh-list
102456183|NCT05950997|Acalabrutinib|acalabrutinib|mesh-list
102456184|NCT05950997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102456185|NCT05950997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456186|NCT05950971|Amiodarone|amiodarone|mesh-list
102456187|NCT05950971|Diltiazem|diltiazem|mesh-list
102456188|NCT05950971|Esmolol|esmolol|mesh-list
102456189|NCT05950971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102456190|NCT05950971|Vasodilator Agents|vasodilator agents|mesh-ancestor
102456191|NCT05950971|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102456192|NCT05950971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102456193|NCT05950971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456194|NCT05950971|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102456195|NCT05950971|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102456196|NCT05950971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102456197|NCT05950971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102456198|NCT05950971|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102456199|NCT05950971|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102456200|NCT05950971|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102456201|NCT05950971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102456202|NCT05950971|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102456203|NCT05950971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102456204|NCT05950971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456205|NCT05950971|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102456206|NCT05950971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102456207|NCT05950971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102456208|NCT05950971|Adrenergic Agents|adrenergic agents|mesh-ancestor
102456209|NCT05950971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102456210|NCT05950945|Trastuzumab|trastuzumab|mesh-list
102456211|NCT05950945|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
102456212|NCT05950945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102456213|NCT05950945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456214|NCT05950945|Immunoconjugates|immunoconjugates|mesh-ancestor
102456215|NCT05950945|Immunologic Factors|immunologic factors|mesh-ancestor
102456216|NCT05950945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456217|NCT05950841|Locust bean gum|locust bean gum|mesh-list
102456218|NCT05950841|Antidiarrheals|antidiarrheals|mesh-ancestor
102456219|NCT05950841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102456220|NCT05950724|Etanercept|etanercept|mesh-list
102456221|NCT05950724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102456222|NCT05950724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102456223|NCT05950724|Analgesics|analgesics|mesh-ancestor
102456224|NCT05950724|Sensory System Agents|sensory system agents|mesh-ancestor
102456225|NCT05950724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102456226|NCT05950724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456227|NCT05950724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102456228|NCT05950724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102456229|NCT05950724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102456230|NCT05950724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102456231|NCT05950724|Immunologic Factors|immunologic factors|mesh-ancestor
102456232|NCT05950711|Ketamine|ketamine|mesh-list
102456233|NCT05950711|Analgesics|analgesics|mesh-ancestor
102456234|NCT05950711|Sensory System Agents|sensory system agents|mesh-ancestor
102456235|NCT05950711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102456236|NCT05950711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456237|NCT05950711|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102456238|NCT05950711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102456239|NCT05950711|Anesthetics, General|anesthetics, general|mesh-ancestor
102456240|NCT05950711|Anesthetics|anesthetics|mesh-ancestor
102456241|NCT05950711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102456242|NCT05950711|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102456243|NCT05950711|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102456244|NCT05950711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102456245|NCT05950711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456246|NCT05950555|Dexmedetomidine|dexmedetomidine|mesh-list
102456247|NCT05950555|Ketamine|ketamine|mesh-list
102456248|NCT05950555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102456249|NCT05950555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102456250|NCT05950555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456251|NCT05950555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102456252|NCT05950555|Analgesics|analgesics|mesh-ancestor
102456253|NCT05950555|Sensory System Agents|sensory system agents|mesh-ancestor
102456254|NCT05950555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102456255|NCT05950555|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102456256|NCT05950555|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102456257|NCT05950555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102456258|NCT05950555|Adrenergic Agents|adrenergic agents|mesh-ancestor
102456259|NCT05950555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102456260|NCT05950555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456261|NCT05950555|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102456262|NCT05950555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102456263|NCT05950555|Anesthetics, General|anesthetics, general|mesh-ancestor
102456264|NCT05950555|Anesthetics|anesthetics|mesh-ancestor
102456265|NCT05950555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102456266|NCT05950555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102456267|NCT05950529|Sorbitol|sorbitol|mesh-list
102456268|NCT05950529|Cathartics|cathartics|mesh-ancestor
102456269|NCT05950529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102456270|NCT05950490|Methotrexate|methotrexate|mesh-list
102456271|NCT05950490|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102456272|NCT05950490|Abortifacient Agents|abortifacient agents|mesh-ancestor
102456273|NCT05950490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102456274|NCT05950490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456275|NCT05950490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102456276|NCT05950490|Antimetabolites|antimetabolites|mesh-ancestor
102456277|NCT05950490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456278|NCT05950490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456279|NCT05950490|Dermatologic Agents|dermatologic agents|mesh-ancestor
102456280|NCT05950490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102456281|NCT05950490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102456282|NCT05950490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102456283|NCT05950490|Immunologic Factors|immunologic factors|mesh-ancestor
102456284|NCT05950490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102456285|NCT05950490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102456286|NCT05950334|Cyclophosphamide|cyclophosphamide|mesh-list
102456287|NCT05950334|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102456288|NCT05950334|Rituximab|rituximab|mesh-list
102456289|NCT05950334|Fludarabine|fludarabine|mesh-list
102456290|NCT05950334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102456291|NCT05950334|Immunologic Factors|immunologic factors|mesh-ancestor
102456292|NCT05950334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456293|NCT05950334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102456294|NCT05950334|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102456295|NCT05950334|Alkylating Agents|alkylating agents|mesh-ancestor
102456296|NCT05950334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456297|NCT05950334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456298|NCT05950334|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102456299|NCT05950334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102456300|NCT05950204|Calcium, Dietary|calcium, dietary|mesh-list
102456301|NCT05950204|Vitamin D|vitamin d|mesh-list
102456302|NCT05950204|Ergocalciferols|ergocalciferols|mesh-list
102456303|NCT05950204|Cholecalciferol|cholecalciferol|mesh-list
102456304|NCT05950204|Vitamins|vitamins|mesh-list
102456305|NCT05950204|Calcium Carbonate|calcium carbonate|mesh-list
102456306|NCT05950204|Calcium|calcium|mesh-list
102456307|NCT05950204|Micronutrients|micronutrients|mesh-ancestor
102456308|NCT05950204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456309|NCT05950204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102456310|NCT05950204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102456311|NCT05950204|Antacids|antacids|mesh-ancestor
102456312|NCT05950204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456313|NCT05950204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102456314|NCT05950152|Meloxicam|meloxicam|mesh-list
102456315|NCT05950152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102456316|NCT05950152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102456317|NCT05950152|Analgesics|analgesics|mesh-ancestor
102456318|NCT05950152|Sensory System Agents|sensory system agents|mesh-ancestor
102456319|NCT05950152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102456320|NCT05950152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456321|NCT05950152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102456322|NCT05950152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102456323|NCT05950152|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102456324|NCT05950152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102456325|NCT05950152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102456326|NCT05950152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456327|NCT05950113|Deoxyglucose|deoxyglucose|mesh-list
102456328|NCT05950113|Cyclophosphamide|cyclophosphamide|mesh-list
102456329|NCT05950113|Fludarabine|fludarabine|mesh-list
102456330|NCT05950113|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102456331|NCT05950113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102456332|NCT05950113|Immunologic Factors|immunologic factors|mesh-ancestor
102456333|NCT05950113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456334|NCT05950113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102456335|NCT05950113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102456336|NCT05950113|Alkylating Agents|alkylating agents|mesh-ancestor
102456337|NCT05950113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456338|NCT05950113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456339|NCT05950113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102456341|NCT05950113|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102456342|NCT05950113|Antiviral Agents|antiviral agents|mesh-ancestor
102456343|NCT05950113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102456344|NCT05950061|Dexetimide|dexetimide|mesh-list
102456345|NCT05950061|Citalopram|citalopram|mesh-list
102456346|NCT05950061|Sertraline|sertraline|mesh-list
102456347|NCT05950061|Escitalopram|escitalopram|mesh-list
102456348|NCT05950061|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102456349|NCT05950061|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102456350|NCT05950061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102456351|NCT05950061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456352|NCT05950061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102456353|NCT05950061|Serotonin Agents|serotonin agents|mesh-ancestor
102456354|NCT05950061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456355|NCT05950061|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102456356|NCT05950061|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102456357|NCT05950061|Parasympatholytics|parasympatholytics|mesh-ancestor
102456358|NCT05950061|Autonomic Agents|autonomic agents|mesh-ancestor
102456359|NCT05950061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102456360|NCT05950061|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102456361|NCT05950061|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102456362|NCT05950061|Cholinergic Agents|cholinergic agents|mesh-ancestor
102456363|NCT05950061|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102456364|NCT05950061|Antidepressive Agents|antidepressive agents|mesh-ancestor
102456365|NCT05950061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102456366|NCT05949762|Azacitidine|azacitidine|mesh-list
102456367|NCT05949762|Venetoclax|venetoclax|mesh-list
102456368|NCT05949762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102456369|NCT05949762|Antimetabolites|antimetabolites|mesh-ancestor
102456370|NCT05949762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456371|NCT05949762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456372|NCT05949762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102456373|NCT05949658|Sirolimus|sirolimus|mesh-list
102456374|NCT05949658|Everolimus|everolimus|mesh-list
102456375|NCT05949658|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102456376|NCT05949658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102456377|NCT05949658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102456378|NCT05949658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456379|NCT05949658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102456380|NCT05949658|Immunologic Factors|immunologic factors|mesh-ancestor
102456381|NCT05949658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456382|NCT05949658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456383|NCT05949658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102456384|NCT05949658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102456385|NCT05949658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102456386|NCT05949658|Antifungal Agents|antifungal agents|mesh-ancestor
102456387|NCT05949554|Ketamine|ketamine|mesh-list
102456388|NCT05949554|Analgesics|analgesics|mesh-ancestor
102456389|NCT05949554|Sensory System Agents|sensory system agents|mesh-ancestor
102456390|NCT05949554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102456391|NCT05949554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456392|NCT05949554|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102456393|NCT05949554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102456394|NCT05949554|Anesthetics, General|anesthetics, general|mesh-ancestor
102456395|NCT05949554|Anesthetics|anesthetics|mesh-ancestor
102456396|NCT05949554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102456397|NCT05949554|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102456398|NCT05949554|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102456399|NCT05949554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102456400|NCT05949554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456401|NCT05949541|Everolimus|everolimus|mesh-list
102456402|NCT05949541|Fulvestrant|fulvestrant|mesh-list
102456403|NCT05949541|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102456404|NCT05949541|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102456405|NCT05949541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102456406|NCT05949541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102456407|NCT05949541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456408|NCT05949541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102456409|NCT05949541|Immunologic Factors|immunologic factors|mesh-ancestor
102456410|NCT05949541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456411|NCT05949541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456412|NCT05949541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102456413|NCT05949541|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102456414|NCT05949541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102456415|NCT05949541|Hormone Antagonists|hormone antagonists|mesh-ancestor
102456416|NCT05949541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102456417|NCT05949541|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102456419|NCT05949424|Lenvatinib|lenvatinib|mesh-list
102456420|NCT05949424|Olaparib|olaparib|mesh-list
102456421|NCT05949424|Palbociclib|palbociclib|mesh-list
102456422|NCT05949424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456423|NCT05949424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102456424|NCT05949424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102456425|NCT05949424|Growth Substances|growth substances|mesh-ancestor
102456426|NCT05949424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456427|NCT05949424|Growth Inhibitors|growth inhibitors|mesh-ancestor
102456428|NCT05949424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102456429|NCT05949424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102456430|NCT05949424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456431|NCT05949424|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102456432|NCT05949411|Lactulose|lactulose|mesh-list
102456433|NCT05949411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102456434|NCT05949385|Itraconazole|itraconazole|mesh-list
102456435|NCT05949385|Antifungal Agents|antifungal agents|mesh-ancestor
102456436|NCT05949385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102456437|NCT05949385|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102456438|NCT05949385|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102456439|NCT05949385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102456440|NCT05949385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456441|NCT05949385|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102456442|NCT05949385|Hormone Antagonists|hormone antagonists|mesh-ancestor
102456443|NCT05949385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102456444|NCT05949385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456445|NCT05949385|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102456446|NCT05944965|Oxybutynin|oxybutynin|mesh-list
102456447|NCT05944965|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102456448|NCT05944965|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102456449|NCT05944965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102456450|NCT05944965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102456451|NCT05944965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456452|NCT05944965|Adrenergic Agents|adrenergic agents|mesh-ancestor
102456453|NCT05944965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102456454|NCT05944965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456455|NCT05944965|Parasympatholytics|parasympatholytics|mesh-ancestor
102456456|NCT05944965|Autonomic Agents|autonomic agents|mesh-ancestor
102456457|NCT05944965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102456458|NCT05944965|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102456459|NCT05944965|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102456460|NCT05944965|Cholinergic Agents|cholinergic agents|mesh-ancestor
102456461|NCT05944965|Urological Agents|urological agents|mesh-ancestor
102456462|NCT05944510|Dextromethorphan|dextromethorphan|mesh-list
102456463|NCT05944510|Antitussive Agents|antitussive agents|mesh-ancestor
102456464|NCT05944510|Respiratory System Agents|respiratory system agents|mesh-ancestor
102456465|NCT05944510|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102456466|NCT05944510|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102456467|NCT05944510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102086562|NCT02171442|Dabigatran|dabigatran|mesh-list
102456468|NCT05944510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456469|NCT05944510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456470|NCT05930028|Atorvastatin|atorvastatin|mesh-list
102456471|NCT05930028|Ezetimibe|ezetimibe|mesh-list
102456472|NCT05930028|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102456473|NCT05930028|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102456474|NCT05930028|Antimetabolites|antimetabolites|mesh-ancestor
102456475|NCT05930028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456476|NCT05930028|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102456477|NCT05930028|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102456478|NCT05930028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102456479|NCT05915442|Quemliclustat|quemliclustat|mesh-list
102456480|NCT05915442|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102456481|NCT05915442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456482|NCT05915442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102456483|NCT05915442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456484|NCT05882357|Ivacaftor|ivacaftor|mesh-list
102456485|NCT05882357|Elexacaftor|elexacaftor|mesh-list
102456486|NCT05882357|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102456487|NCT05882357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102456488|NCT05882357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456489|NCT05765487|Sildenafil Citrate|sildenafil citrate|mesh-list
102456490|NCT05765487|Vasodilator Agents|vasodilator agents|mesh-ancestor
102456491|NCT05765487|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102456492|NCT05765487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102456493|NCT05765487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102456494|NCT05765487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456495|NCT05765487|Urological Agents|urological agents|mesh-ancestor
102456496|NCT05718297|Durvalumab|durvalumab|mesh-list
102456497|NCT05718297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102456498|NCT05718297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456499|NCT05701956|Tenecteplase|tenecteplase|mesh-list
102456500|NCT05701956|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102456501|NCT05701956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102456502|NCT05701956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456503|NCT05662228|Lorazepam|lorazepam|mesh-list
102456504|NCT05662228|Immunoglobulins|immunoglobulins|mesh-list
102456505|NCT05662228|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102456506|NCT05662228|Antibodies|antibodies|mesh-list
102456507|NCT05662228|gamma-Globulins|gamma-globulins|mesh-list
102456508|NCT05662228|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102456509|NCT05662228|Tofacitinib|tofacitinib|mesh-list
102456510|NCT05662228|Immunologic Factors|immunologic factors|mesh-ancestor
102456511|NCT05662228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456512|NCT05662228|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102456513|NCT05662228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102456514|NCT05662228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102456515|NCT05662228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456516|NCT05662228|Anticonvulsants|anticonvulsants|mesh-ancestor
102456517|NCT05662228|Antiemetics|antiemetics|mesh-ancestor
102456518|NCT05662228|Autonomic Agents|autonomic agents|mesh-ancestor
102456519|NCT05662228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102456520|NCT05662228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102456521|NCT05662228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102456522|NCT05662228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102456523|NCT05662228|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102456524|NCT05662228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102456525|NCT05662228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102456526|NCT05662228|GABA Modulators|gaba modulators|mesh-ancestor
102456527|NCT05662228|GABA Agents|gaba agents|mesh-ancestor
102456528|NCT05662228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102456529|NCT05656235|Pembrolizumab|pembrolizumab|mesh-list
102456530|NCT05656235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102456531|NCT05656235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456532|NCT05656235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102456533|NCT05656235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456534|NCT05641246|Diclofenac|diclofenac|mesh-list
102456535|NCT05641246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102456536|NCT05641246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102456537|NCT05641246|Analgesics|analgesics|mesh-ancestor
102456538|NCT05641246|Sensory System Agents|sensory system agents|mesh-ancestor
102456539|NCT05641246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102456540|NCT05641246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456541|NCT05641246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102456542|NCT05641246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102456543|NCT05641246|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102456544|NCT05641246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102456545|NCT05641246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456546|NCT05593627|Lithium Carbonate|lithium carbonate|mesh-list
102456547|NCT05593627|Calcium Carbonate|calcium carbonate|mesh-list
102456548|NCT05593627|Calcium|calcium|mesh-list
102456549|NCT05593627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102456550|NCT05593627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456551|NCT05593627|Antidepressive Agents|antidepressive agents|mesh-ancestor
102456552|NCT05593627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102456553|NCT05593627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102456554|NCT05593627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456555|NCT05593627|Antimanic Agents|antimanic agents|mesh-ancestor
102456556|NCT05593627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102456557|NCT05593627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102456558|NCT05593627|Antacids|antacids|mesh-ancestor
102456559|NCT05593627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102456560|NCT05582096|Tirzepatide|tirzepatide|mesh-list
102456561|NCT05582096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102456562|NCT05582096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456564|NCT05582096|Hormones|hormones|mesh-ancestor
102456565|NCT05582096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102456566|NCT05577715|Farletuzumab|farletuzumab|mesh-list
102456567|NCT05577715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456568|NCT05563961|Acetaminophen|acetaminophen|mesh-list
102456569|NCT05563961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102456570|NCT05563961|Analgesics|analgesics|mesh-ancestor
102456571|NCT05563961|Sensory System Agents|sensory system agents|mesh-ancestor
102456572|NCT05563961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102456573|NCT05563961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456574|NCT05563961|Antipyretics|antipyretics|mesh-ancestor
102456575|NCT05542407|Atezolizumab|atezolizumab|mesh-list
102456576|NCT05542407|TIC10 compound|tic10 compound|mesh-list
102456577|NCT05542407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102456578|NCT05542407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456579|NCT05542407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102456580|NCT05542407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456581|NCT05527834|Ceftibuten|ceftibuten|mesh-list
102456582|NCT05527834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102456583|NCT05527834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102456584|NCT05522660|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102456585|NCT05522660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456586|NCT05522660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102456587|NCT05522660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456588|NCT05507658|Capecitabine|capecitabine|mesh-list
102456589|NCT05507658|Oxaliplatin|oxaliplatin|mesh-list
102456590|NCT05507658|Tislelizumab|tislelizumab|mesh-list
102456591|NCT05507658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102456592|NCT05507658|Antimetabolites|antimetabolites|mesh-ancestor
102456593|NCT05507658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456594|NCT05507658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456595|NCT05507658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102456596|NCT05502250|Gemcitabine|gemcitabine|mesh-list
102456597|NCT05502250|Tislelizumab|tislelizumab|mesh-list
102456598|NCT05502250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456599|NCT05502250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102456600|NCT05502250|Antimetabolites|antimetabolites|mesh-ancestor
102456601|NCT05502250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456602|NCT05502250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102456603|NCT05488678|Ceftibuten|ceftibuten|mesh-list
102456604|NCT05488678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102456605|NCT05488678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102456606|NCT05480306|Bevacizumab|bevacizumab|mesh-list
102456607|NCT05480306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102456608|NCT05480306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456609|NCT05480306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102456610|NCT05480306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102456611|NCT05480306|Growth Substances|growth substances|mesh-ancestor
102456612|NCT05480306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456613|NCT05480306|Growth Inhibitors|growth inhibitors|mesh-ancestor
102456614|NCT05473520|Doxycycline|doxycycline|mesh-list
102456615|NCT05473520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102456616|NCT05473520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102456617|NCT05473520|Antimalarials|antimalarials|mesh-ancestor
102456618|NCT05473520|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102456619|NCT05473520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102456620|NCT05457868|Albuterol|albuterol|mesh-list
102456621|NCT05457868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102456622|NCT05457868|Autonomic Agents|autonomic agents|mesh-ancestor
102456623|NCT05457868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102456624|NCT05457868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456625|NCT05457868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102456626|NCT05457868|Respiratory System Agents|respiratory system agents|mesh-ancestor
102456627|NCT05457868|Tocolytic Agents|tocolytic agents|mesh-ancestor
102456628|NCT05457868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102456629|NCT05457868|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102456630|NCT05457868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102456631|NCT05457868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102456632|NCT05457868|Adrenergic Agents|adrenergic agents|mesh-ancestor
102456633|NCT05457868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102456634|NCT05457868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456635|NCT05448547|Hormones|hormones|mesh-list
102268249|NCT02640053|Paclitaxel|paclitaxel|mesh-list
102456636|NCT05448547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102456637|NCT05448547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456638|NCT05434065|Celecoxib|celecoxib|mesh-list
102456639|NCT05434065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102456640|NCT05434065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102456641|NCT05434065|Analgesics|analgesics|mesh-ancestor
102456642|NCT05434065|Sensory System Agents|sensory system agents|mesh-ancestor
102456643|NCT05434065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102456644|NCT05434065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456645|NCT05434065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102456646|NCT05434065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102456647|NCT05434065|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102456648|NCT05434065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102456649|NCT05434065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102456650|NCT05434065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456651|NCT05425979|Bupivacaine|bupivacaine|mesh-list
102456652|NCT05425979|Mepivacaine|mepivacaine|mesh-list
102456653|NCT05425979|Anesthetics, Local|anesthetics, local|mesh-ancestor
102456654|NCT05425979|Anesthetics|anesthetics|mesh-ancestor
102456655|NCT05425979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102456656|NCT05425979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456657|NCT05425979|Sensory System Agents|sensory system agents|mesh-ancestor
102456658|NCT05425979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102456659|NCT05398757|Midazolam|midazolam|mesh-list
102456660|NCT05398757|Dexmedetomidine|dexmedetomidine|mesh-list
102456661|NCT05398757|Propofol|propofol|mesh-list
102456662|NCT05398757|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102456663|NCT05398757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102456664|NCT05398757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456665|NCT05398757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102456666|NCT05398757|Anesthetics, General|anesthetics, general|mesh-ancestor
102456667|NCT05398757|Anesthetics|anesthetics|mesh-ancestor
102086776|NCT04794790|Buprenorphine|buprenorphine|mesh-list
102456668|NCT05398757|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102456669|NCT05398757|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102456670|NCT05398757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102456671|NCT05398757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102456672|NCT05398757|GABA Modulators|gaba modulators|mesh-ancestor
102456673|NCT05398757|GABA Agents|gaba agents|mesh-ancestor
102456674|NCT05398757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102456675|NCT05398757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456676|NCT05398757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102456677|NCT05398757|Analgesics|analgesics|mesh-ancestor
102456678|NCT05398757|Sensory System Agents|sensory system agents|mesh-ancestor
102456679|NCT05398757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102456680|NCT05398757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102456681|NCT05398757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102456682|NCT05398757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102456683|NCT05398757|Adrenergic Agents|adrenergic agents|mesh-ancestor
102456684|NCT05378269|Tamoxifen|tamoxifen|mesh-list
102456685|NCT05378269|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102456686|NCT05378269|Hormone Antagonists|hormone antagonists|mesh-ancestor
102456687|NCT05378269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102456688|NCT05378269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456689|NCT05378269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102456690|NCT05378269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456691|NCT05378269|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102456692|NCT05378269|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102456693|NCT05378269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102456694|NCT05323552|Curare|curare|mesh-list
102456695|NCT05323552|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102456696|NCT05323552|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102456697|NCT05323552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102456698|NCT05323552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102456699|NCT05323552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456700|NCT05323552|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102456701|NCT05323552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102456702|NCT05323552|Cholinergic Agents|cholinergic agents|mesh-ancestor
102456703|NCT05323552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102456704|NCT05323552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456705|NCT05322954|Psilocybin|psilocybin|mesh-list
102456706|NCT05322954|Hallucinogens|hallucinogens|mesh-ancestor
102456707|NCT05322954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456708|NCT05322954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102268317|NCT02361619|Anticoagulants|anticoagulants|mesh-ancestor
102456709|NCT05310253|Fludrocortisone|fludrocortisone|mesh-list
102456710|NCT05310253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102456712|NCT05291039|Infliximab|infliximab|mesh-list
102456713|NCT05291039|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102456714|NCT05291039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102456715|NCT05291039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102456716|NCT05291039|Dermatologic Agents|dermatologic agents|mesh-ancestor
102456717|NCT05291039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102456718|NCT05274633|Ravulizumab|ravulizumab|mesh-list
102456719|NCT05274633|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102456720|NCT05274633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102456721|NCT05274633|Immunologic Factors|immunologic factors|mesh-ancestor
102456722|NCT05274633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456723|NCT05256901|Glycopyrrolate|glycopyrrolate|mesh-list
102456724|NCT05256901|Neostigmine|neostigmine|mesh-list
102456725|NCT05256901|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102456726|NCT05256901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102456727|NCT05256901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456728|NCT05256901|Cholinergic Agents|cholinergic agents|mesh-ancestor
102456729|NCT05256901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102456730|NCT05256901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456731|NCT05256901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102456732|NCT05256901|Autonomic Agents|autonomic agents|mesh-ancestor
102456733|NCT05256901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102456734|NCT05256901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102268391|NCT00014443|Leprostatic Agents|leprostatic agents|mesh-ancestor
102456735|NCT05256901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102456736|NCT05256901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102456737|NCT05249101|Capecitabine|capecitabine|mesh-list
102456738|NCT05249101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102456739|NCT05249101|Antimetabolites|antimetabolites|mesh-ancestor
102456740|NCT05249101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456741|NCT05249101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456742|NCT05224089|Dexamethasone|dexamethasone|mesh-list
102456743|NCT05224089|Epinephrine|epinephrine|mesh-list
102456744|NCT05224089|Bupivacaine|bupivacaine|mesh-list
102456745|NCT05224089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102456746|NCT05224089|Antiemetics|antiemetics|mesh-ancestor
102456747|NCT05224089|Autonomic Agents|autonomic agents|mesh-ancestor
102456748|NCT05224089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102456749|NCT05224089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456750|NCT05224089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102456751|NCT05224089|Glucocorticoids|glucocorticoids|mesh-ancestor
102456752|NCT05224089|Hormones|hormones|mesh-ancestor
102456753|NCT05224089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102456754|NCT05224089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102456755|NCT05224089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456756|NCT05224089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456757|NCT05224089|Anesthetics, Local|anesthetics, local|mesh-ancestor
102456758|NCT05224089|Anesthetics|anesthetics|mesh-ancestor
102456759|NCT05224089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102456760|NCT05224089|Sensory System Agents|sensory system agents|mesh-ancestor
102456761|NCT05224089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102456762|NCT05224089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102456763|NCT05224089|Adrenergic Agents|adrenergic agents|mesh-ancestor
102456764|NCT05224089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102456765|NCT05224089|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102456766|NCT05224089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102456767|NCT05224089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102456768|NCT05224089|Respiratory System Agents|respiratory system agents|mesh-ancestor
102456769|NCT05224089|Mydriatics|mydriatics|mesh-ancestor
102456770|NCT05224089|Sympathomimetics|sympathomimetics|mesh-ancestor
102456771|NCT05224089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102456772|NCT05205252|Dexamethasone|dexamethasone|mesh-list
102456773|NCT05205252|Lenalidomide|lenalidomide|mesh-list
102456774|NCT05205252|Daratumumab|daratumumab|mesh-list
102456775|NCT05205252|Pomalidomide|pomalidomide|mesh-list
102456776|NCT05205252|Acalabrutinib|acalabrutinib|mesh-list
102456777|NCT05205252|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102456778|NCT05205252|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102456779|NCT05205252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102456780|NCT05205252|Antiemetics|antiemetics|mesh-ancestor
102456781|NCT05205252|Autonomic Agents|autonomic agents|mesh-ancestor
102456782|NCT05205252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102456783|NCT05205252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456784|NCT05205252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102456785|NCT05205252|Glucocorticoids|glucocorticoids|mesh-ancestor
102456786|NCT05205252|Hormones|hormones|mesh-ancestor
102456787|NCT05205252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102456788|NCT05205252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102456789|NCT05205252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456790|NCT05205252|Immunologic Factors|immunologic factors|mesh-ancestor
102456791|NCT05205252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102456792|NCT05205252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102456793|NCT05205252|Growth Substances|growth substances|mesh-ancestor
102456794|NCT05205252|Growth Inhibitors|growth inhibitors|mesh-ancestor
102456795|NCT05205252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102456796|NCT05205252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102456797|NCT05205252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456798|NCT05180240|Cannabidiol|cannabidiol|mesh-list
102456799|NCT05180240|Anticonvulsants|anticonvulsants|mesh-ancestor
102456800|NCT05127044|Bilirubin|bilirubin|mesh-list
102456801|NCT05127044|Antioxidants|antioxidants|mesh-ancestor
102456802|NCT05127044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456803|NCT05127044|Protective Agents|protective agents|mesh-ancestor
102456804|NCT05127044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456805|NCT05125237|Amiloride|amiloride|mesh-list
102456806|NCT05125237|Triamterene|triamterene|mesh-list
102456807|NCT05125237|Diuretics|diuretics|mesh-ancestor
102456808|NCT05125237|Natriuretic Agents|natriuretic agents|mesh-ancestor
102456809|NCT05125237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456810|NCT05125237|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
102456811|NCT05125237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102456812|NCT05125237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102456813|NCT05125237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456814|NCT05125237|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
102456815|NCT05125237|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102456816|NCT05125224|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102456817|NCT05125224|Calcium Channel Blockers|calcium channel blockers|mesh-list
102456818|NCT05125224|1,4-dihydropyridine|1,4-dihydropyridine|mesh-list
102456819|NCT05125224|Calcium|calcium|mesh-list
102456820|NCT05125224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102456821|NCT05125224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456822|NCT05125224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102456823|NCT05125224|Diuretics|diuretics|mesh-ancestor
102456824|NCT05125224|Natriuretic Agents|natriuretic agents|mesh-ancestor
102456825|NCT05125224|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102456826|NCT05125224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102456827|NCT05125224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456828|NCT05057247|Docetaxel|docetaxel|mesh-list
102456829|NCT05057247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456830|NCT05057247|Tubulin Modulators|tubulin modulators|mesh-ancestor
102456831|NCT05057247|Antimitotic Agents|antimitotic agents|mesh-ancestor
102456832|NCT05057247|Mitosis Modulators|mitosis modulators|mesh-ancestor
102456833|NCT05057247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456834|NCT05016947|Dexamethasone|dexamethasone|mesh-list
102456835|NCT05016947|Venetoclax|venetoclax|mesh-list
102456836|NCT05016947|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
102456837|NCT05016947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102456838|NCT05016947|Antiemetics|antiemetics|mesh-ancestor
102456839|NCT05016947|Autonomic Agents|autonomic agents|mesh-ancestor
102456840|NCT05016947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102456841|NCT05016947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456842|NCT05016947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102456843|NCT05016947|Glucocorticoids|glucocorticoids|mesh-ancestor
102456844|NCT05016947|Hormones|hormones|mesh-ancestor
102456845|NCT05016947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102456846|NCT05016947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102456847|NCT05016947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456848|NCT05016947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102456849|NCT05016947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102456850|NCT05016947|Immunotoxins|immunotoxins|mesh-ancestor
102456851|NCT05016947|Immunoconjugates|immunoconjugates|mesh-ancestor
102456852|NCT05016947|Immunologic Factors|immunologic factors|mesh-ancestor
102456853|NCT04989816|Trastuzumab|trastuzumab|mesh-list
102456854|NCT04989816|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
102456855|NCT04989816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102456856|NCT04989816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456857|NCT04989816|Immunoconjugates|immunoconjugates|mesh-ancestor
102456858|NCT04989816|Immunologic Factors|immunologic factors|mesh-ancestor
102456859|NCT04989816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456861|NCT04963712|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102456862|NCT04963712|Immunologic Factors|immunologic factors|mesh-ancestor
102456863|NCT04963712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456864|NCT04870112|Carboplatin|carboplatin|mesh-list
102456865|NCT04870112|Etoposide|etoposide|mesh-list
102456866|NCT04870112|Durvalumab|durvalumab|mesh-list
102456867|NCT04870112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456868|NCT04870112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102456869|NCT04870112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102456870|NCT04870112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102456871|NCT04870112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102456872|NCT04870112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456873|NCT04870112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102456874|NCT04754399|Cannabidiol|cannabidiol|mesh-list
102456875|NCT04754399|Anticonvulsants|anticonvulsants|mesh-ancestor
102456876|NCT04750616|Niacinamide|niacinamide|mesh-list
102456877|NCT04750616|Niacin|niacin|mesh-list
102456878|NCT04750616|Nicotinic Acids|nicotinic acids|mesh-list
102456879|NCT04750616|Vitamin B Complex|vitamin b complex|mesh-ancestor
102456880|NCT04750616|Vitamins|vitamins|mesh-ancestor
102456881|NCT04750616|Micronutrients|micronutrients|mesh-ancestor
102456882|NCT04750616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456883|NCT04750616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102456884|NCT04750616|Antimetabolites|antimetabolites|mesh-ancestor
102456885|NCT04750616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456886|NCT04750616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102456887|NCT04750616|Vasodilator Agents|vasodilator agents|mesh-ancestor
102456888|NCT04734652|Tenofovir|tenofovir|mesh-list
102456889|NCT04734652|Lamivudine|lamivudine|mesh-list
102456890|NCT04734652|Dolutegravir|dolutegravir|mesh-list
102456891|NCT04734652|Antiviral Agents|antiviral agents|mesh-ancestor
102456892|NCT04734652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102456893|NCT04734652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102456894|NCT04734652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102456895|NCT04734652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102456896|NCT04734652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456897|NCT04734652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102456898|NCT04734652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102456899|NCT04734652|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102456900|NCT04734652|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102456901|NCT04697576|Pembrolizumab|pembrolizumab|mesh-list
102456902|NCT04697576|Nivolumab|nivolumab|mesh-list
102456903|NCT04697576|Ipilimumab|ipilimumab|mesh-list
102456904|NCT04697576|Relatlimab|relatlimab|mesh-list
102456905|NCT04697576|Vaccines|vaccines|mesh-list
102456906|NCT04697576|Immunologic Factors|immunologic factors|mesh-ancestor
102456907|NCT04697576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456908|NCT04697576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102456909|NCT04697576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456910|NCT04697576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102456911|NCT04697576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456912|NCT04673422|Montelukast|montelukast|mesh-list
102456913|NCT04673422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102456914|NCT04673422|Respiratory System Agents|respiratory system agents|mesh-ancestor
102456915|NCT04673422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102456916|NCT04673422|Hormone Antagonists|hormone antagonists|mesh-ancestor
102456917|NCT04673422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102456918|NCT04673422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456919|NCT04673422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102456920|NCT04673422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102456921|NCT04673422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456922|NCT04646356|Tacrolimus|tacrolimus|mesh-list
102456923|NCT04646356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102456924|NCT04646356|Immunologic Factors|immunologic factors|mesh-ancestor
102456925|NCT04646356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456926|NCT04646356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102456927|NCT04646356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102456928|NCT04646356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456929|NCT04644068|Paclitaxel|paclitaxel|mesh-list
102456930|NCT04644068|Carboplatin|carboplatin|mesh-list
102456931|NCT04644068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102456932|NCT04644068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456933|NCT04644068|Tubulin Modulators|tubulin modulators|mesh-ancestor
102456934|NCT04644068|Antimitotic Agents|antimitotic agents|mesh-ancestor
102456935|NCT04644068|Mitosis Modulators|mitosis modulators|mesh-ancestor
102456936|NCT04644068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456937|NCT04618016|Vitamins|vitamins|mesh-list
102456938|NCT04618016|Vitamin E|vitamin e|mesh-list
102456939|NCT04618016|Tocopherols|tocopherols|mesh-list
102456940|NCT04618016|Tocotrienols|tocotrienols|mesh-list
102456941|NCT04618016|alpha-Tocopherol|alpha-tocopherol|mesh-list
102456942|NCT04618016|Micronutrients|micronutrients|mesh-ancestor
102456943|NCT04618016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456944|NCT04618016|Antioxidants|antioxidants|mesh-ancestor
102456945|NCT04618016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456946|NCT04618016|Protective Agents|protective agents|mesh-ancestor
102456947|NCT04609566|Pembrolizumab|pembrolizumab|mesh-list
102456948|NCT04609566|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102456949|NCT04609566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102456950|NCT04609566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456951|NCT04609566|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102456952|NCT04609566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456953|NCT04609566|Immunotoxins|immunotoxins|mesh-ancestor
102456954|NCT04609566|Immunoconjugates|immunoconjugates|mesh-ancestor
102456955|NCT04609566|Immunologic Factors|immunologic factors|mesh-ancestor
102456956|NCT04609566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456957|NCT04515472|Hormones|hormones|mesh-list
102456958|NCT04515472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456959|NCT04515472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102456960|NCT04508023|Rivaroxaban|rivaroxaban|mesh-list
102456961|NCT04508023|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102456962|NCT04508023|Antithrombins|antithrombins|mesh-ancestor
102456963|NCT04508023|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102456964|NCT04508023|Protease Inhibitors|protease inhibitors|mesh-ancestor
102456965|NCT04508023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102456966|NCT04508023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456967|NCT04508023|Anticoagulants|anticoagulants|mesh-ancestor
102456968|NCT04505098|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
102456969|NCT04505098|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102456970|NCT04505098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102456971|NCT04489732|Interferons|interferons|mesh-list
102456972|NCT04489732|Interferon-gamma|interferon-gamma|mesh-list
102456973|NCT04489732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456974|NCT04489732|Antiviral Agents|antiviral agents|mesh-ancestor
102456975|NCT04489732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102456976|NCT04451746|Contraceptive Agents|contraceptive agents|mesh-list
102456977|NCT04451746|Contraceptives, Oral|contraceptives, oral|mesh-list
102456978|NCT04451746|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
102456979|NCT04451746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102456980|NCT04451746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102456981|NCT04451746|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102456982|NCT04429542|Pembrolizumab|pembrolizumab|mesh-list
102456983|NCT04429542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102456984|NCT04429542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456985|NCT04429542|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102456986|NCT04429542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456987|NCT04425018|Paclitaxel|paclitaxel|mesh-list
102456988|NCT04425018|Trastuzumab|trastuzumab|mesh-list
102456989|NCT04425018|Pertuzumab|pertuzumab|mesh-list
102456990|NCT04425018|Margetuximab|margetuximab|mesh-list
102456991|NCT04425018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102456992|NCT04425018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102456993|NCT04425018|Tubulin Modulators|tubulin modulators|mesh-ancestor
102456994|NCT04425018|Antimitotic Agents|antimitotic agents|mesh-ancestor
102456995|NCT04425018|Mitosis Modulators|mitosis modulators|mesh-ancestor
102456996|NCT04425018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102456997|NCT04425018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102456998|NCT04363801|Leucovorin|leucovorin|mesh-list
102456999|NCT04363801|Fluorouracil|fluorouracil|mesh-list
102457000|NCT04363801|Capecitabine|capecitabine|mesh-list
102457001|NCT04363801|Oxaliplatin|oxaliplatin|mesh-list
102457002|NCT04363801|Tislelizumab|tislelizumab|mesh-list
102457003|NCT04363801|Calcium|calcium|mesh-list
102457004|NCT04363801|Levoleucovorin|levoleucovorin|mesh-list
102457005|NCT04363801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102457006|NCT04363801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457007|NCT04363801|Antimetabolites|antimetabolites|mesh-ancestor
102457008|NCT04363801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268569|NCT01949116|Micronutrients|micronutrients|mesh-ancestor
102457009|NCT04363801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102457010|NCT04363801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457011|NCT04363801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102457012|NCT04363801|Immunologic Factors|immunologic factors|mesh-ancestor
102457013|NCT04363801|Antidotes|antidotes|mesh-ancestor
102457014|NCT04363801|Protective Agents|protective agents|mesh-ancestor
102457015|NCT04363801|Vitamin B Complex|vitamin b complex|mesh-ancestor
102457016|NCT04363801|Vitamins|vitamins|mesh-ancestor
102457017|NCT04363801|Micronutrients|micronutrients|mesh-ancestor
102457018|NCT04363801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102457019|NCT04300595|Anesthetics|anesthetics|mesh-list
102457020|NCT04300595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102457021|NCT04300595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457022|NCT04227847|Azacitidine|azacitidine|mesh-list
102457023|NCT04227847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102457024|NCT04227847|Antimetabolites|antimetabolites|mesh-ancestor
102457025|NCT04227847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457026|NCT04227847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457027|NCT04227847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102457028|NCT04212026|Nivolumab|nivolumab|mesh-list
102457029|NCT04212026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102457030|NCT04212026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457031|NCT04212026|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102457032|NCT04212026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457033|NCT04187144|Nitrofurantoin|nitrofurantoin|mesh-list
102457034|NCT04187144|Gepotidacin|gepotidacin|mesh-list
102457035|NCT04187144|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102457036|NCT04187144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102457037|NCT04187144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102457038|NCT04187144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102457039|NCT04187144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102457040|NCT04187144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457041|NCT04187144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457042|NCT04161066|Psilocybin|psilocybin|mesh-list
102457043|NCT04161066|Hallucinogens|hallucinogens|mesh-ancestor
102457044|NCT04161066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457045|NCT04161066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102457046|NCT04098250|Erenumab|erenumab|mesh-list
102457047|NCT04098250|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
102457048|NCT04098250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457049|NCT04098250|Analgesics|analgesics|mesh-ancestor
102457050|NCT04098250|Sensory System Agents|sensory system agents|mesh-ancestor
102457051|NCT04098250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102457052|NCT04098250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457053|NCT04096638|Atezolizumab|atezolizumab|mesh-list
102457054|NCT04096638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102457055|NCT04096638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457056|NCT04096638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102457057|NCT04096638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457058|NCT04093323|Interferons|interferons|mesh-list
102457059|NCT04093323|Interferon-alpha|interferon-alpha|mesh-list
102457060|NCT04093323|Interferon alpha-2|interferon alpha-2|mesh-list
102457061|NCT04093323|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
102457062|NCT04093323|Celecoxib|celecoxib|mesh-list
102457063|NCT04093323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102457064|NCT04093323|Benzenesulfonamide|benzenesulfonamide|mesh-list
102457065|NCT04093323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457066|NCT04093323|Antiviral Agents|antiviral agents|mesh-ancestor
102457067|NCT04093323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102457068|NCT04093323|Immunologic Factors|immunologic factors|mesh-ancestor
102457069|NCT04093323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457070|NCT04093323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102457071|NCT04093323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102457072|NCT04093323|Analgesics|analgesics|mesh-ancestor
102457073|NCT04093323|Sensory System Agents|sensory system agents|mesh-ancestor
102457074|NCT04093323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102457075|NCT04093323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102457076|NCT04093323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102457077|NCT04093323|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102457078|NCT04093323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102457079|NCT04093323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102457080|NCT04093323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457081|NCT04093323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102457082|NCT04093323|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102457083|NCT04027946|Pembrolizumab|pembrolizumab|mesh-list
102268647|NCT03092765|Quetmolimab|quetmolimab|mesh-list
102457084|NCT04027946|LMB-100|lmb-100|mesh-list
102457085|NCT04027946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102457086|NCT04027946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457087|NCT04027946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102457088|NCT04027946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457089|NCT04027946|Immunoconjugates|immunoconjugates|mesh-ancestor
102457090|NCT04027946|Immunologic Factors|immunologic factors|mesh-ancestor
102457091|NCT04027946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457093|NCT04017468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102457094|NCT04017468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102457095|NCT03976310|Benralizumab|benralizumab|mesh-list
102457096|NCT03976310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102457097|NCT03976310|Respiratory System Agents|respiratory system agents|mesh-ancestor
102457098|NCT03950570|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102457099|NCT03950570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457100|NCT03949764|Sofosbuvir|sofosbuvir|mesh-list
102457101|NCT03949764|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102457102|NCT03949764|Velpatasvir|velpatasvir|mesh-list
102457103|NCT03949764|Antiviral Agents|antiviral agents|mesh-ancestor
102457104|NCT03949764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102457105|NCT03944954|Dronabinol|dronabinol|mesh-list
102457106|NCT03944954|Hallucinogens|hallucinogens|mesh-ancestor
102457107|NCT03944954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457108|NCT03944954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102457109|NCT03944954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102457110|NCT03944954|Analgesics|analgesics|mesh-ancestor
102457111|NCT03944954|Sensory System Agents|sensory system agents|mesh-ancestor
102457112|NCT03944954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102457113|NCT03944954|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102457114|NCT03944954|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102457115|NCT03944954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102457116|NCT03944954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457117|NCT03944954|Hormones|hormones|mesh-ancestor
102457118|NCT03944954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102457119|NCT03930212|Progesterone|progesterone|mesh-list
102457120|NCT03930212|Progestins|progestins|mesh-ancestor
102457121|NCT03930212|Hormones|hormones|mesh-ancestor
102457122|NCT03930212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102457123|NCT03930212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457124|NCT03901339|Gemcitabine|gemcitabine|mesh-list
102457125|NCT03901339|Capecitabine|capecitabine|mesh-list
102457126|NCT03901339|Vinorelbine|vinorelbine|mesh-list
102457127|NCT03901339|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
102457128|NCT03901339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102457129|NCT03901339|Antimetabolites|antimetabolites|mesh-ancestor
102457130|NCT03901339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457131|NCT03901339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457132|NCT03901339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102457133|NCT03901339|Tubulin Modulators|tubulin modulators|mesh-ancestor
102457134|NCT03901339|Antimitotic Agents|antimitotic agents|mesh-ancestor
102457135|NCT03901339|Mitosis Modulators|mitosis modulators|mesh-ancestor
102457136|NCT03901339|Immunoconjugates|immunoconjugates|mesh-ancestor
102457137|NCT03901339|Immunologic Factors|immunologic factors|mesh-ancestor
102457138|NCT03901339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457139|NCT03893617|Propranolol|propranolol|mesh-list
102457140|NCT03893617|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102457141|NCT03893617|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102457142|NCT03893617|Adrenergic Agents|adrenergic agents|mesh-ancestor
102457143|NCT03893617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102457144|NCT03893617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457145|NCT03893617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457146|NCT03893617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102457147|NCT03893617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102457148|NCT03893617|Vasodilator Agents|vasodilator agents|mesh-ancestor
102457149|NCT03856047|Liraglutide|liraglutide|mesh-list
102457150|NCT03856047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102457151|NCT03856047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457152|NCT03856047|Incretins|incretins|mesh-ancestor
102457153|NCT03856047|Hormones|hormones|mesh-ancestor
102457154|NCT03856047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102457155|NCT03850782|Bimatoprost|bimatoprost|mesh-list
102457156|NCT03850782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102457157|NCT03810742|Irinotecan|irinotecan|mesh-list
102457158|NCT03810742|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102457159|NCT03810742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102457160|NCT03810742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102457161|NCT03810742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457162|NCT03810742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457164|NCT03797014|Emtricitabine|emtricitabine|mesh-list
102457165|NCT03797014|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
102457166|NCT03797014|Antiviral Agents|antiviral agents|mesh-ancestor
102457167|NCT03797014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102457168|NCT03797014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102457169|NCT03797014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102457170|NCT03797014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102457171|NCT03797014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457172|NCT03797014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102457173|NCT03797014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102457174|NCT03787628|Cannabidiol|cannabidiol|mesh-list
102457175|NCT03787628|Anticonvulsants|anticonvulsants|mesh-ancestor
102457176|NCT03761173|Anticoagulants|anticoagulants|mesh-list
102457177|NCT03752684|Calcium|calcium|mesh-list
102457178|NCT03752684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102457179|NCT03752684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457180|NCT03751709|Blinatumomab|blinatumomab|mesh-list
102457181|NCT03751709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457182|NCT03737136|Bortezomib|bortezomib|mesh-list
102457183|NCT03737136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457184|NCT03691376|Aldesleukin|aldesleukin|mesh-list
102457185|NCT03691376|Melphalan|melphalan|mesh-list
102457186|NCT03691376|Mechlorethamine|mechlorethamine|mesh-list
102457187|NCT03691376|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102457188|NCT03691376|Interleukin-2|interleukin-2|mesh-list
102457189|NCT03691376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102457190|NCT03691376|Alkylating Agents|alkylating agents|mesh-ancestor
102457191|NCT03691376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457192|NCT03691376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457193|NCT03691376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102457194|NCT03691376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102457195|NCT03691376|Immunologic Factors|immunologic factors|mesh-ancestor
102457196|NCT03691376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457197|NCT03691376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102457198|NCT03691376|Analgesics|analgesics|mesh-ancestor
102457199|NCT03691376|Sensory System Agents|sensory system agents|mesh-ancestor
102457200|NCT03691376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102457201|NCT03691376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102457202|NCT03691376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102457203|NCT03691376|Antiviral Agents|antiviral agents|mesh-ancestor
102457204|NCT03691376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102457205|NCT03647163|Pembrolizumab|pembrolizumab|mesh-list
102457206|NCT03647163|Nivolumab|nivolumab|mesh-list
102457207|NCT03647163|Ipilimumab|ipilimumab|mesh-list
102457208|NCT03647163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102457209|NCT03647163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457210|NCT03647163|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102457211|NCT03647163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457212|NCT03635749|Atorvastatin|atorvastatin|mesh-list
102457213|NCT03635749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
102457214|NCT03635749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457215|NCT03635749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102457216|NCT03635749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102457217|NCT03635749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102457218|NCT03635749|Antimetabolites|antimetabolites|mesh-ancestor
102457219|NCT03635749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102457220|NCT03599453|Interferons|interferons|mesh-list
102457221|NCT03599453|Interferon-alpha|interferon-alpha|mesh-list
102457222|NCT03599453|Interferon alpha-2|interferon alpha-2|mesh-list
102457223|NCT03599453|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
102457224|NCT03599453|Poly I-C|poly i-c|mesh-list
102457225|NCT03599453|Celecoxib|celecoxib|mesh-list
102457226|NCT03599453|Pembrolizumab|pembrolizumab|mesh-list
102457227|NCT03599453|Immunoglobulins|immunoglobulins|mesh-list
102457228|NCT03599453|Immunoglobulin G|immunoglobulin g|mesh-list
102457229|NCT03599453|Benzenesulfonamide|benzenesulfonamide|mesh-list
102457230|NCT03599453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102457231|NCT03599453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457232|NCT03599453|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102457233|NCT03599453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457234|NCT03599453|Antiviral Agents|antiviral agents|mesh-ancestor
102457235|NCT03599453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102457236|NCT03599453|Immunologic Factors|immunologic factors|mesh-ancestor
102457237|NCT03599453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457238|NCT03599453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102457239|NCT03599453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102457240|NCT03599453|Analgesics|analgesics|mesh-ancestor
102457241|NCT03599453|Sensory System Agents|sensory system agents|mesh-ancestor
102457242|NCT03599453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102457243|NCT03599453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102457244|NCT03599453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102457245|NCT03599453|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102457246|NCT03599453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102457247|NCT03599453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102457248|NCT03599453|Interferon Inducers|interferon inducers|mesh-ancestor
102457249|NCT03599453|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102457250|NCT03573960|Lenvatinib|lenvatinib|mesh-list
102457251|NCT03573960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457252|NCT03573960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102457253|NCT03573960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102457254|NCT03573960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457255|NCT03559647|Atezolizumab|atezolizumab|mesh-list
102457256|NCT03559647|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102457257|NCT03559647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457258|NCT03559647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102457259|NCT03559647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457260|NCT03554473|Temozolomide|temozolomide|mesh-list
102457261|NCT03554473|Topotecan|topotecan|mesh-list
102457262|NCT03554473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102457263|NCT03554473|Alkylating Agents|alkylating agents|mesh-ancestor
102457264|NCT03554473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457265|NCT03554473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457266|NCT03554473|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102457267|NCT03554473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102457268|NCT03554473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102457269|NCT03554291|Famotidine|famotidine|mesh-list
102457270|NCT03554291|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102457271|NCT03554291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102457272|NCT03554291|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102457273|NCT03554291|Histamine Antagonists|histamine antagonists|mesh-ancestor
102457274|NCT03554291|Histamine Agents|histamine agents|mesh-ancestor
102457275|NCT03554291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102457276|NCT03554291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457277|NCT03554291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457278|NCT03524235|Rituximab|rituximab|mesh-list
102457279|NCT03524235|Fludarabine|fludarabine|mesh-list
102457280|NCT03524235|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102457281|NCT03524235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102457282|NCT03524235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457283|NCT03524235|Immunologic Factors|immunologic factors|mesh-ancestor
102457284|NCT03524235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457285|NCT03524235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102457286|NCT03524235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457287|NCT03524235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102457288|NCT03524235|Alkylating Agents|alkylating agents|mesh-ancestor
102457289|NCT03464461|Ketorolac|ketorolac|mesh-list
102457290|NCT03464461|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102457291|NCT03464461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102457292|NCT03464461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102457293|NCT03464461|Analgesics|analgesics|mesh-ancestor
102457294|NCT03464461|Sensory System Agents|sensory system agents|mesh-ancestor
102457295|NCT03464461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102457296|NCT03464461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457297|NCT03464461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102457298|NCT03464461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102457299|NCT03464461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102457300|NCT03464461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102457301|NCT03464461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457302|NCT03440437|Paclitaxel|paclitaxel|mesh-list
102457303|NCT03440437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102457304|NCT03440437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457305|NCT03440437|Tubulin Modulators|tubulin modulators|mesh-ancestor
102457306|NCT03440437|Antimitotic Agents|antimitotic agents|mesh-ancestor
102457307|NCT03440437|Mitosis Modulators|mitosis modulators|mesh-ancestor
102457308|NCT03440437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268866|NCT02347501|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102457309|NCT03392246|Osimertinib|osimertinib|mesh-list
102457310|NCT03392246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457311|NCT03392246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102457312|NCT03392246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102457313|NCT03392246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457314|NCT03387423|Tofacitinib|tofacitinib|mesh-list
102457315|NCT03387423|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102457316|NCT03387423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102457317|NCT03387423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102457318|NCT03387423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457319|NCT03374956|Liraglutide|liraglutide|mesh-list
102457320|NCT03374956|Topiramate|topiramate|mesh-list
102457321|NCT03374956|Phentermine|phentermine|mesh-list
102457322|NCT03374956|Naltrexone|naltrexone|mesh-list
102457323|NCT03374956|Bupropion|bupropion|mesh-list
102457324|NCT03374956|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102457325|NCT03374956|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102457326|NCT03374956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457327|NCT03374956|Sensory System Agents|sensory system agents|mesh-ancestor
102457328|NCT03374956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102457329|NCT03374956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102457330|NCT03374956|Incretins|incretins|mesh-ancestor
102457331|NCT03374956|Hormones|hormones|mesh-ancestor
102457332|NCT03374956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102457333|NCT03374956|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102457334|NCT03374956|Antidepressive Agents|antidepressive agents|mesh-ancestor
102457335|NCT03374956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102457336|NCT03374956|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102457337|NCT03374956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102457338|NCT03374956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102457339|NCT03374956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457340|NCT03374956|Dopamine Agents|dopamine agents|mesh-ancestor
102457341|NCT03374956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102457342|NCT03374956|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102457343|NCT03374956|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102457344|NCT03374956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102457345|NCT03374956|Anticonvulsants|anticonvulsants|mesh-ancestor
102457346|NCT03374956|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102457347|NCT03374956|Appetite Depressants|appetite depressants|mesh-ancestor
102457348|NCT03374956|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102457349|NCT03374956|Sympathomimetics|sympathomimetics|mesh-ancestor
102457350|NCT03374956|Autonomic Agents|autonomic agents|mesh-ancestor
102457351|NCT03374956|Adrenergic Agents|adrenergic agents|mesh-ancestor
102457352|NCT03334682|Doxycycline|doxycycline|mesh-list
102457353|NCT03334682|Spironolactone|spironolactone|mesh-list
102457354|NCT03334682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102457355|NCT03334682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102457356|NCT03334682|Antimalarials|antimalarials|mesh-ancestor
102457357|NCT03334682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102457358|NCT03334682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102457359|NCT03334682|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102457360|NCT03334682|Hormone Antagonists|hormone antagonists|mesh-ancestor
102457361|NCT03334682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102457362|NCT03334682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457363|NCT03334682|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102457364|NCT03334682|Diuretics|diuretics|mesh-ancestor
102457365|NCT03334682|Natriuretic Agents|natriuretic agents|mesh-ancestor
102457366|NCT03211416|Pembrolizumab|pembrolizumab|mesh-list
102457367|NCT03211416|Sorafenib|sorafenib|mesh-list
102457368|NCT03211416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102457369|NCT03211416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457370|NCT03211416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102457371|NCT03211416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457372|NCT03211416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102457373|NCT03211416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102457374|NCT03112603|Mycophenolic Acid|mycophenolic acid|mesh-list
102457375|NCT03112603|Sirolimus|sirolimus|mesh-list
102457376|NCT03112603|Infliximab|infliximab|mesh-list
102457377|NCT03112603|Rituximab|rituximab|mesh-list
102457378|NCT03112603|Methotrexate|methotrexate|mesh-list
102457379|NCT03112603|Everolimus|everolimus|mesh-list
102457380|NCT03112603|Imatinib Mesylate|imatinib mesylate|mesh-list
102457381|NCT03112603|Pentostatin|pentostatin|mesh-list
102268940|NCT03148561|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102457382|NCT03112603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102457383|NCT03112603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457384|NCT03112603|Immunologic Factors|immunologic factors|mesh-ancestor
102457385|NCT03112603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457386|NCT03112603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102457387|NCT03112603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102457388|NCT03112603|Abortifacient Agents|abortifacient agents|mesh-ancestor
102457389|NCT03112603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102457390|NCT03112603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102457391|NCT03112603|Antimetabolites|antimetabolites|mesh-ancestor
102457392|NCT03112603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457393|NCT03112603|Dermatologic Agents|dermatologic agents|mesh-ancestor
102457394|NCT03112603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102457395|NCT03112603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102457396|NCT03112603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102457397|NCT03112603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102457398|NCT03112603|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102457399|NCT03112603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102457400|NCT03112603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102457401|NCT03112603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102457402|NCT03112603|Antitubercular Agents|antitubercular agents|mesh-ancestor
102457403|NCT03112603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102457404|NCT03112603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102457405|NCT03112603|Antifungal Agents|antifungal agents|mesh-ancestor
102457406|NCT03112603|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102457407|NCT03112603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102457408|NCT03112603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102457409|NCT03112603|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
102457410|NCT03110107|Nivolumab|nivolumab|mesh-list
102457411|NCT03110107|Ipilimumab|ipilimumab|mesh-list
102457412|NCT03110107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102457413|NCT03110107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457414|NCT03110107|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102457415|NCT03110107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457416|NCT03073317|Mitogens|mitogens|mesh-list
102457417|NCT03073317|Mitosis Modulators|mitosis modulators|mesh-ancestor
102457418|NCT03073317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457419|NCT03056001|Doxorubicin|doxorubicin|mesh-list
102457420|NCT03056001|Pembrolizumab|pembrolizumab|mesh-list
102457421|NCT03056001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102457422|NCT03056001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457423|NCT03056001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102457424|NCT03056001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102457425|NCT03056001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102457426|NCT03056001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457427|NCT03056001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102457428|NCT03056001|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102457429|NCT02736266|Pembrolizumab|pembrolizumab|mesh-list
102457430|NCT02736266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102457431|NCT02736266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457432|NCT02736266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102457433|NCT02736266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457434|NCT02627963|Sorafenib|sorafenib|mesh-list
102457435|NCT02627963|Tivozanib|tivozanib|mesh-list
102457436|NCT02627963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457437|NCT02627963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102457438|NCT02627963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102457439|NCT02627963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457440|NCT02589691|Rocuronium|rocuronium|mesh-list
102457441|NCT02589691|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102457442|NCT02589691|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102457443|NCT02589691|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102457444|NCT02589691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102457445|NCT02589691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457446|NCT02585258|Prednisolone|prednisolone|mesh-list
102457447|NCT02585258|Glucocorticoids|glucocorticoids|mesh-list
102457448|NCT02585258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102457449|NCT02585258|Hormones|hormones|mesh-ancestor
102457450|NCT02585258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102457451|NCT02585258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457452|NCT02585258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102457453|NCT02585258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457454|NCT02491099|Afatinib|afatinib|mesh-list
102457455|NCT02491099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457456|NCT02491099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102269013|NCT03146689|Analgesics|analgesics|mesh-ancestor
102457457|NCT02491099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102457458|NCT02491099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102457459|NCT02320435|Trastuzumab|trastuzumab|mesh-list
102457460|NCT02320435|Pertuzumab|pertuzumab|mesh-list
102457461|NCT02320435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102457462|NCT02320435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457463|NCT02320292|Rituximab|rituximab|mesh-list
102457464|NCT02320292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102457465|NCT02320292|Antibodies|antibodies|mesh-list
102457466|NCT02320292|Immunoglobulins|immunoglobulins|mesh-list
102457467|NCT02320292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102457468|NCT02320292|Immunologic Factors|immunologic factors|mesh-ancestor
102457469|NCT02320292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457470|NCT02320292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457471|NCT02320292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102457472|NCT02213107|Finasteride|finasteride|mesh-list
102457473|NCT02213107|Dutasteride|dutasteride|mesh-list
102457474|NCT02213107|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102457475|NCT02213107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102457476|NCT02213107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102457477|NCT02213107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457478|NCT02213107|Hormone Antagonists|hormone antagonists|mesh-ancestor
102457479|NCT02213107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102457480|NCT02213107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457481|NCT02213107|Urological Agents|urological agents|mesh-ancestor
102457482|NCT02203604|Aldesleukin|aldesleukin|mesh-list
102457483|NCT02203604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102457484|NCT02203604|Ipilimumab|ipilimumab|mesh-list
102457485|NCT02203604|Interleukin-2|interleukin-2|mesh-list
102457486|NCT02203604|Antibodies|antibodies|mesh-list
102457487|NCT02203604|Immunoglobulins|immunoglobulins|mesh-list
102457488|NCT02203604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102457489|NCT02203604|Immunologic Factors|immunologic factors|mesh-ancestor
102457490|NCT02203604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457491|NCT02203604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457492|NCT02203604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102457493|NCT02203604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457494|NCT02203604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102457495|NCT02203604|Analgesics|analgesics|mesh-ancestor
102457496|NCT02203604|Sensory System Agents|sensory system agents|mesh-ancestor
102457497|NCT02203604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102457498|NCT02203604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102457499|NCT02203604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102457500|NCT02203604|Antiviral Agents|antiviral agents|mesh-ancestor
102457501|NCT02203604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102457502|NCT02188745|Letrozole|letrozole|mesh-list
102457503|NCT02188745|Anastrozole|anastrozole|mesh-list
102457504|NCT02188745|Exemestane|exemestane|mesh-list
102457505|NCT02188745|Estradiol|estradiol|mesh-list
102457506|NCT02188745|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102457507|NCT02188745|Estrogens|estrogens|mesh-ancestor
102457508|NCT02188745|Hormones|hormones|mesh-ancestor
102457509|NCT02188745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102457510|NCT02188745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457511|NCT02188745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457512|NCT02188745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102457513|NCT02188745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102457514|NCT02188745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457515|NCT02188745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102457516|NCT02188745|Hormone Antagonists|hormone antagonists|mesh-ancestor
102457517|NCT02188745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102457518|NCT01874353|Olaparib|olaparib|mesh-list
102457519|NCT01874353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102457520|NCT01874353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102457521|NCT01874353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457522|NCT01874353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457523|NCT01228240|Metformin|metformin|mesh-list
102457524|NCT01228240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102457525|NCT01228240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457526|NCT00701220|Atorvastatin|atorvastatin|mesh-list
102457527|NCT00701220|Calcium|calcium|mesh-list
102457528|NCT00701220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102457529|NCT00701220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457530|NCT00701220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102457531|NCT00701220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102457532|NCT00701220|Antimetabolites|antimetabolites|mesh-ancestor
102612320|NCT00002405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102457533|NCT00701220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457534|NCT00701220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102457535|NCT00701220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102457536|NCT00701220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102457537|NCT00677924|Zalutumumab|zalutumumab|mesh-list
102457538|NCT00677924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102457539|NCT00677924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457540|NCT00251303|Riluzole|riluzole|mesh-list
102457541|NCT00251303|Anticonvulsants|anticonvulsants|mesh-ancestor
102457542|NCT00251303|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102457543|NCT00251303|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102457544|NCT00251303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102457545|NCT00251303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457546|NCT00251303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457547|NCT00251303|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102457548|NCT00251303|Protective Agents|protective agents|mesh-ancestor
102457549|NCT00303823|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
102457550|NCT00303823|Antioxidants|antioxidants|mesh-ancestor
102457551|NCT00303823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457552|NCT00303823|Protective Agents|protective agents|mesh-ancestor
102457553|NCT00303823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457554|NCT00303823|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
102457555|NCT00303823|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102457556|NCT00303823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457557|NCT00303823|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102457558|NCT00300677|Voriconazole|voriconazole|mesh-list
102457559|NCT00300677|Antifungal Agents|antifungal agents|mesh-ancestor
102457560|NCT00300677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102457561|NCT00300677|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102457562|NCT00300677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102457563|NCT00300677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102457564|NCT00300677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457565|NCT00300677|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102457566|NCT00300677|Hormone Antagonists|hormone antagonists|mesh-ancestor
102457567|NCT00300677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102457568|NCT00300677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457569|NCT00300677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102457570|NCT00559845|Paclitaxel|paclitaxel|mesh-list
102457571|NCT00559845|Cyclophosphamide|cyclophosphamide|mesh-list
102457572|NCT00559845|Bevacizumab|bevacizumab|mesh-list
102457573|NCT00559845|Fluorouracil|fluorouracil|mesh-list
102457574|NCT00559845|Epirubicin|epirubicin|mesh-list
102457575|NCT00559845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102457576|NCT00559845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457577|NCT00559845|Tubulin Modulators|tubulin modulators|mesh-ancestor
102457578|NCT00559845|Antimitotic Agents|antimitotic agents|mesh-ancestor
102457579|NCT00559845|Mitosis Modulators|mitosis modulators|mesh-ancestor
102457580|NCT00559845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457581|NCT00559845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102457582|NCT00559845|Immunologic Factors|immunologic factors|mesh-ancestor
102457583|NCT00559845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457584|NCT00559845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102457585|NCT00559845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102457586|NCT00559845|Alkylating Agents|alkylating agents|mesh-ancestor
102457587|NCT00559845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102457588|NCT00559845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102457589|NCT00559845|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102457590|NCT00559845|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102457591|NCT00559845|Growth Substances|growth substances|mesh-ancestor
102457592|NCT00559845|Growth Inhibitors|growth inhibitors|mesh-ancestor
102457593|NCT00559845|Antimetabolites|antimetabolites|mesh-ancestor
102457594|NCT00559845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102457595|NCT00559845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102457596|NCT00559845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102457597|NCT00559845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102457598|NCT00559845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102457599|NCT00304187|Erythromycin|erythromycin|mesh-list
102457600|NCT00304187|Erythromycin Estolate|erythromycin estolate|mesh-list
102457601|NCT00304187|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
102457602|NCT00304187|Erythromycin stearate|erythromycin stearate|mesh-list
102457603|NCT00304187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102457604|NCT00304187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102457605|NCT00304187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102457606|NCT00304187|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102457607|NCT00304187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102457608|NCT00304187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457609|NCT00334633|Metronidazole|metronidazole|mesh-list
102457610|NCT00334633|Tinidazole|tinidazole|mesh-list
102457611|NCT00334633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102457612|NCT00334633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102457613|NCT00334633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102457614|NCT00334633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102457615|NCT00334633|Alkylating Agents|alkylating agents|mesh-ancestor
102457616|NCT00334633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457617|NCT00334633|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
102457618|NCT01393964|Dexamethasone|dexamethasone|mesh-list
102457619|NCT01393964|Dexamethasone acetate|dexamethasone acetate|mesh-list
102457620|NCT01393964|Lenalidomide|lenalidomide|mesh-list
102457621|NCT01393964|Elotuzumab|elotuzumab|mesh-list
102457622|NCT01393964|BB 1101|bb 1101|mesh-list
102457623|NCT01393964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102457624|NCT01393964|Antiemetics|antiemetics|mesh-ancestor
102457625|NCT01393964|Autonomic Agents|autonomic agents|mesh-ancestor
102457626|NCT01393964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102457627|NCT01393964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457628|NCT01393964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102457629|NCT01393964|Glucocorticoids|glucocorticoids|mesh-ancestor
102457630|NCT01393964|Hormones|hormones|mesh-ancestor
102457631|NCT01393964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102457632|NCT01393964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102457633|NCT01393964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457634|NCT01393964|Protease Inhibitors|protease inhibitors|mesh-ancestor
102457635|NCT01393964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102457636|NCT01393964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457637|NCT01393964|Immunologic Factors|immunologic factors|mesh-ancestor
102457638|NCT01393964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102457639|NCT01393964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102457640|NCT01393964|Growth Substances|growth substances|mesh-ancestor
102457641|NCT01393964|Growth Inhibitors|growth inhibitors|mesh-ancestor
102457642|NCT01790555|Diazepam|diazepam|mesh-list
102457643|NCT01790555|Dronabinol|dronabinol|mesh-list
102457644|NCT01790555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102457645|NCT01790555|Anticonvulsants|anticonvulsants|mesh-ancestor
102457646|NCT01790555|Antiemetics|antiemetics|mesh-ancestor
102457647|NCT01790555|Autonomic Agents|autonomic agents|mesh-ancestor
102457648|NCT01790555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102457649|NCT01790555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457650|NCT01790555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102457651|NCT01790555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102457652|NCT01790555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102457653|NCT01790555|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102457654|NCT01790555|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102457655|NCT01790555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102457656|NCT01790555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102457657|NCT01790555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102457658|NCT01790555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102457659|NCT01790555|Anesthetics, General|anesthetics, general|mesh-ancestor
102457660|NCT01790555|Anesthetics|anesthetics|mesh-ancestor
102457661|NCT01790555|GABA Modulators|gaba modulators|mesh-ancestor
102457662|NCT01790555|GABA Agents|gaba agents|mesh-ancestor
102457663|NCT01790555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102457664|NCT01790555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457665|NCT01790555|Hallucinogens|hallucinogens|mesh-ancestor
102457666|NCT01790555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102457667|NCT01790555|Analgesics|analgesics|mesh-ancestor
102457668|NCT01790555|Sensory System Agents|sensory system agents|mesh-ancestor
102457669|NCT01790555|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102457670|NCT01790555|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102457671|NCT01790555|Hormones|hormones|mesh-ancestor
102457672|NCT01790555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102457673|NCT00335725|Hormones|hormones|mesh-list
102457674|NCT00335725|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102457675|NCT00335725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102457676|NCT00335725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457677|NCT01393730|Prednisone|prednisone|mesh-list
102457678|NCT01393730|Abiraterone Acetate|abiraterone acetate|mesh-list
102457679|NCT01393730|Dutasteride|dutasteride|mesh-list
102269232|NCT05007587|Antidotes|antidotes|mesh-ancestor
102457680|NCT01393730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102457681|NCT01393730|Glucocorticoids|glucocorticoids|mesh-ancestor
102457682|NCT01393730|Hormones|hormones|mesh-ancestor
102457683|NCT01393730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102457684|NCT01393730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457685|NCT01393730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102457686|NCT01393730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457687|NCT01393730|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102457688|NCT01393730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102457689|NCT01393730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457690|NCT01393730|Hormone Antagonists|hormone antagonists|mesh-ancestor
102457691|NCT01393730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102457692|NCT01393730|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102457693|NCT00336817|Mycophenolic Acid|mycophenolic acid|mesh-list
102457694|NCT00336817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102457695|NCT00336817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457696|NCT00336817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102457697|NCT00336817|Antitubercular Agents|antitubercular agents|mesh-ancestor
102457698|NCT00336817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102457699|NCT00336817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102457700|NCT00336817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102457701|NCT00336817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457702|NCT00337987|Prednisone|prednisone|mesh-list
102457703|NCT00337987|Cyclophosphamide|cyclophosphamide|mesh-list
102457704|NCT00337987|Vincristine|vincristine|mesh-list
102457705|NCT00337987|Doxorubicin|doxorubicin|mesh-list
102457706|NCT00337987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102457707|NCT00337987|Denileukin diftitox|denileukin diftitox|mesh-list
102457708|NCT00337987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102457709|NCT00337987|Immunologic Factors|immunologic factors|mesh-ancestor
102457710|NCT00337987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457711|NCT00337987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102457712|NCT00337987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102457713|NCT00337987|Alkylating Agents|alkylating agents|mesh-ancestor
102457714|NCT00337987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457715|NCT00337987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457716|NCT00337987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102457717|NCT00337987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102457718|NCT00337987|Glucocorticoids|glucocorticoids|mesh-ancestor
102457719|NCT00337987|Hormones|hormones|mesh-ancestor
102457720|NCT00337987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102457721|NCT00337987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102457722|NCT00337987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102457723|NCT00337987|Tubulin Modulators|tubulin modulators|mesh-ancestor
102457724|NCT00337987|Antimitotic Agents|antimitotic agents|mesh-ancestor
102457725|NCT00337987|Mitosis Modulators|mitosis modulators|mesh-ancestor
102457726|NCT00337987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102457727|NCT00337987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102457728|NCT00337987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102457729|NCT00337987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102457730|NCT01393106|Idelalisib|idelalisib|mesh-list
102457731|NCT01393106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457732|NCT01393106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102457733|NCT01393106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457734|NCT00553059|Dexamethasone|dexamethasone|mesh-list
102457735|NCT00553059|Dronabinol|dronabinol|mesh-list
102457736|NCT00553059|Palonosetron|palonosetron|mesh-list
102457737|NCT00553059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102457738|NCT00553059|Antiemetics|antiemetics|mesh-ancestor
102457739|NCT00553059|Autonomic Agents|autonomic agents|mesh-ancestor
102457740|NCT00553059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102457741|NCT00553059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457742|NCT00553059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102457743|NCT00553059|Glucocorticoids|glucocorticoids|mesh-ancestor
102457744|NCT00553059|Hormones|hormones|mesh-ancestor
102457745|NCT00553059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102457746|NCT00553059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102457747|NCT00553059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457748|NCT00553059|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102457749|NCT00553059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102457750|NCT00553059|Serotonin Agents|serotonin agents|mesh-ancestor
102457751|NCT00553059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102457752|NCT00553059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457753|NCT00553059|Hallucinogens|hallucinogens|mesh-ancestor
102457754|NCT00553059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102457755|NCT00553059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102457756|NCT00553059|Analgesics|analgesics|mesh-ancestor
102457757|NCT00553059|Sensory System Agents|sensory system agents|mesh-ancestor
102457758|NCT00553059|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102457759|NCT00553059|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102457760|NCT02989311|Iron|iron|mesh-list
102457761|NCT02989311|Trace Elements|trace elements|mesh-ancestor
102457762|NCT02989311|Micronutrients|micronutrients|mesh-ancestor
102457763|NCT02989311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457764|NCT00325403|Treprostinil|treprostinil|mesh-list
102457765|NCT00325403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102457766|NCT02015611|Vitamin D|vitamin d|mesh-list
102457767|NCT02015611|Vitamins|vitamins|mesh-ancestor
102457768|NCT02015611|Micronutrients|micronutrients|mesh-ancestor
102457769|NCT02015611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457770|NCT02015611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102457771|NCT01872819|Antineoplastic Agents|antineoplastic agents|mesh-list
102457772|NCT01413542|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102457773|NCT01413542|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
102457774|NCT01413542|Enalaprilat|enalaprilat|mesh-list
102457775|NCT01413542|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
102457776|NCT01413542|Bradykinin|bradykinin|mesh-list
102457777|NCT01413542|Glucagon|glucagon|mesh-list
102457778|NCT01413542|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102457779|NCT01413542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102457780|NCT01413542|Substance P|substance p|mesh-list
102457781|NCT01413542|Neurokinin A|neurokinin a|mesh-list
102457782|NCT01413542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102457783|NCT01413542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457784|NCT01413542|Incretins|incretins|mesh-ancestor
102457785|NCT01413542|Hormones|hormones|mesh-ancestor
102457786|NCT01413542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102457787|NCT01413542|Protease Inhibitors|protease inhibitors|mesh-ancestor
102457788|NCT01413542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102457789|NCT01413542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457790|NCT01413542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102457791|NCT01413542|Natriuretic Agents|natriuretic agents|mesh-ancestor
102457792|NCT01413542|Vasodilator Agents|vasodilator agents|mesh-ancestor
102457793|NCT01413542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102457794|NCT01413542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102457795|NCT01873989|Testosterone|testosterone|mesh-list
102457796|NCT01873989|Androgens|androgens|mesh-ancestor
102457797|NCT01873989|Hormones|hormones|mesh-ancestor
102457798|NCT01873989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102457799|NCT01873989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457800|NCT01875159|Caffeine|caffeine|mesh-list
102457801|NCT01875159|Caffeine citrate|caffeine citrate|mesh-list
102457802|NCT01875159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457803|NCT01875159|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102457804|NCT01875159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457805|NCT01875159|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102457806|NCT01875159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102457807|NCT01875159|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102457808|NCT01875159|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102457809|NCT01875159|Purinergic Agents|purinergic agents|mesh-ancestor
102457810|NCT01875159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102457811|NCT01432574|Vaccines|vaccines|mesh-list
102457812|NCT01432574|Immunologic Factors|immunologic factors|mesh-ancestor
102457813|NCT01432574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457814|NCT00339079|Fluoxetine|fluoxetine|mesh-list
102457815|NCT00339079|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102457816|NCT00339079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102457817|NCT00339079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102457818|NCT00339079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457819|NCT00339079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102457820|NCT00339079|Serotonin Agents|serotonin agents|mesh-ancestor
102457821|NCT00339079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457822|NCT00339079|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102457823|NCT00339079|Antidepressive Agents|antidepressive agents|mesh-ancestor
102457824|NCT00339079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102457825|NCT00339079|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102457826|NCT00339079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102457827|NCT00339079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102457828|NCT01392560|Empagliflozin|empagliflozin|mesh-list
102457829|NCT01392560|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102457830|NCT01392560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457831|NCT01392560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102457832|NCT01392560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457834|NCT00342355|Lopinavir|lopinavir|mesh-list
102457835|NCT00342355|Lamivudine|lamivudine|mesh-list
102457836|NCT00342355|Zidovudine|zidovudine|mesh-list
102457837|NCT00342355|Stavudine|stavudine|mesh-list
102457838|NCT00342355|Didanosine|didanosine|mesh-list
102457839|NCT00342355|Efavirenz|efavirenz|mesh-list
102457840|NCT00342355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102457841|NCT00342355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102457842|NCT00342355|Protease Inhibitors|protease inhibitors|mesh-ancestor
102457843|NCT00342355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102457844|NCT00342355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457845|NCT00342355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102457846|NCT00342355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102457847|NCT00342355|Antiviral Agents|antiviral agents|mesh-ancestor
102457848|NCT00342355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102457849|NCT00342355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102457850|NCT00342355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102457851|NCT00342355|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102457852|NCT00342355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102457853|NCT00342355|Antimetabolites|antimetabolites|mesh-ancestor
102457854|NCT00342355|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102457855|NCT00342355|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102457856|NCT00342355|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102457857|NCT00342355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102457858|NCT00342355|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102457859|NCT00306163|Fluticasone|fluticasone|mesh-list
102457860|NCT00306163|Ciclesonide|ciclesonide|mesh-list
102457861|NCT00306163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102457862|NCT00306163|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102457863|NCT00306163|Autonomic Agents|autonomic agents|mesh-ancestor
102457864|NCT00306163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102457865|NCT00306163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457866|NCT00306163|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102457867|NCT00306163|Respiratory System Agents|respiratory system agents|mesh-ancestor
102457868|NCT00306163|Dermatologic Agents|dermatologic agents|mesh-ancestor
102457869|NCT00306163|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102457870|NCT00306163|Glucocorticoids|glucocorticoids|mesh-ancestor
102457871|NCT00306163|Hormones|hormones|mesh-ancestor
102457872|NCT00306163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102457873|NCT01861665|Bupivacaine|bupivacaine|mesh-list
102457874|NCT01861665|Anesthetics, Local|anesthetics, local|mesh-ancestor
102457875|NCT01861665|Anesthetics|anesthetics|mesh-ancestor
102457876|NCT01861665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102457877|NCT01861665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457878|NCT01861665|Sensory System Agents|sensory system agents|mesh-ancestor
102457879|NCT01861665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102457880|NCT00330161|Vorinostat|vorinostat|mesh-list
102457881|NCT00330161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457882|NCT00330161|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102457883|NCT00330161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102457884|NCT00330161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457885|NCT00552279|Vaccines|vaccines|mesh-list
102457886|NCT00552279|Immunologic Factors|immunologic factors|mesh-ancestor
102457887|NCT00552279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457888|NCT00309751|Atorvastatin|atorvastatin|mesh-list
102457889|NCT00309751|Pitavastatin|pitavastatin|mesh-list
102457890|NCT00309751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102457891|NCT00309751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102457892|NCT00309751|Antimetabolites|antimetabolites|mesh-ancestor
102457893|NCT00309751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457894|NCT00309751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102457895|NCT00309751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102457896|NCT00309751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102457897|NCT04346095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
102457898|NCT04346095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102457899|NCT04346095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457900|NCT02988999|Erythritol|erythritol|mesh-list
102457901|NCT02988999|Vasodilator Agents|vasodilator agents|mesh-ancestor
102457902|NCT00313729|Temozolomide|temozolomide|mesh-list
102457903|NCT00313729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102457904|NCT00313729|Alkylating Agents|alkylating agents|mesh-ancestor
102457905|NCT00313729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457906|NCT00313729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457907|NCT00559377|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102457908|NCT00559377|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102457909|NCT00559377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457911|NCT05266651|Vasodilator Agents|vasodilator agents|mesh-ancestor
102457912|NCT05266651|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102457913|NCT05266651|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102088013|NCT03571737|Analgesics|analgesics|mesh-ancestor
102457914|NCT05266651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102457915|NCT05266651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457916|NCT05266651|Urological Agents|urological agents|mesh-ancestor
102457917|NCT05746689|Sirolimus|sirolimus|mesh-list
102457918|NCT05746689|Prednisone|prednisone|mesh-list
102457919|NCT05746689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102457920|NCT05746689|Glucocorticoids|glucocorticoids|mesh-ancestor
102457921|NCT05746689|Hormones|hormones|mesh-ancestor
102457922|NCT05746689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102457923|NCT05746689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457924|NCT05746689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102457925|NCT05746689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457926|NCT05746689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102457927|NCT05746689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102457928|NCT05746689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102457929|NCT05746689|Antifungal Agents|antifungal agents|mesh-ancestor
102457930|NCT05746689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102457931|NCT05746689|Immunologic Factors|immunologic factors|mesh-ancestor
102457932|NCT01412060|Cariprazine|cariprazine|mesh-list
102457933|NCT01412060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102457934|NCT01412060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102457935|NCT01412060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102457936|NCT01412060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457937|NCT01412060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102457938|NCT00345865|Cytarabine|cytarabine|mesh-list
102457939|NCT00345865|Cyclophosphamide|cyclophosphamide|mesh-list
102457940|NCT00345865|Carmustine|carmustine|mesh-list
102457941|NCT00345865|Etoposide|etoposide|mesh-list
102457942|NCT00345865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102457943|NCT00345865|Immunologic Factors|immunologic factors|mesh-ancestor
102457944|NCT00345865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457945|NCT00345865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102457946|NCT00345865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102457947|NCT00345865|Alkylating Agents|alkylating agents|mesh-ancestor
102457948|NCT00345865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457949|NCT00345865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457950|NCT00345865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102457951|NCT00345865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102457952|NCT00345865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102457953|NCT00345865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102457954|NCT00345865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102457955|NCT00345865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102457956|NCT00345865|Antimetabolites|antimetabolites|mesh-ancestor
102457957|NCT00345865|Antiviral Agents|antiviral agents|mesh-ancestor
102457958|NCT00345865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102457959|NCT00551421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102457960|NCT00551421|Cetuximab|cetuximab|mesh-list
102457961|NCT00551421|Pertuzumab|pertuzumab|mesh-list
102457962|NCT00551421|Irinotecan|irinotecan|mesh-list
102457963|NCT00551421|Antibodies|antibodies|mesh-list
102457964|NCT00551421|Immunoglobulins|immunoglobulins|mesh-list
102457965|NCT00551421|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102457966|NCT00551421|Immunologic Factors|immunologic factors|mesh-ancestor
102457967|NCT00551421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457968|NCT00551421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457969|NCT00551421|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102457970|NCT00551421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102457971|NCT00551421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102457972|NCT00551421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457973|NCT01791751|Clomiphene|clomiphene|mesh-list
102457974|NCT01791751|Enclomiphene|enclomiphene|mesh-list
102457975|NCT01791751|Zuclomiphene|zuclomiphene|mesh-list
102457976|NCT01791751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102457977|NCT01791751|Hormone Antagonists|hormone antagonists|mesh-ancestor
102457978|NCT01791751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102457979|NCT01791751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457980|NCT01791751|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102457981|NCT01791751|Fertility Agents|fertility agents|mesh-ancestor
102457982|NCT01791751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102457983|NCT01791751|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102457984|NCT01791751|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102457985|NCT05266261|Cholecalciferol|cholecalciferol|mesh-list
102457986|NCT05266261|Ibandronic Acid|ibandronic acid|mesh-list
102457987|NCT05266261|Calcium Carbonate|calcium carbonate|mesh-list
102457988|NCT05266261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102457989|NCT05266261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102457990|NCT05266261|Vitamins|vitamins|mesh-ancestor
102457991|NCT05266261|Micronutrients|micronutrients|mesh-ancestor
102457992|NCT05266261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102457993|NCT05266261|Antacids|antacids|mesh-ancestor
102457994|NCT05266261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102457995|NCT05266261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102457996|NCT05266105|Palbociclib|palbociclib|mesh-list
102457997|NCT05266105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102457998|NCT05266105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102457999|NCT05266105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102458000|NCT05266105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458001|NCT01891643|Dexamethasone|dexamethasone|mesh-list
102458002|NCT01891643|Dexamethasone acetate|dexamethasone acetate|mesh-list
102458003|NCT01891643|Lenalidomide|lenalidomide|mesh-list
102458004|NCT01891643|Elotuzumab|elotuzumab|mesh-list
102458005|NCT01891643|BB 1101|bb 1101|mesh-list
102458006|NCT01891643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102458007|NCT01891643|Antiemetics|antiemetics|mesh-ancestor
102458008|NCT01891643|Autonomic Agents|autonomic agents|mesh-ancestor
102458009|NCT01891643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102458010|NCT01891643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458011|NCT01891643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102458012|NCT01891643|Glucocorticoids|glucocorticoids|mesh-ancestor
102458013|NCT01891643|Hormones|hormones|mesh-ancestor
102458014|NCT01891643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102458015|NCT01891643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102458016|NCT01891643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102458017|NCT01891643|Protease Inhibitors|protease inhibitors|mesh-ancestor
102458018|NCT01891643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102458019|NCT01891643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458020|NCT01891643|Immunologic Factors|immunologic factors|mesh-ancestor
102458021|NCT01891643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102458022|NCT01891643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102458023|NCT01891643|Growth Substances|growth substances|mesh-ancestor
102458024|NCT01891643|Growth Inhibitors|growth inhibitors|mesh-ancestor
102458025|NCT05265793|Apatinib|apatinib|mesh-list
102458026|NCT05265793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102458027|NCT05265793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102458028|NCT05265793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102458029|NCT05265793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458030|NCT04005599|Magnesium Sulfate|magnesium sulfate|mesh-list
102458031|NCT04005599|Remifentanil|remifentanil|mesh-list
102458032|NCT04005599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102458033|NCT04005599|Narcotics|narcotics|mesh-ancestor
102458034|NCT04005599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102458035|NCT04005599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458036|NCT04005599|Analgesics|analgesics|mesh-ancestor
102458037|NCT04005599|Sensory System Agents|sensory system agents|mesh-ancestor
102458038|NCT04005599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102458039|NCT04005599|Anesthetics|anesthetics|mesh-ancestor
102458040|NCT04005599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102458041|NCT04005599|Anticonvulsants|anticonvulsants|mesh-ancestor
102458042|NCT04005599|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102458043|NCT04005599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102458044|NCT04005599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088144|NCT03572517|Morphine|morphine|mesh-list
102458045|NCT04005599|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102458046|NCT04005599|Tocolytic Agents|tocolytic agents|mesh-ancestor
102458047|NCT04005599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102458048|NCT00330863|Olanzapine|olanzapine|mesh-list
102458049|NCT00330863|Risperidone|risperidone|mesh-list
102458050|NCT00330863|Aripiprazole|aripiprazole|mesh-list
102458051|NCT00330863|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102458052|NCT00330863|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102458053|NCT00330863|Ziprasidone|ziprasidone|mesh-list
102458054|NCT00330863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102458055|NCT00330863|Serotonin Agents|serotonin agents|mesh-ancestor
102458056|NCT00330863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102458057|NCT00330863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458058|NCT00330863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458059|NCT00330863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102458060|NCT00330863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102458061|NCT00330863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102458062|NCT00330863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102458063|NCT00330863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102458064|NCT00330863|Dopamine Agents|dopamine agents|mesh-ancestor
102458065|NCT00330863|Antiemetics|antiemetics|mesh-ancestor
102458066|NCT00330863|Autonomic Agents|autonomic agents|mesh-ancestor
102458067|NCT00330863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102458068|NCT00330863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102458069|NCT00330863|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102458070|NCT00330863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102458071|NCT00330863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102458072|NCT00330863|Antidepressive Agents|antidepressive agents|mesh-ancestor
102458073|NCT00330863|Dopamine Agonists|dopamine agonists|mesh-ancestor
102458074|NCT00330863|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102458075|NCT00330863|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102458076|NCT00330863|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102458077|NCT00330863|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102458078|NCT01899521|Zinc Sulfate|zinc sulfate|mesh-list
102458079|NCT01899521|Astringents|astringents|mesh-ancestor
102458080|NCT01899521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458081|NCT01899521|Dermatologic Agents|dermatologic agents|mesh-ancestor
102458082|NCT01790009|Acetaminophen|acetaminophen|mesh-list
102458083|NCT01790009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102458084|NCT01790009|Analgesics|analgesics|mesh-ancestor
102458085|NCT01790009|Sensory System Agents|sensory system agents|mesh-ancestor
102458086|NCT01790009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102458087|NCT01790009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458088|NCT01790009|Antipyretics|antipyretics|mesh-ancestor
102458089|NCT05737329|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102458090|NCT05737329|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102458091|NCT05737329|Estradiol|estradiol|mesh-list
102458092|NCT05737329|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102458093|NCT05737329|Estrogens|estrogens|mesh-ancestor
102458094|NCT05737329|Hormones|hormones|mesh-ancestor
102458095|NCT05737329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102458096|NCT05737329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458097|NCT05737329|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102458098|NCT05737329|Contraceptive Agents|contraceptive agents|mesh-ancestor
102458099|NCT05737329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102458100|NCT05737329|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102458101|NCT00317941|Interferon beta-1b|interferon beta-1b|mesh-list
102458102|NCT00317941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102458103|NCT00317941|Immunologic Factors|immunologic factors|mesh-ancestor
102458104|NCT00317941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458105|NCT01790087|Moxifloxacin|moxifloxacin|mesh-list
102458106|NCT01790087|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102458107|NCT01790087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102458108|NCT01790087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102458109|NCT01790087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102458110|NCT01790087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102458111|NCT01790087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458112|NCT01790087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102458113|NCT05266937|Paclitaxel|paclitaxel|mesh-list
102458114|NCT05266937|Carboplatin|carboplatin|mesh-list
102458115|NCT05266937|Atezolizumab|atezolizumab|mesh-list
102458116|NCT05266937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102458117|NCT05266937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102458118|NCT05266937|Tubulin Modulators|tubulin modulators|mesh-ancestor
102458119|NCT05266937|Antimitotic Agents|antimitotic agents|mesh-ancestor
102458120|NCT05266937|Mitosis Modulators|mitosis modulators|mesh-ancestor
102458121|NCT05266937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458122|NCT05266937|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102458123|NCT05266937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102458124|NCT00332579|Naltrexone|naltrexone|mesh-list
102458125|NCT00332579|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102458126|NCT00332579|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102458127|NCT00332579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458128|NCT00332579|Sensory System Agents|sensory system agents|mesh-ancestor
102458129|NCT00332579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102458130|NCT00318409|Bupropion|bupropion|mesh-list
102458131|NCT00318409|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102458132|NCT00318409|Antidepressive Agents|antidepressive agents|mesh-ancestor
102458133|NCT00318409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102458134|NCT00318409|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102458135|NCT00318409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102458136|NCT00318409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102458137|NCT00318409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458138|NCT00318409|Dopamine Agents|dopamine agents|mesh-ancestor
102458139|NCT00318409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102458140|NCT00318409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458141|NCT00318409|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102458142|NCT00318409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102458143|NCT00318409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102458144|NCT00333437|Mycophenolic Acid|mycophenolic acid|mesh-list
102458145|NCT00333437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102458146|NCT00333437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102458147|NCT00333437|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102458148|NCT00333437|Antitubercular Agents|antitubercular agents|mesh-ancestor
102458149|NCT00333437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102458150|NCT00333437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102458151|NCT00333437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102458152|NCT00333437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458153|NCT04129619|Ether|ether|mesh-list
102458154|NCT04129619|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102458155|NCT04129619|Anesthetics, General|anesthetics, general|mesh-ancestor
102458156|NCT04129619|Anesthetics|anesthetics|mesh-ancestor
102458157|NCT04129619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102458158|NCT04129619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458159|NCT00353119|Etanercept|etanercept|mesh-list
102458160|NCT00353119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102458161|NCT00353119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102458162|NCT00353119|Analgesics|analgesics|mesh-ancestor
102458163|NCT00353119|Sensory System Agents|sensory system agents|mesh-ancestor
102458164|NCT00353119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102458165|NCT00353119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458166|NCT00353119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102458167|NCT00353119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102458168|NCT00353119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102458169|NCT00353119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102458170|NCT00353119|Immunologic Factors|immunologic factors|mesh-ancestor
102458171|NCT00353431|Insulin Aspart|insulin aspart|mesh-list
102458172|NCT00353431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102458173|NCT00353431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458174|NCT00353977|Vaccines|vaccines|mesh-list
102458175|NCT00353977|Immunologic Factors|immunologic factors|mesh-ancestor
102458176|NCT00353977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458177|NCT00320281|Botulinum Toxins|botulinum toxins|mesh-list
102458178|NCT00320281|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102458179|NCT00320281|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102458180|NCT00320281|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102458181|NCT00320281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102458182|NCT00320281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458183|NCT00320281|Cholinergic Agents|cholinergic agents|mesh-ancestor
102458184|NCT00320281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102088295|NCT02181348|Vitamin E|vitamin e|mesh-list
102458185|NCT00320281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458186|NCT00320281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102458187|NCT00320281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102458188|NCT01792375|Dinoprostone|dinoprostone|mesh-list
102458189|NCT01792375|Oxytocics|oxytocics|mesh-ancestor
102458190|NCT01792375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102458191|NCT01792375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458192|NCT01392326|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102458193|NCT01392326|Immunologic Factors|immunologic factors|mesh-ancestor
102458194|NCT01392326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458195|NCT00320671|Risperidone|risperidone|mesh-list
102458196|NCT00320671|Aripiprazole|aripiprazole|mesh-list
102458197|NCT00320671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102458198|NCT00320671|Serotonin Agents|serotonin agents|mesh-ancestor
102458199|NCT00320671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102458200|NCT00320671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458201|NCT00320671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458202|NCT00320671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102458203|NCT00320671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102458204|NCT00320671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102458205|NCT00320671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102458206|NCT00320671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102458207|NCT00320671|Dopamine Agents|dopamine agents|mesh-ancestor
102458208|NCT00320671|Antidepressive Agents|antidepressive agents|mesh-ancestor
102458209|NCT00320671|Dopamine Agonists|dopamine agonists|mesh-ancestor
102458210|NCT00320671|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102458211|NCT00320671|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102458212|NCT00320671|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102458213|NCT00320671|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102458214|NCT00320749|Gemcitabine|gemcitabine|mesh-list
102458215|NCT00320749|Capecitabine|capecitabine|mesh-list
102458217|NCT00320749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102458218|NCT00320749|Antimetabolites|antimetabolites|mesh-ancestor
102458219|NCT00320749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458220|NCT00320749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102458221|NCT00320749|Tubulin Modulators|tubulin modulators|mesh-ancestor
102458222|NCT00320749|Antimitotic Agents|antimitotic agents|mesh-ancestor
102458223|NCT00320749|Mitosis Modulators|mitosis modulators|mesh-ancestor
102458224|NCT00354913|Imatinib Mesylate|imatinib mesylate|mesh-list
102458225|NCT00354913|Hydroxyurea|hydroxyurea|mesh-list
102458226|NCT00354913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102458227|NCT00354913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102458228|NCT00354913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102458229|NCT00354913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458230|NCT00354913|Antisickling Agents|antisickling agents|mesh-ancestor
102458231|NCT00354913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102458232|NCT01432262|Vaccines|vaccines|mesh-list
102458233|NCT01432262|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102458234|NCT01432262|Immunologic Factors|immunologic factors|mesh-ancestor
102458235|NCT01432262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458236|NCT00322309|Mirtazapine|mirtazapine|mesh-list
102458237|NCT00322309|Antidepressive Agents|antidepressive agents|mesh-ancestor
102458238|NCT00322309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102458239|NCT00322309|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102458240|NCT00322309|Histamine Antagonists|histamine antagonists|mesh-ancestor
102458241|NCT00322309|Histamine Agents|histamine agents|mesh-ancestor
102458242|NCT00322309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102458243|NCT00322309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458244|NCT00322309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458245|NCT00322309|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102458246|NCT00322309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102458247|NCT00322309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102458248|NCT00322309|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102458249|NCT00322309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102458250|NCT00322309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102458251|NCT00322309|Adrenergic Agents|adrenergic agents|mesh-ancestor
102458252|NCT00322309|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102458253|NCT00322309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102458254|NCT00322309|Serotonin Agents|serotonin agents|mesh-ancestor
102458255|NCT00322309|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102458256|NCT04046744|Lidocaine|lidocaine|mesh-list
102458257|NCT04046744|Analgesics|analgesics|mesh-list
102458258|NCT04046744|Ropivacaine|ropivacaine|mesh-list
102458259|NCT04046744|Anesthetics, Local|anesthetics, local|mesh-list
102458260|NCT04046744|Anesthetics|anesthetics|mesh-list
102458261|NCT04046744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102458262|NCT04046744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458263|NCT04046744|Sensory System Agents|sensory system agents|mesh-ancestor
102458264|NCT04046744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102458265|NCT04046744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102458266|NCT04046744|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102458267|NCT04046744|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102458268|NCT04046744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102458269|NCT04046744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458270|NCT01431950|Fluticasone|fluticasone|mesh-list
102458271|NCT01431950|Xhance|xhance|mesh-list
102458272|NCT01431950|Albuterol|albuterol|mesh-list
102458273|NCT01431950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102458274|NCT01431950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102458275|NCT01431950|Autonomic Agents|autonomic agents|mesh-ancestor
102458276|NCT01431950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102458277|NCT01431950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458278|NCT01431950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102458279|NCT01431950|Respiratory System Agents|respiratory system agents|mesh-ancestor
102154237|NCT03367143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102458280|NCT01431950|Dermatologic Agents|dermatologic agents|mesh-ancestor
102458281|NCT01431950|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102458282|NCT01431950|Tocolytic Agents|tocolytic agents|mesh-ancestor
102458283|NCT01431950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102458284|NCT01431950|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102458285|NCT01431950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102458286|NCT01431950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102458287|NCT01431950|Adrenergic Agents|adrenergic agents|mesh-ancestor
102458288|NCT01431950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102458289|NCT01431950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458290|NCT00551031|Vaccines|vaccines|mesh-list
102458291|NCT00551031|Immunologic Factors|immunologic factors|mesh-ancestor
102458292|NCT00551031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458293|NCT01431716|Epoprostenol|epoprostenol|mesh-list
102458294|NCT01431716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102458295|NCT01431716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102458296|NCT00550953|Amlodipine|amlodipine|mesh-list
102458297|NCT00550953|Telmisartan|telmisartan|mesh-list
102458298|NCT00550953|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
102458299|NCT00550953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102458300|NCT00550953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102458301|NCT00550953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102458302|NCT00550953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458303|NCT00550953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102458304|NCT00550953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458305|NCT00550953|Vasodilator Agents|vasodilator agents|mesh-ancestor
102458306|NCT00550953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102458307|NCT00550953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102458308|NCT00322465|Azithromycin|azithromycin|mesh-list
102458309|NCT00322465|Doxycycline|doxycycline|mesh-list
102458310|NCT00322465|Tinidazole|tinidazole|mesh-list
102458311|NCT00322465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102458312|NCT00322465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102458313|NCT00322465|Antimalarials|antimalarials|mesh-ancestor
102458314|NCT00322465|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102458315|NCT00322465|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102458316|NCT00322465|Alkylating Agents|alkylating agents|mesh-ancestor
102458317|NCT00322465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458318|NCT00322465|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
102458319|NCT00558831|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102458320|NCT00558831|Dermatologic Agents|dermatologic agents|mesh-ancestor
102458321|NCT03021993|Nivolumab|nivolumab|mesh-list
102458322|NCT03021993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102458323|NCT03021993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102458324|NCT03021993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102458325|NCT03021993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458326|NCT01392170|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102458327|NCT01392170|Antiviral Agents|antiviral agents|mesh-ancestor
102458328|NCT01392170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102458329|NCT00558753|Pregabalin|pregabalin|mesh-list
102458330|NCT00558753|Analgesics|analgesics|mesh-ancestor
102458331|NCT00558753|Sensory System Agents|sensory system agents|mesh-ancestor
102458332|NCT00558753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102458333|NCT00558753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458334|NCT00558753|Anticonvulsants|anticonvulsants|mesh-ancestor
102458335|NCT00558753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102458336|NCT00558753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102458337|NCT00558753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458338|NCT00558753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102458339|NCT00558753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102458340|NCT00558753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102458341|NCT00558753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102458342|NCT00558753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102458343|NCT00324259|Estradiol|estradiol|mesh-list
102458344|NCT00324259|Estrogens|estrogens|mesh-ancestor
102458345|NCT00324259|Hormones|hormones|mesh-ancestor
102458346|NCT00324259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102458347|NCT00324259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458348|NCT04598451|Prednisone|prednisone|mesh-list
102458349|NCT04598451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102458350|NCT04598451|Glucocorticoids|glucocorticoids|mesh-ancestor
102458351|NCT04598451|Hormones|hormones|mesh-ancestor
102269917|NCT05370599|Losartan|losartan|mesh-list
102458352|NCT04598451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102458353|NCT04598451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458354|NCT04598451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102458355|NCT04598451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102458356|NCT04600141|Heparin|heparin|mesh-list
102458357|NCT04600141|Calcium heparin|calcium heparin|mesh-list
102458358|NCT04600141|Anticoagulants|anticoagulants|mesh-ancestor
102458359|NCT04600141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102458360|NCT04600141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102458361|NCT04600141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458362|NCT00324415|Fluorouracil|fluorouracil|mesh-list
102458363|NCT00324415|Cetuximab|cetuximab|mesh-list
102458364|NCT00324415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102458365|NCT00324415|Antimetabolites|antimetabolites|mesh-ancestor
102458366|NCT00324415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458367|NCT00324415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102458368|NCT00324415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102458369|NCT00324415|Immunologic Factors|immunologic factors|mesh-ancestor
102458370|NCT00324415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458371|NCT00324415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102458372|NCT00390559|Nicotine|nicotine|mesh-list
102458373|NCT00390559|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102458374|NCT00390559|Autonomic Agents|autonomic agents|mesh-ancestor
102458375|NCT00390559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102458376|NCT00390559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458377|NCT00390559|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102458378|NCT00390559|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102458379|NCT00390559|Cholinergic Agents|cholinergic agents|mesh-ancestor
102458380|NCT00390559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102458381|NCT00390559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458382|NCT02107339|Methadone|methadone|mesh-list
102458383|NCT02107339|Hydromorphone|hydromorphone|mesh-list
102458384|NCT02107339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102458385|NCT02107339|Narcotics|narcotics|mesh-ancestor
102458386|NCT02107339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102458387|NCT02107339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458388|NCT02107339|Analgesics|analgesics|mesh-ancestor
102458389|NCT02107339|Sensory System Agents|sensory system agents|mesh-ancestor
102458390|NCT02107339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102458391|NCT02107339|Antitussive Agents|antitussive agents|mesh-ancestor
102458392|NCT02107339|Respiratory System Agents|respiratory system agents|mesh-ancestor
102458393|NCT00392041|Eszopiclone|eszopiclone|mesh-list
101390253|NCT05581030|Rituximab|rituximab|mesh-list
102458394|NCT00392041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102458395|NCT00392041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102458396|NCT00392041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458397|NCT01390844|Ribavirin|ribavirin|mesh-list
102458398|NCT01390844|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102458399|NCT01390844|Antimetabolites|antimetabolites|mesh-ancestor
102458400|NCT01390844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458401|NCT01390844|Antiviral Agents|antiviral agents|mesh-ancestor
102458402|NCT01390844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102458403|NCT04035278|Vaccines|vaccines|mesh-list
102458404|NCT04035278|Immunologic Factors|immunologic factors|mesh-ancestor
102458405|NCT04035278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458406|NCT00395161|Selenium|selenium|mesh-list
102458407|NCT00395161|Metoclopramide|metoclopramide|mesh-list
102458408|NCT00395161|Antioxidants|antioxidants|mesh-ancestor
102458409|NCT00395161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458410|NCT00395161|Protective Agents|protective agents|mesh-ancestor
102458411|NCT00395161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458412|NCT00395161|Trace Elements|trace elements|mesh-ancestor
102458413|NCT00395161|Micronutrients|micronutrients|mesh-ancestor
102458414|NCT00395161|Antiemetics|antiemetics|mesh-ancestor
102458415|NCT00395161|Autonomic Agents|autonomic agents|mesh-ancestor
102458416|NCT00395161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102458417|NCT00395161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102458418|NCT00395161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102458419|NCT00395161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102458420|NCT00395161|Dopamine Agents|dopamine agents|mesh-ancestor
102458421|NCT00395161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102458422|NCT01409564|Cilostazol|cilostazol|mesh-list
102458423|NCT01409564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102458424|NCT01409564|Autonomic Agents|autonomic agents|mesh-ancestor
102458425|NCT01409564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102458426|NCT01409564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458427|NCT01409564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102458428|NCT01409564|Respiratory System Agents|respiratory system agents|mesh-ancestor
102458429|NCT01409564|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102458430|NCT01409564|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102458431|NCT01409564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458432|NCT01409564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102458433|NCT01409564|Vasodilator Agents|vasodilator agents|mesh-ancestor
102458434|NCT01409564|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102458435|NCT01409564|Protective Agents|protective agents|mesh-ancestor
102458436|NCT01409564|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102458437|NCT01409564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102458438|NCT01409564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102458439|NCT02009449|Leucovorin|leucovorin|mesh-list
102458440|NCT02009449|Paclitaxel|paclitaxel|mesh-list
102458441|NCT02009449|Docetaxel|docetaxel|mesh-list
102458442|NCT02009449|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102458443|NCT02009449|Carboplatin|carboplatin|mesh-list
102458444|NCT02009449|Gemcitabine|gemcitabine|mesh-list
102458445|NCT02009449|Pembrolizumab|pembrolizumab|mesh-list
102458446|NCT02009449|Fluorouracil|fluorouracil|mesh-list
102458447|NCT02009449|Capecitabine|capecitabine|mesh-list
102458448|NCT02009449|Oxaliplatin|oxaliplatin|mesh-list
102458449|NCT02009449|Nivolumab|nivolumab|mesh-list
102458450|NCT02009449|Levoleucovorin|levoleucovorin|mesh-list
102458451|NCT02009449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102458452|NCT02009449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102458453|NCT02009449|Tubulin Modulators|tubulin modulators|mesh-ancestor
102458454|NCT02009449|Antimitotic Agents|antimitotic agents|mesh-ancestor
102458455|NCT02009449|Mitosis Modulators|mitosis modulators|mesh-ancestor
102458456|NCT02009449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458457|NCT02009449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102458458|NCT02009449|Antimetabolites|antimetabolites|mesh-ancestor
102458459|NCT02009449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102458460|NCT02009449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102458461|NCT02009449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102458462|NCT02009449|Immunologic Factors|immunologic factors|mesh-ancestor
102458463|NCT02009449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458464|NCT02009449|Antidotes|antidotes|mesh-ancestor
102458465|NCT02009449|Protective Agents|protective agents|mesh-ancestor
102458466|NCT02009449|Vitamin B Complex|vitamin b complex|mesh-ancestor
102458467|NCT02009449|Vitamins|vitamins|mesh-ancestor
102458468|NCT02009449|Micronutrients|micronutrients|mesh-ancestor
102458469|NCT01794091|Eplerenone|eplerenone|mesh-list
102458470|NCT01794091|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102458471|NCT01794091|Hormone Antagonists|hormone antagonists|mesh-ancestor
102458472|NCT01794091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102458473|NCT01794091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458474|NCT01794091|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102458475|NCT01794091|Diuretics|diuretics|mesh-ancestor
102458476|NCT01794091|Natriuretic Agents|natriuretic agents|mesh-ancestor
102458477|NCT01794091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102458478|NCT01794169|Cytarabine|cytarabine|mesh-list
102458479|NCT01794169|Azacitidine|azacitidine|mesh-list
102458480|NCT01794169|Daunorubicin|daunorubicin|mesh-list
102458481|NCT01794169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102458482|NCT01794169|Antimetabolites|antimetabolites|mesh-ancestor
102458483|NCT01794169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458484|NCT01794169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102458485|NCT01794169|Antiviral Agents|antiviral agents|mesh-ancestor
102458486|NCT01794169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102458487|NCT01794169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102458488|NCT01794169|Immunologic Factors|immunologic factors|mesh-ancestor
102458489|NCT01794169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458490|NCT01794169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102458491|NCT01794169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102458492|NCT01794169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102458493|NCT01794169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102458494|NCT00396019|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102458495|NCT00396019|Antiviral Agents|antiviral agents|mesh-ancestor
102458496|NCT00396019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102458497|NCT01390220|Midazolam|midazolam|mesh-list
102458498|NCT01390220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102458499|NCT01390220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102458500|NCT01390220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102458501|NCT01390220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458502|NCT01390220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102270053|NCT05040360|Antimetabolites|antimetabolites|mesh-ancestor
102458503|NCT01390220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102458504|NCT01390220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102458505|NCT01390220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102458506|NCT01390220|Anesthetics, General|anesthetics, general|mesh-ancestor
102458507|NCT01390220|Anesthetics|anesthetics|mesh-ancestor
102458509|NCT01390220|GABA Agents|gaba agents|mesh-ancestor
102458510|NCT01390220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102458511|NCT01390220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458512|NCT00357331|Potassium Citrate|potassium citrate|mesh-list
102458513|NCT00357331|Diuretics|diuretics|mesh-ancestor
102458514|NCT00357331|Natriuretic Agents|natriuretic agents|mesh-ancestor
102458515|NCT00357331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458516|NCT00357331|Expectorants|expectorants|mesh-ancestor
102458517|NCT00357331|Respiratory System Agents|respiratory system agents|mesh-ancestor
102458518|NCT00550173|Pemetrexed|pemetrexed|mesh-list
102458519|NCT00550173|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102458520|NCT00550173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102458521|NCT00550173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102458522|NCT00550173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458523|NCT00550173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102458524|NCT00550173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102458525|NCT00550173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102458526|NCT04163107|Hydroxychloroquine|hydroxychloroquine|mesh-list
102458527|NCT04163107|Dexamethasone|dexamethasone|mesh-list
102458528|NCT04163107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102458529|NCT04163107|Antiemetics|antiemetics|mesh-ancestor
102458530|NCT04163107|Autonomic Agents|autonomic agents|mesh-ancestor
102458531|NCT04163107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102458532|NCT04163107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458533|NCT04163107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102458534|NCT04163107|Glucocorticoids|glucocorticoids|mesh-ancestor
102458535|NCT04163107|Hormones|hormones|mesh-ancestor
102458536|NCT04163107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102458537|NCT04163107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102458538|NCT04163107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102458539|NCT04163107|Antimalarials|antimalarials|mesh-ancestor
102458540|NCT04163107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102458541|NCT04163107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102458542|NCT04163107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102458543|NCT04163107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102458544|NCT04163107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458545|NCT04163107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102458546|NCT01429298|Hydromorphone|hydromorphone|mesh-list
102458547|NCT01429298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102458548|NCT01429298|Narcotics|narcotics|mesh-ancestor
102458549|NCT01429298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102458550|NCT01429298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458551|NCT01429298|Analgesics|analgesics|mesh-ancestor
102458552|NCT01429298|Sensory System Agents|sensory system agents|mesh-ancestor
102458553|NCT01429298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102458554|NCT01408628|Insulin|insulin|mesh-list
102458555|NCT01408628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102458556|NCT01408628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458557|NCT01389752|Charcoal|charcoal|mesh-list
102458558|NCT01389752|Antidotes|antidotes|mesh-ancestor
102458559|NCT01389752|Protective Agents|protective agents|mesh-ancestor
102458560|NCT01389752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458561|NCT01428128|Arsenic Trioxide|arsenic trioxide|mesh-list
102458562|NCT01428128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102458563|NCT00358501|Defibrotide|defibrotide|mesh-list
102458564|NCT00358501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102458565|NCT00358501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102458566|NCT00358501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458567|NCT00358501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102458568|NCT01427972|Eplerenone|eplerenone|mesh-list
102458569|NCT01427972|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102458570|NCT01427972|Hormone Antagonists|hormone antagonists|mesh-ancestor
102458571|NCT01427972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102458572|NCT01427972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458573|NCT01427972|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102458574|NCT01427972|Diuretics|diuretics|mesh-ancestor
102458575|NCT01427972|Natriuretic Agents|natriuretic agents|mesh-ancestor
102458576|NCT01427972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102458577|NCT00336323|Bevacizumab|bevacizumab|mesh-list
102458578|NCT00336323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102458579|NCT00336323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102458580|NCT00336323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102458581|NCT00336323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102458582|NCT00336323|Growth Substances|growth substances|mesh-ancestor
102458583|NCT00336323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458584|NCT00336323|Growth Inhibitors|growth inhibitors|mesh-ancestor
102458585|NCT01427738|Nystatin|nystatin|mesh-list
102458586|NCT01427738|Gentian Violet|gentian violet|mesh-list
102458587|NCT01427738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102458588|NCT01427738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102458589|NCT01427738|Antifungal Agents|antifungal agents|mesh-ancestor
102458590|NCT01427738|Ionophores|ionophores|mesh-ancestor
102458591|NCT01427738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102458592|NCT01427738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458593|NCT01427738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102458594|NCT01426958|Ritonavir|ritonavir|mesh-list
102458595|NCT01426958|Afatinib|afatinib|mesh-list
102458596|NCT01426958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102458597|NCT01426958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102458598|NCT01426958|Protease Inhibitors|protease inhibitors|mesh-ancestor
102458599|NCT01426958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102458600|NCT01426958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458601|NCT01426958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102458602|NCT01426958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102458603|NCT01426958|Antiviral Agents|antiviral agents|mesh-ancestor
102458604|NCT01426958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102458605|NCT01426958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102458606|NCT01426958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102458607|NCT01426958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102458608|NCT01426958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102458609|NCT00397813|Cyclosporine|cyclosporine|mesh-list
102458610|NCT00397813|Mycophenolic Acid|mycophenolic acid|mesh-list
102458611|NCT00397813|Fludarabine|fludarabine|mesh-list
102458612|NCT00397813|Fludarabine phosphate|fludarabine phosphate|mesh-list
102458613|NCT00397813|Cyclosporins|cyclosporins|mesh-list
102458614|NCT00397813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102458615|NCT00397813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102458616|NCT00397813|Antimetabolites|antimetabolites|mesh-ancestor
102458617|NCT00397813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458618|NCT00397813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102458619|NCT00397813|Immunologic Factors|immunologic factors|mesh-ancestor
102458620|NCT00397813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458621|NCT00397813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102458622|NCT00397813|Antifungal Agents|antifungal agents|mesh-ancestor
102458623|NCT00397813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102458624|NCT00397813|Dermatologic Agents|dermatologic agents|mesh-ancestor
102458625|NCT00397813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102458626|NCT00397813|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102458627|NCT00397813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102458628|NCT00397813|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102458629|NCT00397813|Antitubercular Agents|antitubercular agents|mesh-ancestor
102458630|NCT00397813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102458631|NCT00398983|Decitabine|decitabine|mesh-list
102458632|NCT00398983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102458633|NCT00398983|Antimetabolites|antimetabolites|mesh-ancestor
102458634|NCT00398983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458635|NCT00398983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102458636|NCT00398983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102458637|NCT00358579|Vasopressins|vasopressins|mesh-list
102458638|NCT00358579|Arginine Vasopressin|arginine vasopressin|mesh-list
102458639|NCT00358579|Epinephrine|epinephrine|mesh-list
102458640|NCT00358579|Racepinephrine|racepinephrine|mesh-list
102458641|NCT00358579|Epinephryl borate|epinephryl borate|mesh-list
102458642|NCT00358579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458643|NCT00358579|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102458644|NCT00358579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102458645|NCT00358579|Adrenergic Agents|adrenergic agents|mesh-ancestor
102458646|NCT00358579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102458647|NCT00358579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458648|NCT00358579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102458649|NCT00358579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102458650|NCT00358579|Autonomic Agents|autonomic agents|mesh-ancestor
102458651|NCT00358579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102458652|NCT00358579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102458653|NCT00358579|Respiratory System Agents|respiratory system agents|mesh-ancestor
102458654|NCT00358579|Mydriatics|mydriatics|mesh-ancestor
102458655|NCT00358579|Sympathomimetics|sympathomimetics|mesh-ancestor
102458656|NCT00358579|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102458657|NCT00358579|Hemostatics|hemostatics|mesh-ancestor
102458658|NCT00358579|Coagulants|coagulants|mesh-ancestor
102458659|NCT00358579|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102458660|NCT00358579|Natriuretic Agents|natriuretic agents|mesh-ancestor
102458661|NCT00338039|Gemcitabine|gemcitabine|mesh-list
102458662|NCT00338039|Capecitabine|capecitabine|mesh-list
102458663|NCT00338039|Oxaliplatin|oxaliplatin|mesh-list
102458664|NCT00338039|Cetuximab|cetuximab|mesh-list
102458665|NCT00338039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102458666|NCT00338039|Antimetabolites|antimetabolites|mesh-ancestor
102458667|NCT00338039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458668|NCT00338039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102458669|NCT00338039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102458670|NCT00358657|Mycophenolic Acid|mycophenolic acid|mesh-list
102458671|NCT00358657|Sirolimus|sirolimus|mesh-list
102458672|NCT00358657|Cyclophosphamide|cyclophosphamide|mesh-list
102458673|NCT00358657|Fludarabine|fludarabine|mesh-list
102458674|NCT00358657|Fludarabine phosphate|fludarabine phosphate|mesh-list
102458675|NCT00358657|Tacrolimus|tacrolimus|mesh-list
102458676|NCT00358657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102458677|NCT00358657|Immunologic Factors|immunologic factors|mesh-ancestor
102458678|NCT00358657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458679|NCT00358657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102458680|NCT00358657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102458681|NCT00358657|Alkylating Agents|alkylating agents|mesh-ancestor
102458682|NCT00358657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458683|NCT00358657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102458684|NCT00358657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102458685|NCT00358657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102458686|NCT00358657|Antimetabolites|antimetabolites|mesh-ancestor
102458687|NCT00358657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102458688|NCT00358657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102458689|NCT00358657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102458690|NCT00358657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102458691|NCT00358657|Antitubercular Agents|antitubercular agents|mesh-ancestor
102458692|NCT00358657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102458693|NCT00358657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102458694|NCT00358657|Antifungal Agents|antifungal agents|mesh-ancestor
102458695|NCT00340379|Haloperidol|haloperidol|mesh-list
102458696|NCT00340379|Haloperidol decanoate|haloperidol decanoate|mesh-list
102458697|NCT00340379|Ziprasidone|ziprasidone|mesh-list
102458698|NCT00340379|Sertraline|sertraline|mesh-list
102458699|NCT00340379|Antidepressive Agents|antidepressive agents|mesh-ancestor
102458700|NCT00340379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102458701|NCT00340379|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102458702|NCT00340379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102458703|NCT00340379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102458704|NCT00340379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458705|NCT00340379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102458706|NCT00340379|Serotonin Agents|serotonin agents|mesh-ancestor
102458707|NCT00340379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458708|NCT00340379|Antiemetics|antiemetics|mesh-ancestor
102458709|NCT00340379|Autonomic Agents|autonomic agents|mesh-ancestor
102458710|NCT00340379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102458711|NCT00340379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102458712|NCT00340379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102458713|NCT00340379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102458714|NCT00340379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102458715|NCT00340379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102458716|NCT00340379|Dopamine Agents|dopamine agents|mesh-ancestor
102458717|NCT00340379|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102458718|NCT00340379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102458719|NCT00342563|Mecamylamine|mecamylamine|mesh-list
102458720|NCT00342563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102458721|NCT00342563|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
102458722|NCT00342563|Autonomic Agents|autonomic agents|mesh-ancestor
102458723|NCT00342563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102458724|NCT00342563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458725|NCT00342563|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102458726|NCT00342563|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102458727|NCT00342563|Cholinergic Agents|cholinergic agents|mesh-ancestor
102458728|NCT00342563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102458729|NCT00342563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458730|NCT00358735|Enoxaparin|enoxaparin|mesh-list
102458731|NCT00358735|Anticoagulants|anticoagulants|mesh-ancestor
102458732|NCT00358735|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102458733|NCT00358735|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102458734|NCT00358735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270279|NCT04535401|Antimetabolites|antimetabolites|mesh-ancestor
102458735|NCT01793519|Adalimumab|adalimumab|mesh-list
102458736|NCT01793519|Infliximab|infliximab|mesh-list
102458737|NCT01793519|Etanercept|etanercept|mesh-list
102458738|NCT01793519|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102458739|NCT01793519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102458740|NCT01793519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102458741|NCT01793519|Dermatologic Agents|dermatologic agents|mesh-ancestor
102458742|NCT01793519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102458743|NCT01793519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102458744|NCT01793519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102458745|NCT01793519|Analgesics|analgesics|mesh-ancestor
102458746|NCT01793519|Sensory System Agents|sensory system agents|mesh-ancestor
102458747|NCT01793519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102458748|NCT01793519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458749|NCT01793519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102458750|NCT01793519|Immunologic Factors|immunologic factors|mesh-ancestor
102458751|NCT00345371|Topiramate|topiramate|mesh-list
102458752|NCT00345371|Anticonvulsants|anticonvulsants|mesh-ancestor
102458753|NCT00345371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102458754|NCT00345371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458755|NCT03006276|Celecoxib|celecoxib|mesh-list
102458756|NCT03006276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102458757|NCT03006276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102458758|NCT03006276|Analgesics|analgesics|mesh-ancestor
102458759|NCT03006276|Sensory System Agents|sensory system agents|mesh-ancestor
102458760|NCT03006276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102458761|NCT03006276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458762|NCT03006276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102458763|NCT03006276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102458764|NCT03006276|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102458765|NCT03006276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102458766|NCT03006276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102458767|NCT03006276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458768|NCT00350363|Gatifloxacin|gatifloxacin|mesh-list
102458769|NCT00350363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102458770|NCT00350363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102458771|NCT00350363|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102458772|NCT00350363|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102458773|NCT00350363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102458774|NCT00350363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102458775|NCT00350363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102458776|NCT00350363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458777|NCT00350363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102458778|NCT00351299|Dexmedetomidine|dexmedetomidine|mesh-list
102458779|NCT00351299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102458780|NCT00351299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102458781|NCT00351299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458782|NCT00351299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102458783|NCT00351299|Analgesics|analgesics|mesh-ancestor
102458784|NCT00351299|Sensory System Agents|sensory system agents|mesh-ancestor
102458785|NCT00351299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102458786|NCT00351299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102458787|NCT00351299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102458788|NCT00351299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102458789|NCT00351299|Adrenergic Agents|adrenergic agents|mesh-ancestor
102458790|NCT00351299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102458791|NCT00351299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458792|NCT00352001|Lenalidomide|lenalidomide|mesh-list
102458793|NCT00352001|Azacitidine|azacitidine|mesh-list
102458794|NCT00352001|Immunologic Factors|immunologic factors|mesh-ancestor
102458795|NCT00352001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458796|NCT00352001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102458797|NCT00352001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102458798|NCT00352001|Growth Substances|growth substances|mesh-ancestor
102458799|NCT00352001|Growth Inhibitors|growth inhibitors|mesh-ancestor
102458800|NCT00352001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102458801|NCT00352001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102458802|NCT00352001|Antimetabolites|antimetabolites|mesh-ancestor
102458803|NCT00352001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458804|NCT00352001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102458805|NCT00401401|Zalutumumab|zalutumumab|mesh-list
102458806|NCT00401401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102458807|NCT00401401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102458808|NCT00352781|Nicotine|nicotine|mesh-list
102458809|NCT00352781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102270353|NCT04417517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102458811|NCT00352781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102458812|NCT00352781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458813|NCT00352781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102458814|NCT00352781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102458815|NCT00352781|Cholinergic Agents|cholinergic agents|mesh-ancestor
102458816|NCT00352781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102458817|NCT00352781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458818|NCT02812524|Ipilimumab|ipilimumab|mesh-list
102458819|NCT02812524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102458820|NCT02812524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102458821|NCT02812524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102458822|NCT02812524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458823|NCT01793753|Propofol|propofol|mesh-list
102458824|NCT01793753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102458825|NCT01793753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102458826|NCT01793753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458827|NCT01793753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102458828|NCT01793753|Anesthetics, General|anesthetics, general|mesh-ancestor
102458829|NCT01793753|Anesthetics|anesthetics|mesh-ancestor
102458830|NCT00360685|Mycophenolic Acid|mycophenolic acid|mesh-list
102458831|NCT00360685|Methotrexate|methotrexate|mesh-list
102458832|NCT00360685|Tacrolimus|tacrolimus|mesh-list
102458833|NCT00360685|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102458834|NCT00360685|Abortifacient Agents|abortifacient agents|mesh-ancestor
102458835|NCT00360685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102458836|NCT00360685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458837|NCT00360685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102458838|NCT00360685|Antimetabolites|antimetabolites|mesh-ancestor
102458839|NCT00360685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458840|NCT00360685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102458841|NCT00360685|Dermatologic Agents|dermatologic agents|mesh-ancestor
102458842|NCT00360685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102458843|NCT00360685|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102458844|NCT00360685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102458845|NCT00360685|Immunologic Factors|immunologic factors|mesh-ancestor
102458846|NCT00360685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102458847|NCT00360685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102458848|NCT00360685|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102458849|NCT00360685|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102458850|NCT00360685|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102458851|NCT00360685|Antitubercular Agents|antitubercular agents|mesh-ancestor
102458852|NCT00360685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102458853|NCT00360685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102458854|NCT05487456|Menthol|menthol|mesh-list
102458855|NCT05487456|Nicotine|nicotine|mesh-list
102458856|NCT05487456|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102458857|NCT05487456|Autonomic Agents|autonomic agents|mesh-ancestor
102458858|NCT05487456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102458859|NCT05487456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458860|NCT05487456|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102458861|NCT05487456|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102458862|NCT05487456|Cholinergic Agents|cholinergic agents|mesh-ancestor
102458863|NCT05487456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102458864|NCT05487456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458865|NCT05487456|Antipruritics|antipruritics|mesh-ancestor
102458866|NCT05487456|Dermatologic Agents|dermatologic agents|mesh-ancestor
102458867|NCT00558519|Cytarabine|cytarabine|mesh-list
102458868|NCT00558519|Dexamethasone|dexamethasone|mesh-list
102458869|NCT00558519|Cyclophosphamide|cyclophosphamide|mesh-list
102458870|NCT00558519|Doxorubicin|doxorubicin|mesh-list
102458871|NCT00558519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102458872|NCT00558519|Methotrexate|methotrexate|mesh-list
102458873|NCT00558519|Vincristine|vincristine|mesh-list
102458874|NCT00558519|Daunorubicin|daunorubicin|mesh-list
102458875|NCT00558519|Mercaptopurine|mercaptopurine|mesh-list
102458876|NCT00558519|Pegaspargase|pegaspargase|mesh-list
102458877|NCT00558519|Thioguanine|thioguanine|mesh-list
102458878|NCT00558519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102458879|NCT00558519|Immunologic Factors|immunologic factors|mesh-ancestor
102458880|NCT00558519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458881|NCT00558519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102458882|NCT00558519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102458883|NCT00558519|Alkylating Agents|alkylating agents|mesh-ancestor
102458884|NCT00558519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458885|NCT00558519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102458886|NCT00558519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102458887|NCT00558519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102458888|NCT00558519|Antiemetics|antiemetics|mesh-ancestor
102458889|NCT00558519|Autonomic Agents|autonomic agents|mesh-ancestor
102458890|NCT00558519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102458891|NCT00558519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102458892|NCT00558519|Glucocorticoids|glucocorticoids|mesh-ancestor
102458893|NCT00558519|Hormones|hormones|mesh-ancestor
102458894|NCT00558519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102458895|NCT00558519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102458896|NCT00558519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102458897|NCT00558519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102458898|NCT00558519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102458899|NCT00558519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102458900|NCT00558519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102458901|NCT00558519|Abortifacient Agents|abortifacient agents|mesh-ancestor
102458902|NCT00558519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102458903|NCT00558519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102458904|NCT00558519|Antimetabolites|antimetabolites|mesh-ancestor
102458905|NCT00558519|Dermatologic Agents|dermatologic agents|mesh-ancestor
102458906|NCT00558519|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102458907|NCT00558519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102458908|NCT00558519|Antiviral Agents|antiviral agents|mesh-ancestor
102458909|NCT00558519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102458910|NCT00558519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102458911|NCT00558519|Tubulin Modulators|tubulin modulators|mesh-ancestor
102458912|NCT00558519|Antimitotic Agents|antimitotic agents|mesh-ancestor
102458913|NCT00558519|Mitosis Modulators|mitosis modulators|mesh-ancestor
102458914|NCT00403117|Naltrexone|naltrexone|mesh-list
102458915|NCT00403117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102458916|NCT00403117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102458917|NCT00403117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458918|NCT00403117|Sensory System Agents|sensory system agents|mesh-ancestor
102458919|NCT00403117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102458920|NCT00558285|Glycopyrrolate|glycopyrrolate|mesh-list
102458921|NCT00558285|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102458922|NCT00558285|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102458923|NCT00558285|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102458924|NCT00558285|Cholinergic Agents|cholinergic agents|mesh-ancestor
102458925|NCT00558285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102458926|NCT00558285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458927|NCT00558285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458928|NCT01389596|Pregabalin|pregabalin|mesh-list
102458929|NCT01389596|Analgesics|analgesics|mesh-ancestor
102458930|NCT01389596|Sensory System Agents|sensory system agents|mesh-ancestor
102458931|NCT01389596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102458932|NCT01389596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458933|NCT01389596|Anticonvulsants|anticonvulsants|mesh-ancestor
102458934|NCT01389596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102458935|NCT01389596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102458936|NCT01389596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458937|NCT01389596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102458938|NCT01389596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102458939|NCT01389596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102458940|NCT01389596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102458941|NCT01389596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102458942|NCT00558207|Gemcitabine|gemcitabine|mesh-list
102458943|NCT00558207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102458944|NCT00558207|Antimetabolites|antimetabolites|mesh-ancestor
102458945|NCT00558207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458946|NCT00558207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102458947|NCT00407485|Aflibercept|aflibercept|mesh-list
102458948|NCT00407485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102458949|NCT00407485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102458950|NCT00407485|Growth Substances|growth substances|mesh-ancestor
102458951|NCT00407485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458952|NCT00407485|Growth Inhibitors|growth inhibitors|mesh-ancestor
102458953|NCT00407485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102458954|NCT00354887|Capecitabine|capecitabine|mesh-list
102458955|NCT00354887|Oxaliplatin|oxaliplatin|mesh-list
102458956|NCT00354887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102458957|NCT00354887|Antimetabolites|antimetabolites|mesh-ancestor
102089059|NCT02191332|Nevirapine|nevirapine|mesh-list
102458958|NCT00354887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458959|NCT00354887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102458960|NCT02111863|Aldesleukin|aldesleukin|mesh-list
102458961|NCT02111863|Cyclophosphamide|cyclophosphamide|mesh-list
102458962|NCT02111863|Fludarabine|fludarabine|mesh-list
102458963|NCT02111863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102458964|NCT02111863|Immunologic Factors|immunologic factors|mesh-ancestor
102458965|NCT02111863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458966|NCT02111863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102458967|NCT02111863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102458968|NCT02111863|Alkylating Agents|alkylating agents|mesh-ancestor
102458969|NCT02111863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458970|NCT02111863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102458971|NCT02111863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102458972|NCT02111863|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102458973|NCT02111863|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102458974|NCT02111863|Antiviral Agents|antiviral agents|mesh-ancestor
102458975|NCT02111863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102458976|NCT02660411|Propofol|propofol|mesh-list
102458977|NCT02660411|Sevoflurane|sevoflurane|mesh-list
102458978|NCT02660411|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102458979|NCT02660411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102458980|NCT02660411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458981|NCT02660411|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102458982|NCT02660411|Anesthetics, General|anesthetics, general|mesh-ancestor
102458983|NCT02660411|Anesthetics|anesthetics|mesh-ancestor
102458984|NCT02660411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102458985|NCT02660411|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102458986|NCT02078492|Ketorolac|ketorolac|mesh-list
102458987|NCT02078492|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102458988|NCT02078492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102458989|NCT02078492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102458990|NCT02078492|Analgesics|analgesics|mesh-ancestor
102458991|NCT02078492|Sensory System Agents|sensory system agents|mesh-ancestor
102458992|NCT02078492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102458993|NCT02078492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102458994|NCT02078492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102458995|NCT02078492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102458996|NCT02078492|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102458997|NCT02078492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102458998|NCT02078492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102458999|NCT02988921|Paclitaxel|paclitaxel|mesh-list
102459000|NCT02988921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102459001|NCT02988921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459002|NCT02988921|Tubulin Modulators|tubulin modulators|mesh-ancestor
102459003|NCT02988921|Antimitotic Agents|antimitotic agents|mesh-ancestor
102459004|NCT02988921|Mitosis Modulators|mitosis modulators|mesh-ancestor
102459005|NCT02988921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459006|NCT04528563|Ketorolac|ketorolac|mesh-list
102459007|NCT04528563|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102459008|NCT04528563|Morphine|morphine|mesh-list
102459009|NCT04528563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102459010|NCT04528563|Narcotics|narcotics|mesh-ancestor
102459011|NCT04528563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102459012|NCT04528563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459013|NCT04528563|Analgesics|analgesics|mesh-ancestor
102459014|NCT04528563|Sensory System Agents|sensory system agents|mesh-ancestor
102459015|NCT04528563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102459016|NCT04528563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102459017|NCT04528563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102459018|NCT04528563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102459019|NCT04528563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102459020|NCT04528563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102459021|NCT04528563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102459022|NCT04528563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459023|NCT00355199|Rituximab|rituximab|mesh-list
102459024|NCT00355199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102459025|NCT00355199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459026|NCT00355199|Immunologic Factors|immunologic factors|mesh-ancestor
102459027|NCT00355199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459028|NCT00355199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102459029|NCT01791647|Inositol|inositol|mesh-list
102459030|NCT01791647|Metformin|metformin|mesh-list
102459031|NCT01791647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102459032|NCT01791647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459033|NCT01791647|Vitamin B Complex|vitamin b complex|mesh-ancestor
102459034|NCT01791647|Vitamins|vitamins|mesh-ancestor
102459035|NCT01791647|Micronutrients|micronutrients|mesh-ancestor
102459036|NCT00363883|Vorinostat|vorinostat|mesh-list
102459037|NCT00363883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459038|NCT00363883|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102459039|NCT00363883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102459040|NCT00363883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459041|NCT00364819|Rituximab|rituximab|mesh-list
102459042|NCT00364819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102459043|NCT00364819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459044|NCT00364819|Immunologic Factors|immunologic factors|mesh-ancestor
102459045|NCT00364819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459046|NCT00364819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102459047|NCT04524351|Phenserine|phenserine|mesh-list
102459048|NCT04524351|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102459049|NCT04524351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102459050|NCT04524351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459051|NCT04524351|Cholinergic Agents|cholinergic agents|mesh-ancestor
102459052|NCT04524351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102459053|NCT04524351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459054|NCT04523961|Lidocaine|lidocaine|mesh-list
102459055|NCT04523961|Tetracaine|tetracaine|mesh-list
102459056|NCT04523961|Prilocaine|prilocaine|mesh-list
102459057|NCT04523961|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
102459058|NCT04523961|Anesthetics, Local|anesthetics, local|mesh-ancestor
102459059|NCT04523961|Anesthetics|anesthetics|mesh-ancestor
102459060|NCT04523961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102459061|NCT04523961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459062|NCT04523961|Sensory System Agents|sensory system agents|mesh-ancestor
102459063|NCT04523961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102459064|NCT04523961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102459065|NCT04523961|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102459066|NCT04523961|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102459067|NCT04523961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102459068|NCT04523961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459069|NCT04523961|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
102459070|NCT01792505|Imiquimod|imiquimod|mesh-list
102459071|NCT01792505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102459072|NCT01792505|Immunologic Factors|immunologic factors|mesh-ancestor
102459073|NCT01792505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459074|NCT01792505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459075|NCT01792505|Interferon Inducers|interferon inducers|mesh-ancestor
102459076|NCT00365053|Belinostat|belinostat|mesh-list
102459077|NCT00365053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459078|NCT00365053|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102459079|NCT00365053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102459080|NCT00365053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459081|NCT00555789|Tacrolimus|tacrolimus|mesh-list
102459082|NCT00555789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102459083|NCT00555789|Immunologic Factors|immunologic factors|mesh-ancestor
102459084|NCT00555789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459085|NCT00555789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102459086|NCT00555789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102459087|NCT00555789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459088|NCT04288895|Vortioxetine|vortioxetine|mesh-list
102459089|NCT04288895|Antidepressive Agents|antidepressive agents|mesh-ancestor
102459090|NCT04288895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102459091|NCT04288895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102459092|NCT04288895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102459093|NCT04288895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102459094|NCT04288895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459095|NCT04288895|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102459096|NCT04288895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102459097|NCT04288895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102459098|NCT04288895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459099|NCT04288895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102459100|NCT04288895|Serotonin Agents|serotonin agents|mesh-ancestor
102459101|NCT04288895|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102459102|NCT04288895|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102459103|NCT04288895|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102459104|NCT04288895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102459105|NCT00365209|Curcumin|curcumin|mesh-list
102459106|NCT00365209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102459107|NCT00365209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102459108|NCT00365209|Analgesics|analgesics|mesh-ancestor
102459109|NCT00365209|Sensory System Agents|sensory system agents|mesh-ancestor
102459110|NCT00365209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102459111|NCT00365209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459113|NCT00365209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102459114|NCT00365209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459115|NCT00365209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102459116|NCT00365209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459117|NCT00409825|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
102459118|NCT00409825|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
102459119|NCT00409825|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102459120|NCT00409825|Hormone Antagonists|hormone antagonists|mesh-ancestor
102459121|NCT00409825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102459122|NCT00409825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459123|NCT00409825|Progestins|progestins|mesh-ancestor
102459124|NCT00409825|Hormones|hormones|mesh-ancestor
102459125|NCT00410059|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102459126|NCT00410059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459127|NCT00410059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102459128|NCT00410059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102459129|NCT00410059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459130|NCT04749069|Remifentanil|remifentanil|mesh-list
102459131|NCT04749069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102459132|NCT04749069|Narcotics|narcotics|mesh-ancestor
102459133|NCT04749069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102459134|NCT04749069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459135|NCT04749069|Analgesics|analgesics|mesh-ancestor
102459136|NCT04749069|Sensory System Agents|sensory system agents|mesh-ancestor
102459137|NCT04749069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102459138|NCT00411463|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102459139|NCT00411463|Antidepressive Agents|antidepressive agents|mesh-ancestor
102459140|NCT00411463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102459141|NCT00411463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102459142|NCT00411463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102459143|NCT00411463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102459144|NCT00411463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459145|NCT03239015|Trastuzumab|trastuzumab|mesh-list
102459146|NCT03239015|Everolimus|everolimus|mesh-list
102459147|NCT03239015|Olaparib|olaparib|mesh-list
102459148|NCT03239015|Palbociclib|palbociclib|mesh-list
102459149|NCT03239015|Gefitinib|gefitinib|mesh-list
102459150|NCT03239015|Afatinib|afatinib|mesh-list
102459151|NCT03239015|Vemurafenib|vemurafenib|mesh-list
102459152|NCT03239015|Dabrafenib|dabrafenib|mesh-list
102459153|NCT03239015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
102459154|NCT03239015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102459155|NCT03239015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459156|NCT03239015|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102459157|NCT03239015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102459158|NCT03239015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102459159|NCT03239015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459160|NCT03239015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102459161|NCT03239015|Immunologic Factors|immunologic factors|mesh-ancestor
102459162|NCT03239015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459163|NCT03239015|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102459164|NCT03239015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102459165|NCT03239015|Growth Substances|growth substances|mesh-ancestor
102459166|NCT03239015|Growth Inhibitors|growth inhibitors|mesh-ancestor
102459167|NCT00356993|Nicotine|nicotine|mesh-list
102459168|NCT00356993|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102459169|NCT00356993|Autonomic Agents|autonomic agents|mesh-ancestor
102459170|NCT00356993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102459171|NCT00356993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459172|NCT00356993|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102459173|NCT00356993|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102459174|NCT00356993|Cholinergic Agents|cholinergic agents|mesh-ancestor
102459175|NCT00356993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102459176|NCT00356993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459177|NCT01793077|Leuprolide|leuprolide|mesh-list
102459178|NCT01793077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102459179|NCT01793077|Fertility Agents|fertility agents|mesh-ancestor
102459180|NCT01793077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102459181|NCT01793077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459182|NCT01793077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102459183|NCT01793077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459184|NCT00555477|Anastrozole|anastrozole|mesh-list
102459185|NCT00555477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102459186|NCT00555477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459187|NCT00555477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102459188|NCT00555477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102459189|NCT00555477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102459190|NCT00555477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459191|NCT00555477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102459192|NCT00555477|Hormone Antagonists|hormone antagonists|mesh-ancestor
102459193|NCT00555477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102459194|NCT00555477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459195|NCT00365599|Tamoxifen|tamoxifen|mesh-list
102459196|NCT00365599|Vorinostat|vorinostat|mesh-list
102459197|NCT00365599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459198|NCT00365599|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102459199|NCT00365599|Hormone Antagonists|hormone antagonists|mesh-ancestor
102459200|NCT00365599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102459201|NCT00365599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459202|NCT00365599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102459203|NCT00365599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459204|NCT00365599|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102459205|NCT00365599|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102459206|NCT00365599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102459207|NCT00365599|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102459208|NCT00365599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102459209|NCT00554619|Ambrisentan|ambrisentan|mesh-list
102459210|NCT00554619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102459211|NCT02104739|Exenatide|exenatide|mesh-list
102459212|NCT02104739|Saxagliptin|saxagliptin|mesh-list
102459213|NCT02104739|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102459214|NCT02104739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459215|NCT02104739|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102459216|NCT02104739|Incretins|incretins|mesh-ancestor
102459217|NCT02104739|Hormones|hormones|mesh-ancestor
102459218|NCT02104739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102459219|NCT02104739|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102459220|NCT02104739|Protease Inhibitors|protease inhibitors|mesh-ancestor
102459221|NCT02104739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102089376|NCT02197026|Hylan|hylan|mesh-list
102459222|NCT02104739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459223|NCT00411619|Everolimus|everolimus|mesh-list
102459224|NCT00411619|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102459225|NCT00411619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102459226|NCT00411619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102459227|NCT00411619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459228|NCT00411619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102459229|NCT00411619|Immunologic Factors|immunologic factors|mesh-ancestor
102459230|NCT00411619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459231|NCT00411619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459232|NCT00412087|Vitamin D|vitamin d|mesh-list
102459233|NCT00412087|Ergocalciferols|ergocalciferols|mesh-list
102459234|NCT00412087|Cholecalciferol|cholecalciferol|mesh-list
102459235|NCT00412087|Vitamins|vitamins|mesh-list
102459236|NCT00412087|Micronutrients|micronutrients|mesh-ancestor
102459237|NCT00412087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459238|NCT00412087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102459239|NCT00412087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102459240|NCT00312923|Policosanol|policosanol|mesh-list
102459241|NCT00312923|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102459242|NCT00312923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102459243|NCT00312923|Antimetabolites|antimetabolites|mesh-ancestor
102459244|NCT00312923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459245|NCT00312923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102459246|NCT00312923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102459247|NCT00412243|Cyclophosphamide|cyclophosphamide|mesh-list
102459248|NCT00412243|Clofarabine|clofarabine|mesh-list
102459249|NCT00412243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102459250|NCT00412243|Immunologic Factors|immunologic factors|mesh-ancestor
102459251|NCT00412243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459252|NCT00412243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102459253|NCT00412243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102459254|NCT00412243|Alkylating Agents|alkylating agents|mesh-ancestor
102459255|NCT00412243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459256|NCT00412243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459257|NCT00412243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102459258|NCT00412243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102459259|NCT00412243|Antimetabolites|antimetabolites|mesh-ancestor
102459260|NCT01426412|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102459261|NCT01426412|Immunologic Factors|immunologic factors|mesh-ancestor
102459262|NCT01426412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459263|NCT00315341|Buprenorphine|buprenorphine|mesh-list
102459265|NCT00315341|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102459266|NCT00315341|Naloxone|naloxone|mesh-list
102459267|NCT00315341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102459268|NCT00315341|Narcotics|narcotics|mesh-ancestor
102459269|NCT00315341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102459270|NCT00315341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459271|NCT00315341|Analgesics|analgesics|mesh-ancestor
102459272|NCT00315341|Sensory System Agents|sensory system agents|mesh-ancestor
102459273|NCT00315341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102459274|NCT00315341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102459275|NCT00315341|Antitussive Agents|antitussive agents|mesh-ancestor
102459276|NCT00315341|Respiratory System Agents|respiratory system agents|mesh-ancestor
102459277|NCT02277249|Digoxin|digoxin|mesh-list
102459278|NCT02277249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102459279|NCT02277249|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102459280|NCT02277249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102459281|NCT02277249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459282|NCT02277249|Protective Agents|protective agents|mesh-ancestor
102459283|NCT02277249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459284|NCT04767542|Acetaminophen|acetaminophen|mesh-list
102089380|NCT02197104|Choline|choline|mesh-list
102459285|NCT04767542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459286|NCT04767542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102459287|NCT04767542|Analgesics|analgesics|mesh-ancestor
102459288|NCT04767542|Sensory System Agents|sensory system agents|mesh-ancestor
102459289|NCT04767542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102459290|NCT04767542|Antipyretics|antipyretics|mesh-ancestor
102459291|NCT01794533|Lidocaine|lidocaine|mesh-list
102459292|NCT01794533|Epinephrine|epinephrine|mesh-list
102459293|NCT01794533|Racepinephrine|racepinephrine|mesh-list
102459294|NCT01794533|Fentanyl|fentanyl|mesh-list
102459295|NCT01794533|Epinephryl borate|epinephryl borate|mesh-list
102459296|NCT01794533|Anesthetics, Local|anesthetics, local|mesh-ancestor
102459297|NCT01794533|Anesthetics|anesthetics|mesh-ancestor
102459298|NCT01794533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102459299|NCT01794533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459300|NCT01794533|Sensory System Agents|sensory system agents|mesh-ancestor
102459301|NCT01794533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102459302|NCT01794533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102459303|NCT01794533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102459304|NCT01794533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102459305|NCT01794533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102459306|NCT01794533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459307|NCT01794533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102459308|NCT01794533|Narcotics|narcotics|mesh-ancestor
102459309|NCT01794533|Analgesics|analgesics|mesh-ancestor
102459310|NCT01794533|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102459311|NCT01794533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102459312|NCT01794533|Anesthetics, General|anesthetics, general|mesh-ancestor
102459313|NCT01794533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102459314|NCT01794533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102459315|NCT01794533|Adrenergic Agents|adrenergic agents|mesh-ancestor
102459316|NCT01794533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102459317|NCT01794533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102459318|NCT01794533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102459319|NCT01794533|Autonomic Agents|autonomic agents|mesh-ancestor
102459320|NCT01794533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102459321|NCT01794533|Respiratory System Agents|respiratory system agents|mesh-ancestor
102459322|NCT01794533|Mydriatics|mydriatics|mesh-ancestor
102459323|NCT01794533|Sympathomimetics|sympathomimetics|mesh-ancestor
102459324|NCT01794533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102459325|NCT00412867|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102459326|NCT00412867|Plasminogen|plasminogen|mesh-list
102459327|NCT00412867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102459328|NCT00412867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102459329|NCT00412867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459330|NCT01730833|Paclitaxel|paclitaxel|mesh-list
102459331|NCT01730833|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102459332|NCT01730833|Trastuzumab|trastuzumab|mesh-list
102459333|NCT01730833|Pertuzumab|pertuzumab|mesh-list
102459334|NCT01730833|Antibodies|antibodies|mesh-list
102459335|NCT01730833|Immunoglobulins|immunoglobulins|mesh-list
102459336|NCT01730833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102459337|NCT01730833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459338|NCT01730833|Tubulin Modulators|tubulin modulators|mesh-ancestor
102459339|NCT01730833|Antimitotic Agents|antimitotic agents|mesh-ancestor
102459340|NCT01730833|Mitosis Modulators|mitosis modulators|mesh-ancestor
102459341|NCT01730833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459342|NCT01730833|Immunologic Factors|immunologic factors|mesh-ancestor
102459343|NCT01730833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459344|NCT01730833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102459345|NCT00413335|Rosiglitazone|rosiglitazone|mesh-list
102459346|NCT00413335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102459347|NCT00413335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459348|NCT00414271|Docetaxel|docetaxel|mesh-list
102459349|NCT00414271|Capecitabine|capecitabine|mesh-list
102459350|NCT00414271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459351|NCT00414271|Tubulin Modulators|tubulin modulators|mesh-ancestor
102459352|NCT00414271|Antimitotic Agents|antimitotic agents|mesh-ancestor
102459353|NCT00414271|Mitosis Modulators|mitosis modulators|mesh-ancestor
102459354|NCT00414271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459355|NCT00414271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102459356|NCT00414271|Antimetabolites|antimetabolites|mesh-ancestor
102459357|NCT00360971|Cisplatin|cisplatin|mesh-list
102459358|NCT00360971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459359|NCT01791881|Botulinum Toxins|botulinum toxins|mesh-list
102459360|NCT01791881|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102459361|NCT01791881|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102459362|NCT01791881|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102459363|NCT01791881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102459364|NCT01791881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459365|NCT01791881|Cholinergic Agents|cholinergic agents|mesh-ancestor
102459366|NCT01791881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102459367|NCT01791881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459368|NCT01791881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102459369|NCT01791881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102459370|NCT03636503|Rituximab|rituximab|mesh-list
102459371|NCT03636503|Avelumab|avelumab|mesh-list
102459372|NCT03636503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102459373|NCT03636503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459374|NCT03636503|Immunologic Factors|immunologic factors|mesh-ancestor
102459375|NCT03636503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459376|NCT03636503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102459377|NCT03448159|Fluoxetine|fluoxetine|mesh-list
102459378|NCT03448159|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102459379|NCT03448159|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102459380|NCT03448159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102459381|NCT03448159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459382|NCT03448159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102459383|NCT03448159|Serotonin Agents|serotonin agents|mesh-ancestor
102459384|NCT03448159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459385|NCT03448159|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102459386|NCT03448159|Antidepressive Agents|antidepressive agents|mesh-ancestor
102459387|NCT03448159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102459388|NCT03448159|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102459389|NCT03448159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102459390|NCT03448159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102459391|NCT00361439|Mometasone Furoate|mometasone furoate|mesh-list
102459392|NCT00361439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102459393|NCT00361439|Dermatologic Agents|dermatologic agents|mesh-ancestor
102459394|NCT00361439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102459395|NCT00361595|Zoledronic Acid|zoledronic acid|mesh-list
102459396|NCT00361595|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102459397|NCT00361595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459398|NCT03438487|Vaccines|vaccines|mesh-list
102459399|NCT03438487|Immunologic Factors|immunologic factors|mesh-ancestor
102459400|NCT03438487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459401|NCT03458117|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
102459402|NCT03458117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102459403|NCT03458117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459404|NCT01792037|Methylprednisolone|methylprednisolone|mesh-list
102459405|NCT01792037|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102459406|NCT01792037|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102459407|NCT01792037|Prednisolone|prednisolone|mesh-list
102459408|NCT01792037|Prednisolone acetate|prednisolone acetate|mesh-list
102459409|NCT01792037|Midazolam|midazolam|mesh-list
102459410|NCT01792037|Etomidate|etomidate|mesh-list
102459411|NCT01792037|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102459412|NCT01792037|Prednisolone phosphate|prednisolone phosphate|mesh-list
102459413|NCT01792037|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102459414|NCT01792037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102459415|NCT01792037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102089505|NCT01340937|Immunologic Factors|immunologic factors|mesh-ancestor
102459416|NCT01792037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459417|NCT01792037|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102459418|NCT01792037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102459419|NCT01792037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102459420|NCT01792037|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101391382|NCT05137067|Antimitotic Agents|antimitotic agents|mesh-ancestor
101391383|NCT05137067|Mitosis Modulators|mitosis modulators|mesh-ancestor
102459421|NCT01792037|Anesthetics, General|anesthetics, general|mesh-ancestor
102459423|NCT01792037|GABA Modulators|gaba modulators|mesh-ancestor
102459424|NCT01792037|GABA Agents|gaba agents|mesh-ancestor
102459425|NCT01792037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102459426|NCT01792037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459427|NCT01792037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102459428|NCT01792037|Antiemetics|antiemetics|mesh-ancestor
102459429|NCT01792037|Autonomic Agents|autonomic agents|mesh-ancestor
102459430|NCT01792037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102459431|NCT01792037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102459432|NCT01792037|Glucocorticoids|glucocorticoids|mesh-ancestor
102459433|NCT01792037|Hormones|hormones|mesh-ancestor
102459434|NCT01792037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102459435|NCT01792037|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102459436|NCT01792037|Protective Agents|protective agents|mesh-ancestor
102459437|NCT01792037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102459438|NCT01792037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459439|NCT00373399|Dronabinol|dronabinol|mesh-list
102459440|NCT00373399|Hallucinogens|hallucinogens|mesh-ancestor
102459441|NCT00373399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459442|NCT00373399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102459443|NCT00373399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102459444|NCT00373399|Analgesics|analgesics|mesh-ancestor
102459445|NCT00373399|Sensory System Agents|sensory system agents|mesh-ancestor
102459446|NCT00373399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102459447|NCT00373399|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102459448|NCT00373399|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102459449|NCT00373399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102459450|NCT00373399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459451|NCT00373399|Hormones|hormones|mesh-ancestor
102459452|NCT00373399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102459453|NCT00318929|Valproic Acid|valproic acid|mesh-list
102459454|NCT00318929|Anticonvulsants|anticonvulsants|mesh-ancestor
102459455|NCT00318929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102459456|NCT00318929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459457|NCT00318929|GABA Agents|gaba agents|mesh-ancestor
102459458|NCT00318929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102459459|NCT00318929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459460|NCT00318929|Antimanic Agents|antimanic agents|mesh-ancestor
102459461|NCT00318929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102459462|NCT00318929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102459463|NCT00318929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102459464|NCT00418093|Bevacizumab|bevacizumab|mesh-list
102459465|NCT00418093|Gemcitabine|gemcitabine|mesh-list
102459466|NCT00418093|Oxaliplatin|oxaliplatin|mesh-list
102459467|NCT00418093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102459468|NCT00418093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459469|NCT00418093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102459470|NCT00418093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102459471|NCT00418093|Growth Substances|growth substances|mesh-ancestor
102459472|NCT00418093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459473|NCT00418093|Growth Inhibitors|growth inhibitors|mesh-ancestor
102459474|NCT00418093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102459475|NCT00418093|Antimetabolites|antimetabolites|mesh-ancestor
102459476|NCT00418093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459477|NCT03855371|Decitabine|decitabine|mesh-list
102459478|NCT03855371|Arsenic Trioxide|arsenic trioxide|mesh-list
102459479|NCT03855371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102459480|NCT03855371|Antimetabolites|antimetabolites|mesh-ancestor
102459481|NCT03855371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459482|NCT03855371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459483|NCT03855371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102459484|NCT03284723|Letrozole|letrozole|mesh-list
102459485|NCT03284723|Palbociclib|palbociclib|mesh-list
102459486|NCT03284723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459487|NCT03284723|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102459488|NCT03284723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102459489|NCT03284723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102459490|NCT03284723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459491|NCT03284723|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102459492|NCT03284723|Hormone Antagonists|hormone antagonists|mesh-ancestor
102459493|NCT03284723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102459494|NCT03284723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459495|NCT03284723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102459496|NCT00374803|Mycophenolic Acid|mycophenolic acid|mesh-list
102459497|NCT00374803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102459498|NCT00374803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459499|NCT00374803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102459500|NCT00374803|Antitubercular Agents|antitubercular agents|mesh-ancestor
102459501|NCT00374803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102459502|NCT00374803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102459503|NCT00374803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102459504|NCT00374803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459505|NCT00418951|Voriconazole|voriconazole|mesh-list
102459506|NCT00418951|Amphotericin B|amphotericin b|mesh-list
102459507|NCT00418951|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102459508|NCT00418951|Antifungal Agents|antifungal agents|mesh-ancestor
102459509|NCT00418951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102459510|NCT00418951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102459511|NCT00418951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102459512|NCT00418951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102459513|NCT00418951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459514|NCT00418951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102459515|NCT00418951|Hormone Antagonists|hormone antagonists|mesh-ancestor
102459516|NCT00418951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102459517|NCT00418951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459518|NCT00418951|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102459519|NCT00418951|Amebicides|amebicides|mesh-ancestor
102459520|NCT00418951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102459521|NCT00418951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102459522|NCT00418951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102459523|NCT00363077|Vaccines|vaccines|mesh-list
102459524|NCT00363077|Immunologic Factors|immunologic factors|mesh-ancestor
102459525|NCT00363077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459526|NCT00375973|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102459527|NCT00375973|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102459528|NCT00375973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102459529|NCT00375973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102459530|NCT00375973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459531|NCT00375973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102459532|NCT00375973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459533|NCT00375973|Analgesics|analgesics|mesh-ancestor
102459534|NCT00375973|Sensory System Agents|sensory system agents|mesh-ancestor
102459535|NCT00375973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102459536|NCT00375973|Antidepressive Agents|antidepressive agents|mesh-ancestor
102459537|NCT00375973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102459538|NCT00375973|Dopamine Agents|dopamine agents|mesh-ancestor
102459539|NCT00421603|Topiramate|topiramate|mesh-list
102459540|NCT00421603|Adderall|adderall|mesh-list
102459541|NCT00421603|Anticonvulsants|anticonvulsants|mesh-ancestor
102459542|NCT00421603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102459543|NCT00421603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459544|NCT00421603|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102459545|NCT00363779|Cyclosporine|cyclosporine|mesh-list
102459546|NCT00363779|Cyclosporins|cyclosporins|mesh-list
102459547|NCT00363779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102459548|NCT00363779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459549|NCT00363779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102459550|NCT00363779|Immunologic Factors|immunologic factors|mesh-ancestor
102459551|NCT00363779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459552|NCT00363779|Antifungal Agents|antifungal agents|mesh-ancestor
102459553|NCT00363779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102459554|NCT00363779|Dermatologic Agents|dermatologic agents|mesh-ancestor
102459555|NCT00363779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102459556|NCT00363779|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102459557|NCT01405820|Natalizumab|natalizumab|mesh-list
102459558|NCT01405820|Immunologic Factors|immunologic factors|mesh-ancestor
102459559|NCT01405820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459560|NCT01405742|Factor VIII|factor viii|mesh-list
102459561|NCT01405742|Coagulants|coagulants|mesh-ancestor
102459562|NCT01794767|Heparin|heparin|mesh-list
102459563|NCT01794767|Calcium heparin|calcium heparin|mesh-list
102459564|NCT01794767|Anticoagulants|anticoagulants|mesh-ancestor
102459565|NCT01794767|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102459566|NCT01794767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102459567|NCT01794767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459568|NCT01425632|Bepotastine besilate|bepotastine besilate|mesh-list
102459569|NCT01425632|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102459570|NCT02076152|Bevacizumab|bevacizumab|mesh-list
102459571|NCT02076152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102459572|NCT02076152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459573|NCT02076152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102459574|NCT02076152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102459575|NCT02076152|Growth Substances|growth substances|mesh-ancestor
102459576|NCT02076152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459577|NCT02076152|Growth Inhibitors|growth inhibitors|mesh-ancestor
102459578|NCT03025958|Nimotuzumab|nimotuzumab|mesh-list
102459579|NCT03025958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102459580|NCT03025958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459581|NCT00380029|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102459582|NCT00380029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459583|NCT00380029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102459584|NCT00380029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102459585|NCT00380029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459586|NCT01405508|Brivaracetam|brivaracetam|mesh-list
102459587|NCT01405508|Anticonvulsants|anticonvulsants|mesh-ancestor
102459588|NCT00426283|Fluticasone|fluticasone|mesh-list
102459589|NCT00426283|Xhance|xhance|mesh-list
102459590|NCT00426283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102459591|NCT00426283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102459592|NCT00426283|Autonomic Agents|autonomic agents|mesh-ancestor
102459593|NCT00426283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102459594|NCT00426283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459595|NCT00426283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102459596|NCT00426283|Respiratory System Agents|respiratory system agents|mesh-ancestor
102459597|NCT00426283|Dermatologic Agents|dermatologic agents|mesh-ancestor
102459598|NCT00426283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102459599|NCT00322439|Etanercept|etanercept|mesh-list
102459600|NCT00322439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102459601|NCT00322439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102459602|NCT00322439|Analgesics|analgesics|mesh-ancestor
102459603|NCT00322439|Sensory System Agents|sensory system agents|mesh-ancestor
102459604|NCT00322439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102459605|NCT00322439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459606|NCT00322439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102459607|NCT00322439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102459608|NCT00322439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102459609|NCT00322439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102459610|NCT00322439|Immunologic Factors|immunologic factors|mesh-ancestor
102459611|NCT01795027|Oxaliplatin|oxaliplatin|mesh-list
102459612|NCT01795027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459613|NCT00365261|Eszopiclone|eszopiclone|mesh-list
102459614|NCT00365261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102459615|NCT00365261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102459616|NCT00365261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459617|NCT00426517|Sirolimus|sirolimus|mesh-list
102459618|NCT00426517|Busulfan|busulfan|mesh-list
102459619|NCT00426517|Alemtuzumab|alemtuzumab|mesh-list
102459620|NCT00426517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102459621|NCT00426517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102459622|NCT00426517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102459623|NCT00426517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459624|NCT00426517|Antifungal Agents|antifungal agents|mesh-ancestor
102459625|NCT00426517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102459626|NCT00426517|Immunologic Factors|immunologic factors|mesh-ancestor
102459627|NCT00426517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459628|NCT00426517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459629|NCT00426517|Alkylating Agents|alkylating agents|mesh-ancestor
102459630|NCT00426517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102459631|NCT00426517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102271186|NCT05915260|Adenosine|adenosine|mesh-list
102459632|NCT00426517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102459633|NCT00365417|Cyclophosphamide|cyclophosphamide|mesh-list
102459634|NCT00365417|Bevacizumab|bevacizumab|mesh-list
102459635|NCT00365417|Docetaxel|docetaxel|mesh-list
102459636|NCT00365417|Doxorubicin|doxorubicin|mesh-list
102459637|NCT00365417|Capecitabine|capecitabine|mesh-list
102459638|NCT00365417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102459639|NCT00365417|Immunologic Factors|immunologic factors|mesh-ancestor
102459640|NCT00365417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459641|NCT00365417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102459642|NCT00365417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102459643|NCT00365417|Alkylating Agents|alkylating agents|mesh-ancestor
102459644|NCT00365417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459645|NCT00365417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459646|NCT00365417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102459647|NCT00365417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102459648|NCT00365417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102459649|NCT00365417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102459650|NCT00365417|Growth Substances|growth substances|mesh-ancestor
102459651|NCT00365417|Growth Inhibitors|growth inhibitors|mesh-ancestor
102459652|NCT00365417|Tubulin Modulators|tubulin modulators|mesh-ancestor
102459653|NCT00365417|Antimitotic Agents|antimitotic agents|mesh-ancestor
102459654|NCT00365417|Mitosis Modulators|mitosis modulators|mesh-ancestor
102459655|NCT00365417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102459656|NCT00365417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102459657|NCT00365417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102459658|NCT00365417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102459659|NCT00365417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102459660|NCT00365417|Antimetabolites|antimetabolites|mesh-ancestor
102459661|NCT00427297|Ritonavir|ritonavir|mesh-list
102459662|NCT00427297|Lopinavir|lopinavir|mesh-list
102459663|NCT00427297|Tenofovir|tenofovir|mesh-list
102459664|NCT00427297|Lamivudine|lamivudine|mesh-list
102459665|NCT00427297|Zidovudine|zidovudine|mesh-list
102459666|NCT00427297|Nevirapine|nevirapine|mesh-list
102459667|NCT00427297|Abacavir|abacavir|mesh-list
102459668|NCT00427297|Stavudine|stavudine|mesh-list
102459669|NCT00427297|Didanosine|didanosine|mesh-list
102459670|NCT00427297|Efavirenz|efavirenz|mesh-list
102459671|NCT00427297|Dideoxynucleosides|dideoxynucleosides|mesh-list
102459672|NCT00427297|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102459673|NCT00427297|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102459674|NCT00427297|Protease Inhibitors|protease inhibitors|mesh-ancestor
102459675|NCT00427297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102459676|NCT00427297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459677|NCT00427297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102459678|NCT00427297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102459679|NCT00427297|Antiviral Agents|antiviral agents|mesh-ancestor
102459680|NCT00427297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102459681|NCT00427297|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102459682|NCT00427297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102459683|NCT00427297|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102459684|NCT00427297|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102459685|NCT00427297|Antimetabolites|antimetabolites|mesh-ancestor
102459686|NCT00427297|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102459687|NCT00427297|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102459688|NCT00427297|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102459689|NCT00427297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102459690|NCT00427297|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102459691|NCT00427765|Melphalan|melphalan|mesh-list
102459692|NCT00427765|Busulfan|busulfan|mesh-list
102459693|NCT00427765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102459694|NCT00427765|Alkylating Agents|alkylating agents|mesh-ancestor
102459695|NCT00427765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459696|NCT00427765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459697|NCT00427765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102459698|NCT00427765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102459699|NCT00427765|Immunologic Factors|immunologic factors|mesh-ancestor
102459700|NCT00427765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459701|NCT04346017|Complement System Proteins|complement system proteins|mesh-list
102459702|NCT04346017|Immunologic Factors|immunologic factors|mesh-ancestor
102459703|NCT04346017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459704|NCT00384865|Aspirin|aspirin|mesh-list
102459705|NCT00384865|Simvastatin|simvastatin|mesh-list
102459706|NCT00384865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102459707|NCT00384865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102459708|NCT00384865|Analgesics|analgesics|mesh-ancestor
102271256|NCT05914701|Letermovir|letermovir|mesh-list
102459709|NCT00384865|Sensory System Agents|sensory system agents|mesh-ancestor
102459710|NCT00384865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102459711|NCT00384865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459712|NCT00384865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102459713|NCT00384865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102459714|NCT00384865|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102459715|NCT00384865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102459716|NCT00384865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459717|NCT00384865|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102459718|NCT00384865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102459719|NCT00384865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102459721|NCT00384865|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102459722|NCT00384865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102459723|NCT00384865|Antimetabolites|antimetabolites|mesh-ancestor
102459724|NCT00384865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102459725|NCT00384865|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102459726|NCT00367601|Bevacizumab|bevacizumab|mesh-list
102459727|NCT00367601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102459728|NCT00367601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102459729|NCT00367601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459730|NCT00367601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102459731|NCT00367601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102459732|NCT00367601|Growth Substances|growth substances|mesh-ancestor
102459733|NCT00367601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459734|NCT00367601|Growth Inhibitors|growth inhibitors|mesh-ancestor
102459735|NCT00367601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102459736|NCT00367601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102459737|NCT00367601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459738|NCT00385801|Risperidone|risperidone|mesh-list
102459739|NCT00385801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102459740|NCT00385801|Serotonin Agents|serotonin agents|mesh-ancestor
102459741|NCT00385801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102459742|NCT00385801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459743|NCT00385801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459744|NCT00385801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102459745|NCT00385801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102459746|NCT00385801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102459747|NCT00385801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102459748|NCT00385801|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102459749|NCT00385801|Dopamine Agents|dopamine agents|mesh-ancestor
102459750|NCT00429403|Goserelin|goserelin|mesh-list
102459751|NCT00429403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102459752|NCT00429403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459753|NCT05286931|Ciprofloxacin|ciprofloxacin|mesh-list
102459754|NCT05286931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102459755|NCT05286931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102459756|NCT05286931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102459757|NCT05286931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102459758|NCT05286931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102459759|NCT05286931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459760|NCT05286931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459761|NCT05286931|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102459762|NCT05286931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102459763|NCT00368459|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
102459764|NCT00368459|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102459765|NCT00368459|Hormone Antagonists|hormone antagonists|mesh-ancestor
102459766|NCT00368459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102459767|NCT00368459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459768|NCT00368459|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102459769|NCT00368459|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102459770|NCT00368459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102459771|NCT00429949|Dasatinib|dasatinib|mesh-list
102459772|NCT00429949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459773|NCT00429949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102459774|NCT00429949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102459775|NCT00429949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459776|NCT02078726|Glucagon|glucagon|mesh-list
102459777|NCT02078726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102459778|NCT02078726|Hormones|hormones|mesh-ancestor
102459779|NCT02078726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102459780|NCT02078726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459781|NCT00431041|Solifenacin Succinate|solifenacin succinate|mesh-list
102459782|NCT00431041|Oxybutynin|oxybutynin|mesh-list
102459783|NCT00431041|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102459784|NCT00431041|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102459785|NCT00431041|Cholinergic Agents|cholinergic agents|mesh-ancestor
102459786|NCT00431041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102459787|NCT00431041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459788|NCT00431041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459789|NCT00431041|Urological Agents|urological agents|mesh-ancestor
102459790|NCT00431041|Parasympatholytics|parasympatholytics|mesh-ancestor
102459791|NCT00431041|Autonomic Agents|autonomic agents|mesh-ancestor
102459792|NCT00431041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102459793|NCT00390611|Paclitaxel|paclitaxel|mesh-list
102459794|NCT00390611|Carboplatin|carboplatin|mesh-list
102459795|NCT00390611|Sorafenib|sorafenib|mesh-list
102459796|NCT00390611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102459797|NCT00390611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459798|NCT00390611|Tubulin Modulators|tubulin modulators|mesh-ancestor
102459799|NCT00390611|Antimitotic Agents|antimitotic agents|mesh-ancestor
102459800|NCT00390611|Mitosis Modulators|mitosis modulators|mesh-ancestor
102459801|NCT00390611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459802|NCT00390611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102459803|NCT00390611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102459804|NCT00391079|Nabiximols|nabiximols|mesh-list
102459805|NCT00391079|Analgesics|analgesics|mesh-ancestor
102459806|NCT00391079|Sensory System Agents|sensory system agents|mesh-ancestor
102459807|NCT00391079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102459808|NCT00391079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459809|NCT00387751|Bevacizumab|bevacizumab|mesh-list
102459810|NCT00387751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102459811|NCT00387751|Sorafenib|sorafenib|mesh-list
102459812|NCT00387751|Endothelial Growth Factors|endothelial growth factors|mesh-list
102459813|NCT00387751|Antibodies|antibodies|mesh-list
102459814|NCT00387751|Immunoglobulins|immunoglobulins|mesh-list
102459815|NCT00387751|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102459816|NCT00387751|Immunoglobulin G|immunoglobulin g|mesh-list
102459817|NCT00387751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459818|NCT00387751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102459819|NCT00387751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102459820|NCT00387751|Growth Substances|growth substances|mesh-ancestor
102459821|NCT00387751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459822|NCT00387751|Growth Inhibitors|growth inhibitors|mesh-ancestor
102459823|NCT00387751|Immunologic Factors|immunologic factors|mesh-ancestor
102459824|NCT00387751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102459825|NCT00387751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102459826|NCT00387751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459827|NCT01795235|Atenolol|atenolol|mesh-list
102459828|NCT01795235|Glucagon|glucagon|mesh-list
102459829|NCT01795235|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102459830|NCT01795235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102459831|NCT01795235|Hormones|hormones|mesh-ancestor
102459832|NCT01795235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102459833|NCT01795235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459834|NCT01795235|Incretins|incretins|mesh-ancestor
102459835|NCT01795235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102459836|NCT01795235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102459837|NCT01795235|Sympatholytics|sympatholytics|mesh-ancestor
102459838|NCT01795235|Autonomic Agents|autonomic agents|mesh-ancestor
102089911|NCT02199678|Anesthetics|anesthetics|mesh-ancestor
102459839|NCT01795235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102459840|NCT01795235|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102459841|NCT01795235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102459842|NCT01795235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102459843|NCT01795235|Adrenergic Agents|adrenergic agents|mesh-ancestor
102459844|NCT01795235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102459845|NCT01795235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459846|NCT00387829|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102459847|NCT00387829|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102459848|NCT00387829|Estradiol|estradiol|mesh-list
102459849|NCT00387829|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102459850|NCT00387829|Estrogens|estrogens|mesh-ancestor
102459851|NCT00387829|Hormones|hormones|mesh-ancestor
102459852|NCT00387829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102459853|NCT00387829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459854|NCT00387829|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102459855|NCT00387829|Contraceptive Agents|contraceptive agents|mesh-ancestor
102459856|NCT00387829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102459857|NCT00387829|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102459858|NCT01512407|Ethiodized Oil|ethiodized oil|mesh-list
102459859|NCT01512407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459861|NCT00392951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102459862|NCT00392951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102459863|NCT00392951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102459864|NCT00392951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459865|NCT00392951|Antifungal Agents|antifungal agents|mesh-ancestor
102459866|NCT00392951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102459867|NCT00392951|Immunologic Factors|immunologic factors|mesh-ancestor
102459868|NCT00392951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459869|NCT01424930|Prednisone|prednisone|mesh-list
102459870|NCT01424930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102459871|NCT01424930|Glucocorticoids|glucocorticoids|mesh-ancestor
102459872|NCT01424930|Hormones|hormones|mesh-ancestor
102459873|NCT01424930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102459874|NCT01424930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459875|NCT01424930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102459876|NCT01424930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459877|NCT00389857|Vaccines|vaccines|mesh-list
102459878|NCT00389857|Immunologic Factors|immunologic factors|mesh-ancestor
102459879|NCT00389857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459880|NCT01795183|Amisulpride|amisulpride|mesh-list
102459881|NCT01795183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102459882|NCT01795183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102459883|NCT01795183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102459884|NCT01795183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459885|NCT01795183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102459886|NCT01795183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102459887|NCT01795183|Dopamine Agents|dopamine agents|mesh-ancestor
102459888|NCT01795183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102459889|NCT01795183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459890|NCT01795183|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102459891|NCT01795183|Antidepressive Agents|antidepressive agents|mesh-ancestor
102459892|NCT01424228|Prucalopride|prucalopride|mesh-list
102459893|NCT01424228|Laxatives|laxatives|mesh-ancestor
102459894|NCT01424228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102089984|NCT02208882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102459895|NCT01424228|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
102459896|NCT01424228|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102459897|NCT01424228|Serotonin Agents|serotonin agents|mesh-ancestor
102459898|NCT01424228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102459899|NCT01424228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459900|NCT01424228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459901|NCT03562975|Ocrelizumab|ocrelizumab|mesh-list
102459902|NCT03562975|Immunologic Factors|immunologic factors|mesh-ancestor
102459903|NCT03562975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459904|NCT04750603|Fluticasone|fluticasone|mesh-list
102459905|NCT04750603|Xhance|xhance|mesh-list
102459906|NCT04750603|Albuterol|albuterol|mesh-list
102459907|NCT04750603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102459908|NCT04750603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102459909|NCT04750603|Autonomic Agents|autonomic agents|mesh-ancestor
102459910|NCT04750603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102459911|NCT04750603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459912|NCT04750603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102459913|NCT04750603|Respiratory System Agents|respiratory system agents|mesh-ancestor
102459914|NCT04750603|Dermatologic Agents|dermatologic agents|mesh-ancestor
102459915|NCT04750603|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102459916|NCT04750603|Tocolytic Agents|tocolytic agents|mesh-ancestor
102459917|NCT04750603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102459918|NCT04750603|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102459919|NCT04750603|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102459920|NCT04750603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102459921|NCT04750603|Adrenergic Agents|adrenergic agents|mesh-ancestor
102459922|NCT04750603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102459923|NCT04750603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459924|NCT01423916|Moxifloxacin|moxifloxacin|mesh-list
102459925|NCT01423916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102459926|NCT01423916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102459927|NCT01423916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102459928|NCT01423916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102459929|NCT01423916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102459930|NCT01423916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459931|NCT01423916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459932|NCT00436969|Hyaluronic Acid|hyaluronic acid|mesh-list
102271488|NCT05912621|Hormones|hormones|mesh-ancestor
102459933|NCT00436969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102459934|NCT00436969|Immunologic Factors|immunologic factors|mesh-ancestor
102459935|NCT00436969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459936|NCT00436969|Viscosupplements|viscosupplements|mesh-ancestor
102459937|NCT00436969|Protective Agents|protective agents|mesh-ancestor
102459938|NCT00455689|Leuprolide|leuprolide|mesh-list
102459939|NCT00455689|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102459940|NCT00455689|Fertility Agents|fertility agents|mesh-ancestor
102459941|NCT00455689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102459942|NCT00455689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459943|NCT00455689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102459944|NCT00455689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459945|NCT00394277|Ribavirin|ribavirin|mesh-list
102459946|NCT00394277|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102459947|NCT00394277|Interferon-alpha|interferon-alpha|mesh-list
102459948|NCT00394277|Antimetabolites|antimetabolites|mesh-ancestor
102459949|NCT00394277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459950|NCT00394277|Antiviral Agents|antiviral agents|mesh-ancestor
102459951|NCT00394277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102459952|NCT00394277|Immunologic Factors|immunologic factors|mesh-ancestor
102459953|NCT00394277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459954|NCT00395057|Ranibizumab|ranibizumab|mesh-list
102459955|NCT00395057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102459956|NCT00395057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102459957|NCT00395057|Growth Substances|growth substances|mesh-ancestor
102459958|NCT00395057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459959|NCT00395057|Growth Inhibitors|growth inhibitors|mesh-ancestor
102459960|NCT00395057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102459961|NCT00438451|Lamotrigine|lamotrigine|mesh-list
102459962|NCT00438451|Carbamazepine|carbamazepine|mesh-list
102459963|NCT00438451|Levetiracetam|levetiracetam|mesh-list
102459964|NCT00438451|Anticonvulsants|anticonvulsants|mesh-ancestor
102459965|NCT00438451|Nootropic Agents|nootropic agents|mesh-ancestor
102459966|NCT00438451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102459967|NCT00438451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102459968|NCT00438451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459969|NCT00438451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102459970|NCT00438451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459971|NCT00438451|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102459972|NCT00438451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102459973|NCT00438451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102459974|NCT00438451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102459975|NCT00438451|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102459976|NCT00438451|Antimanic Agents|antimanic agents|mesh-ancestor
102459977|NCT00438451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102459978|NCT00438451|Analgesics|analgesics|mesh-ancestor
102459979|NCT00438451|Sensory System Agents|sensory system agents|mesh-ancestor
102459980|NCT00438451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102459981|NCT00438451|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102459982|NCT00438451|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102459983|NCT00456625|Vaccines|vaccines|mesh-list
102459984|NCT00456625|Immunologic Factors|immunologic factors|mesh-ancestor
102459985|NCT00456625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459986|NCT00457795|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102459987|NCT00457795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102459988|NCT00457795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102459989|NCT00457795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102459990|NCT00457795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102459991|NCT00457795|Adrenergic Agents|adrenergic agents|mesh-ancestor
102459992|NCT00457795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102459993|NCT00457795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102459994|NCT00457795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102459995|NCT04749979|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102459996|NCT04749979|Luteolytic Agents|luteolytic agents|mesh-ancestor
102459997|NCT04749979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102459998|NCT04749979|Contraceptive Agents|contraceptive agents|mesh-ancestor
102459999|NCT04749979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102460000|NCT04749979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460001|NCT04749979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102460002|NCT04749979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102460003|NCT04749979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460004|NCT01423604|Capecitabine|capecitabine|mesh-list
102460005|NCT01423604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102460006|NCT01423604|Antimetabolites|antimetabolites|mesh-ancestor
102460007|NCT01423604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460008|NCT01423604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460009|NCT01402544|Ranibizumab|ranibizumab|mesh-list
102460010|NCT01402544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102460011|NCT01402544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102460012|NCT01402544|Growth Substances|growth substances|mesh-ancestor
102460013|NCT01402544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460014|NCT01402544|Growth Inhibitors|growth inhibitors|mesh-ancestor
102460015|NCT01402544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460016|NCT00460993|Eszopiclone|eszopiclone|mesh-list
102460017|NCT00460993|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102460018|NCT00460993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102460019|NCT00460993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460020|NCT00441883|Latanoprost|latanoprost|mesh-list
102460021|NCT00441883|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102460022|NCT00441883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102460023|NCT00461773|Bevacizumab|bevacizumab|mesh-list
102460024|NCT00461773|Letrozole|letrozole|mesh-list
102460025|NCT00461773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102460026|NCT00461773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460027|NCT00461773|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102460028|NCT00461773|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102460029|NCT00461773|Growth Substances|growth substances|mesh-ancestor
102460030|NCT00461773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460031|NCT00461773|Growth Inhibitors|growth inhibitors|mesh-ancestor
102460032|NCT00461773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102460033|NCT00461773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102460034|NCT00461773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102460035|NCT00461773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460036|NCT00461773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102460037|NCT00461773|Hormone Antagonists|hormone antagonists|mesh-ancestor
102460038|NCT00461773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102460039|NCT00461851|Carboplatin|carboplatin|mesh-list
102460040|NCT00461851|Gemcitabine|gemcitabine|mesh-list
102460041|NCT00461851|Sorafenib|sorafenib|mesh-list
102460042|NCT00461851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460043|NCT00461851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102460044|NCT00461851|Antimetabolites|antimetabolites|mesh-ancestor
102460045|NCT00461851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460046|NCT00461851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102460047|NCT00461851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102460048|NCT00442507|Bevacizumab|bevacizumab|mesh-list
102460049|NCT00442507|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102460050|NCT00442507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102460051|NCT00442507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460052|NCT00442507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102460053|NCT00442507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102460054|NCT00442507|Growth Substances|growth substances|mesh-ancestor
102460055|NCT00442507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460056|NCT00442507|Growth Inhibitors|growth inhibitors|mesh-ancestor
102460057|NCT00442507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102460058|NCT00442507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102460059|NCT00442507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460060|NCT01401530|Denileukin diftitox|denileukin diftitox|mesh-list
102460061|NCT01401530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460062|NCT01387022|Tenofovir|tenofovir|mesh-list
102460063|NCT01387022|Lamivudine|lamivudine|mesh-list
102460064|NCT01387022|Efavirenz|efavirenz|mesh-list
102460065|NCT01387022|Antiviral Agents|antiviral agents|mesh-ancestor
102460066|NCT01387022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102460067|NCT01387022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102460068|NCT01387022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102460069|NCT01387022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102460070|NCT01387022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460071|NCT01387022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102460072|NCT01387022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102460073|NCT01387022|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102460074|NCT01387022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102460075|NCT01387022|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102460076|NCT01387022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102460077|NCT01387022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102460078|NCT01387022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102460079|NCT00374231|Mycophenolic Acid|mycophenolic acid|mesh-list
102460080|NCT00374231|Prednisone|prednisone|mesh-list
102460081|NCT00374231|Tacrolimus|tacrolimus|mesh-list
102460082|NCT00374231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102460083|NCT00374231|Glucocorticoids|glucocorticoids|mesh-ancestor
102460084|NCT00374231|Hormones|hormones|mesh-ancestor
102460085|NCT00374231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102460086|NCT00374231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460087|NCT00374231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102460088|NCT00374231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460089|NCT00374231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102460090|NCT00374231|Immunologic Factors|immunologic factors|mesh-ancestor
102460091|NCT00374231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102460092|NCT00374231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102090175|NCT02220036|Antacids|antacids|mesh-ancestor
102460093|NCT00374231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460094|NCT00374231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102460095|NCT00374231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102460096|NCT00374231|Antitubercular Agents|antitubercular agents|mesh-ancestor
102460097|NCT00374231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102460098|NCT00374231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102460099|NCT00400205|Docetaxel|docetaxel|mesh-list
102460100|NCT00400205|Fluorouracil|fluorouracil|mesh-list
102460101|NCT00400205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460102|NCT00400205|Tubulin Modulators|tubulin modulators|mesh-ancestor
102460103|NCT00400205|Antimitotic Agents|antimitotic agents|mesh-ancestor
102460104|NCT00400205|Mitosis Modulators|mitosis modulators|mesh-ancestor
102460105|NCT00400205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460106|NCT00400205|Antimetabolites|antimetabolites|mesh-ancestor
102460107|NCT00400205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102460108|NCT00400205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102460109|NCT00400205|Immunologic Factors|immunologic factors|mesh-ancestor
102460110|NCT00400205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460111|NCT01386554|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102460112|NCT01386554|Hormones|hormones|mesh-ancestor
102460113|NCT01386554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102460114|NCT01386554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460115|NCT00400439|Dalcetrapib|dalcetrapib|mesh-list
102460116|NCT00400439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102460117|NCT00400439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102460118|NCT00400439|Antimetabolites|antimetabolites|mesh-ancestor
102460119|NCT00400439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460120|NCT00400439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102460121|NCT00448201|Methotrexate|methotrexate|mesh-list
102460122|NCT00448201|Fludarabine phosphate|fludarabine phosphate|mesh-list
102460123|NCT00448201|Fludarabine|fludarabine|mesh-list
102460124|NCT00448201|Busulfan|busulfan|mesh-list
102460125|NCT00448201|Tacrolimus|tacrolimus|mesh-list
102460126|NCT00448201|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102460127|NCT00448201|Sargramostim|sargramostim|mesh-list
102460128|NCT00448201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102460129|NCT00448201|Abortifacient Agents|abortifacient agents|mesh-ancestor
102460130|NCT00448201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102460131|NCT00448201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460132|NCT00448201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102460133|NCT00448201|Antimetabolites|antimetabolites|mesh-ancestor
102460134|NCT00448201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460135|NCT00448201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460136|NCT00448201|Dermatologic Agents|dermatologic agents|mesh-ancestor
102460137|NCT00448201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102460138|NCT00448201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102460139|NCT00448201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102460140|NCT00448201|Immunologic Factors|immunologic factors|mesh-ancestor
102460141|NCT00448201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102460142|NCT00448201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102460143|NCT00448201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102460144|NCT00448201|Alkylating Agents|alkylating agents|mesh-ancestor
102460145|NCT00448201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102460146|NCT00448201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102460147|NCT05287607|Bilirubin|bilirubin|mesh-list
102460148|NCT05287607|Antioxidants|antioxidants|mesh-ancestor
102460149|NCT05287607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460150|NCT05287607|Protective Agents|protective agents|mesh-ancestor
102460151|NCT05287607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460152|NCT00375713|Cetirizine|cetirizine|mesh-list
102460153|NCT00375713|Hydrocortisone|hydrocortisone|mesh-list
102460154|NCT00375713|Levocetirizine|levocetirizine|mesh-list
102460155|NCT00375713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102460156|NCT00375713|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102460157|NCT00375713|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102460158|NCT00375713|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102460159|NCT00375713|Histamine Antagonists|histamine antagonists|mesh-ancestor
102460160|NCT00375713|Histamine Agents|histamine agents|mesh-ancestor
102460161|NCT00375713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102460162|NCT00375713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460163|NCT00375713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460164|NCT00465595|Psilocybin|psilocybin|mesh-list
102460165|NCT00465595|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
102460166|NCT00465595|Hallucinogens|hallucinogens|mesh-ancestor
102460167|NCT00465595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460168|NCT00465595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102460169|NCT00465595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102460170|NCT00465595|Serotonin Agents|serotonin agents|mesh-ancestor
102460171|NCT00465595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102460172|NCT00465595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460173|NCT00465595|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102460174|NCT00376805|Cyclophosphamide|cyclophosphamide|mesh-list
102460175|NCT00376805|Fludarabine|fludarabine|mesh-list
102460176|NCT00376805|Interleukin-2|interleukin-2|mesh-list
102460177|NCT00376805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102460178|NCT00376805|Immunologic Factors|immunologic factors|mesh-ancestor
102460179|NCT00376805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460180|NCT00376805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102460181|NCT00376805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102460182|NCT00376805|Alkylating Agents|alkylating agents|mesh-ancestor
102460183|NCT00376805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460184|NCT00376805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460185|NCT00376805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102460186|NCT00376805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102460187|NCT00376805|Analgesics|analgesics|mesh-ancestor
102460188|NCT00376805|Sensory System Agents|sensory system agents|mesh-ancestor
102460189|NCT00376805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102460190|NCT00448357|Methotrexate|methotrexate|mesh-list
102460191|NCT00448357|Fludarabine phosphate|fludarabine phosphate|mesh-list
102460192|NCT00448357|Fludarabine|fludarabine|mesh-list
102460193|NCT00448357|Busulfan|busulfan|mesh-list
102460194|NCT00448357|Tacrolimus|tacrolimus|mesh-list
102460195|NCT00448357|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102460196|NCT00448357|Thymoglobulin|thymoglobulin|mesh-list
102460197|NCT00448357|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102460198|NCT00448357|Abortifacient Agents|abortifacient agents|mesh-ancestor
102460199|NCT00448357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102460200|NCT00448357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460201|NCT00448357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102460202|NCT00448357|Antimetabolites|antimetabolites|mesh-ancestor
102460203|NCT00448357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460204|NCT00448357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460205|NCT00448357|Dermatologic Agents|dermatologic agents|mesh-ancestor
102460206|NCT00448357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102460207|NCT00448357|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102460208|NCT00448357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102460209|NCT00448357|Immunologic Factors|immunologic factors|mesh-ancestor
102460210|NCT00448357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102460211|NCT00448357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102460212|NCT00448357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102460213|NCT00448357|Alkylating Agents|alkylating agents|mesh-ancestor
102460214|NCT00448357|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102460215|NCT00448357|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102460216|NCT00450073|Vitamin D|vitamin d|mesh-list
102460217|NCT00450073|Ergocalciferols|ergocalciferols|mesh-list
102460218|NCT00450073|Cholecalciferol|cholecalciferol|mesh-list
102460219|NCT00450073|Vitamins|vitamins|mesh-list
102460220|NCT00450073|Micronutrients|micronutrients|mesh-ancestor
102460221|NCT00450073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460222|NCT00450073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102460223|NCT00450073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102460224|NCT00467077|Interferons|interferons|mesh-list
102460225|NCT00467077|Interferon-alpha|interferon-alpha|mesh-list
102460226|NCT00467077|Interferon alpha-2|interferon alpha-2|mesh-list
102460227|NCT00467077|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102460228|NCT00467077|Gefitinib|gefitinib|mesh-list
102460229|NCT00467077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460230|NCT00467077|Antiviral Agents|antiviral agents|mesh-ancestor
102460231|NCT00467077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102460232|NCT00467077|Immunologic Factors|immunologic factors|mesh-ancestor
102460233|NCT00467077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460234|NCT00467077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102460235|NCT00467077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102090321|NCT04425382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102460236|NCT00467077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460237|NCT00467389|Donepezil|donepezil|mesh-list
102460238|NCT00467389|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102460239|NCT00467389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102460240|NCT00467389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460241|NCT00467389|Cholinergic Agents|cholinergic agents|mesh-ancestor
102460242|NCT00467389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102460243|NCT00467389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460244|NCT00467389|Nootropic Agents|nootropic agents|mesh-ancestor
102460245|NCT00377741|Valganciclovir|valganciclovir|mesh-list
102460246|NCT00377741|Antiviral Agents|antiviral agents|mesh-ancestor
102460247|NCT00377741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102460248|NCT00379145|Trabectedin|trabectedin|mesh-list
102460249|NCT00379145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102460250|NCT00379145|Alkylating Agents|alkylating agents|mesh-ancestor
102460251|NCT00379145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460252|NCT00379145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460253|NCT00382031|Zalutumumab|zalutumumab|mesh-list
102460254|NCT00382031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102460255|NCT00382031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102460256|NCT00382031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460257|NCT00382031|Immunologic Factors|immunologic factors|mesh-ancestor
102460258|NCT00382031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460259|NCT00382265|Tamsulosin|tamsulosin|mesh-list
102460260|NCT00382265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102460261|NCT00382265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102460262|NCT00382265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102460263|NCT00382265|Adrenergic Agents|adrenergic agents|mesh-ancestor
102460264|NCT00382265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102460265|NCT00382265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460266|NCT00382265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460267|NCT00382265|Urological Agents|urological agents|mesh-ancestor
102460268|NCT00383747|Nicotine|nicotine|mesh-list
102460269|NCT00383747|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102460270|NCT00383747|Autonomic Agents|autonomic agents|mesh-ancestor
102460271|NCT00383747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102460272|NCT00383747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460273|NCT00383747|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102460274|NCT00383747|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102460275|NCT00383747|Cholinergic Agents|cholinergic agents|mesh-ancestor
102460276|NCT00383747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102460277|NCT00383747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460278|NCT01421342|Aripiprazole|aripiprazole|mesh-list
102460279|NCT01421342|Bupropion|bupropion|mesh-list
102460280|NCT01421342|Antidepressive Agents|antidepressive agents|mesh-list
102460281|NCT01421342|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102460282|NCT01421342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102460283|NCT01421342|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102460284|NCT01421342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102460285|NCT01421342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102460286|NCT01421342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460287|NCT01421342|Dopamine Agents|dopamine agents|mesh-ancestor
102460288|NCT01421342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102460289|NCT01421342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460290|NCT01421342|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102460291|NCT01421342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102460292|NCT01421342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102460293|NCT01421342|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102460294|NCT01421342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102460295|NCT01421342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102460296|NCT01421342|Dopamine Agonists|dopamine agonists|mesh-ancestor
102460297|NCT01421342|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102460298|NCT01421342|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102460299|NCT01421342|Serotonin Agents|serotonin agents|mesh-ancestor
102460300|NCT01421342|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102460301|NCT01421342|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102460302|NCT01421342|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102460303|NCT01421342|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102460304|NCT00403403|Bevacizumab|bevacizumab|mesh-list
102460305|NCT00403403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102460306|NCT00403403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460307|NCT00403403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102460308|NCT00403403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102460309|NCT00403403|Growth Substances|growth substances|mesh-ancestor
102460310|NCT00403403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460311|NCT00403403|Growth Inhibitors|growth inhibitors|mesh-ancestor
102460312|NCT00405353|Methyltestosterone|methyltestosterone|mesh-list
102460313|NCT00405353|Testosterone|testosterone|mesh-list
102460314|NCT00405353|Testosterone undecanoate|testosterone undecanoate|mesh-list
102460315|NCT00405353|Testosterone enanthate|testosterone enanthate|mesh-list
102460316|NCT00405353|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102460317|NCT00405353|Androgens|androgens|mesh-ancestor
102460318|NCT00405353|Hormones|hormones|mesh-ancestor
102460319|NCT00405353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102460320|NCT00405353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460321|NCT00405353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102460322|NCT00405353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460323|NCT00405353|Anabolic Agents|anabolic agents|mesh-ancestor
102460324|NCT01384292|Naloxegol|naloxegol|mesh-list
102460325|NCT01384292|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102460326|NCT01384292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460327|NCT01384292|Sensory System Agents|sensory system agents|mesh-ancestor
102460328|NCT01384292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102460329|NCT00450463|Metronidazole|metronidazole|mesh-list
102460330|NCT00450463|Molgramostim|molgramostim|mesh-list
102460331|NCT00450463|Flutamide|flutamide|mesh-list
102460332|NCT00450463|Sargramostim|sargramostim|mesh-list
102460333|NCT00450463|Immunologic Factors|immunologic factors|mesh-ancestor
102460334|NCT00450463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460335|NCT00450463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460336|NCT00450463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102460337|NCT00450463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102460338|NCT00450463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102460339|NCT00450463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102460340|NCT00450463|Androgen Antagonists|androgen antagonists|mesh-ancestor
102460341|NCT00450463|Hormone Antagonists|hormone antagonists|mesh-ancestor
102460342|NCT00450463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102460343|NCT00450463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102460344|NCT00407381|Ranibizumab|ranibizumab|mesh-list
102460345|NCT00407381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102460346|NCT00407381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102460347|NCT00407381|Growth Substances|growth substances|mesh-ancestor
102460348|NCT00407381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460349|NCT00407381|Growth Inhibitors|growth inhibitors|mesh-ancestor
102460350|NCT00407381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460351|NCT00384449|Ranibizumab|ranibizumab|mesh-list
102460352|NCT00384449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102460353|NCT00384449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102090453|NCT02231658|Liraglutide|liraglutide|mesh-list
102460354|NCT00384449|Growth Substances|growth substances|mesh-ancestor
102460355|NCT00384449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460356|NCT00384449|Growth Inhibitors|growth inhibitors|mesh-ancestor
102460357|NCT00384449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460358|NCT00452335|Lubiprostone|lubiprostone|mesh-list
102460359|NCT00452335|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102460360|NCT00452335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102460361|NCT00452335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460362|NCT00386243|Analgesics, Opioid|analgesics, opioid|mesh-list
102460363|NCT00386243|Analgesics|analgesics|mesh-list
102460364|NCT00386243|Narcotics|narcotics|mesh-ancestor
102460365|NCT00386243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102460366|NCT00386243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460367|NCT00386243|Sensory System Agents|sensory system agents|mesh-ancestor
102460368|NCT00386243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102460369|NCT01400516|Vitamin D|vitamin d|mesh-list
102460370|NCT01400516|Teriparatide|teriparatide|mesh-list
102460371|NCT01400516|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
102460372|NCT01400516|Calcium|calcium|mesh-list
102460373|NCT01400516|Vitamins|vitamins|mesh-ancestor
102460374|NCT01400516|Micronutrients|micronutrients|mesh-ancestor
102460375|NCT01400516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460376|NCT01400516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102460377|NCT01400516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102460378|NCT01400516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102460379|NCT01383356|Metformin|metformin|mesh-list
102460380|NCT01383356|Linagliptin|linagliptin|mesh-list
102460381|NCT01383356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102460382|NCT01383356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460383|NCT01383356|Incretins|incretins|mesh-ancestor
102460384|NCT01383356|Hormones|hormones|mesh-ancestor
102460385|NCT01383356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102460386|NCT01383356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102460387|NCT01383356|Protease Inhibitors|protease inhibitors|mesh-ancestor
102460388|NCT01383356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102460389|NCT01383356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460390|NCT02111447|Propofol|propofol|mesh-list
102460391|NCT02111447|Sevoflurane|sevoflurane|mesh-list
102460392|NCT02111447|Isoflurane|isoflurane|mesh-list
102460393|NCT02111447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102460394|NCT02111447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102460395|NCT02111447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460396|NCT02111447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102460397|NCT02111447|Anesthetics, General|anesthetics, general|mesh-ancestor
102460398|NCT02111447|Anesthetics|anesthetics|mesh-ancestor
102460399|NCT02111447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102460400|NCT02111447|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102460401|NCT05966454|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102460402|NCT05966454|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102460403|NCT05966454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102460404|NCT05966454|Antitubercular Agents|antitubercular agents|mesh-ancestor
102460405|NCT05966441|Curcumin|curcumin|mesh-list
102460406|NCT05966441|Paclitaxel|paclitaxel|mesh-list
102460407|NCT05966441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102460408|NCT05966441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460409|NCT05966441|Tubulin Modulators|tubulin modulators|mesh-ancestor
102460410|NCT05966441|Antimitotic Agents|antimitotic agents|mesh-ancestor
102460411|NCT05966441|Mitosis Modulators|mitosis modulators|mesh-ancestor
102460412|NCT05966441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460413|NCT05966441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102460414|NCT05966441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102460415|NCT05966441|Analgesics|analgesics|mesh-ancestor
102460416|NCT05966441|Sensory System Agents|sensory system agents|mesh-ancestor
102460417|NCT05966441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102460418|NCT05966441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460419|NCT05966441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102460420|NCT05966441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102460421|NCT05966441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102460422|NCT05966376|Hemostatics|hemostatics|mesh-list
102460423|NCT05966376|Coagulants|coagulants|mesh-ancestor
102460424|NCT05966064|Denosumab|denosumab|mesh-list
102460425|NCT05966064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102460426|NCT05966064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460427|NCT05966012|Tranexamic Acid|tranexamic acid|mesh-list
102460428|NCT05966012|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102460429|NCT05966012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102460430|NCT05966012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460431|NCT05966012|Hemostatics|hemostatics|mesh-ancestor
102460432|NCT05966012|Coagulants|coagulants|mesh-ancestor
102460433|NCT05965934|Dapagliflozin|dapagliflozin|mesh-list
102460434|NCT05965934|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102460435|NCT05965934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460436|NCT05965934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102460437|NCT05965934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460438|NCT05965531|Trifluridine|trifluridine|mesh-list
102460439|NCT05965531|Antimetabolites|antimetabolites|mesh-ancestor
102460440|NCT05965531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460441|NCT05965531|Antiviral Agents|antiviral agents|mesh-ancestor
102460442|NCT05965531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102460443|NCT05965479|Trastuzumab|trastuzumab|mesh-list
102460444|NCT05965479|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
102460445|NCT05965479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102460446|NCT05965479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460447|NCT05965479|Immunoconjugates|immunoconjugates|mesh-ancestor
102460448|NCT05965479|Immunologic Factors|immunologic factors|mesh-ancestor
102460449|NCT05965479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460450|NCT05965388|Interferons|interferons|mesh-list
102460451|NCT05965388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460452|NCT05965388|Antiviral Agents|antiviral agents|mesh-ancestor
102460453|NCT05965388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102460454|NCT05965284|Azathioprine|azathioprine|mesh-list
102460455|NCT05965284|Antimetabolites|antimetabolites|mesh-ancestor
102460456|NCT05965284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460457|NCT05965284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102460458|NCT05965284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460459|NCT05965284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102460460|NCT05965284|Immunologic Factors|immunologic factors|mesh-ancestor
102460461|NCT05965284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460462|NCT05965284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102460463|NCT05965167|Teriparatide|teriparatide|mesh-list
102460464|NCT05965167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102460465|NCT05965167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460466|NCT05965167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102460467|NCT05965154|Bevacizumab|bevacizumab|mesh-list
102460468|NCT05965154|Capecitabine|capecitabine|mesh-list
102460469|NCT05965154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102460470|NCT05965154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460471|NCT05965154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102460472|NCT05965154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102460473|NCT05965154|Growth Substances|growth substances|mesh-ancestor
102460474|NCT05965154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460475|NCT05965154|Growth Inhibitors|growth inhibitors|mesh-ancestor
102460476|NCT05965154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102460477|NCT05965154|Antimetabolites|antimetabolites|mesh-ancestor
102460478|NCT05965154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460479|NCT05965141|Bevacizumab|bevacizumab|mesh-list
102460480|NCT05965141|Carboplatin|carboplatin|mesh-list
102460481|NCT05965141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102460482|NCT05965141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460483|NCT05965141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102460484|NCT05965141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102460485|NCT05965141|Growth Substances|growth substances|mesh-ancestor
102460486|NCT05965141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460487|NCT05965141|Growth Inhibitors|growth inhibitors|mesh-ancestor
102460488|NCT05965076|Glycine|glycine|mesh-list
102460489|NCT05965076|Glycine Agents|glycine agents|mesh-ancestor
102460490|NCT05965076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102460491|NCT05965076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460492|NCT05965076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460493|NCT05964985|Lidocaine|lidocaine|mesh-list
102460494|NCT05964985|Ropivacaine|ropivacaine|mesh-list
102460495|NCT05964985|Esketamine|esketamine|mesh-list
102460496|NCT05964985|Anesthetics, Local|anesthetics, local|mesh-ancestor
102460497|NCT05964985|Anesthetics|anesthetics|mesh-ancestor
102460498|NCT05964985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102460499|NCT05964985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460500|NCT05964985|Sensory System Agents|sensory system agents|mesh-ancestor
102460501|NCT05964985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102460502|NCT05964985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102460503|NCT05964985|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102460504|NCT05964985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102460505|NCT05964985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102460506|NCT05964985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460507|NCT05964985|Antidepressive Agents|antidepressive agents|mesh-ancestor
102460508|NCT05964985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102460509|NCT05964920|Methyltestosterone|methyltestosterone|mesh-list
102460510|NCT05964920|Testosterone|testosterone|mesh-list
102460511|NCT05964920|Testosterone undecanoate|testosterone undecanoate|mesh-list
102460512|NCT05964920|Testosterone enanthate|testosterone enanthate|mesh-list
102460513|NCT05964920|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102460514|NCT05964920|Androgens|androgens|mesh-ancestor
102460515|NCT05964920|Hormones|hormones|mesh-ancestor
102460516|NCT05964920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102460517|NCT05964920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460518|NCT05964920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102460519|NCT05964920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460520|NCT05964920|Anabolic Agents|anabolic agents|mesh-ancestor
102460521|NCT05964738|Diuretics|diuretics|mesh-list
102460522|NCT05964738|Natriuretic Agents|natriuretic agents|mesh-ancestor
102460523|NCT05964738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460524|NCT05964686|Edetic Acid|edetic acid|mesh-list
102460525|NCT05964686|Pentetic Acid|pentetic acid|mesh-list
102460526|NCT05964686|Anticoagulants|anticoagulants|mesh-ancestor
102460527|NCT05964686|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102460528|NCT05964686|Chelating Agents|chelating agents|mesh-ancestor
102460529|NCT05964686|Sequestering Agents|sequestering agents|mesh-ancestor
102460530|NCT05964686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460531|NCT05964686|Antidotes|antidotes|mesh-ancestor
102460532|NCT05964686|Protective Agents|protective agents|mesh-ancestor
102460533|NCT05964686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460534|NCT05964686|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102460535|NCT05964543|Capecitabine|capecitabine|mesh-list
102460536|NCT05964543|Oxaliplatin|oxaliplatin|mesh-list
102460537|NCT05964543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102460538|NCT05964543|Antimetabolites|antimetabolites|mesh-ancestor
102460539|NCT05964543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460540|NCT05964543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460541|NCT05964452|Methimazole|methimazole|mesh-list
102460542|NCT05964452|Antithyroid Agents|antithyroid agents|mesh-ancestor
102460543|NCT05964452|Hormone Antagonists|hormone antagonists|mesh-ancestor
102460544|NCT05964452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102460545|NCT05964452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460546|NCT05961644|Cladribine|cladribine|mesh-list
102460547|NCT05961644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460548|NCT05961644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102460549|NCT05961644|Immunologic Factors|immunologic factors|mesh-ancestor
102460550|NCT05961644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460551|NCT05961059|Detox adjuvant|detox adjuvant|mesh-list
102460552|NCT05961059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102460553|NCT05961059|Immunologic Factors|immunologic factors|mesh-ancestor
102460554|NCT05961059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460555|NCT05959850|Ambroxol|ambroxol|mesh-list
102460556|NCT05959850|Expectorants|expectorants|mesh-ancestor
102460557|NCT05959850|Respiratory System Agents|respiratory system agents|mesh-ancestor
102460558|NCT05939245|Furosemide|furosemide|mesh-list
102460559|NCT05939245|Diuretics|diuretics|mesh-ancestor
102460560|NCT05939245|Natriuretic Agents|natriuretic agents|mesh-ancestor
102460561|NCT05939245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460562|NCT05939245|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102460563|NCT05939245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102460564|NCT05939245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460565|NCT05899933|Erythritol|erythritol|mesh-list
102460566|NCT05899933|Vasodilator Agents|vasodilator agents|mesh-ancestor
102460567|NCT05870579|Fulvestrant|fulvestrant|mesh-list
102460568|NCT05870579|Goserelin|goserelin|mesh-list
102460569|NCT05870579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102460570|NCT05870579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460571|NCT05870579|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102460572|NCT05870579|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102460573|NCT05870579|Hormone Antagonists|hormone antagonists|mesh-ancestor
102460574|NCT05870579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102460575|NCT05870579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460576|NCT05838768|Irinotecan|irinotecan|mesh-list
102460577|NCT05838768|Tislelizumab|tislelizumab|mesh-list
102460578|NCT05838768|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102460579|NCT05838768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102460580|NCT05838768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102460581|NCT05838768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460582|NCT05838768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460583|NCT05838768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102460584|NCT05783921|Paclitaxel|paclitaxel|mesh-list
102460585|NCT05783921|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102460586|NCT05783921|Cisplatin|cisplatin|mesh-list
102460587|NCT05783921|Carboplatin|carboplatin|mesh-list
102460588|NCT05783921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102460589|NCT05783921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460590|NCT05783921|Tubulin Modulators|tubulin modulators|mesh-ancestor
102460591|NCT05783921|Antimitotic Agents|antimitotic agents|mesh-ancestor
102460592|NCT05783921|Mitosis Modulators|mitosis modulators|mesh-ancestor
102460593|NCT05783921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460594|NCT05767034|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102460595|NCT05767034|Immunologic Factors|immunologic factors|mesh-ancestor
102460596|NCT05767034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460597|NCT05754073|Oxytocin|oxytocin|mesh-list
102460598|NCT05754073|Oxytocics|oxytocics|mesh-ancestor
102460599|NCT05754073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102460600|NCT05754073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460601|NCT05741372|Metformin|metformin|mesh-list
102460602|NCT05741372|Digoxin|digoxin|mesh-list
102460603|NCT05741372|Furosemide|furosemide|mesh-list
102460604|NCT05741372|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102460605|NCT05741372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102460606|NCT05741372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460607|NCT05741372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102272162|NCT05423340|Nicotine|nicotine|mesh-list
102460608|NCT05741372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102460609|NCT05741372|Antimetabolites|antimetabolites|mesh-ancestor
102612321|NCT00002405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102460610|NCT05741372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460611|NCT05741372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102460612|NCT05741372|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102460613|NCT05741372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102460614|NCT05741372|Diuretics|diuretics|mesh-ancestor
102460615|NCT05741372|Natriuretic Agents|natriuretic agents|mesh-ancestor
102460616|NCT05741372|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102460617|NCT05741372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102460618|NCT05741372|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102460619|NCT05741372|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102460620|NCT05741372|Protective Agents|protective agents|mesh-ancestor
102460621|NCT05740098|Nicotine|nicotine|mesh-list
102460622|NCT05740098|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102460623|NCT05740098|Autonomic Agents|autonomic agents|mesh-ancestor
102460624|NCT05740098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102460625|NCT05740098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460626|NCT05740098|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102460627|NCT05740098|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102460628|NCT05740098|Cholinergic Agents|cholinergic agents|mesh-ancestor
102460629|NCT05740098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102460630|NCT05740098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460631|NCT05730413|Bisoprolol|bisoprolol|mesh-list
102460632|NCT05730413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102090729|NCT04161456|Apremilast|apremilast|mesh-list
102460633|NCT05730413|Sympatholytics|sympatholytics|mesh-ancestor
102460634|NCT05730413|Autonomic Agents|autonomic agents|mesh-ancestor
102460635|NCT05730413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102460636|NCT05730413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460637|NCT05730413|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102460638|NCT05730413|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102460639|NCT05730413|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102460640|NCT05730413|Adrenergic Agents|adrenergic agents|mesh-ancestor
102460641|NCT05730413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102460642|NCT05730413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460643|NCT05725213|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
102460644|NCT05725213|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102460645|NCT05725213|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102460646|NCT05725213|Dermatologic Agents|dermatologic agents|mesh-ancestor
102460647|NCT05720455|Fexofenadine|fexofenadine|mesh-list
102460648|NCT05720455|Pseudoephedrine|pseudoephedrine|mesh-list
102460649|NCT05720455|Ephedrine|ephedrine|mesh-list
102460650|NCT05720455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102460651|NCT05720455|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102460652|NCT05720455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102460653|NCT05720455|Histamine Antagonists|histamine antagonists|mesh-ancestor
102460654|NCT05720455|Histamine Agents|histamine agents|mesh-ancestor
102460655|NCT05720455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102460656|NCT05720455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460657|NCT05720455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460658|NCT05720455|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102460659|NCT05720455|Autonomic Agents|autonomic agents|mesh-ancestor
102460660|NCT05720455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102460661|NCT05720455|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102460662|NCT05720455|Respiratory System Agents|respiratory system agents|mesh-ancestor
102460663|NCT05720455|Nasal Decongestants|nasal decongestants|mesh-ancestor
102460664|NCT05720455|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102460665|NCT05720455|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102460666|NCT05720455|Sympathomimetics|sympathomimetics|mesh-ancestor
102460667|NCT05720455|Adrenergic Agents|adrenergic agents|mesh-ancestor
102460668|NCT05647265|Nivolumab|nivolumab|mesh-list
102460669|NCT05647265|Ipilimumab|ipilimumab|mesh-list
102460670|NCT05647265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102460671|NCT05647265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460672|NCT05647265|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102460673|NCT05647265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460674|NCT05641753|Atorvastatin|atorvastatin|mesh-list
102460675|NCT05641753|Ezetimibe|ezetimibe|mesh-list
102460676|NCT05641753|Evolocumab|evolocumab|mesh-list
102460677|NCT05641753|Calcium|calcium|mesh-list
102460678|NCT05641753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102460679|NCT05641753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460680|NCT05641753|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102460681|NCT05641753|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102460682|NCT05641753|Antimetabolites|antimetabolites|mesh-ancestor
102460683|NCT05641753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460684|NCT05641753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102460685|NCT05641753|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102460686|NCT05641753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102460687|NCT05641753|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102460688|NCT05641753|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102460689|NCT05641753|Protease Inhibitors|protease inhibitors|mesh-ancestor
102460690|NCT05626621|Mometasone Furoate|mometasone furoate|mesh-list
102460691|NCT05626621|Azelastine|azelastine|mesh-list
102460692|NCT05626621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102460693|NCT05626621|Dermatologic Agents|dermatologic agents|mesh-ancestor
102460694|NCT05626621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102460695|NCT05626621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102460696|NCT05626621|Autonomic Agents|autonomic agents|mesh-ancestor
102460697|NCT05626621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102460698|NCT05626621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460699|NCT05626621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102460700|NCT05626621|Respiratory System Agents|respiratory system agents|mesh-ancestor
102460701|NCT05626621|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
102460702|NCT05626621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102460703|NCT05626621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460704|NCT05626621|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102460705|NCT05626621|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102460706|NCT05626621|Histamine Antagonists|histamine antagonists|mesh-ancestor
102460707|NCT05626621|Histamine Agents|histamine agents|mesh-ancestor
102460708|NCT05626621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102460709|NCT05593094|Trastuzumab|trastuzumab|mesh-list
102460710|NCT05593094|Pertuzumab|pertuzumab|mesh-list
102460711|NCT05593094|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102460712|NCT05593094|Maytansine|maytansine|mesh-list
102460713|NCT05593094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102460714|NCT05593094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460715|NCT05593094|Immunotoxins|immunotoxins|mesh-ancestor
102460716|NCT05593094|Immunoconjugates|immunoconjugates|mesh-ancestor
102460717|NCT05593094|Immunologic Factors|immunologic factors|mesh-ancestor
102460718|NCT05593094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460719|NCT05593094|Tubulin Modulators|tubulin modulators|mesh-ancestor
102460720|NCT05593094|Antimitotic Agents|antimitotic agents|mesh-ancestor
102460721|NCT05593094|Mitosis Modulators|mitosis modulators|mesh-ancestor
102460722|NCT05593094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460723|NCT05593094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102460724|NCT05591677|Cycloserine|cycloserine|mesh-list
102460725|NCT05591677|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102460726|NCT05591677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102460727|NCT05591677|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102460728|NCT05591677|Antitubercular Agents|antitubercular agents|mesh-ancestor
102460729|NCT05591677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102460730|NCT05591677|Antimetabolites|antimetabolites|mesh-ancestor
102460731|NCT05591677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460732|NCT05591118|Anticoagulants|anticoagulants|mesh-list
102460733|NCT05588609|Abiraterone Acetate|abiraterone acetate|mesh-list
102460734|NCT05588609|Afatinib|afatinib|mesh-list
102460735|NCT05588609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460736|NCT05588609|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102460737|NCT05588609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102460738|NCT05588609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460739|NCT05588609|Hormone Antagonists|hormone antagonists|mesh-ancestor
102460740|NCT05588609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102460741|NCT05588609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460742|NCT05588609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102460743|NCT05588609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102460744|NCT05567601|Doxorubicin|doxorubicin|mesh-list
102460745|NCT05567601|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102460746|NCT05567601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102460747|NCT05567601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460748|NCT05567601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102460749|NCT05567601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102460750|NCT05567601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102460751|NCT05567601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460752|NCT05541276|Melatonin|melatonin|mesh-list
102460753|NCT05541276|Antioxidants|antioxidants|mesh-ancestor
102460754|NCT05541276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460755|NCT05541276|Protective Agents|protective agents|mesh-ancestor
102460756|NCT05541276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460757|NCT05541276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102460758|NCT05517174|Vaccines|vaccines|mesh-list
102460759|NCT05517174|Immunologic Factors|immunologic factors|mesh-ancestor
102460760|NCT05517174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460761|NCT05513001|Remibrutinib|remibrutinib|mesh-list
102460762|NCT05513001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102460763|NCT05513001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102460764|NCT05513001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460765|NCT05493761|Denosumab|denosumab|mesh-list
102460766|NCT05493761|Alendronate|alendronate|mesh-list
102460767|NCT05493761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102460768|NCT05493761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460769|NCT05492994|Carbon Monoxide|carbon monoxide|mesh-list
102460770|NCT05492994|Antimetabolites|antimetabolites|mesh-ancestor
102460771|NCT05492994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460772|NCT05492994|Gasotransmitters|gasotransmitters|mesh-ancestor
102460773|NCT05492994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102460774|NCT05492994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460775|NCT05434663|Granisetron|granisetron|mesh-list
102460776|NCT05434663|Antiemetics|antiemetics|mesh-ancestor
102460777|NCT05434663|Autonomic Agents|autonomic agents|mesh-ancestor
102460778|NCT05434663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102460779|NCT05434663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460780|NCT05434663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102460781|NCT05434663|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102460782|NCT05434663|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102460783|NCT05434663|Serotonin Agents|serotonin agents|mesh-ancestor
102460784|NCT05434663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102460785|NCT05434663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460786|NCT05434351|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
102460787|NCT05434351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102460788|NCT05434351|Immunologic Factors|immunologic factors|mesh-ancestor
102460789|NCT05434351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460790|NCT05405257|Oxytocin|oxytocin|mesh-list
102460791|NCT05405257|Oxytocics|oxytocics|mesh-ancestor
102460792|NCT05405257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102460793|NCT05405257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460794|NCT05401292|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102460795|NCT05401292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102460796|NCT05401292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102460797|NCT05401292|Dermatologic Agents|dermatologic agents|mesh-ancestor
102460798|NCT05375630|Vitamin K|vitamin k|mesh-list
102460799|NCT05375630|Vitamin K 2|vitamin k 2|mesh-list
102460800|NCT05375630|Vitamins|vitamins|mesh-ancestor
102460801|NCT05375630|Micronutrients|micronutrients|mesh-ancestor
102460802|NCT05375630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460803|NCT05375630|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102460804|NCT05375630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102460805|NCT05375630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460806|NCT05375630|Hemostatics|hemostatics|mesh-ancestor
102460807|NCT05375630|Coagulants|coagulants|mesh-ancestor
102460808|NCT05358535|Propofol|propofol|mesh-list
102460809|NCT05358535|Etomidate|etomidate|mesh-list
102460810|NCT05358535|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102460811|NCT05358535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102460812|NCT05358535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460813|NCT05358535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102460814|NCT05358535|Anesthetics, General|anesthetics, general|mesh-ancestor
102460815|NCT05358535|Anesthetics|anesthetics|mesh-ancestor
102460816|NCT05349188|Melatonin|melatonin|mesh-list
102460817|NCT05349188|Antioxidants|antioxidants|mesh-ancestor
102460818|NCT05349188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460819|NCT05349188|Protective Agents|protective agents|mesh-ancestor
102460820|NCT05349188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460821|NCT05349188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102460822|NCT05307627|Naltrexone|naltrexone|mesh-list
102460823|NCT05307627|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102460824|NCT05307627|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102460825|NCT05307627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460826|NCT05307627|Sensory System Agents|sensory system agents|mesh-ancestor
102460827|NCT05307627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102460828|NCT05303792|Cytarabine|cytarabine|mesh-list
102460829|NCT05303792|Dexamethasone|dexamethasone|mesh-list
102460830|NCT05303792|Prednisone|prednisone|mesh-list
102460831|NCT05303792|Methylprednisolone|methylprednisolone|mesh-list
102460832|NCT05303792|Cyclophosphamide|cyclophosphamide|mesh-list
102460833|NCT05303792|Rituximab|rituximab|mesh-list
102460834|NCT05303792|Doxorubicin|doxorubicin|mesh-list
102460835|NCT05303792|Methotrexate|methotrexate|mesh-list
102460836|NCT05303792|Vincristine|vincristine|mesh-list
102460838|NCT05303792|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
102460839|NCT05303792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102460840|NCT05303792|Immunologic Factors|immunologic factors|mesh-ancestor
102460841|NCT05303792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460842|NCT05303792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102460843|NCT05303792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102460844|NCT05303792|Alkylating Agents|alkylating agents|mesh-ancestor
102460845|NCT05303792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460846|NCT05303792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460847|NCT05303792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102460848|NCT05303792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102460849|NCT05303792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102460850|NCT05303792|Antiemetics|antiemetics|mesh-ancestor
102460851|NCT05303792|Autonomic Agents|autonomic agents|mesh-ancestor
102460852|NCT05303792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102460853|NCT05303792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102460854|NCT05303792|Glucocorticoids|glucocorticoids|mesh-ancestor
102460855|NCT05303792|Hormones|hormones|mesh-ancestor
102460856|NCT05303792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102460857|NCT05303792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102460858|NCT05303792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102460859|NCT05303792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102460860|NCT05303792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102460861|NCT05303792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102460862|NCT05303792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102460863|NCT05303792|Abortifacient Agents|abortifacient agents|mesh-ancestor
102460864|NCT05303792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102460865|NCT05303792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102460866|NCT05303792|Antimetabolites|antimetabolites|mesh-ancestor
102460867|NCT05303792|Dermatologic Agents|dermatologic agents|mesh-ancestor
102460868|NCT05303792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102460869|NCT05303792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102460870|NCT05303792|Antiviral Agents|antiviral agents|mesh-ancestor
102460871|NCT05303792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102460872|NCT05303792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102460873|NCT05303792|Tubulin Modulators|tubulin modulators|mesh-ancestor
102460874|NCT05303792|Antimitotic Agents|antimitotic agents|mesh-ancestor
102460875|NCT05303792|Mitosis Modulators|mitosis modulators|mesh-ancestor
102460876|NCT05303792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102460877|NCT05303792|Protective Agents|protective agents|mesh-ancestor
102460878|NCT05303792|Immunotoxins|immunotoxins|mesh-ancestor
102460879|NCT05303792|Immunoconjugates|immunoconjugates|mesh-ancestor
102460880|NCT05291338|Doxorubicin|doxorubicin|mesh-list
102460881|NCT05291338|Ethiodized Oil|ethiodized oil|mesh-list
102460882|NCT05291338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102460883|NCT05291338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460884|NCT05291338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102460885|NCT05291338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102460886|NCT05291338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102460887|NCT05291338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460888|NCT05268237|Liraglutide|liraglutide|mesh-list
102460889|NCT05268237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102460890|NCT05268237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460891|NCT05268237|Incretins|incretins|mesh-ancestor
102460892|NCT05268237|Hormones|hormones|mesh-ancestor
102460893|NCT05268237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102460894|NCT05222906|Venglustat|venglustat|mesh-list
102460895|NCT05222906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102460896|NCT05222906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460897|NCT05177796|Paclitaxel|paclitaxel|mesh-list
102460898|NCT05177796|Cyclophosphamide|cyclophosphamide|mesh-list
102460899|NCT05177796|Carboplatin|carboplatin|mesh-list
102460900|NCT05177796|Doxorubicin|doxorubicin|mesh-list
102460901|NCT05177796|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102460902|NCT05177796|Pembrolizumab|pembrolizumab|mesh-list
102460903|NCT05177796|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102460904|NCT05177796|Daunorubicin|daunorubicin|mesh-list
102460905|NCT05177796|Panitumumab|panitumumab|mesh-list
102460906|NCT05177796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102460907|NCT05177796|Antibodies|antibodies|mesh-list
102460908|NCT05177796|Immunoglobulins|immunoglobulins|mesh-list
102460909|NCT05177796|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102460910|NCT05177796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102460911|NCT05177796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460912|NCT05177796|Tubulin Modulators|tubulin modulators|mesh-ancestor
102460913|NCT05177796|Antimitotic Agents|antimitotic agents|mesh-ancestor
102460914|NCT05177796|Mitosis Modulators|mitosis modulators|mesh-ancestor
102460915|NCT05177796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460916|NCT05177796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102460917|NCT05177796|Immunologic Factors|immunologic factors|mesh-ancestor
102460918|NCT05177796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460919|NCT05177796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102460920|NCT05177796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102460921|NCT05177796|Alkylating Agents|alkylating agents|mesh-ancestor
102460922|NCT05177796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102460923|NCT05177796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102460924|NCT05177796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102460925|NCT05177796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102460926|NCT05177796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102460927|NCT05177796|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102460928|NCT05119907|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
102460929|NCT05119907|Immunoconjugates|immunoconjugates|mesh-ancestor
102460930|NCT05119907|Immunologic Factors|immunologic factors|mesh-ancestor
102460931|NCT05119907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460932|NCT05106127|Pembrolizumab|pembrolizumab|mesh-list
102460933|NCT05106127|Lenvatinib|lenvatinib|mesh-list
102460934|NCT05106127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102460935|NCT05106127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460936|NCT05106127|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102460937|NCT05106127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460938|NCT05106127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102460939|NCT05106127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102460940|NCT05077215|Pembrolizumab|pembrolizumab|mesh-list
102460941|NCT05077215|Lenvatinib|lenvatinib|mesh-list
102460942|NCT05077215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102460943|NCT05077215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460944|NCT05077215|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102460945|NCT05077215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460946|NCT05077215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102460947|NCT05077215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102460948|NCT05061420|Pembrolizumab|pembrolizumab|mesh-list
102460949|NCT05061420|Cetuximab|cetuximab|mesh-list
102460950|NCT05061420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102460951|NCT05061420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460952|NCT05061420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102460953|NCT05061420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460954|NCT05028829|Atorvastatin|atorvastatin|mesh-list
102460955|NCT05028829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102460956|NCT05028829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102460957|NCT05028829|Antimetabolites|antimetabolites|mesh-ancestor
102460958|NCT05028829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460959|NCT05028829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102460960|NCT05028829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102460961|NCT05028829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102460962|NCT04975997|Dexamethasone|dexamethasone|mesh-list
102460963|NCT04975997|Bortezomib|bortezomib|mesh-list
102460964|NCT04975997|Daratumumab|daratumumab|mesh-list
102460965|NCT04975997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102460966|NCT04975997|Antiemetics|antiemetics|mesh-ancestor
102460967|NCT04975997|Autonomic Agents|autonomic agents|mesh-ancestor
102460968|NCT04975997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102460969|NCT04975997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460970|NCT04975997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102460971|NCT04975997|Glucocorticoids|glucocorticoids|mesh-ancestor
102460972|NCT04975997|Hormones|hormones|mesh-ancestor
102460973|NCT04975997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102460974|NCT04975997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102460975|NCT04975997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102460976|NCT04925479|Niacinamide|niacinamide|mesh-list
102460977|NCT04925479|Vitamin B Complex|vitamin b complex|mesh-ancestor
102460978|NCT04925479|Vitamins|vitamins|mesh-ancestor
102460979|NCT04925479|Micronutrients|micronutrients|mesh-ancestor
102460980|NCT04925479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460981|NCT04912505|Aspirin|aspirin|mesh-list
102460982|NCT04912505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102460983|NCT04912505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102460984|NCT04912505|Analgesics|analgesics|mesh-ancestor
102460985|NCT04912505|Sensory System Agents|sensory system agents|mesh-ancestor
102460986|NCT04912505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102460987|NCT04912505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102460988|NCT04912505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102460989|NCT04912505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102460990|NCT04912505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102460991|NCT04912505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102460992|NCT04912505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102460993|NCT04912505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102460994|NCT04912505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102460995|NCT04912505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102460996|NCT04912505|Antipyretics|antipyretics|mesh-ancestor
102460997|NCT04882813|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102460998|NCT04882813|Dapagliflozin|dapagliflozin|mesh-list
102460999|NCT04882813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102461000|NCT04882813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461001|NCT04882813|Incretins|incretins|mesh-ancestor
102461003|NCT04882813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102461004|NCT04882813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102461005|NCT04882813|Protease Inhibitors|protease inhibitors|mesh-ancestor
102461006|NCT04882813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461007|NCT04882813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461008|NCT04882813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102461009|NCT04879407|Warfarin|warfarin|mesh-list
102461010|NCT04879407|Rivaroxaban|rivaroxaban|mesh-list
102461011|NCT04879407|Anticoagulants|anticoagulants|mesh-ancestor
102461012|NCT04879407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102461013|NCT04879407|Antithrombins|antithrombins|mesh-ancestor
102461014|NCT04879407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102461015|NCT04879407|Protease Inhibitors|protease inhibitors|mesh-ancestor
102461016|NCT04879407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461017|NCT04879407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461018|NCT04843566|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102461019|NCT04843566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102461020|NCT04840615|Ipilimumab|ipilimumab|mesh-list
102461021|NCT04840615|LMB-100|lmb-100|mesh-list
102461022|NCT04840615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102461023|NCT04840615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461024|NCT04840615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102461025|NCT04840615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461026|NCT04840615|Immunoconjugates|immunoconjugates|mesh-ancestor
102461027|NCT04840615|Immunologic Factors|immunologic factors|mesh-ancestor
102461028|NCT04840615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461029|NCT04839692|Hyaluronic Acid|hyaluronic acid|mesh-list
102461030|NCT04839692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102461031|NCT04839692|Immunologic Factors|immunologic factors|mesh-ancestor
102461032|NCT04839692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461033|NCT04839692|Viscosupplements|viscosupplements|mesh-ancestor
102461034|NCT04839692|Protective Agents|protective agents|mesh-ancestor
102461035|NCT04745910|Rasburicase|rasburicase|mesh-list
102461036|NCT04745910|Uric Acid|uric acid|mesh-list
102461037|NCT04745910|Gout Suppressants|gout suppressants|mesh-ancestor
102461038|NCT04745910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102461039|NCT04745910|Antioxidants|antioxidants|mesh-ancestor
102461040|NCT04745910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461041|NCT04745910|Protective Agents|protective agents|mesh-ancestor
102461042|NCT04745910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461043|NCT04736420|Warfarin|warfarin|mesh-list
102461044|NCT04736420|Rivaroxaban|rivaroxaban|mesh-list
102461045|NCT04736420|Anticoagulants|anticoagulants|mesh-ancestor
102461046|NCT04736420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102461047|NCT04736420|Antithrombins|antithrombins|mesh-ancestor
102461048|NCT04736420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102461049|NCT04736420|Protease Inhibitors|protease inhibitors|mesh-ancestor
102461050|NCT04736420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461051|NCT04736420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461052|NCT04715646|Brivaracetam|brivaracetam|mesh-list
102461053|NCT04715646|Anticonvulsants|anticonvulsants|mesh-ancestor
102461054|NCT04691817|Atezolizumab|atezolizumab|mesh-list
102461055|NCT04691817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102461056|NCT04691817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461057|NCT04691817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102461058|NCT04691817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461059|NCT04673942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102461060|NCT04673942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461061|NCT04673942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102272616|NCT05023967|Metformin|metformin|mesh-list
102461062|NCT04673942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461063|NCT04641351|Triamcinolone|triamcinolone|mesh-list
102461064|NCT04641351|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102461065|NCT04641351|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102461066|NCT04641351|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102461067|NCT04641351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102461068|NCT04641351|Glucocorticoids|glucocorticoids|mesh-ancestor
102461069|NCT04641351|Hormones|hormones|mesh-ancestor
102461070|NCT04641351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102461071|NCT04641351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461072|NCT04641351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102461073|NCT04641351|Immunologic Factors|immunologic factors|mesh-ancestor
102461074|NCT04641351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461075|NCT04641351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461076|NCT04629209|TIC10 compound|tic10 compound|mesh-list
102461077|NCT04629209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461078|NCT04623775|Paclitaxel|paclitaxel|mesh-list
102461079|NCT04623775|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102461080|NCT04623775|Carboplatin|carboplatin|mesh-list
102461081|NCT04623775|Nivolumab|nivolumab|mesh-list
102461082|NCT04623775|Pemetrexed|pemetrexed|mesh-list
102461083|NCT04623775|Relatlimab|relatlimab|mesh-list
102461084|NCT04623775|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102461085|NCT04623775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461086|NCT04623775|Tubulin Modulators|tubulin modulators|mesh-ancestor
102461087|NCT04623775|Antimitotic Agents|antimitotic agents|mesh-ancestor
102461088|NCT04623775|Mitosis Modulators|mitosis modulators|mesh-ancestor
102461089|NCT04623775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461090|NCT04623775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102461091|NCT04623775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102461092|NCT04623775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461093|NCT04623775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102461094|NCT04623775|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102461095|NCT04606264|Dexamethasone|dexamethasone|mesh-list
102461096|NCT04606264|Morphine|morphine|mesh-list
102461097|NCT04606264|Hydromorphone|hydromorphone|mesh-list
102461098|NCT04606264|Ondansetron|ondansetron|mesh-list
102461099|NCT04606264|Aprepitant|aprepitant|mesh-list
102461100|NCT04606264|Dimenhydrinate|dimenhydrinate|mesh-list
102461101|NCT04606264|Perphenazine|perphenazine|mesh-list
102461102|NCT04606264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102461103|NCT04606264|Antiemetics|antiemetics|mesh-ancestor
102461104|NCT04606264|Autonomic Agents|autonomic agents|mesh-ancestor
102461105|NCT04606264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102461106|NCT04606264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461107|NCT04606264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102461108|NCT04606264|Glucocorticoids|glucocorticoids|mesh-ancestor
102461109|NCT04606264|Hormones|hormones|mesh-ancestor
102461110|NCT04606264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102461111|NCT04606264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102461112|NCT04606264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461113|NCT04606264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102461114|NCT04606264|Narcotics|narcotics|mesh-ancestor
102461115|NCT04606264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102461116|NCT04606264|Analgesics|analgesics|mesh-ancestor
102461117|NCT04606264|Sensory System Agents|sensory system agents|mesh-ancestor
102461118|NCT04606264|Antipruritics|antipruritics|mesh-ancestor
102461119|NCT04606264|Dermatologic Agents|dermatologic agents|mesh-ancestor
102461120|NCT04606264|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102461121|NCT04606264|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102461122|NCT04606264|Serotonin Agents|serotonin agents|mesh-ancestor
102461123|NCT04606264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102461124|NCT04606264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461125|NCT04606264|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102461126|NCT04606264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102461127|NCT04606264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102461128|NCT04606264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102461129|NCT04606264|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102461130|NCT04606264|Dopamine Agents|dopamine agents|mesh-ancestor
102461131|NCT04606264|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102461132|NCT04606264|Histamine Antagonists|histamine antagonists|mesh-ancestor
102461133|NCT04606264|Histamine Agents|histamine agents|mesh-ancestor
102461134|NCT04594811|Nivolumab|nivolumab|mesh-list
102461135|NCT04594811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102461136|NCT04594811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461137|NCT04594811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102461138|NCT04594811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461139|NCT04593056|Warfarin|warfarin|mesh-list
102461140|NCT04593056|Rivaroxaban|rivaroxaban|mesh-list
102461141|NCT04593056|Anticoagulants|anticoagulants|mesh-ancestor
102461142|NCT04593056|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102461143|NCT04593056|Antithrombins|antithrombins|mesh-ancestor
102461144|NCT04593056|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102461145|NCT04593056|Protease Inhibitors|protease inhibitors|mesh-ancestor
102461146|NCT04593056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461147|NCT04593056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461148|NCT04566380|Bevacizumab|bevacizumab|mesh-list
102461149|NCT04566380|Nivolumab|nivolumab|mesh-list
102461150|NCT04566380|Capecitabine|capecitabine|mesh-list
102461151|NCT04566380|Oxaliplatin|oxaliplatin|mesh-list
102461152|NCT04566380|Temozolomide|temozolomide|mesh-list
102461153|NCT04566380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102461154|NCT04566380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461155|NCT04566380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102461156|NCT04566380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102461157|NCT04566380|Growth Substances|growth substances|mesh-ancestor
102461158|NCT04566380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461159|NCT04566380|Growth Inhibitors|growth inhibitors|mesh-ancestor
102461160|NCT04566380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102461161|NCT04566380|Antimetabolites|antimetabolites|mesh-ancestor
102091260|NCT05590234|Sensory System Agents|sensory system agents|mesh-ancestor
102461162|NCT04566380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461163|NCT04566380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102461164|NCT04566380|Alkylating Agents|alkylating agents|mesh-ancestor
102461165|NCT04566380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102461166|NCT04561180|Dexamethasone|dexamethasone|mesh-list
102461167|NCT04561180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102461168|NCT04561180|Antiemetics|antiemetics|mesh-ancestor
102461169|NCT04561180|Autonomic Agents|autonomic agents|mesh-ancestor
102461170|NCT04561180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102461171|NCT04561180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461172|NCT04561180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102461173|NCT04561180|Glucocorticoids|glucocorticoids|mesh-ancestor
102461174|NCT04561180|Hormones|hormones|mesh-ancestor
102461175|NCT04561180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102461176|NCT04561180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102461177|NCT04561180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461178|NCT04552288|Benralizumab|benralizumab|mesh-list
102461179|NCT04552288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102461180|NCT04552288|Respiratory System Agents|respiratory system agents|mesh-ancestor
102461181|NCT04500665|Colchicine|colchicine|mesh-list
102461182|NCT04500665|Gout Suppressants|gout suppressants|mesh-ancestor
102461183|NCT04500665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102461184|NCT04500665|Tubulin Modulators|tubulin modulators|mesh-ancestor
102461185|NCT04500665|Antimitotic Agents|antimitotic agents|mesh-ancestor
102461186|NCT04500665|Mitosis Modulators|mitosis modulators|mesh-ancestor
102461187|NCT04500665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461188|NCT04500665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461189|NCT04495881|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102461190|NCT04495881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102461191|NCT04495881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461192|NCT04495881|Incretins|incretins|mesh-ancestor
102461193|NCT04495881|Hormones|hormones|mesh-ancestor
102461194|NCT04495881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102461195|NCT04495881|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102461196|NCT04495881|Protease Inhibitors|protease inhibitors|mesh-ancestor
102461197|NCT04495881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461198|NCT04495881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461199|NCT04486625|Aztreonam|aztreonam|mesh-list
102461200|NCT04486625|Avibactam|avibactam|mesh-list
102461201|NCT04486625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102461202|NCT04486625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102461203|NCT04486625|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102461204|NCT04486625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461205|NCT04486625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461206|NCT04410796|Carboplatin|carboplatin|mesh-list
102461207|NCT04410796|Pemetrexed|pemetrexed|mesh-list
102461208|NCT04410796|Osimertinib|osimertinib|mesh-list
102461209|NCT04410796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461210|NCT04410796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461211|NCT04410796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461212|NCT04410796|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102461213|NCT04410796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102461214|NCT04410796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102461216|NCT04401904|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102461217|NCT04401904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461218|NCT04401904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102461219|NCT04401904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461220|NCT04384107|Vaccines|vaccines|mesh-list
102461221|NCT04384107|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102461222|NCT04384107|Immunologic Factors|immunologic factors|mesh-ancestor
102461223|NCT04384107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461224|NCT04329728|Dexamethasone|dexamethasone|mesh-list
102461225|NCT04329728|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102461226|NCT04329728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102461227|NCT04329728|Antiemetics|antiemetics|mesh-ancestor
102461228|NCT04329728|Autonomic Agents|autonomic agents|mesh-ancestor
102461229|NCT04329728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102461230|NCT04329728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461231|NCT04329728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102461232|NCT04329728|Glucocorticoids|glucocorticoids|mesh-ancestor
102461233|NCT04329728|Hormones|hormones|mesh-ancestor
102461234|NCT04329728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102461235|NCT04329728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102461236|NCT04329728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461237|NCT04298697|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102461238|NCT04298697|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102461239|NCT04298697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102461240|NCT04298697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461241|NCT04298697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461242|NCT04298697|Antiviral Agents|antiviral agents|mesh-ancestor
102461243|NCT04298697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102461244|NCT04298697|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102461245|NCT04298697|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102461246|NCT04280848|Temozolomide|temozolomide|mesh-list
102461247|NCT04280848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102461248|NCT04280848|Alkylating Agents|alkylating agents|mesh-ancestor
102461249|NCT04280848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461250|NCT04280848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461251|NCT04262154|Prednisone|prednisone|mesh-list
102461252|NCT04262154|Atezolizumab|atezolizumab|mesh-list
102461253|NCT04262154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102461254|NCT04262154|Glucocorticoids|glucocorticoids|mesh-ancestor
102461255|NCT04262154|Hormones|hormones|mesh-ancestor
102461256|NCT04262154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102461257|NCT04262154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461258|NCT04262154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102461259|NCT04262154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461260|NCT04262154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102461261|NCT04262154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461262|NCT04262154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102461263|NCT04241601|Aldesleukin|aldesleukin|mesh-list
102461264|NCT04241601|Interleukin-2|interleukin-2|mesh-list
102461265|NCT04241601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461266|NCT04241601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102461267|NCT04241601|Analgesics|analgesics|mesh-ancestor
102461268|NCT04241601|Sensory System Agents|sensory system agents|mesh-ancestor
102461269|NCT04241601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102461270|NCT04241601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461271|NCT04241601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102461272|NCT04241601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102461273|NCT04241601|Antiviral Agents|antiviral agents|mesh-ancestor
102461274|NCT04241601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102461275|NCT04214288|Fulvestrant|fulvestrant|mesh-list
102461276|NCT04214288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102461277|NCT04214288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461278|NCT04214288|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102461279|NCT04214288|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102461280|NCT04214288|Hormone Antagonists|hormone antagonists|mesh-ancestor
102461281|NCT04214288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102461282|NCT04214288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461283|NCT04206787|Afatinib|afatinib|mesh-list
102461284|NCT04206787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461285|NCT04206787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102461286|NCT04206787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461287|NCT04206787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461289|NCT04200651|Prednisolone|prednisolone|mesh-list
102461290|NCT04200651|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102461291|NCT04200651|Methylprednisolone|methylprednisolone|mesh-list
102461292|NCT04200651|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102461293|NCT04200651|Prednisolone acetate|prednisolone acetate|mesh-list
102461294|NCT04200651|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102461295|NCT04200651|Prednisolone phosphate|prednisolone phosphate|mesh-list
102461296|NCT04200651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102461297|NCT04200651|Antiemetics|antiemetics|mesh-ancestor
102461298|NCT04200651|Autonomic Agents|autonomic agents|mesh-ancestor
102461299|NCT04200651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102461300|NCT04200651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461301|NCT04200651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102461302|NCT04200651|Glucocorticoids|glucocorticoids|mesh-ancestor
102461303|NCT04200651|Hormones|hormones|mesh-ancestor
102461304|NCT04200651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102461305|NCT04200651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102461306|NCT04200651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461307|NCT04200651|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102461308|NCT04200651|Protective Agents|protective agents|mesh-ancestor
102461309|NCT04170153|Niraparib|niraparib|mesh-list
102461310|NCT04170153|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102461311|NCT04170153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461312|NCT04170153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461313|NCT04170153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461314|NCT04162015|Carboplatin|carboplatin|mesh-list
102461315|NCT04162015|Nivolumab|nivolumab|mesh-list
102461316|NCT04162015|Pemetrexed|pemetrexed|mesh-list
102461317|NCT04162015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461318|NCT04162015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102461319|NCT04162015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102461320|NCT04162015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461321|NCT04162015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461322|NCT04162015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102461323|NCT04162015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102461324|NCT04150965|Thalidomide|thalidomide|mesh-list
102461325|NCT04150965|Dexamethasone|dexamethasone|mesh-list
102461326|NCT04150965|Dexamethasone acetate|dexamethasone acetate|mesh-list
102461327|NCT04150965|Pomalidomide|pomalidomide|mesh-list
102461328|NCT04150965|Elotuzumab|elotuzumab|mesh-list
102461329|NCT04150965|Relatlimab|relatlimab|mesh-list
102461330|NCT04150965|BB 1101|bb 1101|mesh-list
102461331|NCT04150965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102461332|NCT04150965|Antiemetics|antiemetics|mesh-ancestor
102461333|NCT04150965|Autonomic Agents|autonomic agents|mesh-ancestor
102461334|NCT04150965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102461335|NCT04150965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461336|NCT04150965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102461337|NCT04150965|Glucocorticoids|glucocorticoids|mesh-ancestor
102461338|NCT04150965|Hormones|hormones|mesh-ancestor
102461339|NCT04150965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102461340|NCT04150965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102461341|NCT04150965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461342|NCT04150965|Protease Inhibitors|protease inhibitors|mesh-ancestor
102461343|NCT04150965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461344|NCT04150965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461345|NCT04150965|Immunologic Factors|immunologic factors|mesh-ancestor
102461346|NCT04150965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102461347|NCT04150965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102461348|NCT04150965|Growth Substances|growth substances|mesh-ancestor
102461349|NCT04150965|Growth Inhibitors|growth inhibitors|mesh-ancestor
102461350|NCT04150965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102461351|NCT04150965|Leprostatic Agents|leprostatic agents|mesh-ancestor
102461352|NCT04150965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102461353|NCT04150965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102461354|NCT04150965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102461355|NCT04150965|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102461356|NCT04136353|Hormones|hormones|mesh-list
102461357|NCT04136353|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
102461358|NCT04136353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102272912|NCT04630886|Autonomic Agents|autonomic agents|mesh-ancestor
102461359|NCT04136353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461360|NCT04072822|Prednisone|prednisone|mesh-list
102461361|NCT04072822|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102461362|NCT04072822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102461363|NCT04072822|Glucocorticoids|glucocorticoids|mesh-ancestor
102461364|NCT04072822|Hormones|hormones|mesh-ancestor
102461365|NCT04072822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102461366|NCT04072822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461367|NCT04072822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102461368|NCT04072822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461369|NCT04072822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102461370|NCT04058756|Spartalizumab|spartalizumab|mesh-list
102461371|NCT04058756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102461372|NCT04058756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461373|NCT04058756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102461374|NCT04058756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461375|NCT04031846|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102461376|NCT04031846|Immunologic Factors|immunologic factors|mesh-ancestor
102461377|NCT04031846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461378|NCT04013542|Nivolumab|nivolumab|mesh-list
102461379|NCT04013542|Ipilimumab|ipilimumab|mesh-list
102461380|NCT04013542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102461381|NCT04013542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461382|NCT04013542|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102461383|NCT04013542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461384|NCT03953300|Benralizumab|benralizumab|mesh-list
102461385|NCT03953300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102461386|NCT03953300|Respiratory System Agents|respiratory system agents|mesh-ancestor
102461387|NCT03893448|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102461388|NCT03893448|Immunologic Factors|immunologic factors|mesh-ancestor
102461389|NCT03893448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461390|NCT03692871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102461391|NCT03692871|Immunologic Factors|immunologic factors|mesh-ancestor
102461392|NCT03692871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461393|NCT03677154|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
102461394|NCT03677154|Immunoconjugates|immunoconjugates|mesh-ancestor
102461395|NCT03677154|Immunologic Factors|immunologic factors|mesh-ancestor
102461396|NCT03677154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461397|NCT03667846|Topiramate|topiramate|mesh-list
102461398|NCT03667846|Anticonvulsants|anticonvulsants|mesh-ancestor
102461399|NCT03667846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102461400|NCT03667846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461401|NCT03658447|Pembrolizumab|pembrolizumab|mesh-list
102461402|NCT03658447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102461403|NCT03658447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461404|NCT03658447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102461405|NCT03658447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461406|NCT03649880|Misonidazole|misonidazole|mesh-list
102461407|NCT03649880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461408|NCT03649880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102461409|NCT03649880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102461410|NCT03649880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102461411|NCT03565900|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102461412|NCT03565900|Immunologic Factors|immunologic factors|mesh-ancestor
102461413|NCT03565900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461414|NCT03531762|Tepotinib|tepotinib|mesh-list
102461415|NCT03531762|Omeprazole|omeprazole|mesh-list
102461416|NCT03531762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102461417|NCT03531762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102461418|NCT03531762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102461419|NCT03531762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461420|NCT03531762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461421|NCT03531762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461422|NCT03464045|Empagliflozin|empagliflozin|mesh-list
102461423|NCT03464045|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102461424|NCT03464045|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
102091536|NCT05108688|Sumatriptan|sumatriptan|mesh-list
102461425|NCT03464045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461426|NCT03464045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102461427|NCT03464045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461428|NCT03464045|Protease Inhibitors|protease inhibitors|mesh-ancestor
102461429|NCT03464045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461430|NCT03462459|Vancomycin|vancomycin|mesh-list
102461431|NCT03462459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102461432|NCT03462459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102272986|NCT04585815|Axitinib|axitinib|mesh-list
102461433|NCT03443869|Valganciclovir|valganciclovir|mesh-list
102461434|NCT03443869|Acyclovir|acyclovir|mesh-list
102461435|NCT03443869|Letermovir|letermovir|mesh-list
102461436|NCT03443869|Antiviral Agents|antiviral agents|mesh-ancestor
102461437|NCT03443869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102461438|NCT03443869|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102461439|NCT03443869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461440|NCT03443869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461441|NCT03443869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461442|NCT03321630|Pembrolizumab|pembrolizumab|mesh-list
102461443|NCT03321630|Lenvatinib|lenvatinib|mesh-list
102461444|NCT03321630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102461445|NCT03321630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461446|NCT03321630|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102461447|NCT03321630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461448|NCT03321630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102461449|NCT03321630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461450|NCT03253796|Golimumab|golimumab|mesh-list
102461451|NCT03253796|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102461452|NCT03253796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102461453|NCT03253796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102461454|NCT03253796|Immunologic Factors|immunologic factors|mesh-ancestor
102461455|NCT03253796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461456|NCT03241940|Cyclophosphamide|cyclophosphamide|mesh-list
102461457|NCT03241940|Fludarabine|fludarabine|mesh-list
102461458|NCT03241940|Fludarabine phosphate|fludarabine phosphate|mesh-list
102461459|NCT03241940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102461460|NCT03241940|Immunologic Factors|immunologic factors|mesh-ancestor
102461461|NCT03241940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461462|NCT03241940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102461463|NCT03241940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102461464|NCT03241940|Alkylating Agents|alkylating agents|mesh-ancestor
102461465|NCT03241940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461466|NCT03241940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461467|NCT03241940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102461468|NCT03241940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102461469|NCT03241940|Antimetabolites|antimetabolites|mesh-ancestor
102461470|NCT03233854|Cyclophosphamide|cyclophosphamide|mesh-list
102461471|NCT03233854|Fludarabine|fludarabine|mesh-list
102461472|NCT03233854|Fludarabine phosphate|fludarabine phosphate|mesh-list
102461473|NCT03233854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102461474|NCT03233854|Immunologic Factors|immunologic factors|mesh-ancestor
102461475|NCT03233854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461476|NCT03233854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102461477|NCT03233854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102461478|NCT03233854|Alkylating Agents|alkylating agents|mesh-ancestor
102461479|NCT03233854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461480|NCT03233854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461481|NCT03233854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102461482|NCT03233854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102461483|NCT03233854|Antimetabolites|antimetabolites|mesh-ancestor
102461484|NCT03132116|Gentamicins|gentamicins|mesh-list
102461485|NCT03132116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102461486|NCT03132116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102461487|NCT03132116|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102461488|NCT03132116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461489|NCT03132116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461490|NCT03029143|Vedolizumab|vedolizumab|mesh-list
102461491|NCT03029143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102461492|NCT02959164|Gemcitabine|gemcitabine|mesh-list
102461493|NCT02959164|Decitabine|decitabine|mesh-list
102461494|NCT02959164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102461495|NCT02959164|Antimetabolites|antimetabolites|mesh-ancestor
102091591|NCT05076617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102461496|NCT02959164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461497|NCT02959164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461498|NCT02959164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461499|NCT02803502|Thrombin|thrombin|mesh-list
102461500|NCT02803502|Hemostatics|hemostatics|mesh-ancestor
102461501|NCT02803502|Coagulants|coagulants|mesh-ancestor
102461502|NCT02763579|Carboplatin|carboplatin|mesh-list
102461503|NCT02763579|Etoposide|etoposide|mesh-list
102461504|NCT02763579|Atezolizumab|atezolizumab|mesh-list
102461505|NCT02763579|Antibodies|antibodies|mesh-list
102461506|NCT02763579|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102461507|NCT02763579|Immunologic Factors|immunologic factors|mesh-ancestor
102273062|NCT04556773|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
102461508|NCT02763579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461509|NCT02763579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461510|NCT02763579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102461511|NCT02763579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102461512|NCT02763579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102461513|NCT02763579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461514|NCT02763579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461515|NCT02763579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102461516|NCT02763579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102461517|NCT02618577|Edoxaban|edoxaban|mesh-list
102461518|NCT02618577|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102461519|NCT02618577|Antithrombins|antithrombins|mesh-ancestor
102461520|NCT02618577|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102461521|NCT02618577|Protease Inhibitors|protease inhibitors|mesh-ancestor
102461522|NCT02618577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461523|NCT02618577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461524|NCT02618577|Anticoagulants|anticoagulants|mesh-ancestor
102461525|NCT02607722|Nintedanib|nintedanib|mesh-list
102461526|NCT02607722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461527|NCT02607722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102461528|NCT02607722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461529|NCT02607722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461530|NCT02572791|Chlorhexidine|chlorhexidine|mesh-list
102461531|NCT02572791|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102461532|NCT02572791|Mupirocin|mupirocin|mesh-list
102461533|NCT02572791|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102461534|NCT02572791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102461535|NCT02572791|Disinfectants|disinfectants|mesh-ancestor
102461536|NCT02572791|Dermatologic Agents|dermatologic agents|mesh-ancestor
102461537|NCT02572791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102461538|NCT02572791|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102461539|NCT02572791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461540|NCT02572791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461541|NCT02550652|Mycophenolic Acid|mycophenolic acid|mesh-list
102461542|NCT02550652|Prednisone|prednisone|mesh-list
102461543|NCT02550652|Methylprednisolone|methylprednisolone|mesh-list
102461544|NCT02550652|Obinutuzumab|obinutuzumab|mesh-list
102461545|NCT02550652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102461546|NCT02550652|Glucocorticoids|glucocorticoids|mesh-ancestor
102461547|NCT02550652|Hormones|hormones|mesh-ancestor
102461548|NCT02550652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102461549|NCT02550652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461550|NCT02550652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102461551|NCT02550652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461552|NCT02550652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102461553|NCT02550652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102461554|NCT02550652|Antitubercular Agents|antitubercular agents|mesh-ancestor
102461555|NCT02550652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102461556|NCT02550652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102461557|NCT02550652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461558|NCT02550652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461559|NCT02550652|Antiemetics|antiemetics|mesh-ancestor
102461560|NCT02550652|Autonomic Agents|autonomic agents|mesh-ancestor
102461561|NCT02550652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102461562|NCT02550652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102461563|NCT02550652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102461564|NCT02550652|Protective Agents|protective agents|mesh-ancestor
102461565|NCT02550652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102461566|NCT02281084|Azacitidine|azacitidine|mesh-list
102461567|NCT02281084|Durvalumab|durvalumab|mesh-list
102461568|NCT02281084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102091737|NCT04772222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102091738|NCT04772222|Adrenergic Agents|adrenergic agents|mesh-ancestor
102091739|NCT04772222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102091740|NCT04772222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091741|NCT04772222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102461569|NCT02281084|Antimetabolites|antimetabolites|mesh-ancestor
102461570|NCT02281084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461571|NCT02281084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461572|NCT02281084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461573|NCT02281084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102461574|NCT01966120|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102461575|NCT01966120|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102461576|NCT01966120|Dermatologic Agents|dermatologic agents|mesh-ancestor
102461577|NCT01101438|Metformin|metformin|mesh-list
102461578|NCT01101438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102461579|NCT01101438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461580|NCT00840944|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102461581|NCT00840944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461582|NCT00840944|Luteolytic Agents|luteolytic agents|mesh-ancestor
102461583|NCT00840944|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102461584|NCT00840944|Contraceptive Agents|contraceptive agents|mesh-ancestor
102461585|NCT00840944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102461586|NCT00840944|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102461587|NCT00840944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102461588|NCT00840944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461589|NCT00097474|Hydrocortisone|hydrocortisone|mesh-list
102461590|NCT00097474|Melatonin|melatonin|mesh-list
102461591|NCT00097474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102461592|NCT00097474|Antioxidants|antioxidants|mesh-ancestor
102461593|NCT00097474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461594|NCT00097474|Protective Agents|protective agents|mesh-ancestor
102461595|NCT00097474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461596|NCT00097474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102461597|NCT00386477|Povidone-Iodine|povidone-iodine|mesh-list
102461598|NCT00386477|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102461599|NCT00386477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102461600|NCT00453193|Alemtuzumab|alemtuzumab|mesh-list
102461601|NCT00453193|Pentostatin|pentostatin|mesh-list
102461602|NCT00453193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102461603|NCT00453193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461604|NCT00453193|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
102461605|NCT00453193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461606|NCT00453193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461607|NCT00387023|Rituximab|rituximab|mesh-list
102461608|NCT00387023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102461609|NCT00387023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461610|NCT00387023|Immunologic Factors|immunologic factors|mesh-ancestor
102461611|NCT00387023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461612|NCT00387023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102461613|NCT00472849|Cytarabine|cytarabine|mesh-list
102461614|NCT00472849|Rituximab|rituximab|mesh-list
102461615|NCT00472849|Oxaliplatin|oxaliplatin|mesh-list
102461616|NCT00472849|Fludarabine|fludarabine|mesh-list
102461617|NCT00472849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102461618|NCT00472849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461619|NCT00472849|Immunologic Factors|immunologic factors|mesh-ancestor
102461620|NCT00472849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461621|NCT00472849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102461622|NCT00472849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102461623|NCT00472849|Antimetabolites|antimetabolites|mesh-ancestor
102461624|NCT00472849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461625|NCT00472849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102461626|NCT00472849|Antiviral Agents|antiviral agents|mesh-ancestor
102461627|NCT00472849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102461628|NCT00453895|Sunitinib|sunitinib|mesh-list
102461629|NCT00453895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461630|NCT00453895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102461631|NCT00453895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102461632|NCT00453895|Growth Substances|growth substances|mesh-ancestor
102461633|NCT00453895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461634|NCT00453895|Growth Inhibitors|growth inhibitors|mesh-ancestor
102461635|NCT00453895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102461636|NCT00453895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461637|NCT00453895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461638|NCT00528541|Botulinum Toxins|botulinum toxins|mesh-list
102461639|NCT00528541|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102461640|NCT00528541|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102461641|NCT00528541|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102461642|NCT00528541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102461643|NCT00528541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461644|NCT00528541|Cholinergic Agents|cholinergic agents|mesh-ancestor
102461645|NCT00528541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102461646|NCT00528541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461647|NCT00528541|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102461648|NCT00528541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102461649|NCT00409565|Bevacizumab|bevacizumab|mesh-list
102461650|NCT00409565|Cetuximab|cetuximab|mesh-list
102461651|NCT00409565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102461652|NCT00409565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461653|NCT00409565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102461654|NCT00409565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102461655|NCT00409565|Growth Substances|growth substances|mesh-ancestor
102461656|NCT00409565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461657|NCT00409565|Growth Inhibitors|growth inhibitors|mesh-ancestor
102461658|NCT00475501|Methyltestosterone|methyltestosterone|mesh-list
102461659|NCT00475501|Finasteride|finasteride|mesh-list
102461660|NCT00475501|Testosterone|testosterone|mesh-list
102461661|NCT00475501|Testosterone undecanoate|testosterone undecanoate|mesh-list
102461662|NCT00475501|Testosterone enanthate|testosterone enanthate|mesh-list
102461663|NCT00475501|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102461664|NCT00475501|Androgens|androgens|mesh-ancestor
102461665|NCT00475501|Hormones|hormones|mesh-ancestor
102461666|NCT00475501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102461667|NCT00475501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461668|NCT00475501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102461669|NCT00475501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461670|NCT00475501|Anabolic Agents|anabolic agents|mesh-ancestor
102461671|NCT00475501|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102461672|NCT00475501|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102461673|NCT00475501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461674|NCT00475501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461675|NCT00475501|Hormone Antagonists|hormone antagonists|mesh-ancestor
102461676|NCT00475501|Urological Agents|urological agents|mesh-ancestor
102461677|NCT00529555|Minocycline|minocycline|mesh-list
102461678|NCT00529555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102461679|NCT00529555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102461680|NCT00387335|Sunitinib|sunitinib|mesh-list
102461681|NCT00387335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461682|NCT00387335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102461683|NCT00387335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102461684|NCT00387335|Growth Substances|growth substances|mesh-ancestor
102461685|NCT00387335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461686|NCT00387335|Growth Inhibitors|growth inhibitors|mesh-ancestor
102461687|NCT00387335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102461688|NCT00387335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461689|NCT00387335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461690|NCT01797757|Orlistat|orlistat|mesh-list
102461691|NCT01797757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461692|NCT01797757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461693|NCT01797757|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102461694|NCT01797757|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102461695|NCT01796899|Brivaracetam|brivaracetam|mesh-list
102461696|NCT01796899|Anticonvulsants|anticonvulsants|mesh-ancestor
102461697|NCT00477451|Alprazolam|alprazolam|mesh-list
102461698|NCT00477451|Doxapram|doxapram|mesh-list
102461699|NCT00477451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102461700|NCT00477451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102461701|NCT00477451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461702|NCT00477451|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102461703|NCT00477451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102461704|NCT00477451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102461705|NCT00477451|GABA Modulators|gaba modulators|mesh-ancestor
102461706|NCT00477451|GABA Agents|gaba agents|mesh-ancestor
102461707|NCT00477451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102461708|NCT00477451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461709|NCT00477451|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102461710|NCT00477451|Respiratory System Agents|respiratory system agents|mesh-ancestor
102461711|NCT00530803|Lidocaine|lidocaine|mesh-list
102461712|NCT00530803|Tetracaine|tetracaine|mesh-list
102461713|NCT00530803|Prilocaine|prilocaine|mesh-list
102461714|NCT00530803|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
102461715|NCT00530803|Anesthetics, Local|anesthetics, local|mesh-ancestor
102461716|NCT00530803|Anesthetics|anesthetics|mesh-ancestor
102461717|NCT00530803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102461718|NCT00530803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461719|NCT00530803|Sensory System Agents|sensory system agents|mesh-ancestor
102461720|NCT00530803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102461721|NCT00530803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102461722|NCT00530803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102461723|NCT00530803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102461724|NCT00530803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102461725|NCT00530803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461726|NCT00530803|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
102461727|NCT04372927|Cisplatin|cisplatin|mesh-list
102461728|NCT04372927|Etoposide|etoposide|mesh-list
102461729|NCT04372927|Pemetrexed|pemetrexed|mesh-list
102461730|NCT04372927|Etoposide phosphate|etoposide phosphate|mesh-list
102461731|NCT04372927|Durvalumab|durvalumab|mesh-list
102461732|NCT04372927|Podophyllotoxin|podophyllotoxin|mesh-list
102461733|NCT04372927|Immunoglobulins|immunoglobulins|mesh-list
102461734|NCT04372927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102461735|NCT04372927|Immunoglobulin G|immunoglobulin g|mesh-list
102461736|NCT04372927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461737|NCT04372927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102461738|NCT04372927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102461739|NCT04372927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102461740|NCT04372927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461741|NCT04372927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461742|NCT04372927|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102461743|NCT04372927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102461744|NCT04372927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102461745|NCT04372927|Immunologic Factors|immunologic factors|mesh-ancestor
102461746|NCT04372927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461747|NCT04372927|Keratolytic Agents|keratolytic agents|mesh-ancestor
102461748|NCT04372927|Dermatologic Agents|dermatologic agents|mesh-ancestor
102461749|NCT04372927|Tubulin Modulators|tubulin modulators|mesh-ancestor
102461750|NCT04372927|Antimitotic Agents|antimitotic agents|mesh-ancestor
102461751|NCT04372927|Mitosis Modulators|mitosis modulators|mesh-ancestor
102461753|NCT01381874|Prednisolone|prednisolone|mesh-list
102461754|NCT01381874|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102461755|NCT01381874|Methylprednisolone|methylprednisolone|mesh-list
102461756|NCT01381874|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102461757|NCT01381874|Prednisolone acetate|prednisolone acetate|mesh-list
102461758|NCT01381874|Exemestane|exemestane|mesh-list
102461759|NCT01381874|Abiraterone Acetate|abiraterone acetate|mesh-list
102461760|NCT01381874|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102461761|NCT01381874|Prednisolone phosphate|prednisolone phosphate|mesh-list
102461762|NCT01381874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102461763|NCT01381874|Glucocorticoids|glucocorticoids|mesh-ancestor
102461764|NCT01381874|Hormones|hormones|mesh-ancestor
102461765|NCT01381874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102461766|NCT01381874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461767|NCT01381874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102461768|NCT01381874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461769|NCT01381874|Antiemetics|antiemetics|mesh-ancestor
102461770|NCT01381874|Autonomic Agents|autonomic agents|mesh-ancestor
102461771|NCT01381874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102461772|NCT01381874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102461773|NCT01381874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102461774|NCT01381874|Protective Agents|protective agents|mesh-ancestor
102461775|NCT01381874|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102461776|NCT01381874|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102461777|NCT01381874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461778|NCT01381874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461779|NCT01381874|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102461780|NCT01381874|Hormone Antagonists|hormone antagonists|mesh-ancestor
102461781|NCT01381874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102461782|NCT01399190|Bevacizumab|bevacizumab|mesh-list
102461783|NCT01399190|Capecitabine|capecitabine|mesh-list
102461784|NCT01399190|Oxaliplatin|oxaliplatin|mesh-list
102461785|NCT01399190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102461786|NCT01399190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461787|NCT01399190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102461788|NCT01399190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102461789|NCT01399190|Growth Substances|growth substances|mesh-ancestor
102461790|NCT01399190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461791|NCT01399190|Growth Inhibitors|growth inhibitors|mesh-ancestor
102461792|NCT01399190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102461793|NCT01399190|Antimetabolites|antimetabolites|mesh-ancestor
102461794|NCT01399190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461795|NCT01381718|Modafinil|modafinil|mesh-list
102461796|NCT01381718|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102461797|NCT01381718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461798|NCT01381718|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102461799|NCT01381718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102461800|NCT01381718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102461801|NCT01381718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461802|NCT05365178|Fulvestrant|fulvestrant|mesh-list
102461803|NCT05365178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102461804|NCT05365178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461805|NCT05365178|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102461806|NCT05365178|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102461807|NCT05365178|Hormone Antagonists|hormone antagonists|mesh-ancestor
102461808|NCT05365178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102461809|NCT05365178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461811|NCT00479089|Docetaxel|docetaxel|mesh-list
102461812|NCT00479089|Gefitinib|gefitinib|mesh-list
102461813|NCT00479089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102461814|NCT00479089|Antiemetics|antiemetics|mesh-ancestor
102461815|NCT00479089|Autonomic Agents|autonomic agents|mesh-ancestor
102461816|NCT00479089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102461817|NCT00479089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461818|NCT00479089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102461819|NCT00479089|Glucocorticoids|glucocorticoids|mesh-ancestor
102461820|NCT00479089|Hormones|hormones|mesh-ancestor
102461821|NCT00479089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102461822|NCT00479089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102461823|NCT00479089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461824|NCT00479089|Tubulin Modulators|tubulin modulators|mesh-ancestor
102461825|NCT00479089|Antimitotic Agents|antimitotic agents|mesh-ancestor
102461826|NCT00479089|Mitosis Modulators|mitosis modulators|mesh-ancestor
102461827|NCT00479089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461828|NCT00479089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102461829|NCT00479089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461830|NCT01398956|Levetiracetam|levetiracetam|mesh-list
102461831|NCT01398956|Anticonvulsants|anticonvulsants|mesh-ancestor
102461832|NCT01398956|Nootropic Agents|nootropic agents|mesh-ancestor
102461833|NCT00410423|Cytarabine|cytarabine|mesh-list
102461834|NCT00410423|Etoposide|etoposide|mesh-list
102461835|NCT00410423|Mitoxantrone|mitoxantrone|mesh-list
102461836|NCT00410423|Bortezomib|bortezomib|mesh-list
102461837|NCT00410423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102461838|NCT00410423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461839|NCT00410423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102461840|NCT00410423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102461841|NCT00410423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461842|NCT00410423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461843|NCT00410423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102461844|NCT00410423|Antimetabolites|antimetabolites|mesh-ancestor
102461845|NCT00410423|Antiviral Agents|antiviral agents|mesh-ancestor
102461846|NCT00410423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102461847|NCT00410423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102461848|NCT00410423|Immunologic Factors|immunologic factors|mesh-ancestor
102461849|NCT00410423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461850|NCT00410423|Analgesics|analgesics|mesh-ancestor
102461851|NCT00410423|Sensory System Agents|sensory system agents|mesh-ancestor
102461852|NCT00410423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102461853|NCT00387959|Cyclosporine|cyclosporine|mesh-list
102461854|NCT00387959|Mycophenolic Acid|mycophenolic acid|mesh-list
102461855|NCT00387959|Cyclophosphamide|cyclophosphamide|mesh-list
102461856|NCT00387959|Rituximab|rituximab|mesh-list
102461857|NCT00387959|Fludarabine|fludarabine|mesh-list
102461858|NCT00387959|Fludarabine phosphate|fludarabine phosphate|mesh-list
102461859|NCT00387959|Cyclosporins|cyclosporins|mesh-list
102461860|NCT00387959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102461861|NCT00387959|Immunologic Factors|immunologic factors|mesh-ancestor
102461862|NCT00387959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461863|NCT00387959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102461864|NCT00387959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102461865|NCT00387959|Alkylating Agents|alkylating agents|mesh-ancestor
102461866|NCT00387959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461867|NCT00387959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461868|NCT00387959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102461869|NCT00387959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102461870|NCT00387959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102461871|NCT00387959|Antimetabolites|antimetabolites|mesh-ancestor
102461872|NCT00387959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461873|NCT00387959|Antifungal Agents|antifungal agents|mesh-ancestor
102461874|NCT00387959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102461875|NCT00387959|Dermatologic Agents|dermatologic agents|mesh-ancestor
102461876|NCT00387959|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102461877|NCT00387959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102461878|NCT00387959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102461879|NCT00387959|Antitubercular Agents|antitubercular agents|mesh-ancestor
102461880|NCT00387959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102461881|NCT00410891|Gatifloxacin|gatifloxacin|mesh-list
102461882|NCT00410891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102461883|NCT00410891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102461884|NCT00410891|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102461885|NCT00410891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102461886|NCT00410891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102461887|NCT00410891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102461888|NCT00410891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461889|NCT00410891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461890|NCT00410891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461891|NCT01381562|Meropenem|meropenem|mesh-list
102461892|NCT01381562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102461893|NCT01381562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102461894|NCT01381016|Hormones|hormones|mesh-list
102461895|NCT01381016|Estradiol|estradiol|mesh-list
102461896|NCT01381016|Progesterone|progesterone|mesh-list
102461897|NCT01381016|Estrogens|estrogens|mesh-list
102461898|NCT01381016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102461899|NCT01381016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461900|NCT01381016|Progestins|progestins|mesh-ancestor
102461901|NCT00412451|Plasminogen|plasminogen|mesh-list
102461902|NCT00412451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102461903|NCT00412451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102461904|NCT00412451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461905|NCT01398410|Rabeprazole|rabeprazole|mesh-list
102461906|NCT01398410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102461907|NCT01398410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102461908|NCT01398410|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102461909|NCT01398410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461910|NCT01398410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461911|NCT00412529|Entecavir|entecavir|mesh-list
102461912|NCT00412529|Telbivudine|telbivudine|mesh-list
102461913|NCT00412529|Antiviral Agents|antiviral agents|mesh-ancestor
102461914|NCT00412529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102461915|NCT00412529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102461916|NCT00412529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461917|NCT00412529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461918|NCT00412841|Atorvastatin|atorvastatin|mesh-list
102461919|NCT00412841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102461920|NCT00412841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102461921|NCT00412841|Antimetabolites|antimetabolites|mesh-ancestor
102461922|NCT00412841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461923|NCT00412841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102461924|NCT00412841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102461925|NCT00412841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461926|NCT01796483|Clonidine|clonidine|mesh-list
102461927|NCT01796483|Analgesics|analgesics|mesh-ancestor
102461928|NCT01796483|Sensory System Agents|sensory system agents|mesh-ancestor
102461929|NCT01796483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102461930|NCT01796483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461931|NCT01796483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102461932|NCT01796483|Sympatholytics|sympatholytics|mesh-ancestor
102461933|NCT01796483|Autonomic Agents|autonomic agents|mesh-ancestor
102461934|NCT01796483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102461935|NCT01796483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102461936|NCT01796483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102461937|NCT01796483|Adrenergic Agents|adrenergic agents|mesh-ancestor
102461938|NCT01796483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102461939|NCT01796483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461940|NCT00414167|Bupropion|bupropion|mesh-list
102461941|NCT00414167|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102461942|NCT00414167|Antidepressive Agents|antidepressive agents|mesh-ancestor
102461943|NCT00414167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102461944|NCT00414167|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102461945|NCT00414167|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102461946|NCT00414167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102461947|NCT00414167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461948|NCT00414167|Dopamine Agents|dopamine agents|mesh-ancestor
102461949|NCT00414167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102461950|NCT00414167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461951|NCT00414167|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102461952|NCT00414167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102461953|NCT00414167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461954|NCT01380782|Nintedanib|nintedanib|mesh-list
102461955|NCT01380782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461956|NCT01380782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102461957|NCT01380782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461958|NCT01380782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461959|NCT00534001|Bupropion|bupropion|mesh-list
102461960|NCT00534001|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102461961|NCT00534001|Antidepressive Agents|antidepressive agents|mesh-ancestor
102461962|NCT00534001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102461963|NCT00534001|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102461964|NCT00534001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102461965|NCT00534001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102461966|NCT00534001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461967|NCT00534001|Dopamine Agents|dopamine agents|mesh-ancestor
102461968|NCT00534001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102461969|NCT00534001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461970|NCT00534001|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102461971|NCT00534001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102461972|NCT00534001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461973|NCT00481351|Simvastatin|simvastatin|mesh-list
102461974|NCT00481351|Ezetimibe|ezetimibe|mesh-list
102461975|NCT00481351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102461976|NCT00481351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102461977|NCT00481351|Antimetabolites|antimetabolites|mesh-ancestor
102461978|NCT00481351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461979|NCT00481351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102461980|NCT00481351|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102461981|NCT00481351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461982|NCT00455975|Bevacizumab|bevacizumab|mesh-list
102461983|NCT00455975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102461984|NCT00455975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102461985|NCT00455975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102461986|NCT00455975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102461987|NCT00455975|Growth Substances|growth substances|mesh-ancestor
102461988|NCT00455975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102461989|NCT00455975|Growth Inhibitors|growth inhibitors|mesh-ancestor
102461990|NCT05366192|Ritonavir|ritonavir|mesh-list
102461991|NCT05366192|Nirmatrelvir|nirmatrelvir|mesh-list
102461992|NCT05366192|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102461993|NCT05366192|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102461994|NCT05366192|Protease Inhibitors|protease inhibitors|mesh-ancestor
102461995|NCT05366192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102461996|NCT05366192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102461997|NCT05366192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102461998|NCT05366192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102461999|NCT05366192|Antiviral Agents|antiviral agents|mesh-ancestor
102462000|NCT05366192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102462001|NCT05366192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102462002|NCT05366192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102462003|NCT04013672|Pembrolizumab|pembrolizumab|mesh-list
102462004|NCT04013672|Sargramostim|sargramostim|mesh-list
102462005|NCT04013672|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
102462006|NCT04013672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102462007|NCT04013672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102462008|NCT04013672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102462009|NCT04013672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462010|NCT04013672|Immunologic Factors|immunologic factors|mesh-ancestor
102462011|NCT04013672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462012|NCT04013672|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102462013|NCT02078882|Abatacept|abatacept|mesh-list
102462014|NCT02078882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102462015|NCT02078882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462016|NCT02078882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102462017|NCT02078882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102462018|NCT02078882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102462019|NCT02078882|Immunologic Factors|immunologic factors|mesh-ancestor
102462020|NCT02078882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462021|NCT02078882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102462022|NCT00458237|Trastuzumab|trastuzumab|mesh-list
102462023|NCT00458237|Everolimus|everolimus|mesh-list
102462024|NCT00458237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102462025|NCT00458237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102462026|NCT00458237|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102462027|NCT00458237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102462028|NCT00458237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102462029|NCT00458237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462030|NCT00458237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102462031|NCT00458237|Immunologic Factors|immunologic factors|mesh-ancestor
102273619|NCT04150614|Hormones|hormones|mesh-ancestor
102462032|NCT00458237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462033|NCT00418457|Anesthetics|anesthetics|mesh-list
102462034|NCT00418457|Propofol|propofol|mesh-list
102462035|NCT00418457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102462036|NCT00418457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462037|NCT00418457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102462038|NCT00418457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102462039|NCT00418457|Anesthetics, General|anesthetics, general|mesh-ancestor
102462040|NCT01397552|Dexamethasone|dexamethasone|mesh-list
102462041|NCT01397552|Methylprednisolone|methylprednisolone|mesh-list
102462042|NCT01397552|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102462043|NCT01397552|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102462044|NCT01397552|Prednisolone|prednisolone|mesh-list
102462045|NCT01397552|Prednisolone acetate|prednisolone acetate|mesh-list
102092144|NCT03402945|Cefazolin|cefazolin|mesh-list
102462046|NCT01397552|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102462047|NCT01397552|Prednisolone phosphate|prednisolone phosphate|mesh-list
102462048|NCT01397552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102462049|NCT01397552|Antiemetics|antiemetics|mesh-ancestor
102462050|NCT01397552|Autonomic Agents|autonomic agents|mesh-ancestor
102462051|NCT01397552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102462052|NCT01397552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462053|NCT01397552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102462054|NCT01397552|Glucocorticoids|glucocorticoids|mesh-ancestor
102462055|NCT01397552|Hormones|hormones|mesh-ancestor
102462056|NCT01397552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102462057|NCT01397552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102462058|NCT01397552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102462059|NCT01397552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102462060|NCT01397552|Protective Agents|protective agents|mesh-ancestor
102462061|NCT05368376|Metoprolol|metoprolol|mesh-list
102462062|NCT05368376|Labetalol|labetalol|mesh-list
102462063|NCT05368376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102462064|NCT05368376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102462065|NCT05368376|Sympatholytics|sympatholytics|mesh-ancestor
102462066|NCT05368376|Autonomic Agents|autonomic agents|mesh-ancestor
102462067|NCT05368376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102462068|NCT05368376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462069|NCT05368376|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102462070|NCT05368376|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102462071|NCT05368376|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102462072|NCT05368376|Adrenergic Agents|adrenergic agents|mesh-ancestor
102462073|NCT05368376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102462074|NCT05368376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462075|NCT05368376|Sympathomimetics|sympathomimetics|mesh-ancestor
102462076|NCT05368376|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102462077|NCT05368376|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102462078|NCT00482911|Cyclophosphamide|cyclophosphamide|mesh-list
102462079|NCT00482911|Lenalidomide|lenalidomide|mesh-list
102462080|NCT00482911|Sunitinib|sunitinib|mesh-list
102462081|NCT00482911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102462082|NCT00482911|Immunologic Factors|immunologic factors|mesh-ancestor
102462083|NCT00482911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462084|NCT00482911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102462085|NCT00482911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102462086|NCT00482911|Alkylating Agents|alkylating agents|mesh-ancestor
102462087|NCT00482911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462088|NCT00482911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102462089|NCT00482911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102462090|NCT00482911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102462091|NCT00482911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102462092|NCT00482911|Growth Substances|growth substances|mesh-ancestor
102462093|NCT00482911|Growth Inhibitors|growth inhibitors|mesh-ancestor
102462094|NCT00482911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102462095|NCT00482911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102462096|NCT01397162|Fluticasone|fluticasone|mesh-list
102462098|NCT01397162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102462099|NCT01397162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102462100|NCT01397162|Autonomic Agents|autonomic agents|mesh-ancestor
102462101|NCT01397162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102462102|NCT01397162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462103|NCT01397162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102462104|NCT01397162|Respiratory System Agents|respiratory system agents|mesh-ancestor
102462105|NCT01397162|Dermatologic Agents|dermatologic agents|mesh-ancestor
102462106|NCT01397162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102462107|NCT05362916|Letermovir|letermovir|mesh-list
102462108|NCT05362916|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102462109|NCT05362916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102462110|NCT05362916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462111|NCT05362916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102462112|NCT05362916|Antiviral Agents|antiviral agents|mesh-ancestor
102462113|NCT05362916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102462114|NCT00483223|Carboplatin|carboplatin|mesh-list
102462115|NCT00483223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102462116|NCT01397084|Esomeprazole|esomeprazole|mesh-list
102462117|NCT01397084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102462118|NCT01397084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102462119|NCT01397084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102462120|NCT01397084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102462121|NCT01397084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462123|NCT00420017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102462124|NCT00420017|Vasodilator Agents|vasodilator agents|mesh-ancestor
102462125|NCT00420017|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102462126|NCT00420017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102462127|NCT00420017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462128|NCT00420017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102462129|NCT00420017|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102462130|NCT00420017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102462131|NCT00420017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102462132|NCT00420017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102462133|NCT00420017|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102462134|NCT00420017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102462135|NCT00484393|Tetracaine|tetracaine|mesh-list
102462136|NCT00484393|Anesthetics, Local|anesthetics, local|mesh-ancestor
102462137|NCT00484393|Anesthetics|anesthetics|mesh-ancestor
102462138|NCT00484393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102462139|NCT00484393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462140|NCT00484393|Sensory System Agents|sensory system agents|mesh-ancestor
102462141|NCT00484393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102462142|NCT00485485|Docetaxel|docetaxel|mesh-list
102462143|NCT00485485|Imatinib Mesylate|imatinib mesylate|mesh-list
102462144|NCT00485485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102462145|NCT00485485|Tubulin Modulators|tubulin modulators|mesh-ancestor
102462146|NCT00485485|Antimitotic Agents|antimitotic agents|mesh-ancestor
102462147|NCT00485485|Mitosis Modulators|mitosis modulators|mesh-ancestor
102462148|NCT00485485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462149|NCT00485485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102462150|NCT00485485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102462151|NCT00422201|Mifepristone|mifepristone|mesh-list
102462152|NCT00422201|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102462153|NCT00422201|Abortifacient Agents|abortifacient agents|mesh-ancestor
102462154|NCT00422201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102462155|NCT00422201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462156|NCT00422201|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102462157|NCT00422201|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102462158|NCT00422201|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102462159|NCT00422201|Contraceptive Agents|contraceptive agents|mesh-ancestor
102462160|NCT00422201|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102462161|NCT00422201|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102462162|NCT00422201|Hormone Antagonists|hormone antagonists|mesh-ancestor
102462163|NCT00422201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102462164|NCT00422201|Luteolytic Agents|luteolytic agents|mesh-ancestor
102462165|NCT00422201|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102462166|NCT00422201|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102462167|NCT01396148|Sunitinib|sunitinib|mesh-list
102462168|NCT01396148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102462169|NCT01396148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102462170|NCT01396148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102462171|NCT01396148|Growth Substances|growth substances|mesh-ancestor
102462172|NCT01396148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462173|NCT01396148|Growth Inhibitors|growth inhibitors|mesh-ancestor
102462174|NCT01396148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102462175|NCT01396148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102462176|NCT01396148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462177|NCT00485953|Risedronic Acid|risedronic acid|mesh-list
102462178|NCT00485953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102462179|NCT00485953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102462180|NCT00485953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462181|NCT00485953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102462182|NCT00485953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462183|NCT00485953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102462184|NCT00486031|Balsalazide|balsalazide|mesh-list
102462185|NCT00486031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102462186|NCT00486031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102462187|NCT00486031|Analgesics|analgesics|mesh-ancestor
102462188|NCT00486031|Sensory System Agents|sensory system agents|mesh-ancestor
102462189|NCT00486031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102462190|NCT00486031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462191|NCT00486031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102462192|NCT00486031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102462193|NCT00486031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102462194|NCT04019834|Bupivacaine|bupivacaine|mesh-list
102462195|NCT04019834|Anesthetics, Local|anesthetics, local|mesh-ancestor
102462196|NCT04019834|Anesthetics|anesthetics|mesh-ancestor
102462197|NCT04019834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102462198|NCT04019834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462199|NCT04019834|Sensory System Agents|sensory system agents|mesh-ancestor
102462200|NCT04019834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102462201|NCT04017962|Letermovir|letermovir|mesh-list
102462202|NCT04017962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102462203|NCT04017962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102462204|NCT04017962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462205|NCT04017962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102462206|NCT04017962|Antiviral Agents|antiviral agents|mesh-ancestor
102462207|NCT04017962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102462208|NCT01396070|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102462209|NCT01396070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102462210|NCT01396070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102462211|NCT01396070|Immunotoxins|immunotoxins|mesh-ancestor
102462212|NCT01396070|Immunoconjugates|immunoconjugates|mesh-ancestor
102462213|NCT01396070|Immunologic Factors|immunologic factors|mesh-ancestor
102462214|NCT01396070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462215|NCT02108171|Dexmedetomidine|dexmedetomidine|mesh-list
102462216|NCT02108171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102462217|NCT02108171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102462218|NCT02108171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462219|NCT02108171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102462220|NCT02108171|Analgesics|analgesics|mesh-ancestor
102462221|NCT02108171|Sensory System Agents|sensory system agents|mesh-ancestor
102462222|NCT02108171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102462223|NCT02108171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102462224|NCT02108171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102462225|NCT02108171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102462226|NCT02108171|Adrenergic Agents|adrenergic agents|mesh-ancestor
102462227|NCT02108171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102462228|NCT02108171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462229|NCT03940807|Estradiol|estradiol|mesh-list
102462230|NCT03940807|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
102462231|NCT03940807|Estrogens|estrogens|mesh-ancestor
102462232|NCT03940807|Hormones|hormones|mesh-ancestor
102462233|NCT03940807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102462234|NCT03940807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462235|NCT00535873|Lenalidomide|lenalidomide|mesh-list
102462236|NCT00535873|Immunologic Factors|immunologic factors|mesh-ancestor
102462237|NCT00535873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462238|NCT00535873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102462239|NCT00535873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102462240|NCT00535873|Growth Substances|growth substances|mesh-ancestor
102462241|NCT00535873|Growth Inhibitors|growth inhibitors|mesh-ancestor
102462242|NCT00535873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102462243|NCT00487669|Paclitaxel|paclitaxel|mesh-list
102462244|NCT00487669|Pemetrexed|pemetrexed|mesh-list
102462245|NCT00487669|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
102462246|NCT00487669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102462247|NCT00487669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102462248|NCT00487669|Tubulin Modulators|tubulin modulators|mesh-ancestor
102462249|NCT00487669|Antimitotic Agents|antimitotic agents|mesh-ancestor
102462250|NCT00487669|Mitosis Modulators|mitosis modulators|mesh-ancestor
102462251|NCT00487669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462252|NCT00487669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102462253|NCT00487669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102462254|NCT00487669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102462255|NCT00488059|Enfuvirtide|enfuvirtide|mesh-list
102462256|NCT00488059|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
102462257|NCT00488059|Integrase Inhibitors|integrase inhibitors|mesh-list
102462258|NCT00488059|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102462259|NCT00488059|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102462260|NCT00488059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462261|NCT00488059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102462262|NCT00488059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102462263|NCT00488059|Antiviral Agents|antiviral agents|mesh-ancestor
102462264|NCT00488059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102462265|NCT00488059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102462266|NCT02120287|Bevacizumab|bevacizumab|mesh-list
102462267|NCT02120287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102462268|NCT02120287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102462269|NCT02120287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102462270|NCT02120287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102462271|NCT02120287|Growth Substances|growth substances|mesh-ancestor
102462272|NCT02120287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462273|NCT02120287|Growth Inhibitors|growth inhibitors|mesh-ancestor
102462274|NCT00536341|Rituximab|rituximab|mesh-list
102462275|NCT00536341|Fludarabine|fludarabine|mesh-list
102462276|NCT00536341|Lenalidomide|lenalidomide|mesh-list
102462277|NCT00536341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102462278|NCT00536341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102462279|NCT00536341|Immunologic Factors|immunologic factors|mesh-ancestor
102462280|NCT00536341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462281|NCT00536341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102462282|NCT00536341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102462283|NCT00536341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102462284|NCT00536341|Growth Substances|growth substances|mesh-ancestor
102462285|NCT00536341|Growth Inhibitors|growth inhibitors|mesh-ancestor
102462286|NCT02122471|Plecanatide|plecanatide|mesh-list
102462287|NCT02122471|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102462288|NCT02122471|Enzyme Activators|enzyme activators|mesh-ancestor
102462289|NCT02122471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462290|NCT02122471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102462291|NCT00461591|Apaziquone|apaziquone|mesh-list
102462292|NCT00461591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102462293|NCT00533117|Fluoxetine|fluoxetine|mesh-list
102462294|NCT00533117|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102462295|NCT00533117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102462296|NCT00533117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102462297|NCT00533117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462298|NCT00533117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102462299|NCT00533117|Serotonin Agents|serotonin agents|mesh-ancestor
102462300|NCT00533117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462301|NCT00533117|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102462302|NCT00533117|Antidepressive Agents|antidepressive agents|mesh-ancestor
102462303|NCT00533117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102462304|NCT00533117|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102462305|NCT00533117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102462306|NCT00533117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102462307|NCT00423683|PENTA|penta|mesh-list
102462308|NCT00423683|Fondaparinux|fondaparinux|mesh-list
102462309|NCT00423683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102462310|NCT00423683|Antithrombins|antithrombins|mesh-ancestor
102092430|NCT02547662|BB 1101|bb 1101|mesh-list
102462311|NCT00423683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102462312|NCT00423683|Protease Inhibitors|protease inhibitors|mesh-ancestor
102462313|NCT00423683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102462314|NCT00423683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462315|NCT00423683|Anticoagulants|anticoagulants|mesh-ancestor
102462316|NCT00423683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102462317|NCT00423683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102462318|NCT00424619|Vitamin D|vitamin d|mesh-list
102462319|NCT00424619|Ergocalciferols|ergocalciferols|mesh-list
102462320|NCT00424619|Cholecalciferol|cholecalciferol|mesh-list
102462321|NCT00424619|Vitamins|vitamins|mesh-list
102462322|NCT00424619|Micronutrients|micronutrients|mesh-ancestor
102462323|NCT00424619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462324|NCT00424619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102462325|NCT00424619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102462326|NCT00425477|Bexarotene|bexarotene|mesh-list
102462327|NCT00425477|Sargramostim|sargramostim|mesh-list
102462328|NCT00425477|Immunologic Factors|immunologic factors|mesh-ancestor
102273903|NCT03850691|Aldesleukin|aldesleukin|mesh-list
102462329|NCT00425477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462330|NCT00425477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102462332|NCT00427037|Cholecalciferol|cholecalciferol|mesh-list
102462333|NCT00427037|Vitamins|vitamins|mesh-ancestor
102462334|NCT00427037|Micronutrients|micronutrients|mesh-ancestor
102462335|NCT00427037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462336|NCT00427037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102462337|NCT00427037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102462338|NCT02113241|Dapagliflozin|dapagliflozin|mesh-list
102462339|NCT02113241|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102462340|NCT02113241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462341|NCT02113241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102462342|NCT02113241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462343|NCT00427661|Cyclosporine|cyclosporine|mesh-list
102462344|NCT00427661|Fludarabine|fludarabine|mesh-list
102462345|NCT00427661|Busulfan|busulfan|mesh-list
102462346|NCT00427661|Cyclosporins|cyclosporins|mesh-list
102462347|NCT00427661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102462348|NCT00427661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462349|NCT00427661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102462350|NCT00427661|Immunologic Factors|immunologic factors|mesh-ancestor
102462351|NCT00427661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462352|NCT00427661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102462353|NCT00427661|Antifungal Agents|antifungal agents|mesh-ancestor
102462354|NCT00427661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102462355|NCT00427661|Dermatologic Agents|dermatologic agents|mesh-ancestor
102462356|NCT00427661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102462357|NCT00427661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102462358|NCT00427661|Alkylating Agents|alkylating agents|mesh-ancestor
102462359|NCT00427661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102462360|NCT00427661|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102462361|NCT00427973|Cediranib|cediranib|mesh-list
102462362|NCT00427973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102462363|NCT00427973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462364|NCT00427973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102462365|NCT00427973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102462366|NCT01795703|Prednisolone|prednisolone|mesh-list
102462367|NCT01795703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102462368|NCT01795703|Glucocorticoids|glucocorticoids|mesh-ancestor
102462369|NCT01795703|Hormones|hormones|mesh-ancestor
102462370|NCT01795703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102462371|NCT01795703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462372|NCT01795703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102462373|NCT01795703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102462374|NCT00429143|Mycophenolic Acid|mycophenolic acid|mesh-list
102462375|NCT00429143|Cyclophosphamide|cyclophosphamide|mesh-list
102462376|NCT00429143|Tacrolimus|tacrolimus|mesh-list
102462377|NCT00429143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102462378|NCT00429143|Immunologic Factors|immunologic factors|mesh-ancestor
102462379|NCT00429143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462380|NCT00429143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102462381|NCT00429143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102092494|NCT02215265|Cisplatin|cisplatin|mesh-list
102462382|NCT00429143|Alkylating Agents|alkylating agents|mesh-ancestor
102462383|NCT00429143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462384|NCT00429143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102462385|NCT00429143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102462386|NCT00429143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102462387|NCT00429143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102462388|NCT00429143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102462389|NCT00429143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102462390|NCT00429143|Antitubercular Agents|antitubercular agents|mesh-ancestor
102462391|NCT00429143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102462392|NCT00429143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102462393|NCT00432341|Botulinum Toxins|botulinum toxins|mesh-list
102462394|NCT00432341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102462395|NCT00432341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102462396|NCT00432341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102462397|NCT00432341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102462398|NCT00432341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462399|NCT00432341|Cholinergic Agents|cholinergic agents|mesh-ancestor
102462400|NCT00432341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102462401|NCT00432341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462402|NCT00432341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102462403|NCT00432341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102462404|NCT00433745|Vaccines|vaccines|mesh-list
102462405|NCT00433745|Immunologic Factors|immunologic factors|mesh-ancestor
102462406|NCT00433745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462407|NCT01395758|Gemcitabine|gemcitabine|mesh-list
102462408|NCT01395758|Docetaxel|docetaxel|mesh-list
102462409|NCT01395758|Pemetrexed|pemetrexed|mesh-list
102462410|NCT01395758|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102462411|NCT01395758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102462412|NCT01395758|Antimetabolites|antimetabolites|mesh-ancestor
102462413|NCT01395758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462414|NCT01395758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102462415|NCT01395758|Tubulin Modulators|tubulin modulators|mesh-ancestor
102462416|NCT01395758|Antimitotic Agents|antimitotic agents|mesh-ancestor
102462417|NCT01395758|Mitosis Modulators|mitosis modulators|mesh-ancestor
102462418|NCT01395758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102462419|NCT01395758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102462420|NCT01395758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102462421|NCT01395758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102462422|NCT00462605|Entinostat|entinostat|mesh-list
102462423|NCT00462605|Sargramostim|sargramostim|mesh-list
102462424|NCT00462605|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
102462425|NCT00462605|Immunologic Factors|immunologic factors|mesh-ancestor
102462426|NCT00462605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462427|NCT00462605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102462428|NCT00462605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102462429|NCT00462605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462430|NCT00534833|Vaccines|vaccines|mesh-list
102462431|NCT00534833|Immunologic Factors|immunologic factors|mesh-ancestor
102462432|NCT00534833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462433|NCT00434993|Albuterol|albuterol|mesh-list
102462434|NCT00434993|Dimercaprol|dimercaprol|mesh-list
102462435|NCT00434993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102462436|NCT00434993|Autonomic Agents|autonomic agents|mesh-ancestor
102462437|NCT00434993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102462438|NCT00434993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462439|NCT00434993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102462440|NCT00434993|Respiratory System Agents|respiratory system agents|mesh-ancestor
102462441|NCT00434993|Tocolytic Agents|tocolytic agents|mesh-ancestor
102462442|NCT00434993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102462443|NCT00434993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102462444|NCT00434993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102462445|NCT00434993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102462446|NCT00434993|Adrenergic Agents|adrenergic agents|mesh-ancestor
102462447|NCT00434993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102462448|NCT00434993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462449|NCT00434993|Chelating Agents|chelating agents|mesh-ancestor
102462450|NCT00434993|Sequestering Agents|sequestering agents|mesh-ancestor
102462451|NCT01395524|Naloxegol|naloxegol|mesh-list
102462452|NCT01395524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102092598|NCT00576979|Etoposide|etoposide|mesh-list
102462453|NCT01395524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462454|NCT01395524|Sensory System Agents|sensory system agents|mesh-ancestor
102462455|NCT01395524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102462456|NCT04338698|Azithromycin|azithromycin|mesh-list
102462457|NCT04338698|Hydroxychloroquine|hydroxychloroquine|mesh-list
102462458|NCT04338698|Oseltamivir|oseltamivir|mesh-list
102462459|NCT04338698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102462460|NCT04338698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102462461|NCT04338698|Antimalarials|antimalarials|mesh-ancestor
102462462|NCT04338698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102462463|NCT04338698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102462464|NCT04338698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102462465|NCT04338698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462466|NCT04338698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102462467|NCT04338698|Antiviral Agents|antiviral agents|mesh-ancestor
102462468|NCT00435539|Plasminogen|plasminogen|mesh-list
102462469|NCT00435539|Fibrinolysin|fibrinolysin|mesh-list
102462470|NCT00435539|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102462471|NCT00435539|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102462472|NCT00435539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462473|NCT00464711|Escitalopram|escitalopram|mesh-list
102462474|NCT00464711|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102462475|NCT00464711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102462476|NCT00464711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102462477|NCT00464711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154238|NCT03367143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102462478|NCT00464711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102462479|NCT00464711|Serotonin Agents|serotonin agents|mesh-ancestor
102462480|NCT00464711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462481|NCT02078180|Bupropion|bupropion|mesh-list
102462482|NCT02078180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102462483|NCT02078180|Antidepressive Agents|antidepressive agents|mesh-ancestor
102462484|NCT02078180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102462485|NCT02078180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102462486|NCT02078180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102462487|NCT02078180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102462488|NCT02078180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462489|NCT02078180|Dopamine Agents|dopamine agents|mesh-ancestor
102462490|NCT02078180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102462491|NCT02078180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462492|NCT02078180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102462493|NCT02078180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102462494|NCT02078180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102462495|NCT00535613|Propofol|propofol|mesh-list
102462496|NCT00535613|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102462497|NCT00535613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102462498|NCT00535613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462499|NCT00535613|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102462500|NCT00535613|Anesthetics, General|anesthetics, general|mesh-ancestor
102462501|NCT00535613|Anesthetics|anesthetics|mesh-ancestor
102462502|NCT00466661|Acamprosate|acamprosate|mesh-list
102462503|NCT00466661|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102462504|NCT05360576|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102462505|NCT05360576|Etonogestrel|etonogestrel|mesh-list
102462506|NCT05360576|NuvaRing|nuvaring|mesh-list
102462507|NCT05360576|Estradiol|estradiol|mesh-list
102462508|NCT05360576|Estrogens|estrogens|mesh-ancestor
102462509|NCT05360576|Hormones|hormones|mesh-ancestor
102462510|NCT05360576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102462511|NCT05360576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462512|NCT05360576|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102462513|NCT05360576|Contraceptive Agents|contraceptive agents|mesh-ancestor
102462514|NCT05360576|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102462515|NCT05360576|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102462516|NCT05360576|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102462517|NCT05360576|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102462518|NCT00535925|Aspirin|aspirin|mesh-list
102462519|NCT00535925|Atenolol|atenolol|mesh-list
102462520|NCT00535925|Amlodipine|amlodipine|mesh-list
102462521|NCT00535925|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102462522|NCT00535925|Clonidine|clonidine|mesh-list
102462523|NCT00535925|Ramipril|ramipril|mesh-list
102462524|NCT00535925|Irbesartan|irbesartan|mesh-list
102462525|NCT00535925|Doxazosin|doxazosin|mesh-list
102462526|NCT00535925|Furosemide|furosemide|mesh-list
102462527|NCT00535925|Epoetin Alfa|epoetin alfa|mesh-list
102462528|NCT00535925|Simvastatin|simvastatin|mesh-list
102462529|NCT00535925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462530|NCT00535925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102462531|NCT00535925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102462532|NCT00535925|Analgesics|analgesics|mesh-ancestor
102462533|NCT00535925|Sensory System Agents|sensory system agents|mesh-ancestor
102462534|NCT00535925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102462535|NCT00535925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102462536|NCT00535925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102462537|NCT00535925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102462538|NCT00535925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102462539|NCT00535925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462540|NCT00535925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102462541|NCT00535925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102462542|NCT00535925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102462543|NCT00535925|Antipyretics|antipyretics|mesh-ancestor
102462544|NCT00535925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102462545|NCT00535925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102462546|NCT00535925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102462547|NCT00535925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102462548|NCT00535925|Vasodilator Agents|vasodilator agents|mesh-ancestor
102462549|NCT00535925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102462550|NCT00535925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102462551|NCT00535925|Antimetabolites|antimetabolites|mesh-ancestor
102462552|NCT00535925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102462553|NCT00535925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102274153|NCT03542695|Copper|copper|mesh-list
102462554|NCT00535925|Diuretics|diuretics|mesh-ancestor
102462555|NCT00535925|Natriuretic Agents|natriuretic agents|mesh-ancestor
102462556|NCT00535925|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102462557|NCT00535925|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102462558|NCT00535925|Sympatholytics|sympatholytics|mesh-ancestor
102462559|NCT00535925|Autonomic Agents|autonomic agents|mesh-ancestor
102462560|NCT00535925|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102462561|NCT00535925|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102462562|NCT00535925|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102462563|NCT00535925|Adrenergic Agents|adrenergic agents|mesh-ancestor
102462564|NCT00535925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102462565|NCT00535925|Hematinics|hematinics|mesh-ancestor
102462566|NCT00535925|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102462567|NCT00535925|Protease Inhibitors|protease inhibitors|mesh-ancestor
102462568|NCT00535925|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102462569|NCT00535925|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102462570|NCT00535925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102462571|NCT00535925|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102462572|NCT00535925|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102462573|NCT00535925|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102462574|NCT00535925|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102462575|NCT00535925|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102462576|NCT00211172|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102462577|NCT00211172|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102462578|NCT00211172|Adrenergic Agents|adrenergic agents|mesh-ancestor
102462579|NCT00211172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102462580|NCT00211172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462581|NCT00211172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462582|NCT01796093|Digoxin|digoxin|mesh-list
102462583|NCT01796093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102462584|NCT01796093|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102462585|NCT01796093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102462586|NCT01796093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462587|NCT01796093|Protective Agents|protective agents|mesh-ancestor
102462588|NCT01796093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462589|NCT00537511|Etoposide|etoposide|mesh-list
102462590|NCT00537511|Etoposide phosphate|etoposide phosphate|mesh-list
102462591|NCT00537511|Pomalidomide|pomalidomide|mesh-list
102462592|NCT00537511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102462593|NCT00537511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102462594|NCT00537511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102462595|NCT00537511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102462596|NCT00537511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102462597|NCT00537511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462598|NCT00537511|Immunologic Factors|immunologic factors|mesh-ancestor
102462599|NCT00537511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462600|NCT00537511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102462601|NCT00537511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102462602|NCT00537511|Growth Substances|growth substances|mesh-ancestor
102462603|NCT00537511|Growth Inhibitors|growth inhibitors|mesh-ancestor
102462604|NCT00435929|Ritonavir|ritonavir|mesh-list
102462605|NCT00435929|Saquinavir|saquinavir|mesh-list
102462606|NCT00435929|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102462607|NCT00435929|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102462608|NCT00435929|Protease Inhibitors|protease inhibitors|mesh-ancestor
102462609|NCT00435929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102462610|NCT00435929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462611|NCT00435929|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102462612|NCT00435929|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102462613|NCT00435929|Antiviral Agents|antiviral agents|mesh-ancestor
102462614|NCT00435929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102462615|NCT00435929|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102462616|NCT00435929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102462617|NCT00436475|Calcium, Dietary|calcium, dietary|mesh-list
102462618|NCT00436475|Vitamin D|vitamin d|mesh-list
102462619|NCT00436475|Ergocalciferols|ergocalciferols|mesh-list
102462620|NCT00436475|Cholecalciferol|cholecalciferol|mesh-list
102462621|NCT00436475|Vitamins|vitamins|mesh-list
102462622|NCT00436475|Calcium Carbonate|calcium carbonate|mesh-list
102462623|NCT00436475|Calcium|calcium|mesh-list
102462624|NCT00436475|Micronutrients|micronutrients|mesh-ancestor
102462625|NCT00436475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462626|NCT00436475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102462627|NCT00436475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102462628|NCT00436475|Antacids|antacids|mesh-ancestor
102462629|NCT00436475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462630|NCT00436475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102462631|NCT00210626|Epoetin Alfa|epoetin alfa|mesh-list
102462632|NCT00210626|Hematinics|hematinics|mesh-ancestor
102462633|NCT03595514|Dexamethasone|dexamethasone|mesh-list
102462634|NCT03595514|Lidocaine|lidocaine|mesh-list
102462635|NCT03595514|Epinephrine|epinephrine|mesh-list
102462636|NCT03595514|Bupivacaine|bupivacaine|mesh-list
102462637|NCT03595514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102462638|NCT03595514|Antiemetics|antiemetics|mesh-ancestor
102462639|NCT03595514|Autonomic Agents|autonomic agents|mesh-ancestor
102462640|NCT03595514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102462641|NCT03595514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462642|NCT03595514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102462643|NCT03595514|Glucocorticoids|glucocorticoids|mesh-ancestor
102462644|NCT03595514|Hormones|hormones|mesh-ancestor
102462645|NCT03595514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102462646|NCT03595514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102462647|NCT03595514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102462648|NCT03595514|Anesthetics, Local|anesthetics, local|mesh-ancestor
102462649|NCT03595514|Anesthetics|anesthetics|mesh-ancestor
102462650|NCT03595514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102462651|NCT03595514|Sensory System Agents|sensory system agents|mesh-ancestor
102462652|NCT03595514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102462653|NCT03595514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102462654|NCT03595514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102462655|NCT03595514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102462656|NCT03595514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462657|NCT03595514|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102462658|NCT03595514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102462659|NCT03595514|Adrenergic Agents|adrenergic agents|mesh-ancestor
102462660|NCT03595514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102462661|NCT03595514|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102462662|NCT03595514|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102462663|NCT03595514|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102462664|NCT03595514|Respiratory System Agents|respiratory system agents|mesh-ancestor
102462665|NCT03595514|Mydriatics|mydriatics|mesh-ancestor
102462666|NCT03595514|Sympathomimetics|sympathomimetics|mesh-ancestor
102462667|NCT03595514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102462668|NCT00215852|Interferon-alpha|interferon-alpha|mesh-list
102462669|NCT00215852|Antiviral Agents|antiviral agents|mesh-ancestor
102462670|NCT00215852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102462671|NCT00215852|Immunologic Factors|immunologic factors|mesh-ancestor
102462672|NCT00215852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462673|NCT03595046|Dexamethasone|dexamethasone|mesh-list
102462674|NCT03595046|Dexamethasone acetate|dexamethasone acetate|mesh-list
102462675|NCT03595046|Ropivacaine|ropivacaine|mesh-list
102462676|NCT03595046|BB 1101|bb 1101|mesh-list
102462677|NCT03595046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102462678|NCT03595046|Antiemetics|antiemetics|mesh-ancestor
102462679|NCT03595046|Autonomic Agents|autonomic agents|mesh-ancestor
102462680|NCT03595046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102462681|NCT03595046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462682|NCT03595046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102462683|NCT03595046|Glucocorticoids|glucocorticoids|mesh-ancestor
102462684|NCT03595046|Hormones|hormones|mesh-ancestor
102462685|NCT03595046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102462686|NCT03595046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102462687|NCT03595046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102462688|NCT03595046|Protease Inhibitors|protease inhibitors|mesh-ancestor
102462689|NCT03595046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102462690|NCT03595046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462691|NCT03595046|Anesthetics, Local|anesthetics, local|mesh-ancestor
102462692|NCT03595046|Anesthetics|anesthetics|mesh-ancestor
102462693|NCT03595046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102462694|NCT03595046|Sensory System Agents|sensory system agents|mesh-ancestor
102462695|NCT00217022|Budesonide|budesonide|mesh-list
102462696|NCT00217022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102462697|NCT00217022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102462698|NCT00217022|Autonomic Agents|autonomic agents|mesh-ancestor
102462699|NCT00217022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102462700|NCT00217022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462701|NCT00217022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102462702|NCT00217022|Respiratory System Agents|respiratory system agents|mesh-ancestor
102462703|NCT00217022|Glucocorticoids|glucocorticoids|mesh-ancestor
102462704|NCT00217022|Hormones|hormones|mesh-ancestor
102462705|NCT00217022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102462706|NCT03594968|Progesterone|progesterone|mesh-list
102462707|NCT03594968|Progestins|progestins|mesh-ancestor
102462708|NCT03594968|Hormones|hormones|mesh-ancestor
102462709|NCT03594968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102462710|NCT03594968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462711|NCT00538915|Immunoglobulins|immunoglobulins|mesh-list
102462712|NCT00538915|Antibodies|antibodies|mesh-list
102462713|NCT00538915|gamma-Globulins|gamma-globulins|mesh-list
102462714|NCT00538915|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102462715|NCT00538915|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102462716|NCT00538915|Immunologic Factors|immunologic factors|mesh-ancestor
102462717|NCT00538915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462718|NCT00490009|Acetaminophen|acetaminophen|mesh-list
102462719|NCT00490009|Iodine|iodine|mesh-list
102462720|NCT00490009|Diphenhydramine|diphenhydramine|mesh-list
102462721|NCT00490009|Promethazine|promethazine|mesh-list
102462722|NCT00490009|Cadexomer iodine|cadexomer iodine|mesh-list
102462723|NCT00490009|Tositumomab I-131|tositumomab i-131|mesh-list
102462724|NCT00490009|Lugol's solution|lugol's solution|mesh-list
102462725|NCT00490009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102462726|NCT00490009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102462727|NCT00490009|Analgesics|analgesics|mesh-ancestor
102462728|NCT00490009|Sensory System Agents|sensory system agents|mesh-ancestor
102462729|NCT00490009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102462730|NCT00490009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462731|NCT00490009|Antipyretics|antipyretics|mesh-ancestor
102462732|NCT00490009|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102462733|NCT00490009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102462734|NCT00490009|Trace Elements|trace elements|mesh-ancestor
102462735|NCT00490009|Micronutrients|micronutrients|mesh-ancestor
102462736|NCT00490009|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102462737|NCT00490009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102462738|NCT00490009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102462739|NCT00490009|Anesthetics, Local|anesthetics, local|mesh-ancestor
102462740|NCT00490009|Anesthetics|anesthetics|mesh-ancestor
102462741|NCT00490009|Antiemetics|antiemetics|mesh-ancestor
102462742|NCT00490009|Autonomic Agents|autonomic agents|mesh-ancestor
102462743|NCT00490009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102462744|NCT00490009|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102462745|NCT00490009|Histamine Antagonists|histamine antagonists|mesh-ancestor
102462746|NCT00490009|Histamine Agents|histamine agents|mesh-ancestor
102462747|NCT00490009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102462748|NCT00490009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462749|NCT00490009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102462750|NCT00490009|Antipruritics|antipruritics|mesh-ancestor
102462751|NCT00490009|Dermatologic Agents|dermatologic agents|mesh-ancestor
102462752|NCT00490009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102462753|NCT00490009|Hemostatics|hemostatics|mesh-ancestor
102462754|NCT00490009|Coagulants|coagulants|mesh-ancestor
102462755|NCT03769532|Pembrolizumab|pembrolizumab|mesh-list
102462756|NCT03769532|Azacitidine|azacitidine|mesh-list
102462757|NCT03769532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102462758|NCT03769532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102462759|NCT03769532|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102462760|NCT03769532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462761|NCT03769532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102462762|NCT03769532|Antimetabolites|antimetabolites|mesh-ancestor
102462763|NCT03769532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102462764|NCT00490477|Polymyxins|polymyxins|mesh-list
102462765|NCT00490477|Polymyxin B|polymyxin b|mesh-list
102462766|NCT00490477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102462767|NCT00490477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102462768|NCT03997370|Carboplatin|carboplatin|mesh-list
102462769|NCT03997370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102462770|NCT00492973|Cefuroxime|cefuroxime|mesh-list
102462771|NCT00492973|Methylprednisolone|methylprednisolone|mesh-list
102462772|NCT00492973|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102462773|NCT00492973|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102462774|NCT00492973|Prednisolone|prednisolone|mesh-list
102462775|NCT00492973|Prednisolone acetate|prednisolone acetate|mesh-list
102462776|NCT00492973|Clonidine|clonidine|mesh-list
102462777|NCT00492973|Epinephrine|epinephrine|mesh-list
102462778|NCT00492973|Morphine|morphine|mesh-list
102462779|NCT00492973|Bupivacaine|bupivacaine|mesh-list
102462780|NCT00492973|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102462781|NCT00492973|Prednisolone phosphate|prednisolone phosphate|mesh-list
102462782|NCT00492973|Anesthetics, Local|anesthetics, local|mesh-ancestor
102462783|NCT00492973|Anesthetics|anesthetics|mesh-ancestor
102462784|NCT00492973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102462785|NCT00492973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462786|NCT00492973|Sensory System Agents|sensory system agents|mesh-ancestor
102462787|NCT00492973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102462788|NCT00492973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102462789|NCT00492973|Narcotics|narcotics|mesh-ancestor
102462790|NCT00492973|Analgesics|analgesics|mesh-ancestor
102462791|NCT00492973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102462792|NCT00492973|Antiemetics|antiemetics|mesh-ancestor
102462793|NCT00492973|Autonomic Agents|autonomic agents|mesh-ancestor
102462794|NCT00492973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102462795|NCT00492973|Glucocorticoids|glucocorticoids|mesh-ancestor
102462796|NCT00492973|Hormones|hormones|mesh-ancestor
102462797|NCT00492973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102462798|NCT00492973|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102462799|NCT00492973|Protective Agents|protective agents|mesh-ancestor
102462800|NCT00492973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102462801|NCT00492973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102462802|NCT00492973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102462803|NCT00492973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102462804|NCT00492973|Adrenergic Agents|adrenergic agents|mesh-ancestor
102462805|NCT00492973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102462806|NCT00492973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462807|NCT00492973|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102462808|NCT00492973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102462809|NCT00492973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102462810|NCT00492973|Respiratory System Agents|respiratory system agents|mesh-ancestor
102462811|NCT00492973|Mydriatics|mydriatics|mesh-ancestor
102462812|NCT00492973|Sympathomimetics|sympathomimetics|mesh-ancestor
102462813|NCT00492973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102462814|NCT00492973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102462815|NCT00492973|Sympatholytics|sympatholytics|mesh-ancestor
102462816|NCT00492973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102462817|NCT00492973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102462818|NCT00492973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102462819|NCT05630534|Minocycline|minocycline|mesh-list
102462820|NCT05630534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102462821|NCT05630534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102462822|NCT00495079|Vincristine|vincristine|mesh-list
102462823|NCT00495079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102462824|NCT00495079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102462825|NCT00495079|Tubulin Modulators|tubulin modulators|mesh-ancestor
102462826|NCT00495079|Antimitotic Agents|antimitotic agents|mesh-ancestor
102462827|NCT00495079|Mitosis Modulators|mitosis modulators|mesh-ancestor
102462828|NCT00495079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462829|NCT05630222|Acetaminophen|acetaminophen|mesh-list
102462830|NCT05630222|Ibuprofen|ibuprofen|mesh-list
102462831|NCT05630222|Morphine|morphine|mesh-list
102462832|NCT05630222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102462833|NCT05630222|Narcotics|narcotics|mesh-ancestor
102462834|NCT05630222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102462835|NCT05630222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462836|NCT05630222|Analgesics|analgesics|mesh-ancestor
102462837|NCT05630222|Sensory System Agents|sensory system agents|mesh-ancestor
102462838|NCT05630222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102462839|NCT05630222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102462840|NCT05630222|Antipyretics|antipyretics|mesh-ancestor
102462841|NCT05630222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102462842|NCT05630222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102462843|NCT05630222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102092961|NCT01291004|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102462844|NCT05630222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102462845|NCT05630222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102462846|NCT05630222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462847|NCT03594188|Anesthetics|anesthetics|mesh-list
102462848|NCT03594188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102462849|NCT03594188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462850|NCT00539695|Aldesleukin|aldesleukin|mesh-list
102462851|NCT00539695|Interleukin-2|interleukin-2|mesh-list
102462852|NCT00539695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102462853|NCT00539695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102462854|NCT00539695|Analgesics|analgesics|mesh-ancestor
102462855|NCT00539695|Sensory System Agents|sensory system agents|mesh-ancestor
102462856|NCT00539695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102462857|NCT00539695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462858|NCT00539695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102274432|NCT03040596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102462859|NCT00539695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102462860|NCT00539695|Antiviral Agents|antiviral agents|mesh-ancestor
102462861|NCT00539695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102462862|NCT03593954|Ritonavir|ritonavir|mesh-list
102462863|NCT03593954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102462864|NCT03593954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102462865|NCT03593954|Protease Inhibitors|protease inhibitors|mesh-ancestor
102462866|NCT03593954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102462867|NCT03593954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462868|NCT03593954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102462869|NCT03593954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102462870|NCT03593954|Antiviral Agents|antiviral agents|mesh-ancestor
102462871|NCT03593954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102462872|NCT03593954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102462873|NCT03593954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102462874|NCT03590210|Nivolumab|nivolumab|mesh-list
102462875|NCT03590210|Trabectedin|trabectedin|mesh-list
102462876|NCT03590210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102462877|NCT03590210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102462878|NCT03590210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102462879|NCT03590210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462880|NCT03590210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102462881|NCT03590210|Alkylating Agents|alkylating agents|mesh-ancestor
102462882|NCT05632328|Paclitaxel|paclitaxel|mesh-list
102462883|NCT05632328|Gemcitabine|gemcitabine|mesh-list
102462884|NCT05632328|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102462885|NCT05632328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102462886|NCT05632328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102462887|NCT05632328|Tubulin Modulators|tubulin modulators|mesh-ancestor
102462888|NCT05632328|Antimitotic Agents|antimitotic agents|mesh-ancestor
102462889|NCT05632328|Mitosis Modulators|mitosis modulators|mesh-ancestor
102462890|NCT05632328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462891|NCT05632328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102462892|NCT05632328|Antimetabolites|antimetabolites|mesh-ancestor
102462893|NCT05632328|Immunologic Factors|immunologic factors|mesh-ancestor
102462894|NCT05632328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462895|NCT03599726|Donepezil|donepezil|mesh-list
102462896|NCT03599726|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102462897|NCT03599726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102462898|NCT03599726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462899|NCT03599726|Cholinergic Agents|cholinergic agents|mesh-ancestor
102462900|NCT03599726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102462901|NCT03599726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462902|NCT03599726|Nootropic Agents|nootropic agents|mesh-ancestor
102462903|NCT00466817|Valganciclovir|valganciclovir|mesh-list
102462904|NCT00466817|Antiviral Agents|antiviral agents|mesh-ancestor
102462905|NCT00466817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102462906|NCT04406870|Sirolimus|sirolimus|mesh-list
102462907|NCT04406870|Propranolol|propranolol|mesh-list
102462908|NCT04406870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102462909|NCT04406870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102462910|NCT04406870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102462911|NCT04406870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102462912|NCT04406870|Antifungal Agents|antifungal agents|mesh-ancestor
102462913|NCT04406870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102462914|NCT04406870|Immunologic Factors|immunologic factors|mesh-ancestor
102462915|NCT04406870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462916|NCT04406870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462917|NCT04406870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102462918|NCT04406870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102462919|NCT04406870|Adrenergic Agents|adrenergic agents|mesh-ancestor
102462920|NCT04406870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102462921|NCT04406870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102462922|NCT04406870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102462923|NCT04406870|Vasodilator Agents|vasodilator agents|mesh-ancestor
102462924|NCT03985514|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102462925|NCT03985514|Ciprofloxacin|ciprofloxacin|mesh-list
102462926|NCT03985514|Tazobactam|tazobactam|mesh-list
102462927|NCT03985514|Piperacillin|piperacillin|mesh-list
102462928|NCT03985514|Metronidazole|metronidazole|mesh-list
102462929|NCT03985514|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102462930|NCT03985514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102462931|NCT03985514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102462932|NCT03985514|Antitubercular Agents|antitubercular agents|mesh-ancestor
102462933|NCT03985514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102462934|NCT03985514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102462935|NCT03985514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102462936|NCT03985514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462937|NCT03985514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102462938|NCT03985514|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102462939|NCT03985514|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102462940|NCT03985514|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102462941|NCT03985514|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102462942|NCT03985514|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102462943|NCT00540007|Lenalidomide|lenalidomide|mesh-list
102462944|NCT00540007|Immunologic Factors|immunologic factors|mesh-ancestor
102462945|NCT00540007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462946|NCT00540007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102462947|NCT00540007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102462948|NCT00540007|Growth Substances|growth substances|mesh-ancestor
102462949|NCT00540007|Growth Inhibitors|growth inhibitors|mesh-ancestor
102462950|NCT00540007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102462951|NCT02982889|Bupivacaine|bupivacaine|mesh-list
102462952|NCT02982889|Hyaluronic Acid|hyaluronic acid|mesh-list
102462953|NCT02982889|Anesthetics, Local|anesthetics, local|mesh-ancestor
102462954|NCT02982889|Anesthetics|anesthetics|mesh-ancestor
102462955|NCT02982889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102462956|NCT02982889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462957|NCT02982889|Sensory System Agents|sensory system agents|mesh-ancestor
102462958|NCT02982889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102462959|NCT02982889|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102462960|NCT02982889|Immunologic Factors|immunologic factors|mesh-ancestor
102462961|NCT02982889|Viscosupplements|viscosupplements|mesh-ancestor
102462962|NCT02982889|Protective Agents|protective agents|mesh-ancestor
102462963|NCT01867333|Metronidazole|metronidazole|mesh-list
102462964|NCT01867333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102462965|NCT01867333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102462966|NCT01867333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102462967|NCT01867333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102462968|NCT03592082|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102462969|NCT03592082|Bismuth|bismuth|mesh-list
102462970|NCT03592082|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
102462971|NCT03592082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102462972|NCT03592082|Antacids|antacids|mesh-ancestor
102462973|NCT03592082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462974|NCT03592082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102462975|NCT03592082|Antidiarrheals|antidiarrheals|mesh-ancestor
102462976|NCT03598868|Vortioxetine|vortioxetine|mesh-list
102462977|NCT03598868|Antidepressive Agents|antidepressive agents|mesh-ancestor
102462978|NCT03598868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102462979|NCT03598868|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102462980|NCT03598868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102462981|NCT03598868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102462982|NCT03598868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462983|NCT03598868|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102462984|NCT03598868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102462985|NCT03598868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102462986|NCT03598868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102462987|NCT03598868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102462988|NCT03598868|Serotonin Agents|serotonin agents|mesh-ancestor
102462989|NCT03598868|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102462990|NCT03598868|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102462991|NCT03598868|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102462992|NCT03598868|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102462993|NCT00501631|Naltrexone|naltrexone|mesh-list
102462994|NCT00501631|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102462995|NCT00501631|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102462996|NCT00501631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102462997|NCT00501631|Sensory System Agents|sensory system agents|mesh-ancestor
102462998|NCT00501631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102462999|NCT05631704|Midazolam|midazolam|mesh-list
102463000|NCT05631704|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102463001|NCT05631704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102463002|NCT05631704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102463003|NCT05631704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463004|NCT05631704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102463005|NCT05631704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102463006|NCT05631704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102463007|NCT05631704|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102463008|NCT05631704|Anesthetics, General|anesthetics, general|mesh-ancestor
102463009|NCT05631704|Anesthetics|anesthetics|mesh-ancestor
102463010|NCT05631704|GABA Modulators|gaba modulators|mesh-ancestor
102463011|NCT05631704|GABA Agents|gaba agents|mesh-ancestor
102463012|NCT05631704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102463013|NCT05631704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463014|NCT03591536|Pentoxifylline|pentoxifylline|mesh-list
102463015|NCT03591536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102463016|NCT03591536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102463017|NCT03591536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463018|NCT03591536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102463019|NCT03591536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102463020|NCT03591536|Protective Agents|protective agents|mesh-ancestor
102463021|NCT03591536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463022|NCT03591536|Vasodilator Agents|vasodilator agents|mesh-ancestor
102463023|NCT03591536|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102463024|NCT03591536|Antioxidants|antioxidants|mesh-ancestor
102463025|NCT00501943|Interferons|interferons|mesh-list
102463026|NCT00501943|Interferon-beta|interferon-beta|mesh-list
102463027|NCT00501943|Interferon beta-1a|interferon beta-1a|mesh-list
102463028|NCT00501943|Riluzole|riluzole|mesh-list
102463029|NCT00501943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102463030|NCT00501943|Antiviral Agents|antiviral agents|mesh-ancestor
102463031|NCT00501943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102463032|NCT00501943|Immunologic Factors|immunologic factors|mesh-ancestor
102463033|NCT00501943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463034|NCT00501943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102463035|NCT00501943|Anticonvulsants|anticonvulsants|mesh-ancestor
102463036|NCT00501943|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102463037|NCT00501943|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102093151|NCT03477344|Dexmedetomidine|dexmedetomidine|mesh-list
102463038|NCT00501943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102463039|NCT00501943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463040|NCT00501943|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102463041|NCT00501943|Protective Agents|protective agents|mesh-ancestor
102463042|NCT03598634|Riboflavin|riboflavin|mesh-list
102463043|NCT03598634|Vitamin B Complex|vitamin b complex|mesh-ancestor
102463044|NCT03598634|Vitamins|vitamins|mesh-ancestor
102463045|NCT03598634|Micronutrients|micronutrients|mesh-ancestor
102463046|NCT03598634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463047|NCT03598634|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102463048|NCT03598634|Dermatologic Agents|dermatologic agents|mesh-ancestor
102463049|NCT03598556|Vitamin D|vitamin d|mesh-list
102463050|NCT03598556|Cholecalciferol|cholecalciferol|mesh-list
102463051|NCT03598556|Vitamins|vitamins|mesh-ancestor
102463052|NCT03598556|Micronutrients|micronutrients|mesh-ancestor
102463053|NCT03598556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463054|NCT03598556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102463055|NCT03598556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102463056|NCT03024476|Olmesartan|olmesartan|mesh-list
102463057|NCT03024476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102463058|NCT03024476|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102463059|NCT03024476|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102463060|NCT03024476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463061|NCT03590912|Mometasone Furoate|mometasone furoate|mesh-list
102463062|NCT03590912|Cetirizine|cetirizine|mesh-list
102463063|NCT03590912|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102463064|NCT03590912|Cefpodoxime|cefpodoxime|mesh-list
102463065|NCT03590912|Prednisolone|prednisolone|mesh-list
102463066|NCT03590912|Phenylephrine|phenylephrine|mesh-list
102463067|NCT03590912|Oxymetazoline|oxymetazoline|mesh-list
102463068|NCT03590912|Nasal Decongestants|nasal decongestants|mesh-list
102463069|NCT03590912|Levocetirizine|levocetirizine|mesh-list
102463070|NCT03590912|Histamine Antagonists|histamine antagonists|mesh-list
102463071|NCT03590912|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
102463072|NCT03590912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102463073|NCT03590912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102463074|NCT03590912|Glucocorticoids|glucocorticoids|mesh-ancestor
102463075|NCT03590912|Hormones|hormones|mesh-ancestor
102463076|NCT03590912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102463077|NCT03590912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463078|NCT03590912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102463079|NCT03590912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102463080|NCT03590912|Autonomic Agents|autonomic agents|mesh-ancestor
102463081|NCT03590912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102463082|NCT03590912|Protective Agents|protective agents|mesh-ancestor
102463083|NCT03590912|Dermatologic Agents|dermatologic agents|mesh-ancestor
102463084|NCT03590912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102463085|NCT03590912|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102463086|NCT03590912|Histamine Agents|histamine agents|mesh-ancestor
102463087|NCT03590912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102463088|NCT03590912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463089|NCT03590912|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102463090|NCT03590912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102463091|NCT03590912|Adrenergic Agents|adrenergic agents|mesh-ancestor
102463092|NCT03590912|Sympathomimetics|sympathomimetics|mesh-ancestor
102463093|NCT03590912|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102463094|NCT03590912|Respiratory System Agents|respiratory system agents|mesh-ancestor
102463095|NCT03590912|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102463097|NCT03590912|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102463098|NCT00503113|Alendronate|alendronate|mesh-list
102463099|NCT00503113|Ibandronic Acid|ibandronic acid|mesh-list
102463100|NCT00503113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102463101|NCT00503113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463102|NCT00542971|Cytarabine|cytarabine|mesh-list
102463103|NCT00542971|Sorafenib|sorafenib|mesh-list
102463104|NCT00542971|Idarubicin|idarubicin|mesh-list
102463105|NCT00542971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102463106|NCT00542971|Antimetabolites|antimetabolites|mesh-ancestor
102463107|NCT00542971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463108|NCT00542971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102463109|NCT00542971|Antiviral Agents|antiviral agents|mesh-ancestor
102463110|NCT00542971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102463111|NCT00542971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102093296|NCT03478280|Brodalumab|brodalumab|mesh-list
102463112|NCT00542971|Immunologic Factors|immunologic factors|mesh-ancestor
102463113|NCT00542971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463114|NCT00542971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102463115|NCT00542971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102463116|NCT00542971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102463117|NCT00542971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102463118|NCT00542971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102463119|NCT00504751|Dexamethasone|dexamethasone|mesh-list
102463120|NCT00504751|Rituximab|rituximab|mesh-list
102463121|NCT00504751|Etoposide|etoposide|mesh-list
102463122|NCT00504751|Bortezomib|bortezomib|mesh-list
102463123|NCT00504751|Ifosfamide|ifosfamide|mesh-list
102463124|NCT00504751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102463125|NCT00504751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102463126|NCT00504751|Immunologic Factors|immunologic factors|mesh-ancestor
102463127|NCT00504751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463128|NCT00504751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102463129|NCT00504751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102463130|NCT00504751|Antiemetics|antiemetics|mesh-ancestor
102463131|NCT00504751|Autonomic Agents|autonomic agents|mesh-ancestor
102463132|NCT00504751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102463133|NCT00504751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102463134|NCT00504751|Glucocorticoids|glucocorticoids|mesh-ancestor
102463135|NCT00504751|Hormones|hormones|mesh-ancestor
102463136|NCT00504751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102463137|NCT00504751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102463138|NCT00504751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102463139|NCT00504751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102463140|NCT00504751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102463141|NCT00504751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102463142|NCT00504751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463143|NCT00504751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102463144|NCT00504751|Alkylating Agents|alkylating agents|mesh-ancestor
102463145|NCT01013779|Carboplatin|carboplatin|mesh-list
102463146|NCT01013779|Etoposide|etoposide|mesh-list
102463147|NCT01013779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102463148|NCT01013779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102463149|NCT01013779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102463150|NCT01013779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102463151|NCT01013779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102463152|NCT01013779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463153|NCT05630846|Vaccines|vaccines|mesh-list
102463154|NCT05630846|Immunologic Factors|immunologic factors|mesh-ancestor
102463155|NCT05630846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463156|NCT05630768|Vitamin D|vitamin d|mesh-list
102463157|NCT05630768|Risedronic Acid|risedronic acid|mesh-list
102463158|NCT05630768|Calcium|calcium|mesh-list
102463159|NCT05630768|Vitamins|vitamins|mesh-ancestor
102463160|NCT05630768|Micronutrients|micronutrients|mesh-ancestor
102463161|NCT05630768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463162|NCT05630768|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102463163|NCT05630768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102463165|NCT05630768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102463166|NCT05630768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463167|NCT00506155|Bevacizumab|bevacizumab|mesh-list
102463168|NCT00506155|Cisplatin|cisplatin|mesh-list
102463169|NCT00506155|Doxorubicin|doxorubicin|mesh-list
102463170|NCT00506155|Methotrexate|methotrexate|mesh-list
102463171|NCT00506155|Vinblastine|vinblastine|mesh-list
102463172|NCT00506155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102463173|NCT00506155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102463174|NCT00506155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102463175|NCT00506155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102463176|NCT00506155|Growth Substances|growth substances|mesh-ancestor
102463177|NCT00506155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463178|NCT00506155|Growth Inhibitors|growth inhibitors|mesh-ancestor
102463179|NCT00506155|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102463180|NCT00506155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102463181|NCT00506155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102463182|NCT00506155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102463183|NCT00506155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463184|NCT00506155|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102463185|NCT00506155|Abortifacient Agents|abortifacient agents|mesh-ancestor
102463186|NCT00506155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102463187|NCT00506155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102463188|NCT00506155|Antimetabolites|antimetabolites|mesh-ancestor
102463189|NCT00506155|Dermatologic Agents|dermatologic agents|mesh-ancestor
102463190|NCT00506155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102463191|NCT00506155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102463192|NCT00506155|Immunologic Factors|immunologic factors|mesh-ancestor
102463193|NCT00506155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102463194|NCT00506155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102463195|NCT00506155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102463196|NCT00506155|Tubulin Modulators|tubulin modulators|mesh-ancestor
102463197|NCT00506155|Antimitotic Agents|antimitotic agents|mesh-ancestor
102463198|NCT00506155|Mitosis Modulators|mitosis modulators|mesh-ancestor
102463199|NCT03590444|Ranibizumab|ranibizumab|mesh-list
102463200|NCT03590444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102463201|NCT03590444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102463202|NCT03590444|Growth Substances|growth substances|mesh-ancestor
102463203|NCT03590444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463204|NCT03590444|Growth Inhibitors|growth inhibitors|mesh-ancestor
102463205|NCT03590444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102463206|NCT00506857|Fludarabine|fludarabine|mesh-list
102463207|NCT00506857|Fludarabine phosphate|fludarabine phosphate|mesh-list
102463208|NCT00506857|Busulfan|busulfan|mesh-list
102463209|NCT00506857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102463210|NCT00506857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102463211|NCT00506857|Antimetabolites|antimetabolites|mesh-ancestor
102463212|NCT00506857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463213|NCT00506857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102463214|NCT00506857|Immunologic Factors|immunologic factors|mesh-ancestor
102463215|NCT00506857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463216|NCT00506857|Alkylating Agents|alkylating agents|mesh-ancestor
102463217|NCT00506857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102463218|NCT00506857|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102463219|NCT04005170|Paclitaxel|paclitaxel|mesh-list
102463220|NCT04005170|Cisplatin|cisplatin|mesh-list
102463221|NCT04005170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102463222|NCT04005170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102463223|NCT04005170|Tubulin Modulators|tubulin modulators|mesh-ancestor
102463224|NCT04005170|Antimitotic Agents|antimitotic agents|mesh-ancestor
102463225|NCT04005170|Mitosis Modulators|mitosis modulators|mesh-ancestor
102463226|NCT04005170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463227|NCT03597308|Acetaminophen|acetaminophen|mesh-list
102463228|NCT03597308|Ibuprofen|ibuprofen|mesh-list
102463229|NCT03597308|Oxycodone|oxycodone|mesh-list
102463230|NCT03597308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102463231|NCT03597308|Analgesics|analgesics|mesh-ancestor
102463232|NCT03597308|Sensory System Agents|sensory system agents|mesh-ancestor
102463233|NCT03597308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102463234|NCT03597308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463235|NCT03597308|Antipyretics|antipyretics|mesh-ancestor
102463236|NCT03597308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102463237|NCT03597308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102463238|NCT03597308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102463239|NCT03597308|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102463240|NCT03597308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102463241|NCT03597308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463242|NCT03597308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102463243|NCT03597308|Narcotics|narcotics|mesh-ancestor
102463244|NCT03597308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102463245|NCT04750135|Metformin|metformin|mesh-list
102463246|NCT04750135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102463247|NCT04750135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463248|NCT04003922|Adalimumab|adalimumab|mesh-list
102463249|NCT04003922|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102463250|NCT04003922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102463251|NCT04003922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102463252|NCT03781934|Pembrolizumab|pembrolizumab|mesh-list
102463253|NCT03781934|Lenvatinib|lenvatinib|mesh-list
102463254|NCT03781934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102463255|NCT03781934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102463256|NCT03781934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102463257|NCT03781934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463258|NCT03781934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102463259|NCT03781934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102463260|NCT00558571|Empagliflozin|empagliflozin|mesh-list
102463261|NCT00558571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102463262|NCT00558571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463263|NCT00558571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102463264|NCT00558571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463265|NCT03970382|Aldesleukin|aldesleukin|mesh-list
102463266|NCT03970382|Nivolumab|nivolumab|mesh-list
102463267|NCT03970382|Interleukin-2|interleukin-2|mesh-list
102463268|NCT03970382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102463269|NCT03970382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102463270|NCT03970382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102463271|NCT03970382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463272|NCT03970382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102463273|NCT03970382|Analgesics|analgesics|mesh-ancestor
102463274|NCT03970382|Sensory System Agents|sensory system agents|mesh-ancestor
102463275|NCT03970382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102463276|NCT03970382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463277|NCT03970382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102463278|NCT03970382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102463279|NCT03970382|Antiviral Agents|antiviral agents|mesh-ancestor
102463280|NCT03970382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102463281|NCT01797133|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102463282|NCT01797133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102463283|NCT01797133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102463284|NCT01797133|Antitubercular Agents|antitubercular agents|mesh-ancestor
102463285|NCT01797913|Gemcitabine|gemcitabine|mesh-list
102463286|NCT01797913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102463287|NCT01797913|Antimetabolites|antimetabolites|mesh-ancestor
102463288|NCT01797913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463289|NCT01797913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102463290|NCT03596294|Rifampin|rifampin|mesh-list
102463291|NCT03596294|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102463292|NCT03596294|Antitubercular Agents|antitubercular agents|mesh-ancestor
102463293|NCT03596294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102463294|NCT03596294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102463295|NCT03596294|Leprostatic Agents|leprostatic agents|mesh-ancestor
102463296|NCT03596294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102463297|NCT03596294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102463298|NCT03596294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463299|NCT03596294|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102463300|NCT03596294|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102463301|NCT03596294|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102463302|NCT03596294|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102463303|NCT03596294|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102463304|NCT03596294|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102463305|NCT00537407|Ribavirin|ribavirin|mesh-list
102463306|NCT00537407|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102463307|NCT00537407|Antimetabolites|antimetabolites|mesh-ancestor
102463308|NCT00537407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463309|NCT00537407|Antiviral Agents|antiviral agents|mesh-ancestor
102463310|NCT00537407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102463311|NCT00214916|Insulin|insulin|mesh-list
102463312|NCT00214916|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102463313|NCT00214916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102463314|NCT00214916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463315|NCT00438971|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102463316|NCT00438971|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102463317|NCT00438971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102463318|NCT00438971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102463319|NCT00438971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463320|NCT00438971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102463321|NCT00438971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463323|NCT00438971|Sensory System Agents|sensory system agents|mesh-ancestor
102463324|NCT00438971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102463325|NCT00438971|Antidepressive Agents|antidepressive agents|mesh-ancestor
102463326|NCT00438971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102463327|NCT00438971|Dopamine Agents|dopamine agents|mesh-ancestor
102463328|NCT00219284|Levodopa|levodopa|mesh-list
102463329|NCT00219284|Carbidopa|carbidopa|mesh-list
102463330|NCT00219284|Entacapone|entacapone|mesh-list
102463331|NCT00219284|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102463332|NCT00219284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102463333|NCT00219284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102463334|NCT00219284|Dopamine Agents|dopamine agents|mesh-ancestor
102463335|NCT00219284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102463336|NCT00219284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463337|NCT00219284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463338|NCT00219284|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102463339|NCT00219284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102463340|NCT00219284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102463341|NCT00219284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102463342|NCT00219284|Immunologic Factors|immunologic factors|mesh-ancestor
102463343|NCT00219284|Dopamine Agonists|dopamine agonists|mesh-ancestor
102463344|NCT00509041|Dasatinib|dasatinib|mesh-list
102463345|NCT00509041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102463346|NCT00509041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102463347|NCT00509041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102463348|NCT00509041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463349|NCT03781700|Prednisolone|prednisolone|mesh-list
102463350|NCT03781700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102463351|NCT03781700|Glucocorticoids|glucocorticoids|mesh-ancestor
102463352|NCT03781700|Hormones|hormones|mesh-ancestor
102463353|NCT03781700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102463354|NCT03781700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463355|NCT03781700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102463356|NCT03781700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102463357|NCT00439673|Azacitidine|azacitidine|mesh-list
102463358|NCT00439673|Valproic Acid|valproic acid|mesh-list
102463359|NCT00439673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102463360|NCT00439673|Antimetabolites|antimetabolites|mesh-ancestor
102463361|NCT00439673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463362|NCT00439673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102463363|NCT00439673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102463364|NCT00439673|Anticonvulsants|anticonvulsants|mesh-ancestor
102463365|NCT00439673|GABA Agents|gaba agents|mesh-ancestor
102463366|NCT00439673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102463367|NCT00439673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463368|NCT00439673|Antimanic Agents|antimanic agents|mesh-ancestor
102463369|NCT00439673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102463370|NCT00439673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102463371|NCT00439673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102463372|NCT03596060|Fentanyl|fentanyl|mesh-list
102463373|NCT03596060|Morphine|morphine|mesh-list
102463374|NCT03596060|Propofol|propofol|mesh-list
102463375|NCT03596060|Rocuronium|rocuronium|mesh-list
102463376|NCT03596060|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102463377|NCT03596060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102463378|NCT03596060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463379|NCT03596060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102463380|NCT03596060|Anesthetics, General|anesthetics, general|mesh-ancestor
102463381|NCT03596060|Anesthetics|anesthetics|mesh-ancestor
102463382|NCT03596060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102463383|NCT03596060|Narcotics|narcotics|mesh-ancestor
102463384|NCT03596060|Analgesics|analgesics|mesh-ancestor
102463385|NCT03596060|Sensory System Agents|sensory system agents|mesh-ancestor
102463386|NCT03596060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102463387|NCT03596060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102463388|NCT03596060|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102463389|NCT03596060|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102463390|NCT03596060|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102463391|NCT00473837|Chloroquine|chloroquine|mesh-list
102463392|NCT00473837|Amebicides|amebicides|mesh-ancestor
102463393|NCT00473837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102463394|NCT00473837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102463395|NCT00473837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102463396|NCT00473837|Antimalarials|antimalarials|mesh-ancestor
102463397|NCT00473837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102463398|NCT04198922|Acalabrutinib|acalabrutinib|mesh-list
102463399|NCT04198922|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102463400|NCT04198922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102463401|NCT04198922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102463402|NCT04198922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102463403|NCT04198922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463404|NCT00509197|Fluticasone|fluticasone|mesh-list
102463405|NCT00509197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102463406|NCT00509197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102463407|NCT00509197|Autonomic Agents|autonomic agents|mesh-ancestor
102463408|NCT00509197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102463409|NCT00509197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463410|NCT00509197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102463411|NCT00509197|Respiratory System Agents|respiratory system agents|mesh-ancestor
102463412|NCT00509197|Dermatologic Agents|dermatologic agents|mesh-ancestor
102463413|NCT00509197|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102463414|NCT00442013|Lansoprazole|lansoprazole|mesh-list
102463415|NCT00442013|Dexlansoprazole|dexlansoprazole|mesh-list
102463416|NCT00442013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102463417|NCT00442013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102463418|NCT00442013|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102463419|NCT00442013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102463420|NCT00442013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463421|NCT02121067|Levonorgestrel|levonorgestrel|mesh-list
102463422|NCT02121067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102463423|NCT02121067|Contraceptive Agents|contraceptive agents|mesh-ancestor
102463424|NCT02121067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102463425|NCT02121067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463426|NCT02121067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102463427|NCT02121067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102463428|NCT02121067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102463429|NCT00509665|Gemcitabine|gemcitabine|mesh-list
102463430|NCT00509665|Doxorubicin|doxorubicin|mesh-list
102463431|NCT00509665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102463432|NCT00509665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102463433|NCT00509665|Antimetabolites|antimetabolites|mesh-ancestor
102463434|NCT00509665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463435|NCT00509665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102463436|NCT00509665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102463437|NCT00509665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102463438|NCT00509665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102463439|NCT00509665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102463440|NCT00513799|Chlorhexidine|chlorhexidine|mesh-list
102463441|NCT00513799|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102463442|NCT00513799|Mupirocin|mupirocin|mesh-list
102463443|NCT00513799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102463444|NCT00513799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102463445|NCT00513799|Disinfectants|disinfectants|mesh-ancestor
102463446|NCT00513799|Dermatologic Agents|dermatologic agents|mesh-ancestor
102463447|NCT00513799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102463448|NCT00513799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102463449|NCT00513799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102463450|NCT00513799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463451|NCT00442169|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102463452|NCT00216476|Risperidone|risperidone|mesh-list
102463453|NCT00216476|Aripiprazole|aripiprazole|mesh-list
102463454|NCT00216476|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102463455|NCT00216476|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102463456|NCT00216476|Serotonin Agents|serotonin agents|mesh-ancestor
102463457|NCT00216476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102463458|NCT00216476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463459|NCT00216476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463460|NCT00216476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102463461|NCT00216476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102463462|NCT00216476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102463463|NCT00216476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102463464|NCT00216476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102463465|NCT00216476|Dopamine Agents|dopamine agents|mesh-ancestor
102463466|NCT00216476|Antidepressive Agents|antidepressive agents|mesh-ancestor
102463467|NCT00216476|Dopamine Agonists|dopamine agonists|mesh-ancestor
102463468|NCT00216476|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102463469|NCT00216476|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102463470|NCT00216476|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102463471|NCT00216476|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102463472|NCT00515437|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
102463473|NCT00515437|Botulinum Toxins|botulinum toxins|mesh-list
102463474|NCT00515437|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102463475|NCT00515437|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102463476|NCT00515437|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102463477|NCT00515437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102463478|NCT00515437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463479|NCT00515437|Cholinergic Agents|cholinergic agents|mesh-ancestor
102463480|NCT00515437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102463481|NCT00515437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463482|NCT00515437|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102463483|NCT00515437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102463484|NCT00515437|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102463485|NCT00216086|Capecitabine|capecitabine|mesh-list
102463486|NCT00216086|Irinotecan|irinotecan|mesh-list
102463487|NCT00216086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102463488|NCT00216086|Antimetabolites|antimetabolites|mesh-ancestor
102463489|NCT00216086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463490|NCT00216086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102463491|NCT00216086|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102463492|NCT00216086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102463493|NCT00216086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102463494|NCT00474851|Norethindrone|norethindrone|mesh-list
102463495|NCT00474851|Norethindrone Acetate|norethindrone acetate|mesh-list
102463496|NCT00474851|Estrogens|estrogens|mesh-list
102463497|NCT00474851|Hormones|hormones|mesh-ancestor
102463498|NCT00474851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102463499|NCT00474851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463500|NCT00474851|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102463501|NCT00474851|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102463502|NCT00474851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102463503|NCT00474851|Contraceptive Agents|contraceptive agents|mesh-ancestor
102463504|NCT00474851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102463505|NCT00474851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102463506|NCT00474851|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102463507|NCT00215150|Ziprasidone|ziprasidone|mesh-list
102463508|NCT00215150|Sertraline|sertraline|mesh-list
102463509|NCT00215150|Antidepressive Agents|antidepressive agents|mesh-ancestor
102463510|NCT00215150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102463511|NCT00215150|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102463512|NCT00215150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102463513|NCT00215150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102463514|NCT00215150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463515|NCT00215150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102463516|NCT00215150|Serotonin Agents|serotonin agents|mesh-ancestor
102463517|NCT00215150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463518|NCT00215150|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102463519|NCT00215150|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102463520|NCT00215150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102463521|NCT00215150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102463522|NCT00215150|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102463523|NCT00215150|Dopamine Agents|dopamine agents|mesh-ancestor
102463524|NCT04192994|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102463525|NCT04192994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102463526|NCT04198844|Warfarin|warfarin|mesh-list
102463527|NCT04198844|Apixaban|apixaban|mesh-list
102463528|NCT04198844|Anticoagulants|anticoagulants|mesh-ancestor
102463529|NCT04198844|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102463530|NCT04198844|Antithrombins|antithrombins|mesh-ancestor
102463531|NCT04198844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102463532|NCT04198844|Protease Inhibitors|protease inhibitors|mesh-ancestor
102463533|NCT04198844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102463534|NCT04198844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463535|NCT03023852|Oseltamivir|oseltamivir|mesh-list
102463536|NCT03023852|Antiviral Agents|antiviral agents|mesh-ancestor
102463537|NCT03023852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102463538|NCT03023852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102463539|NCT03023852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463540|NCT00213980|Zoledronic Acid|zoledronic acid|mesh-list
102463541|NCT00213980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102463542|NCT00213980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463543|NCT00516217|Galiximab|galiximab|mesh-list
102463544|NCT00516217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102463545|NCT00516217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102463546|NCT04001504|Vaccines|vaccines|mesh-list
102463547|NCT04001504|Immunologic Factors|immunologic factors|mesh-ancestor
102463548|NCT04001504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463549|NCT00516919|Orlistat|orlistat|mesh-list
102463550|NCT00516919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102463551|NCT00516919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463552|NCT00516919|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102463553|NCT00516919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102463554|NCT00547105|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102463555|NCT00547105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102463556|NCT00547105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102463557|NCT00547105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102463558|NCT00547105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463559|NCT04195100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102463560|NCT04195100|Pilocarpine|pilocarpine|mesh-list
102463561|NCT04195100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102463562|NCT04195100|Miotics|miotics|mesh-ancestor
102463563|NCT04195100|Autonomic Agents|autonomic agents|mesh-ancestor
102463564|NCT04195100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102463565|NCT04195100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463566|NCT04195100|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102463567|NCT04195100|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102463568|NCT04195100|Cholinergic Agents|cholinergic agents|mesh-ancestor
102463569|NCT04195100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102463570|NCT04195100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463571|NCT04193774|Anesthetics|anesthetics|mesh-list
102463572|NCT04193774|Benoxinate|benoxinate|mesh-list
102463573|NCT04193774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102463574|NCT04193774|Lubricant Eye Drops|lubricant eye drops|mesh-list
102463575|NCT04193774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102463576|NCT04193774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463577|NCT04193774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102463578|NCT04193774|Anesthetics, Local|anesthetics, local|mesh-ancestor
102463579|NCT04193774|Sensory System Agents|sensory system agents|mesh-ancestor
102463580|NCT04193774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102463581|NCT00518089|Gatifloxacin|gatifloxacin|mesh-list
102463582|NCT00518089|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102463583|NCT00518089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102463584|NCT00518089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102463585|NCT00518089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102463586|NCT00518089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102463587|NCT00518089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102463588|NCT00518089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102463589|NCT00518089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463590|NCT00518089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102463591|NCT02985242|Empagliflozin|empagliflozin|mesh-list
102463592|NCT02985242|Glimepiride|glimepiride|mesh-list
102463593|NCT02985242|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102463594|NCT02985242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463595|NCT02985242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102463596|NCT02985242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463597|NCT02985242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102463598|NCT02985242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102463599|NCT02985242|Immunologic Factors|immunologic factors|mesh-ancestor
102463600|NCT03023774|Lenograstim|lenograstim|mesh-list
102463601|NCT03023774|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102463602|NCT03023774|Immunologic Factors|immunologic factors|mesh-ancestor
102463603|NCT03023774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463604|NCT04196426|Calcium|calcium|mesh-list
102463605|NCT04196426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102463606|NCT04196426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463607|NCT00518713|Clobazam|clobazam|mesh-list
102463608|NCT00518713|Anticonvulsants|anticonvulsants|mesh-ancestor
102463609|NCT00518713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102463610|NCT00518713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102463611|NCT00518713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102463612|NCT00518713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463613|NCT00518713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102463614|NCT00518713|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102463615|NCT00518713|GABA Agonists|gaba agonists|mesh-ancestor
102463616|NCT00518713|GABA Agents|gaba agents|mesh-ancestor
102463617|NCT00518713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102463618|NCT00518713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463619|NCT03948464|Morphine|morphine|mesh-list
102463620|NCT03948464|Methadone|methadone|mesh-list
102463621|NCT03948464|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102463622|NCT03948464|Narcotics|narcotics|mesh-ancestor
102463623|NCT03948464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102463624|NCT03948464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463625|NCT03948464|Analgesics|analgesics|mesh-ancestor
102463626|NCT03948464|Sensory System Agents|sensory system agents|mesh-ancestor
102463627|NCT03948464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102463628|NCT03948464|Antitussive Agents|antitussive agents|mesh-ancestor
102463629|NCT03948464|Respiratory System Agents|respiratory system agents|mesh-ancestor
102463630|NCT04196270|Ropivacaine|ropivacaine|mesh-list
102463631|NCT04196270|Anesthetics, Local|anesthetics, local|mesh-ancestor
102463632|NCT04196270|Anesthetics|anesthetics|mesh-ancestor
102463633|NCT04196270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102463634|NCT04196270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463635|NCT04196270|Sensory System Agents|sensory system agents|mesh-ancestor
102463636|NCT04196270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102463637|NCT04020380|Azithromycin|azithromycin|mesh-list
102463638|NCT04020380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102463639|NCT04020380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102463640|NCT00521989|Prednisolone|prednisolone|mesh-list
102463641|NCT00521989|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102463642|NCT00521989|Methylprednisolone|methylprednisolone|mesh-list
102463643|NCT00521989|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102463644|NCT00521989|Prednisolone acetate|prednisolone acetate|mesh-list
102463645|NCT00521989|Dipyridamole|dipyridamole|mesh-list
102463646|NCT00521989|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102463647|NCT00521989|Prednisolone phosphate|prednisolone phosphate|mesh-list
102463648|NCT00521989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102463649|NCT00521989|Glucocorticoids|glucocorticoids|mesh-ancestor
102463650|NCT00521989|Hormones|hormones|mesh-ancestor
102463651|NCT00521989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102463652|NCT00521989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463653|NCT00521989|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102463654|NCT00521989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102463655|NCT00521989|Antiemetics|antiemetics|mesh-ancestor
102463656|NCT00521989|Autonomic Agents|autonomic agents|mesh-ancestor
102463657|NCT00521989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102463658|NCT00521989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102463659|NCT00521989|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102463660|NCT00521989|Protective Agents|protective agents|mesh-ancestor
102463661|NCT00521989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102463662|NCT00521989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102463663|NCT00521989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463664|NCT00521989|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102463665|NCT00521989|Vasodilator Agents|vasodilator agents|mesh-ancestor
102463666|NCT04029350|Osimertinib|osimertinib|mesh-list
102463667|NCT04029350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102463668|NCT04029350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102463669|NCT04029350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102463670|NCT04029350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463671|NCT00548197|Bevacizumab|bevacizumab|mesh-list
102463672|NCT00548197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102463673|NCT00548197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102463674|NCT00548197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102463675|NCT00548197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102463676|NCT00548197|Growth Substances|growth substances|mesh-ancestor
102463677|NCT00548197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463678|NCT00548197|Growth Inhibitors|growth inhibitors|mesh-ancestor
102463679|NCT04029272|Metformin|metformin|mesh-list
102463680|NCT04029272|Exenatide|exenatide|mesh-list
102463681|NCT04029272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102463682|NCT04029272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463683|NCT04029272|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102463684|NCT04029272|Incretins|incretins|mesh-ancestor
102463685|NCT04029272|Hormones|hormones|mesh-ancestor
102463686|NCT04029272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102463687|NCT00548431|Mercaptopurine|mercaptopurine|mesh-list
102463688|NCT00548431|Antimetabolites|antimetabolites|mesh-ancestor
102463689|NCT00548431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463690|NCT00548431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102463691|NCT00548431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102463692|NCT00548431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102463693|NCT00548431|Immunologic Factors|immunologic factors|mesh-ancestor
102463694|NCT00548431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463695|NCT00548431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102463696|NCT00548431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102463697|NCT04028804|Deoxyglucose|deoxyglucose|mesh-list
102463698|NCT04028804|Fluorides|fluorides|mesh-list
102463699|NCT04028804|Cariostatic Agents|cariostatic agents|mesh-ancestor
102463700|NCT04028804|Protective Agents|protective agents|mesh-ancestor
102463701|NCT04028804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463702|NCT04028804|Antimetabolites|antimetabolites|mesh-ancestor
102463703|NCT04028804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463704|NCT04028804|Antiviral Agents|antiviral agents|mesh-ancestor
102463705|NCT04028804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102463706|NCT00524017|Cetuximab|cetuximab|mesh-list
102463707|NCT00524017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102463708|NCT00524017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102463709|NCT02985554|Nivolumab|nivolumab|mesh-list
102463710|NCT02985554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102463711|NCT02985554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102463712|NCT02985554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102463713|NCT02985554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463714|NCT05560165|Listerine|listerine|mesh-list
102463715|NCT05560165|Anesthetics|anesthetics|mesh-list
102463716|NCT05560165|Anesthetics, Local|anesthetics, local|mesh-list
102463717|NCT05560165|Fluorides|fluorides|mesh-list
102463718|NCT05560165|Sodium Fluoride|sodium fluoride|mesh-list
102463719|NCT05560165|Cariostatic Agents|cariostatic agents|mesh-ancestor
102463720|NCT05560165|Protective Agents|protective agents|mesh-ancestor
102463721|NCT05560165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463722|NCT05560165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102463723|NCT05560165|Sensory System Agents|sensory system agents|mesh-ancestor
102463724|NCT05560165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102463725|NCT05560165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102463726|NCT05560165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102463727|NCT00525421|Curcumin|curcumin|mesh-list
102463728|NCT00525421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102463729|NCT00525421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102463730|NCT00525421|Analgesics|analgesics|mesh-ancestor
102463731|NCT00525421|Sensory System Agents|sensory system agents|mesh-ancestor
102463732|NCT00525421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102463733|NCT00525421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463734|NCT00525421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102463735|NCT00525421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102463736|NCT00525421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102463737|NCT00525421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102463738|NCT00525421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463739|NCT04023110|Carvedilol|carvedilol|mesh-list
102463740|NCT04023110|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102463741|NCT04023110|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102463742|NCT04023110|Adrenergic Agents|adrenergic agents|mesh-ancestor
102463743|NCT04023110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102463744|NCT04023110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463745|NCT04023110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463746|NCT04023110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102463747|NCT04023110|Antioxidants|antioxidants|mesh-ancestor
102463748|NCT04023110|Protective Agents|protective agents|mesh-ancestor
102463749|NCT04023110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102463750|NCT04023110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102463751|NCT04023110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102463752|NCT04023110|Vasodilator Agents|vasodilator agents|mesh-ancestor
102463753|NCT04023110|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102463754|NCT04023110|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102463755|NCT00525733|Ritonavir|ritonavir|mesh-list
102463756|NCT00525733|Darunavir|darunavir|mesh-list
102463757|NCT00525733|Raltegravir Potassium|raltegravir potassium|mesh-list
102463758|NCT00525733|Maraviroc|maraviroc|mesh-list
102463759|NCT00525733|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102463760|NCT00525733|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102463761|NCT00525733|Protease Inhibitors|protease inhibitors|mesh-ancestor
102463762|NCT00525733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102463763|NCT00525733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463764|NCT00525733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102463766|NCT00525733|Antiviral Agents|antiviral agents|mesh-ancestor
102463767|NCT00525733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102463768|NCT00525733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102463769|NCT00525733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102463770|NCT00525733|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102463771|NCT00525733|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102463772|NCT00525733|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102463773|NCT00525733|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102463774|NCT00525733|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102463775|NCT04028024|Urinastatin|urinastatin|mesh-list
102463776|NCT04028024|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102463777|NCT04028024|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102463778|NCT04028024|Protease Inhibitors|protease inhibitors|mesh-ancestor
102463779|NCT04028024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102463780|NCT04028024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463781|NCT00526591|Everolimus|everolimus|mesh-list
102463782|NCT00526591|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102463783|NCT00526591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102463784|NCT00526591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102463785|NCT00526591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463786|NCT00526591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102463787|NCT00526591|Immunologic Factors|immunologic factors|mesh-ancestor
102463788|NCT00526591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463789|NCT00526591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102463790|NCT05559619|Calcium, Dietary|calcium, dietary|mesh-list
102463791|NCT05559619|Vitamin D|vitamin d|mesh-list
102463792|NCT05559619|Cholecalciferol|cholecalciferol|mesh-list
102463793|NCT05559619|Calcium Carbonate|calcium carbonate|mesh-list
102463794|NCT05559619|Calcium|calcium|mesh-list
102463795|NCT05559619|Vitamins|vitamins|mesh-ancestor
102463796|NCT05559619|Micronutrients|micronutrients|mesh-ancestor
102463797|NCT05559619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463798|NCT05559619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102463799|NCT05559619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102463800|NCT05559619|Antacids|antacids|mesh-ancestor
102463801|NCT05559619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463802|NCT05559619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102463803|NCT04194086|Posaconazole|posaconazole|mesh-list
102463804|NCT04194086|Antifungal Agents|antifungal agents|mesh-ancestor
102463805|NCT04194086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102463806|NCT04194086|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102463807|NCT04194086|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102463808|NCT04194086|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102463809|NCT04194086|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102463810|NCT04194086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102463811|NCT04194086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102463812|NCT04194086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463813|NCT04194086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102463814|NCT04194086|Hormone Antagonists|hormone antagonists|mesh-ancestor
102463815|NCT04194086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102463816|NCT04194086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463817|NCT04021862|Antibodies|antibodies|mesh-list
102463818|NCT04021862|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102463819|NCT04021862|Immunologic Factors|immunologic factors|mesh-ancestor
102463820|NCT04021862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463821|NCT04023266|Acetylcysteine|acetylcysteine|mesh-list
102463822|NCT04023266|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102463823|NCT04023266|Antiviral Agents|antiviral agents|mesh-ancestor
102463824|NCT04023266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102463825|NCT04023266|Expectorants|expectorants|mesh-ancestor
102093942|NCT04918576|Hemostatics|hemostatics|mesh-ancestor
102463826|NCT04023266|Respiratory System Agents|respiratory system agents|mesh-ancestor
102463827|NCT04023266|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102463828|NCT04023266|Antioxidants|antioxidants|mesh-ancestor
102463829|NCT04023266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463830|NCT04023266|Protective Agents|protective agents|mesh-ancestor
102463831|NCT04023266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463832|NCT04023266|Antidotes|antidotes|mesh-ancestor
102463833|NCT00475085|Dexamethasone|dexamethasone|mesh-list
102463834|NCT00475085|Aprepitant|aprepitant|mesh-list
102463835|NCT00475085|Palonosetron|palonosetron|mesh-list
102463836|NCT00475085|Granisetron|granisetron|mesh-list
102463837|NCT00475085|Prochlorperazine|prochlorperazine|mesh-list
102463838|NCT00475085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102463839|NCT00475085|Antiemetics|antiemetics|mesh-ancestor
102463840|NCT00475085|Autonomic Agents|autonomic agents|mesh-ancestor
102463841|NCT00475085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102463842|NCT00475085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463843|NCT00475085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102463844|NCT00475085|Glucocorticoids|glucocorticoids|mesh-ancestor
102463845|NCT00475085|Hormones|hormones|mesh-ancestor
102463846|NCT00475085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102463847|NCT00475085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102463848|NCT00475085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102463849|NCT00475085|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102463850|NCT00475085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102463851|NCT00475085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463852|NCT00475085|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102463853|NCT00475085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102463854|NCT00475085|Serotonin Agents|serotonin agents|mesh-ancestor
102463855|NCT00475085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102463856|NCT00475085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102463857|NCT00475085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102463858|NCT00475085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102463859|NCT00475085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102463860|NCT00475085|Dopamine Agents|dopamine agents|mesh-ancestor
102463861|NCT00551707|Prednisolone|prednisolone|mesh-list
102463862|NCT00551707|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102463863|NCT00551707|Methylprednisolone|methylprednisolone|mesh-list
102463864|NCT00551707|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102463865|NCT00551707|Prednisolone acetate|prednisolone acetate|mesh-list
102463866|NCT00551707|Dipyridamole|dipyridamole|mesh-list
102463867|NCT00551707|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102463868|NCT00551707|Prednisolone phosphate|prednisolone phosphate|mesh-list
102463869|NCT00551707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102463870|NCT00551707|Glucocorticoids|glucocorticoids|mesh-ancestor
102463871|NCT00551707|Hormones|hormones|mesh-ancestor
102463872|NCT00551707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102463873|NCT00551707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463874|NCT00551707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102463875|NCT00551707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102463876|NCT00551707|Antiemetics|antiemetics|mesh-ancestor
102463877|NCT00551707|Autonomic Agents|autonomic agents|mesh-ancestor
102463878|NCT00551707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102463879|NCT00551707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102463880|NCT00551707|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102463881|NCT00551707|Protective Agents|protective agents|mesh-ancestor
102463882|NCT00551707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102463883|NCT00551707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102463884|NCT00551707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463885|NCT00551707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102463886|NCT00551707|Vasodilator Agents|vasodilator agents|mesh-ancestor
102463887|NCT04193930|Letrozole|letrozole|mesh-list
102463888|NCT04193930|Menotropins|menotropins|mesh-list
102463889|NCT04193930|Hormones|hormones|mesh-list
102463890|NCT04193930|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102463891|NCT04193930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102463892|NCT04193930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463893|NCT04193930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102463894|NCT04193930|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102463895|NCT04193930|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102463896|NCT04193930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102463897|NCT04193930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463898|NCT04193930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102463899|NCT04193930|Hormone Antagonists|hormone antagonists|mesh-ancestor
102463900|NCT04193930|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102463901|NCT04193930|Fertility Agents|fertility agents|mesh-ancestor
102463902|NCT04193930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102463903|NCT00445211|Heparin|heparin|mesh-list
102463904|NCT00445211|Calcium heparin|calcium heparin|mesh-list
102463905|NCT00445211|Anticoagulants|anticoagulants|mesh-ancestor
102463906|NCT00445211|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102463907|NCT00445211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102463908|NCT00445211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463909|NCT04193852|Dienogest|dienogest|mesh-list
102463910|NCT04193852|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102463911|NCT04193852|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102463912|NCT04193852|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102463913|NCT04193852|Estradiol|estradiol|mesh-list
102463914|NCT04193852|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102463915|NCT04193852|Nandrolone|nandrolone|mesh-list
102463916|NCT04193852|Estrogens|estrogens|mesh-ancestor
102463917|NCT04193852|Hormones|hormones|mesh-ancestor
102463918|NCT04193852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102463919|NCT04193852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463920|NCT04193852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102463921|NCT04193852|Contraceptive Agents|contraceptive agents|mesh-ancestor
102463922|NCT04193852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102463923|NCT04193852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102463924|NCT04193852|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102463925|NCT04193852|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102463926|NCT04193852|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102463927|NCT04193852|Hormone Antagonists|hormone antagonists|mesh-ancestor
102463928|NCT04193852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102463929|NCT04193852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102463930|NCT04193852|Androgens|androgens|mesh-ancestor
102463931|NCT04193852|Anabolic Agents|anabolic agents|mesh-ancestor
102463932|NCT00552409|Cholecalciferol|cholecalciferol|mesh-list
102463933|NCT00552409|Vitamin D|vitamin d|mesh-list
102463934|NCT00552409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102463935|NCT00552409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463936|NCT00552409|Vitamins|vitamins|mesh-ancestor
102463937|NCT00552409|Micronutrients|micronutrients|mesh-ancestor
102463938|NCT00552409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102463939|NCT03830918|Temozolomide|temozolomide|mesh-list
102463940|NCT03830918|Atezolizumab|atezolizumab|mesh-list
102463941|NCT03830918|Niraparib|niraparib|mesh-list
102463942|NCT03830918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102463943|NCT03830918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102463944|NCT03830918|Alkylating Agents|alkylating agents|mesh-ancestor
102463945|NCT03830918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463946|NCT03830918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102463947|NCT03830918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102463948|NCT03830918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102463949|NCT03830918|Immunologic Factors|immunologic factors|mesh-ancestor
102463950|NCT03830918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463951|NCT03830918|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102463952|NCT03830918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102463953|NCT00553735|Cyclosporine|cyclosporine|mesh-list
102463954|NCT00553735|Lubricant Eye Drops|lubricant eye drops|mesh-list
102463955|NCT00553735|Cyclosporins|cyclosporins|mesh-list
102463956|NCT00553735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102463957|NCT00553735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463958|NCT00553735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102463959|NCT00553735|Immunologic Factors|immunologic factors|mesh-ancestor
102463960|NCT00553735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463961|NCT00553735|Antifungal Agents|antifungal agents|mesh-ancestor
102463962|NCT00553735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102463963|NCT00553735|Dermatologic Agents|dermatologic agents|mesh-ancestor
102463964|NCT00553735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102463965|NCT00553735|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102463966|NCT00553735|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102463967|NCT00553735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102463968|NCT00523237|Raltegravir Potassium|raltegravir potassium|mesh-list
102463969|NCT00523237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102463970|NCT00523237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102463971|NCT00523237|Antiviral Agents|antiviral agents|mesh-ancestor
102463972|NCT00523237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102463973|NCT00523237|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102463974|NCT00523237|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102463975|NCT00523237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102463976|NCT00523237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463977|NCT04027166|Methadone|methadone|mesh-list
102463978|NCT04027166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102463979|NCT04027166|Narcotics|narcotics|mesh-ancestor
102463980|NCT04027166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102463981|NCT04027166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102463982|NCT04027166|Analgesics|analgesics|mesh-ancestor
102463983|NCT04027166|Sensory System Agents|sensory system agents|mesh-ancestor
102463984|NCT04027166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102463985|NCT04027166|Antitussive Agents|antitussive agents|mesh-ancestor
102463986|NCT04027166|Respiratory System Agents|respiratory system agents|mesh-ancestor
102463987|NCT00543101|Darunavir|darunavir|mesh-list
102463988|NCT00543101|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102463989|NCT00543101|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102463990|NCT00543101|Protease Inhibitors|protease inhibitors|mesh-ancestor
102463991|NCT00543101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102463992|NCT00543101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102463993|NCT00543101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102463994|NCT00543101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102463995|NCT00543101|Antiviral Agents|antiviral agents|mesh-ancestor
102463996|NCT00543101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102463997|NCT00553969|Carvedilol|carvedilol|mesh-list
102463998|NCT00553969|Lisinopril|lisinopril|mesh-list
102463999|NCT00553969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102464000|NCT00553969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102464001|NCT00553969|Adrenergic Agents|adrenergic agents|mesh-ancestor
102464002|NCT00553969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102464003|NCT00553969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464004|NCT00553969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464005|NCT00553969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102464006|NCT00553969|Antioxidants|antioxidants|mesh-ancestor
102464007|NCT00553969|Protective Agents|protective agents|mesh-ancestor
102464008|NCT00553969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102464009|NCT00553969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102464010|NCT00553969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102464011|NCT00553969|Vasodilator Agents|vasodilator agents|mesh-ancestor
102464012|NCT00553969|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102464013|NCT00553969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102464014|NCT00553969|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102464015|NCT00553969|Protease Inhibitors|protease inhibitors|mesh-ancestor
102464016|NCT00553969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102464017|NCT00553969|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102464018|NCT05533567|Sufentanil|sufentanil|mesh-list
102464019|NCT05533567|Dsuvia|dsuvia|mesh-list
102464020|NCT05533567|Propofol|propofol|mesh-list
102464021|NCT05533567|Cisatracurium|cisatracurium|mesh-list
102464022|NCT05533567|Atracurium|atracurium|mesh-list
102464023|NCT05533567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102464024|NCT05533567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102464025|NCT05533567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464026|NCT05533567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102464027|NCT05533567|Anesthetics, General|anesthetics, general|mesh-ancestor
102464028|NCT05533567|Anesthetics|anesthetics|mesh-ancestor
102464029|NCT05533567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102464030|NCT05533567|Narcotics|narcotics|mesh-ancestor
102464031|NCT05533567|Analgesics|analgesics|mesh-ancestor
102464032|NCT05533567|Sensory System Agents|sensory system agents|mesh-ancestor
102464033|NCT05533567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102464034|NCT05533567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102464035|NCT05533567|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102464036|NCT05533567|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102464037|NCT05533567|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102464038|NCT05533567|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102464039|NCT05533567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102464040|NCT05533567|Cholinergic Agents|cholinergic agents|mesh-ancestor
102464041|NCT05533567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102464042|NCT05533567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464043|NCT04026464|Acetaminophen|acetaminophen|mesh-list
102464044|NCT04026464|Ibuprofen|ibuprofen|mesh-list
102464045|NCT04026464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102464046|NCT04026464|Analgesics|analgesics|mesh-ancestor
102464047|NCT04026464|Sensory System Agents|sensory system agents|mesh-ancestor
102464048|NCT04026464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102464049|NCT04026464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464050|NCT04026464|Antipyretics|antipyretics|mesh-ancestor
102464051|NCT04026464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102464052|NCT04026464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102464053|NCT04026464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102464054|NCT04026464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102464055|NCT04026464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102464056|NCT04026464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464057|NCT04192916|Rivaroxaban|rivaroxaban|mesh-list
102464058|NCT04192916|Apixaban|apixaban|mesh-list
102464059|NCT04192916|Edoxaban|edoxaban|mesh-list
102464060|NCT04192916|Dabigatran|dabigatran|mesh-list
102464061|NCT04192916|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102464062|NCT04192916|Antithrombins|antithrombins|mesh-ancestor
102464063|NCT04192916|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102464064|NCT04192916|Protease Inhibitors|protease inhibitors|mesh-ancestor
102464065|NCT04192916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102464066|NCT04192916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464067|NCT04192916|Anticoagulants|anticoagulants|mesh-ancestor
102275632|NCT02340481|Loperamide|loperamide|mesh-list
102464069|NCT01797991|Dexamethasone acetate|dexamethasone acetate|mesh-list
102464070|NCT01797991|BB 1101|bb 1101|mesh-list
102464071|NCT01797991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102464072|NCT01797991|Antiemetics|antiemetics|mesh-ancestor
102464073|NCT01797991|Autonomic Agents|autonomic agents|mesh-ancestor
102464074|NCT01797991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102464075|NCT01797991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464076|NCT01797991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102464077|NCT01797991|Glucocorticoids|glucocorticoids|mesh-ancestor
102464078|NCT01797991|Hormones|hormones|mesh-ancestor
102464079|NCT01797991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102464080|NCT01797991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102464081|NCT01797991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102464082|NCT01797991|Protease Inhibitors|protease inhibitors|mesh-ancestor
102464083|NCT01797991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102464084|NCT01797991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464085|NCT00475319|Rebamipide|rebamipide|mesh-list
102464086|NCT00475319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102464087|NCT00475319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102464088|NCT00475319|Antioxidants|antioxidants|mesh-ancestor
102464089|NCT00475319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464090|NCT00475319|Protective Agents|protective agents|mesh-ancestor
102464091|NCT00475319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464092|NCT00475319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102464093|NCT04026074|Clonidine|clonidine|mesh-list
102464094|NCT04026074|Fentanyl|fentanyl|mesh-list
102464095|NCT04026074|Remifentanil|remifentanil|mesh-list
102464096|NCT04026074|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
102464097|NCT04026074|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102464098|NCT04026074|Narcotics|narcotics|mesh-ancestor
102464099|NCT04026074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102464100|NCT04026074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464101|NCT04026074|Analgesics|analgesics|mesh-ancestor
102464102|NCT04026074|Sensory System Agents|sensory system agents|mesh-ancestor
102464103|NCT04026074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102464104|NCT04026074|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102464105|NCT04026074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102464106|NCT04026074|Anesthetics, General|anesthetics, general|mesh-ancestor
102464107|NCT04026074|Anesthetics|anesthetics|mesh-ancestor
102464108|NCT04026074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102464109|NCT04026074|Sympatholytics|sympatholytics|mesh-ancestor
102464110|NCT04026074|Autonomic Agents|autonomic agents|mesh-ancestor
102464111|NCT04026074|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102464112|NCT04026074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102464113|NCT04026074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102464114|NCT04026074|Adrenergic Agents|adrenergic agents|mesh-ancestor
102464115|NCT04026074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102464116|NCT04026074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464117|NCT04026074|Anesthetics, Local|anesthetics, local|mesh-ancestor
102464118|NCT04026074|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
102464119|NCT00555997|Ziprasidone|ziprasidone|mesh-list
102464120|NCT00555997|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102464121|NCT00555997|Serotonin Agents|serotonin agents|mesh-ancestor
102464122|NCT00555997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102464123|NCT00555997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464124|NCT00555997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464125|NCT00555997|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102464126|NCT00555997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102464127|NCT00555997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102464128|NCT00555997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102464129|NCT00555997|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102464130|NCT00555997|Dopamine Agents|dopamine agents|mesh-ancestor
102464131|NCT00446147|Pyridoxine|pyridoxine|mesh-list
102464132|NCT00446147|Vitamin B Complex|vitamin b complex|mesh-ancestor
102464133|NCT00446147|Vitamins|vitamins|mesh-ancestor
102464134|NCT00446147|Micronutrients|micronutrients|mesh-ancestor
102464135|NCT00446147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464136|NCT04345471|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
102464137|NCT04345471|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102464138|NCT04345471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102464139|NCT04345471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102464140|NCT04345471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464141|NCT04345471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102464142|NCT04345471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464143|NCT04345471|Antidepressive Agents|antidepressive agents|mesh-ancestor
102464144|NCT04345471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102464145|NCT00476021|Levonorgestrel|levonorgestrel|mesh-list
102464146|NCT00476021|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102464147|NCT00476021|Contraceptive Agents|contraceptive agents|mesh-ancestor
102464148|NCT00476021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102464149|NCT00476021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464150|NCT00476021|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102464151|NCT00476021|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102464152|NCT00476021|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102464153|NCT04192292|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102464154|NCT04192292|Gliclazide|gliclazide|mesh-list
102464155|NCT04192292|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
102464156|NCT04192292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102464157|NCT04192292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464158|NCT04192292|Incretins|incretins|mesh-ancestor
102464159|NCT04192292|Hormones|hormones|mesh-ancestor
102464160|NCT04192292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102464161|NCT04192292|Protease Inhibitors|protease inhibitors|mesh-ancestor
102464162|NCT04192292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102464163|NCT04192292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464164|NCT00448175|Tolterodine Tartrate|tolterodine tartrate|mesh-list
102464165|NCT00448175|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102464166|NCT00448175|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102464167|NCT00448175|Cholinergic Agents|cholinergic agents|mesh-ancestor
102464168|NCT00448175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102464169|NCT00448175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464170|NCT00448175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464171|NCT00448175|Urological Agents|urological agents|mesh-ancestor
102464172|NCT04176835|Oxytocin|oxytocin|mesh-list
102464173|NCT04176835|Oxytocics|oxytocics|mesh-ancestor
102464174|NCT04176835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102464175|NCT04176835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464176|NCT00476645|Fulvestrant|fulvestrant|mesh-list
102464177|NCT00476645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102464178|NCT00476645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102464179|NCT00476645|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102464180|NCT00476645|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102464181|NCT00476645|Hormone Antagonists|hormone antagonists|mesh-ancestor
102464182|NCT00476645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102464183|NCT00476645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464184|NCT00477191|Etanercept|etanercept|mesh-list
102464185|NCT00477191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102464186|NCT00477191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102464187|NCT00477191|Analgesics|analgesics|mesh-ancestor
102464188|NCT00477191|Sensory System Agents|sensory system agents|mesh-ancestor
102464189|NCT00477191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102464190|NCT00477191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464191|NCT00477191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102464192|NCT00477191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102464193|NCT00477191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102464194|NCT00477191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102464195|NCT00477191|Immunologic Factors|immunologic factors|mesh-ancestor
102464196|NCT04025918|Phenylephrine|phenylephrine|mesh-list
102464197|NCT04025918|Oxymetazoline|oxymetazoline|mesh-list
102464198|NCT04025918|Ephedrine|ephedrine|mesh-list
102464199|NCT04025918|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
102464200|NCT04025918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102464201|NCT04025918|Mydriatics|mydriatics|mesh-ancestor
102464202|NCT04025918|Autonomic Agents|autonomic agents|mesh-ancestor
102464203|NCT04025918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102464204|NCT04025918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464205|NCT04025918|Sympathomimetics|sympathomimetics|mesh-ancestor
102464206|NCT04025918|Nasal Decongestants|nasal decongestants|mesh-ancestor
102464207|NCT04025918|Respiratory System Agents|respiratory system agents|mesh-ancestor
102464208|NCT04025918|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102464209|NCT04025918|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102464210|NCT04025918|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102464211|NCT04025918|Adrenergic Agents|adrenergic agents|mesh-ancestor
102464212|NCT04025918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102464213|NCT04025918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464214|NCT04025918|Protective Agents|protective agents|mesh-ancestor
102464215|NCT04025918|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102464216|NCT05415397|Celecoxib|celecoxib|mesh-list
102275779|NCT02338687|Calcium|calcium|mesh-list
102464217|NCT05415397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102464218|NCT05415397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102464219|NCT05415397|Analgesics|analgesics|mesh-ancestor
102464220|NCT05415397|Sensory System Agents|sensory system agents|mesh-ancestor
102464221|NCT05415397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102464222|NCT05415397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464223|NCT05415397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102464224|NCT05415397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102464225|NCT05415397|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102464226|NCT05415397|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102464227|NCT05415397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102464228|NCT05415397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464229|NCT04406246|Nitazoxanide|nitazoxanide|mesh-list
102464230|NCT04406246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102464231|NCT04406246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102464232|NCT02115347|Ertugliflozin|ertugliflozin|mesh-list
102464233|NCT02115347|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102464234|NCT02115347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464235|NCT02115347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102464236|NCT02115347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464237|NCT02115581|Ubiquinone|ubiquinone|mesh-list
102464238|NCT02115581|Coenzyme Q10|coenzyme q10|mesh-list
102464239|NCT02115581|Micronutrients|micronutrients|mesh-ancestor
102464240|NCT02115581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464241|NCT02115581|Vitamins|vitamins|mesh-ancestor
102464242|NCT00477659|Donepezil|donepezil|mesh-list
102464243|NCT00477659|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102464244|NCT00477659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102464245|NCT00477659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464246|NCT00477659|Cholinergic Agents|cholinergic agents|mesh-ancestor
102464247|NCT00477659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102464248|NCT00477659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464249|NCT00477659|Nootropic Agents|nootropic agents|mesh-ancestor
102464250|NCT04191278|Varenicline|varenicline|mesh-list
102464251|NCT04191278|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102464252|NCT04191278|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102464253|NCT04191278|Cholinergic Agents|cholinergic agents|mesh-ancestor
102464254|NCT04191278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102464255|NCT04191278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464256|NCT04191278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464257|NCT04148534|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-list
102464258|NCT04148534|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102464259|NCT04148534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102464260|NCT04148534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102464261|NCT04148534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464262|NCT03988387|Tenofovir|tenofovir|mesh-list
102464263|NCT03988387|Emtricitabine|emtricitabine|mesh-list
102464264|NCT03988387|Antiviral Agents|antiviral agents|mesh-ancestor
102464265|NCT03988387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102464266|NCT03988387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102464267|NCT03988387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102464268|NCT03988387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102464269|NCT03988387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464270|NCT03988387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102464271|NCT03988387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102464272|NCT03748082|Nitric Oxide|nitric oxide|mesh-list
102464273|NCT03748082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102464274|NCT03748082|Autonomic Agents|autonomic agents|mesh-ancestor
102464275|NCT03748082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102464276|NCT03748082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464277|NCT03748082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102464278|NCT03748082|Respiratory System Agents|respiratory system agents|mesh-ancestor
102464279|NCT03748082|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102464280|NCT03748082|Antioxidants|antioxidants|mesh-ancestor
102464281|NCT03748082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464282|NCT03748082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102464283|NCT03748082|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102464284|NCT03748082|Vasodilator Agents|vasodilator agents|mesh-ancestor
102464285|NCT03748082|Gasotransmitters|gasotransmitters|mesh-ancestor
102464286|NCT03748082|Protective Agents|protective agents|mesh-ancestor
102464287|NCT00478361|Paclitaxel|paclitaxel|mesh-list
102464288|NCT00478361|Gemcitabine|gemcitabine|mesh-list
102464289|NCT00478361|Doxorubicin|doxorubicin|mesh-list
102464290|NCT00478361|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102275858|NCT02331823|Isoniazid|isoniazid|mesh-list
102464291|NCT00478361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102464292|NCT00478361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102464293|NCT00478361|Tubulin Modulators|tubulin modulators|mesh-ancestor
102464294|NCT00478361|Antimitotic Agents|antimitotic agents|mesh-ancestor
102464295|NCT00478361|Mitosis Modulators|mitosis modulators|mesh-ancestor
102464296|NCT00478361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464297|NCT00478361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102464298|NCT00478361|Antimetabolites|antimetabolites|mesh-ancestor
102464299|NCT00478361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102464300|NCT00478361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102464301|NCT00478361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102464302|NCT00478361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102464303|NCT02129725|Sildenafil Citrate|sildenafil citrate|mesh-list
102464304|NCT02129725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464305|NCT02129725|Vasodilator Agents|vasodilator agents|mesh-ancestor
102464306|NCT02129725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102464307|NCT02129725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102464308|NCT02129725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102464309|NCT02129725|Urological Agents|urological agents|mesh-ancestor
102464310|NCT00483509|Doxorubicin|doxorubicin|mesh-list
102464311|NCT00483509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102464312|NCT00483509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102464313|NCT00483509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102464314|NCT00483509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102464315|NCT00483509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102464316|NCT00483509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464317|NCT03864211|Immunomodulating Agents|immunomodulating agents|mesh-list
102464318|NCT03864211|Immunologic Factors|immunologic factors|mesh-ancestor
102464319|NCT03864211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464320|NCT03840200|Rucaparib|rucaparib|mesh-list
102464321|NCT03840200|Ipatasertib|ipatasertib|mesh-list
102464322|NCT03840200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102464323|NCT03840200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102464324|NCT03840200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464325|NCT03840200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102464326|NCT03840200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102464327|NCT03842839|Albuterol|albuterol|mesh-list
102464328|NCT03842839|Tiotropium Bromide|tiotropium bromide|mesh-list
102464329|NCT03842839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102464330|NCT03842839|Autonomic Agents|autonomic agents|mesh-ancestor
102464331|NCT03842839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102464332|NCT03842839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464333|NCT03842839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102464334|NCT03842839|Respiratory System Agents|respiratory system agents|mesh-ancestor
102464335|NCT03842839|Parasympatholytics|parasympatholytics|mesh-ancestor
102464336|NCT03842839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102464337|NCT03842839|Cholinergic Agents|cholinergic agents|mesh-ancestor
102464338|NCT03842839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102464339|NCT03842839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464340|NCT03842839|Tocolytic Agents|tocolytic agents|mesh-ancestor
102464341|NCT03842839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102464342|NCT03842839|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102464343|NCT03842839|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102464344|NCT03842839|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102464345|NCT03842839|Adrenergic Agents|adrenergic agents|mesh-ancestor
102464346|NCT00450983|Methotrexate|methotrexate|mesh-list
102464347|NCT00450983|Fludarabine phosphate|fludarabine phosphate|mesh-list
102464348|NCT00450983|Fludarabine|fludarabine|mesh-list
102464349|NCT00450983|Thiotepa|thiotepa|mesh-list
102464350|NCT00450983|Muromonab-CD3|muromonab-cd3|mesh-list
102464351|NCT00450983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102464352|NCT00450983|Abortifacient Agents|abortifacient agents|mesh-ancestor
102464353|NCT00450983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102464354|NCT00450983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464355|NCT00450983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102464356|NCT00450983|Antimetabolites|antimetabolites|mesh-ancestor
102464357|NCT00450983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464358|NCT00450983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102464359|NCT00450983|Dermatologic Agents|dermatologic agents|mesh-ancestor
102464360|NCT00450983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102464361|NCT00450983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102464362|NCT00450983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102464363|NCT00450983|Immunologic Factors|immunologic factors|mesh-ancestor
102464364|NCT00450983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102464365|NCT00450983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102464366|NCT00450983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102464367|NCT00450983|Alkylating Agents|alkylating agents|mesh-ancestor
102464368|NCT00450983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102464369|NCT01796405|Clofarabine|clofarabine|mesh-list
102464370|NCT01796405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102464371|NCT01796405|Antimetabolites|antimetabolites|mesh-ancestor
102464372|NCT01796405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464373|NCT01796405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102464374|NCT03298295|Insulin|insulin|mesh-list
102464375|NCT03298295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102464376|NCT03298295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464377|NCT03649321|Paclitaxel|paclitaxel|mesh-list
102464378|NCT03649321|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102464379|NCT03649321|Gemcitabine|gemcitabine|mesh-list
102464380|NCT03649321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102464381|NCT03649321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102464382|NCT03649321|Tubulin Modulators|tubulin modulators|mesh-ancestor
102464383|NCT03649321|Antimitotic Agents|antimitotic agents|mesh-ancestor
102464384|NCT03649321|Mitosis Modulators|mitosis modulators|mesh-ancestor
102464385|NCT03649321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464386|NCT03649321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102464387|NCT03649321|Antimetabolites|antimetabolites|mesh-ancestor
102464388|NCT04149938|Lidocaine|lidocaine|mesh-list
102464389|NCT04149938|Anesthetics, Local|anesthetics, local|mesh-ancestor
102464390|NCT04149938|Anesthetics|anesthetics|mesh-ancestor
102464391|NCT04149938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102464392|NCT04149938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464393|NCT04149938|Sensory System Agents|sensory system agents|mesh-ancestor
102464394|NCT04149938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102464395|NCT04149938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102464396|NCT04149938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102464397|NCT04149938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102464398|NCT04149938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102464399|NCT04149938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464400|NCT01797601|Insulin|insulin|mesh-list
102464401|NCT01797601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102464402|NCT01797601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102464403|NCT01797601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464404|NCT02984930|Esomeprazole|esomeprazole|mesh-list
102464405|NCT02984930|Mosapride|mosapride|mesh-list
102464406|NCT02984930|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102464407|NCT02984930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102464408|NCT02984930|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102464409|NCT02984930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102464410|NCT02984930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464411|NCT02984930|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102464412|NCT02984930|Serotonin Agents|serotonin agents|mesh-ancestor
102464413|NCT02984930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102464414|NCT02984930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464415|NCT02123017|Lactulose|lactulose|mesh-list
102464416|NCT02123017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102464417|NCT04149626|Midazolam|midazolam|mesh-list
102464418|NCT04149626|Dexmedetomidine|dexmedetomidine|mesh-list
102464419|NCT04149626|Remifentanil|remifentanil|mesh-list
102464420|NCT04149626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102464421|NCT04149626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102464422|NCT04149626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464423|NCT04149626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102464424|NCT04149626|Analgesics|analgesics|mesh-ancestor
102464425|NCT04149626|Sensory System Agents|sensory system agents|mesh-ancestor
102464426|NCT04149626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102464427|NCT04149626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102464428|NCT04149626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102464429|NCT04149626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102464430|NCT04149626|Adrenergic Agents|adrenergic agents|mesh-ancestor
102464431|NCT04149626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102464432|NCT04149626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464433|NCT04149626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102464434|NCT04149626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102464435|NCT04149626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102464436|NCT04149626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102464437|NCT04149626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102464438|NCT04149626|Anesthetics, General|anesthetics, general|mesh-ancestor
102464439|NCT04149626|Anesthetics|anesthetics|mesh-ancestor
102464441|NCT04149626|GABA Agents|gaba agents|mesh-ancestor
102464442|NCT04149626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102464443|NCT04149626|Narcotics|narcotics|mesh-ancestor
102464444|NCT00486863|Praziquantel|praziquantel|mesh-list
102464445|NCT00486863|Anthelmintics|anthelmintics|mesh-ancestor
102464446|NCT00486863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102464447|NCT00486863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102464448|NCT04023344|Insulin Lispro|insulin lispro|mesh-list
102464449|NCT04023344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102464450|NCT04023344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464451|NCT00452387|Prednisone|prednisone|mesh-list
102464452|NCT00452387|Sorafenib|sorafenib|mesh-list
102464453|NCT00452387|Mitoxantrone|mitoxantrone|mesh-list
102464454|NCT00452387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102464455|NCT00452387|Glucocorticoids|glucocorticoids|mesh-ancestor
102464456|NCT00452387|Hormones|hormones|mesh-ancestor
102464457|NCT00452387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102464458|NCT00452387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464459|NCT00452387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102464460|NCT00452387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102464461|NCT00452387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102464462|NCT00452387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102464463|NCT00452387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464464|NCT00452387|Analgesics|analgesics|mesh-ancestor
102464465|NCT00452387|Sensory System Agents|sensory system agents|mesh-ancestor
102464466|NCT00452387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102464467|NCT00452387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102464468|NCT00452387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102464469|NCT03945656|Insulin|insulin|mesh-list
102464470|NCT03945656|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102464471|NCT03945656|Insulin Glargine|insulin glargine|mesh-list
102464472|NCT03945656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102464473|NCT03945656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464474|NCT00452543|Acamprosate|acamprosate|mesh-list
102464475|NCT00452543|Dexetimide|dexetimide|mesh-list
102464476|NCT00452543|Citalopram|citalopram|mesh-list
102464477|NCT00452543|Escitalopram|escitalopram|mesh-list
102464478|NCT00452543|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102464479|NCT00452543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102464480|NCT00452543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102464481|NCT00452543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464482|NCT00452543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102464483|NCT00452543|Serotonin Agents|serotonin agents|mesh-ancestor
102464484|NCT00452543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464485|NCT00452543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102464486|NCT00452543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102464487|NCT00452543|Parasympatholytics|parasympatholytics|mesh-ancestor
102464488|NCT00452543|Autonomic Agents|autonomic agents|mesh-ancestor
102464489|NCT00452543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102464490|NCT00452543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102464491|NCT00452543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102464492|NCT00452543|Cholinergic Agents|cholinergic agents|mesh-ancestor
102464493|NCT00452543|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102464494|NCT00452543|Antidepressive Agents|antidepressive agents|mesh-ancestor
102464495|NCT00452543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102464496|NCT00452543|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102464497|NCT04961359|Vaccines|vaccines|mesh-list
102464498|NCT04961359|Immunologic Factors|immunologic factors|mesh-ancestor
102464499|NCT04961359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464500|NCT05621707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102464501|NCT05621707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464502|NCT05621707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102464503|NCT05621707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102464504|NCT04765904|Fluorides|fluorides|mesh-list
102464505|NCT04765904|Cariostatic Agents|cariostatic agents|mesh-ancestor
102464506|NCT04765904|Protective Agents|protective agents|mesh-ancestor
102464507|NCT04765904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464508|NCT05621551|Dapagliflozin|dapagliflozin|mesh-list
102464509|NCT05621551|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102464510|NCT05621551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464511|NCT05621551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102464512|NCT05621551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464513|NCT00565669|Cyclosporine|cyclosporine|mesh-list
102464514|NCT00565669|Cyclosporins|cyclosporins|mesh-list
102464515|NCT00565669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102464516|NCT00565669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464517|NCT00565669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102464518|NCT00565669|Immunologic Factors|immunologic factors|mesh-ancestor
102464519|NCT00565669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464520|NCT00565669|Antifungal Agents|antifungal agents|mesh-ancestor
102464521|NCT00565669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102464522|NCT00565669|Dermatologic Agents|dermatologic agents|mesh-ancestor
102464523|NCT00565669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102464524|NCT00565669|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102464525|NCT04165135|Factor VIII|factor viii|mesh-list
102464526|NCT04165135|Coagulants|coagulants|mesh-ancestor
102464527|NCT02132533|Nifedipine|nifedipine|mesh-list
102464528|NCT02132533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102464529|NCT02132533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102464530|NCT02132533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464531|NCT02132533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102464532|NCT02132533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464533|NCT02132533|Vasodilator Agents|vasodilator agents|mesh-ancestor
102464534|NCT02132533|Tocolytic Agents|tocolytic agents|mesh-ancestor
102464535|NCT02132533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102464536|NCT03926702|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
102464537|NCT03926702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464538|NCT00567229|Rituximab|rituximab|mesh-list
102464539|NCT00567229|Lenalidomide|lenalidomide|mesh-list
102094746|NCT05624918|Paclitaxel|paclitaxel|mesh-list
102464540|NCT00567229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102464541|NCT00567229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102464542|NCT00567229|Immunologic Factors|immunologic factors|mesh-ancestor
102464543|NCT00567229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464544|NCT00567229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102464545|NCT00567229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102464546|NCT00567229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102464547|NCT00567229|Growth Substances|growth substances|mesh-ancestor
102464548|NCT00567229|Growth Inhibitors|growth inhibitors|mesh-ancestor
102464549|NCT04148846|Dexamethasone|dexamethasone|mesh-list
102464550|NCT04148846|Ketoprofen|ketoprofen|mesh-list
102464551|NCT04148846|Theophylline|theophylline|mesh-list
102464552|NCT04148846|Gabapentin|gabapentin|mesh-list
102464553|NCT04148846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102464554|NCT04148846|Antiemetics|antiemetics|mesh-ancestor
102464555|NCT04148846|Autonomic Agents|autonomic agents|mesh-ancestor
102464556|NCT04148846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102464557|NCT04148846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464558|NCT04148846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102464559|NCT04148846|Glucocorticoids|glucocorticoids|mesh-ancestor
102464560|NCT04148846|Hormones|hormones|mesh-ancestor
102464561|NCT04148846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102464562|NCT04148846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102464563|NCT04148846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102464564|NCT04148846|Analgesics|analgesics|mesh-ancestor
102464565|NCT04148846|Sensory System Agents|sensory system agents|mesh-ancestor
102464566|NCT04148846|Anticonvulsants|anticonvulsants|mesh-ancestor
102464567|NCT04148846|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102464568|NCT04148846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102464569|NCT04148846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102464570|NCT04148846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102464571|NCT04148846|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102464572|NCT04148846|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102464573|NCT04148846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102464574|NCT04148846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464575|NCT04148846|Antimanic Agents|antimanic agents|mesh-ancestor
102464576|NCT04148846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102464577|NCT04148846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102464578|NCT04148846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102464579|NCT04148846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102464580|NCT04148846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102464581|NCT04148846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102464582|NCT04148846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102464583|NCT04148846|Respiratory System Agents|respiratory system agents|mesh-ancestor
102464584|NCT04148846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102464585|NCT04148846|Vasodilator Agents|vasodilator agents|mesh-ancestor
102464586|NCT04148846|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102464587|NCT04148846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102464588|NCT04148846|Purinergic Agents|purinergic agents|mesh-ancestor
102464589|NCT00568087|Acetylcysteine|acetylcysteine|mesh-list
102464590|NCT00568087|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102464592|NCT00568087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102464593|NCT00568087|Expectorants|expectorants|mesh-ancestor
102464594|NCT00568087|Respiratory System Agents|respiratory system agents|mesh-ancestor
102464595|NCT00568087|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102464596|NCT00568087|Antioxidants|antioxidants|mesh-ancestor
102464597|NCT00568087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464598|NCT00568087|Protective Agents|protective agents|mesh-ancestor
102464599|NCT00568087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464600|NCT00568087|Antidotes|antidotes|mesh-ancestor
102464601|NCT00487721|Silymarin|silymarin|mesh-list
102464602|NCT00487721|Antioxidants|antioxidants|mesh-ancestor
102464603|NCT00487721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464604|NCT00487721|Protective Agents|protective agents|mesh-ancestor
102464605|NCT00487721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464606|NCT00568633|Cyclosporine|cyclosporine|mesh-list
102464607|NCT00568633|Mycophenolic Acid|mycophenolic acid|mesh-list
102464608|NCT00568633|Methylprednisolone|methylprednisolone|mesh-list
102464609|NCT00568633|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102464610|NCT00568633|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102464611|NCT00568633|Prednisolone|prednisolone|mesh-list
102464612|NCT00568633|Prednisolone acetate|prednisolone acetate|mesh-list
102464613|NCT00568633|Cyclosporins|cyclosporins|mesh-list
101814562|NCT02558387|Nintedanib|nintedanib|mesh-list
102464614|NCT00568633|Thymoglobulin|thymoglobulin|mesh-list
102464615|NCT00568633|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102464616|NCT00568633|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102464617|NCT00568633|Prednisolone phosphate|prednisolone phosphate|mesh-list
102464618|NCT00568633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102464619|NCT00568633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464620|NCT00568633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102464621|NCT00568633|Immunologic Factors|immunologic factors|mesh-ancestor
102464622|NCT00568633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464623|NCT00568633|Antifungal Agents|antifungal agents|mesh-ancestor
102464624|NCT00568633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102464625|NCT00568633|Dermatologic Agents|dermatologic agents|mesh-ancestor
102464626|NCT00568633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102464627|NCT00568633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102464628|NCT00568633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102464629|NCT00568633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102464630|NCT00568633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102464631|NCT00568633|Antitubercular Agents|antitubercular agents|mesh-ancestor
102464632|NCT00568633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102464633|NCT00568633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102464634|NCT00568633|Antiemetics|antiemetics|mesh-ancestor
102464635|NCT00568633|Autonomic Agents|autonomic agents|mesh-ancestor
102464636|NCT00568633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102464637|NCT00568633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102464638|NCT00568633|Glucocorticoids|glucocorticoids|mesh-ancestor
102464639|NCT00568633|Hormones|hormones|mesh-ancestor
102464640|NCT00568633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102464641|NCT00568633|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102464642|NCT00568633|Protective Agents|protective agents|mesh-ancestor
102464643|NCT00568633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102464644|NCT03022838|Caffeine|caffeine|mesh-list
102464645|NCT03022838|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102464646|NCT03022838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464647|NCT03022838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102464648|NCT03022838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102464649|NCT03022838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464650|NCT03022838|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102464651|NCT03022838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102464652|NCT03022838|Purinergic Agents|purinergic agents|mesh-ancestor
102464653|NCT03022838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102464654|NCT05363449|Naftifine|naftifine|mesh-list
102464655|NCT05363449|Antifungal Agents|antifungal agents|mesh-ancestor
102464656|NCT05363449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102464657|NCT00489281|Mycophenolic Acid|mycophenolic acid|mesh-list
102464658|NCT00489281|Sirolimus|sirolimus|mesh-list
102464659|NCT00489281|Cyclophosphamide|cyclophosphamide|mesh-list
102464660|NCT00489281|Fludarabine|fludarabine|mesh-list
102464661|NCT00489281|Levetiracetam|levetiracetam|mesh-list
102464662|NCT00489281|Thymoglobulin|thymoglobulin|mesh-list
102464663|NCT00489281|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102464664|NCT00489281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102276235|NCT05002517|Methylprednisolone|methylprednisolone|mesh-list
102464665|NCT00489281|Immunologic Factors|immunologic factors|mesh-ancestor
102464666|NCT00489281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464667|NCT00489281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102464668|NCT00489281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102464669|NCT00489281|Alkylating Agents|alkylating agents|mesh-ancestor
102464670|NCT00489281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464671|NCT00489281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102464672|NCT00489281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102464673|NCT00489281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102464674|NCT00489281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102464675|NCT00489281|Antitubercular Agents|antitubercular agents|mesh-ancestor
102464676|NCT00489281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102464677|NCT00489281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102464678|NCT00489281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102464679|NCT00489281|Antifungal Agents|antifungal agents|mesh-ancestor
102464680|NCT00489281|Anticonvulsants|anticonvulsants|mesh-ancestor
102464681|NCT00489281|Nootropic Agents|nootropic agents|mesh-ancestor
102464682|NCT05362513|Ivermectin|ivermectin|mesh-list
102464683|NCT05362513|Permethrin|permethrin|mesh-list
102464684|NCT05362513|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102464685|NCT05362513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102464686|NCT05362513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102464687|NCT05362513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464688|NCT04457297|Trifluridine|trifluridine|mesh-list
102464689|NCT04457297|Antimetabolites|antimetabolites|mesh-ancestor
102464690|NCT04457297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464691|NCT04457297|Antiviral Agents|antiviral agents|mesh-ancestor
102464692|NCT04457297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102464693|NCT04146116|Povidone-Iodine|povidone-iodine|mesh-list
102464694|NCT04146116|Povidone|povidone|mesh-list
102464695|NCT04146116|Plasma Substitutes|plasma substitutes|mesh-ancestor
102464696|NCT04146116|Blood Substitutes|blood substitutes|mesh-ancestor
102464697|NCT04146116|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102464698|NCT04146116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102464699|NCT04145804|Insulin|insulin|mesh-list
102464700|NCT04145804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102464701|NCT04145804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464702|NCT02120261|Triamcinolone|triamcinolone|mesh-list
102464703|NCT02120261|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102464704|NCT02120261|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102464705|NCT02120261|Lidocaine|lidocaine|mesh-list
102464706|NCT02120261|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102464707|NCT02120261|Anesthetics, Local|anesthetics, local|mesh-ancestor
102464708|NCT02120261|Anesthetics|anesthetics|mesh-ancestor
102464709|NCT02120261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102464710|NCT02120261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464711|NCT02120261|Sensory System Agents|sensory system agents|mesh-ancestor
102464712|NCT02120261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102464713|NCT02120261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102464714|NCT02120261|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102464715|NCT02120261|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102464716|NCT02120261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102464717|NCT02120261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464718|NCT02120261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102464719|NCT02120261|Glucocorticoids|glucocorticoids|mesh-ancestor
102464720|NCT02120261|Hormones|hormones|mesh-ancestor
102464721|NCT02120261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102464722|NCT02120261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102464723|NCT02120261|Immunologic Factors|immunologic factors|mesh-ancestor
102464724|NCT02120261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102464725|NCT03907046|Aspirin|aspirin|mesh-list
102464726|NCT03907046|Apixaban|apixaban|mesh-list
102464727|NCT03907046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102464728|NCT03907046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102464729|NCT03907046|Analgesics|analgesics|mesh-ancestor
102464730|NCT03907046|Sensory System Agents|sensory system agents|mesh-ancestor
102464731|NCT03907046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102464732|NCT03907046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464733|NCT03907046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102464734|NCT03907046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102464735|NCT03907046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102464736|NCT03907046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102464737|NCT03907046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464738|NCT03907046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102464739|NCT03907046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102464740|NCT03907046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102464741|NCT03907046|Antipyretics|antipyretics|mesh-ancestor
102276306|NCT04498741|Anesthetics|anesthetics|mesh-ancestor
102464742|NCT03907046|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102464743|NCT03907046|Antithrombins|antithrombins|mesh-ancestor
102464744|NCT03907046|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102464745|NCT03907046|Protease Inhibitors|protease inhibitors|mesh-ancestor
102464746|NCT03907046|Anticoagulants|anticoagulants|mesh-ancestor
102464747|NCT03840421|Cisplatin|cisplatin|mesh-list
102464748|NCT03840421|Gemcitabine|gemcitabine|mesh-list
102464749|NCT03840421|Fluorouracil|fluorouracil|mesh-list
102464750|NCT03840421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102464751|NCT03840421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102464752|NCT03840421|Antimetabolites|antimetabolites|mesh-ancestor
102464753|NCT03840421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464754|NCT03840421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102464755|NCT03840421|Immunologic Factors|immunologic factors|mesh-ancestor
102464756|NCT03840421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464757|NCT00492089|Bevacizumab|bevacizumab|mesh-list
102464758|NCT00492089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102464759|NCT00492089|Antibodies|antibodies|mesh-list
102464760|NCT00492089|Immunoglobulins|immunoglobulins|mesh-list
102464761|NCT00492089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102464762|NCT00492089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102464763|NCT00492089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102464764|NCT00492089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102464765|NCT00492089|Growth Substances|growth substances|mesh-ancestor
102464766|NCT00492089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464767|NCT00492089|Growth Inhibitors|growth inhibitors|mesh-ancestor
102464768|NCT00492089|Immunologic Factors|immunologic factors|mesh-ancestor
102464769|NCT01798537|Vancomycin|vancomycin|mesh-list
102464770|NCT01798537|Colistin|colistin|mesh-list
102464771|NCT01798537|Neomycin|neomycin|mesh-list
102464772|NCT01798537|Nystatin|nystatin|mesh-list
102464773|NCT01798537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102464774|NCT01798537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102464775|NCT01798537|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102464776|NCT01798537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102464777|NCT01798537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464778|NCT01798537|Antifungal Agents|antifungal agents|mesh-ancestor
102464779|NCT01798537|Ionophores|ionophores|mesh-ancestor
102464780|NCT01798537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102464781|NCT04315181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
102464782|NCT04315181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102464783|NCT04315181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464784|NCT03805477|Nintedanib|nintedanib|mesh-list
102464785|NCT03805477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102464786|NCT03805477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102464787|NCT03805477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102464788|NCT03805477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464789|NCT04140422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102464790|NCT04140422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102464791|NCT01797341|Tacrolimus|tacrolimus|mesh-list
102464792|NCT01797341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102464793|NCT01797341|Immunologic Factors|immunologic factors|mesh-ancestor
102464794|NCT01797341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464795|NCT01797341|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102464796|NCT01797341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102464797|NCT01797341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464798|NCT04145570|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102464799|NCT04145570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102464800|NCT04145570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102464801|NCT04145570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102464802|NCT04145570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464803|NCT04145492|Vitamin D|vitamin d|mesh-list
102464804|NCT04145492|Cholecalciferol|cholecalciferol|mesh-list
102464805|NCT04145492|Calcifediol|calcifediol|mesh-list
102464806|NCT04145492|Vitamins|vitamins|mesh-list
102464807|NCT04145492|Vitamin K|vitamin k|mesh-list
102464808|NCT04145492|Vitamin K 2|vitamin k 2|mesh-list
102464809|NCT04145492|Micronutrients|micronutrients|mesh-ancestor
102464810|NCT04145492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464811|NCT04145492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102464812|NCT04145492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102464813|NCT04145492|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102464814|NCT04145492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102276382|NCT03073265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102464815|NCT04145492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464816|NCT04145492|Hemostatics|hemostatics|mesh-ancestor
102464817|NCT04145492|Coagulants|coagulants|mesh-ancestor
102464819|NCT04147754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102464820|NCT04147754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464821|NCT04147754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102464822|NCT04147754|Narcotics|narcotics|mesh-ancestor
102095102|NCT05286801|Deoxyglucose|deoxyglucose|mesh-list
102095103|NCT05286801|Atezolizumab|atezolizumab|mesh-list
102095104|NCT05286801|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102095105|NCT05286801|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102464823|NCT04147754|Analgesics|analgesics|mesh-ancestor
102464824|NCT04147754|Sensory System Agents|sensory system agents|mesh-ancestor
102464825|NCT04147754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102464826|NCT00492401|Decitabine|decitabine|mesh-list
102464827|NCT00492401|Azacitidine|azacitidine|mesh-list
102464828|NCT00492401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102464829|NCT00492401|Antimetabolites|antimetabolites|mesh-ancestor
102464830|NCT00492401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464831|NCT00492401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102464832|NCT00492401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102464833|NCT03674827|Immunomodulating Agents|immunomodulating agents|mesh-list
102464834|NCT03674827|Immunologic Factors|immunologic factors|mesh-ancestor
102464835|NCT03674827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464836|NCT04147286|Atorvastatin|atorvastatin|mesh-list
102464837|NCT04147286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102464838|NCT04147286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102464839|NCT04147286|Antimetabolites|antimetabolites|mesh-ancestor
102464840|NCT04147286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464841|NCT04147286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102464842|NCT04147286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102464843|NCT04147286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102464844|NCT00493181|Oprelvekin|oprelvekin|mesh-list
102464845|NCT00493181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102464846|NCT04143659|Levonorgestrel|levonorgestrel|mesh-list
102464847|NCT04143659|Levonorgestrel butanoate|levonorgestrel butanoate|mesh-list
102464848|NCT04143659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102464849|NCT04143659|Contraceptive Agents|contraceptive agents|mesh-ancestor
102464850|NCT04143659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102464851|NCT04143659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464852|NCT04143659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102464853|NCT04143659|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102464854|NCT04143659|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102464855|NCT04143659|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102464856|NCT00493805|Interferons|interferons|mesh-list
102464857|NCT00493805|Ribavirin|ribavirin|mesh-list
102464858|NCT00493805|Interferon-alpha|interferon-alpha|mesh-list
102464859|NCT00493805|Interferon alpha-2|interferon alpha-2|mesh-list
102464860|NCT00493805|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102464861|NCT00493805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102464862|NCT00493805|Antiviral Agents|antiviral agents|mesh-ancestor
102464863|NCT00493805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102464864|NCT00493805|Antimetabolites|antimetabolites|mesh-ancestor
102464865|NCT00493805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464866|NCT00493805|Immunologic Factors|immunologic factors|mesh-ancestor
102464867|NCT00493805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464868|NCT04145102|Propolis|propolis|mesh-list
102464869|NCT04145102|Fluorides|fluorides|mesh-list
102464870|NCT04145102|Cariostatic Agents|cariostatic agents|mesh-ancestor
102464871|NCT04145102|Protective Agents|protective agents|mesh-ancestor
102464872|NCT04145102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464873|NCT04145102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102464874|NCT05581706|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102464875|NCT05581706|Calcium|calcium|mesh-list
102464876|NCT05581706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102464877|NCT05581706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464878|NCT05581706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102464879|NCT03558373|Immunosuppressive Agents|immunosuppressive agents|mesh-list
102464880|NCT03558373|Immunologic Factors|immunologic factors|mesh-ancestor
102464881|NCT03558373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464882|NCT05183191|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102464883|NCT05183191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464884|NCT03588494|Endostar protein|endostar protein|mesh-list
102464885|NCT03588494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102464886|NCT03588494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102464887|NCT03588494|Growth Substances|growth substances|mesh-ancestor
102464888|NCT03588494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464889|NCT03588494|Growth Inhibitors|growth inhibitors|mesh-ancestor
102095106|NCT05286801|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102464890|NCT03588494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102464891|NCT00550277|Panobinostat|panobinostat|mesh-list
102464892|NCT00550277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102276457|NCT04992533|Sympathomimetics|sympathomimetics|mesh-ancestor
102464893|NCT00550277|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102464894|NCT00550277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102464895|NCT00550277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464897|NCT00550589|Antiviral Agents|antiviral agents|mesh-ancestor
102464898|NCT00550589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102464899|NCT00550589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102464900|NCT00550589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464901|NCT04144712|Caffeine|caffeine|mesh-list
102464902|NCT04144712|Caffeine citrate|caffeine citrate|mesh-list
102464903|NCT04144712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464904|NCT04144712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102464905|NCT04144712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464906|NCT04144712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102464907|NCT04144712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102464908|NCT04144712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102464909|NCT04144712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102464910|NCT04144712|Purinergic Agents|purinergic agents|mesh-ancestor
102464911|NCT04144712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102464912|NCT03588338|Acetaminophen|acetaminophen|mesh-list
102464913|NCT03588338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102464914|NCT03588338|Analgesics|analgesics|mesh-ancestor
102464915|NCT03588338|Sensory System Agents|sensory system agents|mesh-ancestor
102464916|NCT03588338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102464917|NCT03588338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464918|NCT03588338|Antipyretics|antipyretics|mesh-ancestor
102464919|NCT05099185|Trace Elements|trace elements|mesh-list
102464920|NCT05099185|Micronutrients|micronutrients|mesh-list
102464921|NCT05099185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464922|NCT05068609|Nivolumab|nivolumab|mesh-list
102464923|NCT05068609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102464924|NCT05068609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102464925|NCT05068609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102464926|NCT05068609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464927|NCT00496379|Epothilones|epothilones|mesh-list
102464928|NCT00496379|Sagopilone|sagopilone|mesh-list
102464929|NCT00496379|Tubulin Modulators|tubulin modulators|mesh-ancestor
102464930|NCT00496379|Antimitotic Agents|antimitotic agents|mesh-ancestor
102464931|NCT00496379|Mitosis Modulators|mitosis modulators|mesh-ancestor
102464932|NCT00496379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464933|NCT00496379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102464934|NCT00497081|Mirtazapine|mirtazapine|mesh-list
102464935|NCT00497081|Antidepressive Agents|antidepressive agents|mesh-ancestor
102464936|NCT00497081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102464937|NCT00497081|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102464938|NCT00497081|Histamine Antagonists|histamine antagonists|mesh-ancestor
102464939|NCT00497081|Histamine Agents|histamine agents|mesh-ancestor
102464940|NCT00497081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102464941|NCT00497081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464942|NCT00497081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464943|NCT00497081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102464944|NCT00497081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102464945|NCT00497081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102464946|NCT00497081|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102464947|NCT00497081|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102464948|NCT00497081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102464949|NCT00497081|Adrenergic Agents|adrenergic agents|mesh-ancestor
102464950|NCT00497081|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102464951|NCT00497081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102464952|NCT00497081|Serotonin Agents|serotonin agents|mesh-ancestor
102464953|NCT00497081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102464954|NCT01796951|Aspirin|aspirin|mesh-list
102464955|NCT01796951|Celecoxib|celecoxib|mesh-list
102464956|NCT01796951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102464957|NCT01796951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102464958|NCT01796951|Analgesics|analgesics|mesh-ancestor
102464959|NCT01796951|Sensory System Agents|sensory system agents|mesh-ancestor
102464960|NCT01796951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102464961|NCT01796951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464962|NCT01796951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102464963|NCT01796951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102464964|NCT01796951|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102464965|NCT01796951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102276535|NCT02327689|Adefovir|adefovir|mesh-list
102464966|NCT01796951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464967|NCT01796951|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102464968|NCT01796951|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102464969|NCT01796951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102464970|NCT01796951|Antipyretics|antipyretics|mesh-ancestor
102464971|NCT01796951|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102464972|NCT04838041|Imatinib Mesylate|imatinib mesylate|mesh-list
102464973|NCT04838041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102464974|NCT04838041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102464975|NCT04838041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102464976|NCT04838041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464977|NCT03895502|Edoxaban|edoxaban|mesh-list
102464978|NCT03895502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102464979|NCT03895502|Antithrombins|antithrombins|mesh-ancestor
102464980|NCT03895502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102464981|NCT03895502|Protease Inhibitors|protease inhibitors|mesh-ancestor
102464982|NCT03895502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102464983|NCT03895502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464984|NCT03895502|Anticoagulants|anticoagulants|mesh-ancestor
102464985|NCT04143854|Botulinum Toxins|botulinum toxins|mesh-list
102464986|NCT04143854|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102464987|NCT04143854|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102464988|NCT04143854|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102464989|NCT04143854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102464990|NCT04143854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102464991|NCT04143854|Cholinergic Agents|cholinergic agents|mesh-ancestor
102464992|NCT04143854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102464993|NCT04143854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102464994|NCT04143854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102464995|NCT04143854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102464996|NCT03587558|Flecainide|flecainide|mesh-list
102464997|NCT03587558|Carvedilol|carvedilol|mesh-list
102464998|NCT03587558|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102464999|NCT03587558|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102465000|NCT03587558|Adrenergic Agents|adrenergic agents|mesh-ancestor
102465001|NCT03587558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102465002|NCT03587558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465003|NCT03587558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465004|NCT03587558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102465005|NCT03587558|Antioxidants|antioxidants|mesh-ancestor
102465006|NCT03587558|Protective Agents|protective agents|mesh-ancestor
102465007|NCT03587558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102465008|NCT03587558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102095227|NCT05096481|Temozolomide|temozolomide|mesh-list
102465009|NCT03587558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102465010|NCT03587558|Vasodilator Agents|vasodilator agents|mesh-ancestor
102465011|NCT03587558|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102465012|NCT03587558|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102465013|NCT03587558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102465014|NCT03587558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102465015|NCT03587558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102465016|NCT04415905|Propofol|propofol|mesh-list
102465017|NCT04415905|Sevoflurane|sevoflurane|mesh-list
102465018|NCT04415905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102465019|NCT04415905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102465020|NCT04415905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465021|NCT04415905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102465022|NCT04415905|Anesthetics, General|anesthetics, general|mesh-ancestor
102465023|NCT04415905|Anesthetics|anesthetics|mesh-ancestor
102465024|NCT04415905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102465025|NCT04415905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102465026|NCT02979704|Atorvastatin|atorvastatin|mesh-list
102465027|NCT02979704|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102465028|NCT02979704|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102465029|NCT02979704|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102465030|NCT02979704|Antimetabolites|antimetabolites|mesh-ancestor
102465031|NCT02979704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465032|NCT02979704|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102465033|NCT02979704|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102465034|NCT02979704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102465035|NCT03587324|Clopidogrel|clopidogrel|mesh-list
102465036|NCT03587324|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102465037|NCT03587324|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102465038|NCT03587324|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102465039|NCT03587324|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102465040|NCT03587324|Purinergic Agents|purinergic agents|mesh-ancestor
102465041|NCT03587324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102465042|NCT03587324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465043|NCT03587324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465044|NCT03919292|Valproic Acid|valproic acid|mesh-list
102465045|NCT03919292|Anticonvulsants|anticonvulsants|mesh-ancestor
102465046|NCT03919292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102465047|NCT03919292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465048|NCT03919292|GABA Agents|gaba agents|mesh-ancestor
102465049|NCT03919292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102465050|NCT03919292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465051|NCT03919292|Antimanic Agents|antimanic agents|mesh-ancestor
102465052|NCT03919292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102465053|NCT03919292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102465054|NCT03919292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102465055|NCT01798459|Methylphenidate|methylphenidate|mesh-list
102465056|NCT01798459|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102465057|NCT01798459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465058|NCT01798459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102465059|NCT01798459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102465060|NCT01798459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102465061|NCT01798459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465062|NCT01798459|Dopamine Agents|dopamine agents|mesh-ancestor
102465063|NCT01798459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102465064|NCT00555321|Mycophenolic Acid|mycophenolic acid|mesh-list
102465065|NCT00555321|Abatacept|abatacept|mesh-list
102465066|NCT00555321|Tacrolimus|tacrolimus|mesh-list
102465067|NCT00555321|Basiliximab|basiliximab|mesh-list
102465068|NCT00555321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102465069|NCT00555321|Immunologic Factors|immunologic factors|mesh-ancestor
102465070|NCT00555321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465071|NCT00555321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102465072|NCT00555321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102465073|NCT00555321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465074|NCT00555321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102465075|NCT00555321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102465076|NCT00555321|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102465077|NCT00555321|Antitubercular Agents|antitubercular agents|mesh-ancestor
102465078|NCT00555321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102465079|NCT00555321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102465080|NCT00555321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102465081|NCT00555321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102465082|NCT00555321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102465083|NCT05583266|Pentoxifylline|pentoxifylline|mesh-list
102465084|NCT05583266|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102465085|NCT05583266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102465086|NCT05583266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465087|NCT05583266|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102465088|NCT05583266|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102465089|NCT05583266|Protective Agents|protective agents|mesh-ancestor
102465090|NCT05583266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465091|NCT05583266|Vasodilator Agents|vasodilator agents|mesh-ancestor
102465092|NCT05583266|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102465093|NCT05583266|Antioxidants|antioxidants|mesh-ancestor
102465094|NCT04142840|Dexmedetomidine|dexmedetomidine|mesh-list
102465095|NCT04142840|Propofol|propofol|mesh-list
102465096|NCT04142840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102465097|NCT04142840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102465098|NCT04142840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465099|NCT04142840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102465100|NCT04142840|Analgesics|analgesics|mesh-ancestor
102465101|NCT04142840|Sensory System Agents|sensory system agents|mesh-ancestor
102465102|NCT04142840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102465103|NCT04142840|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102465104|NCT04142840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102465105|NCT04142840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102465106|NCT04142840|Adrenergic Agents|adrenergic agents|mesh-ancestor
102465107|NCT04142840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102465108|NCT04142840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465109|NCT04142840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102465110|NCT04142840|Anesthetics, General|anesthetics, general|mesh-ancestor
102465111|NCT04142840|Anesthetics|anesthetics|mesh-ancestor
102276686|NCT03071705|Metformin|metformin|mesh-list
102465112|NCT04142762|Itraconazole|itraconazole|mesh-list
102465114|NCT04142762|Midazolam|midazolam|mesh-list
102465115|NCT04142762|Esomeprazole|esomeprazole|mesh-list
102465116|NCT04142762|Levonorgestrel|levonorgestrel|mesh-list
102465117|NCT04142762|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102465118|NCT04142762|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
102465119|NCT04142762|Contraceptive Agents|contraceptive agents|mesh-list
102465120|NCT04142762|Contraceptives, Oral|contraceptives, oral|mesh-list
102465121|NCT04142762|Estradiol|estradiol|mesh-list
102465122|NCT04142762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102465123|NCT04142762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102465124|NCT04142762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102465125|NCT04142762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465126|NCT04142762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102465127|NCT04142762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102465128|NCT04142762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102465129|NCT04142762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102095364|NCT04766853|Hormones|hormones|mesh-ancestor
102465130|NCT04142762|Anesthetics, General|anesthetics, general|mesh-ancestor
102465131|NCT04142762|Anesthetics|anesthetics|mesh-ancestor
102465132|NCT04142762|GABA Modulators|gaba modulators|mesh-ancestor
102465133|NCT04142762|GABA Agents|gaba agents|mesh-ancestor
102465134|NCT04142762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102465135|NCT04142762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465136|NCT04142762|Estrogens|estrogens|mesh-ancestor
102465137|NCT04142762|Hormones|hormones|mesh-ancestor
102465138|NCT04142762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102465139|NCT04142762|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102465140|NCT04142762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102465141|NCT04142762|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102465142|NCT04142762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102465143|NCT04142762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102465144|NCT04142762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102465145|NCT04142762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102465146|NCT04142762|Antifungal Agents|antifungal agents|mesh-ancestor
102465147|NCT04142762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102465148|NCT04142762|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102465149|NCT04142762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102465150|NCT04142762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102465151|NCT04142762|Hormone Antagonists|hormone antagonists|mesh-ancestor
102465152|NCT04142762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102465153|NCT04142762|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102465154|NCT04142762|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102465155|NCT04142762|Antitubercular Agents|antitubercular agents|mesh-ancestor
102465156|NCT04142762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102465157|NCT04142762|Leprostatic Agents|leprostatic agents|mesh-ancestor
102465158|NCT04142762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102465159|NCT04142762|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102465160|NCT04142762|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102465161|NCT04142762|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102465162|NCT04142762|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102465163|NCT04142762|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102465164|NCT04142762|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102465165|NCT04142762|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102465166|NCT04142762|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102465167|NCT05582876|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102465168|NCT05582876|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
102465169|NCT05582876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465170|NCT02139007|Alendronate|alendronate|mesh-list
102465171|NCT02139007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102465172|NCT02139007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465173|NCT01590277|Ethanol|ethanol|mesh-list
102465174|NCT01590277|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102465175|NCT01590277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102465176|NCT01590277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102465177|NCT01590277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465178|NCT03586466|Buprenorphine|buprenorphine|mesh-list
102465179|NCT03586466|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102465180|NCT03586466|Naloxone|naloxone|mesh-list
102465181|NCT03586466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102465182|NCT03586466|Narcotics|narcotics|mesh-ancestor
102465183|NCT03586466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102276776|NCT04986995|Opicapone|opicapone|mesh-list
102465184|NCT03586466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465186|NCT03586466|Sensory System Agents|sensory system agents|mesh-ancestor
102465187|NCT03586466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102465188|NCT03586466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102465189|NCT00570349|Nitric Oxide|nitric oxide|mesh-list
102465190|NCT00570349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102465191|NCT00570349|Autonomic Agents|autonomic agents|mesh-ancestor
102465192|NCT00570349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102465193|NCT00570349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465194|NCT00570349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102465195|NCT00570349|Respiratory System Agents|respiratory system agents|mesh-ancestor
102465196|NCT00570349|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102465197|NCT00570349|Antioxidants|antioxidants|mesh-ancestor
102465198|NCT00570349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465199|NCT00570349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102465200|NCT00570349|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102465201|NCT00570349|Vasodilator Agents|vasodilator agents|mesh-ancestor
102465202|NCT00570349|Gasotransmitters|gasotransmitters|mesh-ancestor
102465203|NCT00570349|Protective Agents|protective agents|mesh-ancestor
102465204|NCT03586388|Immunomodulating Agents|immunomodulating agents|mesh-list
102465205|NCT03586388|Immunologic Factors|immunologic factors|mesh-ancestor
102465206|NCT03586388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465207|NCT02985086|Cefoxitin|cefoxitin|mesh-list
102465208|NCT02985086|Misoprostol|misoprostol|mesh-list
102465209|NCT02985086|Oxytocin|oxytocin|mesh-list
102465210|NCT02985086|Oxytocics|oxytocics|mesh-ancestor
102465211|NCT02985086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102465212|NCT02985086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465213|NCT02985086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102465214|NCT02985086|Abortifacient Agents|abortifacient agents|mesh-ancestor
102465215|NCT02985086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102465216|NCT02985086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102465217|NCT02985086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102465218|NCT02985086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102465219|NCT04157985|Pembrolizumab|pembrolizumab|mesh-list
102465220|NCT04157985|Nivolumab|nivolumab|mesh-list
102465221|NCT04157985|Ipilimumab|ipilimumab|mesh-list
102465222|NCT04157985|Atezolizumab|atezolizumab|mesh-list
102465223|NCT04157985|Cemiplimab|cemiplimab|mesh-list
102465224|NCT04157985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102465225|NCT04157985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102465226|NCT04157985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102465227|NCT04157985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465228|NCT00609739|Cytarabine|cytarabine|mesh-list
102465229|NCT00609739|Cyclosporine|cyclosporine|mesh-list
102465230|NCT00609739|Methylprednisolone|methylprednisolone|mesh-list
102465231|NCT00609739|Methotrexate|methotrexate|mesh-list
102465232|NCT00609739|Mitoxantrone|mitoxantrone|mesh-list
102465233|NCT00609739|Tretinoin|tretinoin|mesh-list
102465234|NCT00609739|Isotretinoin|isotretinoin|mesh-list
102465235|NCT00609739|Cyclosporins|cyclosporins|mesh-list
102465236|NCT00609739|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102465237|NCT00609739|Abortifacient Agents|abortifacient agents|mesh-ancestor
102465238|NCT00609739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102465239|NCT00609739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465240|NCT00609739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102465241|NCT00609739|Antimetabolites|antimetabolites|mesh-ancestor
102465242|NCT00609739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465243|NCT00609739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102465244|NCT00609739|Dermatologic Agents|dermatologic agents|mesh-ancestor
102465245|NCT00609739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102465246|NCT00609739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102465247|NCT00609739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102465248|NCT00609739|Immunologic Factors|immunologic factors|mesh-ancestor
102465249|NCT00609739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102465250|NCT00609739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102465251|NCT00609739|Antiviral Agents|antiviral agents|mesh-ancestor
102465252|NCT00609739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102465253|NCT00609739|Antifungal Agents|antifungal agents|mesh-ancestor
102465254|NCT00609739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102465255|NCT00609739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102465256|NCT00609739|Antiemetics|antiemetics|mesh-ancestor
102465257|NCT00609739|Autonomic Agents|autonomic agents|mesh-ancestor
102465258|NCT00609739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102465259|NCT00609739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102465260|NCT00609739|Glucocorticoids|glucocorticoids|mesh-ancestor
102276851|NCT03140449|Vitamins|vitamins|mesh-ancestor
102465261|NCT00609739|Hormones|hormones|mesh-ancestor
102465262|NCT00609739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102465263|NCT00609739|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102465264|NCT00609739|Protective Agents|protective agents|mesh-ancestor
102465265|NCT00609739|Analgesics|analgesics|mesh-ancestor
102465266|NCT00609739|Sensory System Agents|sensory system agents|mesh-ancestor
102465267|NCT00609739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102465268|NCT00609739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102465269|NCT00609739|Keratolytic Agents|keratolytic agents|mesh-ancestor
102465270|NCT00610987|Cefazolin|cefazolin|mesh-list
102465271|NCT00610987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102465272|NCT00610987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102465273|NCT04140578|Ertapenem|ertapenem|mesh-list
102465274|NCT04140578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102465275|NCT04140578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102465276|NCT00574171|Capecitabine|capecitabine|mesh-list
102465277|NCT00574171|Lapatinib|lapatinib|mesh-list
102465278|NCT00574171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102465279|NCT00574171|Antimetabolites|antimetabolites|mesh-ancestor
102465280|NCT00574171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465281|NCT00574171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102465282|NCT00574171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102465283|NCT00574171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102465284|NCT03585998|Cisplatin|cisplatin|mesh-list
102465285|NCT03585998|Etoposide|etoposide|mesh-list
102465286|NCT03585998|Durvalumab|durvalumab|mesh-list
102465287|NCT03585998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102465288|NCT03585998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102465289|NCT03585998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102465290|NCT03585998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102465291|NCT03585998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102465292|NCT03585998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465293|NCT03585998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102465294|NCT00612235|Lamotrigine|lamotrigine|mesh-list
102465295|NCT00612235|Carbamazepine|carbamazepine|mesh-list
102465296|NCT00612235|Levetiracetam|levetiracetam|mesh-list
102465297|NCT00612235|Anticonvulsants|anticonvulsants|mesh-ancestor
102465298|NCT00612235|Nootropic Agents|nootropic agents|mesh-ancestor
102465299|NCT00612235|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102465300|NCT00612235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102465301|NCT00612235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465302|NCT00612235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102465303|NCT00612235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465304|NCT00612235|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102465305|NCT00612235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102465306|NCT00612235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102465307|NCT00612235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102465308|NCT00612235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102465309|NCT00612235|Antimanic Agents|antimanic agents|mesh-ancestor
102465310|NCT00612235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102465311|NCT00612235|Analgesics|analgesics|mesh-ancestor
102465312|NCT00612235|Sensory System Agents|sensory system agents|mesh-ancestor
102465313|NCT00612235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102465314|NCT00612235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102465315|NCT00612235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102465316|NCT00575029|Megestrol|megestrol|mesh-list
102465317|NCT00575029|Megestrol Acetate|megestrol acetate|mesh-list
102465318|NCT00575029|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102465319|NCT00575029|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102465320|NCT00575029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102465321|NCT00575029|Contraceptive Agents|contraceptive agents|mesh-ancestor
102465322|NCT00575029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102465323|NCT00575029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465324|NCT00575029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102465325|NCT00575029|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102465326|NCT00575029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102465327|NCT00575029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102465328|NCT00575029|Appetite Stimulants|appetite stimulants|mesh-ancestor
102465329|NCT00575029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102465330|NCT00499109|Carboplatin|carboplatin|mesh-list
102465331|NCT00499109|Gemcitabine|gemcitabine|mesh-list
102465332|NCT00499109|Docetaxel|docetaxel|mesh-list
102465333|NCT00499109|Vinorelbine|vinorelbine|mesh-list
102465334|NCT00499109|Antineoplastic Agents|antineoplastic agents|mesh-list
102465335|NCT00499109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102465336|NCT00499109|Antimetabolites|antimetabolites|mesh-ancestor
102465337|NCT00499109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465338|NCT00499109|Tubulin Modulators|tubulin modulators|mesh-ancestor
102465339|NCT00499109|Antimitotic Agents|antimitotic agents|mesh-ancestor
102465340|NCT00499109|Mitosis Modulators|mitosis modulators|mesh-ancestor
102465341|NCT00499109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102465343|NCT03585530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102465344|NCT03585530|Antimetabolites|antimetabolites|mesh-ancestor
102465345|NCT03585530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465346|NCT03585530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102465347|NCT03585530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102465348|NCT03585530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102465349|NCT03021590|Amoxicillin|amoxicillin|mesh-list
102465350|NCT03021590|Clarithromycin|clarithromycin|mesh-list
102465351|NCT03021590|Levofloxacin|levofloxacin|mesh-list
102465352|NCT03021590|Tinidazole|tinidazole|mesh-list
102465353|NCT03021590|Esomeprazole|esomeprazole|mesh-list
102465354|NCT03021590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102465355|NCT03021590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102465356|NCT03021590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102465357|NCT03021590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102465358|NCT03021590|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102465359|NCT03021590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102465360|NCT03021590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465361|NCT03021590|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102465362|NCT03021590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102465363|NCT03021590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102465364|NCT03021590|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102465365|NCT03021590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102465366|NCT03021590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102465367|NCT03021590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102465368|NCT03021590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102465369|NCT03021590|Alkylating Agents|alkylating agents|mesh-ancestor
102465370|NCT03021590|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
102465371|NCT03021590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102465372|NCT03021590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102465373|NCT02125721|Penicillamine|penicillamine|mesh-list
102465374|NCT02125721|Antidotes|antidotes|mesh-ancestor
102465375|NCT02125721|Protective Agents|protective agents|mesh-ancestor
102465376|NCT02125721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465377|NCT02125721|Chelating Agents|chelating agents|mesh-ancestor
102465378|NCT02125721|Sequestering Agents|sequestering agents|mesh-ancestor
102465379|NCT02125721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465380|NCT02125721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102465381|NCT00552695|Lidocaine|lidocaine|mesh-list
102465382|NCT00552695|Tetracaine|tetracaine|mesh-list
102095636|NCT04404283|Lenalidomide|lenalidomide|mesh-list
102465383|NCT00552695|Anesthetics, Local|anesthetics, local|mesh-ancestor
102465384|NCT00552695|Anesthetics|anesthetics|mesh-ancestor
102465385|NCT00552695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102465386|NCT00552695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465387|NCT00552695|Sensory System Agents|sensory system agents|mesh-ancestor
102465388|NCT00552695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102465389|NCT00552695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102465390|NCT00552695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102465391|NCT00552695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102465392|NCT00552695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102465393|NCT00552695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465394|NCT00615433|Olanzapine|olanzapine|mesh-list
102465395|NCT00615433|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102465396|NCT00615433|Antiemetics|antiemetics|mesh-ancestor
102465397|NCT00615433|Autonomic Agents|autonomic agents|mesh-ancestor
102465398|NCT00615433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102465399|NCT00615433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465400|NCT00615433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102465401|NCT00615433|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102465402|NCT00615433|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102465403|NCT00615433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102465404|NCT00615433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102465405|NCT00615433|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102465406|NCT00615433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102465407|NCT00615433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102465408|NCT00615433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465409|NCT00615433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102465410|NCT00615433|Serotonin Agents|serotonin agents|mesh-ancestor
102276989|NCT04982861|Cefixime|cefixime|mesh-list
102465411|NCT00615433|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102465413|NCT00615433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102465414|NCT00615433|Adrenergic Agents|adrenergic agents|mesh-ancestor
102465415|NCT00615433|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102465416|NCT00615433|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102465417|NCT00615433|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102465418|NCT00615433|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102465419|NCT00615433|Dopamine Agents|dopamine agents|mesh-ancestor
102465420|NCT03899402|Dapagliflozin|dapagliflozin|mesh-list
102465421|NCT03899402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102465422|NCT03899402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465423|NCT03899402|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102465424|NCT03899402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465425|NCT03585374|Acetaminophen|acetaminophen|mesh-list
102465426|NCT03585374|Ketoprofen|ketoprofen|mesh-list
102465427|NCT03585374|Morphine|morphine|mesh-list
102465428|NCT03585374|Methoxyflurane|methoxyflurane|mesh-list
102465429|NCT03585374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102465430|NCT03585374|Narcotics|narcotics|mesh-ancestor
102465431|NCT03585374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102465432|NCT03585374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465433|NCT03585374|Analgesics|analgesics|mesh-ancestor
102465434|NCT03585374|Sensory System Agents|sensory system agents|mesh-ancestor
102465435|NCT03585374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102465436|NCT03585374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102465437|NCT03585374|Antipyretics|antipyretics|mesh-ancestor
102465438|NCT03585374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102465439|NCT03585374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102465440|NCT03585374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102465441|NCT03585374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102465442|NCT03585374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102465443|NCT03585374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465444|NCT03585374|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102465445|NCT03585374|Anesthetics, General|anesthetics, general|mesh-ancestor
102465446|NCT03585374|Anesthetics|anesthetics|mesh-ancestor
102465447|NCT00499343|Rituximab|rituximab|mesh-list
102465448|NCT00499343|Etoposide|etoposide|mesh-list
102465449|NCT00499343|Ifosfamide|ifosfamide|mesh-list
102465450|NCT00499343|Isophosphamide mustard|isophosphamide mustard|mesh-list
102465451|NCT00499343|Sargramostim|sargramostim|mesh-list
102465452|NCT00499343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102465453|NCT00499343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102465454|NCT00499343|Immunologic Factors|immunologic factors|mesh-ancestor
102465455|NCT00499343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465456|NCT00499343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102465457|NCT00499343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102465458|NCT00499343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102465459|NCT00499343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102465460|NCT00499343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102465461|NCT00499343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465462|NCT00499343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102465463|NCT00499343|Alkylating Agents|alkylating agents|mesh-ancestor
102465464|NCT00615589|Fludarabine|fludarabine|mesh-list
102465465|NCT00615589|Busulfan|busulfan|mesh-list
102465466|NCT00615589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102465467|NCT00615589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465468|NCT00615589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102465469|NCT00615589|Immunologic Factors|immunologic factors|mesh-ancestor
102465470|NCT00615589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465471|NCT00615589|Alkylating Agents|alkylating agents|mesh-ancestor
102465472|NCT00615589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102465473|NCT00615589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102465474|NCT00499655|Celecoxib|celecoxib|mesh-list
102465475|NCT00499655|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102465476|NCT00499655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102465477|NCT00499655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102465478|NCT00499655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102465479|NCT00499655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465480|NCT00499655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102465481|NCT00499655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102465482|NCT00499655|Analgesics|analgesics|mesh-ancestor
102465483|NCT00499655|Sensory System Agents|sensory system agents|mesh-ancestor
102465484|NCT00499655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102465485|NCT00499655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465486|NCT00499655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102465487|NCT00499655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102465488|NCT00499655|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102465489|NCT00499655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102465490|NCT03585140|Doxycycline|doxycycline|mesh-list
102465491|NCT03585140|Adapalene|adapalene|mesh-list
102465492|NCT03585140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102465493|NCT03585140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102465494|NCT03585140|Antimalarials|antimalarials|mesh-ancestor
102465495|NCT03585140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102465496|NCT03585140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102465497|NCT03585140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102465498|NCT03585140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102465499|NCT03585140|Analgesics|analgesics|mesh-ancestor
102465500|NCT03585140|Sensory System Agents|sensory system agents|mesh-ancestor
102465501|NCT03585140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102465502|NCT03585140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465503|NCT03585140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102465504|NCT03585140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102465505|NCT03585140|Dermatologic Agents|dermatologic agents|mesh-ancestor
102465506|NCT03584984|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
102465507|NCT03584984|Hemostatics|hemostatics|mesh-ancestor
102465508|NCT03584984|Coagulants|coagulants|mesh-ancestor
102465509|NCT00575887|Temozolomide|temozolomide|mesh-list
102465510|NCT00575887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102465511|NCT00575887|Alkylating Agents|alkylating agents|mesh-ancestor
102465512|NCT00575887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465513|NCT00575887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102465514|NCT00575965|Simvastatin|simvastatin|mesh-list
102465515|NCT00575965|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102465516|NCT00575965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102465517|NCT00575965|Antimetabolites|antimetabolites|mesh-ancestor
102465518|NCT00575965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465519|NCT00575965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102465520|NCT00575965|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102465521|NCT00575965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102465522|NCT03217097|Oxaliplatin|oxaliplatin|mesh-list
102465523|NCT03217097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102465524|NCT03623828|Apomorphine|apomorphine|mesh-list
102465525|NCT03623828|Emetics|emetics|mesh-ancestor
102465526|NCT03623828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465527|NCT03623828|Autonomic Agents|autonomic agents|mesh-ancestor
102465528|NCT03623828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102465529|NCT03623828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102465530|NCT03623828|Dopamine Agonists|dopamine agonists|mesh-ancestor
102465531|NCT03623828|Dopamine Agents|dopamine agents|mesh-ancestor
102465532|NCT03623828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102465533|NCT03623828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465534|NCT00501995|Cyclophosphamide|cyclophosphamide|mesh-list
102465535|NCT00501995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102465536|NCT00501995|Immunologic Factors|immunologic factors|mesh-ancestor
102465537|NCT00501995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465538|NCT00501995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102465539|NCT00501995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102465540|NCT00501995|Alkylating Agents|alkylating agents|mesh-ancestor
102465541|NCT00501995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465542|NCT00501995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102465543|NCT00501995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102465544|NCT03589898|Gabapentin|gabapentin|mesh-list
102465545|NCT03589898|Analgesics|analgesics|mesh-ancestor
102465546|NCT03589898|Sensory System Agents|sensory system agents|mesh-ancestor
102465547|NCT03589898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102465548|NCT03589898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465549|NCT03589898|Anticonvulsants|anticonvulsants|mesh-ancestor
102465550|NCT03589898|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102465551|NCT03589898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102465552|NCT03589898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102465553|NCT03589898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102465554|NCT03589898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102465555|NCT03589898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102465556|NCT03589898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102465557|NCT03589898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465558|NCT03589898|Antimanic Agents|antimanic agents|mesh-ancestor
102465559|NCT00577135|Furosemide|furosemide|mesh-list
102465560|NCT00577135|Diuretics|diuretics|mesh-list
102465561|NCT00577135|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
102465562|NCT00577135|Natriuretic Agents|natriuretic agents|mesh-ancestor
102465563|NCT00577135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465564|NCT00577135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102465565|NCT00577135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465566|NCT00502853|Rituximab|rituximab|mesh-list
102465567|NCT00502853|Methotrexate|methotrexate|mesh-list
102465568|NCT00502853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102465569|NCT00502853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102465570|NCT00502853|Immunologic Factors|immunologic factors|mesh-ancestor
102465571|NCT00502853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465572|NCT00502853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102465573|NCT00502853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102465574|NCT00502853|Abortifacient Agents|abortifacient agents|mesh-ancestor
102465575|NCT00502853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102465576|NCT00502853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102465577|NCT00502853|Antimetabolites|antimetabolites|mesh-ancestor
102465578|NCT00502853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465579|NCT00502853|Dermatologic Agents|dermatologic agents|mesh-ancestor
102465580|NCT00502853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102465581|NCT00502853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102465582|NCT00502853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102465583|NCT00502853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102465584|NCT00617539|Irinotecan|irinotecan|mesh-list
102465585|NCT00617539|Temozolomide|temozolomide|mesh-list
102465586|NCT00617539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102465587|NCT00617539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102465588|NCT00617539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102465589|NCT00617539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465590|NCT00617539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102465591|NCT00617539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102465592|NCT00617539|Alkylating Agents|alkylating agents|mesh-ancestor
102465593|NCT03620123|Docetaxel|docetaxel|mesh-list
102465594|NCT03620123|Nivolumab|nivolumab|mesh-list
102465595|NCT03620123|Ipilimumab|ipilimumab|mesh-list
102465596|NCT03620123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102465597|NCT03620123|Tubulin Modulators|tubulin modulators|mesh-ancestor
102465598|NCT03620123|Antimitotic Agents|antimitotic agents|mesh-ancestor
102465599|NCT03620123|Mitosis Modulators|mitosis modulators|mesh-ancestor
102465600|NCT03620123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465601|NCT03620123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102465602|NCT03620123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102465603|NCT00578071|Capecitabine|capecitabine|mesh-list
102465604|NCT00578071|Oxaliplatin|oxaliplatin|mesh-list
102465605|NCT00578071|Panitumumab|panitumumab|mesh-list
102465606|NCT00578071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102465607|NCT00578071|Antimetabolites|antimetabolites|mesh-ancestor
102465608|NCT00578071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465609|NCT00578071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102465610|NCT00578071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102465611|NCT00555581|Imatinib Mesylate|imatinib mesylate|mesh-list
102465612|NCT00555581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102465613|NCT00555581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102465614|NCT00555581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102465615|NCT00555581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465616|NCT00504023|Imiquimod|imiquimod|mesh-list
102465617|NCT00504023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102465618|NCT00504023|Immunologic Factors|immunologic factors|mesh-ancestor
102465619|NCT00504023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465620|NCT00504023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102465621|NCT00504023|Interferon Inducers|interferon inducers|mesh-ancestor
102465622|NCT03589430|Protein C|protein c|mesh-list
102465623|NCT03589430|Antithrombins|antithrombins|mesh-list
102465624|NCT03589430|Antithrombin III|antithrombin iii|mesh-list
102465625|NCT03589430|Protein S|protein s|mesh-list
102465626|NCT03589430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102465627|NCT03589430|Protease Inhibitors|protease inhibitors|mesh-ancestor
102465628|NCT03589430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102465629|NCT03589430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465630|NCT03589430|Anticoagulants|anticoagulants|mesh-ancestor
102465631|NCT03589430|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102465632|NCT03589430|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102465633|NCT05702762|Gentamicins|gentamicins|mesh-list
102465634|NCT05702762|Cephalexin|cephalexin|mesh-list
102465635|NCT05702762|Nitrofurantoin|nitrofurantoin|mesh-list
102465636|NCT05702762|Cefdinir|cefdinir|mesh-list
102465637|NCT05702762|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102465639|NCT05702762|Sulfamethoxazole|sulfamethoxazole|mesh-list
102465640|NCT05702762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102465641|NCT05702762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102465642|NCT05702762|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102465643|NCT05702762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102465644|NCT05702762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465645|NCT05702762|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102465646|NCT05702762|Antimalarials|antimalarials|mesh-ancestor
102465647|NCT05702762|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102465648|NCT05702762|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102465649|NCT05702762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102465650|NCT05702762|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102465651|NCT05702762|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102465652|NCT05702762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102465653|NCT03580694|Cemiplimab|cemiplimab|mesh-list
102465654|NCT03580694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102465655|NCT03580694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102465656|NCT03583892|Gabapentin|gabapentin|mesh-list
102465657|NCT03583892|Analgesics|analgesics|mesh-ancestor
102465658|NCT03583892|Sensory System Agents|sensory system agents|mesh-ancestor
102465659|NCT03583892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102465660|NCT03583892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465661|NCT03583892|Anticonvulsants|anticonvulsants|mesh-ancestor
102465662|NCT03583892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102465663|NCT03583892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102465664|NCT03583892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102465665|NCT03583892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102465666|NCT03583892|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102465667|NCT03583892|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102465668|NCT03583892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102465669|NCT03583892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465670|NCT03583892|Antimanic Agents|antimanic agents|mesh-ancestor
102465671|NCT03589040|Darunavir|darunavir|mesh-list
102465672|NCT03589040|Rilpivirine|rilpivirine|mesh-list
102465673|NCT03589040|Etonogestrel|etonogestrel|mesh-list
102465674|NCT03589040|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102465675|NCT03589040|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102465676|NCT03589040|Protease Inhibitors|protease inhibitors|mesh-ancestor
102465677|NCT03589040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102465678|NCT03589040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465679|NCT03589040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102465680|NCT03589040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102465681|NCT03589040|Antiviral Agents|antiviral agents|mesh-ancestor
102465682|NCT03589040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102465683|NCT03589040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102465684|NCT03589040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102465685|NCT03589040|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102465686|NCT03589040|Contraceptive Agents|contraceptive agents|mesh-ancestor
102465687|NCT03589040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102465688|NCT03589040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465689|NCT03589040|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102465690|NCT03583424|Cytarabine|cytarabine|mesh-list
102465691|NCT03583424|Etoposide|etoposide|mesh-list
102465692|NCT03583424|Podophyllotoxin|podophyllotoxin|mesh-list
102465693|NCT03583424|Etoposide phosphate|etoposide phosphate|mesh-list
102465694|NCT03583424|Melphalan|melphalan|mesh-list
102465695|NCT03583424|Venetoclax|venetoclax|mesh-list
102465696|NCT03583424|Mechlorethamine|mechlorethamine|mesh-list
102465697|NCT03583424|Carmustine|carmustine|mesh-list
102465698|NCT03583424|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102465699|NCT03583424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102465700|NCT03583424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102465701|NCT03583424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102465702|NCT03583424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102465703|NCT03583424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102465704|NCT03583424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465705|NCT03583424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102465706|NCT03583424|Antimetabolites|antimetabolites|mesh-ancestor
102465707|NCT03583424|Antiviral Agents|antiviral agents|mesh-ancestor
102465708|NCT03583424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102465709|NCT03583424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102465710|NCT03583424|Immunologic Factors|immunologic factors|mesh-ancestor
102465711|NCT03583424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465712|NCT03583424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102465713|NCT03583424|Alkylating Agents|alkylating agents|mesh-ancestor
102465714|NCT03583424|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102465715|NCT03583424|Keratolytic Agents|keratolytic agents|mesh-ancestor
102465716|NCT03583424|Dermatologic Agents|dermatologic agents|mesh-ancestor
102465717|NCT03583424|Tubulin Modulators|tubulin modulators|mesh-ancestor
102465718|NCT03583424|Antimitotic Agents|antimitotic agents|mesh-ancestor
102465719|NCT03583424|Mitosis Modulators|mitosis modulators|mesh-ancestor
102465721|NCT00578305|Methylprednisolone|methylprednisolone|mesh-list
102465722|NCT00578305|Rituximab|rituximab|mesh-list
102465723|NCT00578305|Methotrexate|methotrexate|mesh-list
102465724|NCT00578305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102465725|NCT00578305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102465726|NCT00578305|Immunologic Factors|immunologic factors|mesh-ancestor
102465727|NCT00578305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465728|NCT00578305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102465729|NCT00578305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102465730|NCT00578305|Abortifacient Agents|abortifacient agents|mesh-ancestor
102465731|NCT00578305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102465732|NCT00578305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102465733|NCT00578305|Antimetabolites|antimetabolites|mesh-ancestor
102465734|NCT00578305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465735|NCT00578305|Dermatologic Agents|dermatologic agents|mesh-ancestor
102465736|NCT00578305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102465737|NCT00578305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102465738|NCT00578305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102465739|NCT00578305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102465740|NCT00578305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102465741|NCT00578305|Antiemetics|antiemetics|mesh-ancestor
102465742|NCT00578305|Autonomic Agents|autonomic agents|mesh-ancestor
102465743|NCT00578305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102465744|NCT00578305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102465745|NCT00578305|Glucocorticoids|glucocorticoids|mesh-ancestor
102465746|NCT00578305|Hormones|hormones|mesh-ancestor
102465747|NCT00578305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102465748|NCT00578305|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102465749|NCT00578305|Protective Agents|protective agents|mesh-ancestor
102465750|NCT00578305|Hematinics|hematinics|mesh-ancestor
102465751|NCT00578305|Vitamin B Complex|vitamin b complex|mesh-ancestor
102465752|NCT00578305|Vitamins|vitamins|mesh-ancestor
102465753|NCT00578305|Micronutrients|micronutrients|mesh-ancestor
102465754|NCT00578461|Cytarabine|cytarabine|mesh-list
102465755|NCT00578461|Cyclophosphamide|cyclophosphamide|mesh-list
102465756|NCT00578461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102465757|NCT00578461|Immunologic Factors|immunologic factors|mesh-ancestor
102465758|NCT00578461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465759|NCT00578461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102465760|NCT00578461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102465761|NCT00578461|Alkylating Agents|alkylating agents|mesh-ancestor
102465762|NCT00578461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465763|NCT00578461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102465764|NCT00578461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102465765|NCT00578461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102465766|NCT00578461|Antimetabolites|antimetabolites|mesh-ancestor
102465767|NCT00578461|Antiviral Agents|antiviral agents|mesh-ancestor
102465768|NCT00578461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102465769|NCT03580070|Immunomodulating Agents|immunomodulating agents|mesh-list
102465770|NCT03580070|Immunologic Factors|immunologic factors|mesh-ancestor
102465771|NCT03580070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465772|NCT03156296|Dexmedetomidine|dexmedetomidine|mesh-list
102465773|NCT03156296|Bupivacaine|bupivacaine|mesh-list
102465774|NCT03156296|Anesthetics, Local|anesthetics, local|mesh-ancestor
102465775|NCT03156296|Anesthetics|anesthetics|mesh-ancestor
102465776|NCT03156296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102465777|NCT03156296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465778|NCT03156296|Sensory System Agents|sensory system agents|mesh-ancestor
102465779|NCT03156296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102465780|NCT03156296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102465781|NCT03156296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102465782|NCT03156296|Analgesics|analgesics|mesh-ancestor
102465783|NCT03156296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102465784|NCT03156296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102465785|NCT03156296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102465786|NCT03156296|Adrenergic Agents|adrenergic agents|mesh-ancestor
102465787|NCT03156296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102465788|NCT03156296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465789|NCT00578539|Cytarabine|cytarabine|mesh-list
102465790|NCT00578539|Cyclophosphamide|cyclophosphamide|mesh-list
102465791|NCT00578539|Alemtuzumab|alemtuzumab|mesh-list
102465792|NCT00578539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102465793|NCT00578539|Immunologic Factors|immunologic factors|mesh-ancestor
102465794|NCT00578539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465795|NCT00578539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102465796|NCT00578539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102465797|NCT00578539|Alkylating Agents|alkylating agents|mesh-ancestor
102465798|NCT00578539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465799|NCT00578539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102465800|NCT00578539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102465801|NCT00578539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102465802|NCT00578539|Antimetabolites|antimetabolites|mesh-ancestor
102465803|NCT00578539|Antiviral Agents|antiviral agents|mesh-ancestor
102465804|NCT00578539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102465805|NCT00578539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102465806|NCT00578617|Amiodarone|amiodarone|mesh-list
102465807|NCT00578617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465808|NCT00578617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102465809|NCT00578617|Vasodilator Agents|vasodilator agents|mesh-ancestor
102465810|NCT00578617|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102465811|NCT00578617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102465812|NCT00578617|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102465813|NCT00578617|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102465814|NCT00578617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102465815|NCT00578617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102465816|NCT00578617|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102465817|NCT00578617|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102465818|NCT00578617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102465819|NCT00505895|Rituximab|rituximab|mesh-list
102465820|NCT00505895|Fludarabine|fludarabine|mesh-list
102465821|NCT00505895|Fludarabine phosphate|fludarabine phosphate|mesh-list
102465822|NCT00505895|Melphalan|melphalan|mesh-list
102465823|NCT00505895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102465824|NCT00505895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102465825|NCT00505895|Immunologic Factors|immunologic factors|mesh-ancestor
102465826|NCT00505895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465827|NCT00505895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102465828|NCT00505895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102465829|NCT00505895|Antimetabolites|antimetabolites|mesh-ancestor
102465830|NCT00505895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465831|NCT00505895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102465832|NCT00505895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102465833|NCT00505895|Alkylating Agents|alkylating agents|mesh-ancestor
102465834|NCT00505895|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102465835|NCT03582332|Indomethacin|indomethacin|mesh-list
102465836|NCT03582332|Etoricoxib|etoricoxib|mesh-list
102465837|NCT03582332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102465838|NCT03582332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102465839|NCT03582332|Analgesics|analgesics|mesh-ancestor
102465840|NCT03582332|Sensory System Agents|sensory system agents|mesh-ancestor
102465841|NCT03582332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102465842|NCT03582332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465843|NCT03582332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102465844|NCT03582332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102465845|NCT03582332|Gout Suppressants|gout suppressants|mesh-ancestor
102465846|NCT03582332|Tocolytic Agents|tocolytic agents|mesh-ancestor
102465847|NCT03582332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102465848|NCT03582332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102465849|NCT03582332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102465850|NCT03582332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465851|NCT03582332|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102465852|NCT00619723|Choline|choline|mesh-list
102465853|NCT00619723|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
102465854|NCT00619723|Lipotropic Agents|lipotropic agents|mesh-ancestor
102465855|NCT00619723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102465856|NCT00619723|Antimetabolites|antimetabolites|mesh-ancestor
102465857|NCT00619723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465858|NCT00619723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102465859|NCT00619723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102465860|NCT00619723|Nootropic Agents|nootropic agents|mesh-ancestor
102465861|NCT03582098|Rituximab|rituximab|mesh-list
102465862|NCT03582098|Idelalisib|idelalisib|mesh-list
102465863|NCT03582098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102465864|NCT03582098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102465865|NCT03582098|Immunologic Factors|immunologic factors|mesh-ancestor
102465866|NCT03582098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465867|NCT03582098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102465868|NCT03582098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102465869|NCT03582098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465870|NCT00555893|Oseltamivir|oseltamivir|mesh-list
102465871|NCT00555893|Antiviral Agents|antiviral agents|mesh-ancestor
102465872|NCT00555893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102465873|NCT00555893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102465874|NCT00555893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465875|NCT00578929|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
102465876|NCT00578929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102465877|NCT00578929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102465878|NCT00578929|Analgesics|analgesics|mesh-ancestor
102465879|NCT00578929|Sensory System Agents|sensory system agents|mesh-ancestor
102465880|NCT00578929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102465881|NCT00578929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465882|NCT00578929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102465883|NCT00578929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102465884|NCT00578929|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102465885|NCT00578929|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102465886|NCT00578929|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102465887|NCT00578929|Histamine Antagonists|histamine antagonists|mesh-ancestor
102465888|NCT00578929|Histamine Agents|histamine agents|mesh-ancestor
102465889|NCT00578929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102465890|NCT00578929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465891|NCT00556049|Gemcitabine|gemcitabine|mesh-list
102465892|NCT00556049|Sunitinib|sunitinib|mesh-list
102465893|NCT00556049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102465894|NCT00556049|Antimetabolites|antimetabolites|mesh-ancestor
102465895|NCT00556049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465896|NCT00556049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102465897|NCT00556049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102465898|NCT00556049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102465899|NCT00556049|Growth Substances|growth substances|mesh-ancestor
102465900|NCT00556049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465901|NCT00556049|Growth Inhibitors|growth inhibitors|mesh-ancestor
102465902|NCT00556049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102465903|NCT00556049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102465904|NCT01797107|Azithromycin|azithromycin|mesh-list
102465905|NCT01797107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102465906|NCT01797107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102465907|NCT03155984|Antibodies|antibodies|mesh-list
102465908|NCT03155984|Immunologic Factors|immunologic factors|mesh-ancestor
102465909|NCT03155984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465910|NCT00620191|Metformin|metformin|mesh-list
102465911|NCT00620191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102465912|NCT00620191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465913|NCT00506597|Asparaginase|asparaginase|mesh-list
102465914|NCT00506597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102465915|NCT03589976|Sirolimus|sirolimus|mesh-list
102465916|NCT03589976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102465917|NCT03589976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102465918|NCT03589976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102465919|NCT03589976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102465920|NCT03589976|Antifungal Agents|antifungal agents|mesh-ancestor
102465921|NCT03589976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102465922|NCT03589976|Immunologic Factors|immunologic factors|mesh-ancestor
102465923|NCT03589976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465924|NCT03581630|Naltrexone|naltrexone|mesh-list
102465925|NCT03581630|Bupropion|bupropion|mesh-list
102465926|NCT03581630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102465927|NCT03581630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102465928|NCT03581630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465929|NCT03581630|Sensory System Agents|sensory system agents|mesh-ancestor
102465930|NCT03581630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102465931|NCT03581630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102465932|NCT03581630|Antidepressive Agents|antidepressive agents|mesh-ancestor
102465933|NCT03581630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102465934|NCT03581630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102465935|NCT03581630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102465936|NCT03581630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102465937|NCT03581630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465938|NCT03581630|Dopamine Agents|dopamine agents|mesh-ancestor
102465939|NCT03581630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102465940|NCT03581630|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102465941|NCT03581630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102465942|NCT03581630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102465943|NCT00506675|Atropine|atropine|mesh-list
102465944|NCT00506675|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102465945|NCT00506675|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102465946|NCT00506675|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102465947|NCT00506675|Autonomic Agents|autonomic agents|mesh-ancestor
102465948|NCT00506675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102465949|NCT00506675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465950|NCT00506675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102465951|NCT00506675|Respiratory System Agents|respiratory system agents|mesh-ancestor
102465952|NCT00506675|Mydriatics|mydriatics|mesh-ancestor
102465953|NCT00506675|Parasympatholytics|parasympatholytics|mesh-ancestor
102465954|NCT00506675|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102465955|NCT00506675|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102465956|NCT00506675|Cholinergic Agents|cholinergic agents|mesh-ancestor
102465957|NCT00506675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102465958|NCT00506675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465959|NCT00507767|Dasatinib|dasatinib|mesh-list
102465960|NCT00507767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102465961|NCT00507767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102465962|NCT00507767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102465963|NCT00507767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465964|NCT00621049|Bevacizumab|bevacizumab|mesh-list
102465965|NCT00621049|Carboplatin|carboplatin|mesh-list
102465966|NCT00621049|Docetaxel|docetaxel|mesh-list
102096208|NCT03274492|Hormones|hormones|mesh-ancestor
102465967|NCT00621049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102465968|NCT00621049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102465969|NCT00621049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102465970|NCT00621049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102465971|NCT00621049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102465972|NCT00621049|Growth Substances|growth substances|mesh-ancestor
102465973|NCT00621049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465974|NCT00621049|Growth Inhibitors|growth inhibitors|mesh-ancestor
102465975|NCT00621049|Tubulin Modulators|tubulin modulators|mesh-ancestor
102465976|NCT00621049|Antimitotic Agents|antimitotic agents|mesh-ancestor
102465977|NCT00621049|Mitosis Modulators|mitosis modulators|mesh-ancestor
102465978|NCT00621049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465979|NCT00621049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102465980|NCT00621049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102465981|NCT00508469|Timolol|timolol|mesh-list
102465982|NCT00508469|Travoprost|travoprost|mesh-list
102465983|NCT00508469|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102465984|NCT00508469|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102465985|NCT00508469|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102465986|NCT00508469|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102465987|NCT00508469|Adrenergic Agents|adrenergic agents|mesh-ancestor
102465988|NCT00508469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102465989|NCT00508469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102465990|NCT00508469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465991|NCT00508469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102465992|NCT00508469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102465993|NCT05702996|Eculizumab|eculizumab|mesh-list
102465994|NCT05702996|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102465995|NCT05702996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102465996|NCT05702996|Immunologic Factors|immunologic factors|mesh-ancestor
102465997|NCT05702996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102465998|NCT00580333|Paclitaxel|paclitaxel|mesh-list
102465999|NCT00580333|Cyclophosphamide|cyclophosphamide|mesh-list
102466000|NCT00580333|Bevacizumab|bevacizumab|mesh-list
102466001|NCT00580333|Doxorubicin|doxorubicin|mesh-list
102466002|NCT00580333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102466003|NCT00580333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102466004|NCT00580333|Tubulin Modulators|tubulin modulators|mesh-ancestor
102466005|NCT00580333|Antimitotic Agents|antimitotic agents|mesh-ancestor
102466006|NCT00580333|Mitosis Modulators|mitosis modulators|mesh-ancestor
102466007|NCT00580333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466008|NCT00580333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102466009|NCT00580333|Immunologic Factors|immunologic factors|mesh-ancestor
102466010|NCT00580333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466011|NCT00580333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102466012|NCT00580333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102466014|NCT00580333|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102466015|NCT00580333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102466016|NCT00580333|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102466017|NCT00580333|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102466018|NCT00580333|Growth Substances|growth substances|mesh-ancestor
102466019|NCT00580333|Growth Inhibitors|growth inhibitors|mesh-ancestor
102466020|NCT00580333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102466021|NCT00580333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102466022|NCT00580333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102466023|NCT00580333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102466024|NCT00580645|Varenicline|varenicline|mesh-list
102466025|NCT00580645|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102466026|NCT00580645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102466027|NCT00580645|Cholinergic Agents|cholinergic agents|mesh-ancestor
102466028|NCT00580645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102096278|NCT03125811|Ondansetron|ondansetron|mesh-list
102466029|NCT00580645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466030|NCT00580645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466031|NCT00580957|Trimethaphan|trimethaphan|mesh-list
102466032|NCT00580957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102466033|NCT00580957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102466034|NCT00580957|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
102466035|NCT00580957|Autonomic Agents|autonomic agents|mesh-ancestor
102466036|NCT00580957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102466037|NCT00580957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466038|NCT00580957|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102466039|NCT00580957|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102466040|NCT00580957|Cholinergic Agents|cholinergic agents|mesh-ancestor
102466041|NCT00580957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102466042|NCT00580957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466043|NCT00509249|Aflibercept|aflibercept|mesh-list
102466044|NCT00509249|Endothelial Growth Factors|endothelial growth factors|mesh-list
102466045|NCT00509249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102466046|NCT00509249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102466047|NCT00509249|Growth Substances|growth substances|mesh-ancestor
102466048|NCT00509249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466049|NCT00509249|Growth Inhibitors|growth inhibitors|mesh-ancestor
102466050|NCT00509249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102466051|NCT00624013|Sertraline|sertraline|mesh-list
102466052|NCT00624013|Antidepressive Agents|antidepressive agents|mesh-ancestor
102466053|NCT00624013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102466054|NCT00624013|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102466055|NCT00624013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102466056|NCT00624013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102466057|NCT00624013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466058|NCT00624013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102466059|NCT00624013|Serotonin Agents|serotonin agents|mesh-ancestor
102466060|NCT00624013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466061|NCT02121041|Losartan|losartan|mesh-list
102466062|NCT02121041|Amlodipine|amlodipine|mesh-list
102466063|NCT02121041|Chlorthalidone|chlorthalidone|mesh-list
102466064|NCT02121041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102466065|NCT02121041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102466066|NCT02121041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102466067|NCT02121041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466068|NCT02121041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102466069|NCT02121041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466070|NCT02121041|Vasodilator Agents|vasodilator agents|mesh-ancestor
102466071|NCT02121041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102466072|NCT02121041|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102466073|NCT02121041|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102466074|NCT02121041|Diuretics|diuretics|mesh-ancestor
102466075|NCT02121041|Natriuretic Agents|natriuretic agents|mesh-ancestor
102466076|NCT02121041|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102466077|NCT00509873|Gatifloxacin|gatifloxacin|mesh-list
102466078|NCT00509873|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102466079|NCT00509873|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102466080|NCT00509873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102466081|NCT00509873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102466082|NCT00509873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102466083|NCT00509873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102466084|NCT00509873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102466085|NCT00509873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466086|NCT00509873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102466087|NCT02133781|Vaccines|vaccines|mesh-list
102466088|NCT02133781|Immunologic Factors|immunologic factors|mesh-ancestor
102466089|NCT02133781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466090|NCT01855451|Cetuximab|cetuximab|mesh-list
102096358|NCT02962401|Obinutuzumab|obinutuzumab|mesh-list
102466091|NCT01855451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102466092|NCT01855451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102466093|NCT02134951|Ketamine|ketamine|mesh-list
102466094|NCT02134951|Analgesics|analgesics|mesh-ancestor
102466095|NCT02134951|Sensory System Agents|sensory system agents|mesh-ancestor
102466096|NCT02134951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102466097|NCT02134951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466098|NCT02134951|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102466099|NCT02134951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102466100|NCT02134951|Anesthetics, General|anesthetics, general|mesh-ancestor
102466101|NCT02134951|Anesthetics|anesthetics|mesh-ancestor
102466102|NCT02134951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102466103|NCT02134951|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102466104|NCT02134951|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102466105|NCT02134951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102466106|NCT02134951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466107|NCT03029780|Nivolumab|nivolumab|mesh-list
102466108|NCT03029780|Ipilimumab|ipilimumab|mesh-list
102466109|NCT03029780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102466110|NCT03029780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102466111|NCT03029780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102466112|NCT03029780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466113|NCT00624559|Celecoxib|celecoxib|mesh-list
102466114|NCT00624559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102466115|NCT00624559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102466116|NCT00624559|Analgesics|analgesics|mesh-ancestor
102466117|NCT00624559|Sensory System Agents|sensory system agents|mesh-ancestor
102466118|NCT00624559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102466119|NCT00624559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466120|NCT00624559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102466121|NCT00624559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102466122|NCT00624559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102466123|NCT00624559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102466124|NCT00624559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102466125|NCT00624559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466126|NCT00510809|Ethanol|ethanol|mesh-list
102466127|NCT00510809|Policosanol|policosanol|mesh-list
102466128|NCT00510809|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
102466129|NCT00510809|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102466130|NCT00510809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102466131|NCT00510809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102466132|NCT00510809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466133|NCT00510809|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102466134|NCT00510809|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102466135|NCT00510809|Antimetabolites|antimetabolites|mesh-ancestor
102466136|NCT00510809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466137|NCT00510809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102466138|NCT00510809|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102466139|NCT00510809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102466140|NCT00625729|Aldesleukin|aldesleukin|mesh-list
102466141|NCT00625729|Cyclophosphamide|cyclophosphamide|mesh-list
102466142|NCT00625729|Rituximab|rituximab|mesh-list
102466143|NCT00625729|Fludarabine|fludarabine|mesh-list
102466144|NCT00625729|Fludarabine phosphate|fludarabine phosphate|mesh-list
102466145|NCT00625729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102466146|NCT00625729|Immunologic Factors|immunologic factors|mesh-ancestor
102466147|NCT00625729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466148|NCT00625729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102466149|NCT00625729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102466150|NCT00625729|Alkylating Agents|alkylating agents|mesh-ancestor
102466151|NCT00625729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466152|NCT00625729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102466153|NCT00625729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102466154|NCT00625729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102466155|NCT00625729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102466156|NCT00625729|Antimetabolites|antimetabolites|mesh-ancestor
102466157|NCT00625729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102466158|NCT00625729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102466160|NCT00625729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102466161|NCT00581971|Celecoxib|celecoxib|mesh-list
102466162|NCT00581971|Paclitaxel|paclitaxel|mesh-list
102466163|NCT00581971|Carboplatin|carboplatin|mesh-list
102466164|NCT00581971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102466165|NCT00581971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102466166|NCT00581971|Tubulin Modulators|tubulin modulators|mesh-ancestor
102466167|NCT00581971|Antimitotic Agents|antimitotic agents|mesh-ancestor
102466168|NCT00581971|Mitosis Modulators|mitosis modulators|mesh-ancestor
102466169|NCT00581971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466170|NCT00581971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102466171|NCT00581971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102466172|NCT00581971|Analgesics|analgesics|mesh-ancestor
102466173|NCT00581971|Sensory System Agents|sensory system agents|mesh-ancestor
102466174|NCT00581971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102466175|NCT00581971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466176|NCT00581971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102466177|NCT00581971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102466178|NCT00581971|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102466179|NCT00581971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102466180|NCT00581971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102466181|NCT03029234|Dexamethasone|dexamethasone|mesh-list
102466182|NCT03029234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102466183|NCT03029234|Antiemetics|antiemetics|mesh-ancestor
102466184|NCT03029234|Autonomic Agents|autonomic agents|mesh-ancestor
102466185|NCT03029234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102466186|NCT03029234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466187|NCT03029234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102466188|NCT03029234|Glucocorticoids|glucocorticoids|mesh-ancestor
102466189|NCT03029234|Hormones|hormones|mesh-ancestor
102466190|NCT03029234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102466191|NCT03029234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102466192|NCT03029234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102466193|NCT01670318|Chromium|chromium|mesh-list
102466194|NCT01670318|Everolimus|everolimus|mesh-list
102466195|NCT01670318|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102466196|NCT01670318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102466197|NCT01670318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102466198|NCT01670318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466199|NCT01670318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102466200|NCT01670318|Immunologic Factors|immunologic factors|mesh-ancestor
102466201|NCT01670318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466202|NCT01670318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102466203|NCT01670318|Trace Elements|trace elements|mesh-ancestor
102466204|NCT01670318|Micronutrients|micronutrients|mesh-ancestor
102466205|NCT03155204|Tiotropium Bromide|tiotropium bromide|mesh-list
102466206|NCT03155204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102466207|NCT03155204|Autonomic Agents|autonomic agents|mesh-ancestor
102466208|NCT03155204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102466209|NCT03155204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466210|NCT03155204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102466211|NCT03155204|Respiratory System Agents|respiratory system agents|mesh-ancestor
102466212|NCT03155204|Parasympatholytics|parasympatholytics|mesh-ancestor
102466213|NCT03155204|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102466214|NCT03155204|Cholinergic Agents|cholinergic agents|mesh-ancestor
102466215|NCT03155204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102466216|NCT03155204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466217|NCT03111992|Spartalizumab|spartalizumab|mesh-list
102466218|NCT03111992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102466219|NCT03111992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466220|NCT03111992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102466221|NCT03111992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102466222|NCT00626431|Leuprolide|leuprolide|mesh-list
102466223|NCT00626431|Hormones|hormones|mesh-list
102466224|NCT00626431|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
102466225|NCT00626431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102466226|NCT00626431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466227|NCT00626431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102466228|NCT00626431|Fertility Agents|fertility agents|mesh-ancestor
102466229|NCT00626431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102466230|NCT00626431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102466231|NCT00626431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102466232|NCT01670474|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102466233|NCT01670474|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102466234|NCT01670474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102466235|NCT01670474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466236|NCT00582205|Paclitaxel|paclitaxel|mesh-list
102466237|NCT00582205|Cisplatin|cisplatin|mesh-list
102466238|NCT00582205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102466239|NCT00582205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102466240|NCT00582205|Tubulin Modulators|tubulin modulators|mesh-ancestor
102466241|NCT00582205|Antimitotic Agents|antimitotic agents|mesh-ancestor
102466242|NCT00582205|Mitosis Modulators|mitosis modulators|mesh-ancestor
102466243|NCT00582205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466244|NCT00626743|Amlodipine|amlodipine|mesh-list
102466245|NCT00626743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102466246|NCT00626743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102466247|NCT00626743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102466248|NCT00626743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466249|NCT00626743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102466250|NCT00626743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466251|NCT00626743|Vasodilator Agents|vasodilator agents|mesh-ancestor
102466252|NCT03155048|Estradiol|estradiol|mesh-list
102466253|NCT03155048|Estrogens|estrogens|mesh-list
102466254|NCT03155048|Hormones|hormones|mesh-ancestor
102466255|NCT03155048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102466256|NCT03155048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466257|NCT00627367|Hydromorphone|hydromorphone|mesh-list
102466258|NCT00627367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102466259|NCT00627367|Narcotics|narcotics|mesh-ancestor
102466260|NCT00627367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102466261|NCT00627367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466262|NCT00627367|Analgesics|analgesics|mesh-ancestor
102466263|NCT00627367|Sensory System Agents|sensory system agents|mesh-ancestor
102466264|NCT00627367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102466265|NCT00627679|Budesonide|budesonide|mesh-list
102466266|NCT00627679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102466267|NCT00627679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102466268|NCT00627679|Autonomic Agents|autonomic agents|mesh-ancestor
102466269|NCT00627679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102466270|NCT00627679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466271|NCT00627679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102466272|NCT00627679|Respiratory System Agents|respiratory system agents|mesh-ancestor
102466273|NCT00627679|Glucocorticoids|glucocorticoids|mesh-ancestor
102466274|NCT00627679|Hormones|hormones|mesh-ancestor
102466275|NCT00627679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102466276|NCT00514709|Vaccines|vaccines|mesh-list
102466277|NCT00514709|Immunologic Factors|immunologic factors|mesh-ancestor
102466278|NCT00514709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466279|NCT03154814|Urinastatin|urinastatin|mesh-list
102466280|NCT03154814|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102466281|NCT03154814|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102466282|NCT03154814|Protease Inhibitors|protease inhibitors|mesh-ancestor
102466283|NCT03154814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102466284|NCT03154814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466285|NCT00515021|Eplerenone|eplerenone|mesh-list
102466286|NCT00515021|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102466287|NCT00515021|Hormone Antagonists|hormone antagonists|mesh-ancestor
102466288|NCT00515021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102466289|NCT00515021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466290|NCT00515021|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102466291|NCT00515021|Diuretics|diuretics|mesh-ancestor
102466292|NCT00515021|Natriuretic Agents|natriuretic agents|mesh-ancestor
102466293|NCT00515021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102466294|NCT00515177|Eszopiclone|eszopiclone|mesh-list
102466295|NCT00515177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102466296|NCT00515177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102466297|NCT00515177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466298|NCT01671410|Morphine|morphine|mesh-list
102466299|NCT01671410|Buprenorphine|buprenorphine|mesh-list
102466300|NCT01671410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102466301|NCT01671410|Narcotics|narcotics|mesh-ancestor
102466302|NCT01671410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102466303|NCT01671410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466304|NCT01671410|Analgesics|analgesics|mesh-ancestor
102466305|NCT01671410|Sensory System Agents|sensory system agents|mesh-ancestor
102466306|NCT01671410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102466307|NCT01671410|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102466309|NCT00630253|Mycophenolic Acid|mycophenolic acid|mesh-list
102466310|NCT00630253|Methylprednisolone|methylprednisolone|mesh-list
102466311|NCT00630253|Cyclophosphamide|cyclophosphamide|mesh-list
102466312|NCT00630253|Fludarabine|fludarabine|mesh-list
102466313|NCT00630253|Cyclosporins|cyclosporins|mesh-list
102466314|NCT00630253|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102466315|NCT00630253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102466316|NCT00630253|Immunologic Factors|immunologic factors|mesh-ancestor
102466317|NCT00630253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466318|NCT00630253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102466319|NCT00630253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102466320|NCT00630253|Alkylating Agents|alkylating agents|mesh-ancestor
102466321|NCT00630253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466322|NCT00630253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102466323|NCT00630253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102466324|NCT00630253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102466325|NCT00630253|Antifungal Agents|antifungal agents|mesh-ancestor
102466326|NCT00630253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102466327|NCT00630253|Dermatologic Agents|dermatologic agents|mesh-ancestor
102466328|NCT00630253|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102466329|NCT00630253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102466330|NCT00630253|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102466331|NCT00630253|Antitubercular Agents|antitubercular agents|mesh-ancestor
102466332|NCT00630253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102466333|NCT00630253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102466334|NCT00630253|Antiemetics|antiemetics|mesh-ancestor
102466335|NCT00630253|Autonomic Agents|autonomic agents|mesh-ancestor
102466336|NCT00630253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102466337|NCT00630253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102466338|NCT00630253|Glucocorticoids|glucocorticoids|mesh-ancestor
102466339|NCT00630253|Hormones|hormones|mesh-ancestor
102466340|NCT00630253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102466341|NCT00630253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102466342|NCT00630253|Protective Agents|protective agents|mesh-ancestor
102466343|NCT01671722|Montelukast|montelukast|mesh-list
102466344|NCT01671722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102466345|NCT01671722|Respiratory System Agents|respiratory system agents|mesh-ancestor
102466346|NCT01671722|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102466347|NCT01671722|Hormone Antagonists|hormone antagonists|mesh-ancestor
102466348|NCT01671722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102466349|NCT01671722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466350|NCT01671722|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102466351|NCT01671722|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102466352|NCT01671722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466353|NCT00584701|Risperidone|risperidone|mesh-list
102466354|NCT00584701|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102466355|NCT00584701|Serotonin Agents|serotonin agents|mesh-ancestor
102466356|NCT00584701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102466357|NCT00584701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466358|NCT00584701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466359|NCT00584701|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102466360|NCT00584701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102466361|NCT00584701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102466362|NCT00584701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102466363|NCT00584701|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102466364|NCT00584701|Dopamine Agents|dopamine agents|mesh-ancestor
102466365|NCT00630409|Gemcitabine|gemcitabine|mesh-list
102466366|NCT00630409|Doxorubicin|doxorubicin|mesh-list
102466367|NCT00630409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102466368|NCT00630409|Antimetabolites|antimetabolites|mesh-ancestor
102466369|NCT00630409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466370|NCT00630409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102466371|NCT00630409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102466372|NCT00630409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102466373|NCT00630409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102466374|NCT00630409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102466375|NCT00630955|Memantine|memantine|mesh-list
102466376|NCT00630955|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102466377|NCT00630955|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102466378|NCT00630955|Dopamine Agents|dopamine agents|mesh-ancestor
102466379|NCT00630955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102466380|NCT00630955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466381|NCT00630955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466382|NCT00630955|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102466383|NCT00630955|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102466384|NCT00584857|Paclitaxel|paclitaxel|mesh-list
102466385|NCT00584857|Carboplatin|carboplatin|mesh-list
102466386|NCT00584857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102466387|NCT00584857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102466388|NCT00584857|Tubulin Modulators|tubulin modulators|mesh-ancestor
102466389|NCT00584857|Antimitotic Agents|antimitotic agents|mesh-ancestor
102466390|NCT00584857|Mitosis Modulators|mitosis modulators|mesh-ancestor
102466391|NCT00584857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466392|NCT00585013|Nitric Oxide|nitric oxide|mesh-list
102466393|NCT00585013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102466394|NCT00585013|Autonomic Agents|autonomic agents|mesh-ancestor
102466395|NCT00585013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102466396|NCT00585013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466397|NCT00585013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102466398|NCT00585013|Respiratory System Agents|respiratory system agents|mesh-ancestor
102466399|NCT00585013|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102466400|NCT00585013|Antioxidants|antioxidants|mesh-ancestor
102466401|NCT00585013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466402|NCT00585013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102466403|NCT00585013|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102466404|NCT00585013|Vasodilator Agents|vasodilator agents|mesh-ancestor
102466405|NCT00585013|Gasotransmitters|gasotransmitters|mesh-ancestor
102466406|NCT00585013|Protective Agents|protective agents|mesh-ancestor
102466407|NCT01672112|Oxycodone|oxycodone|mesh-list
102466408|NCT01672112|Codeine|codeine|mesh-list
102466409|NCT01672112|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102466410|NCT01672112|Narcotics|narcotics|mesh-ancestor
102466411|NCT01672112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102466412|NCT01672112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466413|NCT01672112|Analgesics|analgesics|mesh-ancestor
102466414|NCT01672112|Sensory System Agents|sensory system agents|mesh-ancestor
102466415|NCT01672112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102466416|NCT01672112|Antitussive Agents|antitussive agents|mesh-ancestor
102466417|NCT01672112|Respiratory System Agents|respiratory system agents|mesh-ancestor
102466418|NCT00585637|Vitamin D|vitamin d|mesh-list
102466419|NCT00585637|Vitamins|vitamins|mesh-ancestor
102466420|NCT00585637|Micronutrients|micronutrients|mesh-ancestor
102466421|NCT00585637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466422|NCT00585637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102466423|NCT03158792|Enoxaparin|enoxaparin|mesh-list
102466424|NCT03158792|Enoxaparin sodium|enoxaparin sodium|mesh-list
102466425|NCT03158792|Anticoagulants|anticoagulants|mesh-ancestor
102466426|NCT03158792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102466427|NCT03158792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102466428|NCT03158792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466429|NCT01798771|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102466430|NCT01798771|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102466431|NCT01798771|Dermatologic Agents|dermatologic agents|mesh-ancestor
102466432|NCT03158480|Immunomodulating Agents|immunomodulating agents|mesh-list
102466433|NCT03158480|Immunologic Factors|immunologic factors|mesh-ancestor
102466434|NCT03158480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466435|NCT00633919|Prednisone|prednisone|mesh-list
102466436|NCT00633919|Budesonide|budesonide|mesh-list
102466437|NCT00633919|Albuterol|albuterol|mesh-list
102466438|NCT00633919|Formoterol Fumarate|formoterol fumarate|mesh-list
102466439|NCT00633919|Desloratadine|desloratadine|mesh-list
102466440|NCT00633919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102466441|NCT00633919|Glucocorticoids|glucocorticoids|mesh-ancestor
102466442|NCT00633919|Hormones|hormones|mesh-ancestor
102466443|NCT00633919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102466444|NCT00633919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466445|NCT00633919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102466446|NCT00633919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102466447|NCT00633919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102466448|NCT00633919|Autonomic Agents|autonomic agents|mesh-ancestor
102466449|NCT00633919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102466450|NCT00633919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102466451|NCT00633919|Respiratory System Agents|respiratory system agents|mesh-ancestor
102466452|NCT00633919|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102466453|NCT00633919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102466454|NCT00633919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102466455|NCT00633919|Adrenergic Agents|adrenergic agents|mesh-ancestor
102466456|NCT00633919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102466457|NCT00633919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466458|NCT00633919|Tocolytic Agents|tocolytic agents|mesh-ancestor
102466459|NCT00633919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102466460|NCT00633919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102096722|NCT01517100|Hallucinogens|hallucinogens|mesh-ancestor
102466461|NCT00633919|Cholinergic Agents|cholinergic agents|mesh-ancestor
102466462|NCT00633919|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102466463|NCT00633919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102466464|NCT00633919|Histamine Antagonists|histamine antagonists|mesh-ancestor
102466465|NCT00633919|Histamine Agents|histamine agents|mesh-ancestor
102466466|NCT03158246|Vitamin D|vitamin d|mesh-list
102466467|NCT03158246|Zoledronic Acid|zoledronic acid|mesh-list
102466468|NCT03158246|Calcium|calcium|mesh-list
102466469|NCT03158246|Vitamins|vitamins|mesh-ancestor
102466470|NCT03158246|Micronutrients|micronutrients|mesh-ancestor
102466471|NCT03158246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466472|NCT03158246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102466473|NCT03158246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102466474|NCT00515411|Leucovorin|leucovorin|mesh-list
102466475|NCT00515411|Cisplatin|cisplatin|mesh-list
102466476|NCT00515411|Docetaxel|docetaxel|mesh-list
102466477|NCT00515411|Fluorouracil|fluorouracil|mesh-list
102466478|NCT00515411|Trastuzumab|trastuzumab|mesh-list
102466479|NCT00515411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102466480|NCT00515411|Tubulin Modulators|tubulin modulators|mesh-ancestor
102466481|NCT00515411|Antimitotic Agents|antimitotic agents|mesh-ancestor
102466482|NCT00515411|Mitosis Modulators|mitosis modulators|mesh-ancestor
102466483|NCT00515411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466484|NCT00515411|Antimetabolites|antimetabolites|mesh-ancestor
102466485|NCT00515411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102466486|NCT00515411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102466487|NCT00515411|Immunologic Factors|immunologic factors|mesh-ancestor
102466488|NCT00515411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466489|NCT00515411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102466490|NCT00515411|Antidotes|antidotes|mesh-ancestor
102466491|NCT00515411|Protective Agents|protective agents|mesh-ancestor
102466492|NCT00515411|Vitamin B Complex|vitamin b complex|mesh-ancestor
102466493|NCT00515411|Vitamins|vitamins|mesh-ancestor
102466494|NCT00515411|Micronutrients|micronutrients|mesh-ancestor
102466495|NCT00586261|Pioglitazone|pioglitazone|mesh-list
102466496|NCT00586261|Nitroglycerin|nitroglycerin|mesh-list
102466497|NCT00586261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102466498|NCT00586261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466499|NCT00586261|Vasodilator Agents|vasodilator agents|mesh-ancestor
102466500|NCT00515723|Olanzapine|olanzapine|mesh-list
102466501|NCT00515723|Risperidone|risperidone|mesh-list
102466502|NCT00515723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102466503|NCT00515723|Ziprasidone|ziprasidone|mesh-list
102466504|NCT00515723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102466505|NCT00515723|Serotonin Agents|serotonin agents|mesh-ancestor
102466506|NCT00515723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102466507|NCT00515723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466508|NCT00515723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466509|NCT00515723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102466510|NCT00515723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102466511|NCT00515723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102466512|NCT00515723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102466513|NCT00515723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102466514|NCT00515723|Dopamine Agents|dopamine agents|mesh-ancestor
102466515|NCT00515723|Antiemetics|antiemetics|mesh-ancestor
102466516|NCT00515723|Autonomic Agents|autonomic agents|mesh-ancestor
102466517|NCT00515723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102466518|NCT00515723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102466519|NCT00515723|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102466520|NCT00515723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102466521|NCT00515723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102466522|NCT00515723|Antidepressive Agents|antidepressive agents|mesh-ancestor
102466523|NCT04405154|Cisplatin|cisplatin|mesh-list
102466524|NCT04405154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102466525|NCT00586573|Memantine|memantine|mesh-list
102466526|NCT00586573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102466527|NCT00586573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102466528|NCT00586573|Dopamine Agents|dopamine agents|mesh-ancestor
102466529|NCT00586573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102466530|NCT00586573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466531|NCT00586573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466532|NCT00586573|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102466533|NCT00586573|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102466534|NCT01799005|Micronutrients|micronutrients|mesh-list
102466535|NCT01799005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466536|NCT00515879|Cycloserine|cycloserine|mesh-list
102466537|NCT00515879|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102466538|NCT00515879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102466539|NCT00515879|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102466540|NCT00515879|Antitubercular Agents|antitubercular agents|mesh-ancestor
102466541|NCT00515879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102466542|NCT00515879|Antimetabolites|antimetabolites|mesh-ancestor
102466543|NCT00515879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466544|NCT03152942|Aminophylline|aminophylline|mesh-list
102466545|NCT03152942|Progesterone|progesterone|mesh-list
102466546|NCT03152942|Progestins|progestins|mesh-ancestor
102466547|NCT03152942|Hormones|hormones|mesh-ancestor
102466548|NCT03152942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102466549|NCT03152942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466550|NCT03152942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102466551|NCT03152942|Autonomic Agents|autonomic agents|mesh-ancestor
102466552|NCT03152942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102466553|NCT03152942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102466554|NCT03152942|Respiratory System Agents|respiratory system agents|mesh-ancestor
102466555|NCT03152942|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102466556|NCT03152942|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102466557|NCT03152942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102466558|NCT03152942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466559|NCT03152942|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102466560|NCT03152942|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102466561|NCT03152942|Purinergic Agents|purinergic agents|mesh-ancestor
102466562|NCT03152942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102466563|NCT03152942|Protective Agents|protective agents|mesh-ancestor
102466564|NCT00586729|Mafenide|mafenide|mesh-list
102466565|NCT00586729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102466566|NCT00586729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102466567|NCT00586729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102466568|NCT00586729|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102466569|NCT00586729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102466570|NCT00586729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466571|NCT01672346|Adenosine|adenosine|mesh-list
102466572|NCT01672346|Analgesics|analgesics|mesh-ancestor
102466573|NCT01672346|Sensory System Agents|sensory system agents|mesh-ancestor
102466574|NCT01672346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102466575|NCT01672346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466576|NCT01672346|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102466577|NCT01672346|Vasodilator Agents|vasodilator agents|mesh-ancestor
102466578|NCT01672346|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102466579|NCT01672346|Purinergic Agonists|purinergic agonists|mesh-ancestor
102466580|NCT01672346|Purinergic Agents|purinergic agents|mesh-ancestor
102466581|NCT01672346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102466582|NCT01672346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466583|NCT00516503|Ketamine|ketamine|mesh-list
102466584|NCT00516503|Amitriptyline|amitriptyline|mesh-list
102466585|NCT00516503|Baclofen|baclofen|mesh-list
102466586|NCT00516503|Analgesics|analgesics|mesh-ancestor
102466587|NCT00516503|Sensory System Agents|sensory system agents|mesh-ancestor
102466588|NCT00516503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102466589|NCT00516503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466590|NCT00516503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102466591|NCT00516503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102466592|NCT00516503|Anesthetics, General|anesthetics, general|mesh-ancestor
102466593|NCT00516503|Anesthetics|anesthetics|mesh-ancestor
102466594|NCT00516503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102466595|NCT00516503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102466596|NCT00516503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102466597|NCT00516503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102466598|NCT00516503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466599|NCT00516503|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102466600|NCT00516503|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102466601|NCT00516503|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102466602|NCT00516503|GABA Agonists|gaba agonists|mesh-ancestor
102466603|NCT00516503|GABA Agents|gaba agents|mesh-ancestor
102466604|NCT00516503|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102466605|NCT00516503|Antidepressive Agents|antidepressive agents|mesh-ancestor
102466606|NCT00516503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102466607|NCT00516503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102466608|NCT00516503|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102466609|NCT00516503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102466610|NCT00516503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102466611|NCT00516503|Adrenergic Agents|adrenergic agents|mesh-ancestor
102466612|NCT03157310|Gefitinib|gefitinib|mesh-list
102466613|NCT03157310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102466614|NCT03157310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102466615|NCT03157310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102466616|NCT03157310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466617|NCT03157388|Vancomycin|vancomycin|mesh-list
102466618|NCT03157388|Gentamicins|gentamicins|mesh-list
102466619|NCT03157388|Meropenem|meropenem|mesh-list
102466620|NCT03157388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102466621|NCT03157388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102466622|NCT03157388|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102466623|NCT03157388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102466624|NCT03157388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466625|NCT03156920|Sumatriptan|sumatriptan|mesh-list
102466626|NCT03156920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102466627|NCT03156920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102466628|NCT03156920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102466629|NCT03156920|Serotonin Agents|serotonin agents|mesh-ancestor
102466630|NCT03156920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102466631|NCT03156920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466632|NCT03156920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466633|NCT05247385|Ticagrelor|ticagrelor|mesh-list
102466634|NCT05247385|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102466635|NCT05247385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102466636|NCT05247385|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102466637|NCT05247385|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102466638|NCT05247385|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102466639|NCT05247385|Purinergic Agents|purinergic agents|mesh-ancestor
102466640|NCT05247385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102466641|NCT05247385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466642|NCT05247385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466643|NCT03156842|Amlodipine|amlodipine|mesh-list
102466644|NCT03156842|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102466645|NCT03156842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102466646|NCT03156842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102466647|NCT03156842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102466648|NCT03156842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466649|NCT03156842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102466650|NCT03156842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466651|NCT03156842|Vasodilator Agents|vasodilator agents|mesh-ancestor
101550313|NCT00598793|Insulin Glargine|insulin glargine|mesh-list
102466652|NCT03156842|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102466653|NCT03156842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102466654|NCT03156842|Antimetabolites|antimetabolites|mesh-ancestor
102466655|NCT03156842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102466656|NCT03156842|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102466657|NCT03156842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102466658|NCT01672580|Vitamins|vitamins|mesh-list
102466659|NCT01672580|Micronutrients|micronutrients|mesh-ancestor
102466660|NCT01672580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466661|NCT00636649|Escitalopram|escitalopram|mesh-list
102466662|NCT00636649|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102466663|NCT00636649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102466664|NCT00636649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102466665|NCT00636649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466666|NCT00636649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102466667|NCT00636649|Serotonin Agents|serotonin agents|mesh-ancestor
102466668|NCT00636649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466669|NCT05061524|Omalizumab|omalizumab|mesh-list
102466670|NCT05061524|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102466671|NCT05061524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102466672|NCT05061524|Respiratory System Agents|respiratory system agents|mesh-ancestor
102466673|NCT00636805|Dexamethasone|dexamethasone|mesh-list
102466674|NCT00636805|Palonosetron|palonosetron|mesh-list
102466675|NCT00636805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102466676|NCT00636805|Antiemetics|antiemetics|mesh-ancestor
102466677|NCT00636805|Autonomic Agents|autonomic agents|mesh-ancestor
102466678|NCT00636805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102466679|NCT00636805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466680|NCT00636805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102466681|NCT00636805|Glucocorticoids|glucocorticoids|mesh-ancestor
102466682|NCT00636805|Hormones|hormones|mesh-ancestor
102278270|NCT04523935|Antiemetics|antiemetics|mesh-ancestor
102466683|NCT00636805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102466684|NCT00636805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102466685|NCT00636805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102466686|NCT00636805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102466687|NCT00636805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102466688|NCT00636805|Serotonin Agents|serotonin agents|mesh-ancestor
102466689|NCT00636805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102466690|NCT00636805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466691|NCT05247151|Oxytocin|oxytocin|mesh-list
102466692|NCT05247151|Oxytocics|oxytocics|mesh-ancestor
102466693|NCT05247151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102466694|NCT05247151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466695|NCT01676246|Flupirtine|flupirtine|mesh-list
102466696|NCT01676246|Analgesics|analgesics|mesh-ancestor
102466697|NCT01676246|Sensory System Agents|sensory system agents|mesh-ancestor
102466698|NCT01676246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102466699|NCT01676246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466700|NCT00517595|Bevacizumab|bevacizumab|mesh-list
102466701|NCT00517595|Gemcitabine|gemcitabine|mesh-list
102466702|NCT00517595|Pemetrexed|pemetrexed|mesh-list
102466703|NCT00517595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102466704|NCT00517595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102466705|NCT00517595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102466706|NCT00517595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102466707|NCT00517595|Growth Substances|growth substances|mesh-ancestor
102466708|NCT00517595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466709|NCT00517595|Growth Inhibitors|growth inhibitors|mesh-ancestor
102466710|NCT00517595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102466711|NCT00517595|Antimetabolites|antimetabolites|mesh-ancestor
102466712|NCT00517595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466713|NCT00517595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102466714|NCT00517595|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102466715|NCT00517595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102466716|NCT01672814|Riboflavin|riboflavin|mesh-list
102466717|NCT01672814|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102466718|NCT01672814|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102466719|NCT01672814|Vitamin B Complex|vitamin b complex|mesh-ancestor
102466720|NCT01672814|Vitamins|vitamins|mesh-ancestor
102466721|NCT01672814|Micronutrients|micronutrients|mesh-ancestor
101550368|NCT01303965|Sirolimus|sirolimus|mesh-list
102466722|NCT01672814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466723|NCT01672814|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102466724|NCT01672814|Dermatologic Agents|dermatologic agents|mesh-ancestor
102466725|NCT00524225|Oprelvekin|oprelvekin|mesh-list
102466726|NCT00524225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102466727|NCT00669019|Saracatinib|saracatinib|mesh-list
102466728|NCT00669019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102466729|NCT00669019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102466730|NCT00669019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466731|NCT05560373|Huperzine A|huperzine a|mesh-list
102466732|NCT05560373|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102466733|NCT05560373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102466734|NCT05560373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466735|NCT05560373|Cholinergic Agents|cholinergic agents|mesh-ancestor
102466736|NCT05560373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102466737|NCT05560373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466738|NCT05560373|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102466739|NCT05560373|Protective Agents|protective agents|mesh-ancestor
102466740|NCT00670267|Nadolol|nadolol|mesh-list
102466741|NCT00670267|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102466742|NCT00670267|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102466743|NCT00670267|Adrenergic Agents|adrenergic agents|mesh-ancestor
102466744|NCT00670267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102466745|NCT00670267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466746|NCT00670267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466747|NCT00670267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102466748|NCT00670267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102466749|NCT00670267|Sympatholytics|sympatholytics|mesh-ancestor
102466750|NCT00670267|Autonomic Agents|autonomic agents|mesh-ancestor
102466751|NCT00670267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102466752|NCT05621915|Nadroparin|nadroparin|mesh-list
102466753|NCT05621915|Anticoagulants|anticoagulants|mesh-ancestor
102466754|NCT05621915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102466755|NCT05621915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102466756|NCT05621915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466757|NCT01673204|Calcitriol|calcitriol|mesh-list
102466758|NCT01673204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102466759|NCT01673204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466760|NCT01673204|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102466761|NCT01673204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102466762|NCT01673204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466763|NCT01673204|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102466764|NCT01673204|Vitamins|vitamins|mesh-ancestor
102466765|NCT01673204|Micronutrients|micronutrients|mesh-ancestor
102466766|NCT01673204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102466767|NCT04393298|Leucovorin|leucovorin|mesh-list
102466768|NCT04393298|Trifluridine|trifluridine|mesh-list
102466769|NCT04393298|Fluorouracil|fluorouracil|mesh-list
102466770|NCT04393298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466771|NCT04393298|Antimetabolites|antimetabolites|mesh-ancestor
102466772|NCT04393298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466773|NCT04393298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102466774|NCT04393298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102466775|NCT04393298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102466776|NCT04393298|Immunologic Factors|immunologic factors|mesh-ancestor
102466777|NCT04393298|Antiviral Agents|antiviral agents|mesh-ancestor
102466778|NCT04393298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102466779|NCT04393298|Antidotes|antidotes|mesh-ancestor
102466780|NCT04393298|Protective Agents|protective agents|mesh-ancestor
102466781|NCT04393298|Vitamin B Complex|vitamin b complex|mesh-ancestor
102466782|NCT04393298|Vitamins|vitamins|mesh-ancestor
102466783|NCT04393298|Micronutrients|micronutrients|mesh-ancestor
102466784|NCT00641563|Midazolam|midazolam|mesh-list
102466785|NCT00641563|Dexmedetomidine|dexmedetomidine|mesh-list
102466786|NCT00641563|Remifentanil|remifentanil|mesh-list
102466787|NCT00641563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102466788|NCT00641563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102466789|NCT00641563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466790|NCT00641563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102466791|NCT00641563|Analgesics|analgesics|mesh-ancestor
102466792|NCT00641563|Sensory System Agents|sensory system agents|mesh-ancestor
101550442|NCT00600977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102466793|NCT00641563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102466794|NCT00641563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102466795|NCT00641563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102466796|NCT00641563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102466797|NCT00641563|Adrenergic Agents|adrenergic agents|mesh-ancestor
102466798|NCT00641563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102466799|NCT00641563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466800|NCT00641563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102466801|NCT00641563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102466802|NCT00641563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102466803|NCT00641563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102466804|NCT00641563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102466805|NCT00641563|Anesthetics, General|anesthetics, general|mesh-ancestor
102466806|NCT00641563|Anesthetics|anesthetics|mesh-ancestor
102466807|NCT00641563|GABA Modulators|gaba modulators|mesh-ancestor
102466808|NCT00641563|GABA Agents|gaba agents|mesh-ancestor
102466809|NCT00641563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102466810|NCT00641563|Narcotics|narcotics|mesh-ancestor
102466811|NCT05621759|Cyclophosphamide|cyclophosphamide|mesh-list
102466812|NCT05621759|Abatacept|abatacept|mesh-list
102466813|NCT05621759|Tacrolimus|tacrolimus|mesh-list
102466814|NCT05621759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102466815|NCT05621759|Immunologic Factors|immunologic factors|mesh-ancestor
102466816|NCT05621759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466817|NCT05621759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102466818|NCT05621759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102466819|NCT05621759|Alkylating Agents|alkylating agents|mesh-ancestor
102466820|NCT05621759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466821|NCT05621759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102466822|NCT05621759|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102466823|NCT05621759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102466824|NCT05621759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102466825|NCT05621759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102466826|NCT05621759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102466827|NCT02251262|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102466828|NCT02251262|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102466829|NCT02251262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466830|NCT00641641|Tenofovir|tenofovir|mesh-list
102466831|NCT00641641|Emtricitabine|emtricitabine|mesh-list
102466832|NCT00641641|Raltegravir Potassium|raltegravir potassium|mesh-list
102466833|NCT00641641|Antiviral Agents|antiviral agents|mesh-ancestor
102278419|NCT00694655|Vaccines|vaccines|mesh-list
102466834|NCT00641641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102466835|NCT00641641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102466836|NCT00641641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102466837|NCT00641641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102466838|NCT00641641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466839|NCT00641641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102466840|NCT00641641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102466841|NCT00641641|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102466842|NCT00641641|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102466843|NCT03152474|Vitamin A|vitamin a|mesh-list
102466844|NCT03152474|Methylprednisolone|methylprednisolone|mesh-list
102466845|NCT03152474|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102466846|NCT03152474|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102466847|NCT03152474|Prednisolone|prednisolone|mesh-list
102466848|NCT03152474|Prednisolone acetate|prednisolone acetate|mesh-list
102466849|NCT03152474|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102466850|NCT03152474|Prednisolone phosphate|prednisolone phosphate|mesh-list
102466851|NCT03152474|Vitamins|vitamins|mesh-ancestor
102466852|NCT03152474|Micronutrients|micronutrients|mesh-ancestor
102466853|NCT03152474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466854|NCT03152474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102466855|NCT03152474|Antiemetics|antiemetics|mesh-ancestor
102466856|NCT03152474|Autonomic Agents|autonomic agents|mesh-ancestor
102466857|NCT03152474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102466858|NCT03152474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102466859|NCT03152474|Glucocorticoids|glucocorticoids|mesh-ancestor
102466860|NCT03152474|Hormones|hormones|mesh-ancestor
102466861|NCT03152474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102466862|NCT03152474|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102466863|NCT03152474|Protective Agents|protective agents|mesh-ancestor
102466864|NCT03152474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102466865|NCT03152474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102466866|NCT00641797|Diphenhydramine|diphenhydramine|mesh-list
102466867|NCT00641797|Promethazine|promethazine|mesh-list
102466868|NCT00641797|Meclizine|meclizine|mesh-list
102466869|NCT00641797|Lorazepam|lorazepam|mesh-list
102466870|NCT00641797|Ondansetron|ondansetron|mesh-list
102466871|NCT00641797|Antiemetics|antiemetics|mesh-ancestor
102466872|NCT00641797|Autonomic Agents|autonomic agents|mesh-ancestor
102466873|NCT00641797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102466874|NCT00641797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466875|NCT00641797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102466876|NCT00641797|Antipruritics|antipruritics|mesh-ancestor
102466877|NCT00641797|Dermatologic Agents|dermatologic agents|mesh-ancestor
102466878|NCT00641797|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102466879|NCT00641797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102466880|NCT00641797|Serotonin Agents|serotonin agents|mesh-ancestor
102466881|NCT00641797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102466882|NCT00641797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466883|NCT00641797|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102466884|NCT00641797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102466885|NCT00641797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102466886|NCT00641797|Anesthetics, Local|anesthetics, local|mesh-ancestor
102466887|NCT00641797|Anesthetics|anesthetics|mesh-ancestor
102466888|NCT00641797|Sensory System Agents|sensory system agents|mesh-ancestor
102466889|NCT00641797|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102466890|NCT00641797|Histamine Antagonists|histamine antagonists|mesh-ancestor
102466891|NCT00641797|Histamine Agents|histamine agents|mesh-ancestor
102466892|NCT00641797|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102466893|NCT00641797|Anticonvulsants|anticonvulsants|mesh-ancestor
102466894|NCT00641797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102466895|NCT00641797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102466896|NCT00641797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102466897|NCT00641797|GABA Modulators|gaba modulators|mesh-ancestor
102466898|NCT00641797|GABA Agents|gaba agents|mesh-ancestor
102466899|NCT00641797|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102466900|NCT00641797|Cholinergic Agents|cholinergic agents|mesh-ancestor
102466901|NCT04333459|Vaccines|vaccines|mesh-list
102466902|NCT04333459|Immunologic Factors|immunologic factors|mesh-ancestor
102466903|NCT04333459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466904|NCT00671515|Pioglitazone|pioglitazone|mesh-list
102466905|NCT00671515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102466906|NCT00671515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466907|NCT01893320|Decitabine|decitabine|mesh-list
102466908|NCT01893320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102278498|NCT02102789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102466909|NCT01893320|Antimetabolites|antimetabolites|mesh-ancestor
102466910|NCT01893320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466911|NCT01893320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102466912|NCT01893320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102466913|NCT04120766|Nicorandil|nicorandil|mesh-list
102466914|NCT04120766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102466915|NCT04120766|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102466916|NCT04120766|Vasodilator Agents|vasodilator agents|mesh-ancestor
102466917|NCT04120766|Vitamin B Complex|vitamin b complex|mesh-ancestor
102466918|NCT04120766|Vitamins|vitamins|mesh-ancestor
102466919|NCT04120766|Micronutrients|micronutrients|mesh-ancestor
102466920|NCT04120766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466921|NCT00673075|Carvedilol|carvedilol|mesh-list
102466922|NCT00673075|Nebivolol|nebivolol|mesh-list
102466923|NCT00673075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102466924|NCT00673075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102466925|NCT00673075|Adrenergic Agents|adrenergic agents|mesh-ancestor
102466926|NCT00673075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102466927|NCT00673075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466928|NCT00673075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466929|NCT00673075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102466930|NCT00673075|Antioxidants|antioxidants|mesh-ancestor
102466931|NCT00673075|Protective Agents|protective agents|mesh-ancestor
102466932|NCT00673075|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102466933|NCT00673075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102466934|NCT00673075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102466935|NCT00673075|Vasodilator Agents|vasodilator agents|mesh-ancestor
102466936|NCT00673075|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101550584|NCT05271721|Dexamethasone|dexamethasone|mesh-list
102466937|NCT00673075|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102466938|NCT00673075|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102466939|NCT00673075|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102466940|NCT00673075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102466941|NCT02250014|Sargramostim|sargramostim|mesh-list
102466942|NCT02250014|Immunologic Factors|immunologic factors|mesh-ancestor
102466943|NCT02250014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466944|NCT04022096|Lansoprazole|lansoprazole|mesh-list
102466945|NCT04022096|Dexlansoprazole|dexlansoprazole|mesh-list
102466946|NCT04022096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102466947|NCT04022096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102466948|NCT04022096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102466949|NCT04022096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102466950|NCT04022096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466951|NCT00673153|Vorinostat|vorinostat|mesh-list
102466952|NCT00673153|Gemtuzumab|gemtuzumab|mesh-list
102466953|NCT00673153|Calicheamicins|calicheamicins|mesh-list
102466954|NCT00673153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102466955|NCT00673153|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102466956|NCT00673153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102466957|NCT00673153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466958|NCT00673153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102466959|NCT00673153|Immunotoxins|immunotoxins|mesh-ancestor
102466960|NCT00673153|Immunoconjugates|immunoconjugates|mesh-ancestor
102466961|NCT00673153|Immunologic Factors|immunologic factors|mesh-ancestor
102466962|NCT00673153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466963|NCT00673153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102466964|NCT00673855|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102466965|NCT00673855|Lubricant Eye Drops|lubricant eye drops|mesh-list
102466966|NCT00673855|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102466967|NCT00654511|Fentanyl|fentanyl|mesh-list
102466968|NCT00654511|Dexmedetomidine|dexmedetomidine|mesh-list
102466969|NCT00654511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102466970|NCT00654511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102466971|NCT00654511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102466972|NCT00654511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102466973|NCT00654511|Analgesics|analgesics|mesh-ancestor
102466974|NCT00654511|Sensory System Agents|sensory system agents|mesh-ancestor
102466975|NCT00654511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102466976|NCT00654511|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102466977|NCT00654511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102466978|NCT00654511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102466979|NCT00654511|Adrenergic Agents|adrenergic agents|mesh-ancestor
102466980|NCT00654511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102466981|NCT00654511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102466982|NCT00654511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102466983|NCT00654511|Narcotics|narcotics|mesh-ancestor
102466984|NCT00654511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102466985|NCT00654511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102466986|NCT00654511|Anesthetics, General|anesthetics, general|mesh-ancestor
102466987|NCT00654511|Anesthetics|anesthetics|mesh-ancestor
102466988|NCT01670084|Leucovorin|leucovorin|mesh-list
102466989|NCT01670084|Cytarabine|cytarabine|mesh-list
102466990|NCT01670084|Dexamethasone|dexamethasone|mesh-list
102466991|NCT01670084|Prednisone|prednisone|mesh-list
102466992|NCT01670084|Cyclophosphamide|cyclophosphamide|mesh-list
102466993|NCT01670084|Rituximab|rituximab|mesh-list
102466994|NCT01670084|Doxorubicin|doxorubicin|mesh-list
102466995|NCT01670084|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102466996|NCT01670084|Methotrexate|methotrexate|mesh-list
102466997|NCT01670084|Vincristine|vincristine|mesh-list
102466998|NCT01670084|Levoleucovorin|levoleucovorin|mesh-list
102467000|NCT01670084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102467001|NCT01670084|Immunologic Factors|immunologic factors|mesh-ancestor
102467002|NCT01670084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467003|NCT01670084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102467004|NCT01670084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102467005|NCT01670084|Alkylating Agents|alkylating agents|mesh-ancestor
102467006|NCT01670084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467007|NCT01670084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102467008|NCT01670084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102467009|NCT01670084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102467010|NCT01670084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102467011|NCT01670084|Antiemetics|antiemetics|mesh-ancestor
102467012|NCT01670084|Autonomic Agents|autonomic agents|mesh-ancestor
102467013|NCT01670084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102467014|NCT01670084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102467015|NCT01670084|Glucocorticoids|glucocorticoids|mesh-ancestor
102467016|NCT01670084|Hormones|hormones|mesh-ancestor
102467017|NCT01670084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102467018|NCT01670084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102467019|NCT01670084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102467020|NCT01670084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102467021|NCT01670084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102467022|NCT01670084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102467023|NCT01670084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102467024|NCT01670084|Abortifacient Agents|abortifacient agents|mesh-ancestor
102467025|NCT01670084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102467026|NCT01670084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102467027|NCT01670084|Antimetabolites|antimetabolites|mesh-ancestor
102467028|NCT01670084|Dermatologic Agents|dermatologic agents|mesh-ancestor
102467029|NCT01670084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102467030|NCT01670084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102467031|NCT01670084|Antiviral Agents|antiviral agents|mesh-ancestor
102467032|NCT01670084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102467033|NCT01670084|Antidotes|antidotes|mesh-ancestor
102467034|NCT01670084|Protective Agents|protective agents|mesh-ancestor
102467035|NCT01670084|Vitamin B Complex|vitamin b complex|mesh-ancestor
102467036|NCT01670084|Vitamins|vitamins|mesh-ancestor
102467037|NCT01670084|Micronutrients|micronutrients|mesh-ancestor
102467038|NCT01670084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102467039|NCT01670084|Tubulin Modulators|tubulin modulators|mesh-ancestor
102467040|NCT01670084|Antimitotic Agents|antimitotic agents|mesh-ancestor
102467041|NCT01670084|Mitosis Modulators|mitosis modulators|mesh-ancestor
102467042|NCT01670162|Aflibercept|aflibercept|mesh-list
102467043|NCT01670162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102467044|NCT01670162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102467045|NCT01670162|Growth Substances|growth substances|mesh-ancestor
102467046|NCT01670162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467047|NCT01670162|Growth Inhibitors|growth inhibitors|mesh-ancestor
102467048|NCT01670162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102467049|NCT04345783|Apatinib|apatinib|mesh-list
102467050|NCT04345783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102467051|NCT04345783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102467052|NCT04345783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102467053|NCT04345783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467054|NCT00675259|Paclitaxel|paclitaxel|mesh-list
102467055|NCT00675259|Bevacizumab|bevacizumab|mesh-list
102467056|NCT00675259|Carboplatin|carboplatin|mesh-list
102467057|NCT00675259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102278686|NCT02958709|Rifampin|rifampin|mesh-list
102467058|NCT00675259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102467059|NCT00675259|Tubulin Modulators|tubulin modulators|mesh-ancestor
102467060|NCT00675259|Antimitotic Agents|antimitotic agents|mesh-ancestor
102467061|NCT00675259|Mitosis Modulators|mitosis modulators|mesh-ancestor
102467062|NCT00675259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467063|NCT00675259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102467064|NCT00675259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102467065|NCT00675259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102467066|NCT00675259|Growth Substances|growth substances|mesh-ancestor
102467067|NCT00675259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467068|NCT00675259|Growth Inhibitors|growth inhibitors|mesh-ancestor
102467069|NCT01674218|Moxifloxacin|moxifloxacin|mesh-list
102467070|NCT01674218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102467071|NCT01674218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102467072|NCT01674218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102467073|NCT01674218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102467074|NCT01674218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102467075|NCT01674218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467076|NCT01674218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102467077|NCT01670240|Adalimumab|adalimumab|mesh-list
102467078|NCT01670240|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102467079|NCT01670240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102467080|NCT01670240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102467081|NCT04404686|Indomethacin|indomethacin|mesh-list
102467082|NCT04404686|Nifedipine|nifedipine|mesh-list
102467083|NCT04404686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102467084|NCT04404686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102467085|NCT04404686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467086|NCT04404686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102467087|NCT04404686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467088|NCT04404686|Vasodilator Agents|vasodilator agents|mesh-ancestor
102467089|NCT04404686|Tocolytic Agents|tocolytic agents|mesh-ancestor
102467090|NCT04404686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102467091|NCT04404686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102467092|NCT04404686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102467093|NCT04404686|Analgesics|analgesics|mesh-ancestor
102467094|NCT04404686|Sensory System Agents|sensory system agents|mesh-ancestor
102467095|NCT04404686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102467096|NCT04404686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102467097|NCT04404686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102467098|NCT04404686|Gout Suppressants|gout suppressants|mesh-ancestor
102467099|NCT04404686|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102467100|NCT04404686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102467101|NCT00676585|Hydrocortisone|hydrocortisone|mesh-list
102467102|NCT00676585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102467103|NCT00658411|Deferoxamine|deferoxamine|mesh-list
102467104|NCT00658411|Siderophores|siderophores|mesh-ancestor
102467105|NCT00658411|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102467106|NCT00658411|Chelating Agents|chelating agents|mesh-ancestor
102467107|NCT00658411|Sequestering Agents|sequestering agents|mesh-ancestor
102467108|NCT00658411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467109|NCT01674530|Lubiprostone|lubiprostone|mesh-list
102467110|NCT01674530|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102467111|NCT01674530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102467112|NCT01674530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467113|NCT00676897|Simvastatin|simvastatin|mesh-list
102467114|NCT00676897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102467115|NCT00676897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102467116|NCT00676897|Antimetabolites|antimetabolites|mesh-ancestor
102467117|NCT00676897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467118|NCT00676897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102467119|NCT00676897|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102467120|NCT00676897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102467121|NCT02115074|Celecoxib|celecoxib|mesh-list
102467122|NCT02115074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102467123|NCT02115074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102467124|NCT02115074|Analgesics|analgesics|mesh-ancestor
102467125|NCT02115074|Sensory System Agents|sensory system agents|mesh-ancestor
102467126|NCT02115074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102467127|NCT02115074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467128|NCT02115074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102467129|NCT02115074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102467130|NCT02115074|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102467131|NCT02115074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102467132|NCT02115074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102467133|NCT02115074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467134|NCT01674686|Sarpogrelate|sarpogrelate|mesh-list
102467135|NCT01674686|Atorvastatin|atorvastatin|mesh-list
102467136|NCT01674686|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102278719|NCT05103397|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102467137|NCT01674686|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102467139|NCT01674686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467140|NCT01674686|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102467141|NCT01674686|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102467142|NCT01674686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102467143|NCT01674686|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102467144|NCT01674686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102467145|NCT01674686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102467146|NCT01674686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102467147|NCT01674686|Serotonin Agents|serotonin agents|mesh-ancestor
102467148|NCT01674686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102467149|NCT01674686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467150|NCT02082392|Escitalopram|escitalopram|mesh-list
102467151|NCT02082392|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102467152|NCT02082392|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102467153|NCT02082392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102467154|NCT02082392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467155|NCT02082392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102467156|NCT02082392|Serotonin Agents|serotonin agents|mesh-ancestor
102467157|NCT02082392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467158|NCT01674842|Cisplatin|cisplatin|mesh-list
102467159|NCT01674842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102467160|NCT03845894|Bupivacaine|bupivacaine|mesh-list
102467161|NCT03845894|Anesthetics, Local|anesthetics, local|mesh-ancestor
102467162|NCT03845894|Anesthetics|anesthetics|mesh-ancestor
102467163|NCT03845894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102467164|NCT03845894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467165|NCT03845894|Sensory System Agents|sensory system agents|mesh-ancestor
102467166|NCT03845894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102467167|NCT03161132|Doxorubicin|doxorubicin|mesh-list
102467168|NCT03161132|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102467169|NCT03161132|Olaparib|olaparib|mesh-list
102467170|NCT03161132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102467171|NCT03161132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102467172|NCT03161132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102467173|NCT03161132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102467174|NCT03161132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102467175|NCT03161132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467176|NCT03161132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102467177|NCT03844256|Capecitabine|capecitabine|mesh-list
102467178|NCT03844256|Nivolumab|nivolumab|mesh-list
102467179|NCT03844256|Ipilimumab|ipilimumab|mesh-list
102467180|NCT03844256|Mitomycins|mitomycins|mesh-list
102467181|NCT03844256|Mitomycin|mitomycin|mesh-list
102467182|NCT03844256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102467183|NCT03844256|Antimetabolites|antimetabolites|mesh-ancestor
102467184|NCT03844256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467185|NCT03844256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102467186|NCT03844256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102467187|NCT03844256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102467188|NCT03844256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102467189|NCT03844256|Alkylating Agents|alkylating agents|mesh-ancestor
102467190|NCT03844256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102467191|NCT03844256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102467192|NCT01675076|Rivaroxaban|rivaroxaban|mesh-list
102467193|NCT01675076|Apixaban|apixaban|mesh-list
102467194|NCT01675076|Dabigatran|dabigatran|mesh-list
102467195|NCT01675076|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102467196|NCT01675076|Antithrombins|antithrombins|mesh-ancestor
102467197|NCT01675076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102467198|NCT01675076|Protease Inhibitors|protease inhibitors|mesh-ancestor
102467199|NCT01675076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102467200|NCT01675076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467201|NCT01675076|Anticoagulants|anticoagulants|mesh-ancestor
102467202|NCT03838796|Lenvatinib|lenvatinib|mesh-list
102467203|NCT03838796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102467204|NCT03838796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102467205|NCT03838796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101550866|NCT01320683|Antibodies|antibodies|mesh-list
102467206|NCT03838796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467207|NCT03719690|Tipifarnib|tipifarnib|mesh-list
102467208|NCT03719690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102467209|NCT01675466|Anesthetics|anesthetics|mesh-list
102467210|NCT01675466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102278854|NCT02660281|Mesna|mesna|mesh-list
102467211|NCT01675466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467213|NCT01675700|Vasodilator Agents|vasodilator agents|mesh-ancestor
102467214|NCT01676558|Rituximab|rituximab|mesh-list
102467215|NCT01676558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102467216|NCT01676558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102467217|NCT01676558|Immunologic Factors|immunologic factors|mesh-ancestor
102467218|NCT01676558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467219|NCT01676558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102467220|NCT02510300|Sofosbuvir|sofosbuvir|mesh-list
102467221|NCT02510300|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102467222|NCT02510300|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102467223|NCT02510300|Ledipasvir|ledipasvir|mesh-list
102467224|NCT02510300|Velpatasvir|velpatasvir|mesh-list
102467225|NCT02510300|Antiviral Agents|antiviral agents|mesh-ancestor
102467226|NCT02510300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102467227|NCT00678535|Capecitabine|capecitabine|mesh-list
102467228|NCT00678535|Cetuximab|cetuximab|mesh-list
102467229|NCT00678535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102467230|NCT00678535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102467231|NCT00678535|Antimetabolites|antimetabolites|mesh-ancestor
102467232|NCT00678535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467233|NCT00678535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102467234|NCT00659737|Scopolamine|scopolamine|mesh-list
102467235|NCT00659737|Aprepitant|aprepitant|mesh-list
102467236|NCT00659737|Fosaprepitant|fosaprepitant|mesh-list
102467237|NCT00659737|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102467238|NCT00659737|Antiemetics|antiemetics|mesh-ancestor
102467239|NCT00659737|Autonomic Agents|autonomic agents|mesh-ancestor
102467240|NCT00659737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102467241|NCT00659737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467242|NCT00659737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102467243|NCT00659737|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102467244|NCT00659737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102467245|NCT00659737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467246|NCT00659737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102467247|NCT00659737|Mydriatics|mydriatics|mesh-ancestor
102467248|NCT00659737|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102467249|NCT00659737|Cholinergic Agents|cholinergic agents|mesh-ancestor
102467250|NCT00659737|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102467251|NCT00659737|Parasympatholytics|parasympatholytics|mesh-ancestor
102467252|NCT04763876|Ketorolac|ketorolac|mesh-list
102467253|NCT04763876|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102467254|NCT04763876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102467255|NCT04763876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102467256|NCT04763876|Analgesics|analgesics|mesh-ancestor
102467257|NCT04763876|Sensory System Agents|sensory system agents|mesh-ancestor
102467258|NCT04763876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102467259|NCT04763876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467260|NCT04763876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102467261|NCT04763876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102467262|NCT04763876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102467263|NCT04763876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102467264|NCT04763876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467265|NCT00680797|Testosterone|testosterone|mesh-list
102467266|NCT00680797|Estrogens|estrogens|mesh-list
102467267|NCT00680797|Androgens|androgens|mesh-ancestor
102467268|NCT00680797|Hormones|hormones|mesh-ancestor
102467269|NCT00680797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102467270|NCT00680797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467271|NCT02984852|Tenofovir|tenofovir|mesh-list
102467272|NCT02984852|Emtricitabine|emtricitabine|mesh-list
102467273|NCT02984852|Darunavir|darunavir|mesh-list
102467274|NCT02984852|Cobicistat|cobicistat|mesh-list
102467275|NCT02984852|Antiviral Agents|antiviral agents|mesh-ancestor
102467276|NCT02984852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102467277|NCT02984852|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102467278|NCT02984852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102467279|NCT02984852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102467280|NCT02984852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467281|NCT02984852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102467282|NCT02984852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102467283|NCT02984852|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102467284|NCT02984852|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102467285|NCT02984852|Protease Inhibitors|protease inhibitors|mesh-ancestor
102467286|NCT02984852|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102467287|NCT02984852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102467288|NCT00557193|Calcium, Dietary|calcium, dietary|mesh-list
102467289|NCT00557193|Leucovorin|leucovorin|mesh-list
102467290|NCT00557193|Folic Acid|folic acid|mesh-list
102467291|NCT00557193|Cytarabine|cytarabine|mesh-list
102467292|NCT00557193|Dexamethasone|dexamethasone|mesh-list
102467293|NCT00557193|Dexamethasone acetate|dexamethasone acetate|mesh-list
102467294|NCT00557193|Prednisone|prednisone|mesh-list
102467295|NCT00557193|Methylprednisolone|methylprednisolone|mesh-list
102467296|NCT00557193|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102467297|NCT00557193|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102467298|NCT00557193|Prednisolone|prednisolone|mesh-list
102467299|NCT00557193|Prednisolone acetate|prednisolone acetate|mesh-list
102467300|NCT00557193|Hydrocortisone|hydrocortisone|mesh-list
102467301|NCT00557193|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102467302|NCT00557193|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102467303|NCT00557193|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102467304|NCT00557193|Cortisone|cortisone|mesh-list
102467305|NCT00557193|Cyclophosphamide|cyclophosphamide|mesh-list
102467306|NCT00557193|Methotrexate|methotrexate|mesh-list
102467307|NCT00557193|Etoposide|etoposide|mesh-list
102467308|NCT00557193|Vincristine|vincristine|mesh-list
102467309|NCT00557193|Etoposide phosphate|etoposide phosphate|mesh-list
102467310|NCT00557193|Daunorubicin|daunorubicin|mesh-list
102467311|NCT00557193|Asparaginase|asparaginase|mesh-list
102467312|NCT00557193|Mercaptopurine|mercaptopurine|mesh-list
102467313|NCT00557193|Podophyllotoxin|podophyllotoxin|mesh-list
102467314|NCT00557193|Pegaspargase|pegaspargase|mesh-list
102467315|NCT00557193|Lenograstim|lenograstim|mesh-list
102467316|NCT00557193|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102467317|NCT00557193|Prednisolone phosphate|prednisolone phosphate|mesh-list
102467318|NCT00557193|BB 1101|bb 1101|mesh-list
102467319|NCT00557193|Calcium|calcium|mesh-list
102467320|NCT00557193|Levoleucovorin|levoleucovorin|mesh-list
102467321|NCT00557193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102467322|NCT00557193|Immunologic Factors|immunologic factors|mesh-ancestor
102467323|NCT00557193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467324|NCT00557193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102467325|NCT00557193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102467326|NCT00557193|Alkylating Agents|alkylating agents|mesh-ancestor
102467327|NCT00557193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467328|NCT00557193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102467329|NCT00557193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102467330|NCT00557193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102467331|NCT00557193|Antiemetics|antiemetics|mesh-ancestor
102467332|NCT00557193|Autonomic Agents|autonomic agents|mesh-ancestor
102467333|NCT00557193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102467334|NCT00557193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102467335|NCT00557193|Glucocorticoids|glucocorticoids|mesh-ancestor
102467336|NCT00557193|Hormones|hormones|mesh-ancestor
102467337|NCT00557193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102467338|NCT00557193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102467339|NCT00557193|Protease Inhibitors|protease inhibitors|mesh-ancestor
102467340|NCT00557193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102467341|NCT00557193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102467342|NCT00557193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102467343|NCT00557193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102467344|NCT00557193|Abortifacient Agents|abortifacient agents|mesh-ancestor
102467345|NCT00557193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102467346|NCT00557193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102467347|NCT00557193|Antimetabolites|antimetabolites|mesh-ancestor
102467348|NCT00557193|Dermatologic Agents|dermatologic agents|mesh-ancestor
102467349|NCT00557193|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102467350|NCT00557193|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102467351|NCT00557193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102467352|NCT00557193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102467353|NCT00557193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102467354|NCT00557193|Antiviral Agents|antiviral agents|mesh-ancestor
102467355|NCT00557193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102467356|NCT00557193|Antidotes|antidotes|mesh-ancestor
102467357|NCT00557193|Protective Agents|protective agents|mesh-ancestor
102467358|NCT00557193|Vitamin B Complex|vitamin b complex|mesh-ancestor
102467359|NCT00557193|Vitamins|vitamins|mesh-ancestor
102467360|NCT00557193|Micronutrients|micronutrients|mesh-ancestor
102467361|NCT00557193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102467362|NCT00557193|Tubulin Modulators|tubulin modulators|mesh-ancestor
102467363|NCT00557193|Antimitotic Agents|antimitotic agents|mesh-ancestor
102467364|NCT00557193|Mitosis Modulators|mitosis modulators|mesh-ancestor
102467365|NCT00557193|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102467366|NCT00557193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102467367|NCT00557193|Hematinics|hematinics|mesh-ancestor
102467368|NCT00557193|Keratolytic Agents|keratolytic agents|mesh-ancestor
102467369|NCT00660517|Fluticasone|fluticasone|mesh-list
102467371|NCT00660517|Azelastine|azelastine|mesh-list
102467372|NCT00660517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102467373|NCT00660517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102467374|NCT00660517|Autonomic Agents|autonomic agents|mesh-ancestor
102467375|NCT00660517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102467376|NCT00660517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467377|NCT00660517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102467378|NCT00660517|Respiratory System Agents|respiratory system agents|mesh-ancestor
102467379|NCT00660517|Dermatologic Agents|dermatologic agents|mesh-ancestor
102467380|NCT00660517|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102467381|NCT00660517|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
102467382|NCT00660517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102467383|NCT00660517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467384|NCT00660517|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102467385|NCT00660517|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102467386|NCT00660517|Histamine Antagonists|histamine antagonists|mesh-ancestor
102467387|NCT00660517|Histamine Agents|histamine agents|mesh-ancestor
102467388|NCT00660517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102467389|NCT02141581|Vaccines|vaccines|mesh-list
102467390|NCT02141581|Immunologic Factors|immunologic factors|mesh-ancestor
102467391|NCT02141581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551036|NCT01312961|Sympathomimetics|sympathomimetics|mesh-ancestor
102467392|NCT03991299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102467393|NCT03991299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102467394|NCT03991299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102467395|NCT03991299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467396|NCT03991299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102467397|NCT03991299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102467398|NCT03991299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467399|NCT03991299|Cholinergic Agents|cholinergic agents|mesh-ancestor
102467400|NCT03991299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102467401|NCT03819530|Micronutrients|micronutrients|mesh-list
102467402|NCT03819530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467403|NCT02279667|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102467404|NCT02279667|Anticonvulsants|anticonvulsants|mesh-ancestor
102467405|NCT02279667|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102467406|NCT02279667|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102467407|NCT02279667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102467408|NCT02279667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467409|NCT03818672|Rifaximin|rifaximin|mesh-list
102467410|NCT03818672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102467411|NCT03818672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102467412|NCT03818672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102467413|NCT03749018|Prednisone|prednisone|mesh-list
102467414|NCT03749018|Cortisone|cortisone|mesh-list
102467415|NCT03749018|Cyclophosphamide|cyclophosphamide|mesh-list
102467416|NCT03749018|Rituximab|rituximab|mesh-list
102467417|NCT03749018|Doxorubicin|doxorubicin|mesh-list
102467418|NCT03749018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102467419|NCT03749018|Nivolumab|nivolumab|mesh-list
102467420|NCT03749018|Etoposide|etoposide|mesh-list
102467421|NCT03749018|Vincristine|vincristine|mesh-list
102467422|NCT03749018|Etoposide phosphate|etoposide phosphate|mesh-list
102467423|NCT03749018|Podophyllotoxin|podophyllotoxin|mesh-list
102467424|NCT03749018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102467425|NCT03749018|Antibodies|antibodies|mesh-list
102467426|NCT03749018|Immunoglobulins|immunoglobulins|mesh-list
102467427|NCT03749018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102467428|NCT03749018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102467429|NCT03749018|Immunologic Factors|immunologic factors|mesh-ancestor
102467430|NCT03749018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467431|NCT03749018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102467432|NCT03749018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102467433|NCT03749018|Alkylating Agents|alkylating agents|mesh-ancestor
102467434|NCT03749018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467435|NCT03749018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102467436|NCT03749018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102467437|NCT03749018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102467438|NCT03749018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102467439|NCT03749018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102467440|NCT03749018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102467441|NCT03749018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102467442|NCT03749018|Glucocorticoids|glucocorticoids|mesh-ancestor
102467443|NCT03749018|Hormones|hormones|mesh-ancestor
102467444|NCT03749018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102467445|NCT03749018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102467446|NCT03749018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102467447|NCT03749018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102467449|NCT03749018|Antimitotic Agents|antimitotic agents|mesh-ancestor
102467450|NCT03749018|Mitosis Modulators|mitosis modulators|mesh-ancestor
102467451|NCT03749018|Keratolytic Agents|keratolytic agents|mesh-ancestor
102467452|NCT03749018|Dermatologic Agents|dermatologic agents|mesh-ancestor
102467453|NCT01931163|Everolimus|everolimus|mesh-list
102467454|NCT01931163|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102467455|NCT01931163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102467456|NCT01931163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102467457|NCT01931163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467458|NCT01931163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102467459|NCT01931163|Immunologic Factors|immunologic factors|mesh-ancestor
102467460|NCT01931163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467461|NCT01931163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102467462|NCT04763486|Cefazolin|cefazolin|mesh-list
102467463|NCT04763486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102467464|NCT04763486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102467465|NCT02988063|Polidocanol|polidocanol|mesh-list
102467466|NCT02988063|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102467467|NCT02988063|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102467468|NCT03025269|Ocrelizumab|ocrelizumab|mesh-list
102467469|NCT03025269|Immunologic Factors|immunologic factors|mesh-ancestor
102467470|NCT03025269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467471|NCT03744026|Carboplatin|carboplatin|mesh-list
102467472|NCT03744026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102467473|NCT03869450|Lidocaine|lidocaine|mesh-list
102467474|NCT03869450|Hyaluronic Acid|hyaluronic acid|mesh-list
102467475|NCT03869450|Anesthetics, Local|anesthetics, local|mesh-ancestor
102467476|NCT03869450|Anesthetics|anesthetics|mesh-ancestor
102467477|NCT03869450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102467478|NCT03869450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467479|NCT03869450|Sensory System Agents|sensory system agents|mesh-ancestor
102467480|NCT03869450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102467481|NCT03869450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102467482|NCT03869450|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102467483|NCT03869450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102467484|NCT03869450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102467485|NCT03869450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467486|NCT03869450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102467487|NCT03869450|Immunologic Factors|immunologic factors|mesh-ancestor
102467488|NCT03869450|Viscosupplements|viscosupplements|mesh-ancestor
102467489|NCT03869450|Protective Agents|protective agents|mesh-ancestor
102467490|NCT03799874|Carbon Monoxide|carbon monoxide|mesh-list
102467491|NCT03799874|Antimetabolites|antimetabolites|mesh-ancestor
102467492|NCT03799874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467493|NCT03799874|Gasotransmitters|gasotransmitters|mesh-ancestor
102467494|NCT03799874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102467495|NCT03799874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467496|NCT03736928|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102467497|NCT03736928|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102467498|NCT03736928|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102467499|NCT03736928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102467500|NCT03736928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467501|NCT03736928|Cholinergic Agents|cholinergic agents|mesh-ancestor
102467502|NCT03736928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102467503|NCT03736928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467504|NCT03736928|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102467505|NCT03736928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102467506|NCT01101464|Asenapine|asenapine|mesh-list
102467507|NCT01101464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102467508|NCT01101464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102467509|NCT01101464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102467510|NCT01101464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467511|NCT01101464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102467512|NCT03736538|Nitrous Oxide|nitrous oxide|mesh-list
102467513|NCT03736538|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102467514|NCT03736538|Anesthetics, General|anesthetics, general|mesh-ancestor
102467515|NCT03736538|Anesthetics|anesthetics|mesh-ancestor
102467516|NCT03736538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102279095|NCT04967417|Mitosis Modulators|mitosis modulators|mesh-ancestor
102467517|NCT03736538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467518|NCT03736538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102467519|NCT03736538|Analgesics|analgesics|mesh-ancestor
102467520|NCT03736538|Sensory System Agents|sensory system agents|mesh-ancestor
101551173|NCT02875093|Antimetabolites|antimetabolites|mesh-ancestor
102467521|NCT03736538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102467522|NCT01676948|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102467523|NCT01676948|Immunologic Factors|immunologic factors|mesh-ancestor
102467524|NCT01676948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467525|NCT03725930|Clonidine|clonidine|mesh-list
102467526|NCT03725930|Analgesics|analgesics|mesh-ancestor
102467527|NCT03725930|Sensory System Agents|sensory system agents|mesh-ancestor
102467528|NCT03725930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102467529|NCT03725930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467530|NCT03725930|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102467531|NCT03725930|Sympatholytics|sympatholytics|mesh-ancestor
102467532|NCT03725930|Autonomic Agents|autonomic agents|mesh-ancestor
102467533|NCT03725930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102467534|NCT03725930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102467535|NCT03725930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102467536|NCT03725930|Adrenergic Agents|adrenergic agents|mesh-ancestor
102467537|NCT03725930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102467538|NCT03725930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467539|NCT03781388|Bupivacaine|bupivacaine|mesh-list
102467540|NCT03781388|Anesthetics, Local|anesthetics, local|mesh-ancestor
102467541|NCT03781388|Anesthetics|anesthetics|mesh-ancestor
102467542|NCT03781388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102467543|NCT03781388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467544|NCT03781388|Sensory System Agents|sensory system agents|mesh-ancestor
102467545|NCT03781388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102467546|NCT03779048|Phentermine|phentermine|mesh-list
102467547|NCT03779048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102467548|NCT03779048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467549|NCT03779048|Appetite Depressants|appetite depressants|mesh-ancestor
102467550|NCT03779048|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102467551|NCT03779048|Sympathomimetics|sympathomimetics|mesh-ancestor
102467552|NCT03779048|Autonomic Agents|autonomic agents|mesh-ancestor
102467553|NCT03779048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102467554|NCT03779048|Adrenergic Agents|adrenergic agents|mesh-ancestor
102467555|NCT03779048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102467556|NCT03779048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467557|NCT03778580|Pyridoxamine|pyridoxamine|mesh-list
102467558|NCT03778580|Vitamin B Complex|vitamin b complex|mesh-ancestor
102467559|NCT03778580|Vitamins|vitamins|mesh-ancestor
102467560|NCT03778580|Micronutrients|micronutrients|mesh-ancestor
102467561|NCT03778580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467562|NCT03722342|Pembrolizumab|pembrolizumab|mesh-list
102467563|NCT03722342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102467564|NCT03722342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102467565|NCT03722342|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102467566|NCT03722342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467567|NCT03722108|Irinotecan|irinotecan|mesh-list
102467568|NCT03722108|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102467569|NCT03722108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102467570|NCT03722108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102467571|NCT03722108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467572|NCT03722108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102467573|NCT03775070|Simvastatin|simvastatin|mesh-list
102467574|NCT03775070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102467575|NCT03775070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102467576|NCT03775070|Antimetabolites|antimetabolites|mesh-ancestor
102467577|NCT03775070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467578|NCT03775070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102467579|NCT03775070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102467580|NCT03775070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102467581|NCT02083406|Artefenomel|artefenomel|mesh-list
102467582|NCT02083406|Antimalarials|antimalarials|mesh-ancestor
102467583|NCT02083406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102467584|NCT02083406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102467585|NCT02083406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102467586|NCT03773666|Durvalumab|durvalumab|mesh-list
102467587|NCT03773666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102467588|NCT03773666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102467589|NCT04762784|Glucocorticoids|glucocorticoids|mesh-list
102467590|NCT04762784|Hormones|hormones|mesh-ancestor
102467591|NCT04762784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102467592|NCT04762784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467593|NCT00003644|Paclitaxel|paclitaxel|mesh-list
102467594|NCT00003644|Carboplatin|carboplatin|mesh-list
102467595|NCT00003644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102467596|NCT00003644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102467597|NCT00003644|Tubulin Modulators|tubulin modulators|mesh-ancestor
102467598|NCT00003644|Antimitotic Agents|antimitotic agents|mesh-ancestor
102467599|NCT00003644|Mitosis Modulators|mitosis modulators|mesh-ancestor
102467600|NCT00003644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467601|NCT02142049|Lenalidomide|lenalidomide|mesh-list
102467602|NCT02142049|Immunologic Factors|immunologic factors|mesh-ancestor
102467603|NCT02142049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467604|NCT02142049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102467605|NCT02142049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102467606|NCT02142049|Growth Substances|growth substances|mesh-ancestor
102467607|NCT02142049|Growth Inhibitors|growth inhibitors|mesh-ancestor
102467608|NCT02142049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102467609|NCT03716180|Paclitaxel|paclitaxel|mesh-list
102467610|NCT03716180|Trastuzumab|trastuzumab|mesh-list
102467611|NCT03716180|Pertuzumab|pertuzumab|mesh-list
102467612|NCT03716180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102467613|NCT03716180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102467614|NCT03716180|Tubulin Modulators|tubulin modulators|mesh-ancestor
102467615|NCT03716180|Antimitotic Agents|antimitotic agents|mesh-ancestor
102467616|NCT03716180|Mitosis Modulators|mitosis modulators|mesh-ancestor
102467617|NCT03716180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467618|NCT03716180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102467619|NCT03715244|Anesthetics|anesthetics|mesh-list
102467620|NCT03715244|Anesthetics, Local|anesthetics, local|mesh-list
102467621|NCT03715244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102467622|NCT03715244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467623|NCT03715244|Sensory System Agents|sensory system agents|mesh-ancestor
102467624|NCT03715244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102467625|NCT03714620|Ketamine|ketamine|mesh-list
102467626|NCT03714620|Analgesics|analgesics|mesh-ancestor
102467627|NCT03714620|Sensory System Agents|sensory system agents|mesh-ancestor
102467628|NCT03714620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102467629|NCT03714620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467630|NCT03714620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102467631|NCT03714620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102467632|NCT03714620|Anesthetics, General|anesthetics, general|mesh-ancestor
102467633|NCT03714620|Anesthetics|anesthetics|mesh-ancestor
102467634|NCT03714620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102467635|NCT03714620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102467636|NCT03714620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102467637|NCT03714620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102467638|NCT03714620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467639|NCT03629288|Azithromycin|azithromycin|mesh-list
102467640|NCT03629288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102467641|NCT03629288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102467642|NCT04763096|Tacrolimus|tacrolimus|mesh-list
102467643|NCT04763096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102467644|NCT04763096|Immunologic Factors|immunologic factors|mesh-ancestor
102467645|NCT04763096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467646|NCT04763096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102467647|NCT04763096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102467648|NCT04763096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467649|NCT00680953|Denosumab|denosumab|mesh-list
102467650|NCT00680953|Alendronate|alendronate|mesh-list
102467651|NCT00680953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102467652|NCT00680953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467653|NCT00660985|Adapalene|adapalene|mesh-list
102467654|NCT00660985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102467655|NCT00660985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102467656|NCT00660985|Analgesics|analgesics|mesh-ancestor
102467657|NCT00660985|Sensory System Agents|sensory system agents|mesh-ancestor
102467658|NCT00660985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102467659|NCT00660985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551302|NCT01023061|Hormones|hormones|mesh-ancestor
102467660|NCT00660985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102467661|NCT00660985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102467662|NCT00660985|Dermatologic Agents|dermatologic agents|mesh-ancestor
102467663|NCT03551522|Seladelpar|seladelpar|mesh-list
102467664|NCT03551522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102467665|NCT03551522|Antimetabolites|antimetabolites|mesh-ancestor
102612322|NCT00002405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102279247|NCT04952207|Sofosbuvir|sofosbuvir|mesh-list
102467666|NCT03551522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467667|NCT03551522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102467668|NCT03704714|Prednisone|prednisone|mesh-list
102467669|NCT03704714|Cortisone|cortisone|mesh-list
102467670|NCT03704714|Cyclophosphamide|cyclophosphamide|mesh-list
102467671|NCT03704714|Rituximab|rituximab|mesh-list
102467672|NCT03704714|Doxorubicin|doxorubicin|mesh-list
102467673|NCT03704714|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102467674|NCT03704714|Nivolumab|nivolumab|mesh-list
102467675|NCT03704714|Vincristine|vincristine|mesh-list
102467676|NCT03704714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102467677|NCT03704714|Antibodies|antibodies|mesh-list
102467678|NCT03704714|Immunoglobulins|immunoglobulins|mesh-list
102467679|NCT03704714|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102467680|NCT03704714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102467681|NCT03704714|Immunologic Factors|immunologic factors|mesh-ancestor
102467682|NCT03704714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467683|NCT03704714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102467684|NCT03704714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102467685|NCT03704714|Alkylating Agents|alkylating agents|mesh-ancestor
102467686|NCT03704714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467687|NCT03704714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102467688|NCT03704714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102467689|NCT03704714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102467690|NCT03704714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102467691|NCT03704714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102467692|NCT03704714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102467693|NCT03704714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102467694|NCT03704714|Glucocorticoids|glucocorticoids|mesh-ancestor
102467695|NCT03704714|Hormones|hormones|mesh-ancestor
102467696|NCT03704714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102467697|NCT03704714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102467698|NCT03704714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102467699|NCT03704714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102467700|NCT03704714|Tubulin Modulators|tubulin modulators|mesh-ancestor
102467701|NCT03704714|Antimitotic Agents|antimitotic agents|mesh-ancestor
102467702|NCT03704714|Mitosis Modulators|mitosis modulators|mesh-ancestor
102467703|NCT00661141|Ethanol|ethanol|mesh-list
102467704|NCT00661141|Fomepizole|fomepizole|mesh-list
102467705|NCT00661141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102467706|NCT00661141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102467707|NCT00661141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102467708|NCT00661141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467709|NCT00661141|Antidotes|antidotes|mesh-ancestor
102467710|NCT00661141|Protective Agents|protective agents|mesh-ancestor
102467711|NCT00661141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102467712|NCT00661141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467713|NCT03616574|Trifluridine|trifluridine|mesh-list
102467714|NCT03616574|Antimetabolites|antimetabolites|mesh-ancestor
102467715|NCT03616574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467716|NCT03616574|Antiviral Agents|antiviral agents|mesh-ancestor
102467717|NCT03616574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102467718|NCT00681265|Glycerol|glycerol|mesh-list
102467719|NCT00681265|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102467720|NCT00681265|Protective Agents|protective agents|mesh-ancestor
102467721|NCT00681265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467722|NCT01677104|Liraglutide|liraglutide|mesh-list
102467723|NCT01677104|Exenatide|exenatide|mesh-list
102467724|NCT01677104|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102467725|NCT01677104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102467726|NCT01677104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467727|NCT01677104|Incretins|incretins|mesh-ancestor
102467728|NCT01677104|Hormones|hormones|mesh-ancestor
102467729|NCT01677104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102467730|NCT01677104|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102467731|NCT00661453|Valproic Acid|valproic acid|mesh-list
102467732|NCT00661453|Anticonvulsants|anticonvulsants|mesh-ancestor
102467733|NCT00661453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102467734|NCT00661453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467735|NCT00661453|GABA Agents|gaba agents|mesh-ancestor
102467736|NCT00661453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102467737|NCT00661453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467738|NCT00661453|Antimanic Agents|antimanic agents|mesh-ancestor
102467739|NCT00661453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102467740|NCT00661453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102467741|NCT00661453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102467742|NCT03547622|Galantamine|galantamine|mesh-list
102467743|NCT03547622|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102467744|NCT03547622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102467745|NCT03547622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467746|NCT03547622|Cholinergic Agents|cholinergic agents|mesh-ancestor
102467747|NCT03547622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102467748|NCT03547622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467749|NCT03547622|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102467750|NCT03547622|Autonomic Agents|autonomic agents|mesh-ancestor
102467751|NCT03547622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102467752|NCT03547622|Nootropic Agents|nootropic agents|mesh-ancestor
102467753|NCT00681889|Ranibizumab|ranibizumab|mesh-list
102467754|NCT00681889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102467755|NCT00681889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102467756|NCT00681889|Growth Substances|growth substances|mesh-ancestor
102467757|NCT00681889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467758|NCT00681889|Growth Inhibitors|growth inhibitors|mesh-ancestor
102467759|NCT00681889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102467760|NCT03610490|Cyclophosphamide|cyclophosphamide|mesh-list
102467761|NCT03610490|Fludarabine|fludarabine|mesh-list
102467762|NCT03610490|Interleukin-2|interleukin-2|mesh-list
102467763|NCT03610490|Mitogens|mitogens|mesh-list
102467764|NCT03610490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102467765|NCT03610490|Immunologic Factors|immunologic factors|mesh-ancestor
102467766|NCT03610490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467767|NCT03610490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102467768|NCT03610490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102467769|NCT03610490|Alkylating Agents|alkylating agents|mesh-ancestor
102467770|NCT03610490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467771|NCT03610490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102467772|NCT03610490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102467773|NCT03610490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102467774|NCT03610490|Analgesics|analgesics|mesh-ancestor
102467775|NCT03610490|Sensory System Agents|sensory system agents|mesh-ancestor
102467776|NCT03610490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102467777|NCT03610490|Mitosis Modulators|mitosis modulators|mesh-ancestor
102467778|NCT00682357|Methylprednisolone|methylprednisolone|mesh-list
102467779|NCT00682357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102467780|NCT00682357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102467781|NCT00682357|Prednisolone|prednisolone|mesh-list
102467782|NCT00682357|Prednisolone acetate|prednisolone acetate|mesh-list
102467783|NCT00682357|Lidocaine|lidocaine|mesh-list
102467784|NCT00682357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102467785|NCT00682357|Prednisolone phosphate|prednisolone phosphate|mesh-list
102467786|NCT00682357|Anesthetics, Local|anesthetics, local|mesh-ancestor
102467787|NCT00682357|Anesthetics|anesthetics|mesh-ancestor
102467788|NCT00682357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102467789|NCT00682357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467790|NCT00682357|Sensory System Agents|sensory system agents|mesh-ancestor
102467791|NCT00682357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102467792|NCT00682357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102467793|NCT00682357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102467794|NCT00682357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102467795|NCT00682357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102467796|NCT00682357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467797|NCT00682357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102467798|NCT00682357|Antiemetics|antiemetics|mesh-ancestor
102467799|NCT00682357|Autonomic Agents|autonomic agents|mesh-ancestor
102467800|NCT00682357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102467801|NCT00682357|Glucocorticoids|glucocorticoids|mesh-ancestor
102467802|NCT00682357|Hormones|hormones|mesh-ancestor
102467803|NCT00682357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102467804|NCT00682357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102467805|NCT00682357|Protective Agents|protective agents|mesh-ancestor
102467806|NCT00682357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102467807|NCT00682357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102467808|NCT00662155|Zolpidem|zolpidem|mesh-list
102467809|NCT00662155|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102467810|NCT00662155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102467811|NCT00662155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102467812|NCT00662155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467813|NCT00662155|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102467814|NCT00662155|GABA Agonists|gaba agonists|mesh-ancestor
102467815|NCT00662155|GABA Agents|gaba agents|mesh-ancestor
102467816|NCT00662155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102467817|NCT00662155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467819|NCT03546608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102467820|NCT00662545|Tenofovir|tenofovir|mesh-list
102467821|NCT00662545|Lamivudine|lamivudine|mesh-list
102467822|NCT00662545|Emtricitabine|emtricitabine|mesh-list
102467823|NCT00662545|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102467824|NCT00662545|Entecavir|entecavir|mesh-list
102467825|NCT00662545|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102467826|NCT00662545|Antiviral Agents|antiviral agents|mesh-ancestor
102467827|NCT00662545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102467828|NCT00662545|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102467829|NCT00662545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102467830|NCT00662545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102467831|NCT00662545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467832|NCT00662545|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102467833|NCT03539198|Nivolumab|nivolumab|mesh-list
102467834|NCT03539198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102467835|NCT03539198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102467836|NCT03539198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102467837|NCT03539198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467838|NCT00663169|Dexamethasone|dexamethasone|mesh-list
102467839|NCT00663169|Dexamethasone acetate|dexamethasone acetate|mesh-list
102467840|NCT00663169|BB 1101|bb 1101|mesh-list
102467841|NCT00663169|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102467842|NCT00663169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102467843|NCT00663169|Antiemetics|antiemetics|mesh-ancestor
102467844|NCT00663169|Autonomic Agents|autonomic agents|mesh-ancestor
102467845|NCT00663169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102467846|NCT00663169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467847|NCT00663169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102467848|NCT00663169|Glucocorticoids|glucocorticoids|mesh-ancestor
102467849|NCT00663169|Hormones|hormones|mesh-ancestor
102467850|NCT00663169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102467851|NCT00663169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102467852|NCT00663169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102467853|NCT00663169|Protease Inhibitors|protease inhibitors|mesh-ancestor
102467854|NCT00663169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102467855|NCT00663169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467856|NCT00663169|Immunologic Factors|immunologic factors|mesh-ancestor
102467857|NCT00663403|Daptomycin|daptomycin|mesh-list
102467858|NCT00663403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101551506|NCT02873065|Antacids|antacids|mesh-ancestor
102467859|NCT00663403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102467860|NCT00663793|Methyltestosterone|methyltestosterone|mesh-list
102467861|NCT00663793|Finasteride|finasteride|mesh-list
102467862|NCT00663793|Testosterone|testosterone|mesh-list
102467863|NCT00663793|Testosterone undecanoate|testosterone undecanoate|mesh-list
102467864|NCT00663793|Testosterone enanthate|testosterone enanthate|mesh-list
102467865|NCT00663793|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102467866|NCT00663793|Acyline|acyline|mesh-list
102467867|NCT00663793|Androgens|androgens|mesh-ancestor
102467868|NCT00663793|Hormones|hormones|mesh-ancestor
102467869|NCT00663793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102467870|NCT00663793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467871|NCT00663793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102467872|NCT00663793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102467873|NCT00663793|Anabolic Agents|anabolic agents|mesh-ancestor
102467874|NCT00663793|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102467875|NCT00663793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102467876|NCT00663793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102467877|NCT00663793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467878|NCT00663793|Hormone Antagonists|hormone antagonists|mesh-ancestor
102467879|NCT00663793|Urological Agents|urological agents|mesh-ancestor
102467880|NCT03690986|Nivolumab|nivolumab|mesh-list
102467881|NCT03690986|Ipilimumab|ipilimumab|mesh-list
102467882|NCT03690986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102467883|NCT03690986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102467884|NCT03690986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102467885|NCT03690986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467886|NCT03605654|Mycophenolic Acid|mycophenolic acid|mesh-list
102467887|NCT03605654|Tacrolimus|tacrolimus|mesh-list
102467888|NCT03605654|Immunosuppressive Agents|immunosuppressive agents|mesh-list
102467889|NCT03605654|Immunologic Factors|immunologic factors|mesh-ancestor
102467890|NCT03605654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467891|NCT03605654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102467892|NCT03605654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102279525|NCT04426591|Biotin|biotin|mesh-list
102467893|NCT03605654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467894|NCT03605654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102467895|NCT03605654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102467896|NCT03605654|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102467897|NCT03605654|Antitubercular Agents|antitubercular agents|mesh-ancestor
102467898|NCT03605654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102467899|NCT03605654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102467900|NCT02336438|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
102467901|NCT02336438|Cathartics|cathartics|mesh-ancestor
102467902|NCT02336438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102467903|NCT00667615|Prednisone|prednisone|mesh-list
102467904|NCT00667615|Cyclophosphamide|cyclophosphamide|mesh-list
102467905|NCT00667615|Rituximab|rituximab|mesh-list
102467906|NCT00667615|Etoposide|etoposide|mesh-list
102467907|NCT00667615|Vorinostat|vorinostat|mesh-list
102467908|NCT00667615|Lenograstim|lenograstim|mesh-list
102467909|NCT00667615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102467910|NCT00667615|Immunologic Factors|immunologic factors|mesh-ancestor
102467911|NCT00667615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467912|NCT00667615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102467913|NCT00667615|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102467914|NCT00667615|Alkylating Agents|alkylating agents|mesh-ancestor
102467915|NCT00667615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467916|NCT00667615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102467917|NCT00667615|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102467918|NCT00667615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102467919|NCT00667615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102467920|NCT00667615|Glucocorticoids|glucocorticoids|mesh-ancestor
102467921|NCT00667615|Hormones|hormones|mesh-ancestor
102467922|NCT00667615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102467923|NCT00667615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102467924|NCT00667615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102467925|NCT00667615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102467926|NCT00667615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102467927|NCT00667615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102467928|NCT00667615|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102467929|NCT00667615|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102467930|NCT03683810|Lactoferrin|lactoferrin|mesh-list
102467931|NCT03683810|Epoetin Alfa|epoetin alfa|mesh-list
102467932|NCT03683810|Hematinics|hematinics|mesh-ancestor
102467933|NCT03683810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102467934|NCT01587235|Simvastatin|simvastatin|mesh-list
102467935|NCT01587235|Ezetimibe|ezetimibe|mesh-list
102467936|NCT01587235|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
102467937|NCT01587235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102467938|NCT01587235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102467939|NCT01587235|Antimetabolites|antimetabolites|mesh-ancestor
102467940|NCT01587235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467941|NCT01587235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102467942|NCT01587235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102467943|NCT01587235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102467944|NCT03601442|Tisagenlecleucel|tisagenlecleucel|mesh-list
102467945|NCT03601442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102467946|NCT03601442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102467947|NCT00705133|Treprostinil|treprostinil|mesh-list
102467948|NCT00705133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102467949|NCT00652717|Simvastatin|simvastatin|mesh-list
102467950|NCT00652717|Ezetimibe|ezetimibe|mesh-list
102467951|NCT00652717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102467952|NCT00652717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102467953|NCT00652717|Antimetabolites|antimetabolites|mesh-ancestor
102467954|NCT00652717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467955|NCT00652717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102467956|NCT00652717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102467957|NCT00652717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102467958|NCT00553891|Mometasone Furoate|mometasone furoate|mesh-list
102467959|NCT00553891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102467960|NCT00553891|Dermatologic Agents|dermatologic agents|mesh-ancestor
102467961|NCT00553891|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102467962|NCT00684775|Naltrexone|naltrexone|mesh-list
102467963|NCT00684775|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102467964|NCT00684775|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102467965|NCT00684775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467966|NCT00684775|Sensory System Agents|sensory system agents|mesh-ancestor
102467967|NCT00684775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102467968|NCT00395473|Ezetimibe|ezetimibe|mesh-list
102467969|NCT00395473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102467970|NCT00395473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102467971|NCT00395473|Antimetabolites|antimetabolites|mesh-ancestor
102467972|NCT00395473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467973|NCT00395473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102467975|NCT00393211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467976|NCT00393211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467977|NCT00393211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102467978|NCT00393211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102467979|NCT00393211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102467980|NCT00393211|Analgesics|analgesics|mesh-ancestor
102467981|NCT00393211|Sensory System Agents|sensory system agents|mesh-ancestor
102467982|NCT00393211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102467983|NCT00393211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102467984|NCT00393211|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102467985|NCT00393211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102467986|NCT00393211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102467987|NCT03676556|Lidocaine|lidocaine|mesh-list
102467988|NCT03676556|Anesthetics, Local|anesthetics, local|mesh-ancestor
102467989|NCT03676556|Anesthetics|anesthetics|mesh-ancestor
102467990|NCT03676556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102467991|NCT03676556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102467992|NCT03676556|Sensory System Agents|sensory system agents|mesh-ancestor
102467993|NCT03676556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102467994|NCT03676556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102467995|NCT03676556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102467996|NCT03676556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102467997|NCT03676556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101551636|NCT01287117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102467998|NCT03676556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102467999|NCT02144233|Salicylic Acid|salicylic acid|mesh-list
102468000|NCT02144233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102468001|NCT02144233|Antifungal Agents|antifungal agents|mesh-ancestor
102468002|NCT02144233|Keratolytic Agents|keratolytic agents|mesh-ancestor
102468003|NCT02144233|Dermatologic Agents|dermatologic agents|mesh-ancestor
102468004|NCT03592472|Abexinostat|abexinostat|mesh-list
102468005|NCT03592472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102468006|NCT03592472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102468007|NCT03592472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468008|NCT00269191|Ibuprofen|ibuprofen|mesh-list
102468009|NCT00269191|Etoricoxib|etoricoxib|mesh-list
102468010|NCT00269191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102468011|NCT00269191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102468012|NCT00269191|Analgesics|analgesics|mesh-ancestor
102468013|NCT00269191|Sensory System Agents|sensory system agents|mesh-ancestor
102468014|NCT00269191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102468015|NCT00269191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468016|NCT00269191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102468017|NCT00269191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102468018|NCT00269191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102468019|NCT00269191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102468020|NCT00269191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468021|NCT00269191|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102468022|NCT00690235|Pramlintide|pramlintide|mesh-list
102468023|NCT00690235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102468024|NCT00690235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468025|NCT00092833|Ezetimibe|ezetimibe|mesh-list
102468026|NCT00092833|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102468027|NCT00092833|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102468028|NCT00092833|Antimetabolites|antimetabolites|mesh-ancestor
102468029|NCT00092833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468030|NCT00092833|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102468031|NCT01799083|Decitabine|decitabine|mesh-list
102468032|NCT01799083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102468033|NCT01799083|Antimetabolites|antimetabolites|mesh-ancestor
102468034|NCT01799083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468035|NCT01799083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102468036|NCT01799083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102468037|NCT01799161|Theophylline|theophylline|mesh-list
102468038|NCT01799161|Vaccines|vaccines|mesh-list
102468039|NCT01799161|Immunologic Factors|immunologic factors|mesh-ancestor
102468040|NCT01799161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468041|NCT01799161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102468042|NCT01799161|Autonomic Agents|autonomic agents|mesh-ancestor
102468043|NCT01799161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102468044|NCT01799161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102468045|NCT01799161|Respiratory System Agents|respiratory system agents|mesh-ancestor
102468046|NCT01799161|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102468047|NCT01799161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102468048|NCT01799161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468049|NCT01799161|Vasodilator Agents|vasodilator agents|mesh-ancestor
102468050|NCT01799161|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102468051|NCT01799161|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102468052|NCT01799161|Purinergic Agents|purinergic agents|mesh-ancestor
102468053|NCT01799161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102468054|NCT00006110|Paclitaxel|paclitaxel|mesh-list
102468055|NCT00006110|Cyclophosphamide|cyclophosphamide|mesh-list
102468056|NCT00006110|Doxorubicin|doxorubicin|mesh-list
102468057|NCT00006110|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102468058|NCT00006110|Trastuzumab|trastuzumab|mesh-list
102468059|NCT00006110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101551709|NCT01281189|Pramipexole|pramipexole|mesh-list
102468060|NCT00006110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102468061|NCT00006110|Tubulin Modulators|tubulin modulators|mesh-ancestor
102468062|NCT00006110|Antimitotic Agents|antimitotic agents|mesh-ancestor
102468063|NCT00006110|Mitosis Modulators|mitosis modulators|mesh-ancestor
102468064|NCT00006110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468065|NCT00006110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102468066|NCT00006110|Immunologic Factors|immunologic factors|mesh-ancestor
102468067|NCT00006110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468068|NCT00006110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102468069|NCT00006110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102468070|NCT00006110|Alkylating Agents|alkylating agents|mesh-ancestor
102468071|NCT00006110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102468072|NCT00006110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102468073|NCT00006110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102468074|NCT00006110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102468075|NCT00006110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102468076|NCT00006110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102468077|NCT03591770|Vaccines|vaccines|mesh-list
102468078|NCT03591770|Immunologic Factors|immunologic factors|mesh-ancestor
102468079|NCT03591770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468080|NCT00692185|Olanzapine|olanzapine|mesh-list
102468081|NCT00692185|Antiemetics|antiemetics|mesh-ancestor
102468082|NCT00692185|Autonomic Agents|autonomic agents|mesh-ancestor
102468083|NCT00692185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102468084|NCT00692185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468085|NCT00692185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102468086|NCT00692185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102468087|NCT00692185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102468088|NCT00692185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102468089|NCT00692185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102468090|NCT00692185|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102468091|NCT00692185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102468092|NCT00692185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102468093|NCT00692185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468094|NCT00692185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102468095|NCT00692185|Serotonin Agents|serotonin agents|mesh-ancestor
102468096|NCT04270279|Nitroglycerin|nitroglycerin|mesh-list
102468097|NCT04270279|Vasodilator Agents|vasodilator agents|mesh-ancestor
102468098|NCT00692341|Axitinib|axitinib|mesh-list
102468099|NCT00692341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102468100|NCT00692341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102468101|NCT00692341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102468102|NCT00692341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468103|NCT03511976|Methylphenidate|methylphenidate|mesh-list
102468104|NCT03511976|Amphetamine|amphetamine|mesh-list
102468105|NCT03511976|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102468106|NCT03511976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468107|NCT03511976|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102468108|NCT03511976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102468109|NCT03511976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102468110|NCT03511976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468111|NCT03511976|Dopamine Agents|dopamine agents|mesh-ancestor
102468112|NCT03511976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102468113|NCT03511976|Sympathomimetics|sympathomimetics|mesh-ancestor
102468114|NCT03511976|Autonomic Agents|autonomic agents|mesh-ancestor
102468115|NCT03511976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102468116|NCT03511976|Adrenergic Agents|adrenergic agents|mesh-ancestor
102468117|NCT03511976|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102468118|NCT00694603|Cetuximab|cetuximab|mesh-list
102468119|NCT00694603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102468120|NCT00694603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102468121|NCT03582722|Orlistat|orlistat|mesh-list
102468122|NCT03582722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102468123|NCT03582722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468124|NCT03582722|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102468125|NCT03582722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102468126|NCT00590161|Pentoxifylline|pentoxifylline|mesh-list
102468127|NCT00590161|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102468128|NCT00590161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102468129|NCT00590161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468130|NCT00590161|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102468131|NCT00590161|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102468132|NCT00590161|Protective Agents|protective agents|mesh-ancestor
102468133|NCT00590161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468134|NCT00590161|Vasodilator Agents|vasodilator agents|mesh-ancestor
102468135|NCT00590161|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102468136|NCT00590161|Antioxidants|antioxidants|mesh-ancestor
102468137|NCT00590395|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102468138|NCT00590395|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
102468139|NCT00590395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468140|NCT00006170|Bupropion|bupropion|mesh-list
102468141|NCT00006170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102468142|NCT00006170|Antidepressive Agents|antidepressive agents|mesh-ancestor
102468143|NCT00006170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102468144|NCT00006170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102468145|NCT00006170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102468146|NCT00006170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102468147|NCT00006170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468148|NCT00006170|Dopamine Agents|dopamine agents|mesh-ancestor
102468149|NCT00006170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102468150|NCT00006170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468151|NCT00006170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102468152|NCT00006170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102468153|NCT00006170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102468154|NCT02123849|Aspirin|aspirin|mesh-list
102468155|NCT02123849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102468156|NCT02123849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102468157|NCT02123849|Analgesics|analgesics|mesh-ancestor
102468158|NCT02123849|Sensory System Agents|sensory system agents|mesh-ancestor
102468159|NCT02123849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102468160|NCT02123849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468161|NCT02123849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102468162|NCT02123849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102468163|NCT02123849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102468164|NCT02123849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102468165|NCT02123849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468166|NCT02123849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102468167|NCT02123849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102468168|NCT02123849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102468169|NCT02123849|Antipyretics|antipyretics|mesh-ancestor
102468170|NCT05347160|Calcium|calcium|mesh-list
102468171|NCT05347160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102468172|NCT05347160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468173|NCT00671528|Gentamicins|gentamicins|mesh-list
102468174|NCT00671528|Clotrimazole|clotrimazole|mesh-list
102468175|NCT00671528|Miconazole|miconazole|mesh-list
102468176|NCT00671528|Betamethasone|betamethasone|mesh-list
102468177|NCT00671528|Betamethasone Valerate|betamethasone valerate|mesh-list
102468178|NCT00671528|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102468179|NCT00671528|Betamethasone benzoate|betamethasone benzoate|mesh-list
102468180|NCT00671528|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102468181|NCT00671528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102468182|NCT00671528|Glucocorticoids|glucocorticoids|mesh-ancestor
102468183|NCT00671528|Hormones|hormones|mesh-ancestor
102468184|NCT00671528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102468185|NCT00671528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468186|NCT00671528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102468187|NCT00671528|Respiratory System Agents|respiratory system agents|mesh-ancestor
102468188|NCT00671528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102468189|NCT00671528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102279788|NCT04574479|Morphine|morphine|mesh-list
102468190|NCT00671528|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102468191|NCT00671528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102468192|NCT00671528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468193|NCT00671528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102468194|NCT00671528|Antifungal Agents|antifungal agents|mesh-ancestor
102468195|NCT00671528|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102468196|NCT00671528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102468197|NCT00671528|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102468198|NCT00671528|Hormone Antagonists|hormone antagonists|mesh-ancestor
102468199|NCT00671528|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102468200|NCT00671528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102468202|NCT00590863|Mirtazapine|mirtazapine|mesh-list
102468203|NCT00590863|Citalopram|citalopram|mesh-list
102468204|NCT00590863|Bupropion|bupropion|mesh-list
102468205|NCT00590863|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102468206|NCT00590863|Escitalopram|escitalopram|mesh-list
102468207|NCT00590863|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102468208|NCT00590863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102468209|NCT00590863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102468210|NCT00590863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468211|NCT00590863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102468212|NCT00590863|Serotonin Agents|serotonin agents|mesh-ancestor
102468213|NCT00590863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468214|NCT00590863|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102468215|NCT00590863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102468216|NCT00590863|Parasympatholytics|parasympatholytics|mesh-ancestor
102468217|NCT00590863|Autonomic Agents|autonomic agents|mesh-ancestor
102468218|NCT00590863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102468219|NCT00590863|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102468220|NCT00590863|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102468221|NCT00590863|Cholinergic Agents|cholinergic agents|mesh-ancestor
102468222|NCT00590863|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102468223|NCT00590863|Antidepressive Agents|antidepressive agents|mesh-ancestor
102468224|NCT00590863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102468225|NCT00590863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102468226|NCT00590863|Dopamine Agents|dopamine agents|mesh-ancestor
102468227|NCT00590863|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102468228|NCT00590863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102468229|NCT00590863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102468230|NCT00590863|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102468231|NCT00590863|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102468232|NCT00590863|Histamine Antagonists|histamine antagonists|mesh-ancestor
102468233|NCT00590863|Histamine Agents|histamine agents|mesh-ancestor
102468234|NCT00590863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102468235|NCT00590863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102468236|NCT00590863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102468237|NCT00590863|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102468238|NCT00590863|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102468239|NCT00590863|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102468240|NCT00590863|Adrenergic Agents|adrenergic agents|mesh-ancestor
102468241|NCT00590863|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102468242|NCT00590863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102468243|NCT00590863|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102468244|NCT00591019|Modafinil|modafinil|mesh-list
102468245|NCT00591019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102468246|NCT00591019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468247|NCT00591019|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102468248|NCT00591019|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102468249|NCT00591019|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102468250|NCT00591019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468251|NCT02996695|Artesunate|artesunate|mesh-list
102468252|NCT02996695|Chloroquine|chloroquine|mesh-list
102468253|NCT02996695|Antimalarials|antimalarials|mesh-ancestor
102468254|NCT02996695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102468255|NCT02996695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102468256|NCT02996695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102468257|NCT02996695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102468258|NCT02996695|Antiviral Agents|antiviral agents|mesh-ancestor
102468259|NCT02996695|Schistosomicides|schistosomicides|mesh-ancestor
101551909|NCT01012999|Sufentanil|sufentanil|mesh-list
102468260|NCT02996695|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102468261|NCT02996695|Anthelmintics|anthelmintics|mesh-ancestor
102468262|NCT02996695|Amebicides|amebicides|mesh-ancestor
102468263|NCT02996695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102468264|NCT00359138|Cetirizine|cetirizine|mesh-list
102468265|NCT00359138|Loratadine|loratadine|mesh-list
102468266|NCT00359138|Levocetirizine|levocetirizine|mesh-list
102468267|NCT00359138|Desloratadine|desloratadine|mesh-list
102468268|NCT00359138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102468269|NCT00359138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102468270|NCT00359138|Histamine Antagonists|histamine antagonists|mesh-ancestor
102468271|NCT00359138|Histamine Agents|histamine agents|mesh-ancestor
102468272|NCT00359138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102468273|NCT00359138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468274|NCT00359138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468275|NCT00359138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102468276|NCT00359138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102468277|NCT00359138|Cholinergic Agents|cholinergic agents|mesh-ancestor
102468278|NCT00359138|Antipruritics|antipruritics|mesh-ancestor
102468279|NCT00359138|Dermatologic Agents|dermatologic agents|mesh-ancestor
102468280|NCT05503979|Sofosbuvir|sofosbuvir|mesh-list
102468281|NCT05503979|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102468282|NCT05503979|Velpatasvir|velpatasvir|mesh-list
102468283|NCT05503979|Antiviral Agents|antiviral agents|mesh-ancestor
102468284|NCT05503979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102468285|NCT04703621|Daratumumab|daratumumab|mesh-list
102468286|NCT04703621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102468287|NCT02996227|Bupivacaine|bupivacaine|mesh-list
102468288|NCT02996227|Anesthetics, Local|anesthetics, local|mesh-ancestor
102468289|NCT02996227|Anesthetics|anesthetics|mesh-ancestor
102468290|NCT02996227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102468291|NCT02996227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468292|NCT02996227|Sensory System Agents|sensory system agents|mesh-ancestor
102468293|NCT02996227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102468294|NCT00698035|Methyltestosterone|methyltestosterone|mesh-list
102468295|NCT00698035|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102468296|NCT00698035|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102468297|NCT00698035|Testosterone|testosterone|mesh-list
102468298|NCT00698035|Testosterone undecanoate|testosterone undecanoate|mesh-list
102468299|NCT00698035|Testosterone enanthate|testosterone enanthate|mesh-list
102468300|NCT00698035|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102468301|NCT00698035|Estradiol|estradiol|mesh-list
102468302|NCT00698035|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102468303|NCT00698035|Androgens|androgens|mesh-ancestor
102468304|NCT00698035|Hormones|hormones|mesh-ancestor
102468305|NCT00698035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102468306|NCT00698035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468307|NCT00698035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102468308|NCT00698035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102468309|NCT00698035|Anabolic Agents|anabolic agents|mesh-ancestor
102468310|NCT00698035|Estrogens|estrogens|mesh-ancestor
102468311|NCT00698035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102468312|NCT00698035|Contraceptive Agents|contraceptive agents|mesh-ancestor
102468313|NCT00698035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102468314|NCT00698035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102468315|NCT02129075|Poly I-C|poly i-c|mesh-list
102468316|NCT02129075|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102468317|NCT02129075|Poly ICLC|poly iclc|mesh-list
102468318|NCT02129075|Flt3 ligand protein|flt3 ligand protein|mesh-list
102468319|NCT02129075|Interferon Inducers|interferon inducers|mesh-ancestor
102468320|NCT02129075|Immunologic Factors|immunologic factors|mesh-ancestor
102468321|NCT02129075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468322|NCT02129075|Laxatives|laxatives|mesh-ancestor
102468323|NCT02129075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102468324|NCT02129075|Antiviral Agents|antiviral agents|mesh-ancestor
102468325|NCT02129075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102468326|NCT02129075|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101551981|NCT00627991|Valsartan|valsartan|mesh-list
102468327|NCT02129075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102468328|NCT02129075|Protective Agents|protective agents|mesh-ancestor
102468329|NCT02775903|Azacitidine|azacitidine|mesh-list
102468330|NCT02775903|Durvalumab|durvalumab|mesh-list
102468331|NCT02775903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102468332|NCT02775903|Antimetabolites|antimetabolites|mesh-ancestor
102468333|NCT02775903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468334|NCT02775903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102468335|NCT02775903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102468336|NCT02775903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102468337|NCT01933425|Rocuronium|rocuronium|mesh-list
102468338|NCT01933425|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102468339|NCT01933425|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102468340|NCT01933425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102468341|NCT01933425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102468342|NCT01933425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468343|NCT04239599|Leuprolide|leuprolide|mesh-list
102468344|NCT04239599|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102468345|NCT04239599|Fertility Agents|fertility agents|mesh-ancestor
102468346|NCT04239599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102468347|NCT04239599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468348|NCT04239599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102468349|NCT04239599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102468350|NCT03487016|Paclitaxel|paclitaxel|mesh-list
102468351|NCT03487016|Gemcitabine|gemcitabine|mesh-list
102468352|NCT03487016|Oxaliplatin|oxaliplatin|mesh-list
102468353|NCT03487016|Irinotecan|irinotecan|mesh-list
102468354|NCT03487016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102468355|NCT03487016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102468356|NCT03487016|Tubulin Modulators|tubulin modulators|mesh-ancestor
102468357|NCT03487016|Antimitotic Agents|antimitotic agents|mesh-ancestor
102468358|NCT03487016|Mitosis Modulators|mitosis modulators|mesh-ancestor
102468359|NCT03487016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468360|NCT03487016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102468361|NCT03487016|Antimetabolites|antimetabolites|mesh-ancestor
102468362|NCT03487016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102468363|NCT03487016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102468364|NCT03487016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102468365|NCT05346926|Calpastatin|calpastatin|mesh-list
102468366|NCT05346926|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
102468367|NCT05346926|Protease Inhibitors|protease inhibitors|mesh-ancestor
102468368|NCT05346926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102468369|NCT05346926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468370|NCT05292209|Riluzole|riluzole|mesh-list
102468371|NCT05292209|Anticonvulsants|anticonvulsants|mesh-ancestor
102468372|NCT05292209|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102468373|NCT05292209|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102468374|NCT05292209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102468375|NCT05292209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468376|NCT05292209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468377|NCT05292209|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102468378|NCT05292209|Protective Agents|protective agents|mesh-ancestor
102468379|NCT03023319|Pemetrexed|pemetrexed|mesh-list
102468380|NCT03023319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102468381|NCT03023319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102468382|NCT03023319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468383|NCT03023319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102468384|NCT03023319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102468385|NCT02980653|Megestrol|megestrol|mesh-list
102468386|NCT02980653|Megestrol Acetate|megestrol acetate|mesh-list
102468387|NCT02980653|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102468388|NCT02980653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102468389|NCT02980653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102468390|NCT02980653|Contraceptive Agents|contraceptive agents|mesh-ancestor
102468391|NCT02980653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102468392|NCT02980653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468393|NCT02980653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102468394|NCT02980653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102468395|NCT02980653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102468396|NCT02980653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102468397|NCT02980653|Appetite Stimulants|appetite stimulants|mesh-ancestor
102468398|NCT02980653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102468399|NCT05265065|Vaccines|vaccines|mesh-list
102468400|NCT05265065|Immunologic Factors|immunologic factors|mesh-ancestor
102468401|NCT05265065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468402|NCT01677338|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
102468403|NCT01677338|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102468404|NCT01677338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468405|NCT03088280|Thymoglobulin|thymoglobulin|mesh-list
102468406|NCT03088280|Immunologic Factors|immunologic factors|mesh-ancestor
102468407|NCT03088280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468408|NCT03088280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102468409|NCT03087968|Prednisolone|prednisolone|mesh-list
102468410|NCT03087968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102468411|NCT03087968|Glucocorticoids|glucocorticoids|mesh-ancestor
102468412|NCT03087968|Hormones|hormones|mesh-ancestor
102468413|NCT03087968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102468414|NCT03087968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468415|NCT03087968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102468416|NCT03087968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102468417|NCT03845049|Aflibercept|aflibercept|mesh-list
102468418|NCT03845049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102468419|NCT03845049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102468420|NCT03845049|Growth Substances|growth substances|mesh-ancestor
102468421|NCT03845049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468422|NCT03845049|Growth Inhibitors|growth inhibitors|mesh-ancestor
102468423|NCT03845049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102468424|NCT03790839|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102468425|NCT03790839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102468426|NCT03790839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468427|NCT03790839|Incretins|incretins|mesh-ancestor
102468428|NCT03790839|Hormones|hormones|mesh-ancestor
102468429|NCT03790839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102468430|NCT03790839|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102468431|NCT03790839|Protease Inhibitors|protease inhibitors|mesh-ancestor
102468432|NCT03790839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102468433|NCT03790839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468434|NCT03088046|Progesterone|progesterone|mesh-list
102468435|NCT03088046|Progestins|progestins|mesh-ancestor
102468436|NCT03088046|Hormones|hormones|mesh-ancestor
102468437|NCT03088046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102468438|NCT03088046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468439|NCT01677884|Bevacizumab|bevacizumab|mesh-list
102468440|NCT01677884|Capecitabine|capecitabine|mesh-list
102468441|NCT01677884|Irinotecan|irinotecan|mesh-list
102468442|NCT01677884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102468443|NCT01677884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102468444|NCT01677884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102468445|NCT01677884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102468446|NCT01677884|Growth Substances|growth substances|mesh-ancestor
102468447|NCT01677884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468448|NCT01677884|Growth Inhibitors|growth inhibitors|mesh-ancestor
102468449|NCT01677884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102468450|NCT01677884|Antimetabolites|antimetabolites|mesh-ancestor
102468451|NCT01677884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468452|NCT01677884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102468453|NCT01677884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102468454|NCT01677884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102468455|NCT02124083|Vorinostat|vorinostat|mesh-list
102468456|NCT02124083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102468457|NCT02124083|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102468458|NCT02124083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102468459|NCT02124083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468460|NCT02405078|Deoxyglucose|deoxyglucose|mesh-list
102468461|NCT02405078|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102468462|NCT02405078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102468463|NCT02405078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468464|NCT02405078|Antimetabolites|antimetabolites|mesh-ancestor
102468465|NCT02405078|Antiviral Agents|antiviral agents|mesh-ancestor
102468466|NCT02405078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102468467|NCT00701389|Sumatriptan|sumatriptan|mesh-list
102468468|NCT00701389|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102468469|NCT00701389|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102468470|NCT00701389|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102468471|NCT00701389|Serotonin Agents|serotonin agents|mesh-ancestor
102468472|NCT00701389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102468473|NCT00701389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468474|NCT00701389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468475|NCT02336594|Verinurad|verinurad|mesh-list
102468476|NCT02336594|Gout Suppressants|gout suppressants|mesh-ancestor
102468477|NCT02336594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102468478|NCT01799317|Vitamin D|vitamin d|mesh-list
102468479|NCT01799317|Ergocalciferols|ergocalciferols|mesh-list
102468480|NCT01799317|Vitamins|vitamins|mesh-ancestor
102468481|NCT01799317|Micronutrients|micronutrients|mesh-ancestor
102468482|NCT01799317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468483|NCT01799317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102468484|NCT01799317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102468485|NCT03925025|Magnesium Sulfate|magnesium sulfate|mesh-list
102468486|NCT03925025|Nimodipine|nimodipine|mesh-list
102468487|NCT03925025|Analgesics|analgesics|mesh-ancestor
102468488|NCT03925025|Sensory System Agents|sensory system agents|mesh-ancestor
102468489|NCT03925025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102468490|NCT03925025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468491|NCT03925025|Anesthetics|anesthetics|mesh-ancestor
102468492|NCT03925025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102468493|NCT03925025|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102468494|NCT03925025|Anticonvulsants|anticonvulsants|mesh-ancestor
102468495|NCT03925025|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102468496|NCT03925025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102468497|NCT03925025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468498|NCT03925025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102468499|NCT03925025|Tocolytic Agents|tocolytic agents|mesh-ancestor
102468500|NCT03925025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102468501|NCT03925025|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102468502|NCT03925025|Vasodilator Agents|vasodilator agents|mesh-ancestor
102468503|NCT01677962|Poly ICLC|poly iclc|mesh-list
102468504|NCT01677962|Interferon Inducers|interferon inducers|mesh-ancestor
102468505|NCT01677962|Immunologic Factors|immunologic factors|mesh-ancestor
102468506|NCT01677962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468507|NCT00595153|Budesonide|budesonide|mesh-list
102468508|NCT00595153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102468509|NCT00595153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102468510|NCT00595153|Autonomic Agents|autonomic agents|mesh-ancestor
102468511|NCT00595153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102468512|NCT00595153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468513|NCT00595153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102468514|NCT00595153|Respiratory System Agents|respiratory system agents|mesh-ancestor
102468515|NCT00595153|Glucocorticoids|glucocorticoids|mesh-ancestor
102468516|NCT00595153|Hormones|hormones|mesh-ancestor
102468517|NCT00595153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102468518|NCT02995291|Phentolamine|phentolamine|mesh-list
102468519|NCT02995291|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102468520|NCT02995291|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102468521|NCT02995291|Adrenergic Agents|adrenergic agents|mesh-ancestor
102468522|NCT02995291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102468523|NCT02995291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468524|NCT02995291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468525|NCT02995291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102468526|NCT00595231|Rufinamide|rufinamide|mesh-list
102468527|NCT00595231|Anticonvulsants|anticonvulsants|mesh-ancestor
102468528|NCT00595231|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102468529|NCT00595231|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102468530|NCT00595231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102468531|NCT00595231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468532|NCT02995057|Nickel|nickel|mesh-list
102468533|NCT02995057|Trace Elements|trace elements|mesh-ancestor
102468534|NCT02995057|Micronutrients|micronutrients|mesh-ancestor
102468535|NCT02995057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468536|NCT02474173|Paclitaxel|paclitaxel|mesh-list
102468537|NCT02474173|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102468538|NCT02474173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102468539|NCT02474173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102468540|NCT02474173|Tubulin Modulators|tubulin modulators|mesh-ancestor
102468541|NCT02474173|Antimitotic Agents|antimitotic agents|mesh-ancestor
102468542|NCT02474173|Mitosis Modulators|mitosis modulators|mesh-ancestor
102468543|NCT02474173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468544|NCT03482102|Durvalumab|durvalumab|mesh-list
102468545|NCT03482102|Tremelimumab|tremelimumab|mesh-list
102468546|NCT03482102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102468547|NCT03482102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102468548|NCT02402270|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
102468549|NCT02402270|Laxatives|laxatives|mesh-ancestor
102468550|NCT02402270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102468551|NCT00701935|Exenatide|exenatide|mesh-list
102468552|NCT00701935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102468553|NCT00701935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468554|NCT00701935|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102468555|NCT00701935|Incretins|incretins|mesh-ancestor
102468556|NCT00701935|Hormones|hormones|mesh-ancestor
102468557|NCT00701935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102468558|NCT02984696|Estradiol|estradiol|mesh-list
102468559|NCT02984696|Estrogens|estrogens|mesh-ancestor
102468560|NCT02984696|Hormones|hormones|mesh-ancestor
102468561|NCT02984696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102468562|NCT02984696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468563|NCT03277313|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102468564|NCT03277313|Immunologic Factors|immunologic factors|mesh-ancestor
102468565|NCT03277313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468566|NCT00596167|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102468567|NCT00596167|Vancomycin|vancomycin|mesh-list
102468568|NCT00596167|Levofloxacin|levofloxacin|mesh-list
102468569|NCT00596167|Gentamicins|gentamicins|mesh-list
102468570|NCT00596167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102468571|NCT00596167|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102468572|NCT00596167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102468573|NCT00596167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102468574|NCT00596167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102468575|NCT00596167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468576|NCT00596167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102468577|NCT00596167|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102468578|NCT00596167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102468579|NCT00596167|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102468580|NCT03087032|Insulin Glargine|insulin glargine|mesh-list
102468581|NCT03087032|Liraglutide|liraglutide|mesh-list
102468582|NCT03087032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102468583|NCT03087032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468584|NCT03087032|Incretins|incretins|mesh-ancestor
102468585|NCT03087032|Hormones|hormones|mesh-ancestor
102468586|NCT03087032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102468587|NCT02994745|Atorvastatin|atorvastatin|mesh-list
102468588|NCT02994745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102468589|NCT02994745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102468590|NCT02994745|Antimetabolites|antimetabolites|mesh-ancestor
102468591|NCT02994745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468592|NCT02994745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102468593|NCT02994745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102468594|NCT02994745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102468595|NCT00703261|Atorvastatin|atorvastatin|mesh-list
102468596|NCT00703261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102468597|NCT00703261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102468598|NCT00703261|Antimetabolites|antimetabolites|mesh-ancestor
102468599|NCT00703261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468600|NCT00703261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102468601|NCT00703261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102468602|NCT00703261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102468603|NCT04912115|Midazolam|midazolam|mesh-list
102468604|NCT04912115|Ketamine|ketamine|mesh-list
102468605|NCT04912115|Analgesics|analgesics|mesh-ancestor
102468606|NCT04912115|Sensory System Agents|sensory system agents|mesh-ancestor
102468607|NCT04912115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102468608|NCT04912115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468609|NCT04912115|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102468610|NCT04912115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102468611|NCT04912115|Anesthetics, General|anesthetics, general|mesh-ancestor
102468612|NCT04912115|Anesthetics|anesthetics|mesh-ancestor
102468613|NCT04912115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102468614|NCT04912115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102468615|NCT04912115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102468616|NCT04912115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102468617|NCT04912115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468618|NCT04912115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102468619|NCT04912115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102468620|NCT04912115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102468621|NCT04912115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102468622|NCT04912115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102468623|NCT04912115|GABA Modulators|gaba modulators|mesh-ancestor
102468624|NCT04912115|GABA Agents|gaba agents|mesh-ancestor
102468625|NCT04346147|Imatinib Mesylate|imatinib mesylate|mesh-list
102468626|NCT04346147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102468627|NCT04346147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102468628|NCT04346147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102468629|NCT04346147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468630|NCT03478358|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
102468631|NCT03478358|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102468632|NCT03478358|(177)Lu-DOTA-EB-TATE|(177)lu-dota-eb-tate|mesh-list
102468633|NCT03478358|Chelating Agents|chelating agents|mesh-ancestor
102468634|NCT03478358|Sequestering Agents|sequestering agents|mesh-ancestor
102468635|NCT03478358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468636|NCT03478358|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102468637|NCT04200833|Golimumab|golimumab|mesh-list
102280230|NCT04023253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102468638|NCT04200833|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102468639|NCT04200833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102468640|NCT04200833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102468641|NCT04200833|Immunologic Factors|immunologic factors|mesh-ancestor
102468642|NCT04200833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468644|NCT01678352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102468645|NCT01678352|Immunologic Factors|immunologic factors|mesh-ancestor
102468646|NCT01678352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468647|NCT01678352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102468648|NCT01678352|Interferon Inducers|interferon inducers|mesh-ancestor
102468649|NCT01678430|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102468650|NCT01678430|Chlorambucil|chlorambucil|mesh-list
102468651|NCT01678430|Ofatumumab|ofatumumab|mesh-list
102468652|NCT01678430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102468653|NCT01678430|Alkylating Agents|alkylating agents|mesh-ancestor
102468654|NCT01678430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468655|NCT01678430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102468656|NCT01678664|Doxorubicin|doxorubicin|mesh-list
102468657|NCT01678664|Everolimus|everolimus|mesh-list
102468658|NCT01678664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102468659|NCT01678664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102468660|NCT01678664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102468661|NCT01678664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102468662|NCT01678664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102468663|NCT01678664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468664|NCT01678664|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102468665|NCT01678664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102468666|NCT01678664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102468667|NCT01678664|Immunologic Factors|immunologic factors|mesh-ancestor
102468668|NCT01678664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468669|NCT00597493|Temozolomide|temozolomide|mesh-list
102468670|NCT00597493|Sorafenib|sorafenib|mesh-list
102468671|NCT00597493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102468672|NCT00597493|Alkylating Agents|alkylating agents|mesh-ancestor
102468673|NCT00597493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468674|NCT00597493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102468675|NCT00597493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102468676|NCT00597493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102468677|NCT03086954|Immunomodulating Agents|immunomodulating agents|mesh-list
102468678|NCT03086954|Immunologic Factors|immunologic factors|mesh-ancestor
102468679|NCT03086954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468680|NCT03086720|Sodium Hypochlorite|sodium hypochlorite|mesh-list
102468681|NCT03086720|Eusol|eusol|mesh-list
102468682|NCT03086720|Disinfectants|disinfectants|mesh-ancestor
102468683|NCT03086720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102468684|NCT04402112|Pitavastatin|pitavastatin|mesh-list
102468685|NCT04402112|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102468686|NCT04402112|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102468687|NCT04402112|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102468688|NCT04402112|Antimetabolites|antimetabolites|mesh-ancestor
102468689|NCT04402112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468690|NCT04402112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102468691|NCT04402112|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102468692|NCT00597727|Glycerol|glycerol|mesh-list
102468693|NCT00597727|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102468694|NCT00597727|Protective Agents|protective agents|mesh-ancestor
102468695|NCT00597727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468696|NCT03474770|Huperzine A|huperzine a|mesh-list
102468697|NCT03474770|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102468698|NCT03474770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102468699|NCT03474770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468700|NCT03474770|Cholinergic Agents|cholinergic agents|mesh-ancestor
102468701|NCT03474770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102468702|NCT03474770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468703|NCT03474770|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102468704|NCT03474770|Protective Agents|protective agents|mesh-ancestor
102468705|NCT02998645|Cyclosporine|cyclosporine|mesh-list
102468706|NCT02998645|Cyclosporins|cyclosporins|mesh-list
102468707|NCT02998645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102468708|NCT02998645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468709|NCT02998645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102468710|NCT02998645|Immunologic Factors|immunologic factors|mesh-ancestor
102468711|NCT02998645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468712|NCT02998645|Antifungal Agents|antifungal agents|mesh-ancestor
102468713|NCT02998645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102468714|NCT02998645|Dermatologic Agents|dermatologic agents|mesh-ancestor
102468715|NCT02998645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102468716|NCT02998645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102468717|NCT03450122|Aldesleukin|aldesleukin|mesh-list
102468718|NCT03450122|Cyclophosphamide|cyclophosphamide|mesh-list
102468719|NCT03450122|Interleukin-2|interleukin-2|mesh-list
102468720|NCT03450122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102468721|NCT03450122|Immunologic Factors|immunologic factors|mesh-ancestor
102468722|NCT03450122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468723|NCT03450122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102468724|NCT03450122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102468725|NCT03450122|Alkylating Agents|alkylating agents|mesh-ancestor
102468726|NCT03450122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468727|NCT03450122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102468728|NCT03450122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102468729|NCT03450122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102468730|NCT03450122|Analgesics|analgesics|mesh-ancestor
102468731|NCT03450122|Sensory System Agents|sensory system agents|mesh-ancestor
102468732|NCT03450122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102468733|NCT03450122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102468734|NCT03450122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102468735|NCT03450122|Antiviral Agents|antiviral agents|mesh-ancestor
102468736|NCT03450122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102468737|NCT00707863|Escitalopram|escitalopram|mesh-list
102468738|NCT00707863|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102468739|NCT00707863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102468740|NCT00707863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102468741|NCT00707863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468742|NCT00707863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102468743|NCT00707863|Serotonin Agents|serotonin agents|mesh-ancestor
102468744|NCT00707863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468745|NCT00565643|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102468746|NCT00565643|Hyaluronic Acid|hyaluronic acid|mesh-list
102468747|NCT00565643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102468748|NCT00565643|Immunologic Factors|immunologic factors|mesh-ancestor
102468749|NCT00565643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468750|NCT00565643|Viscosupplements|viscosupplements|mesh-ancestor
102468751|NCT00565643|Protective Agents|protective agents|mesh-ancestor
102468752|NCT00565643|Laxatives|laxatives|mesh-ancestor
102468753|NCT00565643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102468754|NCT01798277|Amiodarone|amiodarone|mesh-list
102468755|NCT01798277|Sotalol|sotalol|mesh-list
102468756|NCT01798277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102468757|NCT01798277|Vasodilator Agents|vasodilator agents|mesh-ancestor
102468758|NCT01798277|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102468759|NCT01798277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102468760|NCT01798277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468761|NCT01798277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102468762|NCT01798277|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102468763|NCT01798277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102468764|NCT01798277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102468765|NCT01798277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102468766|NCT01798277|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102468767|NCT01798277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102468768|NCT01798277|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102468769|NCT01798277|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102468770|NCT01798277|Adrenergic Agents|adrenergic agents|mesh-ancestor
102468771|NCT01798277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102468772|NCT01798277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468773|NCT01798277|Sympatholytics|sympatholytics|mesh-ancestor
102468774|NCT01798277|Autonomic Agents|autonomic agents|mesh-ancestor
102468775|NCT01798277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102468776|NCT00598507|Sagopilone|sagopilone|mesh-list
102468777|NCT00598507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102468778|NCT00566813|Exenatide|exenatide|mesh-list
102468779|NCT00566813|Etanercept|etanercept|mesh-list
102468780|NCT00566813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102468781|NCT00566813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102468782|NCT00566813|Analgesics|analgesics|mesh-ancestor
102468783|NCT00566813|Sensory System Agents|sensory system agents|mesh-ancestor
102468784|NCT00566813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102468785|NCT00566813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468786|NCT00566813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102280401|NCT04910477|Atropine|atropine|mesh-list
102468787|NCT00566813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102468788|NCT00566813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102468789|NCT00566813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102468790|NCT00566813|Immunologic Factors|immunologic factors|mesh-ancestor
102468791|NCT00566813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102468792|NCT00566813|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102468794|NCT00566813|Hormones|hormones|mesh-ancestor
102468795|NCT00566813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102468796|NCT00088166|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
102468797|NCT00088166|Hormones|hormones|mesh-ancestor
102468798|NCT00088166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102468799|NCT00088166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468800|NCT00566969|Carvedilol|carvedilol|mesh-list
102468801|NCT00566969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102468802|NCT00566969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102468803|NCT00566969|Adrenergic Agents|adrenergic agents|mesh-ancestor
102468804|NCT00566969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102468805|NCT00566969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468806|NCT00566969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468807|NCT00566969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102468808|NCT00566969|Antioxidants|antioxidants|mesh-ancestor
102468809|NCT00566969|Protective Agents|protective agents|mesh-ancestor
102468810|NCT00566969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102468811|NCT00566969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102468812|NCT00566969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102468813|NCT00566969|Vasodilator Agents|vasodilator agents|mesh-ancestor
102468814|NCT00566969|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102468815|NCT00566969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102468816|NCT03086564|Chlorotrianisene|chlorotrianisene|mesh-list
102468817|NCT03086564|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102468818|NCT03086564|Estrogens|estrogens|mesh-ancestor
102468819|NCT03086564|Hormones|hormones|mesh-ancestor
102468820|NCT03086564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102468821|NCT03086564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468822|NCT03086564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102468823|NCT03086564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102468824|NCT00598663|Insulin|insulin|mesh-list
102468825|NCT00598663|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102468826|NCT00598663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102468827|NCT00598663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468828|NCT00704353|Ferric gluconate|ferric gluconate|mesh-list
102468829|NCT00704353|Iron-Dextran Complex|iron-dextran complex|mesh-list
102468830|NCT00704353|Hematinics|hematinics|mesh-ancestor
102468831|NCT00087698|Pemetrexed|pemetrexed|mesh-list
102468832|NCT00087698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102468833|NCT00087698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102468834|NCT00087698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468835|NCT00087698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102468836|NCT00087698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102468837|NCT03755739|Pembrolizumab|pembrolizumab|mesh-list
102468838|NCT03755739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102468839|NCT03755739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102468840|NCT03755739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102468841|NCT03755739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468842|NCT05245721|Nalbuphine|nalbuphine|mesh-list
102468843|NCT05245721|Bupivacaine|bupivacaine|mesh-list
102468844|NCT05245721|Anesthetics, Local|anesthetics, local|mesh-ancestor
102468845|NCT05245721|Anesthetics|anesthetics|mesh-ancestor
102468846|NCT05245721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102468847|NCT05245721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468848|NCT05245721|Sensory System Agents|sensory system agents|mesh-ancestor
102468849|NCT05245721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102468850|NCT05245721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102468851|NCT05245721|Narcotics|narcotics|mesh-ancestor
102468852|NCT05245721|Analgesics|analgesics|mesh-ancestor
102468853|NCT04402892|Lithium Carbonate|lithium carbonate|mesh-list
102468854|NCT04402892|Antidepressive Agents|antidepressive agents|mesh-ancestor
102468855|NCT04402892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102468856|NCT04402892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102468857|NCT04402892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468858|NCT04402892|Antimanic Agents|antimanic agents|mesh-ancestor
102468859|NCT04402892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102468860|NCT04402892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102468861|NCT04402892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468862|NCT03472586|Nivolumab|nivolumab|mesh-list
102468863|NCT03472586|Ipilimumab|ipilimumab|mesh-list
102468864|NCT03472586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102468865|NCT03472586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102468866|NCT03472586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102468867|NCT03472586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468868|NCT02987985|Acetaminophen|acetaminophen|mesh-list
102468869|NCT02987985|Dexamethasone|dexamethasone|mesh-list
102468870|NCT02987985|Lidocaine|lidocaine|mesh-list
102468871|NCT02987985|Fentanyl|fentanyl|mesh-list
102468872|NCT02987985|Dexmedetomidine|dexmedetomidine|mesh-list
102468873|NCT02987985|Ketamine|ketamine|mesh-list
102468874|NCT02987985|Gabapentin|gabapentin|mesh-list
102468875|NCT02987985|Analgesics, Opioid|analgesics, opioid|mesh-list
102468876|NCT02987985|Ondansetron|ondansetron|mesh-list
102468877|NCT02987985|Sevoflurane|sevoflurane|mesh-list
102468878|NCT02987985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102468879|NCT02987985|Antiemetics|antiemetics|mesh-ancestor
102468880|NCT02987985|Autonomic Agents|autonomic agents|mesh-ancestor
102468881|NCT02987985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102468882|NCT02987985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468883|NCT02987985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102468884|NCT02987985|Glucocorticoids|glucocorticoids|mesh-ancestor
102468885|NCT02987985|Hormones|hormones|mesh-ancestor
102468886|NCT02987985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102468887|NCT02987985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102468888|NCT02987985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102468889|NCT02987985|Anesthetics, Local|anesthetics, local|mesh-ancestor
102468890|NCT02987985|Anesthetics|anesthetics|mesh-ancestor
102468891|NCT02987985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102468892|NCT02987985|Sensory System Agents|sensory system agents|mesh-ancestor
102468893|NCT02987985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102468894|NCT02987985|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102468895|NCT02987985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102468896|NCT02987985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102468897|NCT02987985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468898|NCT02987985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102468899|NCT02987985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102468900|NCT02987985|Analgesics|analgesics|mesh-ancestor
102468901|NCT02987985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102468902|NCT02987985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102468903|NCT02987985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102468904|NCT02987985|Adrenergic Agents|adrenergic agents|mesh-ancestor
102468905|NCT02987985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102468906|NCT02987985|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102468907|NCT02987985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102468908|NCT02987985|Anesthetics, General|anesthetics, general|mesh-ancestor
102468909|NCT02987985|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102468910|NCT02987985|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102468911|NCT02987985|Narcotics|narcotics|mesh-ancestor
102468912|NCT02987985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102468913|NCT02987985|Antipyretics|antipyretics|mesh-ancestor
102468914|NCT02987985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102468915|NCT02987985|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102468916|NCT02987985|Anticonvulsants|anticonvulsants|mesh-ancestor
102468917|NCT02987985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102468918|NCT02987985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102468919|NCT02987985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102468920|NCT02987985|Antimanic Agents|antimanic agents|mesh-ancestor
102468921|NCT02987985|Antipruritics|antipruritics|mesh-ancestor
102468922|NCT02987985|Dermatologic Agents|dermatologic agents|mesh-ancestor
102468923|NCT02987985|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102468924|NCT02987985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102468925|NCT02987985|Serotonin Agents|serotonin agents|mesh-ancestor
102468926|NCT00708721|Clofarabine|clofarabine|mesh-list
102468927|NCT00708721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102468928|NCT00708721|Antimetabolites|antimetabolites|mesh-ancestor
102468929|NCT00708721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468930|NCT00708721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102468931|NCT00087152|Capecitabine|capecitabine|mesh-list
102468932|NCT00087152|Imatinib Mesylate|imatinib mesylate|mesh-list
102280531|NCT03520231|Calcium|calcium|mesh-list
102468933|NCT00087152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102468934|NCT00087152|Antimetabolites|antimetabolites|mesh-ancestor
102468935|NCT00087152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468936|NCT00087152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102468937|NCT00087152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102468938|NCT00087152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102468940|NCT05362799|Letrozole|letrozole|mesh-list
102468941|NCT05362799|Lactitol|lactitol|mesh-list
102468942|NCT05362799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102468943|NCT05362799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468944|NCT05362799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102468945|NCT05362799|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102468946|NCT05362799|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102468947|NCT05362799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102468948|NCT05362799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468949|NCT05362799|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102468950|NCT05362799|Hormone Antagonists|hormone antagonists|mesh-ancestor
102468951|NCT05362799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102468952|NCT05362799|Cathartics|cathartics|mesh-ancestor
102468953|NCT05362799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102468954|NCT01940523|Tranexamic Acid|tranexamic acid|mesh-list
102468955|NCT01940523|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102468956|NCT01940523|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102468957|NCT01940523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468958|NCT01940523|Hemostatics|hemostatics|mesh-ancestor
102468959|NCT01940523|Coagulants|coagulants|mesh-ancestor
102468960|NCT04403282|Eflornithine|eflornithine|mesh-list
102468961|NCT04403282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102468962|NCT04403282|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102468963|NCT04403282|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102468964|NCT04403282|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102468965|NCT04403282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102468966|NCT04403282|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
102468967|NCT04403282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102468968|NCT04403282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468969|NCT02994433|Nitrous Oxide|nitrous oxide|mesh-list
102468970|NCT02994433|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102468971|NCT02994433|Anesthetics, General|anesthetics, general|mesh-ancestor
102468972|NCT02994433|Anesthetics|anesthetics|mesh-ancestor
102468973|NCT02994433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102468974|NCT02994433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468975|NCT02994433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102468976|NCT02994433|Analgesics|analgesics|mesh-ancestor
102468977|NCT02994433|Sensory System Agents|sensory system agents|mesh-ancestor
102468978|NCT02994433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102468979|NCT04388189|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102468980|NCT04388189|Bupropion|bupropion|mesh-list
102468981|NCT04388189|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102468982|NCT04388189|Antidepressive Agents|antidepressive agents|mesh-ancestor
102468983|NCT04388189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102468984|NCT04388189|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102468985|NCT04388189|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102468986|NCT04388189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102468987|NCT04388189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102468988|NCT04388189|Dopamine Agents|dopamine agents|mesh-ancestor
102468989|NCT04388189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102468990|NCT04388189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102468991|NCT04388189|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102468992|NCT04388189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102468993|NCT04388189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102468994|NCT04388189|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102468995|NCT04388189|Analgesics|analgesics|mesh-ancestor
102468996|NCT04388189|Sensory System Agents|sensory system agents|mesh-ancestor
102468997|NCT04388189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102468998|NCT00599053|Azithromycin|azithromycin|mesh-list
102468999|NCT00599053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102469000|NCT00599053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102469001|NCT01941927|Trametinib|trametinib|mesh-list
102469002|NCT01941927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102469003|NCT01941927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102469004|NCT01941927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102469005|NCT01941927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469006|NCT05220917|Insulin|insulin|mesh-list
102469007|NCT05220917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102469008|NCT05220917|Metformin|metformin|mesh-list
102469009|NCT05220917|Insulin Glargine|insulin glargine|mesh-list
102469010|NCT05220917|Pioglitazone|pioglitazone|mesh-list
102469011|NCT05220917|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102469012|NCT05220917|Dapagliflozin|dapagliflozin|mesh-list
102469013|NCT05220917|Liraglutide|liraglutide|mesh-list
102469014|NCT05220917|Empagliflozin|empagliflozin|mesh-list
102469015|NCT05220917|Exenatide|exenatide|mesh-list
102469016|NCT05220917|Glimepiride|glimepiride|mesh-list
102469017|NCT05220917|Linagliptin|linagliptin|mesh-list
102469018|NCT05220917|Rosiglitazone|rosiglitazone|mesh-list
102469019|NCT05220917|Canagliflozin|canagliflozin|mesh-list
102469020|NCT05220917|Saxagliptin|saxagliptin|mesh-list
102469021|NCT05220917|Alogliptin|alogliptin|mesh-list
102469022|NCT05220917|Dulaglutide|dulaglutide|mesh-list
102469023|NCT05220917|Glyburide|glyburide|mesh-list
102469024|NCT05220917|Ertugliflozin|ertugliflozin|mesh-list
102469025|NCT05220917|Lixisenatide|lixisenatide|mesh-list
102469026|NCT05220917|Glipizide|glipizide|mesh-list
102469027|NCT05220917|Xultophy|xultophy|mesh-list
102469028|NCT05220917|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
102469029|NCT05220917|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102469030|NCT05220917|Simvastatin|simvastatin|mesh-list
102469031|NCT05220917|rGLP-1 protein|rglp-1 protein|mesh-list
102469032|NCT05220917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102469033|NCT05220917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469034|NCT05220917|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102469035|NCT05220917|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102469036|NCT05220917|Antimetabolites|antimetabolites|mesh-ancestor
102469037|NCT05220917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469038|NCT05220917|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102469039|NCT05220917|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102469040|NCT05220917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102469041|NCT05220917|Incretins|incretins|mesh-ancestor
102469042|NCT05220917|Hormones|hormones|mesh-ancestor
102469043|NCT05220917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102469044|NCT05220917|Protease Inhibitors|protease inhibitors|mesh-ancestor
102469045|NCT05220917|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102469046|NCT05220917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102469047|NCT05220917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102469048|NCT05220917|Immunologic Factors|immunologic factors|mesh-ancestor
102469049|NCT00086996|Fluorouracil|fluorouracil|mesh-list
102469050|NCT00086996|Oxaliplatin|oxaliplatin|mesh-list
102469051|NCT00086996|Antimetabolites|antimetabolites|mesh-ancestor
102469052|NCT00086996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469053|NCT00086996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102469054|NCT00086996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102469055|NCT00086996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102469056|NCT00086996|Immunologic Factors|immunologic factors|mesh-ancestor
102469057|NCT00086996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469058|NCT01943565|Hydromorphone|hydromorphone|mesh-list
102469059|NCT01943565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102469060|NCT01943565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469061|NCT01943565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102469062|NCT01943565|Narcotics|narcotics|mesh-ancestor
102469063|NCT01943565|Analgesics|analgesics|mesh-ancestor
102469064|NCT01943565|Sensory System Agents|sensory system agents|mesh-ancestor
102469065|NCT01943565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102469066|NCT03316859|Naloxegol|naloxegol|mesh-list
102469067|NCT03316859|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102469068|NCT03316859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469069|NCT03316859|Sensory System Agents|sensory system agents|mesh-ancestor
102469070|NCT03316859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102469071|NCT04401878|Lidocaine|lidocaine|mesh-list
102469072|NCT04401878|Anesthetics, Local|anesthetics, local|mesh-ancestor
102469073|NCT04401878|Anesthetics|anesthetics|mesh-ancestor
102469074|NCT04401878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102469075|NCT04401878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469076|NCT04401878|Sensory System Agents|sensory system agents|mesh-ancestor
102469077|NCT04401878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102469078|NCT04401878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102469079|NCT04401878|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102469080|NCT04401878|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102469081|NCT04401878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102469082|NCT04401878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469083|NCT05362019|Norethindrone|norethindrone|mesh-list
102469084|NCT05362019|Norethindrone enanthate|norethindrone enanthate|mesh-list
102469085|NCT05362019|Norethindrone Acetate|norethindrone acetate|mesh-list
102469086|NCT05362019|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102469087|NCT05362019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102469088|NCT05362019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102469089|NCT05362019|Contraceptive Agents|contraceptive agents|mesh-ancestor
102469090|NCT05362019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102469091|NCT05362019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469092|NCT05362019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102469093|NCT05362019|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102469094|NCT03654105|Aspirin|aspirin|mesh-list
102469095|NCT03654105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102469096|NCT03654105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102469097|NCT03654105|Analgesics|analgesics|mesh-ancestor
102469098|NCT03654105|Sensory System Agents|sensory system agents|mesh-ancestor
102469099|NCT03654105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102469100|NCT03654105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469101|NCT03654105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102469102|NCT03654105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102469103|NCT03654105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102469104|NCT03654105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102469105|NCT03654105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469106|NCT03654105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102469107|NCT03654105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102469108|NCT03654105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102469109|NCT03654105|Antipyretics|antipyretics|mesh-ancestor
102469110|NCT04388111|Morphine|morphine|mesh-list
102469111|NCT04388111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102469112|NCT04388111|Narcotics|narcotics|mesh-ancestor
102469113|NCT04388111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102469114|NCT04388111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469115|NCT04388111|Analgesics|analgesics|mesh-ancestor
102469116|NCT04388111|Sensory System Agents|sensory system agents|mesh-ancestor
102469117|NCT04388111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102469118|NCT03309137|Chlorhexidine|chlorhexidine|mesh-list
102469119|NCT03309137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102469120|NCT03309137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102469121|NCT03309137|Disinfectants|disinfectants|mesh-ancestor
102469122|NCT01881087|Levobupivacaine|levobupivacaine|mesh-list
102469123|NCT01881087|Anesthetics, Local|anesthetics, local|mesh-ancestor
102469124|NCT01881087|Anesthetics|anesthetics|mesh-ancestor
102469125|NCT01881087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102469126|NCT01881087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469127|NCT01881087|Sensory System Agents|sensory system agents|mesh-ancestor
102469128|NCT01881087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102469129|NCT01944423|Cycloserine|cycloserine|mesh-list
102469130|NCT01944423|Nicotine|nicotine|mesh-list
102469131|NCT01944423|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102469132|NCT01944423|Autonomic Agents|autonomic agents|mesh-ancestor
102469133|NCT01944423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102469134|NCT01944423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469135|NCT01944423|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102469136|NCT01944423|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102469137|NCT01944423|Cholinergic Agents|cholinergic agents|mesh-ancestor
102469138|NCT01944423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102469139|NCT01944423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469140|NCT01944423|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102469141|NCT01944423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102469142|NCT01944423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102469143|NCT01944423|Antitubercular Agents|antitubercular agents|mesh-ancestor
102469144|NCT01944423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102469145|NCT01944423|Antimetabolites|antimetabolites|mesh-ancestor
102469146|NCT05305313|Propofol|propofol|mesh-list
102469147|NCT05305313|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102469148|NCT05305313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102469149|NCT05305313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469150|NCT05305313|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102469151|NCT05305313|Anesthetics, General|anesthetics, general|mesh-ancestor
102469152|NCT05305313|Anesthetics|anesthetics|mesh-ancestor
102469153|NCT00600925|Gentamicins|gentamicins|mesh-list
102469154|NCT00600925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102469155|NCT00600925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102469156|NCT00600925|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102469157|NCT00600925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102469158|NCT00600925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469159|NCT02338973|Interferons|interferons|mesh-list
102469160|NCT02338973|Interferon-gamma|interferon-gamma|mesh-list
102469161|NCT02338973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102469162|NCT02338973|Antiviral Agents|antiviral agents|mesh-ancestor
102469163|NCT02338973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102469164|NCT00601627|Gemcitabine|gemcitabine|mesh-list
102469165|NCT00601627|Fluorouracil|fluorouracil|mesh-list
102469166|NCT00601627|Capecitabine|capecitabine|mesh-list
102469167|NCT00601627|Panitumumab|panitumumab|mesh-list
102469168|NCT00601627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102469169|NCT00601627|Antimetabolites|antimetabolites|mesh-ancestor
102469170|NCT00601627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469171|NCT00601627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102469172|NCT00601627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102469173|NCT00601627|Immunologic Factors|immunologic factors|mesh-ancestor
102469174|NCT00601627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469175|NCT00601627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102469177|NCT01947153|Linagliptin|linagliptin|mesh-list
102469178|NCT01947153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102469179|NCT01947153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469180|NCT01947153|Incretins|incretins|mesh-ancestor
102469181|NCT01947153|Hormones|hormones|mesh-ancestor
102469182|NCT01947153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102469183|NCT01947153|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102469184|NCT01947153|Protease Inhibitors|protease inhibitors|mesh-ancestor
102469185|NCT01947153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102469186|NCT01947153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469187|NCT02476409|Tolvaptan|tolvaptan|mesh-list
102469188|NCT02476409|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102469189|NCT02476409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469190|NCT02476409|Natriuretic Agents|natriuretic agents|mesh-ancestor
102469191|NCT02476409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469192|NCT01269853|Bevacizumab|bevacizumab|mesh-list
102469193|NCT01269853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102469194|NCT01269853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102469195|NCT01269853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102469196|NCT01269853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102469197|NCT01269853|Growth Substances|growth substances|mesh-ancestor
102469198|NCT01269853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469199|NCT01269853|Growth Inhibitors|growth inhibitors|mesh-ancestor
102469200|NCT02993575|Floxacillin|floxacillin|mesh-list
102469201|NCT02993575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102469202|NCT02993575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102469203|NCT00603187|Acyline|acyline|mesh-list
102469204|NCT00603187|Hormone Antagonists|hormone antagonists|mesh-ancestor
102469205|NCT00603187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102469206|NCT00603187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469207|NCT01886937|Phentermine|phentermine|mesh-list
102469208|NCT01886937|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102469209|NCT01886937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469210|NCT01886937|Appetite Depressants|appetite depressants|mesh-ancestor
102469211|NCT01886937|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102469212|NCT01886937|Sympathomimetics|sympathomimetics|mesh-ancestor
102469213|NCT01886937|Autonomic Agents|autonomic agents|mesh-ancestor
102469214|NCT01886937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102469215|NCT01886937|Adrenergic Agents|adrenergic agents|mesh-ancestor
102469216|NCT01886937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102469217|NCT01886937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469218|NCT02993341|Tranexamic Acid|tranexamic acid|mesh-list
102469219|NCT02993341|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102469220|NCT02993341|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102469221|NCT02993341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469222|NCT02993341|Hemostatics|hemostatics|mesh-ancestor
102469223|NCT02993341|Coagulants|coagulants|mesh-ancestor
102469224|NCT01219075|Phytoestrogens|phytoestrogens|mesh-list
102469225|NCT01219075|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102469226|NCT01219075|Estrogens|estrogens|mesh-ancestor
102469227|NCT01219075|Hormones|hormones|mesh-ancestor
102469228|NCT01219075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102469229|NCT01219075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469230|NCT00086684|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
102469231|NCT00086684|Anticoagulants|anticoagulants|mesh-ancestor
102469232|NCT02987907|Dexamethasone|dexamethasone|mesh-list
102469233|NCT02987907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102469234|NCT02987907|Antiemetics|antiemetics|mesh-ancestor
102469235|NCT02987907|Autonomic Agents|autonomic agents|mesh-ancestor
102469236|NCT02987907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102469237|NCT02987907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469238|NCT02987907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102280834|NCT04903847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102469239|NCT02987907|Glucocorticoids|glucocorticoids|mesh-ancestor
102469240|NCT02987907|Hormones|hormones|mesh-ancestor
102469241|NCT02987907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102469242|NCT02987907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102469243|NCT02987907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102469244|NCT01887171|Tacrolimus|tacrolimus|mesh-list
102469245|NCT01887171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102469246|NCT01887171|Immunologic Factors|immunologic factors|mesh-ancestor
102469247|NCT01887171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469248|NCT01887171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102469249|NCT01887171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102469250|NCT01887171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469251|NCT00713479|Varenicline|varenicline|mesh-list
102469252|NCT00713479|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102469253|NCT00713479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102469254|NCT00713479|Cholinergic Agents|cholinergic agents|mesh-ancestor
102469255|NCT00713479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102469256|NCT00713479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469257|NCT00713479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469258|NCT03467750|Ketorolac|ketorolac|mesh-list
102469259|NCT03467750|Morphine|morphine|mesh-list
102469260|NCT03467750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102469261|NCT03467750|Narcotics|narcotics|mesh-ancestor
102469262|NCT03467750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102469263|NCT03467750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469264|NCT03467750|Analgesics|analgesics|mesh-ancestor
102469265|NCT03467750|Sensory System Agents|sensory system agents|mesh-ancestor
102469266|NCT03467750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102469267|NCT03467750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102469268|NCT03467750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102469269|NCT03467750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102469270|NCT03467750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102469271|NCT03467750|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102469272|NCT03467750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102469273|NCT03467750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469274|NCT04402580|Mycophenolic Acid|mycophenolic acid|mesh-list
102469275|NCT04402580|Rituximab|rituximab|mesh-list
102469276|NCT04402580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102469277|NCT04402580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102469278|NCT04402580|Immunologic Factors|immunologic factors|mesh-ancestor
102469279|NCT04402580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469280|NCT04402580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102469281|NCT04402580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102469282|NCT04402580|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102469283|NCT04402580|Antitubercular Agents|antitubercular agents|mesh-ancestor
102469284|NCT04402580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102469285|NCT04402580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102469286|NCT04402580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102469287|NCT04402580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469288|NCT01887327|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
102469289|NCT01887327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102469290|NCT01887327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469291|NCT02987751|Insulin|insulin|mesh-list
102469292|NCT02987751|Insulin Glargine|insulin glargine|mesh-list
102469293|NCT02987751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102469294|NCT02987751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469295|NCT04385719|Remdesivir|remdesivir|mesh-list
102469296|NCT04385719|Antimetabolites|antimetabolites|mesh-ancestor
102469297|NCT04385719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469298|NCT04385719|Antiviral Agents|antiviral agents|mesh-ancestor
102469299|NCT04385719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102469300|NCT00082628|Hormones|hormones|mesh-list
102469301|NCT00082628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102469302|NCT00082628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469303|NCT01275859|Letrozole|letrozole|mesh-list
102469304|NCT01275859|Lapatinib|lapatinib|mesh-list
102469305|NCT01275859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102469306|NCT01275859|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102469307|NCT01275859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102469308|NCT01275859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102469309|NCT01275859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469310|NCT01275859|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102469311|NCT01275859|Hormone Antagonists|hormone antagonists|mesh-ancestor
102469312|NCT01275859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102469313|NCT01275859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469314|NCT01275859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102469315|NCT01950039|Betaine|betaine|mesh-list
102469316|NCT01950039|Glycine|glycine|mesh-list
102469317|NCT01950039|Glycine Agents|glycine agents|mesh-ancestor
102469318|NCT01950039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102469319|NCT01950039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469320|NCT01950039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469321|NCT01950039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102469322|NCT01950039|Lipotropic Agents|lipotropic agents|mesh-ancestor
102469323|NCT01950039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102469324|NCT01950039|Antimetabolites|antimetabolites|mesh-ancestor
102469325|NCT01950039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102469326|NCT01275937|Esomeprazole|esomeprazole|mesh-list
102469327|NCT01275937|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102469328|NCT01275937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102469329|NCT01275937|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102469330|NCT01275937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102469331|NCT01275937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469332|NCT02990455|Nicotine|nicotine|mesh-list
102469333|NCT02990455|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102469334|NCT02990455|Autonomic Agents|autonomic agents|mesh-ancestor
102469335|NCT02990455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102469336|NCT02990455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469337|NCT02990455|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102469338|NCT02990455|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102469339|NCT02990455|Cholinergic Agents|cholinergic agents|mesh-ancestor
102469340|NCT02990455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102469341|NCT02990455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469342|NCT01889667|Insulin|insulin|mesh-list
102469343|NCT01889667|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102469344|NCT01889667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102469345|NCT01889667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469346|NCT01276015|Botulinum Toxins|botulinum toxins|mesh-list
102469347|NCT01276015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102469348|NCT01276015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102469349|NCT01276015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102469350|NCT01276015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102469351|NCT01276015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469352|NCT01276015|Cholinergic Agents|cholinergic agents|mesh-ancestor
102469353|NCT01276015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102469354|NCT01276015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469355|NCT01276015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102469356|NCT01276015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102469357|NCT02130635|Nemiralisib|nemiralisib|mesh-list
102469358|NCT02130635|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102469359|NCT02130635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102469360|NCT02130635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469361|NCT01276093|Amiodarone|amiodarone|mesh-list
102469362|NCT01276093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102469363|NCT01276093|Vasodilator Agents|vasodilator agents|mesh-ancestor
102469364|NCT01276093|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102469365|NCT01276093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102469366|NCT01276093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469367|NCT01276093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102469368|NCT01276093|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102469369|NCT01276093|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102469370|NCT01276093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102469371|NCT01276093|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102469372|NCT01276093|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102469373|NCT01276093|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102469374|NCT00557973|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
102469375|NCT00557973|Baclofen|baclofen|mesh-list
102469376|NCT00557973|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102469377|NCT00557973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469378|NCT00557973|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102469379|NCT00557973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102469380|NCT00557973|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102469381|NCT00557973|GABA Agonists|gaba agonists|mesh-ancestor
102469382|NCT00557973|GABA Agents|gaba agents|mesh-ancestor
102469383|NCT00557973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102469384|NCT00557973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469385|NCT00726739|Aldesleukin|aldesleukin|mesh-list
102469386|NCT00726739|Interleukin-2|interleukin-2|mesh-list
102469387|NCT00726739|Vaccines|vaccines|mesh-list
102469388|NCT00726739|Immunologic Factors|immunologic factors|mesh-ancestor
102469389|NCT00726739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469390|NCT00726739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102469391|NCT00726739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102469392|NCT00726739|Analgesics|analgesics|mesh-ancestor
102469393|NCT00726739|Sensory System Agents|sensory system agents|mesh-ancestor
102469394|NCT00726739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102469395|NCT00726739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102469396|NCT00726739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102469397|NCT00726739|Antiviral Agents|antiviral agents|mesh-ancestor
102469398|NCT00726739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102469399|NCT00569309|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102469400|NCT00569309|Immunologic Factors|immunologic factors|mesh-ancestor
102469401|NCT00569309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469402|NCT00569855|Phenoxybenzamine|phenoxybenzamine|mesh-list
102469403|NCT00569855|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102469404|NCT00569855|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102469405|NCT00569855|Adrenergic Agents|adrenergic agents|mesh-ancestor
102469406|NCT00569855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102469407|NCT00569855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469408|NCT00569855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469409|NCT00569855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102469410|NCT00569855|Vasodilator Agents|vasodilator agents|mesh-ancestor
102469411|NCT02991781|Varenicline|varenicline|mesh-list
102469412|NCT02991781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102469413|NCT02991781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102469414|NCT02991781|Cholinergic Agents|cholinergic agents|mesh-ancestor
102469415|NCT02991781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102469416|NCT02991781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469417|NCT02991781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469418|NCT01893801|Paclitaxel|paclitaxel|mesh-list
102469419|NCT01893801|Cisplatin|cisplatin|mesh-list
102469420|NCT01893801|Gemcitabine|gemcitabine|mesh-list
102469421|NCT01893801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102469422|NCT01893801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102469423|NCT01893801|Tubulin Modulators|tubulin modulators|mesh-ancestor
102469424|NCT01893801|Antimitotic Agents|antimitotic agents|mesh-ancestor
102469425|NCT01893801|Mitosis Modulators|mitosis modulators|mesh-ancestor
102469426|NCT01893801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469427|NCT01893801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102469428|NCT01893801|Antimetabolites|antimetabolites|mesh-ancestor
102469429|NCT00570089|Ranolazine|ranolazine|mesh-list
102469430|NCT00570089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102469431|NCT00570089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102469432|NCT00570089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469433|NCT00727597|Efavirenz|efavirenz|mesh-list
102469434|NCT00727597|Fosamprenavir|fosamprenavir|mesh-list
102469435|NCT00727597|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102469436|NCT00727597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102469437|NCT00727597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102469438|NCT00727597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469439|NCT00727597|Antiviral Agents|antiviral agents|mesh-ancestor
102469440|NCT00727597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102469441|NCT00727597|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102469442|NCT00727597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102469443|NCT00727597|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102469444|NCT00727597|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102469445|NCT00727597|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102469446|NCT00727597|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102469447|NCT00727597|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102469448|NCT00727597|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102469449|NCT00727597|Protease Inhibitors|protease inhibitors|mesh-ancestor
102469450|NCT00727597|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102469451|NCT00727597|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102469452|NCT00571259|Gentamicins|gentamicins|mesh-list
102469453|NCT00571259|Heparin|heparin|mesh-list
102469454|NCT00571259|Citric Acid|citric acid|mesh-list
102469455|NCT00571259|Sodium Citrate|sodium citrate|mesh-list
102469456|NCT00571259|Anticoagulants|anticoagulants|mesh-ancestor
102469457|NCT00571259|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102469458|NCT00571259|Chelating Agents|chelating agents|mesh-ancestor
102469459|NCT00571259|Sequestering Agents|sequestering agents|mesh-ancestor
102469460|NCT00571259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281058|NCT02650921|Anesthetics|anesthetics|mesh-ancestor
102469461|NCT00571259|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102469462|NCT00571259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102469463|NCT00571259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102469464|NCT00571259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102469465|NCT00571259|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102469466|NCT00571259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102469467|NCT01893879|Ketoprofen|ketoprofen|mesh-list
102469468|NCT01893879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102469469|NCT01893879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102469470|NCT01893879|Analgesics|analgesics|mesh-ancestor
102469471|NCT01893879|Sensory System Agents|sensory system agents|mesh-ancestor
102469472|NCT01893879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102469473|NCT01893879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469474|NCT01893879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102469475|NCT01893879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102469476|NCT01893879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102469477|NCT01893879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102469478|NCT01893879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469479|NCT01894503|Mometasone Furoate|mometasone furoate|mesh-list
102469480|NCT01894503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102469481|NCT01894503|Dermatologic Agents|dermatologic agents|mesh-ancestor
102469482|NCT01894503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102469483|NCT00571493|Cytarabine|cytarabine|mesh-list
102469484|NCT00571493|Etoposide|etoposide|mesh-list
102469485|NCT00571493|Bortezomib|bortezomib|mesh-list
102469486|NCT00571493|Melphalan|melphalan|mesh-list
102469487|NCT00571493|Carmustine|carmustine|mesh-list
102469488|NCT00571493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102469489|NCT00571493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102469490|NCT00571493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102469491|NCT00571493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102469492|NCT00571493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102469493|NCT00571493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469494|NCT00571493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102469495|NCT00571493|Antimetabolites|antimetabolites|mesh-ancestor
102469496|NCT00571493|Antiviral Agents|antiviral agents|mesh-ancestor
102469497|NCT00571493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102469498|NCT00571493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102469499|NCT00571493|Immunologic Factors|immunologic factors|mesh-ancestor
102469500|NCT00571493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469501|NCT00571493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102469502|NCT00571493|Alkylating Agents|alkylating agents|mesh-ancestor
102469503|NCT00571493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102469504|NCT00571961|Ritonavir|ritonavir|mesh-list
102469505|NCT00571961|Lopinavir|lopinavir|mesh-list
102469506|NCT00571961|Buprenorphine|buprenorphine|mesh-list
102469507|NCT00571961|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102469508|NCT00571961|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102469509|NCT00571961|Protease Inhibitors|protease inhibitors|mesh-ancestor
102469510|NCT00571961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102469511|NCT00571961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469512|NCT00571961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102469513|NCT00571961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102469514|NCT00571961|Antiviral Agents|antiviral agents|mesh-ancestor
102469515|NCT00571961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102469516|NCT00571961|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102469517|NCT00571961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102469518|NCT00571961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102469519|NCT00571961|Narcotics|narcotics|mesh-ancestor
102469520|NCT00571961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102469521|NCT00571961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469522|NCT00571961|Analgesics|analgesics|mesh-ancestor
102469523|NCT00571961|Sensory System Agents|sensory system agents|mesh-ancestor
102469524|NCT00571961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102469525|NCT00571961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102469526|NCT00572117|Topiramate|topiramate|mesh-list
102469527|NCT00572117|Anticonvulsants|anticonvulsants|mesh-ancestor
102469528|NCT00572117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102469529|NCT00572117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469530|NCT01895127|Immunoglobulins|immunoglobulins|mesh-list
102469531|NCT01895127|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102469532|NCT01895127|Antibodies|antibodies|mesh-list
102469533|NCT01895127|Eculizumab|eculizumab|mesh-list
102469534|NCT01895127|Immunologic Factors|immunologic factors|mesh-ancestor
102469535|NCT01895127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469536|NCT01895127|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102469537|NCT01895127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102469538|NCT01953081|Metoclopramide|metoclopramide|mesh-list
102469539|NCT01953081|Antiemetics|antiemetics|mesh-ancestor
102469540|NCT01953081|Autonomic Agents|autonomic agents|mesh-ancestor
102469541|NCT01953081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102469542|NCT01953081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469543|NCT01953081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102469544|NCT01953081|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102469545|NCT01953081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102469546|NCT01953081|Dopamine Agents|dopamine agents|mesh-ancestor
102469547|NCT01953081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102469548|NCT01953081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469549|NCT00572897|Fludarabine|fludarabine|mesh-list
102469550|NCT00572897|Melphalan|melphalan|mesh-list
102469551|NCT00572897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102469552|NCT00572897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469553|NCT00572897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102469554|NCT00572897|Immunologic Factors|immunologic factors|mesh-ancestor
102469555|NCT00572897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469556|NCT00572897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102469557|NCT00572897|Alkylating Agents|alkylating agents|mesh-ancestor
102469558|NCT00572897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102469559|NCT01276717|Vorinostat|vorinostat|mesh-list
102469560|NCT01276717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102469561|NCT01276717|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102469562|NCT01276717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102469563|NCT01276717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469564|NCT02991157|Nimodipine|nimodipine|mesh-list
102469565|NCT02991157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102469566|NCT02991157|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102469567|NCT02991157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102469568|NCT02991157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469569|NCT02991157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102469570|NCT02991157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469571|NCT02991157|Vasodilator Agents|vasodilator agents|mesh-ancestor
102469572|NCT04386499|Folic Acid|folic acid|mesh-list
102469573|NCT04386499|Resveratrol|resveratrol|mesh-list
102469574|NCT04386499|Hematinics|hematinics|mesh-ancestor
102469575|NCT04386499|Vitamin B Complex|vitamin b complex|mesh-ancestor
102469576|NCT04386499|Vitamins|vitamins|mesh-ancestor
102469577|NCT04386499|Micronutrients|micronutrients|mesh-ancestor
102469578|NCT04386499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469579|NCT04386499|Antioxidants|antioxidants|mesh-ancestor
102469580|NCT04386499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469581|NCT04386499|Protective Agents|protective agents|mesh-ancestor
102469582|NCT04386499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102469583|NCT04386499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102469584|NCT00573287|Risperidone|risperidone|mesh-list
102469585|NCT00573287|Clozapine|clozapine|mesh-list
102469586|NCT00573287|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102469587|NCT00573287|Serotonin Agents|serotonin agents|mesh-ancestor
102469588|NCT00573287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102469589|NCT00573287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469590|NCT00573287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469591|NCT00573287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102469592|NCT00573287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102469593|NCT00573287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102469594|NCT00573287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102469595|NCT00573287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102469596|NCT00573287|Dopamine Agents|dopamine agents|mesh-ancestor
102469597|NCT00573287|GABA Antagonists|gaba antagonists|mesh-ancestor
102469598|NCT00573287|GABA Agents|gaba agents|mesh-ancestor
102469599|NCT01896921|Raltegravir Potassium|raltegravir potassium|mesh-list
102469600|NCT01896921|Dolutegravir|dolutegravir|mesh-list
102469601|NCT01896921|Maraviroc|maraviroc|mesh-list
102469602|NCT01896921|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102469603|NCT01896921|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102469604|NCT01896921|Antiviral Agents|antiviral agents|mesh-ancestor
102469605|NCT01896921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102469606|NCT01896921|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102469607|NCT01896921|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102469608|NCT01896921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102469609|NCT01896921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469610|NCT01896921|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102469611|NCT01896921|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102469612|NCT01896921|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102281211|NCT03050411|Apatinib|apatinib|mesh-list
102469614|NCT00749749|Anesthetics, Local|anesthetics, local|mesh-ancestor
102469615|NCT00749749|Anesthetics|anesthetics|mesh-ancestor
102469616|NCT00749749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102469617|NCT00749749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469618|NCT00749749|Sensory System Agents|sensory system agents|mesh-ancestor
102469619|NCT00749749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102469620|NCT02991937|Tazobactam|tazobactam|mesh-list
102469621|NCT02991937|Piperacillin|piperacillin|mesh-list
102469622|NCT02991937|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102469623|NCT02991937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102469624|NCT02991937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102469625|NCT02991937|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102469626|NCT02991937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102469627|NCT02991937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469628|NCT00420667|Enoxaparin|enoxaparin|mesh-list
102469629|NCT00420667|Anticoagulants|anticoagulants|mesh-ancestor
102469630|NCT00420667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102469631|NCT00420667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102469632|NCT00420667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469633|NCT01277107|Zaleplon|zaleplon|mesh-list
102469634|NCT01277107|Anticonvulsants|anticonvulsants|mesh-ancestor
102469635|NCT01277107|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102469636|NCT01277107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102469637|NCT01277107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469638|NCT01277107|GABA Modulators|gaba modulators|mesh-ancestor
102469639|NCT01277107|GABA Agents|gaba agents|mesh-ancestor
102469640|NCT01277107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102469641|NCT01277107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469642|NCT01277185|Calcium, Dietary|calcium, dietary|mesh-list
102469643|NCT01277185|Calcium|calcium|mesh-list
102469644|NCT01277185|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102469645|NCT01277185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469646|NCT01277185|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102469647|NCT01274533|Lenalidomide|lenalidomide|mesh-list
102469648|NCT01274533|Immunologic Factors|immunologic factors|mesh-ancestor
102469649|NCT01274533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469650|NCT01274533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102469651|NCT01274533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102469652|NCT01274533|Growth Substances|growth substances|mesh-ancestor
102469653|NCT01274533|Growth Inhibitors|growth inhibitors|mesh-ancestor
102469654|NCT01274533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102469655|NCT01277497|Calcium|calcium|mesh-list
102469656|NCT01277497|Sevelamer|sevelamer|mesh-list
102469657|NCT01277497|Calcium acetate|calcium acetate|mesh-list
102469658|NCT01277497|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102469659|NCT01277497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469660|NCT01277497|Chelating Agents|chelating agents|mesh-ancestor
102469661|NCT01277497|Sequestering Agents|sequestering agents|mesh-ancestor
102469662|NCT01277497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469663|NCT05735535|Antiviral Agents|antiviral agents|mesh-list
102469664|NCT05735535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102469665|NCT01270087|Adalimumab|adalimumab|mesh-list
102469666|NCT01270087|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102469667|NCT01270087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102469668|NCT01270087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102469669|NCT01958073|Estradiol|estradiol|mesh-list
102469670|NCT01958073|Estrogens|estrogens|mesh-list
102469671|NCT01958073|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
102469672|NCT01958073|Hormones|hormones|mesh-ancestor
102469673|NCT01958073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102469674|NCT01958073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469675|NCT01270165|Telbivudine|telbivudine|mesh-list
102469676|NCT01270165|Antiviral Agents|antiviral agents|mesh-ancestor
102469677|NCT01270165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102469678|NCT01270165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102469679|NCT01270165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102469680|NCT01270165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469681|NCT05740215|Lenvatinib|lenvatinib|mesh-list
102469682|NCT05740215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102469683|NCT05740215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102469684|NCT05740215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102469685|NCT05740215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469686|NCT01277731|Methylprednisolone|methylprednisolone|mesh-list
102469687|NCT01277731|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102469688|NCT01277731|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102469689|NCT01277731|Prednisolone|prednisolone|mesh-list
102469690|NCT01277731|Prednisolone acetate|prednisolone acetate|mesh-list
102469691|NCT01277731|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102469692|NCT01277731|Prednisolone phosphate|prednisolone phosphate|mesh-list
102469693|NCT01277731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102469694|NCT01277731|Antiemetics|antiemetics|mesh-ancestor
102469695|NCT01277731|Autonomic Agents|autonomic agents|mesh-ancestor
102469696|NCT01277731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102469697|NCT01277731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469698|NCT01277731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102469699|NCT01277731|Glucocorticoids|glucocorticoids|mesh-ancestor
102469700|NCT01277731|Hormones|hormones|mesh-ancestor
102469701|NCT01277731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102469702|NCT01277731|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102469703|NCT01277731|Protective Agents|protective agents|mesh-ancestor
102469704|NCT01277731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102469705|NCT01277731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102469706|NCT01898403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102469707|NCT05735379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
102469708|NCT05735379|Cholinergic Antagonists|cholinergic antagonists|mesh-list
102469709|NCT05735379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102469710|NCT05735379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469711|NCT05735379|Cholinergic Agents|cholinergic agents|mesh-ancestor
102469712|NCT05735379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102469713|NCT05735379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469714|NCT00751777|Vaccines|vaccines|mesh-list
102469715|NCT00751777|Immunologic Factors|immunologic factors|mesh-ancestor
102469716|NCT00751777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469717|NCT01902459|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102469718|NCT01902459|Hemostatics|hemostatics|mesh-ancestor
102469719|NCT01902459|Coagulants|coagulants|mesh-ancestor
102469720|NCT01274611|Botulinum Toxins|botulinum toxins|mesh-list
102469721|NCT01274611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102469722|NCT01274611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102469723|NCT01274611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102469724|NCT01274611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102469725|NCT01274611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469726|NCT01274611|Cholinergic Agents|cholinergic agents|mesh-ancestor
102469727|NCT01274611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102469728|NCT01274611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469729|NCT01274611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102469730|NCT01274611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102469731|NCT05735145|Paclitaxel|paclitaxel|mesh-list
102469732|NCT05735145|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102469733|NCT05735145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102469734|NCT05735145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102469735|NCT05735145|Tubulin Modulators|tubulin modulators|mesh-ancestor
102469736|NCT05735145|Antimitotic Agents|antimitotic agents|mesh-ancestor
102469737|NCT05735145|Mitosis Modulators|mitosis modulators|mesh-ancestor
102469738|NCT05735145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469739|NCT01903005|Buprenorphine|buprenorphine|mesh-list
102469740|NCT01903005|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102469741|NCT01903005|Naloxone|naloxone|mesh-list
102469742|NCT01903005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102469743|NCT01903005|Narcotics|narcotics|mesh-ancestor
102469744|NCT01903005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102469745|NCT01903005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469746|NCT01903005|Analgesics|analgesics|mesh-ancestor
102469747|NCT01903005|Sensory System Agents|sensory system agents|mesh-ancestor
102469748|NCT01903005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102469749|NCT01903005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102469750|NCT00614029|Sumatriptan|sumatriptan|mesh-list
102469751|NCT00614029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102469752|NCT00614029|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102469753|NCT00614029|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102469754|NCT00614029|Serotonin Agents|serotonin agents|mesh-ancestor
102469755|NCT00614029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102469756|NCT00614029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469757|NCT00614029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469758|NCT01905423|Albendazole|albendazole|mesh-list
102469759|NCT01905423|Diethylcarbamazine|diethylcarbamazine|mesh-list
102469760|NCT01905423|Piperazine|piperazine|mesh-list
102469761|NCT01905423|Mebendazole|mebendazole|mesh-list
102469762|NCT01905423|Piperazine citrate|piperazine citrate|mesh-list
102469763|NCT01905423|Citric Acid|citric acid|mesh-list
102469764|NCT01905423|Sodium Citrate|sodium citrate|mesh-list
102469765|NCT01905423|DMP 777|dmp 777|mesh-list
102469766|NCT01905423|Anticoagulants|anticoagulants|mesh-ancestor
102469767|NCT01905423|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102469768|NCT01905423|Chelating Agents|chelating agents|mesh-ancestor
102469769|NCT01905423|Sequestering Agents|sequestering agents|mesh-ancestor
102469770|NCT01905423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469771|NCT01905423|Anthelmintics|anthelmintics|mesh-ancestor
102469772|NCT01905423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102469773|NCT01905423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102469774|NCT01905423|Anticestodal Agents|anticestodal agents|mesh-ancestor
102469775|NCT01905423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102469776|NCT01905423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102469777|NCT01905423|Tubulin Modulators|tubulin modulators|mesh-ancestor
102469778|NCT01905423|Antimitotic Agents|antimitotic agents|mesh-ancestor
102469779|NCT01905423|Mitosis Modulators|mitosis modulators|mesh-ancestor
102469780|NCT01905423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102469781|NCT01905423|Filaricides|filaricides|mesh-ancestor
102469782|NCT01905423|Antinematodal Agents|antinematodal agents|mesh-ancestor
102469783|NCT01905423|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
102469784|NCT01905423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102469785|NCT05734911|Niraparib|niraparib|mesh-list
102469786|NCT05734911|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102469787|NCT05734911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102469788|NCT05734911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469789|NCT05734911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102469790|NCT01906515|Chrysarobin|chrysarobin|mesh-list
102469791|NCT01906515|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102469792|NCT01906515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102469793|NCT01906515|Analgesics|analgesics|mesh-ancestor
102469794|NCT01906515|Sensory System Agents|sensory system agents|mesh-ancestor
102469795|NCT01906515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102469796|NCT01906515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469797|NCT01906515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102469798|NCT01906515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102469799|NCT00730483|Doxorubicin|doxorubicin|mesh-list
102469800|NCT00730483|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102469801|NCT00730483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102469802|NCT00730483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102469803|NCT00730483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102469804|NCT00730483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102469805|NCT00730483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102469806|NCT00730483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469807|NCT01907607|Palbociclib|palbociclib|mesh-list
102469808|NCT01907607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102469809|NCT01907607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102469810|NCT01907607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102469811|NCT01907607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469813|NCT00753337|Trace Elements|trace elements|mesh-ancestor
102469814|NCT00753337|Micronutrients|micronutrients|mesh-ancestor
102469815|NCT00753337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469816|NCT01911351|Nitrous Oxide|nitrous oxide|mesh-list
102469817|NCT01911351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102469818|NCT01911351|Anesthetics, General|anesthetics, general|mesh-ancestor
102469819|NCT01911351|Anesthetics|anesthetics|mesh-ancestor
102469820|NCT01911351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102469821|NCT01911351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469822|NCT01911351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102469823|NCT01911351|Analgesics|analgesics|mesh-ancestor
102469824|NCT01911351|Sensory System Agents|sensory system agents|mesh-ancestor
102469825|NCT01911351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102469826|NCT04385407|Ribavirin|ribavirin|mesh-list
102469827|NCT04385407|Sofosbuvir|sofosbuvir|mesh-list
102469828|NCT04385407|Simeprevir|simeprevir|mesh-list
102469829|NCT04385407|Antimetabolites|antimetabolites|mesh-ancestor
102469830|NCT04385407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469831|NCT04385407|Antiviral Agents|antiviral agents|mesh-ancestor
102469832|NCT04385407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102469833|NCT04385407|Protease Inhibitors|protease inhibitors|mesh-ancestor
102469834|NCT04385407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102469835|NCT00573989|Pemetrexed|pemetrexed|mesh-list
102469836|NCT00573989|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102469837|NCT00573989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102469838|NCT00573989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102469839|NCT00573989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469840|NCT00573989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102469841|NCT00573989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102469842|NCT00573989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102469843|NCT02286921|Methyltestosterone|methyltestosterone|mesh-list
102469844|NCT02286921|Testosterone|testosterone|mesh-list
102469845|NCT02286921|Testosterone undecanoate|testosterone undecanoate|mesh-list
102469846|NCT02286921|Testosterone enanthate|testosterone enanthate|mesh-list
102469847|NCT02286921|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102469848|NCT02286921|Androgens|androgens|mesh-ancestor
102469849|NCT02286921|Hormones|hormones|mesh-ancestor
102469850|NCT02286921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102469851|NCT02286921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469852|NCT02286921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102469853|NCT02286921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102469854|NCT02286921|Anabolic Agents|anabolic agents|mesh-ancestor
102469855|NCT00574067|Buprenorphine|buprenorphine|mesh-list
102469856|NCT00574067|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102469857|NCT00574067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102469858|NCT00574067|Narcotics|narcotics|mesh-ancestor
102469859|NCT00574067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102469860|NCT00574067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469861|NCT00574067|Analgesics|analgesics|mesh-ancestor
102469862|NCT00574067|Sensory System Agents|sensory system agents|mesh-ancestor
102469863|NCT00574067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102469864|NCT00574067|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102469865|NCT05734443|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102469866|NCT05734443|Luteolytic Agents|luteolytic agents|mesh-ancestor
102469867|NCT05734443|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102469868|NCT05734443|Contraceptive Agents|contraceptive agents|mesh-ancestor
102469869|NCT05734443|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102469870|NCT05734443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469871|NCT05734443|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102469872|NCT05734443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102469873|NCT05734443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102469874|NCT01913535|Aticaprant|aticaprant|mesh-list
102469875|NCT01913535|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102469876|NCT01913535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469877|NCT01913535|Sensory System Agents|sensory system agents|mesh-ancestor
102469878|NCT01913535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102469879|NCT01914159|Ranibizumab|ranibizumab|mesh-list
102469880|NCT01914159|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102469881|NCT01914159|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102469882|NCT01914159|Growth Substances|growth substances|mesh-ancestor
102469883|NCT01914159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469884|NCT01914159|Growth Inhibitors|growth inhibitors|mesh-ancestor
102469885|NCT01914159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102469886|NCT00576251|Tobramycin|tobramycin|mesh-list
102469887|NCT00576251|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
102469888|NCT00576251|Dexamethasone|dexamethasone|mesh-list
102469889|NCT00576251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102469890|NCT00576251|Antiemetics|antiemetics|mesh-ancestor
102469891|NCT00576251|Autonomic Agents|autonomic agents|mesh-ancestor
102469892|NCT00576251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102469893|NCT00576251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469894|NCT00576251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102469895|NCT00576251|Glucocorticoids|glucocorticoids|mesh-ancestor
102469896|NCT00576251|Hormones|hormones|mesh-ancestor
102469897|NCT00576251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102469898|NCT00576251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102469899|NCT00576251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102469900|NCT00576251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102469901|NCT00576251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102469902|NCT00576251|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102469903|NCT00576251|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102469904|NCT00578279|Ethanol|ethanol|mesh-list
102469905|NCT00578279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102469906|NCT00578279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102469907|NCT00578279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102469908|NCT00578279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469909|NCT00578669|Fluoxetine|fluoxetine|mesh-list
102469910|NCT00578669|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102469911|NCT00578669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102469912|NCT00578669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102469913|NCT00578669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469914|NCT00578669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102469915|NCT00578669|Serotonin Agents|serotonin agents|mesh-ancestor
102469916|NCT00578669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469917|NCT00578669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102469918|NCT00578669|Antidepressive Agents|antidepressive agents|mesh-ancestor
102469919|NCT00578669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102469920|NCT00578669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102469921|NCT00578669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102469922|NCT00578669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102469923|NCT00578903|Cyclophosphamide|cyclophosphamide|mesh-list
102469924|NCT00578903|Methotrexate|methotrexate|mesh-list
102469925|NCT00578903|Alemtuzumab|alemtuzumab|mesh-list
102469926|NCT00578903|Tacrolimus|tacrolimus|mesh-list
102469927|NCT00578903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102469928|NCT00578903|Immunologic Factors|immunologic factors|mesh-ancestor
102469929|NCT00578903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469930|NCT00578903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102469931|NCT00578903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102469932|NCT00578903|Alkylating Agents|alkylating agents|mesh-ancestor
102469933|NCT00578903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469934|NCT00578903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102469935|NCT00578903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102469936|NCT00578903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102469937|NCT00578903|Abortifacient Agents|abortifacient agents|mesh-ancestor
102469938|NCT00578903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102469939|NCT00578903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102469940|NCT00578903|Antimetabolites|antimetabolites|mesh-ancestor
102469941|NCT00578903|Dermatologic Agents|dermatologic agents|mesh-ancestor
102469942|NCT00578903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102469943|NCT00578903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102469944|NCT00578903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102469945|NCT00578903|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102469946|NCT00578903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102469947|NCT01918761|Pemetrexed|pemetrexed|mesh-list
102469948|NCT01918761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102469949|NCT01918761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102469950|NCT01918761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469951|NCT01918761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102469952|NCT01918761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102469953|NCT00579137|Fludarabine|fludarabine|mesh-list
102469954|NCT00579137|Alemtuzumab|alemtuzumab|mesh-list
102469955|NCT00579137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102469956|NCT00579137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102469957|NCT00580073|Leucovorin|leucovorin|mesh-list
102469958|NCT00580073|Fluorouracil|fluorouracil|mesh-list
102469959|NCT00580073|Oxaliplatin|oxaliplatin|mesh-list
102469960|NCT00580073|Cetuximab|cetuximab|mesh-list
102469961|NCT00580073|Antimetabolites|antimetabolites|mesh-ancestor
102469962|NCT00580073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469963|NCT00580073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102469964|NCT00580073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102469965|NCT00580073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102469966|NCT00580073|Immunologic Factors|immunologic factors|mesh-ancestor
102469967|NCT00580073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469968|NCT00580073|Antidotes|antidotes|mesh-ancestor
102469969|NCT00580073|Protective Agents|protective agents|mesh-ancestor
102469970|NCT00580073|Vitamin B Complex|vitamin b complex|mesh-ancestor
102469971|NCT00580073|Vitamins|vitamins|mesh-ancestor
102469972|NCT00580073|Micronutrients|micronutrients|mesh-ancestor
102469973|NCT00580073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102469974|NCT00580151|Clonidine|clonidine|mesh-list
102469975|NCT00580151|Analgesics|analgesics|mesh-ancestor
102469976|NCT00580151|Sensory System Agents|sensory system agents|mesh-ancestor
102469977|NCT00580151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102469978|NCT00580151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469979|NCT00580151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102469980|NCT00580151|Sympatholytics|sympatholytics|mesh-ancestor
102469981|NCT00580151|Autonomic Agents|autonomic agents|mesh-ancestor
102469982|NCT00580151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102469983|NCT00580151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102469984|NCT00580151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102469985|NCT00580151|Adrenergic Agents|adrenergic agents|mesh-ancestor
102469986|NCT00580151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102469987|NCT00580151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469988|NCT01919697|Plecanatide|plecanatide|mesh-list
102469989|NCT01919697|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102469990|NCT01919697|Enzyme Activators|enzyme activators|mesh-ancestor
102469991|NCT01919697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102469992|NCT01919697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102469993|NCT00580229|Prednisone|prednisone|mesh-list
102469994|NCT00580229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102469995|NCT00580229|Glucocorticoids|glucocorticoids|mesh-ancestor
102469996|NCT00580229|Hormones|hormones|mesh-ancestor
102469997|NCT00580229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102469998|NCT00580229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102469999|NCT00580229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102470000|NCT00580229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102470001|NCT00580853|Bupropion|bupropion|mesh-list
102470002|NCT00580853|Varenicline|varenicline|mesh-list
102470003|NCT00580853|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102470004|NCT00580853|Antidepressive Agents|antidepressive agents|mesh-ancestor
102470005|NCT00580853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102470006|NCT00580853|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102470007|NCT00580853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102470008|NCT00580853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102470009|NCT00580853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470010|NCT00580853|Dopamine Agents|dopamine agents|mesh-ancestor
102470011|NCT00580853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102470012|NCT00580853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470013|NCT00580853|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102470014|NCT00580853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102470015|NCT00580853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102470016|NCT00580853|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102470017|NCT00580853|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102470018|NCT00580853|Cholinergic Agents|cholinergic agents|mesh-ancestor
102470019|NCT05739045|Nivolumab|nivolumab|mesh-list
102470020|NCT05739045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102470021|NCT05739045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102470022|NCT05739045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102470023|NCT05739045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470024|NCT00604019|Dopamine|dopamine|mesh-list
102470025|NCT00604019|Norepinephrine|norepinephrine|mesh-list
102470026|NCT00604019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102470027|NCT00604019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102470028|NCT00604019|Adrenergic Agents|adrenergic agents|mesh-ancestor
102470029|NCT00604019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102470030|NCT00604019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470031|NCT00604019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470032|NCT00604019|Sympathomimetics|sympathomimetics|mesh-ancestor
102470033|NCT00604019|Autonomic Agents|autonomic agents|mesh-ancestor
102470034|NCT00604019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102470035|NCT00604019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102470036|NCT00604019|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102470037|NCT00604019|Dopamine Agents|dopamine agents|mesh-ancestor
102470038|NCT00604019|Protective Agents|protective agents|mesh-ancestor
102470039|NCT01922115|Trospium chloride|trospium chloride|mesh-list
102470040|NCT01922115|Parasympatholytics|parasympatholytics|mesh-ancestor
102470041|NCT01922115|Autonomic Agents|autonomic agents|mesh-ancestor
102470042|NCT01922115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102470043|NCT01922115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470044|NCT01922115|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102470045|NCT01922115|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102470046|NCT01922115|Cholinergic Agents|cholinergic agents|mesh-ancestor
102470047|NCT01922115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102470048|NCT01922115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470049|NCT01922115|Urological Agents|urological agents|mesh-ancestor
102470050|NCT00081770|Ribavirin|ribavirin|mesh-list
102470051|NCT00081770|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102470052|NCT00081770|Interferon-alpha|interferon-alpha|mesh-list
102470053|NCT00081770|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102470054|NCT00081770|Antimetabolites|antimetabolites|mesh-ancestor
102470055|NCT00081770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470056|NCT00081770|Antiviral Agents|antiviral agents|mesh-ancestor
102470057|NCT00081770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102470058|NCT00081770|Immunologic Factors|immunologic factors|mesh-ancestor
102470059|NCT00081770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470060|NCT05731323|Cycloserine|cycloserine|mesh-list
102470061|NCT05731323|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102470062|NCT05731323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102470063|NCT05731323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102281685|NCT04969237|Vitamin D|vitamin d|mesh-list
102470064|NCT05731323|Antitubercular Agents|antitubercular agents|mesh-ancestor
102470065|NCT05731323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102470066|NCT05731323|Antimetabolites|antimetabolites|mesh-ancestor
102470067|NCT05731323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470068|NCT00605423|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
102470069|NCT00605423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102470070|NCT00605423|Glucocorticoids|glucocorticoids|mesh-ancestor
102470071|NCT00605423|Hormones|hormones|mesh-ancestor
102470072|NCT00605423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102470073|NCT00605423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470074|NCT01923129|Prazosin|prazosin|mesh-list
102470075|NCT01923129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102470076|NCT01923129|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102470077|NCT01923129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102470078|NCT01923129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102470079|NCT01923129|Adrenergic Agents|adrenergic agents|mesh-ancestor
102470080|NCT01923129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102470081|NCT01923129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470082|NCT01923129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470083|NCT00581867|Insulin|insulin|mesh-list
102470084|NCT00581867|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102470085|NCT00581867|Insulin Aspart|insulin aspart|mesh-list
102470086|NCT00581867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102470087|NCT00581867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470088|NCT01925469|Benzocaine|benzocaine|mesh-list
102470089|NCT01925469|Anesthetics, Local|anesthetics, local|mesh-ancestor
102470090|NCT01925469|Anesthetics|anesthetics|mesh-ancestor
102470091|NCT01925469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102470092|NCT01925469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470093|NCT01925469|Sensory System Agents|sensory system agents|mesh-ancestor
102470094|NCT01925469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102470095|NCT01925781|Nicotine|nicotine|mesh-list
102470096|NCT01925781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102470097|NCT01925781|Autonomic Agents|autonomic agents|mesh-ancestor
102470098|NCT01925781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102470099|NCT01925781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470100|NCT01925781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102470101|NCT01925781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102470102|NCT01925781|Cholinergic Agents|cholinergic agents|mesh-ancestor
102470103|NCT01925781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102470104|NCT01925781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470105|NCT01927887|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102470106|NCT01927887|Hematinics|hematinics|mesh-ancestor
102470107|NCT01927887|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102470108|NCT01927887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102470109|NCT00081458|Teduglutide|teduglutide|mesh-list
102470110|NCT00081458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102470111|NCT00081458|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102470112|NCT00081458|Protective Agents|protective agents|mesh-ancestor
102470113|NCT00081458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470114|NCT00610727|Prochlorperazine|prochlorperazine|mesh-list
102470115|NCT00610727|Antiemetics|antiemetics|mesh-ancestor
102470116|NCT00610727|Autonomic Agents|autonomic agents|mesh-ancestor
102470117|NCT00610727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102470118|NCT00610727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470119|NCT00610727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102470120|NCT00610727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102470121|NCT00610727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102470122|NCT00610727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102470123|NCT00610727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102470124|NCT00610727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102470125|NCT00610727|Dopamine Agents|dopamine agents|mesh-ancestor
102470126|NCT00610727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102470127|NCT00610727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470128|NCT01929291|Vaccines|vaccines|mesh-list
102470129|NCT01929291|Immunologic Factors|immunologic factors|mesh-ancestor
102470130|NCT01929291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470131|NCT01929759|Tenofovir|tenofovir|mesh-list
102470132|NCT01929759|Emtricitabine|emtricitabine|mesh-list
102470133|NCT01929759|Cobicistat|cobicistat|mesh-list
102470134|NCT01929759|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102470135|NCT01929759|Elvitegravir|elvitegravir|mesh-list
102470136|NCT01929759|Antiviral Agents|antiviral agents|mesh-ancestor
102470137|NCT01929759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102470138|NCT01929759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102470139|NCT01929759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102470140|NCT01929759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102470141|NCT01929759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470142|NCT01929759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102470143|NCT01929759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102470144|NCT01929759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102470145|NCT01929759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102470146|NCT01929759|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102470147|NCT03437330|Insulin Glargine|insulin glargine|mesh-list
102470148|NCT03437330|Empagliflozin|empagliflozin|mesh-list
102470149|NCT03437330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102470150|NCT03437330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470151|NCT03437330|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102470152|NCT03437330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470153|NCT01271803|Vemurafenib|vemurafenib|mesh-list
102470154|NCT01271803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102470155|NCT01271803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102470156|NCT01271803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102470157|NCT01271803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470158|NCT00585377|Bevacizumab|bevacizumab|mesh-list
102470159|NCT00585377|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102470160|NCT00585377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102470161|NCT00585377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102470162|NCT00585377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102470163|NCT00585377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102470164|NCT00585377|Growth Substances|growth substances|mesh-ancestor
102470165|NCT00585377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470166|NCT00585377|Growth Inhibitors|growth inhibitors|mesh-ancestor
102470167|NCT00585377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102470168|NCT00585377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102470169|NCT00585377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470170|NCT00080288|Modafinil|modafinil|mesh-list
102470171|NCT00080288|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102470172|NCT00080288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470173|NCT00080288|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102470174|NCT00080288|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102470175|NCT00080288|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102470176|NCT00080288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470177|NCT00610883|Cyclophosphamide|cyclophosphamide|mesh-list
102470178|NCT00610883|Methotrexate|methotrexate|mesh-list
102470179|NCT00610883|Asparaginase|asparaginase|mesh-list
102470180|NCT00610883|Daunorubicin|daunorubicin|mesh-list
102470181|NCT00610883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102470182|NCT00610883|Immunologic Factors|immunologic factors|mesh-ancestor
102470183|NCT00610883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470184|NCT00610883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102470185|NCT00610883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102470186|NCT00610883|Alkylating Agents|alkylating agents|mesh-ancestor
102470187|NCT00610883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470188|NCT00610883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102470189|NCT00610883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102470190|NCT00610883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102470191|NCT00610883|Abortifacient Agents|abortifacient agents|mesh-ancestor
102470192|NCT00610883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102470193|NCT00610883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102470194|NCT00610883|Antimetabolites|antimetabolites|mesh-ancestor
102470195|NCT00610883|Dermatologic Agents|dermatologic agents|mesh-ancestor
102470196|NCT00610883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102470197|NCT00610883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102470198|NCT00610883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102470199|NCT00610883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102470200|NCT00610883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102470201|NCT00610883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102470202|NCT03084380|Cyclophosphamide|cyclophosphamide|mesh-list
102470203|NCT03084380|Fludarabine|fludarabine|mesh-list
102470204|NCT03084380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102470205|NCT03084380|Immunologic Factors|immunologic factors|mesh-ancestor
102470206|NCT03084380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470207|NCT03084380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102470208|NCT03084380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102470209|NCT03084380|Alkylating Agents|alkylating agents|mesh-ancestor
102470210|NCT03084380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470211|NCT03084380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102470212|NCT03084380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102470213|NCT00084344|Afimoxifene|afimoxifene|mesh-list
102470214|NCT00084344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102470215|NCT00084344|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102470216|NCT00084344|Hormone Antagonists|hormone antagonists|mesh-ancestor
102470217|NCT00084344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102470218|NCT00084344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470219|NCT00084344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102470220|NCT00084344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102470221|NCT00611351|Mycophenolic Acid|mycophenolic acid|mesh-list
102470222|NCT00611351|Cyclophosphamide|cyclophosphamide|mesh-list
102470223|NCT00611351|Busulfan|busulfan|mesh-list
102470224|NCT00611351|Tacrolimus|tacrolimus|mesh-list
102470225|NCT00611351|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102470226|NCT00611351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102470227|NCT00611351|Immunologic Factors|immunologic factors|mesh-ancestor
102470228|NCT00611351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470229|NCT00611351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102470230|NCT00611351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102470231|NCT00611351|Alkylating Agents|alkylating agents|mesh-ancestor
102470232|NCT00611351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470233|NCT00611351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102470234|NCT00611351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102470235|NCT00611351|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102470236|NCT00611351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102470237|NCT00611351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102470238|NCT00611351|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102470239|NCT00611351|Antitubercular Agents|antitubercular agents|mesh-ancestor
102470240|NCT00611351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102470241|NCT00611351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102470242|NCT00611897|Acetylcysteine|acetylcysteine|mesh-list
102470243|NCT00611897|Ketamine|ketamine|mesh-list
102470244|NCT00611897|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102470245|NCT00611897|Analgesics|analgesics|mesh-ancestor
102470246|NCT00611897|Sensory System Agents|sensory system agents|mesh-ancestor
102470247|NCT00611897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102470248|NCT00611897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470249|NCT00611897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102470250|NCT00611897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102470251|NCT00611897|Anesthetics, General|anesthetics, general|mesh-ancestor
102470252|NCT00611897|Anesthetics|anesthetics|mesh-ancestor
102470253|NCT00611897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102470254|NCT00611897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102470255|NCT00611897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102470256|NCT00611897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102470257|NCT00611897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470258|NCT00611897|Antiviral Agents|antiviral agents|mesh-ancestor
102470259|NCT00611897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102470260|NCT00611897|Expectorants|expectorants|mesh-ancestor
102470261|NCT00611897|Respiratory System Agents|respiratory system agents|mesh-ancestor
102470262|NCT00611897|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102470263|NCT00611897|Antioxidants|antioxidants|mesh-ancestor
102470264|NCT00611897|Protective Agents|protective agents|mesh-ancestor
102470265|NCT00611897|Antidotes|antidotes|mesh-ancestor
102470266|NCT05711823|Dexamethasone|dexamethasone|mesh-list
102470267|NCT05711823|Dexamethasone acetate|dexamethasone acetate|mesh-list
102470268|NCT05711823|Aprepitant|aprepitant|mesh-list
102470269|NCT05711823|Granisetron|granisetron|mesh-list
102470270|NCT05711823|BB 1101|bb 1101|mesh-list
102470271|NCT05711823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102470272|NCT05711823|Antiemetics|antiemetics|mesh-ancestor
102470273|NCT05711823|Autonomic Agents|autonomic agents|mesh-ancestor
102470274|NCT05711823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102470275|NCT05711823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470276|NCT05711823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102470277|NCT05711823|Glucocorticoids|glucocorticoids|mesh-ancestor
102470278|NCT05711823|Hormones|hormones|mesh-ancestor
102470279|NCT05711823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102470280|NCT05711823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102470281|NCT05711823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102470282|NCT05711823|Protease Inhibitors|protease inhibitors|mesh-ancestor
102470283|NCT05711823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102470284|NCT05711823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470285|NCT05711823|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102470286|NCT05711823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102470287|NCT05711823|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102470288|NCT05711823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102470289|NCT05711823|Serotonin Agents|serotonin agents|mesh-ancestor
102470290|NCT03080324|Fentanyl|fentanyl|mesh-list
102470291|NCT03080324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102470292|NCT03080324|Narcotics|narcotics|mesh-ancestor
102470293|NCT03080324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102470294|NCT03080324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470295|NCT03080324|Analgesics|analgesics|mesh-ancestor
102470296|NCT03080324|Sensory System Agents|sensory system agents|mesh-ancestor
102470297|NCT03080324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102470298|NCT03080324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102470299|NCT03080324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102470300|NCT03080324|Anesthetics, General|anesthetics, general|mesh-ancestor
102470301|NCT03080324|Anesthetics|anesthetics|mesh-ancestor
102470302|NCT03083834|Cosyntropin|cosyntropin|mesh-list
102470303|NCT03083834|Hormones|hormones|mesh-ancestor
102470304|NCT03083834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102470305|NCT03083834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470306|NCT03404180|Dexmedetomidine|dexmedetomidine|mesh-list
102470307|NCT03404180|Propofol|propofol|mesh-list
102470308|NCT03404180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
102470309|NCT03404180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102470310|NCT03404180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470311|NCT03404180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102470312|NCT03404180|Analgesics|analgesics|mesh-ancestor
102470313|NCT03404180|Sensory System Agents|sensory system agents|mesh-ancestor
102470314|NCT03404180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102470315|NCT03404180|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102470316|NCT03404180|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102470317|NCT03404180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102470318|NCT03404180|Adrenergic Agents|adrenergic agents|mesh-ancestor
102470319|NCT03404180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102470320|NCT03404180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470321|NCT03404180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102470322|NCT03404180|Anesthetics, General|anesthetics, general|mesh-ancestor
102470323|NCT03404180|Anesthetics|anesthetics|mesh-ancestor
102470324|NCT02780609|Dexamethasone|dexamethasone|mesh-list
102470325|NCT02780609|Melphalan|melphalan|mesh-list
102470326|NCT02780609|Fosaprepitant|fosaprepitant|mesh-list
102470327|NCT02780609|Aprepitant|aprepitant|mesh-list
102470328|NCT02780609|Antiemetics|antiemetics|mesh-list
102470329|NCT02780609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102470330|NCT02780609|Autonomic Agents|autonomic agents|mesh-ancestor
102470331|NCT02780609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102470332|NCT02780609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470333|NCT02780609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102470334|NCT02780609|Glucocorticoids|glucocorticoids|mesh-ancestor
102470335|NCT02780609|Hormones|hormones|mesh-ancestor
102470336|NCT02780609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102470337|NCT02780609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102470338|NCT02780609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102470339|NCT02780609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102470340|NCT02780609|Alkylating Agents|alkylating agents|mesh-ancestor
102470341|NCT02780609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470342|NCT02780609|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102470343|NCT02780609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102470344|NCT02780609|Immunologic Factors|immunologic factors|mesh-ancestor
102470345|NCT02780609|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102470346|NCT02780609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102470347|NCT03086096|Irinotecan|irinotecan|mesh-list
102470348|NCT03086096|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102470349|NCT03086096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102470350|NCT03086096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102470351|NCT03086096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470352|NCT03086096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102470353|NCT03402152|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102470354|NCT03402152|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102470355|NCT03402152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102470356|NCT03402152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102470357|NCT03402152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470358|NCT03402152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102470359|NCT03402152|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102470360|NCT03402152|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102470361|NCT03402152|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102470362|NCT03402152|Adrenergic Agents|adrenergic agents|mesh-ancestor
102470363|NCT03402152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102470364|NCT03402152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470365|NCT03402152|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102470366|NCT03402152|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102470367|NCT03402152|Serotonin Agents|serotonin agents|mesh-ancestor
102470368|NCT03402152|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102470369|NCT03402152|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102470370|NCT03402152|Dopamine Agents|dopamine agents|mesh-ancestor
102470371|NCT05346146|Paclitaxel|paclitaxel|mesh-list
102470372|NCT05346146|Gemcitabine|gemcitabine|mesh-list
102470373|NCT05346146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102470374|NCT05346146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102470375|NCT05346146|Tubulin Modulators|tubulin modulators|mesh-ancestor
102470376|NCT05346146|Antimitotic Agents|antimitotic agents|mesh-ancestor
102470377|NCT05346146|Mitosis Modulators|mitosis modulators|mesh-ancestor
102470378|NCT05346146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470379|NCT05346146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102470380|NCT05346146|Antimetabolites|antimetabolites|mesh-ancestor
102470381|NCT00613379|Leronlimab|leronlimab|mesh-list
102470382|NCT00613379|HIV Antibodies|hiv antibodies|mesh-list
102470383|NCT00613379|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102470384|NCT00613379|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102470385|NCT00613379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470386|NCT00613379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102470387|NCT00613379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102470388|NCT00613379|Antiviral Agents|antiviral agents|mesh-ancestor
102470389|NCT00613379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102470390|NCT00613379|Immunologic Factors|immunologic factors|mesh-ancestor
102470391|NCT00613379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470392|NCT01271725|Paclitaxel|paclitaxel|mesh-list
102470393|NCT01271725|Vinorelbine|vinorelbine|mesh-list
102470394|NCT01271725|Afatinib|afatinib|mesh-list
102470395|NCT01271725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102470396|NCT01271725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102470397|NCT01271725|Tubulin Modulators|tubulin modulators|mesh-ancestor
102470398|NCT01271725|Antimitotic Agents|antimitotic agents|mesh-ancestor
102470399|NCT01271725|Mitosis Modulators|mitosis modulators|mesh-ancestor
102470400|NCT01271725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470401|NCT01271725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102470402|NCT01271725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102470403|NCT00587483|Lidocaine|lidocaine|mesh-list
102470404|NCT00587483|Amiodarone|amiodarone|mesh-list
102470405|NCT00587483|Anesthetics, Local|anesthetics, local|mesh-ancestor
102470406|NCT00587483|Anesthetics|anesthetics|mesh-ancestor
102470407|NCT00587483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102470408|NCT00587483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470409|NCT00587483|Sensory System Agents|sensory system agents|mesh-ancestor
102470410|NCT00587483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102470411|NCT00587483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102470412|NCT00587483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102470413|NCT00587483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102470414|NCT00587483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102470415|NCT00587483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470416|NCT00587483|Vasodilator Agents|vasodilator agents|mesh-ancestor
102470417|NCT00587483|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102470418|NCT00587483|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102470419|NCT00587483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102470420|NCT00587483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102470421|NCT00587483|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102470422|NCT00587483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102470423|NCT00587483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102470424|NCT03401060|Denosumab|denosumab|mesh-list
102470425|NCT03401060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102470426|NCT03401060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470427|NCT01270321|Everolimus|everolimus|mesh-list
102470428|NCT01270321|Pasireotide|pasireotide|mesh-list
102470429|NCT01270321|Somatostatin|somatostatin|mesh-list
102470430|NCT01270321|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102470431|NCT01270321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102470432|NCT01270321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102470433|NCT01270321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470434|NCT01270321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102282043|NCT03044171|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102470435|NCT01270321|Immunologic Factors|immunologic factors|mesh-ancestor
102470436|NCT01270321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470437|NCT01270321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102470438|NCT01270321|Hormones|hormones|mesh-ancestor
102470439|NCT01270321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102470440|NCT01271023|Insulin|insulin|mesh-list
102470441|NCT01271023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102470442|NCT01271023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470443|NCT03086486|Linezolid|linezolid|mesh-list
102470444|NCT03086486|Bedaquiline|bedaquiline|mesh-list
102470445|NCT03086486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102470446|NCT03086486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102470447|NCT03086486|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102470448|NCT03086486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102470449|NCT03086486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470450|NCT03086486|Antitubercular Agents|antitubercular agents|mesh-ancestor
102470451|NCT02287779|Volixibat|volixibat|mesh-list
102470452|NCT02287779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102470453|NCT00732901|Escitalopram|escitalopram|mesh-list
102470454|NCT00732901|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102470455|NCT00732901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102470456|NCT00732901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102470457|NCT00732901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470458|NCT00732901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102470459|NCT00732901|Serotonin Agents|serotonin agents|mesh-ancestor
102470460|NCT00732901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470461|NCT03083210|Lanreotide|lanreotide|mesh-list
102470462|NCT03083210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102470463|NCT00616109|Sunitinib|sunitinib|mesh-list
102470464|NCT00616109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102470465|NCT00616109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102470466|NCT00616109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102470467|NCT00616109|Growth Substances|growth substances|mesh-ancestor
102470468|NCT00616109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470469|NCT00616109|Growth Inhibitors|growth inhibitors|mesh-ancestor
102470470|NCT00616109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102470471|NCT00616109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102470472|NCT00616109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470473|NCT04401488|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102470474|NCT04401488|Immunologic Factors|immunologic factors|mesh-ancestor
102470475|NCT04401488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470476|NCT00249769|Vaccines|vaccines|mesh-list
102470477|NCT00249769|Immunologic Factors|immunologic factors|mesh-ancestor
102470478|NCT00249769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470479|NCT03434678|Fentanyl|fentanyl|mesh-list
102470480|NCT03434678|Bupivacaine|bupivacaine|mesh-list
102470481|NCT03434678|Propofol|propofol|mesh-list
102470482|NCT03434678|Rocuronium|rocuronium|mesh-list
102470483|NCT03434678|Anesthetics, Local|anesthetics, local|mesh-ancestor
102470484|NCT03434678|Anesthetics|anesthetics|mesh-ancestor
102470485|NCT03434678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102470486|NCT03434678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470487|NCT03434678|Sensory System Agents|sensory system agents|mesh-ancestor
102470488|NCT03434678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102470489|NCT03434678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102470490|NCT03434678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102470491|NCT03434678|Anesthetics, General|anesthetics, general|mesh-ancestor
102470492|NCT03434678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102470493|NCT03434678|Narcotics|narcotics|mesh-ancestor
102470494|NCT03434678|Analgesics|analgesics|mesh-ancestor
102470495|NCT03434678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102470496|NCT03434678|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102470497|NCT03434678|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102470498|NCT03434678|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102470499|NCT05445921|Mepivacaine|mepivacaine|mesh-list
102470500|NCT05445921|Anesthetics, Local|anesthetics, local|mesh-ancestor
102470501|NCT05445921|Anesthetics|anesthetics|mesh-ancestor
102470502|NCT05445921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102470503|NCT05445921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470504|NCT05445921|Sensory System Agents|sensory system agents|mesh-ancestor
102470505|NCT05445921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102470506|NCT03389750|Oxymorphone|oxymorphone|mesh-list
102470507|NCT03389750|Morphine|morphine|mesh-list
102470508|NCT03389750|Oxycodone|oxycodone|mesh-list
102470509|NCT03389750|Hydromorphone|hydromorphone|mesh-list
102470510|NCT03389750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102470511|NCT03389750|Narcotics|narcotics|mesh-ancestor
102470512|NCT03389750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102470513|NCT03389750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470514|NCT03389750|Analgesics|analgesics|mesh-ancestor
102470515|NCT03389750|Sensory System Agents|sensory system agents|mesh-ancestor
102470516|NCT03389750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102470517|NCT03389750|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102470518|NCT03837873|Cytarabine|cytarabine|mesh-list
102470519|NCT03837873|Dexamethasone|dexamethasone|mesh-list
102470520|NCT03837873|Cyclophosphamide|cyclophosphamide|mesh-list
102470521|NCT03837873|Rituximab|rituximab|mesh-list
102470522|NCT03837873|Doxorubicin|doxorubicin|mesh-list
102470523|NCT03837873|Etoposide|etoposide|mesh-list
102470524|NCT03837873|Vincristine|vincristine|mesh-list
102470525|NCT03837873|Lenalidomide|lenalidomide|mesh-list
102470526|NCT03837873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102470527|NCT03837873|Immunologic Factors|immunologic factors|mesh-ancestor
102470528|NCT03837873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470529|NCT03837873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102470530|NCT03837873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102470531|NCT03837873|Alkylating Agents|alkylating agents|mesh-ancestor
102470532|NCT03837873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470533|NCT03837873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102470534|NCT03837873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102470535|NCT03837873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102470536|NCT03837873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102470537|NCT03837873|Antiemetics|antiemetics|mesh-ancestor
102470538|NCT03837873|Autonomic Agents|autonomic agents|mesh-ancestor
102470539|NCT03837873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102470540|NCT03837873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102470541|NCT03837873|Glucocorticoids|glucocorticoids|mesh-ancestor
102470542|NCT03837873|Hormones|hormones|mesh-ancestor
102470543|NCT03837873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102470544|NCT03837873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102470545|NCT03837873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102470546|NCT03837873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102470547|NCT03837873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102470548|NCT03837873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102470549|NCT03837873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102470550|NCT03837873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102470551|NCT03837873|Antimetabolites|antimetabolites|mesh-ancestor
102470552|NCT03837873|Antiviral Agents|antiviral agents|mesh-ancestor
102470553|NCT03837873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102470554|NCT03837873|Tubulin Modulators|tubulin modulators|mesh-ancestor
102470555|NCT03837873|Antimitotic Agents|antimitotic agents|mesh-ancestor
102470556|NCT03837873|Mitosis Modulators|mitosis modulators|mesh-ancestor
102470557|NCT03837873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102470558|NCT03837873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102470559|NCT03837873|Growth Substances|growth substances|mesh-ancestor
102470560|NCT03837873|Growth Inhibitors|growth inhibitors|mesh-ancestor
102470561|NCT03082742|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102470562|NCT03082742|Furosemide|furosemide|mesh-list
102470563|NCT03082742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102470564|NCT03082742|Diuretics|diuretics|mesh-ancestor
102470565|NCT03082742|Natriuretic Agents|natriuretic agents|mesh-ancestor
102470566|NCT03082742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470567|NCT03082742|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102470568|NCT03082742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102470569|NCT03082742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470570|NCT03082742|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102470571|NCT05434533|Tranexamic Acid|tranexamic acid|mesh-list
102470572|NCT05434533|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102470573|NCT05434533|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102470574|NCT05434533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470575|NCT05434533|Hemostatics|hemostatics|mesh-ancestor
102470576|NCT05434533|Coagulants|coagulants|mesh-ancestor
102470577|NCT03432650|Dexamethasone|dexamethasone|mesh-list
102470578|NCT03432650|Bupivacaine|bupivacaine|mesh-list
102470579|NCT03432650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102470580|NCT03432650|Antiemetics|antiemetics|mesh-ancestor
102470581|NCT03432650|Autonomic Agents|autonomic agents|mesh-ancestor
102470582|NCT03432650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102470583|NCT03432650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470584|NCT03432650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102470585|NCT03432650|Glucocorticoids|glucocorticoids|mesh-ancestor
102470586|NCT03432650|Hormones|hormones|mesh-ancestor
102470587|NCT03432650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102470588|NCT03432650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102470589|NCT03432650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102470590|NCT03432650|Anesthetics, Local|anesthetics, local|mesh-ancestor
102470591|NCT03432650|Anesthetics|anesthetics|mesh-ancestor
102470592|NCT03432650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102470593|NCT03432650|Sensory System Agents|sensory system agents|mesh-ancestor
102470594|NCT00248833|Vaccines|vaccines|mesh-list
102470595|NCT00248833|Immunologic Factors|immunologic factors|mesh-ancestor
102470596|NCT00248833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470597|NCT00668525|Dexetimide|dexetimide|mesh-list
102470598|NCT00668525|Citalopram|citalopram|mesh-list
102470599|NCT00668525|Escitalopram|escitalopram|mesh-list
102470600|NCT00668525|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102470601|NCT00668525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102470602|NCT00668525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102470603|NCT00668525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470604|NCT00668525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102470605|NCT00668525|Serotonin Agents|serotonin agents|mesh-ancestor
102470606|NCT00668525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470607|NCT00668525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102470608|NCT00668525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102470609|NCT00668525|Parasympatholytics|parasympatholytics|mesh-ancestor
102470610|NCT00668525|Autonomic Agents|autonomic agents|mesh-ancestor
102470611|NCT00668525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102470612|NCT00668525|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102470613|NCT00668525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102470614|NCT00668525|Cholinergic Agents|cholinergic agents|mesh-ancestor
102470615|NCT00668525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102470616|NCT00668525|Antidepressive Agents|antidepressive agents|mesh-ancestor
102470617|NCT00668525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102470618|NCT05736549|Dexamethasone|dexamethasone|mesh-list
102470619|NCT05736549|Methylprednisolone|methylprednisolone|mesh-list
102470620|NCT05736549|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102470621|NCT05736549|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102470622|NCT05736549|Prednisolone|prednisolone|mesh-list
101554294|NCT01231659|Everolimus|everolimus|mesh-list
102470623|NCT05736549|Prednisolone acetate|prednisolone acetate|mesh-list
102470624|NCT05736549|Dexamethasone acetate|dexamethasone acetate|mesh-list
102470625|NCT05736549|Bupivacaine|bupivacaine|mesh-list
102470626|NCT05736549|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102470627|NCT05736549|Prednisolone phosphate|prednisolone phosphate|mesh-list
102470628|NCT05736549|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102470629|NCT05736549|BB 1101|bb 1101|mesh-list
102470630|NCT05736549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102470631|NCT05736549|Antiemetics|antiemetics|mesh-ancestor
102470632|NCT05736549|Autonomic Agents|autonomic agents|mesh-ancestor
102470633|NCT05736549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102470634|NCT05736549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470635|NCT05736549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102470636|NCT05736549|Glucocorticoids|glucocorticoids|mesh-ancestor
102470637|NCT05736549|Hormones|hormones|mesh-ancestor
102470638|NCT05736549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102470639|NCT05736549|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102470640|NCT05736549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102470641|NCT05736549|Anesthetics, Local|anesthetics, local|mesh-ancestor
102470642|NCT05736549|Anesthetics|anesthetics|mesh-ancestor
102470643|NCT05736549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102470644|NCT05736549|Sensory System Agents|sensory system agents|mesh-ancestor
102470645|NCT05736549|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102470646|NCT05736549|Protective Agents|protective agents|mesh-ancestor
102470647|NCT05736549|Protease Inhibitors|protease inhibitors|mesh-ancestor
102470648|NCT05736549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102470649|NCT05736549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470650|NCT05688488|Curcumin|curcumin|mesh-list
102470651|NCT05688488|Mitomycins|mitomycins|mesh-list
102470652|NCT05688488|Mitomycin|mitomycin|mesh-list
102470653|NCT05688488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102470654|NCT05688488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102470655|NCT05688488|Alkylating Agents|alkylating agents|mesh-ancestor
102470656|NCT05688488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470657|NCT05688488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102470658|NCT05688488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102470659|NCT05688488|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102470660|NCT05688488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102470661|NCT05688488|Analgesics|analgesics|mesh-ancestor
102470662|NCT05688488|Sensory System Agents|sensory system agents|mesh-ancestor
102470663|NCT05688488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102470664|NCT05688488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470665|NCT05688488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102470666|NCT05688488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102470667|NCT00669383|Betamethasone|betamethasone|mesh-list
102470668|NCT00669383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102470669|NCT00669383|Glucocorticoids|glucocorticoids|mesh-ancestor
102470670|NCT00669383|Hormones|hormones|mesh-ancestor
102470671|NCT00669383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102470672|NCT00669383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470673|NCT00669383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102470674|NCT00669383|Respiratory System Agents|respiratory system agents|mesh-ancestor
102470675|NCT00733993|Caffeine|caffeine|mesh-list
102470676|NCT00733993|Amphetamine|amphetamine|mesh-list
102470677|NCT00733993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102470678|NCT00733993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470679|NCT00733993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102470680|NCT00733993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102470681|NCT00733993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470682|NCT00733993|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102470683|NCT00733993|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102470684|NCT00733993|Purinergic Agents|purinergic agents|mesh-ancestor
102470685|NCT00733993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102470686|NCT00733993|Sympathomimetics|sympathomimetics|mesh-ancestor
102470687|NCT00733993|Autonomic Agents|autonomic agents|mesh-ancestor
102470688|NCT00733993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102470689|NCT00733993|Dopamine Agents|dopamine agents|mesh-ancestor
102470690|NCT00733993|Adrenergic Agents|adrenergic agents|mesh-ancestor
102470691|NCT00733993|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102470692|NCT00733993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102470693|NCT00733993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102470694|NCT00733993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102470695|NCT01271257|Misoprostol|misoprostol|mesh-list
102470696|NCT01271257|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102470697|NCT01271257|Abortifacient Agents|abortifacient agents|mesh-ancestor
102470698|NCT01271257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102470699|NCT01271257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470700|NCT01271257|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102470701|NCT01271257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102470702|NCT01271257|Oxytocics|oxytocics|mesh-ancestor
102470703|NCT03082352|Metoprolol|metoprolol|mesh-list
102470704|NCT03082352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102470705|NCT03082352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102470706|NCT03082352|Sympatholytics|sympatholytics|mesh-ancestor
102470707|NCT03082352|Autonomic Agents|autonomic agents|mesh-ancestor
102470708|NCT03082352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102470709|NCT03082352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470710|NCT03082352|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102470711|NCT03082352|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102470712|NCT03082352|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102470713|NCT03082352|Adrenergic Agents|adrenergic agents|mesh-ancestor
102470714|NCT03082352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102470715|NCT03082352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470716|NCT03431168|Azithromycin|azithromycin|mesh-list
102470717|NCT03431168|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102470718|NCT03431168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102470719|NCT03431168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102470720|NCT03431168|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102470721|NCT03431168|Antimalarials|antimalarials|mesh-ancestor
102470722|NCT03431168|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102470723|NCT03431168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102470724|NCT05737563|Capecitabine|capecitabine|mesh-list
102470725|NCT05737563|Irinotecan|irinotecan|mesh-list
102470726|NCT05737563|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102470727|NCT05737563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102470728|NCT05737563|Antimetabolites|antimetabolites|mesh-ancestor
102470729|NCT05737563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470730|NCT05737563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102470731|NCT05737563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102470732|NCT05737563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102470733|NCT05737563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102470734|NCT05737563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102470735|NCT03398252|Doxazosin|doxazosin|mesh-list
102470736|NCT03398252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102470737|NCT03398252|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102470738|NCT03398252|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102470739|NCT03398252|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102470740|NCT03398252|Adrenergic Agents|adrenergic agents|mesh-ancestor
102470741|NCT03398252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102470742|NCT03398252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470743|NCT03398252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470744|NCT02285283|Itraconazole|itraconazole|mesh-list
102470745|NCT02285283|Antifungal Agents|antifungal agents|mesh-ancestor
102470746|NCT02285283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102470747|NCT02285283|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102470748|NCT02285283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102470749|NCT02285283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102470750|NCT02285283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470751|NCT02285283|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102470752|NCT02285283|Hormone Antagonists|hormone antagonists|mesh-ancestor
102470753|NCT02285283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102470754|NCT02285283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470755|NCT02285283|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102470756|NCT03429140|Hyaluronic Acid|hyaluronic acid|mesh-list
102470757|NCT03429140|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102470758|NCT03429140|Immunologic Factors|immunologic factors|mesh-ancestor
101554430|NCT01228071|Testosterone|testosterone|mesh-list
102470759|NCT03429140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470760|NCT03429140|Viscosupplements|viscosupplements|mesh-ancestor
102470761|NCT03429140|Protective Agents|protective agents|mesh-ancestor
102470762|NCT03081494|Spartalizumab|spartalizumab|mesh-list
102470763|NCT03081494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102470764|NCT03081494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470765|NCT03081494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102470766|NCT03081494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102470767|NCT03081728|Acetaminophen|acetaminophen|mesh-list
102470768|NCT03081728|Diclofenac|diclofenac|mesh-list
102470769|NCT03081728|Ropivacaine|ropivacaine|mesh-list
102470770|NCT03081728|Anesthetics, Local|anesthetics, local|mesh-ancestor
102470771|NCT03081728|Anesthetics|anesthetics|mesh-ancestor
102470772|NCT03081728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102470773|NCT03081728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470774|NCT03081728|Sensory System Agents|sensory system agents|mesh-ancestor
102470775|NCT03081728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102470776|NCT03081728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102470777|NCT03081728|Analgesics|analgesics|mesh-ancestor
102470778|NCT03081728|Antipyretics|antipyretics|mesh-ancestor
102470779|NCT03081728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102470780|NCT03081728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102470781|NCT03081728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102470782|NCT03081728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102470783|NCT03081728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102470784|NCT03081728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470785|NCT05651217|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102470786|NCT05651217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102470787|NCT00618917|Manganese|manganese|mesh-list
102470788|NCT00618917|Paclitaxel|paclitaxel|mesh-list
102470789|NCT00618917|Carboplatin|carboplatin|mesh-list
102470790|NCT00618917|Superoxide Dismutase|superoxide dismutase|mesh-list
102470791|NCT00618917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102470792|NCT00618917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102470793|NCT00618917|Tubulin Modulators|tubulin modulators|mesh-ancestor
102470794|NCT00618917|Antimitotic Agents|antimitotic agents|mesh-ancestor
102470795|NCT00618917|Mitosis Modulators|mitosis modulators|mesh-ancestor
102470796|NCT00618917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470797|NCT00618917|Trace Elements|trace elements|mesh-ancestor
102470798|NCT00618917|Micronutrients|micronutrients|mesh-ancestor
102470799|NCT00618917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470800|NCT00618917|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102470801|NCT00618917|Antioxidants|antioxidants|mesh-ancestor
102470802|NCT00618917|Protective Agents|protective agents|mesh-ancestor
102470803|NCT05736081|Dexamethasone|dexamethasone|mesh-list
102470804|NCT05736081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102470805|NCT05736081|Antiemetics|antiemetics|mesh-ancestor
102470806|NCT05736081|Autonomic Agents|autonomic agents|mesh-ancestor
102470807|NCT05736081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102470808|NCT05736081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470809|NCT05736081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102470810|NCT05736081|Glucocorticoids|glucocorticoids|mesh-ancestor
102470811|NCT05736081|Hormones|hormones|mesh-ancestor
102612323|NCT00002405|Protease Inhibitors|protease inhibitors|mesh-ancestor
102470812|NCT05736081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102470813|NCT05736081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102470814|NCT05736081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102470815|NCT00619073|Aspirin|aspirin|mesh-list
102470816|NCT00619073|Clopidogrel|clopidogrel|mesh-list
102470817|NCT00619073|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102470818|NCT00619073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102470819|NCT00619073|Analgesics|analgesics|mesh-ancestor
102470820|NCT00619073|Sensory System Agents|sensory system agents|mesh-ancestor
102470821|NCT00619073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102470822|NCT00619073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470823|NCT00619073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102470824|NCT00619073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102470825|NCT00619073|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102470826|NCT00619073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102470827|NCT00619073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470828|NCT00619073|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102470829|NCT00619073|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102470830|NCT00619073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102470831|NCT00619073|Antipyretics|antipyretics|mesh-ancestor
102470832|NCT00619073|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102470833|NCT00619073|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102470834|NCT00619073|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102470835|NCT00619073|Purinergic Agents|purinergic agents|mesh-ancestor
102470836|NCT00619073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102470837|NCT00670241|Betamethasone|betamethasone|mesh-list
102470838|NCT00670241|1 alpha,24-dihydroxyvitamin D3|1 alpha,24-dihydroxyvitamin d3|mesh-list
102470839|NCT00670241|Calcipotriene|calcipotriene|mesh-list
102470840|NCT00670241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102470841|NCT00670241|Glucocorticoids|glucocorticoids|mesh-ancestor
102470842|NCT00670241|Hormones|hormones|mesh-ancestor
102470843|NCT00670241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102470844|NCT00670241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470845|NCT00670241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102470846|NCT00670241|Respiratory System Agents|respiratory system agents|mesh-ancestor
102470847|NCT00670241|Dermatologic Agents|dermatologic agents|mesh-ancestor
102470848|NCT03088670|Metformin|metformin|mesh-list
102470849|NCT03088670|Vildagliptin|vildagliptin|mesh-list
102470850|NCT03088670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102470851|NCT03088670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470852|NCT03088670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102470853|NCT03088670|Protease Inhibitors|protease inhibitors|mesh-ancestor
102470854|NCT03088670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102470855|NCT03088670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470856|NCT03088358|Enoxaparin|enoxaparin|mesh-list
102470857|NCT03088358|Anticoagulants|anticoagulants|mesh-ancestor
102470858|NCT03088358|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102470859|NCT03088358|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102470860|NCT03088358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470861|NCT03396068|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102470862|NCT03396068|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102470863|NCT03396068|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102470864|NCT03396068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102470865|NCT03396068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470866|NCT03396068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102470867|NCT03396068|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102470868|NCT03396068|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102470869|NCT03396068|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102470870|NCT03396068|Adrenergic Agents|adrenergic agents|mesh-ancestor
102470871|NCT03396068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102470872|NCT03396068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470873|NCT03396068|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102470874|NCT03396068|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102470875|NCT03396068|Serotonin Agents|serotonin agents|mesh-ancestor
102470876|NCT03396068|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102470877|NCT03396068|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102470878|NCT03396068|Dopamine Agents|dopamine agents|mesh-ancestor
102470879|NCT00620945|Phenoxybenzamine|phenoxybenzamine|mesh-list
102470880|NCT00620945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102470881|NCT00620945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102470882|NCT00620945|Adrenergic Agents|adrenergic agents|mesh-ancestor
102470883|NCT00620945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102612324|NCT00002405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102282513|NCT04850261|Nafarelin|nafarelin|mesh-list
102470884|NCT00620945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470885|NCT00620945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470886|NCT00620945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102470887|NCT00620945|Vasodilator Agents|vasodilator agents|mesh-ancestor
102470889|NCT00621179|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102470890|NCT00621179|Fertility Agents|fertility agents|mesh-ancestor
102470891|NCT00621179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102470892|NCT00621179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470893|NCT00621179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102470894|NCT00621179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102470895|NCT00247273|Risedronic Acid|risedronic acid|mesh-list
102470896|NCT00247273|Etidronic Acid|etidronic acid|mesh-list
102470897|NCT00247273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102470898|NCT00247273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102470899|NCT00247273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470900|NCT00247273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102470901|NCT00247273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470902|NCT00247273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102470903|NCT05056233|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102470904|NCT05056233|Lubricant Eye Drops|lubricant eye drops|mesh-list
102470905|NCT05056233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102470906|NCT03382106|Sildenafil Citrate|sildenafil citrate|mesh-list
102470907|NCT03382106|Vasodilator Agents|vasodilator agents|mesh-ancestor
102470908|NCT03382106|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102470909|NCT03382106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102470910|NCT03382106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102470911|NCT03382106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470912|NCT03382106|Urological Agents|urological agents|mesh-ancestor
102470913|NCT00622895|Mycophenolic Acid|mycophenolic acid|mesh-list
102470914|NCT00622895|Fludarabine|fludarabine|mesh-list
102470915|NCT00622895|Fludarabine phosphate|fludarabine phosphate|mesh-list
102470916|NCT00622895|Tacrolimus|tacrolimus|mesh-list
102470917|NCT00622895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102470918|NCT00622895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102470919|NCT00622895|Antimetabolites|antimetabolites|mesh-ancestor
102470920|NCT00622895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470921|NCT00622895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102470922|NCT00622895|Immunologic Factors|immunologic factors|mesh-ancestor
102470923|NCT00622895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470924|NCT00622895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102470925|NCT00622895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102470926|NCT00622895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102470927|NCT00622895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102470928|NCT00622895|Antitubercular Agents|antitubercular agents|mesh-ancestor
102470929|NCT00622895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102470930|NCT00622895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102470931|NCT00672737|Remifentanil|remifentanil|mesh-list
102470932|NCT00672737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102470933|NCT00672737|Narcotics|narcotics|mesh-ancestor
102470934|NCT00672737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102470935|NCT00672737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470936|NCT00672737|Analgesics|analgesics|mesh-ancestor
102470937|NCT00672737|Sensory System Agents|sensory system agents|mesh-ancestor
102470938|NCT00672737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102470939|NCT00673127|Ketoconazole|ketoconazole|mesh-list
102470940|NCT00673127|Hydrocortisone|hydrocortisone|mesh-list
102470941|NCT00673127|Dutasteride|dutasteride|mesh-list
102470942|NCT00673127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102470943|NCT00673127|Antifungal Agents|antifungal agents|mesh-ancestor
102470944|NCT00673127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102470945|NCT00673127|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102470946|NCT00673127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102470947|NCT00673127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102470948|NCT00673127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470949|NCT00673127|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102470950|NCT00673127|Hormone Antagonists|hormone antagonists|mesh-ancestor
102470951|NCT00673127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102470952|NCT00673127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470953|NCT00673127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102470954|NCT00673127|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102470955|NCT00246259|Risperidone|risperidone|mesh-list
102470956|NCT00246259|Antipsychotic Agents|antipsychotic agents|mesh-list
102470957|NCT00246259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102470958|NCT00246259|Serotonin Agents|serotonin agents|mesh-ancestor
102470959|NCT00246259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102470960|NCT00246259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470961|NCT00246259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470962|NCT00246259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102470963|NCT00246259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101554643|NCT02869321|Analgesics|analgesics|mesh-ancestor
102470964|NCT00246259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102470965|NCT00246259|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102470966|NCT00246259|Dopamine Agents|dopamine agents|mesh-ancestor
102470968|NCT00673439|Warfarin|warfarin|mesh-list
102470969|NCT00673439|Fondaparinux|fondaparinux|mesh-list
102470970|NCT00673439|Anticoagulants|anticoagulants|mesh-ancestor
102470971|NCT00673439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102470972|NCT00673439|Antithrombins|antithrombins|mesh-ancestor
102470973|NCT00673439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102470974|NCT00673439|Protease Inhibitors|protease inhibitors|mesh-ancestor
102470975|NCT00673439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102470976|NCT00673439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470977|NCT00673439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102470978|NCT00673439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102470979|NCT03316118|Bupivacaine|bupivacaine|mesh-list
102470980|NCT03316118|Anesthetics, Local|anesthetics, local|mesh-ancestor
102470981|NCT03316118|Anesthetics|anesthetics|mesh-ancestor
102470982|NCT03316118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102470983|NCT03316118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470984|NCT03316118|Sensory System Agents|sensory system agents|mesh-ancestor
102470985|NCT03316118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102470986|NCT03029013|Apatinib|apatinib|mesh-list
102470987|NCT03029013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102470988|NCT03029013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102470989|NCT03029013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102470990|NCT03029013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470991|NCT00674219|Memantine|memantine|mesh-list
102470992|NCT00674219|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102470993|NCT00674219|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102470994|NCT00674219|Dopamine Agents|dopamine agents|mesh-ancestor
102470995|NCT00674219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102470996|NCT00674219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102470997|NCT00674219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102470998|NCT00674219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102470999|NCT00674219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102471000|NCT00246025|Dabigatran|dabigatran|mesh-list
102471001|NCT00246025|Antithrombins|antithrombins|mesh-ancestor
102471002|NCT00246025|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102471003|NCT00246025|Protease Inhibitors|protease inhibitors|mesh-ancestor
102471004|NCT00246025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102471005|NCT00246025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471006|NCT00246025|Anticoagulants|anticoagulants|mesh-ancestor
102471007|NCT03311594|Ethanol|ethanol|mesh-list
102471008|NCT03311594|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102471009|NCT03311594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102471010|NCT03311594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102471011|NCT03311594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471012|NCT05069051|Belimumab|belimumab|mesh-list
102471013|NCT05069051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102471014|NCT05069051|Immunologic Factors|immunologic factors|mesh-ancestor
102471015|NCT05069051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471016|NCT00624923|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
102471017|NCT00624923|Sodium Salicylate|sodium salicylate|mesh-list
102471018|NCT00624923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102471019|NCT00624923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102471020|NCT00624923|Analgesics|analgesics|mesh-ancestor
102471021|NCT00624923|Sensory System Agents|sensory system agents|mesh-ancestor
102471022|NCT00624923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102471023|NCT00624923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471024|NCT00624923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102471025|NCT00624923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102471026|NCT00624923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102471027|NCT00624923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102471028|NCT00624923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471029|NCT05593653|Suvorexant|suvorexant|mesh-list
102471030|NCT05593653|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102471031|NCT05593653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102471032|NCT05593653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102471033|NCT05593653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471034|NCT05593653|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102471035|NCT05593653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102471036|NCT05593653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471037|NCT00735787|Adalimumab|adalimumab|mesh-list
102471038|NCT00735787|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102471039|NCT00735787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102471040|NCT00735787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102471041|NCT00628589|Loxapine|loxapine|mesh-list
102471042|NCT00628589|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102471043|NCT00628589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102471044|NCT00628589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102471045|NCT00628589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471046|NCT00628589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102471047|NCT00628589|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102471048|NCT00628589|Dopamine Agents|dopamine agents|mesh-ancestor
102471049|NCT00628589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102471050|NCT00628589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471051|NCT03375242|Crizotinib|crizotinib|mesh-list
102471052|NCT03375242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102471053|NCT03375242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102471054|NCT03375242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102471055|NCT03375242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471056|NCT01271569|Fospropofol|fospropofol|mesh-list
102471057|NCT01271569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102471058|NCT01271569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102471059|NCT01271569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471060|NCT05686772|Dopamine|dopamine|mesh-list
102471061|NCT05686772|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102471062|NCT05686772|Sympathomimetics|sympathomimetics|mesh-ancestor
102471063|NCT05686772|Autonomic Agents|autonomic agents|mesh-ancestor
102471064|NCT05686772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102471065|NCT05686772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471066|NCT05686772|Dopamine Agents|dopamine agents|mesh-ancestor
102471067|NCT05686772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102471068|NCT05686772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471069|NCT05686772|Protective Agents|protective agents|mesh-ancestor
102471070|NCT04771871|Paclitaxel|paclitaxel|mesh-list
102471071|NCT04771871|Cyclophosphamide|cyclophosphamide|mesh-list
102471072|NCT04771871|Carboplatin|carboplatin|mesh-list
102471073|NCT04771871|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102471074|NCT04771871|Epirubicin|epirubicin|mesh-list
102471075|NCT04771871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102471076|NCT04771871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102471077|NCT04771871|Tubulin Modulators|tubulin modulators|mesh-ancestor
102471078|NCT04771871|Antimitotic Agents|antimitotic agents|mesh-ancestor
102471079|NCT04771871|Mitosis Modulators|mitosis modulators|mesh-ancestor
102471080|NCT04771871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471081|NCT04771871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102471082|NCT04771871|Immunologic Factors|immunologic factors|mesh-ancestor
102471083|NCT04771871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471084|NCT04771871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102471085|NCT04771871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102471086|NCT04771871|Alkylating Agents|alkylating agents|mesh-ancestor
102471087|NCT04771871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102471088|NCT04771871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102471089|NCT04771871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102471090|NCT04771871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102471091|NCT04771871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102471092|NCT04386577|Vitamin D|vitamin d|mesh-list
102471093|NCT04386577|Cholecalciferol|cholecalciferol|mesh-list
102471094|NCT04386577|Vitamins|vitamins|mesh-ancestor
102471095|NCT04386577|Micronutrients|micronutrients|mesh-ancestor
102471096|NCT04386577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471097|NCT04386577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102471098|NCT04386577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102471099|NCT04270669|RC28-E protein|rc28-e protein|mesh-list
102471100|NCT04270669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102471101|NCT04270669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102471102|NCT04270669|Growth Substances|growth substances|mesh-ancestor
102471103|NCT04270669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471104|NCT04270669|Growth Inhibitors|growth inhibitors|mesh-ancestor
102154239|NCT03367143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102471105|NCT04270669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102471106|NCT05680454|Vaccines|vaccines|mesh-list
102471107|NCT05680454|Immunologic Factors|immunologic factors|mesh-ancestor
102471108|NCT05680454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471109|NCT04928703|Ketamine|ketamine|mesh-list
102471110|NCT04928703|Analgesics|analgesics|mesh-ancestor
102471111|NCT04928703|Sensory System Agents|sensory system agents|mesh-ancestor
102471112|NCT04928703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102471113|NCT04928703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471114|NCT04928703|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102471115|NCT04928703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102471116|NCT04928703|Anesthetics, General|anesthetics, general|mesh-ancestor
102471117|NCT04928703|Anesthetics|anesthetics|mesh-ancestor
102471118|NCT04928703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102471119|NCT04928703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102471120|NCT04928703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102471121|NCT04928703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102471122|NCT04928703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471123|NCT04278950|Povidone-Iodine|povidone-iodine|mesh-list
102471124|NCT04278950|Povidone|povidone|mesh-list
102471125|NCT04278950|Plasma Substitutes|plasma substitutes|mesh-ancestor
102471126|NCT04278950|Blood Substitutes|blood substitutes|mesh-ancestor
102471127|NCT04278950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102471128|NCT04278950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102471129|NCT00755755|Iron|iron|mesh-list
102471130|NCT00755755|Ulipristal acetate|ulipristal acetate|mesh-list
102471131|NCT00755755|Trace Elements|trace elements|mesh-ancestor
102471132|NCT00755755|Micronutrients|micronutrients|mesh-ancestor
102471133|NCT00755755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471134|NCT00755755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102471135|NCT00755755|Contraceptive Agents|contraceptive agents|mesh-ancestor
102471136|NCT00755755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102471137|NCT00755755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102471138|NCT05686616|Dapagliflozin|dapagliflozin|mesh-list
102471139|NCT05686616|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102471140|NCT05686616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471141|NCT05686616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102471142|NCT05686616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471143|NCT00674765|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102471144|NCT00674765|Antidepressive Agents|antidepressive agents|mesh-ancestor
102471145|NCT00674765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102471146|NCT00674765|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102471147|NCT00674765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102471148|NCT00674765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102471149|NCT00674765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471150|NCT00755911|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
102471151|NCT00755911|Hemostatics|hemostatics|mesh-ancestor
102471152|NCT00755911|Coagulants|coagulants|mesh-ancestor
102471153|NCT00737737|Morphine|morphine|mesh-list
102471154|NCT00737737|Oxycodone|oxycodone|mesh-list
102471155|NCT00737737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102471156|NCT00737737|Narcotics|narcotics|mesh-ancestor
102471157|NCT00737737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102471158|NCT00737737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471159|NCT00737737|Analgesics|analgesics|mesh-ancestor
102471160|NCT00737737|Sensory System Agents|sensory system agents|mesh-ancestor
102471161|NCT00737737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102471162|NCT05199051|Cytarabine|cytarabine|mesh-list
102471163|NCT05199051|Gemtuzumab|gemtuzumab|mesh-list
102471164|NCT05199051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102471165|NCT05199051|Antimetabolites|antimetabolites|mesh-ancestor
102471166|NCT05199051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471167|NCT05199051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102471168|NCT05199051|Antiviral Agents|antiviral agents|mesh-ancestor
102471169|NCT05199051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102471170|NCT05199051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102471171|NCT05199051|Immunologic Factors|immunologic factors|mesh-ancestor
102471172|NCT05199051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492228|NCT00426608|Alprazolam|alprazolam|mesh-list
102471173|NCT05199051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102471174|NCT05199051|Immunotoxins|immunotoxins|mesh-ancestor
102471175|NCT05199051|Immunoconjugates|immunoconjugates|mesh-ancestor
102471176|NCT00245011|Ifosfamide|ifosfamide|mesh-list
102471177|NCT00245011|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
102471178|NCT00245011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471179|NCT00245011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102471180|NCT00245011|Alkylating Agents|alkylating agents|mesh-ancestor
102471181|NCT00245011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471182|NCT00245011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102471183|NCT00245011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102471185|NCT00245011|Sensory System Agents|sensory system agents|mesh-ancestor
102471186|NCT00245011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102471187|NCT05539053|Acetylcysteine|acetylcysteine|mesh-list
102471188|NCT05539053|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102471189|NCT05539053|Antiviral Agents|antiviral agents|mesh-ancestor
102471190|NCT05539053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102471191|NCT05539053|Expectorants|expectorants|mesh-ancestor
102471192|NCT05539053|Respiratory System Agents|respiratory system agents|mesh-ancestor
102471193|NCT05539053|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102471194|NCT05539053|Antioxidants|antioxidants|mesh-ancestor
102471195|NCT05539053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471196|NCT05539053|Protective Agents|protective agents|mesh-ancestor
102471197|NCT05539053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471198|NCT05539053|Antidotes|antidotes|mesh-ancestor
102471199|NCT00629525|Everolimus|everolimus|mesh-list
102471200|NCT00629525|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102471201|NCT00629525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102471202|NCT00629525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102471203|NCT00629525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471204|NCT00629525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102471205|NCT00629525|Immunologic Factors|immunologic factors|mesh-ancestor
102471206|NCT00629525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471207|NCT00629525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102471208|NCT00244855|Dexamethasone|dexamethasone|mesh-list
102471209|NCT00244855|Rituximab|rituximab|mesh-list
102471210|NCT00244855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102471211|NCT00244855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102471212|NCT00244855|Immunologic Factors|immunologic factors|mesh-ancestor
102471213|NCT00244855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471214|NCT00244855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102471215|NCT00244855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102471216|NCT00244855|Antiemetics|antiemetics|mesh-ancestor
102471217|NCT00244855|Autonomic Agents|autonomic agents|mesh-ancestor
102471218|NCT00244855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102471219|NCT00244855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102471220|NCT00244855|Glucocorticoids|glucocorticoids|mesh-ancestor
102471221|NCT00244855|Hormones|hormones|mesh-ancestor
102471222|NCT00244855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102471223|NCT00244855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102471224|NCT00737893|Epoetin Alfa|epoetin alfa|mesh-list
102471225|NCT00737893|Hematinics|hematinics|mesh-ancestor
102471226|NCT00631319|Hydromorphone|hydromorphone|mesh-list
102471227|NCT00631319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102471228|NCT00631319|Narcotics|narcotics|mesh-ancestor
102471229|NCT00631319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102471230|NCT00631319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471231|NCT00631319|Analgesics|analgesics|mesh-ancestor
102471232|NCT00631319|Sensory System Agents|sensory system agents|mesh-ancestor
102471233|NCT00631319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102471234|NCT00244621|Candesartan|candesartan|mesh-list
102471235|NCT00244621|Candesartan cilexetil|candesartan cilexetil|mesh-list
102471236|NCT00244621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102471237|NCT00244621|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102471238|NCT00244621|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102471239|NCT00244621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471240|NCT00680225|Ranibizumab|ranibizumab|mesh-list
102471241|NCT00680225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102471242|NCT00680225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102471243|NCT00680225|Growth Substances|growth substances|mesh-ancestor
102471244|NCT00680225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471245|NCT00680225|Growth Inhibitors|growth inhibitors|mesh-ancestor
102471246|NCT00680225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102471247|NCT04603391|Cannabidiol|cannabidiol|mesh-list
102471248|NCT04603391|Methylphenidate|methylphenidate|mesh-list
102471249|NCT04603391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102471250|NCT04603391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471251|NCT04603391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102471252|NCT04603391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102471253|NCT04603391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102471254|NCT04603391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471255|NCT04603391|Dopamine Agents|dopamine agents|mesh-ancestor
102154240|NCT03367143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102471256|NCT04603391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102471257|NCT04603391|Anticonvulsants|anticonvulsants|mesh-ancestor
102471259|NCT00738049|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102471260|NCT00738049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471261|NCT02291133|Bleomycin|bleomycin|mesh-list
102471262|NCT02291133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102471263|NCT02291133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102471264|NCT00680459|Ethanol|ethanol|mesh-list
102471265|NCT00680459|Heparin|heparin|mesh-list
102471266|NCT00680459|Anticoagulants|anticoagulants|mesh-list
102471267|NCT00680459|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102471268|NCT00680459|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102471269|NCT00680459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471270|NCT00680459|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102471271|NCT00680459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102471272|NCT00680459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102471273|NCT00680459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471274|NCT00632411|Nicotine|nicotine|mesh-list
102471275|NCT00632411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102471276|NCT00632411|Autonomic Agents|autonomic agents|mesh-ancestor
102471277|NCT00632411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102471278|NCT00632411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471279|NCT00632411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102471280|NCT00632411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102471281|NCT00632411|Cholinergic Agents|cholinergic agents|mesh-ancestor
102471282|NCT00632411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102471283|NCT00632411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471284|NCT05685836|Bevacizumab|bevacizumab|mesh-list
102471285|NCT05685836|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
102471286|NCT05685836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102471287|NCT05685836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102471288|NCT05685836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102471289|NCT05685836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102471290|NCT05685836|Growth Substances|growth substances|mesh-ancestor
102471291|NCT05685836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471292|NCT05685836|Growth Inhibitors|growth inhibitors|mesh-ancestor
102471293|NCT05685836|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102471294|NCT05685836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471295|NCT00632489|Capecitabine|capecitabine|mesh-list
102471296|NCT00632489|Lapatinib|lapatinib|mesh-list
102471297|NCT00632489|Panobinostat|panobinostat|mesh-list
102471298|NCT00632489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102471299|NCT00632489|Antimetabolites|antimetabolites|mesh-ancestor
102471300|NCT00632489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471301|NCT00632489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102471302|NCT00632489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102471303|NCT00632489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102471304|NCT00632489|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102471305|NCT05074875|Carbon Monoxide|carbon monoxide|mesh-list
102471306|NCT05074875|Antimetabolites|antimetabolites|mesh-ancestor
102471307|NCT05074875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471308|NCT05074875|Gasotransmitters|gasotransmitters|mesh-ancestor
102471309|NCT05074875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102471310|NCT05074875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471311|NCT01798979|Midazolam|midazolam|mesh-list
102471312|NCT01798979|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102471313|NCT01798979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102471314|NCT01798979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102471315|NCT01798979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471316|NCT01798979|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102471317|NCT01798979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102471318|NCT01798979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102471319|NCT01798979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102471320|NCT01798979|Anesthetics, General|anesthetics, general|mesh-ancestor
102471321|NCT01798979|Anesthetics|anesthetics|mesh-ancestor
102471322|NCT01798979|GABA Modulators|gaba modulators|mesh-ancestor
102471323|NCT01798979|GABA Agents|gaba agents|mesh-ancestor
102471324|NCT01798979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102471325|NCT01798979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471326|NCT00738361|Paclitaxel|paclitaxel|mesh-list
102471327|NCT00738361|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102471328|NCT00738361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102471329|NCT00738361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102471330|NCT00738361|Tubulin Modulators|tubulin modulators|mesh-ancestor
102471332|NCT00738361|Mitosis Modulators|mitosis modulators|mesh-ancestor
102471333|NCT00738361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471334|NCT01279213|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102471335|NCT01279213|Clozapine|clozapine|mesh-list
102471336|NCT01279213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102471337|NCT01279213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102471338|NCT01279213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102471339|NCT01279213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471340|NCT01279213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102471341|NCT01279213|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102471342|NCT01279213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102471343|NCT01279213|Serotonin Agents|serotonin agents|mesh-ancestor
102471344|NCT01279213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102471345|NCT01279213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471346|NCT01279213|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102471347|NCT01279213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102471348|NCT01279213|Dopamine Agents|dopamine agents|mesh-ancestor
102471349|NCT01279213|GABA Antagonists|gaba antagonists|mesh-ancestor
102471350|NCT01279213|GABA Agents|gaba agents|mesh-ancestor
102471351|NCT00634283|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102471352|NCT00634283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102471353|NCT00634283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102471354|NCT00634283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102471355|NCT00634283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471356|NCT00634283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102471357|NCT00634283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471358|NCT00634283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102471359|NCT00634283|Antidepressive Agents|antidepressive agents|mesh-ancestor
102471360|NCT00634283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102471361|NCT01279291|Paclitaxel|paclitaxel|mesh-list
102471362|NCT01279291|Carboplatin|carboplatin|mesh-list
102471363|NCT01279291|Gemcitabine|gemcitabine|mesh-list
102471364|NCT01279291|Doxorubicin|doxorubicin|mesh-list
102471365|NCT01279291|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102471366|NCT01279291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102471367|NCT01279291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102471368|NCT01279291|Tubulin Modulators|tubulin modulators|mesh-ancestor
102471369|NCT01279291|Antimitotic Agents|antimitotic agents|mesh-ancestor
102471370|NCT01279291|Mitosis Modulators|mitosis modulators|mesh-ancestor
102471371|NCT01279291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471372|NCT01279291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102471373|NCT01279291|Antimetabolites|antimetabolites|mesh-ancestor
102471374|NCT01279291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102471375|NCT01279291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102471376|NCT01279291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102471377|NCT01279291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102471378|NCT04367883|Amantadine|amantadine|mesh-list
102471379|NCT04367883|Histamine Antagonists|histamine antagonists|mesh-list
102471380|NCT04367883|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
102471381|NCT04367883|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102471382|NCT04367883|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102471383|NCT04367883|Antiviral Agents|antiviral agents|mesh-ancestor
102471384|NCT04367883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102471385|NCT04367883|Dopamine Agents|dopamine agents|mesh-ancestor
102471386|NCT04367883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102471387|NCT04367883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471388|NCT04367883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471389|NCT04367883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102471390|NCT04367883|Analgesics|analgesics|mesh-ancestor
102471391|NCT04367883|Sensory System Agents|sensory system agents|mesh-ancestor
102471392|NCT04367883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102471393|NCT04367883|Histamine Agents|histamine agents|mesh-ancestor
102471394|NCT04329039|Somatostatin|somatostatin|mesh-list
102471395|NCT04329039|Hormones|hormones|mesh-ancestor
102471396|NCT04329039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102471397|NCT04329039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471398|NCT00635609|Doxycycline|doxycycline|mesh-list
102471399|NCT00635609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102471400|NCT00635609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102471401|NCT00635609|Antimalarials|antimalarials|mesh-ancestor
102471402|NCT00635609|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102471403|NCT00635609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102471404|NCT04347902|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
102471405|NCT04347902|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102471406|NCT04347902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102471407|NCT03298802|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102471408|NCT03298802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102471410|NCT03298802|Natriuretic Agents|natriuretic agents|mesh-ancestor
102471411|NCT03298802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471412|NCT03298802|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102471413|NCT03298802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102471414|NCT03298802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471415|NCT03066843|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102471416|NCT03066843|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102471417|NCT03066843|Dermatologic Agents|dermatologic agents|mesh-ancestor
102471418|NCT05315336|Antibodies|antibodies|mesh-list
102471419|NCT05315336|Immunologic Factors|immunologic factors|mesh-ancestor
102471420|NCT05315336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471421|NCT04746495|Eplerenone|eplerenone|mesh-list
102471422|NCT04746495|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102471423|NCT04746495|Hormone Antagonists|hormone antagonists|mesh-ancestor
102471424|NCT04746495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102471425|NCT04746495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471426|NCT04746495|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102471427|NCT04746495|Diuretics|diuretics|mesh-ancestor
102471428|NCT04746495|Natriuretic Agents|natriuretic agents|mesh-ancestor
102471429|NCT04746495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102471430|NCT03347786|Verapamil|verapamil|mesh-list
102471431|NCT03347786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102471432|NCT03347786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102471433|NCT03347786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102471434|NCT03347786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471435|NCT03347786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102471436|NCT03347786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471437|NCT03347786|Vasodilator Agents|vasodilator agents|mesh-ancestor
102471438|NCT03288974|Pomalidomide|pomalidomide|mesh-list
102471439|NCT03288974|Immunologic Factors|immunologic factors|mesh-ancestor
102471440|NCT03288974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471441|NCT03288974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102471442|NCT03288974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102471443|NCT03288974|Growth Substances|growth substances|mesh-ancestor
102471444|NCT03288974|Growth Inhibitors|growth inhibitors|mesh-ancestor
102471445|NCT03288974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102471446|NCT03286634|Cytarabine|cytarabine|mesh-list
102471447|NCT03286634|Prednisolone|prednisolone|mesh-list
102471448|NCT03286634|Hydrocortisone|hydrocortisone|mesh-list
101555176|NCT01005316|Prednisone|prednisone|mesh-list
102471449|NCT03286634|Cyclophosphamide|cyclophosphamide|mesh-list
102471450|NCT03286634|Methotrexate|methotrexate|mesh-list
102471451|NCT03286634|Vincristine|vincristine|mesh-list
102471452|NCT03286634|Daunorubicin|daunorubicin|mesh-list
102471453|NCT03286634|Asparaginase|asparaginase|mesh-list
102471454|NCT03286634|Epirubicin|epirubicin|mesh-list
102471455|NCT03286634|Mercaptopurine|mercaptopurine|mesh-list
102471456|NCT03286634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102471457|NCT03286634|Immunologic Factors|immunologic factors|mesh-ancestor
102471458|NCT03286634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471459|NCT03286634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102471460|NCT03286634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102471461|NCT03286634|Alkylating Agents|alkylating agents|mesh-ancestor
101555201|NCT00988429|Anticonvulsants|anticonvulsants|mesh-ancestor
102471462|NCT03286634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471463|NCT03286634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102471464|NCT03286634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102471465|NCT03286634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102471466|NCT03286634|Abortifacient Agents|abortifacient agents|mesh-ancestor
102471467|NCT03286634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102471468|NCT03286634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102471469|NCT03286634|Antimetabolites|antimetabolites|mesh-ancestor
102471470|NCT03286634|Dermatologic Agents|dermatologic agents|mesh-ancestor
102471471|NCT03286634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102471472|NCT03286634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102471473|NCT03286634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102471474|NCT03286634|Antiviral Agents|antiviral agents|mesh-ancestor
102471475|NCT03286634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102471476|NCT03286634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102471477|NCT03286634|Tubulin Modulators|tubulin modulators|mesh-ancestor
102471478|NCT03286634|Antimitotic Agents|antimitotic agents|mesh-ancestor
102471479|NCT03286634|Mitosis Modulators|mitosis modulators|mesh-ancestor
102471480|NCT03286634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102471481|NCT03286634|Glucocorticoids|glucocorticoids|mesh-ancestor
102471482|NCT03286634|Hormones|hormones|mesh-ancestor
102471483|NCT03286634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102471484|NCT03286634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102471485|NCT03286634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102471486|NCT03286634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102471487|NCT03286634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102471488|NCT05000294|Atezolizumab|atezolizumab|mesh-list
102471489|NCT05000294|Tivozanib|tivozanib|mesh-list
102471490|NCT05000294|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102471491|NCT05000294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471492|NCT05000294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102471493|NCT05000294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102471494|NCT05000294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102471495|NCT05000294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102471496|NCT00637247|Gemcitabine|gemcitabine|mesh-list
102471497|NCT00637247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102471498|NCT00637247|Antimetabolites|antimetabolites|mesh-ancestor
102471499|NCT00637247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555241|NCT00981409|Heparin|heparin|mesh-list
102471500|NCT00637247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102471501|NCT04998032|Metformin|metformin|mesh-list
102471502|NCT04998032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102471503|NCT04998032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471504|NCT04388033|Temozolomide|temozolomide|mesh-list
102471505|NCT04388033|Interleukin-12|interleukin-12|mesh-list
102471506|NCT04388033|Vaccines|vaccines|mesh-list
102471507|NCT04388033|Immunologic Factors|immunologic factors|mesh-ancestor
102471508|NCT04388033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471509|NCT04388033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102471510|NCT04388033|Alkylating Agents|alkylating agents|mesh-ancestor
102471511|NCT04388033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471512|NCT04388033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102471513|NCT04388033|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101555249|NCT00981409|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102471514|NCT04388033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102471515|NCT04388033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102471516|NCT04388033|Growth Substances|growth substances|mesh-ancestor
102471517|NCT04388033|Growth Inhibitors|growth inhibitors|mesh-ancestor
102471518|NCT03267680|Indomethacin|indomethacin|mesh-list
102471519|NCT03267680|Cyclophosphamide|cyclophosphamide|mesh-list
102471520|NCT03267680|Omeprazole|omeprazole|mesh-list
102471521|NCT03267680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102471522|NCT03267680|Immunologic Factors|immunologic factors|mesh-ancestor
102471523|NCT03267680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471524|NCT03267680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102471525|NCT03267680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102471526|NCT03267680|Alkylating Agents|alkylating agents|mesh-ancestor
102471527|NCT03267680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471528|NCT03267680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102471529|NCT03267680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102471530|NCT03267680|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102471531|NCT03267680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102471532|NCT03267680|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102471533|NCT03267680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102471534|NCT03267680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102471535|NCT03267680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102471536|NCT03267680|Analgesics|analgesics|mesh-ancestor
102471537|NCT03267680|Sensory System Agents|sensory system agents|mesh-ancestor
102471538|NCT03267680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102471539|NCT03267680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102471540|NCT03267680|Gout Suppressants|gout suppressants|mesh-ancestor
102471541|NCT03267680|Tocolytic Agents|tocolytic agents|mesh-ancestor
102471542|NCT03267680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102471543|NCT03267680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102471544|NCT02980731|Venetoclax|venetoclax|mesh-list
102471545|NCT02980731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102471546|NCT05564390|Cytarabine|cytarabine|mesh-list
102471547|NCT05564390|Azacitidine|azacitidine|mesh-list
102471548|NCT05564390|Daunorubicin|daunorubicin|mesh-list
102471549|NCT05564390|Venetoclax|venetoclax|mesh-list
102471550|NCT05564390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102471551|NCT05564390|Antimetabolites|antimetabolites|mesh-ancestor
102471552|NCT05564390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555286|NCT04131829|Fluoxetine|fluoxetine|mesh-list
102471553|NCT05564390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102471554|NCT05564390|Antiviral Agents|antiviral agents|mesh-ancestor
102471555|NCT05564390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102471556|NCT05564390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102471557|NCT05564390|Immunologic Factors|immunologic factors|mesh-ancestor
102471558|NCT05564390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471559|NCT05564390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102471560|NCT05564390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102471561|NCT05564390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102471562|NCT05564390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102471563|NCT04725591|Insulin|insulin|mesh-list
102471564|NCT04725591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102471565|NCT04725591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471566|NCT02980497|Ethanol|ethanol|mesh-list
102471567|NCT02980497|Listerine|listerine|mesh-list
102471568|NCT02980497|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
102471569|NCT02980497|Sodium Fluoride|sodium fluoride|mesh-list
102471570|NCT02980497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102471571|NCT02980497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101555299|NCT04131829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102471572|NCT02980497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471573|NCT02980497|Cariostatic Agents|cariostatic agents|mesh-ancestor
102471574|NCT02980497|Protective Agents|protective agents|mesh-ancestor
102471575|NCT02652429|Nitric Oxide|nitric oxide|mesh-list
102471576|NCT02652429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102471577|NCT02652429|Autonomic Agents|autonomic agents|mesh-ancestor
102471578|NCT02652429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102471579|NCT02652429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471580|NCT02652429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102471581|NCT02652429|Respiratory System Agents|respiratory system agents|mesh-ancestor
102471582|NCT02652429|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102471583|NCT02652429|Antioxidants|antioxidants|mesh-ancestor
102471584|NCT02652429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471585|NCT02652429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102471586|NCT02652429|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102471587|NCT02652429|Vasodilator Agents|vasodilator agents|mesh-ancestor
102471588|NCT02652429|Gasotransmitters|gasotransmitters|mesh-ancestor
102471589|NCT02652429|Protective Agents|protective agents|mesh-ancestor
102471590|NCT02294253|Buprenorphine|buprenorphine|mesh-list
102471591|NCT02294253|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102471592|NCT02294253|Naloxone|naloxone|mesh-list
102471593|NCT02294253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102471594|NCT02294253|Narcotics|narcotics|mesh-ancestor
102471595|NCT02294253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102471596|NCT02294253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471597|NCT02294253|Analgesics|analgesics|mesh-ancestor
102471598|NCT02294253|Sensory System Agents|sensory system agents|mesh-ancestor
102471599|NCT02294253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102471600|NCT02294253|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102471601|NCT00684983|Capecitabine|capecitabine|mesh-list
102471602|NCT00684983|Lapatinib|lapatinib|mesh-list
102471603|NCT00684983|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102471604|NCT00684983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102471605|NCT00684983|Antimetabolites|antimetabolites|mesh-ancestor
102471606|NCT00684983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471607|NCT00684983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102471608|NCT00684983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102471609|NCT00684983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102471610|NCT00684983|Immunologic Factors|immunologic factors|mesh-ancestor
102471611|NCT00684983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471612|NCT03339596|Epoetin Alfa|epoetin alfa|mesh-list
102471613|NCT03339596|Hematinics|hematinics|mesh-ancestor
102471614|NCT00638651|Imiquimod|imiquimod|mesh-list
102471615|NCT00638651|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102471616|NCT00638651|Immunologic Factors|immunologic factors|mesh-ancestor
102471617|NCT00638651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471618|NCT00638651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102471619|NCT00638651|Interferon Inducers|interferon inducers|mesh-ancestor
102471620|NCT02584647|Sirolimus|sirolimus|mesh-list
102471621|NCT02584647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102471622|NCT02584647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102471623|NCT02584647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102471624|NCT02584647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102471625|NCT02584647|Antifungal Agents|antifungal agents|mesh-ancestor
102471626|NCT02584647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102471627|NCT02584647|Immunologic Factors|immunologic factors|mesh-ancestor
102471628|NCT02584647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471629|NCT00685139|Zonisamide|zonisamide|mesh-list
102471630|NCT00685139|Anticonvulsants|anticonvulsants|mesh-ancestor
102471631|NCT00685139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102471632|NCT00685139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102471633|NCT00685139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471634|NCT00685139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102471635|NCT00685139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471637|NCT00685295|Oxycodone|oxycodone|mesh-list
102471638|NCT00685295|Lansoprazole|lansoprazole|mesh-list
102471639|NCT00685295|Dexlansoprazole|dexlansoprazole|mesh-list
102471640|NCT00685295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102471641|NCT00685295|Narcotics|narcotics|mesh-ancestor
102471642|NCT00685295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102471643|NCT00685295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471644|NCT00685295|Analgesics|analgesics|mesh-ancestor
102471645|NCT00685295|Sensory System Agents|sensory system agents|mesh-ancestor
102471646|NCT00685295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102471647|NCT00685295|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102471648|NCT00685295|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102471649|NCT00685295|Anesthetics, General|anesthetics, general|mesh-ancestor
102471650|NCT00685295|Anesthetics|anesthetics|mesh-ancestor
102471651|NCT00685295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102471652|NCT00685295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102471653|NCT00685295|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102471654|NCT00685295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102471655|NCT00685295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471656|NCT00686231|Lidocaine|lidocaine|mesh-list
102471657|NCT00686231|Nitroglycerin|nitroglycerin|mesh-list
102471658|NCT00686231|Anesthetics, Local|anesthetics, local|mesh-ancestor
102471659|NCT00686231|Anesthetics|anesthetics|mesh-ancestor
102471660|NCT00686231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102471661|NCT00686231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471662|NCT00686231|Sensory System Agents|sensory system agents|mesh-ancestor
102471663|NCT00686231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102471664|NCT00686231|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101555381|NCT00628810|Fluorouracil|fluorouracil|mesh-list
102471665|NCT00686231|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102471666|NCT00686231|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102471667|NCT00686231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102471668|NCT00686231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471669|NCT00686231|Vasodilator Agents|vasodilator agents|mesh-ancestor
102471670|NCT05278208|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102471671|NCT05278208|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102471672|NCT05278208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471673|NCT03335774|Hydrocortisone|hydrocortisone|mesh-list
102471674|NCT03335774|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102471675|NCT03335774|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102471676|NCT03335774|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102471677|NCT03335774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102471678|NCT03335540|Nivolumab|nivolumab|mesh-list
102471679|NCT03335540|Ipilimumab|ipilimumab|mesh-list
102471680|NCT03335540|Relatlimab|relatlimab|mesh-list
102471681|NCT03335540|Linrodostat|linrodostat|mesh-list
102471682|NCT03335540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102471683|NCT03335540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102471684|NCT03335540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102471685|NCT03335540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471686|NCT03335540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102471687|NCT00643097|Temozolomide|temozolomide|mesh-list
102471688|NCT00643097|Sargramostim|sargramostim|mesh-list
102471689|NCT00643097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102471690|NCT00643097|Alkylating Agents|alkylating agents|mesh-ancestor
102471691|NCT00643097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471692|NCT00643097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102471693|NCT00643097|Immunologic Factors|immunologic factors|mesh-ancestor
102471694|NCT00643097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471695|NCT03333668|Guanfacine|guanfacine|mesh-list
102471696|NCT03333668|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102471697|NCT03333668|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102471698|NCT03333668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471699|NCT03333668|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102471700|NCT03333668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102471701|NCT03333668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102471702|NCT03333668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471703|NCT03333668|Dopamine Agents|dopamine agents|mesh-ancestor
102471704|NCT03333668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102471705|NCT03333668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102471706|NCT03333668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102471707|NCT03333668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102471708|NCT03333668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102471709|NCT03333668|Adrenergic Agents|adrenergic agents|mesh-ancestor
102471710|NCT03280160|Ofatumumab|ofatumumab|mesh-list
102471711|NCT03280160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102471712|NCT04683315|Paclitaxel|paclitaxel|mesh-list
102471713|NCT04683315|Gemcitabine|gemcitabine|mesh-list
102471714|NCT04683315|Fluorouracil|fluorouracil|mesh-list
102471715|NCT04683315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102471716|NCT04683315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102471717|NCT04683315|Tubulin Modulators|tubulin modulators|mesh-ancestor
102471718|NCT04683315|Antimitotic Agents|antimitotic agents|mesh-ancestor
102471719|NCT04683315|Mitosis Modulators|mitosis modulators|mesh-ancestor
102471720|NCT04683315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471721|NCT04683315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102471722|NCT04683315|Antimetabolites|antimetabolites|mesh-ancestor
102471723|NCT04683315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102471724|NCT04683315|Immunologic Factors|immunologic factors|mesh-ancestor
102471725|NCT04683315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471726|NCT05502146|Norepinephrine|norepinephrine|mesh-list
102471727|NCT05502146|Bupivacaine|bupivacaine|mesh-list
102471728|NCT05502146|Anesthetics, Local|anesthetics, local|mesh-ancestor
102471729|NCT05502146|Anesthetics|anesthetics|mesh-ancestor
102471730|NCT05502146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102471731|NCT05502146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471732|NCT05502146|Sensory System Agents|sensory system agents|mesh-ancestor
102471733|NCT05502146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102471734|NCT05502146|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102471735|NCT05502146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102471736|NCT05502146|Adrenergic Agents|adrenergic agents|mesh-ancestor
102471737|NCT05502146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102471738|NCT05502146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471739|NCT05502146|Sympathomimetics|sympathomimetics|mesh-ancestor
102471740|NCT05502146|Autonomic Agents|autonomic agents|mesh-ancestor
102471741|NCT05502146|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102471742|NCT04027361|Amphetamine|amphetamine|mesh-list
101555457|NCT04095715|Coagulants|coagulants|mesh-ancestor
102471743|NCT04027361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102471744|NCT04027361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471745|NCT04027361|Sympathomimetics|sympathomimetics|mesh-ancestor
102471746|NCT04027361|Autonomic Agents|autonomic agents|mesh-ancestor
102471747|NCT04027361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102471748|NCT04027361|Dopamine Agents|dopamine agents|mesh-ancestor
102471749|NCT04027361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102471750|NCT04027361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471751|NCT04027361|Adrenergic Agents|adrenergic agents|mesh-ancestor
102471752|NCT04027361|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102471753|NCT04027361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102471754|NCT04027361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102471755|NCT04027361|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102471756|NCT04682847|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102471757|NCT04682847|Hematinics|hematinics|mesh-ancestor
102471758|NCT04682847|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102471759|NCT04682847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102471760|NCT04011839|Levobupivacaine|levobupivacaine|mesh-list
102471761|NCT04011839|Anesthetics, Local|anesthetics, local|mesh-ancestor
102471762|NCT04011839|Anesthetics|anesthetics|mesh-ancestor
102471763|NCT04011839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102471764|NCT04011839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471765|NCT04011839|Sensory System Agents|sensory system agents|mesh-ancestor
102471766|NCT04011839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102471767|NCT03793439|Prednisone|prednisone|mesh-list
102471768|NCT03793439|Tofacitinib|tofacitinib|mesh-list
102471769|NCT03793439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102471770|NCT03793439|Glucocorticoids|glucocorticoids|mesh-ancestor
102471771|NCT03793439|Hormones|hormones|mesh-ancestor
102471772|NCT03793439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102471773|NCT03793439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471774|NCT03793439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102471775|NCT03793439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102471776|NCT03793439|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101555496|NCT02863861|Ketamine|ketamine|mesh-list
102471777|NCT03793439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102471778|NCT03793439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102471779|NCT03793439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283403|NCT05035069|Propofol|propofol|mesh-list
102471781|NCT00687167|Anticonvulsants|anticonvulsants|mesh-ancestor
102471782|NCT00687167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102471783|NCT00687167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102471784|NCT00687167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471785|NCT00687167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102471786|NCT00687167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555513|NCT02863861|Anesthetics|anesthetics|mesh-ancestor
102471788|NCT00687713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102471789|NCT00687713|Antidepressive Agents|antidepressive agents|mesh-ancestor
102471790|NCT00687713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102471791|NCT00687713|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102471792|NCT00687713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102471793|NCT00687713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102471794|NCT00687713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471795|NCT00687713|Dopamine Agents|dopamine agents|mesh-ancestor
102471796|NCT00687713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102471797|NCT00687713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471798|NCT00687713|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102471799|NCT00687713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102471800|NCT00687713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102471801|NCT02304159|Ribavirin|ribavirin|mesh-list
102471802|NCT02304159|Sofosbuvir|sofosbuvir|mesh-list
102471803|NCT02304159|Antimetabolites|antimetabolites|mesh-ancestor
102471804|NCT02304159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471805|NCT02304159|Antiviral Agents|antiviral agents|mesh-ancestor
102471806|NCT02304159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102471807|NCT02143973|Nalbuphine|nalbuphine|mesh-list
102471808|NCT02143973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102471809|NCT02143973|Narcotics|narcotics|mesh-ancestor
102471810|NCT02143973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102471811|NCT02143973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471812|NCT02143973|Analgesics|analgesics|mesh-ancestor
102471813|NCT02143973|Sensory System Agents|sensory system agents|mesh-ancestor
102471814|NCT02143973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102471815|NCT03028701|Budesonide|budesonide|mesh-list
102471816|NCT03028701|Formoterol Fumarate|formoterol fumarate|mesh-list
102471817|NCT03028701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102471818|NCT03028701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102471819|NCT03028701|Autonomic Agents|autonomic agents|mesh-ancestor
102471820|NCT03028701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102471821|NCT03028701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471822|NCT03028701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102471823|NCT03028701|Respiratory System Agents|respiratory system agents|mesh-ancestor
102471824|NCT03028701|Glucocorticoids|glucocorticoids|mesh-ancestor
102471825|NCT03028701|Hormones|hormones|mesh-ancestor
102471826|NCT03028701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102471827|NCT03028701|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102471828|NCT03028701|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102471829|NCT03028701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102471830|NCT03028701|Adrenergic Agents|adrenergic agents|mesh-ancestor
102471831|NCT03028701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102471832|NCT03028701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471833|NCT03686696|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102471834|NCT03686696|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102471835|NCT03686696|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
102471836|NCT03686696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102471837|NCT03686696|Adrenergic Agents|adrenergic agents|mesh-ancestor
102471838|NCT03686696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102471839|NCT03686696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471840|NCT03686696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471841|NCT03686696|Protease Inhibitors|protease inhibitors|mesh-ancestor
102471842|NCT03686696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102471843|NCT02267655|Nitric Oxide|nitric oxide|mesh-list
102471844|NCT02267655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102471845|NCT02267655|Autonomic Agents|autonomic agents|mesh-ancestor
102471846|NCT02267655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102471847|NCT02267655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471848|NCT02267655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102471849|NCT02267655|Respiratory System Agents|respiratory system agents|mesh-ancestor
102471850|NCT02267655|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102471851|NCT02267655|Antioxidants|antioxidants|mesh-ancestor
102471852|NCT02267655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471853|NCT02267655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101555571|NCT00624429|Autonomic Agents|autonomic agents|mesh-ancestor
102471854|NCT02267655|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102471855|NCT02267655|Vasodilator Agents|vasodilator agents|mesh-ancestor
102471856|NCT02267655|Gasotransmitters|gasotransmitters|mesh-ancestor
102471857|NCT02267655|Protective Agents|protective agents|mesh-ancestor
102471858|NCT02209545|Pyridoxine|pyridoxine|mesh-list
102471859|NCT02209545|Vitamin B 6|vitamin b 6|mesh-list
102471860|NCT02209545|Misoprostol|misoprostol|mesh-list
102471861|NCT02209545|Vitamins|vitamins|mesh-ancestor
102471862|NCT02209545|Micronutrients|micronutrients|mesh-ancestor
102471863|NCT02209545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471864|NCT02209545|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102471865|NCT02209545|Abortifacient Agents|abortifacient agents|mesh-ancestor
102471866|NCT02209545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102471867|NCT02209545|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102471868|NCT02209545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102471869|NCT02209545|Oxytocics|oxytocics|mesh-ancestor
102471870|NCT02209545|Vitamin B Complex|vitamin b complex|mesh-ancestor
102471871|NCT04858958|Aflutinib|aflutinib|mesh-list
102471872|NCT04858958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102471873|NCT04858958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102471874|NCT04858958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471875|NCT00690833|Desonide|desonide|mesh-list
102471876|NCT00690833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102471877|NCT03686306|Sildenafil Citrate|sildenafil citrate|mesh-list
102471878|NCT03686306|Vasodilator Agents|vasodilator agents|mesh-ancestor
102471879|NCT03686306|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102471880|NCT03686306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102471881|NCT03686306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102471882|NCT03686306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471883|NCT03686306|Urological Agents|urological agents|mesh-ancestor
102471884|NCT04078269|Immunomodulating Agents|immunomodulating agents|mesh-list
102471885|NCT04078269|Immunologic Factors|immunologic factors|mesh-ancestor
102471886|NCT04078269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471887|NCT00644657|Clopidogrel|clopidogrel|mesh-list
102471888|NCT00644657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102471889|NCT00644657|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102471890|NCT00644657|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102471891|NCT00644657|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102471892|NCT00644657|Purinergic Agents|purinergic agents|mesh-ancestor
102471893|NCT00644657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102471894|NCT00644657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555599|NCT00628576|Dalteparin|dalteparin|mesh-list
102471895|NCT00644657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471896|NCT04613024|Topiramate|topiramate|mesh-list
102471897|NCT04613024|Gabapentin|gabapentin|mesh-list
102471898|NCT04613024|Analgesics|analgesics|mesh-ancestor
102471899|NCT04613024|Sensory System Agents|sensory system agents|mesh-ancestor
102471900|NCT04613024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102471901|NCT04613024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471902|NCT04613024|Anticonvulsants|anticonvulsants|mesh-ancestor
102471903|NCT04613024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102471904|NCT04613024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102471905|NCT04613024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102471906|NCT04613024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102471907|NCT04613024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102471908|NCT04613024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102471909|NCT04613024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102471910|NCT04613024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471911|NCT04613024|Antimanic Agents|antimanic agents|mesh-ancestor
102471912|NCT04613024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102471913|NCT01933815|Bevacizumab|bevacizumab|mesh-list
102471914|NCT01933815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102471915|NCT01933815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102471916|NCT01933815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102471917|NCT01933815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102471918|NCT01933815|Growth Substances|growth substances|mesh-ancestor
102471919|NCT01933815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471920|NCT01933815|Growth Inhibitors|growth inhibitors|mesh-ancestor
102471921|NCT04606316|Nivolumab|nivolumab|mesh-list
102471922|NCT04606316|Ipilimumab|ipilimumab|mesh-list
102471923|NCT04606316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102471924|NCT04606316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102471925|NCT04606316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102471926|NCT04606316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471927|NCT03480971|Tempol|tempol|mesh-list
102471928|NCT03480971|TEMPO|tempo|mesh-list
102471929|NCT03480971|Antioxidants|antioxidants|mesh-ancestor
102471930|NCT03480971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471931|NCT03480971|Protective Agents|protective agents|mesh-ancestor
102471932|NCT03480971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471933|NCT03480971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102471934|NCT03480971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102471935|NCT03480971|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102471936|NCT03480971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102471937|NCT00646763|Lenograstim|lenograstim|mesh-list
102471938|NCT00646763|Sargramostim|sargramostim|mesh-list
102471939|NCT00646763|Mitogens|mitogens|mesh-list
102471940|NCT00646763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102471941|NCT00646763|Immunologic Factors|immunologic factors|mesh-ancestor
102471942|NCT00646763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471943|NCT00646763|Mitosis Modulators|mitosis modulators|mesh-ancestor
102471944|NCT00646763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471945|NCT03237572|Pembrolizumab|pembrolizumab|mesh-list
102471946|NCT03237572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102471947|NCT03237572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102471948|NCT03237572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102471949|NCT03237572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471950|NCT02986347|Epinephrine|epinephrine|mesh-list
102471951|NCT02986347|Racepinephrine|racepinephrine|mesh-list
102471952|NCT02986347|Anesthetics|anesthetics|mesh-list
102471953|NCT02986347|Epinephryl borate|epinephryl borate|mesh-list
102471954|NCT02986347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102471955|NCT02986347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471956|NCT02986347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102471957|NCT02986347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102471958|NCT02986347|Adrenergic Agents|adrenergic agents|mesh-ancestor
102471959|NCT02986347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102471960|NCT02986347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471961|NCT02986347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102471962|NCT02986347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102471963|NCT02986347|Autonomic Agents|autonomic agents|mesh-ancestor
102471964|NCT02986347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102471965|NCT02986347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102471966|NCT02986347|Respiratory System Agents|respiratory system agents|mesh-ancestor
102471967|NCT02986347|Mydriatics|mydriatics|mesh-ancestor
102471968|NCT02986347|Sympathomimetics|sympathomimetics|mesh-ancestor
102471969|NCT02986347|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102471970|NCT00649961|Melatonin|melatonin|mesh-list
102471971|NCT00649961|Antioxidants|antioxidants|mesh-ancestor
101555680|NCT04294966|Analgesics|analgesics|mesh-ancestor
102471972|NCT00649961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471973|NCT00649961|Protective Agents|protective agents|mesh-ancestor
102471974|NCT00649961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471975|NCT00649961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102471976|NCT03235232|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102471977|NCT03235232|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
102471978|NCT03235232|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102471979|NCT03235232|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102471980|NCT03235232|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102471981|NCT03235232|Adrenergic Agents|adrenergic agents|mesh-ancestor
102471982|NCT03235232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102471983|NCT03235232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102471984|NCT03235232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471985|NCT03235232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102471986|NCT03235232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102471987|NCT03235232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102471988|NCT01781637|Omalizumab|omalizumab|mesh-list
102471989|NCT01781637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102471990|NCT01781637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102471991|NCT01781637|Respiratory System Agents|respiratory system agents|mesh-ancestor
102471992|NCT00652145|Mesalamine|mesalamine|mesh-list
102471993|NCT00652145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102471994|NCT00652145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102471995|NCT00652145|Analgesics|analgesics|mesh-ancestor
102471996|NCT00652145|Sensory System Agents|sensory system agents|mesh-ancestor
102471997|NCT00652145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102471998|NCT00652145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102471999|NCT00652145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102472000|NCT00652145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102472001|NCT03231722|Leucovorin|leucovorin|mesh-list
102472002|NCT03231722|Fluorouracil|fluorouracil|mesh-list
102472003|NCT03231722|Oxaliplatin|oxaliplatin|mesh-list
102472004|NCT03231722|Irinotecan|irinotecan|mesh-list
102472005|NCT03231722|Panitumumab|panitumumab|mesh-list
102472006|NCT03231722|Levoleucovorin|levoleucovorin|mesh-list
102472007|NCT03231722|Antimetabolites|antimetabolites|mesh-ancestor
102472008|NCT03231722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472009|NCT03231722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102472010|NCT03231722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102472011|NCT03231722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102472012|NCT03231722|Immunologic Factors|immunologic factors|mesh-ancestor
102472013|NCT03231722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472014|NCT03231722|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102472015|NCT03231722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102472016|NCT03231722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102472017|NCT03231722|Antidotes|antidotes|mesh-ancestor
102472018|NCT03231722|Protective Agents|protective agents|mesh-ancestor
102472019|NCT03231722|Vitamin B Complex|vitamin b complex|mesh-ancestor
102472020|NCT03231722|Vitamins|vitamins|mesh-ancestor
102472021|NCT03231722|Micronutrients|micronutrients|mesh-ancestor
102472022|NCT03231722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102472023|NCT02298933|Eculizumab|eculizumab|mesh-list
102472024|NCT02298933|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102472025|NCT02298933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102472026|NCT02298933|Immunologic Factors|immunologic factors|mesh-ancestor
102472027|NCT02298933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472028|NCT02959775|Vaccines|vaccines|mesh-list
102472029|NCT02959775|Immunologic Factors|immunologic factors|mesh-ancestor
102472030|NCT02959775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472031|NCT04761848|Cilostazol|cilostazol|mesh-list
102472032|NCT04761848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102472033|NCT04761848|Autonomic Agents|autonomic agents|mesh-ancestor
102472034|NCT04761848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102472035|NCT04761848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472036|NCT04761848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102472037|NCT04761848|Respiratory System Agents|respiratory system agents|mesh-ancestor
102472038|NCT04761848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102472039|NCT04761848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102472040|NCT04761848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472041|NCT04761848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101555727|NCT01204671|Vaccines|vaccines|mesh-list
102472042|NCT04761848|Vasodilator Agents|vasodilator agents|mesh-ancestor
102472043|NCT04761848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102472044|NCT04761848|Protective Agents|protective agents|mesh-ancestor
102472045|NCT04761848|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102472046|NCT04761848|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102472047|NCT04761848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102472048|NCT03277196|Ivacaftor|ivacaftor|mesh-list
102472049|NCT03277196|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102472050|NCT03277196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102472051|NCT03277196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472052|NCT04278248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102472053|NCT04278248|Immunologic Factors|immunologic factors|mesh-ancestor
102472054|NCT04278248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472055|NCT04056962|Tacrolimus|tacrolimus|mesh-list
102472056|NCT04056962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102472057|NCT04056962|Immunologic Factors|immunologic factors|mesh-ancestor
102472058|NCT04056962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472059|NCT04056962|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102472060|NCT04056962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102472061|NCT04056962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472062|NCT00693485|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102472063|NCT00693485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102472064|NCT00693485|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102472065|NCT00693485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102472066|NCT00693485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102472067|NCT00693485|Adrenergic Agents|adrenergic agents|mesh-ancestor
102472068|NCT00693485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102472069|NCT00693485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555776|NCT01200069|Analgesics|analgesics|mesh-ancestor
102472070|NCT00693485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472071|NCT00693719|Irinotecan|irinotecan|mesh-list
102472072|NCT00693719|Etoposide|etoposide|mesh-list
102472073|NCT00693719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101555793|NCT01199055|Antimitotic Agents|antimitotic agents|mesh-ancestor
102472074|NCT00693719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102472075|NCT00693719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102472076|NCT00693719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472077|NCT00693719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102472078|NCT00693719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102472079|NCT00693719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102472080|NCT00653861|Lidocaine|lidocaine|mesh-list
102472081|NCT00653861|Anesthetics, Local|anesthetics, local|mesh-ancestor
102472082|NCT00653861|Anesthetics|anesthetics|mesh-ancestor
102472083|NCT00653861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102472084|NCT00653861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472085|NCT00653861|Sensory System Agents|sensory system agents|mesh-ancestor
102472086|NCT00653861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102472087|NCT00653861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102472088|NCT00653861|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102472089|NCT00653861|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102472090|NCT00653861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102472091|NCT00653861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472092|NCT00654329|Fentanyl|fentanyl|mesh-list
102472093|NCT00654329|Dexmedetomidine|dexmedetomidine|mesh-list
102472094|NCT00654329|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102472095|NCT00654329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101555807|NCT01198275|Amiodarone|amiodarone|mesh-list
102472096|NCT00654329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472097|NCT00654329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102472098|NCT00654329|Analgesics|analgesics|mesh-ancestor
102472099|NCT00654329|Sensory System Agents|sensory system agents|mesh-ancestor
102472100|NCT00654329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102472101|NCT00654329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102472102|NCT00654329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102472103|NCT00654329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102472104|NCT00654329|Adrenergic Agents|adrenergic agents|mesh-ancestor
102472105|NCT00654329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101555820|NCT01197417|Magnesium Sulfate|magnesium sulfate|mesh-list
102472106|NCT00654329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472107|NCT00654329|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102472108|NCT00654329|Narcotics|narcotics|mesh-ancestor
102472109|NCT00654329|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102472110|NCT00654329|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102472111|NCT00654329|Anesthetics, General|anesthetics, general|mesh-ancestor
102472112|NCT00654329|Anesthetics|anesthetics|mesh-ancestor
102472113|NCT00695435|Tobramycin|tobramycin|mesh-list
102472114|NCT00695435|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
102472115|NCT00695435|Dexamethasone|dexamethasone|mesh-list
102472116|NCT00695435|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102472117|NCT00695435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102472118|NCT00695435|Antiemetics|antiemetics|mesh-ancestor
102472119|NCT00695435|Autonomic Agents|autonomic agents|mesh-ancestor
102472120|NCT00695435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102472121|NCT00695435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472122|NCT00695435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102472123|NCT00695435|Glucocorticoids|glucocorticoids|mesh-ancestor
102472124|NCT00695435|Hormones|hormones|mesh-ancestor
102472125|NCT00695435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102472126|NCT00695435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102472127|NCT00695435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102472128|NCT00695435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102472129|NCT00695435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102472130|NCT00695435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102472131|NCT00654953|Gabapentin|gabapentin|mesh-list
102472132|NCT00654953|Sertraline|sertraline|mesh-list
102472133|NCT00654953|Analgesics|analgesics|mesh-ancestor
102472134|NCT00654953|Sensory System Agents|sensory system agents|mesh-ancestor
102472135|NCT00654953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102472136|NCT00654953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472137|NCT00654953|Anticonvulsants|anticonvulsants|mesh-ancestor
102472138|NCT00654953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102472139|NCT00654953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102472140|NCT00654953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102472141|NCT00654953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102472142|NCT00654953|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102472143|NCT00654953|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102472144|NCT00654953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102472145|NCT00654953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472146|NCT00654953|Antimanic Agents|antimanic agents|mesh-ancestor
102472147|NCT00654953|Antidepressive Agents|antidepressive agents|mesh-ancestor
102472148|NCT00654953|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102472149|NCT00654953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102472150|NCT00654953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102472152|NCT01790165|Terbinafine|terbinafine|mesh-list
102472153|NCT01790165|Antifungal Agents|antifungal agents|mesh-ancestor
102472154|NCT01790165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102472155|NCT01790165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102472156|NCT01790165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472157|NCT02299089|Octreotide|octreotide|mesh-list
102472158|NCT02299089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102472159|NCT02299089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102472160|NCT02299089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102472161|NCT00655811|Capsaicin|capsaicin|mesh-list
102472162|NCT00655811|Antipruritics|antipruritics|mesh-ancestor
102472163|NCT00655811|Dermatologic Agents|dermatologic agents|mesh-ancestor
102472164|NCT00655811|Sensory System Agents|sensory system agents|mesh-ancestor
102472165|NCT00655811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102472166|NCT00655811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472167|NCT03931551|Trastuzumab|trastuzumab|mesh-list
102472168|NCT03931551|Olaparib|olaparib|mesh-list
102472169|NCT03931551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102472170|NCT03931551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102472171|NCT03931551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102472172|NCT03931551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102472173|NCT03931551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472174|NCT00696293|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102472175|NCT00696293|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102472176|NCT00696293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102472177|NCT00696293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102472178|NCT00696293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472179|NCT00696293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102472180|NCT00696293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472181|NCT00696293|Analgesics|analgesics|mesh-ancestor
102472182|NCT00696293|Sensory System Agents|sensory system agents|mesh-ancestor
102472183|NCT00696293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102472184|NCT00696293|Antidepressive Agents|antidepressive agents|mesh-ancestor
102472185|NCT00696293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102472186|NCT00696293|Dopamine Agents|dopamine agents|mesh-ancestor
102472187|NCT00696449|Adapalene|adapalene|mesh-list
102472188|NCT00696449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102472189|NCT00696449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102472190|NCT00696449|Analgesics|analgesics|mesh-ancestor
102472191|NCT00696449|Sensory System Agents|sensory system agents|mesh-ancestor
102472192|NCT00696449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102472193|NCT00696449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422182|NCT00150384|Amlodipine|amlodipine|mesh-list
102472194|NCT00696449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102472195|NCT00696449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102472196|NCT00696449|Dermatologic Agents|dermatologic agents|mesh-ancestor
102472197|NCT00696761|Alfuzosin|alfuzosin|mesh-list
102472198|NCT00696761|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102472199|NCT00696761|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102472200|NCT00696761|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102472201|NCT00696761|Adrenergic Agents|adrenergic agents|mesh-ancestor
102472202|NCT00696761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102472203|NCT00696761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472204|NCT00696761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472205|NCT00696761|Urological Agents|urological agents|mesh-ancestor
102472206|NCT00656201|Progesterone|progesterone|mesh-list
102472207|NCT00656201|Progestins|progestins|mesh-ancestor
102472208|NCT00656201|Hormones|hormones|mesh-ancestor
101555913|NCT00972595|Ondansetron|ondansetron|mesh-list
102472209|NCT00656201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102472210|NCT00656201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472211|NCT00759291|Acipimox|acipimox|mesh-list
102472212|NCT00759291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102472213|NCT00759291|Antimetabolites|antimetabolites|mesh-ancestor
102472214|NCT00759291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472215|NCT00759291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102472216|NCT00756405|Antioxidants|antioxidants|mesh-list
102472217|NCT00756405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472218|NCT00756405|Protective Agents|protective agents|mesh-ancestor
102472219|NCT00756405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472220|NCT00697541|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102472221|NCT00697541|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102472222|NCT00697541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102472223|NCT00697541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102472224|NCT00697541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102472225|NCT00697541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102472226|NCT00697541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102472227|NCT00697541|Adrenergic Agents|adrenergic agents|mesh-ancestor
102472228|NCT00697541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102472229|NCT00697541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472230|NCT00697541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472232|NCT03889275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102472233|NCT03889275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102472234|NCT00657917|Gentamicins|gentamicins|mesh-list
102472235|NCT00657917|Paromomycin|paromomycin|mesh-list
102472236|NCT00657917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102472237|NCT00657917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102472238|NCT00657917|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102472239|NCT00657917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102472240|NCT00657917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472241|NCT00657917|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102472242|NCT00657917|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102472243|NCT01959945|Hemagglutinins|hemagglutinins|mesh-list
102472244|NCT01959945|Vaccines|vaccines|mesh-list
102472245|NCT01959945|Immunologic Factors|immunologic factors|mesh-ancestor
102472246|NCT01959945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472247|NCT01959945|Agglutinins|agglutinins|mesh-ancestor
102472248|NCT01959945|Coagulants|coagulants|mesh-ancestor
102472249|NCT00700661|Montelukast|montelukast|mesh-list
102472250|NCT00700661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102472251|NCT00700661|Respiratory System Agents|respiratory system agents|mesh-ancestor
102472252|NCT00700661|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102472253|NCT00700661|Hormone Antagonists|hormone antagonists|mesh-ancestor
102472254|NCT00700661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102472255|NCT00700661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472256|NCT00700661|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102472257|NCT00700661|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102472258|NCT00700661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472259|NCT00652847|Ezetimibe|ezetimibe|mesh-list
102472260|NCT00652847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102472261|NCT00652847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102472262|NCT00652847|Antimetabolites|antimetabolites|mesh-ancestor
102472263|NCT00652847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472264|NCT00652847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102472265|NCT00652301|Simvastatin|simvastatin|mesh-list
102472266|NCT00652301|Ezetimibe|ezetimibe|mesh-list
102472267|NCT00652301|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102472268|NCT00652301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102472269|NCT00652301|Antimetabolites|antimetabolites|mesh-ancestor
102472270|NCT00652301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472271|NCT00652301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102472272|NCT00652301|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102472273|NCT00652301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102472274|NCT01961271|Buprenorphine|buprenorphine|mesh-list
102472275|NCT01961271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102472276|NCT01961271|Narcotics|narcotics|mesh-ancestor
102472277|NCT01961271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102472278|NCT01961271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472279|NCT01961271|Analgesics|analgesics|mesh-ancestor
102472280|NCT01961271|Sensory System Agents|sensory system agents|mesh-ancestor
102472281|NCT01961271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102472282|NCT01961271|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102472283|NCT01963143|gamma-Globulins|gamma-globulins|mesh-list
102472284|NCT01963143|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102472285|NCT01963143|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102472286|NCT01963143|Immunologic Factors|immunologic factors|mesh-ancestor
102472287|NCT01963143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472288|NCT03822351|Durvalumab|durvalumab|mesh-list
102472289|NCT03822351|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102472290|NCT03822351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102472291|NCT03822351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102472292|NCT03822351|Immunologic Factors|immunologic factors|mesh-ancestor
102472293|NCT03822351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472294|NCT01963845|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102472295|NCT01963845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102472296|NCT01963845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472297|NCT01963845|Incretins|incretins|mesh-ancestor
102472298|NCT01963845|Hormones|hormones|mesh-ancestor
102472299|NCT01963845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102472300|NCT01963845|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102472301|NCT01963845|Protease Inhibitors|protease inhibitors|mesh-ancestor
102472302|NCT01963845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102472303|NCT01963845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556016|NCT01193127|Mydriatics|mydriatics|mesh-list
102472304|NCT00658619|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102472305|NCT00658619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102472306|NCT00658619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102472307|NCT00658619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102472308|NCT00658619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102472309|NCT00658619|Adrenergic Agents|adrenergic agents|mesh-ancestor
102472310|NCT00658619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102472311|NCT00658619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472312|NCT00658619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472313|NCT01966419|Phenylacetic acid|phenylacetic acid|mesh-list
102472314|NCT01966419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102472315|NCT01966419|Antimetabolites|antimetabolites|mesh-ancestor
102472316|NCT01966419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472317|NCT01966419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102472318|NCT01966809|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
102472319|NCT01966809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102472320|NCT01966809|Dermatologic Agents|dermatologic agents|mesh-ancestor
102472321|NCT01966809|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102472322|NCT04575584|Molnupiravir|molnupiravir|mesh-list
102472323|NCT04575584|Antiviral Agents|antiviral agents|mesh-ancestor
102472324|NCT04575584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102472325|NCT04277702|Montelukast|montelukast|mesh-list
102472326|NCT04277702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102472327|NCT04277702|Respiratory System Agents|respiratory system agents|mesh-ancestor
102472328|NCT04277702|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102472329|NCT04277702|Hormone Antagonists|hormone antagonists|mesh-ancestor
102472330|NCT04277702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102472331|NCT04277702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472332|NCT04277702|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102472333|NCT04277702|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102472334|NCT04277702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472335|NCT00699491|Sirolimus|sirolimus|mesh-list
102472336|NCT00699491|Temsirolimus|temsirolimus|mesh-list
102472337|NCT00699491|MTOR Inhibitors|mtor inhibitors|mesh-list
102472338|NCT00699491|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102472339|NCT00699491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102472340|NCT00699491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102472341|NCT00699491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102472342|NCT00699491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102472343|NCT00699491|Antifungal Agents|antifungal agents|mesh-ancestor
102472344|NCT00699491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102472345|NCT00699491|Immunologic Factors|immunologic factors|mesh-ancestor
102472346|NCT00699491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472347|NCT00699491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102472348|NCT00699491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102472349|NCT00699491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472350|NCT04493216|Dolutegravir|dolutegravir|mesh-list
102472351|NCT04493216|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102472352|NCT04493216|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102472353|NCT04493216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102472354|NCT04493216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472355|NCT04493216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102472356|NCT04493216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102472357|NCT04493216|Antiviral Agents|antiviral agents|mesh-ancestor
102472358|NCT04493216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102472359|NCT03721965|Prednisone|prednisone|mesh-list
102472360|NCT03721965|Methylprednisolone|methylprednisolone|mesh-list
102472361|NCT03721965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102472362|NCT03721965|Glucocorticoids|glucocorticoids|mesh-ancestor
102472363|NCT03721965|Hormones|hormones|mesh-ancestor
102472364|NCT03721965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102472365|NCT03721965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472366|NCT03721965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102472367|NCT03721965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102472368|NCT03721965|Antiemetics|antiemetics|mesh-ancestor
102472369|NCT03721965|Autonomic Agents|autonomic agents|mesh-ancestor
102472370|NCT03721965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102472371|NCT03721965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102472373|NCT03721965|Protective Agents|protective agents|mesh-ancestor
102472374|NCT04399148|Ketotifen|ketotifen|mesh-list
102472375|NCT04399148|Aprepitant|aprepitant|mesh-list
102472376|NCT04399148|Desloratadine|desloratadine|mesh-list
102472377|NCT04399148|Antiemetics|antiemetics|mesh-ancestor
102472378|NCT04399148|Autonomic Agents|autonomic agents|mesh-ancestor
102472379|NCT04399148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102472380|NCT04399148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472381|NCT04399148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102472382|NCT04399148|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102472383|NCT04399148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102472384|NCT04399148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472385|NCT04399148|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102472386|NCT04399148|Cholinergic Agents|cholinergic agents|mesh-ancestor
102472387|NCT04399148|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102472388|NCT04399148|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102472389|NCT04399148|Histamine Antagonists|histamine antagonists|mesh-ancestor
102472390|NCT04399148|Histamine Agents|histamine agents|mesh-ancestor
102472391|NCT04399148|Antipruritics|antipruritics|mesh-ancestor
102472392|NCT04399148|Dermatologic Agents|dermatologic agents|mesh-ancestor
102472393|NCT04399148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102472394|NCT04672382|Morphine|morphine|mesh-list
102472395|NCT04672382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102472396|NCT04672382|Narcotics|narcotics|mesh-ancestor
102472397|NCT04672382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102472398|NCT04672382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472399|NCT04672382|Analgesics|analgesics|mesh-ancestor
102472400|NCT04672382|Sensory System Agents|sensory system agents|mesh-ancestor
102472401|NCT04672382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102472402|NCT00699803|Prednisone|prednisone|mesh-list
102472403|NCT00699803|Prednisolone acetate|prednisolone acetate|mesh-list
102472404|NCT00699803|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102472405|NCT00699803|Methylprednisolone|methylprednisolone|mesh-list
102472406|NCT00699803|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102472407|NCT00699803|Prednisolone|prednisolone|mesh-list
102472408|NCT00699803|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102472409|NCT00699803|Prednisolone phosphate|prednisolone phosphate|mesh-list
102472410|NCT00699803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102472411|NCT00699803|Glucocorticoids|glucocorticoids|mesh-ancestor
102472412|NCT00699803|Hormones|hormones|mesh-ancestor
102472413|NCT00699803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102472414|NCT00699803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472415|NCT00699803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102472416|NCT00699803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102472417|NCT00699803|Antiemetics|antiemetics|mesh-ancestor
102472418|NCT00699803|Autonomic Agents|autonomic agents|mesh-ancestor
102472419|NCT00699803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102472420|NCT00699803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102472421|NCT00699803|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102472422|NCT00699803|Protective Agents|protective agents|mesh-ancestor
102472423|NCT01967433|Diphenhydramine|diphenhydramine|mesh-list
102472424|NCT01967433|Promethazine|promethazine|mesh-list
102472425|NCT01967433|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102472426|NCT01967433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102472427|NCT01967433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102472428|NCT01967433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472429|NCT01967433|Anesthetics, Local|anesthetics, local|mesh-ancestor
102472430|NCT01967433|Anesthetics|anesthetics|mesh-ancestor
102472431|NCT01967433|Sensory System Agents|sensory system agents|mesh-ancestor
102472432|NCT01967433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102472433|NCT01967433|Antiemetics|antiemetics|mesh-ancestor
102472434|NCT01967433|Autonomic Agents|autonomic agents|mesh-ancestor
102472435|NCT01967433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102472436|NCT01967433|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102472437|NCT01967433|Histamine Antagonists|histamine antagonists|mesh-ancestor
102472438|NCT01967433|Histamine Agents|histamine agents|mesh-ancestor
102472439|NCT01967433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102472440|NCT01967433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472441|NCT01967433|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102472442|NCT01967433|Antipruritics|antipruritics|mesh-ancestor
102472443|NCT01967433|Dermatologic Agents|dermatologic agents|mesh-ancestor
102472444|NCT00551447|Simvastatin|simvastatin|mesh-list
102472445|NCT00551447|Ezetimibe|ezetimibe|mesh-list
102472446|NCT00551447|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102472447|NCT00551447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102472448|NCT00551447|Antimetabolites|antimetabolites|mesh-ancestor
102472449|NCT00551447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472450|NCT00551447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102472451|NCT00551447|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102472452|NCT00551447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102472453|NCT01968057|Cyclosporine|cyclosporine|mesh-list
102472454|NCT01968057|Cyclosporins|cyclosporins|mesh-list
102472455|NCT01968057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102472456|NCT01968057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472457|NCT01968057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102472458|NCT01968057|Immunologic Factors|immunologic factors|mesh-ancestor
102472459|NCT01968057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472460|NCT01968057|Antifungal Agents|antifungal agents|mesh-ancestor
102472461|NCT01968057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102472462|NCT01968057|Dermatologic Agents|dermatologic agents|mesh-ancestor
102472463|NCT01968057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102472464|NCT01968057|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102472465|NCT01968135|Contraceptive Agents|contraceptive agents|mesh-list
102472466|NCT01968135|Contraceptives, Oral|contraceptives, oral|mesh-list
102472467|NCT01968135|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
102472468|NCT01968135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102472469|NCT01968135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472470|NCT01968135|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102472471|NCT00658697|Bevacizumab|bevacizumab|mesh-list
102472472|NCT00658697|Docetaxel|docetaxel|mesh-list
102472473|NCT00658697|Bicalutamide|bicalutamide|mesh-list
102472474|NCT00658697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102472475|NCT00658697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102472476|NCT00658697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102472477|NCT00658697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102472478|NCT00658697|Growth Substances|growth substances|mesh-ancestor
101423040|NCT00508885|Niacin|niacin|mesh-list
102472479|NCT00658697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472480|NCT00658697|Growth Inhibitors|growth inhibitors|mesh-ancestor
102472481|NCT00658697|Tubulin Modulators|tubulin modulators|mesh-ancestor
102472482|NCT00658697|Antimitotic Agents|antimitotic agents|mesh-ancestor
102472483|NCT00658697|Mitosis Modulators|mitosis modulators|mesh-ancestor
102472484|NCT00658697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472485|NCT00658697|Androgen Antagonists|androgen antagonists|mesh-ancestor
102472486|NCT00658697|Hormone Antagonists|hormone antagonists|mesh-ancestor
102472487|NCT00658697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102472488|NCT03873116|Berotralstat|berotralstat|mesh-list
102472489|NCT03873116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102472490|NCT03873116|Protease Inhibitors|protease inhibitors|mesh-ancestor
102472491|NCT03873116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102472492|NCT03873116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472493|NCT04399226|Dexmedetomidine|dexmedetomidine|mesh-list
102472494|NCT04399226|Ketamine|ketamine|mesh-list
102472495|NCT04399226|Propofol|propofol|mesh-list
102472496|NCT04399226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102472497|NCT04399226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102472498|NCT04399226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472499|NCT04399226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102472500|NCT04399226|Analgesics|analgesics|mesh-ancestor
102472501|NCT04399226|Sensory System Agents|sensory system agents|mesh-ancestor
102472502|NCT04399226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102472503|NCT04399226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102472504|NCT04399226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102472505|NCT04399226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102472506|NCT04399226|Adrenergic Agents|adrenergic agents|mesh-ancestor
102472507|NCT04399226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102472508|NCT04399226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472509|NCT04399226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102472510|NCT04399226|Anesthetics, General|anesthetics, general|mesh-ancestor
102472511|NCT04399226|Anesthetics|anesthetics|mesh-ancestor
102472512|NCT04399226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102472513|NCT04399226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102472514|NCT04399226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102472515|NCT00659165|Insulin|insulin|mesh-list
102472516|NCT00659165|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102472517|NCT00659165|Insulin Glargine|insulin glargine|mesh-list
102472518|NCT00659165|Insulin Detemir|insulin detemir|mesh-list
102472519|NCT00659165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102472520|NCT00659165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472521|NCT00542087|Diclofenac|diclofenac|mesh-list
102472522|NCT00542087|Etoricoxib|etoricoxib|mesh-list
102472523|NCT00542087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102472525|NCT00542087|Analgesics|analgesics|mesh-ancestor
102472526|NCT00542087|Sensory System Agents|sensory system agents|mesh-ancestor
102472527|NCT00542087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102472528|NCT00542087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556215|NCT05661227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101556216|NCT05661227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102472529|NCT00542087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102472530|NCT00542087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102472531|NCT00542087|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102472532|NCT00542087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102472533|NCT00542087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472534|NCT00542087|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102472535|NCT00541697|Atorvastatin|atorvastatin|mesh-list
102472536|NCT00541697|Simvastatin|simvastatin|mesh-list
102472537|NCT00541697|Ezetimibe|ezetimibe|mesh-list
102472538|NCT00541697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102472539|NCT00541697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102472540|NCT00541697|Antimetabolites|antimetabolites|mesh-ancestor
102472541|NCT00541697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472542|NCT00541697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102472543|NCT00541697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102472544|NCT00541697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102472545|NCT03223376|Paclitaxel|paclitaxel|mesh-list
102472546|NCT03223376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102472547|NCT03223376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102472548|NCT03223376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102472549|NCT03223376|Tubulin Modulators|tubulin modulators|mesh-ancestor
102472550|NCT03223376|Antimitotic Agents|antimitotic agents|mesh-ancestor
102472551|NCT03223376|Mitosis Modulators|mitosis modulators|mesh-ancestor
102472552|NCT03223376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472553|NCT00395603|Atorvastatin|atorvastatin|mesh-list
102472554|NCT00395603|Simvastatin|simvastatin|mesh-list
102472555|NCT00395603|Ezetimibe|ezetimibe|mesh-list
102472556|NCT00395603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102472557|NCT00395603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102472558|NCT00395603|Antimetabolites|antimetabolites|mesh-ancestor
102472559|NCT00395603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472560|NCT00395603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102472561|NCT00395603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102472562|NCT00395603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102472563|NCT00659633|Lidocaine|lidocaine|mesh-list
102472564|NCT00659633|Anesthetics, Local|anesthetics, local|mesh-ancestor
102472565|NCT00659633|Anesthetics|anesthetics|mesh-ancestor
102472566|NCT00659633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102472567|NCT00659633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472568|NCT00659633|Sensory System Agents|sensory system agents|mesh-ancestor
102472569|NCT00659633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102472570|NCT00659633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102472571|NCT00659633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102472572|NCT00659633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102472573|NCT00659633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102472574|NCT00659633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472575|NCT00328523|Ezetimibe|ezetimibe|mesh-list
102472576|NCT00328523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102472577|NCT00328523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102472578|NCT00328523|Antimetabolites|antimetabolites|mesh-ancestor
102472579|NCT00328523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472580|NCT00328523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102472581|NCT00701675|Sertraline|sertraline|mesh-list
102472582|NCT00701675|Antidepressive Agents|antidepressive agents|mesh-ancestor
102472583|NCT00701675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102472584|NCT00701675|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102472585|NCT00701675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102472586|NCT00701675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102472587|NCT00701675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472588|NCT00701675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102472589|NCT00701675|Serotonin Agents|serotonin agents|mesh-ancestor
102472590|NCT00701675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472591|NCT04639310|Ezogabine|ezogabine|mesh-list
102472592|NCT04639310|Anticonvulsants|anticonvulsants|mesh-ancestor
102472593|NCT04639310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102472594|NCT04639310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472595|NCT02300727|Curcumin|curcumin|mesh-list
102284243|NCT05339295|Levofloxacin|levofloxacin|mesh-list
102472596|NCT02300727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102472597|NCT02300727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102472598|NCT02300727|Analgesics|analgesics|mesh-ancestor
102472599|NCT02300727|Sensory System Agents|sensory system agents|mesh-ancestor
102472600|NCT02300727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102472601|NCT02300727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472602|NCT02300727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102472603|NCT02300727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102472604|NCT02300727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102472605|NCT02300727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102472606|NCT02300727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472607|NCT00250445|Diclofenac|diclofenac|mesh-list
102472608|NCT00250445|Etoricoxib|etoricoxib|mesh-list
102472609|NCT00250445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102472610|NCT00250445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102472611|NCT00250445|Analgesics|analgesics|mesh-ancestor
102472612|NCT00250445|Sensory System Agents|sensory system agents|mesh-ancestor
102472613|NCT00250445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102472614|NCT00250445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472615|NCT00250445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102472616|NCT00250445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102472617|NCT00250445|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102472618|NCT00250445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102472619|NCT00250445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472620|NCT00250445|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102472621|NCT00242489|Diclofenac|diclofenac|mesh-list
102472622|NCT00242489|Etoricoxib|etoricoxib|mesh-list
102472623|NCT00242489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102472624|NCT00242489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102472625|NCT00242489|Analgesics|analgesics|mesh-ancestor
102472626|NCT00242489|Sensory System Agents|sensory system agents|mesh-ancestor
102472627|NCT00242489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102472628|NCT00242489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472629|NCT00242489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102472630|NCT00242489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102472631|NCT00242489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102472632|NCT00242489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102472633|NCT00242489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472634|NCT00242489|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102472635|NCT00659945|Ondansetron|ondansetron|mesh-list
102472636|NCT00659945|Aprepitant|aprepitant|mesh-list
102472637|NCT00659945|Antiemetics|antiemetics|mesh-ancestor
102472638|NCT00659945|Autonomic Agents|autonomic agents|mesh-ancestor
102472639|NCT00659945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102472640|NCT00659945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472641|NCT00659945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102472642|NCT00659945|Antipruritics|antipruritics|mesh-ancestor
102472643|NCT00659945|Dermatologic Agents|dermatologic agents|mesh-ancestor
102472644|NCT00659945|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102472645|NCT00659945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102472646|NCT00659945|Serotonin Agents|serotonin agents|mesh-ancestor
102472647|NCT00659945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102472648|NCT00659945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472649|NCT00659945|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102472650|NCT04387565|Vanadium|vanadium|mesh-list
102472651|NCT04387565|Trace Elements|trace elements|mesh-ancestor
102472652|NCT04387565|Micronutrients|micronutrients|mesh-ancestor
102472653|NCT04387565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472654|NCT02141555|Misoprostol|misoprostol|mesh-list
102472655|NCT02141555|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102472656|NCT02141555|Abortifacient Agents|abortifacient agents|mesh-ancestor
102472657|NCT02141555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102472658|NCT02141555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472659|NCT02141555|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102472660|NCT02141555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102472661|NCT02141555|Oxytocics|oxytocics|mesh-ancestor
102472662|NCT01799057|Metformin|metformin|mesh-list
102472663|NCT01799057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102472664|NCT01799057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472665|NCT00588965|Propranolol|propranolol|mesh-list
102472666|NCT00588965|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102472667|NCT00588965|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102472668|NCT00588965|Adrenergic Agents|adrenergic agents|mesh-ancestor
102472669|NCT00588965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102472670|NCT00588965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472671|NCT00588965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472672|NCT00588965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102472673|NCT00588965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102472674|NCT00588965|Vasodilator Agents|vasodilator agents|mesh-ancestor
102472675|NCT00702299|Paclitaxel|paclitaxel|mesh-list
102472676|NCT00702299|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102472677|NCT00702299|Cisplatin|cisplatin|mesh-list
102472678|NCT00702299|Pemetrexed|pemetrexed|mesh-list
102472679|NCT00702299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102472680|NCT00702299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102472681|NCT00702299|Tubulin Modulators|tubulin modulators|mesh-ancestor
102472682|NCT00702299|Antimitotic Agents|antimitotic agents|mesh-ancestor
102472683|NCT00702299|Mitosis Modulators|mitosis modulators|mesh-ancestor
102472684|NCT00702299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556358|NCT05926895|Prilocaine|prilocaine|mesh-list
102472685|NCT00702299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102472686|NCT00702299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102472687|NCT00702299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102472688|NCT00661583|Ranibizumab|ranibizumab|mesh-list
102472689|NCT00661583|Mitomycins|mitomycins|mesh-list
102472690|NCT00661583|Mitomycin|mitomycin|mesh-list
102472691|NCT00661583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102472692|NCT00661583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102472693|NCT00661583|Growth Substances|growth substances|mesh-ancestor
102472694|NCT00661583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472695|NCT00661583|Growth Inhibitors|growth inhibitors|mesh-ancestor
102472696|NCT00661583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102472697|NCT00661583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102472698|NCT00661583|Alkylating Agents|alkylating agents|mesh-ancestor
102472699|NCT00661583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472700|NCT00661583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102472701|NCT00661583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102472702|NCT00661895|Metoprolol|metoprolol|mesh-list
102472703|NCT00661895|Atenolol|atenolol|mesh-list
102472704|NCT00661895|Amlodipine|amlodipine|mesh-list
102472705|NCT00661895|Valsartan|valsartan|mesh-list
102472706|NCT00661895|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102472707|NCT00661895|Clonidine|clonidine|mesh-list
102472708|NCT00661895|Lisinopril|lisinopril|mesh-list
102472709|NCT00661895|Doxazosin|doxazosin|mesh-list
102472710|NCT00661895|Hydralazine|hydralazine|mesh-list
102472711|NCT00661895|Nifedipine|nifedipine|mesh-list
102472712|NCT00661895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102472713|NCT00661895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102472714|NCT00661895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102472715|NCT00661895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472716|NCT00661895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102472717|NCT00661895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472718|NCT00661895|Vasodilator Agents|vasodilator agents|mesh-ancestor
102472719|NCT00661895|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102472720|NCT00661895|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102472721|NCT00661895|Diuretics|diuretics|mesh-ancestor
102472722|NCT00661895|Natriuretic Agents|natriuretic agents|mesh-ancestor
102472723|NCT00661895|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102472724|NCT00661895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102472725|NCT00661895|Sympatholytics|sympatholytics|mesh-ancestor
102472726|NCT00661895|Autonomic Agents|autonomic agents|mesh-ancestor
102472727|NCT00661895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102472728|NCT00661895|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102472729|NCT00661895|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102472730|NCT00661895|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102472731|NCT00661895|Adrenergic Agents|adrenergic agents|mesh-ancestor
102472732|NCT00661895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102472733|NCT00661895|Analgesics|analgesics|mesh-ancestor
102472734|NCT00661895|Sensory System Agents|sensory system agents|mesh-ancestor
102472735|NCT00661895|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102472736|NCT00661895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102472737|NCT00661895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102472738|NCT00661895|Tocolytic Agents|tocolytic agents|mesh-ancestor
102472739|NCT00661895|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102472740|NCT00661895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101556402|NCT05926804|Lansoprazole|lansoprazole|mesh-list
102472741|NCT00661895|Protease Inhibitors|protease inhibitors|mesh-ancestor
102472742|NCT00661895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102472743|NCT00661895|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102472744|NCT00661895|Protective Agents|protective agents|mesh-ancestor
102472745|NCT00661895|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102472746|NCT00661895|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102472747|NCT02312258|Ixazomib|ixazomib|mesh-list
102472748|NCT02312258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102472750|NCT02312258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102472751|NCT02312258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472752|NCT02301039|Pembrolizumab|pembrolizumab|mesh-list
102472753|NCT02301039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102472754|NCT02301039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102472755|NCT02301039|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102472756|NCT02301039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472757|NCT00662675|Pancrelipase|pancrelipase|mesh-list
102472758|NCT00662675|Pancreatin|pancreatin|mesh-list
102472759|NCT00662675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102472760|NCT00591305|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
102472761|NCT00591305|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102472762|NCT00591305|Protective Agents|protective agents|mesh-ancestor
102472763|NCT00591305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472764|NCT00591305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102472765|NCT01799603|Simeprevir|simeprevir|mesh-list
102472766|NCT01799603|Antiviral Agents|antiviral agents|mesh-ancestor
102472767|NCT01799603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102472768|NCT01799603|Protease Inhibitors|protease inhibitors|mesh-ancestor
102472769|NCT01799603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102472770|NCT01799603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472771|NCT03816176|Isavuconazole|isavuconazole|mesh-list
102472772|NCT03816176|Antifungal Agents|antifungal agents|mesh-ancestor
102472773|NCT03816176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102472774|NCT00666029|Atorvastatin|atorvastatin|mesh-list
102472775|NCT00666029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102472776|NCT00666029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102472777|NCT00666029|Antimetabolites|antimetabolites|mesh-ancestor
102472778|NCT00666029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472779|NCT00666029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102472780|NCT00666029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102472781|NCT00666029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102472782|NCT04372940|Tranexamic Acid|tranexamic acid|mesh-list
102472783|NCT04372940|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102472784|NCT04372940|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102472785|NCT04372940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472786|NCT04372940|Hemostatics|hemostatics|mesh-ancestor
102472787|NCT04372940|Coagulants|coagulants|mesh-ancestor
102472788|NCT00592475|Conivaptan|conivaptan|mesh-list
102472789|NCT00592475|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102472790|NCT00592475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472791|NCT00592475|Natriuretic Agents|natriuretic agents|mesh-ancestor
102472792|NCT00592475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472793|NCT03221426|Leucovorin|leucovorin|mesh-list
102472794|NCT03221426|Docetaxel|docetaxel|mesh-list
102472795|NCT03221426|Pembrolizumab|pembrolizumab|mesh-list
102472796|NCT03221426|Fluorouracil|fluorouracil|mesh-list
102472797|NCT03221426|Capecitabine|capecitabine|mesh-list
102472798|NCT03221426|Oxaliplatin|oxaliplatin|mesh-list
102472799|NCT03221426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102472800|NCT03221426|Tubulin Modulators|tubulin modulators|mesh-ancestor
102472801|NCT03221426|Antimitotic Agents|antimitotic agents|mesh-ancestor
102472802|NCT03221426|Mitosis Modulators|mitosis modulators|mesh-ancestor
102472803|NCT03221426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472804|NCT03221426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102472805|NCT03221426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102472806|NCT03221426|Antimetabolites|antimetabolites|mesh-ancestor
102472807|NCT03221426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102472808|NCT03221426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102472809|NCT03221426|Immunologic Factors|immunologic factors|mesh-ancestor
102472810|NCT03221426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472811|NCT03221426|Antidotes|antidotes|mesh-ancestor
102472812|NCT03221426|Protective Agents|protective agents|mesh-ancestor
102472813|NCT03221426|Vitamin B Complex|vitamin b complex|mesh-ancestor
102472814|NCT03221426|Vitamins|vitamins|mesh-ancestor
102472815|NCT03221426|Micronutrients|micronutrients|mesh-ancestor
102472816|NCT01989195|Manganese|manganese|mesh-list
102472817|NCT01989195|Trace Elements|trace elements|mesh-ancestor
102472818|NCT01989195|Micronutrients|micronutrients|mesh-ancestor
102472819|NCT01989195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472820|NCT00592943|Modafinil|modafinil|mesh-list
102472821|NCT00592943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102472822|NCT00592943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472823|NCT00592943|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102472824|NCT00592943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102472825|NCT00592943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102472826|NCT00592943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472827|NCT01973205|Aspirin|aspirin|mesh-list
102472828|NCT01973205|Acetaminophen|acetaminophen|mesh-list
102472829|NCT01973205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102472830|NCT01973205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102472831|NCT01973205|Analgesics|analgesics|mesh-ancestor
102472832|NCT01973205|Sensory System Agents|sensory system agents|mesh-ancestor
102472833|NCT01973205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102472834|NCT01973205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472835|NCT01973205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102472836|NCT01973205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102472837|NCT01973205|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102472838|NCT01973205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102472839|NCT01973205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472840|NCT01973205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102472841|NCT01973205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102472842|NCT01973205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102472843|NCT01973205|Antipyretics|antipyretics|mesh-ancestor
102472844|NCT01990677|Eplerenone|eplerenone|mesh-list
102472845|NCT01990677|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102472846|NCT01990677|Hormone Antagonists|hormone antagonists|mesh-ancestor
102472847|NCT01990677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102472848|NCT01990677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472849|NCT01990677|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102472850|NCT01990677|Diuretics|diuretics|mesh-ancestor
102472851|NCT01990677|Natriuretic Agents|natriuretic agents|mesh-ancestor
102472852|NCT01990677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102472853|NCT00593645|Cytarabine|cytarabine|mesh-list
102472854|NCT00593645|Clofarabine|clofarabine|mesh-list
102472855|NCT00593645|Thymoglobulin|thymoglobulin|mesh-list
102472856|NCT00593645|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102472857|NCT00593645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102472858|NCT00593645|Antimetabolites|antimetabolites|mesh-ancestor
102472859|NCT00593645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472860|NCT00593645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102472861|NCT00593645|Antiviral Agents|antiviral agents|mesh-ancestor
102472862|NCT00593645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102472863|NCT00593645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102472864|NCT00593645|Immunologic Factors|immunologic factors|mesh-ancestor
102472865|NCT00593645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472866|NCT03194126|Misoprostol|misoprostol|mesh-list
102472867|NCT03194126|Mifepristone|mifepristone|mesh-list
102472868|NCT03194126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102472869|NCT03194126|Abortifacient Agents|abortifacient agents|mesh-ancestor
102472870|NCT03194126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102472871|NCT03194126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472872|NCT03194126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102472873|NCT03194126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102472874|NCT03194126|Oxytocics|oxytocics|mesh-ancestor
102472875|NCT03194126|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102472876|NCT03194126|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102472877|NCT03194126|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102472878|NCT03194126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102472879|NCT03194126|Contraceptive Agents|contraceptive agents|mesh-ancestor
102472880|NCT03194126|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102472881|NCT03194126|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102472882|NCT03194126|Hormone Antagonists|hormone antagonists|mesh-ancestor
102472883|NCT03194126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102472884|NCT03194126|Luteolytic Agents|luteolytic agents|mesh-ancestor
102472885|NCT03194126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102472886|NCT03194126|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102472887|NCT03219086|Bupivacaine|bupivacaine|mesh-list
102472888|NCT03219086|Prilocaine|prilocaine|mesh-list
102472889|NCT03219086|Anesthetics|anesthetics|mesh-list
102472890|NCT03219086|Anesthetics, Local|anesthetics, local|mesh-ancestor
102472891|NCT03219086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102472892|NCT03219086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472893|NCT03219086|Sensory System Agents|sensory system agents|mesh-ancestor
102472894|NCT03219086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102472895|NCT02998385|Cisplatin|cisplatin|mesh-list
102472896|NCT02998385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102284541|NCT02524665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102472897|NCT04398290|Nitric Oxide|nitric oxide|mesh-list
102472898|NCT04398290|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102472899|NCT04398290|Autonomic Agents|autonomic agents|mesh-ancestor
102472900|NCT04398290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102472901|NCT04398290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472902|NCT04398290|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102472903|NCT04398290|Respiratory System Agents|respiratory system agents|mesh-ancestor
102472904|NCT04398290|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102472905|NCT04398290|Antioxidants|antioxidants|mesh-ancestor
102472906|NCT04398290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472907|NCT04398290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102472908|NCT04398290|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102472909|NCT04398290|Vasodilator Agents|vasodilator agents|mesh-ancestor
102472910|NCT04398290|Gasotransmitters|gasotransmitters|mesh-ancestor
102472911|NCT04398290|Protective Agents|protective agents|mesh-ancestor
102472912|NCT04397510|Heparin|heparin|mesh-list
102472913|NCT04397510|Anticoagulants|anticoagulants|mesh-ancestor
102472914|NCT04397510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102472915|NCT04397510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102472916|NCT04397510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472917|NCT00704717|Ribavirin|ribavirin|mesh-list
102472918|NCT00704717|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102472919|NCT00704717|Interferon-alpha|interferon-alpha|mesh-list
102472920|NCT00704717|Antimetabolites|antimetabolites|mesh-ancestor
102472921|NCT00704717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472922|NCT00704717|Antiviral Agents|antiviral agents|mesh-ancestor
102472923|NCT00704717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101556577|NCT05690984|Glucocorticoids|glucocorticoids|mesh-ancestor
102472924|NCT00704717|Immunologic Factors|immunologic factors|mesh-ancestor
102472925|NCT00704717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472926|NCT03708224|Atezolizumab|atezolizumab|mesh-list
102472927|NCT03708224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102472928|NCT03708224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472929|NCT03708224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102472930|NCT03708224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102472931|NCT03632642|Floxacillin|floxacillin|mesh-list
102472932|NCT03632642|Penicillin G|penicillin g|mesh-list
102472933|NCT03632642|Penicillin G Benzathine|penicillin g benzathine|mesh-list
102472934|NCT03632642|Penicillin G Procaine|penicillin g procaine|mesh-list
102472935|NCT03632642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102472936|NCT03632642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102472937|NCT00594425|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102472938|NCT00594425|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
102472939|NCT00594425|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102472940|NCT00594425|Dermatologic Agents|dermatologic agents|mesh-ancestor
102472941|NCT04317404|Triamcinolone|triamcinolone|mesh-list
102472942|NCT04317404|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102472943|NCT04317404|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102472944|NCT04317404|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102472945|NCT04317404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102472946|NCT04317404|Glucocorticoids|glucocorticoids|mesh-ancestor
102472947|NCT04317404|Hormones|hormones|mesh-ancestor
102472948|NCT04317404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102472949|NCT04317404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472950|NCT04317404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102472951|NCT04317404|Immunologic Factors|immunologic factors|mesh-ancestor
102472952|NCT04317404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102472953|NCT04317404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472954|NCT04399070|Ketamine|ketamine|mesh-list
102472955|NCT04399070|Esketamine|esketamine|mesh-list
102472956|NCT04399070|Analgesics|analgesics|mesh-ancestor
102472957|NCT04399070|Sensory System Agents|sensory system agents|mesh-ancestor
102472958|NCT04399070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102472959|NCT04399070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556689|NCT05528588|Natriuretic Agents|natriuretic agents|mesh-ancestor
101556690|NCT05528588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556691|NCT05528588|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101556692|NCT05528588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101556693|NCT05528588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556694|NCT05488431|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
101556695|NCT05488431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101556696|NCT05488431|Antimetabolites|antimetabolites|mesh-ancestor
101556697|NCT05488431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556698|NCT05488431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102472960|NCT04399070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102472961|NCT04399070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102472962|NCT04399070|Anesthetics, General|anesthetics, general|mesh-ancestor
102472963|NCT04399070|Anesthetics|anesthetics|mesh-ancestor
102472964|NCT04399070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102472965|NCT04399070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102472966|NCT04399070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102472967|NCT04399070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102472968|NCT04399070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472969|NCT04399070|Antidepressive Agents|antidepressive agents|mesh-ancestor
102472970|NCT04399070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102472971|NCT00667589|Fluocinonide|fluocinonide|mesh-list
102472972|NCT00667589|Tazarotene|tazarotene|mesh-list
102472973|NCT00667589|Emollients|emollients|mesh-list
102472974|NCT00667589|Dermatologic Agents|dermatologic agents|mesh-ancestor
102472975|NCT00667589|Keratolytic Agents|keratolytic agents|mesh-ancestor
102472976|NCT00667589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102472977|NCT00667589|Glucocorticoids|glucocorticoids|mesh-ancestor
102472978|NCT00667589|Hormones|hormones|mesh-ancestor
102472979|NCT00667589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102472980|NCT00667589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472981|NCT00667589|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102472982|NCT00667745|Lithium Carbonate|lithium carbonate|mesh-list
102472983|NCT00667745|Antidepressive Agents|antidepressive agents|mesh-ancestor
102472984|NCT00667745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102472985|NCT00667745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102472986|NCT00667745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102472987|NCT00667745|Antimanic Agents|antimanic agents|mesh-ancestor
102472988|NCT00667745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102472989|NCT00667745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102472990|NCT00667745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102472991|NCT03173612|Cytarabine|cytarabine|mesh-list
102472992|NCT03173612|Etoposide|etoposide|mesh-list
102472993|NCT03173612|Mitoxantrone|mitoxantrone|mesh-list
102472994|NCT03173612|Idarubicin|idarubicin|mesh-list
102472995|NCT03173612|Dasatinib|dasatinib|mesh-list
102472996|NCT03173612|Aclacinomycins|aclacinomycins|mesh-list
102472997|NCT03173612|Lenograstim|lenograstim|mesh-list
102472998|NCT03173612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102472999|NCT03173612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102473000|NCT03173612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102473001|NCT03173612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102473002|NCT03173612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102473003|NCT03173612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473004|NCT03173612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102473005|NCT03173612|Antimetabolites|antimetabolites|mesh-ancestor
102473006|NCT03173612|Antiviral Agents|antiviral agents|mesh-ancestor
102473007|NCT03173612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102473008|NCT03173612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102473009|NCT03173612|Immunologic Factors|immunologic factors|mesh-ancestor
102473010|NCT03173612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473011|NCT03173612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102473012|NCT03173612|Analgesics|analgesics|mesh-ancestor
102473013|NCT03173612|Sensory System Agents|sensory system agents|mesh-ancestor
102473014|NCT03173612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102473015|NCT03173612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102473016|NCT03173612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102473017|NCT00595361|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102473018|NCT00595361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102473019|NCT00595361|Autonomic Agents|autonomic agents|mesh-ancestor
102473020|NCT00595361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102473021|NCT00595361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473022|NCT00595361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102473023|NCT00595361|Respiratory System Agents|respiratory system agents|mesh-ancestor
102473024|NCT00595361|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102473025|NCT00595361|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102473026|NCT00595361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102473027|NCT00595361|Adrenergic Agents|adrenergic agents|mesh-ancestor
102473028|NCT00595361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102473029|NCT00595361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473030|NCT00596453|Ciprofloxacin|ciprofloxacin|mesh-list
101556746|NCT05392946|Daratumumab|daratumumab|mesh-list
102473031|NCT00596453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102473032|NCT00596453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102473033|NCT00596453|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102473034|NCT00596453|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102473035|NCT00596453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102473036|NCT00596453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473037|NCT00596453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102473038|NCT00596453|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102473039|NCT00596453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102473040|NCT00705107|Ribavirin|ribavirin|mesh-list
102473041|NCT00705107|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102473042|NCT00705107|Interferon-alpha|interferon-alpha|mesh-list
102473043|NCT00705107|Antimetabolites|antimetabolites|mesh-ancestor
102473044|NCT00705107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473045|NCT00705107|Antiviral Agents|antiviral agents|mesh-ancestor
102473046|NCT00705107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102284693|NCT03073057|Budesonide|budesonide|mesh-list
102473047|NCT00705107|Immunologic Factors|immunologic factors|mesh-ancestor
102473048|NCT00705107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473049|NCT00240331|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102473050|NCT00240331|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102473051|NCT00240331|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102473052|NCT00240331|Antimetabolites|antimetabolites|mesh-ancestor
102473053|NCT00240331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473054|NCT00240331|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102473055|NCT00240331|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102473056|NCT00240331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102473057|NCT00240097|Carboplatin|carboplatin|mesh-list
102473058|NCT00240097|Oxaliplatin|oxaliplatin|mesh-list
102473059|NCT00240097|Irinotecan|irinotecan|mesh-list
102473060|NCT00240097|Etoposide|etoposide|mesh-list
102473061|NCT00240097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102473062|NCT00240097|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102473063|NCT00240097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102473064|NCT00240097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102473065|NCT00240097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473066|NCT00240097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102473067|NCT00240097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102473068|NCT04270487|Octylonium|octylonium|mesh-list
102473069|NCT04270487|Bromides|bromides|mesh-list
102473070|NCT04270487|Anticonvulsants|anticonvulsants|mesh-ancestor
102473071|NCT04270487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102473072|NCT04270487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102473073|NCT04270487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473074|NCT04270487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102473075|NCT04270487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473076|NCT04270487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102473077|NCT04270487|Parasympatholytics|parasympatholytics|mesh-ancestor
102473078|NCT04270487|Autonomic Agents|autonomic agents|mesh-ancestor
102473079|NCT04270487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102473080|NCT04270487|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102473081|NCT04270487|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102473082|NCT04270487|Cholinergic Agents|cholinergic agents|mesh-ancestor
102473083|NCT04270487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102473084|NCT00739999|Atorvastatin|atorvastatin|mesh-list
102473085|NCT00739999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102473086|NCT00739999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102473087|NCT00739999|Antimetabolites|antimetabolites|mesh-ancestor
102473088|NCT00739999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473089|NCT00739999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102473090|NCT00739999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102473091|NCT00739999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102473092|NCT02997995|Durvalumab|durvalumab|mesh-list
102473093|NCT02997995|Tremelimumab|tremelimumab|mesh-list
101556808|NCT05264974|Vaccines|vaccines|mesh-list
102473094|NCT02997995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102473095|NCT02997995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102473096|NCT03620162|Vaccines|vaccines|mesh-list
102473097|NCT03620162|Immunologic Factors|immunologic factors|mesh-ancestor
102473098|NCT03620162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473099|NCT00742573|Antidepressive Agents|antidepressive agents|mesh-list
102473100|NCT00742573|Bupropion|bupropion|mesh-list
102473101|NCT00742573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102473102|NCT00742573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102473103|NCT00742573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102473104|NCT00742573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473105|NCT00742573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102473106|NCT00742573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473107|NCT00742573|Dopamine Agents|dopamine agents|mesh-ancestor
102473108|NCT00742573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101556818|NCT05111353|Poly ICLC|poly iclc|mesh-list
102473109|NCT00742573|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102473110|NCT00742573|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102473111|NCT00742573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102473112|NCT00742573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102473113|NCT03809923|Lidocaine|lidocaine|mesh-list
102473114|NCT03809923|Dexmedetomidine|dexmedetomidine|mesh-list
102473115|NCT03809923|Anesthetics, Local|anesthetics, local|mesh-ancestor
102473116|NCT03809923|Anesthetics|anesthetics|mesh-ancestor
102473117|NCT03809923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102473118|NCT03809923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473119|NCT03809923|Sensory System Agents|sensory system agents|mesh-ancestor
102473120|NCT03809923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102473122|NCT03809923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102473123|NCT03809923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102473124|NCT03809923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102473125|NCT03809923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473126|NCT03809923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102473127|NCT03809923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102473128|NCT03809923|Analgesics|analgesics|mesh-ancestor
102473129|NCT03809923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102473130|NCT03809923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102473131|NCT03809923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102473132|NCT03809923|Adrenergic Agents|adrenergic agents|mesh-ancestor
102473133|NCT03809923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102473134|NCT00719329|Chlorhexidine|chlorhexidine|mesh-list
102473135|NCT00719329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102473136|NCT00719329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102473137|NCT00719329|Disinfectants|disinfectants|mesh-ancestor
102473138|NCT00602225|Cytarabine|cytarabine|mesh-list
102473139|NCT00602225|Clofarabine|clofarabine|mesh-list
102473140|NCT00602225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102473141|NCT00602225|Antimetabolites|antimetabolites|mesh-ancestor
102473142|NCT00602225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473143|NCT00602225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102473144|NCT00602225|Antiviral Agents|antiviral agents|mesh-ancestor
102473145|NCT00602225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102473146|NCT00602225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102473147|NCT00602225|Immunologic Factors|immunologic factors|mesh-ancestor
102473148|NCT00602225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473149|NCT00602771|Etoposide|etoposide|mesh-list
102473150|NCT00602771|Etoposide phosphate|etoposide phosphate|mesh-list
102473151|NCT00602771|Tipifarnib|tipifarnib|mesh-list
102473152|NCT00602771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102473153|NCT00602771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102473154|NCT00602771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102473155|NCT00602771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102473156|NCT00602771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102473157|NCT00602771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473158|NCT00744211|Sitaxsentan|sitaxsentan|mesh-list
102473159|NCT00744211|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102473160|NCT00744211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556859|NCT04953897|Antimetabolites|antimetabolites|mesh-ancestor
102473161|NCT02997371|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102473162|NCT02997371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102473163|NCT04248998|Metformin|metformin|mesh-list
102473164|NCT04248998|Paclitaxel|paclitaxel|mesh-list
102473165|NCT04248998|Cyclophosphamide|cyclophosphamide|mesh-list
102473166|NCT04248998|Doxorubicin|doxorubicin|mesh-list
102473167|NCT04248998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102473168|NCT04248998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102473169|NCT04248998|Tubulin Modulators|tubulin modulators|mesh-ancestor
102473170|NCT04248998|Antimitotic Agents|antimitotic agents|mesh-ancestor
102473171|NCT04248998|Mitosis Modulators|mitosis modulators|mesh-ancestor
102473172|NCT04248998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473173|NCT04248998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102473174|NCT04248998|Immunologic Factors|immunologic factors|mesh-ancestor
102473175|NCT04248998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473176|NCT04248998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101556888|NCT04867785|Dulaglutide|dulaglutide|mesh-list
102473177|NCT04248998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102473178|NCT04248998|Alkylating Agents|alkylating agents|mesh-ancestor
102473179|NCT04248998|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102473180|NCT04248998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102473181|NCT04248998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102473182|NCT04248998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102473183|NCT04248998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102473184|NCT04248998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102473185|NCT00714233|Metformin|metformin|mesh-list
102473186|NCT00714233|Contraceptive Agents|contraceptive agents|mesh-list
102473187|NCT00714233|Contraceptives, Oral|contraceptives, oral|mesh-list
102473188|NCT00714233|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
102473189|NCT00714233|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
102473190|NCT00714233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102473191|NCT00714233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473192|NCT00714233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102473193|NCT00714233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102473194|NCT00746395|Lubiprostone|lubiprostone|mesh-list
102473195|NCT00746395|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102473196|NCT00746395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102473197|NCT00746395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473198|NCT04205786|Vitamin B 12|vitamin b 12|mesh-list
102473199|NCT04205786|Hydroxocobalamin|hydroxocobalamin|mesh-list
102473200|NCT04205786|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102473201|NCT04205786|Vitamins|vitamins|mesh-ancestor
101556897|NCT04812912|Hormones|hormones|mesh-list
102473202|NCT04205786|Micronutrients|micronutrients|mesh-ancestor
102473203|NCT04205786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473204|NCT04205786|Vitamin B Complex|vitamin b complex|mesh-ancestor
102473205|NCT04205786|Hematinics|hematinics|mesh-ancestor
102473206|NCT04205786|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102473207|NCT04205786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102473208|NCT04205786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473209|NCT04205786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102473210|NCT04205786|Hormone Antagonists|hormone antagonists|mesh-ancestor
102473211|NCT04205786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102473212|NCT00719966|Letrozole|letrozole|mesh-list
102473213|NCT00719966|Anastrozole|anastrozole|mesh-list
102473214|NCT00719966|Exemestane|exemestane|mesh-list
102473215|NCT00719966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102473216|NCT00719966|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102473217|NCT00719966|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102473218|NCT00719966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102473219|NCT00719966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473220|NCT00719966|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102473221|NCT00719966|Hormone Antagonists|hormone antagonists|mesh-ancestor
102473222|NCT00719966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101556924|NCT04767061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101556952|NCT04706507|Ganciclovir|ganciclovir|mesh-list
101556956|NCT04706507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101556957|NCT04706507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101556958|NCT04706507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556959|NCT04691375|Pembrolizumab|pembrolizumab|mesh-list
101556960|NCT04691375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101556961|NCT04691375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102473223|NCT00719966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473224|NCT00719966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102473225|NCT01276067|Donepezil|donepezil|mesh-list
102473226|NCT01276067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102473227|NCT01276067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102473228|NCT01276067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473229|NCT01276067|Cholinergic Agents|cholinergic agents|mesh-ancestor
102473230|NCT01276067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102473231|NCT01276067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473232|NCT01276067|Nootropic Agents|nootropic agents|mesh-ancestor
102473233|NCT04183868|Empagliflozin|empagliflozin|mesh-list
102473234|NCT04183868|Glimepiride|glimepiride|mesh-list
102473235|NCT04183868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102473236|NCT04183868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473237|NCT04183868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102473238|NCT04183868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473239|NCT04183868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102473240|NCT04183868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102473241|NCT04183868|Immunologic Factors|immunologic factors|mesh-ancestor
102473242|NCT02997215|Lidocaine|lidocaine|mesh-list
102473243|NCT02997215|Anesthetics, Local|anesthetics, local|mesh-ancestor
102473244|NCT02997215|Anesthetics|anesthetics|mesh-ancestor
102473245|NCT02997215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102473246|NCT02997215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473247|NCT02997215|Sensory System Agents|sensory system agents|mesh-ancestor
102473248|NCT02997215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102473249|NCT02997215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102473250|NCT02997215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102473251|NCT02997215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102473252|NCT02997215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102473253|NCT02997215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473254|NCT02990507|Methyltestosterone|methyltestosterone|mesh-list
102473255|NCT02990507|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102473256|NCT02990507|Testosterone|testosterone|mesh-list
102473257|NCT02990507|Testosterone undecanoate|testosterone undecanoate|mesh-list
102473258|NCT02990507|Testosterone enanthate|testosterone enanthate|mesh-list
102473259|NCT02990507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102473260|NCT02990507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102473261|NCT02990507|Anabolic Agents|anabolic agents|mesh-ancestor
102473262|NCT02990507|Hormones|hormones|mesh-ancestor
102473263|NCT02990507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102473264|NCT02990507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473265|NCT02990507|Androgens|androgens|mesh-ancestor
102473266|NCT03331484|Rivaroxaban|rivaroxaban|mesh-list
102473267|NCT03331484|Ticagrelor|ticagrelor|mesh-list
102473268|NCT03331484|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102473269|NCT03331484|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102473270|NCT03331484|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102473271|NCT03331484|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102473272|NCT03331484|Purinergic Agents|purinergic agents|mesh-ancestor
102473273|NCT03331484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102473274|NCT03331484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473275|NCT03331484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473276|NCT03331484|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102473277|NCT03331484|Antithrombins|antithrombins|mesh-ancestor
102473278|NCT03331484|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102473279|NCT03331484|Protease Inhibitors|protease inhibitors|mesh-ancestor
102473280|NCT03331484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102473281|NCT03331484|Anticoagulants|anticoagulants|mesh-ancestor
102473283|NCT00721513|Fluorouracil|fluorouracil|mesh-list
102473284|NCT00721513|Cetuximab|cetuximab|mesh-list
102473285|NCT00721513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102473286|NCT00721513|Tubulin Modulators|tubulin modulators|mesh-ancestor
102473287|NCT00721513|Antimitotic Agents|antimitotic agents|mesh-ancestor
102473288|NCT00721513|Mitosis Modulators|mitosis modulators|mesh-ancestor
102473289|NCT00721513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473290|NCT00721513|Antimetabolites|antimetabolites|mesh-ancestor
102473291|NCT00721513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102473292|NCT00721513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102473293|NCT00721513|Immunologic Factors|immunologic factors|mesh-ancestor
102473294|NCT00721513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473295|NCT00721513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102473296|NCT00706121|Vitamins|vitamins|mesh-list
102473297|NCT00706121|Vitamin E|vitamin e|mesh-list
102473298|NCT00706121|Tocopherols|tocopherols|mesh-list
102473299|NCT00706121|Tocotrienols|tocotrienols|mesh-list
102473300|NCT00706121|alpha-Tocopherol|alpha-tocopherol|mesh-list
102473301|NCT00706121|Selenium|selenium|mesh-list
102473302|NCT00706121|Micronutrients|micronutrients|mesh-ancestor
102473303|NCT00706121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473304|NCT00706121|Antioxidants|antioxidants|mesh-ancestor
102473305|NCT00706121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473306|NCT00706121|Protective Agents|protective agents|mesh-ancestor
102473307|NCT00706121|Trace Elements|trace elements|mesh-ancestor
102473308|NCT00746863|Bupivacaine|bupivacaine|mesh-list
102473309|NCT00746863|Anesthetics, Local|anesthetics, local|mesh-ancestor
102473310|NCT00746863|Anesthetics|anesthetics|mesh-ancestor
102473311|NCT00746863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102473312|NCT00746863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473313|NCT00746863|Sensory System Agents|sensory system agents|mesh-ancestor
101557035|NCT04339777|Tacrolimus|tacrolimus|mesh-list
102473314|NCT00746863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102473315|NCT04385563|Docetaxel|docetaxel|mesh-list
102473316|NCT04385563|Trastuzumab|trastuzumab|mesh-list
102473317|NCT04385563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102473318|NCT04385563|Tubulin Modulators|tubulin modulators|mesh-ancestor
102473319|NCT04385563|Antimitotic Agents|antimitotic agents|mesh-ancestor
102473320|NCT04385563|Mitosis Modulators|mitosis modulators|mesh-ancestor
102473321|NCT04385563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473322|NCT04385563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102473323|NCT03568838|Enoxaparin|enoxaparin|mesh-list
102473324|NCT03568838|Anticoagulants|anticoagulants|mesh-ancestor
102473325|NCT03568838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102473326|NCT03568838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102473327|NCT03568838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473328|NCT00726713|Vitamin B 12|vitamin b 12|mesh-list
102473329|NCT00726713|Vitamin B Complex|vitamin b complex|mesh-ancestor
102473330|NCT00726713|Vitamins|vitamins|mesh-ancestor
102473331|NCT00726713|Micronutrients|micronutrients|mesh-ancestor
102473332|NCT00726713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473333|NCT00759187|Chlorhexidine|chlorhexidine|mesh-list
102473334|NCT00759187|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102473335|NCT00759187|Triclosan|triclosan|mesh-list
102473336|NCT00759187|Fluorides|fluorides|mesh-list
102473337|NCT00759187|Sodium Fluoride|sodium fluoride|mesh-list
102473338|NCT00759187|Fluorophosphate|fluorophosphate|mesh-list
102473339|NCT00759187|Cariostatic Agents|cariostatic agents|mesh-ancestor
102473340|NCT00759187|Protective Agents|protective agents|mesh-ancestor
102473341|NCT00759187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473342|NCT00759187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102473343|NCT00759187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102473344|NCT00759187|Disinfectants|disinfectants|mesh-ancestor
101557053|NCT04337970|Axitinib|axitinib|mesh-list
102473345|NCT00759187|Dermatologic Agents|dermatologic agents|mesh-ancestor
102473346|NCT00759187|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102473347|NCT00759187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102473349|NCT00759187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473350|NCT00759187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102473351|NCT03085940|Hydroxychloroquine|hydroxychloroquine|mesh-list
102473352|NCT03085940|Antimalarials|antimalarials|mesh-ancestor
102473353|NCT03085940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102473354|NCT03085940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102473355|NCT03085940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102473356|NCT03085940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102473357|NCT03085940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473358|NCT03085940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102473359|NCT01279915|Linaclotide|linaclotide|mesh-list
102473360|NCT01279915|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102473361|NCT01279915|Enzyme Activators|enzyme activators|mesh-ancestor
102473362|NCT01279915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473363|NCT01279915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102473364|NCT03809455|Fentanyl|fentanyl|mesh-list
102473365|NCT03809455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102473366|NCT03809455|Narcotics|narcotics|mesh-ancestor
101557068|NCT04283656|Estradiol|estradiol|mesh-list
102473367|NCT03809455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102473368|NCT03809455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473369|NCT03809455|Analgesics|analgesics|mesh-ancestor
102473370|NCT03809455|Sensory System Agents|sensory system agents|mesh-ancestor
102473371|NCT03809455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102473372|NCT03809455|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102473373|NCT03809455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102473374|NCT03809455|Anesthetics, General|anesthetics, general|mesh-ancestor
102473375|NCT03809455|Anesthetics|anesthetics|mesh-ancestor
102473376|NCT03618134|Durvalumab|durvalumab|mesh-list
102473377|NCT03618134|Ipilimumab|ipilimumab|mesh-list
102473378|NCT03618134|Tremelimumab|tremelimumab|mesh-list
102473379|NCT03618134|Immunoglobulins|immunoglobulins|mesh-list
102473380|NCT03618134|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102473381|NCT03618134|Immunoglobulin G|immunoglobulin g|mesh-list
102473382|NCT03618134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102473383|NCT03618134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102473384|NCT03618134|Immunologic Factors|immunologic factors|mesh-ancestor
102473385|NCT03618134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473386|NCT03618134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102473387|NCT03618134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473388|NCT02997059|Fluconazole|fluconazole|mesh-list
102473389|NCT02997059|Antifungal Agents|antifungal agents|mesh-ancestor
102473390|NCT02997059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102473391|NCT02997059|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102473392|NCT02997059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102473393|NCT02997059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102473394|NCT02997059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473395|NCT02997059|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102473396|NCT02997059|Hormone Antagonists|hormone antagonists|mesh-ancestor
102473397|NCT02997059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102473398|NCT02997059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473399|NCT02997059|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102473400|NCT02997059|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102473401|NCT00759811|Methotrexate|methotrexate|mesh-list
102473402|NCT00759811|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102473403|NCT00759811|Abortifacient Agents|abortifacient agents|mesh-ancestor
102473404|NCT00759811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102473405|NCT00759811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473406|NCT00759811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102473407|NCT00759811|Antimetabolites|antimetabolites|mesh-ancestor
102473408|NCT00759811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473409|NCT00759811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102473410|NCT00759811|Dermatologic Agents|dermatologic agents|mesh-ancestor
102473411|NCT00759811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102473412|NCT00759811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102473413|NCT00759811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102473414|NCT00759811|Immunologic Factors|immunologic factors|mesh-ancestor
102473415|NCT00759811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102473416|NCT00759811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102473417|NCT03085628|Oxytocin|oxytocin|mesh-list
102473418|NCT03085628|Oxytocics|oxytocics|mesh-ancestor
102285065|NCT05392933|Lidocaine|lidocaine|mesh-list
102473419|NCT03085628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102473420|NCT03085628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473422|NCT01276613|Losartan|losartan|mesh-list
102473423|NCT01276613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102473424|NCT01276613|Antimetabolites|antimetabolites|mesh-ancestor
102473425|NCT01276613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473426|NCT01276613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102473427|NCT01276613|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102473428|NCT01276613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102473429|NCT01276613|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102473430|NCT01276613|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102473431|NCT02428205|Propranolol|propranolol|mesh-list
102473432|NCT02428205|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102473433|NCT02428205|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102473434|NCT02428205|Adrenergic Agents|adrenergic agents|mesh-ancestor
102473435|NCT02428205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102473436|NCT02428205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473437|NCT02428205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473438|NCT02428205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102473439|NCT02428205|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102473440|NCT02428205|Vasodilator Agents|vasodilator agents|mesh-ancestor
102473441|NCT01276691|Aspirin|aspirin|mesh-list
102473442|NCT01276691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102473443|NCT01276691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102473444|NCT01276691|Analgesics|analgesics|mesh-ancestor
102473445|NCT01276691|Sensory System Agents|sensory system agents|mesh-ancestor
102473446|NCT01276691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102473447|NCT01276691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473448|NCT01276691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102473449|NCT01276691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102473450|NCT01276691|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102473451|NCT01276691|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102473452|NCT01276691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473453|NCT01276691|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102473454|NCT01276691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102473455|NCT01276691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102473456|NCT01276691|Antipyretics|antipyretics|mesh-ancestor
102473457|NCT03081416|Diphenhydramine|diphenhydramine|mesh-list
102473458|NCT03081416|Dexamethasone|dexamethasone|mesh-list
102473459|NCT03081416|Ketorolac|ketorolac|mesh-list
102473460|NCT03081416|Ketamine|ketamine|mesh-list
102473461|NCT03081416|Metoclopramide|metoclopramide|mesh-list
102473462|NCT03081416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102473463|NCT03081416|Antiemetics|antiemetics|mesh-ancestor
102473464|NCT03081416|Autonomic Agents|autonomic agents|mesh-ancestor
102473465|NCT03081416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102473466|NCT03081416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473467|NCT03081416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102473468|NCT03081416|Glucocorticoids|glucocorticoids|mesh-ancestor
102473469|NCT03081416|Hormones|hormones|mesh-ancestor
102473470|NCT03081416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102473471|NCT03081416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102473472|NCT03081416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102473473|NCT03081416|Analgesics|analgesics|mesh-ancestor
102473474|NCT03081416|Sensory System Agents|sensory system agents|mesh-ancestor
102473475|NCT03081416|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102473476|NCT03081416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101557185|NCT03945591|Bortezomib|bortezomib|mesh-list
102473477|NCT03081416|Anesthetics, General|anesthetics, general|mesh-ancestor
102473478|NCT03081416|Anesthetics|anesthetics|mesh-ancestor
102473479|NCT03081416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102473480|NCT03081416|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102473481|NCT03081416|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102473482|NCT03081416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102473483|NCT03081416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473484|NCT03081416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102473485|NCT03081416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102473486|NCT03081416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102473487|NCT03081416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102473488|NCT03081416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102473489|NCT03081416|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102473490|NCT03081416|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102473491|NCT03081416|Dopamine Agents|dopamine agents|mesh-ancestor
102473492|NCT03081416|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102285145|NCT02595749|Oxytocin|oxytocin|mesh-list
102473493|NCT03081416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102473494|NCT03081416|Anesthetics, Local|anesthetics, local|mesh-ancestor
102473495|NCT03081416|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102473496|NCT03081416|Histamine Antagonists|histamine antagonists|mesh-ancestor
102473498|NCT03081416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102473499|NCT00706589|Aripiprazole|aripiprazole|mesh-list
102473500|NCT00706589|Antidepressive Agents|antidepressive agents|mesh-ancestor
102473501|NCT00706589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102473502|NCT00706589|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102473503|NCT00706589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102473504|NCT00706589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102473505|NCT00706589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473506|NCT00706589|Dopamine Agonists|dopamine agonists|mesh-ancestor
102473507|NCT00706589|Dopamine Agents|dopamine agents|mesh-ancestor
102473508|NCT00706589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102473509|NCT00706589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473510|NCT00706589|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102473511|NCT00706589|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102473512|NCT00706589|Serotonin Agents|serotonin agents|mesh-ancestor
102473513|NCT00706589|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102473514|NCT00706589|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102473515|NCT00706589|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102473516|NCT00706589|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102473517|NCT01276769|Paclitaxel|paclitaxel|mesh-list
102473518|NCT01276769|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102473519|NCT01276769|Carboplatin|carboplatin|mesh-list
102473520|NCT01276769|Epirubicin|epirubicin|mesh-list
102473521|NCT01276769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102473522|NCT01276769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102473523|NCT01276769|Tubulin Modulators|tubulin modulators|mesh-ancestor
102473524|NCT01276769|Antimitotic Agents|antimitotic agents|mesh-ancestor
102473525|NCT01276769|Mitosis Modulators|mitosis modulators|mesh-ancestor
102473526|NCT01276769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473527|NCT01276769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102473528|NCT01276769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102473529|NCT01276769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102473530|NCT01276769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102473531|NCT01279681|Leucovorin|leucovorin|mesh-list
102473532|NCT01279681|Bevacizumab|bevacizumab|mesh-list
102473533|NCT01279681|Fluorouracil|fluorouracil|mesh-list
102473534|NCT01279681|Capecitabine|capecitabine|mesh-list
102473535|NCT01279681|Oxaliplatin|oxaliplatin|mesh-list
102473536|NCT01279681|Calcium|calcium|mesh-list
102473537|NCT01279681|Levoleucovorin|levoleucovorin|mesh-list
102473538|NCT01279681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102473539|NCT01279681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102473540|NCT01279681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102473541|NCT01279681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102473542|NCT01279681|Growth Substances|growth substances|mesh-ancestor
102473543|NCT01279681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473544|NCT01279681|Growth Inhibitors|growth inhibitors|mesh-ancestor
102473545|NCT01279681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102473546|NCT01279681|Antimetabolites|antimetabolites|mesh-ancestor
102473547|NCT01279681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473548|NCT01279681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102473549|NCT01279681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102473550|NCT01279681|Immunologic Factors|immunologic factors|mesh-ancestor
102473551|NCT01279681|Antidotes|antidotes|mesh-ancestor
102473552|NCT01279681|Protective Agents|protective agents|mesh-ancestor
102473553|NCT01279681|Vitamin B Complex|vitamin b complex|mesh-ancestor
102473554|NCT01279681|Vitamins|vitamins|mesh-ancestor
102473555|NCT01279681|Micronutrients|micronutrients|mesh-ancestor
102473556|NCT01276925|Bupivacaine|bupivacaine|mesh-list
102473557|NCT01276925|Ropivacaine|ropivacaine|mesh-list
102473558|NCT01276925|Anesthetics, Local|anesthetics, local|mesh-ancestor
102473559|NCT01276925|Anesthetics|anesthetics|mesh-ancestor
102473560|NCT01276925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102473561|NCT01276925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473562|NCT01276925|Sensory System Agents|sensory system agents|mesh-ancestor
102473563|NCT01276925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102473564|NCT00728507|Moxifloxacin|moxifloxacin|mesh-list
102473565|NCT00728507|Rifampin|rifampin|mesh-list
102473566|NCT00728507|Isoniazid|isoniazid|mesh-list
102473567|NCT00728507|Pyrazinamide|pyrazinamide|mesh-list
102473568|NCT00728507|Ethambutol|ethambutol|mesh-list
102473569|NCT00728507|Rifapentine|rifapentine|mesh-list
102473570|NCT00728507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102473571|NCT00728507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102473572|NCT00728507|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102473573|NCT00728507|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102473574|NCT00728507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102473575|NCT00728507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473576|NCT00728507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102473577|NCT00728507|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102473578|NCT00728507|Antitubercular Agents|antitubercular agents|mesh-ancestor
102473579|NCT00728507|Leprostatic Agents|leprostatic agents|mesh-ancestor
102473580|NCT00728507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102473581|NCT00728507|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102473582|NCT00728507|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102473583|NCT00728507|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102473584|NCT00728507|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102473585|NCT00728507|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102473586|NCT00728507|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102473587|NCT00728507|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102473588|NCT00728507|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102473589|NCT00728507|Antimetabolites|antimetabolites|mesh-ancestor
102473590|NCT00728507|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102473591|NCT01279057|Fluticasone|fluticasone|mesh-list
102473592|NCT01279057|Xhance|xhance|mesh-list
102473593|NCT01279057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102473594|NCT01279057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102473595|NCT01279057|Autonomic Agents|autonomic agents|mesh-ancestor
102473596|NCT01279057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102473597|NCT01279057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473598|NCT01279057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102473599|NCT01279057|Respiratory System Agents|respiratory system agents|mesh-ancestor
102473600|NCT01279057|Dermatologic Agents|dermatologic agents|mesh-ancestor
102473601|NCT01279057|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102473602|NCT04384783|Hormones|hormones|mesh-list
102473603|NCT04384783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102473604|NCT04384783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473605|NCT03186326|Bevacizumab|bevacizumab|mesh-list
102473606|NCT03186326|Cetuximab|cetuximab|mesh-list
102473607|NCT03186326|Avelumab|avelumab|mesh-list
102473608|NCT03186326|Panitumumab|panitumumab|mesh-list
102473609|NCT03186326|Aflibercept|aflibercept|mesh-list
102473610|NCT03186326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102473611|NCT03186326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102473612|NCT03186326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102473613|NCT03186326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102473614|NCT03186326|Growth Substances|growth substances|mesh-ancestor
102473615|NCT03186326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473616|NCT03186326|Growth Inhibitors|growth inhibitors|mesh-ancestor
102473617|NCT02999633|Acetaminophen|acetaminophen|mesh-list
102473618|NCT02999633|Diphenhydramine|diphenhydramine|mesh-list
102473619|NCT02999633|Promethazine|promethazine|mesh-list
102473620|NCT02999633|Dexamethasone|dexamethasone|mesh-list
102473621|NCT02999633|Dexamethasone acetate|dexamethasone acetate|mesh-list
102473622|NCT02999633|Ranitidine|ranitidine|mesh-list
102473623|NCT02999633|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
102473624|NCT02999633|BB 1101|bb 1101|mesh-list
102473625|NCT02999633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102473626|NCT02999633|Antiemetics|antiemetics|mesh-ancestor
102473627|NCT02999633|Autonomic Agents|autonomic agents|mesh-ancestor
102473628|NCT02999633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102473629|NCT02999633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473630|NCT02999633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102473631|NCT02999633|Glucocorticoids|glucocorticoids|mesh-ancestor
102473632|NCT02999633|Hormones|hormones|mesh-ancestor
102473633|NCT02999633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102473634|NCT02999633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102473635|NCT02999633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102473636|NCT02999633|Protease Inhibitors|protease inhibitors|mesh-ancestor
102473637|NCT02999633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102473638|NCT02999633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473639|NCT02999633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102473640|NCT02999633|Analgesics|analgesics|mesh-ancestor
102473641|NCT02999633|Sensory System Agents|sensory system agents|mesh-ancestor
102473642|NCT02999633|Antipyretics|antipyretics|mesh-ancestor
102473643|NCT02999633|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102473644|NCT02999633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102473645|NCT02999633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102473646|NCT02999633|Anesthetics, Local|anesthetics, local|mesh-ancestor
102473648|NCT02999633|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102473649|NCT02999633|Histamine Antagonists|histamine antagonists|mesh-ancestor
102473650|NCT02999633|Histamine Agents|histamine agents|mesh-ancestor
102473651|NCT02999633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102473652|NCT02999633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102473653|NCT02999633|Antipruritics|antipruritics|mesh-ancestor
102473654|NCT02999633|Dermatologic Agents|dermatologic agents|mesh-ancestor
102473655|NCT02999633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102473656|NCT02999633|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102473657|NCT04749797|Bupivacaine|bupivacaine|mesh-list
102473658|NCT04749797|Anesthetics, Local|anesthetics, local|mesh-ancestor
102473659|NCT04749797|Anesthetics|anesthetics|mesh-ancestor
102473660|NCT04749797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102473661|NCT04749797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473662|NCT04749797|Sensory System Agents|sensory system agents|mesh-ancestor
102473663|NCT04749797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102473664|NCT02991599|Vaccines|vaccines|mesh-list
102473665|NCT02991599|Immunologic Factors|immunologic factors|mesh-ancestor
102473666|NCT02991599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473667|NCT02996513|Vitamin A|vitamin a|mesh-list
102473668|NCT02996513|Vitamins|vitamins|mesh-ancestor
102473669|NCT02996513|Micronutrients|micronutrients|mesh-ancestor
102473670|NCT02996513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473671|NCT04276688|Interferons|interferons|mesh-list
102473672|NCT04276688|Ritonavir|ritonavir|mesh-list
102473673|NCT04276688|Ribavirin|ribavirin|mesh-list
102473674|NCT04276688|Lopinavir|lopinavir|mesh-list
102473675|NCT04276688|Interferon-beta|interferon-beta|mesh-list
102473676|NCT04276688|Interferon beta-1b|interferon beta-1b|mesh-list
102473677|NCT04276688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102473678|NCT04276688|Antiviral Agents|antiviral agents|mesh-ancestor
102473679|NCT04276688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102473680|NCT04276688|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102473681|NCT04276688|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102473682|NCT04276688|Protease Inhibitors|protease inhibitors|mesh-ancestor
102473683|NCT04276688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102473684|NCT04276688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473685|NCT04276688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102473686|NCT04276688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102473687|NCT04276688|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102473688|NCT04276688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102473689|NCT04276688|Antimetabolites|antimetabolites|mesh-ancestor
102473690|NCT04276688|Immunologic Factors|immunologic factors|mesh-ancestor
102473691|NCT04276688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473692|NCT04276688|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102473693|NCT01277627|Efavirenz|efavirenz|mesh-list
102473694|NCT01277627|Nevirapine|nevirapine|mesh-list
102473695|NCT01277627|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
102473696|NCT01277627|Protease Inhibitors|protease inhibitors|mesh-list
102473697|NCT01277627|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102473698|NCT01277627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102473699|NCT01277627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102473700|NCT01277627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473701|NCT01277627|Antiviral Agents|antiviral agents|mesh-ancestor
102473702|NCT01277627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102473703|NCT01277627|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102473704|NCT01277627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102473705|NCT01277627|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102473706|NCT01277627|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102473707|NCT01277627|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102473708|NCT01277627|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102473709|NCT01277627|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102473710|NCT01277627|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102473711|NCT01277627|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102473712|NCT05241470|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102473713|NCT05241470|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102473714|NCT01270451|Insulin|insulin|mesh-list
102473715|NCT01270451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102473716|NCT01270451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473717|NCT00706979|Nicotine|nicotine|mesh-list
102473718|NCT00706979|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102473719|NCT00706979|Autonomic Agents|autonomic agents|mesh-ancestor
102473720|NCT00706979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102473721|NCT00706979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473722|NCT00706979|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102473723|NCT00706979|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102473724|NCT00706979|Cholinergic Agents|cholinergic agents|mesh-ancestor
102473725|NCT00706979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102473726|NCT00706979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473727|NCT01278017|Ceftriaxone|ceftriaxone|mesh-list
102473728|NCT01278017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102473729|NCT01278017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102473730|NCT00716963|Fluticasone|fluticasone|mesh-list
102473731|NCT00716963|Xhance|xhance|mesh-list
102473732|NCT00716963|Budesonide|budesonide|mesh-list
102473733|NCT00716963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102473734|NCT00716963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102473735|NCT00716963|Autonomic Agents|autonomic agents|mesh-ancestor
102473736|NCT00716963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102473737|NCT00716963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473738|NCT00716963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102473739|NCT00716963|Respiratory System Agents|respiratory system agents|mesh-ancestor
102473740|NCT00716963|Dermatologic Agents|dermatologic agents|mesh-ancestor
102473741|NCT00716963|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102473742|NCT00716963|Glucocorticoids|glucocorticoids|mesh-ancestor
102473743|NCT00716963|Hormones|hormones|mesh-ancestor
102473744|NCT00716963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102473745|NCT01270997|Etanercept|etanercept|mesh-list
102473746|NCT01270997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102473747|NCT01270997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102473748|NCT01270997|Analgesics|analgesics|mesh-ancestor
102473749|NCT01270997|Sensory System Agents|sensory system agents|mesh-ancestor
102473750|NCT01270997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102473751|NCT01270997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473752|NCT01270997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102473753|NCT01270997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102473754|NCT01270997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102473755|NCT01270997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102473756|NCT01270997|Immunologic Factors|immunologic factors|mesh-ancestor
102473757|NCT01278745|Rituximab|rituximab|mesh-list
102473758|NCT01278745|Tacrolimus|tacrolimus|mesh-list
102473759|NCT01278745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102473760|NCT01278745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102473761|NCT01278745|Immunologic Factors|immunologic factors|mesh-ancestor
102473762|NCT01278745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473763|NCT01278745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102473764|NCT01278745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102473765|NCT01278745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102473766|NCT01278745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102473767|NCT01278745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473768|NCT02995655|Azacitidine|azacitidine|mesh-list
102473769|NCT02995655|Heparin|heparin|mesh-list
102473770|NCT02995655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102473771|NCT02995655|Antimetabolites|antimetabolites|mesh-ancestor
102473772|NCT02995655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473773|NCT02995655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102473774|NCT02995655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102473775|NCT02995655|Anticoagulants|anticoagulants|mesh-ancestor
102473776|NCT02995655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102473777|NCT02995655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102473778|NCT01271153|Dobutamine|dobutamine|mesh-list
102473779|NCT01271153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102473780|NCT01271153|Sympathomimetics|sympathomimetics|mesh-ancestor
102473781|NCT01271153|Autonomic Agents|autonomic agents|mesh-ancestor
102473782|NCT01271153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102473783|NCT01271153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473784|NCT01271153|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102473785|NCT01271153|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102473786|NCT01271153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102473787|NCT01271153|Adrenergic Agents|adrenergic agents|mesh-ancestor
102473788|NCT01271153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102473789|NCT01271153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473790|NCT01271153|Protective Agents|protective agents|mesh-ancestor
102473791|NCT03809065|Labetalol|labetalol|mesh-list
102473792|NCT03809065|Nitroglycerin|nitroglycerin|mesh-list
102473793|NCT03809065|Vasodilator Agents|vasodilator agents|mesh-ancestor
102473794|NCT03809065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102473795|NCT03809065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102473796|NCT03809065|Adrenergic Agents|adrenergic agents|mesh-ancestor
102473797|NCT03809065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102473798|NCT03809065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473799|NCT03809065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473800|NCT03809065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102473801|NCT03809065|Sympathomimetics|sympathomimetics|mesh-ancestor
102473802|NCT03809065|Autonomic Agents|autonomic agents|mesh-ancestor
102473803|NCT03809065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102473804|NCT03809065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102473805|NCT03809065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102473806|NCT03006926|Pembrolizumab|pembrolizumab|mesh-list
102473807|NCT03006926|Lenvatinib|lenvatinib|mesh-list
102473808|NCT03006926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102473809|NCT03006926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102473810|NCT03006926|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102473811|NCT03006926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473812|NCT03006926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102473813|NCT03006926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102473814|NCT02995187|Apatinib|apatinib|mesh-list
102473815|NCT02995187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102473816|NCT02995187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102473817|NCT02995187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102473818|NCT02995187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473819|NCT01272089|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
102473820|NCT01272089|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102473821|NCT01272089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102473822|NCT01272089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102473823|NCT01272089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102473824|NCT01272089|Analgesics|analgesics|mesh-ancestor
102473825|NCT01272089|Sensory System Agents|sensory system agents|mesh-ancestor
102473826|NCT01272089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102473827|NCT01272089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473828|NCT01272089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102473829|NCT01272089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102473830|NCT01272089|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102473831|NCT01272089|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102473832|NCT01272089|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102473833|NCT01272089|Histamine Antagonists|histamine antagonists|mesh-ancestor
102473834|NCT01272089|Histamine Agents|histamine agents|mesh-ancestor
102473835|NCT01272089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102473836|NCT01272089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473837|NCT00748657|Bevacizumab|bevacizumab|mesh-list
102473838|NCT00748657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102473839|NCT00748657|Endothelial Growth Factors|endothelial growth factors|mesh-list
102473840|NCT00748657|Antibodies|antibodies|mesh-list
102473841|NCT00748657|Immunoglobulins|immunoglobulins|mesh-list
102473842|NCT00748657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102473843|NCT00748657|Immunoglobulin G|immunoglobulin g|mesh-list
102473844|NCT00748657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102473845|NCT00748657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102473846|NCT00748657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102473847|NCT00748657|Growth Substances|growth substances|mesh-ancestor
102473848|NCT00748657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473849|NCT00748657|Growth Inhibitors|growth inhibitors|mesh-ancestor
102473850|NCT00748657|Immunologic Factors|immunologic factors|mesh-ancestor
102473851|NCT02994953|Avelumab|avelumab|mesh-list
102473852|NCT02994953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102473853|NCT02994953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102473854|NCT02994953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102473855|NCT02994953|Immunologic Factors|immunologic factors|mesh-ancestor
102473856|NCT02994953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473857|NCT01273051|Capecitabine|capecitabine|mesh-list
102473858|NCT01273051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102473859|NCT01273051|Antimetabolites|antimetabolites|mesh-ancestor
102473860|NCT01273051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473861|NCT01273051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102473862|NCT02994875|Acetylcysteine|acetylcysteine|mesh-list
102473863|NCT02994875|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102473864|NCT02994875|Antiviral Agents|antiviral agents|mesh-ancestor
102473865|NCT02994875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102473866|NCT02994875|Expectorants|expectorants|mesh-ancestor
102473867|NCT02994875|Respiratory System Agents|respiratory system agents|mesh-ancestor
102473868|NCT02994875|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102473869|NCT02994875|Antioxidants|antioxidants|mesh-ancestor
102473870|NCT02994875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473871|NCT02994875|Protective Agents|protective agents|mesh-ancestor
102473872|NCT02994875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473873|NCT02994875|Antidotes|antidotes|mesh-ancestor
102473874|NCT03809143|Buprenorphine|buprenorphine|mesh-list
102473875|NCT03809143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102473876|NCT03809143|Narcotics|narcotics|mesh-ancestor
102473877|NCT03809143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102473878|NCT03809143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473879|NCT03809143|Analgesics|analgesics|mesh-ancestor
102473880|NCT03809143|Sensory System Agents|sensory system agents|mesh-ancestor
102473881|NCT03809143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102473882|NCT03809143|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102473883|NCT02390960|Sildenafil Citrate|sildenafil citrate|mesh-list
102473884|NCT02390960|Vasodilator Agents|vasodilator agents|mesh-ancestor
102473885|NCT02390960|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102473886|NCT02390960|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102473887|NCT02390960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102473888|NCT02390960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473889|NCT02390960|Urological Agents|urological agents|mesh-ancestor
102473890|NCT00720473|Lamotrigine|lamotrigine|mesh-list
102473891|NCT00720473|Anticonvulsants|anticonvulsants|mesh-ancestor
102473892|NCT00720473|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102473893|NCT00720473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102473894|NCT00720473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473895|NCT00720473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102473896|NCT00720473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473897|NCT00720473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102473898|NCT00720473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102473899|NCT00720473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102473900|NCT00720473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102473901|NCT00720473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102473902|NCT00637832|Prednisolone|prednisolone|mesh-list
102473903|NCT00637832|Cyclophosphamide|cyclophosphamide|mesh-list
102473904|NCT00637832|Rituximab|rituximab|mesh-list
102473905|NCT00637832|Doxorubicin|doxorubicin|mesh-list
102473906|NCT00637832|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102473907|NCT00637832|Vincristine|vincristine|mesh-list
102473908|NCT00637832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102473909|NCT00637832|Immunologic Factors|immunologic factors|mesh-ancestor
102473910|NCT00637832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473911|NCT00637832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102473912|NCT00637832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102473913|NCT00637832|Alkylating Agents|alkylating agents|mesh-ancestor
102473914|NCT00637832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473915|NCT00637832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102473916|NCT00637832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102473917|NCT00637832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101557599|NCT02470585|Veliparib|veliparib|mesh-list
102473918|NCT00637832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102473919|NCT00637832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102473920|NCT00637832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102473921|NCT00637832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102473922|NCT00637832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102473923|NCT00637832|Tubulin Modulators|tubulin modulators|mesh-ancestor
102473924|NCT00637832|Antimitotic Agents|antimitotic agents|mesh-ancestor
102473925|NCT00637832|Mitosis Modulators|mitosis modulators|mesh-ancestor
102473926|NCT00637832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102473927|NCT00637832|Glucocorticoids|glucocorticoids|mesh-ancestor
102473928|NCT00637832|Hormones|hormones|mesh-ancestor
102473929|NCT00637832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102473930|NCT00637832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102473931|NCT00720629|Methotrexate|methotrexate|mesh-list
102473932|NCT00720629|Tacrolimus|tacrolimus|mesh-list
102473933|NCT00720629|Thymoglobulin|thymoglobulin|mesh-list
102473934|NCT00720629|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102473935|NCT00720629|Visilizumab|visilizumab|mesh-list
102473936|NCT00720629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102473937|NCT00720629|Abortifacient Agents|abortifacient agents|mesh-ancestor
102473938|NCT00720629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102473939|NCT00720629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473940|NCT00720629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102473941|NCT00720629|Antimetabolites|antimetabolites|mesh-ancestor
102473942|NCT00720629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473943|NCT00720629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102473944|NCT00720629|Dermatologic Agents|dermatologic agents|mesh-ancestor
102473945|NCT00720629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102473946|NCT00720629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102473947|NCT00720629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102473948|NCT00720629|Immunologic Factors|immunologic factors|mesh-ancestor
102473949|NCT00720629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102473950|NCT00720629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102473951|NCT00720629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102473952|NCT01276327|Pioglitazone|pioglitazone|mesh-list
102473953|NCT01276327|Linagliptin|linagliptin|mesh-list
102473954|NCT01276327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102473955|NCT01276327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473956|NCT01276327|Incretins|incretins|mesh-ancestor
102473958|NCT01276327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102473959|NCT01276327|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102473960|NCT01276327|Protease Inhibitors|protease inhibitors|mesh-ancestor
102473961|NCT01276327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102473962|NCT01276327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473963|NCT05245760|Paclitaxel|paclitaxel|mesh-list
102473964|NCT05245760|Carboplatin|carboplatin|mesh-list
102473965|NCT05245760|Tislelizumab|tislelizumab|mesh-list
102473966|NCT05245760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102473967|NCT05245760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102473968|NCT05245760|Tubulin Modulators|tubulin modulators|mesh-ancestor
102473969|NCT05245760|Antimitotic Agents|antimitotic agents|mesh-ancestor
102473970|NCT05245760|Mitosis Modulators|mitosis modulators|mesh-ancestor
102473971|NCT05245760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473972|NCT05245760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102473973|NCT02674958|Aspirin|aspirin|mesh-list
102473974|NCT02674958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102473975|NCT02674958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102473976|NCT02674958|Analgesics|analgesics|mesh-ancestor
102473977|NCT02674958|Sensory System Agents|sensory system agents|mesh-ancestor
102473978|NCT02674958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102473979|NCT02674958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102473980|NCT02674958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102473981|NCT02674958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102473982|NCT02674958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102473983|NCT02674958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102473984|NCT02674958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102473985|NCT02674958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102473986|NCT02674958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102473987|NCT02674958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102473988|NCT02674958|Antipyretics|antipyretics|mesh-ancestor
102473989|NCT00760435|Infliximab|infliximab|mesh-list
102473990|NCT00760435|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102473991|NCT00760435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102473992|NCT00760435|Dermatologic Agents|dermatologic agents|mesh-ancestor
102473993|NCT00760435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102473994|NCT00760435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102473995|NCT03808129|Lidocaine|lidocaine|mesh-list
102473996|NCT03808129|Bupivacaine|bupivacaine|mesh-list
102473997|NCT03808129|Anesthetics, Local|anesthetics, local|mesh-ancestor
102473998|NCT03808129|Anesthetics|anesthetics|mesh-ancestor
102473999|NCT03808129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102474000|NCT03808129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474001|NCT03808129|Sensory System Agents|sensory system agents|mesh-ancestor
102474002|NCT03808129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101557732|NCT01908777|Cytarabine|cytarabine|mesh-list
102474003|NCT03808129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102474004|NCT03808129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102474005|NCT03808129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102474006|NCT03808129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102474007|NCT03808129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474008|NCT00749125|Escitalopram|escitalopram|mesh-list
102474009|NCT00749125|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102474010|NCT00749125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102474011|NCT00749125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102474012|NCT00749125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474013|NCT00749125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102474014|NCT00749125|Serotonin Agents|serotonin agents|mesh-ancestor
102474015|NCT00749125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474016|NCT02144675|Cytarabine|cytarabine|mesh-list
102474017|NCT02144675|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
102474018|NCT02144675|Salicylates|salicylates|mesh-list
102474019|NCT02144675|Idarubicin|idarubicin|mesh-list
102474020|NCT02144675|Choline|choline|mesh-list
102474021|NCT02144675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102474022|NCT02144675|Antimetabolites|antimetabolites|mesh-ancestor
102285668|NCT05176821|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
102474023|NCT02144675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474024|NCT02144675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102474025|NCT02144675|Antiviral Agents|antiviral agents|mesh-ancestor
102474026|NCT02144675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102474027|NCT02144675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102474028|NCT02144675|Immunologic Factors|immunologic factors|mesh-ancestor
102474029|NCT02144675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474030|NCT02144675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102474031|NCT02144675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102474032|NCT02144675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102474033|NCT02144675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102474034|NCT02144675|Lipotropic Agents|lipotropic agents|mesh-ancestor
102474035|NCT02144675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102474036|NCT02144675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102474037|NCT02144675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102474038|NCT02144675|Nootropic Agents|nootropic agents|mesh-ancestor
102474039|NCT02144675|Analgesics|analgesics|mesh-ancestor
102474040|NCT02144675|Sensory System Agents|sensory system agents|mesh-ancestor
102474041|NCT02144675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102474042|NCT02144675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102474043|NCT02144675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102474044|NCT02144675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102474045|NCT02144675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102474046|NCT02144675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102474047|NCT00749515|Deferasirox|deferasirox|mesh-list
102474048|NCT00749515|Deferoxamine|deferoxamine|mesh-list
102474049|NCT00749515|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102474050|NCT00749515|Chelating Agents|chelating agents|mesh-ancestor
102474051|NCT00749515|Sequestering Agents|sequestering agents|mesh-ancestor
102474052|NCT00749515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474053|NCT00749515|Siderophores|siderophores|mesh-ancestor
102474054|NCT01272557|Doxorubicin|doxorubicin|mesh-list
102474055|NCT01272557|Sorafenib|sorafenib|mesh-list
102474056|NCT01272557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102474057|NCT01272557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102474058|NCT01272557|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102474059|NCT01272557|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102474060|NCT01272557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102474061|NCT01272557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474062|NCT01272557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102474063|NCT00639002|Dexamethasone|dexamethasone|mesh-list
102474064|NCT00639002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102474065|NCT00639002|Antiemetics|antiemetics|mesh-ancestor
102474066|NCT00639002|Autonomic Agents|autonomic agents|mesh-ancestor
101425429|NCT03879122|Docetaxel|docetaxel|mesh-list
102474067|NCT00639002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102474068|NCT00639002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474069|NCT00639002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102474070|NCT00639002|Glucocorticoids|glucocorticoids|mesh-ancestor
102474071|NCT00639002|Hormones|hormones|mesh-ancestor
101557815|NCT01862315|Glucocorticoids|glucocorticoids|mesh-ancestor
102474072|NCT00639002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102474073|NCT00639002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102474074|NCT00639002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102474075|NCT00761137|Tropicamide|tropicamide|mesh-list
102474076|NCT00761137|Mydriatics|mydriatics|mesh-ancestor
102474077|NCT00761137|Autonomic Agents|autonomic agents|mesh-ancestor
102474078|NCT00761137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102474079|NCT00761137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474080|NCT00761137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102474081|NCT00761137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101557823|NCT01745588|Clarithromycin|clarithromycin|mesh-list
102474082|NCT00761137|Cholinergic Agents|cholinergic agents|mesh-ancestor
102474083|NCT00761137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102474084|NCT00761137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474085|NCT02145247|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102474086|NCT02145247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102474087|NCT02145247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474088|NCT01273493|Dexamethasone|dexamethasone|mesh-list
102474089|NCT01273493|Trabectedin|trabectedin|mesh-list
102474090|NCT01273493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102474091|NCT01273493|Antiemetics|antiemetics|mesh-ancestor
102474092|NCT01273493|Autonomic Agents|autonomic agents|mesh-ancestor
102474093|NCT01273493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102474094|NCT01273493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474095|NCT01273493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102474096|NCT01273493|Glucocorticoids|glucocorticoids|mesh-ancestor
102474097|NCT01273493|Hormones|hormones|mesh-ancestor
102285739|NCT05170113|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102474098|NCT01273493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101557831|NCT01745588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102474099|NCT01273493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102474100|NCT01273493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102474101|NCT01273493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102474102|NCT01273493|Alkylating Agents|alkylating agents|mesh-ancestor
102474103|NCT01273493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474104|NCT00638456|Budesonide|budesonide|mesh-list
102474105|NCT00638456|Lansoprazole|lansoprazole|mesh-list
102474106|NCT00638456|Dexlansoprazole|dexlansoprazole|mesh-list
102474107|NCT00638456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102474108|NCT00638456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102474109|NCT00638456|Autonomic Agents|autonomic agents|mesh-ancestor
102474110|NCT00638456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102474111|NCT00638456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474112|NCT00638456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102474113|NCT00638456|Respiratory System Agents|respiratory system agents|mesh-ancestor
102474114|NCT00638456|Glucocorticoids|glucocorticoids|mesh-ancestor
102474115|NCT00638456|Hormones|hormones|mesh-ancestor
102474116|NCT00638456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102474117|NCT00638456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102474118|NCT00638456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102474119|NCT00638456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102474120|NCT00638456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102474121|NCT00638456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474122|NCT01273571|Metformin|metformin|mesh-list
102474123|NCT01273571|Canagliflozin|canagliflozin|mesh-list
102474124|NCT01273571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102474125|NCT01273571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474126|NCT01273571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102474127|NCT01273571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474128|NCT02147899|Secnidazole|secnidazole|mesh-list
102474129|NCT02147899|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102474130|NCT02147899|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102474131|NCT02147899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102474132|NCT02565992|Pembrolizumab|pembrolizumab|mesh-list
102474133|NCT02565992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102474134|NCT02565992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102474135|NCT02565992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102474136|NCT02565992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474137|NCT00762619|Triclosan|triclosan|mesh-list
102474138|NCT00762619|Fluorides|fluorides|mesh-list
102474139|NCT00762619|Cariostatic Agents|cariostatic agents|mesh-ancestor
102474140|NCT00762619|Protective Agents|protective agents|mesh-ancestor
102474141|NCT00762619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474142|NCT00762619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102474143|NCT00762619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101557871|NCT01496976|Antiemetics|antiemetics|mesh-ancestor
102474144|NCT00762619|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102474145|NCT00762619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102474146|NCT00762619|Antimetabolites|antimetabolites|mesh-ancestor
102474147|NCT00762619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474148|NCT00762619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102474149|NCT00735449|Timolol|timolol|mesh-list
102474150|NCT00735449|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102474151|NCT00735449|Latanoprost|latanoprost|mesh-list
102474152|NCT00735449|Maleic acid|maleic acid|mesh-list
102474153|NCT00735449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102474154|NCT00735449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474155|NCT00735449|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102474156|NCT00735449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102474157|NCT00735449|Adrenergic Agents|adrenergic agents|mesh-ancestor
102474158|NCT00735449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102474159|NCT00735449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474160|NCT00735449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102474161|NCT00735449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102474162|NCT00735449|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102474163|NCT00735449|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102474164|NCT00735449|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102474165|NCT00735449|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102474166|NCT00735449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102474167|NCT01273831|Cisatracurium|cisatracurium|mesh-list
102474168|NCT01273831|Atracurium|atracurium|mesh-list
102474169|NCT01273831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102474170|NCT01273831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102285813|NCT04331639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474171|NCT01273831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101557907|NCT00700882|Dasatinib|dasatinib|mesh-list
102474172|NCT01273831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474173|NCT01273831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102474174|NCT01273831|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102474175|NCT01273831|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102474176|NCT01273831|Cholinergic Agents|cholinergic agents|mesh-ancestor
102474177|NCT01273831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102474178|NCT01273831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474179|NCT00735917|Saracatinib|saracatinib|mesh-list
102474180|NCT00735917|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102474181|NCT00735917|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102474182|NCT00735917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474183|NCT00735917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102474184|NCT00735917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102474185|NCT00736073|Aprepitant|aprepitant|mesh-list
102474186|NCT00736073|Antiemetics|antiemetics|mesh-ancestor
102474187|NCT00736073|Autonomic Agents|autonomic agents|mesh-ancestor
102474188|NCT00736073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102474189|NCT00736073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474190|NCT00736073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102474191|NCT00736073|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102474192|NCT00736073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102474193|NCT00736073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474194|NCT00736229|Exenatide|exenatide|mesh-list
102474195|NCT00736229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102474196|NCT00736229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474197|NCT00736229|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102474198|NCT00736229|Incretins|incretins|mesh-ancestor
102474199|NCT00736229|Hormones|hormones|mesh-ancestor
101557923|NCT00673309|Antifungal Agents|antifungal agents|mesh-ancestor
102474200|NCT00736229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102474201|NCT00737243|Paclitaxel|paclitaxel|mesh-list
102474202|NCT00737243|Bevacizumab|bevacizumab|mesh-list
102474203|NCT00737243|Carboplatin|carboplatin|mesh-list
102474204|NCT00737243|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102474205|NCT00737243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102474206|NCT00737243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102474207|NCT00737243|Tubulin Modulators|tubulin modulators|mesh-ancestor
102474208|NCT00737243|Antimitotic Agents|antimitotic agents|mesh-ancestor
102474209|NCT00737243|Mitosis Modulators|mitosis modulators|mesh-ancestor
102474210|NCT00737243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474211|NCT00737243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102474212|NCT00737243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102474213|NCT00737243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102474214|NCT00737243|Growth Substances|growth substances|mesh-ancestor
102474215|NCT00737243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474216|NCT00737243|Growth Inhibitors|growth inhibitors|mesh-ancestor
102474217|NCT00737243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102474218|NCT00737243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102474219|NCT00707759|Mycophenolic Acid|mycophenolic acid|mesh-list
102474220|NCT00707759|Prednisone|prednisone|mesh-list
102474221|NCT00707759|Prednisolone|prednisolone|mesh-list
102474222|NCT00707759|Tacrolimus|tacrolimus|mesh-list
102474223|NCT00707759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102474224|NCT00707759|Glucocorticoids|glucocorticoids|mesh-ancestor
102474225|NCT00707759|Hormones|hormones|mesh-ancestor
101557953|NCT00600496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102474226|NCT00707759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102474227|NCT00707759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474228|NCT00707759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102474229|NCT00707759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102474230|NCT00707759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102474231|NCT00707759|Immunologic Factors|immunologic factors|mesh-ancestor
102474232|NCT00707759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102474233|NCT00707759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102474234|NCT00707759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474235|NCT00707759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102474236|NCT00707759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102474237|NCT00707759|Antitubercular Agents|antitubercular agents|mesh-ancestor
102474238|NCT00707759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102474239|NCT00707759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102474240|NCT01273727|Dexamethasone|dexamethasone|mesh-list
102474241|NCT01273727|Dexamethasone acetate|dexamethasone acetate|mesh-list
102474242|NCT01273727|BB 1101|bb 1101|mesh-list
102474243|NCT01273727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102474244|NCT01273727|Antiemetics|antiemetics|mesh-ancestor
102474245|NCT01273727|Autonomic Agents|autonomic agents|mesh-ancestor
102474246|NCT01273727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102474247|NCT01273727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474248|NCT01273727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102474249|NCT01273727|Glucocorticoids|glucocorticoids|mesh-ancestor
102474251|NCT01273727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102474252|NCT01273727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102474253|NCT01273727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102474254|NCT01273727|Protease Inhibitors|protease inhibitors|mesh-ancestor
102474255|NCT01273727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102474256|NCT01273727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474257|NCT00708071|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102474258|NCT00708071|Thrombin|thrombin|mesh-list
102474259|NCT00708071|Aprotinin|aprotinin|mesh-list
102474260|NCT00708071|Hemostatics|hemostatics|mesh-ancestor
102474261|NCT00708071|Coagulants|coagulants|mesh-ancestor
102474262|NCT00708071|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102474263|NCT00708071|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102474264|NCT00708071|Protease Inhibitors|protease inhibitors|mesh-ancestor
102474265|NCT00708071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102474266|NCT00708071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474267|NCT02994485|Simvastatin|simvastatin|mesh-list
102474268|NCT02994485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102474269|NCT02994485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102474270|NCT02994485|Antimetabolites|antimetabolites|mesh-ancestor
102474271|NCT02994485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474272|NCT02994485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102474273|NCT02994485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102474274|NCT02994485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102474275|NCT02994173|Ketamine|ketamine|mesh-list
102474276|NCT02994173|Oxycodone|oxycodone|mesh-list
102474277|NCT02994173|Esketamine|esketamine|mesh-list
102474278|NCT02994173|Analgesics|analgesics|mesh-ancestor
102474279|NCT02994173|Sensory System Agents|sensory system agents|mesh-ancestor
102474280|NCT02994173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102474281|NCT02994173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474282|NCT02994173|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102474283|NCT02994173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102474284|NCT02994173|Anesthetics, General|anesthetics, general|mesh-ancestor
102474285|NCT02994173|Anesthetics|anesthetics|mesh-ancestor
102474286|NCT02994173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102474287|NCT02994173|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102474288|NCT02994173|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102474289|NCT02994173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102474290|NCT02994173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474291|NCT02994173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102474292|NCT02994173|Narcotics|narcotics|mesh-ancestor
102474293|NCT02994173|Antidepressive Agents|antidepressive agents|mesh-ancestor
102474294|NCT02994173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102474295|NCT00723749|Buprenorphine|buprenorphine|mesh-list
102474296|NCT00723749|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102474297|NCT00723749|Naloxone|naloxone|mesh-list
102474298|NCT00723749|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102474299|NCT00723749|Narcotics|narcotics|mesh-ancestor
102474300|NCT00723749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102474301|NCT00723749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474302|NCT00723749|Analgesics|analgesics|mesh-ancestor
102474303|NCT00723749|Sensory System Agents|sensory system agents|mesh-ancestor
102474304|NCT00723749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102474305|NCT00723749|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102474306|NCT00723827|Temozolomide|temozolomide|mesh-list
102474307|NCT00723827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102474308|NCT00723827|Alkylating Agents|alkylating agents|mesh-ancestor
102474309|NCT00723827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474310|NCT00723827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102474311|NCT02993861|Anticonvulsants|anticonvulsants|mesh-list
102474312|NCT00779311|Bevacizumab|bevacizumab|mesh-list
102474313|NCT00779311|Sorafenib|sorafenib|mesh-list
102474314|NCT00779311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102474315|NCT00779311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102474316|NCT00779311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102474317|NCT00779311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102474318|NCT00779311|Growth Substances|growth substances|mesh-ancestor
102285963|NCT01672723|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102474319|NCT00779311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474320|NCT00779311|Growth Inhibitors|growth inhibitors|mesh-ancestor
102474321|NCT00779311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102474322|NCT00779311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102474323|NCT00779311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474325|NCT01274039|Anticonvulsants|anticonvulsants|mesh-ancestor
102474326|NCT01274039|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102474327|NCT01274039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102474328|NCT01274039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474329|NCT01274039|Diuretics|diuretics|mesh-ancestor
102474330|NCT01274039|Natriuretic Agents|natriuretic agents|mesh-ancestor
102474331|NCT01274039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474332|NCT01274195|Busulfan|busulfan|mesh-list
102474333|NCT01274195|Alkylating Agents|alkylating agents|mesh-ancestor
102474334|NCT01274195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474335|NCT01274195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102474336|NCT01274195|Immunologic Factors|immunologic factors|mesh-ancestor
102474337|NCT01274195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474338|NCT01274195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102474339|NCT01274195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102474340|NCT01274195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102474341|NCT00779701|Insulin|insulin|mesh-list
102474342|NCT00779701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102474343|NCT00779701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474344|NCT00738023|Rosiglitazone|rosiglitazone|mesh-list
102474345|NCT00738023|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102474346|NCT00738023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102474347|NCT00738023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474348|NCT00738023|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102474349|NCT00738023|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102474350|NCT00738023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102474351|NCT03809221|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102474352|NCT03809221|Hormones|hormones|mesh-list
102474353|NCT03809221|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102474354|NCT03809221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102474355|NCT03809221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474356|NCT03809221|Luteolytic Agents|luteolytic agents|mesh-ancestor
102474357|NCT03809221|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102474358|NCT03809221|Contraceptive Agents|contraceptive agents|mesh-ancestor
102474359|NCT03809221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102474360|NCT03809221|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102474361|NCT03809221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102474362|NCT03809221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102474363|NCT02993159|Tamoxifen|tamoxifen|mesh-list
102474364|NCT02993159|Afimoxifene|afimoxifene|mesh-list
101558097|NCT01184859|Hemostatics|hemostatics|mesh-ancestor
102474365|NCT02993159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102474366|NCT02993159|Hormone Antagonists|hormone antagonists|mesh-ancestor
102474367|NCT02993159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102474368|NCT02993159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474369|NCT02993159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102474370|NCT02993159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102474371|NCT02993159|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102474372|NCT02993159|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102474373|NCT02993159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102474374|NCT00723931|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102474375|NCT00723931|Antiviral Agents|antiviral agents|mesh-ancestor
102474376|NCT00723931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102474377|NCT00740129|Zoledronic Acid|zoledronic acid|mesh-list
102474378|NCT00740129|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102474379|NCT00740129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474380|NCT00762853|Triclosan|triclosan|mesh-list
102474381|NCT00762853|Fluorides|fluorides|mesh-list
102474382|NCT00762853|Cariostatic Agents|cariostatic agents|mesh-ancestor
102474383|NCT00762853|Protective Agents|protective agents|mesh-ancestor
102474384|NCT00762853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474385|NCT00762853|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102474386|NCT00762853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102474387|NCT00762853|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102474388|NCT00762853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102474389|NCT00762853|Antimetabolites|antimetabolites|mesh-ancestor
102474390|NCT00762853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474391|NCT00762853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102474392|NCT00724009|Clofarabine|clofarabine|mesh-list
102474393|NCT00724009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102474394|NCT00724009|Antimetabolites|antimetabolites|mesh-ancestor
102474395|NCT00724009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474396|NCT00724009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102474397|NCT01279499|Remifentanil|remifentanil|mesh-list
102474398|NCT01279499|Propofol|propofol|mesh-list
102474399|NCT01279499|Sevoflurane|sevoflurane|mesh-list
102474400|NCT01279499|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102474401|NCT01279499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102474402|NCT01279499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474403|NCT01279499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102474404|NCT01279499|Anesthetics, General|anesthetics, general|mesh-ancestor
102474405|NCT01279499|Anesthetics|anesthetics|mesh-ancestor
102474406|NCT01279499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102474407|NCT01279499|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102474408|NCT01279499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102474409|NCT01279499|Narcotics|narcotics|mesh-ancestor
102474410|NCT01279499|Analgesics|analgesics|mesh-ancestor
102474411|NCT01279499|Sensory System Agents|sensory system agents|mesh-ancestor
102474412|NCT01279499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102474413|NCT02992925|Vaccines|vaccines|mesh-list
102474414|NCT02992925|Immunologic Factors|immunologic factors|mesh-ancestor
102474415|NCT02992925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474416|NCT00780715|Metformin|metformin|mesh-list
102474417|NCT00780715|Pioglitazone|pioglitazone|mesh-list
102474418|NCT00780715|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102474419|NCT00780715|Gliclazide|gliclazide|mesh-list
102474420|NCT00780715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102474421|NCT00780715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474422|NCT00780715|Incretins|incretins|mesh-ancestor
102474423|NCT00780715|Hormones|hormones|mesh-ancestor
102474424|NCT00780715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102474425|NCT00780715|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102474426|NCT00780715|Protease Inhibitors|protease inhibitors|mesh-ancestor
102474427|NCT00780715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102474428|NCT00780715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474429|NCT05318443|Paclitaxel|paclitaxel|mesh-list
102474430|NCT05318443|Carboplatin|carboplatin|mesh-list
102474431|NCT05318443|Bevacizumab|bevacizumab|mesh-list
102474432|NCT05318443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101558156|NCT02890277|Chitosan|chitosan|mesh-list
102474433|NCT05318443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102474434|NCT05318443|Tubulin Modulators|tubulin modulators|mesh-ancestor
102474435|NCT05318443|Antimitotic Agents|antimitotic agents|mesh-ancestor
102474436|NCT05318443|Mitosis Modulators|mitosis modulators|mesh-ancestor
102474437|NCT05318443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474438|NCT05318443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102474439|NCT05318443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102474440|NCT05318443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102474441|NCT05318443|Growth Substances|growth substances|mesh-ancestor
102474442|NCT05318443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474443|NCT05318443|Growth Inhibitors|growth inhibitors|mesh-ancestor
102474444|NCT00740831|Leuprolide|leuprolide|mesh-list
102474445|NCT00740831|Ulipristal acetate|ulipristal acetate|mesh-list
102474446|NCT00740831|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102474447|NCT00740831|Fertility Agents|fertility agents|mesh-ancestor
102474448|NCT00740831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102474449|NCT00740831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474450|NCT00740831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102474451|NCT00740831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102474452|NCT00740831|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102474453|NCT00740831|Contraceptive Agents|contraceptive agents|mesh-ancestor
102474454|NCT00740831|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102474455|NCT01275287|Eculizumab|eculizumab|mesh-list
102474456|NCT01275287|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102474457|NCT01275287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102474458|NCT01275287|Immunologic Factors|immunologic factors|mesh-ancestor
102474459|NCT01275287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474460|NCT01275443|Rilpivirine|rilpivirine|mesh-list
102474461|NCT01275443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102474462|NCT01275443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102474463|NCT01275443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102474464|NCT01275443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474465|NCT01275443|Antiviral Agents|antiviral agents|mesh-ancestor
102474466|NCT01275443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102474467|NCT01275443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102474468|NCT01275443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102474469|NCT01274221|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102474470|NCT01274221|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102474471|NCT01274221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474472|NCT01274221|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102474473|NCT01274221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102474474|NCT01274221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102474475|NCT01274221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474476|NCT01274221|Dopamine Agents|dopamine agents|mesh-ancestor
102474477|NCT01274221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102474478|NCT00741455|Cyclosporine|cyclosporine|mesh-list
102474479|NCT00741455|Cyclophosphamide|cyclophosphamide|mesh-list
102474480|NCT00741455|Methotrexate|methotrexate|mesh-list
102474481|NCT00741455|Fludarabine|fludarabine|mesh-list
102474482|NCT00741455|Cyclosporins|cyclosporins|mesh-list
102474483|NCT00741455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102474484|NCT00741455|Immunologic Factors|immunologic factors|mesh-ancestor
102474485|NCT00741455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474486|NCT00741455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102474487|NCT00741455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102474488|NCT00741455|Alkylating Agents|alkylating agents|mesh-ancestor
102474489|NCT00741455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474490|NCT00741455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102474491|NCT00741455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102474492|NCT00741455|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102474493|NCT00741455|Abortifacient Agents|abortifacient agents|mesh-ancestor
102474494|NCT00741455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102474495|NCT00741455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102474496|NCT00741455|Antimetabolites|antimetabolites|mesh-ancestor
102474497|NCT00741455|Dermatologic Agents|dermatologic agents|mesh-ancestor
102474498|NCT00741455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102474499|NCT00741455|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102474500|NCT00741455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102474501|NCT00741455|Antifungal Agents|antifungal agents|mesh-ancestor
102474502|NCT00741455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102474503|NCT00741455|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102474504|NCT00742313|Hemostatics|hemostatics|mesh-list
102474505|NCT00742313|Coagulants|coagulants|mesh-ancestor
102474507|NCT00742469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102474508|NCT00742469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102474509|NCT00742469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102474510|NCT01275599|Buprenorphine|buprenorphine|mesh-list
102474511|NCT01275599|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102474512|NCT01275599|Naloxone|naloxone|mesh-list
102474513|NCT01275599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102474514|NCT01275599|Narcotics|narcotics|mesh-ancestor
102474515|NCT01275599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102474516|NCT01275599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474517|NCT01275599|Analgesics|analgesics|mesh-ancestor
102474518|NCT01275599|Sensory System Agents|sensory system agents|mesh-ancestor
102474519|NCT01275599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102474520|NCT01275599|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102474521|NCT00782821|Rituximab|rituximab|mesh-list
102474522|NCT00782821|Bortezomib|bortezomib|mesh-list
102474523|NCT00782821|Thymoglobulin|thymoglobulin|mesh-list
102474524|NCT00782821|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102474525|NCT00782821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102474526|NCT00782821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102474527|NCT00782821|Immunologic Factors|immunologic factors|mesh-ancestor
102474528|NCT00782821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558255|NCT01181271|Sirolimus|sirolimus|mesh-list
102474529|NCT00782821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102474530|NCT00782821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102474531|NCT00743093|Acetaminophen|acetaminophen|mesh-list
102474532|NCT00743093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102474533|NCT00743093|Analgesics|analgesics|mesh-ancestor
102474534|NCT00743093|Sensory System Agents|sensory system agents|mesh-ancestor
102474535|NCT00743093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102474536|NCT00743093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474537|NCT00743093|Antipyretics|antipyretics|mesh-ancestor
102474538|NCT03805945|Dexmedetomidine|dexmedetomidine|mesh-list
102474539|NCT03805945|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102474540|NCT03805945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102474541|NCT03805945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474542|NCT03805945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102474543|NCT03805945|Analgesics|analgesics|mesh-ancestor
102474544|NCT03805945|Sensory System Agents|sensory system agents|mesh-ancestor
102474545|NCT03805945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102474546|NCT03805945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102474547|NCT03805945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102474548|NCT03805945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102474549|NCT03805945|Adrenergic Agents|adrenergic agents|mesh-ancestor
102474550|NCT03805945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101558274|NCT01181271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102474551|NCT03805945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474552|NCT04270019|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
102474553|NCT04270019|Laxatives|laxatives|mesh-ancestor
102474554|NCT04270019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102474555|NCT02992301|Alirocumab|alirocumab|mesh-list
102474556|NCT02992301|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102474557|NCT02992301|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102474558|NCT02992301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102474559|NCT02992301|Antimetabolites|antimetabolites|mesh-ancestor
102474560|NCT02992301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474561|NCT02992301|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102474562|NCT02992301|Protease Inhibitors|protease inhibitors|mesh-ancestor
102474563|NCT02992301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102474564|NCT02992301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102474565|NCT00743717|Cobalt|cobalt|mesh-list
102474566|NCT00743717|Trace Elements|trace elements|mesh-ancestor
102474567|NCT00743717|Micronutrients|micronutrients|mesh-ancestor
102474568|NCT00743717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474569|NCT00744965|Glyburide|glyburide|mesh-list
102474570|NCT00744965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102474571|NCT00744965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474572|NCT00763867|Sildenafil Citrate|sildenafil citrate|mesh-list
102474573|NCT00763867|Vasodilator Agents|vasodilator agents|mesh-ancestor
102474574|NCT00763867|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102474575|NCT00763867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102474576|NCT00763867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102474577|NCT00763867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474578|NCT00763867|Urological Agents|urological agents|mesh-ancestor
102474579|NCT00711347|Hyaluronic Acid|hyaluronic acid|mesh-list
102474580|NCT00711347|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102474581|NCT00711347|Immunologic Factors|immunologic factors|mesh-ancestor
102474582|NCT00711347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474583|NCT00711347|Viscosupplements|viscosupplements|mesh-ancestor
102474584|NCT00711347|Protective Agents|protective agents|mesh-ancestor
102474585|NCT01276223|Fluprednisolone|fluprednisolone|mesh-list
102474586|NCT01276223|Difluprednate|difluprednate|mesh-list
102474587|NCT01276223|Glucocorticoids|glucocorticoids|mesh-ancestor
102474588|NCT01276223|Hormones|hormones|mesh-ancestor
102474589|NCT01276223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102474590|NCT01276223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474591|NCT01276223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102474592|NCT00784225|Vitamins|vitamins|mesh-list
102474593|NCT00784225|Vitamin E|vitamin e|mesh-list
102474594|NCT00784225|Tocopherols|tocopherols|mesh-list
102474595|NCT00784225|Tocotrienols|tocotrienols|mesh-list
102474596|NCT00784225|alpha-Tocopherol|alpha-tocopherol|mesh-list
102474597|NCT00784225|Selenium|selenium|mesh-list
102474598|NCT00784225|Micronutrients|micronutrients|mesh-ancestor
102474599|NCT00784225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474600|NCT00784225|Antioxidants|antioxidants|mesh-ancestor
102474601|NCT00784225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474602|NCT00784225|Protective Agents|protective agents|mesh-ancestor
102474603|NCT00784225|Trace Elements|trace elements|mesh-ancestor
102474604|NCT02991911|MEDI3726|medi3726|mesh-list
102474605|NCT02991911|Immunoconjugates|immunoconjugates|mesh-ancestor
102474606|NCT02991911|Immunologic Factors|immunologic factors|mesh-ancestor
102474607|NCT02991911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474608|NCT01275131|Insulin Aspart|insulin aspart|mesh-list
102474609|NCT01275131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102474610|NCT01275131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474611|NCT01273805|Hydroxychloroquine|hydroxychloroquine|mesh-list
102474612|NCT01273805|Antimalarials|antimalarials|mesh-ancestor
101558313|NCT04286035|Anesthetics|anesthetics|mesh-ancestor
102474613|NCT01273805|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102474614|NCT01273805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102474615|NCT01273805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102474616|NCT01273805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102474617|NCT01273805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474618|NCT01273805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102474619|NCT01273181|Aldesleukin|aldesleukin|mesh-list
102474620|NCT01273181|Cyclophosphamide|cyclophosphamide|mesh-list
102474621|NCT01273181|Fludarabine|fludarabine|mesh-list
102474622|NCT01273181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102474623|NCT01273181|Immunologic Factors|immunologic factors|mesh-ancestor
101558334|NCT04286503|Ritonavir|ritonavir|mesh-list
102474624|NCT01273181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474625|NCT01273181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102474626|NCT01273181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102474627|NCT01273181|Alkylating Agents|alkylating agents|mesh-ancestor
102474628|NCT01273181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474629|NCT01273181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102474630|NCT01273181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102474631|NCT01273181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102474632|NCT01273181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102474633|NCT01273181|Antiviral Agents|antiviral agents|mesh-ancestor
102474634|NCT01273181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102474635|NCT01272947|Diclofenac|diclofenac|mesh-list
102474636|NCT01272947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102474637|NCT01272947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102474638|NCT01272947|Analgesics|analgesics|mesh-ancestor
102474639|NCT01272947|Sensory System Agents|sensory system agents|mesh-ancestor
102474640|NCT01272947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102474641|NCT01272947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474642|NCT01272947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102474643|NCT01272947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102474644|NCT01272947|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102474645|NCT01272947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102474646|NCT01272947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474647|NCT01279343|Misoprostol|misoprostol|mesh-list
102474648|NCT01279343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102474649|NCT01279343|Abortifacient Agents|abortifacient agents|mesh-ancestor
102474650|NCT01279343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102474651|NCT01279343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474652|NCT01279343|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102474653|NCT01279343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102474654|NCT01279343|Oxytocics|oxytocics|mesh-ancestor
102474655|NCT01278797|Amlodipine|amlodipine|mesh-list
102474656|NCT01278797|Telmisartan|telmisartan|mesh-list
102474657|NCT01278797|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
102474658|NCT01278797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102474659|NCT01278797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102474660|NCT01278797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101558370|NCT00976573|Bevacizumab|bevacizumab|mesh-list
102474661|NCT01278797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474662|NCT01278797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102474663|NCT01278797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474664|NCT01278797|Vasodilator Agents|vasodilator agents|mesh-ancestor
102474665|NCT01278797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102474666|NCT01278797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102474667|NCT01272635|Azithromycin|azithromycin|mesh-list
102474668|NCT01272635|Prednisolone|prednisolone|mesh-list
101428569|NCT05334017|Cocaine|cocaine|mesh-list
102474669|NCT01272635|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102474670|NCT01272635|Methylprednisolone|methylprednisolone|mesh-list
102474671|NCT01272635|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102474672|NCT01272635|Prednisolone acetate|prednisolone acetate|mesh-list
102474673|NCT01272635|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102474674|NCT01272635|Prednisolone phosphate|prednisolone phosphate|mesh-list
102474675|NCT01272635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102474676|NCT01272635|Glucocorticoids|glucocorticoids|mesh-ancestor
102474677|NCT01272635|Hormones|hormones|mesh-ancestor
102474678|NCT01272635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101558388|NCT00976573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102474679|NCT01272635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474680|NCT01272635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102474681|NCT01272635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102474682|NCT01272635|Antiemetics|antiemetics|mesh-ancestor
102474683|NCT01272635|Autonomic Agents|autonomic agents|mesh-ancestor
102474684|NCT01272635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102474685|NCT01272635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102474686|NCT01272635|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102474687|NCT01272635|Protective Agents|protective agents|mesh-ancestor
102474688|NCT01272635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102474689|NCT01272635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102474690|NCT04387097|Remifentanil|remifentanil|mesh-list
102474691|NCT04387097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102474692|NCT04387097|Narcotics|narcotics|mesh-ancestor
102474693|NCT04387097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102474694|NCT04387097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474695|NCT04387097|Analgesics|analgesics|mesh-ancestor
102474696|NCT04387097|Sensory System Agents|sensory system agents|mesh-ancestor
102474697|NCT04387097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102474699|NCT01270841|Clomiphene|clomiphene|mesh-list
102474700|NCT01270841|Zuclomiphene|zuclomiphene|mesh-list
102474701|NCT01270841|Testosterone|testosterone|mesh-list
102474702|NCT01270841|Androgens|androgens|mesh-ancestor
102474703|NCT01270841|Hormones|hormones|mesh-ancestor
102474704|NCT01270841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102474705|NCT01270841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474706|NCT01270841|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102474707|NCT01270841|Hormone Antagonists|hormone antagonists|mesh-ancestor
102474708|NCT01270841|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102474709|NCT01270841|Fertility Agents|fertility agents|mesh-ancestor
102474710|NCT01270841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102474711|NCT01270841|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102474712|NCT01270841|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102474713|NCT01278407|Donepezil|donepezil|mesh-list
102474714|NCT01278407|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102474715|NCT01278407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102474716|NCT01278407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474717|NCT01278407|Cholinergic Agents|cholinergic agents|mesh-ancestor
102474718|NCT01278407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102474719|NCT01278407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474720|NCT01278407|Nootropic Agents|nootropic agents|mesh-ancestor
102474721|NCT01278173|Vigabatrin|vigabatrin|mesh-list
102474722|NCT01278173|Anticonvulsants|anticonvulsants|mesh-ancestor
102474723|NCT01278173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102474724|NCT01278173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474725|NCT01278173|GABA Agents|gaba agents|mesh-ancestor
102474726|NCT01278173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102474727|NCT01278173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474728|NCT00784303|Lenvatinib|lenvatinib|mesh-list
102474729|NCT00784303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102474730|NCT00784303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102474731|NCT00784303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102474732|NCT00784303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474733|NCT00750815|Dexamethasone|dexamethasone|mesh-list
102474734|NCT00750815|Cyclophosphamide|cyclophosphamide|mesh-list
102474735|NCT00750815|Doxorubicin|doxorubicin|mesh-list
102474736|NCT00750815|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102474737|NCT00750815|Bortezomib|bortezomib|mesh-list
102474738|NCT00750815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102474739|NCT00750815|Immunologic Factors|immunologic factors|mesh-ancestor
102474740|NCT00750815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474741|NCT00750815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102474742|NCT00750815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102474743|NCT00750815|Alkylating Agents|alkylating agents|mesh-ancestor
102474744|NCT00750815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474745|NCT00750815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102474746|NCT00750815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102474747|NCT00750815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102474748|NCT00750815|Antiemetics|antiemetics|mesh-ancestor
102474749|NCT00750815|Autonomic Agents|autonomic agents|mesh-ancestor
102474750|NCT00750815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102474751|NCT00750815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102474752|NCT00750815|Glucocorticoids|glucocorticoids|mesh-ancestor
102474753|NCT00750815|Hormones|hormones|mesh-ancestor
102474754|NCT00750815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102474755|NCT00750815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102474756|NCT00750815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102474757|NCT00750815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102474758|NCT00750815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102474759|NCT00750815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102474760|NCT00784849|Methylene Blue|methylene blue|mesh-list
102474761|NCT00784849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101429031|NCT03985722|Trabectedin|trabectedin|mesh-list
102474762|NCT00784849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474763|NCT01277861|Fentanyl|fentanyl|mesh-list
102474764|NCT01277861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102474765|NCT01277861|Narcotics|narcotics|mesh-ancestor
102474766|NCT01277861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102474767|NCT01277861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474768|NCT01277861|Analgesics|analgesics|mesh-ancestor
102474769|NCT01277861|Sensory System Agents|sensory system agents|mesh-ancestor
102474770|NCT01277861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102286413|NCT00660673|Carbidopa|carbidopa|mesh-list
102474771|NCT01277861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102474772|NCT01277861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102474773|NCT01277861|Anesthetics, General|anesthetics, general|mesh-ancestor
102474774|NCT01277861|Anesthetics|anesthetics|mesh-ancestor
102474775|NCT00786487|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102474776|NCT00786487|Glycerol|glycerol|mesh-list
102474777|NCT00786487|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102474778|NCT00786487|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102474779|NCT00786487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102474780|NCT00786487|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102474781|NCT00786487|Protective Agents|protective agents|mesh-ancestor
102474782|NCT00786487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474783|NCT03805633|Pancrelipase|pancrelipase|mesh-list
102474784|NCT03805633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102474785|NCT01276847|Etanercept|etanercept|mesh-list
102474786|NCT01276847|Ustekinumab|ustekinumab|mesh-list
102474787|NCT01276847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102474788|NCT01276847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102474789|NCT01276847|Analgesics|analgesics|mesh-ancestor
102474790|NCT01276847|Sensory System Agents|sensory system agents|mesh-ancestor
102474791|NCT01276847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102474792|NCT01276847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474793|NCT01276847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102474794|NCT01276847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102474795|NCT01276847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102474796|NCT01276847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102474797|NCT01276847|Immunologic Factors|immunologic factors|mesh-ancestor
102474798|NCT01276847|Dermatologic Agents|dermatologic agents|mesh-ancestor
102474799|NCT00945269|Aldesleukin|aldesleukin|mesh-list
102474800|NCT00945269|Interleukin-2|interleukin-2|mesh-list
102474801|NCT00945269|Denileukin diftitox|denileukin diftitox|mesh-list
102474802|NCT00945269|Immunotoxins|immunotoxins|mesh-list
102474803|NCT00945269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102474804|NCT00945269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102474805|NCT00945269|Analgesics|analgesics|mesh-ancestor
102474806|NCT00945269|Sensory System Agents|sensory system agents|mesh-ancestor
102474807|NCT00945269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102474808|NCT00945269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474809|NCT00945269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102474810|NCT00945269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102474811|NCT00945269|Antiviral Agents|antiviral agents|mesh-ancestor
102474812|NCT00945269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102474813|NCT00945269|Immunoconjugates|immunoconjugates|mesh-ancestor
102474814|NCT00945269|Immunologic Factors|immunologic factors|mesh-ancestor
102474815|NCT01272791|Gemcitabine|gemcitabine|mesh-list
102474816|NCT01272791|Bavituximab|bavituximab|mesh-list
102474817|NCT01272791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102474818|NCT01272791|Antimetabolites|antimetabolites|mesh-ancestor
102474819|NCT01272791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474820|NCT01272791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102474821|NCT01272791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102474822|NCT00765661|Tacrolimus|tacrolimus|mesh-list
101558510|NCT02886351|Anesthetics|anesthetics|mesh-ancestor
102474823|NCT00765661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102474824|NCT00765661|Immunologic Factors|immunologic factors|mesh-ancestor
102474825|NCT00765661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474826|NCT00765661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102474827|NCT00765661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102474828|NCT00765661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474829|NCT00765895|Nortriptyline|nortriptyline|mesh-list
102474830|NCT00765895|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102474831|NCT00765895|Antidepressive Agents|antidepressive agents|mesh-ancestor
102474832|NCT00765895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102474833|NCT00765895|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102474834|NCT00765895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102474835|NCT00765895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102474836|NCT00765895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474837|NCT00765895|Adrenergic Agents|adrenergic agents|mesh-ancestor
102474838|NCT00765895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102474839|NCT00765895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558536|NCT04296370|Fluzoparib|fluzoparib|mesh-list
102474840|NCT01276457|Cyclosporine|cyclosporine|mesh-list
102474841|NCT01276457|Everolimus|everolimus|mesh-list
102474842|NCT01276457|Cyclosporins|cyclosporins|mesh-list
102474843|NCT01276457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102474844|NCT01276457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474845|NCT01276457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102474846|NCT01276457|Immunologic Factors|immunologic factors|mesh-ancestor
102474847|NCT01276457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286489|NCT05555147|Sensory System Agents|sensory system agents|mesh-ancestor
102474848|NCT01276457|Antifungal Agents|antifungal agents|mesh-ancestor
102474849|NCT01276457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102474850|NCT01276457|Dermatologic Agents|dermatologic agents|mesh-ancestor
102474851|NCT01276457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102474852|NCT01276457|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102474853|NCT01276457|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101558557|NCT00997126|Anesthetics|anesthetics|mesh-ancestor
102474854|NCT01276457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102474855|NCT01276457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102474856|NCT03804931|Aminosalicylic Acid|aminosalicylic acid|mesh-list
102474857|NCT03804931|Prednisone|prednisone|mesh-list
102474858|NCT03804931|Mesalamine|mesalamine|mesh-list
102474859|NCT03804931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102474860|NCT03804931|Glucocorticoids|glucocorticoids|mesh-ancestor
102474861|NCT03804931|Hormones|hormones|mesh-ancestor
102474862|NCT03804931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102474863|NCT03804931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474864|NCT03804931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102474865|NCT03804931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102474866|NCT03804931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102474867|NCT03804931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102474868|NCT03804931|Analgesics|analgesics|mesh-ancestor
102474869|NCT03804931|Sensory System Agents|sensory system agents|mesh-ancestor
102474870|NCT03804931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102474871|NCT03804931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102474872|NCT03804931|Antitubercular Agents|antitubercular agents|mesh-ancestor
102474873|NCT03804931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102474874|NCT03804931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102474875|NCT02991131|Linezolid|linezolid|mesh-list
102474876|NCT02991131|Tedizolid|tedizolid|mesh-list
102474877|NCT02991131|Tedizolid phosphate|tedizolid phosphate|mesh-list
102474878|NCT02991131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102474879|NCT02991131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102474880|NCT02991131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102474881|NCT02991131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102474882|NCT02991131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474883|NCT00748865|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102474884|NCT00748865|Lubricant Eye Drops|lubricant eye drops|mesh-list
102474885|NCT00748865|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102474886|NCT00766753|Vaccines|vaccines|mesh-list
102474887|NCT00766753|Immunologic Factors|immunologic factors|mesh-ancestor
102474888|NCT00766753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474889|NCT00767767|Thiopental|thiopental|mesh-list
102474890|NCT00767767|Propofol|propofol|mesh-list
102474891|NCT00767767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102474892|NCT00767767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102474893|NCT00767767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474894|NCT00767767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102474895|NCT00767767|Anesthetics, General|anesthetics, general|mesh-ancestor
102474896|NCT00767767|Anesthetics|anesthetics|mesh-ancestor
102474897|NCT00767767|Anticonvulsants|anticonvulsants|mesh-ancestor
102474898|NCT00767767|GABA Modulators|gaba modulators|mesh-ancestor
102474899|NCT00767767|GABA Agents|gaba agents|mesh-ancestor
102474900|NCT00767767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102474901|NCT00767767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474902|NCT00761345|Gemcitabine|gemcitabine|mesh-list
102474903|NCT00761345|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102474904|NCT00761345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102474905|NCT00761345|Antimetabolites|antimetabolites|mesh-ancestor
102474906|NCT00761345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474907|NCT00761345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102474908|NCT00761345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102474909|NCT00761345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102474910|NCT00762515|Triclosan|triclosan|mesh-list
102474911|NCT00762515|Fluorides|fluorides|mesh-list
101558605|NCT00965341|Androgens|androgens|mesh-ancestor
102474912|NCT00762515|Cariostatic Agents|cariostatic agents|mesh-ancestor
102474913|NCT00762515|Protective Agents|protective agents|mesh-ancestor
102474914|NCT00762515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474915|NCT00762515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102474916|NCT00762515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102474917|NCT00762515|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102474918|NCT00762515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102474919|NCT00762515|Antimetabolites|antimetabolites|mesh-ancestor
102474920|NCT00762515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474921|NCT00762515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102474922|NCT03806933|Botulinum Toxins|botulinum toxins|mesh-list
102474923|NCT03806933|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102474924|NCT03806933|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102474925|NCT03806933|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102474926|NCT03806933|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102474927|NCT03806933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102474928|NCT03806933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474929|NCT03806933|Cholinergic Agents|cholinergic agents|mesh-ancestor
102474930|NCT03806933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102474931|NCT03806933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474932|NCT03806933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101558621|NCT00965263|Cocaine|cocaine|mesh-list
102474933|NCT03806933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102474934|NCT00753935|Aspirin|aspirin|mesh-list
102474935|NCT00753935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102474936|NCT00753935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102474937|NCT00753935|Analgesics|analgesics|mesh-ancestor
102474938|NCT00753935|Sensory System Agents|sensory system agents|mesh-ancestor
102474939|NCT00753935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102474940|NCT00753935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474941|NCT00753935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102474942|NCT00753935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101558635|NCT02886195|Pemetrexed|pemetrexed|mesh-list
102474943|NCT00753935|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102474944|NCT00753935|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102474945|NCT00753935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474946|NCT00753935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102474947|NCT00753935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102474948|NCT00753935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102474949|NCT00753935|Antipyretics|antipyretics|mesh-ancestor
102474950|NCT00779285|Doxorubicin|doxorubicin|mesh-list
102474951|NCT00779285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102474952|NCT00779285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102474953|NCT00779285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102474954|NCT00779285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102474955|NCT00779285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102474956|NCT00779285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102474957|NCT00779285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474958|NCT00786643|Leucovorin|leucovorin|mesh-list
102474959|NCT00786643|Interferons|interferons|mesh-list
102474960|NCT00786643|Interferon-gamma|interferon-gamma|mesh-list
102474961|NCT00786643|Bevacizumab|bevacizumab|mesh-list
102474962|NCT00786643|Fluorouracil|fluorouracil|mesh-list
102474963|NCT00786643|Levoleucovorin|levoleucovorin|mesh-list
102474964|NCT00786643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102474965|NCT00786643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102474966|NCT00786643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102474967|NCT00786643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102474968|NCT00786643|Growth Substances|growth substances|mesh-ancestor
101558660|NCT00965185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102474969|NCT00786643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102474970|NCT00786643|Growth Inhibitors|growth inhibitors|mesh-ancestor
102474971|NCT00786643|Antimetabolites|antimetabolites|mesh-ancestor
102474972|NCT00786643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474973|NCT00786643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102474974|NCT00786643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102474975|NCT00786643|Immunologic Factors|immunologic factors|mesh-ancestor
102474976|NCT00786643|Antiviral Agents|antiviral agents|mesh-ancestor
102474977|NCT00786643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102474978|NCT00786643|Antidotes|antidotes|mesh-ancestor
102474979|NCT00786643|Protective Agents|protective agents|mesh-ancestor
102474980|NCT00786643|Vitamin B Complex|vitamin b complex|mesh-ancestor
102474981|NCT00786643|Vitamins|vitamins|mesh-ancestor
102474982|NCT00786643|Micronutrients|micronutrients|mesh-ancestor
102474983|NCT01276379|Leucovorin|leucovorin|mesh-list
102474984|NCT01276379|Folic Acid|folic acid|mesh-list
102474985|NCT01276379|Fluorouracil|fluorouracil|mesh-list
102474986|NCT01276379|Oxaliplatin|oxaliplatin|mesh-list
102474987|NCT01276379|Irinotecan|irinotecan|mesh-list
102474988|NCT01276379|Cetuximab|cetuximab|mesh-list
102474989|NCT01276379|Levoleucovorin|levoleucovorin|mesh-list
102474990|NCT01276379|Antimetabolites|antimetabolites|mesh-ancestor
102474991|NCT01276379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102474992|NCT01276379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102474993|NCT01276379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102474994|NCT01276379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102474995|NCT01276379|Immunologic Factors|immunologic factors|mesh-ancestor
102474996|NCT01276379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558682|NCT02862145|Antiemetics|antiemetics|mesh-ancestor
102474997|NCT01276379|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102474998|NCT01276379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102474999|NCT01276379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102475000|NCT01276379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102475001|NCT01276379|Antidotes|antidotes|mesh-ancestor
102475002|NCT01276379|Protective Agents|protective agents|mesh-ancestor
102475003|NCT01276379|Vitamin B Complex|vitamin b complex|mesh-ancestor
102475004|NCT01276379|Vitamins|vitamins|mesh-ancestor
102475005|NCT01276379|Micronutrients|micronutrients|mesh-ancestor
102475006|NCT01276379|Hematinics|hematinics|mesh-ancestor
102475007|NCT01275547|Midazolam|midazolam|mesh-list
102475008|NCT01275547|Ketamine|ketamine|mesh-list
102475009|NCT01275547|Morphine|morphine|mesh-list
102475010|NCT01275547|Esketamine|esketamine|mesh-list
102475011|NCT01275547|Analgesics|analgesics|mesh-ancestor
102475012|NCT01275547|Sensory System Agents|sensory system agents|mesh-ancestor
102475013|NCT01275547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102475014|NCT01275547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475015|NCT01275547|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102475016|NCT01275547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102475017|NCT01275547|Anesthetics, General|anesthetics, general|mesh-ancestor
102475018|NCT01275547|Anesthetics|anesthetics|mesh-ancestor
102475019|NCT01275547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102475020|NCT01275547|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102475021|NCT01275547|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102475022|NCT01275547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102475023|NCT01275547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475024|NCT01275547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102475025|NCT01275547|Narcotics|narcotics|mesh-ancestor
102475026|NCT01275547|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102475027|NCT01275547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101558705|NCT01173471|Vitamins|vitamins|mesh-ancestor
102475028|NCT01275547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102475029|NCT01275547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102475030|NCT01275547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102475031|NCT01275547|GABA Modulators|gaba modulators|mesh-ancestor
102475032|NCT01275547|GABA Agents|gaba agents|mesh-ancestor
102475033|NCT01275547|Antidepressive Agents|antidepressive agents|mesh-ancestor
102475034|NCT00789685|Interferons|interferons|mesh-list
102475035|NCT00789685|Interferon-beta|interferon-beta|mesh-list
102475036|NCT00789685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102475037|NCT00789685|Antiviral Agents|antiviral agents|mesh-ancestor
102475038|NCT00789685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102475039|NCT00789685|Immunologic Factors|immunologic factors|mesh-ancestor
101558718|NCT00966355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102475040|NCT00789685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475041|NCT03804229|3-n-butylphthalide|3-n-butylphthalide|mesh-list
102475042|NCT03804229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102475043|NCT03804229|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102475044|NCT03804229|Protective Agents|protective agents|mesh-ancestor
102475045|NCT03804229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475046|NCT02149303|Dabigatran|dabigatran|mesh-list
102475047|NCT02149303|Antithrombins|antithrombins|mesh-ancestor
102475048|NCT02149303|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102475049|NCT02149303|Protease Inhibitors|protease inhibitors|mesh-ancestor
101430710|NCT02936830|Listerine|listerine|mesh-list
102475050|NCT02149303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102475051|NCT02149303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475052|NCT02149303|Anticoagulants|anticoagulants|mesh-ancestor
102475053|NCT03803449|Fentanyl|fentanyl|mesh-list
102475054|NCT03803449|Midazolam|midazolam|mesh-list
102475055|NCT03803449|Propofol|propofol|mesh-list
102475056|NCT03803449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102475057|NCT03803449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102475058|NCT03803449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475059|NCT03803449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102475060|NCT03803449|Anesthetics, General|anesthetics, general|mesh-ancestor
102475061|NCT03803449|Anesthetics|anesthetics|mesh-ancestor
102475062|NCT03803449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102475063|NCT03803449|Narcotics|narcotics|mesh-ancestor
102475064|NCT03803449|Analgesics|analgesics|mesh-ancestor
102475065|NCT03803449|Sensory System Agents|sensory system agents|mesh-ancestor
102475066|NCT03803449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102475067|NCT03803449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102475068|NCT03803449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102475069|NCT03803449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102475070|NCT03803449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102475071|NCT03803449|GABA Modulators|gaba modulators|mesh-ancestor
102475072|NCT03803449|GABA Agents|gaba agents|mesh-ancestor
102475073|NCT03803449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102475074|NCT03803449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475075|NCT03803839|Clodronic Acid|clodronic acid|mesh-list
102475076|NCT03803839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102475077|NCT03803839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475078|NCT00789997|Levofloxacin|levofloxacin|mesh-list
102475079|NCT00789997|Prednisone|prednisone|mesh-list
102475080|NCT00789997|Etanercept|etanercept|mesh-list
102475081|NCT00789997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102475082|NCT00789997|Glucocorticoids|glucocorticoids|mesh-ancestor
102475083|NCT00789997|Hormones|hormones|mesh-ancestor
102475084|NCT00789997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102475085|NCT00789997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475086|NCT00789997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102475087|NCT00789997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102475088|NCT00789997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102475089|NCT00789997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102475090|NCT00789997|Analgesics|analgesics|mesh-ancestor
102475091|NCT00789997|Sensory System Agents|sensory system agents|mesh-ancestor
102475092|NCT00789997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102475093|NCT00789997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102475094|NCT00789997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102475095|NCT00789997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102475096|NCT00789997|Immunologic Factors|immunologic factors|mesh-ancestor
102475097|NCT00789997|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102475098|NCT00789997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101558783|NCT04324307|Antimetabolites|antimetabolites|mesh-ancestor
102475099|NCT00789997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102475100|NCT00789997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102475101|NCT00789997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102475102|NCT00789997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102475103|NCT00789997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475104|NCT00789997|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102475105|NCT00789997|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102475106|NCT00771745|Thymoglobulin|thymoglobulin|mesh-list
102475107|NCT00771745|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102475108|NCT00771745|Immunologic Factors|immunologic factors|mesh-ancestor
102475109|NCT00771745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475110|NCT00771745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102475111|NCT03803215|Theophylline|theophylline|mesh-list
102475112|NCT03803215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102475113|NCT03803215|Autonomic Agents|autonomic agents|mesh-ancestor
102475114|NCT03803215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102475115|NCT03803215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475116|NCT03803215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102475117|NCT03803215|Respiratory System Agents|respiratory system agents|mesh-ancestor
102475118|NCT03803215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102475119|NCT03803215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102475120|NCT03803215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475121|NCT03803215|Vasodilator Agents|vasodilator agents|mesh-ancestor
102475122|NCT03803215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102475123|NCT03803215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102475124|NCT03803215|Purinergic Agents|purinergic agents|mesh-ancestor
102475125|NCT03803215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102475126|NCT00790855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102475127|NCT00790855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102475128|NCT00790855|Alkylating Agents|alkylating agents|mesh-ancestor
102475129|NCT00790855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475130|NCT00790855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102475131|NCT03802747|Durvalumab|durvalumab|mesh-list
102475132|NCT03802747|Tremelimumab|tremelimumab|mesh-list
102475133|NCT03802747|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102475134|NCT03802747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101558804|NCT01296347|Ketamine|ketamine|mesh-list
102475135|NCT03802747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102475136|NCT03802747|Immunologic Factors|immunologic factors|mesh-ancestor
102475137|NCT03802747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475138|NCT00791323|Ketorolac|ketorolac|mesh-list
102475139|NCT00791323|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102475140|NCT00791323|Lubricant Eye Drops|lubricant eye drops|mesh-list
102475141|NCT00791323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102475142|NCT00791323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102475143|NCT00791323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102475144|NCT00791323|Analgesics|analgesics|mesh-ancestor
102475145|NCT00791323|Sensory System Agents|sensory system agents|mesh-ancestor
102475146|NCT00791323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102475147|NCT00791323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475148|NCT00791323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102475149|NCT00791323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102475150|NCT00791323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102475151|NCT00791323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102475152|NCT00791323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475153|NCT00772915|Dexamethasone|dexamethasone|mesh-list
102286789|NCT05541107|Amphotericin B|amphotericin b|mesh-list
102475155|NCT00772915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102475156|NCT00772915|Antiemetics|antiemetics|mesh-ancestor
102475157|NCT00772915|Autonomic Agents|autonomic agents|mesh-ancestor
102475158|NCT00772915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102475159|NCT00772915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475160|NCT00772915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102475161|NCT00772915|Glucocorticoids|glucocorticoids|mesh-ancestor
102475162|NCT00772915|Hormones|hormones|mesh-ancestor
102475163|NCT00772915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102475164|NCT00772915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102475165|NCT00772915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102475166|NCT00772915|Immunologic Factors|immunologic factors|mesh-ancestor
102475167|NCT00772915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102475168|NCT00772915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102475169|NCT00772915|Growth Substances|growth substances|mesh-ancestor
102475170|NCT00772915|Growth Inhibitors|growth inhibitors|mesh-ancestor
102475171|NCT05497453|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102475172|NCT05497453|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102475173|NCT05497453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102475174|NCT05497453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102475175|NCT05497453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475176|NCT05497453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102475177|NCT05497453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102475178|NCT03801733|Sulfasalazine|sulfasalazine|mesh-list
102475179|NCT03801733|Atorvastatin|atorvastatin|mesh-list
102475180|NCT03801733|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102475181|NCT03801733|Simvastatin|simvastatin|mesh-list
102475182|NCT03801733|Pravastatin|pravastatin|mesh-list
102475183|NCT03801733|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102475184|NCT03801733|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102475185|NCT03801733|Antimetabolites|antimetabolites|mesh-ancestor
102475186|NCT03801733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475187|NCT03801733|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102475188|NCT03801733|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102475189|NCT03801733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102475190|NCT03801733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102475191|NCT03801733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102475192|NCT03801733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102475193|NCT03801733|Analgesics|analgesics|mesh-ancestor
102475194|NCT03801733|Sensory System Agents|sensory system agents|mesh-ancestor
102475195|NCT03801733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102475196|NCT03801733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475197|NCT03801733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102475198|NCT03801733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102475199|NCT03801733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102475200|NCT00775411|Dexamethasone|dexamethasone|mesh-list
102475201|NCT00775411|Ranibizumab|ranibizumab|mesh-list
102475202|NCT00775411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102475203|NCT00775411|Antiemetics|antiemetics|mesh-ancestor
102475204|NCT00775411|Autonomic Agents|autonomic agents|mesh-ancestor
102475205|NCT00775411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102475206|NCT00775411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475207|NCT00775411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102475208|NCT00775411|Glucocorticoids|glucocorticoids|mesh-ancestor
102475209|NCT00775411|Hormones|hormones|mesh-ancestor
102475210|NCT00775411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102475211|NCT00775411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102475212|NCT00775411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102475213|NCT00775411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102475214|NCT00775411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102475215|NCT00775411|Growth Substances|growth substances|mesh-ancestor
102475216|NCT00775411|Growth Inhibitors|growth inhibitors|mesh-ancestor
102475217|NCT03801499|Lenvatinib|lenvatinib|mesh-list
102475218|NCT03801499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102475219|NCT03801499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102475220|NCT03801499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101558876|NCT00965731|Crizotinib|crizotinib|mesh-list
102475221|NCT03801499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475222|NCT00808405|Acyclovir|acyclovir|mesh-list
102475223|NCT00808405|Antiviral Agents|antiviral agents|mesh-ancestor
102475224|NCT00808405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102475225|NCT00775645|Acetylcarnitine|acetylcarnitine|mesh-list
102475226|NCT00775645|Vitamin B Complex|vitamin b complex|mesh-ancestor
102475227|NCT00775645|Vitamins|vitamins|mesh-ancestor
102475228|NCT00775645|Micronutrients|micronutrients|mesh-ancestor
102475229|NCT00775645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475230|NCT00775645|Nootropic Agents|nootropic agents|mesh-ancestor
102475231|NCT01974687|Itraconazole|itraconazole|mesh-list
102475232|NCT01974687|Uprifosbuvir|uprifosbuvir|mesh-list
102475233|NCT01974687|Antifungal Agents|antifungal agents|mesh-ancestor
102475234|NCT01974687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102475235|NCT01974687|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102475236|NCT01974687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102475237|NCT01974687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102475238|NCT01974687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475239|NCT01974687|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102475240|NCT01974687|Hormone Antagonists|hormone antagonists|mesh-ancestor
102475241|NCT01974687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102475242|NCT01974687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475243|NCT01974687|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102475244|NCT01974687|Antiviral Agents|antiviral agents|mesh-ancestor
102475245|NCT00795145|Moxifloxacin|moxifloxacin|mesh-list
102475246|NCT00795145|Linezolid|linezolid|mesh-list
102475247|NCT00795145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102475248|NCT00795145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102475249|NCT00795145|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102475250|NCT00795145|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102475251|NCT00795145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101558914|NCT01170663|Ramucirumab|ramucirumab|mesh-list
102475252|NCT00795145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475253|NCT00795145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102475254|NCT00795145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102475255|NCT03801187|Chlorhexidine|chlorhexidine|mesh-list
102475256|NCT03801187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102475257|NCT03801187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102475258|NCT03801187|Disinfectants|disinfectants|mesh-ancestor
102475259|NCT00809185|Everolimus|everolimus|mesh-list
102475260|NCT00809185|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102475261|NCT00809185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102475262|NCT00809185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102475263|NCT00809185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475264|NCT00809185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102475265|NCT00809185|Immunologic Factors|immunologic factors|mesh-ancestor
102475266|NCT00809185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475267|NCT00809185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102475268|NCT03800953|Avelumab|avelumab|mesh-list
102475269|NCT03800953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102475270|NCT03800953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102475271|NCT00795769|Ondansetron|ondansetron|mesh-list
102475272|NCT00795769|Antiemetics|antiemetics|mesh-ancestor
102475273|NCT00795769|Autonomic Agents|autonomic agents|mesh-ancestor
102475274|NCT00795769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102475275|NCT00795769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475276|NCT00795769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102475277|NCT00795769|Antipruritics|antipruritics|mesh-ancestor
102475278|NCT00795769|Dermatologic Agents|dermatologic agents|mesh-ancestor
102475279|NCT00795769|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102475280|NCT00795769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102475281|NCT00795769|Serotonin Agents|serotonin agents|mesh-ancestor
102475282|NCT00795769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102475283|NCT00795769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475284|NCT01975935|Amlexanox|amlexanox|mesh-list
102475285|NCT01975935|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102475286|NCT02305017|Acetaminophen|acetaminophen|mesh-list
102475287|NCT02305017|Opicapone|opicapone|mesh-list
102475288|NCT02305017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102475289|NCT02305017|Analgesics|analgesics|mesh-ancestor
102475290|NCT02305017|Sensory System Agents|sensory system agents|mesh-ancestor
101558950|NCT01169103|Hormones|hormones|mesh-list
102475291|NCT02305017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102475292|NCT02305017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475293|NCT02305017|Antipyretics|antipyretics|mesh-ancestor
102475294|NCT02305017|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102475295|NCT02305017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102475296|NCT02305017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475297|NCT02305017|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102475298|NCT02305017|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102475299|NCT01976871|Rotigotine|rotigotine|mesh-list
102475300|NCT01976871|Dopamine Agonists|dopamine agonists|mesh-ancestor
102475301|NCT01976871|Dopamine Agents|dopamine agents|mesh-ancestor
102475302|NCT01976871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102475303|NCT01976871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475304|NCT01976871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475306|NCT03602781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102475307|NCT03602781|Autonomic Agents|autonomic agents|mesh-ancestor
102475308|NCT03602781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102475309|NCT03602781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475310|NCT03602781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102475311|NCT03602781|Respiratory System Agents|respiratory system agents|mesh-ancestor
102475312|NCT03602781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102475313|NCT03602781|Antioxidants|antioxidants|mesh-ancestor
102475314|NCT03602781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475315|NCT03602781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102475316|NCT03602781|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102475317|NCT03602781|Vasodilator Agents|vasodilator agents|mesh-ancestor
102475318|NCT03602781|Gasotransmitters|gasotransmitters|mesh-ancestor
102475319|NCT03602781|Protective Agents|protective agents|mesh-ancestor
102475320|NCT02280239|Acetaminophen|acetaminophen|mesh-list
102475321|NCT02280239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102475322|NCT02280239|Analgesics|analgesics|mesh-ancestor
102475323|NCT02280239|Sensory System Agents|sensory system agents|mesh-ancestor
101558987|NCT00963547|Lapatinib|lapatinib|mesh-list
102475324|NCT02280239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102475325|NCT02280239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475326|NCT02280239|Antipyretics|antipyretics|mesh-ancestor
102475327|NCT01993875|Lubiprostone|lubiprostone|mesh-list
102475328|NCT01993875|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102475329|NCT01993875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102475330|NCT01993875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475331|NCT00796705|Adalimumab|adalimumab|mesh-list
102475332|NCT00796705|Etanercept|etanercept|mesh-list
102475333|NCT00796705|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102475334|NCT00796705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102475335|NCT00796705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102475336|NCT00796705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101558993|NCT01285310|Thalidomide|thalidomide|mesh-list
102475337|NCT00796705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102475338|NCT00796705|Analgesics|analgesics|mesh-ancestor
102475339|NCT00796705|Sensory System Agents|sensory system agents|mesh-ancestor
102475340|NCT00796705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102475341|NCT00796705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475342|NCT00796705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102475343|NCT00796705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102475344|NCT00796705|Immunologic Factors|immunologic factors|mesh-ancestor
102475345|NCT00809809|Zinc|zinc|mesh-list
102475346|NCT00809809|Trace Elements|trace elements|mesh-ancestor
102475347|NCT00809809|Micronutrients|micronutrients|mesh-ancestor
102475348|NCT00809809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475349|NCT00248651|Amitriptyline|amitriptyline|mesh-list
102475350|NCT00248651|Escitalopram|escitalopram|mesh-list
102475351|NCT00248651|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102475352|NCT00248651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102475353|NCT00248651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101559007|NCT01285310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102475354|NCT00248651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475355|NCT00248651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102475356|NCT00248651|Serotonin Agents|serotonin agents|mesh-ancestor
102475357|NCT00248651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475358|NCT00248651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102475359|NCT00248651|Antidepressive Agents|antidepressive agents|mesh-ancestor
102475360|NCT00248651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102475361|NCT00248651|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102475362|NCT00248651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102475363|NCT00248651|Analgesics|analgesics|mesh-ancestor
101559015|NCT01285310|Growth Inhibitors|growth inhibitors|mesh-ancestor
102475364|NCT00248651|Sensory System Agents|sensory system agents|mesh-ancestor
102475365|NCT00248651|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102475366|NCT00248651|Adrenergic Agents|adrenergic agents|mesh-ancestor
102475367|NCT03800797|Loxoprofen|loxoprofen|mesh-list
102475368|NCT03800797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102475369|NCT03800797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102475370|NCT03800797|Analgesics|analgesics|mesh-ancestor
102475371|NCT03800797|Sensory System Agents|sensory system agents|mesh-ancestor
102475372|NCT03800797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102475373|NCT03800797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475374|NCT03800797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102475375|NCT03800797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102475376|NCT04383067|Aldesleukin|aldesleukin|mesh-list
102287028|NCT04979923|Lidocaine|lidocaine|mesh-list
102475377|NCT04383067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102475378|NCT04383067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102475379|NCT04383067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102475380|NCT04383067|Antiviral Agents|antiviral agents|mesh-ancestor
102475381|NCT04383067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102475382|NCT01994109|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
102475383|NCT01994109|Botulinum Toxins|botulinum toxins|mesh-list
102475384|NCT01994109|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102475385|NCT01994109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102475386|NCT01994109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475387|NCT01994109|Cholinergic Agents|cholinergic agents|mesh-ancestor
102475388|NCT01994109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102475389|NCT01994109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475390|NCT01994109|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102475391|NCT00248495|Pemetrexed|pemetrexed|mesh-list
102475392|NCT00248495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102475393|NCT00248495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102475394|NCT00248495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475395|NCT00248495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102475396|NCT00248495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102475397|NCT04739371|Insulin|insulin|mesh-list
102475398|NCT04739371|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102475399|NCT04739371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102475400|NCT04739371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475401|NCT03809767|Antibodies|antibodies|mesh-list
102475402|NCT03809767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102475403|NCT03809767|Immunologic Factors|immunologic factors|mesh-ancestor
102475404|NCT03809767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475405|NCT03800641|Dexmedetomidine|dexmedetomidine|mesh-list
102475406|NCT03800641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102475407|NCT03800641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102475408|NCT03800641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475409|NCT03800641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102475410|NCT03800641|Analgesics|analgesics|mesh-ancestor
102475411|NCT03800641|Sensory System Agents|sensory system agents|mesh-ancestor
102475412|NCT03800641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102475413|NCT03800641|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102475414|NCT03800641|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102475415|NCT03800641|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102475416|NCT03800641|Adrenergic Agents|adrenergic agents|mesh-ancestor
102475417|NCT03800641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102475418|NCT03800641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475419|NCT03807011|Fentanyl|fentanyl|mesh-list
102475420|NCT03807011|Remifentanil|remifentanil|mesh-list
102475421|NCT03807011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102475422|NCT03807011|Narcotics|narcotics|mesh-ancestor
102475423|NCT03807011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102475424|NCT03807011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475425|NCT03807011|Analgesics|analgesics|mesh-ancestor
102475426|NCT03807011|Sensory System Agents|sensory system agents|mesh-ancestor
102475427|NCT03807011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102475428|NCT03807011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102475429|NCT03807011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102475430|NCT03807011|Anesthetics, General|anesthetics, general|mesh-ancestor
102475431|NCT03807011|Anesthetics|anesthetics|mesh-ancestor
102475432|NCT02986503|Cisplatin|cisplatin|mesh-list
102475433|NCT02986503|Doxorubicin|doxorubicin|mesh-list
102475434|NCT02986503|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102475435|NCT02986503|Methotrexate|methotrexate|mesh-list
102475436|NCT02986503|Ifosfamide|ifosfamide|mesh-list
102475437|NCT02986503|Isophosphamide mustard|isophosphamide mustard|mesh-list
102475438|NCT02986503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102475439|NCT02986503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102475440|NCT02986503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102475441|NCT02986503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102475442|NCT02986503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102475443|NCT02986503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475444|NCT02986503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102475445|NCT02986503|Abortifacient Agents|abortifacient agents|mesh-ancestor
102475446|NCT02986503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102475447|NCT02986503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475448|NCT02986503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102475449|NCT02986503|Antimetabolites|antimetabolites|mesh-ancestor
102475450|NCT02986503|Dermatologic Agents|dermatologic agents|mesh-ancestor
102475451|NCT02986503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102475452|NCT02986503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102475453|NCT02986503|Immunologic Factors|immunologic factors|mesh-ancestor
102475454|NCT02986503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102475455|NCT02986503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102475456|NCT02986503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102475457|NCT02986503|Alkylating Agents|alkylating agents|mesh-ancestor
102475458|NCT01978743|Raltegravir Potassium|raltegravir potassium|mesh-list
102475459|NCT01978743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102475460|NCT01978743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102475461|NCT01978743|Antiviral Agents|antiviral agents|mesh-ancestor
102475462|NCT01978743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102475463|NCT01978743|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102475464|NCT01978743|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102475465|NCT01978743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102475466|NCT01978743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475467|NCT00763061|Timolol|timolol|mesh-list
102475468|NCT00763061|Travoprost|travoprost|mesh-list
102475469|NCT00763061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102475470|NCT00763061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102475471|NCT00763061|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102475472|NCT00763061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102475473|NCT00763061|Adrenergic Agents|adrenergic agents|mesh-ancestor
102475474|NCT00763061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102475475|NCT00763061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475476|NCT00763061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475477|NCT00763061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102475478|NCT00763061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102475479|NCT03806335|Anesthetics|anesthetics|mesh-list
102475480|NCT03806335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102475481|NCT03806335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475482|NCT03806777|Dexmedetomidine|dexmedetomidine|mesh-list
102475483|NCT03806777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102475484|NCT03806777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101433035|NCT00158171|Folic Acid|folic acid|mesh-list
102475485|NCT03806777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475486|NCT03806777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102475487|NCT03806777|Analgesics|analgesics|mesh-ancestor
102475488|NCT03806777|Sensory System Agents|sensory system agents|mesh-ancestor
102475489|NCT03806777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101433076|NCT00183222|Antiemetics|antiemetics|mesh-ancestor
102475490|NCT03806777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102475491|NCT03806777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102475492|NCT03806777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102475493|NCT03806777|Adrenergic Agents|adrenergic agents|mesh-ancestor
102475494|NCT03806777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102475495|NCT03806777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475496|NCT03806387|Alemtuzumab|alemtuzumab|mesh-list
102475497|NCT03806387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102475498|NCT03806387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102475499|NCT00754247|Vitamin E|vitamin e|mesh-list
102475500|NCT00754247|Hydrocortisone|hydrocortisone|mesh-list
102475501|NCT00754247|Vitamins|vitamins|mesh-ancestor
102475502|NCT00754247|Micronutrients|micronutrients|mesh-ancestor
102475503|NCT00754247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475504|NCT00754247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102475505|NCT00754247|Antioxidants|antioxidants|mesh-ancestor
102475506|NCT00754247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475507|NCT00754247|Protective Agents|protective agents|mesh-ancestor
102475508|NCT02305329|Opicapone|opicapone|mesh-list
101559151|NCT01288469|Atorvastatin|atorvastatin|mesh-list
102475509|NCT02305329|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102475510|NCT02305329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102475511|NCT02305329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475512|NCT02305329|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102475513|NCT02305329|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102475514|NCT01979445|Clopidogrel|clopidogrel|mesh-list
101559161|NCT01288469|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102475515|NCT01979445|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102475516|NCT01979445|Cangrelor|cangrelor|mesh-list
102475517|NCT01979445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102475518|NCT01979445|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102475519|NCT01979445|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102475520|NCT01979445|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102475521|NCT01979445|Purinergic Agents|purinergic agents|mesh-ancestor
102475522|NCT01979445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102475523|NCT01979445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475524|NCT01979445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475525|NCT03802565|Tolperisone|tolperisone|mesh-list
102475526|NCT03802565|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102475527|NCT03802565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475528|NCT03802565|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102475529|NCT03802565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102475531|NCT04382443|Gout Suppressants|gout suppressants|mesh-ancestor
102475532|NCT04382443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102475533|NCT04382443|Tubulin Modulators|tubulin modulators|mesh-ancestor
102475534|NCT04382443|Antimitotic Agents|antimitotic agents|mesh-ancestor
102475535|NCT04382443|Mitosis Modulators|mitosis modulators|mesh-ancestor
102475536|NCT04382443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475537|NCT04382443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102475538|NCT04633213|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102475539|NCT04633213|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102475540|NCT01981863|Aminocaproic Acid|aminocaproic acid|mesh-list
102475541|NCT01981863|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102475542|NCT01981863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102475543|NCT01981863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475544|NCT01981863|Hemostatics|hemostatics|mesh-ancestor
102475545|NCT01981863|Coagulants|coagulants|mesh-ancestor
102475546|NCT00245765|Certolizumab Pegol|certolizumab pegol|mesh-list
102475547|NCT00245765|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102475548|NCT00245765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102475549|NCT00245765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102475550|NCT00245765|Immunologic Factors|immunologic factors|mesh-ancestor
102475551|NCT00245765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475552|NCT00245765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102475553|NCT01995045|Triamcinolone|triamcinolone|mesh-list
102475554|NCT01995045|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102475555|NCT01995045|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102475556|NCT01995045|Bupivacaine|bupivacaine|mesh-list
102475557|NCT01995045|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102475558|NCT01995045|Anesthetics, Local|anesthetics, local|mesh-ancestor
102475559|NCT01995045|Anesthetics|anesthetics|mesh-ancestor
102475560|NCT01995045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102475561|NCT01995045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475562|NCT01995045|Sensory System Agents|sensory system agents|mesh-ancestor
102475563|NCT01995045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102475564|NCT01995045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102475565|NCT01995045|Glucocorticoids|glucocorticoids|mesh-ancestor
102475566|NCT01995045|Hormones|hormones|mesh-ancestor
102475567|NCT01995045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102475568|NCT01995045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102475569|NCT01995045|Immunologic Factors|immunologic factors|mesh-ancestor
102475570|NCT01995045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101433791|NCT00190476|Docetaxel|docetaxel|mesh-list
102475571|NCT01995045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475572|NCT04894123|Trifluridine|trifluridine|mesh-list
102475573|NCT04894123|Oxaliplatin|oxaliplatin|mesh-list
102475574|NCT04894123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102475575|NCT04894123|Antimetabolites|antimetabolites|mesh-ancestor
102475576|NCT04894123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475577|NCT04894123|Antiviral Agents|antiviral agents|mesh-ancestor
102475578|NCT04894123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102475579|NCT01982643|Naltrexone|naltrexone|mesh-list
102475580|NCT01982643|Bupropion|bupropion|mesh-list
102475581|NCT01982643|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102475582|NCT01982643|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102475583|NCT01982643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475584|NCT01982643|Sensory System Agents|sensory system agents|mesh-ancestor
102475585|NCT01982643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102475586|NCT01982643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102475587|NCT01982643|Antidepressive Agents|antidepressive agents|mesh-ancestor
102475588|NCT01982643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102475589|NCT01982643|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102475590|NCT01982643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102475591|NCT01982643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102475592|NCT01982643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475593|NCT01982643|Dopamine Agents|dopamine agents|mesh-ancestor
102475594|NCT01982643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102475595|NCT01982643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102475596|NCT01982643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102475597|NCT01982643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102475598|NCT01996839|Loteprednol Etabonate|loteprednol etabonate|mesh-list
102475599|NCT01996839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102475600|NCT00797797|Milnacipran|milnacipran|mesh-list
102475601|NCT00797797|Levomilnacipran|levomilnacipran|mesh-list
102287264|NCT02450487|Piroxicam|piroxicam|mesh-list
101559237|NCT02885961|Antithrombins|antithrombins|mesh-ancestor
102475602|NCT00797797|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102475603|NCT00797797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102475604|NCT00797797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102475605|NCT00797797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475607|NCT00797797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475608|NCT00797797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102475609|NCT00797797|Analgesics|analgesics|mesh-ancestor
102475610|NCT00797797|Sensory System Agents|sensory system agents|mesh-ancestor
102475611|NCT00797797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102475612|NCT00797797|Antidepressive Agents|antidepressive agents|mesh-ancestor
102475613|NCT00797797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102475614|NCT03496233|Grazoprevir|grazoprevir|mesh-list
102475615|NCT03496233|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
102475616|NCT03496233|Antiviral Agents|antiviral agents|mesh-ancestor
102475617|NCT03496233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102475618|NCT04482673|Vitamin D|vitamin d|mesh-list
102475619|NCT04482673|Ergocalciferols|ergocalciferols|mesh-list
102475620|NCT04482673|Cholecalciferol|cholecalciferol|mesh-list
102475621|NCT04482673|Vitamins|vitamins|mesh-list
102475622|NCT04482673|Micronutrients|micronutrients|mesh-ancestor
102475623|NCT04482673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475624|NCT04482673|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102475625|NCT04482673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102475626|NCT00245063|Cediranib|cediranib|mesh-list
102475627|NCT00245063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102475628|NCT00245063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475629|NCT00245063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102475630|NCT00245063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102475631|NCT02151487|Dexamethasone|dexamethasone|mesh-list
102475632|NCT02151487|Dexamethasone acetate|dexamethasone acetate|mesh-list
102475633|NCT02151487|Clonidine|clonidine|mesh-list
102475634|NCT02151487|Ropivacaine|ropivacaine|mesh-list
102475635|NCT02151487|BB 1101|bb 1101|mesh-list
102475636|NCT02151487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102475637|NCT02151487|Antiemetics|antiemetics|mesh-ancestor
102475638|NCT02151487|Autonomic Agents|autonomic agents|mesh-ancestor
102475639|NCT02151487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101559266|NCT02860897|Hormones|hormones|mesh-ancestor
102475640|NCT02151487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475641|NCT02151487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102475642|NCT02151487|Glucocorticoids|glucocorticoids|mesh-ancestor
102475643|NCT02151487|Hormones|hormones|mesh-ancestor
102475644|NCT02151487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102475645|NCT02151487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102475646|NCT02151487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102475647|NCT02151487|Protease Inhibitors|protease inhibitors|mesh-ancestor
102475648|NCT02151487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101559281|NCT04284007|BB 1101|bb 1101|mesh-list
102475649|NCT02151487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475650|NCT02151487|Anesthetics, Local|anesthetics, local|mesh-ancestor
102475651|NCT02151487|Anesthetics|anesthetics|mesh-ancestor
102475652|NCT02151487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102475653|NCT02151487|Sensory System Agents|sensory system agents|mesh-ancestor
102475654|NCT02151487|Analgesics|analgesics|mesh-ancestor
102475655|NCT02151487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102475656|NCT02151487|Sympatholytics|sympatholytics|mesh-ancestor
102475657|NCT02151487|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102475658|NCT02151487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102475659|NCT02151487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102475660|NCT02151487|Adrenergic Agents|adrenergic agents|mesh-ancestor
102475661|NCT02151487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102475662|NCT05318339|Trastuzumab|trastuzumab|mesh-list
102475663|NCT05318339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102475664|NCT05318339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102475665|NCT04703335|Anti-Infective Agents|anti-infective agents|mesh-list
102475666|NCT04703335|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102475667|NCT00764309|Dasatinib|dasatinib|mesh-list
102475668|NCT00764309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102475669|NCT00764309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102475670|NCT00764309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102475671|NCT00764309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475672|NCT02151877|Nitric Oxide|nitric oxide|mesh-list
102475673|NCT02151877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102475674|NCT02151877|Autonomic Agents|autonomic agents|mesh-ancestor
102475675|NCT02151877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102287320|NCT02504541|Anabolic Agents|anabolic agents|mesh-ancestor
102475676|NCT02151877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475677|NCT02151877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102475678|NCT02151877|Respiratory System Agents|respiratory system agents|mesh-ancestor
102475679|NCT02151877|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101559314|NCT00960193|Colchicine|colchicine|mesh-list
102475681|NCT02151877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475682|NCT02151877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102475683|NCT02151877|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102475684|NCT02151877|Vasodilator Agents|vasodilator agents|mesh-ancestor
102475685|NCT02151877|Gasotransmitters|gasotransmitters|mesh-ancestor
102475686|NCT02151877|Protective Agents|protective agents|mesh-ancestor
101559322|NCT00960115|Cyclophosphamide|cyclophosphamide|mesh-list
102475687|NCT00798577|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102475688|NCT00798577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102475689|NCT00799435|Exenatide|exenatide|mesh-list
102475690|NCT00799435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102475691|NCT00799435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475692|NCT00799435|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102475693|NCT00799435|Incretins|incretins|mesh-ancestor
102475694|NCT00799435|Hormones|hormones|mesh-ancestor
102475695|NCT00799435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102475696|NCT04329091|Dexmedetomidine|dexmedetomidine|mesh-list
102475697|NCT04329091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102475698|NCT04329091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102475699|NCT04329091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475700|NCT04329091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102475701|NCT04329091|Analgesics|analgesics|mesh-ancestor
102475702|NCT04329091|Sensory System Agents|sensory system agents|mesh-ancestor
102475703|NCT04329091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101559335|NCT00959647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102475704|NCT04329091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102475705|NCT04329091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102475706|NCT04329091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102475707|NCT04329091|Adrenergic Agents|adrenergic agents|mesh-ancestor
102475708|NCT04329091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102475709|NCT04329091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475710|NCT04382209|Meperidine|meperidine|mesh-list
102475711|NCT04382209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102475712|NCT04382209|Narcotics|narcotics|mesh-ancestor
102475713|NCT04382209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101559343|NCT02725567|Ivacaftor|ivacaftor|mesh-list
102475714|NCT04382209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475715|NCT04382209|Analgesics|analgesics|mesh-ancestor
102475716|NCT04382209|Sensory System Agents|sensory system agents|mesh-ancestor
102475717|NCT04382209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102475718|NCT04382209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102475719|NCT04634071|Bupropion|bupropion|mesh-list
102475720|NCT04634071|Nicotine|nicotine|mesh-list
102475721|NCT04634071|Varenicline|varenicline|mesh-list
102475722|NCT04634071|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102475723|NCT04634071|Autonomic Agents|autonomic agents|mesh-ancestor
102475724|NCT04634071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102475725|NCT04634071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475726|NCT04634071|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102475727|NCT04634071|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102475728|NCT04634071|Cholinergic Agents|cholinergic agents|mesh-ancestor
102475729|NCT04634071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102475730|NCT04634071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475731|NCT04634071|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102475732|NCT04634071|Antidepressive Agents|antidepressive agents|mesh-ancestor
102475733|NCT04634071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102475734|NCT04634071|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102475735|NCT04634071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102475736|NCT04634071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102475737|NCT04634071|Dopamine Agents|dopamine agents|mesh-ancestor
102475738|NCT04634071|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102475739|NCT04634071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102475740|NCT04634071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102475741|NCT03417921|Paclitaxel|paclitaxel|mesh-list
102475742|NCT03417921|Gemcitabine|gemcitabine|mesh-list
102475743|NCT03417921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102475744|NCT03417921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102475745|NCT03417921|Tubulin Modulators|tubulin modulators|mesh-ancestor
102475746|NCT03417921|Antimitotic Agents|antimitotic agents|mesh-ancestor
102475747|NCT03417921|Mitosis Modulators|mitosis modulators|mesh-ancestor
102475748|NCT03417921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287392|NCT03060265|Acetaminophen|acetaminophen|mesh-list
102475749|NCT03417921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102475750|NCT03417921|Antimetabolites|antimetabolites|mesh-ancestor
102475751|NCT03378297|Aspirin|aspirin|mesh-list
102475752|NCT03378297|Metformin|metformin|mesh-list
102475753|NCT03378297|Letrozole|letrozole|mesh-list
102475754|NCT03378297|Olaparib|olaparib|mesh-list
102475755|NCT03378297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102475756|NCT03378297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475757|NCT03378297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102475758|NCT03378297|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102475759|NCT03378297|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102475760|NCT03378297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101559386|NCT04282291|Analgesics|analgesics|mesh-ancestor
102475761|NCT03378297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475762|NCT03378297|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102475763|NCT03378297|Hormone Antagonists|hormone antagonists|mesh-ancestor
102475764|NCT03378297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102475765|NCT03378297|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102475766|NCT03378297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102475767|NCT03378297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102475768|NCT03378297|Analgesics|analgesics|mesh-ancestor
102475769|NCT03378297|Sensory System Agents|sensory system agents|mesh-ancestor
102475770|NCT03378297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102475771|NCT03378297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102475772|NCT03378297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102475773|NCT03378297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101559401|NCT02869009|Aspirin|aspirin|mesh-list
102475774|NCT03378297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102475775|NCT03378297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102475776|NCT03378297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102475777|NCT03378297|Antipyretics|antipyretics|mesh-ancestor
102475778|NCT03367689|Olaparib|olaparib|mesh-list
102475779|NCT03367689|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102475780|NCT03367689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102475781|NCT03367689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475782|NCT03367689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102475783|NCT00243659|Factor VIII|factor viii|mesh-list
102475784|NCT00243659|Coagulants|coagulants|mesh-ancestor
102475785|NCT00814177|Warfarin|warfarin|mesh-list
102475786|NCT00814177|Anticoagulants|anticoagulants|mesh-ancestor
102475787|NCT00243347|Cediranib|cediranib|mesh-list
101559421|NCT02869009|Purinergic Agents|purinergic agents|mesh-ancestor
102475788|NCT00243347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102475789|NCT00243347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102475790|NCT00243347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102475791|NCT00243347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475792|NCT03364491|Tranexamic Acid|tranexamic acid|mesh-list
102475793|NCT03364491|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102475794|NCT03364491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102475795|NCT03364491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475796|NCT03364491|Hemostatics|hemostatics|mesh-ancestor
102475797|NCT03364491|Coagulants|coagulants|mesh-ancestor
102475798|NCT04294069|Azithromycin|azithromycin|mesh-list
102475799|NCT04294069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102475800|NCT04294069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102475801|NCT01997229|Eculizumab|eculizumab|mesh-list
102475802|NCT01997229|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102475803|NCT01997229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102475804|NCT01997229|Immunologic Factors|immunologic factors|mesh-ancestor
102475805|NCT01997229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475806|NCT00800839|Cyclophosphamide|cyclophosphamide|mesh-list
102475807|NCT00800839|Busulfan|busulfan|mesh-list
102475808|NCT00800839|Fludarabine|fludarabine|mesh-list
102475809|NCT00800839|Fludarabine phosphate|fludarabine phosphate|mesh-list
102475810|NCT00800839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102475811|NCT00800839|Immunologic Factors|immunologic factors|mesh-ancestor
102475812|NCT00800839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475813|NCT00800839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102475814|NCT00800839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102475815|NCT00800839|Alkylating Agents|alkylating agents|mesh-ancestor
101559438|NCT01164579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102475816|NCT00800839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475817|NCT00800839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102475818|NCT00800839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102475819|NCT00800839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102475820|NCT00800839|Antimetabolites|antimetabolites|mesh-ancestor
102475821|NCT00814255|Adalimumab|adalimumab|mesh-list
102475822|NCT00814255|Losartan|losartan|mesh-list
102475823|NCT00814255|Lisinopril|lisinopril|mesh-list
102475824|NCT00814255|Atorvastatin|atorvastatin|mesh-list
102475825|NCT00814255|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102475826|NCT00814255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101559450|NCT02857777|Esketamine|esketamine|mesh-list
102475827|NCT00814255|Antimetabolites|antimetabolites|mesh-ancestor
102475828|NCT00814255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475829|NCT00814255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102475830|NCT00814255|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102475831|NCT00814255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102475832|NCT00814255|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102475833|NCT00814255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102475834|NCT00814255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102475835|NCT00814255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102475836|NCT00814255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102475837|NCT00814255|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102475838|NCT00814255|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101559454|NCT00630643|Immunologic Factors|immunologic factors|mesh-ancestor
102475839|NCT00814255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102475840|NCT00814255|Protease Inhibitors|protease inhibitors|mesh-ancestor
102475841|NCT00814255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102475842|NCT00814255|Protective Agents|protective agents|mesh-ancestor
102475843|NCT00814255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475844|NCT02000973|Lidocaine|lidocaine|mesh-list
102475845|NCT02000973|Bupivacaine|bupivacaine|mesh-list
102475846|NCT02000973|Ropivacaine|ropivacaine|mesh-list
102475847|NCT02000973|Anesthetics, Local|anesthetics, local|mesh-ancestor
102475848|NCT02000973|Anesthetics|anesthetics|mesh-ancestor
102475849|NCT02000973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102475850|NCT02000973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475851|NCT02000973|Sensory System Agents|sensory system agents|mesh-ancestor
102475852|NCT02000973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102475853|NCT02000973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102475854|NCT02000973|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102475855|NCT02000973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102475856|NCT02000973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102475857|NCT02000973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475858|NCT02002767|Velpatasvir|velpatasvir|mesh-list
102475859|NCT02002767|Antiviral Agents|antiviral agents|mesh-ancestor
102475860|NCT02002767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102475861|NCT01985685|Thiamine|thiamine|mesh-list
102475862|NCT01985685|Vitamin B Complex|vitamin b complex|mesh-ancestor
102475863|NCT01985685|Vitamins|vitamins|mesh-ancestor
102475864|NCT01985685|Micronutrients|micronutrients|mesh-ancestor
102475865|NCT01985685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475866|NCT00815347|Bosentan|bosentan|mesh-list
102475867|NCT00815347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102475868|NCT00815347|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102475869|NCT00815347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475870|NCT01985763|Genistein|genistein|mesh-list
102475871|NCT01985763|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102475872|NCT01985763|Protective Agents|protective agents|mesh-ancestor
102475873|NCT01985763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475874|NCT01985763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102475875|NCT01985763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102475876|NCT01985763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102475877|NCT01985763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475878|NCT01985763|Phytoestrogens|phytoestrogens|mesh-ancestor
102475879|NCT01985763|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102475880|NCT01985763|Estrogens|estrogens|mesh-ancestor
102475881|NCT01985763|Hormones|hormones|mesh-ancestor
102475882|NCT01985763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102475883|NCT02061969|Insulin Glargine|insulin glargine|mesh-list
102475884|NCT02061969|Linagliptin|linagliptin|mesh-list
102475885|NCT02061969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102475886|NCT02061969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475887|NCT02061969|Incretins|incretins|mesh-ancestor
102475888|NCT02061969|Hormones|hormones|mesh-ancestor
102475889|NCT02061969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102475890|NCT02061969|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102475891|NCT02061969|Protease Inhibitors|protease inhibitors|mesh-ancestor
102475892|NCT02061969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102475893|NCT02061969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475894|NCT02003625|Meloxicam|meloxicam|mesh-list
102475895|NCT02003625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102475896|NCT02003625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102475897|NCT02003625|Analgesics|analgesics|mesh-ancestor
102475898|NCT02003625|Sensory System Agents|sensory system agents|mesh-ancestor
102475899|NCT02003625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102475900|NCT02003625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475901|NCT02003625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102475902|NCT02003625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102475903|NCT02003625|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102475904|NCT02003625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102475905|NCT02003625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102475906|NCT02003625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475907|NCT04037683|Misoprostol|misoprostol|mesh-list
102475908|NCT04037683|Oxytocin|oxytocin|mesh-list
102475909|NCT04037683|Oxytocics|oxytocics|mesh-ancestor
102475910|NCT04037683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102475911|NCT04037683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475912|NCT04037683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102475913|NCT04037683|Abortifacient Agents|abortifacient agents|mesh-ancestor
101407971|NCT00108368|Olanzapine|olanzapine|mesh-list
102475914|NCT04037683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102475915|NCT04037683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102475916|NCT04251247|Fibrin fragment D|fibrin fragment d|mesh-list
102475917|NCT04251247|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102475918|NCT04251247|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102475919|NCT04251247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475920|NCT04251247|Hemostatics|hemostatics|mesh-ancestor
102475921|NCT04251247|Coagulants|coagulants|mesh-ancestor
102475922|NCT02396511|Bevacizumab|bevacizumab|mesh-list
102475923|NCT02396511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101559545|NCT02857153|Serotonin Agents|serotonin agents|mesh-ancestor
102475924|NCT02396511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102475925|NCT02396511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102475926|NCT02396511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102475927|NCT02396511|Growth Substances|growth substances|mesh-ancestor
102475928|NCT02396511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475929|NCT02396511|Growth Inhibitors|growth inhibitors|mesh-ancestor
102475930|NCT00816829|Fenofibrate|fenofibrate|mesh-list
102475931|NCT00816829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102475932|NCT00816829|Antimetabolites|antimetabolites|mesh-ancestor
102475933|NCT00816829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475934|NCT00816829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102475935|NCT02062359|Aldesleukin|aldesleukin|mesh-list
102475936|NCT02062359|Cyclophosphamide|cyclophosphamide|mesh-list
102475937|NCT02062359|Fludarabine|fludarabine|mesh-list
102475938|NCT02062359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102475939|NCT02062359|Immunologic Factors|immunologic factors|mesh-ancestor
102475940|NCT02062359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475941|NCT02062359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102475942|NCT02062359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102475943|NCT02062359|Alkylating Agents|alkylating agents|mesh-ancestor
102475944|NCT02062359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475945|NCT02062359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102475946|NCT02062359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102475947|NCT02062359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102475948|NCT02062359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102475949|NCT02062359|Antiviral Agents|antiviral agents|mesh-ancestor
102475950|NCT02062359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102475951|NCT02397291|Inositol|inositol|mesh-list
102475952|NCT02397291|Vitamin B Complex|vitamin b complex|mesh-ancestor
102475953|NCT02397291|Vitamins|vitamins|mesh-ancestor
102475954|NCT02397291|Micronutrients|micronutrients|mesh-ancestor
102475955|NCT02397291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475956|NCT00816907|Metformin|metformin|mesh-list
102475957|NCT00816907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102475958|NCT00816907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475959|NCT00817219|Betamethasone|betamethasone|mesh-list
101559580|NCT02857309|Diuretics|diuretics|mesh-ancestor
102475960|NCT00817219|Betamethasone Valerate|betamethasone valerate|mesh-list
102475961|NCT00817219|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102475962|NCT00817219|Betamethasone benzoate|betamethasone benzoate|mesh-list
102475963|NCT00817219|Calcipotriene|calcipotriene|mesh-list
102475964|NCT00817219|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102475965|NCT00817219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102475966|NCT00817219|Glucocorticoids|glucocorticoids|mesh-ancestor
102475967|NCT00817219|Hormones|hormones|mesh-ancestor
102475968|NCT00817219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102475969|NCT00817219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475970|NCT00817219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102475971|NCT00817219|Respiratory System Agents|respiratory system agents|mesh-ancestor
102475972|NCT00817219|Dermatologic Agents|dermatologic agents|mesh-ancestor
102475973|NCT00817843|Simvastatin|simvastatin|mesh-list
102475974|NCT00817843|Ezetimibe|ezetimibe|mesh-list
102475975|NCT00817843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102475976|NCT00817843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102475978|NCT00817843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475979|NCT00817843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102475980|NCT00817843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102475981|NCT00817843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102475982|NCT00817999|Clopidogrel|clopidogrel|mesh-list
102475983|NCT00817999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102475984|NCT00817999|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101559597|NCT02857465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102475985|NCT00817999|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102475986|NCT00817999|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102475987|NCT00817999|Purinergic Agents|purinergic agents|mesh-ancestor
102475988|NCT00817999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102475989|NCT00817999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102475990|NCT00817999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102475991|NCT03839485|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102475992|NCT03839485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102475993|NCT03839485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102475994|NCT03839485|Antitubercular Agents|antitubercular agents|mesh-ancestor
101436790|NCT01527149|Hormones|hormones|mesh-ancestor
102475995|NCT02008617|Bupivacaine|bupivacaine|mesh-list
102475996|NCT02008617|Anesthetics, Local|anesthetics, local|mesh-ancestor
102475997|NCT02008617|Anesthetics|anesthetics|mesh-ancestor
102475998|NCT02008617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102475999|NCT02008617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476000|NCT02008617|Sensory System Agents|sensory system agents|mesh-ancestor
102476001|NCT02008617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102476002|NCT03839251|Aripiprazole|aripiprazole|mesh-list
102476003|NCT03839251|Antidepressive Agents|antidepressive agents|mesh-ancestor
102476004|NCT03839251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102476005|NCT03839251|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102476006|NCT03839251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102476007|NCT03839251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102476008|NCT03839251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476009|NCT03839251|Dopamine Agonists|dopamine agonists|mesh-ancestor
102476010|NCT03839251|Dopamine Agents|dopamine agents|mesh-ancestor
102476011|NCT03839251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101436919|NCT00163748|Vinorelbine|vinorelbine|mesh-list
102476012|NCT03839251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476013|NCT03839251|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102476014|NCT03839251|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102476015|NCT03839251|Serotonin Agents|serotonin agents|mesh-ancestor
102476016|NCT03839251|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102476017|NCT03839251|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101559636|NCT01239732|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102476018|NCT03839251|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102476019|NCT03839251|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102476020|NCT00819403|Simvastatin|simvastatin|mesh-list
102476021|NCT00819403|Ezetimibe|ezetimibe|mesh-list
102476022|NCT00819403|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
102476023|NCT00819403|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102476024|NCT00819403|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102476025|NCT00819403|Antimetabolites|antimetabolites|mesh-ancestor
102476026|NCT00819403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476027|NCT00819403|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102476028|NCT00819403|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102476029|NCT00819403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102476030|NCT02010021|Letrozole|letrozole|mesh-list
102476031|NCT02010021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102476032|NCT02010021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102476033|NCT02010021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102476034|NCT02010021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102476035|NCT02010021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476036|NCT02010021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102476037|NCT02010021|Hormone Antagonists|hormone antagonists|mesh-ancestor
102476038|NCT02010021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102476039|NCT02010021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476040|NCT02062905|Dexamethasone|dexamethasone|mesh-list
102476041|NCT02062905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102476042|NCT02062905|Antiemetics|antiemetics|mesh-ancestor
102476043|NCT02062905|Autonomic Agents|autonomic agents|mesh-ancestor
102476044|NCT02062905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102476045|NCT02062905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476046|NCT02062905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102476047|NCT02062905|Glucocorticoids|glucocorticoids|mesh-ancestor
102476048|NCT02062905|Hormones|hormones|mesh-ancestor
102476049|NCT02062905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102476050|NCT02062905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102476051|NCT02062905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102476052|NCT00820573|Metformin|metformin|mesh-list
102476053|NCT00820573|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102476054|NCT00820573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102476055|NCT00820573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476056|NCT00820573|Incretins|incretins|mesh-ancestor
102476057|NCT00820573|Hormones|hormones|mesh-ancestor
102476058|NCT00820573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102476059|NCT00820573|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102476060|NCT00820573|Protease Inhibitors|protease inhibitors|mesh-ancestor
102476061|NCT00820573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102476062|NCT00820573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476063|NCT05217355|Botulinum Toxins|botulinum toxins|mesh-list
102476064|NCT05217355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102476065|NCT05217355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102476066|NCT05217355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102476067|NCT05217355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102476068|NCT05217355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476069|NCT05217355|Cholinergic Agents|cholinergic agents|mesh-ancestor
102476070|NCT05217355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101559684|NCT01962415|Antisickling Agents|antisickling agents|mesh-ancestor
102476071|NCT05217355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476072|NCT05217355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102476073|NCT05217355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102476074|NCT02010645|Decitabine|decitabine|mesh-list
102476075|NCT02010645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102476076|NCT02010645|Antimetabolites|antimetabolites|mesh-ancestor
101559690|NCT02860663|Vitamins|vitamins|mesh-list
102476077|NCT02010645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476078|NCT02010645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102476079|NCT02010645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102476080|NCT02065479|Ticagrelor|ticagrelor|mesh-list
102476081|NCT02065479|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102476082|NCT02065479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101559698|NCT01239342|Everolimus|everolimus|mesh-list
102476083|NCT02065479|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102476084|NCT02065479|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102476085|NCT02065479|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102476086|NCT02065479|Purinergic Agents|purinergic agents|mesh-ancestor
102476087|NCT02065479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102476088|NCT02065479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476089|NCT02065479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476090|NCT05236621|Dexamethasone|dexamethasone|mesh-list
102476091|NCT05236621|Pomalidomide|pomalidomide|mesh-list
102476092|NCT05236621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102476093|NCT05236621|Antiemetics|antiemetics|mesh-ancestor
102476094|NCT05236621|Autonomic Agents|autonomic agents|mesh-ancestor
102476095|NCT05236621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102476096|NCT05236621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559699|NCT01239342|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102476097|NCT05236621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102476098|NCT05236621|Glucocorticoids|glucocorticoids|mesh-ancestor
102476099|NCT05236621|Hormones|hormones|mesh-ancestor
102476100|NCT05236621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102476101|NCT05236621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102476102|NCT05236621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102476103|NCT05236621|Immunologic Factors|immunologic factors|mesh-ancestor
102476104|NCT05236621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101559715|NCT01236534|Lubiprostone|lubiprostone|mesh-list
102476105|NCT05236621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102476106|NCT05236621|Growth Substances|growth substances|mesh-ancestor
102476107|NCT05236621|Growth Inhibitors|growth inhibitors|mesh-ancestor
102476108|NCT02066727|Dexmedetomidine|dexmedetomidine|mesh-list
102476109|NCT02066727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102476110|NCT02066727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102476111|NCT02066727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476112|NCT02066727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102476113|NCT02066727|Analgesics|analgesics|mesh-ancestor
102476114|NCT02066727|Sensory System Agents|sensory system agents|mesh-ancestor
102476115|NCT02066727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102476116|NCT02066727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102476117|NCT02066727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102476118|NCT02066727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102476119|NCT02066727|Adrenergic Agents|adrenergic agents|mesh-ancestor
102476120|NCT02066727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102287767|NCT03059719|Incretins|incretins|mesh-ancestor
102476121|NCT02066727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476122|NCT04349241|Favipiravir|favipiravir|mesh-list
102476123|NCT04349241|Antiviral Agents|antiviral agents|mesh-ancestor
102476124|NCT04349241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102476125|NCT02812615|Micronutrients|micronutrients|mesh-list
102476126|NCT02812615|Trace Elements|trace elements|mesh-list
102476127|NCT02812615|Albendazole|albendazole|mesh-list
102476128|NCT02812615|Pyrantel|pyrantel|mesh-list
101559740|NCT01235442|Hormones|hormones|mesh-ancestor
102476129|NCT02812615|Pyrantel Pamoate|pyrantel pamoate|mesh-list
102476130|NCT02812615|Anthelmintics|anthelmintics|mesh-ancestor
102476131|NCT02812615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102476132|NCT02812615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102476133|NCT02812615|Anticestodal Agents|anticestodal agents|mesh-ancestor
102476134|NCT02812615|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102476135|NCT02812615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102476136|NCT02812615|Tubulin Modulators|tubulin modulators|mesh-ancestor
102476137|NCT02812615|Antimitotic Agents|antimitotic agents|mesh-ancestor
102476138|NCT02812615|Mitosis Modulators|mitosis modulators|mesh-ancestor
102476139|NCT02812615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476140|NCT02812615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102476141|NCT02812615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476142|NCT02812615|Antinematodal Agents|antinematodal agents|mesh-ancestor
102476143|NCT02812615|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
101559742|NCT01163253|Tofacitinib|tofacitinib|mesh-list
102476144|NCT02812615|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102476145|NCT02812615|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102476146|NCT02812615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102476147|NCT02665117|Chlorthalidone|chlorthalidone|mesh-list
102476148|NCT02665117|Magnesium citrate|magnesium citrate|mesh-list
102476149|NCT02665117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476150|NCT02665117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102476151|NCT02665117|Diuretics|diuretics|mesh-ancestor
102476152|NCT02665117|Natriuretic Agents|natriuretic agents|mesh-ancestor
102476153|NCT02665117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476154|NCT02665117|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102476155|NCT02665117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102476156|NCT02665117|Cathartics|cathartics|mesh-ancestor
102476157|NCT02665117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102476158|NCT02151253|Modafinil|modafinil|mesh-list
102476159|NCT02151253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101559764|NCT05304039|Gasotransmitters|gasotransmitters|mesh-ancestor
102476160|NCT02151253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476161|NCT02151253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102476162|NCT02151253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102476163|NCT02151253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102476164|NCT02151253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476165|NCT02069847|Budesonide|budesonide|mesh-list
102476166|NCT02069847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102476167|NCT02069847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102476168|NCT02069847|Autonomic Agents|autonomic agents|mesh-ancestor
102476169|NCT02069847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102476170|NCT02069847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476171|NCT02069847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102476172|NCT02069847|Respiratory System Agents|respiratory system agents|mesh-ancestor
102476173|NCT02069847|Glucocorticoids|glucocorticoids|mesh-ancestor
102476174|NCT02069847|Hormones|hormones|mesh-ancestor
102476175|NCT02069847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102476176|NCT02070237|Enoxaparin|enoxaparin|mesh-list
102476177|NCT02070237|Anticoagulants|anticoagulants|mesh-ancestor
102476178|NCT02070237|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102476179|NCT02070237|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102476180|NCT02070237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476181|NCT02071095|Poly I-C|poly i-c|mesh-list
102476182|NCT02071095|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102476183|NCT02071095|Poly ICLC|poly iclc|mesh-list
102476184|NCT02071095|Interferon Inducers|interferon inducers|mesh-ancestor
102476185|NCT02071095|Immunologic Factors|immunologic factors|mesh-ancestor
102476186|NCT02071095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476187|NCT02071095|Laxatives|laxatives|mesh-ancestor
102476188|NCT02071095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102476189|NCT02071095|Antiviral Agents|antiviral agents|mesh-ancestor
102476190|NCT02071095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102476191|NCT02348359|Ranibizumab|ranibizumab|mesh-list
102476192|NCT02348359|Aflibercept|aflibercept|mesh-list
102476193|NCT02348359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102476194|NCT02348359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102476195|NCT02348359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102476196|NCT02348359|Growth Substances|growth substances|mesh-ancestor
102476197|NCT02348359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476199|NCT02406885|Apixaban|apixaban|mesh-list
102476200|NCT02406885|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102476201|NCT02406885|Antithrombins|antithrombins|mesh-ancestor
102476202|NCT02406885|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102476203|NCT02406885|Protease Inhibitors|protease inhibitors|mesh-ancestor
102476204|NCT02406885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102476205|NCT02406885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476206|NCT02406885|Anticoagulants|anticoagulants|mesh-ancestor
102476207|NCT02408445|Methyltestosterone|methyltestosterone|mesh-list
102476208|NCT02408445|Testosterone|testosterone|mesh-list
102476209|NCT02408445|Testosterone undecanoate|testosterone undecanoate|mesh-list
102476210|NCT02408445|Testosterone enanthate|testosterone enanthate|mesh-list
102476211|NCT02408445|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102476212|NCT02408445|Androgens|androgens|mesh-ancestor
102476213|NCT02408445|Hormones|hormones|mesh-ancestor
102476214|NCT02408445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102476215|NCT02408445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476216|NCT02408445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102476217|NCT02408445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102476218|NCT02408445|Anabolic Agents|anabolic agents|mesh-ancestor
102476219|NCT00388921|Vitamin A|vitamin a|mesh-list
102476220|NCT00388921|Vitamins|vitamins|mesh-ancestor
102476221|NCT00388921|Micronutrients|micronutrients|mesh-ancestor
102476222|NCT00388921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476223|NCT02016885|Glycopyrrolate|glycopyrrolate|mesh-list
102476224|NCT02016885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102476225|NCT02016885|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102476226|NCT02016885|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102476227|NCT02016885|Cholinergic Agents|cholinergic agents|mesh-ancestor
102476228|NCT02016885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101559824|NCT00946153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102476229|NCT02016885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476230|NCT02016885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476231|NCT00142285|Zinc Sulfate|zinc sulfate|mesh-list
102476232|NCT00142285|Astringents|astringents|mesh-ancestor
102476233|NCT00142285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476234|NCT00142285|Dermatologic Agents|dermatologic agents|mesh-ancestor
102476235|NCT02342379|Bevacizumab|bevacizumab|mesh-list
102476236|NCT02342379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102476237|NCT02342379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102476238|NCT02342379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102476239|NCT02342379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102476240|NCT02342379|Growth Substances|growth substances|mesh-ancestor
102476241|NCT02342379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476242|NCT02342379|Growth Inhibitors|growth inhibitors|mesh-ancestor
102476243|NCT02019069|Cytarabine|cytarabine|mesh-list
102476244|NCT02019069|Daunorubicin|daunorubicin|mesh-list
102476245|NCT02019069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102476246|NCT02019069|Antimetabolites|antimetabolites|mesh-ancestor
102476247|NCT02019069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476248|NCT02019069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102476249|NCT02019069|Antiviral Agents|antiviral agents|mesh-ancestor
102476250|NCT02019069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102476251|NCT02019069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102476252|NCT02019069|Immunologic Factors|immunologic factors|mesh-ancestor
102476253|NCT02019069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476254|NCT02019069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102476255|NCT02019069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102476256|NCT02019069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102476257|NCT02019069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102476258|NCT00821821|Edaravone|edaravone|mesh-list
102476259|NCT00821821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102476260|NCT00821821|Antioxidants|antioxidants|mesh-ancestor
102476261|NCT00821821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559860|NCT01231620|Oseltamivir|oseltamivir|mesh-list
102476262|NCT00821821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102476263|NCT00821821|Protective Agents|protective agents|mesh-ancestor
102476264|NCT00821821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476265|NCT00816751|Lidocaine|lidocaine|mesh-list
102476266|NCT00816751|Vasopressins|vasopressins|mesh-list
102476267|NCT00816751|Arginine Vasopressin|arginine vasopressin|mesh-list
102476268|NCT00816751|Anesthetics, Local|anesthetics, local|mesh-ancestor
102476269|NCT00816751|Anesthetics|anesthetics|mesh-ancestor
102476270|NCT00816751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102476271|NCT00816751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476272|NCT00816751|Sensory System Agents|sensory system agents|mesh-ancestor
102476273|NCT00816751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102476274|NCT00816751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102476275|NCT00816751|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102476276|NCT00816751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102476277|NCT00816751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102476278|NCT00816751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476279|NCT00816751|Hemostatics|hemostatics|mesh-ancestor
102476280|NCT00816751|Coagulants|coagulants|mesh-ancestor
102476281|NCT00816751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102476282|NCT00816751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102476283|NCT00816751|Natriuretic Agents|natriuretic agents|mesh-ancestor
102476284|NCT00822523|Botulinum Toxins|botulinum toxins|mesh-list
102476285|NCT00822523|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102476286|NCT00822523|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102476287|NCT00822523|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102476288|NCT00822523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101559874|NCT01231464|Respiratory System Agents|respiratory system agents|mesh-ancestor
102476289|NCT00822523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476290|NCT00822523|Cholinergic Agents|cholinergic agents|mesh-ancestor
102476291|NCT00822523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102476292|NCT00822523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476293|NCT00822523|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102476294|NCT00822523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102476295|NCT02410707|Nitrous Oxide|nitrous oxide|mesh-list
102476296|NCT02410707|Propofol|propofol|mesh-list
102476297|NCT02410707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102476298|NCT02410707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102476299|NCT02410707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476300|NCT02410707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102476301|NCT02410707|Anesthetics, General|anesthetics, general|mesh-ancestor
102476302|NCT02410707|Anesthetics|anesthetics|mesh-ancestor
102476303|NCT02410707|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102476304|NCT02410707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102476305|NCT02410707|Analgesics|analgesics|mesh-ancestor
102476306|NCT02410707|Sensory System Agents|sensory system agents|mesh-ancestor
102476307|NCT02410707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102476308|NCT02343081|Temozolomide|temozolomide|mesh-list
102476309|NCT02343081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102476310|NCT02343081|Alkylating Agents|alkylating agents|mesh-ancestor
102476311|NCT02343081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476312|NCT02343081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102476313|NCT00823303|Calcitriol|calcitriol|mesh-list
102476314|NCT00823303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102476315|NCT00823303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476316|NCT00823303|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102476317|NCT00823303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102476318|NCT00823303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476319|NCT00823303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102476320|NCT00823303|Vitamins|vitamins|mesh-ancestor
102476321|NCT00823303|Micronutrients|micronutrients|mesh-ancestor
102476322|NCT00823303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102476323|NCT00823459|Everolimus|everolimus|mesh-list
102476324|NCT00823459|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102476325|NCT00823459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102476326|NCT00823459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102476327|NCT00823459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476328|NCT00823459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102476329|NCT00823459|Immunologic Factors|immunologic factors|mesh-ancestor
102476330|NCT00823459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476331|NCT00823459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102476332|NCT00825565|Allantoin|allantoin|mesh-list
102476333|NCT00825565|Dermatologic Agents|dermatologic agents|mesh-ancestor
102476334|NCT00803647|Leucovorin|leucovorin|mesh-list
102476335|NCT00803647|Fluorouracil|fluorouracil|mesh-list
102476336|NCT00803647|Oxaliplatin|oxaliplatin|mesh-list
102476337|NCT00803647|Cetuximab|cetuximab|mesh-list
102476338|NCT00803647|Antimetabolites|antimetabolites|mesh-ancestor
102476339|NCT00803647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476340|NCT00803647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102476341|NCT00803647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102476342|NCT00803647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101439127|NCT05572515|Glucocorticoids|glucocorticoids|mesh-ancestor
102476343|NCT00803647|Immunologic Factors|immunologic factors|mesh-ancestor
102476344|NCT00803647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476345|NCT00803647|Antidotes|antidotes|mesh-ancestor
102476346|NCT00803647|Protective Agents|protective agents|mesh-ancestor
102476347|NCT00803647|Vitamin B Complex|vitamin b complex|mesh-ancestor
102476348|NCT00803647|Vitamins|vitamins|mesh-ancestor
102476349|NCT00803647|Micronutrients|micronutrients|mesh-ancestor
102476350|NCT00803647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102476351|NCT00827983|Progesterone|progesterone|mesh-list
102476352|NCT00827983|Progestins|progestins|mesh-ancestor
102476353|NCT00827983|Hormones|hormones|mesh-ancestor
102476354|NCT00827983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101559938|NCT01154673|Maraviroc|maraviroc|mesh-list
102476355|NCT00827983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476356|NCT02346903|Capsaicin|capsaicin|mesh-list
102476357|NCT02346903|Antipruritics|antipruritics|mesh-ancestor
102476358|NCT02346903|Dermatologic Agents|dermatologic agents|mesh-ancestor
102476359|NCT02346903|Sensory System Agents|sensory system agents|mesh-ancestor
102476360|NCT02346903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102476361|NCT02346903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476362|NCT02347605|Nicotine|nicotine|mesh-list
102476363|NCT02347605|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102476364|NCT02347605|Autonomic Agents|autonomic agents|mesh-ancestor
102476365|NCT02347605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102476366|NCT02347605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476367|NCT02347605|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102476368|NCT02347605|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102476369|NCT02347605|Cholinergic Agents|cholinergic agents|mesh-ancestor
102476370|NCT02347605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101559953|NCT01154673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102476371|NCT02347605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476372|NCT02153671|Vaccines|vaccines|mesh-list
102476373|NCT02153671|Immunologic Factors|immunologic factors|mesh-ancestor
102476374|NCT02153671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476375|NCT02413203|Celecoxib|celecoxib|mesh-list
102476376|NCT02413203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102476377|NCT02413203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102476378|NCT02413203|Analgesics|analgesics|mesh-ancestor
102476379|NCT02413203|Sensory System Agents|sensory system agents|mesh-ancestor
102476380|NCT02413203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102476381|NCT02413203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476382|NCT02413203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102476383|NCT02413203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102476384|NCT02413203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102476385|NCT02413203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102476386|NCT02413203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102476387|NCT02413203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476388|NCT02153983|Colchicine|colchicine|mesh-list
102476389|NCT02153983|Gout Suppressants|gout suppressants|mesh-ancestor
102476390|NCT02153983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102476391|NCT02153983|Tubulin Modulators|tubulin modulators|mesh-ancestor
102476392|NCT02153983|Antimitotic Agents|antimitotic agents|mesh-ancestor
102476393|NCT02153983|Mitosis Modulators|mitosis modulators|mesh-ancestor
101559969|NCT02884713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102476394|NCT02153983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476395|NCT02153983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102476396|NCT02348775|Acetylcysteine|acetylcysteine|mesh-list
102476397|NCT02348775|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102476398|NCT02348775|Glycine|glycine|mesh-list
102476399|NCT02348775|Antiviral Agents|antiviral agents|mesh-ancestor
102476400|NCT02348775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102476401|NCT02348775|Expectorants|expectorants|mesh-ancestor
102476402|NCT02348775|Respiratory System Agents|respiratory system agents|mesh-ancestor
102476403|NCT02348775|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102476404|NCT02348775|Antioxidants|antioxidants|mesh-ancestor
102476405|NCT02348775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476406|NCT02348775|Protective Agents|protective agents|mesh-ancestor
102476407|NCT02348775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476408|NCT02348775|Antidotes|antidotes|mesh-ancestor
102476409|NCT02348775|Glycine Agents|glycine agents|mesh-ancestor
102476410|NCT02348775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102476411|NCT00828061|Prednisone|prednisone|mesh-list
102476412|NCT00828061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102476413|NCT00828061|Glucocorticoids|glucocorticoids|mesh-ancestor
102476414|NCT00828061|Hormones|hormones|mesh-ancestor
101559984|NCT01228734|Leucovorin|leucovorin|mesh-list
102476415|NCT00828061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102476416|NCT00828061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476417|NCT00828061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102476418|NCT00828061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102476419|NCT00849121|Vaccines|vaccines|mesh-list
102476420|NCT00849121|Immunologic Factors|immunologic factors|mesh-ancestor
102476421|NCT00849121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476422|NCT02023125|Esomeprazole|esomeprazole|mesh-list
102288084|NCT04958473|Axitinib|axitinib|mesh-list
102476423|NCT02023125|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102476424|NCT02023125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102476425|NCT02023125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102476426|NCT02023125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102476427|NCT02023125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476428|NCT02349477|Gabapentin|gabapentin|mesh-list
102476429|NCT02349477|Analgesics|analgesics|mesh-ancestor
101560013|NCT00951379|Pioglitazone|pioglitazone|mesh-list
102476430|NCT02349477|Sensory System Agents|sensory system agents|mesh-ancestor
102476431|NCT02349477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102476432|NCT02349477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476433|NCT02349477|Anticonvulsants|anticonvulsants|mesh-ancestor
102476434|NCT02349477|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102476435|NCT02349477|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102476436|NCT02349477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102476437|NCT02349477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101560018|NCT01153815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102476438|NCT02349477|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102476439|NCT02349477|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102476440|NCT02349477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102476441|NCT02349477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476442|NCT02349477|Antimanic Agents|antimanic agents|mesh-ancestor
102476443|NCT00828295|Palonosetron|palonosetron|mesh-list
102476444|NCT00828295|Antiemetics|antiemetics|mesh-ancestor
102476445|NCT00828295|Autonomic Agents|autonomic agents|mesh-ancestor
102476446|NCT00828295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102476447|NCT00828295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476448|NCT00828295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102476449|NCT00828295|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102476450|NCT00828295|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102476451|NCT00828295|Serotonin Agents|serotonin agents|mesh-ancestor
102476452|NCT00828295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102476453|NCT00828295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476454|NCT02350569|Sofosbuvir|sofosbuvir|mesh-list
102476455|NCT02350569|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102476456|NCT02350569|Ledipasvir|ledipasvir|mesh-list
102476457|NCT02350569|Antiviral Agents|antiviral agents|mesh-ancestor
102476458|NCT02350569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102476459|NCT02351115|Alprazolam|alprazolam|mesh-list
102476460|NCT02351115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101737962|NCT04170855|Furosemide|furosemide|mesh-list
102476461|NCT02351115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102476462|NCT02351115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476463|NCT02351115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102476464|NCT02351115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102476465|NCT02351115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102476466|NCT02351115|GABA Modulators|gaba modulators|mesh-ancestor
102476467|NCT02351115|GABA Agents|gaba agents|mesh-ancestor
102476468|NCT02351115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102476469|NCT02351115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476470|NCT02025075|Rocuronium|rocuronium|mesh-list
102476471|NCT02025075|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102476472|NCT02025075|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102476473|NCT02025075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102476474|NCT02025075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102476475|NCT02025075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408484|NCT00143442|Reboxetine|reboxetine|mesh-list
102476476|NCT00242567|Zoledronic Acid|zoledronic acid|mesh-list
102476477|NCT00242567|Androgens|androgens|mesh-list
102476478|NCT00242567|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102476479|NCT00242567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476480|NCT00242567|Hormones|hormones|mesh-ancestor
102476481|NCT00242567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102476482|NCT00241631|Fluticasone|fluticasone|mesh-list
102476483|NCT00241631|Xhance|xhance|mesh-list
102476484|NCT00241631|Theophylline|theophylline|mesh-list
102476485|NCT00241631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102476486|NCT00241631|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102476487|NCT00241631|Autonomic Agents|autonomic agents|mesh-ancestor
102476488|NCT00241631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102476489|NCT00241631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476490|NCT00241631|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102476491|NCT00241631|Respiratory System Agents|respiratory system agents|mesh-ancestor
102476492|NCT00241631|Dermatologic Agents|dermatologic agents|mesh-ancestor
102476493|NCT00241631|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102476494|NCT00241631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102476495|NCT00241631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102476496|NCT00241631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476497|NCT00241631|Vasodilator Agents|vasodilator agents|mesh-ancestor
102288144|NCT05587673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738329|NCT00777608|Donepezil|donepezil|mesh-list
102476498|NCT00241631|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102476499|NCT00241631|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102476501|NCT00241631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102476502|NCT02351739|Pembrolizumab|pembrolizumab|mesh-list
102476503|NCT02351739|Acalabrutinib|acalabrutinib|mesh-list
102476504|NCT02351739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102476505|NCT02351739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102476506|NCT02351739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102476507|NCT02351739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476508|NCT00240071|Tamoxifen|tamoxifen|mesh-list
102476509|NCT00240071|Bevacizumab|bevacizumab|mesh-list
102476510|NCT00240071|Letrozole|letrozole|mesh-list
102476511|NCT00240071|Exemestane|exemestane|mesh-list
102476512|NCT00240071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102476513|NCT00240071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102476514|NCT00240071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102476515|NCT00240071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102476516|NCT00240071|Growth Substances|growth substances|mesh-ancestor
102476517|NCT00240071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476518|NCT00240071|Growth Inhibitors|growth inhibitors|mesh-ancestor
102476519|NCT00240071|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102476520|NCT00240071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102476521|NCT00240071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102476522|NCT00240071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476523|NCT00240071|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102476524|NCT00240071|Hormone Antagonists|hormone antagonists|mesh-ancestor
102476525|NCT00240071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102476526|NCT00240071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102476527|NCT00240071|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102476528|NCT00240071|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102476529|NCT00240071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102476530|NCT02352363|Levodopa|levodopa|mesh-list
102476531|NCT02352363|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102476532|NCT02352363|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102476533|NCT02352363|Dopamine Agents|dopamine agents|mesh-ancestor
102476534|NCT02352363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102476535|NCT02352363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476536|NCT02352363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476537|NCT00765947|Amlodipine|amlodipine|mesh-list
102476538|NCT00765947|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102476539|NCT00765947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102476540|NCT00765947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102476541|NCT00765947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102476542|NCT00765947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560111|NCT01740427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102476543|NCT00765947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102476544|NCT00765947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476545|NCT00765947|Vasodilator Agents|vasodilator agents|mesh-ancestor
102476546|NCT00765947|Diuretics|diuretics|mesh-ancestor
102476547|NCT00765947|Natriuretic Agents|natriuretic agents|mesh-ancestor
102476548|NCT00765947|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102476549|NCT05743907|Dapagliflozin|dapagliflozin|mesh-list
102476550|NCT05743907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102476551|NCT05743907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476552|NCT05743907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102476553|NCT05743907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476554|NCT00766649|Sirolimus|sirolimus|mesh-list
102476555|NCT00766649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102476556|NCT00766649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102476557|NCT00766649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102476558|NCT00766649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102476559|NCT00766649|Antifungal Agents|antifungal agents|mesh-ancestor
102476560|NCT00766649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101560139|NCT01227564|Saponin QA-21V1|saponin qa-21v1|mesh-list
102476561|NCT00766649|Immunologic Factors|immunologic factors|mesh-ancestor
102476562|NCT00766649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476563|NCT02352831|Capecitabine|capecitabine|mesh-list
102476564|NCT02352831|Tosedostat|tosedostat|mesh-list
102476565|NCT02352831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102476566|NCT02352831|Antimetabolites|antimetabolites|mesh-ancestor
102476567|NCT02352831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476568|NCT02352831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102476569|NCT02352831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102476570|NCT02353299|Zolpidem|zolpidem|mesh-list
102476571|NCT02353299|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102476572|NCT02353299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102476573|NCT02353299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101738802|NCT02517099|Glucocorticoids|glucocorticoids|mesh-ancestor
102476574|NCT02353299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476575|NCT02353299|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102476576|NCT02353299|GABA Agonists|gaba agonists|mesh-ancestor
102476577|NCT02353299|GABA Agents|gaba agents|mesh-ancestor
102476578|NCT02353299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102476579|NCT02353299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476580|NCT00756977|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
102476581|NCT00756977|Laxatives|laxatives|mesh-ancestor
102476582|NCT00756977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102476583|NCT03808961|Vitamins|vitamins|mesh-list
102476584|NCT03808961|Niacin|niacin|mesh-list
102476585|NCT03808961|Niacinamide|niacinamide|mesh-list
102476586|NCT03808961|Nicotinic Acids|nicotinic acids|mesh-list
102476587|NCT03808961|Vitamin B Complex|vitamin b complex|mesh-list
102476588|NCT03808961|Micronutrients|micronutrients|mesh-ancestor
102476589|NCT03808961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476590|NCT03808961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102476591|NCT03808961|Antimetabolites|antimetabolites|mesh-ancestor
102476592|NCT03808961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476593|NCT03808961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102476594|NCT03808961|Vasodilator Agents|vasodilator agents|mesh-ancestor
102476595|NCT00783965|Tazarotene|tazarotene|mesh-list
102476596|NCT00783965|Dermatologic Agents|dermatologic agents|mesh-ancestor
102476597|NCT00783965|Keratolytic Agents|keratolytic agents|mesh-ancestor
101560164|NCT01735825|Paclitaxel|paclitaxel|mesh-list
102476598|NCT02354859|Gallium nitrate|gallium nitrate|mesh-list
102476599|NCT02354859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102476600|NCT02354859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476601|NCT02354859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102476602|NCT00421551|Ritonavir|ritonavir|mesh-list
102476603|NCT00421551|Darunavir|darunavir|mesh-list
102476604|NCT00421551|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102476605|NCT00421551|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102476606|NCT00421551|Protease Inhibitors|protease inhibitors|mesh-ancestor
102476607|NCT00421551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102476608|NCT00421551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476609|NCT00421551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102476610|NCT00421551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102476611|NCT00421551|Antiviral Agents|antiviral agents|mesh-ancestor
102476612|NCT00421551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102476613|NCT00421551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102476614|NCT00421551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102476615|NCT02356107|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
102476616|NCT02356107|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102476617|NCT02356107|Antidepressive Agents|antidepressive agents|mesh-ancestor
102476618|NCT02356107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102476619|NCT00767507|Cangrelor|cangrelor|mesh-list
102476620|NCT00767507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101560191|NCT02860117|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102476621|NCT00767507|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102476622|NCT00767507|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102476623|NCT00767507|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102476624|NCT00767507|Purinergic Agents|purinergic agents|mesh-ancestor
102476625|NCT00767507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102476626|NCT00767507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476627|NCT00767507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476628|NCT02029755|Anesthetics|anesthetics|mesh-list
102476629|NCT02029755|Anesthetics, Local|anesthetics, local|mesh-list
102476630|NCT02029755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101560200|NCT02853253|SMOFlipid|smoflipid|mesh-list
102476631|NCT02029755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476632|NCT02029755|Sensory System Agents|sensory system agents|mesh-ancestor
102476633|NCT02029755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102476634|NCT03804749|Suramin|suramin|mesh-list
102476635|NCT03804749|Antinematodal Agents|antinematodal agents|mesh-ancestor
102476636|NCT03804749|Anthelmintics|anthelmintics|mesh-ancestor
102476637|NCT03804749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102476638|NCT03804749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102476639|NCT03804749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102476640|NCT03804749|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102476641|NCT03804749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102476642|NCT02312739|Ketorolac|ketorolac|mesh-list
102476643|NCT02312739|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102288296|NCT04943029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102476644|NCT02312739|Nitrous Oxide|nitrous oxide|mesh-list
102476645|NCT02312739|Analgesics|analgesics|mesh-list
102476646|NCT02312739|Lorazepam|lorazepam|mesh-list
102476647|NCT02312739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102476648|NCT02312739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102476649|NCT02312739|Sensory System Agents|sensory system agents|mesh-ancestor
102476650|NCT02312739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102476651|NCT02312739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476652|NCT02312739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101560222|NCT04269109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560223|NCT04269109|Analgesics|analgesics|mesh-ancestor
101560224|NCT04269109|Sensory System Agents|sensory system agents|mesh-ancestor
101560225|NCT04269109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101560226|NCT01226472|Mogamulizumab|mogamulizumab|mesh-list
101560227|NCT01226472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101560228|NCT04268563|Metformin|metformin|mesh-list
101560229|NCT04268563|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101560230|NCT04268563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101739357|NCT00751400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101739358|NCT00751400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739376|NCT00585312|Celecoxib|celecoxib|mesh-list
102476653|NCT02312739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102476654|NCT02312739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102476655|NCT02312739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102476656|NCT02312739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476657|NCT02312739|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102476658|NCT02312739|Anesthetics, General|anesthetics, general|mesh-ancestor
102476659|NCT02312739|Anesthetics|anesthetics|mesh-ancestor
102476660|NCT02312739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102476661|NCT02312739|Anticonvulsants|anticonvulsants|mesh-ancestor
102476662|NCT02312739|Antiemetics|antiemetics|mesh-ancestor
102476663|NCT02312739|Autonomic Agents|autonomic agents|mesh-ancestor
102476664|NCT02312739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102476665|NCT02312739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102476666|NCT02312739|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102476667|NCT02312739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101534873|NCT03451500|Levodopa|levodopa|mesh-list
102476668|NCT02312739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102476669|NCT02312739|GABA Modulators|gaba modulators|mesh-ancestor
102476670|NCT02312739|GABA Agents|gaba agents|mesh-ancestor
102476671|NCT02312739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102476672|NCT02351037|Azacitidine|azacitidine|mesh-list
102476673|NCT02351037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102476674|NCT02351037|Antimetabolites|antimetabolites|mesh-ancestor
102476675|NCT02351037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476676|NCT02351037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102476677|NCT02351037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102476678|NCT05718609|Amoxicillin|amoxicillin|mesh-list
102476679|NCT05718609|Clarithromycin|clarithromycin|mesh-list
102476680|NCT05718609|Furazolidone|furazolidone|mesh-list
102476681|NCT05718609|Rabeprazole|rabeprazole|mesh-list
102476682|NCT05718609|Bismuth|bismuth|mesh-list
102476683|NCT05718609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102476684|NCT05718609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102476685|NCT05718609|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102476686|NCT05718609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102476687|NCT05718609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476688|NCT05718609|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102476689|NCT05718609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102476690|NCT05718609|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102476691|NCT05718609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102476692|NCT05718609|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102476693|NCT05718609|Antacids|antacids|mesh-ancestor
101560262|NCT01218594|Growth Substances|growth substances|mesh-ancestor
102476694|NCT05718609|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102476695|NCT05718609|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102476696|NCT05718609|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
102476697|NCT05718609|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102476698|NCT05718609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102476699|NCT05718609|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102476700|NCT02359305|Acetaminophen|acetaminophen|mesh-list
102476701|NCT02359305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102476702|NCT02359305|Analgesics|analgesics|mesh-ancestor
102476703|NCT02359305|Sensory System Agents|sensory system agents|mesh-ancestor
102476704|NCT02359305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102476705|NCT02359305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476706|NCT02359305|Antipyretics|antipyretics|mesh-ancestor
102476707|NCT02360319|Aripiprazole|aripiprazole|mesh-list
102476708|NCT02360319|Antipsychotic Agents|antipsychotic agents|mesh-list
102476709|NCT02360319|Antidepressive Agents|antidepressive agents|mesh-ancestor
102476710|NCT02360319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102476711|NCT02360319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102476712|NCT02360319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102476713|NCT02360319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476714|NCT02360319|Dopamine Agonists|dopamine agonists|mesh-ancestor
102476715|NCT02360319|Dopamine Agents|dopamine agents|mesh-ancestor
102476716|NCT02360319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102476717|NCT02360319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476718|NCT02360319|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102476719|NCT02360319|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102476720|NCT02360319|Serotonin Agents|serotonin agents|mesh-ancestor
102476721|NCT02360319|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102476722|NCT02360319|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102476723|NCT02360319|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102476724|NCT02360319|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102476725|NCT05718531|Aspirin|aspirin|mesh-list
102476726|NCT05718531|Rivaroxaban|rivaroxaban|mesh-list
102476727|NCT05718531|Clopidogrel|clopidogrel|mesh-list
102476728|NCT05718531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102476729|NCT05718531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102476730|NCT05718531|Analgesics|analgesics|mesh-ancestor
102476731|NCT05718531|Sensory System Agents|sensory system agents|mesh-ancestor
101560302|NCT00950755|Antibodies|antibodies|mesh-list
102476732|NCT05718531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102476733|NCT05718531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476734|NCT05718531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101560306|NCT01147107|Efavirenz|efavirenz|mesh-list
102476735|NCT05718531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102476736|NCT05718531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102476737|NCT05718531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102476738|NCT05718531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476739|NCT05718531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102476740|NCT05718531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102476741|NCT05718531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102476742|NCT05718531|Antipyretics|antipyretics|mesh-ancestor
102476743|NCT05718531|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102476744|NCT05718531|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102476745|NCT05718531|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102476746|NCT05718531|Purinergic Agents|purinergic agents|mesh-ancestor
102476747|NCT05718531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102476748|NCT05718531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102476749|NCT05718531|Antithrombins|antithrombins|mesh-ancestor
101560324|NCT01146951|Rufinamide|rufinamide|mesh-list
102476750|NCT05718531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102476751|NCT05718531|Protease Inhibitors|protease inhibitors|mesh-ancestor
102476752|NCT05718531|Anticoagulants|anticoagulants|mesh-ancestor
102476753|NCT02360631|Varenicline|varenicline|mesh-list
102476754|NCT02360631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102476755|NCT02360631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102476756|NCT02360631|Cholinergic Agents|cholinergic agents|mesh-ancestor
102476757|NCT02360631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101560325|NCT01146951|Anticonvulsants|anticonvulsants|mesh-ancestor
102476758|NCT02360631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476759|NCT02360631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476760|NCT00355095|Epoetin Alfa|epoetin alfa|mesh-list
102476761|NCT00355095|Hematinics|hematinics|mesh-ancestor
102476762|NCT02366871|Enoxaparin|enoxaparin|mesh-list
102476763|NCT02366871|Apixaban|apixaban|mesh-list
102476764|NCT02366871|Anticoagulants|anticoagulants|mesh-ancestor
102476765|NCT02366871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102476766|NCT02366871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102476767|NCT02366871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476768|NCT02366871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102476769|NCT02366871|Antithrombins|antithrombins|mesh-ancestor
102476770|NCT02366871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102476771|NCT02366871|Protease Inhibitors|protease inhibitors|mesh-ancestor
102476772|NCT02366871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102476773|NCT02368431|Zonisamide|zonisamide|mesh-list
102476774|NCT02368431|Anticonvulsants|anticonvulsants|mesh-ancestor
102476775|NCT02368431|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102476776|NCT02368431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102476777|NCT02368431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476778|NCT02368431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102476779|NCT02368431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476780|NCT03836651|Antioxidants|antioxidants|mesh-list
102476781|NCT03836651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476782|NCT03836651|Protective Agents|protective agents|mesh-ancestor
102476783|NCT03836651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476784|NCT02037555|Antithrombins|antithrombins|mesh-list
102476785|NCT02037555|Antithrombin III|antithrombin iii|mesh-list
102476786|NCT02037555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102476787|NCT02037555|Protease Inhibitors|protease inhibitors|mesh-ancestor
102476788|NCT02037555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102476789|NCT02037555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476790|NCT02037555|Anticoagulants|anticoagulants|mesh-ancestor
102476791|NCT03804359|Rituximab|rituximab|mesh-list
102476792|NCT03804359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102476793|NCT03804359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102476794|NCT03804359|Immunologic Factors|immunologic factors|mesh-ancestor
101560366|NCT01146795|Growth Substances|growth substances|mesh-ancestor
102476795|NCT03804359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476796|NCT03804359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102476797|NCT02369211|Acetaminophen|acetaminophen|mesh-list
102476798|NCT02369211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102476799|NCT02369211|Analgesics|analgesics|mesh-ancestor
102476800|NCT02369211|Sensory System Agents|sensory system agents|mesh-ancestor
102476801|NCT02369211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102476802|NCT02369211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476803|NCT02369211|Antipyretics|antipyretics|mesh-ancestor
102476804|NCT02038023|Iron|iron|mesh-list
102476805|NCT02038023|Dextrans|dextrans|mesh-list
102476806|NCT02038023|Iron-Dextran Complex|iron-dextran complex|mesh-list
102476807|NCT02038023|Trace Elements|trace elements|mesh-ancestor
102476808|NCT02038023|Micronutrients|micronutrients|mesh-ancestor
102476809|NCT02038023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476810|NCT02038023|Anticoagulants|anticoagulants|mesh-ancestor
102476811|NCT02038023|Plasma Substitutes|plasma substitutes|mesh-ancestor
102476812|NCT02038023|Blood Substitutes|blood substitutes|mesh-ancestor
102476813|NCT02038023|Hematinics|hematinics|mesh-ancestor
102476814|NCT04384133|Nitric Oxide|nitric oxide|mesh-list
102476815|NCT04384133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102476816|NCT04384133|Autonomic Agents|autonomic agents|mesh-ancestor
102476817|NCT04384133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102476818|NCT04384133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476819|NCT04384133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102476820|NCT04384133|Respiratory System Agents|respiratory system agents|mesh-ancestor
102476821|NCT04384133|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102476822|NCT04384133|Antioxidants|antioxidants|mesh-ancestor
102476823|NCT04384133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476824|NCT04384133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102476825|NCT04384133|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102476826|NCT04384133|Vasodilator Agents|vasodilator agents|mesh-ancestor
102476827|NCT04384133|Gasotransmitters|gasotransmitters|mesh-ancestor
102476828|NCT04384133|Protective Agents|protective agents|mesh-ancestor
102476829|NCT02038179|Allopurinol|allopurinol|mesh-list
102476830|NCT02038179|Antimetabolites|antimetabolites|mesh-ancestor
102476831|NCT02038179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476832|NCT02038179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102476833|NCT02038179|Gout Suppressants|gout suppressants|mesh-ancestor
101740859|NCT00712491|Sirolimus|sirolimus|mesh-list
102476834|NCT02038179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102476835|NCT02038179|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102476836|NCT02038179|Antioxidants|antioxidants|mesh-ancestor
102476837|NCT02038179|Protective Agents|protective agents|mesh-ancestor
102476838|NCT02038179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476839|NCT02369835|Sodium Hypochlorite|sodium hypochlorite|mesh-list
102476840|NCT02369835|Eusol|eusol|mesh-list
102476841|NCT02369835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102476842|NCT02369835|Disinfectants|disinfectants|mesh-ancestor
102476843|NCT02369835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102476844|NCT00768521|Tolterodine Tartrate|tolterodine tartrate|mesh-list
102476845|NCT00768521|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102476846|NCT00768521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102476847|NCT00768521|Cholinergic Agents|cholinergic agents|mesh-ancestor
102476848|NCT00768521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102476849|NCT00768521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476850|NCT00768521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476851|NCT00768521|Urological Agents|urological agents|mesh-ancestor
102476852|NCT00768599|Econazole|econazole|mesh-list
102476853|NCT00768599|Antifungal Agents|antifungal agents|mesh-ancestor
102476854|NCT00768599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102476855|NCT00768599|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102476856|NCT00768599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102476857|NCT00768599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102476858|NCT00768599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476859|NCT00768599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102476860|NCT00768599|Hormone Antagonists|hormone antagonists|mesh-ancestor
102476861|NCT00768599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102476862|NCT00768599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476863|NCT02370693|Mycophenolic Acid|mycophenolic acid|mesh-list
102476864|NCT02370693|Bortezomib|bortezomib|mesh-list
102476865|NCT02370693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102476866|NCT02370693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102476867|NCT02370693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102476868|NCT02370693|Antitubercular Agents|antitubercular agents|mesh-ancestor
102476869|NCT02370693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102476870|NCT02370693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102476871|NCT02370693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102476872|NCT02370693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476873|NCT02039115|Prednisone|prednisone|mesh-list
102288522|NCT03055663|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102476874|NCT02039115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102476875|NCT02039115|Glucocorticoids|glucocorticoids|mesh-ancestor
102476876|NCT02039115|Hormones|hormones|mesh-ancestor
102476877|NCT02039115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102476878|NCT02039115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476879|NCT02039115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102476880|NCT02039115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102476881|NCT00759473|Cycloserine|cycloserine|mesh-list
102476882|NCT00759473|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102476883|NCT00759473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101560452|NCT01143051|Epinephrine|epinephrine|mesh-list
102476884|NCT00759473|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102476885|NCT00759473|Antitubercular Agents|antitubercular agents|mesh-ancestor
102476886|NCT00759473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102476887|NCT00759473|Antimetabolites|antimetabolites|mesh-ancestor
102476888|NCT00759473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476889|NCT00759707|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
102476890|NCT00759707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102476891|NCT00759707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476892|NCT03809273|Trimetazidine|trimetazidine|mesh-list
102476893|NCT03809273|Vasodilator Agents|vasodilator agents|mesh-ancestor
102476894|NCT04384991|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102476895|NCT04384991|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102476896|NCT00354627|Etravirine|etravirine|mesh-list
102476897|NCT00354627|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102476898|NCT00354627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102476899|NCT00354627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102476900|NCT00354627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476901|NCT00354627|Antiviral Agents|antiviral agents|mesh-ancestor
102476902|NCT00354627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102476903|NCT00770861|Nebivolol|nebivolol|mesh-list
102476904|NCT00770861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101560470|NCT05199597|Atropine|atropine|mesh-list
102476905|NCT00770861|Vasodilator Agents|vasodilator agents|mesh-ancestor
102476906|NCT00770861|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102476907|NCT00770861|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102476908|NCT00770861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102476909|NCT00770861|Adrenergic Agents|adrenergic agents|mesh-ancestor
102476910|NCT00770861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102476911|NCT00770861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476912|NCT00770861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476913|NCT03808805|Aprepitant|aprepitant|mesh-list
102476914|NCT03808805|Fosaprepitant|fosaprepitant|mesh-list
101741527|NCT04620291|UB-421|ub-421|mesh-list
102476915|NCT03808805|Hydroxyzine|hydroxyzine|mesh-list
102476916|NCT03808805|Antiemetics|antiemetics|mesh-ancestor
102476917|NCT03808805|Autonomic Agents|autonomic agents|mesh-ancestor
102476918|NCT03808805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102476919|NCT03808805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560490|NCT01139775|Pemetrexed|pemetrexed|mesh-list
102476920|NCT03808805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102476921|NCT03808805|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102476922|NCT03808805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102476923|NCT03808805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476924|NCT03808805|Antipruritics|antipruritics|mesh-ancestor
102476925|NCT03808805|Dermatologic Agents|dermatologic agents|mesh-ancestor
102476926|NCT03808805|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102476927|NCT03808805|Histamine Antagonists|histamine antagonists|mesh-ancestor
102476928|NCT03808805|Histamine Agents|histamine agents|mesh-ancestor
102476929|NCT03803267|Fentanyl|fentanyl|mesh-list
102476930|NCT03803267|Propofol|propofol|mesh-list
102476931|NCT03803267|Atracurium|atracurium|mesh-list
102476932|NCT03803267|Anesthetics|anesthetics|mesh-ancestor
102476933|NCT03803267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102476934|NCT03803267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476935|NCT03803267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102476936|NCT03803267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102476937|NCT03803267|Anesthetics, General|anesthetics, general|mesh-ancestor
102476938|NCT03803267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102476939|NCT03803267|Narcotics|narcotics|mesh-ancestor
102476940|NCT03803267|Analgesics|analgesics|mesh-ancestor
102476941|NCT03803267|Sensory System Agents|sensory system agents|mesh-ancestor
102476942|NCT03803267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102476943|NCT03803267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102476944|NCT03803267|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102476945|NCT03803267|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102476946|NCT03803267|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102476947|NCT03803267|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102476948|NCT03803267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102288605|NCT03055741|Donepezil|donepezil|mesh-list
102476950|NCT03803267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102476951|NCT03803267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476952|NCT00787943|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102476953|NCT00787943|Dermatologic Agents|dermatologic agents|mesh-ancestor
102476954|NCT03808649|Mannitol|mannitol|mesh-list
102476955|NCT03808649|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102476956|NCT03808649|Diuretics|diuretics|mesh-ancestor
102476957|NCT03808649|Natriuretic Agents|natriuretic agents|mesh-ancestor
101560519|NCT01282814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102476958|NCT03808649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476959|NCT00788255|Oxytocin|oxytocin|mesh-list
102476960|NCT00788255|Oxytocics|oxytocics|mesh-ancestor
102476961|NCT00788255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102476962|NCT00788255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476963|NCT02379195|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102476964|NCT02379195|Cyclophosphamide|cyclophosphamide|mesh-list
102476965|NCT02379195|Fludarabine|fludarabine|mesh-list
102476966|NCT02379195|Interleukin-2|interleukin-2|mesh-list
102476967|NCT02379195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102476968|NCT02379195|Immunologic Factors|immunologic factors|mesh-ancestor
102476969|NCT02379195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476970|NCT02379195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102476971|NCT02379195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102476972|NCT02379195|Alkylating Agents|alkylating agents|mesh-ancestor
102476973|NCT02379195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102476974|NCT02379195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102476975|NCT02379195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102476976|NCT02379195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102476977|NCT02379195|Analgesics|analgesics|mesh-ancestor
102476978|NCT02379195|Sensory System Agents|sensory system agents|mesh-ancestor
102476979|NCT02379195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102476980|NCT02379195|Antiviral Agents|antiviral agents|mesh-ancestor
102476981|NCT02379195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102476982|NCT00771875|Acetaminophen|acetaminophen|mesh-list
102476983|NCT00771875|Diphenhydramine|diphenhydramine|mesh-list
102476984|NCT00771875|Methylprednisolone|methylprednisolone|mesh-list
102476985|NCT00771875|Rituximab|rituximab|mesh-list
102476986|NCT00771875|Bortezomib|bortezomib|mesh-list
102476987|NCT00771875|Thymoglobulin|thymoglobulin|mesh-list
102476988|NCT00771875|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102476989|NCT00771875|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
102476990|NCT00771875|Histamine Antagonists|histamine antagonists|mesh-list
102476991|NCT00771875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102476992|NCT00771875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102476993|NCT00771875|Immunologic Factors|immunologic factors|mesh-ancestor
102476994|NCT00771875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102476995|NCT00771875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102476996|NCT00771875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102476997|NCT00771875|Analgesics|analgesics|mesh-ancestor
102476998|NCT00771875|Sensory System Agents|sensory system agents|mesh-ancestor
102476999|NCT00771875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102477000|NCT00771875|Antipyretics|antipyretics|mesh-ancestor
102477001|NCT00771875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102477002|NCT00771875|Antiemetics|antiemetics|mesh-ancestor
102477003|NCT00771875|Autonomic Agents|autonomic agents|mesh-ancestor
102477004|NCT00771875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102477005|NCT00771875|Glucocorticoids|glucocorticoids|mesh-ancestor
102477006|NCT00771875|Hormones|hormones|mesh-ancestor
102477007|NCT00771875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102477008|NCT00771875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102477009|NCT00771875|Protective Agents|protective agents|mesh-ancestor
102477010|NCT00771875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102477011|NCT00771875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102477012|NCT00771875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102477013|NCT00771875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102477014|NCT00771875|Anesthetics, Local|anesthetics, local|mesh-ancestor
102477015|NCT00771875|Anesthetics|anesthetics|mesh-ancestor
102477016|NCT00771875|Histamine Agents|histamine agents|mesh-ancestor
102477017|NCT00771875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102477018|NCT00771875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477019|NCT00771875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102477020|NCT00760019|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
102477021|NCT00760019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102477022|NCT00760019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102477023|NCT00760019|Analgesics|analgesics|mesh-ancestor
102477024|NCT00760019|Sensory System Agents|sensory system agents|mesh-ancestor
102477025|NCT00760019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102477026|NCT00760019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477027|NCT00760019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102477028|NCT00760019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102477029|NCT00789113|Lamotrigine|lamotrigine|mesh-list
102477030|NCT00789113|Anticonvulsants|anticonvulsants|mesh-ancestor
102477031|NCT00789113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102477032|NCT00789113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102477033|NCT00789113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477034|NCT00789113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102477035|NCT00789113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477036|NCT00789113|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102477037|NCT00789113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102477038|NCT00789113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102477039|NCT00789113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102477040|NCT00789113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102477041|NCT03808259|Ketamine|ketamine|mesh-list
102477042|NCT03808259|Esketamine|esketamine|mesh-list
102477043|NCT03808259|Analgesics|analgesics|mesh-ancestor
102477044|NCT03808259|Sensory System Agents|sensory system agents|mesh-ancestor
102477045|NCT03808259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102477046|NCT03808259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477047|NCT03808259|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102477048|NCT03808259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102477049|NCT03808259|Anesthetics, General|anesthetics, general|mesh-ancestor
102477050|NCT03808259|Anesthetics|anesthetics|mesh-ancestor
102477051|NCT03808259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102477052|NCT03808259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102477053|NCT03808259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102477054|NCT03808259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102477055|NCT03808259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477056|NCT03808259|Antidepressive Agents|antidepressive agents|mesh-ancestor
102477057|NCT03808259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102477058|NCT02051595|Vancomycin|vancomycin|mesh-list
102477059|NCT02051595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102477060|NCT02051595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102477061|NCT05742503|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101560618|NCT01218516|Paclitaxel|paclitaxel|mesh-list
102477062|NCT05742503|Medroxyprogesterone|medroxyprogesterone|mesh-list
102477063|NCT05742503|Etonogestrel|etonogestrel|mesh-list
102477064|NCT05742503|Norgestrel|norgestrel|mesh-list
102477065|NCT05742503|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102477066|NCT05742503|Contraceptive Agents|contraceptive agents|mesh-ancestor
102477067|NCT05742503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102477068|NCT05742503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477069|NCT05742503|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102477070|NCT05742503|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102477071|NCT05742503|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102477072|NCT05742503|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102477073|NCT05742503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102477074|NCT05742503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102477075|NCT05742503|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102477076|NCT02388321|Fentanyl|fentanyl|mesh-list
102477077|NCT02388321|Ketamine|ketamine|mesh-list
102477078|NCT02388321|Analgesics|analgesics|mesh-ancestor
102477079|NCT02388321|Sensory System Agents|sensory system agents|mesh-ancestor
102477080|NCT02388321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102477081|NCT02388321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477082|NCT02388321|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102477083|NCT02388321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102477084|NCT02388321|Anesthetics, General|anesthetics, general|mesh-ancestor
102477085|NCT02388321|Anesthetics|anesthetics|mesh-ancestor
102477086|NCT02388321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102477087|NCT02388321|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102477088|NCT02388321|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102477089|NCT02388321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102477090|NCT02388321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477091|NCT02388321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102477092|NCT02388321|Narcotics|narcotics|mesh-ancestor
102477093|NCT02388321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102477094|NCT05742425|Bevacizumab|bevacizumab|mesh-list
101560648|NCT00949117|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101560649|NCT00949117|Histamine Antagonists|histamine antagonists|mesh-ancestor
101560650|NCT00949117|Histamine Agents|histamine agents|mesh-ancestor
101560651|NCT00949117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101560652|NCT00949117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560653|NCT00949117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560654|NCT00949117|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101560655|NCT00949117|Serotonin Agents|serotonin agents|mesh-ancestor
101560656|NCT00949117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101742515|NCT00740103|Sensory System Agents|sensory system agents|mesh-ancestor
101742516|NCT00740103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101742517|NCT00740103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742518|NCT00740103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101742519|NCT00740103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101742520|NCT00740103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101742521|NCT00740103|Immunologic Factors|immunologic factors|mesh-ancestor
101742522|NCT02583828|Cyclophosphamide|cyclophosphamide|mesh-list
101742523|NCT02583828|Letrozole|letrozole|mesh-list
101742524|NCT02583828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101742525|NCT02583828|Immunologic Factors|immunologic factors|mesh-ancestor
101742526|NCT02583828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742527|NCT02583828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101742528|NCT02583828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101493992|NCT02957474|Omeprazole|omeprazole|mesh-list
102477095|NCT05742425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102477096|NCT05742425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102477097|NCT05742425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102477098|NCT05742425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102477099|NCT05742425|Growth Substances|growth substances|mesh-ancestor
102288755|NCT04915807|Taxane|taxane|mesh-list
102477100|NCT05742425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477102|NCT02313675|Acetaminophen|acetaminophen|mesh-list
102477103|NCT02313675|Ketorolac|ketorolac|mesh-list
102477104|NCT02313675|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101560657|NCT04312347|Tamoxifen|tamoxifen|mesh-list
101560658|NCT04312347|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101560659|NCT04312347|Hormone Antagonists|hormone antagonists|mesh-ancestor
101560660|NCT04312347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101560661|NCT04312347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742602|NCT00785291|Bevacizumab|bevacizumab|mesh-list
102477105|NCT02313675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102477106|NCT02313675|Analgesics|analgesics|mesh-ancestor
102477107|NCT02313675|Sensory System Agents|sensory system agents|mesh-ancestor
102477108|NCT02313675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102477109|NCT02313675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477110|NCT02313675|Antipyretics|antipyretics|mesh-ancestor
102477111|NCT02313675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102477112|NCT02313675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102477113|NCT02313675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102477114|NCT02313675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102477115|NCT02313675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102477116|NCT02313675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477117|NCT05568797|Vaccines|vaccines|mesh-list
102477118|NCT05568797|Immunologic Factors|immunologic factors|mesh-ancestor
102477119|NCT05568797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477120|NCT03801629|Morphine|morphine|mesh-list
102477121|NCT03801629|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102477122|NCT03801629|Narcotics|narcotics|mesh-ancestor
102477123|NCT03801629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102477124|NCT03801629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477125|NCT03801629|Analgesics|analgesics|mesh-ancestor
102477126|NCT03801629|Sensory System Agents|sensory system agents|mesh-ancestor
102477127|NCT03801629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102477128|NCT05741021|Paclitaxel|paclitaxel|mesh-list
102477129|NCT05741021|Carboplatin|carboplatin|mesh-list
102477130|NCT05741021|Pemetrexed|pemetrexed|mesh-list
102477131|NCT05741021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102477132|NCT05741021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102477133|NCT05741021|Tubulin Modulators|tubulin modulators|mesh-ancestor
102477134|NCT05741021|Antimitotic Agents|antimitotic agents|mesh-ancestor
102477135|NCT05741021|Mitosis Modulators|mitosis modulators|mesh-ancestor
102477136|NCT05741021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477137|NCT05741021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102477138|NCT05741021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102477139|NCT05741021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102477140|NCT04383977|Etoposide|etoposide|mesh-list
102477141|NCT04383977|Apatinib|apatinib|mesh-list
102477142|NCT04383977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102477143|NCT04383977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102477144|NCT04383977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102477145|NCT04383977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102477146|NCT04383977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101560696|NCT02691156|Carbon Monoxide|carbon monoxide|mesh-list
102477147|NCT04383977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477148|NCT04383977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102477149|NCT02389959|Bevacizumab|bevacizumab|mesh-list
102477150|NCT02389959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102477151|NCT02389959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102477152|NCT02389959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102477153|NCT02389959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102477154|NCT02389959|Growth Substances|growth substances|mesh-ancestor
102477155|NCT02389959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477156|NCT02389959|Growth Inhibitors|growth inhibitors|mesh-ancestor
102477157|NCT00775931|Cyclophosphamide|cyclophosphamide|mesh-list
102477158|NCT00775931|Busulfan|busulfan|mesh-list
102477159|NCT00775931|Fludarabine|fludarabine|mesh-list
102477160|NCT00775931|Fludarabine phosphate|fludarabine phosphate|mesh-list
102477161|NCT00775931|Alemtuzumab|alemtuzumab|mesh-list
102477162|NCT00775931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102477163|NCT00775931|Immunologic Factors|immunologic factors|mesh-ancestor
102477164|NCT00775931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477165|NCT00775931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102477166|NCT00775931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102477167|NCT00775931|Alkylating Agents|alkylating agents|mesh-ancestor
102477168|NCT00775931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477169|NCT00775931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102477170|NCT00775931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102477171|NCT00775931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102477172|NCT00775931|Antimetabolites|antimetabolites|mesh-ancestor
102477173|NCT00775931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102477174|NCT02052141|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
102477175|NCT02052141|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102477176|NCT02052141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102477177|NCT02052141|Immunologic Factors|immunologic factors|mesh-ancestor
102477178|NCT02052141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477179|NCT05734235|Vitamins|vitamins|mesh-list
102477180|NCT05734235|Vitamin E|vitamin e|mesh-list
102477181|NCT05734235|Micronutrients|micronutrients|mesh-ancestor
102477182|NCT05734235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477183|NCT05734235|Antioxidants|antioxidants|mesh-ancestor
102477184|NCT05734235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477185|NCT05734235|Protective Agents|protective agents|mesh-ancestor
102477186|NCT05732129|Irinotecan|irinotecan|mesh-list
102477187|NCT05732129|Fluzoparib|fluzoparib|mesh-list
102477188|NCT05732129|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102477189|NCT05732129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102477190|NCT05732129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102477191|NCT05732129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477192|NCT05732129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102477193|NCT05732129|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102477194|NCT02394951|Pregabalin|pregabalin|mesh-list
102477195|NCT02394951|Analgesics|analgesics|mesh-ancestor
102477196|NCT02394951|Sensory System Agents|sensory system agents|mesh-ancestor
102477197|NCT02394951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102477198|NCT02394951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477199|NCT02394951|Anticonvulsants|anticonvulsants|mesh-ancestor
102477200|NCT02394951|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102477201|NCT02394951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102477202|NCT02394951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477203|NCT02394951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102477204|NCT02394951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102477205|NCT02394951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102477206|NCT02394951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102477207|NCT02394951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102477208|NCT03838367|Leronlimab|leronlimab|mesh-list
102477209|NCT03838367|Carboplatin|carboplatin|mesh-list
102477210|NCT03838367|HIV Antibodies|hiv antibodies|mesh-list
102477211|NCT03838367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102477212|NCT03838367|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102477213|NCT03838367|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102477214|NCT03838367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477215|NCT03838367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102477216|NCT03838367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102477217|NCT03838367|Antiviral Agents|antiviral agents|mesh-ancestor
102477218|NCT03838367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102477219|NCT03838367|Immunologic Factors|immunologic factors|mesh-ancestor
101560748|NCT00937495|Bortezomib|bortezomib|mesh-list
102477220|NCT03838367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477221|NCT00354861|Aluminum sulfate|aluminum sulfate|mesh-list
102477222|NCT00354861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102477223|NCT00354861|Immunologic Factors|immunologic factors|mesh-ancestor
102477224|NCT00354861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477225|NCT04345445|Methylprednisolone|methylprednisolone|mesh-list
102477226|NCT04345445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102477227|NCT04345445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102477228|NCT04345445|Prednisolone|prednisolone|mesh-list
102477229|NCT04345445|Prednisolone acetate|prednisolone acetate|mesh-list
102477230|NCT04345445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102477231|NCT04345445|Prednisolone phosphate|prednisolone phosphate|mesh-list
102477232|NCT04345445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102477233|NCT04345445|Antiemetics|antiemetics|mesh-ancestor
102477234|NCT04345445|Autonomic Agents|autonomic agents|mesh-ancestor
102477235|NCT04345445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102477236|NCT04345445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477237|NCT04345445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102477238|NCT04345445|Glucocorticoids|glucocorticoids|mesh-ancestor
102477239|NCT04345445|Hormones|hormones|mesh-ancestor
102477240|NCT04345445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102477241|NCT04345445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102477242|NCT04345445|Protective Agents|protective agents|mesh-ancestor
102477243|NCT04345445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102477244|NCT04345445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102477245|NCT00354939|Insulin Glargine|insulin glargine|mesh-list
102477246|NCT00354939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102477247|NCT00354939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477248|NCT05713877|Melatonin|melatonin|mesh-list
102477249|NCT05713877|Antioxidants|antioxidants|mesh-ancestor
102477250|NCT05713877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477251|NCT05713877|Protective Agents|protective agents|mesh-ancestor
102477252|NCT05713877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477253|NCT05713877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102477254|NCT00795275|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102477255|NCT00795275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102477256|NCT00795275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477257|NCT00795275|Incretins|incretins|mesh-ancestor
102477258|NCT00795275|Hormones|hormones|mesh-ancestor
102477259|NCT00795275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102477260|NCT00795275|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102477261|NCT00795275|Protease Inhibitors|protease inhibitors|mesh-ancestor
102477262|NCT00795275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102477263|NCT00795275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477264|NCT00777335|Panobinostat|panobinostat|mesh-list
102477265|NCT00777335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102477266|NCT00777335|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102477267|NCT00777335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102477268|NCT00777335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477269|NCT04896645|Albuterol|albuterol|mesh-list
102477270|NCT04896645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102477271|NCT04896645|Autonomic Agents|autonomic agents|mesh-ancestor
102477272|NCT04896645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101560776|NCT05378503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102477273|NCT04896645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477274|NCT04896645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102477275|NCT04896645|Respiratory System Agents|respiratory system agents|mesh-ancestor
102477276|NCT04896645|Tocolytic Agents|tocolytic agents|mesh-ancestor
102477277|NCT04896645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102477278|NCT04896645|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102477279|NCT04896645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102477280|NCT04896645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102477281|NCT04896645|Adrenergic Agents|adrenergic agents|mesh-ancestor
102477282|NCT04896645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102477283|NCT04896645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477284|NCT05644587|Buprenorphine|buprenorphine|mesh-list
102477285|NCT05644587|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102477286|NCT05644587|Naloxone|naloxone|mesh-list
102477287|NCT05644587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102477288|NCT05644587|Narcotics|narcotics|mesh-ancestor
102477289|NCT05644587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102477290|NCT05644587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477291|NCT05644587|Analgesics|analgesics|mesh-ancestor
102477292|NCT05644587|Sensory System Agents|sensory system agents|mesh-ancestor
102477293|NCT05644587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102477294|NCT05644587|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102477295|NCT00355407|Darbepoetin alfa|darbepoetin alfa|mesh-list
102477296|NCT00355407|Hematinics|hematinics|mesh-ancestor
102477297|NCT00355251|Atorvastatin|atorvastatin|mesh-list
101560848|NCT00934843|Hormones|hormones|mesh-ancestor
102477298|NCT00355251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102477299|NCT00355251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102477300|NCT00355251|Antimetabolites|antimetabolites|mesh-ancestor
102477301|NCT00355251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477302|NCT00355251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102477303|NCT00355251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102477304|NCT00355251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102477305|NCT03832127|Fludarabine|fludarabine|mesh-list
102477306|NCT03832127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102477307|NCT04876131|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102477308|NCT04876131|Gentamicins|gentamicins|mesh-list
102477309|NCT04876131|Cephalexin|cephalexin|mesh-list
102477310|NCT04876131|Penicillin G|penicillin g|mesh-list
102477311|NCT04876131|Penicillin G Benzathine|penicillin g benzathine|mesh-list
102477312|NCT04876131|Penicillin G Procaine|penicillin g procaine|mesh-list
102477313|NCT04876131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102477314|NCT04876131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102477315|NCT04876131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102477316|NCT04876131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477317|NCT04825275|Posaconazole|posaconazole|mesh-list
102477318|NCT04825275|Antifungal Agents|antifungal agents|mesh-ancestor
102477319|NCT04825275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102477320|NCT04825275|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102477321|NCT04825275|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102477322|NCT04825275|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101560862|NCT04267237|Atezolizumab|atezolizumab|mesh-list
102477323|NCT04825275|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102477324|NCT04825275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102288972|NCT04893733|Folic Acid|folic acid|mesh-list
102477325|NCT04825275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102477326|NCT04825275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477327|NCT04825275|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101560880|NCT00605683|Apomorphine|apomorphine|mesh-list
102477328|NCT04825275|Hormone Antagonists|hormone antagonists|mesh-ancestor
102477329|NCT04825275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102477330|NCT04825275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477331|NCT00791219|Itraconazole|itraconazole|mesh-list
102477332|NCT00791219|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
102477333|NCT00791219|Antifungal Agents|antifungal agents|mesh-ancestor
102477334|NCT00791219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101560889|NCT00605683|Antioxidants|antioxidants|mesh-ancestor
102477335|NCT00791219|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102477336|NCT00791219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102477337|NCT00791219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102477338|NCT00791219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477339|NCT00791219|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102477340|NCT00791219|Hormone Antagonists|hormone antagonists|mesh-ancestor
101560894|NCT00605683|Autonomic Agents|autonomic agents|mesh-ancestor
102477341|NCT00791219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102477342|NCT00791219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477343|NCT00791219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102477344|NCT04818489|Colchicine|colchicine|mesh-list
102477345|NCT04818489|Gout Suppressants|gout suppressants|mesh-ancestor
102477346|NCT04818489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102477347|NCT04818489|Tubulin Modulators|tubulin modulators|mesh-ancestor
102477348|NCT04818489|Antimitotic Agents|antimitotic agents|mesh-ancestor
102477349|NCT04818489|Mitosis Modulators|mitosis modulators|mesh-ancestor
102477350|NCT04818489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477351|NCT04818489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102477352|NCT00797459|Hyaluronic Acid|hyaluronic acid|mesh-list
102477353|NCT00797459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102477354|NCT00797459|Immunologic Factors|immunologic factors|mesh-ancestor
102477355|NCT00797459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477356|NCT00797459|Viscosupplements|viscosupplements|mesh-ancestor
102477357|NCT00797459|Protective Agents|protective agents|mesh-ancestor
102477358|NCT04807101|Midazolam|midazolam|mesh-list
102477359|NCT04807101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102477360|NCT04807101|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102477361|NCT04807101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102477362|NCT04807101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477363|NCT04807101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102477364|NCT04807101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102477365|NCT04807101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102477366|NCT04807101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102477367|NCT04807101|Anesthetics, General|anesthetics, general|mesh-ancestor
102477368|NCT04807101|Anesthetics|anesthetics|mesh-ancestor
102477369|NCT04807101|GABA Modulators|gaba modulators|mesh-ancestor
102477370|NCT04807101|GABA Agents|gaba agents|mesh-ancestor
102477371|NCT04807101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102477372|NCT04807101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477373|NCT00355953|Genistein|genistein|mesh-list
102477374|NCT00355953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102477375|NCT00355953|Protective Agents|protective agents|mesh-ancestor
102477376|NCT00355953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477377|NCT00355953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102477378|NCT00355953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102477379|NCT00355953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102477380|NCT00355953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477381|NCT00355953|Phytoestrogens|phytoestrogens|mesh-ancestor
102477382|NCT00355953|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102477383|NCT00355953|Estrogens|estrogens|mesh-ancestor
102477384|NCT00355953|Hormones|hormones|mesh-ancestor
102477385|NCT00355953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102477386|NCT05419193|Propranolol|propranolol|mesh-list
102477387|NCT05419193|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102477388|NCT05419193|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102477389|NCT05419193|Adrenergic Agents|adrenergic agents|mesh-ancestor
102477390|NCT05419193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102477391|NCT05419193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477392|NCT05419193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477393|NCT05419193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102477394|NCT05419193|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102477395|NCT05419193|Vasodilator Agents|vasodilator agents|mesh-ancestor
102477396|NCT05416073|Sufentanil|sufentanil|mesh-list
102477397|NCT05416073|Esketamine|esketamine|mesh-list
102477398|NCT05416073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102477399|NCT05416073|Narcotics|narcotics|mesh-ancestor
102477400|NCT05416073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102477401|NCT05416073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477402|NCT05416073|Analgesics|analgesics|mesh-ancestor
102477403|NCT05416073|Sensory System Agents|sensory system agents|mesh-ancestor
102477404|NCT05416073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102477405|NCT05416073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102477406|NCT05416073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102477407|NCT05416073|Anesthetics, General|anesthetics, general|mesh-ancestor
102477408|NCT05416073|Anesthetics|anesthetics|mesh-ancestor
102477409|NCT05416073|Antidepressive Agents|antidepressive agents|mesh-ancestor
102477410|NCT05416073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102477411|NCT05664971|Paclitaxel|paclitaxel|mesh-list
102477412|NCT05664971|Etoposide|etoposide|mesh-list
102477413|NCT05664971|Docetaxel|docetaxel|mesh-list
102477414|NCT05664971|Carboplatin|carboplatin|mesh-list
102477415|NCT05664971|Pemetrexed|pemetrexed|mesh-list
102477416|NCT05664971|Antibodies|antibodies|mesh-list
102477417|NCT05664971|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102477418|NCT05664971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102477419|NCT05664971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102477420|NCT05664971|Tubulin Modulators|tubulin modulators|mesh-ancestor
102477421|NCT05664971|Antimitotic Agents|antimitotic agents|mesh-ancestor
102477422|NCT05664971|Mitosis Modulators|mitosis modulators|mesh-ancestor
102477423|NCT05664971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477424|NCT05664971|Immunologic Factors|immunologic factors|mesh-ancestor
102477425|NCT05664971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477426|NCT05664971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102477427|NCT05664971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102477428|NCT05664971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102477429|NCT05664971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102477430|NCT05664971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102477431|NCT05590299|Immunomodulating Agents|immunomodulating agents|mesh-list
102477432|NCT05590299|Immunologic Factors|immunologic factors|mesh-list
102477433|NCT05590299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477434|NCT04812509|Denosumab|denosumab|mesh-list
102477435|NCT04812509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102477436|NCT04812509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477437|NCT05446623|Sufentanil|sufentanil|mesh-list
102477438|NCT05446623|Dexmedetomidine|dexmedetomidine|mesh-list
102477439|NCT05446623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102477440|NCT05446623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101560986|NCT04322240|Micronutrients|micronutrients|mesh-ancestor
102477441|NCT05446623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477442|NCT05446623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102477443|NCT05446623|Analgesics|analgesics|mesh-ancestor
102477444|NCT05446623|Sensory System Agents|sensory system agents|mesh-ancestor
102477445|NCT05446623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102477446|NCT05446623|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102477447|NCT05446623|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102477448|NCT05446623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102477449|NCT05446623|Adrenergic Agents|adrenergic agents|mesh-ancestor
102477450|NCT05446623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101560996|NCT04321850|Zinc Sulfate|zinc sulfate|mesh-list
102477451|NCT05446623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477452|NCT05446623|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102477453|NCT05446623|Narcotics|narcotics|mesh-ancestor
102477454|NCT05446623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102477455|NCT05446623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102477456|NCT05446623|Anesthetics, General|anesthetics, general|mesh-ancestor
102477457|NCT05446623|Anesthetics|anesthetics|mesh-ancestor
102477458|NCT00792077|Lenalidomide|lenalidomide|mesh-list
102477459|NCT00792077|Immunologic Factors|immunologic factors|mesh-ancestor
102477460|NCT00792077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477461|NCT00792077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102477462|NCT00792077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102477463|NCT00792077|Growth Substances|growth substances|mesh-ancestor
102477464|NCT00792077|Growth Inhibitors|growth inhibitors|mesh-ancestor
102477465|NCT00792077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102477466|NCT02979015|Alirocumab|alirocumab|mesh-list
102477467|NCT02979015|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102477468|NCT02979015|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102477469|NCT02979015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102477470|NCT02979015|Antimetabolites|antimetabolites|mesh-ancestor
102477471|NCT02979015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477472|NCT02979015|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102477473|NCT02979015|Protease Inhibitors|protease inhibitors|mesh-ancestor
102477474|NCT02979015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102477475|NCT02979015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102477476|NCT00799643|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
102477477|NCT00799643|Sodium Salicylate|sodium salicylate|mesh-list
102477478|NCT00799643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102477479|NCT00799643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102477480|NCT00799643|Analgesics|analgesics|mesh-ancestor
102477481|NCT00799643|Sensory System Agents|sensory system agents|mesh-ancestor
102477482|NCT00799643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102477483|NCT00799643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477484|NCT00799643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102477485|NCT00799643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102477486|NCT00799643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102477487|NCT00799643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102477488|NCT00799643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477489|NCT03835013|Exenatide|exenatide|mesh-list
102477490|NCT03835013|Glucagon|glucagon|mesh-list
102477491|NCT03835013|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102477492|NCT03835013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102477493|NCT03835013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477494|NCT03835013|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102477495|NCT03835013|Incretins|incretins|mesh-ancestor
102477496|NCT03835013|Hormones|hormones|mesh-ancestor
102477497|NCT03835013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102477498|NCT03835013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102477499|NCT00800345|Topotecan|topotecan|mesh-list
102477500|NCT00800345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102477501|NCT00800345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102477502|NCT00800345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102477503|NCT00800345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477504|NCT00800345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102477505|NCT03806751|Acetazolamide|acetazolamide|mesh-list
102477506|NCT03806751|Anticonvulsants|anticonvulsants|mesh-ancestor
102477507|NCT03806751|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102477508|NCT03806751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102477509|NCT03806751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477510|NCT03806751|Diuretics|diuretics|mesh-ancestor
102477511|NCT03806751|Natriuretic Agents|natriuretic agents|mesh-ancestor
102477512|NCT03806751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477513|NCT04383275|Capecitabine|capecitabine|mesh-list
102477514|NCT04383275|Trastuzumab|trastuzumab|mesh-list
102477515|NCT04383275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102477516|NCT04383275|Antimetabolites|antimetabolites|mesh-ancestor
102477517|NCT04383275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477518|NCT04383275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102477519|NCT04383275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102477520|NCT03973229|Estradiol|estradiol|mesh-list
102477521|NCT03973229|Estrogens|estrogens|mesh-ancestor
102477522|NCT03973229|Hormones|hormones|mesh-ancestor
102477523|NCT03973229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102477524|NCT03973229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477525|NCT03782103|Ethanol|ethanol|mesh-list
102477526|NCT03782103|Chlorhexidine|chlorhexidine|mesh-list
102477527|NCT03782103|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102477528|NCT03782103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102477529|NCT03782103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102477530|NCT03782103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102477531|NCT03782103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477532|NCT03782103|Disinfectants|disinfectants|mesh-ancestor
102477533|NCT03782103|Dermatologic Agents|dermatologic agents|mesh-ancestor
102477534|NCT05319015|Pembrolizumab|pembrolizumab|mesh-list
102477535|NCT05319015|Lenvatinib|lenvatinib|mesh-list
102477536|NCT05319015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102477537|NCT05319015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102477538|NCT05319015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102477539|NCT05319015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477540|NCT05319015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102477541|NCT05319015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102477542|NCT00810719|Gemcitabine|gemcitabine|mesh-list
102477543|NCT00810719|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102477544|NCT00810719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102477545|NCT00810719|Antimetabolites|antimetabolites|mesh-ancestor
102477546|NCT00810719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477547|NCT00810719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102477548|NCT00810719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102477549|NCT00810719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102477550|NCT03761277|Morphine|morphine|mesh-list
102477551|NCT03761277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102477552|NCT03761277|Narcotics|narcotics|mesh-ancestor
102477553|NCT03761277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102477554|NCT03761277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477555|NCT03761277|Analgesics|analgesics|mesh-ancestor
102477556|NCT03761277|Sensory System Agents|sensory system agents|mesh-ancestor
102477557|NCT03761277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102477558|NCT00810797|Exemestane|exemestane|mesh-list
102477559|NCT00810797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102477560|NCT00810797|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101561105|NCT00927589|Carboplatin|carboplatin|mesh-list
102477561|NCT00810797|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102477562|NCT00810797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102477563|NCT00810797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477564|NCT00810797|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102477565|NCT00810797|Hormone Antagonists|hormone antagonists|mesh-ancestor
102477566|NCT00810797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102477567|NCT00810797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477568|NCT04340505|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
102477569|NCT04340505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102477570|NCT04340505|Glucocorticoids|glucocorticoids|mesh-ancestor
102477571|NCT04340505|Hormones|hormones|mesh-ancestor
102477572|NCT04340505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102477573|NCT04340505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477574|NCT04724447|Valganciclovir|valganciclovir|mesh-list
102477575|NCT04724447|Antiviral Agents|antiviral agents|mesh-ancestor
102477576|NCT04724447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102477577|NCT00355641|Ropinirole|ropinirole|mesh-list
102477578|NCT00355641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102477579|NCT00355641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102477580|NCT00355641|Dopamine Agonists|dopamine agonists|mesh-ancestor
102477581|NCT00355641|Dopamine Agents|dopamine agents|mesh-ancestor
102477582|NCT00355641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102477583|NCT00355641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477584|NCT00355641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477585|NCT00356733|Epoetin Alfa|epoetin alfa|mesh-list
102477586|NCT00356733|Hematinics|hematinics|mesh-ancestor
102477587|NCT04591925|Insulin|insulin|mesh-list
102477588|NCT04591925|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102477589|NCT04591925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102477590|NCT04591925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477591|NCT04542473|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102477592|NCT04542473|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102477593|NCT04542473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102477594|NCT04290689|Botulinum Toxins|botulinum toxins|mesh-list
102477595|NCT04290689|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102477596|NCT04290689|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102477597|NCT04290689|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102477598|NCT04290689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102477599|NCT04290689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477600|NCT04290689|Cholinergic Agents|cholinergic agents|mesh-ancestor
102477601|NCT04290689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102477602|NCT04290689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477603|NCT04290689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102477604|NCT04290689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102477605|NCT00801827|Fallypride|fallypride|mesh-list
102477606|NCT00801827|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102477607|NCT00801827|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102477608|NCT00801827|Dopamine Agents|dopamine agents|mesh-ancestor
102477609|NCT00801827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102477610|NCT00801827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477611|NCT00801827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477612|NCT04112823|Dexamethasone|dexamethasone|mesh-list
102477613|NCT04112823|Dexamethasone acetate|dexamethasone acetate|mesh-list
102477614|NCT04112823|BB 1101|bb 1101|mesh-list
102477615|NCT04112823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102477616|NCT04112823|Antiemetics|antiemetics|mesh-ancestor
102477617|NCT04112823|Autonomic Agents|autonomic agents|mesh-ancestor
102477618|NCT04112823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102477619|NCT04112823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477620|NCT04112823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102477621|NCT04112823|Glucocorticoids|glucocorticoids|mesh-ancestor
102477622|NCT04112823|Hormones|hormones|mesh-ancestor
102477623|NCT04112823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101561167|NCT05937711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102477624|NCT04112823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102477625|NCT04112823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102477627|NCT04112823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101561174|NCT05937711|Dopamine Agents|dopamine agents|mesh-ancestor
102477628|NCT04112823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477629|NCT00802685|Ibuprofen|ibuprofen|mesh-list
102477630|NCT00802685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102477631|NCT00802685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102477632|NCT00802685|Analgesics|analgesics|mesh-ancestor
102477633|NCT00802685|Sensory System Agents|sensory system agents|mesh-ancestor
102477634|NCT00802685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102477635|NCT00802685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477636|NCT00802685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102477637|NCT00802685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102477638|NCT00802685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102477639|NCT00802685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102477640|NCT00802685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477641|NCT03496623|Treprostinil|treprostinil|mesh-list
102477642|NCT03496623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102477643|NCT03496623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102477644|NCT00802919|Varenicline|varenicline|mesh-list
102477645|NCT00802919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102477646|NCT00802919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102477647|NCT00802919|Cholinergic Agents|cholinergic agents|mesh-ancestor
102477648|NCT00802919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102477649|NCT00802919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477650|NCT00802919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477651|NCT04467905|Etripamil|etripamil|mesh-list
102477652|NCT04467905|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102477653|NCT04467905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102477654|NCT04467905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477655|NCT04467905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102477656|NCT04467905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477657|NCT00803543|Valacyclovir|valacyclovir|mesh-list
102477658|NCT00803543|Antiviral Agents|antiviral agents|mesh-ancestor
102477659|NCT00803543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102477660|NCT04099641|Pembrolizumab|pembrolizumab|mesh-list
102477661|NCT04099641|Bavituximab|bavituximab|mesh-list
102477662|NCT04099641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102477663|NCT04099641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102477664|NCT04099641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101561204|NCT05937191|Immunologic Factors|immunologic factors|mesh-ancestor
102477665|NCT04099641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477666|NCT05051735|Acetaminophen|acetaminophen|mesh-list
102477667|NCT05051735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102477668|NCT05051735|Analgesics|analgesics|mesh-ancestor
102477669|NCT05051735|Sensory System Agents|sensory system agents|mesh-ancestor
102477670|NCT05051735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102477671|NCT05051735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477672|NCT05051735|Antipyretics|antipyretics|mesh-ancestor
102477673|NCT04098237|Pancrelipase|pancrelipase|mesh-list
102477674|NCT04098237|Pancreatin|pancreatin|mesh-list
101745268|NCT05434377|Vitamin D|vitamin d|mesh-list
102477675|NCT04098237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102477676|NCT04095221|Irinotecan|irinotecan|mesh-list
102477677|NCT04095221|Prexasertib|prexasertib|mesh-list
102477678|NCT04095221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102477679|NCT04095221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102477680|NCT04095221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102477681|NCT04095221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477682|NCT04095221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102477683|NCT04095221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102477684|NCT03357627|Venetoclax|venetoclax|mesh-list
101745336|NCT00679341|Docetaxel|docetaxel|mesh-list
102477685|NCT03357627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102477686|NCT04923113|Amoxicillin|amoxicillin|mesh-list
102477687|NCT04923113|Minocycline|minocycline|mesh-list
102477688|NCT04923113|Rabeprazole|rabeprazole|mesh-list
102477689|NCT04923113|Bismuth|bismuth|mesh-list
102477690|NCT04923113|Antibodies|antibodies|mesh-list
102477691|NCT04923113|Immunologic Factors|immunologic factors|mesh-ancestor
102477692|NCT04923113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477693|NCT04923113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102477694|NCT04923113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102477695|NCT04923113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102477696|NCT04923113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102477697|NCT04923113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102477698|NCT04923113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102477699|NCT04923113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477700|NCT04923113|Antacids|antacids|mesh-ancestor
102477701|NCT03250923|Acemannan|acemannan|mesh-list
102477702|NCT03250923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102477703|NCT03250923|Immunologic Factors|immunologic factors|mesh-ancestor
102477704|NCT03250923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477705|NCT03250923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102477706|NCT03250923|Antiviral Agents|antiviral agents|mesh-ancestor
102477707|NCT03250923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102477708|NCT03250923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102477709|NCT00805493|Riluzole|riluzole|mesh-list
102477710|NCT00805493|Anticonvulsants|anticonvulsants|mesh-ancestor
101561229|NCT05936489|Aceclidine|aceclidine|mesh-list
102477711|NCT00805493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102477712|NCT00805493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102477713|NCT00805493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102477714|NCT00805493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477715|NCT00805493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477716|NCT00805493|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102477717|NCT00805493|Protective Agents|protective agents|mesh-ancestor
102477718|NCT03236649|Sorafenib|sorafenib|mesh-list
102477719|NCT03236649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102477720|NCT03236649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102477721|NCT03236649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102477722|NCT03236649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477723|NCT00807209|Fentanyl|fentanyl|mesh-list
102477724|NCT00807209|Bupivacaine|bupivacaine|mesh-list
102477725|NCT00807209|Anesthetics, Local|anesthetics, local|mesh-ancestor
102477726|NCT00807209|Anesthetics|anesthetics|mesh-ancestor
101745514|NCT05004350|Fluorouracil|fluorouracil|mesh-list
102477727|NCT00807209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102477728|NCT00807209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477729|NCT00807209|Sensory System Agents|sensory system agents|mesh-ancestor
102477730|NCT00807209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102477731|NCT00807209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102477732|NCT00807209|Narcotics|narcotics|mesh-ancestor
102477733|NCT00807209|Analgesics|analgesics|mesh-ancestor
102477734|NCT00807209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102477735|NCT00807209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102477736|NCT00807209|Anesthetics, General|anesthetics, general|mesh-ancestor
102477737|NCT03220035|Vemurafenib|vemurafenib|mesh-list
102477738|NCT03220035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102477739|NCT03220035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102477740|NCT03220035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102477741|NCT03220035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477742|NCT00807989|Lamotrigine|lamotrigine|mesh-list
102477743|NCT00807989|Carbamazepine|carbamazepine|mesh-list
102477744|NCT00807989|Valproic Acid|valproic acid|mesh-list
102477745|NCT00807989|Anticonvulsants|anticonvulsants|mesh-ancestor
102477746|NCT00807989|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102477747|NCT00807989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102477748|NCT00807989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477749|NCT00807989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102477750|NCT00807989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477751|NCT00807989|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102477752|NCT00807989|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102477753|NCT00807989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102477754|NCT00807989|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102477755|NCT00807989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102477756|NCT00807989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102477757|NCT00807989|GABA Agents|gaba agents|mesh-ancestor
102477758|NCT00807989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102477759|NCT00807989|Antimanic Agents|antimanic agents|mesh-ancestor
102477760|NCT00807989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102477761|NCT00807989|Analgesics|analgesics|mesh-ancestor
102477762|NCT00807989|Sensory System Agents|sensory system agents|mesh-ancestor
102477763|NCT00807989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102477764|NCT00807989|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102477765|NCT00807989|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102477766|NCT05111392|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102477767|NCT00843713|Raltegravir Potassium|raltegravir potassium|mesh-list
102477768|NCT00843713|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102477769|NCT00843713|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102477770|NCT00843713|Antiviral Agents|antiviral agents|mesh-ancestor
102477771|NCT00843713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102477772|NCT00843713|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102477773|NCT00843713|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102477774|NCT00843713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102477775|NCT00843713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477776|NCT04845490|Mitomycins|mitomycins|mesh-list
102289424|NCT02420223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102477777|NCT04845490|Mitomycin|mitomycin|mesh-list
102477778|NCT04845490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102477779|NCT04845490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102477780|NCT04845490|Alkylating Agents|alkylating agents|mesh-ancestor
102477781|NCT04845490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477782|NCT04845490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102477783|NCT04845490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102477784|NCT00357045|Paroxetine|paroxetine|mesh-list
102477785|NCT00357045|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102477786|NCT00357045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102477787|NCT00357045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102477788|NCT00357045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477789|NCT00357045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102477790|NCT00357045|Serotonin Agents|serotonin agents|mesh-ancestor
102477791|NCT00357045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477792|NCT00357045|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102477793|NCT00357045|Antidepressive Agents|antidepressive agents|mesh-ancestor
102477794|NCT00357045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102477795|NCT00357045|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102477796|NCT00357045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102477797|NCT00357045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102477798|NCT04819360|Solifenacin Succinate|solifenacin succinate|mesh-list
102477799|NCT04819360|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102477800|NCT04819360|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102477801|NCT04819360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102477802|NCT04819360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477803|NCT04819360|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102477804|NCT04819360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102477805|NCT04819360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477806|NCT04819360|Cholinergic Agents|cholinergic agents|mesh-ancestor
102477807|NCT04819360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102477808|NCT04819360|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102477809|NCT04819360|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102477810|NCT04819360|Urological Agents|urological agents|mesh-ancestor
102477811|NCT00357123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102477812|NCT00357123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102477813|NCT00357123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102477814|NCT00357123|Antimetabolites|antimetabolites|mesh-ancestor
102477815|NCT00357123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477816|NCT00357123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102477817|NCT00357123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102477818|NCT00357123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102477819|NCT04436458|Niclosamide|niclosamide|mesh-list
102477820|NCT04436458|Anticestodal Agents|anticestodal agents|mesh-ancestor
102477821|NCT04436458|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102477822|NCT04436458|Anthelmintics|anthelmintics|mesh-ancestor
102477823|NCT04436458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102477824|NCT04436458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102477825|NCT04436458|Antinematodal Agents|antinematodal agents|mesh-ancestor
102477826|NCT03834753|Bevacizumab|bevacizumab|mesh-list
102477827|NCT03834753|Ranibizumab|ranibizumab|mesh-list
102477828|NCT03834753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102477829|NCT03834753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102477830|NCT03834753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102477831|NCT03834753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102477832|NCT03834753|Growth Substances|growth substances|mesh-ancestor
102477833|NCT03834753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477834|NCT03834753|Growth Inhibitors|growth inhibitors|mesh-ancestor
102477835|NCT00845039|Irinotecan|irinotecan|mesh-list
102477836|NCT00845039|Cetuximab|cetuximab|mesh-list
102477837|NCT00845039|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102477838|NCT00845039|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102477839|NCT00845039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102477840|NCT00845039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102477841|NCT00845039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477842|NCT00845039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102477843|NCT00845039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102477844|NCT00845039|Immunologic Factors|immunologic factors|mesh-ancestor
102477845|NCT00845039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477846|NCT00845195|Azelastine|azelastine|mesh-list
102477847|NCT00845195|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
102477848|NCT00845195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102477849|NCT00845195|Autonomic Agents|autonomic agents|mesh-ancestor
102477850|NCT00845195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102477851|NCT00845195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477852|NCT00845195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102477853|NCT00845195|Respiratory System Agents|respiratory system agents|mesh-ancestor
102477854|NCT00845195|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
102477855|NCT00845195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102477856|NCT00845195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477857|NCT00845195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102477858|NCT00845195|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102477859|NCT00845195|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102477860|NCT00845195|Histamine Antagonists|histamine antagonists|mesh-ancestor
102477861|NCT00845195|Histamine Agents|histamine agents|mesh-ancestor
102477862|NCT00845195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102477863|NCT00845195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102477864|NCT00845195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102477865|NCT00845195|Analgesics|analgesics|mesh-ancestor
102477866|NCT00845195|Sensory System Agents|sensory system agents|mesh-ancestor
102477867|NCT00845195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102477868|NCT00845195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102477869|NCT00845507|Exenatide|exenatide|mesh-list
102477870|NCT00845507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102477871|NCT00845507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477872|NCT00845507|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102477873|NCT00845507|Incretins|incretins|mesh-ancestor
102477874|NCT00845507|Hormones|hormones|mesh-ancestor
102477875|NCT00845507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102477876|NCT03761914|Pembrolizumab|pembrolizumab|mesh-list
102477877|NCT03761914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102477878|NCT03761914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102477879|NCT03761914|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102477880|NCT03761914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477881|NCT00845663|Certolizumab Pegol|certolizumab pegol|mesh-list
102477882|NCT00845663|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102477883|NCT00845663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102477884|NCT00845663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102477885|NCT00845663|Immunologic Factors|immunologic factors|mesh-ancestor
102477886|NCT00845663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477887|NCT00845663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102477888|NCT03500380|Capecitabine|capecitabine|mesh-list
102477889|NCT03500380|Lapatinib|lapatinib|mesh-list
102477890|NCT03500380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102477891|NCT03500380|Antimetabolites|antimetabolites|mesh-ancestor
102477892|NCT03500380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477893|NCT03500380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102477894|NCT03500380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102477895|NCT03500380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102477896|NCT00534430|Cyclosporine|cyclosporine|mesh-list
102477897|NCT00534430|Mycophenolic Acid|mycophenolic acid|mesh-list
102477898|NCT00534430|Etoposide|etoposide|mesh-list
102477899|NCT00534430|Busulfan|busulfan|mesh-list
102477900|NCT00534430|Cyclosporins|cyclosporins|mesh-list
102477901|NCT00534430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102477902|NCT00534430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102477903|NCT00534430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102477904|NCT00534430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102477905|NCT00534430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102477906|NCT00534430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477907|NCT00534430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102477908|NCT00534430|Immunologic Factors|immunologic factors|mesh-ancestor
102477909|NCT00534430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477910|NCT00534430|Antifungal Agents|antifungal agents|mesh-ancestor
102477911|NCT00534430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102477912|NCT00534430|Dermatologic Agents|dermatologic agents|mesh-ancestor
102477913|NCT00534430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102477914|NCT00534430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102477915|NCT00534430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102477916|NCT00534430|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102477917|NCT00534430|Antitubercular Agents|antitubercular agents|mesh-ancestor
102477918|NCT00534430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102477919|NCT00534430|Alkylating Agents|alkylating agents|mesh-ancestor
102477920|NCT00534430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102477921|NCT00534430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102477922|NCT03092895|Apatinib|apatinib|mesh-list
102477923|NCT03092895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102477924|NCT03092895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102477925|NCT03092895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102477926|NCT03092895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477927|NCT03839771|Ivosidenib|ivosidenib|mesh-list
102477928|NCT03839771|Glycine|glycine|mesh-list
102477929|NCT03839771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102477930|NCT03839771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102477931|NCT03839771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477932|NCT03839771|Glycine Agents|glycine agents|mesh-ancestor
102477933|NCT03839771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102477934|NCT03839771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477935|NCT02593396|Bupropion|bupropion|mesh-list
102477936|NCT02593396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102477937|NCT02593396|Antidepressive Agents|antidepressive agents|mesh-ancestor
102477938|NCT02593396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102477939|NCT02593396|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102477940|NCT02593396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102477941|NCT02593396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102477942|NCT02593396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477943|NCT02593396|Dopamine Agents|dopamine agents|mesh-ancestor
102477944|NCT02593396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102477945|NCT02593396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477946|NCT02593396|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102477947|NCT02593396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102477948|NCT02593396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102477949|NCT00848783|Capecitabine|capecitabine|mesh-list
102477950|NCT00848783|Irinotecan|irinotecan|mesh-list
102477951|NCT00848783|Floxuridine|floxuridine|mesh-list
102477952|NCT00848783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102477953|NCT00848783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102477954|NCT00848783|Antimetabolites|antimetabolites|mesh-ancestor
102477955|NCT00848783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477956|NCT00848783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102477957|NCT00848783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102477958|NCT00848783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102477959|NCT05372536|Cytarabine|cytarabine|mesh-list
102477960|NCT05372536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102477961|NCT05372536|Antimetabolites|antimetabolites|mesh-ancestor
102477962|NCT05372536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477963|NCT05372536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102477964|NCT05372536|Antiviral Agents|antiviral agents|mesh-ancestor
102477965|NCT05372536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102477966|NCT05372536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102477967|NCT05372536|Immunologic Factors|immunologic factors|mesh-ancestor
102477968|NCT05372536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477969|NCT00849251|Dexamethasone|dexamethasone|mesh-list
102477970|NCT00849251|Cyclophosphamide|cyclophosphamide|mesh-list
102477971|NCT00849251|Doxorubicin|doxorubicin|mesh-list
102477972|NCT00849251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102477973|NCT00849251|Bortezomib|bortezomib|mesh-list
102477974|NCT00849251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102477975|NCT00849251|Immunologic Factors|immunologic factors|mesh-ancestor
102477976|NCT00849251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102477977|NCT00849251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102477978|NCT00849251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102477979|NCT00849251|Alkylating Agents|alkylating agents|mesh-ancestor
102477980|NCT00849251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102477981|NCT00849251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102477982|NCT00849251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102477983|NCT00849251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102477984|NCT00849251|Antiemetics|antiemetics|mesh-ancestor
102477985|NCT00849251|Autonomic Agents|autonomic agents|mesh-ancestor
102477986|NCT00849251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102477987|NCT00849251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102477988|NCT00849251|Glucocorticoids|glucocorticoids|mesh-ancestor
102477989|NCT00849251|Hormones|hormones|mesh-ancestor
101561512|NCT05276206|Anesthetics, Local|anesthetics, local|mesh-list
102477990|NCT00849251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102477991|NCT00849251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102477992|NCT00849251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102477993|NCT00849251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102477994|NCT00849251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102477995|NCT00849251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102477996|NCT00850889|Lidocaine|lidocaine|mesh-list
102477997|NCT00850889|Hyaluronic Acid|hyaluronic acid|mesh-list
102477998|NCT00850889|Anesthetics, Local|anesthetics, local|mesh-ancestor
102477999|NCT00850889|Anesthetics|anesthetics|mesh-ancestor
102478000|NCT00850889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102478001|NCT00850889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478002|NCT00850889|Sensory System Agents|sensory system agents|mesh-ancestor
102478003|NCT00850889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102478004|NCT00850889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102478005|NCT00850889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102478006|NCT00850889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102478007|NCT00850889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102478008|NCT00850889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478009|NCT00850889|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102478010|NCT00850889|Immunologic Factors|immunologic factors|mesh-ancestor
102478011|NCT00850889|Viscosupplements|viscosupplements|mesh-ancestor
102478012|NCT00850889|Protective Agents|protective agents|mesh-ancestor
102478013|NCT05254288|Chlorhexidine|chlorhexidine|mesh-list
102478014|NCT05254288|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102478015|NCT05254288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102478016|NCT05254288|Disinfectants|disinfectants|mesh-ancestor
102478017|NCT00851357|Nicotine|nicotine|mesh-list
102478018|NCT00851357|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102478019|NCT00851357|Autonomic Agents|autonomic agents|mesh-ancestor
102478020|NCT00851357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102478021|NCT00851357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478022|NCT00851357|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102478023|NCT00851357|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102478024|NCT00851357|Cholinergic Agents|cholinergic agents|mesh-ancestor
102478025|NCT00851357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102478026|NCT00851357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478027|NCT05105074|Morphine|morphine|mesh-list
102478028|NCT05105074|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102478029|NCT05105074|Narcotics|narcotics|mesh-ancestor
102478030|NCT05105074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102478031|NCT05105074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478032|NCT05105074|Analgesics|analgesics|mesh-ancestor
102478033|NCT05105074|Sensory System Agents|sensory system agents|mesh-ancestor
102478034|NCT05105074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102478035|NCT00364702|Methylphenidate|methylphenidate|mesh-list
102478036|NCT00364702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102478037|NCT00364702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478038|NCT00364702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102478039|NCT00364702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102478040|NCT00364702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101561574|NCT05090124|Adalimumab|adalimumab|mesh-list
102478041|NCT00364702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478042|NCT00364702|Dopamine Agents|dopamine agents|mesh-ancestor
102478043|NCT00364702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102478044|NCT00852761|Clobetasol|clobetasol|mesh-list
102478045|NCT00852761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102478046|NCT00852761|Glucocorticoids|glucocorticoids|mesh-ancestor
102478047|NCT00852761|Hormones|hormones|mesh-ancestor
102478048|NCT00852761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102478049|NCT00852761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478050|NCT03839537|Nitric Oxide|nitric oxide|mesh-list
102478051|NCT03839537|Carbon Monoxide|carbon monoxide|mesh-list
102478052|NCT03839537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102478053|NCT03839537|Autonomic Agents|autonomic agents|mesh-ancestor
102478054|NCT03839537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102478055|NCT03839537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478056|NCT03839537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102478057|NCT03839537|Respiratory System Agents|respiratory system agents|mesh-ancestor
102478058|NCT03839537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102478059|NCT03839537|Antioxidants|antioxidants|mesh-ancestor
102478060|NCT03839537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478061|NCT03839537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102478062|NCT03839537|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102478063|NCT03839537|Vasodilator Agents|vasodilator agents|mesh-ancestor
102478064|NCT03839537|Gasotransmitters|gasotransmitters|mesh-ancestor
102478065|NCT03839537|Protective Agents|protective agents|mesh-ancestor
102478066|NCT03839537|Antimetabolites|antimetabolites|mesh-ancestor
102478067|NCT04082806|Trazodone|trazodone|mesh-list
102478068|NCT04082806|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102478069|NCT04082806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102478070|NCT04082806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102478071|NCT04082806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478072|NCT04082806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102289723|NCT04885075|Diazepam|diazepam|mesh-list
102478073|NCT04082806|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102478074|NCT04082806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102478075|NCT04082806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101561579|NCT05054842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102478076|NCT04082806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478077|NCT04082806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102478078|NCT04082806|Serotonin Agents|serotonin agents|mesh-ancestor
102478079|NCT04082806|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102478080|NCT04082806|Antidepressive Agents|antidepressive agents|mesh-ancestor
102478081|NCT05635786|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102478082|NCT05635786|Tenecteplase|tenecteplase|mesh-list
102478083|NCT05635786|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102478084|NCT05635786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102478085|NCT05635786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478086|NCT00365950|Warfarin|warfarin|mesh-list
102478087|NCT00365950|Anticoagulants|anticoagulants|mesh-ancestor
102478088|NCT02487797|Oxytocin|oxytocin|mesh-list
102478089|NCT02487797|Oxytocics|oxytocics|mesh-ancestor
102478090|NCT02487797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102478091|NCT02487797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478092|NCT01733693|Buprenorphine|buprenorphine|mesh-list
102478093|NCT01733693|Methadone|methadone|mesh-list
102478094|NCT01733693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102478095|NCT01733693|Narcotics|narcotics|mesh-ancestor
102478096|NCT01733693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102478097|NCT01733693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478098|NCT01733693|Analgesics|analgesics|mesh-ancestor
102478099|NCT01733693|Sensory System Agents|sensory system agents|mesh-ancestor
102478100|NCT01733693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102478101|NCT01733693|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102478102|NCT01733693|Antitussive Agents|antitussive agents|mesh-ancestor
102478103|NCT01733693|Respiratory System Agents|respiratory system agents|mesh-ancestor
102478104|NCT00855413|Ritonavir|ritonavir|mesh-list
102478105|NCT00855413|Darunavir|darunavir|mesh-list
102478106|NCT00855413|Etravirine|etravirine|mesh-list
102478107|NCT00855413|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102478108|NCT00855413|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102478109|NCT00855413|Protease Inhibitors|protease inhibitors|mesh-ancestor
102478110|NCT00855413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101561643|NCT04659603|Gemcitabine|gemcitabine|mesh-list
102478111|NCT00855413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478112|NCT00855413|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102478113|NCT00855413|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102478114|NCT00855413|Antiviral Agents|antiviral agents|mesh-ancestor
102478115|NCT00855413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102478116|NCT00855413|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102478117|NCT00855413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102478118|NCT00855413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102478119|NCT00855413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102478120|NCT05599984|Carboplatin|carboplatin|mesh-list
102478121|NCT05599984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102478122|NCT00816101|Anti-Infective Agents|anti-infective agents|mesh-list
102478123|NCT00816101|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102478124|NCT00366262|Naproxen|naproxen|mesh-list
102478125|NCT00366262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102478126|NCT00366262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102478127|NCT00366262|Analgesics|analgesics|mesh-ancestor
102478128|NCT00366262|Sensory System Agents|sensory system agents|mesh-ancestor
102478129|NCT00366262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102478130|NCT00366262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478131|NCT00366262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102478132|NCT00366262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102478133|NCT00366262|Gout Suppressants|gout suppressants|mesh-ancestor
102478134|NCT00366262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102478135|NCT00366262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102478136|NCT00366262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478137|NCT00818363|Bupivacaine|bupivacaine|mesh-list
102478138|NCT00818363|Anesthetics, Local|anesthetics, local|mesh-ancestor
102478139|NCT00818363|Anesthetics|anesthetics|mesh-ancestor
102478140|NCT00818363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102478141|NCT00818363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561666|NCT04526288|Antimetabolites|antimetabolites|mesh-ancestor
102478142|NCT00818363|Sensory System Agents|sensory system agents|mesh-ancestor
102478143|NCT00818363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102478144|NCT00828841|Paclitaxel|paclitaxel|mesh-list
102478145|NCT00828841|Carboplatin|carboplatin|mesh-list
102478146|NCT00828841|Gemcitabine|gemcitabine|mesh-list
102478147|NCT00828841|Cetuximab|cetuximab|mesh-list
102478148|NCT00828841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102478149|NCT00828841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102478150|NCT00828841|Tubulin Modulators|tubulin modulators|mesh-ancestor
102478151|NCT00828841|Antimitotic Agents|antimitotic agents|mesh-ancestor
102478152|NCT00828841|Mitosis Modulators|mitosis modulators|mesh-ancestor
102478153|NCT00828841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478154|NCT00828841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102478155|NCT00828841|Antimetabolites|antimetabolites|mesh-ancestor
102478156|NCT00828841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102478157|NCT05445310|Aflutinib|aflutinib|mesh-list
102478158|NCT05445310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102478159|NCT05445310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102478160|NCT05445310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478161|NCT00858689|Minocycline|minocycline|mesh-list
102478162|NCT00858689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102478163|NCT00858689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102478164|NCT00821795|Insulin|insulin|mesh-list
102478165|NCT00821795|Insulin Aspart|insulin aspart|mesh-list
102478166|NCT00821795|Protamines|protamines|mesh-list
102478167|NCT00821795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102478168|NCT00821795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478169|NCT00821795|Heparin Antagonists|heparin antagonists|mesh-ancestor
102478170|NCT00821795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478171|NCT00821795|Coagulants|coagulants|mesh-ancestor
102478172|NCT00833365|Ibuprofen|ibuprofen|mesh-list
101561697|NCT04480554|Naltrexone|naltrexone|mesh-list
102478173|NCT00833365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102478174|NCT00833365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102478175|NCT00833365|Analgesics|analgesics|mesh-ancestor
102478176|NCT00833365|Sensory System Agents|sensory system agents|mesh-ancestor
102478177|NCT00833365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102478178|NCT00833365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478179|NCT00833365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102478180|NCT00833365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102478181|NCT00833365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102478182|NCT00833365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102478183|NCT00833365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478184|NCT00821951|Vorinostat|vorinostat|mesh-list
102478185|NCT00821951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102478186|NCT00821951|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102478187|NCT00821951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102478188|NCT00821951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478189|NCT00852631|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102478190|NCT00852631|Antidepressive Agents|antidepressive agents|mesh-ancestor
102478191|NCT00852631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102478192|NCT00852631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102478193|NCT00852631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102478194|NCT00852631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102478195|NCT00852631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478196|NCT00860015|Gemcitabine|gemcitabine|mesh-list
102478197|NCT00860015|Pemetrexed|pemetrexed|mesh-list
102478198|NCT00860015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102478199|NCT00860015|Antimetabolites|antimetabolites|mesh-ancestor
102478200|NCT00860015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478201|NCT00860015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102478202|NCT00860015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102478203|NCT00860015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102478204|NCT00860015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102478205|NCT00853333|Midazolam|midazolam|mesh-list
102478206|NCT00853333|Dexmedetomidine|dexmedetomidine|mesh-list
102478207|NCT00853333|Propofol|propofol|mesh-list
102478208|NCT00853333|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102478209|NCT00853333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102478210|NCT00853333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478211|NCT00853333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102478212|NCT00853333|Analgesics|analgesics|mesh-ancestor
102478213|NCT00853333|Sensory System Agents|sensory system agents|mesh-ancestor
102478214|NCT00853333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102478215|NCT00853333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102478216|NCT00853333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102478217|NCT00853333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102478218|NCT00853333|Adrenergic Agents|adrenergic agents|mesh-ancestor
102478219|NCT00853333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102478220|NCT00853333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478221|NCT00853333|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102478222|NCT00853333|Anesthetics, General|anesthetics, general|mesh-ancestor
102289882|NCT05533073|Etoricoxib|etoricoxib|mesh-list
102478224|NCT00853333|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102478225|NCT00853333|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102478226|NCT00853333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102478227|NCT00853333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102478228|NCT00853333|GABA Modulators|gaba modulators|mesh-ancestor
102478229|NCT00853333|GABA Agents|gaba agents|mesh-ancestor
102478230|NCT00822107|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102478231|NCT00822107|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102478232|NCT00822107|Diuretics|diuretics|mesh-ancestor
102478233|NCT00822107|Natriuretic Agents|natriuretic agents|mesh-ancestor
102478234|NCT00822107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561744|NCT04396236|Lasmiditan|lasmiditan|mesh-list
102478235|NCT00822107|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102478236|NCT00822107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102478237|NCT00822107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478238|NCT05236907|Midazolam|midazolam|mesh-list
102478239|NCT05236907|Melatonin|melatonin|mesh-list
102478240|NCT05236907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102478241|NCT05236907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102478242|NCT05236907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101561770|NCT04375605|Vitamins|vitamins|mesh-ancestor
102478243|NCT05236907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478244|NCT05236907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102478245|NCT05236907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102478246|NCT05236907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102478247|NCT05236907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102478248|NCT05236907|Anesthetics, General|anesthetics, general|mesh-ancestor
102478249|NCT05236907|Anesthetics|anesthetics|mesh-ancestor
102478250|NCT05236907|GABA Modulators|gaba modulators|mesh-ancestor
102478251|NCT05236907|GABA Agents|gaba agents|mesh-ancestor
102478252|NCT05236907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102478253|NCT05236907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478254|NCT05236907|Antioxidants|antioxidants|mesh-ancestor
102478255|NCT05236907|Protective Agents|protective agents|mesh-ancestor
102478256|NCT05217706|Ketamine|ketamine|mesh-list
102478257|NCT05217706|Analgesics|analgesics|mesh-ancestor
102478258|NCT05217706|Sensory System Agents|sensory system agents|mesh-ancestor
102478259|NCT05217706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102478260|NCT05217706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478261|NCT05217706|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102478262|NCT05217706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102478263|NCT05217706|Anesthetics, General|anesthetics, general|mesh-ancestor
102478264|NCT05217706|Anesthetics|anesthetics|mesh-ancestor
102478265|NCT05217706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102478266|NCT05217706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102478267|NCT05217706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102478268|NCT05217706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102478269|NCT05217706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478270|NCT00833443|Bupropion|bupropion|mesh-list
102478271|NCT00833443|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102478272|NCT00833443|Antidepressive Agents|antidepressive agents|mesh-ancestor
102478273|NCT00833443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102478274|NCT00833443|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101561798|NCT04268498|Sensory System Agents|sensory system agents|mesh-ancestor
102478275|NCT00833443|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102478276|NCT00833443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102478277|NCT00833443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478278|NCT00833443|Dopamine Agents|dopamine agents|mesh-ancestor
102478279|NCT00833443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102478280|NCT00833443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478281|NCT00833443|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102478282|NCT00833443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102478283|NCT00833443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102478284|NCT05207722|Aldesleukin|aldesleukin|mesh-list
102478285|NCT05207722|Cyclophosphamide|cyclophosphamide|mesh-list
102478286|NCT05207722|Pembrolizumab|pembrolizumab|mesh-list
102478287|NCT05207722|Trastuzumab|trastuzumab|mesh-list
102478288|NCT05207722|Fludarabine|fludarabine|mesh-list
102478289|NCT05207722|Interleukin-2|interleukin-2|mesh-list
102478290|NCT05207722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102478291|NCT05207722|Immunologic Factors|immunologic factors|mesh-ancestor
102478292|NCT05207722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478293|NCT05207722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102478294|NCT05207722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102478295|NCT05207722|Alkylating Agents|alkylating agents|mesh-ancestor
102478296|NCT05207722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289955|NCT05526911|Anesthetics|anesthetics|mesh-ancestor
102478297|NCT05207722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102478298|NCT05207722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102478299|NCT05207722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102478300|NCT05207722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102478301|NCT05207722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102478302|NCT05207722|Analgesics|analgesics|mesh-ancestor
102478303|NCT05207722|Sensory System Agents|sensory system agents|mesh-ancestor
102478304|NCT05207722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102478305|NCT05207722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102478306|NCT05207722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102478307|NCT05207722|Antiviral Agents|antiviral agents|mesh-ancestor
102478308|NCT05207722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102478309|NCT00860171|Iodine|iodine|mesh-list
102478310|NCT00860171|Cadexomer iodine|cadexomer iodine|mesh-list
102478311|NCT00860171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102478312|NCT00860171|Antibodies|antibodies|mesh-list
102478313|NCT00860171|Immunoglobulins|immunoglobulins|mesh-list
102478314|NCT00860171|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102478315|NCT00860171|Immunologic Factors|immunologic factors|mesh-ancestor
102478316|NCT00860171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478317|NCT00860171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102478318|NCT00860171|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102478319|NCT00860171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102478320|NCT00860171|Trace Elements|trace elements|mesh-ancestor
102478321|NCT00860171|Micronutrients|micronutrients|mesh-ancestor
102478322|NCT00366418|Rituximab|rituximab|mesh-list
102478323|NCT00366418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102478324|NCT00366418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102478325|NCT00366418|Immunologic Factors|immunologic factors|mesh-ancestor
102478326|NCT00366418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478327|NCT00366418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102478328|NCT00823043|Timolol|timolol|mesh-list
102478329|NCT00823043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478330|NCT00823043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102478331|NCT00823043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102478332|NCT00823043|Adrenergic Agents|adrenergic agents|mesh-ancestor
102478333|NCT00823043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102478334|NCT00823043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478335|NCT00823043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102478336|NCT00823043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102478337|NCT00862745|Fesoterodine|fesoterodine|mesh-list
102478338|NCT00862745|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102478339|NCT00862745|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102478340|NCT00862745|Cholinergic Agents|cholinergic agents|mesh-ancestor
102478341|NCT00862745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101561884|NCT03994627|Olaratumab|olaratumab|mesh-list
102478342|NCT00862745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478343|NCT00862745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478344|NCT00862745|Urological Agents|urological agents|mesh-ancestor
102478345|NCT02150759|Fentanyl|fentanyl|mesh-list
102478346|NCT02150759|Dexmedetomidine|dexmedetomidine|mesh-list
102478347|NCT02150759|Ketamine|ketamine|mesh-list
102478348|NCT02150759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102478349|NCT02150759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101561890|NCT03971409|Antibodies|antibodies|mesh-list
102478350|NCT02150759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478351|NCT02150759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102478352|NCT02150759|Analgesics|analgesics|mesh-ancestor
102478353|NCT02150759|Sensory System Agents|sensory system agents|mesh-ancestor
102478354|NCT02150759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102478355|NCT02150759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102478356|NCT02150759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102478357|NCT02150759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102478358|NCT02150759|Adrenergic Agents|adrenergic agents|mesh-ancestor
102478359|NCT02150759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102478360|NCT02150759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478361|NCT02150759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102478362|NCT02150759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102478363|NCT02150759|Anesthetics, General|anesthetics, general|mesh-ancestor
102478364|NCT02150759|Anesthetics|anesthetics|mesh-ancestor
102478365|NCT02150759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102478366|NCT02150759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102478367|NCT02150759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102478368|NCT02150759|Narcotics|narcotics|mesh-ancestor
102478369|NCT02150759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102478370|NCT04991350|Bevacizumab|bevacizumab|mesh-list
102478371|NCT04991350|Ranibizumab|ranibizumab|mesh-list
102478372|NCT04991350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102478373|NCT04991350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102478374|NCT04991350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102478375|NCT04991350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102478376|NCT04991350|Growth Substances|growth substances|mesh-ancestor
102478377|NCT04991350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478378|NCT04991350|Growth Inhibitors|growth inhibitors|mesh-ancestor
102478379|NCT00857545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
102478380|NCT00857545|Immunologic Factors|immunologic factors|mesh-ancestor
102478381|NCT00857545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478382|NCT04952194|Levodopa|levodopa|mesh-list
102478383|NCT04952194|Carbidopa|carbidopa|mesh-list
102478384|NCT04952194|Entacapone|entacapone|mesh-list
102478385|NCT04952194|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101561930|NCT03909165|Atropine|atropine|mesh-list
102478386|NCT04952194|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102478387|NCT04952194|Dopamine Agents|dopamine agents|mesh-ancestor
102478388|NCT04952194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102478389|NCT04952194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478390|NCT04952194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478391|NCT04952194|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102478392|NCT04952194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102478393|NCT04952194|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102478394|NCT00835159|Rivastigmine|rivastigmine|mesh-list
102478395|NCT00835159|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102478396|NCT00835159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102478397|NCT00835159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478398|NCT00835159|Cholinergic Agents|cholinergic agents|mesh-ancestor
102478399|NCT00835159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102478400|NCT00835159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478401|NCT00835159|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101561936|NCT03909165|Autonomic Agents|autonomic agents|mesh-ancestor
102478402|NCT00835159|Protective Agents|protective agents|mesh-ancestor
102478403|NCT04860856|Ropivacaine|ropivacaine|mesh-list
102478404|NCT04860856|Anesthetics, Local|anesthetics, local|mesh-ancestor
102478405|NCT04860856|Anesthetics|anesthetics|mesh-ancestor
102478406|NCT04860856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102478407|NCT04860856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478408|NCT04860856|Sensory System Agents|sensory system agents|mesh-ancestor
102478409|NCT04860856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102478410|NCT00827099|Mycophenolic Acid|mycophenolic acid|mesh-list
102478411|NCT00827099|Fludarabine|fludarabine|mesh-list
102478412|NCT00827099|Fludarabine phosphate|fludarabine phosphate|mesh-list
102478413|NCT00827099|Melphalan|melphalan|mesh-list
102478414|NCT00827099|Tacrolimus|tacrolimus|mesh-list
101561959|NCT03800524|Antiviral Agents|antiviral agents|mesh-ancestor
102478415|NCT00827099|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102478416|NCT00827099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102478417|NCT00827099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102478418|NCT00827099|Antimetabolites|antimetabolites|mesh-ancestor
102478419|NCT00827099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478420|NCT00827099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102478421|NCT00827099|Immunologic Factors|immunologic factors|mesh-ancestor
102478422|NCT00827099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478423|NCT00827099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102478424|NCT00827099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102478425|NCT00827099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101561967|NCT03782207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102478426|NCT00827099|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102478427|NCT00827099|Antitubercular Agents|antitubercular agents|mesh-ancestor
102478428|NCT00827099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102478429|NCT00827099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102478430|NCT00827099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102478431|NCT00827099|Alkylating Agents|alkylating agents|mesh-ancestor
102478432|NCT00827099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102478433|NCT00366652|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102478434|NCT00366652|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
102478435|NCT00366652|Desipramine|desipramine|mesh-list
102478436|NCT00366652|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102478437|NCT00366652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102478438|NCT00366652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102478439|NCT00366652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478440|NCT00366652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102478441|NCT00366652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478442|NCT00366652|Analgesics|analgesics|mesh-ancestor
102478443|NCT00366652|Sensory System Agents|sensory system agents|mesh-ancestor
102478444|NCT00366652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102478445|NCT00366652|Antidepressive Agents|antidepressive agents|mesh-ancestor
102478446|NCT00366652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102478447|NCT00366652|Dopamine Agents|dopamine agents|mesh-ancestor
102478448|NCT00366652|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102478449|NCT00366652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102478450|NCT00366652|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102478451|NCT00366652|Adrenergic Agents|adrenergic agents|mesh-ancestor
102478452|NCT00366730|Nitazoxanide|nitazoxanide|mesh-list
102478453|NCT00366730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102478454|NCT00366730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102478455|NCT02617888|Bismuth|bismuth|mesh-list
102478456|NCT02617888|Antacids|antacids|mesh-ancestor
102478457|NCT02617888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478458|NCT02617888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102478459|NCT02620774|Tazobactam|tazobactam|mesh-list
102478460|NCT02620774|Ceftolozane|ceftolozane|mesh-list
102478461|NCT02620774|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
102478462|NCT02620774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102478463|NCT02620774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102478464|NCT02620774|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102478465|NCT02620774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102478466|NCT02620774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478467|NCT02620774|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102478468|NCT02625298|Pemetrexed|pemetrexed|mesh-list
102478469|NCT02625298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102478470|NCT02625298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102478471|NCT02625298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478472|NCT02625298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102478473|NCT02625298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102478474|NCT00858013|Glimepiride|glimepiride|mesh-list
102478475|NCT00858013|Nateglinide|nateglinide|mesh-list
102478476|NCT00858013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102478477|NCT00858013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102478478|NCT00858013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478479|NCT00858013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102478480|NCT00858013|Immunologic Factors|immunologic factors|mesh-ancestor
102478481|NCT02626156|Methyl salicylate|methyl salicylate|mesh-list
102478482|NCT02626156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102478483|NCT00835861|Insulin|insulin|mesh-list
102478484|NCT00835861|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102478485|NCT00835861|Metformin|metformin|mesh-list
102478486|NCT00835861|Insulin, Isophane|insulin, isophane|mesh-list
101562019|NCT03401853|Pembrolizumab|pembrolizumab|mesh-list
102478487|NCT00835861|Isophane Insulin, Human|isophane insulin, human|mesh-list
102478488|NCT00835861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102478489|NCT00835861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478490|NCT00804973|Sumatriptan|sumatriptan|mesh-list
102478491|NCT00804973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102478492|NCT00804973|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102478493|NCT00804973|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102478494|NCT00804973|Serotonin Agents|serotonin agents|mesh-ancestor
102478495|NCT00804973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102478496|NCT00804973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478497|NCT00804973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478498|NCT02628106|Alprostadil|alprostadil|mesh-list
102478499|NCT02628106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102478500|NCT02628106|Vasodilator Agents|vasodilator agents|mesh-ancestor
102478501|NCT02628106|Urological Agents|urological agents|mesh-ancestor
102478502|NCT02629354|Ibuprofen|ibuprofen|mesh-list
102478503|NCT02629354|Caffeine|caffeine|mesh-list
102478504|NCT02629354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102478505|NCT02629354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102478506|NCT02629354|Analgesics|analgesics|mesh-ancestor
102478507|NCT02629354|Sensory System Agents|sensory system agents|mesh-ancestor
102478508|NCT02629354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102478509|NCT02629354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478510|NCT02629354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102478511|NCT02629354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102478512|NCT02629354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102478513|NCT02629354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102478514|NCT02629354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478515|NCT02629354|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102478516|NCT02629354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102478517|NCT02629354|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102478518|NCT02629354|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102478519|NCT02629354|Purinergic Agents|purinergic agents|mesh-ancestor
102478520|NCT02629354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102478521|NCT02834247|Nivolumab|nivolumab|mesh-list
102478522|NCT02834247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102478523|NCT02834247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101562077|NCT03215706|Antimitotic Agents|antimitotic agents|mesh-ancestor
102478524|NCT02834247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102478525|NCT02834247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478527|NCT00859027|Etidronic Acid|etidronic acid|mesh-list
102478528|NCT00859027|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102478529|NCT00859027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102478530|NCT00859027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478531|NCT00859027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102478532|NCT00859027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478533|NCT00859027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102478534|NCT02630992|Amoxicillin|amoxicillin|mesh-list
102478535|NCT02630992|Clavulanic Acid|clavulanic acid|mesh-list
102478536|NCT02630992|Clavulanic Acids|clavulanic acids|mesh-list
102478537|NCT02630992|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102478538|NCT02630992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102478539|NCT02630992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102478540|NCT02630992|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102478541|NCT02630992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102478542|NCT02630992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478543|NCT00836407|Ipilimumab|ipilimumab|mesh-list
102478544|NCT00836407|Vaccines|vaccines|mesh-list
101562125|NCT02811861|Pembrolizumab|pembrolizumab|mesh-list
102478545|NCT00836407|Immunologic Factors|immunologic factors|mesh-ancestor
102478546|NCT00836407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478547|NCT00836407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102478548|NCT00836407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102478549|NCT00836407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102478550|NCT00836407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478551|NCT02631772|Ribavirin|ribavirin|mesh-list
102478552|NCT02631772|Sofosbuvir|sofosbuvir|mesh-list
102478553|NCT02631772|Ledipasvir|ledipasvir|mesh-list
102478554|NCT02631772|Antimetabolites|antimetabolites|mesh-ancestor
102478555|NCT02631772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478556|NCT02631772|Antiviral Agents|antiviral agents|mesh-ancestor
102478557|NCT02631772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102478558|NCT02633488|Metformin|metformin|mesh-list
102478559|NCT02633488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102478560|NCT02633488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478561|NCT00859339|Gemcitabine|gemcitabine|mesh-list
102478562|NCT00859339|Sunitinib|sunitinib|mesh-list
102478563|NCT00859339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102478564|NCT00859339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102478565|NCT00859339|Antimetabolites|antimetabolites|mesh-ancestor
102478566|NCT00859339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478567|NCT00859339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102478568|NCT00859339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102478569|NCT00859339|Growth Substances|growth substances|mesh-ancestor
102478570|NCT00859339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478571|NCT00859339|Growth Inhibitors|growth inhibitors|mesh-ancestor
102478572|NCT00859339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102478573|NCT00859339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102478574|NCT00859495|Doxorubicin|doxorubicin|mesh-list
102478575|NCT00859495|Pemetrexed|pemetrexed|mesh-list
102478576|NCT00859495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102478577|NCT00859495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102478578|NCT00859495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102478579|NCT00859495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102478580|NCT00859495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102478581|NCT00859495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478582|NCT00859495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102478583|NCT00859495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102478584|NCT00355719|Ritonavir|ritonavir|mesh-list
102478585|NCT00355719|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102478586|NCT00355719|Nevirapine|nevirapine|mesh-list
102478587|NCT00355719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102478588|NCT00355719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102478589|NCT00355719|Protease Inhibitors|protease inhibitors|mesh-ancestor
102478590|NCT00355719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102478591|NCT00355719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478592|NCT00355719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102478593|NCT00355719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102478594|NCT00355719|Antiviral Agents|antiviral agents|mesh-ancestor
102478595|NCT00355719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102478596|NCT00355719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101562174|NCT02697344|BB 1101|bb 1101|mesh-list
102478597|NCT00355719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102478598|NCT00355719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102478599|NCT00355719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102478600|NCT00355719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102478601|NCT00355719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102478602|NCT00859651|Vitamin D|vitamin d|mesh-list
102478603|NCT00859651|Cholecalciferol|cholecalciferol|mesh-list
102478604|NCT00859651|Vitamins|vitamins|mesh-ancestor
102478605|NCT00859651|Micronutrients|micronutrients|mesh-ancestor
102478606|NCT00859651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478607|NCT00859651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102478608|NCT00859651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102478609|NCT02633956|Atorvastatin|atorvastatin|mesh-list
102478610|NCT02633956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102478611|NCT02633956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102478612|NCT02633956|Antimetabolites|antimetabolites|mesh-ancestor
102478613|NCT02633956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478614|NCT02633956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102478615|NCT02633956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102478616|NCT02633956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102478617|NCT00836641|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102478618|NCT00836641|Immunologic Factors|immunologic factors|mesh-ancestor
102478619|NCT00836641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478620|NCT00806221|Emollients|emollients|mesh-list
102478621|NCT00806221|Dermatologic Agents|dermatologic agents|mesh-ancestor
102478622|NCT02635828|Promethazine|promethazine|mesh-list
102478623|NCT02635828|Diphenhydramine|diphenhydramine|mesh-list
102478624|NCT02635828|Dexamethasone|dexamethasone|mesh-list
102478625|NCT02635828|Palonosetron|palonosetron|mesh-list
102478626|NCT02635828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102478627|NCT02635828|Antiemetics|antiemetics|mesh-ancestor
102478628|NCT02635828|Autonomic Agents|autonomic agents|mesh-ancestor
101562185|NCT02697344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102478629|NCT02635828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102478630|NCT02635828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478631|NCT02635828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102478632|NCT02635828|Glucocorticoids|glucocorticoids|mesh-ancestor
102478633|NCT02635828|Hormones|hormones|mesh-ancestor
102478634|NCT02635828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101562220|NCT02623426|Hormones|hormones|mesh-ancestor
102478635|NCT02635828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102478636|NCT02635828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102478637|NCT02635828|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102478638|NCT02635828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102478639|NCT02635828|Serotonin Agents|serotonin agents|mesh-ancestor
102478640|NCT02635828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102478641|NCT02635828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478642|NCT02635828|Antipruritics|antipruritics|mesh-ancestor
102478643|NCT02635828|Dermatologic Agents|dermatologic agents|mesh-ancestor
102478644|NCT02635828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102478645|NCT02635828|Histamine Antagonists|histamine antagonists|mesh-ancestor
102478646|NCT02635828|Histamine Agents|histamine agents|mesh-ancestor
102478647|NCT02635828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102478648|NCT02635828|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102478649|NCT02635828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102478650|NCT02635828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102478651|NCT02635828|Anesthetics, Local|anesthetics, local|mesh-ancestor
102478652|NCT02635828|Anesthetics|anesthetics|mesh-ancestor
102478653|NCT02635828|Sensory System Agents|sensory system agents|mesh-ancestor
102478654|NCT02638168|Methylphenidate|methylphenidate|mesh-list
102478655|NCT02638168|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102478656|NCT02638168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478657|NCT02638168|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102478658|NCT02638168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102478659|NCT02638168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102478660|NCT02638168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478661|NCT02638168|Dopamine Agents|dopamine agents|mesh-ancestor
102478662|NCT02638168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102478663|NCT00837031|Gemcitabine|gemcitabine|mesh-list
102478664|NCT00837031|Lenalidomide|lenalidomide|mesh-list
102478665|NCT00837031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102478666|NCT00837031|Antimetabolites|antimetabolites|mesh-ancestor
102478667|NCT00837031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478668|NCT00837031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102478669|NCT00837031|Immunologic Factors|immunologic factors|mesh-ancestor
102478670|NCT00837031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478671|NCT00837031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102478672|NCT00837031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102478673|NCT00837031|Growth Substances|growth substances|mesh-ancestor
102478674|NCT00837031|Growth Inhibitors|growth inhibitors|mesh-ancestor
102478675|NCT02973880|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102478676|NCT02973880|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102478678|NCT04344483|Epinephrine|epinephrine|mesh-list
102478679|NCT04344483|Racepinephrine|racepinephrine|mesh-list
102478680|NCT04344483|Epinephryl borate|epinephryl borate|mesh-list
102478681|NCT04344483|Anesthetics, Local|anesthetics, local|mesh-ancestor
102478682|NCT04344483|Anesthetics|anesthetics|mesh-ancestor
102478683|NCT04344483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102478684|NCT04344483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478685|NCT04344483|Sensory System Agents|sensory system agents|mesh-ancestor
102478686|NCT04344483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102478687|NCT04344483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102478688|NCT04344483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102478689|NCT04344483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102478690|NCT04344483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102478691|NCT04344483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478692|NCT04344483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102478693|NCT04344483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102478694|NCT04344483|Adrenergic Agents|adrenergic agents|mesh-ancestor
102478695|NCT04344483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102478696|NCT04344483|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102478697|NCT04344483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102478698|NCT04344483|Autonomic Agents|autonomic agents|mesh-ancestor
102478699|NCT04344483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102478700|NCT04344483|Respiratory System Agents|respiratory system agents|mesh-ancestor
102478701|NCT04344483|Mydriatics|mydriatics|mesh-ancestor
102478702|NCT04344483|Sympathomimetics|sympathomimetics|mesh-ancestor
102478703|NCT04344483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102478704|NCT02154763|Ropivacaine|ropivacaine|mesh-list
102478705|NCT02154763|Anesthetics, Local|anesthetics, local|mesh-ancestor
102478706|NCT02154763|Anesthetics|anesthetics|mesh-ancestor
102478707|NCT02154763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102478708|NCT02154763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478709|NCT02154763|Sensory System Agents|sensory system agents|mesh-ancestor
102478710|NCT02154763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102478711|NCT02641522|Siltuximab|siltuximab|mesh-list
102478712|NCT02641522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102478713|NCT04964427|Methylphenidate|methylphenidate|mesh-list
102478714|NCT04964427|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102478715|NCT04964427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478716|NCT04964427|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102478717|NCT04964427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102478718|NCT04964427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102478719|NCT04964427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478720|NCT04964427|Dopamine Agents|dopamine agents|mesh-ancestor
102478721|NCT04964427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102478722|NCT00357669|Brivaracetam|brivaracetam|mesh-list
102478723|NCT00357669|Anticonvulsants|anticonvulsants|mesh-ancestor
102478724|NCT00863551|Trospium chloride|trospium chloride|mesh-list
102478725|NCT00863551|Parasympatholytics|parasympatholytics|mesh-ancestor
102478726|NCT00863551|Autonomic Agents|autonomic agents|mesh-ancestor
102478727|NCT00863551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102478728|NCT00863551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478729|NCT00863551|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102478730|NCT00863551|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102478731|NCT00863551|Cholinergic Agents|cholinergic agents|mesh-ancestor
102478732|NCT00863551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102478733|NCT00863551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478734|NCT00863551|Urological Agents|urological agents|mesh-ancestor
102478735|NCT03838575|Chlorhexidine|chlorhexidine|mesh-list
102478736|NCT03838575|Gentamicins|gentamicins|mesh-list
102478737|NCT03838575|Anti-Infective Agents|anti-infective agents|mesh-list
102478738|NCT03838575|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102478739|NCT03838575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102478740|NCT03838575|Disinfectants|disinfectants|mesh-ancestor
102478741|NCT03838575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102478742|NCT03838575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102478743|NCT03838575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478744|NCT03540355|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101562311|NCT01889199|Androgen Antagonists|androgen antagonists|mesh-ancestor
102478745|NCT03540355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102478746|NCT03540355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102478747|NCT03540355|Antimetabolites|antimetabolites|mesh-ancestor
102478748|NCT03540355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478749|NCT03540355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102478750|NCT03540355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102478751|NCT03540355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102478752|NCT04339816|Azithromycin|azithromycin|mesh-list
102478753|NCT04339816|Hydroxychloroquine|hydroxychloroquine|mesh-list
102478754|NCT04339816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102478755|NCT04339816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102478756|NCT04339816|Antimalarials|antimalarials|mesh-ancestor
101562329|NCT01666080|Busulfan|busulfan|mesh-list
102478757|NCT04339816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102478758|NCT04339816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102478759|NCT04339816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102478760|NCT04339816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751164|NCT04692623|Insulin|insulin|mesh-list
102478761|NCT04339816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102478762|NCT05588908|Betamethasone|betamethasone|mesh-list
102478763|NCT05588908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102478764|NCT05588908|Antibodies|antibodies|mesh-list
102478765|NCT05588908|Immunoglobulins|immunoglobulins|mesh-list
102478766|NCT05588908|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102478767|NCT05588908|Immunologic Factors|immunologic factors|mesh-ancestor
102478768|NCT05588908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478769|NCT05588908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102478770|NCT05588908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102478771|NCT05588908|Glucocorticoids|glucocorticoids|mesh-ancestor
102478772|NCT05588908|Hormones|hormones|mesh-ancestor
102478773|NCT05588908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102478774|NCT05588908|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102478775|NCT05588908|Respiratory System Agents|respiratory system agents|mesh-ancestor
102478776|NCT05588830|Belimumab|belimumab|mesh-list
102478777|NCT05588830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102478778|NCT05588830|Immunologic Factors|immunologic factors|mesh-ancestor
102478779|NCT05588830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478780|NCT04740190|Carboplatin|carboplatin|mesh-list
102478781|NCT04740190|Talazoparib|talazoparib|mesh-list
102478782|NCT04740190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102478783|NCT04740190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102478784|NCT04740190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102478785|NCT04740190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478786|NCT00865969|Belinostat|belinostat|mesh-list
102478787|NCT00865969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102478788|NCT00865969|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102478789|NCT00865969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102478790|NCT00865969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478791|NCT05588518|Propolis|propolis|mesh-list
102478792|NCT05588518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102478793|NCT00866749|Cytarabine|cytarabine|mesh-list
102478794|NCT00866749|Cyclophosphamide|cyclophosphamide|mesh-list
102478795|NCT00866749|Doxorubicin|doxorubicin|mesh-list
102478796|NCT00866749|Methotrexate|methotrexate|mesh-list
102478797|NCT00866749|Vincristine|vincristine|mesh-list
102478798|NCT00866749|Daunorubicin|daunorubicin|mesh-list
102478799|NCT00866749|Asparaginase|asparaginase|mesh-list
102478800|NCT00866749|Mercaptopurine|mercaptopurine|mesh-list
102478801|NCT00866749|Thioguanine|thioguanine|mesh-list
102478802|NCT00866749|Pegaspargase|pegaspargase|mesh-list
102478803|NCT00866749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101751269|NCT04508634|Metformin|metformin|mesh-list
102478804|NCT00866749|Immunologic Factors|immunologic factors|mesh-ancestor
102478805|NCT00866749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478806|NCT00866749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102478807|NCT00866749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102478808|NCT00866749|Alkylating Agents|alkylating agents|mesh-ancestor
102478809|NCT00866749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478810|NCT00866749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102478811|NCT00866749|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102478812|NCT00866749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102478813|NCT00866749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102478814|NCT00866749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102478815|NCT00866749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102478816|NCT00866749|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102478817|NCT00866749|Abortifacient Agents|abortifacient agents|mesh-ancestor
102478818|NCT00866749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102478819|NCT00866749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102478820|NCT00866749|Antimetabolites|antimetabolites|mesh-ancestor
102290480|NCT05505461|Antibodies|antibodies|mesh-list
101562387|NCT00992238|Flavoxate|flavoxate|mesh-list
102478821|NCT00866749|Dermatologic Agents|dermatologic agents|mesh-ancestor
102478822|NCT00866749|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102478823|NCT00866749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102478824|NCT00866749|Antiviral Agents|antiviral agents|mesh-ancestor
102478825|NCT00866749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102478826|NCT00866749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102478827|NCT00866749|Tubulin Modulators|tubulin modulators|mesh-ancestor
102478828|NCT00866749|Antimitotic Agents|antimitotic agents|mesh-ancestor
102478829|NCT00866749|Mitosis Modulators|mitosis modulators|mesh-ancestor
102478830|NCT00866905|Cyclophosphamide|cyclophosphamide|mesh-list
102478831|NCT00866905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102478832|NCT00866905|Immunologic Factors|immunologic factors|mesh-ancestor
102478833|NCT00866905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478834|NCT00866905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102478835|NCT00866905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102478836|NCT00866905|Alkylating Agents|alkylating agents|mesh-ancestor
102478837|NCT00866905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478838|NCT00866905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102478839|NCT00866905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102478840|NCT05587426|Iproplatin|iproplatin|mesh-list
102478841|NCT05587426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102478842|NCT00867139|Oseltamivir|oseltamivir|mesh-list
102478843|NCT00867139|Ribavirin|ribavirin|mesh-list
102478844|NCT00867139|Zanamivir|zanamivir|mesh-list
102478845|NCT00867139|Amantadine|amantadine|mesh-list
102478846|NCT00867139|Thiazole-4-carboxamide adenine dinucleotide|thiazole-4-carboxamide adenine dinucleotide|mesh-list
102478847|NCT00867139|Antiviral Agents|antiviral agents|mesh-ancestor
102478848|NCT00867139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102478849|NCT00867139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102478850|NCT00867139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478851|NCT00867139|Antimetabolites|antimetabolites|mesh-ancestor
102478852|NCT00867139|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102478853|NCT00867139|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102478854|NCT00867139|Dopamine Agents|dopamine agents|mesh-ancestor
102478855|NCT00867139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102478856|NCT00867139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478857|NCT00867139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102478858|NCT00867139|Analgesics|analgesics|mesh-ancestor
102478859|NCT00867139|Sensory System Agents|sensory system agents|mesh-ancestor
102478860|NCT00867139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102478861|NCT05342818|Ondansetron|ondansetron|mesh-list
102478862|NCT05342818|Metoclopramide|metoclopramide|mesh-list
102478863|NCT05342818|Neostigmine|neostigmine|mesh-list
102478864|NCT05342818|Antiemetics|antiemetics|mesh-ancestor
102478865|NCT05342818|Autonomic Agents|autonomic agents|mesh-ancestor
102478866|NCT05342818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102478867|NCT05342818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478868|NCT05342818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102478869|NCT05342818|Antipruritics|antipruritics|mesh-ancestor
102478870|NCT05342818|Dermatologic Agents|dermatologic agents|mesh-ancestor
102478871|NCT05342818|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102478872|NCT05342818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102478873|NCT05342818|Serotonin Agents|serotonin agents|mesh-ancestor
102478874|NCT05342818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102478875|NCT05342818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478876|NCT05342818|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102478877|NCT05342818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102478878|NCT05342818|Cholinergic Agents|cholinergic agents|mesh-ancestor
102478879|NCT05342818|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102478880|NCT05342818|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102478881|NCT05342818|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102478882|NCT05342818|Dopamine Agents|dopamine agents|mesh-ancestor
102478883|NCT00867217|Vitamin D|vitamin d|mesh-list
102478884|NCT00867217|Ergocalciferols|ergocalciferols|mesh-list
102478885|NCT00867217|Cholecalciferol|cholecalciferol|mesh-list
102478886|NCT00867217|Vitamins|vitamins|mesh-list
102478887|NCT00867217|Letrozole|letrozole|mesh-list
102478888|NCT00867217|Micronutrients|micronutrients|mesh-ancestor
102478889|NCT00867217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478890|NCT00867217|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102478891|NCT00867217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102478892|NCT00867217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102478893|NCT00867217|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101562456|NCT05940324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102478894|NCT00867217|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102478895|NCT00867217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102478896|NCT00867217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478897|NCT00867217|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102290554|NCT05504213|Fulvestrant|fulvestrant|mesh-list
102478898|NCT00867217|Hormone Antagonists|hormone antagonists|mesh-ancestor
102478899|NCT00867217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102478900|NCT00867451|Melatonin|melatonin|mesh-list
102478901|NCT00867451|Antioxidants|antioxidants|mesh-ancestor
102478902|NCT00867451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478903|NCT00867451|Protective Agents|protective agents|mesh-ancestor
102478904|NCT00867451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478905|NCT00867451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102478906|NCT00867529|Rituximab|rituximab|mesh-list
102478907|NCT00867529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102478908|NCT00867529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102478909|NCT00867529|Immunologic Factors|immunologic factors|mesh-ancestor
102478910|NCT00867529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478911|NCT00867529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102478912|NCT05197270|Aflibercept|aflibercept|mesh-list
102478913|NCT05197270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102478914|NCT05197270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102478915|NCT05197270|Growth Substances|growth substances|mesh-ancestor
102478916|NCT05197270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478917|NCT05197270|Growth Inhibitors|growth inhibitors|mesh-ancestor
102478918|NCT05197270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101562479|NCT05940064|Rituximab|rituximab|mesh-list
102478919|NCT05028946|Muromonab-CD3|muromonab-cd3|mesh-list
102478920|NCT05028946|Immunologic Factors|immunologic factors|mesh-ancestor
102478921|NCT05028946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478922|NCT05028946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102478923|NCT00889915|Methylphenidate|methylphenidate|mesh-list
102478924|NCT00889915|Amphetamine|amphetamine|mesh-list
102478925|NCT00889915|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102478926|NCT00889915|Adderall|adderall|mesh-list
102478927|NCT00889915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102478928|NCT00889915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478929|NCT00889915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102478930|NCT00889915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102478931|NCT00889915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102478932|NCT00889915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478933|NCT00889915|Dopamine Agents|dopamine agents|mesh-ancestor
102478934|NCT00889915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102478935|NCT00889915|Sympathomimetics|sympathomimetics|mesh-ancestor
102478936|NCT00889915|Autonomic Agents|autonomic agents|mesh-ancestor
102478937|NCT00889915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102478938|NCT00889915|Adrenergic Agents|adrenergic agents|mesh-ancestor
102478939|NCT00889915|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102478940|NCT00841087|Insulin|insulin|mesh-list
102478941|NCT00841087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102478942|NCT00841087|Insulin Aspart|insulin aspart|mesh-list
102478943|NCT00841087|Insulin Detemir|insulin detemir|mesh-list
102478944|NCT00841087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102478945|NCT00841087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478946|NCT02685436|Domperidone|domperidone|mesh-list
102478947|NCT02685436|Omeprazole|omeprazole|mesh-list
102478948|NCT02685436|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102478949|NCT02685436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102478950|NCT02685436|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102478951|NCT02685436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101562511|NCT05939882|Respiratory System Agents|respiratory system agents|mesh-ancestor
102478952|NCT02685436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478953|NCT02685436|Antiemetics|antiemetics|mesh-ancestor
102478954|NCT02685436|Autonomic Agents|autonomic agents|mesh-ancestor
102478955|NCT02685436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102478956|NCT02685436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478957|NCT02685436|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102478958|NCT02685436|Dopamine Agents|dopamine agents|mesh-ancestor
102478959|NCT02685436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102478960|NCT00841555|Temozolomide|temozolomide|mesh-list
102478961|NCT00841555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102478962|NCT00841555|Alkylating Agents|alkylating agents|mesh-ancestor
102478963|NCT00841555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478964|NCT00841555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102478965|NCT00842023|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
102478966|NCT00842023|Nitroglycerin|nitroglycerin|mesh-list
102478967|NCT00842023|Vasodilator Agents|vasodilator agents|mesh-ancestor
102478968|NCT00842023|Natriuretic Agents|natriuretic agents|mesh-ancestor
102478969|NCT00842023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478970|NCT00868309|Antivenins|antivenins|mesh-list
102478971|NCT00868309|Immunologic Factors|immunologic factors|mesh-ancestor
102478972|NCT00868309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478973|NCT00368134|Vildagliptin|vildagliptin|mesh-list
102478974|NCT00368134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102478975|NCT00368134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478976|NCT00368134|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102478977|NCT00368134|Protease Inhibitors|protease inhibitors|mesh-ancestor
102478978|NCT00368134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102478979|NCT00368134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478980|NCT02697292|Immunoglobulins|immunoglobulins|mesh-list
102478981|NCT02697292|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102478983|NCT02697292|gamma-Globulins|gamma-globulins|mesh-list
102478984|NCT02697292|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102478985|NCT02697292|Immunologic Factors|immunologic factors|mesh-ancestor
102478986|NCT02697292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478987|NCT02700334|Dapagliflozin|dapagliflozin|mesh-list
102478988|NCT02700334|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101562550|NCT05939648|Vaccines|vaccines|mesh-list
102478989|NCT02700334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102478990|NCT02700334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102478991|NCT02700334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102478992|NCT00868699|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102478993|NCT00868699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102478994|NCT00868699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102478995|NCT00868699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102478996|NCT00868699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524500|NCT01785771|Hormones|hormones|mesh-ancestor
102478997|NCT00868699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102478998|NCT00868699|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102478999|NCT00868699|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102479000|NCT00868699|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102479001|NCT00868699|Adrenergic Agents|adrenergic agents|mesh-ancestor
102479002|NCT00868699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102479003|NCT00868699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479004|NCT00868699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102479005|NCT00868699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102479006|NCT00868699|Serotonin Agents|serotonin agents|mesh-ancestor
101562568|NCT05939180|Antiviral Agents|antiviral agents|mesh-ancestor
102479007|NCT00868699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102479008|NCT00868699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102479009|NCT00868699|Dopamine Agents|dopamine agents|mesh-ancestor
102479010|NCT02701582|Phenylephrine|phenylephrine|mesh-list
102479011|NCT02701582|Epinephrine|epinephrine|mesh-list
102479012|NCT02701582|Oxymetazoline|oxymetazoline|mesh-list
102479013|NCT02701582|Synephrine|synephrine|mesh-list
102479014|NCT02701582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102479015|NCT02701582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101562579|NCT05939076|Dronedarone|dronedarone|mesh-list
102479016|NCT02701582|Adrenergic Agents|adrenergic agents|mesh-ancestor
102479017|NCT02701582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102479018|NCT02701582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479019|NCT02701582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479020|NCT02701582|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102479021|NCT02701582|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102479022|NCT02701582|Autonomic Agents|autonomic agents|mesh-ancestor
102479023|NCT02701582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102479024|NCT02701582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102479025|NCT02701582|Respiratory System Agents|respiratory system agents|mesh-ancestor
102479026|NCT02701582|Mydriatics|mydriatics|mesh-ancestor
102479027|NCT02701582|Sympathomimetics|sympathomimetics|mesh-ancestor
102479028|NCT02701582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102479029|NCT02701582|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102479030|NCT02701582|Nasal Decongestants|nasal decongestants|mesh-ancestor
102479031|NCT02701582|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102479032|NCT02701582|Protective Agents|protective agents|mesh-ancestor
102479033|NCT00869791|Levodopa|levodopa|mesh-list
102479034|NCT00869791|Carbidopa|carbidopa|mesh-list
102479035|NCT00869791|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102479036|NCT00869791|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102479037|NCT00869791|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102479038|NCT00869791|Dopamine Agents|dopamine agents|mesh-ancestor
102479039|NCT00869791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102479040|NCT00869791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479041|NCT00869791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479042|NCT00869791|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102479043|NCT00869791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102479044|NCT00869791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102479045|NCT00869791|Immunologic Factors|immunologic factors|mesh-ancestor
102479046|NCT00869791|Dopamine Agonists|dopamine agonists|mesh-ancestor
102479047|NCT02704702|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102479048|NCT02704702|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101752804|NCT00849550|Antimetabolites|antimetabolites|mesh-ancestor
102479049|NCT02704702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102479050|NCT02704702|Antimetabolites|antimetabolites|mesh-ancestor
102479051|NCT02704702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479052|NCT02704702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102479053|NCT02704702|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102479054|NCT02704702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102479055|NCT00895531|Morphine|morphine|mesh-list
101562622|NCT05937282|Lidocaine|lidocaine|mesh-list
102479056|NCT00895531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102479057|NCT00895531|Narcotics|narcotics|mesh-ancestor
102479058|NCT00895531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102479059|NCT00895531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479060|NCT00895531|Analgesics|analgesics|mesh-ancestor
102479061|NCT00895531|Sensory System Agents|sensory system agents|mesh-ancestor
102479062|NCT00895531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102479063|NCT03215875|Torsemide|torsemide|mesh-list
102479064|NCT03215875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102479065|NCT03215875|Diuretics|diuretics|mesh-ancestor
102479066|NCT03215875|Natriuretic Agents|natriuretic agents|mesh-ancestor
102479067|NCT03215875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479068|NCT03215875|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102479069|NCT03215875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102479070|NCT03215875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479071|NCT02710630|Dabigatran|dabigatran|mesh-list
102479072|NCT02710630|Antithrombins|antithrombins|mesh-ancestor
102479073|NCT02710630|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102479074|NCT02710630|Protease Inhibitors|protease inhibitors|mesh-ancestor
102479075|NCT02710630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102479076|NCT02710630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479077|NCT02710630|Anticoagulants|anticoagulants|mesh-ancestor
102479078|NCT02715700|Methadone|methadone|mesh-list
102479079|NCT02715700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102479080|NCT02715700|Narcotics|narcotics|mesh-ancestor
102479081|NCT02715700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102479082|NCT02715700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479083|NCT02715700|Analgesics|analgesics|mesh-ancestor
102479084|NCT02715700|Sensory System Agents|sensory system agents|mesh-ancestor
102479085|NCT02715700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102479086|NCT02715700|Antitussive Agents|antitussive agents|mesh-ancestor
101562654|NCT05935787|Riboflavin|riboflavin|mesh-list
102479087|NCT02715700|Respiratory System Agents|respiratory system agents|mesh-ancestor
102479088|NCT00895921|Olanzapine|olanzapine|mesh-list
102479089|NCT00895921|Aripiprazole|aripiprazole|mesh-list
102479090|NCT00895921|Antiemetics|antiemetics|mesh-ancestor
102479091|NCT00895921|Autonomic Agents|autonomic agents|mesh-ancestor
102479092|NCT00895921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102479093|NCT00895921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479094|NCT00895921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102479095|NCT00895921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102479096|NCT00895921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102479097|NCT00895921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102479098|NCT00895921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102479099|NCT00895921|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102479100|NCT00895921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102479101|NCT00895921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102479102|NCT00895921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479103|NCT00895921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102479104|NCT00895921|Serotonin Agents|serotonin agents|mesh-ancestor
102479105|NCT00895921|Antidepressive Agents|antidepressive agents|mesh-ancestor
102479106|NCT00895921|Dopamine Agonists|dopamine agonists|mesh-ancestor
102479107|NCT00895921|Dopamine Agents|dopamine agents|mesh-ancestor
102479108|NCT00895921|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102479109|NCT00895921|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102479110|NCT00895921|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102479111|NCT00895921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102479112|NCT00895921|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102479113|NCT00895921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102479114|NCT05315479|Meloxicam|meloxicam|mesh-list
102479115|NCT05315479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102479116|NCT05315479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102479117|NCT05315479|Analgesics|analgesics|mesh-ancestor
102479118|NCT05315479|Sensory System Agents|sensory system agents|mesh-ancestor
102479119|NCT05315479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102479120|NCT05315479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562690|NCT05932251|Metformin|metformin|mesh-list
102479121|NCT05315479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102479122|NCT05315479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102479123|NCT05315479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102479124|NCT05315479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102479125|NCT05315479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102479126|NCT05315479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479127|NCT00883675|Carboplatin|carboplatin|mesh-list
102479129|NCT00883675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102479130|NCT00883675|Tubulin Modulators|tubulin modulators|mesh-ancestor
102479131|NCT00883675|Antimitotic Agents|antimitotic agents|mesh-ancestor
102479132|NCT00883675|Mitosis Modulators|mitosis modulators|mesh-ancestor
102479133|NCT00883675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479134|NCT03215407|Betamethasone|betamethasone|mesh-list
102479135|NCT03215407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102479136|NCT03215407|Glucocorticoids|glucocorticoids|mesh-ancestor
102479137|NCT03215407|Hormones|hormones|mesh-ancestor
102479138|NCT03215407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102479139|NCT03215407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479140|NCT03215407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102479141|NCT03215407|Respiratory System Agents|respiratory system agents|mesh-ancestor
102479142|NCT05310331|Paclitaxel|paclitaxel|mesh-list
102479143|NCT05310331|Antibodies|antibodies|mesh-list
102479144|NCT05310331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102479145|NCT05310331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102479146|NCT05310331|Tubulin Modulators|tubulin modulators|mesh-ancestor
102479147|NCT05310331|Antimitotic Agents|antimitotic agents|mesh-ancestor
102479148|NCT05310331|Mitosis Modulators|mitosis modulators|mesh-ancestor
102479149|NCT05310331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479150|NCT05310331|Immunologic Factors|immunologic factors|mesh-ancestor
101753491|NCT00723918|Methadone|methadone|mesh-list
102479151|NCT05310331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479152|NCT00885079|Rebamipide|rebamipide|mesh-list
102479153|NCT00885079|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102479154|NCT00885079|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102479155|NCT00885079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102479156|NCT00885079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102479157|NCT00885079|Antioxidants|antioxidants|mesh-ancestor
102479158|NCT00885079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479159|NCT00885079|Protective Agents|protective agents|mesh-ancestor
102479160|NCT00885079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479161|NCT00885079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102479162|NCT00896779|Ranibizumab|ranibizumab|mesh-list
102479163|NCT00896779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101562725|NCT05919173|Bupivacaine|bupivacaine|mesh-list
102479164|NCT00896779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102479165|NCT00896779|Growth Substances|growth substances|mesh-ancestor
102479166|NCT00896779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479167|NCT00896779|Growth Inhibitors|growth inhibitors|mesh-ancestor
102479168|NCT00896779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102479169|NCT03214939|Immunomodulating Agents|immunomodulating agents|mesh-list
102479170|NCT03214939|Immunologic Factors|immunologic factors|mesh-ancestor
102479171|NCT03214939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479172|NCT03376477|Lenalidomide|lenalidomide|mesh-list
102479173|NCT03376477|Molgramostim|molgramostim|mesh-list
102479174|NCT03376477|Vaccines|vaccines|mesh-list
102479175|NCT03376477|Sargramostim|sargramostim|mesh-list
102479176|NCT03376477|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102479177|NCT03376477|Immunologic Factors|immunologic factors|mesh-ancestor
102479178|NCT03376477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479179|NCT03376477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102479180|NCT03376477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102479181|NCT03376477|Growth Substances|growth substances|mesh-ancestor
102479182|NCT03376477|Growth Inhibitors|growth inhibitors|mesh-ancestor
102479183|NCT03376477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102479184|NCT02726620|Lidocaine|lidocaine|mesh-list
102479185|NCT02726620|Atropine|atropine|mesh-list
102479186|NCT02726620|Terlipressin|terlipressin|mesh-list
102479187|NCT02726620|Phenylephrine|phenylephrine|mesh-list
102479188|NCT02726620|Dobutamine|dobutamine|mesh-list
102479189|NCT02726620|Dopamine|dopamine|mesh-list
102479190|NCT02726620|Milrinone|milrinone|mesh-list
102479191|NCT02726620|Isoproterenol|isoproterenol|mesh-list
102479192|NCT02726620|Vasopressins|vasopressins|mesh-list
102479193|NCT02726620|Epinephrine|epinephrine|mesh-list
102479194|NCT02726620|Norepinephrine|norepinephrine|mesh-list
102479195|NCT02726620|Ephedrine|ephedrine|mesh-list
102479196|NCT02726620|Glycopyrrolate|glycopyrrolate|mesh-list
102479197|NCT02726620|Bupivacaine|bupivacaine|mesh-list
102479198|NCT02726620|Ropivacaine|ropivacaine|mesh-list
102479199|NCT02726620|Levobupivacaine|levobupivacaine|mesh-list
102479200|NCT02726620|Tetracaine|tetracaine|mesh-list
102479201|NCT02726620|Prilocaine|prilocaine|mesh-list
102479202|NCT02726620|Mepivacaine|mepivacaine|mesh-list
102479203|NCT02726620|Benzocaine|benzocaine|mesh-list
102479204|NCT02726620|Chloroprocaine|chloroprocaine|mesh-list
102479205|NCT02726620|Procaine|procaine|mesh-list
102479206|NCT02726620|Anesthetics|anesthetics|mesh-list
102479207|NCT02726620|Propofol|propofol|mesh-list
102479208|NCT02726620|Sevoflurane|sevoflurane|mesh-list
102479209|NCT02726620|Desflurane|desflurane|mesh-list
102479210|NCT02726620|Isoflurane|isoflurane|mesh-list
102479211|NCT02726620|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102479212|NCT02726620|Plasma-lyte 148|plasma-lyte 148|mesh-list
102479213|NCT02726620|Anesthetics, Local|anesthetics, local|mesh-ancestor
102479214|NCT02726620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102479215|NCT02726620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562771|NCT05906511|Analgesics|analgesics|mesh-ancestor
102479216|NCT02726620|Sensory System Agents|sensory system agents|mesh-ancestor
101754035|NCT00730574|Hydroxocobalamin|hydroxocobalamin|mesh-list
102479217|NCT02726620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102479218|NCT02726620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102479219|NCT02726620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102479220|NCT02726620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102479221|NCT02726620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102479222|NCT02726620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479223|NCT02726620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102479224|NCT02726620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102479225|NCT02726620|Anesthetics, General|anesthetics, general|mesh-ancestor
102479226|NCT02726620|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102479227|NCT02726620|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101562776|NCT05906511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102479228|NCT02726620|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102479229|NCT02726620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102479230|NCT02726620|Adrenergic Agents|adrenergic agents|mesh-ancestor
102479231|NCT02726620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102479232|NCT02726620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102479233|NCT02726620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102479234|NCT02726620|Autonomic Agents|autonomic agents|mesh-ancestor
102479235|NCT02726620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102479236|NCT02726620|Respiratory System Agents|respiratory system agents|mesh-ancestor
102479237|NCT02726620|Mydriatics|mydriatics|mesh-ancestor
102479238|NCT02726620|Sympathomimetics|sympathomimetics|mesh-ancestor
102479239|NCT02726620|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102479240|NCT02726620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102479241|NCT02726620|Nasal Decongestants|nasal decongestants|mesh-ancestor
102479242|NCT02726620|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102479243|NCT02726620|Protective Agents|protective agents|mesh-ancestor
102479244|NCT02726620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102479245|NCT02726620|Parasympatholytics|parasympatholytics|mesh-ancestor
102479246|NCT02726620|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102479247|NCT02726620|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102479248|NCT02726620|Cholinergic Agents|cholinergic agents|mesh-ancestor
102479249|NCT02726620|Hemostatics|hemostatics|mesh-ancestor
102479250|NCT02726620|Coagulants|coagulants|mesh-ancestor
102479251|NCT02726620|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102479252|NCT02726620|Natriuretic Agents|natriuretic agents|mesh-ancestor
102479253|NCT02726620|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102479254|NCT02726620|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102479255|NCT02726620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102479256|NCT02726620|Dopamine Agents|dopamine agents|mesh-ancestor
102479257|NCT02726620|Vasodilator Agents|vasodilator agents|mesh-ancestor
102479258|NCT02726620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102479259|NCT02726620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102479260|NCT02726620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102479261|NCT02726620|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102479262|NCT00887575|Paclitaxel|paclitaxel|mesh-list
102479263|NCT00887575|Carboplatin|carboplatin|mesh-list
102479264|NCT00887575|Sunitinib|sunitinib|mesh-list
102479265|NCT00887575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102479266|NCT00887575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102479267|NCT00887575|Tubulin Modulators|tubulin modulators|mesh-ancestor
102479268|NCT00887575|Antimitotic Agents|antimitotic agents|mesh-ancestor
102479269|NCT00887575|Mitosis Modulators|mitosis modulators|mesh-ancestor
102479270|NCT00887575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479271|NCT00887575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102479272|NCT00887575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102479273|NCT00887575|Growth Substances|growth substances|mesh-ancestor
102479274|NCT00887575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479275|NCT00887575|Growth Inhibitors|growth inhibitors|mesh-ancestor
102479276|NCT00887575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102290929|NCT04856137|Immunologic Factors|immunologic factors|mesh-ancestor
102479277|NCT00887575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102479278|NCT03352843|Primaquine|primaquine|mesh-list
102479279|NCT03352843|Antimalarials|antimalarials|mesh-ancestor
102479280|NCT03352843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102479281|NCT03352843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102479282|NCT03352843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102479283|NCT03238027|Durvalumab|durvalumab|mesh-list
102479284|NCT03238027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102479285|NCT03238027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101562849|NCT05854784|Afamelanotide|afamelanotide|mesh-list
102479286|NCT00887653|Raltegravir Potassium|raltegravir potassium|mesh-list
102479287|NCT00887653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102479288|NCT00887653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102479289|NCT00887653|Antiviral Agents|antiviral agents|mesh-ancestor
102479290|NCT00887653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102479291|NCT00887653|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102479292|NCT00887653|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102479293|NCT00887653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102479294|NCT00887653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479295|NCT00887965|Denosumab|denosumab|mesh-list
102479296|NCT00887965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102479297|NCT00887965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479298|NCT02729038|Gepotidacin|gepotidacin|mesh-list
102479299|NCT02729038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102479300|NCT02729038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102479301|NCT02729038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479302|NCT02729038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102479303|NCT05311813|Hydroxychloroquine|hydroxychloroquine|mesh-list
102479304|NCT05311813|Enoxaparin|enoxaparin|mesh-list
102479305|NCT05311813|Antimalarials|antimalarials|mesh-ancestor
102479306|NCT05311813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102479307|NCT05311813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102479308|NCT05311813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102479309|NCT05311813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102479310|NCT05311813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479311|NCT05311813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102479312|NCT05311813|Anticoagulants|anticoagulants|mesh-ancestor
102479313|NCT05311813|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102479314|NCT05311813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102479315|NCT03214627|Iron|iron|mesh-list
102479316|NCT03214627|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102479317|NCT03214627|Hematinics|hematinics|mesh-list
102479318|NCT03214627|Trace Elements|trace elements|mesh-ancestor
102479319|NCT03214627|Micronutrients|micronutrients|mesh-ancestor
102479320|NCT03214627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479321|NCT00888511|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102479322|NCT00888511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101562877|NCT05821309|Laxatives|laxatives|mesh-ancestor
102479323|NCT00888511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102479324|NCT00888511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102479325|NCT00888511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479326|NCT03214393|Antibodies|antibodies|mesh-list
102479327|NCT03214393|Immunologic Factors|immunologic factors|mesh-ancestor
102479328|NCT03214393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479329|NCT00888979|Nicotine|nicotine|mesh-list
102479330|NCT00888979|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102479331|NCT00888979|Autonomic Agents|autonomic agents|mesh-ancestor
102479332|NCT00888979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102479333|NCT00888979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479334|NCT00888979|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102479335|NCT00888979|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102479336|NCT00888979|Cholinergic Agents|cholinergic agents|mesh-ancestor
102479337|NCT00888979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102479338|NCT00888979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479339|NCT03214159|Ritonavir|ritonavir|mesh-list
102479340|NCT03214159|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102479341|NCT03214159|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102479342|NCT03214159|Protease Inhibitors|protease inhibitors|mesh-ancestor
102479343|NCT03214159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102479344|NCT03214159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479345|NCT03214159|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102479346|NCT03214159|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102479347|NCT03214159|Antiviral Agents|antiviral agents|mesh-ancestor
101562905|NCT05746377|Antiemetics|antiemetics|mesh-ancestor
102479348|NCT03214159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102479349|NCT03214159|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102479350|NCT03214159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102479351|NCT02737072|Durvalumab|durvalumab|mesh-list
102291016|NCT04839913|Antibodies|antibodies|mesh-list
102479352|NCT02737072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102479353|NCT02737072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102479354|NCT05446480|Desloratadine|desloratadine|mesh-list
102479355|NCT05446480|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102479356|NCT05446480|Cholinergic Agents|cholinergic agents|mesh-ancestor
102479357|NCT05446480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102479358|NCT05446480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479359|NCT05446480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479360|NCT05446480|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102479361|NCT05446480|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102479362|NCT05446480|Histamine Antagonists|histamine antagonists|mesh-ancestor
102479363|NCT05446480|Histamine Agents|histamine agents|mesh-ancestor
102479364|NCT03213145|Rifampin|rifampin|mesh-list
102479365|NCT03213145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102479366|NCT03213145|Antitubercular Agents|antitubercular agents|mesh-ancestor
102479367|NCT03213145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102479368|NCT03213145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102479369|NCT03213145|Leprostatic Agents|leprostatic agents|mesh-ancestor
102479370|NCT03213145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102479371|NCT03213145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102479372|NCT03213145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479373|NCT03213145|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101562934|NCT05655949|Cisplatin|cisplatin|mesh-list
102479374|NCT03213145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102479375|NCT03213145|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102479376|NCT03213145|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102479377|NCT03213145|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102479378|NCT03213145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102479379|NCT02722564|Ethanol|ethanol|mesh-list
102479380|NCT02722564|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102479381|NCT02722564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101562939|NCT05655949|Antimetabolites|antimetabolites|mesh-ancestor
102479382|NCT02722564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102479383|NCT02722564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479384|NCT05446090|Nitric Oxide|nitric oxide|mesh-list
102479385|NCT05446090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102479386|NCT05446090|Autonomic Agents|autonomic agents|mesh-ancestor
102479387|NCT05446090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102479388|NCT05446090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479389|NCT05446090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101755400|NCT00424021|Ambrisentan|ambrisentan|mesh-list
102479390|NCT05446090|Respiratory System Agents|respiratory system agents|mesh-ancestor
102479391|NCT05446090|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102479392|NCT05446090|Antioxidants|antioxidants|mesh-ancestor
102479393|NCT05446090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479394|NCT05446090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102479395|NCT05446090|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102479396|NCT05446090|Vasodilator Agents|vasodilator agents|mesh-ancestor
102479397|NCT05446090|Gasotransmitters|gasotransmitters|mesh-ancestor
102479398|NCT05446090|Protective Agents|protective agents|mesh-ancestor
102479399|NCT05444998|Paclitaxel|paclitaxel|mesh-list
102479400|NCT05444998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102479401|NCT05444998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102479402|NCT05444998|Tubulin Modulators|tubulin modulators|mesh-ancestor
102479403|NCT05444998|Antimitotic Agents|antimitotic agents|mesh-ancestor
102479404|NCT05444998|Mitosis Modulators|mitosis modulators|mesh-ancestor
102479405|NCT05444998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479406|NCT05444842|Insulin|insulin|mesh-list
102479407|NCT05444842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102479408|NCT05444842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102479409|NCT05444842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479410|NCT04381741|Antibodies|antibodies|mesh-list
102479411|NCT04381741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102479412|NCT04381741|Immunologic Factors|immunologic factors|mesh-ancestor
102479413|NCT04381741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479414|NCT05444452|Sirolimus|sirolimus|mesh-list
102479415|NCT05444452|Everolimus|everolimus|mesh-list
102479416|NCT05444452|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101562971|NCT05645393|Estrogens|estrogens|mesh-list
102479417|NCT05444452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102479418|NCT05444452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102479419|NCT05444452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479420|NCT05444452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102479421|NCT05444452|Immunologic Factors|immunologic factors|mesh-ancestor
102479422|NCT05444452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479423|NCT05444452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102479424|NCT05444452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102479425|NCT05444452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102479426|NCT05444452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102479427|NCT05444452|Antifungal Agents|antifungal agents|mesh-ancestor
102291092|NCT04845061|Nebivolol|nebivolol|mesh-list
102479428|NCT05444374|Bevacizumab|bevacizumab|mesh-list
102479429|NCT05444374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102479430|NCT05444374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102479431|NCT05444374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102479432|NCT05444374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102479433|NCT05444374|Growth Substances|growth substances|mesh-ancestor
102479434|NCT05444374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479435|NCT05444374|Growth Inhibitors|growth inhibitors|mesh-ancestor
102479436|NCT05444218|Amoxicillin|amoxicillin|mesh-list
102479437|NCT05444218|Metronidazole|metronidazole|mesh-list
102479438|NCT05444218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102479439|NCT05444218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102479440|NCT05444218|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102479441|NCT05444218|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102479442|NCT01830361|Midostaurin|midostaurin|mesh-list
102479443|NCT01830361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102479444|NCT01830361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102479445|NCT01830361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102479446|NCT01830361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479447|NCT01830517|Losartan|losartan|mesh-list
102479448|NCT01830517|Amlodipine|amlodipine|mesh-list
102479449|NCT01830517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102479450|NCT01830517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102479451|NCT01830517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102479452|NCT01830517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479453|NCT01830517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102479454|NCT01830517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479455|NCT01830517|Vasodilator Agents|vasodilator agents|mesh-ancestor
102479456|NCT01830517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102479457|NCT01830517|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102479458|NCT01830517|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102479459|NCT03212833|Insulin|insulin|mesh-list
102479460|NCT03212833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102479461|NCT03212833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479462|NCT05443360|Calcium, Dietary|calcium, dietary|mesh-list
102479463|NCT05443360|Calcium Carbonate|calcium carbonate|mesh-list
102479464|NCT05443360|Calcium|calcium|mesh-list
102479465|NCT05443360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102479466|NCT05443360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479467|NCT05443360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102479468|NCT05443360|Antacids|antacids|mesh-ancestor
102479469|NCT05443360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479470|NCT05443360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102479471|NCT05443282|Hormones|hormones|mesh-list
102479472|NCT05443282|Estradiol|estradiol|mesh-list
102479473|NCT05443282|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102479474|NCT05443282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102479475|NCT05443282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479476|NCT05443282|Estrogens|estrogens|mesh-ancestor
102479477|NCT00904345|Cetuximab|cetuximab|mesh-list
102479478|NCT00904345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102479479|NCT00904345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102479480|NCT05442736|Ciprofloxacin|ciprofloxacin|mesh-list
102479481|NCT05442736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102479482|NCT05442736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102479483|NCT05442736|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102479484|NCT05442736|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102479485|NCT05442736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102479486|NCT05442736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479487|NCT05442736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102479488|NCT05442736|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102479489|NCT05442736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102479490|NCT01830829|Tamsulosin|tamsulosin|mesh-list
102479491|NCT01830829|Dutasteride|dutasteride|mesh-list
102479492|NCT01830829|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102479493|NCT01830829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102479494|NCT01830829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102479495|NCT01830829|Adrenergic Agents|adrenergic agents|mesh-ancestor
102479496|NCT01830829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102479497|NCT01830829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479498|NCT01830829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479499|NCT01830829|Urological Agents|urological agents|mesh-ancestor
102479500|NCT01830829|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102291155|NCT03038425|Ropivacaine|ropivacaine|mesh-list
102479501|NCT01830829|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102479502|NCT01830829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102479503|NCT01830829|Hormone Antagonists|hormone antagonists|mesh-ancestor
102479504|NCT01830829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102479505|NCT03212755|Immunoglobulins|immunoglobulins|mesh-list
102479506|NCT03212755|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102479507|NCT03212755|Antibodies|antibodies|mesh-list
102479508|NCT03212755|Immunoglobulin G|immunoglobulin g|mesh-list
102479509|NCT03212755|Immunologic Factors|immunologic factors|mesh-ancestor
102479510|NCT03212755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479511|NCT05437822|Tranexamic Acid|tranexamic acid|mesh-list
102479512|NCT05437822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102479513|NCT05437822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101563111|NCT05505630|Ketamine|ketamine|mesh-list
102479514|NCT05437822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479515|NCT05437822|Hemostatics|hemostatics|mesh-ancestor
102479516|NCT05437822|Coagulants|coagulants|mesh-ancestor
102479517|NCT03212599|Disulfiram|disulfiram|mesh-list
102479518|NCT03212599|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102479519|NCT03212599|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
102479520|NCT03212599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102479521|NCT03212599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479522|NCT03212053|Hemostatics|hemostatics|mesh-list
102479523|NCT03212053|Coagulants|coagulants|mesh-ancestor
102479524|NCT05311189|Trastuzumab|trastuzumab|mesh-list
102479525|NCT05311189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101563123|NCT05505630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102479526|NCT05311189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102479527|NCT00369772|Darbepoetin alfa|darbepoetin alfa|mesh-list
102479528|NCT00369772|Hematinics|hematinics|mesh-ancestor
102479529|NCT03211897|Midazolam|midazolam|mesh-list
102479530|NCT03211897|Haloperidol|haloperidol|mesh-list
102479531|NCT03211897|Olanzapine|olanzapine|mesh-list
102479532|NCT03211897|Haloperidol decanoate|haloperidol decanoate|mesh-list
102479533|NCT03211897|Ziprasidone|ziprasidone|mesh-list
102479534|NCT03211897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102479535|NCT03211897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102479536|NCT03211897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102479537|NCT03211897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479538|NCT03211897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102479539|NCT03211897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102479540|NCT03211897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102479541|NCT03211897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102479542|NCT03211897|Anesthetics, General|anesthetics, general|mesh-ancestor
102479543|NCT03211897|Anesthetics|anesthetics|mesh-ancestor
102479544|NCT03211897|GABA Modulators|gaba modulators|mesh-ancestor
102479545|NCT03211897|GABA Agents|gaba agents|mesh-ancestor
102479546|NCT03211897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102479547|NCT03211897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479548|NCT03211897|Antiemetics|antiemetics|mesh-ancestor
102479549|NCT03211897|Autonomic Agents|autonomic agents|mesh-ancestor
102479550|NCT03211897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102479551|NCT03211897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102479552|NCT03211897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102479553|NCT03211897|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102479554|NCT03211897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102479555|NCT03211897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102479556|NCT03211897|Serotonin Agents|serotonin agents|mesh-ancestor
102479557|NCT03211897|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102479558|NCT03211897|Dopamine Agents|dopamine agents|mesh-ancestor
102479559|NCT03211897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102479560|NCT03211897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102479561|NCT01831687|Etodolac|etodolac|mesh-list
102479562|NCT01831687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102479563|NCT01831687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102479564|NCT01831687|Analgesics|analgesics|mesh-ancestor
102479565|NCT01831687|Sensory System Agents|sensory system agents|mesh-ancestor
102479566|NCT01831687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102479567|NCT01831687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479568|NCT01831687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102479569|NCT01831687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102479570|NCT01831687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102479571|NCT01831687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102479572|NCT01831687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101563165|NCT05410821|Chelating Agents|chelating agents|mesh-ancestor
102479573|NCT01831687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291235|NCT04842487|Hormones|hormones|mesh-ancestor
102479574|NCT05441254|Paclitaxel|paclitaxel|mesh-list
102479575|NCT05441254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102479576|NCT05441254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102479577|NCT05441254|Tubulin Modulators|tubulin modulators|mesh-ancestor
102479578|NCT05441254|Antimitotic Agents|antimitotic agents|mesh-ancestor
102479579|NCT05441254|Mitosis Modulators|mitosis modulators|mesh-ancestor
102479580|NCT05441254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479581|NCT00369148|Nateglinide|nateglinide|mesh-list
102479582|NCT00369148|Mitiglinide|mitiglinide|mesh-list
102479583|NCT00369148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102479584|NCT00369148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479585|NCT01832467|Cetuximab|cetuximab|mesh-list
102479586|NCT01832467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102479587|NCT01832467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102479588|NCT03211351|Dextrans|dextrans|mesh-list
102479589|NCT03211351|Anticoagulants|anticoagulants|mesh-ancestor
102479590|NCT03211351|Plasma Substitutes|plasma substitutes|mesh-ancestor
102479591|NCT03211351|Blood Substitutes|blood substitutes|mesh-ancestor
102479592|NCT01832623|Vitamin D|vitamin d|mesh-list
102479593|NCT01832623|Vitamins|vitamins|mesh-ancestor
102479594|NCT01832623|Micronutrients|micronutrients|mesh-ancestor
102479595|NCT01832623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479596|NCT01832623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102479597|NCT03211195|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
102479598|NCT03211195|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102479599|NCT03211195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479600|NCT03211195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102479601|NCT03211195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479602|NCT02470390|Fentanyl|fentanyl|mesh-list
102479603|NCT02470390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102479604|NCT02470390|Narcotics|narcotics|mesh-ancestor
102479605|NCT02470390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102479606|NCT02470390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479607|NCT02470390|Analgesics|analgesics|mesh-ancestor
102479608|NCT02470390|Sensory System Agents|sensory system agents|mesh-ancestor
102479609|NCT02470390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102479610|NCT02470390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102479611|NCT02470390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102479612|NCT02470390|Anesthetics, General|anesthetics, general|mesh-ancestor
102479613|NCT02470390|Anesthetics|anesthetics|mesh-ancestor
102479614|NCT00363532|Calcitonin|calcitonin|mesh-list
102479615|NCT00363532|Salmon calcitonin|salmon calcitonin|mesh-list
102479616|NCT00363532|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
102479617|NCT00363532|Katacalcin|katacalcin|mesh-list
102479618|NCT00363532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102479619|NCT00363532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479620|NCT00363532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102479621|NCT00363532|Vasodilator Agents|vasodilator agents|mesh-ancestor
102479622|NCT00363610|Pegaspargase|pegaspargase|mesh-list
102479623|NCT00363610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102479624|NCT00363688|Penicillins|penicillins|mesh-list
102479625|NCT00363688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102479626|NCT00363688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102479627|NCT01832935|Insulin|insulin|mesh-list
102479628|NCT01832935|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102479629|NCT01832935|Insulin Glargine|insulin glargine|mesh-list
102479630|NCT01832935|Isophane Insulin, Human|isophane insulin, human|mesh-list
102479631|NCT01832935|Insulin, Isophane|insulin, isophane|mesh-list
102479632|NCT01832935|Isophane insulin, beef|isophane insulin, beef|mesh-list
102479633|NCT01832935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102479634|NCT01832935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479635|NCT03216733|Sirolimus|sirolimus|mesh-list
102479636|NCT03216733|Temsirolimus|temsirolimus|mesh-list
102479637|NCT03216733|MTOR Inhibitors|mtor inhibitors|mesh-list
102479638|NCT03216733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102479639|NCT03216733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101563230|NCT05311475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102479640|NCT03216733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102479641|NCT03216733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102479642|NCT03216733|Antifungal Agents|antifungal agents|mesh-ancestor
102479643|NCT03216733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102479644|NCT03216733|Immunologic Factors|immunologic factors|mesh-ancestor
102479645|NCT03216733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479646|NCT03216733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102479647|NCT03216733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102479648|NCT03216733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479649|NCT04380181|Milrinone|milrinone|mesh-list
102479650|NCT04380181|Epinephrine|epinephrine|mesh-list
102479651|NCT04380181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102479652|NCT04380181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102479653|NCT04380181|Adrenergic Agents|adrenergic agents|mesh-ancestor
102479654|NCT04380181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102479655|NCT04380181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563248|NCT05302817|Xenon|xenon|mesh-list
102479656|NCT04380181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479657|NCT04380181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102479658|NCT04380181|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102479659|NCT04380181|Autonomic Agents|autonomic agents|mesh-ancestor
102479660|NCT04380181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102479661|NCT04380181|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101563254|NCT05289492|Dexamethasone|dexamethasone|mesh-list
102479662|NCT04380181|Respiratory System Agents|respiratory system agents|mesh-ancestor
102479663|NCT04380181|Mydriatics|mydriatics|mesh-ancestor
102479664|NCT04380181|Sympathomimetics|sympathomimetics|mesh-ancestor
102479665|NCT04380181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102479666|NCT04380181|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102479667|NCT04380181|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102479668|NCT04380181|Vasodilator Agents|vasodilator agents|mesh-ancestor
102479669|NCT04380181|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102479670|NCT04380181|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102479671|NCT04380181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102479672|NCT04380181|Protective Agents|protective agents|mesh-ancestor
102479673|NCT01833559|Insulin|insulin|mesh-list
102479674|NCT01833559|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102479675|NCT01833559|Isophane Insulin, Human|isophane insulin, human|mesh-list
102479676|NCT01833559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102479677|NCT01833559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479678|NCT05394142|Metformin|metformin|mesh-list
102479679|NCT05394142|Pioglitazone|pioglitazone|mesh-list
102479680|NCT05394142|Spironolactone|spironolactone|mesh-list
102479681|NCT05394142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102479682|NCT05394142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479683|NCT05394142|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102479684|NCT05394142|Hormone Antagonists|hormone antagonists|mesh-ancestor
102479685|NCT05394142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102479686|NCT05394142|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102479687|NCT05394142|Diuretics|diuretics|mesh-ancestor
102479688|NCT05394142|Natriuretic Agents|natriuretic agents|mesh-ancestor
102479689|NCT00901225|Plerixafor|plerixafor|mesh-list
102479690|NCT00901225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102479691|NCT00901225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102479692|NCT00901225|Antiviral Agents|antiviral agents|mesh-ancestor
102479693|NCT00901225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102479694|NCT01833715|Morphine|morphine|mesh-list
102479695|NCT01833715|Methadone|methadone|mesh-list
102479696|NCT01833715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102479697|NCT01833715|Narcotics|narcotics|mesh-ancestor
102479698|NCT01833715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102479699|NCT01833715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479700|NCT01833715|Analgesics|analgesics|mesh-ancestor
102479701|NCT01833715|Sensory System Agents|sensory system agents|mesh-ancestor
102479702|NCT01833715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102479703|NCT01833715|Antitussive Agents|antitussive agents|mesh-ancestor
102479704|NCT01833715|Respiratory System Agents|respiratory system agents|mesh-ancestor
102479705|NCT05393050|Methotrexate|methotrexate|mesh-list
102479706|NCT05393050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102479707|NCT05393050|Abortifacient Agents|abortifacient agents|mesh-ancestor
102479708|NCT05393050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102479709|NCT05393050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479710|NCT05393050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102479711|NCT05393050|Antimetabolites|antimetabolites|mesh-ancestor
102479712|NCT05393050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479713|NCT05393050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102479714|NCT05393050|Dermatologic Agents|dermatologic agents|mesh-ancestor
102479715|NCT05393050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102479716|NCT05393050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102479717|NCT05393050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102479718|NCT05393050|Immunologic Factors|immunologic factors|mesh-ancestor
102479719|NCT05393050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102479720|NCT05393050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102479721|NCT03166228|Glycine|glycine|mesh-list
102479722|NCT03166228|Glycine Agents|glycine agents|mesh-ancestor
102479723|NCT03166228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102479724|NCT03166228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479725|NCT03166228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479726|NCT01833793|Levonorgestrel|levonorgestrel|mesh-list
102479727|NCT01833793|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102479728|NCT01833793|Contraceptive Agents|contraceptive agents|mesh-ancestor
102479729|NCT01833793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102479730|NCT01833793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479731|NCT01833793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102479732|NCT01833793|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102479733|NCT01833793|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102479734|NCT03154996|Topotecan|topotecan|mesh-list
102479735|NCT03154996|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102479736|NCT03154996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102479737|NCT03154996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101563320|NCT05198609|Apatinib|apatinib|mesh-list
102479738|NCT03154996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479739|NCT03154996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102479740|NCT02475070|Dapagliflozin|dapagliflozin|mesh-list
102479741|NCT02475070|Vildagliptin|vildagliptin|mesh-list
102479742|NCT02475070|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102479743|NCT02475070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479744|NCT02475070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102479745|NCT02475070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479746|NCT02475070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102479747|NCT02475070|Protease Inhibitors|protease inhibitors|mesh-ancestor
102479748|NCT02475070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102479749|NCT00902161|Propranolol|propranolol|mesh-list
102479750|NCT00902161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102479751|NCT00902161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102479752|NCT00902161|Adrenergic Agents|adrenergic agents|mesh-ancestor
102479753|NCT00902161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102479754|NCT00902161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479755|NCT00902161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479756|NCT00902161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102479757|NCT00902161|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102479758|NCT00902161|Vasodilator Agents|vasodilator agents|mesh-ancestor
102479759|NCT01834183|Gemcitabine|gemcitabine|mesh-list
102479760|NCT01834183|Tivozanib|tivozanib|mesh-list
102479761|NCT01834183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102479762|NCT01834183|Antimetabolites|antimetabolites|mesh-ancestor
102479763|NCT01834183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479764|NCT01834183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102479765|NCT01834183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102479766|NCT01834183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102479767|NCT02478580|Modafinil|modafinil|mesh-list
101563354|NCT05111145|Ivacaftor|ivacaftor|mesh-list
102479768|NCT02478580|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102479769|NCT02478580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479770|NCT02478580|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102479771|NCT02478580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102479772|NCT02478580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102479773|NCT02478580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479774|NCT03210493|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102479775|NCT03210493|Antiviral Agents|antiviral agents|mesh-ancestor
102479776|NCT03210493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102479777|NCT03210025|Methyldopa|methyldopa|mesh-list
101563359|NCT05090033|Ofatumumab|ofatumumab|mesh-list
102479778|NCT03210025|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102479779|NCT03210025|Sympatholytics|sympatholytics|mesh-ancestor
102479780|NCT03210025|Autonomic Agents|autonomic agents|mesh-ancestor
102479781|NCT03210025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102479782|NCT03210025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479783|NCT03210025|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102479784|NCT03210025|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102479785|NCT03210025|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102479786|NCT03210025|Adrenergic Agents|adrenergic agents|mesh-ancestor
102479787|NCT03210025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102479788|NCT03210025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479789|NCT03219853|Selenium|selenium|mesh-list
102479790|NCT03219853|Antioxidants|antioxidants|mesh-ancestor
102479791|NCT03219853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479792|NCT03219853|Protective Agents|protective agents|mesh-ancestor
102479793|NCT03219853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479794|NCT03219853|Trace Elements|trace elements|mesh-ancestor
102479795|NCT03219853|Micronutrients|micronutrients|mesh-ancestor
102479796|NCT05330884|BCG Vaccine|bcg vaccine|mesh-list
102479797|NCT05330884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102479798|NCT05330884|Immunologic Factors|immunologic factors|mesh-ancestor
102479799|NCT05330884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479800|NCT02480998|Vaccines|vaccines|mesh-list
102479801|NCT02480998|Immunologic Factors|immunologic factors|mesh-ancestor
102479802|NCT02480998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479803|NCT00905515|Cyclosporine|cyclosporine|mesh-list
102479805|NCT00905515|Cyclosporins|cyclosporins|mesh-list
102479806|NCT00905515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102479807|NCT00905515|Immunologic Factors|immunologic factors|mesh-ancestor
102479808|NCT00905515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479809|NCT00905515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102479810|NCT00905515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102479811|NCT00905515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479812|NCT00905515|Antifungal Agents|antifungal agents|mesh-ancestor
102479813|NCT00905515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102479814|NCT00905515|Dermatologic Agents|dermatologic agents|mesh-ancestor
102479815|NCT00905515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102479816|NCT03215797|Phenylephrine|phenylephrine|mesh-list
102479817|NCT03215797|Oxymetazoline|oxymetazoline|mesh-list
102479818|NCT03215797|Norepinephrine|norepinephrine|mesh-list
102479819|NCT03215797|Adrenergic Agonists|adrenergic agonists|mesh-list
102479820|NCT03215797|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102479821|NCT03215797|Mydriatics|mydriatics|mesh-ancestor
102479822|NCT03215797|Autonomic Agents|autonomic agents|mesh-ancestor
102479823|NCT03215797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102479824|NCT03215797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479825|NCT03215797|Sympathomimetics|sympathomimetics|mesh-ancestor
102479826|NCT03215797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102479827|NCT03215797|Nasal Decongestants|nasal decongestants|mesh-ancestor
102479828|NCT03215797|Respiratory System Agents|respiratory system agents|mesh-ancestor
102479829|NCT03215797|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102479830|NCT03215797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102479831|NCT03215797|Adrenergic Agents|adrenergic agents|mesh-ancestor
102479832|NCT03215797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102479833|NCT03215797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479834|NCT03215797|Protective Agents|protective agents|mesh-ancestor
102479835|NCT02485834|Docetaxel|docetaxel|mesh-list
102479836|NCT02485834|Capecitabine|capecitabine|mesh-list
102479837|NCT02485834|Irinotecan|irinotecan|mesh-list
102479838|NCT02485834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563421|NCT04941573|Anesthetics|anesthetics|mesh-ancestor
102479839|NCT02485834|Tubulin Modulators|tubulin modulators|mesh-ancestor
102479840|NCT02485834|Antimitotic Agents|antimitotic agents|mesh-ancestor
102479841|NCT02485834|Mitosis Modulators|mitosis modulators|mesh-ancestor
102479842|NCT02485834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479843|NCT02485834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102479844|NCT02485834|Antimetabolites|antimetabolites|mesh-ancestor
102479845|NCT02485834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102479846|NCT02485834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102479847|NCT02485834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102479848|NCT01834885|Fluticasone|fluticasone|mesh-list
102479849|NCT01834885|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102479850|NCT01834885|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102479851|NCT01834885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101563432|NCT04900623|Tubulin Modulators|tubulin modulators|mesh-ancestor
102479852|NCT01834885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102479853|NCT01834885|Autonomic Agents|autonomic agents|mesh-ancestor
102479854|NCT01834885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102479855|NCT01834885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479856|NCT01834885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102479857|NCT01834885|Respiratory System Agents|respiratory system agents|mesh-ancestor
102479858|NCT01834885|Dermatologic Agents|dermatologic agents|mesh-ancestor
102479859|NCT01834885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102479860|NCT01834885|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102479861|NCT01834885|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102479862|NCT01834885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102479863|NCT01834885|Adrenergic Agents|adrenergic agents|mesh-ancestor
102479864|NCT01834885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102479865|NCT01834885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479866|NCT01834885|Glucocorticoids|glucocorticoids|mesh-ancestor
102479867|NCT01834885|Hormones|hormones|mesh-ancestor
102479868|NCT01834885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102479869|NCT01834885|Sympathomimetics|sympathomimetics|mesh-ancestor
102479870|NCT01834963|Interferons|interferons|mesh-list
102479871|NCT01834963|Interferon-alpha|interferon-alpha|mesh-list
102479872|NCT01834963|Cisplatin|cisplatin|mesh-list
102479873|NCT01834963|Fluorouracil|fluorouracil|mesh-list
102479874|NCT01834963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102479875|NCT01834963|Antimetabolites|antimetabolites|mesh-ancestor
102479876|NCT01834963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479877|NCT01834963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102479878|NCT01834963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102479879|NCT01834963|Immunologic Factors|immunologic factors|mesh-ancestor
102479880|NCT01834963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479882|NCT01834963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102479883|NCT04380103|Bevacizumab|bevacizumab|mesh-list
102479884|NCT04380103|Capecitabine|capecitabine|mesh-list
102479885|NCT04380103|Oxaliplatin|oxaliplatin|mesh-list
102479886|NCT04380103|Irinotecan|irinotecan|mesh-list
102479887|NCT04380103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102479888|NCT04380103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102479889|NCT04380103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101563473|NCT04798339|Darbepoetin alfa|darbepoetin alfa|mesh-list
102479890|NCT04380103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102479891|NCT04380103|Growth Substances|growth substances|mesh-ancestor
102479892|NCT04380103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479893|NCT04380103|Growth Inhibitors|growth inhibitors|mesh-ancestor
102479894|NCT04380103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102479895|NCT04380103|Antimetabolites|antimetabolites|mesh-ancestor
102479896|NCT04380103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479897|NCT04380103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102479898|NCT04380103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102479899|NCT04380103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102479900|NCT01954966|Progesterone|progesterone|mesh-list
102479901|NCT01954966|Progestins|progestins|mesh-ancestor
102479902|NCT01954966|Hormones|hormones|mesh-ancestor
102479903|NCT01954966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102479904|NCT01954966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479905|NCT01835353|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102479906|NCT01835353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102479907|NCT03836599|Allopurinol|allopurinol|mesh-list
102479908|NCT03836599|Verinurad|verinurad|mesh-list
102479909|NCT03836599|Antimetabolites|antimetabolites|mesh-ancestor
102479910|NCT03836599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479911|NCT03836599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102479912|NCT03836599|Gout Suppressants|gout suppressants|mesh-ancestor
102479913|NCT03836599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102479914|NCT03836599|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102479915|NCT03836599|Antioxidants|antioxidants|mesh-ancestor
102479916|NCT03836599|Protective Agents|protective agents|mesh-ancestor
102479917|NCT03836599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479918|NCT01839097|Prednisone|prednisone|mesh-list
102479919|NCT01839097|Cyclophosphamide|cyclophosphamide|mesh-list
102479920|NCT01839097|Doxorubicin|doxorubicin|mesh-list
102479921|NCT01839097|Vincristine|vincristine|mesh-list
102479922|NCT01839097|Belinostat|belinostat|mesh-list
102479923|NCT01839097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102479924|NCT01839097|Immunologic Factors|immunologic factors|mesh-ancestor
102479925|NCT01839097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479926|NCT01839097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101563505|NCT04540211|Paclitaxel|paclitaxel|mesh-list
102479927|NCT01839097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102479928|NCT01839097|Alkylating Agents|alkylating agents|mesh-ancestor
102479929|NCT01839097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479930|NCT01839097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102479931|NCT01839097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102479932|NCT01839097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102479933|NCT01839097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102479934|NCT01839097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102479935|NCT01839097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102479936|NCT01839097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102479937|NCT01839097|Glucocorticoids|glucocorticoids|mesh-ancestor
102479938|NCT01839097|Hormones|hormones|mesh-ancestor
102479939|NCT01839097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102479940|NCT01839097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102479941|NCT01839097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102479942|NCT01839097|Tubulin Modulators|tubulin modulators|mesh-ancestor
102479943|NCT01839097|Antimitotic Agents|antimitotic agents|mesh-ancestor
102479944|NCT01839097|Mitosis Modulators|mitosis modulators|mesh-ancestor
102479945|NCT01839097|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102479946|NCT01835665|Nimodipine|nimodipine|mesh-list
102479947|NCT01835665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102479948|NCT01835665|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102479949|NCT01835665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102479950|NCT01835665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479951|NCT01835665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102479952|NCT01835665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479953|NCT01835665|Vasodilator Agents|vasodilator agents|mesh-ancestor
102479954|NCT01839175|Vaccines|vaccines|mesh-list
102479955|NCT01839175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102479957|NCT01839175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479958|NCT01839253|Atenolol|atenolol|mesh-list
102479959|NCT01839253|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102479960|NCT01839253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102479961|NCT01839253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102479962|NCT01839253|Sympatholytics|sympatholytics|mesh-ancestor
102479963|NCT01839253|Autonomic Agents|autonomic agents|mesh-ancestor
102479964|NCT01839253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102479965|NCT01839253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479966|NCT01839253|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102479967|NCT01839253|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102479968|NCT01839253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102479969|NCT01839253|Adrenergic Agents|adrenergic agents|mesh-ancestor
102479970|NCT01839253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102479971|NCT01839253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479972|NCT01839253|Protease Inhibitors|protease inhibitors|mesh-ancestor
102479973|NCT01839253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102479974|NCT01836289|Cyclophosphamide|cyclophosphamide|mesh-list
102479975|NCT01836289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102479976|NCT01836289|Immunologic Factors|immunologic factors|mesh-ancestor
102479977|NCT01836289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479978|NCT01836289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102479979|NCT01836289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102479980|NCT01836289|Alkylating Agents|alkylating agents|mesh-ancestor
102479981|NCT01836289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479982|NCT01836289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102479983|NCT01836289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102479984|NCT01839643|Meloxicam|meloxicam|mesh-list
102479985|NCT01839643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102479986|NCT01839643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102479987|NCT01839643|Analgesics|analgesics|mesh-ancestor
102479988|NCT01839643|Sensory System Agents|sensory system agents|mesh-ancestor
102479989|NCT01839643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102479990|NCT01839643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102479991|NCT01839643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102479992|NCT01839643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102479993|NCT01839643|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102479994|NCT01839643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102479995|NCT01839643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102479996|NCT01839643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102479997|NCT04380025|Pycnogenols|pycnogenols|mesh-list
102479998|NCT04380025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102479999|NCT04380025|Immunologic Factors|immunologic factors|mesh-ancestor
102480000|NCT04380025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480001|NCT04380025|Antioxidants|antioxidants|mesh-ancestor
102480002|NCT04380025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480003|NCT04380025|Protective Agents|protective agents|mesh-ancestor
102480004|NCT04380025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102480005|NCT01836679|Paclitaxel|paclitaxel|mesh-list
102480006|NCT01836679|Carboplatin|carboplatin|mesh-list
102480007|NCT01836679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102480008|NCT01836679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102480009|NCT01836679|Tubulin Modulators|tubulin modulators|mesh-ancestor
102480010|NCT01836679|Antimitotic Agents|antimitotic agents|mesh-ancestor
102480011|NCT01836679|Mitosis Modulators|mitosis modulators|mesh-ancestor
102480012|NCT01836679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480013|NCT00369538|Losartan|losartan|mesh-list
102480014|NCT00369538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102480015|NCT00369538|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102480016|NCT00369538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102480017|NCT00369538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102480018|NCT00369538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102480019|NCT00369538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480020|NCT00369538|Diuretics|diuretics|mesh-ancestor
102480021|NCT00369538|Natriuretic Agents|natriuretic agents|mesh-ancestor
102480022|NCT00369538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480023|NCT00369538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102480024|NCT00369538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102480025|NCT02489734|Sevoflurane|sevoflurane|mesh-list
102480026|NCT02489734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102480027|NCT02489734|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102480028|NCT02489734|Anesthetics, General|anesthetics, general|mesh-ancestor
102480029|NCT02489734|Anesthetics|anesthetics|mesh-ancestor
102480030|NCT02489734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101563610|NCT04251585|Insulin|insulin|mesh-list
102480031|NCT02489734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480032|NCT02490670|Cephalexin|cephalexin|mesh-list
102480033|NCT02490670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102480034|NCT02490670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102480035|NCT01836757|Dimethyl sulfone|dimethyl sulfone|mesh-list
102480036|NCT01836757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102480037|NCT05451472|Calcium|calcium|mesh-list
102480038|NCT05451472|Parathyroid Hormone|parathyroid hormone|mesh-list
102480039|NCT05451472|Hormones|hormones|mesh-list
102480040|NCT05451472|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102480041|NCT05451472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480042|NCT05451472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102480043|NCT03218059|Methotrexate|methotrexate|mesh-list
102480044|NCT03218059|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102480045|NCT03218059|Abortifacient Agents|abortifacient agents|mesh-ancestor
102480046|NCT03218059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102480047|NCT03218059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480048|NCT03218059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102480049|NCT03218059|Antimetabolites|antimetabolites|mesh-ancestor
102480050|NCT03218059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480051|NCT03218059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102480052|NCT03218059|Dermatologic Agents|dermatologic agents|mesh-ancestor
102480053|NCT03218059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102480054|NCT03218059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102480055|NCT03218059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102480056|NCT03218059|Immunologic Factors|immunologic factors|mesh-ancestor
102480057|NCT03218059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102480058|NCT03218059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102480059|NCT01839955|Quinacrine|quinacrine|mesh-list
102480060|NCT01839955|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102480061|NCT01839955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102480062|NCT01839955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102480063|NCT01839955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102480064|NCT01839955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480065|NCT01839955|Anticestodal Agents|anticestodal agents|mesh-ancestor
102480066|NCT01839955|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102480067|NCT01839955|Anthelmintics|anthelmintics|mesh-ancestor
102480068|NCT01839955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102480069|NCT01839955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102480070|NCT01839955|Antimalarials|antimalarials|mesh-ancestor
102480071|NCT01839955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102480072|NCT01839955|Antinematodal Agents|antinematodal agents|mesh-ancestor
102480073|NCT02494102|Modafinil|modafinil|mesh-list
102480074|NCT02494102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102480075|NCT02494102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480076|NCT02494102|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102480077|NCT02494102|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102480078|NCT02494102|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102480079|NCT02494102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480080|NCT00894517|Botulinum Toxins|botulinum toxins|mesh-list
102480081|NCT00894517|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102480082|NCT00894517|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102480083|NCT00894517|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102480084|NCT00894517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102480085|NCT00894517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480086|NCT00894517|Cholinergic Agents|cholinergic agents|mesh-ancestor
102480087|NCT00894517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102480088|NCT00894517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480089|NCT00894517|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102480090|NCT00894517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102480091|NCT01838395|Cytarabine|cytarabine|mesh-list
102480092|NCT01838395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102480093|NCT01838395|Antimetabolites|antimetabolites|mesh-ancestor
102480094|NCT01838395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480095|NCT01838395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102480096|NCT01838395|Antiviral Agents|antiviral agents|mesh-ancestor
102480097|NCT01838395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102480098|NCT01838395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102480099|NCT01838395|Immunologic Factors|immunologic factors|mesh-ancestor
102291753|NCT02604199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102480100|NCT01838395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480102|NCT00422578|Vasodilator Agents|vasodilator agents|mesh-ancestor
102480103|NCT00422578|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102480104|NCT00422578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102480105|NCT00422578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102480106|NCT00422578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480107|NCT00422578|Urological Agents|urological agents|mesh-ancestor
102480108|NCT02494180|Fentanyl|fentanyl|mesh-list
102480109|NCT02494180|Midazolam|midazolam|mesh-list
102480110|NCT02494180|Diazepam|diazepam|mesh-list
102480111|NCT02494180|Meperidine|meperidine|mesh-list
102480112|NCT02494180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102480113|NCT02494180|Narcotics|narcotics|mesh-ancestor
102480114|NCT02494180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102480115|NCT02494180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480116|NCT02494180|Analgesics|analgesics|mesh-ancestor
102480117|NCT02494180|Sensory System Agents|sensory system agents|mesh-ancestor
102480118|NCT02494180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102480119|NCT02494180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102480120|NCT02494180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102480121|NCT02494180|Anesthetics, General|anesthetics, general|mesh-ancestor
102480122|NCT02494180|Anesthetics|anesthetics|mesh-ancestor
101563712|NCT03970954|Analgesics|analgesics|mesh-ancestor
102480123|NCT02494180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102480124|NCT02494180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102480125|NCT02494180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102480126|NCT02494180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102480127|NCT02494180|GABA Modulators|gaba modulators|mesh-ancestor
102480128|NCT02494180|GABA Agents|gaba agents|mesh-ancestor
102480129|NCT02494180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102480130|NCT02494180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480131|NCT02494180|Anticonvulsants|anticonvulsants|mesh-ancestor
102480132|NCT02494180|Antiemetics|antiemetics|mesh-ancestor
102480133|NCT02494180|Autonomic Agents|autonomic agents|mesh-ancestor
102480134|NCT02494180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102480135|NCT02494180|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102480136|NCT02494180|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102480137|NCT02494336|Ropivacaine|ropivacaine|mesh-list
102480138|NCT02494336|Anesthetics, Local|anesthetics, local|mesh-ancestor
102480139|NCT02494336|Anesthetics|anesthetics|mesh-ancestor
102480140|NCT02494336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102480141|NCT02494336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480142|NCT02494336|Sensory System Agents|sensory system agents|mesh-ancestor
102480143|NCT02494336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102480144|NCT02495038|Rocuronium|rocuronium|mesh-list
102480145|NCT02495038|Atracurium|atracurium|mesh-list
102480146|NCT02495038|Cisatracurium|cisatracurium|mesh-list
102480147|NCT02495038|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102480148|NCT02495038|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102480149|NCT02495038|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102480150|NCT02495038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102480151|NCT02495038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480152|NCT02495038|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102480153|NCT02495038|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102480154|NCT02495038|Cholinergic Agents|cholinergic agents|mesh-ancestor
102480155|NCT02495038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102480156|NCT02495038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480157|NCT04956484|Belimumab|belimumab|mesh-list
102480158|NCT04956484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102480159|NCT04956484|Immunologic Factors|immunologic factors|mesh-ancestor
102480160|NCT04956484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480161|NCT05450458|Sorbitol|sorbitol|mesh-list
102480162|NCT05450458|Hyaluronic Acid|hyaluronic acid|mesh-list
102480163|NCT05450458|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102480164|NCT05450458|Immunologic Factors|immunologic factors|mesh-ancestor
102480165|NCT05450458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480166|NCT05450458|Viscosupplements|viscosupplements|mesh-ancestor
102480167|NCT05450458|Protective Agents|protective agents|mesh-ancestor
102480168|NCT05450458|Cathartics|cathartics|mesh-ancestor
102480169|NCT05450458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102480170|NCT01720615|Remifentanil|remifentanil|mesh-list
102480171|NCT01720615|Propofol|propofol|mesh-list
102480172|NCT01720615|Sevoflurane|sevoflurane|mesh-list
102291826|NCT04815265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102480173|NCT01720615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102480174|NCT01720615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102480175|NCT01720615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480176|NCT01720615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102480177|NCT01720615|Anesthetics, General|anesthetics, general|mesh-ancestor
102480178|NCT01720615|Anesthetics|anesthetics|mesh-ancestor
102480179|NCT01720615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102480180|NCT01720615|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102480181|NCT01720615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102480182|NCT01720615|Narcotics|narcotics|mesh-ancestor
102480183|NCT01720615|Analgesics|analgesics|mesh-ancestor
102480184|NCT01720615|Sensory System Agents|sensory system agents|mesh-ancestor
102480185|NCT01720615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102480186|NCT01837927|Glycopyrrolate|glycopyrrolate|mesh-list
102480187|NCT01837927|Tiotropium Bromide|tiotropium bromide|mesh-list
101563778|NCT03722498|Vitamins|vitamins|mesh-ancestor
102480188|NCT01837927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102480189|NCT01837927|Autonomic Agents|autonomic agents|mesh-ancestor
102480190|NCT01837927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102480191|NCT01837927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480192|NCT01837927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102480193|NCT01837927|Respiratory System Agents|respiratory system agents|mesh-ancestor
102480194|NCT01837927|Parasympatholytics|parasympatholytics|mesh-ancestor
102480195|NCT01837927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102480196|NCT01837927|Cholinergic Agents|cholinergic agents|mesh-ancestor
101563787|NCT03648892|Raclopride|raclopride|mesh-list
102480197|NCT01837927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102480198|NCT01837927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480199|NCT01837927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102480200|NCT01837927|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102480201|NCT01838083|Insulin Glargine|insulin glargine|mesh-list
102480202|NCT01838083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102480203|NCT01838083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480204|NCT02504554|Vancomycin|vancomycin|mesh-list
102480205|NCT02504554|Omeprazole|omeprazole|mesh-list
102480206|NCT02504554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102480207|NCT02504554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101563795|NCT03648892|Dopamine Agents|dopamine agents|mesh-ancestor
102480208|NCT02504554|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102480209|NCT02504554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102480210|NCT02504554|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102480211|NCT02504554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102480212|NCT02504554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480213|NCT01838473|Lobeline|lobeline|mesh-list
102480214|NCT01838473|Nicotine|nicotine|mesh-list
102480215|NCT01838473|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102480216|NCT01838473|Autonomic Agents|autonomic agents|mesh-ancestor
102480217|NCT01838473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102480218|NCT01838473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480219|NCT01838473|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102480220|NCT01838473|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102480221|NCT01838473|Cholinergic Agents|cholinergic agents|mesh-ancestor
102480222|NCT01838473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101563814|NCT03619213|Dapagliflozin|dapagliflozin|mesh-list
102480223|NCT01838473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480224|NCT01838473|Respiratory System Agents|respiratory system agents|mesh-ancestor
102480225|NCT04937452|Rotigotine|rotigotine|mesh-list
102480226|NCT04937452|Dopamine Agonists|dopamine agonists|mesh-ancestor
102480227|NCT04937452|Dopamine Agents|dopamine agents|mesh-ancestor
102480228|NCT04937452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102480229|NCT04937452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480230|NCT04937452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480231|NCT01838707|Fentanyl|fentanyl|mesh-list
102480232|NCT01838707|Morphine|morphine|mesh-list
102480233|NCT01838707|Bupivacaine|bupivacaine|mesh-list
102480234|NCT01838707|Anesthetics, Local|anesthetics, local|mesh-ancestor
102480235|NCT01838707|Anesthetics|anesthetics|mesh-ancestor
102480236|NCT01838707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102480237|NCT01838707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480238|NCT01838707|Sensory System Agents|sensory system agents|mesh-ancestor
102480239|NCT01838707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102480240|NCT01838707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102480241|NCT01838707|Narcotics|narcotics|mesh-ancestor
102480242|NCT01838707|Analgesics|analgesics|mesh-ancestor
102480243|NCT01838707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102480244|NCT01838707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102480245|NCT01838707|Anesthetics, General|anesthetics, general|mesh-ancestor
102480246|NCT02506114|Ipilimumab|ipilimumab|mesh-list
102480247|NCT02506114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102480248|NCT02506114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102480249|NCT02506114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102480250|NCT02506114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480251|NCT05449366|Paclitaxel|paclitaxel|mesh-list
102480252|NCT05449366|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102480253|NCT05449366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102480254|NCT05449366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102480255|NCT05449366|Tubulin Modulators|tubulin modulators|mesh-ancestor
102480256|NCT05449366|Antimitotic Agents|antimitotic agents|mesh-ancestor
102480257|NCT05449366|Mitosis Modulators|mitosis modulators|mesh-ancestor
102480258|NCT05449366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480259|NCT04920994|Bupivacaine|bupivacaine|mesh-list
102480260|NCT04920994|Anesthetics, Local|anesthetics, local|mesh-ancestor
102480261|NCT04920994|Anesthetics|anesthetics|mesh-ancestor
102480262|NCT04920994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102480263|NCT04920994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480264|NCT04920994|Sensory System Agents|sensory system agents|mesh-ancestor
102480265|NCT04920994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102480266|NCT02506660|Dexamethasone|dexamethasone|mesh-list
102480267|NCT02506660|Dexamethasone acetate|dexamethasone acetate|mesh-list
102480268|NCT02506660|Bupivacaine|bupivacaine|mesh-list
102480270|NCT02506660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102480271|NCT02506660|Antiemetics|antiemetics|mesh-ancestor
102480272|NCT02506660|Autonomic Agents|autonomic agents|mesh-ancestor
102480273|NCT02506660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102480274|NCT02506660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480275|NCT02506660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102480276|NCT02506660|Glucocorticoids|glucocorticoids|mesh-ancestor
102480277|NCT02506660|Hormones|hormones|mesh-ancestor
102480278|NCT02506660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102480279|NCT02506660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102480280|NCT02506660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102480281|NCT02506660|Protease Inhibitors|protease inhibitors|mesh-ancestor
102480282|NCT02506660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102480283|NCT02506660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480284|NCT02506660|Anesthetics, Local|anesthetics, local|mesh-ancestor
102480285|NCT02506660|Anesthetics|anesthetics|mesh-ancestor
102480286|NCT02506660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102480287|NCT02506660|Sensory System Agents|sensory system agents|mesh-ancestor
102480288|NCT02509624|Selonsertib|selonsertib|mesh-list
102480289|NCT02509624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102480290|NCT02509624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102480291|NCT02509624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480292|NCT01726075|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102480293|NCT01726075|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102480294|NCT01726075|Somatostatin|somatostatin|mesh-list
102480295|NCT01726075|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102480296|NCT01726075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101563883|NCT03162653|Diuretics|diuretics|mesh-ancestor
102480297|NCT01726075|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102480298|NCT01726075|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102480299|NCT01726075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102480300|NCT01726075|Adrenergic Agents|adrenergic agents|mesh-ancestor
102480301|NCT01726075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102480302|NCT01726075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480303|NCT01726075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480304|NCT01726075|Hormones|hormones|mesh-ancestor
101563890|NCT03008278|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102480305|NCT01726075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102480306|NCT00369694|Terlipressin|terlipressin|mesh-list
102480307|NCT00369694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102480308|NCT00369694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102480309|NCT01721707|Latanoprost|latanoprost|mesh-list
102480310|NCT01721707|Brinzolamide|brinzolamide|mesh-list
102480311|NCT01721707|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102480312|NCT01721707|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102480313|NCT01721707|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102480314|NCT01721707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102480315|NCT01721707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480316|NCT05448586|Analgesics, Opioid|analgesics, opioid|mesh-list
102480317|NCT05448586|Narcotics|narcotics|mesh-ancestor
102480318|NCT05448586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102480319|NCT05448586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480320|NCT05448586|Analgesics|analgesics|mesh-ancestor
102480321|NCT05448586|Sensory System Agents|sensory system agents|mesh-ancestor
102480322|NCT05448586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102480323|NCT01726465|Acetylcysteine|acetylcysteine|mesh-list
102480324|NCT01726465|Methylprednisolone|methylprednisolone|mesh-list
102480325|NCT01726465|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102480326|NCT01726465|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102480327|NCT01726465|Prednisolone|prednisolone|mesh-list
102480328|NCT01726465|Prednisolone acetate|prednisolone acetate|mesh-list
102480329|NCT01726465|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102480330|NCT01726465|Prednisolone phosphate|prednisolone phosphate|mesh-list
102480331|NCT01726465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102480332|NCT01726465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102480333|NCT01726465|Antiemetics|antiemetics|mesh-ancestor
102480334|NCT01726465|Autonomic Agents|autonomic agents|mesh-ancestor
102480335|NCT01726465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102480336|NCT01726465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480337|NCT01726465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102480338|NCT01726465|Glucocorticoids|glucocorticoids|mesh-ancestor
102480339|NCT01726465|Hormones|hormones|mesh-ancestor
102480340|NCT01726465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102480341|NCT01726465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102480342|NCT01726465|Protective Agents|protective agents|mesh-ancestor
102480343|NCT01726465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102480344|NCT01726465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102480345|NCT01726465|Antiviral Agents|antiviral agents|mesh-ancestor
102480346|NCT01726465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102480347|NCT01726465|Expectorants|expectorants|mesh-ancestor
102480348|NCT01726465|Respiratory System Agents|respiratory system agents|mesh-ancestor
102480349|NCT01726465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102480350|NCT01726465|Antioxidants|antioxidants|mesh-ancestor
102480351|NCT01726465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480352|NCT01726465|Antidotes|antidotes|mesh-ancestor
102480353|NCT01720303|Insulin|insulin|mesh-list
102480354|NCT01720303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102480355|NCT01720303|Repaglinide|repaglinide|mesh-list
102480356|NCT01720303|Isophane Insulin, Human|isophane insulin, human|mesh-list
102480357|NCT01720303|Insulin, Isophane|insulin, isophane|mesh-list
102480358|NCT01720303|Isophane insulin, beef|isophane insulin, beef|mesh-list
102480359|NCT01720303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102480360|NCT01720303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480361|NCT02733042|Rituximab|rituximab|mesh-list
102480362|NCT02733042|Durvalumab|durvalumab|mesh-list
102480363|NCT02733042|Lenalidomide|lenalidomide|mesh-list
102480364|NCT02733042|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102480365|NCT02733042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102480366|NCT02733042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102480367|NCT02733042|Immunologic Factors|immunologic factors|mesh-ancestor
102480368|NCT02733042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480369|NCT02733042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102480370|NCT02733042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102480371|NCT02733042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102480372|NCT02733042|Growth Substances|growth substances|mesh-ancestor
102480373|NCT02733042|Growth Inhibitors|growth inhibitors|mesh-ancestor
102480374|NCT02733042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102480375|NCT02733042|Alkylating Agents|alkylating agents|mesh-ancestor
102480376|NCT02733042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480377|NCT00912301|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
102480378|NCT00912301|Cathartics|cathartics|mesh-ancestor
102480379|NCT00912301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102480380|NCT04850638|Furosemide|furosemide|mesh-list
102480381|NCT04850638|Diuretics|diuretics|mesh-ancestor
102480382|NCT04850638|Natriuretic Agents|natriuretic agents|mesh-ancestor
102480383|NCT04850638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480384|NCT04850638|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102480385|NCT04850638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102480386|NCT04850638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480387|NCT01726777|Vitamin D|vitamin d|mesh-list
102480388|NCT01726777|Ergocalciferols|ergocalciferols|mesh-list
102480389|NCT01726777|Cholecalciferol|cholecalciferol|mesh-list
102480390|NCT01726777|Vitamins|vitamins|mesh-list
101761713|NCT00562978|Etoposide|etoposide|mesh-list
102480391|NCT01726777|Micronutrients|micronutrients|mesh-ancestor
102480392|NCT01726777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480393|NCT01726777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102480394|NCT01726777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102480395|NCT05532306|Ribavirin|ribavirin|mesh-list
102480396|NCT05532306|Antimetabolites|antimetabolites|mesh-ancestor
102480397|NCT05532306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480398|NCT05532306|Antiviral Agents|antiviral agents|mesh-ancestor
102480399|NCT05532306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102480400|NCT05602038|Morphine|morphine|mesh-list
102480401|NCT05602038|Bupivacaine|bupivacaine|mesh-list
102480402|NCT05602038|Anesthetics, Local|anesthetics, local|mesh-ancestor
102480403|NCT05602038|Anesthetics|anesthetics|mesh-ancestor
102480404|NCT05602038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102480405|NCT05602038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480406|NCT05602038|Sensory System Agents|sensory system agents|mesh-ancestor
102480407|NCT05602038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102480408|NCT05602038|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102480409|NCT05602038|Narcotics|narcotics|mesh-ancestor
102480410|NCT05602038|Analgesics|analgesics|mesh-ancestor
102480411|NCT01722409|Dexmedetomidine|dexmedetomidine|mesh-list
102480412|NCT01722409|Sevoflurane|sevoflurane|mesh-list
102480413|NCT01722409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102480414|NCT01722409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102480415|NCT01722409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480416|NCT01722409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102480417|NCT01722409|Analgesics|analgesics|mesh-ancestor
102480418|NCT01722409|Sensory System Agents|sensory system agents|mesh-ancestor
102480419|NCT01722409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102480420|NCT01722409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102480421|NCT01722409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102480422|NCT01722409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102480423|NCT01722409|Adrenergic Agents|adrenergic agents|mesh-ancestor
102480424|NCT01722409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102480425|NCT01722409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480426|NCT01722409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102480427|NCT01722409|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102480428|NCT01722409|Anesthetics, General|anesthetics, general|mesh-ancestor
102480429|NCT01722409|Anesthetics|anesthetics|mesh-ancestor
102480430|NCT01726933|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102480431|NCT01726933|Dermatologic Agents|dermatologic agents|mesh-ancestor
102480432|NCT01726933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102480433|NCT01726933|Immunologic Factors|immunologic factors|mesh-ancestor
101564015|NCT02197234|Osimertinib|osimertinib|mesh-list
102480434|NCT01726933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480435|NCT01727401|PENTA|penta|mesh-list
102480436|NCT01727401|Fondaparinux|fondaparinux|mesh-list
102480437|NCT01727401|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102480438|NCT01727401|Antithrombins|antithrombins|mesh-ancestor
102480439|NCT01727401|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102480440|NCT01727401|Protease Inhibitors|protease inhibitors|mesh-ancestor
102480441|NCT01727401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102480442|NCT01727401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480443|NCT01727401|Anticoagulants|anticoagulants|mesh-ancestor
102480444|NCT01727401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102480445|NCT01727401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102480446|NCT02513212|Fluorides|fluorides|mesh-list
102480447|NCT02513212|Tin Fluorides|tin fluorides|mesh-list
102480448|NCT02513212|Cariostatic Agents|cariostatic agents|mesh-ancestor
102480449|NCT02513212|Protective Agents|protective agents|mesh-ancestor
102480450|NCT02513212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480451|NCT02513446|Itraconazole|itraconazole|mesh-list
102480452|NCT02513446|Antifungal Agents|antifungal agents|mesh-ancestor
102480453|NCT02513446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102480454|NCT02513446|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102480455|NCT02513446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102480456|NCT02513446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102480457|NCT02513446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480458|NCT02513446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102480459|NCT02513446|Hormone Antagonists|hormone antagonists|mesh-ancestor
102480460|NCT02513446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102480461|NCT02513446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480462|NCT02513446|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102480463|NCT00363844|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102480464|NCT00363844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102480465|NCT00363844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480466|NCT00363844|Incretins|incretins|mesh-ancestor
102480467|NCT00363844|Hormones|hormones|mesh-ancestor
102480468|NCT00363844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102480469|NCT00363844|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102480470|NCT00363844|Protease Inhibitors|protease inhibitors|mesh-ancestor
102480471|NCT00363844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102480472|NCT00363844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480473|NCT04687800|Dexamethasone|dexamethasone|mesh-list
102480474|NCT04687800|Difluprednate|difluprednate|mesh-list
102480475|NCT04687800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102480476|NCT04687800|Antiemetics|antiemetics|mesh-ancestor
102480477|NCT04687800|Autonomic Agents|autonomic agents|mesh-ancestor
102480478|NCT04687800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101564056|NCT01622335|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102480479|NCT04687800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480480|NCT04687800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102480481|NCT04687800|Glucocorticoids|glucocorticoids|mesh-ancestor
102480482|NCT04687800|Hormones|hormones|mesh-ancestor
102480483|NCT04687800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102480484|NCT04687800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102480485|NCT04687800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102480486|NCT00864383|Moxifloxacin|moxifloxacin|mesh-list
102480487|NCT00864383|Rifampin|rifampin|mesh-list
102480488|NCT00864383|Isoniazid|isoniazid|mesh-list
102480489|NCT00864383|Pyrazinamide|pyrazinamide|mesh-list
102480490|NCT00864383|Ethambutol|ethambutol|mesh-list
102480491|NCT00864383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102480492|NCT00864383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102480493|NCT00864383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102480494|NCT00864383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102480495|NCT00864383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101762365|NCT00560794|Blinatumomab|blinatumomab|mesh-list
102480496|NCT00864383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480497|NCT00864383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102480498|NCT00864383|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102480499|NCT00864383|Antitubercular Agents|antitubercular agents|mesh-ancestor
102480500|NCT00864383|Leprostatic Agents|leprostatic agents|mesh-ancestor
102480501|NCT00864383|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102480502|NCT00864383|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102480503|NCT00864383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102480504|NCT00864383|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102480505|NCT00864383|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102480506|NCT00864383|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102480507|NCT00864383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102480508|NCT00864383|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102480509|NCT00864383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102480510|NCT00864383|Antimetabolites|antimetabolites|mesh-ancestor
102480511|NCT00864383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102480512|NCT05532072|Sirolimus|sirolimus|mesh-list
102480513|NCT05532072|Methylprednisolone|methylprednisolone|mesh-list
102480514|NCT05532072|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101564089|NCT01359592|Tubulin Modulators|tubulin modulators|mesh-ancestor
102480515|NCT05532072|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102480516|NCT05532072|Prednisolone|prednisolone|mesh-list
102480517|NCT05532072|Prednisolone acetate|prednisolone acetate|mesh-list
102480518|NCT05532072|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102480519|NCT05532072|Prednisolone phosphate|prednisolone phosphate|mesh-list
102480520|NCT05532072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102480521|NCT05532072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102480522|NCT05532072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102480523|NCT05532072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102480524|NCT05532072|Antifungal Agents|antifungal agents|mesh-ancestor
102480525|NCT05532072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102480526|NCT05532072|Immunologic Factors|immunologic factors|mesh-ancestor
102480527|NCT05532072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480528|NCT05532072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102480529|NCT05532072|Antiemetics|antiemetics|mesh-ancestor
102480530|NCT05532072|Autonomic Agents|autonomic agents|mesh-ancestor
102480531|NCT05532072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102480532|NCT05532072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102480533|NCT05532072|Glucocorticoids|glucocorticoids|mesh-ancestor
102480534|NCT05532072|Hormones|hormones|mesh-ancestor
102480535|NCT05532072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102480536|NCT05532072|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102480537|NCT05532072|Protective Agents|protective agents|mesh-ancestor
102480538|NCT05532072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102480539|NCT00864539|Vitamin D|vitamin d|mesh-list
102480540|NCT00864539|Calcium|calcium|mesh-list
102480541|NCT00864539|Vitamins|vitamins|mesh-ancestor
102480542|NCT00864539|Micronutrients|micronutrients|mesh-ancestor
102480543|NCT00864539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480544|NCT00864539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102480545|NCT00864539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102480546|NCT00827255|Cyclosporine|cyclosporine|mesh-list
102480547|NCT00827255|Cyclosporins|cyclosporins|mesh-list
102480548|NCT00827255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102480549|NCT00827255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480550|NCT00827255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102480551|NCT00827255|Immunologic Factors|immunologic factors|mesh-ancestor
102480552|NCT00827255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480553|NCT00827255|Antifungal Agents|antifungal agents|mesh-ancestor
102480554|NCT00827255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102480555|NCT00827255|Dermatologic Agents|dermatologic agents|mesh-ancestor
102480556|NCT00827255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102480557|NCT00827255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102480559|NCT04458610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102480560|NCT04458610|Zanubrutinib|zanubrutinib|mesh-list
102480561|NCT04458610|Antibodies|antibodies|mesh-list
102480562|NCT04458610|Immunoglobulins|immunoglobulins|mesh-list
102480563|NCT04458610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102480564|NCT04458610|Immunologic Factors|immunologic factors|mesh-ancestor
102480565|NCT04458610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480566|NCT04458610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102480567|NCT04458610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102480568|NCT04458610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102480569|NCT04458610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102480570|NCT04458610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480571|NCT02153489|Bromides|bromides|mesh-list
102480572|NCT02153489|Anticonvulsants|anticonvulsants|mesh-ancestor
102480573|NCT04627012|Pembrolizumab|pembrolizumab|mesh-list
102480574|NCT04627012|Tislelizumab|tislelizumab|mesh-list
102480575|NCT04627012|Lenvatinib|lenvatinib|mesh-list
102480576|NCT04627012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102480577|NCT04627012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102480578|NCT04627012|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102480579|NCT04627012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480580|NCT04627012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102480581|NCT04627012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102480582|NCT00866879|Sirolimus|sirolimus|mesh-list
102480583|NCT00866879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102480584|NCT00866879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102480585|NCT00866879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101564145|NCT00697073|Idebenone|idebenone|mesh-list
102480586|NCT00866879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102480587|NCT00866879|Antifungal Agents|antifungal agents|mesh-ancestor
102480588|NCT00866879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102480589|NCT00866879|Immunologic Factors|immunologic factors|mesh-ancestor
102480590|NCT00866879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480591|NCT02311920|Nivolumab|nivolumab|mesh-list
102480592|NCT02311920|Ipilimumab|ipilimumab|mesh-list
102480593|NCT02311920|Temozolomide|temozolomide|mesh-list
102480594|NCT02311920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102480595|NCT02311920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102480596|NCT02311920|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102480597|NCT02311920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480598|NCT02311920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102480599|NCT02311920|Alkylating Agents|alkylating agents|mesh-ancestor
102480600|NCT02153723|Glatiramer Acetate|glatiramer acetate|mesh-list
102480601|NCT02153723|(T,G)-A-L|(t,g)-a-l|mesh-list
102480602|NCT02153723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102480603|NCT02153723|Immunologic Factors|immunologic factors|mesh-ancestor
102480604|NCT02153723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480605|NCT02153723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102480606|NCT02153723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102480607|NCT00828191|Progesterone|progesterone|mesh-list
102480608|NCT00828191|Progestins|progestins|mesh-ancestor
102480609|NCT00828191|Hormones|hormones|mesh-ancestor
102480610|NCT00828191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102480611|NCT00828191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480612|NCT00867659|Cetrorelix|cetrorelix|mesh-list
102480613|NCT00867659|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102480614|NCT00867659|Fertility Agents|fertility agents|mesh-ancestor
102480615|NCT00867659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102480616|NCT00867659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480617|NCT00867659|Hormone Antagonists|hormone antagonists|mesh-ancestor
102480618|NCT00867659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102480619|NCT05531058|Vaccines|vaccines|mesh-list
102480620|NCT05531058|Immunologic Factors|immunologic factors|mesh-ancestor
102480621|NCT05531058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480622|NCT00828347|Alfacalcidol|alfacalcidol|mesh-list
102480623|NCT00828347|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
102480624|NCT00828347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102480625|NCT00828347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480626|NCT00828347|Vitamins|vitamins|mesh-ancestor
102480627|NCT00828347|Micronutrients|micronutrients|mesh-ancestor
102480628|NCT02939872|Aspirin|aspirin|mesh-list
102480629|NCT02939872|Clopidogrel|clopidogrel|mesh-list
102480630|NCT02939872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102480631|NCT02939872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102480632|NCT02939872|Analgesics|analgesics|mesh-ancestor
102480633|NCT02939872|Sensory System Agents|sensory system agents|mesh-ancestor
102480634|NCT02939872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102480635|NCT02939872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480636|NCT02939872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102480637|NCT02939872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102480638|NCT02939872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102480639|NCT02939872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102480640|NCT02939872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480641|NCT02939872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102480642|NCT02939872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102480643|NCT02939872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102480644|NCT02939872|Antipyretics|antipyretics|mesh-ancestor
102480645|NCT02939872|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102480646|NCT02939872|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102480647|NCT02939872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102480648|NCT02939872|Purinergic Agents|purinergic agents|mesh-ancestor
102480649|NCT02939872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102480650|NCT00829049|Adapalene|adapalene|mesh-list
102480651|NCT00829049|Tazarotene|tazarotene|mesh-list
102480652|NCT00829049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102480653|NCT00829049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102480654|NCT00829049|Analgesics|analgesics|mesh-ancestor
102480655|NCT00829049|Sensory System Agents|sensory system agents|mesh-ancestor
101564222|NCT00932113|Antimetabolites|antimetabolites|mesh-ancestor
102480656|NCT00829049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102480657|NCT00829049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480658|NCT00829049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102480659|NCT00829049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102480660|NCT00829049|Dermatologic Agents|dermatologic agents|mesh-ancestor
102480661|NCT00829049|Keratolytic Agents|keratolytic agents|mesh-ancestor
102480662|NCT02859064|Lanreotide|lanreotide|mesh-list
102480663|NCT02859064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102480664|NCT04303702|Oxytocin|oxytocin|mesh-list
102480665|NCT04303702|Oxytocics|oxytocics|mesh-ancestor
102480666|NCT04303702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102480667|NCT04303702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480668|NCT01727557|Anesthetics|anesthetics|mesh-list
102480669|NCT01727557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102480670|NCT01727557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480671|NCT04529044|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
101564239|NCT00931801|Emtricitabine|emtricitabine|mesh-list
102480672|NCT04529044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480673|NCT04529044|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102480674|NCT00913003|Lidocaine|lidocaine|mesh-list
102480675|NCT00913003|Anesthetics, Local|anesthetics, local|mesh-ancestor
102480676|NCT00913003|Anesthetics|anesthetics|mesh-ancestor
102480677|NCT00913003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102480678|NCT00913003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480679|NCT00913003|Sensory System Agents|sensory system agents|mesh-ancestor
102480680|NCT00913003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102480681|NCT00913003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102480682|NCT00913003|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102480683|NCT00913003|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102480684|NCT00913003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102480685|NCT00913003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480686|NCT00869141|Timolol|timolol|mesh-list
102480687|NCT00869141|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102480688|NCT00869141|Dorzolamide|dorzolamide|mesh-list
102480689|NCT00869141|Brinzolamide|brinzolamide|mesh-list
102480690|NCT00869141|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102480691|NCT00869141|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102480692|NCT00869141|Adrenergic Agents|adrenergic agents|mesh-ancestor
102480693|NCT00869141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102480694|NCT00869141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480695|NCT00869141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480696|NCT00869141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102480697|NCT00869141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102480698|NCT00869141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102480699|NCT00869141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102480700|NCT00869141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102480701|NCT00869141|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102480702|NCT00869141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102480703|NCT01722799|Paclitaxel|paclitaxel|mesh-list
102480704|NCT01722799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102480705|NCT01722799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102480706|NCT01722799|Tubulin Modulators|tubulin modulators|mesh-ancestor
102480707|NCT01722799|Antimitotic Agents|antimitotic agents|mesh-ancestor
102480708|NCT01722799|Mitosis Modulators|mitosis modulators|mesh-ancestor
101564277|NCT00608803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102480709|NCT01722799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480710|NCT04260022|Blinatumomab|blinatumomab|mesh-list
102480711|NCT04260022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102480712|NCT01606176|Nabiximols|nabiximols|mesh-list
102480713|NCT01606176|Analgesics|analgesics|mesh-ancestor
102480714|NCT01606176|Sensory System Agents|sensory system agents|mesh-ancestor
102480715|NCT01606176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102480716|NCT01606176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480717|NCT00913081|Quercetin|quercetin|mesh-list
102480718|NCT00913081|Antioxidants|antioxidants|mesh-ancestor
102480719|NCT00913081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480720|NCT00913081|Protective Agents|protective agents|mesh-ancestor
102480721|NCT00913081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480722|NCT04077424|Hemagglutinins|hemagglutinins|mesh-list
102480723|NCT04077424|Vaccines|vaccines|mesh-list
102480724|NCT04077424|Immunologic Factors|immunologic factors|mesh-ancestor
102480725|NCT04077424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480726|NCT04077424|Agglutinins|agglutinins|mesh-ancestor
102480727|NCT04077424|Coagulants|coagulants|mesh-ancestor
102480728|NCT01727869|Cetuximab|cetuximab|mesh-list
102480729|NCT01727869|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102480730|NCT01727869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102480731|NCT01727869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102480732|NCT01727869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102480733|NCT01727869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102480734|NCT01727869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480735|NCT00371020|Heparin|heparin|mesh-list
102480736|NCT00371020|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102480737|NCT00371020|Tinzaparin|tinzaparin|mesh-list
102480738|NCT00371020|Dalteparin|dalteparin|mesh-list
102480739|NCT00371020|Anticoagulants|anticoagulants|mesh-ancestor
102480740|NCT00371020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102480741|NCT00371020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102480742|NCT00371020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480743|NCT04476628|Budesonide|budesonide|mesh-list
102480744|NCT04476628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102480745|NCT04476628|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102480746|NCT04476628|Autonomic Agents|autonomic agents|mesh-ancestor
102480747|NCT04476628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102480748|NCT04476628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480749|NCT04476628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102480750|NCT04476628|Respiratory System Agents|respiratory system agents|mesh-ancestor
102480751|NCT04476628|Glucocorticoids|glucocorticoids|mesh-ancestor
102480752|NCT04476628|Hormones|hormones|mesh-ancestor
102480753|NCT04476628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102480754|NCT01728181|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102480755|NCT01728181|Tivozanib|tivozanib|mesh-list
102480756|NCT01728181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102480757|NCT01728181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102480758|NCT01728181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102480759|NCT01728181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480760|NCT04378231|Amoxicillin|amoxicillin|mesh-list
102480761|NCT04378231|Clavulanic Acid|clavulanic acid|mesh-list
102480762|NCT04378231|Clavulanic Acids|clavulanic acids|mesh-list
102480763|NCT04378231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102480764|NCT04378231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102480765|NCT04378231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102480766|NCT04378231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102480767|NCT04378231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102480768|NCT04378231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480769|NCT04475302|BCG Vaccine|bcg vaccine|mesh-list
102480770|NCT04475302|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102480771|NCT04475302|Immunologic Factors|immunologic factors|mesh-ancestor
102480772|NCT04475302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480773|NCT01728571|Vitamin D|vitamin d|mesh-list
102480774|NCT01728571|Ergocalciferols|ergocalciferols|mesh-list
102480775|NCT01728571|Cholecalciferol|cholecalciferol|mesh-list
102480776|NCT01728571|Vitamins|vitamins|mesh-list
102480777|NCT01728571|Micronutrients|micronutrients|mesh-ancestor
102480778|NCT01728571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480779|NCT01728571|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102480780|NCT01728571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102480781|NCT00832637|Gemcitabine|gemcitabine|mesh-list
102480782|NCT00832637|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102480783|NCT00832637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102292424|NCT02404311|MF59 oil emulsion|mf59 oil emulsion|mesh-list
102480784|NCT00832637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102480785|NCT00832637|Antimetabolites|antimetabolites|mesh-ancestor
102480786|NCT00832637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480787|NCT00832637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102480788|NCT00832637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102480789|NCT03408457|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102480790|NCT03408457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102480791|NCT00370240|Ropivacaine|ropivacaine|mesh-list
102480792|NCT00370240|Anesthetics, Local|anesthetics, local|mesh-ancestor
102480793|NCT00370240|Anesthetics|anesthetics|mesh-ancestor
102480794|NCT00370240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102480795|NCT00370240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480796|NCT00370240|Sensory System Agents|sensory system agents|mesh-ancestor
102480797|NCT00370240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102480798|NCT03408145|Hyaluronic Acid|hyaluronic acid|mesh-list
102480799|NCT03408145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102480800|NCT03408145|Immunologic Factors|immunologic factors|mesh-ancestor
102480801|NCT03408145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480802|NCT03408145|Viscosupplements|viscosupplements|mesh-ancestor
102480803|NCT03408145|Protective Agents|protective agents|mesh-ancestor
102480804|NCT02475772|Cisplatin|cisplatin|mesh-list
102480805|NCT02475772|Doxorubicin|doxorubicin|mesh-list
101564363|NCT04260607|Anesthetics|anesthetics|mesh-ancestor
102480806|NCT02475772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102480807|NCT02475772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102480808|NCT02475772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102480809|NCT02475772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102480810|NCT02475772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102480811|NCT02475772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101564372|NCT00923845|Sirolimus|sirolimus|mesh-list
102480812|NCT02475772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480813|NCT00915655|Ritonavir|ritonavir|mesh-list
102480814|NCT00915655|Darunavir|darunavir|mesh-list
102480815|NCT00915655|Lamivudine|lamivudine|mesh-list
102480816|NCT00915655|Zidovudine|zidovudine|mesh-list
102480817|NCT00915655|Abacavir|abacavir|mesh-list
102480818|NCT00915655|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102480819|NCT00915655|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102480820|NCT00915655|Protease Inhibitors|protease inhibitors|mesh-ancestor
102480821|NCT00915655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102480822|NCT00915655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480823|NCT00915655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102480824|NCT00915655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102480825|NCT00915655|Antiviral Agents|antiviral agents|mesh-ancestor
102480826|NCT00915655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102480827|NCT00915655|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101564378|NCT00923845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102480828|NCT00915655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102480829|NCT00915655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102480830|NCT00915655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102480831|NCT00915655|Antimetabolites|antimetabolites|mesh-ancestor
102480832|NCT03835507|Epoetin Alfa|epoetin alfa|mesh-list
102480833|NCT03835507|Hematinics|hematinics|mesh-ancestor
102480834|NCT05524974|Paclitaxel|paclitaxel|mesh-list
102480835|NCT05524974|Oxaliplatin|oxaliplatin|mesh-list
102480836|NCT05524974|Apatinib|apatinib|mesh-list
102480837|NCT05524974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101564395|NCT05052541|Analgesics|analgesics|mesh-ancestor
102480838|NCT05524974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102480839|NCT05524974|Tubulin Modulators|tubulin modulators|mesh-ancestor
102480840|NCT05524974|Antimitotic Agents|antimitotic agents|mesh-ancestor
102480841|NCT05524974|Mitosis Modulators|mitosis modulators|mesh-ancestor
102480842|NCT05524974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480843|NCT05524974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102480844|NCT05524974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102480845|NCT00870467|Adalimumab|adalimumab|mesh-list
102480846|NCT00870467|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102480847|NCT00870467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102480848|NCT00870467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102480849|NCT00370318|Acetaminophen|acetaminophen|mesh-list
102480850|NCT00370318|Vaccines|vaccines|mesh-list
102480851|NCT00370318|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102480852|NCT00370318|Immunologic Factors|immunologic factors|mesh-ancestor
102480853|NCT00370318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480854|NCT00370318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102480855|NCT00370318|Analgesics|analgesics|mesh-ancestor
102480856|NCT00370318|Sensory System Agents|sensory system agents|mesh-ancestor
102480857|NCT00370318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102480858|NCT00370318|Antipyretics|antipyretics|mesh-ancestor
102480859|NCT01728961|Lumefantrine|lumefantrine|mesh-list
102480860|NCT01728961|Artemether|artemether|mesh-list
101564407|NCT04260685|Anesthetics|anesthetics|mesh-ancestor
102480861|NCT01728961|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102480862|NCT01728961|Antimalarials|antimalarials|mesh-ancestor
102480863|NCT01728961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102480864|NCT01728961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102480865|NCT01728961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102480866|NCT01723501|Chlorhexidine|chlorhexidine|mesh-list
101764865|NCT00877539|Xhance|xhance|mesh-list
102480867|NCT01723501|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102480868|NCT01723501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102480869|NCT01723501|Disinfectants|disinfectants|mesh-ancestor
102480870|NCT00872027|Escitalopram|escitalopram|mesh-list
102480871|NCT00872027|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102480872|NCT00872027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102480873|NCT00872027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102480874|NCT00872027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480875|NCT00872027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102480876|NCT00872027|Serotonin Agents|serotonin agents|mesh-ancestor
102480877|NCT00872027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480878|NCT01854814|Mycophenolic Acid|mycophenolic acid|mesh-list
102480879|NCT01854814|Losartan|losartan|mesh-list
102480880|NCT01854814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102480881|NCT01854814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102480882|NCT01854814|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102480883|NCT01854814|Antitubercular Agents|antitubercular agents|mesh-ancestor
102480884|NCT01854814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102480885|NCT01854814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102480886|NCT01854814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102480887|NCT01854814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480888|NCT01854814|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102480889|NCT01854814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102480890|NCT01854814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102480891|NCT01854814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102480892|NCT01723657|Gemtuzumab|gemtuzumab|mesh-list
102480893|NCT01723657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102480894|NCT01723657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102480895|NCT01723657|Immunotoxins|immunotoxins|mesh-ancestor
102480896|NCT01723657|Immunoconjugates|immunoconjugates|mesh-ancestor
102480897|NCT01723657|Immunologic Factors|immunologic factors|mesh-ancestor
101564444|NCT00922987|Anticonvulsants|anticonvulsants|mesh-ancestor
102480898|NCT01723657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480899|NCT02576652|Tetracycline|tetracycline|mesh-list
102480900|NCT02576652|Demeclocycline|demeclocycline|mesh-list
102480901|NCT02576652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102480902|NCT02576652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102480903|NCT02576652|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102480904|NCT02576652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102480905|NCT02576652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480906|NCT01743742|Vitamins|vitamins|mesh-list
102480907|NCT01743742|Vitamin E|vitamin e|mesh-list
102480908|NCT01743742|Micronutrients|micronutrients|mesh-ancestor
102480909|NCT01743742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480910|NCT01743742|Antioxidants|antioxidants|mesh-ancestor
102480911|NCT01743742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480912|NCT01743742|Protective Agents|protective agents|mesh-ancestor
102480913|NCT01723735|Ezetimibe|ezetimibe|mesh-list
102480914|NCT01723735|Alirocumab|alirocumab|mesh-list
102480915|NCT01723735|Fenofibrate|fenofibrate|mesh-list
102480916|NCT01723735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102480917|NCT01723735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102480918|NCT01723735|Antimetabolites|antimetabolites|mesh-ancestor
102480919|NCT01723735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480920|NCT01723735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102480921|NCT01723735|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102480922|NCT01723735|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102480923|NCT01723735|Protease Inhibitors|protease inhibitors|mesh-ancestor
102480924|NCT01723735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102480925|NCT00872729|Cysteamine|cysteamine|mesh-list
102480926|NCT00872729|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
102480927|NCT00872729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480928|NCT04640376|Acetaminophen|acetaminophen|mesh-list
101564467|NCT00927901|Maleic acid|maleic acid|mesh-list
102480929|NCT04640376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102480930|NCT04640376|Analgesics|analgesics|mesh-ancestor
102480931|NCT04640376|Sensory System Agents|sensory system agents|mesh-ancestor
102480932|NCT04640376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102480933|NCT04640376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480934|NCT04640376|Antipyretics|antipyretics|mesh-ancestor
102292587|NCT05548465|Sufentanil|sufentanil|mesh-list
102480935|NCT00832871|Mifepristone|mifepristone|mesh-list
102480936|NCT00832871|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102480937|NCT00832871|Abortifacient Agents|abortifacient agents|mesh-ancestor
102480938|NCT00832871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102480939|NCT00832871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480940|NCT00832871|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102480941|NCT00832871|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102480942|NCT00832871|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102480943|NCT00832871|Contraceptive Agents|contraceptive agents|mesh-ancestor
102480944|NCT00832871|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102480945|NCT00832871|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102480946|NCT00832871|Hormone Antagonists|hormone antagonists|mesh-ancestor
102480947|NCT00832871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102480948|NCT00832871|Luteolytic Agents|luteolytic agents|mesh-ancestor
102480949|NCT00832871|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102480950|NCT00832871|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102480951|NCT05530200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102480952|NCT05530200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480953|NCT05530200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102480954|NCT05530200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102480955|NCT01729663|Interferons|interferons|mesh-list
102480956|NCT01729663|Interferon-alpha|interferon-alpha|mesh-list
102480957|NCT01729663|Interferon alpha-2|interferon alpha-2|mesh-list
102480958|NCT01729663|Molgramostim|molgramostim|mesh-list
102480959|NCT01729663|Sargramostim|sargramostim|mesh-list
102480960|NCT01729663|BCG Vaccine|bcg vaccine|mesh-list
102480961|NCT01729663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102480962|NCT01729663|Antiviral Agents|antiviral agents|mesh-ancestor
102480963|NCT01729663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102480964|NCT01729663|Immunologic Factors|immunologic factors|mesh-ancestor
102480965|NCT01729663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480966|NCT01729663|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102480967|NCT05530122|Adalimumab|adalimumab|mesh-list
102480968|NCT05530122|Infliximab|infliximab|mesh-list
102480969|NCT05530122|Golimumab|golimumab|mesh-list
102480970|NCT05530122|Ustekinumab|ustekinumab|mesh-list
102480971|NCT05530122|Vedolizumab|vedolizumab|mesh-list
102480972|NCT05530122|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102480973|NCT05530122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102480974|NCT05530122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102480975|NCT05530122|Dermatologic Agents|dermatologic agents|mesh-ancestor
102480976|NCT05530122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102480977|NCT05530122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102480978|NCT05530122|Immunologic Factors|immunologic factors|mesh-ancestor
102480979|NCT05530122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480980|NCT05208840|Ocrelizumab|ocrelizumab|mesh-list
102480981|NCT05208840|Immunologic Factors|immunologic factors|mesh-ancestor
102480982|NCT05208840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480983|NCT03407599|Insulin Aspart|insulin aspart|mesh-list
102480984|NCT03407599|Insulin, Long-Acting|insulin, long-acting|mesh-list
102480985|NCT03407599|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102480986|NCT03407599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102480987|NCT03407599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480988|NCT05529888|Isotretinoin|isotretinoin|mesh-list
102480989|NCT05529888|Dermatologic Agents|dermatologic agents|mesh-ancestor
102480990|NCT05518578|Huperzine A|huperzine a|mesh-list
102480991|NCT05518578|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102480992|NCT05518578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101564542|NCT01217190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102480993|NCT05518578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102480994|NCT05518578|Cholinergic Agents|cholinergic agents|mesh-ancestor
102480995|NCT05518578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102480996|NCT05518578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102480997|NCT05518578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102480998|NCT05518578|Protective Agents|protective agents|mesh-ancestor
102480999|NCT05518500|Vaccines|vaccines|mesh-list
102481000|NCT05518500|Immunologic Factors|immunologic factors|mesh-ancestor
102481001|NCT05518500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481002|NCT03058978|Etonogestrel|etonogestrel|mesh-list
102481003|NCT03058978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102481004|NCT03058978|Contraceptive Agents|contraceptive agents|mesh-ancestor
102481005|NCT03058978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102481006|NCT03058978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481007|NCT03058978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102481008|NCT00212134|Dipivefrin|dipivefrin|mesh-list
102481009|NCT00212134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102481010|NCT00212134|Adrenergic Agents|adrenergic agents|mesh-ancestor
102481011|NCT00212134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102481012|NCT00212134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481013|NCT00212134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481014|NCT00913627|Ibuprofen|ibuprofen|mesh-list
102481015|NCT00913627|Naproxen|naproxen|mesh-list
102481016|NCT00913627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102481017|NCT00913627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102481018|NCT00913627|Analgesics|analgesics|mesh-ancestor
102481019|NCT00913627|Sensory System Agents|sensory system agents|mesh-ancestor
102481020|NCT00913627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102481021|NCT00913627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481022|NCT00913627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102481023|NCT00913627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102481024|NCT00913627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102481025|NCT00913627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102481026|NCT00913627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564557|NCT05178693|Antimetabolites|antimetabolites|mesh-ancestor
102481027|NCT00913627|Gout Suppressants|gout suppressants|mesh-ancestor
102481028|NCT04297176|Vancomycin|vancomycin|mesh-list
102481029|NCT04297176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102481030|NCT04297176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102481031|NCT02425306|Cyclophosphamide|cyclophosphamide|mesh-list
102481032|NCT02425306|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
102481033|NCT02425306|Poly ICLC|poly iclc|mesh-list
102481034|NCT02425306|Immunologic Factors|immunologic factors|mesh-ancestor
102481035|NCT02425306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481036|NCT02425306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102481037|NCT02425306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102481038|NCT02425306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102481039|NCT02425306|Alkylating Agents|alkylating agents|mesh-ancestor
102481040|NCT02425306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481041|NCT02425306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102481042|NCT02425306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102481043|NCT02425306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102481044|NCT02425306|Interferon Inducers|interferon inducers|mesh-ancestor
102481045|NCT04052698|Factor VIII|factor viii|mesh-list
102481046|NCT04052698|Coagulants|coagulants|mesh-ancestor
102481047|NCT05523102|Acetaminophen|acetaminophen|mesh-list
102481048|NCT05523102|Ketorolac|ketorolac|mesh-list
102481049|NCT05523102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102481050|NCT05523102|Analgesics|analgesics|mesh-ancestor
101564593|NCT01134393|Amlodipine|amlodipine|mesh-list
102481051|NCT05523102|Sensory System Agents|sensory system agents|mesh-ancestor
102481052|NCT05523102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102481053|NCT05523102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481054|NCT05523102|Antipyretics|antipyretics|mesh-ancestor
102481055|NCT05523102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102481056|NCT05523102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102481057|NCT05523102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102481058|NCT05523102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102481059|NCT05523102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102481060|NCT05523102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481061|NCT03407209|Anesthetics|anesthetics|mesh-list
102481062|NCT03407209|Anesthetics, Local|anesthetics, local|mesh-list
101564601|NCT01134393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481063|NCT03407209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102481064|NCT03407209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481065|NCT03407209|Sensory System Agents|sensory system agents|mesh-ancestor
102481066|NCT03407209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102481067|NCT03999268|Insulin|insulin|mesh-list
102481068|NCT03999268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101564613|NCT01217112|Cannabidiol|cannabidiol|mesh-list
102481069|NCT03999268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481070|NCT05517330|Tislelizumab|tislelizumab|mesh-list
102481071|NCT05517330|Afatinib|afatinib|mesh-list
102481072|NCT05517330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102481073|NCT05517330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102481074|NCT05517330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102481075|NCT05517330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102481076|NCT05517330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481077|NCT01729897|Fentanyl|fentanyl|mesh-list
102481078|NCT01729897|Propofol|propofol|mesh-list
102481079|NCT01729897|Etomidate|etomidate|mesh-list
102481080|NCT01729897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102481081|NCT01729897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102481082|NCT01729897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481083|NCT01729897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102481084|NCT01729897|Anesthetics, General|anesthetics, general|mesh-ancestor
102481085|NCT01729897|Anesthetics|anesthetics|mesh-ancestor
102481086|NCT01729897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102481087|NCT01729897|Narcotics|narcotics|mesh-ancestor
102481088|NCT01729897|Analgesics|analgesics|mesh-ancestor
102481089|NCT01729897|Sensory System Agents|sensory system agents|mesh-ancestor
102481090|NCT01729897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102481091|NCT01729897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102481092|NCT01048177|Lidocaine|lidocaine|mesh-list
102481093|NCT01048177|Heparin|heparin|mesh-list
102481094|NCT01048177|Anesthetics, Local|anesthetics, local|mesh-ancestor
102481095|NCT01048177|Anesthetics|anesthetics|mesh-ancestor
102481096|NCT01048177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102481097|NCT01048177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481098|NCT01048177|Sensory System Agents|sensory system agents|mesh-ancestor
102481099|NCT01048177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102481100|NCT01048177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102481101|NCT01048177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102481102|NCT01048177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102481103|NCT01048177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102481104|NCT01048177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481105|NCT01048177|Anticoagulants|anticoagulants|mesh-ancestor
102481106|NCT01048177|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102481107|NCT01048177|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102481108|NCT02740582|Tolcapone|tolcapone|mesh-list
102481109|NCT02740582|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102481110|NCT02740582|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102481111|NCT02740582|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102481112|NCT02740582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102481113|NCT02740582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481114|NCT05453266|Tranexamic Acid|tranexamic acid|mesh-list
102481115|NCT05453266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102481116|NCT05453266|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102481117|NCT05453266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102481118|NCT05453266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481119|NCT05453266|Hemostatics|hemostatics|mesh-ancestor
102481120|NCT05453266|Coagulants|coagulants|mesh-ancestor
102481121|NCT02740660|Caffeine|caffeine|mesh-list
102481122|NCT02740660|Albuterol|albuterol|mesh-list
102481123|NCT02740660|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102481124|NCT02740660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481125|NCT02740660|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102481126|NCT02740660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102481127|NCT02740660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481128|NCT02740660|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102481129|NCT02740660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102481130|NCT02740660|Purinergic Agents|purinergic agents|mesh-ancestor
102481131|NCT02740660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102481132|NCT02740660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102481133|NCT02740660|Autonomic Agents|autonomic agents|mesh-ancestor
102481134|NCT02740660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102481135|NCT02740660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102481136|NCT02740660|Respiratory System Agents|respiratory system agents|mesh-ancestor
102481137|NCT02740660|Tocolytic Agents|tocolytic agents|mesh-ancestor
102481138|NCT02740660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102481139|NCT02740660|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102481140|NCT02740660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102481141|NCT02740660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102481142|NCT02740660|Adrenergic Agents|adrenergic agents|mesh-ancestor
102481143|NCT05516862|Camphor|camphor|mesh-list
102481144|NCT05516862|Salicylates|salicylates|mesh-list
102481145|NCT05516862|Methyl salicylate|methyl salicylate|mesh-list
102481146|NCT05516862|Menthol|menthol|mesh-list
102481147|NCT05516862|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102481148|NCT05516862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102481149|NCT05516862|Antipruritics|antipruritics|mesh-ancestor
102481150|NCT05516862|Dermatologic Agents|dermatologic agents|mesh-ancestor
102481151|NCT05516862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102481152|NCT05516862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102481153|NCT05516862|Analgesics|analgesics|mesh-ancestor
102481154|NCT05516862|Sensory System Agents|sensory system agents|mesh-ancestor
102481155|NCT05516862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102481156|NCT05516862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481157|NCT05516862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102481158|NCT05516862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102481159|NCT05516862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102481160|NCT05516862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102481161|NCT05516862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481162|NCT03929068|Levodopa|levodopa|mesh-list
102481163|NCT03929068|Carbidopa|carbidopa|mesh-list
102481164|NCT03929068|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102481165|NCT03929068|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102481166|NCT03929068|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102481167|NCT03929068|Dopamine Agents|dopamine agents|mesh-ancestor
102481168|NCT03929068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102481169|NCT03929068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481170|NCT03929068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481171|NCT03929068|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102481172|NCT03929068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102481173|NCT03929068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102481174|NCT03929068|Immunologic Factors|immunologic factors|mesh-ancestor
102481175|NCT03929068|Dopamine Agonists|dopamine agonists|mesh-ancestor
102481177|NCT05516784|Ticagrelor|ticagrelor|mesh-list
102481178|NCT05516784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102481179|NCT05516784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102481180|NCT05516784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102481181|NCT05516784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102481182|NCT05516784|Purinergic Agents|purinergic agents|mesh-ancestor
102481183|NCT05516784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102481184|NCT05516784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481185|NCT05516784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481186|NCT02571972|Timolol|timolol|mesh-list
102481187|NCT02571972|Dorzolamide|dorzolamide|mesh-list
102481188|NCT02571972|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102481189|NCT02571972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102481190|NCT02571972|Adrenergic Agents|adrenergic agents|mesh-ancestor
102481191|NCT02571972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102481192|NCT02571972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481193|NCT02571972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481194|NCT02571972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102481195|NCT02571972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102481196|NCT02571972|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102481197|NCT02571972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102481198|NCT04996134|Domperidone|domperidone|mesh-list
102481199|NCT04996134|Antiemetics|antiemetics|mesh-ancestor
102481200|NCT04996134|Autonomic Agents|autonomic agents|mesh-ancestor
102481201|NCT04996134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102481202|NCT04996134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481203|NCT04996134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102481204|NCT04996134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102481205|NCT04996134|Dopamine Agents|dopamine agents|mesh-ancestor
102481206|NCT04996134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102481207|NCT04996134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481208|NCT00371332|Minocycline|minocycline|mesh-list
102481209|NCT00371332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102481210|NCT00371332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102481211|NCT00842075|Pramlintide|pramlintide|mesh-list
102481212|NCT00842075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102481213|NCT00842075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481214|NCT00879359|Paclitaxel|paclitaxel|mesh-list
102481215|NCT00879359|Bevacizumab|bevacizumab|mesh-list
102481216|NCT00879359|Carboplatin|carboplatin|mesh-list
102481217|NCT00879359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102481218|NCT00879359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102481219|NCT00879359|Tubulin Modulators|tubulin modulators|mesh-ancestor
102481220|NCT00879359|Antimitotic Agents|antimitotic agents|mesh-ancestor
102481221|NCT00879359|Mitosis Modulators|mitosis modulators|mesh-ancestor
102481222|NCT00879359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481223|NCT00879359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102481224|NCT00879359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102481225|NCT00879359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102481226|NCT00879359|Growth Substances|growth substances|mesh-ancestor
102481227|NCT00879359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481228|NCT00879359|Growth Inhibitors|growth inhibitors|mesh-ancestor
102481229|NCT00880919|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102481230|NCT00880919|Antidepressive Agents|antidepressive agents|mesh-ancestor
102481231|NCT00880919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102481232|NCT00880919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102481233|NCT00880919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102481234|NCT00880919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102481235|NCT00880919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481236|NCT00880997|Doxazosin|doxazosin|mesh-list
102481237|NCT00880997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102481238|NCT00880997|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102292872|NCT02582671|Ritonavir|ritonavir|mesh-list
102481239|NCT00880997|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102481240|NCT00880997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102481241|NCT00880997|Adrenergic Agents|adrenergic agents|mesh-ancestor
102481242|NCT00880997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102481243|NCT00880997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481244|NCT00880997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481245|NCT00883103|Lidocaine|lidocaine|mesh-list
102481246|NCT00883103|Anesthetics, Local|anesthetics, local|mesh-ancestor
102481247|NCT00883103|Anesthetics|anesthetics|mesh-ancestor
102481248|NCT00883103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102481249|NCT00883103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481250|NCT00883103|Sensory System Agents|sensory system agents|mesh-ancestor
102481251|NCT00883103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102481252|NCT00883103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102481253|NCT00883103|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102481254|NCT00883103|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101564775|NCT01130337|Antimetabolites|antimetabolites|mesh-ancestor
102481255|NCT00883103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102481256|NCT00883103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481257|NCT02742532|Oxytocin|oxytocin|mesh-list
102481258|NCT02742532|Oxytocics|oxytocics|mesh-ancestor
102481259|NCT02742532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102481260|NCT02742532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481261|NCT05521386|Caffeine|caffeine|mesh-list
102481262|NCT05521386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102481263|NCT05521386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481264|NCT05521386|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102481265|NCT05521386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102481266|NCT05521386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481267|NCT05521386|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102481268|NCT05521386|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102481269|NCT05521386|Purinergic Agents|purinergic agents|mesh-ancestor
102481270|NCT05521386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102481271|NCT00370630|Triamcinolone|triamcinolone|mesh-list
102481272|NCT00370630|Bevacizumab|bevacizumab|mesh-list
102481273|NCT00370630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102481274|NCT00370630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102481275|NCT00370630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101564805|NCT01130103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564806|NCT01130103|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101564807|NCT01130103|Antidepressive Agents|antidepressive agents|mesh-ancestor
101564808|NCT01130103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101564809|NCT01130103|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101526750|NCT05293249|Prednisolone|prednisolone|mesh-list
101413058|NCT00480844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101767010|NCT04563754|Proflavine|proflavine|mesh-list
101767011|NCT04563754|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101767012|NCT04563754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101767013|NCT04551521|Trastuzumab|trastuzumab|mesh-list
102481276|NCT00370630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102481277|NCT00370630|Growth Substances|growth substances|mesh-ancestor
102481278|NCT00370630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481279|NCT00370630|Growth Inhibitors|growth inhibitors|mesh-ancestor
102481280|NCT00370630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102481281|NCT00370630|Glucocorticoids|glucocorticoids|mesh-ancestor
102481282|NCT00370630|Hormones|hormones|mesh-ancestor
102481283|NCT00370630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102481284|NCT04984980|Bevacizumab|bevacizumab|mesh-list
101564812|NCT04254523|Morphine|morphine|mesh-list
102481285|NCT04984980|Gemcitabine|gemcitabine|mesh-list
102481286|NCT04984980|Oxaliplatin|oxaliplatin|mesh-list
102481287|NCT04984980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102481288|NCT04984980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102481289|NCT04984980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102481290|NCT04984980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102481291|NCT04984980|Growth Substances|growth substances|mesh-ancestor
102481292|NCT04984980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481293|NCT04984980|Growth Inhibitors|growth inhibitors|mesh-ancestor
102481294|NCT04984980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102481295|NCT04984980|Antimetabolites|antimetabolites|mesh-ancestor
102481296|NCT04984980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481297|NCT00370786|Bevacizumab|bevacizumab|mesh-list
102481298|NCT00370786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102481299|NCT00370786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102481300|NCT00370786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102481301|NCT00370786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102481302|NCT00370786|Growth Substances|growth substances|mesh-ancestor
102481303|NCT00370786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481304|NCT00370786|Growth Inhibitors|growth inhibitors|mesh-ancestor
102481305|NCT03437356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
102481306|NCT03387670|Simvastatin|simvastatin|mesh-list
102481307|NCT03387670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102481308|NCT03387670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102481309|NCT03387670|Antimetabolites|antimetabolites|mesh-ancestor
101564835|NCT00625209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102481310|NCT03387670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292951|NCT05677945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102481311|NCT03387670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102481312|NCT03387670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102481313|NCT03387670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102481314|NCT04979832|Metronidazole|metronidazole|mesh-list
102481315|NCT04979832|Fosfomycin|fosfomycin|mesh-list
102481316|NCT04979832|Molgramostim|molgramostim|mesh-list
102481317|NCT04979832|Sargramostim|sargramostim|mesh-list
102481318|NCT04979832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102481319|NCT04979832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102481320|NCT04979832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102481321|NCT04979832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102481322|NCT04979832|Immunologic Factors|immunologic factors|mesh-ancestor
102481323|NCT04979832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481324|NCT04979832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102481325|NCT05521152|Norepinephrine|norepinephrine|mesh-list
102481326|NCT05521152|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102481327|NCT05521152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102481328|NCT05521152|Adrenergic Agents|adrenergic agents|mesh-ancestor
102481329|NCT05521152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102481330|NCT05521152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481331|NCT05521152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481332|NCT05521152|Sympathomimetics|sympathomimetics|mesh-ancestor
102481333|NCT05521152|Autonomic Agents|autonomic agents|mesh-ancestor
102481334|NCT05521152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102481335|NCT05521152|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102481336|NCT02740114|Oxycodone|oxycodone|mesh-list
102481337|NCT02740114|Bupivacaine|bupivacaine|mesh-list
102481338|NCT02740114|Anesthetics, Local|anesthetics, local|mesh-ancestor
102481339|NCT02740114|Anesthetics|anesthetics|mesh-ancestor
102481340|NCT02740114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102481341|NCT02740114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481342|NCT02740114|Sensory System Agents|sensory system agents|mesh-ancestor
102481343|NCT02740114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102481344|NCT02740114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102481345|NCT02740114|Narcotics|narcotics|mesh-ancestor
102481346|NCT02740114|Analgesics|analgesics|mesh-ancestor
102481347|NCT00371410|Triamcinolone|triamcinolone|mesh-list
102481348|NCT00371410|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102481349|NCT00371410|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102481350|NCT00371410|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102481351|NCT00371410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102481352|NCT00371410|Glucocorticoids|glucocorticoids|mesh-ancestor
102481353|NCT00371410|Hormones|hormones|mesh-ancestor
102481354|NCT00371410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102481355|NCT00371410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481356|NCT00371410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102481357|NCT00371410|Immunologic Factors|immunologic factors|mesh-ancestor
102481358|NCT00371410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102481359|NCT00371410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481360|NCT04295850|Aspirin|aspirin|mesh-list
102481361|NCT04295850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102481362|NCT04295850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102481363|NCT04295850|Analgesics|analgesics|mesh-ancestor
102481364|NCT04295850|Sensory System Agents|sensory system agents|mesh-ancestor
102481365|NCT04295850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102481366|NCT04295850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481367|NCT04295850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102481368|NCT04295850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102481369|NCT04295850|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102481370|NCT04295850|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102481371|NCT04295850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481372|NCT04295850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102481373|NCT04295850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102481374|NCT04295850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102481375|NCT04295850|Antipyretics|antipyretics|mesh-ancestor
102481376|NCT02166905|Poly I-C|poly i-c|mesh-list
102481377|NCT02166905|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102481378|NCT02166905|Poly ICLC|poly iclc|mesh-list
102481379|NCT02166905|Interferon Inducers|interferon inducers|mesh-ancestor
102481380|NCT02166905|Immunologic Factors|immunologic factors|mesh-ancestor
102481381|NCT02166905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481382|NCT02166905|Laxatives|laxatives|mesh-ancestor
102481383|NCT02166905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102481384|NCT02166905|Antiviral Agents|antiviral agents|mesh-ancestor
102481385|NCT02166905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102481386|NCT02743078|Bevacizumab|bevacizumab|mesh-list
102481387|NCT02743078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102481388|NCT02743078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102481389|NCT02743078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102481390|NCT02743078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102481391|NCT02743078|Growth Substances|growth substances|mesh-ancestor
102481392|NCT02743078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481393|NCT02743078|Growth Inhibitors|growth inhibitors|mesh-ancestor
102481395|NCT03323398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102481396|NCT03323398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102481397|NCT00890981|Denosumab|denosumab|mesh-list
102481398|NCT00890981|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102481399|NCT00890981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481400|NCT05515770|Cabotegravir|cabotegravir|mesh-list
102481401|NCT05515770|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102481402|NCT05515770|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102481403|NCT05515770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102481404|NCT05515770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481405|NCT05515770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102481406|NCT05515770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102481407|NCT05515770|Antiviral Agents|antiviral agents|mesh-ancestor
102481408|NCT05515770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102481409|NCT04480138|Interferons|interferons|mesh-list
102481410|NCT04480138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102481411|NCT04480138|Antiviral Agents|antiviral agents|mesh-ancestor
102481412|NCT04480138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102481413|NCT00371488|Lapatinib|lapatinib|mesh-list
102481414|NCT00371488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102481415|NCT00371488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102481416|NCT00371488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102481417|NCT00371488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481418|NCT00883415|Darbepoetin alfa|darbepoetin alfa|mesh-list
102481419|NCT00883415|Hematinics|hematinics|mesh-ancestor
102481420|NCT04337632|Paclitaxel|paclitaxel|mesh-list
102481421|NCT04337632|Carboplatin|carboplatin|mesh-list
102481422|NCT04337632|Doxorubicin|doxorubicin|mesh-list
102481423|NCT04337632|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102481424|NCT04337632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102481425|NCT04337632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102481426|NCT04337632|Tubulin Modulators|tubulin modulators|mesh-ancestor
102481427|NCT04337632|Antimitotic Agents|antimitotic agents|mesh-ancestor
102481428|NCT04337632|Mitosis Modulators|mitosis modulators|mesh-ancestor
102481429|NCT04337632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481430|NCT04337632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102481431|NCT04337632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101564953|NCT04251871|Immunologic Factors|immunologic factors|mesh-ancestor
102481432|NCT04337632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102481433|NCT04337632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102481434|NCT05349058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102481435|NCT05349058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481436|NCT05349058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102481437|NCT05349058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102481438|NCT05348980|Phenylephrine|phenylephrine|mesh-list
102481439|NCT05348980|Oxymetazoline|oxymetazoline|mesh-list
102481440|NCT05348980|Synephrine|synephrine|mesh-list
102481441|NCT05348980|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102481442|NCT05348980|Mydriatics|mydriatics|mesh-ancestor
102481443|NCT05348980|Autonomic Agents|autonomic agents|mesh-ancestor
102481444|NCT05348980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101564962|NCT01128621|Protease Inhibitors|protease inhibitors|mesh-ancestor
102481445|NCT05348980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481446|NCT05348980|Sympathomimetics|sympathomimetics|mesh-ancestor
102481447|NCT05348980|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102481448|NCT05348980|Nasal Decongestants|nasal decongestants|mesh-ancestor
102481449|NCT05348980|Respiratory System Agents|respiratory system agents|mesh-ancestor
102481450|NCT05348980|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102481451|NCT05348980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102481452|NCT05348980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102481453|NCT05348980|Adrenergic Agents|adrenergic agents|mesh-ancestor
102481454|NCT05348980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102481455|NCT05348980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481456|NCT05348980|Protective Agents|protective agents|mesh-ancestor
102481457|NCT00884585|Cyclosporine|cyclosporine|mesh-list
102481458|NCT00884585|Cyclosporins|cyclosporins|mesh-list
102481459|NCT00884585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102481460|NCT00884585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481461|NCT00884585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102481462|NCT00884585|Immunologic Factors|immunologic factors|mesh-ancestor
102293100|NCT05579509|Fentanyl|fentanyl|mesh-list
102481463|NCT00884585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481464|NCT00884585|Antifungal Agents|antifungal agents|mesh-ancestor
102481465|NCT00884585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102481466|NCT00884585|Dermatologic Agents|dermatologic agents|mesh-ancestor
102481467|NCT00884585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102481468|NCT00884585|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102481469|NCT00884897|Oxytocin|oxytocin|mesh-list
102481470|NCT00884897|Oxytocics|oxytocics|mesh-ancestor
102481471|NCT00884897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102481472|NCT00884897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481473|NCT03216473|Botulinum Toxins|botulinum toxins|mesh-list
102481474|NCT03216473|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102481475|NCT03216473|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102481476|NCT03216473|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102481477|NCT03216473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102481478|NCT03216473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481479|NCT03216473|Cholinergic Agents|cholinergic agents|mesh-ancestor
102481480|NCT03216473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102481481|NCT03216473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481482|NCT03216473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102481483|NCT03216473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102481484|NCT03384563|Dexmedetomidine|dexmedetomidine|mesh-list
102481485|NCT03384563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102481486|NCT03384563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102481487|NCT03384563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481488|NCT03384563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102481489|NCT03384563|Analgesics|analgesics|mesh-ancestor
102481490|NCT03384563|Sensory System Agents|sensory system agents|mesh-ancestor
102481491|NCT03384563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102481492|NCT03384563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102481493|NCT03384563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102481494|NCT03384563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102481495|NCT03384563|Adrenergic Agents|adrenergic agents|mesh-ancestor
102481496|NCT03384563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102481497|NCT03384563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481498|NCT04946526|Mechlorethamine|mechlorethamine|mesh-list
102481499|NCT04946526|Alkylating Agents|alkylating agents|mesh-ancestor
102481500|NCT04946526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481501|NCT04946526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102481502|NCT04946526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102481503|NCT02748070|Fluticasone|fluticasone|mesh-list
102481504|NCT02748070|Prednisone|prednisone|mesh-list
102481505|NCT02748070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102481506|NCT02748070|Glucocorticoids|glucocorticoids|mesh-ancestor
102481507|NCT02748070|Hormones|hormones|mesh-ancestor
102481508|NCT02748070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102481509|NCT02748070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481510|NCT02748070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102481511|NCT02748070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102481512|NCT02748070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101768001|NCT04588948|Aflibercept|aflibercept|mesh-list
102481513|NCT02748070|Autonomic Agents|autonomic agents|mesh-ancestor
102481514|NCT02748070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102481515|NCT02748070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102481516|NCT02748070|Respiratory System Agents|respiratory system agents|mesh-ancestor
102481517|NCT02748070|Dermatologic Agents|dermatologic agents|mesh-ancestor
102481518|NCT02748070|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102481519|NCT05311709|Sotorasib|sotorasib|mesh-list
102481520|NCT05311709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101768062|NCT00610155|Tramadol|tramadol|mesh-list
102481521|NCT05311709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481522|NCT05311709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102481523|NCT05311709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102481524|NCT05310383|Tislelizumab|tislelizumab|mesh-list
102481525|NCT05310383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102481526|NCT05310383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102481527|NCT05310305|Antibodies|antibodies|mesh-list
102481528|NCT05310305|Immunologic Factors|immunologic factors|mesh-ancestor
102481529|NCT05310305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481530|NCT05149638|Cosyntropin|cosyntropin|mesh-list
102481531|NCT05149638|Hormones|hormones|mesh-ancestor
102481532|NCT05149638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102481533|NCT05149638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481534|NCT05519670|Niraparib|niraparib|mesh-list
102481535|NCT05519670|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102481536|NCT05519670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102481537|NCT05519670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481538|NCT05519670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102481540|NCT05519592|Anesthetics, Local|anesthetics, local|mesh-ancestor
102481541|NCT05519592|Anesthetics|anesthetics|mesh-ancestor
102481542|NCT05519592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102481543|NCT05519592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481544|NCT05519592|Sensory System Agents|sensory system agents|mesh-ancestor
102481545|NCT05519592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102481546|NCT05519514|Budesonide|budesonide|mesh-list
102481547|NCT05519514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102481548|NCT05519514|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102481549|NCT05519514|Autonomic Agents|autonomic agents|mesh-ancestor
102481550|NCT05519514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102481551|NCT05519514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481552|NCT05519514|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102481553|NCT05519514|Respiratory System Agents|respiratory system agents|mesh-ancestor
102481554|NCT05519514|Glucocorticoids|glucocorticoids|mesh-ancestor
102481555|NCT05519514|Hormones|hormones|mesh-ancestor
102481556|NCT05519514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102481557|NCT02756572|Cytarabine|cytarabine|mesh-list
102481558|NCT02756572|Cyclosporine|cyclosporine|mesh-list
102481559|NCT02756572|Mycophenolic Acid|mycophenolic acid|mesh-list
102481560|NCT02756572|Sirolimus|sirolimus|mesh-list
102481561|NCT02756572|Fludarabine|fludarabine|mesh-list
102481562|NCT02756572|Fludarabine phosphate|fludarabine phosphate|mesh-list
102481563|NCT02756572|Melphalan|melphalan|mesh-list
102481564|NCT02756572|Mechlorethamine|mechlorethamine|mesh-list
102481565|NCT02756572|Mitoxantrone|mitoxantrone|mesh-list
102481566|NCT02756572|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102481567|NCT02756572|Cladribine|cladribine|mesh-list
102481568|NCT02756572|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
102481569|NCT02756572|Cyclosporins|cyclosporins|mesh-list
102481570|NCT02756572|Lenograstim|lenograstim|mesh-list
102481571|NCT02756572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102481572|NCT02756572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102481573|NCT02756572|Antimetabolites|antimetabolites|mesh-ancestor
102481574|NCT02756572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481575|NCT02756572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102481576|NCT02756572|Immunologic Factors|immunologic factors|mesh-ancestor
102481577|NCT02756572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481578|NCT02756572|Antiviral Agents|antiviral agents|mesh-ancestor
102481579|NCT02756572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102481580|NCT02756572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102481581|NCT02756572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102481582|NCT02756572|Antifungal Agents|antifungal agents|mesh-ancestor
102481583|NCT02756572|Dermatologic Agents|dermatologic agents|mesh-ancestor
102481584|NCT02756572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102481585|NCT02756572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102481586|NCT02756572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102481587|NCT02756572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102481588|NCT02756572|Antitubercular Agents|antitubercular agents|mesh-ancestor
102481589|NCT02756572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102481590|NCT02756572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102481591|NCT02756572|Alkylating Agents|alkylating agents|mesh-ancestor
102481592|NCT02756572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102481593|NCT02756572|Analgesics|analgesics|mesh-ancestor
102481594|NCT02756572|Sensory System Agents|sensory system agents|mesh-ancestor
102481595|NCT02756572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102481596|NCT02756572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102481597|NCT02756572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102481598|NCT01049035|Vaccines|vaccines|mesh-list
102481599|NCT01049035|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102481600|NCT01049035|Immunologic Factors|immunologic factors|mesh-ancestor
102481601|NCT01049035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481602|NCT05131698|Lenvatinib|lenvatinib|mesh-list
102481603|NCT05131698|Tislelizumab|tislelizumab|mesh-list
102481604|NCT05131698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102481605|NCT05131698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102481606|NCT05131698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102481607|NCT05131698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481608|NCT05131698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102481609|NCT01724983|Fentanyl|fentanyl|mesh-list
102481610|NCT01724983|Ketamine|ketamine|mesh-list
102481611|NCT01724983|Analgesics|analgesics|mesh-ancestor
102481612|NCT01724983|Sensory System Agents|sensory system agents|mesh-ancestor
102481613|NCT01724983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102481614|NCT01724983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481615|NCT01724983|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102481616|NCT01724983|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102481617|NCT01724983|Anesthetics, General|anesthetics, general|mesh-ancestor
102481618|NCT01724983|Anesthetics|anesthetics|mesh-ancestor
102481619|NCT01724983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102481620|NCT01724983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102481621|NCT01724983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102481622|NCT01724983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102481623|NCT01724983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481624|NCT01724983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102481625|NCT01724983|Narcotics|narcotics|mesh-ancestor
102481626|NCT01724983|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102481627|NCT02973958|Acetaminophen|acetaminophen|mesh-list
102481628|NCT02973958|Ibuprofen|ibuprofen|mesh-list
102481629|NCT02973958|Ketorolac|ketorolac|mesh-list
102481630|NCT02973958|Bupivacaine|bupivacaine|mesh-list
102481631|NCT02973958|Sevoflurane|sevoflurane|mesh-list
102481632|NCT02973958|Anesthetics, Local|anesthetics, local|mesh-ancestor
102481633|NCT02973958|Anesthetics|anesthetics|mesh-ancestor
101565131|NCT04256473|Saruplase|saruplase|mesh-list
102481634|NCT02973958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102481635|NCT02973958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481636|NCT02973958|Sensory System Agents|sensory system agents|mesh-ancestor
102481637|NCT02973958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102481638|NCT02973958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102481639|NCT02973958|Analgesics|analgesics|mesh-ancestor
102481640|NCT02973958|Antipyretics|antipyretics|mesh-ancestor
102481641|NCT02973958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102481642|NCT02973958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102481643|NCT02973958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102481644|NCT02973958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102481645|NCT02973958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102481646|NCT02973958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481647|NCT02973958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102481648|NCT02973958|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102481649|NCT02973958|Anesthetics, General|anesthetics, general|mesh-ancestor
102481650|NCT01048333|Formoterol Fumarate|formoterol fumarate|mesh-list
102481651|NCT01048333|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102481652|NCT01048333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102481653|NCT01048333|Autonomic Agents|autonomic agents|mesh-ancestor
102481654|NCT01048333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102481655|NCT01048333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481656|NCT01048333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102481657|NCT01048333|Respiratory System Agents|respiratory system agents|mesh-ancestor
102481658|NCT01048333|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102481659|NCT01048333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102481660|NCT01048333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102481661|NCT01048333|Adrenergic Agents|adrenergic agents|mesh-ancestor
102481662|NCT01048333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102481663|NCT01048333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481664|NCT05513976|Febuxostat|febuxostat|mesh-list
102481665|NCT05513976|Gout Suppressants|gout suppressants|mesh-ancestor
102481666|NCT05513976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102481667|NCT04335526|Cholestyramine Resin|cholestyramine resin|mesh-list
102481668|NCT04335526|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102481669|NCT04335526|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102481670|NCT04335526|Antimetabolites|antimetabolites|mesh-ancestor
101565155|NCT04318158|Bupivacaine|bupivacaine|mesh-list
102481671|NCT04335526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481672|NCT04335526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102481673|NCT05348434|Ether|ether|mesh-list
102481674|NCT05348434|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102481675|NCT05348434|Anesthetics, General|anesthetics, general|mesh-ancestor
102481676|NCT05348434|Anesthetics|anesthetics|mesh-ancestor
102481677|NCT05348434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102481678|NCT05348434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481679|NCT05519202|Oxaliplatin|oxaliplatin|mesh-list
102481680|NCT05519202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102481681|NCT02281383|BCG Vaccine|bcg vaccine|mesh-list
102481682|NCT02281383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102481683|NCT02281383|Immunologic Factors|immunologic factors|mesh-ancestor
102481684|NCT02281383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481685|NCT01047553|Formoterol Fumarate|formoterol fumarate|mesh-list
102481686|NCT01047553|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102481687|NCT01047553|Autonomic Agents|autonomic agents|mesh-ancestor
102481688|NCT01047553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102481689|NCT01047553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481690|NCT01047553|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102481691|NCT01047553|Respiratory System Agents|respiratory system agents|mesh-ancestor
102481692|NCT01047553|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102481693|NCT01047553|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102481694|NCT01047553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102481695|NCT01047553|Adrenergic Agents|adrenergic agents|mesh-ancestor
102481696|NCT01047553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102481697|NCT01047553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481698|NCT02760862|Hydrocortisone|hydrocortisone|mesh-list
101565181|NCT01207596|Analgesics|analgesics|mesh-ancestor
102481699|NCT02760862|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102481700|NCT02760862|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102481701|NCT02760862|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102481702|NCT02760862|Mannitol|mannitol|mesh-list
102481703|NCT02760862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102481704|NCT02760862|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102481705|NCT02760862|Diuretics|diuretics|mesh-ancestor
102481706|NCT02760862|Natriuretic Agents|natriuretic agents|mesh-ancestor
102481707|NCT02760862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481708|NCT05720637|Serotonin|serotonin|mesh-list
102481709|NCT05720637|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102481710|NCT05720637|Serotonin Agents|serotonin agents|mesh-ancestor
102481711|NCT05720637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102481712|NCT05720637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481713|NCT05720637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481714|NCT05720559|Folic Acid|folic acid|mesh-list
102481715|NCT05720559|Vitamin A|vitamin a|mesh-list
102481716|NCT05720559|Metronidazole|metronidazole|mesh-list
102481717|NCT05720559|Capecitabine|capecitabine|mesh-list
102481718|NCT05720559|Oxaliplatin|oxaliplatin|mesh-list
102481719|NCT05720559|Cetuximab|cetuximab|mesh-list
102481720|NCT05720559|Vitamins|vitamins|mesh-ancestor
102481721|NCT05720559|Micronutrients|micronutrients|mesh-ancestor
102481722|NCT05720559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481723|NCT05720559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102481724|NCT05720559|Antimetabolites|antimetabolites|mesh-ancestor
102481725|NCT05720559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481726|NCT05720559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102481727|NCT05720559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102481728|NCT05720559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102481729|NCT05720559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102481730|NCT05720559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102481731|NCT05720559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102481732|NCT05720559|Hematinics|hematinics|mesh-ancestor
102481733|NCT05720559|Vitamin B Complex|vitamin b complex|mesh-ancestor
102481734|NCT02761252|Montelukast|montelukast|mesh-list
102481735|NCT02761252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102481736|NCT02761252|Respiratory System Agents|respiratory system agents|mesh-ancestor
102481737|NCT02761252|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102481738|NCT02761252|Hormone Antagonists|hormone antagonists|mesh-ancestor
102481739|NCT02761252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102481740|NCT02761252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481741|NCT02761252|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102481742|NCT02761252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102481743|NCT02761252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481744|NCT05714475|Pancrelipase|pancrelipase|mesh-list
102481745|NCT05714475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102481746|NCT01047007|Cisplatin|cisplatin|mesh-list
102481747|NCT01047007|Adavosertib|adavosertib|mesh-list
102481748|NCT01047007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102481749|NCT01047007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102481750|NCT01047007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481751|NCT05443984|Esomeprazole|esomeprazole|mesh-list
102481752|NCT05443984|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102481753|NCT05443984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102481754|NCT05443984|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102481755|NCT05443984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102481756|NCT05443984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481757|NCT01725607|Dexmedetomidine|dexmedetomidine|mesh-list
102481758|NCT01725607|Anesthetics|anesthetics|mesh-list
102481759|NCT01725607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102481760|NCT01725607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481761|NCT01725607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101565245|NCT04597099|Flutamide|flutamide|mesh-list
102481762|NCT01725607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102481763|NCT01725607|Analgesics|analgesics|mesh-ancestor
102481764|NCT01725607|Sensory System Agents|sensory system agents|mesh-ancestor
102481765|NCT01725607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102481766|NCT01725607|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102481767|NCT01725607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101565257|NCT04816513|Ustekinumab|ustekinumab|mesh-list
102481768|NCT01725607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102481769|NCT01725607|Adrenergic Agents|adrenergic agents|mesh-ancestor
102481770|NCT01725607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102481771|NCT01725607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481772|NCT03304379|Celecoxib|celecoxib|mesh-list
102481773|NCT03304379|Diclofenac|diclofenac|mesh-list
102481774|NCT03304379|Fasinumab|fasinumab|mesh-list
102481775|NCT03304379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102481776|NCT03304379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102481777|NCT03304379|Analgesics|analgesics|mesh-ancestor
102481778|NCT03304379|Sensory System Agents|sensory system agents|mesh-ancestor
102481779|NCT03304379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102481780|NCT03304379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481781|NCT03304379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102481782|NCT03304379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102481783|NCT03304379|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102481784|NCT03304379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102481785|NCT03304379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102481786|NCT03304379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481787|NCT00915967|Vancomycin|vancomycin|mesh-list
102481788|NCT00915967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102481789|NCT00915967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102481790|NCT01044745|Mycophenolic Acid|mycophenolic acid|mesh-list
102481791|NCT01044745|Cyclophosphamide|cyclophosphamide|mesh-list
102481792|NCT01044745|Busulfan|busulfan|mesh-list
102481793|NCT01044745|Rituximab|rituximab|mesh-list
102481794|NCT01044745|Fludarabine|fludarabine|mesh-list
102481795|NCT01044745|Fludarabine phosphate|fludarabine phosphate|mesh-list
102481796|NCT01044745|Tacrolimus|tacrolimus|mesh-list
102481797|NCT01044745|Thymoglobulin|thymoglobulin|mesh-list
102481798|NCT01044745|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102481799|NCT01044745|Immunosuppressive Agents|immunosuppressive agents|mesh-list
102481800|NCT01044745|Immunologic Factors|immunologic factors|mesh-ancestor
102481801|NCT01044745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481802|NCT01044745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102481803|NCT01044745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102481804|NCT01044745|Alkylating Agents|alkylating agents|mesh-ancestor
102481805|NCT01044745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481806|NCT01044745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102481807|NCT01044745|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102481808|NCT01044745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101565291|NCT00910273|Immunologic Factors|immunologic factors|mesh-ancestor
102481809|NCT01044745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102481810|NCT01044745|Antimetabolites|antimetabolites|mesh-ancestor
102481811|NCT01044745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102481812|NCT01044745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102481813|NCT01044745|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102481814|NCT01044745|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102481815|NCT01044745|Antitubercular Agents|antitubercular agents|mesh-ancestor
102481816|NCT01044745|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102481817|NCT01044745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102481818|NCT02766244|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101565303|NCT00909181|Oxybutynin|oxybutynin|mesh-list
102481819|NCT02766244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102481820|NCT05031078|Lidocaine|lidocaine|mesh-list
102481821|NCT05031078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481822|NCT05031078|Anesthetics, Local|anesthetics, local|mesh-ancestor
102481823|NCT05031078|Anesthetics|anesthetics|mesh-ancestor
102481824|NCT05031078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102481825|NCT05031078|Sensory System Agents|sensory system agents|mesh-ancestor
102481826|NCT05031078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102481827|NCT05031078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102481828|NCT05031078|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102481829|NCT05031078|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102481830|NCT05031078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102481831|NCT05031078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481832|NCT05513664|Osimertinib|osimertinib|mesh-list
102481833|NCT05513664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102481834|NCT05513664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102481835|NCT05513664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102481836|NCT05513664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481837|NCT03216395|Epinephrine|epinephrine|mesh-list
102481838|NCT03216395|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102481839|NCT03216395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102481840|NCT03216395|Adrenergic Agents|adrenergic agents|mesh-ancestor
102481841|NCT03216395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102481842|NCT03216395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481843|NCT03216395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481844|NCT03216395|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102481845|NCT03216395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102481846|NCT03216395|Autonomic Agents|autonomic agents|mesh-ancestor
102481847|NCT03216395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102481848|NCT03216395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102481849|NCT03216395|Respiratory System Agents|respiratory system agents|mesh-ancestor
102481850|NCT03216395|Mydriatics|mydriatics|mesh-ancestor
102481851|NCT03216395|Sympathomimetics|sympathomimetics|mesh-ancestor
102481852|NCT03216395|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102481853|NCT02767492|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102481854|NCT02767492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102481855|NCT02767492|Glucocorticoids|glucocorticoids|mesh-ancestor
102481856|NCT02767492|Hormones|hormones|mesh-ancestor
102481857|NCT02767492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101427481|NCT02941198|Copper|copper|mesh-list
102481858|NCT02767492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481859|NCT02767492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102481860|NCT02767492|Immunologic Factors|immunologic factors|mesh-ancestor
102481861|NCT01044433|Capecitabine|capecitabine|mesh-list
102481862|NCT01044433|Lapatinib|lapatinib|mesh-list
102481863|NCT01044433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102481864|NCT01044433|Antimetabolites|antimetabolites|mesh-ancestor
102481865|NCT01044433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481866|NCT01044433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102481867|NCT01044433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102481868|NCT01044433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102481869|NCT03400969|Glycerol|glycerol|mesh-list
102481870|NCT03400969|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102481871|NCT03400969|Protective Agents|protective agents|mesh-ancestor
102481872|NCT03400969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481873|NCT04633278|Pembrolizumab|pembrolizumab|mesh-list
102481874|NCT04633278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102481875|NCT04633278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102481876|NCT04633278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102481877|NCT04633278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481878|NCT05518812|Carboprost|carboprost|mesh-list
102481879|NCT05518812|Carboprost tromethamine|carboprost tromethamine|mesh-list
102481880|NCT05518812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102481881|NCT05518812|Abortifacient Agents|abortifacient agents|mesh-ancestor
102481882|NCT05518812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102481883|NCT05518812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481884|NCT05518812|Oxytocics|oxytocics|mesh-ancestor
102481885|NCT04334512|Vitamin D|vitamin d|mesh-list
102481886|NCT04334512|Vitamins|vitamins|mesh-list
102481887|NCT04334512|Azithromycin|azithromycin|mesh-list
102481888|NCT04334512|Hydroxychloroquine|hydroxychloroquine|mesh-list
102481889|NCT04334512|Micronutrients|micronutrients|mesh-ancestor
102481890|NCT04334512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481891|NCT04334512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101565374|NCT01281917|Sirolimus|sirolimus|mesh-list
102481892|NCT04334512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102481893|NCT04334512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102481894|NCT04334512|Antimalarials|antimalarials|mesh-ancestor
102481895|NCT04334512|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102481896|NCT04334512|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102481897|NCT04334512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102481898|NCT04334512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481899|NCT04334512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102481900|NCT01043185|Lesogaberan|lesogaberan|mesh-list
102481901|NCT01043185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102481902|NCT01043185|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102481903|NCT01043185|GABA Agonists|gaba agonists|mesh-ancestor
102481904|NCT01043185|GABA Agents|gaba agents|mesh-ancestor
102481905|NCT01043185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102481906|NCT01043185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481907|NCT01043185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565389|NCT01281839|Ribavirin|ribavirin|mesh-list
102481908|NCT01042093|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102481909|NCT01042093|Clonidine|clonidine|mesh-list
102481910|NCT01042093|Epinephrine|epinephrine|mesh-list
102481911|NCT01042093|Ropivacaine|ropivacaine|mesh-list
102481912|NCT01042093|Anesthetics, Local|anesthetics, local|mesh-ancestor
102481913|NCT01042093|Anesthetics|anesthetics|mesh-ancestor
102481914|NCT01042093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102481915|NCT01042093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481916|NCT01042093|Sensory System Agents|sensory system agents|mesh-ancestor
102481917|NCT01042093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102481918|NCT01042093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102481919|NCT01042093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102481920|NCT01042093|Adrenergic Agents|adrenergic agents|mesh-ancestor
102481921|NCT01042093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102481922|NCT01042093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481923|NCT01042093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102481924|NCT01042093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102481926|NCT01042093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102481927|NCT01042093|Respiratory System Agents|respiratory system agents|mesh-ancestor
102481928|NCT01042093|Mydriatics|mydriatics|mesh-ancestor
102481929|NCT01042093|Sympathomimetics|sympathomimetics|mesh-ancestor
102481930|NCT01042093|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102481931|NCT01042093|Analgesics|analgesics|mesh-ancestor
102481932|NCT01042093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102481933|NCT01042093|Sympatholytics|sympatholytics|mesh-ancestor
102481934|NCT01042093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102481935|NCT01042093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102481936|NCT01042093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102481937|NCT01042093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102481938|NCT01042093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102481939|NCT01042093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102481940|NCT01042093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102481941|NCT03400735|Cefdinir|cefdinir|mesh-list
102481942|NCT03400735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102481943|NCT03400735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102481944|NCT04737928|Latanoprost|latanoprost|mesh-list
102481945|NCT04737928|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102481946|NCT04737928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102481947|NCT01041859|Tapentadol|tapentadol|mesh-list
102481948|NCT01041859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102481949|NCT01041859|Narcotics|narcotics|mesh-ancestor
102481950|NCT01041859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102481951|NCT01041859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481952|NCT01041859|Analgesics|analgesics|mesh-ancestor
102481953|NCT01041859|Sensory System Agents|sensory system agents|mesh-ancestor
102481954|NCT01041859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102481955|NCT01041859|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102481956|NCT01041859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102481957|NCT01041859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102481958|NCT01041859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481959|NCT01041859|Adrenergic Agents|adrenergic agents|mesh-ancestor
102481960|NCT01041859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102481961|NCT03405805|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102481962|NCT03405805|Immunologic Factors|immunologic factors|mesh-ancestor
102481963|NCT03405805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481964|NCT00371878|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102481965|NCT00371878|Immunologic Factors|immunologic factors|mesh-ancestor
102481966|NCT00371878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481967|NCT03400423|Caffeine|caffeine|mesh-list
102481968|NCT03400423|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102481969|NCT03400423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481970|NCT03400423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102481971|NCT03400423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102481972|NCT03400423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481973|NCT03400423|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102481974|NCT03400423|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102481975|NCT03400423|Purinergic Agents|purinergic agents|mesh-ancestor
102481976|NCT03400423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102481977|NCT01040845|Colchicine|colchicine|mesh-list
102481978|NCT01040845|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102481979|NCT01040845|Norethindrone|norethindrone|mesh-list
102481980|NCT01040845|Norethindrone Acetate|norethindrone acetate|mesh-list
102481981|NCT01040845|Estradiol|estradiol|mesh-list
102481982|NCT01040845|Estrogens|estrogens|mesh-ancestor
102481983|NCT01040845|Hormones|hormones|mesh-ancestor
102481984|NCT01040845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102481985|NCT01040845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102481986|NCT01040845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102481987|NCT01040845|Contraceptive Agents|contraceptive agents|mesh-ancestor
102481988|NCT01040845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102481989|NCT01040845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102293625|NCT05097599|Pembrolizumab|pembrolizumab|mesh-list
102481990|NCT01040845|Gout Suppressants|gout suppressants|mesh-ancestor
102481991|NCT01040845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102481992|NCT01040845|Tubulin Modulators|tubulin modulators|mesh-ancestor
102481993|NCT01040845|Antimitotic Agents|antimitotic agents|mesh-ancestor
102481994|NCT01040845|Mitosis Modulators|mitosis modulators|mesh-ancestor
102481995|NCT01040845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102481996|NCT01040845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102481997|NCT01040845|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102481998|NCT01040845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102481999|NCT01040845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102482000|NCT00371956|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
102482001|NCT00371956|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101770790|NCT00988780|Maraviroc|maraviroc|mesh-list
102482002|NCT00371956|Hormone Antagonists|hormone antagonists|mesh-ancestor
102482003|NCT00371956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102482004|NCT00371956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482005|NCT00371956|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101565490|NCT04323527|Filaricides|filaricides|mesh-ancestor
102482006|NCT00371956|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102482007|NCT00371956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102482008|NCT01040689|Tiotropium Bromide|tiotropium bromide|mesh-list
102482009|NCT01040689|Olodaterol|olodaterol|mesh-list
102482010|NCT01040689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102482011|NCT01040689|Autonomic Agents|autonomic agents|mesh-ancestor
102482012|NCT01040689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102482013|NCT01040689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482014|NCT01040689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102482015|NCT01040689|Respiratory System Agents|respiratory system agents|mesh-ancestor
102482016|NCT01040689|Parasympatholytics|parasympatholytics|mesh-ancestor
102482017|NCT01040689|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102482018|NCT01040689|Cholinergic Agents|cholinergic agents|mesh-ancestor
102482019|NCT01040689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102482020|NCT01040689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482021|NCT00372658|Lidocaine|lidocaine|mesh-list
102482022|NCT00372658|Anesthetics, Local|anesthetics, local|mesh-ancestor
102482023|NCT00372658|Anesthetics|anesthetics|mesh-ancestor
102482024|NCT00372658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102482025|NCT00372658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482026|NCT00372658|Sensory System Agents|sensory system agents|mesh-ancestor
102482027|NCT00372658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102482028|NCT00372658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102482029|NCT00372658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102482030|NCT00372658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102482031|NCT00372658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101565502|NCT01266161|Ibuprofen|ibuprofen|mesh-list
102482032|NCT00372658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482033|NCT03400189|Sulthiame|sulthiame|mesh-list
102482034|NCT03400189|Anticonvulsants|anticonvulsants|mesh-ancestor
102482035|NCT01043029|Pioglitazone|pioglitazone|mesh-list
102482036|NCT01043029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102482037|NCT01043029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482038|NCT04282954|Esomeprazole|esomeprazole|mesh-list
102482039|NCT04282954|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102482040|NCT04282954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102482041|NCT04282954|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102482042|NCT04282954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102482043|NCT04282954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482044|NCT05337436|Calcium|calcium|mesh-list
102482045|NCT05337436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102482046|NCT05337436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482047|NCT04755712|Sufentanil|sufentanil|mesh-list
102482048|NCT04755712|Morphine|morphine|mesh-list
102482049|NCT04755712|Bupivacaine|bupivacaine|mesh-list
102482050|NCT04755712|Anesthetics, Local|anesthetics, local|mesh-ancestor
102482051|NCT04755712|Anesthetics|anesthetics|mesh-ancestor
102482052|NCT04755712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102482053|NCT04755712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482054|NCT04755712|Sensory System Agents|sensory system agents|mesh-ancestor
102482055|NCT04755712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102482056|NCT04755712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102482057|NCT04755712|Narcotics|narcotics|mesh-ancestor
102482058|NCT04755712|Analgesics|analgesics|mesh-ancestor
102482059|NCT04755712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102482060|NCT04755712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102482061|NCT04755712|Anesthetics, General|anesthetics, general|mesh-ancestor
102482062|NCT04751812|Analgesics, Opioid|analgesics, opioid|mesh-list
102482063|NCT04751812|Narcotics|narcotics|mesh-ancestor
102482064|NCT04751812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102482065|NCT04751812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482066|NCT04751812|Analgesics|analgesics|mesh-ancestor
102482067|NCT04751812|Sensory System Agents|sensory system agents|mesh-ancestor
102482068|NCT04751812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102482069|NCT02415712|Fomepizole|fomepizole|mesh-list
102482070|NCT02415712|Antidotes|antidotes|mesh-ancestor
102482071|NCT02415712|Protective Agents|protective agents|mesh-ancestor
102482072|NCT02415712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482073|NCT02415712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102482074|NCT02415712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482075|NCT05456698|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
102482076|NCT05456698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102482077|NCT05456698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102482078|NCT05456698|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102482079|NCT05456698|Immunotoxins|immunotoxins|mesh-ancestor
102482080|NCT05456698|Immunoconjugates|immunoconjugates|mesh-ancestor
102482081|NCT05456698|Immunologic Factors|immunologic factors|mesh-ancestor
102482082|NCT05456698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482083|NCT02973724|Remifentanil|remifentanil|mesh-list
102482084|NCT02973724|Propofol|propofol|mesh-list
102482085|NCT02973724|Anesthetics|anesthetics|mesh-ancestor
102482086|NCT02973724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102482087|NCT02973724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482088|NCT02973724|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102482089|NCT02973724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102482090|NCT02973724|Anesthetics, General|anesthetics, general|mesh-ancestor
102482091|NCT02973724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102482092|NCT02973724|Narcotics|narcotics|mesh-ancestor
102482093|NCT02973724|Analgesics|analgesics|mesh-ancestor
102482094|NCT02973724|Sensory System Agents|sensory system agents|mesh-ancestor
102482095|NCT02973724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102482096|NCT05456542|Dexamethasone|dexamethasone|mesh-list
102482097|NCT05456542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102482098|NCT05456542|Antiemetics|antiemetics|mesh-ancestor
102482099|NCT05456542|Autonomic Agents|autonomic agents|mesh-ancestor
102482100|NCT05456542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102482101|NCT05456542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482102|NCT05456542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102482103|NCT05456542|Glucocorticoids|glucocorticoids|mesh-ancestor
102482104|NCT05456542|Hormones|hormones|mesh-ancestor
102482105|NCT05456542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102482106|NCT05456542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102482107|NCT05456542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102482108|NCT05455918|Paclitaxel|paclitaxel|mesh-list
102482109|NCT05455918|Ifosfamide|ifosfamide|mesh-list
102482110|NCT05455918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102482111|NCT05455918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102482112|NCT05455918|Tubulin Modulators|tubulin modulators|mesh-ancestor
102482113|NCT05455918|Antimitotic Agents|antimitotic agents|mesh-ancestor
102482114|NCT05455918|Mitosis Modulators|mitosis modulators|mesh-ancestor
102482115|NCT05455918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482116|NCT05455918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102482117|NCT05455918|Alkylating Agents|alkylating agents|mesh-ancestor
102482118|NCT00889187|Capecitabine|capecitabine|mesh-list
102482119|NCT00889187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102482120|NCT00889187|Antimetabolites|antimetabolites|mesh-ancestor
102482121|NCT00889187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482122|NCT00889187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102482123|NCT04334824|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102482124|NCT04334824|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102482125|NCT04334824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102482126|NCT04334824|Diuretics|diuretics|mesh-ancestor
102482127|NCT04334824|Natriuretic Agents|natriuretic agents|mesh-ancestor
102482128|NCT04334824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482129|NCT04334824|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102482130|NCT04334824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102482131|NCT04334824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482132|NCT04334824|Protease Inhibitors|protease inhibitors|mesh-ancestor
102482133|NCT04334824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102482134|NCT05314127|Fluorouracil|fluorouracil|mesh-list
102482135|NCT05314127|Imiquimod|imiquimod|mesh-list
102482136|NCT05314127|Tazarotene|tazarotene|mesh-list
102482137|NCT05314127|Petrolatum|petrolatum|mesh-list
102482138|NCT05314127|Antimetabolites|antimetabolites|mesh-ancestor
102482139|NCT05314127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565613|NCT04321655|Analgesics|analgesics|mesh-ancestor
102482140|NCT05314127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102482141|NCT05314127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102482142|NCT05314127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102482143|NCT05314127|Immunologic Factors|immunologic factors|mesh-ancestor
102482144|NCT05314127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482145|NCT05314127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102482146|NCT05314127|Interferon Inducers|interferon inducers|mesh-ancestor
102482147|NCT05314127|Dermatologic Agents|dermatologic agents|mesh-ancestor
102482148|NCT05314127|Keratolytic Agents|keratolytic agents|mesh-ancestor
102482149|NCT05314127|Emollients|emollients|mesh-ancestor
102482150|NCT03130127|Terlipressin|terlipressin|mesh-list
101565626|NCT01260467|Memantine|memantine|mesh-list
102482151|NCT03130127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102482152|NCT03130127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102482153|NCT04225078|Moxifloxacin|moxifloxacin|mesh-list
102482154|NCT04225078|Loperamide|loperamide|mesh-list
102482155|NCT04225078|Antidiarrheals|antidiarrheals|mesh-list
102482156|NCT04225078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102482157|NCT04225078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102482158|NCT04225078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102482159|NCT04225078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102482160|NCT04225078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102482161|NCT04225078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482162|NCT04225078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102482163|NCT04225078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102482164|NCT00373048|Mefloquine|mefloquine|mesh-list
102482165|NCT00373048|Antimalarials|antimalarials|mesh-ancestor
102482166|NCT00373048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102482167|NCT00373048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102482168|NCT00373048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102482169|NCT00372892|Rituximab|rituximab|mesh-list
102482170|NCT00372892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102482171|NCT00372892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102482172|NCT00372892|Immunologic Factors|immunologic factors|mesh-ancestor
102482173|NCT00372892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482174|NCT00372892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102482175|NCT00895817|Fluticasone|fluticasone|mesh-list
102482176|NCT00895817|Esomeprazole|esomeprazole|mesh-list
102482177|NCT00895817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102482178|NCT00895817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101565647|NCT05536037|Metformin|metformin|mesh-list
102482179|NCT00895817|Autonomic Agents|autonomic agents|mesh-ancestor
102482180|NCT00895817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102482181|NCT00895817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482182|NCT00895817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102482183|NCT00895817|Respiratory System Agents|respiratory system agents|mesh-ancestor
102482184|NCT00895817|Dermatologic Agents|dermatologic agents|mesh-ancestor
102482185|NCT00895817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102482186|NCT00895817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102482187|NCT00895817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102482188|NCT00895817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102482189|NCT00895817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101565659|NCT00624143|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102482190|NCT00895817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482191|NCT03020303|Spironolactone|spironolactone|mesh-list
102482192|NCT03020303|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102482193|NCT03020303|Hormone Antagonists|hormone antagonists|mesh-ancestor
102482194|NCT03020303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102482195|NCT03020303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482196|NCT03020303|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102482197|NCT03020303|Diuretics|diuretics|mesh-ancestor
102482198|NCT03020303|Natriuretic Agents|natriuretic agents|mesh-ancestor
102482199|NCT04825522|Vancomycin|vancomycin|mesh-list
102482200|NCT04825522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101771957|NCT00779454|Gemcitabine|gemcitabine|mesh-list
102482201|NCT04825522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102482202|NCT00373204|Motexafin gadolinium|motexafin gadolinium|mesh-list
102482203|NCT00373204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102482204|NCT00373204|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102482205|NCT00373204|Dermatologic Agents|dermatologic agents|mesh-ancestor
102482206|NCT00373282|Triamcinolone|triamcinolone|mesh-list
102482207|NCT00373282|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102482208|NCT00373282|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102482209|NCT00373282|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102482210|NCT00373282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102482211|NCT00373282|Glucocorticoids|glucocorticoids|mesh-ancestor
102482212|NCT00373282|Hormones|hormones|mesh-ancestor
102482213|NCT00373282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102482214|NCT00373282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482215|NCT00373282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102482216|NCT00373282|Immunologic Factors|immunologic factors|mesh-ancestor
102482217|NCT00373282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101565693|NCT04320173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102482218|NCT00373282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482219|NCT04382027|Vitamins|vitamins|mesh-list
102482220|NCT04382027|Vitamin K|vitamin k|mesh-list
102482221|NCT04382027|Vitamin K 2|vitamin k 2|mesh-list
102482222|NCT04382027|Micronutrients|micronutrients|mesh-ancestor
102482223|NCT04382027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482224|NCT04382027|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102482225|NCT04382027|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102482226|NCT04382027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482227|NCT04382027|Hemostatics|hemostatics|mesh-ancestor
102482228|NCT04382027|Coagulants|coagulants|mesh-ancestor
102482229|NCT00896441|Citalopram|citalopram|mesh-list
102482230|NCT00896441|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102482231|NCT00896441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102482232|NCT00896441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102482233|NCT00896441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482234|NCT00896441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102482235|NCT00896441|Serotonin Agents|serotonin agents|mesh-ancestor
102482236|NCT00896441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482237|NCT00896441|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102482238|NCT00896441|Antidepressive Agents|antidepressive agents|mesh-ancestor
102482239|NCT00896441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102482240|NCT02790515|Sirolimus|sirolimus|mesh-list
102482241|NCT02790515|Cyclophosphamide|cyclophosphamide|mesh-list
102482242|NCT02790515|Melphalan|melphalan|mesh-list
102482243|NCT02790515|Mechlorethamine|mechlorethamine|mesh-list
102482244|NCT02790515|Thiotepa|thiotepa|mesh-list
102482245|NCT02790515|Rituximab|rituximab|mesh-list
102482246|NCT02790515|Fludarabine|fludarabine|mesh-list
102482247|NCT02790515|Blinatumomab|blinatumomab|mesh-list
102482248|NCT02790515|Tacrolimus|tacrolimus|mesh-list
102482249|NCT02790515|Thymoglobulin|thymoglobulin|mesh-list
102482250|NCT02790515|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102482251|NCT02790515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102482252|NCT02790515|Immunologic Factors|immunologic factors|mesh-ancestor
102482253|NCT02790515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482254|NCT02790515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102482255|NCT02790515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102482256|NCT02790515|Alkylating Agents|alkylating agents|mesh-ancestor
102482257|NCT02790515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482258|NCT02790515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102482259|NCT02790515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102482260|NCT02790515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102482261|NCT02790515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102482262|NCT02790515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102482263|NCT02790515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102482264|NCT02790515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102482265|NCT02790515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102482266|NCT02790515|Antifungal Agents|antifungal agents|mesh-ancestor
102482267|NCT03400111|Acetaminophen|acetaminophen|mesh-list
102482268|NCT03400111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102482269|NCT03400111|Analgesics|analgesics|mesh-ancestor
102482270|NCT03400111|Sensory System Agents|sensory system agents|mesh-ancestor
102482271|NCT03400111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102482272|NCT03400111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482273|NCT03400111|Antipyretics|antipyretics|mesh-ancestor
102482274|NCT03404791|Gemcitabine|gemcitabine|mesh-list
102482275|NCT03404791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102482276|NCT03404791|Antimetabolites|antimetabolites|mesh-ancestor
102482277|NCT03404791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482278|NCT03404791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102482279|NCT00918931|Obatoclax|obatoclax|mesh-list
102482280|NCT00918931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102482281|NCT00918931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482282|NCT03404011|Glycerol|glycerol|mesh-list
102482283|NCT03404011|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102482284|NCT03404011|Protective Agents|protective agents|mesh-ancestor
102482285|NCT03404011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482286|NCT01830491|Aspirin|aspirin|mesh-list
102482287|NCT01830491|Clopidogrel|clopidogrel|mesh-list
102482288|NCT01830491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102482289|NCT01830491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102482290|NCT01830491|Analgesics|analgesics|mesh-ancestor
102482291|NCT01830491|Sensory System Agents|sensory system agents|mesh-ancestor
101565759|NCT01259297|Vasodilator Agents|vasodilator agents|mesh-ancestor
102482292|NCT01830491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102482293|NCT01830491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482294|NCT01830491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102482295|NCT01830491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102482296|NCT01830491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102482297|NCT01830491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102482298|NCT01830491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772933|NCT00746720|Analgesics|analgesics|mesh-ancestor
102482299|NCT01830491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102482300|NCT01830491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102482301|NCT01830491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102482302|NCT01830491|Antipyretics|antipyretics|mesh-ancestor
102482303|NCT01830491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102482304|NCT01830491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102482305|NCT01830491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102482306|NCT01830491|Purinergic Agents|purinergic agents|mesh-ancestor
102482307|NCT01830491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102482308|NCT02778880|Fentanyl|fentanyl|mesh-list
102482309|NCT02778880|Ketamine|ketamine|mesh-list
102482310|NCT02778880|Analgesics|analgesics|mesh-ancestor
102482311|NCT02778880|Sensory System Agents|sensory system agents|mesh-ancestor
102482312|NCT02778880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102482313|NCT02778880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482314|NCT02778880|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102482315|NCT02778880|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102482316|NCT02778880|Anesthetics, General|anesthetics, general|mesh-ancestor
102482317|NCT02778880|Anesthetics|anesthetics|mesh-ancestor
102482318|NCT02778880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102482319|NCT02778880|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102482320|NCT02778880|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102482321|NCT02778880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102482322|NCT02778880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482323|NCT02778880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102482324|NCT02778880|Narcotics|narcotics|mesh-ancestor
102482325|NCT02778880|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102482326|NCT05310929|Labetalol|labetalol|mesh-list
102482327|NCT05310929|Nitroglycerin|nitroglycerin|mesh-list
102482328|NCT05310929|Vasodilator Agents|vasodilator agents|mesh-ancestor
102482329|NCT05310929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102482330|NCT05310929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102482331|NCT05310929|Adrenergic Agents|adrenergic agents|mesh-ancestor
102482332|NCT05310929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102482333|NCT05310929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482334|NCT05310929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482335|NCT05310929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102482336|NCT05310929|Sympathomimetics|sympathomimetics|mesh-ancestor
102482337|NCT05310929|Autonomic Agents|autonomic agents|mesh-ancestor
101565799|NCT00637533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102482338|NCT05310929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102482339|NCT05310929|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102482340|NCT05310929|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102482341|NCT00891995|Insulin|insulin|mesh-list
102482342|NCT00891995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102482343|NCT00891995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482344|NCT02781454|Mexiletine|mexiletine|mesh-list
102482345|NCT02781454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102482346|NCT02781454|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101565809|NCT01257581|Tamoxifen|tamoxifen|mesh-list
102482347|NCT02781454|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102482348|NCT02781454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102482349|NCT02781454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482350|NCT00892697|Ribavirin|ribavirin|mesh-list
102482351|NCT00892697|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102482352|NCT00892697|Antimetabolites|antimetabolites|mesh-ancestor
102482353|NCT00892697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482354|NCT00892697|Antiviral Agents|antiviral agents|mesh-ancestor
102482355|NCT00892697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102482356|NCT02155465|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102482357|NCT02155465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101773380|NCT00752648|Simeprevir|simeprevir|mesh-list
102482358|NCT02155465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102482359|NCT02155465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102482360|NCT02155465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482361|NCT01831193|Curcumin|curcumin|mesh-list
102482362|NCT01831193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101773449|NCT00354679|Irinotecan|irinotecan|mesh-list
102482363|NCT01831193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102482364|NCT01831193|Analgesics|analgesics|mesh-ancestor
102482365|NCT01831193|Sensory System Agents|sensory system agents|mesh-ancestor
102482366|NCT01831193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102482367|NCT01831193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482368|NCT01831193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102482369|NCT01831193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102482370|NCT01831193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102482371|NCT01831193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102482372|NCT01831193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482374|NCT01831505|Rituximab|rituximab|mesh-list
102482375|NCT01831505|Doxorubicin|doxorubicin|mesh-list
102482376|NCT01831505|Vincristine|vincristine|mesh-list
102482377|NCT01831505|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102482378|NCT01831505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102482379|NCT01831505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102482380|NCT01831505|Immunologic Factors|immunologic factors|mesh-ancestor
101565831|NCT00995488|Paclitaxel|paclitaxel|mesh-list
102482381|NCT01831505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482382|NCT01831505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101565848|NCT01256879|Cimetidine|cimetidine|mesh-list
102482383|NCT01831505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102482384|NCT01831505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102482385|NCT01831505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102482386|NCT01831505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102482387|NCT01831505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482388|NCT01831505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102482389|NCT01831505|Tubulin Modulators|tubulin modulators|mesh-ancestor
102482390|NCT01831505|Antimitotic Agents|antimitotic agents|mesh-ancestor
101773640|NCT00788112|Vorinostat|vorinostat|mesh-list
102482391|NCT01831505|Mitosis Modulators|mitosis modulators|mesh-ancestor
102482392|NCT01831505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102482393|NCT01831505|Glucocorticoids|glucocorticoids|mesh-ancestor
102482394|NCT01831505|Hormones|hormones|mesh-ancestor
102482395|NCT01831505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102482396|NCT01831505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102482397|NCT01831505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102482398|NCT01831505|Alkylating Agents|alkylating agents|mesh-ancestor
102482399|NCT02781610|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102482400|NCT02781610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102482401|NCT03214055|Mannitol|mannitol|mesh-list
102482402|NCT03214055|Diuretics|diuretics|mesh-list
102482403|NCT03214055|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102482404|NCT03214055|Natriuretic Agents|natriuretic agents|mesh-ancestor
102482405|NCT03214055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482406|NCT03405337|Factor VIII|factor viii|mesh-list
102482407|NCT03405337|Coagulants|coagulants|mesh-ancestor
102482408|NCT01831661|Metformin|metformin|mesh-list
102482409|NCT01831661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102482410|NCT01831661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482411|NCT05311085|Nicotine|nicotine|mesh-list
102482412|NCT05311085|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102482413|NCT05311085|Autonomic Agents|autonomic agents|mesh-ancestor
102482414|NCT05311085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102482415|NCT05311085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482416|NCT05311085|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102482417|NCT05311085|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102482418|NCT05311085|Cholinergic Agents|cholinergic agents|mesh-ancestor
101565867|NCT01125189|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102482419|NCT05311085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102482420|NCT05311085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482421|NCT03400267|Acetaminophen|acetaminophen|mesh-list
102482422|NCT03400267|Fentanyl|fentanyl|mesh-list
102482423|NCT03400267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102482424|NCT03400267|Narcotics|narcotics|mesh-ancestor
102482425|NCT03400267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102482426|NCT03400267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482427|NCT03400267|Analgesics|analgesics|mesh-ancestor
102482428|NCT03400267|Sensory System Agents|sensory system agents|mesh-ancestor
102482429|NCT03400267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102482430|NCT03400267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102482431|NCT03400267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102482432|NCT03400267|Anesthetics, General|anesthetics, general|mesh-ancestor
102482433|NCT03400267|Anesthetics|anesthetics|mesh-ancestor
102482434|NCT03400267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102482435|NCT03400267|Antipyretics|antipyretics|mesh-ancestor
102482436|NCT01832051|Trastuzumab|trastuzumab|mesh-list
102482437|NCT01832051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102482438|NCT01832051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102482439|NCT01832129|Vitamins|vitamins|mesh-list
102482440|NCT01832129|Hydroxocobalamin|hydroxocobalamin|mesh-list
102482441|NCT01832129|Vitamin B 12|vitamin b 12|mesh-list
102482442|NCT01832129|Vitamin B Complex|vitamin b complex|mesh-list
102294076|NCT00995475|Xhance|xhance|mesh-list
102482443|NCT01832129|Micronutrients|micronutrients|mesh-ancestor
102482444|NCT01832129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482445|NCT01832129|Hematinics|hematinics|mesh-ancestor
102482446|NCT03219359|Methylprednisolone|methylprednisolone|mesh-list
102482447|NCT03219359|Cyclophosphamide|cyclophosphamide|mesh-list
102482448|NCT03219359|Vedolizumab|vedolizumab|mesh-list
102482449|NCT03219359|Thymoglobulin|thymoglobulin|mesh-list
102482450|NCT03219359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102482451|NCT03219359|Immunologic Factors|immunologic factors|mesh-ancestor
102482452|NCT03219359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482453|NCT03219359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101565907|NCT04310631|Ranibizumab|ranibizumab|mesh-list
102482454|NCT03219359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102482455|NCT03219359|Alkylating Agents|alkylating agents|mesh-ancestor
102482456|NCT03219359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482457|NCT03219359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101565915|NCT01256411|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102482458|NCT03219359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102482459|NCT03219359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102482460|NCT03219359|Antiemetics|antiemetics|mesh-ancestor
102482461|NCT03219359|Autonomic Agents|autonomic agents|mesh-ancestor
102482462|NCT03219359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102482463|NCT03219359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102482464|NCT03219359|Glucocorticoids|glucocorticoids|mesh-ancestor
102482465|NCT03219359|Hormones|hormones|mesh-ancestor
102482466|NCT03219359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102482467|NCT03219359|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102482468|NCT03219359|Protective Agents|protective agents|mesh-ancestor
102482469|NCT04380857|Dexamethasone|dexamethasone|mesh-list
102482470|NCT04380857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102482471|NCT04380857|Antiemetics|antiemetics|mesh-ancestor
102482472|NCT04380857|Autonomic Agents|autonomic agents|mesh-ancestor
102482473|NCT04380857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102482474|NCT04380857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482475|NCT04380857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102482476|NCT04380857|Glucocorticoids|glucocorticoids|mesh-ancestor
102482477|NCT04380857|Hormones|hormones|mesh-ancestor
102482478|NCT04380857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102482479|NCT04380857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102482480|NCT04380857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102482481|NCT02903446|Denosumab|denosumab|mesh-list
102482482|NCT02903446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102482483|NCT02903446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482484|NCT01832285|Fluvoxamine|fluvoxamine|mesh-list
102482485|NCT01832285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102482486|NCT01832285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102482487|NCT01832285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102482488|NCT01832285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482489|NCT01832285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102482490|NCT01832285|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102482491|NCT01832285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102482492|NCT01832285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102482493|NCT01832285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482494|NCT01832285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102482495|NCT01832285|Serotonin Agents|serotonin agents|mesh-ancestor
102482496|NCT01832285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102482497|NCT01832285|Antidepressive Agents|antidepressive agents|mesh-ancestor
102482498|NCT01832285|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101565938|NCT00996580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102482499|NCT01832285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102482500|NCT01832285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102482501|NCT01832285|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102482502|NCT01832363|Xenon|xenon|mesh-list
102482503|NCT01832363|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102482504|NCT01832363|Anesthetics, General|anesthetics, general|mesh-ancestor
102482505|NCT01832363|Anesthetics|anesthetics|mesh-ancestor
102482506|NCT01832363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102482507|NCT01832363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482508|NCT02903836|Moxifloxacin|moxifloxacin|mesh-list
102482509|NCT02903836|Nafithromycin|nafithromycin|mesh-list
102482510|NCT02903836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102482511|NCT02903836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102482512|NCT02903836|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102482513|NCT02903836|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102482514|NCT02903836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102482515|NCT02903836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482516|NCT02903836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102482517|NCT02903836|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102294151|NCT03571633|Paclitaxel|paclitaxel|mesh-list
102482518|NCT00014911|Sirolimus|sirolimus|mesh-list
102482519|NCT00014911|Pentamidine|pentamidine|mesh-list
102482521|NCT00014911|Sulfamethoxazole|sulfamethoxazole|mesh-list
102482522|NCT00014911|Ganciclovir|ganciclovir|mesh-list
102482523|NCT00014911|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102482524|NCT00014911|Tacrolimus|tacrolimus|mesh-list
102482525|NCT00014911|Daclizumab|daclizumab|mesh-list
102482526|NCT00014911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102482527|NCT00014911|Immunologic Factors|immunologic factors|mesh-ancestor
102482528|NCT00014911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482529|NCT00014911|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102482530|NCT00014911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102482531|NCT00014911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482532|NCT00014911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102482533|NCT00014911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102482534|NCT00014911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102482535|NCT00014911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102482536|NCT00014911|Antifungal Agents|antifungal agents|mesh-ancestor
102482537|NCT00014911|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102482538|NCT00014911|Antimalarials|antimalarials|mesh-ancestor
102482539|NCT00014911|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102482540|NCT00014911|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102482541|NCT00014911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102482542|NCT00014911|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102482543|NCT00014911|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102482544|NCT00014911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102482545|NCT00014911|Antiviral Agents|antiviral agents|mesh-ancestor
102482546|NCT00014911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102482547|NCT00014911|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102482548|NCT01832675|Bupivacaine|bupivacaine|mesh-list
102482549|NCT01832675|Anesthetics, Local|anesthetics, local|mesh-ancestor
102482550|NCT01832675|Anesthetics|anesthetics|mesh-ancestor
102482551|NCT01832675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102482552|NCT01832675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482553|NCT01832675|Sensory System Agents|sensory system agents|mesh-ancestor
102482554|NCT01832675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102482555|NCT03213587|Apatinib|apatinib|mesh-list
102482556|NCT03213587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102482557|NCT03213587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102482558|NCT03213587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102482559|NCT03213587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482560|NCT00013897|Lamivudine|lamivudine|mesh-list
102482561|NCT00013897|Zidovudine|zidovudine|mesh-list
102482562|NCT00013897|Efavirenz|efavirenz|mesh-list
102482563|NCT00013897|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
102482564|NCT00013897|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102482565|NCT00013897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102482566|NCT00013897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102482567|NCT00013897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102482568|NCT00013897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482569|NCT00013897|Antiviral Agents|antiviral agents|mesh-ancestor
102482570|NCT00013897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102482571|NCT00013897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102482572|NCT00013897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102482573|NCT00013897|Antimetabolites|antimetabolites|mesh-ancestor
102482574|NCT00013897|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101566026|NCT01255163|Exenatide|exenatide|mesh-list
102482575|NCT00013897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102482576|NCT00013897|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102482577|NCT00013897|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102482578|NCT00013897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102482579|NCT00013897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102482580|NCT00013897|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102482581|NCT00013897|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102482582|NCT00013897|Protease Inhibitors|protease inhibitors|mesh-ancestor
102482583|NCT03219983|Bupivacaine|bupivacaine|mesh-list
102482584|NCT03219983|Ropivacaine|ropivacaine|mesh-list
102482585|NCT03219983|Anesthetics, Local|anesthetics, local|mesh-ancestor
102482586|NCT03219983|Anesthetics|anesthetics|mesh-ancestor
102482587|NCT03219983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102482588|NCT03219983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482589|NCT03219983|Sensory System Agents|sensory system agents|mesh-ancestor
102482590|NCT03219983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102482591|NCT04347577|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102482592|NCT04347577|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102482593|NCT04347577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102482595|NCT04347577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482596|NCT04347577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102482597|NCT04347577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482598|NCT04347577|Analgesics|analgesics|mesh-ancestor
102482599|NCT04347577|Sensory System Agents|sensory system agents|mesh-ancestor
102482600|NCT04347577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102482601|NCT04347577|Antidepressive Agents|antidepressive agents|mesh-ancestor
102482602|NCT04347577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102482603|NCT04347577|Dopamine Agents|dopamine agents|mesh-ancestor
102482604|NCT02240017|Carboplatin|carboplatin|mesh-list
102482605|NCT02240017|Gemcitabine|gemcitabine|mesh-list
102482606|NCT02240017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102482607|NCT02240017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102482608|NCT02240017|Antimetabolites|antimetabolites|mesh-ancestor
101774789|NCT00939549|(T,G)-A-L|(t,g)-a-l|mesh-list
102482609|NCT02240017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482610|NCT00899717|Salicylic Acid|salicylic acid|mesh-list
102482611|NCT00899717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102482612|NCT00899717|Antifungal Agents|antifungal agents|mesh-ancestor
102482613|NCT00899717|Keratolytic Agents|keratolytic agents|mesh-ancestor
102482614|NCT00899717|Dermatologic Agents|dermatologic agents|mesh-ancestor
102482615|NCT03219593|Apatinib|apatinib|mesh-list
102482616|NCT03219593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102482617|NCT03219593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102482618|NCT03219593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102482619|NCT03219593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482620|NCT04375267|Olaparib|olaparib|mesh-list
102482621|NCT04375267|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102482622|NCT04375267|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102482623|NCT04375267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102482624|NCT04375267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482625|NCT04375267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102482626|NCT04375267|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102482627|NCT03836807|Ketoprofen|ketoprofen|mesh-list
102482628|NCT03836807|Ketoprofen lysine|ketoprofen lysine|mesh-list
101566066|NCT01122927|Antidepressive Agents|antidepressive agents|mesh-ancestor
102482629|NCT03836807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102482630|NCT03836807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102482631|NCT03836807|Analgesics|analgesics|mesh-ancestor
102482632|NCT03836807|Sensory System Agents|sensory system agents|mesh-ancestor
102482633|NCT03836807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102482634|NCT03836807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482635|NCT03836807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102482636|NCT03836807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102482637|NCT03836807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102482638|NCT03836807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102482639|NCT03836807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482640|NCT02240173|Haloperidol|haloperidol|mesh-list
102482641|NCT02240173|Haloperidol decanoate|haloperidol decanoate|mesh-list
102482642|NCT02240173|Antiemetics|antiemetics|mesh-ancestor
102482643|NCT02240173|Autonomic Agents|autonomic agents|mesh-ancestor
102482644|NCT02240173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102482645|NCT02240173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482646|NCT02240173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102482647|NCT02240173|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102482648|NCT02240173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102482649|NCT02240173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102482650|NCT02240173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102482651|NCT02240173|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102482652|NCT02240173|Dopamine Agents|dopamine agents|mesh-ancestor
102482653|NCT02240173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102482654|NCT02240173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482655|NCT02240173|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102482656|NCT02240641|Antihypertensive Agents|antihypertensive agents|mesh-list
102482657|NCT02240641|Lacidipine|lacidipine|mesh-list
102482658|NCT02240641|Diuretics|diuretics|mesh-list
102482659|NCT02240641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102482660|NCT02240641|Enzyme Inhibitors|enzyme inhibitors|mesh-list
102482661|NCT02240641|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102482662|NCT02240641|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
102482663|NCT02240641|Natriuretic Agents|natriuretic agents|mesh-ancestor
102482664|NCT02240641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566108|NCT04292236|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
102482665|NCT02240641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102482666|NCT02240641|Adrenergic Agents|adrenergic agents|mesh-ancestor
102482667|NCT02240641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102482668|NCT02240641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482669|NCT02240641|Protease Inhibitors|protease inhibitors|mesh-ancestor
102482670|NCT02240641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102482671|NCT02240641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102482672|NCT02240641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102482673|NCT03219671|Nivolumab|nivolumab|mesh-list
102482674|NCT03219671|Ipilimumab|ipilimumab|mesh-list
102482675|NCT03219671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102482676|NCT03219671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102482677|NCT03219671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102482678|NCT03219671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482679|NCT03404635|Rivaroxaban|rivaroxaban|mesh-list
102482680|NCT03404635|Apixaban|apixaban|mesh-list
102482681|NCT03404635|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102482682|NCT03404635|Antithrombins|antithrombins|mesh-ancestor
102482683|NCT03404635|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102482684|NCT03404635|Protease Inhibitors|protease inhibitors|mesh-ancestor
102482685|NCT03404635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102482686|NCT03404635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482687|NCT03404635|Anticoagulants|anticoagulants|mesh-ancestor
102482688|NCT01832987|Trimethoprim|trimethoprim|mesh-list
102482689|NCT01832987|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102482690|NCT01832987|Sulfamethoxazole|sulfamethoxazole|mesh-list
102482691|NCT01832987|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102482692|NCT01832987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102482693|NCT01832987|Antimalarials|antimalarials|mesh-ancestor
102482694|NCT01832987|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102482695|NCT01832987|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102482696|NCT01832987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102482697|NCT01832987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101566120|NCT01121913|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102482698|NCT01832987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482699|NCT01832987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102482700|NCT01832987|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102482701|NCT01832987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102482702|NCT01832987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102482703|NCT03404479|Celecoxib|celecoxib|mesh-list
102482704|NCT03404479|Diacerein|diacerein|mesh-list
102482705|NCT03404479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102482706|NCT03404479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102482707|NCT03404479|Analgesics|analgesics|mesh-ancestor
102482708|NCT03404479|Sensory System Agents|sensory system agents|mesh-ancestor
102482709|NCT03404479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102482710|NCT03404479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482711|NCT03404479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102482712|NCT03404479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102482713|NCT03404479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102482714|NCT03404479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102482715|NCT03404479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102482716|NCT03404479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482717|NCT04380467|Vitamin D|vitamin d|mesh-list
102482718|NCT04380467|Cholecalciferol|cholecalciferol|mesh-list
102482719|NCT04380467|Vitamins|vitamins|mesh-ancestor
102482720|NCT04380467|Micronutrients|micronutrients|mesh-ancestor
102482721|NCT04380467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482722|NCT04380467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102482723|NCT04380467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102482724|NCT03218657|Cyclosporine|cyclosporine|mesh-list
102482725|NCT03218657|Levamisole|levamisole|mesh-list
102482726|NCT03218657|Cyclosporins|cyclosporins|mesh-list
102482727|NCT03218657|Androgens|androgens|mesh-list
102482728|NCT03218657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102482729|NCT03218657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482730|NCT03218657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102482731|NCT03218657|Immunologic Factors|immunologic factors|mesh-ancestor
102482732|NCT03218657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482733|NCT03218657|Antifungal Agents|antifungal agents|mesh-ancestor
102482734|NCT03218657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102482735|NCT03218657|Dermatologic Agents|dermatologic agents|mesh-ancestor
102482736|NCT03218657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102482737|NCT03218657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102482738|NCT03218657|Hormones|hormones|mesh-ancestor
102482739|NCT03218657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102482740|NCT03218657|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102482741|NCT03218657|Antinematodal Agents|antinematodal agents|mesh-ancestor
102482742|NCT03218657|Anthelmintics|anthelmintics|mesh-ancestor
102482743|NCT03218657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102482744|NCT02240719|Everolimus|everolimus|mesh-list
102482745|NCT02240719|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102482746|NCT02240719|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102482747|NCT02240719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102482748|NCT02240719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102482749|NCT02240719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482750|NCT02240719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102482751|NCT02240719|Immunologic Factors|immunologic factors|mesh-ancestor
102482752|NCT02240719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482753|NCT02240719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102482754|NCT02240719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102482755|NCT02240719|Alkylating Agents|alkylating agents|mesh-ancestor
102482756|NCT01833299|Sorafenib|sorafenib|mesh-list
102482757|NCT01833299|Chlorotrianisene|chlorotrianisene|mesh-list
102482758|NCT01833299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102482759|NCT01833299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102482760|NCT01833299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102482761|NCT01833299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482762|NCT01833299|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102482763|NCT01833299|Estrogens|estrogens|mesh-ancestor
102482764|NCT01833299|Hormones|hormones|mesh-ancestor
102482765|NCT01833299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102482766|NCT01833299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482767|NCT01833299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102482768|NCT03213041|Carboplatin|carboplatin|mesh-list
102482769|NCT03213041|Pembrolizumab|pembrolizumab|mesh-list
102482770|NCT03213041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102482771|NCT03213041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102482772|NCT03213041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102482773|NCT03213041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482774|NCT02240875|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
102482775|NCT02240875|Antiviral Agents|antiviral agents|mesh-ancestor
102482776|NCT02240875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102482777|NCT01833611|Entecavir|entecavir|mesh-list
102482778|NCT01833611|Antiviral Agents|antiviral agents|mesh-ancestor
102482779|NCT01833611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102482780|NCT02240953|Warfarin|warfarin|mesh-list
102482781|NCT02240953|Anticoagulants|anticoagulants|mesh-ancestor
102482782|NCT03212729|Anti-Infective Agents|anti-infective agents|mesh-list
102482783|NCT03212729|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102482784|NCT02241031|Oprelvekin|oprelvekin|mesh-list
102482785|NCT02241031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102482786|NCT03212807|Lenalidomide|lenalidomide|mesh-list
102482787|NCT03212807|Durvalumab|durvalumab|mesh-list
102482788|NCT03212807|Immunologic Factors|immunologic factors|mesh-ancestor
102482789|NCT03212807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482790|NCT03212807|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102482791|NCT03212807|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102482792|NCT03212807|Growth Substances|growth substances|mesh-ancestor
102482793|NCT03212807|Growth Inhibitors|growth inhibitors|mesh-ancestor
102482794|NCT03212807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102482795|NCT03212807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102482796|NCT04373941|Lenograstim|lenograstim|mesh-list
102482797|NCT04373941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102482798|NCT04373941|Immunologic Factors|immunologic factors|mesh-ancestor
102482799|NCT04373941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482800|NCT01833767|Cyclophosphamide|cyclophosphamide|mesh-list
102482801|NCT01833767|Interleukin-2|interleukin-2|mesh-list
102482802|NCT01833767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102482803|NCT01833767|Immunologic Factors|immunologic factors|mesh-ancestor
102482804|NCT01833767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482805|NCT01833767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102482806|NCT01833767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102482807|NCT01833767|Alkylating Agents|alkylating agents|mesh-ancestor
102482808|NCT01833767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482809|NCT01833767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102482810|NCT01833767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102482811|NCT01833767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102482812|NCT01833767|Analgesics|analgesics|mesh-ancestor
102482813|NCT01833767|Sensory System Agents|sensory system agents|mesh-ancestor
102482814|NCT01833767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102482815|NCT03213353|Acetaminophen|acetaminophen|mesh-list
102482816|NCT03213353|Phenylpropanolamine|phenylpropanolamine|mesh-list
102482817|NCT03213353|Phenylephrine|phenylephrine|mesh-list
102482818|NCT03213353|Oxymetazoline|oxymetazoline|mesh-list
102482820|NCT03213353|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
101566247|NCT02868580|Lamivudine|lamivudine|mesh-list
102482821|NCT03213353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102482822|NCT03213353|Analgesics|analgesics|mesh-ancestor
102482823|NCT03213353|Sensory System Agents|sensory system agents|mesh-ancestor
102482824|NCT03213353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102482825|NCT03213353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482826|NCT03213353|Antipyretics|antipyretics|mesh-ancestor
102482827|NCT03213353|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102482828|NCT03213353|Mydriatics|mydriatics|mesh-ancestor
102482829|NCT03213353|Autonomic Agents|autonomic agents|mesh-ancestor
102482830|NCT03213353|Sympathomimetics|sympathomimetics|mesh-ancestor
102482831|NCT03213353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102482832|NCT03213353|Nasal Decongestants|nasal decongestants|mesh-ancestor
102482833|NCT03213353|Respiratory System Agents|respiratory system agents|mesh-ancestor
102482834|NCT03213353|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102482835|NCT03213353|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102482836|NCT03213353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102482837|NCT03213353|Adrenergic Agents|adrenergic agents|mesh-ancestor
101566276|NCT01252355|Interferons|interferons|mesh-list
102482838|NCT03213353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102482839|NCT03213353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482840|NCT03213353|Protective Agents|protective agents|mesh-ancestor
102482841|NCT03213353|Expectorants|expectorants|mesh-ancestor
102482842|NCT03213353|Appetite Depressants|appetite depressants|mesh-ancestor
102482843|NCT03213353|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102482844|NCT01834235|Paclitaxel|paclitaxel|mesh-list
102482845|NCT01834235|Gemcitabine|gemcitabine|mesh-list
102482846|NCT01834235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102482847|NCT01834235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102482848|NCT01834235|Tubulin Modulators|tubulin modulators|mesh-ancestor
102482849|NCT01834235|Antimitotic Agents|antimitotic agents|mesh-ancestor
102482850|NCT01834235|Mitosis Modulators|mitosis modulators|mesh-ancestor
102482851|NCT01834235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482852|NCT01834235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102482853|NCT01834235|Antimetabolites|antimetabolites|mesh-ancestor
102482854|NCT03211871|Dexmedetomidine|dexmedetomidine|mesh-list
102482855|NCT03211871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102482856|NCT03211871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102482857|NCT03211871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482858|NCT03211871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102482859|NCT03211871|Analgesics|analgesics|mesh-ancestor
102482860|NCT03211871|Sensory System Agents|sensory system agents|mesh-ancestor
102482861|NCT03211871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102482862|NCT03211871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102482863|NCT03211871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102482864|NCT03211871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102482865|NCT03211871|Adrenergic Agents|adrenergic agents|mesh-ancestor
102482866|NCT03211871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102482867|NCT03211871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482868|NCT03838133|Bupivacaine|bupivacaine|mesh-list
102482869|NCT03838133|Ropivacaine|ropivacaine|mesh-list
102482870|NCT03838133|Anesthetics, Local|anesthetics, local|mesh-ancestor
102482871|NCT03838133|Anesthetics|anesthetics|mesh-ancestor
102482872|NCT03838133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102482873|NCT03838133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482874|NCT03838133|Sensory System Agents|sensory system agents|mesh-ancestor
102482875|NCT03838133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102482876|NCT03217409|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102482877|NCT03217409|Ezetimibe|ezetimibe|mesh-list
102482878|NCT03217409|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102482879|NCT03217409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102482880|NCT03217409|Antimetabolites|antimetabolites|mesh-ancestor
102482881|NCT03217409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482882|NCT03217409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102482883|NCT03217409|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102482884|NCT03217409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102482885|NCT00895193|Aspirin|aspirin|mesh-list
102482886|NCT00895193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102482887|NCT00895193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102482888|NCT00895193|Analgesics|analgesics|mesh-ancestor
102482889|NCT00895193|Sensory System Agents|sensory system agents|mesh-ancestor
102482890|NCT00895193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102482891|NCT00895193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294519|NCT04903509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102482892|NCT00895193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102482893|NCT00895193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102482894|NCT00895193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102482895|NCT00895193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102482896|NCT00895193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482897|NCT00895193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102482898|NCT00895193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102482899|NCT00895193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102482900|NCT00895193|Antipyretics|antipyretics|mesh-ancestor
102482901|NCT01834547|Caffeine|caffeine|mesh-list
102482902|NCT01834547|Methylphenidate|methylphenidate|mesh-list
102482903|NCT01834547|Modafinil|modafinil|mesh-list
102482904|NCT01834547|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102482905|NCT01834547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482906|NCT01834547|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102482907|NCT01834547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102482908|NCT01834547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482909|NCT01834547|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102482910|NCT01834547|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102482911|NCT01834547|Purinergic Agents|purinergic agents|mesh-ancestor
102482912|NCT01834547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102482913|NCT01834547|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102482914|NCT01834547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102482915|NCT01834547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102482916|NCT01834547|Dopamine Agents|dopamine agents|mesh-ancestor
102482917|NCT01834547|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102482918|NCT01834547|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102482919|NCT01834547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102482920|NCT03216941|Ketamine|ketamine|mesh-list
102482921|NCT03216941|Olanzapine|olanzapine|mesh-list
102482922|NCT03216941|Analgesics|analgesics|mesh-ancestor
102482923|NCT03216941|Sensory System Agents|sensory system agents|mesh-ancestor
102482924|NCT03216941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102482925|NCT03216941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482926|NCT03216941|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102482927|NCT03216941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102482928|NCT03216941|Anesthetics, General|anesthetics, general|mesh-ancestor
102482929|NCT03216941|Anesthetics|anesthetics|mesh-ancestor
102482930|NCT03216941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101566358|NCT01207440|Ponatinib|ponatinib|mesh-list
102482931|NCT03216941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102482932|NCT03216941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102482933|NCT03216941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102482934|NCT03216941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482935|NCT03216941|Antiemetics|antiemetics|mesh-ancestor
102482936|NCT03216941|Autonomic Agents|autonomic agents|mesh-ancestor
102482937|NCT03216941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102482938|NCT03216941|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102482939|NCT03216941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102482940|NCT03216941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102482941|NCT03216941|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102482942|NCT03216941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102482943|NCT03216941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102482944|NCT03216941|Serotonin Agents|serotonin agents|mesh-ancestor
102482945|NCT03216707|Capsaicin|capsaicin|mesh-list
102482946|NCT03216707|Antipruritics|antipruritics|mesh-ancestor
102482947|NCT03216707|Dermatologic Agents|dermatologic agents|mesh-ancestor
102482948|NCT03216707|Sensory System Agents|sensory system agents|mesh-ancestor
102482949|NCT03216707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102482950|NCT03216707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482951|NCT01838993|Lidocaine|lidocaine|mesh-list
102482952|NCT01838993|Anesthetics, Local|anesthetics, local|mesh-ancestor
102482953|NCT01838993|Anesthetics|anesthetics|mesh-ancestor
102482954|NCT01838993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102482955|NCT01838993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482956|NCT01838993|Sensory System Agents|sensory system agents|mesh-ancestor
102482957|NCT01838993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102482958|NCT01838993|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102482959|NCT01838993|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102482960|NCT01838993|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102482961|NCT01838993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102294608|NCT02569801|Fulvestrant|fulvestrant|mesh-list
102482962|NCT01838993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102482963|NCT03211013|Oxytocin|oxytocin|mesh-list
102482964|NCT03211013|Oxytocics|oxytocics|mesh-ancestor
102482965|NCT03211013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102482966|NCT03211013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482967|NCT01835561|Thalidomide|thalidomide|mesh-list
102482968|NCT01835561|Pomalidomide|pomalidomide|mesh-list
102482969|NCT01835561|Immunologic Factors|immunologic factors|mesh-ancestor
102482970|NCT01835561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482971|NCT01835561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102482972|NCT01835561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102482973|NCT01835561|Growth Substances|growth substances|mesh-ancestor
102482974|NCT01835561|Growth Inhibitors|growth inhibitors|mesh-ancestor
102482975|NCT01835561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102482976|NCT01835561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102482977|NCT01835561|Leprostatic Agents|leprostatic agents|mesh-ancestor
102482978|NCT01835561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102482979|NCT01835561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102482980|NCT01835639|Vitamin D|vitamin d|mesh-list
102482981|NCT01835639|Cholecalciferol|cholecalciferol|mesh-list
102482982|NCT01835639|Vitamins|vitamins|mesh-ancestor
102482983|NCT01835639|Micronutrients|micronutrients|mesh-ancestor
102482984|NCT01835639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566403|NCT02867800|Thymoglobulin|thymoglobulin|mesh-list
102482985|NCT01835639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102482986|NCT01835639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102482987|NCT01839149|Oxytocin|oxytocin|mesh-list
102482988|NCT01839149|Oxytocics|oxytocics|mesh-ancestor
102482989|NCT01839149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102482990|NCT01839149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482991|NCT01839383|Dialysis Solutions|dialysis solutions|mesh-list
102482992|NCT01839383|Calcium|calcium|mesh-list
102482993|NCT01839383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102482994|NCT01839383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102482995|NCT01839383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102482996|NCT00901199|Deferasirox|deferasirox|mesh-list
102482997|NCT00901199|Deferoxamine|deferoxamine|mesh-list
102482998|NCT00901199|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102482999|NCT00901199|Chelating Agents|chelating agents|mesh-ancestor
102483000|NCT00901199|Sequestering Agents|sequestering agents|mesh-ancestor
102483001|NCT00901199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483002|NCT00901199|Siderophores|siderophores|mesh-ancestor
102483003|NCT01836341|Carboplatin|carboplatin|mesh-list
102483004|NCT01836341|Pemetrexed|pemetrexed|mesh-list
102483005|NCT01836341|Afatinib|afatinib|mesh-list
102483006|NCT01836341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102483007|NCT01836341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102483008|NCT01836341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483009|NCT01836341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102483010|NCT01836341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102483011|NCT01836341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102483012|NCT00906503|Dexamethasone|dexamethasone|mesh-list
102483013|NCT00906503|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102483014|NCT00906503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102483015|NCT00906503|Antiemetics|antiemetics|mesh-ancestor
102483016|NCT00906503|Autonomic Agents|autonomic agents|mesh-ancestor
102483017|NCT00906503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102483018|NCT00906503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483019|NCT00906503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102483020|NCT00906503|Glucocorticoids|glucocorticoids|mesh-ancestor
102483021|NCT00906503|Hormones|hormones|mesh-ancestor
102483022|NCT00906503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102483023|NCT00906503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102483024|NCT00906503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102483025|NCT00906503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102483026|NCT00906503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483027|NCT01836575|Carboplatin|carboplatin|mesh-list
102483028|NCT01836575|Pemetrexed|pemetrexed|mesh-list
102483029|NCT01836575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102483030|NCT01836575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102483031|NCT01836575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483032|NCT01836575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102483033|NCT01836575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102483034|NCT01836653|Bevacizumab|bevacizumab|mesh-list
102483035|NCT01836653|Cetuximab|cetuximab|mesh-list
102483036|NCT01836653|Fluorouracil|fluorouracil|mesh-list
102483037|NCT01836653|Oxaliplatin|oxaliplatin|mesh-list
101566472|NCT00629200|Anthelmintics|anthelmintics|mesh-ancestor
102483038|NCT01836653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102483039|NCT01836653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102483040|NCT01836653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102483041|NCT01836653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102483042|NCT01836653|Growth Substances|growth substances|mesh-ancestor
102483043|NCT01836653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483044|NCT01836653|Growth Inhibitors|growth inhibitors|mesh-ancestor
102483045|NCT01836653|Antimetabolites|antimetabolites|mesh-ancestor
102483046|NCT01836653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483047|NCT01836653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102483048|NCT01836653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102483049|NCT01836653|Immunologic Factors|immunologic factors|mesh-ancestor
102483050|NCT03836885|Apremilast|apremilast|mesh-list
102483051|NCT03836885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102483052|NCT03836885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102483053|NCT03836885|Analgesics|analgesics|mesh-ancestor
102483054|NCT03836885|Sensory System Agents|sensory system agents|mesh-ancestor
102483055|NCT03836885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102483056|NCT03836885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483057|NCT03836885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102483058|NCT03836885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102483059|NCT03836885|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102483060|NCT03836885|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102483061|NCT03836885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102483062|NCT03836885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483063|NCT01837043|Cyclosporine|cyclosporine|mesh-list
102483064|NCT01837043|Abatacept|abatacept|mesh-list
102483065|NCT01837043|Tacrolimus|tacrolimus|mesh-list
102483066|NCT01837043|Cyclosporins|cyclosporins|mesh-list
102483067|NCT01837043|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
102483068|NCT01837043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102483069|NCT01837043|Immunologic Factors|immunologic factors|mesh-ancestor
102483070|NCT01837043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483071|NCT01837043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102483072|NCT01837043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483073|NCT01837043|Antifungal Agents|antifungal agents|mesh-ancestor
102483074|NCT01837043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102483075|NCT01837043|Dermatologic Agents|dermatologic agents|mesh-ancestor
102483076|NCT01837043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102483077|NCT01837043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102483078|NCT01837043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102483079|NCT01837043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102483080|NCT01839773|Paclitaxel|paclitaxel|mesh-list
102483081|NCT01839773|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102483082|NCT01839773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102483083|NCT01839773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102483084|NCT01839773|Tubulin Modulators|tubulin modulators|mesh-ancestor
102483085|NCT01839773|Antimitotic Agents|antimitotic agents|mesh-ancestor
102483086|NCT01839773|Mitosis Modulators|mitosis modulators|mesh-ancestor
102483087|NCT01839773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483088|NCT00909155|Fluoxetine|fluoxetine|mesh-list
102483089|NCT00909155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102483090|NCT00909155|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102483091|NCT00909155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102483092|NCT00909155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102483093|NCT00909155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483094|NCT00909155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102483095|NCT00909155|Serotonin Agents|serotonin agents|mesh-ancestor
102483096|NCT00909155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483097|NCT00909155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102483098|NCT00909155|Antidepressive Agents|antidepressive agents|mesh-ancestor
102483099|NCT00909155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102483100|NCT00909155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101566541|NCT00629278|Mitosis Modulators|mitosis modulators|mesh-ancestor
102483101|NCT00909155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102483102|NCT00909155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102483103|NCT00909155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102483104|NCT01839851|Glucocorticoids|glucocorticoids|mesh-list
102483105|NCT01839851|Hormones|hormones|mesh-ancestor
102483106|NCT01839851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102483107|NCT01839851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483108|NCT01839929|Tacrolimus|tacrolimus|mesh-list
102483109|NCT01839929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102483110|NCT01839929|Immunologic Factors|immunologic factors|mesh-ancestor
102483111|NCT01839929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483112|NCT01839929|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102483113|NCT01839929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102294739|NCT05510323|Methylprednisolone|methylprednisolone|mesh-list
102483114|NCT01839929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483115|NCT04373083|Cemiplimab|cemiplimab|mesh-list
102483116|NCT04373083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102483117|NCT04373083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102483118|NCT03210545|Betamethasone|betamethasone|mesh-list
102483119|NCT03210545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102483120|NCT03210545|Glucocorticoids|glucocorticoids|mesh-ancestor
102483121|NCT03210545|Hormones|hormones|mesh-ancestor
102483122|NCT03210545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102483123|NCT03210545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483124|NCT03210545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102483125|NCT03210545|Respiratory System Agents|respiratory system agents|mesh-ancestor
102483126|NCT04372849|Insulin|insulin|mesh-list
101566566|NCT04207112|Linezolid|linezolid|mesh-list
102483127|NCT04372849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102483128|NCT04372849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483129|NCT03403777|Avelumab|avelumab|mesh-list
102483130|NCT03403777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101414775|NCT00126971|Dapsone|dapsone|mesh-list
102483131|NCT03403777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102483132|NCT02241421|Amoxicillin|amoxicillin|mesh-list
102483133|NCT02241421|Vancomycin|vancomycin|mesh-list
102483134|NCT02241421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102483135|NCT02241421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102483136|NCT01837199|Amoxicillin|amoxicillin|mesh-list
102483137|NCT01837199|Metronidazole|metronidazole|mesh-list
102483138|NCT01837199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102483139|NCT01837199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102483140|NCT01837199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102483141|NCT01837199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102483142|NCT00926185|Lifitegrast|lifitegrast|mesh-list
102483143|NCT00926185|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102483144|NCT00926185|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102483145|NCT02241499|Fluorouracil|fluorouracil|mesh-list
102483146|NCT02241499|Oxaliplatin|oxaliplatin|mesh-list
101577173|NCT04908475|Apremilast|apremilast|mesh-list
102483147|NCT02241499|Antimetabolites|antimetabolites|mesh-ancestor
102483148|NCT02241499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483149|NCT02241499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102483150|NCT02241499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102483151|NCT02241499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102483152|NCT02241499|Immunologic Factors|immunologic factors|mesh-ancestor
102483153|NCT02241499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483154|NCT01837667|Docetaxel|docetaxel|mesh-list
102483155|NCT01837667|LB100|lb100|mesh-list
102483156|NCT01837667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102483157|NCT01837667|Tubulin Modulators|tubulin modulators|mesh-ancestor
102483158|NCT01837667|Antimitotic Agents|antimitotic agents|mesh-ancestor
102483159|NCT01837667|Mitosis Modulators|mitosis modulators|mesh-ancestor
102483160|NCT01837667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483161|NCT01837667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102483162|NCT03833947|Dexamethasone|dexamethasone|mesh-list
102483163|NCT03833947|Lidocaine|lidocaine|mesh-list
102483164|NCT03833947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102483165|NCT03833947|Antiemetics|antiemetics|mesh-ancestor
102483166|NCT03833947|Autonomic Agents|autonomic agents|mesh-ancestor
102483167|NCT03833947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102483168|NCT03833947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483169|NCT03833947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102483170|NCT03833947|Glucocorticoids|glucocorticoids|mesh-ancestor
102483171|NCT03833947|Hormones|hormones|mesh-ancestor
102483172|NCT03833947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102483173|NCT03833947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102483174|NCT03833947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102483175|NCT03833947|Anesthetics, Local|anesthetics, local|mesh-ancestor
102483176|NCT03833947|Anesthetics|anesthetics|mesh-ancestor
102483177|NCT03833947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102483178|NCT03833947|Sensory System Agents|sensory system agents|mesh-ancestor
102483179|NCT03833947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102483180|NCT03833947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102483181|NCT03833947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102483182|NCT03833947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102483183|NCT03833947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483184|NCT03219437|Methotrexate|methotrexate|mesh-list
102483185|NCT03219437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102483186|NCT03219437|Abortifacient Agents|abortifacient agents|mesh-ancestor
102483187|NCT03219437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102483188|NCT03219437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483189|NCT03219437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102483190|NCT03219437|Antimetabolites|antimetabolites|mesh-ancestor
101566614|NCT04654052|Clopidogrel|clopidogrel|mesh-list
102483191|NCT03219437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483192|NCT03219437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102483193|NCT03219437|Dermatologic Agents|dermatologic agents|mesh-ancestor
102483194|NCT03219437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102483195|NCT03219437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102483196|NCT03219437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102483197|NCT03219437|Immunologic Factors|immunologic factors|mesh-ancestor
102483198|NCT03219437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102483199|NCT03219437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102483200|NCT03212963|Clobetasol|clobetasol|mesh-list
102483201|NCT03212963|Halobetasol|halobetasol|mesh-list
102483202|NCT03212963|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102483203|NCT03212963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102483204|NCT03212963|Glucocorticoids|glucocorticoids|mesh-ancestor
102483205|NCT03212963|Hormones|hormones|mesh-ancestor
102483206|NCT03212963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102483207|NCT03212963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483208|NCT03218969|Ecopipam|ecopipam|mesh-list
102483209|NCT03218969|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102483210|NCT03218969|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102483211|NCT03218969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102483212|NCT03218969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483213|NCT03218969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102483214|NCT03218969|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102483215|NCT03218969|Dopamine Agents|dopamine agents|mesh-ancestor
102483216|NCT03218969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102483217|NCT03218969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483218|NCT01830101|Temozolomide|temozolomide|mesh-list
102483219|NCT01830101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102483220|NCT01830101|Alkylating Agents|alkylating agents|mesh-ancestor
102483221|NCT01830101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483222|NCT01830101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102483223|NCT01830335|Indomethacin|indomethacin|mesh-list
102483224|NCT01830335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102483225|NCT01830335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102483226|NCT01830335|Analgesics|analgesics|mesh-ancestor
102483227|NCT01830335|Sensory System Agents|sensory system agents|mesh-ancestor
102483228|NCT01830335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102483229|NCT01830335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483230|NCT01830335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102483231|NCT01830335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102483232|NCT01830335|Gout Suppressants|gout suppressants|mesh-ancestor
102483233|NCT01830335|Tocolytic Agents|tocolytic agents|mesh-ancestor
102483234|NCT01830335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102483235|NCT01830335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102483236|NCT01830335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102483237|NCT01830335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483238|NCT00926263|Moxifloxacin|moxifloxacin|mesh-list
102483239|NCT00926263|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102483240|NCT00926263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102483241|NCT00926263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102483242|NCT00926263|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102483243|NCT00926263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102483244|NCT00926263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102483245|NCT00926263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483246|NCT00926263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102483247|NCT00926263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483248|NCT00926263|Immunologic Factors|immunologic factors|mesh-ancestor
102483249|NCT02242279|Tiotropium Bromide|tiotropium bromide|mesh-list
102483250|NCT02242279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102483251|NCT02242279|Autonomic Agents|autonomic agents|mesh-ancestor
102483252|NCT02242279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102483253|NCT02242279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483254|NCT02242279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102483255|NCT02242279|Respiratory System Agents|respiratory system agents|mesh-ancestor
102483256|NCT02242279|Parasympatholytics|parasympatholytics|mesh-ancestor
102483257|NCT02242279|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102483258|NCT02242279|Cholinergic Agents|cholinergic agents|mesh-ancestor
102483259|NCT02242279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102483260|NCT02242279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483261|NCT04371757|Doxazosin|doxazosin|mesh-list
102483262|NCT04371757|Adrenergic Agents|adrenergic agents|mesh-list
102483263|NCT04371757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102483264|NCT04371757|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102483265|NCT04371757|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102483266|NCT04371757|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102483267|NCT04371757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102483268|NCT04371757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483269|NCT04371757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483270|NCT04371601|Oseltamivir|oseltamivir|mesh-list
102483271|NCT04371601|Hormones|hormones|mesh-list
102483272|NCT04371601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102483273|NCT04371601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483274|NCT04371601|Antiviral Agents|antiviral agents|mesh-ancestor
102483275|NCT04371601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102483276|NCT04371601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102483277|NCT04371601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483278|NCT04371523|Hydroxychloroquine|hydroxychloroquine|mesh-list
102483279|NCT04371523|Antimalarials|antimalarials|mesh-ancestor
102483280|NCT04371523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102483281|NCT04371523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102483282|NCT04371523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102483283|NCT04371523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102483284|NCT04371523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483285|NCT04371523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102483286|NCT02242357|Telmisartan|telmisartan|mesh-list
102483287|NCT02242357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102483288|NCT02242357|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102483289|NCT02242357|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102483290|NCT02242357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483291|NCT03409835|Ramosetron|ramosetron|mesh-list
102483292|NCT03409835|Antiemetics|antiemetics|mesh-ancestor
101566727|NCT00625677|Vaccines|vaccines|mesh-list
102483293|NCT03409835|Autonomic Agents|autonomic agents|mesh-ancestor
102483294|NCT03409835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102483295|NCT03409835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483296|NCT03409835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102483297|NCT03409835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102483298|NCT03409835|Serotonin Agents|serotonin agents|mesh-ancestor
102483299|NCT03409835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102483300|NCT03409835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483301|NCT02242513|Lidocaine|lidocaine|mesh-list
102483302|NCT02242513|Anesthetics, Local|anesthetics, local|mesh-ancestor
102483303|NCT02242513|Anesthetics|anesthetics|mesh-ancestor
102483304|NCT02242513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102483305|NCT02242513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483306|NCT02242513|Sensory System Agents|sensory system agents|mesh-ancestor
102483307|NCT02242513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102483308|NCT02242513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102483309|NCT02242513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102483310|NCT02242513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102483311|NCT02242513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102483312|NCT02242513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483313|NCT03409679|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102483314|NCT03409679|Murepavadin|murepavadin|mesh-list
102483315|NCT03409679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102483316|NCT04371367|Avdoralimab|avdoralimab|mesh-list
102483317|NCT04371367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102483318|NCT04371367|Antiviral Agents|antiviral agents|mesh-ancestor
102483319|NCT04371367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102483320|NCT02242591|Ropivacaine|ropivacaine|mesh-list
102483321|NCT02242591|Anesthetics, Local|anesthetics, local|mesh-ancestor
102483322|NCT02242591|Anesthetics|anesthetics|mesh-ancestor
102483323|NCT02242591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102483324|NCT02242591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483325|NCT02242591|Sensory System Agents|sensory system agents|mesh-ancestor
102483326|NCT02242591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102483327|NCT02982577|Pilocarpine|pilocarpine|mesh-list
102483328|NCT02982577|Miotics|miotics|mesh-ancestor
102483329|NCT02982577|Autonomic Agents|autonomic agents|mesh-ancestor
102483330|NCT02982577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101578227|NCT02700217|Narcotics|narcotics|mesh-ancestor
102483331|NCT02982577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483332|NCT02982577|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102483333|NCT02982577|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102483334|NCT02982577|Cholinergic Agents|cholinergic agents|mesh-ancestor
102483335|NCT02982577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102483336|NCT02982577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483337|NCT01726205|Pregabalin|pregabalin|mesh-list
102483338|NCT01726205|Ropivacaine|ropivacaine|mesh-list
102483339|NCT01726205|Anesthetics, Local|anesthetics, local|mesh-ancestor
102483340|NCT01726205|Anesthetics|anesthetics|mesh-ancestor
102483341|NCT01726205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102483342|NCT01726205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483343|NCT01726205|Sensory System Agents|sensory system agents|mesh-ancestor
102483344|NCT01726205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102483345|NCT01726205|Analgesics|analgesics|mesh-ancestor
102483346|NCT01726205|Anticonvulsants|anticonvulsants|mesh-ancestor
102483347|NCT01726205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102483348|NCT01726205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102483349|NCT01726205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483350|NCT01726205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102483351|NCT01726205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102483352|NCT01726205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102483353|NCT01726205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102483354|NCT02242825|Telmisartan|telmisartan|mesh-list
102483355|NCT02242825|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
102483356|NCT02242825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102483357|NCT02242825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102483358|NCT02242825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102483359|NCT02242825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483360|NCT02242825|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102483361|NCT02242825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102483362|NCT02242825|Diuretics|diuretics|mesh-ancestor
102483363|NCT02242825|Natriuretic Agents|natriuretic agents|mesh-ancestor
102483364|NCT02242825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483365|NCT04370977|Artesunate|artesunate|mesh-list
102483366|NCT04370977|Lumefantrine|lumefantrine|mesh-list
102483367|NCT04370977|Artemether|artemether|mesh-list
102483368|NCT04370977|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102483369|NCT04370977|Amodiaquine|amodiaquine|mesh-list
101566795|NCT02866786|Hormones|hormones|mesh-ancestor
102483370|NCT04370977|Antimalarials|antimalarials|mesh-ancestor
102483371|NCT04370977|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102483372|NCT04370977|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102483373|NCT04370977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102483374|NCT04370977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102483375|NCT04370977|Antiviral Agents|antiviral agents|mesh-ancestor
102483376|NCT04370977|Schistosomicides|schistosomicides|mesh-ancestor
102483377|NCT04370977|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102483378|NCT04370977|Anthelmintics|anthelmintics|mesh-ancestor
102483379|NCT01726283|Riboflavin|riboflavin|mesh-list
102483380|NCT01726283|Vitamin B Complex|vitamin b complex|mesh-ancestor
102483381|NCT01726283|Vitamins|vitamins|mesh-ancestor
102483382|NCT01726283|Micronutrients|micronutrients|mesh-ancestor
102483383|NCT01726283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483384|NCT01726283|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102483385|NCT01726283|Dermatologic Agents|dermatologic agents|mesh-ancestor
102483386|NCT04370431|Edaravone|edaravone|mesh-list
102483387|NCT04370431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102483388|NCT04370431|Antioxidants|antioxidants|mesh-ancestor
102483389|NCT04370431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483390|NCT04370431|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102483391|NCT04370431|Protective Agents|protective agents|mesh-ancestor
101566811|NCT00978562|Hematinics|hematinics|mesh-ancestor
102483392|NCT04370431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483393|NCT02245165|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
102483394|NCT02245165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102483395|NCT02245165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483396|NCT03835871|Beclomethasone|beclomethasone|mesh-list
102483397|NCT03835871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102483398|NCT03835871|Glucocorticoids|glucocorticoids|mesh-ancestor
102483399|NCT03835871|Hormones|hormones|mesh-ancestor
102483400|NCT03835871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102483401|NCT03835871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483402|NCT03835871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101566829|NCT02865460|Coenzyme Q10|coenzyme q10|mesh-list
102483403|NCT03835871|Respiratory System Agents|respiratory system agents|mesh-ancestor
102483404|NCT03402295|Thalidomide|thalidomide|mesh-list
102483405|NCT03402295|Dexamethasone|dexamethasone|mesh-list
102483406|NCT03402295|Cyclophosphamide|cyclophosphamide|mesh-list
102483407|NCT03402295|Bortezomib|bortezomib|mesh-list
102483408|NCT03402295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102483409|NCT03402295|Immunologic Factors|immunologic factors|mesh-ancestor
102483410|NCT03402295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483411|NCT03402295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102295038|NCT02310789|Ivacaftor|ivacaftor|mesh-list
102483412|NCT03402295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102483413|NCT03402295|Alkylating Agents|alkylating agents|mesh-ancestor
102483414|NCT03402295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483415|NCT03402295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102483416|NCT03402295|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102483417|NCT03402295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102483418|NCT03402295|Antiemetics|antiemetics|mesh-ancestor
102483419|NCT03402295|Autonomic Agents|autonomic agents|mesh-ancestor
102483420|NCT03402295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102483421|NCT03402295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102483422|NCT03402295|Glucocorticoids|glucocorticoids|mesh-ancestor
102483423|NCT03402295|Hormones|hormones|mesh-ancestor
101566848|NCT00978250|Antimetabolites|antimetabolites|mesh-ancestor
102483424|NCT03402295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102483425|NCT03402295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102483426|NCT03402295|Leprostatic Agents|leprostatic agents|mesh-ancestor
102483427|NCT03402295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102483428|NCT03402295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102483429|NCT03402295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102483430|NCT03402295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102483431|NCT03402295|Growth Substances|growth substances|mesh-ancestor
102483432|NCT03402295|Growth Inhibitors|growth inhibitors|mesh-ancestor
102483433|NCT02243839|Fibrinolytic Agents|fibrinolytic agents|mesh-list
102483434|NCT02243839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102483435|NCT02243839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483436|NCT02244073|Insulin|insulin|mesh-list
102483437|NCT02244073|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102483438|NCT02244073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102483439|NCT02244073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483440|NCT02244151|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102483441|NCT02244151|Luteolytic Agents|luteolytic agents|mesh-ancestor
102483442|NCT02244151|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102483443|NCT02244151|Contraceptive Agents|contraceptive agents|mesh-ancestor
102483444|NCT02244151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102483445|NCT02244151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483446|NCT02244151|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102483447|NCT02244151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102483448|NCT02244151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102483449|NCT03401827|Paclitaxel|paclitaxel|mesh-list
102483450|NCT03401827|Gemcitabine|gemcitabine|mesh-list
102483451|NCT03401827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102483452|NCT03401827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102483453|NCT03401827|Tubulin Modulators|tubulin modulators|mesh-ancestor
102483454|NCT03401827|Antimitotic Agents|antimitotic agents|mesh-ancestor
102483455|NCT03401827|Mitosis Modulators|mitosis modulators|mesh-ancestor
102483456|NCT03401827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483457|NCT03401827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102483458|NCT03401827|Antimetabolites|antimetabolites|mesh-ancestor
102483459|NCT00909545|Isradipine|isradipine|mesh-list
102483460|NCT00909545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102483461|NCT00909545|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102483462|NCT00909545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102483463|NCT00909545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483464|NCT00909545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102483465|NCT00909545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483466|NCT00909545|Vasodilator Agents|vasodilator agents|mesh-ancestor
102483467|NCT02244229|Tamsulosin|tamsulosin|mesh-list
102483468|NCT02244229|Finasteride|finasteride|mesh-list
102483469|NCT02244229|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102483470|NCT02244229|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102483471|NCT02244229|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102483472|NCT02244229|Adrenergic Agents|adrenergic agents|mesh-ancestor
102483473|NCT02244229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102483474|NCT02244229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483475|NCT02244229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483476|NCT02244229|Urological Agents|urological agents|mesh-ancestor
102483477|NCT02244229|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102483478|NCT02244229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102483479|NCT02244229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102483480|NCT02244229|Hormone Antagonists|hormone antagonists|mesh-ancestor
102483481|NCT02244229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102483482|NCT02157103|Bevacizumab|bevacizumab|mesh-list
102483483|NCT02157103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102483484|NCT02157103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102483485|NCT02157103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102483486|NCT02157103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102483487|NCT02157103|Growth Substances|growth substances|mesh-ancestor
102483488|NCT02157103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483489|NCT02157103|Growth Inhibitors|growth inhibitors|mesh-ancestor
102483490|NCT00924001|Aldesleukin|aldesleukin|mesh-list
102483491|NCT00924001|Cyclophosphamide|cyclophosphamide|mesh-list
102483492|NCT00924001|Fludarabine|fludarabine|mesh-list
102483493|NCT00924001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102483494|NCT00924001|Immunologic Factors|immunologic factors|mesh-ancestor
102483495|NCT00924001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483496|NCT00924001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102483497|NCT00924001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102483498|NCT00924001|Alkylating Agents|alkylating agents|mesh-ancestor
101566920|NCT01204710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102483499|NCT00924001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483500|NCT00924001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102483501|NCT00924001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102483502|NCT00924001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102483503|NCT00924001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102483504|NCT00924001|Antiviral Agents|antiviral agents|mesh-ancestor
102483505|NCT00924001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102483506|NCT02244307|Adrenergic Agents|adrenergic agents|mesh-list
102483507|NCT02244307|Adrenergic Antagonists|adrenergic antagonists|mesh-list
102483508|NCT02244307|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
102483509|NCT02244307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102483510|NCT02244307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566932|NCT01204398|Telmisartan|telmisartan|mesh-list
102483511|NCT02244307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483512|NCT03401593|Fentanyl|fentanyl|mesh-list
102483513|NCT03401593|Midazolam|midazolam|mesh-list
102483514|NCT03401593|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102483515|NCT03401593|Narcotics|narcotics|mesh-ancestor
102483516|NCT03401593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102483517|NCT03401593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483518|NCT03401593|Analgesics|analgesics|mesh-ancestor
102483519|NCT03401593|Sensory System Agents|sensory system agents|mesh-ancestor
102483520|NCT03401593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102483521|NCT03401593|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102483522|NCT03401593|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102483523|NCT03401593|Anesthetics, General|anesthetics, general|mesh-ancestor
102483524|NCT03401593|Anesthetics|anesthetics|mesh-ancestor
102483525|NCT03401593|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102483526|NCT03401593|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102483527|NCT03401593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102483528|NCT03401593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102483529|NCT03401593|GABA Modulators|gaba modulators|mesh-ancestor
102483530|NCT03401593|GABA Agents|gaba agents|mesh-ancestor
102483531|NCT03401593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102483532|NCT03401593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483533|NCT03401515|Propranolol|propranolol|mesh-list
102483534|NCT03401515|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102483535|NCT03401515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102483536|NCT03401515|Adrenergic Agents|adrenergic agents|mesh-ancestor
102483537|NCT03401515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102483538|NCT03401515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483539|NCT03401515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483540|NCT03401515|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102483541|NCT03401515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102483542|NCT03401515|Vasodilator Agents|vasodilator agents|mesh-ancestor
102483543|NCT01726829|Pancrelipase|pancrelipase|mesh-list
102483544|NCT01726829|Pancreatin|pancreatin|mesh-list
102483545|NCT01726829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102483546|NCT03834233|Nivolumab|nivolumab|mesh-list
102483547|NCT03834233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102483548|NCT03834233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102483549|NCT03834233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102483550|NCT03834233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483551|NCT04367155|Tranexamic Acid|tranexamic acid|mesh-list
102483552|NCT04367155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102483553|NCT04367155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102483554|NCT04367155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483555|NCT04367155|Hemostatics|hemostatics|mesh-ancestor
102483556|NCT04367155|Coagulants|coagulants|mesh-ancestor
102483557|NCT01727453|Warfarin|warfarin|mesh-list
102483558|NCT01727453|Anticoagulants|anticoagulants|mesh-ancestor
102483559|NCT01727531|Chloroquine|chloroquine|mesh-list
102483560|NCT01727531|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
102483561|NCT01727531|Amebicides|amebicides|mesh-ancestor
102483562|NCT01727531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102483563|NCT01727531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102483564|NCT01727531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102483565|NCT01727531|Antimalarials|antimalarials|mesh-ancestor
102483566|NCT01727531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102483567|NCT01727531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102483568|NCT01727531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102483569|NCT01727531|Analgesics|analgesics|mesh-ancestor
102483570|NCT01727531|Sensory System Agents|sensory system agents|mesh-ancestor
102483571|NCT01727531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102483572|NCT01727531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483573|NCT01727531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102483574|NCT01727531|Filaricides|filaricides|mesh-ancestor
102483575|NCT01727531|Antinematodal Agents|antinematodal agents|mesh-ancestor
102483576|NCT01727531|Anthelmintics|anthelmintics|mesh-ancestor
102483577|NCT01721135|Moxifloxacin|moxifloxacin|mesh-list
102483578|NCT01721135|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102483579|NCT01721135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102483580|NCT01721135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102483581|NCT01721135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102483582|NCT01721135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102483583|NCT01721135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102483584|NCT01721135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483585|NCT01721135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102483586|NCT01721135|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102483587|NCT01721135|Contraceptive Agents|contraceptive agents|mesh-ancestor
102483588|NCT01721135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102483589|NCT01721135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483590|NCT01721135|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102483591|NCT01721135|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102483592|NCT01721135|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102483593|NCT00929071|Lidocaine|lidocaine|mesh-list
102483594|NCT00929071|Anesthetics, Local|anesthetics, local|mesh-list
102483595|NCT00929071|Anesthetics|anesthetics|mesh-list
102483596|NCT00929071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102483597|NCT00929071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483598|NCT00929071|Sensory System Agents|sensory system agents|mesh-ancestor
102483599|NCT00929071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102483600|NCT00929071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102483601|NCT00929071|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102483602|NCT00929071|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102483603|NCT00929071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102483604|NCT00929071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483605|NCT01721525|Ribavirin|ribavirin|mesh-list
102483606|NCT01721525|Paclitaxel|paclitaxel|mesh-list
102483607|NCT01721525|Carboplatin|carboplatin|mesh-list
102483608|NCT01721525|Afatinib|afatinib|mesh-list
102483609|NCT01721525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102483610|NCT01721525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102483611|NCT01721525|Tubulin Modulators|tubulin modulators|mesh-ancestor
102483612|NCT01721525|Antimitotic Agents|antimitotic agents|mesh-ancestor
102483613|NCT01721525|Mitosis Modulators|mitosis modulators|mesh-ancestor
102483614|NCT01721525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483615|NCT01721525|Antimetabolites|antimetabolites|mesh-ancestor
102483616|NCT01721525|Antiviral Agents|antiviral agents|mesh-ancestor
102483617|NCT01721525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102483618|NCT01721525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102483619|NCT01721525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102483620|NCT01727843|Tranexamic Acid|tranexamic acid|mesh-list
102483621|NCT01727843|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102483622|NCT01727843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102483623|NCT01727843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483624|NCT01727843|Hemostatics|hemostatics|mesh-ancestor
102483625|NCT01727843|Coagulants|coagulants|mesh-ancestor
102483626|NCT01721915|Vitamin D|vitamin d|mesh-list
102483627|NCT01721915|Vitamins|vitamins|mesh-ancestor
102483628|NCT01721915|Micronutrients|micronutrients|mesh-ancestor
102483629|NCT01721915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483630|NCT01721915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102483631|NCT04357483|Thrombin|thrombin|mesh-list
102483632|NCT04357483|Hemostatics|hemostatics|mesh-ancestor
102483633|NCT04357483|Coagulants|coagulants|mesh-ancestor
102483634|NCT01721993|Zoledronic Acid|zoledronic acid|mesh-list
102483635|NCT01721993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102483636|NCT01721993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483637|NCT04366609|Methylphenidate|methylphenidate|mesh-list
102483638|NCT04366609|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102483639|NCT04366609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483640|NCT04366609|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102483641|NCT04366609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101567052|NCT01105377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102483642|NCT04366609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102483643|NCT04366609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483644|NCT04366609|Dopamine Agents|dopamine agents|mesh-ancestor
102483645|NCT04366609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102483646|NCT03407105|Ipilimumab|ipilimumab|mesh-list
102483647|NCT03407105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102483648|NCT03407105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102483649|NCT03407105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101567061|NCT01105065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483650|NCT03407105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483651|NCT01722227|Liraglutide|liraglutide|mesh-list
102483652|NCT01722227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102483653|NCT01722227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483654|NCT01722227|Incretins|incretins|mesh-ancestor
102483655|NCT01722227|Hormones|hormones|mesh-ancestor
102483656|NCT01722227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102483657|NCT01722305|Dexamethasone|dexamethasone|mesh-list
102483658|NCT01722305|Dexamethasone acetate|dexamethasone acetate|mesh-list
102483659|NCT01722305|Pomalidomide|pomalidomide|mesh-list
102483660|NCT01722305|Ichthammol|ichthammol|mesh-list
102483661|NCT01722305|BB 1101|bb 1101|mesh-list
101567069|NCT01111539|Serotonin Agents|serotonin agents|mesh-ancestor
102483662|NCT01722305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102483663|NCT01722305|Antiemetics|antiemetics|mesh-ancestor
102483664|NCT01722305|Autonomic Agents|autonomic agents|mesh-ancestor
102483665|NCT01722305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102483666|NCT01722305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483667|NCT01722305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102483668|NCT01722305|Glucocorticoids|glucocorticoids|mesh-ancestor
102483669|NCT01722305|Hormones|hormones|mesh-ancestor
102483670|NCT01722305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102483671|NCT01722305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102483672|NCT01722305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102483673|NCT01722305|Protease Inhibitors|protease inhibitors|mesh-ancestor
102483674|NCT01722305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102483675|NCT01722305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483676|NCT01722305|Immunologic Factors|immunologic factors|mesh-ancestor
102483677|NCT01722305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102483678|NCT01722305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102483679|NCT01722305|Growth Substances|growth substances|mesh-ancestor
102483680|NCT01722305|Growth Inhibitors|growth inhibitors|mesh-ancestor
102483681|NCT01722305|Dermatologic Agents|dermatologic agents|mesh-ancestor
102483682|NCT04365517|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102483683|NCT04365517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102483684|NCT04365517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483685|NCT04365517|Incretins|incretins|mesh-ancestor
102483686|NCT04365517|Hormones|hormones|mesh-ancestor
102483687|NCT04365517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102483688|NCT04365517|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102483689|NCT04365517|Protease Inhibitors|protease inhibitors|mesh-ancestor
102483690|NCT04365517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102483691|NCT04365517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483692|NCT03406871|Nivolumab|nivolumab|mesh-list
102483693|NCT03406871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102483694|NCT03406871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102483695|NCT03406871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102483696|NCT03406871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483697|NCT04357093|Listerine|listerine|mesh-list
102483698|NCT04357093|Grape Seed Extract|grape seed extract|mesh-list
102483699|NCT04357093|Fluorides|fluorides|mesh-list
102483700|NCT04357093|Sodium Fluoride|sodium fluoride|mesh-list
102483701|NCT04357093|Cariostatic Agents|cariostatic agents|mesh-ancestor
102483702|NCT04357093|Protective Agents|protective agents|mesh-ancestor
102483703|NCT04357093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483704|NCT04357093|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102483705|NCT04357093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102483706|NCT04357093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102483707|NCT04357093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102483708|NCT04357093|Antioxidants|antioxidants|mesh-ancestor
102483709|NCT04357093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483710|NCT03406793|Iron|iron|mesh-list
102483711|NCT03406793|Zinc|zinc|mesh-list
102483712|NCT03406793|Trace Elements|trace elements|mesh-ancestor
102483713|NCT03406793|Micronutrients|micronutrients|mesh-ancestor
102483714|NCT03406793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483715|NCT04365127|Progesterone|progesterone|mesh-list
102483716|NCT04365127|Progestins|progestins|mesh-ancestor
102483717|NCT04365127|Hormones|hormones|mesh-ancestor
102483718|NCT04365127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102483719|NCT04365127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483720|NCT00929383|Hemostatics|hemostatics|mesh-list
102483721|NCT00929383|Coagulants|coagulants|mesh-ancestor
102483722|NCT01722539|Pyrimethamine|pyrimethamine|mesh-list
102483723|NCT01722539|Piperaquine|piperaquine|mesh-list
102483724|NCT01722539|Sulfadoxine|sulfadoxine|mesh-list
102483725|NCT01722539|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
102483726|NCT01722539|Albendazole|albendazole|mesh-list
102483727|NCT01722539|Praziquantel|praziquantel|mesh-list
102483728|NCT01722539|Antimalarials|antimalarials|mesh-ancestor
102483729|NCT01722539|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102483730|NCT01722539|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102483731|NCT01722539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102483732|NCT01722539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102483733|NCT01722539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102483734|NCT01722539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483735|NCT01722539|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102483736|NCT01722539|Anthelmintics|anthelmintics|mesh-ancestor
102483737|NCT01722539|Anticestodal Agents|anticestodal agents|mesh-ancestor
102483738|NCT01722539|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101567149|NCT01254344|Metronidazole|metronidazole|mesh-list
102483739|NCT01722539|Tubulin Modulators|tubulin modulators|mesh-ancestor
102483740|NCT01722539|Antimitotic Agents|antimitotic agents|mesh-ancestor
102483741|NCT01722539|Mitosis Modulators|mitosis modulators|mesh-ancestor
102483742|NCT01722539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102483743|NCT03406403|Anesthetics|anesthetics|mesh-list
102483744|NCT03406403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102483745|NCT03406403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483746|NCT03406169|Sildenafil Citrate|sildenafil citrate|mesh-list
102483747|NCT03406169|Pentoxifylline|pentoxifylline|mesh-list
102483748|NCT03406169|Vasodilator Agents|vasodilator agents|mesh-ancestor
102483749|NCT03406169|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102483750|NCT03406169|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102483751|NCT03406169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102483752|NCT03406169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483753|NCT03406169|Urological Agents|urological agents|mesh-ancestor
102483754|NCT03406169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102483755|NCT03406169|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102483756|NCT03406169|Protective Agents|protective agents|mesh-ancestor
102483757|NCT03406169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483758|NCT03406169|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102483759|NCT03406169|Antioxidants|antioxidants|mesh-ancestor
102483760|NCT04357015|Tranexamic Acid|tranexamic acid|mesh-list
102483761|NCT04357015|Carbetocin|carbetocin|mesh-list
102483762|NCT04357015|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102483763|NCT04357015|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102483764|NCT04357015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483765|NCT04357015|Hemostatics|hemostatics|mesh-ancestor
102483766|NCT04357015|Coagulants|coagulants|mesh-ancestor
102483767|NCT04357015|Oxytocics|oxytocics|mesh-ancestor
102483768|NCT04357015|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102483769|NCT04357015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483770|NCT04364893|Enzyme Inhibitors|enzyme inhibitors|mesh-list
102483771|NCT04364893|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102483772|NCT04364893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
102483773|NCT04364893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567181|NCT01102803|Antimetabolites|antimetabolites|mesh-ancestor
102483774|NCT04364893|Protease Inhibitors|protease inhibitors|mesh-ancestor
102483775|NCT03406091|Plerixafor|plerixafor|mesh-list
102483776|NCT03406091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102483777|NCT03406091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102483778|NCT03406091|Antiviral Agents|antiviral agents|mesh-ancestor
102483779|NCT03406091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102483780|NCT04364815|Hydroxychloroquine|hydroxychloroquine|mesh-list
102483781|NCT04364815|Antimalarials|antimalarials|mesh-ancestor
102483782|NCT04364815|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102483783|NCT04364815|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102483784|NCT04364815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102483785|NCT04364815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102483786|NCT04364815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483787|NCT04364815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102483788|NCT04673383|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
102295413|NCT05485051|Chlorhexidine|chlorhexidine|mesh-list
102483789|NCT04673383|Hallucinogens|hallucinogens|mesh-ancestor
102483790|NCT04673383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483791|NCT04673383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102483792|NCT04673383|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102483794|NCT04673383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102483795|NCT04673383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483796|NCT04673383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102483797|NCT02245243|Delafloxacin|delafloxacin|mesh-list
101581444|NCT05449171|Viscosupplements|viscosupplements|mesh-ancestor
102483798|NCT02245243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102483799|NCT01728935|Tenofovir|tenofovir|mesh-list
102483800|NCT01728935|Antiviral Agents|antiviral agents|mesh-ancestor
102483801|NCT01728935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102483802|NCT01728935|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102483803|NCT01728935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102483804|NCT01728935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102483805|NCT01728935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483806|NCT01728935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102483807|NCT01728935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102483808|NCT03833999|Ondansetron|ondansetron|mesh-list
102483809|NCT03833999|Lactulose|lactulose|mesh-list
102483810|NCT03833999|Antiemetics|antiemetics|mesh-ancestor
102483811|NCT03833999|Autonomic Agents|autonomic agents|mesh-ancestor
102483812|NCT03833999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102483813|NCT03833999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483814|NCT03833999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102483815|NCT03833999|Antipruritics|antipruritics|mesh-ancestor
102483816|NCT03833999|Dermatologic Agents|dermatologic agents|mesh-ancestor
102483817|NCT03833999|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102483818|NCT03833999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102483819|NCT03833999|Serotonin Agents|serotonin agents|mesh-ancestor
102483820|NCT03833999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102483821|NCT03833999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483822|NCT04379219|Methotrexate|methotrexate|mesh-list
102483823|NCT04379219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102483824|NCT04379219|Abortifacient Agents|abortifacient agents|mesh-ancestor
102483825|NCT04379219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102483826|NCT04379219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616714|NCT04107103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102483827|NCT04379219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102483828|NCT04379219|Antimetabolites|antimetabolites|mesh-ancestor
102483829|NCT04379219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483830|NCT04379219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102483831|NCT04379219|Dermatologic Agents|dermatologic agents|mesh-ancestor
102483832|NCT04379219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102483833|NCT04379219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101266326|NCT01781052|Iloprost|iloprost|mesh-list
102483834|NCT04379219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102483835|NCT04379219|Immunologic Factors|immunologic factors|mesh-ancestor
102483836|NCT04379219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102483837|NCT04379219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102483838|NCT04347031|Azithromycin|azithromycin|mesh-list
102483839|NCT04347031|Hydroxychloroquine|hydroxychloroquine|mesh-list
102483840|NCT04347031|Mefloquine|mefloquine|mesh-list
102483841|NCT04347031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101616730|NCT02617810|GABA Agents|gaba agents|mesh-ancestor
102483842|NCT04347031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102483843|NCT04347031|Antimalarials|antimalarials|mesh-ancestor
102483844|NCT04347031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102483845|NCT04347031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102483846|NCT04347031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102483847|NCT04347031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483848|NCT04347031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102483849|NCT02906566|Vitamin A|vitamin a|mesh-list
102483850|NCT02906566|Vitamins|vitamins|mesh-ancestor
102483851|NCT02906566|Micronutrients|micronutrients|mesh-ancestor
102483852|NCT02906566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483853|NCT00913133|Desirudin|desirudin|mesh-list
102483854|NCT00913133|Anticoagulants|anticoagulants|mesh-ancestor
102483855|NCT00913133|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102483856|NCT00913133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102483857|NCT00913133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483858|NCT00373126|Nicotine|nicotine|mesh-list
102483859|NCT00373126|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101267303|NCT01788332|Olaparib|olaparib|mesh-list
101616741|NCT02614612|Prednisolone|prednisolone|mesh-list
101616742|NCT02614612|Prednisolone acetate|prednisolone acetate|mesh-list
101616743|NCT02614612|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101616744|NCT02614612|Prednisolone phosphate|prednisolone phosphate|mesh-list
101616745|NCT02614612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101616746|NCT02614612|Glucocorticoids|glucocorticoids|mesh-ancestor
101775287|NCT01055431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483860|NCT00373126|Autonomic Agents|autonomic agents|mesh-ancestor
102483861|NCT00373126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102483862|NCT00373126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483863|NCT00373126|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102483864|NCT00373126|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102295501|NCT05487001|Hormones|hormones|mesh-ancestor
102483865|NCT00373126|Cholinergic Agents|cholinergic agents|mesh-ancestor
102483866|NCT00373126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102483867|NCT00373126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483868|NCT04378283|Lidocaine|lidocaine|mesh-list
102483869|NCT04378283|Epinephrine|epinephrine|mesh-list
101616748|NCT02614612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101616749|NCT02614612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483870|NCT04378283|Tetracaine|tetracaine|mesh-list
102483871|NCT04378283|Anesthetics|anesthetics|mesh-list
102483872|NCT04378283|Anesthetics, Local|anesthetics, local|mesh-ancestor
102483873|NCT04378283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102483874|NCT04378283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483875|NCT04378283|Sensory System Agents|sensory system agents|mesh-ancestor
102483876|NCT04378283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102483877|NCT04378283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102483878|NCT04378283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101268928|NCT01810926|Treosulfan|treosulfan|mesh-list
102483879|NCT04378283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102483880|NCT04378283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102483881|NCT04378283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483882|NCT04378283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102483883|NCT04378283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102483884|NCT04378283|Adrenergic Agents|adrenergic agents|mesh-ancestor
102483885|NCT04378283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102483886|NCT04378283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102483887|NCT04378283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102483888|NCT04378283|Autonomic Agents|autonomic agents|mesh-ancestor
102483889|NCT04378283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102483890|NCT04378283|Respiratory System Agents|respiratory system agents|mesh-ancestor
102483891|NCT04378283|Mydriatics|mydriatics|mesh-ancestor
102483892|NCT04378283|Sympathomimetics|sympathomimetics|mesh-ancestor
102483893|NCT04378283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102483894|NCT04355845|Sumatriptan|sumatriptan|mesh-list
102483895|NCT04355845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101269001|NCT01811381|Curcumin|curcumin|mesh-list
102483896|NCT04355845|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102483897|NCT04355845|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102483898|NCT04355845|Serotonin Agents|serotonin agents|mesh-ancestor
102483899|NCT04355845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102483900|NCT04355845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483901|NCT04355845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483902|NCT02789410|Morphine|morphine|mesh-list
102483903|NCT02789410|Hydromorphone|hydromorphone|mesh-list
102483904|NCT02789410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102483905|NCT02789410|Narcotics|narcotics|mesh-ancestor
102483906|NCT02789410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102483907|NCT02789410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483908|NCT02789410|Analgesics|analgesics|mesh-ancestor
102483909|NCT02789410|Sensory System Agents|sensory system agents|mesh-ancestor
102483910|NCT02789410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102483911|NCT01729481|Leucovorin|leucovorin|mesh-list
102483912|NCT01729481|Folic Acid|folic acid|mesh-list
102483913|NCT01729481|Gemcitabine|gemcitabine|mesh-list
102483914|NCT01729481|Oxaliplatin|oxaliplatin|mesh-list
102483915|NCT01729481|Irinotecan|irinotecan|mesh-list
102483916|NCT01729481|Levoleucovorin|levoleucovorin|mesh-list
102483917|NCT01729481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102483918|NCT01729481|Antimetabolites|antimetabolites|mesh-ancestor
102483919|NCT01729481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483920|NCT01729481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102483921|NCT01729481|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102483922|NCT01729481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101239207|NCT01614366|Amlodipine|amlodipine|mesh-list
102483923|NCT01729481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102483924|NCT01729481|Antidotes|antidotes|mesh-ancestor
102483925|NCT01729481|Protective Agents|protective agents|mesh-ancestor
102483926|NCT01729481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483927|NCT01729481|Vitamin B Complex|vitamin b complex|mesh-ancestor
102483928|NCT01729481|Vitamins|vitamins|mesh-ancestor
102483929|NCT01729481|Micronutrients|micronutrients|mesh-ancestor
102483930|NCT01729481|Hematinics|hematinics|mesh-ancestor
102483931|NCT00939211|Tiotropium Bromide|tiotropium bromide|mesh-list
102483932|NCT00939211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102483933|NCT00939211|Autonomic Agents|autonomic agents|mesh-ancestor
102483934|NCT00939211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102483935|NCT00939211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483936|NCT00939211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102483937|NCT00939211|Respiratory System Agents|respiratory system agents|mesh-ancestor
102483938|NCT00939211|Parasympatholytics|parasympatholytics|mesh-ancestor
102295565|NCT05472259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101616787|NCT00592852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102483939|NCT00939211|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102483940|NCT00939211|Cholinergic Agents|cholinergic agents|mesh-ancestor
102483941|NCT00939211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102483942|NCT00939211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483944|NCT02793154|rGLP-1 protein|rglp-1 protein|mesh-list
102483945|NCT02793154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102483946|NCT02793154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483947|NCT02793154|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102483948|NCT02793154|Incretins|incretins|mesh-ancestor
102483949|NCT02793154|Hormones|hormones|mesh-ancestor
102483950|NCT02793154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102483951|NCT01723553|Corticosterone|corticosterone|mesh-list
102483952|NCT01723553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102483953|NCT02907268|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102483954|NCT02907268|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102483955|NCT02907268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102483956|NCT02907268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102483957|NCT02907268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483958|NCT02907268|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102483959|NCT02907268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102483960|NCT02907268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102483961|NCT02907268|Cholinergic Agents|cholinergic agents|mesh-ancestor
102483962|NCT02907268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102483963|NCT02909140|Lidocaine|lidocaine|mesh-list
102483964|NCT02909140|Phenylephrine|phenylephrine|mesh-list
102483965|NCT02909140|Epinephrine|epinephrine|mesh-list
102483966|NCT02909140|Oxymetazoline|oxymetazoline|mesh-list
102483967|NCT02909140|Cyclopentolate|cyclopentolate|mesh-list
102483968|NCT02909140|Anesthetics, Local|anesthetics, local|mesh-ancestor
102483969|NCT02909140|Anesthetics|anesthetics|mesh-ancestor
102483970|NCT02909140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102483971|NCT02909140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102483972|NCT02909140|Sensory System Agents|sensory system agents|mesh-ancestor
102483973|NCT02909140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102483974|NCT02909140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102483975|NCT02909140|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102483976|NCT02909140|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102483977|NCT02909140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102483978|NCT02909140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616820|NCT02617654|Hormones|hormones|mesh-ancestor
101616821|NCT02617654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101616822|NCT00700024|Methyltestosterone|methyltestosterone|mesh-list
101616823|NCT00700024|Testosterone|testosterone|mesh-list
101616824|NCT00700024|Testosterone undecanoate|testosterone undecanoate|mesh-list
101616825|NCT00700024|Testosterone enanthate|testosterone enanthate|mesh-list
101616826|NCT00700024|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101616827|NCT00700024|Androgens|androgens|mesh-ancestor
101616828|NCT00700024|Hormones|hormones|mesh-ancestor
101274348|NCT01856517|Sensory System Agents|sensory system agents|mesh-ancestor
101775295|NCT00803556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616829|NCT00700024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101582701|NCT01273610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101582702|NCT01273610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582703|NCT01273610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101582704|NCT01273610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101582705|NCT01273610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582741|NCT00999804|Trastuzumab|trastuzumab|mesh-list
101582742|NCT00999804|Letrozole|letrozole|mesh-list
101582743|NCT00999804|Lapatinib|lapatinib|mesh-list
101582744|NCT00999804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101582745|NCT00999804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582746|NCT00999804|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101582747|NCT00999804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101582748|NCT00999804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101582749|NCT00999804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582750|NCT00999804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101582752|NCT00999804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102483979|NCT02909140|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102483980|NCT02909140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102483981|NCT02909140|Adrenergic Agents|adrenergic agents|mesh-ancestor
102483982|NCT02909140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102483983|NCT02909140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102483984|NCT02909140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102483985|NCT02909140|Autonomic Agents|autonomic agents|mesh-ancestor
102483986|NCT02909140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102483987|NCT02909140|Respiratory System Agents|respiratory system agents|mesh-ancestor
102483988|NCT02909140|Mydriatics|mydriatics|mesh-ancestor
102483989|NCT02909140|Sympathomimetics|sympathomimetics|mesh-ancestor
102483990|NCT02909140|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102483991|NCT02909140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102483992|NCT02909140|Nasal Decongestants|nasal decongestants|mesh-ancestor
102483993|NCT02909140|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102483994|NCT02909140|Protective Agents|protective agents|mesh-ancestor
102483995|NCT02909140|Parasympatholytics|parasympatholytics|mesh-ancestor
102483996|NCT02909140|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102483997|NCT02909140|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102483998|NCT02909140|Cholinergic Agents|cholinergic agents|mesh-ancestor
102483999|NCT01724879|Dasatinib|dasatinib|mesh-list
102484000|NCT01724879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102484001|NCT01724879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102484002|NCT01724879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102484003|NCT01724879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484004|NCT02793856|Cyclophosphamide|cyclophosphamide|mesh-list
102484005|NCT02793856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102484006|NCT02793856|Immunologic Factors|immunologic factors|mesh-ancestor
102484007|NCT02793856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484008|NCT02793856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102484009|NCT02793856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102484010|NCT02793856|Alkylating Agents|alkylating agents|mesh-ancestor
102484011|NCT02793856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484012|NCT02793856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102484013|NCT02793856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102484014|NCT03403985|Calcium|calcium|mesh-list
102295647|NCT02307513|Apremilast|apremilast|mesh-list
102484015|NCT03403985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102484016|NCT03403985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484017|NCT04364425|Triamcinolone|triamcinolone|mesh-list
102484018|NCT04364425|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102484019|NCT04364425|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102484020|NCT04364425|Lidocaine|lidocaine|mesh-list
102484021|NCT04364425|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102484022|NCT04364425|Anesthetics, Local|anesthetics, local|mesh-ancestor
102484023|NCT04364425|Anesthetics|anesthetics|mesh-ancestor
102484024|NCT04364425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102484025|NCT04364425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484026|NCT04364425|Sensory System Agents|sensory system agents|mesh-ancestor
102484027|NCT04364425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102484028|NCT04364425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102484029|NCT04364425|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102484030|NCT04364425|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102484031|NCT04364425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102484032|NCT04364425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484033|NCT04364425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102484034|NCT04364425|Glucocorticoids|glucocorticoids|mesh-ancestor
102484035|NCT04364425|Hormones|hormones|mesh-ancestor
102484036|NCT04364425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102484037|NCT04364425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102484038|NCT04364425|Immunologic Factors|immunologic factors|mesh-ancestor
102484039|NCT04364425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102484040|NCT02911324|Nabilone|nabilone|mesh-list
102484041|NCT02911324|Antiemetics|antiemetics|mesh-ancestor
102484042|NCT02911324|Autonomic Agents|autonomic agents|mesh-ancestor
102484043|NCT02911324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102484044|NCT02911324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484045|NCT02911324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102484046|NCT02911324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102484047|NCT02911324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102484048|NCT02911324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102484049|NCT02911324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102484050|NCT01729403|Metformin|metformin|mesh-list
102484051|NCT01729403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102484052|NCT01729403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484053|NCT04281667|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102484054|NCT04281667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102484055|NCT04355455|Citalopram|citalopram|mesh-list
102484056|NCT04355455|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102484057|NCT04355455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102484058|NCT04355455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102484059|NCT04355455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484060|NCT04355455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102484061|NCT04355455|Serotonin Agents|serotonin agents|mesh-ancestor
102484062|NCT04355455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484063|NCT04355455|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102484064|NCT04355455|Antidepressive Agents|antidepressive agents|mesh-ancestor
102484065|NCT04355455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102484066|NCT00913913|Bevacizumab|bevacizumab|mesh-list
102484067|NCT00913913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102484068|NCT00913913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102484069|NCT00913913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102484070|NCT00913913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102484071|NCT00913913|Growth Substances|growth substances|mesh-ancestor
102484072|NCT00913913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484073|NCT00913913|Growth Inhibitors|growth inhibitors|mesh-ancestor
102484074|NCT00373594|Rituximab|rituximab|mesh-list
102484075|NCT00373594|Fludarabine|fludarabine|mesh-list
102484076|NCT00373594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102484077|NCT00373594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102484078|NCT00373594|Immunologic Factors|immunologic factors|mesh-ancestor
102484079|NCT00373594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484080|NCT00373594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102484081|NCT03403829|Gemcitabine|gemcitabine|mesh-list
102484082|NCT03403829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102484083|NCT03403829|Antimetabolites|antimetabolites|mesh-ancestor
102484084|NCT03403829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484085|NCT03403829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102484086|NCT04364113|Benzocaine|benzocaine|mesh-list
102484087|NCT04364113|Anesthetics, Local|anesthetics, local|mesh-ancestor
102295716|NCT04539379|Tocolytic Agents|tocolytic agents|mesh-ancestor
102484088|NCT04364113|Anesthetics|anesthetics|mesh-ancestor
102484089|NCT04364113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102484090|NCT04364113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484091|NCT04364113|Sensory System Agents|sensory system agents|mesh-ancestor
102484092|NCT04364113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102484093|NCT03403595|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
102484094|NCT03403595|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102484095|NCT03403595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484096|NCT03197194|Aspirin|aspirin|mesh-list
102484097|NCT03197194|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102484098|NCT03197194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102484099|NCT03197194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102484100|NCT03197194|Analgesics|analgesics|mesh-ancestor
102484101|NCT03197194|Sensory System Agents|sensory system agents|mesh-ancestor
101280397|NCT01887119|Diuretics|diuretics|mesh-ancestor
102484102|NCT03197194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102484103|NCT03197194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484104|NCT03197194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102484105|NCT03197194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102484106|NCT03197194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102484107|NCT03197194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102484108|NCT03197194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484109|NCT03197194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101616949|NCT00899847|Hormones|hormones|mesh-ancestor
102484110|NCT03197194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102484111|NCT03197194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102484112|NCT03197194|Antipyretics|antipyretics|mesh-ancestor
102484113|NCT03834935|Pimecrolimus|pimecrolimus|mesh-list
102484114|NCT03834935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102484115|NCT03834935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102484116|NCT03834935|Analgesics|analgesics|mesh-ancestor
102484117|NCT03834935|Sensory System Agents|sensory system agents|mesh-ancestor
102484118|NCT03834935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102484119|NCT03834935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484120|NCT03834935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102484121|NCT03834935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102484122|NCT03834935|Dermatologic Agents|dermatologic agents|mesh-ancestor
102484123|NCT03834935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102484124|NCT03834935|Immunologic Factors|immunologic factors|mesh-ancestor
102484125|NCT03834935|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102484126|NCT03834935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102484127|NCT03834935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484128|NCT02796352|Interleukin-2|interleukin-2|mesh-list
102484129|NCT02796352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102484130|NCT02796352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102484131|NCT02796352|Analgesics|analgesics|mesh-ancestor
102484132|NCT02796352|Sensory System Agents|sensory system agents|mesh-ancestor
102484133|NCT02796352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102484134|NCT02796352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484135|NCT00939367|Zolpidem|zolpidem|mesh-list
102484136|NCT00939367|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102484137|NCT00939367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102484138|NCT00939367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102484139|NCT00939367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484140|NCT00939367|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102484141|NCT00939367|GABA Agonists|gaba agonists|mesh-ancestor
102484142|NCT00939367|GABA Agents|gaba agents|mesh-ancestor
102484143|NCT00939367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102484144|NCT00939367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484145|NCT03168880|Paclitaxel|paclitaxel|mesh-list
102484146|NCT03168880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102484147|NCT03168880|Carboplatin|carboplatin|mesh-list
102484148|NCT03168880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102484149|NCT03168880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102484150|NCT03168880|Tubulin Modulators|tubulin modulators|mesh-ancestor
102484151|NCT03168880|Antimitotic Agents|antimitotic agents|mesh-ancestor
102484152|NCT03168880|Mitosis Modulators|mitosis modulators|mesh-ancestor
102484153|NCT03168880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484154|NCT04347187|Anticoagulants|anticoagulants|mesh-list
102484155|NCT00920075|Alendronate|alendronate|mesh-list
102484156|NCT00920075|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102484157|NCT00920075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484158|NCT04364035|Vesatolimod|vesatolimod|mesh-list
102484159|NCT04364035|Antiviral Agents|antiviral agents|mesh-ancestor
102484160|NCT04364035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102484161|NCT03403439|Itraconazole|itraconazole|mesh-list
102484162|NCT03403439|Antifungal Agents|antifungal agents|mesh-ancestor
102484163|NCT03403439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102484164|NCT03403439|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102484165|NCT03403439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102484166|NCT03403439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102484167|NCT03403439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484168|NCT03403439|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102484169|NCT03403439|Hormone Antagonists|hormone antagonists|mesh-ancestor
102484170|NCT03403439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102484171|NCT03403439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484172|NCT03403439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102484174|NCT04346797|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102484175|NCT04346797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102484176|NCT04346797|Immunologic Factors|immunologic factors|mesh-ancestor
102484177|NCT04346797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484178|NCT04364581|Letrozole|letrozole|mesh-list
102484179|NCT04364581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102484180|NCT04364581|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102484181|NCT04364581|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102484182|NCT04364581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102484183|NCT04364581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484184|NCT04364581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102484185|NCT04364581|Hormone Antagonists|hormone antagonists|mesh-ancestor
102484186|NCT04364581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102484187|NCT04364581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484188|NCT01049009|Metoprolol|metoprolol|mesh-list
102484189|NCT01049009|Nebivolol|nebivolol|mesh-list
102484190|NCT01049009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102484191|NCT01049009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102484192|NCT01049009|Sympatholytics|sympatholytics|mesh-ancestor
102484193|NCT01049009|Autonomic Agents|autonomic agents|mesh-ancestor
102484194|NCT01049009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102484195|NCT01049009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484196|NCT01049009|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102484197|NCT01049009|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102484198|NCT01049009|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102484199|NCT01049009|Adrenergic Agents|adrenergic agents|mesh-ancestor
102484200|NCT01049009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101617010|NCT02603497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484201|NCT01049009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484202|NCT01049009|Vasodilator Agents|vasodilator agents|mesh-ancestor
102484203|NCT01049009|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102484204|NCT01049009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102484205|NCT01049009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102484206|NCT02850874|Gemcitabine|gemcitabine|mesh-list
102484207|NCT02850874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102484208|NCT02850874|Antimetabolites|antimetabolites|mesh-ancestor
102484209|NCT02850874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484210|NCT02850874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102484211|NCT01047683|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
102484212|NCT01047683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102484213|NCT01047683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102484214|NCT02920918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102484215|NCT02920918|Canagliflozin|canagliflozin|mesh-list
102484216|NCT02920918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102484217|NCT02920918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484218|NCT02920918|Incretins|incretins|mesh-ancestor
102484219|NCT02920918|Hormones|hormones|mesh-ancestor
102484220|NCT02920918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102484221|NCT02920918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102484222|NCT02920918|Protease Inhibitors|protease inhibitors|mesh-ancestor
102484223|NCT02920918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102484224|NCT02920918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484225|NCT02920918|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102484226|NCT03403049|Gemcitabine|gemcitabine|mesh-list
102484227|NCT03403049|Capecitabine|capecitabine|mesh-list
102484228|NCT03403049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102484229|NCT03403049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102484230|NCT03403049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102484231|NCT03403049|Antimetabolites|antimetabolites|mesh-ancestor
102484232|NCT03403049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484233|NCT03403049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102484234|NCT03403049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102484235|NCT00944047|Paclitaxel|paclitaxel|mesh-list
102484236|NCT00944047|Cyclophosphamide|cyclophosphamide|mesh-list
102484237|NCT00944047|Doxorubicin|doxorubicin|mesh-list
102484238|NCT00944047|Trastuzumab|trastuzumab|mesh-list
102484239|NCT00944047|Mitogens|mitogens|mesh-list
102484240|NCT00944047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102484241|NCT00944047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102484242|NCT00944047|Tubulin Modulators|tubulin modulators|mesh-ancestor
102484243|NCT00944047|Antimitotic Agents|antimitotic agents|mesh-ancestor
102484244|NCT00944047|Mitosis Modulators|mitosis modulators|mesh-ancestor
102484245|NCT00944047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484246|NCT00944047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102484247|NCT00944047|Immunologic Factors|immunologic factors|mesh-ancestor
102484248|NCT00944047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484249|NCT00944047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102484250|NCT00944047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102484251|NCT00944047|Alkylating Agents|alkylating agents|mesh-ancestor
102484252|NCT00944047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102484253|NCT00944047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102484254|NCT00944047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102484255|NCT00944047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102484256|NCT00944047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102484257|NCT00944047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102484258|NCT02921386|Methyltestosterone|methyltestosterone|mesh-list
102484259|NCT02921386|Testosterone|testosterone|mesh-list
102484260|NCT02921386|Testosterone undecanoate|testosterone undecanoate|mesh-list
102484261|NCT02921386|Testosterone enanthate|testosterone enanthate|mesh-list
102484262|NCT02921386|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102484263|NCT02921386|Androgens|androgens|mesh-ancestor
102484264|NCT02921386|Hormones|hormones|mesh-ancestor
102484265|NCT02921386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102484266|NCT02921386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484267|NCT02921386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102484268|NCT02921386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102484269|NCT02921386|Anabolic Agents|anabolic agents|mesh-ancestor
102484270|NCT03402815|Maraviroc|maraviroc|mesh-list
102484271|NCT03402815|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102484272|NCT03402815|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102484273|NCT03402815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484274|NCT03402815|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102484275|NCT03402815|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102484276|NCT03402815|Antiviral Agents|antiviral agents|mesh-ancestor
102484277|NCT03402815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102484278|NCT03402815|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102484279|NCT02245555|Tamsulosin|tamsulosin|mesh-list
102484280|NCT02245555|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101617072|NCT02839239|Micronutrients|micronutrients|mesh-ancestor
102484281|NCT02245555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102484282|NCT02245555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102484283|NCT02245555|Adrenergic Agents|adrenergic agents|mesh-ancestor
102484284|NCT02245555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102484285|NCT02245555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484286|NCT02245555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484287|NCT02245555|Urological Agents|urological agents|mesh-ancestor
102484288|NCT04354441|Hydroxychloroquine|hydroxychloroquine|mesh-list
102484289|NCT04354441|Antimalarials|antimalarials|mesh-ancestor
102484290|NCT04354441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102484291|NCT04354441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102484292|NCT04354441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102484293|NCT04354441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102484294|NCT04354441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484295|NCT04354441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102484296|NCT02802514|Exenatide|exenatide|mesh-list
102484297|NCT02802514|rGLP-1 protein|rglp-1 protein|mesh-list
102484298|NCT02802514|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102484299|NCT02802514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102484300|NCT02802514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484301|NCT02802514|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102484302|NCT02802514|Incretins|incretins|mesh-ancestor
102484303|NCT02802514|Hormones|hormones|mesh-ancestor
102484304|NCT02802514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102484305|NCT00944671|Calcium, Dietary|calcium, dietary|mesh-list
102484306|NCT00944671|Calcium Carbonate|calcium carbonate|mesh-list
102484307|NCT00944671|Magnesium Hydroxide|magnesium hydroxide|mesh-list
102484308|NCT00944671|Famotidine|famotidine|mesh-list
102484309|NCT00944671|Calcium|calcium|mesh-list
102295936|NCT02489903|Paclitaxel|paclitaxel|mesh-list
102484310|NCT00944671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102484311|NCT00944671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484312|NCT00944671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102484313|NCT00944671|Antacids|antacids|mesh-ancestor
102484314|NCT00944671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484315|NCT00944671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102484316|NCT00944671|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102484317|NCT00944671|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102484318|NCT00944671|Histamine Antagonists|histamine antagonists|mesh-ancestor
102484319|NCT00944671|Histamine Agents|histamine agents|mesh-ancestor
102484320|NCT00944671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102484321|NCT00944749|Cyclosporine|cyclosporine|mesh-list
102484322|NCT00944749|Cyclosporins|cyclosporins|mesh-list
102484323|NCT00944749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102484324|NCT00944749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484325|NCT00944749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102484326|NCT00944749|Immunologic Factors|immunologic factors|mesh-ancestor
102484327|NCT00944749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484328|NCT00944749|Antifungal Agents|antifungal agents|mesh-ancestor
102484329|NCT00944749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102484330|NCT00944749|Dermatologic Agents|dermatologic agents|mesh-ancestor
102484331|NCT00944749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102484332|NCT00944749|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102484333|NCT01047293|Leucovorin|leucovorin|mesh-list
102484334|NCT01047293|Bevacizumab|bevacizumab|mesh-list
102484335|NCT01047293|Oxaliplatin|oxaliplatin|mesh-list
102484336|NCT01047293|Everolimus|everolimus|mesh-list
102484337|NCT01047293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102484338|NCT01047293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102484339|NCT01047293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102484340|NCT01047293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102484341|NCT01047293|Growth Substances|growth substances|mesh-ancestor
102484342|NCT01047293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484343|NCT01047293|Growth Inhibitors|growth inhibitors|mesh-ancestor
102484344|NCT01047293|Antidotes|antidotes|mesh-ancestor
102484345|NCT01047293|Protective Agents|protective agents|mesh-ancestor
102484346|NCT01047293|Vitamin B Complex|vitamin b complex|mesh-ancestor
102484347|NCT01047293|Vitamins|vitamins|mesh-ancestor
102484348|NCT01047293|Micronutrients|micronutrients|mesh-ancestor
102484349|NCT01047293|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102484350|NCT01047293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102484351|NCT01047293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102484352|NCT01047293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484353|NCT01047293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102484354|NCT01047293|Immunologic Factors|immunologic factors|mesh-ancestor
102484355|NCT01045967|Lansoprazole|lansoprazole|mesh-list
102484356|NCT01045967|Dexlansoprazole|dexlansoprazole|mesh-list
102484357|NCT01045967|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102484358|NCT01045967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102484359|NCT01045967|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102484360|NCT01045967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102484361|NCT01045967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484362|NCT02808052|Minocycline|minocycline|mesh-list
102484363|NCT02808052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102484364|NCT02808052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102484365|NCT02924350|Fluorides|fluorides|mesh-list
102484366|NCT02924350|Tin Fluorides|tin fluorides|mesh-list
102484367|NCT02924350|Fluorophosphate|fluorophosphate|mesh-list
102484368|NCT02924350|Cariostatic Agents|cariostatic agents|mesh-ancestor
102484369|NCT02924350|Protective Agents|protective agents|mesh-ancestor
102484370|NCT02924350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484371|NCT02344498|Tenofovir|tenofovir|mesh-list
102484372|NCT02344498|Antiviral Agents|antiviral agents|mesh-ancestor
102484373|NCT02344498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102484374|NCT02344498|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102484375|NCT02344498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102484376|NCT02344498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102484377|NCT02344498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484378|NCT02344498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102484379|NCT02344498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102484380|NCT00945139|Bevacizumab|bevacizumab|mesh-list
102484381|NCT00945139|Doxorubicin|doxorubicin|mesh-list
102484382|NCT00945139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102484383|NCT00945139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102484384|NCT00945139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102484385|NCT00945139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102484386|NCT00945139|Growth Substances|growth substances|mesh-ancestor
102484387|NCT00945139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484388|NCT00945139|Growth Inhibitors|growth inhibitors|mesh-ancestor
102484389|NCT00945139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102484390|NCT00945139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102484391|NCT00945139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102484392|NCT00945139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102484393|NCT00945139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484394|NCT02812342|Tofacitinib|tofacitinib|mesh-list
102484395|NCT02812342|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102484396|NCT02812342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102484397|NCT02812342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102484398|NCT02812342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484399|NCT03871465|Triamcinolone|triamcinolone|mesh-list
102484400|NCT03871465|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102484401|NCT03871465|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102484402|NCT03871465|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102484403|NCT03871465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102484404|NCT03871465|Glucocorticoids|glucocorticoids|mesh-ancestor
102484405|NCT03871465|Hormones|hormones|mesh-ancestor
102484406|NCT03871465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102484407|NCT03871465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484408|NCT03871465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102484409|NCT03871465|Immunologic Factors|immunologic factors|mesh-ancestor
102484410|NCT03871465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102484411|NCT03871465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484412|NCT00931489|Ranibizumab|ranibizumab|mesh-list
102484413|NCT00931489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102484414|NCT00931489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102484415|NCT00931489|Growth Substances|growth substances|mesh-ancestor
102484416|NCT00931489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484417|NCT00931489|Growth Inhibitors|growth inhibitors|mesh-ancestor
102484418|NCT00931489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102484419|NCT04363255|Cisplatin|cisplatin|mesh-list
102484420|NCT04363255|Carboplatin|carboplatin|mesh-list
102484421|NCT04363255|Etoposide|etoposide|mesh-list
102484422|NCT04363255|Etoposide phosphate|etoposide phosphate|mesh-list
102484423|NCT04363255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102484424|NCT04363255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102484425|NCT04363255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102484426|NCT04363255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102484427|NCT04363255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102484428|NCT04363255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484429|NCT00945295|Botulinum Toxins|botulinum toxins|mesh-list
102484430|NCT00945295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102484431|NCT00945295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102484432|NCT00945295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102484433|NCT00945295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102484434|NCT00945295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484435|NCT00945295|Cholinergic Agents|cholinergic agents|mesh-ancestor
102484436|NCT00945295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102484437|NCT00945295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484438|NCT00945295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102484439|NCT00945295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102484440|NCT03490825|Melatonin|melatonin|mesh-list
102484441|NCT03490825|Antioxidants|antioxidants|mesh-ancestor
102484442|NCT03490825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484443|NCT03490825|Protective Agents|protective agents|mesh-ancestor
102484444|NCT03490825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484445|NCT03490825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102484446|NCT04362943|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102484447|NCT04362943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102484448|NCT03317899|Lenograstim|lenograstim|mesh-list
102484449|NCT03317899|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102484450|NCT03317899|Immunologic Factors|immunologic factors|mesh-ancestor
102484451|NCT03317899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484452|NCT04353505|Dexamethasone|dexamethasone|mesh-list
102484453|NCT04353505|Ketorolac|ketorolac|mesh-list
102484454|NCT04353505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102484455|NCT04353505|Antiemetics|antiemetics|mesh-ancestor
102484456|NCT04353505|Autonomic Agents|autonomic agents|mesh-ancestor
102484457|NCT04353505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102484458|NCT04353505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484459|NCT04353505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102484460|NCT04353505|Glucocorticoids|glucocorticoids|mesh-ancestor
102484461|NCT04353505|Hormones|hormones|mesh-ancestor
102484462|NCT04353505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102484463|NCT04353505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102484464|NCT04353505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102484465|NCT04353505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102484466|NCT04353505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102484467|NCT04353505|Analgesics|analgesics|mesh-ancestor
102484468|NCT04353505|Sensory System Agents|sensory system agents|mesh-ancestor
102484469|NCT04353505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102484470|NCT04353505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102484471|NCT04353505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102484472|NCT04353505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484473|NCT02929927|Sodium Hypochlorite|sodium hypochlorite|mesh-list
102484474|NCT02929927|Eusol|eusol|mesh-list
102484475|NCT02929927|Disinfectants|disinfectants|mesh-ancestor
102484476|NCT02929927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102484477|NCT02427451|Venetoclax|venetoclax|mesh-list
102484478|NCT02427451|Obinutuzumab|obinutuzumab|mesh-list
102484479|NCT02427451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102484480|NCT02427451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102484481|NCT04362241|Prednisolone|prednisolone|mesh-list
102484482|NCT04362241|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102484483|NCT04362241|Methylprednisolone|methylprednisolone|mesh-list
102484484|NCT04362241|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101297728|NCT02000947|Durvalumab|durvalumab|mesh-list
102484485|NCT04362241|Prednisolone acetate|prednisolone acetate|mesh-list
102484486|NCT04362241|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102484487|NCT04362241|Prednisolone phosphate|prednisolone phosphate|mesh-list
102484488|NCT04362241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102484489|NCT04362241|Glucocorticoids|glucocorticoids|mesh-ancestor
102484490|NCT04362241|Hormones|hormones|mesh-ancestor
102484491|NCT04362241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102484492|NCT04362241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484493|NCT04362241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102484494|NCT04362241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102484495|NCT04362241|Antiemetics|antiemetics|mesh-ancestor
102484496|NCT04362241|Autonomic Agents|autonomic agents|mesh-ancestor
102484497|NCT04362241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102484498|NCT04362241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102484499|NCT04362241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102484500|NCT04362241|Protective Agents|protective agents|mesh-ancestor
102484501|NCT01384513|Mycophenolic Acid|mycophenolic acid|mesh-list
102484502|NCT01384513|Cyclophosphamide|cyclophosphamide|mesh-list
102484503|NCT01384513|Busulfan|busulfan|mesh-list
102484504|NCT01384513|Fludarabine|fludarabine|mesh-list
102484505|NCT01384513|Fludarabine phosphate|fludarabine phosphate|mesh-list
102484506|NCT01384513|Tacrolimus|tacrolimus|mesh-list
102484507|NCT01384513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102484508|NCT01384513|Immunologic Factors|immunologic factors|mesh-ancestor
102484509|NCT01384513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484510|NCT01384513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102484511|NCT01384513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102484512|NCT01384513|Alkylating Agents|alkylating agents|mesh-ancestor
102484513|NCT01384513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484514|NCT01384513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102484515|NCT01384513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102484516|NCT01384513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102484517|NCT01384513|Antimetabolites|antimetabolites|mesh-ancestor
102484518|NCT01384513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102484519|NCT01384513|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102484520|NCT01384513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102484521|NCT01384513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102484522|NCT01384513|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102484523|NCT01384513|Antitubercular Agents|antitubercular agents|mesh-ancestor
102484524|NCT01384513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102484525|NCT03035617|Bupivacaine|bupivacaine|mesh-list
102484526|NCT03035617|Anesthetics, Local|anesthetics, local|mesh-ancestor
102484527|NCT03035617|Anesthetics|anesthetics|mesh-ancestor
102484528|NCT03035617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102484529|NCT03035617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484530|NCT03035617|Sensory System Agents|sensory system agents|mesh-ancestor
102484531|NCT03035617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102484532|NCT02933320|Rituximab|rituximab|mesh-list
101617275|NCT01074008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102484533|NCT02933320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102484534|NCT02933320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102484535|NCT02933320|Immunologic Factors|immunologic factors|mesh-ancestor
102484536|NCT02933320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484537|NCT02933320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102484539|NCT05563675|Muscarinic Antagonists|muscarinic antagonists|mesh-list
102484540|NCT05563675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102484541|NCT05563675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484542|NCT05563675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484543|NCT05563675|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102484544|NCT05555251|Trastuzumab|trastuzumab|mesh-list
102484545|NCT05555251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102484546|NCT05555251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102484547|NCT03035305|Pyrimethamine|pyrimethamine|mesh-list
102484548|NCT03035305|Sulfadoxine|sulfadoxine|mesh-list
102484549|NCT03035305|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
102484550|NCT03035305|Amodiaquine|amodiaquine|mesh-list
102484551|NCT03035305|Antimalarials|antimalarials|mesh-ancestor
102484552|NCT03035305|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102484553|NCT03035305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102484554|NCT03035305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102484555|NCT03035305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102484556|NCT03035305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102484557|NCT03035305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484558|NCT03035305|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102484559|NCT03034759|Insulin|insulin|mesh-list
102484560|NCT03034759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102484561|NCT03034759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484562|NCT02158273|Fenofibrate|fenofibrate|mesh-list
102484563|NCT02158273|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102484564|NCT02158273|Antimetabolites|antimetabolites|mesh-ancestor
102484565|NCT02158273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484566|NCT02158273|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102484567|NCT02819284|Loteprednol Etabonate|loteprednol etabonate|mesh-list
102484568|NCT02819284|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102484569|NCT04361461|Azithromycin|azithromycin|mesh-list
102484570|NCT04361461|Hydroxychloroquine|hydroxychloroquine|mesh-list
102484571|NCT04361461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102484572|NCT04361461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102484573|NCT04361461|Antimalarials|antimalarials|mesh-ancestor
102484574|NCT04361461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102484575|NCT04361461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102484576|NCT04361461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102484577|NCT04361461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484578|NCT04361461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102484579|NCT03002506|Tazobactam|tazobactam|mesh-list
102484580|NCT03002506|Ceftolozane|ceftolozane|mesh-list
102484581|NCT03002506|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
102484582|NCT03002506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102484583|NCT03002506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102484584|NCT03002506|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102484585|NCT03002506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102484586|NCT03002506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484587|NCT03002506|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102484588|NCT02822950|Ceftazidime|ceftazidime|mesh-list
102484589|NCT02822950|Avibactam|avibactam|mesh-list
102484590|NCT02822950|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
102484591|NCT02822950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102484592|NCT02822950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102484593|NCT02822950|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102484594|NCT02822950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102484595|NCT02822950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484596|NCT02935738|Prednisolone|prednisolone|mesh-list
102484597|NCT02935738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102484598|NCT02935738|Glucocorticoids|glucocorticoids|mesh-ancestor
102484599|NCT02935738|Hormones|hormones|mesh-ancestor
102484600|NCT02935738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102484601|NCT02935738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484602|NCT02935738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102484603|NCT02935738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102484604|NCT00939991|Bevacizumab|bevacizumab|mesh-list
102484605|NCT00939991|Temozolomide|temozolomide|mesh-list
102484606|NCT00939991|Vorinostat|vorinostat|mesh-list
102484607|NCT00939991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102484608|NCT00939991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102484609|NCT00939991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102484610|NCT00939991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102484611|NCT00939991|Growth Substances|growth substances|mesh-ancestor
102484612|NCT00939991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484613|NCT00939991|Growth Inhibitors|growth inhibitors|mesh-ancestor
101617348|NCT01067144|Gabapentin|gabapentin|mesh-list
102484614|NCT00939991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102484615|NCT00939991|Alkylating Agents|alkylating agents|mesh-ancestor
102484616|NCT00939991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484617|NCT00939991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102484618|NCT00939991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102484619|NCT04361305|Tadalafil|tadalafil|mesh-list
102484620|NCT04361305|Vasodilator Agents|vasodilator agents|mesh-ancestor
102484621|NCT04361305|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102484622|NCT04361305|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102484623|NCT04361305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102484624|NCT04361305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484625|NCT04361305|Urological Agents|urological agents|mesh-ancestor
102484626|NCT02245321|Ferrous gluconate|ferrous gluconate|mesh-list
102484627|NCT02245321|Hematinics|hematinics|mesh-ancestor
102484628|NCT04361149|Capsaicin|capsaicin|mesh-list
102484629|NCT04361149|Antipruritics|antipruritics|mesh-ancestor
102484630|NCT04361149|Dermatologic Agents|dermatologic agents|mesh-ancestor
101617350|NCT01067144|Analgesics|analgesics|mesh-ancestor
102484631|NCT04361149|Sensory System Agents|sensory system agents|mesh-ancestor
102484632|NCT04361149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102484633|NCT04361149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484634|NCT05332483|Megestrol|megestrol|mesh-list
102484635|NCT05332483|Megestrol Acetate|megestrol acetate|mesh-list
102484636|NCT05332483|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102484637|NCT05332483|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102484638|NCT05332483|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102484639|NCT05332483|Contraceptive Agents|contraceptive agents|mesh-ancestor
102484640|NCT05332483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102484641|NCT05332483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484642|NCT05332483|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102484643|NCT05332483|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102484644|NCT05332483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102484645|NCT05332483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102484646|NCT05332483|Appetite Stimulants|appetite stimulants|mesh-ancestor
102484647|NCT05332483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102484648|NCT03033589|Bupivacaine|bupivacaine|mesh-list
102484649|NCT03033589|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102484650|NCT03033589|Anesthetics, Local|anesthetics, local|mesh-ancestor
101617380|NCT04106011|Gabapentin|gabapentin|mesh-list
102484651|NCT03033589|Anesthetics|anesthetics|mesh-ancestor
102484652|NCT03033589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102484653|NCT03033589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484654|NCT03033589|Sensory System Agents|sensory system agents|mesh-ancestor
102484655|NCT03033589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102484656|NCT00947167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102484657|NCT00947167|Pertuzumab|pertuzumab|mesh-list
102484658|NCT00947167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102484659|NCT00947167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102484660|NCT00947167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102484661|NCT00947167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484662|NCT00947167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102484663|NCT04360759|Hydroxychloroquine|hydroxychloroquine|mesh-list
102484664|NCT04360759|Chloroquine|chloroquine|mesh-list
102484665|NCT04360759|Antimalarials|antimalarials|mesh-ancestor
102484666|NCT04360759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102484667|NCT04360759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102484668|NCT04360759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102484669|NCT04360759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102484670|NCT04360759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617396|NCT02875886|Amiloride|amiloride|mesh-list
102484671|NCT04360759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102484672|NCT04360759|Amebicides|amebicides|mesh-ancestor
102484673|NCT00940771|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102484674|NCT00940771|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102484675|NCT00940771|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102484676|NCT00940771|Protease Inhibitors|protease inhibitors|mesh-ancestor
102484677|NCT00940771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102484678|NCT00940771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484679|NCT00940771|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102484680|NCT00940771|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102484681|NCT00940771|Antiviral Agents|antiviral agents|mesh-ancestor
102484682|NCT00940771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102484683|NCT03033355|Botulinum Toxins|botulinum toxins|mesh-list
102484684|NCT03033355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102484685|NCT03033355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102484686|NCT03033355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102484687|NCT03033355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101304034|NCT02010723|Polidocanol|polidocanol|mesh-list
102484688|NCT03033355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484689|NCT03033355|Cholinergic Agents|cholinergic agents|mesh-ancestor
102484690|NCT03033355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102484691|NCT03033355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484692|NCT03033355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102484693|NCT03033355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102484694|NCT03033121|Hormones|hormones|mesh-list
102484695|NCT03033121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102484696|NCT03033121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484697|NCT03033199|Dexamethasone|dexamethasone|mesh-list
102484698|NCT03033199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102484699|NCT03033199|Antiemetics|antiemetics|mesh-ancestor
102484700|NCT03033199|Autonomic Agents|autonomic agents|mesh-ancestor
102484701|NCT03033199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102484702|NCT03033199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484703|NCT03033199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102484704|NCT03033199|Glucocorticoids|glucocorticoids|mesh-ancestor
102484705|NCT03033199|Hormones|hormones|mesh-ancestor
101617420|NCT02836821|Rifampin|rifampin|mesh-list
102484706|NCT03033199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102484707|NCT03033199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102484708|NCT03033199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102484709|NCT00940927|Albuterol|albuterol|mesh-list
102484710|NCT00940927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102484711|NCT00940927|Autonomic Agents|autonomic agents|mesh-ancestor
102484712|NCT00940927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102484713|NCT00940927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484714|NCT00940927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102484715|NCT00940927|Respiratory System Agents|respiratory system agents|mesh-ancestor
102484716|NCT00940927|Tocolytic Agents|tocolytic agents|mesh-ancestor
102484717|NCT00940927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102484718|NCT00940927|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102484719|NCT00940927|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102484720|NCT00940927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102484721|NCT00940927|Adrenergic Agents|adrenergic agents|mesh-ancestor
102484722|NCT00940927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102484723|NCT00940927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484724|NCT00934375|Donepezil|donepezil|mesh-list
102484725|NCT00934375|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102484726|NCT00934375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102484727|NCT00934375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484728|NCT00934375|Cholinergic Agents|cholinergic agents|mesh-ancestor
102484729|NCT00934375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101617439|NCT02836743|Antioxidants|antioxidants|mesh-ancestor
102484730|NCT00934375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484731|NCT00934375|Nootropic Agents|nootropic agents|mesh-ancestor
102484732|NCT03002974|Triamcinolone|triamcinolone|mesh-list
102484733|NCT03002974|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102484734|NCT03002974|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102484735|NCT03002974|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102484736|NCT03002974|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102484737|NCT03002974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102484738|NCT03002974|Glucocorticoids|glucocorticoids|mesh-ancestor
102484739|NCT03002974|Hormones|hormones|mesh-ancestor
102484740|NCT03002974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102484741|NCT03002974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484742|NCT03002974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102484743|NCT03002974|Immunologic Factors|immunologic factors|mesh-ancestor
102484744|NCT03002974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102484745|NCT03002974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484746|NCT03002974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102484747|NCT02245477|Mitogens|mitogens|mesh-list
102484748|NCT02245477|Endothelial Growth Factors|endothelial growth factors|mesh-list
102484749|NCT02245477|Mitosis Modulators|mitosis modulators|mesh-ancestor
102484750|NCT02245477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484751|NCT02245477|Growth Substances|growth substances|mesh-ancestor
101617463|NCT00892437|Cobicistat|cobicistat|mesh-list
102484752|NCT02245477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484753|NCT02825212|Sofosbuvir|sofosbuvir|mesh-list
102484754|NCT02825212|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102484755|NCT02825212|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102484756|NCT02825212|Ledipasvir|ledipasvir|mesh-list
102484757|NCT02825212|Velpatasvir|velpatasvir|mesh-list
102484758|NCT02825212|Antiviral Agents|antiviral agents|mesh-ancestor
102484759|NCT02825212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102484760|NCT00373672|Modafinil|modafinil|mesh-list
102484761|NCT00373672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102484762|NCT00373672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484763|NCT00373672|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102484764|NCT00373672|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102484765|NCT00373672|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102484766|NCT00373672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484767|NCT04941703|Magnesium citrate|magnesium citrate|mesh-list
102484768|NCT04941703|Cathartics|cathartics|mesh-ancestor
102484769|NCT04941703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102484770|NCT04359823|Lovastatin|lovastatin|mesh-list
102484771|NCT04359823|L 647318|l 647318|mesh-list
102484772|NCT04359823|Dihydromevinolin|dihydromevinolin|mesh-list
102484773|NCT04359823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102484774|NCT04359823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102484775|NCT04359823|Antimetabolites|antimetabolites|mesh-ancestor
102484776|NCT04359823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484777|NCT04359823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102484778|NCT04359823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102484779|NCT04359823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102484780|NCT03008590|Naltrexone|naltrexone|mesh-list
102484781|NCT03008590|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102484782|NCT03008590|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102484783|NCT03008590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484784|NCT03008590|Sensory System Agents|sensory system agents|mesh-ancestor
102484785|NCT03008590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102484786|NCT04359511|Prednisone|prednisone|mesh-list
102484787|NCT04359511|Hydrocortisone|hydrocortisone|mesh-list
102484788|NCT04359511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102484789|NCT04359511|Glucocorticoids|glucocorticoids|mesh-ancestor
102484790|NCT04359511|Hormones|hormones|mesh-ancestor
102484791|NCT04359511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102484792|NCT04359511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484793|NCT04359511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102484794|NCT04359511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102484795|NCT03032419|Vaccines|vaccines|mesh-list
102484796|NCT03032419|Immunologic Factors|immunologic factors|mesh-ancestor
102484797|NCT03032419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484798|NCT00373906|Bortezomib|bortezomib|mesh-list
102484799|NCT00373906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102484800|NCT00955513|Diclofenac|diclofenac|mesh-list
102484801|NCT00955513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102484802|NCT00955513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102484803|NCT00955513|Analgesics|analgesics|mesh-ancestor
102484804|NCT00955513|Sensory System Agents|sensory system agents|mesh-ancestor
102484805|NCT00955513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102484806|NCT00955513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484807|NCT00955513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102484808|NCT00955513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102484809|NCT00955513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102484810|NCT00955513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102484811|NCT00955513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484812|NCT00935311|Acetaminophen|acetaminophen|mesh-list
102484813|NCT00935311|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
102484814|NCT00935311|Hydrocodone|hydrocodone|mesh-list
102484815|NCT00935311|Oxycodone|oxycodone|mesh-list
102484816|NCT00935311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102484817|NCT00935311|Analgesics|analgesics|mesh-ancestor
102484818|NCT00935311|Sensory System Agents|sensory system agents|mesh-ancestor
102484819|NCT00935311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102484820|NCT00935311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484821|NCT00935311|Antipyretics|antipyretics|mesh-ancestor
102484822|NCT00935311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102484823|NCT00935311|Narcotics|narcotics|mesh-ancestor
102484824|NCT00935311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102484825|NCT00935311|Antitussive Agents|antitussive agents|mesh-ancestor
102484826|NCT00935311|Respiratory System Agents|respiratory system agents|mesh-ancestor
102484827|NCT00935311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102484828|NCT00935311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102484829|NCT00935311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102484830|NCT02946034|Ribavirin|ribavirin|mesh-list
101586486|NCT01165307|Naproxen|naproxen|mesh-list
102484831|NCT02946034|Antimetabolites|antimetabolites|mesh-ancestor
102484832|NCT02946034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484833|NCT02946034|Antiviral Agents|antiviral agents|mesh-ancestor
102296468|NCT05481281|Ketamine|ketamine|mesh-list
102484834|NCT02946034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102484835|NCT00955747|Tagatose|tagatose|mesh-list
102484836|NCT00955747|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102484837|NCT00955747|Chelating Agents|chelating agents|mesh-ancestor
102484838|NCT00955747|Sequestering Agents|sequestering agents|mesh-ancestor
102484839|NCT00955747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484840|NCT02946892|Carvedilol|carvedilol|mesh-list
102484841|NCT02946892|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101617548|NCT05326425|Lazertinib|lazertinib|mesh-list
102484842|NCT02946892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102484843|NCT02946892|Adrenergic Agents|adrenergic agents|mesh-ancestor
102484844|NCT02946892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102484845|NCT02946892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484846|NCT02946892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484847|NCT02946892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102484848|NCT02946892|Antioxidants|antioxidants|mesh-ancestor
102484849|NCT02946892|Protective Agents|protective agents|mesh-ancestor
102484850|NCT02946892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102484851|NCT02946892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102484852|NCT02946892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102484853|NCT02946892|Vasodilator Agents|vasodilator agents|mesh-ancestor
102484854|NCT02946892|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102484855|NCT02946892|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102484856|NCT03402191|Sildenafil Citrate|sildenafil citrate|mesh-list
102484857|NCT03402191|Vasodilator Agents|vasodilator agents|mesh-ancestor
102484858|NCT03402191|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102484859|NCT03402191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102484860|NCT03402191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102484861|NCT03402191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484862|NCT03402191|Urological Agents|urological agents|mesh-ancestor
102484863|NCT03402113|Midazolam|midazolam|mesh-list
102484864|NCT03402113|Dexmedetomidine|dexmedetomidine|mesh-list
102484865|NCT03402113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102484866|NCT03402113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102484867|NCT03402113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484868|NCT03402113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102484869|NCT03402113|Analgesics|analgesics|mesh-ancestor
102484870|NCT03402113|Sensory System Agents|sensory system agents|mesh-ancestor
102484871|NCT03402113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102484872|NCT03402113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102484873|NCT03402113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102484874|NCT03402113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102484875|NCT03402113|Adrenergic Agents|adrenergic agents|mesh-ancestor
102484876|NCT03402113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102484877|NCT03402113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484878|NCT03402113|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102484879|NCT03402113|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102484880|NCT03402113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102484881|NCT03402113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102484882|NCT03402113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102484883|NCT03402113|Anesthetics, General|anesthetics, general|mesh-ancestor
102484884|NCT03402113|Anesthetics|anesthetics|mesh-ancestor
102484885|NCT03402113|GABA Modulators|gaba modulators|mesh-ancestor
102484886|NCT03402113|GABA Agents|gaba agents|mesh-ancestor
102484887|NCT01725113|Calcitriol|calcitriol|mesh-list
102484888|NCT01725113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102484889|NCT01725113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484890|NCT01725113|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102484891|NCT01725113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102484892|NCT01725113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484893|NCT01725113|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102484894|NCT01725113|Vitamins|vitamins|mesh-ancestor
102484895|NCT01725113|Micronutrients|micronutrients|mesh-ancestor
102484896|NCT01725113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102484897|NCT03031405|Oxytocin|oxytocin|mesh-list
102484898|NCT03031405|Oxytocics|oxytocics|mesh-ancestor
102484899|NCT03031405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102484900|NCT03031405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484901|NCT03031249|Cytarabine|cytarabine|mesh-list
102484902|NCT03031249|Tretinoin|tretinoin|mesh-list
102484903|NCT03031249|Arsenic Trioxide|arsenic trioxide|mesh-list
102484904|NCT03031249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102484905|NCT03031249|Antimetabolites|antimetabolites|mesh-ancestor
102484906|NCT03031249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484907|NCT03031249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102484908|NCT03031249|Antiviral Agents|antiviral agents|mesh-ancestor
102484909|NCT03031249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102484910|NCT03031249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102484911|NCT03031249|Immunologic Factors|immunologic factors|mesh-ancestor
102484912|NCT03031249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484913|NCT03031249|Keratolytic Agents|keratolytic agents|mesh-ancestor
102484914|NCT03031249|Dermatologic Agents|dermatologic agents|mesh-ancestor
102484915|NCT02980315|Immunomodulating Agents|immunomodulating agents|mesh-list
102484916|NCT02980315|Immunologic Factors|immunologic factors|mesh-ancestor
102484917|NCT02980315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484918|NCT01042535|Tryptophan|tryptophan|mesh-list
102484919|NCT01042535|Vaccines|vaccines|mesh-list
102484920|NCT01042535|Immunologic Factors|immunologic factors|mesh-ancestor
101274663|NCT01857921|Trimetazidine|trimetazidine|mesh-list
102484921|NCT01042535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484922|NCT01042535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102484923|NCT01042535|Antidepressive Agents|antidepressive agents|mesh-ancestor
102484924|NCT01042535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102484925|NCT03031327|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102484926|NCT03031327|Hyaluronic Acid|hyaluronic acid|mesh-list
102484927|NCT03031327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102484928|NCT03031327|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102484929|NCT03031327|Immunologic Factors|immunologic factors|mesh-ancestor
101617671|NCT00928434|Leuprolide|leuprolide|mesh-list
102484930|NCT03031327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484931|NCT03031327|Viscosupplements|viscosupplements|mesh-ancestor
102484932|NCT03031327|Protective Agents|protective agents|mesh-ancestor
102484933|NCT03401957|Cetuximab|cetuximab|mesh-list
102484934|NCT03401957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102484935|NCT03401957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102484936|NCT04358965|Misoprostol|misoprostol|mesh-list
102484937|NCT04358965|Tranexamic Acid|tranexamic acid|mesh-list
102484938|NCT04358965|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102484939|NCT04358965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102484940|NCT04358965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484941|NCT04358965|Hemostatics|hemostatics|mesh-ancestor
102484942|NCT04358965|Coagulants|coagulants|mesh-ancestor
102484943|NCT04358965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102484944|NCT04358965|Abortifacient Agents|abortifacient agents|mesh-ancestor
102484945|NCT04358965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102484946|NCT04358965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484947|NCT04358965|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102484948|NCT04358965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102484949|NCT04358965|Oxytocics|oxytocics|mesh-ancestor
102484950|NCT01041287|Metoprolol|metoprolol|mesh-list
102484951|NCT01041287|Nebivolol|nebivolol|mesh-list
102484952|NCT01041287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102484953|NCT01041287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102484954|NCT01041287|Sympatholytics|sympatholytics|mesh-ancestor
102484955|NCT01041287|Autonomic Agents|autonomic agents|mesh-ancestor
102484956|NCT01041287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102484957|NCT01041287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484958|NCT01041287|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102484959|NCT01041287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102484960|NCT01041287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102484961|NCT01041287|Adrenergic Agents|adrenergic agents|mesh-ancestor
102484962|NCT01041287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102484963|NCT01041287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484964|NCT01041287|Vasodilator Agents|vasodilator agents|mesh-ancestor
102484965|NCT01041287|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102484966|NCT01041287|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102484967|NCT01041287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102484968|NCT03016741|Prednisone|prednisone|mesh-list
102484969|NCT03016741|Abiraterone Acetate|abiraterone acetate|mesh-list
102484970|NCT03016741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102484971|NCT03016741|Glucocorticoids|glucocorticoids|mesh-ancestor
102484972|NCT03016741|Hormones|hormones|mesh-ancestor
102484973|NCT03016741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102484974|NCT03016741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102484975|NCT03016741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102484976|NCT03016741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102484977|NCT03016741|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101617710|NCT02602483|Ascorbic Acid|ascorbic acid|mesh-list
102484978|NCT03016741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102484979|NCT03016741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484980|NCT03016741|Hormone Antagonists|hormone antagonists|mesh-ancestor
102484981|NCT03016741|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102484982|NCT01042925|Paclitaxel|paclitaxel|mesh-list
102484983|NCT01042925|Trastuzumab|trastuzumab|mesh-list
102484984|NCT01042925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102296613|NCT05479175|Analgesics|analgesics|mesh-ancestor
102484985|NCT01042925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102484986|NCT01042925|Tubulin Modulators|tubulin modulators|mesh-ancestor
102484987|NCT01042925|Antimitotic Agents|antimitotic agents|mesh-ancestor
102484988|NCT01042925|Mitosis Modulators|mitosis modulators|mesh-ancestor
102484989|NCT01042925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102484990|NCT01042925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102484991|NCT03400709|Acetylcysteine|acetylcysteine|mesh-list
102484992|NCT03400709|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102484993|NCT03400709|Antiviral Agents|antiviral agents|mesh-ancestor
102484994|NCT03400709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102484995|NCT03400709|Expectorants|expectorants|mesh-ancestor
102484996|NCT03400709|Respiratory System Agents|respiratory system agents|mesh-ancestor
102484997|NCT03400709|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102484998|NCT03400709|Antioxidants|antioxidants|mesh-ancestor
102484999|NCT03400709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485000|NCT03400709|Protective Agents|protective agents|mesh-ancestor
102485001|NCT03400709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485002|NCT03400709|Antidotes|antidotes|mesh-ancestor
102485003|NCT02049957|Fulvestrant|fulvestrant|mesh-list
102485004|NCT02049957|Exemestane|exemestane|mesh-list
101617749|NCT04254822|Antioxidants|antioxidants|mesh-ancestor
102485005|NCT02049957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102485006|NCT02049957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102485007|NCT02049957|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102485008|NCT02049957|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102485009|NCT02049957|Hormone Antagonists|hormone antagonists|mesh-ancestor
102485010|NCT02049957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102485011|NCT02049957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485012|NCT02049957|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102485013|NCT02049957|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102485014|NCT02049957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102485015|NCT02049957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485016|NCT03030937|Irinotecan|irinotecan|mesh-list
102485017|NCT03030937|Apatinib|apatinib|mesh-list
102485018|NCT03030937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101617760|NCT00891813|Vitamins|vitamins|mesh-ancestor
102485019|NCT03030937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102485020|NCT03030937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102485021|NCT03030937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485022|NCT03030937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102485023|NCT03030937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102485024|NCT00950365|Pemetrexed|pemetrexed|mesh-list
102485025|NCT00950365|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102485026|NCT00950365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102485027|NCT00950365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102485028|NCT00950365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485029|NCT00950365|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102485030|NCT00950365|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102485031|NCT00950365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102485032|NCT01908465|Ebastine|ebastine|mesh-list
102485033|NCT01908465|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102485034|NCT01908465|Histamine Antagonists|histamine antagonists|mesh-ancestor
102485035|NCT01908465|Histamine Agents|histamine agents|mesh-ancestor
102485036|NCT01908465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102485037|NCT01908465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485038|NCT01908465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485039|NCT00950833|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102485040|NCT00950833|Immunologic Factors|immunologic factors|mesh-ancestor
102485041|NCT00950833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485042|NCT02246023|Propofol|propofol|mesh-list
102485043|NCT02246023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102485044|NCT02246023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102485045|NCT02246023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485046|NCT02246023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102485047|NCT02246023|Anesthetics, General|anesthetics, general|mesh-ancestor
102485048|NCT02246023|Anesthetics|anesthetics|mesh-ancestor
102485049|NCT00924053|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102485050|NCT00924053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485051|NCT00924053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102485052|NCT00924053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485053|NCT00357825|Reboxetine|reboxetine|mesh-list
102485054|NCT00357825|Antidepressive Agents|antidepressive agents|mesh-ancestor
102485055|NCT00357825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102485056|NCT00357825|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102485057|NCT00357825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102485058|NCT00357825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102485059|NCT00357825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485060|NCT00357825|Adrenergic Agents|adrenergic agents|mesh-ancestor
102485061|NCT00357825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102485062|NCT00357825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485063|NCT03400241|Bromides|bromides|mesh-list
102485064|NCT03400241|Tiotropium Bromide|tiotropium bromide|mesh-list
102485065|NCT03400241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102485066|NCT03400241|Autonomic Agents|autonomic agents|mesh-ancestor
102485067|NCT03400241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102485068|NCT03400241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485069|NCT03400241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102485070|NCT03400241|Respiratory System Agents|respiratory system agents|mesh-ancestor
102485071|NCT03400241|Parasympatholytics|parasympatholytics|mesh-ancestor
102485072|NCT03400241|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102485073|NCT03400241|Cholinergic Agents|cholinergic agents|mesh-ancestor
102485074|NCT03400241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102485075|NCT03400241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485076|NCT03400241|Anticonvulsants|anticonvulsants|mesh-ancestor
102485077|NCT05706987|Lidocaine|lidocaine|mesh-list
102485078|NCT05706987|Anesthetics, Local|anesthetics, local|mesh-ancestor
102485079|NCT05706987|Anesthetics|anesthetics|mesh-ancestor
102485080|NCT05706987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102485081|NCT05706987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485082|NCT05706987|Sensory System Agents|sensory system agents|mesh-ancestor
102485083|NCT05706987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101587865|NCT05040880|Telmisartan|telmisartan|mesh-list
102485084|NCT05706987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102485085|NCT05706987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102485086|NCT05706987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102485087|NCT05706987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102485088|NCT05706987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485089|NCT00729573|Tenofovir|tenofovir|mesh-list
102485090|NCT00729573|Emtricitabine|emtricitabine|mesh-list
102485091|NCT00729573|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102485092|NCT00729573|Antiviral Agents|antiviral agents|mesh-ancestor
102485093|NCT00729573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102485094|NCT00729573|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102485095|NCT00729573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102485096|NCT00729573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102485097|NCT00729573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485098|NCT00729573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102485099|NCT00729573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102485100|NCT02951182|Ivacaftor|ivacaftor|mesh-list
102485101|NCT02951182|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102485102|NCT02951182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102485103|NCT02951182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485104|NCT02959359|Ribavirin|ribavirin|mesh-list
102485105|NCT02959359|Sofosbuvir|sofosbuvir|mesh-list
102485106|NCT02959359|Ledipasvir|ledipasvir|mesh-list
102485107|NCT02959359|Antimetabolites|antimetabolites|mesh-ancestor
102485108|NCT02959359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485109|NCT02959359|Antiviral Agents|antiviral agents|mesh-ancestor
102485110|NCT02959359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102485111|NCT02829034|Ranolazine|ranolazine|mesh-list
102485112|NCT02829034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102485113|NCT02829034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102485114|NCT02829034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485115|NCT00924209|Bevacizumab|bevacizumab|mesh-list
102485116|NCT00924209|Gemcitabine|gemcitabine|mesh-list
102485117|NCT00924209|Etoposide|etoposide|mesh-list
102485118|NCT00924209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102485119|NCT00924209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102485120|NCT00924209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102485121|NCT00924209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102485122|NCT00924209|Growth Substances|growth substances|mesh-ancestor
102485123|NCT00924209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485124|NCT00924209|Growth Inhibitors|growth inhibitors|mesh-ancestor
102485125|NCT00924209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102485126|NCT00924209|Antimetabolites|antimetabolites|mesh-ancestor
102485127|NCT00924209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485128|NCT00924209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102485129|NCT00924209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102296763|NCT02542631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102485130|NCT00924209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102485131|NCT00924209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102485132|NCT05719467|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102485133|NCT05719467|Parasympatholytics|parasympatholytics|mesh-ancestor
102485134|NCT05719467|Autonomic Agents|autonomic agents|mesh-ancestor
102485135|NCT05719467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102485136|NCT05719467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485137|NCT05719467|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102485138|NCT05719467|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102485139|NCT05719467|Cholinergic Agents|cholinergic agents|mesh-ancestor
102485140|NCT05719467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102485141|NCT05719467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485142|NCT03408119|Vitamin D|vitamin d|mesh-list
102485143|NCT03408119|Calcium|calcium|mesh-list
102485144|NCT03408119|Vitamins|vitamins|mesh-ancestor
102485145|NCT03408119|Micronutrients|micronutrients|mesh-ancestor
102485146|NCT03408119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485147|NCT03408119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102485148|NCT03408119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102485149|NCT03405155|Nivolumab|nivolumab|mesh-list
102485150|NCT03405155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102485151|NCT03405155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102485152|NCT03405155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102485153|NCT03405155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485154|NCT04374929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102485155|NCT04374929|Glucocorticoids|glucocorticoids|mesh-list
102485156|NCT04374929|Hormones|hormones|mesh-ancestor
102485157|NCT04374929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102485158|NCT04374929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485159|NCT05717361|Lidocaine|lidocaine|mesh-list
102485160|NCT05717361|Ketamine|ketamine|mesh-list
102485161|NCT05717361|Remifentanil|remifentanil|mesh-list
102485162|NCT05717361|Anesthetics, Local|anesthetics, local|mesh-ancestor
102485163|NCT05717361|Anesthetics|anesthetics|mesh-ancestor
102485164|NCT05717361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102485165|NCT05717361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485166|NCT05717361|Sensory System Agents|sensory system agents|mesh-ancestor
102485167|NCT05717361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102485168|NCT05717361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102485169|NCT05717361|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102485170|NCT05717361|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102485171|NCT05717361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102485172|NCT05717361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485173|NCT05717361|Analgesics|analgesics|mesh-ancestor
102485174|NCT05717361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102485175|NCT05717361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102485176|NCT05717361|Anesthetics, General|anesthetics, general|mesh-ancestor
102485177|NCT05717361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102485178|NCT05717361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102485179|NCT05717361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102485180|NCT05717361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102485181|NCT05717361|Narcotics|narcotics|mesh-ancestor
102485182|NCT02951884|Bupivacaine|bupivacaine|mesh-list
102485183|NCT02951884|Anesthetics, Local|anesthetics, local|mesh-ancestor
102485184|NCT02951884|Anesthetics|anesthetics|mesh-ancestor
102485185|NCT02951884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102485186|NCT02951884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485187|NCT02951884|Sensory System Agents|sensory system agents|mesh-ancestor
102485188|NCT02951884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102485189|NCT05574387|Metformin|metformin|mesh-list
102485190|NCT05574387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102485191|NCT05574387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485192|NCT02978001|Glycerol|glycerol|mesh-list
102485193|NCT02978001|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102485194|NCT02978001|Protective Agents|protective agents|mesh-ancestor
102485195|NCT02978001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485196|NCT02978313|Cetuximab|cetuximab|mesh-list
102485197|NCT02978313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102485198|NCT02978313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102485199|NCT00014495|Cytarabine|cytarabine|mesh-list
102485200|NCT00014495|Bismuth|bismuth|mesh-list
102485201|NCT00014495|Antibodies|antibodies|mesh-list
102485202|NCT00014495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102485203|NCT00014495|Immunologic Factors|immunologic factors|mesh-ancestor
102296840|NCT02301975|Xhance|xhance|mesh-list
102485204|NCT00014495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485205|NCT00014495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102485206|NCT00014495|Antimetabolites|antimetabolites|mesh-ancestor
102485207|NCT00014495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485208|NCT00014495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102485209|NCT00014495|Antiviral Agents|antiviral agents|mesh-ancestor
102485210|NCT00014495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102485211|NCT00014495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102485212|NCT00014495|Antacids|antacids|mesh-ancestor
102485213|NCT00014495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102485214|NCT05566041|Carboplatin|carboplatin|mesh-list
102485215|NCT05566041|Etoposide|etoposide|mesh-list
102485216|NCT05566041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102485217|NCT05566041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102485218|NCT05566041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102485219|NCT05566041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102485220|NCT05566041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102485221|NCT05566041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485222|NCT04374071|Methylprednisolone|methylprednisolone|mesh-list
102485223|NCT04374071|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102485224|NCT04374071|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102485225|NCT04374071|Prednisolone|prednisolone|mesh-list
102485226|NCT04374071|Prednisolone acetate|prednisolone acetate|mesh-list
102485227|NCT04374071|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102485228|NCT04374071|Prednisolone phosphate|prednisolone phosphate|mesh-list
102485229|NCT04374071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102485230|NCT04374071|Antiemetics|antiemetics|mesh-ancestor
102485231|NCT04374071|Autonomic Agents|autonomic agents|mesh-ancestor
102485232|NCT04374071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102485233|NCT04374071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485234|NCT04374071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102485235|NCT04374071|Glucocorticoids|glucocorticoids|mesh-ancestor
102485236|NCT04374071|Hormones|hormones|mesh-ancestor
102485237|NCT04374071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101617954|NCT04254042|Zofenopril|zofenopril|mesh-list
102485238|NCT04374071|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102485239|NCT04374071|Protective Agents|protective agents|mesh-ancestor
102485240|NCT04374071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102485241|NCT04374071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102485242|NCT00357981|Contraceptive Agents|contraceptive agents|mesh-list
102485243|NCT00357981|Ortho Evra|ortho evra|mesh-list
102485244|NCT00357981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102485245|NCT00357981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485246|NCT00357981|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102485247|NCT03030703|Inositol|inositol|mesh-list
102485248|NCT03030703|Vitamin B Complex|vitamin b complex|mesh-ancestor
102485249|NCT03030703|Vitamins|vitamins|mesh-ancestor
102485250|NCT03030703|Micronutrients|micronutrients|mesh-ancestor
102485251|NCT03030703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485252|NCT02157623|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102485253|NCT02157623|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102485254|NCT02157623|Dermatologic Agents|dermatologic agents|mesh-ancestor
102485255|NCT03030469|Analgesics, Opioid|analgesics, opioid|mesh-list
102485256|NCT03030469|Analgesics|analgesics|mesh-list
102485257|NCT03030469|Narcotics|narcotics|mesh-ancestor
102485258|NCT03030469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102485259|NCT03030469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485260|NCT03030469|Sensory System Agents|sensory system agents|mesh-ancestor
102485261|NCT03030469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102485262|NCT00952081|Clevidipine|clevidipine|mesh-list
102485263|NCT00952081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102485264|NCT00952081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102485265|NCT00952081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485266|NCT00952081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102485267|NCT00952081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485268|NCT05716347|Vaccines|vaccines|mesh-list
102485269|NCT05716347|Immunologic Factors|immunologic factors|mesh-ancestor
102485270|NCT05716347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485271|NCT02959840|Ondansetron|ondansetron|mesh-list
102485272|NCT02959840|Metoclopramide|metoclopramide|mesh-list
102485273|NCT02959840|Antiemetics|antiemetics|mesh-ancestor
102485274|NCT02959840|Autonomic Agents|autonomic agents|mesh-ancestor
102485275|NCT02959840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102485276|NCT02959840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485277|NCT02959840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102485278|NCT02959840|Antipruritics|antipruritics|mesh-ancestor
102485279|NCT02959840|Dermatologic Agents|dermatologic agents|mesh-ancestor
102485280|NCT02959840|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102485281|NCT02959840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102485282|NCT02959840|Serotonin Agents|serotonin agents|mesh-ancestor
102485283|NCT02959840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102485284|NCT02959840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485285|NCT02959840|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102485286|NCT02959840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102485287|NCT02959840|Dopamine Agents|dopamine agents|mesh-ancestor
102485288|NCT04358341|Doxorubicin|doxorubicin|mesh-list
102485289|NCT04358341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102485290|NCT04358341|Fluorouracil|fluorouracil|mesh-list
102485292|NCT04358341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102485293|NCT04358341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102485294|NCT04358341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102485295|NCT04358341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102485296|NCT04358341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102485297|NCT04358341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485298|NCT04358341|Antimetabolites|antimetabolites|mesh-ancestor
102485299|NCT04358341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102485300|NCT04358341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102485301|NCT04358341|Immunologic Factors|immunologic factors|mesh-ancestor
102485302|NCT04358341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485303|NCT04358341|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102485304|NCT02978547|Metformin|metformin|mesh-list
102485305|NCT02978547|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102485306|NCT02978547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485307|NCT02959996|Bupivacaine|bupivacaine|mesh-list
102485308|NCT02959996|Anesthetics, Local|anesthetics, local|mesh-ancestor
102485309|NCT02959996|Anesthetics|anesthetics|mesh-ancestor
102485310|NCT02959996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102485311|NCT02959996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485312|NCT02959996|Sensory System Agents|sensory system agents|mesh-ancestor
102485313|NCT02959996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102485314|NCT00929981|Methylprednisolone|methylprednisolone|mesh-list
102485315|NCT00929981|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102485316|NCT00929981|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102485317|NCT00929981|Prednisolone|prednisolone|mesh-list
102485318|NCT00929981|Prednisolone acetate|prednisolone acetate|mesh-list
102485319|NCT00929981|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102485320|NCT00929981|Prednisolone phosphate|prednisolone phosphate|mesh-list
102485321|NCT00929981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101618058|NCT04669782|Vitamin K|vitamin k|mesh-list
102485322|NCT00929981|Antiemetics|antiemetics|mesh-ancestor
102485323|NCT00929981|Autonomic Agents|autonomic agents|mesh-ancestor
102485324|NCT00929981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102485325|NCT00929981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485326|NCT00929981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102485327|NCT00929981|Glucocorticoids|glucocorticoids|mesh-ancestor
102485328|NCT00929981|Hormones|hormones|mesh-ancestor
102485329|NCT00929981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102485330|NCT00929981|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102485331|NCT00929981|Protective Agents|protective agents|mesh-ancestor
102485332|NCT00929981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102485333|NCT00929981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102485334|NCT00961441|Levetiracetam|levetiracetam|mesh-list
102485335|NCT00961441|Anticonvulsants|anticonvulsants|mesh-ancestor
102485336|NCT00961441|Nootropic Agents|nootropic agents|mesh-ancestor
102485337|NCT02961946|Nitroglycerin|nitroglycerin|mesh-list
102485338|NCT02961946|Vasodilator Agents|vasodilator agents|mesh-ancestor
102485339|NCT02240459|Fesoterodine|fesoterodine|mesh-list
102485340|NCT02240459|Oxybutynin|oxybutynin|mesh-list
102485341|NCT02240459|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102485342|NCT02240459|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102485343|NCT02240459|Cholinergic Agents|cholinergic agents|mesh-ancestor
102485344|NCT02240459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102485345|NCT02240459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485346|NCT02240459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485347|NCT02240459|Urological Agents|urological agents|mesh-ancestor
102485348|NCT02240459|Parasympatholytics|parasympatholytics|mesh-ancestor
102485349|NCT02240459|Autonomic Agents|autonomic agents|mesh-ancestor
102485350|NCT02240459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102485351|NCT02240537|Sargramostim|sargramostim|mesh-list
102485352|NCT02240537|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
102485353|NCT02240537|Immunologic Factors|immunologic factors|mesh-ancestor
102485354|NCT02240537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485355|NCT02240537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102612325|NCT00002405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618084|NCT04247373|Anesthetics|anesthetics|mesh-ancestor
102485356|NCT00962065|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
102485357|NCT00962065|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102485358|NCT00962065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485359|NCT00962065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102485360|NCT00962065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485361|NCT02240927|Enoxaparin|enoxaparin|mesh-list
102485362|NCT02240927|Warfarin|warfarin|mesh-list
102485363|NCT02240927|Enoxaparin sodium|enoxaparin sodium|mesh-list
102485364|NCT02240927|Anticoagulants|anticoagulants|mesh-ancestor
102485365|NCT02240927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102485366|NCT02240927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102485367|NCT02240927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485368|NCT03038308|Ropinirole|ropinirole|mesh-list
102485369|NCT03038308|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102485370|NCT03038308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102485371|NCT03038308|Dopamine Agonists|dopamine agonists|mesh-ancestor
102485372|NCT03038308|Dopamine Agents|dopamine agents|mesh-ancestor
102485373|NCT03038308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102485374|NCT03038308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485375|NCT03038308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485376|NCT04358497|Ibuprofen|ibuprofen|mesh-list
102485377|NCT04358497|Polidocanol|polidocanol|mesh-list
102485378|NCT04358497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102485379|NCT04358497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102485380|NCT04358497|Analgesics|analgesics|mesh-ancestor
102485381|NCT04358497|Sensory System Agents|sensory system agents|mesh-ancestor
102485382|NCT04358497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102485383|NCT04358497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485384|NCT04358497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102485385|NCT04358497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102485386|NCT04358497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102485387|NCT04358497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102485388|NCT04358497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485389|NCT04358497|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102485390|NCT04358497|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102485391|NCT02851108|Primaquine|primaquine|mesh-list
102485392|NCT02851108|Phenothiazine|phenothiazine|mesh-list
102485393|NCT02851108|Methylene Blue|methylene blue|mesh-list
102485394|NCT02851108|Antimalarials|antimalarials|mesh-ancestor
102485395|NCT02851108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102485396|NCT02851108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102485397|NCT02851108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102485398|NCT02851108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102485399|NCT02851108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485400|NCT00930293|Dexetimide|dexetimide|mesh-list
102485401|NCT00930293|Citalopram|citalopram|mesh-list
102485402|NCT00930293|Escitalopram|escitalopram|mesh-list
102485403|NCT00930293|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102485404|NCT00930293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102485405|NCT00930293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102485406|NCT00930293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485407|NCT00930293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102485408|NCT00930293|Serotonin Agents|serotonin agents|mesh-ancestor
102485409|NCT00930293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618140|NCT02829879|Fluorophosphate|fluorophosphate|mesh-list
102485410|NCT00930293|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102485411|NCT00930293|Antidepressive Agents|antidepressive agents|mesh-ancestor
102485412|NCT00930293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102485413|NCT00930293|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102485414|NCT00930293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102485415|NCT00930293|Parasympatholytics|parasympatholytics|mesh-ancestor
102485416|NCT00930293|Autonomic Agents|autonomic agents|mesh-ancestor
102485417|NCT00930293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102485418|NCT00930293|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102485419|NCT00930293|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102485420|NCT00930293|Cholinergic Agents|cholinergic agents|mesh-ancestor
102485421|NCT02855086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102485422|NCT02855086|Cetuximab|cetuximab|mesh-list
102485423|NCT02855086|Antibodies|antibodies|mesh-list
102485424|NCT02855086|Immunoglobulins|immunoglobulins|mesh-list
102485425|NCT02855086|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102485426|NCT02855086|Immunologic Factors|immunologic factors|mesh-ancestor
102485427|NCT02855086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485428|NCT02855086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102297061|NCT05405725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102485429|NCT05368857|Afamelanotide|afamelanotide|mesh-list
102485430|NCT05368857|Dermatologic Agents|dermatologic agents|mesh-ancestor
102485431|NCT04347005|Allopurinol|allopurinol|mesh-list
102485433|NCT04347005|Antimetabolites|antimetabolites|mesh-ancestor
102485434|NCT04347005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485435|NCT04347005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102485436|NCT04347005|Gout Suppressants|gout suppressants|mesh-ancestor
102485437|NCT04347005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102485438|NCT04347005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102485439|NCT04347005|Antioxidants|antioxidants|mesh-ancestor
102485440|NCT04347005|Protective Agents|protective agents|mesh-ancestor
102485441|NCT04347005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485442|NCT00358293|Tizanidine|tizanidine|mesh-list
102485443|NCT00358293|Analgesics|analgesics|mesh-ancestor
102485444|NCT00358293|Sensory System Agents|sensory system agents|mesh-ancestor
102485445|NCT00358293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102485446|NCT00358293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485447|NCT00358293|Anticonvulsants|anticonvulsants|mesh-ancestor
102485448|NCT00358293|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102485449|NCT00358293|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102485450|NCT00358293|Parasympatholytics|parasympatholytics|mesh-ancestor
102485451|NCT00358293|Autonomic Agents|autonomic agents|mesh-ancestor
102485452|NCT00358293|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102485453|NCT00358293|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102485454|NCT00358293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102485455|NCT00358293|Adrenergic Agents|adrenergic agents|mesh-ancestor
101589398|NCT00659659|Benralizumab|benralizumab|mesh-list
102485456|NCT00358293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102485457|NCT00358293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485458|NCT02241083|Dopamine|dopamine|mesh-list
102485459|NCT02241083|Norepinephrine|norepinephrine|mesh-list
102485460|NCT02241083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102485461|NCT02241083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102485462|NCT02241083|Adrenergic Agents|adrenergic agents|mesh-ancestor
102485463|NCT02241083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102485464|NCT02241083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485465|NCT02241083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485466|NCT02241083|Sympathomimetics|sympathomimetics|mesh-ancestor
102485467|NCT02241083|Autonomic Agents|autonomic agents|mesh-ancestor
102485468|NCT02241083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102485469|NCT02241083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102485470|NCT02241083|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102485471|NCT02241083|Dopamine Agents|dopamine agents|mesh-ancestor
102485472|NCT02241083|Protective Agents|protective agents|mesh-ancestor
102485473|NCT04372589|Heparin|heparin|mesh-list
102485474|NCT04372589|Anticoagulants|anticoagulants|mesh-ancestor
102485475|NCT04372589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102485476|NCT04372589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102485477|NCT04372589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485478|NCT04364399|Vaccines|vaccines|mesh-list
102485479|NCT04364399|Immunologic Factors|immunologic factors|mesh-ancestor
102485480|NCT04364399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485481|NCT02982551|Insulin|insulin|mesh-list
102485482|NCT02982551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102485483|NCT02982551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485484|NCT02965924|Phenylephrine|phenylephrine|mesh-list
102485485|NCT02965924|Oxymetazoline|oxymetazoline|mesh-list
102485486|NCT02965924|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102485487|NCT02965924|Mydriatics|mydriatics|mesh-ancestor
102485488|NCT02965924|Autonomic Agents|autonomic agents|mesh-ancestor
102485489|NCT02965924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102485490|NCT02965924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485491|NCT02965924|Sympathomimetics|sympathomimetics|mesh-ancestor
102485492|NCT02965924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102485493|NCT02965924|Nasal Decongestants|nasal decongestants|mesh-ancestor
102485494|NCT02965924|Respiratory System Agents|respiratory system agents|mesh-ancestor
102485495|NCT02965924|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102485496|NCT02965924|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102485497|NCT02965924|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102485498|NCT02965924|Adrenergic Agents|adrenergic agents|mesh-ancestor
102485499|NCT02965924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102485500|NCT02965924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485501|NCT02965924|Protective Agents|protective agents|mesh-ancestor
102297140|NCT02954081|Apremilast|apremilast|mesh-list
102485502|NCT04364321|Diazepam|diazepam|mesh-list
102485503|NCT04364321|Clonazepam|clonazepam|mesh-list
102485504|NCT04364321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102485505|NCT04364321|Anticonvulsants|anticonvulsants|mesh-ancestor
102485506|NCT04364321|Antiemetics|antiemetics|mesh-ancestor
102485507|NCT04364321|Autonomic Agents|autonomic agents|mesh-ancestor
102485508|NCT04364321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101618235|NCT05253066|Docetaxel|docetaxel|mesh-list
102485509|NCT04364321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485510|NCT04364321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102485511|NCT04364321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102485512|NCT04364321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102485513|NCT04364321|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102485514|NCT04364321|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102485515|NCT04364321|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102485516|NCT04364321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102485517|NCT04364321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102485518|NCT04364321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102485519|NCT04364321|Anesthetics, General|anesthetics, general|mesh-ancestor
102485520|NCT04364321|Anesthetics|anesthetics|mesh-ancestor
102485521|NCT04364321|GABA Modulators|gaba modulators|mesh-ancestor
102485522|NCT04364321|GABA Agents|gaba agents|mesh-ancestor
102485523|NCT04364321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102485524|NCT04364321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485525|NCT03039088|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
101589836|NCT02828176|Anesthetics|anesthetics|mesh-list
102485526|NCT03039088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102485527|NCT03039088|Adrenergic Agents|adrenergic agents|mesh-ancestor
102485528|NCT03039088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102485529|NCT03039088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485530|NCT03039088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485531|NCT05528913|Benralizumab|benralizumab|mesh-list
102485532|NCT05528913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102485533|NCT05528913|Respiratory System Agents|respiratory system agents|mesh-ancestor
101618255|NCT04303598|Tenofovir|tenofovir|mesh-list
102485534|NCT04364009|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102485535|NCT04364009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102485536|NCT04371965|Povidone-Iodine|povidone-iodine|mesh-list
102485537|NCT04371965|Povidone|povidone|mesh-list
102485538|NCT04371965|Plasma Substitutes|plasma substitutes|mesh-ancestor
102485539|NCT04371965|Blood Substitutes|blood substitutes|mesh-ancestor
102485540|NCT04371965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102485541|NCT04371965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102485542|NCT02959125|Micronutrients|micronutrients|mesh-list
102485543|NCT02959125|Trace Elements|trace elements|mesh-list
102485544|NCT02959125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485545|NCT02972554|Propranolol|propranolol|mesh-list
102485546|NCT02972554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102485547|NCT02972554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102485548|NCT02972554|Adrenergic Agents|adrenergic agents|mesh-ancestor
102485549|NCT02972554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101618269|NCT04303598|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102485550|NCT02972554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485551|NCT02972554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485552|NCT02972554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102485553|NCT02972554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102485554|NCT02972554|Vasodilator Agents|vasodilator agents|mesh-ancestor
102485555|NCT02241941|Daptomycin|daptomycin|mesh-list
102485556|NCT02241941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102485557|NCT02241941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102485558|NCT00359151|Celecoxib|celecoxib|mesh-list
101618279|NCT00827242|Tadalafil|tadalafil|mesh-list
102485559|NCT00359151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102485560|NCT00359151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102485561|NCT00359151|Analgesics|analgesics|mesh-ancestor
102485562|NCT00359151|Sensory System Agents|sensory system agents|mesh-ancestor
102485563|NCT00359151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102485564|NCT00359151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485565|NCT00359151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102485566|NCT00359151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102485567|NCT00359151|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102485568|NCT00359151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102485569|NCT00359151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102485570|NCT00359151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485571|NCT02242097|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102485572|NCT02242097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102485573|NCT02242097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101618300|NCT00785785|Imatinib Mesylate|imatinib mesylate|mesh-list
102485574|NCT02242097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485575|NCT00374686|Valganciclovir|valganciclovir|mesh-list
102485576|NCT00374686|Antiviral Agents|antiviral agents|mesh-ancestor
102485577|NCT00374686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102485578|NCT04371575|Carbamazepine|carbamazepine|mesh-list
102485579|NCT04371575|Oxcarbazepine|oxcarbazepine|mesh-list
102485580|NCT04371575|Anticonvulsants|anticonvulsants|mesh-ancestor
102485581|NCT04371575|Antimanic Agents|antimanic agents|mesh-ancestor
101618305|NCT00707278|Capecitabine|capecitabine|mesh-list
102485582|NCT04371575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102485583|NCT04371575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102485584|NCT04371575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485585|NCT04371575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102485586|NCT04371575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102485587|NCT04371575|Analgesics|analgesics|mesh-ancestor
102485588|NCT04371575|Sensory System Agents|sensory system agents|mesh-ancestor
102485589|NCT04371575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102485590|NCT04371575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102485591|NCT04371575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102485592|NCT04371575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485593|NCT04371575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102485594|NCT04371575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102485595|NCT04371575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102485596|NCT00359229|Zolpidem|zolpidem|mesh-list
102485597|NCT00359229|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102485598|NCT00359229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102485599|NCT00359229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102485600|NCT00359229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485601|NCT00359229|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102485602|NCT00359229|GABA Agonists|gaba agonists|mesh-ancestor
102485603|NCT00359229|GABA Agents|gaba agents|mesh-ancestor
102485604|NCT00359229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102485605|NCT00359229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485606|NCT04371341|Bupivacaine|bupivacaine|mesh-list
102485607|NCT04371341|Anesthetics, Local|anesthetics, local|mesh-ancestor
102485608|NCT04371341|Anesthetics|anesthetics|mesh-ancestor
101618329|NCT00704314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102485609|NCT04371341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102485610|NCT04371341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485611|NCT04371341|Sensory System Agents|sensory system agents|mesh-ancestor
102485612|NCT04371341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102485613|NCT00374764|Risperidone|risperidone|mesh-list
102485614|NCT00374764|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102485615|NCT00374764|Serotonin Agents|serotonin agents|mesh-ancestor
102485616|NCT00374764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102485617|NCT00374764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485618|NCT00374764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485619|NCT00374764|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102485620|NCT00374764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102485621|NCT00374764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102485622|NCT00374764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102485623|NCT00374764|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102485624|NCT00374764|Dopamine Agents|dopamine agents|mesh-ancestor
102485625|NCT04371185|Ustekinumab|ustekinumab|mesh-list
102485626|NCT04371185|Dermatologic Agents|dermatologic agents|mesh-ancestor
102485627|NCT01005355|Ramucirumab|ramucirumab|mesh-list
102485628|NCT01005355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102485629|NCT02242253|Tiotropium Bromide|tiotropium bromide|mesh-list
102485630|NCT02242253|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102485631|NCT02242253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102485632|NCT02242253|Autonomic Agents|autonomic agents|mesh-ancestor
102485633|NCT02242253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102485634|NCT02242253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485635|NCT02242253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102485636|NCT02242253|Respiratory System Agents|respiratory system agents|mesh-ancestor
102485637|NCT02242253|Parasympatholytics|parasympatholytics|mesh-ancestor
102485638|NCT02242253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102485639|NCT02242253|Cholinergic Agents|cholinergic agents|mesh-ancestor
102485640|NCT02242253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102485641|NCT02242253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485642|NCT02242253|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102485643|NCT02242253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102485644|NCT02242253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102485645|NCT02242253|Adrenergic Agents|adrenergic agents|mesh-ancestor
102485646|NCT05285943|Betamethasone|betamethasone|mesh-list
102485647|NCT05285943|Betamethasone Valerate|betamethasone valerate|mesh-list
102485648|NCT05285943|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102485649|NCT05285943|Betamethasone benzoate|betamethasone benzoate|mesh-list
102485650|NCT05285943|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102485651|NCT05285943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102485652|NCT05285943|Glucocorticoids|glucocorticoids|mesh-ancestor
102485653|NCT05285943|Hormones|hormones|mesh-ancestor
102485654|NCT05285943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102485655|NCT05285943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485656|NCT05285943|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102485657|NCT05285943|Respiratory System Agents|respiratory system agents|mesh-ancestor
102485658|NCT03030001|Antibodies|antibodies|mesh-list
102485659|NCT03030001|Immunologic Factors|immunologic factors|mesh-ancestor
102485660|NCT03030001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485661|NCT02242331|Telmisartan|telmisartan|mesh-list
102485662|NCT02242331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102485663|NCT02242331|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102485664|NCT02242331|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102485665|NCT02242331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485666|NCT05495061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102485667|NCT05495061|Latanoprost|latanoprost|mesh-list
102485668|NCT05495061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102485669|NCT03030157|Pirarubicin|pirarubicin|mesh-list
102485670|NCT03030157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102485671|NCT00359385|Alendronate|alendronate|mesh-list
102485672|NCT00359385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102485673|NCT00359385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485674|NCT03029455|Ivacaftor|ivacaftor|mesh-list
102485675|NCT03029455|VX-659|vx-659|mesh-list
102485676|NCT03029455|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102485677|NCT03029455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102485678|NCT03029455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485679|NCT02245789|Remifentanil|remifentanil|mesh-list
102485680|NCT02245789|Propofol|propofol|mesh-list
102485681|NCT02245789|Anesthetics|anesthetics|mesh-ancestor
102485682|NCT02245789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102485683|NCT02245789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485684|NCT02245789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102485685|NCT02245789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102485686|NCT02245789|Anesthetics, General|anesthetics, general|mesh-ancestor
102485687|NCT02245789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102485688|NCT02245789|Narcotics|narcotics|mesh-ancestor
102485689|NCT02245789|Analgesics|analgesics|mesh-ancestor
102485690|NCT02245789|Sensory System Agents|sensory system agents|mesh-ancestor
102485691|NCT02245789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102485692|NCT04370015|Hydroxychloroquine|hydroxychloroquine|mesh-list
102485693|NCT04370015|Antimalarials|antimalarials|mesh-ancestor
102485694|NCT04370015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102485695|NCT04370015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102485696|NCT04370015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102485697|NCT04370015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102485698|NCT04370015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485699|NCT04370015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102485700|NCT01006369|Hydroxychloroquine|hydroxychloroquine|mesh-list
102485701|NCT01006369|Antimalarials|antimalarials|mesh-ancestor
102485702|NCT01006369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102485703|NCT01006369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102485704|NCT01006369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102485705|NCT01006369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102485706|NCT01006369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485707|NCT01006369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102485708|NCT02242877|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102485709|NCT02242877|Telmisartan|telmisartan|mesh-list
102485710|NCT02242877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102485711|NCT02242877|Diuretics|diuretics|mesh-ancestor
102485712|NCT02242877|Natriuretic Agents|natriuretic agents|mesh-ancestor
102485713|NCT02242877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485714|NCT02242877|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102485715|NCT02242877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102485716|NCT02242877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485717|NCT02242877|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102485718|NCT02242877|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102485719|NCT01007071|Hormones|hormones|mesh-list
102485720|NCT01007071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102485721|NCT01007071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485722|NCT05475639|Diclofenac|diclofenac|mesh-list
102485723|NCT05475639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102485724|NCT05475639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102485725|NCT05475639|Analgesics|analgesics|mesh-ancestor
102485726|NCT05475639|Sensory System Agents|sensory system agents|mesh-ancestor
102485727|NCT05475639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102485728|NCT05475639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485729|NCT05475639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102485730|NCT05475639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102485731|NCT05475639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102485732|NCT05475639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102485733|NCT05475639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485734|NCT02242955|Diazepam|diazepam|mesh-list
102485735|NCT02242955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102485736|NCT02242955|Anticonvulsants|anticonvulsants|mesh-ancestor
102485737|NCT02242955|Antiemetics|antiemetics|mesh-ancestor
102485738|NCT02242955|Autonomic Agents|autonomic agents|mesh-ancestor
102485739|NCT02242955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102485740|NCT02242955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485741|NCT02242955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102485742|NCT02242955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102485743|NCT02242955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102485744|NCT02242955|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102485745|NCT02242955|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102485746|NCT02242955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102485747|NCT02242955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102485748|NCT02242955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102485749|NCT02242955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102485750|NCT02242955|Anesthetics, General|anesthetics, general|mesh-ancestor
102485751|NCT02242955|Anesthetics|anesthetics|mesh-ancestor
102485752|NCT02242955|GABA Modulators|gaba modulators|mesh-ancestor
102485753|NCT02242955|GABA Agents|gaba agents|mesh-ancestor
102485754|NCT02242955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102485755|NCT02242955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485756|NCT02984644|Dapagliflozin|dapagliflozin|mesh-list
102485757|NCT02984644|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102485758|NCT02984644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485759|NCT02984644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102485760|NCT02984644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485761|NCT01008319|Citric Acid|citric acid|mesh-list
102485762|NCT01008319|Sodium Citrate|sodium citrate|mesh-list
102485763|NCT01008319|Clomiphene|clomiphene|mesh-list
102485764|NCT01008319|Enclomiphene|enclomiphene|mesh-list
102485765|NCT01008319|Zuclomiphene|zuclomiphene|mesh-list
102485766|NCT01008319|Anticoagulants|anticoagulants|mesh-ancestor
102485767|NCT01008319|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102485768|NCT01008319|Chelating Agents|chelating agents|mesh-ancestor
102485769|NCT01008319|Sequestering Agents|sequestering agents|mesh-ancestor
102485770|NCT01008319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485771|NCT01008319|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102485772|NCT01008319|Hormone Antagonists|hormone antagonists|mesh-ancestor
102485773|NCT01008319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102485774|NCT01008319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485775|NCT01008319|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102485776|NCT01008319|Fertility Agents|fertility agents|mesh-ancestor
101618485|NCT02829333|Anesthetics|anesthetics|mesh-list
102485777|NCT01008319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102485778|NCT01008319|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102485779|NCT01008319|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102485780|NCT04369391|Moxifloxacin|moxifloxacin|mesh-list
102485781|NCT04369391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102485782|NCT04369391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102485783|NCT04369391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102485784|NCT04369391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102485785|NCT04369391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102485786|NCT04369391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485787|NCT04369391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102485788|NCT00358683|Certolizumab Pegol|certolizumab pegol|mesh-list
102485789|NCT00358683|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102485790|NCT00358683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102485791|NCT00358683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102485792|NCT00358683|Immunologic Factors|immunologic factors|mesh-ancestor
101618495|NCT05251662|Growth Inhibitors|growth inhibitors|mesh-ancestor
102485793|NCT00358683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485794|NCT00358683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102485795|NCT00967369|Carboplatin|carboplatin|mesh-list
102485796|NCT00967369|Etoposide|etoposide|mesh-list
102485797|NCT00967369|Etoposide phosphate|etoposide phosphate|mesh-list
102485798|NCT00967369|Bortezomib|bortezomib|mesh-list
102485799|NCT00967369|Ifosfamide|ifosfamide|mesh-list
102485800|NCT00967369|Isophosphamide mustard|isophosphamide mustard|mesh-list
102485801|NCT00967369|Podophyllotoxin|podophyllotoxin|mesh-list
102297438|NCT02359851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102485802|NCT00967369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102485803|NCT00967369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102485804|NCT00967369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102485805|NCT00967369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102485806|NCT00967369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102485807|NCT00967369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485808|NCT00967369|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102485809|NCT00967369|Alkylating Agents|alkylating agents|mesh-ancestor
102485810|NCT00967369|Keratolytic Agents|keratolytic agents|mesh-ancestor
102485811|NCT00967369|Dermatologic Agents|dermatologic agents|mesh-ancestor
102485812|NCT00967369|Tubulin Modulators|tubulin modulators|mesh-ancestor
102485813|NCT00967369|Antimitotic Agents|antimitotic agents|mesh-ancestor
102485814|NCT00967369|Mitosis Modulators|mitosis modulators|mesh-ancestor
102485815|NCT02245295|Anesthetics|anesthetics|mesh-list
102485816|NCT02245295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102485817|NCT02245295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485818|NCT02880514|Mometasone Furoate|mometasone furoate|mesh-list
102485819|NCT02880514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102485820|NCT02880514|Dermatologic Agents|dermatologic agents|mesh-ancestor
101618531|NCT04244097|Autonomic Agents|autonomic agents|mesh-ancestor
102485821|NCT02880514|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102485822|NCT00968071|Decitabine|decitabine|mesh-list
102485823|NCT00968071|Gemtuzumab|gemtuzumab|mesh-list
102485824|NCT00968071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102485825|NCT00968071|Antimetabolites|antimetabolites|mesh-ancestor
102485826|NCT00968071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485827|NCT00968071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102485828|NCT00968071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102485829|NCT00968071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102485830|NCT00968071|Immunotoxins|immunotoxins|mesh-ancestor
102485831|NCT00968071|Immunoconjugates|immunoconjugates|mesh-ancestor
102485832|NCT00968071|Immunologic Factors|immunologic factors|mesh-ancestor
101618544|NCT00915733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102485833|NCT00968071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485834|NCT00971737|Cyclophosphamide|cyclophosphamide|mesh-list
102485835|NCT00971737|Trastuzumab|trastuzumab|mesh-list
102485836|NCT00971737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102485837|NCT00971737|Immunologic Factors|immunologic factors|mesh-ancestor
102485838|NCT00971737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485839|NCT00971737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101592114|NCT02625103|Clozapine|clozapine|mesh-list
102485840|NCT00971737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102485841|NCT00971737|Alkylating Agents|alkylating agents|mesh-ancestor
102485842|NCT00971737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485843|NCT00971737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102485844|NCT00971737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101618554|NCT00915733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102485845|NCT00971737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102485846|NCT04368377|Aspirin|aspirin|mesh-list
102485848|NCT04368377|Tirofiban|tirofiban|mesh-list
102485849|NCT04368377|Fondaparinux|fondaparinux|mesh-list
102485850|NCT04368377|Clopidogrel|clopidogrel|mesh-list
102485851|NCT04368377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102485852|NCT04368377|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102485853|NCT04368377|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102485854|NCT04368377|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102485855|NCT04368377|Purinergic Agents|purinergic agents|mesh-ancestor
102485856|NCT04368377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102485857|NCT04368377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485858|NCT04368377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485859|NCT04368377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102485860|NCT04368377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102485861|NCT04368377|Analgesics|analgesics|mesh-ancestor
102485862|NCT04368377|Sensory System Agents|sensory system agents|mesh-ancestor
102485863|NCT04368377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102485864|NCT04368377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102485865|NCT04368377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101618572|NCT00913770|Buprenorphine|buprenorphine|mesh-list
102485866|NCT04368377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102485867|NCT04368377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102485868|NCT04368377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102485869|NCT04368377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102485870|NCT04368377|Antipyretics|antipyretics|mesh-ancestor
102485871|NCT04368377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102485872|NCT04368377|Antithrombins|antithrombins|mesh-ancestor
102485873|NCT04368377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102485874|NCT04368377|Protease Inhibitors|protease inhibitors|mesh-ancestor
102485875|NCT04368377|Anticoagulants|anticoagulants|mesh-ancestor
102485876|NCT04361513|Triamcinolone|triamcinolone|mesh-list
102485877|NCT04361513|Bupivacaine|bupivacaine|mesh-list
101618581|NCT00912912|Sunitinib|sunitinib|mesh-list
102485878|NCT04361513|Anesthetics, Local|anesthetics, local|mesh-ancestor
102485879|NCT04361513|Anesthetics|anesthetics|mesh-ancestor
102485880|NCT04361513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102485881|NCT04361513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485882|NCT04361513|Sensory System Agents|sensory system agents|mesh-ancestor
102485883|NCT04361513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102485884|NCT04361513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102485885|NCT04361513|Glucocorticoids|glucocorticoids|mesh-ancestor
102485886|NCT04361513|Hormones|hormones|mesh-ancestor
102485887|NCT04361513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102485888|NCT05595993|Cilostazol|cilostazol|mesh-list
102485889|NCT05595993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102485890|NCT05595993|Autonomic Agents|autonomic agents|mesh-ancestor
102485891|NCT05595993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102485892|NCT05595993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485893|NCT05595993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102485894|NCT05595993|Respiratory System Agents|respiratory system agents|mesh-ancestor
102485895|NCT05595993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102485896|NCT05595993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102485897|NCT05595993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485898|NCT05595993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102485899|NCT05595993|Vasodilator Agents|vasodilator agents|mesh-ancestor
102485900|NCT05595993|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102485901|NCT05595993|Protective Agents|protective agents|mesh-ancestor
102485902|NCT05595993|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102485903|NCT05595993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102485904|NCT05595993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102485905|NCT05593341|Analgesics, Opioid|analgesics, opioid|mesh-list
102485906|NCT05593341|Narcotics|narcotics|mesh-ancestor
102485907|NCT05593341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102485908|NCT05593341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485909|NCT05593341|Analgesics|analgesics|mesh-ancestor
102485910|NCT05593341|Sensory System Agents|sensory system agents|mesh-ancestor
102485911|NCT05593341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102485912|NCT00972205|Paclitaxel|paclitaxel|mesh-list
102485913|NCT00972205|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
102485914|NCT00972205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102485915|NCT00972205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102485916|NCT00972205|Tubulin Modulators|tubulin modulators|mesh-ancestor
102485917|NCT00972205|Antimitotic Agents|antimitotic agents|mesh-ancestor
102485918|NCT00972205|Mitosis Modulators|mitosis modulators|mesh-ancestor
102485919|NCT00972205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485920|NCT00972205|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102485921|NCT00928421|Polidocanol|polidocanol|mesh-list
102485922|NCT00928421|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102485923|NCT00928421|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102485924|NCT03051256|Methadone|methadone|mesh-list
102485925|NCT03051256|D-methadone|d-methadone|mesh-list
102485926|NCT03051256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102485927|NCT03051256|Narcotics|narcotics|mesh-ancestor
102485928|NCT03051256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102485929|NCT03051256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485930|NCT03051256|Analgesics|analgesics|mesh-ancestor
102485931|NCT03051256|Sensory System Agents|sensory system agents|mesh-ancestor
102485932|NCT03051256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102485933|NCT03051256|Antitussive Agents|antitussive agents|mesh-ancestor
102485934|NCT03051256|Respiratory System Agents|respiratory system agents|mesh-ancestor
102485935|NCT03051256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102485936|NCT00932321|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102485937|NCT00932321|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102485938|NCT00932321|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102485939|NCT00932321|Norethindrone|norethindrone|mesh-list
102485940|NCT00932321|Norethindrone Acetate|norethindrone acetate|mesh-list
102485941|NCT00932321|Estradiol|estradiol|mesh-list
102485942|NCT00932321|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102485943|NCT00932321|Estrogens|estrogens|mesh-ancestor
102485944|NCT00932321|Hormones|hormones|mesh-ancestor
102485945|NCT00932321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102485946|NCT00932321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485947|NCT00932321|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102485948|NCT00932321|Contraceptive Agents|contraceptive agents|mesh-ancestor
102485949|NCT00932321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102485950|NCT00932321|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102485951|NCT00932321|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102485952|NCT00932321|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102485953|NCT00932321|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102297581|NCT02531113|Immunologic Factors|immunologic factors|mesh-ancestor
102485954|NCT01011829|Varenicline|varenicline|mesh-list
102485955|NCT01011829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102485956|NCT01011829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102485957|NCT01011829|Cholinergic Agents|cholinergic agents|mesh-ancestor
102485958|NCT01011829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102485959|NCT01011829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485960|NCT01011829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485961|NCT00932477|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102485962|NCT00932477|Lubricant Eye Drops|lubricant eye drops|mesh-list
102485964|NCT00932477|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102485965|NCT00932477|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102485966|NCT00932477|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102485967|NCT00932477|Protective Agents|protective agents|mesh-ancestor
102485968|NCT00932477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485969|NCT00932477|Laxatives|laxatives|mesh-ancestor
102485970|NCT00932477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102485971|NCT00972439|Contraceptive Agents|contraceptive agents|mesh-list
102485972|NCT00972439|Norinyl|norinyl|mesh-list
102485973|NCT00972439|Contraceptives, Oral|contraceptives, oral|mesh-list
102485974|NCT00972439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101618672|NCT00631722|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102485975|NCT00972439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485976|NCT00972439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102485977|NCT00972439|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102485978|NCT00972439|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102485979|NCT00972439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102485980|NCT00358371|Floxacillin|floxacillin|mesh-list
102485981|NCT00358371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102485982|NCT00358371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102485983|NCT02989714|Nivolumab|nivolumab|mesh-list
102485984|NCT02989714|Interleukin-2|interleukin-2|mesh-list
102485985|NCT02989714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102485986|NCT02989714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102485987|NCT02989714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101618680|NCT00845728|Parasympatholytics|parasympatholytics|mesh-ancestor
102485988|NCT02989714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102485989|NCT02989714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102485990|NCT02989714|Analgesics|analgesics|mesh-ancestor
102485991|NCT02989714|Sensory System Agents|sensory system agents|mesh-ancestor
102485992|NCT02989714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102485993|NCT02989714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102485994|NCT04361279|Rituximab|rituximab|mesh-list
102485995|NCT04361279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102485996|NCT04361279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102485997|NCT04361279|Immunologic Factors|immunologic factors|mesh-ancestor
102485998|NCT04361279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618695|NCT00779467|Narcotics|narcotics|mesh-ancestor
102485999|NCT04361279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102486000|NCT05585229|Psilocybin|psilocybin|mesh-list
102486001|NCT05585229|Hallucinogens|hallucinogens|mesh-ancestor
102486002|NCT05585229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486003|NCT05585229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102486004|NCT05582499|Paclitaxel|paclitaxel|mesh-list
102486005|NCT05582499|Cyclophosphamide|cyclophosphamide|mesh-list
102486006|NCT05582499|Carboplatin|carboplatin|mesh-list
102486007|NCT05582499|Trastuzumab|trastuzumab|mesh-list
102486008|NCT05582499|Letrozole|letrozole|mesh-list
102486009|NCT05582499|Epirubicin|epirubicin|mesh-list
102486010|NCT05582499|Pertuzumab|pertuzumab|mesh-list
102486011|NCT05582499|Goserelin|goserelin|mesh-list
102486012|NCT05582499|Fluzoparib|fluzoparib|mesh-list
102486013|NCT05582499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102486014|NCT05582499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102486015|NCT05582499|Tubulin Modulators|tubulin modulators|mesh-ancestor
102486016|NCT05582499|Antimitotic Agents|antimitotic agents|mesh-ancestor
102486017|NCT05582499|Mitosis Modulators|mitosis modulators|mesh-ancestor
102486018|NCT05582499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486019|NCT05582499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102486020|NCT05582499|Immunologic Factors|immunologic factors|mesh-ancestor
102486021|NCT05582499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486022|NCT05582499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102486023|NCT05582499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102486024|NCT05582499|Alkylating Agents|alkylating agents|mesh-ancestor
102486025|NCT05582499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102486026|NCT05582499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102486027|NCT05582499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101618726|NCT04173312|Sensory System Agents|sensory system agents|mesh-ancestor
102486028|NCT05582499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102486029|NCT05582499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102486030|NCT05582499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102486031|NCT05582499|Hormone Antagonists|hormone antagonists|mesh-ancestor
102486032|NCT05582499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102486033|NCT05582499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102486034|NCT05582499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102486035|NCT05582499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102486036|NCT05582499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102486037|NCT05582499|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102486038|NCT02881996|Acetaminophen|acetaminophen|mesh-list
102486039|NCT02881996|Ketorolac|ketorolac|mesh-list
102486040|NCT02881996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102486041|NCT02881996|Analgesics|analgesics|mesh-ancestor
102486042|NCT02881996|Sensory System Agents|sensory system agents|mesh-ancestor
102486043|NCT02881996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102486044|NCT02881996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486045|NCT02881996|Antipyretics|antipyretics|mesh-ancestor
102486046|NCT02881996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102486047|NCT02881996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102486048|NCT02881996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102486049|NCT02881996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102486050|NCT02881996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102486051|NCT02881996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486052|NCT04367831|Heparin|heparin|mesh-list
102486053|NCT04367831|Calcium heparin|calcium heparin|mesh-list
102486054|NCT04367831|Enoxaparin|enoxaparin|mesh-list
102486055|NCT04367831|Enoxaparin sodium|enoxaparin sodium|mesh-list
102486056|NCT04367831|Anticoagulants|anticoagulants|mesh-ancestor
102486057|NCT04367831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102486058|NCT04367831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102486059|NCT04367831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486060|NCT03051646|Aspirin|aspirin|mesh-list
102486061|NCT03051646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102486062|NCT03051646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102486063|NCT03051646|Analgesics|analgesics|mesh-ancestor
102486064|NCT03051646|Sensory System Agents|sensory system agents|mesh-ancestor
102486065|NCT03051646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102486066|NCT03051646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486067|NCT03051646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102486068|NCT03051646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102486069|NCT03051646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102486070|NCT03051646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102486071|NCT03051646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618765|NCT00632268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102486072|NCT03051646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102486073|NCT03051646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102486074|NCT03051646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102486075|NCT03051646|Antipyretics|antipyretics|mesh-ancestor
102486076|NCT04344405|Vitamin D|vitamin d|mesh-list
102486077|NCT04344405|Vitamins|vitamins|mesh-ancestor
102486078|NCT04344405|Micronutrients|micronutrients|mesh-ancestor
102486079|NCT04344405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486080|NCT04344405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102486081|NCT05187429|Nivolumab|nivolumab|mesh-list
102486082|NCT05187429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102486083|NCT05187429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102486084|NCT05187429|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102486085|NCT05187429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486086|NCT02993302|Alfacalcidol|alfacalcidol|mesh-list
102486087|NCT02993302|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
102486088|NCT02993302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102486089|NCT02993302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486090|NCT02993302|Vitamins|vitamins|mesh-ancestor
102486091|NCT02993302|Micronutrients|micronutrients|mesh-ancestor
102486092|NCT00359853|Norfloxacin|norfloxacin|mesh-list
102486093|NCT00359853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102486094|NCT00359853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102486095|NCT00359853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102486096|NCT00359853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102486097|NCT00359853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102486098|NCT00359853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486099|NCT00359853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102486100|NCT00359853|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102486101|NCT00359853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102486102|NCT05168709|Vaccines|vaccines|mesh-list
102486103|NCT05168709|Immunologic Factors|immunologic factors|mesh-ancestor
102486104|NCT05168709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486105|NCT04367051|Spironolactone|spironolactone|mesh-list
102486106|NCT04367051|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102297728|NCT02522377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102486107|NCT04367051|Hormone Antagonists|hormone antagonists|mesh-ancestor
102486108|NCT04367051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102486109|NCT04367051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486110|NCT04367051|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102486111|NCT04367051|Diuretics|diuretics|mesh-ancestor
102486112|NCT04367051|Natriuretic Agents|natriuretic agents|mesh-ancestor
102486113|NCT03111316|Dinoprostone|dinoprostone|mesh-list
102486114|NCT03111316|Oxytocics|oxytocics|mesh-ancestor
102486115|NCT03111316|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102486116|NCT03111316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486117|NCT03054844|Lidocaine|lidocaine|mesh-list
102486118|NCT03054844|Midazolam|midazolam|mesh-list
102486119|NCT03054844|Anesthetics, Local|anesthetics, local|mesh-ancestor
102486120|NCT03054844|Anesthetics|anesthetics|mesh-ancestor
102486121|NCT03054844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102486122|NCT03054844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486123|NCT03054844|Sensory System Agents|sensory system agents|mesh-ancestor
102486124|NCT03054844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102486125|NCT03054844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102486126|NCT03054844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102486127|NCT03054844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102486128|NCT03054844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102486129|NCT03054844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486130|NCT03054844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102486131|NCT03054844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102486132|NCT03054844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102486133|NCT03054844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102486134|NCT03054844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102486135|NCT03054844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102486136|NCT03054844|Anesthetics, General|anesthetics, general|mesh-ancestor
102486137|NCT03054844|GABA Modulators|gaba modulators|mesh-ancestor
102486138|NCT03054844|GABA Agents|gaba agents|mesh-ancestor
102486139|NCT03054844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102486140|NCT05405595|Pembrolizumab|pembrolizumab|mesh-list
102486141|NCT05405595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102486142|NCT05405595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102486143|NCT05405595|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102486144|NCT05405595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486145|NCT00359697|Mannitol|mannitol|mesh-list
102486146|NCT00359697|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102486147|NCT00359697|Diuretics|diuretics|mesh-ancestor
102486148|NCT00359697|Natriuretic Agents|natriuretic agents|mesh-ancestor
102486149|NCT00359697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486150|NCT03111628|Omalizumab|omalizumab|mesh-list
102486151|NCT03111628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102486152|NCT03111628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102486153|NCT03111628|Respiratory System Agents|respiratory system agents|mesh-ancestor
102486154|NCT05120505|Metformin|metformin|mesh-list
102486155|NCT05120505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102486156|NCT05120505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618834|NCT04102267|Sensory System Agents|sensory system agents|mesh-ancestor
102486157|NCT02977533|Acyclovir|acyclovir|mesh-list
102486158|NCT02977533|Antiviral Agents|antiviral agents|mesh-ancestor
102486159|NCT02977533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102486160|NCT01012297|Bevacizumab|bevacizumab|mesh-list
102486161|NCT01012297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102486162|NCT01012297|Gemcitabine|gemcitabine|mesh-list
102486163|NCT01012297|Docetaxel|docetaxel|mesh-list
102486164|NCT01012297|Endothelial Growth Factors|endothelial growth factors|mesh-list
102486165|NCT01012297|Antibodies|antibodies|mesh-list
102486166|NCT01012297|Immunoglobulins|immunoglobulins|mesh-list
102486167|NCT01012297|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102486168|NCT01012297|Lenograstim|lenograstim|mesh-list
102486169|NCT01012297|Immunoglobulin G|immunoglobulin g|mesh-list
102486170|NCT01012297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102486171|NCT01012297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102486172|NCT01012297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102486173|NCT01012297|Growth Substances|growth substances|mesh-ancestor
102486174|NCT01012297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486175|NCT01012297|Growth Inhibitors|growth inhibitors|mesh-ancestor
102486176|NCT01012297|Immunologic Factors|immunologic factors|mesh-ancestor
102486177|NCT01012297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102486178|NCT01012297|Antimetabolites|antimetabolites|mesh-ancestor
102486179|NCT01012297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486180|NCT01012297|Tubulin Modulators|tubulin modulators|mesh-ancestor
102486181|NCT01012297|Antimitotic Agents|antimitotic agents|mesh-ancestor
102486182|NCT01012297|Mitosis Modulators|mitosis modulators|mesh-ancestor
102486183|NCT01012297|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102486185|NCT00923117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102486186|NCT00923117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102486187|NCT00923117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101618865|NCT00916045|Thiotepa|thiotepa|mesh-list
102486188|NCT00923117|Growth Substances|growth substances|mesh-ancestor
102486189|NCT00923117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486190|NCT00923117|Growth Inhibitors|growth inhibitors|mesh-ancestor
102486191|NCT00923117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102486192|NCT00923117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102486193|NCT00923117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486194|NCT03054922|Plasma-lyte 148|plasma-lyte 148|mesh-list
102486195|NCT03054922|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102486196|NCT03054922|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102486197|NCT02977611|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102486198|NCT02977611|Hematinics|hematinics|mesh-ancestor
102486199|NCT04360655|Antibodies|antibodies|mesh-list
102486200|NCT04360655|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102486201|NCT04360655|Immunologic Factors|immunologic factors|mesh-ancestor
102486202|NCT04360655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486203|NCT00375232|Montelukast|montelukast|mesh-list
102486204|NCT00375232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102486205|NCT00375232|Respiratory System Agents|respiratory system agents|mesh-ancestor
102486206|NCT00375232|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102486207|NCT00375232|Hormone Antagonists|hormone antagonists|mesh-ancestor
102486208|NCT00375232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102486209|NCT00375232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486210|NCT00375232|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102486211|NCT00375232|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102486212|NCT00375232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486213|NCT00975637|Brodalumab|brodalumab|mesh-list
102486214|NCT00975637|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102486215|NCT00975637|Dermatologic Agents|dermatologic agents|mesh-ancestor
102486216|NCT00975637|Immunologic Factors|immunologic factors|mesh-ancestor
102486217|NCT00975637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486218|NCT02244437|Acetaminophen|acetaminophen|mesh-list
102486219|NCT02244437|Ibuprofen|ibuprofen|mesh-list
102486220|NCT02244437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102486221|NCT02244437|Analgesics|analgesics|mesh-ancestor
102486222|NCT02244437|Sensory System Agents|sensory system agents|mesh-ancestor
102486223|NCT02244437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102486224|NCT02244437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486225|NCT02244437|Antipyretics|antipyretics|mesh-ancestor
102486226|NCT02244437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102486227|NCT02244437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102486228|NCT02244437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102486229|NCT02244437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102486230|NCT02244437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594015|NCT00864253|Dacarbazine|dacarbazine|mesh-list
102486231|NCT02244437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486232|NCT03023527|Dexamethasone|dexamethasone|mesh-list
102486233|NCT03023527|Nivolumab|nivolumab|mesh-list
102486234|NCT03023527|Pomalidomide|pomalidomide|mesh-list
102486235|NCT03023527|Elotuzumab|elotuzumab|mesh-list
102486236|NCT03023527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102486237|NCT03023527|Antiemetics|antiemetics|mesh-ancestor
102486238|NCT03023527|Autonomic Agents|autonomic agents|mesh-ancestor
102486239|NCT03023527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102486240|NCT03023527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486241|NCT03023527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102486242|NCT03023527|Glucocorticoids|glucocorticoids|mesh-ancestor
102486243|NCT03023527|Hormones|hormones|mesh-ancestor
102486244|NCT03023527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102486245|NCT03023527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102486246|NCT03023527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102486247|NCT03023527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102486248|NCT03023527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102486249|NCT03023527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486250|NCT03023527|Immunologic Factors|immunologic factors|mesh-ancestor
102486251|NCT03023527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102486252|NCT03023527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102486253|NCT03023527|Growth Substances|growth substances|mesh-ancestor
102486254|NCT03023527|Growth Inhibitors|growth inhibitors|mesh-ancestor
102486255|NCT04878627|Cannabidiol|cannabidiol|mesh-list
102486256|NCT04878627|Anticonvulsants|anticonvulsants|mesh-ancestor
102486257|NCT02244515|Dexmedetomidine|dexmedetomidine|mesh-list
102486258|NCT02244515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102486259|NCT02244515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102486260|NCT02244515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486261|NCT02244515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101618930|NCT00774787|Imiquimod|imiquimod|mesh-list
102486262|NCT02244515|Analgesics|analgesics|mesh-ancestor
102486263|NCT02244515|Sensory System Agents|sensory system agents|mesh-ancestor
102486264|NCT02244515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102486265|NCT02244515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102486266|NCT02244515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102486267|NCT02244515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102486268|NCT02244515|Adrenergic Agents|adrenergic agents|mesh-ancestor
102486269|NCT02244515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102486270|NCT02244515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486271|NCT04360031|Mycophenolic Acid|mycophenolic acid|mesh-list
102486272|NCT04360031|Tacrolimus|tacrolimus|mesh-list
102486273|NCT04360031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102486274|NCT04360031|Immunologic Factors|immunologic factors|mesh-ancestor
102486275|NCT04360031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618943|NCT04303988|Bevacizumab|bevacizumab|mesh-list
102486276|NCT04360031|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102486277|NCT04360031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102486278|NCT04360031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486279|NCT04360031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102486280|NCT04360031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102486281|NCT04360031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102486282|NCT04360031|Antitubercular Agents|antitubercular agents|mesh-ancestor
102486283|NCT04360031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102486284|NCT04360031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102486285|NCT04366739|Chlorpromazine|chlorpromazine|mesh-list
102486286|NCT04366739|Antiemetics|antiemetics|mesh-ancestor
102486287|NCT04366739|Autonomic Agents|autonomic agents|mesh-ancestor
102486288|NCT04366739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102486289|NCT04366739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486290|NCT04366739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102486291|NCT04366739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102486292|NCT04366739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102486293|NCT04366739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102486294|NCT04366739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102486295|NCT04366739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102486296|NCT04366739|Dopamine Agents|dopamine agents|mesh-ancestor
102486297|NCT04366739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102486298|NCT04366739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486299|NCT03023059|Levodopa|levodopa|mesh-list
102486300|NCT03023059|Carbidopa|carbidopa|mesh-list
102486301|NCT03023059|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102486302|NCT03023059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102486303|NCT03023059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102486304|NCT03023059|Dopamine Agents|dopamine agents|mesh-ancestor
102486305|NCT03023059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102486306|NCT03023059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486307|NCT03023059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486308|NCT03023059|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102486309|NCT03023059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102486310|NCT03023059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102486311|NCT03023059|Immunologic Factors|immunologic factors|mesh-ancestor
102486312|NCT03023059|Dopamine Agonists|dopamine agonists|mesh-ancestor
102486313|NCT02244827|Levonadifloxacin|levonadifloxacin|mesh-list
102486314|NCT02244827|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102486315|NCT02244827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102486316|NCT02244827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486317|NCT02244827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102486318|NCT02244827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102486319|NCT04359485|Glycolic acid|glycolic acid|mesh-list
102486320|NCT04359485|Keratolytic Agents|keratolytic agents|mesh-ancestor
102486321|NCT04359485|Dermatologic Agents|dermatologic agents|mesh-ancestor
102486322|NCT02976987|Cidofovir|cidofovir|mesh-list
102486323|NCT02976987|Antiviral Agents|antiviral agents|mesh-ancestor
102486324|NCT02976987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102486325|NCT02976987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102486326|NCT02976987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486327|NCT02244281|Tamsulosin|tamsulosin|mesh-list
102486328|NCT02244281|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102486329|NCT02244281|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102486330|NCT02244281|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102486331|NCT02244281|Adrenergic Agents|adrenergic agents|mesh-ancestor
102486332|NCT02244281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102486333|NCT02244281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486334|NCT02244281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486335|NCT02244281|Urological Agents|urological agents|mesh-ancestor
102486336|NCT00361413|Alefacept|alefacept|mesh-list
102486337|NCT00361413|Dermatologic Agents|dermatologic agents|mesh-ancestor
102486338|NCT00361413|Immunologic Factors|immunologic factors|mesh-ancestor
102486339|NCT00361413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486340|NCT03062488|Acetaminophen|acetaminophen|mesh-list
102486341|NCT03062488|Fentanyl|fentanyl|mesh-list
102486342|NCT03062488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102486343|NCT03062488|Narcotics|narcotics|mesh-ancestor
102486344|NCT03062488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102486345|NCT03062488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486346|NCT03062488|Analgesics|analgesics|mesh-ancestor
102486347|NCT03062488|Sensory System Agents|sensory system agents|mesh-ancestor
102486348|NCT03062488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102486349|NCT03062488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102486350|NCT03062488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102486351|NCT03062488|Anesthetics, General|anesthetics, general|mesh-ancestor
102486352|NCT03062488|Anesthetics|anesthetics|mesh-ancestor
102486353|NCT03062488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102486354|NCT03062488|Antipyretics|antipyretics|mesh-ancestor
102486355|NCT00936299|Bupropion|bupropion|mesh-list
102486356|NCT00936299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102486357|NCT00936299|Antidepressive Agents|antidepressive agents|mesh-ancestor
102486358|NCT00936299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102486359|NCT00936299|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102486360|NCT00936299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102486361|NCT00936299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102486362|NCT00936299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486363|NCT00936299|Dopamine Agents|dopamine agents|mesh-ancestor
102486364|NCT00936299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102486365|NCT00936299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486366|NCT00936299|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102486367|NCT00936299|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102486368|NCT00936299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102486369|NCT04375943|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102486370|NCT04375943|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102486371|NCT04375943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486372|NCT04375943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486373|NCT03117634|Aflibercept|aflibercept|mesh-list
102486374|NCT03117634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102486375|NCT03117634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102486376|NCT03117634|Growth Substances|growth substances|mesh-ancestor
102486377|NCT03117634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486378|NCT03117634|Growth Inhibitors|growth inhibitors|mesh-ancestor
102486379|NCT03117634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102486380|NCT00937235|Varenicline|varenicline|mesh-list
102486381|NCT00937235|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102486382|NCT00937235|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102486383|NCT00937235|Cholinergic Agents|cholinergic agents|mesh-ancestor
102486384|NCT00937235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102486385|NCT00937235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486386|NCT00937235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486387|NCT01014403|Enoxaparin|enoxaparin|mesh-list
102486388|NCT01014403|Anticoagulants|anticoagulants|mesh-ancestor
102486389|NCT01014403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102486390|NCT01014403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102486391|NCT01014403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486392|NCT05405608|Ondansetron|ondansetron|mesh-list
102486393|NCT05405608|Antiemetics|antiemetics|mesh-ancestor
102486394|NCT05405608|Autonomic Agents|autonomic agents|mesh-ancestor
102486395|NCT05405608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102486396|NCT05405608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486397|NCT05405608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102486398|NCT05405608|Antipruritics|antipruritics|mesh-ancestor
102486399|NCT05405608|Dermatologic Agents|dermatologic agents|mesh-ancestor
102486400|NCT05405608|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102486401|NCT05405608|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102486402|NCT05405608|Serotonin Agents|serotonin agents|mesh-ancestor
102486403|NCT05405608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102486404|NCT05405608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486405|NCT01014871|Botulinum Toxins|botulinum toxins|mesh-list
102486406|NCT01014871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102486407|NCT01014871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102486408|NCT01014871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102486409|NCT01014871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102486410|NCT01014871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486411|NCT01014871|Cholinergic Agents|cholinergic agents|mesh-ancestor
102486412|NCT01014871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102486413|NCT01014871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486414|NCT01014871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102486415|NCT01014871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102486416|NCT00375466|Tranexamic Acid|tranexamic acid|mesh-list
102486417|NCT00375466|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102486418|NCT00375466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102486419|NCT00375466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486420|NCT00375466|Hemostatics|hemostatics|mesh-ancestor
102486421|NCT00375466|Coagulants|coagulants|mesh-ancestor
102486422|NCT00976183|Vorinostat|vorinostat|mesh-list
102486423|NCT00976183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102486424|NCT00976183|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102486425|NCT00976183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102486426|NCT00976183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486427|NCT04357535|Angiotensin II|angiotensin ii|mesh-list
102486428|NCT04357535|Giapreza|giapreza|mesh-list
102486429|NCT04357535|Enzyme Inhibitors|enzyme inhibitors|mesh-list
102486430|NCT04357535|Angiotensinogen|angiotensinogen|mesh-list
102486431|NCT04357535|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102486432|NCT04357535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
102486433|NCT04357535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486434|NCT04357535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102486435|NCT04357535|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102486436|NCT04357535|Protease Inhibitors|protease inhibitors|mesh-ancestor
102486437|NCT01015807|Clonidine|clonidine|mesh-list
102486438|NCT01015807|Bupivacaine|bupivacaine|mesh-list
102486439|NCT01015807|Anesthetics, Local|anesthetics, local|mesh-ancestor
102486440|NCT01015807|Anesthetics|anesthetics|mesh-ancestor
102486441|NCT01015807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102486442|NCT01015807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486443|NCT01015807|Sensory System Agents|sensory system agents|mesh-ancestor
102486444|NCT01015807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102486445|NCT01015807|Analgesics|analgesics|mesh-ancestor
102486446|NCT01015807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102486447|NCT01015807|Sympatholytics|sympatholytics|mesh-ancestor
102486448|NCT01015807|Autonomic Agents|autonomic agents|mesh-ancestor
102486449|NCT01015807|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102486450|NCT01015807|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102486451|NCT01015807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102486452|NCT01015807|Adrenergic Agents|adrenergic agents|mesh-ancestor
102486453|NCT01015807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102486454|NCT01015807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486455|NCT01575925|Thalidomide|thalidomide|mesh-list
102486456|NCT01575925|Dexamethasone|dexamethasone|mesh-list
102486457|NCT01575925|Dexamethasone acetate|dexamethasone acetate|mesh-list
102486458|NCT01575925|Pomalidomide|pomalidomide|mesh-list
102486459|NCT01575925|BB 1101|bb 1101|mesh-list
102486460|NCT01575925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102486461|NCT01575925|Antiemetics|antiemetics|mesh-ancestor
102486462|NCT01575925|Autonomic Agents|autonomic agents|mesh-ancestor
102486463|NCT01575925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102486464|NCT01575925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486465|NCT01575925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102486466|NCT01575925|Glucocorticoids|glucocorticoids|mesh-ancestor
102486467|NCT01575925|Hormones|hormones|mesh-ancestor
102486468|NCT01575925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102486469|NCT01575925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102486470|NCT01575925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102486471|NCT01575925|Protease Inhibitors|protease inhibitors|mesh-ancestor
102486472|NCT01575925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102486473|NCT01575925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486474|NCT01575925|Immunologic Factors|immunologic factors|mesh-ancestor
102486475|NCT01575925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102486476|NCT01575925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102486477|NCT01575925|Growth Substances|growth substances|mesh-ancestor
102486478|NCT01575925|Growth Inhibitors|growth inhibitors|mesh-ancestor
102486479|NCT01575925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102486480|NCT01575925|Leprostatic Agents|leprostatic agents|mesh-ancestor
102486481|NCT01575925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102486482|NCT01575925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102486483|NCT00936377|Dexmedetomidine|dexmedetomidine|mesh-list
102486484|NCT00936377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102486485|NCT00936377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102486486|NCT00936377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486487|NCT00936377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102486488|NCT00936377|Analgesics|analgesics|mesh-ancestor
102486489|NCT00936377|Sensory System Agents|sensory system agents|mesh-ancestor
102486490|NCT00936377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102486491|NCT00936377|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102486492|NCT00936377|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102486493|NCT00936377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102486494|NCT00936377|Adrenergic Agents|adrenergic agents|mesh-ancestor
102486495|NCT00936377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102486496|NCT00936377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486497|NCT04471233|Pregabalin|pregabalin|mesh-list
102486498|NCT04471233|Analgesics|analgesics|mesh-ancestor
102486499|NCT04471233|Sensory System Agents|sensory system agents|mesh-ancestor
102486500|NCT04471233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102486501|NCT04471233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486502|NCT04471233|Anticonvulsants|anticonvulsants|mesh-ancestor
102486503|NCT04471233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102486504|NCT04471233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102486505|NCT04471233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486506|NCT04471233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102486507|NCT04471233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102486508|NCT04471233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102486509|NCT04471233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102486510|NCT04471233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102486511|NCT04359095|Tenofovir|tenofovir|mesh-list
102486512|NCT04359095|Emtricitabine|emtricitabine|mesh-list
102486513|NCT04359095|Colchicine|colchicine|mesh-list
102486514|NCT04359095|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102486515|NCT04359095|Antiviral Agents|antiviral agents|mesh-ancestor
102486516|NCT04359095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102486517|NCT04359095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102486518|NCT04359095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102486519|NCT04359095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102486520|NCT04359095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486521|NCT04359095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102486522|NCT04359095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102486523|NCT04359095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102486524|NCT04359095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102486525|NCT04359095|Antimetabolites|antimetabolites|mesh-ancestor
102486526|NCT04359095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102486527|NCT04359095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102486528|NCT04359095|Gout Suppressants|gout suppressants|mesh-ancestor
102486529|NCT04359095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102486530|NCT04359095|Tubulin Modulators|tubulin modulators|mesh-ancestor
102486531|NCT04359095|Antimitotic Agents|antimitotic agents|mesh-ancestor
102486532|NCT04359095|Mitosis Modulators|mitosis modulators|mesh-ancestor
102486533|NCT04359095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102486534|NCT02163421|Vedolizumab|vedolizumab|mesh-list
102486535|NCT02163421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102486536|NCT02982395|Ethanol|ethanol|mesh-list
102486537|NCT02982395|Docetaxel|docetaxel|mesh-list
102486538|NCT02982395|Mitomycins|mitomycins|mesh-list
102486539|NCT02982395|Mitomycin|mitomycin|mesh-list
102486540|NCT02982395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102486541|NCT02982395|Tubulin Modulators|tubulin modulators|mesh-ancestor
102486542|NCT02982395|Antimitotic Agents|antimitotic agents|mesh-ancestor
102486543|NCT02982395|Mitosis Modulators|mitosis modulators|mesh-ancestor
102486544|NCT02982395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486545|NCT02982395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102486546|NCT02982395|Alkylating Agents|alkylating agents|mesh-ancestor
102486547|NCT02982395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102486548|NCT02982395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102486549|NCT02982395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102486550|NCT02982395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102486551|NCT02982395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102486552|NCT02982395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486553|NCT02982005|Brodalumab|brodalumab|mesh-list
102486554|NCT02982005|Dermatologic Agents|dermatologic agents|mesh-ancestor
102486555|NCT04736836|Rifaximin|rifaximin|mesh-list
102486556|NCT04736836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102486557|NCT04736836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102486558|NCT04736836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102486559|NCT03126370|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
102486561|NCT03126370|Tenofovir|tenofovir|mesh-list
102486562|NCT03126370|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
102486563|NCT03126370|Protease Inhibitors|protease inhibitors|mesh-list
102486564|NCT03126370|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102486565|NCT03126370|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102486566|NCT03126370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102486567|NCT03126370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486568|NCT03126370|Antiviral Agents|antiviral agents|mesh-ancestor
102486569|NCT03126370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102486570|NCT03126370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102486571|NCT03126370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102486572|NCT03126370|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102486573|NCT04467801|Ipatasertib|ipatasertib|mesh-list
102486574|NCT04467801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102486575|NCT04467801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102486576|NCT04467801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102486577|NCT04467801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486578|NCT01019707|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102486579|NCT01019707|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102486580|NCT01019707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102486581|NCT01019707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102486582|NCT01019707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486583|NCT01019707|Adrenergic Agents|adrenergic agents|mesh-ancestor
102486584|NCT01019707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102486585|NCT01019707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486586|NCT00979615|Azelastine|azelastine|mesh-list
102486587|NCT00979615|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
102486588|NCT00979615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102486589|NCT00979615|Autonomic Agents|autonomic agents|mesh-ancestor
102486590|NCT00979615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102486591|NCT00979615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486592|NCT00979615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102486593|NCT00979615|Respiratory System Agents|respiratory system agents|mesh-ancestor
102486594|NCT00979615|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
102486595|NCT00979615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102486596|NCT00979615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486597|NCT00979615|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102486598|NCT00979615|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102486599|NCT00979615|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102486600|NCT00979615|Histamine Antagonists|histamine antagonists|mesh-ancestor
102486601|NCT00979615|Histamine Agents|histamine agents|mesh-ancestor
102486602|NCT00979615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102486603|NCT00979615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102486604|NCT00979615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102486605|NCT00979615|Analgesics|analgesics|mesh-ancestor
102486606|NCT00979615|Sensory System Agents|sensory system agents|mesh-ancestor
102486607|NCT00979615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102486608|NCT00979615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102486609|NCT03126682|Bupropion|bupropion|mesh-list
102486610|NCT03126682|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102486611|NCT03126682|Antidepressive Agents|antidepressive agents|mesh-ancestor
102486612|NCT03126682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102486613|NCT03126682|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102486614|NCT03126682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102486615|NCT03126682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102486616|NCT03126682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486617|NCT03126682|Dopamine Agents|dopamine agents|mesh-ancestor
102486618|NCT03126682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102486619|NCT03126682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486620|NCT03126682|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102486621|NCT03126682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102486622|NCT03126682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102486623|NCT05236738|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102486624|NCT05236738|Cobicistat|cobicistat|mesh-list
102486625|NCT05236738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102486626|NCT05236738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102486627|NCT05236738|Protease Inhibitors|protease inhibitors|mesh-ancestor
102486628|NCT05236738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102486629|NCT05236738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486630|NCT05236738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102486631|NCT05236738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102486632|NCT05236738|Antiviral Agents|antiviral agents|mesh-ancestor
102486633|NCT05236738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102486634|NCT05236738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102486635|NCT05236738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102486636|NCT00980395|Rituximab|rituximab|mesh-list
102486637|NCT00980395|Bortezomib|bortezomib|mesh-list
102486638|NCT00980395|Cladribine|cladribine|mesh-list
102486639|NCT00980395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102486640|NCT00980395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102486641|NCT00980395|Immunologic Factors|immunologic factors|mesh-ancestor
102486642|NCT00980395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486643|NCT00980395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102486644|NCT00980395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102486645|NCT02976597|Morphine|morphine|mesh-list
102486646|NCT02976597|Bupivacaine|bupivacaine|mesh-list
102486647|NCT02976597|Anesthetics, Local|anesthetics, local|mesh-ancestor
102486648|NCT02976597|Anesthetics|anesthetics|mesh-ancestor
102486649|NCT02976597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102486650|NCT02976597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486651|NCT02976597|Sensory System Agents|sensory system agents|mesh-ancestor
102486652|NCT02976597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102486653|NCT02976597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102486654|NCT02976597|Narcotics|narcotics|mesh-ancestor
102486655|NCT02976597|Analgesics|analgesics|mesh-ancestor
102486656|NCT03020329|Paclitaxel|paclitaxel|mesh-list
102486657|NCT03020329|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102486658|NCT03020329|Cisplatin|cisplatin|mesh-list
102486659|NCT03020329|Fluorouracil|fluorouracil|mesh-list
102486660|NCT03020329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102486661|NCT03020329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102486662|NCT03020329|Tubulin Modulators|tubulin modulators|mesh-ancestor
102486663|NCT03020329|Antimitotic Agents|antimitotic agents|mesh-ancestor
102486664|NCT03020329|Mitosis Modulators|mitosis modulators|mesh-ancestor
101619281|NCT02603575|Sulfanilamides|sulfanilamides|mesh-list
102486665|NCT03020329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486666|NCT03020329|Antimetabolites|antimetabolites|mesh-ancestor
102486667|NCT03020329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102486668|NCT03020329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102486669|NCT03020329|Immunologic Factors|immunologic factors|mesh-ancestor
102486670|NCT03020329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486671|NCT04791579|Ciprofloxacin|ciprofloxacin|mesh-list
102486672|NCT04791579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102486673|NCT04791579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102486674|NCT04791579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102486675|NCT04791579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102486676|NCT04791579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102486677|NCT04791579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486678|NCT04791579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102486679|NCT04791579|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102486680|NCT04791579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102486681|NCT00980785|Ramipril|ramipril|mesh-list
102486682|NCT00980785|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102486683|NCT00980785|Protease Inhibitors|protease inhibitors|mesh-ancestor
102486684|NCT00980785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102486685|NCT00980785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486686|NCT00980785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102486687|NCT04772547|Vigabatrin|vigabatrin|mesh-list
102486688|NCT04772547|Anticonvulsants|anticonvulsants|mesh-ancestor
102486689|NCT04772547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102486690|NCT04772547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486691|NCT04772547|GABA Agents|gaba agents|mesh-ancestor
102486692|NCT04772547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102486693|NCT04772547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486694|NCT05028153|Azithromycin|azithromycin|mesh-list
102486695|NCT05028153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102486696|NCT05028153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102486697|NCT03126760|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102486698|NCT03126760|Hormones|hormones|mesh-ancestor
102486699|NCT03126760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102486700|NCT03126760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486701|NCT05026905|Leucovorin|leucovorin|mesh-list
102486702|NCT05026905|Paclitaxel|paclitaxel|mesh-list
102486703|NCT05026905|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102486704|NCT05026905|Gemcitabine|gemcitabine|mesh-list
102486705|NCT05026905|Oxaliplatin|oxaliplatin|mesh-list
102298322|NCT04203901|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102486706|NCT05026905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102486707|NCT05026905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102486708|NCT05026905|Tubulin Modulators|tubulin modulators|mesh-ancestor
102486709|NCT05026905|Antimitotic Agents|antimitotic agents|mesh-ancestor
102486710|NCT05026905|Mitosis Modulators|mitosis modulators|mesh-ancestor
102486711|NCT05026905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486712|NCT05026905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102486713|NCT05026905|Antimetabolites|antimetabolites|mesh-ancestor
102486714|NCT05026905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486715|NCT05026905|Antidotes|antidotes|mesh-ancestor
102486716|NCT05026905|Protective Agents|protective agents|mesh-ancestor
102486717|NCT05026905|Vitamin B Complex|vitamin b complex|mesh-ancestor
102486719|NCT05026905|Micronutrients|micronutrients|mesh-ancestor
102486720|NCT00982189|Lisinopril|lisinopril|mesh-list
102486721|NCT00982189|Pravastatin|pravastatin|mesh-list
102486722|NCT00982189|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102486723|NCT00982189|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102486724|NCT00982189|Antimetabolites|antimetabolites|mesh-ancestor
102486725|NCT00982189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486726|NCT00982189|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102486727|NCT00982189|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102486728|NCT00982189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102486729|NCT00982189|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102486730|NCT00982189|Protease Inhibitors|protease inhibitors|mesh-ancestor
102486731|NCT00982189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102486732|NCT00982189|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102486733|NCT00982189|Protective Agents|protective agents|mesh-ancestor
102486734|NCT00982189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486735|NCT05017545|Abatacept|abatacept|mesh-list
102486736|NCT05017545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102486737|NCT05017545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486738|NCT05017545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102486739|NCT05017545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102486740|NCT05017545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102486741|NCT05017545|Immunologic Factors|immunologic factors|mesh-ancestor
102486742|NCT05017545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486743|NCT05017545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102486744|NCT03128008|Paclitaxel|paclitaxel|mesh-list
102486745|NCT03128008|Carboplatin|carboplatin|mesh-list
102486746|NCT03128008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102486747|NCT03128008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102486748|NCT03128008|Tubulin Modulators|tubulin modulators|mesh-ancestor
102486749|NCT03128008|Antimitotic Agents|antimitotic agents|mesh-ancestor
102486750|NCT03128008|Mitosis Modulators|mitosis modulators|mesh-ancestor
102486751|NCT03128008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486752|NCT05017311|Escitalopram|escitalopram|mesh-list
102486753|NCT05017311|Brexpiprazole|brexpiprazole|mesh-list
102486754|NCT05017311|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102486755|NCT05017311|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102486756|NCT05017311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102486757|NCT05017311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486758|NCT05017311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102486759|NCT05017311|Serotonin Agents|serotonin agents|mesh-ancestor
102486760|NCT05017311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486761|NCT05017311|Dopamine Agonists|dopamine agonists|mesh-ancestor
102486762|NCT05017311|Dopamine Agents|dopamine agents|mesh-ancestor
102486763|NCT00360087|Bosentan|bosentan|mesh-list
102486764|NCT00360087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102486765|NCT00360087|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102486766|NCT00360087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486767|NCT00982423|Furosemide|furosemide|mesh-list
102486768|NCT00982423|Diuretics|diuretics|mesh-ancestor
102486769|NCT00982423|Natriuretic Agents|natriuretic agents|mesh-ancestor
102486770|NCT00982423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486771|NCT00982423|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102486772|NCT00982423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102486773|NCT00982423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486774|NCT04719819|Anesthetics|anesthetics|mesh-list
102486775|NCT04719819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102486776|NCT04719819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486777|NCT02981719|Gemcitabine|gemcitabine|mesh-list
102298397|NCT02289963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102486778|NCT02981719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102486779|NCT02981719|Antimetabolites|antimetabolites|mesh-ancestor
102486780|NCT02981719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486781|NCT02981719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102486783|NCT03073876|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102486784|NCT03073876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102486785|NCT03073876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486786|NCT03073876|Cholinergic Agents|cholinergic agents|mesh-ancestor
102486787|NCT03073876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102486788|NCT03073876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486789|NCT03073876|Nootropic Agents|nootropic agents|mesh-ancestor
102486790|NCT04718961|Volixibat|volixibat|mesh-list
102486791|NCT04718961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102486792|NCT03130738|Miconazole|miconazole|mesh-list
102486793|NCT03130738|Clotrimazole|clotrimazole|mesh-list
102486794|NCT03130738|Antifungal Agents|antifungal agents|mesh-ancestor
102486795|NCT03130738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102486796|NCT03130738|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102486797|NCT03130738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102486798|NCT03130738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102486799|NCT03130738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486800|NCT03130738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102486801|NCT03130738|Hormone Antagonists|hormone antagonists|mesh-ancestor
102486802|NCT03130738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102486803|NCT03130738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486804|NCT03130738|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102486805|NCT03130738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102486806|NCT03130738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102486807|NCT00984139|Vaccines|vaccines|mesh-list
102486808|NCT00984139|Immunologic Factors|immunologic factors|mesh-ancestor
102486809|NCT00984139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486810|NCT04672395|Vaccines|vaccines|mesh-list
102486811|NCT04672395|1018 oligonucleotide|1018 oligonucleotide|mesh-list
102486812|NCT04672395|Immunologic Factors|immunologic factors|mesh-ancestor
102486813|NCT04672395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486814|NCT04672395|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102486815|NCT00985543|Ritonavir|ritonavir|mesh-list
102486816|NCT00985543|Lopinavir|lopinavir|mesh-list
102486817|NCT00985543|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102486818|NCT00985543|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102486819|NCT00985543|Protease Inhibitors|protease inhibitors|mesh-ancestor
102486820|NCT00985543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102486821|NCT00985543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486822|NCT00985543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102486823|NCT00985543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102486824|NCT00985543|Antiviral Agents|antiviral agents|mesh-ancestor
102486825|NCT00985543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102486826|NCT00985543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102486827|NCT00985543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102486828|NCT05394415|Paclitaxel|paclitaxel|mesh-list
102486829|NCT05394415|Carboplatin|carboplatin|mesh-list
102486830|NCT05394415|Tislelizumab|tislelizumab|mesh-list
102486831|NCT05394415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102486832|NCT05394415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102486833|NCT05394415|Tubulin Modulators|tubulin modulators|mesh-ancestor
102486834|NCT05394415|Antimitotic Agents|antimitotic agents|mesh-ancestor
102486835|NCT05394415|Mitosis Modulators|mitosis modulators|mesh-ancestor
102486836|NCT05394415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486837|NCT05394415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102486838|NCT04352959|Betadex|betadex|mesh-list
102486839|NCT04352959|Sequestering Agents|sequestering agents|mesh-ancestor
102486840|NCT04352959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486841|NCT00360945|Temozolomide|temozolomide|mesh-list
102486842|NCT00360945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102486843|NCT00360945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102486844|NCT00360945|Alkylating Agents|alkylating agents|mesh-ancestor
101619452|NCT02818881|Adrenergic Agents|adrenergic agents|mesh-ancestor
102486845|NCT00360945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486846|NCT03019237|Omalizumab|omalizumab|mesh-list
102486847|NCT03019237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102486848|NCT03019237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102486849|NCT03019237|Respiratory System Agents|respiratory system agents|mesh-ancestor
102486850|NCT00361023|Losartan|losartan|mesh-list
102486851|NCT00361023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102486852|NCT00361023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102486853|NCT00361023|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102486854|NCT00361023|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102486855|NCT00361023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486856|NCT03019081|Isoproterenol|isoproterenol|mesh-list
102486857|NCT03019081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102486858|NCT03019081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102486859|NCT03019081|Adrenergic Agents|adrenergic agents|mesh-ancestor
102486860|NCT03019081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102486861|NCT03019081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486862|NCT03019081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486863|NCT03019081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102486864|NCT03019081|Autonomic Agents|autonomic agents|mesh-ancestor
102486865|NCT03019081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102486866|NCT03019081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102486867|NCT03019081|Respiratory System Agents|respiratory system agents|mesh-ancestor
102486868|NCT03019081|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102486869|NCT03019081|Sympathomimetics|sympathomimetics|mesh-ancestor
102486870|NCT03019081|Protective Agents|protective agents|mesh-ancestor
102486871|NCT00986401|Metformin|metformin|mesh-list
102486872|NCT00986401|Trospium chloride|trospium chloride|mesh-list
102486873|NCT00986401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102486874|NCT00986401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486875|NCT00986401|Parasympatholytics|parasympatholytics|mesh-ancestor
102486876|NCT00986401|Autonomic Agents|autonomic agents|mesh-ancestor
102486877|NCT00986401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102486878|NCT00986401|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102486879|NCT00986401|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102486880|NCT00986401|Cholinergic Agents|cholinergic agents|mesh-ancestor
102486881|NCT00986401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102486882|NCT00986401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486883|NCT00986401|Urological Agents|urological agents|mesh-ancestor
102486884|NCT00375076|Enoxaparin|enoxaparin|mesh-list
102486885|NCT00375076|Anticoagulants|anticoagulants|mesh-ancestor
102486886|NCT00375076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102486887|NCT00375076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102486888|NCT00375076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486889|NCT00987415|Allopurinol|allopurinol|mesh-list
102486890|NCT00987415|Antimetabolites|antimetabolites|mesh-ancestor
102486891|NCT00987415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486892|NCT00987415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102486893|NCT00987415|Gout Suppressants|gout suppressants|mesh-ancestor
102486894|NCT00987415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102486895|NCT00987415|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102486896|NCT00987415|Antioxidants|antioxidants|mesh-ancestor
102486897|NCT00987415|Protective Agents|protective agents|mesh-ancestor
102486898|NCT00987415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486899|NCT04807504|Ropivacaine|ropivacaine|mesh-list
102486900|NCT04807504|Anesthetics, Local|anesthetics, local|mesh-ancestor
102486901|NCT04807504|Anesthetics|anesthetics|mesh-ancestor
102486902|NCT04807504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102486903|NCT04807504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486904|NCT04807504|Sensory System Agents|sensory system agents|mesh-ancestor
102486905|NCT04807504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102486906|NCT04771156|Ketorolac|ketorolac|mesh-list
102486907|NCT04771156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102486908|NCT04771156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102486909|NCT04771156|Analgesics|analgesics|mesh-ancestor
102486910|NCT04771156|Sensory System Agents|sensory system agents|mesh-ancestor
102486911|NCT04771156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102486912|NCT04771156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486913|NCT04771156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102486914|NCT04771156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102486915|NCT04771156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102486916|NCT04771156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102486917|NCT04771156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486918|NCT04707118|Paclitaxel|paclitaxel|mesh-list
102486919|NCT04707118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102486920|NCT04707118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102486921|NCT04707118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102486922|NCT04707118|Tubulin Modulators|tubulin modulators|mesh-ancestor
102486923|NCT04707118|Antimitotic Agents|antimitotic agents|mesh-ancestor
102486924|NCT04707118|Mitosis Modulators|mitosis modulators|mesh-ancestor
102486925|NCT04707118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486926|NCT03086356|Dabigatran|dabigatran|mesh-list
102486927|NCT03086356|Antithrombins|antithrombins|mesh-ancestor
102486928|NCT03086356|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102486929|NCT03086356|Protease Inhibitors|protease inhibitors|mesh-ancestor
102486930|NCT03086356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102486931|NCT03086356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486932|NCT03086356|Anticoagulants|anticoagulants|mesh-ancestor
102486933|NCT03140254|Chlorhexidine|chlorhexidine|mesh-list
102486934|NCT03140254|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102486935|NCT03140254|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102486936|NCT03140254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102486937|NCT03140254|Disinfectants|disinfectants|mesh-ancestor
102486938|NCT03140254|Dermatologic Agents|dermatologic agents|mesh-ancestor
102486939|NCT03140722|Epoetin Alfa|epoetin alfa|mesh-list
102486940|NCT03140722|Hematinics|hematinics|mesh-ancestor
102486941|NCT00982345|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102486942|NCT00982345|Antidepressive Agents|antidepressive agents|mesh-ancestor
102486943|NCT00982345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102486944|NCT00982345|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102486945|NCT00982345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102486946|NCT00982345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102486947|NCT00982345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486948|NCT00375622|Tamoxifen|tamoxifen|mesh-list
102486949|NCT00375622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102486950|NCT00375622|Hormone Antagonists|hormone antagonists|mesh-ancestor
102486951|NCT00375622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102486952|NCT00375622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486953|NCT00375622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102486954|NCT00375622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102486955|NCT00375622|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102486956|NCT00375622|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102486957|NCT00375622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102486958|NCT03087604|Lidocaine|lidocaine|mesh-list
102486959|NCT03087604|Epinephrine|epinephrine|mesh-list
102486960|NCT03087604|Anesthetics, Local|anesthetics, local|mesh-ancestor
102486961|NCT03087604|Anesthetics|anesthetics|mesh-ancestor
102486962|NCT03087604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102486963|NCT03087604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486964|NCT03087604|Sensory System Agents|sensory system agents|mesh-ancestor
102486965|NCT03087604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102486966|NCT03087604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102486967|NCT03087604|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102486968|NCT03087604|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102486969|NCT03087604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102486970|NCT03087604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102486971|NCT03087604|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102486972|NCT03087604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102486973|NCT03087604|Adrenergic Agents|adrenergic agents|mesh-ancestor
102486974|NCT03087604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102486975|NCT03087604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102486976|NCT03087604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102486977|NCT03087604|Autonomic Agents|autonomic agents|mesh-ancestor
102486978|NCT03087604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102486979|NCT03087604|Respiratory System Agents|respiratory system agents|mesh-ancestor
102486980|NCT03087604|Mydriatics|mydriatics|mesh-ancestor
102486981|NCT03087604|Sympathomimetics|sympathomimetics|mesh-ancestor
102486982|NCT03087604|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102486983|NCT00987727|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102486984|NCT00987727|Hyaluronic Acid|hyaluronic acid|mesh-list
102486985|NCT00987727|Glycerol|glycerol|mesh-list
102486986|NCT00987727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102486987|NCT00987727|Immunologic Factors|immunologic factors|mesh-ancestor
102486988|NCT00987727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486989|NCT00987727|Viscosupplements|viscosupplements|mesh-ancestor
102486990|NCT00987727|Protective Agents|protective agents|mesh-ancestor
102486991|NCT00987727|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102486992|NCT00987727|Laxatives|laxatives|mesh-ancestor
102486993|NCT00987727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102486994|NCT02160535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102486995|NCT02160535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102486996|NCT02160535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102486997|NCT02160535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102486998|NCT02160535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102486999|NCT02160535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102487000|NCT02160535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102612326|NCT00002405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102487001|NCT02160535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487002|NCT02160535|Cholinergic Agents|cholinergic agents|mesh-ancestor
102487003|NCT02160535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102487004|NCT04913337|Pembrolizumab|pembrolizumab|mesh-list
102487005|NCT04913337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102487006|NCT04913337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102487007|NCT04913337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102487008|NCT04913337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487009|NCT05386459|Interferons|interferons|mesh-list
102487010|NCT05386459|Interferon-gamma|interferon-gamma|mesh-list
102487011|NCT05386459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102487012|NCT05386459|Antiviral Agents|antiviral agents|mesh-ancestor
102487013|NCT05386459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102487014|NCT03018535|Methylprednisolone|methylprednisolone|mesh-list
102487015|NCT03018535|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102487016|NCT03018535|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102487017|NCT03018535|Prednisolone|prednisolone|mesh-list
102487018|NCT03018535|Prednisolone acetate|prednisolone acetate|mesh-list
102487019|NCT03018535|Cyclophosphamide|cyclophosphamide|mesh-list
102487020|NCT03018535|Rituximab|rituximab|mesh-list
102487021|NCT03018535|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102487022|NCT03018535|Prednisolone phosphate|prednisolone phosphate|mesh-list
102487023|NCT03018535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102487024|NCT03018535|Immunologic Factors|immunologic factors|mesh-ancestor
102487025|NCT03018535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487026|NCT03018535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102487027|NCT03018535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102487028|NCT03018535|Alkylating Agents|alkylating agents|mesh-ancestor
102487029|NCT03018535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487030|NCT03018535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102487031|NCT03018535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102487032|NCT03018535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102487033|NCT03018535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102487034|NCT03018535|Antiemetics|antiemetics|mesh-ancestor
102487035|NCT03018535|Autonomic Agents|autonomic agents|mesh-ancestor
102487036|NCT03018535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102487037|NCT03018535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102487038|NCT03018535|Glucocorticoids|glucocorticoids|mesh-ancestor
102487039|NCT03018535|Hormones|hormones|mesh-ancestor
102487040|NCT03018535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102487041|NCT03018535|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102487042|NCT03018535|Protective Agents|protective agents|mesh-ancestor
102487043|NCT03018535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102487044|NCT04890873|Magnesium Hydroxide|magnesium hydroxide|mesh-list
102487045|NCT04890873|Antacids|antacids|mesh-ancestor
102487046|NCT04890873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487047|NCT04890873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102487048|NCT04889547|Dexamethasone|dexamethasone|mesh-list
102487049|NCT04889547|Dexamethasone acetate|dexamethasone acetate|mesh-list
102487050|NCT04889547|BB 1101|bb 1101|mesh-list
102487051|NCT04889547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102487052|NCT04889547|Antiemetics|antiemetics|mesh-ancestor
102487053|NCT04889547|Autonomic Agents|autonomic agents|mesh-ancestor
102487054|NCT04889547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102487055|NCT04889547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487056|NCT04889547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102487057|NCT04889547|Glucocorticoids|glucocorticoids|mesh-ancestor
102487058|NCT04889547|Hormones|hormones|mesh-ancestor
102487059|NCT04889547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102487060|NCT04889547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102487061|NCT04889547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102487062|NCT04889547|Protease Inhibitors|protease inhibitors|mesh-ancestor
102487063|NCT04889547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102487064|NCT04889547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487065|NCT00989911|Bosentan|bosentan|mesh-list
102487066|NCT00989911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102487067|NCT00989911|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102487068|NCT00989911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487069|NCT02977065|Atorvastatin|atorvastatin|mesh-list
102487070|NCT02977065|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102487071|NCT02977065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102487072|NCT02977065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102487073|NCT02977065|Antimetabolites|antimetabolites|mesh-ancestor
102298695|NCT02287233|Cytarabine|cytarabine|mesh-list
102487074|NCT02977065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487075|NCT02977065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102487076|NCT02977065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102487077|NCT02977065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102487078|NCT03146806|Ketamine|ketamine|mesh-list
102487079|NCT03146806|Analgesics|analgesics|mesh-ancestor
102487080|NCT03146806|Sensory System Agents|sensory system agents|mesh-ancestor
102487081|NCT03146806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102487082|NCT03146806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487083|NCT03146806|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102487084|NCT03146806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102487085|NCT03146806|Anesthetics, General|anesthetics, general|mesh-ancestor
102487086|NCT03146806|Anesthetics|anesthetics|mesh-ancestor
102487087|NCT03146806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102487088|NCT03146806|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102487089|NCT03146806|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102487090|NCT03146806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102487091|NCT03146806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487092|NCT04706806|Acetic Acid|acetic acid|mesh-list
102487093|NCT04706806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102487094|NCT04706806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102487095|NCT02975583|Vorapaxar|vorapaxar|mesh-list
102487096|NCT02975583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102487097|NCT03953235|Nivolumab|nivolumab|mesh-list
102487098|NCT03953235|Ipilimumab|ipilimumab|mesh-list
102487099|NCT03953235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102487100|NCT03953235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102487101|NCT03953235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102487102|NCT03953235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487103|NCT03095638|Dolutegravir|dolutegravir|mesh-list
102487104|NCT03095638|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102487105|NCT03095638|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102487106|NCT03095638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102487107|NCT03095638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487108|NCT03095638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102487109|NCT03095638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102487110|NCT03095638|Antiviral Agents|antiviral agents|mesh-ancestor
102487111|NCT03095638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102487112|NCT04458688|Ocrelizumab|ocrelizumab|mesh-list
102487113|NCT04458688|Immunologic Factors|immunologic factors|mesh-ancestor
102487114|NCT04458688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487115|NCT04450108|Nitric Oxide|nitric oxide|mesh-list
102487116|NCT04450108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102487117|NCT04450108|Autonomic Agents|autonomic agents|mesh-ancestor
102487118|NCT04450108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102487119|NCT04450108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487120|NCT04450108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102487121|NCT04450108|Respiratory System Agents|respiratory system agents|mesh-ancestor
102487122|NCT04450108|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102487123|NCT04450108|Antioxidants|antioxidants|mesh-ancestor
102487124|NCT04450108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487125|NCT04450108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102487126|NCT04450108|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102487127|NCT04450108|Vasodilator Agents|vasodilator agents|mesh-ancestor
102487128|NCT04450108|Gasotransmitters|gasotransmitters|mesh-ancestor
102487129|NCT04450108|Protective Agents|protective agents|mesh-ancestor
102487130|NCT03891849|Octreotide|octreotide|mesh-list
102487131|NCT03891849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102487132|NCT03891849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102487133|NCT03891849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102487134|NCT04341831|Teicoplanin|teicoplanin|mesh-list
102487135|NCT04341831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102487136|NCT04341831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102487137|NCT00361959|Fluticasone|fluticasone|mesh-list
102487138|NCT00361959|Xhance|xhance|mesh-list
102487139|NCT00361959|Bromides|bromides|mesh-list
102487140|NCT00361959|Tiotropium Bromide|tiotropium bromide|mesh-list
102487141|NCT00361959|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102487142|NCT00361959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102487143|NCT00361959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102487144|NCT00361959|Autonomic Agents|autonomic agents|mesh-ancestor
102487145|NCT00361959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102487146|NCT00361959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487147|NCT00361959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102487148|NCT00361959|Respiratory System Agents|respiratory system agents|mesh-ancestor
102487149|NCT00361959|Dermatologic Agents|dermatologic agents|mesh-ancestor
102487150|NCT00361959|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102487151|NCT00361959|Parasympatholytics|parasympatholytics|mesh-ancestor
102487152|NCT00361959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102487153|NCT00361959|Cholinergic Agents|cholinergic agents|mesh-ancestor
102487154|NCT00361959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102487155|NCT00361959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487156|NCT00361959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102487157|NCT00361959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102487158|NCT00361959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102487159|NCT00361959|Adrenergic Agents|adrenergic agents|mesh-ancestor
102487160|NCT00361959|Anticonvulsants|anticonvulsants|mesh-ancestor
102487161|NCT03158116|Aztreonam|aztreonam|mesh-list
102487162|NCT03158116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102487163|NCT03158116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102487164|NCT03096730|Sufentanil|sufentanil|mesh-list
102487165|NCT03096730|Dexmedetomidine|dexmedetomidine|mesh-list
102487166|NCT03096730|Remifentanil|remifentanil|mesh-list
102487167|NCT03096730|Dsuvia|dsuvia|mesh-list
102487168|NCT03096730|Nalmefene|nalmefene|mesh-list
102487169|NCT03096730|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102487170|NCT03096730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102487171|NCT03096730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487172|NCT03096730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102487173|NCT03096730|Analgesics|analgesics|mesh-ancestor
102487174|NCT03096730|Sensory System Agents|sensory system agents|mesh-ancestor
102487175|NCT03096730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102487176|NCT03096730|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102487177|NCT03096730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102487178|NCT03096730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102487179|NCT03096730|Adrenergic Agents|adrenergic agents|mesh-ancestor
102487180|NCT03096730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102487181|NCT03096730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487182|NCT03096730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102487183|NCT03096730|Narcotics|narcotics|mesh-ancestor
102487184|NCT03096730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102487185|NCT03096730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102487186|NCT03096730|Anesthetics, General|anesthetics, general|mesh-ancestor
102487187|NCT03096730|Anesthetics|anesthetics|mesh-ancestor
102487188|NCT03096730|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102487189|NCT00362037|Irbesartan|irbesartan|mesh-list
102487190|NCT00362037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102487191|NCT00362037|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102487192|NCT00362037|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102487193|NCT00362037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487194|NCT03161158|Diuretics|diuretics|mesh-list
102487195|NCT03161158|Natriuretic Agents|natriuretic agents|mesh-ancestor
102487196|NCT03161158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487197|NCT03161938|Dexamethasone|dexamethasone|mesh-list
102487198|NCT03161938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102487199|NCT03161938|Antiemetics|antiemetics|mesh-ancestor
102487200|NCT03161938|Autonomic Agents|autonomic agents|mesh-ancestor
102487201|NCT03161938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102487202|NCT03161938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487203|NCT03161938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102487204|NCT03161938|Glucocorticoids|glucocorticoids|mesh-ancestor
102487205|NCT03161938|Hormones|hormones|mesh-ancestor
102487206|NCT03161938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102487207|NCT03161938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102487208|NCT03161938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102487209|NCT03321045|Trastuzumab|trastuzumab|mesh-list
102487210|NCT03321045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102487211|NCT03321045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102487212|NCT00989989|Ranibizumab|ranibizumab|mesh-list
102487213|NCT00989989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102487214|NCT00989989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102487215|NCT00989989|Growth Substances|growth substances|mesh-ancestor
102487216|NCT00989989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487217|NCT00989989|Growth Inhibitors|growth inhibitors|mesh-ancestor
102487218|NCT00989989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102487219|NCT03802773|Cyclophosphamide|cyclophosphamide|mesh-list
102487220|NCT03802773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102487221|NCT03802773|Immunologic Factors|immunologic factors|mesh-ancestor
102487222|NCT03802773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487223|NCT03802773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102487224|NCT03802773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102487225|NCT03802773|Alkylating Agents|alkylating agents|mesh-ancestor
102487226|NCT03802773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487227|NCT03802773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102487228|NCT03802773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102487229|NCT03018301|Ketamine|ketamine|mesh-list
102487230|NCT03018301|Analgesics|analgesics|mesh-ancestor
102487231|NCT03018301|Sensory System Agents|sensory system agents|mesh-ancestor
102487232|NCT03018301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102487233|NCT03018301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487234|NCT03018301|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102487235|NCT03018301|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102487236|NCT03018301|Anesthetics, General|anesthetics, general|mesh-ancestor
102487237|NCT03018301|Anesthetics|anesthetics|mesh-ancestor
102487238|NCT03018301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102487239|NCT03018301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102487240|NCT03018301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102487241|NCT03018301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102487242|NCT03018301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487243|NCT00990769|Anesthetics|anesthetics|mesh-list
102487244|NCT00990769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102487245|NCT00990769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487246|NCT00991081|Bupropion|bupropion|mesh-list
102487247|NCT00991081|Nicotine|nicotine|mesh-list
102487248|NCT00991081|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102487249|NCT00991081|Autonomic Agents|autonomic agents|mesh-ancestor
102487250|NCT00991081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102487251|NCT00991081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487252|NCT00991081|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102487253|NCT00991081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102487254|NCT00991081|Cholinergic Agents|cholinergic agents|mesh-ancestor
102487255|NCT00991081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102487256|NCT00991081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487257|NCT00991081|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102487258|NCT00991081|Antidepressive Agents|antidepressive agents|mesh-ancestor
102487259|NCT00991081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102487260|NCT00991081|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102487261|NCT00991081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102487262|NCT00991081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102487263|NCT00991081|Dopamine Agents|dopamine agents|mesh-ancestor
102487264|NCT00991081|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102487265|NCT00991081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102487266|NCT00991081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102487267|NCT03168022|Amitriptyline|amitriptyline|mesh-list
102487268|NCT03168022|Cyclobenzaprine|cyclobenzaprine|mesh-list
102487269|NCT03168022|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102487270|NCT03168022|Antidepressive Agents|antidepressive agents|mesh-ancestor
102487271|NCT03168022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102487272|NCT03168022|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102487273|NCT03168022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487274|NCT03168022|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102487275|NCT03168022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102487276|NCT03168022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102487277|NCT03168022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102487278|NCT03168022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102487279|NCT03168022|Analgesics|analgesics|mesh-ancestor
102487280|NCT03168022|Sensory System Agents|sensory system agents|mesh-ancestor
102487281|NCT03168022|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102487282|NCT03168022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102487283|NCT03168022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102487284|NCT03168022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487285|NCT03168022|Adrenergic Agents|adrenergic agents|mesh-ancestor
102487286|NCT03168022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102487287|NCT03102190|Verapamil|verapamil|mesh-list
102487288|NCT03102190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102487289|NCT03102190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102487290|NCT03102190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102487291|NCT03102190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487292|NCT03102190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102487293|NCT03102190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487294|NCT03102190|Vasodilator Agents|vasodilator agents|mesh-ancestor
102487295|NCT03254667|Brodalumab|brodalumab|mesh-list
102487296|NCT03254667|Dermatologic Agents|dermatologic agents|mesh-ancestor
102487297|NCT03102736|Nitroprusside|nitroprusside|mesh-list
102487298|NCT03102736|Ketamine|ketamine|mesh-list
102487299|NCT03102736|Analgesics|analgesics|mesh-ancestor
102298924|NCT04959331|Fosfomycin|fosfomycin|mesh-list
102487300|NCT03102736|Sensory System Agents|sensory system agents|mesh-ancestor
102487301|NCT03102736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102487302|NCT03102736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487303|NCT03102736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102487304|NCT03102736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102487305|NCT03102736|Anesthetics, General|anesthetics, general|mesh-ancestor
102487307|NCT03102736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102487308|NCT03102736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102487309|NCT03102736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102487310|NCT03102736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102487311|NCT03102736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487312|NCT03102736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102487313|NCT03102736|Vasodilator Agents|vasodilator agents|mesh-ancestor
102487314|NCT03102736|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102487315|NCT03743103|Nitroprusside|nitroprusside|mesh-list
102487316|NCT03743103|Esmolol|esmolol|mesh-list
102487317|NCT03743103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102487318|NCT03743103|Vasodilator Agents|vasodilator agents|mesh-ancestor
102487319|NCT03743103|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102487320|NCT03743103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487321|NCT03743103|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102487322|NCT03743103|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102487323|NCT03743103|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102487324|NCT03743103|Adrenergic Agents|adrenergic agents|mesh-ancestor
102487325|NCT03743103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102487326|NCT03743103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487327|NCT04049266|Aflibercept|aflibercept|mesh-list
102487328|NCT04049266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102487329|NCT04049266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102487330|NCT04049266|Growth Substances|growth substances|mesh-ancestor
102487331|NCT04049266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487332|NCT04049266|Growth Inhibitors|growth inhibitors|mesh-ancestor
102487333|NCT04049266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102487334|NCT03217071|Pembrolizumab|pembrolizumab|mesh-list
102487335|NCT03217071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102487336|NCT03217071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102487337|NCT03217071|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102487338|NCT03217071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487339|NCT01502917|Antibodies|antibodies|mesh-list
102487340|NCT01502917|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102487341|NCT01502917|Immunologic Factors|immunologic factors|mesh-ancestor
102487342|NCT01502917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487343|NCT00362505|Clevudine|clevudine|mesh-list
102487344|NCT00362505|Antiviral Agents|antiviral agents|mesh-ancestor
102487345|NCT00362505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102487346|NCT00993187|Metformin|metformin|mesh-list
102487347|NCT00993187|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102487348|NCT00993187|Glimepiride|glimepiride|mesh-list
102487349|NCT00993187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102487350|NCT00993187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487351|NCT00993187|Incretins|incretins|mesh-ancestor
102487352|NCT00993187|Hormones|hormones|mesh-ancestor
102487353|NCT00993187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102487354|NCT00993187|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102487355|NCT00993187|Protease Inhibitors|protease inhibitors|mesh-ancestor
102487356|NCT00993187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102487357|NCT00993187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487358|NCT00993187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102487359|NCT00993187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102487360|NCT00993187|Immunologic Factors|immunologic factors|mesh-ancestor
102487361|NCT03173170|Itraconazole|itraconazole|mesh-list
102487362|NCT03173170|Antifungal Agents|antifungal agents|mesh-ancestor
102487363|NCT03173170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102487364|NCT03173170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102487365|NCT03173170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102487366|NCT03173170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102487367|NCT03173170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487368|NCT03173170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102487369|NCT03173170|Hormone Antagonists|hormone antagonists|mesh-ancestor
102487370|NCT03173170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102487371|NCT03173170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298995|NCT04939987|Anesthetics|anesthetics|mesh-ancestor
102487372|NCT03173170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102487373|NCT03106870|Insulin|insulin|mesh-list
102487374|NCT03106870|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102487375|NCT03106870|Metformin|metformin|mesh-list
102487376|NCT03106870|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
102487377|NCT03106870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102487378|NCT03106870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487379|NCT00375310|Gemcitabine|gemcitabine|mesh-list
102487380|NCT00375310|Sorafenib|sorafenib|mesh-list
102487381|NCT00375310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102487382|NCT00375310|Antimetabolites|antimetabolites|mesh-ancestor
102487383|NCT00375310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487384|NCT00375310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102487385|NCT00375310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102487386|NCT00375310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102487387|NCT03670953|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102487388|NCT03670953|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102487389|NCT03670953|Immunologic Factors|immunologic factors|mesh-ancestor
102487390|NCT03670953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487391|NCT03670953|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102487392|NCT03670953|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102487393|NCT03670953|Dopamine Agonists|dopamine agonists|mesh-ancestor
102487394|NCT03670953|Dopamine Agents|dopamine agents|mesh-ancestor
102487395|NCT03670953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102487396|NCT03670953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487397|NCT04736914|Zanubrutinib|zanubrutinib|mesh-list
102487398|NCT04736914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102487399|NCT04736914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102487400|NCT04736914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102487401|NCT04736914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487402|NCT00362583|Fentanyl|fentanyl|mesh-list
102487403|NCT00362583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102487404|NCT00362583|Narcotics|narcotics|mesh-ancestor
102487405|NCT00362583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102487406|NCT00362583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487407|NCT00362583|Analgesics|analgesics|mesh-ancestor
102487408|NCT00362583|Sensory System Agents|sensory system agents|mesh-ancestor
102487409|NCT00362583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102487410|NCT00362583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102487411|NCT00362583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102487412|NCT00362583|Anesthetics, General|anesthetics, general|mesh-ancestor
102487413|NCT00362583|Anesthetics|anesthetics|mesh-ancestor
102487414|NCT00657241|Valsartan|valsartan|mesh-list
102487415|NCT00657241|Carvedilol|carvedilol|mesh-list
102487416|NCT00657241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102487417|NCT00657241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102487418|NCT00657241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102487419|NCT00657241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487420|NCT00657241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102487421|NCT00657241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102487422|NCT00657241|Adrenergic Agents|adrenergic agents|mesh-ancestor
102487423|NCT00657241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102487424|NCT00657241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487425|NCT00657241|Antioxidants|antioxidants|mesh-ancestor
102487426|NCT00657241|Protective Agents|protective agents|mesh-ancestor
102487427|NCT00657241|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102487428|NCT00657241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102487429|NCT00657241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102487430|NCT00657241|Vasodilator Agents|vasodilator agents|mesh-ancestor
102487431|NCT00657241|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102487432|NCT00657241|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102487433|NCT04342065|Celecoxib|celecoxib|mesh-list
102487434|NCT04342065|Pregabalin|pregabalin|mesh-list
102487435|NCT04342065|Analgesics|analgesics|mesh-ancestor
102487436|NCT04342065|Sensory System Agents|sensory system agents|mesh-ancestor
102487437|NCT04342065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102487438|NCT04342065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487439|NCT04342065|Anticonvulsants|anticonvulsants|mesh-ancestor
102487440|NCT04342065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102487441|NCT04342065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102487442|NCT04342065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487443|NCT04342065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102487444|NCT04342065|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102299069|NCT02486653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102487445|NCT04342065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102487446|NCT04342065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102487447|NCT04342065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102487448|NCT04342065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102487449|NCT04342065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102487450|NCT04342065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102487451|NCT04342065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102487452|NCT04342065|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102487453|NCT04342065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102487454|NCT04342065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102487455|NCT03179410|Avelumab|avelumab|mesh-list
102487456|NCT03179410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102487457|NCT03179410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102487458|NCT00478465|Valganciclovir|valganciclovir|mesh-list
102487459|NCT00478465|Antiviral Agents|antiviral agents|mesh-ancestor
102487460|NCT00478465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102487461|NCT00421785|Acetylcysteine|acetylcysteine|mesh-list
102487462|NCT00421785|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102487463|NCT00421785|Antiviral Agents|antiviral agents|mesh-ancestor
102487464|NCT00421785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102487465|NCT00421785|Expectorants|expectorants|mesh-ancestor
102487466|NCT00421785|Respiratory System Agents|respiratory system agents|mesh-ancestor
102487467|NCT00421785|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102487468|NCT00421785|Antioxidants|antioxidants|mesh-ancestor
102487469|NCT00421785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487470|NCT00421785|Protective Agents|protective agents|mesh-ancestor
102487471|NCT00421785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487472|NCT00421785|Antidotes|antidotes|mesh-ancestor
102487473|NCT02519348|Bevacizumab|bevacizumab|mesh-list
102487474|NCT02519348|Durvalumab|durvalumab|mesh-list
102487475|NCT02519348|Tremelimumab|tremelimumab|mesh-list
102487476|NCT02519348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102487477|NCT02519348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102487478|NCT02519348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102487479|NCT02519348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102487480|NCT02519348|Growth Substances|growth substances|mesh-ancestor
102487481|NCT02519348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487482|NCT02519348|Growth Inhibitors|growth inhibitors|mesh-ancestor
102487483|NCT00421863|Amlodipine|amlodipine|mesh-list
102487484|NCT00421863|Telmisartan|telmisartan|mesh-list
102487485|NCT00421863|Clonidine|clonidine|mesh-list
102487486|NCT00421863|Ramipril|ramipril|mesh-list
102487487|NCT00421863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102487488|NCT00421863|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102487489|NCT00421863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102487490|NCT00421863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487491|NCT00421863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102487492|NCT00421863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487493|NCT00421863|Vasodilator Agents|vasodilator agents|mesh-ancestor
102487494|NCT00421863|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102487495|NCT00421863|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102487496|NCT00421863|Analgesics|analgesics|mesh-ancestor
102487497|NCT00421863|Sensory System Agents|sensory system agents|mesh-ancestor
102487498|NCT00421863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102487499|NCT00421863|Sympatholytics|sympatholytics|mesh-ancestor
102487500|NCT00421863|Autonomic Agents|autonomic agents|mesh-ancestor
102487501|NCT00421863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102487502|NCT00421863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102487503|NCT00421863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102487504|NCT00421863|Adrenergic Agents|adrenergic agents|mesh-ancestor
102487505|NCT00421863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102487506|NCT00421863|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102487507|NCT00421863|Protease Inhibitors|protease inhibitors|mesh-ancestor
102487508|NCT00421863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102487509|NCT00636818|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102487510|NCT00636818|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102487511|NCT00636818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102487512|NCT00636818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102487513|NCT00636818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487514|NCT00636818|Adrenergic Agents|adrenergic agents|mesh-ancestor
102487515|NCT00636818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102487516|NCT00636818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487517|NCT05363722|Bevacizumab|bevacizumab|mesh-list
102299144|NCT02447887|Antiviral Agents|antiviral agents|mesh-ancestor
102487518|NCT05363722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102487519|NCT05363722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102487520|NCT05363722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102487521|NCT05363722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102487522|NCT05363722|Growth Substances|growth substances|mesh-ancestor
102487523|NCT05363722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487524|NCT05363722|Growth Inhibitors|growth inhibitors|mesh-ancestor
102487525|NCT01922492|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102487526|NCT01922492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487527|NCT03127137|Triamcinolone|triamcinolone|mesh-list
102487528|NCT03127137|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102487529|NCT03127137|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102487531|NCT03127137|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102487532|NCT03127137|Anesthetics, Local|anesthetics, local|mesh-ancestor
102487533|NCT03127137|Anesthetics|anesthetics|mesh-ancestor
102487534|NCT03127137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102487535|NCT03127137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487536|NCT03127137|Sensory System Agents|sensory system agents|mesh-ancestor
102487537|NCT03127137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102487538|NCT03127137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102487539|NCT03127137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102487540|NCT03127137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102487541|NCT03127137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102487542|NCT03127137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487543|NCT03127137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102487544|NCT03127137|Glucocorticoids|glucocorticoids|mesh-ancestor
102487545|NCT03127137|Hormones|hormones|mesh-ancestor
102487546|NCT03127137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102487547|NCT03127137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102487548|NCT03127137|Immunologic Factors|immunologic factors|mesh-ancestor
102487549|NCT03127137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102487550|NCT03122847|Methylprednisolone|methylprednisolone|mesh-list
102487551|NCT03122847|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102487552|NCT03122847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102487553|NCT03122847|Prednisolone|prednisolone|mesh-list
102487554|NCT03122847|Prednisolone acetate|prednisolone acetate|mesh-list
102487555|NCT03122847|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102487556|NCT03122847|Prednisolone phosphate|prednisolone phosphate|mesh-list
102487557|NCT03122847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102487558|NCT03122847|Antiemetics|antiemetics|mesh-ancestor
102487559|NCT03122847|Autonomic Agents|autonomic agents|mesh-ancestor
102487560|NCT03122847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102487561|NCT03122847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487562|NCT03122847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102487563|NCT03122847|Glucocorticoids|glucocorticoids|mesh-ancestor
102487564|NCT03122847|Hormones|hormones|mesh-ancestor
102487565|NCT03122847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102487566|NCT03122847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102487567|NCT03122847|Protective Agents|protective agents|mesh-ancestor
102487568|NCT03122847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102487569|NCT03122847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102487570|NCT04342221|Hydroxychloroquine|hydroxychloroquine|mesh-list
102487571|NCT04342221|Antimalarials|antimalarials|mesh-ancestor
102487572|NCT04342221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102487573|NCT04342221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102487574|NCT04342221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102487575|NCT04342221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102487576|NCT04342221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487577|NCT04342221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102487578|NCT03525028|Metformin|metformin|mesh-list
102487579|NCT03525028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102487580|NCT03525028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487581|NCT00636194|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102487582|NCT00754312|Entinostat|entinostat|mesh-list
102487583|NCT00754312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102487584|NCT00754312|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102487585|NCT00754312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102487586|NCT00754312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487587|NCT03623373|Cytarabine|cytarabine|mesh-list
102487588|NCT03623373|Rituximab|rituximab|mesh-list
102487589|NCT03623373|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102487590|NCT03623373|Acalabrutinib|acalabrutinib|mesh-list
102487591|NCT03623373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102487592|NCT03623373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299217|NCT02469415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102487593|NCT03623373|Immunologic Factors|immunologic factors|mesh-ancestor
102487594|NCT03623373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487595|NCT03623373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102487596|NCT03623373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102487597|NCT03623373|Antimetabolites|antimetabolites|mesh-ancestor
102487598|NCT03623373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487599|NCT03623373|Antiviral Agents|antiviral agents|mesh-ancestor
102487600|NCT03623373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102487601|NCT03623373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102487602|NCT03623373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102487603|NCT03623373|Alkylating Agents|alkylating agents|mesh-ancestor
102487604|NCT04736524|Antibodies|antibodies|mesh-list
102487605|NCT04736524|Immunologic Factors|immunologic factors|mesh-ancestor
102487606|NCT04736524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487607|NCT00362661|Hydrocortisone|hydrocortisone|mesh-list
102487608|NCT00362661|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102487609|NCT00362661|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102487610|NCT00362661|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102487611|NCT00362661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102487612|NCT03410446|Ketamine|ketamine|mesh-list
102487613|NCT03410446|Analgesics|analgesics|mesh-ancestor
102487614|NCT03410446|Sensory System Agents|sensory system agents|mesh-ancestor
102487615|NCT03410446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102487616|NCT03410446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487617|NCT03410446|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102487618|NCT03410446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102487619|NCT03410446|Anesthetics, General|anesthetics, general|mesh-ancestor
102487620|NCT03410446|Anesthetics|anesthetics|mesh-ancestor
102487621|NCT03410446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102487622|NCT03410446|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102487623|NCT03410446|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102487624|NCT03410446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102487625|NCT03410446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487626|NCT00375388|Metformin|metformin|mesh-list
102487627|NCT00375388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102487628|NCT00375388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487629|NCT00375778|Memantine|memantine|mesh-list
102487630|NCT00375778|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102487631|NCT00375778|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102487632|NCT00375778|Dopamine Agents|dopamine agents|mesh-ancestor
102487633|NCT00375778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102487634|NCT00375778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487635|NCT00375778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487636|NCT00375778|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102487637|NCT00375778|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102487638|NCT00994123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102487639|NCT00994123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102487640|NCT00994123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102487641|NCT00994123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102487642|NCT00994123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487643|NCT03001726|Docetaxel|docetaxel|mesh-list
102487644|NCT03001726|Oxaliplatin|oxaliplatin|mesh-list
102487645|NCT03001726|Tegafur|tegafur|mesh-list
102487646|NCT03001726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102487647|NCT03001726|Tubulin Modulators|tubulin modulators|mesh-ancestor
102487648|NCT03001726|Antimitotic Agents|antimitotic agents|mesh-ancestor
102487649|NCT03001726|Mitosis Modulators|mitosis modulators|mesh-ancestor
102487650|NCT03001726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487651|NCT03001726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102487652|NCT03001726|Antimetabolites|antimetabolites|mesh-ancestor
102487653|NCT04697329|Levobupivacaine|levobupivacaine|mesh-list
102487654|NCT04697329|Anesthetics, Local|anesthetics, local|mesh-ancestor
102487655|NCT04697329|Anesthetics|anesthetics|mesh-ancestor
102487656|NCT04697329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102487657|NCT04697329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487658|NCT04697329|Sensory System Agents|sensory system agents|mesh-ancestor
102487659|NCT04697329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102487660|NCT03577431|Cyclophosphamide|cyclophosphamide|mesh-list
102487661|NCT03577431|Everolimus|everolimus|mesh-list
102487662|NCT03577431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102487663|NCT03577431|Immunologic Factors|immunologic factors|mesh-ancestor
102487664|NCT03577431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487665|NCT03577431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102487666|NCT03577431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102487667|NCT03577431|Alkylating Agents|alkylating agents|mesh-ancestor
102487668|NCT03577431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487669|NCT03577431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102487670|NCT03577431|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102487671|NCT03577431|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102487672|NCT03577431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102487673|NCT03577431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102487674|NCT04444843|Mycophenolic Acid|mycophenolic acid|mesh-list
102487675|NCT04444843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102487676|NCT04444843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102487677|NCT04444843|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102487678|NCT04444843|Antitubercular Agents|antitubercular agents|mesh-ancestor
102487679|NCT04444843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102487680|NCT04444843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102487681|NCT04444843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102487682|NCT04444843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487683|NCT04353193|Octreotide|octreotide|mesh-list
102487684|NCT04353193|Terlipressin|terlipressin|mesh-list
102487685|NCT04353193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102487686|NCT04353193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102487687|NCT04353193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102487688|NCT04353193|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102487689|NCT04353193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102487690|NCT01023841|Bimatoprost|bimatoprost|mesh-list
102487691|NCT01023841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102487692|NCT01023841|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102487693|NCT01023841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102487694|NCT00635648|Caspofungin|caspofungin|mesh-list
102487695|NCT00635648|Antifungal Agents|antifungal agents|mesh-ancestor
102487696|NCT00635648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102487697|NCT00635648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102487698|NCT00635648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487699|NCT05240456|Solifenacin Succinate|solifenacin succinate|mesh-list
102487700|NCT05240456|Cholinergic Antagonists|cholinergic antagonists|mesh-list
102487701|NCT05240456|Adrenergic Agents|adrenergic agents|mesh-list
102487702|NCT05240456|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-list
102487703|NCT05240456|Adrenergic Agonists|adrenergic agonists|mesh-list
102487704|NCT05240456|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102487705|NCT05240456|Cholinergic Agents|cholinergic agents|mesh-ancestor
102487706|NCT05240456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102487707|NCT05240456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487708|NCT05240456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487709|NCT05240456|Urological Agents|urological agents|mesh-ancestor
102487710|NCT05240456|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102487711|NCT03574779|Paclitaxel|paclitaxel|mesh-list
102487712|NCT03574779|Bevacizumab|bevacizumab|mesh-list
102487713|NCT03574779|Carboplatin|carboplatin|mesh-list
102487714|NCT03574779|Niraparib|niraparib|mesh-list
102487715|NCT03574779|Dostarlimab|dostarlimab|mesh-list
102487716|NCT03574779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102487717|NCT03574779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102487718|NCT03574779|Tubulin Modulators|tubulin modulators|mesh-ancestor
102487719|NCT03574779|Antimitotic Agents|antimitotic agents|mesh-ancestor
102487720|NCT03574779|Mitosis Modulators|mitosis modulators|mesh-ancestor
102487721|NCT03574779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487722|NCT03574779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102487723|NCT03574779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102487724|NCT03574779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102487725|NCT03574779|Growth Substances|growth substances|mesh-ancestor
102487726|NCT03574779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487727|NCT03574779|Growth Inhibitors|growth inhibitors|mesh-ancestor
102487728|NCT03574779|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102487729|NCT03574779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102487730|NCT04341883|Paclitaxel|paclitaxel|mesh-list
102487731|NCT04341883|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102487732|NCT04341883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102487733|NCT04341883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102487734|NCT04341883|Tubulin Modulators|tubulin modulators|mesh-ancestor
102487735|NCT04341883|Antimitotic Agents|antimitotic agents|mesh-ancestor
102487736|NCT04341883|Mitosis Modulators|mitosis modulators|mesh-ancestor
102487737|NCT04341883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487738|NCT00995761|Cisplatin|cisplatin|mesh-list
102487739|NCT00995761|Docetaxel|docetaxel|mesh-list
102487740|NCT00995761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102487741|NCT00995761|Tubulin Modulators|tubulin modulators|mesh-ancestor
102487742|NCT00995761|Antimitotic Agents|antimitotic agents|mesh-ancestor
102487743|NCT00995761|Mitosis Modulators|mitosis modulators|mesh-ancestor
102487744|NCT00995761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487745|NCT00362271|Aripiprazole|aripiprazole|mesh-list
102487746|NCT00362271|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102487747|NCT00362271|Antidepressive Agents|antidepressive agents|mesh-ancestor
102487748|NCT00362271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102487749|NCT00362271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102487750|NCT00362271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102487751|NCT00362271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102487752|NCT00362271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487753|NCT00362271|Dopamine Agonists|dopamine agonists|mesh-ancestor
102487754|NCT00362271|Dopamine Agents|dopamine agents|mesh-ancestor
102487755|NCT00362271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102487756|NCT00362271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487757|NCT00362271|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102487758|NCT00362271|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102487759|NCT00362271|Serotonin Agents|serotonin agents|mesh-ancestor
102487760|NCT00362271|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102487761|NCT00362271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102487762|NCT00362271|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102487763|NCT00362271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102487764|NCT00362271|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102487765|NCT00362271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102487766|NCT00362271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102487767|NCT00362271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102487768|NCT00635102|Cycloserine|cycloserine|mesh-list
102487769|NCT00635102|Glycine|glycine|mesh-list
102487770|NCT00635102|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102487771|NCT00635102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102487772|NCT00635102|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102487773|NCT00635102|Antitubercular Agents|antitubercular agents|mesh-ancestor
102487774|NCT00635102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102487775|NCT00635102|Antimetabolites|antimetabolites|mesh-ancestor
102487776|NCT00635102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487777|NCT00635102|Glycine Agents|glycine agents|mesh-ancestor
102487778|NCT00635102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102487779|NCT00635102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487780|NCT03041883|Riboflavin|riboflavin|mesh-list
102487781|NCT03041883|Vitamin B Complex|vitamin b complex|mesh-ancestor
102487782|NCT03041883|Vitamins|vitamins|mesh-ancestor
102487783|NCT03041883|Micronutrients|micronutrients|mesh-ancestor
102487784|NCT03041883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487785|NCT03041883|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102487786|NCT03041883|Dermatologic Agents|dermatologic agents|mesh-ancestor
102487787|NCT03034005|Budesonide|budesonide|mesh-list
102487788|NCT03034005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102487789|NCT03034005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102487790|NCT03034005|Autonomic Agents|autonomic agents|mesh-ancestor
102487791|NCT03034005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102487792|NCT03034005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487793|NCT03034005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102487794|NCT03034005|Respiratory System Agents|respiratory system agents|mesh-ancestor
101620430|NCT02640222|Vitamin K|vitamin k|mesh-list
102487795|NCT03034005|Glucocorticoids|glucocorticoids|mesh-ancestor
102487796|NCT03034005|Hormones|hormones|mesh-ancestor
102487797|NCT03034005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102487798|NCT04296916|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102487799|NCT04296916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102487800|NCT00635024|Melphalan|melphalan|mesh-list
102487801|NCT00635024|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102487802|NCT00635024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102487803|NCT00635024|Alkylating Agents|alkylating agents|mesh-ancestor
102487804|NCT00635024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487805|NCT00635024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102487806|NCT00635024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102487807|NCT00635024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102487808|NCT00635024|Immunologic Factors|immunologic factors|mesh-ancestor
102487809|NCT00635024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487810|NCT03182920|Lasmiditan|lasmiditan|mesh-list
102487811|NCT03182920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102487812|NCT03182920|Serotonin Agents|serotonin agents|mesh-ancestor
102487813|NCT03182920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102487814|NCT03182920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487815|NCT03182920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487816|NCT03485547|Venetoclax|venetoclax|mesh-list
102487817|NCT03485547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102487818|NCT03187678|Selexipag|selexipag|mesh-list
102487819|NCT03187678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102487820|NCT03192826|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102487821|NCT03192826|Lubricant Eye Drops|lubricant eye drops|mesh-list
102487822|NCT03192826|Dipivefrin|dipivefrin|mesh-list
102487823|NCT03192826|Brinzolamide|brinzolamide|mesh-list
102487824|NCT03192826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102487825|NCT03192826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102487826|NCT03192826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102487827|NCT03192826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102487828|NCT03192826|Adrenergic Agents|adrenergic agents|mesh-ancestor
102487829|NCT03192826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102487830|NCT03192826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487831|NCT03192826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487832|NCT03192826|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102487833|NCT03192826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102487834|NCT03192826|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102487835|NCT03192826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102487836|NCT03287674|Cyclophosphamide|cyclophosphamide|mesh-list
102487837|NCT03287674|Nivolumab|nivolumab|mesh-list
102487838|NCT03287674|Fludarabine|fludarabine|mesh-list
102487839|NCT03287674|Fludarabine phosphate|fludarabine phosphate|mesh-list
102487840|NCT03287674|Ipilimumab|ipilimumab|mesh-list
102487841|NCT03287674|Interleukin-2|interleukin-2|mesh-list
102487842|NCT03287674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102487843|NCT03287674|Immunologic Factors|immunologic factors|mesh-ancestor
102487844|NCT03287674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487845|NCT03287674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102487846|NCT03287674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102487847|NCT03287674|Alkylating Agents|alkylating agents|mesh-ancestor
102487848|NCT03287674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487849|NCT03287674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102487850|NCT03287674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102487851|NCT03287674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102487852|NCT03287674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102487853|NCT03287674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102487854|NCT03287674|Antimetabolites|antimetabolites|mesh-ancestor
102487855|NCT03287674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102487856|NCT03287674|Analgesics|analgesics|mesh-ancestor
102487857|NCT03287674|Sensory System Agents|sensory system agents|mesh-ancestor
102487858|NCT03287674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102487859|NCT00634244|Cytarabine|cytarabine|mesh-list
102487860|NCT00634244|Sirolimus|sirolimus|mesh-list
102487861|NCT00634244|Carboplatin|carboplatin|mesh-list
102487862|NCT00634244|Etoposide|etoposide|mesh-list
102487863|NCT00634244|Etoposide phosphate|etoposide phosphate|mesh-list
102487864|NCT00634244|Topotecan|topotecan|mesh-list
102487865|NCT00634244|Mitoxantrone|mitoxantrone|mesh-list
102487866|NCT00634244|Alvocidib|alvocidib|mesh-list
102487867|NCT00634244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102487868|NCT00634244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102487869|NCT00634244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102487870|NCT00634244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102487871|NCT00634244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102487872|NCT00634244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487873|NCT00634244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102487874|NCT00634244|Antimetabolites|antimetabolites|mesh-ancestor
102487875|NCT00634244|Antiviral Agents|antiviral agents|mesh-ancestor
102487876|NCT00634244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102487877|NCT00634244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102487878|NCT00634244|Immunologic Factors|immunologic factors|mesh-ancestor
102487879|NCT00634244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487880|NCT00634244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102487881|NCT00634244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102487882|NCT00634244|Antifungal Agents|antifungal agents|mesh-ancestor
102487883|NCT00634244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102487884|NCT00634244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102487885|NCT00634244|Analgesics|analgesics|mesh-ancestor
102487886|NCT00634244|Sensory System Agents|sensory system agents|mesh-ancestor
102487887|NCT00634244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102487888|NCT00634244|Growth Inhibitors|growth inhibitors|mesh-ancestor
102487889|NCT00634244|Growth Substances|growth substances|mesh-ancestor
102487890|NCT01922804|Vitamins|vitamins|mesh-list
102487891|NCT01922804|Micronutrients|micronutrients|mesh-ancestor
102487892|NCT01922804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487893|NCT03289858|Bupivacaine|bupivacaine|mesh-list
102487894|NCT03289858|Anesthetics, Local|anesthetics, local|mesh-ancestor
102487895|NCT03289858|Anesthetics|anesthetics|mesh-ancestor
102487896|NCT03289858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102487897|NCT03289858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487899|NCT03289858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102487900|NCT03418714|Salvinorin A|salvinorin a|mesh-list
102487901|NCT03418714|Hallucinogens|hallucinogens|mesh-ancestor
102487902|NCT03418714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487903|NCT03418714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102487904|NCT03421210|Nicotine|nicotine|mesh-list
102487905|NCT03421210|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102487906|NCT03421210|Autonomic Agents|autonomic agents|mesh-ancestor
102487907|NCT03421210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102487908|NCT03421210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487909|NCT03421210|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102487910|NCT03421210|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102487911|NCT03421210|Cholinergic Agents|cholinergic agents|mesh-ancestor
102487912|NCT03421210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102487913|NCT03421210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487914|NCT03294850|Cholic Acids|cholic acids|mesh-list
102487915|NCT03294850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102487916|NCT00996931|Lenalidomide|lenalidomide|mesh-list
102487917|NCT00996931|Immunologic Factors|immunologic factors|mesh-ancestor
102487918|NCT00996931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487919|NCT00996931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102487920|NCT00996931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102487921|NCT00996931|Growth Substances|growth substances|mesh-ancestor
102487922|NCT00996931|Growth Inhibitors|growth inhibitors|mesh-ancestor
102487923|NCT00996931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102487924|NCT00634088|Capecitabine|capecitabine|mesh-list
102487925|NCT00634088|Lapatinib|lapatinib|mesh-list
102487926|NCT00634088|Epothilones|epothilones|mesh-list
102487927|NCT00634088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102487928|NCT00634088|Antimetabolites|antimetabolites|mesh-ancestor
102487929|NCT00634088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487930|NCT00634088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102487931|NCT00634088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102487932|NCT00634088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102487933|NCT00634088|Tubulin Modulators|tubulin modulators|mesh-ancestor
102487934|NCT00634088|Antimitotic Agents|antimitotic agents|mesh-ancestor
102487935|NCT00634088|Mitosis Modulators|mitosis modulators|mesh-ancestor
102487936|NCT03428230|Acetaminophen|acetaminophen|mesh-list
102487937|NCT03428230|Chloroprocaine|chloroprocaine|mesh-list
102487938|NCT03428230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102487939|NCT03428230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102487940|NCT03428230|Analgesics|analgesics|mesh-ancestor
102487941|NCT03428230|Sensory System Agents|sensory system agents|mesh-ancestor
102487942|NCT03428230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102487943|NCT03428230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487944|NCT03428230|Antipyretics|antipyretics|mesh-ancestor
102487945|NCT03428230|Anesthetics, Local|anesthetics, local|mesh-ancestor
102487946|NCT03428230|Anesthetics|anesthetics|mesh-ancestor
102487947|NCT03428230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102487948|NCT03296800|Bexagliflozin|bexagliflozin|mesh-list
102487949|NCT03296800|Rifampin|rifampin|mesh-list
102487950|NCT03296800|Probenecid|probenecid|mesh-list
102487951|NCT03296800|Verapamil|verapamil|mesh-list
102487952|NCT03296800|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102487953|NCT03296800|Antitubercular Agents|antitubercular agents|mesh-ancestor
102487954|NCT03296800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102487955|NCT03296800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102487956|NCT03296800|Leprostatic Agents|leprostatic agents|mesh-ancestor
102487957|NCT03296800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102487958|NCT03296800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102487959|NCT03296800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487960|NCT03296800|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102487961|NCT03296800|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102487962|NCT03296800|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102487963|NCT03296800|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102487964|NCT03296800|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102487965|NCT03296800|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102487966|NCT03296800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102487967|NCT03296800|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102299592|NCT01638533|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102487968|NCT03296800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102487969|NCT03296800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102487970|NCT03296800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487971|NCT03296800|Vasodilator Agents|vasodilator agents|mesh-ancestor
102487972|NCT03296800|Uricosuric Agents|uricosuric agents|mesh-ancestor
102487973|NCT03296800|Gout Suppressants|gout suppressants|mesh-ancestor
102487974|NCT03296800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102487975|NCT03296800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102487976|NCT00634010|Morphine|morphine|mesh-list
102487977|NCT00634010|Methadone|methadone|mesh-list
102487978|NCT00634010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102487979|NCT00634010|Narcotics|narcotics|mesh-ancestor
102487980|NCT00634010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102487981|NCT00634010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487982|NCT00634010|Analgesics|analgesics|mesh-ancestor
102487983|NCT00634010|Sensory System Agents|sensory system agents|mesh-ancestor
102487984|NCT00634010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102487985|NCT00634010|Antitussive Agents|antitussive agents|mesh-ancestor
102487986|NCT00634010|Respiratory System Agents|respiratory system agents|mesh-ancestor
102487987|NCT00633932|Esomeprazole|esomeprazole|mesh-list
102487988|NCT00633932|Omeprazole|omeprazole|mesh-list
102487989|NCT00633932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102487990|NCT00633932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102487991|NCT00633932|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102487992|NCT00633932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102487993|NCT00633932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102487994|NCT01028677|Oxytocin|oxytocin|mesh-list
102487995|NCT01028677|Oxytocics|oxytocics|mesh-ancestor
102487996|NCT01028677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102487997|NCT01028677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102487998|NCT03302416|Hydrocortisone|hydrocortisone|mesh-list
102487999|NCT03302416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102488000|NCT01000285|Raltegravir Potassium|raltegravir potassium|mesh-list
102488001|NCT01000285|Prednisone|prednisone|mesh-list
102488002|NCT01000285|Cyclophosphamide|cyclophosphamide|mesh-list
102488003|NCT01000285|Doxorubicin|doxorubicin|mesh-list
102488004|NCT01000285|Etoposide|etoposide|mesh-list
102488005|NCT01000285|Vincristine|vincristine|mesh-list
102488006|NCT01000285|Bortezomib|bortezomib|mesh-list
102488007|NCT01000285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102488008|NCT01000285|Immunologic Factors|immunologic factors|mesh-ancestor
102488009|NCT01000285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488010|NCT01000285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102488011|NCT01000285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102488012|NCT01000285|Alkylating Agents|alkylating agents|mesh-ancestor
102488013|NCT01000285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488014|NCT01000285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102488015|NCT01000285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101620639|NCT05804591|Pregabalin|pregabalin|mesh-list
102488016|NCT01000285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102488017|NCT01000285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102488018|NCT01000285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102488019|NCT01000285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102488020|NCT01000285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102488021|NCT01000285|Glucocorticoids|glucocorticoids|mesh-ancestor
102488022|NCT01000285|Hormones|hormones|mesh-ancestor
102488023|NCT01000285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102488024|NCT01000285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102488025|NCT01000285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102488026|NCT01000285|Tubulin Modulators|tubulin modulators|mesh-ancestor
102488027|NCT01000285|Antimitotic Agents|antimitotic agents|mesh-ancestor
102488028|NCT01000285|Mitosis Modulators|mitosis modulators|mesh-ancestor
102488029|NCT01000285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102488030|NCT01000285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102488031|NCT01000285|Antiviral Agents|antiviral agents|mesh-ancestor
102488032|NCT01000285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102488033|NCT01000285|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102488034|NCT01000285|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102488035|NCT01000987|Varenicline|varenicline|mesh-list
102488036|NCT01000987|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102488037|NCT01000987|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102488038|NCT01000987|Cholinergic Agents|cholinergic agents|mesh-ancestor
102488039|NCT01000987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102488040|NCT01000987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488041|NCT01000987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488042|NCT00633464|Cetuximab|cetuximab|mesh-list
102488043|NCT00633464|Epothilones|epothilones|mesh-list
102299666|NCT02436889|Mirabegron|mirabegron|mesh-list
102488044|NCT00633464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102488045|NCT00633464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102488046|NCT00633464|Tubulin Modulators|tubulin modulators|mesh-ancestor
102488047|NCT00633464|Antimitotic Agents|antimitotic agents|mesh-ancestor
102488048|NCT00633464|Mitosis Modulators|mitosis modulators|mesh-ancestor
102488049|NCT00633464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488051|NCT03437044|Ticagrelor|ticagrelor|mesh-list
102488052|NCT03437044|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102488053|NCT03437044|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102488054|NCT03437044|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102488055|NCT03437044|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102488056|NCT03437044|Purinergic Agents|purinergic agents|mesh-ancestor
102488057|NCT03437044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102488058|NCT03437044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488059|NCT03437044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488060|NCT01923194|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102488061|NCT01923194|Hormones|hormones|mesh-ancestor
102488062|NCT01923194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102488063|NCT01923194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488064|NCT03303196|Pancrelipase|pancrelipase|mesh-list
102488065|NCT03303196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102488066|NCT00633152|Linezolid|linezolid|mesh-list
102488067|NCT00633152|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
102488068|NCT00633152|Cephalosporins|cephalosporins|mesh-list
102488069|NCT00633152|Aztreonam|aztreonam|mesh-list
102488070|NCT00633152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102488071|NCT00633152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102488072|NCT00633152|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102488073|NCT00633152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102488074|NCT00633152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488075|NCT01030783|Sorafenib|sorafenib|mesh-list
102488076|NCT01030783|Tivozanib|tivozanib|mesh-list
102488077|NCT01030783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102488078|NCT01030783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102488079|NCT01030783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102488080|NCT01030783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488081|NCT00633074|Vaccines|vaccines|mesh-list
102488082|NCT00633074|Immunologic Factors|immunologic factors|mesh-ancestor
102488083|NCT00633074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488084|NCT03304054|Amifampridine|amifampridine|mesh-list
102488085|NCT03304054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102488086|NCT03304054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102488087|NCT03304054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488088|NCT03304054|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102488089|NCT03304054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102488090|NCT03304054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488091|NCT01929278|Clindamycin|clindamycin|mesh-list
102488092|NCT01929278|Clindamycin palmitate|clindamycin palmitate|mesh-list
102488093|NCT01929278|Clindamycin phosphate|clindamycin phosphate|mesh-list
102488094|NCT01929278|Tretinoin|tretinoin|mesh-list
102488095|NCT01929278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102488096|NCT01929278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102488097|NCT01929278|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102488098|NCT01929278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102488099|NCT01929278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488100|NCT01929278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102488101|NCT01929278|Keratolytic Agents|keratolytic agents|mesh-ancestor
102488102|NCT01929278|Dermatologic Agents|dermatologic agents|mesh-ancestor
102488103|NCT03210376|Neostigmine|neostigmine|mesh-list
102488104|NCT03210376|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102488105|NCT03210376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102488106|NCT03210376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488107|NCT03210376|Cholinergic Agents|cholinergic agents|mesh-ancestor
102488108|NCT03210376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102488109|NCT03210376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488110|NCT03210376|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102488111|NCT03210376|Autonomic Agents|autonomic agents|mesh-ancestor
102488112|NCT03210376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102488113|NCT01929512|Metformin|metformin|mesh-list
102488114|NCT01929512|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102488115|NCT01929512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102488116|NCT01929512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488117|NCT01929512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102488118|NCT01929512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102488119|NCT01929512|Antimetabolites|antimetabolites|mesh-ancestor
102488120|NCT01929512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488121|NCT01929512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102488122|NCT01929512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102488123|NCT01929512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102488124|NCT03211234|Ranibizumab|ranibizumab|mesh-list
102488125|NCT03211234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102488126|NCT03211234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102488127|NCT03211234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102488128|NCT03211234|Growth Substances|growth substances|mesh-ancestor
102488129|NCT03211234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488130|NCT03211234|Growth Inhibitors|growth inhibitors|mesh-ancestor
102488131|NCT03211234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102488132|NCT03105518|Acetaminophen|acetaminophen|mesh-list
102488133|NCT03105518|Fentanyl|fentanyl|mesh-list
102488134|NCT03105518|Oxycodone|oxycodone|mesh-list
102488135|NCT03105518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102488136|NCT03105518|Narcotics|narcotics|mesh-ancestor
102488137|NCT03105518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102488138|NCT03105518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488139|NCT03105518|Analgesics|analgesics|mesh-ancestor
102488140|NCT03105518|Sensory System Agents|sensory system agents|mesh-ancestor
102488141|NCT03105518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102488142|NCT03105518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102488143|NCT03105518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102488144|NCT03105518|Anesthetics, General|anesthetics, general|mesh-ancestor
102488145|NCT03105518|Anesthetics|anesthetics|mesh-ancestor
102488146|NCT03105518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102488147|NCT03105518|Antipyretics|antipyretics|mesh-ancestor
102488148|NCT01929668|Ascorbic Acid|ascorbic acid|mesh-list
102488149|NCT01929668|Antioxidants|antioxidants|mesh-ancestor
102488150|NCT01929668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488151|NCT01929668|Protective Agents|protective agents|mesh-ancestor
102488152|NCT01929668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488153|NCT01929668|Vitamins|vitamins|mesh-ancestor
102488154|NCT01929668|Micronutrients|micronutrients|mesh-ancestor
102488155|NCT01929746|Daclizumab|daclizumab|mesh-list
102488156|NCT01929746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102488157|NCT01929746|Immunologic Factors|immunologic factors|mesh-ancestor
102488158|NCT01929746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488159|NCT03506048|Lenvatinib|lenvatinib|mesh-list
102488160|NCT03506048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102488161|NCT03506048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102488162|NCT03506048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102488163|NCT03506048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488164|NCT02161705|Ropivacaine|ropivacaine|mesh-list
102488165|NCT02161705|Anesthetics, Local|anesthetics, local|mesh-ancestor
102488166|NCT02161705|Anesthetics|anesthetics|mesh-ancestor
102488167|NCT02161705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102488168|NCT02161705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488169|NCT02161705|Sensory System Agents|sensory system agents|mesh-ancestor
102488170|NCT02161705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102488171|NCT01929824|Nitric Oxide|nitric oxide|mesh-list
102488172|NCT01929824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102488173|NCT01929824|Autonomic Agents|autonomic agents|mesh-ancestor
102488174|NCT01929824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102488175|NCT01929824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488176|NCT01929824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102488177|NCT01929824|Respiratory System Agents|respiratory system agents|mesh-ancestor
102488178|NCT01929824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102488179|NCT01929824|Antioxidants|antioxidants|mesh-ancestor
102488180|NCT01929824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488181|NCT01929824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102488182|NCT01929824|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102488183|NCT01929824|Vasodilator Agents|vasodilator agents|mesh-ancestor
102488184|NCT01929824|Gasotransmitters|gasotransmitters|mesh-ancestor
102488185|NCT01929824|Protective Agents|protective agents|mesh-ancestor
102488186|NCT01031953|Fosaprepitant|fosaprepitant|mesh-list
102488187|NCT01031953|Aprepitant|aprepitant|mesh-list
102488188|NCT01031953|Antiemetics|antiemetics|mesh-ancestor
102488189|NCT01031953|Autonomic Agents|autonomic agents|mesh-ancestor
102488190|NCT01031953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102488191|NCT01031953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488192|NCT01031953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102488193|NCT01031953|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102488194|NCT01031953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102488195|NCT01031953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488196|NCT01923584|Ubiquinone|ubiquinone|mesh-list
102488197|NCT01923584|Micronutrients|micronutrients|mesh-ancestor
102488198|NCT01923584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488199|NCT00630344|Everolimus|everolimus|mesh-list
102488200|NCT00630344|Bicalutamide|bicalutamide|mesh-list
102488201|NCT00630344|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102488202|NCT00630344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102488203|NCT00630344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102488204|NCT00630344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488205|NCT00630344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102488206|NCT00630344|Immunologic Factors|immunologic factors|mesh-ancestor
102488207|NCT00630344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488208|NCT00630344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102488209|NCT00630344|Androgen Antagonists|androgen antagonists|mesh-ancestor
102488210|NCT00630344|Hormone Antagonists|hormone antagonists|mesh-ancestor
102488211|NCT00630344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102488212|NCT01923818|Aspirin|aspirin|mesh-list
102488213|NCT01923818|Rivaroxaban|rivaroxaban|mesh-list
102488214|NCT01923818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102488215|NCT01923818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102488216|NCT01923818|Analgesics|analgesics|mesh-ancestor
102488217|NCT01923818|Sensory System Agents|sensory system agents|mesh-ancestor
102488218|NCT01923818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102488219|NCT01923818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488220|NCT01923818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102488221|NCT01923818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102488222|NCT01923818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102488223|NCT01923818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102488224|NCT01923818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488225|NCT01923818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101620860|NCT05752734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102488226|NCT01923818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102488227|NCT01923818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102488228|NCT01923818|Antipyretics|antipyretics|mesh-ancestor
102488229|NCT01923818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102488230|NCT01923818|Antithrombins|antithrombins|mesh-ancestor
102488231|NCT01923818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102488232|NCT01923818|Protease Inhibitors|protease inhibitors|mesh-ancestor
102488233|NCT01923818|Anticoagulants|anticoagulants|mesh-ancestor
102488234|NCT02169115|Omalizumab|omalizumab|mesh-list
102488235|NCT02169115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102488236|NCT02169115|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102488237|NCT02169115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102488238|NCT02169115|Respiratory System Agents|respiratory system agents|mesh-ancestor
102488239|NCT02169115|Immunologic Factors|immunologic factors|mesh-ancestor
102488240|NCT02169115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488241|NCT00376792|Docetaxel|docetaxel|mesh-list
102488242|NCT00376792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102488243|NCT00376792|Tubulin Modulators|tubulin modulators|mesh-ancestor
102488244|NCT00376792|Antimitotic Agents|antimitotic agents|mesh-ancestor
102488245|NCT00376792|Mitosis Modulators|mitosis modulators|mesh-ancestor
102488246|NCT00376792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488247|NCT00635882|Mometasone Furoate|mometasone furoate|mesh-list
102488248|NCT00635882|Formoterol Fumarate|formoterol fumarate|mesh-list
102488249|NCT00635882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102488250|NCT00635882|Autonomic Agents|autonomic agents|mesh-ancestor
102488251|NCT00635882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102488252|NCT00635882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488253|NCT00635882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102488254|NCT00635882|Respiratory System Agents|respiratory system agents|mesh-ancestor
102488255|NCT00635882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102488256|NCT00635882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102488257|NCT00635882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102488258|NCT00635882|Adrenergic Agents|adrenergic agents|mesh-ancestor
102488259|NCT00635882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102488260|NCT00635882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488261|NCT00635882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102488262|NCT00635882|Dermatologic Agents|dermatologic agents|mesh-ancestor
102488263|NCT00635882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102488264|NCT03316378|Ropivacaine|ropivacaine|mesh-list
102488265|NCT03316378|Anesthetics, Local|anesthetics, local|mesh-ancestor
102488266|NCT03316378|Anesthetics|anesthetics|mesh-ancestor
102488267|NCT03316378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102488268|NCT03316378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488269|NCT03316378|Sensory System Agents|sensory system agents|mesh-ancestor
102488270|NCT03316378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102488271|NCT00637130|Travoprost|travoprost|mesh-list
102488272|NCT00637130|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102299890|NCT05650437|Vitamins|vitamins|mesh-ancestor
102488274|NCT00637130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102488275|NCT02847559|Bevacizumab|bevacizumab|mesh-list
102488276|NCT02847559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102488277|NCT02847559|Endothelial Growth Factors|endothelial growth factors|mesh-list
102488278|NCT02847559|Antibodies|antibodies|mesh-list
102488279|NCT02847559|Immunoglobulins|immunoglobulins|mesh-list
102488280|NCT02847559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102488281|NCT02847559|Immunoglobulin G|immunoglobulin g|mesh-list
102488282|NCT02847559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102488283|NCT02847559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102488284|NCT02847559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102488285|NCT02847559|Growth Substances|growth substances|mesh-ancestor
102488286|NCT02847559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488287|NCT02847559|Growth Inhibitors|growth inhibitors|mesh-ancestor
102488288|NCT02847559|Immunologic Factors|immunologic factors|mesh-ancestor
102488289|NCT00637052|Filanesib|filanesib|mesh-list
102488290|NCT00637052|Antimitotic Agents|antimitotic agents|mesh-ancestor
102488291|NCT00637052|Mitosis Modulators|mitosis modulators|mesh-ancestor
102488292|NCT00637052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488293|NCT00637052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102488294|NCT01921868|Acetylcarnitine|acetylcarnitine|mesh-list
102488295|NCT01921868|Vitamin B Complex|vitamin b complex|mesh-ancestor
102488296|NCT01921868|Vitamins|vitamins|mesh-ancestor
102488297|NCT01921868|Micronutrients|micronutrients|mesh-ancestor
102488298|NCT01921868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488299|NCT01921868|Nootropic Agents|nootropic agents|mesh-ancestor
102488300|NCT02150785|Streptokinase|streptokinase|mesh-list
102488301|NCT02150785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102488302|NCT02150785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102488303|NCT02150785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488304|NCT01926158|Denosumab|denosumab|mesh-list
102488305|NCT01926158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102488306|NCT01926158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488307|NCT03445390|Acetaminophen|acetaminophen|mesh-list
102488308|NCT03445390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102488309|NCT03445390|Analgesics|analgesics|mesh-ancestor
102488310|NCT03445390|Sensory System Agents|sensory system agents|mesh-ancestor
102488311|NCT03445390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102488312|NCT03445390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488313|NCT03445390|Antipyretics|antipyretics|mesh-ancestor
102488314|NCT00981890|Sunitinib|sunitinib|mesh-list
102488315|NCT00981890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102488316|NCT00981890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102488317|NCT00981890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102488318|NCT00981890|Growth Substances|growth substances|mesh-ancestor
102488319|NCT00981890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488320|NCT00981890|Growth Inhibitors|growth inhibitors|mesh-ancestor
102488321|NCT00981890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102488322|NCT00981890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102488323|NCT00981890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488324|NCT03221764|Amiodarone|amiodarone|mesh-list
102488325|NCT03221764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102488326|NCT03221764|Vasodilator Agents|vasodilator agents|mesh-ancestor
102488327|NCT03221764|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102488328|NCT03221764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102488329|NCT03221764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488330|NCT03221764|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102488331|NCT03221764|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102488332|NCT03221764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102488333|NCT03221764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102488334|NCT03221764|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102488335|NCT03221764|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102488336|NCT03221764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102488337|NCT03122444|Imipramine|imipramine|mesh-list
102488338|NCT03122444|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102488339|NCT03122444|Antidepressive Agents|antidepressive agents|mesh-ancestor
102488340|NCT03122444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102488341|NCT03122444|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102488342|NCT03122444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102488343|NCT03122444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102488344|NCT03122444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488345|NCT03122444|Adrenergic Agents|adrenergic agents|mesh-ancestor
102488346|NCT03122444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102488347|NCT03122444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488348|NCT02169427|Opicapone|opicapone|mesh-list
102488349|NCT02169427|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102488350|NCT02169427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102488351|NCT02169427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488352|NCT02169427|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102488353|NCT02169427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102488354|NCT03454048|Pyrimethamine|pyrimethamine|mesh-list
102488355|NCT03454048|Piperaquine|piperaquine|mesh-list
102488356|NCT03454048|Sulfadoxine|sulfadoxine|mesh-list
102488357|NCT03454048|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
102488358|NCT03454048|Atovaquone|atovaquone|mesh-list
102488359|NCT03454048|Proguanil|proguanil|mesh-list
102488360|NCT03454048|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
102488361|NCT03454048|Antimalarials|antimalarials|mesh-ancestor
102488362|NCT03454048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102488363|NCT03454048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102488364|NCT03454048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102488365|NCT03454048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102488366|NCT03454048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102488367|NCT03454048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488368|NCT03454048|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102488369|NCT03454048|Antimetabolites|antimetabolites|mesh-ancestor
102488370|NCT04396184|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102488371|NCT04396184|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102488372|NCT04396184|Dermatologic Agents|dermatologic agents|mesh-ancestor
102488373|NCT01924286|Prednisone|prednisone|mesh-list
102488374|NCT01924286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102488375|NCT01924286|Glucocorticoids|glucocorticoids|mesh-ancestor
102488376|NCT01924286|Hormones|hormones|mesh-ancestor
102488377|NCT01924286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102488378|NCT01924286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488379|NCT01924286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102488380|NCT01924286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102488381|NCT03455218|Nitric Oxide|nitric oxide|mesh-list
102488382|NCT03455218|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102488383|NCT03455218|Autonomic Agents|autonomic agents|mesh-ancestor
102488384|NCT03455218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102488385|NCT03455218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488386|NCT03455218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102488387|NCT03455218|Respiratory System Agents|respiratory system agents|mesh-ancestor
102488388|NCT03455218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102488389|NCT03455218|Antioxidants|antioxidants|mesh-ancestor
102488390|NCT03455218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488391|NCT03455218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102488392|NCT03455218|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102488393|NCT03455218|Vasodilator Agents|vasodilator agents|mesh-ancestor
102488394|NCT03455218|Gasotransmitters|gasotransmitters|mesh-ancestor
102488395|NCT03455218|Protective Agents|protective agents|mesh-ancestor
102488396|NCT01050907|Miltefosine|miltefosine|mesh-list
102488397|NCT01050907|Antifungal Agents|antifungal agents|mesh-ancestor
102488398|NCT01050907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102488399|NCT01050907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102488400|NCT01050907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102488401|NCT01050907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102488402|NCT01924520|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102488403|NCT01924520|Antidepressive Agents|antidepressive agents|mesh-ancestor
102488404|NCT01924520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102488405|NCT01924520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102488406|NCT01924520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102488407|NCT01924520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102488408|NCT01924520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488409|NCT04433845|Psilocybin|psilocybin|mesh-list
102488410|NCT04433845|Hallucinogens|hallucinogens|mesh-ancestor
102488411|NCT04433845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488412|NCT04433845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102488413|NCT01920386|Acetaminophen|acetaminophen|mesh-list
102488414|NCT01920386|Tramadol|tramadol|mesh-list
102488415|NCT01920386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102488416|NCT01920386|Analgesics|analgesics|mesh-ancestor
102488417|NCT01920386|Sensory System Agents|sensory system agents|mesh-ancestor
102488418|NCT01920386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102488419|NCT01920386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488420|NCT01920386|Antipyretics|antipyretics|mesh-ancestor
102300043|NCT05244057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102488421|NCT01920386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102488422|NCT01920386|Narcotics|narcotics|mesh-ancestor
102488423|NCT01920386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102488424|NCT03460990|Ivacaftor|ivacaftor|mesh-list
102488425|NCT03460990|VX-659|vx-659|mesh-list
102488426|NCT03460990|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102488427|NCT03460990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102488428|NCT03460990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488429|NCT01924832|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102488430|NCT01924832|Dermatologic Agents|dermatologic agents|mesh-ancestor
102488431|NCT01924832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102488432|NCT01924832|Immunologic Factors|immunologic factors|mesh-ancestor
102488433|NCT01924832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488434|NCT01920542|Dexmedetomidine|dexmedetomidine|mesh-list
102488435|NCT01920542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102488436|NCT01920542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102488437|NCT01920542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488438|NCT01920542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102488439|NCT01920542|Analgesics|analgesics|mesh-ancestor
102488440|NCT01920542|Sensory System Agents|sensory system agents|mesh-ancestor
102488441|NCT01920542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102488442|NCT01920542|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102488443|NCT01920542|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102488444|NCT01920542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102488445|NCT01920542|Adrenergic Agents|adrenergic agents|mesh-ancestor
102488446|NCT01920542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102488447|NCT01920542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488448|NCT03319810|gamma-Globulins|gamma-globulins|mesh-list
102488449|NCT03319810|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102488450|NCT03319810|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102488451|NCT03319810|Immunologic Factors|immunologic factors|mesh-ancestor
102488452|NCT03319810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488453|NCT01052701|Ribavirin|ribavirin|mesh-list
102488454|NCT01052701|Abacavir|abacavir|mesh-list
102488455|NCT01052701|Antimetabolites|antimetabolites|mesh-ancestor
102488456|NCT01052701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488457|NCT01052701|Antiviral Agents|antiviral agents|mesh-ancestor
102488458|NCT01052701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102488459|NCT01052701|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102488460|NCT01052701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102488461|NCT01052701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102488462|NCT01052701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102488463|NCT01052701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102488464|NCT01921010|Niacin|niacin|mesh-list
102488465|NCT01921010|Nicotinic Acids|nicotinic acids|mesh-list
102488466|NCT01921010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102488467|NCT01921010|Antimetabolites|antimetabolites|mesh-ancestor
102488468|NCT01921010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488469|NCT01921010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102488470|NCT01921010|Vasodilator Agents|vasodilator agents|mesh-ancestor
102488471|NCT01921010|Vitamin B Complex|vitamin b complex|mesh-ancestor
102488472|NCT01921010|Vitamins|vitamins|mesh-ancestor
102488473|NCT01921010|Micronutrients|micronutrients|mesh-ancestor
102488474|NCT01921010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488475|NCT03325816|Nivolumab|nivolumab|mesh-list
102488476|NCT03325816|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102488477|NCT03325816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102488478|NCT03325816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102488479|NCT03325816|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102488480|NCT03325816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488481|NCT03325816|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102488482|NCT00986570|Botulinum Toxins|botulinum toxins|mesh-list
102488483|NCT00986570|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102488484|NCT00986570|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102488485|NCT00986570|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102488486|NCT00986570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102488487|NCT00986570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488488|NCT00986570|Cholinergic Agents|cholinergic agents|mesh-ancestor
102488489|NCT00986570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102488490|NCT00986570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488491|NCT00986570|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102488492|NCT00986570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102488493|NCT00986258|Tapentadol|tapentadol|mesh-list
102488494|NCT00986258|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102488495|NCT00986258|Narcotics|narcotics|mesh-ancestor
102488496|NCT00986258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102488497|NCT00986258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488498|NCT00986258|Analgesics|analgesics|mesh-ancestor
102488499|NCT00986258|Sensory System Agents|sensory system agents|mesh-ancestor
102488500|NCT00986258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102488501|NCT00986258|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102488502|NCT00986258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102488503|NCT00986258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102488504|NCT00986258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488505|NCT00986258|Adrenergic Agents|adrenergic agents|mesh-ancestor
102488506|NCT00986258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102488507|NCT00986180|Oxycodone|oxycodone|mesh-list
102488508|NCT00986180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102488509|NCT00986180|Narcotics|narcotics|mesh-ancestor
102488510|NCT00986180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102488511|NCT00986180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488512|NCT00986180|Analgesics|analgesics|mesh-ancestor
102488513|NCT00986180|Sensory System Agents|sensory system agents|mesh-ancestor
102488514|NCT00986180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102488515|NCT01056601|Bortezomib|bortezomib|mesh-list
102488516|NCT01056601|Panobinostat|panobinostat|mesh-list
102488517|NCT01056601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102488518|NCT01056601|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102488519|NCT01056601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102488520|NCT01056601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488521|NCT03014947|Adalimumab|adalimumab|mesh-list
102488522|NCT03014947|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102488523|NCT03014947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102488524|NCT03014947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102488525|NCT01057225|Thalidomide|thalidomide|mesh-list
102488526|NCT01057225|Dexamethasone|dexamethasone|mesh-list
102488527|NCT01057225|Cyclophosphamide|cyclophosphamide|mesh-list
102488528|NCT01057225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102488529|NCT01057225|Immunologic Factors|immunologic factors|mesh-ancestor
102488530|NCT01057225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488531|NCT01057225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102488532|NCT01057225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102488533|NCT01057225|Alkylating Agents|alkylating agents|mesh-ancestor
102488534|NCT01057225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488535|NCT01057225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102488536|NCT01057225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102488537|NCT01057225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102488538|NCT01057225|Antiemetics|antiemetics|mesh-ancestor
102488539|NCT01057225|Autonomic Agents|autonomic agents|mesh-ancestor
102488540|NCT01057225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102488541|NCT01057225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102488542|NCT01057225|Glucocorticoids|glucocorticoids|mesh-ancestor
102488543|NCT01057225|Hormones|hormones|mesh-ancestor
102488544|NCT01057225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102488545|NCT01057225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102488546|NCT01057225|Leprostatic Agents|leprostatic agents|mesh-ancestor
102488547|NCT01057225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102488548|NCT01057225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102488549|NCT01057225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102488550|NCT01057225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102488551|NCT01057225|Growth Substances|growth substances|mesh-ancestor
102488552|NCT01057225|Growth Inhibitors|growth inhibitors|mesh-ancestor
102488553|NCT01057381|Dexmedetomidine|dexmedetomidine|mesh-list
102488554|NCT01057381|Morphine|morphine|mesh-list
102488555|NCT01057381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102488556|NCT01057381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102488557|NCT01057381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488558|NCT01057381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102488559|NCT01057381|Analgesics|analgesics|mesh-ancestor
102488560|NCT01057381|Sensory System Agents|sensory system agents|mesh-ancestor
102488561|NCT01057381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102488562|NCT01057381|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102488563|NCT01057381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102488564|NCT01057381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102488565|NCT01057381|Adrenergic Agents|adrenergic agents|mesh-ancestor
102488566|NCT01057381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102488567|NCT01057381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488568|NCT01057381|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102488569|NCT01057381|Narcotics|narcotics|mesh-ancestor
102488570|NCT00986102|Doripenem|doripenem|mesh-list
102488571|NCT00986102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102488572|NCT00986102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102488573|NCT01058239|Rituximab|rituximab|mesh-list
102488574|NCT01058239|Bortezomib|bortezomib|mesh-list
102488575|NCT01058239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102488576|NCT01058239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102488577|NCT01058239|Immunologic Factors|immunologic factors|mesh-ancestor
102488578|NCT01058239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488579|NCT01058239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102488580|NCT01058941|Thioctic Acid|thioctic acid|mesh-list
102488581|NCT01058941|Antioxidants|antioxidants|mesh-ancestor
102488582|NCT01058941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488583|NCT01058941|Protective Agents|protective agents|mesh-ancestor
102488584|NCT01058941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488585|NCT01058941|Vitamin B Complex|vitamin b complex|mesh-ancestor
102488586|NCT01058941|Vitamins|vitamins|mesh-ancestor
102488587|NCT01058941|Micronutrients|micronutrients|mesh-ancestor
102488588|NCT00985946|Panobinostat|panobinostat|mesh-list
102488589|NCT00985946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102488590|NCT00985946|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102488591|NCT00985946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102488592|NCT00985946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488593|NCT02170519|Iloprost|iloprost|mesh-list
102488594|NCT02170519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102488595|NCT02170519|Vasodilator Agents|vasodilator agents|mesh-ancestor
102488596|NCT00985712|Insulin Lispro|insulin lispro|mesh-list
102488597|NCT00985712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102488598|NCT00985712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488599|NCT04275284|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102488600|NCT04275284|Immunologic Factors|immunologic factors|mesh-ancestor
102488601|NCT04275284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488602|NCT01924910|Vitamin D|vitamin d|mesh-list
102488603|NCT01924910|Cholecalciferol|cholecalciferol|mesh-list
102488604|NCT01924910|Vitamins|vitamins|mesh-ancestor
102488605|NCT01924910|Micronutrients|micronutrients|mesh-ancestor
102488606|NCT01924910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488607|NCT01924910|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102488608|NCT01924910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102488609|NCT04395638|Vitamin D|vitamin d|mesh-list
102488610|NCT04395638|Ergocalciferols|ergocalciferols|mesh-list
102488611|NCT04395638|Cholecalciferol|cholecalciferol|mesh-list
102488612|NCT04395638|Vitamins|vitamins|mesh-list
102488613|NCT04395638|Micronutrients|micronutrients|mesh-ancestor
102488614|NCT04395638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488615|NCT04395638|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102488616|NCT04395638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102488617|NCT04347980|Hydroxychloroquine|hydroxychloroquine|mesh-list
102488618|NCT04347980|Dexamethasone|dexamethasone|mesh-list
102488619|NCT04347980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102488620|NCT04347980|Antiemetics|antiemetics|mesh-ancestor
102488621|NCT04347980|Autonomic Agents|autonomic agents|mesh-ancestor
102488622|NCT04347980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102488623|NCT04347980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488624|NCT04347980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102488625|NCT04347980|Glucocorticoids|glucocorticoids|mesh-ancestor
102488626|NCT04347980|Hormones|hormones|mesh-ancestor
102488627|NCT04347980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102488628|NCT04347980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102488629|NCT04347980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102488630|NCT04347980|Antimalarials|antimalarials|mesh-ancestor
102488631|NCT04347980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102488632|NCT04347980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102488633|NCT04347980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102488634|NCT04347980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102488635|NCT04347980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488636|NCT04347980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102488637|NCT01925300|Bisoprolol|bisoprolol|mesh-list
102488638|NCT01925300|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102488639|NCT01925300|Calcium|calcium|mesh-list
102488640|NCT01925300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102488641|NCT01925300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488642|NCT01925300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102488643|NCT01925300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102488644|NCT01925300|Antimetabolites|antimetabolites|mesh-ancestor
102488645|NCT01925300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488646|NCT01925300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102488647|NCT01925300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102488648|NCT01925300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102488649|NCT01925300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102488651|NCT01925300|Autonomic Agents|autonomic agents|mesh-ancestor
102488652|NCT01925300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102488653|NCT01925300|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102488654|NCT01925300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102488655|NCT01925300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102488656|NCT01925300|Adrenergic Agents|adrenergic agents|mesh-ancestor
102488657|NCT01925300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102488658|NCT01921946|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102488659|NCT01921946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102488660|NCT01921946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102488661|NCT01921946|Antimetabolites|antimetabolites|mesh-ancestor
102488662|NCT01921946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488663|NCT01921946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102488664|NCT01921946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102488665|NCT01921946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102488666|NCT01925378|Nelfinavir|nelfinavir|mesh-list
102488667|NCT01925378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102488668|NCT01925378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102488669|NCT01925378|Protease Inhibitors|protease inhibitors|mesh-ancestor
102488670|NCT01925378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102488671|NCT01925378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488672|NCT01925378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102488673|NCT01925378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102488674|NCT01925378|Antiviral Agents|antiviral agents|mesh-ancestor
102488675|NCT01925378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102488676|NCT01925456|Fesoterodine|fesoterodine|mesh-list
102488677|NCT01925456|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102488678|NCT01925456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102488679|NCT01925456|Cholinergic Agents|cholinergic agents|mesh-ancestor
102488680|NCT01925456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102488681|NCT01925456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488682|NCT01925456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488683|NCT01925456|Urological Agents|urological agents|mesh-ancestor
102488684|NCT02255799|Donepezil|donepezil|mesh-list
102488685|NCT02255799|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102488686|NCT02255799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102488687|NCT02255799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488688|NCT02255799|Cholinergic Agents|cholinergic agents|mesh-ancestor
102488689|NCT02255799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102488690|NCT02255799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488691|NCT02255799|Nootropic Agents|nootropic agents|mesh-ancestor
102488692|NCT02226159|Dexamethasone|dexamethasone|mesh-list
102488693|NCT02226159|Dexamethasone acetate|dexamethasone acetate|mesh-list
102488694|NCT02226159|Lidocaine|lidocaine|mesh-list
102488695|NCT02226159|BB 1101|bb 1101|mesh-list
102488696|NCT02226159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102488697|NCT02226159|Antiemetics|antiemetics|mesh-ancestor
102488698|NCT02226159|Autonomic Agents|autonomic agents|mesh-ancestor
102488699|NCT02226159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102488700|NCT02226159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488701|NCT02226159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102488702|NCT02226159|Glucocorticoids|glucocorticoids|mesh-ancestor
102488703|NCT02226159|Hormones|hormones|mesh-ancestor
102488704|NCT02226159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102488705|NCT02226159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102488706|NCT02226159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102488707|NCT02226159|Protease Inhibitors|protease inhibitors|mesh-ancestor
102488708|NCT02226159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102488709|NCT02226159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488710|NCT02226159|Anesthetics, Local|anesthetics, local|mesh-ancestor
102488711|NCT02226159|Anesthetics|anesthetics|mesh-ancestor
102488712|NCT02226159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102488713|NCT02226159|Sensory System Agents|sensory system agents|mesh-ancestor
102488714|NCT02226159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102488715|NCT02226159|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102488716|NCT02226159|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102488717|NCT02226159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102488718|NCT03241030|Acetaminophen|acetaminophen|mesh-list
102488719|NCT03241030|Ibuprofen|ibuprofen|mesh-list
102488720|NCT03241030|Sucralfate|sucralfate|mesh-list
102488721|NCT03241030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102488722|NCT03241030|Analgesics|analgesics|mesh-ancestor
102488723|NCT03241030|Sensory System Agents|sensory system agents|mesh-ancestor
102488724|NCT03241030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102488725|NCT03241030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488727|NCT03241030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102488728|NCT03241030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102488729|NCT03241030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102488730|NCT03241030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102488731|NCT03241030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102488732|NCT03241030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488733|NCT03241030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102488734|NCT03241030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102488735|NCT02184195|Olaparib|olaparib|mesh-list
102488736|NCT02184195|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102488737|NCT02184195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102488738|NCT02184195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488739|NCT02184195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102488740|NCT03241810|Fulvestrant|fulvestrant|mesh-list
102488741|NCT03241810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102488742|NCT03241810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102488743|NCT03241810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102488744|NCT03241810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102488745|NCT03241810|Hormone Antagonists|hormone antagonists|mesh-ancestor
102488746|NCT03241810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102488747|NCT03241810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488748|NCT02129751|Bupropion|bupropion|mesh-list
102488749|NCT02129751|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102488750|NCT02129751|Antidepressive Agents|antidepressive agents|mesh-ancestor
102488751|NCT02129751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102488752|NCT02129751|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102488753|NCT02129751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102488754|NCT02129751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102488755|NCT02129751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488756|NCT02129751|Dopamine Agents|dopamine agents|mesh-ancestor
102488757|NCT02129751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102488758|NCT02129751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488759|NCT02129751|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102488760|NCT02129751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102488761|NCT02129751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102488762|NCT03242590|Methyltestosterone|methyltestosterone|mesh-list
102488763|NCT03242590|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102488764|NCT03242590|Testosterone|testosterone|mesh-list
102488765|NCT03242590|Testosterone undecanoate|testosterone undecanoate|mesh-list
102488766|NCT03242590|Testosterone enanthate|testosterone enanthate|mesh-list
101621457|NCT03867500|Micronutrients|micronutrients|mesh-ancestor
102488767|NCT03242590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102488768|NCT03242590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102488769|NCT03242590|Anabolic Agents|anabolic agents|mesh-ancestor
102488770|NCT03242590|Hormones|hormones|mesh-ancestor
102488771|NCT03242590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102488772|NCT03242590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488773|NCT03242590|Androgens|androgens|mesh-ancestor
102488774|NCT03247738|Cangrelor|cangrelor|mesh-list
102488775|NCT03247738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102488776|NCT03247738|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102488777|NCT03247738|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102488778|NCT03247738|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102488779|NCT03247738|Purinergic Agents|purinergic agents|mesh-ancestor
102488780|NCT03247738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102488781|NCT03247738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488782|NCT03247738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488783|NCT03345160|Immunomodulating Agents|immunomodulating agents|mesh-list
102488784|NCT03345160|Immunologic Factors|immunologic factors|mesh-ancestor
102488785|NCT03345160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488786|NCT01567605|Lidocaine|lidocaine|mesh-list
102488787|NCT01567605|Anesthetics, Local|anesthetics, local|mesh-ancestor
102488788|NCT01567605|Anesthetics|anesthetics|mesh-ancestor
102488789|NCT01567605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102488790|NCT01567605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488791|NCT01567605|Sensory System Agents|sensory system agents|mesh-ancestor
102488792|NCT01567605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102488793|NCT01567605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102488794|NCT01567605|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102488795|NCT01567605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102488796|NCT01567605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102488797|NCT01567605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488798|NCT02604537|Ketorolac|ketorolac|mesh-list
102488799|NCT02604537|Betamethasone|betamethasone|mesh-list
102488800|NCT02604537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102488801|NCT02604537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102488802|NCT02604537|Analgesics|analgesics|mesh-ancestor
102488803|NCT02604537|Sensory System Agents|sensory system agents|mesh-ancestor
102488804|NCT02604537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102488805|NCT02604537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488806|NCT02604537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102488807|NCT02604537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102488808|NCT02604537|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102488809|NCT02604537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102488810|NCT02604537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488811|NCT02604537|Glucocorticoids|glucocorticoids|mesh-ancestor
102488812|NCT02604537|Hormones|hormones|mesh-ancestor
102488813|NCT02604537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102488814|NCT02604537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102488815|NCT02604537|Respiratory System Agents|respiratory system agents|mesh-ancestor
102488816|NCT01384773|Riboflavin|riboflavin|mesh-list
102488817|NCT01384773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102488818|NCT01384773|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102488819|NCT01384773|Vitamin B Complex|vitamin b complex|mesh-ancestor
102488820|NCT01384773|Vitamins|vitamins|mesh-ancestor
102488821|NCT01384773|Micronutrients|micronutrients|mesh-ancestor
102488822|NCT01384773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488823|NCT01384773|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102488824|NCT01384773|Dermatologic Agents|dermatologic agents|mesh-ancestor
102488825|NCT01063075|Carboplatin|carboplatin|mesh-list
102488826|NCT01063075|Cetuximab|cetuximab|mesh-list
102488827|NCT01063075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102488828|NCT01063075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102488829|NCT01341405|Celecoxib|celecoxib|mesh-list
102488830|NCT01341405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102488831|NCT01341405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102488832|NCT01341405|Analgesics|analgesics|mesh-ancestor
102488833|NCT01341405|Sensory System Agents|sensory system agents|mesh-ancestor
102488834|NCT01341405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102488835|NCT01341405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488836|NCT01341405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102488837|NCT01341405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102488838|NCT01341405|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102488839|NCT01341405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102488840|NCT01341405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102488841|NCT01341405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488842|NCT05136157|Insulin|insulin|mesh-list
102488843|NCT05136157|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102488844|NCT05136157|Insulin, Short-Acting|insulin, short-acting|mesh-list
102488845|NCT05136157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102488846|NCT05136157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488847|NCT01921790|Dexamethasone|dexamethasone|mesh-list
102488848|NCT01921790|Gemcitabine|gemcitabine|mesh-list
102488849|NCT01921790|Oxaliplatin|oxaliplatin|mesh-list
102488850|NCT01921790|Bevacizumab|bevacizumab|mesh-list
102488851|NCT01921790|Pegaspargase|pegaspargase|mesh-list
102488852|NCT01921790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102488853|NCT01921790|Antiemetics|antiemetics|mesh-ancestor
102488854|NCT01921790|Autonomic Agents|autonomic agents|mesh-ancestor
102488855|NCT01921790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102488856|NCT01921790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488857|NCT01921790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102488858|NCT01921790|Glucocorticoids|glucocorticoids|mesh-ancestor
102488859|NCT01921790|Hormones|hormones|mesh-ancestor
102488860|NCT01921790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102488861|NCT01921790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102488862|NCT01921790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102488863|NCT01921790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102488864|NCT01921790|Antimetabolites|antimetabolites|mesh-ancestor
102488865|NCT01921790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300498|NCT01068249|Everolimus|everolimus|mesh-list
102488866|NCT01921790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102488867|NCT01921790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102488868|NCT01921790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102488869|NCT01921790|Growth Substances|growth substances|mesh-ancestor
102488870|NCT01921790|Growth Inhibitors|growth inhibitors|mesh-ancestor
102488871|NCT02153541|Antipyrine|antipyrine|mesh-list
102488872|NCT02153541|Benzocaine|benzocaine|mesh-list
102488873|NCT02153541|Glycerol|glycerol|mesh-list
102488874|NCT02153541|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102488875|NCT02153541|Protective Agents|protective agents|mesh-ancestor
102488876|NCT02153541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488877|NCT02153541|Anesthetics, Local|anesthetics, local|mesh-ancestor
102488878|NCT02153541|Anesthetics|anesthetics|mesh-ancestor
102488879|NCT02153541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102488880|NCT02153541|Sensory System Agents|sensory system agents|mesh-ancestor
102488881|NCT02153541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102488882|NCT02153541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102488883|NCT02153541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102488884|NCT02153541|Analgesics|analgesics|mesh-ancestor
102488885|NCT02153541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102488886|NCT02153541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102488887|NCT03487276|Vilobelimab|vilobelimab|mesh-list
102488888|NCT03487276|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102488889|NCT03487276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102488890|NCT03487276|Immunologic Factors|immunologic factors|mesh-ancestor
102488891|NCT03487276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488892|NCT03489850|Ibudilast|ibudilast|mesh-list
102488893|NCT03489850|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102488894|NCT03489850|Autonomic Agents|autonomic agents|mesh-ancestor
102488895|NCT03489850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102488896|NCT03489850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488897|NCT03489850|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102488898|NCT03489850|Respiratory System Agents|respiratory system agents|mesh-ancestor
102488899|NCT03489850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102488900|NCT03489850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102488901|NCT03489850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488902|NCT03489850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102488903|NCT03489850|Vasodilator Agents|vasodilator agents|mesh-ancestor
102488904|NCT03490942|Glucagon|glucagon|mesh-list
102488905|NCT03490942|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102488906|NCT03490942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102488907|NCT03490942|Hormones|hormones|mesh-ancestor
102488908|NCT03490942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101621603|NCT03153280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102488909|NCT03490942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488910|NCT03490942|Incretins|incretins|mesh-ancestor
102488911|NCT00376870|Pioglitazone|pioglitazone|mesh-list
102488912|NCT00376870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102488913|NCT00376870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488914|NCT03015025|Acenocoumarol|acenocoumarol|mesh-list
102488915|NCT03015025|Anticoagulants|anticoagulants|mesh-ancestor
102488916|NCT03256162|Midazolam|midazolam|mesh-list
102488917|NCT03256162|Ketamine|ketamine|mesh-list
102488918|NCT03256162|Analgesics|analgesics|mesh-ancestor
102488919|NCT03256162|Sensory System Agents|sensory system agents|mesh-ancestor
102488920|NCT03256162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102488921|NCT03256162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488922|NCT03256162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102488923|NCT03256162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102488924|NCT03256162|Anesthetics, General|anesthetics, general|mesh-ancestor
102488925|NCT03256162|Anesthetics|anesthetics|mesh-ancestor
102488926|NCT03256162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102488927|NCT03256162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102488928|NCT03256162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102488929|NCT03256162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102488930|NCT03256162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488931|NCT03256162|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102488932|NCT03256162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102488933|NCT03256162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102488934|NCT03256162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102488935|NCT03256162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102488936|NCT03256162|GABA Modulators|gaba modulators|mesh-ancestor
102488937|NCT03256162|GABA Agents|gaba agents|mesh-ancestor
102488938|NCT03493828|Bupivacaine|bupivacaine|mesh-list
102488939|NCT03493828|Anesthetics, Local|anesthetics, local|mesh-ancestor
102488940|NCT03493828|Anesthetics|anesthetics|mesh-ancestor
102488941|NCT03493828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102488942|NCT03493828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488943|NCT03493828|Sensory System Agents|sensory system agents|mesh-ancestor
102488944|NCT03493828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102488945|NCT03496324|Ibuprofen|ibuprofen|mesh-list
102612327|NCT00002405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102488946|NCT03496324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102488947|NCT03496324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102488949|NCT03496324|Sensory System Agents|sensory system agents|mesh-ancestor
102488950|NCT03496324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102488951|NCT03496324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488952|NCT03496324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102488953|NCT03496324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102488954|NCT03496324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102488955|NCT03496324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102488956|NCT03496324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488957|NCT03354598|Ciprofloxacin|ciprofloxacin|mesh-list
102488958|NCT03354598|Probenecid|probenecid|mesh-list
102488959|NCT03354598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102488960|NCT03354598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102488961|NCT03354598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102488962|NCT03354598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102488963|NCT03354598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102488964|NCT03354598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488965|NCT03354598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102488966|NCT03354598|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102488967|NCT03354598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102488968|NCT03354598|Uricosuric Agents|uricosuric agents|mesh-ancestor
102488969|NCT03354598|Gout Suppressants|gout suppressants|mesh-ancestor
102488970|NCT03354598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102488971|NCT02169895|Opicapone|opicapone|mesh-list
102488972|NCT02169895|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
102488973|NCT02169895|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102488974|NCT02169895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102488975|NCT02169895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488976|NCT02169895|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102488977|NCT02169895|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102488978|NCT02169895|Dopamine Agents|dopamine agents|mesh-ancestor
102488979|NCT02169895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101621674|NCT02845596|Cyclosporins|cyclosporins|mesh-list
102488980|NCT02169895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488981|NCT01072669|Ambrisentan|ambrisentan|mesh-list
102488982|NCT01072669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102488983|NCT03014713|Flurbiprofen|flurbiprofen|mesh-list
102488984|NCT03014713|Dexmedetomidine|dexmedetomidine|mesh-list
102488985|NCT03014713|Dezocine|dezocine|mesh-list
102488986|NCT03014713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102488987|NCT03014713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102488988|NCT03014713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102488989|NCT03014713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102488990|NCT03014713|Analgesics|analgesics|mesh-ancestor
102488991|NCT03014713|Sensory System Agents|sensory system agents|mesh-ancestor
102488992|NCT03014713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102488993|NCT03014713|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102488994|NCT03014713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102488995|NCT03014713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102488996|NCT03014713|Adrenergic Agents|adrenergic agents|mesh-ancestor
102488997|NCT03014713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102488998|NCT03014713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102488999|NCT03014713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102489000|NCT03014713|Narcotics|narcotics|mesh-ancestor
102489001|NCT03014713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102489002|NCT03014713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102489003|NCT03014713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102489004|NCT03014713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102489005|NCT03014713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102489006|NCT01074463|Pramipexole|pramipexole|mesh-list
102489007|NCT01074463|Antioxidants|antioxidants|mesh-ancestor
102489008|NCT01074463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489009|NCT01074463|Protective Agents|protective agents|mesh-ancestor
102489010|NCT01074463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489011|NCT01074463|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102489012|NCT01074463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102489013|NCT01074463|Dopamine Agonists|dopamine agonists|mesh-ancestor
102489014|NCT01074463|Dopamine Agents|dopamine agents|mesh-ancestor
102489015|NCT01074463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102489016|NCT01075087|Ropivacaine|ropivacaine|mesh-list
102489017|NCT01075087|Anesthetics, Local|anesthetics, local|mesh-ancestor
102489018|NCT01075087|Anesthetics|anesthetics|mesh-ancestor
102489019|NCT01075087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102489020|NCT01075087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489021|NCT01075087|Sensory System Agents|sensory system agents|mesh-ancestor
102489022|NCT01075087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102489024|NCT01075399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102489025|NCT01075399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489026|NCT03835819|Pembrolizumab|pembrolizumab|mesh-list
102489027|NCT03835819|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
102489028|NCT03835819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102489029|NCT03835819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102489030|NCT03835819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102489031|NCT03835819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489032|NCT03835819|Immunoconjugates|immunoconjugates|mesh-ancestor
102489033|NCT03835819|Immunologic Factors|immunologic factors|mesh-ancestor
102489034|NCT03835819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489035|NCT03358576|Amoxicillin|amoxicillin|mesh-list
102489036|NCT03358576|Metronidazole|metronidazole|mesh-list
102489037|NCT03358576|Ciprofloxacin|ciprofloxacin|mesh-list
102489038|NCT03358576|Clavulanic Acid|clavulanic acid|mesh-list
102489039|NCT03358576|Clavulanic Acids|clavulanic acids|mesh-list
102489040|NCT03358576|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102489041|NCT03358576|Ertapenem|ertapenem|mesh-list
102489042|NCT03358576|Lactams|lactams|mesh-list
102489043|NCT03358576|Probenecid|probenecid|mesh-list
102489044|NCT03358576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102489045|NCT03358576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102489046|NCT03358576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102489047|NCT03358576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102489048|NCT03358576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102489049|NCT03358576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102489050|NCT03358576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102489051|NCT03358576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489052|NCT03358576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102489053|NCT03358576|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102489054|NCT03358576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102489055|NCT03358576|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102489056|NCT03358576|Uricosuric Agents|uricosuric agents|mesh-ancestor
102489057|NCT03358576|Gout Suppressants|gout suppressants|mesh-ancestor
102489058|NCT03358576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102489059|NCT03822013|Miglustat|miglustat|mesh-list
102489060|NCT03822013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102489061|NCT03822013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489062|NCT03822013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102489063|NCT03822013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102489064|NCT03822013|Antiviral Agents|antiviral agents|mesh-ancestor
102489065|NCT03822013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102489066|NCT03822013|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102489067|NCT03822013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102489068|NCT03822013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489069|NCT00376324|Tigecycline|tigecycline|mesh-list
102489070|NCT00376324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102489071|NCT00376324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102489072|NCT00376324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102489073|NCT00376324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102489074|NCT00376324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489075|NCT00376480|Methylprednisolone|methylprednisolone|mesh-list
102489076|NCT00376480|Fludarabine|fludarabine|mesh-list
102489077|NCT00376480|Fludarabine phosphate|fludarabine phosphate|mesh-list
102489078|NCT00376480|Thiotepa|thiotepa|mesh-list
102489079|NCT00376480|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102489080|NCT00376480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102489081|NCT00376480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102489082|NCT00376480|Antimetabolites|antimetabolites|mesh-ancestor
102489083|NCT00376480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489084|NCT00376480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102489085|NCT00376480|Immunologic Factors|immunologic factors|mesh-ancestor
102489086|NCT00376480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489087|NCT00376480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102489088|NCT00376480|Antiemetics|antiemetics|mesh-ancestor
102489089|NCT00376480|Autonomic Agents|autonomic agents|mesh-ancestor
102489090|NCT00376480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102489091|NCT00376480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102489092|NCT00376480|Glucocorticoids|glucocorticoids|mesh-ancestor
102489093|NCT00376480|Hormones|hormones|mesh-ancestor
102489094|NCT00376480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102489095|NCT00376480|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102489096|NCT00376480|Protective Agents|protective agents|mesh-ancestor
102489097|NCT00376480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102489098|NCT00376480|Alkylating Agents|alkylating agents|mesh-ancestor
102489099|NCT00376480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102489100|NCT03016039|Curcumin|curcumin|mesh-list
102489101|NCT03016039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102489102|NCT03016039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102489103|NCT03016039|Analgesics|analgesics|mesh-ancestor
102489104|NCT03016039|Sensory System Agents|sensory system agents|mesh-ancestor
102489105|NCT03016039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102489106|NCT03016039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489107|NCT03016039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102489108|NCT03016039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102489109|NCT03016039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102489110|NCT03016039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102489111|NCT03016039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489112|NCT03753919|Durvalumab|durvalumab|mesh-list
102489113|NCT03753919|Tremelimumab|tremelimumab|mesh-list
102489114|NCT03753919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102489115|NCT03753919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102489116|NCT03498196|Avelumab|avelumab|mesh-list
102489117|NCT03498196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102489118|NCT03498196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102489119|NCT03500302|Evolocumab|evolocumab|mesh-list
102489120|NCT03500302|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102489121|NCT03500302|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102489122|NCT03500302|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102489123|NCT03500302|Antimetabolites|antimetabolites|mesh-ancestor
102489124|NCT03500302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489125|NCT03500302|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102489126|NCT03500302|Protease Inhibitors|protease inhibitors|mesh-ancestor
102489127|NCT03500302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102489128|NCT03500302|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102489129|NCT03501550|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102489130|NCT03501550|Antiviral Agents|antiviral agents|mesh-ancestor
102489131|NCT03501550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102489132|NCT03503578|Ketamine|ketamine|mesh-list
102489133|NCT03503578|Sevoflurane|sevoflurane|mesh-list
102489134|NCT03503578|Analgesics|analgesics|mesh-ancestor
102489135|NCT03503578|Sensory System Agents|sensory system agents|mesh-ancestor
102489136|NCT03503578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102489137|NCT03503578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489138|NCT03503578|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102489139|NCT03503578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102489140|NCT03503578|Anesthetics, General|anesthetics, general|mesh-ancestor
102489141|NCT03503578|Anesthetics|anesthetics|mesh-ancestor
102489142|NCT03503578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102489143|NCT03503578|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102489144|NCT03503578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102489145|NCT03503578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102489146|NCT03503578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489147|NCT03503578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102489148|NCT03503578|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102489149|NCT03270514|Bupivacaine|bupivacaine|mesh-list
102489150|NCT03270514|Anesthetics, Local|anesthetics, local|mesh-ancestor
102489151|NCT03270514|Anesthetics|anesthetics|mesh-ancestor
102489152|NCT03270514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102489153|NCT03270514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489154|NCT03270514|Sensory System Agents|sensory system agents|mesh-ancestor
102489155|NCT03270514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102489156|NCT02178241|Gemcitabine|gemcitabine|mesh-list
102489157|NCT02178241|Halichondrin B|halichondrin b|mesh-list
102489158|NCT02178241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102489159|NCT02178241|Antimetabolites|antimetabolites|mesh-ancestor
101621908|NCT02796105|Hormone Antagonists|hormone antagonists|mesh-ancestor
102489160|NCT02178241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489161|NCT02178241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102489162|NCT02178241|Tubulin Modulators|tubulin modulators|mesh-ancestor
102489163|NCT02178241|Antimitotic Agents|antimitotic agents|mesh-ancestor
102489164|NCT02178241|Mitosis Modulators|mitosis modulators|mesh-ancestor
102489165|NCT03015727|Docetaxel|docetaxel|mesh-list
102489166|NCT03015727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102489167|NCT03015727|Tubulin Modulators|tubulin modulators|mesh-ancestor
102489168|NCT03015727|Antimitotic Agents|antimitotic agents|mesh-ancestor
102489169|NCT03015727|Mitosis Modulators|mitosis modulators|mesh-ancestor
102612328|NCT00002405|Antiviral Agents|antiviral agents|mesh-ancestor
102489170|NCT03015727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489171|NCT03539731|Piperazine|piperazine|mesh-list
102489172|NCT03539731|Antinematodal Agents|antinematodal agents|mesh-ancestor
102489173|NCT03539731|Anthelmintics|anthelmintics|mesh-ancestor
102489174|NCT03539731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102489175|NCT03539731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102489176|NCT01077973|Ibuprofen|ibuprofen|mesh-list
102489177|NCT01077973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102489178|NCT01077973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102489179|NCT01077973|Analgesics|analgesics|mesh-ancestor
102489180|NCT01077973|Sensory System Agents|sensory system agents|mesh-ancestor
102489181|NCT01077973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102489182|NCT01077973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489183|NCT01077973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102489184|NCT01077973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102489185|NCT01077973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102489186|NCT01077973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102489187|NCT01077973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489188|NCT02973646|Tenofovir|tenofovir|mesh-list
102489189|NCT02973646|Entecavir|entecavir|mesh-list
102489190|NCT02973646|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102489191|NCT02973646|Antiviral Agents|antiviral agents|mesh-ancestor
102489192|NCT02973646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102489193|NCT02973646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102489194|NCT02973646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102489195|NCT02973646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102489196|NCT02973646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489197|NCT02973646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102489198|NCT02973646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102489199|NCT01078363|Ramipril|ramipril|mesh-list
102489200|NCT01078363|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102489201|NCT01078363|Protease Inhibitors|protease inhibitors|mesh-ancestor
102489202|NCT01078363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102489203|NCT01078363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489204|NCT01078363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102489205|NCT03371836|Clobazam|clobazam|mesh-list
102489206|NCT03371836|Anticonvulsants|anticonvulsants|mesh-ancestor
102489207|NCT03371836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102489208|NCT03371836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102489209|NCT03371836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102489210|NCT03371836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489211|NCT03371836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102489212|NCT03371836|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102489213|NCT03371836|GABA Agonists|gaba agonists|mesh-ancestor
102489214|NCT03371836|GABA Agents|gaba agents|mesh-ancestor
102489215|NCT03371836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102489216|NCT03371836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489217|NCT01078753|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
102489218|NCT01078753|Hemostatics|hemostatics|mesh-ancestor
102489219|NCT01078753|Coagulants|coagulants|mesh-ancestor
102489220|NCT01078753|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102489221|NCT01078753|Natriuretic Agents|natriuretic agents|mesh-ancestor
102489222|NCT01078753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489223|NCT03372382|Acetaminophen|acetaminophen|mesh-list
102489224|NCT03372382|Ibuprofen|ibuprofen|mesh-list
101621976|NCT04234191|Buprenorphine|buprenorphine|mesh-list
102489225|NCT03372382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102489226|NCT03372382|Analgesics|analgesics|mesh-ancestor
102489227|NCT03372382|Sensory System Agents|sensory system agents|mesh-ancestor
102489228|NCT03372382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102489229|NCT03372382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489230|NCT03372382|Antipyretics|antipyretics|mesh-ancestor
102489231|NCT03372382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102489232|NCT03372382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102489233|NCT03372382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102489234|NCT03372382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102489235|NCT03372382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102489236|NCT03372382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489237|NCT03373162|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102489238|NCT03373162|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102489239|NCT03373162|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102489240|NCT03373162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102489241|NCT03373162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489242|NCT03373162|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102489243|NCT03373162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102489244|NCT03373162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489245|NCT03373162|Cholinergic Agents|cholinergic agents|mesh-ancestor
102489246|NCT03373162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102489247|NCT03374176|Amoxicillin|amoxicillin|mesh-list
102489248|NCT03374176|Metronidazole|metronidazole|mesh-list
102489249|NCT03374176|Clindamycin|clindamycin|mesh-list
102489250|NCT03374176|Clindamycin palmitate|clindamycin palmitate|mesh-list
102489251|NCT03374176|Clindamycin phosphate|clindamycin phosphate|mesh-list
102489252|NCT03374176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102489253|NCT03374176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102489254|NCT03374176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102489255|NCT03374176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102489256|NCT03374176|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102489257|NCT03374176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101622000|NCT02790099|Morphine|morphine|mesh-list
102489258|NCT03374176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489259|NCT03281200|Nintedanib|nintedanib|mesh-list
102489260|NCT03281200|Antineoplastic Agents|antineoplastic agents|mesh-list
102489261|NCT03281200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-list
102489262|NCT03281200|Immunomodulating Agents|immunomodulating agents|mesh-list
102489263|NCT03281200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102489264|NCT03281200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489265|NCT03281200|Immunologic Factors|immunologic factors|mesh-ancestor
102489266|NCT03281200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489267|NCT03378076|Triamcinolone|triamcinolone|mesh-list
102489268|NCT03378076|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102489269|NCT03378076|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102489270|NCT03378076|FX006|fx006|mesh-list
102489271|NCT03378076|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102489272|NCT03378076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102489273|NCT03378076|Glucocorticoids|glucocorticoids|mesh-ancestor
102489274|NCT03378076|Hormones|hormones|mesh-ancestor
102489275|NCT03378076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102489276|NCT03378076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489277|NCT03378076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102489278|NCT03378076|Immunologic Factors|immunologic factors|mesh-ancestor
102489279|NCT03378076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101622027|NCT02794155|Insulin Lispro|insulin lispro|mesh-list
102489280|NCT03378076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489281|NCT03520348|Pantothenic Acid|pantothenic acid|mesh-list
102489282|NCT03520348|Vitamin B Complex|vitamin b complex|mesh-ancestor
102489283|NCT03520348|Vitamins|vitamins|mesh-ancestor
102489284|NCT03520348|Micronutrients|micronutrients|mesh-ancestor
102489285|NCT03520348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489286|NCT03380026|Triamcinolone|triamcinolone|mesh-list
102489287|NCT03380026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102489288|NCT03380026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102489289|NCT03380026|Mechlorethamine|mechlorethamine|mesh-list
102489290|NCT03380026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102489291|NCT03380026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102489292|NCT03380026|Glucocorticoids|glucocorticoids|mesh-ancestor
102489293|NCT03380026|Hormones|hormones|mesh-ancestor
102489294|NCT03380026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102489295|NCT03380026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489296|NCT03380026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102489297|NCT03380026|Immunologic Factors|immunologic factors|mesh-ancestor
102489298|NCT03380026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102489299|NCT03380026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489300|NCT03380026|Alkylating Agents|alkylating agents|mesh-ancestor
102489301|NCT03380026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101622048|NCT02793843|Serotonin Agents|serotonin agents|mesh-ancestor
102489302|NCT03380026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102489303|NCT01079143|Cyclosporine|cyclosporine|mesh-list
102489304|NCT01079143|Mycophenolic Acid|mycophenolic acid|mesh-list
102489305|NCT01079143|Everolimus|everolimus|mesh-list
102489306|NCT01079143|Cyclosporins|cyclosporins|mesh-list
102489307|NCT01079143|Basiliximab|basiliximab|mesh-list
102489308|NCT01079143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102489309|NCT01079143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489310|NCT01079143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102489311|NCT01079143|Immunologic Factors|immunologic factors|mesh-ancestor
102489312|NCT01079143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489313|NCT01079143|Antifungal Agents|antifungal agents|mesh-ancestor
102489314|NCT01079143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102489315|NCT01079143|Dermatologic Agents|dermatologic agents|mesh-ancestor
102489316|NCT01079143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102489317|NCT01079143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102489318|NCT01079143|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102489319|NCT01079143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102489320|NCT01079143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102489321|NCT01079143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102489322|NCT01079143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102489323|NCT01079143|Antitubercular Agents|antitubercular agents|mesh-ancestor
102489324|NCT01079143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102489325|NCT03381742|Clopidogrel|clopidogrel|mesh-list
102489326|NCT03381742|Ticagrelor|ticagrelor|mesh-list
102489327|NCT03381742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102489328|NCT03381742|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102489329|NCT03381742|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102489330|NCT03381742|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102489331|NCT03381742|Purinergic Agents|purinergic agents|mesh-ancestor
102489332|NCT03381742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102489333|NCT03381742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489334|NCT03381742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489335|NCT04735042|Dapagliflozin|dapagliflozin|mesh-list
102489336|NCT04735042|Empagliflozin|empagliflozin|mesh-list
102489337|NCT04735042|Linagliptin|linagliptin|mesh-list
102489338|NCT04735042|Saxagliptin|saxagliptin|mesh-list
102489339|NCT04735042|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102489340|NCT04735042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622057|NCT02801487|Cisplatin|cisplatin|mesh-list
102489341|NCT04735042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102489342|NCT04735042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489343|NCT04735042|Incretins|incretins|mesh-ancestor
102489344|NCT04735042|Hormones|hormones|mesh-ancestor
102489345|NCT04735042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102489346|NCT04735042|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102489347|NCT04735042|Protease Inhibitors|protease inhibitors|mesh-ancestor
102489348|NCT04735042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102489349|NCT04681339|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102489350|NCT04681339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102489351|NCT04681339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102489352|NCT04681339|Antitubercular Agents|antitubercular agents|mesh-ancestor
102489353|NCT00376012|Rifampin|rifampin|mesh-list
102489354|NCT00376012|Isoniazid|isoniazid|mesh-list
102489355|NCT00376012|Pyrazinamide|pyrazinamide|mesh-list
102489356|NCT00376012|Ethambutol|ethambutol|mesh-list
102489357|NCT00376012|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102489358|NCT00376012|Antitubercular Agents|antitubercular agents|mesh-ancestor
102489359|NCT00376012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102489360|NCT00376012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102489361|NCT00376012|Leprostatic Agents|leprostatic agents|mesh-ancestor
102489362|NCT00376012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102489363|NCT00376012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102489364|NCT00376012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489365|NCT00376012|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102489366|NCT00376012|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102489367|NCT00376012|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102489368|NCT00376012|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102489369|NCT00376012|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102489370|NCT00376012|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102489371|NCT00376012|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102489372|NCT00376012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102489373|NCT00376012|Antimetabolites|antimetabolites|mesh-ancestor
102489374|NCT00376012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102489375|NCT02171611|Dabigatran|dabigatran|mesh-list
102489376|NCT02171611|Antithrombins|antithrombins|mesh-ancestor
102489377|NCT02171611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102489378|NCT02171611|Protease Inhibitors|protease inhibitors|mesh-ancestor
102489379|NCT02171611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102489380|NCT02171611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489381|NCT02171611|Anticoagulants|anticoagulants|mesh-ancestor
102489382|NCT01083667|Pyrimethamine|pyrimethamine|mesh-list
102489383|NCT01083667|Antimalarials|antimalarials|mesh-ancestor
102489384|NCT01083667|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102489385|NCT01083667|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102489386|NCT01083667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102489387|NCT01083667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102489388|NCT01083667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102489389|NCT01083667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489390|NCT00942305|Brincidofovir|brincidofovir|mesh-list
102489391|NCT00942305|Antiviral Agents|antiviral agents|mesh-ancestor
102489392|NCT00942305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102489393|NCT01084759|Etoposide|etoposide|mesh-list
102489394|NCT01084759|Methyltestosterone|methyltestosterone|mesh-list
102489395|NCT01084759|Testosterone|testosterone|mesh-list
102489396|NCT01084759|Testosterone undecanoate|testosterone undecanoate|mesh-list
102301026|NCT02198235|Hormones|hormones|mesh-ancestor
102489397|NCT01084759|Testosterone enanthate|testosterone enanthate|mesh-list
102489398|NCT01084759|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102489399|NCT01084759|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102489400|NCT01084759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102489401|NCT01084759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102489402|NCT01084759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102489403|NCT01084759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102489404|NCT01084759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489405|NCT01084759|Androgens|androgens|mesh-ancestor
102489406|NCT01084759|Hormones|hormones|mesh-ancestor
102489407|NCT01084759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102489408|NCT01084759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489409|NCT01084759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102489410|NCT01084759|Anabolic Agents|anabolic agents|mesh-ancestor
102489411|NCT01110187|Lacosamide|lacosamide|mesh-list
102489412|NCT01110187|Fosphenytoin|fosphenytoin|mesh-list
102489413|NCT01110187|Anticonvulsants|anticonvulsants|mesh-ancestor
102489414|NCT01110187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102489415|NCT01110187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102489416|NCT01110187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102489417|NCT01110187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489418|NCT04357301|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
102489419|NCT01110421|Amoxicillin|amoxicillin|mesh-list
101622147|NCT02389374|Chloroquine|chloroquine|mesh-list
102489420|NCT01110421|Clavulanic Acid|clavulanic acid|mesh-list
102489421|NCT01110421|Clavulanic Acids|clavulanic acids|mesh-list
102489422|NCT01110421|Cefepime|cefepime|mesh-list
102489423|NCT01110421|Doripenem|doripenem|mesh-list
102489424|NCT01110421|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102489425|NCT01110421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102489426|NCT01110421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102489427|NCT01110421|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102489428|NCT01110421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102489429|NCT01110421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489430|NCT04358627|Dexmedetomidine|dexmedetomidine|mesh-list
102489431|NCT04358627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102489432|NCT04358627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102489433|NCT04358627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489434|NCT04358627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102489435|NCT04358627|Analgesics|analgesics|mesh-ancestor
102489436|NCT04358627|Sensory System Agents|sensory system agents|mesh-ancestor
102489437|NCT04358627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102489438|NCT04358627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102489439|NCT04358627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102489440|NCT04358627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102489441|NCT04358627|Adrenergic Agents|adrenergic agents|mesh-ancestor
102489442|NCT04358627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102489443|NCT04358627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489444|NCT04356677|Ribavirin|ribavirin|mesh-list
102489445|NCT04356677|Antimetabolites|antimetabolites|mesh-ancestor
102489446|NCT04356677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489447|NCT04356677|Antiviral Agents|antiviral agents|mesh-ancestor
102489448|NCT04356677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102489449|NCT04356833|Plasminogen|plasminogen|mesh-list
102489450|NCT04356833|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102489451|NCT04356833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102489452|NCT04356833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102489453|NCT04356833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489454|NCT05620277|Tocopherols|tocopherols|mesh-list
102489455|NCT05620277|Vitamin E|vitamin e|mesh-list
102489456|NCT05620277|alpha-Tocopherol|alpha-tocopherol|mesh-list
102489457|NCT05620277|Antioxidants|antioxidants|mesh-ancestor
102489458|NCT05620277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489459|NCT05620277|Protective Agents|protective agents|mesh-ancestor
102489460|NCT05620277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489461|NCT05620277|Vitamins|vitamins|mesh-ancestor
102489462|NCT05620277|Micronutrients|micronutrients|mesh-ancestor
102489463|NCT01110499|Bimatoprost|bimatoprost|mesh-list
102489464|NCT01110499|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102489465|NCT01110499|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102489466|NCT01110499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102489467|NCT02174419|Nalbuphine|nalbuphine|mesh-list
102489468|NCT02174419|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102489469|NCT02174419|Narcotics|narcotics|mesh-ancestor
102489470|NCT02174419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102489471|NCT02174419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489472|NCT02174419|Analgesics|analgesics|mesh-ancestor
102489473|NCT02174419|Sensory System Agents|sensory system agents|mesh-ancestor
102489474|NCT02174419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102489475|NCT05620589|Amoxicillin|amoxicillin|mesh-list
102489476|NCT05620589|Tetracycline|tetracycline|mesh-list
102489477|NCT05620589|Esomeprazole|esomeprazole|mesh-list
102489478|NCT05620589|Bismuth|bismuth|mesh-list
102489479|NCT05620589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102489480|NCT05620589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102489481|NCT05620589|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102489482|NCT05620589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102489483|NCT05620589|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102489484|NCT05620589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102489485|NCT05620589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489486|NCT05620589|Antacids|antacids|mesh-ancestor
102489487|NCT05620589|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102489488|NCT01086475|Cycloserine|cycloserine|mesh-list
102489489|NCT01086475|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102489490|NCT01086475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102489491|NCT01086475|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102489492|NCT01086475|Antitubercular Agents|antitubercular agents|mesh-ancestor
102489493|NCT01086475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102489494|NCT01086475|Antimetabolites|antimetabolites|mesh-ancestor
102489495|NCT01086475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489496|NCT01112683|Memantine|memantine|mesh-list
102489497|NCT01112683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102489498|NCT01112683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102489499|NCT01112683|Dopamine Agents|dopamine agents|mesh-ancestor
102489500|NCT01112683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102489501|NCT01112683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489502|NCT01112683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489503|NCT01112683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102489504|NCT01112683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102489505|NCT02245373|Antidepressive Agents|antidepressive agents|mesh-list
102489506|NCT02245373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102489507|NCT04355273|Heparin|heparin|mesh-list
102489508|NCT04355273|Calcium heparin|calcium heparin|mesh-list
102489509|NCT04355273|Anticoagulants|anticoagulants|mesh-ancestor
102489510|NCT04355273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102489511|NCT04355273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102489512|NCT04355273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489513|NCT04355429|Captopril|captopril|mesh-list
102489514|NCT04355429|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102489515|NCT04355429|Protease Inhibitors|protease inhibitors|mesh-ancestor
102489516|NCT04355429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102489517|NCT04355429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489518|NCT04355429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102489519|NCT01114555|Bevacizumab|bevacizumab|mesh-list
102489520|NCT01114555|Irinotecan|irinotecan|mesh-list
102489521|NCT01114555|Temozolomide|temozolomide|mesh-list
102489522|NCT01114555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102489523|NCT01114555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102489524|NCT01114555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102489525|NCT01114555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102489526|NCT01114555|Growth Substances|growth substances|mesh-ancestor
102489527|NCT01114555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489528|NCT01114555|Growth Inhibitors|growth inhibitors|mesh-ancestor
102489529|NCT01114555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102489530|NCT01114555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102489531|NCT01114555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102489532|NCT01114555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489533|NCT01114555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102489534|NCT01114555|Alkylating Agents|alkylating agents|mesh-ancestor
102489535|NCT02673931|Exenatide|exenatide|mesh-list
102489536|NCT02673931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101775304|NCT00936195|Efavirenz|efavirenz|mesh-list
102489537|NCT02673931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489538|NCT02673931|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102489539|NCT02673931|Incretins|incretins|mesh-ancestor
102489540|NCT02673931|Hormones|hormones|mesh-ancestor
102489541|NCT02673931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102489542|NCT01115101|Pirinitramide|pirinitramide|mesh-list
101622267|NCT02788851|Methylphenidate|methylphenidate|mesh-list
102489543|NCT01115101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102489544|NCT01115101|Narcotics|narcotics|mesh-ancestor
102489545|NCT01115101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102489546|NCT01115101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301174|NCT02395081|Vitamin D|vitamin d|mesh-list
102489547|NCT01115101|Analgesics|analgesics|mesh-ancestor
102489548|NCT01115101|Sensory System Agents|sensory system agents|mesh-ancestor
102489549|NCT01115101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102489550|NCT02245529|Tamsulosin|tamsulosin|mesh-list
102489551|NCT02245529|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102489552|NCT02245529|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102489553|NCT02245529|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102489554|NCT02245529|Adrenergic Agents|adrenergic agents|mesh-ancestor
102489555|NCT02245529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102489556|NCT02245529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489557|NCT02245529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489558|NCT02245529|Urological Agents|urological agents|mesh-ancestor
102489559|NCT00947765|Prednisolone|prednisolone|mesh-list
101622280|NCT02788851|Sympathomimetics|sympathomimetics|mesh-ancestor
102489560|NCT00947765|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102489561|NCT00947765|Methylprednisolone|methylprednisolone|mesh-list
102489562|NCT00947765|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102489563|NCT00947765|Prednisolone acetate|prednisolone acetate|mesh-list
102489564|NCT00947765|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102489565|NCT00947765|Prednisolone phosphate|prednisolone phosphate|mesh-list
102489566|NCT00947765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102489567|NCT00947765|Glucocorticoids|glucocorticoids|mesh-ancestor
102489568|NCT00947765|Hormones|hormones|mesh-ancestor
102489569|NCT00947765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102489570|NCT00947765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489571|NCT00947765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102489572|NCT00947765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102489573|NCT00947765|Antiemetics|antiemetics|mesh-ancestor
102489574|NCT00947765|Autonomic Agents|autonomic agents|mesh-ancestor
102489575|NCT00947765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102489576|NCT00947765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102489577|NCT00947765|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102489578|NCT00947765|Protective Agents|protective agents|mesh-ancestor
102489579|NCT01089517|Ranibizumab|ranibizumab|mesh-list
102489580|NCT01089517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102489581|NCT01089517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102489582|NCT01089517|Growth Substances|growth substances|mesh-ancestor
102489583|NCT01089517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489584|NCT01089517|Growth Inhibitors|growth inhibitors|mesh-ancestor
102489585|NCT01089517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102489586|NCT04311515|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102489587|NCT04311515|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102489588|NCT04311515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489589|NCT01089595|Imatinib Mesylate|imatinib mesylate|mesh-list
102489590|NCT01089595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101622316|NCT00815308|Mitosis Modulators|mitosis modulators|mesh-ancestor
102489591|NCT01089595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102489592|NCT01089595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102489593|NCT01089595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489594|NCT04354961|Paclitaxel|paclitaxel|mesh-list
102489595|NCT04354961|Carboplatin|carboplatin|mesh-list
102489596|NCT04354961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102489597|NCT04354961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102489598|NCT04354961|Tubulin Modulators|tubulin modulators|mesh-ancestor
102489599|NCT04354961|Antimitotic Agents|antimitotic agents|mesh-ancestor
102489600|NCT04354961|Mitosis Modulators|mitosis modulators|mesh-ancestor
102489601|NCT04354961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489602|NCT01089751|Trospium chloride|trospium chloride|mesh-list
102489603|NCT01089751|Parasympatholytics|parasympatholytics|mesh-ancestor
102489604|NCT01089751|Autonomic Agents|autonomic agents|mesh-ancestor
102489605|NCT01089751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102489606|NCT01089751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489607|NCT01089751|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102489608|NCT01089751|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102489609|NCT01089751|Cholinergic Agents|cholinergic agents|mesh-ancestor
102489610|NCT01089751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101622333|NCT02610712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102489611|NCT01089751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489612|NCT01089751|Urological Agents|urological agents|mesh-ancestor
102489613|NCT03032315|Amlodipine|amlodipine|mesh-list
102489614|NCT03032315|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102489615|NCT03032315|Telmisartan|telmisartan|mesh-list
102489616|NCT03032315|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
102489617|NCT03032315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102489618|NCT03032315|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102489619|NCT03032315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102489620|NCT03032315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489621|NCT03032315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102489622|NCT03032315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489623|NCT03032315|Vasodilator Agents|vasodilator agents|mesh-ancestor
102489624|NCT03032315|Diuretics|diuretics|mesh-ancestor
102489625|NCT03032315|Natriuretic Agents|natriuretic agents|mesh-ancestor
101622345|NCT00905034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102489626|NCT03032315|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102489627|NCT03032315|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102489628|NCT03032315|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102489629|NCT01090921|Bortezomib|bortezomib|mesh-list
102489630|NCT01090921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102489631|NCT03537274|Interferons|interferons|mesh-list
102489632|NCT03537274|Interferon-alpha|interferon-alpha|mesh-list
102489633|NCT03537274|Interferon alpha-2|interferon alpha-2|mesh-list
102489634|NCT03537274|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102489635|NCT03537274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102489636|NCT03537274|Antiviral Agents|antiviral agents|mesh-ancestor
102489637|NCT03537274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102489638|NCT03537274|Immunologic Factors|immunologic factors|mesh-ancestor
102489639|NCT03537274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489640|NCT00939653|Cytarabine|cytarabine|mesh-list
102489641|NCT00939653|Cyclophosphamide|cyclophosphamide|mesh-list
102489642|NCT00939653|Etoposide|etoposide|mesh-list
102489643|NCT00939653|Clofarabine|clofarabine|mesh-list
102489644|NCT00939653|Lenograstim|lenograstim|mesh-list
102489645|NCT00939653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102489646|NCT00939653|Immunologic Factors|immunologic factors|mesh-ancestor
102489647|NCT00939653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489648|NCT00939653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102489649|NCT00939653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102489650|NCT00939653|Alkylating Agents|alkylating agents|mesh-ancestor
102489651|NCT00939653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489652|NCT00939653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102489653|NCT00939653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102489654|NCT00939653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102489655|NCT00939653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102489656|NCT00939653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102489657|NCT00939653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102489658|NCT00939653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102489659|NCT00939653|Antimetabolites|antimetabolites|mesh-ancestor
102489660|NCT00939653|Antiviral Agents|antiviral agents|mesh-ancestor
102489661|NCT00939653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102489662|NCT00939653|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102489663|NCT04355039|Dexamethasone|dexamethasone|mesh-list
102489664|NCT04355039|Pomalidomide|pomalidomide|mesh-list
102489665|NCT04355039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102489666|NCT04355039|Antiemetics|antiemetics|mesh-ancestor
102489667|NCT04355039|Autonomic Agents|autonomic agents|mesh-ancestor
102489668|NCT04355039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102489669|NCT04355039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489670|NCT04355039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102489671|NCT04355039|Glucocorticoids|glucocorticoids|mesh-ancestor
102489672|NCT04355039|Hormones|hormones|mesh-ancestor
102489673|NCT04355039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102489674|NCT04355039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102489675|NCT04355039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102489676|NCT04355039|Immunologic Factors|immunologic factors|mesh-ancestor
102489677|NCT04355039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102489678|NCT04355039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102489679|NCT04355039|Growth Substances|growth substances|mesh-ancestor
102489680|NCT04355039|Growth Inhibitors|growth inhibitors|mesh-ancestor
102489681|NCT02524405|Corticosterone|corticosterone|mesh-list
102489682|NCT02524405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102489683|NCT03014323|Galantamine|galantamine|mesh-list
102489684|NCT03014323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102489685|NCT03014323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102489686|NCT03014323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489687|NCT03014323|Cholinergic Agents|cholinergic agents|mesh-ancestor
102489688|NCT03014323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102489689|NCT03014323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489690|NCT03014323|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102489691|NCT03014323|Autonomic Agents|autonomic agents|mesh-ancestor
102489692|NCT03014323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102489693|NCT03014323|Nootropic Agents|nootropic agents|mesh-ancestor
102489694|NCT03393208|Metformin|metformin|mesh-list
102489695|NCT03393208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102489696|NCT03393208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489697|NCT01092559|Nitric Oxide|nitric oxide|mesh-list
102489698|NCT01092559|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102489700|NCT01092559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102489701|NCT01092559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489702|NCT01092559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102489703|NCT01092559|Respiratory System Agents|respiratory system agents|mesh-ancestor
102489704|NCT01092559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102489705|NCT01092559|Antioxidants|antioxidants|mesh-ancestor
102489706|NCT01092559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489707|NCT01092559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102489708|NCT01092559|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102489709|NCT01092559|Vasodilator Agents|vasodilator agents|mesh-ancestor
102489710|NCT01092559|Gasotransmitters|gasotransmitters|mesh-ancestor
102489711|NCT01092559|Protective Agents|protective agents|mesh-ancestor
102489712|NCT03587428|Zinc|zinc|mesh-list
101622433|NCT00828568|Imiquimod|imiquimod|mesh-list
102489713|NCT03587428|Trace Elements|trace elements|mesh-ancestor
102489714|NCT03587428|Micronutrients|micronutrients|mesh-ancestor
102489715|NCT03587428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489716|NCT03398278|Oxycodone|oxycodone|mesh-list
102489717|NCT03398278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102489718|NCT03398278|Narcotics|narcotics|mesh-ancestor
102489719|NCT03398278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102489720|NCT03398278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489721|NCT03398278|Analgesics|analgesics|mesh-ancestor
102489722|NCT03398278|Sensory System Agents|sensory system agents|mesh-ancestor
102489723|NCT03398278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102489724|NCT03593902|Methylprednisolone|methylprednisolone|mesh-list
102489725|NCT03593902|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102489726|NCT03593902|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102489727|NCT03593902|Prednisolone|prednisolone|mesh-list
102489728|NCT03593902|Prednisolone acetate|prednisolone acetate|mesh-list
102489729|NCT03593902|Cyclophosphamide|cyclophosphamide|mesh-list
102489730|NCT03593902|Rituximab|rituximab|mesh-list
102489731|NCT03593902|Fludarabine|fludarabine|mesh-list
102489732|NCT03593902|Thymoglobulin|thymoglobulin|mesh-list
102489733|NCT03593902|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102489734|NCT03593902|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102489735|NCT03593902|Prednisolone phosphate|prednisolone phosphate|mesh-list
102489736|NCT03593902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102489737|NCT03593902|Immunologic Factors|immunologic factors|mesh-ancestor
102489738|NCT03593902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489739|NCT03593902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102489740|NCT03593902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102489741|NCT03593902|Alkylating Agents|alkylating agents|mesh-ancestor
101622457|NCT00903630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102489742|NCT03593902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489743|NCT03593902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102489744|NCT03593902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102489745|NCT03593902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102489746|NCT03593902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102489747|NCT03593902|Antiemetics|antiemetics|mesh-ancestor
102489748|NCT03593902|Autonomic Agents|autonomic agents|mesh-ancestor
102489749|NCT03593902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102489750|NCT03593902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101600541|NCT01107353|Imipramine|imipramine|mesh-list
102489751|NCT03593902|Glucocorticoids|glucocorticoids|mesh-ancestor
102489752|NCT03593902|Hormones|hormones|mesh-ancestor
102489753|NCT03593902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102489754|NCT03593902|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102489755|NCT03593902|Protective Agents|protective agents|mesh-ancestor
102489756|NCT03593902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102489757|NCT00948935|Gemcitabine|gemcitabine|mesh-list
102489758|NCT00948935|Irinotecan|irinotecan|mesh-list
102489759|NCT00948935|Panitumumab|panitumumab|mesh-list
102489760|NCT00948935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102489761|NCT00948935|Antimetabolites|antimetabolites|mesh-ancestor
102489762|NCT00948935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489763|NCT00948935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102489764|NCT00948935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102489765|NCT00948935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102489766|NCT00948935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102489767|NCT00948935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102489768|NCT04354805|Chlorpromazine|chlorpromazine|mesh-list
102489769|NCT04354805|Antiemetics|antiemetics|mesh-ancestor
102489770|NCT04354805|Autonomic Agents|autonomic agents|mesh-ancestor
102489771|NCT04354805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102489772|NCT04354805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489773|NCT04354805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102489774|NCT04354805|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102489775|NCT04354805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102489776|NCT04354805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102489777|NCT04354805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102489778|NCT04354805|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102489779|NCT04354805|Dopamine Agents|dopamine agents|mesh-ancestor
102489780|NCT04354805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101622497|NCT01054820|Analgesics|analgesics|mesh-ancestor
102489781|NCT04354805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489782|NCT03944681|Droperidol|droperidol|mesh-list
102489783|NCT03944681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102489784|NCT03944681|Antiemetics|antiemetics|mesh-ancestor
102489785|NCT03944681|Autonomic Agents|autonomic agents|mesh-ancestor
102489786|NCT03944681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102489787|NCT03944681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489788|NCT03944681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102489789|NCT03944681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102489790|NCT03944681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102489791|NCT03944681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102489792|NCT03944681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102489793|NCT03944681|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102489794|NCT03944681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102489795|NCT03944681|Dopamine Agents|dopamine agents|mesh-ancestor
102489796|NCT03944681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102489797|NCT03944681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133720|NCT02295189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101622507|NCT03105843|Miotics|miotics|mesh-ancestor
102489798|NCT03935555|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
102489799|NCT03935555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102489800|NCT03031691|Trifluridine|trifluridine|mesh-list
102489801|NCT03031691|Antimetabolites|antimetabolites|mesh-ancestor
102489802|NCT03031691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489803|NCT03031691|Antiviral Agents|antiviral agents|mesh-ancestor
102489804|NCT03031691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102489805|NCT01093183|Cyclophosphamide|cyclophosphamide|mesh-list
102489806|NCT01093183|Lenalidomide|lenalidomide|mesh-list
102489807|NCT01093183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102489808|NCT01093183|Immunologic Factors|immunologic factors|mesh-ancestor
102489809|NCT01093183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489810|NCT01093183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102489811|NCT01093183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102489812|NCT01093183|Alkylating Agents|alkylating agents|mesh-ancestor
102489813|NCT01093183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489814|NCT01093183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102489815|NCT01093183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102489816|NCT01093183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102489817|NCT01093183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102489818|NCT01093183|Growth Substances|growth substances|mesh-ancestor
102489819|NCT01093183|Growth Inhibitors|growth inhibitors|mesh-ancestor
102489820|NCT02430103|Goserelin|goserelin|mesh-list
102489821|NCT02430103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102489822|NCT02430103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102489823|NCT03031535|Octreotide|octreotide|mesh-list
102489824|NCT03031535|Hormones|hormones|mesh-list
102489825|NCT03031535|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
102489826|NCT03031535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102489827|NCT03031535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489828|NCT03031535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102489829|NCT03031535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102489830|NCT03031535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102489831|NCT01093417|Vitamin D|vitamin d|mesh-list
102489832|NCT01093417|Vitamins|vitamins|mesh-ancestor
102489833|NCT01093417|Micronutrients|micronutrients|mesh-ancestor
102489834|NCT01093417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489835|NCT01093417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102489836|NCT01093651|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102489837|NCT01093651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102489838|NCT01093651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489839|NCT01093651|Incretins|incretins|mesh-ancestor
102489840|NCT01093651|Hormones|hormones|mesh-ancestor
102489841|NCT01093651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102489842|NCT01093651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102489843|NCT01093651|Protease Inhibitors|protease inhibitors|mesh-ancestor
102489844|NCT01093651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102489845|NCT01093651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489846|NCT00362895|Tobramycin|tobramycin|mesh-list
102612329|NCT00002417|Amprenavir|amprenavir|mesh-list
102489847|NCT00362895|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
102489848|NCT00362895|Dexamethasone|dexamethasone|mesh-list
102489849|NCT00362895|Dexamethasone acetate|dexamethasone acetate|mesh-list
102489850|NCT00362895|BB 1101|bb 1101|mesh-list
102489851|NCT00362895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102489852|NCT00362895|Antiemetics|antiemetics|mesh-ancestor
102489853|NCT00362895|Autonomic Agents|autonomic agents|mesh-ancestor
102489854|NCT00362895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102489855|NCT00362895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489856|NCT00362895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102489857|NCT00362895|Glucocorticoids|glucocorticoids|mesh-ancestor
102489858|NCT00362895|Hormones|hormones|mesh-ancestor
102489859|NCT00362895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102489860|NCT00362895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102489861|NCT00362895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102489862|NCT00362895|Protease Inhibitors|protease inhibitors|mesh-ancestor
102489863|NCT00362895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102489864|NCT00362895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489865|NCT00362895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102489866|NCT00362895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102489867|NCT00362895|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102489868|NCT00362895|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102489869|NCT04744623|Mycophenolic Acid|mycophenolic acid|mesh-list
102489870|NCT04744623|Dapsone|dapsone|mesh-list
102489871|NCT04744623|Prednisolone|prednisolone|mesh-list
102489872|NCT04744623|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102489873|NCT04744623|Methylprednisolone|methylprednisolone|mesh-list
102489874|NCT04744623|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102489875|NCT04744623|Prednisolone acetate|prednisolone acetate|mesh-list
102489876|NCT04744623|Triamcinolone|triamcinolone|mesh-list
102489877|NCT04744623|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102489878|NCT04744623|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102489879|NCT04744623|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102489880|NCT04744623|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102489881|NCT04744623|Prednisolone phosphate|prednisolone phosphate|mesh-list
102489882|NCT04744623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102489883|NCT04744623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102489884|NCT04744623|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102489885|NCT04744623|Antitubercular Agents|antitubercular agents|mesh-ancestor
102489886|NCT04744623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102489887|NCT04744623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102489888|NCT04744623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102489889|NCT04744623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489890|NCT04744623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102489891|NCT04744623|Glucocorticoids|glucocorticoids|mesh-ancestor
102489892|NCT04744623|Hormones|hormones|mesh-ancestor
102489893|NCT04744623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102489894|NCT04744623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622614|NCT03044613|Paclitaxel|paclitaxel|mesh-list
102489895|NCT04744623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102489896|NCT04744623|Antiemetics|antiemetics|mesh-ancestor
102489897|NCT04744623|Autonomic Agents|autonomic agents|mesh-ancestor
102489898|NCT04744623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102489899|NCT04744623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102489900|NCT04744623|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102489901|NCT04744623|Protective Agents|protective agents|mesh-ancestor
102489902|NCT04744623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102489903|NCT04744623|Immunologic Factors|immunologic factors|mesh-ancestor
102489904|NCT04744623|Antimalarials|antimalarials|mesh-ancestor
102489905|NCT04744623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102489906|NCT04744623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102489907|NCT04744623|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102489908|NCT04744623|Leprostatic Agents|leprostatic agents|mesh-ancestor
102489909|NCT00939731|Crizotinib|crizotinib|mesh-list
101622626|NCT01372254|Nicotine|nicotine|mesh-list
102489910|NCT00939731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102489911|NCT00939731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102489912|NCT00939731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102489913|NCT00939731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489914|NCT00633945|Lenalidomide|lenalidomide|mesh-list
102489915|NCT00633945|Immunologic Factors|immunologic factors|mesh-ancestor
102489916|NCT00633945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489917|NCT00633945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102489918|NCT00633945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102489919|NCT00633945|Growth Substances|growth substances|mesh-ancestor
102489920|NCT00633945|Growth Inhibitors|growth inhibitors|mesh-ancestor
102301541|NCT01618162|Hormones|hormones|mesh-ancestor
102489921|NCT00633945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102489923|NCT03609047|Docetaxel|docetaxel|mesh-list
102489924|NCT03609047|Cyclophosphamide|cyclophosphamide|mesh-list
102489925|NCT03609047|Doxorubicin|doxorubicin|mesh-list
102489926|NCT03609047|Epirubicin|epirubicin|mesh-list
102489927|NCT03609047|Palbociclib|palbociclib|mesh-list
102489928|NCT03609047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102489929|NCT03609047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102489930|NCT03609047|Tubulin Modulators|tubulin modulators|mesh-ancestor
102489931|NCT03609047|Antimitotic Agents|antimitotic agents|mesh-ancestor
102489932|NCT03609047|Mitosis Modulators|mitosis modulators|mesh-ancestor
102489933|NCT03609047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489934|NCT03609047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102489935|NCT03609047|Immunologic Factors|immunologic factors|mesh-ancestor
102489936|NCT03609047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489937|NCT03609047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102489938|NCT03609047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102489939|NCT03609047|Alkylating Agents|alkylating agents|mesh-ancestor
102489940|NCT03609047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102489941|NCT03609047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102489942|NCT03609047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102489943|NCT03609047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102489944|NCT03609047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102489945|NCT03609047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102489946|NCT01118845|Rituximab|rituximab|mesh-list
102489947|NCT01118845|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102489948|NCT01118845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102489949|NCT01118845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102489950|NCT01118845|Immunologic Factors|immunologic factors|mesh-ancestor
102489951|NCT01118845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489952|NCT01118845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102489953|NCT01118845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102489954|NCT01118845|Alkylating Agents|alkylating agents|mesh-ancestor
102489955|NCT01118845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489956|NCT01130077|Poly ICLC|poly iclc|mesh-list
102489957|NCT01130077|Interferon Inducers|interferon inducers|mesh-ancestor
102489958|NCT01130077|Immunologic Factors|immunologic factors|mesh-ancestor
102489959|NCT01130077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489960|NCT03162731|Nivolumab|nivolumab|mesh-list
102489961|NCT03162731|Ipilimumab|ipilimumab|mesh-list
102489962|NCT03162731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102489963|NCT03162731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102489964|NCT03162731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102489965|NCT03162731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489966|NCT03030911|Fentanyl|fentanyl|mesh-list
102489967|NCT03030911|Midazolam|midazolam|mesh-list
102489968|NCT03030911|Dexmedetomidine|dexmedetomidine|mesh-list
102489969|NCT03030911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102489970|NCT03030911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102489971|NCT03030911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102489972|NCT03030911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102489973|NCT03030911|Analgesics|analgesics|mesh-ancestor
102489974|NCT03030911|Sensory System Agents|sensory system agents|mesh-ancestor
102489975|NCT03030911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102489976|NCT03030911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102489977|NCT03030911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102489978|NCT03030911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102489979|NCT03030911|Adrenergic Agents|adrenergic agents|mesh-ancestor
102489980|NCT03030911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102489981|NCT03030911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102489982|NCT03030911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102489983|NCT03030911|Narcotics|narcotics|mesh-ancestor
102489984|NCT03030911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102489985|NCT03030911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102489986|NCT03030911|Anesthetics, General|anesthetics, general|mesh-ancestor
102489987|NCT03030911|Anesthetics|anesthetics|mesh-ancestor
102489988|NCT03030911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102489989|NCT03030911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102489990|NCT03030911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102489991|NCT03030911|GABA Modulators|gaba modulators|mesh-ancestor
102489992|NCT03030911|GABA Agents|gaba agents|mesh-ancestor
102489993|NCT01120405|Sevoflurane|sevoflurane|mesh-list
102489994|NCT01120405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102489995|NCT01120405|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102489996|NCT01120405|Anesthetics, General|anesthetics, general|mesh-ancestor
102489997|NCT01120405|Anesthetics|anesthetics|mesh-ancestor
102301633|NCT02210091|BAX 855|bax 855|mesh-list
102489998|NCT01120405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102489999|NCT01120405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490000|NCT03013387|Octreotide|octreotide|mesh-list
102490001|NCT03013387|Edotreotide|edotreotide|mesh-list
102490002|NCT03013387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102490003|NCT03013387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102490004|NCT03013387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102490005|NCT03013387|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102490006|NCT03013387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490007|NCT01782989|Doxycycline|doxycycline|mesh-list
102490008|NCT01782989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102490009|NCT01782989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102490010|NCT01782989|Antimalarials|antimalarials|mesh-ancestor
102490011|NCT01782989|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102490012|NCT01782989|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102490013|NCT01120639|Temozolomide|temozolomide|mesh-list
102490014|NCT01120639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102490015|NCT01120639|Alkylating Agents|alkylating agents|mesh-ancestor
102490016|NCT01120639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490017|NCT01120639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102490018|NCT01095757|Plerixafor|plerixafor|mesh-list
102490019|NCT01095757|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102490020|NCT01095757|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102490021|NCT01095757|Antiviral Agents|antiviral agents|mesh-ancestor
102490022|NCT01095757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102490023|NCT03549598|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102490024|NCT03549598|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102490025|NCT03549598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490026|NCT02245451|Ritonavir|ritonavir|mesh-list
102490027|NCT02245451|Tipranavir|tipranavir|mesh-list
102490028|NCT02245451|Methadone|methadone|mesh-list
102490029|NCT02245451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102490030|NCT02245451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102490031|NCT02245451|Protease Inhibitors|protease inhibitors|mesh-ancestor
102490032|NCT02245451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102490033|NCT02245451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490034|NCT02245451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102490035|NCT02245451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102490036|NCT02245451|Antiviral Agents|antiviral agents|mesh-ancestor
102490037|NCT02245451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102490038|NCT02245451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102490039|NCT02245451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102490040|NCT02245451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102490041|NCT02245451|Narcotics|narcotics|mesh-ancestor
102490042|NCT02245451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102490043|NCT02245451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490044|NCT02245451|Analgesics|analgesics|mesh-ancestor
102490045|NCT02245451|Sensory System Agents|sensory system agents|mesh-ancestor
102490046|NCT02245451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102490047|NCT02245451|Antitussive Agents|antitussive agents|mesh-ancestor
102490048|NCT02245451|Respiratory System Agents|respiratory system agents|mesh-ancestor
102490049|NCT01096771|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102490050|NCT01096771|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102490051|NCT01096771|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102490052|NCT01096771|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102490053|NCT00951899|Metformin|metformin|mesh-list
102490054|NCT00951899|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
102490055|NCT00951899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102490056|NCT00951899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490057|NCT00951899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102490058|NCT00951899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102490059|NCT00951899|Antimetabolites|antimetabolites|mesh-ancestor
102490060|NCT00951899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490061|NCT00951899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102490062|NCT01097395|Ribavirin|ribavirin|mesh-list
102490063|NCT01097395|Antimetabolites|antimetabolites|mesh-ancestor
102490064|NCT01097395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490065|NCT01097395|Antiviral Agents|antiviral agents|mesh-ancestor
102490066|NCT01097395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102490067|NCT00467987|Testosterone|testosterone|mesh-list
102490068|NCT00467987|Androgens|androgens|mesh-ancestor
102490069|NCT00467987|Hormones|hormones|mesh-ancestor
102490070|NCT00467987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102490071|NCT00467987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490072|NCT00433589|Tamoxifen|tamoxifen|mesh-list
102490073|NCT00433589|Docetaxel|docetaxel|mesh-list
102490074|NCT00433589|Capecitabine|capecitabine|mesh-list
102490075|NCT00433589|Letrozole|letrozole|mesh-list
102490076|NCT00433589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102490077|NCT00433589|Tubulin Modulators|tubulin modulators|mesh-ancestor
102490078|NCT00433589|Antimitotic Agents|antimitotic agents|mesh-ancestor
102490079|NCT00433589|Mitosis Modulators|mitosis modulators|mesh-ancestor
102490080|NCT00433589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490081|NCT00433589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102490082|NCT00433589|Antimetabolites|antimetabolites|mesh-ancestor
102490083|NCT00433589|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102490084|NCT00433589|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102490085|NCT00433589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102490086|NCT00433589|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102490087|NCT00433589|Hormone Antagonists|hormone antagonists|mesh-ancestor
102490088|NCT00433589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102490089|NCT00433589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490090|NCT00433589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102490091|NCT00433589|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102490092|NCT00433589|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102490093|NCT00433589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102490094|NCT03013075|Morphine|morphine|mesh-list
102490095|NCT03013075|Bupivacaine|bupivacaine|mesh-list
102490096|NCT03013075|Anesthetics|anesthetics|mesh-list
102490097|NCT03013075|Anesthetics, General|anesthetics, general|mesh-list
102490098|NCT03013075|Anesthetics, Local|anesthetics, local|mesh-ancestor
102490099|NCT03013075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102490100|NCT03013075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490101|NCT03013075|Sensory System Agents|sensory system agents|mesh-ancestor
102490102|NCT03013075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102490103|NCT03013075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102490104|NCT03013075|Narcotics|narcotics|mesh-ancestor
102490105|NCT03013075|Analgesics|analgesics|mesh-ancestor
102490106|NCT03030677|Lidocaine|lidocaine|mesh-list
102490107|NCT03030677|Anesthetics, Local|anesthetics, local|mesh-ancestor
102490108|NCT03030677|Anesthetics|anesthetics|mesh-ancestor
102490109|NCT03030677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102490110|NCT03030677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490111|NCT03030677|Sensory System Agents|sensory system agents|mesh-ancestor
102490112|NCT03030677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102490113|NCT03030677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102490114|NCT03030677|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102490115|NCT03030677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102490116|NCT03030677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102490117|NCT03030677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490118|NCT01122901|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
102490119|NCT01122901|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
102490120|NCT01122901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102490121|NCT01122901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490122|NCT01097785|Simvastatin|simvastatin|mesh-list
102490123|NCT01097785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102490124|NCT01097785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102490125|NCT01097785|Antimetabolites|antimetabolites|mesh-ancestor
102490126|NCT01097785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490127|NCT01097785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102490128|NCT01097785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102490129|NCT01097785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102490130|NCT03030287|Paclitaxel|paclitaxel|mesh-list
102490131|NCT03030287|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102490132|NCT03030287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102490133|NCT03030287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102490134|NCT03030287|Tubulin Modulators|tubulin modulators|mesh-ancestor
102490135|NCT03030287|Antimitotic Agents|antimitotic agents|mesh-ancestor
102490136|NCT03030287|Mitosis Modulators|mitosis modulators|mesh-ancestor
102490137|NCT03030287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490138|NCT03030287|Immunologic Factors|immunologic factors|mesh-ancestor
102490139|NCT03030287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490140|NCT03035357|Daratumumab|daratumumab|mesh-list
102490141|NCT03035357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102490142|NCT00940589|Melatonin|melatonin|mesh-list
102490143|NCT00940589|Antioxidants|antioxidants|mesh-ancestor
102490144|NCT00940589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490145|NCT00940589|Protective Agents|protective agents|mesh-ancestor
102490146|NCT00940589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490147|NCT00940589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102490148|NCT02574078|Paclitaxel|paclitaxel|mesh-list
102490149|NCT02574078|Docetaxel|docetaxel|mesh-list
102490150|NCT02574078|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102490151|NCT02574078|Bevacizumab|bevacizumab|mesh-list
102490152|NCT02574078|Carboplatin|carboplatin|mesh-list
102490153|NCT02574078|Gemcitabine|gemcitabine|mesh-list
102490154|NCT02574078|Nivolumab|nivolumab|mesh-list
102490155|NCT02574078|Pemetrexed|pemetrexed|mesh-list
102490156|NCT02574078|Crizotinib|crizotinib|mesh-list
102490157|NCT02574078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102490158|NCT02574078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102490159|NCT02574078|Tubulin Modulators|tubulin modulators|mesh-ancestor
102490160|NCT02574078|Antimitotic Agents|antimitotic agents|mesh-ancestor
102490161|NCT02574078|Mitosis Modulators|mitosis modulators|mesh-ancestor
102490162|NCT02574078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490163|NCT02574078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102490164|NCT02574078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102490165|NCT02574078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102490166|NCT02574078|Growth Substances|growth substances|mesh-ancestor
102490167|NCT02574078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490168|NCT02574078|Growth Inhibitors|growth inhibitors|mesh-ancestor
102490169|NCT02574078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102490170|NCT02574078|Antimetabolites|antimetabolites|mesh-ancestor
102490171|NCT02574078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102490172|NCT02574078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102490173|NCT02574078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102490174|NCT02574078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102490175|NCT02574078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102490176|NCT03605914|Acetaminophen|acetaminophen|mesh-list
102490177|NCT03605914|Diclofenac|diclofenac|mesh-list
102490178|NCT03605914|Hydrocodone|hydrocodone|mesh-list
102490179|NCT03605914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102490180|NCT03605914|Analgesics|analgesics|mesh-ancestor
102490181|NCT03605914|Sensory System Agents|sensory system agents|mesh-ancestor
102490182|NCT03605914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102490183|NCT03605914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490184|NCT03605914|Antipyretics|antipyretics|mesh-ancestor
102490185|NCT03605914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102490186|NCT03605914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102490187|NCT03605914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102490188|NCT03605914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102490189|NCT03605914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102490190|NCT03605914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490191|NCT03605914|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102490192|NCT03605914|Narcotics|narcotics|mesh-ancestor
102490193|NCT03605914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102490194|NCT03605914|Antitussive Agents|antitussive agents|mesh-ancestor
102490195|NCT03605914|Respiratory System Agents|respiratory system agents|mesh-ancestor
102490196|NCT04353479|Decitabine|decitabine|mesh-list
102490197|NCT04353479|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102490198|NCT04353479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102490199|NCT04353479|Antimetabolites|antimetabolites|mesh-ancestor
102490200|NCT04353479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490201|NCT04353479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102490202|NCT04353479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102490203|NCT04353479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102490204|NCT03608488|Vitamin D|vitamin d|mesh-list
102490205|NCT03608488|Vitamins|vitamins|mesh-ancestor
102490206|NCT03608488|Micronutrients|micronutrients|mesh-ancestor
102490207|NCT03608488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490208|NCT03608488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102490209|NCT03035045|Acetaminophen|acetaminophen|mesh-list
102490210|NCT03035045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102490211|NCT03035045|Analgesics|analgesics|mesh-ancestor
102490212|NCT03035045|Sensory System Agents|sensory system agents|mesh-ancestor
102490213|NCT03035045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102490214|NCT03035045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490215|NCT03035045|Antipyretics|antipyretics|mesh-ancestor
102490216|NCT03034733|Dexamethasone|dexamethasone|mesh-list
102490217|NCT03034733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102490218|NCT03034733|Antiemetics|antiemetics|mesh-ancestor
102490219|NCT03034733|Autonomic Agents|autonomic agents|mesh-ancestor
102490220|NCT03034733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102490221|NCT03034733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301841|NCT02132949|Paclitaxel|paclitaxel|mesh-list
102490222|NCT03034733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102490223|NCT03034733|Glucocorticoids|glucocorticoids|mesh-ancestor
102490224|NCT03034733|Hormones|hormones|mesh-ancestor
102490225|NCT03034733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102490226|NCT03034733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102490227|NCT03034733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102490228|NCT05512416|Letrozole|letrozole|mesh-list
102490229|NCT05512416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102490230|NCT05512416|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102490231|NCT05512416|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102490232|NCT05512416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102490233|NCT05512416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490234|NCT05512416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102490235|NCT05512416|Hormone Antagonists|hormone antagonists|mesh-ancestor
102490236|NCT05512416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102490237|NCT05512416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490238|NCT04290624|Listerine|listerine|mesh-list
102490239|NCT04290624|Fluorides|fluorides|mesh-list
102490240|NCT04290624|Sodium Fluoride|sodium fluoride|mesh-list
102490241|NCT04290624|Tin Fluorides|tin fluorides|mesh-list
102490242|NCT04290624|Cariostatic Agents|cariostatic agents|mesh-ancestor
102490243|NCT04290624|Protective Agents|protective agents|mesh-ancestor
102490244|NCT04290624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490245|NCT04290624|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102490246|NCT04290624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102490247|NCT03403504|Oxycodone|oxycodone|mesh-list
102490248|NCT03403504|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102490249|NCT03403504|Narcotics|narcotics|mesh-ancestor
102490250|NCT03403504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102490251|NCT03403504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490252|NCT03403504|Analgesics|analgesics|mesh-ancestor
102490253|NCT03403504|Sensory System Agents|sensory system agents|mesh-ancestor
102490254|NCT03403504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102490255|NCT05512728|Midazolam|midazolam|mesh-list
102490256|NCT05512728|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102490257|NCT05512728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102490258|NCT05512728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102490259|NCT05512728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490260|NCT05512728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102490261|NCT05512728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102490262|NCT05512728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102490263|NCT05512728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102490264|NCT05512728|Anesthetics, General|anesthetics, general|mesh-ancestor
102490265|NCT05512728|Anesthetics|anesthetics|mesh-ancestor
102490266|NCT05512728|GABA Modulators|gaba modulators|mesh-ancestor
102490267|NCT05512728|GABA Agents|gaba agents|mesh-ancestor
102490268|NCT05512728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102490269|NCT05512728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490270|NCT02565810|Adalimumab|adalimumab|mesh-list
102490271|NCT02565810|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102490272|NCT02565810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102490273|NCT02565810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102490274|NCT00940901|Sildenafil Citrate|sildenafil citrate|mesh-list
102490275|NCT00940901|Vasodilator Agents|vasodilator agents|mesh-ancestor
102490276|NCT00940901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102490277|NCT00940901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102490278|NCT00940901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102490279|NCT00940901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490280|NCT00940901|Urological Agents|urological agents|mesh-ancestor
102490281|NCT04353713|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102490282|NCT04353713|Laxatives|laxatives|mesh-ancestor
102490283|NCT04353713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102490284|NCT03565666|Insulin|insulin|mesh-list
102490285|NCT03565666|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102490286|NCT03565666|Insulin Lispro|insulin lispro|mesh-list
102490287|NCT03565666|Insulin Aspart|insulin aspart|mesh-list
102490288|NCT03565666|Pancrelipase|pancrelipase|mesh-list
102490289|NCT03565666|Pancreatin|pancreatin|mesh-list
102490290|NCT03565666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102490291|NCT03565666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490292|NCT03565666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102490293|NCT03620890|Protamines|protamines|mesh-list
102490294|NCT03620890|Heparin Antagonists|heparin antagonists|mesh-ancestor
102490295|NCT03620890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490296|NCT03620890|Coagulants|coagulants|mesh-ancestor
102490297|NCT05507112|Capecitabine|capecitabine|mesh-list
102490298|NCT05507112|Tislelizumab|tislelizumab|mesh-list
102490299|NCT05507112|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102490300|NCT05507112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102490301|NCT05507112|Antimetabolites|antimetabolites|mesh-ancestor
102490302|NCT05507112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490303|NCT05507112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102490304|NCT05507112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102490305|NCT05511948|Hydroquinone|hydroquinone|mesh-list
102490306|NCT05511948|Antioxidants|antioxidants|mesh-ancestor
102490307|NCT05511948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490308|NCT05511948|Protective Agents|protective agents|mesh-ancestor
102490309|NCT05511948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490310|NCT05511948|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102490311|NCT00952133|Dexamethasone|dexamethasone|mesh-list
102490312|NCT00952133|Dexamethasone acetate|dexamethasone acetate|mesh-list
102490313|NCT00952133|Palonosetron|palonosetron|mesh-list
102490314|NCT00952133|BB 1101|bb 1101|mesh-list
102490315|NCT00952133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102490316|NCT00952133|Antiemetics|antiemetics|mesh-ancestor
102490317|NCT00952133|Autonomic Agents|autonomic agents|mesh-ancestor
102490318|NCT00952133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102490319|NCT00952133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490320|NCT00952133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102490321|NCT00952133|Glucocorticoids|glucocorticoids|mesh-ancestor
102490322|NCT00952133|Hormones|hormones|mesh-ancestor
102490323|NCT00952133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102490324|NCT00952133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102490325|NCT00952133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102490326|NCT00952133|Protease Inhibitors|protease inhibitors|mesh-ancestor
102490327|NCT00952133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101622991|NCT05282277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102490328|NCT00952133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490329|NCT00952133|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102490330|NCT00952133|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102490331|NCT00952133|Serotonin Agents|serotonin agents|mesh-ancestor
102490332|NCT00952133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102490333|NCT05042375|Pembrolizumab|pembrolizumab|mesh-list
102490334|NCT05042375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102490335|NCT05042375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102490336|NCT05042375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102490337|NCT05042375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490338|NCT05506566|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102490339|NCT05506566|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102490340|NCT05506566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490341|NCT03023189|Tranexamic Acid|tranexamic acid|mesh-list
102490342|NCT03023189|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102490343|NCT03023189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102490344|NCT03023189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490345|NCT03023189|Hemostatics|hemostatics|mesh-ancestor
102490346|NCT03023189|Coagulants|coagulants|mesh-ancestor
102490347|NCT02561832|Cyclophosphamide|cyclophosphamide|mesh-list
102490348|NCT02561832|Carboplatin|carboplatin|mesh-list
102490349|NCT02561832|Olaparib|olaparib|mesh-list
102490350|NCT02561832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102490351|NCT02561832|Immunologic Factors|immunologic factors|mesh-ancestor
102490352|NCT02561832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490353|NCT02561832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102490354|NCT02561832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102490355|NCT02561832|Alkylating Agents|alkylating agents|mesh-ancestor
102490356|NCT02561832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490357|NCT02561832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102490358|NCT02561832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102490359|NCT02561832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102490360|NCT02561832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102490361|NCT02982161|Celecoxib|celecoxib|mesh-list
102490362|NCT02982161|Tramadol|tramadol|mesh-list
102490363|NCT02982161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102490364|NCT02982161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102490365|NCT02982161|Analgesics|analgesics|mesh-ancestor
102490366|NCT02982161|Sensory System Agents|sensory system agents|mesh-ancestor
102490367|NCT02982161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102490368|NCT02982161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490369|NCT02982161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102490370|NCT02982161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102490371|NCT02982161|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102490372|NCT02982161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102302006|NCT01933672|Incretins|incretins|mesh-ancestor
102490373|NCT02982161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102490374|NCT02982161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490375|NCT02982161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102490376|NCT02982161|Narcotics|narcotics|mesh-ancestor
102490377|NCT02982161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102490378|NCT05506488|Dasatinib|dasatinib|mesh-list
102490379|NCT05506488|Quercetin|quercetin|mesh-list
102490380|NCT05506488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102490381|NCT05506488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102490382|NCT05506488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101623059|NCT04834908|Immune Sera|immune sera|mesh-list
102490383|NCT05506488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490384|NCT05506488|Antioxidants|antioxidants|mesh-ancestor
102490385|NCT05506488|Protective Agents|protective agents|mesh-ancestor
102490386|NCT05506488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490387|NCT00942149|Daptomycin|daptomycin|mesh-list
102490388|NCT00942149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102490389|NCT00942149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102490390|NCT03023111|Miltefosine|miltefosine|mesh-list
102490391|NCT03023111|Meglumine Antimoniate|meglumine antimoniate|mesh-list
102490392|NCT03023111|Molgramostim|molgramostim|mesh-list
102490393|NCT03023111|Sargramostim|sargramostim|mesh-list
102490394|NCT03023111|Immunologic Factors|immunologic factors|mesh-ancestor
102490395|NCT03023111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490396|NCT03023111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102490397|NCT03023111|Antifungal Agents|antifungal agents|mesh-ancestor
102490398|NCT03023111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102490399|NCT03023111|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102490400|NCT03023111|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102490401|NCT03022253|Acetaminophen|acetaminophen|mesh-list
102490402|NCT03022253|Ibuprofen|ibuprofen|mesh-list
102490403|NCT03022253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102490404|NCT03022253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102490405|NCT03022253|Analgesics|analgesics|mesh-ancestor
102490406|NCT03022253|Sensory System Agents|sensory system agents|mesh-ancestor
102490407|NCT03022253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102490408|NCT03022253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490409|NCT03022253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102490410|NCT03022253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102490411|NCT03022253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102490412|NCT03022253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102490413|NCT03022253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490414|NCT03022253|Antipyretics|antipyretics|mesh-ancestor
102490415|NCT01037881|Pimecrolimus|pimecrolimus|mesh-list
102490416|NCT01037881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102490417|NCT01037881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102490418|NCT01037881|Analgesics|analgesics|mesh-ancestor
102490419|NCT01037881|Sensory System Agents|sensory system agents|mesh-ancestor
102490420|NCT01037881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102490421|NCT01037881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490422|NCT01037881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102490423|NCT01037881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102490424|NCT01037881|Dermatologic Agents|dermatologic agents|mesh-ancestor
102490425|NCT01037881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102490426|NCT01037881|Immunologic Factors|immunologic factors|mesh-ancestor
102490427|NCT01037881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102490428|NCT01037881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102490429|NCT01037881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490430|NCT03017807|Antibodies|antibodies|mesh-list
102490431|NCT03017807|Immunologic Factors|immunologic factors|mesh-ancestor
102490432|NCT03017807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490433|NCT03017729|Botulinum Toxins|botulinum toxins|mesh-list
102490434|NCT03017729|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102490435|NCT03017729|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102490436|NCT03017729|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102490437|NCT03017729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102490438|NCT03017729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490439|NCT03017729|Cholinergic Agents|cholinergic agents|mesh-ancestor
102490440|NCT03017729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102490441|NCT03017729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490442|NCT03017729|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102490443|NCT03017729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102490444|NCT03017495|Midazolam|midazolam|mesh-list
102490445|NCT03017495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102490446|NCT03017495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102490447|NCT03017495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101623115|NCT02601235|Phenylephrine|phenylephrine|mesh-list
102490448|NCT03017495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490449|NCT03017495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102490450|NCT03017495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102490451|NCT03017495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102490452|NCT03017495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102490453|NCT03017495|Anesthetics, General|anesthetics, general|mesh-ancestor
102490454|NCT03017495|Anesthetics|anesthetics|mesh-ancestor
102490455|NCT03017495|GABA Modulators|gaba modulators|mesh-ancestor
102490456|NCT03017495|GABA Agents|gaba agents|mesh-ancestor
102490457|NCT03017495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102490458|NCT03017495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490459|NCT01039207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102490460|NCT01039207|Rilotumumab|rilotumumab|mesh-list
102490461|NCT01039207|Antibodies|antibodies|mesh-list
102490462|NCT01039207|Immunoglobulins|immunoglobulins|mesh-list
102490463|NCT01039207|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102490464|NCT01039207|Immunologic Factors|immunologic factors|mesh-ancestor
102490465|NCT01039207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490466|NCT01039207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102490467|NCT02981615|Levofloxacin|levofloxacin|mesh-list
102490468|NCT02981615|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102490469|NCT02981615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102490470|NCT02981615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102490471|NCT02981615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102490472|NCT02981615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102490473|NCT02981615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102490474|NCT02981615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490475|NCT02981615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102490476|NCT02981615|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102490477|NCT02981615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102490479|NCT01125163|Trace Elements|trace elements|mesh-ancestor
102490480|NCT01125163|Micronutrients|micronutrients|mesh-ancestor
102490481|NCT01125163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490482|NCT03019991|Ritonavir|ritonavir|mesh-list
102490483|NCT03019991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102490484|NCT03019991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102490485|NCT03019991|Protease Inhibitors|protease inhibitors|mesh-ancestor
102490486|NCT03019991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102490487|NCT03019991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490488|NCT03019991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102490489|NCT03019991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102490490|NCT03019991|Antiviral Agents|antiviral agents|mesh-ancestor
102490491|NCT03019991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102490492|NCT03019991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102490493|NCT03019991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102490494|NCT05307835|Molgramostim|molgramostim|mesh-list
102490495|NCT05307835|Sargramostim|sargramostim|mesh-list
102490496|NCT05307835|Immunologic Factors|immunologic factors|mesh-ancestor
102490497|NCT05307835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490498|NCT05307835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102490499|NCT00947297|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
102490500|NCT00947297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102490501|NCT03019835|Neostigmine|neostigmine|mesh-list
102490502|NCT03019835|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102490503|NCT03019835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102490504|NCT03019835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490505|NCT03019835|Cholinergic Agents|cholinergic agents|mesh-ancestor
102490506|NCT03019835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102490507|NCT03019835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490508|NCT03019835|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102490509|NCT03019835|Autonomic Agents|autonomic agents|mesh-ancestor
102490510|NCT03019835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102490511|NCT00955877|Morphine|morphine|mesh-list
102490512|NCT00955877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102490513|NCT00955877|Narcotics|narcotics|mesh-ancestor
102490514|NCT00955877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102490515|NCT00955877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490516|NCT00955877|Analgesics|analgesics|mesh-ancestor
102490517|NCT00955877|Sensory System Agents|sensory system agents|mesh-ancestor
102490518|NCT00955877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102490519|NCT03960658|Ketamine|ketamine|mesh-list
102490520|NCT03960658|Analgesics|analgesics|mesh-ancestor
102490521|NCT03960658|Sensory System Agents|sensory system agents|mesh-ancestor
102490522|NCT03960658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102490523|NCT03960658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490524|NCT03960658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102490525|NCT03960658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102490526|NCT03960658|Anesthetics, General|anesthetics, general|mesh-ancestor
102490527|NCT03960658|Anesthetics|anesthetics|mesh-ancestor
102490528|NCT03960658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102490529|NCT03960658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102490530|NCT03960658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102490531|NCT03960658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102490532|NCT03960658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490533|NCT01005407|Vaccines|vaccines|mesh-list
102490534|NCT01005407|Immunologic Factors|immunologic factors|mesh-ancestor
102490535|NCT01005407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490536|NCT03633448|Phenylpropanolamine|phenylpropanolamine|mesh-list
102490537|NCT03633448|Guaifenesin|guaifenesin|mesh-list
102490538|NCT03633448|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
102490539|NCT03633448|Expectorants|expectorants|mesh-ancestor
102490540|NCT03633448|Respiratory System Agents|respiratory system agents|mesh-ancestor
102490541|NCT03633448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102490542|NCT03633448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102490543|NCT03633448|Adrenergic Agents|adrenergic agents|mesh-ancestor
102490544|NCT03633448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102490545|NCT03633448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490546|NCT03633448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490547|NCT03633448|Appetite Depressants|appetite depressants|mesh-ancestor
102490548|NCT03633448|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102490549|NCT03633448|Sympathomimetics|sympathomimetics|mesh-ancestor
102490550|NCT03633448|Autonomic Agents|autonomic agents|mesh-ancestor
102490551|NCT03633448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102490552|NCT03633448|Nasal Decongestants|nasal decongestants|mesh-ancestor
102490553|NCT03633448|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102490554|NCT05313958|Cytarabine|cytarabine|mesh-list
102490555|NCT05313958|Sorafenib|sorafenib|mesh-list
102490556|NCT05313958|Mitoxantrone|mitoxantrone|mesh-list
102490557|NCT05313958|Idarubicin|idarubicin|mesh-list
102490558|NCT05313958|Cladribine|cladribine|mesh-list
101623236|NCT02784561|Antiviral Agents|antiviral agents|mesh-ancestor
102490559|NCT05313958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102490560|NCT05313958|Antimetabolites|antimetabolites|mesh-ancestor
102490561|NCT05313958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490562|NCT05313958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102490563|NCT05313958|Antiviral Agents|antiviral agents|mesh-ancestor
102490564|NCT05313958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102490565|NCT05313958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102490566|NCT05313958|Immunologic Factors|immunologic factors|mesh-ancestor
102490567|NCT05313958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490568|NCT05313958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102490569|NCT05313958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102490570|NCT05313958|Analgesics|analgesics|mesh-ancestor
102490571|NCT05313958|Sensory System Agents|sensory system agents|mesh-ancestor
102490572|NCT05313958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102490573|NCT05313958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102490574|NCT05313958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102490575|NCT05313958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102490576|NCT01006655|Beclomethasone|beclomethasone|mesh-list
102490577|NCT01006655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102490578|NCT01006655|Glucocorticoids|glucocorticoids|mesh-ancestor
102490579|NCT01006655|Hormones|hormones|mesh-ancestor
102490580|NCT01006655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102490581|NCT01006655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490582|NCT01006655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102490583|NCT01006655|Respiratory System Agents|respiratory system agents|mesh-ancestor
102490584|NCT03633526|Ivacaftor|ivacaftor|mesh-list
102490585|NCT03633526|VX-659|vx-659|mesh-list
102490586|NCT03633526|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102490587|NCT03633526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102490588|NCT03633526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490589|NCT01007591|Hydrocortisone|hydrocortisone|mesh-list
102490590|NCT01007591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102490591|NCT03019523|Caffeine|caffeine|mesh-list
102490592|NCT03019523|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102490593|NCT03019523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490594|NCT03019523|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102490595|NCT03019523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102490596|NCT03019523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490597|NCT03019523|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102490598|NCT03019523|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102490599|NCT03019523|Purinergic Agents|purinergic agents|mesh-ancestor
102490600|NCT03019523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102490601|NCT01008059|Alfentanil|alfentanil|mesh-list
102490602|NCT01008059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102490603|NCT01008059|Narcotics|narcotics|mesh-ancestor
102490604|NCT01008059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102490605|NCT01008059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490606|NCT01008059|Analgesics|analgesics|mesh-ancestor
102490607|NCT01008059|Sensory System Agents|sensory system agents|mesh-ancestor
102490608|NCT01008059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102490609|NCT01008059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102490610|NCT01008059|Anesthetics, General|anesthetics, general|mesh-ancestor
102490611|NCT01008059|Anesthetics|anesthetics|mesh-ancestor
102490612|NCT01009619|Azithromycin|azithromycin|mesh-list
102490613|NCT01009619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102490614|NCT01009619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102490615|NCT01010009|Resveratrol|resveratrol|mesh-list
102490616|NCT01010009|Antioxidants|antioxidants|mesh-ancestor
102490617|NCT01010009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490618|NCT01010009|Protective Agents|protective agents|mesh-ancestor
102490619|NCT01010009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490620|NCT01010009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102490621|NCT01010009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102490622|NCT04467424|Lidocaine|lidocaine|mesh-list
102490623|NCT04467424|Ketamine|ketamine|mesh-list
102490624|NCT04467424|Propofol|propofol|mesh-list
102490625|NCT04467424|Anesthetics, Local|anesthetics, local|mesh-ancestor
102490626|NCT04467424|Anesthetics|anesthetics|mesh-ancestor
102490627|NCT04467424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102490628|NCT04467424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490629|NCT04467424|Sensory System Agents|sensory system agents|mesh-ancestor
102490630|NCT04467424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102490631|NCT04467424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102490632|NCT04467424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102490633|NCT04467424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102490634|NCT04467424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102490635|NCT04467424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490636|NCT04467424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102490637|NCT04467424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102490638|NCT04467424|Anesthetics, General|anesthetics, general|mesh-ancestor
102490639|NCT04467424|Analgesics|analgesics|mesh-ancestor
102490640|NCT04467424|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102490641|NCT04467424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102490642|NCT04467424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102490643|NCT04467424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102490644|NCT03016715|Sirolimus|sirolimus|mesh-list
102490645|NCT03016715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102490646|NCT03016715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102490647|NCT03016715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102490648|NCT03016715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102490649|NCT03016715|Antifungal Agents|antifungal agents|mesh-ancestor
102490650|NCT03016715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102490651|NCT03016715|Immunologic Factors|immunologic factors|mesh-ancestor
102490652|NCT03016715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490653|NCT00377104|Alvocidib|alvocidib|mesh-list
102490654|NCT00377104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102490655|NCT00377104|Growth Inhibitors|growth inhibitors|mesh-ancestor
102490656|NCT00377104|Growth Substances|growth substances|mesh-ancestor
102490657|NCT00377104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490658|NCT00377104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102490659|NCT00377104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102490660|NCT00377104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490661|NCT03016793|Puerarin|puerarin|mesh-list
102490662|NCT03016793|Vasodilator Agents|vasodilator agents|mesh-ancestor
102490663|NCT03928522|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102490664|NCT03928522|Vancomycin|vancomycin|mesh-list
102490665|NCT03928522|Tobramycin|tobramycin|mesh-list
102490666|NCT03928522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102490667|NCT01010399|Ritonavir|ritonavir|mesh-list
102490668|NCT01010399|Fosamprenavir|fosamprenavir|mesh-list
102490669|NCT01010399|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102490670|NCT01010399|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102490671|NCT01010399|Protease Inhibitors|protease inhibitors|mesh-ancestor
102490672|NCT01010399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102490673|NCT01010399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490674|NCT01010399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102302295|NCT05368415|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102490675|NCT01010399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102490676|NCT01010399|Antiviral Agents|antiviral agents|mesh-ancestor
102490677|NCT01010399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102490678|NCT01010399|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102490679|NCT01010399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102490680|NCT03638908|Fluoxetine|fluoxetine|mesh-list
102490681|NCT03638908|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102490682|NCT03638908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102490683|NCT03638908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102490684|NCT03638908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490685|NCT03638908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102490686|NCT03638908|Serotonin Agents|serotonin agents|mesh-ancestor
102490687|NCT03638908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490688|NCT03638908|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102490689|NCT03638908|Antidepressive Agents|antidepressive agents|mesh-ancestor
102490690|NCT03638908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102490691|NCT03638908|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102490692|NCT03638908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102490693|NCT03638908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102490694|NCT01041781|Celecoxib|celecoxib|mesh-list
102490695|NCT01041781|Carboplatin|carboplatin|mesh-list
102490696|NCT01041781|Gemcitabine|gemcitabine|mesh-list
102490697|NCT01041781|Pemetrexed|pemetrexed|mesh-list
102490698|NCT01041781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102490699|NCT01041781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102490700|NCT01041781|Antimetabolites|antimetabolites|mesh-ancestor
102490701|NCT01041781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490702|NCT01041781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102490703|NCT01041781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102490704|NCT01041781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102490705|NCT01041781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102490706|NCT01041781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102490707|NCT01041781|Analgesics|analgesics|mesh-ancestor
102490708|NCT01041781|Sensory System Agents|sensory system agents|mesh-ancestor
102490709|NCT01041781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102490710|NCT01041781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490711|NCT01041781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102490712|NCT01041781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102490713|NCT01041781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102490714|NCT01041781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102490715|NCT01010477|Nicotine|nicotine|mesh-list
102490716|NCT01010477|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102490717|NCT01010477|Autonomic Agents|autonomic agents|mesh-ancestor
102490718|NCT01010477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102490719|NCT01010477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490720|NCT01010477|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102490721|NCT01010477|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102490722|NCT01010477|Cholinergic Agents|cholinergic agents|mesh-ancestor
102490723|NCT01010477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102490724|NCT01010477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490725|NCT03921190|Anesthetics|anesthetics|mesh-list
102490726|NCT03921190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102490727|NCT03921190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490728|NCT00953849|Calcitriol|calcitriol|mesh-list
102490729|NCT00953849|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
102490730|NCT00953849|Vitamin D|vitamin d|mesh-list
102490731|NCT00953849|Celecoxib|celecoxib|mesh-list
102490732|NCT00953849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102490733|NCT00953849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102490734|NCT00953849|Analgesics|analgesics|mesh-ancestor
102490735|NCT00953849|Sensory System Agents|sensory system agents|mesh-ancestor
102490736|NCT00953849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102490737|NCT00953849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490738|NCT00953849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102490739|NCT00953849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102490740|NCT00953849|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102490741|NCT00953849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102490742|NCT00953849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102490743|NCT00953849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490744|NCT00953849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102490745|NCT00953849|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102490746|NCT00953849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102490747|NCT00953849|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102490748|NCT00953849|Vitamins|vitamins|mesh-ancestor
102490749|NCT00953849|Micronutrients|micronutrients|mesh-ancestor
102490750|NCT00953849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102490751|NCT04425850|Ivermectin|ivermectin|mesh-list
102490752|NCT04425850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102490753|NCT04425850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102490754|NCT03639766|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102490755|NCT03639766|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102490756|NCT03639766|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102490757|NCT03639766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102490758|NCT03639766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490759|NCT03639766|Cholinergic Agents|cholinergic agents|mesh-ancestor
102490760|NCT03639766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102490761|NCT03639766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490762|NCT03639766|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102490763|NCT03639766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102490764|NCT01042795|Sunitinib|sunitinib|mesh-list
102490765|NCT01042795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102490766|NCT01042795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102490767|NCT01042795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102490768|NCT01042795|Growth Substances|growth substances|mesh-ancestor
102490769|NCT01042795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490770|NCT01042795|Growth Inhibitors|growth inhibitors|mesh-ancestor
102490771|NCT01042795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102490772|NCT01042795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102490773|NCT01042795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490774|NCT03644212|Vitamin D|vitamin d|mesh-list
102490775|NCT03644212|Cholecalciferol|cholecalciferol|mesh-list
102490776|NCT03644212|Vitamins|vitamins|mesh-list
102490777|NCT03644212|Micronutrients|micronutrients|mesh-ancestor
102490778|NCT03644212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490779|NCT03644212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102490780|NCT03644212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102490781|NCT03906448|Temozolomide|temozolomide|mesh-list
102490782|NCT03906448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102490783|NCT03906448|Alkylating Agents|alkylating agents|mesh-ancestor
102490784|NCT03906448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490785|NCT03906448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102490786|NCT01011413|Efavirenz|efavirenz|mesh-list
102490787|NCT01011413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102490788|NCT01011413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102490789|NCT01011413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102490790|NCT01011413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490791|NCT01011413|Antiviral Agents|antiviral agents|mesh-ancestor
102490792|NCT01011413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102490793|NCT01011413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102490794|NCT01011413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102490795|NCT01011413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102490796|NCT01011413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102490797|NCT01011413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102490798|NCT01011413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102490799|NCT03889444|Dexamethasone|dexamethasone|mesh-list
102490800|NCT03889444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102490801|NCT03889444|Antiemetics|antiemetics|mesh-ancestor
102490802|NCT03889444|Autonomic Agents|autonomic agents|mesh-ancestor
102490803|NCT03889444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102490804|NCT03889444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490805|NCT03889444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102490806|NCT03889444|Glucocorticoids|glucocorticoids|mesh-ancestor
102490807|NCT03889444|Hormones|hormones|mesh-ancestor
102490808|NCT03889444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102490809|NCT03889444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102490810|NCT03889444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102490811|NCT01104025|Dexamethasone|dexamethasone|mesh-list
102490812|NCT01104025|Hydrocortisone|hydrocortisone|mesh-list
102490813|NCT01104025|Methotrexate|methotrexate|mesh-list
102490814|NCT01104025|Etoposide|etoposide|mesh-list
102490815|NCT01104025|Thymoglobulin|thymoglobulin|mesh-list
102490816|NCT01104025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102490817|NCT01104025|Antiemetics|antiemetics|mesh-ancestor
102490818|NCT01104025|Autonomic Agents|autonomic agents|mesh-ancestor
102490819|NCT01104025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102490820|NCT01104025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490821|NCT01104025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102490822|NCT01104025|Glucocorticoids|glucocorticoids|mesh-ancestor
102302506|NCT02525471|RNS60|rns60|mesh-list
102490823|NCT01104025|Hormones|hormones|mesh-ancestor
102490824|NCT01104025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102490825|NCT01104025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102490826|NCT01104025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102490827|NCT01104025|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102490828|NCT01104025|Abortifacient Agents|abortifacient agents|mesh-ancestor
102490829|NCT01104025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102490830|NCT01104025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102490831|NCT01104025|Antimetabolites|antimetabolites|mesh-ancestor
102490832|NCT01104025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490833|NCT01104025|Dermatologic Agents|dermatologic agents|mesh-ancestor
102490834|NCT01104025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102490835|NCT01104025|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102490836|NCT01104025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102490837|NCT01104025|Immunologic Factors|immunologic factors|mesh-ancestor
102490838|NCT01104025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102490839|NCT01104025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102490840|NCT01104025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102490841|NCT01104025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102490842|NCT01104025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102490843|NCT03649750|Guaifenesin|guaifenesin|mesh-list
102490844|NCT03649750|Expectorants|expectorants|mesh-ancestor
102490845|NCT03649750|Respiratory System Agents|respiratory system agents|mesh-ancestor
102490846|NCT04343092|Ivermectin|ivermectin|mesh-list
102490847|NCT04343092|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102490848|NCT04343092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102490849|NCT01105117|Epoprostenol|epoprostenol|mesh-list
102490850|NCT01105117|Tezosentan|tezosentan|mesh-list
102490851|NCT01105117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102490852|NCT01105117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102490853|NCT01105117|Vasodilator Agents|vasodilator agents|mesh-ancestor
102490854|NCT03885154|Dihydroergotamine|dihydroergotamine|mesh-list
102490855|NCT03885154|Valproic Acid|valproic acid|mesh-list
102490856|NCT03885154|Anticonvulsants|anticonvulsants|mesh-ancestor
102490857|NCT03885154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102490858|NCT03885154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490859|NCT03885154|GABA Agents|gaba agents|mesh-ancestor
102490860|NCT03885154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102490861|NCT03885154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490862|NCT03885154|Antimanic Agents|antimanic agents|mesh-ancestor
102490863|NCT03885154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102490864|NCT03885154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102490865|NCT03885154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102490866|NCT03885154|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102490867|NCT03885154|Dopamine Agonists|dopamine agonists|mesh-ancestor
102490868|NCT03885154|Dopamine Agents|dopamine agents|mesh-ancestor
102490869|NCT03885154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102490870|NCT03885154|Analgesics|analgesics|mesh-ancestor
102490871|NCT03885154|Sensory System Agents|sensory system agents|mesh-ancestor
102490872|NCT03885154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102490873|NCT01106833|Sirolimus|sirolimus|mesh-list
102490874|NCT01106833|Prednisone|prednisone|mesh-list
102490875|NCT01106833|Temsirolimus|temsirolimus|mesh-list
102490876|NCT01106833|MTOR Inhibitors|mtor inhibitors|mesh-list
102490877|NCT01106833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
102490878|NCT01106833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102490879|NCT01106833|Glucocorticoids|glucocorticoids|mesh-ancestor
102490880|NCT01106833|Hormones|hormones|mesh-ancestor
102490881|NCT01106833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102490882|NCT01106833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490883|NCT01106833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102490884|NCT01106833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102490885|NCT01106833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102490886|NCT01106833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102490887|NCT01106833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102490888|NCT01106833|Antifungal Agents|antifungal agents|mesh-ancestor
102490889|NCT01106833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102490890|NCT01106833|Immunologic Factors|immunologic factors|mesh-ancestor
102490891|NCT01106833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102490892|NCT01106833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102133721|NCT02295189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102490893|NCT01106833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490894|NCT00957047|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102490895|NCT00957047|Anticonvulsants|anticonvulsants|mesh-ancestor
102490896|NCT00957047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102490897|NCT00957047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102490898|NCT00957047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102490899|NCT00957047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490900|NCT00957359|Niacin|niacin|mesh-list
102490901|NCT00957359|Psilocybin|psilocybin|mesh-list
102490902|NCT00957359|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
102490903|NCT00957359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102490904|NCT00957359|Antimetabolites|antimetabolites|mesh-ancestor
102490905|NCT00957359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490906|NCT00957359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102490907|NCT00957359|Vasodilator Agents|vasodilator agents|mesh-ancestor
102490908|NCT00957359|Vitamin B Complex|vitamin b complex|mesh-ancestor
102490909|NCT00957359|Vitamins|vitamins|mesh-ancestor
102490910|NCT00957359|Micronutrients|micronutrients|mesh-ancestor
102490911|NCT00957359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490912|NCT00957359|Hallucinogens|hallucinogens|mesh-ancestor
102490913|NCT00957359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102490914|NCT00957359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102490915|NCT00957359|Serotonin Agents|serotonin agents|mesh-ancestor
102490916|NCT00957359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102490917|NCT00957359|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102490918|NCT00957593|Oxytocin|oxytocin|mesh-list
102490919|NCT00957593|Oxytocics|oxytocics|mesh-ancestor
102490920|NCT00957593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102490921|NCT00957593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490922|NCT00957671|Hormones|hormones|mesh-list
102490923|NCT00957671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102490924|NCT00957671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490925|NCT04322968|Ketorolac|ketorolac|mesh-list
102490926|NCT04322968|Ketamine|ketamine|mesh-list
102490927|NCT04322968|Analgesics|analgesics|mesh-ancestor
102490928|NCT04322968|Sensory System Agents|sensory system agents|mesh-ancestor
102490929|NCT04322968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102490930|NCT04322968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490931|NCT04322968|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102490932|NCT04322968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102490933|NCT04322968|Anesthetics, General|anesthetics, general|mesh-ancestor
102490934|NCT04322968|Anesthetics|anesthetics|mesh-ancestor
102490935|NCT04322968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102490936|NCT04322968|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102490937|NCT04322968|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102490938|NCT04322968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102490939|NCT04322968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490940|NCT04322968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102490941|NCT04322968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102490942|NCT04322968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102490943|NCT04322968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102490944|NCT04322968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102490945|NCT04322968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102490946|NCT03018899|Anesthetics|anesthetics|mesh-list
102490947|NCT03018899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102490948|NCT03018899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490949|NCT00958919|Naloxone|naloxone|mesh-list
102490950|NCT00958919|Endorphins|endorphins|mesh-list
102490951|NCT00958919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102490952|NCT00958919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490953|NCT00958919|Sensory System Agents|sensory system agents|mesh-ancestor
102490954|NCT00958919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102490955|NCT00958919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102490956|NCT00958919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490957|NCT04323592|Methylprednisolone|methylprednisolone|mesh-list
102490958|NCT04323592|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102490959|NCT04323592|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102490960|NCT04323592|Prednisolone|prednisolone|mesh-list
102490961|NCT04323592|Prednisolone acetate|prednisolone acetate|mesh-list
102490962|NCT04323592|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102490963|NCT04323592|Prednisolone phosphate|prednisolone phosphate|mesh-list
102490964|NCT04323592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102490965|NCT04323592|Antiemetics|antiemetics|mesh-ancestor
102490966|NCT04323592|Autonomic Agents|autonomic agents|mesh-ancestor
102490967|NCT04323592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102490968|NCT04323592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490969|NCT04323592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102490970|NCT04323592|Glucocorticoids|glucocorticoids|mesh-ancestor
102490971|NCT04323592|Hormones|hormones|mesh-ancestor
102490972|NCT04323592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102490973|NCT04323592|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102490974|NCT04323592|Protective Agents|protective agents|mesh-ancestor
102490975|NCT04323592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102490976|NCT04323592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102490978|NCT01047241|Ketamine|ketamine|mesh-list
102490979|NCT01047241|Analgesics|analgesics|mesh-ancestor
102490980|NCT01047241|Sensory System Agents|sensory system agents|mesh-ancestor
102490981|NCT01047241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102490982|NCT01047241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102490983|NCT01047241|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102490984|NCT01047241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102490985|NCT01047241|Anesthetics, General|anesthetics, general|mesh-ancestor
102490986|NCT01047241|Anesthetics|anesthetics|mesh-ancestor
102490987|NCT01047241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102490988|NCT01047241|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102490989|NCT01047241|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102490990|NCT01047241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102490991|NCT01047241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102490992|NCT01047241|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102490993|NCT01047241|Narcotics|narcotics|mesh-ancestor
102490994|NCT01047241|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102490995|NCT01012661|Lidocaine|lidocaine|mesh-list
102490996|NCT01012661|Anesthetics, Local|anesthetics, local|mesh-ancestor
102490997|NCT01012661|Anesthetics|anesthetics|mesh-ancestor
102490998|NCT01012661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102490999|NCT01012661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491000|NCT01012661|Sensory System Agents|sensory system agents|mesh-ancestor
102491001|NCT01012661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102491002|NCT01012661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102491003|NCT01012661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102491004|NCT01012661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102491005|NCT01012661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102491006|NCT01012661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491007|NCT03655444|Nivolumab|nivolumab|mesh-list
102491008|NCT03655444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102491009|NCT03655444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102491010|NCT03655444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102491011|NCT03655444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491012|NCT03018977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
102491013|NCT03018977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102491014|NCT03018977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491015|NCT03018821|Tenofovir|tenofovir|mesh-list
102491016|NCT03018821|Entecavir|entecavir|mesh-list
102491017|NCT03018821|Antiviral Agents|antiviral agents|mesh-ancestor
102491018|NCT03018821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102491019|NCT03018821|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102491020|NCT03018821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102491021|NCT03018821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102491022|NCT03018821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491023|NCT03018821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102491024|NCT03018821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102491025|NCT03866434|Anagrelide|anagrelide|mesh-list
102491026|NCT03866434|Omeprazole|omeprazole|mesh-list
102491027|NCT03866434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102491028|NCT03866434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102491029|NCT03866434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102491030|NCT03866434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102491031|NCT03866434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491032|NCT03866434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102491033|NCT03866434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102491034|NCT03866434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102491035|NCT00962039|Citalopram|citalopram|mesh-list
102491036|NCT00962039|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102491037|NCT00962039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102491038|NCT00962039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102491039|NCT00962039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491040|NCT00962039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102491041|NCT00962039|Serotonin Agents|serotonin agents|mesh-ancestor
102491042|NCT00962039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491043|NCT00962039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102491044|NCT00962039|Antidepressive Agents|antidepressive agents|mesh-ancestor
102491045|NCT00962039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102491046|NCT03375385|Dexmedetomidine|dexmedetomidine|mesh-list
102491047|NCT03375385|Propofol|propofol|mesh-list
102491048|NCT03375385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102491049|NCT03375385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102491050|NCT03375385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491051|NCT03375385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102491052|NCT03375385|Analgesics|analgesics|mesh-ancestor
102491053|NCT03375385|Sensory System Agents|sensory system agents|mesh-ancestor
102491054|NCT03375385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102491055|NCT03375385|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102491056|NCT03375385|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102491057|NCT03375385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102491058|NCT03375385|Adrenergic Agents|adrenergic agents|mesh-ancestor
102491059|NCT03375385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102491060|NCT03375385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491061|NCT03375385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102491062|NCT03375385|Anesthetics, General|anesthetics, general|mesh-ancestor
102491063|NCT03375385|Anesthetics|anesthetics|mesh-ancestor
102491064|NCT03018665|Metformin|metformin|mesh-list
102491065|NCT03018665|Exenatide|exenatide|mesh-list
102491066|NCT03018665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102491067|NCT03018665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491068|NCT03018665|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102491069|NCT03018665|Incretins|incretins|mesh-ancestor
102491070|NCT03018665|Hormones|hormones|mesh-ancestor
102491071|NCT03018665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102491072|NCT03012763|Acetaminophen|acetaminophen|mesh-list
102491073|NCT03012763|Fexofenadine|fexofenadine|mesh-list
102491074|NCT03012763|Sulfasalazine|sulfasalazine|mesh-list
102491075|NCT03012763|Valsartan|valsartan|mesh-list
102491076|NCT03012763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102491077|NCT03012763|Analgesics|analgesics|mesh-ancestor
102491078|NCT03012763|Sensory System Agents|sensory system agents|mesh-ancestor
102491079|NCT03012763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102491080|NCT03012763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491081|NCT03012763|Antipyretics|antipyretics|mesh-ancestor
102491082|NCT03012763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102491083|NCT03012763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102491084|NCT03012763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102491085|NCT03012763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491086|NCT03012763|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102491087|NCT03012763|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102491088|NCT03012763|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102491089|NCT03012763|Histamine Antagonists|histamine antagonists|mesh-ancestor
102491090|NCT03012763|Histamine Agents|histamine agents|mesh-ancestor
102491091|NCT03012763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102491092|NCT03012763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102491093|NCT03012763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102491094|NCT03012763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102491095|NCT03012763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102491096|NCT03012763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102491097|NCT03012607|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102491098|NCT03012607|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102491099|NCT03012607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102491100|NCT03012607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102491101|NCT03012607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491102|NCT03012607|Antiviral Agents|antiviral agents|mesh-ancestor
102491103|NCT03012607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102491104|NCT03012607|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102491105|NCT03012607|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102491106|NCT01048879|Oseltamivir|oseltamivir|mesh-list
102491107|NCT01048879|Dialysis Solutions|dialysis solutions|mesh-list
102491108|NCT01048879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102491109|NCT01048879|Antiviral Agents|antiviral agents|mesh-ancestor
102491110|NCT01048879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102491111|NCT01048879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102491112|NCT01048879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491113|NCT04290676|Dexamethasone|dexamethasone|mesh-list
102491114|NCT04290676|Dexamethasone acetate|dexamethasone acetate|mesh-list
102491115|NCT04290676|BB 1101|bb 1101|mesh-list
102491116|NCT04290676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102491117|NCT04290676|Antiemetics|antiemetics|mesh-ancestor
102491118|NCT04290676|Autonomic Agents|autonomic agents|mesh-ancestor
102491119|NCT04290676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102491120|NCT04290676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491121|NCT04290676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102491122|NCT04290676|Glucocorticoids|glucocorticoids|mesh-ancestor
102491123|NCT04290676|Hormones|hormones|mesh-ancestor
102491124|NCT04290676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102491125|NCT04290676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102491126|NCT04290676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102491127|NCT04290676|Protease Inhibitors|protease inhibitors|mesh-ancestor
102491128|NCT04290676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102491129|NCT04290676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491130|NCT03112993|Neostigmine|neostigmine|mesh-list
102491131|NCT03112993|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102491132|NCT03112993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102491133|NCT03112993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491134|NCT03112993|Cholinergic Agents|cholinergic agents|mesh-ancestor
102491135|NCT03112993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102491136|NCT03112993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491137|NCT03112993|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102491138|NCT03112993|Autonomic Agents|autonomic agents|mesh-ancestor
102491139|NCT03112993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102491140|NCT03670030|Sirolimus|sirolimus|mesh-list
102491141|NCT03670030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102491142|NCT03670030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102491143|NCT03670030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102491144|NCT03670030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102491145|NCT03670030|Antifungal Agents|antifungal agents|mesh-ancestor
102491146|NCT03670030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102491147|NCT03670030|Immunologic Factors|immunologic factors|mesh-ancestor
102491148|NCT03670030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491149|NCT03859960|Insulin|insulin|mesh-list
102491150|NCT03859960|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102491151|NCT03859960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102491152|NCT03859960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491153|NCT03857230|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102491154|NCT03857230|Hormones|hormones|mesh-ancestor
102491155|NCT03857230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102491156|NCT03857230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491157|NCT02181127|Glucagon|glucagon|mesh-list
102491158|NCT02181127|Pancrelipase|pancrelipase|mesh-list
102491159|NCT02181127|Pancreatin|pancreatin|mesh-list
102491160|NCT02181127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102491161|NCT02181127|Hormones|hormones|mesh-ancestor
102491162|NCT02181127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102491163|NCT02181127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491164|NCT04332094|Azithromycin|azithromycin|mesh-list
102491165|NCT04332094|Hydroxychloroquine|hydroxychloroquine|mesh-list
102491166|NCT04332094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102491167|NCT04332094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102491168|NCT04332094|Antimalarials|antimalarials|mesh-ancestor
102491169|NCT04332094|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102491170|NCT04332094|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102491171|NCT04332094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102491172|NCT04332094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491173|NCT04332094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102491175|NCT05314270|Trace Elements|trace elements|mesh-ancestor
102491176|NCT05314270|Micronutrients|micronutrients|mesh-ancestor
102491177|NCT05314270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491178|NCT01167829|Testosterone|testosterone|mesh-list
102491179|NCT01167829|Acyline|acyline|mesh-list
102491180|NCT01167829|Androgens|androgens|mesh-ancestor
102491181|NCT01167829|Hormones|hormones|mesh-ancestor
102491182|NCT01167829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102491183|NCT01167829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491184|NCT01167829|Hormone Antagonists|hormone antagonists|mesh-ancestor
102491185|NCT02066623|Everolimus|everolimus|mesh-list
102491186|NCT02066623|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102491187|NCT02066623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102491188|NCT02066623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102491189|NCT02066623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491190|NCT02066623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102491191|NCT02066623|Immunologic Factors|immunologic factors|mesh-ancestor
102491192|NCT02066623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491193|NCT02066623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102491194|NCT04974151|Folic Acid|folic acid|mesh-list
102491195|NCT04974151|Amlodipine|amlodipine|mesh-list
102491196|NCT04974151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102491197|NCT04974151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102491198|NCT04974151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102491199|NCT04974151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491200|NCT04974151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102491201|NCT04974151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491202|NCT04974151|Vasodilator Agents|vasodilator agents|mesh-ancestor
102491203|NCT04974151|Hematinics|hematinics|mesh-ancestor
102491204|NCT04974151|Vitamin B Complex|vitamin b complex|mesh-ancestor
102491205|NCT04974151|Vitamins|vitamins|mesh-ancestor
101623915|NCT00586495|Sorafenib|sorafenib|mesh-list
102491206|NCT04974151|Micronutrients|micronutrients|mesh-ancestor
102491207|NCT01924819|Leucovorin|leucovorin|mesh-list
102491208|NCT01924819|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
102491209|NCT01924819|Cisplatin|cisplatin|mesh-list
102491210|NCT01924819|Docetaxel|docetaxel|mesh-list
102491211|NCT01924819|Fluorouracil|fluorouracil|mesh-list
102491212|NCT01924819|Capecitabine|capecitabine|mesh-list
102491213|NCT01924819|Oxaliplatin|oxaliplatin|mesh-list
102491214|NCT01924819|Epirubicin|epirubicin|mesh-list
102491215|NCT01924819|Levoleucovorin|levoleucovorin|mesh-list
102491216|NCT01924819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102491217|NCT01924819|Tubulin Modulators|tubulin modulators|mesh-ancestor
102491218|NCT01924819|Antimitotic Agents|antimitotic agents|mesh-ancestor
102491219|NCT01924819|Mitosis Modulators|mitosis modulators|mesh-ancestor
102491220|NCT01924819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491221|NCT01924819|Antimetabolites|antimetabolites|mesh-ancestor
102491222|NCT01924819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102491223|NCT01924819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102491224|NCT01924819|Immunologic Factors|immunologic factors|mesh-ancestor
102491225|NCT01924819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491226|NCT01924819|Antidotes|antidotes|mesh-ancestor
102491227|NCT01924819|Protective Agents|protective agents|mesh-ancestor
102491228|NCT01924819|Vitamin B Complex|vitamin b complex|mesh-ancestor
102491229|NCT01924819|Vitamins|vitamins|mesh-ancestor
102491230|NCT01924819|Micronutrients|micronutrients|mesh-ancestor
102491231|NCT01924819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102491232|NCT01924819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102491233|NCT01924819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102491234|NCT01924819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102491235|NCT01168687|Levetiracetam|levetiracetam|mesh-list
102491236|NCT01168687|Anticonvulsants|anticonvulsants|mesh-ancestor
102491237|NCT01168687|Nootropic Agents|nootropic agents|mesh-ancestor
102491238|NCT03685396|Hemostatics|hemostatics|mesh-list
102491239|NCT03685396|Coagulants|coagulants|mesh-ancestor
102491240|NCT01126255|Clobetasol|clobetasol|mesh-list
102491241|NCT01126255|Progesterone|progesterone|mesh-list
102491242|NCT01126255|Progestins|progestins|mesh-ancestor
102491243|NCT01126255|Hormones|hormones|mesh-ancestor
102491244|NCT01126255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102491245|NCT01126255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491246|NCT01126255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102491247|NCT01126255|Glucocorticoids|glucocorticoids|mesh-ancestor
102491248|NCT04198948|Gliclazide|gliclazide|mesh-list
102491249|NCT04198948|Omeprazole|omeprazole|mesh-list
102491250|NCT04198948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102491251|NCT04198948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102491252|NCT04198948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102491253|NCT04198948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102491254|NCT04198948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491255|NCT04198948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102491256|NCT04198948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491257|NCT01169467|Dexmedetomidine|dexmedetomidine|mesh-list
102491258|NCT01169467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102491259|NCT01169467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102491260|NCT01169467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491261|NCT01169467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102491262|NCT01169467|Analgesics|analgesics|mesh-ancestor
102491263|NCT01169467|Sensory System Agents|sensory system agents|mesh-ancestor
102491264|NCT01169467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102491265|NCT01169467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102491266|NCT01169467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102491267|NCT01169467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102491268|NCT01169467|Adrenergic Agents|adrenergic agents|mesh-ancestor
102491269|NCT01169467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102491270|NCT01169467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491271|NCT04822363|Aspirin|aspirin|mesh-list
102491272|NCT04822363|Clopidogrel|clopidogrel|mesh-list
102491273|NCT04822363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102491274|NCT04822363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102491275|NCT04822363|Analgesics|analgesics|mesh-ancestor
102491276|NCT04822363|Sensory System Agents|sensory system agents|mesh-ancestor
102491277|NCT04822363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102491278|NCT04822363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491279|NCT04822363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102491280|NCT04822363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102491281|NCT04822363|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102491282|NCT04822363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102491283|NCT04822363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491284|NCT04822363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102491285|NCT04822363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102491286|NCT04822363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102491287|NCT04822363|Antipyretics|antipyretics|mesh-ancestor
102491288|NCT04822363|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102491289|NCT04822363|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102491290|NCT04822363|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102491291|NCT04822363|Purinergic Agents|purinergic agents|mesh-ancestor
102491292|NCT04822363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102491294|NCT01170247|Analgesics|analgesics|mesh-ancestor
102491295|NCT01170247|Sensory System Agents|sensory system agents|mesh-ancestor
102491296|NCT01170247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102491297|NCT01170247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491298|NCT01170247|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102491299|NCT01170247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102491300|NCT01170247|Anesthetics, General|anesthetics, general|mesh-ancestor
102491301|NCT01170247|Anesthetics|anesthetics|mesh-ancestor
102491302|NCT01170247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102491303|NCT01170247|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102491304|NCT01170247|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102491305|NCT01170247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102491306|NCT01170247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491307|NCT01126099|Prazosin|prazosin|mesh-list
102491308|NCT01126099|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102491309|NCT01126099|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102491310|NCT01126099|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102491311|NCT01126099|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102491312|NCT01126099|Adrenergic Agents|adrenergic agents|mesh-ancestor
102491313|NCT01126099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102491314|NCT01126099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491315|NCT01126099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491316|NCT01170715|Etanercept|etanercept|mesh-list
102491317|NCT01170715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102491318|NCT01170715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102491319|NCT01170715|Analgesics|analgesics|mesh-ancestor
102491320|NCT01170715|Sensory System Agents|sensory system agents|mesh-ancestor
102491321|NCT01170715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102491322|NCT01170715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491323|NCT01170715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102491324|NCT01170715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102491325|NCT01170715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102491326|NCT01170715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102491327|NCT01170715|Immunologic Factors|immunologic factors|mesh-ancestor
102491328|NCT03809182|Fentanyl|fentanyl|mesh-list
102491329|NCT03809182|Dexmedetomidine|dexmedetomidine|mesh-list
102491330|NCT03809182|Morphine|morphine|mesh-list
102491331|NCT03809182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102491332|NCT03809182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102491333|NCT03809182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491334|NCT03809182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102491335|NCT03809182|Analgesics|analgesics|mesh-ancestor
102491336|NCT03809182|Sensory System Agents|sensory system agents|mesh-ancestor
102491337|NCT03809182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102491338|NCT03809182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102491339|NCT03809182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102491340|NCT03809182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102491341|NCT03809182|Adrenergic Agents|adrenergic agents|mesh-ancestor
102491342|NCT03809182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102491343|NCT03809182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491344|NCT03809182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102491345|NCT03809182|Narcotics|narcotics|mesh-ancestor
102491346|NCT03809182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102491347|NCT03809182|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102491348|NCT03809182|Anesthetics, General|anesthetics, general|mesh-ancestor
102491349|NCT03809182|Anesthetics|anesthetics|mesh-ancestor
102491350|NCT01170949|Miltefosine|miltefosine|mesh-list
102302968|NCT05248139|Hormones|hormones|mesh-ancestor
102491351|NCT01170949|Antifungal Agents|antifungal agents|mesh-ancestor
102491352|NCT01170949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102491353|NCT01170949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102491354|NCT01170949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102491355|NCT01170949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102491357|NCT03805672|Enoxaparin sodium|enoxaparin sodium|mesh-list
102491358|NCT03805672|Anticoagulants|anticoagulants|mesh-ancestor
102491359|NCT03805672|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102491360|NCT03805672|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102491361|NCT03805672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491362|NCT03802864|Bupivacaine|bupivacaine|mesh-list
102491363|NCT03802864|Anesthetics, Local|anesthetics, local|mesh-ancestor
102491364|NCT03802864|Anesthetics|anesthetics|mesh-ancestor
102491365|NCT03802864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102491366|NCT03802864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491367|NCT03802864|Sensory System Agents|sensory system agents|mesh-ancestor
102491368|NCT03802864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102491369|NCT03797872|Sulfasalazine|sulfasalazine|mesh-list
102491370|NCT03797872|Methylprednisolone|methylprednisolone|mesh-list
102491371|NCT03797872|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102491372|NCT03797872|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102491373|NCT03797872|Prednisolone|prednisolone|mesh-list
102491374|NCT03797872|Prednisolone acetate|prednisolone acetate|mesh-list
102491375|NCT03797872|Triamcinolone|triamcinolone|mesh-list
102491376|NCT03797872|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102491377|NCT03797872|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102491378|NCT03797872|Methotrexate|methotrexate|mesh-list
102491379|NCT03797872|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102491380|NCT03797872|Leflunomide|leflunomide|mesh-list
102491381|NCT03797872|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102491382|NCT03797872|Prednisolone phosphate|prednisolone phosphate|mesh-list
102491383|NCT03797872|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102491384|NCT03797872|Abortifacient Agents|abortifacient agents|mesh-ancestor
102491385|NCT03797872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102491386|NCT03797872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491387|NCT03797872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102491388|NCT03797872|Antimetabolites|antimetabolites|mesh-ancestor
102491389|NCT03797872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491390|NCT03797872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102491391|NCT03797872|Dermatologic Agents|dermatologic agents|mesh-ancestor
102491392|NCT03797872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102491393|NCT03797872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102491394|NCT03797872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102491395|NCT03797872|Immunologic Factors|immunologic factors|mesh-ancestor
102491396|NCT03797872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102491397|NCT03797872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102491398|NCT03797872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102491399|NCT03797872|Antiemetics|antiemetics|mesh-ancestor
102491400|NCT03797872|Autonomic Agents|autonomic agents|mesh-ancestor
102491401|NCT03797872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102491402|NCT03797872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102491403|NCT03797872|Glucocorticoids|glucocorticoids|mesh-ancestor
102491404|NCT03797872|Hormones|hormones|mesh-ancestor
102491405|NCT03797872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102491406|NCT03797872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102491407|NCT03797872|Protective Agents|protective agents|mesh-ancestor
102491408|NCT03797872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102491409|NCT03797872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102491410|NCT03797872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102491411|NCT03797872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102491412|NCT03797872|Analgesics|analgesics|mesh-ancestor
102491413|NCT03797872|Sensory System Agents|sensory system agents|mesh-ancestor
102491414|NCT01127581|Dinoprostone|dinoprostone|mesh-list
102491415|NCT01127581|Oxytocics|oxytocics|mesh-ancestor
102491416|NCT01127581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102491417|NCT01127581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491418|NCT00377728|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
102491419|NCT00377728|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102491420|NCT00377728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102491421|NCT00377728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102491422|NCT00377728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491423|NCT04498351|Magnesium Sulfate|magnesium sulfate|mesh-list
102491424|NCT04498351|Dexmedetomidine|dexmedetomidine|mesh-list
102491425|NCT04498351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102491426|NCT04498351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102491427|NCT04498351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491428|NCT04498351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102491430|NCT04498351|Sensory System Agents|sensory system agents|mesh-ancestor
102491431|NCT04498351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102491432|NCT04498351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102491433|NCT04498351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102491434|NCT04498351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102491435|NCT04498351|Adrenergic Agents|adrenergic agents|mesh-ancestor
102491436|NCT04498351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102491437|NCT04498351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491438|NCT04498351|Anesthetics|anesthetics|mesh-ancestor
102491439|NCT04498351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102491440|NCT04498351|Anticonvulsants|anticonvulsants|mesh-ancestor
102491441|NCT04498351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102491442|NCT04498351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102491443|NCT04498351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102491444|NCT04498351|Tocolytic Agents|tocolytic agents|mesh-ancestor
102491445|NCT04498351|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102491446|NCT02186665|Calcitriol|calcitriol|mesh-list
102491447|NCT02186665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102491448|NCT02186665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491449|NCT02186665|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102491450|NCT02186665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102491451|NCT02186665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491452|NCT02186665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102491453|NCT02186665|Vitamins|vitamins|mesh-ancestor
102491454|NCT02186665|Micronutrients|micronutrients|mesh-ancestor
102491455|NCT02186665|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102491456|NCT01172197|Ropivacaine|ropivacaine|mesh-list
102491457|NCT01172197|Levobupivacaine|levobupivacaine|mesh-list
102491458|NCT01172197|Anesthetics, Local|anesthetics, local|mesh-ancestor
102491459|NCT01172197|Anesthetics|anesthetics|mesh-ancestor
102491460|NCT01172197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102491461|NCT01172197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491462|NCT01172197|Sensory System Agents|sensory system agents|mesh-ancestor
102491463|NCT01172197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102491464|NCT04141930|Baloxavir|baloxavir|mesh-list
102491465|NCT04141930|Antiviral Agents|antiviral agents|mesh-ancestor
102491466|NCT04141930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102491467|NCT04141930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102491468|NCT04141930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491469|NCT04138498|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
102491470|NCT04138498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102491471|NCT04138498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491472|NCT04138498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102491473|NCT04138498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102491474|NCT04138498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102491475|NCT04138498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491476|NCT04138498|Dopamine Agents|dopamine agents|mesh-ancestor
102491477|NCT04138498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102491478|NCT03746002|Metolazone|metolazone|mesh-list
102491479|NCT03746002|Furosemide|furosemide|mesh-list
102491480|NCT03746002|Diuretics|diuretics|mesh-ancestor
102491481|NCT03746002|Natriuretic Agents|natriuretic agents|mesh-ancestor
102491482|NCT03746002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491483|NCT03746002|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102491484|NCT03746002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102491485|NCT03746002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491486|NCT03746002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102491487|NCT03746002|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102491488|NCT04089982|Varenicline|varenicline|mesh-list
102491489|NCT04089982|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102491490|NCT04089982|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102491491|NCT04089982|Cholinergic Agents|cholinergic agents|mesh-ancestor
102491492|NCT04089982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102491493|NCT04089982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491494|NCT04089982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491495|NCT03783130|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102491496|NCT03783130|Aluminum sulfate|aluminum sulfate|mesh-list
102491497|NCT03783130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102491498|NCT03783130|Immunologic Factors|immunologic factors|mesh-ancestor
102491499|NCT03783130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491500|NCT03783130|Antacids|antacids|mesh-ancestor
102491501|NCT03783130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491502|NCT03783130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102491503|NCT00984542|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102491504|NCT00984542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102491505|NCT00984542|Alkylating Agents|alkylating agents|mesh-ancestor
102491506|NCT00984542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491507|NCT00984542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102491508|NCT00983918|Propofol|propofol|mesh-list
102491509|NCT00983918|Sevoflurane|sevoflurane|mesh-list
102491510|NCT00983918|Desflurane|desflurane|mesh-list
102491511|NCT00983918|Isoflurane|isoflurane|mesh-list
102491512|NCT00983918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102491513|NCT00983918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102491514|NCT00983918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491515|NCT00983918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102491516|NCT00983918|Anesthetics, General|anesthetics, general|mesh-ancestor
102491517|NCT00983918|Anesthetics|anesthetics|mesh-ancestor
102491518|NCT00983918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102491519|NCT00983918|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102491520|NCT01926236|Leucovorin|leucovorin|mesh-list
102491521|NCT01926236|Folic Acid|folic acid|mesh-list
102491522|NCT01926236|Fluorouracil|fluorouracil|mesh-list
102491523|NCT01926236|Oxaliplatin|oxaliplatin|mesh-list
102491524|NCT01926236|Levoleucovorin|levoleucovorin|mesh-list
102491525|NCT01926236|Antimetabolites|antimetabolites|mesh-ancestor
102491526|NCT01926236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491527|NCT01926236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102491528|NCT01926236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102491529|NCT01926236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102491530|NCT01926236|Immunologic Factors|immunologic factors|mesh-ancestor
102491531|NCT01926236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491532|NCT01926236|Antidotes|antidotes|mesh-ancestor
102491533|NCT01926236|Protective Agents|protective agents|mesh-ancestor
102491534|NCT01926236|Vitamin B Complex|vitamin b complex|mesh-ancestor
102491535|NCT01926236|Vitamins|vitamins|mesh-ancestor
102491536|NCT01926236|Micronutrients|micronutrients|mesh-ancestor
102491537|NCT01926236|Hematinics|hematinics|mesh-ancestor
102491538|NCT00983528|Alemtuzumab|alemtuzumab|mesh-list
102491539|NCT00983528|Clofarabine|clofarabine|mesh-list
102491540|NCT00983528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102491541|NCT00983528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102491542|NCT00983528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102491543|NCT00983528|Antimetabolites|antimetabolites|mesh-ancestor
102491544|NCT00983528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491545|NCT00983372|Colchicine|colchicine|mesh-list
102491546|NCT00983372|Diltiazem|diltiazem|mesh-list
102491547|NCT00983372|Gout Suppressants|gout suppressants|mesh-ancestor
102491548|NCT00983372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102491549|NCT00983372|Tubulin Modulators|tubulin modulators|mesh-ancestor
102491550|NCT00983372|Antimitotic Agents|antimitotic agents|mesh-ancestor
102491551|NCT00983372|Mitosis Modulators|mitosis modulators|mesh-ancestor
102491552|NCT00983372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491553|NCT00983372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102491554|NCT00983372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102491555|NCT00983372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102491556|NCT00983372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102491557|NCT00983372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102491558|NCT00983372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491559|NCT00983372|Vasodilator Agents|vasodilator agents|mesh-ancestor
102491560|NCT01173211|Vaccines|vaccines|mesh-list
102491561|NCT01173211|Immunologic Factors|immunologic factors|mesh-ancestor
102491562|NCT01173211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491563|NCT00983294|Azithromycin|azithromycin|mesh-list
102491564|NCT00983294|Colchicine|colchicine|mesh-list
102491565|NCT00983294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102491566|NCT00983294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102491567|NCT00983294|Gout Suppressants|gout suppressants|mesh-ancestor
102491568|NCT00983294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102491569|NCT00983294|Tubulin Modulators|tubulin modulators|mesh-ancestor
102491570|NCT00983294|Antimitotic Agents|antimitotic agents|mesh-ancestor
102303199|NCT05135273|Vaccines|vaccines|mesh-list
102491571|NCT00983294|Mitosis Modulators|mitosis modulators|mesh-ancestor
102491572|NCT00983294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491573|NCT00983294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102491574|NCT01926392|Sulfadiazine|sulfadiazine|mesh-list
102491575|NCT01926392|Silver Sulfadiazine|silver sulfadiazine|mesh-list
102491576|NCT01926392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102491577|NCT01926392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102491578|NCT01926392|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102491579|NCT01926392|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102491580|NCT01926392|Coccidiostats|coccidiostats|mesh-ancestor
102491581|NCT01926392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102491582|NCT05601830|Cytarabine|cytarabine|mesh-list
102491583|NCT05601830|Cyclophosphamide|cyclophosphamide|mesh-list
102491584|NCT05601830|Fludarabine|fludarabine|mesh-list
102491585|NCT05601830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102491586|NCT05601830|Immunologic Factors|immunologic factors|mesh-ancestor
102491587|NCT05601830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491588|NCT05601830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102491589|NCT05601830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102491590|NCT05601830|Alkylating Agents|alkylating agents|mesh-ancestor
102491591|NCT05601830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491592|NCT05601830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102491593|NCT05601830|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102491594|NCT05601830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102491595|NCT05601830|Antimetabolites|antimetabolites|mesh-ancestor
102491596|NCT05601830|Antiviral Agents|antiviral agents|mesh-ancestor
102491597|NCT05601830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102491598|NCT00982280|Tapentadol|tapentadol|mesh-list
102491599|NCT00982280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102491600|NCT00982280|Narcotics|narcotics|mesh-ancestor
102491601|NCT00982280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102491602|NCT00982280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491603|NCT00982280|Analgesics|analgesics|mesh-ancestor
102491604|NCT00982280|Sensory System Agents|sensory system agents|mesh-ancestor
102491605|NCT00982280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102491606|NCT00982280|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102491607|NCT00982280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102491608|NCT00982280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102491609|NCT00982280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491610|NCT00982280|Adrenergic Agents|adrenergic agents|mesh-ancestor
102491611|NCT00982280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102491612|NCT01175395|Triamcinolone|triamcinolone|mesh-list
102491613|NCT01175395|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102491614|NCT01175395|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102491615|NCT01175395|Ranibizumab|ranibizumab|mesh-list
102491616|NCT01175395|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102491617|NCT01175395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102491618|NCT01175395|Glucocorticoids|glucocorticoids|mesh-ancestor
102491619|NCT01175395|Hormones|hormones|mesh-ancestor
102491620|NCT01175395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102491621|NCT01175395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491622|NCT01175395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102491623|NCT01175395|Immunologic Factors|immunologic factors|mesh-ancestor
102491624|NCT01175395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102491625|NCT01175395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491626|NCT01175395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102491627|NCT01175395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102491628|NCT01175395|Growth Substances|growth substances|mesh-ancestor
102491629|NCT01175395|Growth Inhibitors|growth inhibitors|mesh-ancestor
102491630|NCT01175395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102491631|NCT03011905|Acetaminophen|acetaminophen|mesh-list
102491632|NCT03011905|Dexamethasone|dexamethasone|mesh-list
102491633|NCT03011905|Etoricoxib|etoricoxib|mesh-list
102491634|NCT03011905|Oxycodone|oxycodone|mesh-list
102491635|NCT03011905|Ropivacaine|ropivacaine|mesh-list
102491636|NCT03011905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102491637|NCT03011905|Antiemetics|antiemetics|mesh-ancestor
102491638|NCT03011905|Autonomic Agents|autonomic agents|mesh-ancestor
102491639|NCT03011905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102491640|NCT03011905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491641|NCT03011905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102491642|NCT03011905|Glucocorticoids|glucocorticoids|mesh-ancestor
102491643|NCT03011905|Hormones|hormones|mesh-ancestor
102491644|NCT03011905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102491645|NCT03011905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102491646|NCT03011905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102491647|NCT03011905|Anesthetics, Local|anesthetics, local|mesh-ancestor
102491648|NCT03011905|Anesthetics|anesthetics|mesh-ancestor
102303275|NCT02114151|Sofosbuvir|sofosbuvir|mesh-list
102491649|NCT03011905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102491650|NCT03011905|Sensory System Agents|sensory system agents|mesh-ancestor
102491651|NCT03011905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102491652|NCT03011905|Analgesics|analgesics|mesh-ancestor
102491653|NCT03011905|Antipyretics|antipyretics|mesh-ancestor
102491654|NCT03011905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102491655|NCT03011905|Narcotics|narcotics|mesh-ancestor
102491656|NCT03011905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102491657|NCT03011905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102491658|NCT03011905|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102491659|NCT03011905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102491660|NCT03011905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102491661|NCT03011905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491662|NCT01926548|Imatinib Mesylate|imatinib mesylate|mesh-list
102491663|NCT01926548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102491664|NCT01926548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102491665|NCT01926548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102491666|NCT01926548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491667|NCT01176955|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102491668|NCT01176955|Dermatologic Agents|dermatologic agents|mesh-ancestor
102491669|NCT00980798|Hydromorphone|hydromorphone|mesh-list
102491670|NCT00980798|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102491671|NCT00980798|Narcotics|narcotics|mesh-ancestor
102491672|NCT00980798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102491673|NCT00980798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491674|NCT00980798|Analgesics|analgesics|mesh-ancestor
102491675|NCT00980798|Sensory System Agents|sensory system agents|mesh-ancestor
102491676|NCT00980798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102491677|NCT01177189|Thioctic Acid|thioctic acid|mesh-list
102491678|NCT01177189|Vitamins|vitamins|mesh-ancestor
102491679|NCT01177189|Micronutrients|micronutrients|mesh-ancestor
102491680|NCT01177189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491681|NCT01177189|Antioxidants|antioxidants|mesh-ancestor
102491682|NCT01177189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491683|NCT01177189|Protective Agents|protective agents|mesh-ancestor
102491684|NCT01177189|Vitamin B Complex|vitamin b complex|mesh-ancestor
102491685|NCT01926860|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102491686|NCT01926860|Immunologic Factors|immunologic factors|mesh-ancestor
102491687|NCT01926860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491688|NCT01177735|Pomalidomide|pomalidomide|mesh-list
102491689|NCT01177735|Immunologic Factors|immunologic factors|mesh-ancestor
102491690|NCT01177735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491691|NCT01177735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102491692|NCT01177735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102491693|NCT01177735|Growth Substances|growth substances|mesh-ancestor
102491694|NCT01177735|Growth Inhibitors|growth inhibitors|mesh-ancestor
102491695|NCT01177735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102491696|NCT01135069|Tretinoin|tretinoin|mesh-list
102491697|NCT01135069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102491698|NCT01135069|Keratolytic Agents|keratolytic agents|mesh-ancestor
102491699|NCT01135069|Dermatologic Agents|dermatologic agents|mesh-ancestor
102491700|NCT01178281|Thalidomide|thalidomide|mesh-list
102491701|NCT01178281|Pomalidomide|pomalidomide|mesh-list
102491702|NCT01178281|Immunologic Factors|immunologic factors|mesh-ancestor
102491703|NCT01178281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491704|NCT01178281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102491705|NCT01178281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102491706|NCT01178281|Growth Substances|growth substances|mesh-ancestor
102491707|NCT01178281|Growth Inhibitors|growth inhibitors|mesh-ancestor
102491708|NCT01178281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102491709|NCT01178281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102491710|NCT01178281|Leprostatic Agents|leprostatic agents|mesh-ancestor
102491711|NCT01178281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102491712|NCT01178281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102491713|NCT01178827|Mandelic Acids|mandelic acids|mesh-list
102491714|NCT01178827|Oxybutynin|oxybutynin|mesh-list
102491715|NCT01178827|Trospium chloride|trospium chloride|mesh-list
102491716|NCT01178827|Parasympatholytics|parasympatholytics|mesh-ancestor
102491717|NCT01178827|Autonomic Agents|autonomic agents|mesh-ancestor
102491718|NCT01178827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102491719|NCT01178827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491720|NCT01178827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102491721|NCT01178827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102491722|NCT01178827|Cholinergic Agents|cholinergic agents|mesh-ancestor
102491723|NCT01178827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102491724|NCT01178827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491725|NCT01178827|Urological Agents|urological agents|mesh-ancestor
102491726|NCT01178827|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102491727|NCT01178827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102491729|NCT01135537|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102491730|NCT01135537|Immunologic Factors|immunologic factors|mesh-ancestor
102491731|NCT01135537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491732|NCT01135537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102491733|NCT02181517|Ranibizumab|ranibizumab|mesh-list
102491734|NCT02181517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102491735|NCT02181517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102491736|NCT02181517|Growth Substances|growth substances|mesh-ancestor
102491737|NCT02181517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491738|NCT02181517|Growth Inhibitors|growth inhibitors|mesh-ancestor
102491739|NCT02181517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102491740|NCT03010267|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
102491741|NCT03010267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102491742|NCT03010267|Hormone Antagonists|hormone antagonists|mesh-ancestor
102491743|NCT03010267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102491744|NCT03010267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491745|NCT03010267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102491746|NCT03010267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102491747|NCT03010267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102491748|NCT01181323|Vaccines|vaccines|mesh-list
102491749|NCT01181323|Immunologic Factors|immunologic factors|mesh-ancestor
102491750|NCT01181323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491751|NCT03872947|Leucovorin|leucovorin|mesh-list
102491752|NCT03872947|Bevacizumab|bevacizumab|mesh-list
102491753|NCT03872947|Carboplatin|carboplatin|mesh-list
102491754|NCT03872947|Gemcitabine|gemcitabine|mesh-list
102491755|NCT03872947|Pembrolizumab|pembrolizumab|mesh-list
102491756|NCT03872947|Nivolumab|nivolumab|mesh-list
102491757|NCT03872947|Irinotecan|irinotecan|mesh-list
102491758|NCT03872947|Topotecan|topotecan|mesh-list
102491759|NCT03872947|Imiquimod|imiquimod|mesh-list
102491760|NCT03872947|Ramucirumab|ramucirumab|mesh-list
102491761|NCT03872947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102491762|NCT03872947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491763|NCT03872947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102491764|NCT03872947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102491765|NCT03872947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102491766|NCT03872947|Growth Substances|growth substances|mesh-ancestor
102491767|NCT03872947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491768|NCT03872947|Growth Inhibitors|growth inhibitors|mesh-ancestor
102491769|NCT03872947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102491770|NCT03872947|Antimetabolites|antimetabolites|mesh-ancestor
102491771|NCT03872947|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102491772|NCT03872947|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102491773|NCT03872947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102491774|NCT03872947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102491775|NCT03872947|Antidotes|antidotes|mesh-ancestor
102491776|NCT03872947|Protective Agents|protective agents|mesh-ancestor
102491777|NCT03872947|Vitamin B Complex|vitamin b complex|mesh-ancestor
102491778|NCT03872947|Vitamins|vitamins|mesh-ancestor
102491779|NCT03872947|Micronutrients|micronutrients|mesh-ancestor
102491780|NCT03872947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102491781|NCT03872947|Immunologic Factors|immunologic factors|mesh-ancestor
102491782|NCT03872947|Interferon Inducers|interferon inducers|mesh-ancestor
102491783|NCT02246881|Factor VIII|factor viii|mesh-list
102491784|NCT02246881|Coagulants|coagulants|mesh-ancestor
102491785|NCT00980330|Ribavirin|ribavirin|mesh-list
102491786|NCT00980330|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102491787|NCT00980330|Interferon alpha-2|interferon alpha-2|mesh-list
102491788|NCT00980330|Simeprevir|simeprevir|mesh-list
102491789|NCT00980330|Antimetabolites|antimetabolites|mesh-ancestor
102491790|NCT00980330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491791|NCT00980330|Antiviral Agents|antiviral agents|mesh-ancestor
102491792|NCT00980330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102491793|NCT00980330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102491794|NCT00980330|Protease Inhibitors|protease inhibitors|mesh-ancestor
102491795|NCT00980330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102491796|NCT01138735|Adapalene|adapalene|mesh-list
102491797|NCT01138735|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
102491798|NCT01138735|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102491799|NCT01138735|Dermatologic Agents|dermatologic agents|mesh-ancestor
102491800|NCT01138735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102491801|NCT01138735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102491802|NCT01138735|Analgesics|analgesics|mesh-ancestor
102491803|NCT01138735|Sensory System Agents|sensory system agents|mesh-ancestor
102491804|NCT01138735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102491805|NCT01138735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491807|NCT01138735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102491808|NCT00980174|Denosumab|denosumab|mesh-list
102491809|NCT00980174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102491810|NCT00980174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491811|NCT03064568|Misoprostol|misoprostol|mesh-list
102491812|NCT03064568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102491813|NCT03064568|Abortifacient Agents|abortifacient agents|mesh-ancestor
102491814|NCT03064568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102491815|NCT03064568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491816|NCT03064568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102491817|NCT03064568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102491818|NCT03064568|Oxytocics|oxytocics|mesh-ancestor
102491819|NCT01138969|Esomeprazole|esomeprazole|mesh-list
102491820|NCT01138969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102491821|NCT01138969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102491822|NCT01138969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102491823|NCT01138969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102491824|NCT01138969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491825|NCT01139515|Eletriptan|eletriptan|mesh-list
102491826|NCT01139515|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102491827|NCT01139515|Serotonin Agents|serotonin agents|mesh-ancestor
102491828|NCT01139515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102491829|NCT01139515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491830|NCT01139515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491831|NCT00987272|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
102491832|NCT00987272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102491833|NCT00987272|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102491834|NCT00987272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102491835|NCT00987272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102491836|NCT00987272|Analgesics|analgesics|mesh-ancestor
102491837|NCT00987272|Sensory System Agents|sensory system agents|mesh-ancestor
102491838|NCT00987272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102491839|NCT00987272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491840|NCT00987272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102491841|NCT00987272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102491842|NCT00987272|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102491843|NCT00987272|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102491844|NCT00987272|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102491845|NCT00987272|Histamine Antagonists|histamine antagonists|mesh-ancestor
102491846|NCT00987272|Histamine Agents|histamine agents|mesh-ancestor
102491847|NCT00987272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102491848|NCT00987272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491849|NCT03709459|Doxycycline|doxycycline|mesh-list
102491850|NCT03709459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102491851|NCT03709459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102491852|NCT03709459|Antimalarials|antimalarials|mesh-ancestor
102491853|NCT03709459|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102491854|NCT03709459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102491855|NCT00986882|Ibuprofen|ibuprofen|mesh-list
102491856|NCT00986882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102491857|NCT00986882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102491858|NCT00986882|Analgesics|analgesics|mesh-ancestor
102491859|NCT00986882|Sensory System Agents|sensory system agents|mesh-ancestor
102491860|NCT00986882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102491861|NCT00986882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491862|NCT00986882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102491863|NCT00986882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102491864|NCT00986882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102491865|NCT00986882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102491866|NCT00986882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491867|NCT00981656|Fluorouracil|fluorouracil|mesh-list
102491868|NCT00981656|Mitomycins|mitomycins|mesh-list
102491869|NCT00981656|Mitomycin|mitomycin|mesh-list
102491870|NCT00981656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102491871|NCT00981656|Antimetabolites|antimetabolites|mesh-ancestor
102491872|NCT00981656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491873|NCT00981656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102491874|NCT00981656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102491875|NCT00981656|Immunologic Factors|immunologic factors|mesh-ancestor
102491876|NCT00981656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491877|NCT00981656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102491878|NCT00981656|Alkylating Agents|alkylating agents|mesh-ancestor
102491879|NCT00981656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102491880|NCT00981656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102491881|NCT04395170|Immunoglobulins|immunoglobulins|mesh-list
102491882|NCT04395170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102491883|NCT04395170|Antibodies|antibodies|mesh-list
102491884|NCT04395170|Immunologic Factors|immunologic factors|mesh-ancestor
102491885|NCT04395170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491886|NCT01927328|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
102491887|NCT01927328|Hematinics|hematinics|mesh-ancestor
102491888|NCT04552808|Yimitasvir|yimitasvir|mesh-list
102491889|NCT04552808|Antiviral Agents|antiviral agents|mesh-ancestor
102491890|NCT04552808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102491891|NCT01927406|Timolol|timolol|mesh-list
102491892|NCT01927406|Bimatoprost|bimatoprost|mesh-list
102491893|NCT01927406|Travoprost|travoprost|mesh-list
102491894|NCT01927406|Latanoprost|latanoprost|mesh-list
102491895|NCT01927406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491896|NCT01927406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102491897|NCT01927406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102491898|NCT01927406|Adrenergic Agents|adrenergic agents|mesh-ancestor
102491899|NCT01927406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102491900|NCT01927406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491901|NCT01927406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102491902|NCT01927406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102491903|NCT01927406|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102491904|NCT01927406|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102491905|NCT01182493|Insulin|insulin|mesh-list
102491906|NCT01182493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102491907|NCT01182493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491908|NCT01927484|Methotrexate|methotrexate|mesh-list
102491909|NCT01927484|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102491910|NCT01927484|Abortifacient Agents|abortifacient agents|mesh-ancestor
102491911|NCT01927484|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102491912|NCT01927484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491913|NCT01927484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102491914|NCT01927484|Antimetabolites|antimetabolites|mesh-ancestor
102491915|NCT01927484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491916|NCT01927484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102491917|NCT01927484|Dermatologic Agents|dermatologic agents|mesh-ancestor
102491918|NCT01927484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102491919|NCT01927484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102491920|NCT01927484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102491921|NCT01927484|Immunologic Factors|immunologic factors|mesh-ancestor
102491922|NCT01927484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102491923|NCT01927484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102491924|NCT05607446|Montelukast|montelukast|mesh-list
102491925|NCT05607446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102491926|NCT05607446|Respiratory System Agents|respiratory system agents|mesh-ancestor
102491927|NCT05607446|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102491928|NCT05607446|Hormone Antagonists|hormone antagonists|mesh-ancestor
102491929|NCT05607446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102491930|NCT05607446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491931|NCT05607446|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102491932|NCT05607446|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102491933|NCT05607446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491934|NCT02185339|Rocuronium|rocuronium|mesh-list
102491935|NCT02185339|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102491936|NCT02185339|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102491937|NCT02185339|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102491938|NCT02185339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102491939|NCT02185339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491940|NCT03831464|Metformin|metformin|mesh-list
102491941|NCT03831464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102491942|NCT03831464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491943|NCT01928498|Paclitaxel|paclitaxel|mesh-list
102491944|NCT01928498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102491945|NCT01928498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102491946|NCT01928498|Tubulin Modulators|tubulin modulators|mesh-ancestor
102491947|NCT01928498|Antimitotic Agents|antimitotic agents|mesh-ancestor
102491948|NCT01928498|Mitosis Modulators|mitosis modulators|mesh-ancestor
102491949|NCT01928498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491950|NCT04558502|Amoxicillin|amoxicillin|mesh-list
102491951|NCT04558502|Clarithromycin|clarithromycin|mesh-list
102491952|NCT04558502|Minocycline|minocycline|mesh-list
102491953|NCT04558502|Esomeprazole|esomeprazole|mesh-list
102303566|NCT04991597|Sympathomimetics|sympathomimetics|mesh-ancestor
102491955|NCT04558502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102491956|NCT04558502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102491957|NCT04558502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102491958|NCT04558502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102491959|NCT04558502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102491960|NCT04558502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102491961|NCT04558502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491962|NCT04558502|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102491963|NCT04558502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102491964|NCT04558502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102491965|NCT04558502|Antacids|antacids|mesh-ancestor
102491966|NCT01218997|Naltrexone|naltrexone|mesh-list
102491967|NCT01218997|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102491968|NCT01218997|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102491969|NCT01218997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491970|NCT01218997|Sensory System Agents|sensory system agents|mesh-ancestor
102491971|NCT01218997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102491972|NCT01219777|Paclitaxel|paclitaxel|mesh-list
102491973|NCT01219777|Bevacizumab|bevacizumab|mesh-list
102491974|NCT01219777|Carboplatin|carboplatin|mesh-list
102491975|NCT01219777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102491976|NCT01219777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102491977|NCT01219777|Tubulin Modulators|tubulin modulators|mesh-ancestor
102491978|NCT01219777|Antimitotic Agents|antimitotic agents|mesh-ancestor
102491979|NCT01219777|Mitosis Modulators|mitosis modulators|mesh-ancestor
102491980|NCT01219777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102491981|NCT01219777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102491982|NCT01219777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102491983|NCT01219777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102491984|NCT01219777|Growth Substances|growth substances|mesh-ancestor
102491985|NCT01219777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491986|NCT01219777|Growth Inhibitors|growth inhibitors|mesh-ancestor
102491987|NCT05603156|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
102491988|NCT05603156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102491989|NCT05603156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102491990|NCT05603156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102491991|NCT05603156|Immunotoxins|immunotoxins|mesh-ancestor
102491992|NCT05603156|Immunoconjugates|immunoconjugates|mesh-ancestor
102491993|NCT05603156|Immunologic Factors|immunologic factors|mesh-ancestor
102491994|NCT05603156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102491995|NCT04759742|Ropivacaine|ropivacaine|mesh-list
102491996|NCT04759742|Anesthetics, Local|anesthetics, local|mesh-ancestor
102491997|NCT04759742|Anesthetics|anesthetics|mesh-ancestor
102491998|NCT04759742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102491999|NCT04759742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492000|NCT04759742|Sensory System Agents|sensory system agents|mesh-ancestor
102492001|NCT04759742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102492002|NCT01928888|Famotidine|famotidine|mesh-list
102492003|NCT01928888|Hydrotalcite|hydrotalcite|mesh-list
102492004|NCT01928888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102492005|NCT01928888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102492006|NCT01928888|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102492007|NCT01928888|Histamine Antagonists|histamine antagonists|mesh-ancestor
102492008|NCT01928888|Histamine Agents|histamine agents|mesh-ancestor
102492009|NCT01928888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102492010|NCT01928888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492011|NCT01928888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492012|NCT01928888|Antacids|antacids|mesh-ancestor
102492013|NCT04556084|Blinatumomab|blinatumomab|mesh-list
102492014|NCT04556084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102492015|NCT04394234|Warfarin|warfarin|mesh-list
102492016|NCT04394234|Anticoagulants|anticoagulants|mesh-list
102492017|NCT02569710|Simeprevir|simeprevir|mesh-list
102492018|NCT02569710|Odalasvir|odalasvir|mesh-list
102492019|NCT02569710|Antiviral Agents|antiviral agents|mesh-ancestor
102492020|NCT02569710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102492021|NCT02569710|Protease Inhibitors|protease inhibitors|mesh-ancestor
102492022|NCT02569710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102492023|NCT02569710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492024|NCT04550624|Pembrolizumab|pembrolizumab|mesh-list
102492025|NCT04550624|Lenvatinib|lenvatinib|mesh-list
102492026|NCT04550624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102492027|NCT04550624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102492028|NCT04550624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102492029|NCT04550624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492030|NCT04550624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102492031|NCT04550624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102492032|NCT04550546|Nystatin|nystatin|mesh-list
102492033|NCT04550546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102492034|NCT04550546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102492035|NCT04550546|Antifungal Agents|antifungal agents|mesh-ancestor
102492036|NCT04550546|Ionophores|ionophores|mesh-ancestor
102492037|NCT04550546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102492038|NCT04550546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492039|NCT02984072|Menthol|menthol|mesh-list
102492040|NCT02984072|Antipruritics|antipruritics|mesh-ancestor
102492041|NCT02984072|Dermatologic Agents|dermatologic agents|mesh-ancestor
102492042|NCT04589832|Entrectinib|entrectinib|mesh-list
102492043|NCT04589832|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102492044|NCT04589832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102133722|NCT02295189|Analgesics|analgesics|mesh-ancestor
102492045|NCT04589832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492046|NCT05506410|Cytarabine|cytarabine|mesh-list
102492047|NCT05506410|Prednisone|prednisone|mesh-list
102492048|NCT05506410|Rituximab|rituximab|mesh-list
102492049|NCT05506410|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102492050|NCT05506410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102492051|NCT05506410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102492052|NCT05506410|Immunologic Factors|immunologic factors|mesh-ancestor
102492053|NCT05506410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492054|NCT05506410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102492055|NCT05506410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102492056|NCT05506410|Glucocorticoids|glucocorticoids|mesh-ancestor
102492057|NCT05506410|Hormones|hormones|mesh-ancestor
102492058|NCT05506410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102492059|NCT05506410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102492060|NCT05506410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102492061|NCT05506410|Antimetabolites|antimetabolites|mesh-ancestor
102492062|NCT05506410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492063|NCT05506410|Antiviral Agents|antiviral agents|mesh-ancestor
102492064|NCT05506410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102492065|NCT05506410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102492066|NCT05506410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102492067|NCT05506410|Alkylating Agents|alkylating agents|mesh-ancestor
102492068|NCT05506332|Venetoclax|venetoclax|mesh-list
102492069|NCT05506332|Mercaptopurine|mercaptopurine|mesh-list
102492070|NCT05506332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102492071|NCT05506332|Antimetabolites|antimetabolites|mesh-ancestor
102492072|NCT05506332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492073|NCT05506332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102492074|NCT05506332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102492075|NCT05506332|Immunologic Factors|immunologic factors|mesh-ancestor
102492076|NCT05506332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492077|NCT05506332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102492078|NCT05506332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102492079|NCT01927874|Bupivacaine|bupivacaine|mesh-list
102492080|NCT01927874|Anesthetics, Local|anesthetics, local|mesh-ancestor
102492081|NCT01927874|Anesthetics|anesthetics|mesh-ancestor
102492082|NCT01927874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102492083|NCT01927874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492084|NCT01927874|Sensory System Agents|sensory system agents|mesh-ancestor
102492085|NCT01927874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102492086|NCT05604638|Tenecteplase|tenecteplase|mesh-list
102492087|NCT05604638|Tirofiban|tirofiban|mesh-list
102492088|NCT05604638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102492089|NCT05604638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102492090|NCT05604638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492091|NCT05604638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102492092|NCT03033758|Budesonide|budesonide|mesh-list
102492093|NCT03033758|Formoterol Fumarate|formoterol fumarate|mesh-list
102492094|NCT03033758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102492095|NCT03033758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102492096|NCT03033758|Autonomic Agents|autonomic agents|mesh-ancestor
102492097|NCT03033758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102492098|NCT03033758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492099|NCT03033758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102492100|NCT03033758|Respiratory System Agents|respiratory system agents|mesh-ancestor
102492101|NCT03033758|Glucocorticoids|glucocorticoids|mesh-ancestor
102492102|NCT03033758|Hormones|hormones|mesh-ancestor
102492103|NCT03033758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102492104|NCT03033758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102492105|NCT03033758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102492106|NCT03033758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102492107|NCT03033758|Adrenergic Agents|adrenergic agents|mesh-ancestor
102492108|NCT03033758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102492109|NCT03033758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492110|NCT01016483|Gemcitabine|gemcitabine|mesh-list
102492111|NCT01016483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102492112|NCT01016483|Antimetabolites|antimetabolites|mesh-ancestor
102492113|NCT01016483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492114|NCT01016483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102492115|NCT02569476|Obinutuzumab|obinutuzumab|mesh-list
102492116|NCT02569476|Zanubrutinib|zanubrutinib|mesh-list
102492117|NCT02569476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102492118|NCT02569476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102492119|NCT02569476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102492120|NCT02569476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102492121|NCT02569476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492122|NCT00955253|Guanfacine|guanfacine|mesh-list
102492123|NCT00955253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102492124|NCT00955253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102492125|NCT00955253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102492126|NCT00955253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102492127|NCT00955253|Adrenergic Agents|adrenergic agents|mesh-ancestor
102492128|NCT00955253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102492129|NCT00955253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492130|NCT00955253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492131|NCT04394390|Vitamin D|vitamin d|mesh-list
102492132|NCT04394390|Ergocalciferols|ergocalciferols|mesh-list
102492133|NCT04394390|Cholecalciferol|cholecalciferol|mesh-list
102492134|NCT04394390|Vitamins|vitamins|mesh-list
102492135|NCT04394390|Micronutrients|micronutrients|mesh-ancestor
102492136|NCT04394390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492137|NCT04394390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102492138|NCT04394390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102492139|NCT04120454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102492140|NCT04120454|Pembrolizumab|pembrolizumab|mesh-list
102492141|NCT04120454|Ramucirumab|ramucirumab|mesh-list
102492142|NCT04120454|Antibodies|antibodies|mesh-list
102492143|NCT04120454|Immunoglobulins|immunoglobulins|mesh-list
102492144|NCT04120454|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102492145|NCT04120454|Lexatumumab|lexatumumab|mesh-list
102492146|NCT04120454|Immunologic Factors|immunologic factors|mesh-ancestor
102492147|NCT04120454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492148|NCT04120454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102492149|NCT04120454|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102492150|NCT04120454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492151|NCT01017653|Irinotecan|irinotecan|mesh-list
102492152|NCT01017653|Panitumumab|panitumumab|mesh-list
102492153|NCT01017653|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102492154|NCT01017653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102492155|NCT01017653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102492156|NCT01017653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492157|NCT01017653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102492158|NCT01017653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102492159|NCT00966641|Naproxen|naproxen|mesh-list
102492160|NCT00966641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102492161|NCT00966641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102492162|NCT00966641|Analgesics|analgesics|mesh-ancestor
102492163|NCT00966641|Sensory System Agents|sensory system agents|mesh-ancestor
102492164|NCT00966641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102492165|NCT00966641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492166|NCT00966641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102492167|NCT00966641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102492168|NCT00966641|Gout Suppressants|gout suppressants|mesh-ancestor
102492169|NCT00966641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102492170|NCT00966641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102492171|NCT00966641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492172|NCT00970073|Mycophenolic Acid|mycophenolic acid|mesh-list
102492173|NCT00970073|Tacrolimus|tacrolimus|mesh-list
102492174|NCT00970073|Thymoglobulin|thymoglobulin|mesh-list
102492175|NCT00970073|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102492176|NCT00970073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102492177|NCT00970073|Immunologic Factors|immunologic factors|mesh-ancestor
102492178|NCT00970073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492179|NCT00970073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102492180|NCT00970073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102492181|NCT00970073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492182|NCT00970073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102492183|NCT00970073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102492184|NCT00970073|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102492185|NCT00970073|Antitubercular Agents|antitubercular agents|mesh-ancestor
102492186|NCT00970073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102492187|NCT00970073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102492188|NCT00971633|Ondansetron|ondansetron|mesh-list
102492189|NCT00971633|Antiemetics|antiemetics|mesh-ancestor
102492190|NCT00971633|Autonomic Agents|autonomic agents|mesh-ancestor
102492191|NCT00971633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102492192|NCT00971633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492193|NCT00971633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102492194|NCT00971633|Antipruritics|antipruritics|mesh-ancestor
102492195|NCT00971633|Dermatologic Agents|dermatologic agents|mesh-ancestor
102492196|NCT00971633|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102492197|NCT00971633|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102492198|NCT00971633|Serotonin Agents|serotonin agents|mesh-ancestor
102492199|NCT00971633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102492200|NCT00971633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492201|NCT05511246|Ethanol|ethanol|mesh-list
102492202|NCT05511246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102492203|NCT05511246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102492204|NCT05511246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102492205|NCT05511246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492206|NCT00971789|Sirolimus|sirolimus|mesh-list
102492207|NCT00971789|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102492208|NCT00971789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102492209|NCT00971789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102492210|NCT00971789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102492211|NCT00971789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102492212|NCT00971789|Antifungal Agents|antifungal agents|mesh-ancestor
102492213|NCT00971789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102492214|NCT00971789|Immunologic Factors|immunologic factors|mesh-ancestor
102492215|NCT00971789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492216|NCT00971789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492217|NCT00971789|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102492218|NCT05510778|Charcoal|charcoal|mesh-list
102492219|NCT05510778|Antidotes|antidotes|mesh-ancestor
102492220|NCT05510778|Protective Agents|protective agents|mesh-ancestor
102492221|NCT05510778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492222|NCT00972335|Bevacizumab|bevacizumab|mesh-list
102492223|NCT00972335|Everolimus|everolimus|mesh-list
102492224|NCT00972335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102492225|NCT00972335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102492226|NCT00972335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102492227|NCT00972335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102492228|NCT00972335|Growth Substances|growth substances|mesh-ancestor
102492229|NCT00972335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492230|NCT00972335|Growth Inhibitors|growth inhibitors|mesh-ancestor
102492231|NCT00972335|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102492232|NCT00972335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102492233|NCT00972335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102492234|NCT00972335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492235|NCT00972335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102492236|NCT00972335|Immunologic Factors|immunologic factors|mesh-ancestor
102492237|NCT02337530|Carboplatin|carboplatin|mesh-list
102492238|NCT02337530|Pemetrexed|pemetrexed|mesh-list
102492239|NCT02337530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102492240|NCT02337530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102492241|NCT02337530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492242|NCT02337530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102492243|NCT02337530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102492244|NCT03341156|Thrombin|thrombin|mesh-list
102492245|NCT03341156|Hemostatics|hemostatics|mesh-ancestor
102492246|NCT03341156|Coagulants|coagulants|mesh-ancestor
102492247|NCT04122560|Fluconazole|fluconazole|mesh-list
102492248|NCT04122560|Antifungal Agents|antifungal agents|mesh-ancestor
102492249|NCT04122560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102492250|NCT04122560|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102492251|NCT04122560|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102492252|NCT04122560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102492253|NCT04122560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492254|NCT04122560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102492255|NCT04122560|Hormone Antagonists|hormone antagonists|mesh-ancestor
102492256|NCT04122560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102492257|NCT04122560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492258|NCT04122560|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102492259|NCT04122560|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102492260|NCT02569242|Paclitaxel|paclitaxel|mesh-list
102492261|NCT02569242|Docetaxel|docetaxel|mesh-list
102492262|NCT02569242|Nivolumab|nivolumab|mesh-list
102492263|NCT02569242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102492264|NCT02569242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102492265|NCT02569242|Tubulin Modulators|tubulin modulators|mesh-ancestor
102492266|NCT02569242|Antimitotic Agents|antimitotic agents|mesh-ancestor
102492267|NCT02569242|Mitosis Modulators|mitosis modulators|mesh-ancestor
102492268|NCT02569242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492269|NCT02569242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102492270|NCT02569242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102492271|NCT04124588|Hemostatics|hemostatics|mesh-list
102492272|NCT04124588|Coagulants|coagulants|mesh-ancestor
102492273|NCT05501340|Molgramostim|molgramostim|mesh-list
102492274|NCT05501340|Sargramostim|sargramostim|mesh-list
102492275|NCT05501340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102492276|NCT05501340|Immunologic Factors|immunologic factors|mesh-ancestor
102492277|NCT05501340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492278|NCT00972725|Chloroquine|chloroquine|mesh-list
102492279|NCT00972725|Amebicides|amebicides|mesh-ancestor
102492280|NCT00972725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102492281|NCT00972725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102492282|NCT00972725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102492283|NCT00972725|Antimalarials|antimalarials|mesh-ancestor
102492284|NCT00972725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102492285|NCT05600660|Rituximab|rituximab|mesh-list
102492286|NCT05600660|Methotrexate|methotrexate|mesh-list
102492287|NCT05600660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102492288|NCT05600660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102492289|NCT05600660|Immunologic Factors|immunologic factors|mesh-ancestor
102492290|NCT05600660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492291|NCT05600660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102492292|NCT05600660|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102492293|NCT05600660|Abortifacient Agents|abortifacient agents|mesh-ancestor
102492294|NCT05600660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102492295|NCT05600660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102492296|NCT05600660|Antimetabolites|antimetabolites|mesh-ancestor
102492297|NCT05600660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492298|NCT05600660|Dermatologic Agents|dermatologic agents|mesh-ancestor
102492299|NCT05600660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102492300|NCT05600660|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102492301|NCT05600660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102492302|NCT05600660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102492303|NCT00972959|Zoledronic Acid|zoledronic acid|mesh-list
102492304|NCT00972959|Dexamethasone|dexamethasone|mesh-list
102492305|NCT00972959|Bortezomib|bortezomib|mesh-list
102492306|NCT00972959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102492307|NCT00972959|Antiemetics|antiemetics|mesh-ancestor
102492308|NCT00972959|Autonomic Agents|autonomic agents|mesh-ancestor
102492309|NCT00972959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102492310|NCT00972959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492311|NCT00972959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102492312|NCT00972959|Glucocorticoids|glucocorticoids|mesh-ancestor
102492313|NCT00972959|Hormones|hormones|mesh-ancestor
102492314|NCT00972959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102492315|NCT00972959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102492316|NCT00972959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102492317|NCT00972959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102492318|NCT05609240|Cefuroxime|cefuroxime|mesh-list
102492319|NCT05609240|Cefuroxime axetil|cefuroxime axetil|mesh-list
102492320|NCT05609240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102492321|NCT05609240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102492322|NCT00973739|Lapatinib|lapatinib|mesh-list
102492323|NCT00973739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102492324|NCT00973739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102492325|NCT00973739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102492326|NCT00973739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492327|NCT00974051|Insulin|insulin|mesh-list
102303943|NCT02101359|Tetracaine|tetracaine|mesh-list
102492328|NCT00974051|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102492329|NCT00974051|Terbutaline|terbutaline|mesh-list
102492330|NCT00974051|Adrenergic Agonists|adrenergic agonists|mesh-list
102492331|NCT00974051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102492332|NCT00974051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492333|NCT00974051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102492334|NCT00974051|Autonomic Agents|autonomic agents|mesh-ancestor
102492335|NCT00974051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102492336|NCT00974051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102492337|NCT00974051|Respiratory System Agents|respiratory system agents|mesh-ancestor
102492338|NCT00974051|Sympathomimetics|sympathomimetics|mesh-ancestor
102492339|NCT00974051|Tocolytic Agents|tocolytic agents|mesh-ancestor
102492340|NCT00974051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102492341|NCT00974051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102492342|NCT00974051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102492343|NCT00974051|Adrenergic Agents|adrenergic agents|mesh-ancestor
102492344|NCT00974051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102492345|NCT00974051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492346|NCT03017963|Sodium thiosulfate|sodium thiosulfate|mesh-list
102492347|NCT03017963|Antidotes|antidotes|mesh-ancestor
102492348|NCT03017963|Protective Agents|protective agents|mesh-ancestor
102492349|NCT03017963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492350|NCT03017963|Antioxidants|antioxidants|mesh-ancestor
102492351|NCT03017963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492352|NCT03017963|Antitubercular Agents|antitubercular agents|mesh-ancestor
102492353|NCT03017963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102492354|NCT03017963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102492355|NCT03017963|Chelating Agents|chelating agents|mesh-ancestor
102492356|NCT03017963|Sequestering Agents|sequestering agents|mesh-ancestor
102492357|NCT03018353|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102492358|NCT03018353|Antiviral Agents|antiviral agents|mesh-ancestor
102492359|NCT03018353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102492360|NCT00977171|Droxidopa|droxidopa|mesh-list
102492361|NCT00977171|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102492362|NCT00977171|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102492363|NCT04129424|Insulin|insulin|mesh-list
102492364|NCT04129424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102492365|NCT04129424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492366|NCT00955487|Nitric Oxide|nitric oxide|mesh-list
102492367|NCT00955487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102492368|NCT00955487|Autonomic Agents|autonomic agents|mesh-ancestor
102492369|NCT00955487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102492370|NCT00955487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492371|NCT00955487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102492372|NCT00955487|Respiratory System Agents|respiratory system agents|mesh-ancestor
102492373|NCT00955487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102492374|NCT00955487|Antioxidants|antioxidants|mesh-ancestor
102492375|NCT00955487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492376|NCT00955487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102492377|NCT00955487|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102492378|NCT00955487|Vasodilator Agents|vasodilator agents|mesh-ancestor
102492379|NCT00955487|Gasotransmitters|gasotransmitters|mesh-ancestor
102492380|NCT00955487|Protective Agents|protective agents|mesh-ancestor
102492381|NCT04120922|Calcium Carbonate|calcium carbonate|mesh-list
102492382|NCT04120922|Calcium|calcium|mesh-list
102492383|NCT04120922|Sevelamer|sevelamer|mesh-list
102492384|NCT04120922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102492385|NCT04120922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492386|NCT04120922|Antacids|antacids|mesh-ancestor
102492387|NCT04120922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492388|NCT04120922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102492389|NCT04120922|Chelating Agents|chelating agents|mesh-ancestor
102492390|NCT04120922|Sequestering Agents|sequestering agents|mesh-ancestor
102492391|NCT01663740|Valganciclovir|valganciclovir|mesh-list
102492392|NCT01663740|Antiviral Agents|antiviral agents|mesh-ancestor
102492393|NCT01663740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102492394|NCT02984228|Hyaluronic Acid|hyaluronic acid|mesh-list
102492395|NCT02984228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102492396|NCT02984228|Immunologic Factors|immunologic factors|mesh-ancestor
102492397|NCT02984228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492398|NCT02984228|Viscosupplements|viscosupplements|mesh-ancestor
102492399|NCT02984228|Protective Agents|protective agents|mesh-ancestor
102492400|NCT00979121|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102492401|NCT00979121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102492402|NCT00979121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102492403|NCT00979121|Antimetabolites|antimetabolites|mesh-ancestor
102492404|NCT00979121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492405|NCT00979121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102492406|NCT00979121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102492407|NCT00979121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102492408|NCT03828032|Mannitol|mannitol|mesh-list
102492409|NCT03828032|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102492410|NCT03828032|Diuretics|diuretics|mesh-ancestor
102492411|NCT03828032|Natriuretic Agents|natriuretic agents|mesh-ancestor
102492412|NCT03828032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492413|NCT03827876|Calcitriol|calcitriol|mesh-list
102492414|NCT03827876|Betamethasone|betamethasone|mesh-list
102492415|NCT03827876|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102492416|NCT03827876|Calcipotriene|calcipotriene|mesh-list
102492417|NCT03827876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102492418|NCT03827876|Glucocorticoids|glucocorticoids|mesh-ancestor
102492419|NCT03827876|Hormones|hormones|mesh-ancestor
102492420|NCT03827876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102492421|NCT03827876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492422|NCT03827876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102492423|NCT03827876|Respiratory System Agents|respiratory system agents|mesh-ancestor
102492424|NCT03827876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102492425|NCT03827876|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102492426|NCT03827876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102492427|NCT03827876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492428|NCT03827876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102492429|NCT03827876|Vitamins|vitamins|mesh-ancestor
102492430|NCT03827876|Micronutrients|micronutrients|mesh-ancestor
102492431|NCT03827876|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102492432|NCT03827876|Dermatologic Agents|dermatologic agents|mesh-ancestor
102492433|NCT03898934|Vitamin D|vitamin d|mesh-list
102492434|NCT03898934|Vitamins|vitamins|mesh-ancestor
102492435|NCT03898934|Micronutrients|micronutrients|mesh-ancestor
102492436|NCT03898934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492437|NCT03898934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102492438|NCT04128800|Apatinib|apatinib|mesh-list
102492439|NCT04128800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102492440|NCT04128800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102492441|NCT04128800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102492442|NCT04128800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492443|NCT04129112|Propofol|propofol|mesh-list
102492444|NCT04129112|Anesthetics|anesthetics|mesh-ancestor
102492445|NCT04129112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102492446|NCT04129112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492447|NCT04129112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102492448|NCT04129112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102492449|NCT04129112|Anesthetics, General|anesthetics, general|mesh-ancestor
102492450|NCT01608893|Metoprolol|metoprolol|mesh-list
102492451|NCT01608893|Carvedilol|carvedilol|mesh-list
102492452|NCT01608893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102492453|NCT01608893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102492454|NCT01608893|Sympatholytics|sympatholytics|mesh-ancestor
102492455|NCT01608893|Autonomic Agents|autonomic agents|mesh-ancestor
102492456|NCT01608893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102492457|NCT01608893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492458|NCT01608893|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102492459|NCT01608893|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102492460|NCT01608893|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102492461|NCT01608893|Adrenergic Agents|adrenergic agents|mesh-ancestor
102492462|NCT01608893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102492463|NCT01608893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492464|NCT01608893|Antioxidants|antioxidants|mesh-ancestor
102492465|NCT01608893|Protective Agents|protective agents|mesh-ancestor
102492466|NCT01608893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102492467|NCT01608893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102492468|NCT01608893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102492469|NCT01608893|Vasodilator Agents|vasodilator agents|mesh-ancestor
102492470|NCT01608893|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102492471|NCT01608893|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102492472|NCT04128878|Sotalol|sotalol|mesh-list
102492473|NCT04128878|Dofetilide|dofetilide|mesh-list
102492474|NCT04128878|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102492475|NCT04128878|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102492476|NCT04128878|Adrenergic Agents|adrenergic agents|mesh-ancestor
102492477|NCT04128878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102492478|NCT04128878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492479|NCT04128878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492480|NCT04128878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102492481|NCT04128878|Sympatholytics|sympatholytics|mesh-ancestor
102492482|NCT04128878|Autonomic Agents|autonomic agents|mesh-ancestor
102492483|NCT04128878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102492484|NCT04128878|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102492485|NCT04128878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102492486|NCT00979745|Afamelanotide|afamelanotide|mesh-list
102492487|NCT00979745|Dermatologic Agents|dermatologic agents|mesh-ancestor
102492488|NCT00042341|Clofarabine|clofarabine|mesh-list
102492489|NCT00042341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102492490|NCT00042341|Antimetabolites|antimetabolites|mesh-ancestor
102492491|NCT00042341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492492|NCT00042341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102492493|NCT00980681|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
102492494|NCT00980681|Chelating Agents|chelating agents|mesh-ancestor
102492495|NCT00980681|Sequestering Agents|sequestering agents|mesh-ancestor
102492496|NCT00980681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492498|NCT04759196|Levetiracetam|levetiracetam|mesh-list
102492499|NCT04759196|Anticonvulsants|anticonvulsants|mesh-ancestor
102492500|NCT04759196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102492501|NCT04759196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492502|NCT04759196|Nootropic Agents|nootropic agents|mesh-ancestor
102492503|NCT04128254|Apixaban|apixaban|mesh-list
102492504|NCT04128254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102492505|NCT04128254|Antithrombins|antithrombins|mesh-ancestor
102492506|NCT04128254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102492507|NCT04128254|Protease Inhibitors|protease inhibitors|mesh-ancestor
102492508|NCT04128254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102492509|NCT04128254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492510|NCT04128254|Anticoagulants|anticoagulants|mesh-ancestor
102492511|NCT04128020|Nivolumab|nivolumab|mesh-list
102492512|NCT04128020|Azacitidine|azacitidine|mesh-list
102492513|NCT04128020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102492514|NCT04128020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102492515|NCT04128020|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102492516|NCT04128020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492517|NCT04128020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102492518|NCT04128020|Antimetabolites|antimetabolites|mesh-ancestor
102492519|NCT04128020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102492520|NCT03827642|Naloxone|naloxone|mesh-list
102492521|NCT03827642|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102492522|NCT03827642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492523|NCT03827642|Sensory System Agents|sensory system agents|mesh-ancestor
101625203|NCT04218435|Valsartan|valsartan|mesh-list
102492524|NCT03827642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102492525|NCT05510310|Oxytocin|oxytocin|mesh-list
102492526|NCT05510310|Oxytocics|oxytocics|mesh-ancestor
102492527|NCT05510310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102492528|NCT05510310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492529|NCT00981227|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102492530|NCT00981227|Anticonvulsants|anticonvulsants|mesh-ancestor
102492531|NCT00981227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102492532|NCT00981227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102492533|NCT00981227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102492534|NCT00981227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492535|NCT01022567|Ertapenem|ertapenem|mesh-list
102492536|NCT01022567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102492537|NCT01022567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102492538|NCT04411524|Capecitabine|capecitabine|mesh-list
102492539|NCT04411524|Irinotecan|irinotecan|mesh-list
102492540|NCT04411524|Antibodies|antibodies|mesh-list
102492541|NCT04411524|Immunologic Factors|immunologic factors|mesh-ancestor
102492542|NCT04411524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492543|NCT04411524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102492544|NCT04411524|Antimetabolites|antimetabolites|mesh-ancestor
102492545|NCT04411524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492546|NCT04411524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102492547|NCT04411524|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102492548|NCT04411524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102492549|NCT04411524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102492550|NCT04127396|Sorafenib|sorafenib|mesh-list
102492551|NCT04127396|Lenvatinib|lenvatinib|mesh-list
102492552|NCT04127396|Chlorotrianisene|chlorotrianisene|mesh-list
102492553|NCT04127396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102492554|NCT04127396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102492555|NCT04127396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102492556|NCT04127396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492557|NCT04127396|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102492558|NCT04127396|Estrogens|estrogens|mesh-ancestor
102492559|NCT04127396|Hormones|hormones|mesh-ancestor
102492560|NCT04127396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102492561|NCT04127396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492562|NCT04127396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102492563|NCT04120064|Cholecalciferol|cholecalciferol|mesh-list
102492564|NCT04120064|Vitamin D|vitamin d|mesh-list
102492565|NCT04120064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102492566|NCT04120064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492567|NCT04120064|Vitamins|vitamins|mesh-ancestor
102492568|NCT04120064|Micronutrients|micronutrients|mesh-ancestor
102492569|NCT04120064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102492570|NCT00982007|Ferric Compounds|ferric compounds|mesh-list
102492571|NCT00982007|Hematinics|hematinics|mesh-ancestor
102492572|NCT04814940|Menotropins|menotropins|mesh-list
102492573|NCT04814940|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102492574|NCT04814940|Fertility Agents|fertility agents|mesh-ancestor
102492575|NCT04814940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102492576|NCT04814940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492577|NCT05042934|Irinotecan|irinotecan|mesh-list
102492578|NCT05042934|Camptothecin|camptothecin|mesh-list
102492579|NCT05042934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102492580|NCT05042934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102492581|NCT05042934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102492582|NCT05042934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492583|NCT05042934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102492584|NCT05042934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102492585|NCT05505006|Folic Acid|folic acid|mesh-list
102492586|NCT05505006|Vitamin B 12|vitamin b 12|mesh-list
102492587|NCT05505006|Hematinics|hematinics|mesh-ancestor
102492588|NCT05505006|Vitamin B Complex|vitamin b complex|mesh-ancestor
102492589|NCT05505006|Vitamins|vitamins|mesh-ancestor
102492590|NCT05505006|Micronutrients|micronutrients|mesh-ancestor
102492591|NCT05505006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492592|NCT03826706|Pyrithione zinc|pyrithione zinc|mesh-list
102492593|NCT03826706|Keratolytic Agents|keratolytic agents|mesh-ancestor
102492594|NCT03826706|Dermatologic Agents|dermatologic agents|mesh-ancestor
102492595|NCT02979548|Ondansetron|ondansetron|mesh-list
102492596|NCT02979548|Aprepitant|aprepitant|mesh-list
102492597|NCT02979548|Metoclopramide|metoclopramide|mesh-list
102492598|NCT02979548|Antiemetics|antiemetics|mesh-ancestor
102492599|NCT02979548|Autonomic Agents|autonomic agents|mesh-ancestor
102492600|NCT02979548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102492601|NCT02979548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492602|NCT02979548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102492603|NCT02979548|Antipruritics|antipruritics|mesh-ancestor
102492604|NCT02979548|Dermatologic Agents|dermatologic agents|mesh-ancestor
102492605|NCT02979548|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102492606|NCT02979548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102492607|NCT02979548|Serotonin Agents|serotonin agents|mesh-ancestor
102492608|NCT02979548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102492609|NCT02979548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492610|NCT02979548|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102492611|NCT02979548|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102492612|NCT02979548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102492613|NCT02979548|Dopamine Agents|dopamine agents|mesh-ancestor
102492614|NCT03821246|Atezolizumab|atezolizumab|mesh-list
102492615|NCT03821246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102492616|NCT03821246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102492617|NCT03821246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492618|NCT03821246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102492619|NCT03821246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102492620|NCT03821246|Immunologic Factors|immunologic factors|mesh-ancestor
102492621|NCT03821246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492622|NCT03826316|Nalbuphine|nalbuphine|mesh-list
102492623|NCT03826316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102492624|NCT03826316|Narcotics|narcotics|mesh-ancestor
102492625|NCT03826316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102492626|NCT03826316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492627|NCT03826316|Analgesics|analgesics|mesh-ancestor
102492628|NCT03826316|Sensory System Agents|sensory system agents|mesh-ancestor
102492629|NCT03826316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102492630|NCT04393610|Lidocaine|lidocaine|mesh-list
102492631|NCT04393610|Magnesium Sulfate|magnesium sulfate|mesh-list
102492632|NCT04393610|Fentanyl|fentanyl|mesh-list
102492633|NCT04393610|Anesthetics, Local|anesthetics, local|mesh-ancestor
102492634|NCT04393610|Anesthetics|anesthetics|mesh-ancestor
102492635|NCT04393610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102492636|NCT04393610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492637|NCT04393610|Sensory System Agents|sensory system agents|mesh-ancestor
102492638|NCT04393610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102492639|NCT04393610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102492640|NCT04393610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102492641|NCT04393610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102492642|NCT04393610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102492643|NCT04393610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492644|NCT04393610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102492645|NCT04393610|Narcotics|narcotics|mesh-ancestor
102492646|NCT04393610|Analgesics|analgesics|mesh-ancestor
102492647|NCT04393610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102492648|NCT04393610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102492649|NCT04393610|Anesthetics, General|anesthetics, general|mesh-ancestor
102492650|NCT04393610|Anticonvulsants|anticonvulsants|mesh-ancestor
102492651|NCT04393610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102492652|NCT04393610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102492653|NCT04393610|Tocolytic Agents|tocolytic agents|mesh-ancestor
102492654|NCT04393610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102492656|NCT03820466|Atorvastatin|atorvastatin|mesh-list
102492657|NCT03820466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102492658|NCT03820466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102492659|NCT03820466|Analgesics|analgesics|mesh-ancestor
102492660|NCT03820466|Sensory System Agents|sensory system agents|mesh-ancestor
102492661|NCT03820466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102492662|NCT03820466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492663|NCT03820466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102492664|NCT03820466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102492665|NCT03820466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102492666|NCT03820466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102492667|NCT03820466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492668|NCT03820466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102492669|NCT03820466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102492670|NCT03820466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102492671|NCT03820466|Antipyretics|antipyretics|mesh-ancestor
102492672|NCT03820466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102492673|NCT03820466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102492674|NCT03820466|Antimetabolites|antimetabolites|mesh-ancestor
102492675|NCT03820466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102492676|NCT03820466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102492677|NCT03826004|Clemastine|clemastine|mesh-list
102492678|NCT03826004|Antipruritics|antipruritics|mesh-ancestor
102492679|NCT03826004|Dermatologic Agents|dermatologic agents|mesh-ancestor
102492680|NCT03826004|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102492681|NCT03826004|Histamine Antagonists|histamine antagonists|mesh-ancestor
102492682|NCT03826004|Histamine Agents|histamine agents|mesh-ancestor
102492683|NCT03826004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102492684|NCT03826004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492685|NCT03826004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492686|NCT03826004|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102492687|NCT02338076|Petrolatum|petrolatum|mesh-list
102492688|NCT02338076|Emollients|emollients|mesh-ancestor
102492689|NCT02338076|Dermatologic Agents|dermatologic agents|mesh-ancestor
102492690|NCT02978534|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102492691|NCT02978534|Antidepressive Agents|antidepressive agents|mesh-ancestor
102492692|NCT02978534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102492693|NCT02978534|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102492694|NCT02978534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102492695|NCT02978534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102492696|NCT02978534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492697|NCT01222117|Plasminogen|plasminogen|mesh-list
102492698|NCT01222117|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102492699|NCT01222117|Fibrinolysin|fibrinolysin|mesh-list
102492700|NCT01222117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102492701|NCT01222117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102492702|NCT01222117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492703|NCT03825380|Bimatoprost|bimatoprost|mesh-list
102492704|NCT03825380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102492705|NCT01222195|Lenalidomide|lenalidomide|mesh-list
102492706|NCT01222195|Darbepoetin alfa|darbepoetin alfa|mesh-list
102492707|NCT01222195|Immunologic Factors|immunologic factors|mesh-ancestor
102492708|NCT01222195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492709|NCT01222195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102492710|NCT01222195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102492711|NCT01222195|Growth Substances|growth substances|mesh-ancestor
102492712|NCT01222195|Growth Inhibitors|growth inhibitors|mesh-ancestor
102492713|NCT01222195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102492714|NCT01222195|Hematinics|hematinics|mesh-ancestor
102492715|NCT01222273|Vitamin D|vitamin d|mesh-list
102492716|NCT01222273|Cholecalciferol|cholecalciferol|mesh-list
102492717|NCT01222273|Vitamins|vitamins|mesh-ancestor
102492718|NCT01222273|Micronutrients|micronutrients|mesh-ancestor
102492719|NCT01222273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492720|NCT01222273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102492721|NCT01222273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102492722|NCT03161912|Aflibercept|aflibercept|mesh-list
102492723|NCT03161912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102492724|NCT03161912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102492725|NCT03161912|Growth Substances|growth substances|mesh-ancestor
102492726|NCT03161912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492727|NCT03161912|Growth Inhibitors|growth inhibitors|mesh-ancestor
102492728|NCT03161912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102492729|NCT01222585|Metronidazole|metronidazole|mesh-list
102492730|NCT01222585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102492731|NCT01222585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102492732|NCT01222585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102492733|NCT01222585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102492734|NCT04126382|Pulmonary Surfactants|pulmonary surfactants|mesh-list
102492735|NCT04126382|Respiratory System Agents|respiratory system agents|mesh-ancestor
102492736|NCT03829592|Misoprostol|misoprostol|mesh-list
102492737|NCT03829592|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102492738|NCT03829592|Abortifacient Agents|abortifacient agents|mesh-ancestor
102492739|NCT03829592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102492740|NCT03829592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492741|NCT03829592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102492742|NCT03829592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102492743|NCT03829592|Oxytocics|oxytocics|mesh-ancestor
102492744|NCT01142323|Fenofibrate|fenofibrate|mesh-list
102492745|NCT01142323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102492746|NCT01142323|Antimetabolites|antimetabolites|mesh-ancestor
102492747|NCT01142323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492748|NCT01142323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102492749|NCT01142947|Beclomethasone|beclomethasone|mesh-list
102492750|NCT01142947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102492751|NCT01142947|Glucocorticoids|glucocorticoids|mesh-ancestor
102492752|NCT01142947|Hormones|hormones|mesh-ancestor
102492753|NCT01142947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102492754|NCT01142947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492755|NCT01142947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102492756|NCT01142947|Respiratory System Agents|respiratory system agents|mesh-ancestor
102492757|NCT02972294|Iron|iron|mesh-list
102492758|NCT02972294|Tranexamic Acid|tranexamic acid|mesh-list
102492759|NCT02972294|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
102492760|NCT02972294|Ferric Compounds|ferric compounds|mesh-list
102492761|NCT02972294|Trace Elements|trace elements|mesh-ancestor
102492762|NCT02972294|Micronutrients|micronutrients|mesh-ancestor
102492763|NCT02972294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492764|NCT02972294|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102492765|NCT02972294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102492766|NCT02972294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492767|NCT02972294|Hemostatics|hemostatics|mesh-ancestor
102492768|NCT02972294|Coagulants|coagulants|mesh-ancestor
102492769|NCT02972294|Hematinics|hematinics|mesh-ancestor
102492770|NCT02983214|Cilostazol|cilostazol|mesh-list
102492771|NCT02983214|Clopidogrel|clopidogrel|mesh-list
102492772|NCT02983214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102492773|NCT02983214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102492774|NCT02983214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102492775|NCT02983214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102492776|NCT02983214|Purinergic Agents|purinergic agents|mesh-ancestor
102492777|NCT02983214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102492778|NCT02983214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492779|NCT02983214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492780|NCT02983214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102492781|NCT02983214|Autonomic Agents|autonomic agents|mesh-ancestor
102492782|NCT02983214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102492783|NCT02983214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102492784|NCT02983214|Respiratory System Agents|respiratory system agents|mesh-ancestor
102492785|NCT02983214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102492786|NCT02983214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102492787|NCT02983214|Vasodilator Agents|vasodilator agents|mesh-ancestor
102492788|NCT02983214|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102492789|NCT02983214|Protective Agents|protective agents|mesh-ancestor
102492790|NCT02983214|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102492791|NCT02983214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102492792|NCT02983214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102492793|NCT03825068|Anesthetics|anesthetics|mesh-list
102492794|NCT03825068|Anesthetics, General|anesthetics, general|mesh-list
102492795|NCT03825068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102492796|NCT03825068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492797|NCT03824834|Morphine|morphine|mesh-list
102492798|NCT03824834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102492799|NCT03824834|Narcotics|narcotics|mesh-ancestor
102492800|NCT03824834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101625454|NCT02610556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102492801|NCT03824834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492802|NCT03824834|Analgesics|analgesics|mesh-ancestor
102492803|NCT03824834|Sensory System Agents|sensory system agents|mesh-ancestor
102492804|NCT03824834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102492805|NCT03829124|Ketamine|ketamine|mesh-list
102492806|NCT03829124|Propofol|propofol|mesh-list
102492807|NCT03829124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102492808|NCT03829124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102492809|NCT03829124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492810|NCT03829124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102492811|NCT03829124|Anesthetics, General|anesthetics, general|mesh-ancestor
102492812|NCT03829124|Anesthetics|anesthetics|mesh-ancestor
102492813|NCT03829124|Analgesics|analgesics|mesh-ancestor
102492814|NCT03829124|Sensory System Agents|sensory system agents|mesh-ancestor
102492815|NCT03829124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102492816|NCT03829124|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102492817|NCT03829124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102492818|NCT03829124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102492819|NCT03829124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102492820|NCT03829124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492821|NCT02965976|Botulinum Toxins|botulinum toxins|mesh-list
102492822|NCT02965976|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102492823|NCT02965976|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102492824|NCT02965976|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102492825|NCT02965976|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102492826|NCT02965976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102492827|NCT02965976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492828|NCT02965976|Cholinergic Agents|cholinergic agents|mesh-ancestor
102492829|NCT02965976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102492830|NCT02965976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492831|NCT02965976|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102492832|NCT02965976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102492833|NCT04393220|Bevacizumab|bevacizumab|mesh-list
102492834|NCT04393220|Nivolumab|nivolumab|mesh-list
102492835|NCT04393220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102492836|NCT04393220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102492837|NCT04393220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102492838|NCT04393220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102492839|NCT04393220|Growth Substances|growth substances|mesh-ancestor
102492840|NCT04393220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492841|NCT04393220|Growth Inhibitors|growth inhibitors|mesh-ancestor
102492842|NCT04393220|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102492843|NCT04393220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492844|NCT01025453|Sirolimus|sirolimus|mesh-list
102492845|NCT01025453|Sorafenib|sorafenib|mesh-list
102492846|NCT01025453|Temsirolimus|temsirolimus|mesh-list
102492847|NCT01025453|MTOR Inhibitors|mtor inhibitors|mesh-list
102492848|NCT01025453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102492849|NCT01025453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102492850|NCT01025453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102492851|NCT01025453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492852|NCT01025453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102492853|NCT01025453|Immunologic Factors|immunologic factors|mesh-ancestor
102492854|NCT01025453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492855|NCT01025453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102492856|NCT01025453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102492857|NCT01025453|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102492858|NCT01025453|Antifungal Agents|antifungal agents|mesh-ancestor
102492859|NCT05394233|Bevacizumab|bevacizumab|mesh-list
102492860|NCT05394233|Tislelizumab|tislelizumab|mesh-list
102492861|NCT05394233|Pemetrexed|pemetrexed|mesh-list
102492862|NCT05394233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102492863|NCT05394233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102492864|NCT05394233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102492865|NCT05394233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102492866|NCT05394233|Growth Substances|growth substances|mesh-ancestor
102492867|NCT05394233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492868|NCT05394233|Growth Inhibitors|growth inhibitors|mesh-ancestor
102492869|NCT05394233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102492870|NCT05394233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492871|NCT05394233|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102492872|NCT05394233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102492873|NCT03823976|Anesthetics|anesthetics|mesh-list
102492874|NCT03823976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102492875|NCT03823976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492876|NCT00982553|Ribavirin|ribavirin|mesh-list
102492877|NCT00982553|Raltegravir Potassium|raltegravir potassium|mesh-list
102492878|NCT00982553|Antimetabolites|antimetabolites|mesh-ancestor
102492879|NCT00982553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492880|NCT00982553|Antiviral Agents|antiviral agents|mesh-ancestor
102492881|NCT00982553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102492882|NCT00982553|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102492883|NCT00982553|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102492884|NCT00982553|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102492885|NCT00982553|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102492886|NCT00982553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102492887|NCT02943590|Atorvastatin|atorvastatin|mesh-list
102492888|NCT02943590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102492889|NCT02943590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102492890|NCT02943590|Antimetabolites|antimetabolites|mesh-ancestor
102492891|NCT02943590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492892|NCT02943590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102492893|NCT02943590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102492894|NCT02943590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102492895|NCT02939300|Nivolumab|nivolumab|mesh-list
102492896|NCT02939300|Ipilimumab|ipilimumab|mesh-list
102492897|NCT02939300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102492898|NCT02939300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102492899|NCT02939300|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102492900|NCT02939300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492901|NCT04392128|Azithromycin|azithromycin|mesh-list
102492902|NCT04392128|Hydroxychloroquine|hydroxychloroquine|mesh-list
102492903|NCT04392128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102492904|NCT04392128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102492905|NCT04392128|Antimalarials|antimalarials|mesh-ancestor
102492906|NCT04392128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102492907|NCT04392128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102492908|NCT04392128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102492909|NCT04392128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492910|NCT04392128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102492911|NCT02891954|Canagliflozin|canagliflozin|mesh-list
102492912|NCT02891954|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102492913|NCT02891954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492914|NCT02891954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102492915|NCT02891954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492916|NCT02565186|Lasmiditan|lasmiditan|mesh-list
102492917|NCT02565186|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102492918|NCT02565186|Serotonin Agents|serotonin agents|mesh-ancestor
102492919|NCT02565186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102492920|NCT02565186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492921|NCT02565186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492922|NCT04694586|Rifampin|rifampin|mesh-list
102492923|NCT04694586|Isoniazid|isoniazid|mesh-list
102492924|NCT04694586|Pyrazinamide|pyrazinamide|mesh-list
102492925|NCT04694586|Ethambutol|ethambutol|mesh-list
102492926|NCT04694586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102492927|NCT04694586|Antitubercular Agents|antitubercular agents|mesh-ancestor
102492928|NCT04694586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102492929|NCT04694586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102492930|NCT04694586|Leprostatic Agents|leprostatic agents|mesh-ancestor
102492931|NCT04694586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102492932|NCT04694586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102492933|NCT04694586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492934|NCT04694586|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102492935|NCT04694586|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102492936|NCT04694586|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102492937|NCT04694586|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102492938|NCT04694586|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102492939|NCT04694586|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102492940|NCT04694586|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102492941|NCT04694586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102492942|NCT04694586|Antimetabolites|antimetabolites|mesh-ancestor
102492943|NCT04694586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102492944|NCT04274816|Tremelimumab|tremelimumab|mesh-list
102492945|NCT04274816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102492946|NCT05509374|Dexamethasone|dexamethasone|mesh-list
102492947|NCT05509374|Pomalidomide|pomalidomide|mesh-list
102492948|NCT05509374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102492949|NCT05509374|Antiemetics|antiemetics|mesh-ancestor
102492950|NCT05509374|Autonomic Agents|autonomic agents|mesh-ancestor
102492951|NCT05509374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102492952|NCT05509374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492953|NCT05509374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102492954|NCT05509374|Glucocorticoids|glucocorticoids|mesh-ancestor
102492955|NCT05509374|Hormones|hormones|mesh-ancestor
102492956|NCT05509374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102492957|NCT05509374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102492958|NCT05509374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102492959|NCT05509374|Immunologic Factors|immunologic factors|mesh-ancestor
102492960|NCT05509374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102492961|NCT05509374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102492962|NCT05509374|Growth Substances|growth substances|mesh-ancestor
102492963|NCT05509374|Growth Inhibitors|growth inhibitors|mesh-ancestor
102492964|NCT04124822|Prednisolone|prednisolone|mesh-list
102492965|NCT04124822|Piroxicam|piroxicam|mesh-list
102492966|NCT04124822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102492967|NCT04124822|Glucocorticoids|glucocorticoids|mesh-ancestor
102492968|NCT04124822|Hormones|hormones|mesh-ancestor
102492969|NCT04124822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102492970|NCT04124822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492971|NCT04124822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102492972|NCT04124822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102492973|NCT04124822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102492974|NCT04124822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102492975|NCT04124822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102492976|NCT04124822|Analgesics|analgesics|mesh-ancestor
102492977|NCT04124822|Sensory System Agents|sensory system agents|mesh-ancestor
102492978|NCT04124822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102492979|NCT04124822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102492980|NCT04124822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102492981|NCT04124822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492982|NCT05504694|Ofatumumab|ofatumumab|mesh-list
102492983|NCT05504694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102492984|NCT02854670|Capsaicin|capsaicin|mesh-list
102492985|NCT02854670|Antipruritics|antipruritics|mesh-ancestor
102492986|NCT02854670|Dermatologic Agents|dermatologic agents|mesh-ancestor
102492987|NCT02854670|Sensory System Agents|sensory system agents|mesh-ancestor
102492988|NCT02854670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102492989|NCT02854670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102492990|NCT02937272|Paclitaxel|paclitaxel|mesh-list
102492991|NCT02937272|Gemcitabine|gemcitabine|mesh-list
102492992|NCT02937272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102492993|NCT02937272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102492994|NCT02937272|Tubulin Modulators|tubulin modulators|mesh-ancestor
102492995|NCT02937272|Antimitotic Agents|antimitotic agents|mesh-ancestor
102492996|NCT02937272|Mitosis Modulators|mitosis modulators|mesh-ancestor
102492997|NCT02937272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102492998|NCT02937272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102492999|NCT02937272|Antimetabolites|antimetabolites|mesh-ancestor
102493000|NCT03519308|Paclitaxel|paclitaxel|mesh-list
102493001|NCT03519308|Gemcitabine|gemcitabine|mesh-list
102493002|NCT03519308|Nivolumab|nivolumab|mesh-list
102493003|NCT03519308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102493004|NCT03519308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102493005|NCT03519308|Tubulin Modulators|tubulin modulators|mesh-ancestor
102493006|NCT03519308|Antimitotic Agents|antimitotic agents|mesh-ancestor
102493007|NCT03519308|Mitosis Modulators|mitosis modulators|mesh-ancestor
102493008|NCT03519308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493009|NCT03519308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102493010|NCT03519308|Antimetabolites|antimetabolites|mesh-ancestor
102493011|NCT03519308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102304608|NCT01900444|Vaccines|vaccines|mesh-list
102493012|NCT03519308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102493013|NCT03821714|Vitamins|vitamins|mesh-list
102493014|NCT03821714|Hydrocortisone|hydrocortisone|mesh-list
102493015|NCT03821714|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102493016|NCT03821714|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102493017|NCT03821714|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102493018|NCT03821714|Glucocorticoids|glucocorticoids|mesh-list
102493019|NCT03821714|Micronutrients|micronutrients|mesh-ancestor
102493020|NCT03821714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493021|NCT03821714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102493022|NCT03821714|Hormones|hormones|mesh-ancestor
102493023|NCT03821714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102493024|NCT02565108|Cannabidiol|cannabidiol|mesh-list
102493025|NCT02565108|Clobazam|clobazam|mesh-list
102493026|NCT02565108|Anticonvulsants|anticonvulsants|mesh-ancestor
102493027|NCT02565108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102493028|NCT02565108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102493029|NCT02565108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102493030|NCT02565108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493031|NCT02565108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102493032|NCT02565108|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102493033|NCT02565108|GABA Agonists|gaba agonists|mesh-ancestor
102493034|NCT02565108|GABA Agents|gaba agents|mesh-ancestor
102493035|NCT02565108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102493036|NCT02565108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493037|NCT03821168|Bevacizumab|bevacizumab|mesh-list
102493038|NCT03821168|Epoetin Alfa|epoetin alfa|mesh-list
102493039|NCT03821168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102493040|NCT03821168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102493041|NCT03821168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102493042|NCT03821168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102493043|NCT03821168|Growth Substances|growth substances|mesh-ancestor
102493044|NCT03821168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493045|NCT03821168|Growth Inhibitors|growth inhibitors|mesh-ancestor
102493046|NCT03821168|Hematinics|hematinics|mesh-ancestor
102493047|NCT01454180|Leucovorin|leucovorin|mesh-list
102493048|NCT01454180|Gemcitabine|gemcitabine|mesh-list
102493049|NCT01454180|Capecitabine|capecitabine|mesh-list
102493050|NCT01454180|Fluorouracil|fluorouracil|mesh-list
102493051|NCT01454180|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102493052|NCT01454180|Oxaliplatin|oxaliplatin|mesh-list
102493053|NCT01454180|Folfirinox|folfirinox|mesh-list
102493054|NCT01454180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102493055|NCT01454180|Antimetabolites|antimetabolites|mesh-ancestor
102493056|NCT01454180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493057|NCT01454180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102493058|NCT01454180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102493059|NCT01454180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102493060|NCT01454180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102493061|NCT01454180|Immunologic Factors|immunologic factors|mesh-ancestor
102493062|NCT01454180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493063|NCT01454180|Antidotes|antidotes|mesh-ancestor
102493064|NCT01454180|Protective Agents|protective agents|mesh-ancestor
102493065|NCT01454180|Vitamin B Complex|vitamin b complex|mesh-ancestor
102493066|NCT01454180|Vitamins|vitamins|mesh-ancestor
102493067|NCT01454180|Micronutrients|micronutrients|mesh-ancestor
102493068|NCT02564952|Cannabidiol|cannabidiol|mesh-list
102493069|NCT02564952|Clobazam|clobazam|mesh-list
102493070|NCT02564952|Anticonvulsants|anticonvulsants|mesh-ancestor
102493071|NCT02564952|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102493072|NCT02564952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102493073|NCT02564952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102493074|NCT02564952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493075|NCT02564952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101625736|NCT00734929|Hormones|hormones|mesh-ancestor
102493076|NCT02564952|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102493077|NCT02564952|GABA Agonists|gaba agonists|mesh-ancestor
102493078|NCT02564952|GABA Agents|gaba agents|mesh-ancestor
102493079|NCT02564952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102493080|NCT02564952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493081|NCT05564286|Dexamethasone|dexamethasone|mesh-list
102493082|NCT05564286|Fosaprepitant|fosaprepitant|mesh-list
102493083|NCT05564286|Aprepitant|aprepitant|mesh-list
102493084|NCT05564286|Tropisetron|tropisetron|mesh-list
102493085|NCT05564286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102493086|NCT05564286|Antiemetics|antiemetics|mesh-ancestor
102493087|NCT05564286|Autonomic Agents|autonomic agents|mesh-ancestor
102493088|NCT05564286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102493089|NCT05564286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493090|NCT05564286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102493092|NCT05564286|Hormones|hormones|mesh-ancestor
102493093|NCT05564286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102493094|NCT05564286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102493095|NCT05564286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102493096|NCT05564286|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102493097|NCT05564286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102493098|NCT05564286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493099|NCT05564286|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102493100|NCT05564286|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102493101|NCT05564286|Serotonin Agents|serotonin agents|mesh-ancestor
102493102|NCT01454804|Trastuzumab|trastuzumab|mesh-list
102493103|NCT01454804|Lapatinib|lapatinib|mesh-list
102493104|NCT01454804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102493105|NCT01454804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102493106|NCT01454804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102493107|NCT01454804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102493108|NCT01454804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493109|NCT03820622|Paclitaxel|paclitaxel|mesh-list
102493110|NCT03820622|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102493111|NCT03820622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102493112|NCT03820622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102493113|NCT03820622|Tubulin Modulators|tubulin modulators|mesh-ancestor
102493114|NCT03820622|Antimitotic Agents|antimitotic agents|mesh-ancestor
102493115|NCT03820622|Mitosis Modulators|mitosis modulators|mesh-ancestor
102493116|NCT03820622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493117|NCT05504382|Naproxen|naproxen|mesh-list
102493118|NCT05504382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102493119|NCT05504382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102493120|NCT05504382|Analgesics|analgesics|mesh-ancestor
102493121|NCT05504382|Sensory System Agents|sensory system agents|mesh-ancestor
102493122|NCT05504382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102493123|NCT05504382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493124|NCT05504382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102493125|NCT05504382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102493126|NCT05504382|Gout Suppressants|gout suppressants|mesh-ancestor
102493127|NCT05504382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102493128|NCT05504382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102493129|NCT05504382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493130|NCT03823040|Oxiconazole|oxiconazole|mesh-list
102493131|NCT03823040|Antifungal Agents|antifungal agents|mesh-ancestor
102493132|NCT03823040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102493133|NCT02566902|Albuterol|albuterol|mesh-list
102493134|NCT02566902|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102493135|NCT02566902|Autonomic Agents|autonomic agents|mesh-ancestor
102493136|NCT02566902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102493137|NCT02566902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493138|NCT02566902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102493139|NCT02566902|Respiratory System Agents|respiratory system agents|mesh-ancestor
102493140|NCT02566902|Tocolytic Agents|tocolytic agents|mesh-ancestor
102493141|NCT02566902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102493142|NCT02566902|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102493143|NCT02566902|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102493144|NCT02566902|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102493145|NCT02566902|Adrenergic Agents|adrenergic agents|mesh-ancestor
102493146|NCT02566902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102493147|NCT02566902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493148|NCT05508516|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102493149|NCT05508516|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102493150|NCT05508516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102493151|NCT05508516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102493152|NCT05508516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493153|NCT05508516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102493154|NCT05508516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493155|NCT05508516|Analgesics|analgesics|mesh-ancestor
102493156|NCT05508516|Sensory System Agents|sensory system agents|mesh-ancestor
102493157|NCT05508516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102493158|NCT05508516|Antidepressive Agents|antidepressive agents|mesh-ancestor
102493159|NCT05508516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102493160|NCT05508516|Dopamine Agents|dopamine agents|mesh-ancestor
102493161|NCT02902484|Nintedanib|nintedanib|mesh-list
102493162|NCT02902484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102493163|NCT02902484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102493164|NCT02902484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102493165|NCT02902484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493166|NCT01455506|Fludarabine|fludarabine|mesh-list
102493167|NCT01455506|Busulfan|busulfan|mesh-list
102493168|NCT01455506|Decitabine|decitabine|mesh-list
102493169|NCT01455506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102493170|NCT01455506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102493171|NCT01455506|Antimetabolites|antimetabolites|mesh-ancestor
102493172|NCT01455506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493173|NCT01455506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102493174|NCT01455506|Immunologic Factors|immunologic factors|mesh-ancestor
102493175|NCT01455506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493176|NCT01455506|Alkylating Agents|alkylating agents|mesh-ancestor
102493177|NCT01455506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102493178|NCT01455506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102493179|NCT01455506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102493180|NCT02564796|Iron|iron|mesh-list
102493181|NCT02564796|Epoetin Alfa|epoetin alfa|mesh-list
102493182|NCT02564796|Trace Elements|trace elements|mesh-ancestor
102493183|NCT02564796|Micronutrients|micronutrients|mesh-ancestor
102493184|NCT02564796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493185|NCT02564796|Hematinics|hematinics|mesh-ancestor
102493186|NCT05563350|Midazolam|midazolam|mesh-list
102493187|NCT05563350|Omeprazole|omeprazole|mesh-list
102493188|NCT05563350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101625863|NCT00734149|Alkylating Agents|alkylating agents|mesh-ancestor
102493189|NCT05563350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102493190|NCT05563350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102493191|NCT05563350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493192|NCT05563350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102493193|NCT05563350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102493194|NCT05563350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102493195|NCT05563350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102493196|NCT05563350|Anesthetics, General|anesthetics, general|mesh-ancestor
102493197|NCT05563350|Anesthetics|anesthetics|mesh-ancestor
102493198|NCT05563350|GABA Modulators|gaba modulators|mesh-ancestor
102493199|NCT05563350|GABA Agents|gaba agents|mesh-ancestor
102493200|NCT05563350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102493201|NCT05563350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493202|NCT05563350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102493203|NCT05563350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102493204|NCT05563350|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102493205|NCT05563350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102493206|NCT04273100|Lenvatinib|lenvatinib|mesh-list
102493207|NCT04273100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102493208|NCT04273100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102493209|NCT04273100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102493210|NCT04273100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493211|NCT02564718|Rivaroxaban|rivaroxaban|mesh-list
102493212|NCT02564718|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102493213|NCT02564718|Antithrombins|antithrombins|mesh-ancestor
102493214|NCT02564718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102493215|NCT02564718|Protease Inhibitors|protease inhibitors|mesh-ancestor
102493216|NCT02564718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102493217|NCT02564718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493218|NCT02564718|Anticoagulants|anticoagulants|mesh-ancestor
102493219|NCT01453946|Budesonide|budesonide|mesh-list
102493220|NCT01453946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102493221|NCT01453946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102493222|NCT01453946|Autonomic Agents|autonomic agents|mesh-ancestor
102493223|NCT01453946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102493224|NCT01453946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493225|NCT01453946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102493226|NCT01453946|Respiratory System Agents|respiratory system agents|mesh-ancestor
102493227|NCT01453946|Glucocorticoids|glucocorticoids|mesh-ancestor
102493228|NCT01453946|Hormones|hormones|mesh-ancestor
102493229|NCT01453946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102493230|NCT01455896|Exenatide|exenatide|mesh-list
102493231|NCT01455896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102493232|NCT01455896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493233|NCT01455896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102493234|NCT01455896|Incretins|incretins|mesh-ancestor
102493235|NCT01455896|Hormones|hormones|mesh-ancestor
102493236|NCT01455896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102493237|NCT05562882|Daratumumab|daratumumab|mesh-list
102493238|NCT05562882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102493239|NCT05560542|Dexamethasone|dexamethasone|mesh-list
102493240|NCT05560542|Atropine|atropine|mesh-list
102493241|NCT05560542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102493243|NCT05560542|Autonomic Agents|autonomic agents|mesh-ancestor
102493244|NCT05560542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102493245|NCT05560542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493246|NCT05560542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102493247|NCT05560542|Glucocorticoids|glucocorticoids|mesh-ancestor
102493248|NCT05560542|Hormones|hormones|mesh-ancestor
102493249|NCT05560542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102493250|NCT05560542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102493251|NCT05560542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102493252|NCT05560542|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102493253|NCT05560542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102493254|NCT05560542|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102493255|NCT05560542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102493256|NCT05560542|Respiratory System Agents|respiratory system agents|mesh-ancestor
102493257|NCT05560542|Mydriatics|mydriatics|mesh-ancestor
102493258|NCT05560542|Parasympatholytics|parasympatholytics|mesh-ancestor
102493259|NCT05560542|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102493260|NCT05560542|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102493261|NCT05560542|Cholinergic Agents|cholinergic agents|mesh-ancestor
102493262|NCT05560542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102493263|NCT05560542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493264|NCT01455974|Dialysis Solutions|dialysis solutions|mesh-list
102493265|NCT01455974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102493266|NCT05560308|Trastuzumab|trastuzumab|mesh-list
102493267|NCT05560308|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102493268|NCT05560308|Maytansine|maytansine|mesh-list
102493269|NCT05560308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102493270|NCT05560308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102493271|NCT05560308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493272|NCT05560308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102493273|NCT05560308|Tubulin Modulators|tubulin modulators|mesh-ancestor
102493274|NCT05560308|Antimitotic Agents|antimitotic agents|mesh-ancestor
102493275|NCT05560308|Mitosis Modulators|mitosis modulators|mesh-ancestor
102493276|NCT05560308|Immunotoxins|immunotoxins|mesh-ancestor
102493277|NCT05560308|Immunoconjugates|immunoconjugates|mesh-ancestor
102493278|NCT05560308|Immunologic Factors|immunologic factors|mesh-ancestor
102493279|NCT05560308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493280|NCT01456208|Norepinephrine|norepinephrine|mesh-list
102493281|NCT01456208|Angiotensin II|angiotensin ii|mesh-list
102493282|NCT01456208|Giapreza|giapreza|mesh-list
102493283|NCT01456208|Angiotensinogen|angiotensinogen|mesh-list
102493284|NCT01456208|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102493285|NCT01456208|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102493286|NCT01456208|Adrenergic Agents|adrenergic agents|mesh-ancestor
102493287|NCT01456208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102493288|NCT01456208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493289|NCT01456208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493290|NCT01456208|Sympathomimetics|sympathomimetics|mesh-ancestor
102493291|NCT01456208|Autonomic Agents|autonomic agents|mesh-ancestor
102493292|NCT01456208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102493293|NCT01456208|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102493294|NCT01456208|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102493295|NCT01456208|Protease Inhibitors|protease inhibitors|mesh-ancestor
102493296|NCT01456208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102493297|NCT05436522|Propofol|propofol|mesh-list
102493298|NCT05436522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102493299|NCT05436522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102493300|NCT05436522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493301|NCT05436522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102493302|NCT05436522|Anesthetics, General|anesthetics, general|mesh-ancestor
102493303|NCT05436522|Anesthetics|anesthetics|mesh-ancestor
102493304|NCT03780010|Paclitaxel|paclitaxel|mesh-list
102493305|NCT03780010|Carboplatin|carboplatin|mesh-list
102493306|NCT03780010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102493307|NCT03780010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102493308|NCT03780010|Tubulin Modulators|tubulin modulators|mesh-ancestor
102493309|NCT03780010|Antimitotic Agents|antimitotic agents|mesh-ancestor
102493310|NCT03780010|Mitosis Modulators|mitosis modulators|mesh-ancestor
102493311|NCT03780010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493312|NCT03826550|Diclofenac|diclofenac|mesh-list
102493313|NCT03826550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102493314|NCT03826550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102493315|NCT03826550|Analgesics|analgesics|mesh-ancestor
102304905|NCT02472977|Nivolumab|nivolumab|mesh-list
102493316|NCT03826550|Sensory System Agents|sensory system agents|mesh-ancestor
102493317|NCT03826550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102493318|NCT03826550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493319|NCT03826550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102493320|NCT03826550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102493321|NCT03826550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102493322|NCT03826550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102493323|NCT03826550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493324|NCT03827018|Prednisone|prednisone|mesh-list
102493325|NCT03827018|Mavrilimumab|mavrilimumab|mesh-list
102493326|NCT03827018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102493327|NCT03827018|Glucocorticoids|glucocorticoids|mesh-ancestor
102493328|NCT03827018|Hormones|hormones|mesh-ancestor
102493329|NCT03827018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102493330|NCT03827018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493331|NCT03827018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102493332|NCT03827018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102493333|NCT03827018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102493334|NCT05325762|Dexmedetomidine|dexmedetomidine|mesh-list
102493335|NCT05325762|Propofol|propofol|mesh-list
102493336|NCT05325762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102493337|NCT05325762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102493338|NCT05325762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493339|NCT05325762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102493340|NCT05325762|Analgesics|analgesics|mesh-ancestor
102493341|NCT05325762|Sensory System Agents|sensory system agents|mesh-ancestor
102493342|NCT05325762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102493343|NCT05325762|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102493344|NCT05325762|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102493345|NCT05325762|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102493346|NCT05325762|Adrenergic Agents|adrenergic agents|mesh-ancestor
102493347|NCT05325762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102493348|NCT05325762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493349|NCT05325762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102493350|NCT05325762|Anesthetics, General|anesthetics, general|mesh-ancestor
102493351|NCT05325762|Anesthetics|anesthetics|mesh-ancestor
102493352|NCT04391582|Sulfadiazine|sulfadiazine|mesh-list
102493353|NCT04391582|Silver Sulfadiazine|silver sulfadiazine|mesh-list
102493354|NCT04391582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102493355|NCT04391582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102493356|NCT04391582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102493357|NCT04391582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102493358|NCT04391582|Coccidiostats|coccidiostats|mesh-ancestor
102493359|NCT04391582|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102493360|NCT05498064|Ensartinib|ensartinib|mesh-list
102493361|NCT05498064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102493362|NCT05498064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102493363|NCT05498064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102493364|NCT05498064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493365|NCT03767062|Topiramate|topiramate|mesh-list
102493366|NCT03767062|Anticonvulsants|anticonvulsants|mesh-ancestor
102493367|NCT03767062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102493368|NCT03767062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493369|NCT01456364|Ticagrelor|ticagrelor|mesh-list
102493370|NCT01456364|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102493371|NCT01456364|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102493372|NCT01456364|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102493373|NCT01456364|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102493374|NCT01456364|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102493375|NCT01456364|Purinergic Agents|purinergic agents|mesh-ancestor
102493376|NCT01456364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102493377|NCT01456364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493378|NCT01456364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493379|NCT04281420|Niacin|niacin|mesh-list
102493380|NCT04281420|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102493381|NCT04281420|Antimetabolites|antimetabolites|mesh-ancestor
102133723|NCT02295189|Sensory System Agents|sensory system agents|mesh-ancestor
102493382|NCT04281420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493383|NCT04281420|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102493384|NCT04281420|Vasodilator Agents|vasodilator agents|mesh-ancestor
102493385|NCT04281420|Vitamin B Complex|vitamin b complex|mesh-ancestor
102493386|NCT04281420|Vitamins|vitamins|mesh-ancestor
102493387|NCT04281420|Micronutrients|micronutrients|mesh-ancestor
102493388|NCT04281420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493389|NCT03765502|Glucagon|glucagon|mesh-list
102493390|NCT03765502|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102304982|NCT01860040|Pemetrexed|pemetrexed|mesh-list
102493391|NCT03765502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102493392|NCT03765502|Hormones|hormones|mesh-ancestor
102493393|NCT03765502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102493394|NCT03765502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493395|NCT03765502|Incretins|incretins|mesh-ancestor
102493396|NCT04447716|Rituximab|rituximab|mesh-list
102493397|NCT04447716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102493398|NCT04447716|Lenalidomide|lenalidomide|mesh-list
102493399|NCT04447716|Venetoclax|venetoclax|mesh-list
102493400|NCT04447716|Piperidine|piperidine|mesh-list
102493401|NCT04447716|Antibodies|antibodies|mesh-list
102493402|NCT04447716|Immunoglobulins|immunoglobulins|mesh-list
102493403|NCT04447716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102493404|NCT04447716|Immunologic Factors|immunologic factors|mesh-ancestor
102493405|NCT04447716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493406|NCT04447716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102493407|NCT04447716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102493408|NCT04447716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102493409|NCT04447716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102493410|NCT04447716|Growth Substances|growth substances|mesh-ancestor
102493411|NCT04447716|Growth Inhibitors|growth inhibitors|mesh-ancestor
102493412|NCT04447716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493413|NCT04447716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102493414|NCT04447716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102493415|NCT04447716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102493416|NCT05285124|Melatonin|melatonin|mesh-list
102493417|NCT05285124|Antioxidants|antioxidants|mesh-ancestor
102493418|NCT05285124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493419|NCT05285124|Protective Agents|protective agents|mesh-ancestor
102493420|NCT05285124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493421|NCT05285124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102493422|NCT01450046|Vitamin E|vitamin e|mesh-list
102493423|NCT01450046|Tocopherols|tocopherols|mesh-list
102493424|NCT01450046|Tocotrienols|tocotrienols|mesh-list
102493425|NCT01450046|Vitamins|vitamins|mesh-ancestor
102493426|NCT01450046|Micronutrients|micronutrients|mesh-ancestor
102493427|NCT01450046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493428|NCT01450046|Antioxidants|antioxidants|mesh-ancestor
102493429|NCT01450046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493430|NCT01450046|Protective Agents|protective agents|mesh-ancestor
102493431|NCT05497596|Vitamin D|vitamin d|mesh-list
102493432|NCT05497596|Vitamins|vitamins|mesh-ancestor
102493433|NCT05497596|Micronutrients|micronutrients|mesh-ancestor
102493434|NCT05497596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493435|NCT05497596|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102493436|NCT01450124|Boswellic acid|boswellic acid|mesh-list
102493437|NCT01450124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102493438|NCT01450124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102493439|NCT01450124|Analgesics|analgesics|mesh-ancestor
102493440|NCT01450124|Sensory System Agents|sensory system agents|mesh-ancestor
102493441|NCT01450124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102493442|NCT01450124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493443|NCT01450124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102493444|NCT01450124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102493445|NCT03751124|Norethindrone|norethindrone|mesh-list
102493446|NCT03751124|Norethindrone Acetate|norethindrone acetate|mesh-list
102493447|NCT03751124|Estradiol|estradiol|mesh-list
102493448|NCT03751124|Relugolix|relugolix|mesh-list
102493449|NCT03751124|Estrogens|estrogens|mesh-ancestor
102493450|NCT03751124|Hormones|hormones|mesh-ancestor
102493451|NCT03751124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102493452|NCT03751124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493453|NCT03751124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102493454|NCT03751124|Contraceptive Agents|contraceptive agents|mesh-ancestor
102493455|NCT03751124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102493456|NCT03751124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102493457|NCT03751124|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102493458|NCT03751124|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102493459|NCT03751124|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102493460|NCT03751124|Androgen Antagonists|androgen antagonists|mesh-ancestor
102493461|NCT03751124|Hormone Antagonists|hormone antagonists|mesh-ancestor
102493462|NCT02563548|Pembrolizumab|pembrolizumab|mesh-list
102493463|NCT02563548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102305058|NCT01896232|Cinacalcet|cinacalcet|mesh-list
102493464|NCT02563548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102493465|NCT02563548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102493466|NCT02563548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493467|NCT01450358|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102493468|NCT01450358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102493469|NCT04081324|Lasmiditan|lasmiditan|mesh-list
102493470|NCT04081324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102493471|NCT04081324|Serotonin Agents|serotonin agents|mesh-ancestor
102493472|NCT04081324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102493473|NCT04081324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493474|NCT04081324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493475|NCT04042324|Heparin|heparin|mesh-list
102493476|NCT04042324|Calcium heparin|calcium heparin|mesh-list
102493477|NCT04042324|Anticoagulants|anticoagulants|mesh-ancestor
102493478|NCT04042324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493479|NCT04042324|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102493480|NCT04042324|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102493481|NCT04391660|Ethanol|ethanol|mesh-list
102493482|NCT04391660|Sodium Hypochlorite|sodium hypochlorite|mesh-list
102493484|NCT04391660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102493485|NCT04391660|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102493486|NCT04391660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102493487|NCT04391660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102493488|NCT04391660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493489|NCT04391660|Disinfectants|disinfectants|mesh-ancestor
102493490|NCT04842422|Imiquimod|imiquimod|mesh-list
102493491|NCT04842422|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102493492|NCT04842422|Immunologic Factors|immunologic factors|mesh-ancestor
102493493|NCT04842422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493494|NCT04842422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102493495|NCT04842422|Interferon Inducers|interferon inducers|mesh-ancestor
102493496|NCT04066426|Acetaminophen|acetaminophen|mesh-list
102493497|NCT04066426|Dexamethasone|dexamethasone|mesh-list
102493498|NCT04066426|Naproxen|naproxen|mesh-list
102493499|NCT04066426|Codeine|codeine|mesh-list
102493500|NCT04066426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102493501|NCT04066426|Antiemetics|antiemetics|mesh-ancestor
102493502|NCT04066426|Autonomic Agents|autonomic agents|mesh-ancestor
102493503|NCT04066426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102493504|NCT04066426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493505|NCT04066426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102493506|NCT04066426|Glucocorticoids|glucocorticoids|mesh-ancestor
102493507|NCT04066426|Hormones|hormones|mesh-ancestor
102493508|NCT04066426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102493509|NCT04066426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102493510|NCT04066426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102493511|NCT04066426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102493512|NCT04066426|Analgesics|analgesics|mesh-ancestor
102493513|NCT04066426|Sensory System Agents|sensory system agents|mesh-ancestor
102493514|NCT04066426|Antipyretics|antipyretics|mesh-ancestor
102493515|NCT04066426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102493516|NCT04066426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102493517|NCT04066426|Gout Suppressants|gout suppressants|mesh-ancestor
102493518|NCT04066426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102493519|NCT04066426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102493520|NCT04066426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493521|NCT04066426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102493522|NCT04066426|Narcotics|narcotics|mesh-ancestor
102493523|NCT04066426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102493524|NCT04066426|Antitussive Agents|antitussive agents|mesh-ancestor
102493525|NCT04066426|Respiratory System Agents|respiratory system agents|mesh-ancestor
102493526|NCT01450514|Pipamperone|pipamperone|mesh-list
102493527|NCT01450514|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102493528|NCT01450514|Serotonin Agents|serotonin agents|mesh-ancestor
102493529|NCT01450514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102493530|NCT01450514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493531|NCT01450514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493532|NCT01450514|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102493533|NCT01450514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102493534|NCT01450514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102493535|NCT01450514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102493536|NCT04758728|Epinephrine|epinephrine|mesh-list
102493537|NCT04758728|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102493538|NCT04758728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102493539|NCT04758728|Adrenergic Agents|adrenergic agents|mesh-ancestor
102493540|NCT04758728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102493541|NCT04758728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493542|NCT04758728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493543|NCT04758728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102493544|NCT04758728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102493545|NCT04758728|Autonomic Agents|autonomic agents|mesh-ancestor
102493546|NCT04758728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102493547|NCT04758728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102493548|NCT04758728|Respiratory System Agents|respiratory system agents|mesh-ancestor
102493549|NCT04758728|Mydriatics|mydriatics|mesh-ancestor
102493550|NCT04758728|Sympathomimetics|sympathomimetics|mesh-ancestor
102493551|NCT04758728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102493552|NCT02559570|Linaclotide|linaclotide|mesh-list
102493553|NCT02559570|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102493554|NCT02559570|Enzyme Activators|enzyme activators|mesh-ancestor
102493555|NCT02559570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493556|NCT02559570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102493557|NCT04051684|Ropivacaine|ropivacaine|mesh-list
102493558|NCT04051684|Anesthetics, Local|anesthetics, local|mesh-ancestor
102493559|NCT04051684|Anesthetics|anesthetics|mesh-ancestor
102493560|NCT04051684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102493561|NCT04051684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493562|NCT04051684|Sensory System Agents|sensory system agents|mesh-ancestor
102493563|NCT04051684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102493564|NCT04840862|Rifabutin|rifabutin|mesh-list
102493565|NCT04840862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102493566|NCT04840862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102493567|NCT04840862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102493568|NCT04840862|Antitubercular Agents|antitubercular agents|mesh-ancestor
102493569|NCT04840238|Cholecalciferol|cholecalciferol|mesh-list
102493570|NCT04840238|Vitamin D|vitamin d|mesh-list
102493571|NCT04840238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102493572|NCT04840238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493573|NCT04840238|Vitamins|vitamins|mesh-ancestor
102493574|NCT04840238|Micronutrients|micronutrients|mesh-ancestor
102493575|NCT04840238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102493576|NCT03829618|Lidocaine|lidocaine|mesh-list
102493577|NCT03829618|Anesthetics, Local|anesthetics, local|mesh-ancestor
102493578|NCT03829618|Anesthetics|anesthetics|mesh-ancestor
102493579|NCT03829618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102493580|NCT03829618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493581|NCT03829618|Sensory System Agents|sensory system agents|mesh-ancestor
102493582|NCT03829618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102493583|NCT03829618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102493584|NCT03829618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102493585|NCT03829618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102493586|NCT03829618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102493587|NCT03829618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493588|NCT04272788|Infliximab|infliximab|mesh-list
102493589|NCT04272788|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102493590|NCT04272788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102493591|NCT04272788|Dermatologic Agents|dermatologic agents|mesh-ancestor
102493592|NCT04272788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102493593|NCT04272788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102493594|NCT01457690|Tocopherols|tocopherols|mesh-list
102493595|NCT01457690|Vitamin E|vitamin e|mesh-list
102493596|NCT01457690|Tocotrienols|tocotrienols|mesh-list
102493597|NCT01457690|alpha-Tocopherol|alpha-tocopherol|mesh-list
102493598|NCT01457690|Antioxidants|antioxidants|mesh-ancestor
102493599|NCT01457690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493600|NCT01457690|Protective Agents|protective agents|mesh-ancestor
102493601|NCT01457690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493602|NCT01457690|Vitamins|vitamins|mesh-ancestor
102493603|NCT01457690|Micronutrients|micronutrients|mesh-ancestor
102493604|NCT05497206|Metronidazole|metronidazole|mesh-list
102493605|NCT05497206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102493606|NCT05497206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102493607|NCT05497206|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102493608|NCT05497206|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102493609|NCT01451060|Ephedrine|ephedrine|mesh-list
102493610|NCT01451060|Metaraminol|metaraminol|mesh-list
102493611|NCT01451060|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102493612|NCT01451060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493613|NCT01451060|Sympathomimetics|sympathomimetics|mesh-ancestor
102493614|NCT01451060|Autonomic Agents|autonomic agents|mesh-ancestor
102493615|NCT01451060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102493616|NCT01451060|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102493617|NCT01451060|Adrenergic Agents|adrenergic agents|mesh-ancestor
102493618|NCT01451060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102493619|NCT01451060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493620|NCT01451060|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102493621|NCT01451060|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102493622|NCT01451060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102493623|NCT04904562|Angiotensin II|angiotensin ii|mesh-list
102493624|NCT04904562|Giapreza|giapreza|mesh-list
102493625|NCT04904562|Angiotensinogen|angiotensinogen|mesh-list
102493626|NCT04904562|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102493627|NCT04904562|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102493628|NCT04904562|Protease Inhibitors|protease inhibitors|mesh-ancestor
102493629|NCT04904562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102493630|NCT04904562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493631|NCT01143181|Brincidofovir|brincidofovir|mesh-list
102493632|NCT01143181|Antiviral Agents|antiviral agents|mesh-ancestor
102493633|NCT01143181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102493634|NCT01451294|Phenylephrine|phenylephrine|mesh-list
102493635|NCT01451294|Oxymetazoline|oxymetazoline|mesh-list
102493636|NCT01451294|Ephedrine|ephedrine|mesh-list
102493637|NCT01451294|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102493638|NCT01451294|Mydriatics|mydriatics|mesh-ancestor
102493639|NCT01451294|Autonomic Agents|autonomic agents|mesh-ancestor
102493640|NCT01451294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102493641|NCT01451294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493642|NCT01451294|Sympathomimetics|sympathomimetics|mesh-ancestor
102493643|NCT01451294|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102493644|NCT01451294|Nasal Decongestants|nasal decongestants|mesh-ancestor
102493645|NCT01451294|Respiratory System Agents|respiratory system agents|mesh-ancestor
102493646|NCT01451294|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102493647|NCT01451294|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102493648|NCT01451294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102493649|NCT01451294|Adrenergic Agents|adrenergic agents|mesh-ancestor
102493650|NCT01451294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102493651|NCT01451294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493652|NCT01451294|Protective Agents|protective agents|mesh-ancestor
102493653|NCT01451294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102493654|NCT01187017|Cyclophosphamide|cyclophosphamide|mesh-list
102493655|NCT01187017|Fludarabine|fludarabine|mesh-list
102493656|NCT01187017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102493657|NCT01187017|Immunologic Factors|immunologic factors|mesh-ancestor
102493658|NCT01187017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493659|NCT01187017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102493660|NCT01187017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102493661|NCT01187017|Alkylating Agents|alkylating agents|mesh-ancestor
102493662|NCT01187017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493663|NCT01187017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102493664|NCT01187017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102493665|NCT00378118|Antibodies|antibodies|mesh-list
102493666|NCT00378118|Immunoglobulins|immunoglobulins|mesh-list
102493667|NCT00378118|HIV Antibodies|hiv antibodies|mesh-list
102493668|NCT00378118|Immunologic Factors|immunologic factors|mesh-ancestor
102493669|NCT00378118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493670|NCT01224145|Bupivacaine|bupivacaine|mesh-list
102493671|NCT01224145|Anesthetics, Local|anesthetics, local|mesh-ancestor
102493672|NCT01224145|Anesthetics|anesthetics|mesh-ancestor
102493673|NCT01224145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102493674|NCT01224145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493675|NCT01224145|Sensory System Agents|sensory system agents|mesh-ancestor
102493676|NCT01224145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102493677|NCT01451840|Lidocaine|lidocaine|mesh-list
102493678|NCT01451840|Remifentanil|remifentanil|mesh-list
102493679|NCT01451840|Anesthetics, Local|anesthetics, local|mesh-ancestor
102493680|NCT01451840|Anesthetics|anesthetics|mesh-ancestor
102493681|NCT01451840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102493682|NCT01451840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493683|NCT01451840|Sensory System Agents|sensory system agents|mesh-ancestor
102493684|NCT01451840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102493685|NCT01451840|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102493686|NCT01451840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102493687|NCT01451840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102493688|NCT01451840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102493689|NCT01451840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493690|NCT01451840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102493691|NCT01451840|Narcotics|narcotics|mesh-ancestor
102493692|NCT01451840|Analgesics|analgesics|mesh-ancestor
102493693|NCT01451918|Resveratrol|resveratrol|mesh-list
102493694|NCT01451918|Antioxidants|antioxidants|mesh-ancestor
102493695|NCT01451918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493696|NCT01451918|Protective Agents|protective agents|mesh-ancestor
102493697|NCT01451918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493698|NCT01451918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102493699|NCT01451918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102493700|NCT00378196|Ranibizumab|ranibizumab|mesh-list
102493701|NCT00378196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102493702|NCT00378196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102493703|NCT00378196|Growth Substances|growth substances|mesh-ancestor
102493704|NCT00378196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493705|NCT00378196|Growth Inhibitors|growth inhibitors|mesh-ancestor
102493706|NCT00378196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102493707|NCT01188109|Gemcitabine|gemcitabine|mesh-list
102493708|NCT01188109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102493709|NCT01188109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102493710|NCT01188109|Antimetabolites|antimetabolites|mesh-ancestor
102493711|NCT01188109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493712|NCT01458236|Beraprost|beraprost|mesh-list
102493713|NCT01458236|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102493714|NCT01458236|Vasodilator Agents|vasodilator agents|mesh-ancestor
102493715|NCT01146457|Morphine|morphine|mesh-list
102493716|NCT01146457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102493717|NCT01146457|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102493718|NCT01146457|Narcotics|narcotics|mesh-ancestor
102493719|NCT01146457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102493720|NCT01146457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493721|NCT01146457|Analgesics|analgesics|mesh-ancestor
102493722|NCT01146457|Sensory System Agents|sensory system agents|mesh-ancestor
102493723|NCT01146457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102493724|NCT04031430|Antihypertensive Agents|antihypertensive agents|mesh-list
102493725|NCT05495958|Vitamin D|vitamin d|mesh-list
102493726|NCT05495958|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102493727|NCT05495958|Vitamins|vitamins|mesh-ancestor
102493728|NCT05495958|Micronutrients|micronutrients|mesh-ancestor
102493729|NCT05495958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493730|NCT05495958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102493731|NCT05495958|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102493732|NCT04011592|Ketamine|ketamine|mesh-list
102493733|NCT04011592|Analgesics|analgesics|mesh-ancestor
102493734|NCT04011592|Sensory System Agents|sensory system agents|mesh-ancestor
102493735|NCT04011592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102493736|NCT04011592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493737|NCT04011592|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102493738|NCT04011592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102493739|NCT04011592|Anesthetics, General|anesthetics, general|mesh-ancestor
102493740|NCT04011592|Anesthetics|anesthetics|mesh-ancestor
102493741|NCT04011592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102493742|NCT04011592|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102493743|NCT04011592|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102493744|NCT04011592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102493745|NCT04011592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493746|NCT01458470|Memantine|memantine|mesh-list
102493747|NCT01458470|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102493748|NCT01458470|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102493749|NCT01458470|Dopamine Agents|dopamine agents|mesh-ancestor
102493750|NCT01458470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102493751|NCT01458470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493752|NCT01458470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493753|NCT01458470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102493754|NCT01458470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102493755|NCT05025488|Poly ICLC|poly iclc|mesh-list
102493756|NCT05025488|Interferon Inducers|interferon inducers|mesh-ancestor
102493757|NCT05025488|Immunologic Factors|immunologic factors|mesh-ancestor
102493758|NCT05025488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493759|NCT01452542|Eliglustat|eliglustat|mesh-list
102493760|NCT01452542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102493761|NCT01452542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493762|NCT01458548|Rituximab|rituximab|mesh-list
102493763|NCT01458548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102493764|NCT01458548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102493765|NCT01458548|Immunologic Factors|immunologic factors|mesh-ancestor
102493766|NCT01458548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493767|NCT01458548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102493768|NCT05027204|Docetaxel|docetaxel|mesh-list
102493769|NCT05027204|Nivolumab|nivolumab|mesh-list
102493770|NCT05027204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102493771|NCT05027204|Tubulin Modulators|tubulin modulators|mesh-ancestor
102493772|NCT05027204|Antimitotic Agents|antimitotic agents|mesh-ancestor
102493773|NCT05027204|Mitosis Modulators|mitosis modulators|mesh-ancestor
102493774|NCT05027204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493775|NCT05027204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102493776|NCT05027204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102493777|NCT01458626|Mirtazapine|mirtazapine|mesh-list
102493778|NCT01458626|Paroxetine|paroxetine|mesh-list
102493779|NCT01458626|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102493780|NCT01458626|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102493781|NCT01458626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102493782|NCT01458626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493783|NCT01458626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102493784|NCT01458626|Serotonin Agents|serotonin agents|mesh-ancestor
102493785|NCT01458626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493786|NCT01458626|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102493787|NCT01458626|Antidepressive Agents|antidepressive agents|mesh-ancestor
102493788|NCT01458626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102493789|NCT01458626|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102493790|NCT01458626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102493791|NCT01458626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102493792|NCT01458626|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102493793|NCT01458626|Histamine Antagonists|histamine antagonists|mesh-ancestor
102493794|NCT01458626|Histamine Agents|histamine agents|mesh-ancestor
102493795|NCT01458626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102493796|NCT01458626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102493797|NCT01458626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102133724|NCT02295189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102493798|NCT01458626|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102493799|NCT01458626|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102493800|NCT01458626|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102493801|NCT01458626|Adrenergic Agents|adrenergic agents|mesh-ancestor
102493802|NCT01458626|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102493803|NCT01458626|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102493804|NCT01458626|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102493805|NCT00377806|Diclofenac|diclofenac|mesh-list
102493806|NCT00377806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102493807|NCT00377806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102493808|NCT00377806|Analgesics|analgesics|mesh-ancestor
102493809|NCT00377806|Sensory System Agents|sensory system agents|mesh-ancestor
102493810|NCT00377806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102493811|NCT00377806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493812|NCT00377806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102493813|NCT00377806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102493814|NCT00377806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102493815|NCT00377806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102493816|NCT00377806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493817|NCT05495724|Tislelizumab|tislelizumab|mesh-list
102493818|NCT05495724|Disitamab vedotin|disitamab vedotin|mesh-list
102493819|NCT05495724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102493820|NCT05495724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102493821|NCT05495724|Immunoconjugates|immunoconjugates|mesh-ancestor
102493822|NCT05495724|Immunologic Factors|immunologic factors|mesh-ancestor
102493823|NCT05495724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493824|NCT02559414|Aspirin|aspirin|mesh-list
102493825|NCT02559414|Clopidogrel|clopidogrel|mesh-list
102493826|NCT02559414|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102493827|NCT02559414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102493828|NCT02559414|Analgesics|analgesics|mesh-ancestor
102493829|NCT02559414|Sensory System Agents|sensory system agents|mesh-ancestor
102493830|NCT02559414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102493831|NCT02559414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493832|NCT02559414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102493833|NCT02559414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102493834|NCT02559414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102493835|NCT02559414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102493836|NCT02559414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493837|NCT02559414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102493838|NCT02559414|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102493839|NCT02559414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102493840|NCT02559414|Antipyretics|antipyretics|mesh-ancestor
102493841|NCT02559414|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102493842|NCT02559414|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102493843|NCT02559414|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102493844|NCT02559414|Purinergic Agents|purinergic agents|mesh-ancestor
102493845|NCT02559414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102493846|NCT03527264|Nivolumab|nivolumab|mesh-list
102493847|NCT03527264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102493848|NCT03527264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102493849|NCT03527264|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102493850|NCT03527264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493851|NCT04713904|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102493852|NCT04713904|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102493853|NCT04713904|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102493854|NCT04713904|Estradiol|estradiol|mesh-list
102493855|NCT04713904|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102493856|NCT04713904|Estrogens|estrogens|mesh-ancestor
102493857|NCT04713904|Hormones|hormones|mesh-ancestor
102493858|NCT04713904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102493859|NCT04713904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493860|NCT04713904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102493861|NCT04713904|Contraceptive Agents|contraceptive agents|mesh-ancestor
102493862|NCT04713904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102493863|NCT04713904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102493864|NCT04713904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102493865|NCT04713904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102493866|NCT03995680|Mebendazole|mebendazole|mesh-list
102493867|NCT03995680|Piperazine|piperazine|mesh-list
102493868|NCT03995680|Piperazine citrate|piperazine citrate|mesh-list
102493869|NCT03995680|DMP 777|dmp 777|mesh-list
102493870|NCT03995680|Antinematodal Agents|antinematodal agents|mesh-ancestor
102493871|NCT03995680|Anthelmintics|anthelmintics|mesh-ancestor
102493872|NCT03995680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102493873|NCT03995680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102493874|NCT03995680|Tubulin Modulators|tubulin modulators|mesh-ancestor
102493875|NCT03995680|Antimitotic Agents|antimitotic agents|mesh-ancestor
102493876|NCT03995680|Mitosis Modulators|mitosis modulators|mesh-ancestor
102493877|NCT03995680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493878|NCT03995680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102493879|NCT03995680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102493880|NCT01452698|Lansoprazole|lansoprazole|mesh-list
102493881|NCT01452698|Dexlansoprazole|dexlansoprazole|mesh-list
102493882|NCT01452698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102493883|NCT01452698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102493884|NCT01452698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102493885|NCT01452698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102493886|NCT01452698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493887|NCT05029856|Vaccines|vaccines|mesh-list
102493888|NCT05029856|Immunologic Factors|immunologic factors|mesh-ancestor
102493889|NCT05029856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493890|NCT05490342|Antibodies|antibodies|mesh-list
102493891|NCT05490342|Myeloma Proteins|myeloma proteins|mesh-list
102493892|NCT05490342|Paraproteins|paraproteins|mesh-list
102493893|NCT05490342|Immunologic Factors|immunologic factors|mesh-ancestor
102493894|NCT05490342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493895|NCT05495100|Azacitidine|azacitidine|mesh-list
102493896|NCT05495100|Mitoxantrone|mitoxantrone|mesh-list
102493897|NCT05495100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102493898|NCT05495100|Antimetabolites|antimetabolites|mesh-ancestor
102493899|NCT05495100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493900|NCT05495100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102493901|NCT05495100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102493902|NCT05495100|Analgesics|analgesics|mesh-ancestor
102493903|NCT05495100|Sensory System Agents|sensory system agents|mesh-ancestor
102493904|NCT05495100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102493905|NCT05495100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493906|NCT05495100|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102493907|NCT05495100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102493908|NCT03325114|Chlorthalidone|chlorthalidone|mesh-list
102493909|NCT03325114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102493910|NCT03325114|Diuretics|diuretics|mesh-ancestor
102493911|NCT03325114|Natriuretic Agents|natriuretic agents|mesh-ancestor
102493912|NCT03325114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493913|NCT03325114|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102493914|NCT03325114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102493915|NCT03325114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493916|NCT01453400|Aspirin|aspirin|mesh-list
102493917|NCT01453400|Acetaminophen|acetaminophen|mesh-list
102493918|NCT01453400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102493919|NCT01453400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102493920|NCT01453400|Analgesics|analgesics|mesh-ancestor
102493921|NCT01453400|Sensory System Agents|sensory system agents|mesh-ancestor
102493922|NCT01453400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102493923|NCT01453400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493924|NCT01453400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102493925|NCT01453400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102493926|NCT01453400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102493927|NCT01453400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102493928|NCT01453400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493929|NCT01453400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102493930|NCT01453400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102493931|NCT01453400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102493932|NCT01453400|Antipyretics|antipyretics|mesh-ancestor
102493933|NCT05025644|Dobutamine|dobutamine|mesh-list
102493934|NCT05025644|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102493935|NCT05025644|Sympathomimetics|sympathomimetics|mesh-ancestor
102493936|NCT05025644|Autonomic Agents|autonomic agents|mesh-ancestor
102493937|NCT05025644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102493938|NCT05025644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493939|NCT05025644|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102493940|NCT05025644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102493941|NCT05025644|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102493942|NCT05025644|Adrenergic Agents|adrenergic agents|mesh-ancestor
101626582|NCT00806416|Vitamins|vitamins|mesh-ancestor
102493943|NCT05025644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102493944|NCT05025644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493945|NCT05025644|Protective Agents|protective agents|mesh-ancestor
102493946|NCT05494710|Bleomycin|bleomycin|mesh-list
102493947|NCT05494710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102493948|NCT05494710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102493949|NCT03810066|Osimertinib|osimertinib|mesh-list
102493950|NCT03810066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102493951|NCT03810066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102493952|NCT03810066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102493953|NCT03810066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493954|NCT03992482|Immunoglobulins|immunoglobulins|mesh-list
102493955|NCT03992482|Antibodies|antibodies|mesh-list
102493956|NCT03992482|gamma-Globulins|gamma-globulins|mesh-list
102493957|NCT03992482|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102493958|NCT03992482|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102493959|NCT03992482|Immunologic Factors|immunologic factors|mesh-ancestor
102493960|NCT03992482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493961|NCT00377494|Vaccines|vaccines|mesh-list
102493962|NCT00377494|Immunologic Factors|immunologic factors|mesh-ancestor
102493963|NCT00377494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493964|NCT01459250|Agomelatine|agomelatine|mesh-list
102493965|NCT01459250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102493966|NCT01459250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102493967|NCT01459250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493968|NCT04303156|Islatravir|islatravir|mesh-list
102493969|NCT04303156|Antiviral Agents|antiviral agents|mesh-ancestor
102493970|NCT04303156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102493971|NCT04303156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102493972|NCT04303156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493973|NCT04303156|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102493974|NCT04303156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102493975|NCT04303156|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102493976|NCT04390334|Efavirenz|efavirenz|mesh-list
102493977|NCT04390334|Famotidine|famotidine|mesh-list
102493978|NCT04390334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102493979|NCT04390334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102493980|NCT04390334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102493981|NCT04390334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102493982|NCT04390334|Antiviral Agents|antiviral agents|mesh-ancestor
102493983|NCT04390334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102493984|NCT04390334|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102493985|NCT04390334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102493986|NCT04390334|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102493987|NCT04390334|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102493988|NCT04390334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102493989|NCT04390334|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102493990|NCT04390334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102493991|NCT04390334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102493992|NCT04390334|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102493993|NCT04390334|Histamine Antagonists|histamine antagonists|mesh-ancestor
102493994|NCT04390334|Histamine Agents|histamine agents|mesh-ancestor
102493995|NCT04390334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102493996|NCT04390334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102493998|NCT02880020|Ipilimumab|ipilimumab|mesh-list
102493999|NCT02880020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102494000|NCT02880020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102494001|NCT02880020|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102494002|NCT02880020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494003|NCT03150160|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102494004|NCT03150160|Travoprost|travoprost|mesh-list
102494005|NCT03150160|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102494006|NCT03150160|Brinzolamide|brinzolamide|mesh-list
102494007|NCT03150160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102494008|NCT03150160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102494009|NCT03150160|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102494010|NCT03150160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102494011|NCT03150160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102494012|NCT03150160|Adrenergic Agents|adrenergic agents|mesh-ancestor
102494013|NCT03150160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102494014|NCT03150160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494015|NCT03150160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494016|NCT03150160|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102494017|NCT03150160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102494018|NCT01459406|Levan|levan|mesh-list
102494019|NCT01459406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102494020|NCT05489952|Iron|iron|mesh-list
102494021|NCT05489952|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102494022|NCT05489952|Trace Elements|trace elements|mesh-ancestor
102494023|NCT05489952|Micronutrients|micronutrients|mesh-ancestor
102494024|NCT05489952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494025|NCT05489952|Hematinics|hematinics|mesh-ancestor
102494026|NCT01459640|Hyaluronic Acid|hyaluronic acid|mesh-list
102494027|NCT01459640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102494028|NCT01459640|Immunologic Factors|immunologic factors|mesh-ancestor
102494029|NCT01459640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494030|NCT01459640|Viscosupplements|viscosupplements|mesh-ancestor
102494031|NCT01459640|Protective Agents|protective agents|mesh-ancestor
102494032|NCT04257396|Carbon Fiber|carbon fiber|mesh-list
102494033|NCT04257396|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102494034|NCT04257396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102494035|NCT01500772|Ribavirin|ribavirin|mesh-list
102494036|NCT01500772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102494037|NCT01500772|Antimetabolites|antimetabolites|mesh-ancestor
102494038|NCT01500772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494039|NCT01500772|Antiviral Agents|antiviral agents|mesh-ancestor
102494040|NCT01500772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102494041|NCT04272476|Fluoxetine|fluoxetine|mesh-list
102494042|NCT04272476|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102494043|NCT04272476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102494044|NCT04272476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102494045|NCT04272476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494046|NCT04272476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102494047|NCT04272476|Serotonin Agents|serotonin agents|mesh-ancestor
102494048|NCT04272476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494049|NCT04272476|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102494050|NCT04272476|Antidepressive Agents|antidepressive agents|mesh-ancestor
102494051|NCT04272476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102494052|NCT04272476|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102494053|NCT04272476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102494054|NCT04272476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102494055|NCT03984838|Dolutegravir|dolutegravir|mesh-list
102494056|NCT03984838|Rilpivirine|rilpivirine|mesh-list
102494057|NCT03984838|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
102494058|NCT03984838|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102494059|NCT03984838|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102494060|NCT03984838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102494061|NCT03984838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494062|NCT03984838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102494063|NCT03984838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102494064|NCT03984838|Antiviral Agents|antiviral agents|mesh-ancestor
102494065|NCT03984838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102494066|NCT03984838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102494067|NCT03984838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102305652|NCT02405780|Adalimumab|adalimumab|mesh-list
102494068|NCT02994576|Atezolizumab|atezolizumab|mesh-list
102494069|NCT02994576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102494070|NCT02994576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494071|NCT02994576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102494072|NCT02994576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102494073|NCT01890902|Ketoprofen|ketoprofen|mesh-list
102494074|NCT01890902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102494075|NCT01890902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102494076|NCT01890902|Analgesics|analgesics|mesh-ancestor
102494077|NCT01890902|Sensory System Agents|sensory system agents|mesh-ancestor
102494078|NCT01890902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102494079|NCT01890902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494080|NCT01890902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102494081|NCT01890902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102494082|NCT01890902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102494083|NCT01890902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102494084|NCT01890902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494085|NCT04423926|Prednisolone|prednisolone|mesh-list
102494086|NCT04423926|Cyclophosphamide|cyclophosphamide|mesh-list
102494087|NCT04423926|Doxorubicin|doxorubicin|mesh-list
102494088|NCT04423926|Vincristine|vincristine|mesh-list
102494089|NCT04423926|Lenalidomide|lenalidomide|mesh-list
102494090|NCT04423926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102494091|NCT04423926|Immunologic Factors|immunologic factors|mesh-ancestor
102494092|NCT04423926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494093|NCT04423926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102494094|NCT04423926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102494095|NCT04423926|Alkylating Agents|alkylating agents|mesh-ancestor
102494096|NCT04423926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494097|NCT04423926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102494098|NCT04423926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102494099|NCT04423926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102494100|NCT04423926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102494101|NCT04423926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102494102|NCT04423926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102494103|NCT04423926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102494104|NCT04423926|Tubulin Modulators|tubulin modulators|mesh-ancestor
102494105|NCT04423926|Antimitotic Agents|antimitotic agents|mesh-ancestor
102494106|NCT04423926|Mitosis Modulators|mitosis modulators|mesh-ancestor
102494107|NCT04423926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102494108|NCT04423926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102494109|NCT04423926|Growth Substances|growth substances|mesh-ancestor
102494110|NCT04423926|Growth Inhibitors|growth inhibitors|mesh-ancestor
102494111|NCT04423926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102494112|NCT04423926|Glucocorticoids|glucocorticoids|mesh-ancestor
102494113|NCT04423926|Hormones|hormones|mesh-ancestor
102494114|NCT04423926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102494115|NCT04423926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102494116|NCT03979066|Atezolizumab|atezolizumab|mesh-list
102494117|NCT03979066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102494118|NCT03979066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494119|NCT03979066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102494120|NCT03979066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102612330|NCT00002417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102612331|NCT00002417|Antitubercular Agents|antitubercular agents|mesh-ancestor
102612332|NCT00002417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102612333|NCT00002417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102612334|NCT00002417|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102612335|NCT00002417|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102612336|NCT00002417|Protease Inhibitors|protease inhibitors|mesh-ancestor
102612337|NCT00002417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612338|NCT00002417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612339|NCT00002417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101626783|NCT04087915|Antimetabolites|antimetabolites|mesh-ancestor
102612340|NCT00002417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102612341|NCT00002417|Antiviral Agents|antiviral agents|mesh-ancestor
102612342|NCT00002423|Lamivudine|lamivudine|mesh-list
102612343|NCT00002423|Abacavir|abacavir|mesh-list
102612344|NCT00002423|Nelfinavir|nelfinavir|mesh-list
102612345|NCT00002423|Indinavir|indinavir|mesh-list
102612346|NCT00002423|Amprenavir|amprenavir|mesh-list
102612347|NCT00002423|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102305723|NCT02335346|Antidepressive Agents|antidepressive agents|mesh-ancestor
102612348|NCT00002423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102612349|NCT00002423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612350|NCT00002423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494121|NCT03968848|Acalabrutinib|acalabrutinib|mesh-list
102494122|NCT03968848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102494123|NCT05489406|Dolutegravir|dolutegravir|mesh-list
102494124|NCT05489406|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102494125|NCT05489406|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102494126|NCT05489406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102494127|NCT05489406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494128|NCT05489406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102494129|NCT05489406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102494130|NCT05489406|Antiviral Agents|antiviral agents|mesh-ancestor
102494131|NCT05489406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102494132|NCT01479010|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102494133|NCT01479010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102494134|NCT01472692|Febuxostat|febuxostat|mesh-list
102494135|NCT01472692|Gout Suppressants|gout suppressants|mesh-ancestor
102494136|NCT01472692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102494137|NCT00378820|Caseins|caseins|mesh-list
102494138|NCT00378820|Chelating Agents|chelating agents|mesh-ancestor
102494139|NCT00378820|Sequestering Agents|sequestering agents|mesh-ancestor
102494140|NCT00378820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494141|NCT02558400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102494142|NCT02558400|Latanoprost|latanoprost|mesh-list
102494143|NCT02558400|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102494144|NCT04758260|Antioxidants|antioxidants|mesh-list
102494145|NCT04758260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494146|NCT04758260|Protective Agents|protective agents|mesh-ancestor
102494147|NCT04758260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494148|NCT01446250|Ribavirin|ribavirin|mesh-list
102494149|NCT01446250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102494150|NCT01446250|Antimetabolites|antimetabolites|mesh-ancestor
102494151|NCT01446250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494152|NCT01446250|Antiviral Agents|antiviral agents|mesh-ancestor
102494153|NCT01446250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102494154|NCT05493618|Dexamethasone|dexamethasone|mesh-list
102494155|NCT05493618|Pembrolizumab|pembrolizumab|mesh-list
102494156|NCT05493618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102494157|NCT05493618|Antiemetics|antiemetics|mesh-ancestor
102494158|NCT05493618|Autonomic Agents|autonomic agents|mesh-ancestor
102494159|NCT05493618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102494160|NCT05493618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494161|NCT05493618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102494162|NCT05493618|Glucocorticoids|glucocorticoids|mesh-ancestor
102494163|NCT05493618|Hormones|hormones|mesh-ancestor
102494164|NCT05493618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102494165|NCT05493618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102494166|NCT05493618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102494167|NCT05493618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102494168|NCT05493618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102494169|NCT05493618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494170|NCT00379600|Rosiglitazone|rosiglitazone|mesh-list
102494171|NCT00379600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102494172|NCT00379600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494173|NCT05020574|Cephalexin|cephalexin|mesh-list
102494174|NCT05020574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102494175|NCT05020574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102494176|NCT02936206|Tamoxifen|tamoxifen|mesh-list
102494177|NCT02936206|Fulvestrant|fulvestrant|mesh-list
102494178|NCT02936206|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102494179|NCT02936206|Hormone Antagonists|hormone antagonists|mesh-ancestor
102494180|NCT02936206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102494181|NCT02936206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494182|NCT02936206|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102494183|NCT02936206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102494184|NCT02936206|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102494185|NCT02936206|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102494186|NCT02936206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102494187|NCT02936206|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102494188|NCT01891526|Tretinoin|tretinoin|mesh-list
102494189|NCT01891526|Alitretinoin|alitretinoin|mesh-list
102494190|NCT01891526|Isotretinoin|isotretinoin|mesh-list
102494191|NCT01891526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102494192|NCT01891526|Keratolytic Agents|keratolytic agents|mesh-ancestor
102494193|NCT01891526|Dermatologic Agents|dermatologic agents|mesh-ancestor
102494194|NCT01406860|Diphenhydramine|diphenhydramine|mesh-list
102494195|NCT01406860|Promethazine|promethazine|mesh-list
102494196|NCT01406860|Droperidol|droperidol|mesh-list
102494197|NCT01406860|Metoclopramide|metoclopramide|mesh-list
102494198|NCT01406860|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102494199|NCT01406860|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102494200|NCT01406860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102494201|NCT01406860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494202|NCT01406860|Anesthetics, Local|anesthetics, local|mesh-ancestor
102494203|NCT01406860|Anesthetics|anesthetics|mesh-ancestor
102494204|NCT01406860|Sensory System Agents|sensory system agents|mesh-ancestor
102494205|NCT01406860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102494206|NCT01406860|Antiemetics|antiemetics|mesh-ancestor
102494207|NCT01406860|Autonomic Agents|autonomic agents|mesh-ancestor
102494208|NCT01406860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102494209|NCT01406860|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102494210|NCT01406860|Histamine Antagonists|histamine antagonists|mesh-ancestor
102494211|NCT01406860|Histamine Agents|histamine agents|mesh-ancestor
102494212|NCT01406860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102494213|NCT01406860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494214|NCT01406860|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102494215|NCT01406860|Antipruritics|antipruritics|mesh-ancestor
102494216|NCT01406860|Dermatologic Agents|dermatologic agents|mesh-ancestor
102494217|NCT01406860|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102494218|NCT01406860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102494219|NCT01406860|Dopamine Agents|dopamine agents|mesh-ancestor
102494220|NCT01406860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102494221|NCT01406860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102494222|NCT01406860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102494223|NCT01406860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102494225|NCT04138212|Cisplatin|cisplatin|mesh-list
102494226|NCT04138212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102494227|NCT04138212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102494228|NCT04138212|Tubulin Modulators|tubulin modulators|mesh-ancestor
102494229|NCT04138212|Antimitotic Agents|antimitotic agents|mesh-ancestor
102494230|NCT04138212|Mitosis Modulators|mitosis modulators|mesh-ancestor
102494231|NCT04138212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494232|NCT02773576|Risperidone|risperidone|mesh-list
102494233|NCT02773576|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102494234|NCT02773576|Serotonin Agents|serotonin agents|mesh-ancestor
102494235|NCT02773576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102494236|NCT02773576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494237|NCT02773576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494238|NCT02773576|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102494239|NCT02773576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101626921|NCT00248703|Docetaxel|docetaxel|mesh-list
102494240|NCT02773576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102494241|NCT02773576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102494242|NCT02773576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102494243|NCT02773576|Dopamine Agents|dopamine agents|mesh-ancestor
102494244|NCT05022758|Warfarin|warfarin|mesh-list
102494245|NCT05022758|Rivaroxaban|rivaroxaban|mesh-list
102494246|NCT05022758|Anticoagulants|anticoagulants|mesh-ancestor
102494247|NCT05022758|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102494248|NCT05022758|Antithrombins|antithrombins|mesh-ancestor
102494249|NCT05022758|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102494250|NCT05022758|Protease Inhibitors|protease inhibitors|mesh-ancestor
102494251|NCT05022758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102494252|NCT05022758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494253|NCT05021978|Pramoxine|pramoxine|mesh-list
102494254|NCT05021978|Anesthetics, Local|anesthetics, local|mesh-ancestor
102494255|NCT05021978|Anesthetics|anesthetics|mesh-ancestor
102494256|NCT05021978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102494257|NCT05021978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494258|NCT05021978|Sensory System Agents|sensory system agents|mesh-ancestor
102494259|NCT05021978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102494260|NCT04280406|Azithromycin|azithromycin|mesh-list
102494261|NCT04280406|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102494262|NCT04280406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102494263|NCT05599828|Sotorasib|sotorasib|mesh-list
102494264|NCT05599828|Omeprazole|omeprazole|mesh-list
102494265|NCT05599828|Famotidine|famotidine|mesh-list
102494266|NCT05599828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102494267|NCT05599828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102494268|NCT05599828|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102494269|NCT05599828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102494270|NCT05599828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494271|NCT05599828|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102494272|NCT05599828|Histamine Antagonists|histamine antagonists|mesh-ancestor
102494273|NCT05599828|Histamine Agents|histamine agents|mesh-ancestor
102494274|NCT05599828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102494275|NCT05599828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494276|NCT05599828|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102494277|NCT05599828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102494278|NCT05599828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102494279|NCT01350232|Cytarabine|cytarabine|mesh-list
102494280|NCT01350232|Cyclophosphamide|cyclophosphamide|mesh-list
102494281|NCT01350232|Rituximab|rituximab|mesh-list
102494282|NCT01350232|Fludarabine|fludarabine|mesh-list
102494283|NCT01350232|Bortezomib|bortezomib|mesh-list
102494284|NCT01350232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102494285|NCT01350232|Immunologic Factors|immunologic factors|mesh-ancestor
102494286|NCT01350232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494287|NCT01350232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102494288|NCT01350232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102494289|NCT01350232|Alkylating Agents|alkylating agents|mesh-ancestor
102494290|NCT01350232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494291|NCT01350232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102494292|NCT01350232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102494293|NCT01350232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102494294|NCT01350232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102494295|NCT01350232|Antimetabolites|antimetabolites|mesh-ancestor
102494296|NCT01350232|Antiviral Agents|antiviral agents|mesh-ancestor
102494297|NCT01350232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102494298|NCT05493228|Dexmedetomidine|dexmedetomidine|mesh-list
102494299|NCT05493228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102494300|NCT05493228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102494301|NCT05493228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494302|NCT05493228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102494303|NCT05493228|Analgesics|analgesics|mesh-ancestor
102494304|NCT05493228|Sensory System Agents|sensory system agents|mesh-ancestor
102494305|NCT05493228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102494306|NCT05493228|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101626976|NCT00729859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102494307|NCT05493228|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102494308|NCT05493228|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102494309|NCT05493228|Adrenergic Agents|adrenergic agents|mesh-ancestor
102494310|NCT05493228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102494311|NCT05493228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494312|NCT02758132|Denosumab|denosumab|mesh-list
102494313|NCT02758132|Prednisone|prednisone|mesh-list
102494314|NCT02758132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102494315|NCT02758132|Glucocorticoids|glucocorticoids|mesh-ancestor
102494316|NCT02758132|Hormones|hormones|mesh-ancestor
102494317|NCT02758132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102494318|NCT02758132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494319|NCT02758132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102494320|NCT02758132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102494321|NCT02758132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102494322|NCT01891916|Caseins|caseins|mesh-list
102494323|NCT01891916|Chelating Agents|chelating agents|mesh-ancestor
102494324|NCT01891916|Sequestering Agents|sequestering agents|mesh-ancestor
102494325|NCT01891916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494326|NCT01313416|Gemcitabine|gemcitabine|mesh-list
102494327|NCT01313416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102494328|NCT01313416|Antimetabolites|antimetabolites|mesh-ancestor
102494329|NCT01313416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494330|NCT01313416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102494331|NCT05599360|Gemtuzumab|gemtuzumab|mesh-list
102494332|NCT05599360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102494333|NCT05599360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102494334|NCT05599360|Immunotoxins|immunotoxins|mesh-ancestor
102494335|NCT05599360|Immunoconjugates|immunoconjugates|mesh-ancestor
102494336|NCT05599360|Immunologic Factors|immunologic factors|mesh-ancestor
102494337|NCT05599360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494338|NCT05499234|Acetaminophen|acetaminophen|mesh-list
102494339|NCT05499234|Meperidine|meperidine|mesh-list
102494340|NCT05499234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102494341|NCT05499234|Analgesics|analgesics|mesh-ancestor
102494342|NCT05499234|Sensory System Agents|sensory system agents|mesh-ancestor
102494343|NCT05499234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102494344|NCT05499234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494345|NCT05499234|Antipyretics|antipyretics|mesh-ancestor
102494346|NCT05499234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102494347|NCT05499234|Narcotics|narcotics|mesh-ancestor
102494348|NCT05499234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102494349|NCT05499234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102494350|NCT01269034|Insulin|insulin|mesh-list
102494351|NCT01269034|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102494353|NCT01269034|Insulin Glargine|insulin glargine|mesh-list
102494354|NCT01269034|Insulin Detemir|insulin detemir|mesh-list
102494355|NCT01269034|Insulin, Long-Acting|insulin, long-acting|mesh-list
102494356|NCT01269034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102494357|NCT01269034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494358|NCT01269034|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102494359|NCT01269034|Incretins|incretins|mesh-ancestor
102494360|NCT01269034|Hormones|hormones|mesh-ancestor
102494361|NCT01269034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102494362|NCT05599126|Lorazepam|lorazepam|mesh-list
102494363|NCT05599126|Mianserin|mianserin|mesh-list
102494364|NCT05599126|Anticonvulsants|anticonvulsants|mesh-ancestor
102494365|NCT05599126|Antiemetics|antiemetics|mesh-ancestor
102494366|NCT05599126|Autonomic Agents|autonomic agents|mesh-ancestor
102494367|NCT05599126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102494368|NCT05599126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494369|NCT05599126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102494370|NCT05599126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102494371|NCT05599126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102494372|NCT05599126|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102494373|NCT05599126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102494374|NCT05599126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102494375|NCT05599126|GABA Modulators|gaba modulators|mesh-ancestor
102494376|NCT05599126|GABA Agents|gaba agents|mesh-ancestor
102494377|NCT05599126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102494378|NCT05599126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494379|NCT05599126|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102494380|NCT05599126|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102494381|NCT05599126|Adrenergic Agents|adrenergic agents|mesh-ancestor
102494382|NCT05599126|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101627041|NCT02609698|Analgesics|analgesics|mesh-ancestor
102494383|NCT05599126|Histamine Antagonists|histamine antagonists|mesh-ancestor
102494384|NCT05599126|Histamine Agents|histamine agents|mesh-ancestor
102494385|NCT05599126|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102494386|NCT05599126|Serotonin Agents|serotonin agents|mesh-ancestor
102494387|NCT05599126|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102494388|NCT05599126|Antidepressive Agents|antidepressive agents|mesh-ancestor
102494389|NCT01892150|Sunscreening Agents|sunscreening agents|mesh-list
102494390|NCT01892150|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102494391|NCT01892150|Protective Agents|protective agents|mesh-ancestor
102494392|NCT01892150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494393|NCT01892150|Dermatologic Agents|dermatologic agents|mesh-ancestor
102494394|NCT02663752|Deferasirox|deferasirox|mesh-list
102494395|NCT02663752|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102494396|NCT02663752|Chelating Agents|chelating agents|mesh-ancestor
102494397|NCT02663752|Sequestering Agents|sequestering agents|mesh-ancestor
102494398|NCT02663752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494399|NCT01253668|Antibodies|antibodies|mesh-list
102494400|NCT01253668|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102494401|NCT01253668|Immunologic Factors|immunologic factors|mesh-ancestor
102494402|NCT01253668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494403|NCT01890200|Ribavirin|ribavirin|mesh-list
102494404|NCT01890200|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102494405|NCT01890200|Antimetabolites|antimetabolites|mesh-ancestor
102494406|NCT01890200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494407|NCT01890200|Antiviral Agents|antiviral agents|mesh-ancestor
102494408|NCT01890200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102494409|NCT01662648|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102494410|NCT01662648|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102494411|NCT01662648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102494412|NCT01662648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102494413|NCT01662648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494414|NCT01662648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102494415|NCT01662648|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102494416|NCT01662648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102494417|NCT01662648|Serotonin Agents|serotonin agents|mesh-ancestor
102494418|NCT01662648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102494419|NCT01662648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494420|NCT01662648|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102494421|NCT01662648|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102494422|NCT01662648|Dopamine Agents|dopamine agents|mesh-ancestor
102494423|NCT05586620|Mitomycins|mitomycins|mesh-list
102494424|NCT05586620|Mitomycin|mitomycin|mesh-list
102306022|NCT05649241|Nicotine|nicotine|mesh-list
102494425|NCT05586620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102494426|NCT05586620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102494427|NCT05586620|Alkylating Agents|alkylating agents|mesh-ancestor
102494428|NCT05586620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494429|NCT05586620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102494430|NCT05586620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102494431|NCT01893788|Eplerenone|eplerenone|mesh-list
102494432|NCT01893788|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102494433|NCT01893788|Hormone Antagonists|hormone antagonists|mesh-ancestor
102494434|NCT01893788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102494435|NCT01893788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494436|NCT01893788|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102494437|NCT01893788|Diuretics|diuretics|mesh-ancestor
102494438|NCT01893788|Natriuretic Agents|natriuretic agents|mesh-ancestor
102494439|NCT01893788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102494440|NCT01231750|Capsaicin|capsaicin|mesh-list
102494441|NCT01231750|Antipruritics|antipruritics|mesh-ancestor
102494442|NCT01231750|Dermatologic Agents|dermatologic agents|mesh-ancestor
102494443|NCT01231750|Sensory System Agents|sensory system agents|mesh-ancestor
102494444|NCT01231750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102494445|NCT01231750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494446|NCT05488860|Triamcinolone|triamcinolone|mesh-list
102494447|NCT05488860|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102494448|NCT05488860|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102494449|NCT05488860|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102494450|NCT05488860|Photosensitizing Agents|photosensitizing agents|mesh-list
102494451|NCT05488860|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102494452|NCT05488860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102494453|NCT05488860|Glucocorticoids|glucocorticoids|mesh-ancestor
102494454|NCT05488860|Hormones|hormones|mesh-ancestor
102494455|NCT05488860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102494456|NCT05488860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494457|NCT05488860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102494458|NCT05488860|Immunologic Factors|immunologic factors|mesh-ancestor
102494459|NCT05488860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102494460|NCT05488860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494461|NCT05488860|Dermatologic Agents|dermatologic agents|mesh-ancestor
102494462|NCT02549716|Acetaminophen|acetaminophen|mesh-list
102494463|NCT02549716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102494464|NCT02549716|Analgesics|analgesics|mesh-ancestor
102494465|NCT02549716|Sensory System Agents|sensory system agents|mesh-ancestor
102494466|NCT02549716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102494467|NCT02549716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494468|NCT02549716|Antipyretics|antipyretics|mesh-ancestor
102494469|NCT01207726|Azacitidine|azacitidine|mesh-list
102494470|NCT01207726|Entinostat|entinostat|mesh-list
102494471|NCT01207726|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
102494472|NCT01207726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102494473|NCT01207726|Antimetabolites|antimetabolites|mesh-ancestor
102494474|NCT01207726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494475|NCT01207726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102494476|NCT01207726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102494477|NCT02534038|Quinidine|quinidine|mesh-list
102494478|NCT02534038|Dextromethorphan|dextromethorphan|mesh-list
102494479|NCT02534038|Antitussive Agents|antitussive agents|mesh-ancestor
102494480|NCT02534038|Respiratory System Agents|respiratory system agents|mesh-ancestor
102494481|NCT02534038|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102494482|NCT02534038|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102494483|NCT02534038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102494484|NCT02534038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494485|NCT02534038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494486|NCT02534038|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102494487|NCT02534038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102494488|NCT02534038|Adrenergic Agents|adrenergic agents|mesh-ancestor
102494489|NCT02534038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102494490|NCT02534038|Antimalarials|antimalarials|mesh-ancestor
102494491|NCT02534038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102494492|NCT02534038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102494493|NCT02534038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102494494|NCT02534038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102494495|NCT02534038|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102494496|NCT02534038|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102494497|NCT02534038|Cholinergic Agents|cholinergic agents|mesh-ancestor
102494498|NCT02534038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102494499|NCT02534038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102612351|NCT00002423|Antiviral Agents|antiviral agents|mesh-ancestor
102306096|NCT02325518|Timolol|timolol|mesh-list
102494501|NCT02534038|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102494502|NCT02534038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102494503|NCT01202110|Propranolol|propranolol|mesh-list
102494504|NCT01202110|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102494505|NCT01202110|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102494506|NCT01202110|Adrenergic Agents|adrenergic agents|mesh-ancestor
102494507|NCT01202110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102494508|NCT01202110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494509|NCT01202110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494510|NCT01202110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102494511|NCT01202110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102494512|NCT01202110|Vasodilator Agents|vasodilator agents|mesh-ancestor
102494513|NCT02556918|Insulin|insulin|mesh-list
102494514|NCT02556918|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102494515|NCT02556918|Insulin Glargine|insulin glargine|mesh-list
102494516|NCT02556918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102494517|NCT02556918|Insulin Aspart|insulin aspart|mesh-list
102494518|NCT02556918|Insulin Lispro|insulin lispro|mesh-list
102494519|NCT02556918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102494520|NCT02556918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494521|NCT02556918|Incretins|incretins|mesh-ancestor
102494522|NCT02556918|Hormones|hormones|mesh-ancestor
101627187|NCT00808210|Glucocorticoids|glucocorticoids|mesh-ancestor
102494523|NCT02556918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102494524|NCT02556918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102494525|NCT02556918|Protease Inhibitors|protease inhibitors|mesh-ancestor
102494526|NCT02556918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102494527|NCT02556918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494528|NCT00379756|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
102494529|NCT00379756|Vasodilator Agents|vasodilator agents|mesh-ancestor
102494530|NCT00379756|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102494531|NCT00379756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102494532|NCT00379756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102494533|NCT00379756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494534|NCT00379756|Urological Agents|urological agents|mesh-ancestor
102494535|NCT02518750|Cytarabine|cytarabine|mesh-list
102494536|NCT02518750|Dexamethasone|dexamethasone|mesh-list
102494537|NCT02518750|Hydrocortisone|hydrocortisone|mesh-list
102494538|NCT02518750|Cyclophosphamide|cyclophosphamide|mesh-list
102494539|NCT02518750|Methotrexate|methotrexate|mesh-list
102494540|NCT02518750|Etoposide|etoposide|mesh-list
102494541|NCT02518750|Vincristine|vincristine|mesh-list
102494542|NCT02518750|Bortezomib|bortezomib|mesh-list
102494543|NCT02518750|Asparaginase|asparaginase|mesh-list
102494544|NCT02518750|Mitoxantrone|mitoxantrone|mesh-list
102494545|NCT02518750|Mercaptopurine|mercaptopurine|mesh-list
102494546|NCT02518750|Clofarabine|clofarabine|mesh-list
102494547|NCT02518750|Panobinostat|panobinostat|mesh-list
102494548|NCT02518750|Pegaspargase|pegaspargase|mesh-list
102494549|NCT02518750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102494550|NCT02518750|Immunologic Factors|immunologic factors|mesh-ancestor
102494551|NCT02518750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494552|NCT02518750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102494553|NCT02518750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102494554|NCT02518750|Alkylating Agents|alkylating agents|mesh-ancestor
102494555|NCT02518750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494556|NCT02518750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102494557|NCT02518750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102494558|NCT02518750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102494559|NCT02518750|Antiemetics|antiemetics|mesh-ancestor
102494560|NCT02518750|Autonomic Agents|autonomic agents|mesh-ancestor
102494561|NCT02518750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102494562|NCT02518750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102494563|NCT02518750|Glucocorticoids|glucocorticoids|mesh-ancestor
102494564|NCT02518750|Hormones|hormones|mesh-ancestor
102494565|NCT02518750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102494566|NCT02518750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102494567|NCT02518750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102494568|NCT02518750|Abortifacient Agents|abortifacient agents|mesh-ancestor
102494569|NCT02518750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102494570|NCT02518750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102494571|NCT02518750|Antimetabolites|antimetabolites|mesh-ancestor
102494572|NCT02518750|Dermatologic Agents|dermatologic agents|mesh-ancestor
102494573|NCT02518750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102494574|NCT02518750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102306169|NCT04953923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102494575|NCT02518750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102494576|NCT02518750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102494577|NCT02518750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102494578|NCT02518750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102494579|NCT02518750|Antiviral Agents|antiviral agents|mesh-ancestor
102494580|NCT02518750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102494581|NCT02518750|Tubulin Modulators|tubulin modulators|mesh-ancestor
102494582|NCT02518750|Antimitotic Agents|antimitotic agents|mesh-ancestor
102494583|NCT02518750|Mitosis Modulators|mitosis modulators|mesh-ancestor
102494584|NCT02518750|Analgesics|analgesics|mesh-ancestor
102494585|NCT02518750|Sensory System Agents|sensory system agents|mesh-ancestor
102494586|NCT02518750|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102494587|NCT01194856|Ritonavir|ritonavir|mesh-list
102494588|NCT01194856|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102494589|NCT01194856|Efavirenz|efavirenz|mesh-list
102494590|NCT01194856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102494591|NCT01194856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102494592|NCT01194856|Protease Inhibitors|protease inhibitors|mesh-ancestor
102494593|NCT01194856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102494594|NCT01194856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494595|NCT01194856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102494596|NCT01194856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102494597|NCT01194856|Antiviral Agents|antiviral agents|mesh-ancestor
102494598|NCT01194856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102494599|NCT01194856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102494600|NCT01194856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102494601|NCT01194856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102494602|NCT01194856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102494603|NCT01194856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102494604|NCT01194856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102494605|NCT01194856|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102494606|NCT01194856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102494607|NCT01194856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102494608|NCT01182610|Paclitaxel|paclitaxel|mesh-list
102494609|NCT01182610|Carboplatin|carboplatin|mesh-list
102494610|NCT01182610|Fluorouracil|fluorouracil|mesh-list
102494611|NCT01182610|Panitumumab|panitumumab|mesh-list
102494612|NCT01182610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102494613|NCT01182610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102494614|NCT01182610|Tubulin Modulators|tubulin modulators|mesh-ancestor
102494615|NCT01182610|Antimitotic Agents|antimitotic agents|mesh-ancestor
102494616|NCT01182610|Mitosis Modulators|mitosis modulators|mesh-ancestor
102494617|NCT01182610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494618|NCT01182610|Antimetabolites|antimetabolites|mesh-ancestor
102494619|NCT01182610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102494620|NCT01182610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102494621|NCT01182610|Immunologic Factors|immunologic factors|mesh-ancestor
102494622|NCT01182610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494623|NCT01182610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102494624|NCT05491902|Flutemetamol|flutemetamol|mesh-list
102494625|NCT05491902|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102494626|NCT05491902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494627|NCT05485896|Pembrolizumab|pembrolizumab|mesh-list
102494628|NCT05485896|Lenvatinib|lenvatinib|mesh-list
102494629|NCT05485896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102494630|NCT05485896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102494631|NCT05485896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102494632|NCT05485896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494633|NCT05485896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102494634|NCT05485896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102494635|NCT05507398|Metformin|metformin|mesh-list
102494636|NCT05507398|Atorvastatin|atorvastatin|mesh-list
102494637|NCT05507398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102494638|NCT05507398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494639|NCT05507398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102494640|NCT05507398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102494641|NCT05507398|Antimetabolites|antimetabolites|mesh-ancestor
102494642|NCT05507398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494643|NCT05507398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102494644|NCT05507398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102494645|NCT05507398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102494646|NCT05487300|Levodopa|levodopa|mesh-list
102494647|NCT05487300|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102494648|NCT05487300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102494649|NCT05487300|Dopamine Agents|dopamine agents|mesh-ancestor
102494650|NCT05487300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102494651|NCT05487300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494652|NCT05487300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494653|NCT01147042|Interferons|interferons|mesh-list
102494654|NCT01147042|Interferon-gamma|interferon-gamma|mesh-list
102494655|NCT01147042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102494656|NCT01147042|Antiviral Agents|antiviral agents|mesh-ancestor
102494657|NCT01147042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102494659|NCT05485272|Cariostatic Agents|cariostatic agents|mesh-ancestor
102494660|NCT05485272|Protective Agents|protective agents|mesh-ancestor
102494661|NCT05485272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494662|NCT01108666|Nelfinavir|nelfinavir|mesh-list
102494663|NCT01108666|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102494664|NCT01108666|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102494665|NCT01108666|Protease Inhibitors|protease inhibitors|mesh-ancestor
102494666|NCT01108666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102494667|NCT01108666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494668|NCT01108666|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102494669|NCT01108666|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102494670|NCT01108666|Antiviral Agents|antiviral agents|mesh-ancestor
102494671|NCT01108666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102494672|NCT02317276|Triamcinolone|triamcinolone|mesh-list
102494673|NCT02317276|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102494674|NCT02317276|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102494675|NCT02317276|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102494676|NCT02317276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102494677|NCT02317276|Glucocorticoids|glucocorticoids|mesh-ancestor
102494678|NCT02317276|Hormones|hormones|mesh-ancestor
102494679|NCT02317276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102494680|NCT02317276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494681|NCT02317276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102494682|NCT02317276|Immunologic Factors|immunologic factors|mesh-ancestor
102494683|NCT02317276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102494684|NCT02317276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494685|NCT01662492|Botulinum Toxins|botulinum toxins|mesh-list
102494686|NCT01662492|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102494687|NCT01662492|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102494688|NCT01662492|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102494689|NCT01662492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102494690|NCT01662492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494691|NCT01662492|Cholinergic Agents|cholinergic agents|mesh-ancestor
102494692|NCT01662492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102494693|NCT01662492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494694|NCT01662492|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102494695|NCT01662492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102494696|NCT00378976|Valacyclovir|valacyclovir|mesh-list
102494697|NCT00378976|Antiviral Agents|antiviral agents|mesh-ancestor
102494698|NCT00378976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102494699|NCT05342974|Misoprostol|misoprostol|mesh-list
102494700|NCT05342974|Atorvastatin|atorvastatin|mesh-list
102494701|NCT05342974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102494702|NCT05342974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102494703|NCT05342974|Antimetabolites|antimetabolites|mesh-ancestor
102494704|NCT05342974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494705|NCT05342974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102494706|NCT05342974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102494707|NCT05342974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102494708|NCT05342974|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102494709|NCT05342974|Abortifacient Agents|abortifacient agents|mesh-ancestor
102494710|NCT05342974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102494711|NCT05342974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494712|NCT05342974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102494713|NCT05342974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102494714|NCT05342974|Oxytocics|oxytocics|mesh-ancestor
102494715|NCT02297230|Paclitaxel|paclitaxel|mesh-list
102494716|NCT02297230|Capecitabine|capecitabine|mesh-list
102494717|NCT02297230|Trastuzumab|trastuzumab|mesh-list
102494718|NCT02297230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102494719|NCT02297230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102494720|NCT02297230|Tubulin Modulators|tubulin modulators|mesh-ancestor
102494721|NCT02297230|Antimitotic Agents|antimitotic agents|mesh-ancestor
102494722|NCT02297230|Mitosis Modulators|mitosis modulators|mesh-ancestor
102494723|NCT02297230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494724|NCT02297230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102494725|NCT02297230|Antimetabolites|antimetabolites|mesh-ancestor
102494726|NCT02297230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102494727|NCT02282332|Ticagrelor|ticagrelor|mesh-list
102494728|NCT02282332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102494729|NCT02282332|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102494730|NCT02282332|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102494731|NCT02282332|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102494732|NCT02282332|Purinergic Agents|purinergic agents|mesh-ancestor
102494733|NCT02282332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102494734|NCT02282332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494735|NCT02282332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494736|NCT02287636|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102494737|NCT02287636|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102494738|NCT02287636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494739|NCT05486988|Antineoplastic Agents|antineoplastic agents|mesh-list
102494740|NCT02253394|Ambrisentan|ambrisentan|mesh-list
102494741|NCT02253394|Spironolactone|spironolactone|mesh-list
102494742|NCT02253394|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102494743|NCT02253394|Hormone Antagonists|hormone antagonists|mesh-ancestor
102494744|NCT02253394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102494745|NCT02253394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494746|NCT02253394|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102494747|NCT02253394|Diuretics|diuretics|mesh-ancestor
102494748|NCT02253394|Natriuretic Agents|natriuretic agents|mesh-ancestor
102494749|NCT02253394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102494750|NCT05479032|Amantadine|amantadine|mesh-list
102494751|NCT05479032|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102494752|NCT05479032|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102494753|NCT05479032|Antiviral Agents|antiviral agents|mesh-ancestor
102494754|NCT05479032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102494755|NCT05479032|Dopamine Agents|dopamine agents|mesh-ancestor
102494756|NCT05479032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102494757|NCT05479032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494758|NCT05479032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494759|NCT05479032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102494760|NCT05479032|Analgesics|analgesics|mesh-ancestor
102494761|NCT05479032|Sensory System Agents|sensory system agents|mesh-ancestor
102494762|NCT05479032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102494763|NCT02236546|Deoxyglucose|deoxyglucose|mesh-list
102494764|NCT02236546|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102494765|NCT02236546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102494766|NCT02236546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494767|NCT02236546|Antimetabolites|antimetabolites|mesh-ancestor
102494768|NCT02236546|Antiviral Agents|antiviral agents|mesh-ancestor
102494769|NCT02236546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102494770|NCT05484648|Dexamethasone|dexamethasone|mesh-list
102494771|NCT05484648|Dexmedetomidine|dexmedetomidine|mesh-list
102494772|NCT05484648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102494773|NCT05484648|Antiemetics|antiemetics|mesh-ancestor
102494774|NCT05484648|Autonomic Agents|autonomic agents|mesh-ancestor
102494775|NCT05484648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102494776|NCT05484648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494777|NCT05484648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102494778|NCT05484648|Glucocorticoids|glucocorticoids|mesh-ancestor
102494779|NCT05484648|Hormones|hormones|mesh-ancestor
102494780|NCT05484648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102494781|NCT05484648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102494782|NCT05484648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102494783|NCT05484648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102494784|NCT05484648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102494785|NCT05484648|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102494786|NCT05484648|Analgesics|analgesics|mesh-ancestor
102494787|NCT05484648|Sensory System Agents|sensory system agents|mesh-ancestor
102494788|NCT05484648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102494789|NCT05484648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102494790|NCT05484648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102494791|NCT05484648|Adrenergic Agents|adrenergic agents|mesh-ancestor
102494792|NCT05484648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102494793|NCT05484648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494794|NCT05478954|Pyrimethamine|pyrimethamine|mesh-list
102494795|NCT05478954|Sulfadoxine|sulfadoxine|mesh-list
102494796|NCT05478954|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
102494797|NCT05478954|Amodiaquine|amodiaquine|mesh-list
102494799|NCT05478954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102494800|NCT05478954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102494801|NCT05478954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102494802|NCT05478954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102494803|NCT05478954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102494804|NCT05478954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494805|NCT05478954|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102494806|NCT02137096|Carboplatin|carboplatin|mesh-list
102494807|NCT02137096|Etoposide|etoposide|mesh-list
102494808|NCT02137096|Ifosfamide|ifosfamide|mesh-list
102494809|NCT02137096|Etoposide phosphate|etoposide phosphate|mesh-list
102494810|NCT02137096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102494811|NCT02137096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102494812|NCT02137096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102494813|NCT02137096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102494814|NCT02137096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102494815|NCT02137096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494816|NCT02137096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102494817|NCT02137096|Alkylating Agents|alkylating agents|mesh-ancestor
102494818|NCT02130622|Promethazine|promethazine|mesh-list
102494819|NCT02130622|Diphenhydramine|diphenhydramine|mesh-list
102494820|NCT02130622|Antipruritics|antipruritics|mesh-ancestor
102494821|NCT02130622|Dermatologic Agents|dermatologic agents|mesh-ancestor
102494822|NCT02130622|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102494823|NCT02130622|Histamine Antagonists|histamine antagonists|mesh-ancestor
102494824|NCT02130622|Histamine Agents|histamine agents|mesh-ancestor
102494825|NCT02130622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102494826|NCT02130622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494827|NCT02130622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494828|NCT02130622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102494829|NCT02130622|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102494830|NCT02130622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102494831|NCT02130622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102494832|NCT02130622|Anesthetics, Local|anesthetics, local|mesh-ancestor
102494833|NCT02130622|Anesthetics|anesthetics|mesh-ancestor
102494834|NCT02130622|Sensory System Agents|sensory system agents|mesh-ancestor
102494835|NCT02130622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102494836|NCT02130622|Antiemetics|antiemetics|mesh-ancestor
102494837|NCT02130622|Autonomic Agents|autonomic agents|mesh-ancestor
102494838|NCT02130622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102494839|NCT02134912|Pemetrexed|pemetrexed|mesh-list
102494840|NCT02134912|Crizotinib|crizotinib|mesh-list
102494841|NCT02134912|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102494842|NCT02134912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102494843|NCT02134912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102494844|NCT02134912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494845|NCT02134912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102494846|NCT02134912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102494847|NCT02134912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102494848|NCT02094352|Ketamine|ketamine|mesh-list
102494849|NCT02094352|Analgesics|analgesics|mesh-ancestor
102494850|NCT02094352|Sensory System Agents|sensory system agents|mesh-ancestor
102494851|NCT02094352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102494852|NCT02094352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494853|NCT02094352|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102494854|NCT02094352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102494855|NCT02094352|Anesthetics, General|anesthetics, general|mesh-ancestor
102494856|NCT02094352|Anesthetics|anesthetics|mesh-ancestor
102494857|NCT02094352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102494858|NCT02094352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102494859|NCT02094352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102494860|NCT02094352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102494861|NCT02094352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494862|NCT05478876|Immunomodulating Agents|immunomodulating agents|mesh-list
102494863|NCT05478876|Immunologic Factors|immunologic factors|mesh-ancestor
102494864|NCT05478876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494865|NCT01188421|Clonidine|clonidine|mesh-list
102494866|NCT01188421|Buprenorphine|buprenorphine|mesh-list
102494867|NCT01188421|Tramadol|tramadol|mesh-list
102494868|NCT01188421|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102494869|NCT01188421|Naloxone|naloxone|mesh-list
102494870|NCT01188421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102494871|NCT01188421|Narcotics|narcotics|mesh-ancestor
102494872|NCT01188421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102494873|NCT01188421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494874|NCT01188421|Analgesics|analgesics|mesh-ancestor
102494875|NCT01188421|Sensory System Agents|sensory system agents|mesh-ancestor
102494876|NCT01188421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102494877|NCT01188421|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102494878|NCT01188421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102494879|NCT01188421|Sympatholytics|sympatholytics|mesh-ancestor
102494880|NCT01188421|Autonomic Agents|autonomic agents|mesh-ancestor
102494881|NCT01188421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102494882|NCT01188421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102494883|NCT01188421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102494884|NCT01188421|Adrenergic Agents|adrenergic agents|mesh-ancestor
102494885|NCT01188421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102494886|NCT01188421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494887|NCT01006018|Pioglitazone|pioglitazone|mesh-list
102494888|NCT01006018|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102494889|NCT01006018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102494890|NCT01006018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494891|NCT01006018|Incretins|incretins|mesh-ancestor
102494892|NCT01006018|Hormones|hormones|mesh-ancestor
102494893|NCT01006018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102494894|NCT01006018|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102494895|NCT01006018|Protease Inhibitors|protease inhibitors|mesh-ancestor
102494896|NCT01006018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102494897|NCT01006018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494898|NCT00996502|Prednisone|prednisone|mesh-list
102494899|NCT00996502|Bevacizumab|bevacizumab|mesh-list
102494900|NCT00996502|Docetaxel|docetaxel|mesh-list
102494901|NCT00996502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102494902|NCT00996502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102494903|NCT00996502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102494904|NCT00996502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102494905|NCT00996502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102494906|NCT00996502|Growth Substances|growth substances|mesh-ancestor
102494907|NCT00996502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494908|NCT00996502|Growth Inhibitors|growth inhibitors|mesh-ancestor
102494909|NCT00996502|Tubulin Modulators|tubulin modulators|mesh-ancestor
102494910|NCT00996502|Antimitotic Agents|antimitotic agents|mesh-ancestor
102494911|NCT00996502|Mitosis Modulators|mitosis modulators|mesh-ancestor
102494912|NCT00996502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494913|NCT00996502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102494914|NCT00996502|Glucocorticoids|glucocorticoids|mesh-ancestor
102494915|NCT00996502|Hormones|hormones|mesh-ancestor
102494916|NCT00996502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102494917|NCT00996502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102494918|NCT00996502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102494919|NCT00996502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102494920|NCT00984490|Metformin|metformin|mesh-list
102494921|NCT00984490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102494922|NCT00984490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494923|NCT05484024|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102494924|NCT05484024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494925|NCT05484024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102494926|NCT05484024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102494927|NCT02027272|Dexamethasone|dexamethasone|mesh-list
102494928|NCT02027272|Glucocorticoids|glucocorticoids|mesh-list
102494929|NCT02027272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102494930|NCT02027272|Antiemetics|antiemetics|mesh-ancestor
101627593|NCT02692989|Anesthetics|anesthetics|mesh-list
102494931|NCT02027272|Autonomic Agents|autonomic agents|mesh-ancestor
102494932|NCT02027272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102494933|NCT02027272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494934|NCT02027272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102494935|NCT02027272|Hormones|hormones|mesh-ancestor
102494936|NCT02027272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102494937|NCT02027272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102494938|NCT02027272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102494939|NCT05475444|Ciprofloxacin|ciprofloxacin|mesh-list
102494940|NCT05475444|Chitosan|chitosan|mesh-list
102494941|NCT05475444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102494942|NCT05475444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102494943|NCT05475444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102494944|NCT05475444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102494945|NCT05475444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102494946|NCT05475444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494947|NCT05475444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102494948|NCT05475444|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102494949|NCT05475444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102494950|NCT05475444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102494951|NCT05475444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102494952|NCT05475444|Antimetabolites|antimetabolites|mesh-ancestor
102494953|NCT05475444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102494954|NCT05475444|Chelating Agents|chelating agents|mesh-ancestor
102494955|NCT05475444|Sequestering Agents|sequestering agents|mesh-ancestor
102494956|NCT05475444|Hemostatics|hemostatics|mesh-ancestor
102494957|NCT05475444|Coagulants|coagulants|mesh-ancestor
102494958|NCT03472092|Amitriptyline|amitriptyline|mesh-list
102494959|NCT03472092|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102494960|NCT03472092|Antidepressive Agents|antidepressive agents|mesh-ancestor
102494961|NCT03472092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102494962|NCT03472092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102494963|NCT03472092|Analgesics|analgesics|mesh-ancestor
102494964|NCT03472092|Sensory System Agents|sensory system agents|mesh-ancestor
102494965|NCT03472092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102494966|NCT03472092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494967|NCT03472092|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102494968|NCT03472092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102494969|NCT03472092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102494970|NCT03472092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494971|NCT03472092|Adrenergic Agents|adrenergic agents|mesh-ancestor
102494972|NCT03472092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102494973|NCT01996852|Sildenafil Citrate|sildenafil citrate|mesh-list
102494974|NCT01996852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494975|NCT01996852|Vasodilator Agents|vasodilator agents|mesh-ancestor
102494976|NCT01996852|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102494977|NCT01996852|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102494978|NCT01996852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102494979|NCT01996852|Urological Agents|urological agents|mesh-ancestor
102494980|NCT05478330|Flutamide|flutamide|mesh-list
102494981|NCT05478330|Androgen Antagonists|androgen antagonists|mesh-ancestor
102494982|NCT05478330|Hormone Antagonists|hormone antagonists|mesh-ancestor
102494983|NCT05478330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102494984|NCT05478330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102494985|NCT05478330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102494986|NCT05478330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102494987|NCT00978874|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102494988|NCT00978874|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102494989|NCT00978874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494990|NCT04331626|Gemcitabine|gemcitabine|mesh-list
102494991|NCT04331626|Nivolumab|nivolumab|mesh-list
102494992|NCT04331626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102494993|NCT04331626|Antimetabolites|antimetabolites|mesh-ancestor
102494994|NCT04331626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102494995|NCT04331626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101627667|NCT04085575|Coagulants|coagulants|mesh-ancestor
102494996|NCT04331626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102494997|NCT04331626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102494998|NCT03699540|Ethanol|ethanol|mesh-list
102494999|NCT03699540|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102495000|NCT03699540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102495001|NCT03699540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102495002|NCT03699540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495003|NCT00970606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102495004|NCT00970606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102495005|NCT00970606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102495006|NCT00970606|Antimetabolites|antimetabolites|mesh-ancestor
102495007|NCT00970606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495008|NCT00970606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102495009|NCT00970606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102495010|NCT00970606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102495011|NCT01973062|Rituximab|rituximab|mesh-list
102495012|NCT01973062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102495013|NCT01973062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102495014|NCT01973062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102495015|NCT01973062|Immunologic Factors|immunologic factors|mesh-ancestor
102495016|NCT01973062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495017|NCT01973062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102495018|NCT03661320|Gemcitabine|gemcitabine|mesh-list
102495019|NCT03661320|Nivolumab|nivolumab|mesh-list
102495020|NCT03661320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102495021|NCT03661320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102495022|NCT03661320|Antimetabolites|antimetabolites|mesh-ancestor
102495023|NCT03661320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495024|NCT03661320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102495025|NCT03661320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102495027|NCT00981370|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102495028|NCT00981370|Chelating Agents|chelating agents|mesh-ancestor
102495029|NCT00981370|Sequestering Agents|sequestering agents|mesh-ancestor
102495030|NCT00981370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495031|NCT00979810|Alovudine|alovudine|mesh-list
102495032|NCT00979810|Antiviral Agents|antiviral agents|mesh-ancestor
102495033|NCT00979810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102495034|NCT00947284|Nalbuphine|nalbuphine|mesh-list
102495035|NCT00947284|Naloxone|naloxone|mesh-list
102495036|NCT00947284|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102495037|NCT00947284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495038|NCT00947284|Sensory System Agents|sensory system agents|mesh-ancestor
102495039|NCT00947284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102495040|NCT00947284|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102495041|NCT00947284|Narcotics|narcotics|mesh-ancestor
102495042|NCT00947284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102495043|NCT00947284|Analgesics|analgesics|mesh-ancestor
102495044|NCT00932152|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102495045|NCT00932152|Bevacizumab|bevacizumab|mesh-list
102495046|NCT00932152|Fulvestrant|fulvestrant|mesh-list
102495047|NCT00932152|Anastrozole|anastrozole|mesh-list
102495048|NCT00932152|Analgesics|analgesics|mesh-list
102495049|NCT00932152|Antiemetics|antiemetics|mesh-list
102495050|NCT00932152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102495051|NCT00932152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102495052|NCT00932152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102495053|NCT00932152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102495054|NCT00932152|Growth Substances|growth substances|mesh-ancestor
102495055|NCT00932152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495056|NCT00932152|Growth Inhibitors|growth inhibitors|mesh-ancestor
102495057|NCT00932152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102495058|NCT00932152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102495059|NCT00932152|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102495060|NCT00932152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102495061|NCT00932152|Hormone Antagonists|hormone antagonists|mesh-ancestor
102495062|NCT00932152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102495063|NCT00932152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102495064|NCT00932152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102495065|NCT00932152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102495066|NCT00932152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495067|NCT00932152|Sensory System Agents|sensory system agents|mesh-ancestor
102495068|NCT00932152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102495069|NCT00932152|Autonomic Agents|autonomic agents|mesh-ancestor
102495070|NCT00932152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102495071|NCT01916590|Bupivacaine|bupivacaine|mesh-list
102495072|NCT01916590|Anesthetics, Local|anesthetics, local|mesh-ancestor
102495073|NCT01916590|Anesthetics|anesthetics|mesh-ancestor
102495074|NCT01916590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102495075|NCT01916590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495076|NCT01916590|Sensory System Agents|sensory system agents|mesh-ancestor
102495077|NCT01916590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102495078|NCT01890694|Tolvaptan|tolvaptan|mesh-list
102495079|NCT01890694|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102495080|NCT01890694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495081|NCT01890694|Natriuretic Agents|natriuretic agents|mesh-ancestor
102495082|NCT01890694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495083|NCT05474898|Magnesium Sulfate|magnesium sulfate|mesh-list
102495084|NCT05474898|Analgesics|analgesics|mesh-ancestor
102495085|NCT05474898|Sensory System Agents|sensory system agents|mesh-ancestor
102495086|NCT05474898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102495087|NCT05474898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495088|NCT05474898|Anesthetics|anesthetics|mesh-ancestor
102495089|NCT05474898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102495090|NCT05474898|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102495091|NCT05474898|Anticonvulsants|anticonvulsants|mesh-ancestor
102495092|NCT05474898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102495093|NCT05474898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102495094|NCT05474898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495095|NCT05474898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102495096|NCT05474898|Tocolytic Agents|tocolytic agents|mesh-ancestor
102495097|NCT05474898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102495098|NCT03428958|Leucovorin|leucovorin|mesh-list
102495099|NCT03428958|Bevacizumab|bevacizumab|mesh-list
102495100|NCT03428958|Cetuximab|cetuximab|mesh-list
102495101|NCT03428958|Panitumumab|panitumumab|mesh-list
102495102|NCT03428958|Oxaliplatin|oxaliplatin|mesh-list
102495103|NCT03428958|Irinotecan|irinotecan|mesh-list
102495104|NCT03428958|Levoleucovorin|levoleucovorin|mesh-list
102495105|NCT03428958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102495106|NCT03428958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102495107|NCT03428958|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102495108|NCT03428958|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102495109|NCT03428958|Growth Substances|growth substances|mesh-ancestor
102495110|NCT03428958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495111|NCT03428958|Growth Inhibitors|growth inhibitors|mesh-ancestor
102495112|NCT03428958|Antidotes|antidotes|mesh-ancestor
102495113|NCT03428958|Protective Agents|protective agents|mesh-ancestor
102495114|NCT03428958|Vitamin B Complex|vitamin b complex|mesh-ancestor
102495115|NCT03428958|Vitamins|vitamins|mesh-ancestor
102495116|NCT03428958|Micronutrients|micronutrients|mesh-ancestor
102495117|NCT03428958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102495118|NCT03428958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102495119|NCT03428958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102495120|NCT03428958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495121|NCT01844206|Morphine|morphine|mesh-list
102495122|NCT01844206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102495123|NCT01844206|Narcotics|narcotics|mesh-ancestor
102495124|NCT01844206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102495125|NCT01844206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495126|NCT01844206|Analgesics|analgesics|mesh-ancestor
102495127|NCT01844206|Sensory System Agents|sensory system agents|mesh-ancestor
102495128|NCT01844206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102495129|NCT03626454|Norepinephrine|norepinephrine|mesh-list
102495130|NCT03626454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102495131|NCT03626454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102495132|NCT03626454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102495133|NCT03626454|Adrenergic Agents|adrenergic agents|mesh-ancestor
102495134|NCT03626454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102495135|NCT03626454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495136|NCT03626454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495137|NCT03626454|Sympathomimetics|sympathomimetics|mesh-ancestor
102495138|NCT03626454|Autonomic Agents|autonomic agents|mesh-ancestor
102495139|NCT03626454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102495140|NCT03626454|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102495141|NCT01830790|Sildenafil Citrate|sildenafil citrate|mesh-list
102495142|NCT01830790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495143|NCT01830790|Vasodilator Agents|vasodilator agents|mesh-ancestor
102495144|NCT01830790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102495145|NCT01830790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102495146|NCT01830790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102495147|NCT01830790|Urological Agents|urological agents|mesh-ancestor
102495148|NCT01662102|Rituximab|rituximab|mesh-list
102495149|NCT01662102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102495150|NCT01662102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102495151|NCT01662102|Immunologic Factors|immunologic factors|mesh-ancestor
102495152|NCT01662102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495153|NCT01662102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102495154|NCT03950076|Edoxaban|edoxaban|mesh-list
102495155|NCT03950076|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102495156|NCT03950076|Antithrombins|antithrombins|mesh-ancestor
102495157|NCT03950076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102495158|NCT03950076|Protease Inhibitors|protease inhibitors|mesh-ancestor
102495159|NCT03950076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102495160|NCT03950076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495161|NCT03950076|Anticoagulants|anticoagulants|mesh-ancestor
102495162|NCT05292976|Albuterol|albuterol|mesh-list
102495163|NCT05292976|Methacholine Chloride|methacholine chloride|mesh-list
102495164|NCT05292976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102495165|NCT05292976|Autonomic Agents|autonomic agents|mesh-ancestor
102495166|NCT05292976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102495167|NCT05292976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495168|NCT05292976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102495169|NCT05292976|Respiratory System Agents|respiratory system agents|mesh-ancestor
102495170|NCT05292976|Tocolytic Agents|tocolytic agents|mesh-ancestor
102495171|NCT05292976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102495172|NCT05292976|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102495173|NCT05292976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102495174|NCT05292976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102495175|NCT05292976|Adrenergic Agents|adrenergic agents|mesh-ancestor
102495176|NCT05292976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102495177|NCT05292976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495179|NCT05292976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102495180|NCT05292976|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
102495181|NCT05292976|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102495182|NCT05292976|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102495183|NCT05292976|Cholinergic Agents|cholinergic agents|mesh-ancestor
102495184|NCT00850720|Hydrocortisone|hydrocortisone|mesh-list
102495185|NCT00850720|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102495186|NCT00850720|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102495187|NCT00850720|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102495188|NCT00850720|Vasopressins|vasopressins|mesh-list
102495189|NCT00850720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495190|NCT00850720|Hemostatics|hemostatics|mesh-ancestor
102495191|NCT00850720|Coagulants|coagulants|mesh-ancestor
102495192|NCT00850720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102495193|NCT00850720|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102495194|NCT00850720|Natriuretic Agents|natriuretic agents|mesh-ancestor
102495195|NCT00850720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102495196|NCT00843310|Dexamethasone|dexamethasone|mesh-list
102495197|NCT00843310|Lenalidomide|lenalidomide|mesh-list
102495198|NCT00843310|Melphalan|melphalan|mesh-list
102495199|NCT00843310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102495200|NCT00843310|Antiemetics|antiemetics|mesh-ancestor
102495201|NCT00843310|Autonomic Agents|autonomic agents|mesh-ancestor
102495202|NCT00843310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102495203|NCT00843310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495204|NCT00843310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102495205|NCT00843310|Glucocorticoids|glucocorticoids|mesh-ancestor
102495206|NCT00843310|Hormones|hormones|mesh-ancestor
102495207|NCT00843310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102495208|NCT00843310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102495209|NCT00843310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102495210|NCT00843310|Immunologic Factors|immunologic factors|mesh-ancestor
102495211|NCT00843310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102495212|NCT00843310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102495213|NCT00843310|Growth Substances|growth substances|mesh-ancestor
102495214|NCT00843310|Growth Inhibitors|growth inhibitors|mesh-ancestor
102495215|NCT00843310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102495216|NCT00843310|Alkylating Agents|alkylating agents|mesh-ancestor
102495217|NCT00843310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495218|NCT00843310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102495219|NCT00843310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102495220|NCT00809458|Vitamin E|vitamin e|mesh-list
102495221|NCT00809458|Tocopherols|tocopherols|mesh-list
102495222|NCT00809458|Tocotrienols|tocotrienols|mesh-list
102495223|NCT00809458|alpha-Tocopherol|alpha-tocopherol|mesh-list
102495224|NCT00809458|Vitamins|vitamins|mesh-ancestor
102495225|NCT00809458|Micronutrients|micronutrients|mesh-ancestor
102495226|NCT00809458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495227|NCT00809458|Antioxidants|antioxidants|mesh-ancestor
102495228|NCT00809458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495229|NCT00809458|Protective Agents|protective agents|mesh-ancestor
102495230|NCT01701622|Febuxostat|febuxostat|mesh-list
102495231|NCT01701622|Gout Suppressants|gout suppressants|mesh-ancestor
102495232|NCT01701622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102495233|NCT01675960|Gabapentin|gabapentin|mesh-list
102495234|NCT01675960|Analgesics|analgesics|mesh-ancestor
102495235|NCT01675960|Sensory System Agents|sensory system agents|mesh-ancestor
102495236|NCT01675960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102495237|NCT01675960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495238|NCT01675960|Anticonvulsants|anticonvulsants|mesh-ancestor
102495239|NCT01675960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102495240|NCT01675960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102495241|NCT01675960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102495242|NCT01675960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102495243|NCT01675960|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102495244|NCT01675960|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102495245|NCT01675960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102495246|NCT01675960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495247|NCT01675960|Antimanic Agents|antimanic agents|mesh-ancestor
102306851|NCT02458469|Buspirone|buspirone|mesh-list
102495248|NCT01607320|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
102495249|NCT01607320|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102495250|NCT01607320|Clomiphene|clomiphene|mesh-list
102495251|NCT01607320|Medroxyprogesterone|medroxyprogesterone|mesh-list
102495252|NCT01607320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102495253|NCT01607320|Hormone Antagonists|hormone antagonists|mesh-ancestor
102495254|NCT01607320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102495255|NCT01607320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495256|NCT01607320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102495257|NCT01607320|Fertility Agents|fertility agents|mesh-ancestor
102495258|NCT01607320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102495259|NCT01607320|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102495260|NCT01607320|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102495261|NCT01607320|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102495262|NCT01607320|Contraceptive Agents|contraceptive agents|mesh-ancestor
102495263|NCT01607320|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102495264|NCT01607320|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102495265|NCT01607320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102495266|NCT01607320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102495267|NCT01607320|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102495268|NCT01607320|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102495269|NCT01607320|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102495270|NCT01607320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102495271|NCT01606150|Lidocaine|lidocaine|mesh-list
102495272|NCT01606150|Anesthetics, Local|anesthetics, local|mesh-ancestor
102495273|NCT01606150|Anesthetics|anesthetics|mesh-ancestor
102495274|NCT01606150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102495275|NCT01606150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495276|NCT01606150|Sensory System Agents|sensory system agents|mesh-ancestor
102495277|NCT01606150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102495278|NCT01606150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102495279|NCT01606150|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102495280|NCT01606150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102495281|NCT01606150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102495282|NCT01606150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495283|NCT01602016|Leucovorin|leucovorin|mesh-list
102495284|NCT01602016|Folic Acid|folic acid|mesh-list
102495285|NCT01602016|Levoleucovorin|levoleucovorin|mesh-list
102495286|NCT01602016|Antidotes|antidotes|mesh-ancestor
102495287|NCT01602016|Protective Agents|protective agents|mesh-ancestor
102495288|NCT01602016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495289|NCT01602016|Vitamin B Complex|vitamin b complex|mesh-ancestor
102495290|NCT01602016|Vitamins|vitamins|mesh-ancestor
102495291|NCT01602016|Micronutrients|micronutrients|mesh-ancestor
102495292|NCT01602016|Hematinics|hematinics|mesh-ancestor
102495293|NCT00731770|Fluticasone|fluticasone|mesh-list
102495295|NCT00731770|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102495296|NCT00731770|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102495297|NCT00731770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102495298|NCT00731770|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102495299|NCT00731770|Autonomic Agents|autonomic agents|mesh-ancestor
102495300|NCT00731770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102495301|NCT00731770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495302|NCT00731770|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102495303|NCT00731770|Respiratory System Agents|respiratory system agents|mesh-ancestor
102495304|NCT00731770|Dermatologic Agents|dermatologic agents|mesh-ancestor
102495305|NCT00731770|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102495306|NCT00731770|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102495307|NCT00731770|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102495308|NCT00731770|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102495309|NCT00731770|Adrenergic Agents|adrenergic agents|mesh-ancestor
102495310|NCT00731770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102495311|NCT00731770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495312|NCT00731770|Glucocorticoids|glucocorticoids|mesh-ancestor
102495313|NCT00731770|Hormones|hormones|mesh-ancestor
102495314|NCT00731770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102495315|NCT00731770|Sympathomimetics|sympathomimetics|mesh-ancestor
102495316|NCT00719914|Eptifibatide|eptifibatide|mesh-list
102495317|NCT00719914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102495318|NCT01566370|Zonisamide|zonisamide|mesh-list
102495319|NCT01566370|Anticonvulsants|anticonvulsants|mesh-ancestor
102495320|NCT01566370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102495321|NCT01566370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102306929|NCT02457611|Sofosbuvir|sofosbuvir|mesh-list
102495322|NCT01566370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495323|NCT01566370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102495324|NCT01566370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495325|NCT03414684|Carboplatin|carboplatin|mesh-list
102495326|NCT03414684|Nivolumab|nivolumab|mesh-list
102495327|NCT03414684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102495328|NCT03414684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102495329|NCT03414684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102495330|NCT03414684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495331|NCT01558492|Paclitaxel|paclitaxel|mesh-list
102495332|NCT01558492|Carboplatin|carboplatin|mesh-list
102495333|NCT01558492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102495334|NCT01558492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102495335|NCT01558492|Tubulin Modulators|tubulin modulators|mesh-ancestor
102495336|NCT01558492|Antimitotic Agents|antimitotic agents|mesh-ancestor
102495337|NCT01558492|Mitosis Modulators|mitosis modulators|mesh-ancestor
101628004|NCT02731612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495338|NCT01558492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495339|NCT03579472|Halichondrin B|halichondrin b|mesh-list
102495340|NCT03579472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495341|NCT03579472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102495342|NCT03579472|Tubulin Modulators|tubulin modulators|mesh-ancestor
102495343|NCT03579472|Antimitotic Agents|antimitotic agents|mesh-ancestor
102495344|NCT03579472|Mitosis Modulators|mitosis modulators|mesh-ancestor
102495345|NCT05286190|Bupivacaine|bupivacaine|mesh-list
102495346|NCT05286190|Anesthetics, Local|anesthetics, local|mesh-ancestor
102495347|NCT05286190|Anesthetics|anesthetics|mesh-ancestor
102495348|NCT05286190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102495349|NCT05286190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495350|NCT05286190|Sensory System Agents|sensory system agents|mesh-ancestor
102495351|NCT05286190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102495352|NCT03399552|Avelumab|avelumab|mesh-list
102495353|NCT03399552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102495354|NCT03399552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102495355|NCT00691444|Melatonin|melatonin|mesh-list
102495356|NCT00691444|Antioxidants|antioxidants|mesh-ancestor
102495357|NCT00691444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495358|NCT00691444|Protective Agents|protective agents|mesh-ancestor
102495359|NCT00691444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495360|NCT00691444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102495361|NCT05477004|Ketamine|ketamine|mesh-list
102495362|NCT05477004|Analgesics|analgesics|mesh-ancestor
102495363|NCT05477004|Sensory System Agents|sensory system agents|mesh-ancestor
102495364|NCT05477004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102495365|NCT05477004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495366|NCT05477004|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102495367|NCT05477004|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102495368|NCT05477004|Anesthetics, General|anesthetics, general|mesh-ancestor
102495369|NCT05477004|Anesthetics|anesthetics|mesh-ancestor
102495370|NCT05477004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102495371|NCT05477004|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102495372|NCT05477004|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102495373|NCT05477004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102495374|NCT05477004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495375|NCT05482464|Caseins|caseins|mesh-list
102495376|NCT05482464|Chelating Agents|chelating agents|mesh-ancestor
102495377|NCT05482464|Sequestering Agents|sequestering agents|mesh-ancestor
102495378|NCT05482464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495379|NCT01530880|Acetaminophen|acetaminophen|mesh-list
102495380|NCT01530880|Ibuprofen|ibuprofen|mesh-list
102495381|NCT01530880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102495382|NCT01530880|Analgesics|analgesics|mesh-ancestor
102495383|NCT01530880|Sensory System Agents|sensory system agents|mesh-ancestor
102495384|NCT01530880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102495385|NCT01530880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495386|NCT01530880|Antipyretics|antipyretics|mesh-ancestor
102495387|NCT01530880|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102495388|NCT01530880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102495389|NCT01530880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102495390|NCT01530880|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102495391|NCT01530880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102495392|NCT01530880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495393|NCT05482074|Olaparib|olaparib|mesh-list
102495394|NCT05482074|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102495395|NCT05482074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102495396|NCT05482074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495397|NCT05482074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102495398|NCT00678574|Fluoxetine|fluoxetine|mesh-list
102495399|NCT00678574|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102495400|NCT00678574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102495401|NCT00678574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102495402|NCT00678574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495403|NCT00678574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102495404|NCT00678574|Serotonin Agents|serotonin agents|mesh-ancestor
102495405|NCT00678574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495406|NCT00678574|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102495407|NCT00678574|Antidepressive Agents|antidepressive agents|mesh-ancestor
102495408|NCT00678574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102495409|NCT00678574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102495410|NCT00678574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102495411|NCT00678574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102495412|NCT01475500|Dimercaprol|dimercaprol|mesh-list
102495413|NCT01475500|Chelating Agents|chelating agents|mesh-ancestor
102495414|NCT01475500|Sequestering Agents|sequestering agents|mesh-ancestor
102495415|NCT01475500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495416|NCT02551692|Nicotine|nicotine|mesh-list
102495417|NCT02551692|Varenicline|varenicline|mesh-list
102495418|NCT02551692|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102495419|NCT02551692|Autonomic Agents|autonomic agents|mesh-ancestor
102495420|NCT02551692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102495421|NCT02551692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495422|NCT02551692|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102495423|NCT02551692|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102495424|NCT02551692|Cholinergic Agents|cholinergic agents|mesh-ancestor
102495425|NCT02551692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102495426|NCT02551692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495427|NCT00542542|Fentanyl|fentanyl|mesh-list
102495428|NCT00542542|Midazolam|midazolam|mesh-list
102495429|NCT00542542|Propofol|propofol|mesh-list
102495430|NCT00542542|Ropivacaine|ropivacaine|mesh-list
102495431|NCT00542542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102495432|NCT00542542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102495433|NCT00542542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495434|NCT00542542|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102495435|NCT00542542|Anesthetics, General|anesthetics, general|mesh-ancestor
102495436|NCT00542542|Anesthetics|anesthetics|mesh-ancestor
102495437|NCT00542542|Anesthetics, Local|anesthetics, local|mesh-ancestor
102495438|NCT00542542|Sensory System Agents|sensory system agents|mesh-ancestor
102495439|NCT00542542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102495440|NCT00542542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102495441|NCT00542542|Narcotics|narcotics|mesh-ancestor
102495442|NCT00542542|Analgesics|analgesics|mesh-ancestor
102495443|NCT00542542|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102495444|NCT00542542|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102495445|NCT00542542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102495446|NCT00542542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102495447|NCT00542542|GABA Modulators|gaba modulators|mesh-ancestor
102495448|NCT00542542|GABA Agents|gaba agents|mesh-ancestor
102495449|NCT00542542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102495450|NCT00542542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495451|NCT05471544|Pyrimethamine|pyrimethamine|mesh-list
102495452|NCT05471544|Sulfadoxine|sulfadoxine|mesh-list
102495453|NCT05471544|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
102495454|NCT05471544|Amodiaquine|amodiaquine|mesh-list
102495455|NCT05471544|Antimalarials|antimalarials|mesh-ancestor
102495456|NCT05471544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102495457|NCT05471544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102495458|NCT05471544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102495459|NCT05471544|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102495460|NCT05471544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102495461|NCT05471544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495462|NCT05471544|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102495463|NCT03333486|Cyclophosphamide|cyclophosphamide|mesh-list
102495464|NCT03333486|Fludarabine|fludarabine|mesh-list
102495465|NCT03333486|Fludarabine phosphate|fludarabine phosphate|mesh-list
102495466|NCT03333486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102495467|NCT03333486|Immunologic Factors|immunologic factors|mesh-ancestor
102495468|NCT03333486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495469|NCT03333486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102495470|NCT03333486|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102495471|NCT03333486|Alkylating Agents|alkylating agents|mesh-ancestor
102495472|NCT03333486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495473|NCT03333486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102495474|NCT03333486|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102495475|NCT03333486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102495476|NCT03333486|Antimetabolites|antimetabolites|mesh-ancestor
102495477|NCT02598778|Chlorhexidine|chlorhexidine|mesh-list
102495478|NCT02598778|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102495479|NCT02598778|Listerine|listerine|mesh-list
102495480|NCT02598778|Fluorides|fluorides|mesh-list
102495481|NCT02598778|Sodium Fluoride|sodium fluoride|mesh-list
102495482|NCT02598778|Cariostatic Agents|cariostatic agents|mesh-ancestor
102495483|NCT02598778|Protective Agents|protective agents|mesh-ancestor
102495484|NCT02598778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495485|NCT02598778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102495486|NCT02598778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102495487|NCT02598778|Disinfectants|disinfectants|mesh-ancestor
102495488|NCT02598778|Dermatologic Agents|dermatologic agents|mesh-ancestor
102495489|NCT00642382|Hyaluronic Acid|hyaluronic acid|mesh-list
102495490|NCT00642382|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102495491|NCT00642382|Immunologic Factors|immunologic factors|mesh-ancestor
102495492|NCT00642382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495493|NCT00642382|Viscosupplements|viscosupplements|mesh-ancestor
102495494|NCT00642382|Protective Agents|protective agents|mesh-ancestor
102495495|NCT05476380|Paclitaxel|paclitaxel|mesh-list
102495496|NCT05476380|Cisplatin|cisplatin|mesh-list
102495497|NCT05476380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102495498|NCT05476380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102495499|NCT05476380|Tubulin Modulators|tubulin modulators|mesh-ancestor
102495500|NCT05476380|Antimitotic Agents|antimitotic agents|mesh-ancestor
102495501|NCT05476380|Mitosis Modulators|mitosis modulators|mesh-ancestor
102495502|NCT05476380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495503|NCT00634972|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102495504|NCT00634972|Ketorolac|ketorolac|mesh-list
102495505|NCT00634972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102495506|NCT00634972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102495507|NCT00634972|Analgesics|analgesics|mesh-ancestor
102495508|NCT00634972|Sensory System Agents|sensory system agents|mesh-ancestor
102495509|NCT00634972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102495510|NCT00634972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495511|NCT00634972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102495512|NCT00634972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102495513|NCT00634972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102495514|NCT00634972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102495515|NCT00634972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495516|NCT00529282|Vancomycin|vancomycin|mesh-list
102495517|NCT00529282|Cefepime|cefepime|mesh-list
102495518|NCT00529282|Ceftobiprole|ceftobiprole|mesh-list
102495519|NCT00529282|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
102495520|NCT00529282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102495521|NCT00529282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102495522|NCT00623974|Teriparatide|teriparatide|mesh-list
102495523|NCT00623974|Calcitriol|calcitriol|mesh-list
102495524|NCT00623974|Calcium|calcium|mesh-list
102495525|NCT00623974|Parathyroid Hormone|parathyroid hormone|mesh-list
102495526|NCT00623974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102495527|NCT00623974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495528|NCT00623974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102495529|NCT00623974|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102495530|NCT00623974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102495531|NCT00623974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495532|NCT00623974|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102495533|NCT00623974|Vitamins|vitamins|mesh-ancestor
102495534|NCT00623974|Micronutrients|micronutrients|mesh-ancestor
102495535|NCT02550288|Atorvastatin|atorvastatin|mesh-list
102495536|NCT02550288|Ezetimibe|ezetimibe|mesh-list
102495537|NCT02550288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102495538|NCT02550288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102495539|NCT02550288|Antimetabolites|antimetabolites|mesh-ancestor
102495540|NCT02550288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495541|NCT02550288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102495542|NCT02550288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102495543|NCT02550288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102495544|NCT00380146|Pyrimethamine|pyrimethamine|mesh-list
102495545|NCT00380146|Sulfadoxine|sulfadoxine|mesh-list
102495546|NCT00380146|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
102307145|NCT01610596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102495547|NCT00380146|Antimalarials|antimalarials|mesh-ancestor
102495548|NCT00380146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102495549|NCT00380146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102495550|NCT00380146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102495551|NCT00380146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102495552|NCT00380146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102495553|NCT00380146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495554|NCT00380146|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102495555|NCT00496756|Sorafenib|sorafenib|mesh-list
102495556|NCT00496756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102495557|NCT00496756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102495558|NCT00496756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102495559|NCT00496756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495560|NCT00500890|Cyclophosphamide|cyclophosphamide|mesh-list
102495561|NCT00500890|Carboplatin|carboplatin|mesh-list
102495562|NCT00500890|Etoposide|etoposide|mesh-list
102495563|NCT00500890|Vincristine|vincristine|mesh-list
102495564|NCT00500890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102495565|NCT00500890|Immunologic Factors|immunologic factors|mesh-ancestor
102495566|NCT00500890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495567|NCT00500890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102495568|NCT00500890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102495569|NCT00500890|Alkylating Agents|alkylating agents|mesh-ancestor
102495570|NCT00500890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495571|NCT00500890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102495572|NCT00500890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102495573|NCT00500890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102495574|NCT00500890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102495575|NCT00500890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102495576|NCT00500890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102495577|NCT00500890|Tubulin Modulators|tubulin modulators|mesh-ancestor
102495578|NCT00500890|Antimitotic Agents|antimitotic agents|mesh-ancestor
102495579|NCT00500890|Mitosis Modulators|mitosis modulators|mesh-ancestor
102495580|NCT00000736|Zidovudine|zidovudine|mesh-list
102495581|NCT00000736|Antimetabolites|antimetabolites|mesh-ancestor
102495582|NCT00000736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495583|NCT00000736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102495584|NCT00000736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102495585|NCT00000736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102495586|NCT00000736|Antiviral Agents|antiviral agents|mesh-ancestor
102495587|NCT00000736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102495588|NCT00000736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102495589|NCT00000736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102495590|NCT00379522|Vasopressins|vasopressins|mesh-list
102495591|NCT00379522|Arginine Vasopressin|arginine vasopressin|mesh-list
102495592|NCT00379522|Hemostatics|hemostatics|mesh-ancestor
102495593|NCT00379522|Coagulants|coagulants|mesh-ancestor
102495594|NCT00379522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102495595|NCT00379522|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102495596|NCT00379522|Natriuretic Agents|natriuretic agents|mesh-ancestor
102495597|NCT00379522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495598|NCT00421954|Ziprasidone|ziprasidone|mesh-list
102495599|NCT00421954|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102495600|NCT00421954|Serotonin Agents|serotonin agents|mesh-ancestor
102495601|NCT00421954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102495602|NCT00421954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495603|NCT00421954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495604|NCT00421954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102495605|NCT00421954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102495606|NCT00421954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102495607|NCT00421954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102495608|NCT00421954|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102495609|NCT00421954|Dopamine Agents|dopamine agents|mesh-ancestor
102495610|NCT01662336|Ritonavir|ritonavir|mesh-list
102495611|NCT01662336|Lopinavir|lopinavir|mesh-list
102495612|NCT01662336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102495613|NCT01662336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102495614|NCT01662336|Protease Inhibitors|protease inhibitors|mesh-ancestor
102495615|NCT01662336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102495616|NCT01662336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495617|NCT01662336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102495618|NCT01662336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101971989|NCT00313768|Paclitaxel|paclitaxel|mesh-list
102495619|NCT01662336|Antiviral Agents|antiviral agents|mesh-ancestor
102495620|NCT01662336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102495621|NCT01662336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102495622|NCT01662336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102307226|NCT02453555|Hormones|hormones|mesh-ancestor
102495623|NCT00000766|Ganciclovir|ganciclovir|mesh-list
102495624|NCT00000766|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102495625|NCT00000766|Foscarnet|foscarnet|mesh-list
102495626|NCT00000766|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
102495627|NCT00000766|Antiviral Agents|antiviral agents|mesh-ancestor
102495628|NCT00000766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102495629|NCT00000766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102495630|NCT00000766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102495631|NCT00000766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495632|NCT00000766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102495633|NCT00000772|Ribavirin|ribavirin|mesh-list
102495634|NCT00000772|Didanosine|didanosine|mesh-list
102495635|NCT00000772|Antimetabolites|antimetabolites|mesh-ancestor
102495636|NCT00000772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495637|NCT00000772|Antiviral Agents|antiviral agents|mesh-ancestor
102495638|NCT00000772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102495639|NCT00000772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102495640|NCT00000772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102495641|NCT00000772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102495642|NCT00000772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102495643|NCT00000772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102495644|NCT00572260|Daptomycin|daptomycin|mesh-list
102495645|NCT00572260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102495646|NCT00572260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102495647|NCT00000778|Pyridoxine|pyridoxine|mesh-list
102495648|NCT00000778|Vitamin B 6|vitamin b 6|mesh-list
102495649|NCT00000778|Levofloxacin|levofloxacin|mesh-list
102495650|NCT00000778|Isoniazid|isoniazid|mesh-list
102495651|NCT00000778|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102495652|NCT00000778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102495653|NCT00000778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102495654|NCT00000778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102495655|NCT00000778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102495656|NCT00000778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102495657|NCT00000778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495658|NCT00000778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102495659|NCT00000778|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102495660|NCT00000778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102495661|NCT00000778|Antitubercular Agents|antitubercular agents|mesh-ancestor
102495662|NCT00000778|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102495663|NCT00000778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102495664|NCT00000778|Antimetabolites|antimetabolites|mesh-ancestor
102495665|NCT00000778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102495666|NCT00000778|Vitamin B Complex|vitamin b complex|mesh-ancestor
102495667|NCT00000778|Vitamins|vitamins|mesh-ancestor
102495668|NCT00000778|Micronutrients|micronutrients|mesh-ancestor
102495669|NCT00000778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495670|NCT00000796|Pyridoxine|pyridoxine|mesh-list
102495671|NCT00000796|Vitamin B 6|vitamin b 6|mesh-list
102495672|NCT00000796|Levofloxacin|levofloxacin|mesh-list
102495673|NCT00000796|Cycloserine|cycloserine|mesh-list
102495674|NCT00000796|Rifampin|rifampin|mesh-list
102495675|NCT00000796|Isoniazid|isoniazid|mesh-list
102495676|NCT00000796|Amikacin|amikacin|mesh-list
102495677|NCT00000796|Pyrazinamide|pyrazinamide|mesh-list
102495678|NCT00000796|Ethambutol|ethambutol|mesh-list
102495679|NCT00000796|Clofazimine|clofazimine|mesh-list
102495680|NCT00000796|Aminosalicylic Acid|aminosalicylic acid|mesh-list
102495681|NCT00000796|Streptomycin|streptomycin|mesh-list
102495682|NCT00000796|Ethionamide|ethionamide|mesh-list
102495683|NCT00000796|Capreomycin|capreomycin|mesh-list
102495684|NCT00000796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102495685|NCT00000796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102495686|NCT00000796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102495687|NCT00000796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102495688|NCT00000796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102495689|NCT00000796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102495690|NCT00000796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495691|NCT00000796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102495692|NCT00000796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102495693|NCT00000796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102495694|NCT00000796|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102495695|NCT00000796|Antitubercular Agents|antitubercular agents|mesh-ancestor
102495696|NCT00000796|Leprostatic Agents|leprostatic agents|mesh-ancestor
102495697|NCT00000796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102495698|NCT00000796|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102495699|NCT00000796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102495700|NCT00000796|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102495701|NCT00000796|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102495702|NCT00000796|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102495703|NCT00000796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102495704|NCT00000796|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102495706|NCT00000796|Antimetabolites|antimetabolites|mesh-ancestor
102495707|NCT00000796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102495708|NCT00000796|Vitamin B Complex|vitamin b complex|mesh-ancestor
102495709|NCT00000796|Vitamins|vitamins|mesh-ancestor
102495710|NCT00000796|Micronutrients|micronutrients|mesh-ancestor
102495711|NCT00000796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495712|NCT00000796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102495713|NCT00000796|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102495714|NCT00000802|Dapsone|dapsone|mesh-list
102495715|NCT00000802|Atovaquone|atovaquone|mesh-list
102495716|NCT00000802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102495717|NCT00000802|Antimalarials|antimalarials|mesh-ancestor
102495718|NCT00000802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102495719|NCT00000802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102495720|NCT00000802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102495721|NCT00000802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102495722|NCT00000802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495723|NCT00000802|Leprostatic Agents|leprostatic agents|mesh-ancestor
102495724|NCT00000802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102495725|NCT02389946|Sirolimus|sirolimus|mesh-list
102495726|NCT02389946|Everolimus|everolimus|mesh-list
102495727|NCT02389946|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102495728|NCT02389946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102495729|NCT02389946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102495730|NCT02389946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495731|NCT02389946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102495732|NCT02389946|Immunologic Factors|immunologic factors|mesh-ancestor
102495733|NCT02389946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495734|NCT02389946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102495735|NCT02389946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102495736|NCT02389946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102495737|NCT02389946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102495738|NCT02389946|Antifungal Agents|antifungal agents|mesh-ancestor
102495739|NCT00245128|Imatinib Mesylate|imatinib mesylate|mesh-list
102495740|NCT00245128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102495741|NCT00245128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102495742|NCT00245128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102495743|NCT00245128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495744|NCT00268450|Paclitaxel|paclitaxel|mesh-list
102495745|NCT00268450|Bevacizumab|bevacizumab|mesh-list
102495746|NCT00268450|Gemcitabine|gemcitabine|mesh-list
102495747|NCT00268450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102495748|NCT00268450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102495749|NCT00268450|Tubulin Modulators|tubulin modulators|mesh-ancestor
102495750|NCT00268450|Antimitotic Agents|antimitotic agents|mesh-ancestor
102495751|NCT00268450|Mitosis Modulators|mitosis modulators|mesh-ancestor
102495752|NCT00268450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495753|NCT00268450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102495754|NCT00268450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102495755|NCT00268450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102495756|NCT00268450|Growth Substances|growth substances|mesh-ancestor
102495757|NCT00268450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495758|NCT00268450|Growth Inhibitors|growth inhibitors|mesh-ancestor
102495759|NCT00268450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102495760|NCT00268450|Antimetabolites|antimetabolites|mesh-ancestor
102495761|NCT00000808|Nevirapine|nevirapine|mesh-list
102495762|NCT00000808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102495763|NCT00000808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102495764|NCT00000808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102495765|NCT00000808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495766|NCT00000808|Antiviral Agents|antiviral agents|mesh-ancestor
102495767|NCT00000808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102495768|NCT00000808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102495769|NCT00000808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102495770|NCT00000808|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102495771|NCT00000808|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102495772|NCT01892384|BI 409306|bi 409306|mesh-list
102495773|NCT01892384|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102307375|NCT01815580|Antiviral Agents|antiviral agents|mesh-ancestor
102495774|NCT01892384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102495775|NCT01892384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495776|NCT00000814|Zidovudine|zidovudine|mesh-list
102495777|NCT00000814|Nevirapine|nevirapine|mesh-list
102495778|NCT00000814|Didanosine|didanosine|mesh-list
102495779|NCT00000814|Antimetabolites|antimetabolites|mesh-ancestor
102495780|NCT00000814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495781|NCT00000814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102495782|NCT00000814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102495783|NCT00000814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102495784|NCT00000814|Antiviral Agents|antiviral agents|mesh-ancestor
102495785|NCT00000814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102495786|NCT00000814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102495787|NCT00000814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102495788|NCT00000814|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102495789|NCT00000814|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102495790|NCT02661932|Letrozole|letrozole|mesh-list
102495791|NCT02661932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102495792|NCT02661932|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102495793|NCT02661932|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102495794|NCT02661932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102495795|NCT02661932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495796|NCT02661932|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102495797|NCT02661932|Hormone Antagonists|hormone antagonists|mesh-ancestor
102495798|NCT02661932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102495799|NCT02661932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495800|NCT00177970|Immunoglobulins|immunoglobulins|mesh-list
102495801|NCT00177970|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102495802|NCT00177970|Antibodies|antibodies|mesh-list
102495803|NCT00177970|Immunoglobulin G|immunoglobulin g|mesh-list
102495804|NCT00177970|gamma-Globulins|gamma-globulins|mesh-list
102495805|NCT00177970|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102495806|NCT00177970|Immunologic Factors|immunologic factors|mesh-ancestor
102495807|NCT00177970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495808|NCT01892618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102495809|NCT01892618|Immunologic Factors|immunologic factors|mesh-ancestor
102495810|NCT01892618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495811|NCT00088972|Celecoxib|celecoxib|mesh-list
102495812|NCT00088972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102495813|NCT00088972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102495814|NCT00088972|Analgesics|analgesics|mesh-ancestor
102495815|NCT00088972|Sensory System Agents|sensory system agents|mesh-ancestor
102495816|NCT00088972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102495817|NCT00088972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495818|NCT00088972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102495819|NCT00088972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102495820|NCT00088972|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102495821|NCT00088972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102495822|NCT00088972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102495823|NCT00088972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495824|NCT00089128|Gemcitabine|gemcitabine|mesh-list
102495825|NCT00089128|Irinotecan|irinotecan|mesh-list
102495826|NCT00089128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102495827|NCT00089128|Antimetabolites|antimetabolites|mesh-ancestor
102495828|NCT00089128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495829|NCT00089128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102495830|NCT00089128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102495831|NCT00089128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102495832|NCT00089128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102495833|NCT00000838|Lamivudine|lamivudine|mesh-list
102495834|NCT00000838|Zidovudine|zidovudine|mesh-list
102495835|NCT00000838|Stavudine|stavudine|mesh-list
102495836|NCT00000838|Didanosine|didanosine|mesh-list
102495837|NCT00000838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102495838|NCT00000838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102495839|NCT00000838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102495840|NCT00000838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495841|NCT00000838|Antiviral Agents|antiviral agents|mesh-ancestor
102495842|NCT00000838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102495843|NCT00000838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102495844|NCT00000838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102495845|NCT00000838|Antimetabolites|antimetabolites|mesh-ancestor
102495846|NCT00001768|Immunoglobulins|immunoglobulins|mesh-list
102495847|NCT00001768|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102495848|NCT00001768|Antibodies|antibodies|mesh-list
102495849|NCT00001768|gamma-Globulins|gamma-globulins|mesh-list
102495850|NCT00001768|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102495851|NCT00001768|Immunologic Factors|immunologic factors|mesh-ancestor
102495852|NCT00001768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495853|NCT00000844|Interferons|interferons|mesh-list
102495854|NCT00000844|Interferon-alpha|interferon-alpha|mesh-list
102495855|NCT00000844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102495856|NCT00000844|Antiviral Agents|antiviral agents|mesh-ancestor
102495857|NCT00000844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102495858|NCT00000844|Immunologic Factors|immunologic factors|mesh-ancestor
102495859|NCT00000844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495861|NCT00014560|Sargramostim|sargramostim|mesh-list
102495862|NCT00014560|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102495863|NCT00014560|Immunologic Factors|immunologic factors|mesh-ancestor
102495864|NCT00014560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495865|NCT00020722|Cyclophosphamide|cyclophosphamide|mesh-list
102495866|NCT00020722|Ifosfamide|ifosfamide|mesh-list
102495867|NCT00020722|Thiotepa|thiotepa|mesh-list
102495868|NCT00020722|Carboplatin|carboplatin|mesh-list
102495869|NCT00020722|Etoposide|etoposide|mesh-list
102495870|NCT00020722|Etoposide phosphate|etoposide phosphate|mesh-list
102495871|NCT00020722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102495872|NCT00020722|Immunologic Factors|immunologic factors|mesh-ancestor
102495873|NCT00020722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495874|NCT00020722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102495875|NCT00020722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102495876|NCT00020722|Alkylating Agents|alkylating agents|mesh-ancestor
102495877|NCT00020722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495878|NCT00020722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102495879|NCT00020722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102495880|NCT00020722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102495881|NCT00020722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102495882|NCT00020722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102495883|NCT00020722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102495884|NCT02649764|Cytarabine|cytarabine|mesh-list
102495885|NCT02649764|Fludarabine|fludarabine|mesh-list
102495886|NCT02649764|Fludarabine phosphate|fludarabine phosphate|mesh-list
102495887|NCT02649764|Prexasertib|prexasertib|mesh-list
102495888|NCT02649764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102495889|NCT02649764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102495890|NCT02649764|Antimetabolites|antimetabolites|mesh-ancestor
102495891|NCT02649764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495892|NCT02649764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102495893|NCT02649764|Immunologic Factors|immunologic factors|mesh-ancestor
102495894|NCT02649764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495895|NCT02649764|Antiviral Agents|antiviral agents|mesh-ancestor
102495896|NCT02649764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102495897|NCT02649764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102495898|NCT02649764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102495899|NCT04051996|Decitabine|decitabine|mesh-list
102495900|NCT04051996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102495901|NCT04051996|Antimetabolites|antimetabolites|mesh-ancestor
102495902|NCT04051996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495903|NCT04051996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102495904|NCT04051996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102495905|NCT02126878|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102495906|NCT02126878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102495907|NCT02126878|Glucocorticoids|glucocorticoids|mesh-ancestor
102495908|NCT02126878|Hormones|hormones|mesh-ancestor
102495909|NCT02126878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102495910|NCT02126878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495911|NCT02126878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102495912|NCT02126878|Immunologic Factors|immunologic factors|mesh-ancestor
102495913|NCT02634008|Ritonavir|ritonavir|mesh-list
102495914|NCT02634008|Ribavirin|ribavirin|mesh-list
102495915|NCT02634008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102495916|NCT02634008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102495917|NCT02634008|Protease Inhibitors|protease inhibitors|mesh-ancestor
102495918|NCT02634008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102495919|NCT02634008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495920|NCT02634008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102495921|NCT02634008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102495922|NCT02634008|Antiviral Agents|antiviral agents|mesh-ancestor
102495923|NCT02634008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102495924|NCT02634008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102495925|NCT02634008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102495926|NCT02634008|Antimetabolites|antimetabolites|mesh-ancestor
102495927|NCT00000850|Indinavir|indinavir|mesh-list
102495928|NCT00000850|Sargramostim|sargramostim|mesh-list
102495929|NCT00000850|Immunologic Factors|immunologic factors|mesh-ancestor
102495930|NCT00000850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495931|NCT00000850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102495932|NCT00000850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102495933|NCT00000850|Protease Inhibitors|protease inhibitors|mesh-ancestor
102495934|NCT00000850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102495935|NCT00000850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495936|NCT00000850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102495937|NCT00000850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102495938|NCT00000850|Antiviral Agents|antiviral agents|mesh-ancestor
102495939|NCT00000850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102495940|NCT00000856|Ganciclovir|ganciclovir|mesh-list
102495941|NCT00000856|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102495942|NCT00000856|Foscarnet|foscarnet|mesh-list
102495943|NCT00000856|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
102495944|NCT00000856|Antiviral Agents|antiviral agents|mesh-ancestor
102495945|NCT00000856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102495946|NCT00000856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102495947|NCT00000856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102495948|NCT00000856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495949|NCT00000856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102495950|NCT00001810|Voriconazole|voriconazole|mesh-list
102495951|NCT00001810|Antifungal Agents|antifungal agents|mesh-ancestor
102495952|NCT00001810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102495953|NCT00001810|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102495954|NCT00001810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102495955|NCT00001810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102495956|NCT00001810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495957|NCT00001810|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102495958|NCT00001810|Hormone Antagonists|hormone antagonists|mesh-ancestor
102495959|NCT00001810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102495960|NCT00001810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102495961|NCT00001810|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102495962|NCT00000862|Zidovudine|zidovudine|mesh-list
102495963|NCT00000862|Antimetabolites|antimetabolites|mesh-ancestor
102495964|NCT00000862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495965|NCT00000862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102495966|NCT00000862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102495967|NCT00000862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102495968|NCT00000862|Antiviral Agents|antiviral agents|mesh-ancestor
102495969|NCT00000862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102495970|NCT00000862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102495971|NCT00000862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102495972|NCT02344472|Paclitaxel|paclitaxel|mesh-list
102495973|NCT02344472|Vinorelbine|vinorelbine|mesh-list
102495974|NCT02344472|Docetaxel|docetaxel|mesh-list
102495975|NCT02344472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102495976|NCT02344472|Capecitabine|capecitabine|mesh-list
102495977|NCT02344472|Trastuzumab|trastuzumab|mesh-list
102495978|NCT02344472|Letrozole|letrozole|mesh-list
102495979|NCT02344472|Fulvestrant|fulvestrant|mesh-list
102495980|NCT02344472|Pertuzumab|pertuzumab|mesh-list
102495981|NCT02344472|Anastrozole|anastrozole|mesh-list
102495982|NCT02344472|Exemestane|exemestane|mesh-list
102495983|NCT02344472|Goserelin|goserelin|mesh-list
102495984|NCT02344472|Leuprolide|leuprolide|mesh-list
102495985|NCT02344472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102495986|NCT02344472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102495987|NCT02344472|Tubulin Modulators|tubulin modulators|mesh-ancestor
102495988|NCT02344472|Antimitotic Agents|antimitotic agents|mesh-ancestor
102495989|NCT02344472|Mitosis Modulators|mitosis modulators|mesh-ancestor
102495990|NCT02344472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102495991|NCT02344472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102495992|NCT02344472|Antimetabolites|antimetabolites|mesh-ancestor
102495993|NCT02344472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102495994|NCT02344472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102495995|NCT02344472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102495996|NCT02344472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102495997|NCT02344472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102495998|NCT02344472|Hormone Antagonists|hormone antagonists|mesh-ancestor
102495999|NCT02344472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102496000|NCT02344472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496001|NCT02344472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102496002|NCT02344472|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102496003|NCT02344472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102496004|NCT02344472|Fertility Agents|fertility agents|mesh-ancestor
102496005|NCT02344472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102496006|NCT02338232|Telmisartan|telmisartan|mesh-list
102496007|NCT02338232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102496008|NCT02338232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102496009|NCT02338232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102496010|NCT02338232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496011|NCT01780636|Botulinum Toxins|botulinum toxins|mesh-list
102496012|NCT01780636|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102496013|NCT01780636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102496014|NCT01780636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496015|NCT01780636|Cholinergic Agents|cholinergic agents|mesh-ancestor
102496016|NCT01780636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102496017|NCT01780636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496018|NCT00000868|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102496019|NCT00000868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102496020|NCT00000868|Immunologic Factors|immunologic factors|mesh-ancestor
102496021|NCT00000868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496023|NCT00000868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496024|NCT00000868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102496025|NCT05586464|Bismuth|bismuth|mesh-list
102496026|NCT05586464|Antacids|antacids|mesh-ancestor
102496027|NCT05586464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496028|NCT05586464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102496029|NCT01561378|Insulin Aspart|insulin aspart|mesh-list
102496030|NCT01561378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102496031|NCT01561378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496032|NCT02608268|Decitabine|decitabine|mesh-list
102496033|NCT02608268|Spartalizumab|spartalizumab|mesh-list
102496034|NCT02608268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102496035|NCT02608268|Antimetabolites|antimetabolites|mesh-ancestor
102496036|NCT02608268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496037|NCT02608268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102496038|NCT02608268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102496039|NCT02608268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102496040|NCT02608268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102496041|NCT00000880|Cyclosporine|cyclosporine|mesh-list
102496042|NCT00000880|Cyclosporins|cyclosporins|mesh-list
102496043|NCT00000880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102496044|NCT00000880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496045|NCT00000880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102496046|NCT00000880|Immunologic Factors|immunologic factors|mesh-ancestor
102496047|NCT00000880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496048|NCT00000880|Antifungal Agents|antifungal agents|mesh-ancestor
102496049|NCT00000880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102496050|NCT00000880|Dermatologic Agents|dermatologic agents|mesh-ancestor
102496051|NCT00000880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102496052|NCT00000880|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102496053|NCT02308280|Bortezomib|bortezomib|mesh-list
102496054|NCT02308280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102496055|NCT02795156|Afatinib|afatinib|mesh-list
102496056|NCT02795156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102496057|NCT02795156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102496058|NCT02795156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102496059|NCT02795156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496060|NCT02279654|Lenalidomide|lenalidomide|mesh-list
102496061|NCT02279654|Immunologic Factors|immunologic factors|mesh-ancestor
102496062|NCT02279654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496063|NCT02279654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102496064|NCT02279654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102496065|NCT02279654|Growth Substances|growth substances|mesh-ancestor
102496066|NCT02279654|Growth Inhibitors|growth inhibitors|mesh-ancestor
102496067|NCT02279654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102496068|NCT02780024|Metformin|metformin|mesh-list
102496069|NCT02780024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102496070|NCT02780024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496071|NCT02268656|Propofol|propofol|mesh-list
102496072|NCT02268656|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102496073|NCT02268656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102496074|NCT02268656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496075|NCT02268656|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102496076|NCT02268656|Anesthetics, General|anesthetics, general|mesh-ancestor
102307671|NCT01807234|Ketorolac|ketorolac|mesh-list
102496077|NCT02268656|Anesthetics|anesthetics|mesh-ancestor
102496078|NCT02564978|Minocycline|minocycline|mesh-list
102496079|NCT02564978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102496080|NCT02564978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102496081|NCT02554890|Valsartan|valsartan|mesh-list
102496082|NCT02554890|Enalapril|enalapril|mesh-list
102496083|NCT02554890|Enalaprilat|enalaprilat|mesh-list
102496084|NCT02554890|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102496085|NCT02554890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102496086|NCT02554890|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102496087|NCT02554890|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102496088|NCT02554890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496089|NCT02554890|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102496090|NCT02554890|Protease Inhibitors|protease inhibitors|mesh-ancestor
102496091|NCT02554890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102496092|NCT00001864|Atropine|atropine|mesh-list
102496093|NCT00001864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102496094|NCT00001864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102496095|NCT00001864|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102496096|NCT00001864|Autonomic Agents|autonomic agents|mesh-ancestor
102496097|NCT00001864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102496098|NCT00001864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496099|NCT00001864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102496100|NCT00001864|Respiratory System Agents|respiratory system agents|mesh-ancestor
102496101|NCT00001864|Mydriatics|mydriatics|mesh-ancestor
102496102|NCT00001864|Parasympatholytics|parasympatholytics|mesh-ancestor
102496103|NCT00001864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102496104|NCT00001864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102496105|NCT00001864|Cholinergic Agents|cholinergic agents|mesh-ancestor
102496106|NCT00001864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102496107|NCT00001864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496108|NCT02229656|Olaparib|olaparib|mesh-list
102496109|NCT02229656|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102496110|NCT02229656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102496111|NCT02229656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496112|NCT02229656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102496113|NCT00001870|Acetylcholine|acetylcholine|mesh-list
102496114|NCT00001870|Vasodilator Agents|vasodilator agents|mesh-ancestor
102496115|NCT00001870|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102496116|NCT00001870|Cholinergic Agents|cholinergic agents|mesh-ancestor
102496117|NCT00001870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102496118|NCT00001870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496119|NCT00001870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496120|NCT03252600|Dexamethasone|dexamethasone|mesh-list
102496121|NCT03252600|Dexamethasone acetate|dexamethasone acetate|mesh-list
102496122|NCT03252600|Cyclophosphamide|cyclophosphamide|mesh-list
102496123|NCT03252600|Lenalidomide|lenalidomide|mesh-list
102496124|NCT03252600|Elotuzumab|elotuzumab|mesh-list
102496125|NCT03252600|Ichthammol|ichthammol|mesh-list
102496126|NCT03252600|BB 1101|bb 1101|mesh-list
102496127|NCT03252600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102496128|NCT03252600|Immunologic Factors|immunologic factors|mesh-ancestor
102496129|NCT03252600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496130|NCT03252600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102496131|NCT03252600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102496132|NCT03252600|Alkylating Agents|alkylating agents|mesh-ancestor
102496133|NCT03252600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496134|NCT03252600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102496135|NCT03252600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102496136|NCT03252600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102496137|NCT03252600|Antiemetics|antiemetics|mesh-ancestor
102496138|NCT03252600|Autonomic Agents|autonomic agents|mesh-ancestor
102496139|NCT03252600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102496140|NCT03252600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102496141|NCT03252600|Glucocorticoids|glucocorticoids|mesh-ancestor
102496142|NCT03252600|Hormones|hormones|mesh-ancestor
102496143|NCT03252600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102496144|NCT03252600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102496145|NCT03252600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102496146|NCT03252600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102496147|NCT03252600|Growth Substances|growth substances|mesh-ancestor
102496148|NCT03252600|Growth Inhibitors|growth inhibitors|mesh-ancestor
102496149|NCT03252600|Protease Inhibitors|protease inhibitors|mesh-ancestor
102496150|NCT03252600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102496151|NCT03252600|Dermatologic Agents|dermatologic agents|mesh-ancestor
102496152|NCT02749526|Tegafur|tegafur|mesh-list
102496153|NCT02749526|Endostar protein|endostar protein|mesh-list
102496154|NCT02749526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102496155|NCT02749526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102496156|NCT02749526|Antimetabolites|antimetabolites|mesh-ancestor
102496157|NCT02749526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496158|NCT02749526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102496159|NCT02749526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102496160|NCT02749526|Growth Substances|growth substances|mesh-ancestor
102496161|NCT02749526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496162|NCT02749526|Growth Inhibitors|growth inhibitors|mesh-ancestor
102496163|NCT00000916|Lamivudine|lamivudine|mesh-list
102496164|NCT00000916|Zidovudine|zidovudine|mesh-list
102496165|NCT00000916|Stavudine|stavudine|mesh-list
102496166|NCT00000916|Didanosine|didanosine|mesh-list
102496167|NCT00000916|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
102496168|NCT00000916|Indinavir|indinavir|mesh-list
102496169|NCT00000916|Hydroxyurea|hydroxyurea|mesh-list
102496170|NCT00000916|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102496171|NCT00000916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102496172|NCT00000916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102496173|NCT00000916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496174|NCT00000916|Antiviral Agents|antiviral agents|mesh-ancestor
102496175|NCT00000916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102496176|NCT00000916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102496177|NCT00000916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102496178|NCT00000916|Antimetabolites|antimetabolites|mesh-ancestor
102496179|NCT00000916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102496180|NCT00000916|Antisickling Agents|antisickling agents|mesh-ancestor
102496181|NCT00000916|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102496182|NCT00000916|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102496183|NCT00000916|Protease Inhibitors|protease inhibitors|mesh-ancestor
102496184|NCT02548364|Vitamin D|vitamin d|mesh-list
102496185|NCT02548364|Calcifediol|calcifediol|mesh-list
102496186|NCT02548364|Vitamins|vitamins|mesh-ancestor
102496187|NCT02548364|Micronutrients|micronutrients|mesh-ancestor
102496188|NCT02548364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496189|NCT02548364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102496190|NCT00000130|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102496191|NCT00000130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102496192|NCT02221310|Gemtuzumab|gemtuzumab|mesh-list
102496193|NCT02221310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102496194|NCT02221310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102496195|NCT02221310|Immunotoxins|immunotoxins|mesh-ancestor
102496196|NCT02221310|Immunoconjugates|immunoconjugates|mesh-ancestor
102496197|NCT02221310|Immunologic Factors|immunologic factors|mesh-ancestor
102496198|NCT02221310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496199|NCT00000160|Xenon|xenon|mesh-list
102496200|NCT00000160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102496201|NCT00000160|Anesthetics, General|anesthetics, general|mesh-ancestor
102496202|NCT00000160|Anesthetics|anesthetics|mesh-ancestor
102496203|NCT00000160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102496204|NCT00000160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496205|NCT00000178|Prednisone|prednisone|mesh-list
102496206|NCT00000178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102496207|NCT00000178|Glucocorticoids|glucocorticoids|mesh-ancestor
102496208|NCT00000178|Hormones|hormones|mesh-ancestor
102496209|NCT00000178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102496210|NCT00000178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496211|NCT00000178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102496212|NCT00000178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102496213|NCT05480280|Leucovorin|leucovorin|mesh-list
102496214|NCT05480280|Fluorouracil|fluorouracil|mesh-list
102496215|NCT05480280|Oxaliplatin|oxaliplatin|mesh-list
102496216|NCT05480280|Calcium|calcium|mesh-list
102496217|NCT05480280|Levoleucovorin|levoleucovorin|mesh-list
102496218|NCT05480280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102496219|NCT05480280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496220|NCT05480280|Antimetabolites|antimetabolites|mesh-ancestor
102496221|NCT05480280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496222|NCT05480280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102496223|NCT05480280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102496224|NCT05480280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102496225|NCT05480280|Immunologic Factors|immunologic factors|mesh-ancestor
102496226|NCT05480280|Antidotes|antidotes|mesh-ancestor
102496227|NCT05480280|Protective Agents|protective agents|mesh-ancestor
102496228|NCT05480280|Vitamin B Complex|vitamin b complex|mesh-ancestor
102496229|NCT05480280|Vitamins|vitamins|mesh-ancestor
102496230|NCT05480280|Micronutrients|micronutrients|mesh-ancestor
102496231|NCT00001906|Interleukin-12|interleukin-12|mesh-list
102307820|NCT02421419|Hormones|hormones|mesh-ancestor
102496232|NCT00001906|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102496233|NCT00001906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102496234|NCT00001906|Immunologic Factors|immunologic factors|mesh-ancestor
102496235|NCT00001906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496236|NCT00001906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102496237|NCT00001906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102496238|NCT00001906|Growth Substances|growth substances|mesh-ancestor
102496239|NCT00001906|Growth Inhibitors|growth inhibitors|mesh-ancestor
102496240|NCT00001906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102496241|NCT00001906|Antacids|antacids|mesh-ancestor
102496242|NCT00001906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496243|NCT00001906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102496244|NCT00000196|Naltrexone|naltrexone|mesh-list
102496245|NCT00000196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102496246|NCT00000196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102496247|NCT00000196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496248|NCT00000196|Sensory System Agents|sensory system agents|mesh-ancestor
102496249|NCT00000196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102496250|NCT00000946|polysaccharide-K|polysaccharide-k|mesh-list
102496251|NCT00000946|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102496252|NCT00000946|Immunologic Factors|immunologic factors|mesh-ancestor
102496253|NCT00000946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496254|NCT00000946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102496255|NCT00000946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102496256|NCT00000946|Antiviral Agents|antiviral agents|mesh-ancestor
102496257|NCT00000946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102496258|NCT00000946|Interferon Inducers|interferon inducers|mesh-ancestor
102496259|NCT00000946|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102496260|NCT00000946|Protective Agents|protective agents|mesh-ancestor
102496261|NCT02543346|Cetirizine|cetirizine|mesh-list
102496262|NCT02543346|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102496263|NCT02543346|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102496264|NCT02543346|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102496265|NCT02543346|Histamine Antagonists|histamine antagonists|mesh-ancestor
102496266|NCT02543346|Histamine Agents|histamine agents|mesh-ancestor
102496267|NCT02543346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102496268|NCT02543346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496269|NCT02543346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496270|NCT04390100|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
102496271|NCT04390100|Hyaluronic Acid|hyaluronic acid|mesh-list
102496272|NCT04390100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102496273|NCT04390100|Immunologic Factors|immunologic factors|mesh-ancestor
102496274|NCT04390100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496275|NCT04390100|Viscosupplements|viscosupplements|mesh-ancestor
102496276|NCT04390100|Protective Agents|protective agents|mesh-ancestor
102496277|NCT04390100|Hemostatics|hemostatics|mesh-ancestor
102496278|NCT04390100|Coagulants|coagulants|mesh-ancestor
102496279|NCT00000202|Buprenorphine|buprenorphine|mesh-list
102496280|NCT00000202|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102496281|NCT00000202|Narcotics|narcotics|mesh-ancestor
102496282|NCT00000202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102496283|NCT00000202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496284|NCT00000202|Analgesics|analgesics|mesh-ancestor
102496285|NCT00000202|Sensory System Agents|sensory system agents|mesh-ancestor
102496286|NCT00000202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102496287|NCT00000202|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102496288|NCT00000208|Buprenorphine|buprenorphine|mesh-list
102496289|NCT00000208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102496290|NCT00000208|Narcotics|narcotics|mesh-ancestor
102496291|NCT00000208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102496292|NCT00000208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496293|NCT00000208|Analgesics|analgesics|mesh-ancestor
102496294|NCT00000208|Sensory System Agents|sensory system agents|mesh-ancestor
102496295|NCT00000208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102496296|NCT00000208|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102496297|NCT00001930|Amantadine|amantadine|mesh-list
102496298|NCT00001930|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102496299|NCT00001930|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102496300|NCT00001930|Antiviral Agents|antiviral agents|mesh-ancestor
102496301|NCT00001930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102496302|NCT00001930|Dopamine Agents|dopamine agents|mesh-ancestor
102496303|NCT00001930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102496304|NCT00001930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307895|NCT02420717|Antimitotic Agents|antimitotic agents|mesh-ancestor
102496305|NCT00001930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496306|NCT00001930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102496307|NCT00001930|Analgesics|analgesics|mesh-ancestor
102496308|NCT00001930|Sensory System Agents|sensory system agents|mesh-ancestor
102496309|NCT00001930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102496310|NCT00000964|Foscarnet|foscarnet|mesh-list
102496311|NCT00000964|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
102496312|NCT00000964|Ranitidine|ranitidine|mesh-list
102496313|NCT00000964|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
102496314|NCT00000964|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102496315|NCT00000964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102496316|NCT00000964|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102496317|NCT00000964|Histamine Antagonists|histamine antagonists|mesh-ancestor
102496318|NCT00000964|Histamine Agents|histamine agents|mesh-ancestor
102496319|NCT00000964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102496320|NCT00000964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496321|NCT00000964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496322|NCT00000964|Antiviral Agents|antiviral agents|mesh-ancestor
102496323|NCT00000964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102496324|NCT00000964|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102496325|NCT00000964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102496326|NCT00000964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102496327|NCT00000976|Zidovudine|zidovudine|mesh-list
102496328|NCT00000976|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
102496329|NCT00000976|Antimetabolites|antimetabolites|mesh-ancestor
102496330|NCT00000976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496331|NCT00000976|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102496332|NCT00000976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102496333|NCT00000976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102496334|NCT00000976|Antiviral Agents|antiviral agents|mesh-ancestor
102496335|NCT00000976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102496336|NCT00000976|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102496337|NCT00000976|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102496338|NCT00000976|Immunologic Factors|immunologic factors|mesh-ancestor
102496339|NCT00000976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496340|NCT00000226|Buprenorphine|buprenorphine|mesh-list
102496341|NCT00000226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102496342|NCT00000226|Narcotics|narcotics|mesh-ancestor
102496343|NCT00000226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102496344|NCT00000226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496345|NCT00000226|Analgesics|analgesics|mesh-ancestor
102496346|NCT00000226|Sensory System Agents|sensory system agents|mesh-ancestor
102496347|NCT00000226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102496348|NCT00000226|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102496349|NCT00000982|Zidovudine|zidovudine|mesh-list
102496350|NCT00000982|Didanosine|didanosine|mesh-list
102496351|NCT00000982|Antimetabolites|antimetabolites|mesh-ancestor
102496352|NCT00000982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496353|NCT00000982|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102496354|NCT00000982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102496355|NCT00000982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102496356|NCT00000982|Antiviral Agents|antiviral agents|mesh-ancestor
102496357|NCT00000982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102496358|NCT00000982|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102496359|NCT00000982|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102496360|NCT02549196|Donepezil|donepezil|mesh-list
102496361|NCT02549196|Solifenacin Succinate|solifenacin succinate|mesh-list
102496362|NCT02549196|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102496363|NCT02549196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102496364|NCT02549196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496365|NCT02549196|Cholinergic Agents|cholinergic agents|mesh-ancestor
102496366|NCT02549196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102496367|NCT02549196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496368|NCT02549196|Nootropic Agents|nootropic agents|mesh-ancestor
102496369|NCT02549196|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102496370|NCT02549196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102496371|NCT02549196|Urological Agents|urological agents|mesh-ancestor
102496372|NCT00000988|Stavudine|stavudine|mesh-list
102496373|NCT00000988|Antimetabolites|antimetabolites|mesh-ancestor
102496374|NCT00000988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496375|NCT00000988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102496376|NCT00000988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102496377|NCT00000988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102496378|NCT00000988|Antiviral Agents|antiviral agents|mesh-ancestor
102496379|NCT00000988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102496380|NCT00000988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102496381|NCT00000988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102496382|NCT00000232|Buprenorphine|buprenorphine|mesh-list
102496383|NCT00000232|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102496384|NCT00000232|Narcotics|narcotics|mesh-ancestor
102496385|NCT00000232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102496386|NCT00000232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496387|NCT00000232|Analgesics|analgesics|mesh-ancestor
102496388|NCT00000232|Sensory System Agents|sensory system agents|mesh-ancestor
102496389|NCT00000232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102496390|NCT00000232|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102496391|NCT00000238|Buprenorphine|buprenorphine|mesh-list
102496392|NCT00000238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102496393|NCT00000238|Narcotics|narcotics|mesh-ancestor
102496394|NCT00000238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102496395|NCT00000238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496396|NCT00000238|Analgesics|analgesics|mesh-ancestor
102496397|NCT00000238|Sensory System Agents|sensory system agents|mesh-ancestor
102496398|NCT00000238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102496399|NCT00000238|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102496400|NCT00000244|Dynorphins|dynorphins|mesh-list
102496401|NCT00000244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102496402|NCT00000244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496403|NCT00000244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496404|NCT00000994|Zidovudine|zidovudine|mesh-list
102496405|NCT00000994|Antimetabolites|antimetabolites|mesh-ancestor
102496406|NCT00000994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496407|NCT00000994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102496408|NCT00000994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102496409|NCT00000994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102496410|NCT00000994|Antiviral Agents|antiviral agents|mesh-ancestor
102496411|NCT00000994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102496412|NCT00000994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102496413|NCT00000994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102496414|NCT00001006|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
102496415|NCT00001006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102496416|NCT00001006|Immunologic Factors|immunologic factors|mesh-ancestor
102496417|NCT00001006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496418|NCT00001006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102496419|NCT00001006|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102496420|NCT00001006|Protective Agents|protective agents|mesh-ancestor
102496421|NCT00001006|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102496422|NCT00001006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102496423|NCT00001006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102496424|NCT00001006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496425|NCT00001006|Antiviral Agents|antiviral agents|mesh-ancestor
102496426|NCT00001006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102496427|NCT00001954|Etanercept|etanercept|mesh-list
102496428|NCT00001954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102496429|NCT00001954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102496430|NCT00001954|Analgesics|analgesics|mesh-ancestor
102496431|NCT00001954|Sensory System Agents|sensory system agents|mesh-ancestor
102496432|NCT00001954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102496433|NCT00001954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496434|NCT00001954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102496435|NCT00001954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102496436|NCT00001954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102496437|NCT00001954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102496438|NCT00001954|Immunologic Factors|immunologic factors|mesh-ancestor
102496439|NCT02904954|Durvalumab|durvalumab|mesh-list
102496440|NCT02904954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102496441|NCT02904954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102496442|NCT02904954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102496443|NCT02904954|Immunologic Factors|immunologic factors|mesh-ancestor
102496444|NCT02904954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496445|NCT00000250|Nitrous Oxide|nitrous oxide|mesh-list
102496446|NCT00000250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102496447|NCT00000250|Anesthetics, General|anesthetics, general|mesh-ancestor
102496448|NCT00000250|Anesthetics|anesthetics|mesh-ancestor
102496449|NCT00000250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102496450|NCT00000250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496451|NCT00000250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102496452|NCT00000250|Analgesics|analgesics|mesh-ancestor
102496453|NCT00000250|Sensory System Agents|sensory system agents|mesh-ancestor
102496454|NCT00000250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102496455|NCT03244020|Aspirin|aspirin|mesh-list
102496456|NCT03244020|Enoxaparin|enoxaparin|mesh-list
102496457|NCT03244020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102496458|NCT03244020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102496459|NCT03244020|Analgesics|analgesics|mesh-ancestor
102496460|NCT03244020|Sensory System Agents|sensory system agents|mesh-ancestor
102496461|NCT03244020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102496462|NCT03244020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496463|NCT03244020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102496464|NCT03244020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102496465|NCT03244020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102496466|NCT03244020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102496467|NCT03244020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496468|NCT03244020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102496469|NCT03244020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102496470|NCT03244020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102496471|NCT03244020|Antipyretics|antipyretics|mesh-ancestor
102496472|NCT03244020|Anticoagulants|anticoagulants|mesh-ancestor
102496473|NCT00000262|Nitrous Oxide|nitrous oxide|mesh-list
102496474|NCT00000262|Sevoflurane|sevoflurane|mesh-list
102496475|NCT00000262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102496476|NCT00000262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102496477|NCT00000262|Anesthetics, General|anesthetics, general|mesh-ancestor
102496478|NCT00000262|Anesthetics|anesthetics|mesh-ancestor
102496479|NCT00000262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102496480|NCT00000262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496481|NCT00000262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102496482|NCT00000262|Analgesics|analgesics|mesh-ancestor
102496483|NCT00000262|Sensory System Agents|sensory system agents|mesh-ancestor
102496484|NCT00000262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102496485|NCT00001024|Zidovudine|zidovudine|mesh-list
102496486|NCT00001024|Didanosine|didanosine|mesh-list
102496487|NCT00001024|Antimetabolites|antimetabolites|mesh-ancestor
102496488|NCT00001024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496489|NCT00001024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102496490|NCT00001024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102496491|NCT00001024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102496492|NCT00001024|Antiviral Agents|antiviral agents|mesh-ancestor
102496493|NCT00001024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102496494|NCT00001024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102496495|NCT00001024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102496496|NCT00000268|Bupropion|bupropion|mesh-list
102496497|NCT00000268|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102496498|NCT00000268|Antidepressive Agents|antidepressive agents|mesh-ancestor
102496499|NCT00000268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102496500|NCT00000268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102496501|NCT00000268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102496502|NCT00000268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102496503|NCT00000268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496504|NCT00000268|Dopamine Agents|dopamine agents|mesh-ancestor
102496505|NCT00000268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102496506|NCT00000268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496507|NCT00000268|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102496508|NCT00000268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102496509|NCT00000268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102496510|NCT02847624|Tolvaptan|tolvaptan|mesh-list
102496511|NCT02847624|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102496512|NCT02847624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496513|NCT02847624|Natriuretic Agents|natriuretic agents|mesh-ancestor
102496514|NCT02847624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496515|NCT00001042|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102496516|NCT00001042|MF59 oil emulsion|mf59 oil emulsion|mesh-list
102496517|NCT00001042|Acetylmuramyl-Alanyl-Isoglutamine|acetylmuramyl-alanyl-isoglutamine|mesh-list
102496518|NCT00001042|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102496519|NCT00001042|Immunologic Factors|immunologic factors|mesh-ancestor
102496520|NCT00001042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496521|NCT00001042|Antacids|antacids|mesh-ancestor
102496522|NCT00001042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496523|NCT00001042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102496524|NCT00982865|Niacinamide|niacinamide|mesh-list
102496525|NCT00982865|Vitamin B Complex|vitamin b complex|mesh-ancestor
102496526|NCT00982865|Vitamins|vitamins|mesh-ancestor
102496527|NCT00982865|Micronutrients|micronutrients|mesh-ancestor
102496528|NCT00982865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496529|NCT00001054|Valacyclovir|valacyclovir|mesh-list
102496530|NCT00001054|Antiviral Agents|antiviral agents|mesh-ancestor
102496531|NCT00001054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102496532|NCT02521844|Pembrolizumab|pembrolizumab|mesh-list
102496533|NCT02521844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102496534|NCT02521844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102496535|NCT02521844|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102496536|NCT02521844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496537|NCT01226719|Leucovorin|leucovorin|mesh-list
102496538|NCT01226719|Fluorouracil|fluorouracil|mesh-list
102496539|NCT01226719|Oxaliplatin|oxaliplatin|mesh-list
102496540|NCT01226719|Irinotecan|irinotecan|mesh-list
102496541|NCT01226719|Panitumumab|panitumumab|mesh-list
102496542|NCT01226719|Antimetabolites|antimetabolites|mesh-ancestor
102496543|NCT01226719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496544|NCT01226719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102496545|NCT01226719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102496546|NCT01226719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102496547|NCT01226719|Immunologic Factors|immunologic factors|mesh-ancestor
102496548|NCT01226719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496549|NCT01226719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102496550|NCT01226719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102496551|NCT01226719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102496552|NCT01226719|Antidotes|antidotes|mesh-ancestor
102496553|NCT01226719|Protective Agents|protective agents|mesh-ancestor
102496554|NCT01226719|Vitamin B Complex|vitamin b complex|mesh-ancestor
102496555|NCT01226719|Vitamins|vitamins|mesh-ancestor
102496556|NCT01226719|Micronutrients|micronutrients|mesh-ancestor
102496557|NCT01226719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102496558|NCT00001072|polysaccharide-K|polysaccharide-k|mesh-list
102496559|NCT00001072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102496560|NCT00001072|Immunologic Factors|immunologic factors|mesh-ancestor
102496561|NCT00001072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496562|NCT00001072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102496563|NCT00001072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102496564|NCT00001072|Antiviral Agents|antiviral agents|mesh-ancestor
102496565|NCT00001072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102496566|NCT00001072|Interferon Inducers|interferon inducers|mesh-ancestor
102496567|NCT00001072|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102496568|NCT00001072|Protective Agents|protective agents|mesh-ancestor
102496569|NCT04331470|Ritonavir|ritonavir|mesh-list
102496570|NCT04331470|Lopinavir|lopinavir|mesh-list
102496571|NCT04331470|Chloroquine|chloroquine|mesh-list
102496572|NCT04331470|Levamisole|levamisole|mesh-list
102496573|NCT04331470|Hydroxychloroquine|hydroxychloroquine|mesh-list
102496574|NCT04331470|Budesonide|budesonide|mesh-list
102496575|NCT04331470|Formoterol Fumarate|formoterol fumarate|mesh-list
102496576|NCT04331470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102496577|NCT04331470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102496578|NCT04331470|Protease Inhibitors|protease inhibitors|mesh-ancestor
102496579|NCT04331470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102496580|NCT04331470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496581|NCT04331470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102496582|NCT04331470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102496583|NCT04331470|Antiviral Agents|antiviral agents|mesh-ancestor
102496584|NCT04331470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102496585|NCT04331470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102496586|NCT04331470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102496587|NCT04331470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102496588|NCT04331470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102496589|NCT04331470|Autonomic Agents|autonomic agents|mesh-ancestor
102496590|NCT04331470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102496591|NCT04331470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496592|NCT04331470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102496593|NCT04331470|Respiratory System Agents|respiratory system agents|mesh-ancestor
102496594|NCT04331470|Glucocorticoids|glucocorticoids|mesh-ancestor
102496595|NCT04331470|Hormones|hormones|mesh-ancestor
102496596|NCT04331470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102496597|NCT04331470|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102496598|NCT04331470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102496599|NCT04331470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102496600|NCT04331470|Adrenergic Agents|adrenergic agents|mesh-ancestor
102496601|NCT04331470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102496602|NCT04331470|Amebicides|amebicides|mesh-ancestor
102496603|NCT04331470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102496604|NCT04331470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102496605|NCT04331470|Antimalarials|antimalarials|mesh-ancestor
102496606|NCT04331470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102496607|NCT04331470|Antinematodal Agents|antinematodal agents|mesh-ancestor
102496608|NCT04331470|Anthelmintics|anthelmintics|mesh-ancestor
102496609|NCT04331470|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102496610|NCT04331470|Immunologic Factors|immunologic factors|mesh-ancestor
102496611|NCT00001090|Sargramostim|sargramostim|mesh-list
102496612|NCT00001090|Immunologic Factors|immunologic factors|mesh-ancestor
102496613|NCT00001090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496614|NCT01147627|Insulin|insulin|mesh-list
102496615|NCT01147627|Pioglitazone|pioglitazone|mesh-list
102496616|NCT01147627|Exenatide|exenatide|mesh-list
102496617|NCT01147627|Insulin Lispro|insulin lispro|mesh-list
102496618|NCT01147627|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102496619|NCT01147627|Protamines|protamines|mesh-list
102496620|NCT01147627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102496621|NCT01147627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496622|NCT01147627|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102496623|NCT01147627|Incretins|incretins|mesh-ancestor
102496624|NCT01147627|Hormones|hormones|mesh-ancestor
102496625|NCT01147627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102496626|NCT01147627|Heparin Antagonists|heparin antagonists|mesh-ancestor
102496627|NCT01147627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496628|NCT01147627|Coagulants|coagulants|mesh-ancestor
102496629|NCT02548962|Dexamethasone|dexamethasone|mesh-list
102496630|NCT02548962|Pomalidomide|pomalidomide|mesh-list
102496631|NCT02548962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102496632|NCT02548962|Antiemetics|antiemetics|mesh-ancestor
102496633|NCT02548962|Autonomic Agents|autonomic agents|mesh-ancestor
102496634|NCT02548962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102496635|NCT02548962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496636|NCT02548962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102496637|NCT02548962|Glucocorticoids|glucocorticoids|mesh-ancestor
102496638|NCT02548962|Hormones|hormones|mesh-ancestor
102496639|NCT02548962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102496640|NCT02548962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102496641|NCT02548962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102496642|NCT02548962|Immunologic Factors|immunologic factors|mesh-ancestor
102496643|NCT02548962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102496644|NCT02548962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102496645|NCT02548962|Growth Substances|growth substances|mesh-ancestor
102496646|NCT02548962|Growth Inhibitors|growth inhibitors|mesh-ancestor
102496647|NCT00000274|Flupenthixol|flupenthixol|mesh-list
102496648|NCT00000274|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
102496649|NCT00000274|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102496650|NCT00000274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102496651|NCT00000274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102496652|NCT00000274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496653|NCT00000274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102496654|NCT00000274|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102496655|NCT00000274|Dopamine Agents|dopamine agents|mesh-ancestor
102496656|NCT00000274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102496657|NCT00000274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496658|NCT02743598|Liraglutide|liraglutide|mesh-list
102496659|NCT02743598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102496660|NCT02743598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496661|NCT02743598|Incretins|incretins|mesh-ancestor
102496662|NCT02743598|Hormones|hormones|mesh-ancestor
102496663|NCT02743598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102496664|NCT00000280|Nimodipine|nimodipine|mesh-list
102496665|NCT00000280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102496666|NCT00000280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102496667|NCT00000280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102496668|NCT00000280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496669|NCT00000280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102496670|NCT00000280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496671|NCT00000280|Vasodilator Agents|vasodilator agents|mesh-ancestor
102496672|NCT00000286|Nefazodone|nefazodone|mesh-list
102496673|NCT00000286|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102496674|NCT00000286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102496675|NCT00000286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102496676|NCT00000286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496677|NCT00000286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102496678|NCT00000286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496679|NCT00000286|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102496680|NCT00000286|Antidepressive Agents|antidepressive agents|mesh-ancestor
102496681|NCT00000286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102496682|NCT00000286|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102496683|NCT00000286|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102496684|NCT00000286|Serotonin Agents|serotonin agents|mesh-ancestor
102496685|NCT01188577|Epinephrine|epinephrine|mesh-list
102308282|NCT01736176|Levodopa|levodopa|mesh-list
102496687|NCT01188577|Epinephryl borate|epinephryl borate|mesh-list
102496688|NCT01188577|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102496689|NCT01188577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102496690|NCT01188577|Adrenergic Agents|adrenergic agents|mesh-ancestor
102496691|NCT01188577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102496692|NCT01188577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496693|NCT01188577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496694|NCT01188577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102496695|NCT01188577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102496696|NCT01188577|Autonomic Agents|autonomic agents|mesh-ancestor
102496697|NCT01188577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102496698|NCT01188577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102496699|NCT01188577|Respiratory System Agents|respiratory system agents|mesh-ancestor
102496700|NCT01188577|Mydriatics|mydriatics|mesh-ancestor
102496701|NCT01188577|Sympathomimetics|sympathomimetics|mesh-ancestor
102496702|NCT01188577|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102496703|NCT02507336|Thalidomide|thalidomide|mesh-list
102496704|NCT02507336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102496705|NCT02507336|Immunologic Factors|immunologic factors|mesh-ancestor
102496706|NCT02507336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496707|NCT02507336|Leprostatic Agents|leprostatic agents|mesh-ancestor
102496708|NCT02507336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102496709|NCT02507336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102496710|NCT02507336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102496711|NCT02507336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102496712|NCT02507336|Growth Substances|growth substances|mesh-ancestor
102496713|NCT02507336|Growth Inhibitors|growth inhibitors|mesh-ancestor
102496714|NCT02507336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102496715|NCT00000292|Cocaine|cocaine|mesh-list
102496716|NCT00000292|Anesthetics, Local|anesthetics, local|mesh-ancestor
102496717|NCT00000292|Anesthetics|anesthetics|mesh-ancestor
102496718|NCT00000292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102496719|NCT00000292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496720|NCT00000292|Sensory System Agents|sensory system agents|mesh-ancestor
102496721|NCT00000292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102496722|NCT00000292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102496723|NCT00000292|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102496724|NCT00000292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102496725|NCT00000292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102496726|NCT00000292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496727|NCT00000292|Dopamine Agents|dopamine agents|mesh-ancestor
102496728|NCT00000292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102496729|NCT00000298|Buprenorphine|buprenorphine|mesh-list
102496730|NCT00000298|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102496731|NCT00000298|Naloxone|naloxone|mesh-list
102496732|NCT00000298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102496733|NCT00000298|Narcotics|narcotics|mesh-ancestor
102496734|NCT00000298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102496735|NCT00000298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496736|NCT00000298|Analgesics|analgesics|mesh-ancestor
102496737|NCT00000298|Sensory System Agents|sensory system agents|mesh-ancestor
102496738|NCT00000298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102496739|NCT00000298|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102496740|NCT00000304|Amphetamine|amphetamine|mesh-list
102496741|NCT00000304|Dextroamphetamine|dextroamphetamine|mesh-list
102496742|NCT00000304|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102496743|NCT00000304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496744|NCT00000304|Sympathomimetics|sympathomimetics|mesh-ancestor
102496745|NCT00000304|Autonomic Agents|autonomic agents|mesh-ancestor
102496746|NCT00000304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102496747|NCT00000304|Dopamine Agents|dopamine agents|mesh-ancestor
102496748|NCT00000304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102496749|NCT00000304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496750|NCT00000304|Adrenergic Agents|adrenergic agents|mesh-ancestor
102496751|NCT00000304|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102496752|NCT00000304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102496753|NCT00000304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102496754|NCT00000304|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102496755|NCT02548650|Aspirin|aspirin|mesh-list
102496756|NCT02548650|Clopidogrel|clopidogrel|mesh-list
102496757|NCT02548650|Vorapaxar|vorapaxar|mesh-list
102496758|NCT02548650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102496759|NCT02548650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102496760|NCT02548650|Analgesics|analgesics|mesh-ancestor
102496761|NCT02548650|Sensory System Agents|sensory system agents|mesh-ancestor
102496762|NCT02548650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102496763|NCT02548650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496764|NCT02548650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102496766|NCT02548650|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102496767|NCT02548650|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102496768|NCT02548650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496769|NCT02548650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102496770|NCT02548650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102496771|NCT02548650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102496772|NCT02548650|Antipyretics|antipyretics|mesh-ancestor
102496773|NCT02548650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102496774|NCT02548650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102496775|NCT02548650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102496776|NCT02548650|Purinergic Agents|purinergic agents|mesh-ancestor
102496777|NCT02548650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102496778|NCT00000310|Risperidone|risperidone|mesh-list
102496779|NCT00000310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102496780|NCT00000310|Serotonin Agents|serotonin agents|mesh-ancestor
102496781|NCT00000310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102496782|NCT00000310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496783|NCT00000310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496784|NCT00000310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102496785|NCT00000310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102496786|NCT00000310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102496787|NCT00000310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102496788|NCT00000310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102496789|NCT00000310|Dopamine Agents|dopamine agents|mesh-ancestor
102496790|NCT02734004|Bevacizumab|bevacizumab|mesh-list
102496791|NCT02734004|Durvalumab|durvalumab|mesh-list
102496792|NCT02734004|Olaparib|olaparib|mesh-list
102496793|NCT02734004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102496794|NCT02734004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102496795|NCT02734004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102496796|NCT02734004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102496797|NCT02734004|Growth Substances|growth substances|mesh-ancestor
102496798|NCT02734004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496799|NCT02734004|Growth Inhibitors|growth inhibitors|mesh-ancestor
102496800|NCT02734004|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102496801|NCT02734004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102496802|NCT02734004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496803|NCT01227655|Levodopa|levodopa|mesh-list
102496804|NCT01227655|Carbidopa|carbidopa|mesh-list
102496805|NCT01227655|Opicapone|opicapone|mesh-list
102496806|NCT01227655|Benserazide|benserazide|mesh-list
102496807|NCT01227655|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102496808|NCT01227655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102496809|NCT01227655|Dopamine Agents|dopamine agents|mesh-ancestor
102496810|NCT01227655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102496811|NCT01227655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496812|NCT01227655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496813|NCT01227655|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102496814|NCT01227655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102496815|NCT01227655|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102496816|NCT00000316|Cocaine|cocaine|mesh-list
102496817|NCT00000316|Anesthetics, Local|anesthetics, local|mesh-ancestor
102496818|NCT00000316|Anesthetics|anesthetics|mesh-ancestor
102496819|NCT00000316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102496820|NCT00000316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496821|NCT00000316|Sensory System Agents|sensory system agents|mesh-ancestor
102496822|NCT00000316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102496823|NCT00000316|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102496824|NCT00000316|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102496825|NCT00000316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102496826|NCT00000316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102496827|NCT00000316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496828|NCT00000316|Dopamine Agents|dopamine agents|mesh-ancestor
102496829|NCT00000316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102496830|NCT05459532|Molnupiravir|molnupiravir|mesh-list
102496831|NCT05459532|Antiviral Agents|antiviral agents|mesh-ancestor
102496832|NCT05459532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102308418|NCT02367833|NuvaRing|nuvaring|mesh-list
102496833|NCT00001990|Atovaquone|atovaquone|mesh-list
102496834|NCT00001990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102496835|NCT00001990|Antimalarials|antimalarials|mesh-ancestor
102496836|NCT00001990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102496837|NCT00001990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102496838|NCT00001990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102496839|NCT00001990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496840|NCT01026623|Sirolimus|sirolimus|mesh-list
102496841|NCT01026623|Temsirolimus|temsirolimus|mesh-list
102496842|NCT01026623|MTOR Inhibitors|mtor inhibitors|mesh-list
102496843|NCT01026623|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102496844|NCT01026623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102496845|NCT01026623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102496846|NCT01026623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102496847|NCT01026623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102496848|NCT01026623|Antifungal Agents|antifungal agents|mesh-ancestor
102496849|NCT01026623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102496850|NCT01026623|Immunologic Factors|immunologic factors|mesh-ancestor
102496851|NCT01026623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496852|NCT01026623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102496853|NCT01026623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102496854|NCT01026623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496855|NCT00001996|Atovaquone|atovaquone|mesh-list
102496856|NCT00001996|Pentamidine|pentamidine|mesh-list
102496857|NCT00001996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102496858|NCT00001996|Antimalarials|antimalarials|mesh-ancestor
102496859|NCT00001996|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102496860|NCT00001996|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102496861|NCT00001996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102496862|NCT00001996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496863|NCT00001996|Antifungal Agents|antifungal agents|mesh-ancestor
102496864|NCT00001996|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102496865|NCT02725424|Docetaxel|docetaxel|mesh-list
102496866|NCT02725424|Oxaliplatin|oxaliplatin|mesh-list
102496867|NCT02725424|Trastuzumab|trastuzumab|mesh-list
102496868|NCT02725424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102496869|NCT02725424|Tubulin Modulators|tubulin modulators|mesh-ancestor
102496870|NCT02725424|Antimitotic Agents|antimitotic agents|mesh-ancestor
102496871|NCT02725424|Mitosis Modulators|mitosis modulators|mesh-ancestor
102496872|NCT02725424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496873|NCT02725424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102496874|NCT01189279|Bimatoprost|bimatoprost|mesh-list
102496875|NCT01189279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102496876|NCT00001108|Ritonavir|ritonavir|mesh-list
102496877|NCT00001108|Nelfinavir|nelfinavir|mesh-list
102496878|NCT00001108|Saquinavir|saquinavir|mesh-list
102496879|NCT00001108|Lamivudine|lamivudine|mesh-list
102496880|NCT00001108|Nevirapine|nevirapine|mesh-list
102496881|NCT00001108|Stavudine|stavudine|mesh-list
102496882|NCT00001108|Didanosine|didanosine|mesh-list
102496883|NCT00001108|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102496884|NCT00001108|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102496885|NCT00001108|Protease Inhibitors|protease inhibitors|mesh-ancestor
102496886|NCT00001108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102496887|NCT00001108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496888|NCT00001108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102496889|NCT00001108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102496890|NCT00001108|Antiviral Agents|antiviral agents|mesh-ancestor
102496891|NCT00001108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102496892|NCT00001108|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102496893|NCT00001108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102496894|NCT00001108|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102496895|NCT00001108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102496896|NCT00001108|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102496897|NCT00001108|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102496898|NCT00001108|Antimetabolites|antimetabolites|mesh-ancestor
102496899|NCT00000328|Analgesics, Opioid|analgesics, opioid|mesh-list
102496900|NCT00000328|Narcotics|narcotics|mesh-ancestor
102496901|NCT00000328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102496902|NCT00000328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496903|NCT00000328|Analgesics|analgesics|mesh-ancestor
102496904|NCT00000328|Sensory System Agents|sensory system agents|mesh-ancestor
102496905|NCT00000328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102496906|NCT00380224|Olanzapine|olanzapine|mesh-list
102496907|NCT00380224|Antiemetics|antiemetics|mesh-ancestor
102496908|NCT00380224|Autonomic Agents|autonomic agents|mesh-ancestor
102496909|NCT00380224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102308488|NCT02364947|Nalmefene|nalmefene|mesh-list
102496910|NCT00380224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496911|NCT00380224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102496912|NCT00380224|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102496913|NCT00380224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102496914|NCT00380224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102496915|NCT00380224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102496916|NCT00380224|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102496917|NCT00380224|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102496918|NCT00380224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102496919|NCT00380224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496920|NCT00380224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102496921|NCT00380224|Serotonin Agents|serotonin agents|mesh-ancestor
102496922|NCT00002002|Leucovorin|leucovorin|mesh-list
102496923|NCT00002002|Trimethoprim|trimethoprim|mesh-list
102496924|NCT00002002|Sulfamethoxazole|sulfamethoxazole|mesh-list
102496925|NCT00002002|Calcium|calcium|mesh-list
102496926|NCT00002002|Levoleucovorin|levoleucovorin|mesh-list
102496927|NCT00002002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102496928|NCT00002002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496929|NCT00002002|Antidotes|antidotes|mesh-ancestor
102496930|NCT00002002|Protective Agents|protective agents|mesh-ancestor
102496931|NCT00002002|Vitamin B Complex|vitamin b complex|mesh-ancestor
102496932|NCT00002002|Vitamins|vitamins|mesh-ancestor
102496933|NCT00002002|Micronutrients|micronutrients|mesh-ancestor
102496934|NCT00002002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102496935|NCT00002002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102496936|NCT00002002|Antimalarials|antimalarials|mesh-ancestor
102496937|NCT00002002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102496938|NCT00002002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102496939|NCT00002002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102496940|NCT00002002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102496941|NCT00002002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496942|NCT00002002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102496943|NCT00002002|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102496944|NCT00002002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102496945|NCT02535000|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102496946|NCT02535000|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102496947|NCT02535000|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102496948|NCT02535000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102496949|NCT02535000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496950|NCT02535000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102496951|NCT02535000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496952|NCT02535000|Analgesics|analgesics|mesh-ancestor
102496953|NCT02535000|Sensory System Agents|sensory system agents|mesh-ancestor
102496954|NCT02535000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102496955|NCT02535000|Antidepressive Agents|antidepressive agents|mesh-ancestor
102496956|NCT02535000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102496957|NCT02535000|Dopamine Agents|dopamine agents|mesh-ancestor
102496958|NCT00380380|Vildagliptin|vildagliptin|mesh-list
102496959|NCT00380380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102496960|NCT00380380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496961|NCT00380380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102496962|NCT00380380|Protease Inhibitors|protease inhibitors|mesh-ancestor
102496963|NCT00380380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102496964|NCT00380380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496965|NCT01228903|Allopurinol|allopurinol|mesh-list
102496966|NCT01228903|Antimetabolites|antimetabolites|mesh-ancestor
102496967|NCT01228903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496968|NCT01228903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102496969|NCT01228903|Gout Suppressants|gout suppressants|mesh-ancestor
102496970|NCT01228903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102496971|NCT01228903|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102496972|NCT01228903|Antioxidants|antioxidants|mesh-ancestor
102496973|NCT01228903|Protective Agents|protective agents|mesh-ancestor
102496974|NCT01228903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496975|NCT01189747|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102496976|NCT01189747|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102496977|NCT01189747|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102496978|NCT01189747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102496979|NCT01189747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496980|NCT01189747|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102496981|NCT01189747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102496982|NCT01189747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496983|NCT01189747|Cholinergic Agents|cholinergic agents|mesh-ancestor
102496984|NCT01189747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102496985|NCT00001126|Cidofovir|cidofovir|mesh-list
102496986|NCT00001126|Antiviral Agents|antiviral agents|mesh-ancestor
102496987|NCT00001126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102496988|NCT00001126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102496989|NCT00001126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496990|NCT00002008|Sargramostim|sargramostim|mesh-list
102496991|NCT00002008|Immunologic Factors|immunologic factors|mesh-ancestor
102496992|NCT00002008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102496993|NCT00001132|Abacavir|abacavir|mesh-list
102496994|NCT00001132|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102496995|NCT00001132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102496996|NCT00001132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102496997|NCT00001132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102496998|NCT00001132|Antiviral Agents|antiviral agents|mesh-ancestor
102496999|NCT00001132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102497000|NCT00001132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102497001|NCT00001132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102497002|NCT01149733|Tamsulosin|tamsulosin|mesh-list
102497003|NCT01149733|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102497004|NCT01149733|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102497005|NCT01149733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102497006|NCT01149733|Adrenergic Agents|adrenergic agents|mesh-ancestor
102497007|NCT01149733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102497008|NCT01149733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497009|NCT01149733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497010|NCT01149733|Urological Agents|urological agents|mesh-ancestor
102497011|NCT02498912|Cyclophosphamide|cyclophosphamide|mesh-list
102497012|NCT02498912|Fludarabine|fludarabine|mesh-list
102497013|NCT02498912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102497014|NCT02498912|Immunologic Factors|immunologic factors|mesh-ancestor
102497015|NCT02498912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497016|NCT02498912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102497017|NCT02498912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102497018|NCT02498912|Alkylating Agents|alkylating agents|mesh-ancestor
102497019|NCT02498912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497020|NCT02498912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102497021|NCT02498912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102497022|NCT00002014|Zidovudine|zidovudine|mesh-list
102497023|NCT00002014|Didanosine|didanosine|mesh-list
102497024|NCT00002014|Antimetabolites|antimetabolites|mesh-ancestor
102497025|NCT00002014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497026|NCT00002014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102497027|NCT00002014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102497028|NCT00002014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102497029|NCT00002014|Antiviral Agents|antiviral agents|mesh-ancestor
102497030|NCT00002014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102497031|NCT00002014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102497032|NCT00002014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102497033|NCT00000334|Buprenorphine|buprenorphine|mesh-list
102497034|NCT00000334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102497035|NCT00000334|Narcotics|narcotics|mesh-ancestor
102497036|NCT00000334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102497037|NCT00000334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497038|NCT00000334|Analgesics|analgesics|mesh-ancestor
102497039|NCT00000334|Sensory System Agents|sensory system agents|mesh-ancestor
102497040|NCT00000334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102497041|NCT00000334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102497042|NCT00000340|Pemoline|pemoline|mesh-list
102497043|NCT00000340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102497044|NCT00000340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497045|NCT00002020|Zidovudine|zidovudine|mesh-list
102497046|NCT00002020|Antimetabolites|antimetabolites|mesh-ancestor
102497047|NCT00002020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497048|NCT00002020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102497049|NCT00002020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102497050|NCT00002020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102497051|NCT00002020|Antiviral Agents|antiviral agents|mesh-ancestor
102497052|NCT00002020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102497053|NCT00002020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102497054|NCT00002020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102497055|NCT00002026|Acyclovir|acyclovir|mesh-list
102497056|NCT00002026|Antiviral Agents|antiviral agents|mesh-ancestor
102497057|NCT00002026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102497058|NCT00000352|Dextromethorphan|dextromethorphan|mesh-list
102497059|NCT00000352|Antitussive Agents|antitussive agents|mesh-ancestor
102497060|NCT00000352|Respiratory System Agents|respiratory system agents|mesh-ancestor
102497061|NCT00000352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102497062|NCT00000352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102497063|NCT00000352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102497064|NCT00000352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497065|NCT00000352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497066|NCT00002032|Rifabutin|rifabutin|mesh-list
102497067|NCT00002032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102497068|NCT00002032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102497069|NCT00002032|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102497070|NCT00002032|Antitubercular Agents|antitubercular agents|mesh-ancestor
102497071|NCT01229527|Meperidine|meperidine|mesh-list
102497072|NCT01229527|Remifentanil|remifentanil|mesh-list
102497073|NCT01229527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102497074|NCT01229527|Narcotics|narcotics|mesh-ancestor
102497075|NCT01229527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102497076|NCT01229527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497077|NCT01229527|Analgesics|analgesics|mesh-ancestor
102497078|NCT01229527|Sensory System Agents|sensory system agents|mesh-ancestor
102497079|NCT01229527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102497080|NCT01229527|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102497081|NCT02723162|Acetylcysteine|acetylcysteine|mesh-list
102497082|NCT02723162|Varenicline|varenicline|mesh-list
102497083|NCT02723162|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102497084|NCT02723162|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102497085|NCT02723162|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102497086|NCT02723162|Cholinergic Agents|cholinergic agents|mesh-ancestor
102497087|NCT02723162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102497088|NCT02723162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497089|NCT02723162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497090|NCT02723162|Antiviral Agents|antiviral agents|mesh-ancestor
102497091|NCT02723162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102497092|NCT02723162|Expectorants|expectorants|mesh-ancestor
102497093|NCT02723162|Respiratory System Agents|respiratory system agents|mesh-ancestor
102497094|NCT02723162|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102497095|NCT02723162|Antioxidants|antioxidants|mesh-ancestor
102497096|NCT02723162|Protective Agents|protective agents|mesh-ancestor
102497097|NCT02723162|Antidotes|antidotes|mesh-ancestor
102497098|NCT00000358|Lofexidine|lofexidine|mesh-list
102497099|NCT00000358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102497100|NCT00000358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102497101|NCT00000358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497102|NCT00000358|Sensory System Agents|sensory system agents|mesh-ancestor
102497103|NCT00000358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102497104|NCT00000358|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102497105|NCT00000358|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102497106|NCT00000358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102497107|NCT00000358|Adrenergic Agents|adrenergic agents|mesh-ancestor
102497108|NCT00000358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102497109|NCT00000358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497110|NCT00000376|Desipramine|desipramine|mesh-list
102497111|NCT00000376|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102497112|NCT00000376|Antidepressive Agents|antidepressive agents|mesh-ancestor
102497113|NCT00000376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102497114|NCT00000376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102497115|NCT00000376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497116|NCT00000376|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102497117|NCT00000376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102497118|NCT00000376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102497119|NCT00000376|Adrenergic Agents|adrenergic agents|mesh-ancestor
102497120|NCT00000376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102497121|NCT00000376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497122|NCT02143388|Cisplatin|cisplatin|mesh-list
102497123|NCT02143388|Capecitabine|capecitabine|mesh-list
102497124|NCT02143388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102497125|NCT02143388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102497126|NCT02143388|Antimetabolites|antimetabolites|mesh-ancestor
102497127|NCT02143388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497128|NCT00001228|Interferons|interferons|mesh-list
102497129|NCT00001228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102497130|NCT00001228|Antiviral Agents|antiviral agents|mesh-ancestor
102497131|NCT00001228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102497132|NCT02483936|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102497133|NCT02483936|Olmesartan|olmesartan|mesh-list
102497134|NCT02483936|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
102497135|NCT02483936|Chlorthalidone|chlorthalidone|mesh-list
102497136|NCT02483936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102497137|NCT02483936|Diuretics|diuretics|mesh-ancestor
102497138|NCT02483936|Natriuretic Agents|natriuretic agents|mesh-ancestor
102497139|NCT02483936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497140|NCT02483936|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102497141|NCT02483936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102497142|NCT02483936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497143|NCT02483936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102497144|NCT02483936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102497145|NCT00002038|Fluconazole|fluconazole|mesh-list
102497146|NCT00002038|Antifungal Agents|antifungal agents|mesh-ancestor
102497147|NCT00002038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102497148|NCT00002038|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102497149|NCT00002038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102497150|NCT00002038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102497151|NCT00002038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497152|NCT00002038|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102497153|NCT00002038|Hormone Antagonists|hormone antagonists|mesh-ancestor
102497154|NCT00002038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102497155|NCT00002038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497156|NCT00002038|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102497157|NCT00002038|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102497159|NCT01894334|Tranexamic Acid|tranexamic acid|mesh-list
102497160|NCT01894334|Urinastatin|urinastatin|mesh-list
102497161|NCT01894334|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102497162|NCT01894334|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102497163|NCT01894334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497164|NCT01894334|Hemostatics|hemostatics|mesh-ancestor
102497165|NCT01894334|Coagulants|coagulants|mesh-ancestor
102497166|NCT01894334|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102497167|NCT01894334|Antioxidants|antioxidants|mesh-ancestor
102497168|NCT01894334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102497169|NCT01894334|Protective Agents|protective agents|mesh-ancestor
102497170|NCT01894334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497171|NCT01894334|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102497172|NCT01894334|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102497173|NCT01894334|Protease Inhibitors|protease inhibitors|mesh-ancestor
102497174|NCT01894334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102497175|NCT00002044|Zidovudine|zidovudine|mesh-list
102497176|NCT00002044|Antimetabolites|antimetabolites|mesh-ancestor
102497177|NCT00002044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497178|NCT00002044|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102497179|NCT00002044|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102497180|NCT00002044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102497181|NCT00002044|Antiviral Agents|antiviral agents|mesh-ancestor
102497182|NCT00002044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102497183|NCT00002044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102497184|NCT00002044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102497185|NCT00001282|Zidovudine|zidovudine|mesh-list
102497186|NCT00001282|Interleukin-2|interleukin-2|mesh-list
102497187|NCT00001282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102497188|NCT00001282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102497189|NCT00001282|Analgesics|analgesics|mesh-ancestor
102497190|NCT00001282|Sensory System Agents|sensory system agents|mesh-ancestor
102497191|NCT00001282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102497192|NCT00001282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497193|NCT00001282|Antimetabolites|antimetabolites|mesh-ancestor
102497194|NCT00001282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497195|NCT00001282|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102497196|NCT00001282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102497197|NCT00001282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102497198|NCT00001282|Antiviral Agents|antiviral agents|mesh-ancestor
102497199|NCT00001282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102497200|NCT00001282|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102497201|NCT00001282|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102497202|NCT01150981|Rosiglitazone|rosiglitazone|mesh-list
102497203|NCT01150981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102497204|NCT01150981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497205|NCT00001300|Doxorubicin|doxorubicin|mesh-list
102497206|NCT00001300|Ifosfamide|ifosfamide|mesh-list
102497207|NCT00001300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102497208|NCT00001300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308792|NCT02358863|Vitamins|vitamins|mesh-ancestor
102497209|NCT00001300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102497210|NCT00001300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102497211|NCT00001300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102497212|NCT00001300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497213|NCT00001300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102497214|NCT00001300|Alkylating Agents|alkylating agents|mesh-ancestor
102497215|NCT00000400|Alendronate|alendronate|mesh-list
102497216|NCT00000400|Teriparatide|teriparatide|mesh-list
102497217|NCT00000400|Hormones|hormones|mesh-list
102497218|NCT00000400|Parathyroid Hormone|parathyroid hormone|mesh-list
102497219|NCT00000400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102497220|NCT00000400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497221|NCT00000400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102497222|NCT00000400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102497223|NCT01195597|Nicotine|nicotine|mesh-list
102497224|NCT01195597|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102497225|NCT01195597|Autonomic Agents|autonomic agents|mesh-ancestor
102497226|NCT01195597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102497227|NCT01195597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497228|NCT01195597|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102497229|NCT01195597|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102497230|NCT01195597|Cholinergic Agents|cholinergic agents|mesh-ancestor
102497231|NCT01195597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102497232|NCT01195597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497233|NCT00002050|Thymopentin|thymopentin|mesh-list
102497234|NCT00002050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102497235|NCT00002050|Immunologic Factors|immunologic factors|mesh-ancestor
102497236|NCT00002050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497237|NCT04389866|Hyaluronic Acid|hyaluronic acid|mesh-list
102497238|NCT04389866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102497239|NCT04389866|Immunologic Factors|immunologic factors|mesh-ancestor
102497240|NCT04389866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497241|NCT04389866|Viscosupplements|viscosupplements|mesh-ancestor
102497242|NCT04389866|Protective Agents|protective agents|mesh-ancestor
102497243|NCT00000412|Alendronate|alendronate|mesh-list
102497244|NCT00000412|Calcitriol|calcitriol|mesh-list
102497245|NCT00000412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102497246|NCT00000412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497247|NCT00000412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102497248|NCT00000412|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102497249|NCT00000412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102497250|NCT00000412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497251|NCT00000412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102497252|NCT00000412|Vitamins|vitamins|mesh-ancestor
102497253|NCT00000412|Micronutrients|micronutrients|mesh-ancestor
102497254|NCT00002056|Pentamidine|pentamidine|mesh-list
102497255|NCT00002056|Antifungal Agents|antifungal agents|mesh-ancestor
102497256|NCT00002056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102497257|NCT00002056|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102497258|NCT00002056|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102497259|NCT00002056|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102497260|NCT03110562|Dexamethasone|dexamethasone|mesh-list
102497261|NCT03110562|Bortezomib|bortezomib|mesh-list
102497262|NCT03110562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102497263|NCT03110562|Antiemetics|antiemetics|mesh-ancestor
102497264|NCT03110562|Autonomic Agents|autonomic agents|mesh-ancestor
102497265|NCT03110562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102497266|NCT03110562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497267|NCT03110562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102497268|NCT03110562|Glucocorticoids|glucocorticoids|mesh-ancestor
102497269|NCT03110562|Hormones|hormones|mesh-ancestor
102497270|NCT03110562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102497271|NCT03110562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102497272|NCT03110562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102497273|NCT00380614|Lamivudine|lamivudine|mesh-list
102497274|NCT00380614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102497275|NCT00380614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102497276|NCT00380614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102497277|NCT00380614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497278|NCT00380614|Antiviral Agents|antiviral agents|mesh-ancestor
102497279|NCT00380614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102497280|NCT00380614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102497281|NCT00380614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102497282|NCT00000430|Alendronate|alendronate|mesh-list
102497283|NCT00000430|Estrogens|estrogens|mesh-list
102497284|NCT00000430|Progestins|progestins|mesh-list
102497285|NCT00000430|Hormones|hormones|mesh-ancestor
102497286|NCT00000430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102497287|NCT00000430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497288|NCT00000430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102497289|NCT00380770|Lamivudine|lamivudine|mesh-list
102497290|NCT00380770|Stavudine|stavudine|mesh-list
102497291|NCT00380770|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
102497292|NCT00380770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102497293|NCT00380770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102497294|NCT00380770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102497295|NCT00380770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497296|NCT00380770|Antiviral Agents|antiviral agents|mesh-ancestor
102497297|NCT00380770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102497298|NCT00380770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102497299|NCT00380770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102497300|NCT00380770|Antimetabolites|antimetabolites|mesh-ancestor
102497301|NCT01231399|Calcium, Dietary|calcium, dietary|mesh-list
102497302|NCT01231399|Leucovorin|leucovorin|mesh-list
102497303|NCT01231399|Fluorouracil|fluorouracil|mesh-list
102497304|NCT01231399|Oxaliplatin|oxaliplatin|mesh-list
102497305|NCT01231399|Everolimus|everolimus|mesh-list
102497306|NCT01231399|Calcium|calcium|mesh-list
102497307|NCT01231399|Levoleucovorin|levoleucovorin|mesh-list
102497308|NCT01231399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102497309|NCT01231399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497310|NCT01231399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102497311|NCT01231399|Antimetabolites|antimetabolites|mesh-ancestor
102497312|NCT01231399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497313|NCT01231399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102497314|NCT01231399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102497315|NCT01231399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102497316|NCT01231399|Immunologic Factors|immunologic factors|mesh-ancestor
102497317|NCT01231399|Antidotes|antidotes|mesh-ancestor
102497318|NCT01231399|Protective Agents|protective agents|mesh-ancestor
102497319|NCT01231399|Vitamin B Complex|vitamin b complex|mesh-ancestor
102497320|NCT01231399|Vitamins|vitamins|mesh-ancestor
102497321|NCT01231399|Micronutrients|micronutrients|mesh-ancestor
102497322|NCT01231399|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102497323|NCT01231399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102497324|NCT01231399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102497325|NCT00002062|Spiramycin|spiramycin|mesh-list
102497326|NCT00002062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102497327|NCT00002062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102497328|NCT00002062|Coccidiostats|coccidiostats|mesh-ancestor
102497329|NCT00002062|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102497330|NCT00002062|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102497331|NCT01231633|Dexamethasone|dexamethasone|mesh-list
102497332|NCT01231633|Bevacizumab|bevacizumab|mesh-list
102497333|NCT01231633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102497334|NCT01231633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102497335|NCT01231633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102497336|NCT01231633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102497337|NCT01231633|Growth Substances|growth substances|mesh-ancestor
102497338|NCT01231633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497339|NCT01231633|Growth Inhibitors|growth inhibitors|mesh-ancestor
102497340|NCT01231633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102497341|NCT01231633|Antiemetics|antiemetics|mesh-ancestor
102497342|NCT01231633|Autonomic Agents|autonomic agents|mesh-ancestor
102497343|NCT01231633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102497344|NCT01231633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102497345|NCT01231633|Glucocorticoids|glucocorticoids|mesh-ancestor
102497346|NCT01231633|Hormones|hormones|mesh-ancestor
102497347|NCT01231633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102497348|NCT01231633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102497349|NCT00000442|Naltrexone|naltrexone|mesh-list
102497350|NCT00000442|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102497351|NCT00000442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102497352|NCT00000442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497353|NCT00000442|Sensory System Agents|sensory system agents|mesh-ancestor
102497354|NCT00000442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102497355|NCT00002068|Fluconazole|fluconazole|mesh-list
102497356|NCT00002068|Amphotericin B|amphotericin b|mesh-list
102497357|NCT00002068|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102497358|NCT00002068|Antifungal Agents|antifungal agents|mesh-ancestor
102497359|NCT00002068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102497360|NCT00002068|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102497361|NCT00002068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102497362|NCT00002068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102497363|NCT00002068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497364|NCT00002068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102497365|NCT00002068|Hormone Antagonists|hormone antagonists|mesh-ancestor
102497366|NCT00002068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102497367|NCT00002068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497368|NCT00002068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102497369|NCT00002068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102497370|NCT00002068|Amebicides|amebicides|mesh-ancestor
102497371|NCT00002068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102497372|NCT00002068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102497373|NCT00002068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102497374|NCT00000448|Naltrexone|naltrexone|mesh-list
102497375|NCT00000448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102497376|NCT00000448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102497377|NCT00000448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497378|NCT00000448|Sensory System Agents|sensory system agents|mesh-ancestor
102497379|NCT00000448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102497380|NCT00001318|Interferons|interferons|mesh-list
102497381|NCT00001318|Interferon-gamma|interferon-gamma|mesh-list
102497382|NCT00001318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102497383|NCT00001318|Antiviral Agents|antiviral agents|mesh-ancestor
102497384|NCT00001318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102497385|NCT00002074|Fluconazole|fluconazole|mesh-list
102497386|NCT00002074|Amphotericin B|amphotericin b|mesh-list
102497387|NCT00002074|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102497388|NCT00002074|Antifungal Agents|antifungal agents|mesh-ancestor
102497389|NCT00002074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102497390|NCT00002074|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102497391|NCT00002074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102497392|NCT00002074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102497393|NCT00002074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497394|NCT00002074|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102497395|NCT00002074|Hormone Antagonists|hormone antagonists|mesh-ancestor
102497396|NCT00002074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102497397|NCT00002074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497398|NCT00002074|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102497399|NCT00002074|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102497400|NCT00002074|Amebicides|amebicides|mesh-ancestor
102497401|NCT00002074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102497402|NCT00002074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102497403|NCT00002074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102497404|NCT00001354|Zidovudine|zidovudine|mesh-list
102497405|NCT00001354|Interleukin-2|interleukin-2|mesh-list
102497406|NCT00001354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102497407|NCT00001354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102497408|NCT00001354|Analgesics|analgesics|mesh-ancestor
102497409|NCT00001354|Sensory System Agents|sensory system agents|mesh-ancestor
102497410|NCT00001354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102497411|NCT00001354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497412|NCT00001354|Antimetabolites|antimetabolites|mesh-ancestor
102497413|NCT00001354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497414|NCT00001354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102497415|NCT00001354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102497416|NCT00001354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102497417|NCT00001354|Antiviral Agents|antiviral agents|mesh-ancestor
102497418|NCT00001354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102497419|NCT00001354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102497420|NCT00001354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102497421|NCT00000454|Nicotine|nicotine|mesh-list
102497422|NCT00000454|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102497423|NCT00000454|Autonomic Agents|autonomic agents|mesh-ancestor
102497424|NCT00000454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102497425|NCT00000454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497426|NCT00000454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102497427|NCT00000454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102497428|NCT00000454|Cholinergic Agents|cholinergic agents|mesh-ancestor
102497429|NCT00000454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102497430|NCT00000454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497431|NCT00002080|Rifabutin|rifabutin|mesh-list
102497432|NCT00002080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102497433|NCT00002080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102497434|NCT00002080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102497435|NCT00002080|Antitubercular Agents|antitubercular agents|mesh-ancestor
102497437|NCT00000484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102497438|NCT00000484|Diuretics|diuretics|mesh-ancestor
102497439|NCT00000484|Natriuretic Agents|natriuretic agents|mesh-ancestor
102497440|NCT00000484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497441|NCT00000484|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102497442|NCT00000484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102497443|NCT00000484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497444|NCT00000496|Aspirin|aspirin|mesh-list
102497445|NCT00000496|Dipyridamole|dipyridamole|mesh-list
102497446|NCT00000496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102497447|NCT00000496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102497448|NCT00000496|Analgesics|analgesics|mesh-ancestor
102497449|NCT00000496|Sensory System Agents|sensory system agents|mesh-ancestor
102497450|NCT00000496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102497451|NCT00000496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497452|NCT00000496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102497453|NCT00000496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102497454|NCT00000496|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102497455|NCT00000496|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102497456|NCT00000496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497457|NCT00000496|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102497458|NCT00000496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102497459|NCT00000496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102497460|NCT00000496|Antipyretics|antipyretics|mesh-ancestor
102497461|NCT00000496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102497462|NCT00000496|Vasodilator Agents|vasodilator agents|mesh-ancestor
102497463|NCT00002086|Interferons|interferons|mesh-list
102497464|NCT00002086|Interferon-alpha|interferon-alpha|mesh-list
102497465|NCT00002086|Zidovudine|zidovudine|mesh-list
102497466|NCT00002086|Zalcitabine|zalcitabine|mesh-list
102497467|NCT00002086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102497468|NCT00002086|Antiviral Agents|antiviral agents|mesh-ancestor
102497469|NCT00002086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102497470|NCT00002086|Immunologic Factors|immunologic factors|mesh-ancestor
102497471|NCT00002086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497472|NCT00002086|Antimetabolites|antimetabolites|mesh-ancestor
102497473|NCT00002086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497474|NCT00002086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102497475|NCT00002086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102497476|NCT00002086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102497477|NCT00002086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102497478|NCT00002086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102497479|NCT01151449|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
102497480|NCT01151449|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
102497481|NCT01151449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102497482|NCT01151449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497483|NCT00001384|Paclitaxel|paclitaxel|mesh-list
102497484|NCT00001384|Cyclophosphamide|cyclophosphamide|mesh-list
102497485|NCT00001384|Doxorubicin|doxorubicin|mesh-list
102497486|NCT00001384|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102497487|NCT00001384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102497488|NCT00001384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102497489|NCT00001384|Tubulin Modulators|tubulin modulators|mesh-ancestor
102497490|NCT00001384|Antimitotic Agents|antimitotic agents|mesh-ancestor
102497491|NCT00001384|Mitosis Modulators|mitosis modulators|mesh-ancestor
102497492|NCT00001384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497493|NCT00001384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102497494|NCT00001384|Immunologic Factors|immunologic factors|mesh-ancestor
102497495|NCT00001384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497496|NCT00001384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102497497|NCT00001384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102497498|NCT00001384|Alkylating Agents|alkylating agents|mesh-ancestor
102497499|NCT00001384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102497500|NCT00001384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102497501|NCT00001384|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102497502|NCT00001384|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102497503|NCT00001384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102497504|NCT01151761|Cisplatin|cisplatin|mesh-list
102497505|NCT01151761|Carboplatin|carboplatin|mesh-list
102497506|NCT01151761|Gemcitabine|gemcitabine|mesh-list
102497507|NCT01151761|Fluorouracil|fluorouracil|mesh-list
102497508|NCT01151761|Capecitabine|capecitabine|mesh-list
102309090|NCT02006667|Trastuzumab|trastuzumab|mesh-list
102497509|NCT01151761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102497510|NCT01151761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102497511|NCT01151761|Antimetabolites|antimetabolites|mesh-ancestor
102497512|NCT01151761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497513|NCT01151761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102497514|NCT01151761|Immunologic Factors|immunologic factors|mesh-ancestor
102497515|NCT01151761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497517|NCT00002092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102497518|NCT00002092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102497519|NCT00002092|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102497520|NCT00002092|Histamine Antagonists|histamine antagonists|mesh-ancestor
102497521|NCT00002092|Histamine Agents|histamine agents|mesh-ancestor
102497522|NCT00002092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102497523|NCT00002092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497524|NCT00002092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497525|NCT00002092|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102497526|NCT00002092|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102497527|NCT00002092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102497528|NCT00002098|Didanosine|didanosine|mesh-list
102497529|NCT00002098|Lentinan|lentinan|mesh-list
102497530|NCT00002098|Antimetabolites|antimetabolites|mesh-ancestor
102497531|NCT00002098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497532|NCT00002098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102497533|NCT00002098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102497534|NCT00002098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102497535|NCT00002098|Antiviral Agents|antiviral agents|mesh-ancestor
102497536|NCT00002098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102497537|NCT00002098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102497538|NCT00002098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102497539|NCT00002098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102497540|NCT00002098|Immunologic Factors|immunologic factors|mesh-ancestor
102497541|NCT00002098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497542|NCT00002098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102497543|NCT01196377|Albuterol|albuterol|mesh-list
102497544|NCT01196377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102497545|NCT01196377|Autonomic Agents|autonomic agents|mesh-ancestor
102497546|NCT01196377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102497547|NCT01196377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497548|NCT01196377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102497549|NCT01196377|Respiratory System Agents|respiratory system agents|mesh-ancestor
102497550|NCT01196377|Tocolytic Agents|tocolytic agents|mesh-ancestor
102497551|NCT01196377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102497552|NCT01196377|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102497553|NCT01196377|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102497554|NCT01196377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102497555|NCT01196377|Adrenergic Agents|adrenergic agents|mesh-ancestor
102497556|NCT01196377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102497557|NCT01196377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497558|NCT00001426|Paclitaxel|paclitaxel|mesh-list
102497559|NCT00001426|Cyclophosphamide|cyclophosphamide|mesh-list
102497560|NCT00001426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102497561|NCT00001426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102497562|NCT00001426|Tubulin Modulators|tubulin modulators|mesh-ancestor
102497563|NCT00001426|Antimitotic Agents|antimitotic agents|mesh-ancestor
102497564|NCT00001426|Mitosis Modulators|mitosis modulators|mesh-ancestor
102497565|NCT00001426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497566|NCT00001426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102497567|NCT00001426|Immunologic Factors|immunologic factors|mesh-ancestor
102497568|NCT00001426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497569|NCT00001426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102497570|NCT00001426|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102497571|NCT00001426|Alkylating Agents|alkylating agents|mesh-ancestor
102497572|NCT00001426|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102497573|NCT02463266|Sulfamethazine|sulfamethazine|mesh-list
102497574|NCT02463266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102497575|NCT00002104|Thalidomide|thalidomide|mesh-list
102497576|NCT00002104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102497577|NCT00002104|Immunologic Factors|immunologic factors|mesh-ancestor
102497578|NCT00002104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497579|NCT00002104|Leprostatic Agents|leprostatic agents|mesh-ancestor
102497580|NCT00002104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102497581|NCT00002104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102497582|NCT00002104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102497583|NCT00002104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102497584|NCT00002104|Growth Substances|growth substances|mesh-ancestor
102497585|NCT00002104|Growth Inhibitors|growth inhibitors|mesh-ancestor
102497586|NCT00002104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102497588|NCT00001438|Tretinoin|tretinoin|mesh-list
102497589|NCT00001438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102497590|NCT00001438|Keratolytic Agents|keratolytic agents|mesh-ancestor
102497591|NCT00001438|Dermatologic Agents|dermatologic agents|mesh-ancestor
102497592|NCT00001438|Antiviral Agents|antiviral agents|mesh-ancestor
102497593|NCT00001438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102497594|NCT00001444|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
102497595|NCT00001444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102497596|NCT00001444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102497597|NCT00001444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102497598|NCT00001444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497599|NCT00000574|Ibuprofen|ibuprofen|mesh-list
102497600|NCT00000574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102497601|NCT00000574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102497602|NCT00000574|Analgesics|analgesics|mesh-ancestor
102497603|NCT00000574|Sensory System Agents|sensory system agents|mesh-ancestor
102497604|NCT00000574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102497605|NCT00000574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497606|NCT00000574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102497607|NCT00000574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102497608|NCT00000574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102497609|NCT00000574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102497610|NCT00000574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497611|NCT00002110|Zidovudine|zidovudine|mesh-list
102497612|NCT00002110|Cysteamine|cysteamine|mesh-list
102497613|NCT00002110|Antimetabolites|antimetabolites|mesh-ancestor
102497614|NCT00002110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497615|NCT00002110|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102497616|NCT00002110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102497617|NCT00002110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102497618|NCT00002110|Antiviral Agents|antiviral agents|mesh-ancestor
102497619|NCT00002110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102497620|NCT00002110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102497621|NCT00002110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102497622|NCT00002110|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
102497623|NCT00001450|Paclitaxel|paclitaxel|mesh-list
102497624|NCT00001450|Cisplatin|cisplatin|mesh-list
102497625|NCT00001450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102497626|NCT00001450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102497627|NCT00001450|Tubulin Modulators|tubulin modulators|mesh-ancestor
102497628|NCT00001450|Antimitotic Agents|antimitotic agents|mesh-ancestor
102497629|NCT00001450|Mitosis Modulators|mitosis modulators|mesh-ancestor
102497630|NCT00001450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497631|NCT00000580|Immunoglobulins|immunoglobulins|mesh-list
102497632|NCT00000580|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102497633|NCT00000580|Antibodies|antibodies|mesh-list
102497634|NCT00000580|gamma-Globulins|gamma-globulins|mesh-list
102497635|NCT00000580|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102497636|NCT00000580|Immunologic Factors|immunologic factors|mesh-ancestor
102497637|NCT00000580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497638|NCT00002116|Cidofovir|cidofovir|mesh-list
102497639|NCT00002116|Antiviral Agents|antiviral agents|mesh-ancestor
102497640|NCT00002116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102497641|NCT00002116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102497642|NCT00002116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497643|NCT00001498|Leucovorin|leucovorin|mesh-list
102497644|NCT00001498|Paclitaxel|paclitaxel|mesh-list
102497645|NCT00001498|Cyclophosphamide|cyclophosphamide|mesh-list
102497646|NCT00001498|Doxorubicin|doxorubicin|mesh-list
102497647|NCT00001498|Fluorouracil|fluorouracil|mesh-list
102497648|NCT00001498|Methotrexate|methotrexate|mesh-list
102497649|NCT00001498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102497650|NCT00001498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102497651|NCT00001498|Tubulin Modulators|tubulin modulators|mesh-ancestor
102497652|NCT00001498|Antimitotic Agents|antimitotic agents|mesh-ancestor
102497653|NCT00001498|Mitosis Modulators|mitosis modulators|mesh-ancestor
102497654|NCT00001498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497655|NCT00001498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102497656|NCT00001498|Immunologic Factors|immunologic factors|mesh-ancestor
102497657|NCT00001498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309248|NCT01641367|Tenofovir|tenofovir|mesh-list
102497658|NCT00001498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102497659|NCT00001498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102497661|NCT00001498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102497662|NCT00001498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102497663|NCT00001498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102497664|NCT00001498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102497665|NCT00001498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102497666|NCT00001498|Antimetabolites|antimetabolites|mesh-ancestor
102497667|NCT00001498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102497668|NCT00001498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102497669|NCT00001498|Abortifacient Agents|abortifacient agents|mesh-ancestor
102497670|NCT00001498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102497671|NCT00001498|Dermatologic Agents|dermatologic agents|mesh-ancestor
102497672|NCT00001498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102497673|NCT00001498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102497674|NCT00001498|Antidotes|antidotes|mesh-ancestor
102497675|NCT00001498|Protective Agents|protective agents|mesh-ancestor
102497676|NCT00001498|Vitamin B Complex|vitamin b complex|mesh-ancestor
102497677|NCT00001498|Vitamins|vitamins|mesh-ancestor
102497678|NCT00001498|Micronutrients|micronutrients|mesh-ancestor
102497679|NCT00001504|Tretinoin|tretinoin|mesh-list
102497680|NCT00001504|Alitretinoin|alitretinoin|mesh-list
102497681|NCT00001504|Isotretinoin|isotretinoin|mesh-list
102497682|NCT00001504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102497683|NCT00001504|Keratolytic Agents|keratolytic agents|mesh-ancestor
102497684|NCT00001504|Dermatologic Agents|dermatologic agents|mesh-ancestor
102497685|NCT02688140|Cytarabine|cytarabine|mesh-list
102497686|NCT02688140|Methotrexate|methotrexate|mesh-list
102497687|NCT02688140|Mercaptopurine|mercaptopurine|mesh-list
102497688|NCT02688140|Mitoxantrone|mitoxantrone|mesh-list
102497689|NCT02688140|Idarubicin|idarubicin|mesh-list
102497690|NCT02688140|Tretinoin|tretinoin|mesh-list
102497691|NCT02688140|Arsenic Trioxide|arsenic trioxide|mesh-list
101974022|NCT01329367|Antioxidants|antioxidants|mesh-list
102497692|NCT02688140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102497693|NCT02688140|Abortifacient Agents|abortifacient agents|mesh-ancestor
102497694|NCT02688140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102497695|NCT02688140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497696|NCT02688140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102497697|NCT02688140|Antimetabolites|antimetabolites|mesh-ancestor
102497698|NCT02688140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497699|NCT02688140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102497700|NCT02688140|Dermatologic Agents|dermatologic agents|mesh-ancestor
102497701|NCT02688140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102497702|NCT02688140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102497703|NCT02688140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102497704|NCT02688140|Immunologic Factors|immunologic factors|mesh-ancestor
102497705|NCT02688140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102497706|NCT02688140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102497707|NCT02688140|Antiviral Agents|antiviral agents|mesh-ancestor
102497708|NCT02688140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102497709|NCT02688140|Analgesics|analgesics|mesh-ancestor
102497710|NCT02688140|Sensory System Agents|sensory system agents|mesh-ancestor
102497711|NCT02688140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102497712|NCT02688140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102497713|NCT02688140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102497714|NCT02688140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102497715|NCT02688140|Keratolytic Agents|keratolytic agents|mesh-ancestor
102497716|NCT00002122|Azithromycin|azithromycin|mesh-list
102497717|NCT00002122|Rifabutin|rifabutin|mesh-list
102497718|NCT00002122|Fluconazole|fluconazole|mesh-list
102497719|NCT00002122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102497720|NCT00002122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102497721|NCT00002122|Antifungal Agents|antifungal agents|mesh-ancestor
102497722|NCT00002122|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102497723|NCT00002122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102497724|NCT00002122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102497725|NCT00002122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497726|NCT00002122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102497727|NCT00002122|Hormone Antagonists|hormone antagonists|mesh-ancestor
102497728|NCT00002122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102497729|NCT00002122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497730|NCT00002122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102497731|NCT00002122|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102497732|NCT00002122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102497733|NCT00002122|Antitubercular Agents|antitubercular agents|mesh-ancestor
102309319|NCT02003391|Timolol|timolol|mesh-list
102497734|NCT05456334|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
102497735|NCT05456334|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102497736|NCT05456334|Dermatologic Agents|dermatologic agents|mesh-ancestor
102497737|NCT00001534|Losartan|losartan|mesh-list
102497738|NCT00001534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102497739|NCT00001534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102497740|NCT00001534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102497741|NCT00001534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102497742|NCT00001534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497743|NCT01027559|Sertraline|sertraline|mesh-list
102497744|NCT01027559|Antidepressive Agents|antidepressive agents|mesh-ancestor
102497745|NCT01027559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102497746|NCT01027559|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102497747|NCT01027559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102497748|NCT01027559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102497749|NCT01027559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497750|NCT01027559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102497751|NCT01027559|Serotonin Agents|serotonin agents|mesh-ancestor
102497752|NCT01027559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497753|NCT00002128|Adefovir|adefovir|mesh-list
102497754|NCT00002128|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
102497755|NCT00002128|Antiviral Agents|antiviral agents|mesh-ancestor
102497756|NCT00002128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101974087|NCT01223131|Isophane insulin, beef|isophane insulin, beef|mesh-list
102497757|NCT00002128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102497758|NCT00002128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102497759|NCT00002128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102497760|NCT00002128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497761|NCT00001570|Vinblastine|vinblastine|mesh-list
102497762|NCT00001570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102497763|NCT00001570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102497764|NCT00001570|Tubulin Modulators|tubulin modulators|mesh-ancestor
102497765|NCT00001570|Antimitotic Agents|antimitotic agents|mesh-ancestor
102497766|NCT00001570|Mitosis Modulators|mitosis modulators|mesh-ancestor
102497767|NCT00001570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497768|NCT00000628|Zidovudine|zidovudine|mesh-list
102497769|NCT00000628|L-697661|l-697661|mesh-list
102497770|NCT00000628|Antimetabolites|antimetabolites|mesh-ancestor
102497771|NCT00000628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497772|NCT00000628|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102497773|NCT00000628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102497774|NCT00000628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102497775|NCT00000628|Antiviral Agents|antiviral agents|mesh-ancestor
102497776|NCT00000628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102497777|NCT00000628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102497778|NCT00000628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102497779|NCT00000634|Nevirapine|nevirapine|mesh-list
102497780|NCT00000634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102497781|NCT00000634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102497782|NCT00000634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102497783|NCT00000634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497784|NCT00000634|Antiviral Agents|antiviral agents|mesh-ancestor
102497785|NCT00000634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102497786|NCT00000634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102497787|NCT00000634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102497788|NCT00000634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102497789|NCT00000634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102497790|NCT01661790|Bevacizumab|bevacizumab|mesh-list
102497791|NCT01661790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102497792|NCT01661790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102497793|NCT01661790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102497794|NCT01661790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102497795|NCT01661790|Growth Substances|growth substances|mesh-ancestor
102497796|NCT01661790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497797|NCT01661790|Growth Inhibitors|growth inhibitors|mesh-ancestor
102497798|NCT00002134|Ganciclovir|ganciclovir|mesh-list
102497799|NCT00002134|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102497800|NCT00002134|Antiviral Agents|antiviral agents|mesh-ancestor
102497801|NCT00002134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102497802|NCT00002134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102497803|NCT00002134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102497804|NCT00002134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497805|NCT00985907|Bortezomib|bortezomib|mesh-list
102497806|NCT00985907|Melphalan|melphalan|mesh-list
102497807|NCT00985907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102497808|NCT00985907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102497809|NCT00985907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102497810|NCT00985907|Alkylating Agents|alkylating agents|mesh-ancestor
102497811|NCT00985907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497812|NCT00985907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102497813|NCT00985907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102497814|NCT00985907|Immunologic Factors|immunologic factors|mesh-ancestor
102497815|NCT00985907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497816|NCT00985907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102497818|NCT00002140|Clarithromycin|clarithromycin|mesh-list
102497819|NCT00002140|Ethambutol|ethambutol|mesh-list
102497820|NCT00002140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102497821|NCT00002140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102497822|NCT00002140|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102497823|NCT00002140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102497824|NCT00002140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497825|NCT00002140|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101974157|NCT03132038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102497826|NCT00002140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102497827|NCT00002140|Antitubercular Agents|antitubercular agents|mesh-ancestor
102497828|NCT00000658|Leucovorin|leucovorin|mesh-list
102497829|NCT00000658|Cytarabine|cytarabine|mesh-list
102497830|NCT00000658|Dexamethasone|dexamethasone|mesh-list
102497831|NCT00000658|Cyclophosphamide|cyclophosphamide|mesh-list
102497832|NCT00000658|Doxorubicin|doxorubicin|mesh-list
102497833|NCT00000658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102497834|NCT00000658|Methotrexate|methotrexate|mesh-list
102497835|NCT00000658|Vincristine|vincristine|mesh-list
102497836|NCT00000658|Bleomycin|bleomycin|mesh-list
102497837|NCT00000658|Allopurinol|allopurinol|mesh-list
102497838|NCT00000658|Sargramostim|sargramostim|mesh-list
102497839|NCT00000658|Levoleucovorin|levoleucovorin|mesh-list
102497840|NCT00000658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102497841|NCT00000658|Immunologic Factors|immunologic factors|mesh-ancestor
102497842|NCT00000658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497843|NCT00000658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102497844|NCT00000658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102497845|NCT00000658|Alkylating Agents|alkylating agents|mesh-ancestor
102497846|NCT00000658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497847|NCT00000658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102497848|NCT00000658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102497849|NCT00000658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102497850|NCT00000658|Antiemetics|antiemetics|mesh-ancestor
102497851|NCT00000658|Autonomic Agents|autonomic agents|mesh-ancestor
102497852|NCT00000658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102497853|NCT00000658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102497854|NCT00000658|Glucocorticoids|glucocorticoids|mesh-ancestor
102497855|NCT00000658|Hormones|hormones|mesh-ancestor
102497856|NCT00000658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102497857|NCT00000658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102497858|NCT00000658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102497859|NCT00000658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102497860|NCT00000658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102497861|NCT00000658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102497862|NCT00000658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102497863|NCT00000658|Abortifacient Agents|abortifacient agents|mesh-ancestor
102497864|NCT00000658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102497865|NCT00000658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102497866|NCT00000658|Antimetabolites|antimetabolites|mesh-ancestor
102497867|NCT00000658|Dermatologic Agents|dermatologic agents|mesh-ancestor
102497868|NCT00000658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102497869|NCT00000658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102497870|NCT00000658|Antiviral Agents|antiviral agents|mesh-ancestor
102497871|NCT00000658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102497872|NCT00000658|Antidotes|antidotes|mesh-ancestor
102497873|NCT00000658|Protective Agents|protective agents|mesh-ancestor
102497874|NCT00000658|Vitamin B Complex|vitamin b complex|mesh-ancestor
102497875|NCT00000658|Vitamins|vitamins|mesh-ancestor
102497876|NCT00000658|Micronutrients|micronutrients|mesh-ancestor
102497877|NCT00000658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102497878|NCT00000658|Tubulin Modulators|tubulin modulators|mesh-ancestor
102497879|NCT00000658|Antimitotic Agents|antimitotic agents|mesh-ancestor
102497880|NCT00000658|Mitosis Modulators|mitosis modulators|mesh-ancestor
102497881|NCT00000658|Gout Suppressants|gout suppressants|mesh-ancestor
102497882|NCT00000658|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102497883|NCT00000658|Antioxidants|antioxidants|mesh-ancestor
102497884|NCT02684474|HBOC 201|hboc 201|mesh-list
102497885|NCT02684474|Blood Substitutes|blood substitutes|mesh-ancestor
102497886|NCT01027793|Tretinoin|tretinoin|mesh-list
102497887|NCT01027793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102497888|NCT01027793|Keratolytic Agents|keratolytic agents|mesh-ancestor
102497889|NCT01027793|Dermatologic Agents|dermatologic agents|mesh-ancestor
102497890|NCT00002146|Foscarnet|foscarnet|mesh-list
102497891|NCT00002146|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
102497892|NCT00002146|Magnesium Sulfate|magnesium sulfate|mesh-list
102497893|NCT00002146|Analgesics|analgesics|mesh-ancestor
102497894|NCT00002146|Sensory System Agents|sensory system agents|mesh-ancestor
102497895|NCT00002146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102497896|NCT00002146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497897|NCT00002146|Anesthetics|anesthetics|mesh-ancestor
102497898|NCT00002146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102497899|NCT00002146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102497900|NCT00002146|Anticonvulsants|anticonvulsants|mesh-ancestor
102497901|NCT00002146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102497902|NCT00002146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102497903|NCT00002146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497904|NCT00002146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102497905|NCT00002146|Tocolytic Agents|tocolytic agents|mesh-ancestor
102497906|NCT00002146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102497907|NCT00002146|Antiviral Agents|antiviral agents|mesh-ancestor
102497908|NCT00002146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102497909|NCT00002146|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102497910|NCT00002146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102497911|NCT00002146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102497912|NCT04389554|Fibrin fragment D|fibrin fragment d|mesh-list
102497913|NCT04389554|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102497914|NCT04389554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102497915|NCT04389554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497916|NCT04389554|Hemostatics|hemostatics|mesh-ancestor
102497917|NCT04389554|Coagulants|coagulants|mesh-ancestor
102497918|NCT03051516|Vaccines|vaccines|mesh-list
102497919|NCT03051516|Immunologic Factors|immunologic factors|mesh-ancestor
102497920|NCT03051516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497921|NCT01029587|Eculizumab|eculizumab|mesh-list
102497922|NCT01029587|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102497923|NCT01029587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102497924|NCT01029587|Immunologic Factors|immunologic factors|mesh-ancestor
102497925|NCT01029587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497926|NCT00000664|Zidovudine|zidovudine|mesh-list
102497927|NCT00000664|Interleukin-2|interleukin-2|mesh-list
102497928|NCT00000664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102497929|NCT00000664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102497930|NCT00000664|Analgesics|analgesics|mesh-ancestor
102497931|NCT00000664|Sensory System Agents|sensory system agents|mesh-ancestor
102497932|NCT00000664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102497933|NCT00000664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497934|NCT00000664|Antimetabolites|antimetabolites|mesh-ancestor
102497935|NCT00000664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497936|NCT00000664|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102497937|NCT00000664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102497938|NCT00000664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102497939|NCT00000664|Antiviral Agents|antiviral agents|mesh-ancestor
102497940|NCT00000664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102497941|NCT00000664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102497942|NCT00000664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102497943|NCT00000670|Zidovudine|zidovudine|mesh-list
102497944|NCT00000670|Probenecid|probenecid|mesh-list
102497945|NCT00000670|Antimetabolites|antimetabolites|mesh-ancestor
102497946|NCT00000670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497947|NCT00000670|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102497948|NCT00000670|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102497949|NCT00000670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102497950|NCT00000670|Antiviral Agents|antiviral agents|mesh-ancestor
102497951|NCT00000670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102497952|NCT00000670|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102497953|NCT00000670|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102497954|NCT00000670|Uricosuric Agents|uricosuric agents|mesh-ancestor
102497955|NCT00000670|Gout Suppressants|gout suppressants|mesh-ancestor
102497956|NCT00000670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102497957|NCT00002158|Nitazoxanide|nitazoxanide|mesh-list
102497958|NCT00002158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102497959|NCT00002158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102497960|NCT00000694|Interferons|interferons|mesh-list
102497961|NCT00000694|Interferon-alpha|interferon-alpha|mesh-list
102497962|NCT00000694|Interferon alpha-2|interferon alpha-2|mesh-list
102497963|NCT00000694|Zidovudine|zidovudine|mesh-list
102497964|NCT00000694|Sargramostim|sargramostim|mesh-list
102497965|NCT00000694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102497966|NCT00000694|Antiviral Agents|antiviral agents|mesh-ancestor
102497967|NCT00000694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102497968|NCT00000694|Immunologic Factors|immunologic factors|mesh-ancestor
102497969|NCT00000694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497970|NCT00000694|Antimetabolites|antimetabolites|mesh-ancestor
102497971|NCT00000694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497972|NCT00000694|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102497973|NCT00000694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102497974|NCT00000694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102497975|NCT00000694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102497976|NCT00000694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102497977|NCT01894412|Etanercept|etanercept|mesh-list
102497978|NCT01894412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102497979|NCT01894412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102497980|NCT01894412|Analgesics|analgesics|mesh-ancestor
102497981|NCT01894412|Sensory System Agents|sensory system agents|mesh-ancestor
102497982|NCT01894412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102497983|NCT01894412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102497984|NCT01894412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102497985|NCT01894412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102497986|NCT01894412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102497987|NCT01894412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102497988|NCT01894412|Immunologic Factors|immunologic factors|mesh-ancestor
102497989|NCT00000700|Zidovudine|zidovudine|mesh-list
102497990|NCT00000700|Antimetabolites|antimetabolites|mesh-ancestor
102497991|NCT00000700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102497992|NCT00000700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102497993|NCT00000700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102497994|NCT00000700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102497995|NCT00000700|Antiviral Agents|antiviral agents|mesh-ancestor
102497996|NCT00000700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102497997|NCT00000700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102497998|NCT00000700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102497999|NCT00002164|Nelfinavir|nelfinavir|mesh-list
102498000|NCT00002164|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102498001|NCT00002164|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102498002|NCT00002164|Protease Inhibitors|protease inhibitors|mesh-ancestor
102498003|NCT00002164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102498004|NCT00002164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498005|NCT00002164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102498006|NCT00002164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102498007|NCT00002164|Antiviral Agents|antiviral agents|mesh-ancestor
102498008|NCT00002164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498009|NCT00000706|Zidovudine|zidovudine|mesh-list
102498010|NCT00000706|Quinine|quinine|mesh-list
102498011|NCT00000706|Probenecid|probenecid|mesh-list
102498012|NCT00000706|Antimetabolites|antimetabolites|mesh-ancestor
102498013|NCT00000706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498014|NCT00000706|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102498015|NCT00000706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102498016|NCT00000706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102498017|NCT00000706|Antiviral Agents|antiviral agents|mesh-ancestor
102498018|NCT00000706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498019|NCT00000706|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102498020|NCT00000706|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102498021|NCT00000706|Antimalarials|antimalarials|mesh-ancestor
102498022|NCT00000706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102498023|NCT00000706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102498024|NCT00000706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102498025|NCT00000706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498026|NCT00000706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102498027|NCT00000706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102498028|NCT00000706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102498029|NCT00000706|Analgesics|analgesics|mesh-ancestor
102498030|NCT00000706|Sensory System Agents|sensory system agents|mesh-ancestor
102498031|NCT00000706|Uricosuric Agents|uricosuric agents|mesh-ancestor
102498032|NCT00000706|Gout Suppressants|gout suppressants|mesh-ancestor
102498033|NCT00000706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102498034|NCT00988325|Oseltamivir|oseltamivir|mesh-list
102498035|NCT00988325|Antiviral Agents|antiviral agents|mesh-ancestor
102498036|NCT00988325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498037|NCT00988325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102498038|NCT00988325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498039|NCT00002296|Inosine Pranobex|inosine pranobex|mesh-list
102498040|NCT00002296|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102498041|NCT00002296|Immunologic Factors|immunologic factors|mesh-ancestor
102498042|NCT00002296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498043|NCT00002296|Antiviral Agents|antiviral agents|mesh-ancestor
102498044|NCT00002296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498045|NCT00002302|Epoetin Alfa|epoetin alfa|mesh-list
102498046|NCT00002302|Hematinics|hematinics|mesh-ancestor
102498047|NCT00002170|Nelfinavir|nelfinavir|mesh-list
102498048|NCT00002170|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102498049|NCT00002170|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102498050|NCT00002170|Protease Inhibitors|protease inhibitors|mesh-ancestor
102498051|NCT00002170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102498052|NCT00002170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498053|NCT00002170|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102498054|NCT00002170|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102498055|NCT00002170|Antiviral Agents|antiviral agents|mesh-ancestor
102498056|NCT00002170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498057|NCT00002308|Stavudine|stavudine|mesh-list
102498058|NCT00002308|Antimetabolites|antimetabolites|mesh-ancestor
102498059|NCT00002308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498060|NCT00002308|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102498061|NCT00002308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102498062|NCT00002308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102498063|NCT00002308|Antiviral Agents|antiviral agents|mesh-ancestor
102498064|NCT00002308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498065|NCT00002308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102498066|NCT00002308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102498067|NCT00000724|Leucovorin|leucovorin|mesh-list
102498068|NCT00000724|Trimetrexate|trimetrexate|mesh-list
102498069|NCT00000724|Calcium|calcium|mesh-list
102498070|NCT00000724|Levoleucovorin|levoleucovorin|mesh-list
102498071|NCT00000724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102498072|NCT00000724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498073|NCT00000724|Antidotes|antidotes|mesh-ancestor
102498074|NCT00000724|Protective Agents|protective agents|mesh-ancestor
102498075|NCT00000724|Vitamin B Complex|vitamin b complex|mesh-ancestor
102498076|NCT00000724|Vitamins|vitamins|mesh-ancestor
102498077|NCT00000724|Micronutrients|micronutrients|mesh-ancestor
102498078|NCT00000724|Antifungal Agents|antifungal agents|mesh-ancestor
102498079|NCT00000724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498080|NCT00000724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102498081|NCT00000724|Antimetabolites|antimetabolites|mesh-ancestor
102498082|NCT00000724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498083|NCT00000724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102498084|NCT00000724|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102498085|NCT00000724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102498086|NCT00000730|Leucovorin|leucovorin|mesh-list
102498087|NCT00000730|Trimethoprim|trimethoprim|mesh-list
102498088|NCT00000730|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102498089|NCT00000730|Sulfamethoxazole|sulfamethoxazole|mesh-list
102498090|NCT00000730|Pentamidine|pentamidine|mesh-list
102498091|NCT00000730|Trimetrexate|trimetrexate|mesh-list
102498092|NCT00000730|Methylprednisolone|methylprednisolone|mesh-list
102498093|NCT00000730|Levoleucovorin|levoleucovorin|mesh-list
102498094|NCT00000730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498095|NCT00000730|Antidotes|antidotes|mesh-ancestor
102498096|NCT00000730|Protective Agents|protective agents|mesh-ancestor
102498097|NCT00000730|Vitamin B Complex|vitamin b complex|mesh-ancestor
102498098|NCT00000730|Vitamins|vitamins|mesh-ancestor
102498099|NCT00000730|Micronutrients|micronutrients|mesh-ancestor
102498100|NCT00000730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102498101|NCT00000730|Antiemetics|antiemetics|mesh-ancestor
102498102|NCT00000730|Autonomic Agents|autonomic agents|mesh-ancestor
102498103|NCT00000730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102498104|NCT00000730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102498105|NCT00000730|Glucocorticoids|glucocorticoids|mesh-ancestor
102498106|NCT00000730|Hormones|hormones|mesh-ancestor
102498107|NCT00000730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102498108|NCT00000730|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102498109|NCT00000730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102498110|NCT00000730|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102498111|NCT00000730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498112|NCT00000730|Antimalarials|antimalarials|mesh-ancestor
102498113|NCT00000730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102498114|NCT00000730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102498115|NCT00000730|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102498116|NCT00000730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102498117|NCT00000730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498118|NCT00000730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102498119|NCT00000730|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102498120|NCT00000730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102498121|NCT00000730|Antifungal Agents|antifungal agents|mesh-ancestor
102498122|NCT00000730|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102498123|NCT00000730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102498124|NCT00000730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102498125|NCT00000730|Antimetabolites|antimetabolites|mesh-ancestor
102498126|NCT00002176|Nelfinavir|nelfinavir|mesh-list
102498127|NCT00002176|Stavudine|stavudine|mesh-list
102498128|NCT00002176|Didanosine|didanosine|mesh-list
102498129|NCT00002176|Hydroxyurea|hydroxyurea|mesh-list
102498130|NCT00002176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102498131|NCT00002176|Antisickling Agents|antisickling agents|mesh-ancestor
102498132|NCT00002176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102498133|NCT00002176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498134|NCT00002176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102498135|NCT00002176|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102498136|NCT00002176|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102498137|NCT00002176|Protease Inhibitors|protease inhibitors|mesh-ancestor
102498138|NCT00002176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102498139|NCT00002176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102498140|NCT00002176|Antiviral Agents|antiviral agents|mesh-ancestor
102498141|NCT00002176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498142|NCT00002176|Antimetabolites|antimetabolites|mesh-ancestor
102498143|NCT00002176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102498144|NCT01990196|Dasatinib|dasatinib|mesh-list
102498145|NCT01990196|Trametinib|trametinib|mesh-list
102498146|NCT01990196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102498147|NCT01990196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102498148|NCT01990196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102498149|NCT01990196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498150|NCT00381316|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
102498151|NCT00381316|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102498152|NCT00381316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498153|NCT00002182|Megestrol|megestrol|mesh-list
102498154|NCT00002182|Megestrol Acetate|megestrol acetate|mesh-list
102498155|NCT00002182|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102498156|NCT00002182|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102498157|NCT00002182|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102498158|NCT00002182|Contraceptive Agents|contraceptive agents|mesh-ancestor
102498159|NCT00002182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102498160|NCT00002182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498161|NCT00002182|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102498162|NCT00002182|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102498163|NCT00002182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102498164|NCT00002182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102498165|NCT00002182|Appetite Stimulants|appetite stimulants|mesh-ancestor
102498166|NCT00002182|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102498167|NCT00002320|Lamivudine|lamivudine|mesh-list
102498168|NCT00002320|Zidovudine|zidovudine|mesh-list
102498169|NCT00002320|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102498170|NCT00002320|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102498171|NCT00002320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102498172|NCT00002320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498173|NCT00002320|Antiviral Agents|antiviral agents|mesh-ancestor
102498174|NCT00002320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498175|NCT00002320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102498176|NCT00002320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102498177|NCT00002320|Antimetabolites|antimetabolites|mesh-ancestor
102498178|NCT02167217|Prednisolone|prednisolone|mesh-list
102498179|NCT02167217|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102498180|NCT02167217|Methylprednisolone|methylprednisolone|mesh-list
102498181|NCT02167217|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102498182|NCT02167217|Prednisolone acetate|prednisolone acetate|mesh-list
102498183|NCT02167217|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102498184|NCT02167217|Prednisolone phosphate|prednisolone phosphate|mesh-list
102498185|NCT02167217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102498186|NCT02167217|Glucocorticoids|glucocorticoids|mesh-ancestor
102498187|NCT02167217|Hormones|hormones|mesh-ancestor
102498188|NCT02167217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102498189|NCT02167217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498190|NCT02167217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102498191|NCT02167217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102498192|NCT02167217|Antiemetics|antiemetics|mesh-ancestor
102498193|NCT02167217|Autonomic Agents|autonomic agents|mesh-ancestor
102498194|NCT02167217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102498195|NCT02167217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102498196|NCT02167217|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102498197|NCT02167217|Protective Agents|protective agents|mesh-ancestor
102498198|NCT00002326|Zidovudine|zidovudine|mesh-list
102498199|NCT00002326|Adefovir|adefovir|mesh-list
102498200|NCT00002326|Antimetabolites|antimetabolites|mesh-ancestor
102498201|NCT00002326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498202|NCT00002326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102498203|NCT00002326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102498204|NCT00002326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102498205|NCT00002326|Antiviral Agents|antiviral agents|mesh-ancestor
102498206|NCT00002326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498207|NCT00002326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102498208|NCT00002326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102498209|NCT01152697|Haloperidol|haloperidol|mesh-list
102498210|NCT01152697|Haloperidol decanoate|haloperidol decanoate|mesh-list
102498211|NCT01152697|Antiemetics|antiemetics|mesh-ancestor
102498212|NCT01152697|Autonomic Agents|autonomic agents|mesh-ancestor
102498213|NCT01152697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102498214|NCT01152697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498215|NCT01152697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102498216|NCT01152697|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102498217|NCT01152697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102498218|NCT01152697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102498219|NCT01152697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102498220|NCT01152697|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102498221|NCT01152697|Dopamine Agents|dopamine agents|mesh-ancestor
102498222|NCT01152697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102498223|NCT01152697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498224|NCT01152697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102498225|NCT00002188|Alitretinoin|alitretinoin|mesh-list
102498226|NCT00002188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102498227|NCT00002188|Dermatologic Agents|dermatologic agents|mesh-ancestor
102498228|NCT00002332|Thymopentin|thymopentin|mesh-list
102498229|NCT00002332|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102498230|NCT00002332|Immunologic Factors|immunologic factors|mesh-ancestor
102498231|NCT00002332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498232|NCT05571644|Leucovorin|leucovorin|mesh-list
102498233|NCT05571644|Fluorouracil|fluorouracil|mesh-list
102498234|NCT05571644|Oxaliplatin|oxaliplatin|mesh-list
102498235|NCT05571644|Irinotecan|irinotecan|mesh-list
102498236|NCT05571644|Levoleucovorin|levoleucovorin|mesh-list
102498237|NCT05571644|Antimetabolites|antimetabolites|mesh-ancestor
102498238|NCT05571644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498239|NCT05571644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102498240|NCT05571644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102498241|NCT05571644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102498242|NCT05571644|Immunologic Factors|immunologic factors|mesh-ancestor
102498243|NCT05571644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498244|NCT05571644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102498245|NCT05571644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102498246|NCT05571644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102498247|NCT05571644|Antidotes|antidotes|mesh-ancestor
102498248|NCT05571644|Protective Agents|protective agents|mesh-ancestor
102498249|NCT05571644|Vitamin B Complex|vitamin b complex|mesh-ancestor
102498250|NCT05571644|Vitamins|vitamins|mesh-ancestor
102498251|NCT05571644|Micronutrients|micronutrients|mesh-ancestor
102498252|NCT03011281|Tofacitinib|tofacitinib|mesh-list
102498253|NCT03011281|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102498254|NCT03011281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102498255|NCT03011281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102498256|NCT03011281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498257|NCT00002194|Clarithromycin|clarithromycin|mesh-list
102498258|NCT00002194|Erythromycin|erythromycin|mesh-list
102498259|NCT00002194|Erythromycin Estolate|erythromycin estolate|mesh-list
102498260|NCT00002194|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
102498261|NCT00002194|Erythromycin stearate|erythromycin stearate|mesh-list
102498262|NCT00002194|Nevirapine|nevirapine|mesh-list
102498263|NCT00002194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102498264|NCT00002194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498265|NCT00002194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102498266|NCT00002194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102309842|NCT03167437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102498267|NCT00002194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498268|NCT00002194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102498269|NCT00002194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102498270|NCT00002194|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102498271|NCT00002194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102498272|NCT00002194|Antiviral Agents|antiviral agents|mesh-ancestor
102498273|NCT00002194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102498274|NCT00002194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102498275|NCT00002194|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102498276|NCT00002194|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102498277|NCT00002194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102498279|NCT04756622|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102498280|NCT04756622|Antiviral Agents|antiviral agents|mesh-ancestor
102498281|NCT04756622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498282|NCT04756622|Expectorants|expectorants|mesh-ancestor
102498283|NCT04756622|Respiratory System Agents|respiratory system agents|mesh-ancestor
102498284|NCT04756622|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102498285|NCT04756622|Antioxidants|antioxidants|mesh-ancestor
102498286|NCT04756622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498287|NCT04756622|Protective Agents|protective agents|mesh-ancestor
102498288|NCT04756622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498289|NCT04756622|Antidotes|antidotes|mesh-ancestor
102498290|NCT00002344|Azithromycin|azithromycin|mesh-list
102498291|NCT00002344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102498292|NCT00002344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498293|NCT01198327|Ranibizumab|ranibizumab|mesh-list
102498294|NCT01198327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102498295|NCT01198327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102498296|NCT01198327|Growth Substances|growth substances|mesh-ancestor
102498297|NCT01198327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498298|NCT01198327|Growth Inhibitors|growth inhibitors|mesh-ancestor
102498299|NCT01198327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102498300|NCT00002200|Abacavir|abacavir|mesh-list
102498301|NCT00002200|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102498302|NCT00002200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102498303|NCT00002200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102498304|NCT00002200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498305|NCT00002200|Antiviral Agents|antiviral agents|mesh-ancestor
102498306|NCT00002200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498307|NCT00002200|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102498308|NCT00002200|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102498309|NCT00002356|Fomivirsen|fomivirsen|mesh-list
102498310|NCT00002356|Antiviral Agents|antiviral agents|mesh-ancestor
102498311|NCT00002356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498312|NCT00994175|Pioglitazone|pioglitazone|mesh-list
102498313|NCT00994175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102498314|NCT00994175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498315|NCT00002206|Adefovir|adefovir|mesh-list
102498316|NCT00002206|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
102498317|NCT00002206|Antiviral Agents|antiviral agents|mesh-ancestor
102498318|NCT00002206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498319|NCT00002206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102498320|NCT00002206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102498321|NCT00002206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102498322|NCT00002206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498323|NCT02403986|Lidocaine|lidocaine|mesh-list
102498324|NCT02403986|Anesthetics, Local|anesthetics, local|mesh-ancestor
102498325|NCT02403986|Anesthetics|anesthetics|mesh-ancestor
102498326|NCT02403986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102498327|NCT02403986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498328|NCT02403986|Sensory System Agents|sensory system agents|mesh-ancestor
102498329|NCT02403986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102498330|NCT02403986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102498331|NCT02403986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102498332|NCT02403986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102498333|NCT02403986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102498334|NCT02403986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498335|NCT00002212|Bexarotene|bexarotene|mesh-list
102498336|NCT00002212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102498337|NCT00002362|Emtricitabine|emtricitabine|mesh-list
102498338|NCT00002362|Efavirenz|efavirenz|mesh-list
102498339|NCT00002362|Abacavir|abacavir|mesh-list
102498340|NCT00002362|Stavudine|stavudine|mesh-list
102498341|NCT00002362|Antiviral Agents|antiviral agents|mesh-ancestor
102498342|NCT00002362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498343|NCT00002362|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102498344|NCT00002362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102498345|NCT00002362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102498346|NCT00002362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498347|NCT00002362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102498348|NCT00002362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102498349|NCT00002362|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102498350|NCT00002362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102498351|NCT00002362|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102498352|NCT00002362|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102498353|NCT00002362|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102498354|NCT00002362|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102498355|NCT00002362|Antimetabolites|antimetabolites|mesh-ancestor
102498356|NCT02168309|Labetalol|labetalol|mesh-list
102498357|NCT02168309|Nifedipine|nifedipine|mesh-list
102498358|NCT02168309|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102498359|NCT02168309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102498360|NCT02168309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498361|NCT02168309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102498362|NCT02168309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498363|NCT02168309|Vasodilator Agents|vasodilator agents|mesh-ancestor
102498364|NCT02168309|Tocolytic Agents|tocolytic agents|mesh-ancestor
102498365|NCT02168309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102498366|NCT02168309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102498367|NCT02168309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102498368|NCT02168309|Adrenergic Agents|adrenergic agents|mesh-ancestor
102498369|NCT02168309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102498370|NCT02168309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102498371|NCT02168309|Sympathomimetics|sympathomimetics|mesh-ancestor
102498372|NCT02168309|Autonomic Agents|autonomic agents|mesh-ancestor
102498373|NCT02168309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101974687|NCT05218629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102498374|NCT02168309|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102498375|NCT02168309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102498376|NCT00002368|Lamivudine|lamivudine|mesh-list
102498377|NCT00002368|Nevirapine|nevirapine|mesh-list
102498378|NCT00002368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102498379|NCT00002368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102498380|NCT00002368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102498381|NCT00002368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498382|NCT00002368|Antiviral Agents|antiviral agents|mesh-ancestor
102498383|NCT00002368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498384|NCT00002368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102498385|NCT00002368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102498386|NCT00002368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102498387|NCT00002368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102498388|NCT01199965|Dihydroergotamine|dihydroergotamine|mesh-list
102498389|NCT01199965|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102498390|NCT01199965|Dopamine Agonists|dopamine agonists|mesh-ancestor
102498391|NCT01199965|Dopamine Agents|dopamine agents|mesh-ancestor
102498392|NCT01199965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102498393|NCT01199965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498394|NCT01199965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498395|NCT01199965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102498396|NCT01199965|Analgesics|analgesics|mesh-ancestor
102498397|NCT01199965|Sensory System Agents|sensory system agents|mesh-ancestor
102498398|NCT01199965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102498399|NCT00995501|Insulin|insulin|mesh-list
102498400|NCT00995501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102498401|NCT00995501|Dexamethasone|dexamethasone|mesh-list
102498402|NCT00995501|Dexamethasone acetate|dexamethasone acetate|mesh-list
102498403|NCT00995501|Anesthetics|anesthetics|mesh-list
102498404|NCT00995501|Sodium sulfate|sodium sulfate|mesh-list
102498405|NCT00995501|BB 1101|bb 1101|mesh-list
102498406|NCT00995501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102498407|NCT00995501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498408|NCT00995501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102498409|NCT00995501|Antiemetics|antiemetics|mesh-ancestor
102498410|NCT00995501|Autonomic Agents|autonomic agents|mesh-ancestor
102498411|NCT00995501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102498412|NCT00995501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102498413|NCT00995501|Glucocorticoids|glucocorticoids|mesh-ancestor
102498414|NCT00995501|Hormones|hormones|mesh-ancestor
102498415|NCT00995501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102498416|NCT00995501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102498417|NCT00995501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102309994|NCT05813132|Carboplatin|carboplatin|mesh-list
102498418|NCT00995501|Protease Inhibitors|protease inhibitors|mesh-ancestor
102498419|NCT00995501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102498420|NCT00995501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498421|NCT00995501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102498422|NCT00995501|Cathartics|cathartics|mesh-ancestor
102498423|NCT00002374|Ritonavir|ritonavir|mesh-list
102498424|NCT00002374|Nelfinavir|nelfinavir|mesh-list
102498425|NCT00002374|Saquinavir|saquinavir|mesh-list
102498426|NCT00002374|Stavudine|stavudine|mesh-list
102498427|NCT00002374|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102498428|NCT00002374|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102498429|NCT00002374|Protease Inhibitors|protease inhibitors|mesh-ancestor
102498430|NCT00002374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102498431|NCT00002374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498432|NCT00002374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102498433|NCT00002374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102498434|NCT00002374|Antiviral Agents|antiviral agents|mesh-ancestor
102498435|NCT00002374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498436|NCT00002374|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102498437|NCT00002374|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102498438|NCT00002374|Antimetabolites|antimetabolites|mesh-ancestor
102498439|NCT00002374|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102498440|NCT00002374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102498441|NCT00002380|Nelfinavir|nelfinavir|mesh-list
102498442|NCT00002380|Saquinavir|saquinavir|mesh-list
102498443|NCT00002380|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102498444|NCT00002380|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101974756|NCT05017272|Analgesics|analgesics|mesh-ancestor
102498445|NCT00002380|Protease Inhibitors|protease inhibitors|mesh-ancestor
102498446|NCT00002380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102498447|NCT00002380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498448|NCT00002380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102498449|NCT00002380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102498450|NCT00002380|Antiviral Agents|antiviral agents|mesh-ancestor
102498451|NCT00002380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498452|NCT00002380|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102498453|NCT00002380|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102498454|NCT00002386|Lamivudine|lamivudine|mesh-list
102498455|NCT00002386|Zidovudine|zidovudine|mesh-list
102498456|NCT00002386|Stavudine|stavudine|mesh-list
102498457|NCT00002386|Didanosine|didanosine|mesh-list
102498458|NCT00002386|Zalcitabine|zalcitabine|mesh-list
102498459|NCT00002386|Indinavir|indinavir|mesh-list
102498460|NCT00002386|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102498461|NCT00002386|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102498462|NCT00002386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102498463|NCT00002386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498464|NCT00002386|Antiviral Agents|antiviral agents|mesh-ancestor
102498465|NCT00002386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498466|NCT00002386|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102498467|NCT00002386|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102498468|NCT00002386|Antimetabolites|antimetabolites|mesh-ancestor
102498469|NCT00002386|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102498470|NCT00002386|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102498471|NCT00002386|Protease Inhibitors|protease inhibitors|mesh-ancestor
102498472|NCT01942694|Vitamin D|vitamin d|mesh-list
102498473|NCT01942694|Cholecalciferol|cholecalciferol|mesh-list
102498474|NCT01942694|Vitamins|vitamins|mesh-ancestor
102498475|NCT01942694|Micronutrients|micronutrients|mesh-ancestor
102498476|NCT01942694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498477|NCT01942694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102498478|NCT01942694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102498479|NCT01153711|Ketoconazole|ketoconazole|mesh-list
102498480|NCT01153711|Antifungal Agents|antifungal agents|mesh-ancestor
102498481|NCT01153711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498482|NCT01153711|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102498483|NCT01153711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102498484|NCT01153711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102498485|NCT01153711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498486|NCT01153711|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102498487|NCT01153711|Hormone Antagonists|hormone antagonists|mesh-ancestor
102498488|NCT01153711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102498489|NCT01153711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498490|NCT01153711|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102498491|NCT02168855|Nicotine|nicotine|mesh-list
102498492|NCT02168855|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102498493|NCT02168855|Autonomic Agents|autonomic agents|mesh-ancestor
102310073|NCT05775887|Vaccines|vaccines|mesh-list
102498494|NCT02168855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102498495|NCT02168855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498496|NCT02168855|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102498497|NCT02168855|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102498498|NCT02168855|Cholinergic Agents|cholinergic agents|mesh-ancestor
102498499|NCT02168855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102498500|NCT02168855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498501|NCT05751850|Leucovorin|leucovorin|mesh-list
102498502|NCT05751850|Paclitaxel|paclitaxel|mesh-list
102498503|NCT05751850|Gemcitabine|gemcitabine|mesh-list
102498504|NCT05751850|Fluorouracil|fluorouracil|mesh-list
102498505|NCT05751850|Oxaliplatin|oxaliplatin|mesh-list
102498506|NCT05751850|Calcium|calcium|mesh-list
102498507|NCT05751850|Levoleucovorin|levoleucovorin|mesh-list
102498508|NCT05751850|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102498509|NCT05751850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102498510|NCT05751850|Tubulin Modulators|tubulin modulators|mesh-ancestor
102498511|NCT05751850|Antimitotic Agents|antimitotic agents|mesh-ancestor
102498512|NCT05751850|Mitosis Modulators|mitosis modulators|mesh-ancestor
102498513|NCT05751850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498514|NCT05751850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102498515|NCT05751850|Antimetabolites|antimetabolites|mesh-ancestor
102498516|NCT05751850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102498517|NCT05751850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498518|NCT05751850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102498519|NCT05751850|Immunologic Factors|immunologic factors|mesh-ancestor
102498520|NCT05751850|Antidotes|antidotes|mesh-ancestor
102498521|NCT05751850|Protective Agents|protective agents|mesh-ancestor
102498522|NCT05751850|Vitamin B Complex|vitamin b complex|mesh-ancestor
102498523|NCT05751850|Vitamins|vitamins|mesh-ancestor
102498524|NCT05751850|Micronutrients|micronutrients|mesh-ancestor
102498525|NCT01938248|Aspirin|aspirin|mesh-list
102498526|NCT01938248|Apixaban|apixaban|mesh-list
102498527|NCT01938248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102498528|NCT01938248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102498529|NCT01938248|Analgesics|analgesics|mesh-ancestor
102498530|NCT01938248|Sensory System Agents|sensory system agents|mesh-ancestor
102498531|NCT01938248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102498532|NCT01938248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498533|NCT01938248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102498534|NCT01938248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102498535|NCT01938248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102498536|NCT01938248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102498537|NCT01938248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498538|NCT01938248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102498539|NCT01938248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102498540|NCT01938248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102498541|NCT01938248|Antipyretics|antipyretics|mesh-ancestor
102498542|NCT01938248|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102498543|NCT01938248|Antithrombins|antithrombins|mesh-ancestor
102498544|NCT01938248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102498545|NCT01938248|Protease Inhibitors|protease inhibitors|mesh-ancestor
102498546|NCT01938248|Anticoagulants|anticoagulants|mesh-ancestor
102498547|NCT00002230|Efavirenz|efavirenz|mesh-list
102498548|NCT00002230|Stavudine|stavudine|mesh-list
102498549|NCT00002230|Didanosine|didanosine|mesh-list
102498550|NCT00002230|Hydroxyurea|hydroxyurea|mesh-list
102498551|NCT00002230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102498552|NCT00002230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102498553|NCT00002230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102498554|NCT00002230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498555|NCT00002230|Antiviral Agents|antiviral agents|mesh-ancestor
102498556|NCT00002230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498557|NCT00002230|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102498558|NCT00002230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102498559|NCT00002230|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102498560|NCT00002230|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102498561|NCT00002230|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102498562|NCT00002230|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102498563|NCT00002230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102498564|NCT00002230|Antisickling Agents|antisickling agents|mesh-ancestor
102498565|NCT00002230|Antimetabolites|antimetabolites|mesh-ancestor
102498566|NCT00002230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102498567|NCT00002230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102498568|NCT03009877|Fentanyl|fentanyl|mesh-list
102498569|NCT03009877|Midazolam|midazolam|mesh-list
102498570|NCT03009877|Propofol|propofol|mesh-list
102498571|NCT03009877|Rocuronium|rocuronium|mesh-list
102498572|NCT03009877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102498573|NCT03009877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102498574|NCT03009877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498575|NCT03009877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102498576|NCT03009877|Anesthetics, General|anesthetics, general|mesh-ancestor
102498578|NCT03009877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102498579|NCT03009877|Narcotics|narcotics|mesh-ancestor
102498580|NCT03009877|Analgesics|analgesics|mesh-ancestor
102498581|NCT03009877|Sensory System Agents|sensory system agents|mesh-ancestor
102498582|NCT03009877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102498583|NCT03009877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102498584|NCT03009877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102498585|NCT03009877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102498586|NCT03009877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102498587|NCT03009877|GABA Modulators|gaba modulators|mesh-ancestor
102498588|NCT03009877|GABA Agents|gaba agents|mesh-ancestor
102498589|NCT03009877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102498590|NCT03009877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498591|NCT03009877|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102498592|NCT03009877|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102498593|NCT03009877|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102498594|NCT00002392|Thalidomide|thalidomide|mesh-list
102498595|NCT00002392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102498596|NCT00002392|Immunologic Factors|immunologic factors|mesh-ancestor
102498597|NCT00002392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498598|NCT00002392|Leprostatic Agents|leprostatic agents|mesh-ancestor
102498599|NCT00002392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102498600|NCT00002392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498601|NCT00002392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102498602|NCT00002392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102498603|NCT00002392|Growth Substances|growth substances|mesh-ancestor
102498604|NCT00002392|Growth Inhibitors|growth inhibitors|mesh-ancestor
102498605|NCT00002392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102498606|NCT00002398|Adefovir|adefovir|mesh-list
102498607|NCT00002398|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
102498608|NCT00002398|Antiviral Agents|antiviral agents|mesh-ancestor
102498609|NCT00002398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498610|NCT00002398|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102498611|NCT00002398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102498612|NCT00002398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102498613|NCT00002398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498614|NCT00997139|Polymyxins|polymyxins|mesh-list
102498615|NCT00997139|Neomycin|neomycin|mesh-list
102498616|NCT00997139|Bacitracin|bacitracin|mesh-list
102498617|NCT00997139|Polymyxin B|polymyxin b|mesh-list
102498618|NCT00997139|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
102498619|NCT00997139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102498620|NCT00997139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498621|NCT00997139|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102498622|NCT00997139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102498623|NCT00997139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498624|NCT00997139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102498625|NCT00002236|Zidovudine|zidovudine|mesh-list
102498626|NCT00002236|Delavirdine|delavirdine|mesh-list
102498627|NCT00002236|Indinavir|indinavir|mesh-list
102498628|NCT00002236|Antimetabolites|antimetabolites|mesh-ancestor
102498629|NCT00002236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498630|NCT00002236|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102498631|NCT00002236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102498632|NCT00002236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102498633|NCT00002236|Antiviral Agents|antiviral agents|mesh-ancestor
102498634|NCT00002236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498635|NCT00002236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102498636|NCT00002236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102498637|NCT00002236|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102498638|NCT00002236|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102498639|NCT00002236|Protease Inhibitors|protease inhibitors|mesh-ancestor
102498640|NCT01241539|Dabigatran|dabigatran|mesh-list
102498641|NCT01241539|Antithrombins|antithrombins|mesh-ancestor
102498642|NCT01241539|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102498643|NCT01241539|Protease Inhibitors|protease inhibitors|mesh-ancestor
102498644|NCT01241539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102498645|NCT01241539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498646|NCT01241539|Anticoagulants|anticoagulants|mesh-ancestor
102498647|NCT00002404|Valacyclovir|valacyclovir|mesh-list
102498648|NCT00002404|Antiviral Agents|antiviral agents|mesh-ancestor
102498649|NCT00002404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498651|NCT05593757|Verapamil|verapamil|mesh-list
102498652|NCT05593757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102498653|NCT05593757|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102498654|NCT05593757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102498655|NCT05593757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498656|NCT05593757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102498657|NCT05593757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498658|NCT05593757|Vasodilator Agents|vasodilator agents|mesh-ancestor
102498659|NCT05593757|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102498660|NCT05593757|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102498661|NCT05593757|Adrenergic Agents|adrenergic agents|mesh-ancestor
102498662|NCT05593757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102498663|NCT05593757|Antimalarials|antimalarials|mesh-ancestor
102498664|NCT05593757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102498665|NCT05593757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102498666|NCT05593757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498667|NCT05593757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102498668|NCT05593757|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102498669|NCT05593757|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102498670|NCT05593757|Cholinergic Agents|cholinergic agents|mesh-ancestor
102498671|NCT05593757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102498672|NCT05593757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102498673|NCT05593757|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102498674|NCT05593757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102498675|NCT01242241|Propofol|propofol|mesh-list
102498676|NCT01242241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102498677|NCT01242241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102498678|NCT01242241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498679|NCT01242241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102498680|NCT01242241|Anesthetics, General|anesthetics, general|mesh-ancestor
102498681|NCT01242241|Anesthetics|anesthetics|mesh-ancestor
102498682|NCT02393690|Iodine|iodine|mesh-list
102498683|NCT02393690|Cadexomer iodine|cadexomer iodine|mesh-list
102498684|NCT02393690|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102498685|NCT02393690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498686|NCT02393690|Trace Elements|trace elements|mesh-ancestor
102498687|NCT02393690|Micronutrients|micronutrients|mesh-ancestor
102498688|NCT02393690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498689|NCT01200433|Dexmedetomidine|dexmedetomidine|mesh-list
102498690|NCT01200433|Propofol|propofol|mesh-list
102498691|NCT01200433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102498692|NCT01200433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102498693|NCT01200433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498694|NCT01200433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102498695|NCT01200433|Analgesics|analgesics|mesh-ancestor
102498696|NCT01200433|Sensory System Agents|sensory system agents|mesh-ancestor
102498697|NCT01200433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102498698|NCT01200433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102498699|NCT01200433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102498700|NCT01200433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102498701|NCT01200433|Adrenergic Agents|adrenergic agents|mesh-ancestor
102498702|NCT01200433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102498703|NCT01200433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975016|NCT04188548|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102498704|NCT01200433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102498705|NCT01200433|Anesthetics, General|anesthetics, general|mesh-ancestor
102498706|NCT01200433|Anesthetics|anesthetics|mesh-ancestor
102498707|NCT00002410|Lamivudine|lamivudine|mesh-list
102498708|NCT00002410|Zidovudine|zidovudine|mesh-list
102498709|NCT00002410|Indinavir|indinavir|mesh-list
102498710|NCT00002410|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102498711|NCT00002410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102498712|NCT00002410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102498713|NCT00002410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498714|NCT00002410|Antiviral Agents|antiviral agents|mesh-ancestor
102498715|NCT00002410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498716|NCT00002410|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102498717|NCT00002410|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102498718|NCT00002410|Antimetabolites|antimetabolites|mesh-ancestor
102498719|NCT00002410|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102498720|NCT00002410|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102498721|NCT00002410|Protease Inhibitors|protease inhibitors|mesh-ancestor
102498722|NCT01243333|Deoxyglucose|deoxyglucose|mesh-list
102498723|NCT01243333|Alovudine|alovudine|mesh-list
102498724|NCT01243333|Dideoxynucleosides|dideoxynucleosides|mesh-list
102498725|NCT01243333|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102498726|NCT01243333|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102498727|NCT01243333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498728|NCT01243333|Antimetabolites|antimetabolites|mesh-ancestor
102498729|NCT01243333|Antiviral Agents|antiviral agents|mesh-ancestor
102498730|NCT01243333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498731|NCT01243333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102498732|NCT01243333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102498733|NCT01243333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102498734|NCT01924052|Calcitonin|calcitonin|mesh-list
102498735|NCT01924052|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
102498736|NCT01924052|Katacalcin|katacalcin|mesh-list
102498737|NCT01924052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102498738|NCT01924052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498739|NCT01924052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102498740|NCT01924052|Vasodilator Agents|vasodilator agents|mesh-ancestor
102498741|NCT00002416|Lamivudine|lamivudine|mesh-list
102498742|NCT00002416|Emtricitabine|emtricitabine|mesh-list
102498743|NCT00002416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102498744|NCT00002416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102498745|NCT00002416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102498746|NCT00002416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498747|NCT00002416|Antiviral Agents|antiviral agents|mesh-ancestor
102498748|NCT00002416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498749|NCT00002416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102498750|NCT00002416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102498751|NCT00002254|Alovudine|alovudine|mesh-list
102498752|NCT00002254|Antiviral Agents|antiviral agents|mesh-ancestor
102498753|NCT00002254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498754|NCT01897454|Calcium, Dietary|calcium, dietary|mesh-list
102498755|NCT01897454|Leucovorin|leucovorin|mesh-list
102498756|NCT01897454|Folic Acid|folic acid|mesh-list
102498757|NCT01897454|Gemcitabine|gemcitabine|mesh-list
102498758|NCT01897454|Fluorouracil|fluorouracil|mesh-list
102498759|NCT01897454|Oxaliplatin|oxaliplatin|mesh-list
102498760|NCT01897454|Irinotecan|irinotecan|mesh-list
102498761|NCT01897454|Camptothecin|camptothecin|mesh-list
102498762|NCT01897454|Calcium|calcium|mesh-list
102498763|NCT01897454|Levoleucovorin|levoleucovorin|mesh-list
102498764|NCT01897454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102498765|NCT01897454|Antimetabolites|antimetabolites|mesh-ancestor
102498766|NCT01897454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498767|NCT01897454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102498768|NCT01897454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102498769|NCT01897454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498770|NCT01897454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102498771|NCT01897454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102498772|NCT01897454|Immunologic Factors|immunologic factors|mesh-ancestor
102498773|NCT01897454|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102498774|NCT01897454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102498775|NCT01897454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102498776|NCT01897454|Antidotes|antidotes|mesh-ancestor
102498777|NCT01897454|Protective Agents|protective agents|mesh-ancestor
102498778|NCT01897454|Vitamin B Complex|vitamin b complex|mesh-ancestor
102498779|NCT01897454|Vitamins|vitamins|mesh-ancestor
102498780|NCT01897454|Micronutrients|micronutrients|mesh-ancestor
102498781|NCT01897454|Hematinics|hematinics|mesh-ancestor
102498782|NCT01897454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102498783|NCT01243567|Timolol|timolol|mesh-list
102498784|NCT01243567|Bimatoprost|bimatoprost|mesh-list
102498785|NCT01243567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102498786|NCT01243567|Latanoprost|latanoprost|mesh-list
102498787|NCT01243567|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102498788|NCT01243567|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102498789|NCT01243567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102498790|NCT01243567|Adrenergic Agents|adrenergic agents|mesh-ancestor
102498791|NCT01243567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102498792|NCT01243567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498793|NCT01243567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498794|NCT01243567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102498795|NCT01243567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102498796|NCT01001195|Bimatoprost|bimatoprost|mesh-list
102498797|NCT01001195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102498798|NCT01001195|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102498799|NCT01001195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102310368|NCT05004662|Nicotine|nicotine|mesh-list
102498800|NCT00381472|Ropinirole|ropinirole|mesh-list
102498801|NCT00381472|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102498802|NCT00381472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102498803|NCT00381472|Dopamine Agonists|dopamine agonists|mesh-ancestor
102498804|NCT00381472|Dopamine Agents|dopamine agents|mesh-ancestor
102498805|NCT00381472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102498806|NCT00381472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498807|NCT00381472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498808|NCT02185729|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102498809|NCT02185729|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102498810|NCT02185729|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102498811|NCT02185729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102498812|NCT01460654|Alendronate|alendronate|mesh-list
102498813|NCT01460654|Methyltestosterone|methyltestosterone|mesh-list
102498814|NCT01460654|Testosterone|testosterone|mesh-list
102498815|NCT01460654|Testosterone undecanoate|testosterone undecanoate|mesh-list
102498816|NCT01460654|Testosterone enanthate|testosterone enanthate|mesh-list
102498817|NCT01460654|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102498818|NCT01460654|Androgens|androgens|mesh-ancestor
102498819|NCT01460654|Hormones|hormones|mesh-ancestor
102498820|NCT01460654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102498821|NCT01460654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498822|NCT01460654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102498823|NCT01460654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102498824|NCT01460654|Anabolic Agents|anabolic agents|mesh-ancestor
102498825|NCT01460654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102498826|NCT01001975|Sunscreening Agents|sunscreening agents|mesh-list
102498827|NCT01001975|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102498828|NCT01001975|Protective Agents|protective agents|mesh-ancestor
102498829|NCT01001975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498830|NCT01001975|Dermatologic Agents|dermatologic agents|mesh-ancestor
102498831|NCT01459484|Cisplatin|cisplatin|mesh-list
102498832|NCT01459484|Doxorubicin|doxorubicin|mesh-list
102498833|NCT01459484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102498834|NCT01459484|Methotrexate|methotrexate|mesh-list
102498835|NCT01459484|Ifosfamide|ifosfamide|mesh-list
102498836|NCT01459484|Mifamurtide|mifamurtide|mesh-list
102498837|NCT01459484|Acetylmuramyl-Alanyl-Isoglutamine|acetylmuramyl-alanyl-isoglutamine|mesh-list
102498838|NCT01459484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102498839|NCT01459484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102498840|NCT01459484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102498841|NCT01459484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102498842|NCT01459484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102498843|NCT01459484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498844|NCT01459484|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102498845|NCT01459484|Abortifacient Agents|abortifacient agents|mesh-ancestor
102498846|NCT01459484|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102498847|NCT01459484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498848|NCT01459484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102498849|NCT01459484|Antimetabolites|antimetabolites|mesh-ancestor
102498850|NCT01459484|Dermatologic Agents|dermatologic agents|mesh-ancestor
102498851|NCT01459484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102498852|NCT01459484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102498853|NCT01459484|Immunologic Factors|immunologic factors|mesh-ancestor
102498854|NCT01459484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102498855|NCT01459484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102498856|NCT01459484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102498857|NCT01459484|Alkylating Agents|alkylating agents|mesh-ancestor
102498858|NCT01459484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102498859|NCT00002260|Alovudine|alovudine|mesh-list
102498860|NCT00002260|Antiviral Agents|antiviral agents|mesh-ancestor
102498861|NCT00002260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498862|NCT01444040|Travoprost|travoprost|mesh-list
102498863|NCT01444040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102498864|NCT00002266|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
102498865|NCT00002266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102498866|NCT00002266|Immunologic Factors|immunologic factors|mesh-ancestor
102498867|NCT00002266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498868|NCT00002266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102498869|NCT00002266|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102498870|NCT00002266|Protective Agents|protective agents|mesh-ancestor
102498871|NCT00002266|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102498872|NCT00002266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102498873|NCT00002266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102498874|NCT00002266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498875|NCT00002266|Antiviral Agents|antiviral agents|mesh-ancestor
102498876|NCT00002266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498877|NCT05751304|Dexmedetomidine|dexmedetomidine|mesh-list
102498878|NCT05751304|Ketamine|ketamine|mesh-list
102498879|NCT05751304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102498880|NCT05751304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102498881|NCT05751304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498882|NCT05751304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102498883|NCT05751304|Analgesics|analgesics|mesh-ancestor
102498884|NCT05751304|Sensory System Agents|sensory system agents|mesh-ancestor
102498885|NCT05751304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102498886|NCT05751304|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102498887|NCT05751304|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102498888|NCT05751304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102498889|NCT05751304|Adrenergic Agents|adrenergic agents|mesh-ancestor
102498890|NCT05751304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102498891|NCT05751304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498892|NCT05751304|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102498893|NCT05751304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102498894|NCT05751304|Anesthetics, General|anesthetics, general|mesh-ancestor
102498895|NCT05751304|Anesthetics|anesthetics|mesh-ancestor
102498896|NCT05751304|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102498897|NCT05751304|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102498898|NCT01202071|Rabeprazole|rabeprazole|mesh-list
102498899|NCT01202071|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102498900|NCT01202071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102498901|NCT01202071|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102498902|NCT01202071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102498903|NCT01202071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498904|NCT00002428|Vaccines|vaccines|mesh-list
102498905|NCT00002428|Immunologic Factors|immunologic factors|mesh-ancestor
102498906|NCT00002428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498907|NCT01422746|Metformin|metformin|mesh-list
102498908|NCT01422746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102498909|NCT01422746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498910|NCT00002272|Foscarnet|foscarnet|mesh-list
102498911|NCT00002272|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
102498912|NCT00002272|Antiviral Agents|antiviral agents|mesh-ancestor
102498913|NCT00002272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498914|NCT00002272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102498915|NCT00002272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102498916|NCT00002272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102498917|NCT00002272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498918|NCT01002755|Lenalidomide|lenalidomide|mesh-list
102498919|NCT01002755|Ofatumumab|ofatumumab|mesh-list
102498920|NCT01002755|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102498921|NCT01002755|Immunologic Factors|immunologic factors|mesh-ancestor
102498922|NCT01002755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498923|NCT01002755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102498924|NCT01002755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102498925|NCT01002755|Growth Substances|growth substances|mesh-ancestor
102498926|NCT01002755|Growth Inhibitors|growth inhibitors|mesh-ancestor
102498927|NCT01002755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102498928|NCT00002434|Leucovorin|leucovorin|mesh-list
102498929|NCT00002434|Trimetrexate|trimetrexate|mesh-list
102498930|NCT00002434|Calcium|calcium|mesh-list
102498931|NCT00002434|Levoleucovorin|levoleucovorin|mesh-list
102498932|NCT00002434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102498933|NCT00002434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498934|NCT00002434|Antidotes|antidotes|mesh-ancestor
102498935|NCT00002434|Protective Agents|protective agents|mesh-ancestor
102498936|NCT00002434|Vitamin B Complex|vitamin b complex|mesh-ancestor
102498937|NCT00002434|Vitamins|vitamins|mesh-ancestor
102498938|NCT00002434|Micronutrients|micronutrients|mesh-ancestor
102498939|NCT00002434|Antifungal Agents|antifungal agents|mesh-ancestor
102498940|NCT00002434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498941|NCT00002434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102498942|NCT00002434|Antimetabolites|antimetabolites|mesh-ancestor
102498943|NCT00002434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498944|NCT00002434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102498945|NCT00002434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102498946|NCT00002434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102498947|NCT00002278|Diclazuril|diclazuril|mesh-list
102498948|NCT00002278|Coccidiostats|coccidiostats|mesh-ancestor
102498949|NCT00002278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102498950|NCT00002278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102498951|NCT00002278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498952|NCT01885130|Dimenhydrinate|dimenhydrinate|mesh-list
102498953|NCT01885130|Antiemetics|antiemetics|mesh-ancestor
102310521|NCT04388852|Ipilimumab|ipilimumab|mesh-list
102498954|NCT01885130|Autonomic Agents|autonomic agents|mesh-ancestor
102498955|NCT01885130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102498956|NCT01885130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498957|NCT01885130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102498958|NCT01885130|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102498959|NCT01885130|Histamine Antagonists|histamine antagonists|mesh-ancestor
102498960|NCT01885130|Histamine Agents|histamine agents|mesh-ancestor
102498961|NCT01885130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102498962|NCT01885130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498963|NCT01003301|Omalizumab|omalizumab|mesh-list
102498964|NCT01003301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102498965|NCT01003301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102498966|NCT01003301|Respiratory System Agents|respiratory system agents|mesh-ancestor
102498967|NCT00002440|Ritonavir|ritonavir|mesh-list
102498968|NCT00002440|Nelfinavir|nelfinavir|mesh-list
102498969|NCT00002440|Indinavir|indinavir|mesh-list
102498970|NCT00002440|Saquinavir|saquinavir|mesh-list
102498971|NCT00002440|Amprenavir|amprenavir|mesh-list
102498972|NCT00002440|Abacavir|abacavir|mesh-list
102498973|NCT00002440|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102498974|NCT00002440|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102498975|NCT00002440|Protease Inhibitors|protease inhibitors|mesh-ancestor
102498976|NCT00002440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102498977|NCT00002440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102498978|NCT00002440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102498979|NCT00002440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102498980|NCT00002440|Antiviral Agents|antiviral agents|mesh-ancestor
102498981|NCT00002440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102498982|NCT00002440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102498983|NCT00002440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102498984|NCT00002440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102498985|NCT00002440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102498986|NCT00002440|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102498987|NCT00002440|Antitubercular Agents|antitubercular agents|mesh-ancestor
102498988|NCT00002440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102498989|NCT01421810|Dexamethasone|dexamethasone|mesh-list
102498990|NCT01421810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102498991|NCT01421810|Antiemetics|antiemetics|mesh-ancestor
102498992|NCT01421810|Autonomic Agents|autonomic agents|mesh-ancestor
102498993|NCT01421810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102498994|NCT01421810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102498995|NCT01421810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102498996|NCT01421810|Glucocorticoids|glucocorticoids|mesh-ancestor
102498997|NCT01421810|Hormones|hormones|mesh-ancestor
102498998|NCT01421810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102498999|NCT01421810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102499000|NCT01421810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102499001|NCT00002284|Zidovudine|zidovudine|mesh-list
102499002|NCT00002284|Antimetabolites|antimetabolites|mesh-ancestor
102499003|NCT00002284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499004|NCT00002284|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102499005|NCT00002284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102499006|NCT00002284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102499007|NCT00002284|Antiviral Agents|antiviral agents|mesh-ancestor
102499008|NCT00002284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102499009|NCT00002284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102499010|NCT00002284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102499011|NCT01243957|Fluoxetine|fluoxetine|mesh-list
102499012|NCT01243957|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102499013|NCT01243957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102499014|NCT01243957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102499015|NCT01243957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499016|NCT01243957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102499017|NCT01243957|Serotonin Agents|serotonin agents|mesh-ancestor
102499018|NCT01243957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499019|NCT01243957|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102499020|NCT01243957|Antidepressive Agents|antidepressive agents|mesh-ancestor
102499021|NCT01243957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102499022|NCT01243957|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102499023|NCT01243957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102499024|NCT01243957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102499025|NCT00002446|Fluconazole|fluconazole|mesh-list
102499026|NCT00002446|Posaconazole|posaconazole|mesh-list
102499027|NCT00002446|Antifungal Agents|antifungal agents|mesh-ancestor
102499028|NCT00002446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102499029|NCT00002446|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102499030|NCT00002446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102499031|NCT00002446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102499032|NCT00002446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499033|NCT00002446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102499034|NCT00002446|Hormone Antagonists|hormone antagonists|mesh-ancestor
102499035|NCT00002446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102499036|NCT00002446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499037|NCT00002446|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102499038|NCT00002446|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102499039|NCT00002446|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102499040|NCT00002446|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102499041|NCT00002446|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102499042|NCT01884740|Bevacizumab|bevacizumab|mesh-list
102499043|NCT01884740|Cetuximab|cetuximab|mesh-list
102499044|NCT01884740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102499045|NCT01884740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102499046|NCT01884740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102499047|NCT01884740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102499048|NCT01884740|Growth Substances|growth substances|mesh-ancestor
102499049|NCT01884740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499050|NCT01884740|Growth Inhibitors|growth inhibitors|mesh-ancestor
102499051|NCT00002290|Zidovudine|zidovudine|mesh-list
102499052|NCT00002290|Acyclovir|acyclovir|mesh-list
102499053|NCT00002290|Antimetabolites|antimetabolites|mesh-ancestor
102499054|NCT00002290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499055|NCT00002290|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102499056|NCT00002290|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102499057|NCT00002290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102499058|NCT00002290|Antiviral Agents|antiviral agents|mesh-ancestor
102499059|NCT00002290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102499060|NCT00002290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102499061|NCT00002290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102499062|NCT01003769|Acetic Acid|acetic acid|mesh-list
102499063|NCT01003769|Lenalidomide|lenalidomide|mesh-list
102499064|NCT01003769|Retinol acetate|retinol acetate|mesh-list
102499065|NCT01003769|Gossypol acetic acid|gossypol acetic acid|mesh-list
102499066|NCT01003769|Gossypol|gossypol|mesh-list
102499067|NCT01003769|Immunologic Factors|immunologic factors|mesh-ancestor
102499068|NCT01003769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499069|NCT01003769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102499070|NCT01003769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102499071|NCT01003769|Growth Substances|growth substances|mesh-ancestor
102499072|NCT01003769|Growth Inhibitors|growth inhibitors|mesh-ancestor
102499073|NCT01003769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102499074|NCT01003769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102499075|NCT01003769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102499076|NCT01003769|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102499077|NCT01003769|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102499078|NCT01003769|Protective Agents|protective agents|mesh-ancestor
102499079|NCT01003769|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102499080|NCT01003769|Contraceptive Agents|contraceptive agents|mesh-ancestor
102499081|NCT01003769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102499082|NCT01003769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102499083|NCT01003769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102499084|NCT01003769|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
102499085|NCT01003769|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
102499086|NCT00002452|Indinavir|indinavir|mesh-list
102499087|NCT00002452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102499088|NCT00002452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102499089|NCT00002452|Protease Inhibitors|protease inhibitors|mesh-ancestor
102499090|NCT00002452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102499091|NCT00002452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499092|NCT00002452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102499093|NCT00002452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102499094|NCT00002452|Antiviral Agents|antiviral agents|mesh-ancestor
102499095|NCT00002452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102499096|NCT01004393|Bromides|bromides|mesh-list
102499097|NCT01004393|Methylnaltrexone|methylnaltrexone|mesh-list
102499098|NCT01004393|Anticonvulsants|anticonvulsants|mesh-ancestor
102499099|NCT01004393|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102499100|NCT01004393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499101|NCT01004393|Sensory System Agents|sensory system agents|mesh-ancestor
102499102|NCT01004393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102499103|NCT00002458|Antibodies|antibodies|mesh-list
102310662|NCT03907423|Metformin|metformin|mesh-list
102499104|NCT00002458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102499106|NCT00002458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499107|NCT00002470|Interferons|interferons|mesh-list
102499108|NCT00002470|Interferon-alpha|interferon-alpha|mesh-list
102499109|NCT00002470|Fluorouracil|fluorouracil|mesh-list
102499110|NCT00002470|Antimetabolites|antimetabolites|mesh-ancestor
102499111|NCT00002470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499112|NCT00002470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102499113|NCT00002470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102499114|NCT00002470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102499115|NCT00002470|Immunologic Factors|immunologic factors|mesh-ancestor
102499116|NCT00002470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499117|NCT00002470|Antiviral Agents|antiviral agents|mesh-ancestor
102499118|NCT00002470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102499119|NCT00002476|Leucovorin|leucovorin|mesh-list
102499120|NCT00002476|Cobalt|cobalt|mesh-list
102499121|NCT00002476|Fluorouracil|fluorouracil|mesh-list
102499122|NCT00002476|Methotrexate|methotrexate|mesh-list
102499123|NCT00002476|Vincristine|vincristine|mesh-list
102499124|NCT00002476|Bleomycin|bleomycin|mesh-list
102499125|NCT00002476|Calcium|calcium|mesh-list
102499126|NCT00002476|Levoleucovorin|levoleucovorin|mesh-list
102499127|NCT00002476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102499128|NCT00002476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499129|NCT00002476|Antimetabolites|antimetabolites|mesh-ancestor
102499130|NCT00002476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499131|NCT00002476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102499132|NCT00002476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102499133|NCT00002476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102499134|NCT00002476|Immunologic Factors|immunologic factors|mesh-ancestor
102499135|NCT00002476|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102499136|NCT00002476|Abortifacient Agents|abortifacient agents|mesh-ancestor
102499137|NCT00002476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102499138|NCT00002476|Dermatologic Agents|dermatologic agents|mesh-ancestor
102499139|NCT00002476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102499140|NCT00002476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102499141|NCT00002476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102499142|NCT00002476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102499143|NCT00002476|Antidotes|antidotes|mesh-ancestor
102499144|NCT00002476|Protective Agents|protective agents|mesh-ancestor
102499145|NCT00002476|Vitamin B Complex|vitamin b complex|mesh-ancestor
102499146|NCT00002476|Vitamins|vitamins|mesh-ancestor
102499147|NCT00002476|Micronutrients|micronutrients|mesh-ancestor
102499148|NCT00002476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102499149|NCT00002476|Tubulin Modulators|tubulin modulators|mesh-ancestor
102499150|NCT00002476|Antimitotic Agents|antimitotic agents|mesh-ancestor
102499151|NCT00002476|Mitosis Modulators|mitosis modulators|mesh-ancestor
102499152|NCT00002476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102499153|NCT00002476|Trace Elements|trace elements|mesh-ancestor
102499154|NCT01876628|Clindamycin|clindamycin|mesh-list
102499155|NCT01876628|Clindamycin palmitate|clindamycin palmitate|mesh-list
102499156|NCT01876628|Clindamycin phosphate|clindamycin phosphate|mesh-list
102499157|NCT01876628|Floxacillin|floxacillin|mesh-list
102499158|NCT01876628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102499159|NCT01876628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102499160|NCT01876628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102499161|NCT01876628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102499162|NCT01876628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499163|NCT01004705|Aspirin|aspirin|mesh-list
102499164|NCT01004705|Ramipril|ramipril|mesh-list
102499165|NCT01004705|Simvastatin|simvastatin|mesh-list
102499166|NCT01004705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102499167|NCT01004705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102499168|NCT01004705|Antimetabolites|antimetabolites|mesh-ancestor
102499169|NCT01004705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499170|NCT01004705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102499171|NCT01004705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102499172|NCT01004705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102499173|NCT01004705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102499174|NCT01004705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102499175|NCT01004705|Analgesics|analgesics|mesh-ancestor
102499176|NCT01004705|Sensory System Agents|sensory system agents|mesh-ancestor
102499177|NCT01004705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102499178|NCT01004705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499179|NCT01004705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102499180|NCT01004705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102499181|NCT01004705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102499182|NCT01004705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102499183|NCT01004705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102499184|NCT01004705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102499185|NCT01004705|Antipyretics|antipyretics|mesh-ancestor
102499186|NCT01004705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102499187|NCT01004705|Protease Inhibitors|protease inhibitors|mesh-ancestor
102499188|NCT01004705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102499189|NCT00002482|Cyclophosphamide|cyclophosphamide|mesh-list
102499190|NCT00002482|Muromonab-CD3|muromonab-cd3|mesh-list
102499191|NCT00002482|Antibodies|antibodies|mesh-list
102499192|NCT00002482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102499193|NCT00002482|Immunologic Factors|immunologic factors|mesh-ancestor
102499194|NCT00002482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499195|NCT00002482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102499196|NCT00002482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102499197|NCT00002482|Alkylating Agents|alkylating agents|mesh-ancestor
102499198|NCT00002482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499199|NCT00002482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102499200|NCT00002482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102499201|NCT01004939|PENTA|penta|mesh-list
102499202|NCT01004939|Fondaparinux|fondaparinux|mesh-list
102499203|NCT01004939|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102499204|NCT01004939|Antithrombins|antithrombins|mesh-ancestor
102499205|NCT01004939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102499206|NCT01004939|Protease Inhibitors|protease inhibitors|mesh-ancestor
102499207|NCT01004939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102499208|NCT01004939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499209|NCT01004939|Anticoagulants|anticoagulants|mesh-ancestor
102499210|NCT01004939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102499211|NCT01004939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102499212|NCT05750758|Rivaroxaban|rivaroxaban|mesh-list
102499213|NCT05750758|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102499214|NCT05750758|Antithrombins|antithrombins|mesh-ancestor
102499215|NCT05750758|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102499216|NCT05750758|Protease Inhibitors|protease inhibitors|mesh-ancestor
102499217|NCT05750758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102499218|NCT05750758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499219|NCT05750758|Anticoagulants|anticoagulants|mesh-ancestor
102499220|NCT00002488|Cyclophosphamide|cyclophosphamide|mesh-list
102499221|NCT00002488|Etoposide|etoposide|mesh-list
102499222|NCT00002488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102499223|NCT00002488|Immunologic Factors|immunologic factors|mesh-ancestor
102499224|NCT00002488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499225|NCT00002488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102499226|NCT00002488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102499227|NCT00002488|Alkylating Agents|alkylating agents|mesh-ancestor
102499228|NCT00002488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499229|NCT00002488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102499230|NCT00002488|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102499231|NCT00002488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102499232|NCT00002488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102499233|NCT00002488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102499234|NCT00002488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102499235|NCT01245595|Aminophylline|aminophylline|mesh-list
102499236|NCT01245595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102499237|NCT01245595|Autonomic Agents|autonomic agents|mesh-ancestor
102499238|NCT01245595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102499239|NCT01245595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499240|NCT01245595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102499241|NCT01245595|Respiratory System Agents|respiratory system agents|mesh-ancestor
102499242|NCT01245595|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102499243|NCT01245595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102499244|NCT01245595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102499245|NCT01245595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499246|NCT01245595|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102499247|NCT01245595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102499248|NCT01245595|Purinergic Agents|purinergic agents|mesh-ancestor
102499249|NCT01245595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102499250|NCT01245595|Protective Agents|protective agents|mesh-ancestor
102499251|NCT01864772|Cetuximab|cetuximab|mesh-list
102499252|NCT01864772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102499253|NCT01864772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102499254|NCT00002494|Leucovorin|leucovorin|mesh-list
102499255|NCT00002494|Cobalt|cobalt|mesh-list
102310842|NCT02915744|Paclitaxel|paclitaxel|mesh-list
102499256|NCT00002494|Cytarabine|cytarabine|mesh-list
102499257|NCT00002494|Dexamethasone|dexamethasone|mesh-list
102499258|NCT00002494|Prednisone|prednisone|mesh-list
102499259|NCT00002494|Hydrocortisone|hydrocortisone|mesh-list
102499260|NCT00002494|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102499261|NCT00002494|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102499262|NCT00002494|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102499263|NCT00002494|Cyclophosphamide|cyclophosphamide|mesh-list
102499264|NCT00002494|Ifosfamide|ifosfamide|mesh-list
102499265|NCT00002494|Doxorubicin|doxorubicin|mesh-list
102499266|NCT00002494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102499267|NCT00002494|Methotrexate|methotrexate|mesh-list
102499268|NCT00002494|Etoposide|etoposide|mesh-list
102499269|NCT00002494|Vincristine|vincristine|mesh-list
102499270|NCT00002494|Levoleucovorin|levoleucovorin|mesh-list
102499271|NCT00002494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102499272|NCT00002494|Immunologic Factors|immunologic factors|mesh-ancestor
102499273|NCT00002494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499274|NCT00002494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102499275|NCT00002494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102499276|NCT00002494|Alkylating Agents|alkylating agents|mesh-ancestor
102499277|NCT00002494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499278|NCT00002494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102499279|NCT00002494|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102499280|NCT00002494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102499281|NCT00002494|Antiemetics|antiemetics|mesh-ancestor
102499282|NCT00002494|Autonomic Agents|autonomic agents|mesh-ancestor
102499283|NCT00002494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102499284|NCT00002494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102499285|NCT00002494|Glucocorticoids|glucocorticoids|mesh-ancestor
102499286|NCT00002494|Hormones|hormones|mesh-ancestor
102499287|NCT00002494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102499288|NCT00002494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102499289|NCT00002494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102499290|NCT00002494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102499291|NCT00002494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102499292|NCT00002494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102499293|NCT00002494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102499294|NCT00002494|Abortifacient Agents|abortifacient agents|mesh-ancestor
102499295|NCT00002494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102499296|NCT00002494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102499297|NCT00002494|Antimetabolites|antimetabolites|mesh-ancestor
102499298|NCT00002494|Dermatologic Agents|dermatologic agents|mesh-ancestor
102499299|NCT00002494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102499300|NCT00002494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102499301|NCT00002494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102499302|NCT00002494|Antiviral Agents|antiviral agents|mesh-ancestor
102499303|NCT00002494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102499304|NCT00002494|Antidotes|antidotes|mesh-ancestor
102499305|NCT00002494|Protective Agents|protective agents|mesh-ancestor
102499306|NCT00002494|Vitamin B Complex|vitamin b complex|mesh-ancestor
102499307|NCT00002494|Vitamins|vitamins|mesh-ancestor
102499308|NCT00002494|Micronutrients|micronutrients|mesh-ancestor
102499309|NCT00002494|Tubulin Modulators|tubulin modulators|mesh-ancestor
102499310|NCT00002494|Antimitotic Agents|antimitotic agents|mesh-ancestor
102499311|NCT00002494|Mitosis Modulators|mitosis modulators|mesh-ancestor
102499312|NCT00002494|Trace Elements|trace elements|mesh-ancestor
102499313|NCT00002506|Interferons|interferons|mesh-list
102499314|NCT00002506|Interferon-alpha|interferon-alpha|mesh-list
102499315|NCT00002506|Isotretinoin|isotretinoin|mesh-list
102499316|NCT00002506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102499317|NCT00002506|Antiviral Agents|antiviral agents|mesh-ancestor
102499318|NCT00002506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102499319|NCT00002506|Immunologic Factors|immunologic factors|mesh-ancestor
102499320|NCT00002506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499321|NCT00002506|Dermatologic Agents|dermatologic agents|mesh-ancestor
102499322|NCT01895894|Mycophenolic Acid|mycophenolic acid|mesh-list
102499323|NCT01895894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102499324|NCT01895894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102499325|NCT01895894|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102499326|NCT01895894|Antitubercular Agents|antitubercular agents|mesh-ancestor
102499327|NCT01895894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102499328|NCT01895894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102499329|NCT01895894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102499330|NCT01895894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499331|NCT02165111|Botulinum Toxins|botulinum toxins|mesh-list
102310886|NCT02491632|Dexamethasone acetate|dexamethasone acetate|mesh-list
102499332|NCT02165111|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102499333|NCT02165111|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102499334|NCT02165111|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102499335|NCT02165111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102499336|NCT02165111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499337|NCT02165111|Cholinergic Agents|cholinergic agents|mesh-ancestor
102499338|NCT02165111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102499339|NCT02165111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499340|NCT02165111|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102499341|NCT02165111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102499342|NCT05750446|Riociguat|riociguat|mesh-list
102499343|NCT05750446|Enzyme Activators|enzyme activators|mesh-ancestor
102499344|NCT05750446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499345|NCT05750290|Irinotecan|irinotecan|mesh-list
102499346|NCT05750290|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102499347|NCT05750290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102499348|NCT05750290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102499349|NCT05750290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499350|NCT05750290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102499351|NCT03845621|Salicylic Acid|salicylic acid|mesh-list
102499352|NCT03845621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102499353|NCT03845621|Antifungal Agents|antifungal agents|mesh-ancestor
101975656|NCT01221103|Hormones|hormones|mesh-ancestor
102499354|NCT03845621|Keratolytic Agents|keratolytic agents|mesh-ancestor
102499355|NCT03845621|Dermatologic Agents|dermatologic agents|mesh-ancestor
102499356|NCT04456517|Ranolazine|ranolazine|mesh-list
102499357|NCT04456517|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102499358|NCT04456517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102499359|NCT04456517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499360|NCT01840046|Interleukin-2|interleukin-2|mesh-list
102499361|NCT01840046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102499362|NCT01840046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102499363|NCT01840046|Analgesics|analgesics|mesh-ancestor
102499364|NCT01840046|Sensory System Agents|sensory system agents|mesh-ancestor
102499365|NCT01840046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102499366|NCT01840046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499367|NCT00437216|Clobetasol|clobetasol|mesh-list
102499368|NCT00437216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102499369|NCT00437216|Glucocorticoids|glucocorticoids|mesh-ancestor
102499370|NCT00437216|Hormones|hormones|mesh-ancestor
102499371|NCT00437216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102499372|NCT00437216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499373|NCT00002524|Leucovorin|leucovorin|mesh-list
102499374|NCT00002524|Cytarabine|cytarabine|mesh-list
102499375|NCT00002524|Zidovudine|zidovudine|mesh-list
102499376|NCT00002524|Trimethoprim|trimethoprim|mesh-list
102499377|NCT00002524|Sulfamethoxazole|sulfamethoxazole|mesh-list
102499378|NCT00002524|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102499379|NCT00002524|Pentamidine|pentamidine|mesh-list
102499380|NCT00002524|Prednisone|prednisone|mesh-list
102499381|NCT00002524|Methylprednisolone|methylprednisolone|mesh-list
102499382|NCT00002524|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102499383|NCT00002524|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102499384|NCT00002524|Prednisolone|prednisolone|mesh-list
102499385|NCT00002524|Prednisolone acetate|prednisolone acetate|mesh-list
102499386|NCT00002524|Cyclophosphamide|cyclophosphamide|mesh-list
102499387|NCT00002524|Ifosfamide|ifosfamide|mesh-list
102499388|NCT00002524|Doxorubicin|doxorubicin|mesh-list
102499389|NCT00002524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102499390|NCT00002524|Fluorouracil|fluorouracil|mesh-list
102499391|NCT00002524|Methotrexate|methotrexate|mesh-list
102499392|NCT00002524|Etoposide|etoposide|mesh-list
102499393|NCT00002524|Vincristine|vincristine|mesh-list
102499394|NCT00002524|Bleomycin|bleomycin|mesh-list
102499395|NCT00002524|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102499396|NCT00002524|Prednisolone phosphate|prednisolone phosphate|mesh-list
102499397|NCT00002524|Levoleucovorin|levoleucovorin|mesh-list
102499398|NCT00002524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102499399|NCT00002524|Immunologic Factors|immunologic factors|mesh-ancestor
102499400|NCT00002524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499401|NCT00002524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102499402|NCT00002524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102499403|NCT00002524|Alkylating Agents|alkylating agents|mesh-ancestor
102499404|NCT00002524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499405|NCT00002524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102499406|NCT00002524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102499407|NCT00002524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102499408|NCT00002524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102499409|NCT00002524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102499410|NCT00002524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102499411|NCT00002524|Antimetabolites|antimetabolites|mesh-ancestor
102499412|NCT00002524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102499413|NCT00002524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102499414|NCT00002524|Glucocorticoids|glucocorticoids|mesh-ancestor
102499415|NCT00002524|Hormones|hormones|mesh-ancestor
102499416|NCT00002524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102499417|NCT00002524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102499418|NCT00002524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102499419|NCT00002524|Abortifacient Agents|abortifacient agents|mesh-ancestor
102499420|NCT00002524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102499421|NCT00002524|Dermatologic Agents|dermatologic agents|mesh-ancestor
102499422|NCT00002524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102499423|NCT00002524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102499424|NCT00002524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102499425|NCT00002524|Antiviral Agents|antiviral agents|mesh-ancestor
102499426|NCT00002524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102499427|NCT00002524|Antidotes|antidotes|mesh-ancestor
102499428|NCT00002524|Protective Agents|protective agents|mesh-ancestor
102499429|NCT00002524|Vitamin B Complex|vitamin b complex|mesh-ancestor
102499430|NCT00002524|Vitamins|vitamins|mesh-ancestor
102499431|NCT00002524|Micronutrients|micronutrients|mesh-ancestor
102499432|NCT00002524|Tubulin Modulators|tubulin modulators|mesh-ancestor
102499433|NCT00002524|Antimitotic Agents|antimitotic agents|mesh-ancestor
102499434|NCT00002524|Mitosis Modulators|mitosis modulators|mesh-ancestor
102499435|NCT00002524|Antiemetics|antiemetics|mesh-ancestor
102499436|NCT00002524|Autonomic Agents|autonomic agents|mesh-ancestor
102499437|NCT00002524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102499438|NCT00002524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102499439|NCT00002524|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102499440|NCT00002524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102499441|NCT00002524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102499442|NCT00002524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102499443|NCT00002524|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102499444|NCT00002524|Antimalarials|antimalarials|mesh-ancestor
102499445|NCT00002524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102499446|NCT00002524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102499447|NCT00002524|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102499448|NCT00002524|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102499449|NCT00002524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102499450|NCT00002524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102499451|NCT00002524|Antifungal Agents|antifungal agents|mesh-ancestor
102499452|NCT00002524|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102499453|NCT00002536|Vincristine|vincristine|mesh-list
102499454|NCT00002536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102499455|NCT00002536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102499456|NCT00002536|Tubulin Modulators|tubulin modulators|mesh-ancestor
102499457|NCT00002536|Antimitotic Agents|antimitotic agents|mesh-ancestor
102499458|NCT00002536|Mitosis Modulators|mitosis modulators|mesh-ancestor
102499459|NCT00002536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499460|NCT01203319|Vaccines|vaccines|mesh-list
102499461|NCT01203319|Immunologic Factors|immunologic factors|mesh-ancestor
102499462|NCT01203319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499463|NCT01344200|Celecoxib|celecoxib|mesh-list
102499464|NCT01344200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102499465|NCT01344200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102499466|NCT01344200|Analgesics|analgesics|mesh-ancestor
102499467|NCT01344200|Sensory System Agents|sensory system agents|mesh-ancestor
102499468|NCT01344200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102499469|NCT01344200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499470|NCT01344200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102499471|NCT01344200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102499472|NCT01344200|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102499473|NCT01344200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102499474|NCT01344200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102499475|NCT01344200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499476|NCT01204255|Diphenhydramine|diphenhydramine|mesh-list
102499477|NCT01204255|Promethazine|promethazine|mesh-list
102499478|NCT01204255|Lorazepam|lorazepam|mesh-list
102499479|NCT01204255|Haloperidol|haloperidol|mesh-list
102499480|NCT01204255|Haloperidol decanoate|haloperidol decanoate|mesh-list
102499481|NCT01204255|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102499482|NCT01204255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102499483|NCT01204255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102499484|NCT01204255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499485|NCT01204255|Anesthetics, Local|anesthetics, local|mesh-ancestor
102499486|NCT01204255|Anesthetics|anesthetics|mesh-ancestor
102499487|NCT01204255|Sensory System Agents|sensory system agents|mesh-ancestor
102311038|NCT01559935|Growth Substances|growth substances|mesh-ancestor
102499488|NCT01204255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102499489|NCT01204255|Antiemetics|antiemetics|mesh-ancestor
102499490|NCT01204255|Autonomic Agents|autonomic agents|mesh-ancestor
102499491|NCT01204255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102499492|NCT01204255|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102499493|NCT01204255|Histamine Antagonists|histamine antagonists|mesh-ancestor
102499494|NCT01204255|Histamine Agents|histamine agents|mesh-ancestor
102499495|NCT01204255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102499496|NCT01204255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499497|NCT01204255|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102499498|NCT01204255|Antipruritics|antipruritics|mesh-ancestor
102499499|NCT01204255|Dermatologic Agents|dermatologic agents|mesh-ancestor
102499500|NCT01204255|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102499501|NCT01204255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102499502|NCT01204255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102499503|NCT01204255|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102499504|NCT01204255|Dopamine Agents|dopamine agents|mesh-ancestor
102499505|NCT01204255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102499506|NCT01204255|Anticonvulsants|anticonvulsants|mesh-ancestor
102499507|NCT01204255|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102499508|NCT01204255|GABA Modulators|gaba modulators|mesh-ancestor
102499509|NCT01204255|GABA Agents|gaba agents|mesh-ancestor
102499511|NCT00002542|Cyclophosphamide|cyclophosphamide|mesh-list
102499512|NCT00002542|Doxorubicin|doxorubicin|mesh-list
102499513|NCT00002542|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102499514|NCT00002542|Fluorouracil|fluorouracil|mesh-list
102499515|NCT00002542|Methotrexate|methotrexate|mesh-list
102499516|NCT00002542|Epirubicin|epirubicin|mesh-list
102499517|NCT00002542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102499518|NCT00002542|Immunologic Factors|immunologic factors|mesh-ancestor
102499519|NCT00002542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499520|NCT00002542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102499521|NCT00002542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102499522|NCT00002542|Alkylating Agents|alkylating agents|mesh-ancestor
102499523|NCT00002542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499524|NCT00002542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102499525|NCT00002542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102499526|NCT00002542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102499527|NCT00002542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102499528|NCT00002542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102499529|NCT00002542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102499530|NCT00002542|Antimetabolites|antimetabolites|mesh-ancestor
102499531|NCT00002542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102499532|NCT00002542|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102499533|NCT00002542|Abortifacient Agents|abortifacient agents|mesh-ancestor
102499534|NCT00002542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102499535|NCT00002542|Dermatologic Agents|dermatologic agents|mesh-ancestor
102499536|NCT00002542|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102499537|NCT00002542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102499538|NCT00002542|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102499539|NCT00002542|Hormone Antagonists|hormone antagonists|mesh-ancestor
102499540|NCT00002542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102499541|NCT00002542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102499542|NCT00002542|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102499543|NCT00002542|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102499544|NCT00002542|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102499545|NCT01156597|Pioglitazone|pioglitazone|mesh-list
102499546|NCT01156597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102499547|NCT01156597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499548|NCT01823198|Aldesleukin|aldesleukin|mesh-list
102499549|NCT01823198|Fludarabine|fludarabine|mesh-list
102499550|NCT01823198|Fludarabine phosphate|fludarabine phosphate|mesh-list
102499551|NCT01823198|Busulfan|busulfan|mesh-list
102499552|NCT01823198|Interleukin-2|interleukin-2|mesh-list
102499553|NCT01823198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102499554|NCT01823198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102499555|NCT01823198|Antimetabolites|antimetabolites|mesh-ancestor
102499556|NCT01823198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499557|NCT01823198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102499558|NCT01823198|Immunologic Factors|immunologic factors|mesh-ancestor
102499559|NCT01823198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499560|NCT01823198|Alkylating Agents|alkylating agents|mesh-ancestor
102499561|NCT01823198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102499562|NCT01823198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102499563|NCT01823198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102499565|NCT01823198|Sensory System Agents|sensory system agents|mesh-ancestor
102499566|NCT01823198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102499567|NCT01823198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102499568|NCT01823198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102499569|NCT01823198|Antiviral Agents|antiviral agents|mesh-ancestor
102499570|NCT01823198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102499571|NCT05750056|Lidocaine|lidocaine|mesh-list
102499572|NCT05750056|Sufentanil|sufentanil|mesh-list
102499573|NCT05750056|Dsuvia|dsuvia|mesh-list
102499574|NCT05750056|Propofol|propofol|mesh-list
102499575|NCT05750056|Anesthetics, Local|anesthetics, local|mesh-ancestor
102499576|NCT05750056|Anesthetics|anesthetics|mesh-ancestor
102499577|NCT05750056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102499578|NCT05750056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499579|NCT05750056|Sensory System Agents|sensory system agents|mesh-ancestor
102499580|NCT05750056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102499581|NCT05750056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102499582|NCT05750056|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102499583|NCT05750056|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102499584|NCT05750056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102499585|NCT05750056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499586|NCT05750056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102499587|NCT05750056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102499588|NCT05750056|Anesthetics, General|anesthetics, general|mesh-ancestor
102499589|NCT05750056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102499590|NCT05750056|Narcotics|narcotics|mesh-ancestor
102499591|NCT05750056|Analgesics|analgesics|mesh-ancestor
102499592|NCT05750056|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102499593|NCT03011125|Dexlansoprazole|dexlansoprazole|mesh-list
102499594|NCT03011125|Lansoprazole|lansoprazole|mesh-list
102499595|NCT03011125|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102499596|NCT03011125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102499597|NCT03011125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102499598|NCT03011125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102499599|NCT03011125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499600|NCT05749900|Gemcitabine|gemcitabine|mesh-list
102499601|NCT05749900|Nivolumab|nivolumab|mesh-list
102499602|NCT05749900|Trastuzumab|trastuzumab|mesh-list
102499603|NCT05749900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102499604|NCT05749900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102499605|NCT05749900|Antimetabolites|antimetabolites|mesh-ancestor
102499606|NCT05749900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499607|NCT05749900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102499608|NCT05749900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102499609|NCT03442751|Riboflavin|riboflavin|mesh-list
102499610|NCT03442751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102499611|NCT03442751|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102499612|NCT03442751|Vitamin B Complex|vitamin b complex|mesh-ancestor
102499613|NCT03442751|Vitamins|vitamins|mesh-ancestor
102499614|NCT03442751|Micronutrients|micronutrients|mesh-ancestor
102499615|NCT03442751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499616|NCT03442751|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102499617|NCT03442751|Dermatologic Agents|dermatologic agents|mesh-ancestor
102499618|NCT05749666|Prednisolone|prednisolone|mesh-list
102499619|NCT05749666|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102499620|NCT05749666|Methylprednisolone|methylprednisolone|mesh-list
102499621|NCT05749666|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102499622|NCT05749666|Prednisolone acetate|prednisolone acetate|mesh-list
102499623|NCT05749666|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102499624|NCT05749666|Prednisolone phosphate|prednisolone phosphate|mesh-list
102499625|NCT05749666|Tofacitinib|tofacitinib|mesh-list
102499626|NCT05749666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102499627|NCT05749666|Glucocorticoids|glucocorticoids|mesh-ancestor
102499628|NCT05749666|Hormones|hormones|mesh-ancestor
102499629|NCT05749666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102499630|NCT05749666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499631|NCT05749666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102499632|NCT05749666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102499633|NCT05749666|Antiemetics|antiemetics|mesh-ancestor
102499634|NCT05749666|Autonomic Agents|autonomic agents|mesh-ancestor
102499635|NCT05749666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102499636|NCT05749666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102311187|NCT04567108|Sensory System Agents|sensory system agents|mesh-ancestor
102499637|NCT05749666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102499638|NCT05749666|Protective Agents|protective agents|mesh-ancestor
102499639|NCT05749666|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102499640|NCT05749666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102499641|NCT05749666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102499642|NCT05749666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499643|NCT05449535|Omalizumab|omalizumab|mesh-list
102499644|NCT05449535|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102499645|NCT05449535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102499646|NCT05449535|Respiratory System Agents|respiratory system agents|mesh-ancestor
102499647|NCT05749276|Daratumumab|daratumumab|mesh-list
102499648|NCT05749276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102499649|NCT05749042|Cisplatin|cisplatin|mesh-list
102499650|NCT05749042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102499651|NCT02940509|Magnesium Sulfate|magnesium sulfate|mesh-list
102499652|NCT02940509|Ketamine|ketamine|mesh-list
102499653|NCT02940509|Analgesics|analgesics|mesh-ancestor
102499654|NCT02940509|Sensory System Agents|sensory system agents|mesh-ancestor
102499655|NCT02940509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102499656|NCT02940509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499657|NCT02940509|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102499658|NCT02940509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102499659|NCT02940509|Anesthetics, General|anesthetics, general|mesh-ancestor
102499660|NCT02940509|Anesthetics|anesthetics|mesh-ancestor
102499661|NCT02940509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102499662|NCT02940509|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102499663|NCT02940509|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102499664|NCT02940509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102499665|NCT02940509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499666|NCT02940509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102499667|NCT02940509|Anticonvulsants|anticonvulsants|mesh-ancestor
102499668|NCT02940509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102499669|NCT02940509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102499670|NCT02940509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102499671|NCT02940509|Tocolytic Agents|tocolytic agents|mesh-ancestor
102499672|NCT02940509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102499673|NCT02530697|Miltefosine|miltefosine|mesh-list
102499674|NCT02530697|Meglumine Antimoniate|meglumine antimoniate|mesh-list
102499675|NCT02530697|Pentoxifylline|pentoxifylline|mesh-list
102499676|NCT02530697|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102499677|NCT02530697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102499678|NCT02530697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499679|NCT02530697|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102499680|NCT02530697|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102499681|NCT02530697|Protective Agents|protective agents|mesh-ancestor
102499682|NCT02530697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499683|NCT02530697|Vasodilator Agents|vasodilator agents|mesh-ancestor
102499684|NCT02530697|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102499685|NCT02530697|Antioxidants|antioxidants|mesh-ancestor
102499686|NCT02530697|Antifungal Agents|antifungal agents|mesh-ancestor
102499687|NCT02530697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102499688|NCT02530697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102499689|NCT02530697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102499690|NCT02530697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102499691|NCT02170649|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102499692|NCT02170649|Anticonvulsants|anticonvulsants|mesh-ancestor
102499693|NCT02170649|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102499694|NCT02170649|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102499695|NCT02170649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102499696|NCT02170649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499697|NCT04094207|Pentoxifylline|pentoxifylline|mesh-list
102499698|NCT04094207|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102499699|NCT04094207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102499700|NCT04094207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499701|NCT04094207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102499702|NCT04094207|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102499703|NCT04094207|Protective Agents|protective agents|mesh-ancestor
102499704|NCT04094207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499705|NCT04094207|Vasodilator Agents|vasodilator agents|mesh-ancestor
102499706|NCT04094207|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102499707|NCT04094207|Antioxidants|antioxidants|mesh-ancestor
102499708|NCT02144831|Aspirin|aspirin|mesh-list
102499709|NCT02144831|Clopidogrel|clopidogrel|mesh-list
102499710|NCT02144831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102499711|NCT02144831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102499712|NCT02144831|Analgesics|analgesics|mesh-ancestor
102311265|NCT01961349|Anesthetics|anesthetics|mesh-ancestor
102499713|NCT02144831|Sensory System Agents|sensory system agents|mesh-ancestor
102499714|NCT02144831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102499715|NCT02144831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499716|NCT02144831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102499717|NCT02144831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102499718|NCT02144831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102499719|NCT02144831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101976017|NCT02294656|Glucocorticoids|glucocorticoids|mesh-ancestor
102499720|NCT02144831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499721|NCT02144831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102499722|NCT02144831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102499723|NCT02144831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102499724|NCT02144831|Antipyretics|antipyretics|mesh-ancestor
102499725|NCT02144831|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102499726|NCT02144831|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102499727|NCT02144831|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102499728|NCT02144831|Purinergic Agents|purinergic agents|mesh-ancestor
102499729|NCT02144831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102499730|NCT05276219|Furosemide|furosemide|mesh-list
102499731|NCT05276219|Isosorbide|isosorbide|mesh-list
102499732|NCT05276219|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
102499733|NCT05276219|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
102499734|NCT05276219|Diuretics|diuretics|mesh-ancestor
102499735|NCT05276219|Natriuretic Agents|natriuretic agents|mesh-ancestor
102499736|NCT05276219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499737|NCT05276219|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102499738|NCT05276219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102499739|NCT05276219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499740|NCT05276219|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102499741|NCT05276219|Vasodilator Agents|vasodilator agents|mesh-ancestor
102499742|NCT05276219|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102499743|NCT05232461|Ciprofloxacin|ciprofloxacin|mesh-list
102499744|NCT05232461|Celecoxib|celecoxib|mesh-list
102499745|NCT05232461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102499746|NCT05232461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102499747|NCT05232461|Analgesics|analgesics|mesh-ancestor
102499748|NCT05232461|Sensory System Agents|sensory system agents|mesh-ancestor
102499749|NCT05232461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102499750|NCT05232461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499751|NCT05232461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102499752|NCT05232461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102499753|NCT05232461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102499754|NCT05232461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102499755|NCT05232461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102499756|NCT05232461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499757|NCT05232461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102499758|NCT05232461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102499759|NCT05232461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102499760|NCT05232461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102499761|NCT05232461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102499762|NCT05232461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102499763|NCT05232461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102499764|NCT01804790|Capecitabine|capecitabine|mesh-list
102499765|NCT01804790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102499766|NCT01804790|Antimetabolites|antimetabolites|mesh-ancestor
102499767|NCT01804790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499768|NCT01804790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102499769|NCT05623774|Imatinib Mesylate|imatinib mesylate|mesh-list
102499770|NCT05623774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102499771|NCT05623774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102499772|NCT05623774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102499773|NCT05623774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499774|NCT01313702|Atenolol|atenolol|mesh-list
102499775|NCT01313702|Lisinopril|lisinopril|mesh-list
102499776|NCT01313702|Simvastatin|simvastatin|mesh-list
102499777|NCT01313702|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102499778|NCT01313702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102499779|NCT01313702|Antimetabolites|antimetabolites|mesh-ancestor
102499780|NCT01313702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499781|NCT01313702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102499782|NCT01313702|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102499783|NCT01313702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102499784|NCT01313702|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102499785|NCT01313702|Protease Inhibitors|protease inhibitors|mesh-ancestor
102499786|NCT01313702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102499787|NCT01313702|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102499788|NCT01313702|Protective Agents|protective agents|mesh-ancestor
102499789|NCT01313702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499790|NCT01313702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102499791|NCT01313702|Sympatholytics|sympatholytics|mesh-ancestor
102499792|NCT01313702|Autonomic Agents|autonomic agents|mesh-ancestor
102499793|NCT01313702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102499794|NCT01313702|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102499795|NCT01313702|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102499796|NCT01313702|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102499797|NCT01313702|Adrenergic Agents|adrenergic agents|mesh-ancestor
102499798|NCT01313702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102499799|NCT04868708|Paclitaxel|paclitaxel|mesh-list
102499800|NCT04868708|Bevacizumab|bevacizumab|mesh-list
102499801|NCT04868708|Carboplatin|carboplatin|mesh-list
102499802|NCT04868708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102499803|NCT04868708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102499804|NCT04868708|Tubulin Modulators|tubulin modulators|mesh-ancestor
102499805|NCT04868708|Antimitotic Agents|antimitotic agents|mesh-ancestor
102499806|NCT04868708|Mitosis Modulators|mitosis modulators|mesh-ancestor
102499807|NCT04868708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499808|NCT04868708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102499809|NCT04868708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102499810|NCT04868708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102499811|NCT04868708|Growth Substances|growth substances|mesh-ancestor
102499812|NCT04868708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499813|NCT04868708|Growth Inhibitors|growth inhibitors|mesh-ancestor
102499814|NCT05732272|Bupropion|bupropion|mesh-list
102499815|NCT05732272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102499816|NCT05732272|Antidepressive Agents|antidepressive agents|mesh-ancestor
102499817|NCT05732272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102499818|NCT05732272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102499819|NCT05732272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102499820|NCT05732272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102499821|NCT05732272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499822|NCT05732272|Dopamine Agents|dopamine agents|mesh-ancestor
102499823|NCT05732272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102499824|NCT05732272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499825|NCT05732272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102499826|NCT05732272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102499827|NCT05732272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102499828|NCT05513872|Nicotine|nicotine|mesh-list
102499829|NCT05513872|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102499830|NCT05513872|Autonomic Agents|autonomic agents|mesh-ancestor
102499831|NCT05513872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102499832|NCT05513872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499833|NCT05513872|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102499834|NCT05513872|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102499835|NCT05513872|Cholinergic Agents|cholinergic agents|mesh-ancestor
102499836|NCT05513872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102499837|NCT05513872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499838|NCT05445856|Fentanyl|fentanyl|mesh-list
102499839|NCT05445856|Methadone|methadone|mesh-list
102499840|NCT05445856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102499841|NCT05445856|Narcotics|narcotics|mesh-ancestor
102499842|NCT05445856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102499843|NCT05445856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499844|NCT05445856|Analgesics|analgesics|mesh-ancestor
102499845|NCT05445856|Sensory System Agents|sensory system agents|mesh-ancestor
102499846|NCT05445856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102499847|NCT05445856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102499848|NCT05445856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102499849|NCT05445856|Anesthetics, General|anesthetics, general|mesh-ancestor
102499850|NCT05445856|Anesthetics|anesthetics|mesh-ancestor
102499851|NCT05445856|Antitussive Agents|antitussive agents|mesh-ancestor
102499852|NCT05445856|Respiratory System Agents|respiratory system agents|mesh-ancestor
102499853|NCT00382330|Ciclopirox|ciclopirox|mesh-list
102499854|NCT00382330|Antifungal Agents|antifungal agents|mesh-ancestor
102499855|NCT00382330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102499856|NCT05520892|Immunoglobulins|immunoglobulins|mesh-list
102499857|NCT05520892|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102499858|NCT05520892|Antibodies|antibodies|mesh-list
102499859|NCT05520892|gamma-Globulins|gamma-globulins|mesh-list
102499860|NCT05520892|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102499861|NCT05520892|Immunologic Factors|immunologic factors|mesh-ancestor
102311409|NCT01970475|Adalimumab|adalimumab|mesh-list
102499862|NCT05520892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499864|NCT05397964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102499865|NCT05397964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499866|NCT00002548|Interferons|interferons|mesh-list
102499867|NCT00002548|Interferon-alpha|interferon-alpha|mesh-list
102499868|NCT00002548|Dexamethasone|dexamethasone|mesh-list
102499869|NCT00002548|Prednisone|prednisone|mesh-list
102499870|NCT00002548|Cyclophosphamide|cyclophosphamide|mesh-list
102499871|NCT00002548|Melphalan|melphalan|mesh-list
102499872|NCT00002548|Carmustine|carmustine|mesh-list
102499873|NCT00002548|Doxorubicin|doxorubicin|mesh-list
102499874|NCT00002548|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102499875|NCT00002548|Vincristine|vincristine|mesh-list
102499876|NCT00002548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102499877|NCT00002548|Immunologic Factors|immunologic factors|mesh-ancestor
102499878|NCT00002548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499879|NCT00002548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102499880|NCT00002548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102499881|NCT00002548|Alkylating Agents|alkylating agents|mesh-ancestor
102499882|NCT00002548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499883|NCT00002548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102499884|NCT00002548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102499885|NCT00002548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102499886|NCT00002548|Antiemetics|antiemetics|mesh-ancestor
102499887|NCT00002548|Autonomic Agents|autonomic agents|mesh-ancestor
102499888|NCT00002548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102499889|NCT00002548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102499890|NCT00002548|Glucocorticoids|glucocorticoids|mesh-ancestor
102499891|NCT00002548|Hormones|hormones|mesh-ancestor
102499892|NCT00002548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102499893|NCT00002548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102499894|NCT00002548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102499895|NCT00002548|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102499896|NCT00002548|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102499897|NCT00002548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102499898|NCT00002548|Antiviral Agents|antiviral agents|mesh-ancestor
102499899|NCT00002548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102499900|NCT00002548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102499901|NCT00002548|Tubulin Modulators|tubulin modulators|mesh-ancestor
102499902|NCT00002548|Antimitotic Agents|antimitotic agents|mesh-ancestor
102499903|NCT00002548|Mitosis Modulators|mitosis modulators|mesh-ancestor
102499904|NCT02087306|Brincidofovir|brincidofovir|mesh-list
102499905|NCT02087306|Antiviral Agents|antiviral agents|mesh-ancestor
102499906|NCT02087306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102499907|NCT00002554|Cyclophosphamide|cyclophosphamide|mesh-list
102499908|NCT00002554|Busulfan|busulfan|mesh-list
102499909|NCT00002554|Methotrexate|methotrexate|mesh-list
102499910|NCT00002554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102499911|NCT00002554|Immunologic Factors|immunologic factors|mesh-ancestor
102499912|NCT00002554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499913|NCT00002554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102499914|NCT00002554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102499915|NCT00002554|Alkylating Agents|alkylating agents|mesh-ancestor
102499916|NCT00002554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499917|NCT00002554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102499918|NCT00002554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102499919|NCT00002554|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102499920|NCT00002554|Abortifacient Agents|abortifacient agents|mesh-ancestor
102499921|NCT00002554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102499922|NCT00002554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102499923|NCT00002554|Antimetabolites|antimetabolites|mesh-ancestor
102499924|NCT00002554|Dermatologic Agents|dermatologic agents|mesh-ancestor
102499925|NCT00002554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102499926|NCT00002554|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102499927|NCT00002554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102499928|NCT00002560|Antibodies|antibodies|mesh-list
102499929|NCT00002560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102499930|NCT00002560|Sargramostim|sargramostim|mesh-list
102499931|NCT00002560|Immunologic Factors|immunologic factors|mesh-ancestor
102499932|NCT00002560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499933|NCT00002566|Cyclophosphamide|cyclophosphamide|mesh-list
102499934|NCT00002566|Ifosfamide|ifosfamide|mesh-list
102499935|NCT00002566|Carboplatin|carboplatin|mesh-list
102499936|NCT00002566|Etoposide|etoposide|mesh-list
102499937|NCT00002566|Vinblastine|vinblastine|mesh-list
102499938|NCT00002566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102499939|NCT00002566|Immunologic Factors|immunologic factors|mesh-ancestor
102499940|NCT00002566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499941|NCT00002566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102499942|NCT00002566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102499943|NCT00002566|Alkylating Agents|alkylating agents|mesh-ancestor
102499944|NCT00002566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499945|NCT00002566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102499946|NCT00002566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102499947|NCT00002566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102499948|NCT00002566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102499949|NCT00002566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102499950|NCT00002566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102499951|NCT00002566|Tubulin Modulators|tubulin modulators|mesh-ancestor
102499952|NCT00002566|Antimitotic Agents|antimitotic agents|mesh-ancestor
102499953|NCT00002566|Mitosis Modulators|mitosis modulators|mesh-ancestor
102499954|NCT00002572|Aldesleukin|aldesleukin|mesh-list
102499955|NCT00002572|Muromonab-CD3|muromonab-cd3|mesh-list
102499956|NCT00002572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102499957|NCT00002572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102499958|NCT00002572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102499959|NCT00002572|Antiviral Agents|antiviral agents|mesh-ancestor
102499960|NCT00002572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102499961|NCT00002572|Immunologic Factors|immunologic factors|mesh-ancestor
102499962|NCT00002572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499963|NCT00002572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102499964|NCT00002578|Leucovorin|leucovorin|mesh-list
102499965|NCT00002578|Cytarabine|cytarabine|mesh-list
102499966|NCT00002578|Methotrexate|methotrexate|mesh-list
102499967|NCT00002578|Gallium nitrate|gallium nitrate|mesh-list
102499968|NCT00002578|Calcium|calcium|mesh-list
102499969|NCT00002578|Levoleucovorin|levoleucovorin|mesh-list
102499970|NCT00002578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102499971|NCT00002578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102499972|NCT00002578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102499973|NCT00002578|Abortifacient Agents|abortifacient agents|mesh-ancestor
102499974|NCT00002578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102499975|NCT00002578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102499976|NCT00002578|Antimetabolites|antimetabolites|mesh-ancestor
102499977|NCT00002578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102499978|NCT00002578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102499979|NCT00002578|Dermatologic Agents|dermatologic agents|mesh-ancestor
102499980|NCT00002578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102499981|NCT00002578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102499982|NCT00002578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102499983|NCT00002578|Immunologic Factors|immunologic factors|mesh-ancestor
102499984|NCT00002578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102499985|NCT00002578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102499986|NCT00002578|Antiviral Agents|antiviral agents|mesh-ancestor
102499987|NCT00002578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102499988|NCT00002578|Antidotes|antidotes|mesh-ancestor
102499989|NCT00002578|Protective Agents|protective agents|mesh-ancestor
102499990|NCT00002578|Vitamin B Complex|vitamin b complex|mesh-ancestor
102499991|NCT00002578|Vitamins|vitamins|mesh-ancestor
102499992|NCT00002578|Micronutrients|micronutrients|mesh-ancestor
102499993|NCT00002590|Leucovorin|leucovorin|mesh-list
102499994|NCT00002590|Cytarabine|cytarabine|mesh-list
102499995|NCT00002590|Prednisone|prednisone|mesh-list
102499996|NCT00002590|Cyclophosphamide|cyclophosphamide|mesh-list
102499997|NCT00002590|Doxorubicin|doxorubicin|mesh-list
102499998|NCT00002590|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102499999|NCT00002590|Methotrexate|methotrexate|mesh-list
102500000|NCT00002590|Etoposide|etoposide|mesh-list
102500001|NCT00002590|Vincristine|vincristine|mesh-list
102500002|NCT00002590|Daunorubicin|daunorubicin|mesh-list
102500003|NCT00002590|Asparaginase|asparaginase|mesh-list
102500004|NCT00002590|Pegaspargase|pegaspargase|mesh-list
102500005|NCT00002590|Thioguanine|thioguanine|mesh-list
102500006|NCT00002590|Levoleucovorin|levoleucovorin|mesh-list
102500007|NCT00002590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102500008|NCT00002590|Immunologic Factors|immunologic factors|mesh-ancestor
102500009|NCT00002590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976296|NCT02295748|Deflazacort|deflazacort|mesh-list
102500010|NCT00002590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102500011|NCT00002590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102500012|NCT00002590|Alkylating Agents|alkylating agents|mesh-ancestor
102500013|NCT00002590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500014|NCT00002590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102500015|NCT00002590|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102500016|NCT00002590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102500017|NCT00002590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102500018|NCT00002590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102500019|NCT00002590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102500020|NCT00002590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102500021|NCT00002590|Glucocorticoids|glucocorticoids|mesh-ancestor
102500022|NCT00002590|Hormones|hormones|mesh-ancestor
102500023|NCT00002590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102500024|NCT00002590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102500025|NCT00002590|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102500026|NCT00002590|Abortifacient Agents|abortifacient agents|mesh-ancestor
102500027|NCT00002590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102500028|NCT00002590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102500029|NCT00002590|Antimetabolites|antimetabolites|mesh-ancestor
102500030|NCT00002590|Dermatologic Agents|dermatologic agents|mesh-ancestor
102500031|NCT00002590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102500032|NCT00002590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102500033|NCT00002590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102500034|NCT00002590|Antiviral Agents|antiviral agents|mesh-ancestor
102500035|NCT00002590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102500036|NCT00002590|Antidotes|antidotes|mesh-ancestor
102500037|NCT00002590|Protective Agents|protective agents|mesh-ancestor
102500038|NCT00002590|Vitamin B Complex|vitamin b complex|mesh-ancestor
102500039|NCT00002590|Vitamins|vitamins|mesh-ancestor
102500040|NCT00002590|Micronutrients|micronutrients|mesh-ancestor
102500041|NCT00002590|Tubulin Modulators|tubulin modulators|mesh-ancestor
102500042|NCT00002590|Antimitotic Agents|antimitotic agents|mesh-ancestor
102500043|NCT00002590|Mitosis Modulators|mitosis modulators|mesh-ancestor
102500044|NCT00002596|Cyclophosphamide|cyclophosphamide|mesh-list
102500045|NCT00002596|Carboplatin|carboplatin|mesh-list
102500046|NCT00002596|Etoposide|etoposide|mesh-list
102500047|NCT00002596|Bleomycin|bleomycin|mesh-list
102500048|NCT00002596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102500049|NCT00002596|Immunologic Factors|immunologic factors|mesh-ancestor
102500050|NCT00002596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500051|NCT00002596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102500052|NCT00002596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102500053|NCT00002596|Alkylating Agents|alkylating agents|mesh-ancestor
102500054|NCT00002596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500055|NCT00002596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102500056|NCT00002596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102500057|NCT00002596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102500058|NCT00002596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102500059|NCT00002596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102500060|NCT00002596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102500061|NCT00002596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102500062|NCT00199082|Cytarabine|cytarabine|mesh-list
102500063|NCT00199082|Dexamethasone|dexamethasone|mesh-list
102500064|NCT00199082|Prednisolone|prednisolone|mesh-list
102500065|NCT00199082|Cyclophosphamide|cyclophosphamide|mesh-list
102500066|NCT00199082|Ifosfamide|ifosfamide|mesh-list
102500067|NCT00199082|Rituximab|rituximab|mesh-list
102500068|NCT00199082|Methotrexate|methotrexate|mesh-list
102500069|NCT00199082|Vincristine|vincristine|mesh-list
102500070|NCT00199082|Doxorubicin|doxorubicin|mesh-list
102500071|NCT00199082|Vindesine|vindesine|mesh-list
102500072|NCT00199082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102500073|NCT00199082|Immunologic Factors|immunologic factors|mesh-ancestor
102500074|NCT00199082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500075|NCT00199082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102500076|NCT00199082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102500077|NCT00199082|Alkylating Agents|alkylating agents|mesh-ancestor
102500078|NCT00199082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500079|NCT00199082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102500080|NCT00199082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102500081|NCT00199082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102500082|NCT00199082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102500083|NCT00199082|Antiemetics|antiemetics|mesh-ancestor
102500084|NCT00199082|Autonomic Agents|autonomic agents|mesh-ancestor
102500085|NCT00199082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102500086|NCT00199082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102500087|NCT00199082|Glucocorticoids|glucocorticoids|mesh-ancestor
102500088|NCT00199082|Hormones|hormones|mesh-ancestor
102500089|NCT00199082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102500090|NCT00199082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102500091|NCT00199082|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102500092|NCT00199082|Abortifacient Agents|abortifacient agents|mesh-ancestor
102311638|NCT01634113|Bromides|bromides|mesh-list
102500093|NCT00199082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102500094|NCT00199082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102500095|NCT00199082|Antimetabolites|antimetabolites|mesh-ancestor
102500096|NCT00199082|Dermatologic Agents|dermatologic agents|mesh-ancestor
102500097|NCT00199082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102500098|NCT00199082|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102500099|NCT00199082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102500100|NCT00199082|Antiviral Agents|antiviral agents|mesh-ancestor
102500101|NCT00199082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102500102|NCT00199082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102500103|NCT00199082|Tubulin Modulators|tubulin modulators|mesh-ancestor
102500104|NCT00199082|Antimitotic Agents|antimitotic agents|mesh-ancestor
102500105|NCT00199082|Mitosis Modulators|mitosis modulators|mesh-ancestor
102500106|NCT00199082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102500107|NCT00199082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102500108|NCT00199082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102500109|NCT00194090|Celecoxib|celecoxib|mesh-list
102500110|NCT00194090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102500111|NCT00194090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102500112|NCT00194090|Analgesics|analgesics|mesh-ancestor
102500113|NCT00194090|Sensory System Agents|sensory system agents|mesh-ancestor
102500114|NCT00194090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102500115|NCT00194090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500116|NCT00194090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102500117|NCT00194090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102500118|NCT00194090|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102500119|NCT00194090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102500120|NCT00194090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102500121|NCT00194090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500122|NCT00002608|Tamoxifen|tamoxifen|mesh-list
102500123|NCT00002608|Doxorubicin|doxorubicin|mesh-list
102500124|NCT00002608|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102500125|NCT00002608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102500126|NCT00002608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102500127|NCT00002608|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102500128|NCT00002608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102500129|NCT00002608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102500130|NCT00002608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500131|NCT00002608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102500132|NCT00002608|Hormone Antagonists|hormone antagonists|mesh-ancestor
102500133|NCT00002608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102500134|NCT00002608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500135|NCT00002608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102500136|NCT00002608|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102500137|NCT00002608|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102500138|NCT00002608|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102500139|NCT00002620|Cobalt|cobalt|mesh-list
102500140|NCT00002620|Carmustine|carmustine|mesh-list
102500141|NCT00002620|Mitolactol|mitolactol|mesh-list
102500142|NCT00002620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102500143|NCT00002620|Alkylating Agents|alkylating agents|mesh-ancestor
102500144|NCT00002620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500145|NCT00002620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102500146|NCT00002620|Trace Elements|trace elements|mesh-ancestor
102500147|NCT00002620|Micronutrients|micronutrients|mesh-ancestor
102500148|NCT00002620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500149|NCT04160000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
102500150|NCT00002638|Cytarabine|cytarabine|mesh-list
102500151|NCT00002638|Cyclophosphamide|cyclophosphamide|mesh-list
102500152|NCT00002638|Carmustine|carmustine|mesh-list
102500153|NCT00002638|Etoposide|etoposide|mesh-list
102500154|NCT00002638|Sargramostim|sargramostim|mesh-list
102500155|NCT00002638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102500156|NCT00002638|Immunologic Factors|immunologic factors|mesh-ancestor
102500157|NCT00002638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500158|NCT00002638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102500159|NCT00002638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102500160|NCT00002638|Alkylating Agents|alkylating agents|mesh-ancestor
102500161|NCT00002638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500162|NCT00002638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102500163|NCT00002638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102500164|NCT00002638|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102500165|NCT00002638|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102500166|NCT00002638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102500167|NCT00002638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102500168|NCT00002638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102500169|NCT00002638|Antimetabolites|antimetabolites|mesh-ancestor
102500170|NCT00002638|Antiviral Agents|antiviral agents|mesh-ancestor
102500171|NCT00002638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102500172|NCT05120362|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
102500173|NCT05120362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102500174|NCT05120362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102500175|NCT05120362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500176|NCT01896440|Ondansetron|ondansetron|mesh-list
102500177|NCT01896440|Antiemetics|antiemetics|mesh-ancestor
102500178|NCT01896440|Autonomic Agents|autonomic agents|mesh-ancestor
102500179|NCT01896440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102500180|NCT01896440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500181|NCT01896440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102500182|NCT01896440|Antipruritics|antipruritics|mesh-ancestor
102500183|NCT01896440|Dermatologic Agents|dermatologic agents|mesh-ancestor
102500184|NCT01896440|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102500185|NCT01896440|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102500186|NCT01896440|Serotonin Agents|serotonin agents|mesh-ancestor
102500187|NCT01896440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102500188|NCT01896440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500189|NCT00002656|NSC 366140|nsc 366140|mesh-list
102500190|NCT00002656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102500191|NCT00002662|Paclitaxel|paclitaxel|mesh-list
102500192|NCT00002662|Docetaxel|docetaxel|mesh-list
102500193|NCT00002662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102500194|NCT00002662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102500195|NCT00002662|Tubulin Modulators|tubulin modulators|mesh-ancestor
102500196|NCT00002662|Antimitotic Agents|antimitotic agents|mesh-ancestor
102500197|NCT00002662|Mitosis Modulators|mitosis modulators|mesh-ancestor
102500198|NCT00002662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500199|NCT00054314|IDN 5109|idn 5109|mesh-list
102500200|NCT00054314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102500201|NCT01743950|Bevacizumab|bevacizumab|mesh-list
102500202|NCT01743950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102500203|NCT01743950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102500204|NCT01743950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102500205|NCT01743950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102500206|NCT01743950|Growth Substances|growth substances|mesh-ancestor
102500207|NCT01743950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500208|NCT01743950|Growth Inhibitors|growth inhibitors|mesh-ancestor
102500209|NCT00002674|Cytarabine|cytarabine|mesh-list
102500210|NCT00002674|Etoposide|etoposide|mesh-list
102500211|NCT00002674|Mitoxantrone|mitoxantrone|mesh-list
102500212|NCT00002674|Hydroxyurea|hydroxyurea|mesh-list
102500213|NCT00002674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102500214|NCT00002674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102500215|NCT00002674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102500216|NCT00002674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102500217|NCT00002674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102500218|NCT00002674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500219|NCT00002674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102500220|NCT00002674|Antimetabolites|antimetabolites|mesh-ancestor
102500221|NCT00002674|Antiviral Agents|antiviral agents|mesh-ancestor
102500222|NCT00002674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102500223|NCT00002674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102500224|NCT00002674|Immunologic Factors|immunologic factors|mesh-ancestor
102500225|NCT00002674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500226|NCT00002674|Analgesics|analgesics|mesh-ancestor
102500227|NCT00002674|Sensory System Agents|sensory system agents|mesh-ancestor
102500228|NCT00002674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102500229|NCT00002674|Antisickling Agents|antisickling agents|mesh-ancestor
102500230|NCT00002674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102500231|NCT01743872|Dextrans|dextrans|mesh-list
102500232|NCT01743872|Anticoagulants|anticoagulants|mesh-ancestor
102500233|NCT01743872|Plasma Substitutes|plasma substitutes|mesh-ancestor
102500234|NCT01743872|Blood Substitutes|blood substitutes|mesh-ancestor
102500235|NCT00002680|Tamoxifen|tamoxifen|mesh-list
102500236|NCT00002680|Cyclophosphamide|cyclophosphamide|mesh-list
102500237|NCT00002680|Melphalan|melphalan|mesh-list
102500238|NCT00002680|Thiotepa|thiotepa|mesh-list
102500239|NCT00002680|Megestrol|megestrol|mesh-list
102500240|NCT00002680|Megestrol Acetate|megestrol acetate|mesh-list
102500241|NCT00002680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102500242|NCT00002680|Immunologic Factors|immunologic factors|mesh-ancestor
102500243|NCT00002680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500244|NCT00002680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102500245|NCT00002680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102500246|NCT00002680|Alkylating Agents|alkylating agents|mesh-ancestor
102612352|NCT00002423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102500247|NCT00002680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500248|NCT00002680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102500249|NCT00002680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102500250|NCT00002680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102500251|NCT00002680|Hormone Antagonists|hormone antagonists|mesh-ancestor
102500252|NCT00002680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102500253|NCT00002680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102500254|NCT00002680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102500255|NCT00002680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102500256|NCT00002680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102500257|NCT00002680|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102500258|NCT00002680|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102500259|NCT00002680|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102500260|NCT00002680|Contraceptive Agents|contraceptive agents|mesh-ancestor
102500261|NCT00002680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102500262|NCT00002680|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102500263|NCT00002680|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102500264|NCT00002680|Appetite Stimulants|appetite stimulants|mesh-ancestor
102500265|NCT00002680|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102500266|NCT00002692|Leucovorin|leucovorin|mesh-list
102500267|NCT00002692|Fluorouracil|fluorouracil|mesh-list
102500268|NCT00002692|Calcium|calcium|mesh-list
102500269|NCT00002692|Levoleucovorin|levoleucovorin|mesh-list
102500270|NCT00002692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102500271|NCT00002692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500272|NCT00002692|Antimetabolites|antimetabolites|mesh-ancestor
102500273|NCT00002692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500274|NCT00002692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102500275|NCT00002692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102500276|NCT00002692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102500277|NCT00002692|Immunologic Factors|immunologic factors|mesh-ancestor
102500278|NCT00002692|Antidotes|antidotes|mesh-ancestor
102500279|NCT00002692|Protective Agents|protective agents|mesh-ancestor
102500280|NCT00002692|Vitamin B Complex|vitamin b complex|mesh-ancestor
102500281|NCT00002692|Vitamins|vitamins|mesh-ancestor
102500282|NCT00002692|Micronutrients|micronutrients|mesh-ancestor
102500283|NCT05293210|Dexamethasone|dexamethasone|mesh-list
102500284|NCT05293210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102500285|NCT05293210|Antiemetics|antiemetics|mesh-ancestor
102500286|NCT05293210|Autonomic Agents|autonomic agents|mesh-ancestor
102500287|NCT05293210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102500288|NCT05293210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500289|NCT05293210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102500290|NCT05293210|Glucocorticoids|glucocorticoids|mesh-ancestor
102500291|NCT05293210|Hormones|hormones|mesh-ancestor
102500292|NCT05293210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102500293|NCT05293210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102500294|NCT05293210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102500295|NCT01895348|Dexmedetomidine|dexmedetomidine|mesh-list
102500296|NCT01895348|Remifentanil|remifentanil|mesh-list
102500297|NCT01895348|Propofol|propofol|mesh-list
102500298|NCT01895348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102500299|NCT01895348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102500300|NCT01895348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500301|NCT01895348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102500302|NCT01895348|Analgesics|analgesics|mesh-ancestor
102500303|NCT01895348|Sensory System Agents|sensory system agents|mesh-ancestor
102500304|NCT01895348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102500305|NCT01895348|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102500306|NCT01895348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102500307|NCT01895348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102500308|NCT01895348|Adrenergic Agents|adrenergic agents|mesh-ancestor
102500309|NCT01895348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102500310|NCT01895348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500311|NCT01895348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102500312|NCT01895348|Anesthetics, General|anesthetics, general|mesh-ancestor
102500313|NCT01895348|Anesthetics|anesthetics|mesh-ancestor
102500314|NCT01895348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102500315|NCT01895348|Narcotics|narcotics|mesh-ancestor
102500316|NCT04194554|Leuprolide|leuprolide|mesh-list
102500317|NCT04194554|Abiraterone Acetate|abiraterone acetate|mesh-list
102500318|NCT04194554|Niraparib|niraparib|mesh-list
102500319|NCT04194554|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102500320|NCT04194554|Fertility Agents|fertility agents|mesh-ancestor
102311879|NCT04630821|Eusol|eusol|mesh-list
102500321|NCT04194554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102500322|NCT04194554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500323|NCT04194554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102500324|NCT04194554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102500325|NCT04194554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102500326|NCT04194554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102500327|NCT04194554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500328|NCT04194554|Hormone Antagonists|hormone antagonists|mesh-ancestor
102500329|NCT04194554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102500330|NCT04194554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102500331|NCT04194554|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102500332|NCT05073718|Aspirin|aspirin|mesh-list
102500333|NCT05073718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102500334|NCT05073718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102500335|NCT05073718|Analgesics|analgesics|mesh-ancestor
102500336|NCT05073718|Sensory System Agents|sensory system agents|mesh-ancestor
102500337|NCT05073718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102500338|NCT05073718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500339|NCT05073718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102500340|NCT05073718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102500341|NCT05073718|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102500342|NCT05073718|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102500343|NCT05073718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500344|NCT05073718|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102500345|NCT05073718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102500346|NCT05073718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102500347|NCT05073718|Antipyretics|antipyretics|mesh-ancestor
102500348|NCT04784000|Carbamazepine|carbamazepine|mesh-list
102500349|NCT04784000|Anticonvulsants|anticonvulsants|mesh-ancestor
102500350|NCT04784000|Antimanic Agents|antimanic agents|mesh-ancestor
102500351|NCT04784000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102500352|NCT04784000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102500353|NCT04784000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500354|NCT04784000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102500355|NCT04784000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102500356|NCT04784000|Analgesics|analgesics|mesh-ancestor
102500357|NCT04784000|Sensory System Agents|sensory system agents|mesh-ancestor
102500358|NCT04784000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102500359|NCT04784000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102500360|NCT04784000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102500361|NCT04784000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500362|NCT04784000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102500363|NCT04784000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102500364|NCT05271292|Chiauranib|chiauranib|mesh-list
102500365|NCT05271292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102500366|NCT05271292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102500367|NCT05271292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102500368|NCT05271292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500369|NCT05266846|Bevacizumab|bevacizumab|mesh-list
102500370|NCT05266846|Pembrolizumab|pembrolizumab|mesh-list
102500371|NCT05266846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102500372|NCT05266846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102500373|NCT05266846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102500374|NCT05266846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102500375|NCT05266846|Growth Substances|growth substances|mesh-ancestor
102500376|NCT05266846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500377|NCT05266846|Growth Inhibitors|growth inhibitors|mesh-ancestor
102500378|NCT05266846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102500379|NCT05266846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500380|NCT01113476|Paclitaxel|paclitaxel|mesh-list
102500381|NCT01113476|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102500382|NCT01113476|Bevacizumab|bevacizumab|mesh-list
102500383|NCT01113476|Gemcitabine|gemcitabine|mesh-list
102500384|NCT01113476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102500385|NCT01113476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102500386|NCT01113476|Tubulin Modulators|tubulin modulators|mesh-ancestor
102500387|NCT01113476|Antimitotic Agents|antimitotic agents|mesh-ancestor
102500388|NCT01113476|Mitosis Modulators|mitosis modulators|mesh-ancestor
102500389|NCT01113476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500390|NCT01113476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102500391|NCT01113476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102500392|NCT01113476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102311933|NCT02308007|Terconazole|terconazole|mesh-list
102500393|NCT01113476|Growth Substances|growth substances|mesh-ancestor
102500394|NCT01113476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500395|NCT01113476|Growth Inhibitors|growth inhibitors|mesh-ancestor
102500396|NCT01113476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102500397|NCT01113476|Antimetabolites|antimetabolites|mesh-ancestor
102500398|NCT01107236|Naproxen|naproxen|mesh-list
102500399|NCT01107236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102500400|NCT01107236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102500401|NCT01107236|Analgesics|analgesics|mesh-ancestor
102500402|NCT01107236|Sensory System Agents|sensory system agents|mesh-ancestor
102500403|NCT01107236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102500404|NCT01107236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500405|NCT01107236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102500406|NCT01107236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102500407|NCT01107236|Gout Suppressants|gout suppressants|mesh-ancestor
102500408|NCT01107236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102500409|NCT01107236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102500410|NCT01107236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500411|NCT00002704|Leucovorin|leucovorin|mesh-list
102500412|NCT00002704|Cytarabine|cytarabine|mesh-list
102500413|NCT00002704|Dexamethasone|dexamethasone|mesh-list
102500414|NCT00002704|Hydrocortisone|hydrocortisone|mesh-list
102500415|NCT00002704|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102500416|NCT00002704|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102500417|NCT00002704|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102500418|NCT00002704|Cyclophosphamide|cyclophosphamide|mesh-list
102500419|NCT00002704|Thiotepa|thiotepa|mesh-list
102500420|NCT00002704|Methotrexate|methotrexate|mesh-list
102500421|NCT00002704|Etoposide|etoposide|mesh-list
102500422|NCT00002704|Vincristine|vincristine|mesh-list
102500423|NCT00002704|Daunorubicin|daunorubicin|mesh-list
102500424|NCT00002704|Asparaginase|asparaginase|mesh-list
102500425|NCT00002704|Mercaptopurine|mercaptopurine|mesh-list
102500426|NCT00002704|Levoleucovorin|levoleucovorin|mesh-list
102500427|NCT00002704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102500428|NCT00002704|Immunologic Factors|immunologic factors|mesh-ancestor
102500429|NCT00002704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500430|NCT00002704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102500431|NCT00002704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102500432|NCT00002704|Alkylating Agents|alkylating agents|mesh-ancestor
102500433|NCT00002704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500434|NCT00002704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102500435|NCT00002704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102500436|NCT00002704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102500437|NCT00002704|Antiemetics|antiemetics|mesh-ancestor
102500438|NCT00002704|Autonomic Agents|autonomic agents|mesh-ancestor
102500439|NCT00002704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102500440|NCT00002704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102500441|NCT00002704|Glucocorticoids|glucocorticoids|mesh-ancestor
102500442|NCT00002704|Hormones|hormones|mesh-ancestor
102500443|NCT00002704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102500444|NCT00002704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102500445|NCT00002704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102500446|NCT00002704|Abortifacient Agents|abortifacient agents|mesh-ancestor
102500447|NCT00002704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102500448|NCT00002704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102500449|NCT00002704|Antimetabolites|antimetabolites|mesh-ancestor
102500450|NCT00002704|Dermatologic Agents|dermatologic agents|mesh-ancestor
102500451|NCT00002704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102500452|NCT00002704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102500453|NCT00002704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102500454|NCT00002704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102500455|NCT00002704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102500456|NCT00002704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102500457|NCT00002704|Antiviral Agents|antiviral agents|mesh-ancestor
102500458|NCT00002704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102500459|NCT00002704|Antidotes|antidotes|mesh-ancestor
102500460|NCT00002704|Protective Agents|protective agents|mesh-ancestor
102500461|NCT00002704|Vitamin B Complex|vitamin b complex|mesh-ancestor
102500462|NCT00002704|Vitamins|vitamins|mesh-ancestor
102500463|NCT00002704|Micronutrients|micronutrients|mesh-ancestor
102500464|NCT00002704|Tubulin Modulators|tubulin modulators|mesh-ancestor
102500465|NCT00002704|Antimitotic Agents|antimitotic agents|mesh-ancestor
102500466|NCT00002704|Mitosis Modulators|mitosis modulators|mesh-ancestor
102500467|NCT00002704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102500468|NCT00002716|Leucovorin|leucovorin|mesh-list
102500469|NCT00002716|Dexamethasone|dexamethasone|mesh-list
102500470|NCT00002716|Fluorouracil|fluorouracil|mesh-list
102500471|NCT00002716|Floxuridine|floxuridine|mesh-list
102500472|NCT00002716|Calcium|calcium|mesh-list
102500473|NCT00002716|Levoleucovorin|levoleucovorin|mesh-list
102500474|NCT00002716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102500475|NCT00002716|Antiemetics|antiemetics|mesh-ancestor
102500476|NCT00002716|Autonomic Agents|autonomic agents|mesh-ancestor
102500477|NCT00002716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102500478|NCT00002716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500479|NCT00002716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102500480|NCT00002716|Glucocorticoids|glucocorticoids|mesh-ancestor
102500481|NCT00002716|Hormones|hormones|mesh-ancestor
102500482|NCT00002716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102500483|NCT00002716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102500484|NCT00002716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102500485|NCT00002716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102500486|NCT00002716|Antimetabolites|antimetabolites|mesh-ancestor
102500487|NCT00002716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500488|NCT00002716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102500489|NCT00002716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102500490|NCT00002716|Immunologic Factors|immunologic factors|mesh-ancestor
102500491|NCT00002716|Antidotes|antidotes|mesh-ancestor
102500492|NCT00002716|Protective Agents|protective agents|mesh-ancestor
102500493|NCT00002716|Vitamin B Complex|vitamin b complex|mesh-ancestor
102500494|NCT00002716|Vitamins|vitamins|mesh-ancestor
102500495|NCT00002716|Micronutrients|micronutrients|mesh-ancestor
102500496|NCT02533674|Gemcitabine|gemcitabine|mesh-list
102500497|NCT02533674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102500498|NCT02533674|Antimetabolites|antimetabolites|mesh-ancestor
102500499|NCT02533674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500500|NCT02533674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102500501|NCT00002722|Leucovorin|leucovorin|mesh-list
102500502|NCT00002722|Fluorouracil|fluorouracil|mesh-list
102500503|NCT00002722|Calcium|calcium|mesh-list
102500504|NCT00002722|Levoleucovorin|levoleucovorin|mesh-list
102500505|NCT00002722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102500506|NCT00002722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102500507|NCT00002722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500508|NCT00002722|Antimetabolites|antimetabolites|mesh-ancestor
102500509|NCT00002722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500510|NCT00002722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102500511|NCT00002722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102500512|NCT00002722|Immunologic Factors|immunologic factors|mesh-ancestor
102500513|NCT00002722|Antidotes|antidotes|mesh-ancestor
102500514|NCT00002722|Protective Agents|protective agents|mesh-ancestor
102500515|NCT00002722|Vitamin B Complex|vitamin b complex|mesh-ancestor
102500516|NCT00002722|Vitamins|vitamins|mesh-ancestor
102500517|NCT00002722|Micronutrients|micronutrients|mesh-ancestor
102500518|NCT00002734|Interferons|interferons|mesh-list
102500519|NCT00002734|Interferon-alpha|interferon-alpha|mesh-list
102500520|NCT00002734|Paclitaxel|paclitaxel|mesh-list
102500521|NCT00002734|Topotecan|topotecan|mesh-list
102500522|NCT00002734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102500523|NCT00002734|Antibodies|antibodies|mesh-list
102500524|NCT00002734|Immunoglobulins|immunoglobulins|mesh-list
102500525|NCT00002734|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102500526|NCT00002734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102500527|NCT00002734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102500528|NCT00002734|Tubulin Modulators|tubulin modulators|mesh-ancestor
102500529|NCT00002734|Antimitotic Agents|antimitotic agents|mesh-ancestor
102500530|NCT00002734|Mitosis Modulators|mitosis modulators|mesh-ancestor
102500531|NCT00002734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500532|NCT00002734|Immunologic Factors|immunologic factors|mesh-ancestor
102500533|NCT00002734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500534|NCT00002734|Antiviral Agents|antiviral agents|mesh-ancestor
102500535|NCT00002734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102500536|NCT00002734|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102500537|NCT00002734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102500538|NCT00002734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102500539|NCT04783610|Ethanol|ethanol|mesh-list
102500540|NCT04783610|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102500541|NCT04783610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102500542|NCT04783610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102500543|NCT04783610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500544|NCT00002740|Cobalt|cobalt|mesh-list
102500545|NCT00002740|Cyclophosphamide|cyclophosphamide|mesh-list
102500546|NCT00002740|Carboplatin|carboplatin|mesh-list
102500547|NCT00002740|Doxorubicin|doxorubicin|mesh-list
102500548|NCT00002740|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102500549|NCT00002740|Etoposide|etoposide|mesh-list
102500550|NCT00002740|Vincristine|vincristine|mesh-list
102500551|NCT00002740|Lenograstim|lenograstim|mesh-list
102500552|NCT00002740|Mesna|mesna|mesh-list
102500553|NCT00002740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102500554|NCT00002740|Immunologic Factors|immunologic factors|mesh-ancestor
102500555|NCT00002740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500556|NCT00002740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102500557|NCT00002740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102500558|NCT00002740|Alkylating Agents|alkylating agents|mesh-ancestor
102500559|NCT00002740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500560|NCT00002740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102500561|NCT00002740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102500562|NCT00002740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102500563|NCT00002740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102500564|NCT00002740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102500565|NCT00002740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102500566|NCT00002740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102500567|NCT00002740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102500568|NCT00002740|Tubulin Modulators|tubulin modulators|mesh-ancestor
102500569|NCT00002740|Antimitotic Agents|antimitotic agents|mesh-ancestor
102500570|NCT00002740|Mitosis Modulators|mitosis modulators|mesh-ancestor
102500571|NCT00002740|Protective Agents|protective agents|mesh-ancestor
102500572|NCT00002740|Trace Elements|trace elements|mesh-ancestor
102500573|NCT00002740|Micronutrients|micronutrients|mesh-ancestor
102500574|NCT00002746|Aldesleukin|aldesleukin|mesh-list
102500575|NCT00002746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102500576|NCT00002746|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102500577|NCT00002746|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102500578|NCT00002746|Antiviral Agents|antiviral agents|mesh-ancestor
102500579|NCT00002746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102500580|NCT01049945|Dexamethasone|dexamethasone|mesh-list
102500581|NCT01049945|Lenalidomide|lenalidomide|mesh-list
102500582|NCT01049945|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102500583|NCT01049945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102500584|NCT01049945|Antiemetics|antiemetics|mesh-ancestor
102500585|NCT01049945|Autonomic Agents|autonomic agents|mesh-ancestor
102500586|NCT01049945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102500587|NCT01049945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500588|NCT01049945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102500589|NCT01049945|Glucocorticoids|glucocorticoids|mesh-ancestor
102500590|NCT01049945|Hormones|hormones|mesh-ancestor
102500591|NCT01049945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102500592|NCT01049945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102500593|NCT01049945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102500594|NCT01049945|Immunologic Factors|immunologic factors|mesh-ancestor
102500595|NCT01049945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102500596|NCT01049945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102500597|NCT01049945|Growth Substances|growth substances|mesh-ancestor
102500598|NCT01049945|Growth Inhibitors|growth inhibitors|mesh-ancestor
102500599|NCT01049945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102500600|NCT01049945|Alkylating Agents|alkylating agents|mesh-ancestor
102500601|NCT01049945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500602|NCT00002752|Antibodies|antibodies|mesh-list
102500603|NCT00002752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102500604|NCT00002752|Immunologic Factors|immunologic factors|mesh-ancestor
102500605|NCT00002752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500606|NCT01050647|Castor Oil|castor oil|mesh-list
102500607|NCT01050647|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
102500608|NCT01050647|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
102500609|NCT01050647|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102500610|NCT01050647|Hormone Antagonists|hormone antagonists|mesh-ancestor
102500611|NCT01050647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102500612|NCT01050647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500613|NCT01050647|Progestins|progestins|mesh-ancestor
102500614|NCT01050647|Hormones|hormones|mesh-ancestor
102500615|NCT01050647|Cathartics|cathartics|mesh-ancestor
102500616|NCT01050647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102500617|NCT04825678|Erenumab|erenumab|mesh-list
102500618|NCT04825678|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
102500619|NCT04825678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500620|NCT04825678|Analgesics|analgesics|mesh-ancestor
102500621|NCT04825678|Sensory System Agents|sensory system agents|mesh-ancestor
102500622|NCT04825678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102500623|NCT04825678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500624|NCT00002764|Doxorubicin|doxorubicin|mesh-list
102500625|NCT00002764|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102500626|NCT00002764|Ifosfamide|ifosfamide|mesh-list
102500627|NCT00002764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102500628|NCT00002764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102500629|NCT00002764|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102500630|NCT00002764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102500631|NCT00002764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102500632|NCT00002764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500633|NCT00002764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102500634|NCT00002764|Alkylating Agents|alkylating agents|mesh-ancestor
102500635|NCT01688492|Ipilimumab|ipilimumab|mesh-list
102500636|NCT01688492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102500637|NCT01688492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102500638|NCT01688492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102500639|NCT01688492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500640|NCT05167175|Prednisone|prednisone|mesh-list
102500641|NCT05167175|Olaparib|olaparib|mesh-list
102500642|NCT05167175|Abiraterone Acetate|abiraterone acetate|mesh-list
102500643|NCT05167175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102500644|NCT05167175|Glucocorticoids|glucocorticoids|mesh-ancestor
102500645|NCT05167175|Hormones|hormones|mesh-ancestor
102500646|NCT05167175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102500647|NCT05167175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500648|NCT05167175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102500649|NCT05167175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102500650|NCT05167175|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102500651|NCT05167175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102500652|NCT05167175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500653|NCT05167175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102500654|NCT05167175|Hormone Antagonists|hormone antagonists|mesh-ancestor
102500655|NCT05167175|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102500656|NCT00002788|Dexamethasone|dexamethasone|mesh-list
102500657|NCT00002788|Cyclophosphamide|cyclophosphamide|mesh-list
102500658|NCT00002788|Etoposide|etoposide|mesh-list
102500659|NCT00002788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102500660|NCT00002788|Immunologic Factors|immunologic factors|mesh-ancestor
102500661|NCT00002788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500662|NCT00002788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102500663|NCT00002788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102500664|NCT00002788|Alkylating Agents|alkylating agents|mesh-ancestor
102500665|NCT00002788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500666|NCT00002788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102500667|NCT00002788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102500668|NCT00002788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102500669|NCT00002788|Antiemetics|antiemetics|mesh-ancestor
102500670|NCT00002788|Autonomic Agents|autonomic agents|mesh-ancestor
102500671|NCT00002788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102500672|NCT00002788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102500673|NCT00002788|Glucocorticoids|glucocorticoids|mesh-ancestor
102500674|NCT00002788|Hormones|hormones|mesh-ancestor
102500675|NCT00002788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102500676|NCT00002788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102500677|NCT00002788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102500678|NCT00002788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102500679|NCT00002788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102500680|NCT00002788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102500681|NCT04352933|Hydroxychloroquine|hydroxychloroquine|mesh-list
102500682|NCT04352933|Antimalarials|antimalarials|mesh-ancestor
102500683|NCT04352933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102500684|NCT04352933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102500685|NCT04352933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102500686|NCT04352933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102500687|NCT04352933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500688|NCT04352933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102500689|NCT04783792|Ascorbic Acid|ascorbic acid|mesh-list
102500690|NCT04783792|Antioxidants|antioxidants|mesh-ancestor
102500691|NCT04783792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500692|NCT04783792|Protective Agents|protective agents|mesh-ancestor
102500693|NCT04783792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500694|NCT04783792|Vitamins|vitamins|mesh-ancestor
102500695|NCT04783792|Micronutrients|micronutrients|mesh-ancestor
102500696|NCT05002816|Elotuzumab|elotuzumab|mesh-list
102500697|NCT05002816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102312242|NCT02308046|Terconazole|terconazole|mesh-list
102500698|NCT01676402|Vaccines|vaccines|mesh-list
102500699|NCT01676402|Immunologic Factors|immunologic factors|mesh-ancestor
102500700|NCT01676402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500701|NCT01052831|Naltrexone|naltrexone|mesh-list
102500702|NCT01052831|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102500703|NCT01052831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102500704|NCT01052831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500705|NCT01052831|Sensory System Agents|sensory system agents|mesh-ancestor
102500706|NCT01052831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102500707|NCT04330300|Losartan|losartan|mesh-list
102500708|NCT04330300|Verapamil|verapamil|mesh-list
102500709|NCT04330300|Felodipine|felodipine|mesh-list
102500710|NCT04330300|Amlodipine|amlodipine|mesh-list
102500711|NCT04330300|Valsartan|valsartan|mesh-list
102500712|NCT04330300|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102500713|NCT04330300|Telmisartan|telmisartan|mesh-list
102500714|NCT04330300|Candesartan|candesartan|mesh-list
102500715|NCT04330300|Ramipril|ramipril|mesh-list
102500716|NCT04330300|Olmesartan|olmesartan|mesh-list
102500717|NCT04330300|Enalapril|enalapril|mesh-list
102500718|NCT04330300|Lisinopril|lisinopril|mesh-list
102500719|NCT04330300|Irbesartan|irbesartan|mesh-list
102500720|NCT04330300|Chlorthalidone|chlorthalidone|mesh-list
102500721|NCT04330300|Perindopril|perindopril|mesh-list
102500722|NCT04330300|Diltiazem|diltiazem|mesh-list
102500723|NCT04330300|Benazepril|benazepril|mesh-list
102500724|NCT04330300|Captopril|captopril|mesh-list
102500725|NCT04330300|Indapamide|indapamide|mesh-list
102500726|NCT04330300|Nicardipine|nicardipine|mesh-list
102500727|NCT04330300|Nimodipine|nimodipine|mesh-list
102500728|NCT04330300|Quinapril|quinapril|mesh-list
102500729|NCT04330300|Metolazone|metolazone|mesh-list
102500730|NCT04330300|Trandolapril|trandolapril|mesh-list
102500731|NCT04330300|Fosinopril|fosinopril|mesh-list
102500732|NCT04330300|Eprosartan|eprosartan|mesh-list
102500733|NCT04330300|Nitrendipine|nitrendipine|mesh-list
102500734|NCT04330300|Bendroflumethiazide|bendroflumethiazide|mesh-list
102500735|NCT04330300|Chlorothiazide|chlorothiazide|mesh-list
102500736|NCT04330300|Nifedipine|nifedipine|mesh-list
102500737|NCT04330300|Calcium Channel Blockers|calcium channel blockers|mesh-list
102500738|NCT04330300|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
102500739|NCT04330300|Diuretics|diuretics|mesh-list
102500740|NCT04330300|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102500741|NCT04330300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102500742|NCT04330300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500743|NCT04330300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102500744|NCT04330300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102500745|NCT04330300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500746|NCT04330300|Vasodilator Agents|vasodilator agents|mesh-ancestor
102500747|NCT04330300|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102500748|NCT04330300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102500749|NCT04330300|Natriuretic Agents|natriuretic agents|mesh-ancestor
102500750|NCT04330300|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102500751|NCT04330300|Protease Inhibitors|protease inhibitors|mesh-ancestor
102500752|NCT04330300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102500753|NCT04330300|Tocolytic Agents|tocolytic agents|mesh-ancestor
102500754|NCT04330300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102500755|NCT04330300|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102500756|NCT04330300|Protective Agents|protective agents|mesh-ancestor
102500757|NCT04330300|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
102500758|NCT04352855|Tazobactam|tazobactam|mesh-list
102500759|NCT04352855|Ceftolozane|ceftolozane|mesh-list
102500760|NCT04352855|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
102500761|NCT04352855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102500762|NCT04352855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102500763|NCT04352855|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102500764|NCT04352855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102500765|NCT04352855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500766|NCT04352855|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102500767|NCT04782128|RC28-E protein|rc28-e protein|mesh-list
102500768|NCT04782128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102500769|NCT04782128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102500770|NCT04782128|Growth Substances|growth substances|mesh-ancestor
102500771|NCT04782128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500772|NCT04782128|Growth Inhibitors|growth inhibitors|mesh-ancestor
102500773|NCT04782128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102500774|NCT00995150|Levonorgestrel|levonorgestrel|mesh-list
102500775|NCT00995150|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102500776|NCT00995150|Contraceptive Agents|contraceptive agents|mesh-ancestor
102500777|NCT00995150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102500778|NCT00995150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500779|NCT00995150|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102500780|NCT00995150|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102500781|NCT00995150|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102500782|NCT00382642|Ondansetron|ondansetron|mesh-list
102500783|NCT00382642|Antiemetics|antiemetics|mesh-ancestor
102500784|NCT00382642|Autonomic Agents|autonomic agents|mesh-ancestor
102500785|NCT00382642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102500786|NCT00382642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500787|NCT00382642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102500788|NCT00382642|Antipruritics|antipruritics|mesh-ancestor
102500789|NCT00382642|Dermatologic Agents|dermatologic agents|mesh-ancestor
102500790|NCT00382642|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102500791|NCT00382642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102500792|NCT00382642|Serotonin Agents|serotonin agents|mesh-ancestor
102500793|NCT00382642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102500794|NCT00382642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500796|NCT01054079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101977077|NCT01230463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102500797|NCT01054079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500798|NCT01054079|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
102500799|NCT01054079|Hormone Antagonists|hormone antagonists|mesh-ancestor
102500800|NCT01054079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102500801|NCT02544750|Cannabidiol|cannabidiol|mesh-list
102500802|NCT02544750|Anticonvulsants|anticonvulsants|mesh-ancestor
102500803|NCT01662050|Cytarabine|cytarabine|mesh-list
102500804|NCT01662050|Rituximab|rituximab|mesh-list
102500805|NCT01662050|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102500806|NCT01662050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102500807|NCT01662050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102500808|NCT01662050|Immunologic Factors|immunologic factors|mesh-ancestor
102500809|NCT01662050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500810|NCT01662050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102500811|NCT01662050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102500812|NCT01662050|Antimetabolites|antimetabolites|mesh-ancestor
102500813|NCT01662050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500814|NCT01662050|Antiviral Agents|antiviral agents|mesh-ancestor
102500815|NCT01662050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102500816|NCT01662050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102500817|NCT01662050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102500818|NCT01662050|Alkylating Agents|alkylating agents|mesh-ancestor
102500819|NCT04748848|Azacitidine|azacitidine|mesh-list
102500820|NCT04748848|Venetoclax|venetoclax|mesh-list
102500821|NCT04748848|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
102500822|NCT04748848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102500823|NCT04748848|Antimetabolites|antimetabolites|mesh-ancestor
102500824|NCT04748848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500825|NCT04748848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102500826|NCT04748848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102500827|NCT02171195|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102500828|NCT02171195|Anticonvulsants|anticonvulsants|mesh-ancestor
102500829|NCT02171195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102500830|NCT02171195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102500831|NCT02171195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102500832|NCT02171195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500833|NCT01620788|Losartan|losartan|mesh-list
102500834|NCT01620788|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102500835|NCT01620788|Indapamide|indapamide|mesh-list
102500836|NCT01620788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102500837|NCT01620788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102500838|NCT01620788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102500839|NCT01620788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102500840|NCT01620788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500841|NCT01620788|Diuretics|diuretics|mesh-ancestor
102500842|NCT01620788|Natriuretic Agents|natriuretic agents|mesh-ancestor
102500843|NCT01620788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500844|NCT01620788|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102500845|NCT01620788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102500846|NCT03014843|Bromides|bromides|mesh-list
102500847|NCT03014843|Naloxone|naloxone|mesh-list
102500848|NCT03014843|Methylnaltrexone|methylnaltrexone|mesh-list
102500849|NCT03014843|Anticonvulsants|anticonvulsants|mesh-ancestor
102500850|NCT03014843|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102500851|NCT03014843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500852|NCT03014843|Sensory System Agents|sensory system agents|mesh-ancestor
102500853|NCT03014843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102500854|NCT05081375|Enoxaparin|enoxaparin|mesh-list
102312388|NCT02304302|Memantine|memantine|mesh-list
102500855|NCT05081375|Anticoagulants|anticoagulants|mesh-ancestor
102500856|NCT05081375|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102500857|NCT05081375|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102500858|NCT05081375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500859|NCT04755062|Micronutrients|micronutrients|mesh-list
102500860|NCT04755062|Trace Elements|trace elements|mesh-list
102500861|NCT04755062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500862|NCT03852797|Ketamine|ketamine|mesh-list
102500863|NCT03852797|Propofol|propofol|mesh-list
102500864|NCT03852797|Etomidate|etomidate|mesh-list
102500865|NCT03852797|Oxytocin|oxytocin|mesh-list
102500866|NCT03852797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102500867|NCT03852797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102500868|NCT03852797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500869|NCT03852797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102500870|NCT03852797|Anesthetics, General|anesthetics, general|mesh-ancestor
102500871|NCT03852797|Anesthetics|anesthetics|mesh-ancestor
102500872|NCT03852797|Analgesics|analgesics|mesh-ancestor
102500873|NCT03852797|Sensory System Agents|sensory system agents|mesh-ancestor
102500874|NCT03852797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102500875|NCT03852797|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102500876|NCT03852797|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102500877|NCT03852797|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102500878|NCT03852797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102500879|NCT03852797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500880|NCT03852797|Oxytocics|oxytocics|mesh-ancestor
102500881|NCT03852797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102500882|NCT01055171|Propranolol|propranolol|mesh-list
102500883|NCT01055171|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102500884|NCT01055171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102500885|NCT01055171|Adrenergic Agents|adrenergic agents|mesh-ancestor
102500886|NCT01055171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102500887|NCT01055171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500888|NCT01055171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500889|NCT01055171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102500890|NCT01055171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102500891|NCT01055171|Vasodilator Agents|vasodilator agents|mesh-ancestor
102500892|NCT01057277|Everolimus|everolimus|mesh-list
102500893|NCT01057277|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102500894|NCT01057277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102500895|NCT01057277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102500896|NCT01057277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500897|NCT01057277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102500898|NCT01057277|Immunologic Factors|immunologic factors|mesh-ancestor
102500899|NCT01057277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500900|NCT01057277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102500901|NCT00866840|Riluzole|riluzole|mesh-list
102500902|NCT00866840|Anticonvulsants|anticonvulsants|mesh-ancestor
102500903|NCT00866840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102500904|NCT00866840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102500905|NCT00866840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102500906|NCT00866840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500907|NCT00866840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500908|NCT00866840|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102500909|NCT00866840|Protective Agents|protective agents|mesh-ancestor
102500910|NCT04349722|Scopolamine|scopolamine|mesh-list
102500911|NCT04349722|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102500912|NCT04349722|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102500913|NCT04349722|Antiemetics|antiemetics|mesh-ancestor
102500914|NCT04349722|Autonomic Agents|autonomic agents|mesh-ancestor
102500915|NCT04349722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102500916|NCT04349722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500917|NCT04349722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102500918|NCT04349722|Mydriatics|mydriatics|mesh-ancestor
102500919|NCT04349722|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102500920|NCT04349722|Cholinergic Agents|cholinergic agents|mesh-ancestor
102500921|NCT04349722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102500922|NCT04349722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500923|NCT04349722|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102500924|NCT04349722|Parasympatholytics|parasympatholytics|mesh-ancestor
102500925|NCT01058993|Plerixafor|plerixafor|mesh-list
102500926|NCT01058993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102500927|NCT01058993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102500928|NCT01058993|Antiviral Agents|antiviral agents|mesh-ancestor
102500929|NCT01058993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102500930|NCT04652518|Pirfenidone|pirfenidone|mesh-list
102500931|NCT04652518|Analgesics|analgesics|mesh-ancestor
102500932|NCT04652518|Sensory System Agents|sensory system agents|mesh-ancestor
102500933|NCT04652518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102500934|NCT04652518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500935|NCT04652518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102500936|NCT04652518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102500937|NCT04652518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102500938|NCT04652518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102500939|NCT04652518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102500940|NCT01059305|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102500941|NCT01059305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102500942|NCT01059305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102500943|NCT01059305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102500944|NCT01059305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500945|NCT04650490|Immunomodulating Agents|immunomodulating agents|mesh-list
102500946|NCT04650490|Immunologic Factors|immunologic factors|mesh-ancestor
102500947|NCT04650490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500948|NCT03850379|Ciprofloxacin|ciprofloxacin|mesh-list
102500949|NCT03850379|Levofloxacin|levofloxacin|mesh-list
102500950|NCT03850379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102500951|NCT03850379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102500952|NCT03850379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102500953|NCT03850379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102500954|NCT03850379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102500955|NCT03850379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500956|NCT03850379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102500957|NCT03850379|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102500958|NCT03850379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102500959|NCT03850379|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102500960|NCT03014687|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102500961|NCT03014687|Cefdinir|cefdinir|mesh-list
102500962|NCT03014687|Cephalosporins|cephalosporins|mesh-list
102500963|NCT03014687|Trimethoprim|trimethoprim|mesh-list
102500964|NCT03014687|Sulfamethoxazole|sulfamethoxazole|mesh-list
102500965|NCT03014687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102500966|NCT03014687|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102500967|NCT03014687|Antimalarials|antimalarials|mesh-ancestor
102500968|NCT03014687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102500969|NCT03014687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102500970|NCT03014687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102500971|NCT03014687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102500972|NCT03014687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500973|NCT03014687|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102500974|NCT03014687|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102500975|NCT03014687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102500976|NCT04199572|Acetaminophen|acetaminophen|mesh-list
102500977|NCT04199572|Diclofenac|diclofenac|mesh-list
102500978|NCT04199572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102500979|NCT04199572|Analgesics|analgesics|mesh-ancestor
102500980|NCT04199572|Sensory System Agents|sensory system agents|mesh-ancestor
102500981|NCT04199572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102500982|NCT04199572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500983|NCT04199572|Antipyretics|antipyretics|mesh-ancestor
102500984|NCT04199572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102500985|NCT04199572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102500986|NCT04199572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102500987|NCT04199572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102500988|NCT04199572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102500989|NCT04199572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102500990|NCT00383032|Mifepristone|mifepristone|mesh-list
102500991|NCT00383032|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102500992|NCT00383032|Abortifacient Agents|abortifacient agents|mesh-ancestor
102500993|NCT00383032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102500994|NCT00383032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102500995|NCT00383032|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102500996|NCT00383032|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102500997|NCT00383032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102500998|NCT00383032|Contraceptive Agents|contraceptive agents|mesh-ancestor
102500999|NCT00383032|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102501000|NCT00383032|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102501001|NCT00383032|Hormone Antagonists|hormone antagonists|mesh-ancestor
102501002|NCT00383032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102312528|NCT02269943|Azacitidine|azacitidine|mesh-list
102501003|NCT00383032|Luteolytic Agents|luteolytic agents|mesh-ancestor
102501004|NCT00383032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102501005|NCT00383032|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102501006|NCT02169479|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102501007|NCT02169479|Opicapone|opicapone|mesh-list
102501008|NCT02169479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102501009|NCT02169479|Immunologic Factors|immunologic factors|mesh-ancestor
102501010|NCT02169479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501011|NCT02169479|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102501012|NCT02169479|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102501013|NCT02169479|Dopamine Agonists|dopamine agonists|mesh-ancestor
102501014|NCT02169479|Dopamine Agents|dopamine agents|mesh-ancestor
102501015|NCT02169479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102501016|NCT02169479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501017|NCT02169479|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102501018|NCT02169479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102501019|NCT04302454|Leuprolide|leuprolide|mesh-list
102501020|NCT04302454|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102501021|NCT04302454|Fertility Agents|fertility agents|mesh-ancestor
102501022|NCT04302454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102501023|NCT04302454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501024|NCT04302454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102501025|NCT04302454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501026|NCT01059851|Suvorexant|suvorexant|mesh-list
102501027|NCT01059851|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102501028|NCT01059851|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102501029|NCT01059851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102501030|NCT01059851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501031|NCT01059851|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102501032|NCT01059851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102501033|NCT01059851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501034|NCT02169869|Levonorgestrel|levonorgestrel|mesh-list
102501035|NCT02169869|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102501036|NCT02169869|Contraceptive Agents|contraceptive agents|mesh-ancestor
102501037|NCT02169869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102501038|NCT02169869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501039|NCT02169869|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102501040|NCT02169869|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102501041|NCT02169869|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102501042|NCT01059929|Fentanyl|fentanyl|mesh-list
102501043|NCT01059929|Midazolam|midazolam|mesh-list
102501044|NCT01059929|Dexmedetomidine|dexmedetomidine|mesh-list
102501045|NCT01059929|Propofol|propofol|mesh-list
102501046|NCT01059929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102501047|NCT01059929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102501048|NCT01059929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501049|NCT01059929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102501050|NCT01059929|Analgesics|analgesics|mesh-ancestor
102501051|NCT01059929|Sensory System Agents|sensory system agents|mesh-ancestor
102501052|NCT01059929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102501053|NCT01059929|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102501054|NCT01059929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102501055|NCT01059929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102501056|NCT01059929|Adrenergic Agents|adrenergic agents|mesh-ancestor
102501057|NCT01059929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102501058|NCT01059929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501059|NCT01059929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102501060|NCT01059929|Anesthetics, General|anesthetics, general|mesh-ancestor
102501061|NCT01059929|Anesthetics|anesthetics|mesh-ancestor
102501062|NCT01059929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102501063|NCT01059929|Narcotics|narcotics|mesh-ancestor
102501064|NCT01059929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102501065|NCT01059929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102501066|NCT01059929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102501067|NCT01059929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102501068|NCT01059929|GABA Modulators|gaba modulators|mesh-ancestor
102501069|NCT01059929|GABA Agents|gaba agents|mesh-ancestor
102501070|NCT04828031|Vitamin D|vitamin d|mesh-list
102501071|NCT04828031|Vitamins|vitamins|mesh-ancestor
102501072|NCT04828031|Micronutrients|micronutrients|mesh-ancestor
102501073|NCT04828031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501074|NCT04828031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102501075|NCT04162522|Escitalopram|escitalopram|mesh-list
102501076|NCT04162522|Brexpiprazole|brexpiprazole|mesh-list
102501077|NCT04162522|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102312604|NCT01749826|Sensory System Agents|sensory system agents|mesh-ancestor
102501078|NCT04162522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102501079|NCT04162522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102501080|NCT04162522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501081|NCT04162522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102501082|NCT04162522|Serotonin Agents|serotonin agents|mesh-ancestor
102501083|NCT04162522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501084|NCT04162522|Dopamine Agonists|dopamine agonists|mesh-ancestor
102501085|NCT04162522|Dopamine Agents|dopamine agents|mesh-ancestor
102501086|NCT04896658|Dexamethasone|dexamethasone|mesh-list
102501087|NCT04896658|Cyclophosphamide|cyclophosphamide|mesh-list
102501088|NCT04896658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102501089|NCT04896658|Immunologic Factors|immunologic factors|mesh-ancestor
102501090|NCT04896658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501091|NCT04896658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102501092|NCT04896658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102501093|NCT04896658|Alkylating Agents|alkylating agents|mesh-ancestor
102501094|NCT04896658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501095|NCT04896658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501096|NCT04896658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102501097|NCT04896658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102501098|NCT04896658|Antiemetics|antiemetics|mesh-ancestor
102501099|NCT04896658|Autonomic Agents|autonomic agents|mesh-ancestor
102501100|NCT04896658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102501101|NCT04896658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102501102|NCT04896658|Glucocorticoids|glucocorticoids|mesh-ancestor
102501103|NCT04896658|Hormones|hormones|mesh-ancestor
102501104|NCT04896658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102501105|NCT04896658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102501106|NCT01062269|Cholestyramine Resin|cholestyramine resin|mesh-list
102501107|NCT01062269|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102501108|NCT01062269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102501109|NCT01062269|Antimetabolites|antimetabolites|mesh-ancestor
102501110|NCT01062269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501111|NCT01062269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102501112|NCT04156828|Dexamethasone|dexamethasone|mesh-list
102501113|NCT04156828|Dexamethasone acetate|dexamethasone acetate|mesh-list
102501114|NCT04156828|Rituximab|rituximab|mesh-list
102501115|NCT04156828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102501116|NCT04156828|Carboplatin|carboplatin|mesh-list
102501117|NCT04156828|Gemcitabine|gemcitabine|mesh-list
102501118|NCT04156828|Antibodies|antibodies|mesh-list
102501119|NCT04156828|Immunoglobulins|immunoglobulins|mesh-list
102501120|NCT04156828|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102501121|NCT04156828|Lenograstim|lenograstim|mesh-list
102501122|NCT04156828|BB 1101|bb 1101|mesh-list
102501123|NCT04156828|Immunologic Factors|immunologic factors|mesh-ancestor
102501124|NCT04156828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501125|NCT04156828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501126|NCT04156828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102501127|NCT04156828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102501128|NCT04156828|Antiemetics|antiemetics|mesh-ancestor
102501129|NCT04156828|Autonomic Agents|autonomic agents|mesh-ancestor
102501130|NCT04156828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102501131|NCT04156828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102501132|NCT04156828|Glucocorticoids|glucocorticoids|mesh-ancestor
102501133|NCT04156828|Hormones|hormones|mesh-ancestor
102501134|NCT04156828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102501135|NCT04156828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102501136|NCT04156828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102501137|NCT04156828|Antimetabolites|antimetabolites|mesh-ancestor
102501138|NCT04156828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501139|NCT04156828|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102501140|NCT04156828|Protease Inhibitors|protease inhibitors|mesh-ancestor
102501141|NCT04156828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102501142|NCT01063049|Bisacodyl|bisacodyl|mesh-list
102501143|NCT01063049|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
102501144|NCT01063049|Cathartics|cathartics|mesh-ancestor
102501145|NCT01063049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102501146|NCT01063049|Laxatives|laxatives|mesh-ancestor
102501147|NCT04883242|Dexamethasone|dexamethasone|mesh-list
102501148|NCT04883242|Dexamethasone acetate|dexamethasone acetate|mesh-list
102501149|NCT04883242|Pomalidomide|pomalidomide|mesh-list
102501150|NCT04883242|Ichthammol|ichthammol|mesh-list
102501151|NCT04883242|BB 1101|bb 1101|mesh-list
102501152|NCT04883242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102501153|NCT04883242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102501154|NCT04883242|Antiemetics|antiemetics|mesh-ancestor
102501155|NCT04883242|Autonomic Agents|autonomic agents|mesh-ancestor
102501156|NCT04883242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102501157|NCT04883242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501158|NCT04883242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102501159|NCT04883242|Glucocorticoids|glucocorticoids|mesh-ancestor
102501160|NCT04883242|Hormones|hormones|mesh-ancestor
102501161|NCT04883242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102501162|NCT04883242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102501163|NCT04883242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501164|NCT04883242|Protease Inhibitors|protease inhibitors|mesh-ancestor
102501165|NCT04883242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102501166|NCT04883242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501167|NCT04883242|Immunologic Factors|immunologic factors|mesh-ancestor
102501168|NCT04883242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102501169|NCT04883242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102501170|NCT04883242|Growth Substances|growth substances|mesh-ancestor
102501171|NCT04883242|Growth Inhibitors|growth inhibitors|mesh-ancestor
102501172|NCT04883242|Dermatologic Agents|dermatologic agents|mesh-ancestor
102501173|NCT04104178|Clindamycin|clindamycin|mesh-list
102501174|NCT04104178|Clindamycin palmitate|clindamycin palmitate|mesh-list
102501175|NCT04104178|Clindamycin phosphate|clindamycin phosphate|mesh-list
102501176|NCT04104178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102501177|NCT04104178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102501178|NCT04104178|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102501179|NCT04104178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102501180|NCT04104178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501181|NCT03661138|Upadacitinib|upadacitinib|mesh-list
102501182|NCT03661138|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102501183|NCT03661138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102501184|NCT03661138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102501185|NCT03661138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501186|NCT03661138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102501187|NCT04588792|Furosemide|furosemide|mesh-list
102501188|NCT04588792|Diuretics|diuretics|mesh-ancestor
102501189|NCT04588792|Natriuretic Agents|natriuretic agents|mesh-ancestor
101977484|NCT01233583|Infliximab|infliximab|mesh-list
102501190|NCT04588792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501191|NCT04588792|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102501192|NCT04588792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102501193|NCT04588792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501194|NCT04081792|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102501195|NCT04081792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102501196|NCT04075396|Lazertinib|lazertinib|mesh-list
102501197|NCT04075396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102501198|NCT04075396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102501199|NCT04075396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501200|NCT04038970|Methotrexate|methotrexate|mesh-list
102501201|NCT04038970|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102501202|NCT04038970|Abortifacient Agents|abortifacient agents|mesh-ancestor
102501203|NCT04038970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102501204|NCT04038970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501205|NCT04038970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102501206|NCT04038970|Antimetabolites|antimetabolites|mesh-ancestor
102501207|NCT04038970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501208|NCT04038970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501209|NCT04038970|Dermatologic Agents|dermatologic agents|mesh-ancestor
102501210|NCT04038970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102501211|NCT04038970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102501212|NCT04038970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102501213|NCT04038970|Immunologic Factors|immunologic factors|mesh-ancestor
102501214|NCT04038970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102501215|NCT04038970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102501216|NCT02181738|Doxorubicin|doxorubicin|mesh-list
102501217|NCT02181738|Nivolumab|nivolumab|mesh-list
102501218|NCT02181738|Dacarbazine|dacarbazine|mesh-list
102501219|NCT02181738|Vinblastine|vinblastine|mesh-list
102501220|NCT02181738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102501221|NCT02181738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501222|NCT02181738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102501223|NCT02181738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102501224|NCT02181738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102501225|NCT02181738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501226|NCT02181738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102501227|NCT02181738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102312755|NCT02169271|Antipyretics|antipyretics|mesh-ancestor
102501228|NCT02181738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102501229|NCT02181738|Alkylating Agents|alkylating agents|mesh-ancestor
102501230|NCT02181738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102501231|NCT02181738|Tubulin Modulators|tubulin modulators|mesh-ancestor
102501232|NCT02181738|Antimitotic Agents|antimitotic agents|mesh-ancestor
102501233|NCT02181738|Mitosis Modulators|mitosis modulators|mesh-ancestor
102501234|NCT05426304|Agomelatine|agomelatine|mesh-list
102501235|NCT05426304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102501236|NCT05426304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102501237|NCT05426304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501238|NCT03955198|Durvalumab|durvalumab|mesh-list
102501239|NCT03955198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102501240|NCT03955198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501241|NCT04494958|Palbociclib|palbociclib|mesh-list
102501242|NCT04494958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501243|NCT04494958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102501244|NCT04494958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102501245|NCT04494958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501246|NCT00382954|Bortezomib|bortezomib|mesh-list
102501247|NCT00382954|Idarubicin|idarubicin|mesh-list
102501248|NCT00382954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501249|NCT00382954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102501250|NCT00382954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102501251|NCT00382954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102501252|NCT00382954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102501253|NCT00382954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501254|NCT01246063|Dexamethasone|dexamethasone|mesh-list
102501255|NCT01246063|Doxorubicin|doxorubicin|mesh-list
102501256|NCT01246063|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102501257|NCT01246063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102501258|NCT01246063|Antiemetics|antiemetics|mesh-ancestor
102501259|NCT01246063|Autonomic Agents|autonomic agents|mesh-ancestor
102501260|NCT01246063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102501261|NCT01246063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501262|NCT01246063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102501263|NCT01246063|Glucocorticoids|glucocorticoids|mesh-ancestor
102501264|NCT01246063|Hormones|hormones|mesh-ancestor
102501265|NCT01246063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102501266|NCT01246063|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102501267|NCT01246063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501268|NCT01246063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102501269|NCT01246063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102501270|NCT01246063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102501271|NCT01246063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102501272|NCT01246063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501273|NCT03836014|Dexamethasone|dexamethasone|mesh-list
102501274|NCT03836014|Dexamethasone acetate|dexamethasone acetate|mesh-list
102501275|NCT03836014|Lenalidomide|lenalidomide|mesh-list
102501276|NCT03836014|Daratumumab|daratumumab|mesh-list
102501277|NCT03836014|BB 1101|bb 1101|mesh-list
102501278|NCT03836014|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102501279|NCT03836014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102501280|NCT03836014|Antiemetics|antiemetics|mesh-ancestor
102501281|NCT03836014|Autonomic Agents|autonomic agents|mesh-ancestor
102501282|NCT03836014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102501283|NCT03836014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501284|NCT03836014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102501285|NCT03836014|Glucocorticoids|glucocorticoids|mesh-ancestor
102501286|NCT03836014|Hormones|hormones|mesh-ancestor
102501287|NCT03836014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102501288|NCT03836014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102501289|NCT03836014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501290|NCT03836014|Protease Inhibitors|protease inhibitors|mesh-ancestor
102501291|NCT03836014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102501292|NCT03836014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501293|NCT03836014|Immunologic Factors|immunologic factors|mesh-ancestor
102501294|NCT03836014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102501295|NCT03836014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102501296|NCT03836014|Growth Substances|growth substances|mesh-ancestor
102501297|NCT03836014|Growth Inhibitors|growth inhibitors|mesh-ancestor
102501298|NCT01205503|Cyclophosphamide|cyclophosphamide|mesh-list
102501299|NCT01205503|Doxorubicin|doxorubicin|mesh-list
102501300|NCT01205503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102501301|NCT01205503|Immunologic Factors|immunologic factors|mesh-ancestor
102501302|NCT01205503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501303|NCT01205503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102501304|NCT01205503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102501305|NCT01205503|Alkylating Agents|alkylating agents|mesh-ancestor
102501306|NCT01205503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501307|NCT01205503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501308|NCT01205503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102501309|NCT01205503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102501310|NCT01205503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102501311|NCT01205503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102501312|NCT01205503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102501313|NCT03187834|Amoxicillin|amoxicillin|mesh-list
102501314|NCT03187834|Azithromycin|azithromycin|mesh-list
102501315|NCT03187834|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102501316|NCT03187834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102501317|NCT03187834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102501318|NCT03187834|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102501319|NCT03187834|Antimalarials|antimalarials|mesh-ancestor
102501320|NCT03187834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102501321|NCT03187834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102501322|NCT01206595|Bupivacaine|bupivacaine|mesh-list
102501323|NCT01206595|Anesthetics, Local|anesthetics, local|mesh-ancestor
102501324|NCT01206595|Anesthetics|anesthetics|mesh-ancestor
102501325|NCT01206595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102501326|NCT01206595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501327|NCT01206595|Sensory System Agents|sensory system agents|mesh-ancestor
102501328|NCT01206595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102501329|NCT04385992|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102501330|NCT04385992|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102501331|NCT04385992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501332|NCT01158703|Aspirin|aspirin|mesh-list
102501333|NCT01158703|Clopidogrel|clopidogrel|mesh-list
102501334|NCT01158703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102501335|NCT01158703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102501336|NCT01158703|Analgesics|analgesics|mesh-ancestor
102501337|NCT01158703|Sensory System Agents|sensory system agents|mesh-ancestor
102501338|NCT01158703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102501339|NCT01158703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501340|NCT01158703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102501341|NCT01158703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102501342|NCT01158703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102501343|NCT01158703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102501344|NCT01158703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501345|NCT01158703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102501346|NCT01158703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102501347|NCT01158703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102501348|NCT01158703|Antipyretics|antipyretics|mesh-ancestor
102501349|NCT01158703|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102501350|NCT01158703|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102501351|NCT01158703|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102501352|NCT01158703|Purinergic Agents|purinergic agents|mesh-ancestor
102501353|NCT01158703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102501354|NCT03009643|Nitric Oxide|nitric oxide|mesh-list
102501355|NCT03009643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102501356|NCT03009643|Autonomic Agents|autonomic agents|mesh-ancestor
102501357|NCT03009643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102501358|NCT03009643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501359|NCT03009643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102501360|NCT03009643|Respiratory System Agents|respiratory system agents|mesh-ancestor
102501361|NCT03009643|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102501362|NCT03009643|Antioxidants|antioxidants|mesh-ancestor
102501363|NCT03009643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501364|NCT03009643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102501365|NCT03009643|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102501366|NCT03009643|Vasodilator Agents|vasodilator agents|mesh-ancestor
102501367|NCT03009643|Gasotransmitters|gasotransmitters|mesh-ancestor
102501368|NCT03009643|Protective Agents|protective agents|mesh-ancestor
102501369|NCT04275232|Plasminogen|plasminogen|mesh-list
102501370|NCT04275232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102501371|NCT04275232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102501372|NCT04275232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501373|NCT01207765|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102501374|NCT01207765|Immunologic Factors|immunologic factors|mesh-ancestor
102501375|NCT01207765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501376|NCT03786796|Olaparib|olaparib|mesh-list
102612353|NCT00002423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102501377|NCT03786796|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102501378|NCT03786796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102501379|NCT03786796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977623|NCT01136941|Zileuton|zileuton|mesh-list
102501380|NCT03786796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501381|NCT03779854|Vidarabine|vidarabine|mesh-list
102501382|NCT03779854|Cyclophosphamide|cyclophosphamide|mesh-list
102501383|NCT03779854|Busulfan|busulfan|mesh-list
102501384|NCT03779854|Thiotepa|thiotepa|mesh-list
102501385|NCT03779854|Methotrexate|methotrexate|mesh-list
102501386|NCT03779854|Fludarabine|fludarabine|mesh-list
102501387|NCT03779854|Fludarabine phosphate|fludarabine phosphate|mesh-list
102501388|NCT03779854|Tacrolimus|tacrolimus|mesh-list
102501389|NCT03779854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102501390|NCT03779854|Immunologic Factors|immunologic factors|mesh-ancestor
102501391|NCT03779854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501392|NCT03779854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102501393|NCT03779854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102501394|NCT03779854|Alkylating Agents|alkylating agents|mesh-ancestor
102501395|NCT03779854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501396|NCT03779854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501397|NCT03779854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102501398|NCT03779854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102501399|NCT03779854|Abortifacient Agents|abortifacient agents|mesh-ancestor
102501400|NCT03779854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102501401|NCT03779854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102501402|NCT03779854|Antimetabolites|antimetabolites|mesh-ancestor
102501403|NCT03779854|Dermatologic Agents|dermatologic agents|mesh-ancestor
102501404|NCT03779854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102501405|NCT03779854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102501406|NCT03779854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102501407|NCT03779854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102501408|NCT03779854|Antiviral Agents|antiviral agents|mesh-ancestor
102501409|NCT03779854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102501410|NCT03089866|Midazolam|midazolam|mesh-list
102501411|NCT03089866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102501412|NCT03089866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102501413|NCT03089866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102501414|NCT03089866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501415|NCT03089866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102501416|NCT03089866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102501417|NCT03089866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102501418|NCT03089866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102501419|NCT03089866|Anesthetics, General|anesthetics, general|mesh-ancestor
102501420|NCT03089866|Anesthetics|anesthetics|mesh-ancestor
102501421|NCT03089866|GABA Modulators|gaba modulators|mesh-ancestor
102501422|NCT03089866|GABA Agents|gaba agents|mesh-ancestor
102501423|NCT03089866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102501424|NCT03089866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501425|NCT00002890|Lintuzumab|lintuzumab|mesh-list
102501426|NCT00002890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102501427|NCT00002890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501428|NCT00002896|Leucovorin|leucovorin|mesh-list
102501429|NCT00002896|Cobalt|cobalt|mesh-list
102501430|NCT00002896|Fluorouracil|fluorouracil|mesh-list
102501431|NCT00002896|Calcium|calcium|mesh-list
102501432|NCT00002896|Levoleucovorin|levoleucovorin|mesh-list
102501433|NCT00002896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102501434|NCT00002896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501435|NCT00002896|Antimetabolites|antimetabolites|mesh-ancestor
102501436|NCT00002896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501437|NCT00002896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102501438|NCT00002896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501439|NCT00002896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102501440|NCT00002896|Immunologic Factors|immunologic factors|mesh-ancestor
102501441|NCT00002896|Antidotes|antidotes|mesh-ancestor
102501442|NCT00002896|Protective Agents|protective agents|mesh-ancestor
102501443|NCT00002896|Vitamin B Complex|vitamin b complex|mesh-ancestor
102501444|NCT00002896|Vitamins|vitamins|mesh-ancestor
102501445|NCT00002896|Micronutrients|micronutrients|mesh-ancestor
102501446|NCT00002896|Trace Elements|trace elements|mesh-ancestor
102501447|NCT01249027|Everolimus|everolimus|mesh-list
102501448|NCT01249027|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102501449|NCT01249027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102501450|NCT01249027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102501451|NCT01249027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501452|NCT01249027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102501453|NCT01249027|Immunologic Factors|immunologic factors|mesh-ancestor
102501454|NCT01249027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501455|NCT01249027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501457|NCT00002902|Raltitrexed|raltitrexed|mesh-list
102501458|NCT00002902|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102501459|NCT00002902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102501460|NCT00002902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102501461|NCT00002902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501462|NCT00002902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501463|NCT00002902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102501464|NCT00002902|Antimetabolites|antimetabolites|mesh-ancestor
102501465|NCT00002902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102501466|NCT02992756|Mitogens|mitogens|mesh-list
102501467|NCT02992756|Mitosis Modulators|mitosis modulators|mesh-ancestor
102501468|NCT02992756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501469|NCT01250899|Vitamin D|vitamin d|mesh-list
102501470|NCT01250899|Vitamins|vitamins|mesh-ancestor
102501471|NCT01250899|Micronutrients|micronutrients|mesh-ancestor
102501472|NCT01250899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501473|NCT01250899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102501474|NCT01212445|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
102501475|NCT01212445|Laxatives|laxatives|mesh-list
102501476|NCT01212445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102501477|NCT00002908|Vincristine|vincristine|mesh-list
102501478|NCT00002908|Bryostatin 1|bryostatin 1|mesh-list
102501479|NCT00002908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102501480|NCT00002908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501481|NCT00002908|Tubulin Modulators|tubulin modulators|mesh-ancestor
102501482|NCT00002908|Antimitotic Agents|antimitotic agents|mesh-ancestor
102501483|NCT00002908|Mitosis Modulators|mitosis modulators|mesh-ancestor
102501484|NCT00002908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501485|NCT00002908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102501486|NCT00002908|Immunologic Factors|immunologic factors|mesh-ancestor
102501487|NCT00002908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501488|NCT00002920|Tamoxifen|tamoxifen|mesh-list
102501489|NCT00002920|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102501490|NCT00002920|Medroxyprogesterone|medroxyprogesterone|mesh-list
102501491|NCT00002920|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102501492|NCT00002920|Hormone Antagonists|hormone antagonists|mesh-ancestor
102501493|NCT00002920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102501494|NCT00002920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501495|NCT00002920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102501496|NCT00002920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501497|NCT00002920|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102501498|NCT00002920|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102501499|NCT00002920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102501500|NCT00002920|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102501501|NCT00002920|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102501502|NCT00002920|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102501503|NCT00002920|Contraceptive Agents|contraceptive agents|mesh-ancestor
102501504|NCT00002920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102501505|NCT00002920|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102501506|NCT00002920|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102501507|NCT00002920|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102501508|NCT01250977|Donepezil|donepezil|mesh-list
102501509|NCT01250977|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102501510|NCT01250977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102501511|NCT01250977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501512|NCT01250977|Cholinergic Agents|cholinergic agents|mesh-ancestor
102501513|NCT01250977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102501514|NCT01250977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501515|NCT01250977|Nootropic Agents|nootropic agents|mesh-ancestor
102501516|NCT01161121|Adenosine|adenosine|mesh-list
102501517|NCT01161121|Regadenoson|regadenoson|mesh-list
102501518|NCT01161121|Analgesics|analgesics|mesh-ancestor
102501519|NCT01161121|Sensory System Agents|sensory system agents|mesh-ancestor
102501520|NCT01161121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102501521|NCT01161121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501522|NCT01161121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102501523|NCT01161121|Vasodilator Agents|vasodilator agents|mesh-ancestor
102501524|NCT01161121|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102501525|NCT01161121|Purinergic Agonists|purinergic agonists|mesh-ancestor
102501526|NCT01161121|Purinergic Agents|purinergic agents|mesh-ancestor
102501527|NCT01161121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102501528|NCT01161121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501529|NCT01161121|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
102501530|NCT03010579|Epoetin Alfa|epoetin alfa|mesh-list
102501531|NCT03010579|Ferrous succinate|ferrous succinate|mesh-list
102501532|NCT03010579|Hematinics|hematinics|mesh-list
102501533|NCT01214083|Acetylcysteine|acetylcysteine|mesh-list
102501534|NCT01214083|Naltrexone|naltrexone|mesh-list
102501535|NCT01214083|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102501536|NCT01214083|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102501537|NCT01214083|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102501538|NCT01214083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501539|NCT01214083|Sensory System Agents|sensory system agents|mesh-ancestor
102501540|NCT01214083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102501541|NCT01214083|Antiviral Agents|antiviral agents|mesh-ancestor
102501542|NCT01214083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102501543|NCT01214083|Expectorants|expectorants|mesh-ancestor
102501544|NCT01214083|Respiratory System Agents|respiratory system agents|mesh-ancestor
102501545|NCT01214083|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102501546|NCT01214083|Antioxidants|antioxidants|mesh-ancestor
102501547|NCT01214083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501548|NCT01214083|Protective Agents|protective agents|mesh-ancestor
102501549|NCT01214083|Antidotes|antidotes|mesh-ancestor
102501550|NCT01254877|Ondansetron|ondansetron|mesh-list
102501551|NCT01254877|Antiemetics|antiemetics|mesh-ancestor
102501552|NCT01254877|Autonomic Agents|autonomic agents|mesh-ancestor
102501553|NCT01254877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102501554|NCT01254877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501555|NCT01254877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102501556|NCT01254877|Antipruritics|antipruritics|mesh-ancestor
102501557|NCT01254877|Dermatologic Agents|dermatologic agents|mesh-ancestor
102501558|NCT01254877|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102501559|NCT01254877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102501560|NCT01254877|Serotonin Agents|serotonin agents|mesh-ancestor
102501561|NCT01254877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102501562|NCT01254877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501563|NCT02189317|Bupivacaine|bupivacaine|mesh-list
102501564|NCT02189317|Anesthetics, Local|anesthetics, local|mesh-ancestor
102501565|NCT02189317|Anesthetics|anesthetics|mesh-ancestor
102501566|NCT02189317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102501567|NCT02189317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501568|NCT02189317|Sensory System Agents|sensory system agents|mesh-ancestor
102501569|NCT02189317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102501570|NCT03713944|Bevacizumab|bevacizumab|mesh-list
102501571|NCT03713944|Atezolizumab|atezolizumab|mesh-list
102501572|NCT03713944|Carboplatin|carboplatin|mesh-list
102501573|NCT03713944|Pemetrexed|pemetrexed|mesh-list
102501574|NCT03713944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102501575|NCT03713944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501576|NCT03713944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102501577|NCT03713944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102501578|NCT03713944|Growth Substances|growth substances|mesh-ancestor
102501579|NCT03713944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501580|NCT03713944|Growth Inhibitors|growth inhibitors|mesh-ancestor
102501581|NCT03713944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102501582|NCT03713944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501583|NCT03713944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102501584|NCT03713944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102501585|NCT03713944|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102501586|NCT01214161|Lidocaine|lidocaine|mesh-list
102501587|NCT01214161|Anesthetics, Local|anesthetics, local|mesh-ancestor
102501588|NCT01214161|Anesthetics|anesthetics|mesh-ancestor
102501589|NCT01214161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102501590|NCT01214161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501591|NCT01214161|Sensory System Agents|sensory system agents|mesh-ancestor
102501592|NCT01214161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102501593|NCT01214161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102501594|NCT01214161|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102501595|NCT01214161|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102501596|NCT01214161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102501597|NCT01214161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501598|NCT02945800|Paclitaxel|paclitaxel|mesh-list
102501599|NCT02945800|Gemcitabine|gemcitabine|mesh-list
102501600|NCT02945800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102501601|NCT02945800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501602|NCT02945800|Tubulin Modulators|tubulin modulators|mesh-ancestor
102313126|NCT01629667|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102501603|NCT02945800|Antimitotic Agents|antimitotic agents|mesh-ancestor
102501604|NCT02945800|Mitosis Modulators|mitosis modulators|mesh-ancestor
102501605|NCT02945800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501606|NCT02945800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102501607|NCT02945800|Antimetabolites|antimetabolites|mesh-ancestor
102501608|NCT02981329|Metformin|metformin|mesh-list
102501609|NCT02981329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102501610|NCT02981329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501611|NCT00383656|Hormones|hormones|mesh-list
102501612|NCT00383656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102501613|NCT00383656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501614|NCT01214317|Mitoxantrone|mitoxantrone|mesh-list
102501615|NCT01214317|Analgesics|analgesics|mesh-ancestor
102501616|NCT01214317|Sensory System Agents|sensory system agents|mesh-ancestor
102501617|NCT01214317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102501618|NCT01214317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501619|NCT01214317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501620|NCT01214317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102501621|NCT01214317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102501622|NCT01214317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102501623|NCT01214317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501624|NCT00383812|Bevacizumab|bevacizumab|mesh-list
102501625|NCT00383812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102501626|NCT00383812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501627|NCT00383812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102501628|NCT00383812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102501629|NCT00383812|Growth Substances|growth substances|mesh-ancestor
102501630|NCT00383812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501631|NCT00383812|Growth Inhibitors|growth inhibitors|mesh-ancestor
102501632|NCT02189629|Trifarotene|trifarotene|mesh-list
102501633|NCT02189629|Dermatologic Agents|dermatologic agents|mesh-ancestor
102501634|NCT00002926|Cytarabine|cytarabine|mesh-list
102501635|NCT00002926|Etoposide|etoposide|mesh-list
102501636|NCT00002926|Idarubicin|idarubicin|mesh-list
102501637|NCT00002926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102501638|NCT00002926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501639|NCT00002926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102501640|NCT00002926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102501641|NCT00002926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102501642|NCT00002926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501643|NCT00002926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102501644|NCT00002926|Antimetabolites|antimetabolites|mesh-ancestor
102501645|NCT00002926|Antiviral Agents|antiviral agents|mesh-ancestor
102501646|NCT00002926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102501647|NCT00002926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102501648|NCT00002926|Immunologic Factors|immunologic factors|mesh-ancestor
102501649|NCT00002926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501650|NCT00002926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102501651|NCT01281007|Acyclovir|acyclovir|mesh-list
102501652|NCT01281007|Famciclovir|famciclovir|mesh-list
102501653|NCT01281007|Antiviral Agents|antiviral agents|mesh-ancestor
102501654|NCT01281007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102501655|NCT01281007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102501656|NCT01281007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102501657|NCT01281007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501658|NCT02898610|Colchicine|colchicine|mesh-list
102501659|NCT02898610|Gout Suppressants|gout suppressants|mesh-ancestor
102501660|NCT02898610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102501661|NCT02898610|Tubulin Modulators|tubulin modulators|mesh-ancestor
102501662|NCT02898610|Antimitotic Agents|antimitotic agents|mesh-ancestor
102501663|NCT02898610|Mitosis Modulators|mitosis modulators|mesh-ancestor
102501664|NCT02898610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501665|NCT02898610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501666|NCT01281475|Levodopa|levodopa|mesh-list
102501667|NCT01281475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102501668|NCT01281475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102501669|NCT01281475|Dopamine Agents|dopamine agents|mesh-ancestor
102501670|NCT01281475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102501671|NCT01281475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501672|NCT01281475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501673|NCT00002932|Cisplatin|cisplatin|mesh-list
102501674|NCT00002932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501675|NCT01572662|Methotrexate|methotrexate|mesh-list
102501676|NCT01572662|Fludarabine phosphate|fludarabine phosphate|mesh-list
102501677|NCT01572662|Fludarabine|fludarabine|mesh-list
102501678|NCT01572662|Busulfan|busulfan|mesh-list
102313209|NCT02255279|Vaccines|vaccines|mesh-list
102501680|NCT01572662|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102501681|NCT01572662|Abortifacient Agents|abortifacient agents|mesh-ancestor
102501682|NCT01572662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102501683|NCT01572662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501684|NCT01572662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102501685|NCT01572662|Antimetabolites|antimetabolites|mesh-ancestor
102501686|NCT01572662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501687|NCT01572662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501688|NCT01572662|Dermatologic Agents|dermatologic agents|mesh-ancestor
102501689|NCT01572662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102501690|NCT01572662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102501691|NCT01572662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102501692|NCT01572662|Immunologic Factors|immunologic factors|mesh-ancestor
102501693|NCT01572662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102501694|NCT01572662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102501695|NCT01572662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102501696|NCT01572662|Alkylating Agents|alkylating agents|mesh-ancestor
102501697|NCT01572662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102501698|NCT01572662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102501699|NCT02822092|Risperidone|risperidone|mesh-list
102501700|NCT02822092|Aripiprazole|aripiprazole|mesh-list
102501701|NCT02822092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102501702|NCT02822092|Serotonin Agents|serotonin agents|mesh-ancestor
102501703|NCT02822092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102501704|NCT02822092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501705|NCT02822092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501706|NCT02822092|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102501707|NCT02822092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102501708|NCT02822092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102501709|NCT02822092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102501710|NCT02822092|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102501711|NCT02822092|Dopamine Agents|dopamine agents|mesh-ancestor
102501712|NCT02822092|Antidepressive Agents|antidepressive agents|mesh-ancestor
102501713|NCT02822092|Dopamine Agonists|dopamine agonists|mesh-ancestor
102501714|NCT02822092|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102501715|NCT02822092|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102501716|NCT02822092|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102501717|NCT02822092|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102501718|NCT01258153|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102501719|NCT01258153|MEN 11420|men 11420|mesh-list
102501720|NCT01258153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102501721|NCT01258153|Autonomic Agents|autonomic agents|mesh-ancestor
102501722|NCT01258153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102501723|NCT01258153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501724|NCT01258153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102501725|NCT01258153|Respiratory System Agents|respiratory system agents|mesh-ancestor
102501726|NCT01555268|Cytarabine|cytarabine|mesh-list
102501727|NCT01555268|Trebananib|trebananib|mesh-list
102501728|NCT01555268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102501729|NCT01555268|Antimetabolites|antimetabolites|mesh-ancestor
102501730|NCT01555268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501731|NCT01555268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501732|NCT01555268|Antiviral Agents|antiviral agents|mesh-ancestor
102501733|NCT01555268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102501734|NCT01555268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102501735|NCT01555268|Immunologic Factors|immunologic factors|mesh-ancestor
102501736|NCT01555268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501737|NCT01555268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102501738|NCT01555268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102501739|NCT01555268|Growth Substances|growth substances|mesh-ancestor
102501740|NCT01555268|Growth Inhibitors|growth inhibitors|mesh-ancestor
102501741|NCT04781270|Bevacizumab|bevacizumab|mesh-list
102501742|NCT04781270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102501743|NCT04781270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501744|NCT04781270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102501745|NCT04781270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102501746|NCT04781270|Growth Substances|growth substances|mesh-ancestor
102501747|NCT04781270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501748|NCT04781270|Growth Inhibitors|growth inhibitors|mesh-ancestor
102501749|NCT00003394|Paclitaxel|paclitaxel|mesh-list
102501750|NCT00003394|Carboplatin|carboplatin|mesh-list
102501751|NCT00003394|Leuprolide|leuprolide|mesh-list
102501752|NCT00003394|Goserelin|goserelin|mesh-list
102501753|NCT00003394|Estramustine|estramustine|mesh-list
102501754|NCT00003394|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102501755|NCT00003394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501756|NCT00003394|Tubulin Modulators|tubulin modulators|mesh-ancestor
102501757|NCT00003394|Antimitotic Agents|antimitotic agents|mesh-ancestor
102501758|NCT00003394|Mitosis Modulators|mitosis modulators|mesh-ancestor
102501759|NCT00003394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501760|NCT00003394|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102501761|NCT00003394|Fertility Agents|fertility agents|mesh-ancestor
102501762|NCT00003394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102501763|NCT00003394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501764|NCT00003394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102501765|NCT00003394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102501766|NCT00003394|Alkylating Agents|alkylating agents|mesh-ancestor
102501767|NCT00003400|Melphalan|melphalan|mesh-list
102501768|NCT00003400|Vinorelbine|vinorelbine|mesh-list
102501769|NCT00003400|Carmustine|carmustine|mesh-list
102501770|NCT00003400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501771|NCT00003400|Immunologic Factors|immunologic factors|mesh-ancestor
102501772|NCT00003400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501773|NCT00003400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102501774|NCT00003400|Alkylating Agents|alkylating agents|mesh-ancestor
102501775|NCT00003400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501776|NCT00003400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102501777|NCT00003400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102501778|NCT00003400|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102501779|NCT00003400|Tubulin Modulators|tubulin modulators|mesh-ancestor
102501780|NCT00003400|Antimitotic Agents|antimitotic agents|mesh-ancestor
102501781|NCT00003400|Mitosis Modulators|mitosis modulators|mesh-ancestor
102501782|NCT04348370|Vaccines|vaccines|mesh-list
102501783|NCT04348370|BCG Vaccine|bcg vaccine|mesh-list
102501784|NCT04348370|Immunologic Factors|immunologic factors|mesh-ancestor
102501785|NCT04348370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501786|NCT04348370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102501787|NCT00002944|Carboplatin|carboplatin|mesh-list
102501788|NCT00002944|Vincristine|vincristine|mesh-list
102501789|NCT00002944|Thioguanine|thioguanine|mesh-list
102501790|NCT00002944|Lomustine|lomustine|mesh-list
102501791|NCT00002944|Procarbazine|procarbazine|mesh-list
102501792|NCT00002944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501793|NCT00002944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102501794|NCT00002944|Tubulin Modulators|tubulin modulators|mesh-ancestor
102501795|NCT00002944|Antimitotic Agents|antimitotic agents|mesh-ancestor
102501796|NCT00002944|Mitosis Modulators|mitosis modulators|mesh-ancestor
102501797|NCT00002944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501798|NCT00002944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102501799|NCT00002944|Antimetabolites|antimetabolites|mesh-ancestor
102501800|NCT00002944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102501801|NCT00002944|Alkylating Agents|alkylating agents|mesh-ancestor
102501802|NCT04778072|Iron|iron|mesh-list
102501803|NCT04778072|Trace Elements|trace elements|mesh-ancestor
102501804|NCT04778072|Micronutrients|micronutrients|mesh-ancestor
102501805|NCT04778072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501806|NCT00002950|Topotecan|topotecan|mesh-list
102501807|NCT00002950|Sargramostim|sargramostim|mesh-list
102501808|NCT00002950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102501809|NCT00002950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102501810|NCT00002950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102501811|NCT00002950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501812|NCT00002950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501813|NCT00002950|Immunologic Factors|immunologic factors|mesh-ancestor
102501814|NCT00002950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501815|NCT00777140|Deferoxamine|deferoxamine|mesh-list
102501816|NCT00777140|Siderophores|siderophores|mesh-ancestor
102501817|NCT00777140|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102501818|NCT00777140|Chelating Agents|chelating agents|mesh-ancestor
102501819|NCT00777140|Sequestering Agents|sequestering agents|mesh-ancestor
102501820|NCT00777140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501821|NCT00003406|Carboplatin|carboplatin|mesh-list
102501822|NCT00003406|Docetaxel|docetaxel|mesh-list
102501823|NCT00003406|Ifosfamide|ifosfamide|mesh-list
102501824|NCT00003406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501825|NCT00003406|Tubulin Modulators|tubulin modulators|mesh-ancestor
102501826|NCT00003406|Antimitotic Agents|antimitotic agents|mesh-ancestor
102501827|NCT00003406|Mitosis Modulators|mitosis modulators|mesh-ancestor
102501828|NCT00003406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501829|NCT00003406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102501830|NCT00003406|Alkylating Agents|alkylating agents|mesh-ancestor
102501832|NCT00003412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102501833|NCT00003412|Immunologic Factors|immunologic factors|mesh-ancestor
102501834|NCT00003412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501835|NCT00003412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102501836|NCT00003412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102501837|NCT00003412|Growth Substances|growth substances|mesh-ancestor
102501838|NCT00003412|Growth Inhibitors|growth inhibitors|mesh-ancestor
102501839|NCT00003412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501840|NCT04780958|Vitamin A|vitamin a|mesh-list
102501841|NCT04780958|Vitamins|vitamins|mesh-ancestor
102501842|NCT04780958|Micronutrients|micronutrients|mesh-ancestor
102501843|NCT04780958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501844|NCT00002968|Edrecolomab|edrecolomab|mesh-list
102501845|NCT00002968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102501846|NCT00002968|Immunologic Factors|immunologic factors|mesh-ancestor
102501847|NCT00002968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501848|NCT04780412|Alprostadil|alprostadil|mesh-list
102501849|NCT04780412|Misoprostol|misoprostol|mesh-list
102501850|NCT04780412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102501851|NCT04780412|Abortifacient Agents|abortifacient agents|mesh-ancestor
102501852|NCT04780412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102501853|NCT04780412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501854|NCT04780412|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102501855|NCT04780412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102501856|NCT04780412|Oxytocics|oxytocics|mesh-ancestor
102501857|NCT04780412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102501858|NCT04780412|Vasodilator Agents|vasodilator agents|mesh-ancestor
102501859|NCT04780412|Urological Agents|urological agents|mesh-ancestor
102501860|NCT00002974|Carboplatin|carboplatin|mesh-list
102501861|NCT00002974|Etoposide|etoposide|mesh-list
102501862|NCT00002974|Ifosfamide|ifosfamide|mesh-list
102501863|NCT00002974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501864|NCT00002974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102501865|NCT00002974|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102501866|NCT00002974|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102501867|NCT00002974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102501868|NCT00002974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501869|NCT00002974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102501870|NCT00002974|Alkylating Agents|alkylating agents|mesh-ancestor
102501871|NCT00754364|Carboplatin|carboplatin|mesh-list
102501872|NCT00754364|Gemcitabine|gemcitabine|mesh-list
102501873|NCT00754364|Pemetrexed|pemetrexed|mesh-list
102501874|NCT00754364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501875|NCT00754364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102501876|NCT00754364|Antimetabolites|antimetabolites|mesh-ancestor
102501877|NCT00754364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501878|NCT00754364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102501879|NCT00754364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102501880|NCT00754364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102501881|NCT02612896|Praziquantel|praziquantel|mesh-list
102501882|NCT02612896|Anthelmintics|anthelmintics|mesh-ancestor
102501883|NCT02612896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102501884|NCT02612896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102501885|NCT00002980|Decitabine|decitabine|mesh-list
102501886|NCT00002980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102501887|NCT00002980|Antimetabolites|antimetabolites|mesh-ancestor
102501888|NCT00002980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501889|NCT00002980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501890|NCT00002980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102501891|NCT00002986|Topotecan|topotecan|mesh-list
102501892|NCT00002986|Carmustine|carmustine|mesh-list
102501893|NCT00002986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102501894|NCT00002986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102501895|NCT00002986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102501896|NCT00002986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501897|NCT00002986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501898|NCT00002986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102501899|NCT00002986|Alkylating Agents|alkylating agents|mesh-ancestor
102501900|NCT00003418|Tamoxifen|tamoxifen|mesh-list
102501901|NCT00003418|Exemestane|exemestane|mesh-list
102501902|NCT00003418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501903|NCT00003418|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102501904|NCT00003418|Hormone Antagonists|hormone antagonists|mesh-ancestor
102501905|NCT00003418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102501906|NCT00003418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501907|NCT00003418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102501908|NCT00003418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501909|NCT00003418|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102501910|NCT00003418|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102501911|NCT00003418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102501912|NCT00003418|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102501913|NCT00003418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102501914|NCT00003418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102501915|NCT04777838|Amitriptyline|amitriptyline|mesh-list
102501916|NCT04777838|Citalopram|citalopram|mesh-list
102501917|NCT04777838|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102501918|NCT04777838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102501919|NCT04777838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102501920|NCT04777838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501921|NCT04777838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102501922|NCT04777838|Serotonin Agents|serotonin agents|mesh-ancestor
102501923|NCT04777838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501924|NCT04777838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102501925|NCT04777838|Antidepressive Agents|antidepressive agents|mesh-ancestor
102501926|NCT04777838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102501927|NCT04777838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102501928|NCT04777838|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102501929|NCT04777838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102501930|NCT04777838|Analgesics|analgesics|mesh-ancestor
102501931|NCT04777838|Sensory System Agents|sensory system agents|mesh-ancestor
102501932|NCT04777838|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102501933|NCT04777838|Adrenergic Agents|adrenergic agents|mesh-ancestor
102501934|NCT00003424|Tamoxifen|tamoxifen|mesh-list
102501935|NCT00003424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102501936|NCT00003424|Hormone Antagonists|hormone antagonists|mesh-ancestor
102501937|NCT00003424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102501938|NCT00003424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501939|NCT00003424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102501940|NCT00003424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501941|NCT00003424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102501942|NCT00003424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102501943|NCT00003424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102501944|NCT00002998|Gemcitabine|gemcitabine|mesh-list
102501945|NCT00002998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501946|NCT00002998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102501947|NCT00002998|Antimetabolites|antimetabolites|mesh-ancestor
102501948|NCT00002998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501949|NCT00003004|Paclitaxel|paclitaxel|mesh-list
102501950|NCT00003004|Alvocidib|alvocidib|mesh-list
102501951|NCT00003004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102501952|NCT00003004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501953|NCT00003004|Tubulin Modulators|tubulin modulators|mesh-ancestor
102501954|NCT00003004|Antimitotic Agents|antimitotic agents|mesh-ancestor
102501955|NCT00003004|Mitosis Modulators|mitosis modulators|mesh-ancestor
102501956|NCT00003004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501957|NCT00003004|Growth Inhibitors|growth inhibitors|mesh-ancestor
102501958|NCT00003004|Growth Substances|growth substances|mesh-ancestor
102501959|NCT00003004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501960|NCT00003004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102501961|NCT00003004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102501962|NCT04776512|Bupivacaine|bupivacaine|mesh-list
102501963|NCT04776512|Anesthetics, Local|anesthetics, local|mesh-ancestor
102501964|NCT04776512|Anesthetics|anesthetics|mesh-ancestor
102501965|NCT04776512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102501966|NCT04776512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501967|NCT04776512|Sensory System Agents|sensory system agents|mesh-ancestor
102501968|NCT04776512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102501969|NCT04776590|Tislelizumab|tislelizumab|mesh-list
102501970|NCT04776590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102501971|NCT04776590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501972|NCT00003436|Cytarabine|cytarabine|mesh-list
102501973|NCT00003436|Hydrocortisone|hydrocortisone|mesh-list
102501974|NCT00003436|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102501975|NCT00003436|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102501976|NCT00003436|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102501977|NCT00003436|Methotrexate|methotrexate|mesh-list
102501978|NCT00003436|Etoposide|etoposide|mesh-list
102501979|NCT00003436|Daunorubicin|daunorubicin|mesh-list
102313510|NCT02260154|Mebeverine|mebeverine|mesh-list
102501980|NCT00003436|Asparaginase|asparaginase|mesh-list
102501981|NCT00003436|Mitoxantrone|mitoxantrone|mesh-list
102501982|NCT00003436|Amsacrine|amsacrine|mesh-list
102501983|NCT00003436|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102501984|NCT00003436|Abortifacient Agents|abortifacient agents|mesh-ancestor
102501985|NCT00003436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102501986|NCT00003436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102501987|NCT00003436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102501988|NCT00003436|Antimetabolites|antimetabolites|mesh-ancestor
102501989|NCT00003436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102501990|NCT00003436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102501991|NCT00003436|Dermatologic Agents|dermatologic agents|mesh-ancestor
102501992|NCT00003436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102501993|NCT00003436|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102501994|NCT00003436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102501995|NCT00003436|Immunologic Factors|immunologic factors|mesh-ancestor
102501996|NCT00003436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102501997|NCT00003436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102501998|NCT00003436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102501999|NCT00003436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102502000|NCT00003436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102502001|NCT00003436|Antiviral Agents|antiviral agents|mesh-ancestor
102502002|NCT00003436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102502003|NCT00003436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102502004|NCT00003436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102502005|NCT00003436|Analgesics|analgesics|mesh-ancestor
102502006|NCT00003436|Sensory System Agents|sensory system agents|mesh-ancestor
102502007|NCT00003436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102502008|NCT02432378|Celecoxib|celecoxib|mesh-list
102502009|NCT02432378|Cisplatin|cisplatin|mesh-list
102502010|NCT02432378|Vaccines|vaccines|mesh-list
102502011|NCT02432378|Immunologic Factors|immunologic factors|mesh-ancestor
102502012|NCT02432378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502013|NCT02432378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502014|NCT02432378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102502015|NCT02432378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102502016|NCT02432378|Analgesics|analgesics|mesh-ancestor
102502017|NCT02432378|Sensory System Agents|sensory system agents|mesh-ancestor
102502018|NCT02432378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102502019|NCT02432378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102502020|NCT02432378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102502021|NCT02432378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102502022|NCT02432378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102502023|NCT02432378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102502024|NCT02432378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502025|NCT00003466|Temozolomide|temozolomide|mesh-list
102502026|NCT00003466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102502027|NCT00003466|Alkylating Agents|alkylating agents|mesh-ancestor
102502028|NCT00003466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502029|NCT00003466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502030|NCT00003478|Antibodies|antibodies|mesh-list
102502031|NCT00003478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102502032|NCT00003478|Immunologic Factors|immunologic factors|mesh-ancestor
102502033|NCT00003478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502034|NCT00003016|Tamoxifen|tamoxifen|mesh-list
102502035|NCT00003016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102502036|NCT00003016|Hormone Antagonists|hormone antagonists|mesh-ancestor
102502037|NCT00003016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102502038|NCT00003016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502039|NCT00003016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102502040|NCT00003016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502041|NCT00003016|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102502042|NCT00003016|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102502043|NCT00003016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102502044|NCT00003022|Antibodies|antibodies|mesh-list
102502045|NCT00003022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102502046|NCT00003022|Immunologic Factors|immunologic factors|mesh-ancestor
102502047|NCT00003022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502048|NCT01258387|Mitogens|mitogens|mesh-list
102502049|NCT01258387|Mitosis Modulators|mitosis modulators|mesh-ancestor
102502050|NCT01258387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502051|NCT00003484|Irinotecan|irinotecan|mesh-list
102502052|NCT00003484|Carmustine|carmustine|mesh-list
102313577|NCT01697956|Beclomethasone|beclomethasone|mesh-list
102502053|NCT00003484|Antibodies|antibodies|mesh-list
102502054|NCT00003484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102502055|NCT00003484|Immunologic Factors|immunologic factors|mesh-ancestor
102502056|NCT00003484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502057|NCT00003484|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102502058|NCT00003484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102502059|NCT00003484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102502060|NCT00003484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502061|NCT00003484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502062|NCT00003484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102502063|NCT00003484|Alkylating Agents|alkylating agents|mesh-ancestor
102502065|NCT00003490|Cyclophosphamide|cyclophosphamide|mesh-list
102502066|NCT00003490|Vincristine|vincristine|mesh-list
102502067|NCT00003490|Sargramostim|sargramostim|mesh-list
102502068|NCT00003490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102502069|NCT00003490|Immunologic Factors|immunologic factors|mesh-ancestor
102502070|NCT00003490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502071|NCT00003490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102502072|NCT00003490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102502073|NCT00003490|Alkylating Agents|alkylating agents|mesh-ancestor
102502074|NCT00003490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502075|NCT00003490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502076|NCT00003490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102502077|NCT00003490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102502078|NCT00003490|Glucocorticoids|glucocorticoids|mesh-ancestor
102502079|NCT00003490|Hormones|hormones|mesh-ancestor
102502080|NCT00003490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102502081|NCT00003490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102502082|NCT00003490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102502083|NCT00003490|Tubulin Modulators|tubulin modulators|mesh-ancestor
102502084|NCT00003490|Antimitotic Agents|antimitotic agents|mesh-ancestor
102502085|NCT00003490|Mitosis Modulators|mitosis modulators|mesh-ancestor
102502086|NCT00003034|Doxorubicin|doxorubicin|mesh-list
102502087|NCT00003034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102502088|NCT00003034|Ranpirnase|ranpirnase|mesh-list
102502089|NCT00003034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102502090|NCT00003034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502091|NCT00003034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102502092|NCT00003034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102502093|NCT00003034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102502094|NCT00003034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502095|NCT00003034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102502096|NCT00383890|Dexmedetomidine|dexmedetomidine|mesh-list
102502097|NCT00383890|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102502098|NCT00383890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102502099|NCT00383890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502100|NCT00383890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102502101|NCT00383890|Analgesics|analgesics|mesh-ancestor
102502102|NCT00383890|Sensory System Agents|sensory system agents|mesh-ancestor
102502103|NCT00383890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102502104|NCT00383890|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102502105|NCT00383890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102502106|NCT00383890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102502107|NCT00383890|Adrenergic Agents|adrenergic agents|mesh-ancestor
102502108|NCT00383890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102502109|NCT00383890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502110|NCT00003046|Interleukin-12|interleukin-12|mesh-list
102502111|NCT00003046|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102502112|NCT00003046|Immunologic Factors|immunologic factors|mesh-ancestor
102502113|NCT00003046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502114|NCT00003046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102502115|NCT00003046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102502116|NCT00003046|Growth Substances|growth substances|mesh-ancestor
102502117|NCT00003046|Growth Inhibitors|growth inhibitors|mesh-ancestor
102502118|NCT00003046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502119|NCT00003052|Doxorubicin|doxorubicin|mesh-list
102502120|NCT00003052|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102502121|NCT00003052|Etoposide|etoposide|mesh-list
102502122|NCT00003052|Ifosfamide|ifosfamide|mesh-list
102502123|NCT00003052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102502124|NCT00003052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502125|NCT00003052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102502126|NCT00003052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102502127|NCT00003052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102502128|NCT00003052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502129|NCT00003052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102502130|NCT00003052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102502131|NCT00003052|Alkylating Agents|alkylating agents|mesh-ancestor
102502132|NCT00003058|Troglitazone|troglitazone|mesh-list
102502133|NCT00003058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102502134|NCT00003058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502135|NCT04775732|Infliximab|infliximab|mesh-list
102502136|NCT04775732|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102502137|NCT04775732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102502138|NCT04775732|Dermatologic Agents|dermatologic agents|mesh-ancestor
102502139|NCT04775732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102502140|NCT04775732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102502141|NCT04754750|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102502142|NCT04754750|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102502143|NCT04754750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102502144|NCT04754750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102502145|NCT04754750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502146|NCT04754750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102502147|NCT04754750|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102502148|NCT04754750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102502149|NCT04754750|Serotonin Agents|serotonin agents|mesh-ancestor
102502150|NCT04754750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102502151|NCT04754750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502152|NCT04754750|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102502153|NCT04754750|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102502154|NCT04754750|Dopamine Agents|dopamine agents|mesh-ancestor
102502155|NCT00003064|Paclitaxel|paclitaxel|mesh-list
102502156|NCT00003064|Etoposide|etoposide|mesh-list
102502157|NCT00003064|Carboplatin|carboplatin|mesh-list
102502158|NCT00003064|Topotecan|topotecan|mesh-list
102502159|NCT00003064|Thiotepa|thiotepa|mesh-list
102502160|NCT00003064|Etoposide phosphate|etoposide phosphate|mesh-list
102502161|NCT00003064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102502162|NCT00003064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502163|NCT00003064|Tubulin Modulators|tubulin modulators|mesh-ancestor
102502164|NCT00003064|Antimitotic Agents|antimitotic agents|mesh-ancestor
102502165|NCT00003064|Mitosis Modulators|mitosis modulators|mesh-ancestor
102502166|NCT00003064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502167|NCT00003064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102502168|NCT00003064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102502169|NCT00003064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102502170|NCT00003064|Immunologic Factors|immunologic factors|mesh-ancestor
102502171|NCT00003064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502172|NCT00003064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102502173|NCT00003064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102502174|NCT00003064|Alkylating Agents|alkylating agents|mesh-ancestor
102502175|NCT00003064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102502176|NCT00003064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102502177|NCT00003544|Irinotecan|irinotecan|mesh-list
102502178|NCT00003544|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102502179|NCT00003544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102502180|NCT00003544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102502181|NCT00003544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502182|NCT00003544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502183|NCT03475394|Chlorhexidine|chlorhexidine|mesh-list
102502184|NCT03475394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102502185|NCT03475394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102502186|NCT03475394|Disinfectants|disinfectants|mesh-ancestor
102502187|NCT01269424|Temozolomide|temozolomide|mesh-list
102502188|NCT01269424|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
102502189|NCT01269424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102502190|NCT01269424|Alkylating Agents|alkylating agents|mesh-ancestor
102502191|NCT01269424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502192|NCT01269424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502193|NCT01269424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102502194|NCT03395912|Anesthetics|anesthetics|mesh-list
102502195|NCT03395912|Anesthetics, Local|anesthetics, local|mesh-list
102502196|NCT03395912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102502197|NCT03395912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502198|NCT03395912|Sensory System Agents|sensory system agents|mesh-ancestor
102502199|NCT03395912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102502200|NCT00384436|Escitalopram|escitalopram|mesh-list
102502201|NCT00384436|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102502202|NCT00384436|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102502203|NCT00384436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102502204|NCT00384436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502205|NCT00384436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102502207|NCT00384436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502208|NCT00003562|Carboplatin|carboplatin|mesh-list
102502209|NCT00003562|Docetaxel|docetaxel|mesh-list
102502210|NCT00003562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502211|NCT00003562|Tubulin Modulators|tubulin modulators|mesh-ancestor
102502212|NCT00003562|Antimitotic Agents|antimitotic agents|mesh-ancestor
102502213|NCT00003562|Mitosis Modulators|mitosis modulators|mesh-ancestor
102502214|NCT00003562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502215|NCT04775576|Anesthetics|anesthetics|mesh-list
102502216|NCT04775576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102502217|NCT04775576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502218|NCT00003568|Aldesleukin|aldesleukin|mesh-list
102502219|NCT00003568|Freund's Adjuvant|freund's adjuvant|mesh-list
102502220|NCT00003568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502221|NCT00003568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102502222|NCT00003568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102502223|NCT00003568|Antiviral Agents|antiviral agents|mesh-ancestor
102502224|NCT00003568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102502225|NCT00003568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102502226|NCT00003568|Immunologic Factors|immunologic factors|mesh-ancestor
102502227|NCT00003568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502228|NCT00003070|Enalapril|enalapril|mesh-list
102502229|NCT00003070|Enalaprilat|enalaprilat|mesh-list
102502230|NCT00003070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102502231|NCT00003070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502232|NCT00003070|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102502233|NCT00003070|Protease Inhibitors|protease inhibitors|mesh-ancestor
102502234|NCT00003070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102502235|NCT00003076|Eflornithine|eflornithine|mesh-list
102502236|NCT00003076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502237|NCT00003076|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102502238|NCT00003076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102502239|NCT00003076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102502240|NCT00003076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102502241|NCT00003076|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
102502242|NCT00003076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102502243|NCT00003076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502244|NCT01896518|Nicotine|nicotine|mesh-list
102502245|NCT01896518|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102502246|NCT01896518|Autonomic Agents|autonomic agents|mesh-ancestor
102502247|NCT01896518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102502248|NCT01896518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502249|NCT01896518|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102502250|NCT01896518|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102502251|NCT01896518|Cholinergic Agents|cholinergic agents|mesh-ancestor
102502252|NCT01896518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102502253|NCT01896518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502254|NCT00003082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102502255|NCT00003082|Antibodies|antibodies|mesh-list
102502256|NCT00003082|Immunoglobulins|immunoglobulins|mesh-list
102502257|NCT00003082|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102502258|NCT00003082|Immunologic Factors|immunologic factors|mesh-ancestor
102502259|NCT00003082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502260|NCT00003082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502261|NCT00003088|Paclitaxel|paclitaxel|mesh-list
102502262|NCT00003088|Cyclophosphamide|cyclophosphamide|mesh-list
102502263|NCT00003088|Doxorubicin|doxorubicin|mesh-list
102502264|NCT00003088|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102502265|NCT00003088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102502266|NCT00003088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502267|NCT00003088|Tubulin Modulators|tubulin modulators|mesh-ancestor
102502268|NCT00003088|Antimitotic Agents|antimitotic agents|mesh-ancestor
102502269|NCT00003088|Mitosis Modulators|mitosis modulators|mesh-ancestor
102502270|NCT00003088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502271|NCT00003088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102502272|NCT00003088|Immunologic Factors|immunologic factors|mesh-ancestor
102502273|NCT00003088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502274|NCT00003088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102502275|NCT00003088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102313803|NCT04835870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502276|NCT00003088|Alkylating Agents|alkylating agents|mesh-ancestor
102502277|NCT00003088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102502278|NCT00003088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102502279|NCT00003088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102502280|NCT00003088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102502282|NCT04775030|Salicylic Acid|salicylic acid|mesh-list
102502283|NCT04775030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102502284|NCT04775030|Antifungal Agents|antifungal agents|mesh-ancestor
102502285|NCT04775030|Keratolytic Agents|keratolytic agents|mesh-ancestor
102502286|NCT04775030|Dermatologic Agents|dermatologic agents|mesh-ancestor
102502287|NCT05423210|Atezolizumab|atezolizumab|mesh-list
102502288|NCT05423210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102502289|NCT05423210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502290|NCT05423210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102502291|NCT05423210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502292|NCT00755560|Albendazole|albendazole|mesh-list
102502293|NCT00755560|Anthelmintics|anthelmintics|mesh-ancestor
102502294|NCT00755560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102502295|NCT00755560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102502296|NCT00755560|Anticestodal Agents|anticestodal agents|mesh-ancestor
102502297|NCT00755560|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102502298|NCT00755560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102502299|NCT00755560|Tubulin Modulators|tubulin modulators|mesh-ancestor
102502300|NCT00755560|Antimitotic Agents|antimitotic agents|mesh-ancestor
102502301|NCT00755560|Mitosis Modulators|mitosis modulators|mesh-ancestor
102502302|NCT00755560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502303|NCT00755560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502304|NCT05405894|Zoledronic Acid|zoledronic acid|mesh-list
102502305|NCT05405894|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102502306|NCT05405894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502307|NCT00003118|Fluorouracil|fluorouracil|mesh-list
102502308|NCT00003118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502309|NCT00003118|Antimetabolites|antimetabolites|mesh-ancestor
102502310|NCT00003118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502311|NCT00003118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102502312|NCT00003118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102502313|NCT00003118|Immunologic Factors|immunologic factors|mesh-ancestor
102502314|NCT00003118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502315|NCT00003124|Leuprolide|leuprolide|mesh-list
102502316|NCT00003124|Flutamide|flutamide|mesh-list
102502317|NCT00003124|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102502318|NCT00003124|Fertility Agents|fertility agents|mesh-ancestor
102502319|NCT00003124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102502320|NCT00003124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502321|NCT00003124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102502322|NCT00003124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502323|NCT00003124|Androgen Antagonists|androgen antagonists|mesh-ancestor
102502324|NCT00003124|Hormone Antagonists|hormone antagonists|mesh-ancestor
102502325|NCT00003124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102502326|NCT00003580|Amifostine|amifostine|mesh-list
102502327|NCT00003580|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102502328|NCT00003580|Protective Agents|protective agents|mesh-ancestor
102502329|NCT00003580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502330|NCT00056498|Risperidone|risperidone|mesh-list
102502331|NCT00056498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102502332|NCT00056498|Serotonin Agents|serotonin agents|mesh-ancestor
102502333|NCT00056498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102502334|NCT00056498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502335|NCT00056498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502336|NCT00056498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102502337|NCT00056498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102502338|NCT00056498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102502339|NCT00056498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102502340|NCT00056498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102502341|NCT00056498|Dopamine Agents|dopamine agents|mesh-ancestor
102502342|NCT04330144|Hydroxychloroquine|hydroxychloroquine|mesh-list
102502343|NCT04330144|Antimalarials|antimalarials|mesh-ancestor
102502344|NCT04330144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102502345|NCT04330144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102502346|NCT04330144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102502347|NCT04330144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102502348|NCT04330144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502349|NCT04330144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102502350|NCT00003130|Paclitaxel|paclitaxel|mesh-list
102502351|NCT00003130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102313917|NCT04589546|Niacin|niacin|mesh-list
102502352|NCT00003130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502353|NCT00003130|Tubulin Modulators|tubulin modulators|mesh-ancestor
102502354|NCT00003130|Antimitotic Agents|antimitotic agents|mesh-ancestor
102502355|NCT00003130|Mitosis Modulators|mitosis modulators|mesh-ancestor
102502356|NCT00003130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502357|NCT00058370|Vincristine|vincristine|mesh-list
102502358|NCT00058370|Lomustine|lomustine|mesh-list
102502359|NCT00058370|Antibodies|antibodies|mesh-list
102502360|NCT00058370|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102502361|NCT00058370|Immunologic Factors|immunologic factors|mesh-ancestor
102502362|NCT00058370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502363|NCT00058370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502364|NCT00058370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102502365|NCT00058370|Tubulin Modulators|tubulin modulators|mesh-ancestor
102502366|NCT00058370|Antimitotic Agents|antimitotic agents|mesh-ancestor
102502367|NCT00058370|Mitosis Modulators|mitosis modulators|mesh-ancestor
102502368|NCT00058370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502369|NCT00058370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102502370|NCT00058370|Alkylating Agents|alkylating agents|mesh-ancestor
102502371|NCT00059228|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102502372|NCT00059228|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102502373|NCT00059228|Estradiol|estradiol|mesh-list
102502374|NCT00059228|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102502375|NCT00059228|Estrogens|estrogens|mesh-ancestor
102502376|NCT00059228|Hormones|hormones|mesh-ancestor
102502377|NCT00059228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102502378|NCT00059228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502379|NCT00059228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102502380|NCT00059228|Contraceptive Agents|contraceptive agents|mesh-ancestor
102502381|NCT00059228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102502382|NCT00059228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102502383|NCT00060008|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102502384|NCT00060008|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102502385|NCT00060008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502386|NCT00062738|Paroxetine|paroxetine|mesh-list
102502387|NCT00062738|Nortriptyline|nortriptyline|mesh-list
102502388|NCT00062738|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101978625|NCT02318056|Bacitracin|bacitracin|mesh-list
102502389|NCT00062738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102502390|NCT00062738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102502391|NCT00062738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502392|NCT00062738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102502393|NCT00062738|Serotonin Agents|serotonin agents|mesh-ancestor
102502394|NCT00062738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502395|NCT00062738|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102502396|NCT00062738|Antidepressive Agents|antidepressive agents|mesh-ancestor
102502397|NCT00062738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102502398|NCT00062738|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102502399|NCT00062738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102502400|NCT00062738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102502401|NCT00062738|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102502402|NCT00062738|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102502403|NCT00062738|Adrenergic Agents|adrenergic agents|mesh-ancestor
102502404|NCT00063362|Lamotrigine|lamotrigine|mesh-list
102502405|NCT00063362|Valproic Acid|valproic acid|mesh-list
102502406|NCT00063362|Lithium Carbonate|lithium carbonate|mesh-list
102502407|NCT00063362|Antidepressive Agents|antidepressive agents|mesh-ancestor
102502408|NCT00063362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102502409|NCT00063362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102502410|NCT00063362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502411|NCT00063362|Antimanic Agents|antimanic agents|mesh-ancestor
102502412|NCT00063362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102502413|NCT00063362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102502414|NCT00063362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502415|NCT00063362|Anticonvulsants|anticonvulsants|mesh-ancestor
102502416|NCT00063362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102502417|NCT00063362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102502418|NCT00063362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102502419|NCT00063362|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102502420|NCT00063362|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102502421|NCT00063362|GABA Agents|gaba agents|mesh-ancestor
102502422|NCT00063362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102502423|NCT00064844|Nicotine|nicotine|mesh-list
102502424|NCT00064844|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102502425|NCT00064844|Autonomic Agents|autonomic agents|mesh-ancestor
102502426|NCT00064844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102502427|NCT00064844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502428|NCT00064844|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102502429|NCT00064844|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102502430|NCT00064844|Cholinergic Agents|cholinergic agents|mesh-ancestor
102502431|NCT00064844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102502432|NCT00064844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502433|NCT02668562|Ticagrelor|ticagrelor|mesh-list
102502434|NCT02668562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102502435|NCT02668562|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102502436|NCT02668562|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102502437|NCT02668562|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102502438|NCT02668562|Purinergic Agents|purinergic agents|mesh-ancestor
102502439|NCT02668562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102502440|NCT02668562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502441|NCT02668562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502442|NCT00067028|Cytarabine|cytarabine|mesh-list
102502443|NCT00067028|Clofarabine|clofarabine|mesh-list
102502444|NCT00067028|Idarubicin|idarubicin|mesh-list
102502445|NCT00067028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102502446|NCT00067028|Antimetabolites|antimetabolites|mesh-ancestor
102502447|NCT00067028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502448|NCT00067028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502449|NCT00067028|Antiviral Agents|antiviral agents|mesh-ancestor
102502450|NCT00067028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102502451|NCT00067028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102502452|NCT00067028|Immunologic Factors|immunologic factors|mesh-ancestor
102502453|NCT00067028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502454|NCT00067028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102502455|NCT00067028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102502456|NCT00067028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102502457|NCT00067028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102502458|NCT00067808|Decitabine|decitabine|mesh-list
102502459|NCT00067808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102502460|NCT00067808|Antimetabolites|antimetabolites|mesh-ancestor
102502461|NCT00067808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502462|NCT00067808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502463|NCT00067808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102502464|NCT05174312|Diuretics|diuretics|mesh-list
102502465|NCT05174312|Natriuretic Agents|natriuretic agents|mesh-ancestor
102502466|NCT05174312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502467|NCT00493870|Cyclophosphamide|cyclophosphamide|mesh-list
102502468|NCT00493870|Docetaxel|docetaxel|mesh-list
102502469|NCT00493870|Doxorubicin|doxorubicin|mesh-list
102502470|NCT00493870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102502471|NCT00493870|Immunologic Factors|immunologic factors|mesh-ancestor
102502472|NCT00493870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502473|NCT00493870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102502474|NCT00493870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102502475|NCT00493870|Alkylating Agents|alkylating agents|mesh-ancestor
102502476|NCT00493870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502477|NCT00493870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502478|NCT00493870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102502479|NCT00493870|Tubulin Modulators|tubulin modulators|mesh-ancestor
102502480|NCT00493870|Antimitotic Agents|antimitotic agents|mesh-ancestor
102502481|NCT00493870|Mitosis Modulators|mitosis modulators|mesh-ancestor
102502482|NCT00493870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102502483|NCT00493870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102502484|NCT00493870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102502485|NCT00493870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102502486|NCT03287336|Tranexamic Acid|tranexamic acid|mesh-list
102502487|NCT03287336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102502488|NCT03287336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102502489|NCT03287336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502490|NCT03287336|Hemostatics|hemostatics|mesh-ancestor
102502491|NCT03287336|Coagulants|coagulants|mesh-ancestor
102502492|NCT00003136|Cyclophosphamide|cyclophosphamide|mesh-list
102502493|NCT00003136|Carboplatin|carboplatin|mesh-list
102502494|NCT00003136|Amifostine|amifostine|mesh-list
102502495|NCT00003136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102502496|NCT00003136|Immunologic Factors|immunologic factors|mesh-ancestor
102502497|NCT00003136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502498|NCT00003136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102502499|NCT00003136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102314031|NCT02191579|Topiramate|topiramate|mesh-list
102502500|NCT00003136|Alkylating Agents|alkylating agents|mesh-ancestor
102502501|NCT00003136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502502|NCT00003136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502503|NCT00003136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102502504|NCT00003136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102502505|NCT00003136|Protective Agents|protective agents|mesh-ancestor
102502507|NCT00003598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502508|NCT00003598|Keratolytic Agents|keratolytic agents|mesh-ancestor
102502509|NCT00003598|Dermatologic Agents|dermatologic agents|mesh-ancestor
102502510|NCT00003604|Aldesleukin|aldesleukin|mesh-list
102502511|NCT00003604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502512|NCT00003604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102502513|NCT00003604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102502514|NCT00003604|Antiviral Agents|antiviral agents|mesh-ancestor
102502515|NCT00003604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102502516|NCT00002794|Carboplatin|carboplatin|mesh-list
102502517|NCT00002794|Vincristine|vincristine|mesh-list
102502518|NCT00002794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502519|NCT00002794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102502520|NCT00002794|Tubulin Modulators|tubulin modulators|mesh-ancestor
102502521|NCT00002794|Antimitotic Agents|antimitotic agents|mesh-ancestor
102502522|NCT00002794|Mitosis Modulators|mitosis modulators|mesh-ancestor
102502523|NCT00002794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502524|NCT00003610|Capsaicin|capsaicin|mesh-list
102502525|NCT00003610|Antipruritics|antipruritics|mesh-ancestor
102502526|NCT00003610|Dermatologic Agents|dermatologic agents|mesh-ancestor
102502527|NCT00003610|Sensory System Agents|sensory system agents|mesh-ancestor
102502528|NCT00003610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102502529|NCT00003610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502530|NCT00003616|Irinotecan|irinotecan|mesh-list
102502531|NCT00003616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102502532|NCT00003616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102502533|NCT00003616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102502534|NCT00003616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502535|NCT00003616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502536|NCT01063829|Letermovir|letermovir|mesh-list
102502537|NCT01063829|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102502538|NCT01063829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102502539|NCT01063829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502540|NCT01063829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502541|NCT01063829|Antiviral Agents|antiviral agents|mesh-ancestor
102502542|NCT01063829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102502543|NCT00072566|Cyclophosphamide|cyclophosphamide|mesh-list
102502544|NCT00072566|Bevacizumab|bevacizumab|mesh-list
102502545|NCT00072566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102502546|NCT00072566|Antibodies|antibodies|mesh-list
102502547|NCT00072566|Immunoglobulins|immunoglobulins|mesh-list
102502548|NCT00072566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102502549|NCT00072566|Immunoglobulin G|immunoglobulin g|mesh-list
102502550|NCT00072566|Endothelial Growth Factors|endothelial growth factors|mesh-list
102502551|NCT00072566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102502552|NCT00072566|Immunologic Factors|immunologic factors|mesh-ancestor
102502553|NCT00072566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502554|NCT00072566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102502555|NCT00072566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102502556|NCT00072566|Alkylating Agents|alkylating agents|mesh-ancestor
102502557|NCT00072566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502558|NCT00072566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502559|NCT00072566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102502560|NCT00072566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102502561|NCT00072566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102502562|NCT00072566|Growth Substances|growth substances|mesh-ancestor
102502563|NCT00072566|Growth Inhibitors|growth inhibitors|mesh-ancestor
102502564|NCT00003622|Paclitaxel|paclitaxel|mesh-list
102502565|NCT00003622|Vinorelbine|vinorelbine|mesh-list
102502566|NCT00003622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102502567|NCT00003622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502568|NCT00003622|Tubulin Modulators|tubulin modulators|mesh-ancestor
102502569|NCT00003622|Antimitotic Agents|antimitotic agents|mesh-ancestor
102502570|NCT00003622|Mitosis Modulators|mitosis modulators|mesh-ancestor
102502571|NCT00003622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502572|NCT00003148|Aldesleukin|aldesleukin|mesh-list
102502573|NCT00003148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502574|NCT00003148|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102502575|NCT00003148|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102502576|NCT00003148|Antiviral Agents|antiviral agents|mesh-ancestor
102502577|NCT00003148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102502578|NCT00384046|Testosterone|testosterone|mesh-list
102502579|NCT00384046|Androgens|androgens|mesh-ancestor
102502580|NCT00384046|Hormones|hormones|mesh-ancestor
102502581|NCT00384046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102502582|NCT00384046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502583|NCT00002800|Cytarabine|cytarabine|mesh-list
102502584|NCT00002800|Etoposide|etoposide|mesh-list
102502585|NCT00002800|Idarubicin|idarubicin|mesh-list
102502586|NCT00002800|Lintuzumab|lintuzumab|mesh-list
102502587|NCT00002800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102502588|NCT00002800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502589|NCT00002800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102502590|NCT00002800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102502591|NCT00002800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102502592|NCT00002800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502593|NCT00002800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102502594|NCT00002800|Antimetabolites|antimetabolites|mesh-ancestor
102502595|NCT00002800|Antiviral Agents|antiviral agents|mesh-ancestor
102502596|NCT00002800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102502597|NCT00002800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102502598|NCT00002800|Immunologic Factors|immunologic factors|mesh-ancestor
102502599|NCT00002800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502600|NCT00002800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102502601|NCT00002800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102502602|NCT05061992|Lactulose|lactulose|mesh-list
102502603|NCT05061992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102502604|NCT00002806|Vincristine|vincristine|mesh-list
102502605|NCT00002806|Lomustine|lomustine|mesh-list
102502606|NCT00002806|Procarbazine|procarbazine|mesh-list
102502607|NCT00002806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102502608|NCT00002806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502609|NCT00002806|Tubulin Modulators|tubulin modulators|mesh-ancestor
102502610|NCT00002806|Antimitotic Agents|antimitotic agents|mesh-ancestor
102502611|NCT00002806|Mitosis Modulators|mitosis modulators|mesh-ancestor
102502612|NCT00002806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502613|NCT00002806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102502614|NCT00002806|Alkylating Agents|alkylating agents|mesh-ancestor
102502615|NCT00003160|Paclitaxel|paclitaxel|mesh-list
102502616|NCT00003160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102502617|NCT00003160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502618|NCT00003160|Tubulin Modulators|tubulin modulators|mesh-ancestor
102502619|NCT00003160|Antimitotic Agents|antimitotic agents|mesh-ancestor
102502620|NCT00003160|Mitosis Modulators|mitosis modulators|mesh-ancestor
102502621|NCT00003160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502622|NCT00002812|Cytarabine|cytarabine|mesh-list
102502623|NCT00002812|Dexamethasone|dexamethasone|mesh-list
102502624|NCT00002812|Prednisone|prednisone|mesh-list
102502625|NCT00002812|Cyclophosphamide|cyclophosphamide|mesh-list
102502626|NCT00002812|Doxorubicin|doxorubicin|mesh-list
102502627|NCT00002812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102502628|NCT00002812|Methotrexate|methotrexate|mesh-list
102502629|NCT00002812|Vincristine|vincristine|mesh-list
102502630|NCT00002812|Daunorubicin|daunorubicin|mesh-list
102502631|NCT00002812|Asparaginase|asparaginase|mesh-list
102502632|NCT00002812|Mercaptopurine|mercaptopurine|mesh-list
102502633|NCT00002812|Idarubicin|idarubicin|mesh-list
102502634|NCT00002812|Pegaspargase|pegaspargase|mesh-list
102502635|NCT00002812|Thioguanine|thioguanine|mesh-list
102502636|NCT00002812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102502637|NCT00002812|Immunologic Factors|immunologic factors|mesh-ancestor
102502638|NCT00002812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502639|NCT00002812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102502640|NCT00002812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102502641|NCT00002812|Alkylating Agents|alkylating agents|mesh-ancestor
102502642|NCT00002812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502643|NCT00002812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502644|NCT00002812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102502645|NCT00002812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102502646|NCT00002812|Antiemetics|antiemetics|mesh-ancestor
102502647|NCT00002812|Autonomic Agents|autonomic agents|mesh-ancestor
102502648|NCT00002812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102502649|NCT00002812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102502650|NCT00002812|Glucocorticoids|glucocorticoids|mesh-ancestor
102502651|NCT00002812|Hormones|hormones|mesh-ancestor
102502652|NCT00002812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102502653|NCT00002812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102502654|NCT00002812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102502655|NCT00002812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102502656|NCT00002812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102502657|NCT00002812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102502658|NCT00002812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102502659|NCT00002812|Abortifacient Agents|abortifacient agents|mesh-ancestor
102502660|NCT00002812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102502661|NCT00002812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102502662|NCT00002812|Antimetabolites|antimetabolites|mesh-ancestor
102502663|NCT00002812|Dermatologic Agents|dermatologic agents|mesh-ancestor
102502664|NCT00002812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102502665|NCT00002812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102502666|NCT00002812|Antiviral Agents|antiviral agents|mesh-ancestor
102502667|NCT00002812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102502668|NCT00002812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102502669|NCT00002812|Tubulin Modulators|tubulin modulators|mesh-ancestor
102502670|NCT00002812|Antimitotic Agents|antimitotic agents|mesh-ancestor
102502671|NCT00002812|Mitosis Modulators|mitosis modulators|mesh-ancestor
102502673|NCT01258855|Aflibercept|aflibercept|mesh-list
102502674|NCT01258855|Interleukin-2|interleukin-2|mesh-list
102502675|NCT01258855|Endothelial Growth Factors|endothelial growth factors|mesh-list
102502676|NCT01258855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102502677|NCT01258855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102502678|NCT01258855|Growth Substances|growth substances|mesh-ancestor
102502679|NCT01258855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502680|NCT01258855|Growth Inhibitors|growth inhibitors|mesh-ancestor
102502681|NCT01258855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502682|NCT01258855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102502683|NCT01258855|Analgesics|analgesics|mesh-ancestor
102502684|NCT01258855|Sensory System Agents|sensory system agents|mesh-ancestor
102502685|NCT01258855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102502686|NCT01258855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102502687|NCT01258855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102502688|NCT01258855|Antiviral Agents|antiviral agents|mesh-ancestor
102502689|NCT01258855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102502690|NCT00003166|Vincristine|vincristine|mesh-list
102502691|NCT00003166|Bryostatin 1|bryostatin 1|mesh-list
102502692|NCT00003166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102502693|NCT00003166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502694|NCT00003166|Tubulin Modulators|tubulin modulators|mesh-ancestor
102502695|NCT00003166|Antimitotic Agents|antimitotic agents|mesh-ancestor
102502696|NCT00003166|Mitosis Modulators|mitosis modulators|mesh-ancestor
102502697|NCT00003166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502698|NCT00003166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102502699|NCT00003166|Immunologic Factors|immunologic factors|mesh-ancestor
102502700|NCT00003166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502701|NCT00003172|Interferons|interferons|mesh-list
102502702|NCT00003172|Interferon-alpha|interferon-alpha|mesh-list
102502703|NCT00003172|Docetaxel|docetaxel|mesh-list
102502704|NCT00003172|Doxorubicin|doxorubicin|mesh-list
102502705|NCT00003172|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102502706|NCT00003172|Fluorouracil|fluorouracil|mesh-list
102502707|NCT00003172|Hydroxyurea|hydroxyurea|mesh-list
102502708|NCT00003172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502709|NCT00003172|Tubulin Modulators|tubulin modulators|mesh-ancestor
102502710|NCT00003172|Antimitotic Agents|antimitotic agents|mesh-ancestor
102502711|NCT00003172|Mitosis Modulators|mitosis modulators|mesh-ancestor
102502712|NCT00003172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502713|NCT00003172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102502714|NCT00003172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102502715|NCT00003172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102502716|NCT00003172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102502717|NCT00003172|Antimetabolites|antimetabolites|mesh-ancestor
102502718|NCT00003172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102502719|NCT00003172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102502720|NCT00003172|Immunologic Factors|immunologic factors|mesh-ancestor
102502721|NCT00003172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502722|NCT00003172|Antiviral Agents|antiviral agents|mesh-ancestor
102502723|NCT00003172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102502724|NCT00003172|Antisickling Agents|antisickling agents|mesh-ancestor
102502725|NCT00003172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102502726|NCT00003634|Oregovomab|oregovomab|mesh-list
102502727|NCT00003634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102502728|NCT00003634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502729|NCT02191033|Nicotine|nicotine|mesh-list
102502730|NCT02191033|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102502731|NCT02191033|Autonomic Agents|autonomic agents|mesh-ancestor
102502732|NCT02191033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102502733|NCT02191033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502734|NCT02191033|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102502735|NCT02191033|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102502736|NCT02191033|Cholinergic Agents|cholinergic agents|mesh-ancestor
102502737|NCT02191033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102502738|NCT02191033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502740|NCT00002818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102502741|NCT00002818|Antimetabolites|antimetabolites|mesh-ancestor
102502742|NCT00002818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502743|NCT00002818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502744|NCT00002818|Antiviral Agents|antiviral agents|mesh-ancestor
102502745|NCT00002818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102502746|NCT00002818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102502747|NCT00002818|Immunologic Factors|immunologic factors|mesh-ancestor
102502748|NCT00002818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502749|NCT00003640|Doxorubicin|doxorubicin|mesh-list
102502750|NCT00003640|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102502751|NCT00003640|Methotrexate|methotrexate|mesh-list
102502752|NCT00003640|Vinblastine|vinblastine|mesh-list
102502753|NCT00003640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502754|NCT00003640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102502755|NCT00003640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102502756|NCT00003640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102502757|NCT00003640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102502758|NCT00003640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502759|NCT00003640|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102502760|NCT00003640|Abortifacient Agents|abortifacient agents|mesh-ancestor
102502761|NCT00003640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102502762|NCT00003640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502763|NCT00003640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102502764|NCT00003640|Antimetabolites|antimetabolites|mesh-ancestor
102502765|NCT00003640|Dermatologic Agents|dermatologic agents|mesh-ancestor
102502766|NCT00003640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102502767|NCT00003640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102502768|NCT00003640|Immunologic Factors|immunologic factors|mesh-ancestor
102502769|NCT00003640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102502770|NCT00003640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102502771|NCT00003640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102502772|NCT00003640|Tubulin Modulators|tubulin modulators|mesh-ancestor
102502773|NCT00003640|Antimitotic Agents|antimitotic agents|mesh-ancestor
102502774|NCT00003640|Mitosis Modulators|mitosis modulators|mesh-ancestor
102502775|NCT00002824|Ganciclovir|ganciclovir|mesh-list
102502776|NCT00002824|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102502777|NCT00002824|Antiviral Agents|antiviral agents|mesh-ancestor
102502778|NCT00002824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102502779|NCT00002824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102502780|NCT00002824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102502781|NCT00002824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502782|NCT00003178|Idarubicin|idarubicin|mesh-list
102502783|NCT00003178|Cladribine|cladribine|mesh-list
102502784|NCT00003178|Lenograstim|lenograstim|mesh-list
102502785|NCT00003178|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102502786|NCT00003178|Immunologic Factors|immunologic factors|mesh-ancestor
102502787|NCT00003178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502788|NCT00003178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102502789|NCT00003178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502790|NCT00003178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102502791|NCT00003178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102502792|NCT00003178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102502793|NCT00003178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502794|NCT00003178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102502795|NCT01260649|Ketamine|ketamine|mesh-list
102502796|NCT01260649|Anesthetics|anesthetics|mesh-list
102502797|NCT01260649|Analgesics|analgesics|mesh-ancestor
102502798|NCT01260649|Sensory System Agents|sensory system agents|mesh-ancestor
102502799|NCT01260649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102502800|NCT01260649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502801|NCT01260649|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102502802|NCT01260649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102502803|NCT01260649|Anesthetics, General|anesthetics, general|mesh-ancestor
102502804|NCT01260649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102502805|NCT01260649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102502806|NCT01260649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102502807|NCT01260649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102502808|NCT01260649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502810|NCT01260883|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102502811|NCT01260883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102502812|NCT01260883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102502813|NCT01260883|Analgesics|analgesics|mesh-ancestor
102502814|NCT01260883|Sensory System Agents|sensory system agents|mesh-ancestor
102502815|NCT01260883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102502816|NCT01260883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502817|NCT01260883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102502818|NCT01260883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102502819|NCT01260883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102502820|NCT01260883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102502821|NCT01260883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502822|NCT00076622|Antidepressive Agents|antidepressive agents|mesh-list
102502823|NCT00076622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102502824|NCT00423202|Ambrisentan|ambrisentan|mesh-list
102502825|NCT00423202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102502826|NCT00003184|Vaccines|vaccines|mesh-list
102502827|NCT00003184|Sargramostim|sargramostim|mesh-list
102502828|NCT00003184|BCG Vaccine|bcg vaccine|mesh-list
102502829|NCT00003184|Immunologic Factors|immunologic factors|mesh-ancestor
102502830|NCT00003184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502831|NCT00003184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102502832|NCT00003190|Cytarabine|cytarabine|mesh-list
102502833|NCT00003190|Etoposide|etoposide|mesh-list
102502834|NCT00003190|Daunorubicin|daunorubicin|mesh-list
102502835|NCT00003190|Etoposide phosphate|etoposide phosphate|mesh-list
102502836|NCT00003190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102502837|NCT00003190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502838|NCT00003190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102502839|NCT00003190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102502840|NCT00003190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102502841|NCT00003190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502842|NCT00003190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102502843|NCT00003190|Antimetabolites|antimetabolites|mesh-ancestor
102502844|NCT00003190|Antiviral Agents|antiviral agents|mesh-ancestor
102502845|NCT00003190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102502846|NCT00003190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102502847|NCT00003190|Immunologic Factors|immunologic factors|mesh-ancestor
102502848|NCT00003190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502849|NCT00003190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102502850|NCT00003652|Fluorouracil|fluorouracil|mesh-list
102502851|NCT00003652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502852|NCT00003652|Antimetabolites|antimetabolites|mesh-ancestor
102502853|NCT00003652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502854|NCT00003652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102502855|NCT00003652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102502856|NCT00003652|Immunologic Factors|immunologic factors|mesh-ancestor
102502857|NCT00003652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502858|NCT04773236|Lidocaine|lidocaine|mesh-list
102502859|NCT04773236|Anesthetics, Local|anesthetics, local|mesh-ancestor
102502860|NCT04773236|Anesthetics|anesthetics|mesh-ancestor
102502861|NCT04773236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102502862|NCT04773236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502863|NCT04773236|Sensory System Agents|sensory system agents|mesh-ancestor
102502864|NCT04773236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102502865|NCT04773236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102502866|NCT04773236|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102502867|NCT04773236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102502868|NCT04773236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102502869|NCT04773236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502870|NCT00003658|Cyclophosphamide|cyclophosphamide|mesh-list
102502871|NCT00003658|Rituximab|rituximab|mesh-list
102502872|NCT00003658|Pentostatin|pentostatin|mesh-list
102502873|NCT00003658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102502874|NCT00003658|Immunologic Factors|immunologic factors|mesh-ancestor
102502875|NCT00003658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502876|NCT00003658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102502877|NCT00003658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102502878|NCT00003658|Alkylating Agents|alkylating agents|mesh-ancestor
102502879|NCT00003658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502880|NCT00003658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502881|NCT00003658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102502882|NCT00003658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102502883|NCT00003658|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
102502884|NCT00003658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102502885|NCT00002836|Cyclophosphamide|cyclophosphamide|mesh-list
102502886|NCT00002836|Thiotepa|thiotepa|mesh-list
102502887|NCT00002836|Carmustine|carmustine|mesh-list
102502888|NCT00002836|Cisplatin|cisplatin|mesh-list
102502889|NCT00002836|Etoposide|etoposide|mesh-list
102502890|NCT00002836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102502891|NCT00002836|Immunologic Factors|immunologic factors|mesh-ancestor
102502892|NCT00002836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502893|NCT00002836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102502894|NCT00002836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102502895|NCT00002836|Alkylating Agents|alkylating agents|mesh-ancestor
102502896|NCT00002836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502897|NCT00002836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502898|NCT00002836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102502899|NCT00002836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102502900|NCT00002836|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102502901|NCT00002836|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102502902|NCT00002836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102502903|NCT00003664|Interferons|interferons|mesh-list
102502904|NCT00003664|Interferon-alpha|interferon-alpha|mesh-list
102502905|NCT00003664|Aldesleukin|aldesleukin|mesh-list
102502906|NCT00003664|Gemcitabine|gemcitabine|mesh-list
102502907|NCT00003664|Fluorouracil|fluorouracil|mesh-list
102502908|NCT00003664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102502909|NCT00003664|Antimetabolites|antimetabolites|mesh-ancestor
102502910|NCT00003664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502911|NCT00003664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502912|NCT00003664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102502913|NCT00003664|Immunologic Factors|immunologic factors|mesh-ancestor
102502914|NCT00003664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502915|NCT00003664|Antiviral Agents|antiviral agents|mesh-ancestor
102502916|NCT00003664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102502917|NCT00003664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102502918|NCT00003664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102502919|NCT00003196|Cyclosporine|cyclosporine|mesh-list
102502920|NCT00003196|Mycophenolic Acid|mycophenolic acid|mesh-list
102502921|NCT00003196|Cyclosporins|cyclosporins|mesh-list
102502922|NCT00003196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102502923|NCT00003196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502924|NCT00003196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102502925|NCT00003196|Immunologic Factors|immunologic factors|mesh-ancestor
102502926|NCT00003196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502927|NCT00003196|Antifungal Agents|antifungal agents|mesh-ancestor
102502928|NCT00003196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102502929|NCT00003196|Dermatologic Agents|dermatologic agents|mesh-ancestor
102502930|NCT00003196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102502931|NCT00003196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102502932|NCT00003196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102502933|NCT00003196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502934|NCT00003196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102502935|NCT00003196|Antitubercular Agents|antitubercular agents|mesh-ancestor
102502936|NCT00003196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102502937|NCT00003202|Gemcitabine|gemcitabine|mesh-list
102502938|NCT00003202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502939|NCT00003202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102502940|NCT00003202|Antimetabolites|antimetabolites|mesh-ancestor
102502941|NCT00003202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502942|NCT00002854|Paclitaxel|paclitaxel|mesh-list
102502943|NCT00002854|Etoposide|etoposide|mesh-list
102502944|NCT00002854|Cyclophosphamide|cyclophosphamide|mesh-list
102502945|NCT00002854|Carboplatin|carboplatin|mesh-list
102502946|NCT00002854|Ifosfamide|ifosfamide|mesh-list
102502947|NCT00002854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102502948|NCT00002854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502949|NCT00002854|Tubulin Modulators|tubulin modulators|mesh-ancestor
102502950|NCT00002854|Antimitotic Agents|antimitotic agents|mesh-ancestor
102502951|NCT00002854|Mitosis Modulators|mitosis modulators|mesh-ancestor
102502952|NCT00002854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502953|NCT00002854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102502954|NCT00002854|Immunologic Factors|immunologic factors|mesh-ancestor
102502955|NCT00002854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502956|NCT00002854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102502957|NCT00002854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102502958|NCT00002854|Alkylating Agents|alkylating agents|mesh-ancestor
102502959|NCT00002854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102502960|NCT00002854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102502961|NCT00002854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102502962|NCT00002854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102502963|NCT02308202|Perindopril|perindopril|mesh-list
102502964|NCT02308202|Doxazosin|doxazosin|mesh-list
102502965|NCT02308202|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102502966|NCT02308202|Protease Inhibitors|protease inhibitors|mesh-ancestor
102502967|NCT02308202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102502968|NCT02308202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502969|NCT02308202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102502970|NCT02308202|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102502971|NCT02308202|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102502972|NCT02308202|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102502973|NCT02308202|Adrenergic Agents|adrenergic agents|mesh-ancestor
102502974|NCT02308202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102502975|NCT02308202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502976|NCT00003214|Paclitaxel|paclitaxel|mesh-list
102502977|NCT00003214|Cyclophosphamide|cyclophosphamide|mesh-list
102502978|NCT00003214|Carboplatin|carboplatin|mesh-list
102502979|NCT00003214|Doxorubicin|doxorubicin|mesh-list
102502980|NCT00003214|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102502981|NCT00003214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102502982|NCT00003214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102502983|NCT00003214|Tubulin Modulators|tubulin modulators|mesh-ancestor
102502984|NCT00003214|Antimitotic Agents|antimitotic agents|mesh-ancestor
102502985|NCT00003214|Mitosis Modulators|mitosis modulators|mesh-ancestor
102502986|NCT00003214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102502987|NCT00003214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102502988|NCT00003214|Immunologic Factors|immunologic factors|mesh-ancestor
102502989|NCT00003214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102502990|NCT00003214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102502991|NCT00003214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102502992|NCT00003214|Alkylating Agents|alkylating agents|mesh-ancestor
102502993|NCT00003214|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102502994|NCT00003214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102502995|NCT00003214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102502996|NCT00003214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102502997|NCT00003214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102502998|NCT00384592|Esomeprazole|esomeprazole|mesh-list
102502999|NCT00384592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102503000|NCT00384592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102503001|NCT00384592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102503002|NCT00384592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503003|NCT00384592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503004|NCT00003220|Bryostatin 1|bryostatin 1|mesh-list
102503005|NCT00003220|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102503006|NCT00003220|Immunologic Factors|immunologic factors|mesh-ancestor
102503007|NCT00003220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503008|NCT00003220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503009|NCT00002866|Docetaxel|docetaxel|mesh-list
102503010|NCT00002866|Epirubicin|epirubicin|mesh-list
102503011|NCT00002866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503012|NCT00002866|Tubulin Modulators|tubulin modulators|mesh-ancestor
102503013|NCT00002866|Antimitotic Agents|antimitotic agents|mesh-ancestor
102503014|NCT00002866|Mitosis Modulators|mitosis modulators|mesh-ancestor
102503015|NCT00002866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503016|NCT00002866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102503017|NCT00002866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102503018|NCT00002866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102503019|NCT00002866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503020|NCT00003232|Clodronic Acid|clodronic acid|mesh-list
102503021|NCT00003232|Prednisone|prednisone|mesh-list
102503022|NCT00003232|Mitoxantrone|mitoxantrone|mesh-list
102503023|NCT00003232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102503024|NCT00003232|Glucocorticoids|glucocorticoids|mesh-ancestor
102503025|NCT00003232|Hormones|hormones|mesh-ancestor
102503026|NCT00003232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102503027|NCT00003232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503028|NCT00003232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102503029|NCT00003232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503030|NCT00003232|Analgesics|analgesics|mesh-ancestor
102503031|NCT00003232|Sensory System Agents|sensory system agents|mesh-ancestor
102503032|NCT00003232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102503033|NCT00003232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102503034|NCT00003232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102503035|NCT00003232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503036|NCT00003232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503037|NCT00003232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102503038|NCT00003238|Perillyl alcohol|perillyl alcohol|mesh-list
102503039|NCT00003238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503040|NCT00003238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503041|NCT00003238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503042|NCT00002884|Fluorouracil|fluorouracil|mesh-list
102503043|NCT00002884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503044|NCT00002884|Antimetabolites|antimetabolites|mesh-ancestor
102503045|NCT00002884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503046|NCT00002884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102503047|NCT00002884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102503048|NCT00002884|Immunologic Factors|immunologic factors|mesh-ancestor
102503049|NCT00002884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503050|NCT00003682|Methylprednisolone|methylprednisolone|mesh-list
102503051|NCT00003682|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102503052|NCT00003682|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102503053|NCT00003682|Prednisolone|prednisolone|mesh-list
102503054|NCT00003682|Prednisolone acetate|prednisolone acetate|mesh-list
102503055|NCT00003682|Doxorubicin|doxorubicin|mesh-list
102503056|NCT00003682|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102503057|NCT00003682|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102503058|NCT00003682|Prednisolone phosphate|prednisolone phosphate|mesh-list
102503059|NCT00003682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102503060|NCT00003682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503061|NCT00003682|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102503062|NCT00003682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102503063|NCT00003682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503064|NCT00003682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503065|NCT00003682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102503066|NCT00003682|Antiemetics|antiemetics|mesh-ancestor
102503067|NCT00003682|Autonomic Agents|autonomic agents|mesh-ancestor
102503068|NCT00003682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102503069|NCT00003682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503070|NCT00003682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102503071|NCT00003682|Glucocorticoids|glucocorticoids|mesh-ancestor
102503072|NCT00003682|Hormones|hormones|mesh-ancestor
102503073|NCT00003682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102503074|NCT00003682|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102503075|NCT00003682|Protective Agents|protective agents|mesh-ancestor
102503076|NCT00003682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102503077|NCT00003688|Dactinomycin|dactinomycin|mesh-list
102503078|NCT00003688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102503079|NCT00003688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102503080|NCT00003688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102503081|NCT00003688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503082|NCT00003688|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102503083|NCT00003688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503084|NCT00003688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503085|NCT00003688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102503086|NCT00003934|Cytarabine|cytarabine|mesh-list
102503087|NCT00003934|Methotrexate|methotrexate|mesh-list
102503088|NCT00003934|Mercaptopurine|mercaptopurine|mesh-list
102503089|NCT00003934|Daunorubicin|daunorubicin|mesh-list
102503090|NCT00003934|Arsenic Trioxide|arsenic trioxide|mesh-list
102503091|NCT00003934|Tretinoin|tretinoin|mesh-list
102503092|NCT00003934|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102503093|NCT00003934|Abortifacient Agents|abortifacient agents|mesh-ancestor
102503094|NCT00003934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102503095|NCT00003934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503096|NCT00003934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102503097|NCT00003934|Antimetabolites|antimetabolites|mesh-ancestor
102503098|NCT00003934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503099|NCT00003934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503100|NCT00003934|Dermatologic Agents|dermatologic agents|mesh-ancestor
102503101|NCT00003934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503102|NCT00003934|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102503103|NCT00003934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102503104|NCT00003934|Immunologic Factors|immunologic factors|mesh-ancestor
102503105|NCT00003934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102503106|NCT00003934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102503107|NCT00003934|Antiviral Agents|antiviral agents|mesh-ancestor
102503108|NCT00003934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102503109|NCT00003934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102503110|NCT00003934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102503111|NCT00003934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102503112|NCT00003934|Keratolytic Agents|keratolytic agents|mesh-ancestor
102503113|NCT00003694|Cytarabine|cytarabine|mesh-list
102503114|NCT00003694|Homoharringtonine|homoharringtonine|mesh-list
102503115|NCT00003694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102503116|NCT00003694|Antimetabolites|antimetabolites|mesh-ancestor
102503117|NCT00003694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503118|NCT00003694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503119|NCT00003694|Antiviral Agents|antiviral agents|mesh-ancestor
102503120|NCT00003694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102503121|NCT00003694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102503122|NCT00003694|Immunologic Factors|immunologic factors|mesh-ancestor
102503123|NCT00003694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503124|NCT00003694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102503125|NCT00003694|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102503126|NCT00003694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503127|NCT00003250|Fenretinide|fenretinide|mesh-list
102503128|NCT00003250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503129|NCT00003250|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102503130|NCT00003250|Protective Agents|protective agents|mesh-ancestor
102503131|NCT00003250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503132|NCT00003256|Alvocidib|alvocidib|mesh-list
102503133|NCT00003256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503134|NCT00003256|Growth Inhibitors|growth inhibitors|mesh-ancestor
102503135|NCT00003256|Growth Substances|growth substances|mesh-ancestor
102503136|NCT00003256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503137|NCT00003256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102503138|NCT00003256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503139|NCT00003256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503140|NCT00003946|Danazol|danazol|mesh-list
102503141|NCT00003946|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102503142|NCT00003946|Hormone Antagonists|hormone antagonists|mesh-ancestor
102503143|NCT00003946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102503144|NCT00003946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503145|NCT04679480|Cemiplimab|cemiplimab|mesh-list
102503146|NCT04679480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102503147|NCT04679480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503148|NCT00003262|Prednisone|prednisone|mesh-list
102503149|NCT00003262|Doxorubicin|doxorubicin|mesh-list
102503150|NCT00003262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102503151|NCT00003262|Epirubicin|epirubicin|mesh-list
102503152|NCT00003262|Bleomycin|bleomycin|mesh-list
102503153|NCT00003262|Etoposide|etoposide|mesh-list
102503154|NCT00003262|Vincristine|vincristine|mesh-list
102503155|NCT00003262|Vinblastine|vinblastine|mesh-list
102503156|NCT00003262|Mechlorethamine|mechlorethamine|mesh-list
102503157|NCT00003262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102503158|NCT00003262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503159|NCT00003262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102503160|NCT00003262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102503161|NCT00003262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503162|NCT00003262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503163|NCT00003262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102503164|NCT00003262|Glucocorticoids|glucocorticoids|mesh-ancestor
102503165|NCT00003262|Hormones|hormones|mesh-ancestor
102503166|NCT00003262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102503167|NCT00003262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503168|NCT00003262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102503169|NCT00003262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102503170|NCT00003262|Tubulin Modulators|tubulin modulators|mesh-ancestor
102503171|NCT00003262|Antimitotic Agents|antimitotic agents|mesh-ancestor
102503172|NCT00003262|Mitosis Modulators|mitosis modulators|mesh-ancestor
102503173|NCT00003262|Alkylating Agents|alkylating agents|mesh-ancestor
102503174|NCT00003262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102503175|NCT00003700|Leucovorin|leucovorin|mesh-list
102503176|NCT00003700|Cytarabine|cytarabine|mesh-list
102503177|NCT00003700|Prednisone|prednisone|mesh-list
102503178|NCT00003700|Cyclophosphamide|cyclophosphamide|mesh-list
102503179|NCT00003700|Methotrexate|methotrexate|mesh-list
102503180|NCT00003700|Vincristine|vincristine|mesh-list
102503181|NCT00003700|Daunorubicin|daunorubicin|mesh-list
102503182|NCT00003700|Asparaginase|asparaginase|mesh-list
102503183|NCT00003700|Mercaptopurine|mercaptopurine|mesh-list
102503184|NCT00003700|Allopurinol|allopurinol|mesh-list
102503185|NCT00003700|Levoleucovorin|levoleucovorin|mesh-list
102503186|NCT00003700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102503187|NCT00003700|Immunologic Factors|immunologic factors|mesh-ancestor
102503188|NCT00003700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979426|NCT02322580|Analgesics|analgesics|mesh-ancestor
102503189|NCT00003700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102503190|NCT00003700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102503191|NCT00003700|Alkylating Agents|alkylating agents|mesh-ancestor
102503192|NCT00003700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503193|NCT00003700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503194|NCT00003700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102503195|NCT00003700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102503196|NCT00003700|Glucocorticoids|glucocorticoids|mesh-ancestor
102503197|NCT00003700|Hormones|hormones|mesh-ancestor
102503198|NCT00003700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102503199|NCT00003700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102503200|NCT00003700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102503201|NCT00003700|Abortifacient Agents|abortifacient agents|mesh-ancestor
102503202|NCT00003700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102503203|NCT00003700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102503204|NCT00003700|Antimetabolites|antimetabolites|mesh-ancestor
102503205|NCT00003700|Dermatologic Agents|dermatologic agents|mesh-ancestor
102503206|NCT00003700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503207|NCT00003700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102503208|NCT00003700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102503209|NCT00003700|Antiviral Agents|antiviral agents|mesh-ancestor
102503210|NCT00003700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102503211|NCT00003700|Antidotes|antidotes|mesh-ancestor
102503212|NCT00003700|Protective Agents|protective agents|mesh-ancestor
102503213|NCT00003700|Vitamin B Complex|vitamin b complex|mesh-ancestor
102503214|NCT00003700|Vitamins|vitamins|mesh-ancestor
102503215|NCT00003700|Micronutrients|micronutrients|mesh-ancestor
102503216|NCT00003700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102503217|NCT00003700|Tubulin Modulators|tubulin modulators|mesh-ancestor
102503218|NCT00003700|Antimitotic Agents|antimitotic agents|mesh-ancestor
102503219|NCT00003700|Mitosis Modulators|mitosis modulators|mesh-ancestor
102503220|NCT00003700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102503221|NCT00003700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102503222|NCT00003700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102503223|NCT00003700|Gout Suppressants|gout suppressants|mesh-ancestor
102503224|NCT00003700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102503225|NCT00003700|Antioxidants|antioxidants|mesh-ancestor
102503226|NCT00003706|Pemetrexed|pemetrexed|mesh-list
102503227|NCT00003706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503228|NCT00003706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503229|NCT00003706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503230|NCT00003706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102503231|NCT00003706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102503232|NCT00003958|Dactinomycin|dactinomycin|mesh-list
102503233|NCT00003958|Cactinomycin|cactinomycin|mesh-list
102503234|NCT00003958|Cyclophosphamide|cyclophosphamide|mesh-list
102503235|NCT00003958|Vincristine|vincristine|mesh-list
102503236|NCT00003958|Topotecan|topotecan|mesh-list
102503237|NCT00003958|Sargramostim|sargramostim|mesh-list
102503238|NCT00003958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102503239|NCT00003958|Immunologic Factors|immunologic factors|mesh-ancestor
102503240|NCT00003958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503241|NCT00003958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102503242|NCT00003958|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102503243|NCT00003958|Alkylating Agents|alkylating agents|mesh-ancestor
102503244|NCT00003958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503245|NCT00003958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503246|NCT00003958|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102503247|NCT00003958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102503248|NCT00003958|Tubulin Modulators|tubulin modulators|mesh-ancestor
102503249|NCT00003958|Antimitotic Agents|antimitotic agents|mesh-ancestor
102503250|NCT00003958|Mitosis Modulators|mitosis modulators|mesh-ancestor
102503251|NCT00003958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102503252|NCT00003958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102503253|NCT00003958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503254|NCT00003958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102503255|NCT00003958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102503256|NCT00003958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102503257|NCT00003958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102503258|NCT00003958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102503259|NCT00003712|Sirolimus|sirolimus|mesh-list
102503260|NCT00003712|Temsirolimus|temsirolimus|mesh-list
102503261|NCT00003712|MTOR Inhibitors|mtor inhibitors|mesh-list
102503262|NCT00003712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102503263|NCT00003712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503264|NCT00003712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503265|NCT00003712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102503266|NCT00003712|Immunologic Factors|immunologic factors|mesh-ancestor
102503267|NCT00003712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503268|NCT00003712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503269|NCT00003712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102503270|NCT00003712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102503271|NCT00003712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102503272|NCT00003712|Antifungal Agents|antifungal agents|mesh-ancestor
102503273|NCT00003268|Cytarabine|cytarabine|mesh-list
102503274|NCT00003268|Idarubicin|idarubicin|mesh-list
102503275|NCT00003268|Amifostine|amifostine|mesh-list
102503276|NCT00003268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102503277|NCT00003268|Antimetabolites|antimetabolites|mesh-ancestor
102503278|NCT00003268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503279|NCT00003268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503280|NCT00003268|Antiviral Agents|antiviral agents|mesh-ancestor
102503281|NCT00003268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102503282|NCT00003268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102503283|NCT00003268|Immunologic Factors|immunologic factors|mesh-ancestor
102503284|NCT00003268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503285|NCT00003268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102503286|NCT00003268|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102503287|NCT00003268|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102503288|NCT00003268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503289|NCT00003268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102503290|NCT00003268|Protective Agents|protective agents|mesh-ancestor
102503291|NCT00083720|Cetuximab|cetuximab|mesh-list
102503292|NCT00083720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102503293|NCT00083720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503294|NCT00003274|Sargramostim|sargramostim|mesh-list
102503295|NCT00003274|Freund's Adjuvant|freund's adjuvant|mesh-list
102503296|NCT00003274|Immunologic Factors|immunologic factors|mesh-ancestor
102503297|NCT00003274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503298|NCT00003274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102503299|NCT00003280|Rituximab|rituximab|mesh-list
102503300|NCT00003280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102503301|NCT00003280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503302|NCT00003280|Immunologic Factors|immunologic factors|mesh-ancestor
102503303|NCT00003280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503304|NCT00003280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102503305|NCT00384124|Imiquimod|imiquimod|mesh-list
102503306|NCT00384124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102503307|NCT00384124|Immunologic Factors|immunologic factors|mesh-ancestor
102503308|NCT00384124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503309|NCT00384124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503310|NCT00384124|Interferon Inducers|interferon inducers|mesh-ancestor
102503311|NCT00003718|Temozolomide|temozolomide|mesh-list
102503312|NCT00003718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102503313|NCT00003718|Alkylating Agents|alkylating agents|mesh-ancestor
102503314|NCT00003718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503315|NCT00003718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503316|NCT00003970|Irinotecan|irinotecan|mesh-list
102503317|NCT00003970|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102503318|NCT00003970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102503319|NCT00003970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503320|NCT00003970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503321|NCT00003970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503322|NCT00085436|Interferons|interferons|mesh-list
102503323|NCT00085436|Interferon-alpha|interferon-alpha|mesh-list
102503324|NCT00085436|Interferon alpha-2|interferon alpha-2|mesh-list
102503325|NCT00085436|Aldesleukin|aldesleukin|mesh-list
102503326|NCT00085436|Vaccines|vaccines|mesh-list
102503327|NCT00085436|Immunologic Factors|immunologic factors|mesh-ancestor
102503328|NCT00085436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503329|NCT00085436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503330|NCT00085436|Antiviral Agents|antiviral agents|mesh-ancestor
102503331|NCT00085436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102503332|NCT00085436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102503333|NCT00085436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102503334|NCT00384202|Tacrolimus|tacrolimus|mesh-list
102503335|NCT00384202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102503336|NCT00384202|Immunologic Factors|immunologic factors|mesh-ancestor
102503337|NCT00384202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503338|NCT00384202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102503339|NCT00384202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503340|NCT00384202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503341|NCT00086138|Sertraline|sertraline|mesh-list
102503342|NCT00086138|Antidepressive Agents|antidepressive agents|mesh-ancestor
102503343|NCT00086138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102503344|NCT00086138|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102503345|NCT00086138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102503346|NCT00086138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102503347|NCT00086138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503348|NCT00086138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102503349|NCT00086138|Serotonin Agents|serotonin agents|mesh-ancestor
102503350|NCT00086138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503351|NCT04329130|Lenalidomide|lenalidomide|mesh-list
102503352|NCT04329130|Immunologic Factors|immunologic factors|mesh-ancestor
102503353|NCT04329130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503354|NCT04329130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102503355|NCT04329130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102503356|NCT04329130|Growth Substances|growth substances|mesh-ancestor
102503357|NCT04329130|Growth Inhibitors|growth inhibitors|mesh-ancestor
102503358|NCT04329130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503359|NCT00384280|Rifampin|rifampin|mesh-list
102503360|NCT00384280|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102503361|NCT00384280|Antitubercular Agents|antitubercular agents|mesh-ancestor
102503362|NCT00384280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102503363|NCT00384280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102503364|NCT00384280|Leprostatic Agents|leprostatic agents|mesh-ancestor
102503365|NCT00384280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102503366|NCT00384280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503367|NCT00384280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503368|NCT00384280|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102503369|NCT00384280|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102503370|NCT00384280|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102503371|NCT00384280|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102503372|NCT00384280|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102503373|NCT00384280|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102503374|NCT00003976|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
102503375|NCT00003976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503376|NCT00003976|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102503377|NCT00003976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503378|NCT00003976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503379|NCT00003730|Fluorouracil|fluorouracil|mesh-list
102503380|NCT00003730|Vinorelbine|vinorelbine|mesh-list
102503381|NCT00003730|Antimetabolites|antimetabolites|mesh-ancestor
102503382|NCT00003730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503383|NCT00003730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102503384|NCT00003730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503385|NCT00003730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102503386|NCT00003730|Immunologic Factors|immunologic factors|mesh-ancestor
102503387|NCT00003730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503388|NCT00003730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102503389|NCT00003730|Tubulin Modulators|tubulin modulators|mesh-ancestor
102503390|NCT00003730|Antimitotic Agents|antimitotic agents|mesh-ancestor
102503391|NCT00003730|Mitosis Modulators|mitosis modulators|mesh-ancestor
102503392|NCT01881308|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
102503393|NCT01881308|Antirheumatic Agents|antirheumatic agents|mesh-list
102503394|NCT01881308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102503395|NCT00003292|Ifosfamide|ifosfamide|mesh-list
102503396|NCT00003292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102503397|NCT00003292|Alkylating Agents|alkylating agents|mesh-ancestor
102503398|NCT00003292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503399|NCT00003292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503400|NCT00088634|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102503401|NCT00088634|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102503402|NCT00088634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102503403|NCT00088634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102503404|NCT00088634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503405|NCT00088634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102503406|NCT00088634|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102503407|NCT00088634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102503408|NCT00088634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102503409|NCT00088634|Adrenergic Agents|adrenergic agents|mesh-ancestor
102503410|NCT00088634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102503411|NCT00088634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503412|NCT00088634|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102503413|NCT00088634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102503414|NCT00088634|Serotonin Agents|serotonin agents|mesh-ancestor
102503415|NCT00088634|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102503416|NCT00088634|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102503417|NCT00088634|Dopamine Agents|dopamine agents|mesh-ancestor
102503418|NCT00003736|Motexafin gadolinium|motexafin gadolinium|mesh-list
102503419|NCT00003736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503420|NCT00003736|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102503421|NCT00003736|Dermatologic Agents|dermatologic agents|mesh-ancestor
102503422|NCT00003994|Carboplatin|carboplatin|mesh-list
102503423|NCT00003994|Fluorouracil|fluorouracil|mesh-list
102503424|NCT00003994|Vincristine|vincristine|mesh-list
102503425|NCT00003994|Amifostine|amifostine|mesh-list
102503426|NCT00003994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503427|NCT00003994|Antimetabolites|antimetabolites|mesh-ancestor
102503428|NCT00003994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503429|NCT00003994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102503430|NCT00003994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102503431|NCT00003994|Immunologic Factors|immunologic factors|mesh-ancestor
102503432|NCT00003994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503433|NCT00003994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102503434|NCT00003994|Tubulin Modulators|tubulin modulators|mesh-ancestor
102503435|NCT00003994|Antimitotic Agents|antimitotic agents|mesh-ancestor
102503436|NCT00003994|Mitosis Modulators|mitosis modulators|mesh-ancestor
102503437|NCT00003994|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102503438|NCT00003994|Protective Agents|protective agents|mesh-ancestor
102503439|NCT00003742|Paclitaxel|paclitaxel|mesh-list
102503440|NCT00003742|Irinotecan|irinotecan|mesh-list
102503441|NCT00003742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102503442|NCT00003742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503443|NCT00003742|Tubulin Modulators|tubulin modulators|mesh-ancestor
102503444|NCT00003742|Antimitotic Agents|antimitotic agents|mesh-ancestor
102503445|NCT00003742|Mitosis Modulators|mitosis modulators|mesh-ancestor
102503446|NCT00003742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503447|NCT00003742|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102503448|NCT00003742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102503449|NCT00003742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503450|NCT00003304|Temozolomide|temozolomide|mesh-list
102503451|NCT00003304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102503452|NCT00003304|Alkylating Agents|alkylating agents|mesh-ancestor
102503453|NCT00003304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503454|NCT00003304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503455|NCT00004006|Cyclophosphamide|cyclophosphamide|mesh-list
102503456|NCT00004006|Carboplatin|carboplatin|mesh-list
102503457|NCT00004006|Doxorubicin|doxorubicin|mesh-list
102503458|NCT00004006|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102503459|NCT00004006|Etoposide|etoposide|mesh-list
102503460|NCT00004006|Topotecan|topotecan|mesh-list
102503461|NCT00004006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102503462|NCT00004006|Immunologic Factors|immunologic factors|mesh-ancestor
102503463|NCT00004006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503464|NCT00004006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102503465|NCT00004006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102503466|NCT00004006|Alkylating Agents|alkylating agents|mesh-ancestor
102503467|NCT00004006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503468|NCT00004006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503469|NCT00004006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102503470|NCT00004006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102503471|NCT00004006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102503472|NCT00004006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102503473|NCT00004006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503474|NCT00004006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102503475|NCT00004006|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102503476|NCT00003316|Gemcitabine|gemcitabine|mesh-list
102503477|NCT00003316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102503478|NCT00003316|Antimetabolites|antimetabolites|mesh-ancestor
102503479|NCT00003316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503480|NCT00003316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503481|NCT00089024|Leucovorin|leucovorin|mesh-list
102503482|NCT00089024|Gemcitabine|gemcitabine|mesh-list
102503483|NCT00089024|Fluorouracil|fluorouracil|mesh-list
102503484|NCT00089024|Oxaliplatin|oxaliplatin|mesh-list
102503485|NCT00089024|Calcium|calcium|mesh-list
102503486|NCT00089024|Levoleucovorin|levoleucovorin|mesh-list
102503487|NCT00089024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102503488|NCT00089024|Antimetabolites|antimetabolites|mesh-ancestor
102503489|NCT00089024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503490|NCT00089024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503491|NCT00089024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102503492|NCT00089024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503493|NCT00089024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102503494|NCT00089024|Immunologic Factors|immunologic factors|mesh-ancestor
102503495|NCT00089024|Antidotes|antidotes|mesh-ancestor
102503496|NCT00089024|Protective Agents|protective agents|mesh-ancestor
102503497|NCT00089024|Vitamin B Complex|vitamin b complex|mesh-ancestor
102503498|NCT00089024|Vitamins|vitamins|mesh-ancestor
102503499|NCT00089024|Micronutrients|micronutrients|mesh-ancestor
102503500|NCT00003322|Paclitaxel|paclitaxel|mesh-list
102503501|NCT00003322|Cisplatin|cisplatin|mesh-list
102503502|NCT00003322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102503503|NCT00003322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503504|NCT00003322|Tubulin Modulators|tubulin modulators|mesh-ancestor
102503505|NCT00003322|Antimitotic Agents|antimitotic agents|mesh-ancestor
102503506|NCT00003322|Mitosis Modulators|mitosis modulators|mesh-ancestor
102503507|NCT00003322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503508|NCT00519818|Hydrocortisone|hydrocortisone|mesh-list
102503509|NCT00519818|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102503510|NCT00519818|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102503511|NCT00519818|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102503512|NCT00519818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102503513|NCT00003748|Irinotecan|irinotecan|mesh-list
102503514|NCT00003748|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102503515|NCT00003748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102503516|NCT00003748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503517|NCT00003748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503518|NCT00003748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503519|NCT00089102|Gemcitabine|gemcitabine|mesh-list
102503520|NCT00089102|Irinotecan|irinotecan|mesh-list
102503521|NCT00089102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102503522|NCT00089102|Antimetabolites|antimetabolites|mesh-ancestor
102503523|NCT00089102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503524|NCT00089102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503525|NCT00089102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102503526|NCT00089102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102503527|NCT00089102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503528|NCT00004012|Capecitabine|capecitabine|mesh-list
102503529|NCT00004012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102503530|NCT00004012|Antimetabolites|antimetabolites|mesh-ancestor
102503531|NCT00004012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503532|NCT00004012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503533|NCT00003754|Thalidomide|thalidomide|mesh-list
102503534|NCT00003754|Cyclophosphamide|cyclophosphamide|mesh-list
102503535|NCT00003754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102503536|NCT00003754|Immunologic Factors|immunologic factors|mesh-ancestor
102503537|NCT00003754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503538|NCT00003754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102503539|NCT00003754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102503540|NCT00003754|Alkylating Agents|alkylating agents|mesh-ancestor
102503541|NCT00003754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503542|NCT00003754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503543|NCT00003754|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102503544|NCT00003754|Leprostatic Agents|leprostatic agents|mesh-ancestor
102503545|NCT00003754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102503546|NCT00003754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102503547|NCT00003754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102503548|NCT00003754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102503549|NCT00003754|Growth Substances|growth substances|mesh-ancestor
102503550|NCT00003754|Growth Inhibitors|growth inhibitors|mesh-ancestor
102503551|NCT00003328|Porfiromycin|porfiromycin|mesh-list
102503552|NCT00003328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102503553|NCT00003328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503554|NCT00004024|Aldesleukin|aldesleukin|mesh-list
102503555|NCT00004024|Sargramostim|sargramostim|mesh-list
102503556|NCT00004024|Muromonab-CD3|muromonab-cd3|mesh-list
102503557|NCT00004024|Immunologic Factors|immunologic factors|mesh-ancestor
102503558|NCT00004024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503559|NCT00004024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503560|NCT00004024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102503561|NCT00004024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102503562|NCT00004024|Antiviral Agents|antiviral agents|mesh-ancestor
102503563|NCT00004024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102503564|NCT00004024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102503566|NCT00003334|Doxorubicin|doxorubicin|mesh-list
102503567|NCT00003334|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101979806|NCT01372982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503568|NCT00003334|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102503569|NCT00003334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503570|NCT00003334|Tubulin Modulators|tubulin modulators|mesh-ancestor
102503571|NCT00003334|Antimitotic Agents|antimitotic agents|mesh-ancestor
102503572|NCT00003334|Mitosis Modulators|mitosis modulators|mesh-ancestor
102503573|NCT00003334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503574|NCT00003334|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102503575|NCT00003334|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102503576|NCT00003334|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102503577|NCT00003334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503578|NCT00093782|Sirolimus|sirolimus|mesh-list
102503579|NCT00093782|Temsirolimus|temsirolimus|mesh-list
102503580|NCT00093782|MTOR Inhibitors|mtor inhibitors|mesh-list
102503581|NCT00093782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102503582|NCT00093782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503583|NCT00093782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503584|NCT00093782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102503585|NCT00093782|Immunologic Factors|immunologic factors|mesh-ancestor
102503586|NCT00093782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503587|NCT00093782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503588|NCT00093782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102503589|NCT00093782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102503590|NCT00093782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102503591|NCT00093782|Antifungal Agents|antifungal agents|mesh-ancestor
102503592|NCT00003760|Irofulven|irofulven|mesh-list
102503593|NCT00003760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102503594|NCT00003760|Alkylating Agents|alkylating agents|mesh-ancestor
102503595|NCT00003760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503596|NCT00003760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503597|NCT04771754|Dolutegravir|dolutegravir|mesh-list
102503598|NCT04771754|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102503599|NCT04771754|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102503600|NCT04771754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503601|NCT04771754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503602|NCT04771754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102503603|NCT04771754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102503604|NCT04771754|Antiviral Agents|antiviral agents|mesh-ancestor
102503605|NCT04771754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102503606|NCT00003766|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
102503607|NCT00003766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503608|NCT00003766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503609|NCT00003766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503610|NCT00004030|Doxorubicin|doxorubicin|mesh-list
102503611|NCT00004030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102503612|NCT00004030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102503613|NCT00004030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503614|NCT00004030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102503615|NCT00004030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102503616|NCT00004030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503617|NCT00004030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503618|NCT04389320|Hydroxychloroquine|hydroxychloroquine|mesh-list
102503619|NCT04389320|Antimalarials|antimalarials|mesh-ancestor
102503620|NCT04389320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102503621|NCT04389320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102503622|NCT04389320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102503623|NCT04389320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503624|NCT04389320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503625|NCT04389320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102503626|NCT00003340|Cyclophosphamide|cyclophosphamide|mesh-list
102503627|NCT00003340|Topotecan|topotecan|mesh-list
102503628|NCT00003340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102503629|NCT00003340|Immunologic Factors|immunologic factors|mesh-ancestor
102503630|NCT00003340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503631|NCT00003340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102503632|NCT00003340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102503633|NCT00003340|Alkylating Agents|alkylating agents|mesh-ancestor
102503634|NCT00003340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315160|NCT02244944|Ezetimibe|ezetimibe|mesh-list
102503635|NCT00003340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503636|NCT00003340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102503637|NCT00003340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102503638|NCT00003340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102503639|NCT00003340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503641|NCT00004036|Carboplatin|carboplatin|mesh-list
102503642|NCT00004036|Sargramostim|sargramostim|mesh-list
102503643|NCT00004036|Amifostine|amifostine|mesh-list
102503644|NCT00004036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102503645|NCT00004036|Immunologic Factors|immunologic factors|mesh-ancestor
102503646|NCT00004036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503647|NCT00004036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102503648|NCT00004036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102503649|NCT00004036|Alkylating Agents|alkylating agents|mesh-ancestor
102503650|NCT00004036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503651|NCT00004036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503652|NCT00004036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102503653|NCT00004036|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102503654|NCT00004036|Protective Agents|protective agents|mesh-ancestor
102503655|NCT00003346|Acetaminophen|acetaminophen|mesh-list
102503656|NCT00003346|Acetylcysteine|acetylcysteine|mesh-list
102503657|NCT00003346|Carmustine|carmustine|mesh-list
102503658|NCT00003346|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102503659|NCT00003346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102503660|NCT00003346|Analgesics|analgesics|mesh-ancestor
102503661|NCT00003346|Sensory System Agents|sensory system agents|mesh-ancestor
102503662|NCT00003346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102503663|NCT00003346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503664|NCT00003346|Antipyretics|antipyretics|mesh-ancestor
102503665|NCT00003346|Antiviral Agents|antiviral agents|mesh-ancestor
102503666|NCT00003346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102503667|NCT00003346|Expectorants|expectorants|mesh-ancestor
102503668|NCT00003346|Respiratory System Agents|respiratory system agents|mesh-ancestor
102503669|NCT00003346|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102503670|NCT00003346|Antioxidants|antioxidants|mesh-ancestor
102503671|NCT00003346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503672|NCT00003346|Protective Agents|protective agents|mesh-ancestor
102503673|NCT00003346|Antidotes|antidotes|mesh-ancestor
102503674|NCT00003346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102503675|NCT00003346|Alkylating Agents|alkylating agents|mesh-ancestor
102503676|NCT00003346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503677|NCT00096122|Cytarabine|cytarabine|mesh-list
102503678|NCT00096122|Idarubicin|idarubicin|mesh-list
102503679|NCT00096122|Tipifarnib|tipifarnib|mesh-list
102503680|NCT00096122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102503681|NCT00096122|Antimetabolites|antimetabolites|mesh-ancestor
102503682|NCT00096122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503683|NCT00096122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503684|NCT00096122|Antiviral Agents|antiviral agents|mesh-ancestor
102503685|NCT00096122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102503686|NCT00096122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102503687|NCT00096122|Immunologic Factors|immunologic factors|mesh-ancestor
102503688|NCT00096122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503689|NCT00096122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102503690|NCT00096122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102503691|NCT00096122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102503692|NCT00096122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503693|NCT00003778|Dolastatin 10|dolastatin 10|mesh-list
102503694|NCT00003778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503695|NCT00003778|Tubulin Modulators|tubulin modulators|mesh-ancestor
102503696|NCT00003778|Antimitotic Agents|antimitotic agents|mesh-ancestor
102503697|NCT00003778|Mitosis Modulators|mitosis modulators|mesh-ancestor
102503698|NCT00003778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503699|NCT00004042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102503700|NCT00004042|Antibodies|antibodies|mesh-list
102503701|NCT00004042|Immunoglobulins|immunoglobulins|mesh-list
102503702|NCT00004042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102503703|NCT00004042|Immunologic Factors|immunologic factors|mesh-ancestor
102503704|NCT00004042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503705|NCT00004042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503706|NCT00003784|Prednisone|prednisone|mesh-list
102503707|NCT00003784|Cyclophosphamide|cyclophosphamide|mesh-list
102503708|NCT00003784|Doxorubicin|doxorubicin|mesh-list
102503709|NCT00003784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102503710|NCT00003784|Vincristine|vincristine|mesh-list
102503711|NCT00003784|Tositumomab I-131|tositumomab i-131|mesh-list
101979941|NCT01319942|Sorafenib|sorafenib|mesh-list
102503712|NCT00003784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102503714|NCT00003784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503715|NCT00003784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102503716|NCT00003784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102503717|NCT00003784|Alkylating Agents|alkylating agents|mesh-ancestor
102503718|NCT00003784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503719|NCT00003784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503720|NCT00003784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102503721|NCT00003784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102503722|NCT00003784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102503723|NCT00003784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102503724|NCT00003784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503725|NCT00003784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102503726|NCT00003784|Glucocorticoids|glucocorticoids|mesh-ancestor
102503727|NCT00003784|Hormones|hormones|mesh-ancestor
102503728|NCT00003784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102503729|NCT00003784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102503730|NCT00003784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102503731|NCT00003784|Tubulin Modulators|tubulin modulators|mesh-ancestor
102503732|NCT00003784|Antimitotic Agents|antimitotic agents|mesh-ancestor
102503733|NCT00003784|Mitosis Modulators|mitosis modulators|mesh-ancestor
102503734|NCT00003352|Cyclophosphamide|cyclophosphamide|mesh-list
102503735|NCT00003352|Docetaxel|docetaxel|mesh-list
102503736|NCT00003352|Doxorubicin|doxorubicin|mesh-list
102503737|NCT00003352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102503738|NCT00003352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102503739|NCT00003352|Immunologic Factors|immunologic factors|mesh-ancestor
102503740|NCT00003352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503741|NCT00003352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102503742|NCT00003352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102503743|NCT00003352|Alkylating Agents|alkylating agents|mesh-ancestor
102503744|NCT00003352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503745|NCT00003352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503746|NCT00003352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102503747|NCT00003352|Tubulin Modulators|tubulin modulators|mesh-ancestor
102503748|NCT00003352|Antimitotic Agents|antimitotic agents|mesh-ancestor
102503749|NCT00003352|Mitosis Modulators|mitosis modulators|mesh-ancestor
102503750|NCT00003352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102503751|NCT00003352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102503752|NCT00003352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102503753|NCT00003352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503754|NCT00004048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102503755|NCT00004048|Doxorubicin|doxorubicin|mesh-list
102503756|NCT00004048|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102503757|NCT00004048|Antibodies|antibodies|mesh-list
102503758|NCT00004048|Immunoglobulins|immunoglobulins|mesh-list
102503759|NCT00004048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102503760|NCT00004048|Immunologic Factors|immunologic factors|mesh-ancestor
102503761|NCT00004048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503762|NCT00004048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503763|NCT00004048|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102503764|NCT00004048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102503765|NCT00004048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102503766|NCT00004048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503767|NCT00004048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503768|NCT00003358|Gemcitabine|gemcitabine|mesh-list
102503769|NCT00003358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503770|NCT00003358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102503771|NCT00003358|Antimetabolites|antimetabolites|mesh-ancestor
102503772|NCT00003358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503773|NCT00004060|Exatecan|exatecan|mesh-list
102503774|NCT00004060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102503775|NCT00004060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102503776|NCT00004060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503777|NCT00004060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503778|NCT00004060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503779|NCT00384826|Paclitaxel|paclitaxel|mesh-list
102503780|NCT00384826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102503781|NCT00384826|Carboplatin|carboplatin|mesh-list
102503782|NCT00384826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102503783|NCT00384826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503784|NCT00384826|Tubulin Modulators|tubulin modulators|mesh-ancestor
102503785|NCT00384826|Antimitotic Agents|antimitotic agents|mesh-ancestor
102503786|NCT00384826|Mitosis Modulators|mitosis modulators|mesh-ancestor
102503787|NCT00384826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503788|NCT00384826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102503789|NCT00384826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503790|NCT00003364|Cyclophosphamide|cyclophosphamide|mesh-list
102503791|NCT00003364|Doxorubicin|doxorubicin|mesh-list
102503792|NCT00003364|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102503794|NCT00003364|Vincristine|vincristine|mesh-list
102503795|NCT00003364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102503796|NCT00003364|Immunologic Factors|immunologic factors|mesh-ancestor
102503797|NCT00003364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503798|NCT00003364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102503799|NCT00003364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102503800|NCT00003364|Alkylating Agents|alkylating agents|mesh-ancestor
102503801|NCT00003364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503802|NCT00003364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503803|NCT00003364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102503804|NCT00003364|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102503805|NCT00003364|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102503806|NCT00003364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102503807|NCT00003364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503808|NCT00003364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102503809|NCT00003364|Tubulin Modulators|tubulin modulators|mesh-ancestor
102503810|NCT00003364|Antimitotic Agents|antimitotic agents|mesh-ancestor
102503811|NCT00003364|Mitosis Modulators|mitosis modulators|mesh-ancestor
102503812|NCT00004066|Gemcitabine|gemcitabine|mesh-list
102503813|NCT00004066|Docetaxel|docetaxel|mesh-list
102503814|NCT00004066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102503815|NCT00004066|Antimetabolites|antimetabolites|mesh-ancestor
102503816|NCT00004066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503817|NCT00004066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503818|NCT00004066|Tubulin Modulators|tubulin modulators|mesh-ancestor
102503819|NCT00004066|Antimitotic Agents|antimitotic agents|mesh-ancestor
102503820|NCT00004066|Mitosis Modulators|mitosis modulators|mesh-ancestor
102503821|NCT00003370|Irofulven|irofulven|mesh-list
102503822|NCT00003370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102503823|NCT00003370|Alkylating Agents|alkylating agents|mesh-ancestor
102503824|NCT00003370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503825|NCT00003370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503826|NCT00003382|Gemcitabine|gemcitabine|mesh-list
102503827|NCT00003382|Topotecan|topotecan|mesh-list
102503828|NCT00003382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102503829|NCT00003382|Antimetabolites|antimetabolites|mesh-ancestor
102503830|NCT00003382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503831|NCT00003382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503832|NCT00003382|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102503833|NCT00003382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102503834|NCT00003382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503835|NCT00004834|Imipramine|imipramine|mesh-list
102503836|NCT00004834|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102503837|NCT00004834|Antidepressive Agents|antidepressive agents|mesh-ancestor
102503838|NCT00004834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102503839|NCT00004834|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102503840|NCT00004834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102503841|NCT00004834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102503842|NCT00004834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503843|NCT00004834|Adrenergic Agents|adrenergic agents|mesh-ancestor
102503844|NCT00004834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102503845|NCT00004834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503846|NCT00004840|Hormones|hormones|mesh-list
102503847|NCT00004840|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
102503848|NCT00004840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102503849|NCT00004840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503850|NCT00004852|Lamivudine|lamivudine|mesh-list
102503851|NCT00004852|Zidovudine|zidovudine|mesh-list
102503852|NCT00004852|Efavirenz|efavirenz|mesh-list
102503853|NCT00004852|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102503854|NCT00004852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102503855|NCT00004852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503856|NCT00004852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503857|NCT00004852|Antiviral Agents|antiviral agents|mesh-ancestor
102503858|NCT00004852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102503859|NCT00004852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102503860|NCT00004852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102503862|NCT00004852|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102503863|NCT00004852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102503864|NCT00004852|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102503865|NCT00004852|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102503866|NCT00004852|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102503867|NCT00004852|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102503868|NCT00004858|Genistein|genistein|mesh-list
102503869|NCT00004858|Immunoconjugates|immunoconjugates|mesh-list
102503870|NCT00004858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102503871|NCT00004858|Protective Agents|protective agents|mesh-ancestor
102503872|NCT00004858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503873|NCT00004858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503874|NCT00004858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102503875|NCT00004858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503876|NCT00004858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503877|NCT00004858|Phytoestrogens|phytoestrogens|mesh-ancestor
102503878|NCT00004858|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102503879|NCT00004858|Estrogens|estrogens|mesh-ancestor
102503880|NCT00004858|Hormones|hormones|mesh-ancestor
102503881|NCT00004858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102503882|NCT00004858|Immunologic Factors|immunologic factors|mesh-ancestor
102503883|NCT00004864|Docetaxel|docetaxel|mesh-list
102503884|NCT00004864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503885|NCT00004864|Tubulin Modulators|tubulin modulators|mesh-ancestor
102503886|NCT00004864|Antimitotic Agents|antimitotic agents|mesh-ancestor
102503887|NCT00004864|Mitosis Modulators|mitosis modulators|mesh-ancestor
102503888|NCT00004864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503889|NCT00003796|Irofulven|irofulven|mesh-list
102503890|NCT00003796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102503891|NCT00003796|Alkylating Agents|alkylating agents|mesh-ancestor
102503892|NCT00003796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503893|NCT00003796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503894|NCT00003802|NSC 366140|nsc 366140|mesh-list
102503895|NCT00003802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503896|NCT02972866|Budesonide|budesonide|mesh-list
102503897|NCT02972866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102503898|NCT02972866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102503899|NCT02972866|Autonomic Agents|autonomic agents|mesh-ancestor
102503900|NCT02972866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102503901|NCT02972866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503902|NCT02972866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102503903|NCT02972866|Respiratory System Agents|respiratory system agents|mesh-ancestor
102503904|NCT02972866|Glucocorticoids|glucocorticoids|mesh-ancestor
102503905|NCT02972866|Hormones|hormones|mesh-ancestor
102503906|NCT02972866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102503907|NCT00003814|Eflornithine|eflornithine|mesh-list
102503908|NCT00003814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503909|NCT00003814|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102503910|NCT00003814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102503911|NCT00003814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102503912|NCT00003814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102503913|NCT00003814|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
102503914|NCT00003814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503915|NCT00003814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503916|NCT00003832|Bromodeoxyuridine|bromodeoxyuridine|mesh-list
102503917|NCT00003832|5-bromouridine|5-bromouridine|mesh-list
102503918|NCT00003832|Antimetabolites|antimetabolites|mesh-ancestor
102503919|NCT00003832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503920|NCT00003832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102503921|NCT00003832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503922|NCT00003832|Antiviral Agents|antiviral agents|mesh-ancestor
102503923|NCT00003832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102503924|NCT00003850|Thalidomide|thalidomide|mesh-list
102503925|NCT00003850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102503926|NCT00003850|Immunologic Factors|immunologic factors|mesh-ancestor
102503927|NCT00003850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503928|NCT00003850|Leprostatic Agents|leprostatic agents|mesh-ancestor
102503929|NCT00003850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102503930|NCT00003850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102503931|NCT00003850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102503932|NCT00003850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102503933|NCT00003850|Growth Substances|growth substances|mesh-ancestor
102315460|NCT01627249|Bevacizumab|bevacizumab|mesh-list
102503934|NCT00003850|Growth Inhibitors|growth inhibitors|mesh-ancestor
102503935|NCT00003850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503937|NCT00004072|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
102503938|NCT00004072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102503939|NCT00004072|Alkylating Agents|alkylating agents|mesh-ancestor
102503940|NCT00004072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503941|NCT00004072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503942|NCT00004072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503943|NCT00004078|Irinotecan|irinotecan|mesh-list
102503944|NCT00004078|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102503945|NCT00004078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102503946|NCT00004078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503947|NCT00004078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503948|NCT00004078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503949|NCT00003856|Temoporfin|temoporfin|mesh-list
102503950|NCT00003856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503951|NCT00003856|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102503952|NCT00003856|Dermatologic Agents|dermatologic agents|mesh-ancestor
102503953|NCT00014222|Paclitaxel|paclitaxel|mesh-list
102503954|NCT00014222|Cyclophosphamide|cyclophosphamide|mesh-list
102503955|NCT00014222|Doxorubicin|doxorubicin|mesh-list
102503956|NCT00014222|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102503957|NCT00014222|Fluorouracil|fluorouracil|mesh-list
102503958|NCT00014222|Epirubicin|epirubicin|mesh-list
102503959|NCT00014222|Epoetin Alfa|epoetin alfa|mesh-list
102503960|NCT00014222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102503961|NCT00014222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503962|NCT00014222|Tubulin Modulators|tubulin modulators|mesh-ancestor
102503963|NCT00014222|Antimitotic Agents|antimitotic agents|mesh-ancestor
102503964|NCT00014222|Mitosis Modulators|mitosis modulators|mesh-ancestor
102503965|NCT00014222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503966|NCT00014222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102503967|NCT00014222|Immunologic Factors|immunologic factors|mesh-ancestor
102503968|NCT00014222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503969|NCT00014222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102503970|NCT00014222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102503971|NCT00014222|Alkylating Agents|alkylating agents|mesh-ancestor
102503972|NCT00014222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102503973|NCT00014222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102503974|NCT00014222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102503975|NCT00014222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102503976|NCT00014222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503977|NCT00014222|Antimetabolites|antimetabolites|mesh-ancestor
102503978|NCT00014222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102503979|NCT00014222|Hematinics|hematinics|mesh-ancestor
102503980|NCT00004870|Irinotecan|irinotecan|mesh-list
102503981|NCT00004870|Oblimersen|oblimersen|mesh-list
102503982|NCT00004870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102503983|NCT00004870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102503984|NCT00004870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102503985|NCT00004870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102503986|NCT00004870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503987|NCT00004084|Epratuzumab|epratuzumab|mesh-list
102503988|NCT00004084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102503989|NCT00004084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503990|NCT00004876|Thalidomide|thalidomide|mesh-list
102503991|NCT00004876|Carboplatin|carboplatin|mesh-list
102503992|NCT00004876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102503993|NCT00004876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102503994|NCT00004876|Immunologic Factors|immunologic factors|mesh-ancestor
102503995|NCT00004876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102503996|NCT00004876|Leprostatic Agents|leprostatic agents|mesh-ancestor
102503997|NCT00004876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102503998|NCT00004876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102503999|NCT00004876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102504000|NCT00004876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102504001|NCT00004876|Growth Substances|growth substances|mesh-ancestor
102504002|NCT00004876|Growth Inhibitors|growth inhibitors|mesh-ancestor
102504003|NCT00003862|Leucovorin|leucovorin|mesh-list
102504004|NCT00003862|Paclitaxel|paclitaxel|mesh-list
102504005|NCT00003862|Fluorouracil|fluorouracil|mesh-list
102504006|NCT00003862|Calcium|calcium|mesh-list
102504007|NCT00003862|Levoleucovorin|levoleucovorin|mesh-list
102504008|NCT00003862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102504009|NCT00003862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504010|NCT00003862|Tubulin Modulators|tubulin modulators|mesh-ancestor
102504011|NCT00003862|Antimitotic Agents|antimitotic agents|mesh-ancestor
102504012|NCT00003862|Mitosis Modulators|mitosis modulators|mesh-ancestor
102504013|NCT00003862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504014|NCT00003862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102504015|NCT00003862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504016|NCT00003862|Antimetabolites|antimetabolites|mesh-ancestor
102504017|NCT00003862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102504018|NCT00003862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102504019|NCT00003862|Immunologic Factors|immunologic factors|mesh-ancestor
102504020|NCT00003862|Antidotes|antidotes|mesh-ancestor
102504021|NCT00003862|Protective Agents|protective agents|mesh-ancestor
102504022|NCT00003862|Vitamin B Complex|vitamin b complex|mesh-ancestor
102504023|NCT00003862|Vitamins|vitamins|mesh-ancestor
102504024|NCT00003862|Micronutrients|micronutrients|mesh-ancestor
102504025|NCT00003868|Cyclophosphamide|cyclophosphamide|mesh-list
102504026|NCT00003868|Methotrexate|methotrexate|mesh-list
102504027|NCT00003868|Antibodies|antibodies|mesh-list
102504028|NCT00003868|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102504029|NCT00003868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102504030|NCT00003868|Immunologic Factors|immunologic factors|mesh-ancestor
102504031|NCT00003868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504032|NCT00003868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102504033|NCT00003868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102504034|NCT00003868|Alkylating Agents|alkylating agents|mesh-ancestor
102504035|NCT00003868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504036|NCT00003868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504037|NCT00003868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102504038|NCT00003868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102504039|NCT00003868|Abortifacient Agents|abortifacient agents|mesh-ancestor
102504040|NCT00003868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102504041|NCT00003868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102504042|NCT00003868|Antimetabolites|antimetabolites|mesh-ancestor
102504043|NCT00003868|Dermatologic Agents|dermatologic agents|mesh-ancestor
102504044|NCT00003868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102504045|NCT00003868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102504046|NCT00003868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102504047|NCT00003874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102504048|NCT00003874|Antibodies|antibodies|mesh-list
102504049|NCT00003874|Immunoglobulins|immunoglobulins|mesh-list
102504050|NCT00003874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102504051|NCT00003874|Immunologic Factors|immunologic factors|mesh-ancestor
102504052|NCT00003874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504053|NCT00003874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504054|NCT00004090|Gemcitabine|gemcitabine|mesh-list
102504055|NCT00004090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504056|NCT00004090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102504057|NCT00004090|Antimetabolites|antimetabolites|mesh-ancestor
102504058|NCT00004090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504059|NCT00004102|Leucovorin|leucovorin|mesh-list
102504060|NCT00004102|Fluorouracil|fluorouracil|mesh-list
102504061|NCT00004102|Oxaliplatin|oxaliplatin|mesh-list
102504062|NCT00004102|Calcium|calcium|mesh-list
102504063|NCT00004102|Levoleucovorin|levoleucovorin|mesh-list
102504064|NCT00004102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102504065|NCT00004102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504066|NCT00004102|Antimetabolites|antimetabolites|mesh-ancestor
102504067|NCT00004102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504068|NCT00004102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102504069|NCT00004102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504070|NCT00004102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102504071|NCT00004102|Immunologic Factors|immunologic factors|mesh-ancestor
102504072|NCT00004102|Antidotes|antidotes|mesh-ancestor
102504073|NCT00004102|Protective Agents|protective agents|mesh-ancestor
102504074|NCT00004102|Vitamin B Complex|vitamin b complex|mesh-ancestor
102504075|NCT00004102|Vitamins|vitamins|mesh-ancestor
102504076|NCT00004102|Micronutrients|micronutrients|mesh-ancestor
102504077|NCT00003880|Paclitaxel|paclitaxel|mesh-list
102504078|NCT00003880|Carboplatin|carboplatin|mesh-list
102504079|NCT00003880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102504080|NCT00003880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504081|NCT00003880|Tubulin Modulators|tubulin modulators|mesh-ancestor
102504082|NCT00003880|Antimitotic Agents|antimitotic agents|mesh-ancestor
102504083|NCT00003880|Mitosis Modulators|mitosis modulators|mesh-ancestor
102504084|NCT00003880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504085|NCT00004108|Exatecan|exatecan|mesh-list
102504086|NCT00004108|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102504087|NCT00004108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102504088|NCT00004108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102504089|NCT00004108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504091|NCT00004900|Cyclophosphamide|cyclophosphamide|mesh-list
102504092|NCT00004900|Thiotepa|thiotepa|mesh-list
102504093|NCT00004900|Carboplatin|carboplatin|mesh-list
102504094|NCT00004900|Etoposide|etoposide|mesh-list
102504095|NCT00004900|Anastrozole|anastrozole|mesh-list
102504096|NCT00004900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102504097|NCT00004900|Immunologic Factors|immunologic factors|mesh-ancestor
102504098|NCT00004900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504099|NCT00004900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102504100|NCT00004900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102504101|NCT00004900|Alkylating Agents|alkylating agents|mesh-ancestor
102504102|NCT00004900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504103|NCT00004900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504104|NCT00004900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102504105|NCT00004900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102504106|NCT00004900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102504107|NCT00004900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102504108|NCT00004900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102504109|NCT00004900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102504110|NCT00004900|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102504111|NCT00004900|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102504112|NCT00004900|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102504113|NCT00004900|Hormone Antagonists|hormone antagonists|mesh-ancestor
102504114|NCT00004900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102504115|NCT00004114|Cytarabine|cytarabine|mesh-list
102504116|NCT00004114|Cyclophosphamide|cyclophosphamide|mesh-list
102504117|NCT00004114|Fludarabine|fludarabine|mesh-list
102504118|NCT00004114|Fludarabine phosphate|fludarabine phosphate|mesh-list
102504119|NCT00004114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102504120|NCT00004114|Immunologic Factors|immunologic factors|mesh-ancestor
102504121|NCT00004114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504122|NCT00004114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102504123|NCT00004114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102504124|NCT00004114|Alkylating Agents|alkylating agents|mesh-ancestor
102504125|NCT00004114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504126|NCT00004114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504127|NCT00004114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102504128|NCT00004114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102504129|NCT00004114|Antimetabolites|antimetabolites|mesh-ancestor
102504130|NCT00004114|Antiviral Agents|antiviral agents|mesh-ancestor
102504131|NCT00004114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102504132|NCT00004906|Pamidronate|pamidronate|mesh-list
102504133|NCT00004906|Cyclophosphamide|cyclophosphamide|mesh-list
102504134|NCT00004906|Thiotepa|thiotepa|mesh-list
102504135|NCT00004906|Carboplatin|carboplatin|mesh-list
102504136|NCT00004906|Docetaxel|docetaxel|mesh-list
102504137|NCT00004906|Doxorubicin|doxorubicin|mesh-list
102504138|NCT00004906|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102504139|NCT00004906|Etoposide|etoposide|mesh-list
102504140|NCT00004906|Anastrozole|anastrozole|mesh-list
102504141|NCT00004906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102504142|NCT00004906|Immunologic Factors|immunologic factors|mesh-ancestor
102504143|NCT00004906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504144|NCT00004906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102504145|NCT00004906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102504146|NCT00004906|Alkylating Agents|alkylating agents|mesh-ancestor
102504147|NCT00004906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504148|NCT00004906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504149|NCT00004906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102504150|NCT00004906|Tubulin Modulators|tubulin modulators|mesh-ancestor
102504151|NCT00004906|Antimitotic Agents|antimitotic agents|mesh-ancestor
102504152|NCT00004906|Mitosis Modulators|mitosis modulators|mesh-ancestor
102504153|NCT00004906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102504154|NCT00004906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102504155|NCT00004906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102504156|NCT00004906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102504157|NCT00004906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102504158|NCT00004906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102504159|NCT00004906|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102504160|NCT00004906|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102504161|NCT00004906|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102504162|NCT00004906|Hormone Antagonists|hormone antagonists|mesh-ancestor
102504163|NCT00004906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102504164|NCT00004906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102504166|NCT00004918|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
102504167|NCT00004918|Immunologic Factors|immunologic factors|mesh-ancestor
102504168|NCT00004918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504169|NCT00004918|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102504170|NCT00003892|ISIS 5132|isis 5132|mesh-list
102504171|NCT00003892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504172|NCT00003892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102504173|NCT00003892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504174|NCT00004132|Cyclophosphamide|cyclophosphamide|mesh-list
102504175|NCT00004132|Ifosfamide|ifosfamide|mesh-list
102504176|NCT00004132|Etoposide|etoposide|mesh-list
102504177|NCT00004132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102504178|NCT00004132|Immunologic Factors|immunologic factors|mesh-ancestor
102504179|NCT00004132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504180|NCT00004132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102504181|NCT00004132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102504182|NCT00004132|Alkylating Agents|alkylating agents|mesh-ancestor
102504183|NCT00004132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504184|NCT00004132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504185|NCT00004132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102504186|NCT00004132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102504187|NCT00004132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102504188|NCT00004132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102504189|NCT00004132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102504190|NCT00004138|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102504191|NCT00004138|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102504192|NCT00004138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504193|NCT05776940|Dexamethasone|dexamethasone|mesh-list
102504194|NCT05776940|Dexamethasone acetate|dexamethasone acetate|mesh-list
102504195|NCT05776940|Bortezomib|bortezomib|mesh-list
102504196|NCT05776940|Daratumumab|daratumumab|mesh-list
102504197|NCT05776940|BB 1101|bb 1101|mesh-list
102504198|NCT05776940|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102504199|NCT05776940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102504200|NCT05776940|Antiemetics|antiemetics|mesh-ancestor
102504201|NCT05776940|Autonomic Agents|autonomic agents|mesh-ancestor
102504202|NCT05776940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102504203|NCT05776940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504204|NCT05776940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102504205|NCT05776940|Glucocorticoids|glucocorticoids|mesh-ancestor
102504206|NCT05776940|Hormones|hormones|mesh-ancestor
102504207|NCT05776940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102504208|NCT05776940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102504209|NCT05776940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504210|NCT05776940|Protease Inhibitors|protease inhibitors|mesh-ancestor
102504211|NCT05776940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102504212|NCT05776940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504213|NCT05776940|Immunologic Factors|immunologic factors|mesh-ancestor
102504214|NCT05776862|Ursolic acid|ursolic acid|mesh-list
102504215|NCT05776862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102504216|NCT05776862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102504217|NCT05776862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504218|NCT05776862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102504219|NCT05776862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102504220|NCT05776862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504221|NCT05776862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102504222|NCT05776862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102504223|NCT05776862|Analgesics|analgesics|mesh-ancestor
102504224|NCT05776862|Sensory System Agents|sensory system agents|mesh-ancestor
102504225|NCT05776862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102504226|NCT05776862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504227|NCT05776862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102504228|NCT05776862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102504229|NCT05776758|Cisplatin|cisplatin|mesh-list
102504230|NCT05776758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504231|NCT05776407|Cyclophosphamide|cyclophosphamide|mesh-list
102504232|NCT05776407|Fludarabine|fludarabine|mesh-list
102504233|NCT05776407|Etoposide|etoposide|mesh-list
102504234|NCT05776407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102504235|NCT05776407|Immunologic Factors|immunologic factors|mesh-ancestor
102504236|NCT05776407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504237|NCT05776407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102315751|NCT01922271|Respiratory System Agents|respiratory system agents|mesh-ancestor
102504238|NCT05776407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102504239|NCT05776407|Alkylating Agents|alkylating agents|mesh-ancestor
102504240|NCT05776407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504241|NCT05776407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504242|NCT05776407|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102504243|NCT05776407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102504244|NCT05776407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102504245|NCT05776407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102504246|NCT05776407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102504248|NCT05776212|Cariostatic Agents|cariostatic agents|mesh-ancestor
102504249|NCT05776212|Protective Agents|protective agents|mesh-ancestor
102504250|NCT05776212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504251|NCT05776186|Bupivacaine|bupivacaine|mesh-list
102504252|NCT05776186|Anesthetics, Local|anesthetics, local|mesh-ancestor
102504253|NCT05776186|Anesthetics|anesthetics|mesh-ancestor
102504254|NCT05776186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102504255|NCT05776186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504256|NCT05776186|Sensory System Agents|sensory system agents|mesh-ancestor
102504257|NCT05776186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102504258|NCT05776043|Dapagliflozin|dapagliflozin|mesh-list
102504259|NCT05776043|Empagliflozin|empagliflozin|mesh-list
101980483|NCT05194904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102504260|NCT05776043|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102504261|NCT05776043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504262|NCT05776043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102504263|NCT05776043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504264|NCT05775965|Aspirin|aspirin|mesh-list
102504265|NCT05775965|Rivaroxaban|rivaroxaban|mesh-list
102504266|NCT05775965|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102504267|NCT05775965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102504268|NCT05775965|Analgesics|analgesics|mesh-ancestor
102504269|NCT05775965|Sensory System Agents|sensory system agents|mesh-ancestor
102504270|NCT05775965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102504271|NCT05775965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504272|NCT05775965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102504273|NCT05775965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102504274|NCT05775965|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102504275|NCT05775965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102504276|NCT05775965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504277|NCT05775965|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102504278|NCT05775965|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102504279|NCT05775965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102504280|NCT05775965|Antipyretics|antipyretics|mesh-ancestor
102504281|NCT05775965|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102504282|NCT05775965|Antithrombins|antithrombins|mesh-ancestor
102504283|NCT05775965|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102504284|NCT05775965|Protease Inhibitors|protease inhibitors|mesh-ancestor
102504285|NCT05775965|Anticoagulants|anticoagulants|mesh-ancestor
102504286|NCT05775939|Deoxyglucose|deoxyglucose|mesh-list
102504287|NCT05775939|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102504288|NCT05775939|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102504289|NCT05775939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504290|NCT05775939|Antimetabolites|antimetabolites|mesh-ancestor
102504291|NCT05775939|Antiviral Agents|antiviral agents|mesh-ancestor
102504292|NCT05775939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102504293|NCT05775900|Capecitabine|capecitabine|mesh-list
102504294|NCT05775900|Cetuximab|cetuximab|mesh-list
102504295|NCT05775900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102504296|NCT05775900|Antimetabolites|antimetabolites|mesh-ancestor
102504297|NCT05775900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504298|NCT05775900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504299|NCT05775900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102504300|NCT05775874|Tislelizumab|tislelizumab|mesh-list
102504301|NCT05775874|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102504302|NCT05775874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102504303|NCT05775874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504304|NCT05775874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504305|NCT05775861|Dexmedetomidine|dexmedetomidine|mesh-list
102504306|NCT05775861|Ropivacaine|ropivacaine|mesh-list
102504307|NCT05775861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102504308|NCT05775861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102504309|NCT05775861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504310|NCT05775861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102504311|NCT05775861|Analgesics|analgesics|mesh-ancestor
102504312|NCT05775861|Sensory System Agents|sensory system agents|mesh-ancestor
102504313|NCT05775861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102504314|NCT05775861|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102504315|NCT05775861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102504316|NCT05775861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102504317|NCT05775861|Adrenergic Agents|adrenergic agents|mesh-ancestor
102504318|NCT05775861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102504319|NCT05775861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504320|NCT05775861|Anesthetics, Local|anesthetics, local|mesh-ancestor
102504321|NCT05775861|Anesthetics|anesthetics|mesh-ancestor
102504322|NCT05775770|Insulin|insulin|mesh-list
102504323|NCT05775770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102504324|NCT05775770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504325|NCT05775731|Hemostatics|hemostatics|mesh-list
102504326|NCT05775731|Coagulants|coagulants|mesh-ancestor
102504327|NCT05775705|Antibodies|antibodies|mesh-list
102504328|NCT05775705|Immunologic Factors|immunologic factors|mesh-ancestor
102504329|NCT05775705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504330|NCT05775692|Fluconazole|fluconazole|mesh-list
102504331|NCT05775692|Antifungal Agents|antifungal agents|mesh-ancestor
102504332|NCT05775692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102504333|NCT05775692|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102504334|NCT05775692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102504335|NCT05775692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102504336|NCT05775692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504337|NCT05775692|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102504338|NCT05775692|Hormone Antagonists|hormone antagonists|mesh-ancestor
102504339|NCT05775692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102504340|NCT05775692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504341|NCT05775692|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102504342|NCT05775692|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102504343|NCT05775536|Aspirin|aspirin|mesh-list
102504344|NCT05775536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102504345|NCT05775536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102504346|NCT05775536|Analgesics|analgesics|mesh-ancestor
102504347|NCT05775536|Sensory System Agents|sensory system agents|mesh-ancestor
102504348|NCT05775536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102504349|NCT05775536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504350|NCT05775536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102504351|NCT05775536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102504352|NCT05775536|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102504353|NCT05775536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102504354|NCT05775536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504355|NCT05775536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102504356|NCT05775536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102504357|NCT05775536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102504358|NCT05775536|Antipyretics|antipyretics|mesh-ancestor
102504359|NCT00004126|Paclitaxel|paclitaxel|mesh-list
102504360|NCT00004126|Oxaliplatin|oxaliplatin|mesh-list
102504361|NCT00004126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102504362|NCT00004126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504363|NCT00004126|Tubulin Modulators|tubulin modulators|mesh-ancestor
102504364|NCT00004126|Antimitotic Agents|antimitotic agents|mesh-ancestor
102504365|NCT00004126|Mitosis Modulators|mitosis modulators|mesh-ancestor
102504366|NCT00004126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504367|NCT05774964|Folic Acid|folic acid|mesh-list
102504368|NCT05774964|Vitamin A|vitamin a|mesh-list
102504369|NCT05774964|Metronidazole|metronidazole|mesh-list
102504370|NCT05774964|Oxaliplatin|oxaliplatin|mesh-list
102504371|NCT05774964|Cetuximab|cetuximab|mesh-list
102504372|NCT05774964|Tegafur|tegafur|mesh-list
102504373|NCT05774964|Vitamins|vitamins|mesh-ancestor
102504374|NCT05774964|Micronutrients|micronutrients|mesh-ancestor
102504375|NCT05774964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504376|NCT05774964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504377|NCT05774964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102504378|NCT05774964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102504379|NCT05774964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102504380|NCT05774964|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102504381|NCT05774964|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102504382|NCT05774964|Hematinics|hematinics|mesh-ancestor
102504383|NCT05774964|Vitamin B Complex|vitamin b complex|mesh-ancestor
102504384|NCT05774964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504385|NCT05774964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102504386|NCT05774964|Antimetabolites|antimetabolites|mesh-ancestor
102504387|NCT05774691|Heparin|heparin|mesh-list
102504388|NCT05774691|Calcium heparin|calcium heparin|mesh-list
102504389|NCT05774691|Protamines|protamines|mesh-list
102504390|NCT05774691|Anticoagulants|anticoagulants|mesh-ancestor
102504391|NCT05774691|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102504392|NCT05774691|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102504393|NCT05774691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504394|NCT05774691|Heparin Antagonists|heparin antagonists|mesh-ancestor
102504395|NCT05774691|Coagulants|coagulants|mesh-ancestor
102504396|NCT05773976|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102504397|NCT05773976|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102504398|NCT05773963|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102504399|NCT05773963|Lubricant Eye Drops|lubricant eye drops|mesh-list
102504400|NCT05773963|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102504401|NCT05773222|Apixaban|apixaban|mesh-list
102504402|NCT05773222|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102504403|NCT05773222|Antithrombins|antithrombins|mesh-ancestor
102504404|NCT05773222|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102504405|NCT05773222|Protease Inhibitors|protease inhibitors|mesh-ancestor
102504406|NCT05773222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102504407|NCT05773222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504408|NCT05773222|Anticoagulants|anticoagulants|mesh-ancestor
102504409|NCT05638594|Carboplatin|carboplatin|mesh-list
102504410|NCT05638594|Docetaxel|docetaxel|mesh-list
102504411|NCT05638594|Trastuzumab|trastuzumab|mesh-list
102504412|NCT05638594|Letrozole|letrozole|mesh-list
102504413|NCT05638594|Pertuzumab|pertuzumab|mesh-list
102504414|NCT05638594|Hormones|hormones|mesh-list
102504415|NCT05638594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504416|NCT05638594|Tubulin Modulators|tubulin modulators|mesh-ancestor
102504417|NCT05638594|Antimitotic Agents|antimitotic agents|mesh-ancestor
102504418|NCT05638594|Mitosis Modulators|mitosis modulators|mesh-ancestor
102504419|NCT05638594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504420|NCT05638594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102504421|NCT05638594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102504422|NCT05638594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504423|NCT05638594|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102504424|NCT05638594|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102504425|NCT05638594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102504426|NCT05638594|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102504427|NCT05638594|Hormone Antagonists|hormone antagonists|mesh-ancestor
102504428|NCT05635227|Dexamethasone|dexamethasone|mesh-list
102504429|NCT05635227|Olanzapine|olanzapine|mesh-list
102504430|NCT05635227|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102504431|NCT05635227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102504432|NCT05635227|Antiemetics|antiemetics|mesh-ancestor
102504433|NCT05635227|Autonomic Agents|autonomic agents|mesh-ancestor
102504434|NCT05635227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102504435|NCT05635227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504436|NCT05635227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102504437|NCT05635227|Glucocorticoids|glucocorticoids|mesh-ancestor
102504438|NCT05635227|Hormones|hormones|mesh-ancestor
102504439|NCT05635227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102504440|NCT05635227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102504441|NCT05635227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504442|NCT05635227|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102504443|NCT05635227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102504444|NCT05635227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102504445|NCT05635227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102504446|NCT05635227|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102504447|NCT05635227|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102504448|NCT05635227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102504449|NCT05635227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504450|NCT05635227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102504451|NCT05635227|Serotonin Agents|serotonin agents|mesh-ancestor
102504452|NCT05519254|Lactoferrin|lactoferrin|mesh-list
102504453|NCT05519254|Muramidase|muramidase|mesh-list
102504454|NCT05519254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102504455|NCT05493475|Fentanyl|fentanyl|mesh-list
102504456|NCT05493475|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102504457|NCT05493475|Narcotics|narcotics|mesh-ancestor
102504458|NCT05493475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102504459|NCT05493475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504460|NCT05493475|Analgesics|analgesics|mesh-ancestor
102504461|NCT05493475|Sensory System Agents|sensory system agents|mesh-ancestor
102504462|NCT05493475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102504463|NCT05493475|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102504464|NCT05493475|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102504465|NCT05493475|Anesthetics, General|anesthetics, general|mesh-ancestor
102504466|NCT05493475|Anesthetics|anesthetics|mesh-ancestor
102504467|NCT05463341|Fentanyl|fentanyl|mesh-list
102504468|NCT05463341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102504469|NCT05463341|Narcotics|narcotics|mesh-ancestor
102504470|NCT05463341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102504471|NCT05463341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504472|NCT05463341|Analgesics|analgesics|mesh-ancestor
102504473|NCT05463341|Sensory System Agents|sensory system agents|mesh-ancestor
102504474|NCT05463341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102504475|NCT05463341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102504476|NCT05463341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102504477|NCT05463341|Anesthetics, General|anesthetics, general|mesh-ancestor
102504478|NCT05463341|Anesthetics|anesthetics|mesh-ancestor
102504479|NCT05429970|Etodolac|etodolac|mesh-list
102504480|NCT05429970|Propofol|propofol|mesh-list
102504481|NCT05429970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102504482|NCT05429970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102504483|NCT05429970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504484|NCT05429970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102504485|NCT05429970|Anesthetics, General|anesthetics, general|mesh-ancestor
102504486|NCT05429970|Anesthetics|anesthetics|mesh-ancestor
102504487|NCT05429970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102504488|NCT05429970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102504489|NCT05429970|Analgesics|analgesics|mesh-ancestor
102504490|NCT05429970|Sensory System Agents|sensory system agents|mesh-ancestor
102504491|NCT05429970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102504492|NCT05429970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102504493|NCT05429970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102504494|NCT05429970|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102504495|NCT05429970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102504496|NCT05429970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102504497|NCT05429970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504498|NCT05376904|Ropivacaine|ropivacaine|mesh-list
102504499|NCT05376904|Anesthetics, Local|anesthetics, local|mesh-ancestor
102504500|NCT05376904|Anesthetics|anesthetics|mesh-ancestor
102504501|NCT05376904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102504502|NCT05376904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504503|NCT05376904|Sensory System Agents|sensory system agents|mesh-ancestor
102504504|NCT05376904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102504505|NCT05329740|Methylprednisolone|methylprednisolone|mesh-list
102504506|NCT05329740|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102504507|NCT05329740|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102504508|NCT05329740|Prednisolone|prednisolone|mesh-list
102504509|NCT05329740|Prednisolone acetate|prednisolone acetate|mesh-list
102504510|NCT05329740|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102504511|NCT05329740|Prednisolone phosphate|prednisolone phosphate|mesh-list
102504512|NCT05329740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102504513|NCT05329740|Antiemetics|antiemetics|mesh-ancestor
102504514|NCT05329740|Autonomic Agents|autonomic agents|mesh-ancestor
102504515|NCT05329740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102504516|NCT05329740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504517|NCT05329740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102504518|NCT05329740|Glucocorticoids|glucocorticoids|mesh-ancestor
102504519|NCT05329740|Hormones|hormones|mesh-ancestor
102504520|NCT05329740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102504521|NCT05329740|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102504522|NCT05329740|Protective Agents|protective agents|mesh-ancestor
102504523|NCT05329740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102504524|NCT05329740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504525|NCT05298670|Metformin|metformin|mesh-list
102504526|NCT05298670|Interferons|interferons|mesh-list
102504527|NCT05298670|Interferon-beta|interferon-beta|mesh-list
102504528|NCT05298670|Interferon beta-1a|interferon beta-1a|mesh-list
102504529|NCT05298670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102504530|NCT05298670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504531|NCT05298670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504532|NCT05298670|Antiviral Agents|antiviral agents|mesh-ancestor
102504533|NCT05298670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102504534|NCT05298670|Immunologic Factors|immunologic factors|mesh-ancestor
102504535|NCT05298670|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102504536|NCT05297851|Riboflavin|riboflavin|mesh-list
102504537|NCT05297851|Niacinamide|niacinamide|mesh-list
102504538|NCT05297851|Niacin|niacin|mesh-list
102504539|NCT05297851|Nicotinic Acids|nicotinic acids|mesh-list
102316051|NCT01683994|Docetaxel|docetaxel|mesh-list
102504540|NCT05297851|Vitamin B Complex|vitamin b complex|mesh-ancestor
102504541|NCT05297851|Vitamins|vitamins|mesh-ancestor
102504542|NCT05297851|Micronutrients|micronutrients|mesh-ancestor
102504543|NCT05297851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504544|NCT05297851|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102504546|NCT05297851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102504547|NCT05297851|Antimetabolites|antimetabolites|mesh-ancestor
102504548|NCT05297851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504549|NCT05297851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102504550|NCT05297851|Vasodilator Agents|vasodilator agents|mesh-ancestor
102504551|NCT05252598|Psilocybin|psilocybin|mesh-list
102504552|NCT05252598|Hallucinogens|hallucinogens|mesh-ancestor
102504553|NCT05252598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504554|NCT05252598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102504555|NCT05223829|Brexanolone|brexanolone|mesh-list
102504556|NCT05223829|Neurosteroids|neurosteroids|mesh-ancestor
102504557|NCT05223829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102504558|NCT05223829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504559|NCT05223829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504560|NCT05223829|GABA Modulators|gaba modulators|mesh-ancestor
102504561|NCT05223829|GABA Agents|gaba agents|mesh-ancestor
102504562|NCT05180006|Bevacizumab|bevacizumab|mesh-list
102504563|NCT05180006|Trastuzumab|trastuzumab|mesh-list
102504564|NCT05180006|Atezolizumab|atezolizumab|mesh-list
102504565|NCT05180006|Pertuzumab|pertuzumab|mesh-list
102504566|NCT05180006|Ipatasertib|ipatasertib|mesh-list
102504567|NCT05180006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102504568|NCT05180006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504569|NCT05180006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102504570|NCT05180006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102504571|NCT05180006|Growth Substances|growth substances|mesh-ancestor
102504572|NCT05180006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504573|NCT05180006|Growth Inhibitors|growth inhibitors|mesh-ancestor
102504574|NCT05180006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102504575|NCT05180006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504576|NCT05180006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102504577|NCT05180006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102504578|NCT05148884|Befiradol|befiradol|mesh-list
102504579|NCT05148884|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102504580|NCT05148884|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102504581|NCT05148884|Serotonin Agents|serotonin agents|mesh-ancestor
102504582|NCT05148884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102504583|NCT05148884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504584|NCT05148884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504585|NCT05144854|Capecitabine|capecitabine|mesh-list
102504586|NCT05144854|Tegafur|tegafur|mesh-list
102504587|NCT05144854|Oxaliplatin|oxaliplatin|mesh-list
102504588|NCT05144854|Nivolumab|nivolumab|mesh-list
102504589|NCT05144854|Ipilimumab|ipilimumab|mesh-list
102504590|NCT05144854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102504591|NCT05144854|Antimetabolites|antimetabolites|mesh-ancestor
102504592|NCT05144854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504593|NCT05144854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504594|NCT05144854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102504595|NCT05144854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102504596|NCT05099666|Doxorubicin|doxorubicin|mesh-list
102504597|NCT05099666|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102504598|NCT05099666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504599|NCT05099666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102504600|NCT05099666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102504601|NCT05099666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102504602|NCT05099666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504603|NCT05042817|Sufentanil|sufentanil|mesh-list
102504604|NCT05042817|Morphine|morphine|mesh-list
102504605|NCT05042817|Prilocaine|prilocaine|mesh-list
102504606|NCT05042817|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102504607|NCT05042817|Narcotics|narcotics|mesh-ancestor
102504608|NCT05042817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102504609|NCT05042817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504610|NCT05042817|Analgesics|analgesics|mesh-ancestor
102504611|NCT05042817|Sensory System Agents|sensory system agents|mesh-ancestor
102504612|NCT05042817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102504613|NCT05042817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102504614|NCT05042817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102504615|NCT05042817|Anesthetics, General|anesthetics, general|mesh-ancestor
102504616|NCT05042817|Anesthetics|anesthetics|mesh-ancestor
102504617|NCT05042817|Anesthetics, Local|anesthetics, local|mesh-ancestor
102504618|NCT04914234|Metoprolol|metoprolol|mesh-list
102504619|NCT04914234|Atenolol|atenolol|mesh-list
102504620|NCT04914234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102504621|NCT04914234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102504622|NCT04914234|Sympatholytics|sympatholytics|mesh-ancestor
102504623|NCT04914234|Autonomic Agents|autonomic agents|mesh-ancestor
102504624|NCT04914234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102504625|NCT04914234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504626|NCT04914234|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102504627|NCT04914234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102504628|NCT04914234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102504629|NCT04914234|Adrenergic Agents|adrenergic agents|mesh-ancestor
102504630|NCT04914234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102504631|NCT04914234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504632|NCT04895566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102504633|NCT04895566|Antibodies|antibodies|mesh-list
102504634|NCT04895566|Immunoglobulins|immunoglobulins|mesh-list
102504635|NCT04895566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102504636|NCT04895566|Immunologic Factors|immunologic factors|mesh-ancestor
102504637|NCT04895566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504638|NCT04895566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504639|NCT04779320|Vedolizumab|vedolizumab|mesh-list
102504640|NCT04779320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102504641|NCT04779307|Vedolizumab|vedolizumab|mesh-list
102504642|NCT04779307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102504643|NCT04762199|Osimertinib|osimertinib|mesh-list
102504644|NCT04762199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504645|NCT04762199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102504646|NCT04762199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102504647|NCT04762199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504648|NCT04737187|Trifluridine|trifluridine|mesh-list
102504649|NCT04737187|Bevacizumab|bevacizumab|mesh-list
102504650|NCT04737187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102504651|NCT04737187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504652|NCT04737187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102504653|NCT04737187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102504654|NCT04737187|Growth Substances|growth substances|mesh-ancestor
102504655|NCT04737187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504656|NCT04737187|Growth Inhibitors|growth inhibitors|mesh-ancestor
102504657|NCT04737187|Antimetabolites|antimetabolites|mesh-ancestor
102504658|NCT04737187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504659|NCT04737187|Antiviral Agents|antiviral agents|mesh-ancestor
102504660|NCT04737187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102504661|NCT04733157|Tranexamic Acid|tranexamic acid|mesh-list
102504662|NCT04733157|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102504663|NCT04733157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102504664|NCT04733157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504665|NCT04733157|Hemostatics|hemostatics|mesh-ancestor
102504666|NCT04733157|Coagulants|coagulants|mesh-ancestor
102504667|NCT04723147|Levodopa|levodopa|mesh-list
102504668|NCT04723147|Carbidopa|carbidopa|mesh-list
102504669|NCT04723147|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102504670|NCT04723147|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102504671|NCT04723147|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102504672|NCT04723147|Dopamine Agents|dopamine agents|mesh-ancestor
102504673|NCT04723147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102504674|NCT04723147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504675|NCT04723147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504676|NCT04723147|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102504677|NCT04723147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102504678|NCT04723147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102504679|NCT04723147|Immunologic Factors|immunologic factors|mesh-ancestor
102504680|NCT04723147|Dopamine Agonists|dopamine agonists|mesh-ancestor
102504681|NCT04662710|Leucovorin|leucovorin|mesh-list
102504682|NCT04662710|Pembrolizumab|pembrolizumab|mesh-list
102504683|NCT04662710|Capecitabine|capecitabine|mesh-list
102504684|NCT04662710|Oxaliplatin|oxaliplatin|mesh-list
102504685|NCT04662710|Lenvatinib|lenvatinib|mesh-list
102504686|NCT04662710|Levoleucovorin|levoleucovorin|mesh-list
102504687|NCT04662710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102504688|NCT04662710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504689|NCT04662710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102504690|NCT04662710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504691|NCT04662710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102316215|NCT02193776|Antimetabolites|antimetabolites|mesh-ancestor
102504692|NCT04662710|Antimetabolites|antimetabolites|mesh-ancestor
102504693|NCT04662710|Antidotes|antidotes|mesh-ancestor
102504694|NCT04662710|Protective Agents|protective agents|mesh-ancestor
102504695|NCT04662710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504696|NCT04662710|Vitamin B Complex|vitamin b complex|mesh-ancestor
102504697|NCT04662710|Vitamins|vitamins|mesh-ancestor
102504698|NCT04662710|Micronutrients|micronutrients|mesh-ancestor
102504699|NCT04662710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102504700|NCT04662710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102504701|NCT04659174|Xanomeline|xanomeline|mesh-list
102504702|NCT04659174|Trospium chloride|trospium chloride|mesh-list
102504703|NCT04659174|Parasympatholytics|parasympatholytics|mesh-ancestor
102504704|NCT04659174|Autonomic Agents|autonomic agents|mesh-ancestor
102504705|NCT04659174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102504706|NCT04659174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504707|NCT04659174|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102504708|NCT04659174|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102504709|NCT04659174|Cholinergic Agents|cholinergic agents|mesh-ancestor
102504710|NCT04659174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102504711|NCT04659174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504712|NCT04659174|Urological Agents|urological agents|mesh-ancestor
102504713|NCT04659174|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102504714|NCT04659174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102504715|NCT04659174|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102504716|NCT04659174|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102504717|NCT04653662|Carbamide Peroxide|carbamide peroxide|mesh-list
102504718|NCT04653662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102504719|NCT04653662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102504720|NCT04643405|Paclitaxel|paclitaxel|mesh-list
102504721|NCT04643405|Gemcitabine|gemcitabine|mesh-list
102504722|NCT04643405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102504723|NCT04643405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504724|NCT04643405|Tubulin Modulators|tubulin modulators|mesh-ancestor
102504725|NCT04643405|Antimitotic Agents|antimitotic agents|mesh-ancestor
102504726|NCT04643405|Mitosis Modulators|mitosis modulators|mesh-ancestor
102504727|NCT04643405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504728|NCT04643405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102504729|NCT04643405|Antimetabolites|antimetabolites|mesh-ancestor
102504730|NCT04633122|Sunitinib|sunitinib|mesh-list
102504731|NCT04633122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504732|NCT04633122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102504733|NCT04633122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102504734|NCT04633122|Growth Substances|growth substances|mesh-ancestor
102504735|NCT04633122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504736|NCT04633122|Growth Inhibitors|growth inhibitors|mesh-ancestor
102504737|NCT04633122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102504738|NCT04633122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102504739|NCT04633122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504740|NCT04531046|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
102504741|NCT04531046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102504742|NCT04531046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504743|NCT04500158|Lidocaine|lidocaine|mesh-list
102504744|NCT04500158|Anesthetics, Local|anesthetics, local|mesh-ancestor
102504745|NCT04500158|Anesthetics|anesthetics|mesh-ancestor
102504746|NCT04500158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102504747|NCT04500158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504748|NCT04500158|Sensory System Agents|sensory system agents|mesh-ancestor
102504749|NCT04500158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102504750|NCT04500158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102504751|NCT04500158|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102504752|NCT04500158|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102504753|NCT04500158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102504754|NCT04500158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504755|NCT04439279|Trametinib|trametinib|mesh-list
102504756|NCT04439279|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
102504757|NCT04439279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504758|NCT04439279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102504759|NCT04439279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102504760|NCT04439279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504761|NCT04439279|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102504762|NCT04439279|Protective Agents|protective agents|mesh-ancestor
102504763|NCT04439279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504764|NCT04439279|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102504765|NCT04439279|Antioxidants|antioxidants|mesh-ancestor
102504766|NCT04304755|Zoledronic Acid|zoledronic acid|mesh-list
102504767|NCT04304755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102504768|NCT04304755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504769|NCT04273165|Etravirine|etravirine|mesh-list
102504770|NCT04273165|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102504771|NCT04273165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102504772|NCT04273165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102504773|NCT04273165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504774|NCT04273165|Antiviral Agents|antiviral agents|mesh-ancestor
102504775|NCT04273165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102504776|NCT04179968|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102504777|NCT04179968|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102504778|NCT04179968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504779|NCT04140526|Pembrolizumab|pembrolizumab|mesh-list
102504780|NCT04140526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102504781|NCT04140526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504782|NCT04140526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102504783|NCT04140526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504784|NCT04041128|Olaparib|olaparib|mesh-list
102504785|NCT04041128|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102504786|NCT04041128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102504787|NCT04041128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504788|NCT04041128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504789|NCT04030962|Lifitegrast|lifitegrast|mesh-list
102504790|NCT04030962|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102504791|NCT04030962|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102504792|NCT03951753|Tirzepatide|tirzepatide|mesh-list
102504793|NCT03951753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102504794|NCT03951753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504795|NCT03951753|Incretins|incretins|mesh-ancestor
102504796|NCT03951753|Hormones|hormones|mesh-ancestor
102504797|NCT03951753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102504798|NCT03947671|Acetaminophen|acetaminophen|mesh-list
102504799|NCT03947671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102504800|NCT03947671|Analgesics|analgesics|mesh-ancestor
102504801|NCT03947671|Sensory System Agents|sensory system agents|mesh-ancestor
102504802|NCT03947671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102504803|NCT03947671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504804|NCT03947671|Antipyretics|antipyretics|mesh-ancestor
102504805|NCT03941964|Azacitidine|azacitidine|mesh-list
102504806|NCT03941964|Decitabine|decitabine|mesh-list
102504807|NCT03941964|Venetoclax|venetoclax|mesh-list
102504808|NCT03941964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102504809|NCT03941964|Antimetabolites|antimetabolites|mesh-ancestor
102504810|NCT03941964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504811|NCT03941964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504812|NCT03941964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102504813|NCT03837509|Daratumumab|daratumumab|mesh-list
102504814|NCT03837509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504815|NCT03808077|Rocuronium|rocuronium|mesh-list
102504816|NCT03808077|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102504817|NCT03808077|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102504818|NCT03808077|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102504819|NCT03808077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102504820|NCT03808077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504821|NCT03630705|Vaccines|vaccines|mesh-list
102504822|NCT03630705|Immunologic Factors|immunologic factors|mesh-ancestor
102504823|NCT03630705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504824|NCT03603184|Paclitaxel|paclitaxel|mesh-list
102504825|NCT03603184|Carboplatin|carboplatin|mesh-list
102504826|NCT03603184|Atezolizumab|atezolizumab|mesh-list
102504827|NCT03603184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102504828|NCT03603184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504829|NCT03603184|Tubulin Modulators|tubulin modulators|mesh-ancestor
102504830|NCT03603184|Antimitotic Agents|antimitotic agents|mesh-ancestor
102504831|NCT03603184|Mitosis Modulators|mitosis modulators|mesh-ancestor
102504832|NCT03603184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504833|NCT03603184|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102504834|NCT03603184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102504835|NCT03507452|BAY 2287411|bay 2287411|mesh-list
102504836|NCT03507452|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102504837|NCT03507452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504838|NCT03493490|Diclofenac|diclofenac|mesh-list
102504839|NCT03493490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102504840|NCT03493490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102504841|NCT03493490|Analgesics|analgesics|mesh-ancestor
102504842|NCT03493490|Sensory System Agents|sensory system agents|mesh-ancestor
102504843|NCT03493490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102504844|NCT03493490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504845|NCT03493490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102504846|NCT03493490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102504847|NCT03493490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102504848|NCT03493490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102504849|NCT03493490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504851|NCT03377491|Gemcitabine|gemcitabine|mesh-list
102504852|NCT03377491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102504853|NCT03377491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504854|NCT03377491|Tubulin Modulators|tubulin modulators|mesh-ancestor
102504855|NCT03377491|Antimitotic Agents|antimitotic agents|mesh-ancestor
102504856|NCT03377491|Mitosis Modulators|mitosis modulators|mesh-ancestor
102504857|NCT03377491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504858|NCT03377491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102504859|NCT03377491|Antimetabolites|antimetabolites|mesh-ancestor
102504860|NCT03298087|Leuprolide|leuprolide|mesh-list
102504861|NCT03298087|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102504862|NCT03298087|Fertility Agents|fertility agents|mesh-ancestor
102504863|NCT03298087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102504864|NCT03298087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504865|NCT03298087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102504866|NCT03298087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504867|NCT03297359|Dalteparin|dalteparin|mesh-list
102504868|NCT03297359|Tinzaparin|tinzaparin|mesh-list
102504869|NCT03297359|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102504870|NCT03297359|Anticoagulants|anticoagulants|mesh-ancestor
102504871|NCT03297359|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102504872|NCT03297359|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102504873|NCT03297359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504874|NCT03189719|Pembrolizumab|pembrolizumab|mesh-list
102504875|NCT03189719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504876|NCT03189719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102504877|NCT03189719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102504878|NCT03189719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504879|NCT02889081|Vitamin D|vitamin d|mesh-list
102504880|NCT02889081|Vitamins|vitamins|mesh-ancestor
102504881|NCT02889081|Micronutrients|micronutrients|mesh-ancestor
102504882|NCT02889081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504883|NCT02889081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102504884|NCT02856594|Dexmedetomidine|dexmedetomidine|mesh-list
102504885|NCT02856594|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102504886|NCT02856594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102504887|NCT02856594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504888|NCT02856594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102504889|NCT02856594|Analgesics|analgesics|mesh-ancestor
102504890|NCT02856594|Sensory System Agents|sensory system agents|mesh-ancestor
102504891|NCT02856594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102504892|NCT02856594|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102504893|NCT02856594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102504894|NCT02856594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102504895|NCT02856594|Adrenergic Agents|adrenergic agents|mesh-ancestor
102504896|NCT02856594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102504897|NCT02856594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504898|NCT02840539|Cytarabine|cytarabine|mesh-list
102504899|NCT02840539|Dexamethasone|dexamethasone|mesh-list
102504900|NCT02840539|Dexamethasone acetate|dexamethasone acetate|mesh-list
102504901|NCT02840539|Bortezomib|bortezomib|mesh-list
102504902|NCT02840539|BB 1101|bb 1101|mesh-list
102504903|NCT02840539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102504904|NCT02840539|Antiemetics|antiemetics|mesh-ancestor
102504905|NCT02840539|Autonomic Agents|autonomic agents|mesh-ancestor
102504906|NCT02840539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102504907|NCT02840539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504908|NCT02840539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102504909|NCT02840539|Glucocorticoids|glucocorticoids|mesh-ancestor
102504910|NCT02840539|Hormones|hormones|mesh-ancestor
102504911|NCT02840539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102504912|NCT02840539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102504913|NCT02840539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504914|NCT02840539|Protease Inhibitors|protease inhibitors|mesh-ancestor
102504915|NCT02840539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102504916|NCT02840539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504917|NCT02840539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102504918|NCT02840539|Antimetabolites|antimetabolites|mesh-ancestor
102504919|NCT02840539|Antiviral Agents|antiviral agents|mesh-ancestor
102504920|NCT02840539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102504921|NCT02840539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102504922|NCT02840539|Immunologic Factors|immunologic factors|mesh-ancestor
102504923|NCT02453594|Pembrolizumab|pembrolizumab|mesh-list
102504924|NCT02453594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102504925|NCT02453594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504926|NCT02453594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102504927|NCT02453594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504928|NCT02342782|Cytarabine|cytarabine|mesh-list
102504929|NCT02342782|Etoposide|etoposide|mesh-list
102504930|NCT02342782|Melphalan|melphalan|mesh-list
102504931|NCT02342782|Carmustine|carmustine|mesh-list
102504932|NCT02342782|Basiliximab|basiliximab|mesh-list
102504933|NCT02342782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102504934|NCT02342782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504935|NCT02342782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102504936|NCT02342782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102504937|NCT02342782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102504938|NCT02342782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504939|NCT02342782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102504940|NCT02342782|Antimetabolites|antimetabolites|mesh-ancestor
102504941|NCT02342782|Antiviral Agents|antiviral agents|mesh-ancestor
102504942|NCT02342782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102504943|NCT02342782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102504944|NCT02342782|Immunologic Factors|immunologic factors|mesh-ancestor
102504945|NCT02342782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504946|NCT02342782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102504947|NCT02342782|Alkylating Agents|alkylating agents|mesh-ancestor
102504948|NCT02342782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102504949|NCT02291055|Durvalumab|durvalumab|mesh-list
102504950|NCT02291055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102504951|NCT02291055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504952|NCT02112864|Dexamethasone|dexamethasone|mesh-list
102504953|NCT02112864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102504954|NCT02112864|Antiemetics|antiemetics|mesh-ancestor
102504955|NCT02112864|Autonomic Agents|autonomic agents|mesh-ancestor
102504956|NCT02112864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102504957|NCT02112864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504958|NCT02112864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102504959|NCT02112864|Glucocorticoids|glucocorticoids|mesh-ancestor
102504960|NCT02112864|Hormones|hormones|mesh-ancestor
102504961|NCT02112864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102504962|NCT02112864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102504963|NCT02112864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504964|NCT02106988|Dexamethasone|dexamethasone|mesh-list
102504965|NCT02106988|Carboplatin|carboplatin|mesh-list
102504966|NCT02106988|Etoposide|etoposide|mesh-list
102504967|NCT02106988|Ifosfamide|ifosfamide|mesh-list
102504968|NCT02106988|Etoposide phosphate|etoposide phosphate|mesh-list
102504969|NCT02106988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102504970|NCT02106988|Antiemetics|antiemetics|mesh-ancestor
102504971|NCT02106988|Autonomic Agents|autonomic agents|mesh-ancestor
102504972|NCT02106988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102504973|NCT02106988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504974|NCT02106988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102504975|NCT02106988|Glucocorticoids|glucocorticoids|mesh-ancestor
102504976|NCT02106988|Hormones|hormones|mesh-ancestor
102504977|NCT02106988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102504978|NCT02106988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102504979|NCT02106988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102504980|NCT02106988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102504981|NCT02106988|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102504982|NCT02106988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102504983|NCT02106988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102504984|NCT02106988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504985|NCT02106988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102504986|NCT02106988|Alkylating Agents|alkylating agents|mesh-ancestor
102504987|NCT01237457|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102504988|NCT01237457|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102504989|NCT01237457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102504990|NCT00723697|Buprenorphine|buprenorphine|mesh-list
102504991|NCT00723697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102504992|NCT00723697|Narcotics|narcotics|mesh-ancestor
102504993|NCT00723697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102316504|NCT05398913|Rimonabant|rimonabant|mesh-list
102504994|NCT00723697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102504995|NCT00723697|Analgesics|analgesics|mesh-ancestor
102504996|NCT00723697|Sensory System Agents|sensory system agents|mesh-ancestor
102504997|NCT00723697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102504998|NCT00723697|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102504999|NCT00684073|Buprenorphine|buprenorphine|mesh-list
102505000|NCT00684073|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102505001|NCT00684073|Naloxone|naloxone|mesh-list
102505002|NCT00684073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102505003|NCT00684073|Narcotics|narcotics|mesh-ancestor
102505004|NCT00684073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102505005|NCT00684073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505006|NCT00684073|Analgesics|analgesics|mesh-ancestor
102505007|NCT00684073|Sensory System Agents|sensory system agents|mesh-ancestor
102505008|NCT00684073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102505009|NCT00684073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102505010|NCT00603109|Rimonabant|rimonabant|mesh-list
102505011|NCT00603109|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102505012|NCT00603109|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
102505013|NCT00603109|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102505014|NCT00603109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102505015|NCT00603109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505016|NCT00603109|Hormones|hormones|mesh-ancestor
102505017|NCT00603109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102505018|NCT00603109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505019|NCT00199095|Cytarabine|cytarabine|mesh-list
102505020|NCT00199095|Dexamethasone|dexamethasone|mesh-list
102505021|NCT00199095|Cyclophosphamide|cyclophosphamide|mesh-list
102505022|NCT00199095|Ifosfamide|ifosfamide|mesh-list
102505023|NCT00199095|Methotrexate|methotrexate|mesh-list
102505024|NCT00199095|Vincristine|vincristine|mesh-list
102505025|NCT00199095|Doxorubicin|doxorubicin|mesh-list
102505026|NCT00199095|Mercaptopurine|mercaptopurine|mesh-list
102505027|NCT00199095|Idarubicin|idarubicin|mesh-list
102505028|NCT00199095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102505029|NCT00199095|Immunologic Factors|immunologic factors|mesh-ancestor
102505030|NCT00199095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505031|NCT00199095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102505032|NCT00199095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102505033|NCT00199095|Alkylating Agents|alkylating agents|mesh-ancestor
102505034|NCT00199095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505035|NCT00199095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505036|NCT00199095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102505037|NCT00199095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102505038|NCT00199095|Antiemetics|antiemetics|mesh-ancestor
102505039|NCT00199095|Autonomic Agents|autonomic agents|mesh-ancestor
102505040|NCT00199095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102505041|NCT00199095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102505042|NCT00199095|Glucocorticoids|glucocorticoids|mesh-ancestor
102505043|NCT00199095|Hormones|hormones|mesh-ancestor
102505044|NCT00199095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102505045|NCT00199095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102505046|NCT00199095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102505047|NCT00199095|Abortifacient Agents|abortifacient agents|mesh-ancestor
102505048|NCT00199095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102505049|NCT00199095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102505050|NCT00199095|Antimetabolites|antimetabolites|mesh-ancestor
102505051|NCT00199095|Dermatologic Agents|dermatologic agents|mesh-ancestor
102505052|NCT00199095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102505053|NCT00199095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102505054|NCT00199095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102505055|NCT00199095|Antiviral Agents|antiviral agents|mesh-ancestor
102505056|NCT00199095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102505057|NCT00199095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102505058|NCT00199095|Tubulin Modulators|tubulin modulators|mesh-ancestor
102505059|NCT00199095|Antimitotic Agents|antimitotic agents|mesh-ancestor
102505060|NCT00199095|Mitosis Modulators|mitosis modulators|mesh-ancestor
102505061|NCT00199095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102505062|NCT00199095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102505063|NCT00199095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102505064|NCT00199056|Cytarabine|cytarabine|mesh-list
102505065|NCT00199056|Dexamethasone|dexamethasone|mesh-list
102505066|NCT00199056|Prednisolone|prednisolone|mesh-list
102505067|NCT00199056|Cyclophosphamide|cyclophosphamide|mesh-list
102505068|NCT00199056|Ifosfamide|ifosfamide|mesh-list
102505069|NCT00199056|Methotrexate|methotrexate|mesh-list
102505070|NCT00199056|Fludarabine|fludarabine|mesh-list
102505071|NCT00199056|Vincristine|vincristine|mesh-list
102505072|NCT00199056|Doxorubicin|doxorubicin|mesh-list
102505073|NCT00199056|Daunorubicin|daunorubicin|mesh-list
102505074|NCT00199056|Asparaginase|asparaginase|mesh-list
102505075|NCT00199056|Mercaptopurine|mercaptopurine|mesh-list
102505076|NCT00199056|Idarubicin|idarubicin|mesh-list
102505077|NCT00199056|Thioguanine|thioguanine|mesh-list
102505078|NCT00199056|Vindesine|vindesine|mesh-list
102505079|NCT00199056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102505080|NCT00199056|Immunologic Factors|immunologic factors|mesh-ancestor
102505081|NCT00199056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505082|NCT00199056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102505083|NCT00199056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102505084|NCT00199056|Alkylating Agents|alkylating agents|mesh-ancestor
102505085|NCT00199056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505086|NCT00199056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505087|NCT00199056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102505088|NCT00199056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102505089|NCT00199056|Antiemetics|antiemetics|mesh-ancestor
102505090|NCT00199056|Autonomic Agents|autonomic agents|mesh-ancestor
102505091|NCT00199056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102505092|NCT00199056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102505093|NCT00199056|Glucocorticoids|glucocorticoids|mesh-ancestor
102505094|NCT00199056|Hormones|hormones|mesh-ancestor
102505095|NCT00199056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102505096|NCT00199056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102505097|NCT00199056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102505098|NCT00199056|Abortifacient Agents|abortifacient agents|mesh-ancestor
102505099|NCT00199056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102505100|NCT00199056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102505101|NCT00199056|Antimetabolites|antimetabolites|mesh-ancestor
102505102|NCT00199056|Dermatologic Agents|dermatologic agents|mesh-ancestor
102505103|NCT00199056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102505104|NCT00199056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102505105|NCT00199056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102505106|NCT00199056|Antiviral Agents|antiviral agents|mesh-ancestor
102505107|NCT00199056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102505108|NCT00199056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102505109|NCT00199056|Tubulin Modulators|tubulin modulators|mesh-ancestor
102505110|NCT00199056|Antimitotic Agents|antimitotic agents|mesh-ancestor
102505111|NCT00199056|Mitosis Modulators|mitosis modulators|mesh-ancestor
102505112|NCT00199056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102505113|NCT00199056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102505114|NCT00199056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102505115|NCT00199030|Alemtuzumab|alemtuzumab|mesh-list
102505116|NCT00199030|Cladribine|cladribine|mesh-list
102505117|NCT00199030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102505118|NCT00199030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505119|NCT00199030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102505120|NCT00199030|Immunologic Factors|immunologic factors|mesh-ancestor
102505121|NCT00199030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505122|NCT00198978|Cytarabine|cytarabine|mesh-list
102505123|NCT00198978|Dexamethasone|dexamethasone|mesh-list
102505124|NCT00198978|Prednisolone|prednisolone|mesh-list
102505125|NCT00198978|Cyclophosphamide|cyclophosphamide|mesh-list
102505126|NCT00198978|Rituximab|rituximab|mesh-list
102505127|NCT00198978|Methotrexate|methotrexate|mesh-list
102505128|NCT00198978|Vincristine|vincristine|mesh-list
102505129|NCT00198978|Asparaginase|asparaginase|mesh-list
102505130|NCT00198978|Mercaptopurine|mercaptopurine|mesh-list
102505131|NCT00198978|Idarubicin|idarubicin|mesh-list
102505132|NCT00198978|Lenograstim|lenograstim|mesh-list
102505133|NCT00198978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102505134|NCT00198978|Immunologic Factors|immunologic factors|mesh-ancestor
102505135|NCT00198978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505136|NCT00198978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102505137|NCT00198978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102505138|NCT00198978|Alkylating Agents|alkylating agents|mesh-ancestor
102505139|NCT00198978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505140|NCT00198978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505141|NCT00198978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102505142|NCT00198978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102505143|NCT00198978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102505144|NCT00198978|Antiemetics|antiemetics|mesh-ancestor
102505145|NCT00198978|Autonomic Agents|autonomic agents|mesh-ancestor
102505146|NCT00198978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102505147|NCT00198978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102505148|NCT00198978|Glucocorticoids|glucocorticoids|mesh-ancestor
102505149|NCT00198978|Hormones|hormones|mesh-ancestor
102505150|NCT00198978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102505151|NCT00198978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102505152|NCT00198978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102505154|NCT00198978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102505155|NCT00198978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102505156|NCT00198978|Antimetabolites|antimetabolites|mesh-ancestor
102505157|NCT00198978|Dermatologic Agents|dermatologic agents|mesh-ancestor
102505158|NCT00198978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102505159|NCT00198978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102505160|NCT00198978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102505161|NCT00198978|Antiviral Agents|antiviral agents|mesh-ancestor
102505162|NCT00198978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102505163|NCT00198978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102505164|NCT00198978|Tubulin Modulators|tubulin modulators|mesh-ancestor
102505165|NCT00198978|Antimitotic Agents|antimitotic agents|mesh-ancestor
102505166|NCT00198978|Mitosis Modulators|mitosis modulators|mesh-ancestor
102505167|NCT00198978|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102505168|NCT00198978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102505169|NCT00198978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102505170|NCT00198978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102505171|NCT00109395|Midazolam|midazolam|mesh-list
102505172|NCT00109395|Lorazepam|lorazepam|mesh-list
102505173|NCT00109395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102505174|NCT00109395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102505175|NCT00109395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102505176|NCT00109395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505177|NCT00109395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102505178|NCT00109395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102505179|NCT00109395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102505180|NCT00109395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102505181|NCT00109395|Anesthetics, General|anesthetics, general|mesh-ancestor
102505182|NCT00109395|Anesthetics|anesthetics|mesh-ancestor
102505183|NCT00109395|GABA Modulators|gaba modulators|mesh-ancestor
102505184|NCT00109395|GABA Agents|gaba agents|mesh-ancestor
102505185|NCT00109395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102505186|NCT00109395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505187|NCT00109395|Anticonvulsants|anticonvulsants|mesh-ancestor
102505188|NCT00109395|Antiemetics|antiemetics|mesh-ancestor
102505189|NCT00109395|Autonomic Agents|autonomic agents|mesh-ancestor
102505190|NCT00109395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102505191|NCT00109395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102505192|NCT01215643|Ribavirin|ribavirin|mesh-list
102505193|NCT01215643|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102505194|NCT01215643|Antimetabolites|antimetabolites|mesh-ancestor
102505195|NCT01215643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505196|NCT01215643|Antiviral Agents|antiviral agents|mesh-ancestor
102505197|NCT01215643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102505198|NCT00004924|Paclitaxel|paclitaxel|mesh-list
102505199|NCT00004924|Irinotecan|irinotecan|mesh-list
102505200|NCT00004924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102505201|NCT00004924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505202|NCT00004924|Tubulin Modulators|tubulin modulators|mesh-ancestor
102505203|NCT00004924|Antimitotic Agents|antimitotic agents|mesh-ancestor
102505204|NCT00004924|Mitosis Modulators|mitosis modulators|mesh-ancestor
102505205|NCT00004924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505206|NCT00004924|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102505207|NCT00004924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102505208|NCT00004924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102505209|NCT00004144|Gemcitabine|gemcitabine|mesh-list
102505210|NCT00004144|Bryostatin 1|bryostatin 1|mesh-list
102505211|NCT00004144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102505212|NCT00004144|Antimetabolites|antimetabolites|mesh-ancestor
102505213|NCT00004144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505214|NCT00004144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505215|NCT00004144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102505216|NCT00004144|Immunologic Factors|immunologic factors|mesh-ancestor
102505217|NCT00004144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505218|NCT00004150|Leucovorin|leucovorin|mesh-list
102505219|NCT00004150|Fluorouracil|fluorouracil|mesh-list
102505220|NCT00004150|Calcium|calcium|mesh-list
102505221|NCT00004150|Levoleucovorin|levoleucovorin|mesh-list
102505222|NCT00004150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102505223|NCT00004150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505224|NCT00004150|Antimetabolites|antimetabolites|mesh-ancestor
102505225|NCT00004150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316729|NCT03943901|Hormones|hormones|mesh-ancestor
102505226|NCT00004150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102505227|NCT00004150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505228|NCT00004150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102505229|NCT00004150|Immunologic Factors|immunologic factors|mesh-ancestor
102505230|NCT00004150|Antidotes|antidotes|mesh-ancestor
102505231|NCT00004150|Protective Agents|protective agents|mesh-ancestor
102505232|NCT00004150|Vitamin B Complex|vitamin b complex|mesh-ancestor
102505233|NCT00004150|Vitamins|vitamins|mesh-ancestor
102505234|NCT00004150|Micronutrients|micronutrients|mesh-ancestor
102505235|NCT00004930|Doxorubicin|doxorubicin|mesh-list
102505236|NCT00004930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102505237|NCT00004930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102505238|NCT00004930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505239|NCT00004930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102505240|NCT00004930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102505241|NCT00004930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102505242|NCT00004930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505243|NCT00003928|Gemcitabine|gemcitabine|mesh-list
102505244|NCT00003928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505245|NCT00003928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102505246|NCT00003928|Antimetabolites|antimetabolites|mesh-ancestor
102505247|NCT00003928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505248|NCT00004162|Doxorubicin|doxorubicin|mesh-list
102505249|NCT00004162|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102505250|NCT00004162|Methotrexate|methotrexate|mesh-list
102505251|NCT00004162|Vincristine|vincristine|mesh-list
102505252|NCT00004162|Sargramostim|sargramostim|mesh-list
102505253|NCT00004162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102505254|NCT00004162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505255|NCT00004162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102505256|NCT00004162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102505257|NCT00004162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102505258|NCT00004162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505259|NCT00004162|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102505260|NCT00004162|Abortifacient Agents|abortifacient agents|mesh-ancestor
102505261|NCT00004162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102505262|NCT00004162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505263|NCT00004162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102505264|NCT00004162|Antimetabolites|antimetabolites|mesh-ancestor
102505265|NCT00004162|Dermatologic Agents|dermatologic agents|mesh-ancestor
102505266|NCT00004162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102505267|NCT00004162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102505268|NCT00004162|Immunologic Factors|immunologic factors|mesh-ancestor
102505269|NCT00004162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102505270|NCT00004162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102505271|NCT00004162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102505272|NCT00004162|Tubulin Modulators|tubulin modulators|mesh-ancestor
102505273|NCT00004162|Antimitotic Agents|antimitotic agents|mesh-ancestor
102505274|NCT00004162|Mitosis Modulators|mitosis modulators|mesh-ancestor
102505275|NCT00004984|Insulin|insulin|mesh-list
102505276|NCT00004984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102505277|NCT00004984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102505278|NCT00004984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505279|NCT00004174|Paclitaxel|paclitaxel|mesh-list
102505280|NCT00004174|Cyclophosphamide|cyclophosphamide|mesh-list
102505281|NCT00004174|Thiotepa|thiotepa|mesh-list
102505282|NCT00004174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102505283|NCT00004174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505284|NCT00004174|Tubulin Modulators|tubulin modulators|mesh-ancestor
102505285|NCT00004174|Antimitotic Agents|antimitotic agents|mesh-ancestor
102505286|NCT00004174|Mitosis Modulators|mitosis modulators|mesh-ancestor
102505287|NCT00004174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505288|NCT00004174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102505289|NCT00004174|Immunologic Factors|immunologic factors|mesh-ancestor
102505290|NCT00004174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505291|NCT00004174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102505292|NCT00004174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102505293|NCT00004174|Alkylating Agents|alkylating agents|mesh-ancestor
102505294|NCT00004174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102505295|NCT01284517|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102505296|NCT01284517|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102505297|NCT01284517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102505298|NCT01284517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102505299|NCT01284517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505300|NCT01284517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102316806|NCT01542034|Deoxycholic Acid|deoxycholic acid|mesh-list
102505301|NCT01284517|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102505302|NCT01284517|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102505303|NCT01284517|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102505304|NCT01284517|Adrenergic Agents|adrenergic agents|mesh-ancestor
102505305|NCT01284517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102505306|NCT01284517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505307|NCT01284517|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102505308|NCT01284517|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102505309|NCT01284517|Serotonin Agents|serotonin agents|mesh-ancestor
102505310|NCT01284517|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102505311|NCT01284517|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102505312|NCT01284517|Dopamine Agents|dopamine agents|mesh-ancestor
102505313|NCT00004990|Dexamethasone|dexamethasone|mesh-list
102505314|NCT00004990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102505315|NCT00004990|Antiemetics|antiemetics|mesh-ancestor
102505316|NCT00004990|Autonomic Agents|autonomic agents|mesh-ancestor
102505317|NCT00004990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102505318|NCT00004990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505319|NCT00004990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102505320|NCT00004990|Glucocorticoids|glucocorticoids|mesh-ancestor
102505321|NCT00004990|Hormones|hormones|mesh-ancestor
102505322|NCT00004990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102505323|NCT00004990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102505324|NCT00004990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505325|NCT01216735|Fluticasone|fluticasone|mesh-list
102505326|NCT01216735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102505327|NCT01216735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102505328|NCT01216735|Autonomic Agents|autonomic agents|mesh-ancestor
102505329|NCT01216735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102505330|NCT01216735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505331|NCT01216735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102505332|NCT01216735|Respiratory System Agents|respiratory system agents|mesh-ancestor
102505333|NCT01216735|Dermatologic Agents|dermatologic agents|mesh-ancestor
102505334|NCT01216735|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102505335|NCT00004186|Carboplatin|carboplatin|mesh-list
102505336|NCT00004186|Etoposide|etoposide|mesh-list
102505337|NCT00004186|Topotecan|topotecan|mesh-list
102505338|NCT00004186|Ifosfamide|ifosfamide|mesh-list
102505339|NCT00004186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505340|NCT00004186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102505341|NCT00004186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102505342|NCT00004186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102505343|NCT00004186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102505344|NCT00004186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505345|NCT00004186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102505346|NCT00004186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102505347|NCT00004186|Alkylating Agents|alkylating agents|mesh-ancestor
102505348|NCT00004192|Cytarabine|cytarabine|mesh-list
102505349|NCT00004192|Methylprednisolone|methylprednisolone|mesh-list
102505350|NCT00004192|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102505351|NCT00004192|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102505352|NCT00004192|Prednisolone|prednisolone|mesh-list
102505353|NCT00004192|Prednisolone acetate|prednisolone acetate|mesh-list
102505354|NCT00004192|Etoposide|etoposide|mesh-list
102505355|NCT00004192|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102505356|NCT00004192|Prednisolone phosphate|prednisolone phosphate|mesh-list
102505357|NCT00004192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505358|NCT00004192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102505359|NCT00004192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102505360|NCT00004192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102505361|NCT00004192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102505362|NCT00004192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505363|NCT00004192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102505364|NCT00004192|Antimetabolites|antimetabolites|mesh-ancestor
102505365|NCT00004192|Antiviral Agents|antiviral agents|mesh-ancestor
102505366|NCT00004192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102505367|NCT00004192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102505368|NCT00004192|Immunologic Factors|immunologic factors|mesh-ancestor
102505369|NCT00004192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505370|NCT00004192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102505371|NCT00004192|Antiemetics|antiemetics|mesh-ancestor
102505372|NCT00004192|Autonomic Agents|autonomic agents|mesh-ancestor
102505373|NCT00004192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102505374|NCT00004192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102505375|NCT00004192|Glucocorticoids|glucocorticoids|mesh-ancestor
102505376|NCT00004192|Hormones|hormones|mesh-ancestor
102505377|NCT00004192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102505378|NCT00004192|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102505380|NCT00004192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102505381|NCT00005002|Lamivudine|lamivudine|mesh-list
102505382|NCT00005002|Zidovudine|zidovudine|mesh-list
102505383|NCT00005002|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
102505384|NCT00005002|Nelfinavir|nelfinavir|mesh-list
102505385|NCT00005002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102505386|NCT00005002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102505387|NCT00005002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102505388|NCT00005002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505389|NCT00005002|Antiviral Agents|antiviral agents|mesh-ancestor
102505390|NCT00005002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102505391|NCT00005002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102505392|NCT00005002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102505393|NCT00005002|Antimetabolites|antimetabolites|mesh-ancestor
102505394|NCT00005002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102505395|NCT00005002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102505396|NCT00005002|Protease Inhibitors|protease inhibitors|mesh-ancestor
102505397|NCT00004198|Sargramostim|sargramostim|mesh-list
102505398|NCT00004198|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
102505399|NCT00004198|Vaccines|vaccines|mesh-list
102505400|NCT00004198|Immunologic Factors|immunologic factors|mesh-ancestor
102505401|NCT00004198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505402|NCT00004198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102505403|NCT01264705|Sorafenib|sorafenib|mesh-list
102505404|NCT01264705|Bavituximab|bavituximab|mesh-list
102505405|NCT01264705|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102505406|NCT01264705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505407|NCT01264705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102505408|NCT01264705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102505409|NCT01264705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505410|NCT01264705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102505411|NCT01264705|Immunologic Factors|immunologic factors|mesh-ancestor
102505412|NCT01264705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505413|NCT00004204|Temozolomide|temozolomide|mesh-list
102505414|NCT00004204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102505415|NCT00004204|Alkylating Agents|alkylating agents|mesh-ancestor
102505416|NCT00004204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505417|NCT00004204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505418|NCT01217515|Diltiazem|diltiazem|mesh-list
102505419|NCT01217515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102505420|NCT01217515|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102505421|NCT01217515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102505422|NCT01217515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505423|NCT01217515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102505424|NCT01217515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505425|NCT01217515|Vasodilator Agents|vasodilator agents|mesh-ancestor
102505426|NCT00005014|Risperidone|risperidone|mesh-list
102505427|NCT00005014|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102505428|NCT00005014|Serotonin Agents|serotonin agents|mesh-ancestor
102505429|NCT00005014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102505430|NCT00005014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505431|NCT00005014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505432|NCT00005014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102505433|NCT00005014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102505434|NCT00005014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102505435|NCT00005014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102505436|NCT00005014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102505437|NCT00005014|Dopamine Agents|dopamine agents|mesh-ancestor
102505438|NCT03009799|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102505439|NCT03009799|Laxatives|laxatives|mesh-ancestor
102505440|NCT03009799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102505441|NCT00005026|Paclitaxel|paclitaxel|mesh-list
102505442|NCT00005026|Carboplatin|carboplatin|mesh-list
102505443|NCT00005026|Topotecan|topotecan|mesh-list
102505444|NCT00005026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102505445|NCT00005026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505446|NCT00005026|Tubulin Modulators|tubulin modulators|mesh-ancestor
102505447|NCT00005026|Antimitotic Agents|antimitotic agents|mesh-ancestor
102505448|NCT00005026|Mitosis Modulators|mitosis modulators|mesh-ancestor
102505449|NCT00005026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505450|NCT00005026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102505451|NCT00005026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102505452|NCT00005026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102505453|NCT00016718|Emtricitabine|emtricitabine|mesh-list
102505455|NCT00016718|Didanosine|didanosine|mesh-list
102505456|NCT00016718|Antiviral Agents|antiviral agents|mesh-ancestor
102505457|NCT00016718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102505458|NCT00016718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102505459|NCT00016718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102505460|NCT00016718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102505461|NCT00016718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505462|NCT00016718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102505463|NCT00016718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102505464|NCT00016718|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102505465|NCT00016718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102505466|NCT00016718|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102505467|NCT00016718|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102505468|NCT00016718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102505469|NCT00016718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102505470|NCT00016718|Antimetabolites|antimetabolites|mesh-ancestor
102505471|NCT00004216|Ciprofloxacin|ciprofloxacin|mesh-list
102505472|NCT00004216|Ceftriaxone|ceftriaxone|mesh-list
102505473|NCT00004216|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102505474|NCT00004216|Cefixime|cefixime|mesh-list
102505475|NCT00004216|Trimethoprim|trimethoprim|mesh-list
102505476|NCT00004216|Sulfamethoxazole|sulfamethoxazole|mesh-list
102505477|NCT00004216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102505478|NCT00004216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102505479|NCT00004216|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102505480|NCT00004216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102505481|NCT00004216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102505482|NCT00004216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505483|NCT00004216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505484|NCT00004216|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102505485|NCT00004216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102505486|NCT00004216|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102505487|NCT00004216|Antimalarials|antimalarials|mesh-ancestor
102505488|NCT00004216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102505489|NCT00004216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102505490|NCT00004216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102505491|NCT00004216|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102505492|NCT00004216|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102505493|NCT00005032|Paclitaxel|paclitaxel|mesh-list
102505494|NCT00005032|Oblimersen|oblimersen|mesh-list
102505495|NCT00005032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102505496|NCT00005032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505497|NCT00005032|Tubulin Modulators|tubulin modulators|mesh-ancestor
102505498|NCT00005032|Antimitotic Agents|antimitotic agents|mesh-ancestor
102505499|NCT00005032|Mitosis Modulators|mitosis modulators|mesh-ancestor
102505500|NCT00005032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505501|NCT00005038|Aldesleukin|aldesleukin|mesh-list
102505502|NCT00005038|Histamine|histamine|mesh-list
102505503|NCT00005038|Histamine phosphate|histamine phosphate|mesh-list
102505504|NCT00005038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505505|NCT00005038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102505506|NCT00005038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102505507|NCT00005038|Antiviral Agents|antiviral agents|mesh-ancestor
102505508|NCT00005038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102505509|NCT00005038|Histamine Agonists|histamine agonists|mesh-ancestor
102505510|NCT00005038|Histamine Agents|histamine agents|mesh-ancestor
102505511|NCT00005038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102505512|NCT00005038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505513|NCT00005038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505514|NCT00019682|Aldesleukin|aldesleukin|mesh-list
102505515|NCT00019682|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
102505516|NCT00019682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505517|NCT00019682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102505518|NCT00019682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102505519|NCT00019682|Antiviral Agents|antiviral agents|mesh-ancestor
102505520|NCT00019682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102505521|NCT00019682|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102505522|NCT00019682|Immunologic Factors|immunologic factors|mesh-ancestor
102505523|NCT00019682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505524|NCT00005050|Fluorouracil|fluorouracil|mesh-list
102505525|NCT00005050|Oxaliplatin|oxaliplatin|mesh-list
102505526|NCT00005050|Eniluracil|eniluracil|mesh-list
102505528|NCT00005050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505529|NCT00005050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102505530|NCT00005050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505531|NCT00005050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102505532|NCT00005050|Immunologic Factors|immunologic factors|mesh-ancestor
102505533|NCT00005050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505534|NCT00005050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102505535|NCT00005578|Prednisone|prednisone|mesh-list
102505536|NCT00005578|Cyclophosphamide|cyclophosphamide|mesh-list
102505537|NCT00005578|Doxorubicin|doxorubicin|mesh-list
102505538|NCT00005578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102505539|NCT00005578|Etoposide|etoposide|mesh-list
102505540|NCT00005578|Vincristine|vincristine|mesh-list
102505541|NCT00005578|Bleomycin|bleomycin|mesh-list
102505542|NCT00005578|Dexrazoxane|dexrazoxane|mesh-list
102505543|NCT00005578|Razoxane|razoxane|mesh-list
102505544|NCT00005578|Lenograstim|lenograstim|mesh-list
102505545|NCT00005578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102505546|NCT00005578|Immunologic Factors|immunologic factors|mesh-ancestor
102505547|NCT00005578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505548|NCT00005578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102505549|NCT00005578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102505550|NCT00005578|Alkylating Agents|alkylating agents|mesh-ancestor
102505551|NCT00005578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505552|NCT00005578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505553|NCT00005578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102505554|NCT00005578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102505555|NCT00005578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102505556|NCT00005578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102505557|NCT00005578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102505558|NCT00005578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102505559|NCT00005578|Glucocorticoids|glucocorticoids|mesh-ancestor
102505560|NCT00005578|Hormones|hormones|mesh-ancestor
102505561|NCT00005578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102505562|NCT00005578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102505563|NCT00005578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102505564|NCT00005578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102505565|NCT00005578|Tubulin Modulators|tubulin modulators|mesh-ancestor
102505566|NCT00005578|Antimitotic Agents|antimitotic agents|mesh-ancestor
102505567|NCT00005578|Mitosis Modulators|mitosis modulators|mesh-ancestor
102505568|NCT00005578|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102505569|NCT00005578|Protective Agents|protective agents|mesh-ancestor
102505570|NCT00022490|Cytarabine|cytarabine|mesh-list
102505571|NCT00022490|Imatinib Mesylate|imatinib mesylate|mesh-list
102505572|NCT00022490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102505573|NCT00022490|Antimetabolites|antimetabolites|mesh-ancestor
102505574|NCT00022490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505575|NCT00022490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505576|NCT00022490|Antiviral Agents|antiviral agents|mesh-ancestor
102505577|NCT00022490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102154241|NCT03367143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154242|NCT03367143|Immunologic Factors|immunologic factors|mesh-ancestor
102154243|NCT03367143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154244|NCT03367143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102154245|NCT03367143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102154246|NCT03367143|Growth Substances|growth substances|mesh-ancestor
102154247|NCT03367143|Growth Inhibitors|growth inhibitors|mesh-ancestor
102154248|NCT03367143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102154249|NCT03367143|Alkylating Agents|alkylating agents|mesh-ancestor
102154250|NCT03372681|Antidiarrheals|antidiarrheals|mesh-list
102154251|NCT03372681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102154252|NCT04762316|Pyridoxal|pyridoxal|mesh-list
102154253|NCT04762316|Pyridoxine|pyridoxine|mesh-list
102154254|NCT04762316|Vitamin B 6|vitamin b 6|mesh-list
102154255|NCT04762316|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
102154256|NCT04762316|Vitamin B Complex|vitamin b complex|mesh-ancestor
102154257|NCT04762316|Vitamins|vitamins|mesh-ancestor
102154258|NCT04762316|Micronutrients|micronutrients|mesh-ancestor
102154259|NCT04762316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154260|NCT03372447|Thiamine|thiamine|mesh-list
102154261|NCT03372447|Pyridoxine|pyridoxine|mesh-list
102154262|NCT03372447|Hydroxocobalamin|hydroxocobalamin|mesh-list
102154263|NCT03372447|Vitamin B 12|vitamin b 12|mesh-list
102154264|NCT03372447|Vitamin B Complex|vitamin b complex|mesh-ancestor
102154265|NCT03372447|Vitamins|vitamins|mesh-ancestor
102505578|NCT00022490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102505579|NCT00022490|Immunologic Factors|immunologic factors|mesh-ancestor
102505580|NCT00022490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505581|NCT00022490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102505583|NCT00386230|Zidovudine|zidovudine|mesh-list
102505584|NCT00386230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505585|NCT00386230|Antimetabolites|antimetabolites|mesh-ancestor
102505586|NCT00386230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102505587|NCT00386230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102505588|NCT00386230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102505589|NCT00386230|Antiviral Agents|antiviral agents|mesh-ancestor
102505590|NCT00386230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102505591|NCT00386230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102505592|NCT00386230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102505593|NCT00097448|Prednisone|prednisone|mesh-list
102505594|NCT00097448|Methylprednisolone|methylprednisolone|mesh-list
102505595|NCT00097448|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102505596|NCT00097448|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102505597|NCT00097448|Prednisolone|prednisolone|mesh-list
102505598|NCT00097448|Prednisolone acetate|prednisolone acetate|mesh-list
102505599|NCT00097448|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102505600|NCT00097448|Prednisolone phosphate|prednisolone phosphate|mesh-list
102505601|NCT00097448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102505602|NCT00097448|Glucocorticoids|glucocorticoids|mesh-ancestor
102505603|NCT00097448|Hormones|hormones|mesh-ancestor
102505604|NCT00097448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102505605|NCT00097448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505606|NCT00097448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102505607|NCT00097448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505608|NCT00097448|Antiemetics|antiemetics|mesh-ancestor
102505609|NCT00097448|Autonomic Agents|autonomic agents|mesh-ancestor
102505610|NCT00097448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102505611|NCT00097448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102505612|NCT00097448|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102505613|NCT00097448|Protective Agents|protective agents|mesh-ancestor
102505614|NCT00004246|Fludarabine|fludarabine|mesh-list
102505615|NCT00004246|Fludarabine phosphate|fludarabine phosphate|mesh-list
102505616|NCT00004246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505617|NCT00004246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102505618|NCT00004246|Antimetabolites|antimetabolites|mesh-ancestor
102505619|NCT00004246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505620|NCT00004246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102505621|NCT00004246|Immunologic Factors|immunologic factors|mesh-ancestor
102505622|NCT00004246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505623|NCT00028262|Cysteamine|cysteamine|mesh-list
102505624|NCT00028262|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
102505625|NCT00028262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505626|NCT00005056|Bryostatin 1|bryostatin 1|mesh-list
102505627|NCT00005056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102505628|NCT00005056|Immunologic Factors|immunologic factors|mesh-ancestor
102505629|NCT00005056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505630|NCT00005056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505631|NCT00004252|Leucovorin|leucovorin|mesh-list
102505632|NCT00004252|Fluorouracil|fluorouracil|mesh-list
102505633|NCT00004252|Calcium|calcium|mesh-list
102505634|NCT00004252|Levoleucovorin|levoleucovorin|mesh-list
102505635|NCT00004252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102505636|NCT00004252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505637|NCT00004252|Antimetabolites|antimetabolites|mesh-ancestor
102505638|NCT00004252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505639|NCT00004252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102505640|NCT00004252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505641|NCT00004252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102505642|NCT00004252|Immunologic Factors|immunologic factors|mesh-ancestor
102505643|NCT00004252|Antidotes|antidotes|mesh-ancestor
102505644|NCT00004252|Protective Agents|protective agents|mesh-ancestor
102505645|NCT00004252|Vitamin B Complex|vitamin b complex|mesh-ancestor
102505646|NCT00004252|Vitamins|vitamins|mesh-ancestor
102505647|NCT00004252|Micronutrients|micronutrients|mesh-ancestor
102505648|NCT00005590|Levofloxacin|levofloxacin|mesh-list
102505649|NCT00005590|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102505650|NCT00005590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102505651|NCT00005590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102505652|NCT00005590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102154266|NCT03372447|Micronutrients|micronutrients|mesh-ancestor
102505653|NCT00005590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102505654|NCT00005590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102505655|NCT00005590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505656|NCT00005590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505657|NCT00005590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102505658|NCT00005590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102505659|NCT00005596|Leucovorin|leucovorin|mesh-list
102505660|NCT00005596|Cytarabine|cytarabine|mesh-list
102505661|NCT00005596|Dexamethasone|dexamethasone|mesh-list
102505662|NCT00005596|Cyclophosphamide|cyclophosphamide|mesh-list
102505663|NCT00005596|Methotrexate|methotrexate|mesh-list
102505664|NCT00005596|Vincristine|vincristine|mesh-list
102505665|NCT00005596|Daunorubicin|daunorubicin|mesh-list
102505666|NCT00005596|Mercaptopurine|mercaptopurine|mesh-list
102505667|NCT00005596|Pegaspargase|pegaspargase|mesh-list
102505668|NCT00005596|Thioguanine|thioguanine|mesh-list
102505669|NCT00005596|Levoleucovorin|levoleucovorin|mesh-list
102505670|NCT00005596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102505671|NCT00005596|Immunologic Factors|immunologic factors|mesh-ancestor
102505672|NCT00005596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505673|NCT00005596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102505674|NCT00005596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102505675|NCT00005596|Alkylating Agents|alkylating agents|mesh-ancestor
102505676|NCT00005596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505677|NCT00005596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505678|NCT00005596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102505679|NCT00005596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102505680|NCT00005596|Antiemetics|antiemetics|mesh-ancestor
102505681|NCT00005596|Autonomic Agents|autonomic agents|mesh-ancestor
102505682|NCT00005596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102505683|NCT00005596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102505684|NCT00005596|Glucocorticoids|glucocorticoids|mesh-ancestor
102505685|NCT00005596|Hormones|hormones|mesh-ancestor
102505686|NCT00005596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102505687|NCT00005596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102505688|NCT00005596|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102505689|NCT00005596|Abortifacient Agents|abortifacient agents|mesh-ancestor
102505690|NCT00005596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102505691|NCT00005596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102505692|NCT00005596|Antimetabolites|antimetabolites|mesh-ancestor
102505693|NCT00005596|Dermatologic Agents|dermatologic agents|mesh-ancestor
102505694|NCT00005596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102505695|NCT00005596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102505696|NCT00005596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102505697|NCT00005596|Antiviral Agents|antiviral agents|mesh-ancestor
102505698|NCT00005596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102505699|NCT00005596|Antidotes|antidotes|mesh-ancestor
102505700|NCT00005596|Protective Agents|protective agents|mesh-ancestor
102505701|NCT00005596|Vitamin B Complex|vitamin b complex|mesh-ancestor
102505702|NCT00005596|Vitamins|vitamins|mesh-ancestor
102505703|NCT00005596|Micronutrients|micronutrients|mesh-ancestor
102505704|NCT00005596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102505705|NCT00005596|Tubulin Modulators|tubulin modulators|mesh-ancestor
102505706|NCT00005596|Antimitotic Agents|antimitotic agents|mesh-ancestor
102505707|NCT00005596|Mitosis Modulators|mitosis modulators|mesh-ancestor
102505708|NCT00005596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102505709|NCT00005596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102505710|NCT00005596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102505711|NCT00005068|Leucovorin|leucovorin|mesh-list
102505712|NCT00005068|Fluorouracil|fluorouracil|mesh-list
102505713|NCT00005068|Oxaliplatin|oxaliplatin|mesh-list
102505714|NCT00005068|Irinotecan|irinotecan|mesh-list
102505715|NCT00005068|Calcium|calcium|mesh-list
102505716|NCT00005068|Levoleucovorin|levoleucovorin|mesh-list
102505717|NCT00005068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102505718|NCT00005068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505719|NCT00005068|Antimetabolites|antimetabolites|mesh-ancestor
102505720|NCT00005068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505721|NCT00005068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102505722|NCT00005068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505723|NCT00005068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102505724|NCT00005068|Immunologic Factors|immunologic factors|mesh-ancestor
102505725|NCT00005068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102505726|NCT00005068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102505727|NCT00005068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102505728|NCT00005068|Antidotes|antidotes|mesh-ancestor
102505729|NCT00005068|Protective Agents|protective agents|mesh-ancestor
102505730|NCT00005068|Vitamin B Complex|vitamin b complex|mesh-ancestor
102505731|NCT00005068|Vitamins|vitamins|mesh-ancestor
102505732|NCT00005068|Micronutrients|micronutrients|mesh-ancestor
102505733|NCT00004264|Docetaxel|docetaxel|mesh-list
102505734|NCT00004264|Amifostine|amifostine|mesh-list
102505735|NCT00004264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505736|NCT00004264|Tubulin Modulators|tubulin modulators|mesh-ancestor
102505737|NCT00004264|Antimitotic Agents|antimitotic agents|mesh-ancestor
102505738|NCT00004264|Mitosis Modulators|mitosis modulators|mesh-ancestor
102505739|NCT00004264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505740|NCT00004264|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102505741|NCT00004264|Protective Agents|protective agents|mesh-ancestor
102505742|NCT00004264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505743|NCT00005074|Alvocidib|alvocidib|mesh-list
102505744|NCT00005074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505745|NCT00005074|Growth Inhibitors|growth inhibitors|mesh-ancestor
102505746|NCT00005074|Growth Substances|growth substances|mesh-ancestor
102505747|NCT00005074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505748|NCT00005074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102505749|NCT00005074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102505750|NCT00005074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505751|NCT00005602|Carboplatin|carboplatin|mesh-list
102505752|NCT00005602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505753|NCT00004276|Thalidomide|thalidomide|mesh-list
102505754|NCT00004276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102505755|NCT00004276|Immunologic Factors|immunologic factors|mesh-ancestor
102505756|NCT00004276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505757|NCT00004276|Leprostatic Agents|leprostatic agents|mesh-ancestor
102505758|NCT00004276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102505759|NCT00004276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102505760|NCT00004276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102505761|NCT00004276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102505762|NCT00004276|Growth Substances|growth substances|mesh-ancestor
102505763|NCT00004276|Growth Inhibitors|growth inhibitors|mesh-ancestor
102505764|NCT00004276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505765|NCT00004288|Olsalazine|olsalazine|mesh-list
102505766|NCT00004288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102505767|NCT00004288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102505768|NCT00004288|Analgesics|analgesics|mesh-ancestor
102505769|NCT00004288|Sensory System Agents|sensory system agents|mesh-ancestor
102505770|NCT00004288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102505771|NCT00004288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505772|NCT00004288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102505773|NCT00004288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102505774|NCT00004288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102505775|NCT00005086|Gemcitabine|gemcitabine|mesh-list
102505776|NCT00005086|Docetaxel|docetaxel|mesh-list
102505777|NCT00005086|Methotrexate|methotrexate|mesh-list
102505778|NCT00005086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505779|NCT00005086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102505780|NCT00005086|Antimetabolites|antimetabolites|mesh-ancestor
102505781|NCT00005086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505782|NCT00005086|Tubulin Modulators|tubulin modulators|mesh-ancestor
102505783|NCT00005086|Antimitotic Agents|antimitotic agents|mesh-ancestor
102505784|NCT00005086|Mitosis Modulators|mitosis modulators|mesh-ancestor
102505785|NCT00005086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102505786|NCT00005086|Abortifacient Agents|abortifacient agents|mesh-ancestor
102505787|NCT00005086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102505788|NCT00005086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505789|NCT00005086|Dermatologic Agents|dermatologic agents|mesh-ancestor
102505790|NCT00005086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102505791|NCT00005086|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102505792|NCT00005086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102505793|NCT00005086|Immunologic Factors|immunologic factors|mesh-ancestor
102505794|NCT00005086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102505795|NCT00005086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102505796|NCT00005614|Gemcitabine|gemcitabine|mesh-list
102505797|NCT00005614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102505798|NCT00005614|Antimetabolites|antimetabolites|mesh-ancestor
102505799|NCT00005614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505800|NCT00005614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505801|NCT00101036|Lapatinib|lapatinib|mesh-list
102505802|NCT00101036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505803|NCT00101036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102505804|NCT00101036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102505805|NCT00101036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505806|NCT00004300|Bromocriptine|bromocriptine|mesh-list
102505807|NCT00004300|Sertraline|sertraline|mesh-list
102505808|NCT00004300|Antidepressive Agents|antidepressive agents|mesh-ancestor
102505810|NCT00004300|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102505811|NCT00004300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102505812|NCT00004300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102505813|NCT00004300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505814|NCT00004300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102505815|NCT00004300|Serotonin Agents|serotonin agents|mesh-ancestor
102505816|NCT00004300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505817|NCT00004300|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102505818|NCT00004300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102505819|NCT00004300|Hormone Antagonists|hormone antagonists|mesh-ancestor
102505820|NCT00004300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102505821|NCT00004300|Dopamine Agonists|dopamine agonists|mesh-ancestor
102505822|NCT00004300|Dopamine Agents|dopamine agents|mesh-ancestor
102505823|NCT00005626|Irinotecan|irinotecan|mesh-list
102505824|NCT00005626|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102505825|NCT00005626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102505826|NCT00005626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102505827|NCT00005626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505828|NCT00005626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505829|NCT00005092|Cyclophosphamide|cyclophosphamide|mesh-list
102505830|NCT00005092|Thiotepa|thiotepa|mesh-list
102505831|NCT00005092|Methoxsalen|methoxsalen|mesh-list
102505832|NCT00005092|Furocoumarins|furocoumarins|mesh-list
102505833|NCT00005092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102505834|NCT00005092|Immunologic Factors|immunologic factors|mesh-ancestor
102505835|NCT00005092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505836|NCT00005092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102505837|NCT00005092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102505838|NCT00005092|Alkylating Agents|alkylating agents|mesh-ancestor
102505839|NCT00005092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505840|NCT00005092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505841|NCT00005092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102505842|NCT00005092|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102505843|NCT00005092|Dermatologic Agents|dermatologic agents|mesh-ancestor
102505844|NCT00005638|Irinotecan|irinotecan|mesh-list
102505845|NCT00005638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505846|NCT00005638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102505847|NCT00005638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102505848|NCT00005638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102505849|NCT00005638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505850|NCT00005104|Metformin|metformin|mesh-list
102505851|NCT00005104|Clomiphene|clomiphene|mesh-list
102505852|NCT00005104|Enclomiphene|enclomiphene|mesh-list
102505853|NCT00005104|Zuclomiphene|zuclomiphene|mesh-list
102505854|NCT00005104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102505855|NCT00005104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505856|NCT00005104|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102505857|NCT00005104|Hormone Antagonists|hormone antagonists|mesh-ancestor
102505858|NCT00005104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102505859|NCT00005104|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102505860|NCT00005104|Fertility Agents|fertility agents|mesh-ancestor
101982057|NCT01586299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102505861|NCT00005104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102505862|NCT00005104|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102505863|NCT00005104|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102505864|NCT00005110|Albuterol|albuterol|mesh-list
102505865|NCT00005110|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102505866|NCT00005110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102505867|NCT00005110|Autonomic Agents|autonomic agents|mesh-ancestor
102505868|NCT00005110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102505869|NCT00005110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505870|NCT00005110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102505871|NCT00005110|Respiratory System Agents|respiratory system agents|mesh-ancestor
102505872|NCT00005110|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102505873|NCT00005110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102505874|NCT00005110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102505875|NCT00005110|Adrenergic Agents|adrenergic agents|mesh-ancestor
102505876|NCT00005110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102505877|NCT00005110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505878|NCT00005110|Tocolytic Agents|tocolytic agents|mesh-ancestor
102505879|NCT00005110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102505880|NCT00004330|Hormones|hormones|mesh-list
102505881|NCT00004330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102505882|NCT00004330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505883|NCT00005668|Itraconazole|itraconazole|mesh-list
102505884|NCT00005668|Antifungal Agents|antifungal agents|mesh-ancestor
102505885|NCT00005668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102505886|NCT00005668|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102505887|NCT00005668|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102505888|NCT00005668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102505889|NCT00005668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505890|NCT00005668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102505891|NCT00005668|Hormone Antagonists|hormone antagonists|mesh-ancestor
102505892|NCT00005668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102505893|NCT00005668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505894|NCT00005668|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102505895|NCT00030992|Diphenhydramine|diphenhydramine|mesh-list
102505896|NCT00030992|Promethazine|promethazine|mesh-list
102505897|NCT00030992|Ranitidine|ranitidine|mesh-list
102505898|NCT00030992|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
102505899|NCT00030992|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102505900|NCT00030992|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102505901|NCT00030992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102505902|NCT00030992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505903|NCT00030992|Anesthetics, Local|anesthetics, local|mesh-ancestor
102505904|NCT00030992|Anesthetics|anesthetics|mesh-ancestor
102505905|NCT00030992|Sensory System Agents|sensory system agents|mesh-ancestor
102505906|NCT00030992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102505907|NCT00030992|Antiemetics|antiemetics|mesh-ancestor
102505908|NCT00030992|Autonomic Agents|autonomic agents|mesh-ancestor
102505909|NCT00030992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102505910|NCT00030992|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102505911|NCT00030992|Histamine Antagonists|histamine antagonists|mesh-ancestor
101982132|NCT04770740|Hemostatics|hemostatics|mesh-ancestor
102505912|NCT00030992|Histamine Agents|histamine agents|mesh-ancestor
102505913|NCT00030992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102505914|NCT00030992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505915|NCT00030992|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102505916|NCT00030992|Antipruritics|antipruritics|mesh-ancestor
102505917|NCT00030992|Dermatologic Agents|dermatologic agents|mesh-ancestor
102505918|NCT00030992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102505919|NCT00030992|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102505920|NCT00004360|Chlorothiazide|chlorothiazide|mesh-list
102505921|NCT00004360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102505922|NCT00004360|Diuretics|diuretics|mesh-ancestor
102505923|NCT00004360|Natriuretic Agents|natriuretic agents|mesh-ancestor
102505924|NCT00004360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505925|NCT00004360|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102505926|NCT00004360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102505927|NCT00004360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505928|NCT00385450|Nelfinavir|nelfinavir|mesh-list
102505929|NCT00385450|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102505930|NCT00385450|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102505931|NCT00385450|Protease Inhibitors|protease inhibitors|mesh-ancestor
102505932|NCT00385450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102505933|NCT00385450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505934|NCT00385450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102505935|NCT00385450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102505936|NCT00385450|Antiviral Agents|antiviral agents|mesh-ancestor
102505937|NCT00385450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102505938|NCT00004390|Morphine|morphine|mesh-list
102505939|NCT00004390|Methadone|methadone|mesh-list
102505940|NCT00004390|Nortriptyline|nortriptyline|mesh-list
102505941|NCT00004390|Desipramine|desipramine|mesh-list
102505942|NCT00004390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102505943|NCT00004390|Narcotics|narcotics|mesh-ancestor
102505944|NCT00004390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102505945|NCT00004390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505946|NCT00004390|Analgesics|analgesics|mesh-ancestor
102505947|NCT00004390|Sensory System Agents|sensory system agents|mesh-ancestor
102505948|NCT00004390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102505949|NCT00004390|Antitussive Agents|antitussive agents|mesh-ancestor
102505950|NCT00004390|Respiratory System Agents|respiratory system agents|mesh-ancestor
102505951|NCT00004390|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102505952|NCT00004390|Antidepressive Agents|antidepressive agents|mesh-ancestor
102505953|NCT00004390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102505954|NCT00004390|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102505955|NCT00004390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102505956|NCT00004390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102505957|NCT00004390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505958|NCT00004390|Adrenergic Agents|adrenergic agents|mesh-ancestor
102505959|NCT00004390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102505960|NCT00004390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102505961|NCT00004396|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
102505962|NCT00004396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102505963|NCT00004396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505964|NCT00004402|Calcitriol|calcitriol|mesh-list
102505965|NCT00004402|Interferons|interferons|mesh-list
102505966|NCT00004402|Interferon-gamma|interferon-gamma|mesh-list
102505967|NCT00004402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102505968|NCT00004402|Antiviral Agents|antiviral agents|mesh-ancestor
102505969|NCT00004402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102505970|NCT00004402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102505971|NCT00004402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505972|NCT00004402|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102505973|NCT00004402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102505974|NCT00004402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505975|NCT00004402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102505976|NCT00004402|Vitamins|vitamins|mesh-ancestor
102505977|NCT00004402|Micronutrients|micronutrients|mesh-ancestor
102505978|NCT00004402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102505979|NCT00004420|Evening primrose oil|evening primrose oil|mesh-list
102505980|NCT00004420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102505981|NCT00004420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102505982|NCT00004420|Analgesics|analgesics|mesh-ancestor
102505983|NCT00004420|Sensory System Agents|sensory system agents|mesh-ancestor
101982183|NCT03899077|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102505984|NCT00004420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102505985|NCT00004420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505986|NCT00004420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102505987|NCT00004420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102505988|NCT00004420|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102505989|NCT00004420|Antimetabolites|antimetabolites|mesh-ancestor
102505990|NCT00004420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102505991|NCT00004420|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102505992|NCT00004420|Dermatologic Agents|dermatologic agents|mesh-ancestor
102505993|NCT00004426|Leuprolide|leuprolide|mesh-list
102505994|NCT00004426|Hormones|hormones|mesh-list
102505995|NCT00004426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102505996|NCT00004426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102505997|NCT00004426|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102505998|NCT00004426|Fertility Agents|fertility agents|mesh-ancestor
102505999|NCT00004426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102506000|NCT00004426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102506001|NCT00004426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506002|NCT00004438|Leuprolide|leuprolide|mesh-list
102506003|NCT00004438|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102506004|NCT00004438|Fertility Agents|fertility agents|mesh-ancestor
102506005|NCT00004438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102506006|NCT00004438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506007|NCT00004438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102506008|NCT00004438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506009|NCT01217749|Ofatumumab|ofatumumab|mesh-list
102506010|NCT01217749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506011|NCT02197273|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102506012|NCT02197273|Epinephrine|epinephrine|mesh-list
102506013|NCT02197273|Fentanyl|fentanyl|mesh-list
102506014|NCT02197273|Morphine|morphine|mesh-list
102506015|NCT02197273|Bupivacaine|bupivacaine|mesh-list
102506016|NCT02197273|Ropivacaine|ropivacaine|mesh-list
102506017|NCT02197273|Anesthetics, Local|anesthetics, local|mesh-ancestor
102506018|NCT02197273|Anesthetics|anesthetics|mesh-ancestor
102506019|NCT02197273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102506020|NCT02197273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506021|NCT02197273|Sensory System Agents|sensory system agents|mesh-ancestor
102506022|NCT02197273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102506023|NCT02197273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102506024|NCT02197273|Narcotics|narcotics|mesh-ancestor
102506025|NCT02197273|Analgesics|analgesics|mesh-ancestor
102506026|NCT02197273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102506027|NCT02197273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102506028|NCT02197273|Anesthetics, General|anesthetics, general|mesh-ancestor
102506029|NCT02197273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102506030|NCT02197273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102506031|NCT02197273|Adrenergic Agents|adrenergic agents|mesh-ancestor
102506032|NCT02197273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102506033|NCT02197273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506034|NCT02197273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102506035|NCT02197273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102506036|NCT02197273|Autonomic Agents|autonomic agents|mesh-ancestor
102506037|NCT02197273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102506038|NCT02197273|Respiratory System Agents|respiratory system agents|mesh-ancestor
102506039|NCT02197273|Mydriatics|mydriatics|mesh-ancestor
102506040|NCT02197273|Sympathomimetics|sympathomimetics|mesh-ancestor
102506041|NCT02197273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102506042|NCT02197273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102506043|NCT02197273|Glucocorticoids|glucocorticoids|mesh-ancestor
102506044|NCT02197273|Hormones|hormones|mesh-ancestor
102506045|NCT02197273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102506046|NCT02197273|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102506047|NCT02197273|Protective Agents|protective agents|mesh-ancestor
102506048|NCT02197273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102506049|NCT02197273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506050|NCT00004444|Paromomycin|paromomycin|mesh-list
102506051|NCT00004444|Streptomycin|streptomycin|mesh-list
102506052|NCT00004444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102506053|NCT00004444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102506054|NCT00004444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102506055|NCT00004444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102506056|NCT00004444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102506057|NCT00004444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102506058|NCT00004444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506059|NCT00004450|Interferons|interferons|mesh-list
102506060|NCT00004450|Interferon-beta|interferon-beta|mesh-list
102506061|NCT00004450|Thalidomide|thalidomide|mesh-list
102506062|NCT00004450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506063|NCT00004450|Antiviral Agents|antiviral agents|mesh-ancestor
102506064|NCT00004450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102506065|NCT00004450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102506066|NCT00004450|Immunologic Factors|immunologic factors|mesh-ancestor
102506067|NCT00004450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506068|NCT00004450|Leprostatic Agents|leprostatic agents|mesh-ancestor
102506069|NCT00004450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102506070|NCT00004450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102506071|NCT00004450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102506072|NCT00004450|Growth Substances|growth substances|mesh-ancestor
102506073|NCT00004450|Growth Inhibitors|growth inhibitors|mesh-ancestor
102506074|NCT00004468|Calcitriol|calcitriol|mesh-list
102506075|NCT00004468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102506076|NCT00004468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506077|NCT00004468|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102506078|NCT00004468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102506079|NCT00004468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506080|NCT00004468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102506081|NCT00004468|Vitamins|vitamins|mesh-ancestor
102506082|NCT00004468|Micronutrients|micronutrients|mesh-ancestor
102506083|NCT00004468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102506084|NCT01288807|Milnacipran|milnacipran|mesh-list
102506085|NCT01288807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102506086|NCT01288807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102506087|NCT01288807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102506088|NCT01288807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506089|NCT01288807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102506090|NCT01288807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506091|NCT01288807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102506092|NCT01288807|Analgesics|analgesics|mesh-ancestor
102506093|NCT01288807|Sensory System Agents|sensory system agents|mesh-ancestor
102506094|NCT01288807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102506095|NCT00005764|Lamivudine|lamivudine|mesh-list
102506096|NCT00005764|Zidovudine|zidovudine|mesh-list
102506097|NCT00005764|Abacavir|abacavir|mesh-list
102506098|NCT00005764|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
102506099|NCT00005764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102506100|NCT00005764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102506101|NCT00005764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102506102|NCT00005764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506103|NCT00005764|Antiviral Agents|antiviral agents|mesh-ancestor
102506104|NCT00005764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102506105|NCT00005764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102506106|NCT00005764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102506107|NCT00005764|Antimetabolites|antimetabolites|mesh-ancestor
102506109|NCT01289275|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102506110|NCT01289275|Autonomic Agents|autonomic agents|mesh-ancestor
102506111|NCT01289275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102506112|NCT01289275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506113|NCT01289275|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102506114|NCT01289275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102506115|NCT01289275|Cholinergic Agents|cholinergic agents|mesh-ancestor
102506116|NCT01289275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102506117|NCT01289275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506118|NCT00004474|Cyclophosphamide|cyclophosphamide|mesh-list
102506119|NCT00004474|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102506120|NCT00004474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102506121|NCT00004474|Immunologic Factors|immunologic factors|mesh-ancestor
102506122|NCT00004474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506123|NCT00004474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102506124|NCT00004474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102506125|NCT00004474|Alkylating Agents|alkylating agents|mesh-ancestor
102506126|NCT00004474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506127|NCT00004474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506128|NCT00004474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102506129|NCT00004480|Botulinum Toxins|botulinum toxins|mesh-list
102506130|NCT00004480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102506131|NCT00004480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102506132|NCT00004480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102506133|NCT00004480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102506134|NCT00004480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506135|NCT00004480|Cholinergic Agents|cholinergic agents|mesh-ancestor
102506136|NCT00004480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102506137|NCT00004480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506138|NCT00004480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102506139|NCT00004480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102506140|NCT00004486|Fluoxetine|fluoxetine|mesh-list
102506141|NCT00004486|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102506142|NCT00004486|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102506143|NCT00004486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102506144|NCT00004486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506145|NCT00004486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102506146|NCT00004486|Serotonin Agents|serotonin agents|mesh-ancestor
102506147|NCT00004486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506148|NCT00004486|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102506149|NCT00004486|Antidepressive Agents|antidepressive agents|mesh-ancestor
102506150|NCT00004486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102506151|NCT00004486|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102506152|NCT00004486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102506153|NCT00004486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102506154|NCT00004492|Clotrimazole|clotrimazole|mesh-list
102506155|NCT00004492|Miconazole|miconazole|mesh-list
102506156|NCT00004492|Hydroxyurea|hydroxyurea|mesh-list
102506157|NCT00004492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506158|NCT00004492|Antisickling Agents|antisickling agents|mesh-ancestor
102506159|NCT00004492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102506160|NCT00004492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506161|NCT00004492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102506162|NCT00004492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102506163|NCT00004492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102506164|NCT00004492|Antifungal Agents|antifungal agents|mesh-ancestor
102506165|NCT00004492|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102506166|NCT00004492|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102506167|NCT00004492|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102506168|NCT00004492|Hormone Antagonists|hormone antagonists|mesh-ancestor
102506169|NCT00004492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102506170|NCT00004492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506171|NCT00004492|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102506172|NCT00004492|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102506173|NCT00005776|Nitric Oxide|nitric oxide|mesh-list
102506174|NCT00005776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102506175|NCT00005776|Autonomic Agents|autonomic agents|mesh-ancestor
102506176|NCT00005776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102506177|NCT00005776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506178|NCT00005776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102506179|NCT00005776|Respiratory System Agents|respiratory system agents|mesh-ancestor
102506180|NCT00005776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102506182|NCT00005776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506183|NCT00005776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102506184|NCT00005776|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102506185|NCT00005776|Vasodilator Agents|vasodilator agents|mesh-ancestor
102506186|NCT00005776|Gasotransmitters|gasotransmitters|mesh-ancestor
102506187|NCT00005776|Protective Agents|protective agents|mesh-ancestor
102506188|NCT00005782|Lenograstim|lenograstim|mesh-list
102506189|NCT00005782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102506190|NCT00005782|Immunologic Factors|immunologic factors|mesh-ancestor
102506191|NCT00005782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506192|NCT01290913|Omalizumab|omalizumab|mesh-list
102506193|NCT01290913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102506194|NCT01290913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102506195|NCT01290913|Respiratory System Agents|respiratory system agents|mesh-ancestor
102506196|NCT00004552|Acamprosate|acamprosate|mesh-list
102506197|NCT00004552|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102506198|NCT00101660|Dasatinib|dasatinib|mesh-list
102506199|NCT00101660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506200|NCT00101660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102506201|NCT00101660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102506202|NCT00101660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506203|NCT01267279|Zoledronic Acid|zoledronic acid|mesh-list
102506204|NCT01267279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102506205|NCT01267279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506206|NCT00005800|Docetaxel|docetaxel|mesh-list
102506207|NCT00005800|Doxorubicin|doxorubicin|mesh-list
102506208|NCT00005800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102506209|NCT00005800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506210|NCT00005800|Tubulin Modulators|tubulin modulators|mesh-ancestor
102506211|NCT00005800|Antimitotic Agents|antimitotic agents|mesh-ancestor
102506212|NCT00005800|Mitosis Modulators|mitosis modulators|mesh-ancestor
102506213|NCT00005800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506214|NCT00005800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102506215|NCT00005800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102506216|NCT00005800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102506217|NCT00005800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102506218|NCT00004564|Clopidogrel|clopidogrel|mesh-list
102506219|NCT00004564|Atorvastatin|atorvastatin|mesh-list
102506220|NCT00004564|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102506221|NCT00004564|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102506222|NCT00004564|Antimetabolites|antimetabolites|mesh-ancestor
102506223|NCT00004564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506224|NCT00004564|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102506225|NCT00004564|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102506226|NCT00004564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102506227|NCT00004564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102506228|NCT00004564|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102506229|NCT00004564|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102506230|NCT00004564|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102506231|NCT00004564|Purinergic Agents|purinergic agents|mesh-ancestor
102506232|NCT00004564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102506233|NCT00004564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506234|NCT01268527|Calcipotriene|calcipotriene|mesh-list
102506235|NCT01268527|Dermatologic Agents|dermatologic agents|mesh-ancestor
102506236|NCT00005806|Paclitaxel|paclitaxel|mesh-list
102506237|NCT00005806|Carboplatin|carboplatin|mesh-list
102506238|NCT00005806|Gefitinib|gefitinib|mesh-list
102506239|NCT00005806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102506240|NCT00005806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506241|NCT00005806|Tubulin Modulators|tubulin modulators|mesh-ancestor
102506242|NCT00005806|Antimitotic Agents|antimitotic agents|mesh-ancestor
102506243|NCT00005806|Mitosis Modulators|mitosis modulators|mesh-ancestor
102506244|NCT00005806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506245|NCT00005806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102506246|NCT00005806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102506247|NCT00005812|Temozolomide|temozolomide|mesh-list
102506248|NCT00005812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102506249|NCT00005812|Alkylating Agents|alkylating agents|mesh-ancestor
102506250|NCT00005812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506251|NCT00005812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506252|NCT01270555|Bupropion|bupropion|mesh-list
102317756|NCT01552408|Ranibizumab|ranibizumab|mesh-list
102506253|NCT01270555|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102506254|NCT01270555|Antidepressive Agents|antidepressive agents|mesh-ancestor
102506255|NCT01270555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102506256|NCT01270555|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102506257|NCT01270555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102506258|NCT01270555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102506259|NCT01270555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506260|NCT01270555|Dopamine Agents|dopamine agents|mesh-ancestor
102506261|NCT01270555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102506262|NCT01270555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982471|NCT03895411|Sympatholytics|sympatholytics|mesh-ancestor
102506263|NCT01270555|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102506264|NCT01270555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102506265|NCT01270555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102506266|NCT00004582|Ritonavir|ritonavir|mesh-list
102506267|NCT00004582|Lopinavir|lopinavir|mesh-list
102506268|NCT00004582|Efavirenz|efavirenz|mesh-list
102506269|NCT00004582|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102506270|NCT00004582|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102506271|NCT00004582|Protease Inhibitors|protease inhibitors|mesh-ancestor
102506272|NCT00004582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102506273|NCT00004582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506274|NCT00004582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102506275|NCT00004582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102506276|NCT00004582|Antiviral Agents|antiviral agents|mesh-ancestor
102506277|NCT00004582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102506278|NCT00004582|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102506279|NCT00004582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102506280|NCT00004582|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102506281|NCT00004582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102506282|NCT00004582|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102506283|NCT00004582|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102506284|NCT00004582|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102506285|NCT00004582|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102506286|NCT00004582|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102506287|NCT00004690|Monolaurin|monolaurin|mesh-list
102506288|NCT00004690|Cariostatic Agents|cariostatic agents|mesh-ancestor
102506289|NCT00004690|Protective Agents|protective agents|mesh-ancestor
102506290|NCT00004690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506291|NCT00004696|Morphine|morphine|mesh-list
102506292|NCT00004696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102506293|NCT00004696|Narcotics|narcotics|mesh-ancestor
102506294|NCT00004696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102506295|NCT00004696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506296|NCT00004696|Analgesics|analgesics|mesh-ancestor
102506297|NCT00004696|Sensory System Agents|sensory system agents|mesh-ancestor
102506298|NCT00004696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102506299|NCT00004744|Immunoglobulins|immunoglobulins|mesh-list
102506300|NCT00004744|Antibodies|antibodies|mesh-list
102506301|NCT00004744|gamma-Globulins|gamma-globulins|mesh-list
102506302|NCT00004744|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102506303|NCT00004744|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102506304|NCT00004744|Immunologic Factors|immunologic factors|mesh-ancestor
102506305|NCT00004744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506306|NCT01292005|Pentoxifylline|pentoxifylline|mesh-list
102506307|NCT01292005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102506308|NCT01292005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102506309|NCT01292005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506310|NCT01292005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102506311|NCT01292005|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102506312|NCT01292005|Protective Agents|protective agents|mesh-ancestor
102506313|NCT01292005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506314|NCT01292005|Vasodilator Agents|vasodilator agents|mesh-ancestor
102506315|NCT01292005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102506316|NCT01292005|Antioxidants|antioxidants|mesh-ancestor
102506317|NCT00004762|Cladribine|cladribine|mesh-list
102506318|NCT00004762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506319|NCT00004762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102506320|NCT00004762|Immunologic Factors|immunologic factors|mesh-ancestor
102506321|NCT00004762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506322|NCT00004786|Iloprost|iloprost|mesh-list
102506323|NCT00004786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102506324|NCT00004786|Vasodilator Agents|vasodilator agents|mesh-ancestor
102506325|NCT01272583|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102154267|NCT03372447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506326|NCT01272583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102506327|NCT01272583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506328|NCT01272583|Incretins|incretins|mesh-ancestor
102506329|NCT01272583|Hormones|hormones|mesh-ancestor
102506330|NCT01272583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102506331|NCT01272583|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102506332|NCT01272583|Protease Inhibitors|protease inhibitors|mesh-ancestor
102506333|NCT01272583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102506334|NCT01272583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506335|NCT00004804|Interferons|interferons|mesh-list
102506336|NCT00004804|Interferon-alpha|interferon-alpha|mesh-list
102506337|NCT00004804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506338|NCT00004804|Antiviral Agents|antiviral agents|mesh-ancestor
102506339|NCT00004804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102506340|NCT00004804|Immunologic Factors|immunologic factors|mesh-ancestor
102506341|NCT00004804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506342|NCT00386074|Fe(III)-EDTA|fe(iii)-edta|mesh-list
102506343|NCT00386074|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102506344|NCT00386074|Chelating Agents|chelating agents|mesh-ancestor
102506345|NCT00386074|Sequestering Agents|sequestering agents|mesh-ancestor
102506346|NCT00386074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506347|NCT00004810|Aminosalicylic Acid|aminosalicylic acid|mesh-list
102506348|NCT00004810|Antitubercular Agents|antitubercular agents|mesh-ancestor
102506349|NCT00004810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102506350|NCT00004810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102506351|NCT00004816|Antibodies|antibodies|mesh-list
102506352|NCT00004816|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102506353|NCT00004816|Immunologic Factors|immunologic factors|mesh-ancestor
102506354|NCT00004816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506355|NCT01341301|Mycophenolic Acid|mycophenolic acid|mesh-list
102506356|NCT01341301|Cyclophosphamide|cyclophosphamide|mesh-list
102506357|NCT01341301|Tacrolimus|tacrolimus|mesh-list
102506358|NCT01341301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102506359|NCT01341301|Immunologic Factors|immunologic factors|mesh-ancestor
102506360|NCT01341301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506361|NCT01341301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102506362|NCT01341301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102506363|NCT01341301|Alkylating Agents|alkylating agents|mesh-ancestor
102506364|NCT01341301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506365|NCT01341301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506366|NCT01341301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102506367|NCT01341301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102506368|NCT01341301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102506369|NCT01341301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102506370|NCT01341301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102506371|NCT01341301|Antitubercular Agents|antitubercular agents|mesh-ancestor
102506372|NCT01341301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102506373|NCT01341301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102506374|NCT01273207|Cyclosporine|cyclosporine|mesh-list
102506375|NCT01273207|Cyclosporins|cyclosporins|mesh-list
102506376|NCT01273207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102506377|NCT01273207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506378|NCT01273207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102506379|NCT01273207|Immunologic Factors|immunologic factors|mesh-ancestor
102506380|NCT01273207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506381|NCT01273207|Antifungal Agents|antifungal agents|mesh-ancestor
102506382|NCT01273207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102506383|NCT01273207|Dermatologic Agents|dermatologic agents|mesh-ancestor
102506384|NCT01273207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102506385|NCT01273207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102506386|NCT01342549|Naltrexone|naltrexone|mesh-list
102506387|NCT01342549|Valproic Acid|valproic acid|mesh-list
102506388|NCT01342549|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102506389|NCT01342549|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102506390|NCT01342549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506391|NCT01342549|Sensory System Agents|sensory system agents|mesh-ancestor
102506392|NCT01342549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102506393|NCT01342549|Anticonvulsants|anticonvulsants|mesh-ancestor
102506394|NCT01342549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102506395|NCT01342549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506396|NCT01342549|GABA Agents|gaba agents|mesh-ancestor
102506397|NCT01342549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102506398|NCT01342549|Antimanic Agents|antimanic agents|mesh-ancestor
102506399|NCT01342549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102506400|NCT01342549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102506401|NCT01342549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102506402|NCT01295515|Interferons|interferons|mesh-list
102506403|NCT01295515|Interferon-alpha|interferon-alpha|mesh-list
102506404|NCT01295515|Interferon alpha-2|interferon alpha-2|mesh-list
102506405|NCT01295515|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102506406|NCT01295515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506407|NCT01295515|Antiviral Agents|antiviral agents|mesh-ancestor
102506408|NCT01295515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102506409|NCT01295515|Immunologic Factors|immunologic factors|mesh-ancestor
102506410|NCT01295515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506411|NCT01277341|Bepotastine besilate|bepotastine besilate|mesh-list
102506412|NCT01277341|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102506413|NCT00101816|Dasatinib|dasatinib|mesh-list
102506414|NCT00101816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506415|NCT00101816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102506416|NCT00101816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102506417|NCT00101816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506418|NCT00102518|Aripiprazole|aripiprazole|mesh-list
102506419|NCT00102518|Antidepressive Agents|antidepressive agents|mesh-ancestor
102506420|NCT00102518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102506421|NCT00102518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102506422|NCT00102518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102506423|NCT00102518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102506424|NCT00102518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506425|NCT00102518|Dopamine Agonists|dopamine agonists|mesh-ancestor
102506426|NCT00102518|Dopamine Agents|dopamine agents|mesh-ancestor
102506427|NCT00102518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102506428|NCT00102518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506429|NCT00102518|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102506430|NCT00102518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102506431|NCT00102518|Serotonin Agents|serotonin agents|mesh-ancestor
102506432|NCT00102518|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102506433|NCT00102518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102506434|NCT00102518|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102506435|NCT00102518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102506436|NCT00103376|Bortezomib|bortezomib|mesh-list
102506437|NCT00103376|Androgens|androgens|mesh-list
102506438|NCT00103376|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
102506439|NCT00103376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506440|NCT00103376|Hormones|hormones|mesh-ancestor
102506441|NCT00103376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102506442|NCT00103376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506443|NCT00103376|Androgen Antagonists|androgen antagonists|mesh-ancestor
102506444|NCT00103376|Hormone Antagonists|hormone antagonists|mesh-ancestor
102506445|NCT00042224|Clozapine|clozapine|mesh-list
102506446|NCT00042224|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102506447|NCT00042224|Serotonin Agents|serotonin agents|mesh-ancestor
102506448|NCT00042224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102506449|NCT00042224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506450|NCT00042224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506451|NCT00042224|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102506452|NCT00042224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102506453|NCT00042224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102506454|NCT00042224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102506455|NCT00042224|GABA Antagonists|gaba antagonists|mesh-ancestor
102506456|NCT00042224|GABA Agents|gaba agents|mesh-ancestor
102506457|NCT01296763|Irinotecan|irinotecan|mesh-list
102506458|NCT01296763|Olaparib|olaparib|mesh-list
102506459|NCT01296763|Mitomycins|mitomycins|mesh-list
102506460|NCT01296763|Mitomycin|mitomycin|mesh-list
102506461|NCT01296763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506462|NCT01296763|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102506463|NCT01296763|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102506464|NCT01296763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102506465|NCT01296763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506466|NCT01296763|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102506467|NCT01296763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102506468|NCT01296763|Alkylating Agents|alkylating agents|mesh-ancestor
102506469|NCT01296763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102506470|NCT01349491|Ranolazine|ranolazine|mesh-list
102506471|NCT01349491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102506472|NCT01349491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102506473|NCT01349491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506474|NCT01280695|Pioglitazone|pioglitazone|mesh-list
102506475|NCT01280695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102506476|NCT01280695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506477|NCT00103844|Imatinib Mesylate|imatinib mesylate|mesh-list
102506478|NCT00103844|Dasatinib|dasatinib|mesh-list
102506479|NCT00103844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506480|NCT00103844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102506481|NCT00103844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102506482|NCT00103844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506483|NCT01402375|Acetaminophen|acetaminophen|mesh-list
102506484|NCT01402375|Oxycodone|oxycodone|mesh-list
102506485|NCT01402375|Hydrocodone|hydrocodone|mesh-list
102506486|NCT01402375|Codeine|codeine|mesh-list
102506487|NCT01402375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102506488|NCT01402375|Analgesics|analgesics|mesh-ancestor
102506489|NCT01402375|Sensory System Agents|sensory system agents|mesh-ancestor
102506490|NCT01402375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102506491|NCT01402375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506492|NCT01402375|Antipyretics|antipyretics|mesh-ancestor
102506493|NCT01402375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102506494|NCT01402375|Narcotics|narcotics|mesh-ancestor
102506495|NCT01402375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102506496|NCT01402375|Antitussive Agents|antitussive agents|mesh-ancestor
102506497|NCT01402375|Respiratory System Agents|respiratory system agents|mesh-ancestor
102506498|NCT01302379|Metformin|metformin|mesh-list
102506499|NCT01302379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102506500|NCT01302379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506501|NCT01351753|Metformin|metformin|mesh-list
102506502|NCT01351753|Topiramate|topiramate|mesh-list
102506503|NCT01351753|Orlistat|orlistat|mesh-list
102506504|NCT01351753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102506505|NCT01351753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506506|NCT01351753|Anticonvulsants|anticonvulsants|mesh-ancestor
102506507|NCT01351753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102506508|NCT01351753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506509|NCT01351753|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102506510|NCT01351753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102506511|NCT00104858|Cyclosporine|cyclosporine|mesh-list
102506512|NCT00104858|Mycophenolic Acid|mycophenolic acid|mesh-list
102506513|NCT00104858|Rituximab|rituximab|mesh-list
102506514|NCT00104858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102506515|NCT00104858|Fludarabine|fludarabine|mesh-list
102506516|NCT00104858|Fludarabine phosphate|fludarabine phosphate|mesh-list
102506517|NCT00104858|Antibodies|antibodies|mesh-list
102506518|NCT00104858|Immunoglobulins|immunoglobulins|mesh-list
102506519|NCT00104858|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102506520|NCT00104858|Cyclosporins|cyclosporins|mesh-list
102506521|NCT00104858|Immunologic Factors|immunologic factors|mesh-ancestor
102506522|NCT00104858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506523|NCT00104858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506524|NCT00104858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102506525|NCT00104858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102506526|NCT00104858|Antimetabolites|antimetabolites|mesh-ancestor
102506527|NCT00104858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506528|NCT00104858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102506529|NCT00104858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102506530|NCT00104858|Antifungal Agents|antifungal agents|mesh-ancestor
102506531|NCT00104858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102506532|NCT00104858|Dermatologic Agents|dermatologic agents|mesh-ancestor
102506533|NCT00104858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102506534|NCT00104858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102506535|NCT00104858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102506536|NCT00104858|Antitubercular Agents|antitubercular agents|mesh-ancestor
102506537|NCT00104858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102506538|NCT01407523|Levetiracetam|levetiracetam|mesh-list
102506539|NCT01407523|Anticonvulsants|anticonvulsants|mesh-ancestor
102506540|NCT01407523|Nootropic Agents|nootropic agents|mesh-ancestor
102506541|NCT00047060|Cyclosporine|cyclosporine|mesh-list
102506542|NCT00047060|Fludarabine|fludarabine|mesh-list
102506543|NCT00047060|Alemtuzumab|alemtuzumab|mesh-list
102506544|NCT00047060|Cyclosporins|cyclosporins|mesh-list
102506545|NCT00047060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506546|NCT00047060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506547|NCT00047060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102506548|NCT00047060|Immunologic Factors|immunologic factors|mesh-ancestor
102506549|NCT00047060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506550|NCT00047060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102506551|NCT00047060|Antifungal Agents|antifungal agents|mesh-ancestor
102506552|NCT00047060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102506553|NCT00047060|Dermatologic Agents|dermatologic agents|mesh-ancestor
102506554|NCT00047060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102506555|NCT00047060|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102506556|NCT00047060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102506557|NCT01304407|Calcium|calcium|mesh-list
102506558|NCT01304407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102506559|NCT01304407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506560|NCT00106106|Acamprosate|acamprosate|mesh-list
102506561|NCT00106106|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102506562|NCT01304641|Atorvastatin|atorvastatin|mesh-list
102506563|NCT01304641|Simvastatin|simvastatin|mesh-list
102506564|NCT01304641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102506565|NCT01304641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102506566|NCT01304641|Antimetabolites|antimetabolites|mesh-ancestor
102506567|NCT01304641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506568|NCT01304641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102506569|NCT01304641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102506570|NCT01304641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102506571|NCT04753112|Valsartan|valsartan|mesh-list
102506572|NCT04753112|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102506573|NCT04753112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102506574|NCT04753112|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102506575|NCT04753112|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102506576|NCT04753112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506577|NCT01409239|Insulin|insulin|mesh-list
102506578|NCT01409239|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102506579|NCT01409239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102506580|NCT01409239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506581|NCT00108524|Orlistat|orlistat|mesh-list
102506582|NCT00108524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102506583|NCT00108524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506584|NCT00108524|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102506585|NCT00108524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102506586|NCT00052442|10-deazaaminopterin|10-deazaaminopterin|mesh-list
102506587|NCT00052442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506588|NCT00052442|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102506589|NCT00052442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102506590|NCT00052442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506591|NCT01410409|Acetaminophen|acetaminophen|mesh-list
102506592|NCT01410409|Pantoprazole|pantoprazole|mesh-list
102506593|NCT01410409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102506594|NCT01410409|Analgesics|analgesics|mesh-ancestor
102506595|NCT01410409|Sensory System Agents|sensory system agents|mesh-ancestor
102506596|NCT01410409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102506597|NCT01410409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506598|NCT01410409|Antipyretics|antipyretics|mesh-ancestor
102506599|NCT01410409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102506600|NCT01410409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102506601|NCT01410409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102506602|NCT01410409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102506603|NCT01410409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506604|NCT01410565|Apaziquone|apaziquone|mesh-list
102506605|NCT01410565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506606|NCT01357135|Metformin|metformin|mesh-list
102506607|NCT01357135|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102506608|NCT01357135|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102506609|NCT01357135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506610|NCT01357135|Incretins|incretins|mesh-ancestor
102506611|NCT01357135|Hormones|hormones|mesh-ancestor
102506612|NCT01357135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101982815|NCT01154959|Moxifloxacin|moxifloxacin|mesh-list
102506613|NCT01357135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102506614|NCT01357135|Protease Inhibitors|protease inhibitors|mesh-ancestor
102506615|NCT01357135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102506616|NCT01357135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506617|NCT02324335|Brilacidin|brilacidin|mesh-list
102506618|NCT02324335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102506619|NCT01411501|Mosapride|mosapride|mesh-list
102506620|NCT01411501|Citric Acid|citric acid|mesh-list
102506621|NCT01411501|Sodium Citrate|sodium citrate|mesh-list
102506622|NCT01411501|Anticoagulants|anticoagulants|mesh-ancestor
102506623|NCT01411501|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102506624|NCT01411501|Chelating Agents|chelating agents|mesh-ancestor
102506625|NCT01411501|Sequestering Agents|sequestering agents|mesh-ancestor
102506626|NCT01411501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506627|NCT01411501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102506628|NCT01411501|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102506629|NCT01411501|Serotonin Agents|serotonin agents|mesh-ancestor
102506630|NCT01411501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102506631|NCT01411501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506632|NCT01310179|Fludarabine|fludarabine|mesh-list
102506633|NCT01310179|Fludarabine phosphate|fludarabine phosphate|mesh-list
102506634|NCT01310179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506635|NCT01310179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102506636|NCT01310179|Antimetabolites|antimetabolites|mesh-ancestor
102506637|NCT01310179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506638|NCT01310179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102506639|NCT01310179|Immunologic Factors|immunologic factors|mesh-ancestor
102506640|NCT01310179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506641|NCT01412281|Vaccines|vaccines|mesh-list
102506642|NCT01412281|Immunologic Factors|immunologic factors|mesh-ancestor
102506643|NCT01412281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506644|NCT01359007|Leucovorin|leucovorin|mesh-list
102506645|NCT01359007|Oxaliplatin|oxaliplatin|mesh-list
102506646|NCT01359007|Irinotecan|irinotecan|mesh-list
102506647|NCT01359007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506648|NCT01359007|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102506649|NCT01359007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102506650|NCT01359007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102506651|NCT01359007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506652|NCT01359007|Antidotes|antidotes|mesh-ancestor
102506653|NCT01359007|Protective Agents|protective agents|mesh-ancestor
102506654|NCT01359007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506655|NCT01359007|Vitamin B Complex|vitamin b complex|mesh-ancestor
102506656|NCT01359007|Vitamins|vitamins|mesh-ancestor
102506657|NCT01359007|Micronutrients|micronutrients|mesh-ancestor
102506658|NCT01414153|Bevacizumab|bevacizumab|mesh-list
102506659|NCT01414153|Ranibizumab|ranibizumab|mesh-list
102506660|NCT01414153|Aflibercept|aflibercept|mesh-list
102506661|NCT01414153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102506662|NCT01414153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102506663|NCT01414153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506664|NCT01414153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102506665|NCT01414153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102506666|NCT01414153|Growth Substances|growth substances|mesh-ancestor
102506667|NCT01414153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506668|NCT01414153|Growth Inhibitors|growth inhibitors|mesh-ancestor
102506669|NCT01414153|Immunologic Factors|immunologic factors|mesh-ancestor
102506670|NCT01311895|Hydromorphone|hydromorphone|mesh-list
102506671|NCT01311895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102506672|NCT01311895|Narcotics|narcotics|mesh-ancestor
102506673|NCT01311895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102506674|NCT01311895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506675|NCT01311895|Analgesics|analgesics|mesh-ancestor
102506676|NCT01311895|Sensory System Agents|sensory system agents|mesh-ancestor
102506677|NCT01311895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102506678|NCT01362127|Cisplatin|cisplatin|mesh-list
102506679|NCT01362127|Carboplatin|carboplatin|mesh-list
102506680|NCT01362127|Oxaliplatin|oxaliplatin|mesh-list
102506681|NCT01362127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506682|NCT01362205|Dexmedetomidine|dexmedetomidine|mesh-list
102506683|NCT01362205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102506684|NCT01362205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102506685|NCT01362205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506686|NCT01362205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102506687|NCT01362205|Analgesics|analgesics|mesh-ancestor
102506688|NCT01362205|Sensory System Agents|sensory system agents|mesh-ancestor
102506689|NCT01362205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102506690|NCT01362205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102506691|NCT01362205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102506692|NCT01362205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102506693|NCT01362205|Adrenergic Agents|adrenergic agents|mesh-ancestor
102506694|NCT01362205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102506695|NCT01362205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506696|NCT00052910|Leucovorin|leucovorin|mesh-list
102506697|NCT00052910|Fluorouracil|fluorouracil|mesh-list
102506698|NCT00052910|Epirubicin|epirubicin|mesh-list
102506699|NCT00052910|Calcium|calcium|mesh-list
102506700|NCT00052910|Levoleucovorin|levoleucovorin|mesh-list
102506701|NCT00052910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506702|NCT00052910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102506703|NCT00052910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506704|NCT00052910|Antimetabolites|antimetabolites|mesh-ancestor
102318207|NCT01504204|Adapalene|adapalene|mesh-list
102506705|NCT00052910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506706|NCT00052910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102506707|NCT00052910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102506708|NCT00052910|Immunologic Factors|immunologic factors|mesh-ancestor
102506709|NCT00052910|Antidotes|antidotes|mesh-ancestor
102506710|NCT00052910|Protective Agents|protective agents|mesh-ancestor
102506711|NCT00052910|Vitamin B Complex|vitamin b complex|mesh-ancestor
102506712|NCT00052910|Vitamins|vitamins|mesh-ancestor
102506713|NCT00052910|Micronutrients|micronutrients|mesh-ancestor
102506714|NCT00052910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102506715|NCT00052910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102506716|NCT00052910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102506717|NCT00052910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102506718|NCT01363843|Leucovorin|leucovorin|mesh-list
102506719|NCT01363843|Oxaliplatin|oxaliplatin|mesh-list
102506720|NCT01363843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506721|NCT01363843|Antidotes|antidotes|mesh-ancestor
102506722|NCT01363843|Protective Agents|protective agents|mesh-ancestor
102506723|NCT01363843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506724|NCT01363843|Vitamin B Complex|vitamin b complex|mesh-ancestor
102506725|NCT01363843|Vitamins|vitamins|mesh-ancestor
102506726|NCT01363843|Micronutrients|micronutrients|mesh-ancestor
102506727|NCT02092298|Sodium thiosulfate|sodium thiosulfate|mesh-list
102506728|NCT02092298|Cisplatin|cisplatin|mesh-list
102506729|NCT02092298|Mitomycins|mitomycins|mesh-list
102506730|NCT02092298|Mitomycin|mitomycin|mesh-list
102506731|NCT02092298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506732|NCT02092298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102506733|NCT02092298|Alkylating Agents|alkylating agents|mesh-ancestor
102506734|NCT02092298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506735|NCT02092298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102506736|NCT02092298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102506737|NCT02092298|Antidotes|antidotes|mesh-ancestor
102506738|NCT02092298|Protective Agents|protective agents|mesh-ancestor
102506739|NCT02092298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506740|NCT02092298|Antioxidants|antioxidants|mesh-ancestor
102506741|NCT02092298|Antitubercular Agents|antitubercular agents|mesh-ancestor
102506742|NCT02092298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102506743|NCT02092298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102506744|NCT02092298|Chelating Agents|chelating agents|mesh-ancestor
102506745|NCT02092298|Sequestering Agents|sequestering agents|mesh-ancestor
102506746|NCT00151814|Olmesartan|olmesartan|mesh-list
102506747|NCT00151814|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
102506748|NCT00151814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102506749|NCT00151814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102506750|NCT00151814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102506751|NCT00151814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506752|NCT00153842|Bexarotene|bexarotene|mesh-list
102506753|NCT00153842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506754|NCT01314001|Nicotine|nicotine|mesh-list
102506755|NCT01314001|Varenicline|varenicline|mesh-list
102506756|NCT01314001|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102506757|NCT01314001|Autonomic Agents|autonomic agents|mesh-ancestor
102506758|NCT01314001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102506759|NCT01314001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506760|NCT01314001|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102506761|NCT01314001|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102506762|NCT01314001|Cholinergic Agents|cholinergic agents|mesh-ancestor
102506763|NCT01314001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102506764|NCT01314001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506765|NCT01363999|Atorvastatin|atorvastatin|mesh-list
102506766|NCT01363999|Dalcetrapib|dalcetrapib|mesh-list
102506767|NCT01363999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102506768|NCT01363999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102506769|NCT01363999|Antimetabolites|antimetabolites|mesh-ancestor
102506770|NCT01363999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506771|NCT01363999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102506772|NCT01363999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102506773|NCT01363999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102506774|NCT00257894|Baclofen|baclofen|mesh-list
102506775|NCT00257894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506776|NCT00257894|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102506777|NCT00257894|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102506778|NCT00257894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102506779|NCT00257894|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102506780|NCT00257894|GABA Agonists|gaba agonists|mesh-ancestor
102506781|NCT00257894|GABA Agents|gaba agents|mesh-ancestor
102506782|NCT00257894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102506783|NCT00257894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506784|NCT00258128|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
102506785|NCT00258128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102506786|NCT00258128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102318287|NCT01502644|Morphine|morphine|mesh-list
102506787|NCT00258128|Analgesics|analgesics|mesh-ancestor
102506788|NCT00258128|Sensory System Agents|sensory system agents|mesh-ancestor
102506789|NCT00258128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102506790|NCT00258128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506791|NCT00258128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102506792|NCT00258128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102506793|NCT01364623|Methyltestosterone|methyltestosterone|mesh-list
102506794|NCT01364623|Testosterone|testosterone|mesh-list
102506795|NCT01364623|Testosterone undecanoate|testosterone undecanoate|mesh-list
102506796|NCT01364623|Testosterone enanthate|testosterone enanthate|mesh-list
102506797|NCT01364623|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102506798|NCT01364623|Androgens|androgens|mesh-ancestor
102506799|NCT01364623|Hormones|hormones|mesh-ancestor
102506800|NCT01364623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102506801|NCT01364623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506802|NCT01364623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102506803|NCT01364623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506804|NCT01364623|Anabolic Agents|anabolic agents|mesh-ancestor
102506805|NCT00258206|Cyclophosphamide|cyclophosphamide|mesh-list
102506806|NCT00258206|Rituximab|rituximab|mesh-list
102506807|NCT00258206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102506808|NCT00258206|Immunologic Factors|immunologic factors|mesh-ancestor
102506809|NCT00258206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506810|NCT00258206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102506811|NCT00258206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102506812|NCT00258206|Alkylating Agents|alkylating agents|mesh-ancestor
102506813|NCT00258206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506814|NCT00258206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506815|NCT00258206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102506816|NCT00258206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102506817|NCT01063907|Bortezomib|bortezomib|mesh-list
102506818|NCT01063907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506819|NCT01316263|Olaratumab|olaratumab|mesh-list
102506820|NCT01316263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506821|NCT03015857|Phenylephrine|phenylephrine|mesh-list
102506822|NCT03015857|Oxymetazoline|oxymetazoline|mesh-list
102506823|NCT03015857|Norepinephrine|norepinephrine|mesh-list
102506824|NCT03015857|Fentanyl|fentanyl|mesh-list
102506825|NCT03015857|Bupivacaine|bupivacaine|mesh-list
102506826|NCT03015857|Anesthetics, Local|anesthetics, local|mesh-ancestor
102506827|NCT03015857|Anesthetics|anesthetics|mesh-ancestor
102506828|NCT03015857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102506829|NCT03015857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506830|NCT03015857|Sensory System Agents|sensory system agents|mesh-ancestor
102506831|NCT03015857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102506832|NCT03015857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102506833|NCT03015857|Narcotics|narcotics|mesh-ancestor
102506834|NCT03015857|Analgesics|analgesics|mesh-ancestor
102506835|NCT03015857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102506836|NCT03015857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102506837|NCT03015857|Anesthetics, General|anesthetics, general|mesh-ancestor
102506838|NCT03015857|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102506839|NCT03015857|Mydriatics|mydriatics|mesh-ancestor
102506840|NCT03015857|Autonomic Agents|autonomic agents|mesh-ancestor
102506841|NCT03015857|Sympathomimetics|sympathomimetics|mesh-ancestor
102506842|NCT03015857|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102506843|NCT03015857|Nasal Decongestants|nasal decongestants|mesh-ancestor
102506844|NCT03015857|Respiratory System Agents|respiratory system agents|mesh-ancestor
102506845|NCT03015857|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102506846|NCT03015857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102506847|NCT03015857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102506848|NCT03015857|Adrenergic Agents|adrenergic agents|mesh-ancestor
102506849|NCT03015857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102506850|NCT03015857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506851|NCT03015857|Protective Agents|protective agents|mesh-ancestor
102506852|NCT03295487|Estrogens|estrogens|mesh-list
102506853|NCT03295487|Hormones|hormones|mesh-ancestor
102506854|NCT03295487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102506855|NCT03295487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506856|NCT03016091|Pembrolizumab|pembrolizumab|mesh-list
102506857|NCT03016091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102506858|NCT03016091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506859|NCT03016091|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102506860|NCT03016091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506861|NCT03015701|Mifepristone|mifepristone|mesh-list
102506862|NCT03015701|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102506863|NCT03015701|Abortifacient Agents|abortifacient agents|mesh-ancestor
102506864|NCT03015701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102506865|NCT03015701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506866|NCT03015701|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102506867|NCT03015701|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102506868|NCT03015701|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102506869|NCT03015701|Contraceptive Agents|contraceptive agents|mesh-ancestor
102506870|NCT03015701|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102506871|NCT03015701|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102506872|NCT03015701|Hormone Antagonists|hormone antagonists|mesh-ancestor
102506873|NCT03015701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102506874|NCT03015701|Luteolytic Agents|luteolytic agents|mesh-ancestor
102506875|NCT03015701|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102506876|NCT03015701|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102506877|NCT03047135|Olaparib|olaparib|mesh-list
102506878|NCT03047135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102506879|NCT03047135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102506880|NCT03047135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506881|NCT03047135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506882|NCT04780061|Vitamin D|vitamin d|mesh-list
102506883|NCT04780061|Cholecalciferol|cholecalciferol|mesh-list
102506884|NCT04780061|Vitamins|vitamins|mesh-list
102506885|NCT04780061|Vitamin K|vitamin k|mesh-list
102506886|NCT04780061|Vitamin K 2|vitamin k 2|mesh-list
102506887|NCT04780061|Micronutrients|micronutrients|mesh-ancestor
102506888|NCT04780061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506889|NCT04780061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102506890|NCT04780061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102506891|NCT04780061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506892|NCT04780061|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102506893|NCT04780061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102506894|NCT04780061|Hemostatics|hemostatics|mesh-ancestor
102506895|NCT04780061|Coagulants|coagulants|mesh-ancestor
102506896|NCT02172755|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102506897|NCT02172755|Anticonvulsants|anticonvulsants|mesh-ancestor
102506898|NCT02172755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102506899|NCT02172755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102506900|NCT02172755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102506901|NCT02172755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506902|NCT02973737|Capecitabine|capecitabine|mesh-list
102506903|NCT02973737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102506904|NCT02973737|Antimetabolites|antimetabolites|mesh-ancestor
102506905|NCT02973737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506906|NCT02973737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506907|NCT02872025|Pembrolizumab|pembrolizumab|mesh-list
102506908|NCT02872025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102506909|NCT02872025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506910|NCT02872025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102506911|NCT02872025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506912|NCT02762669|Oxytocin|oxytocin|mesh-list
102506913|NCT02762669|Oxytocics|oxytocics|mesh-ancestor
102506914|NCT02762669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102506915|NCT02762669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506916|NCT01072643|Dexmedetomidine|dexmedetomidine|mesh-list
102506917|NCT01072643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102506918|NCT01072643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102506919|NCT01072643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506920|NCT01072643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102506921|NCT01072643|Analgesics|analgesics|mesh-ancestor
102506922|NCT01072643|Sensory System Agents|sensory system agents|mesh-ancestor
102506923|NCT01072643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102506924|NCT01072643|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102506925|NCT01072643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102506926|NCT01072643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102506927|NCT01072643|Adrenergic Agents|adrenergic agents|mesh-ancestor
102506928|NCT01072643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102506929|NCT01072643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506930|NCT01076231|Etoposide|etoposide|mesh-list
102506931|NCT01076231|Etoposide phosphate|etoposide phosphate|mesh-list
102506932|NCT01076231|Podophyllotoxin|podophyllotoxin|mesh-list
102506933|NCT01076231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506934|NCT01076231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102506935|NCT01076231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102506936|NCT01076231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102506937|NCT01076231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102506938|NCT01076231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506939|NCT01076231|Keratolytic Agents|keratolytic agents|mesh-ancestor
102506940|NCT01076231|Dermatologic Agents|dermatologic agents|mesh-ancestor
102506941|NCT01076231|Tubulin Modulators|tubulin modulators|mesh-ancestor
102506942|NCT01076231|Antimitotic Agents|antimitotic agents|mesh-ancestor
102506943|NCT01076231|Mitosis Modulators|mitosis modulators|mesh-ancestor
102506944|NCT00117962|Carboplatin|carboplatin|mesh-list
102506946|NCT00117962|Cetuximab|cetuximab|mesh-list
102506947|NCT00117962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506948|NCT00117962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102506949|NCT00117962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506950|NCT00117962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102506951|NCT00117962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102506952|NCT00117962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102506953|NCT00118274|Cyclophosphamide|cyclophosphamide|mesh-list
102506954|NCT00118274|Vaccines|vaccines|mesh-list
102506955|NCT00118274|Freund's Adjuvant|freund's adjuvant|mesh-list
102506956|NCT00118274|Immunologic Factors|immunologic factors|mesh-ancestor
102506957|NCT00118274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506958|NCT00118274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102506959|NCT00118274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102506960|NCT00118274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102506961|NCT00118274|Alkylating Agents|alkylating agents|mesh-ancestor
102506962|NCT00118274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506963|NCT00118274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102506964|NCT00118274|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102506965|NCT00118274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102506966|NCT01898000|Chlorhexidine|chlorhexidine|mesh-list
102506967|NCT01898000|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102506968|NCT01898000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102506969|NCT01898000|Disinfectants|disinfectants|mesh-ancestor
102506970|NCT00166166|Fluconazole|fluconazole|mesh-list
102506971|NCT00166166|Nitroprusside|nitroprusside|mesh-list
102506972|NCT00166166|Tetraethylammonium|tetraethylammonium|mesh-list
102506973|NCT00166166|Acetylcholine|acetylcholine|mesh-list
102506974|NCT00166166|Bradykinin|bradykinin|mesh-list
102506975|NCT00166166|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
102506976|NCT00166166|Kininogens|kininogens|mesh-list
102506977|NCT00166166|Antifungal Agents|antifungal agents|mesh-ancestor
102506978|NCT00166166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102506979|NCT00166166|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102506980|NCT00166166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102506981|NCT00166166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102506982|NCT00166166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102506983|NCT00166166|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102506984|NCT00166166|Hormone Antagonists|hormone antagonists|mesh-ancestor
102506985|NCT00166166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102506986|NCT00166166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102506987|NCT00166166|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102506988|NCT00166166|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102506989|NCT00166166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102506990|NCT00166166|Vasodilator Agents|vasodilator agents|mesh-ancestor
102506991|NCT00166166|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102506992|NCT00166166|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102506993|NCT00166166|Cholinergic Agents|cholinergic agents|mesh-ancestor
102506994|NCT00166166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102506995|NCT00166166|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
102506996|NCT00166166|Protease Inhibitors|protease inhibitors|mesh-ancestor
102506997|NCT00166166|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102506998|NCT00166166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102506999|NCT00118352|Cyclosporine|cyclosporine|mesh-list
102507000|NCT00118352|Mycophenolic Acid|mycophenolic acid|mesh-list
102507001|NCT00118352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102507002|NCT00118352|Alemtuzumab|alemtuzumab|mesh-list
102507003|NCT00118352|Fludarabine|fludarabine|mesh-list
102507004|NCT00118352|Fludarabine phosphate|fludarabine phosphate|mesh-list
102507005|NCT00118352|Antibodies|antibodies|mesh-list
102507006|NCT00118352|Immunoglobulins|immunoglobulins|mesh-list
102507007|NCT00118352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102507008|NCT00118352|Cyclosporins|cyclosporins|mesh-list
102507009|NCT00118352|Immunologic Factors|immunologic factors|mesh-ancestor
102507010|NCT00118352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507011|NCT00118352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102507012|NCT00118352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102507013|NCT00118352|Antimetabolites|antimetabolites|mesh-ancestor
102507014|NCT00118352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507015|NCT00118352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102507016|NCT00118352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102507017|NCT00118352|Antifungal Agents|antifungal agents|mesh-ancestor
102507018|NCT00118352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102507019|NCT00118352|Dermatologic Agents|dermatologic agents|mesh-ancestor
102507020|NCT00118352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102507021|NCT00118352|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102507022|NCT00118352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102507023|NCT00118352|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102507024|NCT00118352|Antitubercular Agents|antitubercular agents|mesh-ancestor
102507025|NCT00118352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102507026|NCT01111331|Empagliflozin|empagliflozin|mesh-list
102507027|NCT01111331|Warfarin|warfarin|mesh-list
102507028|NCT01111331|Anticoagulants|anticoagulants|mesh-ancestor
102507029|NCT01111331|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102507030|NCT01111331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507031|NCT01111331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102507032|NCT01111331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507033|NCT00167102|Alefacept|alefacept|mesh-list
102507034|NCT00167102|Dermatologic Agents|dermatologic agents|mesh-ancestor
102507035|NCT00167102|Immunologic Factors|immunologic factors|mesh-ancestor
102507036|NCT00167102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507037|NCT01859819|Cytarabine|cytarabine|mesh-list
102507038|NCT01859819|Rituximab|rituximab|mesh-list
102507039|NCT01859819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102507040|NCT01859819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102507041|NCT01859819|Immunologic Factors|immunologic factors|mesh-ancestor
102507042|NCT01859819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507043|NCT01859819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102507044|NCT01859819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102507045|NCT01859819|Antimetabolites|antimetabolites|mesh-ancestor
102507046|NCT01859819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507047|NCT01859819|Antiviral Agents|antiviral agents|mesh-ancestor
102507048|NCT01859819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102507049|NCT01859819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102507050|NCT01795313|Imiquimod|imiquimod|mesh-list
102507051|NCT01795313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102507052|NCT01795313|Immunologic Factors|immunologic factors|mesh-ancestor
102507053|NCT01795313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507054|NCT01795313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102507055|NCT01795313|Interferon Inducers|interferon inducers|mesh-ancestor
102507056|NCT02176031|Methylprednisolone|methylprednisolone|mesh-list
102507057|NCT02176031|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102507058|NCT02176031|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102507059|NCT02176031|Prednisolone|prednisolone|mesh-list
102507060|NCT02176031|Prednisolone acetate|prednisolone acetate|mesh-list
102507061|NCT02176031|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102507062|NCT02176031|Prednisolone phosphate|prednisolone phosphate|mesh-list
102507063|NCT02176031|Natalizumab|natalizumab|mesh-list
102507064|NCT02176031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102507065|NCT02176031|Antiemetics|antiemetics|mesh-ancestor
102507066|NCT02176031|Autonomic Agents|autonomic agents|mesh-ancestor
102507067|NCT02176031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102507068|NCT02176031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507069|NCT02176031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102507070|NCT02176031|Glucocorticoids|glucocorticoids|mesh-ancestor
102507071|NCT02176031|Hormones|hormones|mesh-ancestor
102507072|NCT02176031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102507073|NCT02176031|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102507074|NCT02176031|Protective Agents|protective agents|mesh-ancestor
102507075|NCT02176031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102507076|NCT02176031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102507077|NCT02176031|Immunologic Factors|immunologic factors|mesh-ancestor
102507078|NCT03013361|Bupivacaine|bupivacaine|mesh-list
102507079|NCT03013361|Ropivacaine|ropivacaine|mesh-list
102507080|NCT03013361|Anesthetics, Local|anesthetics, local|mesh-ancestor
102507081|NCT03013361|Anesthetics|anesthetics|mesh-ancestor
102507082|NCT03013361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102507083|NCT03013361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507084|NCT03013361|Sensory System Agents|sensory system agents|mesh-ancestor
102507085|NCT03013361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102507086|NCT01077401|Ranibizumab|ranibizumab|mesh-list
102507087|NCT01077401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102318655|NCT02139644|Xhance|xhance|mesh-list
102507088|NCT01077401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102507089|NCT01077401|Growth Substances|growth substances|mesh-ancestor
102507090|NCT01077401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507091|NCT01077401|Growth Inhibitors|growth inhibitors|mesh-ancestor
102507092|NCT01077401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102507094|NCT01316341|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102507095|NCT01316341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507096|NCT01316341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102507097|NCT01316341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507098|NCT01112735|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102507099|NCT01112735|Hemostatics|hemostatics|mesh-ancestor
102507100|NCT01112735|Coagulants|coagulants|mesh-ancestor
102507101|NCT03014297|Everolimus|everolimus|mesh-list
102507102|NCT03014297|Fosbretabulin|fosbretabulin|mesh-list
102507103|NCT03014297|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102507104|NCT03014297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102507105|NCT03014297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102507106|NCT03014297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507107|NCT03014297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102507108|NCT03014297|Immunologic Factors|immunologic factors|mesh-ancestor
102507109|NCT03014297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507110|NCT03014297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102507111|NCT03014297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102507112|NCT01034111|Metformin|metformin|mesh-list
102507113|NCT01034111|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102507114|NCT01034111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102507115|NCT01034111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507116|NCT01034111|Incretins|incretins|mesh-ancestor
102507117|NCT01034111|Hormones|hormones|mesh-ancestor
102507118|NCT01034111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102507119|NCT01034111|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102507120|NCT01034111|Protease Inhibitors|protease inhibitors|mesh-ancestor
102507121|NCT01034111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102507122|NCT01034111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507123|NCT01114997|Lidocaine|lidocaine|mesh-list
102507124|NCT01114997|Esmolol|esmolol|mesh-list
102507125|NCT01114997|Anesthetics, Local|anesthetics, local|mesh-ancestor
102507126|NCT01114997|Anesthetics|anesthetics|mesh-ancestor
102507127|NCT01114997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102507128|NCT01114997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507129|NCT01114997|Sensory System Agents|sensory system agents|mesh-ancestor
102507130|NCT01114997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102507131|NCT01114997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102507132|NCT01114997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102507133|NCT01114997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102507134|NCT01114997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102507135|NCT01114997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507136|NCT01114997|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102507137|NCT01114997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102507138|NCT01114997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102507139|NCT01114997|Adrenergic Agents|adrenergic agents|mesh-ancestor
102507140|NCT01114997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102507141|NCT00118742|Cyclosporine|cyclosporine|mesh-list
102507142|NCT00118742|Sirolimus|sirolimus|mesh-list
102507143|NCT00118742|Mycophenolic Acid|mycophenolic acid|mesh-list
102507144|NCT00118742|Tacrolimus|tacrolimus|mesh-list
102507145|NCT00118742|Cyclosporins|cyclosporins|mesh-list
102507146|NCT00118742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102507147|NCT00118742|Immunologic Factors|immunologic factors|mesh-ancestor
102507148|NCT00118742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507149|NCT00118742|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102507150|NCT00118742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102507151|NCT00118742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507152|NCT00118742|Antifungal Agents|antifungal agents|mesh-ancestor
102507153|NCT00118742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102507154|NCT00118742|Dermatologic Agents|dermatologic agents|mesh-ancestor
102507155|NCT00118742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102507156|NCT00118742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102507157|NCT00118742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102507158|NCT00118742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102507159|NCT00118742|Antitubercular Agents|antitubercular agents|mesh-ancestor
102507160|NCT00118742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102507161|NCT01317667|Vaccines|vaccines|mesh-list
102318677|NCT02139644|Hormones|hormones|mesh-ancestor
102507162|NCT01317667|Immunologic Factors|immunologic factors|mesh-ancestor
102507163|NCT01317667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507164|NCT00167180|Cyclophosphamide|cyclophosphamide|mesh-list
102507165|NCT00167180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102507166|NCT00167180|Immunologic Factors|immunologic factors|mesh-ancestor
102507167|NCT00167180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507168|NCT00167180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102507169|NCT00167180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102507170|NCT00167180|Alkylating Agents|alkylating agents|mesh-ancestor
102507171|NCT00167180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507172|NCT00167180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102507173|NCT00167180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102507175|NCT01317901|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102507176|NCT01317901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102507177|NCT01317901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102507178|NCT01317901|Immunologic Factors|immunologic factors|mesh-ancestor
102507179|NCT01317901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507180|NCT01317901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102507181|NCT01317901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102507182|NCT01317901|Alkylating Agents|alkylating agents|mesh-ancestor
102507183|NCT01317901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507184|NCT03008551|Metformin|metformin|mesh-list
102507185|NCT03008551|Empagliflozin|empagliflozin|mesh-list
102507186|NCT03008551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102507187|NCT03008551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507188|NCT03008551|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102507189|NCT03008551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507190|NCT01366885|Vitamin D|vitamin d|mesh-list
102507191|NCT01366885|Cholecalciferol|cholecalciferol|mesh-list
102507192|NCT01366885|Vitamins|vitamins|mesh-ancestor
102507193|NCT01366885|Micronutrients|micronutrients|mesh-ancestor
102507194|NCT01366885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507195|NCT01366885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102507196|NCT01366885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102507197|NCT01899170|Carfentanil|carfentanil|mesh-list
102507198|NCT01899170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102507199|NCT01899170|Narcotics|narcotics|mesh-ancestor
102507200|NCT01899170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102507201|NCT01899170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507202|NCT01899170|Analgesics|analgesics|mesh-ancestor
102507203|NCT01899170|Sensory System Agents|sensory system agents|mesh-ancestor
102507204|NCT01899170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102507205|NCT01425229|Bosentan|bosentan|mesh-list
102507206|NCT01425229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102507207|NCT01425229|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102507208|NCT01425229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507209|NCT00258362|Carboplatin|carboplatin|mesh-list
102507210|NCT00258362|Docetaxel|docetaxel|mesh-list
102507211|NCT00258362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102507212|NCT00258362|Tubulin Modulators|tubulin modulators|mesh-ancestor
102507213|NCT00258362|Antimitotic Agents|antimitotic agents|mesh-ancestor
102507214|NCT00258362|Mitosis Modulators|mitosis modulators|mesh-ancestor
102507215|NCT00258362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507216|NCT00258830|Vaccines|vaccines|mesh-list
102507217|NCT00258830|Immunologic Factors|immunologic factors|mesh-ancestor
102507218|NCT00258830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507219|NCT02539368|Infliximab|infliximab|mesh-list
102507220|NCT02539368|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102507221|NCT02539368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102507222|NCT02539368|Dermatologic Agents|dermatologic agents|mesh-ancestor
102507223|NCT02539368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102507224|NCT02539368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102507225|NCT01425307|Hydroxyurea|hydroxyurea|mesh-list
102507226|NCT01425307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102507227|NCT01425307|Antisickling Agents|antisickling agents|mesh-ancestor
102507228|NCT01425307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102507229|NCT01425307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507230|NCT01425307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102507231|NCT01035749|Vaccines|vaccines|mesh-list
102507232|NCT01035749|Immunologic Factors|immunologic factors|mesh-ancestor
102507233|NCT01035749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507234|NCT00123110|Metformin|metformin|mesh-list
102507235|NCT00123110|Leuprolide|leuprolide|mesh-list
102507236|NCT00123110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102507237|NCT00123110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507238|NCT00123110|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102507239|NCT00123110|Fertility Agents|fertility agents|mesh-ancestor
102507240|NCT00123110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102507241|NCT00123110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102507242|NCT00123110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102507244|NCT01425853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102507245|NCT01425853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102507246|NCT01425853|Analgesics|analgesics|mesh-ancestor
102507247|NCT01425853|Sensory System Agents|sensory system agents|mesh-ancestor
102507248|NCT01425853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102507249|NCT01425853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507250|NCT01425853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102507251|NCT01425853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102507252|NCT01425853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102507253|NCT01425853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102507254|NCT01425853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102507255|NCT01425853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507256|NCT01426867|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102507257|NCT01426867|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102507258|NCT01426867|Brinzolamide|brinzolamide|mesh-list
102507259|NCT01426867|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102507260|NCT01426867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102507261|NCT01426867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102507262|NCT01426867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102507263|NCT01426867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102507264|NCT01426867|Adrenergic Agents|adrenergic agents|mesh-ancestor
102507265|NCT01426867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102507266|NCT01426867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507267|NCT01426867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507268|NCT01426867|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102507269|NCT01426867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102507270|NCT00168428|Botulinum Toxins|botulinum toxins|mesh-list
102507271|NCT00168428|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102507272|NCT00168428|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102507273|NCT00168428|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102507274|NCT00168428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102507275|NCT00168428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507276|NCT00168428|Cholinergic Agents|cholinergic agents|mesh-ancestor
102507277|NCT00168428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102507278|NCT00168428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507279|NCT00168428|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102507280|NCT00168428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102507281|NCT01427881|Cyclosporine|cyclosporine|mesh-list
102507282|NCT01427881|Cyclophosphamide|cyclophosphamide|mesh-list
102507283|NCT01427881|Busulfan|busulfan|mesh-list
102507284|NCT01427881|Fludarabine|fludarabine|mesh-list
102507285|NCT01427881|Fludarabine phosphate|fludarabine phosphate|mesh-list
102507286|NCT01427881|Cyclosporins|cyclosporins|mesh-list
102507287|NCT01427881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102507288|NCT01427881|Immunologic Factors|immunologic factors|mesh-ancestor
102507289|NCT01427881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507290|NCT01427881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102507291|NCT01427881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102507292|NCT01427881|Alkylating Agents|alkylating agents|mesh-ancestor
102507293|NCT01427881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507294|NCT01427881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102507295|NCT01427881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102507296|NCT01427881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102507297|NCT01427881|Antimetabolites|antimetabolites|mesh-ancestor
102507298|NCT01427881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102507299|NCT01427881|Antifungal Agents|antifungal agents|mesh-ancestor
102507300|NCT01427881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102507301|NCT01427881|Dermatologic Agents|dermatologic agents|mesh-ancestor
102507302|NCT01427881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102507303|NCT02112734|Vitamin D|vitamin d|mesh-list
102507304|NCT02112734|Ergocalciferols|ergocalciferols|mesh-list
102507305|NCT02112734|Cholecalciferol|cholecalciferol|mesh-list
102507306|NCT02112734|Vitamins|vitamins|mesh-list
102507307|NCT02112734|Micronutrients|micronutrients|mesh-ancestor
102507308|NCT02112734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507309|NCT02112734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102507310|NCT02112734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102507311|NCT01319773|Cyclosporine|cyclosporine|mesh-list
102507312|NCT01319773|Cyclosporins|cyclosporins|mesh-list
102507313|NCT01319773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102507314|NCT01319773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507315|NCT01319773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102507316|NCT01319773|Immunologic Factors|immunologic factors|mesh-ancestor
102507317|NCT01319773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507318|NCT01319773|Antifungal Agents|antifungal agents|mesh-ancestor
102507319|NCT01319773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102507320|NCT01319773|Dermatologic Agents|dermatologic agents|mesh-ancestor
102507321|NCT01319773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102507322|NCT01319773|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102507323|NCT01319851|Alefacept|alefacept|mesh-list
102507324|NCT01319851|Dermatologic Agents|dermatologic agents|mesh-ancestor
102507325|NCT01319851|Immunologic Factors|immunologic factors|mesh-ancestor
102507326|NCT01319851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507327|NCT04351867|Docetaxel|docetaxel|mesh-list
102507328|NCT04351867|Capecitabine|capecitabine|mesh-list
102507329|NCT04351867|Oxaliplatin|oxaliplatin|mesh-list
102507330|NCT04351867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102507331|NCT04351867|Tubulin Modulators|tubulin modulators|mesh-ancestor
102507332|NCT04351867|Antimitotic Agents|antimitotic agents|mesh-ancestor
102507333|NCT04351867|Mitosis Modulators|mitosis modulators|mesh-ancestor
102507334|NCT04351867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507335|NCT04351867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102507336|NCT04351867|Antimetabolites|antimetabolites|mesh-ancestor
102507337|NCT00262730|Temozolomide|temozolomide|mesh-list
102507338|NCT00262730|Poly ICLC|poly iclc|mesh-list
102507339|NCT00262730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102507340|NCT00262730|Alkylating Agents|alkylating agents|mesh-ancestor
102507341|NCT00262730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507342|NCT00262730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102507343|NCT00262730|Interferon Inducers|interferon inducers|mesh-ancestor
102507344|NCT00262730|Immunologic Factors|immunologic factors|mesh-ancestor
102507345|NCT00262730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507346|NCT04262934|Vitamin D|vitamin d|mesh-list
102507347|NCT04262934|Cholecalciferol|cholecalciferol|mesh-list
102507348|NCT04262934|Vitamins|vitamins|mesh-ancestor
102507349|NCT04262934|Micronutrients|micronutrients|mesh-ancestor
102507350|NCT04262934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507351|NCT04262934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102507352|NCT04262934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102507353|NCT00262964|Niacin|niacin|mesh-list
102507354|NCT00262964|Fenofibrate|fenofibrate|mesh-list
102507355|NCT00262964|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102507356|NCT00262964|Antimetabolites|antimetabolites|mesh-ancestor
102507357|NCT00262964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507358|NCT00262964|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102507359|NCT00262964|Vasodilator Agents|vasodilator agents|mesh-ancestor
102507360|NCT00262964|Vitamin B Complex|vitamin b complex|mesh-ancestor
102507361|NCT00262964|Vitamins|vitamins|mesh-ancestor
102507362|NCT00262964|Micronutrients|micronutrients|mesh-ancestor
102507363|NCT00262964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507364|NCT00124514|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102507365|NCT00124514|Luteolytic Agents|luteolytic agents|mesh-ancestor
102507366|NCT00124514|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102507367|NCT00124514|Contraceptive Agents|contraceptive agents|mesh-ancestor
102507368|NCT00124514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102507369|NCT00124514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507370|NCT00124514|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102507371|NCT00124514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102507372|NCT00124514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102507373|NCT01899248|Sevoflurane|sevoflurane|mesh-list
102507374|NCT01899248|Desflurane|desflurane|mesh-list
102507375|NCT01899248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102507376|NCT01899248|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102507377|NCT01899248|Anesthetics, General|anesthetics, general|mesh-ancestor
102507378|NCT01899248|Anesthetics|anesthetics|mesh-ancestor
102507379|NCT01899248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102507380|NCT01899248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507381|NCT01322815|Leucovorin|leucovorin|mesh-list
102507382|NCT01322815|Fluorouracil|fluorouracil|mesh-list
102507383|NCT01322815|Oxaliplatin|oxaliplatin|mesh-list
102507384|NCT01322815|Irinotecan|irinotecan|mesh-list
102507385|NCT01322815|Bevacizumab|bevacizumab|mesh-list
102507386|NCT01322815|Levoleucovorin|levoleucovorin|mesh-list
102507387|NCT01322815|Antimetabolites|antimetabolites|mesh-ancestor
102507388|NCT01322815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507389|NCT01322815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102507390|NCT01322815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102507391|NCT01322815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102507392|NCT01322815|Immunologic Factors|immunologic factors|mesh-ancestor
102507393|NCT01322815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507394|NCT01322815|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102507395|NCT01322815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102507396|NCT01322815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102507397|NCT01322815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102507398|NCT01322815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102507399|NCT01322815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102507400|NCT01322815|Growth Substances|growth substances|mesh-ancestor
102507401|NCT01322815|Growth Inhibitors|growth inhibitors|mesh-ancestor
102507402|NCT01322815|Antidotes|antidotes|mesh-ancestor
102507403|NCT01322815|Protective Agents|protective agents|mesh-ancestor
102507404|NCT01322815|Vitamin B Complex|vitamin b complex|mesh-ancestor
102507405|NCT01322815|Vitamins|vitamins|mesh-ancestor
102507406|NCT01322815|Micronutrients|micronutrients|mesh-ancestor
102507407|NCT00176228|Lamotrigine|lamotrigine|mesh-list
102507408|NCT00176228|Anticonvulsants|anticonvulsants|mesh-ancestor
102507409|NCT00176228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102507410|NCT00176228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102507411|NCT00176228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507412|NCT00176228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102507413|NCT00176228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507414|NCT00176228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102507415|NCT00176228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102507416|NCT00176228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102507417|NCT00176228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102507418|NCT00176228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102507419|NCT00176306|Levofloxacin|levofloxacin|mesh-list
102507420|NCT00176306|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102507421|NCT00176306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102507422|NCT00176306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102507423|NCT00176306|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102507424|NCT00176306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102507425|NCT00176306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102507426|NCT00176306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507427|NCT00176306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102507428|NCT00176306|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102507429|NCT00176306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102507430|NCT01429987|Plecanatide|plecanatide|mesh-list
102507431|NCT01429987|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102507432|NCT01429987|Enzyme Activators|enzyme activators|mesh-ancestor
102507433|NCT01429987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507434|NCT01429987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102507435|NCT00265616|Pentobarbital|pentobarbital|mesh-list
102507436|NCT00265616|Thiopental|thiopental|mesh-list
102507437|NCT00265616|Propofol|propofol|mesh-list
102507438|NCT00265616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102507439|NCT00265616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102507440|NCT00265616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507441|NCT00265616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102507442|NCT00265616|Anesthetics, General|anesthetics, general|mesh-ancestor
102507443|NCT00265616|Anesthetics|anesthetics|mesh-ancestor
102507444|NCT00265616|Anticonvulsants|anticonvulsants|mesh-ancestor
102507445|NCT00265616|GABA Modulators|gaba modulators|mesh-ancestor
102507446|NCT00265616|GABA Agents|gaba agents|mesh-ancestor
102507447|NCT00265616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102507448|NCT00265616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507449|NCT00265616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102507450|NCT00176852|Vidarabine|vidarabine|mesh-list
102507451|NCT00176852|Cyclophosphamide|cyclophosphamide|mesh-list
102507452|NCT00176852|Busulfan|busulfan|mesh-list
102507453|NCT00176852|Fludarabine|fludarabine|mesh-list
102507454|NCT00176852|Fludarabine phosphate|fludarabine phosphate|mesh-list
102507455|NCT00176852|Alemtuzumab|alemtuzumab|mesh-list
102507456|NCT00176852|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102507457|NCT00176852|Lenograstim|lenograstim|mesh-list
102507458|NCT00176852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102507459|NCT00176852|Immunologic Factors|immunologic factors|mesh-ancestor
102507460|NCT00176852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507461|NCT00176852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102507462|NCT00176852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102507463|NCT00176852|Alkylating Agents|alkylating agents|mesh-ancestor
102507464|NCT00176852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507465|NCT00176852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102507466|NCT00176852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102507467|NCT00176852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102507468|NCT00176852|Antimetabolites|antimetabolites|mesh-ancestor
102507469|NCT00176852|Antiviral Agents|antiviral agents|mesh-ancestor
102507470|NCT00176852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102507471|NCT00176852|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102507472|NCT00176852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102507473|NCT01323517|Dactinomycin|dactinomycin|mesh-list
102507474|NCT01323517|Ipilimumab|ipilimumab|mesh-list
102507475|NCT01323517|Melphalan|melphalan|mesh-list
102507476|NCT01323517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102507477|NCT01323517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102507478|NCT01323517|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102507479|NCT01323517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507480|NCT01323517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102507481|NCT01323517|Alkylating Agents|alkylating agents|mesh-ancestor
102507482|NCT01323517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102507483|NCT01323517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102507484|NCT01323517|Immunologic Factors|immunologic factors|mesh-ancestor
102507485|NCT01323517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507486|NCT01323517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102507487|NCT01323517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102507488|NCT01323517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102507489|NCT01323517|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102507490|NCT01323517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102507491|NCT01323517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102507492|NCT01323595|Celecoxib|celecoxib|mesh-list
102507493|NCT01323595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102507494|NCT01323595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102507495|NCT01323595|Analgesics|analgesics|mesh-ancestor
102507496|NCT01323595|Sensory System Agents|sensory system agents|mesh-ancestor
102507497|NCT01323595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102507498|NCT01323595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507499|NCT01323595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102507500|NCT01323595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102507501|NCT01323595|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102507502|NCT01323595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102507503|NCT01323595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102507504|NCT01323595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507505|NCT01376557|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
102507506|NCT01376557|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102507507|NCT01376557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507508|NCT01376557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102507509|NCT01376557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507510|NCT01431391|Leuprolide|leuprolide|mesh-list
102507511|NCT01431391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102507512|NCT01431391|Fertility Agents|fertility agents|mesh-ancestor
102507513|NCT01431391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102507514|NCT01431391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507515|NCT01431391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102507516|NCT01431391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102507517|NCT03009097|Atorvastatin|atorvastatin|mesh-list
102507518|NCT03009097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102507519|NCT03009097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102507520|NCT03009097|Antimetabolites|antimetabolites|mesh-ancestor
102507521|NCT03009097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507522|NCT03009097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102507523|NCT03009097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102507524|NCT03009097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102507525|NCT01325311|Vitamin D|vitamin d|mesh-list
102507526|NCT01325311|Cholecalciferol|cholecalciferol|mesh-list
102507527|NCT01325311|Genistein|genistein|mesh-list
102507528|NCT01325311|Vitamins|vitamins|mesh-ancestor
102507529|NCT01325311|Micronutrients|micronutrients|mesh-ancestor
102507530|NCT01325311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507531|NCT01325311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102507532|NCT01325311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102507533|NCT01325311|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102507534|NCT01325311|Protective Agents|protective agents|mesh-ancestor
102507535|NCT01325311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102507536|NCT01325311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102507537|NCT01325311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102507538|NCT01325311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507539|NCT01325311|Phytoestrogens|phytoestrogens|mesh-ancestor
102507540|NCT01325311|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102507541|NCT01325311|Estrogens|estrogens|mesh-ancestor
102507542|NCT01325311|Hormones|hormones|mesh-ancestor
102507543|NCT01325311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102507544|NCT01432015|Aprepitant|aprepitant|mesh-list
102507545|NCT01432015|Fosaprepitant|fosaprepitant|mesh-list
102507546|NCT01432015|Antiemetics|antiemetics|mesh-ancestor
102507547|NCT01432015|Autonomic Agents|autonomic agents|mesh-ancestor
102507548|NCT01432015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102507549|NCT01432015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507550|NCT01432015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102507551|NCT01432015|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102507552|NCT01432015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102507553|NCT01432015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507554|NCT01080677|Propranolol|propranolol|mesh-list
102507555|NCT01080677|Caffeine|caffeine|mesh-list
102507556|NCT01080677|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102507557|NCT01080677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507558|NCT01080677|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102507559|NCT01080677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102507560|NCT01080677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507561|NCT01080677|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102507562|NCT01080677|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102507563|NCT01080677|Purinergic Agents|purinergic agents|mesh-ancestor
102507564|NCT01080677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102507565|NCT01080677|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102507566|NCT01080677|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102507567|NCT01080677|Adrenergic Agents|adrenergic agents|mesh-ancestor
102507568|NCT01080677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102507569|NCT01080677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102507570|NCT01080677|Vasodilator Agents|vasodilator agents|mesh-ancestor
102507571|NCT01378273|Epoetin Alfa|epoetin alfa|mesh-list
102507572|NCT01378273|Hematinics|hematinics|mesh-ancestor
102507573|NCT01432405|Pioglitazone|pioglitazone|mesh-list
102507574|NCT01432405|Exenatide|exenatide|mesh-list
102507575|NCT01432405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102507576|NCT01432405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507577|NCT01432405|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102507578|NCT01432405|Incretins|incretins|mesh-ancestor
102507579|NCT01432405|Hormones|hormones|mesh-ancestor
102507580|NCT01432405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102507581|NCT01432561|Cysteamine|cysteamine|mesh-list
102507582|NCT01432561|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
102507583|NCT01432561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507584|NCT01116401|Leuprolide|leuprolide|mesh-list
102507585|NCT01116401|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102507586|NCT01116401|Fertility Agents|fertility agents|mesh-ancestor
102507587|NCT01116401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102507588|NCT01116401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507589|NCT01116401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102507590|NCT01116401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102507591|NCT03008317|Chromium|chromium|mesh-list
102507592|NCT03008317|Trace Elements|trace elements|mesh-ancestor
102507593|NCT03008317|Micronutrients|micronutrients|mesh-ancestor
102507594|NCT03008317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507595|NCT01433107|Terbinafine|terbinafine|mesh-list
102507596|NCT01433107|Antifungal Agents|antifungal agents|mesh-ancestor
102507597|NCT01433107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102507598|NCT01433107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102507599|NCT01433107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507600|NCT01082939|Cyclophosphamide|cyclophosphamide|mesh-list
102507601|NCT01082939|Rituximab|rituximab|mesh-list
102507602|NCT01082939|Fludarabine|fludarabine|mesh-list
102507603|NCT01082939|Fludarabine phosphate|fludarabine phosphate|mesh-list
102507604|NCT01082939|Alemtuzumab|alemtuzumab|mesh-list
102507605|NCT01082939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102507606|NCT01082939|Immunologic Factors|immunologic factors|mesh-ancestor
102507607|NCT01082939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507608|NCT01082939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102507609|NCT01082939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102507610|NCT01082939|Alkylating Agents|alkylating agents|mesh-ancestor
102507611|NCT01082939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507612|NCT01082939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102507613|NCT01082939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102507614|NCT01082939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102507615|NCT01082939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102507616|NCT01082939|Antimetabolites|antimetabolites|mesh-ancestor
102507617|NCT01381471|Fluticasone|fluticasone|mesh-list
102507618|NCT01381471|Xhance|xhance|mesh-list
102507619|NCT01381471|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102507620|NCT01381471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102507621|NCT01381471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102507622|NCT01381471|Autonomic Agents|autonomic agents|mesh-ancestor
102507623|NCT01381471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102507624|NCT01381471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507625|NCT01381471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102507626|NCT01381471|Respiratory System Agents|respiratory system agents|mesh-ancestor
102507627|NCT01381471|Dermatologic Agents|dermatologic agents|mesh-ancestor
102507628|NCT01381471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102507629|NCT01381471|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102507630|NCT01381471|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102507631|NCT01381471|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102507632|NCT01381471|Adrenergic Agents|adrenergic agents|mesh-ancestor
102507633|NCT01381471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102507634|NCT01381471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507635|NCT05422092|Pioglitazone|pioglitazone|mesh-list
102507636|NCT05422092|Canagliflozin|canagliflozin|mesh-list
102507637|NCT05422092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102507638|NCT05422092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507639|NCT05422092|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102507640|NCT05422092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507641|NCT05448456|Tranexamic Acid|tranexamic acid|mesh-list
102507642|NCT05448456|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102507643|NCT05448456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102507644|NCT05448456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507645|NCT05448456|Hemostatics|hemostatics|mesh-ancestor
102507646|NCT05448456|Coagulants|coagulants|mesh-ancestor
102507647|NCT05448378|Inositol|inositol|mesh-list
102507648|NCT05448378|Vitamin B Complex|vitamin b complex|mesh-ancestor
102507649|NCT05448378|Vitamins|vitamins|mesh-ancestor
102507650|NCT05448378|Micronutrients|micronutrients|mesh-ancestor
102507651|NCT05448378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507652|NCT01434121|Ascorbic Acid|ascorbic acid|mesh-list
102507653|NCT01434121|Vitamins|vitamins|mesh-ancestor
102507654|NCT01434121|Micronutrients|micronutrients|mesh-ancestor
102507655|NCT01434121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507656|NCT01434121|Antioxidants|antioxidants|mesh-ancestor
102507657|NCT01434121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507658|NCT01434121|Protective Agents|protective agents|mesh-ancestor
102507659|NCT01381861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102507660|NCT01381861|Immunologic Factors|immunologic factors|mesh-ancestor
102507661|NCT01381861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507662|NCT01040819|Pioglitazone|pioglitazone|mesh-list
102507663|NCT01040819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102507664|NCT01040819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507665|NCT01041209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102507666|NCT01041209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102507667|NCT01084265|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102507668|NCT01084265|Hormones|hormones|mesh-list
102507669|NCT01084265|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102507670|NCT01084265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102507671|NCT01084265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507672|NCT01084265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102507673|NCT01084499|Letrozole|letrozole|mesh-list
102507674|NCT01084499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102507675|NCT01084499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102507676|NCT01084499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102507677|NCT01084499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102507678|NCT01084499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507679|NCT01084499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102507680|NCT01084499|Hormone Antagonists|hormone antagonists|mesh-ancestor
102507681|NCT01084499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102507682|NCT01084499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507683|NCT01118273|Diphenhydramine|diphenhydramine|mesh-list
102507684|NCT01118273|Promethazine|promethazine|mesh-list
102507685|NCT01118273|Ibuprofen|ibuprofen|mesh-list
102507686|NCT01118273|Naproxen|naproxen|mesh-list
102507687|NCT01118273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319183|NCT02623205|Escitalopram|escitalopram|mesh-list
102507688|NCT01118273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102507689|NCT01118273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102507690|NCT01118273|Analgesics|analgesics|mesh-ancestor
102507691|NCT01118273|Sensory System Agents|sensory system agents|mesh-ancestor
102507692|NCT01118273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102507693|NCT01118273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507694|NCT01118273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102507695|NCT01118273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102507696|NCT01118273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102507697|NCT01118273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102507698|NCT01118273|Gout Suppressants|gout suppressants|mesh-ancestor
102507699|NCT01118273|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102507700|NCT01118273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102507701|NCT01118273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102507702|NCT01118273|Anesthetics, Local|anesthetics, local|mesh-ancestor
102507703|NCT01118273|Anesthetics|anesthetics|mesh-ancestor
102507704|NCT01118273|Antiemetics|antiemetics|mesh-ancestor
102507705|NCT01118273|Autonomic Agents|autonomic agents|mesh-ancestor
102507706|NCT01118273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102507707|NCT01118273|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102507708|NCT01118273|Histamine Antagonists|histamine antagonists|mesh-ancestor
102507709|NCT01118273|Histamine Agents|histamine agents|mesh-ancestor
101983921|NCT03403374|Evolocumab|evolocumab|mesh-list
102507710|NCT01118273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102507711|NCT01118273|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102507712|NCT01118273|Antipruritics|antipruritics|mesh-ancestor
102507713|NCT01118273|Dermatologic Agents|dermatologic agents|mesh-ancestor
102507714|NCT01085903|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
102507715|NCT01085903|Modafinil|modafinil|mesh-list
102507716|NCT01085903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102507717|NCT01085903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507718|NCT01085903|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102507719|NCT01085903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102507720|NCT01085903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102507721|NCT01085903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507722|NCT01118741|Disulfiram|disulfiram|mesh-list
102507723|NCT01118741|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102507724|NCT01118741|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
102507725|NCT01118741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102507726|NCT01118741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507727|NCT01439815|Fluticasone|fluticasone|mesh-list
102507728|NCT01439815|Xhance|xhance|mesh-list
102507729|NCT01439815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102507730|NCT01439815|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102507731|NCT01439815|Autonomic Agents|autonomic agents|mesh-ancestor
102507732|NCT01439815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102507733|NCT01439815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507734|NCT01439815|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102507735|NCT01439815|Respiratory System Agents|respiratory system agents|mesh-ancestor
102507736|NCT01439815|Dermatologic Agents|dermatologic agents|mesh-ancestor
102507737|NCT01439815|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102507738|NCT01332253|Ibuprofen|ibuprofen|mesh-list
102507739|NCT01332253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102507740|NCT01332253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102507741|NCT01332253|Analgesics|analgesics|mesh-ancestor
102507742|NCT01332253|Sensory System Agents|sensory system agents|mesh-ancestor
102507743|NCT01332253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102507744|NCT01332253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507745|NCT01332253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102507746|NCT01332253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102507747|NCT01332253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102507748|NCT01332253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102507749|NCT01332253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507750|NCT01332721|Bevacizumab|bevacizumab|mesh-list
102507751|NCT01332721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102507752|NCT01332721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102507753|NCT01332721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102507754|NCT01332721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102507755|NCT01332721|Growth Substances|growth substances|mesh-ancestor
102507756|NCT01332721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507757|NCT01332721|Growth Inhibitors|growth inhibitors|mesh-ancestor
102507758|NCT01384591|Acetylcysteine|acetylcysteine|mesh-list
102507759|NCT01384591|Losartan|losartan|mesh-list
102507760|NCT01384591|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102507761|NCT01384591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102507762|NCT01384591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102507763|NCT01384591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102507764|NCT01384591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102507765|NCT01384591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507767|NCT01384591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102507768|NCT01384591|Expectorants|expectorants|mesh-ancestor
102507769|NCT01384591|Respiratory System Agents|respiratory system agents|mesh-ancestor
101983980|NCT01586611|Antidotes|antidotes|mesh-ancestor
102507770|NCT01384591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102507771|NCT01384591|Antioxidants|antioxidants|mesh-ancestor
102507772|NCT01384591|Protective Agents|protective agents|mesh-ancestor
102507773|NCT01384591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507774|NCT01384591|Antidotes|antidotes|mesh-ancestor
102507775|NCT01086605|Pixantrone|pixantrone|mesh-list
102507776|NCT01086605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102507777|NCT01086605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102507778|NCT01086605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102507779|NCT01086605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507780|NCT01086605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102507781|NCT00265850|Leucovorin|leucovorin|mesh-list
102507782|NCT00265850|Folic Acid|folic acid|mesh-list
102507783|NCT00265850|Bevacizumab|bevacizumab|mesh-list
102507784|NCT00265850|Cetuximab|cetuximab|mesh-list
102507785|NCT00265850|Fluorouracil|fluorouracil|mesh-list
102507786|NCT00265850|Oxaliplatin|oxaliplatin|mesh-list
102507787|NCT00265850|Irinotecan|irinotecan|mesh-list
102507788|NCT00265850|Levoleucovorin|levoleucovorin|mesh-list
102507789|NCT00265850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102507790|NCT00265850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102507791|NCT00265850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102507792|NCT00265850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102507793|NCT00265850|Growth Substances|growth substances|mesh-ancestor
102507794|NCT00265850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507795|NCT00265850|Growth Inhibitors|growth inhibitors|mesh-ancestor
102507796|NCT00265850|Antimetabolites|antimetabolites|mesh-ancestor
102507797|NCT00265850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507798|NCT00265850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102507799|NCT00265850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102507800|NCT00265850|Immunologic Factors|immunologic factors|mesh-ancestor
102507801|NCT00265850|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102507802|NCT00265850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102507803|NCT00265850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102507804|NCT00265850|Antidotes|antidotes|mesh-ancestor
102507805|NCT00265850|Protective Agents|protective agents|mesh-ancestor
102507806|NCT00265850|Vitamin B Complex|vitamin b complex|mesh-ancestor
102507807|NCT00265850|Vitamins|vitamins|mesh-ancestor
102507808|NCT00265850|Micronutrients|micronutrients|mesh-ancestor
102507809|NCT00265850|Hematinics|hematinics|mesh-ancestor
102507810|NCT00125372|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102507811|NCT00125372|Bexarotene|bexarotene|mesh-list
102507812|NCT00125372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102507813|NCT00125372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102507814|NCT00125372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102507815|NCT00125372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507816|NCT00125528|Cycloserine|cycloserine|mesh-list
102507817|NCT00125528|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102507818|NCT00125528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102507819|NCT00125528|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102507820|NCT00125528|Antitubercular Agents|antitubercular agents|mesh-ancestor
102507821|NCT00125528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102507822|NCT00125528|Antimetabolites|antimetabolites|mesh-ancestor
102507823|NCT00125528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507824|NCT01390909|Oxcarbazepine|oxcarbazepine|mesh-list
102507825|NCT01390909|Anticonvulsants|anticonvulsants|mesh-list
102507826|NCT01390909|Lactitol|lactitol|mesh-list
102507827|NCT01390909|Cathartics|cathartics|mesh-ancestor
102507828|NCT01390909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102507829|NCT01390909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507830|NCT01390909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102507831|NCT01390909|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102507832|NCT01390909|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102507833|NCT01390909|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102507834|NCT01390909|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102507835|NCT01042145|Dexamethasone|dexamethasone|mesh-list
102507836|NCT01042145|Prednisone|prednisone|mesh-list
102507837|NCT01042145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102507838|NCT01042145|Antiemetics|antiemetics|mesh-ancestor
102507839|NCT01042145|Autonomic Agents|autonomic agents|mesh-ancestor
102507840|NCT01042145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102507841|NCT01042145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984040|NCT01268995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102507842|NCT01042145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102507843|NCT01042145|Glucocorticoids|glucocorticoids|mesh-ancestor
102507844|NCT01042145|Hormones|hormones|mesh-ancestor
102507845|NCT01042145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102507846|NCT01042145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102507847|NCT01042145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102507848|NCT01043393|Desoximetasone|desoximetasone|mesh-list
102507849|NCT01043393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102507850|NCT01043393|Glucocorticoids|glucocorticoids|mesh-ancestor
102507851|NCT01043393|Hormones|hormones|mesh-ancestor
102507852|NCT01043393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102507853|NCT01043393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507854|NCT01087931|Bupivacaine|bupivacaine|mesh-list
102507855|NCT01087931|Anesthetics, Local|anesthetics, local|mesh-ancestor
102507856|NCT01087931|Anesthetics|anesthetics|mesh-ancestor
102507857|NCT01087931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102507858|NCT01087931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507859|NCT01087931|Sensory System Agents|sensory system agents|mesh-ancestor
102507860|NCT01087931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102507861|NCT01336933|Prednisone|prednisone|mesh-list
102507862|NCT01336933|Cyclophosphamide|cyclophosphamide|mesh-list
102507863|NCT01336933|Etoposide|etoposide|mesh-list
102507864|NCT01336933|Vincristine|vincristine|mesh-list
102507865|NCT01336933|Etoposide phosphate|etoposide phosphate|mesh-list
102507866|NCT01336933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102507867|NCT01336933|Immunologic Factors|immunologic factors|mesh-ancestor
102507868|NCT01336933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507869|NCT01336933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102507870|NCT01336933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102507871|NCT01336933|Alkylating Agents|alkylating agents|mesh-ancestor
102507872|NCT01336933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507873|NCT01336933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102507874|NCT01336933|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102507875|NCT01336933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102507876|NCT01336933|Glucocorticoids|glucocorticoids|mesh-ancestor
102507877|NCT01336933|Hormones|hormones|mesh-ancestor
102507878|NCT01336933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102507879|NCT01336933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102507880|NCT01336933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102507881|NCT01336933|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102507882|NCT01336933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102507883|NCT01336933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102507884|NCT01336933|Tubulin Modulators|tubulin modulators|mesh-ancestor
102507885|NCT01336933|Antimitotic Agents|antimitotic agents|mesh-ancestor
102507886|NCT01336933|Mitosis Modulators|mitosis modulators|mesh-ancestor
102507887|NCT03009409|Ketamine|ketamine|mesh-list
102507888|NCT03009409|Analgesics|analgesics|mesh-ancestor
102507889|NCT03009409|Sensory System Agents|sensory system agents|mesh-ancestor
102507890|NCT03009409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102507891|NCT03009409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507892|NCT03009409|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102507893|NCT03009409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102507894|NCT03009409|Anesthetics, General|anesthetics, general|mesh-ancestor
102507895|NCT03009409|Anesthetics|anesthetics|mesh-ancestor
102507896|NCT03009409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102507897|NCT03009409|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102507898|NCT03009409|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102507899|NCT03009409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102507900|NCT03009409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507901|NCT00176930|Cyclophosphamide|cyclophosphamide|mesh-list
102507902|NCT00176930|Busulfan|busulfan|mesh-list
102507903|NCT00176930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102507904|NCT00176930|Immunologic Factors|immunologic factors|mesh-ancestor
102507905|NCT00176930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507906|NCT00176930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102507907|NCT00176930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102507908|NCT00176930|Alkylating Agents|alkylating agents|mesh-ancestor
102507909|NCT00176930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507910|NCT00176930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102507911|NCT00176930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102507912|NCT01473745|Daminozide|daminozide|mesh-list
102507913|NCT01473745|Plant Growth Regulators|plant growth regulators|mesh-ancestor
102507914|NCT01473745|Growth Substances|growth substances|mesh-ancestor
102507915|NCT01473745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154268|NCT03372447|Hematinics|hematinics|mesh-ancestor
102507916|NCT00178178|Bupivacaine|bupivacaine|mesh-list
102507917|NCT00178178|Anesthetics, Local|anesthetics, local|mesh-ancestor
102507918|NCT00178178|Anesthetics|anesthetics|mesh-ancestor
102507919|NCT00178178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102507920|NCT00178178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507921|NCT00178178|Sensory System Agents|sensory system agents|mesh-ancestor
102507922|NCT00178178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102507923|NCT01441843|Lorazepam|lorazepam|mesh-list
102507924|NCT01441843|Anticonvulsants|anticonvulsants|mesh-ancestor
102507925|NCT01441843|Antiemetics|antiemetics|mesh-ancestor
102507926|NCT01441843|Autonomic Agents|autonomic agents|mesh-ancestor
102507927|NCT01441843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102507928|NCT01441843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507929|NCT01441843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102507930|NCT01441843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102507931|NCT01441843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102507932|NCT01441843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102507933|NCT01441843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102507934|NCT01441843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102507935|NCT01441843|GABA Modulators|gaba modulators|mesh-ancestor
102507936|NCT01441843|GABA Agents|gaba agents|mesh-ancestor
102507937|NCT01441843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102507938|NCT01441843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507939|NCT00178646|Botulinum Toxins|botulinum toxins|mesh-list
102507940|NCT00178646|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102507941|NCT00178646|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102507942|NCT00178646|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102507943|NCT00178646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102507944|NCT00178646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507945|NCT00178646|Cholinergic Agents|cholinergic agents|mesh-ancestor
102507946|NCT00178646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102507947|NCT00178646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507948|NCT00178646|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102507949|NCT00178646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102507950|NCT01089569|Insulin Glargine|insulin glargine|mesh-list
102507951|NCT01089569|Exenatide|exenatide|mesh-list
102507952|NCT01089569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102507953|NCT01089569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507954|NCT01089569|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102507955|NCT01089569|Incretins|incretins|mesh-ancestor
102507956|NCT01089569|Hormones|hormones|mesh-ancestor
102507957|NCT01089569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102507958|NCT00128180|Methylprednisolone|methylprednisolone|mesh-list
102507959|NCT00128180|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102507960|NCT00128180|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102507961|NCT00128180|Prednisolone|prednisolone|mesh-list
102507962|NCT00128180|Prednisolone acetate|prednisolone acetate|mesh-list
102507963|NCT00128180|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102507964|NCT00128180|Prednisolone phosphate|prednisolone phosphate|mesh-list
102507965|NCT00128180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102507966|NCT00128180|Antiemetics|antiemetics|mesh-ancestor
102507967|NCT00128180|Autonomic Agents|autonomic agents|mesh-ancestor
102507968|NCT00128180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102507969|NCT00128180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507970|NCT00128180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102507971|NCT00128180|Glucocorticoids|glucocorticoids|mesh-ancestor
102507972|NCT00128180|Hormones|hormones|mesh-ancestor
102507973|NCT00128180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102507974|NCT00128180|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102507975|NCT00128180|Protective Agents|protective agents|mesh-ancestor
102507976|NCT00128180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102507977|NCT00128180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102507978|NCT01121939|Bevacizumab|bevacizumab|mesh-list
102507979|NCT01121939|Pertuzumab|pertuzumab|mesh-list
102507980|NCT01121939|Octreotide|octreotide|mesh-list
102507981|NCT01121939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102507982|NCT01121939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102507983|NCT01121939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102507984|NCT01121939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102507985|NCT01121939|Growth Substances|growth substances|mesh-ancestor
102507986|NCT01121939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507987|NCT01121939|Growth Inhibitors|growth inhibitors|mesh-ancestor
102507988|NCT01121939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102507989|NCT01121939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102507990|NCT03013751|Udenafil|udenafil|mesh-list
102507991|NCT03013751|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102507992|NCT03013751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102507993|NCT03013751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102507994|NCT03013751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102507995|NCT01897844|Somatostatin|somatostatin|mesh-list
102507996|NCT01897844|Hormones|hormones|mesh-ancestor
102507997|NCT01897844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102507998|NCT01897844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102507999|NCT00131378|Hormones|hormones|mesh-list
102508000|NCT00131378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102508001|NCT00131378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508002|NCT01445821|Methylprednisolone|methylprednisolone|mesh-list
102508003|NCT01445821|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102508004|NCT01445821|Cyclophosphamide|cyclophosphamide|mesh-list
102508005|NCT01445821|Fludarabine|fludarabine|mesh-list
102508006|NCT01445821|Thymoglobulin|thymoglobulin|mesh-list
102508007|NCT01445821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102508008|NCT01445821|Immunologic Factors|immunologic factors|mesh-ancestor
102508009|NCT01445821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508010|NCT01445821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102508011|NCT01445821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102508012|NCT01445821|Alkylating Agents|alkylating agents|mesh-ancestor
102508013|NCT01445821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508014|NCT01445821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102508015|NCT01445821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102508016|NCT01445821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102508017|NCT01445821|Antiemetics|antiemetics|mesh-ancestor
102508018|NCT01445821|Autonomic Agents|autonomic agents|mesh-ancestor
102508019|NCT01445821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102508020|NCT01445821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102508021|NCT01445821|Glucocorticoids|glucocorticoids|mesh-ancestor
102508022|NCT01445821|Hormones|hormones|mesh-ancestor
102508023|NCT01445821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102508024|NCT01445821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102508025|NCT01445821|Protective Agents|protective agents|mesh-ancestor
102508026|NCT01445821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102508027|NCT00182000|Cycloserine|cycloserine|mesh-list
102508028|NCT00182000|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102508029|NCT00182000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102508030|NCT00182000|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102508031|NCT00182000|Antitubercular Agents|antitubercular agents|mesh-ancestor
102508032|NCT00182000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102508033|NCT00182000|Antimetabolites|antimetabolites|mesh-ancestor
102508034|NCT00182000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508035|NCT01092923|Sevoflurane|sevoflurane|mesh-list
102508036|NCT01092923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102508037|NCT01092923|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102508038|NCT01092923|Anesthetics, General|anesthetics, general|mesh-ancestor
102508039|NCT01092923|Anesthetics|anesthetics|mesh-ancestor
102508040|NCT01092923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102508041|NCT01092923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508042|NCT03013439|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
102508043|NCT03013439|Hematinics|hematinics|mesh-ancestor
102508044|NCT00131456|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101984256|NCT01166035|Immunologic Factors|immunologic factors|mesh-ancestor
102508045|NCT00131456|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102508046|NCT00131456|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102508047|NCT00131456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102508048|NCT00131456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508049|NCT00131456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102508050|NCT00131456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508051|NCT00131456|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102508052|NCT00131456|Antidepressive Agents|antidepressive agents|mesh-ancestor
102508053|NCT00131456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102508054|NCT01093469|Decanoic acid|decanoic acid|mesh-list
102508055|NCT01093469|Petrolatum|petrolatum|mesh-list
102508056|NCT01093469|Emollients|emollients|mesh-ancestor
102508057|NCT01093469|Dermatologic Agents|dermatologic agents|mesh-ancestor
102508058|NCT01093469|Antifungal Agents|antifungal agents|mesh-ancestor
102508059|NCT01093469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102508060|NCT02543658|Neostigmine|neostigmine|mesh-list
102508061|NCT02543658|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102508062|NCT02543658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102508063|NCT02543658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508064|NCT02543658|Cholinergic Agents|cholinergic agents|mesh-ancestor
102508065|NCT02543658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102508066|NCT02543658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508067|NCT02543658|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102508068|NCT02543658|Autonomic Agents|autonomic agents|mesh-ancestor
102508069|NCT02543658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102508070|NCT00183092|Quinacrine|quinacrine|mesh-list
102508071|NCT00183092|Anticestodal Agents|anticestodal agents|mesh-ancestor
102508072|NCT00183092|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102508073|NCT00183092|Anthelmintics|anthelmintics|mesh-ancestor
102508074|NCT00183092|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102508075|NCT00183092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102508076|NCT00183092|Antimalarials|antimalarials|mesh-ancestor
102508077|NCT00183092|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102508078|NCT00183092|Antinematodal Agents|antinematodal agents|mesh-ancestor
102508079|NCT00183092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102508080|NCT00183092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102508081|NCT00183092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508082|NCT00132002|Vorinostat|vorinostat|mesh-list
102508083|NCT00132002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102508084|NCT00132002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102508085|NCT00132002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102508086|NCT00132002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508087|NCT00183794|Gemcitabine|gemcitabine|mesh-list
102508088|NCT00183794|Docetaxel|docetaxel|mesh-list
102508089|NCT00183794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102508090|NCT00183794|Antimetabolites|antimetabolites|mesh-ancestor
102508091|NCT00183794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508092|NCT00183794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102508093|NCT00183794|Tubulin Modulators|tubulin modulators|mesh-ancestor
102508094|NCT00183794|Antimitotic Agents|antimitotic agents|mesh-ancestor
102508095|NCT00183794|Mitosis Modulators|mitosis modulators|mesh-ancestor
102508096|NCT00270296|Ritonavir|ritonavir|mesh-list
102508097|NCT00270296|Lopinavir|lopinavir|mesh-list
102508098|NCT00270296|Lamivudine|lamivudine|mesh-list
102508099|NCT00270296|Zidovudine|zidovudine|mesh-list
102508100|NCT00270296|Nevirapine|nevirapine|mesh-list
102508101|NCT00270296|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
102508102|NCT00270296|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102508103|NCT00270296|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102508104|NCT00270296|Protease Inhibitors|protease inhibitors|mesh-ancestor
102508105|NCT00270296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102508106|NCT00270296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508107|NCT00270296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102508108|NCT00270296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102508109|NCT00270296|Antiviral Agents|antiviral agents|mesh-ancestor
102508110|NCT00270296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102508111|NCT00270296|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102508112|NCT00270296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102508113|NCT00270296|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102508114|NCT00270296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102508115|NCT00270296|Antimetabolites|antimetabolites|mesh-ancestor
102508116|NCT00270296|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102508117|NCT00270296|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102508118|NCT01047527|Nicotine|nicotine|mesh-list
102508119|NCT01047527|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102508120|NCT01047527|Autonomic Agents|autonomic agents|mesh-ancestor
102508121|NCT01047527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102508122|NCT01047527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508123|NCT01047527|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102508124|NCT01047527|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102508125|NCT01047527|Cholinergic Agents|cholinergic agents|mesh-ancestor
102508126|NCT01047527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102508127|NCT01047527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508128|NCT03013127|Pembrolizumab|pembrolizumab|mesh-list
102508129|NCT03013127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102508130|NCT03013127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102508131|NCT03013127|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102508132|NCT03013127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508133|NCT01048697|Ethambutol|ethambutol|mesh-list
102508134|NCT01048697|Antitubercular Agents|antitubercular agents|mesh-ancestor
102508135|NCT01048697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102508136|NCT01048697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102508137|NCT01049243|Fluocinonide|fluocinonide|mesh-list
102508138|NCT01049243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102508139|NCT01049243|Glucocorticoids|glucocorticoids|mesh-ancestor
102508140|NCT01049243|Hormones|hormones|mesh-ancestor
102508141|NCT01049243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102508142|NCT01049243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508144|NCT03013205|Triamcinolone|triamcinolone|mesh-list
102508145|NCT03013205|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102508146|NCT03013205|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102508147|NCT03013205|Lidocaine|lidocaine|mesh-list
102508148|NCT03013205|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102508149|NCT03013205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102508150|NCT03013205|Glucocorticoids|glucocorticoids|mesh-ancestor
102508151|NCT03013205|Hormones|hormones|mesh-ancestor
102508152|NCT03013205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102508153|NCT03013205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508154|NCT03013205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102508155|NCT03013205|Immunologic Factors|immunologic factors|mesh-ancestor
102508156|NCT03013205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102508157|NCT03013205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508158|NCT03013205|Anesthetics, Local|anesthetics, local|mesh-ancestor
102508159|NCT03013205|Anesthetics|anesthetics|mesh-ancestor
102508160|NCT03013205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102508161|NCT03013205|Sensory System Agents|sensory system agents|mesh-ancestor
102508162|NCT03013205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102508163|NCT03013205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102508164|NCT03013205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102508165|NCT03013205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102508166|NCT03013205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102508167|NCT01094717|Tazarotene|tazarotene|mesh-list
102508168|NCT01094717|Acitretin|acitretin|mesh-list
102508169|NCT01094717|Dermatologic Agents|dermatologic agents|mesh-ancestor
102508170|NCT01094717|Keratolytic Agents|keratolytic agents|mesh-ancestor
102508171|NCT01095497|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
102508172|NCT01095497|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102508173|NCT01095497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102508174|NCT01095497|Immunologic Factors|immunologic factors|mesh-ancestor
102508175|NCT01095497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508176|NCT01095887|Eculizumab|eculizumab|mesh-list
102508177|NCT01095887|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102508178|NCT01095887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102508179|NCT01095887|Immunologic Factors|immunologic factors|mesh-ancestor
102508180|NCT01095887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508181|NCT03110315|Suvorexant|suvorexant|mesh-list
102508182|NCT03110315|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102508183|NCT03110315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102508184|NCT03110315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102508185|NCT03110315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508186|NCT03110315|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102508187|NCT03110315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102508188|NCT03110315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508189|NCT05307341|Sufentanil|sufentanil|mesh-list
102508190|NCT05307341|Dsuvia|dsuvia|mesh-list
102508191|NCT05307341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102508192|NCT05307341|Narcotics|narcotics|mesh-ancestor
102508193|NCT05307341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102508194|NCT05307341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508195|NCT05307341|Analgesics|analgesics|mesh-ancestor
102508196|NCT05307341|Sensory System Agents|sensory system agents|mesh-ancestor
102508197|NCT05307341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102508198|NCT05307341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102508199|NCT05307341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102508200|NCT05307341|Anesthetics, General|anesthetics, general|mesh-ancestor
102508201|NCT05307341|Anesthetics|anesthetics|mesh-ancestor
102508202|NCT01100255|Ketamine|ketamine|mesh-list
102508203|NCT01100255|Analgesics|analgesics|mesh-ancestor
102508204|NCT01100255|Sensory System Agents|sensory system agents|mesh-ancestor
102508205|NCT01100255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102508206|NCT01100255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508207|NCT01100255|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102508208|NCT01100255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102508209|NCT01100255|Anesthetics, General|anesthetics, general|mesh-ancestor
102508210|NCT01100255|Anesthetics|anesthetics|mesh-ancestor
102508211|NCT01100255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102508212|NCT01100255|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102508213|NCT01100255|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102508214|NCT01100255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102508215|NCT01100255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508216|NCT03012347|Sunscreening Agents|sunscreening agents|mesh-list
102508217|NCT03012347|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102508218|NCT03012347|Protective Agents|protective agents|mesh-ancestor
102508219|NCT03012347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508220|NCT03012347|Dermatologic Agents|dermatologic agents|mesh-ancestor
102508222|NCT01100723|Calcitriol|calcitriol|mesh-list
102508223|NCT01100723|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
102508224|NCT01100723|Cinacalcet|cinacalcet|mesh-list
102508225|NCT01100723|Vitamins|vitamins|mesh-ancestor
102508226|NCT01100723|Micronutrients|micronutrients|mesh-ancestor
102508227|NCT01100723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508228|NCT01100723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102508229|NCT01100723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102508230|NCT01100723|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102508231|NCT01100723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102508232|NCT01100723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508233|NCT01100723|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102508234|NCT01100723|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
102508235|NCT01100723|Hormone Antagonists|hormone antagonists|mesh-ancestor
102508236|NCT01100723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102508237|NCT05306405|Misoprostol|misoprostol|mesh-list
102508238|NCT05306405|Estradiol|estradiol|mesh-list
102508239|NCT05306405|Estrogens|estrogens|mesh-ancestor
102508240|NCT05306405|Hormones|hormones|mesh-ancestor
102508241|NCT05306405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102508242|NCT05306405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508243|NCT05306405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102508244|NCT05306405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102508245|NCT05306405|Abortifacient Agents|abortifacient agents|mesh-ancestor
102508246|NCT05306405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102508247|NCT05306405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102508248|NCT05306405|Oxytocics|oxytocics|mesh-ancestor
102508249|NCT04352621|Ketamine|ketamine|mesh-list
102508250|NCT04352621|Analgesics|analgesics|mesh-ancestor
102508251|NCT04352621|Sensory System Agents|sensory system agents|mesh-ancestor
102508252|NCT04352621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102508253|NCT04352621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508254|NCT04352621|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102508255|NCT04352621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102508256|NCT04352621|Anesthetics, General|anesthetics, general|mesh-ancestor
102508257|NCT04352621|Anesthetics|anesthetics|mesh-ancestor
102508258|NCT04352621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102508259|NCT04352621|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102508260|NCT04352621|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102508261|NCT04352621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102508262|NCT04352621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508263|NCT02246855|Immunoglobulins|immunoglobulins|mesh-list
102508264|NCT02246855|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102508265|NCT02246855|Antibodies|antibodies|mesh-list
102508266|NCT02246855|Immunologic Factors|immunologic factors|mesh-ancestor
102508267|NCT02246855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508268|NCT05272397|Methylphenidate|methylphenidate|mesh-list
102508269|NCT05272397|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102508270|NCT05272397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508271|NCT05272397|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102508272|NCT05272397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102508273|NCT05272397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102508274|NCT05272397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508275|NCT05272397|Dopamine Agents|dopamine agents|mesh-ancestor
102508276|NCT05272397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102508277|NCT00185900|Magnesium Sulfate|magnesium sulfate|mesh-list
102508278|NCT00185900|Nifedipine|nifedipine|mesh-list
102508279|NCT00185900|Analgesics|analgesics|mesh-ancestor
102508280|NCT00185900|Sensory System Agents|sensory system agents|mesh-ancestor
102508281|NCT00185900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102508282|NCT00185900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508283|NCT00185900|Anesthetics|anesthetics|mesh-ancestor
102508284|NCT00185900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102508285|NCT00185900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102508286|NCT00185900|Anticonvulsants|anticonvulsants|mesh-ancestor
102508287|NCT00185900|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102319786|NCT02252081|Metformin|metformin|mesh-list
102508288|NCT00185900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102508289|NCT00185900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508290|NCT00185900|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102508291|NCT00185900|Tocolytic Agents|tocolytic agents|mesh-ancestor
102508292|NCT00185900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102508293|NCT00185900|Vasodilator Agents|vasodilator agents|mesh-ancestor
102508294|NCT00186056|Mifepristone|mifepristone|mesh-list
102508295|NCT00186056|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102508296|NCT00186056|Abortifacient Agents|abortifacient agents|mesh-ancestor
102508297|NCT00186056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102508298|NCT00186056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508299|NCT00186056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102508300|NCT00186056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102508301|NCT00186056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102508302|NCT00186056|Contraceptive Agents|contraceptive agents|mesh-ancestor
102508303|NCT00186056|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102508304|NCT00186056|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102508305|NCT00186056|Hormone Antagonists|hormone antagonists|mesh-ancestor
102508306|NCT00186056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102508307|NCT00186056|Luteolytic Agents|luteolytic agents|mesh-ancestor
102508308|NCT00186056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102508309|NCT00186056|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102508310|NCT00186446|Bupropion|bupropion|mesh-list
102508311|NCT00186446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102508312|NCT00186446|Antidepressive Agents|antidepressive agents|mesh-ancestor
102508313|NCT00186446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102508314|NCT00186446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102508315|NCT00186446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102508316|NCT00186446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102508317|NCT00186446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508318|NCT00186446|Dopamine Agents|dopamine agents|mesh-ancestor
102508319|NCT00186446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102508320|NCT00186446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508321|NCT00186446|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102508322|NCT00186446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102508323|NCT00186446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102508324|NCT00136760|Bupropion|bupropion|mesh-list
102508325|NCT00136760|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102508326|NCT00136760|Antidepressive Agents|antidepressive agents|mesh-ancestor
102508327|NCT00136760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102508328|NCT00136760|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102508329|NCT00136760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102508330|NCT00136760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102508331|NCT00136760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508332|NCT00136760|Dopamine Agents|dopamine agents|mesh-ancestor
102508333|NCT00136760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102508334|NCT00136760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508335|NCT00136760|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102508336|NCT00136760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102508337|NCT00136760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102508338|NCT00189098|Trimethoprim|trimethoprim|mesh-list
102508339|NCT00189098|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102508340|NCT00189098|Sulfamethoxazole|sulfamethoxazole|mesh-list
102508341|NCT00189098|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102508342|NCT00189098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102508343|NCT00189098|Antimalarials|antimalarials|mesh-ancestor
102508344|NCT00189098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102508345|NCT00189098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102508346|NCT00189098|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102508347|NCT00189098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102508348|NCT00189098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508349|NCT00189098|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102508350|NCT00189098|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102508351|NCT00189098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102508352|NCT00189098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102508353|NCT00145418|Docetaxel|docetaxel|mesh-list
102508354|NCT00145418|Oxaliplatin|oxaliplatin|mesh-list
102508355|NCT00145418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102508356|NCT00145418|Tubulin Modulators|tubulin modulators|mesh-ancestor
102508357|NCT00145418|Antimitotic Agents|antimitotic agents|mesh-ancestor
102508358|NCT00145418|Mitosis Modulators|mitosis modulators|mesh-ancestor
102508359|NCT00145418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508361|NCT04751318|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102508362|NCT04751318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102508363|NCT04751318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102508364|NCT04751318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508365|NCT04751318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102508366|NCT04751318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508367|NCT04751318|Analgesics|analgesics|mesh-ancestor
102508368|NCT04751318|Sensory System Agents|sensory system agents|mesh-ancestor
102508369|NCT04751318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102508370|NCT04751318|Antidepressive Agents|antidepressive agents|mesh-ancestor
102508371|NCT04751318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102508372|NCT04751318|Dopamine Agents|dopamine agents|mesh-ancestor
102508373|NCT01107665|Paclitaxel|paclitaxel|mesh-list
102508374|NCT01107665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102508375|NCT01107665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102508376|NCT01107665|Tubulin Modulators|tubulin modulators|mesh-ancestor
102508377|NCT01107665|Antimitotic Agents|antimitotic agents|mesh-ancestor
102508378|NCT01107665|Mitosis Modulators|mitosis modulators|mesh-ancestor
102508379|NCT01107665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508380|NCT03012659|Contraceptive Agents|contraceptive agents|mesh-list
102508381|NCT03012659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102508382|NCT03012659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508383|NCT01447225|Carboplatin|carboplatin|mesh-list
102508384|NCT01447225|Gemcitabine|gemcitabine|mesh-list
102508385|NCT01447225|Pemetrexed|pemetrexed|mesh-list
102508386|NCT01447225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102508387|NCT01447225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102508388|NCT01447225|Antimetabolites|antimetabolites|mesh-ancestor
102508389|NCT01447225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508390|NCT01447225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102508391|NCT01447225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102508392|NCT01447225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102508393|NCT01447849|Lubiprostone|lubiprostone|mesh-list
102508394|NCT01447849|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102508395|NCT01447849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102508396|NCT01447849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508397|NCT00277394|Heparin|heparin|mesh-list
102508398|NCT00277394|Tinzaparin|tinzaparin|mesh-list
102508399|NCT00277394|Anticoagulants|anticoagulants|mesh-ancestor
102508400|NCT00277394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102508401|NCT00277394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102508402|NCT00277394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508403|NCT01450189|Tenofovir|tenofovir|mesh-list
102508404|NCT01450189|Emtricitabine|emtricitabine|mesh-list
102508405|NCT01450189|Raltegravir Potassium|raltegravir potassium|mesh-list
102508406|NCT01450189|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102508407|NCT01450189|Antiviral Agents|antiviral agents|mesh-ancestor
102508408|NCT01450189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102508409|NCT01450189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102508410|NCT01450189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102508411|NCT01450189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102508412|NCT01450189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508413|NCT01450189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102508414|NCT01450189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102508415|NCT01450189|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102508416|NCT01450189|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102508417|NCT00278876|Imatinib Mesylate|imatinib mesylate|mesh-list
102508418|NCT00278876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102508419|NCT00278876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102508420|NCT00278876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102508421|NCT00278876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508422|NCT01474213|Dexmedetomidine|dexmedetomidine|mesh-list
102508423|NCT01474213|Remifentanil|remifentanil|mesh-list
102508424|NCT01474213|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102508425|NCT01474213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102508426|NCT01474213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508427|NCT01474213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102508428|NCT01474213|Analgesics|analgesics|mesh-ancestor
102508429|NCT01474213|Sensory System Agents|sensory system agents|mesh-ancestor
102508430|NCT01474213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102508431|NCT01474213|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102508432|NCT01474213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102508433|NCT01474213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102508434|NCT01474213|Adrenergic Agents|adrenergic agents|mesh-ancestor
102508435|NCT01474213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102508436|NCT01474213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508437|NCT01474213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102508438|NCT01474213|Narcotics|narcotics|mesh-ancestor
102508439|NCT00147212|Trabectedin|trabectedin|mesh-list
102508440|NCT00147212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102508441|NCT00147212|Alkylating Agents|alkylating agents|mesh-ancestor
102508442|NCT00147212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508443|NCT00147212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102508444|NCT01474915|Promethazine|promethazine|mesh-list
102508445|NCT01474915|Diphenhydramine|diphenhydramine|mesh-list
102508446|NCT01474915|Dexamethasone|dexamethasone|mesh-list
102508447|NCT01474915|Ondansetron|ondansetron|mesh-list
102508448|NCT01474915|Aprepitant|aprepitant|mesh-list
102508449|NCT01474915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102508450|NCT01474915|Antiemetics|antiemetics|mesh-ancestor
102508451|NCT01474915|Autonomic Agents|autonomic agents|mesh-ancestor
102508452|NCT01474915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102508453|NCT01474915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508454|NCT01474915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102508455|NCT01474915|Glucocorticoids|glucocorticoids|mesh-ancestor
102508456|NCT01474915|Hormones|hormones|mesh-ancestor
102508457|NCT01474915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102508458|NCT01474915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102508459|NCT01474915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102508460|NCT01474915|Antipruritics|antipruritics|mesh-ancestor
102508461|NCT01474915|Dermatologic Agents|dermatologic agents|mesh-ancestor
102508462|NCT01474915|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102508463|NCT01474915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102508464|NCT01474915|Serotonin Agents|serotonin agents|mesh-ancestor
102508465|NCT01474915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102508466|NCT01474915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508467|NCT01474915|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102508468|NCT01474915|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102508469|NCT01474915|Histamine Antagonists|histamine antagonists|mesh-ancestor
102508470|NCT01474915|Histamine Agents|histamine agents|mesh-ancestor
102508471|NCT01474915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102508472|NCT01474915|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102508473|NCT01474915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102508474|NCT01474915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102508475|NCT01474915|Anesthetics, Local|anesthetics, local|mesh-ancestor
102508476|NCT01474915|Anesthetics|anesthetics|mesh-ancestor
102508477|NCT01474915|Sensory System Agents|sensory system agents|mesh-ancestor
102508478|NCT01899794|Mandelic Acids|mandelic acids|mesh-list
102508479|NCT01899794|Oxybutynin|oxybutynin|mesh-list
102508480|NCT01899794|Parasympatholytics|parasympatholytics|mesh-ancestor
102508481|NCT01899794|Autonomic Agents|autonomic agents|mesh-ancestor
102508482|NCT01899794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102508483|NCT01899794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508484|NCT01899794|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102508485|NCT01899794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102508486|NCT01899794|Cholinergic Agents|cholinergic agents|mesh-ancestor
102508487|NCT01899794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102508488|NCT01899794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508489|NCT01899794|Urological Agents|urological agents|mesh-ancestor
102508490|NCT01899794|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102508491|NCT01899794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102508492|NCT01391299|Botulinum Toxins|botulinum toxins|mesh-list
102508493|NCT01391299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102508494|NCT01391299|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102508495|NCT01391299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102508496|NCT01391299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102508497|NCT01391299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508498|NCT01391299|Cholinergic Agents|cholinergic agents|mesh-ancestor
102508499|NCT01391299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102508500|NCT01391299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508501|NCT01391299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102508502|NCT01391299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102508503|NCT02099084|Teduglutide|teduglutide|mesh-list
102508504|NCT02099084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102320016|NCT01630811|Quinidine|quinidine|mesh-list
102508505|NCT02099084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102508506|NCT02099084|Protective Agents|protective agents|mesh-ancestor
102508507|NCT02099084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508508|NCT00281918|Cyclophosphamide|cyclophosphamide|mesh-list
102508509|NCT00281918|Rituximab|rituximab|mesh-list
102508510|NCT00281918|Fludarabine|fludarabine|mesh-list
102508511|NCT00281918|Fludarabine phosphate|fludarabine phosphate|mesh-list
102508512|NCT00281918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102508513|NCT00281918|Immunologic Factors|immunologic factors|mesh-ancestor
102508514|NCT00281918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508515|NCT00281918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102508516|NCT00281918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102508517|NCT00281918|Alkylating Agents|alkylating agents|mesh-ancestor
102508518|NCT00281918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508519|NCT00281918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102508520|NCT00281918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102508521|NCT00281918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102508522|NCT00281918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102508523|NCT00281918|Antimetabolites|antimetabolites|mesh-ancestor
102508524|NCT00201734|Paclitaxel|paclitaxel|mesh-list
102508525|NCT00201734|Carboplatin|carboplatin|mesh-list
102508526|NCT00201734|Capecitabine|capecitabine|mesh-list
102508527|NCT00201734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102508528|NCT00201734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102508529|NCT00201734|Tubulin Modulators|tubulin modulators|mesh-ancestor
101984764|NCT05625893|Bevacizumab|bevacizumab|mesh-list
102508530|NCT00201734|Antimitotic Agents|antimitotic agents|mesh-ancestor
102508531|NCT00201734|Mitosis Modulators|mitosis modulators|mesh-ancestor
102508532|NCT00201734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508533|NCT00201734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102508534|NCT00201734|Antimetabolites|antimetabolites|mesh-ancestor
102508535|NCT00203216|Levetiracetam|levetiracetam|mesh-list
102508536|NCT00203216|Anticonvulsants|anticonvulsants|mesh-ancestor
102508537|NCT00203216|Nootropic Agents|nootropic agents|mesh-ancestor
102508538|NCT05156060|Ketamine|ketamine|mesh-list
102508539|NCT05156060|Gabapentin|gabapentin|mesh-list
102508540|NCT05156060|Analgesics|analgesics|mesh-ancestor
102508541|NCT05156060|Sensory System Agents|sensory system agents|mesh-ancestor
102508542|NCT05156060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102508543|NCT05156060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508544|NCT05156060|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102508545|NCT05156060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102508546|NCT05156060|Anesthetics, General|anesthetics, general|mesh-ancestor
102508547|NCT05156060|Anesthetics|anesthetics|mesh-ancestor
102508548|NCT05156060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102508549|NCT05156060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102508550|NCT05156060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102508551|NCT05156060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102508552|NCT05156060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508553|NCT05156060|Anticonvulsants|anticonvulsants|mesh-ancestor
102508554|NCT05156060|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102508555|NCT05156060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102508556|NCT05156060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102508557|NCT05156060|Antimanic Agents|antimanic agents|mesh-ancestor
102508558|NCT00206336|Topiramate|topiramate|mesh-list
102508559|NCT00206336|Anticonvulsants|anticonvulsants|mesh-ancestor
102508560|NCT00206336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102508561|NCT00206336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508562|NCT00210470|Zinc|zinc|mesh-list
102508563|NCT00210470|Indomethacin|indomethacin|mesh-list
102508564|NCT00210470|Cyclophosphamide|cyclophosphamide|mesh-list
102508565|NCT00210470|Omeprazole|omeprazole|mesh-list
102508566|NCT00210470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102508567|NCT00210470|Immunologic Factors|immunologic factors|mesh-ancestor
102508568|NCT00210470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508569|NCT00210470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102508570|NCT00210470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102508571|NCT00210470|Alkylating Agents|alkylating agents|mesh-ancestor
102508572|NCT00210470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508573|NCT00210470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102508574|NCT00210470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102508575|NCT00210470|Trace Elements|trace elements|mesh-ancestor
102508576|NCT00210470|Micronutrients|micronutrients|mesh-ancestor
102508577|NCT00210470|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102508578|NCT00210470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102508579|NCT00210470|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102508580|NCT00210470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102508581|NCT00210470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102508582|NCT00210470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102508583|NCT00210470|Analgesics|analgesics|mesh-ancestor
102508584|NCT00210470|Sensory System Agents|sensory system agents|mesh-ancestor
102508585|NCT00210470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102508586|NCT00210470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102508587|NCT00210470|Gout Suppressants|gout suppressants|mesh-ancestor
102508588|NCT00210470|Tocolytic Agents|tocolytic agents|mesh-ancestor
102508589|NCT00210470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102508590|NCT00210470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102508591|NCT01108445|Everolimus|everolimus|mesh-list
102508592|NCT01108445|Sunitinib|sunitinib|mesh-list
102508593|NCT01108445|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102508594|NCT01108445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102508595|NCT01108445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102508596|NCT01108445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508597|NCT01108445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102508598|NCT01108445|Immunologic Factors|immunologic factors|mesh-ancestor
102508599|NCT01108445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984819|NCT01288339|Antidotes|antidotes|mesh-ancestor
102508600|NCT01108445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102508601|NCT01108445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102508602|NCT01108445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102508603|NCT01108445|Growth Substances|growth substances|mesh-ancestor
102508604|NCT01108445|Growth Inhibitors|growth inhibitors|mesh-ancestor
102508605|NCT01108757|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102508606|NCT01108757|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102508607|NCT01108757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102508608|NCT01108757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102508609|NCT01108757|Antimalarials|antimalarials|mesh-ancestor
102508610|NCT01108757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102508611|NCT01108757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102508612|NCT04352153|Febuxostat|febuxostat|mesh-list
102508613|NCT04352153|Citric Acid|citric acid|mesh-list
102508614|NCT04352153|Anticoagulants|anticoagulants|mesh-ancestor
102508615|NCT04352153|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102508616|NCT04352153|Chelating Agents|chelating agents|mesh-ancestor
102508617|NCT04352153|Sequestering Agents|sequestering agents|mesh-ancestor
102508618|NCT04352153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508619|NCT04352153|Gout Suppressants|gout suppressants|mesh-ancestor
102508620|NCT04352153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102508621|NCT05215067|Docetaxel|docetaxel|mesh-list
102508622|NCT05215067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102508623|NCT05215067|Tubulin Modulators|tubulin modulators|mesh-ancestor
102508624|NCT05215067|Antimitotic Agents|antimitotic agents|mesh-ancestor
102508625|NCT05215067|Mitosis Modulators|mitosis modulators|mesh-ancestor
102508626|NCT05215067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508627|NCT01162733|Vancomycin|vancomycin|mesh-list
102508628|NCT01162733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102508629|NCT01162733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102508630|NCT02530242|Carbon Monoxide|carbon monoxide|mesh-list
102508631|NCT02530242|Antimetabolites|antimetabolites|mesh-ancestor
102508632|NCT02530242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508633|NCT02530242|Gasotransmitters|gasotransmitters|mesh-ancestor
102508634|NCT02530242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102508635|NCT02530242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508636|NCT05410860|Etripamil|etripamil|mesh-list
102508637|NCT05410860|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102508638|NCT05410860|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102508639|NCT05410860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508640|NCT05410860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102508641|NCT05410860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508642|NCT01131065|Immunoglobulins|immunoglobulins|mesh-list
102508643|NCT01131065|Antibodies|antibodies|mesh-list
102508644|NCT01131065|gamma-Globulins|gamma-globulins|mesh-list
102508645|NCT01131065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102508646|NCT01131065|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102508647|NCT01131065|Immunologic Factors|immunologic factors|mesh-ancestor
102508648|NCT01131065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508649|NCT01165541|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102508650|NCT01165541|Mirtazapine|mirtazapine|mesh-list
102508651|NCT01165541|Antidepressive Agents|antidepressive agents|mesh-ancestor
102508652|NCT01165541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102508653|NCT01165541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102508654|NCT01165541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102508655|NCT01165541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102508656|NCT01165541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508657|NCT01165541|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102508659|NCT01165541|Histamine Agents|histamine agents|mesh-ancestor
102508660|NCT01165541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102508661|NCT01165541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508662|NCT01165541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102508663|NCT01165541|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102508664|NCT01165541|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102508665|NCT01165541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102508666|NCT01165541|Adrenergic Agents|adrenergic agents|mesh-ancestor
102508667|NCT01165541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102508668|NCT01165541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102508669|NCT01165541|Serotonin Agents|serotonin agents|mesh-ancestor
102508670|NCT01165541|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102508671|NCT00284180|Trastuzumab|trastuzumab|mesh-list
102508672|NCT00284180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102508673|NCT00284180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102508674|NCT04087460|Vaccines|vaccines|mesh-list
102508675|NCT04087460|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102508676|NCT04087460|Immunologic Factors|immunologic factors|mesh-ancestor
102508677|NCT04087460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508678|NCT05031806|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102508679|NCT05031806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102508680|NCT01899404|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102508681|NCT01899404|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102508682|NCT01899404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508683|NCT00287222|Bevacizumab|bevacizumab|mesh-list
102508684|NCT00287222|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102508685|NCT00287222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102508686|NCT00287222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102508687|NCT00287222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102508688|NCT00287222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102508689|NCT00287222|Growth Substances|growth substances|mesh-ancestor
102508690|NCT00287222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508691|NCT00287222|Growth Inhibitors|growth inhibitors|mesh-ancestor
102508692|NCT00287222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102508693|NCT00287222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102508694|NCT00287222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508695|NCT00218426|Naltrexone|naltrexone|mesh-list
102508696|NCT00218426|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102508697|NCT00218426|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102508698|NCT00218426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508699|NCT00218426|Sensory System Agents|sensory system agents|mesh-ancestor
102508700|NCT00218426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102508701|NCT01134575|Rituximab|rituximab|mesh-list
102508702|NCT01134575|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
102508703|NCT01134575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102508704|NCT01134575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102508705|NCT01134575|Immunologic Factors|immunologic factors|mesh-ancestor
102508706|NCT01134575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508707|NCT01134575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102508708|NCT01134575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102508709|NCT01134575|Immunotoxins|immunotoxins|mesh-ancestor
102508710|NCT01134575|Immunoconjugates|immunoconjugates|mesh-ancestor
102508711|NCT01790672|Ethanol|ethanol|mesh-list
102508712|NCT01790672|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102508713|NCT01790672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102508714|NCT01790672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102508715|NCT01790672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508716|NCT00223262|Lamotrigine|lamotrigine|mesh-list
102508717|NCT00223262|Anticonvulsants|anticonvulsants|mesh-ancestor
102508718|NCT00223262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102508719|NCT00223262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102508720|NCT00223262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508721|NCT00223262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102508722|NCT00223262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508723|NCT00223262|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102508724|NCT00223262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102508725|NCT00223262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102508726|NCT00223262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102508727|NCT00223262|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102508728|NCT00290654|Tamoxifen|tamoxifen|mesh-list
102508729|NCT00290654|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102508730|NCT00290654|Hormone Antagonists|hormone antagonists|mesh-ancestor
102508731|NCT00290654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102508732|NCT00290654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508733|NCT00290654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102508734|NCT00290654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102508735|NCT00290654|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102508736|NCT00290654|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102508737|NCT00290654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102508738|NCT00290810|Bevacizumab|bevacizumab|mesh-list
102508739|NCT00290810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102508740|NCT00290810|Antibodies|antibodies|mesh-list
102508741|NCT00290810|Immunoglobulins|immunoglobulins|mesh-list
102508742|NCT00290810|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102508743|NCT00290810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102508744|NCT00290810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102508745|NCT00290810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102508746|NCT00290810|Growth Substances|growth substances|mesh-ancestor
102508747|NCT00290810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508748|NCT00290810|Growth Inhibitors|growth inhibitors|mesh-ancestor
102508749|NCT00290810|Immunologic Factors|immunologic factors|mesh-ancestor
102508750|NCT04042142|Glucagon|glucagon|mesh-list
102508751|NCT04042142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102508752|NCT04042142|Hormones|hormones|mesh-ancestor
102508753|NCT04042142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102508754|NCT04042142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508755|NCT01138475|Cholecalciferol|cholecalciferol|mesh-list
102508756|NCT01138475|Vitamin D|vitamin d|mesh-list
102508757|NCT01138475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102508758|NCT01138475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508759|NCT01138475|Vitamins|vitamins|mesh-ancestor
102508760|NCT01138475|Micronutrients|micronutrients|mesh-ancestor
102508761|NCT01138475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102508762|NCT00293540|Tamoxifen|tamoxifen|mesh-list
102508763|NCT00293540|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102508764|NCT00293540|Hormone Antagonists|hormone antagonists|mesh-ancestor
102508765|NCT00293540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102508766|NCT00293540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508767|NCT00293540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102508768|NCT00293540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102508769|NCT00293540|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102508770|NCT00293540|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102508771|NCT00293540|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102508772|NCT03012113|Mirabegron|mirabegron|mesh-list
102508773|NCT03012113|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102508774|NCT03012113|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102508775|NCT03012113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102508776|NCT03012113|Adrenergic Agents|adrenergic agents|mesh-ancestor
102508777|NCT03012113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102508778|NCT03012113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508779|NCT03012113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508780|NCT03012113|Urological Agents|urological agents|mesh-ancestor
102508781|NCT01139801|Misoprostol|misoprostol|mesh-list
102508782|NCT01139801|Oxytocin|oxytocin|mesh-list
102508783|NCT01139801|Oxytocics|oxytocics|mesh-ancestor
102508784|NCT01139801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102508785|NCT01139801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508786|NCT01139801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102508787|NCT01139801|Abortifacient Agents|abortifacient agents|mesh-ancestor
102508788|NCT01139801|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102508789|NCT01139801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102508790|NCT00294632|Rituximab|rituximab|mesh-list
102508791|NCT00294632|Lenalidomide|lenalidomide|mesh-list
102508792|NCT00294632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102508793|NCT00294632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102508794|NCT00294632|Immunologic Factors|immunologic factors|mesh-ancestor
102508795|NCT00294632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508796|NCT00294632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101985036|NCT03134131|TIC10 compound|tic10 compound|mesh-list
102508797|NCT00294632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102508798|NCT00294632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102508799|NCT00294632|Growth Substances|growth substances|mesh-ancestor
102508800|NCT00294632|Growth Inhibitors|growth inhibitors|mesh-ancestor
102508801|NCT01898624|Mirabegron|mirabegron|mesh-list
102508802|NCT01898624|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102154269|NCT03376191|Apatinib|apatinib|mesh-list
102508803|NCT01898624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102508804|NCT01898624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102508805|NCT01898624|Adrenergic Agents|adrenergic agents|mesh-ancestor
102508806|NCT01898624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102508807|NCT01898624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508808|NCT01898624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508809|NCT01898624|Urological Agents|urological agents|mesh-ancestor
102508810|NCT01140191|Gentamicins|gentamicins|mesh-list
102508811|NCT01140191|Paromomycin|paromomycin|mesh-list
102508812|NCT01140191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102508813|NCT01140191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102508814|NCT01140191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102508815|NCT01140191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102508816|NCT01140191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508817|NCT01140191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102508818|NCT01140191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102508819|NCT01141049|Gabapentin|gabapentin|mesh-list
102508820|NCT01141049|Analgesics|analgesics|mesh-ancestor
102508821|NCT01141049|Sensory System Agents|sensory system agents|mesh-ancestor
102508822|NCT01141049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102508823|NCT01141049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508824|NCT01141049|Anticonvulsants|anticonvulsants|mesh-ancestor
102508825|NCT01141049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102508826|NCT01141049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102508827|NCT01141049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102508828|NCT01141049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102508829|NCT01141049|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102508830|NCT01141049|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102508831|NCT01141049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102508832|NCT01141049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508833|NCT01141049|Antimanic Agents|antimanic agents|mesh-ancestor
102508834|NCT01141595|Verapamil|verapamil|mesh-list
102508835|NCT01141595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102508836|NCT01141595|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102508837|NCT01141595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102508838|NCT01141595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508839|NCT01141595|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102508840|NCT01141595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508841|NCT01141595|Vasodilator Agents|vasodilator agents|mesh-ancestor
102508842|NCT01167569|Ascorbic Acid|ascorbic acid|mesh-list
102508843|NCT01167569|Vitamins|vitamins|mesh-ancestor
102508844|NCT01167569|Micronutrients|micronutrients|mesh-ancestor
102508845|NCT01167569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508846|NCT01167569|Antioxidants|antioxidants|mesh-ancestor
102508847|NCT01167569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508848|NCT01167569|Protective Agents|protective agents|mesh-ancestor
102508849|NCT00296192|Rotigotine|rotigotine|mesh-list
102508850|NCT00296192|Dopamine Agonists|dopamine agonists|mesh-ancestor
102508851|NCT00296192|Dopamine Agents|dopamine agents|mesh-ancestor
102508852|NCT00296192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102508853|NCT00296192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508854|NCT00296192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508855|NCT04312139|Lincomycin|lincomycin|mesh-list
102508856|NCT04312139|Calcium|calcium|mesh-list
102508857|NCT04312139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102508858|NCT04312139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508859|NCT04312139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102508860|NCT04312139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102508861|NCT04312139|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102508862|NCT04312139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102508863|NCT04312139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508864|NCT00297596|Oxaliplatin|oxaliplatin|mesh-list
102508865|NCT00297596|Trastuzumab|trastuzumab|mesh-list
102508866|NCT00297596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102508867|NCT00297596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102508868|NCT01144637|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
102508869|NCT01144637|Antiviral Agents|antiviral agents|mesh-ancestor
102508870|NCT01144637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102508871|NCT00298610|Artesunate|artesunate|mesh-list
102508872|NCT00298610|Atovaquone|atovaquone|mesh-list
102508873|NCT00298610|Proguanil|proguanil|mesh-list
102508874|NCT00298610|Quinidine|quinidine|mesh-list
102508875|NCT00298610|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
102508876|NCT00298610|Antimalarials|antimalarials|mesh-ancestor
102508877|NCT00298610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102508878|NCT00298610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102508879|NCT00298610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102508880|NCT00298610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102508881|NCT00298610|Antiviral Agents|antiviral agents|mesh-ancestor
102508882|NCT00298610|Schistosomicides|schistosomicides|mesh-ancestor
102508883|NCT00298610|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102508884|NCT00298610|Anthelmintics|anthelmintics|mesh-ancestor
102508885|NCT00298610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102508886|NCT00298610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508887|NCT00298610|Antimetabolites|antimetabolites|mesh-ancestor
102508888|NCT00298610|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102508889|NCT00298610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102508890|NCT00298610|Adrenergic Agents|adrenergic agents|mesh-ancestor
102508891|NCT00298610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102508892|NCT00298610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508893|NCT00298610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102508894|NCT00298610|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102508895|NCT00298610|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102508896|NCT00298610|Cholinergic Agents|cholinergic agents|mesh-ancestor
102508897|NCT00298610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102508898|NCT00298610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102508899|NCT00298610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102508900|NCT00298610|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102508901|NCT00298610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102508902|NCT01144949|Silodosin|silodosin|mesh-list
102508903|NCT01144949|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102508904|NCT01144949|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102508905|NCT01144949|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102508906|NCT01144949|Adrenergic Agents|adrenergic agents|mesh-ancestor
102508907|NCT01144949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102508908|NCT01144949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508909|NCT01144949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508910|NCT01144949|Urological Agents|urological agents|mesh-ancestor
102508911|NCT00215930|Carboplatin|carboplatin|mesh-list
102508912|NCT00215930|Gemcitabine|gemcitabine|mesh-list
102508913|NCT00215930|Docetaxel|docetaxel|mesh-list
102508914|NCT00215930|Vinorelbine|vinorelbine|mesh-list
102508915|NCT00215930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102508916|NCT00215930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102508917|NCT00215930|Antimetabolites|antimetabolites|mesh-ancestor
102508918|NCT00215930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508919|NCT00215930|Tubulin Modulators|tubulin modulators|mesh-ancestor
102508920|NCT00215930|Antimitotic Agents|antimitotic agents|mesh-ancestor
102508921|NCT00215930|Mitosis Modulators|mitosis modulators|mesh-ancestor
102508922|NCT00215930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102508923|NCT01145183|Doxazosin|doxazosin|mesh-list
102508924|NCT01145183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102508925|NCT01145183|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102508926|NCT01145183|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102508927|NCT01145183|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102508928|NCT01145183|Adrenergic Agents|adrenergic agents|mesh-ancestor
102508929|NCT01145183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102508930|NCT01145183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508931|NCT01145183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508932|NCT00230126|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102508933|NCT00230126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102508934|NCT00230126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102508935|NCT00230126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102508936|NCT00230126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508937|NCT04128722|Sirolimus|sirolimus|mesh-list
102508938|NCT04128722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102508939|NCT04128722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102508940|NCT04128722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102508941|NCT04128722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102508942|NCT04128722|Antifungal Agents|antifungal agents|mesh-ancestor
102508943|NCT04128722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102508944|NCT04128722|Immunologic Factors|immunologic factors|mesh-ancestor
102508945|NCT04128722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508946|NCT01169519|Sildenafil Citrate|sildenafil citrate|mesh-list
102508947|NCT01169519|Vasodilator Agents|vasodilator agents|mesh-ancestor
102508948|NCT01169519|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102508949|NCT01169519|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102508950|NCT01169519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102508951|NCT01169519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508953|NCT04071977|Antioxidants|antioxidants|mesh-list
102508954|NCT04071977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508955|NCT04071977|Protective Agents|protective agents|mesh-ancestor
102508956|NCT04071977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508957|NCT02101190|Opicapone|opicapone|mesh-list
102508958|NCT02101190|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102508959|NCT02101190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102508960|NCT02101190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508961|NCT02101190|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102508962|NCT02101190|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102508963|NCT01170533|Omeprazole|omeprazole|mesh-list
102508964|NCT01170533|Pantoprazole|pantoprazole|mesh-list
102508965|NCT01170533|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102508966|NCT01170533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102508967|NCT01170533|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102508968|NCT01170533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102508969|NCT01170533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508970|NCT01147601|Timolol|timolol|mesh-list
102508971|NCT01147601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102508972|NCT01147601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102508973|NCT01147601|Adrenergic Agents|adrenergic agents|mesh-ancestor
102508974|NCT01147601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102508975|NCT01147601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508976|NCT01147601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508977|NCT01147601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102508978|NCT01147601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102508979|NCT03011645|Ziprasidone|ziprasidone|mesh-list
102508980|NCT03011645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102508981|NCT03011645|Serotonin Agents|serotonin agents|mesh-ancestor
102508982|NCT03011645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102508983|NCT03011645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102508984|NCT03011645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102508985|NCT03011645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102508986|NCT03011645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102508987|NCT03011645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102508988|NCT03011645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102508989|NCT03011645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102508990|NCT03011645|Dopamine Agents|dopamine agents|mesh-ancestor
102508991|NCT01149785|Ketoconazole|ketoconazole|mesh-list
102508992|NCT01149785|Crizotinib|crizotinib|mesh-list
102508993|NCT01149785|Antifungal Agents|antifungal agents|mesh-ancestor
102508994|NCT01149785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102508995|NCT01149785|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102508996|NCT01149785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102508997|NCT01149785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102508998|NCT01149785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985217|NCT01180933|Vitamins|vitamins|mesh-ancestor
102508999|NCT01149785|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102509000|NCT01149785|Hormone Antagonists|hormone antagonists|mesh-ancestor
102509001|NCT01149785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102509002|NCT01149785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509003|NCT01149785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102509004|NCT01149785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102509005|NCT01149785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102509006|NCT02182115|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
102509007|NCT02182115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102509008|NCT03011567|Acetaminophen|acetaminophen|mesh-list
102509009|NCT03011567|Ibuprofen|ibuprofen|mesh-list
102509010|NCT03011567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102509011|NCT03011567|Analgesics|analgesics|mesh-ancestor
102509012|NCT03011567|Sensory System Agents|sensory system agents|mesh-ancestor
102509013|NCT03011567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102509014|NCT03011567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509015|NCT03011567|Antipyretics|antipyretics|mesh-ancestor
102509016|NCT03011567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102509017|NCT03011567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102509018|NCT03011567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102509019|NCT03011567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102509020|NCT03011567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102509021|NCT03011567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509022|NCT01173029|Antihypertensive Agents|antihypertensive agents|mesh-list
102509023|NCT01173029|Calcium Channel Blockers|calcium channel blockers|mesh-list
102509024|NCT01173029|Diuretics|diuretics|mesh-list
102509025|NCT01173029|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102509026|NCT01173029|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
102509027|NCT01173029|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
102509028|NCT01173029|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
102509029|NCT01173029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102509030|NCT01173029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509031|NCT01173029|Natriuretic Agents|natriuretic agents|mesh-ancestor
102509032|NCT01173029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509033|NCT01173029|Protease Inhibitors|protease inhibitors|mesh-ancestor
102509034|NCT01173029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102509035|NCT01173029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102509036|NCT01173029|Hormone Antagonists|hormone antagonists|mesh-ancestor
102509037|NCT01173029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102509038|NCT01173029|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102509039|NCT01174823|Bepotastine besilate|bepotastine besilate|mesh-list
102509040|NCT01174823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102509041|NCT01174823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102509042|NCT01174823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102509043|NCT03886649|Venetoclax|venetoclax|mesh-list
102509044|NCT03886649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102509045|NCT01151813|Varenicline|varenicline|mesh-list
102509046|NCT01151813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102509047|NCT01151813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102509048|NCT01151813|Cholinergic Agents|cholinergic agents|mesh-ancestor
102509049|NCT01151813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102509050|NCT01151813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509051|NCT01151813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509052|NCT03877991|Cannabidiol|cannabidiol|mesh-list
102509053|NCT03877991|Anticonvulsants|anticonvulsants|mesh-ancestor
102509054|NCT03835949|Atezolizumab|atezolizumab|mesh-list
102509055|NCT03835949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102509056|NCT03835949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509057|NCT03835949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102509058|NCT03835949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102509059|NCT01177709|Metformin|metformin|mesh-list
102509060|NCT01177709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102509061|NCT01177709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509062|NCT01179113|Esmolol|esmolol|mesh-list
102509063|NCT01179113|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102509064|NCT01179113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102509065|NCT01179113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102509066|NCT01179113|Adrenergic Agents|adrenergic agents|mesh-ancestor
102509067|NCT01179113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102509068|NCT01179113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509069|NCT01179113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509070|NCT01152515|Remifentanil|remifentanil|mesh-list
102509071|NCT01152515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102509072|NCT01152515|Narcotics|narcotics|mesh-ancestor
102509073|NCT01152515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102509074|NCT01152515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509075|NCT01152515|Analgesics|analgesics|mesh-ancestor
102509076|NCT01152515|Sensory System Agents|sensory system agents|mesh-ancestor
102509077|NCT01152515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102509078|NCT03011177|Linagliptin|linagliptin|mesh-list
102509079|NCT03011177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102509080|NCT03011177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509081|NCT03011177|Incretins|incretins|mesh-ancestor
102509082|NCT03011177|Hormones|hormones|mesh-ancestor
102509083|NCT03011177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102509084|NCT03011177|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102509085|NCT03011177|Protease Inhibitors|protease inhibitors|mesh-ancestor
102509086|NCT03011177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102509087|NCT03011177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509088|NCT03465527|Prednisolone|prednisolone|mesh-list
102509089|NCT03465527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102509090|NCT03465527|Glucocorticoids|glucocorticoids|mesh-ancestor
102509091|NCT03465527|Hormones|hormones|mesh-ancestor
102509092|NCT03465527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102509093|NCT03465527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509094|NCT03465527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102509095|NCT03465527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102509096|NCT03418805|Ibuprofen|ibuprofen|mesh-list
102320602|NCT01830543|Vitamins|vitamins|mesh-ancestor
102509097|NCT03418805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102509098|NCT03418805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102509099|NCT03418805|Analgesics|analgesics|mesh-ancestor
102509100|NCT03418805|Sensory System Agents|sensory system agents|mesh-ancestor
102509101|NCT03418805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102509102|NCT03418805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509103|NCT03418805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102509104|NCT03418805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102509105|NCT03418805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102509106|NCT03418805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102509107|NCT03418805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509108|NCT01156571|Clopidogrel|clopidogrel|mesh-list
102509109|NCT01156571|Cangrelor|cangrelor|mesh-list
102509110|NCT01156571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102509111|NCT01156571|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102509112|NCT01156571|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102509113|NCT01156571|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102509114|NCT01156571|Purinergic Agents|purinergic agents|mesh-ancestor
102509115|NCT01156571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102509116|NCT01156571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509117|NCT01156571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509118|NCT01220687|Nitric Oxide|nitric oxide|mesh-list
102509119|NCT01220687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102509120|NCT01220687|Autonomic Agents|autonomic agents|mesh-ancestor
102509121|NCT01220687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102509122|NCT01220687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509123|NCT01220687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102509124|NCT01220687|Respiratory System Agents|respiratory system agents|mesh-ancestor
102509125|NCT01220687|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102509126|NCT01220687|Antioxidants|antioxidants|mesh-ancestor
102509127|NCT01220687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509128|NCT01220687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102509129|NCT01220687|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102509130|NCT01220687|Vasodilator Agents|vasodilator agents|mesh-ancestor
102509131|NCT01220687|Gasotransmitters|gasotransmitters|mesh-ancestor
102509132|NCT01220687|Protective Agents|protective agents|mesh-ancestor
102509133|NCT03010865|Butyric Acid|butyric acid|mesh-list
102509134|NCT03010865|Histamine Antagonists|histamine antagonists|mesh-ancestor
102509135|NCT03010865|Histamine Agents|histamine agents|mesh-ancestor
102509136|NCT03010865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102509137|NCT03010865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509138|NCT03010865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509139|NCT01157429|Cycloserine|cycloserine|mesh-list
102509140|NCT01157429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102509141|NCT01157429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102509142|NCT01157429|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102509143|NCT01157429|Antitubercular Agents|antitubercular agents|mesh-ancestor
102509144|NCT01157429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102509145|NCT01157429|Antimetabolites|antimetabolites|mesh-ancestor
102509146|NCT01157429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509147|NCT00234884|Adalimumab|adalimumab|mesh-list
102509148|NCT00234884|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102509149|NCT00234884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102509150|NCT00234884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102509151|NCT01602666|Carboplatin|carboplatin|mesh-list
102509152|NCT01602666|Etoposide|etoposide|mesh-list
102509153|NCT01602666|Etoposide phosphate|etoposide phosphate|mesh-list
102509154|NCT01602666|Ifosfamide|ifosfamide|mesh-list
102509155|NCT01602666|Isophosphamide mustard|isophosphamide mustard|mesh-list
102509156|NCT01602666|Podophyllotoxin|podophyllotoxin|mesh-list
102509157|NCT01602666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102509158|NCT01602666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102509159|NCT01602666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102509160|NCT01602666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102509161|NCT01602666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102509162|NCT01602666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509163|NCT01602666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102509164|NCT01602666|Alkylating Agents|alkylating agents|mesh-ancestor
102509165|NCT01602666|Keratolytic Agents|keratolytic agents|mesh-ancestor
102509166|NCT01602666|Dermatologic Agents|dermatologic agents|mesh-ancestor
102509167|NCT01602666|Tubulin Modulators|tubulin modulators|mesh-ancestor
102509168|NCT01602666|Antimitotic Agents|antimitotic agents|mesh-ancestor
102509169|NCT01602666|Mitosis Modulators|mitosis modulators|mesh-ancestor
102154270|NCT03376191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102509170|NCT05415462|Vaccines|vaccines|mesh-list
102509171|NCT05415462|Immunologic Factors|immunologic factors|mesh-ancestor
102509172|NCT05415462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509173|NCT00300482|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102509174|NCT00300482|Calcium|calcium|mesh-list
102509175|NCT00300482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101985402|NCT01287715|Analgesics|analgesics|mesh-ancestor
102509176|NCT00300482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509177|NCT00300482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102509178|NCT00300482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102509179|NCT00300482|Antimetabolites|antimetabolites|mesh-ancestor
102509180|NCT00300482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509181|NCT00300482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102509182|NCT00300482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102509183|NCT00300482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102509184|NCT05439876|Melatonin|melatonin|mesh-list
102509185|NCT05439876|Antioxidants|antioxidants|mesh-ancestor
102509186|NCT05439876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509187|NCT05439876|Protective Agents|protective agents|mesh-ancestor
102509188|NCT05439876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509189|NCT05439876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102509190|NCT00301028|Paclitaxel|paclitaxel|mesh-list
102509191|NCT00301028|Carboplatin|carboplatin|mesh-list
102509192|NCT00301028|Cetuximab|cetuximab|mesh-list
102509193|NCT00301028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102509194|NCT00301028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102509195|NCT00301028|Tubulin Modulators|tubulin modulators|mesh-ancestor
102509196|NCT00301028|Antimitotic Agents|antimitotic agents|mesh-ancestor
102509197|NCT00301028|Mitosis Modulators|mitosis modulators|mesh-ancestor
102509198|NCT00301028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509199|NCT00301028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102509200|NCT00301418|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102509201|NCT00301418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102509202|NCT00301418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102509203|NCT00301418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102509204|NCT00301418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509205|NCT05414838|Vitamin D|vitamin d|mesh-list
102509206|NCT05414838|Curcumin|curcumin|mesh-list
102509207|NCT05414838|Vitamins|vitamins|mesh-ancestor
102509208|NCT05414838|Micronutrients|micronutrients|mesh-ancestor
102509209|NCT05414838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509210|NCT05414838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102509211|NCT05414838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102509212|NCT05414838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102509213|NCT05414838|Analgesics|analgesics|mesh-ancestor
102509214|NCT05414838|Sensory System Agents|sensory system agents|mesh-ancestor
102509215|NCT05414838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102509216|NCT05414838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102509217|NCT05414838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102509218|NCT05414838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102509219|NCT05414838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102509220|NCT05414838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509221|NCT05414214|Anesthetics|anesthetics|mesh-list
102509222|NCT05414214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102509223|NCT05414214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509224|NCT05014230|Analgesics, Opioid|analgesics, opioid|mesh-list
102509225|NCT05014230|Narcotics|narcotics|mesh-ancestor
102509226|NCT05014230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102509227|NCT05014230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509228|NCT05014230|Analgesics|analgesics|mesh-ancestor
102509229|NCT05014230|Sensory System Agents|sensory system agents|mesh-ancestor
102509230|NCT05014230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102509231|NCT01896284|Aflibercept|aflibercept|mesh-list
102509232|NCT01896284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102509233|NCT01896284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102509234|NCT01896284|Growth Substances|growth substances|mesh-ancestor
102509235|NCT01896284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509236|NCT01896284|Growth Inhibitors|growth inhibitors|mesh-ancestor
102509237|NCT01896284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102509238|NCT05438160|Coal Tar|coal tar|mesh-list
102509239|NCT05438160|Keratolytic Agents|keratolytic agents|mesh-ancestor
102509240|NCT05438160|Dermatologic Agents|dermatologic agents|mesh-ancestor
102509241|NCT03954990|Metronidazole|metronidazole|mesh-list
102509242|NCT03954990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102509243|NCT03954990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102509244|NCT03954990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102509245|NCT03954990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102509246|NCT01478581|Dexamethasone|dexamethasone|mesh-list
102509247|NCT01478581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102509248|NCT01478581|Antiemetics|antiemetics|mesh-ancestor
102509249|NCT01478581|Autonomic Agents|autonomic agents|mesh-ancestor
102509250|NCT01478581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102509251|NCT01478581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509252|NCT01478581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102509253|NCT01478581|Glucocorticoids|glucocorticoids|mesh-ancestor
102509254|NCT01478581|Hormones|hormones|mesh-ancestor
102509255|NCT01478581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102509256|NCT01478581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102509257|NCT01478581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102509258|NCT00239642|Iron|iron|mesh-list
102509259|NCT00239642|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102509260|NCT00239642|Trace Elements|trace elements|mesh-ancestor
102509261|NCT00239642|Micronutrients|micronutrients|mesh-ancestor
102509262|NCT00239642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509263|NCT00239642|Hematinics|hematinics|mesh-ancestor
102509264|NCT01351896|Lenalidomide|lenalidomide|mesh-list
102509265|NCT01351896|Vaccines|vaccines|mesh-list
102509266|NCT01351896|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102509267|NCT01351896|Immunologic Factors|immunologic factors|mesh-ancestor
102509268|NCT01351896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509269|NCT01351896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102509270|NCT01351896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102509271|NCT01351896|Growth Substances|growth substances|mesh-ancestor
102509272|NCT01351896|Growth Inhibitors|growth inhibitors|mesh-ancestor
102509273|NCT01351896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102509274|NCT00241904|Propranolol|propranolol|mesh-list
102509275|NCT00241904|Metoprolol|metoprolol|mesh-list
102509276|NCT00241904|Atenolol|atenolol|mesh-list
102509277|NCT00241904|Lisinopril|lisinopril|mesh-list
102509278|NCT00241904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
102509279|NCT00241904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102509280|NCT00241904|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102509281|NCT00241904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102509282|NCT00241904|Adrenergic Agents|adrenergic agents|mesh-ancestor
102509283|NCT00241904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102509284|NCT00241904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509285|NCT00241904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509286|NCT00241904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102509287|NCT00241904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102509288|NCT00241904|Vasodilator Agents|vasodilator agents|mesh-ancestor
102509289|NCT00241904|Sympatholytics|sympatholytics|mesh-ancestor
102509290|NCT00241904|Autonomic Agents|autonomic agents|mesh-ancestor
102509291|NCT00241904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102509292|NCT00241904|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102509293|NCT00241904|Protease Inhibitors|protease inhibitors|mesh-ancestor
102509294|NCT00241904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102509295|NCT00241904|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102509296|NCT00241904|Protective Agents|protective agents|mesh-ancestor
102509297|NCT01791296|Dexmedetomidine|dexmedetomidine|mesh-list
102509298|NCT01791296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102509299|NCT01791296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102509300|NCT01791296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509301|NCT01791296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102509302|NCT01791296|Analgesics|analgesics|mesh-ancestor
102509303|NCT01791296|Sensory System Agents|sensory system agents|mesh-ancestor
102509304|NCT01791296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102509305|NCT01791296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102509306|NCT01791296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102509307|NCT01791296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102509308|NCT01791296|Adrenergic Agents|adrenergic agents|mesh-ancestor
102509309|NCT01791296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102509310|NCT01791296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509311|NCT01479127|Silicon|silicon|mesh-list
102509312|NCT01479127|Levodopa|levodopa|mesh-list
102509313|NCT01479127|Carbidopa|carbidopa|mesh-list
102509314|NCT01479127|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102509315|NCT01479127|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102509316|NCT01479127|Dopamine Agents|dopamine agents|mesh-ancestor
102509317|NCT01479127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102509318|NCT01479127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509319|NCT01479127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509320|NCT01479127|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102509322|NCT01479127|Trace Elements|trace elements|mesh-ancestor
102509323|NCT01479127|Micronutrients|micronutrients|mesh-ancestor
102509324|NCT03917966|Docetaxel|docetaxel|mesh-list
102509325|NCT03917966|Apatinib|apatinib|mesh-list
102509326|NCT03917966|Nedaplatin|nedaplatin|mesh-list
102509327|NCT03917966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102509328|NCT03917966|Tubulin Modulators|tubulin modulators|mesh-ancestor
102509329|NCT03917966|Antimitotic Agents|antimitotic agents|mesh-ancestor
102509330|NCT03917966|Mitosis Modulators|mitosis modulators|mesh-ancestor
102509331|NCT03917966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509332|NCT03917966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102509333|NCT03917966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102509334|NCT00243152|Lamotrigine|lamotrigine|mesh-list
102509335|NCT00243152|Anticonvulsants|anticonvulsants|mesh-list
102509336|NCT00243152|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102509337|NCT00243152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102509338|NCT00243152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509339|NCT00243152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102509340|NCT00243152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509341|NCT00243152|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102509342|NCT00243152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102509343|NCT00243152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102509344|NCT00243152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102509345|NCT00243152|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102509346|NCT01453075|Valacyclovir|valacyclovir|mesh-list
102509347|NCT01453075|Antiviral Agents|antiviral agents|mesh-ancestor
102509348|NCT01453075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102509349|NCT01791374|Rilotumumab|rilotumumab|mesh-list
102509350|NCT01791374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102509351|NCT01791374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102509352|NCT01791374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102509353|NCT01791374|Immunologic Factors|immunologic factors|mesh-ancestor
102509354|NCT01791374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509355|NCT03783416|Ixazomib|ixazomib|mesh-list
102509356|NCT03783416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102509357|NCT03783416|Protease Inhibitors|protease inhibitors|mesh-ancestor
102509358|NCT03783416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102509359|NCT03783416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509360|NCT00248534|Methylprednisolone|methylprednisolone|mesh-list
102509361|NCT00248534|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102509362|NCT00248534|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102509363|NCT00248534|Prednisolone|prednisolone|mesh-list
102509364|NCT00248534|Prednisolone acetate|prednisolone acetate|mesh-list
102509365|NCT00248534|Rituximab|rituximab|mesh-list
102509366|NCT00248534|Temozolomide|temozolomide|mesh-list
102509367|NCT00248534|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102509368|NCT00248534|Prednisolone phosphate|prednisolone phosphate|mesh-list
102509369|NCT00248534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102509370|NCT00248534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102509371|NCT00248534|Immunologic Factors|immunologic factors|mesh-ancestor
102509372|NCT00248534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509373|NCT00248534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102509374|NCT00248534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102509375|NCT00248534|Alkylating Agents|alkylating agents|mesh-ancestor
102509376|NCT00248534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509377|NCT00248534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102509378|NCT00248534|Antiemetics|antiemetics|mesh-ancestor
102509379|NCT00248534|Autonomic Agents|autonomic agents|mesh-ancestor
102509380|NCT00248534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102509381|NCT00248534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102509382|NCT00248534|Glucocorticoids|glucocorticoids|mesh-ancestor
102509383|NCT00248534|Hormones|hormones|mesh-ancestor
102509384|NCT00248534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102509385|NCT00248534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102509386|NCT00248534|Protective Agents|protective agents|mesh-ancestor
102509387|NCT00248534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102509388|NCT00248612|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102509389|NCT00248612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102509390|NCT00248612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102509391|NCT00248612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102509392|NCT00248612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509393|NCT00248612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102509394|NCT00248612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509395|NCT00248612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102509396|NCT00248612|Antidepressive Agents|antidepressive agents|mesh-ancestor
102509397|NCT00248612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102509398|NCT05266820|Thalidomide|thalidomide|mesh-list
102509399|NCT05266820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102509400|NCT05266820|Immunologic Factors|immunologic factors|mesh-ancestor
102509401|NCT05266820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509402|NCT05266820|Leprostatic Agents|leprostatic agents|mesh-ancestor
102509403|NCT05266820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102509404|NCT05266820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102509405|NCT05266820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102509406|NCT05266820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102509407|NCT05266820|Growth Substances|growth substances|mesh-ancestor
102509408|NCT05266820|Growth Inhibitors|growth inhibitors|mesh-ancestor
102509409|NCT05266820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102509410|NCT03549650|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
102509411|NCT03549650|Anticoagulants|anticoagulants|mesh-ancestor
102509412|NCT01454791|Diclofenac|diclofenac|mesh-list
102509413|NCT01454791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102509414|NCT01454791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102509415|NCT01454791|Analgesics|analgesics|mesh-ancestor
102509416|NCT01454791|Sensory System Agents|sensory system agents|mesh-ancestor
102509417|NCT01454791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102509418|NCT01454791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509419|NCT01454791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102509420|NCT01454791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102509421|NCT01454791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102509422|NCT01454791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102509423|NCT01454791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509424|NCT02099006|Ketoprofen|ketoprofen|mesh-list
102509425|NCT02099006|Ketamine|ketamine|mesh-list
102509426|NCT02099006|Gabapentin|gabapentin|mesh-list
102509427|NCT02099006|Amitriptyline|amitriptyline|mesh-list
102509428|NCT02099006|Baclofen|baclofen|mesh-list
102509429|NCT02099006|Loperamide|loperamide|mesh-list
102509430|NCT02099006|Antidiarrheals|antidiarrheals|mesh-list
102509431|NCT02099006|Analgesics|analgesics|mesh-ancestor
102509432|NCT02099006|Sensory System Agents|sensory system agents|mesh-ancestor
102509433|NCT02099006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102509434|NCT02099006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509435|NCT02099006|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102509436|NCT02099006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102509437|NCT02099006|Anesthetics, General|anesthetics, general|mesh-ancestor
102509438|NCT02099006|Anesthetics|anesthetics|mesh-ancestor
102509439|NCT02099006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102509440|NCT02099006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102509441|NCT02099006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102509442|NCT02099006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102509443|NCT02099006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509444|NCT02099006|Anticonvulsants|anticonvulsants|mesh-ancestor
102509445|NCT02099006|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102509446|NCT02099006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102509447|NCT02099006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102509448|NCT02099006|Antimanic Agents|antimanic agents|mesh-ancestor
102509449|NCT02099006|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102509450|NCT02099006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102509451|NCT02099006|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102509452|NCT02099006|GABA Agonists|gaba agonists|mesh-ancestor
102509453|NCT02099006|GABA Agents|gaba agents|mesh-ancestor
102509454|NCT02099006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102509455|NCT02099006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102509456|NCT02099006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102509457|NCT02099006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102509458|NCT02099006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102509459|NCT02099006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102509460|NCT02099006|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102509461|NCT02099006|Antidepressive Agents|antidepressive agents|mesh-ancestor
102509462|NCT02099006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102509463|NCT02099006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102509464|NCT02099006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102509465|NCT02099006|Adrenergic Agents|adrenergic agents|mesh-ancestor
102509466|NCT02099006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102509467|NCT05266274|Azacitidine|azacitidine|mesh-list
102509468|NCT05266274|Antibodies|antibodies|mesh-list
102509469|NCT05266274|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102509470|NCT05266274|Immunologic Factors|immunologic factors|mesh-ancestor
102509471|NCT05266274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509472|NCT05266274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102509473|NCT05266274|Antimetabolites|antimetabolites|mesh-ancestor
102509474|NCT05266274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509475|NCT05266274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102509476|NCT05266274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102509477|NCT05265962|Decitabine|decitabine|mesh-list
102509478|NCT05265962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102509479|NCT05265962|Antimetabolites|antimetabolites|mesh-ancestor
102509480|NCT05265962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509481|NCT05265962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102509482|NCT05265962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102509483|NCT00324896|Eszopiclone|eszopiclone|mesh-list
102509484|NCT00324896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102509485|NCT00324896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102509486|NCT00324896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509487|NCT01479517|Tetracaine|tetracaine|mesh-list
102509488|NCT01479517|Anesthetics, Local|anesthetics, local|mesh-ancestor
102509489|NCT01479517|Anesthetics|anesthetics|mesh-ancestor
102509490|NCT01479517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102509491|NCT01479517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509492|NCT01479517|Sensory System Agents|sensory system agents|mesh-ancestor
102509493|NCT01479517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102509494|NCT01480219|Voriconazole|voriconazole|mesh-list
102509495|NCT01480219|Antifungal Agents|antifungal agents|mesh-ancestor
102509496|NCT01480219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102509497|NCT01480219|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102509498|NCT01480219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102509499|NCT01480219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102509500|NCT01480219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509501|NCT01480219|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102509502|NCT01480219|Hormone Antagonists|hormone antagonists|mesh-ancestor
102509503|NCT01480219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102509504|NCT01480219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509505|NCT01480219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102509506|NCT01480297|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
102509507|NCT01480297|Sodium Salicylate|sodium salicylate|mesh-list
102509508|NCT01480297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102509509|NCT01480297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102509510|NCT01480297|Analgesics|analgesics|mesh-ancestor
102509511|NCT01480297|Sensory System Agents|sensory system agents|mesh-ancestor
102509512|NCT01480297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102509513|NCT01480297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509514|NCT01480297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102509515|NCT01480297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102509516|NCT01480297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102509517|NCT01480297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102509518|NCT01480297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509519|NCT01480843|Insulin Glargine|insulin glargine|mesh-list
102509520|NCT01480843|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102509521|NCT01480843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509522|NCT01392703|Dasatinib|dasatinib|mesh-list
101705564|NCT04318210|Tenofovir|tenofovir|mesh-list
102509523|NCT01392703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102509524|NCT01392703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102509525|NCT01392703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102509526|NCT01392703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509527|NCT01392859|Levocetirizine|levocetirizine|mesh-list
102509528|NCT01392859|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102509529|NCT01392859|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102509530|NCT01392859|Histamine Antagonists|histamine antagonists|mesh-ancestor
102509531|NCT01392859|Histamine Agents|histamine agents|mesh-ancestor
102509532|NCT01392859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102509533|NCT01392859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509534|NCT01392859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509535|NCT01457521|Ibuprofen|ibuprofen|mesh-list
102509536|NCT01457521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102509537|NCT01457521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102509538|NCT01457521|Analgesics|analgesics|mesh-ancestor
102509539|NCT01457521|Sensory System Agents|sensory system agents|mesh-ancestor
102509540|NCT01457521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102509541|NCT01457521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509542|NCT01457521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102509543|NCT01457521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102509544|NCT01457521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102509545|NCT01457521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102509546|NCT01457521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509547|NCT00325442|Treprostinil|treprostinil|mesh-list
102509548|NCT00325442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102509549|NCT01393717|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102509550|NCT01393717|Antibodies|antibodies|mesh-list
102509551|NCT01393717|Immunoglobulins|immunoglobulins|mesh-list
102509552|NCT01393717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102509553|NCT01393717|Immunoconjugates|immunoconjugates|mesh-list
102509554|NCT01393717|Immunologic Factors|immunologic factors|mesh-ancestor
102509555|NCT01393717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509556|NCT01393717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102509557|NCT01393717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102509558|NCT01393717|Immunotoxins|immunotoxins|mesh-ancestor
102509559|NCT01460875|Interferons|interferons|mesh-list
102509560|NCT01460875|Interferon-alpha|interferon-alpha|mesh-list
102509561|NCT01460875|Interferon alpha-2|interferon alpha-2|mesh-list
102509562|NCT01460875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102509563|NCT01460875|Antiviral Agents|antiviral agents|mesh-ancestor
102509564|NCT01460875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102509565|NCT01460875|Immunologic Factors|immunologic factors|mesh-ancestor
102509566|NCT01460875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509567|NCT01481545|Leucovorin|leucovorin|mesh-list
102509568|NCT01481545|Bevacizumab|bevacizumab|mesh-list
102509569|NCT01481545|Fluorouracil|fluorouracil|mesh-list
102509570|NCT01481545|Oxaliplatin|oxaliplatin|mesh-list
102509571|NCT01481545|Raltitrexed|raltitrexed|mesh-list
102509572|NCT01481545|Levoleucovorin|levoleucovorin|mesh-list
102509573|NCT01481545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102509574|NCT01481545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102509575|NCT01481545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102509576|NCT01481545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102509577|NCT01481545|Growth Substances|growth substances|mesh-ancestor
102509578|NCT01481545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509579|NCT01481545|Growth Inhibitors|growth inhibitors|mesh-ancestor
102509580|NCT01481545|Antimetabolites|antimetabolites|mesh-ancestor
102509581|NCT01481545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509582|NCT01481545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102509583|NCT01481545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102509584|NCT01481545|Immunologic Factors|immunologic factors|mesh-ancestor
102509585|NCT01481545|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102509586|NCT01481545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102509587|NCT01481545|Antidotes|antidotes|mesh-ancestor
102509588|NCT01481545|Protective Agents|protective agents|mesh-ancestor
102509589|NCT01481545|Vitamin B Complex|vitamin b complex|mesh-ancestor
102509590|NCT01481545|Vitamins|vitamins|mesh-ancestor
102509591|NCT01481545|Micronutrients|micronutrients|mesh-ancestor
102509592|NCT01482091|Fentanyl|fentanyl|mesh-list
102509593|NCT01482091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102509594|NCT01482091|Narcotics|narcotics|mesh-ancestor
101985820|NCT00003875|Analgesics|analgesics|mesh-ancestor
102509595|NCT01482091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102509596|NCT01482091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509597|NCT01482091|Analgesics|analgesics|mesh-ancestor
102509598|NCT01482091|Sensory System Agents|sensory system agents|mesh-ancestor
102509599|NCT01482091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102509600|NCT01482091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102509601|NCT01482091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102509602|NCT01482091|Anesthetics, General|anesthetics, general|mesh-ancestor
102509603|NCT01482091|Anesthetics|anesthetics|mesh-ancestor
102509604|NCT00327392|Fospropofol|fospropofol|mesh-list
102509605|NCT00327392|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102509606|NCT00327392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102509607|NCT00327392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509608|NCT01791608|Zinc|zinc|mesh-list
102509609|NCT01791608|Zinc Sulfate|zinc sulfate|mesh-list
102509610|NCT01791608|Trace Elements|trace elements|mesh-ancestor
102509611|NCT01791608|Micronutrients|micronutrients|mesh-ancestor
102509612|NCT01791608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509613|NCT01791608|Astringents|astringents|mesh-ancestor
102509614|NCT01791608|Dermatologic Agents|dermatologic agents|mesh-ancestor
102509615|NCT04346030|Triamcinolone|triamcinolone|mesh-list
102509616|NCT04346030|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102509617|NCT04346030|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102509618|NCT04346030|Lidocaine|lidocaine|mesh-list
102509619|NCT04346030|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102509620|NCT04346030|Anesthetics, Local|anesthetics, local|mesh-ancestor
102509621|NCT04346030|Anesthetics|anesthetics|mesh-ancestor
102509622|NCT04346030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102509623|NCT04346030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509624|NCT04346030|Sensory System Agents|sensory system agents|mesh-ancestor
102509625|NCT04346030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102509626|NCT04346030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102509627|NCT04346030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102509628|NCT04346030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102509629|NCT04346030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102509630|NCT04346030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509631|NCT04346030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102509632|NCT04346030|Glucocorticoids|glucocorticoids|mesh-ancestor
102509634|NCT04346030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102509635|NCT04346030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102509636|NCT04346030|Immunologic Factors|immunologic factors|mesh-ancestor
102509637|NCT04346030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102509638|NCT05075330|Analgesics, Opioid|analgesics, opioid|mesh-list
102509639|NCT05075330|Narcotics|narcotics|mesh-ancestor
102509640|NCT05075330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102509641|NCT05075330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509642|NCT05075330|Analgesics|analgesics|mesh-ancestor
102509643|NCT05075330|Sensory System Agents|sensory system agents|mesh-ancestor
102509644|NCT05075330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102509645|NCT02108288|Carteolol|carteolol|mesh-list
102509646|NCT02108288|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102509647|NCT02108288|Latanoprost|latanoprost|mesh-list
102509648|NCT02108288|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102509649|NCT02108288|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102509650|NCT02108288|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102509651|NCT02108288|Adrenergic Agents|adrenergic agents|mesh-ancestor
102509652|NCT02108288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102509653|NCT02108288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509654|NCT02108288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509655|NCT02108288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102509656|NCT02108288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102509657|NCT02108288|Sympatholytics|sympatholytics|mesh-ancestor
102509658|NCT02108288|Autonomic Agents|autonomic agents|mesh-ancestor
102509659|NCT02108288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102509660|NCT02106494|Dexamethasone|dexamethasone|mesh-list
102509661|NCT02106494|Ondansetron|ondansetron|mesh-list
102509662|NCT02106494|Fosaprepitant|fosaprepitant|mesh-list
102509663|NCT02106494|Aprepitant|aprepitant|mesh-list
102509664|NCT02106494|Granisetron|granisetron|mesh-list
102509665|NCT02106494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102509666|NCT02106494|Antiemetics|antiemetics|mesh-ancestor
102509667|NCT02106494|Autonomic Agents|autonomic agents|mesh-ancestor
102509668|NCT02106494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102509669|NCT02106494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509670|NCT02106494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102509671|NCT02106494|Glucocorticoids|glucocorticoids|mesh-ancestor
102509672|NCT02106494|Hormones|hormones|mesh-ancestor
102509673|NCT02106494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102509674|NCT02106494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102509675|NCT02106494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102509676|NCT02106494|Antipruritics|antipruritics|mesh-ancestor
102509677|NCT02106494|Dermatologic Agents|dermatologic agents|mesh-ancestor
102509678|NCT02106494|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102509679|NCT02106494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102509680|NCT02106494|Serotonin Agents|serotonin agents|mesh-ancestor
102509681|NCT02106494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102509682|NCT02106494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509683|NCT02106494|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102509684|NCT00335504|Sulindac|sulindac|mesh-list
102509685|NCT00335504|Atorvastatin|atorvastatin|mesh-list
102509686|NCT00335504|Calcium|calcium|mesh-list
102509687|NCT00335504|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102509688|NCT00335504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509689|NCT00335504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102509690|NCT00335504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102509691|NCT00335504|Antimetabolites|antimetabolites|mesh-ancestor
102509692|NCT00335504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509693|NCT00335504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102509694|NCT00335504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102509695|NCT00335504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102509696|NCT00335504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102321197|NCT02090413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102509697|NCT00335504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102509698|NCT00335504|Analgesics|analgesics|mesh-ancestor
102509699|NCT00335504|Sensory System Agents|sensory system agents|mesh-ancestor
102509700|NCT00335504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102509701|NCT00335504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102509702|NCT00335504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102509703|NCT00335504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102509704|NCT00335504|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102509705|NCT01183169|Ribavirin|ribavirin|mesh-list
102509706|NCT01183169|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102509707|NCT01183169|Antimetabolites|antimetabolites|mesh-ancestor
102509708|NCT01183169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509709|NCT01183169|Antiviral Agents|antiviral agents|mesh-ancestor
102509710|NCT01183169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102509711|NCT01183481|Aprepitant|aprepitant|mesh-list
102509712|NCT01183481|Granisetron|granisetron|mesh-list
102509713|NCT01183481|Antiemetics|antiemetics|mesh-ancestor
102509714|NCT01183481|Autonomic Agents|autonomic agents|mesh-ancestor
102509715|NCT01183481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102509716|NCT01183481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509717|NCT01183481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102509718|NCT01183481|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102509719|NCT01183481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102509720|NCT01183481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509721|NCT01183481|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102509722|NCT01183481|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102509723|NCT01183481|Serotonin Agents|serotonin agents|mesh-ancestor
102509724|NCT01183559|Paclitaxel|paclitaxel|mesh-list
102509725|NCT01183559|Carboplatin|carboplatin|mesh-list
102509726|NCT01183559|Fluorouracil|fluorouracil|mesh-list
102509727|NCT01183559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102509728|NCT01183559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102509729|NCT01183559|Tubulin Modulators|tubulin modulators|mesh-ancestor
102509730|NCT01183559|Antimitotic Agents|antimitotic agents|mesh-ancestor
102509731|NCT01183559|Mitosis Modulators|mitosis modulators|mesh-ancestor
102509732|NCT01183559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509733|NCT01183559|Antimetabolites|antimetabolites|mesh-ancestor
102509734|NCT01183559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102509735|NCT01183559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102509736|NCT01183559|Immunologic Factors|immunologic factors|mesh-ancestor
102509737|NCT01183559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509738|NCT01184417|Phenobarbital|phenobarbital|mesh-list
102509739|NCT01184417|Anticonvulsants|anticonvulsants|mesh-ancestor
102509740|NCT01184417|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102509741|NCT01184417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102509742|NCT01184417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509743|NCT01184417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102509744|NCT01184417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102509745|NCT01184417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102509746|NCT01184417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509747|NCT01184417|GABA Modulators|gaba modulators|mesh-ancestor
102509748|NCT01184417|GABA Agents|gaba agents|mesh-ancestor
102509749|NCT01184417|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102509750|NCT01184417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102509751|NCT01184417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102509752|NCT01159067|Deferasirox|deferasirox|mesh-list
102509753|NCT01159067|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102509754|NCT01159067|Chelating Agents|chelating agents|mesh-ancestor
102509755|NCT01159067|Sequestering Agents|sequestering agents|mesh-ancestor
102509756|NCT01159067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509757|NCT01222091|Propranolol|propranolol|mesh-list
102509758|NCT01222091|Remifentanil|remifentanil|mesh-list
102509759|NCT01222091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102509760|NCT01222091|Narcotics|narcotics|mesh-ancestor
102509761|NCT01222091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102509762|NCT01222091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509763|NCT01222091|Analgesics|analgesics|mesh-ancestor
102509764|NCT01222091|Sensory System Agents|sensory system agents|mesh-ancestor
102509765|NCT01222091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102509766|NCT01222091|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102509767|NCT01222091|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102509768|NCT01222091|Adrenergic Agents|adrenergic agents|mesh-ancestor
102509769|NCT01222091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102509770|NCT01222091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509771|NCT01222091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102509772|NCT01222091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102509773|NCT01222091|Vasodilator Agents|vasodilator agents|mesh-ancestor
102509774|NCT01225055|Teriparatide|teriparatide|mesh-list
102509775|NCT01225055|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102509776|NCT01225055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509777|NCT01225055|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102509778|NCT01336140|Aminophylline|aminophylline|mesh-list
102509779|NCT01336140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102509780|NCT01336140|Autonomic Agents|autonomic agents|mesh-ancestor
102509781|NCT01336140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102509782|NCT01336140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509783|NCT01336140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102509784|NCT01336140|Respiratory System Agents|respiratory system agents|mesh-ancestor
102509785|NCT01336140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102509786|NCT01336140|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102509787|NCT01336140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102509788|NCT01336140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509789|NCT01336140|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102509790|NCT01336140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102509791|NCT01336140|Purinergic Agents|purinergic agents|mesh-ancestor
102509792|NCT01336140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102509793|NCT01336140|Protective Agents|protective agents|mesh-ancestor
102509794|NCT01184885|Sirolimus|sirolimus|mesh-list
102509795|NCT01184885|Cyclophosphamide|cyclophosphamide|mesh-list
102509796|NCT01184885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102509797|NCT01184885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102509798|NCT01184885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509799|NCT01184885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102509800|NCT01184885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101986033|NCT01588639|Insulin|insulin|mesh-list
102509801|NCT01184885|Antifungal Agents|antifungal agents|mesh-ancestor
102509802|NCT01184885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102509803|NCT01184885|Immunologic Factors|immunologic factors|mesh-ancestor
102509804|NCT01184885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509805|NCT01184885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102509806|NCT01184885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102509807|NCT01184885|Alkylating Agents|alkylating agents|mesh-ancestor
102509808|NCT01184885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102509809|NCT01187381|Trastuzumab|trastuzumab|mesh-list
102509810|NCT01187381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102509811|NCT01187381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102509812|NCT01225289|Vitamin A|vitamin a|mesh-list
102509813|NCT01225289|Retinol palmitate|retinol palmitate|mesh-list
102509814|NCT01225289|Vitamins|vitamins|mesh-ancestor
102509815|NCT01225289|Micronutrients|micronutrients|mesh-ancestor
102509816|NCT01225289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509817|NCT01225289|Antioxidants|antioxidants|mesh-ancestor
102509818|NCT01225289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509819|NCT01225289|Protective Agents|protective agents|mesh-ancestor
102509820|NCT01225289|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102509821|NCT01225289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102509822|NCT01161563|Leuprolide|leuprolide|mesh-list
102509823|NCT01161563|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102509824|NCT01161563|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102509825|NCT01161563|Fertility Agents|fertility agents|mesh-ancestor
102509826|NCT01161563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102509827|NCT01161563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509828|NCT01161563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102509829|NCT01161563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102509830|NCT01161563|Luteolytic Agents|luteolytic agents|mesh-ancestor
102509831|NCT01161563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102509832|NCT01161563|Contraceptive Agents|contraceptive agents|mesh-ancestor
102509833|NCT01161563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102509834|NCT01189409|Sennosides|sennosides|mesh-list
102509835|NCT01189409|Laxatives|laxatives|mesh-ancestor
102509836|NCT01189409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102509837|NCT03010475|Furosemide|furosemide|mesh-list
102509838|NCT03010475|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102509839|NCT03010475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102509840|NCT03010475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102509841|NCT03010475|Antimetabolites|antimetabolites|mesh-ancestor
102509842|NCT03010475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509843|NCT03010475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102509844|NCT03010475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102509845|NCT03010475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102509846|NCT03010475|Diuretics|diuretics|mesh-ancestor
102321354|NCT02152007|Sirolimus|sirolimus|mesh-list
102509847|NCT03010475|Natriuretic Agents|natriuretic agents|mesh-ancestor
102509848|NCT03010475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509849|NCT03010475|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102509850|NCT03010475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102509851|NCT02191865|Nintedanib|nintedanib|mesh-list
102509852|NCT02191865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102509853|NCT02191865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102509854|NCT02191865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102509855|NCT02191865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509856|NCT04352465|Methotrexate|methotrexate|mesh-list
102509857|NCT04352465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102509858|NCT04352465|Abortifacient Agents|abortifacient agents|mesh-ancestor
102509859|NCT04352465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102509860|NCT04352465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509861|NCT04352465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102509862|NCT04352465|Antimetabolites|antimetabolites|mesh-ancestor
102509863|NCT04352465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509864|NCT04352465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102509865|NCT04352465|Dermatologic Agents|dermatologic agents|mesh-ancestor
102509866|NCT04352465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101986096|NCT01185847|Antimetabolites|antimetabolites|mesh-ancestor
102509867|NCT04352465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102509868|NCT04352465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102509869|NCT04352465|Immunologic Factors|immunologic factors|mesh-ancestor
102509870|NCT04352465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102509871|NCT04352465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102509872|NCT01191749|Alemtuzumab|alemtuzumab|mesh-list
102509873|NCT01191749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102509874|NCT01191749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102509875|NCT00343460|Dexamethasone|dexamethasone|mesh-list
102509876|NCT00343460|Palonosetron|palonosetron|mesh-list
102509877|NCT00343460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102509878|NCT00343460|Antiemetics|antiemetics|mesh-ancestor
102509879|NCT00343460|Autonomic Agents|autonomic agents|mesh-ancestor
102509880|NCT00343460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102509881|NCT00343460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509882|NCT00343460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102509883|NCT00343460|Glucocorticoids|glucocorticoids|mesh-ancestor
102509884|NCT00343460|Hormones|hormones|mesh-ancestor
102509885|NCT00343460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102509886|NCT00343460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102509887|NCT00343460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102509888|NCT00343460|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102509889|NCT00343460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102509890|NCT00343460|Serotonin Agents|serotonin agents|mesh-ancestor
102509891|NCT00343460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102509892|NCT00343460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509893|NCT04934696|Contraceptive Agents|contraceptive agents|mesh-list
102509894|NCT04934696|Contraceptives, Oral|contraceptives, oral|mesh-list
102509895|NCT04934696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102509896|NCT04934696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509897|NCT04934696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102509898|NCT01192139|Metformin|metformin|mesh-list
102509899|NCT01192139|Saxagliptin|saxagliptin|mesh-list
102509900|NCT01192139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102509901|NCT01192139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509902|NCT01192139|Incretins|incretins|mesh-ancestor
102509903|NCT01192139|Hormones|hormones|mesh-ancestor
102509904|NCT01192139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102509905|NCT01192139|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102509906|NCT01192139|Protease Inhibitors|protease inhibitors|mesh-ancestor
102509907|NCT01192139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102509908|NCT01192139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509909|NCT04892186|Inositol|inositol|mesh-list
102509910|NCT04892186|Metformin|metformin|mesh-list
102509911|NCT04892186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102509912|NCT04892186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509913|NCT04892186|Vitamin B Complex|vitamin b complex|mesh-ancestor
102509914|NCT04892186|Vitamins|vitamins|mesh-ancestor
102509915|NCT04892186|Micronutrients|micronutrients|mesh-ancestor
102509916|NCT01229423|Bimatoprost|bimatoprost|mesh-list
102509917|NCT01229423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102509918|NCT01229891|Vitamin D|vitamin d|mesh-list
102509919|NCT01229891|Ergocalciferols|ergocalciferols|mesh-list
102509920|NCT01229891|Cholecalciferol|cholecalciferol|mesh-list
102509921|NCT01229891|Vitamins|vitamins|mesh-list
102509922|NCT01229891|Micronutrients|micronutrients|mesh-ancestor
102509923|NCT01229891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509924|NCT01229891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102509925|NCT01229891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102509926|NCT01283555|Tenofovir|tenofovir|mesh-list
102509927|NCT01283555|Antiviral Agents|antiviral agents|mesh-ancestor
102509928|NCT01283555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102509929|NCT01283555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102509930|NCT01283555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102509931|NCT01283555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102509932|NCT01283555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509933|NCT01283555|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102509934|NCT01283555|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102509935|NCT01194089|Nicotine|nicotine|mesh-list
102509936|NCT01194089|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102509937|NCT01194089|Autonomic Agents|autonomic agents|mesh-ancestor
102509938|NCT01194089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102509939|NCT01194089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509940|NCT01194089|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102509941|NCT01194089|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102509942|NCT01194089|Cholinergic Agents|cholinergic agents|mesh-ancestor
102509943|NCT01194089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102509944|NCT01194089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509945|NCT01650350|Naltrexone|naltrexone|mesh-list
102509946|NCT01650350|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102509947|NCT01650350|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102509948|NCT01650350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509949|NCT01650350|Sensory System Agents|sensory system agents|mesh-ancestor
102509950|NCT01650350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102509951|NCT00349388|Mesalamine|mesalamine|mesh-list
102509952|NCT00349388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102509953|NCT00349388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102509954|NCT00349388|Analgesics|analgesics|mesh-ancestor
102509955|NCT00349388|Sensory System Agents|sensory system agents|mesh-ancestor
102509956|NCT00349388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102509957|NCT00349388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509958|NCT00349388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102509959|NCT00349388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102509960|NCT00349778|Cyclophosphamide|cyclophosphamide|mesh-list
102509961|NCT00349778|Melphalan|melphalan|mesh-list
102509962|NCT00349778|Carmustine|carmustine|mesh-list
102509963|NCT00349778|Etoposide|etoposide|mesh-list
102509964|NCT00349778|Etoposide phosphate|etoposide phosphate|mesh-list
102509965|NCT00349778|Lenograstim|lenograstim|mesh-list
102509966|NCT00349778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102509967|NCT00349778|Immunologic Factors|immunologic factors|mesh-ancestor
102509968|NCT00349778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509969|NCT00349778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102509970|NCT00349778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102509971|NCT00349778|Alkylating Agents|alkylating agents|mesh-ancestor
102509972|NCT00349778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509973|NCT00349778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102509974|NCT00349778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102509975|NCT00349778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102509976|NCT00349778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102509977|NCT00349778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102509978|NCT00349778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102509979|NCT00349778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102509980|NCT00305084|Doxorubicin|doxorubicin|mesh-list
102509981|NCT00305084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102509982|NCT00305084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102509983|NCT00305084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102509984|NCT00305084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102509985|NCT00305084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102509986|NCT00305084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509987|NCT00305162|Clopidogrel|clopidogrel|mesh-list
102509988|NCT00305162|Cangrelor|cangrelor|mesh-list
102509989|NCT00305162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102509990|NCT00305162|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102509991|NCT00305162|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102509992|NCT00305162|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102509993|NCT00305162|Purinergic Agents|purinergic agents|mesh-ancestor
102509994|NCT00305162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102509995|NCT00305162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102509996|NCT00305162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102509997|NCT00351416|Letrozole|letrozole|mesh-list
102509998|NCT00351416|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102509999|NCT00351416|LHRH, N-Ac-2-Nal(1)-4-Cl-Phe(2)-3-Pal(3)-Arg(5)-Glu(6)-AlaNH2(10)-|lhrh, n-ac-2-nal(1)-4-cl-phe(2)-3-pal(3)-arg(5)-glu(6)-alanh2(10)-|mesh-list
102510000|NCT00351416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510001|NCT00351416|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102510002|NCT00351416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102510003|NCT00351416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510004|NCT00351416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101986243|NCT01292083|Azacitidine|azacitidine|mesh-list
102510005|NCT00351416|Hormone Antagonists|hormone antagonists|mesh-ancestor
102510006|NCT00351416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102510007|NCT00351416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510008|NCT00305942|Carboplatin|carboplatin|mesh-list
102510009|NCT00305942|Topotecan|topotecan|mesh-list
102510010|NCT00305942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510011|NCT00305942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102510012|NCT00305942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102510013|NCT00305942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102510014|NCT00305942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510015|NCT00352976|Mycophenolic Acid|mycophenolic acid|mesh-list
102510016|NCT00352976|Sirolimus|sirolimus|mesh-list
102510017|NCT00352976|Cyclophosphamide|cyclophosphamide|mesh-list
102510018|NCT00352976|Fludarabine|fludarabine|mesh-list
102510019|NCT00352976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102510020|NCT00352976|Immunologic Factors|immunologic factors|mesh-ancestor
102510021|NCT00352976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510022|NCT00352976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102510023|NCT00352976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102510024|NCT00352976|Alkylating Agents|alkylating agents|mesh-ancestor
102510025|NCT00352976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510026|NCT00352976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510027|NCT00352976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102510028|NCT00352976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102510029|NCT00352976|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102510030|NCT00352976|Antitubercular Agents|antitubercular agents|mesh-ancestor
102510031|NCT00352976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102510032|NCT00352976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102510033|NCT00352976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102510034|NCT00352976|Antifungal Agents|antifungal agents|mesh-ancestor
102510035|NCT00306488|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102510036|NCT00306488|Antioxidants|antioxidants|mesh-list
102510037|NCT00306488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102510038|NCT00306488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510039|NCT00306488|Protective Agents|protective agents|mesh-ancestor
102510040|NCT00306488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510041|NCT01793636|Everolimus|everolimus|mesh-list
102510042|NCT01793636|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102510043|NCT01793636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102510044|NCT01793636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102510045|NCT01793636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510046|NCT01793636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102510047|NCT01793636|Immunologic Factors|immunologic factors|mesh-ancestor
102510048|NCT01793636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510049|NCT01793636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510050|NCT00353522|Dalcetrapib|dalcetrapib|mesh-list
102510051|NCT00353522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102510052|NCT00353522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102510053|NCT00353522|Antimetabolites|antimetabolites|mesh-ancestor
102510054|NCT00353522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510055|NCT00353522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102510056|NCT00310076|Thalidomide|thalidomide|mesh-list
102510057|NCT00310076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102510058|NCT00310076|Immunologic Factors|immunologic factors|mesh-ancestor
102510059|NCT00310076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986306|NCT01101815|Naltrexone|naltrexone|mesh-list
102510060|NCT00310076|Leprostatic Agents|leprostatic agents|mesh-ancestor
102510061|NCT00310076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102510062|NCT00310076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102510063|NCT00310076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102510064|NCT00310076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102510065|NCT00310076|Growth Substances|growth substances|mesh-ancestor
102510066|NCT00310076|Growth Inhibitors|growth inhibitors|mesh-ancestor
102510067|NCT00310076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510068|NCT00353834|Insulin|insulin|mesh-list
102510069|NCT00353834|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102510070|NCT00353834|Insulin Glargine|insulin glargine|mesh-list
102510071|NCT00353834|Exenatide|exenatide|mesh-list
102510073|NCT00353834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510074|NCT00353834|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102510075|NCT00353834|Incretins|incretins|mesh-ancestor
102510076|NCT00353834|Hormones|hormones|mesh-ancestor
102510077|NCT00353834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102510078|NCT05344404|Niacinamide|niacinamide|mesh-list
102510079|NCT05344404|Niacin|niacin|mesh-list
102510080|NCT05344404|Nicotinic Acids|nicotinic acids|mesh-list
102510081|NCT05344404|Vitamin B Complex|vitamin b complex|mesh-ancestor
102510082|NCT05344404|Vitamins|vitamins|mesh-ancestor
102510083|NCT05344404|Micronutrients|micronutrients|mesh-ancestor
102510084|NCT05344404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510085|NCT05344404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102510086|NCT05344404|Antimetabolites|antimetabolites|mesh-ancestor
102510087|NCT05344404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510088|NCT05344404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102510089|NCT05344404|Vasodilator Agents|vasodilator agents|mesh-ancestor
102510090|NCT00354224|Capecitabine|capecitabine|mesh-list
102510091|NCT00354224|Oxaliplatin|oxaliplatin|mesh-list
102510092|NCT00354224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102510093|NCT00354224|Antimetabolites|antimetabolites|mesh-ancestor
102510094|NCT00354224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510095|NCT00354224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510096|NCT01792388|Vitamin D|vitamin d|mesh-list
102510097|NCT01792388|Vitamins|vitamins|mesh-ancestor
102510098|NCT01792388|Micronutrients|micronutrients|mesh-ancestor
102510099|NCT01792388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510100|NCT01792388|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102510101|NCT05395104|Midazolam|midazolam|mesh-list
102510102|NCT05395104|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102510103|NCT05395104|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102510104|NCT05395104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102510105|NCT05395104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510106|NCT05395104|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102510107|NCT05395104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102510108|NCT05395104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102510109|NCT05395104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102510110|NCT05395104|Anesthetics, General|anesthetics, general|mesh-ancestor
102510111|NCT05395104|Anesthetics|anesthetics|mesh-ancestor
102510112|NCT05395104|GABA Modulators|gaba modulators|mesh-ancestor
102510113|NCT05395104|GABA Agents|gaba agents|mesh-ancestor
102510114|NCT05395104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102510115|NCT05395104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510116|NCT01793870|Carvedilol|carvedilol|mesh-list
102510117|NCT01793870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102510118|NCT01793870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102510119|NCT01793870|Adrenergic Agents|adrenergic agents|mesh-ancestor
102510120|NCT01793870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102510121|NCT01793870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510122|NCT01793870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510123|NCT01793870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102510124|NCT01793870|Antioxidants|antioxidants|mesh-ancestor
102510125|NCT01793870|Protective Agents|protective agents|mesh-ancestor
102510126|NCT01793870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102510127|NCT01793870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102510128|NCT01793870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102510129|NCT01793870|Vasodilator Agents|vasodilator agents|mesh-ancestor
102510130|NCT01793870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102510131|NCT01793870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102510132|NCT01793948|Metformin|metformin|mesh-list
102510133|NCT01793948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102510134|NCT01793948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510135|NCT00310466|Immunomodulating Agents|immunomodulating agents|mesh-list
102510136|NCT00310466|Immunologic Factors|immunologic factors|mesh-ancestor
102510137|NCT00310466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510138|NCT00355394|Metoclopramide|metoclopramide|mesh-list
102510139|NCT00355394|Antiemetics|antiemetics|mesh-ancestor
102510140|NCT00355394|Autonomic Agents|autonomic agents|mesh-ancestor
102510141|NCT00355394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102510142|NCT00355394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510143|NCT00355394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102510144|NCT00355394|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102510145|NCT00355394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102510146|NCT00355394|Dopamine Agents|dopamine agents|mesh-ancestor
102510147|NCT00355394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102510148|NCT00355394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510149|NCT00311246|Adalimumab|adalimumab|mesh-list
102510150|NCT00311246|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102510151|NCT00311246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102510152|NCT00311246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102510153|NCT02105324|Pancrelipase|pancrelipase|mesh-list
102510154|NCT02105324|Pancreatin|pancreatin|mesh-list
102510155|NCT02105324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102510156|NCT02105558|Anesthetics|anesthetics|mesh-list
102510157|NCT02105558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102510158|NCT02105558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510159|NCT02106962|Bacitracin|bacitracin|mesh-list
102510160|NCT02106962|Tranexamic Acid|tranexamic acid|mesh-list
102510161|NCT02106962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102510162|NCT02106962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102510163|NCT02106962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510164|NCT02106962|Hemostatics|hemostatics|mesh-ancestor
102510165|NCT02106962|Coagulants|coagulants|mesh-ancestor
102510166|NCT02106962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102510167|NCT02106962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102510168|NCT02106962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102510169|NCT00315146|Pioglitazone|pioglitazone|mesh-list
102510170|NCT00315146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102510171|NCT00315146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510172|NCT01792700|Amoxicillin|amoxicillin|mesh-list
102510173|NCT01792700|Moxifloxacin|moxifloxacin|mesh-list
102510174|NCT01792700|Metronidazole|metronidazole|mesh-list
102510175|NCT01792700|Tetracycline|tetracycline|mesh-list
102510176|NCT01792700|Esomeprazole|esomeprazole|mesh-list
102510177|NCT01792700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102510178|NCT01792700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102510179|NCT01792700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102510180|NCT01792700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102510181|NCT01792700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102510182|NCT01792700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510183|NCT01792700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101986413|NCT01186549|Lidocaine|lidocaine|mesh-list
102510184|NCT01792700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102510185|NCT01792700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102510186|NCT01792700|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102510187|NCT01792700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102510188|NCT01792700|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102510189|NCT01792700|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102510190|NCT00315302|Atropine|atropine|mesh-list
102510191|NCT00315302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102510192|NCT00315302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102510193|NCT00315302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102510194|NCT00315302|Autonomic Agents|autonomic agents|mesh-ancestor
102510195|NCT00315302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102510196|NCT00315302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510197|NCT00315302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102510198|NCT00315302|Respiratory System Agents|respiratory system agents|mesh-ancestor
102510199|NCT00315302|Mydriatics|mydriatics|mesh-ancestor
102510200|NCT00315302|Parasympatholytics|parasympatholytics|mesh-ancestor
102510201|NCT00315302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102510202|NCT00315302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102510203|NCT00315302|Cholinergic Agents|cholinergic agents|mesh-ancestor
102510204|NCT00315302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102510205|NCT00315302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510206|NCT00316862|Irinotecan|irinotecan|mesh-list
102510207|NCT00316862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510208|NCT00316862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102510209|NCT00316862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102510210|NCT00316862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102510211|NCT00316862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510212|NCT00317720|Trastuzumab|trastuzumab|mesh-list
102510213|NCT00317720|Everolimus|everolimus|mesh-list
102510214|NCT00317720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102510215|NCT00317720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510216|NCT00317720|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102510217|NCT00317720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102510218|NCT00317720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102510219|NCT00317720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510220|NCT00317720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102510221|NCT00317720|Immunologic Factors|immunologic factors|mesh-ancestor
102510222|NCT00317720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510223|NCT00357032|Belinostat|belinostat|mesh-list
102510224|NCT00357032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510225|NCT00357032|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102510226|NCT00357032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102510227|NCT00357032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510229|NCT00357734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510230|NCT00357734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102510231|NCT00357734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102510232|NCT00357734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510233|NCT00318812|Iron|iron|mesh-list
102510234|NCT00318812|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102510235|NCT00318812|Trace Elements|trace elements|mesh-ancestor
102510236|NCT00318812|Micronutrients|micronutrients|mesh-ancestor
102510237|NCT00318812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510238|NCT00318812|Hematinics|hematinics|mesh-ancestor
102510239|NCT00362882|Docetaxel|docetaxel|mesh-list
102510240|NCT00362882|Bortezomib|bortezomib|mesh-list
102510241|NCT00362882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510242|NCT00362882|Tubulin Modulators|tubulin modulators|mesh-ancestor
102510243|NCT00362882|Antimitotic Agents|antimitotic agents|mesh-ancestor
102510244|NCT00362882|Mitosis Modulators|mitosis modulators|mesh-ancestor
102510245|NCT00362882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510246|NCT00365144|Bevacizumab|bevacizumab|mesh-list
102510247|NCT00365144|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102510248|NCT00365144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102510249|NCT00365144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510250|NCT00365144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102510251|NCT00365144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102510252|NCT00365144|Growth Substances|growth substances|mesh-ancestor
102510253|NCT00365144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510254|NCT00365144|Growth Inhibitors|growth inhibitors|mesh-ancestor
101986474|NCT01291459|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102510255|NCT00365144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102510256|NCT00365144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102510257|NCT00365144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510258|NCT05339022|Coal Tar|coal tar|mesh-list
102510259|NCT05339022|Keratolytic Agents|keratolytic agents|mesh-ancestor
102510260|NCT05339022|Dermatologic Agents|dermatologic agents|mesh-ancestor
102510261|NCT00366626|Naltrexone|naltrexone|mesh-list
102510262|NCT00366626|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102510263|NCT00366626|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102510264|NCT00366626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510265|NCT00366626|Sensory System Agents|sensory system agents|mesh-ancestor
102510266|NCT00366626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102510267|NCT00367016|Omalizumab|omalizumab|mesh-list
102510268|NCT00367016|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102510269|NCT00367016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102510270|NCT00367016|Respiratory System Agents|respiratory system agents|mesh-ancestor
102510271|NCT04422678|Imatinib Mesylate|imatinib mesylate|mesh-list
102510272|NCT04422678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510273|NCT04422678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102510274|NCT04422678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102510275|NCT04422678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510276|NCT00573378|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102510277|NCT00573378|Antiviral Agents|antiviral agents|mesh-ancestor
102510278|NCT00573378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102510279|NCT05334654|Enoxaparin|enoxaparin|mesh-list
102510280|NCT05334654|Enoxaparin sodium|enoxaparin sodium|mesh-list
102510281|NCT05334654|Bivalirudin|bivalirudin|mesh-list
102510282|NCT05334654|Anticoagulants|anticoagulants|mesh-ancestor
102510283|NCT05334654|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102510284|NCT05334654|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102510285|NCT05334654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510286|NCT05334654|Antithrombins|antithrombins|mesh-ancestor
102510287|NCT05334654|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102510288|NCT05334654|Protease Inhibitors|protease inhibitors|mesh-ancestor
102510289|NCT05334654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102510290|NCT03561584|Sulfasalazine|sulfasalazine|mesh-list
102510291|NCT03561584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102510292|NCT03561584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102510293|NCT03561584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102510294|NCT03561584|Analgesics|analgesics|mesh-ancestor
102510295|NCT03561584|Sensory System Agents|sensory system agents|mesh-ancestor
102510296|NCT03561584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102510297|NCT03561584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510298|NCT03561584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102510299|NCT03561584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102510300|NCT03561584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102510301|NCT00369512|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102510302|NCT00369512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510303|NCT00369512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102510304|NCT00369512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102510305|NCT00369512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510306|NCT00324272|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102510307|NCT00324272|Hemostatics|hemostatics|mesh-ancestor
102510308|NCT00324272|Coagulants|coagulants|mesh-ancestor
102510309|NCT00369590|Aflibercept|aflibercept|mesh-list
102510310|NCT00369590|Endothelial Growth Factors|endothelial growth factors|mesh-list
102510311|NCT00369590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102510312|NCT00369590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102510313|NCT00369590|Growth Substances|growth substances|mesh-ancestor
102510314|NCT00369590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510315|NCT00369590|Growth Inhibitors|growth inhibitors|mesh-ancestor
102510316|NCT00369590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510317|NCT03932136|Sulforaphane|sulforaphane|mesh-list
102510318|NCT03932136|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102510319|NCT03932136|Protective Agents|protective agents|mesh-ancestor
102510320|NCT03932136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510321|NCT03932136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510322|NCT00324350|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102510323|NCT00324350|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
102510324|NCT00324350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510325|NCT00324350|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102510326|NCT00324350|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102510327|NCT00324350|Antimetabolites|antimetabolites|mesh-ancestor
102510328|NCT00324350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510329|NCT00324350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102510330|NCT00324350|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102510331|NCT00390182|Gemcitabine|gemcitabine|mesh-list
102510332|NCT00390182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102510333|NCT00390182|Antimetabolites|antimetabolites|mesh-ancestor
102510334|NCT00390182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510335|NCT00390182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510336|NCT05366868|Metformin|metformin|mesh-list
102510337|NCT05366868|Vildagliptin|vildagliptin|mesh-list
102510338|NCT05366868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102510339|NCT05366868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510340|NCT05366868|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102510341|NCT05366868|Protease Inhibitors|protease inhibitors|mesh-ancestor
102510342|NCT05366868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102510343|NCT05366868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510344|NCT05610774|Dexmedetomidine|dexmedetomidine|mesh-list
102510345|NCT05610774|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102510346|NCT05610774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102510347|NCT05610774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510348|NCT05610774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102510349|NCT05610774|Analgesics|analgesics|mesh-ancestor
102510350|NCT05610774|Sensory System Agents|sensory system agents|mesh-ancestor
102510351|NCT05610774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102510352|NCT05610774|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102510353|NCT05610774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102510354|NCT05610774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102510355|NCT05610774|Adrenergic Agents|adrenergic agents|mesh-ancestor
102510356|NCT05610774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102510357|NCT05610774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510358|NCT00369746|Citalopram|citalopram|mesh-list
102510359|NCT00369746|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102510360|NCT00369746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102510361|NCT00369746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102510362|NCT00369746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510363|NCT00369746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102510364|NCT00369746|Serotonin Agents|serotonin agents|mesh-ancestor
102510365|NCT00369746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510366|NCT00369746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102510367|NCT00369746|Antidepressive Agents|antidepressive agents|mesh-ancestor
102510368|NCT00369746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102510369|NCT00392054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
102510370|NCT02525874|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102510371|NCT02525874|Dermatologic Agents|dermatologic agents|mesh-ancestor
102510372|NCT02525874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102510373|NCT02525874|Immunologic Factors|immunologic factors|mesh-ancestor
102510374|NCT02525874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510375|NCT05329428|Vitamin D|vitamin d|mesh-list
102510376|NCT05329428|Ergocalciferols|ergocalciferols|mesh-list
102510377|NCT05329428|Cholecalciferol|cholecalciferol|mesh-list
102510378|NCT05329428|Vitamins|vitamins|mesh-list
102510379|NCT05329428|Micronutrients|micronutrients|mesh-ancestor
102510380|NCT05329428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510381|NCT05329428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102510382|NCT05329428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102510383|NCT01794572|Melphalan|melphalan|mesh-list
102510384|NCT01794572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102510385|NCT01794572|Alkylating Agents|alkylating agents|mesh-ancestor
102510386|NCT01794572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510387|NCT01794572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510388|NCT01794572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102510389|NCT01794572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102510390|NCT01794572|Immunologic Factors|immunologic factors|mesh-ancestor
102510391|NCT01794572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510392|NCT05385432|Mycophenolic Acid|mycophenolic acid|mesh-list
102510393|NCT05385432|Tacrolimus|tacrolimus|mesh-list
102510394|NCT05385432|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102510395|NCT05385432|Basiliximab|basiliximab|mesh-list
102510396|NCT05385432|Immunosuppressive Agents|immunosuppressive agents|mesh-list
102510397|NCT05385432|Thymoglobulin|thymoglobulin|mesh-list
102510398|NCT05385432|Immunologic Factors|immunologic factors|mesh-ancestor
102510399|NCT05385432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510400|NCT05385432|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102510401|NCT05385432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102510402|NCT05385432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510403|NCT05385432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102510404|NCT05385432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510405|NCT05385432|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102510406|NCT05385432|Antitubercular Agents|antitubercular agents|mesh-ancestor
102510407|NCT05385432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102510408|NCT05385432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102510409|NCT00392444|Sunitinib|sunitinib|mesh-list
102510410|NCT00392444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510411|NCT00392444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102510412|NCT00392444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102510413|NCT00392444|Growth Substances|growth substances|mesh-ancestor
102510414|NCT00392444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510415|NCT00392444|Growth Inhibitors|growth inhibitors|mesh-ancestor
102510416|NCT00392444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102510417|NCT00392444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102510418|NCT00392444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510419|NCT02528214|Prednisone|prednisone|mesh-list
102510420|NCT02528214|Prednisolone|prednisolone|mesh-list
102510421|NCT02528214|Albuterol|albuterol|mesh-list
102510422|NCT02528214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102510423|NCT02528214|Glucocorticoids|glucocorticoids|mesh-ancestor
102510424|NCT02528214|Hormones|hormones|mesh-ancestor
102510425|NCT02528214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102510426|NCT02528214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510427|NCT02528214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102510428|NCT02528214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510429|NCT02528214|Autonomic Agents|autonomic agents|mesh-ancestor
102510430|NCT02528214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102510431|NCT02528214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102510432|NCT02528214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102510433|NCT02528214|Respiratory System Agents|respiratory system agents|mesh-ancestor
102510434|NCT02528214|Tocolytic Agents|tocolytic agents|mesh-ancestor
102510435|NCT02528214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102510436|NCT02528214|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102510437|NCT02528214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102510438|NCT02528214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102510439|NCT02528214|Adrenergic Agents|adrenergic agents|mesh-ancestor
102510440|NCT02528214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102510441|NCT02528214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510442|NCT00392678|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
102510443|NCT00392678|Sodium Salicylate|sodium salicylate|mesh-list
102510444|NCT00392678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102510445|NCT00392678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102510446|NCT00392678|Analgesics|analgesics|mesh-ancestor
102510447|NCT00392678|Sensory System Agents|sensory system agents|mesh-ancestor
102510448|NCT00392678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102510449|NCT00392678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510450|NCT00392678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102510451|NCT00392678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102510452|NCT00392678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102510453|NCT00392678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102510454|NCT00392678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510455|NCT05902299|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102510456|NCT05902299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102510457|NCT05902260|Immunomodulating Agents|immunomodulating agents|mesh-list
102510458|NCT05902260|Immunologic Factors|immunologic factors|mesh-ancestor
102510459|NCT05902260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510460|NCT05902221|Amoxicillin|amoxicillin|mesh-list
102510461|NCT05902221|Moxifloxacin|moxifloxacin|mesh-list
102510463|NCT05902221|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102510464|NCT05902221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102510465|NCT05902221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102510466|NCT05902221|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102510467|NCT05902221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102510468|NCT05902221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102510469|NCT05902221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986697|NCT03473314|Nitric Oxide|nitric oxide|mesh-list
102510470|NCT05902221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510471|NCT05902221|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102510472|NCT05902221|Contraceptive Agents|contraceptive agents|mesh-ancestor
102510473|NCT05902221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102510474|NCT05902221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510475|NCT05902221|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102510476|NCT05902221|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102510477|NCT05902221|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102510478|NCT05902221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102510479|NCT05902221|Antitubercular Agents|antitubercular agents|mesh-ancestor
102510480|NCT05902221|Leprostatic Agents|leprostatic agents|mesh-ancestor
102510481|NCT05902221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102510482|NCT05902221|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102510483|NCT05902221|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102510484|NCT05902221|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102510485|NCT05902221|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102510486|NCT05902221|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102510487|NCT05902221|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102510488|NCT05902208|Antiviral Agents|antiviral agents|mesh-list
102510489|NCT05902208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102510490|NCT05902169|Carboplatin|carboplatin|mesh-list
102510491|NCT05902169|Temozolomide|temozolomide|mesh-list
102510492|NCT05902169|Lomustine|lomustine|mesh-list
102510493|NCT05902169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510494|NCT05902169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102510495|NCT05902169|Alkylating Agents|alkylating agents|mesh-ancestor
102510496|NCT05902169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510497|NCT05902078|Calcitriol|calcitriol|mesh-list
102510498|NCT05902078|Eldecalcitol|eldecalcitol|mesh-list
102510499|NCT05902078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102510500|NCT05902078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510501|NCT05902078|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102510502|NCT05902078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102510503|NCT05902078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510504|NCT05902078|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102510505|NCT05902078|Vitamins|vitamins|mesh-ancestor
102510506|NCT05902078|Micronutrients|micronutrients|mesh-ancestor
102510507|NCT05902078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102510508|NCT05901935|Capecitabine|capecitabine|mesh-list
102510509|NCT05901935|Trastuzumab|trastuzumab|mesh-list
102510510|NCT05901935|Vinorelbine|vinorelbine|mesh-list
102510511|NCT05901935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102510512|NCT05901935|Antimetabolites|antimetabolites|mesh-ancestor
102510513|NCT05901935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510514|NCT05901935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510515|NCT05901935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102510516|NCT05901935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102510517|NCT05901935|Tubulin Modulators|tubulin modulators|mesh-ancestor
102510518|NCT05901935|Antimitotic Agents|antimitotic agents|mesh-ancestor
102510519|NCT05901935|Mitosis Modulators|mitosis modulators|mesh-ancestor
102510520|NCT05901766|Micronutrients|micronutrients|mesh-list
102322020|NCT01621880|Bevacizumab|bevacizumab|mesh-list
102510521|NCT05901766|Trace Elements|trace elements|mesh-list
102510522|NCT05901766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510523|NCT05901701|Salicylic Acid|salicylic acid|mesh-list
102510524|NCT05901701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102510525|NCT05901701|Antifungal Agents|antifungal agents|mesh-ancestor
102510526|NCT05901701|Keratolytic Agents|keratolytic agents|mesh-ancestor
102510527|NCT05901701|Dermatologic Agents|dermatologic agents|mesh-ancestor
102510528|NCT05901571|Dexetimide|dexetimide|mesh-list
102510529|NCT05901571|Citalopram|citalopram|mesh-list
102510530|NCT05901571|Escitalopram|escitalopram|mesh-list
102510531|NCT05901571|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102510532|NCT05901571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102510533|NCT05901571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102510534|NCT05901571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510535|NCT05901571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102510536|NCT05901571|Serotonin Agents|serotonin agents|mesh-ancestor
102510537|NCT05901571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510538|NCT05901571|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102510539|NCT05901571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102510540|NCT05901571|Parasympatholytics|parasympatholytics|mesh-ancestor
102510541|NCT05901571|Autonomic Agents|autonomic agents|mesh-ancestor
102510542|NCT05901571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102510543|NCT05901571|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102510544|NCT05901571|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102510545|NCT05901571|Cholinergic Agents|cholinergic agents|mesh-ancestor
102510546|NCT05901571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102510547|NCT05901571|Antidepressive Agents|antidepressive agents|mesh-ancestor
102510548|NCT05901571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102510549|NCT05901454|Vaccines|vaccines|mesh-list
102510550|NCT05901454|Immunologic Factors|immunologic factors|mesh-ancestor
102510551|NCT05901454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510552|NCT05901441|Sufentanil|sufentanil|mesh-list
102510553|NCT05901441|Hydromorphone|hydromorphone|mesh-list
102510554|NCT05901441|Ropivacaine|ropivacaine|mesh-list
102510555|NCT05901441|Anesthetics, Local|anesthetics, local|mesh-ancestor
102510556|NCT05901441|Anesthetics|anesthetics|mesh-ancestor
102510557|NCT05901441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102510558|NCT05901441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510559|NCT05901441|Sensory System Agents|sensory system agents|mesh-ancestor
102510560|NCT05901441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102510561|NCT05901441|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102510562|NCT05901441|Narcotics|narcotics|mesh-ancestor
102510563|NCT05901441|Analgesics|analgesics|mesh-ancestor
102510564|NCT05901441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102510565|NCT05901441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102510566|NCT05901441|Anesthetics, General|anesthetics, general|mesh-ancestor
102510567|NCT05901389|Lidocaine|lidocaine|mesh-list
102510568|NCT05901389|Anesthetics, Local|anesthetics, local|mesh-ancestor
102510569|NCT05901389|Anesthetics|anesthetics|mesh-ancestor
102510570|NCT05901389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102510571|NCT05901389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510572|NCT05901389|Sensory System Agents|sensory system agents|mesh-ancestor
102510573|NCT05901389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102510574|NCT05901389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102510575|NCT05901389|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102510576|NCT05901389|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102510577|NCT05901389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102510578|NCT05901389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510579|NCT05901194|Lenvatinib|lenvatinib|mesh-list
102510580|NCT05901194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510581|NCT05901194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102510582|NCT05901194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102510583|NCT05901194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510584|NCT05901051|Amoxicillin|amoxicillin|mesh-list
102510585|NCT05901051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102510586|NCT05901051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102510587|NCT05901012|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
102510588|NCT05901012|Hallucinogens|hallucinogens|mesh-ancestor
102510589|NCT05901012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510590|NCT05901012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102510591|NCT05901012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102510592|NCT05901012|Serotonin Agents|serotonin agents|mesh-ancestor
102510593|NCT05901012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102510594|NCT05901012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322099|NCT02079805|Telmisartan|telmisartan|mesh-list
102510595|NCT05901012|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102510596|NCT05900921|Paclitaxel|paclitaxel|mesh-list
102510597|NCT05900921|Carboplatin|carboplatin|mesh-list
102510598|NCT05900921|Tislelizumab|tislelizumab|mesh-list
102510599|NCT05900921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102510600|NCT05900921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510601|NCT05900921|Tubulin Modulators|tubulin modulators|mesh-ancestor
102510602|NCT05900921|Antimitotic Agents|antimitotic agents|mesh-ancestor
102510603|NCT05900921|Mitosis Modulators|mitosis modulators|mesh-ancestor
102510604|NCT05900921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510605|NCT05900921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102510606|NCT05900895|Olaparib|olaparib|mesh-list
102510607|NCT05900895|Estradiol|estradiol|mesh-list
102510608|NCT05900895|Estrogens|estrogens|mesh-ancestor
102510609|NCT05900895|Hormones|hormones|mesh-ancestor
102510610|NCT05900895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102510611|NCT05900895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510612|NCT05900895|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102510613|NCT05900895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102510614|NCT05900895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510615|NCT05900895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510616|NCT05899699|Adapalene|adapalene|mesh-list
102510617|NCT05899699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102510618|NCT05899699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102510619|NCT05899699|Analgesics|analgesics|mesh-ancestor
102510620|NCT05899699|Sensory System Agents|sensory system agents|mesh-ancestor
102510621|NCT05899699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102510622|NCT05899699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510623|NCT05899699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102510624|NCT05899699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102510625|NCT05899699|Dermatologic Agents|dermatologic agents|mesh-ancestor
102510626|NCT05899608|Pembrolizumab|pembrolizumab|mesh-list
102510627|NCT05899608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102510628|NCT05899608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510629|NCT05899608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102510630|NCT05899608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510631|NCT05898854|FAPI-46|fapi-46|mesh-list
102510632|NCT05898854|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102510633|NCT05898854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510634|NCT05897151|Anesthetics|anesthetics|mesh-list
102510635|NCT05897151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102510636|NCT05897151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510637|NCT05897138|Lenvatinib|lenvatinib|mesh-list
102510638|NCT05897138|Tislelizumab|tislelizumab|mesh-list
102510639|NCT05897138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510640|NCT05897138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102510641|NCT05897138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102510642|NCT05897138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510643|NCT05897138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102510644|NCT05895162|Fluconazole|fluconazole|mesh-list
102510645|NCT05895162|Antifungal Agents|antifungal agents|mesh-ancestor
102510646|NCT05895162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102510647|NCT05895162|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102510648|NCT05895162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102510649|NCT05895162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102510650|NCT05895162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510651|NCT05895162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102510652|NCT05895162|Hormone Antagonists|hormone antagonists|mesh-ancestor
102510653|NCT05895162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102510654|NCT05895162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510655|NCT05895162|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102510656|NCT05895162|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102510657|NCT05894603|Ritonavir|ritonavir|mesh-list
102510658|NCT05894603|Nirmatrelvir|nirmatrelvir|mesh-list
102510659|NCT05894603|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
102510660|NCT05894603|Molnupiravir|molnupiravir|mesh-list
102510661|NCT05894603|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102510662|NCT05894603|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102510663|NCT05894603|Protease Inhibitors|protease inhibitors|mesh-ancestor
102510664|NCT05894603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102510665|NCT05894603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510666|NCT05894603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102510667|NCT05894603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102322177|NCT05887258|Anesthetics|anesthetics|mesh-list
102510668|NCT05894603|Antiviral Agents|antiviral agents|mesh-ancestor
102510669|NCT05894603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102510670|NCT05894603|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102510671|NCT05894603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102510672|NCT05886335|Cyclophosphamide|cyclophosphamide|mesh-list
102510673|NCT05886335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102510674|NCT05886335|Immunologic Factors|immunologic factors|mesh-ancestor
102510675|NCT05886335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510676|NCT05886335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102510677|NCT05886335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102510678|NCT05886335|Alkylating Agents|alkylating agents|mesh-ancestor
102510679|NCT05886335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510680|NCT05886335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510681|NCT05886335|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102510682|NCT05877326|Anesthetics|anesthetics|mesh-list
102510683|NCT05877326|Propofol|propofol|mesh-list
102510684|NCT05877326|Sevoflurane|sevoflurane|mesh-list
102510685|NCT05877326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102510686|NCT05877326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510687|NCT05877326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102510688|NCT05877326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102510689|NCT05877326|Anesthetics, General|anesthetics, general|mesh-ancestor
102510690|NCT05877326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102510691|NCT05877326|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102510692|NCT05837000|Magnesium Sulfate|magnesium sulfate|mesh-list
102510693|NCT05837000|Dexmedetomidine|dexmedetomidine|mesh-list
102510694|NCT05837000|Ketamine|ketamine|mesh-list
102510695|NCT05837000|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102510696|NCT05837000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102510697|NCT05837000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510698|NCT05837000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102510699|NCT05837000|Analgesics|analgesics|mesh-ancestor
102510700|NCT05837000|Sensory System Agents|sensory system agents|mesh-ancestor
102510701|NCT05837000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102510702|NCT05837000|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102510703|NCT05837000|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102510704|NCT05837000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102510705|NCT05837000|Adrenergic Agents|adrenergic agents|mesh-ancestor
102510706|NCT05837000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102510707|NCT05837000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510708|NCT05837000|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102510709|NCT05837000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102510710|NCT05837000|Anesthetics, General|anesthetics, general|mesh-ancestor
102510711|NCT05837000|Anesthetics|anesthetics|mesh-ancestor
102510712|NCT05837000|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102510713|NCT05837000|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102510714|NCT05837000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102510715|NCT05837000|Anticonvulsants|anticonvulsants|mesh-ancestor
102510716|NCT05837000|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102510717|NCT05837000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102510718|NCT05837000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102510719|NCT05837000|Tocolytic Agents|tocolytic agents|mesh-ancestor
102510720|NCT05837000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102510721|NCT05834036|Amoxicillin|amoxicillin|mesh-list
102510722|NCT05834036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102510723|NCT05834036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102510724|NCT05833139|Itraconazole|itraconazole|mesh-list
102510725|NCT05833139|Antifungal Agents|antifungal agents|mesh-ancestor
102510726|NCT05833139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102510727|NCT05833139|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102510728|NCT05833139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102510729|NCT05833139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102510730|NCT05833139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510731|NCT05833139|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102510732|NCT05833139|Hormone Antagonists|hormone antagonists|mesh-ancestor
102510733|NCT05833139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102510734|NCT05833139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510735|NCT05833139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102510736|NCT05821296|Methamphetamine|methamphetamine|mesh-list
102510737|NCT05821296|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102510738|NCT05821296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510739|NCT05821296|Sympathomimetics|sympathomimetics|mesh-ancestor
102510740|NCT05821296|Autonomic Agents|autonomic agents|mesh-ancestor
102510741|NCT05821296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102510742|NCT05821296|Dopamine Agents|dopamine agents|mesh-ancestor
102510743|NCT05821296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102510744|NCT05821296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510745|NCT05821296|Adrenergic Agents|adrenergic agents|mesh-ancestor
102510746|NCT05821296|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102510747|NCT05821296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102510748|NCT05821296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102510749|NCT05821296|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102510750|NCT05736861|Ivermectin|ivermectin|mesh-list
102510751|NCT05736861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102510752|NCT05736861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102510753|NCT05728372|Copper|copper|mesh-list
102510754|NCT05728372|Pembrolizumab|pembrolizumab|mesh-list
102510755|NCT05728372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102510756|NCT05728372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510757|NCT05728372|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102510758|NCT05728372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510759|NCT05728372|Trace Elements|trace elements|mesh-ancestor
102510760|NCT05728372|Micronutrients|micronutrients|mesh-ancestor
102510761|NCT05728372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510762|NCT05707273|Cyclophosphamide|cyclophosphamide|mesh-list
102510763|NCT05707273|Fludarabine|fludarabine|mesh-list
102510764|NCT05707273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102510765|NCT05707273|Immunologic Factors|immunologic factors|mesh-ancestor
102510766|NCT05707273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510767|NCT05707273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102510768|NCT05707273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102510769|NCT05707273|Alkylating Agents|alkylating agents|mesh-ancestor
102510770|NCT05707273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510771|NCT05707273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510772|NCT05707273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102510773|NCT05705856|Ustekinumab|ustekinumab|mesh-list
102510774|NCT05705856|Dermatologic Agents|dermatologic agents|mesh-ancestor
102510775|NCT05672173|Cyclophosphamide|cyclophosphamide|mesh-list
102510776|NCT05672173|Nivolumab|nivolumab|mesh-list
102510777|NCT05672173|Fludarabine|fludarabine|mesh-list
102510778|NCT05672173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102510779|NCT05672173|Immunologic Factors|immunologic factors|mesh-ancestor
102510780|NCT05672173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510781|NCT05672173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102510782|NCT05672173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102510783|NCT05672173|Alkylating Agents|alkylating agents|mesh-ancestor
102510784|NCT05672173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510785|NCT05672173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510786|NCT05672173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102510787|NCT05672173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102510788|NCT05672173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102510789|NCT05661643|Temozolomide|temozolomide|mesh-list
102510790|NCT05661643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102510791|NCT05661643|Alkylating Agents|alkylating agents|mesh-ancestor
102510792|NCT05661643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510793|NCT05661643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510794|NCT05659056|Paclitaxel|paclitaxel|mesh-list
102510795|NCT05659056|Trastuzumab|trastuzumab|mesh-list
102510796|NCT05659056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102510797|NCT05659056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510798|NCT05659056|Tubulin Modulators|tubulin modulators|mesh-ancestor
102510799|NCT05659056|Antimitotic Agents|antimitotic agents|mesh-ancestor
102510800|NCT05659056|Mitosis Modulators|mitosis modulators|mesh-ancestor
102510801|NCT05659056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510802|NCT05659056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102510803|NCT05654649|Dexamethasone|dexamethasone|mesh-list
102510804|NCT05654649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102510805|NCT05654649|Antiemetics|antiemetics|mesh-ancestor
102510806|NCT05654649|Autonomic Agents|autonomic agents|mesh-ancestor
102510807|NCT05654649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102510808|NCT05654649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510809|NCT05654649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102510810|NCT05654649|Glucocorticoids|glucocorticoids|mesh-ancestor
102510811|NCT05654649|Hormones|hormones|mesh-ancestor
102510812|NCT05654649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102510813|NCT05654649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102510814|NCT05654649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510816|NCT05649748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102510817|NCT05629234|Osimertinib|osimertinib|mesh-list
102510818|NCT05629234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510819|NCT05629234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102510820|NCT05629234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102510821|NCT05629234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510822|NCT05570825|Pembrolizumab|pembrolizumab|mesh-list
102510823|NCT05570825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102510824|NCT05570825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510825|NCT05570825|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102510826|NCT05570825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510827|NCT05567315|Anesthetics|anesthetics|mesh-list
102510828|NCT05567315|Anesthetics, Local|anesthetics, local|mesh-list
102510829|NCT05567315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102510830|NCT05567315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510831|NCT05567315|Sensory System Agents|sensory system agents|mesh-ancestor
102510832|NCT05567315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102510833|NCT05547386|Edetic Acid|edetic acid|mesh-list
102510834|NCT05547386|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102510835|NCT05547386|Chelating Agents|chelating agents|mesh-ancestor
102510836|NCT05547386|Sequestering Agents|sequestering agents|mesh-ancestor
102510837|NCT05547386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510838|NCT05547386|Anticoagulants|anticoagulants|mesh-ancestor
102510839|NCT05547386|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102510840|NCT05547386|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102510841|NCT05519111|Dronabinol|dronabinol|mesh-list
102510842|NCT05519111|Hallucinogens|hallucinogens|mesh-ancestor
102510843|NCT05519111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510844|NCT05519111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102510845|NCT05519111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102510846|NCT05519111|Analgesics|analgesics|mesh-ancestor
102510847|NCT05519111|Sensory System Agents|sensory system agents|mesh-ancestor
102510848|NCT05519111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102510849|NCT05519111|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102510850|NCT05519111|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102510851|NCT05519111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102510852|NCT05519111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510853|NCT05519111|Hormones|hormones|mesh-ancestor
102510854|NCT05519111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102510855|NCT05463133|Sirolimus|sirolimus|mesh-list
102510856|NCT05463133|Cyclophosphamide|cyclophosphamide|mesh-list
102510857|NCT05463133|Busulfan|busulfan|mesh-list
102510858|NCT05463133|Alemtuzumab|alemtuzumab|mesh-list
102510859|NCT05463133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102510860|NCT05463133|Immunologic Factors|immunologic factors|mesh-ancestor
102510861|NCT05463133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510862|NCT05463133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102510863|NCT05463133|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102510864|NCT05463133|Alkylating Agents|alkylating agents|mesh-ancestor
102510865|NCT05463133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510866|NCT05463133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510867|NCT05463133|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102510868|NCT05463133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102510869|NCT05463133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102510870|NCT05463133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102510871|NCT05463133|Antifungal Agents|antifungal agents|mesh-ancestor
102510872|NCT05463133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102510873|NCT05427474|Propranolol|propranolol|mesh-list
102510874|NCT05427474|Gabapentin|gabapentin|mesh-list
102510875|NCT05427474|Analgesics|analgesics|mesh-ancestor
102510876|NCT05427474|Sensory System Agents|sensory system agents|mesh-ancestor
102510877|NCT05427474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102510878|NCT05427474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510879|NCT05427474|Anticonvulsants|anticonvulsants|mesh-ancestor
102510880|NCT05427474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102510881|NCT05427474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102510882|NCT05427474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102510883|NCT05427474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102510884|NCT05427474|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102510885|NCT05427474|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102510886|NCT05427474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102510887|NCT05427474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510888|NCT05427474|Antimanic Agents|antimanic agents|mesh-ancestor
102510889|NCT05427474|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102510890|NCT05427474|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102510891|NCT05427474|Adrenergic Agents|adrenergic agents|mesh-ancestor
102510892|NCT05427474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102510893|NCT05427474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102510894|NCT05427474|Vasodilator Agents|vasodilator agents|mesh-ancestor
102510896|NCT05418647|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102510897|NCT05340673|Petrolatum|petrolatum|mesh-list
102510898|NCT05340673|Mineral Oil|mineral oil|mesh-list
102510899|NCT05340673|Emollients|emollients|mesh-ancestor
102510900|NCT05340673|Dermatologic Agents|dermatologic agents|mesh-ancestor
102510901|NCT05320406|Leuprolide|leuprolide|mesh-list
102510902|NCT05320406|Relugolix|relugolix|mesh-list
102510903|NCT05320406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102510904|NCT05320406|Fertility Agents|fertility agents|mesh-ancestor
102510905|NCT05320406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102510906|NCT05320406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510907|NCT05320406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102510908|NCT05320406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510909|NCT05320406|Androgen Antagonists|androgen antagonists|mesh-ancestor
102510910|NCT05320406|Hormone Antagonists|hormone antagonists|mesh-ancestor
102510911|NCT05320406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102510912|NCT05312151|Psilocybin|psilocybin|mesh-list
102510913|NCT05312151|Hallucinogens|hallucinogens|mesh-ancestor
102510914|NCT05312151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510915|NCT05312151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102510916|NCT05307198|Capecitabine|capecitabine|mesh-list
102510917|NCT05307198|Oxaliplatin|oxaliplatin|mesh-list
102510918|NCT05307198|Antibodies|antibodies|mesh-list
102510919|NCT05307198|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102510920|NCT05307198|Immunologic Factors|immunologic factors|mesh-ancestor
102510921|NCT05307198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510922|NCT05307198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102510923|NCT05307198|Antimetabolites|antimetabolites|mesh-ancestor
102510924|NCT05307198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510925|NCT05307198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510926|NCT05299073|Denosumab|denosumab|mesh-list
102510927|NCT05299073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102510928|NCT05299073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510929|NCT05243290|Niacinamide|niacinamide|mesh-list
102510930|NCT05243290|Niacin|niacin|mesh-list
102510931|NCT05243290|Nicotinic Acids|nicotinic acids|mesh-list
102510932|NCT05243290|Vitamin B Complex|vitamin b complex|mesh-ancestor
102510933|NCT05243290|Vitamins|vitamins|mesh-ancestor
102510934|NCT05243290|Micronutrients|micronutrients|mesh-ancestor
102510935|NCT05243290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510936|NCT05243290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102510937|NCT05243290|Antimetabolites|antimetabolites|mesh-ancestor
102510938|NCT05243290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510939|NCT05243290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102510940|NCT05243290|Vasodilator Agents|vasodilator agents|mesh-ancestor
102510941|NCT05221398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102510942|NCT05221398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510943|NCT05221398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102510944|NCT05221398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510945|NCT05213221|Lenvatinib|lenvatinib|mesh-list
102510946|NCT05213221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510947|NCT05213221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102510948|NCT05213221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102510949|NCT05213221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510950|NCT05213208|Propofol|propofol|mesh-list
102510951|NCT05213208|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102510952|NCT05213208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102510953|NCT05213208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510954|NCT05213208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102510955|NCT05213208|Anesthetics, General|anesthetics, general|mesh-ancestor
102510956|NCT05213208|Anesthetics|anesthetics|mesh-ancestor
102510957|NCT05212337|Denosumab|denosumab|mesh-list
102510958|NCT05212337|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102510959|NCT05212337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510960|NCT05123040|Prednisone|prednisone|mesh-list
102510961|NCT05123040|Methylprednisolone|methylprednisolone|mesh-list
102510962|NCT05123040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102510963|NCT05123040|Glucocorticoids|glucocorticoids|mesh-ancestor
102510964|NCT05123040|Hormones|hormones|mesh-ancestor
102510965|NCT05123040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102510966|NCT05123040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510967|NCT05123040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102510968|NCT05123040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102510969|NCT05123040|Antiemetics|antiemetics|mesh-ancestor
102510970|NCT05123040|Autonomic Agents|autonomic agents|mesh-ancestor
102510971|NCT05123040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102510972|NCT05123040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102510973|NCT05123040|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102510974|NCT05123040|Protective Agents|protective agents|mesh-ancestor
102510975|NCT05096702|Primaquine|primaquine|mesh-list
102510976|NCT05096702|Tafenoquine|tafenoquine|mesh-list
102510977|NCT05096702|Antimalarials|antimalarials|mesh-ancestor
102510978|NCT05096702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102510979|NCT05096702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102510980|NCT05096702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102510981|NCT05017454|Mometasone Furoate|mometasone furoate|mesh-list
102510982|NCT05017454|Valproic Acid|valproic acid|mesh-list
102510983|NCT05017454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102510984|NCT05017454|Dermatologic Agents|dermatologic agents|mesh-ancestor
102510985|NCT05017454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102510986|NCT05017454|Anticonvulsants|anticonvulsants|mesh-ancestor
102510987|NCT05017454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102510988|NCT05017454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102510989|NCT05017454|GABA Agents|gaba agents|mesh-ancestor
102510990|NCT05017454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102510991|NCT05017454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102510992|NCT05017454|Antimanic Agents|antimanic agents|mesh-ancestor
102510993|NCT05017454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102510994|NCT05017454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102510995|NCT05017454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102510996|NCT05013424|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102510997|NCT05013424|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102510998|NCT05013424|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102510999|NCT05013424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102511000|NCT05013424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511001|NCT05013424|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102511002|NCT05013424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102511003|NCT05013424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511004|NCT05013424|Cholinergic Agents|cholinergic agents|mesh-ancestor
102511005|NCT05013424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102511006|NCT04999215|Choline|choline|mesh-list
102511007|NCT04999215|Lipotropic Agents|lipotropic agents|mesh-ancestor
102511008|NCT04999215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102511009|NCT04999215|Antimetabolites|antimetabolites|mesh-ancestor
102511010|NCT04999215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511011|NCT04999215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102511012|NCT04999215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102511013|NCT04999215|Nootropic Agents|nootropic agents|mesh-ancestor
102511014|NCT04991025|Certolizumab Pegol|certolizumab pegol|mesh-list
102511015|NCT04991025|Carboplatin|carboplatin|mesh-list
102511016|NCT04991025|Gemcitabine|gemcitabine|mesh-list
102511017|NCT04991025|Nivolumab|nivolumab|mesh-list
102511018|NCT04991025|Pemetrexed|pemetrexed|mesh-list
102511019|NCT04991025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511020|NCT04991025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102511021|NCT04991025|Antimetabolites|antimetabolites|mesh-ancestor
102511022|NCT04991025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511023|NCT04991025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102511024|NCT04991025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102511025|NCT04991025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102511026|NCT04991025|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102511027|NCT04991025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102511028|NCT04991025|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102511029|NCT04991025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102511030|NCT04991025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102511031|NCT04991025|Immunologic Factors|immunologic factors|mesh-ancestor
102511032|NCT04991025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511033|NCT04991025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102511034|NCT04935658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
102511035|NCT04935658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102511036|NCT04935658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511037|NCT04930315|Apatinib|apatinib|mesh-list
102511038|NCT04930315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511039|NCT04930315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102511040|NCT04930315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102511041|NCT04930315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511042|NCT04887857|Azacitidine|azacitidine|mesh-list
102511043|NCT04887857|Venetoclax|venetoclax|mesh-list
102511044|NCT04887857|Cc-486|cc-486|mesh-list
102511045|NCT04887857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102511046|NCT04887857|Antimetabolites|antimetabolites|mesh-ancestor
102511047|NCT04887857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511048|NCT04887857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511049|NCT04887857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102511050|NCT04855266|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102511051|NCT04855266|Hematinics|hematinics|mesh-ancestor
102511052|NCT04832399|Natalizumab|natalizumab|mesh-list
102511053|NCT04832399|Immunologic Factors|immunologic factors|mesh-ancestor
102511054|NCT04832399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511055|NCT04772209|Heparin|heparin|mesh-list
102511056|NCT04772209|Anticoagulants|anticoagulants|mesh-ancestor
102511057|NCT04772209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102511058|NCT04772209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102511059|NCT04772209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511060|NCT04757662|Tadalafil|tadalafil|mesh-list
102511061|NCT04757662|Vasodilator Agents|vasodilator agents|mesh-ancestor
102511062|NCT04757662|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102511063|NCT04757662|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102511064|NCT04757662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102511065|NCT04757662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511066|NCT04757662|Urological Agents|urological agents|mesh-ancestor
102511067|NCT04756050|Epinephrine|epinephrine|mesh-list
102511068|NCT04756050|Racepinephrine|racepinephrine|mesh-list
102511069|NCT04756050|Bupivacaine|bupivacaine|mesh-list
102511070|NCT04756050|Prilocaine|prilocaine|mesh-list
102511071|NCT04756050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102511072|NCT04756050|Epinephryl borate|epinephryl borate|mesh-list
102511073|NCT04756050|Anesthetics, Local|anesthetics, local|mesh-ancestor
102511074|NCT04756050|Anesthetics|anesthetics|mesh-ancestor
102511075|NCT04756050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102511076|NCT04756050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511077|NCT04756050|Sensory System Agents|sensory system agents|mesh-ancestor
102511078|NCT04756050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102511079|NCT04756050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102511080|NCT04756050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102511081|NCT04756050|Adrenergic Agents|adrenergic agents|mesh-ancestor
102511082|NCT04756050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102511083|NCT04756050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511084|NCT04756050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102511085|NCT04756050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102511086|NCT04756050|Autonomic Agents|autonomic agents|mesh-ancestor
102511087|NCT04756050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102511088|NCT04756050|Respiratory System Agents|respiratory system agents|mesh-ancestor
102511089|NCT04756050|Mydriatics|mydriatics|mesh-ancestor
102511090|NCT04756050|Sympathomimetics|sympathomimetics|mesh-ancestor
101987316|NCT01209845|Ketamine|ketamine|mesh-list
102511091|NCT04756050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102511092|NCT04731103|Lamivudine|lamivudine|mesh-list
102511093|NCT04731103|Zidovudine|zidovudine|mesh-list
102511094|NCT04731103|Abacavir|abacavir|mesh-list
102511095|NCT04731103|Dideoxynucleosides|dideoxynucleosides|mesh-list
102511096|NCT04731103|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102511097|NCT04731103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102511098|NCT04731103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102511099|NCT04731103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511100|NCT04731103|Antiviral Agents|antiviral agents|mesh-ancestor
102511101|NCT04731103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102511102|NCT04731103|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102511103|NCT04731103|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102511104|NCT04731103|Antimetabolites|antimetabolites|mesh-ancestor
102511105|NCT04716712|Azithromycin|azithromycin|mesh-list
102511106|NCT04716712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102511107|NCT04716712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102511108|NCT04683640|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
102511109|NCT04683640|GABA Agents|gaba agents|mesh-ancestor
102511110|NCT04683640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102511111|NCT04683640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511112|NCT04683640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511113|NCT04680221|Bupivacaine|bupivacaine|mesh-list
102511114|NCT04680221|Anesthetics, Local|anesthetics, local|mesh-ancestor
102511115|NCT04680221|Anesthetics|anesthetics|mesh-ancestor
102511116|NCT04680221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102511117|NCT04680221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511118|NCT04680221|Sensory System Agents|sensory system agents|mesh-ancestor
102511119|NCT04680221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102511120|NCT04668144|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102511121|NCT04668144|Cangrelor|cangrelor|mesh-list
102511122|NCT04668144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102511123|NCT04668144|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102511124|NCT04668144|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102511125|NCT04668144|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102511126|NCT04668144|Purinergic Agents|purinergic agents|mesh-ancestor
102511127|NCT04668144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102511128|NCT04668144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511129|NCT04668144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511130|NCT04667078|Cangrelor|cangrelor|mesh-list
102511131|NCT04667078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102511132|NCT04667078|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102511133|NCT04667078|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102511134|NCT04667078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102511135|NCT04667078|Purinergic Agents|purinergic agents|mesh-ancestor
102511136|NCT04667078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102511137|NCT04667078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511138|NCT04667078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511139|NCT04644796|Bupivacaine|bupivacaine|mesh-list
102511140|NCT04644796|Anesthetics, Local|anesthetics, local|mesh-ancestor
102511141|NCT04644796|Anesthetics|anesthetics|mesh-ancestor
102511142|NCT04644796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102511143|NCT04644796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511144|NCT04644796|Sensory System Agents|sensory system agents|mesh-ancestor
102511145|NCT04644796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102511146|NCT04639414|Empagliflozin|empagliflozin|mesh-list
102511147|NCT04639414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102511148|NCT04639414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511149|NCT04639414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102511150|NCT04639414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511151|NCT04621929|Topiramate|topiramate|mesh-list
102511152|NCT04621929|Phentermine|phentermine|mesh-list
102511153|NCT04621929|Allopurinol|allopurinol|mesh-list
102511154|NCT04621929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511155|NCT04621929|Anticonvulsants|anticonvulsants|mesh-ancestor
102511156|NCT04621929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102511157|NCT04621929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511158|NCT04621929|Antimetabolites|antimetabolites|mesh-ancestor
102511159|NCT04621929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102511160|NCT04621929|Gout Suppressants|gout suppressants|mesh-ancestor
102511161|NCT04621929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102511162|NCT04621929|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102511163|NCT04621929|Antioxidants|antioxidants|mesh-ancestor
102511164|NCT04621929|Protective Agents|protective agents|mesh-ancestor
102511165|NCT04621929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102511166|NCT04621929|Appetite Depressants|appetite depressants|mesh-ancestor
102511167|NCT04621929|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102511168|NCT04621929|Sympathomimetics|sympathomimetics|mesh-ancestor
102511169|NCT04621929|Autonomic Agents|autonomic agents|mesh-ancestor
102511170|NCT04621929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102511171|NCT04621929|Adrenergic Agents|adrenergic agents|mesh-ancestor
102511172|NCT04621929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102511173|NCT04593927|Siponimod|siponimod|mesh-list
102511174|NCT04593927|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102511175|NCT04593927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511176|NCT04593927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102511177|NCT04593927|Immunologic Factors|immunologic factors|mesh-ancestor
102511178|NCT04593927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511179|NCT04572763|Venetoclax|venetoclax|mesh-list
102511180|NCT04572763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511181|NCT04568161|Cyclophosphamide|cyclophosphamide|mesh-list
102511182|NCT04568161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102511183|NCT04568161|Immunologic Factors|immunologic factors|mesh-ancestor
102511184|NCT04568161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511185|NCT04568161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102511186|NCT04568161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102511187|NCT04568161|Alkylating Agents|alkylating agents|mesh-ancestor
102511188|NCT04568161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511189|NCT04568161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511190|NCT04568161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102511191|NCT04556370|Norepinephrine|norepinephrine|mesh-list
102322699|NCT05345717|Abatacept|abatacept|mesh-list
102511192|NCT04556370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102511193|NCT04556370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102511194|NCT04556370|Adrenergic Agents|adrenergic agents|mesh-ancestor
102511195|NCT04556370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102511196|NCT04556370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511197|NCT04556370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511198|NCT04556370|Sympathomimetics|sympathomimetics|mesh-ancestor
102511199|NCT04556370|Autonomic Agents|autonomic agents|mesh-ancestor
102511200|NCT04556370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102511201|NCT04556370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102511202|NCT04535882|polysaccharide-K|polysaccharide-k|mesh-list
102511203|NCT04535882|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102511204|NCT04535882|Immunologic Factors|immunologic factors|mesh-ancestor
102511205|NCT04535882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511206|NCT04535882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102511207|NCT04535882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511208|NCT04535882|Antiviral Agents|antiviral agents|mesh-ancestor
102511209|NCT04535882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102511210|NCT04535882|Interferon Inducers|interferon inducers|mesh-ancestor
102511211|NCT04535882|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102511212|NCT04535882|Protective Agents|protective agents|mesh-ancestor
102511213|NCT04535687|Fluzoparib|fluzoparib|mesh-list
102511214|NCT04535687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102511215|NCT04535687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102511216|NCT04535687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511217|NCT04535687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511218|NCT04527887|Dexamethasone|dexamethasone|mesh-list
102511219|NCT04527887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102511220|NCT04527887|Antiemetics|antiemetics|mesh-ancestor
102511221|NCT04527887|Autonomic Agents|autonomic agents|mesh-ancestor
102511222|NCT04527887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102511223|NCT04527887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511224|NCT04527887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102511225|NCT04527887|Glucocorticoids|glucocorticoids|mesh-ancestor
102511226|NCT04527887|Hormones|hormones|mesh-ancestor
102511227|NCT04527887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102511228|NCT04527887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102511229|NCT04527887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511230|NCT04474847|Abatacept|abatacept|mesh-list
102511231|NCT04474847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102511232|NCT04474847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511233|NCT04474847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102511234|NCT04474847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511235|NCT04474847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102511236|NCT04474847|Immunologic Factors|immunologic factors|mesh-ancestor
102511237|NCT04474847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511238|NCT04474847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102511239|NCT04436926|Analgesics, Opioid|analgesics, opioid|mesh-list
102511240|NCT04436926|Narcotics|narcotics|mesh-ancestor
102511241|NCT04436926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102511242|NCT04436926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511243|NCT04436926|Analgesics|analgesics|mesh-ancestor
102511244|NCT04436926|Sensory System Agents|sensory system agents|mesh-ancestor
102511245|NCT04436926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102511246|NCT04423055|Contraceptive Agents|contraceptive agents|mesh-list
102511247|NCT04423055|Etonogestrel|etonogestrel|mesh-list
102511248|NCT04423055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102511249|NCT04423055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511250|NCT04423055|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102511251|NCT04423055|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102511252|NCT04418401|Antibodies|antibodies|mesh-list
102511253|NCT04418401|Immunologic Factors|immunologic factors|mesh-ancestor
102511254|NCT04418401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511255|NCT04407754|Inositol|inositol|mesh-list
102511256|NCT04407754|Vitamin B Complex|vitamin b complex|mesh-ancestor
102511257|NCT04407754|Vitamins|vitamins|mesh-ancestor
102511258|NCT04407754|Micronutrients|micronutrients|mesh-ancestor
102511259|NCT04407754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511260|NCT04385602|Dexmedetomidine|dexmedetomidine|mesh-list
102511261|NCT04385602|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102511262|NCT04385602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102511263|NCT04385602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511264|NCT04385602|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102511265|NCT04385602|Analgesics|analgesics|mesh-ancestor
102511266|NCT04385602|Sensory System Agents|sensory system agents|mesh-ancestor
102511267|NCT04385602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102511268|NCT04385602|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102511269|NCT04385602|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102511270|NCT04385602|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102511271|NCT04385602|Adrenergic Agents|adrenergic agents|mesh-ancestor
102511272|NCT04385602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102511273|NCT04385602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511274|NCT04379713|Vaccines|vaccines|mesh-list
102511275|NCT04379713|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102511276|NCT04379713|Immunologic Factors|immunologic factors|mesh-ancestor
102511277|NCT04379713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511278|NCT04323280|Dexamethasone|dexamethasone|mesh-list
102511279|NCT04323280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102511280|NCT04323280|Antiemetics|antiemetics|mesh-ancestor
102511281|NCT04323280|Autonomic Agents|autonomic agents|mesh-ancestor
102511282|NCT04323280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102511283|NCT04323280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511284|NCT04323280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102511285|NCT04323280|Glucocorticoids|glucocorticoids|mesh-ancestor
102511286|NCT04323280|Hormones|hormones|mesh-ancestor
102511287|NCT04323280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102511288|NCT04323280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102511289|NCT04323280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511290|NCT04218773|Phenylephrine|phenylephrine|mesh-list
102511291|NCT04218773|Oxymetazoline|oxymetazoline|mesh-list
102511292|NCT04218773|Norepinephrine|norepinephrine|mesh-list
102511293|NCT04218773|Synephrine|synephrine|mesh-list
102511294|NCT04218773|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102511295|NCT04218773|Mydriatics|mydriatics|mesh-ancestor
102511296|NCT04218773|Autonomic Agents|autonomic agents|mesh-ancestor
102511297|NCT04218773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102511298|NCT04218773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511299|NCT04218773|Sympathomimetics|sympathomimetics|mesh-ancestor
102511300|NCT04218773|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102511301|NCT04218773|Nasal Decongestants|nasal decongestants|mesh-ancestor
102511302|NCT04218773|Respiratory System Agents|respiratory system agents|mesh-ancestor
102511303|NCT04218773|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102511304|NCT04218773|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102511305|NCT04218773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102511306|NCT04218773|Adrenergic Agents|adrenergic agents|mesh-ancestor
102511307|NCT04218773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102511308|NCT04218773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511309|NCT04218773|Protective Agents|protective agents|mesh-ancestor
102511310|NCT04217447|Aspirin|aspirin|mesh-list
102511311|NCT04217447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102511312|NCT04217447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102511313|NCT04217447|Analgesics|analgesics|mesh-ancestor
102511314|NCT04217447|Sensory System Agents|sensory system agents|mesh-ancestor
102511315|NCT04217447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102511316|NCT04217447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511317|NCT04217447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102511318|NCT04217447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102511319|NCT04217447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102511320|NCT04217447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102511321|NCT04217447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511322|NCT04217447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102511323|NCT04217447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102511324|NCT04217447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102511325|NCT04217447|Antipyretics|antipyretics|mesh-ancestor
102511326|NCT04126031|Ceftazidime|ceftazidime|mesh-list
102511327|NCT04126031|Avibactam|avibactam|mesh-list
102511328|NCT04126031|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
102511329|NCT04126031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102511330|NCT04126031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102511331|NCT04126031|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102511332|NCT04126031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102511333|NCT04126031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511334|NCT04100824|Nimodipine|nimodipine|mesh-list
102511335|NCT04100824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102511336|NCT04100824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102511337|NCT04100824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102511338|NCT04100824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511339|NCT04100824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102511340|NCT04100824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322846|NCT04907253|Quercetin|quercetin|mesh-list
102511341|NCT04100824|Vasodilator Agents|vasodilator agents|mesh-ancestor
102511342|NCT04088851|Metformin|metformin|mesh-list
102511343|NCT04088851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102511344|NCT04088851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511345|NCT04074265|Ketorolac|ketorolac|mesh-list
102511346|NCT04074265|Epinephrine|epinephrine|mesh-list
102511347|NCT04074265|Ropivacaine|ropivacaine|mesh-list
102511348|NCT04074265|Anesthetics, Local|anesthetics, local|mesh-ancestor
102511349|NCT04074265|Anesthetics|anesthetics|mesh-ancestor
102511350|NCT04074265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102511351|NCT04074265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511352|NCT04074265|Sensory System Agents|sensory system agents|mesh-ancestor
102511353|NCT04074265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102511354|NCT04074265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102511355|NCT04074265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102511356|NCT04074265|Adrenergic Agents|adrenergic agents|mesh-ancestor
102511357|NCT04074265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102511358|NCT04074265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511359|NCT04074265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102511360|NCT04074265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102511361|NCT04074265|Autonomic Agents|autonomic agents|mesh-ancestor
102511362|NCT04074265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102511363|NCT04074265|Respiratory System Agents|respiratory system agents|mesh-ancestor
102511364|NCT04074265|Mydriatics|mydriatics|mesh-ancestor
102511365|NCT04074265|Sympathomimetics|sympathomimetics|mesh-ancestor
102511366|NCT04074265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102511367|NCT04074265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102511368|NCT04074265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102511369|NCT04074265|Analgesics|analgesics|mesh-ancestor
102511370|NCT04074265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102511371|NCT04074265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102511372|NCT04074265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102511373|NCT04074265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102511374|NCT04058067|Aflibercept|aflibercept|mesh-list
102511375|NCT04058067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102511376|NCT04058067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102511377|NCT04058067|Growth Substances|growth substances|mesh-ancestor
102511378|NCT04058067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511379|NCT04058067|Growth Inhibitors|growth inhibitors|mesh-ancestor
102511380|NCT04058067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511381|NCT03998735|Lobeline|lobeline|mesh-list
102511382|NCT03998735|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102511383|NCT03998735|Autonomic Agents|autonomic agents|mesh-ancestor
102511384|NCT03998735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102511385|NCT03998735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511386|NCT03998735|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102511387|NCT03998735|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102511388|NCT03998735|Cholinergic Agents|cholinergic agents|mesh-ancestor
102511389|NCT03998735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102511390|NCT03998735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511391|NCT03998735|Respiratory System Agents|respiratory system agents|mesh-ancestor
102511393|NCT03993327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102511394|NCT03993327|Antibodies|antibodies|mesh-list
102511395|NCT03993327|Immunoglobulins|immunoglobulins|mesh-list
102511396|NCT03993327|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102511397|NCT03993327|Immunologic Factors|immunologic factors|mesh-ancestor
102511398|NCT03993327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511399|NCT03993327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511400|NCT03993327|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102511401|NCT03993327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102511402|NCT03993327|Trace Elements|trace elements|mesh-ancestor
102511403|NCT03993327|Micronutrients|micronutrients|mesh-ancestor
102511404|NCT03983057|Antibodies|antibodies|mesh-list
102511405|NCT03983057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102511406|NCT03983057|Immunologic Factors|immunologic factors|mesh-ancestor
102511407|NCT03983057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511408|NCT03933215|Cladribine|cladribine|mesh-list
102511409|NCT03933215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511410|NCT03933215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102511411|NCT03933215|Immunologic Factors|immunologic factors|mesh-ancestor
102511412|NCT03933215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511413|NCT03802799|Cannabidiol|cannabidiol|mesh-list
102322919|NCT04746235|Antimetabolites|antimetabolites|mesh-ancestor
102511414|NCT03802799|Anticonvulsants|anticonvulsants|mesh-ancestor
102511415|NCT03789110|Nivolumab|nivolumab|mesh-list
102511416|NCT03789110|Ipilimumab|ipilimumab|mesh-list
102511417|NCT03789110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102511418|NCT03789110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511419|NCT03789110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102511420|NCT03789110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511422|NCT03759028|Ibuprofen|ibuprofen|mesh-list
102511423|NCT03759028|Oxycodone|oxycodone|mesh-list
102511424|NCT03759028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102511425|NCT03759028|Analgesics|analgesics|mesh-ancestor
102511426|NCT03759028|Sensory System Agents|sensory system agents|mesh-ancestor
102511427|NCT03759028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102511428|NCT03759028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511429|NCT03759028|Antipyretics|antipyretics|mesh-ancestor
102511430|NCT03759028|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102511431|NCT03759028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102511432|NCT03759028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102511433|NCT03759028|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102511434|NCT03759028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102511435|NCT03759028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511436|NCT03759028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102511437|NCT03759028|Narcotics|narcotics|mesh-ancestor
102511438|NCT03759028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102511439|NCT03716921|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102511440|NCT03716921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102511441|NCT03716921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102511442|NCT03716921|Antitubercular Agents|antitubercular agents|mesh-ancestor
102511443|NCT03693560|Metformin|metformin|mesh-list
102511444|NCT03693560|Glimepiride|glimepiride|mesh-list
102511445|NCT03693560|Vildagliptin|vildagliptin|mesh-list
102511446|NCT03693560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102511447|NCT03693560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511448|NCT03693560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102511449|NCT03693560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102511450|NCT03693560|Immunologic Factors|immunologic factors|mesh-ancestor
102511451|NCT03693560|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102511452|NCT03693560|Protease Inhibitors|protease inhibitors|mesh-ancestor
102511453|NCT03693560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102511454|NCT03693560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511455|NCT03675893|Metformin|metformin|mesh-list
102511456|NCT03675893|Letrozole|letrozole|mesh-list
102511457|NCT03675893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102511458|NCT03675893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511459|NCT03675893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511460|NCT03675893|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102511461|NCT03675893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102511462|NCT03675893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102511463|NCT03675893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511464|NCT03675893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102511465|NCT03675893|Hormone Antagonists|hormone antagonists|mesh-ancestor
102511466|NCT03675893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102511467|NCT03624062|Insulin|insulin|mesh-list
102511468|NCT03624062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102511469|NCT03624062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511470|NCT03574090|Amoxicillin|amoxicillin|mesh-list
102511471|NCT03574090|Clavulanic Acid|clavulanic acid|mesh-list
102511472|NCT03574090|Clavulanic Acids|clavulanic acids|mesh-list
102511473|NCT03574090|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102511474|NCT03574090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102511475|NCT03574090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102511476|NCT03574090|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102511477|NCT03574090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102511478|NCT03574090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511479|NCT03522246|Nivolumab|nivolumab|mesh-list
102511480|NCT03522246|Rucaparib|rucaparib|mesh-list
102511481|NCT03522246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102511482|NCT03522246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511483|NCT03522246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102511484|NCT03522246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511485|NCT03522246|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102511486|NCT03522246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102511487|NCT03498716|Paclitaxel|paclitaxel|mesh-list
102511488|NCT03498716|Cyclophosphamide|cyclophosphamide|mesh-list
102511489|NCT03498716|Doxorubicin|doxorubicin|mesh-list
102511490|NCT03498716|Atezolizumab|atezolizumab|mesh-list
102511491|NCT03498716|Epirubicin|epirubicin|mesh-list
102511492|NCT03498716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102511493|NCT03498716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511494|NCT03498716|Tubulin Modulators|tubulin modulators|mesh-ancestor
102511495|NCT03498716|Antimitotic Agents|antimitotic agents|mesh-ancestor
102511496|NCT03498716|Mitosis Modulators|mitosis modulators|mesh-ancestor
102511497|NCT03498716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511498|NCT03498716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102511499|NCT03498716|Immunologic Factors|immunologic factors|mesh-ancestor
102511500|NCT03498716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511501|NCT03498716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102511502|NCT03498716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102511503|NCT03498716|Alkylating Agents|alkylating agents|mesh-ancestor
102511504|NCT03498716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102511505|NCT03498716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102511506|NCT03498716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102511507|NCT03498716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102511508|NCT03498716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102511509|NCT03498716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102511510|NCT03498716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102511511|NCT03429543|Empagliflozin|empagliflozin|mesh-list
102511512|NCT03429543|Linagliptin|linagliptin|mesh-list
102511513|NCT03429543|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102511514|NCT03429543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511515|NCT03429543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102511516|NCT03429543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511517|NCT03429543|Incretins|incretins|mesh-ancestor
102511518|NCT03429543|Hormones|hormones|mesh-ancestor
102511519|NCT03429543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102511520|NCT03429543|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102511521|NCT03429543|Protease Inhibitors|protease inhibitors|mesh-ancestor
102511522|NCT03429543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102511523|NCT03417544|Trastuzumab|trastuzumab|mesh-list
102511524|NCT03417544|Atezolizumab|atezolizumab|mesh-list
102511525|NCT03417544|Pertuzumab|pertuzumab|mesh-list
102511526|NCT03417544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102511527|NCT03417544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511528|NCT03417544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102511529|NCT03417544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511530|NCT03363464|Empagliflozin|empagliflozin|mesh-list
102511531|NCT03363464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
102511532|NCT03363464|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102511533|NCT03363464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511534|NCT03363464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102511535|NCT03363464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511536|NCT03363464|Protease Inhibitors|protease inhibitors|mesh-ancestor
102511537|NCT03363464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102511538|NCT03233204|Olaparib|olaparib|mesh-list
102511539|NCT03233204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102511540|NCT03233204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102511541|NCT03233204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511542|NCT03233204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511543|NCT03179930|Pembrolizumab|pembrolizumab|mesh-list
102511544|NCT03179930|Entinostat|entinostat|mesh-list
102511545|NCT03179930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102511546|NCT03179930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511547|NCT03179930|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102511548|NCT03179930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511549|NCT03179930|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102511550|NCT03179930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102511551|NCT03113851|Molgramostim|molgramostim|mesh-list
102511552|NCT03113851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511553|NCT03043313|Trastuzumab|trastuzumab|mesh-list
102511554|NCT03043313|Tucatinib|tucatinib|mesh-list
102511555|NCT03043313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102511556|NCT03043313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511557|NCT03043313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102511558|NCT03043313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102511559|NCT03043313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511560|NCT02972840|Rituximab|rituximab|mesh-list
102511561|NCT02972840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102511562|NCT02972840|Acalabrutinib|acalabrutinib|mesh-list
102511563|NCT02972840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102511564|NCT02972840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511565|NCT02972840|Immunologic Factors|immunologic factors|mesh-ancestor
102511566|NCT02972840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511567|NCT02972840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102511568|NCT02972840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102511569|NCT02972840|Alkylating Agents|alkylating agents|mesh-ancestor
102511570|NCT02972840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511571|NCT02903381|Dexamethasone|dexamethasone|mesh-list
102511572|NCT02903381|Nivolumab|nivolumab|mesh-list
102511573|NCT02903381|Lenalidomide|lenalidomide|mesh-list
102511574|NCT02903381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102511575|NCT02903381|Antiemetics|antiemetics|mesh-ancestor
102511576|NCT02903381|Autonomic Agents|autonomic agents|mesh-ancestor
102511577|NCT02903381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101987793|NCT01110785|Antimetabolites|antimetabolites|mesh-ancestor
102511578|NCT02903381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511579|NCT02903381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102511580|NCT02903381|Glucocorticoids|glucocorticoids|mesh-ancestor
102511581|NCT02903381|Hormones|hormones|mesh-ancestor
102511582|NCT02903381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102511583|NCT02903381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102511584|NCT02903381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511585|NCT02903381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102511586|NCT02903381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102511587|NCT02903381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511588|NCT02903381|Immunologic Factors|immunologic factors|mesh-ancestor
102511589|NCT02903381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102511590|NCT02903381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102511591|NCT02903381|Growth Substances|growth substances|mesh-ancestor
102511592|NCT02903381|Growth Inhibitors|growth inhibitors|mesh-ancestor
102511593|NCT02744391|Levodopa|levodopa|mesh-list
102511594|NCT02744391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102511595|NCT02744391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102511596|NCT02744391|Dopamine Agents|dopamine agents|mesh-ancestor
102511597|NCT02744391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102511598|NCT02744391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511599|NCT02744391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511600|NCT02462837|Mirabegron|mirabegron|mesh-list
102511601|NCT02462837|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102511602|NCT02462837|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102511603|NCT02462837|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102511604|NCT02462837|Adrenergic Agents|adrenergic agents|mesh-ancestor
102511605|NCT02462837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102511606|NCT02462837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511607|NCT02462837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511608|NCT02462837|Urological Agents|urological agents|mesh-ancestor
102511609|NCT02346201|Methylphenidate|methylphenidate|mesh-list
102511610|NCT02346201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102511611|NCT02346201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511612|NCT02346201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102511613|NCT02346201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102511614|NCT02346201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102511615|NCT02346201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511616|NCT02346201|Dopamine Agents|dopamine agents|mesh-ancestor
102511617|NCT02346201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102511618|NCT02331134|Lenograstim|lenograstim|mesh-list
102511619|NCT02331134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102511620|NCT02331134|Immunologic Factors|immunologic factors|mesh-ancestor
102511621|NCT02331134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511622|NCT02078427|BAX 855|bax 855|mesh-list
102511623|NCT02078427|Coagulants|coagulants|mesh-ancestor
102511624|NCT02042378|Rucaparib|rucaparib|mesh-list
102511625|NCT02042378|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102511626|NCT02042378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102511627|NCT02042378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511628|NCT02042378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511629|NCT02019706|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
102511630|NCT02019706|Dopamine Agents|dopamine agents|mesh-ancestor
102511631|NCT02019706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102511632|NCT02019706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511633|NCT02019706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511634|NCT01866930|Interferons|interferons|mesh-list
102511635|NCT01866930|Ribavirin|ribavirin|mesh-list
102511636|NCT01866930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511637|NCT01866930|Antiviral Agents|antiviral agents|mesh-ancestor
102511638|NCT01866930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102511639|NCT01866930|Antimetabolites|antimetabolites|mesh-ancestor
102511640|NCT01866930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511641|NCT01682187|Lomustine|lomustine|mesh-list
102511642|NCT01682187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102511643|NCT01682187|Alkylating Agents|alkylating agents|mesh-ancestor
102511644|NCT01682187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511645|NCT01682187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511646|NCT01621568|Sunitinib|sunitinib|mesh-list
102511647|NCT01621568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511648|NCT01621568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102511649|NCT01621568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102511650|NCT01621568|Growth Substances|growth substances|mesh-ancestor
102511651|NCT01621568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511652|NCT01621568|Growth Inhibitors|growth inhibitors|mesh-ancestor
102511653|NCT01621568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102511654|NCT01621568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102511655|NCT01621568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511656|NCT01366612|Vidarabine|vidarabine|mesh-list
102511657|NCT01366612|Fludarabine|fludarabine|mesh-list
102511658|NCT01366612|Fludarabine phosphate|fludarabine phosphate|mesh-list
102511659|NCT01366612|Busulfan|busulfan|mesh-list
102511660|NCT01366612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511661|NCT01366612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102511662|NCT01366612|Antimetabolites|antimetabolites|mesh-ancestor
102511663|NCT01366612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511664|NCT01366612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102511665|NCT01366612|Immunologic Factors|immunologic factors|mesh-ancestor
102511666|NCT01366612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511667|NCT01366612|Antiviral Agents|antiviral agents|mesh-ancestor
102511668|NCT01366612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102511669|NCT01366612|Alkylating Agents|alkylating agents|mesh-ancestor
102511670|NCT01366612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102511671|NCT01366612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102511672|NCT00813293|Sorafenib|sorafenib|mesh-list
102511673|NCT00813293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511674|NCT00813293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102511675|NCT00813293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102511676|NCT00813293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511677|NCT00777036|Dasatinib|dasatinib|mesh-list
102511678|NCT00777036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511679|NCT00777036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102511680|NCT00777036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102511681|NCT00777036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511682|NCT00481091|Navitoclax|navitoclax|mesh-list
102511683|NCT00481091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511684|NCT00003641|Interferons|interferons|mesh-list
102511685|NCT00003641|Interferon-alpha|interferon-alpha|mesh-list
102511686|NCT00003641|Interferon alpha-2|interferon alpha-2|mesh-list
102511687|NCT00003641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511688|NCT00003641|Antiviral Agents|antiviral agents|mesh-ancestor
102511689|NCT00003641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102511690|NCT00003641|Immunologic Factors|immunologic factors|mesh-ancestor
102511691|NCT00003641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511692|NCT00392834|Leucovorin|leucovorin|mesh-list
102511693|NCT00392834|Cytarabine|cytarabine|mesh-list
102511694|NCT00392834|Hydrocortisone|hydrocortisone|mesh-list
102511695|NCT00392834|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102511696|NCT00392834|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102511697|NCT00392834|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102511698|NCT00392834|Cyclophosphamide|cyclophosphamide|mesh-list
102511699|NCT00392834|Ifosfamide|ifosfamide|mesh-list
102511700|NCT00392834|Rituximab|rituximab|mesh-list
102511701|NCT00392834|Doxorubicin|doxorubicin|mesh-list
102511702|NCT00392834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102511703|NCT00392834|Methotrexate|methotrexate|mesh-list
102511704|NCT00392834|Etoposide|etoposide|mesh-list
102511705|NCT00392834|Vincristine|vincristine|mesh-list
102511706|NCT00392834|Levoleucovorin|levoleucovorin|mesh-list
102511707|NCT00392834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102511708|NCT00392834|Immunologic Factors|immunologic factors|mesh-ancestor
102511709|NCT00392834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511710|NCT00392834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102511711|NCT00392834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102511712|NCT00392834|Alkylating Agents|alkylating agents|mesh-ancestor
102511713|NCT00392834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511714|NCT00392834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511715|NCT00392834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102511716|NCT00392834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102511717|NCT00392834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102511718|NCT00392834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102511719|NCT00392834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102511720|NCT00392834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102511721|NCT00392834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102511722|NCT00392834|Abortifacient Agents|abortifacient agents|mesh-ancestor
102511723|NCT00392834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102511724|NCT00392834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102511725|NCT00392834|Antimetabolites|antimetabolites|mesh-ancestor
102511726|NCT00392834|Dermatologic Agents|dermatologic agents|mesh-ancestor
102511727|NCT00392834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102511728|NCT00392834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102511729|NCT00392834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102511730|NCT00392834|Antiviral Agents|antiviral agents|mesh-ancestor
102511731|NCT00392834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102511732|NCT00392834|Antidotes|antidotes|mesh-ancestor
102511733|NCT00392834|Protective Agents|protective agents|mesh-ancestor
102511734|NCT00392834|Vitamin B Complex|vitamin b complex|mesh-ancestor
102511735|NCT00392834|Vitamins|vitamins|mesh-ancestor
102511736|NCT00392834|Micronutrients|micronutrients|mesh-ancestor
102511737|NCT00392834|Tubulin Modulators|tubulin modulators|mesh-ancestor
102511738|NCT00392834|Antimitotic Agents|antimitotic agents|mesh-ancestor
102511739|NCT00392834|Mitosis Modulators|mitosis modulators|mesh-ancestor
102511740|NCT00392834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102511741|NCT00393380|Teriparatide|teriparatide|mesh-list
102511742|NCT00393380|Hormones|hormones|mesh-list
102511743|NCT00393380|Parathyroid Hormone|parathyroid hormone|mesh-list
102511744|NCT00393380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102511745|NCT00393380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511746|NCT00393380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102511747|NCT00393380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102511748|NCT05361642|Lidocaine|lidocaine|mesh-list
102511749|NCT05361642|Dexmedetomidine|dexmedetomidine|mesh-list
102511750|NCT05361642|Bupivacaine|bupivacaine|mesh-list
102511751|NCT05361642|Anesthetics, Local|anesthetics, local|mesh-ancestor
102511752|NCT05361642|Anesthetics|anesthetics|mesh-ancestor
102511753|NCT05361642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102511754|NCT05361642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511755|NCT05361642|Sensory System Agents|sensory system agents|mesh-ancestor
102511756|NCT05361642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102511757|NCT05361642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102511758|NCT05361642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102511759|NCT05361642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102511760|NCT05361642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102511761|NCT05361642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511762|NCT05361642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102511763|NCT05361642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102511764|NCT05361642|Analgesics|analgesics|mesh-ancestor
102511765|NCT05361642|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102511766|NCT05361642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102511767|NCT05361642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102511768|NCT05361642|Adrenergic Agents|adrenergic agents|mesh-ancestor
102511769|NCT05361642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102511770|NCT00395876|Tenecteplase|tenecteplase|mesh-list
102511771|NCT00395876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102511772|NCT00395876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102511773|NCT00395876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511774|NCT02662634|Paclitaxel|paclitaxel|mesh-list
102511775|NCT02662634|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102511776|NCT02662634|Cisplatin|cisplatin|mesh-list
102511777|NCT02662634|Carboplatin|carboplatin|mesh-list
102511778|NCT02662634|Pemetrexed|pemetrexed|mesh-list
102511779|NCT02662634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102511780|NCT02662634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511781|NCT02662634|Tubulin Modulators|tubulin modulators|mesh-ancestor
102511782|NCT02662634|Antimitotic Agents|antimitotic agents|mesh-ancestor
102511783|NCT02662634|Mitosis Modulators|mitosis modulators|mesh-ancestor
102511784|NCT02662634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511785|NCT02662634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102511786|NCT02662634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102511787|NCT02662634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102511788|NCT00396032|Tenecteplase|tenecteplase|mesh-list
102511789|NCT00396032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102511790|NCT00396032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102511791|NCT00396032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511792|NCT02277782|Fentanyl|fentanyl|mesh-list
102511793|NCT02277782|Hydromorphone|hydromorphone|mesh-list
102511794|NCT02277782|Bupivacaine|bupivacaine|mesh-list
102511795|NCT02277782|Anesthetics, Local|anesthetics, local|mesh-ancestor
102511796|NCT02277782|Anesthetics|anesthetics|mesh-ancestor
102511797|NCT02277782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102511798|NCT02277782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511799|NCT02277782|Sensory System Agents|sensory system agents|mesh-ancestor
102511800|NCT02277782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102511801|NCT02277782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102511802|NCT02277782|Narcotics|narcotics|mesh-ancestor
102511803|NCT02277782|Analgesics|analgesics|mesh-ancestor
102511804|NCT02277782|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102511805|NCT02277782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102511806|NCT02277782|Anesthetics, General|anesthetics, general|mesh-ancestor
102511807|NCT05287100|Midodrine|midodrine|mesh-list
102511808|NCT05287100|Sympathomimetics|sympathomimetics|mesh-ancestor
102511809|NCT05287100|Autonomic Agents|autonomic agents|mesh-ancestor
102511810|NCT05287100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102511811|NCT05287100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511812|NCT05287100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102511813|NCT05287100|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102511814|NCT05287100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102511815|NCT05287100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102511816|NCT05287100|Adrenergic Agents|adrenergic agents|mesh-ancestor
102511817|NCT05287100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102511818|NCT05287100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511819|NCT02271230|Vitamin D|vitamin d|mesh-list
102511820|NCT02271230|Ergocalciferols|ergocalciferols|mesh-list
102511821|NCT02271230|Cholecalciferol|cholecalciferol|mesh-list
102511822|NCT02271230|Vitamins|vitamins|mesh-list
102511823|NCT02271230|Micronutrients|micronutrients|mesh-ancestor
102511824|NCT02271230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511825|NCT02271230|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102511826|NCT02271230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102511827|NCT05321706|Dapagliflozin|dapagliflozin|mesh-list
102511828|NCT05321706|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102511829|NCT05321706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511830|NCT05321706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102511831|NCT05321706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511832|NCT05514990|Dexamethasone|dexamethasone|mesh-list
102511833|NCT05514990|Dexamethasone acetate|dexamethasone acetate|mesh-list
102511834|NCT05514990|Pembrolizumab|pembrolizumab|mesh-list
102511835|NCT05514990|Bortezomib|bortezomib|mesh-list
102511836|NCT05514990|Ichthammol|ichthammol|mesh-list
102511837|NCT05514990|BB 1101|bb 1101|mesh-list
101988048|NCT05156437|Vancomycin|vancomycin|mesh-list
102511838|NCT05514990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102511839|NCT05514990|Antiemetics|antiemetics|mesh-ancestor
102511840|NCT05514990|Autonomic Agents|autonomic agents|mesh-ancestor
102511841|NCT05514990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102511842|NCT05514990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511843|NCT05514990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102511844|NCT05514990|Glucocorticoids|glucocorticoids|mesh-ancestor
102511845|NCT05514990|Hormones|hormones|mesh-ancestor
102511846|NCT05514990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102511847|NCT05514990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102511848|NCT05514990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511849|NCT05514990|Protease Inhibitors|protease inhibitors|mesh-ancestor
102511850|NCT05514990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102511851|NCT05514990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511852|NCT05514990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102511853|NCT05514990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102511854|NCT05514990|Dermatologic Agents|dermatologic agents|mesh-ancestor
102511855|NCT00396266|Plerixafor|plerixafor|mesh-list
102511856|NCT00396266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102511857|NCT00396266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102511858|NCT00396266|Antiviral Agents|antiviral agents|mesh-ancestor
102511859|NCT00396266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102511860|NCT04271384|Nivolumab|nivolumab|mesh-list
102511861|NCT04271384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102511862|NCT04271384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511863|NCT04271384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102511864|NCT04271384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511865|NCT05610384|Ibuprofen|ibuprofen|mesh-list
102511866|NCT05610384|Ketorolac|ketorolac|mesh-list
102511867|NCT05610384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102511868|NCT05610384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102511870|NCT05610384|Sensory System Agents|sensory system agents|mesh-ancestor
102511871|NCT05610384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102511872|NCT05610384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511873|NCT05610384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102511874|NCT05610384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102511875|NCT05610384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102511876|NCT05610384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102511877|NCT05610384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511878|NCT03570632|Metformin|metformin|mesh-list
102511879|NCT03570632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102511880|NCT03570632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511881|NCT00397904|Irinotecan|irinotecan|mesh-list
102511882|NCT00397904|Cetuximab|cetuximab|mesh-list
102511883|NCT00397904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511884|NCT00397904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102511885|NCT00397904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102511886|NCT00397904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102511887|NCT00397904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511888|NCT00397904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102511889|NCT00398918|Zonisamide|zonisamide|mesh-list
102511890|NCT00398918|Anticonvulsants|anticonvulsants|mesh-ancestor
102511891|NCT00398918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102511892|NCT00398918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102511893|NCT00398918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511894|NCT00398918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102511895|NCT00398918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511896|NCT05380752|Tecovirimat|tecovirimat|mesh-list
102511897|NCT05380752|Antiviral Agents|antiviral agents|mesh-ancestor
102511898|NCT05380752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102511899|NCT00401414|Warfarin|warfarin|mesh-list
102511900|NCT00401414|Anticoagulants|anticoagulants|mesh-ancestor
102511901|NCT00370838|Clonidine|clonidine|mesh-list
102511902|NCT00370838|Levetiracetam|levetiracetam|mesh-list
102511903|NCT00370838|Analgesics|analgesics|mesh-ancestor
102511904|NCT00370838|Sensory System Agents|sensory system agents|mesh-ancestor
102511905|NCT00370838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102511906|NCT00370838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511907|NCT00370838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102511908|NCT00370838|Sympatholytics|sympatholytics|mesh-ancestor
102511909|NCT00370838|Autonomic Agents|autonomic agents|mesh-ancestor
102511910|NCT00370838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102511911|NCT00370838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102511912|NCT00370838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102511913|NCT00370838|Adrenergic Agents|adrenergic agents|mesh-ancestor
102511914|NCT00370838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102511915|NCT00370838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511916|NCT00370838|Anticonvulsants|anticonvulsants|mesh-ancestor
102511917|NCT00370838|Nootropic Agents|nootropic agents|mesh-ancestor
102511918|NCT01795430|Etoposide|etoposide|mesh-list
102511919|NCT01795430|Etoposide phosphate|etoposide phosphate|mesh-list
102511920|NCT01795430|Melphalan|melphalan|mesh-list
102511921|NCT01795430|Busulfan|busulfan|mesh-list
102511922|NCT01795430|Topotecan|topotecan|mesh-list
102511923|NCT01795430|Ifosfamide|ifosfamide|mesh-list
102511924|NCT01795430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102511925|NCT01795430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511926|NCT01795430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102511927|NCT01795430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102511928|NCT01795430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102511929|NCT01795430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511930|NCT01795430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102511931|NCT01795430|Alkylating Agents|alkylating agents|mesh-ancestor
102511932|NCT01795430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102511933|NCT01795430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102511934|NCT01795430|Immunologic Factors|immunologic factors|mesh-ancestor
102511935|NCT01795430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511936|NCT01795430|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102511937|NCT04750382|Gemcitabine|gemcitabine|mesh-list
102511938|NCT04750382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102511939|NCT04750382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102511940|NCT04750382|Antimetabolites|antimetabolites|mesh-ancestor
102511941|NCT04750382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511942|NCT00401882|Metoprolol|metoprolol|mesh-list
102511943|NCT00401882|Epinephrine|epinephrine|mesh-list
102511944|NCT00401882|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102511946|NCT00401882|Adrenergic Agents|adrenergic agents|mesh-ancestor
102511947|NCT00401882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102511948|NCT00401882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511949|NCT00401882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511950|NCT00401882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102511951|NCT00401882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102511952|NCT00401882|Autonomic Agents|autonomic agents|mesh-ancestor
102511953|NCT00401882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102511954|NCT00401882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102511955|NCT00401882|Respiratory System Agents|respiratory system agents|mesh-ancestor
102511956|NCT00401882|Mydriatics|mydriatics|mesh-ancestor
102511957|NCT00401882|Sympathomimetics|sympathomimetics|mesh-ancestor
102511958|NCT00401882|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102511959|NCT00401882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102511960|NCT00401882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102511961|NCT00401882|Sympatholytics|sympatholytics|mesh-ancestor
102511962|NCT00401882|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102511963|NCT00401882|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102511964|NCT00401882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102511965|NCT00373334|Nizatidine|nizatidine|mesh-list
102511966|NCT00373334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102511967|NCT00373334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102511968|NCT00373334|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102511969|NCT00373334|Histamine Antagonists|histamine antagonists|mesh-ancestor
102511970|NCT00373334|Histamine Agents|histamine agents|mesh-ancestor
102511971|NCT00373334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102511972|NCT00373334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511973|NCT00373334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511974|NCT04749914|Dabigatran|dabigatran|mesh-list
102511975|NCT04749914|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102511976|NCT04749914|Lasmiditan|lasmiditan|mesh-list
102511977|NCT04749914|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102511978|NCT04749914|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102511979|NCT04749914|Antimetabolites|antimetabolites|mesh-ancestor
102511980|NCT04749914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511981|NCT04749914|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102511982|NCT04749914|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102511983|NCT04749914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102511984|NCT04749914|Antithrombins|antithrombins|mesh-ancestor
102511985|NCT04749914|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102511986|NCT04749914|Protease Inhibitors|protease inhibitors|mesh-ancestor
102511987|NCT04749914|Anticoagulants|anticoagulants|mesh-ancestor
102511988|NCT04749914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102511989|NCT04749914|Serotonin Agents|serotonin agents|mesh-ancestor
102511990|NCT04749914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102511991|NCT04749914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102511992|NCT00402194|Losartan|losartan|mesh-list
102511993|NCT00402194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102511994|NCT00402194|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102511995|NCT00402194|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102511996|NCT00402194|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102511997|NCT00402194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102511998|NCT05305404|Dexamethasone|dexamethasone|mesh-list
102511999|NCT05305404|Dexamethasone acetate|dexamethasone acetate|mesh-list
102512000|NCT05305404|BB 1101|bb 1101|mesh-list
102512001|NCT05305404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102512002|NCT05305404|Antiemetics|antiemetics|mesh-ancestor
102512003|NCT05305404|Autonomic Agents|autonomic agents|mesh-ancestor
102512004|NCT05305404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102512005|NCT05305404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512006|NCT05305404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102512007|NCT05305404|Glucocorticoids|glucocorticoids|mesh-ancestor
102512008|NCT05305404|Hormones|hormones|mesh-ancestor
102512009|NCT05305404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102512010|NCT05305404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102512011|NCT05305404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102512012|NCT05305404|Protease Inhibitors|protease inhibitors|mesh-ancestor
102512013|NCT05305404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102512014|NCT05305404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512015|NCT00402896|Mitogens|mitogens|mesh-list
102512016|NCT00402896|Endothelial Growth Factors|endothelial growth factors|mesh-list
102512017|NCT00402896|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102512018|NCT00402896|Mitosis Modulators|mitosis modulators|mesh-ancestor
102512019|NCT00402896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512020|NCT00402896|Growth Substances|growth substances|mesh-ancestor
102512021|NCT00402896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512022|NCT00402896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102512023|NCT00402896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102512024|NCT05268120|Doxycycline|doxycycline|mesh-list
102512025|NCT05268120|Rifampin|rifampin|mesh-list
102512026|NCT05268120|Trimethoprim|trimethoprim|mesh-list
102512027|NCT05268120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102512028|NCT05268120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102512029|NCT05268120|Antimalarials|antimalarials|mesh-ancestor
102512030|NCT05268120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102512031|NCT05268120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102512032|NCT05268120|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102512033|NCT05268120|Antitubercular Agents|antitubercular agents|mesh-ancestor
102512034|NCT05268120|Leprostatic Agents|leprostatic agents|mesh-ancestor
102512035|NCT05268120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102512036|NCT05268120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102512037|NCT05268120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512038|NCT05268120|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102512039|NCT05268120|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102512040|NCT05268120|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102512041|NCT05268120|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102512042|NCT05268120|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102512043|NCT05268120|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102512044|NCT05268120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102512045|NCT05268120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102512046|NCT05268120|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102512047|NCT05268120|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102512048|NCT05268120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102512049|NCT00405704|Trimethoprim|trimethoprim|mesh-list
102512050|NCT00405704|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102512051|NCT00405704|Sulfamethoxazole|sulfamethoxazole|mesh-list
102512052|NCT00405704|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102512053|NCT00405704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102512054|NCT00405704|Antimalarials|antimalarials|mesh-ancestor
102512055|NCT00405704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102512056|NCT00405704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102512057|NCT00405704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102512058|NCT00405704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102512059|NCT00405704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512060|NCT00405704|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102512061|NCT00405704|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102512062|NCT00405704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102512063|NCT00405704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102512064|NCT01657266|Nepafenac|nepafenac|mesh-list
102512065|NCT01657266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102512066|NCT01657266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102512067|NCT01657266|Analgesics|analgesics|mesh-ancestor
102512068|NCT01657266|Sensory System Agents|sensory system agents|mesh-ancestor
102512069|NCT01657266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102512070|NCT01657266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512071|NCT01657266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102512072|NCT01657266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102512073|NCT00375830|Diphosphonates|diphosphonates|mesh-list
102512074|NCT00375830|Methylene diphosphonate|methylene diphosphonate|mesh-list
102512075|NCT00375830|Listerine|listerine|mesh-list
102512076|NCT00375830|Deoxyglucose|deoxyglucose|mesh-list
102512077|NCT00375830|Fluorides|fluorides|mesh-list
102512078|NCT00375830|Sodium Fluoride|sodium fluoride|mesh-list
102512079|NCT00375830|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102512080|NCT00375830|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
102512081|NCT00375830|Cariostatic Agents|cariostatic agents|mesh-ancestor
102512082|NCT00375830|Protective Agents|protective agents|mesh-ancestor
102512083|NCT00375830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512084|NCT00375830|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102512085|NCT00375830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512086|NCT00375830|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102512087|NCT00375830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102512088|NCT00375830|Antimetabolites|antimetabolites|mesh-ancestor
102512089|NCT00375830|Antiviral Agents|antiviral agents|mesh-ancestor
102512090|NCT00375830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102512091|NCT05286008|Dexamethasone|dexamethasone|mesh-list
102512092|NCT05286008|Ropivacaine|ropivacaine|mesh-list
102512093|NCT05286008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102512094|NCT05286008|Antiemetics|antiemetics|mesh-ancestor
102512095|NCT05286008|Autonomic Agents|autonomic agents|mesh-ancestor
102512096|NCT05286008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102512097|NCT05286008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512098|NCT05286008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102512099|NCT05286008|Glucocorticoids|glucocorticoids|mesh-ancestor
102512100|NCT05286008|Hormones|hormones|mesh-ancestor
102512101|NCT05286008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102512102|NCT05286008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102512103|NCT05286008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102512104|NCT05286008|Anesthetics, Local|anesthetics, local|mesh-ancestor
102512105|NCT05286008|Anesthetics|anesthetics|mesh-ancestor
102512106|NCT05286008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102512107|NCT05286008|Sensory System Agents|sensory system agents|mesh-ancestor
102512108|NCT05302284|Carboplatin|carboplatin|mesh-list
102512109|NCT05302284|Gemcitabine|gemcitabine|mesh-list
102512110|NCT05302284|Disitamab vedotin|disitamab vedotin|mesh-list
102512111|NCT05302284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102512112|NCT05302284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102512113|NCT05302284|Antimetabolites|antimetabolites|mesh-ancestor
102512114|NCT05302284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512115|NCT05302284|Immunoconjugates|immunoconjugates|mesh-ancestor
102512116|NCT05302284|Immunologic Factors|immunologic factors|mesh-ancestor
102512117|NCT05302284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512118|NCT05300802|Dexmedetomidine|dexmedetomidine|mesh-list
102512119|NCT05300802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102512120|NCT05300802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102512121|NCT05300802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512122|NCT05300802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102512123|NCT05300802|Analgesics|analgesics|mesh-ancestor
102512124|NCT05300802|Sensory System Agents|sensory system agents|mesh-ancestor
102512125|NCT05300802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102512126|NCT05300802|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102512127|NCT05300802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102512128|NCT05300802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102512129|NCT05300802|Adrenergic Agents|adrenergic agents|mesh-ancestor
102512130|NCT05300802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102512131|NCT05300802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512132|NCT05299476|Bevacizumab|bevacizumab|mesh-list
102512133|NCT05299476|Tislelizumab|tislelizumab|mesh-list
102512134|NCT05299476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102512135|NCT05299476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102512136|NCT05299476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102512137|NCT05299476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102512138|NCT05299476|Growth Substances|growth substances|mesh-ancestor
102512139|NCT05299476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512140|NCT05299476|Growth Inhibitors|growth inhibitors|mesh-ancestor
102512141|NCT00405938|Bevacizumab|bevacizumab|mesh-list
102512142|NCT00405938|Fulvestrant|fulvestrant|mesh-list
102512143|NCT00405938|Anastrozole|anastrozole|mesh-list
102512144|NCT00405938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102512145|NCT00405938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102512146|NCT00405938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102512147|NCT00405938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102512148|NCT00405938|Growth Substances|growth substances|mesh-ancestor
102512149|NCT00405938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512150|NCT00405938|Growth Inhibitors|growth inhibitors|mesh-ancestor
102512151|NCT00405938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102512152|NCT00405938|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102512153|NCT00405938|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102512154|NCT00405938|Hormone Antagonists|hormone antagonists|mesh-ancestor
102512155|NCT00405938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102512156|NCT00405938|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102512157|NCT00405938|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102512158|NCT00405938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102512159|NCT00405938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512160|NCT05299398|Trazodone|trazodone|mesh-list
102512161|NCT05299398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102512162|NCT05299398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102512163|NCT05299398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102512164|NCT05299398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512165|NCT05299398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102512166|NCT05299398|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102512167|NCT05299398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102512168|NCT05299398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102512169|NCT05299398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512170|NCT05299398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102512171|NCT05299398|Serotonin Agents|serotonin agents|mesh-ancestor
102512172|NCT05299398|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102512173|NCT05299398|Antidepressive Agents|antidepressive agents|mesh-ancestor
102512175|NCT01793480|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102512176|NCT01793480|Narcotics|narcotics|mesh-ancestor
102512177|NCT01793480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102512178|NCT01793480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512179|NCT01793480|Analgesics|analgesics|mesh-ancestor
102512180|NCT01793480|Sensory System Agents|sensory system agents|mesh-ancestor
102512181|NCT01793480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102512182|NCT01793480|Antitussive Agents|antitussive agents|mesh-ancestor
102512183|NCT01793480|Respiratory System Agents|respiratory system agents|mesh-ancestor
102512184|NCT05299086|Fluticasone|fluticasone|mesh-list
102512185|NCT05299086|Xhance|xhance|mesh-list
102512186|NCT05299086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102512187|NCT05299086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102512188|NCT05299086|Autonomic Agents|autonomic agents|mesh-ancestor
102512189|NCT05299086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102512190|NCT05299086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512191|NCT05299086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102512192|NCT05299086|Respiratory System Agents|respiratory system agents|mesh-ancestor
102512193|NCT05299086|Dermatologic Agents|dermatologic agents|mesh-ancestor
102512194|NCT05299086|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102512195|NCT05299008|Bethanechol|bethanechol|mesh-list
102512196|NCT05299008|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102512197|NCT05299008|Autonomic Agents|autonomic agents|mesh-ancestor
102512198|NCT05299008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102512199|NCT05299008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512200|NCT05299008|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102512201|NCT05299008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102512202|NCT05299008|Cholinergic Agents|cholinergic agents|mesh-ancestor
102512203|NCT05299008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102512204|NCT05299008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512205|NCT05258292|Insulin|insulin|mesh-list
102512206|NCT05258292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102512207|NCT05258292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512208|NCT00378326|Tacrolimus|tacrolimus|mesh-list
102512209|NCT00378326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102512210|NCT00378326|Immunologic Factors|immunologic factors|mesh-ancestor
102512211|NCT00378326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512212|NCT00378326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102512213|NCT00378326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102512214|NCT00378326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512215|NCT05256264|Ketamine|ketamine|mesh-list
102512216|NCT05256264|Analgesics|analgesics|mesh-ancestor
102512217|NCT05256264|Sensory System Agents|sensory system agents|mesh-ancestor
102512218|NCT05256264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102512219|NCT05256264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512220|NCT05256264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102512221|NCT05256264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102512222|NCT05256264|Anesthetics, General|anesthetics, general|mesh-ancestor
102512223|NCT05256264|Anesthetics|anesthetics|mesh-ancestor
102512224|NCT05256264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102512225|NCT05256264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102512226|NCT05256264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102512227|NCT05256264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102512228|NCT05256264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512229|NCT00379574|Prednisolone|prednisolone|mesh-list
102512230|NCT00379574|Cyclophosphamide|cyclophosphamide|mesh-list
102512231|NCT00379574|Doxorubicin|doxorubicin|mesh-list
102512232|NCT00379574|Vincristine|vincristine|mesh-list
102512233|NCT00379574|Bortezomib|bortezomib|mesh-list
102512234|NCT00379574|Lenograstim|lenograstim|mesh-list
102512235|NCT00379574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102512236|NCT00379574|Immunologic Factors|immunologic factors|mesh-ancestor
102512237|NCT00379574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512238|NCT00379574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102512239|NCT00379574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102512240|NCT00379574|Alkylating Agents|alkylating agents|mesh-ancestor
102512241|NCT00379574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512242|NCT00379574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102512243|NCT00379574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102512244|NCT00379574|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102512245|NCT00379574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102512246|NCT00379574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102512247|NCT00379574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102512248|NCT00379574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102512249|NCT00379574|Tubulin Modulators|tubulin modulators|mesh-ancestor
102512250|NCT00379574|Antimitotic Agents|antimitotic agents|mesh-ancestor
101988474|NCT01124435|Celecoxib|celecoxib|mesh-list
102512251|NCT00379574|Mitosis Modulators|mitosis modulators|mesh-ancestor
102512252|NCT00379574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102512253|NCT00379574|Glucocorticoids|glucocorticoids|mesh-ancestor
102512254|NCT00379574|Hormones|hormones|mesh-ancestor
102512255|NCT00379574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102512256|NCT00379574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102512257|NCT00379574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102512258|NCT05256108|Oxycodone|oxycodone|mesh-list
102512259|NCT05256108|Tramadol|tramadol|mesh-list
102512260|NCT05256108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102512261|NCT05256108|Narcotics|narcotics|mesh-ancestor
102512262|NCT05256108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102512263|NCT05256108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512264|NCT05256108|Analgesics|analgesics|mesh-ancestor
102512265|NCT05256108|Sensory System Agents|sensory system agents|mesh-ancestor
102512266|NCT05256108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102512267|NCT00407654|Aflibercept|aflibercept|mesh-list
102512268|NCT00407654|Endothelial Growth Factors|endothelial growth factors|mesh-list
102512269|NCT00407654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102512270|NCT00407654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102512271|NCT00407654|Growth Substances|growth substances|mesh-ancestor
102512272|NCT00407654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512273|NCT00407654|Growth Inhibitors|growth inhibitors|mesh-ancestor
102512274|NCT00407654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102512275|NCT05484492|Calcium|calcium|mesh-list
102512276|NCT05484492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102512277|NCT05484492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512278|NCT00407888|Paclitaxel|paclitaxel|mesh-list
102512279|NCT00407888|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102512280|NCT00407888|Cyclophosphamide|cyclophosphamide|mesh-list
102512281|NCT00407888|Doxorubicin|doxorubicin|mesh-list
102512282|NCT00407888|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102512283|NCT00407888|Trastuzumab|trastuzumab|mesh-list
102512284|NCT00407888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102512285|NCT00407888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102512286|NCT00407888|Tubulin Modulators|tubulin modulators|mesh-ancestor
102512287|NCT00407888|Antimitotic Agents|antimitotic agents|mesh-ancestor
102512288|NCT00407888|Mitosis Modulators|mitosis modulators|mesh-ancestor
102512289|NCT00407888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512290|NCT00407888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102512291|NCT00407888|Immunologic Factors|immunologic factors|mesh-ancestor
102512292|NCT00407888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512293|NCT00407888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102512294|NCT00407888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102512295|NCT00407888|Alkylating Agents|alkylating agents|mesh-ancestor
102512296|NCT00407888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102512297|NCT00407888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102512298|NCT00407888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102512299|NCT00407888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102512300|NCT00407888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102512301|NCT00407888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102512302|NCT00407966|Cytarabine|cytarabine|mesh-list
102512303|NCT00407966|Mitoxantrone|mitoxantrone|mesh-list
102512304|NCT00407966|Alvocidib|alvocidib|mesh-list
102512305|NCT00407966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102512306|NCT00407966|Antimetabolites|antimetabolites|mesh-ancestor
102512307|NCT00407966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512308|NCT00407966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102512309|NCT00407966|Antiviral Agents|antiviral agents|mesh-ancestor
102512310|NCT00407966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102512311|NCT00407966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102512312|NCT00407966|Immunologic Factors|immunologic factors|mesh-ancestor
102512313|NCT00407966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512314|NCT00407966|Analgesics|analgesics|mesh-ancestor
102512315|NCT00407966|Sensory System Agents|sensory system agents|mesh-ancestor
102512316|NCT00407966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102512317|NCT00407966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102512318|NCT00407966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102512319|NCT00407966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102512320|NCT00407966|Growth Inhibitors|growth inhibitors|mesh-ancestor
102512321|NCT00407966|Growth Substances|growth substances|mesh-ancestor
102512322|NCT00407966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102512323|NCT00408200|Sotalol|sotalol|mesh-list
102512324|NCT00408200|Flecainide|flecainide|mesh-list
102512325|NCT00408200|Propafenone|propafenone|mesh-list
102512326|NCT00408200|Dofetilide|dofetilide|mesh-list
102512327|NCT00408200|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102512328|NCT00408200|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102512329|NCT00408200|Adrenergic Agents|adrenergic agents|mesh-ancestor
102512330|NCT00408200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102512331|NCT00408200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512332|NCT00408200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512333|NCT00408200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102512334|NCT00408200|Sympatholytics|sympatholytics|mesh-ancestor
102512335|NCT00408200|Autonomic Agents|autonomic agents|mesh-ancestor
102512336|NCT00408200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102512337|NCT00408200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102512338|NCT00408200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102512339|NCT00408200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102512340|NCT00408200|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102512341|NCT05255406|Aflutinib|aflutinib|mesh-list
102512342|NCT05255406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102512343|NCT05255406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102512344|NCT05255406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512345|NCT05250050|Amoxicillin|amoxicillin|mesh-list
102512346|NCT05250050|Metronidazole|metronidazole|mesh-list
102512347|NCT05250050|Clarithromycin|clarithromycin|mesh-list
102512348|NCT05250050|Levofloxacin|levofloxacin|mesh-list
102512349|NCT05250050|Tetracycline|tetracycline|mesh-list
102512350|NCT05250050|Potassium Citrate|potassium citrate|mesh-list
102512351|NCT05250050|Esomeprazole|esomeprazole|mesh-list
102512352|NCT05250050|Bismuth|bismuth|mesh-list
102512353|NCT05250050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512354|NCT05250050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102512355|NCT05250050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102512356|NCT05250050|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102512357|NCT05250050|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102512358|NCT05250050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102512359|NCT05250050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102512360|NCT05250050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102512361|NCT05250050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102512362|NCT05250050|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102512363|NCT05250050|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102512364|NCT05250050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102512365|NCT05250050|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102512366|NCT05250050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102512367|NCT05250050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102512368|NCT05250050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102512369|NCT05250050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102512370|NCT05250050|Antacids|antacids|mesh-ancestor
102512371|NCT05250050|Diuretics|diuretics|mesh-ancestor
102512372|NCT05250050|Natriuretic Agents|natriuretic agents|mesh-ancestor
102512373|NCT05250050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512374|NCT05250050|Expectorants|expectorants|mesh-ancestor
102512375|NCT05250050|Respiratory System Agents|respiratory system agents|mesh-ancestor
102512376|NCT05499390|Pembrolizumab|pembrolizumab|mesh-list
102512377|NCT05499390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102512378|NCT05499390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102512379|NCT05499390|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102512380|NCT05499390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512381|NCT05294328|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102512382|NCT05294328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102512383|NCT05294328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102512384|NCT05294328|Aceclidine|aceclidine|mesh-list
102512385|NCT05294328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102512386|NCT05294328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102512387|NCT05294328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102512388|NCT05294328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102512389|NCT05294328|Adrenergic Agents|adrenergic agents|mesh-ancestor
102512390|NCT05294328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102323894|NCT01846221|Narcotics|narcotics|mesh-ancestor
102512391|NCT05294328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512392|NCT05294328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512393|NCT05294328|Miotics|miotics|mesh-ancestor
102512394|NCT05294328|Autonomic Agents|autonomic agents|mesh-ancestor
102512395|NCT05294328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102512396|NCT05294328|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102512397|NCT05254236|Vaccines|vaccines|mesh-list
102512398|NCT05254236|Immunologic Factors|immunologic factors|mesh-ancestor
102512399|NCT05254236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512400|NCT05292690|Caffeine|caffeine|mesh-list
102512401|NCT05292690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102512402|NCT05292690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512403|NCT05292690|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102512404|NCT05292690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102512405|NCT05292690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512406|NCT05292690|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102512407|NCT05292690|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102512408|NCT05292690|Purinergic Agents|purinergic agents|mesh-ancestor
102512409|NCT05292690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102512410|NCT00382148|Omalizumab|omalizumab|mesh-list
102512411|NCT00382148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102512412|NCT00382148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102512413|NCT00382148|Respiratory System Agents|respiratory system agents|mesh-ancestor
102512414|NCT05292066|Pregabalin|pregabalin|mesh-list
102512415|NCT05292066|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102512416|NCT05292066|Analgesics|analgesics|mesh-ancestor
102512417|NCT05292066|Sensory System Agents|sensory system agents|mesh-ancestor
102512418|NCT05292066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102512419|NCT05292066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512420|NCT05292066|Anticonvulsants|anticonvulsants|mesh-ancestor
102512421|NCT05292066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102512422|NCT05292066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102512423|NCT05292066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512424|NCT05292066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102512425|NCT05292066|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102512426|NCT05292066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102512427|NCT05292066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102512428|NCT05292066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102512429|NCT05292066|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102512430|NCT05292066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102512431|NCT05292066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102512432|NCT05292066|Antidepressive Agents|antidepressive agents|mesh-ancestor
102512433|NCT05292066|Dopamine Agents|dopamine agents|mesh-ancestor
102512434|NCT04270994|Misoprostol|misoprostol|mesh-list
102512435|NCT04270994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102512436|NCT04270994|Abortifacient Agents|abortifacient agents|mesh-ancestor
102512437|NCT04270994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102512438|NCT04270994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512439|NCT04270994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102512440|NCT04270994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102512441|NCT04270994|Oxytocics|oxytocics|mesh-ancestor
102512442|NCT02111798|Bupropion|bupropion|mesh-list
102512443|NCT02111798|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102512444|NCT02111798|Antidepressive Agents|antidepressive agents|mesh-ancestor
102512445|NCT02111798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102512446|NCT02111798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102512447|NCT02111798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102512448|NCT02111798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102512449|NCT02111798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512450|NCT02111798|Dopamine Agents|dopamine agents|mesh-ancestor
102512451|NCT02111798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102512452|NCT02111798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512453|NCT02111798|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102512454|NCT02111798|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102512455|NCT02111798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102512456|NCT05290662|Cyclophosphamide|cyclophosphamide|mesh-list
102512457|NCT05290662|Fludarabine|fludarabine|mesh-list
102512458|NCT05290662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102512459|NCT05290662|Immunologic Factors|immunologic factors|mesh-ancestor
102512460|NCT05290662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512461|NCT05290662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102512462|NCT05290662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102512463|NCT05290662|Alkylating Agents|alkylating agents|mesh-ancestor
102512464|NCT05290662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512465|NCT05290662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102512466|NCT05290662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102512467|NCT05143502|Fluticasone|fluticasone|mesh-list
102512469|NCT05143502|Prednisolone|prednisolone|mesh-list
102512470|NCT05143502|Montelukast|montelukast|mesh-list
102512471|NCT05143502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102512472|NCT05143502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102512473|NCT05143502|Autonomic Agents|autonomic agents|mesh-ancestor
102512474|NCT05143502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102512475|NCT05143502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512476|NCT05143502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102512477|NCT05143502|Respiratory System Agents|respiratory system agents|mesh-ancestor
102512478|NCT05143502|Dermatologic Agents|dermatologic agents|mesh-ancestor
102512479|NCT05143502|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102512480|NCT05143502|Glucocorticoids|glucocorticoids|mesh-ancestor
102512481|NCT05143502|Hormones|hormones|mesh-ancestor
102512482|NCT05143502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102512483|NCT05143502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102512484|NCT05143502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102512485|NCT05143502|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102512486|NCT05143502|Hormone Antagonists|hormone antagonists|mesh-ancestor
102512487|NCT05143502|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102512488|NCT05143502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102512489|NCT05143502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512490|NCT05290116|Apatinib|apatinib|mesh-list
102512491|NCT05290116|Tislelizumab|tislelizumab|mesh-list
102512492|NCT05290116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102512493|NCT05290116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102512494|NCT05290116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102512495|NCT05290116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512496|NCT05290116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102512497|NCT00409292|Everolimus|everolimus|mesh-list
102512498|NCT00409292|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102512499|NCT00409292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102512500|NCT00409292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102512501|NCT00409292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512502|NCT00409292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102512503|NCT00409292|Immunologic Factors|immunologic factors|mesh-ancestor
102512504|NCT00409292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512505|NCT00409292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102512506|NCT05246046|Bromides|bromides|mesh-list
102512507|NCT05246046|Tiotropium Bromide|tiotropium bromide|mesh-list
102512508|NCT05246046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102512509|NCT05246046|Autonomic Agents|autonomic agents|mesh-ancestor
102512510|NCT05246046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102512511|NCT05246046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512512|NCT05246046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102512513|NCT05246046|Respiratory System Agents|respiratory system agents|mesh-ancestor
102512514|NCT05246046|Parasympatholytics|parasympatholytics|mesh-ancestor
102512515|NCT05246046|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102512516|NCT05246046|Cholinergic Agents|cholinergic agents|mesh-ancestor
102512517|NCT05246046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102512518|NCT05246046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512519|NCT05246046|Anticonvulsants|anticonvulsants|mesh-ancestor
102512520|NCT00383942|Misoprostol|misoprostol|mesh-list
102512521|NCT00383942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102512522|NCT00383942|Abortifacient Agents|abortifacient agents|mesh-ancestor
102512523|NCT00383942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102512524|NCT00383942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512525|NCT00383942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102512526|NCT00383942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102512527|NCT00383942|Oxytocics|oxytocics|mesh-ancestor
102512528|NCT05288400|Amlodipine|amlodipine|mesh-list
102512529|NCT05288400|Bisoprolol|bisoprolol|mesh-list
102512530|NCT05288400|Perindopril|perindopril|mesh-list
102512531|NCT05288400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102512532|NCT05288400|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102512533|NCT05288400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102512534|NCT05288400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512535|NCT05288400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102512536|NCT05288400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512537|NCT05288400|Vasodilator Agents|vasodilator agents|mesh-ancestor
102512538|NCT05288400|Sympatholytics|sympatholytics|mesh-ancestor
102512539|NCT05288400|Autonomic Agents|autonomic agents|mesh-ancestor
102512540|NCT05288400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102512541|NCT05288400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102512542|NCT05288400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102512543|NCT05288400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102512544|NCT05288400|Adrenergic Agents|adrenergic agents|mesh-ancestor
102512545|NCT05288400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102512546|NCT05288400|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102512547|NCT05288400|Protease Inhibitors|protease inhibitors|mesh-ancestor
102512548|NCT05288400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102512550|NCT05474040|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102512551|NCT05474040|Narcotics|narcotics|mesh-ancestor
102512552|NCT05474040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102512553|NCT05474040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512554|NCT05474040|Analgesics|analgesics|mesh-ancestor
102512555|NCT05474040|Sensory System Agents|sensory system agents|mesh-ancestor
102512556|NCT05474040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102512557|NCT00410150|Albuterol|albuterol|mesh-list
102512558|NCT00410150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102512559|NCT00410150|Autonomic Agents|autonomic agents|mesh-ancestor
102512560|NCT00410150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102512561|NCT00410150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512562|NCT00410150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102512563|NCT00410150|Respiratory System Agents|respiratory system agents|mesh-ancestor
102512564|NCT00410150|Tocolytic Agents|tocolytic agents|mesh-ancestor
102512565|NCT00410150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102512566|NCT00410150|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102512567|NCT00410150|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102512568|NCT00410150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102512569|NCT00410150|Adrenergic Agents|adrenergic agents|mesh-ancestor
102512570|NCT00410150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102512571|NCT00410150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512572|NCT00385268|Acamprosate|acamprosate|mesh-list
102512573|NCT00385268|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102512574|NCT05287464|Pembrolizumab|pembrolizumab|mesh-list
102512575|NCT05287464|Nivolumab|nivolumab|mesh-list
102512576|NCT05287464|Ipilimumab|ipilimumab|mesh-list
102512577|NCT05287464|Atezolizumab|atezolizumab|mesh-list
102512578|NCT05287464|Avelumab|avelumab|mesh-list
102512579|NCT05287464|Lenvatinib|lenvatinib|mesh-list
102512580|NCT05287464|Axitinib|axitinib|mesh-list
102512581|NCT05287464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102512582|NCT05287464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102512583|NCT05287464|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102512584|NCT05287464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512585|NCT05287464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102512586|NCT05287464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102512587|NCT01657500|Gentamicins|gentamicins|mesh-list
102512588|NCT01657500|Dextrans|dextrans|mesh-list
102512589|NCT01657500|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102512590|NCT01657500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102512591|NCT01657500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102512592|NCT01657500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102512593|NCT01657500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102512594|NCT01657500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512595|NCT01657500|Anticoagulants|anticoagulants|mesh-ancestor
102512596|NCT01657500|Plasma Substitutes|plasma substitutes|mesh-ancestor
102512597|NCT01657500|Blood Substitutes|blood substitutes|mesh-ancestor
102512598|NCT00411086|Rituximab|rituximab|mesh-list
102512599|NCT00411086|Molgramostim|molgramostim|mesh-list
102512600|NCT00411086|Sargramostim|sargramostim|mesh-list
102512601|NCT00411086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102512602|NCT00411086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102512603|NCT00411086|Immunologic Factors|immunologic factors|mesh-ancestor
102512604|NCT00411086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512605|NCT00411086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102512606|NCT01658904|Melphalan|melphalan|mesh-list
102512607|NCT01658904|Immunologic Factors|immunologic factors|mesh-ancestor
102512608|NCT01658904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512609|NCT01658904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102512610|NCT01658904|Alkylating Agents|alkylating agents|mesh-ancestor
102512611|NCT01658904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512612|NCT01658904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102512613|NCT01658904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102512614|NCT01658904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102512615|NCT05238948|Midazolam|midazolam|mesh-list
102512616|NCT05238948|CKD-506|ckd-506|mesh-list
102512617|NCT05238948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102512618|NCT05238948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102512619|NCT05238948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102512620|NCT05238948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512621|NCT05238948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102512622|NCT05238948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102512623|NCT05238948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102512624|NCT05238948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102512625|NCT05238948|Anesthetics, General|anesthetics, general|mesh-ancestor
102512626|NCT05238948|Anesthetics|anesthetics|mesh-ancestor
102512627|NCT05238948|GABA Modulators|gaba modulators|mesh-ancestor
102512628|NCT05238948|GABA Agents|gaba agents|mesh-ancestor
102512629|NCT05238948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102512630|NCT05238948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512631|NCT05238948|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102512632|NCT05238948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102512633|NCT00385580|Dasatinib|dasatinib|mesh-list
102512634|NCT00385580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102512635|NCT00385580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102512636|NCT00385580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102512637|NCT00385580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512638|NCT05236530|Metformin|metformin|mesh-list
102512639|NCT05236530|Repaglinide|repaglinide|mesh-list
102512640|NCT05236530|Lumefantrine|lumefantrine|mesh-list
102512641|NCT05236530|Dolutegravir|dolutegravir|mesh-list
102512642|NCT05236530|Midazolam|midazolam|mesh-list
102512643|NCT05236530|Dextromethorphan|dextromethorphan|mesh-list
102512644|NCT05236530|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102512645|NCT05236530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102512646|NCT05236530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512647|NCT05236530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102512648|NCT05236530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102512649|NCT05236530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102512650|NCT05236530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102512651|NCT05236530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102512652|NCT05236530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102512653|NCT05236530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102512654|NCT05236530|Anesthetics, General|anesthetics, general|mesh-ancestor
102512655|NCT05236530|Anesthetics|anesthetics|mesh-ancestor
102512656|NCT05236530|GABA Modulators|gaba modulators|mesh-ancestor
102512657|NCT05236530|GABA Agents|gaba agents|mesh-ancestor
102512658|NCT05236530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102512659|NCT05236530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512660|NCT05236530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102512661|NCT05236530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102512662|NCT05236530|Antimetabolites|antimetabolites|mesh-ancestor
102512663|NCT05236530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102512664|NCT05236530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102512665|NCT05236530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102512666|NCT05236530|Antimalarials|antimalarials|mesh-ancestor
102512667|NCT05236530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102512668|NCT05236530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102512669|NCT05236530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102512670|NCT05236530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102512671|NCT05236530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102512672|NCT05236530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102512673|NCT05236530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102512674|NCT05236530|Antiviral Agents|antiviral agents|mesh-ancestor
102512675|NCT05236530|Antitussive Agents|antitussive agents|mesh-ancestor
102512676|NCT05236530|Respiratory System Agents|respiratory system agents|mesh-ancestor
102512677|NCT05236530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102512678|NCT05236530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102512679|NCT00455702|Cycloserine|cycloserine|mesh-list
102512680|NCT00455702|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102512681|NCT00455702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102512682|NCT00455702|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102512683|NCT00455702|Antitubercular Agents|antitubercular agents|mesh-ancestor
102512684|NCT00455702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102512685|NCT00455702|Antimetabolites|antimetabolites|mesh-ancestor
102512686|NCT00455702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512687|NCT00456014|Desipramine|desipramine|mesh-list
102512688|NCT00456014|Escitalopram|escitalopram|mesh-list
102512689|NCT00456014|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102512690|NCT00456014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102512691|NCT00456014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102512692|NCT00456014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512693|NCT00456014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102512694|NCT00456014|Serotonin Agents|serotonin agents|mesh-ancestor
102512695|NCT00456014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512696|NCT00456014|Antidepressive Agents|antidepressive agents|mesh-ancestor
102512697|NCT00456014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102512698|NCT00456014|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102512699|NCT00456014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102512700|NCT00456014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102512701|NCT00456014|Adrenergic Agents|adrenergic agents|mesh-ancestor
102512702|NCT05235516|Cisplatin|cisplatin|mesh-list
102512703|NCT05235516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102512704|NCT00411398|Memantine|memantine|mesh-list
102512705|NCT00411398|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102512706|NCT00411398|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102512707|NCT00411398|Dopamine Agents|dopamine agents|mesh-ancestor
102512708|NCT00411398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102512709|NCT00411398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512710|NCT00411398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512711|NCT00411398|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102512712|NCT00411398|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102512713|NCT05231694|Mitogens|mitogens|mesh-list
102512714|NCT05231694|Mitosis Modulators|mitosis modulators|mesh-ancestor
102512715|NCT05231694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512716|NCT00457730|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102512717|NCT00457730|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102512718|NCT00457730|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102512719|NCT00457730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102512720|NCT00457730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512721|NCT00457730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102512722|NCT00457730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512723|NCT00457730|Analgesics|analgesics|mesh-ancestor
102512724|NCT00457730|Sensory System Agents|sensory system agents|mesh-ancestor
102512725|NCT00457730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102512726|NCT00457730|Antidepressive Agents|antidepressive agents|mesh-ancestor
102512727|NCT00457730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102512728|NCT00457730|Dopamine Agents|dopamine agents|mesh-ancestor
102512729|NCT00458822|Dexamethasone|dexamethasone|mesh-list
102512730|NCT00458822|Bortezomib|bortezomib|mesh-list
102512731|NCT00458822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102512732|NCT00458822|Antiemetics|antiemetics|mesh-ancestor
102512733|NCT00458822|Autonomic Agents|autonomic agents|mesh-ancestor
102512734|NCT00458822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102512735|NCT00458822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512736|NCT00458822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102512737|NCT00458822|Glucocorticoids|glucocorticoids|mesh-ancestor
102512738|NCT00458822|Hormones|hormones|mesh-ancestor
102512739|NCT00458822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102512740|NCT00458822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102512741|NCT00458822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102512742|NCT00389168|Atenolol|atenolol|mesh-list
102512743|NCT00389168|Irbesartan|irbesartan|mesh-list
102512744|NCT00389168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102512745|NCT00389168|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102512746|NCT00389168|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102512747|NCT00389168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512748|NCT00389168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102512749|NCT00389168|Sympatholytics|sympatholytics|mesh-ancestor
102512750|NCT00389168|Autonomic Agents|autonomic agents|mesh-ancestor
102512751|NCT00389168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102512752|NCT00389168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512753|NCT00389168|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102512754|NCT00389168|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102512755|NCT00389168|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102512756|NCT00389168|Adrenergic Agents|adrenergic agents|mesh-ancestor
102512757|NCT00389168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102512758|NCT00462020|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102512759|NCT00462020|Metronidazole|metronidazole|mesh-list
102512760|NCT00462020|Ceftriaxone|ceftriaxone|mesh-list
102512761|NCT00462020|Clavulanic Acids|clavulanic acids|mesh-list
102512762|NCT00462020|Clavulanic Acid|clavulanic acid|mesh-list
102512763|NCT00462020|Ampicillin|ampicillin|mesh-list
102512764|NCT00462020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102512765|NCT00462020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102512766|NCT00462020|Antitubercular Agents|antitubercular agents|mesh-ancestor
102512767|NCT00462020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102324269|NCT02027311|Anesthetics|anesthetics|mesh-ancestor
102512768|NCT00462020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102512769|NCT00462020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102512770|NCT00462020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512771|NCT00462020|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102512772|NCT05177718|Natalizumab|natalizumab|mesh-list
102512773|NCT05177718|Immunologic Factors|immunologic factors|mesh-ancestor
102512774|NCT05177718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512775|NCT00414206|Mecamylamine|mecamylamine|mesh-list
102512776|NCT00414206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102512777|NCT00414206|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
102512778|NCT00414206|Autonomic Agents|autonomic agents|mesh-ancestor
102512779|NCT00414206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102512780|NCT00414206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512781|NCT00414206|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102512782|NCT00414206|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102512783|NCT00414206|Cholinergic Agents|cholinergic agents|mesh-ancestor
102512784|NCT00414206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102512785|NCT00414206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512786|NCT05480046|Risperidone|risperidone|mesh-list
102512787|NCT05480046|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102512788|NCT05480046|Serotonin Agents|serotonin agents|mesh-ancestor
102512789|NCT05480046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102512790|NCT05480046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512791|NCT05480046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512792|NCT05480046|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102512793|NCT05480046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102512794|NCT05480046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102512795|NCT05480046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102512796|NCT05480046|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102512797|NCT05480046|Dopamine Agents|dopamine agents|mesh-ancestor
102512798|NCT04241640|Nefopam|nefopam|mesh-list
102512799|NCT04241640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102512800|NCT04241640|Analgesics|analgesics|mesh-ancestor
102512801|NCT04241640|Sensory System Agents|sensory system agents|mesh-ancestor
102512802|NCT04241640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102512803|NCT04241640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512804|NCT00462332|Vidarabine|vidarabine|mesh-list
102512805|NCT00462332|Fludarabine|fludarabine|mesh-list
102512806|NCT00462332|Fludarabine phosphate|fludarabine phosphate|mesh-list
102512807|NCT00462332|Alemtuzumab|alemtuzumab|mesh-list
102512808|NCT00462332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102512809|NCT00462332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102512810|NCT00462332|Antimetabolites|antimetabolites|mesh-ancestor
102512811|NCT00462332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512812|NCT00462332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102512813|NCT00462332|Immunologic Factors|immunologic factors|mesh-ancestor
102512814|NCT00462332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512815|NCT00462332|Antiviral Agents|antiviral agents|mesh-ancestor
102512816|NCT00462332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102512817|NCT00462332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102512818|NCT00462644|Fentanyl|fentanyl|mesh-list
102512819|NCT00462644|Midazolam|midazolam|mesh-list
102512820|NCT00462644|Etomidate|etomidate|mesh-list
102512821|NCT00462644|Succinylcholine|succinylcholine|mesh-list
102512822|NCT00462644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102512823|NCT00462644|Narcotics|narcotics|mesh-ancestor
102512824|NCT00462644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102512825|NCT00462644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512826|NCT00462644|Analgesics|analgesics|mesh-ancestor
102512827|NCT00462644|Sensory System Agents|sensory system agents|mesh-ancestor
102512828|NCT00462644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102512829|NCT00462644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102512830|NCT00462644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102512831|NCT00462644|Anesthetics, General|anesthetics, general|mesh-ancestor
102512832|NCT00462644|Anesthetics|anesthetics|mesh-ancestor
102512833|NCT00462644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102512834|NCT00462644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102512835|NCT00462644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102512836|NCT00462644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102512837|NCT00462644|GABA Modulators|gaba modulators|mesh-ancestor
102512838|NCT00462644|GABA Agents|gaba agents|mesh-ancestor
102512839|NCT00462644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101989050|NCT03931343|Sensory System Agents|sensory system agents|mesh-ancestor
102512840|NCT00462644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512841|NCT00462644|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
102512842|NCT00462644|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102512843|NCT00462644|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102512844|NCT00462722|Ibuprofen|ibuprofen|mesh-list
102512845|NCT00462722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102512846|NCT00462722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102512847|NCT00462722|Analgesics|analgesics|mesh-ancestor
102512848|NCT00462722|Sensory System Agents|sensory system agents|mesh-ancestor
102512849|NCT00462722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102512850|NCT00462722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512851|NCT00462722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102512852|NCT00462722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102512853|NCT00462722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102512854|NCT00462722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102512855|NCT00462722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512856|NCT05272254|Povidone-Iodine|povidone-iodine|mesh-list
102512857|NCT05272254|Povidone|povidone|mesh-list
102512858|NCT05272254|Plasma Substitutes|plasma substitutes|mesh-ancestor
102512859|NCT05272254|Blood Substitutes|blood substitutes|mesh-ancestor
102512860|NCT05272254|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102512861|NCT05272254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102512862|NCT00528398|Cytarabine|cytarabine|mesh-list
102512863|NCT00528398|Idarubicin|idarubicin|mesh-list
102512864|NCT00528398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102512865|NCT00528398|Antimetabolites|antimetabolites|mesh-ancestor
102512866|NCT00528398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512867|NCT00528398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102512868|NCT00528398|Antiviral Agents|antiviral agents|mesh-ancestor
102512869|NCT00528398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102512870|NCT00528398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102512871|NCT00528398|Immunologic Factors|immunologic factors|mesh-ancestor
102512872|NCT00528398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512873|NCT00528398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102512874|NCT00528398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102512875|NCT00528398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102512876|NCT00528398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102512877|NCT00528788|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
102512878|NCT00528788|Vitamins|vitamins|mesh-ancestor
102512879|NCT00528788|Micronutrients|micronutrients|mesh-ancestor
102512880|NCT00528788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512881|NCT00528788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102512882|NCT00414518|Ritonavir|ritonavir|mesh-list
102512883|NCT00414518|Lopinavir|lopinavir|mesh-list
102512884|NCT00414518|Tenofovir|tenofovir|mesh-list
102512885|NCT00414518|Emtricitabine|emtricitabine|mesh-list
102512886|NCT00414518|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102512887|NCT00414518|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102512888|NCT00414518|Protease Inhibitors|protease inhibitors|mesh-ancestor
102512889|NCT00414518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102512890|NCT00414518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512891|NCT00414518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102512892|NCT00414518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102512893|NCT00414518|Antiviral Agents|antiviral agents|mesh-ancestor
102512894|NCT00414518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102512895|NCT00414518|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102512896|NCT00414518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102512897|NCT00414518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102512898|NCT00414518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102512899|NCT01795664|Fluticasone|fluticasone|mesh-list
102512900|NCT01795664|Xhance|xhance|mesh-list
102512901|NCT01795664|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102512902|NCT01795664|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102512903|NCT01795664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102512904|NCT01795664|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102512905|NCT01795664|Autonomic Agents|autonomic agents|mesh-ancestor
102512906|NCT01795664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102512907|NCT01795664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512908|NCT01795664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102512909|NCT01795664|Respiratory System Agents|respiratory system agents|mesh-ancestor
102512910|NCT01795664|Dermatologic Agents|dermatologic agents|mesh-ancestor
102512911|NCT01795664|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102512912|NCT01795664|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102512913|NCT01795664|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102512914|NCT01795664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102512915|NCT01795664|Adrenergic Agents|adrenergic agents|mesh-ancestor
102512916|NCT01795664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102512917|NCT01795664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512918|NCT01795664|Glucocorticoids|glucocorticoids|mesh-ancestor
102512919|NCT01795664|Hormones|hormones|mesh-ancestor
102324418|NCT01840605|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102512920|NCT01795664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102512921|NCT01795664|Sympathomimetics|sympathomimetics|mesh-ancestor
102512922|NCT05271084|Pentoxifylline|pentoxifylline|mesh-list
102512923|NCT05271084|Dexetimide|dexetimide|mesh-list
102512924|NCT05271084|Citalopram|citalopram|mesh-list
102512925|NCT05271084|Escitalopram|escitalopram|mesh-list
102512926|NCT05271084|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102512927|NCT05271084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102512928|NCT05271084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102512929|NCT05271084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512930|NCT05271084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102512931|NCT05271084|Serotonin Agents|serotonin agents|mesh-ancestor
102512932|NCT05271084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512933|NCT05271084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102512934|NCT05271084|Antidepressive Agents|antidepressive agents|mesh-ancestor
102512935|NCT05271084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102512936|NCT05271084|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102512937|NCT05271084|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102512938|NCT05271084|Parasympatholytics|parasympatholytics|mesh-ancestor
102512939|NCT05271084|Autonomic Agents|autonomic agents|mesh-ancestor
102512940|NCT05271084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102512941|NCT05271084|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102512942|NCT05271084|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102512943|NCT05271084|Cholinergic Agents|cholinergic agents|mesh-ancestor
102512944|NCT05271084|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102512945|NCT05271084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102512946|NCT05271084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102512947|NCT05271084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102512948|NCT05271084|Protective Agents|protective agents|mesh-ancestor
102512949|NCT05271084|Vasodilator Agents|vasodilator agents|mesh-ancestor
102512950|NCT05271084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102512951|NCT05271084|Antioxidants|antioxidants|mesh-ancestor
102512952|NCT00531518|Lamotrigine|lamotrigine|mesh-list
102512953|NCT00531518|Aripiprazole|aripiprazole|mesh-list
102512954|NCT00531518|Bupropion|bupropion|mesh-list
102512955|NCT00531518|Fluoxetine|fluoxetine|mesh-list
102512956|NCT00531518|Sertraline|sertraline|mesh-list
102512957|NCT00531518|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102512958|NCT00531518|Antidepressive Agents|antidepressive agents|mesh-ancestor
102512959|NCT00531518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102512960|NCT00531518|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102512961|NCT00531518|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102512962|NCT00531518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102512963|NCT00531518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512964|NCT00531518|Dopamine Agents|dopamine agents|mesh-ancestor
102512965|NCT00531518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102512966|NCT00531518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102512967|NCT00531518|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102512968|NCT00531518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102512969|NCT00531518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102512970|NCT00531518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102512971|NCT00531518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102512972|NCT00531518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102512973|NCT00531518|Dopamine Agonists|dopamine agonists|mesh-ancestor
102512974|NCT00531518|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102512975|NCT00531518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102512976|NCT00531518|Serotonin Agents|serotonin agents|mesh-ancestor
102512977|NCT00531518|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102512978|NCT00531518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102512979|NCT00531518|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102512980|NCT00531518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102512981|NCT00531518|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102512982|NCT00531518|Anticonvulsants|anticonvulsants|mesh-ancestor
102512983|NCT00531518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102512984|NCT00531518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102512985|NCT00531518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102512986|NCT00533546|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
102512987|NCT00533546|Protein C|protein c|mesh-list
102512988|NCT00533546|Anticoagulants|anticoagulants|mesh-ancestor
102512989|NCT00533546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102512990|NCT00533546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102512991|NCT00533546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102512992|NCT00533546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102324492|NCT02012959|Tolvaptan|tolvaptan|mesh-list
102512994|NCT00534794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102512995|NCT00534794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102512996|NCT00534794|Analgesics|analgesics|mesh-ancestor
102512997|NCT00534794|Sensory System Agents|sensory system agents|mesh-ancestor
102512998|NCT00534794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102512999|NCT00534794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513000|NCT00534794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102513001|NCT00534794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102513002|NCT00534794|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102513003|NCT00534794|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102513004|NCT00534794|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102513005|NCT00534794|Histamine Antagonists|histamine antagonists|mesh-ancestor
102513006|NCT00534794|Histamine Agents|histamine agents|mesh-ancestor
102513007|NCT00534794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102513008|NCT00534794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513009|NCT01658436|Dactolisib|dactolisib|mesh-list
102513010|NCT01658436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102513011|NCT05168280|Dexmedetomidine|dexmedetomidine|mesh-list
102513012|NCT05168280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102513013|NCT05168280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102513014|NCT05168280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513015|NCT05168280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102513016|NCT05168280|Analgesics|analgesics|mesh-ancestor
102513017|NCT05168280|Sensory System Agents|sensory system agents|mesh-ancestor
102513018|NCT05168280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102513019|NCT05168280|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102513020|NCT05168280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102513021|NCT05168280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102513022|NCT05168280|Adrenergic Agents|adrenergic agents|mesh-ancestor
102513023|NCT05168280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102513024|NCT05168280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513025|NCT05053854|Talazoparib|talazoparib|mesh-list
102513026|NCT05053854|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102513027|NCT05053854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102513028|NCT05053854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513029|NCT05053854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102513030|NCT00464204|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
102513031|NCT00464204|Plasma Substitutes|plasma substitutes|mesh-ancestor
102513032|NCT00464204|Blood Substitutes|blood substitutes|mesh-ancestor
102513033|NCT00464438|Moxifloxacin|moxifloxacin|mesh-list
102513034|NCT00464438|Gatifloxacin|gatifloxacin|mesh-list
102513035|NCT00464438|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102513036|NCT00464438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102513037|NCT00464438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102513038|NCT00464438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102513039|NCT00464438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102513040|NCT00464438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102513041|NCT00464438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513042|NCT00464438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102513043|NCT00464438|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102513044|NCT00465530|Gentamicins|gentamicins|mesh-list
102513045|NCT00465530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102513046|NCT00465530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102513047|NCT00465530|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102513048|NCT00465530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102513049|NCT00465530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513050|NCT00466310|Risperidone|risperidone|mesh-list
102513051|NCT00466310|Aripiprazole|aripiprazole|mesh-list
102513052|NCT00466310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102513053|NCT00466310|Serotonin Agents|serotonin agents|mesh-ancestor
102513054|NCT00466310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102513055|NCT00466310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513056|NCT00466310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513057|NCT00466310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102513058|NCT00466310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102513059|NCT00466310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102513060|NCT00466310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102513061|NCT00466310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102513062|NCT00466310|Dopamine Agents|dopamine agents|mesh-ancestor
102513063|NCT00466310|Antidepressive Agents|antidepressive agents|mesh-ancestor
102324568|NCT02011945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102513064|NCT00466310|Dopamine Agonists|dopamine agonists|mesh-ancestor
102513065|NCT00466310|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102513066|NCT00466310|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102513067|NCT00466310|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102513068|NCT00466310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102513070|NCT03463460|Sunitinib|sunitinib|mesh-list
102513071|NCT03463460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102513072|NCT03463460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102513073|NCT03463460|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102513074|NCT03463460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513075|NCT03463460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102513076|NCT03463460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102513077|NCT03463460|Growth Substances|growth substances|mesh-ancestor
102513078|NCT03463460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513079|NCT03463460|Growth Inhibitors|growth inhibitors|mesh-ancestor
102513080|NCT03463460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102513081|NCT03463460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102513082|NCT00535652|Ertapenem|ertapenem|mesh-list
102513083|NCT00535652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102513084|NCT00535652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102513085|NCT00418028|Capecitabine|capecitabine|mesh-list
102513086|NCT00418028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102513087|NCT00418028|Antimetabolites|antimetabolites|mesh-ancestor
102513088|NCT00418028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513089|NCT00418028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102513090|NCT00537290|Rituximab|rituximab|mesh-list
102513091|NCT00537290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102513092|NCT00537290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102513093|NCT00537290|Immunologic Factors|immunologic factors|mesh-ancestor
102513094|NCT00537290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513095|NCT00537290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102513096|NCT00538304|Bimatoprost|bimatoprost|mesh-list
102513097|NCT00538304|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102513098|NCT00538304|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102513099|NCT00538304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102513100|NCT00538616|Dexmedetomidine|dexmedetomidine|mesh-list
102513101|NCT00538616|Propofol|propofol|mesh-list
102513102|NCT00538616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102513103|NCT00538616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102513104|NCT00538616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513105|NCT00538616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102513106|NCT00538616|Analgesics|analgesics|mesh-ancestor
102513107|NCT00538616|Sensory System Agents|sensory system agents|mesh-ancestor
102513108|NCT00538616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102513109|NCT00538616|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102513110|NCT00538616|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102513111|NCT00538616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102513112|NCT00538616|Adrenergic Agents|adrenergic agents|mesh-ancestor
102513113|NCT00538616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102513114|NCT00538616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513115|NCT00538616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102513116|NCT00538616|Anesthetics, General|anesthetics, general|mesh-ancestor
102513117|NCT00538616|Anesthetics|anesthetics|mesh-ancestor
102513118|NCT00469274|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102513119|NCT00469274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102513120|NCT00469274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102513121|NCT00469274|Antitubercular Agents|antitubercular agents|mesh-ancestor
102513122|NCT05157126|Gentamicins|gentamicins|mesh-list
102513123|NCT05157126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102513124|NCT05157126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102513125|NCT05157126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102513126|NCT05157126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102513127|NCT05157126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513128|NCT00469508|Modafinil|modafinil|mesh-list
102513129|NCT00469508|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102513130|NCT00469508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513131|NCT00469508|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102513132|NCT00469508|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102513133|NCT00469508|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102513134|NCT00469508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513135|NCT05096832|Vaccines|vaccines|mesh-list
102513136|NCT05096832|Immunologic Factors|immunologic factors|mesh-ancestor
102324638|NCT01966003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102513137|NCT05096832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513138|NCT00470600|Ibuprofen|ibuprofen|mesh-list
102513139|NCT00470600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102513140|NCT00470600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102513141|NCT00470600|Analgesics|analgesics|mesh-ancestor
102513142|NCT00470600|Sensory System Agents|sensory system agents|mesh-ancestor
102513143|NCT00470600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102513144|NCT00470600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513145|NCT00470600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102513146|NCT00470600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102513147|NCT00470600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102513148|NCT00470600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102513149|NCT00470600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513150|NCT00471068|Timolol|timolol|mesh-list
102513151|NCT00471068|Travoprost|travoprost|mesh-list
102513152|NCT00471068|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102513153|NCT00471068|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102513154|NCT00471068|Adrenergic Agents|adrenergic agents|mesh-ancestor
102513155|NCT00471068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102513156|NCT00471068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513157|NCT00471068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513158|NCT00471068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102513159|NCT00471068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102513160|NCT00471380|Timolol|timolol|mesh-list
102513161|NCT00471380|Travoprost|travoprost|mesh-list
102513162|NCT00471380|Dorzolamide|dorzolamide|mesh-list
102513163|NCT00471380|Brinzolamide|brinzolamide|mesh-list
102513164|NCT00471380|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102513165|NCT00471380|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102513166|NCT00471380|Adrenergic Agents|adrenergic agents|mesh-ancestor
102513167|NCT00471380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102513168|NCT00471380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513169|NCT00471380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513170|NCT00471380|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102513171|NCT00471380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102513172|NCT00471380|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102513173|NCT00471380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102513174|NCT00471848|Thymoglobulin|thymoglobulin|mesh-list
102513175|NCT00471848|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102513176|NCT00471848|Immunologic Factors|immunologic factors|mesh-ancestor
102513177|NCT00471848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513178|NCT00471848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102513179|NCT00538850|Fentanyl|fentanyl|mesh-list
102513180|NCT00538850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102513181|NCT00538850|Narcotics|narcotics|mesh-ancestor
102513182|NCT00538850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102513183|NCT00538850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513184|NCT00538850|Analgesics|analgesics|mesh-ancestor
102513185|NCT00538850|Sensory System Agents|sensory system agents|mesh-ancestor
102513186|NCT00538850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102513187|NCT00538850|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102513188|NCT00538850|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102513189|NCT00538850|Anesthetics, General|anesthetics, general|mesh-ancestor
102513190|NCT00538850|Anesthetics|anesthetics|mesh-ancestor
102513191|NCT00418262|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102513192|NCT00418262|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102513193|NCT00418262|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102513194|NCT00418262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102513195|NCT00418262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513196|NCT00418262|Adrenergic Agents|adrenergic agents|mesh-ancestor
102513197|NCT00418262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102513198|NCT00418262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513199|NCT00418574|Abagovomab|abagovomab|mesh-list
102513200|NCT00418574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102513201|NCT00418574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102513202|NCT00473642|Ranibizumab|ranibizumab|mesh-list
102513203|NCT00473642|Verteporfin|verteporfin|mesh-list
102513204|NCT00473642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101989425|NCT03930875|Aspirin|aspirin|mesh-list
102513205|NCT00473642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102513206|NCT00473642|Growth Substances|growth substances|mesh-ancestor
102513207|NCT00473642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513208|NCT00473642|Growth Inhibitors|growth inhibitors|mesh-ancestor
102513209|NCT00473642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102513210|NCT00473642|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102513211|NCT00473642|Dermatologic Agents|dermatologic agents|mesh-ancestor
102513212|NCT00539942|PENTA|penta|mesh-list
102513214|NCT00539942|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102513215|NCT00539942|Antithrombins|antithrombins|mesh-ancestor
102513216|NCT00539942|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102513217|NCT00539942|Protease Inhibitors|protease inhibitors|mesh-ancestor
102513218|NCT00539942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102513219|NCT00539942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513220|NCT00539942|Anticoagulants|anticoagulants|mesh-ancestor
102513221|NCT00539942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102513222|NCT00539942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102513223|NCT00419666|Calcitriol|calcitriol|mesh-list
102513224|NCT00419666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102513225|NCT00419666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513226|NCT00419666|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102513227|NCT00419666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102513228|NCT00419666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513229|NCT00419666|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102513230|NCT00419666|Vitamins|vitamins|mesh-ancestor
102513231|NCT00419666|Micronutrients|micronutrients|mesh-ancestor
102513232|NCT00419666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102513233|NCT00540722|Acetic Acid|acetic acid|mesh-list
102513234|NCT00540722|Retinol acetate|retinol acetate|mesh-list
102513235|NCT00540722|Gossypol acetic acid|gossypol acetic acid|mesh-list
102513236|NCT00540722|Gossypol|gossypol|mesh-list
102513237|NCT00540722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102513238|NCT00540722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102513239|NCT00540722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102513240|NCT00540722|Immunologic Factors|immunologic factors|mesh-ancestor
102513241|NCT00540722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513242|NCT00540722|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102513243|NCT00540722|Protective Agents|protective agents|mesh-ancestor
102513244|NCT00540722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102513245|NCT00540722|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102513246|NCT00540722|Contraceptive Agents|contraceptive agents|mesh-ancestor
102513247|NCT00540722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102513248|NCT00540722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102513249|NCT00540722|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102513250|NCT00540722|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
102513251|NCT00540722|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
102513252|NCT00542750|Acetylcysteine|acetylcysteine|mesh-list
102513253|NCT00542750|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102513254|NCT00542750|Antiviral Agents|antiviral agents|mesh-ancestor
102513255|NCT00542750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102513256|NCT00542750|Expectorants|expectorants|mesh-ancestor
102513257|NCT00542750|Respiratory System Agents|respiratory system agents|mesh-ancestor
102513258|NCT00542750|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102513259|NCT00542750|Antioxidants|antioxidants|mesh-ancestor
102513260|NCT00542750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513261|NCT00542750|Protective Agents|protective agents|mesh-ancestor
102513262|NCT00542750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513263|NCT00542750|Antidotes|antidotes|mesh-ancestor
102513264|NCT00475904|Gabapentin|gabapentin|mesh-list
102513265|NCT00475904|Analgesics|analgesics|mesh-ancestor
102513266|NCT00475904|Sensory System Agents|sensory system agents|mesh-ancestor
102513267|NCT00475904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102513268|NCT00475904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513269|NCT00475904|Anticonvulsants|anticonvulsants|mesh-ancestor
102513270|NCT00475904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102513271|NCT00475904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102513272|NCT00475904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102513273|NCT00475904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102513274|NCT00475904|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102513275|NCT00475904|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102513276|NCT00475904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101989483|NCT03439137|Hematinics|hematinics|mesh-ancestor
102513277|NCT00475904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513278|NCT00475904|Antimanic Agents|antimanic agents|mesh-ancestor
102513279|NCT00420992|Naltrexone|naltrexone|mesh-list
102513280|NCT00420992|Morphine|morphine|mesh-list
102513281|NCT00420992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102513282|NCT00420992|Narcotics|narcotics|mesh-ancestor
102513283|NCT00420992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102513284|NCT00420992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513285|NCT00420992|Analgesics|analgesics|mesh-ancestor
102513286|NCT00420992|Sensory System Agents|sensory system agents|mesh-ancestor
102513287|NCT00420992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102513288|NCT00420992|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102513289|NCT00420992|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102513290|NCT00423878|Olanzapine|olanzapine|mesh-list
102513291|NCT00423878|Risperidone|risperidone|mesh-list
102513292|NCT00423878|Aripiprazole|aripiprazole|mesh-list
102513293|NCT00423878|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102513294|NCT00423878|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102513295|NCT00423878|Serotonin Agents|serotonin agents|mesh-ancestor
102513296|NCT00423878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102513297|NCT00423878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513298|NCT00423878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513299|NCT00423878|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102513300|NCT00423878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102513301|NCT00423878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102513302|NCT00423878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102513303|NCT00423878|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102513304|NCT00423878|Dopamine Agents|dopamine agents|mesh-ancestor
102513305|NCT00423878|Antiemetics|antiemetics|mesh-ancestor
102513306|NCT00423878|Autonomic Agents|autonomic agents|mesh-ancestor
102513307|NCT00423878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102513308|NCT00423878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102513309|NCT00423878|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102513310|NCT00423878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102513311|NCT00423878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102513312|NCT00423878|Antidepressive Agents|antidepressive agents|mesh-ancestor
102513313|NCT00423878|Dopamine Agonists|dopamine agonists|mesh-ancestor
102513314|NCT00423878|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102513315|NCT00423878|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102513316|NCT00423878|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102513317|NCT00423878|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102513318|NCT00480740|Dexmedetomidine|dexmedetomidine|mesh-list
102513319|NCT00480740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102513320|NCT00480740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102513321|NCT00480740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513322|NCT00480740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102513323|NCT00480740|Analgesics|analgesics|mesh-ancestor
102513324|NCT00480740|Sensory System Agents|sensory system agents|mesh-ancestor
102513325|NCT00480740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102513326|NCT00480740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102513327|NCT00480740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102513328|NCT00480740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102513329|NCT00480740|Adrenergic Agents|adrenergic agents|mesh-ancestor
102513330|NCT00480740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102513331|NCT00480740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513332|NCT00424502|Rituximab|rituximab|mesh-list
102513333|NCT00424502|Methotrexate|methotrexate|mesh-list
102513334|NCT00424502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102513335|NCT00424502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102513336|NCT00424502|Immunologic Factors|immunologic factors|mesh-ancestor
102513337|NCT00424502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513338|NCT00424502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102513339|NCT00424502|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102513340|NCT00424502|Abortifacient Agents|abortifacient agents|mesh-ancestor
102513341|NCT00424502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102513342|NCT00424502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102513343|NCT00424502|Antimetabolites|antimetabolites|mesh-ancestor
102513344|NCT00424502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513345|NCT00424502|Dermatologic Agents|dermatologic agents|mesh-ancestor
102513346|NCT00424502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102513347|NCT00424502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102513348|NCT00424502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102513349|NCT00424502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102513350|NCT00425672|Interleukin-2|interleukin-2|mesh-list
102513351|NCT00425672|Denileukin diftitox|denileukin diftitox|mesh-list
102513352|NCT00425672|Immunotoxins|immunotoxins|mesh-list
102513353|NCT00425672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102513354|NCT00425672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102513355|NCT00425672|Analgesics|analgesics|mesh-ancestor
102513356|NCT00425672|Sensory System Agents|sensory system agents|mesh-ancestor
102513357|NCT00425672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102513358|NCT00425672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513359|NCT00425672|Immunoconjugates|immunoconjugates|mesh-ancestor
102513360|NCT00425672|Immunologic Factors|immunologic factors|mesh-ancestor
102513361|NCT00544076|Sildenafil Citrate|sildenafil citrate|mesh-list
102513362|NCT00544076|Alprostadil|alprostadil|mesh-list
102324863|NCT01985126|Antiemetics|antiemetics|mesh-ancestor
102513363|NCT00544076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513364|NCT00544076|Vasodilator Agents|vasodilator agents|mesh-ancestor
102513365|NCT00544076|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102513366|NCT00544076|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102513367|NCT00544076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102513368|NCT00544076|Urological Agents|urological agents|mesh-ancestor
102513369|NCT00544076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102513370|NCT00544778|Doxorubicin|doxorubicin|mesh-list
102513371|NCT00544778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102513372|NCT00544778|Dexrazoxane|dexrazoxane|mesh-list
102513373|NCT00544778|Irinotecan|irinotecan|mesh-list
102513374|NCT00544778|Ifosfamide|ifosfamide|mesh-list
102513375|NCT00544778|Razoxane|razoxane|mesh-list
102513376|NCT00544778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102513377|NCT00544778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102513378|NCT00544778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102513379|NCT00544778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102513380|NCT00544778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102513381|NCT00544778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513382|NCT00544778|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102513383|NCT00544778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513384|NCT00544778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102513385|NCT00544778|Alkylating Agents|alkylating agents|mesh-ancestor
102513386|NCT00544778|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102513387|NCT00544778|Protective Agents|protective agents|mesh-ancestor
102513388|NCT00544778|Antimitotic Agents|antimitotic agents|mesh-ancestor
102513389|NCT00544778|Mitosis Modulators|mitosis modulators|mesh-ancestor
102513390|NCT00484874|Tositumomab I-131|tositumomab i-131|mesh-list
102513391|NCT00484874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102513392|NCT00486824|Indomethacin|indomethacin|mesh-list
102513393|NCT00486824|Nifedipine|nifedipine|mesh-list
102513394|NCT00486824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102513395|NCT00486824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102513396|NCT00486824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513397|NCT00486824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102513398|NCT00486824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513399|NCT00486824|Vasodilator Agents|vasodilator agents|mesh-ancestor
102513400|NCT00486824|Tocolytic Agents|tocolytic agents|mesh-ancestor
102513401|NCT00486824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102513402|NCT00486824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102513403|NCT00486824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102513404|NCT00486824|Analgesics|analgesics|mesh-ancestor
102513405|NCT00486824|Sensory System Agents|sensory system agents|mesh-ancestor
102513406|NCT00486824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102513407|NCT00486824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102513408|NCT00486824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102513409|NCT00486824|Gout Suppressants|gout suppressants|mesh-ancestor
102513410|NCT00486824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102513411|NCT00486824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102513412|NCT00489086|Tazarotene|tazarotene|mesh-list
102513413|NCT00489086|Dermatologic Agents|dermatologic agents|mesh-ancestor
102513414|NCT00489086|Keratolytic Agents|keratolytic agents|mesh-ancestor
102513415|NCT00489866|Aripiprazole|aripiprazole|mesh-list
102513416|NCT00489866|Antidepressive Agents|antidepressive agents|mesh-ancestor
102513417|NCT00489866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102513418|NCT00489866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102513419|NCT00489866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102513420|NCT00489866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102513421|NCT00489866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513422|NCT00489866|Dopamine Agonists|dopamine agonists|mesh-ancestor
102513423|NCT00489866|Dopamine Agents|dopamine agents|mesh-ancestor
102513424|NCT00489866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102513425|NCT00489866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513426|NCT00489866|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102513427|NCT00489866|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102513428|NCT00489866|Serotonin Agents|serotonin agents|mesh-ancestor
102513429|NCT00489866|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102513430|NCT00489866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102513431|NCT00489866|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102513432|NCT00489866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102513433|NCT00546104|Dasatinib|dasatinib|mesh-list
102513434|NCT00546104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102513435|NCT00546104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102513436|NCT00546104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102513437|NCT00546104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513438|NCT00546728|Metformin|metformin|mesh-list
102513439|NCT00546728|Exenatide|exenatide|mesh-list
102513440|NCT00546728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102513441|NCT00546728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513442|NCT00546728|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102513443|NCT00546728|Incretins|incretins|mesh-ancestor
102513444|NCT00546728|Hormones|hormones|mesh-ancestor
102513445|NCT00546728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102513446|NCT00547586|Bromides|bromides|mesh-list
102513447|NCT00547586|Methylnaltrexone|methylnaltrexone|mesh-list
102513448|NCT00547586|Anticonvulsants|anticonvulsants|mesh-ancestor
102513449|NCT00547586|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102513450|NCT00547586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513451|NCT00547586|Sensory System Agents|sensory system agents|mesh-ancestor
102513452|NCT00547586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102513453|NCT00548132|Chlorhexidine|chlorhexidine|mesh-list
102513454|NCT00548132|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102513455|NCT00548132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102513456|NCT00548132|Disinfectants|disinfectants|mesh-ancestor
102513457|NCT00490100|Mecasermin|mecasermin|mesh-list
102513458|NCT00490100|Growth Substances|growth substances|mesh-ancestor
102513459|NCT00490100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513460|NCT00490802|Oxytocin|oxytocin|mesh-list
102513461|NCT00490802|Oxytocics|oxytocics|mesh-ancestor
102513462|NCT00490802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102513463|NCT00490802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513464|NCT00550394|Topiramate|topiramate|mesh-list
102513465|NCT00550394|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102513466|NCT00550394|Antidepressive Agents|antidepressive agents|mesh-ancestor
102513467|NCT00550394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102513468|NCT00550394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102513469|NCT00550394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102513470|NCT00550394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102513471|NCT00550394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513472|NCT00550394|Anticonvulsants|anticonvulsants|mesh-ancestor
102513473|NCT00550394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102513474|NCT00550862|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102513475|NCT00550862|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102513476|NCT00550862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102513477|NCT00551174|Ibandronic Acid|ibandronic acid|mesh-list
102513478|NCT00551174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102513479|NCT00551174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513480|NCT00492206|Cetuximab|cetuximab|mesh-list
102513481|NCT00492206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102513482|NCT00492206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102513483|NCT00431132|Estradiol|estradiol|mesh-list
102513484|NCT00431132|Estrogens|estrogens|mesh-ancestor
102513485|NCT00431132|Hormones|hormones|mesh-ancestor
102513486|NCT00431132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102513487|NCT00431132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513488|NCT00493064|Niacin|niacin|mesh-list
102513489|NCT00493064|Nicotinic Acids|nicotinic acids|mesh-list
102513490|NCT00493064|Niacinamide|niacinamide|mesh-list
102513491|NCT00493064|Prednisolone|prednisolone|mesh-list
102513492|NCT00493064|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102513493|NCT00493064|Methylprednisolone|methylprednisolone|mesh-list
102513494|NCT00493064|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102513495|NCT00493064|Prednisolone acetate|prednisolone acetate|mesh-list
102513496|NCT00493064|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102513497|NCT00493064|Prednisolone phosphate|prednisolone phosphate|mesh-list
102513498|NCT00493064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102513499|NCT00493064|Glucocorticoids|glucocorticoids|mesh-ancestor
102513500|NCT00493064|Hormones|hormones|mesh-ancestor
102513501|NCT00493064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102513502|NCT00493064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513503|NCT00493064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102513504|NCT00493064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102513505|NCT00493064|Antiemetics|antiemetics|mesh-ancestor
102513506|NCT00493064|Autonomic Agents|autonomic agents|mesh-ancestor
102513507|NCT00493064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102513508|NCT00493064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102513509|NCT00493064|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102513510|NCT00493064|Protective Agents|protective agents|mesh-ancestor
102513511|NCT00493064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102513512|NCT00493064|Antimetabolites|antimetabolites|mesh-ancestor
102513513|NCT00493064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513514|NCT00493064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102513515|NCT00493064|Vasodilator Agents|vasodilator agents|mesh-ancestor
102513516|NCT00493064|Vitamin B Complex|vitamin b complex|mesh-ancestor
102513517|NCT00493064|Vitamins|vitamins|mesh-ancestor
102513518|NCT00493064|Micronutrients|micronutrients|mesh-ancestor
102513519|NCT00552422|Domperidone|domperidone|mesh-list
102513520|NCT00552422|Antiemetics|antiemetics|mesh-ancestor
102513521|NCT00552422|Autonomic Agents|autonomic agents|mesh-ancestor
102513522|NCT00552422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102513523|NCT00552422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513524|NCT00552422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102513525|NCT00552422|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102513526|NCT00552422|Dopamine Agents|dopamine agents|mesh-ancestor
102513527|NCT00552422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102513528|NCT00552422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513529|NCT00432458|Zoledronic Acid|zoledronic acid|mesh-list
102513530|NCT00432458|Thalidomide|thalidomide|mesh-list
102513531|NCT00432458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102513532|NCT00432458|Immunologic Factors|immunologic factors|mesh-ancestor
102513533|NCT00432458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513534|NCT00432458|Leprostatic Agents|leprostatic agents|mesh-ancestor
102513535|NCT00432458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102513536|NCT00432458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102513537|NCT00432458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102513538|NCT00432458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102513539|NCT00432458|Growth Substances|growth substances|mesh-ancestor
102513540|NCT00432458|Growth Inhibitors|growth inhibitors|mesh-ancestor
102513541|NCT00432458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102513542|NCT00432458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102513543|NCT00433550|Capecitabine|capecitabine|mesh-list
102513544|NCT00433550|Oxaliplatin|oxaliplatin|mesh-list
102513545|NCT00433550|Irinotecan|irinotecan|mesh-list
102513546|NCT00433550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102513547|NCT00433550|Antimetabolites|antimetabolites|mesh-ancestor
102513548|NCT00433550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513549|NCT00433550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102513550|NCT00433550|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102513551|NCT00433550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102513552|NCT00433550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102513553|NCT02208037|Mycophenolic Acid|mycophenolic acid|mesh-list
102513554|NCT02208037|Maraviroc|maraviroc|mesh-list
102513555|NCT02208037|Cyclophosphamide|cyclophosphamide|mesh-list
102513556|NCT02208037|Methotrexate|methotrexate|mesh-list
102513557|NCT02208037|Bortezomib|bortezomib|mesh-list
102513558|NCT02208037|Tacrolimus|tacrolimus|mesh-list
102513559|NCT02208037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102513560|NCT02208037|Immunologic Factors|immunologic factors|mesh-ancestor
102513561|NCT02208037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513562|NCT02208037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102513563|NCT02208037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102513564|NCT02208037|Alkylating Agents|alkylating agents|mesh-ancestor
102513565|NCT02208037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513566|NCT02208037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102513567|NCT02208037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102513568|NCT02208037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102513569|NCT02208037|Abortifacient Agents|abortifacient agents|mesh-ancestor
102513570|NCT02208037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102513571|NCT02208037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102513572|NCT02208037|Antimetabolites|antimetabolites|mesh-ancestor
102513573|NCT02208037|Dermatologic Agents|dermatologic agents|mesh-ancestor
102513574|NCT02208037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102513575|NCT02208037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102513576|NCT02208037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102513577|NCT02208037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102513578|NCT02208037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102513579|NCT02208037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102513580|NCT02208037|Antitubercular Agents|antitubercular agents|mesh-ancestor
102513581|NCT02208037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102513582|NCT02208037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102513583|NCT02208037|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102513584|NCT02208037|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102513585|NCT02208037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102513586|NCT02208037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102513587|NCT02208037|Antiviral Agents|antiviral agents|mesh-ancestor
102513588|NCT02208037|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102513589|NCT03007927|Dexamethasone|dexamethasone|mesh-list
102513590|NCT03007927|Bupivacaine|bupivacaine|mesh-list
102513591|NCT03007927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102513592|NCT03007927|Antiemetics|antiemetics|mesh-ancestor
102513593|NCT03007927|Autonomic Agents|autonomic agents|mesh-ancestor
102513594|NCT03007927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102513595|NCT03007927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513597|NCT03007927|Glucocorticoids|glucocorticoids|mesh-ancestor
102513598|NCT03007927|Hormones|hormones|mesh-ancestor
102513599|NCT03007927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102513600|NCT03007927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102513601|NCT03007927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102513602|NCT03007927|Anesthetics, Local|anesthetics, local|mesh-ancestor
102513603|NCT03007927|Anesthetics|anesthetics|mesh-ancestor
102513604|NCT03007927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102513605|NCT03007927|Sensory System Agents|sensory system agents|mesh-ancestor
102513606|NCT05041842|Trastuzumab|trastuzumab|mesh-list
102513607|NCT05041842|Pertuzumab|pertuzumab|mesh-list
102513608|NCT05041842|Tucatinib|tucatinib|mesh-list
102513609|NCT05041842|Hormones|hormones|mesh-list
102513610|NCT05041842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102513611|NCT05041842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102513612|NCT05041842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102513613|NCT05041842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513614|NCT05041842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102513615|NCT05041842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102513616|NCT05041842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513617|NCT05150496|Vaccines|vaccines|mesh-list
102513618|NCT05150496|Immunologic Factors|immunologic factors|mesh-ancestor
102513619|NCT05150496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513620|NCT00496340|Rituximab|rituximab|mesh-list
102513621|NCT00496340|Busulfan|busulfan|mesh-list
102513622|NCT00496340|Pentostatin|pentostatin|mesh-list
102513623|NCT00496340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102513624|NCT00496340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102513625|NCT00496340|Immunologic Factors|immunologic factors|mesh-ancestor
102513626|NCT00496340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513627|NCT00496340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102513628|NCT00496340|Alkylating Agents|alkylating agents|mesh-ancestor
102513629|NCT00496340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513630|NCT00496340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102513631|NCT00496340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102513632|NCT00496340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102513633|NCT00496340|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
102513634|NCT00496340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102513635|NCT05090358|Canagliflozin|canagliflozin|mesh-list
102513636|NCT05090358|Fulvestrant|fulvestrant|mesh-list
102513637|NCT05090358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102513638|NCT05090358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102513639|NCT05090358|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102513640|NCT05090358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102513641|NCT05090358|Hormone Antagonists|hormone antagonists|mesh-ancestor
101989843|NCT01225913|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102513642|NCT05090358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102513643|NCT05090358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513644|NCT05090358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102513645|NCT05090358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513646|NCT05090358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102513647|NCT00496808|Trastuzumab|trastuzumab|mesh-list
102513648|NCT00496808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102513649|NCT00496808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102513650|NCT05148078|Anesthetics|anesthetics|mesh-list
102513651|NCT05148078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102513652|NCT05148078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513653|NCT01795820|Ticagrelor|ticagrelor|mesh-list
102513654|NCT01795820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102513655|NCT01795820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102513656|NCT01795820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102513657|NCT01795820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102513658|NCT01795820|Purinergic Agents|purinergic agents|mesh-ancestor
102513659|NCT01795820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102513660|NCT01795820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513661|NCT01795820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513662|NCT01484041|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102513663|NCT01484041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102513664|NCT01484041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102325159|NCT01962103|Paclitaxel|paclitaxel|mesh-list
102513665|NCT01484041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513666|NCT01484041|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102513667|NCT01484041|Hormone Antagonists|hormone antagonists|mesh-ancestor
102513668|NCT01484041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102513669|NCT01484041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513670|NCT00555152|Lapatinib|lapatinib|mesh-list
102513671|NCT00555152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102513672|NCT00555152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102513673|NCT00555152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102513674|NCT00555152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513675|NCT01461499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
102513676|NCT01461499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513677|NCT00555464|Prednisone|prednisone|mesh-list
102513678|NCT00555464|Prednisolone|prednisolone|mesh-list
102513679|NCT00555464|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102513680|NCT00555464|Methylprednisolone|methylprednisolone|mesh-list
102513681|NCT00555464|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102513682|NCT00555464|Prednisolone acetate|prednisolone acetate|mesh-list
102513683|NCT00555464|Vincristine|vincristine|mesh-list
102513684|NCT00555464|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102513685|NCT00555464|Prednisolone phosphate|prednisolone phosphate|mesh-list
102513686|NCT00555464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102513687|NCT00555464|Glucocorticoids|glucocorticoids|mesh-ancestor
102513688|NCT00555464|Hormones|hormones|mesh-ancestor
102513689|NCT00555464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102513690|NCT00555464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513691|NCT00555464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102513692|NCT00555464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102513693|NCT00555464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102513694|NCT00555464|Tubulin Modulators|tubulin modulators|mesh-ancestor
102513695|NCT00555464|Antimitotic Agents|antimitotic agents|mesh-ancestor
102513696|NCT00555464|Mitosis Modulators|mitosis modulators|mesh-ancestor
102513697|NCT00555464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513698|NCT00555464|Antiemetics|antiemetics|mesh-ancestor
102513699|NCT00555464|Autonomic Agents|autonomic agents|mesh-ancestor
102513700|NCT00555464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102513701|NCT00555464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102513702|NCT00555464|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102513703|NCT00555464|Protective Agents|protective agents|mesh-ancestor
102513704|NCT01795976|Cyclophosphamide|cyclophosphamide|mesh-list
102513705|NCT01795976|Fludarabine|fludarabine|mesh-list
102513706|NCT01795976|Interleukin-2|interleukin-2|mesh-list
102513707|NCT01795976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102513708|NCT01795976|Immunologic Factors|immunologic factors|mesh-ancestor
102513709|NCT01795976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513710|NCT01795976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102513711|NCT01795976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102513712|NCT01795976|Alkylating Agents|alkylating agents|mesh-ancestor
102513713|NCT01795976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513714|NCT01795976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102513715|NCT01795976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102513716|NCT01795976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102513717|NCT01795976|Analgesics|analgesics|mesh-ancestor
102513718|NCT01795976|Sensory System Agents|sensory system agents|mesh-ancestor
102513719|NCT01795976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102513720|NCT01461733|Amiodarone|amiodarone|mesh-list
102513721|NCT01461733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102513722|NCT01461733|Vasodilator Agents|vasodilator agents|mesh-ancestor
102513723|NCT01461733|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102513724|NCT01461733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102513725|NCT01461733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513726|NCT01461733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102513727|NCT01461733|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102513728|NCT01461733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102513729|NCT01461733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102513730|NCT01461733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102513731|NCT01461733|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102513732|NCT01461733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102513733|NCT01462279|Thiamine|thiamine|mesh-list
102513734|NCT01462279|Vitamin B Complex|vitamin b complex|mesh-ancestor
102513735|NCT01462279|Vitamins|vitamins|mesh-ancestor
102513736|NCT01462279|Micronutrients|micronutrients|mesh-ancestor
102325233|NCT02007434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102513737|NCT01462279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513739|NCT00435812|Immunologic Factors|immunologic factors|mesh-ancestor
102513740|NCT00435812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513741|NCT05081466|Vitamin D|vitamin d|mesh-list
102513742|NCT05081466|Calcium|calcium|mesh-list
102513743|NCT05081466|Vitamins|vitamins|mesh-ancestor
102513744|NCT05081466|Micronutrients|micronutrients|mesh-ancestor
102513745|NCT05081466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513746|NCT05081466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102513747|NCT05081466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102513748|NCT01464229|Iloperidone|iloperidone|mesh-list
102513749|NCT01464229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102513750|NCT01464229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102513751|NCT01464229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102513752|NCT01464229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513753|NCT01464229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102513754|NCT00556478|Lidocaine|lidocaine|mesh-list
102513755|NCT00556478|Prilocaine|prilocaine|mesh-list
102513756|NCT00556478|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
102513757|NCT00556478|Anesthetics, Local|anesthetics, local|mesh-ancestor
102513758|NCT00556478|Anesthetics|anesthetics|mesh-ancestor
102513759|NCT00556478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102513760|NCT00556478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513761|NCT00556478|Sensory System Agents|sensory system agents|mesh-ancestor
102513762|NCT00556478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102513763|NCT00556478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102513764|NCT00556478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102513765|NCT00556478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102513766|NCT00556478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102513767|NCT00556478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513768|NCT00556478|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
102513769|NCT00500240|Insulin|insulin|mesh-list
102513770|NCT00500240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102513771|NCT00500240|Insulin Glargine|insulin glargine|mesh-list
102513772|NCT00500240|Insulin Aspart|insulin aspart|mesh-list
102513773|NCT00500240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102513774|NCT00500240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513775|NCT01469767|Fluocinonide|fluocinonide|mesh-list
102513776|NCT01469767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102513777|NCT01469767|Glucocorticoids|glucocorticoids|mesh-ancestor
102513778|NCT01469767|Hormones|hormones|mesh-ancestor
102513779|NCT01469767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102513780|NCT01469767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513781|NCT01469767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102513782|NCT05029596|Heparin|heparin|mesh-list
102513783|NCT05029596|Calcium heparin|calcium heparin|mesh-list
102513784|NCT05029596|Anticoagulants|anticoagulants|mesh-ancestor
102513785|NCT05029596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102513786|NCT05029596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102513787|NCT05029596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513788|NCT03246620|Diazepam|diazepam|mesh-list
102513789|NCT03246620|Haloperidol|haloperidol|mesh-list
102513790|NCT03246620|Olanzapine|olanzapine|mesh-list
102513791|NCT03246620|Haloperidol decanoate|haloperidol decanoate|mesh-list
102513792|NCT03246620|Antiemetics|antiemetics|mesh-ancestor
102513793|NCT03246620|Autonomic Agents|autonomic agents|mesh-ancestor
102513794|NCT03246620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102513795|NCT03246620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513796|NCT03246620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102513797|NCT03246620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102513798|NCT03246620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102513799|NCT03246620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102513800|NCT03246620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102513801|NCT03246620|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102513802|NCT03246620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102513803|NCT03246620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102513804|NCT03246620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513805|NCT03246620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102513806|NCT03246620|Serotonin Agents|serotonin agents|mesh-ancestor
102513807|NCT03246620|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102513808|NCT03246620|Dopamine Agents|dopamine agents|mesh-ancestor
102513809|NCT03246620|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102513810|NCT03246620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102513811|NCT03246620|Anticonvulsants|anticonvulsants|mesh-ancestor
102513812|NCT03246620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102513813|NCT03246620|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102513814|NCT03246620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102513815|NCT03246620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102513816|NCT03246620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102513817|NCT03246620|Anesthetics, General|anesthetics, general|mesh-ancestor
102513818|NCT03246620|Anesthetics|anesthetics|mesh-ancestor
102513819|NCT03246620|GABA Modulators|gaba modulators|mesh-ancestor
102513820|NCT03246620|GABA Agents|gaba agents|mesh-ancestor
102513821|NCT05080218|Adalimumab|adalimumab|mesh-list
102513822|NCT05080218|Golimumab|golimumab|mesh-list
102513823|NCT05080218|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
102513824|NCT05080218|Etanercept|etanercept|mesh-list
102513825|NCT05080218|Abatacept|abatacept|mesh-list
102513826|NCT05080218|Upadacitinib|upadacitinib|mesh-list
102513827|NCT05080218|Ixekizumab|ixekizumab|mesh-list
102513828|NCT05080218|Tofacitinib|tofacitinib|mesh-list
102513829|NCT05080218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102513830|NCT05080218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102513831|NCT05080218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102513832|NCT05080218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102513833|NCT05080218|Analgesics|analgesics|mesh-ancestor
102513834|NCT05080218|Sensory System Agents|sensory system agents|mesh-ancestor
102513835|NCT05080218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102513836|NCT05080218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513837|NCT05080218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101990057|NCT01226771|Ribavirin|ribavirin|mesh-list
102513838|NCT05080218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102513839|NCT05080218|Immunologic Factors|immunologic factors|mesh-ancestor
102513840|NCT05080218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102513841|NCT05080218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513842|NCT05080218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102513843|NCT05080218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102513844|NCT05080218|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102513845|NCT05080218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102513846|NCT05080218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102513847|NCT05080218|Dermatologic Agents|dermatologic agents|mesh-ancestor
102513848|NCT01470859|Levodopa|levodopa|mesh-list
102513849|NCT01470859|Carbidopa|carbidopa|mesh-list
102513850|NCT01470859|Pramipexole|pramipexole|mesh-list
102513851|NCT01470859|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102513852|NCT01470859|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102513853|NCT01470859|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102513854|NCT01470859|Dopamine Agents|dopamine agents|mesh-ancestor
102513855|NCT01470859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102513856|NCT01470859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513857|NCT01470859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513858|NCT01470859|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102513859|NCT01470859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102513860|NCT01470859|Antioxidants|antioxidants|mesh-ancestor
102513861|NCT01470859|Protective Agents|protective agents|mesh-ancestor
102513862|NCT01470859|Dopamine Agonists|dopamine agonists|mesh-ancestor
102513863|NCT01470859|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102513864|NCT01470859|Immunologic Factors|immunologic factors|mesh-ancestor
102513865|NCT00436046|Interferons|interferons|mesh-list
102513866|NCT00436046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102513867|NCT00436046|Antiviral Agents|antiviral agents|mesh-ancestor
102513868|NCT00436046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102513869|NCT01471639|Ketorolac|ketorolac|mesh-list
102513870|NCT01471639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102513871|NCT01471639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102513872|NCT01471639|Analgesics|analgesics|mesh-ancestor
102513873|NCT01471639|Sensory System Agents|sensory system agents|mesh-ancestor
102513874|NCT01471639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102513875|NCT01471639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513876|NCT01471639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102513877|NCT01471639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102513878|NCT01471639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102513879|NCT01471639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102513880|NCT01471639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513881|NCT05622656|Dexmedetomidine|dexmedetomidine|mesh-list
102513882|NCT05622656|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102513883|NCT05622656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102513884|NCT05622656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513885|NCT05622656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102325389|NCT02006732|Parasympatholytics|parasympatholytics|mesh-ancestor
102513886|NCT05622656|Analgesics|analgesics|mesh-ancestor
102513887|NCT05622656|Sensory System Agents|sensory system agents|mesh-ancestor
102513888|NCT05622656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102513889|NCT05622656|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102513890|NCT05622656|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102513891|NCT05622656|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102513892|NCT05622656|Adrenergic Agents|adrenergic agents|mesh-ancestor
102513893|NCT05622656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102513894|NCT05622656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513895|NCT05079126|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
102513896|NCT05079126|Antioxidants|antioxidants|mesh-ancestor
102513897|NCT05079126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513898|NCT05079126|Protective Agents|protective agents|mesh-ancestor
102513899|NCT05079126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513900|NCT05079126|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102513901|NCT05079126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102513902|NCT05140278|Artesunate|artesunate|mesh-list
102513903|NCT05140278|Antimalarials|antimalarials|mesh-ancestor
102513904|NCT05140278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102513905|NCT05140278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102513906|NCT05140278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102513907|NCT05140278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102513908|NCT05140278|Antiviral Agents|antiviral agents|mesh-ancestor
102513909|NCT05140278|Schistosomicides|schistosomicides|mesh-ancestor
102513910|NCT05140278|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102513911|NCT05140278|Anthelmintics|anthelmintics|mesh-ancestor
102513912|NCT00436904|Rituximab|rituximab|mesh-list
102513913|NCT00436904|Alemtuzumab|alemtuzumab|mesh-list
102513914|NCT00436904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102513915|NCT00436904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102513916|NCT00436904|Immunologic Factors|immunologic factors|mesh-ancestor
102513917|NCT00436904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513918|NCT00436904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102513919|NCT00438854|Dasatinib|dasatinib|mesh-list
102513920|NCT00438854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102513921|NCT00438854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102513922|NCT00438854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102513923|NCT00438854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513924|NCT01485055|Infliximab|infliximab|mesh-list
102513925|NCT01485055|Basiliximab|basiliximab|mesh-list
102513926|NCT01485055|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102513927|NCT01485055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102513928|NCT01485055|Dermatologic Agents|dermatologic agents|mesh-ancestor
102513929|NCT01485055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102513930|NCT01485055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102513931|NCT01485055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102513932|NCT01485055|Immunologic Factors|immunologic factors|mesh-ancestor
102513933|NCT01485055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513934|NCT05028348|Dexamethasone|dexamethasone|mesh-list
102513935|NCT05028348|Pomalidomide|pomalidomide|mesh-list
102513936|NCT05028348|Elotuzumab|elotuzumab|mesh-list
102513937|NCT05028348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102513938|NCT05028348|Antiemetics|antiemetics|mesh-ancestor
102513939|NCT05028348|Autonomic Agents|autonomic agents|mesh-ancestor
102513940|NCT05028348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102513941|NCT05028348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513942|NCT05028348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102513943|NCT05028348|Glucocorticoids|glucocorticoids|mesh-ancestor
102513944|NCT05028348|Hormones|hormones|mesh-ancestor
102513945|NCT05028348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102513946|NCT05028348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102513947|NCT05028348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102513948|NCT05028348|Immunologic Factors|immunologic factors|mesh-ancestor
102513949|NCT05028348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102513950|NCT05028348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102513951|NCT05028348|Growth Substances|growth substances|mesh-ancestor
102513952|NCT05028348|Growth Inhibitors|growth inhibitors|mesh-ancestor
102513953|NCT01486615|Melatonin|melatonin|mesh-list
102513954|NCT01486615|Alprazolam|alprazolam|mesh-list
102513955|NCT01486615|Azaperone|azaperone|mesh-list
102513956|NCT01486615|Antioxidants|antioxidants|mesh-ancestor
102513957|NCT01486615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513958|NCT01486615|Protective Agents|protective agents|mesh-ancestor
102513959|NCT01486615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513960|NCT01486615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102325458|NCT02006576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102513961|NCT01486615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102513962|NCT01486615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102513963|NCT01486615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102513964|NCT01486615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102513965|NCT01486615|GABA Modulators|gaba modulators|mesh-ancestor
102513966|NCT01486615|GABA Agents|gaba agents|mesh-ancestor
102513967|NCT01486615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102513968|NCT01486615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102513969|NCT01486615|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102513970|NCT01486615|Dopamine Agents|dopamine agents|mesh-ancestor
102513971|NCT00503750|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102513972|NCT00503750|Vinorelbine|vinorelbine|mesh-list
102513973|NCT00503750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102513974|NCT00503750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102513975|NCT00503750|Tubulin Modulators|tubulin modulators|mesh-ancestor
102513976|NCT00503750|Antimitotic Agents|antimitotic agents|mesh-ancestor
102513977|NCT00503750|Mitosis Modulators|mitosis modulators|mesh-ancestor
102513978|NCT00503750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513979|NCT05077332|Celecoxib|celecoxib|mesh-list
102513980|NCT05077332|Famotidine|famotidine|mesh-list
102513981|NCT05077332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102513982|NCT05077332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102513983|NCT05077332|Analgesics|analgesics|mesh-ancestor
102513984|NCT05077332|Sensory System Agents|sensory system agents|mesh-ancestor
102513985|NCT05077332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102513986|NCT05077332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102513987|NCT05077332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102513988|NCT05077332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102513989|NCT05077332|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102513990|NCT05077332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102513991|NCT05077332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102513992|NCT05077332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102513993|NCT05077332|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102513994|NCT05077332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102513995|NCT05077332|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102513996|NCT05077332|Histamine Antagonists|histamine antagonists|mesh-ancestor
102513997|NCT05077332|Histamine Agents|histamine agents|mesh-ancestor
102513998|NCT05077332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102513999|NCT00439946|Treprostinil|treprostinil|mesh-list
102514000|NCT00439946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102514001|NCT04227678|Heparin|heparin|mesh-list
102514002|NCT04227678|Anticoagulants|anticoagulants|mesh-ancestor
102514003|NCT04227678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102514004|NCT04227678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102514005|NCT04227678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514006|NCT00508118|Nicardipine|nicardipine|mesh-list
102514007|NCT00508118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102514008|NCT00508118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102514009|NCT00508118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102514010|NCT00508118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514011|NCT00508118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102514012|NCT00508118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514013|NCT00508118|Vasodilator Agents|vasodilator agents|mesh-ancestor
102514014|NCT05139030|Bupivacaine|bupivacaine|mesh-list
102514015|NCT05139030|Anesthetics, Local|anesthetics, local|mesh-ancestor
102514016|NCT05139030|Anesthetics|anesthetics|mesh-ancestor
102514017|NCT05139030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102514018|NCT05139030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514019|NCT05139030|Sensory System Agents|sensory system agents|mesh-ancestor
102514020|NCT05139030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102514021|NCT00440180|Anastrozole|anastrozole|mesh-list
102514022|NCT00440180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102514023|NCT00440180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102514024|NCT00440180|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102514025|NCT00440180|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102514026|NCT00440180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102514027|NCT00440180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514028|NCT00440180|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102514029|NCT00440180|Hormone Antagonists|hormone antagonists|mesh-ancestor
102514030|NCT00440180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102514031|NCT00440180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514032|NCT05021484|Felzartamab|felzartamab|mesh-list
102514033|NCT05021484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102514034|NCT05021484|Immunologic Factors|immunologic factors|mesh-ancestor
102514035|NCT05021484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514036|NCT05021094|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102514037|NCT05021094|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102514038|NCT05021094|Estradiol|estradiol|mesh-list
102325538|NCT01472380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102514039|NCT05021094|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102514040|NCT05021094|Dydrogesterone|dydrogesterone|mesh-list
102514041|NCT05021094|Estrogens|estrogens|mesh-ancestor
102514042|NCT05021094|Hormones|hormones|mesh-ancestor
102514043|NCT05021094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102514044|NCT05021094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514045|NCT05021094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102514046|NCT05021094|Contraceptive Agents|contraceptive agents|mesh-ancestor
102514047|NCT05021094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102514048|NCT05021094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102514049|NCT05021094|Progestins|progestins|mesh-ancestor
102514050|NCT01364298|Pregabalin|pregabalin|mesh-list
102514051|NCT01364298|Gabapentin|gabapentin|mesh-list
102514052|NCT01364298|Analgesics|analgesics|mesh-ancestor
102514053|NCT01364298|Sensory System Agents|sensory system agents|mesh-ancestor
102514054|NCT01364298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102514055|NCT01364298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514056|NCT01364298|Anticonvulsants|anticonvulsants|mesh-ancestor
102514057|NCT01364298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102514058|NCT01364298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102514059|NCT01364298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514060|NCT01364298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102514061|NCT01364298|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102514062|NCT01364298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102514063|NCT01364298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102514064|NCT01364298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102514065|NCT01364298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102514066|NCT01364298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102514067|NCT01364298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102514068|NCT01364298|Antimanic Agents|antimanic agents|mesh-ancestor
102514069|NCT04421742|Beclomethasone|beclomethasone|mesh-list
102514070|NCT04421742|Formoterol Fumarate|formoterol fumarate|mesh-list
102514071|NCT04421742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102514072|NCT04421742|Autonomic Agents|autonomic agents|mesh-ancestor
102514073|NCT04421742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102514074|NCT04421742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514075|NCT04421742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102514076|NCT04421742|Respiratory System Agents|respiratory system agents|mesh-ancestor
102514077|NCT04421742|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102514078|NCT04421742|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102514079|NCT04421742|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102514080|NCT04421742|Adrenergic Agents|adrenergic agents|mesh-ancestor
102514081|NCT04421742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102514082|NCT04421742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514083|NCT04421742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102514084|NCT04421742|Glucocorticoids|glucocorticoids|mesh-ancestor
102514085|NCT04421742|Hormones|hormones|mesh-ancestor
102514086|NCT04421742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101990310|NCT01227239|Oxaliplatin|oxaliplatin|mesh-list
102514087|NCT01488019|Formoterol Fumarate|formoterol fumarate|mesh-list
102514088|NCT01488019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102514089|NCT01488019|Autonomic Agents|autonomic agents|mesh-ancestor
102514090|NCT01488019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102514091|NCT01488019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514092|NCT01488019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102514093|NCT01488019|Respiratory System Agents|respiratory system agents|mesh-ancestor
102514094|NCT01488019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102514095|NCT01488019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102514096|NCT01488019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102514097|NCT01488019|Adrenergic Agents|adrenergic agents|mesh-ancestor
102514098|NCT01488019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102514099|NCT01488019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514100|NCT01488409|Acipimox|acipimox|mesh-list
102514101|NCT01488409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102514102|NCT01488409|Antimetabolites|antimetabolites|mesh-ancestor
102514103|NCT01488409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514104|NCT01488409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102514105|NCT01488877|Spironolactone|spironolactone|mesh-list
102514106|NCT01488877|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102514107|NCT01488877|Hormone Antagonists|hormone antagonists|mesh-ancestor
102514108|NCT01488877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102514109|NCT01488877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514110|NCT01488877|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102514111|NCT01488877|Diuretics|diuretics|mesh-ancestor
102514112|NCT01488877|Natriuretic Agents|natriuretic agents|mesh-ancestor
102514114|NCT01364922|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
102514115|NCT01364922|Hydrocodone|hydrocodone|mesh-list
102514116|NCT01364922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102514117|NCT01364922|Analgesics|analgesics|mesh-ancestor
102514118|NCT01364922|Sensory System Agents|sensory system agents|mesh-ancestor
102514119|NCT01364922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102514120|NCT01364922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514121|NCT01364922|Antipyretics|antipyretics|mesh-ancestor
102514122|NCT01364922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102514123|NCT01364922|Narcotics|narcotics|mesh-ancestor
102514124|NCT01364922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102514125|NCT01364922|Antitussive Agents|antitussive agents|mesh-ancestor
102514126|NCT01364922|Respiratory System Agents|respiratory system agents|mesh-ancestor
102514127|NCT01364922|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102514128|NCT01364922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102514129|NCT01364922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102514130|NCT01489969|Melatonin|melatonin|mesh-list
102514131|NCT01489969|Antioxidants|antioxidants|mesh-ancestor
102514132|NCT01489969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514133|NCT01489969|Protective Agents|protective agents|mesh-ancestor
102514134|NCT01489969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514135|NCT01489969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102514136|NCT00509288|Aldesleukin|aldesleukin|mesh-list
102514137|NCT00509288|Cyclophosphamide|cyclophosphamide|mesh-list
102514138|NCT00509288|Fludarabine|fludarabine|mesh-list
102514139|NCT00509288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102514140|NCT00509288|Immunologic Factors|immunologic factors|mesh-ancestor
102514141|NCT00509288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514142|NCT00509288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102514143|NCT00509288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102514144|NCT00509288|Alkylating Agents|alkylating agents|mesh-ancestor
102514145|NCT00509288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514146|NCT00509288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102514147|NCT00509288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102514148|NCT00509288|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102514149|NCT00509288|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102514150|NCT00509288|Antiviral Agents|antiviral agents|mesh-ancestor
102514151|NCT00509288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102514152|NCT00442364|Polidocanol|polidocanol|mesh-list
102514153|NCT00442364|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102514154|NCT00442364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102514155|NCT00510224|Octreotide|octreotide|mesh-list
102514156|NCT00510224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102514157|NCT00510224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102514158|NCT00510224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102514159|NCT05070156|Vaccines|vaccines|mesh-list
102514160|NCT05070156|Immunologic Factors|immunologic factors|mesh-ancestor
102514161|NCT05070156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514162|NCT00511706|Dexamethasone|dexamethasone|mesh-list
102514163|NCT00511706|Ranibizumab|ranibizumab|mesh-list
102514164|NCT00511706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102514165|NCT00511706|Antiemetics|antiemetics|mesh-ancestor
102514166|NCT00511706|Autonomic Agents|autonomic agents|mesh-ancestor
102514167|NCT00511706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102514168|NCT00511706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514169|NCT00511706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102514170|NCT00511706|Glucocorticoids|glucocorticoids|mesh-ancestor
102514171|NCT00511706|Hormones|hormones|mesh-ancestor
102514172|NCT00511706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102514173|NCT00511706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102514174|NCT00511706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102514175|NCT00511706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102514176|NCT00511706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102514177|NCT00511706|Growth Substances|growth substances|mesh-ancestor
102514178|NCT00511706|Growth Inhibitors|growth inhibitors|mesh-ancestor
102514179|NCT05067894|Vaccines|vaccines|mesh-list
102514180|NCT05067894|Immunologic Factors|immunologic factors|mesh-ancestor
102514181|NCT05067894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514182|NCT01493947|Metronidazole|metronidazole|mesh-list
102514183|NCT01493947|Ivermectin|ivermectin|mesh-list
102514184|NCT01493947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102514185|NCT01493947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102514186|NCT01493947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102514187|NCT01493947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102514188|NCT00445484|Lenalidomide|lenalidomide|mesh-list
102514189|NCT00445484|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102514190|NCT00445484|Immunologic Factors|immunologic factors|mesh-ancestor
102514191|NCT00445484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514192|NCT00445484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102514193|NCT00445484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102514194|NCT00445484|Growth Substances|growth substances|mesh-ancestor
102514195|NCT00445484|Growth Inhibitors|growth inhibitors|mesh-ancestor
102514196|NCT00445484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102514197|NCT01495585|Lonafarnib|lonafarnib|mesh-list
102514198|NCT01495585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102514199|NCT01495585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514200|NCT00446264|Sirolimus|sirolimus|mesh-list
102514201|NCT00446264|Tacrolimus|tacrolimus|mesh-list
102514202|NCT00446264|Daclizumab|daclizumab|mesh-list
102514203|NCT00446264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102514204|NCT00446264|Immunologic Factors|immunologic factors|mesh-ancestor
102514205|NCT00446264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514206|NCT00446264|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102514207|NCT00446264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102514208|NCT00446264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514209|NCT00446264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102514210|NCT00446264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102514211|NCT00446264|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102514212|NCT00446264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102514213|NCT00446264|Antifungal Agents|antifungal agents|mesh-ancestor
102514214|NCT01495819|Nicotine|nicotine|mesh-list
102514215|NCT01495819|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102514216|NCT01495819|Autonomic Agents|autonomic agents|mesh-ancestor
102514217|NCT01495819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102514218|NCT01495819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514219|NCT01495819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102514220|NCT01495819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102514221|NCT01495819|Cholinergic Agents|cholinergic agents|mesh-ancestor
102514222|NCT01495819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102514223|NCT01495819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514224|NCT04214886|Cyclophosphamide|cyclophosphamide|mesh-list
102514225|NCT04214886|Fludarabine|fludarabine|mesh-list
102514226|NCT04214886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102514227|NCT04214886|Immunologic Factors|immunologic factors|mesh-ancestor
102514228|NCT04214886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514229|NCT04214886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102514230|NCT04214886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102514231|NCT04214886|Alkylating Agents|alkylating agents|mesh-ancestor
102514232|NCT04214886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514233|NCT04214886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102514234|NCT04214886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102514235|NCT00512876|Bevacizumab|bevacizumab|mesh-list
102514236|NCT00512876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102514237|NCT00512876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102514238|NCT00512876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102514239|NCT00512876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102514240|NCT00512876|Growth Substances|growth substances|mesh-ancestor
102514241|NCT00512876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514242|NCT00512876|Growth Inhibitors|growth inhibitors|mesh-ancestor
102514243|NCT05127876|Ephedrine|ephedrine|mesh-list
102514244|NCT05127876|Pseudoephedrine|pseudoephedrine|mesh-list
102514245|NCT05127876|Ondansetron|ondansetron|mesh-list
102514246|NCT05127876|Antiemetics|antiemetics|mesh-ancestor
102514247|NCT05127876|Autonomic Agents|autonomic agents|mesh-ancestor
102514248|NCT05127876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102514249|NCT05127876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514250|NCT05127876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102514251|NCT05127876|Antipruritics|antipruritics|mesh-ancestor
102514252|NCT05127876|Dermatologic Agents|dermatologic agents|mesh-ancestor
102514253|NCT05127876|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102514254|NCT05127876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102514255|NCT05127876|Serotonin Agents|serotonin agents|mesh-ancestor
102514256|NCT05127876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102514257|NCT05127876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514258|NCT05127876|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102514259|NCT05127876|Sympathomimetics|sympathomimetics|mesh-ancestor
102514260|NCT05127876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102514261|NCT05127876|Adrenergic Agents|adrenergic agents|mesh-ancestor
102514262|NCT05127876|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102514263|NCT05127876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102514265|NCT05127876|Nasal Decongestants|nasal decongestants|mesh-ancestor
102514266|NCT01496131|Cyclophosphamide|cyclophosphamide|mesh-list
102514267|NCT01496131|Goserelin|goserelin|mesh-list
102514268|NCT01496131|Immunologic Factors|immunologic factors|mesh-ancestor
102514269|NCT01496131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514270|NCT01496131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102514271|NCT01496131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102514272|NCT01496131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102514273|NCT01496131|Alkylating Agents|alkylating agents|mesh-ancestor
102514274|NCT01496131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514275|NCT01496131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102514276|NCT01496131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102514277|NCT01496131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102514278|NCT02520726|Sertraline|sertraline|mesh-list
102514279|NCT02520726|Antidepressive Agents|antidepressive agents|mesh-ancestor
102514280|NCT02520726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102514281|NCT02520726|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102514282|NCT02520726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102514283|NCT02520726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102514284|NCT02520726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514285|NCT02520726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102514286|NCT02520726|Serotonin Agents|serotonin agents|mesh-ancestor
102514287|NCT02520726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514288|NCT00450242|Lidocaine|lidocaine|mesh-list
102514289|NCT00450242|Anesthetics, Local|anesthetics, local|mesh-ancestor
102514290|NCT00450242|Anesthetics|anesthetics|mesh-ancestor
101990490|NCT05165914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102514291|NCT00450242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102514292|NCT00450242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514293|NCT00450242|Sensory System Agents|sensory system agents|mesh-ancestor
102514294|NCT00450242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102514295|NCT00450242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102514296|NCT00450242|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102514297|NCT00450242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102514298|NCT00450242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102514299|NCT00450242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514300|NCT00517010|Ranibizumab|ranibizumab|mesh-list
102514301|NCT00517010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102514302|NCT00517010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102514303|NCT00517010|Growth Substances|growth substances|mesh-ancestor
102514304|NCT00517010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514305|NCT00517010|Growth Inhibitors|growth inhibitors|mesh-ancestor
102514306|NCT00517010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102514307|NCT00517556|Contraceptive Agents|contraceptive agents|mesh-list
102514308|NCT00517556|Contraceptives, Oral|contraceptives, oral|mesh-list
102514309|NCT00517556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102514310|NCT00517556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514311|NCT00517556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102514312|NCT00519584|Bupivacaine|bupivacaine|mesh-list
102514313|NCT00519584|Ropivacaine|ropivacaine|mesh-list
102514314|NCT00519584|Anesthetics, Local|anesthetics, local|mesh-ancestor
102514315|NCT00519584|Anesthetics|anesthetics|mesh-ancestor
102514316|NCT00519584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102514317|NCT00519584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514318|NCT00519584|Sensory System Agents|sensory system agents|mesh-ancestor
102514319|NCT00519584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102514320|NCT05122884|Milrinone|milrinone|mesh-list
102514321|NCT05122884|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102514322|NCT05122884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102514323|NCT05122884|Vasodilator Agents|vasodilator agents|mesh-ancestor
102514324|NCT05122884|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102514325|NCT05122884|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102514326|NCT05122884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102514327|NCT05122884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514328|NCT05122884|Protective Agents|protective agents|mesh-ancestor
102514329|NCT05122884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514330|NCT00520286|Modafinil|modafinil|mesh-list
102514331|NCT00520286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102514332|NCT00520286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514333|NCT00520286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102514334|NCT00520286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102514335|NCT00520286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102514336|NCT00520286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514337|NCT01796288|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102514338|NCT01796288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102514339|NCT01796288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102514340|NCT01796288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101990563|NCT01131689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102514341|NCT01796288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514342|NCT01395043|Epinephrine|epinephrine|mesh-list
102514343|NCT01395043|Bupivacaine|bupivacaine|mesh-list
102514344|NCT01395043|Anesthetics, Local|anesthetics, local|mesh-ancestor
102514345|NCT01395043|Anesthetics|anesthetics|mesh-ancestor
102514346|NCT01395043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102514347|NCT01395043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514348|NCT01395043|Sensory System Agents|sensory system agents|mesh-ancestor
102514349|NCT01395043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102514350|NCT01395043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102514351|NCT01395043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102514352|NCT01395043|Adrenergic Agents|adrenergic agents|mesh-ancestor
102514353|NCT01395043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102514354|NCT01395043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514355|NCT01395043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102514356|NCT01395043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102514357|NCT01395043|Autonomic Agents|autonomic agents|mesh-ancestor
102514358|NCT01395043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102514359|NCT01395043|Respiratory System Agents|respiratory system agents|mesh-ancestor
102514360|NCT01395043|Mydriatics|mydriatics|mesh-ancestor
102514361|NCT01395043|Sympathomimetics|sympathomimetics|mesh-ancestor
102514362|NCT01395043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102514363|NCT00521456|Ketorolac|ketorolac|mesh-list
102514364|NCT00521456|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102514365|NCT00521456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102514366|NCT00521456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102514367|NCT00521456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102514368|NCT00521456|Analgesics|analgesics|mesh-ancestor
102514369|NCT00521456|Sensory System Agents|sensory system agents|mesh-ancestor
102514370|NCT00521456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102514371|NCT00521456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514372|NCT00521456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102514373|NCT00521456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102514374|NCT00521456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102514375|NCT00521456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102514376|NCT00521456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514377|NCT01796366|Insulin|insulin|mesh-list
102514378|NCT01796366|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102514379|NCT01796366|Insulin Glargine|insulin glargine|mesh-list
102514380|NCT01796366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102514381|NCT01796366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514382|NCT03326180|Bupivacaine|bupivacaine|mesh-list
102514383|NCT03326180|Anesthetics, Local|anesthetics, local|mesh-ancestor
102514384|NCT03326180|Anesthetics|anesthetics|mesh-ancestor
102514385|NCT03326180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102514386|NCT03326180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514387|NCT03326180|Sensory System Agents|sensory system agents|mesh-ancestor
102514388|NCT03326180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102514389|NCT01498549|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102514390|NCT01498549|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102514391|NCT01498549|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102514392|NCT01498549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102514393|NCT01498549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514394|NCT01498549|Adrenergic Agents|adrenergic agents|mesh-ancestor
102514395|NCT01498549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102514396|NCT01498549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514397|NCT01796444|Hormones|hormones|mesh-list
102514398|NCT01796444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102514399|NCT01796444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514400|NCT01542541|Rifaximin|rifaximin|mesh-list
102514401|NCT01542541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102514402|NCT01542541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102514403|NCT01542541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102514404|NCT00524264|Ketorolac|ketorolac|mesh-list
102514405|NCT00524264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102514406|NCT00524264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102514407|NCT00524264|Analgesics|analgesics|mesh-ancestor
102514408|NCT00524264|Sensory System Agents|sensory system agents|mesh-ancestor
102514409|NCT00524264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102514410|NCT00524264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514411|NCT00524264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102514412|NCT00524264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102514413|NCT00524264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102514414|NCT00524264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102514415|NCT00524264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514416|NCT00452426|Analgesics, Opioid|analgesics, opioid|mesh-list
102514417|NCT00452426|Narcotics|narcotics|mesh-ancestor
102514418|NCT00452426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102514419|NCT00452426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514420|NCT00452426|Analgesics|analgesics|mesh-ancestor
102514421|NCT00452426|Sensory System Agents|sensory system agents|mesh-ancestor
102514422|NCT00452426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102514423|NCT05117814|Zanubrutinib|zanubrutinib|mesh-list
102514424|NCT05117814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102514425|NCT05117814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102514426|NCT05117814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102514427|NCT05117814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514428|NCT00524342|Oprelvekin|oprelvekin|mesh-list
102514429|NCT00524342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102514430|NCT00524576|Vaccines|vaccines|mesh-list
102514431|NCT00524576|Immunologic Factors|immunologic factors|mesh-ancestor
102514432|NCT00524576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514433|NCT04950660|Caffeine|caffeine|mesh-list
102514434|NCT04950660|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102514435|NCT04950660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514436|NCT04950660|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102514437|NCT04950660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102514438|NCT04950660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514439|NCT04950660|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102514440|NCT04950660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102514441|NCT04950660|Purinergic Agents|purinergic agents|mesh-ancestor
102514442|NCT04950660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102514443|NCT02516202|Estradiol|estradiol|mesh-list
102514444|NCT02516202|Estrogens|estrogens|mesh-ancestor
102514445|NCT02516202|Hormones|hormones|mesh-ancestor
102514446|NCT02516202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102514447|NCT02516202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514448|NCT00526058|Clotrimazole|clotrimazole|mesh-list
102514449|NCT00526058|Miconazole|miconazole|mesh-list
102514450|NCT00526058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102514451|NCT00526058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102514452|NCT00526058|Antifungal Agents|antifungal agents|mesh-ancestor
102514453|NCT00526058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102514454|NCT00526058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102514455|NCT00526058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102514456|NCT00526058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514457|NCT00526058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102514458|NCT00526058|Hormone Antagonists|hormone antagonists|mesh-ancestor
102514459|NCT00526058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102514460|NCT00526058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514461|NCT00526058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102514462|NCT00526058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102514463|NCT00526292|Cyclophosphamide|cyclophosphamide|mesh-list
102514464|NCT00526292|Fludarabine|fludarabine|mesh-list
102514465|NCT00526292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102514466|NCT00526292|Immunologic Factors|immunologic factors|mesh-ancestor
102514467|NCT00526292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514468|NCT00526292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102514469|NCT00526292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102514470|NCT00526292|Alkylating Agents|alkylating agents|mesh-ancestor
102514471|NCT00526292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514472|NCT00526292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102514473|NCT00526292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102514474|NCT02124044|Asunaprevir|asunaprevir|mesh-list
102514475|NCT02124044|Protease Inhibitors|protease inhibitors|mesh-ancestor
102514476|NCT02124044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102514477|NCT02124044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514478|NCT01502761|Magnesium Sulfate|magnesium sulfate|mesh-list
102514479|NCT01502761|Analgesics|analgesics|mesh-ancestor
102514480|NCT01502761|Sensory System Agents|sensory system agents|mesh-ancestor
102514481|NCT01502761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102514482|NCT01502761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514483|NCT01502761|Anesthetics|anesthetics|mesh-ancestor
102514484|NCT01502761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102514485|NCT01502761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102514486|NCT01502761|Anticonvulsants|anticonvulsants|mesh-ancestor
102514487|NCT01502761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102514488|NCT01502761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102514489|NCT01502761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514490|NCT01502761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102514491|NCT01502761|Tocolytic Agents|tocolytic agents|mesh-ancestor
102514492|NCT01502761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102514493|NCT01504477|Bortezomib|bortezomib|mesh-list
102514494|NCT01504477|Panitumumab|panitumumab|mesh-list
102514495|NCT01504477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102514496|NCT01504477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102514497|NCT02124512|Rifaximin|rifaximin|mesh-list
102514498|NCT02124512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102514499|NCT02124512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102514500|NCT02124512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102514501|NCT01504711|Fosaprepitant|fosaprepitant|mesh-list
102514502|NCT01504711|Aprepitant|aprepitant|mesh-list
102514503|NCT01504711|Antiemetics|antiemetics|mesh-ancestor
102514504|NCT01504711|Autonomic Agents|autonomic agents|mesh-ancestor
102514505|NCT01504711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102514506|NCT01504711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514507|NCT01504711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102514508|NCT01504711|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102514509|NCT01504711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102514510|NCT01504711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514511|NCT02209519|Metronidazole|metronidazole|mesh-list
102514512|NCT02209519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102514513|NCT02209519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102514514|NCT02209519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102514515|NCT02209519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102514516|NCT02129660|Glycopyrrolate|glycopyrrolate|mesh-list
102514517|NCT02129660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102514518|NCT02129660|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102514519|NCT02129660|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102514520|NCT02129660|Cholinergic Agents|cholinergic agents|mesh-ancestor
102514521|NCT02129660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102514522|NCT02129660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514523|NCT02129660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514524|NCT01505179|Ranolazine|ranolazine|mesh-list
102514525|NCT01505179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102514526|NCT01505179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102514527|NCT01505179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514528|NCT01797848|Ribavirin|ribavirin|mesh-list
102514529|NCT01797848|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102514530|NCT01797848|Antimetabolites|antimetabolites|mesh-ancestor
102514531|NCT01797848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514532|NCT01797848|Antiviral Agents|antiviral agents|mesh-ancestor
102514533|NCT01797848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102514534|NCT01398943|Antioxidants|antioxidants|mesh-list
102514535|NCT01398943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514536|NCT01398943|Protective Agents|protective agents|mesh-ancestor
102514537|NCT01398943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514538|NCT01550341|Buprenorphine|buprenorphine|mesh-list
102514539|NCT01550341|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102514540|NCT01550341|Naloxone|naloxone|mesh-list
102514541|NCT01550341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102514542|NCT01550341|Narcotics|narcotics|mesh-ancestor
102514543|NCT01550341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102514544|NCT01550341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514545|NCT01550341|Analgesics|analgesics|mesh-ancestor
102514546|NCT01550341|Sensory System Agents|sensory system agents|mesh-ancestor
102514547|NCT01550341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102514548|NCT01550341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102514549|NCT02125292|Mesalamine|mesalamine|mesh-list
102514550|NCT02125292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102514551|NCT02125292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102514552|NCT02125292|Analgesics|analgesics|mesh-ancestor
102514553|NCT02125292|Sensory System Agents|sensory system agents|mesh-ancestor
102514554|NCT02125292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102514555|NCT02125292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514556|NCT02125292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102154271|NCT03376191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102514558|NCT05079698|177Lu-PSMA-617|177lu-psma-617|mesh-list
102514559|NCT05079698|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102514560|NCT05079698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514561|NCT01653912|Paclitaxel|paclitaxel|mesh-list
102514562|NCT01653912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102514563|NCT01653912|Carboplatin|carboplatin|mesh-list
102514564|NCT01653912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102514565|NCT01653912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102514566|NCT01653912|Tubulin Modulators|tubulin modulators|mesh-ancestor
102514567|NCT01653912|Antimitotic Agents|antimitotic agents|mesh-ancestor
102514568|NCT01653912|Mitosis Modulators|mitosis modulators|mesh-ancestor
102514569|NCT01653912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514570|NCT04132388|Adalimumab|adalimumab|mesh-list
102514571|NCT04132388|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102514572|NCT04132388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102514573|NCT04132388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102514574|NCT02514174|Afatinib|afatinib|mesh-list
102514575|NCT02514174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102514576|NCT02514174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102514577|NCT02514174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102514578|NCT02514174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514579|NCT02132468|Fosbretabulin|fosbretabulin|mesh-list
102514580|NCT02132468|Combretastatin|combretastatin|mesh-list
102514581|NCT02132468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102514582|NCT02132468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102514583|NCT02132468|Tubulin Modulators|tubulin modulators|mesh-ancestor
102514584|NCT02132468|Antimitotic Agents|antimitotic agents|mesh-ancestor
102514585|NCT02132468|Mitosis Modulators|mitosis modulators|mesh-ancestor
102514586|NCT02132468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514587|NCT01508455|Fentanyl|fentanyl|mesh-list
102514588|NCT01508455|Midazolam|midazolam|mesh-list
102514589|NCT01508455|Dexmedetomidine|dexmedetomidine|mesh-list
102514590|NCT01508455|Morphine|morphine|mesh-list
102514591|NCT01508455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102514592|NCT01508455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102514593|NCT01508455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514594|NCT01508455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102514595|NCT01508455|Analgesics|analgesics|mesh-ancestor
102514596|NCT01508455|Sensory System Agents|sensory system agents|mesh-ancestor
102514597|NCT01508455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102514598|NCT01508455|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102514599|NCT01508455|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102514600|NCT01508455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102514601|NCT01508455|Adrenergic Agents|adrenergic agents|mesh-ancestor
102514602|NCT01508455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102514603|NCT01508455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514604|NCT01508455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102514605|NCT01508455|Narcotics|narcotics|mesh-ancestor
102514606|NCT01508455|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102514607|NCT01508455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102514608|NCT01508455|Anesthetics, General|anesthetics, general|mesh-ancestor
102514609|NCT01508455|Anesthetics|anesthetics|mesh-ancestor
102514610|NCT01508455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102514611|NCT01508455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102514612|NCT01508455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102514613|NCT01508455|GABA Modulators|gaba modulators|mesh-ancestor
102514614|NCT01508455|GABA Agents|gaba agents|mesh-ancestor
102514615|NCT01509625|Fulvestrant|fulvestrant|mesh-list
102514616|NCT01509625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102514617|NCT01509625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102514618|NCT01509625|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102514619|NCT01509625|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102514620|NCT01509625|Hormone Antagonists|hormone antagonists|mesh-ancestor
102514621|NCT01509625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102514622|NCT01509625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514623|NCT02482428|Imiquimod|imiquimod|mesh-list
102514624|NCT02482428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102514625|NCT02482428|Immunologic Factors|immunologic factors|mesh-ancestor
102514626|NCT02482428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514627|NCT02482428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102514628|NCT02482428|Interferon Inducers|interferon inducers|mesh-ancestor
102514629|NCT01510327|Aspirin|aspirin|mesh-list
102514630|NCT01510327|Everolimus|everolimus|mesh-list
102514631|NCT01510327|Ticlopidine|ticlopidine|mesh-list
102514632|NCT01510327|Clopidogrel|clopidogrel|mesh-list
102326142|NCT04659044|Rituximab|rituximab|mesh-list
102514633|NCT01510327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102514634|NCT01510327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102514635|NCT01510327|Analgesics|analgesics|mesh-ancestor
102514636|NCT01510327|Sensory System Agents|sensory system agents|mesh-ancestor
102514637|NCT01510327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102514638|NCT01510327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514639|NCT01510327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102514640|NCT01510327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102514641|NCT01510327|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102514642|NCT01510327|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102514643|NCT01510327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514644|NCT01510327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102514645|NCT01510327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102514646|NCT01510327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102514647|NCT01510327|Antipyretics|antipyretics|mesh-ancestor
102514648|NCT01510327|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102514649|NCT01510327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102514650|NCT01510327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102514651|NCT01510327|Immunologic Factors|immunologic factors|mesh-ancestor
102514652|NCT01510327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102514653|NCT01510327|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102514654|NCT01510327|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102514655|NCT01510327|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102514656|NCT01510327|Purinergic Agents|purinergic agents|mesh-ancestor
102514657|NCT01510327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102514658|NCT01510327|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102514659|NCT01510327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102514660|NCT01401595|Dexetimide|dexetimide|mesh-list
102514661|NCT01401595|Citalopram|citalopram|mesh-list
102514662|NCT01401595|Escitalopram|escitalopram|mesh-list
102514663|NCT01401595|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102514664|NCT01401595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102514665|NCT01401595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102514666|NCT01401595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514667|NCT01401595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102514668|NCT01401595|Serotonin Agents|serotonin agents|mesh-ancestor
102514669|NCT01401595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514670|NCT01401595|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101990883|NCT04211272|Vasodilator Agents|vasodilator agents|mesh-ancestor
102514671|NCT01401595|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102514672|NCT01401595|Parasympatholytics|parasympatholytics|mesh-ancestor
102514673|NCT01401595|Autonomic Agents|autonomic agents|mesh-ancestor
102514674|NCT01401595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102514675|NCT01401595|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102514676|NCT01401595|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102514677|NCT01401595|Cholinergic Agents|cholinergic agents|mesh-ancestor
102514678|NCT01401595|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102514679|NCT01401595|Antidepressive Agents|antidepressive agents|mesh-ancestor
102514680|NCT01401595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102514681|NCT01511809|Ritonavir|ritonavir|mesh-list
102514682|NCT01511809|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102514683|NCT01511809|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102514684|NCT01511809|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102514685|NCT01511809|Protease Inhibitors|protease inhibitors|mesh-ancestor
102514686|NCT01511809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102514687|NCT01511809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514688|NCT01511809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102514689|NCT01511809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102514690|NCT01511809|Antiviral Agents|antiviral agents|mesh-ancestor
102514691|NCT01511809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102514692|NCT01511809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102514693|NCT01511809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102514694|NCT02480712|Sofosbuvir|sofosbuvir|mesh-list
102514695|NCT02480712|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102514696|NCT02480712|Velpatasvir|velpatasvir|mesh-list
102514697|NCT02480712|Antiviral Agents|antiviral agents|mesh-ancestor
102514698|NCT02480712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102514699|NCT03916094|Trastuzumab|trastuzumab|mesh-list
102514700|NCT03916094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102514701|NCT03916094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102514702|NCT04986852|Pembrolizumab|pembrolizumab|mesh-list
102514703|NCT04986852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102514704|NCT04986852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102326210|NCT01972724|Metformin|metformin|mesh-list
102514705|NCT04986852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102514706|NCT04986852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514707|NCT00115700|Prednisolone|prednisolone|mesh-list
102514708|NCT00115700|Cyclophosphamide|cyclophosphamide|mesh-list
102514709|NCT00115700|Rituximab|rituximab|mesh-list
102514710|NCT00115700|Vincristine|vincristine|mesh-list
102514711|NCT00115700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102514712|NCT00115700|Immunologic Factors|immunologic factors|mesh-ancestor
102514713|NCT00115700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514714|NCT00115700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102514715|NCT00115700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102514716|NCT00115700|Alkylating Agents|alkylating agents|mesh-ancestor
102514717|NCT00115700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514718|NCT00115700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102514719|NCT00115700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102514720|NCT00115700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102514721|NCT00115700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102514722|NCT00115700|Tubulin Modulators|tubulin modulators|mesh-ancestor
102514723|NCT00115700|Antimitotic Agents|antimitotic agents|mesh-ancestor
102514724|NCT00115700|Mitosis Modulators|mitosis modulators|mesh-ancestor
102514725|NCT00115700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102514726|NCT00115700|Glucocorticoids|glucocorticoids|mesh-ancestor
102514727|NCT00115700|Hormones|hormones|mesh-ancestor
102514728|NCT00115700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102514729|NCT00115700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102514730|NCT01553539|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
102514731|NCT01553539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102514732|NCT01553539|Vasodilator Agents|vasodilator agents|mesh-ancestor
102514733|NCT03243890|Vitamin D|vitamin d|mesh-list
102514734|NCT03243890|Vitamin K 2|vitamin k 2|mesh-list
102514735|NCT03243890|Vitamin K|vitamin k|mesh-list
102514736|NCT03243890|Menaquinone 7|menaquinone 7|mesh-list
102514737|NCT03243890|Vitamins|vitamins|mesh-ancestor
102514738|NCT03243890|Micronutrients|micronutrients|mesh-ancestor
102514739|NCT03243890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514740|NCT03243890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102514741|NCT03243890|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102514742|NCT03243890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102514743|NCT03243890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514744|NCT03243890|Hemostatics|hemostatics|mesh-ancestor
102514745|NCT03243890|Coagulants|coagulants|mesh-ancestor
102514746|NCT00560612|Paroxetine|paroxetine|mesh-list
102514747|NCT00560612|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102514748|NCT00560612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102514749|NCT00560612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102514750|NCT00560612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514751|NCT00560612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102514752|NCT00560612|Serotonin Agents|serotonin agents|mesh-ancestor
102514753|NCT00560612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514754|NCT00560612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102514755|NCT00560612|Antidepressive Agents|antidepressive agents|mesh-ancestor
102514756|NCT00560612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102514757|NCT00560612|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102514758|NCT00560612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102514759|NCT00560612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102514760|NCT01556347|Rituximab|rituximab|mesh-list
102514761|NCT01556347|Bortezomib|bortezomib|mesh-list
102514762|NCT01556347|Thymoglobulin|thymoglobulin|mesh-list
102514763|NCT01556347|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102514764|NCT01556347|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102514765|NCT01556347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102514766|NCT01556347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102514767|NCT01556347|Immunologic Factors|immunologic factors|mesh-ancestor
102514768|NCT01556347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514769|NCT01556347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102514770|NCT01556347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102514771|NCT00561002|Vaccines|vaccines|mesh-list
102514772|NCT00561002|Immunologic Factors|immunologic factors|mesh-ancestor
102514773|NCT00561002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514774|NCT03236792|Dexamethasone|dexamethasone|mesh-list
102514775|NCT03236792|Cyclophosphamide|cyclophosphamide|mesh-list
102514776|NCT03236792|Ixazomib|ixazomib|mesh-list
102514777|NCT03236792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102514778|NCT03236792|Immunologic Factors|immunologic factors|mesh-ancestor
102514779|NCT03236792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514780|NCT03236792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102514781|NCT03236792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102514782|NCT03236792|Alkylating Agents|alkylating agents|mesh-ancestor
102514783|NCT03236792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514784|NCT03236792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102514785|NCT03236792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102514786|NCT03236792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102514787|NCT03236792|Antiemetics|antiemetics|mesh-ancestor
102514788|NCT03236792|Autonomic Agents|autonomic agents|mesh-ancestor
102514789|NCT03236792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102514790|NCT03236792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102514791|NCT03236792|Glucocorticoids|glucocorticoids|mesh-ancestor
102514792|NCT03236792|Hormones|hormones|mesh-ancestor
102514793|NCT03236792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102514794|NCT03236792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102514795|NCT03236792|Protease Inhibitors|protease inhibitors|mesh-ancestor
102514796|NCT03236792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102514797|NCT03725384|Ascorbic Acid|ascorbic acid|mesh-list
102514798|NCT03725384|Iron|iron|mesh-list
102514799|NCT03725384|Vitamins|vitamins|mesh-ancestor
102514800|NCT03725384|Micronutrients|micronutrients|mesh-ancestor
102514801|NCT03725384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514802|NCT03725384|Trace Elements|trace elements|mesh-ancestor
102514803|NCT03725384|Antioxidants|antioxidants|mesh-ancestor
102514804|NCT03725384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514805|NCT03725384|Protective Agents|protective agents|mesh-ancestor
102514806|NCT01556425|Naltrexone|naltrexone|mesh-list
102514807|NCT01556425|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102514808|NCT01556425|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102514809|NCT01556425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514810|NCT01556425|Sensory System Agents|sensory system agents|mesh-ancestor
102514811|NCT01556425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102514812|NCT01798628|Abiraterone Acetate|abiraterone acetate|mesh-list
102514813|NCT01798628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102514814|NCT01798628|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102514815|NCT01798628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102514816|NCT01798628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514817|NCT01798628|Hormone Antagonists|hormone antagonists|mesh-ancestor
102514818|NCT01798628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102514819|NCT01798628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514820|NCT01798628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102514821|NCT03143270|Nivolumab|nivolumab|mesh-list
102514822|NCT03143270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102514823|NCT03143270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102514824|NCT03143270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102514825|NCT03143270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514826|NCT00562328|Rituximab|rituximab|mesh-list
102514827|NCT00562328|Alemtuzumab|alemtuzumab|mesh-list
102514828|NCT00562328|Sargramostim|sargramostim|mesh-list
102514829|NCT00562328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102514830|NCT00562328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102514831|NCT00562328|Immunologic Factors|immunologic factors|mesh-ancestor
102514832|NCT00562328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514833|NCT00562328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102514834|NCT01514149|Metformin|metformin|mesh-list
102514835|NCT01514149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102514836|NCT01514149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514837|NCT05566093|Ethanol|ethanol|mesh-list
102514838|NCT05566093|Polidocanol|polidocanol|mesh-list
102514839|NCT05566093|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102514840|NCT05566093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102514841|NCT05566093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102514842|NCT05566093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514843|NCT05566093|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102514844|NCT05566093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102514845|NCT01558063|Ketamine|ketamine|mesh-list
102514846|NCT01558063|Analgesics|analgesics|mesh-ancestor
102514847|NCT01558063|Sensory System Agents|sensory system agents|mesh-ancestor
102514848|NCT01558063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102514849|NCT01558063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514850|NCT01558063|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102514851|NCT01558063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102514852|NCT01558063|Anesthetics, General|anesthetics, general|mesh-ancestor
102514853|NCT01558063|Anesthetics|anesthetics|mesh-ancestor
102514854|NCT01558063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102514855|NCT01558063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102514856|NCT01558063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102514857|NCT01558063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102514858|NCT01558063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514859|NCT03641846|Tadalafil|tadalafil|mesh-list
102514860|NCT03641846|Vasodilator Agents|vasodilator agents|mesh-ancestor
102514861|NCT03641846|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102514862|NCT03641846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102514863|NCT03641846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102514864|NCT03641846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514865|NCT03641846|Urological Agents|urological agents|mesh-ancestor
102514866|NCT03474458|Doxycycline|doxycycline|mesh-list
102514867|NCT03474458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102514868|NCT03474458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102514869|NCT03474458|Antimalarials|antimalarials|mesh-ancestor
102514870|NCT03474458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102514871|NCT03474458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102514872|NCT01516957|Brodalumab|brodalumab|mesh-list
102514873|NCT01516957|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102514874|NCT01516957|Dermatologic Agents|dermatologic agents|mesh-ancestor
102514875|NCT01516957|Immunologic Factors|immunologic factors|mesh-ancestor
102514876|NCT01516957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514877|NCT01519063|Naltrexone|naltrexone|mesh-list
102514878|NCT01519063|Memantine|memantine|mesh-list
102514879|NCT01519063|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102514880|NCT01519063|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102514881|NCT01519063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514882|NCT01519063|Sensory System Agents|sensory system agents|mesh-ancestor
102514883|NCT01519063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102514884|NCT01519063|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102514885|NCT01519063|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102514886|NCT01519063|Dopamine Agents|dopamine agents|mesh-ancestor
102514887|NCT01519063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102514888|NCT01519063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514889|NCT01519063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102514890|NCT01519063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102514891|NCT01559857|Pioglitazone|pioglitazone|mesh-list
102514892|NCT01559857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102514893|NCT01559857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514894|NCT05565625|Sunscreening Agents|sunscreening agents|mesh-list
102514895|NCT05565625|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102514896|NCT05565625|Protective Agents|protective agents|mesh-ancestor
102514897|NCT05565625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514898|NCT05565625|Dermatologic Agents|dermatologic agents|mesh-ancestor
102514899|NCT00754208|Methylphenidate|methylphenidate|mesh-list
102514900|NCT00754208|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102514901|NCT00754208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514902|NCT00754208|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102514903|NCT00754208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102514904|NCT00754208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102514905|NCT00754208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514906|NCT00754208|Dopamine Agents|dopamine agents|mesh-ancestor
102514907|NCT00754208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102514908|NCT01562041|Ranolazine|ranolazine|mesh-list
102514909|NCT01562041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102514910|NCT01562041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102514911|NCT01562041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514912|NCT00634166|Anti-Infective Agents|anti-infective agents|mesh-list
102514913|NCT00634166|Amphotericin B|amphotericin b|mesh-list
102514914|NCT00634166|Clotrimazole|clotrimazole|mesh-list
102514915|NCT00634166|Miconazole|miconazole|mesh-list
102514916|NCT00634166|Bacitracin|bacitracin|mesh-list
102514917|NCT00634166|Mafenide|mafenide|mesh-list
102514918|NCT00634166|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102514919|NCT00634166|Antifungal Agents|antifungal agents|mesh-list
102514920|NCT00634166|Amebicides|amebicides|mesh-ancestor
102514921|NCT00634166|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102514922|NCT00634166|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102514923|NCT00634166|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102514924|NCT00634166|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102514925|NCT00634166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102514926|NCT00634166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102514927|NCT00634166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514928|NCT00634166|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102514929|NCT00634166|Hormone Antagonists|hormone antagonists|mesh-ancestor
102514930|NCT00634166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102514931|NCT00634166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514932|NCT00634166|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102514933|NCT00634166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102514934|NCT00634166|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102514935|NCT00565370|Capecitabine|capecitabine|mesh-list
102514936|NCT00565370|Sorafenib|sorafenib|mesh-list
102514937|NCT00565370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102514938|NCT00565370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102514939|NCT00565370|Antimetabolites|antimetabolites|mesh-ancestor
102514940|NCT00565370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514941|NCT00565370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102514942|NCT00565370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102514943|NCT03303950|Cyclophosphamide|cyclophosphamide|mesh-list
102514944|NCT03303950|Busulfan|busulfan|mesh-list
102514945|NCT03303950|Fludarabine|fludarabine|mesh-list
102514946|NCT03303950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102514947|NCT03303950|Immunologic Factors|immunologic factors|mesh-ancestor
102514948|NCT03303950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514949|NCT03303950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102514950|NCT03303950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102514951|NCT03303950|Alkylating Agents|alkylating agents|mesh-ancestor
102514952|NCT03303950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514953|NCT03303950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102514954|NCT03303950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102514955|NCT01563055|Ofatumumab|ofatumumab|mesh-list
102514956|NCT01563055|Chlorambucil|chlorambucil|mesh-list
102514957|NCT01563055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102514958|NCT01563055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102514959|NCT01563055|Alkylating Agents|alkylating agents|mesh-ancestor
102514960|NCT01563055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514961|NCT00565916|Estradiol|estradiol|mesh-list
102514962|NCT00565916|Estrogens|estrogens|mesh-list
102514963|NCT00565916|Progesterone|progesterone|mesh-list
102514964|NCT00565916|Hormones|hormones|mesh-ancestor
102514965|NCT00565916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102514966|NCT00565916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514967|NCT00565916|Progestins|progestins|mesh-ancestor
102514968|NCT03258320|Docetaxel|docetaxel|mesh-list
102514969|NCT03258320|Mitoxantrone|mitoxantrone|mesh-list
102514970|NCT03258320|Satraplatin|satraplatin|mesh-list
102514971|NCT03258320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102514972|NCT03258320|Tubulin Modulators|tubulin modulators|mesh-ancestor
102514973|NCT03258320|Antimitotic Agents|antimitotic agents|mesh-ancestor
102514974|NCT03258320|Mitosis Modulators|mitosis modulators|mesh-ancestor
102514975|NCT03258320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514976|NCT03258320|Analgesics|analgesics|mesh-ancestor
102514977|NCT03258320|Sensory System Agents|sensory system agents|mesh-ancestor
102514978|NCT03258320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102514979|NCT03258320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514980|NCT03258320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102514981|NCT03258320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102514982|NCT03258320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102514983|NCT01797926|Losartan|losartan|mesh-list
102514984|NCT01797926|Amlodipine|amlodipine|mesh-list
102514985|NCT01797926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102514986|NCT01797926|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102514987|NCT01797926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102514988|NCT01797926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102514989|NCT01797926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102514990|NCT01797926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102514991|NCT01797926|Vasodilator Agents|vasodilator agents|mesh-ancestor
102514992|NCT01797926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102514993|NCT01797926|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102514994|NCT01797926|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102514995|NCT03008083|Clopidogrel|clopidogrel|mesh-list
102514996|NCT03008083|Ticagrelor|ticagrelor|mesh-list
102514997|NCT03008083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102514998|NCT03008083|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102514999|NCT03008083|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102515000|NCT03008083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102515001|NCT03008083|Purinergic Agents|purinergic agents|mesh-ancestor
102515002|NCT03008083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102515003|NCT03008083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515004|NCT03008083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515005|NCT05559398|Glenzocimab|glenzocimab|mesh-list
102326513|NCT01617434|Hormones|hormones|mesh-ancestor
102515006|NCT05559398|Anticoagulants|anticoagulants|mesh-ancestor
102515007|NCT00566150|Levetiracetam|levetiracetam|mesh-list
102515008|NCT00566150|Anticonvulsants|anticonvulsants|mesh-ancestor
102515009|NCT00566150|Nootropic Agents|nootropic agents|mesh-ancestor
102515010|NCT00566540|Paclitaxel|paclitaxel|mesh-list
102515011|NCT00566540|Cisplatin|cisplatin|mesh-list
102515012|NCT00566540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102515013|NCT00566540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102515014|NCT00566540|Tubulin Modulators|tubulin modulators|mesh-ancestor
102515015|NCT00566540|Antimitotic Agents|antimitotic agents|mesh-ancestor
102515016|NCT00566540|Mitosis Modulators|mitosis modulators|mesh-ancestor
102515017|NCT00566540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515018|NCT00567008|Varenicline|varenicline|mesh-list
102515019|NCT00567008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102515020|NCT00567008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102515021|NCT00567008|Cholinergic Agents|cholinergic agents|mesh-ancestor
102515022|NCT00567008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102515023|NCT00567008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515024|NCT00567008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515025|NCT00567320|Varenicline|varenicline|mesh-list
102515026|NCT00567320|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102515027|NCT00567320|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102515028|NCT00567320|Cholinergic Agents|cholinergic agents|mesh-ancestor
102515029|NCT00567320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102515030|NCT00567320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515031|NCT00567320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515032|NCT01522417|Tirofiban|tirofiban|mesh-list
102515033|NCT01522417|Eptifibatide|eptifibatide|mesh-list
102515034|NCT01522417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102515035|NCT01522417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102515036|NCT01522417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515037|NCT01522417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102515038|NCT00568022|Capecitabine|capecitabine|mesh-list
102515039|NCT00568022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102515040|NCT00568022|Antimetabolites|antimetabolites|mesh-ancestor
102515041|NCT00568022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515042|NCT00568022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102515043|NCT01522963|Nicotine|nicotine|mesh-list
102515044|NCT01522963|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102515045|NCT01522963|Autonomic Agents|autonomic agents|mesh-ancestor
102515046|NCT01522963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102515047|NCT01522963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515048|NCT01522963|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102515049|NCT01522963|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102515050|NCT01522963|Cholinergic Agents|cholinergic agents|mesh-ancestor
102515051|NCT01522963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102515052|NCT01522963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515053|NCT03094286|Durvalumab|durvalumab|mesh-list
102515054|NCT03094286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102515055|NCT03094286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102515056|NCT03071666|Vitamin B 12|vitamin b 12|mesh-list
102515057|NCT03071666|Vitamins|vitamins|mesh-ancestor
102515058|NCT03071666|Micronutrients|micronutrients|mesh-ancestor
102515059|NCT03071666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515060|NCT03071666|Vitamin B Complex|vitamin b complex|mesh-ancestor
102515061|NCT05533580|Sufentanil|sufentanil|mesh-list
102515062|NCT05533580|Dsuvia|dsuvia|mesh-list
102515063|NCT05533580|Propofol|propofol|mesh-list
102515064|NCT05533580|Cisatracurium|cisatracurium|mesh-list
102515065|NCT05533580|Atracurium|atracurium|mesh-list
102515066|NCT05533580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102515067|NCT05533580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102515068|NCT05533580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515069|NCT05533580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102515070|NCT05533580|Anesthetics, General|anesthetics, general|mesh-ancestor
102515071|NCT05533580|Anesthetics|anesthetics|mesh-ancestor
102515072|NCT05533580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102515073|NCT05533580|Narcotics|narcotics|mesh-ancestor
102515074|NCT05533580|Analgesics|analgesics|mesh-ancestor
102515075|NCT05533580|Sensory System Agents|sensory system agents|mesh-ancestor
102515076|NCT05533580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102515077|NCT05533580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102515078|NCT05533580|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102515079|NCT05533580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101991304|NCT01304797|Immunologic Factors|immunologic factors|mesh-ancestor
102515080|NCT05533580|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102515081|NCT05533580|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102515082|NCT05533580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102515083|NCT05533580|Cholinergic Agents|cholinergic agents|mesh-ancestor
102515084|NCT05533580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102515085|NCT05533580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515086|NCT02129426|Midazolam|midazolam|mesh-list
102515087|NCT02129426|Dexmedetomidine|dexmedetomidine|mesh-list
102515088|NCT02129426|Ketamine|ketamine|mesh-list
102515089|NCT02129426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102515090|NCT02129426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102515091|NCT02129426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515092|NCT02129426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102515093|NCT02129426|Analgesics|analgesics|mesh-ancestor
102515094|NCT02129426|Sensory System Agents|sensory system agents|mesh-ancestor
102515095|NCT02129426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102515096|NCT02129426|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102515097|NCT02129426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102515098|NCT02129426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102515099|NCT02129426|Adrenergic Agents|adrenergic agents|mesh-ancestor
102515100|NCT02129426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102515101|NCT02129426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515102|NCT02129426|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102515103|NCT02129426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102515104|NCT02129426|Anesthetics, General|anesthetics, general|mesh-ancestor
102515105|NCT02129426|Anesthetics|anesthetics|mesh-ancestor
102515106|NCT02129426|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102515107|NCT02129426|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102515108|NCT02129426|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102515109|NCT02129426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102515110|NCT02129426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102515111|NCT02129426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102515112|NCT02129426|GABA Modulators|gaba modulators|mesh-ancestor
102515113|NCT02129426|GABA Agents|gaba agents|mesh-ancestor
102515114|NCT01523821|Protease Inhibitors|protease inhibitors|mesh-list
102515115|NCT01523821|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
102515116|NCT01523821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102515117|NCT01523821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515118|NCT01523821|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102515119|NCT01523821|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102515120|NCT05409716|Hemostatics|hemostatics|mesh-list
102515121|NCT05409716|Coagulants|coagulants|mesh-ancestor
102515122|NCT05395910|Paclitaxel|paclitaxel|mesh-list
102515123|NCT05395910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102515124|NCT05395910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102515125|NCT05395910|Tubulin Modulators|tubulin modulators|mesh-ancestor
102515126|NCT05395910|Antimitotic Agents|antimitotic agents|mesh-ancestor
102515127|NCT05395910|Mitosis Modulators|mitosis modulators|mesh-ancestor
102515128|NCT05395910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515129|NCT05389046|Dexetimide|dexetimide|mesh-list
102515130|NCT05389046|Aripiprazole|aripiprazole|mesh-list
102515131|NCT05389046|Citalopram|citalopram|mesh-list
102515132|NCT05389046|Escitalopram|escitalopram|mesh-list
102515133|NCT05389046|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102515134|NCT05389046|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102515135|NCT05389046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102515136|NCT05389046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515137|NCT05389046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102515138|NCT05389046|Serotonin Agents|serotonin agents|mesh-ancestor
102515139|NCT05389046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515140|NCT05389046|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102515141|NCT05389046|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101991371|NCT01649947|Hydroxychloroquine|hydroxychloroquine|mesh-list
102515142|NCT05389046|Parasympatholytics|parasympatholytics|mesh-ancestor
102515143|NCT05389046|Autonomic Agents|autonomic agents|mesh-ancestor
102515144|NCT05389046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102515145|NCT05389046|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102515146|NCT05389046|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102515147|NCT05389046|Cholinergic Agents|cholinergic agents|mesh-ancestor
102515148|NCT05389046|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102515149|NCT05389046|Antidepressive Agents|antidepressive agents|mesh-ancestor
102515150|NCT05389046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102515151|NCT05389046|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102515152|NCT05389046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102515153|NCT05389046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102515154|NCT05389046|Dopamine Agonists|dopamine agonists|mesh-ancestor
102515155|NCT05389046|Dopamine Agents|dopamine agents|mesh-ancestor
102515156|NCT05389046|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102515157|NCT05389046|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102515158|NCT05389046|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102515159|NCT05389046|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102515160|NCT05389046|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102515161|NCT05389046|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102515162|NCT01566409|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
102515163|NCT01566409|Laxatives|laxatives|mesh-ancestor
102515164|NCT01566409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102515165|NCT02184416|Everolimus|everolimus|mesh-list
102515166|NCT02184416|Temsirolimus|temsirolimus|mesh-list
102515167|NCT02184416|Sorafenib|sorafenib|mesh-list
102515168|NCT02184416|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102515169|NCT02184416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102515170|NCT02184416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102515171|NCT02184416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515172|NCT02184416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102515173|NCT02184416|Immunologic Factors|immunologic factors|mesh-ancestor
102515174|NCT02184416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515175|NCT02184416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102515176|NCT01568905|Nicotine|nicotine|mesh-list
102515177|NCT01568905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102515178|NCT01568905|Autonomic Agents|autonomic agents|mesh-ancestor
102515179|NCT01568905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102515180|NCT01568905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515181|NCT01568905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102515182|NCT01568905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102515183|NCT01568905|Cholinergic Agents|cholinergic agents|mesh-ancestor
102515184|NCT01568905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102515185|NCT01568905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515186|NCT01569451|Rituximab|rituximab|mesh-list
102515187|NCT01569451|Glatiramer Acetate|glatiramer acetate|mesh-list
102515188|NCT01569451|(T,G)-A-L|(t,g)-a-l|mesh-list
102515189|NCT01569451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102515190|NCT01569451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102515191|NCT01569451|Immunologic Factors|immunologic factors|mesh-ancestor
102515192|NCT01569451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515193|NCT01569451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102515194|NCT01569451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102515195|NCT01569451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102515196|NCT02132936|Calcipotriene|calcipotriene|mesh-list
102515197|NCT02132936|Dermatologic Agents|dermatologic agents|mesh-ancestor
102515198|NCT01528891|Dexmedetomidine|dexmedetomidine|mesh-list
102515199|NCT01528891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102515200|NCT01528891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102515201|NCT01528891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515202|NCT01528891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102515203|NCT01528891|Analgesics|analgesics|mesh-ancestor
102515204|NCT01528891|Sensory System Agents|sensory system agents|mesh-ancestor
102515205|NCT01528891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102515206|NCT01528891|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101711253|NCT02696837|Rocuronium|rocuronium|mesh-list
102515207|NCT01528891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102515208|NCT01528891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102515209|NCT01528891|Adrenergic Agents|adrenergic agents|mesh-ancestor
102515210|NCT01528891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102515211|NCT01528891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515212|NCT01529203|Botulinum Toxins|botulinum toxins|mesh-list
102515213|NCT01529203|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102515214|NCT01529203|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102515215|NCT01529203|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102515216|NCT01529203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102515217|NCT01529203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515218|NCT01529203|Cholinergic Agents|cholinergic agents|mesh-ancestor
102515219|NCT01529203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102515220|NCT01529203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515221|NCT01529203|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102515222|NCT01529203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102515223|NCT01529827|Mycophenolic Acid|mycophenolic acid|mesh-list
102515224|NCT01529827|Methotrexate|methotrexate|mesh-list
102515225|NCT01529827|Fludarabine phosphate|fludarabine phosphate|mesh-list
102515226|NCT01529827|Fludarabine|fludarabine|mesh-list
102515227|NCT01529827|Melphalan|melphalan|mesh-list
102515228|NCT01529827|Tacrolimus|tacrolimus|mesh-list
102515229|NCT01529827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102515230|NCT01529827|Abortifacient Agents|abortifacient agents|mesh-ancestor
102515231|NCT01529827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102515232|NCT01529827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515233|NCT01529827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102515234|NCT01529827|Antimetabolites|antimetabolites|mesh-ancestor
102515235|NCT01529827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515236|NCT01529827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102515237|NCT01529827|Dermatologic Agents|dermatologic agents|mesh-ancestor
102515238|NCT01529827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102515239|NCT01529827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102515240|NCT01529827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102515241|NCT01529827|Immunologic Factors|immunologic factors|mesh-ancestor
102515242|NCT01529827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102515243|NCT01529827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102515244|NCT01529827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102515245|NCT01529827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102515246|NCT01529827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102515247|NCT01529827|Antitubercular Agents|antitubercular agents|mesh-ancestor
102515248|NCT01529827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102515249|NCT01529827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102515250|NCT01529827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102515251|NCT01529827|Alkylating Agents|alkylating agents|mesh-ancestor
102515252|NCT01529827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102515253|NCT01571557|Dexamethasone|dexamethasone|mesh-list
102515254|NCT01571557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102515255|NCT01571557|Antiemetics|antiemetics|mesh-ancestor
102515256|NCT01571557|Autonomic Agents|autonomic agents|mesh-ancestor
102515257|NCT01571557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102515258|NCT01571557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515259|NCT01571557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102515260|NCT01571557|Glucocorticoids|glucocorticoids|mesh-ancestor
102515261|NCT01571557|Hormones|hormones|mesh-ancestor
102515262|NCT01571557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102515263|NCT01571557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102515264|NCT01571557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102515265|NCT00569660|Azacitidine|azacitidine|mesh-list
102515266|NCT00569660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102515267|NCT00569660|Antimetabolites|antimetabolites|mesh-ancestor
102515268|NCT00569660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515269|NCT00569660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102515270|NCT00569660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102515271|NCT01573273|Oxytocin|oxytocin|mesh-list
102515272|NCT01573273|Oxytocics|oxytocics|mesh-ancestor
102515273|NCT01573273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102515274|NCT01573273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515275|NCT00572234|Bupropion|bupropion|mesh-list
102515276|NCT00572234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102515277|NCT00572234|Antidepressive Agents|antidepressive agents|mesh-ancestor
102515278|NCT00572234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102515279|NCT00572234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102515280|NCT00572234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102515281|NCT00572234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102515282|NCT00572234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515283|NCT00572234|Dopamine Agents|dopamine agents|mesh-ancestor
102515284|NCT00572234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102515285|NCT00572234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515286|NCT00572234|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102515287|NCT00572234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102515288|NCT00572234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102515289|NCT00572468|Simvastatin|simvastatin|mesh-list
102515290|NCT00572468|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102515291|NCT00572468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102515292|NCT00572468|Antimetabolites|antimetabolites|mesh-ancestor
102515293|NCT00572468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515294|NCT00572468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102515295|NCT00572468|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102515296|NCT00572468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102515297|NCT02339246|Tacrolimus|tacrolimus|mesh-list
102515298|NCT02339246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102515299|NCT02339246|Immunologic Factors|immunologic factors|mesh-ancestor
102515300|NCT02339246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515301|NCT02339246|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102515302|NCT02339246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102515303|NCT02339246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515304|NCT00572936|Timolol|timolol|mesh-list
102515305|NCT00572936|Dorzolamide|dorzolamide|mesh-list
102515306|NCT00572936|Latanoprost|latanoprost|mesh-list
102326809|NCT01909466|Aripiprazole|aripiprazole|mesh-list
102515307|NCT00572936|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102515308|NCT00572936|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102515309|NCT00572936|Adrenergic Agents|adrenergic agents|mesh-ancestor
102515310|NCT00572936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102515311|NCT00572936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515312|NCT00572936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515313|NCT00572936|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102515314|NCT00572936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102515315|NCT00572936|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102515316|NCT00572936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102515317|NCT00572936|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102515318|NCT00572936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102515319|NCT05085626|Fluzoparib|fluzoparib|mesh-list
102515320|NCT05085626|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102515321|NCT05085626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102515322|NCT05085626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515323|NCT05085626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102515324|NCT05041946|Methylphenidate|methylphenidate|mesh-list
102515325|NCT05041946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102515326|NCT05041946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515327|NCT05041946|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102515328|NCT05041946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102515329|NCT05041946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102515330|NCT05041946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515331|NCT05041946|Dopamine Agents|dopamine agents|mesh-ancestor
102515332|NCT05041946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102515333|NCT05092412|Carboplatin|carboplatin|mesh-list
102515334|NCT05092412|Etoposide|etoposide|mesh-list
102515335|NCT05092412|Durvalumab|durvalumab|mesh-list
102515336|NCT05092412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102515337|NCT05092412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102515338|NCT05092412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102515339|NCT05092412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102515340|NCT05092412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102515341|NCT05092412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515342|NCT05092412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102515343|NCT00574340|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102515344|NCT00574340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515345|NCT05004896|Midazolam|midazolam|mesh-list
102515346|NCT05004896|Ketamine|ketamine|mesh-list
102515347|NCT05004896|Analgesics|analgesics|mesh-ancestor
102515348|NCT05004896|Sensory System Agents|sensory system agents|mesh-ancestor
102515349|NCT05004896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102515350|NCT05004896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515351|NCT05004896|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102515352|NCT05004896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102515353|NCT05004896|Anesthetics, General|anesthetics, general|mesh-ancestor
102515354|NCT05004896|Anesthetics|anesthetics|mesh-ancestor
102515355|NCT05004896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102515356|NCT05004896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102515357|NCT05004896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102515358|NCT05004896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102515359|NCT05004896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515360|NCT05004896|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102515361|NCT05004896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102515362|NCT05004896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102515363|NCT05004896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102515364|NCT05004896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102515365|NCT05004896|GABA Modulators|gaba modulators|mesh-ancestor
102515366|NCT05004896|GABA Agents|gaba agents|mesh-ancestor
102515367|NCT00576680|Temozolomide|temozolomide|mesh-list
102515368|NCT00576680|Everolimus|everolimus|mesh-list
102515369|NCT00576680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102515370|NCT00576680|Alkylating Agents|alkylating agents|mesh-ancestor
102515371|NCT00576680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515372|NCT00576680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102515373|NCT00576680|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102515374|NCT00576680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102515375|NCT00576680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102515376|NCT00576680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102515377|NCT00576680|Immunologic Factors|immunologic factors|mesh-ancestor
102515378|NCT00576680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515379|NCT04866602|Atovaquone|atovaquone|mesh-list
102515380|NCT04866602|Proguanil|proguanil|mesh-list
102515381|NCT04866602|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
102515382|NCT04866602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102515383|NCT04866602|Antimalarials|antimalarials|mesh-ancestor
102515384|NCT04866602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102515385|NCT04866602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102515386|NCT04866602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102515387|NCT04866602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515388|NCT04866602|Antimetabolites|antimetabolites|mesh-ancestor
102515389|NCT04730648|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
102515390|NCT04730648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102515391|NCT04730648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102515392|NCT04730648|Antimetabolites|antimetabolites|mesh-ancestor
102515393|NCT04730648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515394|NCT04730648|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102515395|NCT04730648|Protease Inhibitors|protease inhibitors|mesh-ancestor
102515396|NCT04730648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102515397|NCT04730648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102515398|NCT00578552|Gabapentin|gabapentin|mesh-list
102515399|NCT00578552|Analgesics|analgesics|mesh-ancestor
102515400|NCT00578552|Sensory System Agents|sensory system agents|mesh-ancestor
102515401|NCT00578552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102515402|NCT00578552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515403|NCT00578552|Anticonvulsants|anticonvulsants|mesh-ancestor
102515404|NCT00578552|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102515405|NCT00578552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102515406|NCT00578552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102515407|NCT00578552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102515408|NCT00578552|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102515409|NCT00578552|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102515410|NCT00578552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102515411|NCT00578552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515412|NCT00578552|Antimanic Agents|antimanic agents|mesh-ancestor
102515413|NCT01532089|Bevacizumab|bevacizumab|mesh-list
102515414|NCT01532089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102515415|NCT01532089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102515416|NCT01532089|Endothelial Growth Factors|endothelial growth factors|mesh-list
102515417|NCT01532089|Antibodies|antibodies|mesh-list
102515418|NCT01532089|Immunoglobulins|immunoglobulins|mesh-list
102515419|NCT01532089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102515420|NCT01532089|Immunoglobulin G|immunoglobulin g|mesh-list
102515421|NCT01532089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102515422|NCT01532089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102515423|NCT01532089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102515424|NCT01532089|Growth Substances|growth substances|mesh-ancestor
102515425|NCT01532089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515426|NCT01532089|Growth Inhibitors|growth inhibitors|mesh-ancestor
102515427|NCT01532089|Immunologic Factors|immunologic factors|mesh-ancestor
102515428|NCT01532089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102515429|NCT01532089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102515430|NCT01532089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515431|NCT00579878|Hydroxychloroquine|hydroxychloroquine|mesh-list
102515432|NCT00579878|Sulfasalazine|sulfasalazine|mesh-list
102515433|NCT00579878|Methotrexate|methotrexate|mesh-list
102515434|NCT00579878|Leflunomide|leflunomide|mesh-list
102515435|NCT00579878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102515436|NCT00579878|Abortifacient Agents|abortifacient agents|mesh-ancestor
102515437|NCT00579878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102515438|NCT00579878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515439|NCT00579878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102515440|NCT00579878|Antimetabolites|antimetabolites|mesh-ancestor
102515441|NCT00579878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515442|NCT00579878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102515443|NCT00579878|Dermatologic Agents|dermatologic agents|mesh-ancestor
102515444|NCT00579878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102515445|NCT00579878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102515446|NCT00579878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102515447|NCT00579878|Immunologic Factors|immunologic factors|mesh-ancestor
102515448|NCT00579878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102515449|NCT00579878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102515450|NCT00579878|Antimalarials|antimalarials|mesh-ancestor
102515451|NCT00579878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102515452|NCT00579878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102515453|NCT00579878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102515454|NCT00579878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102515455|NCT00579878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102326957|NCT01906346|Cocaine|cocaine|mesh-list
102515456|NCT00579878|Analgesics|analgesics|mesh-ancestor
102515457|NCT00579878|Sensory System Agents|sensory system agents|mesh-ancestor
102515458|NCT00579878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102515459|NCT00579878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102515460|NCT00579878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102515461|NCT01533259|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102515462|NCT01533259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102515463|NCT01533259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102515464|NCT01533259|Antiviral Agents|antiviral agents|mesh-ancestor
102515465|NCT01533259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102515466|NCT05246072|Ivermectin|ivermectin|mesh-list
102515467|NCT05246072|Colchicine|colchicine|mesh-list
102515468|NCT05246072|Gout Suppressants|gout suppressants|mesh-ancestor
102515469|NCT05246072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102515470|NCT05246072|Tubulin Modulators|tubulin modulators|mesh-ancestor
102515471|NCT05246072|Antimitotic Agents|antimitotic agents|mesh-ancestor
102515472|NCT05246072|Mitosis Modulators|mitosis modulators|mesh-ancestor
102515473|NCT05246072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515474|NCT05246072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102515475|NCT05246072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102515476|NCT05246072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102515477|NCT02135432|Ivacaftor|ivacaftor|mesh-list
102515478|NCT02135432|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102515479|NCT02135432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102515480|NCT02135432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515481|NCT05245994|Carboplatin|carboplatin|mesh-list
102515482|NCT05245994|Etoposide|etoposide|mesh-list
102515483|NCT05245994|Durvalumab|durvalumab|mesh-list
102515484|NCT05245994|Olaparib|olaparib|mesh-list
102515485|NCT05245994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102515486|NCT05245994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102515487|NCT05245994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102515488|NCT05245994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102515489|NCT05245994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102515490|NCT05245994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515491|NCT05245994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102515492|NCT05245994|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102515493|NCT05245604|Cyclosporine|cyclosporine|mesh-list
102515494|NCT05245604|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102515495|NCT05245604|Cyclosporins|cyclosporins|mesh-list
102515496|NCT05245604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102515497|NCT05245604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515498|NCT05245604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102515499|NCT05245604|Immunologic Factors|immunologic factors|mesh-ancestor
102515500|NCT05245604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515501|NCT05245604|Antifungal Agents|antifungal agents|mesh-ancestor
102515502|NCT05245604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102515503|NCT05245604|Dermatologic Agents|dermatologic agents|mesh-ancestor
102515504|NCT05245604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102515505|NCT05245604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102515506|NCT05245604|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102515507|NCT05245448|Tetrandrine|tetrandrine|mesh-list
102515508|NCT05245448|Antimalarials|antimalarials|mesh-ancestor
102515509|NCT05245448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102515510|NCT05245448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102515511|NCT05245448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102515512|NCT05245448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102515513|NCT05245448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102515514|NCT05245448|Antiviral Agents|antiviral agents|mesh-ancestor
102515515|NCT05245448|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102515516|NCT05245448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102515517|NCT05245448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515518|NCT05245448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102515519|NCT05245448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515520|NCT05245448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102515521|NCT05245448|Immunologic Factors|immunologic factors|mesh-ancestor
102515522|NCT00581048|Vitamin E|vitamin e|mesh-list
102515523|NCT00581048|Tocopherols|tocopherols|mesh-list
102515524|NCT00581048|alpha-Tocopherol|alpha-tocopherol|mesh-list
102515525|NCT00581048|Vitamins|vitamins|mesh-ancestor
102515526|NCT00581048|Micronutrients|micronutrients|mesh-ancestor
102515527|NCT00581048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515528|NCT00581048|Antioxidants|antioxidants|mesh-ancestor
102515529|NCT00581048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515530|NCT00581048|Protective Agents|protective agents|mesh-ancestor
101863161|NCT00451217|Glycopyrrolate|glycopyrrolate|mesh-list
102515531|NCT01798472|Cimetidine|cimetidine|mesh-list
102515532|NCT01798472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102515533|NCT01798472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102515534|NCT01798472|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102515535|NCT01798472|Histamine Antagonists|histamine antagonists|mesh-ancestor
102515536|NCT01798472|Histamine Agents|histamine agents|mesh-ancestor
102515537|NCT01798472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102515538|NCT01798472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515539|NCT01798472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515540|NCT01798472|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102515541|NCT01798472|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102515542|NCT01798472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102515543|NCT01579513|Methylprednisolone|methylprednisolone|mesh-list
102515544|NCT01579513|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102515545|NCT01579513|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102515546|NCT01579513|Prednisolone|prednisolone|mesh-list
102515547|NCT01579513|Prednisolone acetate|prednisolone acetate|mesh-list
102515548|NCT01579513|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102515549|NCT01579513|Prednisolone phosphate|prednisolone phosphate|mesh-list
102515550|NCT01579513|Glucocorticoids|glucocorticoids|mesh-list
102515551|NCT01579513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102515552|NCT01579513|Antiemetics|antiemetics|mesh-ancestor
102515553|NCT01579513|Autonomic Agents|autonomic agents|mesh-ancestor
102515554|NCT01579513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102515555|NCT01579513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515556|NCT01579513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102515557|NCT01579513|Hormones|hormones|mesh-ancestor
102515558|NCT01579513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102515559|NCT01579513|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102515560|NCT01579513|Protective Agents|protective agents|mesh-ancestor
102515561|NCT01579513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102515562|NCT01579513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102515563|NCT01534897|Dabrafenib|dabrafenib|mesh-list
102515564|NCT01534897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102515565|NCT01534897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102515566|NCT01534897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102515567|NCT01534897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515568|NCT05121350|Epirubicin|epirubicin|mesh-list
102515569|NCT05121350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102515570|NCT05121350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102515571|NCT05121350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102515572|NCT05121350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102515573|NCT05121350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102515574|NCT05121350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515575|NCT00583622|Bevacizumab|bevacizumab|mesh-list
102515576|NCT00583622|Carboplatin|carboplatin|mesh-list
102515577|NCT00583622|Gemcitabine|gemcitabine|mesh-list
102515578|NCT00583622|Docetaxel|docetaxel|mesh-list
102515579|NCT00583622|Melphalan|melphalan|mesh-list
102515580|NCT00583622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102515581|NCT00583622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102515582|NCT00583622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102515583|NCT00583622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102515584|NCT00583622|Growth Substances|growth substances|mesh-ancestor
102515585|NCT00583622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515586|NCT00583622|Growth Inhibitors|growth inhibitors|mesh-ancestor
102515587|NCT00583622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102515588|NCT00583622|Antimetabolites|antimetabolites|mesh-ancestor
102515589|NCT00583622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515590|NCT00583622|Tubulin Modulators|tubulin modulators|mesh-ancestor
102515591|NCT00583622|Antimitotic Agents|antimitotic agents|mesh-ancestor
102515592|NCT00583622|Mitosis Modulators|mitosis modulators|mesh-ancestor
102515593|NCT00583622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102515594|NCT00583622|Alkylating Agents|alkylating agents|mesh-ancestor
102515595|NCT00583622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102515596|NCT00583622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102515597|NCT00583622|Immunologic Factors|immunologic factors|mesh-ancestor
102515598|NCT00583700|Vitamin E|vitamin e|mesh-list
102515599|NCT00583700|Pentoxifylline|pentoxifylline|mesh-list
102515600|NCT00583700|Vitamins|vitamins|mesh-ancestor
102515601|NCT00583700|Micronutrients|micronutrients|mesh-ancestor
102515602|NCT00583700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515603|NCT00583700|Antioxidants|antioxidants|mesh-ancestor
102515604|NCT00583700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515605|NCT00583700|Protective Agents|protective agents|mesh-ancestor
102515606|NCT00583700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102515607|NCT00583700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102515608|NCT00583700|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102515609|NCT00583700|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102515610|NCT00583700|Vasodilator Agents|vasodilator agents|mesh-ancestor
102515611|NCT00583700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102515613|NCT05540743|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102515614|NCT05540743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102515615|NCT05540743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102515616|NCT01537315|Hydroxychloroquine|hydroxychloroquine|mesh-list
102515617|NCT01537315|Antimalarials|antimalarials|mesh-ancestor
102515618|NCT01537315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102515619|NCT01537315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102515620|NCT01537315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102515621|NCT01537315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102515622|NCT01537315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515623|NCT01537315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102515624|NCT04257188|Anesthetics|anesthetics|mesh-list
102515625|NCT04257188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102515626|NCT04257188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515627|NCT04224428|Fexofenadine|fexofenadine|mesh-list
102515628|NCT04224428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102515629|NCT04224428|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102515630|NCT04224428|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102515631|NCT04224428|Histamine Antagonists|histamine antagonists|mesh-ancestor
102515632|NCT04224428|Histamine Agents|histamine agents|mesh-ancestor
102515633|NCT04224428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102515634|NCT04224428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515635|NCT04224428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515636|NCT04224194|Adalimumab|adalimumab|mesh-list
102515637|NCT04224194|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102515638|NCT04224194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102515639|NCT04224194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102515640|NCT00584948|Memantine|memantine|mesh-list
102515641|NCT00584948|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102515642|NCT00584948|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102515643|NCT00584948|Dopamine Agents|dopamine agents|mesh-ancestor
102515644|NCT00584948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102515645|NCT00584948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515646|NCT00584948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515647|NCT00584948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102515648|NCT00584948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102515649|NCT00605072|Metoprolol|metoprolol|mesh-list
102515650|NCT00605072|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102515651|NCT00605072|Candesartan|candesartan|mesh-list
102515652|NCT00605072|Candesartan cilexetil|candesartan cilexetil|mesh-list
102515653|NCT00605072|Lisinopril|lisinopril|mesh-list
102515654|NCT00605072|Nifedipine|nifedipine|mesh-list
102515655|NCT00605072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102515656|NCT00605072|Diuretics|diuretics|mesh-ancestor
102515657|NCT00605072|Natriuretic Agents|natriuretic agents|mesh-ancestor
102515658|NCT00605072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515659|NCT00605072|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102515660|NCT00605072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102515661|NCT00605072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515662|NCT00605072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102515663|NCT00605072|Sympatholytics|sympatholytics|mesh-ancestor
102515664|NCT00605072|Autonomic Agents|autonomic agents|mesh-ancestor
102515665|NCT00605072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102515666|NCT00605072|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102515667|NCT00605072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102515668|NCT00605072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102515669|NCT00605072|Adrenergic Agents|adrenergic agents|mesh-ancestor
102515670|NCT00605072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101991903|NCT03446638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102515671|NCT00605072|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102515672|NCT00605072|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102515673|NCT00605072|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102515674|NCT00605072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102515675|NCT00605072|Vasodilator Agents|vasodilator agents|mesh-ancestor
102515676|NCT00605072|Tocolytic Agents|tocolytic agents|mesh-ancestor
102515677|NCT00605072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102515678|NCT00605072|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102515679|NCT00605072|Protease Inhibitors|protease inhibitors|mesh-ancestor
102515680|NCT00605072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102515681|NCT00605072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102515682|NCT00605072|Protective Agents|protective agents|mesh-ancestor
102515683|NCT00585104|Simendan|simendan|mesh-list
102515684|NCT00585104|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102515685|NCT00585104|Vasodilator Agents|vasodilator agents|mesh-ancestor
102515686|NCT00585104|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102515687|NCT00585104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102515688|NCT00585104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102515689|NCT00585104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515690|NCT00585104|Protective Agents|protective agents|mesh-ancestor
102515691|NCT00585104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515692|NCT00585182|Enoxaparin|enoxaparin|mesh-list
102515693|NCT00585182|Anticoagulants|anticoagulants|mesh-ancestor
102515694|NCT00585182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102515695|NCT00585182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102515696|NCT00585182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515697|NCT04856228|Lidocaine|lidocaine|mesh-list
102515698|NCT04856228|Anesthetics, Local|anesthetics, local|mesh-ancestor
102515699|NCT04856228|Anesthetics|anesthetics|mesh-ancestor
102515700|NCT04856228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102515701|NCT04856228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515702|NCT04856228|Sensory System Agents|sensory system agents|mesh-ancestor
102515703|NCT04856228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102515704|NCT04856228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102515705|NCT04856228|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102515706|NCT04856228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102515707|NCT04856228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102515708|NCT04856228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515709|NCT00605384|Tenofovir|tenofovir|mesh-list
102515710|NCT00605384|Lamivudine|lamivudine|mesh-list
102515711|NCT00605384|Entecavir|entecavir|mesh-list
102515712|NCT00605384|Adefovir|adefovir|mesh-list
102515713|NCT00605384|Antiviral Agents|antiviral agents|mesh-ancestor
102515714|NCT00605384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102515715|NCT00605384|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102515716|NCT00605384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102515717|NCT00605384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102515718|NCT00605384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515719|NCT00605384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102515720|NCT00605384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102515721|NCT00586196|Donepezil|donepezil|mesh-list
102515722|NCT00586196|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102515723|NCT00586196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102515724|NCT00586196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515725|NCT00586196|Cholinergic Agents|cholinergic agents|mesh-ancestor
102515726|NCT00586196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102515727|NCT00586196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515728|NCT00586196|Nootropic Agents|nootropic agents|mesh-ancestor
102515729|NCT00605696|Insulin|insulin|mesh-list
102515730|NCT00605696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102515731|NCT00605696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515732|NCT00587132|Secretin|secretin|mesh-list
102515733|NCT00587132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102515734|NCT00587132|Hormones|hormones|mesh-ancestor
102515735|NCT00587132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102515736|NCT00587132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515737|NCT00587678|Simvastatin|simvastatin|mesh-list
102515738|NCT00587678|Ezetimibe|ezetimibe|mesh-list
102515739|NCT00587678|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102515740|NCT00587678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102515741|NCT00587678|Antimetabolites|antimetabolites|mesh-ancestor
102515742|NCT00587678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515743|NCT00587678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102515744|NCT00587678|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102515745|NCT00587678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102515746|NCT02138006|Insulin|insulin|mesh-list
102515747|NCT02138006|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102515748|NCT02138006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102515749|NCT02138006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515750|NCT04545008|Acetylcysteine|acetylcysteine|mesh-list
102515751|NCT04545008|Famotidine|famotidine|mesh-list
102515752|NCT04545008|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102515753|NCT04545008|Antiviral Agents|antiviral agents|mesh-ancestor
102515754|NCT04545008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102515755|NCT04545008|Expectorants|expectorants|mesh-ancestor
102515756|NCT04545008|Respiratory System Agents|respiratory system agents|mesh-ancestor
102515757|NCT04545008|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102515759|NCT04545008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515760|NCT04545008|Protective Agents|protective agents|mesh-ancestor
102515761|NCT04545008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515762|NCT04545008|Antidotes|antidotes|mesh-ancestor
102515763|NCT04545008|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102515764|NCT04545008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102515765|NCT04545008|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102515766|NCT04545008|Histamine Antagonists|histamine antagonists|mesh-ancestor
102515767|NCT04545008|Histamine Agents|histamine agents|mesh-ancestor
102515768|NCT04545008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102515769|NCT04527770|Dexamethasone|dexamethasone|mesh-list
102515770|NCT04527770|Midazolam|midazolam|mesh-list
102515771|NCT04527770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102515772|NCT04527770|Antiemetics|antiemetics|mesh-ancestor
102515773|NCT04527770|Autonomic Agents|autonomic agents|mesh-ancestor
102515774|NCT04527770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102515775|NCT04527770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515776|NCT04527770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102515777|NCT04527770|Glucocorticoids|glucocorticoids|mesh-ancestor
102515778|NCT04527770|Hormones|hormones|mesh-ancestor
102515779|NCT04527770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102515780|NCT04527770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102515781|NCT04527770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102515782|NCT04527770|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102515783|NCT04527770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102515784|NCT04527770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102515785|NCT04527770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102515786|NCT04527770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102515787|NCT04527770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102515788|NCT04527770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102515789|NCT04527770|Anesthetics, General|anesthetics, general|mesh-ancestor
102515790|NCT04527770|Anesthetics|anesthetics|mesh-ancestor
102515791|NCT04527770|GABA Modulators|gaba modulators|mesh-ancestor
102515792|NCT04527770|GABA Agents|gaba agents|mesh-ancestor
102515793|NCT04527770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102515794|NCT04527770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515795|NCT01798940|Pioglitazone|pioglitazone|mesh-list
102515796|NCT01798940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102515797|NCT01798940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515798|NCT00609128|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
102515799|NCT00609128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102515800|NCT00609128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102515801|NCT00609128|Analgesics|analgesics|mesh-ancestor
102515802|NCT00609128|Sensory System Agents|sensory system agents|mesh-ancestor
102515803|NCT00609128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102515804|NCT00609128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515805|NCT00609128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102515806|NCT00609128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102515807|NCT00609128|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102515808|NCT00609128|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102515809|NCT00609128|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102515810|NCT00609128|Histamine Antagonists|histamine antagonists|mesh-ancestor
102515811|NCT00609128|Histamine Agents|histamine agents|mesh-ancestor
102515812|NCT00609128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102515813|NCT00609128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515814|NCT00668564|Cyclophosphamide|cyclophosphamide|mesh-list
102515815|NCT00668564|Busulfan|busulfan|mesh-list
102515816|NCT00668564|Alemtuzumab|alemtuzumab|mesh-list
102515817|NCT00668564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102515818|NCT00668564|Immunologic Factors|immunologic factors|mesh-ancestor
102515819|NCT00668564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515820|NCT00668564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102515821|NCT00668564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102515822|NCT00668564|Alkylating Agents|alkylating agents|mesh-ancestor
102515823|NCT00668564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515824|NCT00668564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102515825|NCT00668564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102515826|NCT00668564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102515827|NCT00610688|Vitamin D|vitamin d|mesh-list
102515828|NCT00610688|Ergocalciferols|ergocalciferols|mesh-list
102515829|NCT00610688|Cholecalciferol|cholecalciferol|mesh-list
102515830|NCT00610688|Vitamins|vitamins|mesh-list
102327328|NCT01932788|Vitamin D|vitamin d|mesh-list
102515831|NCT00610688|Micronutrients|micronutrients|mesh-ancestor
102515832|NCT00610688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515833|NCT00610688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102515834|NCT00610688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102515835|NCT00669578|Pomalidomide|pomalidomide|mesh-list
102515836|NCT00669578|Immunologic Factors|immunologic factors|mesh-ancestor
102515837|NCT00669578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515838|NCT00669578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102515839|NCT00669578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102515840|NCT00669578|Growth Substances|growth substances|mesh-ancestor
102515841|NCT00669578|Growth Inhibitors|growth inhibitors|mesh-ancestor
102515842|NCT00669578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102515843|NCT02137382|Pancrelipase|pancrelipase|mesh-list
102515844|NCT02137382|Pancreatin|pancreatin|mesh-list
102515845|NCT02137382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102515846|NCT00611468|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102515847|NCT00611468|Topotecan|topotecan|mesh-list
102515848|NCT00611468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102515849|NCT00611468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102515850|NCT00611468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102515851|NCT00611468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515852|NCT00611468|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102515853|NCT00611468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102515854|NCT00670202|Fasudil|fasudil|mesh-list
102515855|NCT00670202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102515856|NCT00670202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102515857|NCT00670202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515858|NCT00670202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102515859|NCT00670202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515860|NCT00670202|Vasodilator Agents|vasodilator agents|mesh-ancestor
102515861|NCT00670202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102515862|NCT00670202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102515863|NCT00670982|Bevacizumab|bevacizumab|mesh-list
102515864|NCT00670982|Trastuzumab|trastuzumab|mesh-list
102515865|NCT00670982|Vinorelbine|vinorelbine|mesh-list
102515866|NCT00670982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102515867|NCT00670982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102515868|NCT00670982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102515869|NCT00670982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102515870|NCT00670982|Growth Substances|growth substances|mesh-ancestor
102515871|NCT00670982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515872|NCT00670982|Growth Inhibitors|growth inhibitors|mesh-ancestor
102515873|NCT00670982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102515874|NCT00670982|Tubulin Modulators|tubulin modulators|mesh-ancestor
102515875|NCT00670982|Antimitotic Agents|antimitotic agents|mesh-ancestor
102515876|NCT00670982|Mitosis Modulators|mitosis modulators|mesh-ancestor
102515877|NCT00670982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515878|NCT00612560|Anastrozole|anastrozole|mesh-list
102515879|NCT00612560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102515880|NCT00612560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102515881|NCT00612560|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102515882|NCT00612560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102515883|NCT00612560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102515884|NCT00612560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515885|NCT00612560|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102515886|NCT00612560|Hormone Antagonists|hormone antagonists|mesh-ancestor
102515887|NCT00612560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102515888|NCT00612560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515889|NCT00612716|Cyclophosphamide|cyclophosphamide|mesh-list
102515890|NCT00612716|Busulfan|busulfan|mesh-list
102515891|NCT00612716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102515892|NCT00612716|Immunologic Factors|immunologic factors|mesh-ancestor
102515893|NCT00612716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515894|NCT00612716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102515895|NCT00612716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102515896|NCT00612716|Alkylating Agents|alkylating agents|mesh-ancestor
102515897|NCT00612716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515898|NCT00612716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102515899|NCT00612716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102515900|NCT04220684|Cytarabine|cytarabine|mesh-list
102515901|NCT04220684|Fludarabine|fludarabine|mesh-list
102515902|NCT04220684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102515903|NCT04220684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102515904|NCT04220684|Antimetabolites|antimetabolites|mesh-ancestor
102154272|NCT03376191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102515905|NCT04220684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515906|NCT04220684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102515907|NCT04220684|Immunologic Factors|immunologic factors|mesh-ancestor
102515908|NCT04220684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515909|NCT04220684|Antiviral Agents|antiviral agents|mesh-ancestor
102515910|NCT04220684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102515911|NCT00613028|Bevacizumab|bevacizumab|mesh-list
102515912|NCT00613028|Etoposide|etoposide|mesh-list
102515913|NCT00613028|Temozolomide|temozolomide|mesh-list
102515914|NCT00613028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102515915|NCT00613028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102515916|NCT00613028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102515917|NCT00613028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102515918|NCT00613028|Growth Substances|growth substances|mesh-ancestor
102515919|NCT00613028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515920|NCT00613028|Growth Inhibitors|growth inhibitors|mesh-ancestor
102515921|NCT00613028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102515922|NCT00613028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102515923|NCT00613028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102515924|NCT00613028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102515925|NCT00613028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515926|NCT00613028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102515927|NCT00613028|Alkylating Agents|alkylating agents|mesh-ancestor
102515928|NCT01799798|Denosumab|denosumab|mesh-list
102515929|NCT01799798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102515930|NCT01799798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515931|NCT00614198|Caseins|caseins|mesh-list
102515932|NCT00614198|Chelating Agents|chelating agents|mesh-ancestor
102515933|NCT00614198|Sequestering Agents|sequestering agents|mesh-ancestor
102515934|NCT00614198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515935|NCT00616772|Choline|choline|mesh-list
102515936|NCT00616772|Atorvastatin|atorvastatin|mesh-list
102515937|NCT00616772|Fenofibric acid|fenofibric acid|mesh-list
102515938|NCT00616772|Fenofibrate|fenofibrate|mesh-list
102515939|NCT00616772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102515940|NCT00616772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102515941|NCT00616772|Antimetabolites|antimetabolites|mesh-ancestor
102515942|NCT00616772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515943|NCT00616772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102515944|NCT00616772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102515945|NCT00616772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102515946|NCT00616772|Lipotropic Agents|lipotropic agents|mesh-ancestor
102515947|NCT00616772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102515948|NCT00616772|Nootropic Agents|nootropic agents|mesh-ancestor
102515949|NCT00672854|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102515950|NCT00672854|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102515951|NCT00672854|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102515952|NCT00672854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102515953|NCT00672932|Raltegravir Potassium|raltegravir potassium|mesh-list
102515954|NCT00672932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102515955|NCT00672932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102515956|NCT00672932|Antiviral Agents|antiviral agents|mesh-ancestor
102515957|NCT00672932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102515958|NCT00672932|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102515959|NCT00672932|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102515960|NCT00672932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102515961|NCT00672932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515962|NCT02513550|Ixekizumab|ixekizumab|mesh-list
102515963|NCT02513550|Dermatologic Agents|dermatologic agents|mesh-ancestor
102515964|NCT00673712|Analgesics, Opioid|analgesics, opioid|mesh-list
102515965|NCT00673712|Narcotics|narcotics|mesh-ancestor
102515966|NCT00673712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102515967|NCT00673712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515968|NCT00673712|Analgesics|analgesics|mesh-ancestor
102515969|NCT00673712|Sensory System Agents|sensory system agents|mesh-ancestor
102515970|NCT00673712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102515971|NCT04062032|Aspirin|aspirin|mesh-list
102515972|NCT04062032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102515973|NCT04062032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102515974|NCT04062032|Analgesics|analgesics|mesh-ancestor
102515975|NCT04062032|Sensory System Agents|sensory system agents|mesh-ancestor
102515976|NCT04062032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102515977|NCT04062032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515978|NCT04062032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102515979|NCT04062032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102515980|NCT04062032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102515981|NCT04062032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102515982|NCT04062032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102515983|NCT04062032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102515984|NCT04062032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102515985|NCT04062032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102515986|NCT04062032|Antipyretics|antipyretics|mesh-ancestor
102515987|NCT00617396|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102515988|NCT00617396|Antidepressive Agents|antidepressive agents|mesh-ancestor
102515989|NCT00617396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102515990|NCT00617396|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102515991|NCT00617396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102515992|NCT00617396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102515993|NCT00617396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102515994|NCT03722966|Nicotine|nicotine|mesh-list
102515995|NCT03722966|Varenicline|varenicline|mesh-list
102515996|NCT03722966|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102515997|NCT03722966|Autonomic Agents|autonomic agents|mesh-ancestor
102515998|NCT03722966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102515999|NCT03722966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516000|NCT03722966|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102516001|NCT03722966|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102516002|NCT03722966|Cholinergic Agents|cholinergic agents|mesh-ancestor
102516003|NCT03722966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102516004|NCT03722966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516005|NCT01581541|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
102516006|NCT01581541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102516007|NCT01582477|Bupivacaine|bupivacaine|mesh-list
102516008|NCT01582477|Anesthetics, Local|anesthetics, local|mesh-ancestor
102516009|NCT01582477|Anesthetics|anesthetics|mesh-ancestor
102516010|NCT01582477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102516011|NCT01582477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516012|NCT01582477|Sensory System Agents|sensory system agents|mesh-ancestor
102516013|NCT01582477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102516014|NCT03001687|Vitamin D|vitamin d|mesh-list
102516015|NCT03001687|Vitamins|vitamins|mesh-ancestor
102516016|NCT03001687|Micronutrients|micronutrients|mesh-ancestor
102516017|NCT03001687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516018|NCT03001687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102516019|NCT03001609|Abivertinib|abivertinib|mesh-list
102516020|NCT03001609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102516021|NCT03001609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102516022|NCT03001609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516023|NCT03007381|Ketorolac|ketorolac|mesh-list
102516024|NCT03007381|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102516025|NCT03007381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102516026|NCT03007381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102516027|NCT03007381|Analgesics|analgesics|mesh-ancestor
102516028|NCT03007381|Sensory System Agents|sensory system agents|mesh-ancestor
102516029|NCT03007381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102516030|NCT03007381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516031|NCT03007381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102516032|NCT03007381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102516033|NCT03007381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102516034|NCT03007381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102516035|NCT03007381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516036|NCT01585129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102516037|NCT01585129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102516038|NCT01585129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102516039|NCT01585129|Antitubercular Agents|antitubercular agents|mesh-ancestor
102516040|NCT01585207|Vigabatrin|vigabatrin|mesh-list
102516041|NCT01585207|Anticonvulsants|anticonvulsants|mesh-ancestor
102516042|NCT01585207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102516043|NCT01585207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516044|NCT01585207|GABA Agents|gaba agents|mesh-ancestor
102516045|NCT01585207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102516046|NCT01585207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516047|NCT03007303|Olanzapine|olanzapine|mesh-list
102516048|NCT03007303|Risperidone|risperidone|mesh-list
102516049|NCT03007303|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102516050|NCT03007303|Ziprasidone|ziprasidone|mesh-list
102516051|NCT03007303|Antipsychotic Agents|antipsychotic agents|mesh-list
102516052|NCT03007303|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102516053|NCT03007303|Serotonin Agents|serotonin agents|mesh-ancestor
102516054|NCT03007303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102516055|NCT03007303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516056|NCT03007303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516057|NCT03007303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102516058|NCT03007303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102516059|NCT03007303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102516060|NCT03007303|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102516061|NCT03007303|Dopamine Agents|dopamine agents|mesh-ancestor
102516062|NCT03007303|Antiemetics|antiemetics|mesh-ancestor
102516063|NCT03007303|Autonomic Agents|autonomic agents|mesh-ancestor
102516064|NCT03007303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102516065|NCT03007303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102516066|NCT03007303|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102516067|NCT03007303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102516068|NCT03007303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102516069|NCT03007303|Antidepressive Agents|antidepressive agents|mesh-ancestor
102516070|NCT01585441|Finasteride|finasteride|mesh-list
102516071|NCT01585441|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102516072|NCT01585441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102516073|NCT01585441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102516074|NCT01585441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516075|NCT01585441|Hormone Antagonists|hormone antagonists|mesh-ancestor
102516076|NCT01585441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102516077|NCT01585441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516078|NCT01585441|Urological Agents|urological agents|mesh-ancestor
102516079|NCT00617942|Paclitaxel|paclitaxel|mesh-list
102516080|NCT00617942|Carboplatin|carboplatin|mesh-list
102516081|NCT00617942|Trastuzumab|trastuzumab|mesh-list
102516082|NCT00617942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102516083|NCT00617942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102516084|NCT00617942|Tubulin Modulators|tubulin modulators|mesh-ancestor
102516085|NCT00617942|Antimitotic Agents|antimitotic agents|mesh-ancestor
102516086|NCT00617942|Mitosis Modulators|mitosis modulators|mesh-ancestor
102516087|NCT00617942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516088|NCT00617942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102516089|NCT00618332|Mometasone Furoate|mometasone furoate|mesh-list
102516090|NCT00618332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102516091|NCT00618332|Dermatologic Agents|dermatologic agents|mesh-ancestor
102516092|NCT00618332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102516093|NCT01588561|Nicotine|nicotine|mesh-list
102516094|NCT01588561|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102516095|NCT01588561|Autonomic Agents|autonomic agents|mesh-ancestor
102516096|NCT01588561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102516097|NCT01588561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516098|NCT01588561|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102516099|NCT01588561|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102516100|NCT01588561|Cholinergic Agents|cholinergic agents|mesh-ancestor
102516101|NCT01588561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102516102|NCT01588561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516103|NCT00619190|Aripiprazole|aripiprazole|mesh-list
102516104|NCT00619190|Antidepressive Agents|antidepressive agents|mesh-ancestor
102516105|NCT00619190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102516106|NCT00619190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102516107|NCT00619190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102516108|NCT00619190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102516109|NCT00619190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516110|NCT00619190|Dopamine Agonists|dopamine agonists|mesh-ancestor
102516111|NCT00619190|Dopamine Agents|dopamine agents|mesh-ancestor
102516112|NCT00619190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102516113|NCT00619190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516114|NCT00619190|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102516115|NCT00619190|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102516116|NCT00619190|Serotonin Agents|serotonin agents|mesh-ancestor
102516117|NCT00619190|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102516118|NCT00619190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102516119|NCT00619190|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102516120|NCT00619190|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102516121|NCT01589263|Tamsulosin|tamsulosin|mesh-list
102516122|NCT01589263|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102516123|NCT01589263|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102516124|NCT01589263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102516125|NCT01589263|Adrenergic Agents|adrenergic agents|mesh-ancestor
102516126|NCT01589263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102516127|NCT01589263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516128|NCT01589263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516129|NCT01589263|Urological Agents|urological agents|mesh-ancestor
102516130|NCT01590979|Ranolazine|ranolazine|mesh-list
102516131|NCT01590979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102516132|NCT01590979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102516133|NCT01590979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516134|NCT00619970|Rifaximin|rifaximin|mesh-list
102516135|NCT00619970|Lactulose|lactulose|mesh-list
102516136|NCT00619970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102516137|NCT00619970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102516138|NCT00619970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102516139|NCT01591837|Vaccines|vaccines|mesh-list
102516140|NCT01591837|Immunologic Factors|immunologic factors|mesh-ancestor
102516141|NCT01591837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516142|NCT01592851|Fluorides|fluorides|mesh-list
102516143|NCT01592851|Tin Fluorides|tin fluorides|mesh-list
102516144|NCT01592851|Fluorophosphate|fluorophosphate|mesh-list
102516145|NCT01592851|Cariostatic Agents|cariostatic agents|mesh-ancestor
102516146|NCT01592851|Protective Agents|protective agents|mesh-ancestor
102516147|NCT01592851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516148|NCT00675584|Budesonide|budesonide|mesh-list
102516149|NCT00675584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102516150|NCT00675584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102516151|NCT00675584|Autonomic Agents|autonomic agents|mesh-ancestor
102516152|NCT00675584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102516153|NCT00675584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516154|NCT00675584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102516155|NCT00675584|Respiratory System Agents|respiratory system agents|mesh-ancestor
102516156|NCT00675584|Glucocorticoids|glucocorticoids|mesh-ancestor
102516157|NCT00675584|Hormones|hormones|mesh-ancestor
102516158|NCT00675584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102516159|NCT03376646|Paclitaxel|paclitaxel|mesh-list
102516160|NCT03376646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102516161|NCT03376646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102516162|NCT03376646|Tubulin Modulators|tubulin modulators|mesh-ancestor
102516163|NCT03376646|Antimitotic Agents|antimitotic agents|mesh-ancestor
102516164|NCT03376646|Mitosis Modulators|mitosis modulators|mesh-ancestor
102516165|NCT03376646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516166|NCT00676364|Lidocaine|lidocaine|mesh-list
102516167|NCT00676364|Anesthetics, Local|anesthetics, local|mesh-list
102516168|NCT00676364|Anesthetics|anesthetics|mesh-list
102516169|NCT00676364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102516170|NCT00676364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516171|NCT00676364|Sensory System Agents|sensory system agents|mesh-ancestor
102516172|NCT00676364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102516173|NCT00676364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102516174|NCT00676364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102516175|NCT00676364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102516176|NCT00676364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102516177|NCT00676364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516178|NCT00676676|Testosterone|testosterone|mesh-list
102516179|NCT00676676|Androgens|androgens|mesh-ancestor
102516180|NCT00676676|Hormones|hormones|mesh-ancestor
102516181|NCT00676676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102516182|NCT00676676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516183|NCT00621530|Ketorolac|ketorolac|mesh-list
102516184|NCT00621530|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102516185|NCT00621530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102516186|NCT00621530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102516187|NCT00621530|Analgesics|analgesics|mesh-ancestor
102516188|NCT00621530|Sensory System Agents|sensory system agents|mesh-ancestor
102516189|NCT00621530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102516190|NCT00621530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516191|NCT00621530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102516192|NCT00621530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102516193|NCT00621530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102516194|NCT00621530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102516195|NCT00621530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516196|NCT02513472|Pembrolizumab|pembrolizumab|mesh-list
102516197|NCT02513472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102516198|NCT02513472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102516199|NCT02513472|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102516200|NCT02513472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516201|NCT00621686|Bevacizumab|bevacizumab|mesh-list
102516202|NCT00621686|Sorafenib|sorafenib|mesh-list
102516203|NCT00621686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102516204|NCT00621686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102516205|NCT00621686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102516206|NCT00621686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102516207|NCT00621686|Growth Substances|growth substances|mesh-ancestor
102516208|NCT00621686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516209|NCT00621686|Growth Inhibitors|growth inhibitors|mesh-ancestor
102516210|NCT00621686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102516211|NCT00621686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102516212|NCT00621686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516213|NCT02924714|Imatinib Mesylate|imatinib mesylate|mesh-list
102516214|NCT02924714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102516215|NCT02924714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102516216|NCT02924714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102516217|NCT02924714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516218|NCT00678470|Alefacept|alefacept|mesh-list
102516219|NCT00678470|Dermatologic Agents|dermatologic agents|mesh-ancestor
102516220|NCT00678470|Immunologic Factors|immunologic factors|mesh-ancestor
102516221|NCT00678470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516222|NCT00623012|Sirolimus|sirolimus|mesh-list
102516223|NCT00623012|Tacrolimus|tacrolimus|mesh-list
102516224|NCT00623012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102516225|NCT00623012|Immunologic Factors|immunologic factors|mesh-ancestor
102516226|NCT00623012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516227|NCT00623012|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102516228|NCT00623012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102516229|NCT00623012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516230|NCT00623012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102516231|NCT00623012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102516232|NCT00623012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102516233|NCT00623012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102516234|NCT00623012|Antifungal Agents|antifungal agents|mesh-ancestor
102516235|NCT02592356|Lenvatinib|lenvatinib|mesh-list
102516236|NCT02592356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101992465|NCT01233947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102516237|NCT02592356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102516238|NCT02592356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102516239|NCT02592356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516240|NCT02446964|Mycophenolic Acid|mycophenolic acid|mesh-list
102516241|NCT02446964|Cyclophosphamide|cyclophosphamide|mesh-list
102516242|NCT02446964|Fludarabine|fludarabine|mesh-list
102516243|NCT02446964|Fludarabine phosphate|fludarabine phosphate|mesh-list
102516244|NCT02446964|Tacrolimus|tacrolimus|mesh-list
102516245|NCT02446964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102516246|NCT02446964|Immunologic Factors|immunologic factors|mesh-ancestor
102516247|NCT02446964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516248|NCT02446964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102516249|NCT02446964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102516250|NCT02446964|Alkylating Agents|alkylating agents|mesh-ancestor
102516251|NCT02446964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516252|NCT02446964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102516253|NCT02446964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102516254|NCT02446964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102516255|NCT02446964|Antimetabolites|antimetabolites|mesh-ancestor
102516256|NCT02446964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102516257|NCT02446964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102516258|NCT02446964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102516259|NCT02446964|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102516260|NCT02446964|Antitubercular Agents|antitubercular agents|mesh-ancestor
102516261|NCT02446964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102516262|NCT02446964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102516263|NCT01799954|Vaccines|vaccines|mesh-list
102516264|NCT01799954|Immunologic Factors|immunologic factors|mesh-ancestor
102516265|NCT01799954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516266|NCT00623714|Fluticasone|fluticasone|mesh-list
102516267|NCT00623714|Xhance|xhance|mesh-list
102516268|NCT00623714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102516269|NCT00623714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102516270|NCT00623714|Autonomic Agents|autonomic agents|mesh-ancestor
102516271|NCT00623714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102516272|NCT00623714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516273|NCT00623714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102516274|NCT00623714|Respiratory System Agents|respiratory system agents|mesh-ancestor
102516275|NCT00623714|Dermatologic Agents|dermatologic agents|mesh-ancestor
102516276|NCT00623714|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102516277|NCT02174822|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102516278|NCT02174822|Paroxetine|paroxetine|mesh-list
102516279|NCT02174822|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102516280|NCT02174822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102516281|NCT02174822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102516282|NCT02174822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516283|NCT02174822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102516284|NCT02174822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516285|NCT02174822|Analgesics|analgesics|mesh-ancestor
102516286|NCT02174822|Sensory System Agents|sensory system agents|mesh-ancestor
102516287|NCT02174822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102516288|NCT02174822|Antidepressive Agents|antidepressive agents|mesh-ancestor
102516289|NCT02174822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102516290|NCT02174822|Dopamine Agents|dopamine agents|mesh-ancestor
102516291|NCT02174822|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102516292|NCT02174822|Serotonin Agents|serotonin agents|mesh-ancestor
102516293|NCT02174822|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102516294|NCT02174822|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102516295|NCT02174822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102516296|NCT02174822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102516297|NCT00624416|Prednisolone|prednisolone|mesh-list
102516298|NCT00624416|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102516299|NCT00624416|Methylprednisolone|methylprednisolone|mesh-list
102516300|NCT00624416|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102516301|NCT00624416|Prednisolone acetate|prednisolone acetate|mesh-list
102516302|NCT00624416|Cortisone|cortisone|mesh-list
102516303|NCT00624416|Isoproterenol|isoproterenol|mesh-list
102516304|NCT00624416|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102516305|NCT00624416|Prednisolone phosphate|prednisolone phosphate|mesh-list
102516306|NCT00624416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102516307|NCT00624416|Glucocorticoids|glucocorticoids|mesh-ancestor
102516308|NCT00624416|Hormones|hormones|mesh-ancestor
102516309|NCT00624416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102516310|NCT00624416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516311|NCT00624416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102516312|NCT00624416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102516313|NCT00624416|Antiemetics|antiemetics|mesh-ancestor
102516314|NCT00624416|Autonomic Agents|autonomic agents|mesh-ancestor
102516315|NCT00624416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102516316|NCT00624416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102516317|NCT00624416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102516318|NCT00624416|Protective Agents|protective agents|mesh-ancestor
102516319|NCT00624416|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102516320|NCT00624416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102516321|NCT00624416|Adrenergic Agents|adrenergic agents|mesh-ancestor
102516322|NCT00624416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102516323|NCT00624416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516324|NCT00624416|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102516325|NCT00624416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102516326|NCT00624416|Respiratory System Agents|respiratory system agents|mesh-ancestor
102516327|NCT00624416|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102516328|NCT00624416|Sympathomimetics|sympathomimetics|mesh-ancestor
102516329|NCT01872260|Letrozole|letrozole|mesh-list
102516330|NCT01872260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102516331|NCT01872260|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102516332|NCT01872260|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102516333|NCT01872260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102516334|NCT01872260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516335|NCT01872260|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102516336|NCT01872260|Hormone Antagonists|hormone antagonists|mesh-ancestor
102516337|NCT01872260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102516338|NCT01872260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516339|NCT00626210|Modafinil|modafinil|mesh-list
102516340|NCT00626210|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102516341|NCT00626210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516342|NCT00626210|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102516343|NCT00626210|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102516344|NCT00626210|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102516345|NCT00626210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516346|NCT00653276|Cyclosporine|cyclosporine|mesh-list
102516347|NCT00653276|Ezetimibe|ezetimibe|mesh-list
102516348|NCT00653276|Cyclosporins|cyclosporins|mesh-list
102516349|NCT00653276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102516350|NCT00653276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516351|NCT00653276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102516352|NCT00653276|Immunologic Factors|immunologic factors|mesh-ancestor
102516353|NCT00653276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516354|NCT00653276|Antifungal Agents|antifungal agents|mesh-ancestor
102516355|NCT00653276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101992610|NCT03790345|Vitamins|vitamins|mesh-list
102516356|NCT00653276|Dermatologic Agents|dermatologic agents|mesh-ancestor
102516357|NCT00653276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102516358|NCT00653276|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102516359|NCT00653276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102516360|NCT00653276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102516361|NCT00653276|Antimetabolites|antimetabolites|mesh-ancestor
102516362|NCT00653276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102516363|NCT00683852|Aripiprazole|aripiprazole|mesh-list
102516364|NCT00683852|Antidepressive Agents|antidepressive agents|mesh-ancestor
102516365|NCT00683852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102516366|NCT00683852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102516367|NCT00683852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102516368|NCT00683852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102516369|NCT00683852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516370|NCT00683852|Dopamine Agonists|dopamine agonists|mesh-ancestor
102516371|NCT00683852|Dopamine Agents|dopamine agents|mesh-ancestor
102516372|NCT00683852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102516373|NCT00683852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516374|NCT00683852|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102516375|NCT00683852|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102516376|NCT00683852|Serotonin Agents|serotonin agents|mesh-ancestor
102516377|NCT00683852|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102516378|NCT00683852|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102516379|NCT00683852|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102516380|NCT00683852|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102516381|NCT03006835|Clopidogrel|clopidogrel|mesh-list
102516382|NCT03006835|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102516383|NCT03006835|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102516384|NCT03006835|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102516385|NCT03006835|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102516386|NCT03006835|Purinergic Agents|purinergic agents|mesh-ancestor
102516387|NCT03006835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102516388|NCT03006835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516389|NCT03006835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516390|NCT03006757|Titanium dioxide|titanium dioxide|mesh-list
102516391|NCT03006757|Sunscreening Agents|sunscreening agents|mesh-ancestor
102516392|NCT03006757|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102516393|NCT03006757|Protective Agents|protective agents|mesh-ancestor
102516394|NCT03006757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516395|NCT03006757|Dermatologic Agents|dermatologic agents|mesh-ancestor
102516396|NCT03006757|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102516397|NCT05566405|Anesthetics|anesthetics|mesh-list
102516398|NCT05566405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102516399|NCT05566405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516400|NCT03000127|Testosterone|testosterone|mesh-list
102516401|NCT03000127|Androgens|androgens|mesh-ancestor
102516402|NCT03000127|Hormones|hormones|mesh-ancestor
102516403|NCT03000127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102516404|NCT03000127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516405|NCT02999815|Immunoglobulins|immunoglobulins|mesh-list
102516406|NCT02999815|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102516407|NCT02999815|Antibodies|antibodies|mesh-list
102516408|NCT02999815|Antitoxins|antitoxins|mesh-list
102516409|NCT02999815|Immunologic Factors|immunologic factors|mesh-ancestor
102516410|NCT02999815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516411|NCT03006679|Meropenem|meropenem|mesh-list
102516412|NCT03006679|Tazobactam|tazobactam|mesh-list
102516413|NCT03006679|Piperacillin|piperacillin|mesh-list
102516414|NCT03006679|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102516415|NCT03006679|Vaborbactam|vaborbactam|mesh-list
102516416|NCT03006679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102516417|NCT03006679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102516418|NCT03006679|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102516419|NCT03006679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102516420|NCT03006679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516421|NCT03006445|Dotinurad|dotinurad|mesh-list
102516422|NCT03006445|Uricosuric Agents|uricosuric agents|mesh-ancestor
102516423|NCT03006445|Gout Suppressants|gout suppressants|mesh-ancestor
102516424|NCT03006445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102516425|NCT03006211|Nitric Oxide|nitric oxide|mesh-list
102516426|NCT03006211|Nitrous Oxide|nitrous oxide|mesh-list
102516427|NCT03006211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102516428|NCT03006211|Anesthetics, General|anesthetics, general|mesh-ancestor
102516429|NCT03006211|Anesthetics|anesthetics|mesh-ancestor
102516430|NCT03006211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102516431|NCT03006211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516432|NCT03006211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102516433|NCT03006211|Analgesics|analgesics|mesh-ancestor
102516434|NCT03006211|Sensory System Agents|sensory system agents|mesh-ancestor
102516435|NCT03006211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102516436|NCT03006211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102516437|NCT03006211|Autonomic Agents|autonomic agents|mesh-ancestor
102516438|NCT03006211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102516439|NCT03006211|Respiratory System Agents|respiratory system agents|mesh-ancestor
102516440|NCT03006211|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102516441|NCT03006211|Antioxidants|antioxidants|mesh-ancestor
102516442|NCT03006211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516443|NCT03006211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102516444|NCT03006211|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102516445|NCT03006211|Vasodilator Agents|vasodilator agents|mesh-ancestor
102516446|NCT03006211|Gasotransmitters|gasotransmitters|mesh-ancestor
102516447|NCT03006211|Protective Agents|protective agents|mesh-ancestor
102516448|NCT02248051|CXA-10|cxa-10|mesh-list
102516449|NCT02248051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102516450|NCT02247505|Tadalafil|tadalafil|mesh-list
102516451|NCT02247505|Tamsulosin|tamsulosin|mesh-list
102516452|NCT02247505|Vasodilator Agents|vasodilator agents|mesh-ancestor
102516453|NCT02247505|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102516454|NCT02247505|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102516455|NCT02247505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102516456|NCT02247505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516457|NCT02247505|Urological Agents|urological agents|mesh-ancestor
102516458|NCT02247505|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102516459|NCT02247505|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102516460|NCT02247505|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102516461|NCT02247505|Adrenergic Agents|adrenergic agents|mesh-ancestor
102516462|NCT02247505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102516463|NCT02247505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516464|NCT04707625|Aflibercept|aflibercept|mesh-list
102516465|NCT04707625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102516466|NCT04707625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102516467|NCT04707625|Growth Substances|growth substances|mesh-ancestor
102516468|NCT04707625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516469|NCT04707625|Growth Inhibitors|growth inhibitors|mesh-ancestor
102516470|NCT04707625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102516471|NCT02248129|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102516472|NCT02248129|Telmisartan|telmisartan|mesh-list
102516473|NCT02248129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102516474|NCT02248129|Diuretics|diuretics|mesh-ancestor
102516475|NCT02248129|Natriuretic Agents|natriuretic agents|mesh-ancestor
102516476|NCT02248129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516477|NCT02248129|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102516478|NCT02248129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102516479|NCT02248129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516480|NCT02248129|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102516481|NCT02248129|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102516482|NCT02248207|Pramipexole|pramipexole|mesh-list
102516483|NCT02248207|Antioxidants|antioxidants|mesh-ancestor
102516484|NCT02248207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516485|NCT02248207|Protective Agents|protective agents|mesh-ancestor
102516486|NCT02248207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516487|NCT02248207|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102516488|NCT02248207|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102516489|NCT02248207|Dopamine Agonists|dopamine agonists|mesh-ancestor
102516490|NCT02248207|Dopamine Agents|dopamine agents|mesh-ancestor
102516491|NCT02248207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102516492|NCT00683930|Mycophenolic Acid|mycophenolic acid|mesh-list
102516493|NCT00683930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102516494|NCT00683930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102516495|NCT00683930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102516496|NCT00683930|Antitubercular Agents|antitubercular agents|mesh-ancestor
102516497|NCT00683930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102516498|NCT00683930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102516499|NCT00683930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102516500|NCT00683930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516501|NCT00684242|Lenalidomide|lenalidomide|mesh-list
102327998|NCT01597557|Tocolytic Agents|tocolytic agents|mesh-ancestor
102516502|NCT00684242|Immunologic Factors|immunologic factors|mesh-ancestor
102516503|NCT00684242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516504|NCT00684242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102516505|NCT00684242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102516506|NCT00684242|Growth Substances|growth substances|mesh-ancestor
102516507|NCT00684242|Growth Inhibitors|growth inhibitors|mesh-ancestor
102516508|NCT00684242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102516509|NCT00651560|Simvastatin|simvastatin|mesh-list
102516511|NCT00651560|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102516512|NCT00651560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102516513|NCT00651560|Antimetabolites|antimetabolites|mesh-ancestor
102516514|NCT00651560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516515|NCT00651560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102516516|NCT00651560|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102516517|NCT00651560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102516518|NCT00684554|Buprenorphine|buprenorphine|mesh-list
102516519|NCT00684554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102516520|NCT00684554|Narcotics|narcotics|mesh-ancestor
102516521|NCT00684554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102516522|NCT00684554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516523|NCT00684554|Analgesics|analgesics|mesh-ancestor
102516524|NCT00684554|Sensory System Agents|sensory system agents|mesh-ancestor
102516525|NCT00684554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102516526|NCT00684554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102516527|NCT00551876|Simvastatin|simvastatin|mesh-list
102516528|NCT00551876|Ezetimibe|ezetimibe|mesh-list
102516529|NCT00551876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102516530|NCT00551876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102516531|NCT00551876|Antimetabolites|antimetabolites|mesh-ancestor
102516532|NCT00551876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516533|NCT00551876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102516534|NCT00551876|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102516535|NCT00551876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102516536|NCT04451863|Caryophyllene|caryophyllene|mesh-list
102516537|NCT04451863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516538|NCT04451863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102516539|NCT04451863|Analgesics|analgesics|mesh-ancestor
102516540|NCT04451863|Sensory System Agents|sensory system agents|mesh-ancestor
102516541|NCT04451863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102516542|NCT04451863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102516543|NCT04451863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102516544|NCT04451863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102516545|NCT00628394|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102516546|NCT00628394|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102516547|NCT00628394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102516548|NCT00628394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102516549|NCT00628394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516550|NCT00628394|Adrenergic Agents|adrenergic agents|mesh-ancestor
102516551|NCT00628394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102516552|NCT00628394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516553|NCT00251576|Heparin|heparin|mesh-list
102516554|NCT00251576|Calcium heparin|calcium heparin|mesh-list
102516555|NCT00251576|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102516556|NCT00251576|Tinzaparin|tinzaparin|mesh-list
102516557|NCT00251576|Dalteparin|dalteparin|mesh-list
102516558|NCT00251576|Tirofiban|tirofiban|mesh-list
102516559|NCT00251576|Simvastatin|simvastatin|mesh-list
102516560|NCT00251576|Anticoagulants|anticoagulants|mesh-ancestor
102516561|NCT00251576|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102516562|NCT00251576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102516563|NCT00251576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516564|NCT00251576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102516565|NCT00251576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102516566|NCT00251576|Antimetabolites|antimetabolites|mesh-ancestor
102516567|NCT00251576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102516568|NCT00251576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102516569|NCT00251576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102516570|NCT00251576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102516571|NCT04387604|Ranibizumab|ranibizumab|mesh-list
102516572|NCT04387604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102516573|NCT04387604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102516574|NCT04387604|Growth Substances|growth substances|mesh-ancestor
102516575|NCT04387604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516576|NCT04387604|Growth Inhibitors|growth inhibitors|mesh-ancestor
102516577|NCT04387604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102516578|NCT03005665|Acetazolamide|acetazolamide|mesh-list
102516579|NCT03005665|Anticonvulsants|anticonvulsants|mesh-ancestor
102516580|NCT03005665|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102516581|NCT03005665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102516582|NCT03005665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516583|NCT03005665|Diuretics|diuretics|mesh-ancestor
102516584|NCT03005665|Natriuretic Agents|natriuretic agents|mesh-ancestor
102516585|NCT03005665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516586|NCT00628628|Rasburicase|rasburicase|mesh-list
102516587|NCT00628628|Gout Suppressants|gout suppressants|mesh-ancestor
102516588|NCT00628628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102516589|NCT04386811|Calcitriol|calcitriol|mesh-list
102516590|NCT04386811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102516591|NCT04386811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516592|NCT04386811|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102516593|NCT04386811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102516594|NCT04386811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516595|NCT04386811|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102516596|NCT04386811|Vitamins|vitamins|mesh-ancestor
102516597|NCT04386811|Micronutrients|micronutrients|mesh-ancestor
102516598|NCT04386811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102516599|NCT04357873|Pembrolizumab|pembrolizumab|mesh-list
102516600|NCT04357873|Vorinostat|vorinostat|mesh-list
102516601|NCT04357873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102516602|NCT04357873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102516603|NCT04357873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102516604|NCT04357873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516605|NCT04357873|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102516606|NCT04357873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102516607|NCT00630734|Ritonavir|ritonavir|mesh-list
102516608|NCT00630734|Darunavir|darunavir|mesh-list
102516609|NCT00630734|Pravastatin|pravastatin|mesh-list
102516610|NCT00630734|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102516611|NCT00630734|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102516612|NCT00630734|Protease Inhibitors|protease inhibitors|mesh-ancestor
102516613|NCT00630734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102516614|NCT00630734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516615|NCT00630734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102516616|NCT00630734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102516617|NCT00630734|Antiviral Agents|antiviral agents|mesh-ancestor
102516618|NCT00630734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102516619|NCT00630734|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102516620|NCT00630734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102516621|NCT00630734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102516622|NCT00630734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102516623|NCT00630734|Antimetabolites|antimetabolites|mesh-ancestor
102516624|NCT00630734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102516625|NCT00630734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102516626|NCT05644249|Doxorubicin|doxorubicin|mesh-list
102516627|NCT05644249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102516628|NCT05644249|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102516629|NCT05644249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102516630|NCT05644249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102516631|NCT05644249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102516632|NCT05644249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516633|NCT00686582|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
102516634|NCT00686582|Antiviral Agents|antiviral agents|mesh-ancestor
102516635|NCT00686582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102516636|NCT00631358|Dexamethasone|dexamethasone|mesh-list
102516637|NCT00631358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102516638|NCT00631358|Antiemetics|antiemetics|mesh-ancestor
102516639|NCT00631358|Autonomic Agents|autonomic agents|mesh-ancestor
102516640|NCT00631358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102516641|NCT00631358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516642|NCT00631358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102516643|NCT00631358|Glucocorticoids|glucocorticoids|mesh-ancestor
102516644|NCT00631358|Hormones|hormones|mesh-ancestor
102516645|NCT00631358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102516646|NCT00631358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102516647|NCT00631358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102516648|NCT02248753|Metoprolol|metoprolol|mesh-list
102516649|NCT02248753|Digoxin|digoxin|mesh-list
102516650|NCT02248753|Amiodarone|amiodarone|mesh-list
102328171|NCT01783821|Budesonide|budesonide|mesh-list
102516652|NCT02248753|Flecainide|flecainide|mesh-list
102516653|NCT02248753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102516654|NCT02248753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102516655|NCT02248753|Sympatholytics|sympatholytics|mesh-ancestor
102516656|NCT02248753|Autonomic Agents|autonomic agents|mesh-ancestor
102516657|NCT02248753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102516658|NCT02248753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516659|NCT02248753|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102516660|NCT02248753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102516661|NCT02248753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102516662|NCT02248753|Adrenergic Agents|adrenergic agents|mesh-ancestor
102516663|NCT02248753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102516664|NCT02248753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516665|NCT02248753|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102516666|NCT02248753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102516667|NCT02248753|Protective Agents|protective agents|mesh-ancestor
102516668|NCT02248753|Vasodilator Agents|vasodilator agents|mesh-ancestor
102516669|NCT02248753|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102516670|NCT02248753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102516671|NCT02248753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102516672|NCT02248753|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102516673|NCT02248753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102516674|NCT02248753|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102516675|NCT02248753|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102516676|NCT02248753|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102516677|NCT02248753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102516678|NCT02248753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102516679|NCT02248753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102516680|NCT00687674|Dexamethasone|dexamethasone|mesh-list
102516681|NCT00687674|Lenalidomide|lenalidomide|mesh-list
102516682|NCT00687674|Sorafenib|sorafenib|mesh-list
102516683|NCT00687674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102516684|NCT00687674|Antiemetics|antiemetics|mesh-ancestor
102516685|NCT00687674|Autonomic Agents|autonomic agents|mesh-ancestor
102516686|NCT00687674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102516687|NCT00687674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516688|NCT00687674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102516689|NCT00687674|Glucocorticoids|glucocorticoids|mesh-ancestor
102516690|NCT00687674|Hormones|hormones|mesh-ancestor
102516691|NCT00687674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102516692|NCT00687674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102516693|NCT00687674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102516694|NCT00687674|Immunologic Factors|immunologic factors|mesh-ancestor
102516695|NCT00687674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102516696|NCT00687674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102516697|NCT00687674|Growth Substances|growth substances|mesh-ancestor
102516698|NCT00687674|Growth Inhibitors|growth inhibitors|mesh-ancestor
102516699|NCT00687674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102516700|NCT00687674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102516701|NCT00687674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516702|NCT00687908|Adapalene|adapalene|mesh-list
102516703|NCT00687908|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102516704|NCT00687908|Dermatologic Agents|dermatologic agents|mesh-ancestor
102516705|NCT00687908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102516706|NCT00687908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102516707|NCT00687908|Analgesics|analgesics|mesh-ancestor
102516708|NCT00687908|Sensory System Agents|sensory system agents|mesh-ancestor
102516709|NCT00687908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102516710|NCT00687908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516711|NCT00687908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102516712|NCT00687908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102516713|NCT00689078|Loteprednol Etabonate|loteprednol etabonate|mesh-list
102516714|NCT00689078|Prednisolone|prednisolone|mesh-list
102516715|NCT00689078|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102516716|NCT00689078|Methylprednisolone|methylprednisolone|mesh-list
102516717|NCT00689078|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102516718|NCT00689078|Prednisolone acetate|prednisolone acetate|mesh-list
102516719|NCT00689078|Lubricant Eye Drops|lubricant eye drops|mesh-list
102516720|NCT00689078|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102516721|NCT00689078|Prednisolone phosphate|prednisolone phosphate|mesh-list
102516722|NCT00689078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102516723|NCT00689078|Glucocorticoids|glucocorticoids|mesh-ancestor
102516724|NCT00689078|Hormones|hormones|mesh-ancestor
102516725|NCT00689078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102516726|NCT00689078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516727|NCT00689078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102516728|NCT00689078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102516730|NCT00689078|Autonomic Agents|autonomic agents|mesh-ancestor
102516731|NCT00689078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102516732|NCT00689078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102516733|NCT00689078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102516734|NCT00689078|Protective Agents|protective agents|mesh-ancestor
102516735|NCT00689078|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102516736|NCT00689078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102516737|NCT00689078|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102516738|NCT05568979|Vaccines|vaccines|mesh-list
102516739|NCT05568979|Immunologic Factors|immunologic factors|mesh-ancestor
102516740|NCT05568979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516741|NCT03005353|Clotrimazole|clotrimazole|mesh-list
102516742|NCT03005353|Miconazole|miconazole|mesh-list
102516743|NCT03005353|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102516744|NCT03005353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102516745|NCT03005353|Antifungal Agents|antifungal agents|mesh-ancestor
102516746|NCT03005353|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102516747|NCT03005353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102516748|NCT03005353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102516749|NCT03005353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516750|NCT03005353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102516751|NCT03005353|Hormone Antagonists|hormone antagonists|mesh-ancestor
102516752|NCT03005353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102516753|NCT03005353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516754|NCT03005353|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102516755|NCT03005353|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102516756|NCT00588536|Leucovorin|leucovorin|mesh-list
102516757|NCT00588536|Methotrexate|methotrexate|mesh-list
102516758|NCT00588536|Thioguanine|thioguanine|mesh-list
102516759|NCT00588536|Calcium|calcium|mesh-list
102516760|NCT00588536|Levoleucovorin|levoleucovorin|mesh-list
102516761|NCT00588536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102516762|NCT00588536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516763|NCT00588536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102516764|NCT00588536|Abortifacient Agents|abortifacient agents|mesh-ancestor
102516765|NCT00588536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102516766|NCT00588536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102516767|NCT00588536|Antimetabolites|antimetabolites|mesh-ancestor
102516768|NCT00588536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516769|NCT00588536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102516770|NCT00588536|Dermatologic Agents|dermatologic agents|mesh-ancestor
102516771|NCT00588536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102516772|NCT00588536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102516773|NCT00588536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102516774|NCT00588536|Immunologic Factors|immunologic factors|mesh-ancestor
102516775|NCT00588536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102516776|NCT00588536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102516777|NCT00588536|Antidotes|antidotes|mesh-ancestor
102516778|NCT00588536|Protective Agents|protective agents|mesh-ancestor
102516779|NCT00588536|Vitamin B Complex|vitamin b complex|mesh-ancestor
102516780|NCT00588536|Vitamins|vitamins|mesh-ancestor
102516781|NCT00588536|Micronutrients|micronutrients|mesh-ancestor
102516782|NCT03977233|Leucovorin|leucovorin|mesh-list
102516783|NCT03977233|Oxaliplatin|oxaliplatin|mesh-list
102516784|NCT03977233|Irinotecan|irinotecan|mesh-list
102516785|NCT03977233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102516786|NCT03977233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102516787|NCT03977233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102516788|NCT03977233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102516789|NCT03977233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516790|NCT03977233|Antidotes|antidotes|mesh-ancestor
102516791|NCT03977233|Protective Agents|protective agents|mesh-ancestor
102516792|NCT03977233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516793|NCT03977233|Vitamin B Complex|vitamin b complex|mesh-ancestor
102516794|NCT03977233|Vitamins|vitamins|mesh-ancestor
102516795|NCT03977233|Micronutrients|micronutrients|mesh-ancestor
102516796|NCT03951649|Acetaminophen|acetaminophen|mesh-list
102516797|NCT03951649|Caffeine|caffeine|mesh-list
102328290|NCT01408030|Growth Substances|growth substances|mesh-ancestor
102516798|NCT03951649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102516799|NCT03951649|Analgesics|analgesics|mesh-ancestor
102516800|NCT03951649|Sensory System Agents|sensory system agents|mesh-ancestor
102516801|NCT03951649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102516802|NCT03951649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516803|NCT03951649|Antipyretics|antipyretics|mesh-ancestor
102516804|NCT03951649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102516805|NCT03951649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102516806|NCT03951649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102516807|NCT03951649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516808|NCT03951649|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102516809|NCT03951649|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102516810|NCT03951649|Purinergic Agents|purinergic agents|mesh-ancestor
102516811|NCT03951649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102516812|NCT00590018|Hydrocortisone|hydrocortisone|mesh-list
102516813|NCT00590018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102516814|NCT02219503|Ritonavir|ritonavir|mesh-list
102516815|NCT02219503|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102516816|NCT02219503|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102516817|NCT02219503|Protease Inhibitors|protease inhibitors|mesh-ancestor
102516818|NCT02219503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102516819|NCT02219503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516820|NCT02219503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102516821|NCT02219503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102516822|NCT02219503|Antiviral Agents|antiviral agents|mesh-ancestor
102516823|NCT02219503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102516824|NCT02219503|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102516825|NCT02219503|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102516826|NCT00592124|Tenofovir|tenofovir|mesh-list
102516827|NCT00592124|Antiviral Agents|antiviral agents|mesh-ancestor
102516828|NCT00592124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102516829|NCT00592124|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102516830|NCT00592124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102516831|NCT00592124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102516832|NCT00592124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516833|NCT00592124|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102516834|NCT00592124|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102516835|NCT02221219|Indomethacin|indomethacin|mesh-list
102516836|NCT02221219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102516837|NCT02221219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102516838|NCT02221219|Analgesics|analgesics|mesh-ancestor
102516839|NCT02221219|Sensory System Agents|sensory system agents|mesh-ancestor
102516840|NCT02221219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101993085|NCT03706950|Elsulfavirine|elsulfavirine|mesh-list
102516841|NCT02221219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516842|NCT02221219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102516843|NCT02221219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102516844|NCT02221219|Gout Suppressants|gout suppressants|mesh-ancestor
102516845|NCT02221219|Tocolytic Agents|tocolytic agents|mesh-ancestor
102516846|NCT02221219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102516847|NCT02221219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102516848|NCT02221219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102516849|NCT02221219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516850|NCT00593450|Bevacizumab|bevacizumab|mesh-list
102516851|NCT00593450|Ranibizumab|ranibizumab|mesh-list
102516852|NCT00593450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102516853|NCT00593450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102516854|NCT00593450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102516855|NCT00593450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102516856|NCT00593450|Growth Substances|growth substances|mesh-ancestor
102516857|NCT00593450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516858|NCT00593450|Growth Inhibitors|growth inhibitors|mesh-ancestor
102516859|NCT00631748|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102516860|NCT00631748|Antidepressive Agents|antidepressive agents|mesh-ancestor
102516861|NCT00631748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102516862|NCT00631748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102516863|NCT00631748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102516864|NCT00631748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102516865|NCT00631748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516866|NCT00594230|Panobinostat|panobinostat|mesh-list
102516867|NCT00594230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102516868|NCT00594230|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102516869|NCT00594230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102516870|NCT00594230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516871|NCT00594308|Cyclosporine|cyclosporine|mesh-list
102516872|NCT00594308|Mycophenolic Acid|mycophenolic acid|mesh-list
102328364|NCT01426438|Aspirin|aspirin|mesh-list
102516873|NCT00594308|Cyclophosphamide|cyclophosphamide|mesh-list
102516874|NCT00594308|Fludarabine|fludarabine|mesh-list
102516875|NCT00594308|Cyclosporins|cyclosporins|mesh-list
102516876|NCT00594308|Basiliximab|basiliximab|mesh-list
102516877|NCT00594308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102516878|NCT00594308|Immunologic Factors|immunologic factors|mesh-ancestor
102516879|NCT00594308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516880|NCT00594308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102516881|NCT00594308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102516882|NCT00594308|Alkylating Agents|alkylating agents|mesh-ancestor
102516883|NCT00594308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516884|NCT00594308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102516885|NCT00594308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102516886|NCT00594308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102516887|NCT00594308|Antifungal Agents|antifungal agents|mesh-ancestor
102516888|NCT00594308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102516889|NCT00594308|Dermatologic Agents|dermatologic agents|mesh-ancestor
102516890|NCT00594308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102516891|NCT00594308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102516892|NCT00594308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102516893|NCT00594308|Antitubercular Agents|antitubercular agents|mesh-ancestor
102516894|NCT00594308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102516895|NCT02137538|Letrozole|letrozole|mesh-list
102516896|NCT02137538|Anastrozole|anastrozole|mesh-list
102516897|NCT02137538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102516898|NCT02137538|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102516899|NCT02137538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102516900|NCT02137538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102516901|NCT02137538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516902|NCT02137538|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102516903|NCT02137538|Hormone Antagonists|hormone antagonists|mesh-ancestor
102133726|NCT02295189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102516904|NCT02137538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102516905|NCT02137538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516906|NCT02137538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102516907|NCT00595556|Zonisamide|zonisamide|mesh-list
102516908|NCT00595556|Anticonvulsants|anticonvulsants|mesh-ancestor
102516909|NCT00595556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102516910|NCT00595556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102516911|NCT00595556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516912|NCT00595556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102516913|NCT00595556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516914|NCT00595790|Vaccines|vaccines|mesh-list
102516915|NCT00595790|Immunologic Factors|immunologic factors|mesh-ancestor
102516916|NCT00595790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516917|NCT00595946|Lubiprostone|lubiprostone|mesh-list
102516918|NCT00595946|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102516919|NCT00595946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102516920|NCT00595946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516921|NCT00597038|Dasatinib|dasatinib|mesh-list
102516922|NCT00597038|Dacarbazine|dacarbazine|mesh-list
102516923|NCT00597038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102516924|NCT00597038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102516925|NCT00597038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102516926|NCT00597038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516927|NCT00597038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102516928|NCT00597038|Alkylating Agents|alkylating agents|mesh-ancestor
102516929|NCT00597428|Lubiprostone|lubiprostone|mesh-list
102516930|NCT00597428|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102516931|NCT00597428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102516932|NCT00597428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516933|NCT00597818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102516934|NCT00597818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
102516935|NCT00597818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102516936|NCT00597818|Analgesics|analgesics|mesh-ancestor
102516937|NCT00597818|Sensory System Agents|sensory system agents|mesh-ancestor
102516938|NCT00597818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102516939|NCT00597818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516940|NCT00597818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102516941|NCT00597896|Pramipexole|pramipexole|mesh-list
102516942|NCT00597896|Antioxidants|antioxidants|mesh-ancestor
102516943|NCT00597896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516944|NCT00597896|Protective Agents|protective agents|mesh-ancestor
102516945|NCT00597896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516946|NCT00597896|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102516947|NCT00597896|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102516948|NCT00597896|Dopamine Agonists|dopamine agonists|mesh-ancestor
102516949|NCT00597896|Dopamine Agents|dopamine agents|mesh-ancestor
102516950|NCT00597896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102516952|NCT01790282|Progesterone|progesterone|mesh-list
102516953|NCT01790282|Estrogens|estrogens|mesh-ancestor
102516954|NCT01790282|Hormones|hormones|mesh-ancestor
102516955|NCT01790282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102516956|NCT01790282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516957|NCT01790282|Progestins|progestins|mesh-ancestor
102516958|NCT03843541|Acetylcysteine|acetylcysteine|mesh-list
102516959|NCT03843541|Ambroxol|ambroxol|mesh-list
102516960|NCT03843541|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102516961|NCT03843541|Antiviral Agents|antiviral agents|mesh-ancestor
102516962|NCT03843541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102516963|NCT03843541|Expectorants|expectorants|mesh-ancestor
102516964|NCT03843541|Respiratory System Agents|respiratory system agents|mesh-ancestor
102516965|NCT03843541|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102516966|NCT03843541|Antioxidants|antioxidants|mesh-ancestor
102516967|NCT03843541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516968|NCT03843541|Protective Agents|protective agents|mesh-ancestor
102516969|NCT03843541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516970|NCT03843541|Antidotes|antidotes|mesh-ancestor
102516971|NCT00639158|Choline|choline|mesh-list
102516972|NCT00639158|Atorvastatin|atorvastatin|mesh-list
102516973|NCT00639158|Ezetimibe|ezetimibe|mesh-list
102516974|NCT00639158|Fenofibric acid|fenofibric acid|mesh-list
102516975|NCT00639158|Fenofibrate|fenofibrate|mesh-list
102516976|NCT00639158|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102516977|NCT00639158|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102516978|NCT00639158|Antimetabolites|antimetabolites|mesh-ancestor
102516979|NCT00639158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102516980|NCT00639158|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102516981|NCT00639158|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102516982|NCT00639158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102516983|NCT00639158|Lipotropic Agents|lipotropic agents|mesh-ancestor
102516984|NCT00639158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102516985|NCT00639158|Nootropic Agents|nootropic agents|mesh-ancestor
102516986|NCT02248987|Antipsychotic Agents|antipsychotic agents|mesh-list
102516987|NCT02248987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102516988|NCT02248987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102516989|NCT02248987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516990|NCT02248987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102516991|NCT00692978|Fluticasone|fluticasone|mesh-list
102516992|NCT00692978|Xhance|xhance|mesh-list
102516993|NCT00692978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102516994|NCT00692978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102516995|NCT00692978|Autonomic Agents|autonomic agents|mesh-ancestor
102516996|NCT00692978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102516997|NCT00692978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102516998|NCT00692978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102516999|NCT00692978|Respiratory System Agents|respiratory system agents|mesh-ancestor
102517000|NCT00692978|Dermatologic Agents|dermatologic agents|mesh-ancestor
102517001|NCT00692978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102517002|NCT00601718|Rituximab|rituximab|mesh-list
102517003|NCT00601718|Carboplatin|carboplatin|mesh-list
102517004|NCT00601718|Etoposide|etoposide|mesh-list
102517005|NCT00601718|Etoposide phosphate|etoposide phosphate|mesh-list
102517006|NCT00601718|Ifosfamide|ifosfamide|mesh-list
102517007|NCT00601718|Vorinostat|vorinostat|mesh-list
102517008|NCT00601718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102517009|NCT00601718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102517010|NCT00601718|Immunologic Factors|immunologic factors|mesh-ancestor
102517011|NCT00601718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517012|NCT00601718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102517013|NCT00601718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102517014|NCT00601718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102517015|NCT00601718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102517016|NCT00601718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102517017|NCT00601718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517018|NCT00601718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102517019|NCT00601718|Alkylating Agents|alkylating agents|mesh-ancestor
102517020|NCT00601718|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102517021|NCT00601796|Cyclophosphamide|cyclophosphamide|mesh-list
102328511|NCT01402492|Naloxone|naloxone|mesh-list
102517022|NCT00601796|Tretinoin|tretinoin|mesh-list
102517023|NCT00601796|Vaccines|vaccines|mesh-list
102517025|NCT00601796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517026|NCT00601796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102517027|NCT00601796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102517028|NCT00601796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102517029|NCT00601796|Alkylating Agents|alkylating agents|mesh-ancestor
102517030|NCT00601796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517031|NCT00601796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102517032|NCT00601796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102517033|NCT00601796|Keratolytic Agents|keratolytic agents|mesh-ancestor
102517034|NCT00601796|Dermatologic Agents|dermatologic agents|mesh-ancestor
102517035|NCT00693992|Sunitinib|sunitinib|mesh-list
102517036|NCT00693992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102517037|NCT00693992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102517038|NCT00693992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102517039|NCT00693992|Growth Substances|growth substances|mesh-ancestor
102517040|NCT00693992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517041|NCT00693992|Growth Inhibitors|growth inhibitors|mesh-ancestor
102517042|NCT00693992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102517043|NCT00693992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102517044|NCT00693992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517045|NCT00645710|Gemcitabine|gemcitabine|mesh-list
102517046|NCT00645710|Floxuridine|floxuridine|mesh-list
102517047|NCT00645710|Antibodies|antibodies|mesh-list
102517048|NCT00645710|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102517049|NCT00645710|Immunologic Factors|immunologic factors|mesh-ancestor
102517050|NCT00645710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517051|NCT00645710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102517052|NCT00645710|Antimetabolites|antimetabolites|mesh-ancestor
102517053|NCT00645710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517054|NCT00645710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102517055|NCT00603044|Fluticasone|fluticasone|mesh-list
102517056|NCT00603044|Xhance|xhance|mesh-list
102517057|NCT00603044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102517058|NCT00603044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102517059|NCT00603044|Autonomic Agents|autonomic agents|mesh-ancestor
102517060|NCT00603044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102517061|NCT00603044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517062|NCT00603044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102517063|NCT00603044|Respiratory System Agents|respiratory system agents|mesh-ancestor
102517064|NCT00603044|Dermatologic Agents|dermatologic agents|mesh-ancestor
102517065|NCT00603044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102517066|NCT00646646|Midazolam|midazolam|mesh-list
102517067|NCT00646646|Dexmedetomidine|dexmedetomidine|mesh-list
102517068|NCT00646646|Propofol|propofol|mesh-list
102517069|NCT00646646|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102517070|NCT00646646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102517071|NCT00646646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517072|NCT00646646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102517073|NCT00646646|Analgesics|analgesics|mesh-ancestor
102517074|NCT00646646|Sensory System Agents|sensory system agents|mesh-ancestor
102517075|NCT00646646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102517076|NCT00646646|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102517077|NCT00646646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102517078|NCT00646646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102517079|NCT00646646|Adrenergic Agents|adrenergic agents|mesh-ancestor
102517080|NCT00646646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102517081|NCT00646646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517082|NCT00646646|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102517083|NCT00646646|Anesthetics, General|anesthetics, general|mesh-ancestor
102517084|NCT00646646|Anesthetics|anesthetics|mesh-ancestor
102517085|NCT00646646|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102517086|NCT00646646|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102517087|NCT00646646|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102517088|NCT00646646|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102517089|NCT00646646|GABA Modulators|gaba modulators|mesh-ancestor
102517090|NCT00646646|GABA Agents|gaba agents|mesh-ancestor
102517091|NCT02998424|Propofol|propofol|mesh-list
102517092|NCT02998424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102517093|NCT02998424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102517094|NCT02998424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517095|NCT02998424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102517096|NCT02998424|Anesthetics, General|anesthetics, general|mesh-ancestor
102517097|NCT02998424|Anesthetics|anesthetics|mesh-ancestor
102517098|NCT00696488|Fluorouracil|fluorouracil|mesh-list
102517099|NCT00696488|Antimetabolites|antimetabolites|mesh-ancestor
102517100|NCT00696488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517101|NCT00696488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102517102|NCT00696488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102517103|NCT00696488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102517104|NCT00696488|Immunologic Factors|immunologic factors|mesh-ancestor
102517105|NCT00696488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517106|NCT00648908|4-Aminopyridine|4-aminopyridine|mesh-list
102517107|NCT00648908|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102517108|NCT00648908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102517109|NCT00648908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517110|NCT00650078|Prednisone|prednisone|mesh-list
102517111|NCT00650078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102517112|NCT00650078|Glucocorticoids|glucocorticoids|mesh-ancestor
102517113|NCT00650078|Hormones|hormones|mesh-ancestor
102133727|NCT03519633|Neostigmine|neostigmine|mesh-list
102517114|NCT00650078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102517115|NCT00650078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517116|NCT00650078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102517117|NCT00650078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102517118|NCT01799486|Adefovir|adefovir|mesh-list
102517119|NCT01799486|Telbivudine|telbivudine|mesh-list
102517120|NCT01799486|Antiviral Agents|antiviral agents|mesh-ancestor
102517121|NCT01799486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102517122|NCT01799486|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102517123|NCT01799486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102517124|NCT01799486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102517125|NCT01799486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517126|NCT00650546|Exenatide|exenatide|mesh-list
102517127|NCT00650546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102517128|NCT00650546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517129|NCT00650546|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102517130|NCT00650546|Incretins|incretins|mesh-ancestor
102517131|NCT00650546|Hormones|hormones|mesh-ancestor
102517132|NCT00650546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102517133|NCT00650858|Plasminogen|plasminogen|mesh-list
102517134|NCT00650858|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102517135|NCT00650858|Fibrinolytic Agents|fibrinolytic agents|mesh-list
102517136|NCT00650858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102517137|NCT00650858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517138|NCT00651482|Bevacizumab|bevacizumab|mesh-list
102517139|NCT00651482|Everolimus|everolimus|mesh-list
102517140|NCT00651482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102517141|NCT00651482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102517142|NCT00651482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102517143|NCT00651482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102517144|NCT00651482|Growth Substances|growth substances|mesh-ancestor
102517145|NCT00651482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517146|NCT00651482|Growth Inhibitors|growth inhibitors|mesh-ancestor
102517147|NCT00651482|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102517148|NCT00651482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102517149|NCT00651482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102517150|NCT00651482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517151|NCT00651482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102517152|NCT00651482|Immunologic Factors|immunologic factors|mesh-ancestor
102517153|NCT00654836|Bevacizumab|bevacizumab|mesh-list
102517154|NCT00654836|Carboplatin|carboplatin|mesh-list
102517155|NCT00654836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102517156|NCT00654836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102517157|NCT00654836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102517158|NCT00654836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102517159|NCT00654836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102517160|NCT00654836|Growth Substances|growth substances|mesh-ancestor
102517161|NCT00654836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517162|NCT00654836|Growth Inhibitors|growth inhibitors|mesh-ancestor
102517163|NCT02997800|Labetalol|labetalol|mesh-list
102517164|NCT02997800|Fentanyl|fentanyl|mesh-list
102517165|NCT02997800|Esmolol|esmolol|mesh-list
102517166|NCT02997800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102517167|NCT02997800|Narcotics|narcotics|mesh-ancestor
102517168|NCT02997800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102517169|NCT02997800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517170|NCT02997800|Analgesics|analgesics|mesh-ancestor
102517171|NCT02997800|Sensory System Agents|sensory system agents|mesh-ancestor
102517172|NCT02997800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102517173|NCT02997800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102517174|NCT02997800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102517175|NCT02997800|Anesthetics, General|anesthetics, general|mesh-ancestor
102517176|NCT02997800|Anesthetics|anesthetics|mesh-ancestor
102517177|NCT02997800|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102517178|NCT02997800|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102517179|NCT02997800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102517180|NCT02997800|Adrenergic Agents|adrenergic agents|mesh-ancestor
102517181|NCT02997800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102517182|NCT02997800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517183|NCT02997800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102517184|NCT02997800|Sympathomimetics|sympathomimetics|mesh-ancestor
102517185|NCT02997800|Autonomic Agents|autonomic agents|mesh-ancestor
102517186|NCT02997800|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102517187|NCT02997800|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102517188|NCT00701636|Daptomycin|daptomycin|mesh-list
102517189|NCT00701636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102517190|NCT00701636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102517191|NCT00701714|Epoetin Alfa|epoetin alfa|mesh-list
102517192|NCT00701714|Hematinics|hematinics|mesh-ancestor
102517193|NCT00655538|Dalcetrapib|dalcetrapib|mesh-list
102517194|NCT00655538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102517195|NCT00655538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102517196|NCT00655538|Antimetabolites|antimetabolites|mesh-ancestor
102517197|NCT00655538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517198|NCT00655538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102517199|NCT00656630|Naltrexone|naltrexone|mesh-list
102517200|NCT00656630|Acamprosate|acamprosate|mesh-list
102517201|NCT00656630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102517202|NCT00656630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102517203|NCT00656630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517204|NCT00656630|Sensory System Agents|sensory system agents|mesh-ancestor
102517205|NCT00656630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102517206|NCT01362998|Fentanyl|fentanyl|mesh-list
102517207|NCT01362998|Morphine|morphine|mesh-list
102517208|NCT01362998|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102517209|NCT01362998|Narcotics|narcotics|mesh-ancestor
102517210|NCT01362998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102517211|NCT01362998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517212|NCT01362998|Analgesics|analgesics|mesh-ancestor
102517213|NCT01362998|Sensory System Agents|sensory system agents|mesh-ancestor
102517214|NCT01362998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102517215|NCT01362998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102517216|NCT01362998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102517217|NCT01362998|Anesthetics, General|anesthetics, general|mesh-ancestor
102517218|NCT01362998|Anesthetics|anesthetics|mesh-ancestor
102517219|NCT04387526|Sofosbuvir|sofosbuvir|mesh-list
102517220|NCT04387526|Antiviral Agents|antiviral agents|mesh-ancestor
102517221|NCT04387526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102517222|NCT00658112|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102517223|NCT00658112|Dermatologic Agents|dermatologic agents|mesh-ancestor
102517224|NCT02997332|Docetaxel|docetaxel|mesh-list
102517225|NCT02997332|Fluorouracil|fluorouracil|mesh-list
102517226|NCT02997332|Durvalumab|durvalumab|mesh-list
102517227|NCT02997332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102517228|NCT02997332|Tubulin Modulators|tubulin modulators|mesh-ancestor
102517229|NCT02997332|Antimitotic Agents|antimitotic agents|mesh-ancestor
102517230|NCT02997332|Mitosis Modulators|mitosis modulators|mesh-ancestor
102517231|NCT02997332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517232|NCT02997332|Antimetabolites|antimetabolites|mesh-ancestor
102517233|NCT02997332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102517234|NCT02997332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102517235|NCT02997332|Immunologic Factors|immunologic factors|mesh-ancestor
102517236|NCT02997332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517237|NCT02997332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102517238|NCT04345094|Hydroquinone|hydroquinone|mesh-list
102517239|NCT04345094|Antioxidants|antioxidants|mesh-ancestor
102517240|NCT04345094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517241|NCT04345094|Protective Agents|protective agents|mesh-ancestor
102517242|NCT04345094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517243|NCT04345094|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102517244|NCT00702884|Sunitinib|sunitinib|mesh-list
102517245|NCT00702884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101993497|NCT03337152|Primaquine|primaquine|mesh-list
102517246|NCT00702884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102517247|NCT00702884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102517248|NCT00702884|Growth Substances|growth substances|mesh-ancestor
102517249|NCT00702884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517250|NCT00702884|Growth Inhibitors|growth inhibitors|mesh-ancestor
102517251|NCT00702884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102517252|NCT00702884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102517253|NCT00702884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517255|NCT00703508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102517256|NCT00703508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517257|NCT01284335|Gemcitabine|gemcitabine|mesh-list
102517258|NCT01284335|Docetaxel|docetaxel|mesh-list
102517259|NCT01284335|Temozolomide|temozolomide|mesh-list
102517260|NCT01284335|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102517261|NCT01284335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102517262|NCT01284335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102517263|NCT01284335|Antimetabolites|antimetabolites|mesh-ancestor
102517264|NCT01284335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517265|NCT01284335|Tubulin Modulators|tubulin modulators|mesh-ancestor
102517266|NCT01284335|Antimitotic Agents|antimitotic agents|mesh-ancestor
102517267|NCT01284335|Mitosis Modulators|mitosis modulators|mesh-ancestor
102517268|NCT01284335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102517269|NCT01284335|Alkylating Agents|alkylating agents|mesh-ancestor
102517270|NCT01284335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102517271|NCT01284335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102517272|NCT01194479|Formoterol Fumarate|formoterol fumarate|mesh-list
102517273|NCT01194479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102517274|NCT01194479|Autonomic Agents|autonomic agents|mesh-ancestor
102517275|NCT01194479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102517276|NCT01194479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517277|NCT01194479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102517278|NCT01194479|Respiratory System Agents|respiratory system agents|mesh-ancestor
102517279|NCT01194479|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102517280|NCT01194479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102517281|NCT01194479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102517282|NCT01194479|Adrenergic Agents|adrenergic agents|mesh-ancestor
102517283|NCT01194479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102517284|NCT01194479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517285|NCT01230593|Tobramycin|tobramycin|mesh-list
102517286|NCT01230593|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
102517287|NCT01230593|Dexamethasone|dexamethasone|mesh-list
102517288|NCT01230593|Dexamethasone acetate|dexamethasone acetate|mesh-list
102517289|NCT01230593|BB 1101|bb 1101|mesh-list
102517290|NCT01230593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102517291|NCT01230593|Antiemetics|antiemetics|mesh-ancestor
102517292|NCT01230593|Autonomic Agents|autonomic agents|mesh-ancestor
102517293|NCT01230593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102517294|NCT01230593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517295|NCT01230593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102517296|NCT01230593|Glucocorticoids|glucocorticoids|mesh-ancestor
102517297|NCT01230593|Hormones|hormones|mesh-ancestor
102517298|NCT01230593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102517299|NCT01230593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102517300|NCT01230593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102517301|NCT01230593|Protease Inhibitors|protease inhibitors|mesh-ancestor
102517302|NCT01230593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102517303|NCT01230593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517304|NCT01230593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102517305|NCT01230593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102517306|NCT01230593|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102517307|NCT01230593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102517308|NCT01195025|Chrysarobin|chrysarobin|mesh-list
102517309|NCT01195025|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
102517310|NCT01195025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102517311|NCT01195025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102517312|NCT01195025|Analgesics|analgesics|mesh-ancestor
102517313|NCT01195025|Sensory System Agents|sensory system agents|mesh-ancestor
102517314|NCT01195025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102517315|NCT01195025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517316|NCT01195025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102517317|NCT01195025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102517318|NCT01195025|Plasma Substitutes|plasma substitutes|mesh-ancestor
102517319|NCT01195025|Blood Substitutes|blood substitutes|mesh-ancestor
102517320|NCT00703664|Bortezomib|bortezomib|mesh-list
102517321|NCT00703664|Vorinostat|vorinostat|mesh-list
102517322|NCT00703664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102517323|NCT00703664|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102517324|NCT00703664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102517325|NCT00703664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517326|NCT00658736|Triamcinolone|triamcinolone|mesh-list
102517327|NCT00658736|Bupivacaine|bupivacaine|mesh-list
102517328|NCT00658736|Anesthetics, Local|anesthetics, local|mesh-ancestor
102517329|NCT00658736|Anesthetics|anesthetics|mesh-ancestor
102517330|NCT00658736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102517331|NCT00658736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517332|NCT00658736|Sensory System Agents|sensory system agents|mesh-ancestor
102517333|NCT00658736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102517334|NCT00658736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102517335|NCT00658736|Glucocorticoids|glucocorticoids|mesh-ancestor
102517336|NCT00658736|Hormones|hormones|mesh-ancestor
102517337|NCT00658736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102517338|NCT00659360|Saracatinib|saracatinib|mesh-list
102517339|NCT00659360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102517340|NCT00659360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102517341|NCT00659360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517342|NCT01197833|Polidocanol|polidocanol|mesh-list
102517343|NCT01197833|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102517344|NCT01197833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102517345|NCT04270370|Atorvastatin|atorvastatin|mesh-list
102517346|NCT04270370|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102517347|NCT04270370|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102517348|NCT04270370|Antimetabolites|antimetabolites|mesh-ancestor
102517349|NCT04270370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517350|NCT04270370|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102517351|NCT04270370|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102517352|NCT04270370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102517353|NCT01288781|Acetazolamide|acetazolamide|mesh-list
102517354|NCT01288781|Anticonvulsants|anticonvulsants|mesh-ancestor
102517355|NCT01288781|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102517356|NCT01288781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102517357|NCT01288781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517358|NCT01288781|Diuretics|diuretics|mesh-ancestor
102517359|NCT01288781|Natriuretic Agents|natriuretic agents|mesh-ancestor
102517360|NCT01288781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517361|NCT02990078|Sildenafil Citrate|sildenafil citrate|mesh-list
102517362|NCT02990078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517363|NCT02990078|Vasodilator Agents|vasodilator agents|mesh-ancestor
102517364|NCT02990078|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102517365|NCT02990078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102517366|NCT02990078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102517367|NCT02990078|Urological Agents|urological agents|mesh-ancestor
102517368|NCT01288859|Curcumin|curcumin|mesh-list
102517369|NCT01288859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102517370|NCT01288859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102517371|NCT01288859|Analgesics|analgesics|mesh-ancestor
102517372|NCT01288859|Sensory System Agents|sensory system agents|mesh-ancestor
102517373|NCT01288859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102517374|NCT01288859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517375|NCT01288859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102517376|NCT01288859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102517377|NCT01288859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102517378|NCT01288859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102517379|NCT01288859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517380|NCT01235195|Sertraline|sertraline|mesh-list
102517381|NCT01235195|Antidepressive Agents|antidepressive agents|mesh-ancestor
102517382|NCT01235195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102517383|NCT01235195|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102517384|NCT01235195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102517385|NCT01235195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101993620|NCT05183646|Propagermanium|propagermanium|mesh-list
102517386|NCT01235195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517387|NCT01235195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102517388|NCT01235195|Serotonin Agents|serotonin agents|mesh-ancestor
102517389|NCT01235195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517390|NCT02996942|Factor VIII|factor viii|mesh-list
102517391|NCT02996942|Coagulants|coagulants|mesh-ancestor
102517392|NCT01199237|Glycopyrrolate|glycopyrrolate|mesh-list
102517393|NCT01199237|Sevoflurane|sevoflurane|mesh-list
102517394|NCT01199237|Desflurane|desflurane|mesh-list
102517395|NCT01199237|Rocuronium|rocuronium|mesh-list
102517396|NCT01199237|Neostigmine|neostigmine|mesh-list
102517397|NCT01199237|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102517398|NCT01199237|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102517399|NCT01199237|Anesthetics, General|anesthetics, general|mesh-ancestor
102517400|NCT01199237|Anesthetics|anesthetics|mesh-ancestor
102517401|NCT01199237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102517402|NCT01199237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517403|NCT01199237|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102517404|NCT01199237|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102517405|NCT01199237|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102517406|NCT01199237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102517407|NCT01199237|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102517408|NCT01199237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102517409|NCT01199237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517410|NCT01199237|Cholinergic Agents|cholinergic agents|mesh-ancestor
102517411|NCT01199237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102517412|NCT01199237|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102517413|NCT01199237|Autonomic Agents|autonomic agents|mesh-ancestor
102517414|NCT01199237|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102517415|NCT01199237|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102517416|NCT01199237|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102517417|NCT01235897|Paclitaxel|paclitaxel|mesh-list
102517418|NCT01235897|Trastuzumab|trastuzumab|mesh-list
102517419|NCT01235897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102517420|NCT01235897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102517421|NCT01235897|Tubulin Modulators|tubulin modulators|mesh-ancestor
102517422|NCT01235897|Antimitotic Agents|antimitotic agents|mesh-ancestor
102517423|NCT01235897|Mitosis Modulators|mitosis modulators|mesh-ancestor
102517424|NCT01235897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517425|NCT01235897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102517426|NCT01236053|Gabapentin|gabapentin|mesh-list
102517427|NCT01236053|Analgesics|analgesics|mesh-ancestor
102517428|NCT01236053|Sensory System Agents|sensory system agents|mesh-ancestor
102517429|NCT01236053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102517430|NCT01236053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517431|NCT01236053|Anticonvulsants|anticonvulsants|mesh-ancestor
102517432|NCT01236053|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102517433|NCT01236053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102517434|NCT01236053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102517435|NCT01236053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102517436|NCT01236053|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102517437|NCT01236053|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102517438|NCT01236053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102517439|NCT01236053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517440|NCT01236053|Antimanic Agents|antimanic agents|mesh-ancestor
102517441|NCT00703976|Bevacizumab|bevacizumab|mesh-list
102517442|NCT00703976|Cetuximab|cetuximab|mesh-list
102517443|NCT00703976|Pemetrexed|pemetrexed|mesh-list
102517444|NCT00703976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102517445|NCT00703976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102517446|NCT00703976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102517447|NCT00703976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102517448|NCT00703976|Growth Substances|growth substances|mesh-ancestor
102517449|NCT00703976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517450|NCT00703976|Growth Inhibitors|growth inhibitors|mesh-ancestor
102517451|NCT00703976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102517452|NCT00703976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517453|NCT00703976|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102517454|NCT00703976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102517455|NCT00661544|Ascorbic Acid|ascorbic acid|mesh-list
102517456|NCT00661544|Melphalan|melphalan|mesh-list
102517457|NCT00661544|Arsenic Trioxide|arsenic trioxide|mesh-list
102517458|NCT00661544|Vitamins|vitamins|mesh-ancestor
102517459|NCT00661544|Micronutrients|micronutrients|mesh-ancestor
102517460|NCT00661544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517461|NCT00661544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102517462|NCT00661544|Alkylating Agents|alkylating agents|mesh-ancestor
102517463|NCT00661544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517464|NCT00661544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102517465|NCT00661544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102517466|NCT00661544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102517467|NCT00661544|Immunologic Factors|immunologic factors|mesh-ancestor
102517468|NCT00661544|Antioxidants|antioxidants|mesh-ancestor
102517469|NCT00661544|Protective Agents|protective agents|mesh-ancestor
102517470|NCT00706550|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102517471|NCT00706550|Immunologic Factors|immunologic factors|mesh-ancestor
102517472|NCT00706550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517473|NCT02979392|Paclitaxel|paclitaxel|mesh-list
102517474|NCT02979392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102517475|NCT02979392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102517476|NCT02979392|Tubulin Modulators|tubulin modulators|mesh-ancestor
102517477|NCT02979392|Antimitotic Agents|antimitotic agents|mesh-ancestor
102517478|NCT02979392|Mitosis Modulators|mitosis modulators|mesh-ancestor
102517479|NCT02979392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517480|NCT02999906|Treprostinil|treprostinil|mesh-list
102517481|NCT02999906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102517482|NCT01238471|Propranolol|propranolol|mesh-list
102517483|NCT01238471|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102517484|NCT01238471|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102517485|NCT01238471|Adrenergic Agents|adrenergic agents|mesh-ancestor
102517486|NCT01238471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102517487|NCT01238471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517488|NCT01238471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517489|NCT01238471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102517490|NCT01238471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102517491|NCT01238471|Vasodilator Agents|vasodilator agents|mesh-ancestor
102517492|NCT00664430|Calcitriol|calcitriol|mesh-list
102517493|NCT00664430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102517494|NCT00664430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517495|NCT00664430|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102517496|NCT00664430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102517497|NCT00664430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517498|NCT00664430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102517499|NCT00664430|Vitamins|vitamins|mesh-ancestor
102517500|NCT00664430|Micronutrients|micronutrients|mesh-ancestor
102517501|NCT00664430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102517502|NCT01292447|Lidocaine|lidocaine|mesh-list
102517503|NCT01292447|Anesthetics, Local|anesthetics, local|mesh-ancestor
102517504|NCT01292447|Anesthetics|anesthetics|mesh-ancestor
102517505|NCT01292447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102517506|NCT01292447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517507|NCT01292447|Sensory System Agents|sensory system agents|mesh-ancestor
102517508|NCT01292447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102517509|NCT01292447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102517510|NCT01292447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102517511|NCT01292447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102517512|NCT01292447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102517513|NCT01292447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517514|NCT00704912|Orlistat|orlistat|mesh-list
102517515|NCT00704912|Contraceptive Agents|contraceptive agents|mesh-list
102517516|NCT00704912|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
102517517|NCT00704912|Contraceptives, Oral|contraceptives, oral|mesh-list
102517518|NCT00704912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102517519|NCT00704912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517520|NCT00704912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102517521|NCT00704912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102517522|NCT00704912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517523|NCT00704912|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102517524|NCT00704912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102517525|NCT00704912|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102517526|NCT00704912|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102517527|NCT00704912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102517528|NCT00704912|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
102517529|NCT00704912|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102517530|NCT02195921|Antiemetics|antiemetics|mesh-list
102517531|NCT02195921|Autonomic Agents|autonomic agents|mesh-ancestor
102517532|NCT02195921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102517533|NCT02195921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517534|NCT02195921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102517535|NCT02189213|Sertraline|sertraline|mesh-list
102517536|NCT02189213|Antidepressive Agents|antidepressive agents|mesh-ancestor
102517537|NCT02189213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102517538|NCT02189213|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102517539|NCT02189213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102517540|NCT02189213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102517541|NCT02189213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517542|NCT02189213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102517543|NCT02189213|Serotonin Agents|serotonin agents|mesh-ancestor
102517544|NCT02189213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517545|NCT01241903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102517546|NCT01241903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102517547|NCT01241903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102329032|NCT04023604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102517548|NCT01241903|Antimetabolites|antimetabolites|mesh-ancestor
102517549|NCT01241903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517550|NCT01241903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102517551|NCT01241903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102517552|NCT01241903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102517553|NCT00666848|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102517554|NCT00666848|Enalapril|enalapril|mesh-list
102517555|NCT00666848|Enalaprilat|enalaprilat|mesh-list
102517556|NCT00666848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102517557|NCT00666848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517558|NCT00666848|Incretins|incretins|mesh-ancestor
102517559|NCT00666848|Hormones|hormones|mesh-ancestor
102517560|NCT00666848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102517561|NCT00666848|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102517562|NCT00666848|Protease Inhibitors|protease inhibitors|mesh-ancestor
102517563|NCT00666848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102517564|NCT00666848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517565|NCT00666848|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102517566|NCT00666848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102517567|NCT01287377|Nicotine|nicotine|mesh-list
102517568|NCT01287377|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102517569|NCT01287377|Autonomic Agents|autonomic agents|mesh-ancestor
102517570|NCT01287377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102517571|NCT01287377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517572|NCT01287377|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102517573|NCT01287377|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102517574|NCT01287377|Cholinergic Agents|cholinergic agents|mesh-ancestor
102517575|NCT01287377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102517576|NCT01287377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517577|NCT01511042|Norepinephrine|norepinephrine|mesh-list
102517578|NCT01511042|Angiotensin II|angiotensin ii|mesh-list
102517579|NCT01511042|Giapreza|giapreza|mesh-list
102517580|NCT01511042|Angiotensinogen|angiotensinogen|mesh-list
102517581|NCT01511042|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102517582|NCT01511042|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102517583|NCT01511042|Adrenergic Agents|adrenergic agents|mesh-ancestor
102517584|NCT01511042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102517585|NCT01511042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517586|NCT01511042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517587|NCT01511042|Sympathomimetics|sympathomimetics|mesh-ancestor
102517588|NCT01511042|Autonomic Agents|autonomic agents|mesh-ancestor
102517589|NCT01511042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102517590|NCT01511042|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102517591|NCT01511042|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102517592|NCT01511042|Protease Inhibitors|protease inhibitors|mesh-ancestor
102517593|NCT01511042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102517594|NCT00667004|Ecabet|ecabet|mesh-list
102517595|NCT00667004|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102517596|NCT00667004|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102517597|NCT00667004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102517598|NCT00667004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102517599|NCT00667004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102517600|NCT00667004|Protease Inhibitors|protease inhibitors|mesh-ancestor
102517601|NCT00667004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102517602|NCT00667004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517603|NCT00667004|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102517604|NCT00667004|Protective Agents|protective agents|mesh-ancestor
102517605|NCT00667004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517606|NCT00667004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102517607|NCT01204853|Sitaxsentan|sitaxsentan|mesh-list
102517608|NCT01204853|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102517609|NCT01204853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517610|NCT01028846|Diazoxide|diazoxide|mesh-list
102517611|NCT01028846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102517612|NCT01028846|Vasodilator Agents|vasodilator agents|mesh-ancestor
102517613|NCT04386122|Loxoprofen|loxoprofen|mesh-list
102517614|NCT04386122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102517615|NCT04386122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102517616|NCT04386122|Analgesics|analgesics|mesh-ancestor
102517617|NCT04386122|Sensory System Agents|sensory system agents|mesh-ancestor
102517618|NCT04386122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102517619|NCT04386122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517620|NCT04386122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102517621|NCT04386122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102517622|NCT03009461|Sorafenib|sorafenib|mesh-list
102517623|NCT03009461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102517624|NCT03009461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102517625|NCT03009461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102517626|NCT03009461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517627|NCT02990702|Bupivacaine|bupivacaine|mesh-list
102517628|NCT02990702|Anesthetics, Local|anesthetics, local|mesh-ancestor
102517629|NCT02990702|Anesthetics|anesthetics|mesh-ancestor
102517630|NCT02990702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102517631|NCT02990702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517632|NCT02990702|Sensory System Agents|sensory system agents|mesh-ancestor
102517633|NCT02990702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102517634|NCT02995304|Midazolam|midazolam|mesh-list
102517635|NCT02995304|Morphine|morphine|mesh-list
102517636|NCT02995304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102517637|NCT02995304|Narcotics|narcotics|mesh-ancestor
102517638|NCT02995304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102517639|NCT02995304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517640|NCT02995304|Analgesics|analgesics|mesh-ancestor
102517641|NCT02995304|Sensory System Agents|sensory system agents|mesh-ancestor
102517642|NCT02995304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102517643|NCT02995304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102517644|NCT02995304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102517645|NCT02995304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102517646|NCT02995304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102517647|NCT02995304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102517648|NCT02995304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102517649|NCT02995304|Anesthetics, General|anesthetics, general|mesh-ancestor
102517650|NCT02995304|Anesthetics|anesthetics|mesh-ancestor
102517651|NCT02995304|GABA Modulators|gaba modulators|mesh-ancestor
102517652|NCT02995304|GABA Agents|gaba agents|mesh-ancestor
102517653|NCT02995304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102517654|NCT02995304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517655|NCT02990858|Leronlimab|leronlimab|mesh-list
102517656|NCT02990858|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102517657|NCT02990858|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102517658|NCT02990858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517659|NCT02990858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102517660|NCT02990858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102517661|NCT02990858|Antiviral Agents|antiviral agents|mesh-ancestor
102517662|NCT02990858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102517663|NCT00725504|Lidocaine|lidocaine|mesh-list
102517664|NCT00725504|Anesthetics, Local|anesthetics, local|mesh-ancestor
102517665|NCT00725504|Anesthetics|anesthetics|mesh-ancestor
102517666|NCT00725504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102517667|NCT00725504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517668|NCT00725504|Sensory System Agents|sensory system agents|mesh-ancestor
102517669|NCT00725504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102517670|NCT00725504|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102517671|NCT00725504|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102517672|NCT00725504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102517673|NCT00725504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102517674|NCT00725504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517675|NCT03830684|Baicalein|baicalein|mesh-list
102517676|NCT03830684|Antioxidants|antioxidants|mesh-ancestor
102517677|NCT03830684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517678|NCT03830684|Protective Agents|protective agents|mesh-ancestor
102517679|NCT03830684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517680|NCT03830684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102517681|NCT03830684|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
102517682|NCT03830684|Hormone Antagonists|hormone antagonists|mesh-ancestor
102517683|NCT03830684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102517684|NCT02990546|Midodrine|midodrine|mesh-list
102517685|NCT02990546|Sympathomimetics|sympathomimetics|mesh-ancestor
102517686|NCT02990546|Autonomic Agents|autonomic agents|mesh-ancestor
102517687|NCT02990546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102517688|NCT02990546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517689|NCT02990546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102517690|NCT02990546|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102517691|NCT02990546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102517692|NCT02990546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102517693|NCT02990546|Adrenergic Agents|adrenergic agents|mesh-ancestor
102517694|NCT02990546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102517695|NCT02990546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517696|NCT00727064|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102517697|NCT00727064|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
102517698|NCT00727064|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102517699|NCT00727064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102517700|NCT00727064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102517701|NCT00727064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517702|NCT00727064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102517703|NCT00727064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517704|NCT00727064|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102517705|NCT00727064|Antidepressive Agents|antidepressive agents|mesh-ancestor
102517706|NCT00727064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102517707|NCT01294163|Propofol|propofol|mesh-list
102517708|NCT01294163|Sevoflurane|sevoflurane|mesh-list
102517709|NCT01294163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102517710|NCT01294163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102517711|NCT01294163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517712|NCT01294163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102517713|NCT01294163|Anesthetics, General|anesthetics, general|mesh-ancestor
102517714|NCT01294163|Anesthetics|anesthetics|mesh-ancestor
102517715|NCT01294163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102517716|NCT01294163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102517717|NCT01294319|Dexamethasone|dexamethasone|mesh-list
102517718|NCT01294319|Dexamethasone acetate|dexamethasone acetate|mesh-list
102517719|NCT01294319|Spironolactone|spironolactone|mesh-list
102517720|NCT01294319|Mifepristone|mifepristone|mesh-list
102517721|NCT01294319|BB 1101|bb 1101|mesh-list
102517722|NCT01294319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102517723|NCT01294319|Antiemetics|antiemetics|mesh-ancestor
102517724|NCT01294319|Autonomic Agents|autonomic agents|mesh-ancestor
102517725|NCT01294319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102517726|NCT01294319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517727|NCT01294319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102517728|NCT01294319|Glucocorticoids|glucocorticoids|mesh-ancestor
102517729|NCT01294319|Hormones|hormones|mesh-ancestor
102517730|NCT01294319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102517731|NCT01294319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102517732|NCT01294319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102517733|NCT01294319|Protease Inhibitors|protease inhibitors|mesh-ancestor
102517734|NCT01294319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102517735|NCT01294319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517736|NCT01294319|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102517737|NCT01294319|Hormone Antagonists|hormone antagonists|mesh-ancestor
102517738|NCT01294319|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102517739|NCT01294319|Diuretics|diuretics|mesh-ancestor
102517740|NCT01294319|Natriuretic Agents|natriuretic agents|mesh-ancestor
102517741|NCT01294319|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102517742|NCT01294319|Abortifacient Agents|abortifacient agents|mesh-ancestor
102517743|NCT01294319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102517744|NCT01294319|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102517745|NCT01294319|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102517746|NCT01294319|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102517747|NCT01294319|Contraceptive Agents|contraceptive agents|mesh-ancestor
102517748|NCT01294319|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102517749|NCT01294319|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102517750|NCT01294319|Luteolytic Agents|luteolytic agents|mesh-ancestor
102517751|NCT01294319|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102517752|NCT01294319|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102517753|NCT00727298|Infliximab|infliximab|mesh-list
102517754|NCT00727298|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102517755|NCT00727298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102517756|NCT00727298|Dermatologic Agents|dermatologic agents|mesh-ancestor
102517757|NCT00727298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102517758|NCT00727298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102517759|NCT02990312|Sirolimus|sirolimus|mesh-list
102517760|NCT02990312|Maraviroc|maraviroc|mesh-list
102517761|NCT02990312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102517762|NCT02990312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102517763|NCT02990312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102517764|NCT02990312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102517765|NCT02990312|Antifungal Agents|antifungal agents|mesh-ancestor
102517766|NCT02990312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102517767|NCT02990312|Immunologic Factors|immunologic factors|mesh-ancestor
102517768|NCT02990312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517769|NCT02990312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517770|NCT02990312|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102517771|NCT02990312|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102517772|NCT02990312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102517773|NCT02990312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102517774|NCT02990312|Antiviral Agents|antiviral agents|mesh-ancestor
102517775|NCT02990312|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102517777|NCT01295879|Ergocalciferols|ergocalciferols|mesh-list
102517778|NCT01295879|Vitamins|vitamins|mesh-ancestor
102517779|NCT01295879|Micronutrients|micronutrients|mesh-ancestor
102517780|NCT01295879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517781|NCT01295879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102517782|NCT01295879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102517783|NCT01244633|Ecopipam|ecopipam|mesh-list
102517784|NCT01244633|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102517785|NCT01244633|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102517786|NCT01244633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102517787|NCT01244633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517788|NCT01244633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102517789|NCT01244633|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102517790|NCT01244633|Dopamine Agents|dopamine agents|mesh-ancestor
102517791|NCT01244633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102517792|NCT01244633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517793|NCT01296191|Moxifloxacin|moxifloxacin|mesh-list
102517794|NCT01296191|Besifloxacin|besifloxacin|mesh-list
102517795|NCT01296191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102517796|NCT01296191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102517797|NCT01296191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102517798|NCT01296191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102517799|NCT01296191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102517800|NCT01296191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517801|NCT01296191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102517802|NCT01244711|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102517803|NCT01244711|Antidepressive Agents|antidepressive agents|mesh-ancestor
102517804|NCT01244711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102517805|NCT01244711|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102517806|NCT01244711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102517807|NCT01244711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102517808|NCT01244711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517809|NCT01210079|Gabapentin|gabapentin|mesh-list
102517810|NCT01210079|Analgesics|analgesics|mesh-ancestor
102517811|NCT01210079|Sensory System Agents|sensory system agents|mesh-ancestor
102517812|NCT01210079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102517813|NCT01210079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517814|NCT01210079|Anticonvulsants|anticonvulsants|mesh-ancestor
102517815|NCT01210079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102517816|NCT01210079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102517817|NCT01210079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102517818|NCT01210079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102517819|NCT01210079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102517820|NCT01210079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102517821|NCT01210079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102517822|NCT01210079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517823|NCT01210079|Antimanic Agents|antimanic agents|mesh-ancestor
102517824|NCT01245647|Naltrexone|naltrexone|mesh-list
102517825|NCT01245647|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102517826|NCT01245647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102517827|NCT01245647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517828|NCT01245647|Sensory System Agents|sensory system agents|mesh-ancestor
102517829|NCT01245647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102517830|NCT00708110|Dolutegravir|dolutegravir|mesh-list
102517831|NCT00708110|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102517832|NCT00708110|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102517833|NCT00708110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102517834|NCT00708110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517835|NCT00708110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102517836|NCT00708110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102517837|NCT00708110|Antiviral Agents|antiviral agents|mesh-ancestor
102517838|NCT00708110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102517839|NCT01296815|Bevacizumab|bevacizumab|mesh-list
102517840|NCT01296815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102517841|NCT01296815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102517842|NCT01296815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102517843|NCT01296815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102517844|NCT01296815|Growth Substances|growth substances|mesh-ancestor
102517845|NCT01296815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517846|NCT01296815|Growth Inhibitors|growth inhibitors|mesh-ancestor
102517847|NCT01276262|Contraceptive Agents|contraceptive agents|mesh-list
102517848|NCT01276262|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
102517849|NCT01276262|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
102517850|NCT01276262|Contraceptives, Oral|contraceptives, oral|mesh-list
102517851|NCT01276262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101994103|NCT02620150|Escitalopram|escitalopram|mesh-list
102517852|NCT01276262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517853|NCT01276262|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102517854|NCT01276262|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102517855|NCT01276262|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102517856|NCT01276262|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102517857|NCT01276262|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102517858|NCT01276262|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
102517859|NCT01276262|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102517860|NCT01276262|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102517862|NCT01276496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102517863|NCT01276496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102517864|NCT01276496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102517865|NCT01276496|Tubulin Modulators|tubulin modulators|mesh-ancestor
102517866|NCT01276496|Antimitotic Agents|antimitotic agents|mesh-ancestor
102517867|NCT01276496|Mitosis Modulators|mitosis modulators|mesh-ancestor
102517868|NCT01276496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517869|NCT01297595|Crizotinib|crizotinib|mesh-list
102517870|NCT01297595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102517871|NCT01297595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102517872|NCT01297595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102517873|NCT01297595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517874|NCT02992418|Vaccines|vaccines|mesh-list
102517875|NCT02992418|Immunologic Factors|immunologic factors|mesh-ancestor
102517876|NCT02992418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517877|NCT01276730|Interferons|interferons|mesh-list
102517878|NCT01276730|Tretinoin|tretinoin|mesh-list
102517879|NCT01276730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102517880|NCT01276730|Antiviral Agents|antiviral agents|mesh-ancestor
102517881|NCT01276730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102517882|NCT01276730|Keratolytic Agents|keratolytic agents|mesh-ancestor
102517883|NCT01276730|Dermatologic Agents|dermatologic agents|mesh-ancestor
102517884|NCT01298063|Afatinib|afatinib|mesh-list
102517885|NCT01298063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102517886|NCT01298063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102517887|NCT01298063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102517888|NCT01298063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517889|NCT02999594|Tramadol|tramadol|mesh-list
102517890|NCT02999594|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102517891|NCT02999594|Narcotics|narcotics|mesh-ancestor
102517892|NCT02999594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102517893|NCT02999594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517894|NCT02999594|Analgesics|analgesics|mesh-ancestor
102517895|NCT02999594|Sensory System Agents|sensory system agents|mesh-ancestor
102517896|NCT02999594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102517897|NCT01298219|Lubiprostone|lubiprostone|mesh-list
102517898|NCT01298219|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102517899|NCT01298219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102517900|NCT01298219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517901|NCT01276886|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102517902|NCT01276886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102517903|NCT02322242|Dexamethasone|dexamethasone|mesh-list
102517904|NCT02322242|Dexamethasone acetate|dexamethasone acetate|mesh-list
102517905|NCT02322242|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102517906|NCT02322242|BB 1101|bb 1101|mesh-list
102517907|NCT02322242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102517908|NCT02322242|Antiemetics|antiemetics|mesh-ancestor
102517909|NCT02322242|Autonomic Agents|autonomic agents|mesh-ancestor
102517910|NCT02322242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102517911|NCT02322242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517912|NCT02322242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102517913|NCT02322242|Glucocorticoids|glucocorticoids|mesh-ancestor
102517914|NCT02322242|Hormones|hormones|mesh-ancestor
102517915|NCT02322242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102517916|NCT02322242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102517917|NCT02322242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102517918|NCT02322242|Protease Inhibitors|protease inhibitors|mesh-ancestor
102329411|NCT05536284|Bisoprolol|bisoprolol|mesh-list
102517919|NCT02322242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102517920|NCT02322242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517921|NCT01211873|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
102517922|NCT01211873|Chelating Agents|chelating agents|mesh-ancestor
102517923|NCT01211873|Sequestering Agents|sequestering agents|mesh-ancestor
102517924|NCT01211873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517925|NCT02993588|Melatonin|melatonin|mesh-list
102517926|NCT02993588|Antioxidants|antioxidants|mesh-ancestor
102517927|NCT02993588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517928|NCT02993588|Protective Agents|protective agents|mesh-ancestor
102517929|NCT02993588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517930|NCT02993588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102517931|NCT01270178|Entecavir|entecavir|mesh-list
102517932|NCT01270178|Antiviral Agents|antiviral agents|mesh-ancestor
102517933|NCT01270178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102517934|NCT01270412|Mitogens|mitogens|mesh-list
102517935|NCT01270412|Hyaluronic Acid|hyaluronic acid|mesh-list
102517936|NCT01270412|Mitosis Modulators|mitosis modulators|mesh-ancestor
102517937|NCT01270412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517938|NCT01270412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102517939|NCT01270412|Immunologic Factors|immunologic factors|mesh-ancestor
102517940|NCT01270412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517941|NCT01270412|Viscosupplements|viscosupplements|mesh-ancestor
102517942|NCT01270412|Protective Agents|protective agents|mesh-ancestor
102517943|NCT02992496|Midazolam|midazolam|mesh-list
102517944|NCT02992496|Ketamine|ketamine|mesh-list
102517945|NCT02992496|Analgesics|analgesics|mesh-ancestor
102517946|NCT02992496|Sensory System Agents|sensory system agents|mesh-ancestor
102517947|NCT02992496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102517948|NCT02992496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517949|NCT02992496|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102517950|NCT02992496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102517951|NCT02992496|Anesthetics, General|anesthetics, general|mesh-ancestor
102517952|NCT02992496|Anesthetics|anesthetics|mesh-ancestor
102517953|NCT02992496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102517954|NCT02992496|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102517955|NCT02992496|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102517956|NCT02992496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102517957|NCT02992496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517958|NCT02992496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102517959|NCT02992496|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102517960|NCT02992496|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102517961|NCT02992496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102517962|NCT02992496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102517963|NCT02992496|GABA Modulators|gaba modulators|mesh-ancestor
102517964|NCT02992496|GABA Agents|gaba agents|mesh-ancestor
102517965|NCT00729482|Everolimus|everolimus|mesh-list
102517966|NCT00729482|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102517967|NCT00729482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102517968|NCT00729482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102517969|NCT00729482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517970|NCT00729482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102517971|NCT00729482|Immunologic Factors|immunologic factors|mesh-ancestor
102517972|NCT00729482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517973|NCT00729482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102517974|NCT01270490|Interferons|interferons|mesh-list
102517975|NCT01270490|Interferon-gamma|interferon-gamma|mesh-list
102517976|NCT01270490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102517977|NCT01270490|Antiviral Agents|antiviral agents|mesh-ancestor
102517978|NCT01270490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102517979|NCT01278056|Deferasirox|deferasirox|mesh-list
102517980|NCT01278056|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102517981|NCT01278056|Chelating Agents|chelating agents|mesh-ancestor
102517982|NCT01278056|Sequestering Agents|sequestering agents|mesh-ancestor
102517983|NCT01278056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517984|NCT02992652|Allopurinol|allopurinol|mesh-list
102517985|NCT02992652|Antimetabolites|antimetabolites|mesh-ancestor
102517986|NCT02992652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102517987|NCT02992652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102517988|NCT02992652|Gout Suppressants|gout suppressants|mesh-ancestor
102517989|NCT02992652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102517990|NCT02992652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102517991|NCT02992652|Antioxidants|antioxidants|mesh-ancestor
102517992|NCT02992652|Protective Agents|protective agents|mesh-ancestor
102517993|NCT02992652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102517994|NCT01270724|Paclitaxel|paclitaxel|mesh-list
102517995|NCT01270724|Gemcitabine|gemcitabine|mesh-list
102517996|NCT01270724|Oxaliplatin|oxaliplatin|mesh-list
102517997|NCT01270724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102517998|NCT01270724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102517999|NCT01270724|Tubulin Modulators|tubulin modulators|mesh-ancestor
102518000|NCT01270724|Antimitotic Agents|antimitotic agents|mesh-ancestor
102518001|NCT01270724|Mitosis Modulators|mitosis modulators|mesh-ancestor
102518002|NCT01270724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518003|NCT01270724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102518004|NCT01270724|Antimetabolites|antimetabolites|mesh-ancestor
102518005|NCT00709826|Gemcitabine|gemcitabine|mesh-list
102518006|NCT00709826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102518007|NCT00709826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102518008|NCT00709826|Antimetabolites|antimetabolites|mesh-ancestor
102518009|NCT00709826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518010|NCT00709826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102518011|NCT00709826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102518012|NCT00709826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102518013|NCT01271114|Terlipressin|terlipressin|mesh-list
102518014|NCT01271114|Norepinephrine|norepinephrine|mesh-list
102518015|NCT01271114|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102518016|NCT01271114|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102518017|NCT01271114|Adrenergic Agents|adrenergic agents|mesh-ancestor
102518018|NCT01271114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102518019|NCT01271114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518020|NCT01271114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518021|NCT01271114|Sympathomimetics|sympathomimetics|mesh-ancestor
102518022|NCT01271114|Autonomic Agents|autonomic agents|mesh-ancestor
102518023|NCT01271114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102518024|NCT01271114|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102518025|NCT01271114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102518026|NCT02992340|Gemcitabine|gemcitabine|mesh-list
102518027|NCT02992340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102518028|NCT02992340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102518029|NCT02992340|Antimetabolites|antimetabolites|mesh-ancestor
102518030|NCT02992340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518031|NCT00711464|Modafinil|modafinil|mesh-list
102518032|NCT00711464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102518033|NCT00711464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518034|NCT00711464|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102518035|NCT00711464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102518036|NCT00711464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102518037|NCT00711464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518038|NCT01278290|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102518039|NCT01278290|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
102518040|NCT01278290|Luteolytic Agents|luteolytic agents|mesh-ancestor
102518041|NCT01278290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102518042|NCT01278290|Contraceptive Agents|contraceptive agents|mesh-ancestor
102518043|NCT01278290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102518044|NCT01278290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518045|NCT01278290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102518046|NCT01278290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102518047|NCT01278290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102518048|NCT01278290|Hormones|hormones|mesh-ancestor
102518049|NCT01278290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102518050|NCT01278446|Caseins|caseins|mesh-list
102518051|NCT01278446|Chelating Agents|chelating agents|mesh-ancestor
102518052|NCT01278446|Sequestering Agents|sequestering agents|mesh-ancestor
102518053|NCT01278446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518054|NCT02339558|Nivolumab|nivolumab|mesh-list
102518055|NCT02339558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102518056|NCT02339558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102518057|NCT02339558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102518058|NCT02339558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518059|NCT00731198|Drotaverin|drotaverin|mesh-list
102518060|NCT00731198|Scopolamine|scopolamine|mesh-list
102518061|NCT00731198|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102518062|NCT00731198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102518063|NCT00731198|Antiemetics|antiemetics|mesh-ancestor
102518064|NCT00731198|Autonomic Agents|autonomic agents|mesh-ancestor
102518065|NCT00731198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102518066|NCT00731198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518067|NCT00731198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102518068|NCT00731198|Mydriatics|mydriatics|mesh-ancestor
102518069|NCT00731198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102518070|NCT00731198|Cholinergic Agents|cholinergic agents|mesh-ancestor
102518071|NCT00731198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102518072|NCT00731198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518073|NCT00731198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102518074|NCT00731198|Parasympatholytics|parasympatholytics|mesh-ancestor
102518075|NCT00731198|Analgesics|analgesics|mesh-ancestor
102518076|NCT00731198|Sensory System Agents|sensory system agents|mesh-ancestor
102518077|NCT00731198|Vasodilator Agents|vasodilator agents|mesh-ancestor
102518078|NCT01278602|Rituximab|rituximab|mesh-list
102518079|NCT01278602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102518080|NCT01278602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102518081|NCT01278602|Immunologic Factors|immunologic factors|mesh-ancestor
102518082|NCT01278602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518083|NCT01278602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102518084|NCT00712244|Hyaluronic Acid|hyaluronic acid|mesh-list
102518085|NCT00712244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102518086|NCT00712244|Immunologic Factors|immunologic factors|mesh-ancestor
102518087|NCT00712244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518088|NCT00712244|Viscosupplements|viscosupplements|mesh-ancestor
102518089|NCT00712244|Protective Agents|protective agents|mesh-ancestor
102518090|NCT02991950|Parnaparin|parnaparin|mesh-list
102518091|NCT02991950|Anticoagulants|anticoagulants|mesh-ancestor
102518092|NCT02991950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102518093|NCT02991950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102518094|NCT02991950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518095|NCT01271582|Leucovorin|leucovorin|mesh-list
102518096|NCT01271582|Irinotecan|irinotecan|mesh-list
102518097|NCT01271582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102518098|NCT01271582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102518099|NCT01271582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102518100|NCT01271582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518101|NCT01271582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102518102|NCT01271582|Antidotes|antidotes|mesh-ancestor
102518103|NCT01271582|Protective Agents|protective agents|mesh-ancestor
102518104|NCT01271582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518105|NCT01271582|Vitamin B Complex|vitamin b complex|mesh-ancestor
102518106|NCT01271582|Vitamins|vitamins|mesh-ancestor
102518107|NCT01271582|Micronutrients|micronutrients|mesh-ancestor
102518108|NCT01271660|Pregabalin|pregabalin|mesh-list
102518109|NCT01271660|Analgesics|analgesics|mesh-ancestor
102518110|NCT01271660|Sensory System Agents|sensory system agents|mesh-ancestor
102518111|NCT01271660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102518112|NCT01271660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518113|NCT01271660|Anticonvulsants|anticonvulsants|mesh-ancestor
102518114|NCT01271660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102518115|NCT01271660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102518116|NCT01271660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518117|NCT01271660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102518118|NCT01271660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102518119|NCT01271660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102518120|NCT01271660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102518121|NCT01271660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102518123|NCT00731588|Vitamin B Complex|vitamin b complex|mesh-ancestor
102518124|NCT00731588|Vitamins|vitamins|mesh-ancestor
102518125|NCT00731588|Micronutrients|micronutrients|mesh-ancestor
102518126|NCT00731588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518127|NCT01271894|Efavirenz|efavirenz|mesh-list
102518128|NCT01271894|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102518129|NCT01271894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102518130|NCT01271894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102518131|NCT01271894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518132|NCT01271894|Antiviral Agents|antiviral agents|mesh-ancestor
102518133|NCT01271894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101994382|NCT04678479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102518134|NCT01271894|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102518135|NCT01271894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102518136|NCT01271894|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102518137|NCT01271894|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102518138|NCT01271894|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102518139|NCT01271894|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102518140|NCT01278758|Vadimezan|vadimezan|mesh-list
102518141|NCT01278758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102518142|NCT00717626|Factor VIII|factor viii|mesh-list
102518143|NCT00717626|Coagulants|coagulants|mesh-ancestor
102518144|NCT01272128|Interferons|interferons|mesh-list
102518145|NCT01272128|Interferon-beta|interferon-beta|mesh-list
102518146|NCT01272128|Interferon beta-1a|interferon beta-1a|mesh-list
102518147|NCT01272128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102518148|NCT01272128|Antiviral Agents|antiviral agents|mesh-ancestor
102518149|NCT01272128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102518150|NCT01272128|Immunologic Factors|immunologic factors|mesh-ancestor
102518151|NCT01272128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518152|NCT01272128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102518153|NCT00719186|Letrozole|letrozole|mesh-list
102518154|NCT00719186|Clomiphene|clomiphene|mesh-list
102518155|NCT00719186|Enclomiphene|enclomiphene|mesh-list
102518156|NCT00719186|Zuclomiphene|zuclomiphene|mesh-list
102518157|NCT00719186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518158|NCT00719186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102518159|NCT00719186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102518160|NCT00719186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102518161|NCT00719186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102518162|NCT00719186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102518163|NCT00719186|Hormone Antagonists|hormone antagonists|mesh-ancestor
102518164|NCT00719186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102518165|NCT00719186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518166|NCT00719186|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102518167|NCT00719186|Fertility Agents|fertility agents|mesh-ancestor
102518168|NCT00719186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102518169|NCT00719186|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102518170|NCT00719186|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102518171|NCT00721136|Heparin|heparin|mesh-list
102518172|NCT00721136|Warfarin|warfarin|mesh-list
102518173|NCT00721136|Anticoagulants|anticoagulants|mesh-ancestor
102518174|NCT00721136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102518175|NCT00721136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102518176|NCT00721136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518177|NCT00737204|Modafinil|modafinil|mesh-list
102518178|NCT00737204|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102518179|NCT00737204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518180|NCT00737204|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102518181|NCT00737204|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102518182|NCT00737204|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102518183|NCT00737204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518184|NCT00722072|Sorafenib|sorafenib|mesh-list
102518185|NCT00722072|Fulvestrant|fulvestrant|mesh-list
102518186|NCT00722072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102518187|NCT00722072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102518188|NCT00722072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102518189|NCT00722072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518190|NCT00722072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102518191|NCT00722072|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102518192|NCT00722072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102518193|NCT00722072|Hormone Antagonists|hormone antagonists|mesh-ancestor
102518194|NCT00722072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102518195|NCT00722072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518196|NCT01275170|Imipenem|imipenem|mesh-list
102518197|NCT01275170|Relebactam|relebactam|mesh-list
102518198|NCT01275170|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
102518199|NCT01275170|Midazolam|midazolam|mesh-list
102518200|NCT01275170|Caffeine|caffeine|mesh-list
102518201|NCT01275170|Omeprazole|omeprazole|mesh-list
102518202|NCT01275170|Cilastatin|cilastatin|mesh-list
102518203|NCT01275170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102518204|NCT01275170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102518205|NCT01275170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102518206|NCT01275170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518207|NCT01275170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102518208|NCT01275170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102518209|NCT01275170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102518210|NCT01275170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102518211|NCT01275170|Anesthetics, General|anesthetics, general|mesh-ancestor
102518212|NCT01275170|Anesthetics|anesthetics|mesh-ancestor
102518213|NCT01275170|GABA Modulators|gaba modulators|mesh-ancestor
102518214|NCT01275170|GABA Agents|gaba agents|mesh-ancestor
102518215|NCT01275170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102518216|NCT01275170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518217|NCT01275170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102518218|NCT01275170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102329713|NCT04677816|Vitamin D|vitamin d|mesh-list
102518219|NCT01275170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102518220|NCT01275170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102518221|NCT01275170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102518222|NCT01275170|Purinergic Agents|purinergic agents|mesh-ancestor
102518223|NCT01275170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102518224|NCT01275170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102518225|NCT01275170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102518226|NCT01275170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102518227|NCT01275170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102518228|NCT01275170|Protease Inhibitors|protease inhibitors|mesh-ancestor
102518229|NCT01275170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102518230|NCT04385654|Axitinib|axitinib|mesh-list
102518231|NCT04385654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102518232|NCT04385654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102518233|NCT04385654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102518234|NCT04385654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518235|NCT01273064|Interferons|interferons|mesh-list
102518236|NCT01273064|Ribavirin|ribavirin|mesh-list
102518237|NCT01273064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102518238|NCT01273064|Antiviral Agents|antiviral agents|mesh-ancestor
102518239|NCT01273064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102518240|NCT01273064|Antimetabolites|antimetabolites|mesh-ancestor
102518241|NCT01273064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518242|NCT01272986|Immunoglobulin G|immunoglobulin g|mesh-list
102518243|NCT01272986|Immunologic Factors|immunologic factors|mesh-ancestor
102518244|NCT01272986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518245|NCT01272908|Rituximab|rituximab|mesh-list
102518246|NCT01272908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102518247|NCT01272908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102518248|NCT01272908|Immunologic Factors|immunologic factors|mesh-ancestor
102518249|NCT01272908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518250|NCT01272908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102518251|NCT01271504|Sorafenib|sorafenib|mesh-list
102518252|NCT01271504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102518253|NCT01271504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102518254|NCT01271504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102518255|NCT01271504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518256|NCT02144714|Adalimumab|adalimumab|mesh-list
102518257|NCT02144714|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102518258|NCT02144714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102518259|NCT02144714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102518260|NCT00741026|Olanzapine|olanzapine|mesh-list
102518261|NCT00741026|Antiemetics|antiemetics|mesh-ancestor
102518262|NCT00741026|Autonomic Agents|autonomic agents|mesh-ancestor
102518263|NCT00741026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102518264|NCT00741026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518265|NCT00741026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102518266|NCT00741026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102518267|NCT00741026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102518268|NCT00741026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102518269|NCT00741026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102518270|NCT00741026|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102518271|NCT00741026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102518272|NCT00741026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102518273|NCT00741026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518274|NCT00741026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102518275|NCT00741026|Serotonin Agents|serotonin agents|mesh-ancestor
102518276|NCT00741104|Infliximab|infliximab|mesh-list
102518277|NCT00741104|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102518278|NCT00741104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102518279|NCT00741104|Dermatologic Agents|dermatologic agents|mesh-ancestor
102518280|NCT00741104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102518281|NCT00741104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102518282|NCT01273298|Bisoprolol|bisoprolol|mesh-list
102518283|NCT01273298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102518284|NCT01273298|Sympatholytics|sympatholytics|mesh-ancestor
102518285|NCT01273298|Autonomic Agents|autonomic agents|mesh-ancestor
102518286|NCT01273298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102518287|NCT01273298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518288|NCT01273298|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102518289|NCT01273298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102518290|NCT01273298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102518291|NCT01273298|Adrenergic Agents|adrenergic agents|mesh-ancestor
102518292|NCT01273298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102518293|NCT01273298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518294|NCT01270802|Tenofovir|tenofovir|mesh-list
102518295|NCT01270802|Emtricitabine|emtricitabine|mesh-list
102518296|NCT01270802|Efavirenz|efavirenz|mesh-list
102518297|NCT01270802|Raltegravir Potassium|raltegravir potassium|mesh-list
102518298|NCT01270802|Antiviral Agents|antiviral agents|mesh-ancestor
102518299|NCT01270802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102518300|NCT01270802|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102518301|NCT01270802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102518302|NCT01270802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102518303|NCT01270802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518304|NCT01270802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102518305|NCT01270802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102518306|NCT01270802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102518307|NCT01270802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102518308|NCT01270802|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102518309|NCT01270802|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102518310|NCT01270802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102518311|NCT01270802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102518312|NCT01270802|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102518313|NCT01270802|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102518314|NCT01273454|Hydromorphone|hydromorphone|mesh-list
102518315|NCT01273454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102518316|NCT01273454|Narcotics|narcotics|mesh-ancestor
102518317|NCT01273454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102518318|NCT01273454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518319|NCT01273454|Analgesics|analgesics|mesh-ancestor
102518320|NCT01273454|Sensory System Agents|sensory system agents|mesh-ancestor
102518321|NCT01273454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102518322|NCT01270256|Budesonide|budesonide|mesh-list
102518323|NCT01270256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102518324|NCT01270256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102518325|NCT01270256|Autonomic Agents|autonomic agents|mesh-ancestor
102518326|NCT01270256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102518327|NCT01270256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518328|NCT01270256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102518329|NCT01270256|Respiratory System Agents|respiratory system agents|mesh-ancestor
102518330|NCT01270256|Glucocorticoids|glucocorticoids|mesh-ancestor
102518331|NCT01270256|Hormones|hormones|mesh-ancestor
102518332|NCT01270256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102518333|NCT01279694|Prednisone|prednisone|mesh-list
102518334|NCT01279694|Melphalan|melphalan|mesh-list
102518335|NCT01279694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102518336|NCT01279694|Glucocorticoids|glucocorticoids|mesh-ancestor
102518337|NCT01279694|Hormones|hormones|mesh-ancestor
102518338|NCT01279694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101994591|NCT03110510|Vitamin B Complex|vitamin b complex|mesh-ancestor
102518339|NCT01279694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518340|NCT01279694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102518341|NCT01279694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102518342|NCT01279694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102518343|NCT01279694|Alkylating Agents|alkylating agents|mesh-ancestor
102518344|NCT01279694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518345|NCT01279694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102518346|NCT01279694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102518347|NCT01279694|Immunologic Factors|immunologic factors|mesh-ancestor
102518348|NCT01273532|Tapentadol|tapentadol|mesh-list
102518349|NCT01273532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102518350|NCT01273532|Narcotics|narcotics|mesh-ancestor
102518351|NCT01273532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102518352|NCT01273532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518353|NCT01273532|Analgesics|analgesics|mesh-ancestor
102518354|NCT01273532|Sensory System Agents|sensory system agents|mesh-ancestor
102518355|NCT01273532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102518356|NCT01273532|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102518357|NCT01273532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102518358|NCT01273532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102518359|NCT01273532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518360|NCT01273532|Adrenergic Agents|adrenergic agents|mesh-ancestor
102518361|NCT01273532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102518362|NCT00744380|Midazolam|midazolam|mesh-list
102518363|NCT00744380|Dexmedetomidine|dexmedetomidine|mesh-list
102518364|NCT00744380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102518365|NCT00744380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102518366|NCT00744380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518367|NCT00744380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102518368|NCT00744380|Analgesics|analgesics|mesh-ancestor
102518369|NCT00744380|Sensory System Agents|sensory system agents|mesh-ancestor
102518370|NCT00744380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102518371|NCT00744380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102518372|NCT00744380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102518373|NCT00744380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102518374|NCT00744380|Adrenergic Agents|adrenergic agents|mesh-ancestor
102518375|NCT00744380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102518376|NCT00744380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518377|NCT00744380|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102518378|NCT00744380|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102518379|NCT00744380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102518380|NCT00744380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102518381|NCT00744380|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102518382|NCT00744380|Anesthetics, General|anesthetics, general|mesh-ancestor
102518383|NCT00744380|Anesthetics|anesthetics|mesh-ancestor
102518384|NCT00744380|GABA Modulators|gaba modulators|mesh-ancestor
102518385|NCT00744380|GABA Agents|gaba agents|mesh-ancestor
102518386|NCT00744692|Fludarabine|fludarabine|mesh-list
102518387|NCT00744692|Melphalan|melphalan|mesh-list
102518388|NCT00744692|Thiotepa|thiotepa|mesh-list
102518389|NCT00744692|Hydroxyurea|hydroxyurea|mesh-list
102518390|NCT00744692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102518391|NCT00744692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518392|NCT00744692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102518393|NCT00744692|Immunologic Factors|immunologic factors|mesh-ancestor
102518394|NCT00744692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518395|NCT00744692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102518396|NCT00744692|Alkylating Agents|alkylating agents|mesh-ancestor
102518397|NCT00744692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102518398|NCT00744692|Antisickling Agents|antisickling agents|mesh-ancestor
102518399|NCT00744692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102518400|NCT00744692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102518401|NCT00744848|Epinephrine|epinephrine|mesh-list
102518402|NCT00744848|Bupivacaine|bupivacaine|mesh-list
102518403|NCT00744848|Anesthetics, Local|anesthetics, local|mesh-ancestor
102518404|NCT00744848|Anesthetics|anesthetics|mesh-ancestor
102518405|NCT00744848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102518406|NCT00744848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518407|NCT00744848|Sensory System Agents|sensory system agents|mesh-ancestor
102518408|NCT00744848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102518409|NCT00744848|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102518410|NCT00744848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102518411|NCT00744848|Adrenergic Agents|adrenergic agents|mesh-ancestor
102518412|NCT00744848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102518413|NCT00744848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518414|NCT00744848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102518415|NCT00744848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102518416|NCT00744848|Autonomic Agents|autonomic agents|mesh-ancestor
102518417|NCT00744848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102518418|NCT00744848|Respiratory System Agents|respiratory system agents|mesh-ancestor
102518419|NCT00744848|Mydriatics|mydriatics|mesh-ancestor
102518420|NCT00744848|Sympathomimetics|sympathomimetics|mesh-ancestor
102518421|NCT00744848|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102518422|NCT03830606|Paclitaxel|paclitaxel|mesh-list
102518423|NCT03830606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102518424|NCT03830606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102518425|NCT03830606|Tubulin Modulators|tubulin modulators|mesh-ancestor
102518426|NCT03830606|Antimitotic Agents|antimitotic agents|mesh-ancestor
102518427|NCT03830606|Mitosis Modulators|mitosis modulators|mesh-ancestor
102518428|NCT03830606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518429|NCT01278134|Ritonavir|ritonavir|mesh-list
102518430|NCT01278134|Ribavirin|ribavirin|mesh-list
102518431|NCT01278134|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102518432|NCT01278134|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102518433|NCT01278134|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102518434|NCT01278134|Protease Inhibitors|protease inhibitors|mesh-ancestor
102518435|NCT01278134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102518436|NCT01278134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518437|NCT01278134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102518438|NCT01278134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102518439|NCT01278134|Antiviral Agents|antiviral agents|mesh-ancestor
102518440|NCT01278134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102518441|NCT01278134|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102518442|NCT01278134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102329930|NCT03852628|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102518443|NCT01278134|Antimetabolites|antimetabolites|mesh-ancestor
102518444|NCT01273844|Bortezomib|bortezomib|mesh-list
102518445|NCT01273844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102518446|NCT01271348|Etoricoxib|etoricoxib|mesh-list
102518447|NCT01271348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102518448|NCT01271348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102518449|NCT01271348|Analgesics|analgesics|mesh-ancestor
102518450|NCT01271348|Sensory System Agents|sensory system agents|mesh-ancestor
102518451|NCT01271348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102518452|NCT01271348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518453|NCT01271348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102518454|NCT01271348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102518455|NCT01271348|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102518456|NCT01271348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102518457|NCT01271348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102518458|NCT01271348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518459|NCT04385264|Hydroxychloroquine|hydroxychloroquine|mesh-list
102518460|NCT04385264|Mannitol|mannitol|mesh-list
102518461|NCT04385264|Antimalarials|antimalarials|mesh-ancestor
102518462|NCT04385264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102518463|NCT04385264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102518464|NCT04385264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102518465|NCT04385264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102518466|NCT04385264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518467|NCT04385264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102518468|NCT04385264|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102518469|NCT04385264|Diuretics|diuretics|mesh-ancestor
102518470|NCT04385264|Natriuretic Agents|natriuretic agents|mesh-ancestor
102518471|NCT04385264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518472|NCT00746954|Acetazolamide|acetazolamide|mesh-list
102518473|NCT00746954|Buspirone|buspirone|mesh-list
102518474|NCT00746954|Anticonvulsants|anticonvulsants|mesh-ancestor
102518475|NCT00746954|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102518476|NCT00746954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102518477|NCT00746954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518478|NCT00746954|Diuretics|diuretics|mesh-ancestor
102518479|NCT00746954|Natriuretic Agents|natriuretic agents|mesh-ancestor
102518480|NCT00746954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518481|NCT00746954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102518482|NCT00746954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102518483|NCT00746954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102518484|NCT00746954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102518485|NCT00746954|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102518486|NCT00746954|Serotonin Agents|serotonin agents|mesh-ancestor
102518487|NCT00746954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102518488|NCT00752102|Calcitriol|calcitriol|mesh-list
102518489|NCT00752102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102518490|NCT00752102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518491|NCT00752102|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102518492|NCT00752102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102518493|NCT00752102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518494|NCT00752102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102518495|NCT00752102|Vitamins|vitamins|mesh-ancestor
102518496|NCT00752102|Micronutrients|micronutrients|mesh-ancestor
102518497|NCT00752102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102518498|NCT00723632|Ribavirin|ribavirin|mesh-list
102518499|NCT00723632|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102518500|NCT00723632|Antimetabolites|antimetabolites|mesh-ancestor
102518501|NCT00723632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518502|NCT00723632|Antiviral Agents|antiviral agents|mesh-ancestor
102518503|NCT00723632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102518504|NCT01279616|Mycophenolic Acid|mycophenolic acid|mesh-list
102518505|NCT01279616|Cyclophosphamide|cyclophosphamide|mesh-list
102518506|NCT01279616|Busulfan|busulfan|mesh-list
102518507|NCT01279616|Rituximab|rituximab|mesh-list
102518508|NCT01279616|Fludarabine|fludarabine|mesh-list
102518509|NCT01279616|Fludarabine phosphate|fludarabine phosphate|mesh-list
102518510|NCT01279616|Tacrolimus|tacrolimus|mesh-list
102518511|NCT01279616|Thymoglobulin|thymoglobulin|mesh-list
102518512|NCT01279616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102518513|NCT01279616|Immunologic Factors|immunologic factors|mesh-ancestor
102518514|NCT01279616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518515|NCT01279616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102518516|NCT01279616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102518517|NCT01279616|Alkylating Agents|alkylating agents|mesh-ancestor
102330006|NCT03623633|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102518518|NCT01279616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518519|NCT01279616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102518520|NCT01279616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102518521|NCT01279616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102518522|NCT01279616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102518523|NCT01279616|Antimetabolites|antimetabolites|mesh-ancestor
102518524|NCT01279616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102518525|NCT01279616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102518526|NCT01279616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102518527|NCT01279616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102518528|NCT01279616|Antitubercular Agents|antitubercular agents|mesh-ancestor
102518529|NCT01279616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102518530|NCT01279616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102518531|NCT01275638|Prednisolone|prednisolone|mesh-list
102518532|NCT01275638|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102518533|NCT01275638|Methylprednisolone|methylprednisolone|mesh-list
102518534|NCT01275638|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102518535|NCT01275638|Prednisolone acetate|prednisolone acetate|mesh-list
102518536|NCT01275638|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102518537|NCT01275638|Prednisolone phosphate|prednisolone phosphate|mesh-list
102518538|NCT01275638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102518539|NCT01275638|Glucocorticoids|glucocorticoids|mesh-ancestor
102518540|NCT01275638|Hormones|hormones|mesh-ancestor
102518541|NCT01275638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102518542|NCT01275638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518543|NCT01275638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102518544|NCT01275638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102518545|NCT01275638|Antiemetics|antiemetics|mesh-ancestor
102518546|NCT01275638|Autonomic Agents|autonomic agents|mesh-ancestor
102518547|NCT01275638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102518548|NCT01275638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102518549|NCT01275638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102518550|NCT01275638|Protective Agents|protective agents|mesh-ancestor
102518551|NCT00724568|Dexamethasone|dexamethasone|mesh-list
102518552|NCT00724568|Lenalidomide|lenalidomide|mesh-list
102518553|NCT00724568|Bortezomib|bortezomib|mesh-list
101994804|NCT01321021|Losartan|losartan|mesh-list
102518554|NCT00724568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102518555|NCT00724568|Antiemetics|antiemetics|mesh-ancestor
102518556|NCT00724568|Autonomic Agents|autonomic agents|mesh-ancestor
102518557|NCT00724568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102518558|NCT00724568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518559|NCT00724568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102518560|NCT00724568|Glucocorticoids|glucocorticoids|mesh-ancestor
102518561|NCT00724568|Hormones|hormones|mesh-ancestor
102518562|NCT00724568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102518563|NCT00724568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102518564|NCT00724568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102518565|NCT00724568|Immunologic Factors|immunologic factors|mesh-ancestor
102518566|NCT00724568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102518567|NCT00724568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102518568|NCT00724568|Growth Substances|growth substances|mesh-ancestor
102518569|NCT00724568|Growth Inhibitors|growth inhibitors|mesh-ancestor
102518570|NCT01274000|Ramosetron|ramosetron|mesh-list
102518571|NCT01274000|Antiemetics|antiemetics|mesh-ancestor
102518572|NCT01274000|Autonomic Agents|autonomic agents|mesh-ancestor
102518573|NCT01274000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102518574|NCT01274000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518575|NCT01274000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102518576|NCT01274000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102518577|NCT01274000|Serotonin Agents|serotonin agents|mesh-ancestor
102518578|NCT01274000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102518579|NCT01274000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518580|NCT04272320|Bupivacaine|bupivacaine|mesh-list
102518581|NCT04272320|Anesthetics, Local|anesthetics, local|mesh-ancestor
102518582|NCT04272320|Anesthetics|anesthetics|mesh-ancestor
102518583|NCT04272320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102518584|NCT04272320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518585|NCT04272320|Sensory System Agents|sensory system agents|mesh-ancestor
102518586|NCT04272320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102518587|NCT01277744|Cisplatin|cisplatin|mesh-list
102518588|NCT01277744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102518589|NCT01277822|Losartan|losartan|mesh-list
102518590|NCT01277822|Amlodipine|amlodipine|mesh-list
102518591|NCT01277822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102518592|NCT01277822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102518593|NCT01277822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102518594|NCT01277822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518595|NCT01277822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102518596|NCT01277822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518597|NCT01277822|Vasodilator Agents|vasodilator agents|mesh-ancestor
102518598|NCT01277822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102518599|NCT01277822|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102518600|NCT01277822|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102518601|NCT00249002|Paclitaxel|paclitaxel|mesh-list
102518602|NCT00249002|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102518603|NCT00249002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102518604|NCT00249002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102518605|NCT00249002|Tubulin Modulators|tubulin modulators|mesh-ancestor
102518606|NCT00249002|Antimitotic Agents|antimitotic agents|mesh-ancestor
102518607|NCT00249002|Mitosis Modulators|mitosis modulators|mesh-ancestor
102518608|NCT00249002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518609|NCT00748826|Infliximab|infliximab|mesh-list
102518610|NCT00748826|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102518611|NCT00748826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102518612|NCT00748826|Dermatologic Agents|dermatologic agents|mesh-ancestor
102518613|NCT00748826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102518614|NCT00748826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102518615|NCT00246740|Doxycycline|doxycycline|mesh-list
102518616|NCT00246740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102518617|NCT00246740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102518618|NCT00246740|Antimalarials|antimalarials|mesh-ancestor
102518619|NCT00246740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102518620|NCT00246740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102518621|NCT01274624|Leucovorin|leucovorin|mesh-list
102518622|NCT01274624|Bevacizumab|bevacizumab|mesh-list
102518623|NCT01274624|Fluorouracil|fluorouracil|mesh-list
102518624|NCT01274624|Irinotecan|irinotecan|mesh-list
102518625|NCT01274624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102518626|NCT01274624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102518627|NCT01274624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102518628|NCT01274624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102518629|NCT01274624|Growth Substances|growth substances|mesh-ancestor
102518630|NCT01274624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518631|NCT01274624|Growth Inhibitors|growth inhibitors|mesh-ancestor
102518632|NCT01274624|Antimetabolites|antimetabolites|mesh-ancestor
102518633|NCT01274624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518634|NCT01274624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102518635|NCT01274624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102518636|NCT01274624|Immunologic Factors|immunologic factors|mesh-ancestor
102518637|NCT01274624|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102518638|NCT01274624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102518639|NCT01274624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102518640|NCT01274624|Antidotes|antidotes|mesh-ancestor
102518641|NCT01274624|Protective Agents|protective agents|mesh-ancestor
102518642|NCT01274624|Vitamin B Complex|vitamin b complex|mesh-ancestor
102518643|NCT01274624|Vitamins|vitamins|mesh-ancestor
102518644|NCT01274624|Micronutrients|micronutrients|mesh-ancestor
102518645|NCT00761930|Listerine|listerine|mesh-list
102518646|NCT00761930|Triclosan|triclosan|mesh-list
102518647|NCT00761930|Fluorides|fluorides|mesh-list
102518648|NCT00761930|Sodium Fluoride|sodium fluoride|mesh-list
102518649|NCT00761930|Cariostatic Agents|cariostatic agents|mesh-ancestor
102518650|NCT00761930|Protective Agents|protective agents|mesh-ancestor
102518651|NCT00761930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518652|NCT00761930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102518653|NCT00761930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102518654|NCT00761930|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102518655|NCT00761930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102518656|NCT00761930|Antimetabolites|antimetabolites|mesh-ancestor
102518657|NCT00761930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518658|NCT00761930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102518659|NCT00245102|Sorafenib|sorafenib|mesh-list
102518660|NCT00245102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102518661|NCT00245102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102518662|NCT00245102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102518663|NCT00245102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518664|NCT01275014|Dexamethasone|dexamethasone|mesh-list
102518665|NCT01275014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102518666|NCT01275014|Antiemetics|antiemetics|mesh-ancestor
102518667|NCT01275014|Autonomic Agents|autonomic agents|mesh-ancestor
102518668|NCT01275014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102518669|NCT01275014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330162|NCT03052608|Crizotinib|crizotinib|mesh-list
102518670|NCT01275014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102518671|NCT01275014|Glucocorticoids|glucocorticoids|mesh-ancestor
102518672|NCT01275014|Hormones|hormones|mesh-ancestor
102518673|NCT01275014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102518674|NCT01275014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102518675|NCT01275014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102518676|NCT01275248|Ondansetron|ondansetron|mesh-list
102518677|NCT01275248|Antiemetics|antiemetics|mesh-ancestor
102518678|NCT01275248|Autonomic Agents|autonomic agents|mesh-ancestor
102518679|NCT01275248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102518680|NCT01275248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518681|NCT01275248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102518682|NCT01275248|Antipruritics|antipruritics|mesh-ancestor
102518683|NCT01275248|Dermatologic Agents|dermatologic agents|mesh-ancestor
102518684|NCT01275248|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102518685|NCT01275248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102518686|NCT01275248|Serotonin Agents|serotonin agents|mesh-ancestor
102518687|NCT01275248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102518688|NCT01275248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518689|NCT00756236|Metoprolol|metoprolol|mesh-list
102518690|NCT00756236|Esmolol|esmolol|mesh-list
102518691|NCT00756236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102518692|NCT00756236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102518693|NCT00756236|Sympatholytics|sympatholytics|mesh-ancestor
102518694|NCT00756236|Autonomic Agents|autonomic agents|mesh-ancestor
102518695|NCT00756236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102518696|NCT00756236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518697|NCT00756236|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102518698|NCT00756236|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102518699|NCT00756236|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102518700|NCT00756236|Adrenergic Agents|adrenergic agents|mesh-ancestor
102518701|NCT00756236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102518702|NCT00756236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518703|NCT00762320|Ritonavir|ritonavir|mesh-list
102518704|NCT00762320|Lopinavir|lopinavir|mesh-list
102518705|NCT00762320|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102518706|NCT00762320|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102518707|NCT00762320|Protease Inhibitors|protease inhibitors|mesh-ancestor
102518708|NCT00762320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102518709|NCT00762320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518710|NCT00762320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102518711|NCT00762320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102518712|NCT00762320|Antiviral Agents|antiviral agents|mesh-ancestor
102518713|NCT00762320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102518714|NCT00762320|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102518715|NCT00762320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102518716|NCT00244712|Tenofovir|tenofovir|mesh-list
102518717|NCT00244712|Lamivudine|lamivudine|mesh-list
102518718|NCT00244712|Emtricitabine|emtricitabine|mesh-list
102518719|NCT00244712|Abacavir|abacavir|mesh-list
102518720|NCT00244712|Antiviral Agents|antiviral agents|mesh-ancestor
102518721|NCT00244712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102518722|NCT00244712|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102518723|NCT00244712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102518724|NCT00244712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102518725|NCT00244712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518726|NCT00244712|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102518727|NCT00244712|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102518728|NCT00725270|Mifepristone|mifepristone|mesh-list
102518729|NCT00725270|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102518730|NCT00725270|Abortifacient Agents|abortifacient agents|mesh-ancestor
102518731|NCT00725270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102518732|NCT00725270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518733|NCT00725270|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102518734|NCT00725270|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102518735|NCT00725270|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102518736|NCT00725270|Contraceptive Agents|contraceptive agents|mesh-ancestor
102518737|NCT00725270|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102518738|NCT00725270|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102518739|NCT00725270|Hormone Antagonists|hormone antagonists|mesh-ancestor
102518740|NCT00725270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102518741|NCT00725270|Luteolytic Agents|luteolytic agents|mesh-ancestor
102518742|NCT00725270|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102518743|NCT00725270|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102330233|NCT02704208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102518744|NCT00243932|Ubiquinone|ubiquinone|mesh-list
102518745|NCT00243932|Coenzyme Q10|coenzyme q10|mesh-list
102518746|NCT00243932|Micronutrients|micronutrients|mesh-ancestor
102518747|NCT00243932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518748|NCT00243932|Vitamins|vitamins|mesh-ancestor
102518749|NCT00243386|Factor VIII|factor viii|mesh-list
102518750|NCT00243386|Coagulants|coagulants|mesh-ancestor
102518751|NCT03807362|CC-11050|cc-11050|mesh-list
102518752|NCT03807362|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102518753|NCT03807362|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102518754|NCT03807362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102518755|NCT03807362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518756|NCT01275560|Metronidazole|metronidazole|mesh-list
102518757|NCT01275560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102518758|NCT01275560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102518759|NCT01275560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102518760|NCT01275560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102518761|NCT00762710|Prazosin|prazosin|mesh-list
102518762|NCT00762710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102518763|NCT00762710|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102518764|NCT00762710|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102518765|NCT00762710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102518766|NCT00762710|Adrenergic Agents|adrenergic agents|mesh-ancestor
101995021|NCT03113123|Antiviral Agents|antiviral agents|mesh-ancestor
102518767|NCT00762710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102518768|NCT00762710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518769|NCT00762710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518770|NCT00756548|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
102518771|NCT00756548|Laxatives|laxatives|mesh-ancestor
102518772|NCT00756548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102518773|NCT00243074|Cediranib|cediranib|mesh-list
102518774|NCT00243074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102518775|NCT00243074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518776|NCT00243074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102518777|NCT00243074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102518778|NCT00241358|Plerixafor|plerixafor|mesh-list
102518779|NCT00241358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102518780|NCT00241358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102518781|NCT00241358|Antiviral Agents|antiviral agents|mesh-ancestor
102518782|NCT00241358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102518783|NCT00778310|Methylphenidate|methylphenidate|mesh-list
102518784|NCT00778310|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102518785|NCT00778310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518786|NCT00778310|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102518787|NCT00778310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102518788|NCT00778310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102518789|NCT00778310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518790|NCT00778310|Dopamine Agents|dopamine agents|mesh-ancestor
102518791|NCT00778310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102518792|NCT03801278|Bemarituzumab|bemarituzumab|mesh-list
102518793|NCT03801278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102518794|NCT03801278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102518795|NCT01247285|Fluoxetine|fluoxetine|mesh-list
102518796|NCT01247285|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102518797|NCT01247285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102518798|NCT01247285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102518799|NCT01247285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518800|NCT01247285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102518801|NCT01247285|Serotonin Agents|serotonin agents|mesh-ancestor
102518802|NCT01247285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518803|NCT01247285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102518804|NCT01247285|Antidepressive Agents|antidepressive agents|mesh-ancestor
102518805|NCT01247285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102518806|NCT01247285|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102518807|NCT01247285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102518808|NCT01247285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102518809|NCT03806582|Norepinephrine|norepinephrine|mesh-list
102518810|NCT03806582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102518811|NCT03806582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102518812|NCT03806582|Adrenergic Agents|adrenergic agents|mesh-ancestor
102518813|NCT03806582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102518814|NCT03806582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518815|NCT03806582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518816|NCT03806582|Sympathomimetics|sympathomimetics|mesh-ancestor
102518817|NCT03806582|Autonomic Agents|autonomic agents|mesh-ancestor
102518818|NCT03806582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102518819|NCT03806582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102518820|NCT00779558|Heparin|heparin|mesh-list
102518821|NCT00779558|Calcium heparin|calcium heparin|mesh-list
102518822|NCT00779558|Anticoagulants|anticoagulants|mesh-ancestor
102518823|NCT00779558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102518824|NCT00779558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102518825|NCT00779558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518826|NCT00758342|Travoprost|travoprost|mesh-list
102518827|NCT00758342|Brinzolamide|brinzolamide|mesh-list
102518828|NCT00758342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102518829|NCT00758342|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102518830|NCT00758342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102518831|NCT00758342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518832|NCT01301183|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102518833|NCT01301183|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102518834|NCT01301183|Estradiol|estradiol|mesh-list
102518835|NCT01301183|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102518836|NCT01301183|Mecasermin|mecasermin|mesh-list
102518837|NCT01301183|Estrogens|estrogens|mesh-ancestor
102518838|NCT01301183|Hormones|hormones|mesh-ancestor
102518839|NCT01301183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102518840|NCT01301183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518841|NCT01301183|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102518842|NCT01301183|Contraceptive Agents|contraceptive agents|mesh-ancestor
102518843|NCT01301183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102518844|NCT01301183|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102518845|NCT01301183|Growth Substances|growth substances|mesh-ancestor
102518846|NCT00758420|Polidocanol|polidocanol|mesh-list
102518847|NCT00758420|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102518848|NCT00758420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102518849|NCT01213043|Protease Inhibitors|protease inhibitors|mesh-list
102518850|NCT01213043|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
102518851|NCT01213043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102518852|NCT01213043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518853|NCT01213043|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102518854|NCT01213043|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102518855|NCT01213199|Adapalene|adapalene|mesh-list
102518856|NCT01213199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102518857|NCT01213199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102518858|NCT01213199|Analgesics|analgesics|mesh-ancestor
102518859|NCT01213199|Sensory System Agents|sensory system agents|mesh-ancestor
102518860|NCT01213199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102518861|NCT01213199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518862|NCT01213199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102518863|NCT01213199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102518864|NCT01213199|Dermatologic Agents|dermatologic agents|mesh-ancestor
102518865|NCT03809702|Pregabalin|pregabalin|mesh-list
102518866|NCT03809702|Analgesics|analgesics|mesh-ancestor
102518867|NCT03809702|Sensory System Agents|sensory system agents|mesh-ancestor
102518868|NCT03809702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102518869|NCT03809702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518870|NCT03809702|Anticonvulsants|anticonvulsants|mesh-ancestor
102518871|NCT03809702|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102518872|NCT03809702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102518873|NCT03809702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518874|NCT03809702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102518875|NCT03809702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102518876|NCT03809702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102518877|NCT03809702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102518878|NCT03809702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102518879|NCT03806036|Vitamin D|vitamin d|mesh-list
102518880|NCT03806036|Clomiphene|clomiphene|mesh-list
102518881|NCT03806036|Enclomiphene|enclomiphene|mesh-list
102518882|NCT03806036|Zuclomiphene|zuclomiphene|mesh-list
102518883|NCT03806036|Vitamins|vitamins|mesh-ancestor
102518884|NCT03806036|Micronutrients|micronutrients|mesh-ancestor
102518885|NCT03806036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518886|NCT03806036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102518887|NCT03806036|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102518888|NCT03806036|Hormone Antagonists|hormone antagonists|mesh-ancestor
102518889|NCT03806036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102518890|NCT03806036|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102518891|NCT03806036|Fertility Agents|fertility agents|mesh-ancestor
102518892|NCT03806036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102518893|NCT03806036|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102518894|NCT03806036|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102518895|NCT00780026|Insulin|insulin|mesh-list
102518896|NCT00780026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102518897|NCT00780026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518898|NCT01214057|Remifentanil|remifentanil|mesh-list
102518899|NCT01214057|Propofol|propofol|mesh-list
102518900|NCT01214057|Sevoflurane|sevoflurane|mesh-list
102518901|NCT01214057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102518902|NCT01214057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102518903|NCT01214057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518904|NCT01214057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102518905|NCT01214057|Anesthetics, General|anesthetics, general|mesh-ancestor
102518906|NCT01214057|Anesthetics|anesthetics|mesh-ancestor
102518907|NCT01214057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102518908|NCT01214057|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102518909|NCT01214057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102518910|NCT01214057|Narcotics|narcotics|mesh-ancestor
102518911|NCT01214057|Analgesics|analgesics|mesh-ancestor
102518912|NCT01214057|Sensory System Agents|sensory system agents|mesh-ancestor
102518913|NCT01214057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102518914|NCT03809546|Dronabinol|dronabinol|mesh-list
102518915|NCT03809546|Hallucinogens|hallucinogens|mesh-ancestor
102518916|NCT03809546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518917|NCT03809546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102518918|NCT03809546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102518919|NCT03809546|Analgesics|analgesics|mesh-ancestor
102518920|NCT03809546|Sensory System Agents|sensory system agents|mesh-ancestor
102518921|NCT03809546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102518922|NCT03809546|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102518923|NCT03809546|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102518924|NCT03809546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102518925|NCT03809546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518926|NCT03809546|Hormones|hormones|mesh-ancestor
102518927|NCT03809546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102518928|NCT03809312|Amoxicillin|amoxicillin|mesh-list
102518929|NCT03809312|Clavulanic Acids|clavulanic acids|mesh-list
102518930|NCT03809312|Clavulanic Acid|clavulanic acid|mesh-list
102518931|NCT03809312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102518932|NCT03809312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102518933|NCT03809312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102518934|NCT03809312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518935|NCT03809312|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102518936|NCT01247363|Globalagliatin|globalagliatin|mesh-list
102518937|NCT01247363|Enzyme Activators|enzyme activators|mesh-ancestor
102518938|NCT01247363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518939|NCT00780494|Bevacizumab|bevacizumab|mesh-list
102518940|NCT00780494|Carboplatin|carboplatin|mesh-list
102518941|NCT00780494|Capecitabine|capecitabine|mesh-list
102518942|NCT00780494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102518943|NCT00780494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102518944|NCT00780494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102518945|NCT00780494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102518946|NCT00780494|Growth Substances|growth substances|mesh-ancestor
102518947|NCT00780494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518948|NCT00780494|Growth Inhibitors|growth inhibitors|mesh-ancestor
102518949|NCT00780494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102518950|NCT00780494|Antimetabolites|antimetabolites|mesh-ancestor
102518951|NCT00780494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518952|NCT00763412|Repaglinide|repaglinide|mesh-list
102518953|NCT00763412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102518954|NCT00763412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518955|NCT01302743|Metformin|metformin|mesh-list
102518956|NCT01302743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102518957|NCT01302743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518958|NCT00763490|Mycophenolic Acid|mycophenolic acid|mesh-list
102518959|NCT00763490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102518960|NCT00763490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102518961|NCT00763490|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102518962|NCT00763490|Antitubercular Agents|antitubercular agents|mesh-ancestor
102518963|NCT00763490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102518964|NCT00763490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102518965|NCT00763490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102518966|NCT00763490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518967|NCT01214759|Tenofovir|tenofovir|mesh-list
102518968|NCT01214759|Emtricitabine|emtricitabine|mesh-list
102330467|NCT01744652|Dasatinib|dasatinib|mesh-list
102518969|NCT01214759|Raltegravir Potassium|raltegravir potassium|mesh-list
102518970|NCT01214759|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102518971|NCT01214759|Antiviral Agents|antiviral agents|mesh-ancestor
102518972|NCT01214759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102518973|NCT01214759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102518974|NCT01214759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102518975|NCT01214759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102518976|NCT01214759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518977|NCT01214759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102518978|NCT01214759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102518979|NCT01214759|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102518980|NCT01214759|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102518981|NCT00780962|Acetylcysteine|acetylcysteine|mesh-list
102518982|NCT00780962|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102518983|NCT00780962|Antiviral Agents|antiviral agents|mesh-ancestor
102518984|NCT00780962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102518985|NCT00780962|Expectorants|expectorants|mesh-ancestor
102518986|NCT00780962|Respiratory System Agents|respiratory system agents|mesh-ancestor
102518987|NCT00780962|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102518988|NCT00780962|Antioxidants|antioxidants|mesh-ancestor
102518989|NCT00780962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102518990|NCT00780962|Protective Agents|protective agents|mesh-ancestor
102518991|NCT00780962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518992|NCT00780962|Antidotes|antidotes|mesh-ancestor
102518993|NCT00764738|Ranibizumab|ranibizumab|mesh-list
102518994|NCT00764738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102518995|NCT00764738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102518996|NCT00764738|Growth Substances|growth substances|mesh-ancestor
102518997|NCT00764738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102518998|NCT00764738|Growth Inhibitors|growth inhibitors|mesh-ancestor
102518999|NCT00764738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102519000|NCT00781508|Sildenafil Citrate|sildenafil citrate|mesh-list
102519001|NCT00781508|Vasodilator Agents|vasodilator agents|mesh-ancestor
102519002|NCT00781508|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102519003|NCT00781508|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102519004|NCT00781508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102519005|NCT00781508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519006|NCT00781508|Urological Agents|urological agents|mesh-ancestor
102519007|NCT03805568|Dexmedetomidine|dexmedetomidine|mesh-list
102519008|NCT03805568|Remifentanil|remifentanil|mesh-list
102519009|NCT03805568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102519010|NCT03805568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102519011|NCT03805568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519012|NCT03805568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102519013|NCT03805568|Analgesics|analgesics|mesh-ancestor
102519014|NCT03805568|Sensory System Agents|sensory system agents|mesh-ancestor
102519015|NCT03805568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102519016|NCT03805568|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102519017|NCT03805568|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102519018|NCT03805568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102519019|NCT03805568|Adrenergic Agents|adrenergic agents|mesh-ancestor
102519020|NCT03805568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102519021|NCT03805568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519022|NCT03805568|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102519023|NCT03805568|Narcotics|narcotics|mesh-ancestor
102519025|NCT00781898|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102519026|NCT00781898|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102519027|NCT00781898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519028|NCT00781898|Sensory System Agents|sensory system agents|mesh-ancestor
102519029|NCT00781898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102519030|NCT00765128|Ketorolac|ketorolac|mesh-list
102519031|NCT00765128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102519032|NCT00765128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102519033|NCT00765128|Analgesics|analgesics|mesh-ancestor
102519034|NCT00765128|Sensory System Agents|sensory system agents|mesh-ancestor
102519035|NCT00765128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102519036|NCT00765128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519037|NCT00765128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102519038|NCT00765128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102519039|NCT00765128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102519040|NCT00765128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102519041|NCT00765128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519042|NCT00765206|Omeprazole|omeprazole|mesh-list
102519043|NCT00765206|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
102519044|NCT00765206|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102519045|NCT00765206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101995307|NCT03433534|Nivolumab|nivolumab|mesh-list
102519046|NCT00765206|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102519047|NCT00765206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102519048|NCT00765206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519050|NCT03809156|Riociguat|riociguat|mesh-list
102519051|NCT03809156|Enzyme Activators|enzyme activators|mesh-ancestor
102519052|NCT03809156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519053|NCT03809156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102519054|NCT03808844|Propofol|propofol|mesh-list
102519055|NCT03808844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102519056|NCT03808844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102519057|NCT03808844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519058|NCT03808844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102519059|NCT03808844|Anesthetics, General|anesthetics, general|mesh-ancestor
102519060|NCT03808844|Anesthetics|anesthetics|mesh-ancestor
102519061|NCT03809078|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102519062|NCT03809078|Bombesin|bombesin|mesh-list
102519063|NCT03809078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102519064|NCT03809078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519065|NCT03809078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102519066|NCT03809078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519067|NCT05316428|Ethanol|ethanol|mesh-list
102519068|NCT05316428|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102519069|NCT05316428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102519070|NCT05316428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102519071|NCT05316428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519072|NCT03805178|Abatacept|abatacept|mesh-list
102519073|NCT03805178|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102519074|NCT03805178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519075|NCT03805178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102519076|NCT03805178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102519077|NCT03805178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102519078|NCT03805178|Immunologic Factors|immunologic factors|mesh-ancestor
102519079|NCT03805178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519080|NCT03805178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102519081|NCT01303835|Naltrexone|naltrexone|mesh-list
102519082|NCT01303835|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102519083|NCT01303835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102519084|NCT01303835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519085|NCT01303835|Sensory System Agents|sensory system agents|mesh-ancestor
102519086|NCT01303835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102519087|NCT01250717|Dexamethasone|dexamethasone|mesh-list
102519088|NCT01250717|Goserelin|goserelin|mesh-list
102519089|NCT01250717|Estramustine|estramustine|mesh-list
102519090|NCT01250717|Docetaxel|docetaxel|mesh-list
102519091|NCT01250717|Bicalutamide|bicalutamide|mesh-list
102519092|NCT01250717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102519093|NCT01250717|Antiemetics|antiemetics|mesh-ancestor
102519094|NCT01250717|Autonomic Agents|autonomic agents|mesh-ancestor
102519095|NCT01250717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102519096|NCT01250717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519097|NCT01250717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102519098|NCT01250717|Glucocorticoids|glucocorticoids|mesh-ancestor
102519099|NCT01250717|Hormones|hormones|mesh-ancestor
102519100|NCT01250717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102519101|NCT01250717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102519102|NCT01250717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102519103|NCT01250717|Tubulin Modulators|tubulin modulators|mesh-ancestor
102519104|NCT01250717|Antimitotic Agents|antimitotic agents|mesh-ancestor
102519105|NCT01250717|Mitosis Modulators|mitosis modulators|mesh-ancestor
102519106|NCT01250717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519107|NCT01250717|Androgen Antagonists|androgen antagonists|mesh-ancestor
102519108|NCT01250717|Hormone Antagonists|hormone antagonists|mesh-ancestor
102519109|NCT01250717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102519110|NCT01250717|Alkylating Agents|alkylating agents|mesh-ancestor
102519111|NCT03804866|Doxorubicin|doxorubicin|mesh-list
102519112|NCT03804866|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102519113|NCT03804866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102519114|NCT03804866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102519115|NCT03804866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102519116|NCT03804866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102519117|NCT03804866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102519118|NCT03804866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519119|NCT01251575|Cyclosporine|cyclosporine|mesh-list
102519120|NCT01251575|Sirolimus|sirolimus|mesh-list
102519121|NCT01251575|Mycophenolic Acid|mycophenolic acid|mesh-list
102519122|NCT01251575|Fludarabine|fludarabine|mesh-list
102519123|NCT01251575|Fludarabine phosphate|fludarabine phosphate|mesh-list
102519124|NCT01251575|Cyclosporins|cyclosporins|mesh-list
102519125|NCT01251575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102519126|NCT01251575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102519127|NCT01251575|Antimetabolites|antimetabolites|mesh-ancestor
102519128|NCT01251575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519129|NCT01251575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102519130|NCT01251575|Immunologic Factors|immunologic factors|mesh-ancestor
102519131|NCT01251575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519132|NCT01251575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102519133|NCT01251575|Antifungal Agents|antifungal agents|mesh-ancestor
102519134|NCT01251575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102519135|NCT01251575|Dermatologic Agents|dermatologic agents|mesh-ancestor
102519136|NCT01251575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102519137|NCT01251575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102519138|NCT01251575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102519139|NCT01251575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102519140|NCT01251575|Antitubercular Agents|antitubercular agents|mesh-ancestor
102519141|NCT01251575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102519142|NCT00782756|Bevacizumab|bevacizumab|mesh-list
102519143|NCT00782756|Temozolomide|temozolomide|mesh-list
102519144|NCT00782756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102519145|NCT00782756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102519146|NCT00782756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102519147|NCT00782756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102519148|NCT00782756|Growth Substances|growth substances|mesh-ancestor
102519149|NCT00782756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519150|NCT00782756|Growth Inhibitors|growth inhibitors|mesh-ancestor
102519151|NCT00782756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102519152|NCT00782756|Alkylating Agents|alkylating agents|mesh-ancestor
102519153|NCT00782756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519154|NCT03808142|Interferon beta-1b|interferon beta-1b|mesh-list
102519155|NCT03808142|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102519156|NCT03808142|Immunologic Factors|immunologic factors|mesh-ancestor
102519157|NCT03808142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519158|NCT01306175|Empagliflozin|empagliflozin|mesh-list
102519159|NCT01306175|Digoxin|digoxin|mesh-list
102519160|NCT01306175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102519161|NCT01306175|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102519162|NCT01306175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102519163|NCT01306175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519164|NCT01306175|Protective Agents|protective agents|mesh-ancestor
102519165|NCT01306175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519166|NCT01306175|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102519167|NCT01306175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102519168|NCT01215929|Dextroamphetamine|dextroamphetamine|mesh-list
102519169|NCT01215929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102519170|NCT01215929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519171|NCT01215929|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102519172|NCT01215929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102519173|NCT01215929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102519174|NCT01215929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519175|NCT01215929|Dopamine Agents|dopamine agents|mesh-ancestor
102519176|NCT01215929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102519177|NCT00767624|Antidepressive Agents|antidepressive agents|mesh-list
102519178|NCT00767624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102519179|NCT01216241|Daptomycin|daptomycin|mesh-list
102519180|NCT01216241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102519181|NCT01216241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102519182|NCT01216397|Metformin|metformin|mesh-list
102519183|NCT01216397|Linagliptin|linagliptin|mesh-list
102519184|NCT01216397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102519185|NCT01216397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519186|NCT01216397|Incretins|incretins|mesh-ancestor
102519187|NCT01216397|Hormones|hormones|mesh-ancestor
102519188|NCT01216397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102519189|NCT01216397|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102519190|NCT01216397|Protease Inhibitors|protease inhibitors|mesh-ancestor
102519191|NCT01216397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612354|NCT00002423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102519192|NCT01216397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519193|NCT04345406|Chloroquine|chloroquine|mesh-list
102519194|NCT04345406|Enalapril|enalapril|mesh-list
102519195|NCT04345406|Captopril|captopril|mesh-list
102519196|NCT04345406|Amebicides|amebicides|mesh-ancestor
102519197|NCT04345406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102519198|NCT04345406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102519199|NCT04345406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102519200|NCT04345406|Antimalarials|antimalarials|mesh-ancestor
102519201|NCT04345406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102519202|NCT04345406|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102519203|NCT04345406|Protease Inhibitors|protease inhibitors|mesh-ancestor
102519204|NCT04345406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102519205|NCT04345406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519206|NCT04345406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102519207|NCT05621174|Dextroamphetamine|dextroamphetamine|mesh-list
102519208|NCT05621174|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102519209|NCT05621174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519210|NCT05621174|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102519211|NCT05621174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102519212|NCT05621174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102519213|NCT05621174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519214|NCT05621174|Dopamine Agents|dopamine agents|mesh-ancestor
102519215|NCT05621174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102519216|NCT01216943|Timolol|timolol|mesh-list
102519217|NCT01216943|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102519218|NCT01216943|Bimatoprost|bimatoprost|mesh-list
102519219|NCT01216943|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102519220|NCT01216943|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102519221|NCT01216943|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102519222|NCT01216943|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102519223|NCT01216943|Adrenergic Agents|adrenergic agents|mesh-ancestor
102519224|NCT01216943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102519225|NCT01216943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519226|NCT01216943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519227|NCT01216943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102519228|NCT01216943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102519229|NCT01216943|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102519230|NCT01216943|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102519231|NCT01216943|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102519232|NCT00783614|Aspirin|aspirin|mesh-list
102519233|NCT00783614|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102519234|NCT00783614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102519235|NCT00783614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102519236|NCT00783614|Analgesics|analgesics|mesh-ancestor
102519237|NCT00783614|Sensory System Agents|sensory system agents|mesh-ancestor
102519238|NCT00783614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102519239|NCT00783614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519240|NCT00783614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102519241|NCT00783614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102519242|NCT00783614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102519243|NCT00783614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102519244|NCT00783614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519245|NCT00783614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102519246|NCT00783614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102519247|NCT00783614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102519248|NCT00783614|Antipyretics|antipyretics|mesh-ancestor
102519249|NCT00783614|Antiviral Agents|antiviral agents|mesh-ancestor
102519250|NCT00783614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102519251|NCT01252745|Methyltestosterone|methyltestosterone|mesh-list
102519252|NCT01252745|Testosterone|testosterone|mesh-list
102519253|NCT01252745|Testosterone undecanoate|testosterone undecanoate|mesh-list
102519254|NCT01252745|Testosterone enanthate|testosterone enanthate|mesh-list
102519255|NCT01252745|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102519256|NCT01252745|Androgens|androgens|mesh-ancestor
102519257|NCT01252745|Hormones|hormones|mesh-ancestor
102519258|NCT01252745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102519259|NCT01252745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519260|NCT01252745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102519261|NCT01252745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102519262|NCT01252745|Anabolic Agents|anabolic agents|mesh-ancestor
102519263|NCT04278872|SJX-653|sjx-653|mesh-list
102519264|NCT04278872|Hormone Antagonists|hormone antagonists|mesh-ancestor
102612355|NCT00002423|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102330765|NCT01726335|Risperidone|risperidone|mesh-list
102519265|NCT04278872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102519266|NCT04278872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519267|NCT03807596|Hyaluronic Acid|hyaluronic acid|mesh-list
102519268|NCT03807596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102519269|NCT03807596|Immunologic Factors|immunologic factors|mesh-ancestor
102519270|NCT03807596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519271|NCT03807596|Viscosupplements|viscosupplements|mesh-ancestor
102519272|NCT03807596|Protective Agents|protective agents|mesh-ancestor
102519273|NCT01217411|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
102519274|NCT01217411|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
102519275|NCT01217411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102519276|NCT01217411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519277|NCT01253525|Paclitaxel|paclitaxel|mesh-list
102519278|NCT01253525|Ramucirumab|ramucirumab|mesh-list
102519279|NCT01253525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102519280|NCT01253525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102519281|NCT01253525|Tubulin Modulators|tubulin modulators|mesh-ancestor
102519282|NCT01253525|Antimitotic Agents|antimitotic agents|mesh-ancestor
102519283|NCT01253525|Mitosis Modulators|mitosis modulators|mesh-ancestor
102519284|NCT01253525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519285|NCT05310968|Aspirin|aspirin|mesh-list
102519286|NCT05310968|Tirofiban|tirofiban|mesh-list
102519287|NCT05310968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102519288|NCT05310968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102519289|NCT05310968|Analgesics|analgesics|mesh-ancestor
102519290|NCT05310968|Sensory System Agents|sensory system agents|mesh-ancestor
102519291|NCT05310968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102519292|NCT05310968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519293|NCT05310968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102519294|NCT05310968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102519295|NCT05310968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102519296|NCT05310968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102519297|NCT05310968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519298|NCT05310968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102519299|NCT05310968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102519300|NCT05310968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102519301|NCT05310968|Antipyretics|antipyretics|mesh-ancestor
102519302|NCT00768716|Acetaminophen|acetaminophen|mesh-list
102519303|NCT00768716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102519304|NCT00768716|Analgesics|analgesics|mesh-ancestor
102519305|NCT00768716|Sensory System Agents|sensory system agents|mesh-ancestor
102519306|NCT00768716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102519307|NCT00768716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519308|NCT00768716|Antipyretics|antipyretics|mesh-ancestor
102519309|NCT05743634|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102519310|NCT05743634|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102519311|NCT05743634|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102519312|NCT05743634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102519313|NCT05743634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519314|NCT05743634|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102519315|NCT05743634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102519316|NCT05743634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519317|NCT05743634|Cholinergic Agents|cholinergic agents|mesh-ancestor
102519318|NCT05743634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102519319|NCT05583188|Paclitaxel|paclitaxel|mesh-list
102519320|NCT05583188|Vinorelbine|vinorelbine|mesh-list
102519321|NCT05583188|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102519322|NCT05583188|Gemcitabine|gemcitabine|mesh-list
102519323|NCT05583188|Nivolumab|nivolumab|mesh-list
102519324|NCT05583188|Pemetrexed|pemetrexed|mesh-list
102519325|NCT05583188|Carboplatin|carboplatin|mesh-list
102519326|NCT05583188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102519327|NCT05583188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102519328|NCT05583188|Tubulin Modulators|tubulin modulators|mesh-ancestor
102519329|NCT05583188|Antimitotic Agents|antimitotic agents|mesh-ancestor
102519330|NCT05583188|Mitosis Modulators|mitosis modulators|mesh-ancestor
102519331|NCT05583188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519332|NCT05583188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102519333|NCT05583188|Antimetabolites|antimetabolites|mesh-ancestor
102519334|NCT05583188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102519335|NCT05583188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102519336|NCT05583188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102519337|NCT05583188|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102519338|NCT05583188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102519339|NCT01218971|Naltrexone|naltrexone|mesh-list
102519340|NCT01218971|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102519341|NCT01218971|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102519342|NCT01218971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519343|NCT01218971|Sensory System Agents|sensory system agents|mesh-ancestor
102519344|NCT01218971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102519345|NCT01337687|Oxytocin|oxytocin|mesh-list
102519346|NCT01337687|Oxytocics|oxytocics|mesh-ancestor
102519347|NCT01337687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102519348|NCT01337687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519349|NCT04351919|Azithromycin|azithromycin|mesh-list
102519350|NCT04351919|Hydroxychloroquine|hydroxychloroquine|mesh-list
102519351|NCT04351919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102519352|NCT04351919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102519353|NCT04351919|Antimalarials|antimalarials|mesh-ancestor
102519354|NCT04351919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102519355|NCT04351919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102519356|NCT04351919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102519357|NCT04351919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519358|NCT04351919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102519359|NCT00769886|Ketotifen|ketotifen|mesh-list
102519360|NCT00769886|Naphazoline|naphazoline|mesh-list
102519361|NCT00769886|Antipruritics|antipruritics|mesh-ancestor
102519362|NCT00769886|Dermatologic Agents|dermatologic agents|mesh-ancestor
102519363|NCT00769886|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102519364|NCT00769886|Histamine Antagonists|histamine antagonists|mesh-ancestor
102519365|NCT00769886|Histamine Agents|histamine agents|mesh-ancestor
102519366|NCT00769886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102519367|NCT00769886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519368|NCT00769886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519369|NCT00769886|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102519370|NCT00769886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102519371|NCT00769886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102519372|NCT00769886|Adrenergic Agents|adrenergic agents|mesh-ancestor
102519373|NCT00769886|Nasal Decongestants|nasal decongestants|mesh-ancestor
102519374|NCT00769886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102519375|NCT00769886|Respiratory System Agents|respiratory system agents|mesh-ancestor
102519376|NCT00794144|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
102519377|NCT00794144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102519378|NCT00794144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102519379|NCT00794144|Analgesics|analgesics|mesh-ancestor
102519380|NCT00794144|Sensory System Agents|sensory system agents|mesh-ancestor
102519381|NCT00794144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102519382|NCT00794144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519383|NCT00794144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102519384|NCT00794144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102519385|NCT00794144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102519386|NCT00794144|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102519387|NCT00794144|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102519388|NCT00794144|Histamine Antagonists|histamine antagonists|mesh-ancestor
102519389|NCT00794144|Histamine Agents|histamine agents|mesh-ancestor
102519390|NCT00794144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102519391|NCT00794144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519392|NCT01309451|Dexamethasone|dexamethasone|mesh-list
102519393|NCT01309451|Bevacizumab|bevacizumab|mesh-list
102519394|NCT01309451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102519395|NCT01309451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102519396|NCT01309451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102519397|NCT01309451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102519398|NCT01309451|Growth Substances|growth substances|mesh-ancestor
102519399|NCT01309451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519400|NCT01309451|Growth Inhibitors|growth inhibitors|mesh-ancestor
102519401|NCT01309451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102519402|NCT01309451|Antiemetics|antiemetics|mesh-ancestor
102519403|NCT01309451|Autonomic Agents|autonomic agents|mesh-ancestor
102519404|NCT01309451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102519405|NCT01309451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102519406|NCT01309451|Glucocorticoids|glucocorticoids|mesh-ancestor
102519407|NCT01309451|Hormones|hormones|mesh-ancestor
102519408|NCT01309451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102519409|NCT01309451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102519410|NCT00771056|Hydroxychloroquine|hydroxychloroquine|mesh-list
102519411|NCT00771056|Antimalarials|antimalarials|mesh-ancestor
102519412|NCT00771056|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102330916|NCT01874145|(T,G)-A-L|(t,g)-a-l|mesh-list
102519413|NCT00771056|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102519414|NCT00771056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102519415|NCT00771056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102519416|NCT00771056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519417|NCT00771056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102519418|NCT00795002|Cytarabine|cytarabine|mesh-list
102519419|NCT00795002|Mitoxantrone|mitoxantrone|mesh-list
102519420|NCT00795002|Alvocidib|alvocidib|mesh-list
102519421|NCT00795002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102519422|NCT00795002|Antimetabolites|antimetabolites|mesh-ancestor
102519423|NCT00795002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519424|NCT00795002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102519425|NCT00795002|Antiviral Agents|antiviral agents|mesh-ancestor
102519426|NCT00795002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102519427|NCT00795002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102519428|NCT00795002|Immunologic Factors|immunologic factors|mesh-ancestor
102519429|NCT00795002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519430|NCT00795002|Analgesics|analgesics|mesh-ancestor
102519431|NCT00795002|Sensory System Agents|sensory system agents|mesh-ancestor
102519432|NCT00795002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102519433|NCT00795002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102519434|NCT00795002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102519435|NCT00795002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102519436|NCT00795002|Growth Inhibitors|growth inhibitors|mesh-ancestor
102519437|NCT00795002|Growth Substances|growth substances|mesh-ancestor
102519438|NCT00795002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102519439|NCT05742698|Nabilone|nabilone|mesh-list
102519440|NCT05742698|Antiemetics|antiemetics|mesh-ancestor
102519441|NCT05742698|Autonomic Agents|autonomic agents|mesh-ancestor
102519442|NCT05742698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102519443|NCT05742698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519444|NCT05742698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102519445|NCT05742698|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102519446|NCT05742698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102519447|NCT05742698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102519448|NCT05742698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102519449|NCT03802838|Amisulpride|amisulpride|mesh-list
102519450|NCT03802838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102519451|NCT03802838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102519452|NCT03802838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102519453|NCT03802838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519454|NCT03802838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102519455|NCT03802838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102519456|NCT03802838|Dopamine Agents|dopamine agents|mesh-ancestor
102519457|NCT03802838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102519458|NCT03802838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519459|NCT03802838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102519460|NCT03802838|Antidepressive Agents|antidepressive agents|mesh-ancestor
102519461|NCT00772304|Azelastine|azelastine|mesh-list
102519462|NCT00772304|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
102519463|NCT00772304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102519464|NCT00772304|Autonomic Agents|autonomic agents|mesh-ancestor
102519465|NCT00772304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102519466|NCT00772304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519467|NCT00772304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102519468|NCT00772304|Respiratory System Agents|respiratory system agents|mesh-ancestor
102519469|NCT00772304|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
102519470|NCT00772304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102519471|NCT00772304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519472|NCT00772304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102519473|NCT00772304|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102519474|NCT00772304|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102519475|NCT00772304|Histamine Antagonists|histamine antagonists|mesh-ancestor
102519476|NCT00772304|Histamine Agents|histamine agents|mesh-ancestor
102519477|NCT00772304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102519478|NCT00772304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102519479|NCT00772304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102519480|NCT00772304|Analgesics|analgesics|mesh-ancestor
102519481|NCT00772304|Sensory System Agents|sensory system agents|mesh-ancestor
102519482|NCT00772304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102519483|NCT00772304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102519484|NCT01310231|Metformin|metformin|mesh-list
102519485|NCT01310231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102519486|NCT01310231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519487|NCT00789074|Varenicline|varenicline|mesh-list
102519488|NCT00789074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102519489|NCT00789074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102519490|NCT00789074|Cholinergic Agents|cholinergic agents|mesh-ancestor
102519491|NCT00789074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102519492|NCT00789074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519493|NCT00789074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519494|NCT01338857|Sorafenib|sorafenib|mesh-list
102519495|NCT01338857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102519496|NCT01338857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102519497|NCT01338857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102519498|NCT01338857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519499|NCT01339013|Anesthetics|anesthetics|mesh-list
102519500|NCT01339013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102519501|NCT01339013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519502|NCT01339091|Vancomycin|vancomycin|mesh-list
102519503|NCT01339091|Linezolid|linezolid|mesh-list
102519504|NCT01339091|Dalbavancin|dalbavancin|mesh-list
102519505|NCT01339091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102519506|NCT01339091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102519507|NCT01339091|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102519508|NCT01339091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102519509|NCT01339091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519510|NCT01339247|Halofantrine|halofantrine|mesh-list
102519511|NCT01339247|Paroxetine|paroxetine|mesh-list
102519512|NCT01339247|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102519513|NCT01339247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102519514|NCT01339247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102519515|NCT01339247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519516|NCT01339247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102519517|NCT01339247|Serotonin Agents|serotonin agents|mesh-ancestor
102519518|NCT01339247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519519|NCT01339247|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102519520|NCT01339247|Antidepressive Agents|antidepressive agents|mesh-ancestor
102519521|NCT01339247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102519522|NCT01339247|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102519523|NCT01339247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102519524|NCT01339247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102519525|NCT01339247|Antimalarials|antimalarials|mesh-ancestor
102519526|NCT01339247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102519527|NCT01339247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102519528|NCT01339247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102519529|NCT00772772|Vitamin D|vitamin d|mesh-list
102519530|NCT00772772|Ergocalciferols|ergocalciferols|mesh-list
102519531|NCT00772772|Cholecalciferol|cholecalciferol|mesh-list
102519532|NCT00772772|Vitamins|vitamins|mesh-list
102519533|NCT00772772|Micronutrients|micronutrients|mesh-ancestor
102519534|NCT00772772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519535|NCT00772772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102519536|NCT00772772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102519537|NCT00773474|Lonafarnib|lonafarnib|mesh-list
102519538|NCT00773474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102519539|NCT00773474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519540|NCT01310855|Gefitinib|gefitinib|mesh-list
102519541|NCT01310855|Cediranib|cediranib|mesh-list
102519542|NCT01310855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102519543|NCT01310855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519544|NCT01310855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102519545|NCT01310855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102519546|NCT00773786|Formoterol Fumarate|formoterol fumarate|mesh-list
102519547|NCT00773786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102519548|NCT00773786|Autonomic Agents|autonomic agents|mesh-ancestor
102519549|NCT00773786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102519550|NCT00773786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519551|NCT00773786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102519552|NCT00773786|Respiratory System Agents|respiratory system agents|mesh-ancestor
102519553|NCT00773786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102519554|NCT00773786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102519555|NCT00773786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102519556|NCT00773786|Adrenergic Agents|adrenergic agents|mesh-ancestor
102519557|NCT00773786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102519558|NCT00773786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519559|NCT01258049|Artemether|artemether|mesh-list
102519560|NCT01258049|Quinine|quinine|mesh-list
102519561|NCT01258049|Antimalarials|antimalarials|mesh-ancestor
102519562|NCT01258049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102519563|NCT01258049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102519564|NCT01258049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102519565|NCT01258049|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102519566|NCT01258049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519567|NCT01258049|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102519568|NCT01258049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102519569|NCT01258049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102519571|NCT01258049|Sensory System Agents|sensory system agents|mesh-ancestor
102519572|NCT03802214|Vedolizumab|vedolizumab|mesh-list
102519573|NCT03802214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102519574|NCT03801746|Cyclosporine|cyclosporine|mesh-list
102519575|NCT03801746|Rifampin|rifampin|mesh-list
102519576|NCT03801746|Probenecid|probenecid|mesh-list
102519577|NCT03801746|Cyclosporins|cyclosporins|mesh-list
102519578|NCT03801746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102519579|NCT03801746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519580|NCT03801746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102519581|NCT03801746|Immunologic Factors|immunologic factors|mesh-ancestor
102519582|NCT03801746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519583|NCT03801746|Antifungal Agents|antifungal agents|mesh-ancestor
102519584|NCT03801746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102519585|NCT03801746|Dermatologic Agents|dermatologic agents|mesh-ancestor
102519586|NCT03801746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102519587|NCT03801746|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102519588|NCT03801746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102519589|NCT03801746|Antitubercular Agents|antitubercular agents|mesh-ancestor
102519590|NCT03801746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102519591|NCT03801746|Leprostatic Agents|leprostatic agents|mesh-ancestor
102519592|NCT03801746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102519593|NCT03801746|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102519594|NCT03801746|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102519595|NCT03801746|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102519596|NCT03801746|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102519597|NCT03801746|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102519598|NCT03801746|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102519599|NCT03801746|Uricosuric Agents|uricosuric agents|mesh-ancestor
102519600|NCT03801746|Gout Suppressants|gout suppressants|mesh-ancestor
102519601|NCT03801668|Paclitaxel|paclitaxel|mesh-list
102519602|NCT03801668|Oxaliplatin|oxaliplatin|mesh-list
102519603|NCT03801668|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102519604|NCT03801668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102519605|NCT03801668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102519606|NCT03801668|Tubulin Modulators|tubulin modulators|mesh-ancestor
102519607|NCT03801668|Antimitotic Agents|antimitotic agents|mesh-ancestor
102519608|NCT03801668|Mitosis Modulators|mitosis modulators|mesh-ancestor
102519609|NCT03801668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519610|NCT05414006|Ketamine|ketamine|mesh-list
102519611|NCT05414006|Esketamine|esketamine|mesh-list
102519612|NCT05414006|Analgesics|analgesics|mesh-ancestor
102519613|NCT05414006|Sensory System Agents|sensory system agents|mesh-ancestor
102519614|NCT05414006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102519615|NCT05414006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519616|NCT05414006|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102519617|NCT05414006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102519618|NCT05414006|Anesthetics, General|anesthetics, general|mesh-ancestor
102519619|NCT05414006|Anesthetics|anesthetics|mesh-ancestor
102519620|NCT05414006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102519621|NCT05414006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102519622|NCT05414006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102519623|NCT05414006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102519624|NCT05414006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519625|NCT05414006|Antidepressive Agents|antidepressive agents|mesh-ancestor
102519626|NCT05414006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102519627|NCT02199041|Mycophenolic Acid|mycophenolic acid|mesh-list
102519628|NCT02199041|Methylprednisolone|methylprednisolone|mesh-list
102519629|NCT02199041|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102519630|NCT02199041|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102519631|NCT02199041|Prednisolone|prednisolone|mesh-list
102519632|NCT02199041|Prednisolone acetate|prednisolone acetate|mesh-list
102519633|NCT02199041|Cyclophosphamide|cyclophosphamide|mesh-list
102519634|NCT02199041|Melphalan|melphalan|mesh-list
102519635|NCT02199041|Mechlorethamine|mechlorethamine|mesh-list
102519636|NCT02199041|Thiotepa|thiotepa|mesh-list
102519637|NCT02199041|Fludarabine|fludarabine|mesh-list
102331140|NCT01704651|Alvimopan|alvimopan|mesh-list
102519638|NCT02199041|Tacrolimus|tacrolimus|mesh-list
102519639|NCT02199041|Lenograstim|lenograstim|mesh-list
102519640|NCT02199041|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102519641|NCT02199041|Prednisolone phosphate|prednisolone phosphate|mesh-list
102519642|NCT02199041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102519643|NCT02199041|Immunologic Factors|immunologic factors|mesh-ancestor
102519644|NCT02199041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519645|NCT02199041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102519646|NCT02199041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102519647|NCT02199041|Alkylating Agents|alkylating agents|mesh-ancestor
102519648|NCT02199041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519649|NCT02199041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102519650|NCT02199041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102519651|NCT02199041|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102519652|NCT02199041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102519653|NCT02199041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102519654|NCT02199041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102519655|NCT02199041|Antitubercular Agents|antitubercular agents|mesh-ancestor
102519656|NCT02199041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102519657|NCT02199041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102519658|NCT02199041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102519659|NCT02199041|Antiemetics|antiemetics|mesh-ancestor
102519660|NCT02199041|Autonomic Agents|autonomic agents|mesh-ancestor
102519661|NCT02199041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102519662|NCT02199041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102519663|NCT02199041|Glucocorticoids|glucocorticoids|mesh-ancestor
102519664|NCT02199041|Hormones|hormones|mesh-ancestor
102519665|NCT02199041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102519666|NCT02199041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102519667|NCT02199041|Protective Agents|protective agents|mesh-ancestor
102519668|NCT02199041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102519669|NCT02199041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102519670|NCT00789776|Mycophenolic Acid|mycophenolic acid|mesh-list
102519671|NCT00789776|Cyclophosphamide|cyclophosphamide|mesh-list
102519672|NCT00789776|Fludarabine|fludarabine|mesh-list
102519673|NCT00789776|Fludarabine phosphate|fludarabine phosphate|mesh-list
102519674|NCT00789776|Tacrolimus|tacrolimus|mesh-list
102519675|NCT00789776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102519676|NCT00789776|Immunologic Factors|immunologic factors|mesh-ancestor
102519677|NCT00789776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519678|NCT00789776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102519679|NCT00789776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102519680|NCT00789776|Alkylating Agents|alkylating agents|mesh-ancestor
102519681|NCT00789776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519682|NCT00789776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102519683|NCT00789776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102519684|NCT00789776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102519685|NCT00789776|Antimetabolites|antimetabolites|mesh-ancestor
102519686|NCT00789776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102519687|NCT00789776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102519688|NCT00789776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102519689|NCT00789776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102519690|NCT00789776|Antitubercular Agents|antitubercular agents|mesh-ancestor
102519691|NCT00789776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102519692|NCT00789776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102519693|NCT03801590|Riboflavin|riboflavin|mesh-list
102519694|NCT03801590|Vitamin B Complex|vitamin b complex|mesh-ancestor
102519695|NCT03801590|Vitamins|vitamins|mesh-ancestor
102519696|NCT03801590|Micronutrients|micronutrients|mesh-ancestor
102519697|NCT03801590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519698|NCT03801590|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102519699|NCT03801590|Dermatologic Agents|dermatologic agents|mesh-ancestor
102519700|NCT00775658|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
102519701|NCT00775658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102519702|NCT00775658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102519703|NCT00775658|Analgesics|analgesics|mesh-ancestor
102519704|NCT00775658|Sensory System Agents|sensory system agents|mesh-ancestor
102519705|NCT00775658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102519706|NCT00775658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519707|NCT00775658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102519708|NCT00775658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102519709|NCT00775658|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102519710|NCT00775658|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102519711|NCT00775658|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102519712|NCT00775658|Histamine Antagonists|histamine antagonists|mesh-ancestor
102519713|NCT00775658|Histamine Agents|histamine agents|mesh-ancestor
102519714|NCT00775658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102519715|NCT00775658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519716|NCT02199197|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
102519717|NCT02199197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102519718|NCT00799604|Clevidipine|clevidipine|mesh-list
102519719|NCT00799604|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102519720|NCT00799604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102519721|NCT00799604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519722|NCT00799604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102519723|NCT00799604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519724|NCT01259063|Gemcitabine|gemcitabine|mesh-list
102519725|NCT01259063|Everolimus|everolimus|mesh-list
102519726|NCT01259063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102519727|NCT01259063|Antimetabolites|antimetabolites|mesh-ancestor
102519728|NCT01259063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519729|NCT01259063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102519730|NCT01259063|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102519731|NCT01259063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102519732|NCT01259063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102519733|NCT01259063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102519734|NCT01259063|Immunologic Factors|immunologic factors|mesh-ancestor
102519735|NCT01259063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519736|NCT04383548|Immunoglobulins|immunoglobulins|mesh-list
102519737|NCT04383548|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102519738|NCT04383548|Antibodies|antibodies|mesh-list
102519739|NCT04383548|Immunologic Factors|immunologic factors|mesh-ancestor
102519740|NCT04383548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519741|NCT01313897|Bortezomib|bortezomib|mesh-list
102519742|NCT01313897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102519743|NCT01341977|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102519744|NCT04351763|Amiodarone|amiodarone|mesh-list
102519745|NCT04351763|Verapamil|verapamil|mesh-list
102519746|NCT04351763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102519747|NCT04351763|Vasodilator Agents|vasodilator agents|mesh-ancestor
102519748|NCT04351763|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102519749|NCT04351763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102519750|NCT04351763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519751|NCT04351763|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102519752|NCT04351763|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102519753|NCT04351763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102519754|NCT04351763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102519755|NCT04351763|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102519756|NCT04351763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102519757|NCT04351763|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102519758|NCT04351763|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102519759|NCT04351763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102519760|NCT04351763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519761|NCT00801398|Oxymorphone|oxymorphone|mesh-list
102519762|NCT00801398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102519763|NCT00801398|Narcotics|narcotics|mesh-ancestor
102519764|NCT00801398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102519765|NCT00801398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519766|NCT00801398|Analgesics|analgesics|mesh-ancestor
102519767|NCT00801398|Sensory System Agents|sensory system agents|mesh-ancestor
102519768|NCT00801398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102519769|NCT00801398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102519770|NCT01342523|Nicotine|nicotine|mesh-list
102519771|NCT01342523|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102519772|NCT01342523|Autonomic Agents|autonomic agents|mesh-ancestor
102519773|NCT01342523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102519774|NCT01342523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519775|NCT01342523|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102519776|NCT01342523|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102519777|NCT01342523|Cholinergic Agents|cholinergic agents|mesh-ancestor
102519778|NCT01342523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102519779|NCT01342523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519780|NCT01342757|Temozolomide|temozolomide|mesh-list
102519781|NCT01342757|Vorinostat|vorinostat|mesh-list
102519782|NCT01342757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102519783|NCT01342757|Alkylating Agents|alkylating agents|mesh-ancestor
102519784|NCT01342757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519785|NCT01342757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102519786|NCT01342757|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102519787|NCT01342757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102519788|NCT02199743|Haloperidol|haloperidol|mesh-list
102519789|NCT02199743|Haloperidol decanoate|haloperidol decanoate|mesh-list
102519790|NCT02199743|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102519791|NCT02199743|Perphenazine|perphenazine|mesh-list
102519792|NCT02199743|Antiemetics|antiemetics|mesh-ancestor
102519793|NCT02199743|Autonomic Agents|autonomic agents|mesh-ancestor
102519794|NCT02199743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102519795|NCT02199743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519796|NCT02199743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102519797|NCT02199743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102519798|NCT02199743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102519799|NCT02199743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102519800|NCT02199743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102519801|NCT02199743|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102519802|NCT02199743|Dopamine Agents|dopamine agents|mesh-ancestor
102519803|NCT02199743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102519804|NCT02199743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519805|NCT02199743|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102519806|NCT02199743|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102519807|NCT02199743|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102519808|NCT02199743|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102519809|NCT02199743|Adrenergic Agents|adrenergic agents|mesh-ancestor
102519810|NCT02199743|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102519811|NCT02199743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102519812|NCT02199743|Serotonin Agents|serotonin agents|mesh-ancestor
101996080|NCT03311841|Rifampin|rifampin|mesh-list
102519813|NCT02199743|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102519814|NCT00776594|Bevacizumab|bevacizumab|mesh-list
102519815|NCT00776594|Bicalutamide|bicalutamide|mesh-list
102519816|NCT00776594|Androgens|androgens|mesh-list
102519817|NCT00776594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102519818|NCT00776594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102519819|NCT00776594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102519820|NCT00776594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102519821|NCT00776594|Growth Substances|growth substances|mesh-ancestor
102519822|NCT00776594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519823|NCT00776594|Growth Inhibitors|growth inhibitors|mesh-ancestor
102519824|NCT00776594|Hormones|hormones|mesh-ancestor
102519825|NCT00776594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102519826|NCT00776594|Androgen Antagonists|androgen antagonists|mesh-ancestor
102519827|NCT00776594|Hormone Antagonists|hormone antagonists|mesh-ancestor
102519828|NCT00777062|Naltrexone|naltrexone|mesh-list
102519829|NCT00777062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102519830|NCT00777062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102519831|NCT00777062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519832|NCT00777062|Sensory System Agents|sensory system agents|mesh-ancestor
102519833|NCT00777062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102519834|NCT02193347|Temozolomide|temozolomide|mesh-list
102519835|NCT02193347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102519836|NCT02193347|Alkylating Agents|alkylating agents|mesh-ancestor
102519837|NCT02193347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519838|NCT02193347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102519839|NCT01318577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102519840|NCT01318967|Furosemide|furosemide|mesh-list
102519841|NCT01318967|Diuretics|diuretics|mesh-ancestor
102519842|NCT01318967|Natriuretic Agents|natriuretic agents|mesh-ancestor
102519843|NCT01318967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519844|NCT01318967|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102519845|NCT01318967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102519846|NCT01318967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519847|NCT01319045|Iloprost|iloprost|mesh-list
102519848|NCT01319045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102519849|NCT01319045|Vasodilator Agents|vasodilator agents|mesh-ancestor
102519850|NCT01348607|Methylphenidate|methylphenidate|mesh-list
102519851|NCT01348607|Modafinil|modafinil|mesh-list
102519852|NCT01348607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102519853|NCT01348607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519854|NCT01348607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102519855|NCT01348607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102519856|NCT01348607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102519857|NCT01348607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519858|NCT01348607|Dopamine Agents|dopamine agents|mesh-ancestor
102519859|NCT01348607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102519860|NCT01348607|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102519861|NCT01348607|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102519862|NCT01348607|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102519863|NCT01268111|Ergocalciferols|ergocalciferols|mesh-list
102519864|NCT01268111|Vitamin D|vitamin d|mesh-list
102519865|NCT01268111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102519866|NCT01268111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519867|NCT01268111|Vitamins|vitamins|mesh-ancestor
102519868|NCT01268111|Micronutrients|micronutrients|mesh-ancestor
102519869|NCT01268111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102519870|NCT01349231|Ketamine|ketamine|mesh-list
102519871|NCT01349231|Analgesics|analgesics|mesh-ancestor
102519872|NCT01349231|Sensory System Agents|sensory system agents|mesh-ancestor
102519873|NCT01349231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102519874|NCT01349231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519875|NCT01349231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102519876|NCT01349231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102519877|NCT01349231|Anesthetics, General|anesthetics, general|mesh-ancestor
102519878|NCT01349231|Anesthetics|anesthetics|mesh-ancestor
102519879|NCT01349231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102519880|NCT01349231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102519881|NCT01349231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102519882|NCT01349231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102519883|NCT01349231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519884|NCT01350245|Mycophenolic Acid|mycophenolic acid|mesh-list
102519885|NCT01350245|Cyclophosphamide|cyclophosphamide|mesh-list
102519886|NCT01350245|Tacrolimus|tacrolimus|mesh-list
102519887|NCT01350245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102519888|NCT01350245|Immunologic Factors|immunologic factors|mesh-ancestor
102519889|NCT01350245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519890|NCT01350245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102519891|NCT01350245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102519892|NCT01350245|Alkylating Agents|alkylating agents|mesh-ancestor
102519893|NCT01350245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519894|NCT01350245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102519895|NCT01350245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102519896|NCT01350245|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102519897|NCT01350245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102519898|NCT01350245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102519899|NCT01350245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102519900|NCT01350245|Antitubercular Agents|antitubercular agents|mesh-ancestor
102519901|NCT01350245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102519902|NCT01350245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102519903|NCT01321151|Resveratrol|resveratrol|mesh-list
102519904|NCT01321151|Antioxidants|antioxidants|mesh-ancestor
102519905|NCT01321151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519906|NCT01321151|Protective Agents|protective agents|mesh-ancestor
102519907|NCT01321151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519908|NCT01321151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102519909|NCT01321151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102519910|NCT01350947|Azacitidine|azacitidine|mesh-list
102519911|NCT01350947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102519912|NCT01350947|Antimetabolites|antimetabolites|mesh-ancestor
102519913|NCT01350947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519914|NCT01350947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102519915|NCT01350947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102519916|NCT01269047|Exenatide|exenatide|mesh-list
102519917|NCT01269047|Pramlintide|pramlintide|mesh-list
102519918|NCT01269047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102519919|NCT01269047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519920|NCT01269047|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102519921|NCT01269047|Incretins|incretins|mesh-ancestor
102519922|NCT01269047|Hormones|hormones|mesh-ancestor
102519923|NCT01269047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102519924|NCT03800264|Hydrocortisone|hydrocortisone|mesh-list
102519925|NCT03800264|Bisoprolol|bisoprolol|mesh-list
102519926|NCT03800264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102519927|NCT03800264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102519928|NCT03800264|Sympatholytics|sympatholytics|mesh-ancestor
102519929|NCT03800264|Autonomic Agents|autonomic agents|mesh-ancestor
102519930|NCT03800264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102519931|NCT03800264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519932|NCT03800264|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102519933|NCT03800264|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102519934|NCT03800264|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102519935|NCT03800264|Adrenergic Agents|adrenergic agents|mesh-ancestor
102331436|NCT03976258|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102519936|NCT03800264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102519937|NCT03800264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519938|NCT05287724|Acetylcysteine|acetylcysteine|mesh-list
102519939|NCT05287724|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102519940|NCT05287724|Antiviral Agents|antiviral agents|mesh-ancestor
102519941|NCT05287724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102519942|NCT05287724|Expectorants|expectorants|mesh-ancestor
102519943|NCT05287724|Respiratory System Agents|respiratory system agents|mesh-ancestor
102519944|NCT05287724|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102519945|NCT05287724|Antioxidants|antioxidants|mesh-ancestor
102519946|NCT05287724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519947|NCT05287724|Protective Agents|protective agents|mesh-ancestor
102519948|NCT05287724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519949|NCT05287724|Antidotes|antidotes|mesh-ancestor
102519950|NCT01321541|Rituximab|rituximab|mesh-list
102519951|NCT01321541|Gemcitabine|gemcitabine|mesh-list
102519952|NCT01321541|Pixantrone|pixantrone|mesh-list
102519953|NCT01321541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102519954|NCT01321541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102519955|NCT01321541|Immunologic Factors|immunologic factors|mesh-ancestor
102519956|NCT01321541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519957|NCT01321541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102519958|NCT01321541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102519959|NCT01321541|Antimetabolites|antimetabolites|mesh-ancestor
102519960|NCT01321541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519961|NCT01321541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102519962|NCT01321541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102519963|NCT01321541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102519964|NCT03801434|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
102519965|NCT03801434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102519966|NCT03801434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102519967|NCT03801434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519968|NCT05201612|Pembrolizumab|pembrolizumab|mesh-list
102519969|NCT05201612|Olaparib|olaparib|mesh-list
102519970|NCT05201612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102519971|NCT05201612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102519972|NCT05201612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102519973|NCT05201612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519974|NCT05201612|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102519975|NCT05201612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102519976|NCT01271855|Glycerol|glycerol|mesh-list
102519977|NCT01271855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519978|NCT01271855|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102519979|NCT01271855|Protective Agents|protective agents|mesh-ancestor
102519980|NCT04865978|Warfarin|warfarin|mesh-list
102519981|NCT04865978|Apixaban|apixaban|mesh-list
102519982|NCT04865978|Anticoagulants|anticoagulants|mesh-ancestor
102519983|NCT04865978|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102519984|NCT04865978|Antithrombins|antithrombins|mesh-ancestor
102519985|NCT04865978|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102519986|NCT04865978|Protease Inhibitors|protease inhibitors|mesh-ancestor
102519987|NCT04865978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102519988|NCT04865978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102519989|NCT01354145|Celecoxib|celecoxib|mesh-list
102519990|NCT01354145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102519991|NCT01354145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102519992|NCT01354145|Analgesics|analgesics|mesh-ancestor
102519993|NCT01354145|Sensory System Agents|sensory system agents|mesh-ancestor
102519994|NCT01354145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102519995|NCT01354145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102519996|NCT01354145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102519997|NCT01354145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102519998|NCT01354145|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102519999|NCT01354145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102520000|NCT01354145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102520001|NCT01354145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520002|NCT05168462|Norepinephrine|norepinephrine|mesh-list
102520003|NCT05168462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102520004|NCT05168462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102520005|NCT05168462|Adrenergic Agents|adrenergic agents|mesh-ancestor
102520006|NCT05168462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102520007|NCT05168462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520008|NCT05168462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331513|NCT00215644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102520009|NCT05168462|Sympathomimetics|sympathomimetics|mesh-ancestor
102520010|NCT05168462|Autonomic Agents|autonomic agents|mesh-ancestor
102520011|NCT05168462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102520012|NCT05168462|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102520013|NCT02196857|Azacitidine|azacitidine|mesh-list
102520014|NCT02196857|Sorafenib|sorafenib|mesh-list
102520015|NCT02196857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102520016|NCT02196857|Antimetabolites|antimetabolites|mesh-ancestor
102520017|NCT02196857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520018|NCT02196857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102520019|NCT02196857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102520020|NCT02196857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102520021|NCT01272245|Cytarabine|cytarabine|mesh-list
102520022|NCT01272245|Homoharringtonine|homoharringtonine|mesh-list
102520023|NCT01272245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102520024|NCT01272245|Antimetabolites|antimetabolites|mesh-ancestor
102520025|NCT01272245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520026|NCT01272245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102520027|NCT01272245|Antiviral Agents|antiviral agents|mesh-ancestor
102520028|NCT01272245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102520029|NCT01272245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102520030|NCT01272245|Immunologic Factors|immunologic factors|mesh-ancestor
102520031|NCT01272245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520032|NCT01272245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102520033|NCT01272245|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102520034|NCT01272245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102520035|NCT00802100|Metformin|metformin|mesh-list
102520036|NCT00802100|Benztropine|benztropine|mesh-list
102520037|NCT00802100|Olanzapine|olanzapine|mesh-list
102520038|NCT00802100|Aripiprazole|aripiprazole|mesh-list
102520039|NCT00802100|Perphenazine|perphenazine|mesh-list
102520040|NCT00802100|Simvastatin|simvastatin|mesh-list
102520041|NCT00802100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102520042|NCT00802100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520043|NCT00802100|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102520044|NCT00802100|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102520045|NCT00802100|Antimetabolites|antimetabolites|mesh-ancestor
102520046|NCT00802100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520047|NCT00802100|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102520048|NCT00802100|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102520049|NCT00802100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102520050|NCT00802100|Antiemetics|antiemetics|mesh-ancestor
102520051|NCT00802100|Autonomic Agents|autonomic agents|mesh-ancestor
102520052|NCT00802100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102520053|NCT00802100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102520054|NCT00802100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102520055|NCT00802100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102520056|NCT00802100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102520057|NCT00802100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102520058|NCT00802100|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102520059|NCT00802100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102520060|NCT00802100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102520061|NCT00802100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102520062|NCT00802100|Serotonin Agents|serotonin agents|mesh-ancestor
102520063|NCT00802100|Antidepressive Agents|antidepressive agents|mesh-ancestor
102520064|NCT00802100|Dopamine Agonists|dopamine agonists|mesh-ancestor
102520065|NCT00802100|Dopamine Agents|dopamine agents|mesh-ancestor
102520066|NCT00802100|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102520067|NCT00802100|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102520068|NCT00802100|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102520069|NCT00802100|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102520070|NCT00802100|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102520071|NCT00802100|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102520072|NCT00802100|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102520073|NCT00802100|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102520074|NCT00802100|Parasympatholytics|parasympatholytics|mesh-ancestor
102520075|NCT00802100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102520076|NCT00802100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102520077|NCT00802100|Cholinergic Agents|cholinergic agents|mesh-ancestor
102520078|NCT00802100|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102520079|NCT00809276|Cyclophosphamide|cyclophosphamide|mesh-list
102520080|NCT00809276|Busulfan|busulfan|mesh-list
102520081|NCT00809276|Fludarabine|fludarabine|mesh-list
102520082|NCT00809276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102520083|NCT00809276|Immunologic Factors|immunologic factors|mesh-ancestor
102520084|NCT00809276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520085|NCT00809276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102520086|NCT00809276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102520087|NCT00809276|Alkylating Agents|alkylating agents|mesh-ancestor
102520088|NCT00809276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520089|NCT00809276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102520090|NCT00809276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102520091|NCT00802412|Topiramate|topiramate|mesh-list
102520092|NCT00802412|Anticonvulsants|anticonvulsants|mesh-ancestor
102520093|NCT00802412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102520094|NCT00802412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520095|NCT01355705|Aspirin|aspirin|mesh-list
102520096|NCT01355705|Dexamethasone|dexamethasone|mesh-list
102520097|NCT01355705|Dexamethasone acetate|dexamethasone acetate|mesh-list
102520098|NCT01355705|Lenalidomide|lenalidomide|mesh-list
102520099|NCT01355705|Amrubicin|amrubicin|mesh-list
102520100|NCT01355705|BB 1101|bb 1101|mesh-list
102520101|NCT01355705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102520102|NCT01355705|Antiemetics|antiemetics|mesh-ancestor
102520103|NCT01355705|Autonomic Agents|autonomic agents|mesh-ancestor
102520104|NCT01355705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102520105|NCT01355705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520106|NCT01355705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102520107|NCT01355705|Glucocorticoids|glucocorticoids|mesh-ancestor
102520108|NCT01355705|Hormones|hormones|mesh-ancestor
102520109|NCT01355705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102520110|NCT01355705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102520111|NCT01355705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102520112|NCT01355705|Protease Inhibitors|protease inhibitors|mesh-ancestor
102520113|NCT01355705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102520114|NCT01355705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520115|NCT01355705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102520116|NCT01355705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102520117|NCT01355705|Analgesics|analgesics|mesh-ancestor
102520118|NCT01355705|Sensory System Agents|sensory system agents|mesh-ancestor
102520119|NCT01355705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102520120|NCT01355705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102520121|NCT01355705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102520122|NCT01355705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102520123|NCT01355705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102520124|NCT01355705|Antipyretics|antipyretics|mesh-ancestor
102520125|NCT01355705|Immunologic Factors|immunologic factors|mesh-ancestor
102520126|NCT01355705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102520127|NCT01355705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102520128|NCT01355705|Growth Substances|growth substances|mesh-ancestor
102520129|NCT01355705|Growth Inhibitors|growth inhibitors|mesh-ancestor
102520130|NCT01327157|Salicylic Acid|salicylic acid|mesh-list
102520131|NCT01327157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102520132|NCT01327157|Antifungal Agents|antifungal agents|mesh-ancestor
102520133|NCT01327157|Keratolytic Agents|keratolytic agents|mesh-ancestor
102520134|NCT01327157|Dermatologic Agents|dermatologic agents|mesh-ancestor
102520135|NCT00802880|Dacarbazine|dacarbazine|mesh-list
102520136|NCT00802880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102520137|NCT00802880|Alkylating Agents|alkylating agents|mesh-ancestor
102520138|NCT00802880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520139|NCT00802880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102520140|NCT05118854|Cisplatin|cisplatin|mesh-list
102520141|NCT05118854|Carboplatin|carboplatin|mesh-list
102520142|NCT05118854|Pemetrexed|pemetrexed|mesh-list
102520143|NCT05118854|Sotorasib|sotorasib|mesh-list
102520144|NCT05118854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102520145|NCT05118854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102520146|NCT05118854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520147|NCT05118854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102520148|NCT05118854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102520149|NCT05118854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102520150|NCT05118854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102520151|NCT03839888|Atropine|atropine|mesh-list
102520152|NCT03839888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102520153|NCT03839888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102520154|NCT03839888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102520155|NCT03839888|Autonomic Agents|autonomic agents|mesh-ancestor
102520156|NCT03839888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102520157|NCT03839888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520158|NCT03839888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102520159|NCT03839888|Respiratory System Agents|respiratory system agents|mesh-ancestor
102520160|NCT03839888|Mydriatics|mydriatics|mesh-ancestor
102520161|NCT03839888|Parasympatholytics|parasympatholytics|mesh-ancestor
102520162|NCT03839888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102520163|NCT03839888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102520165|NCT03839888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102520166|NCT03839888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520167|NCT05089526|Lidocaine|lidocaine|mesh-list
102520168|NCT05089526|Fentanyl|fentanyl|mesh-list
102520169|NCT05089526|Dexmedetomidine|dexmedetomidine|mesh-list
102520170|NCT05089526|Ketamine|ketamine|mesh-list
102520171|NCT05089526|Anesthetics, Local|anesthetics, local|mesh-ancestor
102520172|NCT05089526|Anesthetics|anesthetics|mesh-ancestor
102520173|NCT05089526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102520174|NCT05089526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520175|NCT05089526|Sensory System Agents|sensory system agents|mesh-ancestor
102520176|NCT05089526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102520177|NCT05089526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102520178|NCT05089526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102520179|NCT05089526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102520180|NCT05089526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102520181|NCT05089526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520182|NCT05089526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102520183|NCT05089526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102520184|NCT05089526|Analgesics|analgesics|mesh-ancestor
102520185|NCT05089526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102520186|NCT05089526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102520187|NCT05089526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102520188|NCT05089526|Adrenergic Agents|adrenergic agents|mesh-ancestor
102520189|NCT05089526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102520190|NCT05089526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102520191|NCT05089526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102520192|NCT05089526|Anesthetics, General|anesthetics, general|mesh-ancestor
102520193|NCT05089526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102520194|NCT05089526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102520195|NCT05089526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102520196|NCT05089526|Narcotics|narcotics|mesh-ancestor
102520197|NCT05089526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102520198|NCT04382846|Nitazoxanide|nitazoxanide|mesh-list
102520199|NCT04382846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102520200|NCT04382846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102520201|NCT01274897|Lactitol|lactitol|mesh-list
102520202|NCT01274897|Cathartics|cathartics|mesh-ancestor
102520203|NCT01274897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102520204|NCT02323217|Isocarboxazid|isocarboxazid|mesh-list
102520205|NCT02323217|Idazoxan|idazoxan|mesh-list
102520206|NCT02323217|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102520207|NCT02323217|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102520208|NCT02323217|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102520209|NCT02323217|Adrenergic Agents|adrenergic agents|mesh-ancestor
102520210|NCT02323217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102520211|NCT02323217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520212|NCT02323217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520213|NCT02323217|Antidepressive Agents|antidepressive agents|mesh-ancestor
102520214|NCT02323217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102520215|NCT02323217|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102520216|NCT02323217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102520217|NCT04382768|Ibuprofen|ibuprofen|mesh-list
102520218|NCT04382768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102520219|NCT04382768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102520220|NCT04382768|Analgesics|analgesics|mesh-ancestor
102520221|NCT04382768|Sensory System Agents|sensory system agents|mesh-ancestor
102520222|NCT04382768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102520223|NCT04382768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520224|NCT04382768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102520225|NCT04382768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102520226|NCT04382768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102520227|NCT04382768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102520228|NCT04382768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520229|NCT03932162|Insulin|insulin|mesh-list
102520230|NCT03932162|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102520231|NCT03932162|Mitogens|mitogens|mesh-list
102520232|NCT03932162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102520233|NCT03932162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520234|NCT03932162|Mitosis Modulators|mitosis modulators|mesh-ancestor
102520235|NCT03932162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520236|NCT04155164|Metformin|metformin|mesh-list
102520237|NCT04155164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102520238|NCT04155164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520239|NCT00806078|Quinine|quinine|mesh-list
102520240|NCT00806078|Antimalarials|antimalarials|mesh-ancestor
102520241|NCT00806078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102520242|NCT00806078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102520243|NCT00806078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102520244|NCT00806078|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102520245|NCT00806078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520246|NCT00806078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102520247|NCT00806078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102520248|NCT00806078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102520249|NCT00806078|Analgesics|analgesics|mesh-ancestor
102520250|NCT00806078|Sensory System Agents|sensory system agents|mesh-ancestor
102520251|NCT00806234|Metformin|metformin|mesh-list
102520252|NCT00806234|Olanzapine|olanzapine|mesh-list
102520253|NCT00806234|Risperidone|risperidone|mesh-list
102520254|NCT00806234|Aripiprazole|aripiprazole|mesh-list
102520255|NCT00806234|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102520256|NCT00806234|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102520257|NCT00806234|Ziprasidone|ziprasidone|mesh-list
102520258|NCT00806234|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102520259|NCT00806234|Asenapine|asenapine|mesh-list
102520260|NCT00806234|Iloperidone|iloperidone|mesh-list
102520261|NCT00806234|Perphenazine|perphenazine|mesh-list
102520262|NCT00806234|Fluoxetine|fluoxetine|mesh-list
102520263|NCT00806234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102520264|NCT00806234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520265|NCT00806234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102520266|NCT00806234|Serotonin Agents|serotonin agents|mesh-ancestor
102520267|NCT00806234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102520268|NCT00806234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520269|NCT00806234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102520270|NCT00806234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102520271|NCT00806234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102520272|NCT00806234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102520273|NCT00806234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102520274|NCT00806234|Dopamine Agents|dopamine agents|mesh-ancestor
102520275|NCT00806234|Antiemetics|antiemetics|mesh-ancestor
102520276|NCT00806234|Autonomic Agents|autonomic agents|mesh-ancestor
102520277|NCT00806234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102520278|NCT00806234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102520279|NCT00806234|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102520280|NCT00806234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102520281|NCT00806234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102520282|NCT00806234|Antidepressive Agents|antidepressive agents|mesh-ancestor
102520283|NCT00806234|Dopamine Agonists|dopamine agonists|mesh-ancestor
102520284|NCT00806234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102520285|NCT00806234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102520286|NCT00806234|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102520287|NCT00806234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102520288|NCT00806234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102520289|NCT00806234|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102520290|NCT00806234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102520291|NCT00806234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102520292|NCT00806234|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102520293|NCT00806234|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102520294|NCT00806234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102520295|NCT00806234|Adrenergic Agents|adrenergic agents|mesh-ancestor
102520296|NCT01275365|Methyltestosterone|methyltestosterone|mesh-list
102520297|NCT01275365|Testosterone|testosterone|mesh-list
102520298|NCT01275365|Testosterone undecanoate|testosterone undecanoate|mesh-list
102520299|NCT01275365|Testosterone enanthate|testosterone enanthate|mesh-list
102520300|NCT01275365|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102520301|NCT01275365|Androgens|androgens|mesh-ancestor
102520302|NCT01275365|Hormones|hormones|mesh-ancestor
102520303|NCT01275365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102520304|NCT01275365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520305|NCT01275365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102520306|NCT01275365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102520307|NCT01275365|Anabolic Agents|anabolic agents|mesh-ancestor
102520308|NCT00811850|Timolol|timolol|mesh-list
102520309|NCT00811850|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102520310|NCT00811850|Dorzolamide|dorzolamide|mesh-list
102520311|NCT00811850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102520312|NCT00811850|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102520313|NCT00811850|Maleic acid|maleic acid|mesh-list
102520314|NCT00811850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102520315|NCT00811850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520316|NCT00811850|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102520317|NCT00811850|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102520318|NCT00811850|Adrenergic Agents|adrenergic agents|mesh-ancestor
102520319|NCT00811850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102520320|NCT00811850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520321|NCT00811850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102520322|NCT00811850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102520323|NCT00811850|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102520324|NCT00811850|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102520325|NCT00811850|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102520326|NCT00811850|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102520327|NCT03678506|Apixaban|apixaban|mesh-list
102520328|NCT03678506|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102520329|NCT03678506|Antithrombins|antithrombins|mesh-ancestor
102520330|NCT03678506|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102520331|NCT03678506|Protease Inhibitors|protease inhibitors|mesh-ancestor
102520332|NCT03678506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102520333|NCT03678506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520334|NCT03678506|Anticoagulants|anticoagulants|mesh-ancestor
102520335|NCT00844298|Cytarabine|cytarabine|mesh-list
102520336|NCT00844298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102520337|NCT00844298|Antimetabolites|antimetabolites|mesh-ancestor
101996602|NCT03410836|Sensory System Agents|sensory system agents|mesh-ancestor
102520338|NCT00844298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520339|NCT00844298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102520340|NCT00844298|Antiviral Agents|antiviral agents|mesh-ancestor
102520341|NCT00844298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102520342|NCT00844298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102520343|NCT00844298|Immunologic Factors|immunologic factors|mesh-ancestor
102520344|NCT00844298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520345|NCT01329185|Valganciclovir|valganciclovir|mesh-list
102520346|NCT01329185|Antiviral Agents|antiviral agents|mesh-ancestor
102520347|NCT01329185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102520348|NCT01276301|Empagliflozin|empagliflozin|mesh-list
102520349|NCT01276301|Verapamil|verapamil|mesh-list
102520350|NCT01276301|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102520351|NCT01276301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520352|NCT01276301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102520353|NCT01276301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520354|NCT01276301|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102520355|NCT01276301|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102520356|NCT01276301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102520357|NCT01276301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102520358|NCT01276301|Vasodilator Agents|vasodilator agents|mesh-ancestor
102520359|NCT00845000|Levodopa|levodopa|mesh-list
102520360|NCT00845000|Carbidopa|carbidopa|mesh-list
102520361|NCT00845000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102520362|NCT00845000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102520363|NCT00845000|Dopamine Agents|dopamine agents|mesh-ancestor
102520364|NCT00845000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102520365|NCT00845000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520366|NCT00845000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520367|NCT00845000|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102520368|NCT00845000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102520369|NCT01330043|Bupropion|bupropion|mesh-list
102520370|NCT01330043|Nicotine|nicotine|mesh-list
102520371|NCT01330043|Varenicline|varenicline|mesh-list
102520372|NCT01330043|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102520373|NCT01330043|Autonomic Agents|autonomic agents|mesh-ancestor
102520374|NCT01330043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102520375|NCT01330043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520376|NCT01330043|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102520377|NCT01330043|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102520378|NCT01330043|Cholinergic Agents|cholinergic agents|mesh-ancestor
102520379|NCT01330043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102520380|NCT01330043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520381|NCT01330043|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102520382|NCT01330043|Antidepressive Agents|antidepressive agents|mesh-ancestor
102520383|NCT01330043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102520384|NCT01330043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102520385|NCT01330043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102520386|NCT01330043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102520387|NCT01330043|Dopamine Agents|dopamine agents|mesh-ancestor
102520388|NCT01330043|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102520389|NCT01330043|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102520390|NCT01330043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102520391|NCT01330355|Gatifloxacin|gatifloxacin|mesh-list
102520392|NCT01330355|Besifloxacin|besifloxacin|mesh-list
102520393|NCT01330355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102520394|NCT01330355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102520395|NCT01330355|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102520396|NCT01330355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102520397|NCT01330355|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102520398|NCT01330355|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102520399|NCT01330355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102520400|NCT01330355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520401|NCT01330355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102520402|NCT02193815|Calcitriol|calcitriol|mesh-list
102520403|NCT02193815|Calcipotriene|calcipotriene|mesh-list
102520404|NCT02193815|Tofacitinib|tofacitinib|mesh-list
102520405|NCT02193815|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102520406|NCT02193815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102520407|NCT02193815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102520408|NCT02193815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520409|NCT02193815|Dermatologic Agents|dermatologic agents|mesh-ancestor
102520410|NCT02193815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102520411|NCT02193815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520412|NCT02193815|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102520413|NCT02193815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102520414|NCT02193815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102520415|NCT02193815|Vitamins|vitamins|mesh-ancestor
102520416|NCT02193815|Micronutrients|micronutrients|mesh-ancestor
102520417|NCT02193815|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102520418|NCT01277081|Acetaminophen|acetaminophen|mesh-list
102520419|NCT01277081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102520420|NCT01277081|Analgesics|analgesics|mesh-ancestor
102520421|NCT01277081|Sensory System Agents|sensory system agents|mesh-ancestor
102520422|NCT01277081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102520423|NCT01277081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520424|NCT01277081|Antipyretics|antipyretics|mesh-ancestor
102520425|NCT01361633|Cycloserine|cycloserine|mesh-list
102520426|NCT01361633|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102520427|NCT01361633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102520428|NCT01361633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102520429|NCT01361633|Antitubercular Agents|antitubercular agents|mesh-ancestor
102520430|NCT01361633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102520431|NCT01361633|Antimetabolites|antimetabolites|mesh-ancestor
102520432|NCT01361633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520433|NCT01331213|Pregabalin|pregabalin|mesh-list
102520434|NCT01331213|Analgesics|analgesics|mesh-ancestor
102520435|NCT01331213|Sensory System Agents|sensory system agents|mesh-ancestor
102520436|NCT01331213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102520437|NCT01331213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520438|NCT01331213|Anticonvulsants|anticonvulsants|mesh-ancestor
102520439|NCT01331213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102520440|NCT01331213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102520441|NCT01331213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520442|NCT01331213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102520443|NCT01331213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102520444|NCT01331213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102520445|NCT01331213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102520446|NCT01331213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102520447|NCT01332071|Metformin|metformin|mesh-list
102520448|NCT01332071|Rosiglitazone|rosiglitazone|mesh-list
102520449|NCT01332071|Maleic acid|maleic acid|mesh-list
102520450|NCT01332071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102520451|NCT01332071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520452|NCT01332071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102520453|NCT01332071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520454|NCT01277159|Dexamethasone|dexamethasone|mesh-list
102520455|NCT01277159|Dexamethasone acetate|dexamethasone acetate|mesh-list
102520456|NCT01277159|Buprenorphine|buprenorphine|mesh-list
102520457|NCT01277159|BB 1101|bb 1101|mesh-list
102520458|NCT01277159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102520459|NCT01277159|Antiemetics|antiemetics|mesh-ancestor
102520460|NCT01277159|Autonomic Agents|autonomic agents|mesh-ancestor
102520461|NCT01277159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102331965|NCT04027348|Octreotide|octreotide|mesh-list
102520462|NCT01277159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520463|NCT01277159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102520464|NCT01277159|Glucocorticoids|glucocorticoids|mesh-ancestor
102520465|NCT01277159|Hormones|hormones|mesh-ancestor
102520466|NCT01277159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102520467|NCT01277159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102520468|NCT01277159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102520469|NCT01277159|Protease Inhibitors|protease inhibitors|mesh-ancestor
102520470|NCT01277159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102520471|NCT01277159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520472|NCT01277159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102520473|NCT01277159|Narcotics|narcotics|mesh-ancestor
102520474|NCT01277159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102520475|NCT01277159|Analgesics|analgesics|mesh-ancestor
102520476|NCT01277159|Sensory System Agents|sensory system agents|mesh-ancestor
102520477|NCT01277159|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102520478|NCT01362959|Nicotine|nicotine|mesh-list
102520479|NCT01362959|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102520480|NCT01362959|Autonomic Agents|autonomic agents|mesh-ancestor
102520481|NCT01362959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102520482|NCT01362959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520483|NCT01362959|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102520484|NCT01362959|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102520485|NCT01362959|Cholinergic Agents|cholinergic agents|mesh-ancestor
102520486|NCT01362959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102520487|NCT01362959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520488|NCT01332461|Fluticasone|fluticasone|mesh-list
102520490|NCT01332461|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102520491|NCT01332461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102520492|NCT01332461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102520493|NCT01332461|Autonomic Agents|autonomic agents|mesh-ancestor
102520494|NCT01332461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102520495|NCT01332461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520496|NCT01332461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102520497|NCT01332461|Respiratory System Agents|respiratory system agents|mesh-ancestor
102520498|NCT01332461|Dermatologic Agents|dermatologic agents|mesh-ancestor
102520499|NCT01332461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102520500|NCT01332461|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102520501|NCT01332461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102520502|NCT01332461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102520503|NCT01332461|Adrenergic Agents|adrenergic agents|mesh-ancestor
102520504|NCT01332461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102520505|NCT01332461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520506|NCT01279187|Teriparatide|teriparatide|mesh-list
102520507|NCT01279187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102520508|NCT01279187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520509|NCT01279187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102520510|NCT01280123|Pioglitazone|pioglitazone|mesh-list
102520511|NCT01280123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102520512|NCT01280123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520513|NCT03608696|Buprenorphine|buprenorphine|mesh-list
102520514|NCT03608696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102520515|NCT03608696|Narcotics|narcotics|mesh-ancestor
102520516|NCT03608696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102520517|NCT03608696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520518|NCT03608696|Analgesics|analgesics|mesh-ancestor
102520519|NCT03608696|Sensory System Agents|sensory system agents|mesh-ancestor
102520520|NCT03608696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102520521|NCT03608696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102520522|NCT01334723|Finasteride|finasteride|mesh-list
102520523|NCT01334723|Dutasteride|dutasteride|mesh-list
102520524|NCT01334723|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
102520525|NCT01334723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102520526|NCT01334723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102520527|NCT01334723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520528|NCT01334723|Hormone Antagonists|hormone antagonists|mesh-ancestor
102520529|NCT01334723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102520530|NCT01334723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520531|NCT01334723|Urological Agents|urological agents|mesh-ancestor
102520532|NCT04311710|Nivolumab|nivolumab|mesh-list
102520533|NCT04311710|Ipilimumab|ipilimumab|mesh-list
102520534|NCT04311710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102520535|NCT04311710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102520536|NCT04311710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102520537|NCT04311710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520539|NCT01334957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102520540|NCT01334957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102520541|NCT01334957|Analgesics|analgesics|mesh-ancestor
102520542|NCT01334957|Sensory System Agents|sensory system agents|mesh-ancestor
102520543|NCT01334957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102520544|NCT01334957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520545|NCT01334957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102520546|NCT01334957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102520547|NCT01334957|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102520548|NCT01334957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102520549|NCT01334957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520550|NCT01402427|Verapamil|verapamil|mesh-list
102520551|NCT01402427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102520552|NCT01402427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102520553|NCT01402427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102520554|NCT01402427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520555|NCT01402427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102520556|NCT01402427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520557|NCT01402427|Vasodilator Agents|vasodilator agents|mesh-ancestor
102520558|NCT01365611|Fluticasone|fluticasone|mesh-list
102520559|NCT01365611|Xhance|xhance|mesh-list
102520560|NCT01365611|Ketorolac|ketorolac|mesh-list
102520561|NCT01365611|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102520562|NCT01365611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102520563|NCT01365611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102520564|NCT01365611|Autonomic Agents|autonomic agents|mesh-ancestor
102520565|NCT01365611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102520566|NCT01365611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520567|NCT01365611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102520568|NCT01365611|Respiratory System Agents|respiratory system agents|mesh-ancestor
102520569|NCT01365611|Dermatologic Agents|dermatologic agents|mesh-ancestor
102520570|NCT01365611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102520571|NCT01365611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102520572|NCT01365611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102520573|NCT01365611|Analgesics|analgesics|mesh-ancestor
102520574|NCT01365611|Sensory System Agents|sensory system agents|mesh-ancestor
102520575|NCT01365611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102520576|NCT01365611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102520577|NCT01365611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102520578|NCT01365611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520579|NCT01472549|Ethanol|ethanol|mesh-list
102520580|NCT01472549|Chlorhexidine|chlorhexidine|mesh-list
102520581|NCT01472549|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102520582|NCT01472549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102520583|NCT01472549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102520584|NCT01472549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520585|NCT01472549|Disinfectants|disinfectants|mesh-ancestor
102520586|NCT00852644|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102520587|NCT00852644|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102520588|NCT00852644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520589|NCT01404923|Mebeverine|mebeverine|mesh-list
102520590|NCT01404923|Alverine|alverine|mesh-list
102520591|NCT01404923|Parasympatholytics|parasympatholytics|mesh-list
102520592|NCT01404923|Autonomic Agents|autonomic agents|mesh-ancestor
102520593|NCT01404923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102520594|NCT01404923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520595|NCT01404923|Anticonvulsants|anticonvulsants|mesh-ancestor
102520596|NCT01368263|Letrozole|letrozole|mesh-list
102520597|NCT01368263|Anastrozole|anastrozole|mesh-list
102520598|NCT01368263|Goserelin|goserelin|mesh-list
102520599|NCT01368263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102520600|NCT01368263|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102520601|NCT01368263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102520602|NCT01368263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102520603|NCT01368263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520604|NCT01368263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102520605|NCT01368263|Hormone Antagonists|hormone antagonists|mesh-ancestor
102520606|NCT01368263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102520607|NCT01368263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520608|NCT01368263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102520609|NCT00815360|Triamcinolone|triamcinolone|mesh-list
102520610|NCT00815360|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102520611|NCT00815360|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102520612|NCT00815360|Ranibizumab|ranibizumab|mesh-list
102520613|NCT00815360|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102520614|NCT00815360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102520615|NCT00815360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102520616|NCT00815360|Growth Substances|growth substances|mesh-ancestor
102520617|NCT00815360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520618|NCT00815360|Growth Inhibitors|growth inhibitors|mesh-ancestor
102520619|NCT00815360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102520620|NCT00815360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102520621|NCT00815360|Glucocorticoids|glucocorticoids|mesh-ancestor
102520622|NCT00815360|Hormones|hormones|mesh-ancestor
102520623|NCT00815360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102520624|NCT00815360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102520625|NCT00815360|Immunologic Factors|immunologic factors|mesh-ancestor
102520626|NCT00815360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102520627|NCT00815360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520628|NCT01474109|Macitentan|macitentan|mesh-list
102520629|NCT01474109|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
102520630|NCT01474109|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102520631|NCT01474109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520632|NCT01474109|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
102520633|NCT01405937|Ribavirin|ribavirin|mesh-list
102520634|NCT01405937|Antimetabolites|antimetabolites|mesh-ancestor
102520635|NCT01405937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520636|NCT01405937|Antiviral Agents|antiviral agents|mesh-ancestor
102520637|NCT01405937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102520638|NCT01368653|Nicotine|nicotine|mesh-list
102520639|NCT01368653|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102520640|NCT01368653|Autonomic Agents|autonomic agents|mesh-ancestor
102520641|NCT01368653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102520642|NCT01368653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520643|NCT01368653|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102520644|NCT01368653|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102520645|NCT01368653|Cholinergic Agents|cholinergic agents|mesh-ancestor
102520646|NCT01368653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102520647|NCT01368653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520648|NCT01407107|Nitroglycerin|nitroglycerin|mesh-list
102520649|NCT01407107|Vasodilator Agents|vasodilator agents|mesh-ancestor
102520650|NCT01368809|Fentanyl|fentanyl|mesh-list
102520651|NCT01368809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102520652|NCT01368809|Narcotics|narcotics|mesh-ancestor
102520653|NCT01368809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102520654|NCT01368809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520655|NCT01368809|Analgesics|analgesics|mesh-ancestor
102520656|NCT01368809|Sensory System Agents|sensory system agents|mesh-ancestor
102520657|NCT01368809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102520658|NCT01368809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102520659|NCT01368809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102520660|NCT01368809|Anesthetics, General|anesthetics, general|mesh-ancestor
102520661|NCT01368809|Anesthetics|anesthetics|mesh-ancestor
102520662|NCT01369745|Prednisone|prednisone|mesh-list
102520663|NCT01369745|Prednisolone|prednisolone|mesh-list
102520664|NCT01369745|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102520665|NCT01369745|Methylprednisolone|methylprednisolone|mesh-list
102520666|NCT01369745|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102520667|NCT01369745|Prednisolone acetate|prednisolone acetate|mesh-list
102520668|NCT01369745|Dipyridamole|dipyridamole|mesh-list
102520669|NCT01369745|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102520670|NCT01369745|Prednisolone phosphate|prednisolone phosphate|mesh-list
102520671|NCT01369745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102520672|NCT01369745|Glucocorticoids|glucocorticoids|mesh-ancestor
102520673|NCT01369745|Hormones|hormones|mesh-ancestor
102520674|NCT01369745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102520675|NCT01369745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520676|NCT01369745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102520677|NCT01369745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102520678|NCT01369745|Antiemetics|antiemetics|mesh-ancestor
102520679|NCT01369745|Autonomic Agents|autonomic agents|mesh-ancestor
102520680|NCT01369745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102520681|NCT01369745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102520682|NCT01369745|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102520683|NCT01369745|Protective Agents|protective agents|mesh-ancestor
102520684|NCT01369745|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102520685|NCT01369745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102520686|NCT01369745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520687|NCT01369745|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102520688|NCT01369745|Vasodilator Agents|vasodilator agents|mesh-ancestor
102520689|NCT01475513|Moxifloxacin|moxifloxacin|mesh-list
102520690|NCT01475513|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102520691|NCT01475513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102520692|NCT01475513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102520693|NCT01475513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102520694|NCT01475513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102520695|NCT01475513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102520696|NCT01475513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520697|NCT01475513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102520698|NCT01475513|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102520699|NCT01475513|Contraceptive Agents|contraceptive agents|mesh-ancestor
102520700|NCT01475513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102520701|NCT01475513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520702|NCT01475513|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102520703|NCT01475513|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102520704|NCT01475513|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102520705|NCT01407575|Buprenorphine|buprenorphine|mesh-list
102520706|NCT01407575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102520707|NCT01407575|Narcotics|narcotics|mesh-ancestor
102520708|NCT01407575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102520709|NCT01407575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520710|NCT01407575|Analgesics|analgesics|mesh-ancestor
102520711|NCT01407575|Sensory System Agents|sensory system agents|mesh-ancestor
102520712|NCT01407575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102520713|NCT01407575|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102520714|NCT01476449|Ranibizumab|ranibizumab|mesh-list
102520715|NCT01476449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102520716|NCT01476449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102520717|NCT01476449|Growth Substances|growth substances|mesh-ancestor
102520718|NCT01476449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520719|NCT01476449|Growth Inhibitors|growth inhibitors|mesh-ancestor
102520720|NCT01476449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102520721|NCT01370369|Testosterone|testosterone|mesh-list
102520722|NCT01370369|Androgens|androgens|mesh-ancestor
102520723|NCT01370369|Hormones|hormones|mesh-ancestor
102520724|NCT01370369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102520725|NCT01370369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520726|NCT01477463|Vitamin D|vitamin d|mesh-list
102520727|NCT01477463|Ergocalciferols|ergocalciferols|mesh-list
102520728|NCT01477463|Cholecalciferol|cholecalciferol|mesh-list
102520729|NCT01477463|Vitamins|vitamins|mesh-list
102520730|NCT01477463|Micronutrients|micronutrients|mesh-ancestor
102520731|NCT01477463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520732|NCT01477463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102520733|NCT01477463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102520734|NCT02203565|Sodium Hypochlorite|sodium hypochlorite|mesh-list
102520735|NCT02203565|Eusol|eusol|mesh-list
102520736|NCT02203565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102520737|NCT02203565|Disinfectants|disinfectants|mesh-ancestor
102520738|NCT02203565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102520739|NCT01375127|Tofacitinib|tofacitinib|mesh-list
102520740|NCT01375127|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102520741|NCT01375127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102520742|NCT01375127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102520743|NCT01375127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520744|NCT00857714|Lapatinib|lapatinib|mesh-list
102520745|NCT00857714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102520746|NCT00857714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102520747|NCT00857714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102520748|NCT00857714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520749|NCT00858962|Raltegravir Potassium|raltegravir potassium|mesh-list
102520750|NCT00858962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102520751|NCT00858962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102520752|NCT00858962|Antiviral Agents|antiviral agents|mesh-ancestor
102520753|NCT00858962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102520754|NCT00858962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102520755|NCT00858962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102520756|NCT00858962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102520757|NCT00858962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520758|NCT01376297|Dexamethasone|dexamethasone|mesh-list
102520759|NCT01376297|Aprepitant|aprepitant|mesh-list
102520760|NCT01376297|Palonosetron|palonosetron|mesh-list
102520761|NCT01376297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102520762|NCT01376297|Antiemetics|antiemetics|mesh-ancestor
102520763|NCT01376297|Autonomic Agents|autonomic agents|mesh-ancestor
102332267|NCT03920722|Rituximab|rituximab|mesh-list
102520764|NCT01376297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102520765|NCT01376297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520767|NCT01376297|Glucocorticoids|glucocorticoids|mesh-ancestor
102520768|NCT01376297|Hormones|hormones|mesh-ancestor
102520769|NCT01376297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102520770|NCT01376297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102520771|NCT01376297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102520772|NCT01376297|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102520773|NCT01376297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102520774|NCT01376297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520775|NCT01376297|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102520776|NCT01376297|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102520777|NCT01376297|Serotonin Agents|serotonin agents|mesh-ancestor
102520778|NCT00859040|Pasireotide|pasireotide|mesh-list
102520779|NCT00859040|Hormones|hormones|mesh-ancestor
102520780|NCT00859040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102520781|NCT00859040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520782|NCT00859508|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102520783|NCT00859508|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102520784|NCT00859508|Estradiol|estradiol|mesh-list
102520785|NCT00859508|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102520786|NCT00859508|Estrogens|estrogens|mesh-ancestor
102520787|NCT00859508|Hormones|hormones|mesh-ancestor
102520788|NCT00859508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102520789|NCT00859508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520790|NCT00859508|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102520791|NCT00859508|Contraceptive Agents|contraceptive agents|mesh-ancestor
102520792|NCT00859508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102520793|NCT00859508|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102520794|NCT01377467|Denosumab|denosumab|mesh-list
102520795|NCT01377467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102520796|NCT01377467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520797|NCT02348762|Acetylcysteine|acetylcysteine|mesh-list
102520798|NCT02348762|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102520799|NCT02348762|Glycine|glycine|mesh-list
102520800|NCT02348762|Antiviral Agents|antiviral agents|mesh-ancestor
102520801|NCT02348762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102520802|NCT02348762|Expectorants|expectorants|mesh-ancestor
102520803|NCT02348762|Respiratory System Agents|respiratory system agents|mesh-ancestor
102520804|NCT02348762|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102520805|NCT02348762|Antioxidants|antioxidants|mesh-ancestor
102520806|NCT02348762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520807|NCT02348762|Protective Agents|protective agents|mesh-ancestor
102520808|NCT02348762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520809|NCT02348762|Antidotes|antidotes|mesh-ancestor
102520810|NCT02348762|Glycine Agents|glycine agents|mesh-ancestor
102520811|NCT02348762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102520812|NCT01377623|Dexmedetomidine|dexmedetomidine|mesh-list
102520813|NCT01377623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102520814|NCT01377623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102520815|NCT01377623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520816|NCT01377623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102520817|NCT01377623|Analgesics|analgesics|mesh-ancestor
102520818|NCT01377623|Sensory System Agents|sensory system agents|mesh-ancestor
102520819|NCT01377623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102520820|NCT01377623|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102520821|NCT01377623|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102520822|NCT01377623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102520823|NCT01377623|Adrenergic Agents|adrenergic agents|mesh-ancestor
102520824|NCT01377623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102520825|NCT01377623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520826|NCT01486043|Metformin|metformin|mesh-list
102520827|NCT01486043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102520828|NCT01486043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520829|NCT01490723|Mycophenolic Acid|mycophenolic acid|mesh-list
102520830|NCT01490723|Rituximab|rituximab|mesh-list
102520831|NCT01490723|Methotrexate|methotrexate|mesh-list
102520832|NCT01490723|Fludarabine|fludarabine|mesh-list
102520833|NCT01490723|Fludarabine phosphate|fludarabine phosphate|mesh-list
102520834|NCT01490723|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102520835|NCT01490723|Tacrolimus|tacrolimus|mesh-list
102520836|NCT01490723|Thymoglobulin|thymoglobulin|mesh-list
102520837|NCT01490723|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102520838|NCT01490723|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102520839|NCT01490723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102520840|NCT01490723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102520841|NCT01490723|Immunologic Factors|immunologic factors|mesh-ancestor
102520842|NCT01490723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520843|NCT01490723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102520844|NCT01490723|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102520845|NCT01490723|Abortifacient Agents|abortifacient agents|mesh-ancestor
102520846|NCT01490723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102520847|NCT01490723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102520848|NCT01490723|Antimetabolites|antimetabolites|mesh-ancestor
102520849|NCT01490723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520850|NCT01490723|Dermatologic Agents|dermatologic agents|mesh-ancestor
102520851|NCT01490723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102520852|NCT01490723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102520853|NCT01490723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102520854|NCT01490723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102520855|NCT01490723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102520856|NCT01490723|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102520857|NCT01490723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102520858|NCT01490723|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102520859|NCT01490723|Antitubercular Agents|antitubercular agents|mesh-ancestor
102520860|NCT01490723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102520861|NCT01490723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102520862|NCT01490723|Alkylating Agents|alkylating agents|mesh-ancestor
102520863|NCT01491113|Levetiracetam|levetiracetam|mesh-list
102520864|NCT01491113|Anticonvulsants|anticonvulsants|mesh-ancestor
102520865|NCT01491113|Nootropic Agents|nootropic agents|mesh-ancestor
102520866|NCT03839498|Axitinib|axitinib|mesh-list
102520867|NCT03839498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102520868|NCT03839498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102520869|NCT03839498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102520870|NCT03839498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520871|NCT02252432|Ketamine|ketamine|mesh-list
102520872|NCT02252432|Methadone|methadone|mesh-list
102520873|NCT02252432|Analgesics|analgesics|mesh-ancestor
102520874|NCT02252432|Sensory System Agents|sensory system agents|mesh-ancestor
102520875|NCT02252432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102520876|NCT02252432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520877|NCT02252432|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102520878|NCT02252432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102520879|NCT02252432|Anesthetics, General|anesthetics, general|mesh-ancestor
102520880|NCT02252432|Anesthetics|anesthetics|mesh-ancestor
102520881|NCT02252432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102520882|NCT02252432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102520883|NCT02252432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102520884|NCT02252432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102520885|NCT02252432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520886|NCT02252432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102520887|NCT02252432|Narcotics|narcotics|mesh-ancestor
102520888|NCT02252432|Antitussive Agents|antitussive agents|mesh-ancestor
102520889|NCT02252432|Respiratory System Agents|respiratory system agents|mesh-ancestor
102520890|NCT01492673|Cyclophosphamide|cyclophosphamide|mesh-list
102520891|NCT01492673|Bevacizumab|bevacizumab|mesh-list
102520892|NCT01492673|Topotecan|topotecan|mesh-list
102520893|NCT01492673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102520894|NCT01492673|Immunologic Factors|immunologic factors|mesh-ancestor
102520895|NCT01492673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520896|NCT01492673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102520897|NCT01492673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102520898|NCT01492673|Alkylating Agents|alkylating agents|mesh-ancestor
102520899|NCT01492673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520900|NCT01492673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102520901|NCT01492673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102520902|NCT01492673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102520903|NCT01492673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102520904|NCT01492673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102520905|NCT01492673|Growth Substances|growth substances|mesh-ancestor
102520906|NCT01492673|Growth Inhibitors|growth inhibitors|mesh-ancestor
102520907|NCT01492673|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102520908|NCT01492673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102520909|NCT01492673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102520910|NCT00818324|Rebamipide|rebamipide|mesh-list
102520911|NCT00818324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102520912|NCT00818324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102520913|NCT00818324|Antioxidants|antioxidants|mesh-ancestor
102520914|NCT00818324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520915|NCT00818324|Protective Agents|protective agents|mesh-ancestor
102520916|NCT00818324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520917|NCT00818324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102520918|NCT01419275|Xenon|xenon|mesh-list
102520919|NCT01419275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102520920|NCT01419275|Anesthetics, General|anesthetics, general|mesh-ancestor
102520921|NCT01419275|Anesthetics|anesthetics|mesh-ancestor
102520922|NCT01419275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102520923|NCT01419275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520924|NCT02155010|Dexmedetomidine|dexmedetomidine|mesh-list
102520925|NCT02155010|Bupivacaine|bupivacaine|mesh-list
102520926|NCT02155010|Anesthetics, Local|anesthetics, local|mesh-ancestor
102520927|NCT02155010|Anesthetics|anesthetics|mesh-ancestor
102520928|NCT02155010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102520929|NCT02155010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520930|NCT02155010|Sensory System Agents|sensory system agents|mesh-ancestor
102520931|NCT02155010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102520932|NCT02155010|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102520933|NCT02155010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102520934|NCT02155010|Analgesics|analgesics|mesh-ancestor
102520935|NCT02155010|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102520936|NCT02155010|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102520937|NCT02155010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102520938|NCT02155010|Adrenergic Agents|adrenergic agents|mesh-ancestor
102520939|NCT02155010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102520940|NCT02155010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520941|NCT01495481|Adenosine|adenosine|mesh-list
102520942|NCT01495481|Dexmedetomidine|dexmedetomidine|mesh-list
102520943|NCT01495481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102520944|NCT01495481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102520945|NCT01495481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520946|NCT01495481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102520947|NCT01495481|Analgesics|analgesics|mesh-ancestor
102520948|NCT01495481|Sensory System Agents|sensory system agents|mesh-ancestor
102520949|NCT01495481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102520950|NCT01495481|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102520951|NCT01495481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102520952|NCT01495481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102520953|NCT01495481|Adrenergic Agents|adrenergic agents|mesh-ancestor
102520954|NCT01495481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102520955|NCT01495481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520956|NCT01495481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102520957|NCT01495481|Vasodilator Agents|vasodilator agents|mesh-ancestor
102520958|NCT01495481|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102520959|NCT01495481|Purinergic Agonists|purinergic agonists|mesh-ancestor
102520960|NCT01495481|Purinergic Agents|purinergic agents|mesh-ancestor
102520961|NCT01379183|Erythromycin|erythromycin|mesh-list
102520962|NCT01379183|Erythromycin Estolate|erythromycin estolate|mesh-list
102520963|NCT01379183|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
102520964|NCT01379183|Erythromycin stearate|erythromycin stearate|mesh-list
102520965|NCT01379183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102520966|NCT01379183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102520967|NCT01379183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102520968|NCT01379183|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102520969|NCT01379183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102520970|NCT01379183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520971|NCT01380197|Morphine|morphine|mesh-list
102520972|NCT01380197|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102520973|NCT01380197|Narcotics|narcotics|mesh-ancestor
102520974|NCT01380197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102520975|NCT01380197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520976|NCT01380197|Analgesics|analgesics|mesh-ancestor
102520977|NCT01380197|Sensory System Agents|sensory system agents|mesh-ancestor
102520978|NCT01380197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102520979|NCT00862784|Leucovorin|leucovorin|mesh-list
102520980|NCT00862784|Folic Acid|folic acid|mesh-list
102520981|NCT00862784|Oxaliplatin|oxaliplatin|mesh-list
102520982|NCT00862784|Fluorouracil|fluorouracil|mesh-list
102520983|NCT00862784|Ramucirumab|ramucirumab|mesh-list
102520984|NCT00862784|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102520985|NCT00862784|Levoleucovorin|levoleucovorin|mesh-list
102520986|NCT00862784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102520987|NCT00862784|Antimetabolites|antimetabolites|mesh-ancestor
102332491|NCT01866657|Sympathomimetics|sympathomimetics|mesh-ancestor
102520988|NCT00862784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102520989|NCT00862784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102520990|NCT00862784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102520991|NCT00862784|Immunologic Factors|immunologic factors|mesh-ancestor
102520992|NCT00862784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102520993|NCT00862784|Antidotes|antidotes|mesh-ancestor
102520994|NCT00862784|Protective Agents|protective agents|mesh-ancestor
102520995|NCT00862784|Vitamin B Complex|vitamin b complex|mesh-ancestor
102520996|NCT00862784|Vitamins|vitamins|mesh-ancestor
102520997|NCT00862784|Micronutrients|micronutrients|mesh-ancestor
102520998|NCT00862784|Hematinics|hematinics|mesh-ancestor
102520999|NCT00864032|Sorafenib|sorafenib|mesh-list
102521000|NCT00864032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102521001|NCT00864032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102521002|NCT00864032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102521003|NCT00864032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521004|NCT00820664|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102521005|NCT00820664|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102521006|NCT00820664|Estradiol|estradiol|mesh-list
102521007|NCT00820664|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102521008|NCT00820664|Estrogens|estrogens|mesh-ancestor
102521009|NCT00820664|Hormones|hormones|mesh-ancestor
102521010|NCT00820664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102521011|NCT00820664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521012|NCT00820664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102521013|NCT00820664|Contraceptive Agents|contraceptive agents|mesh-ancestor
102521014|NCT00820664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102521015|NCT00820664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102521016|NCT01380743|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
102521017|NCT01380743|Antiviral Agents|antiviral agents|mesh-ancestor
102521018|NCT01380743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102521019|NCT01380743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102521020|NCT01380743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521021|NCT01419977|Dalteparin|dalteparin|mesh-list
102521022|NCT01419977|Tinzaparin|tinzaparin|mesh-list
102521023|NCT01419977|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102521024|NCT01419977|Anticoagulants|anticoagulants|mesh-ancestor
102521025|NCT01419977|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102521026|NCT01419977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102521027|NCT01419977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521028|NCT01499147|Vidarabine|vidarabine|mesh-list
102521029|NCT01499147|Fludarabine|fludarabine|mesh-list
102521030|NCT01499147|Fludarabine phosphate|fludarabine phosphate|mesh-list
102521031|NCT01499147|Melphalan|melphalan|mesh-list
102521032|NCT01499147|Busulfan|busulfan|mesh-list
102521033|NCT01499147|Thymoglobulin|thymoglobulin|mesh-list
102521034|NCT01499147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102521035|NCT01499147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102521036|NCT01499147|Antimetabolites|antimetabolites|mesh-ancestor
102521037|NCT01499147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521038|NCT01499147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102521039|NCT01499147|Immunologic Factors|immunologic factors|mesh-ancestor
102521040|NCT01499147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521041|NCT01499147|Antiviral Agents|antiviral agents|mesh-ancestor
102521042|NCT01499147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102521043|NCT01499147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102521044|NCT01499147|Alkylating Agents|alkylating agents|mesh-ancestor
102521045|NCT01499147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102521046|NCT00823082|Antithrombins|antithrombins|mesh-list
102521047|NCT00823082|Antithrombin III|antithrombin iii|mesh-list
102521048|NCT00823082|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102521049|NCT00823082|Protease Inhibitors|protease inhibitors|mesh-ancestor
102521050|NCT00823082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102521051|NCT00823082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521052|NCT00823082|Anticoagulants|anticoagulants|mesh-ancestor
102521053|NCT01382303|Pentoxifylline|pentoxifylline|mesh-list
102521054|NCT01382303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102521055|NCT01382303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102521056|NCT01382303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521057|NCT01382303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102521058|NCT01382303|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102521059|NCT01382303|Protective Agents|protective agents|mesh-ancestor
102521060|NCT01382303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521061|NCT01382303|Vasodilator Agents|vasodilator agents|mesh-ancestor
102521062|NCT01382303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102521063|NCT01382303|Antioxidants|antioxidants|mesh-ancestor
102521064|NCT05236634|Tadalafil|tadalafil|mesh-list
102521065|NCT05236634|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
102521066|NCT05236634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
102521067|NCT05236634|Vasodilator Agents|vasodilator agents|mesh-ancestor
102521068|NCT05236634|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102521069|NCT05236634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102521070|NCT05236634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521071|NCT05236634|Urological Agents|urological agents|mesh-ancestor
102521072|NCT05236634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102521073|NCT05236634|Adrenergic Agents|adrenergic agents|mesh-ancestor
102521074|NCT05236634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102521075|NCT05236634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521076|NCT01422161|Botulinum Toxins|botulinum toxins|mesh-list
102521077|NCT01422161|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102521078|NCT01422161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102521079|NCT01422161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102521080|NCT01422161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521081|NCT01422161|Cholinergic Agents|cholinergic agents|mesh-ancestor
102521082|NCT01422161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102521083|NCT01422161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521084|NCT01422161|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102521085|NCT01422161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102521086|NCT05236166|Anticonvulsants|anticonvulsants|mesh-list
102521087|NCT01502813|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
102521088|NCT01502813|Nootropic Agents|nootropic agents|mesh-ancestor
102521089|NCT00865202|Tryptophan|tryptophan|mesh-list
102521090|NCT00865202|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102521091|NCT00865202|Antidepressive Agents|antidepressive agents|mesh-ancestor
102521092|NCT00865202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102521093|NCT01424033|Acetylcysteine|acetylcysteine|mesh-list
102521094|NCT01424033|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102521095|NCT01424033|Antiviral Agents|antiviral agents|mesh-ancestor
102521096|NCT01424033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102521097|NCT01424033|Expectorants|expectorants|mesh-ancestor
102521098|NCT01424033|Respiratory System Agents|respiratory system agents|mesh-ancestor
102521099|NCT01424033|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102521100|NCT01424033|Antioxidants|antioxidants|mesh-ancestor
102521101|NCT01424033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521102|NCT01424033|Protective Agents|protective agents|mesh-ancestor
102521103|NCT01424033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521104|NCT01424033|Antidotes|antidotes|mesh-ancestor
102521105|NCT01503749|Lenograstim|lenograstim|mesh-list
102521106|NCT01503749|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102521107|NCT01503749|Immunologic Factors|immunologic factors|mesh-ancestor
102521108|NCT01503749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521109|NCT00867932|Eculizumab|eculizumab|mesh-list
102521110|NCT00867932|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102521111|NCT00867932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102521112|NCT00867932|Immunologic Factors|immunologic factors|mesh-ancestor
102521113|NCT00867932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521114|NCT00825266|Pioglitazone|pioglitazone|mesh-list
102521115|NCT00825266|Bosentan|bosentan|mesh-list
102521116|NCT00825266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102521117|NCT00825266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521118|NCT00825266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102521119|NCT00825266|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102521120|NCT00825266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521121|NCT01385189|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102521122|NCT01385189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102521123|NCT01385189|Immunologic Factors|immunologic factors|mesh-ancestor
102521124|NCT01385189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521125|NCT01385189|Antacids|antacids|mesh-ancestor
102521126|NCT01385189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521127|NCT01385189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102521128|NCT01386983|Finasteride|finasteride|mesh-list
102521129|NCT01386983|Dutasteride|dutasteride|mesh-list
102521130|NCT01386983|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102521131|NCT01386983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102521132|NCT01386983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102521133|NCT01386983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521134|NCT01386983|Hormone Antagonists|hormone antagonists|mesh-ancestor
102521135|NCT01386983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102521136|NCT01386983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521137|NCT01386983|Urological Agents|urological agents|mesh-ancestor
102521138|NCT01387139|Ketamine|ketamine|mesh-list
102521139|NCT01387139|Propofol|propofol|mesh-list
102332641|NCT01709409|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
102521140|NCT01387139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102521141|NCT01387139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102521142|NCT01387139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521143|NCT01387139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102521144|NCT01387139|Anesthetics, General|anesthetics, general|mesh-ancestor
102521145|NCT01387139|Anesthetics|anesthetics|mesh-ancestor
102521146|NCT01387139|Analgesics|analgesics|mesh-ancestor
102521147|NCT01387139|Sensory System Agents|sensory system agents|mesh-ancestor
102521148|NCT01387139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102521149|NCT01387139|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102521150|NCT01387139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102521151|NCT01387139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102521152|NCT01387139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102521153|NCT01387139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521154|NCT00870896|Tiotropium Bromide|tiotropium bromide|mesh-list
102521155|NCT00870896|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102521156|NCT00870896|Autonomic Agents|autonomic agents|mesh-ancestor
102521157|NCT00870896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102521158|NCT00870896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521159|NCT00870896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102521160|NCT00870896|Respiratory System Agents|respiratory system agents|mesh-ancestor
102521161|NCT00870896|Parasympatholytics|parasympatholytics|mesh-ancestor
102521162|NCT00870896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102521163|NCT00870896|Cholinergic Agents|cholinergic agents|mesh-ancestor
102521164|NCT00870896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102521165|NCT00870896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521166|NCT00825344|Etanercept|etanercept|mesh-list
102521167|NCT00825344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102521168|NCT00825344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102521169|NCT00825344|Analgesics|analgesics|mesh-ancestor
102521170|NCT00825344|Sensory System Agents|sensory system agents|mesh-ancestor
102521171|NCT00825344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102521172|NCT00825344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521173|NCT00825344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102521174|NCT00825344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102521175|NCT00825344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102521176|NCT00825344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102521177|NCT00825344|Immunologic Factors|immunologic factors|mesh-ancestor
102521178|NCT01426763|Complement C1s|complement c1s|mesh-list
102521179|NCT01426763|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
102521180|NCT01426763|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
102521181|NCT01426763|Immunologic Factors|immunologic factors|mesh-ancestor
102521182|NCT01426763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521183|NCT01426763|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102521184|NCT01426763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102521185|NCT00825500|Loxapine|loxapine|mesh-list
102521186|NCT00825500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102521187|NCT00825500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102521188|NCT00825500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102521189|NCT00825500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521190|NCT00825500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102521191|NCT00825500|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102521192|NCT00825500|Dopamine Agents|dopamine agents|mesh-ancestor
102521193|NCT00825500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102521194|NCT00825500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521195|NCT01505933|Dexmedetomidine|dexmedetomidine|mesh-list
102521196|NCT01505933|Propofol|propofol|mesh-list
102521197|NCT01505933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102521198|NCT01505933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102521199|NCT01505933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521200|NCT01505933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102521201|NCT01505933|Analgesics|analgesics|mesh-ancestor
102521202|NCT01505933|Sensory System Agents|sensory system agents|mesh-ancestor
102521203|NCT01505933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102521204|NCT01505933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102521205|NCT01505933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102521206|NCT01505933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102521207|NCT01505933|Adrenergic Agents|adrenergic agents|mesh-ancestor
102521208|NCT01505933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102521209|NCT01505933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521210|NCT01505933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102521211|NCT01505933|Anesthetics, General|anesthetics, general|mesh-ancestor
102521212|NCT01505933|Anesthetics|anesthetics|mesh-ancestor
102521213|NCT00825734|Sorafenib|sorafenib|mesh-list
102521214|NCT00825734|Epothilones|epothilones|mesh-list
102521215|NCT00825734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102521216|NCT00825734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102521217|NCT00825734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102521218|NCT00825734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521219|NCT00825734|Tubulin Modulators|tubulin modulators|mesh-ancestor
102521220|NCT00825734|Antimitotic Agents|antimitotic agents|mesh-ancestor
102521221|NCT00825734|Mitosis Modulators|mitosis modulators|mesh-ancestor
102521222|NCT00872534|Aspirin|aspirin|mesh-list
102521223|NCT00872534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102521224|NCT00872534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102521225|NCT00872534|Analgesics|analgesics|mesh-ancestor
102521226|NCT00872534|Sensory System Agents|sensory system agents|mesh-ancestor
102521227|NCT00872534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102521228|NCT00872534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521229|NCT00872534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102521230|NCT00872534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102521231|NCT00872534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102521232|NCT00872534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102521233|NCT00872534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521234|NCT00872534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102521235|NCT00872534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102521236|NCT00872534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102521237|NCT00872534|Antipyretics|antipyretics|mesh-ancestor
102521238|NCT02513160|Beclomethasone|beclomethasone|mesh-list
102521239|NCT02513160|Albuterol|albuterol|mesh-list
102521240|NCT02513160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102521241|NCT02513160|Autonomic Agents|autonomic agents|mesh-ancestor
102521242|NCT02513160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102521243|NCT02513160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521244|NCT02513160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102521245|NCT02513160|Respiratory System Agents|respiratory system agents|mesh-ancestor
102521246|NCT02513160|Tocolytic Agents|tocolytic agents|mesh-ancestor
102521247|NCT02513160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102521248|NCT02513160|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102521249|NCT02513160|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102521250|NCT02513160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102521251|NCT02513160|Adrenergic Agents|adrenergic agents|mesh-ancestor
102521252|NCT02513160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102521253|NCT02513160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521254|NCT02513160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102521255|NCT02513160|Glucocorticoids|glucocorticoids|mesh-ancestor
102521256|NCT02513160|Hormones|hormones|mesh-ancestor
102521257|NCT02513160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102521258|NCT01507103|Cyclophosphamide|cyclophosphamide|mesh-list
102521259|NCT01507103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102521260|NCT01507103|Immunologic Factors|immunologic factors|mesh-ancestor
102521261|NCT01507103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521262|NCT01507103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102521263|NCT01507103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102521264|NCT01507103|Alkylating Agents|alkylating agents|mesh-ancestor
102521265|NCT01507103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521266|NCT01507103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102521267|NCT01507103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102521268|NCT02480010|Pertuzumab|pertuzumab|mesh-list
102521269|NCT02480010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102521270|NCT02480010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102521271|NCT00876200|Minoxidil|minoxidil|mesh-list
102521272|NCT00876200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102521273|NCT00876200|Vasodilator Agents|vasodilator agents|mesh-ancestor
102521274|NCT02512302|Glycopyrrolate|glycopyrrolate|mesh-list
102521275|NCT02512302|Bromides|bromides|mesh-list
102521276|NCT02512302|Charcoal|charcoal|mesh-list
102521277|NCT02512302|Anticonvulsants|anticonvulsants|mesh-ancestor
102521278|NCT02512302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102521279|NCT02512302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102521280|NCT02512302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102521281|NCT02512302|Cholinergic Agents|cholinergic agents|mesh-ancestor
102521282|NCT02512302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102521283|NCT02512302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521284|NCT02512302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521285|NCT02512302|Antidotes|antidotes|mesh-ancestor
102521286|NCT02512302|Protective Agents|protective agents|mesh-ancestor
102521287|NCT01507181|Midazolam|midazolam|mesh-list
102521288|NCT01507181|Ketamine|ketamine|mesh-list
102521289|NCT01507181|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-list
102521290|NCT01507181|N-Methylaspartate|n-methylaspartate|mesh-list
102521291|NCT01507181|Analgesics|analgesics|mesh-ancestor
102521292|NCT01507181|Sensory System Agents|sensory system agents|mesh-ancestor
102521293|NCT01507181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102521294|NCT01507181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521295|NCT01507181|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102521296|NCT01507181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102521297|NCT01507181|Anesthetics, General|anesthetics, general|mesh-ancestor
102521298|NCT01507181|Anesthetics|anesthetics|mesh-ancestor
102521299|NCT01507181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102521300|NCT01507181|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102521301|NCT01507181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102521302|NCT01507181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521303|NCT01507181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102521304|NCT01507181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102521305|NCT01507181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102521306|NCT01507181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102521307|NCT01507181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102521308|NCT01507181|GABA Modulators|gaba modulators|mesh-ancestor
102521309|NCT01507181|GABA Agents|gaba agents|mesh-ancestor
102521310|NCT01507181|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
102521311|NCT01428245|Estradiol|estradiol|mesh-list
102521312|NCT01428245|Estrogens|estrogens|mesh-list
102521313|NCT01428245|Progesterone|progesterone|mesh-list
102521314|NCT01428245|Hormones|hormones|mesh-ancestor
102521315|NCT01428245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102521316|NCT01428245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521317|NCT01428245|Progestins|progestins|mesh-ancestor
102521318|NCT00877370|Ertapenem|ertapenem|mesh-list
102521319|NCT00877370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102521320|NCT00877370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102521321|NCT00877604|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
102521322|NCT00877604|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102521323|NCT00877604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102521324|NCT00877604|Antiviral Agents|antiviral agents|mesh-ancestor
102521325|NCT00877604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102521326|NCT01508117|Axitinib|axitinib|mesh-list
102521327|NCT01508117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102521328|NCT01508117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102521329|NCT01508117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102521330|NCT01508117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521331|NCT00878228|Ondansetron|ondansetron|mesh-list
102521332|NCT00878228|Antiemetics|antiemetics|mesh-ancestor
102521333|NCT00878228|Autonomic Agents|autonomic agents|mesh-ancestor
102521334|NCT00878228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102521335|NCT00878228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521336|NCT00878228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102521337|NCT00878228|Antipruritics|antipruritics|mesh-ancestor
102521338|NCT00878228|Dermatologic Agents|dermatologic agents|mesh-ancestor
102521339|NCT00878228|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102521340|NCT00878228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102521341|NCT00878228|Serotonin Agents|serotonin agents|mesh-ancestor
102521342|NCT00878228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102521343|NCT00878228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521344|NCT01391273|Bimatoprost|bimatoprost|mesh-list
102521345|NCT01391273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102521346|NCT01391273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102521347|NCT01429259|Meropenem|meropenem|mesh-list
102521348|NCT01429259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102521349|NCT01429259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102521350|NCT05177198|Clindamycin|clindamycin|mesh-list
102521351|NCT05177198|Clindamycin palmitate|clindamycin palmitate|mesh-list
102521352|NCT05177198|Clindamycin phosphate|clindamycin phosphate|mesh-list
102521353|NCT05177198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102521354|NCT05177198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102521355|NCT05177198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102521356|NCT05177198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102521357|NCT05177198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521358|NCT01392989|Cyclosporine|cyclosporine|mesh-list
102521359|NCT01392989|Mycophenolic Acid|mycophenolic acid|mesh-list
102521360|NCT01392989|Cyclosporins|cyclosporins|mesh-list
102521361|NCT01392989|Thymoglobulin|thymoglobulin|mesh-list
102521362|NCT01392989|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102521363|NCT01392989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102521364|NCT01392989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521365|NCT01392989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102521366|NCT01392989|Immunologic Factors|immunologic factors|mesh-ancestor
102521367|NCT01392989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521368|NCT01392989|Antifungal Agents|antifungal agents|mesh-ancestor
102521369|NCT01392989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102521370|NCT01392989|Dermatologic Agents|dermatologic agents|mesh-ancestor
102521371|NCT01392989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102521372|NCT01392989|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102521373|NCT01392989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102521374|NCT01392989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102521375|NCT01392989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102521376|NCT01392989|Antitubercular Agents|antitubercular agents|mesh-ancestor
102521377|NCT01392989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102521378|NCT01393457|Levodopa|levodopa|mesh-list
102521379|NCT01393457|Carbidopa|carbidopa|mesh-list
102521380|NCT01393457|Ropinirole|ropinirole|mesh-list
102521381|NCT01393457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102521382|NCT01393457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102521383|NCT01393457|Dopamine Agents|dopamine agents|mesh-ancestor
102521384|NCT01393457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102521385|NCT01393457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521386|NCT01393457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521387|NCT01393457|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102521388|NCT01393457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102521389|NCT01393457|Dopamine Agonists|dopamine agonists|mesh-ancestor
102521390|NCT02518464|Ticagrelor|ticagrelor|mesh-list
102521391|NCT02518464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102521392|NCT02518464|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102521393|NCT02518464|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102521394|NCT02518464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102521395|NCT02518464|Purinergic Agents|purinergic agents|mesh-ancestor
102521396|NCT02518464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102521397|NCT02518464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521398|NCT02518464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521399|NCT02479230|Gemcitabine|gemcitabine|mesh-list
102521400|NCT02479230|Vaccines|vaccines|mesh-list
102521401|NCT02479230|Immunologic Factors|immunologic factors|mesh-ancestor
102521402|NCT02479230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521403|NCT02479230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102521404|NCT02479230|Antimetabolites|antimetabolites|mesh-ancestor
102521405|NCT02479230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521406|NCT02479230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102521407|NCT04985136|Sorafenib|sorafenib|mesh-list
102521408|NCT04985136|Apatinib|apatinib|mesh-list
102521409|NCT04985136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102521410|NCT04985136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102521411|NCT04985136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102521412|NCT04985136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521413|NCT04411446|Vitamin D|vitamin d|mesh-list
102521414|NCT04411446|Cholecalciferol|cholecalciferol|mesh-list
102521415|NCT04411446|Vitamins|vitamins|mesh-ancestor
102521416|NCT04411446|Micronutrients|micronutrients|mesh-ancestor
102521417|NCT04411446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521418|NCT04411446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102521419|NCT04411446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102521420|NCT01510379|Promethazine|promethazine|mesh-list
102521421|NCT01510379|Diphenhydramine|diphenhydramine|mesh-list
102521422|NCT01510379|Ondansetron|ondansetron|mesh-list
102521423|NCT01510379|Antiemetics|antiemetics|mesh-ancestor
102521424|NCT01510379|Autonomic Agents|autonomic agents|mesh-ancestor
102521425|NCT01510379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102521426|NCT01510379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521427|NCT01510379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102521428|NCT01510379|Antipruritics|antipruritics|mesh-ancestor
102521429|NCT01510379|Dermatologic Agents|dermatologic agents|mesh-ancestor
102521430|NCT01510379|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102521431|NCT01510379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102521432|NCT01510379|Serotonin Agents|serotonin agents|mesh-ancestor
102521433|NCT01510379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102521434|NCT01510379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521435|NCT01510379|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102521436|NCT01510379|Histamine Antagonists|histamine antagonists|mesh-ancestor
102521437|NCT01510379|Histamine Agents|histamine agents|mesh-ancestor
102521438|NCT01510379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102521439|NCT01510379|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102521440|NCT01510379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102521441|NCT01510379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102332946|NCT04146298|Antibodies|antibodies|mesh-list
102521442|NCT01510379|Anesthetics, Local|anesthetics, local|mesh-ancestor
102521443|NCT01510379|Anesthetics|anesthetics|mesh-ancestor
102521444|NCT01510379|Sensory System Agents|sensory system agents|mesh-ancestor
102521445|NCT01363986|Trastuzumab|trastuzumab|mesh-list
102521446|NCT01363986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102521447|NCT01363986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102521448|NCT01510457|Milnacipran|milnacipran|mesh-list
102521449|NCT01510457|Levomilnacipran|levomilnacipran|mesh-list
102521450|NCT01510457|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102521451|NCT01510457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102521452|NCT01510457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102521453|NCT01510457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521454|NCT01510457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102521455|NCT01510457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521456|NCT01510457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102521457|NCT01510457|Analgesics|analgesics|mesh-ancestor
102521458|NCT01510457|Sensory System Agents|sensory system agents|mesh-ancestor
102521459|NCT01510457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102521460|NCT01510457|Antidepressive Agents|antidepressive agents|mesh-ancestor
102521461|NCT01510457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102521462|NCT02478372|Bupivacaine|bupivacaine|mesh-list
102521463|NCT02478372|Ropivacaine|ropivacaine|mesh-list
102521464|NCT02478372|Levobupivacaine|levobupivacaine|mesh-list
102521465|NCT02478372|Anesthetics, Local|anesthetics, local|mesh-ancestor
102521466|NCT02478372|Anesthetics|anesthetics|mesh-ancestor
102521467|NCT02478372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102521468|NCT02478372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521469|NCT02478372|Sensory System Agents|sensory system agents|mesh-ancestor
102521470|NCT02478372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102521471|NCT01511315|Ustekinumab|ustekinumab|mesh-list
102521472|NCT01511315|Dermatologic Agents|dermatologic agents|mesh-ancestor
102521473|NCT01654536|Ciclesonide|ciclesonide|mesh-list
102521474|NCT01654536|Glucocorticoids|glucocorticoids|mesh-ancestor
102521475|NCT01654536|Hormones|hormones|mesh-ancestor
102521476|NCT01654536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102521477|NCT01654536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521478|NCT01654536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102521479|NCT01654380|Insulin Glargine|insulin glargine|mesh-list
102521480|NCT01654380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102521481|NCT01654380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521482|NCT02509026|Etanercept|etanercept|mesh-list
102521483|NCT02509026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102521484|NCT02509026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102521485|NCT02509026|Analgesics|analgesics|mesh-ancestor
102521486|NCT02509026|Sensory System Agents|sensory system agents|mesh-ancestor
102521487|NCT02509026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102521488|NCT02509026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521489|NCT02509026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102521490|NCT02509026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102521491|NCT02509026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102521492|NCT02509026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102521493|NCT02509026|Immunologic Factors|immunologic factors|mesh-ancestor
102521494|NCT03439280|Dexamethasone|dexamethasone|mesh-list
102521495|NCT03439280|Pomalidomide|pomalidomide|mesh-list
102521496|NCT03439280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102521497|NCT03439280|Antiemetics|antiemetics|mesh-ancestor
102521498|NCT03439280|Autonomic Agents|autonomic agents|mesh-ancestor
102521499|NCT03439280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102521500|NCT03439280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521501|NCT03439280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102521502|NCT03439280|Glucocorticoids|glucocorticoids|mesh-ancestor
102521503|NCT03439280|Hormones|hormones|mesh-ancestor
102521504|NCT03439280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102521505|NCT03439280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102521506|NCT03439280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102521507|NCT03439280|Immunologic Factors|immunologic factors|mesh-ancestor
102521508|NCT03439280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102521509|NCT03439280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102521510|NCT03439280|Growth Substances|growth substances|mesh-ancestor
102521511|NCT03439280|Growth Inhibitors|growth inhibitors|mesh-ancestor
102521512|NCT00828074|Sorafenib|sorafenib|mesh-list
102521513|NCT00828074|Vinorelbine|vinorelbine|mesh-list
102521514|NCT00828074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102521515|NCT00828074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102521516|NCT00828074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102521517|NCT00828074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521518|NCT00828074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102521519|NCT00828074|Tubulin Modulators|tubulin modulators|mesh-ancestor
102521520|NCT00828074|Antimitotic Agents|antimitotic agents|mesh-ancestor
102521521|NCT00828074|Mitosis Modulators|mitosis modulators|mesh-ancestor
102521522|NCT03434444|Propranolol|propranolol|mesh-list
102521523|NCT03434444|Oxytocin|oxytocin|mesh-list
102521524|NCT03434444|Oxytocics|oxytocics|mesh-ancestor
102521525|NCT03434444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102521526|NCT03434444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521527|NCT03434444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102521528|NCT03434444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102521529|NCT03434444|Adrenergic Agents|adrenergic agents|mesh-ancestor
102521530|NCT03434444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102521531|NCT03434444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521532|NCT03434444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102521533|NCT03434444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102521534|NCT03434444|Vasodilator Agents|vasodilator agents|mesh-ancestor
102521535|NCT04382300|Thalidomide|thalidomide|mesh-list
102521536|NCT04382300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102521537|NCT04382300|Immunologic Factors|immunologic factors|mesh-ancestor
102521538|NCT04382300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521539|NCT04382300|Leprostatic Agents|leprostatic agents|mesh-ancestor
102521540|NCT04382300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102521541|NCT04382300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102521542|NCT04382300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102521543|NCT04382300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102521544|NCT04382300|Growth Substances|growth substances|mesh-ancestor
102521545|NCT04382300|Growth Inhibitors|growth inhibitors|mesh-ancestor
102521546|NCT04382300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102521547|NCT01430819|Vaccines|vaccines|mesh-list
102521548|NCT01430819|Immunologic Factors|immunologic factors|mesh-ancestor
102521549|NCT01430819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521550|NCT00828542|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102521551|NCT00828542|Medroxyprogesterone|medroxyprogesterone|mesh-list
102521552|NCT00828542|Desogestrel|desogestrel|mesh-list
102521553|NCT00828542|Etonogestrel|etonogestrel|mesh-list
102521554|NCT00828542|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102521555|NCT00828542|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102521556|NCT00828542|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102521557|NCT00828542|Contraceptive Agents|contraceptive agents|mesh-ancestor
102521558|NCT00828542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102521559|NCT00828542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521560|NCT00828542|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102521561|NCT00828542|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102521562|NCT00828542|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102521563|NCT00828542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102521564|NCT00828542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102521565|NCT00828542|Progestins|progestins|mesh-ancestor
102521566|NCT00828542|Hormones|hormones|mesh-ancestor
102521567|NCT00828542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102521568|NCT01395329|Metoprolol|metoprolol|mesh-list
102521569|NCT01395329|Nebivolol|nebivolol|mesh-list
102521570|NCT01395329|Nitroprusside|nitroprusside|mesh-list
102521571|NCT01395329|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
102521572|NCT01395329|BQ 788|bq 788|mesh-list
102521573|NCT01395329|Acetylcholine|acetylcholine|mesh-list
102521574|NCT01395329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102521575|NCT01395329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102521576|NCT01395329|Sympatholytics|sympatholytics|mesh-ancestor
102521577|NCT01395329|Autonomic Agents|autonomic agents|mesh-ancestor
102521578|NCT01395329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102521579|NCT01395329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521580|NCT01395329|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102521581|NCT01395329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102521582|NCT01395329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102521583|NCT01395329|Adrenergic Agents|adrenergic agents|mesh-ancestor
102521584|NCT01395329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102521585|NCT01395329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521586|NCT01395329|Vasodilator Agents|vasodilator agents|mesh-ancestor
102521587|NCT01395329|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102521588|NCT01395329|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102521589|NCT01395329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102521590|NCT01395329|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102521591|NCT01395329|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102521592|NCT01395329|Cholinergic Agents|cholinergic agents|mesh-ancestor
102521593|NCT01395329|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102521594|NCT01395329|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
102521595|NCT00882206|Cytarabine|cytarabine|mesh-list
102521596|NCT00882206|Prednisone|prednisone|mesh-list
102521597|NCT00882206|Doxorubicin|doxorubicin|mesh-list
102521598|NCT00882206|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102521599|NCT00882206|Methotrexate|methotrexate|mesh-list
102521600|NCT00882206|Vincristine|vincristine|mesh-list
102521601|NCT00882206|Imatinib Mesylate|imatinib mesylate|mesh-list
102521602|NCT00882206|Decitabine|decitabine|mesh-list
102521603|NCT00882206|Asparaginase|asparaginase|mesh-list
102521604|NCT00882206|Vorinostat|vorinostat|mesh-list
102521605|NCT00882206|Pegaspargase|pegaspargase|mesh-list
102521606|NCT00882206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102521607|NCT00882206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102521608|NCT00882206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102521609|NCT00882206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102521610|NCT00882206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102521611|NCT00882206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521612|NCT00882206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102521613|NCT00882206|Glucocorticoids|glucocorticoids|mesh-ancestor
102521614|NCT00882206|Hormones|hormones|mesh-ancestor
102521615|NCT00882206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102521616|NCT00882206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521617|NCT00882206|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102521618|NCT00882206|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102521619|NCT00882206|Abortifacient Agents|abortifacient agents|mesh-ancestor
102521620|NCT00882206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102521621|NCT00882206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102521622|NCT00882206|Antimetabolites|antimetabolites|mesh-ancestor
102521623|NCT00882206|Dermatologic Agents|dermatologic agents|mesh-ancestor
102521624|NCT00882206|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102521625|NCT00882206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102521626|NCT00882206|Immunologic Factors|immunologic factors|mesh-ancestor
102521627|NCT00882206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102521628|NCT00882206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102521629|NCT00882206|Antiviral Agents|antiviral agents|mesh-ancestor
102521630|NCT00882206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102521631|NCT00882206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102521632|NCT00882206|Tubulin Modulators|tubulin modulators|mesh-ancestor
102521633|NCT00882206|Antimitotic Agents|antimitotic agents|mesh-ancestor
102521634|NCT00882206|Mitosis Modulators|mitosis modulators|mesh-ancestor
102521635|NCT00882206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102521636|NCT00882206|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102521637|NCT00831272|Naltrexone|naltrexone|mesh-list
102521638|NCT00831272|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102521639|NCT00831272|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102521640|NCT00831272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521641|NCT00831272|Sensory System Agents|sensory system agents|mesh-ancestor
102521642|NCT00831272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102521643|NCT00885092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102521644|NCT01512251|Vemurafenib|vemurafenib|mesh-list
102521645|NCT01512251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102521646|NCT01512251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102521647|NCT01512251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102521648|NCT01512251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521649|NCT00885638|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102521650|NCT00885638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102521651|NCT00885638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521652|NCT00885638|Incretins|incretins|mesh-ancestor
102521653|NCT00885638|Hormones|hormones|mesh-ancestor
102521654|NCT00885638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102521655|NCT00885638|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102521656|NCT00885638|Protease Inhibitors|protease inhibitors|mesh-ancestor
102521657|NCT00885638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102521658|NCT00885638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521659|NCT01512797|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102521660|NCT01512797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102521661|NCT01512797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521662|NCT01512797|Incretins|incretins|mesh-ancestor
102521663|NCT01512797|Hormones|hormones|mesh-ancestor
102521664|NCT01512797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102521665|NCT01512797|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102521666|NCT01512797|Protease Inhibitors|protease inhibitors|mesh-ancestor
102521667|NCT01512797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102521668|NCT01512797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521669|NCT05620940|Naltrexone|naltrexone|mesh-list
102521670|NCT05620940|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102521671|NCT05620940|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102521672|NCT05620940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521673|NCT05620940|Sensory System Agents|sensory system agents|mesh-ancestor
102521674|NCT05620940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102521675|NCT01395797|Pioglitazone|pioglitazone|mesh-list
102521676|NCT01395797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102521677|NCT01395797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521678|NCT05124704|Ropivacaine|ropivacaine|mesh-list
102521679|NCT05124704|Anesthetics, Local|anesthetics, local|mesh-ancestor
102521680|NCT05124704|Anesthetics|anesthetics|mesh-ancestor
102521681|NCT05124704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102521682|NCT05124704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521683|NCT05124704|Sensory System Agents|sensory system agents|mesh-ancestor
102521684|NCT05124704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102521685|NCT02203019|Fentanyl|fentanyl|mesh-list
102521686|NCT02203019|Dexmedetomidine|dexmedetomidine|mesh-list
102521687|NCT02203019|Propofol|propofol|mesh-list
102521688|NCT02203019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102521689|NCT02203019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102521690|NCT02203019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521691|NCT02203019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102521692|NCT02203019|Analgesics|analgesics|mesh-ancestor
102521693|NCT02203019|Sensory System Agents|sensory system agents|mesh-ancestor
102521694|NCT02203019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102521695|NCT02203019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102521696|NCT02203019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102521697|NCT02203019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102521698|NCT02203019|Adrenergic Agents|adrenergic agents|mesh-ancestor
102521699|NCT02203019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102521700|NCT02203019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521701|NCT02203019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102521702|NCT02203019|Anesthetics, General|anesthetics, general|mesh-ancestor
102521703|NCT02203019|Anesthetics|anesthetics|mesh-ancestor
102521704|NCT02203019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102521705|NCT02203019|Narcotics|narcotics|mesh-ancestor
102521706|NCT02203019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102521707|NCT00886262|Vasopressins|vasopressins|mesh-list
102521708|NCT00886262|Arginine Vasopressin|arginine vasopressin|mesh-list
102521709|NCT00886262|Hemostatics|hemostatics|mesh-ancestor
102521710|NCT00886262|Coagulants|coagulants|mesh-ancestor
102521711|NCT00886262|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102521712|NCT00886262|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102521713|NCT00886262|Natriuretic Agents|natriuretic agents|mesh-ancestor
102521714|NCT00886262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521715|NCT00887510|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102521716|NCT00887510|Trandolapril|trandolapril|mesh-list
102521717|NCT00887510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102521718|NCT00887510|Diuretics|diuretics|mesh-ancestor
102521719|NCT00887510|Natriuretic Agents|natriuretic agents|mesh-ancestor
102521720|NCT00887510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521721|NCT00887510|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102521722|NCT00887510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102521723|NCT00887510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521724|NCT00887510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102521725|NCT00887510|Protease Inhibitors|protease inhibitors|mesh-ancestor
102521726|NCT00887510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102521727|NCT01431989|Amoxicillin|amoxicillin|mesh-list
102521728|NCT01431989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102521729|NCT01431989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102521730|NCT01397591|Bortezomib|bortezomib|mesh-list
102521731|NCT01397591|Ofatumumab|ofatumumab|mesh-list
102521732|NCT01397591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102521733|NCT03855332|Cilostazol|cilostazol|mesh-list
102521734|NCT03855332|Sildenafil Citrate|sildenafil citrate|mesh-list
102521735|NCT03855332|Vasodilator Agents|vasodilator agents|mesh-ancestor
102521736|NCT03855332|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102521737|NCT03855332|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102521738|NCT03855332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102521739|NCT03855332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521740|NCT03855332|Urological Agents|urological agents|mesh-ancestor
102521741|NCT03855332|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102521742|NCT03855332|Autonomic Agents|autonomic agents|mesh-ancestor
102521743|NCT03855332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102333245|NCT04804540|Vedolizumab|vedolizumab|mesh-list
102521744|NCT03855332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521745|NCT03855332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102521746|NCT03855332|Respiratory System Agents|respiratory system agents|mesh-ancestor
102521747|NCT03855332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102521748|NCT03855332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102521749|NCT03855332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102521750|NCT03855332|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102521751|NCT03855332|Protective Agents|protective agents|mesh-ancestor
102521752|NCT03855332|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102521753|NCT02335580|Somatostatin|somatostatin|mesh-list
102521754|NCT02335580|Hormones|hormones|mesh-ancestor
102521755|NCT02335580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102521756|NCT02335580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521757|NCT02476968|Olaparib|olaparib|mesh-list
102521758|NCT02476968|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102521759|NCT02476968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102521760|NCT02476968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521761|NCT02476968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102521762|NCT01514513|Permethrin|permethrin|mesh-list
102521763|NCT01514513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102521764|NCT01514513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521765|NCT04981860|Povidone-Iodine|povidone-iodine|mesh-list
102521766|NCT04981860|Povidone|povidone|mesh-list
102521767|NCT04981860|Plasma Substitutes|plasma substitutes|mesh-ancestor
102521768|NCT04981860|Blood Substitutes|blood substitutes|mesh-ancestor
102521769|NCT04981860|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102521770|NCT04981860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102521771|NCT01432145|Methotrexate|methotrexate|mesh-list
102521772|NCT01432145|Mercaptopurine|mercaptopurine|mesh-list
102521773|NCT01432145|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102521774|NCT01432145|Abortifacient Agents|abortifacient agents|mesh-ancestor
102521775|NCT01432145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102521776|NCT01432145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521777|NCT01432145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102521778|NCT01432145|Antimetabolites|antimetabolites|mesh-ancestor
102521779|NCT01432145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521780|NCT01432145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102521781|NCT01432145|Dermatologic Agents|dermatologic agents|mesh-ancestor
102521782|NCT01432145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102521783|NCT01432145|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102521784|NCT01432145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102521785|NCT01432145|Immunologic Factors|immunologic factors|mesh-ancestor
102521786|NCT01432145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102521787|NCT01432145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102521788|NCT04979520|Brodalumab|brodalumab|mesh-list
102521789|NCT04979520|Dermatologic Agents|dermatologic agents|mesh-ancestor
102521790|NCT01432379|Botulinum Toxins|botulinum toxins|mesh-list
102521791|NCT01432379|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102521792|NCT01432379|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102521793|NCT01432379|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102521794|NCT01432379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102521795|NCT01432379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521796|NCT01432379|Cholinergic Agents|cholinergic agents|mesh-ancestor
102521797|NCT01432379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102521798|NCT01432379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521799|NCT01432379|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102521800|NCT01432379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102521801|NCT02504892|Everolimus|everolimus|mesh-list
102521802|NCT02504892|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102521803|NCT02504892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102521804|NCT02504892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102521805|NCT02504892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521806|NCT02504892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102521807|NCT02504892|Immunologic Factors|immunologic factors|mesh-ancestor
102521808|NCT02504892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521809|NCT02504892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102521810|NCT01432535|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102521811|NCT01432535|Antiviral Agents|antiviral agents|mesh-ancestor
102521812|NCT01432535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102521813|NCT05946902|Mirabegron|mirabegron|mesh-list
102521814|NCT05946902|Tolterodine Tartrate|tolterodine tartrate|mesh-list
102521815|NCT05946902|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102521816|NCT05946902|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102521817|NCT05946902|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102521818|NCT05946902|Adrenergic Agents|adrenergic agents|mesh-ancestor
102521819|NCT05946902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102521820|NCT05946902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521821|NCT05946902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521822|NCT05946902|Urological Agents|urological agents|mesh-ancestor
102521823|NCT05946902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102521824|NCT05946902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102521825|NCT05946902|Cholinergic Agents|cholinergic agents|mesh-ancestor
102521826|NCT05946811|Macitentan|macitentan|mesh-list
102521827|NCT05946811|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
102521828|NCT05946811|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102521829|NCT05946811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521830|NCT05946811|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
102521831|NCT05946798|Insulin Aspart|insulin aspart|mesh-list
102521832|NCT05946798|Acetylcholine|acetylcholine|mesh-list
102521833|NCT05946798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102521834|NCT05946798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521835|NCT05946798|Vasodilator Agents|vasodilator agents|mesh-ancestor
102521836|NCT05946798|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102521837|NCT05946798|Cholinergic Agents|cholinergic agents|mesh-ancestor
102521838|NCT05946798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102521839|NCT05946798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521840|NCT05946785|Insulin Aspart|insulin aspart|mesh-list
102521841|NCT05946785|Acetylcholine|acetylcholine|mesh-list
102521842|NCT05946785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102521843|NCT05946785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521844|NCT05946785|Vasodilator Agents|vasodilator agents|mesh-ancestor
102521845|NCT05946785|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102521846|NCT05946785|Cholinergic Agents|cholinergic agents|mesh-ancestor
102521847|NCT05946785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102521848|NCT05946785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521849|NCT05946772|Cyclosporine|cyclosporine|mesh-list
102521850|NCT05946772|Cyclosporins|cyclosporins|mesh-list
102521851|NCT05946772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102521852|NCT05946772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521853|NCT05946772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102521854|NCT05946772|Immunologic Factors|immunologic factors|mesh-ancestor
102521855|NCT05946772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521856|NCT05946772|Antifungal Agents|antifungal agents|mesh-ancestor
102521857|NCT05946772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102521858|NCT05946772|Dermatologic Agents|dermatologic agents|mesh-ancestor
102521859|NCT05946772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102521860|NCT05946772|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102521861|NCT05946655|Metronidazole|metronidazole|mesh-list
102521862|NCT05946655|Ofloxacin|ofloxacin|mesh-list
102521863|NCT05946655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102521864|NCT05946655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102521865|NCT05946655|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102521866|NCT05946655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102521867|NCT05946655|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102521868|NCT05946655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102521869|NCT05946655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102521870|NCT05946655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102521871|NCT05946655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521872|NCT05946655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102521873|NCT05946655|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102521874|NCT05946655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102521875|NCT05946642|Ivermectin|ivermectin|mesh-list
102521876|NCT05946642|Pyrimethamine|pyrimethamine|mesh-list
102521877|NCT05946642|Piperaquine|piperaquine|mesh-list
102521878|NCT05946642|Sulfadoxine|sulfadoxine|mesh-list
102521879|NCT05946642|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
102521880|NCT05946642|Amodiaquine|amodiaquine|mesh-list
102521881|NCT05946642|Artenimol|artenimol|mesh-list
102521882|NCT05946642|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102521883|NCT05946642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102521884|NCT05946642|Antimalarials|antimalarials|mesh-ancestor
102521885|NCT05946642|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102521886|NCT05946642|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102521887|NCT05946642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102521888|NCT05946642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521889|NCT05946642|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102521890|NCT05946564|Pioglitazone|pioglitazone|mesh-list
102521891|NCT05946564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102521892|NCT05946564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521893|NCT05946551|Cetirizine|cetirizine|mesh-list
102521894|NCT05946551|Naltrexone|naltrexone|mesh-list
102333395|NCT03883828|Chlorhexidine|chlorhexidine|mesh-list
102521896|NCT05946551|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102521897|NCT05946551|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102521898|NCT05946551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521899|NCT05946551|Sensory System Agents|sensory system agents|mesh-ancestor
102521900|NCT05946551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102521901|NCT05946551|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102521902|NCT05946551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102521903|NCT05946551|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102521904|NCT05946551|Histamine Antagonists|histamine antagonists|mesh-ancestor
102521905|NCT05946551|Histamine Agents|histamine agents|mesh-ancestor
102521906|NCT05946551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102521907|NCT05946551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521908|NCT05946551|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102521909|NCT05946551|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102521910|NCT05946551|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102521911|NCT05946486|Rituximab|rituximab|mesh-list
102521912|NCT05946486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102521913|NCT05946486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102521914|NCT05946486|Immunologic Factors|immunologic factors|mesh-ancestor
102521915|NCT05946486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521916|NCT05946486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102521917|NCT05946148|Empagliflozin|empagliflozin|mesh-list
102521918|NCT05946148|Dulaglutide|dulaglutide|mesh-list
102521919|NCT05946148|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102521920|NCT05946148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521921|NCT05946148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102521922|NCT05946148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521923|NCT05946135|Lansoprazole|lansoprazole|mesh-list
102521924|NCT05946135|Dexlansoprazole|dexlansoprazole|mesh-list
102521925|NCT05946135|Fexuprazan|fexuprazan|mesh-list
102521926|NCT05946135|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102521927|NCT05946135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102521928|NCT05946135|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102521929|NCT05946135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102521930|NCT05946135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521931|NCT05946122|Atorvastatin|atorvastatin|mesh-list
102521932|NCT05946122|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102521933|NCT05946122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102521934|NCT05946122|Antimetabolites|antimetabolites|mesh-ancestor
102521935|NCT05946122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521936|NCT05946122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102521937|NCT05946122|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102521938|NCT05946122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102521939|NCT05946005|Povidone-Iodine|povidone-iodine|mesh-list
102521940|NCT05946005|Lidocaine|lidocaine|mesh-list
102521941|NCT05946005|Povidone|povidone|mesh-list
102521942|NCT05946005|Anesthetics, Local|anesthetics, local|mesh-ancestor
102521943|NCT05946005|Anesthetics|anesthetics|mesh-ancestor
102521944|NCT05946005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102521945|NCT05946005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521946|NCT05946005|Sensory System Agents|sensory system agents|mesh-ancestor
102521947|NCT05946005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102521948|NCT05946005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102521949|NCT05946005|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102521950|NCT05946005|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102521951|NCT05946005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102521952|NCT05946005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521953|NCT05946005|Plasma Substitutes|plasma substitutes|mesh-ancestor
102521954|NCT05946005|Blood Substitutes|blood substitutes|mesh-ancestor
102521955|NCT05946005|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102521956|NCT05946005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102521957|NCT05945979|Biotin|biotin|mesh-list
102521958|NCT05945979|Vitamin B Complex|vitamin b complex|mesh-ancestor
102521959|NCT05945979|Vitamins|vitamins|mesh-ancestor
102521960|NCT05945979|Micronutrients|micronutrients|mesh-ancestor
102521961|NCT05945979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521962|NCT05945875|Panitumumab|panitumumab|mesh-list
102521963|NCT05945875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102521964|NCT05945875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102521965|NCT05945797|Dexamethasone|dexamethasone|mesh-list
102521966|NCT05945797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102521967|NCT05945797|Antiemetics|antiemetics|mesh-ancestor
102521968|NCT05945797|Autonomic Agents|autonomic agents|mesh-ancestor
102521969|NCT05945797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102521970|NCT05945797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521971|NCT05945797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102521972|NCT05945797|Glucocorticoids|glucocorticoids|mesh-ancestor
102521974|NCT05945797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102521975|NCT05945797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102521976|NCT05945797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102521977|NCT05945771|Grape Seed Extract|grape seed extract|mesh-list
102521978|NCT05945771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101998234|NCT05762744|Incretins|incretins|mesh-ancestor
102521979|NCT05945771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102521980|NCT05945771|Antioxidants|antioxidants|mesh-ancestor
102521981|NCT05945771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521982|NCT05945771|Protective Agents|protective agents|mesh-ancestor
102521983|NCT05945771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521984|NCT05945745|Immunomodulating Agents|immunomodulating agents|mesh-list
102521985|NCT05945745|Immunologic Factors|immunologic factors|mesh-ancestor
102521986|NCT05945745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521987|NCT05945732|Trastuzumab|trastuzumab|mesh-list
102521988|NCT05945732|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
102521989|NCT05945732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102521990|NCT05945732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102521991|NCT05945732|Immunoconjugates|immunoconjugates|mesh-ancestor
102521992|NCT05945732|Immunologic Factors|immunologic factors|mesh-ancestor
102521993|NCT05945732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102521994|NCT05945680|Tranexamic Acid|tranexamic acid|mesh-list
102521995|NCT05945680|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102521996|NCT05945680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102521997|NCT05945680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102521998|NCT05945680|Hemostatics|hemostatics|mesh-ancestor
102521999|NCT05945680|Coagulants|coagulants|mesh-ancestor
102522000|NCT05945615|Phenylephrine|phenylephrine|mesh-list
102522001|NCT05945615|Oxymetazoline|oxymetazoline|mesh-list
102522002|NCT05945615|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102522003|NCT05945615|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102522004|NCT05945615|Adrenergic Agents|adrenergic agents|mesh-ancestor
102522005|NCT05945615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102522006|NCT05945615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522007|NCT05945615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522008|NCT05945615|Sympathomimetics|sympathomimetics|mesh-ancestor
102522009|NCT05945615|Autonomic Agents|autonomic agents|mesh-ancestor
102522010|NCT05945615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102522011|NCT05945615|Nasal Decongestants|nasal decongestants|mesh-ancestor
102522012|NCT05945615|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102522013|NCT05945615|Respiratory System Agents|respiratory system agents|mesh-ancestor
102522014|NCT05945615|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102522015|NCT05945615|Mydriatics|mydriatics|mesh-ancestor
102522016|NCT05945615|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102522017|NCT05945615|Protective Agents|protective agents|mesh-ancestor
102522018|NCT05945420|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
102522019|NCT05945420|Hemostatics|hemostatics|mesh-ancestor
102522020|NCT05945420|Coagulants|coagulants|mesh-ancestor
102522021|NCT05945420|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102522022|NCT05945420|Natriuretic Agents|natriuretic agents|mesh-ancestor
102522023|NCT05945420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522024|NCT05945368|Trastuzumab|trastuzumab|mesh-list
102522025|NCT05945368|Pertuzumab|pertuzumab|mesh-list
102522026|NCT05945368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102522027|NCT05945368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522028|NCT05945342|Fluoxetine|fluoxetine|mesh-list
102522029|NCT05945342|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102522030|NCT05945342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102522031|NCT05945342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102522032|NCT05945342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522033|NCT05945342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102522034|NCT05945342|Serotonin Agents|serotonin agents|mesh-ancestor
102522035|NCT05945342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522036|NCT05945342|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102522037|NCT05945342|Antidepressive Agents|antidepressive agents|mesh-ancestor
102522038|NCT05945342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102522039|NCT05945342|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102522040|NCT05945342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102522041|NCT05945342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102522042|NCT05945173|Ethanol|ethanol|mesh-list
102522043|NCT05945173|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102522044|NCT05945173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102522045|NCT05945173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102522046|NCT05945173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522047|NCT05945160|Thioctic Acid|thioctic acid|mesh-list
102522048|NCT05945160|Ubiquinone|ubiquinone|mesh-list
102522049|NCT05945160|Coenzyme Q10|coenzyme q10|mesh-list
102522050|NCT05945160|Antioxidants|antioxidants|mesh-ancestor
102522051|NCT05945160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522052|NCT05945160|Protective Agents|protective agents|mesh-ancestor
102522053|NCT05945160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522054|NCT05945160|Vitamin B Complex|vitamin b complex|mesh-ancestor
102522055|NCT05945160|Vitamins|vitamins|mesh-ancestor
102522056|NCT05945160|Micronutrients|micronutrients|mesh-ancestor
102522057|NCT05944952|Buprenorphine|buprenorphine|mesh-list
102522058|NCT05944952|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102522059|NCT05944952|Naloxone|naloxone|mesh-list
102522060|NCT05944952|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102522061|NCT05944952|Narcotics|narcotics|mesh-ancestor
102522062|NCT05944952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102522063|NCT05944952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522064|NCT05944952|Analgesics|analgesics|mesh-ancestor
102522065|NCT05944952|Sensory System Agents|sensory system agents|mesh-ancestor
102522066|NCT05944952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102522067|NCT05944952|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102522068|NCT05944107|Heparin|heparin|mesh-list
102522069|NCT05944107|Anticoagulants|anticoagulants|mesh-ancestor
102522070|NCT05944107|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102522071|NCT05944107|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102522072|NCT05944107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522073|NCT05943496|Obinutuzumab|obinutuzumab|mesh-list
102522074|NCT05943496|Acalabrutinib|acalabrutinib|mesh-list
102522075|NCT05943496|Immunoglobulins|immunoglobulins|mesh-list
102522076|NCT05943496|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102522077|NCT05943496|Immunologic Factors|immunologic factors|mesh-ancestor
102522078|NCT05943496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522079|NCT05943496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102522080|NCT05943496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522081|NCT05943496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102522082|NCT05943496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102522083|NCT05943496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522084|NCT05943080|Epinephrine|epinephrine|mesh-list
102522085|NCT05943080|Racepinephrine|racepinephrine|mesh-list
102522086|NCT05943080|Bupivacaine|bupivacaine|mesh-list
102522087|NCT05943080|Epinephryl borate|epinephryl borate|mesh-list
102522088|NCT05943080|Anesthetics, Local|anesthetics, local|mesh-ancestor
102522089|NCT05943080|Anesthetics|anesthetics|mesh-ancestor
102522090|NCT05943080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102522091|NCT05943080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522092|NCT05943080|Sensory System Agents|sensory system agents|mesh-ancestor
102522093|NCT05943080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102522094|NCT05943080|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102522095|NCT05943080|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102522096|NCT05943080|Adrenergic Agents|adrenergic agents|mesh-ancestor
102522097|NCT05943080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102522098|NCT05943080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522099|NCT05943080|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102522100|NCT05943080|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102522101|NCT05943080|Autonomic Agents|autonomic agents|mesh-ancestor
102522102|NCT05943080|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102522103|NCT05943080|Respiratory System Agents|respiratory system agents|mesh-ancestor
102522104|NCT05943080|Mydriatics|mydriatics|mesh-ancestor
102522105|NCT05943080|Sympathomimetics|sympathomimetics|mesh-ancestor
101998374|NCT04065074|Hormones|hormones|mesh-ancestor
102522106|NCT05943080|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102522107|NCT05938946|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102522108|NCT05929495|Metformin|metformin|mesh-list
102522109|NCT05929495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102522110|NCT05929495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522111|NCT05889468|Aspirin|aspirin|mesh-list
102522112|NCT05889468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102522113|NCT05889468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102522114|NCT05889468|Analgesics|analgesics|mesh-ancestor
102522115|NCT05889468|Sensory System Agents|sensory system agents|mesh-ancestor
102522116|NCT05889468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102522117|NCT05889468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522118|NCT05889468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102522119|NCT05889468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102522120|NCT05889468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102522121|NCT05889468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102522122|NCT05889468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522123|NCT05889468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102522124|NCT05889468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102522125|NCT05889468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102522126|NCT05889468|Antipyretics|antipyretics|mesh-ancestor
102522127|NCT05879120|Pembrolizumab|pembrolizumab|mesh-list
102522128|NCT05879120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102522129|NCT05879120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522130|NCT05879120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102522131|NCT05879120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522132|NCT05867147|Moxifloxacin|moxifloxacin|mesh-list
102522133|NCT05867147|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102522134|NCT05867147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102522135|NCT05867147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102522136|NCT05867147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102522137|NCT05867147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102522138|NCT05867147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102522139|NCT05867147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522140|NCT05867147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522141|NCT05867147|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102522142|NCT05867147|Contraceptive Agents|contraceptive agents|mesh-ancestor
102522143|NCT05867147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102522144|NCT05867147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522145|NCT05867147|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102522146|NCT05867147|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102522147|NCT05867147|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102522148|NCT05827484|Losartan|losartan|mesh-list
102522149|NCT05827484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102522150|NCT05827484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102522151|NCT05827484|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102522152|NCT05827484|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102522153|NCT05827484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522154|NCT05820841|Acalabrutinib|acalabrutinib|mesh-list
102522155|NCT05820841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522156|NCT05818085|Allopurinol|allopurinol|mesh-list
102522157|NCT05818085|Antimetabolites|antimetabolites|mesh-ancestor
102522158|NCT05818085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522159|NCT05818085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102522160|NCT05818085|Gout Suppressants|gout suppressants|mesh-ancestor
102522161|NCT05818085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102522162|NCT05818085|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102522163|NCT05818085|Antioxidants|antioxidants|mesh-ancestor
102522164|NCT05818085|Protective Agents|protective agents|mesh-ancestor
102522165|NCT05818085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522166|NCT05806567|Belumosudil|belumosudil|mesh-list
102522167|NCT05806567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102522168|NCT05806567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102522169|NCT05806567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522170|NCT05786443|Empagliflozin|empagliflozin|mesh-list
102522171|NCT05786443|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102522172|NCT05786443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522173|NCT05786443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102522174|NCT05786443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522175|NCT05731518|Irinotecan|irinotecan|mesh-list
102522176|NCT05731518|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102522177|NCT05731518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102522178|NCT05731518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102522179|NCT05731518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522180|NCT05731518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522181|NCT05728944|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102522182|NCT05728944|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102522183|NCT05728944|Aceclidine|aceclidine|mesh-list
102522184|NCT05728944|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102522185|NCT05728944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102522186|NCT05728944|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102522187|NCT05728944|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102522188|NCT05728944|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102522189|NCT05728944|Adrenergic Agents|adrenergic agents|mesh-ancestor
102522190|NCT05728944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102522191|NCT05728944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522192|NCT05728944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522193|NCT05728944|Miotics|miotics|mesh-ancestor
102522194|NCT05728944|Autonomic Agents|autonomic agents|mesh-ancestor
102522195|NCT05728944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102522196|NCT05728944|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102522197|NCT05722561|Nicotine|nicotine|mesh-list
102522198|NCT05722561|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102522199|NCT05722561|Autonomic Agents|autonomic agents|mesh-ancestor
102522200|NCT05722561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102522201|NCT05722561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522202|NCT05722561|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102522203|NCT05722561|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102522204|NCT05722561|Cholinergic Agents|cholinergic agents|mesh-ancestor
102522205|NCT05722561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102522206|NCT05722561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522207|NCT05712278|Cytarabine|cytarabine|mesh-list
102522208|NCT05712278|Fludarabine|fludarabine|mesh-list
102522209|NCT05712278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522210|NCT05712278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102522211|NCT05712278|Antimetabolites|antimetabolites|mesh-ancestor
102522212|NCT05712278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522213|NCT05712278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102522214|NCT05712278|Immunologic Factors|immunologic factors|mesh-ancestor
102522215|NCT05712278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522216|NCT05712278|Antiviral Agents|antiviral agents|mesh-ancestor
102522217|NCT05712278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102522218|NCT05696795|Abrocitinib|abrocitinib|mesh-list
102522219|NCT05696795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102522220|NCT05696795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102522221|NCT05696795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522222|NCT05687123|Sunitinib|sunitinib|mesh-list
102522223|NCT05687123|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102522224|NCT05687123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522225|NCT05687123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102522226|NCT05687123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102522227|NCT05687123|Growth Substances|growth substances|mesh-ancestor
102522228|NCT05687123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522229|NCT05687123|Growth Inhibitors|growth inhibitors|mesh-ancestor
102522230|NCT05687123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102522231|NCT05687123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102522232|NCT05687123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522233|NCT05687123|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102522234|NCT05687110|Novobiocin|novobiocin|mesh-list
102522235|NCT05687110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102522236|NCT05687110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102522237|NCT05687110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102522238|NCT05687110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522239|NCT05687110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102522240|NCT05683392|Insulin|insulin|mesh-list
102522241|NCT05683392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102522242|NCT05683392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522243|NCT05674565|Magnesium Sulfate|magnesium sulfate|mesh-list
102522244|NCT05674565|Analgesics|analgesics|mesh-ancestor
102522245|NCT05674565|Sensory System Agents|sensory system agents|mesh-ancestor
102522246|NCT05674565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102522247|NCT05674565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522248|NCT05674565|Anesthetics|anesthetics|mesh-ancestor
102522249|NCT05674565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102522250|NCT05674565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102522251|NCT05674565|Anticonvulsants|anticonvulsants|mesh-ancestor
102522252|NCT05674565|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102522253|NCT05674565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102522254|NCT05674565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522255|NCT05674565|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102522256|NCT05674565|Tocolytic Agents|tocolytic agents|mesh-ancestor
102522257|NCT05674565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102522258|NCT05664737|Luspatercept|luspatercept|mesh-list
102522259|NCT05664737|Hematinics|hematinics|mesh-ancestor
102522260|NCT05656027|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102522261|NCT05656027|Aceclidine|aceclidine|mesh-list
102522262|NCT05656027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102522263|NCT05656027|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102522264|NCT05656027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102522265|NCT05656027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102522266|NCT05656027|Adrenergic Agents|adrenergic agents|mesh-ancestor
102522267|NCT05656027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102522268|NCT05656027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522269|NCT05656027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522270|NCT05656027|Miotics|miotics|mesh-ancestor
102522271|NCT05656027|Autonomic Agents|autonomic agents|mesh-ancestor
102522272|NCT05656027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102522273|NCT05656027|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102522274|NCT05618925|Cyclophosphamide|cyclophosphamide|mesh-list
102522275|NCT05618925|Rituximab|rituximab|mesh-list
102522276|NCT05618925|Fludarabine|fludarabine|mesh-list
102522277|NCT05618925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102522278|NCT05618925|Immunologic Factors|immunologic factors|mesh-ancestor
102522279|NCT05618925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522280|NCT05618925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102522281|NCT05618925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102522282|NCT05618925|Alkylating Agents|alkylating agents|mesh-ancestor
102522283|NCT05618925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522284|NCT05618925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522285|NCT05618925|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102522286|NCT05618925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102522287|NCT05554276|Antibodies|antibodies|mesh-list
102522288|NCT05554276|Immunologic Factors|immunologic factors|mesh-ancestor
102522289|NCT05554276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522290|NCT05531942|Aspirin|aspirin|mesh-list
102522291|NCT05531942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102522292|NCT05531942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102522293|NCT05531942|Analgesics|analgesics|mesh-ancestor
102522294|NCT05531942|Sensory System Agents|sensory system agents|mesh-ancestor
102522295|NCT05531942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102522296|NCT05531942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522297|NCT05531942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102522298|NCT05531942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102522299|NCT05531942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102522300|NCT05531942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102522301|NCT05531942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522302|NCT05531942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102522303|NCT05531942|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102522304|NCT05531942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102522305|NCT05531942|Antipyretics|antipyretics|mesh-ancestor
102522306|NCT05479916|Caseins|caseins|mesh-list
102522307|NCT05479916|Chelating Agents|chelating agents|mesh-ancestor
102522308|NCT05479916|Sequestering Agents|sequestering agents|mesh-ancestor
102522309|NCT05479916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522310|NCT05466279|Midazolam|midazolam|mesh-list
102522311|NCT05466279|Propofol|propofol|mesh-list
102522312|NCT05466279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102522313|NCT05466279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102522314|NCT05466279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522315|NCT05466279|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102522316|NCT05466279|Anesthetics, General|anesthetics, general|mesh-ancestor
102522317|NCT05466279|Anesthetics|anesthetics|mesh-ancestor
102522318|NCT05466279|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102522319|NCT05466279|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102522320|NCT05466279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102522321|NCT05466279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102522322|NCT05466279|GABA Modulators|gaba modulators|mesh-ancestor
102522323|NCT05466279|GABA Agents|gaba agents|mesh-ancestor
102522324|NCT05466279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102522325|NCT05466279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522326|NCT05451940|Hydroxyurea|hydroxyurea|mesh-list
102522327|NCT05451940|Epoetin Alfa|epoetin alfa|mesh-list
102522328|NCT05451940|Hematinics|hematinics|mesh-list
102522329|NCT05451940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522330|NCT05451940|Antisickling Agents|antisickling agents|mesh-ancestor
102522331|NCT05451940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102522332|NCT05451940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522333|NCT05451940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102522334|NCT05447559|Cefazolin|cefazolin|mesh-list
102522335|NCT05447559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102522336|NCT05447559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102522337|NCT05425420|Methadone|methadone|mesh-list
102522338|NCT05425420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102522339|NCT05425420|Narcotics|narcotics|mesh-ancestor
102522340|NCT05425420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102522341|NCT05425420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522342|NCT05425420|Analgesics|analgesics|mesh-ancestor
102333851|NCT04763434|Analgesics|analgesics|mesh-ancestor
102522343|NCT05425420|Sensory System Agents|sensory system agents|mesh-ancestor
102522344|NCT05425420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102522346|NCT05425420|Respiratory System Agents|respiratory system agents|mesh-ancestor
102522347|NCT05422664|Lacosamide|lacosamide|mesh-list
102522348|NCT05422664|Anticonvulsants|anticonvulsants|mesh-ancestor
102522349|NCT05422664|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102522350|NCT05422664|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102522351|NCT05422664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102522352|NCT05422664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522353|NCT05411497|Cyclophosphamide|cyclophosphamide|mesh-list
102522354|NCT05411497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102522355|NCT05411497|Immunologic Factors|immunologic factors|mesh-ancestor
102522356|NCT05411497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522357|NCT05411497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102522358|NCT05411497|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102522359|NCT05411497|Alkylating Agents|alkylating agents|mesh-ancestor
102522360|NCT05411497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522361|NCT05411497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522362|NCT05411497|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102522363|NCT05407961|Dulaglutide|dulaglutide|mesh-list
102522364|NCT05407961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102522365|NCT05407961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522366|NCT05403086|Ketamine|ketamine|mesh-list
102522367|NCT05403086|Psilocybin|psilocybin|mesh-list
102522368|NCT05403086|Hallucinogens|hallucinogens|mesh-list
102522369|NCT05403086|Analgesics|analgesics|mesh-ancestor
102522370|NCT05403086|Sensory System Agents|sensory system agents|mesh-ancestor
102522371|NCT05403086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102522372|NCT05403086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522373|NCT05403086|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102522374|NCT05403086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102522375|NCT05403086|Anesthetics, General|anesthetics, general|mesh-ancestor
102522376|NCT05403086|Anesthetics|anesthetics|mesh-ancestor
102522377|NCT05403086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102522378|NCT05403086|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102522379|NCT05403086|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102522380|NCT05403086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102522381|NCT05403086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522382|NCT05403086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102522383|NCT05388929|Analgesics, Opioid|analgesics, opioid|mesh-list
102522384|NCT05388929|Methocarbamol|methocarbamol|mesh-list
102522385|NCT05388929|Narcotics|narcotics|mesh-ancestor
102522386|NCT05388929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102522387|NCT05388929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522388|NCT05388929|Analgesics|analgesics|mesh-ancestor
102522389|NCT05388929|Sensory System Agents|sensory system agents|mesh-ancestor
102522390|NCT05388929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102522391|NCT05388929|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102522392|NCT05388929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102522393|NCT05341583|Ensartinib|ensartinib|mesh-list
102522394|NCT05341583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522395|NCT05341583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102522396|NCT05341583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102522397|NCT05341583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522398|NCT05269004|Ocrelizumab|ocrelizumab|mesh-list
102522399|NCT05269004|Immunologic Factors|immunologic factors|mesh-ancestor
102522400|NCT05269004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522401|NCT05256069|Propranolol|propranolol|mesh-list
102522402|NCT05256069|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102522403|NCT05256069|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102522404|NCT05256069|Adrenergic Agents|adrenergic agents|mesh-ancestor
102522405|NCT05256069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102522406|NCT05256069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522407|NCT05256069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522408|NCT05256069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102522409|NCT05256069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102522410|NCT05256069|Vasodilator Agents|vasodilator agents|mesh-ancestor
102522411|NCT05199571|Ofatumumab|ofatumumab|mesh-list
102522412|NCT05199571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522413|NCT05160805|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102522414|NCT05160805|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102522415|NCT05155436|Amlodipine|amlodipine|mesh-list
102522416|NCT05155436|Telmisartan|telmisartan|mesh-list
102333940|NCT03694834|Pembrolizumab|pembrolizumab|mesh-list
102522417|NCT05155436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102522418|NCT05155436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102522419|NCT05155436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102522420|NCT05155436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522421|NCT05155436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102522422|NCT05155436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522423|NCT05155436|Vasodilator Agents|vasodilator agents|mesh-ancestor
102522424|NCT05155436|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102522425|NCT05155436|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102522426|NCT05103696|Propofol|propofol|mesh-list
102522427|NCT05103696|Etomidate|etomidate|mesh-list
102522428|NCT05103696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102522429|NCT05103696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102522430|NCT05103696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522431|NCT05103696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102522432|NCT05103696|Anesthetics, General|anesthetics, general|mesh-ancestor
102522433|NCT05103696|Anesthetics|anesthetics|mesh-ancestor
102522434|NCT04984811|Atezolizumab|atezolizumab|mesh-list
102522435|NCT04984811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102522436|NCT04984811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522437|NCT04984811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102522438|NCT04984811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522439|NCT04981041|Clopidogrel|clopidogrel|mesh-list
102522440|NCT04981041|Ticagrelor|ticagrelor|mesh-list
102522441|NCT04981041|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102522442|NCT04981041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102522443|NCT04981041|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102522444|NCT04981041|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102522445|NCT04981041|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102522446|NCT04981041|Purinergic Agents|purinergic agents|mesh-ancestor
102522447|NCT04981041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102522448|NCT04981041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522449|NCT04981041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522450|NCT04898725|Vitamin D|vitamin d|mesh-list
102522451|NCT04898725|Cholecalciferol|cholecalciferol|mesh-list
102522452|NCT04898725|Vitamins|vitamins|mesh-ancestor
102522453|NCT04898725|Micronutrients|micronutrients|mesh-ancestor
102522454|NCT04898725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522455|NCT04898725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102522456|NCT04898725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102522457|NCT04894435|Vaccines|vaccines|mesh-list
102522458|NCT04894435|Immunologic Factors|immunologic factors|mesh-ancestor
102522459|NCT04894435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522460|NCT04878211|Interferons|interferons|mesh-list
102522461|NCT04878211|Ofatumumab|ofatumumab|mesh-list
102522462|NCT04878211|Glatiramer Acetate|glatiramer acetate|mesh-list
102522463|NCT04878211|(T,G)-A-L|(t,g)-a-l|mesh-list
102522464|NCT04878211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522465|NCT04878211|Antiviral Agents|antiviral agents|mesh-ancestor
102522466|NCT04878211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102522467|NCT04878211|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102522468|NCT04878211|Immunologic Factors|immunologic factors|mesh-ancestor
102522469|NCT04878211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522470|NCT04878211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102522471|NCT04878211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102522472|NCT04862975|Tenofovir|tenofovir|mesh-list
102522473|NCT04862975|Emtricitabine|emtricitabine|mesh-list
102522474|NCT04862975|Efavirenz|efavirenz|mesh-list
102522475|NCT04862975|Dolutegravir|dolutegravir|mesh-list
102522476|NCT04862975|Antiviral Agents|antiviral agents|mesh-ancestor
102522477|NCT04862975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102522478|NCT04862975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102522479|NCT04862975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102522480|NCT04862975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102522481|NCT04862975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522482|NCT04862975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102522483|NCT04862975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102522484|NCT04862975|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102522485|NCT04862975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102522486|NCT04862975|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102522487|NCT04862975|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102522488|NCT04862975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102522489|NCT04862975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102522490|NCT04862975|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102522491|NCT04862975|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102522492|NCT04840550|Lansoprazole|lansoprazole|mesh-list
102522494|NCT04840550|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102522495|NCT04840550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102522496|NCT04840550|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102522497|NCT04840550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102522498|NCT04840550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522499|NCT04756063|Ascorbic Acid|ascorbic acid|mesh-list
102522500|NCT04756063|Vitamins|vitamins|mesh-ancestor
102522501|NCT04756063|Micronutrients|micronutrients|mesh-ancestor
102522502|NCT04756063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522503|NCT04756063|Antioxidants|antioxidants|mesh-ancestor
102522504|NCT04756063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522505|NCT04756063|Protective Agents|protective agents|mesh-ancestor
102522506|NCT04747496|Edoxaban|edoxaban|mesh-list
102522507|NCT04747496|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102522508|NCT04747496|Antithrombins|antithrombins|mesh-ancestor
102522509|NCT04747496|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102522510|NCT04747496|Protease Inhibitors|protease inhibitors|mesh-ancestor
102522511|NCT04747496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102522512|NCT04747496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522513|NCT04747496|Anticoagulants|anticoagulants|mesh-ancestor
102522514|NCT04744662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102522515|NCT04744662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102522516|NCT04736745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102522517|NCT04736745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102522518|NCT04736745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102522519|NCT04736745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522520|NCT04736745|Cholinergic Agents|cholinergic agents|mesh-ancestor
102522521|NCT04736745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102522522|NCT04736745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522523|NCT04731844|Curcumin|curcumin|mesh-list
102522524|NCT04731844|Piperine|piperine|mesh-list
102522525|NCT04731844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102522526|NCT04731844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102522527|NCT04731844|Analgesics|analgesics|mesh-ancestor
102522528|NCT04731844|Sensory System Agents|sensory system agents|mesh-ancestor
102522529|NCT04731844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102522530|NCT04731844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522531|NCT04731844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102522532|NCT04731844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102522533|NCT04731844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522534|NCT04731844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102522535|NCT04731844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522536|NCT04731844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102522537|NCT04660539|Mycophenolic Acid|mycophenolic acid|mesh-list
102522538|NCT04660539|Azathioprine|azathioprine|mesh-list
102522539|NCT04660539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102522540|NCT04660539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522541|NCT04660539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102522542|NCT04660539|Antitubercular Agents|antitubercular agents|mesh-ancestor
102522543|NCT04660539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102522544|NCT04660539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102522545|NCT04660539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102522546|NCT04660539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522547|NCT04660539|Antimetabolites|antimetabolites|mesh-ancestor
102522548|NCT04660539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102522549|NCT04660539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102522550|NCT04660539|Immunologic Factors|immunologic factors|mesh-ancestor
102522551|NCT04660539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522552|NCT04660539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102522553|NCT04521231|Blinatumomab|blinatumomab|mesh-list
102522554|NCT04521231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522555|NCT04520607|Lorecivivint|lorecivivint|mesh-list
102522556|NCT04520607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102522557|NCT04512365|Dronabinol|dronabinol|mesh-list
102522558|NCT04512365|Hallucinogens|hallucinogens|mesh-ancestor
102522559|NCT04512365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522560|NCT04512365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102522561|NCT04512365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102522562|NCT04512365|Analgesics|analgesics|mesh-ancestor
102522563|NCT04512365|Sensory System Agents|sensory system agents|mesh-ancestor
102522564|NCT04512365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102522565|NCT04512365|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102522566|NCT04512365|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102334072|NCT03673072|Gemcitabine|gemcitabine|mesh-list
102522567|NCT04512365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102522568|NCT04512365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522569|NCT04512365|Hormones|hormones|mesh-ancestor
102522570|NCT04512365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102522571|NCT04480853|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102522572|NCT04480853|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102522573|NCT04480853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522574|NCT04480853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102522575|NCT04480853|Immunologic Factors|immunologic factors|mesh-ancestor
102522576|NCT04480853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522577|NCT04452214|Carboplatin|carboplatin|mesh-list
102522578|NCT04452214|Pembrolizumab|pembrolizumab|mesh-list
102522579|NCT04452214|Pemetrexed|pemetrexed|mesh-list
102522580|NCT04452214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522581|NCT04452214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102522582|NCT04452214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102522583|NCT04452214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522584|NCT04452214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102522585|NCT04452214|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102522586|NCT04452214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102522587|NCT04431258|Folfirinox|folfirinox|mesh-list
102522588|NCT04431258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522589|NCT04417621|Trametinib|trametinib|mesh-list
102522590|NCT04417621|Naporafenib|naporafenib|mesh-list
102522591|NCT04417621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522592|NCT04417621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102522593|NCT04417621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102522594|NCT04417621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522595|NCT04398719|Capsaicin|capsaicin|mesh-list
102522596|NCT04398719|Antipruritics|antipruritics|mesh-ancestor
102522597|NCT04398719|Dermatologic Agents|dermatologic agents|mesh-ancestor
102522598|NCT04398719|Sensory System Agents|sensory system agents|mesh-ancestor
102522599|NCT04398719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102522600|NCT04398719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522601|NCT04373317|Pimavanserin|pimavanserin|mesh-list
102522602|NCT04373317|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102522603|NCT04373317|Antidepressive Agents|antidepressive agents|mesh-ancestor
102522604|NCT04373317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102522605|NCT04373317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102522606|NCT04373317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102522607|NCT04373317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102522608|NCT04373317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522609|NCT04373317|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102522610|NCT04373317|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102522611|NCT04373317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102522612|NCT04373317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102522613|NCT04373317|Serotonin Agents|serotonin agents|mesh-ancestor
102522614|NCT04373317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102522615|NCT04373317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522616|NCT04339270|Azithromycin|azithromycin|mesh-list
102522617|NCT04339270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102522618|NCT04339270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102522619|NCT04317105|Nivolumab|nivolumab|mesh-list
102522620|NCT04317105|Ipilimumab|ipilimumab|mesh-list
102522621|NCT04317105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102522622|NCT04317105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522623|NCT04317105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102522624|NCT04317105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522625|NCT04262193|Suvorexant|suvorexant|mesh-list
102522626|NCT04262193|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102522627|NCT04262193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102522628|NCT04262193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102522629|NCT04262193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522630|NCT04262193|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102522631|NCT04262193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102522632|NCT04262193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522633|NCT04261439|Tislelizumab|tislelizumab|mesh-list
102522634|NCT04261439|Spartalizumab|spartalizumab|mesh-list
102522635|NCT04261439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102522636|NCT04261439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522637|NCT04261439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102522638|NCT04261439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522639|NCT04207944|Sulindac|sulindac|mesh-list
102522640|NCT04207944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102522641|NCT04207944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102522642|NCT04207944|Analgesics|analgesics|mesh-ancestor
102522643|NCT04207944|Sensory System Agents|sensory system agents|mesh-ancestor
102522644|NCT04207944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102522645|NCT04207944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522646|NCT04207944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102522647|NCT04207944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102522648|NCT04207944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522649|NCT04207944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102522650|NCT04207944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102522651|NCT04207944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522652|NCT04184622|Tirzepatide|tirzepatide|mesh-list
102522653|NCT04184622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102522654|NCT04184622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522655|NCT04184622|Incretins|incretins|mesh-ancestor
102522656|NCT04184622|Hormones|hormones|mesh-ancestor
102522657|NCT04184622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102522658|NCT04108156|Ranibizumab|ranibizumab|mesh-list
102522659|NCT04108156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102522660|NCT04108156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102522661|NCT04108156|Growth Substances|growth substances|mesh-ancestor
102522662|NCT04108156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522663|NCT04108156|Growth Inhibitors|growth inhibitors|mesh-ancestor
102522664|NCT04108156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522665|NCT04080427|Dronabinol|dronabinol|mesh-list
102522666|NCT04080427|Hallucinogens|hallucinogens|mesh-ancestor
102522667|NCT04080427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522668|NCT04080427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102522669|NCT04080427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102522670|NCT04080427|Analgesics|analgesics|mesh-ancestor
102522671|NCT04080427|Sensory System Agents|sensory system agents|mesh-ancestor
102522672|NCT04080427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102522673|NCT04080427|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102522674|NCT04080427|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102522675|NCT04080427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102522676|NCT04080427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522677|NCT04080427|Hormones|hormones|mesh-ancestor
102522678|NCT04080427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102522679|NCT04032704|Pembrolizumab|pembrolizumab|mesh-list
102522680|NCT04032704|SGN-LIV1A|sgn-liv1a|mesh-list
102522681|NCT04032704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102522682|NCT04032704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522683|NCT04032704|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102522684|NCT04032704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522685|NCT04032704|Immunoconjugates|immunoconjugates|mesh-ancestor
102522686|NCT04032704|Immunologic Factors|immunologic factors|mesh-ancestor
102522687|NCT04032704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522688|NCT03941262|Pembrolizumab|pembrolizumab|mesh-list
102522689|NCT03941262|Avelumab|avelumab|mesh-list
102522690|NCT03941262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102522691|NCT03941262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522692|NCT03941262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102522693|NCT03941262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522694|NCT03933631|Ofloxacin|ofloxacin|mesh-list
102522695|NCT03933631|Prednisolone|prednisolone|mesh-list
102522696|NCT03933631|Prednisolone acetate|prednisolone acetate|mesh-list
102522697|NCT03933631|Pilocarpine|pilocarpine|mesh-list
102522698|NCT03933631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102522699|NCT03933631|Glucocorticoids|glucocorticoids|mesh-ancestor
102522700|NCT03933631|Hormones|hormones|mesh-ancestor
102522701|NCT03933631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102522702|NCT03933631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522703|NCT03933631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102522704|NCT03933631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522705|NCT03933631|Autonomic Agents|autonomic agents|mesh-ancestor
102522706|NCT03933631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102522707|NCT03933631|Miotics|miotics|mesh-ancestor
102522708|NCT03933631|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102522709|NCT03933631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102522710|NCT03933631|Cholinergic Agents|cholinergic agents|mesh-ancestor
102522711|NCT03933631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102522712|NCT03933631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334221|NCT01672762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102522713|NCT03933631|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102522714|NCT03933631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102522715|NCT03933631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102522716|NCT03933631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102522717|NCT03933631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102522718|NCT03933631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102522719|NCT03933631|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102522720|NCT03933631|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102522721|NCT03919435|Trimethoprim|trimethoprim|mesh-list
102522722|NCT03919435|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102522723|NCT03919435|Sulfamethoxazole|sulfamethoxazole|mesh-list
102522724|NCT03919435|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102522725|NCT03919435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102522726|NCT03919435|Antimalarials|antimalarials|mesh-ancestor
102522727|NCT03919435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102522728|NCT03919435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102522729|NCT03919435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102522730|NCT03919435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102522731|NCT03919435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522732|NCT03919435|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102522733|NCT03919435|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102522734|NCT03919435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102522735|NCT03919435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102522736|NCT03911414|Inositol|inositol|mesh-list
102522737|NCT03911414|Acetylcysteine|acetylcysteine|mesh-list
102522738|NCT03911414|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102522739|NCT03911414|Antiviral Agents|antiviral agents|mesh-ancestor
102522740|NCT03911414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102522741|NCT03911414|Expectorants|expectorants|mesh-ancestor
102522742|NCT03911414|Respiratory System Agents|respiratory system agents|mesh-ancestor
102522743|NCT03911414|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102522744|NCT03911414|Antioxidants|antioxidants|mesh-ancestor
102522745|NCT03911414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522746|NCT03911414|Protective Agents|protective agents|mesh-ancestor
102522747|NCT03911414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522748|NCT03911414|Antidotes|antidotes|mesh-ancestor
102522749|NCT03911414|Vitamin B Complex|vitamin b complex|mesh-ancestor
102522750|NCT03911414|Vitamins|vitamins|mesh-ancestor
102522751|NCT03911414|Micronutrients|micronutrients|mesh-ancestor
102522752|NCT03901001|Sirolimus|sirolimus|mesh-list
102522753|NCT03901001|Oseltamivir|oseltamivir|mesh-list
102522754|NCT03901001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102522755|NCT03901001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102522756|NCT03901001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102522757|NCT03901001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522758|NCT03901001|Antifungal Agents|antifungal agents|mesh-ancestor
102522759|NCT03901001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102522760|NCT03901001|Immunologic Factors|immunologic factors|mesh-ancestor
102522761|NCT03901001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522762|NCT03901001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102522763|NCT03901001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522764|NCT03901001|Antiviral Agents|antiviral agents|mesh-ancestor
102522765|NCT03900988|Acetylcysteine|acetylcysteine|mesh-list
102522766|NCT03900988|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102522767|NCT03900988|Antiviral Agents|antiviral agents|mesh-ancestor
102522768|NCT03900988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102522769|NCT03900988|Expectorants|expectorants|mesh-ancestor
102522770|NCT03900988|Respiratory System Agents|respiratory system agents|mesh-ancestor
102522771|NCT03900988|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102522772|NCT03900988|Antioxidants|antioxidants|mesh-ancestor
102522773|NCT03900988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522774|NCT03900988|Protective Agents|protective agents|mesh-ancestor
102522775|NCT03900988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522776|NCT03900988|Antidotes|antidotes|mesh-ancestor
102522777|NCT03900754|Oxytocin|oxytocin|mesh-list
102522778|NCT03900754|Oxytocics|oxytocics|mesh-ancestor
102522779|NCT03900754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102522780|NCT03900754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522781|NCT03861091|Risedronic Acid|risedronic acid|mesh-list
102522782|NCT03861091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102522783|NCT03861091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102522784|NCT03861091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522785|NCT03861091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102522786|NCT03861091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522787|NCT03861091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102522788|NCT03781414|Tacrolimus|tacrolimus|mesh-list
102522789|NCT03781414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102522790|NCT03781414|Immunologic Factors|immunologic factors|mesh-ancestor
102522791|NCT03781414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522792|NCT03781414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102522793|NCT03781414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102522794|NCT03781414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522795|NCT03772717|Immunoglobulins|immunoglobulins|mesh-list
102522796|NCT03772717|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102522797|NCT03772717|gamma-Globulins|gamma-globulins|mesh-list
102522798|NCT03772717|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102522799|NCT03772717|Immunologic Factors|immunologic factors|mesh-ancestor
102522800|NCT03772717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522801|NCT03740100|MTOR Inhibitors|mtor inhibitors|mesh-list
102522802|NCT03740100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102522803|NCT03740100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102522804|NCT03740100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522805|NCT03740100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102522806|NCT03740100|Immunologic Factors|immunologic factors|mesh-ancestor
102522807|NCT03740100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522808|NCT03740100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522809|NCT03729869|Progesterone|progesterone|mesh-list
102522810|NCT03729869|Progestins|progestins|mesh-ancestor
102522811|NCT03729869|Hormones|hormones|mesh-ancestor
102522812|NCT03729869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102522813|NCT03729869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522814|NCT03718065|Lofexidine|lofexidine|mesh-list
102522815|NCT03718065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102522816|NCT03718065|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102522817|NCT03718065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522818|NCT03718065|Sensory System Agents|sensory system agents|mesh-ancestor
102522819|NCT03718065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102522820|NCT03718065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102522821|NCT03718065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102522822|NCT03718065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102522823|NCT03718065|Adrenergic Agents|adrenergic agents|mesh-ancestor
102522824|NCT03718065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102522825|NCT03718065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522826|NCT03706690|Durvalumab|durvalumab|mesh-list
102522827|NCT03706690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102522828|NCT03706690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522829|NCT03456700|Sirolimus|sirolimus|mesh-list
102522830|NCT03456700|Auranofin|auranofin|mesh-list
102522831|NCT03456700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102522832|NCT03456700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102522833|NCT03456700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102522834|NCT03456700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522835|NCT03456700|Antifungal Agents|antifungal agents|mesh-ancestor
102522836|NCT03456700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102522837|NCT03456700|Immunologic Factors|immunologic factors|mesh-ancestor
102522838|NCT03456700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522839|NCT03456700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102522840|NCT03401450|Bupivacaine|bupivacaine|mesh-list
102522841|NCT03401450|Anesthetics, Local|anesthetics, local|mesh-ancestor
102522842|NCT03401450|Anesthetics|anesthetics|mesh-ancestor
102522843|NCT03401450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102522844|NCT03401450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522845|NCT03401450|Sensory System Agents|sensory system agents|mesh-ancestor
102522846|NCT03401450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102522847|NCT03356483|Niacin|niacin|mesh-list
102522848|NCT03356483|Nicotinic Acids|nicotinic acids|mesh-list
102522849|NCT03356483|Psilocybin|psilocybin|mesh-list
102522850|NCT03356483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102522851|NCT03356483|Antimetabolites|antimetabolites|mesh-ancestor
102522852|NCT03356483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522853|NCT03356483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102522854|NCT03356483|Vasodilator Agents|vasodilator agents|mesh-ancestor
102522855|NCT03356483|Vitamin B Complex|vitamin b complex|mesh-ancestor
102522856|NCT03356483|Vitamins|vitamins|mesh-ancestor
102522857|NCT03356483|Micronutrients|micronutrients|mesh-ancestor
102522858|NCT03356483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522859|NCT03356483|Hallucinogens|hallucinogens|mesh-ancestor
102522860|NCT03356483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102522861|NCT03328026|Interferons|interferons|mesh-list
102334383|NCT00087646|Ribavirin|ribavirin|mesh-list
102522862|NCT03328026|Cyclophosphamide|cyclophosphamide|mesh-list
102522863|NCT03328026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102522864|NCT03328026|Immunologic Factors|immunologic factors|mesh-ancestor
102522865|NCT03328026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522866|NCT03328026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102522867|NCT03328026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102522868|NCT03328026|Alkylating Agents|alkylating agents|mesh-ancestor
102522869|NCT03328026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522870|NCT03328026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522871|NCT03328026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102522872|NCT03328026|Antiviral Agents|antiviral agents|mesh-ancestor
102522873|NCT03328026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102522874|NCT03326063|Ifetroban|ifetroban|mesh-list
102522875|NCT03326063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102522876|NCT03324984|Bupivacaine|bupivacaine|mesh-list
102522877|NCT03324984|Chloroprocaine|chloroprocaine|mesh-list
102522878|NCT03324984|Anesthetics, Local|anesthetics, local|mesh-ancestor
102522879|NCT03324984|Anesthetics|anesthetics|mesh-ancestor
102522880|NCT03324984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102522881|NCT03324984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522882|NCT03324984|Sensory System Agents|sensory system agents|mesh-ancestor
102522883|NCT03324984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102522884|NCT03310957|Pembrolizumab|pembrolizumab|mesh-list
102522885|NCT03310957|SGN-LIV1A|sgn-liv1a|mesh-list
102522886|NCT03310957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102522887|NCT03310957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522888|NCT03310957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102522889|NCT03310957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522890|NCT03310957|Immunoconjugates|immunoconjugates|mesh-ancestor
102522891|NCT03310957|Immunologic Factors|immunologic factors|mesh-ancestor
102522892|NCT03310957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522893|NCT03275857|Cisplatin|cisplatin|mesh-list
102522894|NCT03275857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522895|NCT03260712|Gemcitabine|gemcitabine|mesh-list
102522896|NCT03260712|Pembrolizumab|pembrolizumab|mesh-list
102522897|NCT03260712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522898|NCT03260712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102522899|NCT03260712|Antimetabolites|antimetabolites|mesh-ancestor
102522900|NCT03260712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522901|NCT03260712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102522902|NCT03260712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102522903|NCT03177291|Pirfenidone|pirfenidone|mesh-list
102522904|NCT03177291|Paclitaxel|paclitaxel|mesh-list
102522905|NCT03177291|Carboplatin|carboplatin|mesh-list
102522906|NCT03177291|Pemetrexed|pemetrexed|mesh-list
102522907|NCT03177291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102522908|NCT03177291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522909|NCT03177291|Tubulin Modulators|tubulin modulators|mesh-ancestor
102522910|NCT03177291|Antimitotic Agents|antimitotic agents|mesh-ancestor
102522911|NCT03177291|Mitosis Modulators|mitosis modulators|mesh-ancestor
102522912|NCT03177291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522913|NCT03177291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102522914|NCT03177291|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102522915|NCT03177291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102522916|NCT03177291|Analgesics|analgesics|mesh-ancestor
102522917|NCT03177291|Sensory System Agents|sensory system agents|mesh-ancestor
102522918|NCT03177291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102522919|NCT03177291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522920|NCT03177291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102522921|NCT03177291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102522922|NCT03177291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102522923|NCT03177291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102522924|NCT03128359|Mycophenolic Acid|mycophenolic acid|mesh-list
102522925|NCT03128359|Cyclophosphamide|cyclophosphamide|mesh-list
102522926|NCT03128359|Melphalan|melphalan|mesh-list
102522927|NCT03128359|Busulfan|busulfan|mesh-list
102522928|NCT03128359|Fludarabine|fludarabine|mesh-list
102522929|NCT03128359|Fludarabine phosphate|fludarabine phosphate|mesh-list
102522930|NCT03128359|Tacrolimus|tacrolimus|mesh-list
102522931|NCT03128359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102522932|NCT03128359|Immunologic Factors|immunologic factors|mesh-ancestor
102522933|NCT03128359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522934|NCT03128359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102522935|NCT03128359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102522936|NCT03128359|Alkylating Agents|alkylating agents|mesh-ancestor
102522937|NCT03128359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522938|NCT03128359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522939|NCT03128359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102522940|NCT03128359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102522942|NCT03128359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102522943|NCT03128359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102522944|NCT03128359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102522945|NCT03128359|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102522946|NCT03128359|Antitubercular Agents|antitubercular agents|mesh-ancestor
102522947|NCT03128359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102522948|NCT03128359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102522949|NCT02764762|Adalimumab|adalimumab|mesh-list
102522950|NCT02764762|Methotrexate|methotrexate|mesh-list
102522951|NCT02764762|Vedolizumab|vedolizumab|mesh-list
102522952|NCT02764762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102522953|NCT02764762|Abortifacient Agents|abortifacient agents|mesh-ancestor
102522954|NCT02764762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102522955|NCT02764762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522956|NCT02764762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102522957|NCT02764762|Antimetabolites|antimetabolites|mesh-ancestor
102522958|NCT02764762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522959|NCT02764762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522960|NCT02764762|Dermatologic Agents|dermatologic agents|mesh-ancestor
102522961|NCT02764762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102522962|NCT02764762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102522963|NCT02764762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102522964|NCT02764762|Immunologic Factors|immunologic factors|mesh-ancestor
102522965|NCT02764762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102522966|NCT02764762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102522967|NCT02764762|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102522968|NCT02764762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102522969|NCT02764762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102522970|NCT02666547|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102522971|NCT02666547|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102522972|NCT02666547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522973|NCT02654990|Dexamethasone|dexamethasone|mesh-list
102522974|NCT02654990|Bortezomib|bortezomib|mesh-list
102522975|NCT02654990|Panobinostat|panobinostat|mesh-list
102522976|NCT02654990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102522977|NCT02654990|Antiemetics|antiemetics|mesh-ancestor
102522978|NCT02654990|Autonomic Agents|autonomic agents|mesh-ancestor
102522979|NCT02654990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102522980|NCT02654990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102522981|NCT02654990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102522982|NCT02654990|Glucocorticoids|glucocorticoids|mesh-ancestor
102522983|NCT02654990|Hormones|hormones|mesh-ancestor
102522984|NCT02654990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102522985|NCT02654990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102522986|NCT02654990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102522987|NCT02654990|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102522988|NCT02654990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102522989|NCT02654990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522990|NCT02650401|Entrectinib|entrectinib|mesh-list
102522991|NCT02650401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102522992|NCT02650401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102522993|NCT02650401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522994|NCT02568267|Entrectinib|entrectinib|mesh-list
102522995|NCT02568267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102522996|NCT02568267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102522997|NCT02568267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102522998|NCT02521363|Taxane|taxane|mesh-list
102522999|NCT02521363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102523000|NCT02407509|Everolimus|everolimus|mesh-list
102523001|NCT02407509|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102523002|NCT02407509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102523003|NCT02407509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102523004|NCT02407509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523005|NCT02407509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102523006|NCT02407509|Immunologic Factors|immunologic factors|mesh-ancestor
102523007|NCT02407509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523008|NCT02407509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102523009|NCT02340962|Interferons|interferons|mesh-list
102523010|NCT02340962|Ribavirin|ribavirin|mesh-list
102523011|NCT02340962|Interferon-alpha|interferon-alpha|mesh-list
102523012|NCT02340962|Interferon alpha-2|interferon alpha-2|mesh-list
102523013|NCT02340962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102523014|NCT02340962|Antiviral Agents|antiviral agents|mesh-ancestor
102523015|NCT02340962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102523016|NCT02340962|Antimetabolites|antimetabolites|mesh-ancestor
102523017|NCT02340962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523018|NCT02340962|Immunologic Factors|immunologic factors|mesh-ancestor
102523019|NCT02340962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523020|NCT02309645|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102523021|NCT02309645|Hemostatics|hemostatics|mesh-ancestor
102523022|NCT02309645|Coagulants|coagulants|mesh-ancestor
102523023|NCT02059499|Fluorouracil|fluorouracil|mesh-list
102523024|NCT02059499|Imiquimod|imiquimod|mesh-list
102523025|NCT02059499|Antimetabolites|antimetabolites|mesh-ancestor
102523026|NCT02059499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523027|NCT02059499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102523028|NCT02059499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102523029|NCT02059499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102523030|NCT02059499|Immunologic Factors|immunologic factors|mesh-ancestor
102523031|NCT02059499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523032|NCT02059499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102523033|NCT02059499|Interferon Inducers|interferon inducers|mesh-ancestor
102523034|NCT01750073|Paclitaxel|paclitaxel|mesh-list
102523035|NCT01750073|Cyclophosphamide|cyclophosphamide|mesh-list
102523036|NCT01750073|Doxorubicin|doxorubicin|mesh-list
102523037|NCT01750073|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102523038|NCT01750073|Trastuzumab|trastuzumab|mesh-list
102523039|NCT01750073|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102523040|NCT01750073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102523041|NCT01750073|Antibodies|antibodies|mesh-list
102523042|NCT01750073|Immunoglobulins|immunoglobulins|mesh-list
102523043|NCT01750073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102523044|NCT01750073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102523045|NCT01750073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102523046|NCT01750073|Tubulin Modulators|tubulin modulators|mesh-ancestor
102523047|NCT01750073|Antimitotic Agents|antimitotic agents|mesh-ancestor
102523048|NCT01750073|Mitosis Modulators|mitosis modulators|mesh-ancestor
102523049|NCT01750073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523050|NCT01750073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102523051|NCT01750073|Immunologic Factors|immunologic factors|mesh-ancestor
102523052|NCT01750073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523053|NCT01750073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102523054|NCT01750073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102523055|NCT01750073|Alkylating Agents|alkylating agents|mesh-ancestor
102523056|NCT01750073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102523057|NCT01750073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102523058|NCT01750073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102523059|NCT01750073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102523060|NCT01750073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102523061|NCT01607879|Androgens|androgens|mesh-list
102523062|NCT01607879|Hormones|hormones|mesh-ancestor
102523063|NCT01607879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102523064|NCT01607879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523065|NCT01582191|Everolimus|everolimus|mesh-list
102523066|NCT01582191|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102523067|NCT01582191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102523068|NCT01582191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102523069|NCT01582191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523070|NCT01582191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102523071|NCT01582191|Immunologic Factors|immunologic factors|mesh-ancestor
102523072|NCT01582191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523073|NCT01582191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102523074|NCT01120249|Everolimus|everolimus|mesh-list
102523075|NCT01120249|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102523076|NCT01120249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102523077|NCT01120249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102523078|NCT01120249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523079|NCT01120249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102523080|NCT01120249|Immunologic Factors|immunologic factors|mesh-ancestor
102523081|NCT01120249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523082|NCT01120249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102523083|NCT00788125|Carboplatin|carboplatin|mesh-list
102523084|NCT00788125|Etoposide|etoposide|mesh-list
102523085|NCT00788125|Dasatinib|dasatinib|mesh-list
102523086|NCT00788125|Ifosfamide|ifosfamide|mesh-list
102523087|NCT00788125|Etoposide phosphate|etoposide phosphate|mesh-list
102523088|NCT00788125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102523089|NCT00788125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102523090|NCT00788125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102523091|NCT00788125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102523093|NCT00788125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523094|NCT00788125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102523095|NCT00788125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102523096|NCT00788125|Alkylating Agents|alkylating agents|mesh-ancestor
102523097|NCT00676715|Interferons|interferons|mesh-list
102523098|NCT00676715|Interferon-beta|interferon-beta|mesh-list
102523099|NCT00676715|Ocrelizumab|ocrelizumab|mesh-list
102523100|NCT00676715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102523101|NCT00676715|Antiviral Agents|antiviral agents|mesh-ancestor
102523102|NCT00676715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102523103|NCT00676715|Immunologic Factors|immunologic factors|mesh-ancestor
102523104|NCT00676715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523105|NCT00579969|Timolol|timolol|mesh-list
102523106|NCT00579969|Latanoprost|latanoprost|mesh-list
102523107|NCT00579969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102523108|NCT00579969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102523109|NCT00579969|Adrenergic Agents|adrenergic agents|mesh-ancestor
102523110|NCT00579969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102523111|NCT00579969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523112|NCT00579969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523113|NCT00579969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102523114|NCT00579969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102523115|NCT00579969|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102523116|NCT00579969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102523117|NCT00516373|Olaparib|olaparib|mesh-list
102523118|NCT00516373|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102523119|NCT00516373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102523120|NCT00516373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523121|NCT00516373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102523122|NCT00890162|Omalizumab|omalizumab|mesh-list
102523123|NCT00890162|Epinephrine|epinephrine|mesh-list
102523124|NCT00890162|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102523125|NCT00890162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102523126|NCT00890162|Adrenergic Agents|adrenergic agents|mesh-ancestor
102523127|NCT00890162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102523128|NCT00890162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523129|NCT00890162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523130|NCT00890162|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102523131|NCT00890162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102523132|NCT00890162|Autonomic Agents|autonomic agents|mesh-ancestor
102523133|NCT00890162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102523134|NCT00890162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102523135|NCT00890162|Respiratory System Agents|respiratory system agents|mesh-ancestor
102523136|NCT00890162|Mydriatics|mydriatics|mesh-ancestor
102523137|NCT00890162|Sympathomimetics|sympathomimetics|mesh-ancestor
102523138|NCT00890162|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102523139|NCT00890162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102523140|NCT01433081|Magnesium Sulfate|magnesium sulfate|mesh-list
102523141|NCT01433081|Analgesics|analgesics|mesh-ancestor
102523142|NCT01433081|Sensory System Agents|sensory system agents|mesh-ancestor
102523143|NCT01433081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102523144|NCT01433081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523145|NCT01433081|Anesthetics|anesthetics|mesh-ancestor
102523146|NCT01433081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102523147|NCT01433081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102523148|NCT01433081|Anticonvulsants|anticonvulsants|mesh-ancestor
102523149|NCT01433081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102523150|NCT01433081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102523151|NCT01433081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523152|NCT01433081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102523153|NCT01433081|Tocolytic Agents|tocolytic agents|mesh-ancestor
102523154|NCT01433081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102523155|NCT00890396|Hydroxyurea|hydroxyurea|mesh-list
102523156|NCT00890396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102523157|NCT00890396|Antisickling Agents|antisickling agents|mesh-ancestor
102523158|NCT00890396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102523159|NCT00890396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523160|NCT00890396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102523161|NCT01401023|Tigecycline|tigecycline|mesh-list
102523162|NCT01401023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102523163|NCT01401023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102523164|NCT01401023|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102523165|NCT01401023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102523166|NCT01401023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523167|NCT01515995|Magnesium Sulfate|magnesium sulfate|mesh-list
102523168|NCT01515995|Analgesics|analgesics|mesh-ancestor
102523169|NCT01515995|Sensory System Agents|sensory system agents|mesh-ancestor
102523170|NCT01515995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102523171|NCT01515995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523172|NCT01515995|Anesthetics|anesthetics|mesh-ancestor
102523173|NCT01515995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102523174|NCT01515995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102523175|NCT01515995|Anticonvulsants|anticonvulsants|mesh-ancestor
102523176|NCT01515995|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102523177|NCT01515995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102523178|NCT01515995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523179|NCT01515995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102523180|NCT01515995|Tocolytic Agents|tocolytic agents|mesh-ancestor
102523181|NCT01515995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102523182|NCT01436045|Insulin glulisine|insulin glulisine|mesh-list
102523183|NCT01436045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102523184|NCT01436045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523185|NCT01519271|Rivastigmine|rivastigmine|mesh-list
102523186|NCT01519271|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102523187|NCT01519271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102523188|NCT01519271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523189|NCT01519271|Cholinergic Agents|cholinergic agents|mesh-ancestor
102523190|NCT01519271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102523191|NCT01519271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523192|NCT01519271|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102523193|NCT01519271|Protective Agents|protective agents|mesh-ancestor
102523194|NCT01436279|Mifepristone|mifepristone|mesh-list
102523195|NCT01436279|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102523196|NCT01436279|Abortifacient Agents|abortifacient agents|mesh-ancestor
102523197|NCT01436279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102523198|NCT01436279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523199|NCT01436279|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102523200|NCT01436279|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102523201|NCT01436279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102523202|NCT01436279|Contraceptive Agents|contraceptive agents|mesh-ancestor
102523203|NCT01436279|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102523204|NCT01436279|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102523205|NCT01436279|Hormone Antagonists|hormone antagonists|mesh-ancestor
102523206|NCT01436279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102523207|NCT01436279|Luteolytic Agents|luteolytic agents|mesh-ancestor
102523208|NCT01436279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102523209|NCT01436279|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102523210|NCT02210195|Aprepitant|aprepitant|mesh-list
102523211|NCT02210195|Antiemetics|antiemetics|mesh-ancestor
102523212|NCT02210195|Autonomic Agents|autonomic agents|mesh-ancestor
102523213|NCT02210195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102523214|NCT02210195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523215|NCT02210195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102523216|NCT02210195|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102523217|NCT02210195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102523218|NCT02210195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523219|NCT01437449|Carboplatin|carboplatin|mesh-list
102523220|NCT01437449|Docetaxel|docetaxel|mesh-list
102523221|NCT01437449|Cetuximab|cetuximab|mesh-list
102523222|NCT01437449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102523223|NCT01437449|Tubulin Modulators|tubulin modulators|mesh-ancestor
102523224|NCT01437449|Antimitotic Agents|antimitotic agents|mesh-ancestor
102523225|NCT01437449|Mitosis Modulators|mitosis modulators|mesh-ancestor
102523226|NCT01437449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523227|NCT01437449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102523228|NCT00836888|Nivolumab|nivolumab|mesh-list
102523229|NCT00836888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102523230|NCT00836888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102523231|NCT00836888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102523232|NCT00836888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523233|NCT02262026|Saracatinib|saracatinib|mesh-list
102523234|NCT02262026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102523235|NCT02262026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102523236|NCT02262026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523237|NCT00889226|Atorvastatin|atorvastatin|mesh-list
102523238|NCT00889226|Pitavastatin|pitavastatin|mesh-list
102523239|NCT00889226|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102523241|NCT00889226|Antimetabolites|antimetabolites|mesh-ancestor
101999497|NCT03898583|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102523242|NCT00889226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523243|NCT00889226|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102523244|NCT00889226|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102523245|NCT00889226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102523246|NCT00837200|Doxorubicin|doxorubicin|mesh-list
102523247|NCT00837200|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102523248|NCT00837200|Asparaginase|asparaginase|mesh-list
102523249|NCT00837200|Pegaspargase|pegaspargase|mesh-list
102523250|NCT00837200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102523251|NCT00837200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102523252|NCT00837200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102523253|NCT00837200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102523254|NCT00837200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102523255|NCT00837200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523256|NCT00837512|Insulin|insulin|mesh-list
102523257|NCT00837512|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102523258|NCT00837512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102523259|NCT00837512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523260|NCT00837590|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
102523261|NCT00837590|Sodium Salicylate|sodium salicylate|mesh-list
102523262|NCT00837590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102523263|NCT00837590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102523264|NCT00837590|Analgesics|analgesics|mesh-ancestor
102523265|NCT00837590|Sensory System Agents|sensory system agents|mesh-ancestor
102523266|NCT00837590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102523267|NCT00837590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523268|NCT00837590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102523269|NCT00837590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102523270|NCT00837590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102523271|NCT00837590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102523272|NCT00837590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523273|NCT00891176|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102523274|NCT00891176|Immunologic Factors|immunologic factors|mesh-ancestor
102523275|NCT00891176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523276|NCT00839540|Caspofungin|caspofungin|mesh-list
102523277|NCT00839540|Micafungin|micafungin|mesh-list
102523278|NCT00839540|Antifungal Agents|antifungal agents|mesh-ancestor
102523279|NCT00839540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102523280|NCT00839540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102523281|NCT00839540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523282|NCT02966912|Magnesium Oxide|magnesium oxide|mesh-list
102523283|NCT02966912|Antacids|antacids|mesh-ancestor
102523284|NCT02966912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523285|NCT02966912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102523286|NCT02964182|Nicotine|nicotine|mesh-list
102523287|NCT02964182|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102523288|NCT02964182|Autonomic Agents|autonomic agents|mesh-ancestor
102523289|NCT02964182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102523290|NCT02964182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523291|NCT02964182|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102523292|NCT02964182|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102523293|NCT02964182|Cholinergic Agents|cholinergic agents|mesh-ancestor
102523294|NCT02964182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102523295|NCT02964182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523296|NCT01437605|Poly I-C|poly i-c|mesh-list
102523297|NCT01437605|Interferon Inducers|interferon inducers|mesh-ancestor
102523298|NCT01437605|Immunologic Factors|immunologic factors|mesh-ancestor
102523299|NCT01437605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523300|NCT01437605|Antiviral Agents|antiviral agents|mesh-ancestor
102523301|NCT01437605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102523302|NCT01541735|Pantoprazole|pantoprazole|mesh-list
102523303|NCT01541735|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102523304|NCT01541735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102523305|NCT01541735|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102523306|NCT01541735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102523307|NCT01541735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523308|NCT01541891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102523309|NCT01541891|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102523310|NCT01520207|Mannitol|mannitol|mesh-list
102523311|NCT01520207|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102523312|NCT01520207|Diuretics|diuretics|mesh-ancestor
102523313|NCT01520207|Natriuretic Agents|natriuretic agents|mesh-ancestor
102523314|NCT01520207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523315|NCT01203722|Mycophenolic Acid|mycophenolic acid|mesh-list
102523317|NCT01203722|Fludarabine|fludarabine|mesh-list
102523318|NCT01203722|Cyclophosphamide|cyclophosphamide|mesh-list
102523319|NCT01203722|Tacrolimus|tacrolimus|mesh-list
102523320|NCT01203722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102523321|NCT01203722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523322|NCT01203722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102523323|NCT01203722|Immunologic Factors|immunologic factors|mesh-ancestor
102523324|NCT01203722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523325|NCT01203722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102523326|NCT01203722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102523327|NCT01203722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102523328|NCT01203722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102523329|NCT01203722|Alkylating Agents|alkylating agents|mesh-ancestor
102523330|NCT01203722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102523331|NCT01203722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102523332|NCT01203722|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102523333|NCT01203722|Antitubercular Agents|antitubercular agents|mesh-ancestor
102523334|NCT01203722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102523335|NCT01203722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102523336|NCT01203722|Antifungal Agents|antifungal agents|mesh-ancestor
102523337|NCT01520519|Rituximab|rituximab|mesh-list
102523338|NCT01520519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102523339|NCT01520519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102523340|NCT01520519|Immunologic Factors|immunologic factors|mesh-ancestor
102523341|NCT01520519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523342|NCT01520519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102523343|NCT03008057|Vitamin D|vitamin d|mesh-list
102523344|NCT03008057|Ergocalciferols|ergocalciferols|mesh-list
102523345|NCT03008057|Cholecalciferol|cholecalciferol|mesh-list
102523346|NCT03008057|Vitamins|vitamins|mesh-list
102523347|NCT03008057|Micronutrients|micronutrients|mesh-ancestor
102523348|NCT03008057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523349|NCT03008057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102523350|NCT03008057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102523351|NCT01542125|Lidocaine|lidocaine|mesh-list
102523352|NCT01542125|Anesthetics, Local|anesthetics, local|mesh-ancestor
102523353|NCT01542125|Anesthetics|anesthetics|mesh-ancestor
102523354|NCT01542125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102523355|NCT01542125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523356|NCT01542125|Sensory System Agents|sensory system agents|mesh-ancestor
102523357|NCT01542125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102523358|NCT01542125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102523359|NCT01542125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102523360|NCT01542125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102523361|NCT01542125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102523362|NCT01542125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523363|NCT03216668|Silymarin|silymarin|mesh-list
102523364|NCT03216668|Antioxidants|antioxidants|mesh-ancestor
102523365|NCT03216668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523366|NCT03216668|Protective Agents|protective agents|mesh-ancestor
102523367|NCT03216668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523368|NCT02548832|Bezafibrate|bezafibrate|mesh-list
102523369|NCT02548832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102523370|NCT02548832|Antimetabolites|antimetabolites|mesh-ancestor
102523371|NCT02548832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523372|NCT02548832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102523373|NCT03216278|Metformin|metformin|mesh-list
102523374|NCT03216278|Dapagliflozin|dapagliflozin|mesh-list
102523375|NCT03216278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102523376|NCT03216278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523377|NCT03216278|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102523378|NCT03216278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523379|NCT05310344|Paclitaxel|paclitaxel|mesh-list
102523380|NCT05310344|Bevacizumab|bevacizumab|mesh-list
102523381|NCT05310344|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102523382|NCT05310344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102523383|NCT05310344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102523384|NCT05310344|Tubulin Modulators|tubulin modulators|mesh-ancestor
102523385|NCT05310344|Antimitotic Agents|antimitotic agents|mesh-ancestor
102334899|NCT01842620|Metformin|metformin|mesh-list
102523386|NCT05310344|Mitosis Modulators|mitosis modulators|mesh-ancestor
102523387|NCT05310344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523388|NCT05310344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102523389|NCT05310344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102523390|NCT05310344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102523391|NCT05310344|Growth Substances|growth substances|mesh-ancestor
102523392|NCT05310344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523393|NCT05310344|Growth Inhibitors|growth inhibitors|mesh-ancestor
102523394|NCT04381520|Antihypertensive Agents|antihypertensive agents|mesh-list
102523395|NCT00837902|Atenolol|atenolol|mesh-list
102523396|NCT00837902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102523397|NCT00837902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102523398|NCT00837902|Sympatholytics|sympatholytics|mesh-ancestor
102523399|NCT00837902|Autonomic Agents|autonomic agents|mesh-ancestor
102523400|NCT00837902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102523401|NCT00837902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523402|NCT00837902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102523403|NCT00837902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102523404|NCT00837902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102523405|NCT00837902|Adrenergic Agents|adrenergic agents|mesh-ancestor
102523406|NCT00837902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102523407|NCT00837902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523408|NCT04382144|Bupivacaine|bupivacaine|mesh-list
102523409|NCT04382144|Anesthetics, Local|anesthetics, local|mesh-ancestor
102523410|NCT04382144|Anesthetics|anesthetics|mesh-ancestor
102523411|NCT04382144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102523412|NCT04382144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523413|NCT04382144|Sensory System Agents|sensory system agents|mesh-ancestor
102523414|NCT04382144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102523415|NCT03215966|Tadalafil|tadalafil|mesh-list
102523416|NCT03215966|Macitentan|macitentan|mesh-list
102523417|NCT03215966|Vasodilator Agents|vasodilator agents|mesh-ancestor
102523418|NCT03215966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102523419|NCT03215966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102523420|NCT03215966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102523421|NCT03215966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523422|NCT03215966|Urological Agents|urological agents|mesh-ancestor
102523423|NCT03215966|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
102523424|NCT03215966|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102523425|NCT03215966|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
102523426|NCT03215498|Insulin|insulin|mesh-list
102523427|NCT03215498|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102523428|NCT03215498|Insulin Aspart|insulin aspart|mesh-list
102523429|NCT03215498|Insulin, Long-Acting|insulin, long-acting|mesh-list
102523430|NCT03215498|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102523431|NCT03215498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102523432|NCT03215498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523433|NCT01441037|Danazol|danazol|mesh-list
102523434|NCT01441037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102523435|NCT01441037|Hormone Antagonists|hormone antagonists|mesh-ancestor
102523436|NCT01441037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102523437|NCT01441037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523438|NCT00891878|Capecitabine|capecitabine|mesh-list
102523439|NCT00891878|Sunitinib|sunitinib|mesh-list
102523440|NCT00891878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102523441|NCT00891878|Antimetabolites|antimetabolites|mesh-ancestor
102523442|NCT00891878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523443|NCT00891878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102523444|NCT00891878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102523445|NCT00891878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102523446|NCT00891878|Growth Substances|growth substances|mesh-ancestor
102523447|NCT00891878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523448|NCT00891878|Growth Inhibitors|growth inhibitors|mesh-ancestor
102523449|NCT00891878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102523450|NCT00891878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102523451|NCT01445873|Sitaxsentan|sitaxsentan|mesh-list
102523452|NCT01445873|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102523453|NCT01445873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523454|NCT03838328|Tranexamic Acid|tranexamic acid|mesh-list
102523455|NCT03838328|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102523456|NCT03838328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102523457|NCT03838328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523458|NCT03838328|Hemostatics|hemostatics|mesh-ancestor
102523459|NCT03838328|Coagulants|coagulants|mesh-ancestor
102523460|NCT01526213|Fexofenadine|fexofenadine|mesh-list
102334973|NCT05604742|Belimumab|belimumab|mesh-list
102523461|NCT01526213|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102523462|NCT01526213|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102523463|NCT01526213|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102523464|NCT01526213|Histamine Antagonists|histamine antagonists|mesh-ancestor
102523465|NCT01526213|Histamine Agents|histamine agents|mesh-ancestor
102523466|NCT01526213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102523467|NCT01526213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523468|NCT01526213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523469|NCT01549223|Misoprostol|misoprostol|mesh-list
102523470|NCT01549223|Oxytocin|oxytocin|mesh-list
102523471|NCT01549223|Carboprost|carboprost|mesh-list
102523472|NCT01549223|Carboprost tromethamine|carboprost tromethamine|mesh-list
102523473|NCT01549223|Methylergonovine|methylergonovine|mesh-list
102523474|NCT01549223|Maleic acid|maleic acid|mesh-list
102523475|NCT01549223|Oxytocics|oxytocics|mesh-ancestor
102523476|NCT01549223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102523477|NCT01549223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523478|NCT01549223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102523479|NCT01549223|Abortifacient Agents|abortifacient agents|mesh-ancestor
102523480|NCT01549223|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102523481|NCT01549223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102523482|NCT01549223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102523483|NCT01549223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523484|NCT00895934|Azacitidine|azacitidine|mesh-list
102523485|NCT00895934|Vorinostat|vorinostat|mesh-list
102523486|NCT00895934|Gemtuzumab|gemtuzumab|mesh-list
102523487|NCT00895934|Calicheamicins|calicheamicins|mesh-list
102523488|NCT00895934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102523489|NCT00895934|Antimetabolites|antimetabolites|mesh-ancestor
102523490|NCT00895934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523491|NCT00895934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102523492|NCT00895934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102523493|NCT00895934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102523494|NCT00895934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102523495|NCT00895934|Immunotoxins|immunotoxins|mesh-ancestor
102523496|NCT00895934|Immunoconjugates|immunoconjugates|mesh-ancestor
102523497|NCT00895934|Immunologic Factors|immunologic factors|mesh-ancestor
102523498|NCT00895934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523499|NCT00895934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102523500|NCT01550471|Ciclesonide|ciclesonide|mesh-list
102523501|NCT01550471|Beclomethasone|beclomethasone|mesh-list
102523502|NCT01550471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102523503|NCT01550471|Glucocorticoids|glucocorticoids|mesh-ancestor
102523504|NCT01550471|Hormones|hormones|mesh-ancestor
102523505|NCT01550471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102523506|NCT01550471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523507|NCT01550471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102523508|NCT01550471|Respiratory System Agents|respiratory system agents|mesh-ancestor
102523509|NCT01550471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102523510|NCT03215264|Hydroxychloroquine|hydroxychloroquine|mesh-list
102523511|NCT03215264|Entinostat|entinostat|mesh-list
102523512|NCT03215264|Antimalarials|antimalarials|mesh-ancestor
102523513|NCT03215264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102523514|NCT03215264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102523515|NCT03215264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102523516|NCT03215264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102523517|NCT03215264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523518|NCT03215264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102523519|NCT03215264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102523520|NCT03215264|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102523521|NCT01447511|Rifampin|rifampin|mesh-list
102523522|NCT01447511|Fluconazole|fluconazole|mesh-list
102523523|NCT01447511|Warfarin|warfarin|mesh-list
102523524|NCT01447511|Anticoagulants|anticoagulants|mesh-ancestor
102523525|NCT01447511|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102523526|NCT01447511|Antitubercular Agents|antitubercular agents|mesh-ancestor
102523527|NCT01447511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102523528|NCT01447511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102523529|NCT01447511|Leprostatic Agents|leprostatic agents|mesh-ancestor
102523530|NCT01447511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102523531|NCT01447511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102523532|NCT01447511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523533|NCT01447511|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102523534|NCT01447511|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102523535|NCT01447511|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102523536|NCT01447511|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102523537|NCT01447511|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102523538|NCT01447511|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102523539|NCT01447511|Antifungal Agents|antifungal agents|mesh-ancestor
102523540|NCT01447511|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102523541|NCT01447511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102523542|NCT01447511|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102523543|NCT01447511|Hormone Antagonists|hormone antagonists|mesh-ancestor
102523544|NCT01447511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102523545|NCT01447511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523546|NCT01447511|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102523547|NCT01447511|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102523548|NCT01831622|Methylphenidate|methylphenidate|mesh-list
102523549|NCT01831622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102523550|NCT01831622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523551|NCT01831622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102523552|NCT01831622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102523553|NCT01831622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102523554|NCT01831622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523555|NCT01831622|Dopamine Agents|dopamine agents|mesh-ancestor
102523556|NCT01831622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102523557|NCT04380818|Ritonavir|ritonavir|mesh-list
102523558|NCT04380818|Lopinavir|lopinavir|mesh-list
102523559|NCT04380818|Azithromycin|azithromycin|mesh-list
102523560|NCT04380818|Hydroxychloroquine|hydroxychloroquine|mesh-list
102523561|NCT04380818|Heparin|heparin|mesh-list
102523562|NCT04380818|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102523563|NCT04380818|Tinzaparin|tinzaparin|mesh-list
102523564|NCT04380818|Dalteparin|dalteparin|mesh-list
102523565|NCT04380818|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102523566|NCT04380818|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102523567|NCT04380818|Protease Inhibitors|protease inhibitors|mesh-ancestor
102523568|NCT04380818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102523569|NCT04380818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523570|NCT04380818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102523571|NCT04380818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102523572|NCT04380818|Antiviral Agents|antiviral agents|mesh-ancestor
102523573|NCT04380818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102523574|NCT04380818|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102523575|NCT04380818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102523576|NCT04380818|Anticoagulants|anticoagulants|mesh-ancestor
102523577|NCT04380818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102523578|NCT04380818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102523579|NCT04380818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102523580|NCT04380818|Antimalarials|antimalarials|mesh-ancestor
102523581|NCT04380818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102523582|NCT04380818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102523583|NCT04380818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102523584|NCT05312294|Vaccines|vaccines|mesh-list
102523585|NCT05312294|Immunologic Factors|immunologic factors|mesh-ancestor
102523586|NCT05312294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523587|NCT01550705|Isoniazid|isoniazid|mesh-list
102523588|NCT01550705|Antitubercular Agents|antitubercular agents|mesh-ancestor
102523589|NCT01550705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102523590|NCT01550705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102523591|NCT01550705|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102523592|NCT01550705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102523593|NCT01550705|Antimetabolites|antimetabolites|mesh-ancestor
102523594|NCT01550705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523595|NCT01550705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102523596|NCT01831700|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102523597|NCT01831700|Lisinopril|lisinopril|mesh-list
102523598|NCT01831700|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
102523599|NCT01831700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102523600|NCT01831700|Diuretics|diuretics|mesh-ancestor
102523601|NCT01831700|Natriuretic Agents|natriuretic agents|mesh-ancestor
102523602|NCT01831700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523603|NCT01831700|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102523604|NCT01831700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102523605|NCT01831700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523606|NCT01831700|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102523607|NCT01831700|Protease Inhibitors|protease inhibitors|mesh-ancestor
102523608|NCT01831700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102523609|NCT01831700|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102523610|NCT01831700|Protective Agents|protective agents|mesh-ancestor
102523611|NCT01531439|Naloxone|naloxone|mesh-list
102523612|NCT01531439|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102523613|NCT01531439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523614|NCT01531439|Sensory System Agents|sensory system agents|mesh-ancestor
102523615|NCT01531439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102523616|NCT03214874|Torsemide|torsemide|mesh-list
102523617|NCT03214874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102523618|NCT03214874|Diuretics|diuretics|mesh-ancestor
102523619|NCT03214874|Natriuretic Agents|natriuretic agents|mesh-ancestor
102523620|NCT03214874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523621|NCT03214874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102523622|NCT03214874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102523623|NCT03214874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523624|NCT02504268|Methotrexate|methotrexate|mesh-list
102523625|NCT02504268|Abatacept|abatacept|mesh-list
102523626|NCT02504268|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102523627|NCT02504268|Abortifacient Agents|abortifacient agents|mesh-ancestor
102523628|NCT02504268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102523629|NCT02504268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523630|NCT02504268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102523631|NCT02504268|Antimetabolites|antimetabolites|mesh-ancestor
102523632|NCT02504268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523633|NCT02504268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102523634|NCT02504268|Dermatologic Agents|dermatologic agents|mesh-ancestor
102523635|NCT02504268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102523636|NCT02504268|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102523637|NCT02504268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102523638|NCT02504268|Immunologic Factors|immunologic factors|mesh-ancestor
102523639|NCT02504268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102523640|NCT02504268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102523641|NCT02504268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102523642|NCT02504268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102523643|NCT00904826|Eculizumab|eculizumab|mesh-list
102523644|NCT00904826|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102523645|NCT00904826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102523646|NCT00904826|Immunologic Factors|immunologic factors|mesh-ancestor
102523647|NCT00904826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523648|NCT05311514|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102523649|NCT05311514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102523650|NCT01448525|Bimatoprost|bimatoprost|mesh-list
102523651|NCT01448525|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102523652|NCT01448525|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102523653|NCT01448525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102523654|NCT01654302|Lidocaine|lidocaine|mesh-list
102523655|NCT01654302|Tetracaine|tetracaine|mesh-list
102523656|NCT01654302|Anesthetics, Local|anesthetics, local|mesh-ancestor
102523657|NCT01654302|Anesthetics|anesthetics|mesh-ancestor
102523658|NCT01654302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102523659|NCT01654302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523660|NCT01654302|Sensory System Agents|sensory system agents|mesh-ancestor
102523661|NCT01654302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102523662|NCT01654302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102523663|NCT01654302|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102523664|NCT01654302|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102523665|NCT01654302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102523666|NCT01654302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523667|NCT01832558|Eplerenone|eplerenone|mesh-list
102523668|NCT01832558|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102523669|NCT01832558|Hormone Antagonists|hormone antagonists|mesh-ancestor
102523670|NCT01832558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102523671|NCT01832558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523672|NCT01832558|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102523673|NCT01832558|Diuretics|diuretics|mesh-ancestor
102523674|NCT01832558|Natriuretic Agents|natriuretic agents|mesh-ancestor
102523675|NCT01832558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102523676|NCT02476422|Ibuprofen|ibuprofen|mesh-list
102523677|NCT02476422|Diclofenac|diclofenac|mesh-list
102523678|NCT02476422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102523679|NCT02476422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102523680|NCT02476422|Analgesics|analgesics|mesh-ancestor
102523681|NCT02476422|Sensory System Agents|sensory system agents|mesh-ancestor
102523682|NCT02476422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102523683|NCT02476422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335198|NCT05185024|Iron|iron|mesh-list
102523684|NCT02476422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102523685|NCT02476422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102523686|NCT02476422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102523687|NCT02476422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102523688|NCT02476422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523689|NCT01450319|Cetuximab|cetuximab|mesh-list
102523690|NCT01450319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102523691|NCT01450319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102523692|NCT01552343|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
102523693|NCT01552343|Hemostatics|hemostatics|mesh-ancestor
102523694|NCT01552343|Coagulants|coagulants|mesh-ancestor
102523695|NCT01552343|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102523696|NCT01552343|Natriuretic Agents|natriuretic agents|mesh-ancestor
102523697|NCT01552343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523698|NCT02475564|Resveratrol|resveratrol|mesh-list
102523699|NCT02475564|Antioxidants|antioxidants|mesh-ancestor
102523700|NCT02475564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523701|NCT02475564|Protective Agents|protective agents|mesh-ancestor
102523702|NCT02475564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523703|NCT02475564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102523704|NCT02475564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102523705|NCT00893984|Nebivolol|nebivolol|mesh-list
102523706|NCT00893984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102523707|NCT00893984|Vasodilator Agents|vasodilator agents|mesh-ancestor
102523708|NCT00893984|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102523709|NCT00893984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102523710|NCT00893984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102523711|NCT00893984|Adrenergic Agents|adrenergic agents|mesh-ancestor
102523712|NCT00893984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102523713|NCT00893984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523714|NCT00893984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523715|NCT01832870|Ipilimumab|ipilimumab|mesh-list
102523716|NCT01832870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102523717|NCT01832870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102523718|NCT01832870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102523719|NCT01832870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523720|NCT01553201|Botulinum Toxins|botulinum toxins|mesh-list
102523721|NCT01553201|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102523722|NCT01553201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102523723|NCT01553201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523724|NCT01553201|Cholinergic Agents|cholinergic agents|mesh-ancestor
102523725|NCT01553201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102523726|NCT01553201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523727|NCT03214172|Rivaroxaban|rivaroxaban|mesh-list
102523728|NCT03214172|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102523729|NCT03214172|Antithrombins|antithrombins|mesh-ancestor
102523730|NCT03214172|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102523731|NCT03214172|Protease Inhibitors|protease inhibitors|mesh-ancestor
102523732|NCT03214172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102523733|NCT03214172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523734|NCT03214172|Anticoagulants|anticoagulants|mesh-ancestor
102523735|NCT01832948|Leucovorin|leucovorin|mesh-list
102523736|NCT01832948|Folic Acid|folic acid|mesh-list
102523737|NCT01832948|Oxaliplatin|oxaliplatin|mesh-list
102523738|NCT01832948|Endostar protein|endostar protein|mesh-list
102523739|NCT01832948|Levoleucovorin|levoleucovorin|mesh-list
102523740|NCT01832948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102523741|NCT01832948|Antidotes|antidotes|mesh-ancestor
102523742|NCT01832948|Protective Agents|protective agents|mesh-ancestor
102523743|NCT01832948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523744|NCT01832948|Vitamin B Complex|vitamin b complex|mesh-ancestor
102523745|NCT01832948|Vitamins|vitamins|mesh-ancestor
102523746|NCT01832948|Micronutrients|micronutrients|mesh-ancestor
102523747|NCT01832948|Hematinics|hematinics|mesh-ancestor
102523748|NCT01832948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102523749|NCT01832948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102523750|NCT01832948|Growth Substances|growth substances|mesh-ancestor
102523751|NCT01832948|Growth Inhibitors|growth inhibitors|mesh-ancestor
102523752|NCT01533077|Levodopa|levodopa|mesh-list
102523753|NCT01533077|Carbidopa|carbidopa|mesh-list
102523754|NCT01533077|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102523755|NCT01533077|Opicapone|opicapone|mesh-list
102523756|NCT01533077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102523757|NCT01533077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102523758|NCT01533077|Dopamine Agents|dopamine agents|mesh-ancestor
102523759|NCT01533077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102612356|NCT00002423|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102523760|NCT01533077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523761|NCT01533077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523762|NCT01533077|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102523763|NCT01533077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102523764|NCT01533077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102523765|NCT01533077|Immunologic Factors|immunologic factors|mesh-ancestor
102523766|NCT01533077|Dopamine Agonists|dopamine agonists|mesh-ancestor
102523767|NCT01533077|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102523768|NCT01534013|Insulin|insulin|mesh-list
102523769|NCT01534013|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102523770|NCT01534013|Pancrelipase|pancrelipase|mesh-list
102523771|NCT01534013|Pancreatin|pancreatin|mesh-list
102523772|NCT01534013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102523773|NCT01534013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523774|NCT01534013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102523775|NCT03211988|Entinostat|entinostat|mesh-list
102523776|NCT03211988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102523777|NCT03211988|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102523778|NCT03211988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102523779|NCT03211988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523780|NCT01833728|Acetaminophen|acetaminophen|mesh-list
102523781|NCT01833728|Propacetamol|propacetamol|mesh-list
102523782|NCT01833728|Nefopam|nefopam|mesh-list
102523783|NCT01833728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102523784|NCT01833728|Analgesics|analgesics|mesh-ancestor
102523785|NCT01833728|Sensory System Agents|sensory system agents|mesh-ancestor
102523786|NCT01833728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102523787|NCT01833728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523788|NCT01833728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102523789|NCT01833728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102523790|NCT01833728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102523791|NCT01833728|Antipyretics|antipyretics|mesh-ancestor
102523792|NCT03213392|Anesthetics|anesthetics|mesh-list
102523793|NCT03213392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102523794|NCT03213392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523795|NCT03219788|Remifentanil|remifentanil|mesh-list
102523796|NCT03219788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102523797|NCT03219788|Narcotics|narcotics|mesh-ancestor
102523798|NCT03219788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102523799|NCT03219788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523800|NCT03219788|Analgesics|analgesics|mesh-ancestor
102523801|NCT03219788|Sensory System Agents|sensory system agents|mesh-ancestor
102523802|NCT03219788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102523803|NCT03219710|Dexamethasone|dexamethasone|mesh-list
102523804|NCT03219710|Ondansetron|ondansetron|mesh-list
102523805|NCT03219710|Olanzapine|olanzapine|mesh-list
102523806|NCT03219710|Aprepitant|aprepitant|mesh-list
102523807|NCT03219710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102523808|NCT03219710|Antiemetics|antiemetics|mesh-ancestor
102523809|NCT03219710|Autonomic Agents|autonomic agents|mesh-ancestor
102523810|NCT03219710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102523811|NCT03219710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523812|NCT03219710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102523813|NCT03219710|Glucocorticoids|glucocorticoids|mesh-ancestor
102523814|NCT03219710|Hormones|hormones|mesh-ancestor
102523815|NCT03219710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102523816|NCT03219710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102523817|NCT03219710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102523818|NCT03219710|Antipruritics|antipruritics|mesh-ancestor
102523819|NCT03219710|Dermatologic Agents|dermatologic agents|mesh-ancestor
102523820|NCT03219710|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102523821|NCT03219710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102523822|NCT03219710|Serotonin Agents|serotonin agents|mesh-ancestor
102523823|NCT03219710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102523824|NCT03219710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523825|NCT03219710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102523826|NCT03219710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102523827|NCT03219710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102523828|NCT03219710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102523829|NCT03219710|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102523830|NCT03219710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102523831|NCT03219710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102523832|NCT03219710|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102523833|NCT01532141|Opicapone|opicapone|mesh-list
102523834|NCT01532141|Rasagiline|rasagiline|mesh-list
102523835|NCT01532141|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102523836|NCT01532141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102523837|NCT01532141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523838|NCT01532141|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102523839|NCT01532141|Protective Agents|protective agents|mesh-ancestor
102523840|NCT01532141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523841|NCT01532141|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102523842|NCT01532141|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102523843|NCT01532141|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102523844|NCT00899600|Ketamine|ketamine|mesh-list
102523845|NCT00899600|Analgesics|analgesics|mesh-ancestor
102523846|NCT00899600|Sensory System Agents|sensory system agents|mesh-ancestor
102523847|NCT00899600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102523848|NCT00899600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523849|NCT00899600|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102523850|NCT00899600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102523851|NCT00899600|Anesthetics, General|anesthetics, general|mesh-ancestor
102523852|NCT00899600|Anesthetics|anesthetics|mesh-ancestor
102523853|NCT00899600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102523854|NCT00899600|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102523855|NCT00899600|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102523856|NCT00899600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102523857|NCT00899600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523858|NCT03219554|Palbociclib|palbociclib|mesh-list
102523859|NCT03219554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102523860|NCT03219554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102523861|NCT03219554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102523862|NCT03219554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523863|NCT01554371|Cyclophosphamide|cyclophosphamide|mesh-list
102523864|NCT01554371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102523865|NCT01554371|Immunologic Factors|immunologic factors|mesh-ancestor
102523866|NCT01554371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523867|NCT01554371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102523868|NCT01554371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102523869|NCT01554371|Alkylating Agents|alkylating agents|mesh-ancestor
102523870|NCT01554371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523871|NCT01554371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102523872|NCT01554371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102523873|NCT01451411|Conivaptan|conivaptan|mesh-list
102523874|NCT01451411|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102523875|NCT01451411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523876|NCT01451411|Natriuretic Agents|natriuretic agents|mesh-ancestor
102523877|NCT01451411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523878|NCT03837938|Dipropizine|dipropizine|mesh-list
102523879|NCT03837938|Antitussive Agents|antitussive agents|mesh-ancestor
102523880|NCT03837938|Respiratory System Agents|respiratory system agents|mesh-ancestor
102523881|NCT01554683|Levetiracetam|levetiracetam|mesh-list
102523882|NCT01554683|Anticonvulsants|anticonvulsants|mesh-ancestor
102523883|NCT01554683|Nootropic Agents|nootropic agents|mesh-ancestor
102523884|NCT00905060|Temozolomide|temozolomide|mesh-list
102523885|NCT00905060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102523886|NCT00905060|Alkylating Agents|alkylating agents|mesh-ancestor
102523887|NCT00905060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523888|NCT00905060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102523889|NCT01535573|Dexetimide|dexetimide|mesh-list
102523890|NCT01535573|Citalopram|citalopram|mesh-list
102523891|NCT01535573|Escitalopram|escitalopram|mesh-list
102523892|NCT01535573|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102523893|NCT01535573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102523894|NCT01535573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102523895|NCT01535573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523896|NCT01535573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102523897|NCT01535573|Serotonin Agents|serotonin agents|mesh-ancestor
102523898|NCT01535573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523899|NCT01535573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102523900|NCT01535573|Antidepressive Agents|antidepressive agents|mesh-ancestor
102523901|NCT01535573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102523902|NCT01535573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102000175|NCT01262183|Panitumumab|panitumumab|mesh-list
102523903|NCT01535573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102523904|NCT01535573|Parasympatholytics|parasympatholytics|mesh-ancestor
102523905|NCT01535573|Autonomic Agents|autonomic agents|mesh-ancestor
102523906|NCT01535573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102523907|NCT01535573|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102523908|NCT01535573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102523909|NCT01535573|Cholinergic Agents|cholinergic agents|mesh-ancestor
102523910|NCT01834508|Entecavir|entecavir|mesh-list
102523911|NCT01834508|Adefovir|adefovir|mesh-list
102523912|NCT01834508|Antiviral Agents|antiviral agents|mesh-ancestor
102523913|NCT01834508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102523914|NCT01834508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102523915|NCT01834508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102523916|NCT01834508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102523917|NCT01834508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523918|NCT01537835|Anti-Infective Agents|anti-infective agents|mesh-list
102523919|NCT01537835|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102523920|NCT03213002|Capecitabine|capecitabine|mesh-list
102523921|NCT03213002|Temozolomide|temozolomide|mesh-list
102523922|NCT03213002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102523923|NCT03213002|Antimetabolites|antimetabolites|mesh-ancestor
102523924|NCT03213002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523925|NCT03213002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102523926|NCT03213002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102523927|NCT03213002|Alkylating Agents|alkylating agents|mesh-ancestor
102523928|NCT01556633|Oseltamivir|oseltamivir|mesh-list
102523929|NCT01556633|Antiviral Agents|antiviral agents|mesh-ancestor
102523930|NCT01556633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102523931|NCT01556633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102523932|NCT01556633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523933|NCT03218852|Prednisone|prednisone|mesh-list
102523934|NCT03218852|Cyclophosphamide|cyclophosphamide|mesh-list
102523935|NCT03218852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102523936|NCT03218852|Immunologic Factors|immunologic factors|mesh-ancestor
102523937|NCT03218852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523938|NCT03218852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102523939|NCT03218852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102523940|NCT03218852|Alkylating Agents|alkylating agents|mesh-ancestor
102523941|NCT03218852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523942|NCT03218852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102523943|NCT03218852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102523944|NCT03218852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102523945|NCT03218852|Glucocorticoids|glucocorticoids|mesh-ancestor
102523946|NCT03218852|Hormones|hormones|mesh-ancestor
102523947|NCT03218852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102523948|NCT03218852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102523949|NCT01834898|Oxycodone|oxycodone|mesh-list
102523950|NCT01834898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102523951|NCT01834898|Narcotics|narcotics|mesh-ancestor
102523952|NCT01834898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102523953|NCT01834898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523954|NCT01834898|Analgesics|analgesics|mesh-ancestor
102523955|NCT01834898|Sensory System Agents|sensory system agents|mesh-ancestor
102523956|NCT01834898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102523957|NCT01557959|Docetaxel|docetaxel|mesh-list
102523958|NCT01557959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102523959|NCT01557959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102523960|NCT01557959|Tubulin Modulators|tubulin modulators|mesh-ancestor
102523961|NCT01557959|Antimitotic Agents|antimitotic agents|mesh-ancestor
102523962|NCT01557959|Mitosis Modulators|mitosis modulators|mesh-ancestor
102523963|NCT01557959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523964|NCT01557959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102523965|NCT01557959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102523966|NCT03212456|Analgesics, Opioid|analgesics, opioid|mesh-list
102523967|NCT03212456|Ropivacaine|ropivacaine|mesh-list
102523968|NCT03212456|Anesthetics, Local|anesthetics, local|mesh-ancestor
102523969|NCT03212456|Anesthetics|anesthetics|mesh-ancestor
102523970|NCT03212456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102000231|NCT01155791|Hormones|hormones|mesh-ancestor
102523971|NCT03212456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523972|NCT03212456|Sensory System Agents|sensory system agents|mesh-ancestor
102523973|NCT03212456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102523974|NCT03212456|Narcotics|narcotics|mesh-ancestor
102523975|NCT03212456|Analgesics|analgesics|mesh-ancestor
102523976|NCT03217838|Azacitidine|azacitidine|mesh-list
102523977|NCT03217838|Venetoclax|venetoclax|mesh-list
102523978|NCT03217838|Pyrazole|pyrazole|mesh-list
102523979|NCT03217838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102523980|NCT03217838|Antimetabolites|antimetabolites|mesh-ancestor
102523981|NCT03217838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523982|NCT03217838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102523983|NCT03217838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102523984|NCT01558661|Axitinib|axitinib|mesh-list
102612357|NCT00002423|Protease Inhibitors|protease inhibitors|mesh-ancestor
102523985|NCT01558661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102523986|NCT01558661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102523987|NCT01558661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102523988|NCT01558661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102523989|NCT01835288|Arsenic Trioxide|arsenic trioxide|mesh-list
102523990|NCT01835288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102523991|NCT02502864|Cyclophosphamide|cyclophosphamide|mesh-list
102523993|NCT02502864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102523994|NCT02502864|Immunologic Factors|immunologic factors|mesh-ancestor
102523995|NCT02502864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102523996|NCT02502864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102523997|NCT02502864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102523998|NCT02502864|Alkylating Agents|alkylating agents|mesh-ancestor
102523999|NCT02502864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524000|NCT02502864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102524001|NCT02502864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102524002|NCT02502864|Tubulin Modulators|tubulin modulators|mesh-ancestor
102524003|NCT02502864|Antimitotic Agents|antimitotic agents|mesh-ancestor
102524004|NCT02502864|Mitosis Modulators|mitosis modulators|mesh-ancestor
102524005|NCT03217760|Hydrocortisone|hydrocortisone|mesh-list
102524006|NCT03217760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102524007|NCT03217292|Tramadol|tramadol|mesh-list
102524008|NCT03217292|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102524009|NCT03217292|Narcotics|narcotics|mesh-ancestor
102524010|NCT03217292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102524011|NCT03217292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524012|NCT03217292|Analgesics|analgesics|mesh-ancestor
102524013|NCT03217292|Sensory System Agents|sensory system agents|mesh-ancestor
102524014|NCT03217292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102524015|NCT03217448|Warfarin|warfarin|mesh-list
102524016|NCT03217448|Dabigatran|dabigatran|mesh-list
102524017|NCT03217448|Anticoagulants|anticoagulants|mesh-ancestor
102524018|NCT03217448|Antithrombins|antithrombins|mesh-ancestor
102524019|NCT03217448|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102524020|NCT03217448|Protease Inhibitors|protease inhibitors|mesh-ancestor
102524021|NCT03217448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102524022|NCT03217448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524023|NCT01457573|Tamsulosin|tamsulosin|mesh-list
102524024|NCT01457573|Solifenacin Succinate|solifenacin succinate|mesh-list
102524025|NCT01457573|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102524026|NCT01457573|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102524027|NCT01457573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102524028|NCT01457573|Adrenergic Agents|adrenergic agents|mesh-ancestor
102524029|NCT01457573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102524030|NCT01457573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524031|NCT01457573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524032|NCT01457573|Urological Agents|urological agents|mesh-ancestor
102524033|NCT01457573|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102524034|NCT01457573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102524035|NCT01457573|Cholinergic Agents|cholinergic agents|mesh-ancestor
102524036|NCT01560143|Tigecycline|tigecycline|mesh-list
102524037|NCT01560143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102524038|NCT01560143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102524039|NCT01560143|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102524040|NCT01560143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102524041|NCT01560143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524042|NCT01836224|Terlipressin|terlipressin|mesh-list
102524043|NCT01836224|Norepinephrine|norepinephrine|mesh-list
102524044|NCT01836224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102524045|NCT01836224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102524046|NCT01836224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102524047|NCT01836224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102524048|NCT01836224|Adrenergic Agents|adrenergic agents|mesh-ancestor
102524049|NCT01836224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102524050|NCT01836224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524051|NCT01836224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524052|NCT01836224|Sympathomimetics|sympathomimetics|mesh-ancestor
102524053|NCT01836224|Autonomic Agents|autonomic agents|mesh-ancestor
102524054|NCT01836224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102524055|NCT01836536|Bevacizumab|bevacizumab|mesh-list
102524056|NCT01836536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102524057|NCT01836536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102524058|NCT01836536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102524059|NCT01836536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102524060|NCT01836536|Growth Substances|growth substances|mesh-ancestor
102524061|NCT01836536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524062|NCT01836536|Growth Inhibitors|growth inhibitors|mesh-ancestor
102524063|NCT03216980|Antioxidants|antioxidants|mesh-list
102524064|NCT03216980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524065|NCT03216980|Protective Agents|protective agents|mesh-ancestor
102524066|NCT03216980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524068|NCT00895232|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102524069|NCT00895232|Trace Elements|trace elements|mesh-ancestor
102524070|NCT00895232|Micronutrients|micronutrients|mesh-ancestor
102524071|NCT00895232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524072|NCT00895232|Hematinics|hematinics|mesh-ancestor
102524073|NCT03211052|Leuprolide|leuprolide|mesh-list
102524074|NCT03211052|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102524075|NCT03211052|Fertility Agents|fertility agents|mesh-ancestor
102524076|NCT03211052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102524077|NCT03211052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524078|NCT03211052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102524079|NCT03211052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102524080|NCT01560923|Tryptophan|tryptophan|mesh-list
102524081|NCT01560923|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102524082|NCT01560923|Antidepressive Agents|antidepressive agents|mesh-ancestor
102524083|NCT01560923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102524084|NCT01839032|Vinorelbine|vinorelbine|mesh-list
102524085|NCT01839032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102524086|NCT01839032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102524087|NCT01839032|Tubulin Modulators|tubulin modulators|mesh-ancestor
102524088|NCT01839032|Antimitotic Agents|antimitotic agents|mesh-ancestor
102524089|NCT01839032|Mitosis Modulators|mitosis modulators|mesh-ancestor
102524090|NCT01839032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524091|NCT01457885|Busulfan|busulfan|mesh-list
102524092|NCT01457885|Clofarabine|clofarabine|mesh-list
102524093|NCT01457885|Alkylating Agents|alkylating agents|mesh-ancestor
102524094|NCT01457885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524095|NCT01457885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102524096|NCT01457885|Immunologic Factors|immunologic factors|mesh-ancestor
102524097|NCT01457885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524098|NCT01457885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102524099|NCT01457885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102524100|NCT01457885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102524101|NCT01457885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102524102|NCT01457885|Antimetabolites|antimetabolites|mesh-ancestor
102524103|NCT01460225|Lubiprostone|lubiprostone|mesh-list
102524104|NCT01460225|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102524105|NCT01460225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102524106|NCT01460225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524107|NCT01561469|Vancomycin|vancomycin|mesh-list
102524108|NCT01561469|Linezolid|linezolid|mesh-list
102524109|NCT01561469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102524110|NCT01561469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102524111|NCT01561469|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102524112|NCT01561469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102524113|NCT01561469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524114|NCT01561703|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102524115|NCT01561703|Amoxicillin|amoxicillin|mesh-list
102524116|NCT01561703|Azithromycin|azithromycin|mesh-list
102524117|NCT01561703|Clindamycin|clindamycin|mesh-list
102524118|NCT01561703|Clavulanic Acid|clavulanic acid|mesh-list
102524119|NCT01561703|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102524120|NCT01561703|Cephalexin|cephalexin|mesh-list
102524121|NCT01561703|Cefdinir|cefdinir|mesh-list
102524122|NCT01561703|Cefaclor|cefaclor|mesh-list
102524123|NCT01561703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102524124|NCT01561703|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102524125|NCT01561703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102524126|NCT01561703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524127|NCT01561703|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102524128|NCT01839500|Trastuzumab|trastuzumab|mesh-list
102524129|NCT01839500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102524130|NCT01839500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102524131|NCT02501928|Fesoterodine|fesoterodine|mesh-list
102524132|NCT02501928|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102524133|NCT02501928|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102524134|NCT02501928|Cholinergic Agents|cholinergic agents|mesh-ancestor
102524135|NCT02501928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102524136|NCT02501928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524137|NCT02501928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524138|NCT02501928|Urological Agents|urological agents|mesh-ancestor
102524139|NCT01462253|Cyclophosphamide|cyclophosphamide|mesh-list
102524140|NCT01462253|Clofarabine|clofarabine|mesh-list
102524141|NCT01462253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102524142|NCT01462253|Immunologic Factors|immunologic factors|mesh-ancestor
102524143|NCT01462253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524144|NCT01462253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102524145|NCT01462253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102524146|NCT01462253|Alkylating Agents|alkylating agents|mesh-ancestor
102524147|NCT01462253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524148|NCT01462253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102524149|NCT01462253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102524150|NCT01462253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102524151|NCT01462253|Antimetabolites|antimetabolites|mesh-ancestor
102524152|NCT01837394|Acetaminophen|acetaminophen|mesh-list
102524153|NCT01837394|Morphine|morphine|mesh-list
102524154|NCT01837394|Ondansetron|ondansetron|mesh-list
102524155|NCT01837394|Metoclopramide|metoclopramide|mesh-list
102524156|NCT01837394|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102524157|NCT01837394|Narcotics|narcotics|mesh-ancestor
102524158|NCT01837394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102524159|NCT01837394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524160|NCT01837394|Analgesics|analgesics|mesh-ancestor
102524161|NCT01837394|Sensory System Agents|sensory system agents|mesh-ancestor
102524162|NCT01837394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102524163|NCT01837394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102524164|NCT01837394|Antipyretics|antipyretics|mesh-ancestor
102524165|NCT01837394|Antiemetics|antiemetics|mesh-ancestor
102524166|NCT01837394|Autonomic Agents|autonomic agents|mesh-ancestor
102524167|NCT01837394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102524168|NCT01837394|Antipruritics|antipruritics|mesh-ancestor
102524169|NCT01837394|Dermatologic Agents|dermatologic agents|mesh-ancestor
102524170|NCT01837394|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102524171|NCT01837394|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102524172|NCT01837394|Serotonin Agents|serotonin agents|mesh-ancestor
102524173|NCT01837394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102524174|NCT01837394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524175|NCT01837394|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102524176|NCT01837394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102524177|NCT01837394|Dopamine Agents|dopamine agents|mesh-ancestor
102524178|NCT01462565|Epoprostenol|epoprostenol|mesh-list
102524179|NCT01462565|Tezosentan|tezosentan|mesh-list
102524180|NCT01462565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102524181|NCT01462565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102524182|NCT01462565|Vasodilator Agents|vasodilator agents|mesh-ancestor
102524183|NCT01837628|Lidocaine|lidocaine|mesh-list
102524184|NCT01837628|Mineral Oil|mineral oil|mesh-list
102524185|NCT01837628|Anesthetics, Local|anesthetics, local|mesh-ancestor
102524186|NCT01837628|Anesthetics|anesthetics|mesh-ancestor
102524187|NCT01837628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102524188|NCT01837628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524189|NCT01837628|Sensory System Agents|sensory system agents|mesh-ancestor
102524190|NCT01837628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102524191|NCT01837628|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102524192|NCT01837628|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102524193|NCT01837628|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102524194|NCT01837628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102524195|NCT01837628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524196|NCT01837628|Emollients|emollients|mesh-ancestor
102524197|NCT01837628|Dermatologic Agents|dermatologic agents|mesh-ancestor
102524198|NCT01462877|Fenofibrate|fenofibrate|mesh-list
102524199|NCT01462877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102524200|NCT01462877|Antimetabolites|antimetabolites|mesh-ancestor
102524201|NCT01462877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524202|NCT01462877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102524203|NCT04972656|Ambrisentan|ambrisentan|mesh-list
102524204|NCT04972656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102524205|NCT03210506|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102524206|NCT03210506|Antiviral Agents|antiviral agents|mesh-ancestor
102524207|NCT03210506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102524208|NCT02500758|Chloroxylenol|chloroxylenol|mesh-list
102524209|NCT02500758|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102524210|NCT02500758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102524211|NCT02500758|Disinfectants|disinfectants|mesh-ancestor
102524212|NCT02500758|Schistosomicides|schistosomicides|mesh-ancestor
102524213|NCT02500758|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102524214|NCT02500758|Anthelmintics|anthelmintics|mesh-ancestor
102524215|NCT02500758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102524216|NCT01839812|Cosyntropin|cosyntropin|mesh-list
102524217|NCT01839812|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102524218|NCT01839812|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
102524219|NCT01839812|beta-Endorphin|beta-endorphin|mesh-list
102524220|NCT01839812|Hormones|hormones|mesh-ancestor
102524221|NCT01839812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102524222|NCT01839812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524223|NCT01839812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102524224|NCT01839812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524225|NCT01839890|Paclitaxel|paclitaxel|mesh-list
102524226|NCT01839890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102524227|NCT01839890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102524228|NCT01839890|Tubulin Modulators|tubulin modulators|mesh-ancestor
102524229|NCT01839890|Antimitotic Agents|antimitotic agents|mesh-ancestor
102524230|NCT01839890|Mitosis Modulators|mitosis modulators|mesh-ancestor
102524231|NCT01839890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524232|NCT02205983|Acetaminophen|acetaminophen|mesh-list
102524233|NCT02205983|Hydromorphone|hydromorphone|mesh-list
102524234|NCT02205983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102524235|NCT02205983|Analgesics|analgesics|mesh-ancestor
102524236|NCT02205983|Sensory System Agents|sensory system agents|mesh-ancestor
102524237|NCT02205983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102524238|NCT02205983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524239|NCT02205983|Antipyretics|antipyretics|mesh-ancestor
102524240|NCT02205983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102524241|NCT02205983|Narcotics|narcotics|mesh-ancestor
102524242|NCT02205983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102524243|NCT01839968|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102524244|NCT01839968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102524245|NCT03210038|Lidocaine|lidocaine|mesh-list
102524246|NCT03210038|Anesthetics, Local|anesthetics, local|mesh-ancestor
102524247|NCT03210038|Anesthetics|anesthetics|mesh-ancestor
102524248|NCT03210038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102524249|NCT03210038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524250|NCT03210038|Sensory System Agents|sensory system agents|mesh-ancestor
102524251|NCT03210038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102524252|NCT03210038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102524253|NCT03210038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102524254|NCT03210038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102524255|NCT03210038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102524256|NCT03210038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524257|NCT02472756|Rituximab|rituximab|mesh-list
102000527|NCT01159301|Sorafenib|sorafenib|mesh-list
102524258|NCT02472756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102524259|NCT02472756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102524260|NCT02472756|Immunologic Factors|immunologic factors|mesh-ancestor
102524261|NCT02472756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524262|NCT02472756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102524263|NCT01464359|Cyclophosphamide|cyclophosphamide|mesh-list
102524264|NCT01464359|Busulfan|busulfan|mesh-list
102524265|NCT01464359|Fludarabine|fludarabine|mesh-list
102524266|NCT01464359|Interleukin-2|interleukin-2|mesh-list
102524267|NCT01464359|Allopurinol|allopurinol|mesh-list
102524268|NCT01464359|Levetiracetam|levetiracetam|mesh-list
102524269|NCT01464359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102524270|NCT01464359|Immunologic Factors|immunologic factors|mesh-ancestor
102524271|NCT01464359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524272|NCT01464359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102524273|NCT01464359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102524274|NCT01464359|Alkylating Agents|alkylating agents|mesh-ancestor
102524275|NCT01464359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524276|NCT01464359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102524277|NCT01464359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102524278|NCT01464359|Antimetabolites|antimetabolites|mesh-ancestor
102524279|NCT01464359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102524280|NCT01464359|Analgesics|analgesics|mesh-ancestor
102524281|NCT01464359|Sensory System Agents|sensory system agents|mesh-ancestor
102524282|NCT01464359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102524283|NCT01464359|Anticonvulsants|anticonvulsants|mesh-ancestor
102524284|NCT01464359|Nootropic Agents|nootropic agents|mesh-ancestor
102524285|NCT01464359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102524286|NCT01464359|Gout Suppressants|gout suppressants|mesh-ancestor
102524287|NCT01464359|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102335793|NCT01609790|Growth Inhibitors|growth inhibitors|mesh-ancestor
102524288|NCT01464359|Antioxidants|antioxidants|mesh-ancestor
102524289|NCT01464359|Protective Agents|protective agents|mesh-ancestor
102524290|NCT04969224|Ivacaftor|ivacaftor|mesh-list
102524291|NCT04969224|Elexacaftor|elexacaftor|mesh-list
102524292|NCT04969224|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102524293|NCT04969224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102524294|NCT04969224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524295|NCT01838252|Hyaluronic Acid|hyaluronic acid|mesh-list
102524296|NCT01838252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102524297|NCT01838252|Immunologic Factors|immunologic factors|mesh-ancestor
102524298|NCT01838252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524299|NCT01838252|Viscosupplements|viscosupplements|mesh-ancestor
102524300|NCT01838252|Protective Agents|protective agents|mesh-ancestor
102524301|NCT01838330|Psyllium|psyllium|mesh-list
102524302|NCT01838330|Cathartics|cathartics|mesh-ancestor
102524303|NCT01838330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102524304|NCT02498652|Allopurinol|allopurinol|mesh-list
102524305|NCT02498652|Verinurad|verinurad|mesh-list
102524306|NCT02498652|Antimetabolites|antimetabolites|mesh-ancestor
102524307|NCT02498652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524308|NCT02498652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102524309|NCT02498652|Gout Suppressants|gout suppressants|mesh-ancestor
102524310|NCT02498652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102524311|NCT02498652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102524312|NCT02498652|Antioxidants|antioxidants|mesh-ancestor
102524313|NCT02498652|Protective Agents|protective agents|mesh-ancestor
102524314|NCT02498652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524315|NCT03213158|Ixazomib|ixazomib|mesh-list
102524316|NCT03213158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102524317|NCT03213158|Protease Inhibitors|protease inhibitors|mesh-ancestor
102524318|NCT03213158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102524319|NCT03213158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524320|NCT02498418|Rifaximin|rifaximin|mesh-list
102524321|NCT02498418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102524322|NCT02498418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102524323|NCT02498418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102524324|NCT03219476|Tamoxifen|tamoxifen|mesh-list
102524325|NCT03219476|Letrozole|letrozole|mesh-list
102524326|NCT03219476|Anastrozole|anastrozole|mesh-list
102524327|NCT03219476|Exemestane|exemestane|mesh-list
102524328|NCT03219476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102524329|NCT03219476|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102524330|NCT03219476|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102524331|NCT03219476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102524332|NCT03219476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524333|NCT03219476|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102524334|NCT03219476|Hormone Antagonists|hormone antagonists|mesh-ancestor
102524335|NCT03219476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102524336|NCT03219476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524337|NCT03219476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102524338|NCT03219476|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102524339|NCT03219476|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102524340|NCT03219476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102524341|NCT02472366|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
102524342|NCT02472366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102524343|NCT02472366|Glucocorticoids|glucocorticoids|mesh-ancestor
102524344|NCT02472366|Hormones|hormones|mesh-ancestor
102524345|NCT02472366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102524346|NCT02472366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524347|NCT01724606|Sorafenib|sorafenib|mesh-list
102524348|NCT01724606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102524349|NCT01724606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102524350|NCT01724606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102524351|NCT01724606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524352|NCT03219164|Aztreonam|aztreonam|mesh-list
102524353|NCT03219164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102524354|NCT03219164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102524355|NCT01720238|Lamivudine|lamivudine|mesh-list
102524356|NCT01720238|Adefovir|adefovir|mesh-list
102524357|NCT01720238|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
102524358|NCT01720238|Entecavir|entecavir|mesh-list
102524359|NCT01720238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102524360|NCT01720238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102524361|NCT01720238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102524362|NCT01720238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524363|NCT01720238|Antiviral Agents|antiviral agents|mesh-ancestor
102524364|NCT01720238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102524365|NCT01720238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102524366|NCT01720238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102524367|NCT03836222|Pentoxifylline|pentoxifylline|mesh-list
102524368|NCT03836222|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102524369|NCT03836222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102524370|NCT03836222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524371|NCT03836222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102524372|NCT03836222|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102524373|NCT03836222|Protective Agents|protective agents|mesh-ancestor
102524374|NCT03836222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524375|NCT03836222|Vasodilator Agents|vasodilator agents|mesh-ancestor
102524376|NCT03836222|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102524377|NCT03836222|Antioxidants|antioxidants|mesh-ancestor
102524378|NCT01830218|Anesthetics|anesthetics|mesh-list
102524379|NCT01830218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102524380|NCT01830218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524381|NCT00910208|Morphine|morphine|mesh-list
102524382|NCT00910208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102524383|NCT00910208|Narcotics|narcotics|mesh-ancestor
102524384|NCT00910208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102524385|NCT00910208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524386|NCT00910208|Analgesics|analgesics|mesh-ancestor
102524387|NCT00910208|Sensory System Agents|sensory system agents|mesh-ancestor
102524388|NCT00910208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102524389|NCT01566539|Vasopressins|vasopressins|mesh-list
102524390|NCT01566539|Arginine Vasopressin|arginine vasopressin|mesh-list
102524391|NCT01566539|Lorazepam|lorazepam|mesh-list
102524392|NCT01566539|Oxytocin|oxytocin|mesh-list
102524393|NCT01566539|Oxytocics|oxytocics|mesh-ancestor
102524394|NCT01566539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102524395|NCT01566539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524396|NCT01566539|Anticonvulsants|anticonvulsants|mesh-ancestor
102524397|NCT01566539|Antiemetics|antiemetics|mesh-ancestor
102524398|NCT01566539|Autonomic Agents|autonomic agents|mesh-ancestor
102524399|NCT01566539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102524400|NCT01566539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102524401|NCT01566539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102524402|NCT01566539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102524403|NCT01566539|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102000653|NCT03876587|Docetaxel|docetaxel|mesh-list
102524404|NCT01566539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102524405|NCT01566539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102524406|NCT01566539|GABA Modulators|gaba modulators|mesh-ancestor
102524407|NCT01566539|GABA Agents|gaba agents|mesh-ancestor
102524408|NCT01566539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102524409|NCT01566539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524410|NCT01566539|Hemostatics|hemostatics|mesh-ancestor
102524411|NCT01566539|Coagulants|coagulants|mesh-ancestor
102524412|NCT01566539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102524413|NCT01566539|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102524414|NCT01566539|Natriuretic Agents|natriuretic agents|mesh-ancestor
102524415|NCT04967664|Capsaicin|capsaicin|mesh-list
102524416|NCT04967664|Antipruritics|antipruritics|mesh-ancestor
102524417|NCT04967664|Dermatologic Agents|dermatologic agents|mesh-ancestor
102524418|NCT04967664|Sensory System Agents|sensory system agents|mesh-ancestor
102524419|NCT04967664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102524420|NCT04967664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524421|NCT01725776|Milrinone|milrinone|mesh-list
102524422|NCT01725776|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102524423|NCT01725776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102524424|NCT01725776|Vasodilator Agents|vasodilator agents|mesh-ancestor
102524425|NCT01725776|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102524426|NCT01725776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102524427|NCT01725776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102524428|NCT01725776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524429|NCT01725776|Protective Agents|protective agents|mesh-ancestor
102524430|NCT01725776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524431|NCT01830296|Morphine|morphine|mesh-list
102524432|NCT01830296|Remifentanil|remifentanil|mesh-list
102524433|NCT01830296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102524434|NCT01830296|Narcotics|narcotics|mesh-ancestor
102524435|NCT01830296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102524436|NCT01830296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524437|NCT01830296|Analgesics|analgesics|mesh-ancestor
102524438|NCT01830296|Sensory System Agents|sensory system agents|mesh-ancestor
102524439|NCT01830296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102524440|NCT05564819|Acetaminophen|acetaminophen|mesh-list
102335944|NCT05929937|Analgesics|analgesics|mesh-ancestor
102524441|NCT05564819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102524442|NCT05564819|Analgesics|analgesics|mesh-ancestor
102524443|NCT05564819|Sensory System Agents|sensory system agents|mesh-ancestor
102524444|NCT05564819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102524445|NCT05564819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524446|NCT05564819|Antipyretics|antipyretics|mesh-ancestor
102524447|NCT01720394|Dinoprostone|dinoprostone|mesh-list
102524448|NCT01720394|Oxytocics|oxytocics|mesh-ancestor
102524449|NCT01720394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102524450|NCT01720394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524451|NCT01467947|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
102524452|NCT01467947|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
102524453|NCT01467947|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102524454|NCT01467947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102524455|NCT01467947|Immunologic Factors|immunologic factors|mesh-ancestor
102524456|NCT01467947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524457|NCT00910520|Botulinum Toxins|botulinum toxins|mesh-list
102524458|NCT00910520|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102524459|NCT00910520|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102524460|NCT00910520|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102524461|NCT00910520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102524462|NCT00910520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524463|NCT00910520|Cholinergic Agents|cholinergic agents|mesh-ancestor
102524464|NCT00910520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102524465|NCT00910520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524466|NCT00910520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102000727|NCT03876041|Dexamethasone|dexamethasone|mesh-list
102524467|NCT00910520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102524468|NCT01568255|Ergocalciferols|ergocalciferols|mesh-list
102524469|NCT01568255|Vitamin D|vitamin d|mesh-list
102524470|NCT01568255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102524471|NCT01568255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524472|NCT01568255|Vitamins|vitamins|mesh-ancestor
102524473|NCT01568255|Micronutrients|micronutrients|mesh-ancestor
102524474|NCT01568255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102524475|NCT01720628|Angiogenin|angiogenin|mesh-list
102524476|NCT01720628|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
102524477|NCT01720628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102524478|NCT01720628|Growth Substances|growth substances|mesh-ancestor
102524479|NCT01720628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524480|NCT01569191|Anti-Allergic Agents|anti-allergic agents|mesh-list
102524481|NCT01569191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102524482|NCT01569191|Lubricant Eye Drops|lubricant eye drops|mesh-list
102524483|NCT01569191|Epinastine|epinastine|mesh-list
102524484|NCT01569191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102524485|NCT01569191|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102524486|NCT01569191|Histamine Antagonists|histamine antagonists|mesh-ancestor
102524487|NCT01569191|Histamine Agents|histamine agents|mesh-ancestor
102524488|NCT01569191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102524489|NCT01569191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524490|NCT01569191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524491|NCT03409874|Diclofenac|diclofenac|mesh-list
102524492|NCT03409874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102524493|NCT03409874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102524494|NCT03409874|Analgesics|analgesics|mesh-ancestor
102524495|NCT03409874|Sensory System Agents|sensory system agents|mesh-ancestor
102524496|NCT03409874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102524497|NCT03409874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524498|NCT03409874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102524499|NCT03409874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102524500|NCT03409874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102524501|NCT03409874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102524502|NCT03409874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524503|NCT01726088|Modafinil|modafinil|mesh-list
102524504|NCT01726088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102524505|NCT01726088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524506|NCT01726088|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102524507|NCT01726088|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102524508|NCT01726088|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102524509|NCT01726088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524510|NCT01468337|Interferons|interferons|mesh-list
102524511|NCT01468337|Interferon-gamma|interferon-gamma|mesh-list
102524512|NCT01468337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102524513|NCT01468337|Antiviral Agents|antiviral agents|mesh-ancestor
102524514|NCT01468337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102524515|NCT00911612|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
102524516|NCT00911612|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102524517|NCT00911612|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102524518|NCT00911612|Antimetabolites|antimetabolites|mesh-ancestor
102524519|NCT00911612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524520|NCT00911612|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102524521|NCT05562089|Paclitaxel|paclitaxel|mesh-list
102524522|NCT05562089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102524523|NCT05562089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102524524|NCT05562089|Tubulin Modulators|tubulin modulators|mesh-ancestor
102524525|NCT05562089|Antimitotic Agents|antimitotic agents|mesh-ancestor
102524526|NCT05562089|Mitosis Modulators|mitosis modulators|mesh-ancestor
102524527|NCT05562089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524528|NCT01726478|Oxytocin|oxytocin|mesh-list
102524529|NCT01726478|Oxytocics|oxytocics|mesh-ancestor
102524530|NCT01726478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102524531|NCT01726478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524532|NCT04379492|Hydroxychloroquine|hydroxychloroquine|mesh-list
102524533|NCT04379492|Antimalarials|antimalarials|mesh-ancestor
102524534|NCT04379492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102524535|NCT04379492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102524536|NCT04379492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102524537|NCT04379492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102133728|NCT03519633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102524538|NCT04379492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524539|NCT04379492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102524540|NCT03409250|Ranibizumab|ranibizumab|mesh-list
102524541|NCT03409250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102524542|NCT03409250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102524543|NCT03409250|Growth Substances|growth substances|mesh-ancestor
102524544|NCT03409250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524545|NCT03409250|Growth Inhibitors|growth inhibitors|mesh-ancestor
102524546|NCT03409250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102524547|NCT01569815|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102524548|NCT01569815|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102524549|NCT01569815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524550|NCT01469585|Doxycycline|doxycycline|mesh-list
102524551|NCT01469585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102524552|NCT01469585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102524553|NCT01469585|Antimalarials|antimalarials|mesh-ancestor
102524554|NCT01469585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102524555|NCT01469585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102524556|NCT01720940|Vancomycin|vancomycin|mesh-list
102524557|NCT01720940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102524558|NCT01720940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102524559|NCT00915590|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102524560|NCT00915590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102524561|NCT01721798|Copper|copper|mesh-list
102524562|NCT01721798|Levonorgestrel|levonorgestrel|mesh-list
102524563|NCT01721798|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102524564|NCT01721798|Contraceptive Agents|contraceptive agents|mesh-ancestor
102000858|NCT03878771|Clobetasol|clobetasol|mesh-list
102524565|NCT01721798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102524566|NCT01721798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524567|NCT01721798|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102524568|NCT01721798|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102524569|NCT01721798|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102524570|NCT01721798|Trace Elements|trace elements|mesh-ancestor
102524571|NCT01721798|Micronutrients|micronutrients|mesh-ancestor
102524572|NCT02497404|Fludarabine|fludarabine|mesh-list
102524573|NCT02497404|Azacitidine|azacitidine|mesh-list
102524574|NCT02497404|Melphalan|melphalan|mesh-list
102524575|NCT02497404|Alemtuzumab|alemtuzumab|mesh-list
102524576|NCT02497404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102524577|NCT02497404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102524578|NCT02497404|Antimetabolites|antimetabolites|mesh-ancestor
102524579|NCT02497404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524580|NCT02497404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102524581|NCT02497404|Immunologic Factors|immunologic factors|mesh-ancestor
102524582|NCT02497404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524583|NCT02497404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102524584|NCT02497404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102524585|NCT02497404|Alkylating Agents|alkylating agents|mesh-ancestor
102524586|NCT02497404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102524587|NCT02497404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102524588|NCT01573169|Enoxaparin|enoxaparin|mesh-list
102524589|NCT01573169|Anticoagulants|anticoagulants|mesh-ancestor
102524590|NCT01573169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102524591|NCT01573169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102524592|NCT01573169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524594|NCT04205994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102524595|NCT04205994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102524596|NCT04205994|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102524597|NCT04205994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102524598|NCT04205994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524599|NCT02218307|Mupirocin|mupirocin|mesh-list
102524600|NCT02218307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102524601|NCT02218307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102524602|NCT02218307|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102524603|NCT02218307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102524604|NCT02218307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524605|NCT01722110|Indomethacin|indomethacin|mesh-list
102524606|NCT01722110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102524607|NCT01722110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102524608|NCT01722110|Analgesics|analgesics|mesh-ancestor
102524609|NCT01722110|Sensory System Agents|sensory system agents|mesh-ancestor
102524610|NCT01722110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102133729|NCT03519633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102524611|NCT01722110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524612|NCT01722110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102524613|NCT01722110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102524614|NCT01722110|Gout Suppressants|gout suppressants|mesh-ancestor
102524615|NCT01722110|Tocolytic Agents|tocolytic agents|mesh-ancestor
102524616|NCT01722110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102524617|NCT01722110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102524618|NCT01722110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102524619|NCT01722110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524620|NCT01573949|Metformin|metformin|mesh-list
102524621|NCT01573949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102524622|NCT01573949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524623|NCT01574183|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
102524624|NCT01574183|Antidepressive Agents|antidepressive agents|mesh-ancestor
102524625|NCT01574183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102524626|NCT01574183|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102524627|NCT01574183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102524628|NCT01574183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102524629|NCT01574183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524630|NCT01574183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102524631|NCT01574183|Serotonin Agents|serotonin agents|mesh-ancestor
102524632|NCT01574183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524633|NCT01574183|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102524634|NCT01574183|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102524635|NCT01574807|Lidocaine|lidocaine|mesh-list
102524636|NCT01574807|Mepivacaine|mepivacaine|mesh-list
102524637|NCT01574807|Anesthetics, Local|anesthetics, local|mesh-ancestor
102524638|NCT01574807|Anesthetics|anesthetics|mesh-ancestor
102524639|NCT01574807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102524640|NCT01574807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524641|NCT01574807|Sensory System Agents|sensory system agents|mesh-ancestor
102524642|NCT01574807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102524643|NCT01574807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102524644|NCT01574807|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102524645|NCT01574807|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102524646|NCT01574807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102524647|NCT01574807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524648|NCT01575275|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102524649|NCT01575275|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102524650|NCT01575275|Dermatologic Agents|dermatologic agents|mesh-ancestor
102524651|NCT01728272|Metoprolol|metoprolol|mesh-list
102524652|NCT01728272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102524653|NCT01728272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102524654|NCT01728272|Sympatholytics|sympatholytics|mesh-ancestor
102524655|NCT01728272|Autonomic Agents|autonomic agents|mesh-ancestor
102524656|NCT01728272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102524657|NCT01728272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524658|NCT01728272|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102524659|NCT01728272|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102524660|NCT01728272|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102524661|NCT01728272|Adrenergic Agents|adrenergic agents|mesh-ancestor
102524662|NCT01728272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102336170|NCT05839366|Remifentanil|remifentanil|mesh-list
102524663|NCT01728272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524664|NCT03835286|Ascorbic Acid|ascorbic acid|mesh-list
102524665|NCT03835286|Vitamins|vitamins|mesh-ancestor
102524666|NCT03835286|Micronutrients|micronutrients|mesh-ancestor
102524667|NCT03835286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524668|NCT03835286|Antioxidants|antioxidants|mesh-ancestor
102524669|NCT03835286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524670|NCT03835286|Protective Agents|protective agents|mesh-ancestor
102524671|NCT04377386|Vitamin D|vitamin d|mesh-list
102524672|NCT04377386|Ergocalciferols|ergocalciferols|mesh-list
102524673|NCT04377386|Cholecalciferol|cholecalciferol|mesh-list
102524674|NCT04377386|Vitamins|vitamins|mesh-list
102524675|NCT04377386|Micronutrients|micronutrients|mesh-ancestor
102524676|NCT04377386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524677|NCT04377386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102524678|NCT04377386|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102524679|NCT01728740|Metformin|metformin|mesh-list
102524680|NCT01728740|Acarbose|acarbose|mesh-list
102524681|NCT01728740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102524682|NCT01728740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524683|NCT01728740|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102524684|NCT01728740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102524685|NCT01728740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524686|NCT01728818|Gemcitabine|gemcitabine|mesh-list
102524687|NCT01728818|Afatinib|afatinib|mesh-list
102524688|NCT01728818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102524689|NCT01728818|Antimetabolites|antimetabolites|mesh-ancestor
102524690|NCT01728818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524691|NCT01728818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102524692|NCT01728818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102524693|NCT01728818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102524694|NCT03835520|Immunomodulating Agents|immunomodulating agents|mesh-list
102524695|NCT03835520|Immunologic Factors|immunologic factors|mesh-ancestor
102524696|NCT03835520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524697|NCT01728974|Anesthetics|anesthetics|mesh-list
102524698|NCT01728974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102524699|NCT01728974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524700|NCT03407300|Docetaxel|docetaxel|mesh-list
102524701|NCT03407300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102524702|NCT03407300|Tubulin Modulators|tubulin modulators|mesh-ancestor
102524703|NCT03407300|Antimitotic Agents|antimitotic agents|mesh-ancestor
102524704|NCT03407300|Mitosis Modulators|mitosis modulators|mesh-ancestor
102524705|NCT03407300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524706|NCT01722968|Paclitaxel|paclitaxel|mesh-list
102524707|NCT01722968|Bevacizumab|bevacizumab|mesh-list
102524708|NCT01722968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102524709|NCT01722968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102524710|NCT01722968|Tubulin Modulators|tubulin modulators|mesh-ancestor
102524711|NCT01722968|Antimitotic Agents|antimitotic agents|mesh-ancestor
102524712|NCT01722968|Mitosis Modulators|mitosis modulators|mesh-ancestor
102524713|NCT01722968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524714|NCT01722968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102524715|NCT01722968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102524716|NCT01722968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102524717|NCT01722968|Growth Substances|growth substances|mesh-ancestor
102524718|NCT01722968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524719|NCT01722968|Growth Inhibitors|growth inhibitors|mesh-ancestor
102524720|NCT04379180|Bosentan|bosentan|mesh-list
102524721|NCT04379180|Sildenafil Citrate|sildenafil citrate|mesh-list
102524722|NCT04379180|Tadalafil|tadalafil|mesh-list
102524723|NCT04379180|Vasodilator Agents|vasodilator agents|mesh-ancestor
102524724|NCT04379180|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102524725|NCT04379180|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102524726|NCT04379180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102524727|NCT04379180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524728|NCT04379180|Urological Agents|urological agents|mesh-ancestor
102524729|NCT04379180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102524730|NCT04379180|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102524731|NCT01576523|Complement C1s|complement c1s|mesh-list
102524732|NCT01576523|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
102524733|NCT01576523|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
102524734|NCT01576523|Immunologic Factors|immunologic factors|mesh-ancestor
102524735|NCT01576523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524736|NCT01576523|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102524737|NCT01576523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102524739|NCT03406676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102524740|NCT03406676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524741|NCT03001739|Urapidil|urapidil|mesh-list
102524742|NCT03001739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102524743|NCT03001739|Vasodilator Agents|vasodilator agents|mesh-ancestor
102524744|NCT03001739|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102524745|NCT03001739|Serotonin Agents|serotonin agents|mesh-ancestor
102524746|NCT03001739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102524747|NCT03001739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524748|NCT03001739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524749|NCT03001739|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102524750|NCT03001739|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102524751|NCT03001739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102524752|NCT03001739|Adrenergic Agents|adrenergic agents|mesh-ancestor
102524753|NCT03001661|Dinoprostone|dinoprostone|mesh-list
102524754|NCT03001661|Oxytocics|oxytocics|mesh-ancestor
102524755|NCT03001661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102524756|NCT03001661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524757|NCT03006965|Factor VIII|factor viii|mesh-list
102524758|NCT03006965|BAX 855|bax 855|mesh-list
102524759|NCT03006965|Coagulants|coagulants|mesh-ancestor
102524760|NCT04379102|Anesthetics|anesthetics|mesh-list
102524761|NCT04379102|Anesthetics, Local|anesthetics, local|mesh-list
102524762|NCT04379102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102524763|NCT04379102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524764|NCT04379102|Sensory System Agents|sensory system agents|mesh-ancestor
102524765|NCT04379102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102524766|NCT02469246|Lamivudine|lamivudine|mesh-list
102524767|NCT02469246|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102524768|NCT02469246|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102524769|NCT02469246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102524770|NCT02469246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524771|NCT02469246|Antiviral Agents|antiviral agents|mesh-ancestor
102524772|NCT02469246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102524773|NCT02469246|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102524774|NCT02469246|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102524775|NCT01723202|Trametinib|trametinib|mesh-list
102524776|NCT01723202|Dabrafenib|dabrafenib|mesh-list
102524777|NCT01723202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102524778|NCT01723202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102524779|NCT01723202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102524780|NCT01723202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524781|NCT01578317|Vaccines|vaccines|mesh-list
102524782|NCT01578317|Immunologic Factors|immunologic factors|mesh-ancestor
102524783|NCT01578317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524784|NCT03830216|Insulin|insulin|mesh-list
102524785|NCT03830216|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102524786|NCT03830216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102524787|NCT03830216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524788|NCT01726946|Ribavirin|ribavirin|mesh-list
102524789|NCT01726946|Antimetabolites|antimetabolites|mesh-ancestor
102524790|NCT01726946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524791|NCT01726946|Antiviral Agents|antiviral agents|mesh-ancestor
102524792|NCT01726946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102524793|NCT01723670|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
102524794|NCT01723670|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
102524795|NCT01723670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102524796|NCT01723670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524797|NCT01723748|Hormones|hormones|mesh-list
102524798|NCT01723748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102524799|NCT01723748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524800|NCT02469090|Apomorphine|apomorphine|mesh-list
102524801|NCT02469090|Emetics|emetics|mesh-ancestor
102524802|NCT02469090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524803|NCT02469090|Autonomic Agents|autonomic agents|mesh-ancestor
102524804|NCT02469090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102524805|NCT02469090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102524806|NCT02469090|Dopamine Agonists|dopamine agonists|mesh-ancestor
102524807|NCT02469090|Dopamine Agents|dopamine agents|mesh-ancestor
102524808|NCT02469090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102524809|NCT02469090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524810|NCT02496000|Insulin|insulin|mesh-list
102524811|NCT02496000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102524812|NCT02496000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524813|NCT02517528|Ritonavir|ritonavir|mesh-list
102524814|NCT02517528|Ribavirin|ribavirin|mesh-list
102524815|NCT02517528|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102524816|NCT02517528|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102524817|NCT02517528|Protease Inhibitors|protease inhibitors|mesh-ancestor
102524818|NCT02517528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102524819|NCT02517528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524820|NCT02517528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102524821|NCT02517528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102524822|NCT02517528|Antiviral Agents|antiviral agents|mesh-ancestor
102524823|NCT02517528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102524824|NCT02517528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102524825|NCT02517528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102524826|NCT02517528|Antimetabolites|antimetabolites|mesh-ancestor
102524827|NCT01727336|Axitinib|axitinib|mesh-list
102524828|NCT01727336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102524829|NCT01727336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102524830|NCT01727336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102524831|NCT01727336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524832|NCT01578707|Ofatumumab|ofatumumab|mesh-list
102524833|NCT01578707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102524834|NCT03835442|Baclofen|baclofen|mesh-list
102524835|NCT03835442|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102524836|NCT03835442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524837|NCT03835442|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102524838|NCT03835442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102524839|NCT03835442|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102524840|NCT03835442|GABA Agonists|gaba agonists|mesh-ancestor
102524841|NCT03835442|GABA Agents|gaba agents|mesh-ancestor
102524842|NCT03835442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102524843|NCT03835442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524844|NCT01722656|Aflibercept|aflibercept|mesh-list
102524845|NCT01722656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102524846|NCT01722656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102524847|NCT01722656|Growth Substances|growth substances|mesh-ancestor
102524848|NCT01722656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524849|NCT01722656|Growth Inhibitors|growth inhibitors|mesh-ancestor
102524850|NCT01722656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102524851|NCT04963764|Amoxicillin|amoxicillin|mesh-list
102524852|NCT04963764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102524853|NCT04963764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102524854|NCT03405584|Amoxicillin|amoxicillin|mesh-list
102524855|NCT03405584|Potassium Citrate|potassium citrate|mesh-list
102524856|NCT03405584|Esomeprazole|esomeprazole|mesh-list
102524857|NCT03405584|Bismuth|bismuth|mesh-list
102524858|NCT03405584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524859|NCT03405584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102524860|NCT03405584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102524861|NCT03405584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102524862|NCT03405584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102524863|NCT03405584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102524864|NCT03405584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102524865|NCT03405584|Antacids|antacids|mesh-ancestor
102524866|NCT03405584|Diuretics|diuretics|mesh-ancestor
102524867|NCT03405584|Natriuretic Agents|natriuretic agents|mesh-ancestor
102524868|NCT03405584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524869|NCT03405584|Expectorants|expectorants|mesh-ancestor
102524870|NCT03405584|Respiratory System Agents|respiratory system agents|mesh-ancestor
102524871|NCT03007121|Sufentanil|sufentanil|mesh-list
102524872|NCT03007121|Morphine|morphine|mesh-list
102524873|NCT03007121|Dsuvia|dsuvia|mesh-list
102524874|NCT03007121|Bupivacaine|bupivacaine|mesh-list
102524875|NCT03007121|Anesthetics, Local|anesthetics, local|mesh-ancestor
102524876|NCT03007121|Anesthetics|anesthetics|mesh-ancestor
102524877|NCT03007121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102524878|NCT03007121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524879|NCT03007121|Sensory System Agents|sensory system agents|mesh-ancestor
102524880|NCT03007121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102524881|NCT03007121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102524882|NCT03007121|Narcotics|narcotics|mesh-ancestor
102524883|NCT03007121|Analgesics|analgesics|mesh-ancestor
102524884|NCT03007121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102524885|NCT03007121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102524886|NCT03007121|Anesthetics, General|anesthetics, general|mesh-ancestor
102524887|NCT01725152|Ganaxolone|ganaxolone|mesh-list
102524888|NCT01725152|Neurosteroids|neurosteroids|mesh-ancestor
102524889|NCT01725152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102612358|NCT00002423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102524890|NCT01725152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524891|NCT01725152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524892|NCT01725152|GABA Modulators|gaba modulators|mesh-ancestor
102524894|NCT02980913|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102524895|NCT02980913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102524896|NCT02981303|Pembrolizumab|pembrolizumab|mesh-list
102524897|NCT02981303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102524898|NCT02981303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102524899|NCT02981303|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102524900|NCT02981303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524901|NCT02981459|Mirabegron|mirabegron|mesh-list
102524902|NCT02981459|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102524903|NCT02981459|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102524904|NCT02981459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102524905|NCT02981459|Adrenergic Agents|adrenergic agents|mesh-ancestor
102524906|NCT02981459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102524907|NCT02981459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524908|NCT02981459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524909|NCT02981459|Urological Agents|urological agents|mesh-ancestor
102524910|NCT01724138|Deferasirox|deferasirox|mesh-list
102524911|NCT01724138|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102524912|NCT01724138|Chelating Agents|chelating agents|mesh-ancestor
102524913|NCT01724138|Sequestering Agents|sequestering agents|mesh-ancestor
102524914|NCT01724138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524915|NCT03006809|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102524916|NCT03006809|Metronidazole|metronidazole|mesh-list
102524917|NCT03006809|Vancomycin|vancomycin|mesh-list
102524918|NCT03006809|Neomycin|neomycin|mesh-list
102524919|NCT03006809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102524920|NCT03006809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102524921|NCT03006809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102524922|NCT03006809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102524923|NCT03006809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102524924|NCT03006809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524925|NCT01580423|Aprepitant|aprepitant|mesh-list
102524926|NCT01580423|Antiemetics|antiemetics|mesh-ancestor
102524927|NCT01580423|Autonomic Agents|autonomic agents|mesh-ancestor
102524928|NCT01580423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102524929|NCT01580423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524930|NCT01580423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102524931|NCT01580423|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102524932|NCT01580423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102524933|NCT01580423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524934|NCT01049984|Rasagiline|rasagiline|mesh-list
102524935|NCT01049984|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102524936|NCT01049984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102524937|NCT01049984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524938|NCT01049984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102524939|NCT01049984|Protective Agents|protective agents|mesh-ancestor
102524940|NCT01049984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524941|NCT03001271|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
102524942|NCT03001271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102524943|NCT03001271|Vasodilator Agents|vasodilator agents|mesh-ancestor
102524944|NCT03001349|Octreotide|octreotide|mesh-list
102524945|NCT03001349|Edotreotide|edotreotide|mesh-list
102524946|NCT03001349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524947|NCT03001349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102524948|NCT03001349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102524949|NCT03001349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102524950|NCT03001349|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102524951|NCT03001193|Oxytocin|oxytocin|mesh-list
102524952|NCT03001193|Oxytocics|oxytocics|mesh-ancestor
102524953|NCT03001193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102001206|NCT01269437|Hormones|hormones|mesh-ancestor
102524954|NCT03001193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524955|NCT01049360|Formoterol Fumarate|formoterol fumarate|mesh-list
102524956|NCT01049360|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102524957|NCT01049360|Autonomic Agents|autonomic agents|mesh-ancestor
102524958|NCT01049360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102524959|NCT01049360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524960|NCT01049360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102524961|NCT01049360|Respiratory System Agents|respiratory system agents|mesh-ancestor
102524962|NCT01049360|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102524963|NCT01049360|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102524965|NCT01049360|Adrenergic Agents|adrenergic agents|mesh-ancestor
102524966|NCT01049360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102524967|NCT01049360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524968|NCT02494596|Capecitabine|capecitabine|mesh-list
102524969|NCT02494596|Pertuzumab|pertuzumab|mesh-list
102524970|NCT02494596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102524971|NCT02494596|Antimetabolites|antimetabolites|mesh-ancestor
102524972|NCT02494596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524973|NCT02494596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102524974|NCT02494596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102524975|NCT01048502|Fenofibrate|fenofibrate|mesh-list
102524976|NCT01048502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102524977|NCT01048502|Antimetabolites|antimetabolites|mesh-ancestor
102524978|NCT01048502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524979|NCT01048502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102524980|NCT01583543|Olaparib|olaparib|mesh-list
102524981|NCT01583543|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102524982|NCT01583543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102524983|NCT01583543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524984|NCT01583543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102524985|NCT01724372|Aripiprazole|aripiprazole|mesh-list
102524986|NCT01724372|Antipsychotic Agents|antipsychotic agents|mesh-list
102524987|NCT01724372|Fluoxetine|fluoxetine|mesh-list
102524988|NCT01724372|Antidepressive Agents|antidepressive agents|mesh-list
102524989|NCT01724372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102524990|NCT01724372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102524991|NCT01724372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102524992|NCT01724372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102524993|NCT01724372|Dopamine Agonists|dopamine agonists|mesh-ancestor
102524994|NCT01724372|Dopamine Agents|dopamine agents|mesh-ancestor
102524995|NCT01724372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102524996|NCT01724372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102524997|NCT01724372|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102524998|NCT01724372|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102524999|NCT01724372|Serotonin Agents|serotonin agents|mesh-ancestor
102525000|NCT01724372|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102525001|NCT01724372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102525002|NCT01724372|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102525003|NCT01724372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102525004|NCT01724372|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102525005|NCT01724372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102525006|NCT01724372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102525007|NCT01724372|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102525008|NCT01724372|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102525009|NCT01724372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102525010|NCT01724372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102525011|NCT02464410|Analgesics, Opioid|analgesics, opioid|mesh-list
102525012|NCT02464410|Narcotics|narcotics|mesh-ancestor
102525013|NCT02464410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102525014|NCT02464410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525015|NCT02464410|Analgesics|analgesics|mesh-ancestor
102525016|NCT02464410|Sensory System Agents|sensory system agents|mesh-ancestor
102525017|NCT02464410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102525018|NCT03006419|Thymoglobulin|thymoglobulin|mesh-list
102525019|NCT03006419|Basiliximab|basiliximab|mesh-list
102525020|NCT03006419|Immunologic Factors|immunologic factors|mesh-ancestor
102525021|NCT03006419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525022|NCT03006419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102525023|NCT03405272|Antibodies|antibodies|mesh-list
102525024|NCT03405272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102525025|NCT03405272|Immunologic Factors|immunologic factors|mesh-ancestor
102525026|NCT03405272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525027|NCT03405194|Efavirenz|efavirenz|mesh-list
102525028|NCT03405194|Cobicistat|cobicistat|mesh-list
102525029|NCT03405194|Elvitegravir|elvitegravir|mesh-list
102525030|NCT03405194|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102525031|NCT03405194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102525032|NCT03405194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102525033|NCT03405194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525034|NCT03405194|Antiviral Agents|antiviral agents|mesh-ancestor
102525035|NCT03405194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102525036|NCT03405194|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102525037|NCT03405194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102525038|NCT03405194|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102525039|NCT03405194|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102525040|NCT03405194|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102525041|NCT03405194|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102525042|NCT03405194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102525043|NCT03405194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102525044|NCT03405194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102525045|NCT03405194|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102525046|NCT03006107|Piroxicam|piroxicam|mesh-list
102525047|NCT03006107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102525048|NCT03006107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102525049|NCT03006107|Analgesics|analgesics|mesh-ancestor
102525050|NCT03006107|Sensory System Agents|sensory system agents|mesh-ancestor
102525051|NCT03006107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102525052|NCT03006107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525053|NCT03006107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102525054|NCT03006107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102525055|NCT03006107|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102525056|NCT03006107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102525057|NCT03006107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525058|NCT01046396|Adapalene|adapalene|mesh-list
102525059|NCT01046396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102525060|NCT01046396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102525061|NCT01046396|Analgesics|analgesics|mesh-ancestor
102525062|NCT01046396|Sensory System Agents|sensory system agents|mesh-ancestor
102525063|NCT01046396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102525064|NCT01046396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525065|NCT01046396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102525066|NCT01046396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102525067|NCT01046396|Dermatologic Agents|dermatologic agents|mesh-ancestor
102525068|NCT01046084|Lansoprazole|lansoprazole|mesh-list
102525069|NCT01046084|Dexlansoprazole|dexlansoprazole|mesh-list
102525070|NCT01046084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102525071|NCT01046084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102525072|NCT01046084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102525073|NCT01046084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102525074|NCT01046084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525075|NCT01045694|Triamcinolone|triamcinolone|mesh-list
102525076|NCT01045694|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102525077|NCT01045694|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102525078|NCT01045694|Lidocaine|lidocaine|mesh-list
102525079|NCT01045694|Botulinum Toxins|botulinum toxins|mesh-list
102525080|NCT01045694|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102525081|NCT01045694|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102525082|NCT01045694|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102525083|NCT01045694|Anesthetics, Local|anesthetics, local|mesh-ancestor
102525084|NCT01045694|Anesthetics|anesthetics|mesh-ancestor
102525085|NCT01045694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102525086|NCT01045694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525087|NCT01045694|Sensory System Agents|sensory system agents|mesh-ancestor
102525088|NCT01045694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102525089|NCT01045694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102525090|NCT01045694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102525091|NCT01045694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102525092|NCT01045694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102525093|NCT01045694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525094|NCT01045694|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102525095|NCT01045694|Cholinergic Agents|cholinergic agents|mesh-ancestor
102525096|NCT01045694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102525097|NCT01045694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102525098|NCT01045694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102525099|NCT01045694|Glucocorticoids|glucocorticoids|mesh-ancestor
102525100|NCT01045694|Hormones|hormones|mesh-ancestor
102525101|NCT01045694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102525102|NCT01045694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102525103|NCT01045694|Immunologic Factors|immunologic factors|mesh-ancestor
102525104|NCT01045694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102525105|NCT01586975|Aspirin|aspirin|mesh-list
102525106|NCT01586975|Clopidogrel|clopidogrel|mesh-list
102525107|NCT01586975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102525108|NCT01586975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102525109|NCT01586975|Analgesics|analgesics|mesh-ancestor
102525110|NCT01586975|Sensory System Agents|sensory system agents|mesh-ancestor
102525111|NCT01586975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102525112|NCT01586975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525113|NCT01586975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102525114|NCT01586975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102525115|NCT01586975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102525116|NCT01586975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102525117|NCT01586975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525118|NCT01586975|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102525119|NCT01586975|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102525120|NCT01586975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102525121|NCT01586975|Antipyretics|antipyretics|mesh-ancestor
102525122|NCT01586975|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102525123|NCT01586975|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102525124|NCT01586975|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102525125|NCT01586975|Purinergic Agents|purinergic agents|mesh-ancestor
102525126|NCT01586975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102525127|NCT03000413|Fentanyl|fentanyl|mesh-list
102525128|NCT03000413|Ketamine|ketamine|mesh-list
102525129|NCT03000413|Analgesics|analgesics|mesh-ancestor
102525130|NCT03000413|Sensory System Agents|sensory system agents|mesh-ancestor
102525131|NCT03000413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102525132|NCT03000413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525133|NCT03000413|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102525134|NCT03000413|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102525135|NCT03000413|Anesthetics, General|anesthetics, general|mesh-ancestor
102525136|NCT03000413|Anesthetics|anesthetics|mesh-ancestor
102525137|NCT03000413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102525138|NCT03000413|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102525139|NCT03000413|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102525140|NCT03000413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102525141|NCT03000413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525142|NCT03000413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102525143|NCT03000413|Narcotics|narcotics|mesh-ancestor
102525144|NCT03000413|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102525145|NCT01724918|Lacosamide|lacosamide|mesh-list
102525146|NCT01724918|Anticonvulsants|anticonvulsants|mesh-ancestor
102525147|NCT01724918|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102525148|NCT01724918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102525149|NCT01724918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102525150|NCT01724918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525151|NCT01588457|Lamotrigine|lamotrigine|mesh-list
102525152|NCT01588457|Valproic Acid|valproic acid|mesh-list
102525153|NCT01588457|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102525154|NCT01588457|Lithium Carbonate|lithium carbonate|mesh-list
102525155|NCT01588457|Antidepressive Agents|antidepressive agents|mesh-ancestor
102525156|NCT01588457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102525157|NCT01588457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102525158|NCT01588457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102525159|NCT01588457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102525160|NCT01588457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525161|NCT01588457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102525162|NCT01588457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525163|NCT01588457|Antimanic Agents|antimanic agents|mesh-ancestor
102525164|NCT01588457|Anticonvulsants|anticonvulsants|mesh-ancestor
102525165|NCT01588457|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102525166|NCT01588457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102525167|NCT01588457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102525168|NCT01588457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102525169|NCT01588457|GABA Agents|gaba agents|mesh-ancestor
102525170|NCT01588457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102525171|NCT03005639|Vemurafenib|vemurafenib|mesh-list
102525172|NCT03005639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102525173|NCT03005639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102525174|NCT03005639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102525175|NCT03005639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525176|NCT01590875|Adenosine|adenosine|mesh-list
102525177|NCT01590875|Analgesics|analgesics|mesh-ancestor
102525178|NCT01590875|Sensory System Agents|sensory system agents|mesh-ancestor
102525179|NCT01590875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102525180|NCT01590875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525181|NCT01590875|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102525182|NCT01590875|Vasodilator Agents|vasodilator agents|mesh-ancestor
102525183|NCT01590875|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102525184|NCT01590875|Purinergic Agonists|purinergic agonists|mesh-ancestor
102525185|NCT01590875|Purinergic Agents|purinergic agents|mesh-ancestor
102525186|NCT01590875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102525187|NCT01590875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525188|NCT03404414|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102525189|NCT03404414|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102525190|NCT03404414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525191|NCT01725230|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102525192|NCT01725230|Simvastatin|simvastatin|mesh-list
102525193|NCT01725230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102525194|NCT01725230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102525195|NCT01725230|Antimetabolites|antimetabolites|mesh-ancestor
102525196|NCT01725230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525197|NCT01725230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102525198|NCT01725230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102525199|NCT01725230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102525200|NCT01591733|Capecitabine|capecitabine|mesh-list
102525201|NCT01591733|Oxaliplatin|oxaliplatin|mesh-list
102525202|NCT01591733|Irinotecan|irinotecan|mesh-list
102525203|NCT01591733|Folfirinox|folfirinox|mesh-list
102525204|NCT01591733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102525205|NCT01591733|Antimetabolites|antimetabolites|mesh-ancestor
102525206|NCT01591733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525207|NCT01591733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102525208|NCT01591733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102525209|NCT01591733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102525210|NCT01591733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102525211|NCT03005405|Methamphetamine|methamphetamine|mesh-list
102525212|NCT03005405|Fluorides|fluorides|mesh-list
102525213|NCT03005405|Cariostatic Agents|cariostatic agents|mesh-ancestor
102525214|NCT03005405|Protective Agents|protective agents|mesh-ancestor
102525215|NCT03005405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525216|NCT03005405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102525217|NCT03005405|Sympathomimetics|sympathomimetics|mesh-ancestor
102525218|NCT03005405|Autonomic Agents|autonomic agents|mesh-ancestor
102525219|NCT03005405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102525220|NCT03005405|Dopamine Agents|dopamine agents|mesh-ancestor
102525221|NCT03005405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102525222|NCT03005405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525223|NCT03005405|Adrenergic Agents|adrenergic agents|mesh-ancestor
102525224|NCT03005405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102525225|NCT03005405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102525226|NCT03005405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102525227|NCT03005405|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102525228|NCT03005717|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102525229|NCT03005717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102525230|NCT03005717|Autonomic Agents|autonomic agents|mesh-ancestor
102525231|NCT03005717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102525232|NCT03005717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525233|NCT03005717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102525234|NCT03005717|Respiratory System Agents|respiratory system agents|mesh-ancestor
102525235|NCT03005717|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102525236|NCT03005717|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102525237|NCT03005717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102525238|NCT03005717|Adrenergic Agents|adrenergic agents|mesh-ancestor
102525239|NCT03005717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102525240|NCT03005717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525241|NCT03005483|Gabapentin|gabapentin|mesh-list
102525242|NCT03005483|Analgesics|analgesics|mesh-ancestor
102525243|NCT03005483|Sensory System Agents|sensory system agents|mesh-ancestor
102525244|NCT03005483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102525245|NCT03005483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525246|NCT03005483|Anticonvulsants|anticonvulsants|mesh-ancestor
102525247|NCT03005483|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102525248|NCT03005483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102525249|NCT03005483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102525250|NCT03005483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102525251|NCT03005483|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102525252|NCT03005483|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102525253|NCT03005483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102525254|NCT03005483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525255|NCT03005483|Antimanic Agents|antimanic agents|mesh-ancestor
102525256|NCT01593215|Yohimbine|yohimbine|mesh-list
102525257|NCT01593215|Mydriatics|mydriatics|mesh-ancestor
102525258|NCT01593215|Autonomic Agents|autonomic agents|mesh-ancestor
102525259|NCT01593215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102525260|NCT01593215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525261|NCT01593215|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102525262|NCT01593215|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102525263|NCT01593215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102525264|NCT01593215|Adrenergic Agents|adrenergic agents|mesh-ancestor
102525265|NCT01593215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102525266|NCT01593215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525267|NCT01593215|Urological Agents|urological agents|mesh-ancestor
102525269|NCT05404919|Entecavir|entecavir|mesh-list
102525270|NCT05404919|Immunoglobulins|immunoglobulins|mesh-list
102525271|NCT05404919|Antibodies|antibodies|mesh-list
102525272|NCT05404919|gamma-Globulins|gamma-globulins|mesh-list
102525273|NCT05404919|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102525274|NCT05404919|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102525275|NCT05404919|Antiviral Agents|antiviral agents|mesh-ancestor
102525276|NCT05404919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102525277|NCT05404919|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102525278|NCT05404919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102525279|NCT05404919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102525280|NCT05404919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525281|NCT05404919|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102525282|NCT05404919|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102525283|NCT05404919|Immunologic Factors|immunologic factors|mesh-ancestor
102525284|NCT05404919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525285|NCT03005015|Doxorubicin|doxorubicin|mesh-list
102525286|NCT03005015|Lenvatinib|lenvatinib|mesh-list
102525287|NCT03005015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102525288|NCT03005015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102525289|NCT03005015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102525290|NCT03005015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102525291|NCT03005015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102525292|NCT03005015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525293|NCT03005015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102525294|NCT03005171|Lidocaine|lidocaine|mesh-list
102525295|NCT03005171|Bupivacaine|bupivacaine|mesh-list
102525296|NCT03005171|Anesthetics, Local|anesthetics, local|mesh-ancestor
102525297|NCT03005171|Anesthetics|anesthetics|mesh-ancestor
102525298|NCT03005171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102525299|NCT03005171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525300|NCT03005171|Sensory System Agents|sensory system agents|mesh-ancestor
102525301|NCT03005171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102525302|NCT03005171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102525303|NCT03005171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102525304|NCT03005171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102525305|NCT03005171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102525306|NCT03005171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525307|NCT01041638|Vitamin A|vitamin a|mesh-list
102525308|NCT01041638|Aldesleukin|aldesleukin|mesh-list
102525309|NCT01041638|Interleukin-2|interleukin-2|mesh-list
102525310|NCT01041638|Tretinoin|tretinoin|mesh-list
102525311|NCT01041638|Dinutuximab|dinutuximab|mesh-list
102525312|NCT01041638|Isotretinoin|isotretinoin|mesh-list
102525313|NCT01041638|Sargramostim|sargramostim|mesh-list
102525314|NCT01041638|Vitamins|vitamins|mesh-ancestor
102525315|NCT01041638|Micronutrients|micronutrients|mesh-ancestor
102525316|NCT01041638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525317|NCT01041638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102525318|NCT01041638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102525319|NCT01041638|Analgesics|analgesics|mesh-ancestor
102525320|NCT01041638|Sensory System Agents|sensory system agents|mesh-ancestor
102525321|NCT01041638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102525322|NCT01041638|Immunologic Factors|immunologic factors|mesh-ancestor
102525323|NCT01041638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102525324|NCT01041638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102525325|NCT01041638|Antiviral Agents|antiviral agents|mesh-ancestor
102525326|NCT01041638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102525327|NCT01041638|Keratolytic Agents|keratolytic agents|mesh-ancestor
102525328|NCT01041638|Dermatologic Agents|dermatologic agents|mesh-ancestor
102525329|NCT03004625|Ribavirin|ribavirin|mesh-list
102525330|NCT03004625|Asunaprevir|asunaprevir|mesh-list
102525331|NCT03004625|Antimetabolites|antimetabolites|mesh-ancestor
102525332|NCT03004625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525333|NCT03004625|Antiviral Agents|antiviral agents|mesh-ancestor
102525334|NCT03004625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102525335|NCT03004625|Protease Inhibitors|protease inhibitors|mesh-ancestor
102525336|NCT03004625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102525337|NCT05566301|Clopidogrel|clopidogrel|mesh-list
102525338|NCT05566301|Ticagrelor|ticagrelor|mesh-list
102525339|NCT05566301|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102525340|NCT05566301|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102525341|NCT05566301|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102525342|NCT05566301|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102525343|NCT05566301|Purinergic Agents|purinergic agents|mesh-ancestor
102525344|NCT05566301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102525345|NCT05566301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525346|NCT05566301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525347|NCT03404024|Mitogens|mitogens|mesh-list
102525348|NCT03404024|Mitosis Modulators|mitosis modulators|mesh-ancestor
102525349|NCT03404024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525350|NCT05131919|Pembrolizumab|pembrolizumab|mesh-list
102525351|NCT05131919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102525352|NCT05131919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102525353|NCT05131919|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102525354|NCT05131919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525355|NCT01725542|Ribavirin|ribavirin|mesh-list
102525356|NCT01725542|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102525357|NCT01725542|Asunaprevir|asunaprevir|mesh-list
102525358|NCT01725542|Antimetabolites|antimetabolites|mesh-ancestor
102525359|NCT01725542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525360|NCT01725542|Antiviral Agents|antiviral agents|mesh-ancestor
102525361|NCT01725542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102525362|NCT01725542|Protease Inhibitors|protease inhibitors|mesh-ancestor
102525363|NCT01725542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102525364|NCT01725620|Etanercept|etanercept|mesh-list
102525365|NCT01725620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102525366|NCT01725620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102525367|NCT01725620|Analgesics|analgesics|mesh-ancestor
102525368|NCT01725620|Sensory System Agents|sensory system agents|mesh-ancestor
102525369|NCT01725620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102525370|NCT01725620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525371|NCT01725620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102525372|NCT01725620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102525373|NCT01725620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102525374|NCT01725620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102525375|NCT01725620|Immunologic Factors|immunologic factors|mesh-ancestor
102525376|NCT01045460|Cyclophosphamide|cyclophosphamide|mesh-list
102525377|NCT01045460|Melphalan|melphalan|mesh-list
102525378|NCT01045460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102525379|NCT01045460|Immunologic Factors|immunologic factors|mesh-ancestor
102525380|NCT01045460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525381|NCT01045460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102525382|NCT01045460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102525383|NCT01045460|Alkylating Agents|alkylating agents|mesh-ancestor
102525384|NCT01045460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525385|NCT01045460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102525386|NCT01045460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102525387|NCT03403790|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102525388|NCT03403790|Antidepressive Agents|antidepressive agents|mesh-ancestor
102525389|NCT03403790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102525390|NCT03403790|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102525391|NCT03403790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102525392|NCT03403790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102525393|NCT03403790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525394|NCT05014919|Vortioxetine|vortioxetine|mesh-list
102525395|NCT05014919|Antidepressive Agents|antidepressive agents|mesh-ancestor
102525396|NCT05014919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102525397|NCT05014919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102525398|NCT05014919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102525399|NCT05014919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102525400|NCT05014919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525401|NCT05014919|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102525402|NCT05014919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102525403|NCT05014919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102525404|NCT05014919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525405|NCT05014919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102525406|NCT05014919|Serotonin Agents|serotonin agents|mesh-ancestor
102525407|NCT05014919|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102525408|NCT05014919|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102336927|NCT03585465|Nivolumab|nivolumab|mesh-list
102525409|NCT05014919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102525410|NCT05014919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102525411|NCT03406286|Tolvaptan|tolvaptan|mesh-list
102525412|NCT03406286|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102525413|NCT03406286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525414|NCT03406286|Natriuretic Agents|natriuretic agents|mesh-ancestor
102525415|NCT03406286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525416|NCT05672537|Gemcitabine|gemcitabine|mesh-list
102525417|NCT05672537|Durvalumab|durvalumab|mesh-list
102525418|NCT05672537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102525419|NCT05672537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102525420|NCT05672537|Antimetabolites|antimetabolites|mesh-ancestor
102525421|NCT05672537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525422|NCT05672537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102525423|NCT03400592|Irinotecan|irinotecan|mesh-list
102525424|NCT03400592|Nimotuzumab|nimotuzumab|mesh-list
102525425|NCT03400592|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102525426|NCT03400592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102525427|NCT03400592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102525428|NCT03400592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525429|NCT03400592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102525430|NCT03400592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102525431|NCT02218463|Estradiol|estradiol|mesh-list
102525432|NCT02218463|Estrogens|estrogens|mesh-ancestor
102525433|NCT02218463|Hormones|hormones|mesh-ancestor
102525434|NCT02218463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102525435|NCT02218463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525436|NCT00919802|Oxytocin|oxytocin|mesh-list
102525437|NCT00919802|Oxytocics|oxytocics|mesh-ancestor
102525438|NCT00919802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102525439|NCT00919802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525440|NCT02222129|Bupivacaine|bupivacaine|mesh-list
102525441|NCT02222129|Anesthetics, Local|anesthetics, local|mesh-ancestor
102525442|NCT02222129|Anesthetics|anesthetics|mesh-ancestor
102525443|NCT02222129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102525444|NCT02222129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525445|NCT02222129|Sensory System Agents|sensory system agents|mesh-ancestor
102525446|NCT02222129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102525447|NCT03003611|Anesthetics|anesthetics|mesh-list
102525448|NCT03003611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102525449|NCT03003611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525450|NCT03401294|Leucovorin|leucovorin|mesh-list
102525451|NCT03401294|Bevacizumab|bevacizumab|mesh-list
102525452|NCT03401294|Oxaliplatin|oxaliplatin|mesh-list
102525453|NCT03401294|Irinotecan|irinotecan|mesh-list
102525454|NCT03401294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102525455|NCT03401294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102525456|NCT03401294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102525457|NCT03401294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102525458|NCT03401294|Growth Substances|growth substances|mesh-ancestor
102525459|NCT03401294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525460|NCT03401294|Growth Inhibitors|growth inhibitors|mesh-ancestor
102525461|NCT03401294|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102525462|NCT03401294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102525463|NCT03401294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102525464|NCT03401294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525465|NCT03401294|Antidotes|antidotes|mesh-ancestor
102525466|NCT03401294|Protective Agents|protective agents|mesh-ancestor
102525467|NCT03401294|Vitamin B Complex|vitamin b complex|mesh-ancestor
102525468|NCT03401294|Vitamins|vitamins|mesh-ancestor
102525469|NCT03401294|Micronutrients|micronutrients|mesh-ancestor
102525470|NCT03402698|Cholecalciferol|cholecalciferol|mesh-list
102525471|NCT03402698|Vitamin D|vitamin d|mesh-list
102525472|NCT03402698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102525473|NCT03402698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525474|NCT03402698|Vitamins|vitamins|mesh-ancestor
102525475|NCT03402698|Micronutrients|micronutrients|mesh-ancestor
102525476|NCT03402698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102525477|NCT03406520|Chlorhexidine|chlorhexidine|mesh-list
102525478|NCT03406520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102525479|NCT03406520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102525480|NCT03406520|Disinfectants|disinfectants|mesh-ancestor
102525481|NCT02248181|Pramipexole|pramipexole|mesh-list
102525482|NCT02248181|Antioxidants|antioxidants|mesh-ancestor
102525483|NCT02248181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525484|NCT02248181|Protective Agents|protective agents|mesh-ancestor
102525485|NCT02248181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525486|NCT02248181|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102525487|NCT02248181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102525488|NCT02248181|Dopamine Agonists|dopamine agonists|mesh-ancestor
102525489|NCT02248181|Dopamine Agents|dopamine agents|mesh-ancestor
102525490|NCT02248181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102525492|NCT03003143|Anticonvulsants|anticonvulsants|mesh-ancestor
102525493|NCT03003143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102525494|NCT03003143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525495|NCT03003143|GABA Agents|gaba agents|mesh-ancestor
102525496|NCT03003143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102525497|NCT03003143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525498|NCT02462928|Ranibizumab|ranibizumab|mesh-list
102525499|NCT02462928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102525500|NCT02462928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102525501|NCT02462928|Growth Substances|growth substances|mesh-ancestor
102525502|NCT02462928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525503|NCT02462928|Growth Inhibitors|growth inhibitors|mesh-ancestor
102525504|NCT02462928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102525505|NCT03002831|Tegafur|tegafur|mesh-list
102525506|NCT03002831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102525507|NCT03002831|Antimetabolites|antimetabolites|mesh-ancestor
102525508|NCT03002831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525509|NCT03002831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102525510|NCT02248259|Itraconazole|itraconazole|mesh-list
102525511|NCT02248259|BI 409306|bi 409306|mesh-list
102525512|NCT02248259|Antifungal Agents|antifungal agents|mesh-ancestor
102525513|NCT02248259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102525514|NCT02248259|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102525515|NCT02248259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102525516|NCT02248259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102525517|NCT02248259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525518|NCT02248259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102525519|NCT02248259|Hormone Antagonists|hormone antagonists|mesh-ancestor
102525520|NCT02248259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102525521|NCT02248259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525522|NCT02248259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102525523|NCT02248259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102525524|NCT04526951|Aspirin|aspirin|mesh-list
102525525|NCT04526951|Tenecteplase|tenecteplase|mesh-list
102525526|NCT04526951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102525527|NCT04526951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102525528|NCT04526951|Analgesics|analgesics|mesh-ancestor
102525529|NCT04526951|Sensory System Agents|sensory system agents|mesh-ancestor
102525530|NCT04526951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102525531|NCT04526951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525532|NCT04526951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102525533|NCT04526951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102525534|NCT04526951|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102525535|NCT04526951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102525536|NCT04526951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525537|NCT04526951|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102525538|NCT04526951|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102525539|NCT04526951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102525540|NCT04526951|Antipyretics|antipyretics|mesh-ancestor
102525541|NCT02248415|Anesthetics|anesthetics|mesh-list
102525542|NCT02248415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102525543|NCT02248415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525544|NCT02248571|Bevacizumab|bevacizumab|mesh-list
102525545|NCT02248571|Capecitabine|capecitabine|mesh-list
102525546|NCT02248571|Everolimus|everolimus|mesh-list
102525547|NCT02248571|Exemestane|exemestane|mesh-list
102525548|NCT02248571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102525549|NCT02248571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102525550|NCT02248571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102525551|NCT02248571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102525552|NCT02248571|Growth Substances|growth substances|mesh-ancestor
102525553|NCT02248571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525554|NCT02248571|Growth Inhibitors|growth inhibitors|mesh-ancestor
102525555|NCT02248571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102525556|NCT02248571|Antimetabolites|antimetabolites|mesh-ancestor
102525557|NCT02248571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525558|NCT02248571|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102525559|NCT02248571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102525560|NCT02248571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102525561|NCT02248571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102525562|NCT02248571|Immunologic Factors|immunologic factors|mesh-ancestor
102525563|NCT02248571|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102525564|NCT02248571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102525565|NCT02248571|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102525566|NCT02248571|Hormone Antagonists|hormone antagonists|mesh-ancestor
102525567|NCT02248571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102525568|NCT00019604|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102525569|NCT00019604|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102525570|NCT00019604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525572|NCT03002675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102525573|NCT03002675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525574|NCT03002675|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102525575|NCT03002675|Incretins|incretins|mesh-ancestor
102525576|NCT03002675|Hormones|hormones|mesh-ancestor
102525577|NCT03002675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102525578|NCT02246270|Heparin|heparin|mesh-list
102525579|NCT02246270|Calcium heparin|calcium heparin|mesh-list
102525580|NCT02246270|Anticoagulants|anticoagulants|mesh-ancestor
102525581|NCT02246270|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102525582|NCT02246270|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102525583|NCT02246270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525584|NCT02247557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102525585|NCT02247557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102525586|NCT02247557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102525587|NCT02247557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102525588|NCT02247557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525589|NCT02247557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102525590|NCT02247557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102525591|NCT02247557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525592|NCT02247557|Cholinergic Agents|cholinergic agents|mesh-ancestor
102525593|NCT02247557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102525594|NCT04374188|Ciprofloxacin|ciprofloxacin|mesh-list
102525595|NCT04374188|Levofloxacin|levofloxacin|mesh-list
102525596|NCT04374188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102001874|NCT03226275|Autonomic Agents|autonomic agents|mesh-ancestor
102525597|NCT04374188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102525598|NCT04374188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102525599|NCT04374188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102525600|NCT04374188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102525601|NCT04374188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525602|NCT04374188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102525603|NCT04374188|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102525604|NCT04374188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102525605|NCT04374188|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102525606|NCT04374032|Enkephalin, Methionine|enkephalin, methionine|mesh-list
102525607|NCT04374032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102525608|NCT04374032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525609|NCT04374032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525610|NCT03401606|Dexmedetomidine|dexmedetomidine|mesh-list
102525611|NCT03401606|Remifentanil|remifentanil|mesh-list
102525612|NCT03401606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102525613|NCT03401606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102525614|NCT03401606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525615|NCT03401606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102525616|NCT03401606|Analgesics|analgesics|mesh-ancestor
102525617|NCT03401606|Sensory System Agents|sensory system agents|mesh-ancestor
102525618|NCT03401606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102525619|NCT03401606|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102525620|NCT03401606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102525621|NCT03401606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102525622|NCT03401606|Adrenergic Agents|adrenergic agents|mesh-ancestor
102525623|NCT03401606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102525624|NCT03401606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525625|NCT03401606|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102525626|NCT03401606|Narcotics|narcotics|mesh-ancestor
102525627|NCT02516592|Fluticasone|fluticasone|mesh-list
102525628|NCT02516592|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102525629|NCT02516592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102525630|NCT02516592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102525631|NCT02516592|Autonomic Agents|autonomic agents|mesh-ancestor
102525632|NCT02516592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102525633|NCT02516592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525634|NCT02516592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102525635|NCT02516592|Respiratory System Agents|respiratory system agents|mesh-ancestor
102525636|NCT02516592|Dermatologic Agents|dermatologic agents|mesh-ancestor
102525637|NCT02516592|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102525638|NCT02516592|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102525639|NCT02516592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102525640|NCT02516592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102525641|NCT02516592|Adrenergic Agents|adrenergic agents|mesh-ancestor
102525642|NCT02516592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102525643|NCT02516592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525644|NCT03401372|Doxycycline|doxycycline|mesh-list
102525645|NCT03401372|Dexamethasone|dexamethasone|mesh-list
102525646|NCT03401372|Cyclophosphamide|cyclophosphamide|mesh-list
102525648|NCT03401372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102525649|NCT03401372|Immunologic Factors|immunologic factors|mesh-ancestor
102525650|NCT03401372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525651|NCT03401372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102525652|NCT03401372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102525653|NCT03401372|Alkylating Agents|alkylating agents|mesh-ancestor
102525654|NCT03401372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525655|NCT03401372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102001939|NCT01275911|Remifentanil|remifentanil|mesh-list
102525656|NCT03401372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102525657|NCT03401372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102525658|NCT03401372|Antiemetics|antiemetics|mesh-ancestor
102525659|NCT03401372|Autonomic Agents|autonomic agents|mesh-ancestor
102525660|NCT03401372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102525661|NCT03401372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102525662|NCT03401372|Glucocorticoids|glucocorticoids|mesh-ancestor
102525663|NCT03401372|Hormones|hormones|mesh-ancestor
102525664|NCT03401372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102525665|NCT03401372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102525666|NCT03401372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102525667|NCT03401372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102525668|NCT03401372|Antimalarials|antimalarials|mesh-ancestor
102525669|NCT03401372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102525670|NCT03401372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102525671|NCT04934904|Ropivacaine|ropivacaine|mesh-list
102525672|NCT04934904|Anesthetics, Local|anesthetics, local|mesh-ancestor
102525673|NCT04934904|Anesthetics|anesthetics|mesh-ancestor
102525674|NCT04934904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102525675|NCT04934904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525676|NCT04934904|Sensory System Agents|sensory system agents|mesh-ancestor
102525677|NCT04934904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102525678|NCT02219321|Lidocaine|lidocaine|mesh-list
102525679|NCT02219321|Anesthetics, Local|anesthetics, local|mesh-ancestor
102525680|NCT02219321|Anesthetics|anesthetics|mesh-ancestor
102525681|NCT02219321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102525682|NCT02219321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525683|NCT02219321|Sensory System Agents|sensory system agents|mesh-ancestor
102525684|NCT02219321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102525685|NCT02219321|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102525686|NCT02219321|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102525687|NCT02219321|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102525688|NCT02219321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102525689|NCT02219321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525690|NCT04955574|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102525691|NCT04955574|Metronidazole|metronidazole|mesh-list
102525692|NCT04955574|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102525693|NCT04955574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102525694|NCT04955574|Antitubercular Agents|antitubercular agents|mesh-ancestor
102525695|NCT04955574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102525696|NCT04955574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102525697|NCT04716335|Harmine|harmine|mesh-list
102525698|NCT04716335|Hallucinogens|hallucinogens|mesh-ancestor
102525699|NCT04716335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525700|NCT04716335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102525701|NCT04716335|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102525702|NCT04716335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102525703|NCT04716335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525704|NCT02221349|Listerine|listerine|mesh-list
102525705|NCT02221349|Fluorides|fluorides|mesh-list
102337242|NCT02338609|Everolimus|everolimus|mesh-list
102525706|NCT02221349|Sodium Fluoride|sodium fluoride|mesh-list
102525707|NCT02221349|Tin Fluorides|tin fluorides|mesh-list
102525708|NCT02221349|Cariostatic Agents|cariostatic agents|mesh-ancestor
102525709|NCT02221349|Protective Agents|protective agents|mesh-ancestor
102525710|NCT02221349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525711|NCT02221349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102525712|NCT02221349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102525713|NCT02461758|Vaccines|vaccines|mesh-list
102525714|NCT02461758|Immunologic Factors|immunologic factors|mesh-ancestor
102525715|NCT02461758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525716|NCT02461290|Rituximab|rituximab|mesh-list
102525717|NCT02461290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102525718|NCT02461290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102525719|NCT02461290|Immunologic Factors|immunologic factors|mesh-ancestor
102525720|NCT02461290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525721|NCT02461290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102525722|NCT04376528|Cyclosporine|cyclosporine|mesh-list
102525723|NCT04376528|Mycophenolic Acid|mycophenolic acid|mesh-list
102525724|NCT04376528|Cyclosporins|cyclosporins|mesh-list
102525725|NCT04376528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102525726|NCT04376528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525727|NCT04376528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102525728|NCT04376528|Immunologic Factors|immunologic factors|mesh-ancestor
102525729|NCT04376528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525730|NCT04376528|Antifungal Agents|antifungal agents|mesh-ancestor
102525731|NCT04376528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102525732|NCT04376528|Dermatologic Agents|dermatologic agents|mesh-ancestor
102525733|NCT04376528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102525734|NCT04376528|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102525735|NCT04376528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102525736|NCT04376528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102525737|NCT04376528|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102525738|NCT04376528|Antitubercular Agents|antitubercular agents|mesh-ancestor
102525739|NCT04376528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102525740|NCT02461134|Ponesimod|ponesimod|mesh-list
102525741|NCT02461134|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102525742|NCT02461134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525743|NCT02461134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102525744|NCT02461134|Immunologic Factors|immunologic factors|mesh-ancestor
102525745|NCT02461134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525746|NCT04373018|Chlorhexidine|chlorhexidine|mesh-list
102525747|NCT04373018|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102525748|NCT04373018|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102525749|NCT04373018|Sodium Hypochlorite|sodium hypochlorite|mesh-list
102525750|NCT04373018|Eusol|eusol|mesh-list
102525751|NCT04373018|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102525752|NCT04373018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102525753|NCT04373018|Disinfectants|disinfectants|mesh-ancestor
102525754|NCT04373018|Dermatologic Agents|dermatologic agents|mesh-ancestor
102525755|NCT04594733|Minocycline|minocycline|mesh-list
102525756|NCT04594733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102525757|NCT04594733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102525758|NCT02223065|Dapagliflozin|dapagliflozin|mesh-list
102525759|NCT02223065|Saxagliptin|saxagliptin|mesh-list
102525760|NCT02223065|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102525761|NCT02223065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525762|NCT02223065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102525763|NCT02223065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525764|NCT02223065|Incretins|incretins|mesh-ancestor
102525765|NCT02223065|Hormones|hormones|mesh-ancestor
102525766|NCT02223065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102525767|NCT02223065|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102525768|NCT02223065|Protease Inhibitors|protease inhibitors|mesh-ancestor
102525769|NCT02223065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102525770|NCT04366232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102525771|NCT04366232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102525772|NCT02241200|Darbepoetin alfa|darbepoetin alfa|mesh-list
102525773|NCT02241200|Hematinics|hematinics|mesh-ancestor
102525774|NCT02241278|Ketamine|ketamine|mesh-list
102525775|NCT02241278|Analgesics|analgesics|mesh-ancestor
102525776|NCT02241278|Sensory System Agents|sensory system agents|mesh-ancestor
102525777|NCT02241278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102525778|NCT02241278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525779|NCT02241278|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102525780|NCT02241278|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102525781|NCT02241278|Anesthetics, General|anesthetics, general|mesh-ancestor
102525782|NCT02241278|Anesthetics|anesthetics|mesh-ancestor
102525783|NCT02241278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102525784|NCT02241278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102525785|NCT02241278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102525786|NCT02241278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102525787|NCT02241278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525788|NCT04347512|Azithromycin|azithromycin|mesh-list
102525789|NCT04347512|Hydroxychloroquine|hydroxychloroquine|mesh-list
102525790|NCT04347512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102525791|NCT04347512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102525792|NCT04347512|Antimalarials|antimalarials|mesh-ancestor
102525793|NCT04347512|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102525794|NCT04347512|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102525795|NCT04347512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102525796|NCT04347512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525797|NCT04347512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102525798|NCT02460978|Dapagliflozin|dapagliflozin|mesh-list
102525799|NCT02460978|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102525800|NCT02460978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525801|NCT02460978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102525802|NCT02460978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525803|NCT04372316|Vitamin B 12|vitamin b 12|mesh-list
102525804|NCT04372316|Vitamin B Complex|vitamin b complex|mesh-ancestor
102525805|NCT04372316|Vitamins|vitamins|mesh-ancestor
102525806|NCT04372316|Micronutrients|micronutrients|mesh-ancestor
102525807|NCT04372316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525808|NCT02221739|Ipilimumab|ipilimumab|mesh-list
102525809|NCT02221739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102525810|NCT02221739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102525811|NCT02221739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102525812|NCT02221739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525813|NCT02241356|Methamphetamine|methamphetamine|mesh-list
102525814|NCT02241356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102525815|NCT02241356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525816|NCT02241356|Sympathomimetics|sympathomimetics|mesh-ancestor
102525817|NCT02241356|Autonomic Agents|autonomic agents|mesh-ancestor
102525818|NCT02241356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102525819|NCT02241356|Dopamine Agents|dopamine agents|mesh-ancestor
102525820|NCT02241356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102525821|NCT02241356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525822|NCT02241356|Adrenergic Agents|adrenergic agents|mesh-ancestor
102525823|NCT02241356|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102525824|NCT02241356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102525825|NCT02241356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102525826|NCT02241356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102525827|NCT04365686|Propofol|propofol|mesh-list
102525828|NCT04365686|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102525829|NCT04365686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102525830|NCT04365686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525831|NCT04365686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102525832|NCT04365686|Anesthetics, General|anesthetics, general|mesh-ancestor
102525833|NCT04365686|Anesthetics|anesthetics|mesh-ancestor
102525834|NCT02241590|Entecavir|entecavir|mesh-list
102525835|NCT02241590|Antiviral Agents|antiviral agents|mesh-ancestor
102525836|NCT02241590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102525837|NCT04083755|Ferric Compounds|ferric compounds|mesh-list
102525838|NCT04083755|Hematinics|hematinics|mesh-ancestor
102525839|NCT04372082|Hydroxychloroquine|hydroxychloroquine|mesh-list
102525840|NCT04372082|Niclosamide|niclosamide|mesh-list
102525841|NCT04372082|Diltiazem|diltiazem|mesh-list
102525842|NCT04372082|Antimalarials|antimalarials|mesh-ancestor
102525843|NCT04372082|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102525844|NCT04372082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102525845|NCT04372082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102525846|NCT04372082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102525847|NCT04372082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525848|NCT04372082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102525849|NCT04372082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102525850|NCT04372082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102525851|NCT04372082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102525852|NCT04372082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102525853|NCT04372082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525854|NCT04372082|Vasodilator Agents|vasodilator agents|mesh-ancestor
102525855|NCT04372082|Anticestodal Agents|anticestodal agents|mesh-ancestor
102525856|NCT04372082|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102525857|NCT04372082|Anthelmintics|anthelmintics|mesh-ancestor
102525858|NCT04372082|Antinematodal Agents|antinematodal agents|mesh-ancestor
102525860|NCT05363111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102525861|NCT05363111|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
102525862|NCT05363111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102525863|NCT05363111|Immunologic Factors|immunologic factors|mesh-ancestor
102525864|NCT05363111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525865|NCT05363111|Chelating Agents|chelating agents|mesh-ancestor
102525866|NCT05363111|Sequestering Agents|sequestering agents|mesh-ancestor
102525867|NCT05363111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525868|NCT02489448|Durvalumab|durvalumab|mesh-list
102525869|NCT02489448|Tremelimumab|tremelimumab|mesh-list
102525870|NCT02489448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102525871|NCT02489448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102525872|NCT00926588|Analgesics|analgesics|mesh-list
102525873|NCT00926588|Sensory System Agents|sensory system agents|mesh-ancestor
102525874|NCT00926588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102525875|NCT00926588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525876|NCT04371926|Hydroxychloroquine|hydroxychloroquine|mesh-list
102525877|NCT04371926|Antimalarials|antimalarials|mesh-ancestor
102525878|NCT04371926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102525879|NCT04371926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102525880|NCT04371926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102525881|NCT04371926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102525882|NCT04371926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525883|NCT04371926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102525884|NCT02248883|Moxifloxacin|moxifloxacin|mesh-list
102525885|NCT02248883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102525886|NCT02248883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102525887|NCT02248883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102525888|NCT02248883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102525889|NCT02248883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102525890|NCT02248883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525891|NCT02248883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102525892|NCT04364906|Anesthetics|anesthetics|mesh-list
102525893|NCT04364906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102525894|NCT04364906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525895|NCT04134845|Dantrolene|dantrolene|mesh-list
102525896|NCT04134845|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102525897|NCT04134845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525898|NCT04134845|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102525899|NCT04134845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102525900|NCT02488980|Mefloquine|mefloquine|mesh-list
102525901|NCT02488980|Tafenoquine|tafenoquine|mesh-list
102525902|NCT02488980|Antimalarials|antimalarials|mesh-ancestor
102525903|NCT02488980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102525904|NCT02488980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102525905|NCT02488980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102525906|NCT02227667|Durvalumab|durvalumab|mesh-list
102525907|NCT02227667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102525908|NCT02227667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102525909|NCT02242214|Misoprostol|misoprostol|mesh-list
102525910|NCT02242214|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102525911|NCT02242214|Abortifacient Agents|abortifacient agents|mesh-ancestor
102525912|NCT02242214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102525913|NCT02242214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525914|NCT02242214|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102525915|NCT02242214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102525916|NCT02242214|Oxytocics|oxytocics|mesh-ancestor
102525917|NCT02245256|Dexmedetomidine|dexmedetomidine|mesh-list
102525918|NCT02245256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102525919|NCT02245256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102525920|NCT02245256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525921|NCT02245256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102525922|NCT02245256|Analgesics|analgesics|mesh-ancestor
102525923|NCT02245256|Sensory System Agents|sensory system agents|mesh-ancestor
102525924|NCT02245256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102525925|NCT02245256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102525926|NCT02245256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102525927|NCT02245256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102525928|NCT02245256|Adrenergic Agents|adrenergic agents|mesh-ancestor
102525929|NCT02245256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102525930|NCT02245256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525931|NCT05208983|Vaccines|vaccines|mesh-list
102525932|NCT05208983|Immunologic Factors|immunologic factors|mesh-ancestor
102525933|NCT05208983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525935|NCT02242292|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102525936|NCT02242292|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102525937|NCT02242292|Antiemetics|antiemetics|mesh-ancestor
102525938|NCT02242292|Autonomic Agents|autonomic agents|mesh-ancestor
102525939|NCT02242292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102525940|NCT02242292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525941|NCT02242292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102525942|NCT02242292|Mydriatics|mydriatics|mesh-ancestor
102525943|NCT02242292|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102525944|NCT02242292|Cholinergic Agents|cholinergic agents|mesh-ancestor
102525945|NCT02242292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102525946|NCT02242292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525947|NCT02242292|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102525948|NCT02242292|Parasympatholytics|parasympatholytics|mesh-ancestor
102525949|NCT02242370|Telmisartan|telmisartan|mesh-list
102525950|NCT02242370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102525951|NCT02242370|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102525952|NCT02242370|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102525953|NCT02242370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525954|NCT04371146|Methylphenidate|methylphenidate|mesh-list
102525955|NCT04371146|Reboxetine|reboxetine|mesh-list
102525956|NCT04371146|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102525957|NCT04371146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525958|NCT04371146|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102525959|NCT04371146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102525960|NCT04371146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102525961|NCT04371146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525962|NCT04371146|Dopamine Agents|dopamine agents|mesh-ancestor
102525963|NCT04371146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102525964|NCT04371146|Antidepressive Agents|antidepressive agents|mesh-ancestor
102525965|NCT04371146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102525966|NCT04371146|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102525967|NCT04371146|Adrenergic Agents|adrenergic agents|mesh-ancestor
102525968|NCT01623479|Bimatoprost|bimatoprost|mesh-list
102525969|NCT01623479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102525970|NCT04347200|Anticoagulants|anticoagulants|mesh-list
102525971|NCT04347200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
102525972|NCT04364516|Vitamin K|vitamin k|mesh-list
102525973|NCT04364516|Anticoagulants|anticoagulants|mesh-list
102525974|NCT04364516|Vitamins|vitamins|mesh-ancestor
102525975|NCT04364516|Micronutrients|micronutrients|mesh-ancestor
102525976|NCT04364516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525977|NCT04364516|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102525978|NCT04364516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102525979|NCT04364516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525980|NCT04364516|Hemostatics|hemostatics|mesh-ancestor
102525981|NCT04364516|Coagulants|coagulants|mesh-ancestor
102525982|NCT01623869|Trebananib|trebananib|mesh-list
102525983|NCT01623869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102525984|NCT01623869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102525985|NCT01623869|Growth Substances|growth substances|mesh-ancestor
102525986|NCT01623869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102525987|NCT01623869|Growth Inhibitors|growth inhibitors|mesh-ancestor
102525988|NCT01623869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102525989|NCT02242838|Telmisartan|telmisartan|mesh-list
102525990|NCT02242838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102525991|NCT02242838|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102525992|NCT02242838|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102525993|NCT02242838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525994|NCT03207347|Niraparib|niraparib|mesh-list
102525995|NCT03207347|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102525996|NCT03207347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102525997|NCT03207347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102525998|NCT03207347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102525999|NCT02249039|Clonidine|clonidine|mesh-list
102526000|NCT02249039|Analgesics|analgesics|mesh-ancestor
102526001|NCT02249039|Sensory System Agents|sensory system agents|mesh-ancestor
102526002|NCT02249039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102526003|NCT02249039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526004|NCT02249039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102526005|NCT02249039|Sympatholytics|sympatholytics|mesh-ancestor
102526006|NCT02249039|Autonomic Agents|autonomic agents|mesh-ancestor
102526007|NCT02249039|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102526008|NCT02249039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102526009|NCT02249039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102526010|NCT02249039|Adrenergic Agents|adrenergic agents|mesh-ancestor
102526011|NCT02249039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102526012|NCT02249039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526013|NCT04370288|Acetylcysteine|acetylcysteine|mesh-list
102526014|NCT04370288|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102526015|NCT04370288|Methylene Blue|methylene blue|mesh-list
102526016|NCT04370288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526017|NCT04370288|Antioxidants|antioxidants|mesh-ancestor
102526018|NCT04370288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526019|NCT04370288|Protective Agents|protective agents|mesh-ancestor
102526020|NCT04370288|Antiviral Agents|antiviral agents|mesh-ancestor
102526021|NCT04370288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102526022|NCT04370288|Expectorants|expectorants|mesh-ancestor
102526023|NCT04370288|Respiratory System Agents|respiratory system agents|mesh-ancestor
102526024|NCT04370288|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102526025|NCT04370288|Antidotes|antidotes|mesh-ancestor
102526026|NCT04370288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102526027|NCT02993705|Trabectedin|trabectedin|mesh-list
102526028|NCT02993705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102526029|NCT02993705|Alkylating Agents|alkylating agents|mesh-ancestor
102526030|NCT02993705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526031|NCT02993705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102526032|NCT02243618|Rebamipide|rebamipide|mesh-list
102526033|NCT02243618|Polaprezinc|polaprezinc|mesh-list
102526034|NCT02243618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102526035|NCT02243618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102526036|NCT02243618|Antioxidants|antioxidants|mesh-ancestor
102526037|NCT02243618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526038|NCT02243618|Protective Agents|protective agents|mesh-ancestor
102526039|NCT02243618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526040|NCT02243618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102526041|NCT02243852|Hormones|hormones|mesh-list
102526042|NCT02243852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102526043|NCT02243852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526044|NCT03150329|Pembrolizumab|pembrolizumab|mesh-list
102526045|NCT03150329|Vorinostat|vorinostat|mesh-list
102526046|NCT03150329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102526047|NCT03150329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102526048|NCT03150329|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102526049|NCT03150329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526050|NCT03150329|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102526051|NCT03150329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102526052|NCT03102125|Regadenoson|regadenoson|mesh-list
102526053|NCT03102125|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
102526054|NCT03102125|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102526055|NCT03102125|Purinergic Agonists|purinergic agonists|mesh-ancestor
102526056|NCT03102125|Purinergic Agents|purinergic agents|mesh-ancestor
102526057|NCT03102125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102526058|NCT03102125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526059|NCT03102125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526060|NCT04369586|Meplazumab|meplazumab|mesh-list
102526061|NCT04369586|Antiviral Agents|antiviral agents|mesh-ancestor
102526062|NCT04369586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102526063|NCT02231177|Tiotropium Bromide|tiotropium bromide|mesh-list
102526064|NCT02231177|Olodaterol|olodaterol|mesh-list
102526065|NCT02231177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102526066|NCT02231177|Autonomic Agents|autonomic agents|mesh-ancestor
102526067|NCT02231177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102526068|NCT02231177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526069|NCT02231177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102526070|NCT02231177|Respiratory System Agents|respiratory system agents|mesh-ancestor
102526071|NCT02231177|Parasympatholytics|parasympatholytics|mesh-ancestor
102526072|NCT02231177|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102526073|NCT02231177|Cholinergic Agents|cholinergic agents|mesh-ancestor
102526074|NCT02231177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102526075|NCT02231177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526076|NCT03283007|Nintedanib|nintedanib|mesh-list
102526077|NCT03283007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102526078|NCT03283007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102526079|NCT03283007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102526080|NCT03283007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526081|NCT02244086|Bupivacaine|bupivacaine|mesh-list
102526082|NCT02244086|Anesthetics, Local|anesthetics, local|mesh-ancestor
102526083|NCT02244086|Anesthetics|anesthetics|mesh-ancestor
102526084|NCT02244086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102526085|NCT02244086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526086|NCT02244086|Sensory System Agents|sensory system agents|mesh-ancestor
102526087|NCT02244086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102526088|NCT01630109|Metoclopramide|metoclopramide|mesh-list
102526089|NCT01630109|Antiemetics|antiemetics|mesh-ancestor
102526090|NCT01630109|Autonomic Agents|autonomic agents|mesh-ancestor
102526091|NCT01630109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102526092|NCT01630109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526093|NCT01630109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102526094|NCT01630109|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102526095|NCT01630109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102526096|NCT01630109|Dopamine Agents|dopamine agents|mesh-ancestor
102526097|NCT01630109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102526098|NCT01630109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526099|NCT04367948|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102526100|NCT04367948|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102526101|NCT04367948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526102|NCT01632215|Gabapentin|gabapentin|mesh-list
102526103|NCT01632215|Anticonvulsants|anticonvulsants|mesh-list
102526104|NCT01632215|Analgesics|analgesics|mesh-ancestor
102526105|NCT01632215|Sensory System Agents|sensory system agents|mesh-ancestor
102526106|NCT01632215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102526107|NCT01632215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526108|NCT01632215|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102526109|NCT01632215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102526110|NCT01632215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102526111|NCT01632215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102526112|NCT01632215|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102526113|NCT01632215|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102526114|NCT01632215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102526115|NCT01632215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526116|NCT01632215|Antimanic Agents|antimanic agents|mesh-ancestor
102526117|NCT02244242|Tamsulosin|tamsulosin|mesh-list
102526118|NCT02244242|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102526119|NCT02244242|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102526120|NCT02244242|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102526121|NCT02244242|Adrenergic Agents|adrenergic agents|mesh-ancestor
102526122|NCT02244242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102526123|NCT02244242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526124|NCT02244242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526125|NCT02244242|Urological Agents|urological agents|mesh-ancestor
102526126|NCT03127631|Atorvastatin|atorvastatin|mesh-list
102526127|NCT03127631|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102526128|NCT03127631|Simvastatin|simvastatin|mesh-list
102526129|NCT03127631|Pravastatin|pravastatin|mesh-list
102526130|NCT03127631|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102526131|NCT03127631|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102526132|NCT03127631|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102526133|NCT03127631|Antimetabolites|antimetabolites|mesh-ancestor
102526134|NCT03127631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526135|NCT03127631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102526136|NCT03127631|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102526137|NCT03127631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102526138|NCT03127631|Protease Inhibitors|protease inhibitors|mesh-ancestor
102526139|NCT02244320|Tamsulosin|tamsulosin|mesh-list
102526140|NCT02244320|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102526141|NCT02244320|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102526142|NCT02244320|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102526143|NCT02244320|Adrenergic Agents|adrenergic agents|mesh-ancestor
102526144|NCT02244320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102526145|NCT02244320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526146|NCT02244320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526147|NCT02244320|Urological Agents|urological agents|mesh-ancestor
102526148|NCT02244632|Bevacizumab|bevacizumab|mesh-list
102526149|NCT02244632|Fluorouracil|fluorouracil|mesh-list
102526150|NCT02244632|Oxaliplatin|oxaliplatin|mesh-list
102526151|NCT02244632|Irinotecan|irinotecan|mesh-list
102526152|NCT02244632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102526153|NCT02244632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102526154|NCT02244632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102526155|NCT02244632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102526156|NCT02244632|Growth Substances|growth substances|mesh-ancestor
102526157|NCT02244632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526158|NCT02244632|Growth Inhibitors|growth inhibitors|mesh-ancestor
102526159|NCT02244632|Antimetabolites|antimetabolites|mesh-ancestor
102526160|NCT02244632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526161|NCT02244632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102526162|NCT02244632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102526163|NCT02244632|Immunologic Factors|immunologic factors|mesh-ancestor
102526164|NCT02244632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102526165|NCT02244632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102526166|NCT02244632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102526167|NCT03060083|Nicotine|nicotine|mesh-list
102526168|NCT03060083|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102526169|NCT03060083|Autonomic Agents|autonomic agents|mesh-ancestor
102526170|NCT03060083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102526171|NCT03060083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526172|NCT03060083|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102526173|NCT03060083|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102526174|NCT03060083|Cholinergic Agents|cholinergic agents|mesh-ancestor
102526175|NCT03060083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102526176|NCT03060083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526177|NCT02244710|Clopidogrel|clopidogrel|mesh-list
102526178|NCT02244710|Ticagrelor|ticagrelor|mesh-list
102526179|NCT02244710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102526180|NCT02244710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102526181|NCT02244710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102526182|NCT02244710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102526183|NCT02244710|Purinergic Agents|purinergic agents|mesh-ancestor
102526184|NCT02244710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102526185|NCT02244710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526186|NCT02244710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526187|NCT04362332|Hydroxychloroquine|hydroxychloroquine|mesh-list
102526188|NCT04362332|Chloroquine|chloroquine|mesh-list
102526189|NCT04362332|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
102526190|NCT04362332|Antimalarials|antimalarials|mesh-ancestor
102526191|NCT04362332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102526192|NCT04362332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102526193|NCT04362332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102526194|NCT04362332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102526195|NCT04362332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526196|NCT04362332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102526197|NCT04362332|Amebicides|amebicides|mesh-ancestor
102526198|NCT04362332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102526199|NCT04362332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102526200|NCT04362332|Analgesics|analgesics|mesh-ancestor
102526201|NCT04362332|Sensory System Agents|sensory system agents|mesh-ancestor
102526202|NCT04362332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102526203|NCT04362332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526204|NCT04362332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102526205|NCT04362332|Filaricides|filaricides|mesh-ancestor
102526206|NCT04362332|Antinematodal Agents|antinematodal agents|mesh-ancestor
102526207|NCT04362332|Anthelmintics|anthelmintics|mesh-ancestor
102526208|NCT02308241|Ribavirin|ribavirin|mesh-list
102526209|NCT02308241|Antimetabolites|antimetabolites|mesh-ancestor
102526210|NCT02308241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526211|NCT02308241|Antiviral Agents|antiviral agents|mesh-ancestor
102526212|NCT02308241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102526213|NCT00932282|Omalizumab|omalizumab|mesh-list
102526214|NCT00932282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102526215|NCT00932282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102526216|NCT00932282|Respiratory System Agents|respiratory system agents|mesh-ancestor
102526217|NCT02159495|Cyclophosphamide|cyclophosphamide|mesh-list
102526218|NCT02159495|Fludarabine|fludarabine|mesh-list
102526219|NCT02159495|Fludarabine phosphate|fludarabine phosphate|mesh-list
102526220|NCT02159495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102526221|NCT02159495|Immunologic Factors|immunologic factors|mesh-ancestor
102526222|NCT02159495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526223|NCT02159495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102526224|NCT02159495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102526225|NCT02159495|Alkylating Agents|alkylating agents|mesh-ancestor
102526226|NCT02159495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526227|NCT02159495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102526228|NCT02159495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102526229|NCT02159495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102337756|NCT01905943|Cyclophosphamide|cyclophosphamide|mesh-list
102526230|NCT02159495|Antimetabolites|antimetabolites|mesh-ancestor
102526231|NCT01632995|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102526232|NCT01632995|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102526233|NCT01632995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102526234|NCT01632995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102526235|NCT01632995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526236|NCT01632995|Antiviral Agents|antiviral agents|mesh-ancestor
102526237|NCT01632995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102526238|NCT01632995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102526239|NCT01632995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102526240|NCT02245022|Tenofovir|tenofovir|mesh-list
102526241|NCT02245022|Lamivudine|lamivudine|mesh-list
102526242|NCT02245022|Efavirenz|efavirenz|mesh-list
102526243|NCT02245022|Dolutegravir|dolutegravir|mesh-list
102526244|NCT02245022|Antiviral Agents|antiviral agents|mesh-ancestor
102526245|NCT02245022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102526246|NCT02245022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102526247|NCT02245022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102526248|NCT02245022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102526249|NCT02245022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526250|NCT02245022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102526251|NCT02245022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102526252|NCT02245022|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102526253|NCT02245022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102526254|NCT02245022|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102526255|NCT02245022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102526256|NCT02245022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102526257|NCT02245022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102526258|NCT02245022|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102526259|NCT02245022|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102526260|NCT02224313|Estradiol|estradiol|mesh-list
102526261|NCT02224313|Progesterone|progesterone|mesh-list
102526262|NCT02224313|Estrogens|estrogens|mesh-ancestor
102526263|NCT02224313|Hormones|hormones|mesh-ancestor
102526264|NCT02224313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102526265|NCT02224313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526266|NCT02224313|Progestins|progestins|mesh-ancestor
102526267|NCT04362410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102526268|NCT04362410|Immunologic Factors|immunologic factors|mesh-ancestor
102526269|NCT04362410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526270|NCT02460198|Pembrolizumab|pembrolizumab|mesh-list
102526271|NCT02460198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102526272|NCT02460198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102526273|NCT02460198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102526274|NCT02460198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526275|NCT01633853|Vitamin D|vitamin d|mesh-list
102526276|NCT01633853|Ergocalciferols|ergocalciferols|mesh-list
102526277|NCT01633853|Cholecalciferol|cholecalciferol|mesh-list
102526278|NCT01633853|Vitamins|vitamins|mesh-list
102526279|NCT01633853|Micronutrients|micronutrients|mesh-ancestor
102526280|NCT01633853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526281|NCT01633853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102526282|NCT01633853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102526283|NCT04361552|Immunoglobulins|immunoglobulins|mesh-list
102526284|NCT04361552|Immunoglobulin G|immunoglobulin g|mesh-list
102526285|NCT04361552|Immunologic Factors|immunologic factors|mesh-ancestor
102526286|NCT04361552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526287|NCT04376216|Prednisone|prednisone|mesh-list
102526288|NCT04376216|Prednisolone|prednisolone|mesh-list
102526289|NCT04376216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102526290|NCT04376216|Glucocorticoids|glucocorticoids|mesh-ancestor
102526291|NCT04376216|Hormones|hormones|mesh-ancestor
102526292|NCT04376216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102526293|NCT04376216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526294|NCT04376216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102526295|NCT04376216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102526296|NCT02452320|Acetaminophen|acetaminophen|mesh-list
102526297|NCT02452320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102526298|NCT02452320|Analgesics|analgesics|mesh-ancestor
102526299|NCT02452320|Sensory System Agents|sensory system agents|mesh-ancestor
102526300|NCT02452320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102526301|NCT02452320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526302|NCT02452320|Antipyretics|antipyretics|mesh-ancestor
102526303|NCT02459964|Fentanyl|fentanyl|mesh-list
102526304|NCT02459964|Hydromorphone|hydromorphone|mesh-list
102526305|NCT02459964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102526306|NCT02459964|Narcotics|narcotics|mesh-ancestor
102526307|NCT02459964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102526308|NCT02459964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526309|NCT02459964|Analgesics|analgesics|mesh-ancestor
102526310|NCT02459964|Sensory System Agents|sensory system agents|mesh-ancestor
102526311|NCT02459964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102526312|NCT02459964|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102526313|NCT02459964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102526314|NCT02459964|Anesthetics, General|anesthetics, general|mesh-ancestor
102526315|NCT02459964|Anesthetics|anesthetics|mesh-ancestor
102526316|NCT01635101|Acetaminophen|acetaminophen|mesh-list
102526317|NCT01635101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102526318|NCT01635101|Analgesics|analgesics|mesh-ancestor
102526319|NCT01635101|Sensory System Agents|sensory system agents|mesh-ancestor
102526320|NCT01635101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102526321|NCT01635101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526322|NCT01635101|Antipyretics|antipyretics|mesh-ancestor
102526323|NCT02087111|Interferons|interferons|mesh-list
102526324|NCT02087111|Ribavirin|ribavirin|mesh-list
102526325|NCT02087111|Interferon-alpha|interferon-alpha|mesh-list
102526326|NCT02087111|Interferon alpha-2|interferon alpha-2|mesh-list
102526327|NCT02087111|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102526328|NCT02087111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102526329|NCT02087111|Antiviral Agents|antiviral agents|mesh-ancestor
102526330|NCT02087111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102526331|NCT02087111|Antimetabolites|antimetabolites|mesh-ancestor
102526332|NCT02087111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526333|NCT02087111|Immunologic Factors|immunologic factors|mesh-ancestor
102526334|NCT02087111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526335|NCT00932438|Leucovorin|leucovorin|mesh-list
102526336|NCT00932438|Bevacizumab|bevacizumab|mesh-list
102526337|NCT00932438|Fluorouracil|fluorouracil|mesh-list
102526338|NCT00932438|Oxaliplatin|oxaliplatin|mesh-list
102526339|NCT00932438|Irinotecan|irinotecan|mesh-list
102526340|NCT00932438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102526341|NCT00932438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102526342|NCT00932438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102526343|NCT00932438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102526344|NCT00932438|Growth Substances|growth substances|mesh-ancestor
102526345|NCT00932438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526346|NCT00932438|Growth Inhibitors|growth inhibitors|mesh-ancestor
102526347|NCT00932438|Antimetabolites|antimetabolites|mesh-ancestor
102526348|NCT00932438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526349|NCT00932438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102526350|NCT00932438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102526351|NCT00932438|Immunologic Factors|immunologic factors|mesh-ancestor
102526352|NCT00932438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102526353|NCT00932438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102526354|NCT00932438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102526355|NCT00932438|Antidotes|antidotes|mesh-ancestor
102526356|NCT00932438|Protective Agents|protective agents|mesh-ancestor
102526357|NCT00932438|Vitamin B Complex|vitamin b complex|mesh-ancestor
102526358|NCT00932438|Vitamins|vitamins|mesh-ancestor
102526359|NCT00932438|Micronutrients|micronutrients|mesh-ancestor
102526360|NCT01869413|Tranexamic Acid|tranexamic acid|mesh-list
102526361|NCT01869413|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102526362|NCT01869413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102526363|NCT01869413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526364|NCT01869413|Hemostatics|hemostatics|mesh-ancestor
102526365|NCT01869413|Coagulants|coagulants|mesh-ancestor
102526366|NCT02982512|Dexmedetomidine|dexmedetomidine|mesh-list
102526367|NCT02982512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102526368|NCT02982512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102526369|NCT02982512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526370|NCT02982512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102526371|NCT02982512|Analgesics|analgesics|mesh-ancestor
102526372|NCT02982512|Sensory System Agents|sensory system agents|mesh-ancestor
102526373|NCT02982512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102526374|NCT02982512|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102526375|NCT02982512|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102526376|NCT02982512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102526377|NCT02982512|Adrenergic Agents|adrenergic agents|mesh-ancestor
102526378|NCT02982512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102526379|NCT02982512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526380|NCT01555697|Memantine|memantine|mesh-list
102526381|NCT01555697|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102337898|NCT00985504|Analgesics|analgesics|mesh-ancestor
102526382|NCT01555697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102526383|NCT01555697|Dopamine Agents|dopamine agents|mesh-ancestor
102526384|NCT01555697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102526385|NCT01555697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526386|NCT01555697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526387|NCT01555697|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102526388|NCT01555697|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102526389|NCT02982434|Botulinum Toxins|botulinum toxins|mesh-list
102526390|NCT02982434|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102526391|NCT02982434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102526392|NCT02982434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526393|NCT02982434|Cholinergic Agents|cholinergic agents|mesh-ancestor
102526394|NCT02982434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102526395|NCT02982434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526396|NCT02451930|Pembrolizumab|pembrolizumab|mesh-list
102526397|NCT02451930|Necitumumab|necitumumab|mesh-list
102526398|NCT02451930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102526399|NCT02451930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102526400|NCT02451930|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102526401|NCT02451930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526402|NCT04358120|Hyaluronic Acid|hyaluronic acid|mesh-list
102526403|NCT04358120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102526404|NCT04358120|Immunologic Factors|immunologic factors|mesh-ancestor
102526405|NCT04358120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526406|NCT04358120|Viscosupplements|viscosupplements|mesh-ancestor
102526407|NCT04358120|Protective Agents|protective agents|mesh-ancestor
102526408|NCT00932828|Immunomodulating Agents|immunomodulating agents|mesh-list
102526409|NCT00932828|Immunologic Factors|immunologic factors|mesh-list
102526410|NCT00932828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526411|NCT00928694|Fenofibrate|fenofibrate|mesh-list
102526412|NCT00928694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102526413|NCT00928694|Antimetabolites|antimetabolites|mesh-ancestor
102526414|NCT00928694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526415|NCT00928694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102526417|NCT01639157|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102526418|NCT01639157|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102526419|NCT01639157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102526420|NCT01639157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526421|NCT01639157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102526422|NCT01639157|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102526423|NCT01639157|Serotonin Agents|serotonin agents|mesh-ancestor
102526424|NCT01639157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102526425|NCT01639157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526426|NCT02451696|Everolimus|everolimus|mesh-list
102526427|NCT02451696|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102526428|NCT02451696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102526429|NCT02451696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102526430|NCT02451696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526431|NCT02451696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102526432|NCT02451696|Immunologic Factors|immunologic factors|mesh-ancestor
102526433|NCT02451696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526434|NCT02451696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102526435|NCT00928772|Midazolam|midazolam|mesh-list
102526436|NCT00928772|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102526437|NCT00928772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102526438|NCT00928772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102526439|NCT00928772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526440|NCT00928772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102526441|NCT00928772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102526442|NCT00928772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102526443|NCT00928772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102526444|NCT00928772|Anesthetics, General|anesthetics, general|mesh-ancestor
102526445|NCT00928772|Anesthetics|anesthetics|mesh-ancestor
102526446|NCT00928772|GABA Modulators|gaba modulators|mesh-ancestor
102526447|NCT00928772|GABA Agents|gaba agents|mesh-ancestor
102526448|NCT00928772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102526449|NCT00928772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526450|NCT02459418|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102526451|NCT02459418|Hormones|hormones|mesh-ancestor
102526452|NCT02459418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102526453|NCT02459418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526454|NCT04361318|Hydroxychloroquine|hydroxychloroquine|mesh-list
102337976|NCT00984568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102526455|NCT04361318|Nitazoxanide|nitazoxanide|mesh-list
102526456|NCT04361318|Antimalarials|antimalarials|mesh-ancestor
102526457|NCT04361318|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102526458|NCT04361318|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102526459|NCT04361318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102526460|NCT04361318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102526461|NCT04361318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526462|NCT04361318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102526463|NCT04925076|Ethanol|ethanol|mesh-list
102526464|NCT04925076|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102526465|NCT04925076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102526466|NCT04925076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102526467|NCT04925076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526468|NCT01598207|Dronabinol|dronabinol|mesh-list
102526469|NCT01598207|Hallucinogens|hallucinogens|mesh-ancestor
102526470|NCT01598207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526471|NCT01598207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102526472|NCT01598207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102526473|NCT01598207|Analgesics|analgesics|mesh-ancestor
102526474|NCT01598207|Sensory System Agents|sensory system agents|mesh-ancestor
102526475|NCT01598207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102526476|NCT01598207|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102526477|NCT01598207|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102526478|NCT01598207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102526479|NCT01598207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526480|NCT01598207|Hormones|hormones|mesh-ancestor
102526481|NCT01598207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102526482|NCT01640171|Ketorolac|ketorolac|mesh-list
102526483|NCT01640171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102526484|NCT01640171|Lidocaine|lidocaine|mesh-list
102526485|NCT01640171|Proxymetacaine|proxymetacaine|mesh-list
102526486|NCT01640171|Anesthetics|anesthetics|mesh-list
102526487|NCT01640171|Anesthetics, Local|anesthetics, local|mesh-ancestor
102526488|NCT01640171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102526489|NCT01640171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526490|NCT01640171|Sensory System Agents|sensory system agents|mesh-ancestor
102526491|NCT01640171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102526492|NCT01640171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102526493|NCT01640171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102526494|NCT01640171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102526495|NCT01640171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102526496|NCT01640171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526497|NCT01640171|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102526498|NCT01640171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102526499|NCT01640171|Analgesics|analgesics|mesh-ancestor
102526500|NCT01640171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102526501|NCT01640171|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102526502|NCT01640171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102526503|NCT04361474|Budesonide|budesonide|mesh-list
102526504|NCT04361474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102526505|NCT04361474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102526506|NCT04361474|Autonomic Agents|autonomic agents|mesh-ancestor
102526507|NCT04361474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102526508|NCT04361474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526509|NCT04361474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102526510|NCT04361474|Respiratory System Agents|respiratory system agents|mesh-ancestor
102526511|NCT04361474|Glucocorticoids|glucocorticoids|mesh-ancestor
102526512|NCT04361474|Hormones|hormones|mesh-ancestor
102526513|NCT04361474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102526514|NCT04366622|Riociguat|riociguat|mesh-list
102526515|NCT04366622|Enzyme Activators|enzyme activators|mesh-ancestor
102526516|NCT04366622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526517|NCT02245334|Povidone-Iodine|povidone-iodine|mesh-list
102526518|NCT02245334|Povidone|povidone|mesh-list
102526519|NCT02245334|Plasma Substitutes|plasma substitutes|mesh-ancestor
102526520|NCT02245334|Blood Substitutes|blood substitutes|mesh-ancestor
102526521|NCT02245334|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102526522|NCT02245334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102526523|NCT04762160|Rituximab|rituximab|mesh-list
102526524|NCT04762160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102526525|NCT04762160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102526526|NCT04762160|Immunologic Factors|immunologic factors|mesh-ancestor
102526527|NCT04762160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526528|NCT04762160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102526529|NCT02487498|Glycopyrrolate|glycopyrrolate|mesh-list
102526530|NCT02487498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102526531|NCT02487498|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102526532|NCT02487498|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102526533|NCT02487498|Cholinergic Agents|cholinergic agents|mesh-ancestor
102526534|NCT02487498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102526535|NCT02487498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526536|NCT02487498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526537|NCT04356872|Doxorubicin|doxorubicin|mesh-list
102526538|NCT04356872|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102526539|NCT04356872|Ifosfamide|ifosfamide|mesh-list
102526540|NCT04356872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102526541|NCT04356872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102526542|NCT04356872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102526543|NCT04356872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102526544|NCT04356872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102526545|NCT04356872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526546|NCT04356872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102526547|NCT04356872|Alkylating Agents|alkylating agents|mesh-ancestor
102526548|NCT02487108|Acetaminophen|acetaminophen|mesh-list
102526549|NCT02487108|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
102526550|NCT02487108|Hydrocodone|hydrocodone|mesh-list
102526551|NCT02487108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102526552|NCT02487108|Analgesics|analgesics|mesh-ancestor
102526553|NCT02487108|Sensory System Agents|sensory system agents|mesh-ancestor
102526554|NCT02487108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102526555|NCT02487108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526556|NCT02487108|Antipyretics|antipyretics|mesh-ancestor
102526557|NCT02487108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102526558|NCT02487108|Narcotics|narcotics|mesh-ancestor
102526559|NCT02487108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102526560|NCT02487108|Antitussive Agents|antitussive agents|mesh-ancestor
102526561|NCT02487108|Respiratory System Agents|respiratory system agents|mesh-ancestor
102526562|NCT02487108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102526563|NCT02487108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102526564|NCT02487108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102526565|NCT02487030|Sofosbuvir|sofosbuvir|mesh-list
102526566|NCT02487030|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102526567|NCT02487030|Ledipasvir|ledipasvir|mesh-list
102526568|NCT02487030|Antiviral Agents|antiviral agents|mesh-ancestor
102526569|NCT02487030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102526570|NCT02486952|Prednisone|prednisone|mesh-list
102526571|NCT02486952|Cyclophosphamide|cyclophosphamide|mesh-list
102526572|NCT02486952|Rituximab|rituximab|mesh-list
102526573|NCT02486952|Vincristine|vincristine|mesh-list
102526574|NCT02486952|Doxorubicin|doxorubicin|mesh-list
102526575|NCT02486952|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102526576|NCT02486952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102526577|NCT02486952|Immunologic Factors|immunologic factors|mesh-ancestor
102526578|NCT02486952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526579|NCT02486952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102526580|NCT02486952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102526581|NCT02486952|Alkylating Agents|alkylating agents|mesh-ancestor
102526582|NCT02486952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526583|NCT02486952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102526584|NCT02486952|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102526585|NCT02486952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102526586|NCT02486952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102526587|NCT02486952|Glucocorticoids|glucocorticoids|mesh-ancestor
102526588|NCT02486952|Hormones|hormones|mesh-ancestor
102526589|NCT02486952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102526590|NCT02486952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102526591|NCT02486952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102526592|NCT02486952|Tubulin Modulators|tubulin modulators|mesh-ancestor
102526593|NCT02486952|Antimitotic Agents|antimitotic agents|mesh-ancestor
102526594|NCT02486952|Mitosis Modulators|mitosis modulators|mesh-ancestor
102526595|NCT02486952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102526596|NCT02486952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102526597|NCT02486952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102526598|NCT02486952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102526599|NCT02486796|Ubiquinone|ubiquinone|mesh-list
102526600|NCT02486796|Coenzyme Q10|coenzyme q10|mesh-list
102526601|NCT02486796|Melatonin|melatonin|mesh-list
102526602|NCT02486796|Antioxidants|antioxidants|mesh-ancestor
102526603|NCT02486796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338126|NCT01927588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102526604|NCT02486796|Protective Agents|protective agents|mesh-ancestor
102526605|NCT02486796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526606|NCT02486796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102526607|NCT02486796|Micronutrients|micronutrients|mesh-ancestor
102526608|NCT02486796|Vitamins|vitamins|mesh-ancestor
102526609|NCT00620477|Levobupivacaine|levobupivacaine|mesh-list
102526610|NCT00620477|Anesthetics, Local|anesthetics, local|mesh-ancestor
102526611|NCT00620477|Anesthetics|anesthetics|mesh-ancestor
102526612|NCT00620477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102526613|NCT00620477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526614|NCT00620477|Sensory System Agents|sensory system agents|mesh-ancestor
102526615|NCT00620477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102526616|NCT01641653|Midazolam|midazolam|mesh-list
102526617|NCT01641653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102526618|NCT01641653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102526619|NCT01641653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102526620|NCT01641653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526621|NCT01641653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102526622|NCT01641653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102526623|NCT01641653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102526624|NCT01641653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102526625|NCT01641653|Anesthetics, General|anesthetics, general|mesh-ancestor
102526626|NCT01641653|Anesthetics|anesthetics|mesh-ancestor
102526627|NCT01641653|GABA Modulators|gaba modulators|mesh-ancestor
102526628|NCT01641653|GABA Agents|gaba agents|mesh-ancestor
102526629|NCT01641653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102526630|NCT01641653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526631|NCT01600703|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102526632|NCT01600703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102526633|NCT01600703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526634|NCT01600703|Incretins|incretins|mesh-ancestor
102526635|NCT01600703|Hormones|hormones|mesh-ancestor
102526636|NCT01600703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102526637|NCT01600703|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102526638|NCT01600703|Protease Inhibitors|protease inhibitors|mesh-ancestor
102526639|NCT01600703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102526640|NCT01600703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526641|NCT02450526|Botulinum Toxins|botulinum toxins|mesh-list
102526642|NCT02450526|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102526643|NCT02450526|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102526644|NCT02450526|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102526645|NCT02450526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102526646|NCT02450526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526647|NCT02450526|Cholinergic Agents|cholinergic agents|mesh-ancestor
102526648|NCT02450526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102526649|NCT02450526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526650|NCT02450526|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102526651|NCT02450526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102526652|NCT01605539|Cannabidiol|cannabidiol|mesh-list
102526653|NCT01605539|Anticonvulsants|anticonvulsants|mesh-ancestor
102526654|NCT02458638|Atezolizumab|atezolizumab|mesh-list
102526655|NCT02458638|Antibodies|antibodies|mesh-list
102526656|NCT02458638|Immunologic Factors|immunologic factors|mesh-ancestor
102526657|NCT02458638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526658|NCT02458638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102526659|NCT02458638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526660|NCT02458638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102526661|NCT02458638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102526662|NCT01607411|Fluorides|fluorides|mesh-list
102526663|NCT01607411|Cariostatic Agents|cariostatic agents|mesh-ancestor
102526664|NCT01607411|Protective Agents|protective agents|mesh-ancestor
102526665|NCT01607411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526666|NCT01691339|Vaccines|vaccines|mesh-list
102526667|NCT01691339|Immunologic Factors|immunologic factors|mesh-ancestor
102526668|NCT01691339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526669|NCT02233751|Methyltestosterone|methyltestosterone|mesh-list
102526670|NCT02233751|Testosterone|testosterone|mesh-list
102526671|NCT02233751|Testosterone undecanoate|testosterone undecanoate|mesh-list
102526672|NCT02233751|Testosterone enanthate|testosterone enanthate|mesh-list
102526673|NCT02233751|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102526674|NCT02233751|Androgens|androgens|mesh-ancestor
102526675|NCT02233751|Hormones|hormones|mesh-ancestor
102526676|NCT02233751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102526677|NCT02233751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526678|NCT02233751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102338203|NCT00981526|GABA Antagonists|gaba antagonists|mesh-ancestor
102526679|NCT02233751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102526680|NCT02233751|Anabolic Agents|anabolic agents|mesh-ancestor
102526681|NCT01607645|Cytarabine|cytarabine|mesh-list
102526682|NCT01607645|Decitabine|decitabine|mesh-list
102526683|NCT01607645|Azacitidine|azacitidine|mesh-list
102526684|NCT01607645|Idarubicin|idarubicin|mesh-list
102526685|NCT01607645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102526686|NCT01607645|Antimetabolites|antimetabolites|mesh-ancestor
102526687|NCT01607645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526688|NCT01607645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102526689|NCT01607645|Antiviral Agents|antiviral agents|mesh-ancestor
102526690|NCT01607645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102526691|NCT01607645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102526692|NCT01607645|Immunologic Factors|immunologic factors|mesh-ancestor
102526693|NCT01607645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526694|NCT01607645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102526695|NCT01607645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102526696|NCT01607645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102526697|NCT01607645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102526698|NCT01647581|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102526699|NCT01647581|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
102526700|NCT01647581|beta-Endorphin|beta-endorphin|mesh-list
102526701|NCT01647581|Hormones|hormones|mesh-ancestor
102526702|NCT01647581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102526703|NCT01647581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526704|NCT01647581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102526705|NCT01647581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526706|NCT01608659|Botulinum Toxins|botulinum toxins|mesh-list
102526707|NCT01608659|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102526708|NCT01608659|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102526709|NCT01608659|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102526710|NCT01608659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102526711|NCT01608659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526712|NCT01608659|Cholinergic Agents|cholinergic agents|mesh-ancestor
102526713|NCT01608659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102526714|NCT01608659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526715|NCT01608659|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102526716|NCT01608659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102526717|NCT01649609|Mycophenolic Acid|mycophenolic acid|mesh-list
102526718|NCT01649609|Sirolimus|sirolimus|mesh-list
102526719|NCT01649609|Tacrolimus|tacrolimus|mesh-list
102526720|NCT01649609|Antimetabolites|antimetabolites|mesh-list
102526721|NCT01649609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102526722|NCT01649609|Immunologic Factors|immunologic factors|mesh-ancestor
102526723|NCT01649609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526724|NCT01649609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102526725|NCT01649609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102526726|NCT01649609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526727|NCT01649609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102526728|NCT01649609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102526729|NCT01649609|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102526730|NCT01649609|Antitubercular Agents|antitubercular agents|mesh-ancestor
102526731|NCT01649609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102526732|NCT01649609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102526733|NCT01649609|Antifungal Agents|antifungal agents|mesh-ancestor
102526734|NCT02449902|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102526735|NCT02449902|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102526736|NCT02449902|Estradiol|estradiol|mesh-list
102526737|NCT02449902|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102526738|NCT02449902|Estrogens|estrogens|mesh-ancestor
102526739|NCT02449902|Hormones|hormones|mesh-ancestor
102526740|NCT02449902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102526741|NCT02449902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526742|NCT02449902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102526743|NCT02449902|Contraceptive Agents|contraceptive agents|mesh-ancestor
102526744|NCT02449902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102526745|NCT02449902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102526746|NCT02449044|Tolvaptan|tolvaptan|mesh-list
102526747|NCT02449044|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102526748|NCT02449044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526749|NCT02449044|Natriuretic Agents|natriuretic agents|mesh-ancestor
102526750|NCT02449044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526751|NCT04942626|Capecitabine|capecitabine|mesh-list
102526752|NCT04942626|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102526753|NCT04942626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102526754|NCT04942626|Antimetabolites|antimetabolites|mesh-ancestor
102526755|NCT04942626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526756|NCT04942626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102526757|NCT04942626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102526758|NCT04942470|Propolis|propolis|mesh-list
102526759|NCT04942470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102526760|NCT02228681|Tamoxifen|tamoxifen|mesh-list
102526761|NCT02228681|Everolimus|everolimus|mesh-list
102526762|NCT02228681|Letrozole|letrozole|mesh-list
102526763|NCT02228681|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102526764|NCT02228681|Medroxyprogesterone|medroxyprogesterone|mesh-list
102526765|NCT02228681|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102526766|NCT02228681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102526767|NCT02228681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102526768|NCT02228681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526769|NCT02228681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102526770|NCT02228681|Immunologic Factors|immunologic factors|mesh-ancestor
102526771|NCT02228681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526772|NCT02228681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102526773|NCT02228681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102526774|NCT02228681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102526775|NCT02228681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102526776|NCT02228681|Hormone Antagonists|hormone antagonists|mesh-ancestor
102526777|NCT02228681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102526778|NCT02228681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102526779|NCT02228681|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102526780|NCT02228681|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102526781|NCT02228681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102526782|NCT02228681|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102526783|NCT02228681|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102526784|NCT02228681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102526785|NCT02228681|Contraceptive Agents|contraceptive agents|mesh-ancestor
102526786|NCT02228681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102526787|NCT02228681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102526788|NCT02228681|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102526789|NCT02228681|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102526790|NCT00942578|Prednisone|prednisone|mesh-list
102526791|NCT00942578|Bevacizumab|bevacizumab|mesh-list
102526792|NCT00942578|Lenalidomide|lenalidomide|mesh-list
102526793|NCT00942578|Docetaxel|docetaxel|mesh-list
102526794|NCT00942578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102526795|NCT00942578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102526796|NCT00942578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102526797|NCT00942578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102526798|NCT00942578|Growth Substances|growth substances|mesh-ancestor
102526799|NCT00942578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526800|NCT00942578|Growth Inhibitors|growth inhibitors|mesh-ancestor
102526801|NCT00942578|Tubulin Modulators|tubulin modulators|mesh-ancestor
102526802|NCT00942578|Antimitotic Agents|antimitotic agents|mesh-ancestor
102526803|NCT00942578|Mitosis Modulators|mitosis modulators|mesh-ancestor
102526804|NCT00942578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526805|NCT00942578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102526806|NCT00942578|Glucocorticoids|glucocorticoids|mesh-ancestor
102526807|NCT00942578|Hormones|hormones|mesh-ancestor
102526808|NCT00942578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102526809|NCT00942578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102526810|NCT00942578|Immunologic Factors|immunologic factors|mesh-ancestor
102526811|NCT02229461|Aspirin|aspirin|mesh-list
102526812|NCT02229461|Naproxen|naproxen|mesh-list
102526813|NCT02229461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102526814|NCT02229461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102526815|NCT02229461|Analgesics|analgesics|mesh-ancestor
102526816|NCT02229461|Sensory System Agents|sensory system agents|mesh-ancestor
102526817|NCT02229461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102526818|NCT02229461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526819|NCT02229461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102526820|NCT02229461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102526821|NCT02229461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102526822|NCT02229461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102526823|NCT02229461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526824|NCT02229461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102338349|NCT03828058|Immunologic Factors|immunologic factors|mesh-ancestor
102526825|NCT02229461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102526826|NCT02229461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102526827|NCT02229461|Antipyretics|antipyretics|mesh-ancestor
102526828|NCT02229461|Gout Suppressants|gout suppressants|mesh-ancestor
102526829|NCT04641104|Thiamine|thiamine|mesh-list
102526830|NCT04641104|Vitamin B Complex|vitamin b complex|mesh-ancestor
102526831|NCT04641104|Vitamins|vitamins|mesh-ancestor
102526832|NCT04641104|Micronutrients|micronutrients|mesh-ancestor
102526833|NCT04641104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526834|NCT04359680|Nitazoxanide|nitazoxanide|mesh-list
102526835|NCT04359680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102526836|NCT04359680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102526837|NCT02237417|Aripiprazole|aripiprazole|mesh-list
102526838|NCT02237417|Antipsychotic Agents|antipsychotic agents|mesh-list
102526839|NCT02237417|Antidepressive Agents|antidepressive agents|mesh-ancestor
102526840|NCT02237417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102526841|NCT02237417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102526842|NCT02237417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102526843|NCT02237417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526844|NCT02237417|Dopamine Agonists|dopamine agonists|mesh-ancestor
102526845|NCT02237417|Dopamine Agents|dopamine agents|mesh-ancestor
102526846|NCT02237417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102526847|NCT02237417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526848|NCT02237417|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102526849|NCT02237417|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102526850|NCT02237417|Serotonin Agents|serotonin agents|mesh-ancestor
102526851|NCT02237417|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102526852|NCT02237417|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102526853|NCT02237417|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102526854|NCT02237417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102526855|NCT04603898|Ascorbic Acid|ascorbic acid|mesh-list
102526856|NCT04603898|Antioxidants|antioxidants|mesh-ancestor
102526857|NCT04603898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526858|NCT04603898|Protective Agents|protective agents|mesh-ancestor
102526859|NCT04603898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526860|NCT04603898|Vitamins|vitamins|mesh-ancestor
102526861|NCT04603898|Micronutrients|micronutrients|mesh-ancestor
102526862|NCT02245490|Tamsulosin|tamsulosin|mesh-list
102526863|NCT02245490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102526864|NCT02245490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102526865|NCT02245490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102526866|NCT02245490|Adrenergic Agents|adrenergic agents|mesh-ancestor
102526867|NCT02245490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102526868|NCT02245490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526869|NCT02245490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526870|NCT02245490|Urological Agents|urological agents|mesh-ancestor
102526871|NCT04355936|Telmisartan|telmisartan|mesh-list
102526872|NCT04355936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102526873|NCT04355936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102526874|NCT04355936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102526875|NCT04355936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526876|NCT00934934|Anidulafungin|anidulafungin|mesh-list
102526877|NCT00934934|Antifungal Agents|antifungal agents|mesh-ancestor
102526878|NCT00934934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102526879|NCT01651793|Caffeine|caffeine|mesh-list
102526880|NCT01651793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102526881|NCT01651793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526882|NCT01651793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102526883|NCT01651793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102526884|NCT01651793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526885|NCT01651793|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102526886|NCT01651793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102526887|NCT01651793|Purinergic Agents|purinergic agents|mesh-ancestor
102526888|NCT01651793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102526889|NCT01652495|Methylprednisolone|methylprednisolone|mesh-list
102526890|NCT01652495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102526891|NCT01652495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102526892|NCT01652495|Prednisolone|prednisolone|mesh-list
102526893|NCT01652495|Prednisolone acetate|prednisolone acetate|mesh-list
102526894|NCT01652495|Triamcinolone|triamcinolone|mesh-list
102526895|NCT01652495|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102526896|NCT01652495|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102526897|NCT01652495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102526898|NCT01652495|Prednisolone phosphate|prednisolone phosphate|mesh-list
102526899|NCT01652495|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102526900|NCT01652495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102526901|NCT01652495|Antiemetics|antiemetics|mesh-ancestor
102526902|NCT01652495|Autonomic Agents|autonomic agents|mesh-ancestor
102526903|NCT01652495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102526904|NCT01652495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526905|NCT01652495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102526906|NCT01652495|Glucocorticoids|glucocorticoids|mesh-ancestor
102526907|NCT01652495|Hormones|hormones|mesh-ancestor
102526908|NCT01652495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102526909|NCT01652495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102526910|NCT01652495|Protective Agents|protective agents|mesh-ancestor
102526911|NCT01652495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102526912|NCT01652495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102526913|NCT01652495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102526914|NCT01652495|Immunologic Factors|immunologic factors|mesh-ancestor
102526915|NCT01652495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102526916|NCT01652495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526917|NCT00935792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102526918|NCT00935792|Alemtuzumab|alemtuzumab|mesh-list
102526919|NCT00935792|Everolimus|everolimus|mesh-list
102526920|NCT00935792|Antibodies|antibodies|mesh-list
102526921|NCT00935792|Immunoglobulins|immunoglobulins|mesh-list
102526922|NCT00935792|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102526923|NCT00935792|Immunologic Factors|immunologic factors|mesh-ancestor
102526924|NCT00935792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526925|NCT00935792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102526926|NCT00935792|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102526927|NCT00935792|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102526928|NCT00935792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102526929|NCT00935792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526930|NCT00935792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102526931|NCT01699607|Amphetamine|amphetamine|mesh-list
102526932|NCT01699607|Dextroamphetamine|dextroamphetamine|mesh-list
102526933|NCT01699607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102526934|NCT01699607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526935|NCT01699607|Sympathomimetics|sympathomimetics|mesh-ancestor
102526936|NCT01699607|Autonomic Agents|autonomic agents|mesh-ancestor
102526937|NCT01699607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102526938|NCT01699607|Dopamine Agents|dopamine agents|mesh-ancestor
102526939|NCT01699607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102526940|NCT01699607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526941|NCT01699607|Adrenergic Agents|adrenergic agents|mesh-ancestor
102526942|NCT01699607|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102526943|NCT01699607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102526944|NCT01699607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102526945|NCT01699607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102526946|NCT04355468|Analgesics, Opioid|analgesics, opioid|mesh-list
102526947|NCT04355468|Anesthetics|anesthetics|mesh-list
102526948|NCT04355468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102526949|NCT04355468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526950|NCT04355468|Narcotics|narcotics|mesh-ancestor
102526951|NCT04355468|Analgesics|analgesics|mesh-ancestor
102526952|NCT04355468|Sensory System Agents|sensory system agents|mesh-ancestor
102526953|NCT04355468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102526954|NCT01653509|Acyclovir|acyclovir|mesh-list
102526955|NCT01653509|Antiviral Agents|antiviral agents|mesh-ancestor
102526956|NCT01653509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102526957|NCT01614509|Triamcinolone|triamcinolone|mesh-list
102526958|NCT01614509|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102526959|NCT01614509|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102526960|NCT01614509|Bevacizumab|bevacizumab|mesh-list
102526961|NCT01614509|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102526962|NCT01614509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102526963|NCT01614509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102526964|NCT01614509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102526965|NCT01614509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102526966|NCT01614509|Growth Substances|growth substances|mesh-ancestor
102526967|NCT01614509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526968|NCT01614509|Growth Inhibitors|growth inhibitors|mesh-ancestor
102526969|NCT01614509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102526970|NCT01614509|Glucocorticoids|glucocorticoids|mesh-ancestor
102526971|NCT01614509|Hormones|hormones|mesh-ancestor
102526972|NCT01614509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102526973|NCT01614509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102526974|NCT01614509|Immunologic Factors|immunologic factors|mesh-ancestor
102526975|NCT01614509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102526976|NCT01614509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526977|NCT01614743|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102526978|NCT01614743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102526979|NCT01614743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102526980|NCT01614743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526981|NCT01614743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102526982|NCT01614743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102526983|NCT01614743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526984|NCT01614743|Cholinergic Agents|cholinergic agents|mesh-ancestor
102526985|NCT01614743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102526986|NCT00943202|Vaccines|vaccines|mesh-list
102526987|NCT00943202|Immunologic Factors|immunologic factors|mesh-ancestor
102526988|NCT00943202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102526989|NCT01654445|Tenecteplase|tenecteplase|mesh-list
102526990|NCT01654445|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102526991|NCT01654445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102526992|NCT01654445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102526993|NCT01703039|Riluzole|riluzole|mesh-list
102526994|NCT01703039|Sertraline|sertraline|mesh-list
102526995|NCT01703039|Antidepressive Agents|antidepressive agents|mesh-ancestor
102526996|NCT01703039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102526997|NCT01703039|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102526998|NCT01703039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102526999|NCT01703039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102527000|NCT01703039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527001|NCT01703039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102527002|NCT01703039|Serotonin Agents|serotonin agents|mesh-ancestor
102527003|NCT01703039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527004|NCT01703039|Anticonvulsants|anticonvulsants|mesh-ancestor
102527005|NCT01703039|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102527006|NCT01703039|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102527007|NCT01703039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102527008|NCT01703039|Protective Agents|protective agents|mesh-ancestor
102527009|NCT01656629|Vitamin D|vitamin d|mesh-list
102527010|NCT01656629|Alendronate|alendronate|mesh-list
102527011|NCT01656629|Teriparatide|teriparatide|mesh-list
102527012|NCT01656629|Calcium|calcium|mesh-list
102527013|NCT01656629|Vitamins|vitamins|mesh-ancestor
102527014|NCT01656629|Micronutrients|micronutrients|mesh-ancestor
102527015|NCT01656629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527016|NCT01656629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102527017|NCT01656629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102527018|NCT01703507|Ipilimumab|ipilimumab|mesh-list
102527019|NCT01703507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102527020|NCT01703507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102527021|NCT01703507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102527022|NCT01703507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527023|NCT02158520|Paclitaxel|paclitaxel|mesh-list
102527024|NCT02158520|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102527025|NCT02158520|Bevacizumab|bevacizumab|mesh-list
102527026|NCT02158520|Ipilimumab|ipilimumab|mesh-list
102527027|NCT02158520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102527028|NCT02158520|Endothelial Growth Factors|endothelial growth factors|mesh-list
102527029|NCT02158520|Antibodies|antibodies|mesh-list
102527030|NCT02158520|Immunoglobulins|immunoglobulins|mesh-list
102527031|NCT02158520|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102527032|NCT02158520|Immunoglobulin G|immunoglobulin g|mesh-list
102527033|NCT02158520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102527034|NCT02158520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102527035|NCT02158520|Tubulin Modulators|tubulin modulators|mesh-ancestor
102527036|NCT02158520|Antimitotic Agents|antimitotic agents|mesh-ancestor
102527037|NCT02158520|Mitosis Modulators|mitosis modulators|mesh-ancestor
102527038|NCT02158520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527039|NCT02158520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102527040|NCT02158520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102527041|NCT02158520|Growth Substances|growth substances|mesh-ancestor
102527042|NCT02158520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527043|NCT02158520|Growth Inhibitors|growth inhibitors|mesh-ancestor
102527044|NCT02158520|Immunologic Factors|immunologic factors|mesh-ancestor
102527045|NCT02158520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102527046|NCT01704521|Ribavirin|ribavirin|mesh-list
102527047|NCT01704521|Antimetabolites|antimetabolites|mesh-ancestor
102527048|NCT01704521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527049|NCT01704521|Antiviral Agents|antiviral agents|mesh-ancestor
102527050|NCT01704521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102338575|NCT02735902|Micronutrients|micronutrients|mesh-ancestor
102527051|NCT01617083|Azithromycin|azithromycin|mesh-list
102527052|NCT01617083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102527053|NCT01617083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102527054|NCT04359524|Vitamin D|vitamin d|mesh-list
102527055|NCT04359524|Cholecalciferol|cholecalciferol|mesh-list
102527056|NCT04359524|Vitamins|vitamins|mesh-ancestor
102527057|NCT04359524|Micronutrients|micronutrients|mesh-ancestor
102527058|NCT04359524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527059|NCT04359524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102527060|NCT04359524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102527061|NCT01658657|Metoprolol|metoprolol|mesh-list
102527062|NCT01658657|Amlodipine|amlodipine|mesh-list
102527063|NCT01658657|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102527064|NCT01658657|Lisinopril|lisinopril|mesh-list
102527065|NCT01658657|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
102527066|NCT01658657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102527067|NCT01658657|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102527068|NCT01658657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102527069|NCT01658657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527070|NCT01658657|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102527071|NCT01658657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527072|NCT01658657|Vasodilator Agents|vasodilator agents|mesh-ancestor
102527073|NCT01658657|Diuretics|diuretics|mesh-ancestor
102527074|NCT01658657|Natriuretic Agents|natriuretic agents|mesh-ancestor
102527075|NCT01658657|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102527076|NCT01658657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102527077|NCT01658657|Sympatholytics|sympatholytics|mesh-ancestor
102527078|NCT01658657|Autonomic Agents|autonomic agents|mesh-ancestor
102527079|NCT01658657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102527080|NCT01658657|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102527081|NCT01658657|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102527082|NCT01658657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102527083|NCT01658657|Adrenergic Agents|adrenergic agents|mesh-ancestor
102527084|NCT01658657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102527085|NCT01658657|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102527086|NCT01658657|Protease Inhibitors|protease inhibitors|mesh-ancestor
102527087|NCT01658657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102527088|NCT01658657|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102527089|NCT01658657|Protective Agents|protective agents|mesh-ancestor
102527090|NCT04359212|Heparin|heparin|mesh-list
102527091|NCT04359212|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102527092|NCT04359212|Tinzaparin|tinzaparin|mesh-list
102527093|NCT04359212|Dalteparin|dalteparin|mesh-list
102527094|NCT04359212|PENTA|penta|mesh-list
102527095|NCT04359212|Fondaparinux|fondaparinux|mesh-list
102527096|NCT04359212|Anticoagulants|anticoagulants|mesh-ancestor
102527097|NCT04359212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102527098|NCT04359212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102527099|NCT04359212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527100|NCT04359212|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102527101|NCT04359212|Antithrombins|antithrombins|mesh-ancestor
102527102|NCT04359212|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102527103|NCT04359212|Protease Inhibitors|protease inhibitors|mesh-ancestor
102527104|NCT04359212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102527105|NCT01620047|Fentanyl|fentanyl|mesh-list
102527106|NCT01620047|Ropivacaine|ropivacaine|mesh-list
102527107|NCT01620047|Anesthetics, Local|anesthetics, local|mesh-ancestor
102527108|NCT01620047|Anesthetics|anesthetics|mesh-ancestor
102527109|NCT01620047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102527110|NCT01620047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527111|NCT01620047|Sensory System Agents|sensory system agents|mesh-ancestor
102527112|NCT01620047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102527113|NCT01620047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102527114|NCT01620047|Narcotics|narcotics|mesh-ancestor
102527115|NCT01620047|Analgesics|analgesics|mesh-ancestor
102527116|NCT01620047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102527117|NCT01620047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102527118|NCT01620047|Anesthetics, General|anesthetics, general|mesh-ancestor
102527119|NCT00944450|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102527120|NCT00944450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102527121|NCT00944450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527122|NCT00944450|Incretins|incretins|mesh-ancestor
102527123|NCT00944450|Hormones|hormones|mesh-ancestor
102527124|NCT00944450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102527125|NCT00944450|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102338659|NCT01455922|Exenatide|exenatide|mesh-list
102527126|NCT00944450|Protease Inhibitors|protease inhibitors|mesh-ancestor
102527127|NCT00944450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102527128|NCT00944450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527129|NCT03875144|Cisplatin|cisplatin|mesh-list
102527130|NCT03875144|Doxorubicin|doxorubicin|mesh-list
102527131|NCT03875144|Pemetrexed|pemetrexed|mesh-list
102527132|NCT03875144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102527133|NCT03875144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102527134|NCT03875144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102527135|NCT03875144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102527136|NCT03875144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102527137|NCT03875144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527138|NCT03875144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102527139|NCT03875144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102527140|NCT01661621|Doxazosin|doxazosin|mesh-list
102527141|NCT01661621|Tolterodine Tartrate|tolterodine tartrate|mesh-list
102527142|NCT01661621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102527143|NCT01661621|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102527144|NCT01661621|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102527145|NCT01661621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102527146|NCT01661621|Adrenergic Agents|adrenergic agents|mesh-ancestor
102527147|NCT01661621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102527148|NCT01661621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527149|NCT01661621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527150|NCT01661621|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102527151|NCT01661621|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102527152|NCT01661621|Cholinergic Agents|cholinergic agents|mesh-ancestor
102527153|NCT01661621|Urological Agents|urological agents|mesh-ancestor
102527154|NCT01620593|Metformin|metformin|mesh-list
102527155|NCT01620593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102527156|NCT01620593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527157|NCT00939536|Zolpidem|zolpidem|mesh-list
102527158|NCT00939536|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102527159|NCT00939536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102527160|NCT00939536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102527161|NCT00939536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527162|NCT00939536|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102527163|NCT00939536|GABA Agonists|gaba agonists|mesh-ancestor
102527164|NCT00939536|GABA Agents|gaba agents|mesh-ancestor
102527165|NCT00939536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102527166|NCT00939536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527167|NCT02982122|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
102527168|NCT04358354|Fluorouracil|fluorouracil|mesh-list
102527169|NCT04358354|Oxaliplatin|oxaliplatin|mesh-list
102527170|NCT04358354|Irinotecan|irinotecan|mesh-list
102527171|NCT04358354|Antimetabolites|antimetabolites|mesh-ancestor
102527172|NCT04358354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527173|NCT04358354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102527174|NCT04358354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102527175|NCT04358354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102527176|NCT04358354|Immunologic Factors|immunologic factors|mesh-ancestor
102527177|NCT04358354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527178|NCT04358354|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102527179|NCT04358354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102527180|NCT04358354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102527181|NCT03516968|Cholecalciferol|cholecalciferol|mesh-list
102527182|NCT03516968|Vitamin D|vitamin d|mesh-list
102527183|NCT03516968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102527184|NCT03516968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527185|NCT03516968|Vitamins|vitamins|mesh-ancestor
102527186|NCT03516968|Micronutrients|micronutrients|mesh-ancestor
102527187|NCT03516968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102527188|NCT04355156|Axitinib|axitinib|mesh-list
102527189|NCT04355156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102527190|NCT04355156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102527191|NCT04355156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102527192|NCT04355156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527193|NCT03320018|Minocycline|minocycline|mesh-list
102527194|NCT03320018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102527195|NCT03320018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102527196|NCT03032666|Sofosbuvir|sofosbuvir|mesh-list
102527197|NCT03032666|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102527198|NCT03032666|Velpatasvir|velpatasvir|mesh-list
102527199|NCT03032666|Antiviral Agents|antiviral agents|mesh-ancestor
102527200|NCT03032666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102527201|NCT04354376|Telmisartan|telmisartan|mesh-list
102527202|NCT04354376|1,4-dihydropyridine|1,4-dihydropyridine|mesh-list
102527203|NCT04354376|Diuretics|diuretics|mesh-list
102527204|NCT04354376|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
102527205|NCT04354376|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
102527206|NCT04354376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102527207|NCT04354376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102527208|NCT04354376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102527209|NCT04354376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527210|NCT04354376|Natriuretic Agents|natriuretic agents|mesh-ancestor
102527211|NCT04354376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527212|NCT04354376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102527213|NCT04354376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102527214|NCT04354376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102527215|NCT02777372|Sertraline|sertraline|mesh-list
102527216|NCT02777372|Antidepressive Agents|antidepressive agents|mesh-ancestor
102527217|NCT02777372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102527218|NCT02777372|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102527219|NCT02777372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102527220|NCT02777372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102527221|NCT02777372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527222|NCT02777372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102527223|NCT02777372|Serotonin Agents|serotonin agents|mesh-ancestor
102527224|NCT02777372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527225|NCT03032042|Azithromycin|azithromycin|mesh-list
102527226|NCT03032042|Albendazole|albendazole|mesh-list
102527227|NCT03032042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102527228|NCT03032042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102527229|NCT03032042|Anthelmintics|anthelmintics|mesh-ancestor
102527230|NCT03032042|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102527231|NCT03032042|Anticestodal Agents|anticestodal agents|mesh-ancestor
102527232|NCT03032042|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102527233|NCT03032042|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102527234|NCT03032042|Tubulin Modulators|tubulin modulators|mesh-ancestor
102527235|NCT03032042|Antimitotic Agents|antimitotic agents|mesh-ancestor
102527236|NCT03032042|Mitosis Modulators|mitosis modulators|mesh-ancestor
102527237|NCT03032042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527238|NCT03032042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102527239|NCT01623323|Fluticasone|fluticasone|mesh-list
102527241|NCT01623323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102527242|NCT01623323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102527243|NCT01623323|Autonomic Agents|autonomic agents|mesh-ancestor
102527244|NCT01623323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102527245|NCT01623323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527246|NCT01623323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102527247|NCT01623323|Respiratory System Agents|respiratory system agents|mesh-ancestor
102527248|NCT01623323|Dermatologic Agents|dermatologic agents|mesh-ancestor
102527249|NCT01623323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102527250|NCT01709747|Hydromorphone|hydromorphone|mesh-list
102527251|NCT01709747|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102527252|NCT01709747|Narcotics|narcotics|mesh-ancestor
102527253|NCT01709747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102527254|NCT01709747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527255|NCT01709747|Analgesics|analgesics|mesh-ancestor
102527256|NCT01709747|Sensory System Agents|sensory system agents|mesh-ancestor
102527257|NCT01709747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102527258|NCT03031808|Lidocaine|lidocaine|mesh-list
102527259|NCT03031808|Rocuronium|rocuronium|mesh-list
102527260|NCT03031808|Anesthetics, Local|anesthetics, local|mesh-ancestor
102527261|NCT03031808|Anesthetics|anesthetics|mesh-ancestor
102527262|NCT03031808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102527263|NCT03031808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527264|NCT03031808|Sensory System Agents|sensory system agents|mesh-ancestor
102527265|NCT03031808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102527266|NCT03031808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102527267|NCT03031808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102527268|NCT03031808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102527269|NCT03031808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102527270|NCT03031808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527271|NCT03031808|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102527272|NCT03031808|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102527273|NCT03031808|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102527274|NCT01662791|Rifaximin|rifaximin|mesh-list
102527275|NCT01662791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102527276|NCT01662791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102527277|NCT01662791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102527278|NCT03035084|Vitamin D|vitamin d|mesh-list
102527279|NCT03035084|Ergocalciferols|ergocalciferols|mesh-list
102527280|NCT03035084|Cholecalciferol|cholecalciferol|mesh-list
102527281|NCT03035084|Vitamins|vitamins|mesh-list
102527282|NCT03035084|Micronutrients|micronutrients|mesh-ancestor
102527283|NCT03035084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527284|NCT03035084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102527285|NCT03035084|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102527286|NCT03034850|Doxorubicin|doxorubicin|mesh-list
102527287|NCT03034850|Fluorouracil|fluorouracil|mesh-list
102527288|NCT03034850|Ifosfamide|ifosfamide|mesh-list
102527289|NCT03034850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102527290|NCT03034850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102527291|NCT03034850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102527292|NCT03034850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102527293|NCT03034850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102527294|NCT03034850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527295|NCT03034850|Antimetabolites|antimetabolites|mesh-ancestor
102527296|NCT03034850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102527297|NCT03034850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102527298|NCT03034850|Immunologic Factors|immunologic factors|mesh-ancestor
102527299|NCT03034850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527300|NCT03034850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102527301|NCT03034850|Alkylating Agents|alkylating agents|mesh-ancestor
102527302|NCT01663259|Cetuximab|cetuximab|mesh-list
102527303|NCT01663259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102527304|NCT01663259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102527305|NCT03031184|Mirtazapine|mirtazapine|mesh-list
102527306|NCT03031184|Antidepressive Agents|antidepressive agents|mesh-ancestor
102527307|NCT03031184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102527308|NCT03031184|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102527309|NCT03031184|Histamine Antagonists|histamine antagonists|mesh-ancestor
102527310|NCT03031184|Histamine Agents|histamine agents|mesh-ancestor
102527311|NCT03031184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102527312|NCT03031184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527313|NCT03031184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527314|NCT03031184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102527315|NCT03031184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102527316|NCT03031184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102527317|NCT03031184|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102527318|NCT03031184|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102527319|NCT03031184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102527320|NCT03031184|Adrenergic Agents|adrenergic agents|mesh-ancestor
102527321|NCT03031184|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102527322|NCT03031184|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102527323|NCT03031184|Serotonin Agents|serotonin agents|mesh-ancestor
102527324|NCT03031184|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102527325|NCT02238977|Bupropion|bupropion|mesh-list
102527326|NCT02238977|Fluoxetine|fluoxetine|mesh-list
102527327|NCT02238977|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102527328|NCT02238977|Antidepressive Agents|antidepressive agents|mesh-ancestor
102527329|NCT02238977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102527330|NCT02238977|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102527331|NCT02238977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102527332|NCT02238977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102527333|NCT02238977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527334|NCT02238977|Dopamine Agents|dopamine agents|mesh-ancestor
102527335|NCT02238977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102527336|NCT02238977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527337|NCT02238977|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102527338|NCT02238977|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102527339|NCT02238977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102527340|NCT02238977|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102003643|NCT01176851|Glycopyrrolate|glycopyrrolate|mesh-list
102527341|NCT02238977|Serotonin Agents|serotonin agents|mesh-ancestor
102527342|NCT03034382|Lidocaine|lidocaine|mesh-list
102527343|NCT03034382|Epinephrine|epinephrine|mesh-list
102527344|NCT03034382|Morphine|morphine|mesh-list
102527345|NCT03034382|Nalbuphine|nalbuphine|mesh-list
102527346|NCT03034382|Bupivacaine|bupivacaine|mesh-list
102527347|NCT03034382|Anesthetics, Local|anesthetics, local|mesh-ancestor
102527348|NCT03034382|Anesthetics|anesthetics|mesh-ancestor
102527349|NCT03034382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102527350|NCT03034382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527351|NCT03034382|Sensory System Agents|sensory system agents|mesh-ancestor
102527352|NCT03034382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102527353|NCT03034382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102527354|NCT03034382|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102527355|NCT03034382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102527356|NCT03034382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102527357|NCT03034382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527358|NCT03034382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102527359|NCT03034382|Narcotics|narcotics|mesh-ancestor
102527360|NCT03034382|Analgesics|analgesics|mesh-ancestor
102527361|NCT03034382|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102527362|NCT03034382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102527363|NCT03034382|Adrenergic Agents|adrenergic agents|mesh-ancestor
102527364|NCT03034382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102527365|NCT03034382|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102527366|NCT03034382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102527367|NCT03034382|Autonomic Agents|autonomic agents|mesh-ancestor
102527368|NCT03034382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102527369|NCT03034382|Respiratory System Agents|respiratory system agents|mesh-ancestor
102527370|NCT03034382|Mydriatics|mydriatics|mesh-ancestor
102527371|NCT03034382|Sympathomimetics|sympathomimetics|mesh-ancestor
102527372|NCT03034382|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102527373|NCT01664741|Nicotine|nicotine|mesh-list
102527374|NCT01664741|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102527375|NCT01664741|Autonomic Agents|autonomic agents|mesh-ancestor
102527376|NCT01664741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102527377|NCT01664741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527378|NCT01664741|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102527379|NCT01664741|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102527380|NCT01664741|Cholinergic Agents|cholinergic agents|mesh-ancestor
102527381|NCT01664741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102527382|NCT01664741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527383|NCT02062346|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
102527384|NCT02062346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102527385|NCT02062346|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102527386|NCT02062346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527387|NCT03030950|Dexmedetomidine|dexmedetomidine|mesh-list
102527388|NCT03030950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102527389|NCT03030950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102527390|NCT03030950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527391|NCT03030950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102527392|NCT03030950|Analgesics|analgesics|mesh-ancestor
102527393|NCT03030950|Sensory System Agents|sensory system agents|mesh-ancestor
102527394|NCT03030950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102527395|NCT03030950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102527396|NCT03030950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102527397|NCT03030950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102527398|NCT03030950|Adrenergic Agents|adrenergic agents|mesh-ancestor
102527399|NCT03030950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102527400|NCT03030950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527401|NCT02022644|Irinotecan|irinotecan|mesh-list
102527402|NCT02022644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102527403|NCT02022644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102527404|NCT02022644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102527405|NCT02022644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527406|NCT02022644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102527407|NCT01664897|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102527408|NCT01664897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102527409|NCT01664897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102527410|NCT01664897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102527411|NCT01664897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527412|NCT03030716|Proanthocyanidin|proanthocyanidin|mesh-list
102527413|NCT03030716|Grape Seed Extract|grape seed extract|mesh-list
102527414|NCT03030716|Procyanidin|procyanidin|mesh-list
102527415|NCT03030716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102527416|NCT03030716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102527417|NCT03030716|Antioxidants|antioxidants|mesh-ancestor
102527418|NCT03030716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527419|NCT03030716|Protective Agents|protective agents|mesh-ancestor
102527420|NCT03030716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527421|NCT03030716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102527422|NCT03030716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102527423|NCT03030716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102338956|NCT02773732|Etoposide|etoposide|mesh-list
102527424|NCT04353362|Amoxicillin|amoxicillin|mesh-list
102527426|NCT04353362|Ofloxacin|ofloxacin|mesh-list
102527427|NCT04353362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102527428|NCT04353362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102527429|NCT04353362|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102527430|NCT04353362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102527431|NCT04353362|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102527432|NCT04353362|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102527433|NCT04353362|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102527434|NCT04353362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102527435|NCT04353362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527436|NCT04353362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102527437|NCT04353362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102527438|NCT04353362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102527439|NCT00946478|Pimecrolimus|pimecrolimus|mesh-list
102527440|NCT00946478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102527441|NCT00946478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102527442|NCT00946478|Analgesics|analgesics|mesh-ancestor
102527443|NCT00946478|Sensory System Agents|sensory system agents|mesh-ancestor
102527444|NCT00946478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102527445|NCT00946478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527446|NCT00946478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102527447|NCT00946478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102527448|NCT00946478|Dermatologic Agents|dermatologic agents|mesh-ancestor
102527449|NCT00946478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102527450|NCT00946478|Immunologic Factors|immunologic factors|mesh-ancestor
102527451|NCT00946478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102527452|NCT00946478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102527453|NCT00946478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527454|NCT02249741|Ibandronic Acid|ibandronic acid|mesh-list
102527455|NCT02249741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102527456|NCT02249741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527457|NCT03033836|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102527458|NCT03033836|Dolutegravir|dolutegravir|mesh-list
102527459|NCT03033836|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102527460|NCT03033836|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102527461|NCT03033836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102527462|NCT03033836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527463|NCT03033836|Antiviral Agents|antiviral agents|mesh-ancestor
102527464|NCT03033836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102527465|NCT03033836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102527466|NCT03033836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102527467|NCT03033836|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102527468|NCT03033836|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102527469|NCT03030560|Lidocaine|lidocaine|mesh-list
102527470|NCT03030560|Anesthetics, Local|anesthetics, local|mesh-ancestor
102527471|NCT03030560|Anesthetics|anesthetics|mesh-ancestor
102527472|NCT03030560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102527473|NCT03030560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527474|NCT03030560|Sensory System Agents|sensory system agents|mesh-ancestor
102527475|NCT03030560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102527476|NCT03030560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102527477|NCT03030560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102527478|NCT03030560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102527479|NCT03030560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102527480|NCT03030560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527481|NCT03033368|Rilpivirine|rilpivirine|mesh-list
102527482|NCT03033368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102527483|NCT03033368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102527484|NCT03033368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102527485|NCT03033368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527486|NCT03033368|Antiviral Agents|antiviral agents|mesh-ancestor
102527487|NCT03033368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102527488|NCT03033368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102527489|NCT03033368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102527490|NCT03031262|Cytarabine|cytarabine|mesh-list
102527491|NCT03031262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102527492|NCT03031262|Antimetabolites|antimetabolites|mesh-ancestor
102527493|NCT03031262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527494|NCT03031262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102527495|NCT03031262|Antiviral Agents|antiviral agents|mesh-ancestor
102527496|NCT03031262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102527497|NCT03031262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102527498|NCT03031262|Immunologic Factors|immunologic factors|mesh-ancestor
102527499|NCT03031262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527500|NCT03032978|Calcium, Dietary|calcium, dietary|mesh-list
102527501|NCT03032978|Calcium|calcium|mesh-list
102527502|NCT03032978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102527503|NCT03032978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527504|NCT03032978|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102527505|NCT03030248|Vancomycin|vancomycin|mesh-list
102527506|NCT03030248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102527507|NCT03030248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102527508|NCT03028532|Clomiphene|clomiphene|mesh-list
102527509|NCT03028532|Enclomiphene|enclomiphene|mesh-list
102527510|NCT03028532|Zuclomiphene|zuclomiphene|mesh-list
102527511|NCT03028532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102527512|NCT03028532|Hormone Antagonists|hormone antagonists|mesh-ancestor
102527513|NCT03028532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102527514|NCT03028532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527515|NCT03028532|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102527516|NCT03028532|Fertility Agents|fertility agents|mesh-ancestor
102527517|NCT03028532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102527518|NCT03028532|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102527519|NCT03028532|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102527520|NCT03017768|Tryptophan|tryptophan|mesh-list
102527521|NCT03017768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102527522|NCT03017768|Antidepressive Agents|antidepressive agents|mesh-ancestor
102527523|NCT03017768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102527524|NCT01006538|Ranibizumab|ranibizumab|mesh-list
102527525|NCT01006538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102527526|NCT01006538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102527527|NCT01006538|Growth Substances|growth substances|mesh-ancestor
102527528|NCT01006538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527529|NCT01006538|Growth Inhibitors|growth inhibitors|mesh-ancestor
102527530|NCT01006538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102527531|NCT03017222|Ondansetron|ondansetron|mesh-list
102527532|NCT03017222|Ramosetron|ramosetron|mesh-list
102527533|NCT03017222|Antiemetics|antiemetics|mesh-ancestor
102527534|NCT03017222|Autonomic Agents|autonomic agents|mesh-ancestor
102527535|NCT03017222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102527536|NCT03017222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527537|NCT03017222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102527538|NCT03017222|Antipruritics|antipruritics|mesh-ancestor
102527539|NCT03017222|Dermatologic Agents|dermatologic agents|mesh-ancestor
102527540|NCT03017222|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102527541|NCT03017222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102527542|NCT03017222|Serotonin Agents|serotonin agents|mesh-ancestor
102527543|NCT03017222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102527544|NCT03017222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527545|NCT03025724|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102527546|NCT03025724|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102527547|NCT03025724|Dermatologic Agents|dermatologic agents|mesh-ancestor
102527548|NCT01010282|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102527549|NCT01010282|Lubricant Eye Drops|lubricant eye drops|mesh-list
102527550|NCT01010282|Glycerol|glycerol|mesh-list
102527551|NCT01010282|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102527552|NCT01010282|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102527553|NCT01010282|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102527554|NCT01010282|Protective Agents|protective agents|mesh-ancestor
102527555|NCT01010282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527556|NCT01010282|Laxatives|laxatives|mesh-ancestor
102527557|NCT01010282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102527558|NCT03016988|Cytarabine|cytarabine|mesh-list
102527559|NCT03016988|Fludarabine|fludarabine|mesh-list
102527560|NCT03016988|Bortezomib|bortezomib|mesh-list
102527561|NCT03016988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102527562|NCT03016988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102527563|NCT03016988|Antimetabolites|antimetabolites|mesh-ancestor
102527564|NCT03016988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527565|NCT03016988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102527566|NCT03016988|Immunologic Factors|immunologic factors|mesh-ancestor
102527567|NCT03016988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527568|NCT03016988|Antiviral Agents|antiviral agents|mesh-ancestor
102527569|NCT03016988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102527570|NCT03017066|Anesthetics|anesthetics|mesh-list
102527571|NCT03017066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102527572|NCT03017066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527573|NCT03016832|Irbesartan|irbesartan|mesh-list
102527574|NCT03016832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102527575|NCT03016832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102527576|NCT03016832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102527577|NCT03016832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527579|NCT00955916|Imatinib Mesylate|imatinib mesylate|mesh-list
102527580|NCT00955916|Cladribine|cladribine|mesh-list
102527581|NCT00955916|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102527582|NCT00955916|Antimetabolites|antimetabolites|mesh-ancestor
102527583|NCT00955916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527584|NCT00955916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102527585|NCT00955916|Antiviral Agents|antiviral agents|mesh-ancestor
102527586|NCT00955916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102527587|NCT00955916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102527588|NCT00955916|Immunologic Factors|immunologic factors|mesh-ancestor
102527589|NCT00955916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527590|NCT00955916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102527591|NCT00955916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102527592|NCT01668017|Niacinamide|niacinamide|mesh-list
102527593|NCT01668017|Vitamin B Complex|vitamin b complex|mesh-ancestor
102527594|NCT01668017|Vitamins|vitamins|mesh-ancestor
102527595|NCT01668017|Micronutrients|micronutrients|mesh-ancestor
102527596|NCT01668017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527597|NCT01010984|Doxorubicin|doxorubicin|mesh-list
102527598|NCT01010984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102527599|NCT01010984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102527600|NCT01010984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102527601|NCT01010984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102527602|NCT01010984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102527603|NCT01010984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527604|NCT05214599|Budesonide|budesonide|mesh-list
102527605|NCT05214599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102527606|NCT05214599|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102527607|NCT05214599|Autonomic Agents|autonomic agents|mesh-ancestor
102527608|NCT05214599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102527609|NCT05214599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527610|NCT05214599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102527611|NCT05214599|Respiratory System Agents|respiratory system agents|mesh-ancestor
102527612|NCT05214599|Glucocorticoids|glucocorticoids|mesh-ancestor
102527613|NCT05214599|Hormones|hormones|mesh-ancestor
102527614|NCT05214599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102527615|NCT01011218|Modafinil|modafinil|mesh-list
102527616|NCT01011218|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102527617|NCT01011218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527618|NCT01011218|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102527619|NCT01011218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102003918|NCT01181063|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102527620|NCT01011218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102527621|NCT01011218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527622|NCT03023306|Antiemetics|antiemetics|mesh-list
102527623|NCT03023306|Autonomic Agents|autonomic agents|mesh-ancestor
102527624|NCT03023306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102527625|NCT03023306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527626|NCT03023306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102527627|NCT05710367|Dapagliflozin|dapagliflozin|mesh-list
102527628|NCT05710367|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102527629|NCT05710367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527630|NCT05710367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102527631|NCT05710367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527632|NCT00957242|Warfarin|warfarin|mesh-list
102527633|NCT00957242|Anticoagulants|anticoagulants|mesh-ancestor
102527634|NCT01014728|Propofol|propofol|mesh-list
102527635|NCT01014728|Sevoflurane|sevoflurane|mesh-list
102527636|NCT01014728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102527637|NCT01014728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102527638|NCT01014728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527639|NCT01014728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102527640|NCT01014728|Anesthetics, General|anesthetics, general|mesh-ancestor
102527641|NCT01014728|Anesthetics|anesthetics|mesh-ancestor
102527642|NCT01014728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102527643|NCT01014728|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102527644|NCT01015586|Lamotrigine|lamotrigine|mesh-list
102527645|NCT01015586|Anticonvulsants|anticonvulsants|mesh-ancestor
102527646|NCT01015586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102527647|NCT01015586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102527648|NCT01015586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527649|NCT01015586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102527650|NCT01015586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527651|NCT01015586|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102527652|NCT01015586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102527653|NCT01015586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102527654|NCT01015586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102527655|NCT01015586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102527656|NCT01680653|Glucagon|glucagon|mesh-list
102527657|NCT01680653|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102527658|NCT01680653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102527659|NCT01680653|Hormones|hormones|mesh-ancestor
102527660|NCT01680653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102527661|NCT01680653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527662|NCT01680653|Incretins|incretins|mesh-ancestor
102527663|NCT02448810|Fluorouracil|fluorouracil|mesh-list
102527664|NCT02448810|Panitumumab|panitumumab|mesh-list
102527665|NCT02448810|Antimetabolites|antimetabolites|mesh-ancestor
102527666|NCT02448810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527667|NCT02448810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102527668|NCT02448810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102527669|NCT02448810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102527670|NCT02448810|Immunologic Factors|immunologic factors|mesh-ancestor
102527671|NCT02448810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527672|NCT02448810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102527673|NCT01680887|Varenicline|varenicline|mesh-list
102527674|NCT01680887|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102527675|NCT01680887|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102527676|NCT01680887|Cholinergic Agents|cholinergic agents|mesh-ancestor
102527677|NCT01680887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102527678|NCT01680887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527679|NCT01680887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527680|NCT01016678|Naproxen|naproxen|mesh-list
102527681|NCT01016678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102527682|NCT01016678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102527683|NCT01016678|Analgesics|analgesics|mesh-ancestor
102527684|NCT01016678|Sensory System Agents|sensory system agents|mesh-ancestor
102527685|NCT01016678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102527686|NCT01016678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527687|NCT01016678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102527688|NCT01016678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102527689|NCT01016678|Gout Suppressants|gout suppressants|mesh-ancestor
102527690|NCT01016678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102527691|NCT01016678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102527692|NCT01016678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527693|NCT02457546|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102527694|NCT02457546|Hemostatics|hemostatics|mesh-ancestor
102527695|NCT02457546|Coagulants|coagulants|mesh-ancestor
102527696|NCT01016834|Sumatriptan|sumatriptan|mesh-list
102527697|NCT01016834|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102527698|NCT01016834|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102527699|NCT01016834|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102527700|NCT01016834|Serotonin Agents|serotonin agents|mesh-ancestor
102527701|NCT01016834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102527702|NCT01016834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527703|NCT01016834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527704|NCT04923594|Mazindol|mazindol|mesh-list
102527705|NCT04923594|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102527706|NCT04923594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527707|NCT04923594|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102527708|NCT04923594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102527709|NCT04923594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102527710|NCT04923594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527711|NCT04923594|Adrenergic Agents|adrenergic agents|mesh-ancestor
102527712|NCT04923594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102527713|NCT04923594|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102527714|NCT04923594|Dopamine Agents|dopamine agents|mesh-ancestor
102527715|NCT00961532|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
102527716|NCT00961532|Hemostatics|hemostatics|mesh-ancestor
102527717|NCT00961532|Coagulants|coagulants|mesh-ancestor
102527718|NCT00961532|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102527719|NCT00961532|Natriuretic Agents|natriuretic agents|mesh-ancestor
102527720|NCT00961532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527721|NCT02447718|Vaccines|vaccines|mesh-list
102527722|NCT02447718|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102527723|NCT02447718|Immunologic Factors|immunologic factors|mesh-ancestor
102527724|NCT02447718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527725|NCT03016442|Dinoprostone|dinoprostone|mesh-list
102527726|NCT03016442|Oxytocics|oxytocics|mesh-ancestor
102527727|NCT03016442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102527728|NCT03016442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527729|NCT01682135|Ramucirumab|ramucirumab|mesh-list
102527730|NCT01682135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102527731|NCT02249897|Cholestyramine Resin|cholestyramine resin|mesh-list
102527732|NCT02249897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102527733|NCT02249897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102527734|NCT02249897|Antimetabolites|antimetabolites|mesh-ancestor
102527735|NCT02249897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527736|NCT02249897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102527737|NCT00963872|Cyclophosphamide|cyclophosphamide|mesh-list
102527738|NCT00963872|Fludarabine|fludarabine|mesh-list
102527739|NCT00963872|Fludarabine phosphate|fludarabine phosphate|mesh-list
102527740|NCT00963872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102527741|NCT00963872|Immunologic Factors|immunologic factors|mesh-ancestor
102527742|NCT00963872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527743|NCT00963872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102527744|NCT00963872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102527745|NCT00963872|Alkylating Agents|alkylating agents|mesh-ancestor
102527746|NCT00963872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527747|NCT00963872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102527748|NCT00963872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102527749|NCT00963872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102527750|NCT00963872|Antimetabolites|antimetabolites|mesh-ancestor
102527751|NCT00964496|Thalidomide|thalidomide|mesh-list
102527752|NCT00964496|Ferrous succinate|ferrous succinate|mesh-list
102527753|NCT00964496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102527754|NCT00964496|Immunologic Factors|immunologic factors|mesh-ancestor
102527755|NCT00964496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527756|NCT00964496|Leprostatic Agents|leprostatic agents|mesh-ancestor
102527757|NCT00964496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102527758|NCT00964496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102527759|NCT00964496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102527760|NCT00964496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102527761|NCT00964496|Growth Substances|growth substances|mesh-ancestor
102527762|NCT00964496|Growth Inhibitors|growth inhibitors|mesh-ancestor
102527763|NCT00964496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102527764|NCT00964496|Hematinics|hematinics|mesh-ancestor
102527765|NCT01685411|Mycophenolic Acid|mycophenolic acid|mesh-list
102527766|NCT01685411|Cyclophosphamide|cyclophosphamide|mesh-list
102527767|NCT01685411|Busulfan|busulfan|mesh-list
102527768|NCT01685411|Allopurinol|allopurinol|mesh-list
102527769|NCT01685411|Levetiracetam|levetiracetam|mesh-list
102527770|NCT01685411|Tacrolimus|tacrolimus|mesh-list
102527771|NCT01685411|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102527772|NCT01685411|Lenograstim|lenograstim|mesh-list
102527773|NCT01685411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102527774|NCT01685411|Immunologic Factors|immunologic factors|mesh-ancestor
102527775|NCT01685411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527776|NCT01685411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102527777|NCT01685411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102527778|NCT01685411|Alkylating Agents|alkylating agents|mesh-ancestor
102527779|NCT01685411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527780|NCT01685411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102527781|NCT01685411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102527782|NCT01685411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102527783|NCT01685411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102527784|NCT01685411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102527785|NCT01685411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102527786|NCT01685411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102527787|NCT01685411|Antitubercular Agents|antitubercular agents|mesh-ancestor
102527788|NCT01685411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102527789|NCT01685411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102527790|NCT01685411|Anticonvulsants|anticonvulsants|mesh-ancestor
102527791|NCT01685411|Nootropic Agents|nootropic agents|mesh-ancestor
102527792|NCT01685411|Antimetabolites|antimetabolites|mesh-ancestor
102527793|NCT01685411|Gout Suppressants|gout suppressants|mesh-ancestor
102527794|NCT01685411|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102527795|NCT01685411|Antioxidants|antioxidants|mesh-ancestor
102339332|NCT04411069|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102527796|NCT01685411|Protective Agents|protective agents|mesh-ancestor
102527797|NCT02243813|Psilocybin|psilocybin|mesh-list
102527799|NCT02243813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527800|NCT02243813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102527801|NCT02991209|Testosterone|testosterone|mesh-list
102527802|NCT02991209|Androgens|androgens|mesh-ancestor
102527803|NCT02991209|Hormones|hormones|mesh-ancestor
102527804|NCT02991209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102527805|NCT02991209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527806|NCT03019562|Fentanyl|fentanyl|mesh-list
102527807|NCT03019562|Oxycodone|oxycodone|mesh-list
102527808|NCT03019562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102527809|NCT03019562|Narcotics|narcotics|mesh-ancestor
102527810|NCT03019562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102527811|NCT03019562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527812|NCT03019562|Analgesics|analgesics|mesh-ancestor
102527813|NCT03019562|Sensory System Agents|sensory system agents|mesh-ancestor
102527814|NCT03019562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102527815|NCT03019562|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102527816|NCT03019562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102527817|NCT03019562|Anesthetics, General|anesthetics, general|mesh-ancestor
102527818|NCT03019562|Anesthetics|anesthetics|mesh-ancestor
102527819|NCT00969878|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102527820|NCT00969878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102527821|NCT00969878|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102527822|NCT00969878|Immunologic Factors|immunologic factors|mesh-ancestor
102527823|NCT00969878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527824|NCT00969878|Antacids|antacids|mesh-ancestor
102527825|NCT00969878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527826|NCT00969878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102527827|NCT05677919|Venetoclax|venetoclax|mesh-list
102527828|NCT05677919|Pirtobrutinib|pirtobrutinib|mesh-list
102527829|NCT05677919|Pyrazole|pyrazole|mesh-list
102527830|NCT05677919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102527831|NCT05677919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102527832|NCT05677919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102527833|NCT05677919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527834|NCT00970814|Levetiracetam|levetiracetam|mesh-list
102527835|NCT00970814|Anticonvulsants|anticonvulsants|mesh-ancestor
102527836|NCT00970814|Nootropic Agents|nootropic agents|mesh-ancestor
102527837|NCT02486406|Ritonavir|ritonavir|mesh-list
102527838|NCT02486406|Ribavirin|ribavirin|mesh-list
102527839|NCT02486406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102527840|NCT02486406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102527841|NCT02486406|Protease Inhibitors|protease inhibitors|mesh-ancestor
102527842|NCT02486406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102527843|NCT02486406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527844|NCT02486406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102527845|NCT02486406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102527846|NCT02486406|Antiviral Agents|antiviral agents|mesh-ancestor
102527847|NCT02486406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102527848|NCT02486406|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102527849|NCT02486406|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102527850|NCT02486406|Antimetabolites|antimetabolites|mesh-ancestor
102527851|NCT01688609|Paclitaxel|paclitaxel|mesh-list
102527852|NCT01688609|Trastuzumab|trastuzumab|mesh-list
102527853|NCT01688609|Lapatinib|lapatinib|mesh-list
102527854|NCT01688609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102527855|NCT01688609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102527856|NCT01688609|Tubulin Modulators|tubulin modulators|mesh-ancestor
102527857|NCT01688609|Antimitotic Agents|antimitotic agents|mesh-ancestor
102527858|NCT01688609|Mitosis Modulators|mitosis modulators|mesh-ancestor
102527859|NCT01688609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527860|NCT01688609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102527861|NCT01688609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102527862|NCT01688609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102527863|NCT02485158|Dronabinol|dronabinol|mesh-list
102527864|NCT02485158|Amphetamine|amphetamine|mesh-list
102527865|NCT02485158|Dextroamphetamine|dextroamphetamine|mesh-list
102527866|NCT02485158|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102527867|NCT02485158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527868|NCT02485158|Sympathomimetics|sympathomimetics|mesh-ancestor
102527869|NCT02485158|Autonomic Agents|autonomic agents|mesh-ancestor
102527870|NCT02485158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102527871|NCT02485158|Dopamine Agents|dopamine agents|mesh-ancestor
102527872|NCT02485158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102527873|NCT02485158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527874|NCT02485158|Adrenergic Agents|adrenergic agents|mesh-ancestor
102527875|NCT02485158|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102527876|NCT02485158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102527877|NCT02485158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102527878|NCT02485158|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102527879|NCT02485158|Hallucinogens|hallucinogens|mesh-ancestor
102527880|NCT02485158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102527881|NCT02485158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102527882|NCT02485158|Analgesics|analgesics|mesh-ancestor
102527883|NCT02485158|Sensory System Agents|sensory system agents|mesh-ancestor
102527884|NCT02485158|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102527885|NCT02485158|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102527886|NCT02485158|Hormones|hormones|mesh-ancestor
102527887|NCT02485158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102527888|NCT02455518|Acetaminophen|acetaminophen|mesh-list
102527889|NCT02455518|Ibuprofen|ibuprofen|mesh-list
102527890|NCT02455518|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
102527891|NCT02455518|Oxycodone|oxycodone|mesh-list
102527892|NCT02455518|Hydrocodone|hydrocodone|mesh-list
102527893|NCT02455518|Codeine|codeine|mesh-list
102527894|NCT02455518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102527895|NCT02455518|Analgesics|analgesics|mesh-ancestor
102527896|NCT02455518|Sensory System Agents|sensory system agents|mesh-ancestor
102527897|NCT02455518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102527898|NCT02455518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527899|NCT02455518|Antipyretics|antipyretics|mesh-ancestor
102527900|NCT02455518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102527901|NCT02455518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102527902|NCT02455518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102527903|NCT02455518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102527904|NCT02455518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102527905|NCT02455518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527906|NCT02455518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102527907|NCT02455518|Narcotics|narcotics|mesh-ancestor
102527908|NCT02455518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102527909|NCT02455518|Antitussive Agents|antitussive agents|mesh-ancestor
102527910|NCT02455518|Respiratory System Agents|respiratory system agents|mesh-ancestor
102527911|NCT00972374|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102527912|NCT00972374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102527913|NCT00972374|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102527914|NCT00972374|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102527915|NCT00972374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102527916|NCT00972374|Adrenergic Agents|adrenergic agents|mesh-ancestor
102527917|NCT00972374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102527918|NCT00972374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527919|NCT00972374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527920|NCT03018626|Prednisone|prednisone|mesh-list
102527921|NCT03018626|Cyclophosphamide|cyclophosphamide|mesh-list
102527922|NCT03018626|Rituximab|rituximab|mesh-list
102527923|NCT03018626|Doxorubicin|doxorubicin|mesh-list
102527924|NCT03018626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102527925|NCT03018626|Etoposide|etoposide|mesh-list
102527926|NCT03018626|Vincristine|vincristine|mesh-list
102527927|NCT03018626|Bleomycin|bleomycin|mesh-list
102527928|NCT03018626|Vindesine|vindesine|mesh-list
102527929|NCT03018626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102527930|NCT03018626|Immunologic Factors|immunologic factors|mesh-ancestor
102527931|NCT03018626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527932|NCT03018626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102527933|NCT03018626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102527934|NCT03018626|Alkylating Agents|alkylating agents|mesh-ancestor
102527935|NCT03018626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527936|NCT03018626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102527937|NCT03018626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102527938|NCT03018626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102527939|NCT03018626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102527940|NCT03018626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102527941|NCT03018626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102527942|NCT03018626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102527943|NCT03018626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102527944|NCT03018626|Glucocorticoids|glucocorticoids|mesh-ancestor
102527945|NCT03018626|Hormones|hormones|mesh-ancestor
102527946|NCT03018626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102527947|NCT03018626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102527948|NCT03018626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102339483|NCT01895335|Teriflunomide|teriflunomide|mesh-list
102527949|NCT03018626|Tubulin Modulators|tubulin modulators|mesh-ancestor
102527950|NCT03018626|Antimitotic Agents|antimitotic agents|mesh-ancestor
102527951|NCT03018626|Mitosis Modulators|mitosis modulators|mesh-ancestor
102527952|NCT01689779|Vitamin D|vitamin d|mesh-list
102527953|NCT01689779|Cholecalciferol|cholecalciferol|mesh-list
102527954|NCT01689779|Vitamins|vitamins|mesh-ancestor
102527955|NCT01689779|Micronutrients|micronutrients|mesh-ancestor
102527956|NCT01689779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527957|NCT01689779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102527958|NCT01689779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102527959|NCT05388500|Paclitaxel|paclitaxel|mesh-list
102527960|NCT05388500|Trastuzumab|trastuzumab|mesh-list
102527961|NCT05388500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102527962|NCT05388500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102527963|NCT05388500|Tubulin Modulators|tubulin modulators|mesh-ancestor
102527964|NCT05388500|Antimitotic Agents|antimitotic agents|mesh-ancestor
102527965|NCT05388500|Mitosis Modulators|mitosis modulators|mesh-ancestor
102527966|NCT05388500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527967|NCT05388500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102527968|NCT00974246|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102527969|NCT00974246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102527970|NCT00974246|Autonomic Agents|autonomic agents|mesh-ancestor
102527971|NCT00974246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102527972|NCT00974246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527973|NCT00974246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102527974|NCT00974246|Respiratory System Agents|respiratory system agents|mesh-ancestor
102527975|NCT00974246|Glucocorticoids|glucocorticoids|mesh-ancestor
102527976|NCT00974246|Hormones|hormones|mesh-ancestor
102527977|NCT00974246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102527978|NCT00974246|Sympathomimetics|sympathomimetics|mesh-ancestor
102527979|NCT00974480|Tretinoin|tretinoin|mesh-list
102527980|NCT00974480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102527981|NCT00974480|Keratolytic Agents|keratolytic agents|mesh-ancestor
102527982|NCT00974480|Dermatologic Agents|dermatologic agents|mesh-ancestor
102527983|NCT00975650|Testosterone|testosterone|mesh-list
102527984|NCT00975650|Androgens|androgens|mesh-ancestor
102527985|NCT00975650|Hormones|hormones|mesh-ancestor
102527986|NCT00975650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102527987|NCT00975650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102527988|NCT00979940|Atorvastatin|atorvastatin|mesh-list
102527989|NCT00979940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102527990|NCT00979940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102527991|NCT00979940|Antimetabolites|antimetabolites|mesh-ancestor
102527992|NCT00979940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102527993|NCT00979940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102527994|NCT00979940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102527995|NCT00979940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102527996|NCT03018236|Ethanol|ethanol|mesh-list
102527997|NCT03018236|Acetylcysteine|acetylcysteine|mesh-list
102527998|NCT03018236|Cocaine|cocaine|mesh-list
102527999|NCT03018236|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102528000|NCT03018236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102528001|NCT03018236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102528002|NCT03018236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102528003|NCT03018236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528004|NCT03018236|Antiviral Agents|antiviral agents|mesh-ancestor
102528005|NCT03018236|Expectorants|expectorants|mesh-ancestor
102528006|NCT03018236|Respiratory System Agents|respiratory system agents|mesh-ancestor
102528007|NCT03018236|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102528008|NCT03018236|Antioxidants|antioxidants|mesh-ancestor
102528009|NCT03018236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528010|NCT03018236|Protective Agents|protective agents|mesh-ancestor
102528011|NCT03018236|Antidotes|antidotes|mesh-ancestor
102528012|NCT03018236|Anesthetics, Local|anesthetics, local|mesh-ancestor
102528013|NCT03018236|Anesthetics|anesthetics|mesh-ancestor
102528014|NCT03018236|Sensory System Agents|sensory system agents|mesh-ancestor
102528015|NCT03018236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102528016|NCT03018236|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102528017|NCT03018236|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102528018|NCT03018236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102528019|NCT03018236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102528020|NCT03018236|Dopamine Agents|dopamine agents|mesh-ancestor
102528021|NCT03018236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102528022|NCT02659241|Adavosertib|adavosertib|mesh-list
102528023|NCT02659241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102528024|NCT02659241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528026|NCT00982592|Fluorouracil|fluorouracil|mesh-list
102528027|NCT00982592|Oxaliplatin|oxaliplatin|mesh-list
102528028|NCT00982592|Calcium|calcium|mesh-list
102528029|NCT00982592|Levoleucovorin|levoleucovorin|mesh-list
102528030|NCT00982592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102528031|NCT00982592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528032|NCT00982592|Antimetabolites|antimetabolites|mesh-ancestor
102528033|NCT00982592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528034|NCT00982592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102528035|NCT00982592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102528036|NCT00982592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102528037|NCT00982592|Immunologic Factors|immunologic factors|mesh-ancestor
102528038|NCT00982592|Antidotes|antidotes|mesh-ancestor
102528039|NCT00982592|Protective Agents|protective agents|mesh-ancestor
102528040|NCT00982592|Vitamin B Complex|vitamin b complex|mesh-ancestor
102528041|NCT00982592|Vitamins|vitamins|mesh-ancestor
102528042|NCT00982592|Micronutrients|micronutrients|mesh-ancestor
102528043|NCT00983216|Ketoconazole|ketoconazole|mesh-list
102528044|NCT00983216|Colchicine|colchicine|mesh-list
102528045|NCT00983216|Gout Suppressants|gout suppressants|mesh-ancestor
102528046|NCT00983216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102528047|NCT00983216|Tubulin Modulators|tubulin modulators|mesh-ancestor
102528048|NCT00983216|Antimitotic Agents|antimitotic agents|mesh-ancestor
102528049|NCT00983216|Mitosis Modulators|mitosis modulators|mesh-ancestor
102528050|NCT00983216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528051|NCT00983216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102528052|NCT00983216|Antifungal Agents|antifungal agents|mesh-ancestor
102528053|NCT00983216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102528054|NCT00983216|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102528055|NCT00983216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102528056|NCT00983216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102528057|NCT00983216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102528058|NCT00983216|Hormone Antagonists|hormone antagonists|mesh-ancestor
102528059|NCT00983216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102528060|NCT00983216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528061|NCT00983216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102528062|NCT01788020|Dexamethasone|dexamethasone|mesh-list
102528063|NCT01788020|Dexamethasone acetate|dexamethasone acetate|mesh-list
102528064|NCT01788020|Cyclophosphamide|cyclophosphamide|mesh-list
102528065|NCT01788020|Rituximab|rituximab|mesh-list
102528066|NCT01788020|Bortezomib|bortezomib|mesh-list
102528067|NCT01788020|BB 1101|bb 1101|mesh-list
102528068|NCT01788020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102528069|NCT01788020|Immunologic Factors|immunologic factors|mesh-ancestor
102528070|NCT01788020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528071|NCT01788020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102528072|NCT01788020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102528073|NCT01788020|Alkylating Agents|alkylating agents|mesh-ancestor
102528074|NCT01788020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528075|NCT01788020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102528076|NCT01788020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102528077|NCT01788020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102528078|NCT01788020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102528079|NCT01788020|Antiemetics|antiemetics|mesh-ancestor
102528080|NCT01788020|Autonomic Agents|autonomic agents|mesh-ancestor
102528081|NCT01788020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102528082|NCT01788020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102528083|NCT01788020|Glucocorticoids|glucocorticoids|mesh-ancestor
102528084|NCT01788020|Hormones|hormones|mesh-ancestor
102528085|NCT01788020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102528086|NCT01788020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102528087|NCT01788020|Protease Inhibitors|protease inhibitors|mesh-ancestor
102528088|NCT01788020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102528089|NCT02435849|Tisagenlecleucel|tisagenlecleucel|mesh-list
102528090|NCT02435849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102528091|NCT02435849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102528092|NCT02249585|Iodine|iodine|mesh-list
102528093|NCT02249585|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102528094|NCT02249585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102528095|NCT02249585|Trace Elements|trace elements|mesh-ancestor
102528096|NCT02249585|Micronutrients|micronutrients|mesh-ancestor
102528097|NCT02249585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528098|NCT05478863|Caffeine|caffeine|mesh-list
102528099|NCT05478863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102528100|NCT05478863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528101|NCT05478863|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102528102|NCT05478863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102528103|NCT05478863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528104|NCT05478863|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102528105|NCT05478863|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102528106|NCT05478863|Purinergic Agents|purinergic agents|mesh-ancestor
102528107|NCT05478863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102528108|NCT01774487|Pentoxifylline|pentoxifylline|mesh-list
102528109|NCT01774487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102528110|NCT01774487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102528111|NCT01774487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528112|NCT01774487|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102528113|NCT01774487|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102528114|NCT01774487|Protective Agents|protective agents|mesh-ancestor
102528115|NCT01774487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528116|NCT01774487|Vasodilator Agents|vasodilator agents|mesh-ancestor
102528117|NCT01774487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102528118|NCT01774487|Antioxidants|antioxidants|mesh-ancestor
102528119|NCT04409600|Botulinum Toxins|botulinum toxins|mesh-list
102528120|NCT04409600|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102528121|NCT04409600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102528122|NCT04409600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528123|NCT04409600|Cholinergic Agents|cholinergic agents|mesh-ancestor
102528124|NCT04409600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102528125|NCT04409600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528126|NCT02161484|Bupivacaine|bupivacaine|mesh-list
102528127|NCT02161484|Anesthetics, Local|anesthetics, local|mesh-ancestor
102528128|NCT02161484|Anesthetics|anesthetics|mesh-ancestor
102528129|NCT02161484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102528130|NCT02161484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528131|NCT02161484|Sensory System Agents|sensory system agents|mesh-ancestor
102528132|NCT02161484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102528133|NCT00988832|Infliximab|infliximab|mesh-list
102528134|NCT00988832|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102528135|NCT00988832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102528136|NCT00988832|Dermatologic Agents|dermatologic agents|mesh-ancestor
102528137|NCT00988832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102528138|NCT00988832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102528139|NCT01023776|Vaccines|vaccines|mesh-list
102528140|NCT01023776|Immunologic Factors|immunologic factors|mesh-ancestor
102528141|NCT01023776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528142|NCT00989768|Botulinum Toxins|botulinum toxins|mesh-list
102528143|NCT00989768|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102528144|NCT00989768|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102528145|NCT00989768|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102528146|NCT00989768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102528147|NCT00989768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528148|NCT00989768|Cholinergic Agents|cholinergic agents|mesh-ancestor
102528149|NCT00989768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102528150|NCT00989768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528151|NCT00989768|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102528152|NCT00989768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102528153|NCT00990236|Enoxaparin|enoxaparin|mesh-list
102528154|NCT00990236|Enoxaparin sodium|enoxaparin sodium|mesh-list
102528155|NCT00990236|Anticoagulants|anticoagulants|mesh-ancestor
102528156|NCT00990236|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102528157|NCT00990236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102528158|NCT00990236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528159|NCT01024010|Vidarabine|vidarabine|mesh-list
102528160|NCT01024010|Cyclophosphamide|cyclophosphamide|mesh-list
102528161|NCT01024010|Ofatumumab|ofatumumab|mesh-list
102528162|NCT01024010|Pentostatin|pentostatin|mesh-list
102528163|NCT01024010|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102528164|NCT01024010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102528165|NCT01024010|Immunologic Factors|immunologic factors|mesh-ancestor
102528166|NCT01024010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528167|NCT01024010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102528168|NCT01024010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102528169|NCT01024010|Alkylating Agents|alkylating agents|mesh-ancestor
102528170|NCT01024010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528171|NCT01024010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102528172|NCT01024010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102528173|NCT01024010|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
102528174|NCT01024010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102528175|NCT01024010|Antimetabolites|antimetabolites|mesh-ancestor
102528176|NCT01024010|Antiviral Agents|antiviral agents|mesh-ancestor
102528177|NCT01024010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102528178|NCT02484690|Ranibizumab|ranibizumab|mesh-list
102528179|NCT02484690|Faricimab|faricimab|mesh-list
102528180|NCT02484690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102528181|NCT02484690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102528182|NCT02484690|Growth Substances|growth substances|mesh-ancestor
102528183|NCT02484690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528184|NCT02484690|Growth Inhibitors|growth inhibitors|mesh-ancestor
102528185|NCT02484690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102528186|NCT01027598|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102528187|NCT01027598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102528188|NCT01027598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102528189|NCT01027598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102528190|NCT01027598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528191|NCT01654224|Vaccines|vaccines|mesh-list
102528192|NCT01654224|Immunologic Factors|immunologic factors|mesh-ancestor
102528193|NCT01654224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528194|NCT02447328|Fulvestrant|fulvestrant|mesh-list
102528195|NCT02447328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102528196|NCT02447328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102528197|NCT02447328|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102528198|NCT02447328|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102528199|NCT02447328|Hormone Antagonists|hormone antagonists|mesh-ancestor
102528200|NCT02447328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102528201|NCT02447328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528202|NCT02447250|Albuterol|albuterol|mesh-list
102528203|NCT02447250|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102528204|NCT02447250|Autonomic Agents|autonomic agents|mesh-ancestor
102528205|NCT02447250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102528206|NCT02447250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528207|NCT02447250|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102528208|NCT02447250|Respiratory System Agents|respiratory system agents|mesh-ancestor
102528209|NCT02447250|Tocolytic Agents|tocolytic agents|mesh-ancestor
102528210|NCT02447250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102528211|NCT02447250|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102528212|NCT02447250|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102528213|NCT02447250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102528214|NCT02447250|Adrenergic Agents|adrenergic agents|mesh-ancestor
102528215|NCT02447250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102528216|NCT02447250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528217|NCT00993200|Warfarin|warfarin|mesh-list
102528218|NCT00993200|Anticoagulants|anticoagulants|mesh-ancestor
102528219|NCT00993824|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
102528220|NCT00993824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102528221|NCT00993824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102528222|NCT00993824|Antimetabolites|antimetabolites|mesh-ancestor
102528223|NCT00993824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528224|NCT00993824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102528225|NCT02447172|Gentamicins|gentamicins|mesh-list
102528226|NCT02447172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102528227|NCT02447172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102528228|NCT02447172|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102528229|NCT02447172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102528230|NCT02447172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528231|NCT02163824|Loteprednol Etabonate|loteprednol etabonate|mesh-list
102528232|NCT02163824|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102528233|NCT04200066|Tamoxifen|tamoxifen|mesh-list
102528234|NCT04200066|Temozolomide|temozolomide|mesh-list
102528235|NCT04200066|Maprotiline|maprotiline|mesh-list
102528236|NCT04200066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102528237|NCT04200066|Alkylating Agents|alkylating agents|mesh-ancestor
102528238|NCT04200066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528239|NCT04200066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102528240|NCT04200066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102528241|NCT04200066|Hormone Antagonists|hormone antagonists|mesh-ancestor
102528242|NCT04200066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102528243|NCT04200066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528244|NCT04200066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102528245|NCT04200066|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102528246|NCT04200066|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102528247|NCT04200066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102339792|NCT01452568|Antipyretics|antipyretics|mesh-ancestor
102528248|NCT04200066|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102528249|NCT04200066|Antidepressive Agents|antidepressive agents|mesh-ancestor
102528250|NCT04200066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102528251|NCT04200066|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102528252|NCT04200066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102528253|NCT04200066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102528254|NCT04200066|Adrenergic Agents|adrenergic agents|mesh-ancestor
102528255|NCT04200066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102528256|NCT02455050|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102528257|NCT02455050|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102528258|NCT02455050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102528259|NCT02455050|Laxatives|laxatives|mesh-ancestor
102528260|NCT02455050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102528261|NCT00994760|Fentanyl|fentanyl|mesh-list
102528262|NCT00994760|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102528263|NCT00994760|Narcotics|narcotics|mesh-ancestor
102528264|NCT00994760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102528265|NCT00994760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528266|NCT00994760|Analgesics|analgesics|mesh-ancestor
102528267|NCT00994760|Sensory System Agents|sensory system agents|mesh-ancestor
102528268|NCT00994760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102528269|NCT00994760|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102528270|NCT00994760|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102528271|NCT00994760|Anesthetics, General|anesthetics, general|mesh-ancestor
102528272|NCT00994760|Anesthetics|anesthetics|mesh-ancestor
102528273|NCT00995072|Metoprolol|metoprolol|mesh-list
102528274|NCT00995072|Nebivolol|nebivolol|mesh-list
102528275|NCT00995072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102528276|NCT00995072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102528277|NCT00995072|Sympatholytics|sympatholytics|mesh-ancestor
102528278|NCT00995072|Autonomic Agents|autonomic agents|mesh-ancestor
102528279|NCT00995072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102528280|NCT00995072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528281|NCT00995072|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102528282|NCT00995072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102528283|NCT00995072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102528284|NCT00995072|Adrenergic Agents|adrenergic agents|mesh-ancestor
102528285|NCT00995072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102528286|NCT00995072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528287|NCT00995072|Vasodilator Agents|vasodilator agents|mesh-ancestor
102528288|NCT00995072|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102528289|NCT00995072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102528290|NCT00995072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102528291|NCT01027910|Doxorubicin|doxorubicin|mesh-list
102528292|NCT01027910|Abexinostat|abexinostat|mesh-list
102528293|NCT01027910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102528294|NCT01027910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102528295|NCT01027910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102528296|NCT01027910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102528297|NCT01027910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102528298|NCT01027910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528299|NCT01027910|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102528300|NCT01031420|Doxorubicin|doxorubicin|mesh-list
102528301|NCT01031420|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102528302|NCT01031420|Methotrexate|methotrexate|mesh-list
102528303|NCT01031420|Vinblastine|vinblastine|mesh-list
102528304|NCT01031420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102528305|NCT01031420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102528306|NCT01031420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102528307|NCT01031420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102528308|NCT01031420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102528309|NCT01031420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528310|NCT01031420|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102528311|NCT01031420|Abortifacient Agents|abortifacient agents|mesh-ancestor
102528312|NCT01031420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102528313|NCT01031420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528314|NCT01031420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102528315|NCT01031420|Antimetabolites|antimetabolites|mesh-ancestor
102528316|NCT01031420|Dermatologic Agents|dermatologic agents|mesh-ancestor
102528317|NCT01031420|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102528318|NCT01031420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102528319|NCT01031420|Immunologic Factors|immunologic factors|mesh-ancestor
102528320|NCT01031420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102339870|NCT04847752|Antipyretics|antipyretics|mesh-ancestor
102528321|NCT01031420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102528322|NCT01031420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102528323|NCT01031420|Tubulin Modulators|tubulin modulators|mesh-ancestor
102528324|NCT01031420|Antimitotic Agents|antimitotic agents|mesh-ancestor
102528325|NCT01031420|Mitosis Modulators|mitosis modulators|mesh-ancestor
102528326|NCT01031498|Ondansetron|ondansetron|mesh-list
102528327|NCT01031498|Palonosetron|palonosetron|mesh-list
102528328|NCT01031498|Antiemetics|antiemetics|mesh-ancestor
102528329|NCT01031498|Autonomic Agents|autonomic agents|mesh-ancestor
102528330|NCT01031498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102528331|NCT01031498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528332|NCT01031498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102528333|NCT01031498|Antipruritics|antipruritics|mesh-ancestor
102528334|NCT01031498|Dermatologic Agents|dermatologic agents|mesh-ancestor
102528335|NCT01031498|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102528336|NCT01031498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102528337|NCT01031498|Serotonin Agents|serotonin agents|mesh-ancestor
102528338|NCT01031498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102528339|NCT01031498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528340|NCT01031810|Tranylcypromine|tranylcypromine|mesh-list
102528341|NCT01031810|Antidepressive Agents|antidepressive agents|mesh-ancestor
102528342|NCT01031810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102528343|NCT01031810|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102528344|NCT01031810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102528345|NCT01031810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528346|NCT01031810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102528347|NCT01031810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102528348|NCT01031810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102528349|NCT01031810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528350|NCT03425006|Pembrolizumab|pembrolizumab|mesh-list
102528351|NCT03425006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102528352|NCT03425006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102528353|NCT03425006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102528354|NCT03425006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528355|NCT00998426|Immunoglobulins|immunoglobulins|mesh-list
102528356|NCT00998426|Antibodies|antibodies|mesh-list
102528357|NCT00998426|gamma-Globulins|gamma-globulins|mesh-list
102528358|NCT00998426|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102528359|NCT00998426|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102528360|NCT00998426|Immunoglobulin G|immunoglobulin g|mesh-list
102528361|NCT00998426|Immunologic Factors|immunologic factors|mesh-ancestor
102528362|NCT00998426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528363|NCT00998582|Tenofovir|tenofovir|mesh-list
102528364|NCT00998582|Antiviral Agents|antiviral agents|mesh-ancestor
102528365|NCT00998582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102528366|NCT00998582|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102528367|NCT00998582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102528368|NCT00998582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102528369|NCT00998582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528370|NCT00998582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102528371|NCT00998582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102528372|NCT02168660|Vitamin D|vitamin d|mesh-list
102528373|NCT02168660|Cholecalciferol|cholecalciferol|mesh-list
102528374|NCT02168660|Vitamins|vitamins|mesh-ancestor
102528375|NCT02168660|Micronutrients|micronutrients|mesh-ancestor
102528376|NCT02168660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528377|NCT02168660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102528378|NCT02168660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102528379|NCT01003106|Ranibizumab|ranibizumab|mesh-list
102528380|NCT01003106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102528381|NCT01003106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102528382|NCT01003106|Growth Substances|growth substances|mesh-ancestor
102528383|NCT01003106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528384|NCT01003106|Growth Inhibitors|growth inhibitors|mesh-ancestor
102528385|NCT01003106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102528386|NCT01003418|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102528387|NCT01003418|Immunologic Factors|immunologic factors|mesh-ancestor
102528388|NCT01003418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528389|NCT01004042|Botulinum Toxins|botulinum toxins|mesh-list
102528390|NCT01004042|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102528391|NCT01004042|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102528392|NCT01004042|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102528393|NCT01004042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102528394|NCT01004042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528395|NCT01004042|Cholinergic Agents|cholinergic agents|mesh-ancestor
102528396|NCT01004042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102528397|NCT01004042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528398|NCT01004042|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102528399|NCT01004042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102528400|NCT01004354|Ergocalciferols|ergocalciferols|mesh-list
102528401|NCT01004354|Vitamin D|vitamin d|mesh-list
102528402|NCT01004354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102528403|NCT01004354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528404|NCT01004354|Vitamins|vitamins|mesh-ancestor
102528405|NCT01004354|Micronutrients|micronutrients|mesh-ancestor
102528406|NCT01004354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102528407|NCT02417064|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102528408|NCT02417064|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102528409|NCT02417064|Sertraline|sertraline|mesh-list
102528410|NCT02417064|Antidepressive Agents|antidepressive agents|mesh-list
102528411|NCT02417064|Esketamine|esketamine|mesh-list
102528412|NCT02417064|Escitalopram|escitalopram|mesh-list
102528413|NCT02417064|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102528414|NCT02417064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102528415|NCT02417064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102528416|NCT02417064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528417|NCT02417064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102528418|NCT02417064|Serotonin Agents|serotonin agents|mesh-ancestor
102528419|NCT02417064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528420|NCT02417064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102528421|NCT02417064|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102528422|NCT02417064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102528423|NCT02417064|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102528424|NCT02417064|Analgesics|analgesics|mesh-ancestor
102528425|NCT02417064|Sensory System Agents|sensory system agents|mesh-ancestor
102528426|NCT02417064|Dopamine Agents|dopamine agents|mesh-ancestor
102528427|NCT01004744|Anastrozole|anastrozole|mesh-list
102528428|NCT01004744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102528429|NCT01004744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102528430|NCT01004744|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102528431|NCT01004744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102528432|NCT01004744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102528433|NCT01004744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528434|NCT01004744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102528435|NCT01004744|Hormone Antagonists|hormone antagonists|mesh-ancestor
102528436|NCT01004744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102528437|NCT01004744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528438|NCT01005290|Ramipril|ramipril|mesh-list
102528439|NCT01005290|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102528440|NCT01005290|Protease Inhibitors|protease inhibitors|mesh-ancestor
102528441|NCT01005290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102528442|NCT01005290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528443|NCT01005290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102528444|NCT04478474|Ganciclovir|ganciclovir|mesh-list
102528445|NCT04478474|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102528446|NCT04478474|Antiviral Agents|antiviral agents|mesh-ancestor
102528447|NCT04478474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102528448|NCT04478474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102528449|NCT04478474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102528450|NCT04478474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528451|NCT05592860|Insulin|insulin|mesh-list
102528452|NCT05592860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102528453|NCT05592860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528454|NCT01051778|Aspirin|aspirin|mesh-list
102528455|NCT01051778|Heparin|heparin|mesh-list
102528456|NCT01051778|Enoxaparin|enoxaparin|mesh-list
102528457|NCT01051778|Calcium heparin|calcium heparin|mesh-list
102528458|NCT01051778|Calcium|calcium|mesh-list
102528459|NCT01051778|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102528460|NCT01051778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528461|NCT01051778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102528462|NCT01051778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102528463|NCT01051778|Analgesics|analgesics|mesh-ancestor
102528464|NCT01051778|Sensory System Agents|sensory system agents|mesh-ancestor
102528465|NCT01051778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102528466|NCT01051778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102528467|NCT01051778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102528468|NCT01051778|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102528469|NCT01051778|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102528470|NCT01051778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528471|NCT01051778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102528472|NCT01051778|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102528473|NCT01051778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102528474|NCT01051778|Antipyretics|antipyretics|mesh-ancestor
102528475|NCT01051778|Anticoagulants|anticoagulants|mesh-ancestor
102528476|NCT02169440|Opicapone|opicapone|mesh-list
102528477|NCT02169440|Warfarin|warfarin|mesh-list
102528478|NCT02169440|Anticoagulants|anticoagulants|mesh-ancestor
102528479|NCT02169440|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102528480|NCT02169440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102528481|NCT02169440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528482|NCT02169440|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102528483|NCT02169440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102528484|NCT03015350|Sevoflurane|sevoflurane|mesh-list
102528485|NCT03015350|Desflurane|desflurane|mesh-list
102528486|NCT03015350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102528487|NCT03015350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102528488|NCT03015350|Anesthetics, General|anesthetics, general|mesh-ancestor
102528489|NCT03015350|Anesthetics|anesthetics|mesh-ancestor
102528490|NCT03015350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102528491|NCT03015350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528492|NCT01054742|Ribavirin|ribavirin|mesh-list
102528493|NCT01054742|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102528494|NCT01054742|Antimetabolites|antimetabolites|mesh-ancestor
102528495|NCT01054742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528496|NCT01054742|Antiviral Agents|antiviral agents|mesh-ancestor
102528497|NCT01054742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102528498|NCT04171466|Metronidazole|metronidazole|mesh-list
102528499|NCT04171466|Ciprofloxacin|ciprofloxacin|mesh-list
102528500|NCT04171466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102528501|NCT04171466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102528502|NCT04171466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102528503|NCT04171466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102528504|NCT04171466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102528505|NCT04171466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102528506|NCT04171466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102528507|NCT04171466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528508|NCT04171466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102528509|NCT04171466|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102528510|NCT04171466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102528511|NCT02170376|Levodopa|levodopa|mesh-list
102528512|NCT02170376|Carbidopa|carbidopa|mesh-list
102528513|NCT02170376|Opicapone|opicapone|mesh-list
102528514|NCT02170376|Entacapone|entacapone|mesh-list
102528515|NCT02170376|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102528516|NCT02170376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102528517|NCT02170376|Dopamine Agents|dopamine agents|mesh-ancestor
102528518|NCT02170376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102528519|NCT02170376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528520|NCT02170376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528521|NCT02170376|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102528522|NCT02170376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102528523|NCT02170376|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102528524|NCT02170532|Albuterol|albuterol|mesh-list
102528525|NCT02170532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102528526|NCT02170532|Autonomic Agents|autonomic agents|mesh-ancestor
102528527|NCT02170532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102528528|NCT02170532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528529|NCT02170532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102528530|NCT02170532|Respiratory System Agents|respiratory system agents|mesh-ancestor
102528531|NCT02170532|Tocolytic Agents|tocolytic agents|mesh-ancestor
102528532|NCT02170532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102528533|NCT02170532|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102528534|NCT02170532|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102528535|NCT02170532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102528536|NCT02170532|Adrenergic Agents|adrenergic agents|mesh-ancestor
102528537|NCT02170532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102528538|NCT02170532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528539|NCT04079582|Dialysis Solutions|dialysis solutions|mesh-list
102528540|NCT04079582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102528541|NCT02175212|Ascorbic Acid|ascorbic acid|mesh-list
102528542|NCT02175212|Methyltestosterone|methyltestosterone|mesh-list
102528543|NCT02175212|Androgens|androgens|mesh-list
102528544|NCT02175212|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
102528545|NCT02175212|Hormones|hormones|mesh-ancestor
102528546|NCT02175212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102528547|NCT02175212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528548|NCT02175212|Antioxidants|antioxidants|mesh-ancestor
102528549|NCT02175212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528550|NCT02175212|Protective Agents|protective agents|mesh-ancestor
102528551|NCT02175212|Vitamins|vitamins|mesh-ancestor
102528552|NCT02175212|Micronutrients|micronutrients|mesh-ancestor
102528553|NCT02175212|Estrogens|estrogens|mesh-ancestor
102528554|NCT02175212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102528555|NCT02175212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102528556|NCT02175212|Anabolic Agents|anabolic agents|mesh-ancestor
102528557|NCT03014882|Acetylcysteine|acetylcysteine|mesh-list
102528558|NCT03014882|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102528559|NCT03014882|Antiviral Agents|antiviral agents|mesh-ancestor
102528560|NCT03014882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102528561|NCT03014882|Expectorants|expectorants|mesh-ancestor
102528562|NCT03014882|Respiratory System Agents|respiratory system agents|mesh-ancestor
102528563|NCT03014882|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102528564|NCT03014882|Antioxidants|antioxidants|mesh-ancestor
102528565|NCT03014882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528566|NCT03014882|Protective Agents|protective agents|mesh-ancestor
102528567|NCT03014882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528568|NCT03014882|Antidotes|antidotes|mesh-ancestor
102528569|NCT02171234|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102528570|NCT02171234|Anticonvulsants|anticonvulsants|mesh-ancestor
102528571|NCT02171234|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102528572|NCT02171234|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102528573|NCT02171234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102528574|NCT02171234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528575|NCT01061528|Nicotine|nicotine|mesh-list
102528576|NCT01061528|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102528577|NCT01061528|Autonomic Agents|autonomic agents|mesh-ancestor
102528578|NCT01061528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102528579|NCT01061528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528580|NCT01061528|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102528581|NCT01061528|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102528582|NCT01061528|Cholinergic Agents|cholinergic agents|mesh-ancestor
102528583|NCT01061528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102528584|NCT01061528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528585|NCT01062230|Bortezomib|bortezomib|mesh-list
102528586|NCT01062230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102528587|NCT01064882|Bimatoprost|bimatoprost|mesh-list
102528588|NCT01064882|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102528589|NCT01064882|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102528590|NCT01064882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102528591|NCT01065506|Nicotine|nicotine|mesh-list
102528592|NCT01065506|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102528593|NCT01065506|Autonomic Agents|autonomic agents|mesh-ancestor
102528594|NCT01065506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102528595|NCT01065506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528596|NCT01065506|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102528597|NCT01065506|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102528598|NCT01065506|Cholinergic Agents|cholinergic agents|mesh-ancestor
102528599|NCT01065506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102004906|NCT01291511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102528600|NCT01065506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528601|NCT03817736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102528602|NCT03817736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528603|NCT03817736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102528604|NCT03817736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102528605|NCT03811886|Natalizumab|natalizumab|mesh-list
102528606|NCT03811886|Immunologic Factors|immunologic factors|mesh-ancestor
102528607|NCT03811886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528608|NCT01066364|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
102528609|NCT01066364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102528610|NCT01066364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102528611|NCT01066364|Antimetabolites|antimetabolites|mesh-ancestor
102528612|NCT01066364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528613|NCT01066364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102528614|NCT01066520|Diclofenac|diclofenac|mesh-list
102528615|NCT01066520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102528616|NCT01066520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102528617|NCT01066520|Analgesics|analgesics|mesh-ancestor
102528618|NCT01066520|Sensory System Agents|sensory system agents|mesh-ancestor
102528619|NCT01066520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102528620|NCT01066520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528621|NCT01066520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102528622|NCT01066520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102528623|NCT01066520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102528624|NCT01066520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102528625|NCT01066520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528626|NCT03014804|Nivolumab|nivolumab|mesh-list
102528627|NCT03014804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102528628|NCT03014804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102528629|NCT03014804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102528630|NCT03014804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528631|NCT05224388|Heparin|heparin|mesh-list
102528632|NCT05224388|Enoxaparin|enoxaparin|mesh-list
102528633|NCT05224388|Anticoagulants|anticoagulants|mesh-ancestor
102528634|NCT05224388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102528635|NCT05224388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102528636|NCT05224388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528637|NCT03520790|Paclitaxel|paclitaxel|mesh-list
102528638|NCT03520790|Gemcitabine|gemcitabine|mesh-list
102528639|NCT03520790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102528640|NCT03520790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102528641|NCT03520790|Tubulin Modulators|tubulin modulators|mesh-ancestor
102528642|NCT03520790|Antimitotic Agents|antimitotic agents|mesh-ancestor
102528643|NCT03520790|Mitosis Modulators|mitosis modulators|mesh-ancestor
102528644|NCT03520790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528645|NCT03520790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102528646|NCT03520790|Antimetabolites|antimetabolites|mesh-ancestor
102528647|NCT02416908|Cytarabine|cytarabine|mesh-list
102528648|NCT02416908|Plerixafor|plerixafor|mesh-list
102528649|NCT02416908|2'-deoxyadenosine|2'-deoxyadenosine|mesh-list
102528650|NCT02416908|Cladribine|cladribine|mesh-list
102528651|NCT02416908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102528652|NCT02416908|Antimetabolites|antimetabolites|mesh-ancestor
102528653|NCT02416908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528654|NCT02416908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102528655|NCT02416908|Antiviral Agents|antiviral agents|mesh-ancestor
102528656|NCT02416908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102528657|NCT02416908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102528658|NCT02416908|Immunologic Factors|immunologic factors|mesh-ancestor
102528659|NCT02416908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528660|NCT02416908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102528661|NCT02416908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102528662|NCT01070810|Thiamine|thiamine|mesh-list
102528663|NCT01070810|Vitamin B Complex|vitamin b complex|mesh-ancestor
102528664|NCT01070810|Vitamins|vitamins|mesh-ancestor
102528665|NCT01070810|Micronutrients|micronutrients|mesh-ancestor
102528666|NCT01070810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528667|NCT01071044|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102528668|NCT01071044|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102528669|NCT01071044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528670|NCT01071044|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102528671|NCT01071044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102528672|NCT01071044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102528673|NCT01071044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528674|NCT01071044|Dopamine Agents|dopamine agents|mesh-ancestor
102528675|NCT01071044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102528676|NCT05150756|Lidocaine|lidocaine|mesh-list
102528677|NCT05150756|Morphine|morphine|mesh-list
102528678|NCT05150756|Anesthetics, Local|anesthetics, local|mesh-ancestor
102528679|NCT05150756|Anesthetics|anesthetics|mesh-ancestor
102528680|NCT05150756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102528681|NCT05150756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528682|NCT05150756|Sensory System Agents|sensory system agents|mesh-ancestor
102528683|NCT05150756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102528684|NCT05150756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102528685|NCT05150756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102528686|NCT05150756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102528687|NCT05150756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102528688|NCT05150756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528689|NCT05150756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102528690|NCT05150756|Narcotics|narcotics|mesh-ancestor
102528691|NCT05150756|Analgesics|analgesics|mesh-ancestor
102528692|NCT01072136|Azithromycin|azithromycin|mesh-list
102528693|NCT01072136|Cefixime|cefixime|mesh-list
102528694|NCT01072136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102528695|NCT01072136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102528696|NCT05135858|Methotrexate|methotrexate|mesh-list
102528697|NCT05135858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102528698|NCT05135858|Abortifacient Agents|abortifacient agents|mesh-ancestor
102528699|NCT05135858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102528700|NCT05135858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528701|NCT05135858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102528702|NCT05135858|Antimetabolites|antimetabolites|mesh-ancestor
102528703|NCT05135858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528704|NCT05135858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102528705|NCT05135858|Dermatologic Agents|dermatologic agents|mesh-ancestor
102528706|NCT05135858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102528707|NCT05135858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102528708|NCT05135858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102528709|NCT05135858|Immunologic Factors|immunologic factors|mesh-ancestor
102528710|NCT05135858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102528711|NCT05135858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102528712|NCT03012230|Pembrolizumab|pembrolizumab|mesh-list
102528713|NCT03012230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102528714|NCT03012230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102528715|NCT03012230|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102528716|NCT03012230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528717|NCT03005444|Enoxaparin|enoxaparin|mesh-list
102528718|NCT03005444|Nadroparin|nadroparin|mesh-list
102528719|NCT03005444|Rivaroxaban|rivaroxaban|mesh-list
102528720|NCT03005444|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102528721|NCT03005444|Antithrombins|antithrombins|mesh-ancestor
102528722|NCT03005444|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102528723|NCT03005444|Protease Inhibitors|protease inhibitors|mesh-ancestor
102528724|NCT03005444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102528725|NCT03005444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528726|NCT03005444|Anticoagulants|anticoagulants|mesh-ancestor
102528727|NCT03005444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102528728|NCT03005444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102528729|NCT01076270|Plerixafor|plerixafor|mesh-list
102528730|NCT01076270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102528731|NCT01076270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102528732|NCT01076270|Antiviral Agents|antiviral agents|mesh-ancestor
102005043|NCT04507750|Apatinib|apatinib|mesh-list
102528733|NCT01076270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102528734|NCT01076504|Carboplatin|carboplatin|mesh-list
102528735|NCT01076504|Amrubicin|amrubicin|mesh-list
102528736|NCT01076504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102528737|NCT01076972|Ritonavir|ritonavir|mesh-list
102528738|NCT01076972|Lopinavir|lopinavir|mesh-list
102528739|NCT01076972|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102528740|NCT01076972|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102528741|NCT01076972|Protease Inhibitors|protease inhibitors|mesh-ancestor
102528742|NCT01076972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102528743|NCT01076972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528744|NCT01076972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102528745|NCT01076972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102528746|NCT01076972|Antiviral Agents|antiviral agents|mesh-ancestor
102528747|NCT01076972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102528748|NCT01076972|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102528749|NCT01076972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102528750|NCT02174432|Nalbuphine|nalbuphine|mesh-list
102528751|NCT02174432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102528752|NCT02174432|Narcotics|narcotics|mesh-ancestor
102528753|NCT02174432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102528754|NCT02174432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528755|NCT02174432|Analgesics|analgesics|mesh-ancestor
102528756|NCT02174432|Sensory System Agents|sensory system agents|mesh-ancestor
102528757|NCT02174432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102528758|NCT02176382|Zoledronic Acid|zoledronic acid|mesh-list
102528759|NCT02176382|Denosumab|denosumab|mesh-list
102528760|NCT02176382|Teriparatide|teriparatide|mesh-list
102528761|NCT02176382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102528762|NCT02176382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528763|NCT02176382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102528764|NCT01077596|Bupropion|bupropion|mesh-list
102528765|NCT01077596|Antidepressive Agents|antidepressive agents|mesh-list
102528766|NCT01077596|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
102528767|NCT01077596|Serotonin|serotonin|mesh-list
102528768|NCT01077596|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
102528769|NCT01077596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102528770|NCT01077596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102528771|NCT01077596|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102528772|NCT01077596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102340317|NCT02400814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102528773|NCT01077596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102528774|NCT01077596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528775|NCT01077596|Dopamine Agents|dopamine agents|mesh-ancestor
102528776|NCT01077596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102528777|NCT01077596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528778|NCT01077596|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102528779|NCT01077596|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102528780|NCT01077596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102528781|NCT01077596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102528782|NCT01077596|Serotonin Agents|serotonin agents|mesh-ancestor
102528783|NCT03013712|Immunomodulating Agents|immunomodulating agents|mesh-list
102528784|NCT03013712|Immunologic Factors|immunologic factors|mesh-ancestor
102528785|NCT03013712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528786|NCT02740868|Xenon|xenon|mesh-list
102528787|NCT02740868|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102528788|NCT02740868|Anesthetics, General|anesthetics, general|mesh-ancestor
102528789|NCT02740868|Anesthetics|anesthetics|mesh-ancestor
102528790|NCT02740868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102528791|NCT02740868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528792|NCT02414958|Empagliflozin|empagliflozin|mesh-list
102528793|NCT02414958|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102528794|NCT02414958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528795|NCT02414958|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102528796|NCT02414958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528797|NCT03016208|Misoprostol|misoprostol|mesh-list
102528798|NCT03016208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102528799|NCT03016208|Abortifacient Agents|abortifacient agents|mesh-ancestor
102528800|NCT03016208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102528801|NCT03016208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005111|NCT01060579|Latanoprost|latanoprost|mesh-list
102528802|NCT03016208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102528803|NCT03016208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102528804|NCT03016208|Oxytocics|oxytocics|mesh-ancestor
102528805|NCT03013790|Melatonin|melatonin|mesh-list
102528806|NCT03013790|Antioxidants|antioxidants|mesh-ancestor
102528807|NCT03013790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528808|NCT03013790|Protective Agents|protective agents|mesh-ancestor
102528809|NCT03013790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528810|NCT03013790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102528811|NCT01078376|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
102528812|NCT01078376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102528813|NCT01078376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102528814|NCT01078376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528815|NCT02485184|Propranolol|propranolol|mesh-list
102528816|NCT02485184|Warfarin|warfarin|mesh-list
102528817|NCT02485184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102528818|NCT02485184|Anticoagulants|anticoagulants|mesh-ancestor
102528819|NCT02485184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102528820|NCT02485184|Adrenergic Agents|adrenergic agents|mesh-ancestor
102528821|NCT02485184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102528822|NCT02485184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528823|NCT02485184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528824|NCT02485184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102528825|NCT02485184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102528826|NCT02485184|Vasodilator Agents|vasodilator agents|mesh-ancestor
102528827|NCT03015818|Calcium|calcium|mesh-list
102528828|NCT03015818|Fluorides|fluorides|mesh-list
102528829|NCT03015818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102528830|NCT03015818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528831|NCT03015818|Cariostatic Agents|cariostatic agents|mesh-ancestor
102528832|NCT03015818|Protective Agents|protective agents|mesh-ancestor
102528833|NCT01080248|Gemcitabine|gemcitabine|mesh-list
102528834|NCT01080248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102528835|NCT01080248|Antimetabolites|antimetabolites|mesh-ancestor
102528836|NCT01080248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528837|NCT01080248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102528838|NCT02452476|Poractant alfa|poractant alfa|mesh-list
102528839|NCT02452476|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
102528840|NCT02452476|Respiratory System Agents|respiratory system agents|mesh-ancestor
102528841|NCT01082588|Pravastatin|pravastatin|mesh-list
102528842|NCT01082588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102528843|NCT01082588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102528844|NCT01082588|Antimetabolites|antimetabolites|mesh-ancestor
102340404|NCT01928056|Montelukast|montelukast|mesh-list
102528845|NCT01082588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528846|NCT01082588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102528847|NCT01082588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102528848|NCT01082588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102528849|NCT02413398|Dapagliflozin|dapagliflozin|mesh-list
102528850|NCT02413398|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102528851|NCT02413398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528852|NCT02413398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102528853|NCT02413398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528854|NCT02441946|Anastrozole|anastrozole|mesh-list
102528855|NCT02441946|Loperamide|loperamide|mesh-list
102528856|NCT02441946|Antidiarrheals|antidiarrheals|mesh-list
102528857|NCT02441946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102528858|NCT02441946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102528859|NCT02441946|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102528860|NCT02441946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102528861|NCT02441946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102528862|NCT02441946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528863|NCT02441946|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102528864|NCT02441946|Hormone Antagonists|hormone antagonists|mesh-ancestor
102528865|NCT02441946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102528866|NCT02441946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528867|NCT02441946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102528868|NCT01083368|Sirolimus|sirolimus|mesh-list
102528869|NCT01083368|Bevacizumab|bevacizumab|mesh-list
102528870|NCT01083368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102528871|NCT01083368|Temsirolimus|temsirolimus|mesh-list
102528872|NCT01083368|MTOR Inhibitors|mtor inhibitors|mesh-list
102528873|NCT01083368|Antibodies|antibodies|mesh-list
102528874|NCT01083368|Immunoglobulins|immunoglobulins|mesh-list
102528875|NCT01083368|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102528876|NCT01083368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102528877|NCT01083368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102528878|NCT01083368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102528879|NCT01083368|Growth Substances|growth substances|mesh-ancestor
102528880|NCT01083368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528881|NCT01083368|Growth Inhibitors|growth inhibitors|mesh-ancestor
102528882|NCT01083368|Immunologic Factors|immunologic factors|mesh-ancestor
102528883|NCT01083368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102528884|NCT01083368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102528885|NCT01083368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102528886|NCT01083368|Antifungal Agents|antifungal agents|mesh-ancestor
102528887|NCT01083368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102528888|NCT01083368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102528889|NCT01083368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102528890|NCT01083368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528891|NCT02387580|Artefenomel|artefenomel|mesh-list
102528892|NCT02387580|Antimalarials|antimalarials|mesh-ancestor
102528893|NCT02387580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102528894|NCT02387580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102528895|NCT02387580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102528896|NCT02440854|Afatinib|afatinib|mesh-list
102528897|NCT02440854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102528898|NCT02440854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102528899|NCT02440854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102528900|NCT02440854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528901|NCT01084148|V0034CR|v0034cr|mesh-list
102528902|NCT01084148|Emollients|emollients|mesh-ancestor
102528903|NCT01084148|Dermatologic Agents|dermatologic agents|mesh-ancestor
102528904|NCT01085006|Tranexamic Acid|tranexamic acid|mesh-list
102528905|NCT01085006|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102528906|NCT01085006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102528907|NCT01085006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528908|NCT01085006|Hemostatics|hemostatics|mesh-ancestor
102528909|NCT01085006|Coagulants|coagulants|mesh-ancestor
102528910|NCT01085786|Amoxicillin|amoxicillin|mesh-list
102528911|NCT01085786|Metronidazole|metronidazole|mesh-list
102528912|NCT01085786|Clarithromycin|clarithromycin|mesh-list
102528913|NCT01085786|Esomeprazole|esomeprazole|mesh-list
102528914|NCT01085786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102528915|NCT01085786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102528916|NCT01085786|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102528917|NCT01085786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102528918|NCT01085786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102528919|NCT01085786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102528920|NCT01085786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102528921|NCT01085786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612359|NCT00002423|Antitubercular Agents|antitubercular agents|mesh-ancestor
102528922|NCT01085786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528923|NCT01085786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102528924|NCT01085786|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102528925|NCT01085786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102528926|NCT02170220|Vortioxetine|vortioxetine|mesh-list
102528927|NCT02170220|Antidepressive Agents|antidepressive agents|mesh-ancestor
102528928|NCT02170220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102528929|NCT02170220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102528930|NCT02170220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102528931|NCT02170220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102528932|NCT02170220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528933|NCT02170220|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102528934|NCT02170220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102528935|NCT02170220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102528936|NCT02170220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528937|NCT02170220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102528938|NCT02170220|Serotonin Agents|serotonin agents|mesh-ancestor
102528939|NCT02170220|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102528940|NCT02170220|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102528941|NCT02170220|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102528942|NCT02170220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102528943|NCT01036802|Warfarin|warfarin|mesh-list
102528944|NCT01036802|Anticoagulants|anticoagulants|mesh-ancestor
102528945|NCT01037192|Vancomycin|vancomycin|mesh-list
102528946|NCT01037192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102528947|NCT01037192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102528948|NCT02386098|Ritonavir|ritonavir|mesh-list
102528949|NCT02386098|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102528950|NCT02386098|Tenofovir|tenofovir|mesh-list
102528951|NCT02386098|Dolutegravir|dolutegravir|mesh-list
102528952|NCT02386098|BMS-955176|bms-955176|mesh-list
102528953|NCT02386098|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102528954|NCT02386098|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102528955|NCT02386098|Protease Inhibitors|protease inhibitors|mesh-ancestor
102528956|NCT02386098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102528957|NCT02386098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528958|NCT02386098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102528959|NCT02386098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102528960|NCT02386098|Antiviral Agents|antiviral agents|mesh-ancestor
102528961|NCT02386098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102528962|NCT02386098|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102528963|NCT02386098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102528964|NCT02386098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102528965|NCT02386098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102528966|NCT02386098|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102528967|NCT02386098|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102528968|NCT01089062|Dihydroergotamine|dihydroergotamine|mesh-list
102528969|NCT01089062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102528970|NCT01089062|Dopamine Agonists|dopamine agonists|mesh-ancestor
102528971|NCT01089062|Dopamine Agents|dopamine agents|mesh-ancestor
102528972|NCT01089062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102528973|NCT01089062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102528974|NCT01089062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528975|NCT01089062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102528976|NCT01089062|Analgesics|analgesics|mesh-ancestor
102528977|NCT01089062|Sensory System Agents|sensory system agents|mesh-ancestor
102528978|NCT01089062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102528979|NCT02412618|Misoprostol|misoprostol|mesh-list
102528980|NCT02412618|Mifepristone|mifepristone|mesh-list
102528981|NCT02412618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102528982|NCT02412618|Abortifacient Agents|abortifacient agents|mesh-ancestor
102528983|NCT02412618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102528984|NCT02412618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102528985|NCT02412618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102528986|NCT02412618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102528987|NCT02412618|Oxytocics|oxytocics|mesh-ancestor
102528988|NCT02412618|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102528989|NCT02412618|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102528990|NCT02412618|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102528991|NCT02412618|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102528992|NCT02412618|Contraceptive Agents|contraceptive agents|mesh-ancestor
102528993|NCT02412618|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102528994|NCT02412618|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102528995|NCT02412618|Hormone Antagonists|hormone antagonists|mesh-ancestor
102528996|NCT02412618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102528997|NCT02412618|Luteolytic Agents|luteolytic agents|mesh-ancestor
102528998|NCT02412618|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102528999|NCT02412618|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102529000|NCT02179892|Acetaminophen|acetaminophen|mesh-list
102529001|NCT02179892|Dexamethasone|dexamethasone|mesh-list
102529002|NCT02179892|Dexamethasone acetate|dexamethasone acetate|mesh-list
102529003|NCT02179892|Bupivacaine|bupivacaine|mesh-list
102529004|NCT02179892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102529005|NCT02179892|Antiemetics|antiemetics|mesh-ancestor
102529006|NCT02179892|Autonomic Agents|autonomic agents|mesh-ancestor
102529007|NCT02179892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102529008|NCT02179892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529009|NCT02179892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102529010|NCT02179892|Glucocorticoids|glucocorticoids|mesh-ancestor
102529012|NCT02179892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102529013|NCT02179892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102529014|NCT02179892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102529015|NCT02179892|Anesthetics, Local|anesthetics, local|mesh-ancestor
102529016|NCT02179892|Anesthetics|anesthetics|mesh-ancestor
102529017|NCT02179892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102529018|NCT02179892|Sensory System Agents|sensory system agents|mesh-ancestor
102529019|NCT02179892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102529020|NCT02179892|Analgesics|analgesics|mesh-ancestor
102529021|NCT02179892|Antipyretics|antipyretics|mesh-ancestor
102529022|NCT01092338|Vitamin D|vitamin d|mesh-list
102529023|NCT01092338|Cholecalciferol|cholecalciferol|mesh-list
102529024|NCT01092338|Vitamins|vitamins|mesh-ancestor
102529025|NCT01092338|Micronutrients|micronutrients|mesh-ancestor
102529026|NCT01092338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529027|NCT01092338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102529028|NCT01092338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102529029|NCT01110434|Topiramate|topiramate|mesh-list
102529030|NCT01110434|Anticonvulsants|anticonvulsants|mesh-ancestor
102529031|NCT01110434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102529032|NCT01110434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529033|NCT01042496|Lamotrigine|lamotrigine|mesh-list
102529034|NCT01042496|Anticonvulsants|anticonvulsants|mesh-ancestor
102529035|NCT01042496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102529036|NCT01042496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102529037|NCT01042496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529038|NCT01042496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102529039|NCT01042496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529040|NCT01042496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102529041|NCT01042496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102529042|NCT01042496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102529043|NCT01042496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102529044|NCT01042496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102529045|NCT01111058|Everolimus|everolimus|mesh-list
102529046|NCT01111058|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102529047|NCT01111058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102529048|NCT01111058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102529049|NCT01111058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529050|NCT01111058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102529051|NCT01111058|Immunologic Factors|immunologic factors|mesh-ancestor
102529052|NCT01111058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529053|NCT01111058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102529054|NCT01094522|Morphine|morphine|mesh-list
102529055|NCT01094522|Methadone|methadone|mesh-list
102529056|NCT01094522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102529057|NCT01094522|Narcotics|narcotics|mesh-ancestor
102529058|NCT01094522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102529059|NCT01094522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529060|NCT01094522|Analgesics|analgesics|mesh-ancestor
102529061|NCT01094522|Sensory System Agents|sensory system agents|mesh-ancestor
102529062|NCT01094522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102529063|NCT01094522|Antitussive Agents|antitussive agents|mesh-ancestor
102529064|NCT01094522|Respiratory System Agents|respiratory system agents|mesh-ancestor
102529065|NCT02178800|Cabotegravir|cabotegravir|mesh-list
102529066|NCT02178800|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102529067|NCT02178800|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102529068|NCT02178800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102529069|NCT02178800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529070|NCT02178800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102340612|NCT02209636|Antioxidants|antioxidants|mesh-ancestor
102529071|NCT02178800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102529072|NCT02178800|Antiviral Agents|antiviral agents|mesh-ancestor
102529073|NCT02178800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102529075|NCT01044212|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
102529076|NCT01044212|Cathartics|cathartics|mesh-ancestor
102529077|NCT01044212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102529078|NCT01044212|Antidiarrheals|antidiarrheals|mesh-ancestor
102529079|NCT02174510|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102529080|NCT02174510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102529081|NCT02174510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102529082|NCT02174510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102529083|NCT02174510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529084|NCT02174510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102529085|NCT02174510|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102529086|NCT02174510|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102529087|NCT02174510|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102529088|NCT02174510|Adrenergic Agents|adrenergic agents|mesh-ancestor
102529089|NCT02174510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102529090|NCT02174510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529091|NCT02174510|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102529092|NCT02174510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102529093|NCT02174510|Serotonin Agents|serotonin agents|mesh-ancestor
102529094|NCT02174510|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102529095|NCT02174510|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102529096|NCT02174510|Dopamine Agents|dopamine agents|mesh-ancestor
102529097|NCT00585195|Itraconazole|itraconazole|mesh-list
102529098|NCT00585195|Rifampin|rifampin|mesh-list
102529099|NCT00585195|Crizotinib|crizotinib|mesh-list
102529100|NCT00585195|Antifungal Agents|antifungal agents|mesh-ancestor
102529101|NCT00585195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102529102|NCT00585195|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102529103|NCT00585195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102529104|NCT00585195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102529105|NCT00585195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529106|NCT00585195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102529107|NCT00585195|Hormone Antagonists|hormone antagonists|mesh-ancestor
102529108|NCT00585195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102529109|NCT00585195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529110|NCT00585195|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102529111|NCT00585195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102529112|NCT00585195|Antitubercular Agents|antitubercular agents|mesh-ancestor
102529113|NCT00585195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102529114|NCT00585195|Leprostatic Agents|leprostatic agents|mesh-ancestor
102529115|NCT00585195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102529116|NCT00585195|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102529117|NCT00585195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102529118|NCT00585195|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102529119|NCT00585195|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102529120|NCT00585195|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102529121|NCT00585195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102529122|NCT00585195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102529123|NCT00585195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102529124|NCT01113398|Bevacizumab|bevacizumab|mesh-list
102529125|NCT01113398|Rilotumumab|rilotumumab|mesh-list
102529126|NCT01113398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102529127|NCT01113398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102529128|NCT01113398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102529129|NCT01113398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102529130|NCT01113398|Growth Substances|growth substances|mesh-ancestor
102529131|NCT01113398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529132|NCT01113398|Growth Inhibitors|growth inhibitors|mesh-ancestor
102529133|NCT03013556|Tenofovir|tenofovir|mesh-list
102529134|NCT03013556|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102529135|NCT03013556|Interferon-alpha|interferon-alpha|mesh-list
102529136|NCT03013556|Antiviral Agents|antiviral agents|mesh-ancestor
102529137|NCT03013556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102529138|NCT03013556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102529139|NCT03013556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102529140|NCT03013556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102529141|NCT03013556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529142|NCT03013556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102529143|NCT03013556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102529144|NCT03013556|Immunologic Factors|immunologic factors|mesh-ancestor
102529145|NCT03013556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529146|NCT01113632|Ofatumumab|ofatumumab|mesh-list
102529147|NCT01113632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102529148|NCT00458835|Ciclesonide|ciclesonide|mesh-list
102529149|NCT00458835|Glucocorticoids|glucocorticoids|mesh-ancestor
102529150|NCT00458835|Hormones|hormones|mesh-ancestor
102529151|NCT00458835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102529152|NCT00458835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529153|NCT00458835|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102529154|NCT01044758|Levetiracetam|levetiracetam|mesh-list
102529155|NCT01044758|Anticonvulsants|anticonvulsants|mesh-ancestor
102529156|NCT01044758|Nootropic Agents|nootropic agents|mesh-ancestor
102529157|NCT01115582|Cholic Acids|cholic acids|mesh-list
102529158|NCT01115582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102529159|NCT03013400|Ebselen|ebselen|mesh-list
102529160|NCT03013400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102529161|NCT03013400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102529162|NCT03013400|Analgesics|analgesics|mesh-ancestor
102529163|NCT03013400|Sensory System Agents|sensory system agents|mesh-ancestor
102529164|NCT03013400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102529165|NCT03013400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529166|NCT03013400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102529167|NCT03013400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102529168|NCT03013400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102529169|NCT03013400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102529170|NCT03013400|Antioxidants|antioxidants|mesh-ancestor
102529171|NCT03013400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529172|NCT03013400|Protective Agents|protective agents|mesh-ancestor
102529173|NCT03013400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102529174|NCT03013400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102529175|NCT03013400|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102529176|NCT02439138|Idelalisib|idelalisib|mesh-list
102529177|NCT02439138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102529178|NCT02439138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102529179|NCT02439138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529180|NCT01097642|Cetuximab|cetuximab|mesh-list
102529181|NCT01097642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102529182|NCT01097642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102529183|NCT01048658|Sevoflurane|sevoflurane|mesh-list
102529184|NCT01048658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102529185|NCT01048658|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102529186|NCT01048658|Anesthetics, General|anesthetics, general|mesh-ancestor
102529187|NCT01048658|Anesthetics|anesthetics|mesh-ancestor
102529188|NCT01048658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102529189|NCT01048658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529190|NCT04341675|Sirolimus|sirolimus|mesh-list
102529191|NCT04341675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102529192|NCT04341675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102529193|NCT04341675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102529194|NCT04341675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102529195|NCT04341675|Antifungal Agents|antifungal agents|mesh-ancestor
102529196|NCT04341675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102529197|NCT04341675|Immunologic Factors|immunologic factors|mesh-ancestor
102529198|NCT04341675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529199|NCT02445807|Clobetasol|clobetasol|mesh-list
102529200|NCT02445807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102529201|NCT02445807|Glucocorticoids|glucocorticoids|mesh-ancestor
102529202|NCT02445807|Hormones|hormones|mesh-ancestor
102529203|NCT02445807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102529204|NCT02445807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529205|NCT00362973|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102529206|NCT00362973|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102529207|NCT00362973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529208|NCT01116986|Nicotine|nicotine|mesh-list
102529209|NCT01116986|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102529210|NCT01116986|Autonomic Agents|autonomic agents|mesh-ancestor
102529211|NCT01116986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102529212|NCT01116986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529213|NCT01116986|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102529214|NCT01116986|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102529215|NCT01116986|Cholinergic Agents|cholinergic agents|mesh-ancestor
102529216|NCT01116986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102529217|NCT01116986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529218|NCT01098500|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102340760|NCT02317744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102529219|NCT01098500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102529220|NCT01098500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102529221|NCT01098500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529223|NCT01099202|Hematinics|hematinics|mesh-ancestor
102529224|NCT02448303|Pembrolizumab|pembrolizumab|mesh-list
102529225|NCT02448303|Acalabrutinib|acalabrutinib|mesh-list
102529226|NCT02448303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102529227|NCT02448303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102529228|NCT02448303|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102529229|NCT02448303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529230|NCT02415855|Dabigatran|dabigatran|mesh-list
102529231|NCT02415855|Antithrombins|antithrombins|mesh-ancestor
102529232|NCT02415855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102529233|NCT02415855|Protease Inhibitors|protease inhibitors|mesh-ancestor
102529234|NCT02415855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102529235|NCT02415855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529236|NCT02415855|Anticoagulants|anticoagulants|mesh-ancestor
102529237|NCT00363285|Cyproterone Acetate|cyproterone acetate|mesh-list
102529238|NCT00363285|Hormones|hormones|mesh-list
102529239|NCT00363285|Cyproterone|cyproterone|mesh-list
102529240|NCT00363285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102529241|NCT00363285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529242|NCT00363285|Androgen Antagonists|androgen antagonists|mesh-ancestor
102529243|NCT00363285|Hormone Antagonists|hormone antagonists|mesh-ancestor
102529244|NCT00363285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102529245|NCT00363285|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102529246|NCT00363285|Contraceptive Agents|contraceptive agents|mesh-ancestor
102529247|NCT00363285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102529248|NCT02424357|Povidone-Iodine|povidone-iodine|mesh-list
102529249|NCT02424357|Povidone|povidone|mesh-list
102529250|NCT02424357|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102529251|NCT02424357|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102529252|NCT02424357|Plasma Substitutes|plasma substitutes|mesh-ancestor
102529253|NCT02424357|Blood Substitutes|blood substitutes|mesh-ancestor
102529254|NCT02424357|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102529255|NCT02424357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102529256|NCT02425449|Succinylcholine|succinylcholine|mesh-list
102529257|NCT02425449|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
102529258|NCT02425449|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102529259|NCT02425449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102529260|NCT02425449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102529261|NCT02425449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529262|NCT02455167|Ribavirin|ribavirin|mesh-list
102529263|NCT02455167|Sofosbuvir|sofosbuvir|mesh-list
102529264|NCT02455167|Antimetabolites|antimetabolites|mesh-ancestor
102529265|NCT02455167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529266|NCT02455167|Antiviral Agents|antiviral agents|mesh-ancestor
102529267|NCT02455167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102529268|NCT02434497|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102529269|NCT02434497|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102529270|NCT02434497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102529271|NCT02434497|Antimetabolites|antimetabolites|mesh-ancestor
102529272|NCT02434497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529273|NCT02434497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102529274|NCT02434497|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102529275|NCT02434497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102529276|NCT02435901|Cyclosporine|cyclosporine|mesh-list
102529277|NCT02435901|Mycophenolic Acid|mycophenolic acid|mesh-list
102529278|NCT02435901|Fludarabine|fludarabine|mesh-list
102529279|NCT02435901|Melphalan|melphalan|mesh-list
102529280|NCT02435901|Alemtuzumab|alemtuzumab|mesh-list
102529281|NCT02435901|Tacrolimus|tacrolimus|mesh-list
102529282|NCT02435901|Cyclosporins|cyclosporins|mesh-list
102529283|NCT02435901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102529284|NCT02435901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529285|NCT02435901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102529286|NCT02435901|Immunologic Factors|immunologic factors|mesh-ancestor
102529287|NCT02435901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529288|NCT02435901|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102529289|NCT02435901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102529290|NCT02435901|Antifungal Agents|antifungal agents|mesh-ancestor
102529291|NCT02435901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102529292|NCT02435901|Dermatologic Agents|dermatologic agents|mesh-ancestor
102529293|NCT02435901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102529294|NCT02435901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102529295|NCT02435901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102529296|NCT02435901|Antitubercular Agents|antitubercular agents|mesh-ancestor
102529297|NCT02435901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102529298|NCT02435901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102529299|NCT02435901|Alkylating Agents|alkylating agents|mesh-ancestor
102529300|NCT02435901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102529301|NCT02435901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102529302|NCT02437383|Propranolol|propranolol|mesh-list
102529303|NCT02437383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102529304|NCT02437383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102529305|NCT02437383|Adrenergic Agents|adrenergic agents|mesh-ancestor
102529306|NCT02437383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102529307|NCT02437383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529308|NCT02437383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529309|NCT02437383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102529310|NCT02437383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102529311|NCT02437383|Vasodilator Agents|vasodilator agents|mesh-ancestor
102529312|NCT02385708|Chlorhexidine|chlorhexidine|mesh-list
102529313|NCT02385708|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102529314|NCT02385708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102529315|NCT02385708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102529316|NCT02385708|Disinfectants|disinfectants|mesh-ancestor
102529317|NCT02385708|Dermatologic Agents|dermatologic agents|mesh-ancestor
102529318|NCT01099358|Fluorouracil|fluorouracil|mesh-list
102529319|NCT01099358|Cetuximab|cetuximab|mesh-list
102529320|NCT01099358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102529321|NCT01099358|Antimetabolites|antimetabolites|mesh-ancestor
102529322|NCT01099358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529323|NCT01099358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102529324|NCT01099358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102529325|NCT01099358|Immunologic Factors|immunologic factors|mesh-ancestor
102529326|NCT01099358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529327|NCT01099358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102529328|NCT01118624|Vitamins|vitamins|mesh-list
102529329|NCT01118624|Folic Acid|folic acid|mesh-list
102529330|NCT01118624|Vitamin B 12|vitamin b 12|mesh-list
102529331|NCT01118624|Vitamin B Complex|vitamin b complex|mesh-list
102529332|NCT01118624|10-deazaaminopterin|10-deazaaminopterin|mesh-list
102529333|NCT01118624|Aminopterin|aminopterin|mesh-list
102529334|NCT01118624|Micronutrients|micronutrients|mesh-ancestor
102529335|NCT01118624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529336|NCT01118624|Hematinics|hematinics|mesh-ancestor
102529337|NCT01118624|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102529338|NCT01118624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102529339|NCT01118624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529340|NCT01118624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102529341|NCT02439879|Thioctic Acid|thioctic acid|mesh-list
102529342|NCT02439879|Antioxidants|antioxidants|mesh-ancestor
102529343|NCT02439879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529344|NCT02439879|Protective Agents|protective agents|mesh-ancestor
102529345|NCT02439879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529346|NCT02439879|Vitamin B Complex|vitamin b complex|mesh-ancestor
102529347|NCT02439879|Vitamins|vitamins|mesh-ancestor
102529348|NCT02439879|Micronutrients|micronutrients|mesh-ancestor
102529349|NCT03371108|Insulin Glargine|insulin glargine|mesh-list
102529350|NCT03371108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102529351|NCT03371108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529352|NCT01100606|Pancrelipase|pancrelipase|mesh-list
102529353|NCT01100606|Pancreatin|pancreatin|mesh-list
102529354|NCT01100606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102529355|NCT03013010|Oxaliplatin|oxaliplatin|mesh-list
102529356|NCT03013010|Tegafur|tegafur|mesh-list
102529357|NCT03013010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102529358|NCT03013010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102529359|NCT03013010|Antimetabolites|antimetabolites|mesh-ancestor
102529360|NCT03013010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529361|NCT02518191|Goserelin|goserelin|mesh-list
102529362|NCT02518191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102529363|NCT02518191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102529364|NCT01119794|Bortezomib|bortezomib|mesh-list
102529365|NCT01119794|Ofatumumab|ofatumumab|mesh-list
102529366|NCT01119794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102529367|NCT02926196|Avelumab|avelumab|mesh-list
102529368|NCT02926196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102529369|NCT02926196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102340912|NCT01276600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102529370|NCT01103414|Pioglitazone|pioglitazone|mesh-list
102529371|NCT01103414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102529372|NCT01103414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529373|NCT02180828|Fluconazole|fluconazole|mesh-list
102529374|NCT02180828|Clotrimazole|clotrimazole|mesh-list
102529375|NCT02180828|Miconazole|miconazole|mesh-list
102529376|NCT02180828|Antifungal Agents|antifungal agents|mesh-ancestor
102529377|NCT02180828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102529378|NCT02180828|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102529379|NCT02180828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102529380|NCT02180828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102529381|NCT02180828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529382|NCT02180828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102529383|NCT02180828|Hormone Antagonists|hormone antagonists|mesh-ancestor
102529384|NCT02180828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102529385|NCT02180828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529386|NCT02180828|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102529387|NCT02180828|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102529388|NCT02180828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102529389|NCT02180828|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102529390|NCT02525523|Alicaforsen|alicaforsen|mesh-list
102529391|NCT02525523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102529392|NCT02525523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102529393|NCT02525523|Immunologic Factors|immunologic factors|mesh-ancestor
102529394|NCT02525523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529395|NCT02528409|Vortioxetine|vortioxetine|mesh-list
102529396|NCT02528409|Antidepressive Agents|antidepressive agents|mesh-ancestor
102529397|NCT02528409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102529398|NCT02528409|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102529399|NCT02528409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102529400|NCT02528409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102529401|NCT02528409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529402|NCT02528409|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102529403|NCT02528409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102529404|NCT02528409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102529405|NCT02528409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529406|NCT02528409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102529407|NCT02528409|Serotonin Agents|serotonin agents|mesh-ancestor
102529408|NCT02528409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102529409|NCT02528409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102529410|NCT02528409|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102529411|NCT02528409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102529412|NCT02530281|Glycopyrrolate|glycopyrrolate|mesh-list
102529413|NCT02530281|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102529414|NCT02530281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102529415|NCT02530281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102529416|NCT02530281|Cholinergic Agents|cholinergic agents|mesh-ancestor
102529417|NCT02530281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102529418|NCT02530281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529419|NCT02530281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529420|NCT03013634|Dexmedetomidine|dexmedetomidine|mesh-list
102529421|NCT03013634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102529422|NCT03013634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102529423|NCT03013634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529424|NCT03013634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102529425|NCT03013634|Analgesics|analgesics|mesh-ancestor
102529426|NCT03013634|Sensory System Agents|sensory system agents|mesh-ancestor
102529427|NCT03013634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102529428|NCT03013634|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102529429|NCT03013634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102529430|NCT03013634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102529431|NCT03013634|Adrenergic Agents|adrenergic agents|mesh-ancestor
102529432|NCT03013634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102529433|NCT03013634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529434|NCT02980094|Vitamins|vitamins|mesh-list
102529435|NCT02980094|Vitamin E|vitamin e|mesh-list
102529436|NCT02980094|Tocopherols|tocopherols|mesh-list
102529437|NCT02980094|Tocotrienols|tocotrienols|mesh-list
102529438|NCT02980094|alpha-Tocopherol|alpha-tocopherol|mesh-list
102529439|NCT02980094|Selenium|selenium|mesh-list
102529440|NCT02980094|Antioxidants|antioxidants|mesh-list
102529441|NCT02980094|Micronutrients|micronutrients|mesh-ancestor
102529442|NCT02980094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529443|NCT02980094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529444|NCT02980094|Protective Agents|protective agents|mesh-ancestor
102529445|NCT02980094|Trace Elements|trace elements|mesh-ancestor
102529446|NCT03013322|Physostigmine|physostigmine|mesh-list
102529447|NCT03013322|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102529448|NCT03013322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102529449|NCT03013322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529450|NCT03013322|Cholinergic Agents|cholinergic agents|mesh-ancestor
102529451|NCT03013322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102529452|NCT03013322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529453|NCT03013322|Miotics|miotics|mesh-ancestor
102529454|NCT03013322|Autonomic Agents|autonomic agents|mesh-ancestor
102529455|NCT03013322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102529456|NCT02469597|Furosemide|furosemide|mesh-list
102529457|NCT02469597|Diuretics|diuretics|mesh-ancestor
102529458|NCT02469597|Natriuretic Agents|natriuretic agents|mesh-ancestor
102529459|NCT02469597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529460|NCT02469597|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102529461|NCT02469597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102529462|NCT02469597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529463|NCT02183792|Furosemide|furosemide|mesh-list
102529464|NCT02183792|Tolvaptan|tolvaptan|mesh-list
102529465|NCT02183792|Diuretics|diuretics|mesh-ancestor
102529466|NCT02183792|Natriuretic Agents|natriuretic agents|mesh-ancestor
102529467|NCT02183792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529468|NCT02183792|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102529469|NCT02183792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102529470|NCT02183792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529471|NCT02183792|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102529472|NCT00363519|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102529473|NCT00363519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102529474|NCT00363519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529475|NCT00363519|Incretins|incretins|mesh-ancestor
102529476|NCT00363519|Hormones|hormones|mesh-ancestor
102529477|NCT00363519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102529478|NCT00363519|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102529479|NCT00363519|Protease Inhibitors|protease inhibitors|mesh-ancestor
102529480|NCT00363519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102529481|NCT00363519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529482|NCT04743687|Zanubrutinib|zanubrutinib|mesh-list
102529483|NCT04743687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102529484|NCT04743687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102529485|NCT04743687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102529486|NCT04743687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529487|NCT02542761|Carbon Fiber|carbon fiber|mesh-list
102529488|NCT02542761|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102529489|NCT02542761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102529490|NCT02475837|Vorapaxar|vorapaxar|mesh-list
102529491|NCT02475837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102529492|NCT01124786|Gemcitabine|gemcitabine|mesh-list
102529493|NCT01124786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102529494|NCT01124786|Antimetabolites|antimetabolites|mesh-ancestor
102529495|NCT01124786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529496|NCT01124786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102529497|NCT01125098|Amoxicillin|amoxicillin|mesh-list
102529498|NCT01125098|Clavulanic Acid|clavulanic acid|mesh-list
102529499|NCT01125098|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102529500|NCT01125098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102529501|NCT01125098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102529502|NCT01125098|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102529503|NCT01125098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102529504|NCT01125098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529505|NCT02478489|Naltrexone|naltrexone|mesh-list
102529506|NCT02478489|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102529507|NCT02478489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102529508|NCT02478489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529509|NCT02478489|Sensory System Agents|sensory system agents|mesh-ancestor
102529510|NCT02478489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102529511|NCT02322320|Lenalidomide|lenalidomide|mesh-list
102529512|NCT02322320|Immunologic Factors|immunologic factors|mesh-ancestor
102529513|NCT02322320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529514|NCT02322320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102529515|NCT02322320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102529516|NCT02322320|Growth Substances|growth substances|mesh-ancestor
102529517|NCT02322320|Growth Inhibitors|growth inhibitors|mesh-ancestor
102529518|NCT02322320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102529520|NCT05308160|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102529521|NCT05308160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529522|NCT05308160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102529523|NCT05308160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529524|NCT01127438|Fospropofol|fospropofol|mesh-list
102529525|NCT01127438|Propofol|propofol|mesh-list
102529526|NCT01127438|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102529527|NCT01127438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102529528|NCT01127438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529529|NCT01127438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102529530|NCT01127438|Anesthetics, General|anesthetics, general|mesh-ancestor
102529531|NCT01127438|Anesthetics|anesthetics|mesh-ancestor
102529532|NCT05307614|Moxifloxacin|moxifloxacin|mesh-list
102529533|NCT05307614|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102529534|NCT05307614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102529535|NCT05307614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102529536|NCT05307614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102529537|NCT05307614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102529538|NCT05307614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102529539|NCT05307614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529540|NCT05307614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102529541|NCT05307614|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102529542|NCT05307614|Contraceptive Agents|contraceptive agents|mesh-ancestor
102529543|NCT05307614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102005866|NCT03193047|Protease Inhibitors|protease inhibitors|mesh-ancestor
102529544|NCT05307614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529545|NCT05307614|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102529546|NCT05307614|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102529547|NCT05307614|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102529548|NCT02481219|Erythromycin|erythromycin|mesh-list
102529549|NCT02481219|Erythromycin Estolate|erythromycin estolate|mesh-list
102529550|NCT02481219|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
102529551|NCT02481219|Erythromycin stearate|erythromycin stearate|mesh-list
102529552|NCT02481219|Metoclopramide|metoclopramide|mesh-list
102529553|NCT02481219|Bisacodyl|bisacodyl|mesh-list
102529554|NCT02481219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102529555|NCT02481219|Antiemetics|antiemetics|mesh-ancestor
102529556|NCT02481219|Autonomic Agents|autonomic agents|mesh-ancestor
102529557|NCT02481219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102529558|NCT02481219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529559|NCT02481219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102529560|NCT02481219|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102529561|NCT02481219|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102529562|NCT02481219|Dopamine Agents|dopamine agents|mesh-ancestor
102529563|NCT02481219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102529564|NCT02481219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529565|NCT02481219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102529566|NCT02481219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102529567|NCT02481219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102529568|NCT02481219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102529569|NCT02481219|Cathartics|cathartics|mesh-ancestor
102529570|NCT02481219|Laxatives|laxatives|mesh-ancestor
102529571|NCT02481297|Rituximab|rituximab|mesh-list
102529572|NCT02481297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102529573|NCT02481297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102529574|NCT02481297|Immunologic Factors|immunologic factors|mesh-ancestor
102529575|NCT02481297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529576|NCT02481297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102529577|NCT02481375|Iron|iron|mesh-list
102529578|NCT02481375|Trace Elements|trace elements|mesh-list
102529579|NCT02481375|Micronutrients|micronutrients|mesh-list
102529580|NCT02481375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529581|NCT01164098|Rituximab|rituximab|mesh-list
102529582|NCT01164098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102529583|NCT01164098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102529584|NCT01164098|Immunologic Factors|immunologic factors|mesh-ancestor
102529585|NCT01164098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529586|NCT01164098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102529587|NCT01165112|Rituximab|rituximab|mesh-list
102529588|NCT01165112|Carboplatin|carboplatin|mesh-list
102529589|NCT01165112|Etoposide|etoposide|mesh-list
102529590|NCT01165112|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102529591|NCT01165112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102529592|NCT01165112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102529593|NCT01165112|Immunologic Factors|immunologic factors|mesh-ancestor
102529594|NCT01165112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529595|NCT01165112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102529596|NCT01165112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102529597|NCT01165112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102529598|NCT01165112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102529599|NCT01165112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102529600|NCT01165112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529601|NCT01165112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102529602|NCT01165112|Alkylating Agents|alkylating agents|mesh-ancestor
102529603|NCT01129778|Omeprazole|omeprazole|mesh-list
102529604|NCT01129778|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
102529605|NCT01129778|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
102529606|NCT01129778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102529607|NCT01129778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102529608|NCT01129778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102529609|NCT01129778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529610|NCT02556333|Tenofovir|tenofovir|mesh-list
102529611|NCT02556333|Emtricitabine|emtricitabine|mesh-list
102529612|NCT02556333|Antiviral Agents|antiviral agents|mesh-ancestor
102529613|NCT02556333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102529614|NCT02556333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102529615|NCT02556333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102529616|NCT02556333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102005930|NCT03346642|Decitabine|decitabine|mesh-list
102529617|NCT02556333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529618|NCT02556333|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102529619|NCT02556333|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102529620|NCT01166126|Sirolimus|sirolimus|mesh-list
102529621|NCT01166126|Temsirolimus|temsirolimus|mesh-list
102529622|NCT01166126|MTOR Inhibitors|mtor inhibitors|mesh-list
102529623|NCT01166126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102529624|NCT01166126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102529625|NCT01166126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529626|NCT01166126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102529627|NCT01166126|Immunologic Factors|immunologic factors|mesh-ancestor
102529628|NCT01166126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529629|NCT01166126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102529630|NCT01166126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102529631|NCT01166126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102529632|NCT01166126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102529633|NCT01166126|Antifungal Agents|antifungal agents|mesh-ancestor
102529634|NCT05306990|Atorvastatin|atorvastatin|mesh-list
102529635|NCT05306990|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102529636|NCT05306990|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102529637|NCT05306990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102529638|NCT05306990|Antimetabolites|antimetabolites|mesh-ancestor
102529639|NCT05306990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529640|NCT05306990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102529641|NCT05306990|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102529642|NCT05306990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102529643|NCT02557035|Dexamethasone|dexamethasone|mesh-list
102529644|NCT02557035|Palonosetron|palonosetron|mesh-list
102529645|NCT02557035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102529646|NCT02557035|Antiemetics|antiemetics|mesh-ancestor
102529647|NCT02557035|Autonomic Agents|autonomic agents|mesh-ancestor
102529648|NCT02557035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102529649|NCT02557035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529650|NCT02557035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102529651|NCT02557035|Glucocorticoids|glucocorticoids|mesh-ancestor
102529652|NCT02557035|Hormones|hormones|mesh-ancestor
102529653|NCT02557035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102529654|NCT02557035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102529655|NCT02557035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102529656|NCT02557035|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102529657|NCT02557035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102529658|NCT02557035|Serotonin Agents|serotonin agents|mesh-ancestor
102529659|NCT02557035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102529660|NCT02557035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529661|NCT04341207|Azithromycin|azithromycin|mesh-list
102529662|NCT04341207|Hydroxychloroquine|hydroxychloroquine|mesh-list
102529663|NCT04341207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102529664|NCT04341207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102529665|NCT04341207|Antimalarials|antimalarials|mesh-ancestor
102529666|NCT04341207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102341213|NCT00199108|Dexamethasone|dexamethasone|mesh-list
102529667|NCT04341207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102529668|NCT04341207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102529669|NCT04341207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529670|NCT04341207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102529671|NCT02411292|Enoxaparin|enoxaparin|mesh-list
102529672|NCT02411292|Anticoagulants|anticoagulants|mesh-ancestor
102529673|NCT02411292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102529674|NCT02411292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102529675|NCT02411292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529676|NCT02486211|Amantadine|amantadine|mesh-list
102529677|NCT02486211|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102529678|NCT02486211|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102529679|NCT02486211|Antiviral Agents|antiviral agents|mesh-ancestor
102529680|NCT02486211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102529681|NCT02486211|Dopamine Agents|dopamine agents|mesh-ancestor
102529682|NCT02486211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102529683|NCT02486211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529684|NCT02486211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529685|NCT02486211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102529686|NCT02486211|Analgesics|analgesics|mesh-ancestor
102529687|NCT02486211|Sensory System Agents|sensory system agents|mesh-ancestor
102529688|NCT02486211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102529689|NCT01167452|Trimethoprim|trimethoprim|mesh-list
102529690|NCT01167452|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102529691|NCT01167452|Sulfamethoxazole|sulfamethoxazole|mesh-list
102529692|NCT01167452|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102529693|NCT01167452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102529694|NCT01167452|Antimalarials|antimalarials|mesh-ancestor
102529695|NCT01167452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102529696|NCT01167452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102529697|NCT01167452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102529698|NCT01167452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102529699|NCT01167452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529700|NCT01167452|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102529701|NCT01167452|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102529702|NCT01167452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102529703|NCT01167452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102529704|NCT02487225|Pentoxifylline|pentoxifylline|mesh-list
102529705|NCT02487225|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102529706|NCT02487225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102529707|NCT02487225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529708|NCT02487225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102529709|NCT02487225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102529710|NCT02487225|Protective Agents|protective agents|mesh-ancestor
102529711|NCT02487225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529712|NCT02487225|Vasodilator Agents|vasodilator agents|mesh-ancestor
102529713|NCT02487225|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102529714|NCT02487225|Antioxidants|antioxidants|mesh-ancestor
102529715|NCT02384850|Leucovorin|leucovorin|mesh-list
102529716|NCT02384850|Folic Acid|folic acid|mesh-list
102529717|NCT02384850|Fluorouracil|fluorouracil|mesh-list
102529718|NCT02384850|Oxaliplatin|oxaliplatin|mesh-list
102529719|NCT02384850|Levoleucovorin|levoleucovorin|mesh-list
102529720|NCT02384850|Antimetabolites|antimetabolites|mesh-ancestor
102529721|NCT02384850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529722|NCT02384850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102529723|NCT02384850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102529724|NCT02384850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102529725|NCT02384850|Immunologic Factors|immunologic factors|mesh-ancestor
102529726|NCT02384850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529727|NCT02384850|Antidotes|antidotes|mesh-ancestor
102529728|NCT02384850|Protective Agents|protective agents|mesh-ancestor
102529729|NCT02384850|Vitamin B Complex|vitamin b complex|mesh-ancestor
102529730|NCT02384850|Vitamins|vitamins|mesh-ancestor
102529731|NCT02384850|Micronutrients|micronutrients|mesh-ancestor
102529732|NCT02384850|Hematinics|hematinics|mesh-ancestor
102529733|NCT02558829|Insulin|insulin|mesh-list
102529734|NCT02558829|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102529735|NCT02558829|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102529736|NCT02558829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529737|NCT02487303|Acetaminophen|acetaminophen|mesh-list
102529738|NCT02487303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102529739|NCT02487303|Analgesics|analgesics|mesh-ancestor
102529740|NCT02487303|Sensory System Agents|sensory system agents|mesh-ancestor
102529741|NCT02487303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102529742|NCT02487303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529743|NCT02487303|Antipyretics|antipyretics|mesh-ancestor
102529744|NCT01168934|Crizotinib|crizotinib|mesh-list
102529745|NCT01168934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102529746|NCT01168934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102529747|NCT01168934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102529748|NCT01168934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529749|NCT05305508|Mannitol|mannitol|mesh-list
102529750|NCT05305508|Calcium Dobesilate|calcium dobesilate|mesh-list
102529751|NCT05305508|Calcium|calcium|mesh-list
102529752|NCT05305508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102529753|NCT05305508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529754|NCT05305508|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102529755|NCT05305508|Diuretics|diuretics|mesh-ancestor
102529756|NCT05305508|Natriuretic Agents|natriuretic agents|mesh-ancestor
102529757|NCT05305508|Hemostatics|hemostatics|mesh-ancestor
102529758|NCT05305508|Coagulants|coagulants|mesh-ancestor
102529759|NCT01170884|Timolol|timolol|mesh-list
102529760|NCT01170884|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102529761|NCT01170884|Bimatoprost|bimatoprost|mesh-list
102529762|NCT01170884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102529763|NCT01170884|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102529764|NCT01170884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529765|NCT01170884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102529766|NCT01170884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102529767|NCT01170884|Adrenergic Agents|adrenergic agents|mesh-ancestor
102529768|NCT01170884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102529769|NCT01170884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529770|NCT01170884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102529771|NCT01170884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102529772|NCT01170884|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102529773|NCT01170884|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102529774|NCT01170884|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102529775|NCT01171118|Physostigmine|physostigmine|mesh-list
102529776|NCT01171118|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102529777|NCT01171118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102529778|NCT01171118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529779|NCT01171118|Cholinergic Agents|cholinergic agents|mesh-ancestor
102529780|NCT01171118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102529781|NCT01171118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529782|NCT01171118|Miotics|miotics|mesh-ancestor
102529783|NCT01171118|Autonomic Agents|autonomic agents|mesh-ancestor
102529784|NCT01171118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102529785|NCT03011918|Vitamin D|vitamin d|mesh-list
102529786|NCT03011918|Vitamins|vitamins|mesh-ancestor
102529787|NCT03011918|Micronutrients|micronutrients|mesh-ancestor
102529788|NCT03011918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529789|NCT03011918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102529790|NCT05296460|Dapsone|dapsone|mesh-list
102529791|NCT05296460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102529792|NCT05296460|Antimalarials|antimalarials|mesh-ancestor
102529793|NCT05296460|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102529794|NCT05296460|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102529795|NCT05296460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102529796|NCT05296460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102529797|NCT05296460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529798|NCT05296460|Leprostatic Agents|leprostatic agents|mesh-ancestor
102529799|NCT05296460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102529800|NCT01136798|Exenatide|exenatide|mesh-list
102529801|NCT01136798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102529802|NCT01136798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529803|NCT01136798|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102529804|NCT01136798|Incretins|incretins|mesh-ancestor
102529805|NCT01136798|Hormones|hormones|mesh-ancestor
102529806|NCT01136798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102529807|NCT01172522|Fexofenadine|fexofenadine|mesh-list
102529808|NCT01172522|Terfenadine|terfenadine|mesh-list
102529809|NCT01172522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102529810|NCT01172522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102529811|NCT01172522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102529812|NCT01172522|Histamine Antagonists|histamine antagonists|mesh-ancestor
102529813|NCT01172522|Histamine Agents|histamine agents|mesh-ancestor
102529814|NCT01172522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102529815|NCT01172522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529816|NCT01172522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529817|NCT01172600|Nitrous Oxide|nitrous oxide|mesh-list
102529818|NCT01172600|Entonox|entonox|mesh-list
102529819|NCT01172600|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102529820|NCT01172600|Anesthetics, General|anesthetics, general|mesh-ancestor
102529821|NCT01172600|Anesthetics|anesthetics|mesh-ancestor
102529822|NCT01172600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102529823|NCT01172600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529824|NCT01172600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102529826|NCT01172600|Sensory System Agents|sensory system agents|mesh-ancestor
102529827|NCT01172600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102529828|NCT01172600|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
102529829|NCT02246816|Opium|opium|mesh-list
102529830|NCT02246816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102529831|NCT02246816|Narcotics|narcotics|mesh-ancestor
102529832|NCT02246816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102529833|NCT02246816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529834|NCT02246816|Analgesics|analgesics|mesh-ancestor
102529835|NCT02246816|Sensory System Agents|sensory system agents|mesh-ancestor
102529836|NCT02246816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102529837|NCT02246816|Antidiarrheals|antidiarrheals|mesh-ancestor
102529838|NCT02246816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102529839|NCT02246816|Antitussive Agents|antitussive agents|mesh-ancestor
102529840|NCT02246816|Respiratory System Agents|respiratory system agents|mesh-ancestor
102529841|NCT01137890|Zonisamide|zonisamide|mesh-list
102529842|NCT01137890|Cocaine|cocaine|mesh-list
102529843|NCT01137890|Anticonvulsants|anticonvulsants|mesh-ancestor
102529844|NCT01137890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102529845|NCT01137890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102529846|NCT01137890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529847|NCT01137890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102529848|NCT01137890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529849|NCT01137890|Anesthetics, Local|anesthetics, local|mesh-ancestor
102529850|NCT01137890|Anesthetics|anesthetics|mesh-ancestor
102529851|NCT01137890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102529852|NCT01137890|Sensory System Agents|sensory system agents|mesh-ancestor
102529853|NCT01137890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102529854|NCT01137890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102529855|NCT01137890|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102529856|NCT01137890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102529857|NCT01137890|Dopamine Agents|dopamine agents|mesh-ancestor
102529858|NCT01137890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102529859|NCT01138124|Gabapentin|gabapentin|mesh-list
102529860|NCT01138124|Analgesics|analgesics|mesh-ancestor
102529861|NCT01138124|Sensory System Agents|sensory system agents|mesh-ancestor
102529862|NCT01138124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102529863|NCT01138124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529864|NCT01138124|Anticonvulsants|anticonvulsants|mesh-ancestor
102529865|NCT01138124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102529866|NCT01138124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102529867|NCT01138124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102529868|NCT01138124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102529869|NCT01138124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102529870|NCT01138124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102529871|NCT01138124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102529872|NCT01138124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529873|NCT01138124|Antimanic Agents|antimanic agents|mesh-ancestor
102529874|NCT02560779|Sorafenib|sorafenib|mesh-list
102529875|NCT02560779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102529876|NCT02560779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102529877|NCT02560779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102529878|NCT02560779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529879|NCT01138514|Clindamycin|clindamycin|mesh-list
102529880|NCT01138514|Clindamycin palmitate|clindamycin palmitate|mesh-list
102529881|NCT01138514|Clindamycin phosphate|clindamycin phosphate|mesh-list
102529882|NCT01138514|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102529883|NCT01138514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102529884|NCT01138514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102529885|NCT01138514|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102529886|NCT01138514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102529887|NCT01138514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529888|NCT01138514|Dermatologic Agents|dermatologic agents|mesh-ancestor
102529889|NCT02561481|Sulforaphane|sulforaphane|mesh-list
102529890|NCT02561481|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102529891|NCT02561481|Protective Agents|protective agents|mesh-ancestor
102529892|NCT02561481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529893|NCT02561481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102529894|NCT01173848|Cholecalciferol|cholecalciferol|mesh-list
102529895|NCT01173848|Vitamin D|vitamin d|mesh-list
102529896|NCT01173848|Ergocalciferols|ergocalciferols|mesh-list
102529897|NCT01173848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102529898|NCT01173848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529900|NCT01173848|Micronutrients|micronutrients|mesh-ancestor
102529901|NCT01173848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102529902|NCT01174082|Vaccines|vaccines|mesh-list
102529903|NCT01174082|Sargramostim|sargramostim|mesh-list
102529904|NCT01174082|Immunologic Factors|immunologic factors|mesh-ancestor
102529905|NCT01174082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529906|NCT01175798|Vitamin D|vitamin d|mesh-list
102529907|NCT01175798|Cholecalciferol|cholecalciferol|mesh-list
102529908|NCT01175798|Vitamins|vitamins|mesh-ancestor
102529909|NCT01175798|Micronutrients|micronutrients|mesh-ancestor
102529910|NCT01175798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529911|NCT01175798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102529912|NCT01175798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102529913|NCT02246894|Factor VIII|factor viii|mesh-list
102529914|NCT02246894|Coagulants|coagulants|mesh-ancestor
102529915|NCT05177510|Mifepristone|mifepristone|mesh-list
102529916|NCT05177510|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102529917|NCT05177510|Abortifacient Agents|abortifacient agents|mesh-ancestor
102529918|NCT05177510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102529919|NCT05177510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529920|NCT05177510|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102529921|NCT05177510|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102529922|NCT05177510|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102529923|NCT05177510|Contraceptive Agents|contraceptive agents|mesh-ancestor
102529924|NCT05177510|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102529925|NCT05177510|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102529926|NCT05177510|Hormone Antagonists|hormone antagonists|mesh-ancestor
102529927|NCT05177510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102529928|NCT05177510|Luteolytic Agents|luteolytic agents|mesh-ancestor
102529929|NCT05177510|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102529930|NCT05177510|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102529931|NCT03011996|Amoxicillin|amoxicillin|mesh-list
102529932|NCT03011996|Clarithromycin|clarithromycin|mesh-list
102529933|NCT03011996|Pantoprazole|pantoprazole|mesh-list
102529934|NCT03011996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102529935|NCT03011996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102529936|NCT03011996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102529937|NCT03011996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102529938|NCT03011996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529939|NCT03011996|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102529940|NCT03011996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102529941|NCT03011996|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102529942|NCT03011996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102529943|NCT03011996|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102529944|NCT01178216|Rituximab|rituximab|mesh-list
102529945|NCT01178216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102529946|NCT01178216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102529947|NCT01178216|Immunologic Factors|immunologic factors|mesh-ancestor
102529948|NCT01178216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529949|NCT01178216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102529950|NCT01178528|Carvedilol|carvedilol|mesh-list
102529951|NCT01178528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102529952|NCT01178528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102529953|NCT01178528|Adrenergic Agents|adrenergic agents|mesh-ancestor
102529954|NCT01178528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102529955|NCT01178528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529956|NCT01178528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529957|NCT01178528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102529958|NCT01178528|Antioxidants|antioxidants|mesh-ancestor
102529959|NCT01178528|Protective Agents|protective agents|mesh-ancestor
102529960|NCT01178528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102529961|NCT01178528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102529962|NCT01178528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102529963|NCT01178528|Vasodilator Agents|vasodilator agents|mesh-ancestor
102529964|NCT01178528|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102529965|NCT01178528|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102529966|NCT02980250|Domperidone|domperidone|mesh-list
102529967|NCT02980250|Antiemetics|antiemetics|mesh-ancestor
102529968|NCT02980250|Autonomic Agents|autonomic agents|mesh-ancestor
102529969|NCT02980250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102529970|NCT02980250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529971|NCT02980250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102529972|NCT02980250|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102529973|NCT02980250|Dopamine Agents|dopamine agents|mesh-ancestor
102529974|NCT02980250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102529975|NCT02980250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102529976|NCT02491437|Progesterone|progesterone|mesh-list
102529977|NCT02491437|Dydrogesterone|dydrogesterone|mesh-list
102529978|NCT02491437|Progestins|progestins|mesh-ancestor
102529979|NCT02491437|Hormones|hormones|mesh-ancestor
102529980|NCT02491437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102529981|NCT02491437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529982|NCT02383758|Bisacodyl|bisacodyl|mesh-list
102529983|NCT02383758|Glycerol|glycerol|mesh-list
102529984|NCT02383758|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102529985|NCT02383758|Protective Agents|protective agents|mesh-ancestor
102529986|NCT02383758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529987|NCT02383758|Cathartics|cathartics|mesh-ancestor
102529988|NCT02383758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102529989|NCT02383758|Laxatives|laxatives|mesh-ancestor
102529990|NCT02492451|Progesterone|progesterone|mesh-list
102529991|NCT02492451|Progestins|progestins|mesh-ancestor
102529992|NCT02492451|Hormones|hormones|mesh-ancestor
102529993|NCT02492451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102529994|NCT02492451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102529995|NCT02410278|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102529996|NCT02410278|Montelukast|montelukast|mesh-list
102529997|NCT02410278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102529998|NCT02410278|Respiratory System Agents|respiratory system agents|mesh-ancestor
102529999|NCT02410278|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102530000|NCT02410278|Hormone Antagonists|hormone antagonists|mesh-ancestor
102530001|NCT02410278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102530002|NCT02410278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530003|NCT02410278|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102530004|NCT02410278|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102530005|NCT02410278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530006|NCT02410278|Dermatologic Agents|dermatologic agents|mesh-ancestor
102530007|NCT02410278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102530008|NCT02410278|Immunologic Factors|immunologic factors|mesh-ancestor
102530009|NCT01181258|Methylprednisolone|methylprednisolone|mesh-list
102530010|NCT01181258|Cyclophosphamide|cyclophosphamide|mesh-list
102530011|NCT01181258|Rituximab|rituximab|mesh-list
102530012|NCT01181258|Fludarabine|fludarabine|mesh-list
102530013|NCT01181258|Interleukin-2|interleukin-2|mesh-list
102530014|NCT01181258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102530015|NCT01181258|Immunologic Factors|immunologic factors|mesh-ancestor
102530016|NCT01181258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530017|NCT01181258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102530018|NCT01181258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102530019|NCT01181258|Alkylating Agents|alkylating agents|mesh-ancestor
102530020|NCT01181258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530021|NCT01181258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102530022|NCT01181258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102530023|NCT01181258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102530024|NCT01181258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102530025|NCT01181258|Antiemetics|antiemetics|mesh-ancestor
102530026|NCT01181258|Autonomic Agents|autonomic agents|mesh-ancestor
102530027|NCT01181258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102530028|NCT01181258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102530029|NCT01181258|Glucocorticoids|glucocorticoids|mesh-ancestor
102530030|NCT01181258|Hormones|hormones|mesh-ancestor
102530031|NCT01181258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102530032|NCT01181258|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102530033|NCT01181258|Protective Agents|protective agents|mesh-ancestor
102530034|NCT01181258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102530035|NCT01181258|Analgesics|analgesics|mesh-ancestor
102530036|NCT01181258|Sensory System Agents|sensory system agents|mesh-ancestor
102530037|NCT02570139|Protective Agents|protective agents|mesh-list
102530038|NCT02570139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530039|NCT02410200|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102530040|NCT02410200|Dermatologic Agents|dermatologic agents|mesh-ancestor
102530041|NCT02410200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102530042|NCT02410200|Immunologic Factors|immunologic factors|mesh-ancestor
102530043|NCT02410200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530044|NCT02409732|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102530045|NCT02409732|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102341593|NCT02090374|Interferon Inducers|interferon inducers|mesh-ancestor
102530046|NCT02409732|Dermatologic Agents|dermatologic agents|mesh-ancestor
102530047|NCT02494713|Ketoconazole|ketoconazole|mesh-list
102530048|NCT02494713|Docetaxel|docetaxel|mesh-list
102530049|NCT02494713|Doxorubicin|doxorubicin|mesh-list
102530050|NCT02494713|Estramustine|estramustine|mesh-list
102530051|NCT02494713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102530052|NCT02494713|Tubulin Modulators|tubulin modulators|mesh-ancestor
102530053|NCT02494713|Antimitotic Agents|antimitotic agents|mesh-ancestor
102530054|NCT02494713|Mitosis Modulators|mitosis modulators|mesh-ancestor
102530055|NCT02494713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530056|NCT02494713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102530057|NCT02494713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102530058|NCT02494713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102530059|NCT02494713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102530060|NCT02494713|Antifungal Agents|antifungal agents|mesh-ancestor
102530061|NCT02494713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102530062|NCT02494713|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102530063|NCT02494713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102530064|NCT02494713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102530065|NCT02494713|Hormone Antagonists|hormone antagonists|mesh-ancestor
102530066|NCT02494713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102530067|NCT02494713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530068|NCT02494713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102530069|NCT02494713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102530070|NCT02494713|Alkylating Agents|alkylating agents|mesh-ancestor
102530071|NCT02494713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102530072|NCT02495103|Metformin|metformin|mesh-list
102530073|NCT02495103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102530074|NCT02495103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530075|NCT02382276|Nalmefene|nalmefene|mesh-list
102530076|NCT02382276|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102530077|NCT02382276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530078|NCT02382276|Sensory System Agents|sensory system agents|mesh-ancestor
102530079|NCT02382276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102530080|NCT02571153|Ketamine|ketamine|mesh-list
102530081|NCT02571153|Analgesics|analgesics|mesh-ancestor
102530082|NCT02571153|Sensory System Agents|sensory system agents|mesh-ancestor
102530083|NCT02571153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102530084|NCT02571153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530085|NCT02571153|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102530086|NCT02571153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102530087|NCT02571153|Anesthetics, General|anesthetics, general|mesh-ancestor
102530088|NCT02571153|Anesthetics|anesthetics|mesh-ancestor
102530089|NCT02571153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102530090|NCT02571153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102530091|NCT02571153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102530092|NCT02571153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102530093|NCT02571153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530094|NCT04573322|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
102530095|NCT04573322|Antioxidants|antioxidants|mesh-ancestor
102530096|NCT04573322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530097|NCT04573322|Protective Agents|protective agents|mesh-ancestor
102530098|NCT04573322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530099|NCT04573322|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102530100|NCT04573322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102530101|NCT01143818|Methyltestosterone|methyltestosterone|mesh-list
102530102|NCT01143818|Testosterone|testosterone|mesh-list
102530103|NCT01143818|Testosterone undecanoate|testosterone undecanoate|mesh-list
102530104|NCT01143818|Testosterone enanthate|testosterone enanthate|mesh-list
102530105|NCT01143818|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102530106|NCT01143818|Androgens|androgens|mesh-ancestor
102530107|NCT01143818|Hormones|hormones|mesh-ancestor
102530108|NCT01143818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102530109|NCT01143818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530110|NCT01143818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102530111|NCT01143818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102530112|NCT01143818|Anabolic Agents|anabolic agents|mesh-ancestor
102530113|NCT02573181|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102530114|NCT02573181|Immunologic Factors|immunologic factors|mesh-ancestor
102530115|NCT02573181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530116|NCT02498769|Botulinum Toxins|botulinum toxins|mesh-list
102530117|NCT02498769|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102530118|NCT02498769|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102530119|NCT02498769|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102530120|NCT02498769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102530121|NCT02498769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530122|NCT02498769|Cholinergic Agents|cholinergic agents|mesh-ancestor
102530123|NCT02498769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102530124|NCT02498769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530125|NCT02498769|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102530126|NCT02498769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102530127|NCT01650558|Chloroquine|chloroquine|mesh-list
102530128|NCT01650558|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102530129|NCT01650558|Amebicides|amebicides|mesh-ancestor
102530130|NCT01650558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102530131|NCT01650558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102530132|NCT01650558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102530133|NCT01650558|Antimalarials|antimalarials|mesh-ancestor
102530134|NCT01650558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102530135|NCT01650558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102530136|NCT01650558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102530137|NCT02579343|Dexetimide|dexetimide|mesh-list
102530138|NCT02579343|Citalopram|citalopram|mesh-list
102530139|NCT02579343|Escitalopram|escitalopram|mesh-list
102530140|NCT02579343|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102530141|NCT02579343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102530142|NCT02579343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102530143|NCT02579343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530144|NCT02579343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102530145|NCT02579343|Serotonin Agents|serotonin agents|mesh-ancestor
102530146|NCT02579343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530147|NCT02579343|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102530148|NCT02579343|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102530149|NCT02579343|Parasympatholytics|parasympatholytics|mesh-ancestor
102530150|NCT02579343|Autonomic Agents|autonomic agents|mesh-ancestor
102530151|NCT02579343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102530152|NCT02579343|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102530153|NCT02579343|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102530154|NCT02579343|Cholinergic Agents|cholinergic agents|mesh-ancestor
102530155|NCT02579343|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102530156|NCT02579343|Antidepressive Agents|antidepressive agents|mesh-ancestor
102530157|NCT02579343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102530158|NCT01144442|Paclitaxel|paclitaxel|mesh-list
102530159|NCT01144442|Carboplatin|carboplatin|mesh-list
102530160|NCT01144442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102530161|NCT01144442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102530162|NCT01144442|Tubulin Modulators|tubulin modulators|mesh-ancestor
102530163|NCT01144442|Antimitotic Agents|antimitotic agents|mesh-ancestor
102530164|NCT01144442|Mitosis Modulators|mitosis modulators|mesh-ancestor
102530165|NCT01144442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530166|NCT02499081|Ixazomib|ixazomib|mesh-list
102530167|NCT02499081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102530168|NCT02499081|Protease Inhibitors|protease inhibitors|mesh-ancestor
102530169|NCT02499081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102530170|NCT02499081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530171|NCT02380248|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102530172|NCT02380248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102530173|NCT02501265|Nicotine|nicotine|mesh-list
102530174|NCT02501265|Varenicline|varenicline|mesh-list
102530175|NCT02501265|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102530176|NCT02501265|Autonomic Agents|autonomic agents|mesh-ancestor
102530177|NCT02501265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102530178|NCT02501265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530179|NCT02501265|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102530180|NCT02501265|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102530181|NCT02501265|Cholinergic Agents|cholinergic agents|mesh-ancestor
102530182|NCT02501265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102530183|NCT02501265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530184|NCT02408016|Aldesleukin|aldesleukin|mesh-list
102530185|NCT02408016|Cyclophosphamide|cyclophosphamide|mesh-list
102530186|NCT02408016|Interleukin-2|interleukin-2|mesh-list
102530187|NCT02408016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102530188|NCT02408016|Immunologic Factors|immunologic factors|mesh-ancestor
102006502|NCT03844451|Mydriatics|mydriatics|mesh-ancestor
102530189|NCT02408016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530190|NCT02408016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102530191|NCT02408016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102530192|NCT02408016|Alkylating Agents|alkylating agents|mesh-ancestor
102530193|NCT02408016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530194|NCT02408016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102530196|NCT02408016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102530197|NCT02408016|Analgesics|analgesics|mesh-ancestor
102530198|NCT02408016|Sensory System Agents|sensory system agents|mesh-ancestor
102530199|NCT02408016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102530200|NCT02408016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102530201|NCT02408016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102530202|NCT02408016|Antiviral Agents|antiviral agents|mesh-ancestor
102530203|NCT02408016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102530204|NCT02579421|Progesterone|progesterone|mesh-list
102530205|NCT02579421|Progestins|progestins|mesh-ancestor
102530206|NCT02579421|Hormones|hormones|mesh-ancestor
102530207|NCT02579421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102530208|NCT02579421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530209|NCT00422175|Siponimod|siponimod|mesh-list
102530210|NCT00422175|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102530211|NCT00422175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530212|NCT00422175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102530213|NCT00422175|Immunologic Factors|immunologic factors|mesh-ancestor
102530214|NCT00422175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530215|NCT01186250|Pioglitazone|pioglitazone|mesh-list
102530216|NCT01186250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102530217|NCT01186250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530218|NCT01186406|Bevacizumab|bevacizumab|mesh-list
102530219|NCT01186406|Temozolomide|temozolomide|mesh-list
102530220|NCT01186406|Carmustine|carmustine|mesh-list
102530221|NCT01186406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102530222|NCT01186406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102530223|NCT01186406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102530224|NCT01186406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102530225|NCT01186406|Growth Substances|growth substances|mesh-ancestor
102530226|NCT01186406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530227|NCT01186406|Growth Inhibitors|growth inhibitors|mesh-ancestor
102530228|NCT01186406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102530229|NCT01186406|Alkylating Agents|alkylating agents|mesh-ancestor
102530230|NCT01186406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530231|NCT02407704|Lorazepam|lorazepam|mesh-list
102530232|NCT02407704|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102530233|NCT02407704|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102530234|NCT02407704|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102530235|NCT02407704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102530236|NCT02407704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530237|NCT02407704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102530238|NCT02407704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530239|NCT02407704|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102530240|NCT02407704|Antidepressive Agents|antidepressive agents|mesh-ancestor
102530241|NCT02407704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102530242|NCT02407704|Anticonvulsants|anticonvulsants|mesh-ancestor
102530243|NCT02407704|Antiemetics|antiemetics|mesh-ancestor
102530244|NCT02407704|Autonomic Agents|autonomic agents|mesh-ancestor
102530245|NCT02407704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102530246|NCT02407704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102530247|NCT02407704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102530248|NCT02407704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102530249|NCT02407704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102530250|NCT02407704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102530251|NCT02407704|GABA Modulators|gaba modulators|mesh-ancestor
102530252|NCT02407704|GABA Agents|gaba agents|mesh-ancestor
102530253|NCT02581839|Dexamethasone|dexamethasone|mesh-list
102530254|NCT02581839|Dexamethasone acetate|dexamethasone acetate|mesh-list
102530255|NCT02581839|BB 1101|bb 1101|mesh-list
102530256|NCT02581839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102530257|NCT02581839|Antiemetics|antiemetics|mesh-ancestor
102530258|NCT02581839|Autonomic Agents|autonomic agents|mesh-ancestor
102530259|NCT02581839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102006563|NCT01198925|Piperacillin|piperacillin|mesh-list
102530260|NCT02581839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530261|NCT02581839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102530262|NCT02581839|Glucocorticoids|glucocorticoids|mesh-ancestor
102530263|NCT02581839|Hormones|hormones|mesh-ancestor
102530264|NCT02581839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102530265|NCT02581839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102530266|NCT02581839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102530267|NCT02581839|Protease Inhibitors|protease inhibitors|mesh-ancestor
102530268|NCT02581839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102530269|NCT02581839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530270|NCT02504775|Acetaminophen|acetaminophen|mesh-list
102530271|NCT02504775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102530272|NCT02504775|Analgesics|analgesics|mesh-ancestor
102530273|NCT02504775|Sensory System Agents|sensory system agents|mesh-ancestor
102530274|NCT02504775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102530275|NCT02504775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530276|NCT02504775|Antipyretics|antipyretics|mesh-ancestor
102530277|NCT02504931|Sertraline|sertraline|mesh-list
102530278|NCT02504931|Antidepressive Agents|antidepressive agents|mesh-ancestor
102530279|NCT02504931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102530280|NCT02504931|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102530281|NCT02504931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102530282|NCT02504931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102530283|NCT02504931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530284|NCT02504931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102530285|NCT02504931|Serotonin Agents|serotonin agents|mesh-ancestor
102530286|NCT02504931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530287|NCT02584725|Tranexamic Acid|tranexamic acid|mesh-list
102530288|NCT02584725|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102530289|NCT02584725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102530290|NCT02584725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530291|NCT02584725|Hemostatics|hemostatics|mesh-ancestor
102530292|NCT02584725|Coagulants|coagulants|mesh-ancestor
102530293|NCT04423029|Nivolumab|nivolumab|mesh-list
102530294|NCT04423029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102530295|NCT04423029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102530296|NCT04423029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102530297|NCT04423029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530298|NCT01186562|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102530299|NCT01186562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102530300|NCT01186562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530301|NCT01186562|Incretins|incretins|mesh-ancestor
102530302|NCT01186562|Hormones|hormones|mesh-ancestor
102530303|NCT01186562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102530304|NCT01186562|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102530305|NCT01186562|Protease Inhibitors|protease inhibitors|mesh-ancestor
102530306|NCT01186562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102530307|NCT01186562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530308|NCT01187498|Oxybutynin|oxybutynin|mesh-list
102530309|NCT01187498|Parasympatholytics|parasympatholytics|mesh-ancestor
102530310|NCT01187498|Autonomic Agents|autonomic agents|mesh-ancestor
102530311|NCT01187498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102530312|NCT01187498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530313|NCT01187498|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102530314|NCT01187498|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102530315|NCT01187498|Cholinergic Agents|cholinergic agents|mesh-ancestor
102530316|NCT01187498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102530317|NCT01187498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530318|NCT01187498|Urological Agents|urological agents|mesh-ancestor
102530319|NCT01148420|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102530320|NCT01148420|Medroxyprogesterone|medroxyprogesterone|mesh-list
102530321|NCT01148420|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102530322|NCT01148420|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102530323|NCT01148420|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102530324|NCT01148420|Contraceptive Agents|contraceptive agents|mesh-ancestor
102530325|NCT01148420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102530326|NCT01148420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530327|NCT01148420|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102530328|NCT01148420|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102530329|NCT01148420|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102530330|NCT01148420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102530331|NCT01148420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102530332|NCT01149434|Everolimus|everolimus|mesh-list
102530333|NCT01149434|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102530334|NCT01149434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102530335|NCT01149434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102530336|NCT01149434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530337|NCT01149434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102530338|NCT01149434|Immunologic Factors|immunologic factors|mesh-ancestor
102530339|NCT01149434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530340|NCT01149434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102530341|NCT01150760|Alvimopan|alvimopan|mesh-list
102530342|NCT01150760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102530343|NCT01150838|Propofol|propofol|mesh-list
102530344|NCT01150838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102530345|NCT01150838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102530346|NCT01150838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530347|NCT01150838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102530348|NCT01150838|Anesthetics, General|anesthetics, general|mesh-ancestor
102530349|NCT01150838|Anesthetics|anesthetics|mesh-ancestor
102530350|NCT01189292|Dexamethasone|dexamethasone|mesh-list
102530351|NCT01189292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102530352|NCT01189292|Antiemetics|antiemetics|mesh-ancestor
102530353|NCT01189292|Autonomic Agents|autonomic agents|mesh-ancestor
102530354|NCT01189292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102530355|NCT01189292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530356|NCT01189292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102530357|NCT01189292|Glucocorticoids|glucocorticoids|mesh-ancestor
102530358|NCT01189292|Hormones|hormones|mesh-ancestor
102530359|NCT01189292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102530360|NCT01189292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102530361|NCT01189292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102530362|NCT01189370|Sorafenib|sorafenib|mesh-list
102530363|NCT01189370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102530364|NCT01189370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102530365|NCT01189370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102530366|NCT01189370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530367|NCT01189760|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102530368|NCT01189760|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102530369|NCT01189760|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102530370|NCT01189760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102530371|NCT01189760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530372|NCT01189760|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102530373|NCT01189760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102530374|NCT01189760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530375|NCT01189760|Cholinergic Agents|cholinergic agents|mesh-ancestor
102530376|NCT01189760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102530377|NCT03010202|Dexamethasone|dexamethasone|mesh-list
102530378|NCT03010202|Rituximab|rituximab|mesh-list
102530379|NCT03010202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102530380|NCT03010202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102530381|NCT03010202|Immunologic Factors|immunologic factors|mesh-ancestor
102530382|NCT03010202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530383|NCT03010202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102530384|NCT03010202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102530385|NCT03010202|Antiemetics|antiemetics|mesh-ancestor
102530386|NCT03010202|Autonomic Agents|autonomic agents|mesh-ancestor
102530387|NCT03010202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102530388|NCT03010202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102530389|NCT03010202|Glucocorticoids|glucocorticoids|mesh-ancestor
102530390|NCT03010202|Hormones|hormones|mesh-ancestor
102006701|NCT03034356|Levetiracetam|levetiracetam|mesh-list
102530391|NCT03010202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102530392|NCT03010202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102530393|NCT01191320|Enclomiphene|enclomiphene|mesh-list
102530394|NCT01191320|Clomiphene|clomiphene|mesh-list
102530395|NCT01191320|Zuclomiphene|zuclomiphene|mesh-list
102530396|NCT01191320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102530397|NCT01191320|Hormone Antagonists|hormone antagonists|mesh-ancestor
102530398|NCT01191320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102530399|NCT01191320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530400|NCT01191320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102530401|NCT01191320|Fertility Agents|fertility agents|mesh-ancestor
102530402|NCT01191320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102530403|NCT01191320|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102530404|NCT01191320|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102530405|NCT01151852|Imatinib Mesylate|imatinib mesylate|mesh-list
102530406|NCT01151852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102530407|NCT01151852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102530408|NCT01151852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102530409|NCT01151852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530410|NCT01191398|Atropine|atropine|mesh-list
102530411|NCT01191398|Glycopyrrolate|glycopyrrolate|mesh-list
102530412|NCT01191398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102530413|NCT01191398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102530414|NCT01191398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102530415|NCT01191398|Autonomic Agents|autonomic agents|mesh-ancestor
102530416|NCT01191398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102530417|NCT01191398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530418|NCT01191398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102530419|NCT01191398|Respiratory System Agents|respiratory system agents|mesh-ancestor
102530420|NCT01191398|Mydriatics|mydriatics|mesh-ancestor
102530421|NCT01191398|Parasympatholytics|parasympatholytics|mesh-ancestor
102530422|NCT01191398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102530423|NCT01191398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102530424|NCT01191398|Cholinergic Agents|cholinergic agents|mesh-ancestor
102530425|NCT01191398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102530426|NCT01191398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530427|NCT01191476|Propofol|propofol|mesh-list
102530428|NCT01191476|Sevoflurane|sevoflurane|mesh-list
102530429|NCT01191476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102530430|NCT01191476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102530431|NCT01191476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530432|NCT01191476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102530433|NCT01191476|Anesthetics, General|anesthetics, general|mesh-ancestor
102530434|NCT01191476|Anesthetics|anesthetics|mesh-ancestor
102530435|NCT01191476|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102530436|NCT01191476|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102530437|NCT02508207|Ivacaftor|ivacaftor|mesh-list
102530438|NCT02508207|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102530439|NCT02508207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102530440|NCT02508207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530441|NCT02509065|Pancrelipase|pancrelipase|mesh-list
102530442|NCT02509065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102530443|NCT01194674|Plasminogen|plasminogen|mesh-list
102530444|NCT01194674|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102530445|NCT01194674|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102530446|NCT01194674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530447|NCT02509767|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102530448|NCT02509767|Medroxyprogesterone|medroxyprogesterone|mesh-list
102530449|NCT02509767|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102530450|NCT02509767|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102530451|NCT02509767|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102530452|NCT02509767|Contraceptive Agents|contraceptive agents|mesh-ancestor
102530453|NCT02509767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102530454|NCT02509767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530455|NCT02509767|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102530456|NCT02509767|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102530457|NCT02509767|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102530458|NCT02509767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102530459|NCT02509767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102530460|NCT01154192|Dexamethasone|dexamethasone|mesh-list
102530461|NCT01154192|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102530462|NCT01154192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102530463|NCT01154192|Antiemetics|antiemetics|mesh-ancestor
102530464|NCT01154192|Autonomic Agents|autonomic agents|mesh-ancestor
102530465|NCT01154192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102530466|NCT01154192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530467|NCT01154192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102530468|NCT01154192|Glucocorticoids|glucocorticoids|mesh-ancestor
102530469|NCT01154192|Hormones|hormones|mesh-ancestor
102530470|NCT01154192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102530471|NCT01154192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102530472|NCT01154192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102530473|NCT01154192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102530474|NCT02511561|Ciprofloxacin|ciprofloxacin|mesh-list
102530475|NCT02511561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102530476|NCT02511561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102530477|NCT02511561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102530478|NCT02511561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102530479|NCT02511561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102530480|NCT02511561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530481|NCT02511561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102530482|NCT02511561|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102530483|NCT02511561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102530484|NCT01195922|Sirolimus|sirolimus|mesh-list
102530485|NCT01195922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102530486|NCT01195922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102530487|NCT01195922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102530488|NCT01195922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102530489|NCT01195922|Antifungal Agents|antifungal agents|mesh-ancestor
102342005|NCT01499355|Mycophenolic Acid|mycophenolic acid|mesh-list
102530490|NCT01195922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102530491|NCT01195922|Immunologic Factors|immunologic factors|mesh-ancestor
102530492|NCT01195922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530493|NCT02512575|Prednisolone|prednisolone|mesh-list
102530494|NCT02512575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102530495|NCT02512575|Glucocorticoids|glucocorticoids|mesh-ancestor
102530496|NCT02512575|Hormones|hormones|mesh-ancestor
102530497|NCT02512575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102530498|NCT02512575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530499|NCT02512575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102530500|NCT02512575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102530501|NCT01199744|Zanamivir|zanamivir|mesh-list
102530502|NCT01199744|Antiviral Agents|antiviral agents|mesh-ancestor
102530503|NCT01199744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102530504|NCT01199744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102530505|NCT01199744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530506|NCT03702374|Antioxidants|antioxidants|mesh-list
102530507|NCT03702374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530508|NCT03702374|Protective Agents|protective agents|mesh-ancestor
102530509|NCT03702374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530510|NCT02512809|Dexmedetomidine|dexmedetomidine|mesh-list
102530511|NCT02512809|Isoflurane|isoflurane|mesh-list
102530512|NCT02512809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102530513|NCT02512809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102530514|NCT02512809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530515|NCT02512809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102530516|NCT02512809|Analgesics|analgesics|mesh-ancestor
102530517|NCT02512809|Sensory System Agents|sensory system agents|mesh-ancestor
102530518|NCT02512809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102530519|NCT02512809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102530520|NCT02512809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102530521|NCT02512809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102530522|NCT02512809|Adrenergic Agents|adrenergic agents|mesh-ancestor
102530523|NCT02512809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102530524|NCT02512809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530525|NCT02512809|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102530526|NCT02512809|Anesthetics, General|anesthetics, general|mesh-ancestor
102530527|NCT02512809|Anesthetics|anesthetics|mesh-ancestor
102530528|NCT01201772|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102530529|NCT01201772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102530530|NCT01202162|Sevoflurane|sevoflurane|mesh-list
102530531|NCT01202162|Desflurane|desflurane|mesh-list
102530532|NCT01202162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102530533|NCT01202162|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102530534|NCT01202162|Anesthetics, General|anesthetics, general|mesh-ancestor
102530535|NCT01202162|Anesthetics|anesthetics|mesh-ancestor
102530536|NCT01202162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102530537|NCT01202162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530538|NCT01159262|Fentanyl|fentanyl|mesh-list
102530539|NCT01159262|Midazolam|midazolam|mesh-list
102530540|NCT01159262|Dexmedetomidine|dexmedetomidine|mesh-list
102530541|NCT01159262|Morphine|morphine|mesh-list
102530542|NCT01159262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102530543|NCT01159262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102530544|NCT01159262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530545|NCT01159262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102530546|NCT01159262|Analgesics|analgesics|mesh-ancestor
102530547|NCT01159262|Sensory System Agents|sensory system agents|mesh-ancestor
102530548|NCT01159262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102530549|NCT01159262|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102530550|NCT01159262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102530551|NCT01159262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102530552|NCT01159262|Adrenergic Agents|adrenergic agents|mesh-ancestor
102530553|NCT01159262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102530554|NCT01159262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530555|NCT01159262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102530556|NCT01159262|Narcotics|narcotics|mesh-ancestor
102530557|NCT01159262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102530558|NCT01159262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102530559|NCT01159262|Anesthetics, General|anesthetics, general|mesh-ancestor
102530560|NCT01159262|Anesthetics|anesthetics|mesh-ancestor
102530561|NCT01159262|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102530562|NCT01159262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102530563|NCT01159262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102530564|NCT01159262|GABA Modulators|gaba modulators|mesh-ancestor
102530565|NCT01159262|GABA Agents|gaba agents|mesh-ancestor
102530566|NCT03011060|Capecitabine|capecitabine|mesh-list
102530567|NCT03011060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102530568|NCT03011060|Antimetabolites|antimetabolites|mesh-ancestor
102530569|NCT03011060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530570|NCT03011060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102530571|NCT03010670|Oxytocin|oxytocin|mesh-list
102530572|NCT03010670|Oxytocics|oxytocics|mesh-ancestor
102530573|NCT03010670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102530574|NCT03010670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530575|NCT04377711|Ciclesonide|ciclesonide|mesh-list
102530576|NCT04377711|Glucocorticoids|glucocorticoids|mesh-ancestor
102530577|NCT04377711|Hormones|hormones|mesh-ancestor
102530578|NCT04377711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102530579|NCT04377711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530580|NCT04377711|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102530581|NCT04366713|Capecitabine|capecitabine|mesh-list
102530582|NCT04366713|Loperamide|loperamide|mesh-list
102530583|NCT04366713|Antidiarrheals|antidiarrheals|mesh-list
102530584|NCT04366713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102530585|NCT04366713|Antimetabolites|antimetabolites|mesh-ancestor
102530586|NCT04366713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530587|NCT04366713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102530588|NCT04366713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102530589|NCT03413384|Ceftriaxone|ceftriaxone|mesh-list
102530590|NCT03413384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102530591|NCT03413384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102530592|NCT02976441|Temozolomide|temozolomide|mesh-list
102530593|NCT02976441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102530594|NCT02976441|Alkylating Agents|alkylating agents|mesh-ancestor
102530595|NCT02976441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530596|NCT02976441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102530597|NCT00363753|Aspirin|aspirin|mesh-list
102530598|NCT00363753|Clopidogrel|clopidogrel|mesh-list
102530599|NCT00363753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102530600|NCT00363753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102530601|NCT00363753|Analgesics|analgesics|mesh-ancestor
102530602|NCT00363753|Sensory System Agents|sensory system agents|mesh-ancestor
102530603|NCT00363753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102530604|NCT00363753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530605|NCT00363753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102530606|NCT00363753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102530607|NCT00363753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102530608|NCT00363753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102530609|NCT00363753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530610|NCT00363753|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102530611|NCT00363753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102530612|NCT00363753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102530613|NCT00363753|Antipyretics|antipyretics|mesh-ancestor
102530614|NCT00363753|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102530615|NCT00363753|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102530616|NCT00363753|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102530617|NCT00363753|Purinergic Agents|purinergic agents|mesh-ancestor
102530618|NCT00363753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102530619|NCT02434770|Vaccines|vaccines|mesh-list
102530620|NCT02434770|Immunologic Factors|immunologic factors|mesh-ancestor
102530621|NCT02434770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530622|NCT01203644|Bupivacaine|bupivacaine|mesh-list
102530623|NCT01203644|Anesthetics, Local|anesthetics, local|mesh-ancestor
102530624|NCT01203644|Anesthetics|anesthetics|mesh-ancestor
102530625|NCT01203644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102530626|NCT01203644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530627|NCT01203644|Sensory System Agents|sensory system agents|mesh-ancestor
102530628|NCT01203644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102530629|NCT00363831|Oxaliplatin|oxaliplatin|mesh-list
102530630|NCT00363831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102530631|NCT02433834|Glycopyrrolate|glycopyrrolate|mesh-list
102530632|NCT02433834|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102530633|NCT02433834|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102530634|NCT02433834|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102530635|NCT02433834|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102530636|NCT02433834|Cholinergic Agents|cholinergic agents|mesh-ancestor
102530637|NCT02433834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102530638|NCT02433834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530639|NCT02433834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530640|NCT02433834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102530642|NCT02433834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102530643|NCT02433834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102530644|NCT02433834|Respiratory System Agents|respiratory system agents|mesh-ancestor
102530645|NCT02433834|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102530646|NCT02433834|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102530647|NCT02433834|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102530648|NCT02433834|Adrenergic Agents|adrenergic agents|mesh-ancestor
102530649|NCT02433678|Dapagliflozin|dapagliflozin|mesh-list
102530650|NCT02433678|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102530651|NCT02433678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530652|NCT02433678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102530653|NCT02433678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530654|NCT00363909|Dexetimide|dexetimide|mesh-list
102530655|NCT00363909|Citalopram|citalopram|mesh-list
102530656|NCT00363909|Escitalopram|escitalopram|mesh-list
102530657|NCT00363909|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102530658|NCT00363909|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102530659|NCT00363909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102530660|NCT00363909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530661|NCT00363909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102530662|NCT00363909|Serotonin Agents|serotonin agents|mesh-ancestor
102530663|NCT00363909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530664|NCT00363909|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102530665|NCT00363909|Antidepressive Agents|antidepressive agents|mesh-ancestor
102530666|NCT00363909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102530667|NCT00363909|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102530668|NCT00363909|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102530669|NCT00363909|Parasympatholytics|parasympatholytics|mesh-ancestor
102530670|NCT00363909|Autonomic Agents|autonomic agents|mesh-ancestor
102530671|NCT00363909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102530672|NCT00363909|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102530673|NCT00363909|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102530674|NCT00363909|Cholinergic Agents|cholinergic agents|mesh-ancestor
102530675|NCT01205828|Temozolomide|temozolomide|mesh-list
102530676|NCT01205828|Veliparib|veliparib|mesh-list
102530677|NCT01205828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102530678|NCT01205828|Alkylating Agents|alkylating agents|mesh-ancestor
102530679|NCT01205828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530680|NCT01205828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102530681|NCT01205828|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102530682|NCT01205828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102530683|NCT02515305|Clindamycin|clindamycin|mesh-list
102530684|NCT02515305|Clindamycin palmitate|clindamycin palmitate|mesh-list
102530685|NCT02515305|Clindamycin phosphate|clindamycin phosphate|mesh-list
102530686|NCT02515305|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102530687|NCT02515305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102530688|NCT02515305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102530689|NCT02515305|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102530690|NCT02515305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102530691|NCT02515305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530692|NCT02515305|Dermatologic Agents|dermatologic agents|mesh-ancestor
102530693|NCT01206452|Prednisone|prednisone|mesh-list
102530694|NCT01206452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102530695|NCT01206452|Glucocorticoids|glucocorticoids|mesh-ancestor
102530696|NCT01206452|Hormones|hormones|mesh-ancestor
102530697|NCT01206452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102530698|NCT01206452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530699|NCT01206452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102530700|NCT01206452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102530701|NCT01206608|Bupivacaine|bupivacaine|mesh-list
102530702|NCT01206608|Anesthetics, Local|anesthetics, local|mesh-ancestor
102530703|NCT01206608|Anesthetics|anesthetics|mesh-ancestor
102530704|NCT01206608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102530705|NCT01206608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530706|NCT01206608|Sensory System Agents|sensory system agents|mesh-ancestor
102530707|NCT01206608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102530708|NCT03010436|Benralizumab|benralizumab|mesh-list
102530709|NCT03010436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102530710|NCT03010436|Respiratory System Agents|respiratory system agents|mesh-ancestor
102530711|NCT02432040|Atorvastatin|atorvastatin|mesh-list
102530712|NCT02432040|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102530713|NCT02432040|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102530714|NCT02432040|Antimetabolites|antimetabolites|mesh-ancestor
102530715|NCT02432040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530716|NCT02432040|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102530717|NCT02432040|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102530718|NCT02432040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102530719|NCT02517021|Dexamethasone|dexamethasone|mesh-list
102530720|NCT02517021|Palonosetron|palonosetron|mesh-list
102530721|NCT02517021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102530722|NCT02517021|Antiemetics|antiemetics|mesh-ancestor
102530723|NCT02517021|Autonomic Agents|autonomic agents|mesh-ancestor
102530724|NCT02517021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102530725|NCT02517021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530726|NCT02517021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102530727|NCT02517021|Glucocorticoids|glucocorticoids|mesh-ancestor
102530728|NCT02517021|Hormones|hormones|mesh-ancestor
102530729|NCT02517021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102530730|NCT02517021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102530731|NCT02517021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102530732|NCT02517021|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102530733|NCT02517021|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102530734|NCT02517021|Serotonin Agents|serotonin agents|mesh-ancestor
102530735|NCT02517021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102530736|NCT02517021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530737|NCT05859217|Atezolizumab|atezolizumab|mesh-list
102530738|NCT05859217|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102530739|NCT05859217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530740|NCT05859217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102530741|NCT05859217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102530742|NCT05859126|Choline|choline|mesh-list
102530743|NCT05859126|Lipotropic Agents|lipotropic agents|mesh-ancestor
102530744|NCT05859126|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102530745|NCT05859126|Antimetabolites|antimetabolites|mesh-ancestor
102530746|NCT05859126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530747|NCT05859126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102530748|NCT05859126|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102530749|NCT05859126|Nootropic Agents|nootropic agents|mesh-ancestor
102530750|NCT05858671|Fenugreek seed meal|fenugreek seed meal|mesh-list
102530751|NCT05858671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102530752|NCT05858671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530753|NCT05858645|Deucravacitinib|deucravacitinib|mesh-list
102530754|NCT05858645|Dermatologic Agents|dermatologic agents|mesh-ancestor
102530755|NCT05858645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102530756|NCT05858645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102530757|NCT05858645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530758|NCT05858216|Chlorpheniramine|chlorpheniramine|mesh-list
102530759|NCT05858216|Antipruritics|antipruritics|mesh-ancestor
102530760|NCT05858216|Dermatologic Agents|dermatologic agents|mesh-ancestor
102530761|NCT05858216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102530762|NCT05858216|Histamine Antagonists|histamine antagonists|mesh-ancestor
102530763|NCT05858216|Histamine Agents|histamine agents|mesh-ancestor
102530764|NCT05858216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102530765|NCT05858216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530766|NCT05858216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530767|NCT05858216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102530768|NCT05858177|Temozolomide|temozolomide|mesh-list
102530769|NCT05858177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102530770|NCT05858177|Alkylating Agents|alkylating agents|mesh-ancestor
102530771|NCT05858177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530772|NCT05858177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102530773|NCT05857982|Dexamethasone|dexamethasone|mesh-list
102530774|NCT05857982|Mitoxantrone|mitoxantrone|mesh-list
102530775|NCT05857982|Daratumumab|daratumumab|mesh-list
102530776|NCT05857982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102530777|NCT05857982|Antiemetics|antiemetics|mesh-ancestor
102530778|NCT05857982|Autonomic Agents|autonomic agents|mesh-ancestor
102530779|NCT05857982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102530780|NCT05857982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530781|NCT05857982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102530782|NCT05857982|Glucocorticoids|glucocorticoids|mesh-ancestor
102530783|NCT05857982|Hormones|hormones|mesh-ancestor
102530784|NCT05857982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102530785|NCT05857982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102530786|NCT05857982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102530787|NCT05857982|Analgesics|analgesics|mesh-ancestor
102530788|NCT05857982|Sensory System Agents|sensory system agents|mesh-ancestor
102530789|NCT05857982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102530790|NCT05857982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102530791|NCT05857982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102530792|NCT05857982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530793|NCT05857891|Epoetin Alfa|epoetin alfa|mesh-list
102530794|NCT05857891|Hematinics|hematinics|mesh-ancestor
102530795|NCT05857748|Lifitegrast|lifitegrast|mesh-list
102530796|NCT05857748|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102530797|NCT05857748|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102530798|NCT05844618|Triamcinolone|triamcinolone|mesh-list
102530799|NCT05844618|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102530800|NCT05844618|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102530801|NCT05844618|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102530802|NCT05844618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102530803|NCT05844618|Glucocorticoids|glucocorticoids|mesh-ancestor
102530804|NCT05844618|Hormones|hormones|mesh-ancestor
102530805|NCT05844618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102530806|NCT05844618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530807|NCT05844618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102530808|NCT05844618|Immunologic Factors|immunologic factors|mesh-ancestor
102530809|NCT05844618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102530810|NCT05844618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530811|NCT05836025|Sirolimus|sirolimus|mesh-list
102530812|NCT05836025|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102530813|NCT05836025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102530814|NCT05836025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102530815|NCT05836025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102530816|NCT05836025|Antifungal Agents|antifungal agents|mesh-ancestor
102530817|NCT05836025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102530818|NCT05836025|Immunologic Factors|immunologic factors|mesh-ancestor
102530819|NCT05836025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530820|NCT05796752|Memantine|memantine|mesh-list
102530821|NCT05796752|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102530822|NCT05796752|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102530823|NCT05796752|Dopamine Agents|dopamine agents|mesh-ancestor
102530824|NCT05796752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102530825|NCT05796752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530826|NCT05796752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530827|NCT05796752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102530828|NCT05796752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102530829|NCT05794971|Irinotecan|irinotecan|mesh-list
102530830|NCT05794971|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102530831|NCT05794971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102530832|NCT05794971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102530833|NCT05794971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530834|NCT05794971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102530835|NCT05785195|Nitric Oxide|nitric oxide|mesh-list
102530836|NCT05785195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102530837|NCT05785195|Autonomic Agents|autonomic agents|mesh-ancestor
102530838|NCT05785195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102530839|NCT05785195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530840|NCT05785195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102530841|NCT05785195|Respiratory System Agents|respiratory system agents|mesh-ancestor
102530842|NCT05785195|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102530843|NCT05785195|Antioxidants|antioxidants|mesh-ancestor
102530844|NCT05785195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530845|NCT05785195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102530846|NCT05785195|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102530847|NCT05785195|Vasodilator Agents|vasodilator agents|mesh-ancestor
102530848|NCT05785195|Gasotransmitters|gasotransmitters|mesh-ancestor
102530849|NCT05785195|Protective Agents|protective agents|mesh-ancestor
102530850|NCT05735717|Rituximab|rituximab|mesh-list
102530851|NCT05735717|Fludarabine|fludarabine|mesh-list
102530852|NCT05735717|Melphalan|melphalan|mesh-list
102530853|NCT05735717|Busulfan|busulfan|mesh-list
102530854|NCT05735717|Levetiracetam|levetiracetam|mesh-list
102530855|NCT05735717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102530856|NCT05735717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102530857|NCT05735717|Immunologic Factors|immunologic factors|mesh-ancestor
102530858|NCT05735717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530859|NCT05735717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102530860|NCT05735717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530861|NCT05735717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102530862|NCT05735717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102530863|NCT05735717|Alkylating Agents|alkylating agents|mesh-ancestor
102530864|NCT05735717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102530865|NCT05735717|Anticonvulsants|anticonvulsants|mesh-ancestor
102530866|NCT05735717|Nootropic Agents|nootropic agents|mesh-ancestor
102530867|NCT05693675|Methadone|methadone|mesh-list
102530868|NCT05693675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102530869|NCT05693675|Narcotics|narcotics|mesh-ancestor
102530870|NCT05693675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102530871|NCT05693675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530872|NCT05693675|Analgesics|analgesics|mesh-ancestor
102530873|NCT05693675|Sensory System Agents|sensory system agents|mesh-ancestor
102530874|NCT05693675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102530875|NCT05693675|Antitussive Agents|antitussive agents|mesh-ancestor
102530876|NCT05693675|Respiratory System Agents|respiratory system agents|mesh-ancestor
102530877|NCT05655273|Tacrolimus|tacrolimus|mesh-list
102530878|NCT05655273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102530879|NCT05655273|Immunologic Factors|immunologic factors|mesh-ancestor
102530880|NCT05655273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530881|NCT05655273|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102530882|NCT05655273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102530883|NCT05655273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530884|NCT05642078|Vaccines|vaccines|mesh-list
102530885|NCT05642078|Immunologic Factors|immunologic factors|mesh-ancestor
102530886|NCT05642078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530887|NCT05624151|Magnesium Sulfate|magnesium sulfate|mesh-list
102530888|NCT05624151|Dexmedetomidine|dexmedetomidine|mesh-list
102530889|NCT05624151|Bupivacaine|bupivacaine|mesh-list
102530890|NCT05624151|Anesthetics, Local|anesthetics, local|mesh-ancestor
102530891|NCT05624151|Anesthetics|anesthetics|mesh-ancestor
102530892|NCT05624151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102530893|NCT05624151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530894|NCT05624151|Sensory System Agents|sensory system agents|mesh-ancestor
102530895|NCT05624151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102530896|NCT05624151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102530897|NCT05624151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102530898|NCT05624151|Analgesics|analgesics|mesh-ancestor
102530899|NCT05624151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102530900|NCT05624151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102530901|NCT05624151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102530902|NCT05624151|Adrenergic Agents|adrenergic agents|mesh-ancestor
102530903|NCT05624151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102530904|NCT05624151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530905|NCT05624151|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102530906|NCT05624151|Anticonvulsants|anticonvulsants|mesh-ancestor
102530907|NCT05624151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102530908|NCT05624151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102530909|NCT05624151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102530910|NCT05624151|Tocolytic Agents|tocolytic agents|mesh-ancestor
102530911|NCT05624151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102530912|NCT05620914|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
102530913|NCT05620914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102530914|NCT05620914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102530915|NCT05584007|Floxacillin|floxacillin|mesh-list
102530916|NCT05584007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102530917|NCT05584007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102530918|NCT05570292|Folic Acid|folic acid|mesh-list
102530919|NCT05570292|Domperidone|domperidone|mesh-list
102530920|NCT05570292|Hematinics|hematinics|mesh-ancestor
102530921|NCT05570292|Vitamin B Complex|vitamin b complex|mesh-ancestor
102530922|NCT05570292|Vitamins|vitamins|mesh-ancestor
102530923|NCT05570292|Micronutrients|micronutrients|mesh-ancestor
102530924|NCT05570292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530925|NCT05570292|Antiemetics|antiemetics|mesh-ancestor
102530926|NCT05570292|Autonomic Agents|autonomic agents|mesh-ancestor
102530927|NCT05570292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102530928|NCT05570292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102530929|NCT05570292|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102530930|NCT05570292|Dopamine Agents|dopamine agents|mesh-ancestor
102530931|NCT05570292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102530932|NCT05570292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530933|NCT05554939|Cyclophosphamide|cyclophosphamide|mesh-list
102530934|NCT05554939|Mechlorethamine|mechlorethamine|mesh-list
102530935|NCT05554939|Doxorubicin|doxorubicin|mesh-list
102530936|NCT05554939|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102530937|NCT05554939|Fludarabine|fludarabine|mesh-list
102530938|NCT05554939|Fludarabine phosphate|fludarabine phosphate|mesh-list
102530939|NCT05554939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102530940|NCT05554939|Immunologic Factors|immunologic factors|mesh-ancestor
102530941|NCT05554939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530942|NCT05554939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102530943|NCT05554939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102530944|NCT05554939|Alkylating Agents|alkylating agents|mesh-ancestor
102530945|NCT05554939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530946|NCT05554939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102530947|NCT05554939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102530948|NCT05554939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102530949|NCT05554939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102530950|NCT05554939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102530951|NCT05554939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102530952|NCT05554939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102530953|NCT05554939|Antimetabolites|antimetabolites|mesh-ancestor
102530954|NCT05545891|Aripiprazole|aripiprazole|mesh-list
102530955|NCT05545891|Antidepressive Agents|antidepressive agents|mesh-ancestor
102530956|NCT05545891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102530957|NCT05545891|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102530958|NCT05545891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102530959|NCT05545891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102530960|NCT05545891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530961|NCT05545891|Dopamine Agonists|dopamine agonists|mesh-ancestor
102530962|NCT05545891|Dopamine Agents|dopamine agents|mesh-ancestor
102530963|NCT05545891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102530964|NCT05545891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530965|NCT05545891|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102530966|NCT05545891|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102530967|NCT05545891|Serotonin Agents|serotonin agents|mesh-ancestor
102530968|NCT05545891|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102530969|NCT05545891|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102530970|NCT05545891|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102530971|NCT05545891|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102530972|NCT05535166|Cyclophosphamide|cyclophosphamide|mesh-list
102530973|NCT05535166|Carboplatin|carboplatin|mesh-list
102530974|NCT05535166|Methotrexate|methotrexate|mesh-list
102530975|NCT05535166|Etoposide|etoposide|mesh-list
102530976|NCT05535166|Vincristine|vincristine|mesh-list
102530977|NCT05535166|Topotecan|topotecan|mesh-list
102530978|NCT05535166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102530979|NCT05535166|Immunologic Factors|immunologic factors|mesh-ancestor
102530980|NCT05535166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102530981|NCT05535166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102530982|NCT05535166|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102530983|NCT05535166|Alkylating Agents|alkylating agents|mesh-ancestor
102530984|NCT05535166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102530985|NCT05535166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102530986|NCT05535166|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102530987|NCT05535166|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102530988|NCT05535166|Abortifacient Agents|abortifacient agents|mesh-ancestor
102530989|NCT05535166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102530990|NCT05535166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102530991|NCT05535166|Antimetabolites|antimetabolites|mesh-ancestor
102530992|NCT05535166|Dermatologic Agents|dermatologic agents|mesh-ancestor
102530993|NCT05535166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102530994|NCT05535166|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102530995|NCT05535166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102530996|NCT05535166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102530997|NCT05535166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102530998|NCT05535166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102530999|NCT05535166|Tubulin Modulators|tubulin modulators|mesh-ancestor
102531000|NCT05535166|Antimitotic Agents|antimitotic agents|mesh-ancestor
102531001|NCT05535166|Mitosis Modulators|mitosis modulators|mesh-ancestor
102531002|NCT05535166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102531003|NCT05533697|Pembrolizumab|pembrolizumab|mesh-list
102531004|NCT05533697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102531005|NCT05533697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102531006|NCT05533697|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102531007|NCT05533697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531008|NCT05528458|Osimertinib|osimertinib|mesh-list
102531009|NCT05528458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102531010|NCT05528458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102531011|NCT05528458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102531012|NCT05528458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531013|NCT05493215|Imatinib Mesylate|imatinib mesylate|mesh-list
102531014|NCT05493215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342541|NCT00107536|Lapatinib|lapatinib|mesh-list
102531015|NCT05493215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102531016|NCT05493215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102531017|NCT05493215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531018|NCT05467761|Psilocybin|psilocybin|mesh-list
102531019|NCT05467761|Hallucinogens|hallucinogens|mesh-ancestor
102531020|NCT05467761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531021|NCT05467761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102531022|NCT05440864|Durvalumab|durvalumab|mesh-list
102531023|NCT05440864|Tremelimumab|tremelimumab|mesh-list
102531024|NCT05440864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102531025|NCT05440864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102531026|NCT05418361|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102531027|NCT05418361|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
102531028|NCT05418361|Protease Inhibitors|protease inhibitors|mesh-ancestor
102531029|NCT05418361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102531030|NCT05418361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531031|NCT05399498|Psilocybin|psilocybin|mesh-list
102531032|NCT05399498|Hallucinogens|hallucinogens|mesh-ancestor
102531033|NCT05399498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531034|NCT05399498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102531035|NCT05379530|Anesthetics|anesthetics|mesh-list
102531036|NCT05379530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102531037|NCT05379530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531038|NCT05282901|Pembrolizumab|pembrolizumab|mesh-list
102531039|NCT05282901|Lenvatinib|lenvatinib|mesh-list
102531040|NCT05282901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102531041|NCT05282901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102531042|NCT05282901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102531043|NCT05282901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531044|NCT05282901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102531045|NCT05282901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102531046|NCT05272605|Vaccines|vaccines|mesh-list
102531047|NCT05272605|Immunologic Factors|immunologic factors|mesh-ancestor
102531048|NCT05272605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531049|NCT05265286|Factor VIII|factor viii|mesh-list
102531050|NCT05265286|Coagulants|coagulants|mesh-ancestor
102531051|NCT05233202|Simendan|simendan|mesh-list
102531052|NCT05233202|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102531053|NCT05233202|Vasodilator Agents|vasodilator agents|mesh-ancestor
102531054|NCT05233202|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102531055|NCT05233202|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102531056|NCT05233202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102531057|NCT05233202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531058|NCT05233202|Protective Agents|protective agents|mesh-ancestor
102531059|NCT05233202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531060|NCT05232123|Cannabidiol|cannabidiol|mesh-list
102531061|NCT05232123|Anticonvulsants|anticonvulsants|mesh-ancestor
102531062|NCT05229055|Ketamine|ketamine|mesh-list
102531063|NCT05229055|Analgesics|analgesics|mesh-ancestor
102531064|NCT05229055|Sensory System Agents|sensory system agents|mesh-ancestor
102531065|NCT05229055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102531066|NCT05229055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531067|NCT05229055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102531068|NCT05229055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102531069|NCT05229055|Anesthetics, General|anesthetics, general|mesh-ancestor
102531070|NCT05229055|Anesthetics|anesthetics|mesh-ancestor
102531071|NCT05229055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102531072|NCT05229055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102531073|NCT05229055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102531074|NCT05229055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102531075|NCT05229055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531076|NCT05151471|Edaravone|edaravone|mesh-list
102531077|NCT05151471|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102531078|NCT05151471|Antioxidants|antioxidants|mesh-ancestor
102531079|NCT05151471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531080|NCT05151471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102531081|NCT05151471|Protective Agents|protective agents|mesh-ancestor
102531082|NCT05151471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531083|NCT05009992|TIC10 compound|tic10 compound|mesh-list
102531084|NCT05009992|Dopamine|dopamine|mesh-list
102531085|NCT05009992|GDC-0084|gdc-0084|mesh-list
102531086|NCT05009992|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102531087|NCT05009992|Sympathomimetics|sympathomimetics|mesh-ancestor
102531088|NCT05009992|Autonomic Agents|autonomic agents|mesh-ancestor
102531089|NCT05009992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102531090|NCT05009992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531091|NCT05009992|Dopamine Agents|dopamine agents|mesh-ancestor
102531092|NCT05009992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102531093|NCT05009992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531094|NCT05009992|Protective Agents|protective agents|mesh-ancestor
102531095|NCT05009992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102531096|NCT05009992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102531098|NCT04992312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102531099|NCT04992312|Hormones|hormones|mesh-ancestor
102531100|NCT04992312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102531101|NCT04992312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531102|NCT04986072|Nitroprusside|nitroprusside|mesh-list
102531103|NCT04986072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102531104|NCT04986072|Vasodilator Agents|vasodilator agents|mesh-ancestor
102531105|NCT04986072|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102531106|NCT04986072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531107|NCT04965935|Dapagliflozin|dapagliflozin|mesh-list
102531108|NCT04965935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102531109|NCT04965935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531110|NCT04965935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102531111|NCT04965935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531112|NCT04964869|Epinephrine|epinephrine|mesh-list
102531113|NCT04964869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102531114|NCT04964869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102531115|NCT04964869|Adrenergic Agents|adrenergic agents|mesh-ancestor
102531116|NCT04964869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102531117|NCT04964869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531118|NCT04964869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531119|NCT04964869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102531120|NCT04964869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102531121|NCT04964869|Autonomic Agents|autonomic agents|mesh-ancestor
102531122|NCT04964869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102531123|NCT04964869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102531124|NCT04964869|Respiratory System Agents|respiratory system agents|mesh-ancestor
102531125|NCT04964869|Mydriatics|mydriatics|mesh-ancestor
102531126|NCT04964869|Sympathomimetics|sympathomimetics|mesh-ancestor
102531127|NCT04964869|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102531128|NCT04936841|Pembrolizumab|pembrolizumab|mesh-list
102531129|NCT04936841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102531130|NCT04936841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102531131|NCT04936841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102531132|NCT04936841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531133|NCT04930536|Acalabrutinib|acalabrutinib|mesh-list
102531134|NCT04930536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102531135|NCT04893291|Sirolimus|sirolimus|mesh-list
102531136|NCT04893291|Everolimus|everolimus|mesh-list
102531137|NCT04893291|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102531138|NCT04893291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102531139|NCT04893291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102531140|NCT04893291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531141|NCT04893291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102531142|NCT04893291|Immunologic Factors|immunologic factors|mesh-ancestor
102531143|NCT04893291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531144|NCT04893291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102531145|NCT04893291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102531146|NCT04893291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102531147|NCT04893291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102531148|NCT04893291|Antifungal Agents|antifungal agents|mesh-ancestor
102531149|NCT04864743|Factor VIII|factor viii|mesh-list
102531150|NCT04864743|Coagulants|coagulants|mesh-ancestor
102531151|NCT04847453|Dexamethasone|dexamethasone|mesh-list
102531152|NCT04847453|Dexamethasone acetate|dexamethasone acetate|mesh-list
102531153|NCT04847453|Venetoclax|venetoclax|mesh-list
102531154|NCT04847453|Ixazomib|ixazomib|mesh-list
102531155|NCT04847453|Ichthammol|ichthammol|mesh-list
102531156|NCT04847453|BB 1101|bb 1101|mesh-list
102531157|NCT04847453|Glycine|glycine|mesh-list
102531158|NCT04847453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102531159|NCT04847453|Antiemetics|antiemetics|mesh-ancestor
102531160|NCT04847453|Autonomic Agents|autonomic agents|mesh-ancestor
102531161|NCT04847453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102531162|NCT04847453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531163|NCT04847453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102531164|NCT04847453|Glucocorticoids|glucocorticoids|mesh-ancestor
102531165|NCT04847453|Hormones|hormones|mesh-ancestor
102531166|NCT04847453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102531167|NCT04847453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102531168|NCT04847453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102531169|NCT04847453|Protease Inhibitors|protease inhibitors|mesh-ancestor
102531170|NCT04847453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102531171|NCT04847453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531172|NCT04847453|Dermatologic Agents|dermatologic agents|mesh-ancestor
102531173|NCT04847453|Glycine Agents|glycine agents|mesh-ancestor
102531174|NCT04847453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102531175|NCT04803422|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102531176|NCT04803422|Amoxicillin|amoxicillin|mesh-list
102531177|NCT04803422|Metronidazole|metronidazole|mesh-list
102531179|NCT04803422|Piperacillin|piperacillin|mesh-list
102531180|NCT04803422|Clavulanic Acids|clavulanic acids|mesh-list
102531181|NCT04803422|Clavulanic Acid|clavulanic acid|mesh-list
102531182|NCT04803422|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102531183|NCT04803422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102531184|NCT04803422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102531185|NCT04803422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102531186|NCT04803422|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102531187|NCT04803422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102531188|NCT04803422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531189|NCT04791943|Melatonin|melatonin|mesh-list
102531190|NCT04791943|Antioxidants|antioxidants|mesh-ancestor
102531191|NCT04791943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531192|NCT04791943|Protective Agents|protective agents|mesh-ancestor
102531193|NCT04791943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531194|NCT04791943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102531195|NCT04770532|Insulin|insulin|mesh-list
102531196|NCT04770532|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102531197|NCT04770532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102531198|NCT04770532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531199|NCT04731779|Cannabidiol|cannabidiol|mesh-list
102531200|NCT04731779|Anticonvulsants|anticonvulsants|mesh-ancestor
102531201|NCT04717765|Vitamin E|vitamin e|mesh-list
102531202|NCT04717765|alpha-Tocopherol|alpha-tocopherol|mesh-list
102531203|NCT04717765|Tocopherols|tocopherols|mesh-list
102531204|NCT04717765|Antioxidants|antioxidants|mesh-ancestor
102531205|NCT04717765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531206|NCT04717765|Protective Agents|protective agents|mesh-ancestor
102531207|NCT04717765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531208|NCT04717765|Vitamins|vitamins|mesh-ancestor
102531209|NCT04717765|Micronutrients|micronutrients|mesh-ancestor
102531210|NCT04715568|Losartan|losartan|mesh-list
102531211|NCT04715568|Antihypertensive Agents|antihypertensive agents|mesh-list
102531212|NCT04715568|Angiotensin II|angiotensin ii|mesh-list
102531213|NCT04715568|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
102531214|NCT04715568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102531215|NCT04715568|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102531216|NCT04715568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531217|NCT04715568|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102531218|NCT04665947|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
102531219|NCT04665947|Chelating Agents|chelating agents|mesh-ancestor
102531220|NCT04665947|Sequestering Agents|sequestering agents|mesh-ancestor
102531221|NCT04665947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531222|NCT04658849|Pioglitazone|pioglitazone|mesh-list
102531223|NCT04658849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102531224|NCT04658849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531225|NCT04616313|Xenon|xenon|mesh-list
102531226|NCT04616313|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102531227|NCT04616313|Anesthetics, General|anesthetics, general|mesh-ancestor
102531228|NCT04616313|Anesthetics|anesthetics|mesh-ancestor
102531229|NCT04616313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102531230|NCT04616313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531231|NCT04577404|Edaravone|edaravone|mesh-list
102531232|NCT04577404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102531233|NCT04577404|Antioxidants|antioxidants|mesh-ancestor
102531234|NCT04577404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531235|NCT04577404|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102531236|NCT04577404|Protective Agents|protective agents|mesh-ancestor
102531237|NCT04577404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531238|NCT04569084|Edaravone|edaravone|mesh-list
102531239|NCT04569084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102531240|NCT04569084|Antioxidants|antioxidants|mesh-ancestor
102531241|NCT04569084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531242|NCT04569084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102531243|NCT04569084|Protective Agents|protective agents|mesh-ancestor
102531244|NCT04569084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531245|NCT04566887|Acalabrutinib|acalabrutinib|mesh-list
102531246|NCT04566887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102531247|NCT04452747|Dinoprostone|dinoprostone|mesh-list
102531248|NCT04452747|Oxytocics|oxytocics|mesh-ancestor
102531249|NCT04452747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102531250|NCT04452747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531251|NCT04421339|Melatonin|melatonin|mesh-list
102531252|NCT04421339|Antioxidants|antioxidants|mesh-ancestor
102531253|NCT04421339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531254|NCT04421339|Protective Agents|protective agents|mesh-ancestor
102531255|NCT04421339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531256|NCT04421339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102531257|NCT04418661|Pembrolizumab|pembrolizumab|mesh-list
102531258|NCT04418661|Adagrasib|adagrasib|mesh-list
102531259|NCT04418661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102531260|NCT04418661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102531261|NCT04418661|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102531262|NCT04418661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531263|NCT04342572|Melphalan|melphalan|mesh-list
102531264|NCT04342572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102531265|NCT04342572|Alkylating Agents|alkylating agents|mesh-ancestor
102531266|NCT04342572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531267|NCT04342572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102531268|NCT04342572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102531269|NCT04342572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102531270|NCT04342572|Immunologic Factors|immunologic factors|mesh-ancestor
102531271|NCT04342572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531272|NCT04250051|Vidarabine|vidarabine|mesh-list
102531273|NCT04250051|Cytarabine|cytarabine|mesh-list
102531274|NCT04250051|Fludarabine|fludarabine|mesh-list
102531275|NCT04250051|Fludarabine phosphate|fludarabine phosphate|mesh-list
102531276|NCT04250051|Ivosidenib|ivosidenib|mesh-list
102531277|NCT04250051|Lenograstim|lenograstim|mesh-list
102531278|NCT04250051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102531279|NCT04250051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102531280|NCT04250051|Antimetabolites|antimetabolites|mesh-ancestor
102531281|NCT04250051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531282|NCT04250051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102531283|NCT04250051|Immunologic Factors|immunologic factors|mesh-ancestor
102531284|NCT04250051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531285|NCT04250051|Antiviral Agents|antiviral agents|mesh-ancestor
102531286|NCT04250051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102531287|NCT04250051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102531288|NCT04250051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102531289|NCT04207060|Indomethacin|indomethacin|mesh-list
102531290|NCT04207060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102531291|NCT04207060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102531292|NCT04207060|Analgesics|analgesics|mesh-ancestor
102531293|NCT04207060|Sensory System Agents|sensory system agents|mesh-ancestor
102531294|NCT04207060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102531295|NCT04207060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531296|NCT04207060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102531297|NCT04207060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102531298|NCT04207060|Gout Suppressants|gout suppressants|mesh-ancestor
102531299|NCT04207060|Tocolytic Agents|tocolytic agents|mesh-ancestor
102531300|NCT04207060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102531301|NCT04207060|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102531302|NCT04207060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102531303|NCT04207060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531304|NCT04204980|Daratumumab|daratumumab|mesh-list
102531305|NCT04204980|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102531306|NCT04204980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102531307|NCT04204980|Immunologic Factors|immunologic factors|mesh-ancestor
102531308|NCT04204980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531309|NCT04165824|Edaravone|edaravone|mesh-list
102531310|NCT04165824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102531311|NCT04165824|Antioxidants|antioxidants|mesh-ancestor
102531312|NCT04165824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531313|NCT04165824|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102531314|NCT04165824|Protective Agents|protective agents|mesh-ancestor
102531315|NCT04165824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531316|NCT04108039|Cetrorelix|cetrorelix|mesh-list
102531317|NCT04108039|Progesterone|progesterone|mesh-list
102531318|NCT04108039|Ganirelix|ganirelix|mesh-list
102531319|NCT04108039|Progestins|progestins|mesh-ancestor
102531320|NCT04108039|Hormones|hormones|mesh-ancestor
102531321|NCT04108039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102531322|NCT04108039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531323|NCT04108039|Hormone Antagonists|hormone antagonists|mesh-ancestor
102531324|NCT04108039|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102531325|NCT04108039|Fertility Agents|fertility agents|mesh-ancestor
102531326|NCT04108039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102531327|NCT04069169|Lidocaine|lidocaine|mesh-list
102531328|NCT04069169|Anesthetics, Local|anesthetics, local|mesh-ancestor
102531329|NCT04069169|Anesthetics|anesthetics|mesh-ancestor
102531330|NCT04069169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102531331|NCT04069169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531332|NCT04069169|Sensory System Agents|sensory system agents|mesh-ancestor
102531333|NCT04069169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102531334|NCT04069169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102531335|NCT04069169|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102531336|NCT04069169|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102531337|NCT04069169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102531338|NCT04069169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531339|NCT03997097|Sildenafil Citrate|sildenafil citrate|mesh-list
102531340|NCT03997097|Vasodilator Agents|vasodilator agents|mesh-ancestor
102531341|NCT03997097|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102531342|NCT03997097|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102531343|NCT03997097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102531344|NCT03997097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531345|NCT03997097|Urological Agents|urological agents|mesh-ancestor
102531346|NCT03988036|Pembrolizumab|pembrolizumab|mesh-list
102531347|NCT03988036|Trastuzumab|trastuzumab|mesh-list
102531348|NCT03988036|Pertuzumab|pertuzumab|mesh-list
102531349|NCT03988036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102531350|NCT03988036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102531351|NCT03988036|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102531352|NCT03988036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531353|NCT03899987|Aspirin|aspirin|mesh-list
102531354|NCT03899987|Interferons|interferons|mesh-list
102531355|NCT03899987|Interferon-alpha|interferon-alpha|mesh-list
102531356|NCT03899987|Interferon alpha-2|interferon alpha-2|mesh-list
102531357|NCT03899987|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
102531358|NCT03899987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102531359|NCT03899987|Antiviral Agents|antiviral agents|mesh-ancestor
102531360|NCT03899987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102531361|NCT03899987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102531362|NCT03899987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102531363|NCT03899987|Analgesics|analgesics|mesh-ancestor
102531364|NCT03899987|Sensory System Agents|sensory system agents|mesh-ancestor
102531365|NCT03899987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102531366|NCT03899987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531367|NCT03899987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102531368|NCT03899987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102531369|NCT03899987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102531370|NCT03899987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102531371|NCT03899987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531372|NCT03899987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102531373|NCT03899987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102531374|NCT03899987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102531375|NCT03899987|Antipyretics|antipyretics|mesh-ancestor
102531376|NCT03899987|Immunologic Factors|immunologic factors|mesh-ancestor
102531377|NCT03850028|Atezolizumab|atezolizumab|mesh-list
102531378|NCT03850028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102531379|NCT03850028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531380|NCT03850028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102531381|NCT03850028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102531382|NCT03725436|Paclitaxel|paclitaxel|mesh-list
102531383|NCT03725436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102531384|NCT03725436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102531385|NCT03725436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102531386|NCT03725436|Tubulin Modulators|tubulin modulators|mesh-ancestor
102531387|NCT03725436|Antimitotic Agents|antimitotic agents|mesh-ancestor
102531388|NCT03725436|Mitosis Modulators|mitosis modulators|mesh-ancestor
102531389|NCT03725436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531390|NCT03678688|Bedaquiline|bedaquiline|mesh-list
102531391|NCT03678688|Diarylquinolines|diarylquinolines|mesh-list
102531392|NCT03678688|Antitubercular Agents|antitubercular agents|mesh-ancestor
102531393|NCT03678688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102531394|NCT03678688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102531396|NCT03602612|Fludarabine|fludarabine|mesh-list
102531397|NCT03602612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102531398|NCT03602612|Immunologic Factors|immunologic factors|mesh-ancestor
102531399|NCT03602612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531400|NCT03602612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102531401|NCT03602612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102531402|NCT03602612|Alkylating Agents|alkylating agents|mesh-ancestor
102531403|NCT03602612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531404|NCT03602612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102531405|NCT03602612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102531406|NCT03554044|Tamoxifen|tamoxifen|mesh-list
102531407|NCT03554044|Paclitaxel|paclitaxel|mesh-list
102531408|NCT03554044|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102531409|NCT03554044|Carboplatin|carboplatin|mesh-list
102531410|NCT03554044|Gemcitabine|gemcitabine|mesh-list
102531411|NCT03554044|Letrozole|letrozole|mesh-list
102531412|NCT03554044|Fulvestrant|fulvestrant|mesh-list
102531413|NCT03554044|Anastrozole|anastrozole|mesh-list
102531414|NCT03554044|Exemestane|exemestane|mesh-list
102531415|NCT03554044|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
102531416|NCT03554044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102531417|NCT03554044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102531418|NCT03554044|Tubulin Modulators|tubulin modulators|mesh-ancestor
102531419|NCT03554044|Antimitotic Agents|antimitotic agents|mesh-ancestor
102531420|NCT03554044|Mitosis Modulators|mitosis modulators|mesh-ancestor
102531421|NCT03554044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531422|NCT03554044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102531423|NCT03554044|Antimetabolites|antimetabolites|mesh-ancestor
102531424|NCT03554044|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102531425|NCT03554044|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102531426|NCT03554044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102531427|NCT03554044|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102531428|NCT03554044|Hormone Antagonists|hormone antagonists|mesh-ancestor
102531429|NCT03554044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102531430|NCT03554044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531431|NCT03554044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102531432|NCT03554044|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102531433|NCT03554044|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102531434|NCT03554044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102531435|NCT03554044|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102531436|NCT03554044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102531437|NCT03524937|Melatonin|melatonin|mesh-list
102531438|NCT03524937|Antioxidants|antioxidants|mesh-ancestor
102531439|NCT03524937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531440|NCT03524937|Protective Agents|protective agents|mesh-ancestor
102531441|NCT03524937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531442|NCT03524937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102531443|NCT03505710|Trastuzumab|trastuzumab|mesh-list
102531444|NCT03505710|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
102531445|NCT03505710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102531446|NCT03505710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102531447|NCT03505710|Immunoconjugates|immunoconjugates|mesh-ancestor
102531448|NCT03505710|Immunologic Factors|immunologic factors|mesh-ancestor
102531449|NCT03505710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531450|NCT03435458|Misoprostol|misoprostol|mesh-list
102531451|NCT03435458|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102531452|NCT03435458|Abortifacient Agents|abortifacient agents|mesh-ancestor
102531453|NCT03435458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102531454|NCT03435458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531455|NCT03435458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102531456|NCT03435458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102531457|NCT03435458|Oxytocics|oxytocics|mesh-ancestor
102531458|NCT03323476|Mycophenolic Acid|mycophenolic acid|mesh-list
102531459|NCT03323476|Prednisone|prednisone|mesh-list
102531460|NCT03323476|Rituximab|rituximab|mesh-list
102531461|NCT03323476|Immunosuppressive Agents|immunosuppressive agents|mesh-list
102531462|NCT03323476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102531463|NCT03323476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102531464|NCT03323476|Immunologic Factors|immunologic factors|mesh-ancestor
102531465|NCT03323476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531466|NCT03323476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102531467|NCT03323476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102531468|NCT03323476|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102531469|NCT03323476|Antitubercular Agents|antitubercular agents|mesh-ancestor
102531470|NCT03323476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102531471|NCT03323476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102531472|NCT03323476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102531473|NCT03323476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531474|NCT03323476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102531475|NCT03323476|Glucocorticoids|glucocorticoids|mesh-ancestor
102531476|NCT03323476|Hormones|hormones|mesh-ancestor
102531477|NCT03323476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102531478|NCT03323476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102531479|NCT03260569|Nitric Oxide|nitric oxide|mesh-list
102531480|NCT03260569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102531481|NCT03260569|Autonomic Agents|autonomic agents|mesh-ancestor
102531482|NCT03260569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102531483|NCT03260569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531484|NCT03260569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102531485|NCT03260569|Respiratory System Agents|respiratory system agents|mesh-ancestor
102531486|NCT03260569|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102531487|NCT03260569|Antioxidants|antioxidants|mesh-ancestor
102531488|NCT03260569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531489|NCT03260569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102531490|NCT03260569|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102531491|NCT03260569|Vasodilator Agents|vasodilator agents|mesh-ancestor
102531492|NCT03260569|Gasotransmitters|gasotransmitters|mesh-ancestor
102531493|NCT03260569|Protective Agents|protective agents|mesh-ancestor
102531494|NCT03188796|Vitamin D|vitamin d|mesh-list
102531495|NCT03188796|Cholecalciferol|cholecalciferol|mesh-list
102531496|NCT03188796|Vitamins|vitamins|mesh-ancestor
102531497|NCT03188796|Micronutrients|micronutrients|mesh-ancestor
102531498|NCT03188796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531499|NCT03188796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102531500|NCT03188796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102531501|NCT03184194|Cyclophosphamide|cyclophosphamide|mesh-list
102531502|NCT03184194|Nivolumab|nivolumab|mesh-list
102531503|NCT03184194|Daratumumab|daratumumab|mesh-list
102531504|NCT03184194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102531505|NCT03184194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102531506|NCT03184194|Immunologic Factors|immunologic factors|mesh-ancestor
102531507|NCT03184194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531508|NCT03184194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102531509|NCT03184194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102531510|NCT03184194|Alkylating Agents|alkylating agents|mesh-ancestor
102531511|NCT03184194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531512|NCT03184194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102531513|NCT03184194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102531514|NCT03184194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102531515|NCT03184194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102531516|NCT03096041|Analgesics|analgesics|mesh-list
102531517|NCT03096041|Sensory System Agents|sensory system agents|mesh-ancestor
102531518|NCT03096041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102531519|NCT03096041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531520|NCT03018366|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102531521|NCT03018366|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102531522|NCT03018366|Estradiol|estradiol|mesh-list
102531523|NCT03018366|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102531524|NCT03018366|Progesterone|progesterone|mesh-list
102531525|NCT03018366|Estrogens|estrogens|mesh-ancestor
102531526|NCT03018366|Hormones|hormones|mesh-ancestor
102531527|NCT03018366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102531528|NCT03018366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531529|NCT03018366|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102531530|NCT03018366|Contraceptive Agents|contraceptive agents|mesh-ancestor
102531531|NCT03018366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102531532|NCT03018366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102531533|NCT03018366|Progestins|progestins|mesh-ancestor
102531534|NCT02889159|Imiquimod|imiquimod|mesh-list
102531535|NCT02889159|Histamine|histamine|mesh-list
102531536|NCT02889159|Histamine phosphate|histamine phosphate|mesh-list
102531537|NCT02889159|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102531538|NCT02889159|Immunologic Factors|immunologic factors|mesh-ancestor
102531539|NCT02889159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531540|NCT02889159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102531541|NCT02889159|Interferon Inducers|interferon inducers|mesh-ancestor
102531542|NCT02889159|Histamine Agonists|histamine agonists|mesh-ancestor
102531543|NCT02889159|Histamine Agents|histamine agents|mesh-ancestor
102531544|NCT02889159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102531545|NCT02889159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531546|NCT02841280|Chlorthalidone|chlorthalidone|mesh-list
102531547|NCT02841280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102531548|NCT02841280|Diuretics|diuretics|mesh-ancestor
102531549|NCT02841280|Natriuretic Agents|natriuretic agents|mesh-ancestor
102531550|NCT02841280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531551|NCT02841280|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102531552|NCT02841280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102531553|NCT02841280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531554|NCT02813356|Naloxegol|naloxegol|mesh-list
102531555|NCT02813356|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102531556|NCT02813356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531557|NCT02813356|Sensory System Agents|sensory system agents|mesh-ancestor
102531558|NCT02813356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102531559|NCT02760329|Nitric Oxide|nitric oxide|mesh-list
102531560|NCT02760329|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102531561|NCT02760329|Autonomic Agents|autonomic agents|mesh-ancestor
102531562|NCT02760329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102531563|NCT02760329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531564|NCT02760329|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102531565|NCT02760329|Respiratory System Agents|respiratory system agents|mesh-ancestor
102531566|NCT02760329|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102531567|NCT02760329|Antioxidants|antioxidants|mesh-ancestor
102531568|NCT02760329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531569|NCT02760329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102531570|NCT02760329|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102531571|NCT02760329|Vasodilator Agents|vasodilator agents|mesh-ancestor
102531572|NCT02760329|Gasotransmitters|gasotransmitters|mesh-ancestor
102531573|NCT02760329|Protective Agents|protective agents|mesh-ancestor
102531574|NCT02723500|Xenon|xenon|mesh-list
102007889|NCT05199324|Antimalarials|antimalarials|mesh-ancestor
102531575|NCT02723500|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102531576|NCT02723500|Anesthetics, General|anesthetics, general|mesh-ancestor
102531577|NCT02723500|Anesthetics|anesthetics|mesh-ancestor
102531578|NCT02723500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102531579|NCT02723500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531580|NCT02678182|Capecitabine|capecitabine|mesh-list
102531581|NCT02678182|Trastuzumab|trastuzumab|mesh-list
102531582|NCT02678182|Durvalumab|durvalumab|mesh-list
102531583|NCT02678182|Ramucirumab|ramucirumab|mesh-list
102531584|NCT02678182|Rucaparib|rucaparib|mesh-list
102531585|NCT02678182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102531586|NCT02678182|Antimetabolites|antimetabolites|mesh-ancestor
102531587|NCT02678182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531588|NCT02678182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102531589|NCT02678182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102531590|NCT02678182|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102531591|NCT02678182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102531592|NCT02620865|Calcium, Dietary|calcium, dietary|mesh-list
102531593|NCT02620865|Leucovorin|leucovorin|mesh-list
102531594|NCT02620865|Folic Acid|folic acid|mesh-list
102531595|NCT02620865|Aldesleukin|aldesleukin|mesh-list
102531596|NCT02620865|Paclitaxel|paclitaxel|mesh-list
102531597|NCT02620865|Camptothecin|camptothecin|mesh-list
102531598|NCT02620865|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102531599|NCT02620865|Gemcitabine|gemcitabine|mesh-list
102531600|NCT02620865|Fluorouracil|fluorouracil|mesh-list
102531601|NCT02620865|Oxaliplatin|oxaliplatin|mesh-list
102531602|NCT02620865|Irinotecan|irinotecan|mesh-list
102531603|NCT02620865|Interleukin-2|interleukin-2|mesh-list
102531604|NCT02620865|Antibodies|antibodies|mesh-list
102531605|NCT02620865|Immunoglobulins|immunoglobulins|mesh-list
102531606|NCT02620865|Sargramostim|sargramostim|mesh-list
102531607|NCT02620865|Calcium|calcium|mesh-list
102531608|NCT02620865|Levoleucovorin|levoleucovorin|mesh-list
102531609|NCT02620865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102531610|NCT02620865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102531611|NCT02620865|Tubulin Modulators|tubulin modulators|mesh-ancestor
102531612|NCT02620865|Antimitotic Agents|antimitotic agents|mesh-ancestor
102531613|NCT02620865|Mitosis Modulators|mitosis modulators|mesh-ancestor
102531614|NCT02620865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531615|NCT02620865|Immunologic Factors|immunologic factors|mesh-ancestor
102531616|NCT02620865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531617|NCT02620865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102531618|NCT02620865|Antimetabolites|antimetabolites|mesh-ancestor
102531619|NCT02620865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102531620|NCT02620865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102531621|NCT02620865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102531622|NCT02620865|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102531623|NCT02620865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102531624|NCT02620865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102531625|NCT02620865|Antidotes|antidotes|mesh-ancestor
102531626|NCT02620865|Protective Agents|protective agents|mesh-ancestor
102531627|NCT02620865|Vitamin B Complex|vitamin b complex|mesh-ancestor
102531628|NCT02620865|Vitamins|vitamins|mesh-ancestor
102531629|NCT02620865|Micronutrients|micronutrients|mesh-ancestor
102531630|NCT02620865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102531631|NCT02620865|Analgesics|analgesics|mesh-ancestor
102531632|NCT02620865|Sensory System Agents|sensory system agents|mesh-ancestor
102531633|NCT02620865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102531634|NCT02620865|Hematinics|hematinics|mesh-ancestor
102531635|NCT02620865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102531636|NCT02620865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102531637|NCT02620865|Antiviral Agents|antiviral agents|mesh-ancestor
102531638|NCT02620865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102531639|NCT02505477|Acetylcysteine|acetylcysteine|mesh-list
102531640|NCT02505477|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102531641|NCT02505477|Antiviral Agents|antiviral agents|mesh-ancestor
102531642|NCT02505477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102531643|NCT02505477|Expectorants|expectorants|mesh-ancestor
102531644|NCT02505477|Respiratory System Agents|respiratory system agents|mesh-ancestor
102531645|NCT02505477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102531646|NCT02505477|Antioxidants|antioxidants|mesh-ancestor
102531647|NCT02505477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531648|NCT02505477|Protective Agents|protective agents|mesh-ancestor
102531649|NCT02505477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531650|NCT02505477|Antidotes|antidotes|mesh-ancestor
102531652|NCT02484885|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102531653|NCT02484885|Anesthetics, General|anesthetics, general|mesh-ancestor
102531654|NCT02484885|Anesthetics|anesthetics|mesh-ancestor
102531655|NCT02484885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102531656|NCT02484885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531657|NCT02418572|Testosterone|testosterone|mesh-list
102531658|NCT02418572|Androgens|androgens|mesh-ancestor
102531659|NCT02418572|Hormones|hormones|mesh-ancestor
102531660|NCT02418572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102531661|NCT02418572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531662|NCT02345330|Interleukin-12|interleukin-12|mesh-list
102531663|NCT02345330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102531664|NCT02345330|Immunologic Factors|immunologic factors|mesh-ancestor
102531665|NCT02345330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531666|NCT02345330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102531667|NCT02345330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102531668|NCT02345330|Growth Substances|growth substances|mesh-ancestor
102531669|NCT02345330|Growth Inhibitors|growth inhibitors|mesh-ancestor
102531670|NCT02345330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102531671|NCT01665677|Atorvastatin|atorvastatin|mesh-list
102531672|NCT01665677|Calcium|calcium|mesh-list
102531673|NCT01665677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102531674|NCT01665677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531675|NCT01665677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102531676|NCT01665677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102531677|NCT01665677|Antimetabolites|antimetabolites|mesh-ancestor
102531678|NCT01665677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531679|NCT01665677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102531680|NCT01665677|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102531681|NCT01665677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102531682|NCT01530373|Clonidine|clonidine|mesh-list
102531683|NCT01530373|Solifenacin Succinate|solifenacin succinate|mesh-list
102531684|NCT01530373|Analgesics|analgesics|mesh-ancestor
102531685|NCT01530373|Sensory System Agents|sensory system agents|mesh-ancestor
102531686|NCT01530373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102531687|NCT01530373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531688|NCT01530373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102531689|NCT01530373|Sympatholytics|sympatholytics|mesh-ancestor
102531690|NCT01530373|Autonomic Agents|autonomic agents|mesh-ancestor
102531691|NCT01530373|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102531692|NCT01530373|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102531693|NCT01530373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102531694|NCT01530373|Adrenergic Agents|adrenergic agents|mesh-ancestor
102531695|NCT01530373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102531696|NCT01530373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531697|NCT01530373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102531698|NCT01530373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102531699|NCT01530373|Cholinergic Agents|cholinergic agents|mesh-ancestor
102531700|NCT01530373|Urological Agents|urological agents|mesh-ancestor
102531701|NCT01499953|PENTA|penta|mesh-list
102531702|NCT01499953|Rivaroxaban|rivaroxaban|mesh-list
102531703|NCT01499953|Fondaparinux|fondaparinux|mesh-list
102531704|NCT01499953|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102531705|NCT01499953|Antithrombins|antithrombins|mesh-ancestor
102531706|NCT01499953|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102531707|NCT01499953|Protease Inhibitors|protease inhibitors|mesh-ancestor
102531708|NCT01499953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102531709|NCT01499953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531710|NCT01499953|Anticoagulants|anticoagulants|mesh-ancestor
102531711|NCT01499953|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102531712|NCT01499953|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102531713|NCT01440816|Interleukin-12|interleukin-12|mesh-list
102531714|NCT01440816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102531715|NCT01440816|Immunologic Factors|immunologic factors|mesh-ancestor
102531716|NCT01440816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531717|NCT01440816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102531718|NCT01440816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102531719|NCT01440816|Growth Substances|growth substances|mesh-ancestor
102531720|NCT01440816|Growth Inhibitors|growth inhibitors|mesh-ancestor
102531721|NCT01440816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102531722|NCT01348919|Dexamethasone|dexamethasone|mesh-list
102531723|NCT01348919|Lenalidomide|lenalidomide|mesh-list
102531724|NCT01348919|Delanzomib|delanzomib|mesh-list
102531725|NCT01348919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102531726|NCT01348919|Antiemetics|antiemetics|mesh-ancestor
102531727|NCT01348919|Autonomic Agents|autonomic agents|mesh-ancestor
102531728|NCT01348919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102531729|NCT01348919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531730|NCT01348919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102531731|NCT01348919|Glucocorticoids|glucocorticoids|mesh-ancestor
102531732|NCT01348919|Hormones|hormones|mesh-ancestor
102531733|NCT01348919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102531734|NCT01348919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102531735|NCT01348919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102531736|NCT01348919|Immunologic Factors|immunologic factors|mesh-ancestor
102531737|NCT01348919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102531738|NCT01348919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102531739|NCT01348919|Growth Substances|growth substances|mesh-ancestor
102531740|NCT01348919|Growth Inhibitors|growth inhibitors|mesh-ancestor
102531741|NCT01348919|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
102531742|NCT01348919|Protease Inhibitors|protease inhibitors|mesh-ancestor
102531743|NCT01348919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102531744|NCT01348919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531745|NCT01333046|Azacitidine|azacitidine|mesh-list
102531746|NCT01333046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102531747|NCT01333046|Antimetabolites|antimetabolites|mesh-ancestor
102531748|NCT01333046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531749|NCT01333046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102531750|NCT01333046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102531751|NCT01280994|Xenon|xenon|mesh-list
102531752|NCT01280994|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102531753|NCT01280994|Anesthetics, General|anesthetics, general|mesh-ancestor
102531754|NCT01280994|Anesthetics|anesthetics|mesh-ancestor
102531755|NCT01280994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102531756|NCT01280994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531757|NCT01217970|Ibudilast|ibudilast|mesh-list
102531758|NCT01217970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102531759|NCT01217970|Autonomic Agents|autonomic agents|mesh-ancestor
102531760|NCT01217970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102531761|NCT01217970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531762|NCT01217970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102531763|NCT01217970|Respiratory System Agents|respiratory system agents|mesh-ancestor
102531764|NCT01217970|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102531765|NCT01217970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102531766|NCT01217970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531767|NCT01217970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102531768|NCT01217970|Vasodilator Agents|vasodilator agents|mesh-ancestor
102531769|NCT02431806|Milnacipran|milnacipran|mesh-list
102531770|NCT02431806|Fluoxetine|fluoxetine|mesh-list
102531771|NCT02431806|Levomilnacipran|levomilnacipran|mesh-list
102531772|NCT02431806|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102531773|NCT02431806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102531774|NCT02431806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102531775|NCT02431806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531776|NCT02431806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102531777|NCT02431806|Serotonin Agents|serotonin agents|mesh-ancestor
102531778|NCT02431806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531779|NCT02431806|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102531780|NCT02431806|Antidepressive Agents|antidepressive agents|mesh-ancestor
102531781|NCT02431806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102531782|NCT02431806|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102531783|NCT02431806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102531784|NCT02431806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102531785|NCT02431806|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102531786|NCT02431806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102531787|NCT02431806|Analgesics|analgesics|mesh-ancestor
102531788|NCT02431806|Sensory System Agents|sensory system agents|mesh-ancestor
102531789|NCT02431806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102531790|NCT05159193|Cyclophosphamide|cyclophosphamide|mesh-list
102531791|NCT05159193|Carboplatin|carboplatin|mesh-list
102531792|NCT05159193|Docetaxel|docetaxel|mesh-list
102531793|NCT05159193|Doxorubicin|doxorubicin|mesh-list
102531794|NCT05159193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102531795|NCT05159193|Trastuzumab|trastuzumab|mesh-list
102531796|NCT05159193|Pertuzumab|pertuzumab|mesh-list
102531797|NCT05159193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102531798|NCT05159193|Immunologic Factors|immunologic factors|mesh-ancestor
102531799|NCT05159193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531800|NCT05159193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102531801|NCT05159193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102531802|NCT05159193|Alkylating Agents|alkylating agents|mesh-ancestor
102531803|NCT05159193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531804|NCT05159193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102531805|NCT05159193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102531806|NCT05159193|Tubulin Modulators|tubulin modulators|mesh-ancestor
102531807|NCT05159193|Antimitotic Agents|antimitotic agents|mesh-ancestor
102531808|NCT05159193|Mitosis Modulators|mitosis modulators|mesh-ancestor
102531809|NCT05159193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102531810|NCT05159193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102531811|NCT05159193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102531812|NCT05159193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102531813|NCT05159193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102531814|NCT05220813|Lidocaine|lidocaine|mesh-list
102531815|NCT05220813|Bupivacaine|bupivacaine|mesh-list
102531816|NCT05220813|Anesthetics, Local|anesthetics, local|mesh-ancestor
102531817|NCT05220813|Anesthetics|anesthetics|mesh-ancestor
102531818|NCT05220813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102531819|NCT05220813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531820|NCT05220813|Sensory System Agents|sensory system agents|mesh-ancestor
102531821|NCT05220813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102531822|NCT05220813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102531823|NCT05220813|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102531824|NCT05220813|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102531825|NCT05220813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102531826|NCT05220813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531827|NCT01650246|Lesinurad|lesinurad|mesh-list
102531828|NCT01650246|Gout Suppressants|gout suppressants|mesh-ancestor
102531829|NCT01650246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102531830|NCT01650246|Uricosuric Agents|uricosuric agents|mesh-ancestor
102531831|NCT01212302|Clopidogrel|clopidogrel|mesh-list
102531832|NCT01212302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531833|NCT01212302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531834|NCT01212302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102531835|NCT01212302|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102531836|NCT01212302|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102531837|NCT01212302|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102531838|NCT01212302|Purinergic Agents|purinergic agents|mesh-ancestor
102531839|NCT01212302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102531840|NCT01284296|Chrysarobin|chrysarobin|mesh-list
102531841|NCT01284296|Lidocaine|lidocaine|mesh-list
102531842|NCT01284296|Anesthetics, Local|anesthetics, local|mesh-ancestor
102531843|NCT01284296|Anesthetics|anesthetics|mesh-ancestor
102531844|NCT01284296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102531845|NCT01284296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531846|NCT01284296|Sensory System Agents|sensory system agents|mesh-ancestor
102531847|NCT01284296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102531848|NCT01284296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102531849|NCT01284296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102531850|NCT01284296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102531851|NCT01284296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102531852|NCT01284296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531853|NCT01284296|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102531854|NCT01284296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102531855|NCT01284296|Analgesics|analgesics|mesh-ancestor
102531856|NCT01284296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102531857|NCT01284296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102531858|NCT00364143|Irinotecan|irinotecan|mesh-list
102531859|NCT00364143|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102531860|NCT00364143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102531861|NCT00364143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102531862|NCT00364143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531863|NCT00364143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102531864|NCT01652664|Timolol|timolol|mesh-list
102531865|NCT01652664|Travoprost|travoprost|mesh-list
102531866|NCT01652664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102531867|NCT01652664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102531868|NCT01652664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102531869|NCT01652664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102531870|NCT01652664|Adrenergic Agents|adrenergic agents|mesh-ancestor
102531871|NCT01652664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102531872|NCT01652664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531873|NCT01652664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531874|NCT01652664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102531875|NCT01652664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102531876|NCT04055649|Paclitaxel|paclitaxel|mesh-list
102531877|NCT04055649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102531878|NCT04055649|TIC10 compound|tic10 compound|mesh-list
102531879|NCT04055649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102531880|NCT04055649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102531881|NCT04055649|Tubulin Modulators|tubulin modulators|mesh-ancestor
102531882|NCT04055649|Antimitotic Agents|antimitotic agents|mesh-ancestor
102531883|NCT04055649|Mitosis Modulators|mitosis modulators|mesh-ancestor
102531884|NCT04055649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531885|NCT04899492|Nicotine|nicotine|mesh-list
102531886|NCT04899492|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102531887|NCT04899492|Autonomic Agents|autonomic agents|mesh-ancestor
102531888|NCT04899492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102531889|NCT04899492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531890|NCT04899492|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102531891|NCT04899492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102531892|NCT04899492|Cholinergic Agents|cholinergic agents|mesh-ancestor
102531893|NCT04899492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102531894|NCT04899492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531895|NCT00364221|Rosiglitazone|rosiglitazone|mesh-list
102531896|NCT00364221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102531897|NCT00364221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531898|NCT01286402|Bupropion|bupropion|mesh-list
102531899|NCT01286402|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102531900|NCT01286402|Antidepressive Agents|antidepressive agents|mesh-ancestor
102531901|NCT01286402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102531902|NCT01286402|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102531903|NCT01286402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102531904|NCT01286402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102531905|NCT01286402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531906|NCT01286402|Dopamine Agents|dopamine agents|mesh-ancestor
102531907|NCT01286402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102531908|NCT01286402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531909|NCT01286402|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102531910|NCT01286402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102531911|NCT01286402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102531912|NCT01222832|Bacitracin|bacitracin|mesh-list
102531913|NCT01222832|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102531914|NCT01222832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102531915|NCT01222832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102531916|NCT04297605|Paclitaxel|paclitaxel|mesh-list
102531917|NCT04297605|Pembrolizumab|pembrolizumab|mesh-list
102531918|NCT04297605|Pemetrexed|pemetrexed|mesh-list
102531919|NCT04297605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102531920|NCT04297605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102531921|NCT04297605|Tubulin Modulators|tubulin modulators|mesh-ancestor
102531922|NCT04297605|Antimitotic Agents|antimitotic agents|mesh-ancestor
102343432|NCT05241288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102531923|NCT04297605|Mitosis Modulators|mitosis modulators|mesh-ancestor
102531924|NCT04297605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008233|NCT03725995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102531925|NCT04297605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102531926|NCT04297605|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102531927|NCT04297605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102531928|NCT04297605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102531929|NCT04297605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102531930|NCT02379390|Prednisone|prednisone|mesh-list
102531931|NCT02379390|Abiraterone Acetate|abiraterone acetate|mesh-list
102531932|NCT02379390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102531933|NCT02379390|Glucocorticoids|glucocorticoids|mesh-ancestor
102531934|NCT02379390|Hormones|hormones|mesh-ancestor
102531935|NCT02379390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102531936|NCT02379390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531937|NCT02379390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102531938|NCT02379390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102531939|NCT02379390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102531940|NCT02379390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102531941|NCT02379390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531942|NCT02379390|Hormone Antagonists|hormone antagonists|mesh-ancestor
102531943|NCT02379390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102531944|NCT04932915|Niclosamide|niclosamide|mesh-list
102531945|NCT04932915|Anticestodal Agents|anticestodal agents|mesh-ancestor
102531946|NCT04932915|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102531947|NCT04932915|Anthelmintics|anthelmintics|mesh-ancestor
102531948|NCT04932915|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102531949|NCT04932915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102531950|NCT04932915|Antinematodal Agents|antinematodal agents|mesh-ancestor
102531951|NCT01223378|Latanoprost|latanoprost|mesh-list
102531952|NCT01223378|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102531953|NCT01223378|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102531954|NCT03780075|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
102531955|NCT03780075|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102531956|NCT03780075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531957|NCT01224626|Linezolid|linezolid|mesh-list
102531958|NCT01224626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102531959|NCT01224626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102531960|NCT01224626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102531961|NCT01224626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102531962|NCT01224626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531963|NCT01289522|Cetuximab|cetuximab|mesh-list
102531964|NCT01289522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102531965|NCT01289522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102531966|NCT01226420|Alefacept|alefacept|mesh-list
102531967|NCT01226420|Dermatologic Agents|dermatologic agents|mesh-ancestor
102531968|NCT01226420|Immunologic Factors|immunologic factors|mesh-ancestor
102531969|NCT01226420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531970|NCT04743453|Dapagliflozin|dapagliflozin|mesh-list
102531971|NCT04743453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102531972|NCT04743453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531973|NCT04743453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102531974|NCT04743453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531975|NCT04274517|Chlorhexidine|chlorhexidine|mesh-list
102531976|NCT04274517|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102531977|NCT04274517|Povidone-Iodine|povidone-iodine|mesh-list
102531978|NCT04274517|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102531979|NCT04274517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102531980|NCT04274517|Disinfectants|disinfectants|mesh-ancestor
102531981|NCT04274517|Dermatologic Agents|dermatologic agents|mesh-ancestor
102531982|NCT00365001|Methotrexate|methotrexate|mesh-list
102531983|NCT00365001|Simvastatin|simvastatin|mesh-list
102531984|NCT00365001|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102531985|NCT00365001|Abortifacient Agents|abortifacient agents|mesh-ancestor
102531986|NCT00365001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102531987|NCT00365001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102531988|NCT00365001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102531989|NCT00365001|Antimetabolites|antimetabolites|mesh-ancestor
102531990|NCT00365001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102531991|NCT00365001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102531992|NCT00365001|Dermatologic Agents|dermatologic agents|mesh-ancestor
102531993|NCT00365001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102531994|NCT00365001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102531995|NCT00365001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102531996|NCT00365001|Immunologic Factors|immunologic factors|mesh-ancestor
102343507|NCT05076019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102531997|NCT00365001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102531998|NCT00365001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102531999|NCT00365001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102532000|NCT00365001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102532001|NCT00365001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102532002|NCT00365001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102532003|NCT01289912|Everolimus|everolimus|mesh-list
102532004|NCT01289912|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102532005|NCT01289912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102532006|NCT01289912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102532007|NCT01289912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532008|NCT01289912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102532009|NCT01289912|Immunologic Factors|immunologic factors|mesh-ancestor
102532010|NCT01289912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532011|NCT01289912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102532012|NCT03192345|Cemiplimab|cemiplimab|mesh-list
102532013|NCT03192345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102532014|NCT03192345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102532015|NCT03069963|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
102532016|NCT03069963|Antacids|antacids|mesh-ancestor
102532017|NCT03069963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532018|NCT03069963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102532019|NCT01227434|Palbociclib|palbociclib|mesh-list
102532020|NCT01227434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102532021|NCT01227434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102532022|NCT01227434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102532023|NCT01227434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532024|NCT01714739|Nivolumab|nivolumab|mesh-list
102532025|NCT01714739|Ipilimumab|ipilimumab|mesh-list
102532026|NCT01714739|Immunoglobulins|immunoglobulins|mesh-list
102532027|NCT01714739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102532028|NCT01714739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102532029|NCT01714739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102532030|NCT01714739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532031|NCT01714739|Immunologic Factors|immunologic factors|mesh-ancestor
102532032|NCT01714739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532033|NCT05440383|Leuprolide|leuprolide|mesh-list
102532034|NCT05440383|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102532035|NCT05440383|Fertility Agents|fertility agents|mesh-ancestor
102532036|NCT05440383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102532037|NCT05440383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532038|NCT05440383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102532039|NCT05440383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102532040|NCT02377479|Letrozole|letrozole|mesh-list
102532041|NCT02377479|Clomiphene|clomiphene|mesh-list
102532042|NCT02377479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102532043|NCT02377479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102532044|NCT02377479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102532045|NCT02377479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102532046|NCT02377479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532047|NCT02377479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102532048|NCT02377479|Hormone Antagonists|hormone antagonists|mesh-ancestor
102532049|NCT02377479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102532050|NCT02377479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532051|NCT02377479|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102532052|NCT02377479|Fertility Agents|fertility agents|mesh-ancestor
102532053|NCT02377479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102532054|NCT02377479|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102532055|NCT02377479|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102532056|NCT01291784|Antibodies|antibodies|mesh-list
102532057|NCT01291784|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102532058|NCT01291784|Immunologic Factors|immunologic factors|mesh-ancestor
102532059|NCT01291784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532060|NCT05457647|Riboflavin|riboflavin|mesh-list
102532061|NCT05457647|Vitamin B Complex|vitamin b complex|mesh-ancestor
102532062|NCT05457647|Vitamins|vitamins|mesh-ancestor
102532063|NCT05457647|Micronutrients|micronutrients|mesh-ancestor
102532064|NCT05457647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532065|NCT05457647|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102532066|NCT05457647|Dermatologic Agents|dermatologic agents|mesh-ancestor
102532067|NCT01213316|Raltegravir Potassium|raltegravir potassium|mesh-list
102532068|NCT01213316|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102532069|NCT01213316|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102532070|NCT01213316|Antiviral Agents|antiviral agents|mesh-ancestor
102532071|NCT01213316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102532072|NCT01213316|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102532073|NCT01213316|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102532074|NCT01213316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102532075|NCT01213316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532076|NCT05439629|Ranibizumab|ranibizumab|mesh-list
102532077|NCT05439629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102532078|NCT05439629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102532079|NCT05439629|Growth Substances|growth substances|mesh-ancestor
102532080|NCT05439629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532081|NCT05439629|Growth Inhibitors|growth inhibitors|mesh-ancestor
102532082|NCT05439629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102532083|NCT01229228|Naproxen|naproxen|mesh-list
102532084|NCT01229228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102532085|NCT01229228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102532086|NCT01229228|Analgesics|analgesics|mesh-ancestor
102532087|NCT01229228|Sensory System Agents|sensory system agents|mesh-ancestor
102532088|NCT01229228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102532089|NCT01229228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532090|NCT01229228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102532091|NCT01229228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102532092|NCT01229228|Gout Suppressants|gout suppressants|mesh-ancestor
102532093|NCT01229228|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102532094|NCT01229228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102532095|NCT01229228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532096|NCT01292252|Teriparatide|teriparatide|mesh-list
102532097|NCT01292252|Parathyroid Hormone|parathyroid hormone|mesh-list
102532098|NCT01292252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532099|NCT01292252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102532100|NCT01292252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102532101|NCT02192684|Pioglitazone|pioglitazone|mesh-list
102532102|NCT02192684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102532103|NCT02192684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532104|NCT02243579|Pembrolizumab|pembrolizumab|mesh-list
102532105|NCT02243579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102532106|NCT02243579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102532107|NCT02243579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102532108|NCT02243579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532109|NCT00003407|Cytarabine|cytarabine|mesh-list
102532110|NCT00003407|Mitoxantrone|mitoxantrone|mesh-list
102532111|NCT00003407|Amifostine|amifostine|mesh-list
102532112|NCT00003407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102532113|NCT00003407|Antimetabolites|antimetabolites|mesh-ancestor
102532114|NCT00003407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532115|NCT00003407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102532116|NCT00003407|Antiviral Agents|antiviral agents|mesh-ancestor
102532117|NCT00003407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102532118|NCT00003407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102532119|NCT00003407|Immunologic Factors|immunologic factors|mesh-ancestor
102532120|NCT00003407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532121|NCT00003407|Analgesics|analgesics|mesh-ancestor
102532122|NCT00003407|Sensory System Agents|sensory system agents|mesh-ancestor
102532123|NCT00003407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102532124|NCT00003407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102532125|NCT00003407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102532126|NCT00003407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102532127|NCT00003407|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102532128|NCT00003407|Protective Agents|protective agents|mesh-ancestor
102008439|NCT03339700|Busulfan|busulfan|mesh-list
102532129|NCT04838717|Doxycycline|doxycycline|mesh-list
102532130|NCT04838717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102532131|NCT04838717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102532132|NCT04838717|Antimalarials|antimalarials|mesh-ancestor
102532133|NCT04838717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102532134|NCT04838717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102532135|NCT01710137|Varenicline|varenicline|mesh-list
102532136|NCT01710137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102532137|NCT01710137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102532138|NCT01710137|Cholinergic Agents|cholinergic agents|mesh-ancestor
102532139|NCT01710137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102532140|NCT01710137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532141|NCT01710137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532142|NCT01710839|Ranibizumab|ranibizumab|mesh-list
102532143|NCT01710839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102532144|NCT01710839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102343669|NCT04909073|Afatinib|afatinib|mesh-list
102532145|NCT01710839|Growth Substances|growth substances|mesh-ancestor
102532146|NCT01710839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532147|NCT01710839|Growth Inhibitors|growth inhibitors|mesh-ancestor
102532148|NCT01710839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102532149|NCT01215110|Bedaquiline|bedaquiline|mesh-list
102532150|NCT01215110|Antitubercular Agents|antitubercular agents|mesh-ancestor
102532151|NCT01215110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102532152|NCT01215110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102532153|NCT02980757|Gliclazide|gliclazide|mesh-list
102532154|NCT02980757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102532155|NCT02980757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532156|NCT01229462|Timolol|timolol|mesh-list
102532157|NCT01229462|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102532158|NCT01229462|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102532159|NCT01229462|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102532160|NCT01229462|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102532161|NCT01229462|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102532162|NCT01229462|Adrenergic Agents|adrenergic agents|mesh-ancestor
102532163|NCT01229462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102532164|NCT01229462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532165|NCT01229462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532166|NCT01229462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102532167|NCT01229462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102532168|NCT01229462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102532169|NCT01229462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102532170|NCT01229462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102532171|NCT01292642|Nicotine|nicotine|mesh-list
102532172|NCT01292642|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102532173|NCT01292642|Autonomic Agents|autonomic agents|mesh-ancestor
102532174|NCT01292642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102532175|NCT01292642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532176|NCT01292642|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102532177|NCT01292642|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102532178|NCT01292642|Cholinergic Agents|cholinergic agents|mesh-ancestor
102532179|NCT01292642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102532180|NCT01292642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532181|NCT01231334|Clindamycin|clindamycin|mesh-list
102532182|NCT01231334|Clindamycin palmitate|clindamycin palmitate|mesh-list
102532183|NCT01231334|Clindamycin phosphate|clindamycin phosphate|mesh-list
102532184|NCT01231334|Dapsone|dapsone|mesh-list
102532185|NCT01231334|Adapalene|adapalene|mesh-list
102532186|NCT01231334|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102532187|NCT01231334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102532188|NCT01231334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102532189|NCT01231334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102532190|NCT01231334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102532191|NCT01231334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532192|NCT01231334|Dermatologic Agents|dermatologic agents|mesh-ancestor
102532193|NCT01231334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102532194|NCT01231334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102532195|NCT01231334|Analgesics|analgesics|mesh-ancestor
102532196|NCT01231334|Sensory System Agents|sensory system agents|mesh-ancestor
102532197|NCT01231334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102532198|NCT01231334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532199|NCT01231334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102532200|NCT01231334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102532201|NCT01231334|Antimalarials|antimalarials|mesh-ancestor
102532202|NCT01231334|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102532203|NCT01231334|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102532204|NCT01231334|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102532205|NCT01231334|Leprostatic Agents|leprostatic agents|mesh-ancestor
102532206|NCT04771481|Metoclopramide|metoclopramide|mesh-list
102532207|NCT04771481|Antiemetics|antiemetics|mesh-ancestor
102532208|NCT04771481|Autonomic Agents|autonomic agents|mesh-ancestor
102532209|NCT04771481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102532210|NCT04771481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532211|NCT04771481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102532212|NCT04771481|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102532213|NCT04771481|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102532214|NCT04771481|Dopamine Agents|dopamine agents|mesh-ancestor
102532215|NCT04771481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102532216|NCT04771481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532217|NCT01292798|Ranibizumab|ranibizumab|mesh-list
102532218|NCT01292798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102532219|NCT01292798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102532220|NCT01292798|Growth Substances|growth substances|mesh-ancestor
102532221|NCT01292798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532222|NCT01292798|Growth Inhibitors|growth inhibitors|mesh-ancestor
102532223|NCT01292798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102532224|NCT03009500|Methylprednisolone|methylprednisolone|mesh-list
102532225|NCT03009500|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102532226|NCT03009500|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102532227|NCT03009500|Prednisolone|prednisolone|mesh-list
102532228|NCT03009500|Prednisolone acetate|prednisolone acetate|mesh-list
102532230|NCT03009500|Bupivacaine|bupivacaine|mesh-list
102532231|NCT03009500|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102532232|NCT03009500|Prednisolone phosphate|prednisolone phosphate|mesh-list
102532233|NCT03009500|Anesthetics, Local|anesthetics, local|mesh-ancestor
102532234|NCT03009500|Anesthetics|anesthetics|mesh-ancestor
102532235|NCT03009500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102532236|NCT03009500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532237|NCT03009500|Sensory System Agents|sensory system agents|mesh-ancestor
102532238|NCT03009500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102532239|NCT03009500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102532240|NCT03009500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102532241|NCT03009500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102532242|NCT03009500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102532243|NCT03009500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532244|NCT03009500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102532245|NCT03009500|Antiemetics|antiemetics|mesh-ancestor
102532246|NCT03009500|Autonomic Agents|autonomic agents|mesh-ancestor
102532247|NCT03009500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102532248|NCT03009500|Glucocorticoids|glucocorticoids|mesh-ancestor
102532249|NCT03009500|Hormones|hormones|mesh-ancestor
102532250|NCT03009500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102532251|NCT03009500|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102532252|NCT03009500|Protective Agents|protective agents|mesh-ancestor
102532253|NCT03009500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102532254|NCT03009500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102532255|NCT01715207|Atenolol|atenolol|mesh-list
102532256|NCT01715207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102532257|NCT01715207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102532258|NCT01715207|Sympatholytics|sympatholytics|mesh-ancestor
102532259|NCT01715207|Autonomic Agents|autonomic agents|mesh-ancestor
102532260|NCT01715207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102532261|NCT01715207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532262|NCT01715207|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102532263|NCT01715207|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102532264|NCT01715207|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102532265|NCT01715207|Adrenergic Agents|adrenergic agents|mesh-ancestor
102532266|NCT01715207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102532267|NCT01715207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532268|NCT01716221|Dexetimide|dexetimide|mesh-list
102532269|NCT01716221|Bupropion|bupropion|mesh-list
102532270|NCT01716221|Citalopram|citalopram|mesh-list
102532271|NCT01716221|Escitalopram|escitalopram|mesh-list
102532272|NCT01716221|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102532273|NCT01716221|Antidepressive Agents|antidepressive agents|mesh-ancestor
102532274|NCT01716221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102532275|NCT01716221|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102532276|NCT01716221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102532277|NCT01716221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102532278|NCT01716221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532279|NCT01716221|Dopamine Agents|dopamine agents|mesh-ancestor
102532280|NCT01716221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102532281|NCT01716221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532282|NCT01716221|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102532283|NCT01716221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102532284|NCT01716221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102532285|NCT01716221|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102532286|NCT01716221|Serotonin Agents|serotonin agents|mesh-ancestor
102532287|NCT01716221|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102532288|NCT01716221|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102532289|NCT01716221|Parasympatholytics|parasympatholytics|mesh-ancestor
102532290|NCT01716221|Autonomic Agents|autonomic agents|mesh-ancestor
102532291|NCT01716221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102532292|NCT01716221|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102532293|NCT01716221|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102532294|NCT01716221|Cholinergic Agents|cholinergic agents|mesh-ancestor
102532295|NCT01215344|Diphosphonates|diphosphonates|mesh-list
102532296|NCT01215344|Dexamethasone|dexamethasone|mesh-list
102532297|NCT01215344|Dexamethasone acetate|dexamethasone acetate|mesh-list
102532298|NCT01215344|Doxorubicin|doxorubicin|mesh-list
102532299|NCT01215344|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102532300|NCT01215344|Lenalidomide|lenalidomide|mesh-list
102532301|NCT01215344|Bortezomib|bortezomib|mesh-list
102532302|NCT01215344|BB 1101|bb 1101|mesh-list
102532303|NCT01215344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102532304|NCT01215344|Antiemetics|antiemetics|mesh-ancestor
102532305|NCT01215344|Autonomic Agents|autonomic agents|mesh-ancestor
102532306|NCT01215344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102532307|NCT01215344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532308|NCT01215344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102532309|NCT01215344|Glucocorticoids|glucocorticoids|mesh-ancestor
102532310|NCT01215344|Hormones|hormones|mesh-ancestor
102532311|NCT01215344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102532312|NCT01215344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102532313|NCT01215344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102532314|NCT01215344|Protease Inhibitors|protease inhibitors|mesh-ancestor
102532315|NCT01215344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102532316|NCT01215344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532317|NCT01215344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102532318|NCT01215344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102532319|NCT01215344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102532320|NCT01215344|Immunologic Factors|immunologic factors|mesh-ancestor
102532321|NCT01215344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102532322|NCT01215344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102532323|NCT01215344|Growth Substances|growth substances|mesh-ancestor
102532324|NCT01215344|Growth Inhibitors|growth inhibitors|mesh-ancestor
102532325|NCT01215344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102532326|NCT01231412|Cyclosporine|cyclosporine|mesh-list
102532327|NCT01231412|Sirolimus|sirolimus|mesh-list
102532328|NCT01231412|Mycophenolic Acid|mycophenolic acid|mesh-list
102532329|NCT01231412|Fludarabine|fludarabine|mesh-list
102532330|NCT01231412|Fludarabine phosphate|fludarabine phosphate|mesh-list
102532331|NCT01231412|Cyclosporins|cyclosporins|mesh-list
102532332|NCT01231412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102532333|NCT01231412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102532334|NCT01231412|Antimetabolites|antimetabolites|mesh-ancestor
102532335|NCT01231412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532336|NCT01231412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102532337|NCT01231412|Immunologic Factors|immunologic factors|mesh-ancestor
102532338|NCT01231412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532339|NCT01231412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102532340|NCT01231412|Antifungal Agents|antifungal agents|mesh-ancestor
102532341|NCT01231412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102532342|NCT01231412|Dermatologic Agents|dermatologic agents|mesh-ancestor
102532343|NCT01231412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102532344|NCT01231412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102532345|NCT01231412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102532346|NCT01231412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102532347|NCT01231412|Antitubercular Agents|antitubercular agents|mesh-ancestor
102532348|NCT01231412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102532349|NCT01719653|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
102532350|NCT01719653|Laxatives|laxatives|mesh-ancestor
102532351|NCT01719653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102532352|NCT04580771|Cisplatin|cisplatin|mesh-list
102532353|NCT04580771|Vaccines|vaccines|mesh-list
102532354|NCT04580771|Immunologic Factors|immunologic factors|mesh-ancestor
102532355|NCT04580771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532356|NCT04580771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102532357|NCT01720277|Vaccines|vaccines|mesh-list
102532358|NCT01720277|Immunologic Factors|immunologic factors|mesh-ancestor
102532359|NCT01720277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532360|NCT04514393|Methotrexate|methotrexate|mesh-list
102532361|NCT04514393|Temozolomide|temozolomide|mesh-list
102532362|NCT04514393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102532363|NCT04514393|Abortifacient Agents|abortifacient agents|mesh-ancestor
102532364|NCT04514393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102532365|NCT04514393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532366|NCT04514393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102532367|NCT04514393|Antimetabolites|antimetabolites|mesh-ancestor
102532368|NCT04514393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532369|NCT04514393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102532370|NCT04514393|Dermatologic Agents|dermatologic agents|mesh-ancestor
102532371|NCT04514393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102532372|NCT04514393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102532373|NCT04514393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102532374|NCT04514393|Immunologic Factors|immunologic factors|mesh-ancestor
102532375|NCT04514393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102532376|NCT04514393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102532377|NCT04514393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102532378|NCT04514393|Alkylating Agents|alkylating agents|mesh-ancestor
102532379|NCT01232504|Molgramostim|molgramostim|mesh-list
102532380|NCT01232504|Lenograstim|lenograstim|mesh-list
102532381|NCT01232504|Sargramostim|sargramostim|mesh-list
102532382|NCT01232504|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102532383|NCT01232504|Immunologic Factors|immunologic factors|mesh-ancestor
102532384|NCT01232504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532385|NCT01232504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102532386|NCT01737593|Acetaminophen|acetaminophen|mesh-list
102532387|NCT01737593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102532388|NCT01737593|Analgesics|analgesics|mesh-ancestor
102532389|NCT01737593|Sensory System Agents|sensory system agents|mesh-ancestor
102532390|NCT01737593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102532391|NCT01737593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532392|NCT01737593|Antipyretics|antipyretics|mesh-ancestor
102532393|NCT01217840|Vitamin D|vitamin d|mesh-list
102008722|NCT05863416|Analgesics|analgesics|mesh-ancestor
102532394|NCT01217840|Ergocalciferols|ergocalciferols|mesh-list
102532395|NCT01217840|Vitamins|vitamins|mesh-ancestor
102532396|NCT01217840|Micronutrients|micronutrients|mesh-ancestor
102532397|NCT01217840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532398|NCT01217840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102532399|NCT01217840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102532400|NCT01721603|Trametinib|trametinib|mesh-list
102532401|NCT01721603|Dabrafenib|dabrafenib|mesh-list
102532402|NCT01721603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102532403|NCT01721603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102532404|NCT01721603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102532405|NCT01721603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532406|NCT01296542|Moxifloxacin|moxifloxacin|mesh-list
102532407|NCT01296542|Besifloxacin|besifloxacin|mesh-list
102532408|NCT01296542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102532409|NCT01296542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102532410|NCT01296542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102532411|NCT01296542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102532412|NCT01296542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102532413|NCT01296542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532414|NCT01296542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102532415|NCT01234766|Rituximab|rituximab|mesh-list
102532416|NCT01234766|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102532417|NCT01234766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102532418|NCT01234766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102532419|NCT01234766|Immunologic Factors|immunologic factors|mesh-ancestor
102532420|NCT01234766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532421|NCT01234766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102532422|NCT01234766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102532423|NCT01234766|Alkylating Agents|alkylating agents|mesh-ancestor
102532424|NCT01234766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532425|NCT01234922|Losartan|losartan|mesh-list
102532426|NCT01234922|Ramipril|ramipril|mesh-list
102532427|NCT01234922|Lisinopril|lisinopril|mesh-list
102532428|NCT01234922|Benazepril|benazepril|mesh-list
102532429|NCT01234922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102532430|NCT01234922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102532431|NCT01234922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102532432|NCT01234922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102532433|NCT01234922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532434|NCT01234922|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102532435|NCT01234922|Protease Inhibitors|protease inhibitors|mesh-ancestor
102532436|NCT01234922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102532437|NCT01234922|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102532438|NCT01234922|Protective Agents|protective agents|mesh-ancestor
102532439|NCT01234922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532440|NCT01337336|Fluticasone|fluticasone|mesh-list
102532442|NCT01337336|Tiotropium Bromide|tiotropium bromide|mesh-list
102532443|NCT01337336|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102532444|NCT01337336|Ipratropium|ipratropium|mesh-list
102532445|NCT01337336|Cholinergic Antagonists|cholinergic antagonists|mesh-list
102532446|NCT01337336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102532447|NCT01337336|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102532448|NCT01337336|Autonomic Agents|autonomic agents|mesh-ancestor
102532449|NCT01337336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102532450|NCT01337336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532451|NCT01337336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102532452|NCT01337336|Respiratory System Agents|respiratory system agents|mesh-ancestor
102532453|NCT01337336|Dermatologic Agents|dermatologic agents|mesh-ancestor
102532454|NCT01337336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102532455|NCT01337336|Parasympatholytics|parasympatholytics|mesh-ancestor
102532456|NCT01337336|Cholinergic Agents|cholinergic agents|mesh-ancestor
102532457|NCT01337336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102532458|NCT01337336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532459|NCT01337336|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102532460|NCT01337336|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102532461|NCT01337336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102532462|NCT01337336|Adrenergic Agents|adrenergic agents|mesh-ancestor
102532463|NCT01239212|Levetiracetam|levetiracetam|mesh-list
102532464|NCT01239212|Anticonvulsants|anticonvulsants|mesh-ancestor
102532465|NCT01239212|Nootropic Agents|nootropic agents|mesh-ancestor
102532466|NCT01242644|Ketorolac|ketorolac|mesh-list
102532467|NCT01242644|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102532468|NCT01242644|Morphine|morphine|mesh-list
102532469|NCT01242644|Ropivacaine|ropivacaine|mesh-list
102532470|NCT01242644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102532471|NCT01242644|Narcotics|narcotics|mesh-ancestor
102532472|NCT01242644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102532473|NCT01242644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532474|NCT01242644|Analgesics|analgesics|mesh-ancestor
102532475|NCT01242644|Sensory System Agents|sensory system agents|mesh-ancestor
102532476|NCT01242644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102532477|NCT01242644|Anesthetics, Local|anesthetics, local|mesh-ancestor
102532478|NCT01242644|Anesthetics|anesthetics|mesh-ancestor
102532479|NCT01242644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102532480|NCT01242644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102532481|NCT01242644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102532482|NCT01242644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102532483|NCT01242644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102532484|NCT01242644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102532485|NCT01242644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532486|NCT01303406|Idebenone|idebenone|mesh-list
102532487|NCT01303406|Antioxidants|antioxidants|mesh-ancestor
102532488|NCT01303406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532489|NCT01303406|Protective Agents|protective agents|mesh-ancestor
102532490|NCT01303406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532491|NCT02597907|Aprepitant|aprepitant|mesh-list
102532492|NCT02597907|Palonosetron|palonosetron|mesh-list
102532493|NCT02597907|Ramosetron|ramosetron|mesh-list
102532494|NCT02597907|Antiemetics|antiemetics|mesh-ancestor
102532495|NCT02597907|Autonomic Agents|autonomic agents|mesh-ancestor
102532496|NCT02597907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102532497|NCT02597907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532498|NCT02597907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102532499|NCT02597907|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102532500|NCT02597907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102532501|NCT02597907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532502|NCT02597907|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102532503|NCT02597907|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102532504|NCT02597907|Serotonin Agents|serotonin agents|mesh-ancestor
102532505|NCT02600325|Grazoprevir|grazoprevir|mesh-list
102532506|NCT02600325|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
102532507|NCT02600325|Antiviral Agents|antiviral agents|mesh-ancestor
102532508|NCT02600325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102532509|NCT02600715|Morphine|morphine|mesh-list
102532510|NCT02600715|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102532511|NCT02600715|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102532512|NCT02600715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102532513|NCT02600715|Narcotics|narcotics|mesh-ancestor
102532514|NCT02600715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102532515|NCT02600715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532516|NCT02600715|Analgesics|analgesics|mesh-ancestor
102532517|NCT02600715|Sensory System Agents|sensory system agents|mesh-ancestor
102532518|NCT02600715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102532519|NCT02600715|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102532520|NCT02600715|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102532521|NCT02600715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102532522|NCT02600715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532523|NCT02600715|Cholinergic Agents|cholinergic agents|mesh-ancestor
102532524|NCT02600715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102532525|NCT04743297|Dinoprostone|dinoprostone|mesh-list
102532526|NCT04743297|Oxytocics|oxytocics|mesh-ancestor
102532527|NCT04743297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102532528|NCT04743297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532529|NCT04176783|Analgesics, Opioid|analgesics, opioid|mesh-list
102532530|NCT04176783|Narcotics|narcotics|mesh-ancestor
102532531|NCT04176783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102532532|NCT04176783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532533|NCT04176783|Analgesics|analgesics|mesh-ancestor
102532534|NCT04176783|Sensory System Agents|sensory system agents|mesh-ancestor
102532535|NCT04176783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102532536|NCT00365313|Celecoxib|celecoxib|mesh-list
102532537|NCT00365313|Esomeprazole|esomeprazole|mesh-list
102532538|NCT00365313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102532539|NCT00365313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102532540|NCT00365313|Analgesics|analgesics|mesh-ancestor
102532541|NCT00365313|Sensory System Agents|sensory system agents|mesh-ancestor
102532542|NCT00365313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102532543|NCT00365313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532544|NCT00365313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102532545|NCT00365313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102532546|NCT00365313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102532547|NCT00365313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102532548|NCT00365313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102532549|NCT00365313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532550|NCT00365313|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102532551|NCT00365313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102532552|NCT00365313|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102532553|NCT02605395|Rabeprazole|rabeprazole|mesh-list
102532554|NCT02605395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102532555|NCT02605395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102532556|NCT02605395|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102532557|NCT02605395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102532558|NCT02605395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532559|NCT04166721|Atezolizumab|atezolizumab|mesh-list
102532560|NCT04166721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102532561|NCT04166721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532562|NCT04166721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102532563|NCT04166721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102532564|NCT04343001|Aspirin|aspirin|mesh-list
102532565|NCT04343001|Losartan|losartan|mesh-list
102532566|NCT04343001|Simvastatin|simvastatin|mesh-list
102532567|NCT04343001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102532568|NCT04343001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102532569|NCT04343001|Analgesics|analgesics|mesh-ancestor
102532570|NCT04343001|Sensory System Agents|sensory system agents|mesh-ancestor
102532571|NCT04343001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102532572|NCT04343001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532573|NCT04343001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102532574|NCT04343001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102532575|NCT04343001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102532576|NCT04343001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102532577|NCT04343001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532578|NCT04343001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102532579|NCT04343001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102532580|NCT04343001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102532581|NCT04343001|Antipyretics|antipyretics|mesh-ancestor
102532582|NCT04343001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102532583|NCT04343001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102532584|NCT04343001|Antimetabolites|antimetabolites|mesh-ancestor
102532585|NCT04343001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102532586|NCT04343001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102532587|NCT04343001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102532588|NCT04343001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102532589|NCT04343001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102532590|NCT04343001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102532591|NCT02865135|Vaccines|vaccines|mesh-list
102532592|NCT02865135|Immunologic Factors|immunologic factors|mesh-ancestor
102532593|NCT02865135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532594|NCT04742205|Tranexamic Acid|tranexamic acid|mesh-list
102532595|NCT04742205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102532596|NCT04742205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102532597|NCT04742205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532598|NCT04742205|Hemostatics|hemostatics|mesh-ancestor
102532599|NCT04742205|Coagulants|coagulants|mesh-ancestor
102532601|NCT04743063|Valsartan|valsartan|mesh-list
102532602|NCT04743063|Telmisartan|telmisartan|mesh-list
102532603|NCT04743063|Candesartan|candesartan|mesh-list
102532604|NCT04743063|Olmesartan|olmesartan|mesh-list
102532605|NCT04743063|Irbesartan|irbesartan|mesh-list
102532606|NCT04743063|Eprosartan|eprosartan|mesh-list
101728720|NCT00815516|Micafungin|micafungin|mesh-list
102532607|NCT04743063|Angiotensin II|angiotensin ii|mesh-list
102532608|NCT04743063|Giapreza|giapreza|mesh-list
102532609|NCT04743063|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102532610|NCT04743063|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
102532611|NCT04743063|Angiotensinogen|angiotensinogen|mesh-list
102532612|NCT04743063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102532613|NCT04743063|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102532614|NCT04743063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532615|NCT04743063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102532616|NCT04743063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102532617|NCT04743063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102532618|NCT04743063|Protease Inhibitors|protease inhibitors|mesh-ancestor
102532619|NCT04743063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102532620|NCT04743063|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
102532621|NCT01739699|Acetaminophen|acetaminophen|mesh-list
102532622|NCT01739699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102532623|NCT01739699|Analgesics|analgesics|mesh-ancestor
102532624|NCT01739699|Sensory System Agents|sensory system agents|mesh-ancestor
102532625|NCT01739699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102532626|NCT01739699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532627|NCT01739699|Antipyretics|antipyretics|mesh-ancestor
102532628|NCT04154787|Rituximab|rituximab|mesh-list
102532629|NCT04154787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102532630|NCT04154787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102532631|NCT04154787|Immunologic Factors|immunologic factors|mesh-ancestor
102532632|NCT04154787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532633|NCT04154787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102532634|NCT01740713|Deferiprone|deferiprone|mesh-list
102532635|NCT01740713|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102532636|NCT01740713|Chelating Agents|chelating agents|mesh-ancestor
102532637|NCT01740713|Sequestering Agents|sequestering agents|mesh-ancestor
102532638|NCT01740713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532639|NCT02613117|Fluorides|fluorides|mesh-list
102532640|NCT02613117|Tin Fluorides|tin fluorides|mesh-list
102532641|NCT02613117|Cariostatic Agents|cariostatic agents|mesh-ancestor
102532642|NCT02613117|Protective Agents|protective agents|mesh-ancestor
102532643|NCT02613117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532644|NCT01742117|Clopidogrel|clopidogrel|mesh-list
102532645|NCT01742117|Ticagrelor|ticagrelor|mesh-list
102532646|NCT01742117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102532647|NCT01742117|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102532648|NCT01742117|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102532649|NCT01742117|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102532650|NCT01742117|Purinergic Agents|purinergic agents|mesh-ancestor
102532651|NCT01742117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102532652|NCT01742117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532653|NCT01742117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532654|NCT02613897|Dapagliflozin|dapagliflozin|mesh-list
102532655|NCT02613897|Saxagliptin|saxagliptin|mesh-list
102532656|NCT02613897|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102532657|NCT02613897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532658|NCT02613897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102532659|NCT02613897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532660|NCT02613897|Incretins|incretins|mesh-ancestor
102532661|NCT02613897|Hormones|hormones|mesh-ancestor
102532662|NCT02613897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102008999|NCT05422131|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102532663|NCT02613897|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102532664|NCT02613897|Protease Inhibitors|protease inhibitors|mesh-ancestor
102532665|NCT02613897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102532666|NCT02615535|Alprostadil|alprostadil|mesh-list
102532667|NCT02615535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102532668|NCT02615535|Vasodilator Agents|vasodilator agents|mesh-ancestor
102532669|NCT02615535|Urological Agents|urological agents|mesh-ancestor
102532670|NCT05732181|Lidocaine|lidocaine|mesh-list
102532671|NCT05732181|Anesthetics, Local|anesthetics, local|mesh-ancestor
102532672|NCT05732181|Anesthetics|anesthetics|mesh-ancestor
102532673|NCT05732181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102532674|NCT05732181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532675|NCT05732181|Sensory System Agents|sensory system agents|mesh-ancestor
102532676|NCT05732181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102532677|NCT05732181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102532678|NCT05732181|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102532679|NCT05732181|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102532680|NCT05732181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102532681|NCT05732181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532682|NCT01342172|Lenalidomide|lenalidomide|mesh-list
102532683|NCT01342172|Immunologic Factors|immunologic factors|mesh-ancestor
102532684|NCT01342172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532685|NCT01342172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102532686|NCT01342172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102532687|NCT01342172|Growth Substances|growth substances|mesh-ancestor
102532688|NCT01342172|Growth Inhibitors|growth inhibitors|mesh-ancestor
102532689|NCT01342172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102532690|NCT01243112|Lidocaine|lidocaine|mesh-list
102532691|NCT01243112|Epinephrine|epinephrine|mesh-list
102532692|NCT01243112|Racepinephrine|racepinephrine|mesh-list
102532693|NCT01243112|Bupivacaine|bupivacaine|mesh-list
102532694|NCT01243112|Epinephryl borate|epinephryl borate|mesh-list
102532695|NCT01243112|Anesthetics, Local|anesthetics, local|mesh-ancestor
102532696|NCT01243112|Anesthetics|anesthetics|mesh-ancestor
102532697|NCT01243112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102532698|NCT01243112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532699|NCT01243112|Sensory System Agents|sensory system agents|mesh-ancestor
102532700|NCT01243112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102532701|NCT01243112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102532702|NCT01243112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102532703|NCT01243112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102532704|NCT01243112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102532705|NCT01243112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532706|NCT01243112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102532707|NCT01243112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102532708|NCT01243112|Adrenergic Agents|adrenergic agents|mesh-ancestor
102532709|NCT01243112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102532710|NCT01243112|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102532711|NCT01243112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102532712|NCT01243112|Autonomic Agents|autonomic agents|mesh-ancestor
102532713|NCT01243112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102532714|NCT01243112|Respiratory System Agents|respiratory system agents|mesh-ancestor
102532715|NCT01243112|Mydriatics|mydriatics|mesh-ancestor
102532716|NCT01243112|Sympathomimetics|sympathomimetics|mesh-ancestor
102532717|NCT01243112|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102532718|NCT01243580|Moxifloxacin|moxifloxacin|mesh-list
102532719|NCT01243580|Contraceptive Agents|contraceptive agents|mesh-list
102532720|NCT01243580|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102532721|NCT01243580|Contraceptives, Oral|contraceptives, oral|mesh-list
102532722|NCT01243580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102532723|NCT01243580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532724|NCT01243580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102532725|NCT01243580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102532726|NCT01243580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102532727|NCT01243580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102532728|NCT01243580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102532729|NCT01243580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102532730|NCT01243580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532731|NCT01243580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102532732|NCT01243580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102532733|NCT01243580|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102532734|NCT01743521|Ribavirin|ribavirin|mesh-list
102532735|NCT01743521|Antimetabolites|antimetabolites|mesh-ancestor
102532736|NCT01743521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532737|NCT01743521|Antiviral Agents|antiviral agents|mesh-ancestor
102532738|NCT01743521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102532739|NCT00361803|Topotecan|topotecan|mesh-list
102532740|NCT00361803|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102532741|NCT00361803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102532742|NCT00361803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102532743|NCT00361803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532744|NCT00361803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102532745|NCT00361881|Acyclovir|acyclovir|mesh-list
102532746|NCT00361881|Hydrocortisone|hydrocortisone|mesh-list
102532747|NCT00361881|Antiviral Agents|antiviral agents|mesh-ancestor
102532748|NCT00361881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102532749|NCT00361881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102532750|NCT01743677|Moxifloxacin|moxifloxacin|mesh-list
102532751|NCT01743677|Tofacitinib|tofacitinib|mesh-list
102532752|NCT01743677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102532753|NCT01743677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102532754|NCT01743677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102532755|NCT01743677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102532756|NCT01743677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102532757|NCT01743677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532758|NCT01743677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102532759|NCT01743677|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102532760|NCT01743677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102532761|NCT00365937|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
102532762|NCT00365937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
102532763|NCT00365937|Immunologic Factors|immunologic factors|mesh-ancestor
102532764|NCT00365937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532765|NCT01246076|Lenalidomide|lenalidomide|mesh-list
102532766|NCT01246076|Immunologic Factors|immunologic factors|mesh-ancestor
102532767|NCT01246076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532768|NCT01246076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102532769|NCT01246076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102532770|NCT01246076|Growth Substances|growth substances|mesh-ancestor
102532771|NCT01246076|Growth Inhibitors|growth inhibitors|mesh-ancestor
102532772|NCT01246076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102532773|NCT00364455|Epoetin Alfa|epoetin alfa|mesh-list
102532774|NCT00364455|Hematinics|hematinics|mesh-ancestor
102532775|NCT01307462|Fluticasone|fluticasone|mesh-list
102532776|NCT01307462|Xhance|xhance|mesh-list
102532777|NCT01307462|Azithromycin|azithromycin|mesh-list
102532778|NCT01307462|Montelukast|montelukast|mesh-list
102532779|NCT01307462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102532780|NCT01307462|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102532781|NCT01307462|Autonomic Agents|autonomic agents|mesh-ancestor
102532782|NCT01307462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102532783|NCT01307462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532784|NCT01307462|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102532785|NCT01307462|Respiratory System Agents|respiratory system agents|mesh-ancestor
102532786|NCT01307462|Dermatologic Agents|dermatologic agents|mesh-ancestor
102532787|NCT01307462|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102532788|NCT01307462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102532789|NCT01307462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102532790|NCT01307462|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102532791|NCT01307462|Hormone Antagonists|hormone antagonists|mesh-ancestor
102532792|NCT01307462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102532793|NCT01307462|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102532794|NCT01307462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102532795|NCT01307462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532796|NCT05731089|Aflibercept|aflibercept|mesh-list
102532797|NCT05731089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102532798|NCT05731089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102532799|NCT05731089|Growth Substances|growth substances|mesh-ancestor
102532800|NCT05731089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532801|NCT05731089|Growth Inhibitors|growth inhibitors|mesh-ancestor
102532802|NCT05731089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102532803|NCT01307618|Interleukin-12|interleukin-12|mesh-list
102532804|NCT01307618|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102532805|NCT01307618|Immunologic Factors|immunologic factors|mesh-ancestor
102532806|NCT01307618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532807|NCT01307618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102532808|NCT01307618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102532809|NCT01307618|Growth Substances|growth substances|mesh-ancestor
102532810|NCT01307618|Growth Inhibitors|growth inhibitors|mesh-ancestor
102532811|NCT01307618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102532812|NCT01307930|Anidulafungin|anidulafungin|mesh-list
102532813|NCT01307930|Antifungal Agents|antifungal agents|mesh-ancestor
102532814|NCT01307930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102532815|NCT05371197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102532816|NCT05371197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532817|NCT05371197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102532818|NCT05371197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102532819|NCT01746095|Vancomycin|vancomycin|mesh-list
102532820|NCT01746095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102532821|NCT01746095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102532822|NCT05730777|Paclitaxel|paclitaxel|mesh-list
102532823|NCT05730777|Carboplatin|carboplatin|mesh-list
102532824|NCT05730777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102532825|NCT05730777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102532826|NCT05730777|Tubulin Modulators|tubulin modulators|mesh-ancestor
102532827|NCT05730777|Antimitotic Agents|antimitotic agents|mesh-ancestor
102532828|NCT05730777|Mitosis Modulators|mitosis modulators|mesh-ancestor
102532829|NCT05730777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532830|NCT04425239|Leucovorin|leucovorin|mesh-list
102532831|NCT04425239|Folic Acid|folic acid|mesh-list
102532832|NCT04425239|Fluorouracil|fluorouracil|mesh-list
102532833|NCT04425239|Irinotecan|irinotecan|mesh-list
102532834|NCT04425239|Panitumumab|panitumumab|mesh-list
102532835|NCT04425239|Levoleucovorin|levoleucovorin|mesh-list
102532836|NCT04425239|Antimetabolites|antimetabolites|mesh-ancestor
102532837|NCT04425239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532838|NCT04425239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102532839|NCT04425239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102532840|NCT04425239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102532841|NCT04425239|Immunologic Factors|immunologic factors|mesh-ancestor
102532842|NCT04425239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532843|NCT04425239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102532844|NCT04425239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102532845|NCT04425239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102532846|NCT04425239|Antidotes|antidotes|mesh-ancestor
102532847|NCT04425239|Protective Agents|protective agents|mesh-ancestor
102532848|NCT04425239|Vitamin B Complex|vitamin b complex|mesh-ancestor
102532849|NCT04425239|Vitamins|vitamins|mesh-ancestor
102532850|NCT04425239|Micronutrients|micronutrients|mesh-ancestor
102532851|NCT04425239|Hematinics|hematinics|mesh-ancestor
102532852|NCT04425239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102532853|NCT01309802|Botulinum Toxins|botulinum toxins|mesh-list
102532854|NCT01309802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102532855|NCT01309802|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102532856|NCT01309802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102532857|NCT01309802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102532858|NCT01309802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532859|NCT01309802|Cholinergic Agents|cholinergic agents|mesh-ancestor
102532860|NCT01309802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102532861|NCT01309802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532862|NCT01309802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102532863|NCT01309802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102532864|NCT00366093|Eszopiclone|eszopiclone|mesh-list
102532865|NCT00366093|Zopiclone|zopiclone|mesh-list
102532866|NCT00366093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102532867|NCT00366093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102532868|NCT00366093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532869|NCT04379999|Aspirin|aspirin|mesh-list
102532870|NCT04379999|Atorvastatin|atorvastatin|mesh-list
102532871|NCT04379999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102532872|NCT04379999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102532873|NCT04379999|Analgesics|analgesics|mesh-ancestor
102532874|NCT04379999|Sensory System Agents|sensory system agents|mesh-ancestor
102009189|NCT04737889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102532875|NCT04379999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102532876|NCT04379999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532877|NCT04379999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102532878|NCT04379999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102532879|NCT04379999|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102532880|NCT04379999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102532881|NCT04379999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532882|NCT04379999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102532883|NCT04379999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102532884|NCT04379999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102532885|NCT04379999|Antipyretics|antipyretics|mesh-ancestor
102532886|NCT04379999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102532887|NCT04379999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102532888|NCT04379999|Antimetabolites|antimetabolites|mesh-ancestor
102532889|NCT04379999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102532890|NCT04379999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102532891|NCT03009422|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
102532892|NCT03009422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102532893|NCT03009422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102532894|NCT03009422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102532895|NCT03009422|Schistosomicides|schistosomicides|mesh-ancestor
102532896|NCT03009422|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102532897|NCT03009422|Anthelmintics|anthelmintics|mesh-ancestor
102532898|NCT05730621|Aspirin|aspirin|mesh-list
102532899|NCT05730621|Sarpogrelate|sarpogrelate|mesh-list
102532900|NCT05730621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102532901|NCT05730621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102532902|NCT05730621|Analgesics|analgesics|mesh-ancestor
102532903|NCT05730621|Sensory System Agents|sensory system agents|mesh-ancestor
102532904|NCT05730621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102532905|NCT05730621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532906|NCT05730621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102532907|NCT05730621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102532908|NCT05730621|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102532909|NCT05730621|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102532910|NCT05730621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532911|NCT05730621|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102532912|NCT05730621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102532913|NCT05730621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102532914|NCT05730621|Antipyretics|antipyretics|mesh-ancestor
102532915|NCT05730621|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102532916|NCT05730621|Serotonin Agents|serotonin agents|mesh-ancestor
102532917|NCT05730621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102532918|NCT01346072|Tolvaptan|tolvaptan|mesh-list
102532919|NCT01346072|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102532920|NCT01346072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532921|NCT01346072|Natriuretic Agents|natriuretic agents|mesh-ancestor
102532922|NCT01346072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532923|NCT04292483|Nitric Oxide|nitric oxide|mesh-list
102532924|NCT04292483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102532925|NCT04292483|Autonomic Agents|autonomic agents|mesh-ancestor
102532926|NCT04292483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102532927|NCT04292483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532928|NCT04292483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102532929|NCT04292483|Respiratory System Agents|respiratory system agents|mesh-ancestor
102532930|NCT04292483|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102532931|NCT04292483|Antioxidants|antioxidants|mesh-ancestor
102532932|NCT04292483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532933|NCT04292483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102532934|NCT04292483|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102532935|NCT04292483|Vasodilator Agents|vasodilator agents|mesh-ancestor
102532936|NCT04292483|Gasotransmitters|gasotransmitters|mesh-ancestor
102532937|NCT04292483|Protective Agents|protective agents|mesh-ancestor
102532938|NCT01347008|Sildenafil Citrate|sildenafil citrate|mesh-list
102532939|NCT01347008|Citric Acid|citric acid|mesh-list
102532940|NCT01347008|Sodium Citrate|sodium citrate|mesh-list
102532941|NCT01347008|Anticoagulants|anticoagulants|mesh-ancestor
102532942|NCT01347008|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102532943|NCT01347008|Chelating Agents|chelating agents|mesh-ancestor
102532944|NCT01347008|Sequestering Agents|sequestering agents|mesh-ancestor
102532945|NCT01347008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532946|NCT01347008|Vasodilator Agents|vasodilator agents|mesh-ancestor
102532947|NCT01347008|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102532948|NCT01347008|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102532949|NCT01347008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102532950|NCT01347008|Urological Agents|urological agents|mesh-ancestor
102532951|NCT05343429|Aspirin|aspirin|mesh-list
102532952|NCT05343429|Benzydamine|benzydamine|mesh-list
102532953|NCT05343429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102532954|NCT05343429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102532955|NCT05343429|Analgesics|analgesics|mesh-ancestor
102532956|NCT05343429|Sensory System Agents|sensory system agents|mesh-ancestor
102532957|NCT05343429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102532958|NCT05343429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532959|NCT05343429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102532960|NCT05343429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102532961|NCT05343429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102532962|NCT05343429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102532963|NCT05343429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532964|NCT05343429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102532965|NCT05343429|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102532966|NCT05343429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102532967|NCT05343429|Antipyretics|antipyretics|mesh-ancestor
102532968|NCT01310582|Sevoflurane|sevoflurane|mesh-list
102532969|NCT01310582|Desflurane|desflurane|mesh-list
102532970|NCT01310582|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102532971|NCT01310582|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102532972|NCT01310582|Anesthetics, General|anesthetics, general|mesh-ancestor
102532973|NCT01310582|Anesthetics|anesthetics|mesh-ancestor
102532974|NCT01310582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102532975|NCT01310582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532976|NCT01311674|Vaccines|vaccines|mesh-list
102532977|NCT01311674|Immunologic Factors|immunologic factors|mesh-ancestor
102532978|NCT01311674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532980|NCT05081193|Testosterone|testosterone|mesh-list
102532981|NCT05081193|Testosterone undecanoate|testosterone undecanoate|mesh-list
102532982|NCT05081193|Testosterone enanthate|testosterone enanthate|mesh-list
102532983|NCT05081193|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102532984|NCT05081193|Androgens|androgens|mesh-ancestor
102532985|NCT05081193|Hormones|hormones|mesh-ancestor
102532986|NCT05081193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102532987|NCT05081193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102532988|NCT05081193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102532989|NCT05081193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102532990|NCT05081193|Anabolic Agents|anabolic agents|mesh-ancestor
102532991|NCT01349972|Cytarabine|cytarabine|mesh-list
102532992|NCT01349972|Daunorubicin|daunorubicin|mesh-list
102532993|NCT01349972|Mitoxantrone|mitoxantrone|mesh-list
102532994|NCT01349972|Alvocidib|alvocidib|mesh-list
102532995|NCT01349972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102532996|NCT01349972|Antimetabolites|antimetabolites|mesh-ancestor
102532997|NCT01349972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102532998|NCT01349972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102532999|NCT01349972|Antiviral Agents|antiviral agents|mesh-ancestor
102533000|NCT01349972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102533001|NCT01349972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102533002|NCT01349972|Immunologic Factors|immunologic factors|mesh-ancestor
102533003|NCT01349972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533004|NCT01349972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102533005|NCT01349972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102533006|NCT01349972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102533007|NCT01349972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102533008|NCT01349972|Analgesics|analgesics|mesh-ancestor
102533009|NCT01349972|Sensory System Agents|sensory system agents|mesh-ancestor
102533010|NCT01349972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102533011|NCT01349972|Growth Inhibitors|growth inhibitors|mesh-ancestor
102533012|NCT01349972|Growth Substances|growth substances|mesh-ancestor
102533013|NCT01349972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102533014|NCT01248104|Tranexamic Acid|tranexamic acid|mesh-list
102533015|NCT01248104|Aminocaproic Acid|aminocaproic acid|mesh-list
102533016|NCT01248104|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102533017|NCT01248104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102533018|NCT01248104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533019|NCT01248104|Hemostatics|hemostatics|mesh-ancestor
102533020|NCT01248104|Coagulants|coagulants|mesh-ancestor
102533021|NCT01748045|Nitric Oxide|nitric oxide|mesh-list
102533022|NCT01748045|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102533023|NCT01748045|Autonomic Agents|autonomic agents|mesh-ancestor
102533024|NCT01748045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102533025|NCT01748045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533026|NCT01748045|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102533027|NCT01748045|Respiratory System Agents|respiratory system agents|mesh-ancestor
102533028|NCT01748045|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102533029|NCT01748045|Antioxidants|antioxidants|mesh-ancestor
102533030|NCT01748045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533031|NCT01748045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102533032|NCT01748045|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102533033|NCT01748045|Vasodilator Agents|vasodilator agents|mesh-ancestor
102533034|NCT01748045|Gasotransmitters|gasotransmitters|mesh-ancestor
102533035|NCT01748045|Protective Agents|protective agents|mesh-ancestor
102533036|NCT01312766|Menotropins|menotropins|mesh-list
102533037|NCT01312766|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102533038|NCT01312766|Fertility Agents|fertility agents|mesh-ancestor
102533039|NCT01312766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102533040|NCT01312766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533041|NCT01749215|Topiramate|topiramate|mesh-list
102533042|NCT01749215|Anticonvulsants|anticonvulsants|mesh-ancestor
102533043|NCT01749215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102533044|NCT01749215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533045|NCT04522167|Aflibercept|aflibercept|mesh-list
102533046|NCT04522167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102533047|NCT04522167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102533048|NCT04522167|Growth Substances|growth substances|mesh-ancestor
102533049|NCT04522167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533050|NCT04522167|Growth Inhibitors|growth inhibitors|mesh-ancestor
102533051|NCT04522167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102533052|NCT01248416|Letrozole|letrozole|mesh-list
102533053|NCT01248416|Anastrozole|anastrozole|mesh-list
102533054|NCT01248416|Hormones|hormones|mesh-list
102533055|NCT01248416|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102533056|NCT01248416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102533057|NCT01248416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533058|NCT01248416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102533059|NCT01248416|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102533060|NCT01248416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102533061|NCT01248416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533062|NCT01248416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102533063|NCT01248416|Hormone Antagonists|hormone antagonists|mesh-ancestor
102533064|NCT01248416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102533065|NCT01749293|Cyclophosphamide|cyclophosphamide|mesh-list
102533066|NCT01749293|Busulfan|busulfan|mesh-list
102533067|NCT01749293|Fludarabine|fludarabine|mesh-list
102533068|NCT01749293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102533069|NCT01749293|Immunologic Factors|immunologic factors|mesh-ancestor
102533070|NCT01749293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533071|NCT01749293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102533072|NCT01749293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102533073|NCT01749293|Alkylating Agents|alkylating agents|mesh-ancestor
102533074|NCT01749293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533075|NCT01749293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102533076|NCT01749293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102533077|NCT01250210|Levonorgestrel|levonorgestrel|mesh-list
102533078|NCT01250210|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102533079|NCT01250210|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
102533080|NCT01250210|Estradiol|estradiol|mesh-list
102533081|NCT01250210|Estrogens|estrogens|mesh-ancestor
102533082|NCT01250210|Hormones|hormones|mesh-ancestor
102533083|NCT01250210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102533084|NCT01250210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533085|NCT01250210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102533086|NCT01250210|Contraceptive Agents|contraceptive agents|mesh-ancestor
102533087|NCT01250210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102533088|NCT01250210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102533089|NCT01250210|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102533090|NCT01250210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102009417|NCT03668119|Nivolumab|nivolumab|mesh-list
102533091|NCT01250210|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102533092|NCT01250210|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102533093|NCT01749605|Ciprofloxacin|ciprofloxacin|mesh-list
102533094|NCT01749605|Nitrofurantoin|nitrofurantoin|mesh-list
102533095|NCT01749605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102533096|NCT01749605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102533097|NCT01749605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102533098|NCT01749605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102533099|NCT01749605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102533100|NCT01749605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533101|NCT01749605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102533102|NCT01749605|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102533103|NCT01749605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102533104|NCT01749605|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102533105|NCT01312844|Scopolamine|scopolamine|mesh-list
102533106|NCT01312844|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102533107|NCT01312844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102533108|NCT01312844|Antiemetics|antiemetics|mesh-ancestor
102533109|NCT01312844|Autonomic Agents|autonomic agents|mesh-ancestor
102533110|NCT01312844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102533111|NCT01312844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533112|NCT01312844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102533113|NCT01312844|Mydriatics|mydriatics|mesh-ancestor
102533114|NCT01312844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102533115|NCT01312844|Cholinergic Agents|cholinergic agents|mesh-ancestor
102533116|NCT01312844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102533117|NCT01312844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533118|NCT01312844|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102533119|NCT01312844|Parasympatholytics|parasympatholytics|mesh-ancestor
102533120|NCT01750931|Meloxicam|meloxicam|mesh-list
102533121|NCT01750931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102533122|NCT01750931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102533123|NCT01750931|Analgesics|analgesics|mesh-ancestor
102533124|NCT01750931|Sensory System Agents|sensory system agents|mesh-ancestor
102533125|NCT01750931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102533126|NCT01750931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533127|NCT01750931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102533128|NCT01750931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102533129|NCT01750931|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102533130|NCT01750931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102533131|NCT01750931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102533132|NCT01750931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533133|NCT01731041|Ticagrelor|ticagrelor|mesh-list
102533134|NCT01731041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102533135|NCT01731041|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102533136|NCT01731041|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102533137|NCT01731041|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102533138|NCT01731041|Purinergic Agents|purinergic agents|mesh-ancestor
102533139|NCT01731041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102533140|NCT01731041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533141|NCT01731041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533142|NCT01313936|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
102533143|NCT01313936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102533144|NCT01313936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102533145|NCT01313936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533146|NCT01313936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102533147|NCT01752413|Ferrous gluconate|ferrous gluconate|mesh-list
102533148|NCT01752413|Hematinics|hematinics|mesh-ancestor
102533149|NCT01731119|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102533150|NCT01731119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102533151|NCT01731119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102533152|NCT01731119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102533153|NCT01731119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533154|NCT01731119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102533155|NCT01731119|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102533156|NCT01731119|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102533157|NCT01731119|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102533158|NCT01731119|Adrenergic Agents|adrenergic agents|mesh-ancestor
102533159|NCT01731119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102533160|NCT01731119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533161|NCT01731119|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102533162|NCT01731119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102533163|NCT01731119|Serotonin Agents|serotonin agents|mesh-ancestor
102533164|NCT01731119|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102533165|NCT01731119|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102533166|NCT01731119|Dopamine Agents|dopamine agents|mesh-ancestor
102533167|NCT01732445|Danazol|danazol|mesh-list
102533168|NCT01732445|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
102533169|NCT01732445|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102533170|NCT01732445|Hormone Antagonists|hormone antagonists|mesh-ancestor
102533171|NCT01732445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102533172|NCT01732445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533173|NCT01732445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102533174|NCT01732445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102533175|NCT01732445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533176|NCT01250834|Dulaglutide|dulaglutide|mesh-list
102533177|NCT01250834|Atorvastatin|atorvastatin|mesh-list
102533178|NCT01250834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102533179|NCT01250834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102533180|NCT01250834|Antimetabolites|antimetabolites|mesh-ancestor
102533181|NCT01250834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533182|NCT01250834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102533183|NCT01250834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102533184|NCT01250834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102533185|NCT01250834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102533186|NCT01250834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533187|NCT04387695|Sorafenib|sorafenib|mesh-list
102533188|NCT04387695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102533189|NCT04387695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102533190|NCT04387695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102533191|NCT04387695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533192|NCT01354652|Lamivudine|lamivudine|mesh-list
102533193|NCT01354652|Entecavir|entecavir|mesh-list
102533194|NCT01354652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102533195|NCT01354652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102533196|NCT01354652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102533197|NCT01354652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533198|NCT01354652|Antiviral Agents|antiviral agents|mesh-ancestor
102533199|NCT01354652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102344712|NCT06018025|Antibodies|antibodies|mesh-list
102533201|NCT01354652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102533202|NCT01753739|Bepotastine besilate|bepotastine besilate|mesh-list
102533203|NCT01753739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102533204|NCT01250990|Niacin|niacin|mesh-list
102533205|NCT01250990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102533206|NCT01250990|Antimetabolites|antimetabolites|mesh-ancestor
102533207|NCT01250990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533208|NCT01250990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102533209|NCT01250990|Vasodilator Agents|vasodilator agents|mesh-ancestor
102533210|NCT01250990|Vitamin B Complex|vitamin b complex|mesh-ancestor
102533211|NCT01250990|Vitamins|vitamins|mesh-ancestor
102533212|NCT01250990|Micronutrients|micronutrients|mesh-ancestor
102533213|NCT01250990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533214|NCT02990975|Ketamine|ketamine|mesh-list
102533215|NCT02990975|Analgesics|analgesics|mesh-ancestor
102533216|NCT02990975|Sensory System Agents|sensory system agents|mesh-ancestor
102533217|NCT02990975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102533218|NCT02990975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533219|NCT02990975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102533220|NCT02990975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102533221|NCT02990975|Anesthetics, General|anesthetics, general|mesh-ancestor
102533222|NCT02990975|Anesthetics|anesthetics|mesh-ancestor
102533223|NCT02990975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102533224|NCT02990975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102533225|NCT02990975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102533226|NCT02990975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102533227|NCT02990975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533228|NCT01315574|Travoprost|travoprost|mesh-list
102533229|NCT01315574|Latanoprost|latanoprost|mesh-list
102533230|NCT01315574|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102533231|NCT01315574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102533232|NCT01315574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102533233|NCT00422331|Lithium Carbonate|lithium carbonate|mesh-list
102533234|NCT00422331|Antidepressive Agents|antidepressive agents|mesh-ancestor
102533235|NCT00422331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102533236|NCT00422331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102533237|NCT00422331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533238|NCT00422331|Antimanic Agents|antimanic agents|mesh-ancestor
102533239|NCT00422331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102533240|NCT00422331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102533241|NCT00422331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533242|NCT01316042|Metformin|metformin|mesh-list
102533243|NCT01316042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102533244|NCT01316042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533245|NCT01754909|Enalapril|enalapril|mesh-list
102533246|NCT01754909|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102533247|NCT01754909|Protease Inhibitors|protease inhibitors|mesh-ancestor
102533248|NCT01754909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102533249|NCT01754909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533250|NCT01754909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102533251|NCT04340349|Hydroxychloroquine|hydroxychloroquine|mesh-list
102533252|NCT04340349|Bromhexine|bromhexine|mesh-list
102533253|NCT04340349|Antimalarials|antimalarials|mesh-ancestor
102533254|NCT04340349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102533255|NCT04340349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102533256|NCT04340349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102533257|NCT04340349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102533258|NCT04340349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533259|NCT04340349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102533260|NCT04340349|Expectorants|expectorants|mesh-ancestor
102533261|NCT04340349|Respiratory System Agents|respiratory system agents|mesh-ancestor
102533262|NCT04268771|Rituximab|rituximab|mesh-list
102533263|NCT04268771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102533264|NCT04268771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102533265|NCT04268771|Immunologic Factors|immunologic factors|mesh-ancestor
102533266|NCT04268771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533267|NCT04268771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102533268|NCT04267809|Vitamin D|vitamin d|mesh-list
102533269|NCT04267809|Metformin|metformin|mesh-list
102533270|NCT04267809|Calcium|calcium|mesh-list
102533271|NCT04267809|Vitamins|vitamins|mesh-ancestor
102533272|NCT04267809|Micronutrients|micronutrients|mesh-ancestor
102533273|NCT04267809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344784|NCT06017284|Tubulin Modulators|tubulin modulators|mesh-ancestor
102533274|NCT04267809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102533275|NCT04267809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102533276|NCT04267809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102533277|NCT02242409|Paclitaxel|paclitaxel|mesh-list
102533278|NCT02242409|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102533279|NCT02242409|Gemcitabine|gemcitabine|mesh-list
102533280|NCT02242409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102533281|NCT02242409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102533282|NCT02242409|Tubulin Modulators|tubulin modulators|mesh-ancestor
102533283|NCT02242409|Antimitotic Agents|antimitotic agents|mesh-ancestor
102533284|NCT02242409|Mitosis Modulators|mitosis modulators|mesh-ancestor
102533285|NCT02242409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533286|NCT02242409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102533287|NCT02242409|Antimetabolites|antimetabolites|mesh-ancestor
102533288|NCT00366873|Calcium|calcium|mesh-list
102533289|NCT00366873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102533290|NCT00366873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533291|NCT05317325|Vaccines|vaccines|mesh-list
102533292|NCT05317325|Immunologic Factors|immunologic factors|mesh-ancestor
102533293|NCT05317325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533294|NCT04182399|Zonisamide|zonisamide|mesh-list
102533295|NCT04182399|Anticonvulsants|anticonvulsants|mesh-ancestor
102533296|NCT04182399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102533297|NCT04182399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102533298|NCT04182399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533299|NCT04182399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102533300|NCT04182399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533301|NCT04246619|Pregabalin|pregabalin|mesh-list
102533302|NCT04246619|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102533303|NCT04246619|Analgesics|analgesics|mesh-ancestor
102533304|NCT04246619|Sensory System Agents|sensory system agents|mesh-ancestor
102533305|NCT04246619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102533306|NCT04246619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533307|NCT04246619|Anticonvulsants|anticonvulsants|mesh-ancestor
102533308|NCT04246619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102533309|NCT04246619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102533310|NCT04246619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533311|NCT04246619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102533312|NCT04246619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102533313|NCT04246619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102533314|NCT04246619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102533315|NCT04246619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102533316|NCT04246619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102533317|NCT04246619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102533318|NCT04246619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102533319|NCT04246619|Antidepressive Agents|antidepressive agents|mesh-ancestor
102533320|NCT04246619|Dopamine Agents|dopamine agents|mesh-ancestor
102533321|NCT01757561|Propofol|propofol|mesh-list
102533322|NCT01757561|Sevoflurane|sevoflurane|mesh-list
102533323|NCT01757561|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102533324|NCT01757561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102533325|NCT01757561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533326|NCT01757561|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102533327|NCT01757561|Anesthetics, General|anesthetics, general|mesh-ancestor
102533328|NCT01757561|Anesthetics|anesthetics|mesh-ancestor
102533329|NCT01757561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102533330|NCT01757561|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102533331|NCT02618187|Vancomycin|vancomycin|mesh-list
102533332|NCT02618187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102533333|NCT02618187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102533334|NCT05316857|Itraconazole|itraconazole|mesh-list
102533335|NCT05316857|Rifampin|rifampin|mesh-list
102533336|NCT05316857|Antifungal Agents|antifungal agents|mesh-ancestor
102533337|NCT05316857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102533338|NCT05316857|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102533339|NCT05316857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102533340|NCT05316857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102533341|NCT05316857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533342|NCT05316857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102533343|NCT05316857|Hormone Antagonists|hormone antagonists|mesh-ancestor
102533344|NCT05316857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102533345|NCT05316857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533346|NCT05316857|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102533347|NCT05316857|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102533348|NCT05316857|Antitubercular Agents|antitubercular agents|mesh-ancestor
102533349|NCT05316857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102533350|NCT05316857|Leprostatic Agents|leprostatic agents|mesh-ancestor
102533351|NCT05316857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102533352|NCT05316857|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102533353|NCT05316857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102533354|NCT05316857|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102533355|NCT05316857|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102533356|NCT05316857|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102533357|NCT05316857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102533359|NCT01759277|Anesthetics, Local|anesthetics, local|mesh-list
102533360|NCT01759277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102533361|NCT01759277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533362|NCT01759277|Sensory System Agents|sensory system agents|mesh-ancestor
102533363|NCT01759277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102533364|NCT02618343|Ondansetron|ondansetron|mesh-list
102533365|NCT02618343|Antiemetics|antiemetics|mesh-ancestor
102533366|NCT02618343|Autonomic Agents|autonomic agents|mesh-ancestor
102533367|NCT02618343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102533368|NCT02618343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533369|NCT02618343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102533370|NCT02618343|Antipruritics|antipruritics|mesh-ancestor
102533371|NCT02618343|Dermatologic Agents|dermatologic agents|mesh-ancestor
102533372|NCT02618343|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102533373|NCT02618343|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102533374|NCT02618343|Serotonin Agents|serotonin agents|mesh-ancestor
102533375|NCT02618343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102533376|NCT02618343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533377|NCT02991053|Ketamine|ketamine|mesh-list
102533378|NCT02991053|Analgesics|analgesics|mesh-ancestor
102533379|NCT02991053|Sensory System Agents|sensory system agents|mesh-ancestor
102533380|NCT02991053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102533381|NCT02991053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533382|NCT02991053|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102533383|NCT02991053|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102533384|NCT02991053|Anesthetics, General|anesthetics, general|mesh-ancestor
102533385|NCT02991053|Anesthetics|anesthetics|mesh-ancestor
102533386|NCT02991053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102533387|NCT02991053|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102533388|NCT02991053|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102533389|NCT02991053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102533390|NCT02991053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533391|NCT01251536|Cetuximab|cetuximab|mesh-list
102533392|NCT01251536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102533393|NCT01251536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102533394|NCT02620683|Lidocaine|lidocaine|mesh-list
102533395|NCT02620683|Anesthetics, Local|anesthetics, local|mesh-ancestor
102533396|NCT02620683|Anesthetics|anesthetics|mesh-ancestor
102533397|NCT02620683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102533398|NCT02620683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533399|NCT02620683|Sensory System Agents|sensory system agents|mesh-ancestor
102533400|NCT02620683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102533401|NCT02620683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102533402|NCT02620683|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102533403|NCT02620683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102533404|NCT02620683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102533405|NCT02620683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533406|NCT01355588|Ketorolac|ketorolac|mesh-list
102533407|NCT01355588|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102533408|NCT01355588|Lidocaine|lidocaine|mesh-list
102533409|NCT01355588|Anesthetics, Local|anesthetics, local|mesh-ancestor
102533410|NCT01355588|Anesthetics|anesthetics|mesh-ancestor
102533411|NCT01355588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102533412|NCT01355588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533413|NCT01355588|Sensory System Agents|sensory system agents|mesh-ancestor
102533414|NCT01355588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102533415|NCT01355588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102533416|NCT01355588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102533417|NCT01355588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102533418|NCT01355588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102533419|NCT01355588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344935|NCT06005480|Prilocaine|prilocaine|mesh-list
102533420|NCT01355588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102533421|NCT01355588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102533422|NCT01355588|Analgesics|analgesics|mesh-ancestor
102533423|NCT01355588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102533424|NCT01355588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102533425|NCT01355588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102533426|NCT01355588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102533427|NCT02621619|Acetaminophen|acetaminophen|mesh-list
102533428|NCT02621619|Hydromorphone|hydromorphone|mesh-list
102533429|NCT02621619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102533430|NCT02621619|Analgesics|analgesics|mesh-ancestor
102533431|NCT02621619|Sensory System Agents|sensory system agents|mesh-ancestor
102533432|NCT02621619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102533433|NCT02621619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533434|NCT02621619|Antipyretics|antipyretics|mesh-ancestor
102533435|NCT02621619|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102533436|NCT02621619|Narcotics|narcotics|mesh-ancestor
102533437|NCT02621619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102533438|NCT01253642|Docetaxel|docetaxel|mesh-list
102533439|NCT01253642|Phenelzine|phenelzine|mesh-list
102533440|NCT01253642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102533441|NCT01253642|Tubulin Modulators|tubulin modulators|mesh-ancestor
102533442|NCT01253642|Antimitotic Agents|antimitotic agents|mesh-ancestor
102533443|NCT01253642|Mitosis Modulators|mitosis modulators|mesh-ancestor
102533444|NCT01253642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533445|NCT01253642|Antidepressive Agents|antidepressive agents|mesh-ancestor
102533446|NCT01253642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102533447|NCT01253642|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102533448|NCT01253642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102533449|NCT01357148|Metformin|metformin|mesh-list
102533450|NCT01357148|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102533451|NCT01357148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102533452|NCT01357148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533453|NCT01357148|Incretins|incretins|mesh-ancestor
102533454|NCT01357148|Hormones|hormones|mesh-ancestor
102533455|NCT01357148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102533456|NCT01357148|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102533457|NCT01357148|Protease Inhibitors|protease inhibitors|mesh-ancestor
102533458|NCT01357148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102533459|NCT01357148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533460|NCT02623803|Lidocaine|lidocaine|mesh-list
102533461|NCT02623803|Anesthetics, Local|anesthetics, local|mesh-ancestor
102533462|NCT02623803|Anesthetics|anesthetics|mesh-ancestor
102533463|NCT02623803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102533464|NCT02623803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533465|NCT02623803|Sensory System Agents|sensory system agents|mesh-ancestor
102533466|NCT02623803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102533467|NCT02623803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102533468|NCT02623803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102533469|NCT02623803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102533470|NCT02623803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102533471|NCT02623803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533472|NCT02322788|Terbutaline|terbutaline|mesh-list
102533473|NCT02322788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102533474|NCT02322788|Autonomic Agents|autonomic agents|mesh-ancestor
102533475|NCT02322788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102533476|NCT02322788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533477|NCT02322788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102533478|NCT02322788|Respiratory System Agents|respiratory system agents|mesh-ancestor
102533479|NCT02322788|Sympathomimetics|sympathomimetics|mesh-ancestor
102533480|NCT02322788|Tocolytic Agents|tocolytic agents|mesh-ancestor
102533481|NCT02322788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102533482|NCT02322788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102533483|NCT02322788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102533484|NCT02322788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102533485|NCT02322788|Adrenergic Agents|adrenergic agents|mesh-ancestor
102533486|NCT02322788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102533487|NCT02322788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533488|NCT02625207|Maraviroc|maraviroc|mesh-list
102533489|NCT02625207|Darunavir|darunavir|mesh-list
102533490|NCT02625207|Cobicistat|cobicistat|mesh-list
102533491|NCT02625207|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
102533492|NCT02625207|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102533493|NCT02625207|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102533494|NCT02625207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533495|NCT02625207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102533496|NCT02625207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102533497|NCT02625207|Antiviral Agents|antiviral agents|mesh-ancestor
102533498|NCT02625207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102533499|NCT02625207|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102533500|NCT02625207|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102533501|NCT02625207|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102533502|NCT02625207|Protease Inhibitors|protease inhibitors|mesh-ancestor
102533503|NCT02625207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102533504|NCT02625207|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102533505|NCT02625207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102533506|NCT05315999|Palonosetron|palonosetron|mesh-list
102533507|NCT05315999|Antiemetics|antiemetics|mesh-ancestor
102533508|NCT05315999|Autonomic Agents|autonomic agents|mesh-ancestor
102533509|NCT05315999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102533510|NCT05315999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533511|NCT05315999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102533512|NCT05315999|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102533513|NCT05315999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102533514|NCT05315999|Serotonin Agents|serotonin agents|mesh-ancestor
102533515|NCT05315999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102533516|NCT05315999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533517|NCT01763645|Paclitaxel|paclitaxel|mesh-list
102533518|NCT01763645|Bevacizumab|bevacizumab|mesh-list
102533519|NCT01763645|Carboplatin|carboplatin|mesh-list
102533520|NCT01763645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102533521|NCT01763645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102533522|NCT01763645|Tubulin Modulators|tubulin modulators|mesh-ancestor
102533523|NCT01763645|Antimitotic Agents|antimitotic agents|mesh-ancestor
102533524|NCT01763645|Mitosis Modulators|mitosis modulators|mesh-ancestor
102533525|NCT01763645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533526|NCT01763645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102533527|NCT01763645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102533528|NCT01763645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102533529|NCT01763645|Growth Substances|growth substances|mesh-ancestor
102533530|NCT01763645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533531|NCT01763645|Growth Inhibitors|growth inhibitors|mesh-ancestor
102533532|NCT02253173|Estradiol|estradiol|mesh-list
102533533|NCT02253173|Estrogens|estrogens|mesh-ancestor
102533534|NCT02253173|Hormones|hormones|mesh-ancestor
102533535|NCT02253173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102533536|NCT02253173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533537|NCT03924791|Dexamethasone|dexamethasone|mesh-list
102533538|NCT03924791|Methylprednisolone|methylprednisolone|mesh-list
102533539|NCT03924791|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102533540|NCT03924791|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102533541|NCT03924791|Prednisolone|prednisolone|mesh-list
102533542|NCT03924791|Prednisolone acetate|prednisolone acetate|mesh-list
102533543|NCT03924791|Lidocaine|lidocaine|mesh-list
102533544|NCT03924791|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102533545|NCT03924791|Prednisolone phosphate|prednisolone phosphate|mesh-list
102533546|NCT03924791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102533547|NCT03924791|Antiemetics|antiemetics|mesh-ancestor
102533548|NCT03924791|Autonomic Agents|autonomic agents|mesh-ancestor
102533549|NCT03924791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102533550|NCT03924791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533551|NCT03924791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102533552|NCT03924791|Glucocorticoids|glucocorticoids|mesh-ancestor
102533553|NCT03924791|Hormones|hormones|mesh-ancestor
102533554|NCT03924791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102009882|NCT03512353|Dexamethasone|dexamethasone|mesh-list
102533555|NCT03924791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102533556|NCT03924791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102533557|NCT03924791|Anesthetics, Local|anesthetics, local|mesh-ancestor
102533558|NCT03924791|Anesthetics|anesthetics|mesh-ancestor
102533559|NCT03924791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102533560|NCT03924791|Sensory System Agents|sensory system agents|mesh-ancestor
102533561|NCT03924791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102533562|NCT03924791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102533563|NCT03924791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102533564|NCT03924791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102533565|NCT03924791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533566|NCT03924791|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102533567|NCT03924791|Protective Agents|protective agents|mesh-ancestor
102533568|NCT01318694|Ribavirin|ribavirin|mesh-list
102533569|NCT01318694|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102533570|NCT01318694|Antimetabolites|antimetabolites|mesh-ancestor
102533571|NCT01318694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533572|NCT01318694|Antiviral Agents|antiviral agents|mesh-ancestor
102533573|NCT01318694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102533574|NCT03009578|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102533575|NCT03009578|Hematinics|hematinics|mesh-ancestor
102533576|NCT01361048|Metronidazole|metronidazole|mesh-list
102533577|NCT01361048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102533578|NCT01361048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102533579|NCT01361048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102533580|NCT01361048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102533581|NCT01766219|Thioctic Acid|thioctic acid|mesh-list
102533582|NCT01766219|Antioxidants|antioxidants|mesh-ancestor
102533583|NCT01766219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533584|NCT01766219|Protective Agents|protective agents|mesh-ancestor
102533585|NCT01766219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533586|NCT01766219|Vitamin B Complex|vitamin b complex|mesh-ancestor
102533587|NCT01766219|Vitamins|vitamins|mesh-ancestor
102533588|NCT01766219|Micronutrients|micronutrients|mesh-ancestor
102533589|NCT01767155|Doxorubicin|doxorubicin|mesh-list
102533590|NCT01767155|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102533591|NCT01767155|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102533592|NCT01767155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102533593|NCT01767155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102533594|NCT01767155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102533595|NCT01767155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102533596|NCT01767155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533597|NCT01362686|Rivastigmine|rivastigmine|mesh-list
102533598|NCT01362686|Donepezil|donepezil|mesh-list
102533599|NCT01362686|Galantamine|galantamine|mesh-list
102533600|NCT01362686|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102533601|NCT01362686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102533602|NCT01362686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533603|NCT01362686|Cholinergic Agents|cholinergic agents|mesh-ancestor
102533604|NCT01362686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102533605|NCT01362686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533606|NCT01362686|Nootropic Agents|nootropic agents|mesh-ancestor
102533607|NCT01362686|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102533608|NCT01362686|Autonomic Agents|autonomic agents|mesh-ancestor
102533609|NCT01362686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102533610|NCT01362686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102533611|NCT01362686|Protective Agents|protective agents|mesh-ancestor
102533612|NCT01322048|Propranolol|propranolol|mesh-list
102533613|NCT01322048|Clonidine|clonidine|mesh-list
102533614|NCT01322048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102533615|NCT01322048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102533616|NCT01322048|Adrenergic Agents|adrenergic agents|mesh-ancestor
102533617|NCT01322048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102533618|NCT01322048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533619|NCT01322048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533620|NCT01322048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102533621|NCT01322048|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102533622|NCT01322048|Vasodilator Agents|vasodilator agents|mesh-ancestor
102533623|NCT01322048|Analgesics|analgesics|mesh-ancestor
102533624|NCT01322048|Sensory System Agents|sensory system agents|mesh-ancestor
102533625|NCT01322048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102533626|NCT01322048|Sympatholytics|sympatholytics|mesh-ancestor
102533627|NCT01322048|Autonomic Agents|autonomic agents|mesh-ancestor
102533628|NCT01322048|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102533629|NCT01322048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102533630|NCT01322048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102533631|NCT01322360|Morphine|morphine|mesh-list
102533632|NCT01322360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102533633|NCT01322360|Narcotics|narcotics|mesh-ancestor
102533634|NCT01322360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102533635|NCT01322360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533636|NCT01322360|Analgesics|analgesics|mesh-ancestor
102533637|NCT01322360|Sensory System Agents|sensory system agents|mesh-ancestor
102533638|NCT01322360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102533639|NCT04351724|Ritonavir|ritonavir|mesh-list
102533640|NCT04351724|Lopinavir|lopinavir|mesh-list
102533641|NCT04351724|Hydroxychloroquine|hydroxychloroquine|mesh-list
102345158|NCT05868577|Anesthetics|anesthetics|mesh-list
102533642|NCT04351724|Chloroquine|chloroquine|mesh-list
102533643|NCT04351724|Remdesivir|remdesivir|mesh-list
102533644|NCT04351724|Candesartan|candesartan|mesh-list
102533645|NCT04351724|Candesartan cilexetil|candesartan cilexetil|mesh-list
102533646|NCT04351724|Antihypertensive Agents|antihypertensive agents|mesh-list
102533647|NCT04351724|Rivaroxaban|rivaroxaban|mesh-list
102533648|NCT04351724|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102533649|NCT04351724|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102533650|NCT04351724|Protease Inhibitors|protease inhibitors|mesh-ancestor
102533651|NCT04351724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102533652|NCT04351724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533653|NCT04351724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102533654|NCT04351724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102533655|NCT04351724|Antiviral Agents|antiviral agents|mesh-ancestor
102533656|NCT04351724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102533657|NCT04351724|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102533658|NCT04351724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102533659|NCT04351724|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102533660|NCT04351724|Antithrombins|antithrombins|mesh-ancestor
102533661|NCT04351724|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102533662|NCT04351724|Anticoagulants|anticoagulants|mesh-ancestor
102533663|NCT04351724|Antimalarials|antimalarials|mesh-ancestor
102533664|NCT04351724|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102533665|NCT04351724|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102533666|NCT04351724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102533667|NCT04351724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102533668|NCT04351724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102533669|NCT04351724|Amebicides|amebicides|mesh-ancestor
102533670|NCT04351724|Antimetabolites|antimetabolites|mesh-ancestor
102533671|NCT01767701|Raltegravir Potassium|raltegravir potassium|mesh-list
102533672|NCT01767701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102533673|NCT01767701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102533674|NCT01767701|Antiviral Agents|antiviral agents|mesh-ancestor
102533675|NCT01767701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102533676|NCT01767701|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102533677|NCT01767701|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102533678|NCT01767701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102533679|NCT01767701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533680|NCT04351412|Fluorides|fluorides|mesh-list
102533681|NCT04351412|Fluorides, Topical|fluorides, topical|mesh-list
102533682|NCT04351412|Cariostatic Agents|cariostatic agents|mesh-ancestor
102533683|NCT04351412|Protective Agents|protective agents|mesh-ancestor
102533684|NCT04351412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533685|NCT01364090|Interferons|interferons|mesh-list
102533686|NCT01364090|Ribavirin|ribavirin|mesh-list
102533687|NCT01364090|Interferon-alpha|interferon-alpha|mesh-list
102533688|NCT01364090|Interferon alpha-2|interferon alpha-2|mesh-list
102533689|NCT01364090|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102533690|NCT01364090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102533691|NCT01364090|Antiviral Agents|antiviral agents|mesh-ancestor
102533692|NCT01364090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102533693|NCT01364090|Antimetabolites|antimetabolites|mesh-ancestor
102533694|NCT01364090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533695|NCT01364090|Immunologic Factors|immunologic factors|mesh-ancestor
102533696|NCT01364090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533697|NCT03684785|Pembrolizumab|pembrolizumab|mesh-list
102533698|NCT03684785|Cemiplimab|cemiplimab|mesh-list
102533699|NCT03684785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102533700|NCT03684785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102533701|NCT03684785|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102010029|NCT04860713|Aspirin|aspirin|mesh-list
102533702|NCT03684785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533703|NCT01364558|Diazepam|diazepam|mesh-list
102533704|NCT01364558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102533705|NCT01364558|Anticonvulsants|anticonvulsants|mesh-ancestor
102533706|NCT01364558|Antiemetics|antiemetics|mesh-ancestor
102533707|NCT01364558|Autonomic Agents|autonomic agents|mesh-ancestor
102533708|NCT01364558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102533709|NCT01364558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533710|NCT01364558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102533711|NCT01364558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102533712|NCT01364558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102533713|NCT01364558|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102533714|NCT01364558|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102533715|NCT01364558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102533716|NCT01364558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102533717|NCT01364558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102533718|NCT01364558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102533719|NCT01364558|Anesthetics, General|anesthetics, general|mesh-ancestor
102533720|NCT01364558|Anesthetics|anesthetics|mesh-ancestor
102533721|NCT01364558|GABA Modulators|gaba modulators|mesh-ancestor
102533722|NCT01364558|GABA Agents|gaba agents|mesh-ancestor
102533723|NCT01364558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102533724|NCT01364558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533726|NCT01323140|Androgens|androgens|mesh-ancestor
102533727|NCT01323140|Hormones|hormones|mesh-ancestor
102533728|NCT01323140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102533729|NCT01323140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533730|NCT03516305|Alprazolam|alprazolam|mesh-list
102533731|NCT03516305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102533732|NCT03516305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102533733|NCT03516305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533734|NCT03516305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102533735|NCT03516305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102533736|NCT03516305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102533737|NCT03516305|GABA Modulators|gaba modulators|mesh-ancestor
102533738|NCT03516305|GABA Agents|gaba agents|mesh-ancestor
102533739|NCT03516305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102533740|NCT03516305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533741|NCT03823287|Aflibercept|aflibercept|mesh-list
102533742|NCT03823287|Faricimab|faricimab|mesh-list
102533743|NCT03823287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102533744|NCT03823287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102533745|NCT03823287|Growth Substances|growth substances|mesh-ancestor
102533746|NCT03823287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533747|NCT03823287|Growth Inhibitors|growth inhibitors|mesh-ancestor
102533748|NCT03823287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102533749|NCT02244671|Botulinum Toxins|botulinum toxins|mesh-list
102533750|NCT02244671|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102533751|NCT02244671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102533752|NCT02244671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533753|NCT02244671|Cholinergic Agents|cholinergic agents|mesh-ancestor
102533754|NCT02244671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102533755|NCT02244671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533756|NCT02626611|Omalizumab|omalizumab|mesh-list
102533757|NCT02626611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102533758|NCT02626611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102533759|NCT02626611|Respiratory System Agents|respiratory system agents|mesh-ancestor
102533760|NCT01260662|Ketamine|ketamine|mesh-list
102533761|NCT01260662|Propofol|propofol|mesh-list
102533762|NCT01260662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102533763|NCT01260662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102533764|NCT01260662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533765|NCT01260662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102533766|NCT01260662|Anesthetics, General|anesthetics, general|mesh-ancestor
102533767|NCT01260662|Anesthetics|anesthetics|mesh-ancestor
102533768|NCT01260662|Analgesics|analgesics|mesh-ancestor
102533769|NCT01260662|Sensory System Agents|sensory system agents|mesh-ancestor
102533770|NCT01260662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102533771|NCT01260662|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102533772|NCT01260662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102533773|NCT01260662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102533774|NCT01260662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102010097|NCT03796403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102533775|NCT01260662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533776|NCT02327117|Tranexamic Acid|tranexamic acid|mesh-list
102533777|NCT02327117|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102533778|NCT02327117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102533779|NCT02327117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533780|NCT02327117|Hemostatics|hemostatics|mesh-ancestor
102533781|NCT02327117|Coagulants|coagulants|mesh-ancestor
102533782|NCT01365650|Fluticasone|fluticasone|mesh-list
102533783|NCT01365650|Xhance|xhance|mesh-list
102533784|NCT01365650|Ketorolac|ketorolac|mesh-list
102533785|NCT01365650|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102533786|NCT01365650|Phenylephrine|phenylephrine|mesh-list
102533787|NCT01365650|Oxymetazoline|oxymetazoline|mesh-list
102533788|NCT01365650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102533789|NCT01365650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102533790|NCT01365650|Autonomic Agents|autonomic agents|mesh-ancestor
102533791|NCT01365650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102533792|NCT01365650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533793|NCT01365650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102533794|NCT01365650|Respiratory System Agents|respiratory system agents|mesh-ancestor
102533795|NCT01365650|Dermatologic Agents|dermatologic agents|mesh-ancestor
102533796|NCT01365650|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102533797|NCT01365650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102533798|NCT01365650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102533799|NCT01365650|Analgesics|analgesics|mesh-ancestor
102533800|NCT01365650|Sensory System Agents|sensory system agents|mesh-ancestor
102533801|NCT01365650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102533802|NCT01365650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102533803|NCT01365650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102533804|NCT01365650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533805|NCT01365650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102533806|NCT01365650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102533807|NCT01365650|Adrenergic Agents|adrenergic agents|mesh-ancestor
102533808|NCT01365650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102533809|NCT01365650|Sympathomimetics|sympathomimetics|mesh-ancestor
102533810|NCT01365650|Nasal Decongestants|nasal decongestants|mesh-ancestor
102533811|NCT01365650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102533812|NCT01365650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102533813|NCT01365650|Mydriatics|mydriatics|mesh-ancestor
102533814|NCT01365650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102533815|NCT01365650|Protective Agents|protective agents|mesh-ancestor
102533816|NCT01324700|Dexetimide|dexetimide|mesh-list
102533817|NCT01324700|Citalopram|citalopram|mesh-list
102533818|NCT01324700|Escitalopram|escitalopram|mesh-list
102533819|NCT01324700|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
102533820|NCT01324700|Serotonin|serotonin|mesh-list
102533821|NCT01324700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102533822|NCT01324700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102533823|NCT01324700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533824|NCT01324700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102533825|NCT01324700|Serotonin Agents|serotonin agents|mesh-ancestor
102533826|NCT01324700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533827|NCT01324700|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102533828|NCT01324700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102533829|NCT01324700|Parasympatholytics|parasympatholytics|mesh-ancestor
102533830|NCT01324700|Autonomic Agents|autonomic agents|mesh-ancestor
102533831|NCT01324700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102533832|NCT01324700|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102533833|NCT01324700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102533834|NCT01324700|Cholinergic Agents|cholinergic agents|mesh-ancestor
102533835|NCT01324700|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102533836|NCT01324700|Antidepressive Agents|antidepressive agents|mesh-ancestor
102533837|NCT01324700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102533838|NCT01324700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102533839|NCT04769297|Ketamine|ketamine|mesh-list
102533840|NCT04769297|Analgesics|analgesics|mesh-ancestor
102533841|NCT04769297|Sensory System Agents|sensory system agents|mesh-ancestor
102533842|NCT04769297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102533843|NCT04769297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533844|NCT04769297|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102533845|NCT04769297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102010172|NCT03636048|Bupivacaine|bupivacaine|mesh-list
102533846|NCT04769297|Anesthetics, General|anesthetics, general|mesh-ancestor
102533847|NCT04769297|Anesthetics|anesthetics|mesh-ancestor
102533848|NCT04769297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102533849|NCT04769297|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102533850|NCT04769297|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102533851|NCT04769297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102533852|NCT04769297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533853|NCT02631057|Warfarin|warfarin|mesh-list
102533854|NCT02631057|Dabigatran|dabigatran|mesh-list
102533855|NCT02631057|Anticoagulants|anticoagulants|mesh-ancestor
102533856|NCT02631057|Antithrombins|antithrombins|mesh-ancestor
102533857|NCT02631057|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102533858|NCT02631057|Protease Inhibitors|protease inhibitors|mesh-ancestor
102533859|NCT02631057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102533860|NCT02631057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533861|NCT02631525|Propofol|propofol|mesh-list
102533862|NCT02631525|Desflurane|desflurane|mesh-list
102533863|NCT02631525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102533864|NCT02631525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102533865|NCT02631525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533866|NCT02631525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102533867|NCT02631525|Anesthetics, General|anesthetics, general|mesh-ancestor
102533868|NCT02631525|Anesthetics|anesthetics|mesh-ancestor
102533869|NCT02631525|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102533870|NCT03162497|Azithromycin|azithromycin|mesh-list
102533871|NCT03162497|Doxycycline|doxycycline|mesh-list
102533872|NCT03162497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102533873|NCT03162497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102533874|NCT03162497|Antimalarials|antimalarials|mesh-ancestor
102533875|NCT03162497|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102533876|NCT03162497|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102533877|NCT05167643|Anastrozole|anastrozole|mesh-list
102533878|NCT05167643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102533879|NCT05167643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102533880|NCT05167643|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102533881|NCT05167643|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102533882|NCT05167643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102533883|NCT05167643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533884|NCT05167643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102533885|NCT05167643|Hormone Antagonists|hormone antagonists|mesh-ancestor
102533886|NCT05167643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102533887|NCT05167643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533888|NCT01366196|Pregabalin|pregabalin|mesh-list
102533889|NCT01366196|Analgesics|analgesics|mesh-ancestor
102533890|NCT01366196|Sensory System Agents|sensory system agents|mesh-ancestor
102533891|NCT01366196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102533892|NCT01366196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533893|NCT01366196|Anticonvulsants|anticonvulsants|mesh-ancestor
102533894|NCT01366196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102533895|NCT01366196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102533896|NCT01366196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533897|NCT01366196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102533898|NCT01366196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102533899|NCT01366196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102533900|NCT01366196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102533901|NCT01366196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102533902|NCT01366976|Acetaminophen|acetaminophen|mesh-list
102533903|NCT01366976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102533904|NCT01366976|Analgesics|analgesics|mesh-ancestor
102533905|NCT01366976|Sensory System Agents|sensory system agents|mesh-ancestor
102533906|NCT01366976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102533907|NCT01366976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533908|NCT01366976|Antipyretics|antipyretics|mesh-ancestor
102533909|NCT01777217|Solifenacin Succinate|solifenacin succinate|mesh-list
102533910|NCT01777217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102533911|NCT01777217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102533912|NCT01777217|Cholinergic Agents|cholinergic agents|mesh-ancestor
102533913|NCT01777217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102533914|NCT01777217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533915|NCT01777217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533916|NCT01777217|Urological Agents|urological agents|mesh-ancestor
102533917|NCT02251379|Fluticasone|fluticasone|mesh-list
102533918|NCT02251379|Xhance|xhance|mesh-list
102533919|NCT02251379|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102533920|NCT02251379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102533921|NCT02251379|Autonomic Agents|autonomic agents|mesh-ancestor
102533922|NCT02251379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102533923|NCT02251379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533924|NCT02251379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102533925|NCT02251379|Respiratory System Agents|respiratory system agents|mesh-ancestor
102533926|NCT02251379|Glucocorticoids|glucocorticoids|mesh-ancestor
102533927|NCT02251379|Hormones|hormones|mesh-ancestor
102533928|NCT02251379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102533929|NCT02251379|Sympathomimetics|sympathomimetics|mesh-ancestor
102533930|NCT02251379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102533931|NCT02251379|Dermatologic Agents|dermatologic agents|mesh-ancestor
102533932|NCT02251379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102533933|NCT02255513|Methylphenidate|methylphenidate|mesh-list
102533934|NCT02255513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102533935|NCT02255513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533936|NCT02255513|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102533937|NCT02255513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102533938|NCT02255513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102533939|NCT02255513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533940|NCT02255513|Dopamine Agents|dopamine agents|mesh-ancestor
102533941|NCT02255513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102533942|NCT01778465|Salicylic Acid|salicylic acid|mesh-list
102533943|NCT01778465|Salicylates|salicylates|mesh-list
102533944|NCT01778465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102533945|NCT01778465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102533946|NCT01778465|Analgesics|analgesics|mesh-ancestor
102533947|NCT01778465|Sensory System Agents|sensory system agents|mesh-ancestor
102533948|NCT01778465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102533949|NCT01778465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533950|NCT01778465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102533951|NCT01778465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102533952|NCT01778465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102533953|NCT01778465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102533954|NCT01778465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533955|NCT01778465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102533956|NCT01778465|Antifungal Agents|antifungal agents|mesh-ancestor
102533957|NCT01778465|Keratolytic Agents|keratolytic agents|mesh-ancestor
102533958|NCT01778465|Dermatologic Agents|dermatologic agents|mesh-ancestor
102533959|NCT01779167|Thalidomide|thalidomide|mesh-list
102533960|NCT01779167|Rituximab|rituximab|mesh-list
102533961|NCT01779167|Lenalidomide|lenalidomide|mesh-list
102533962|NCT01779167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102533963|NCT01779167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102533964|NCT01779167|Immunologic Factors|immunologic factors|mesh-ancestor
102533965|NCT01779167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533966|NCT01779167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102533967|NCT01779167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102533968|NCT01779167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102533969|NCT01779167|Growth Substances|growth substances|mesh-ancestor
102533970|NCT01779167|Growth Inhibitors|growth inhibitors|mesh-ancestor
102533971|NCT01779167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102533972|NCT01779167|Leprostatic Agents|leprostatic agents|mesh-ancestor
102533973|NCT01779167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102533974|NCT01779167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102533975|NCT01780337|Oxytocin|oxytocin|mesh-list
102533976|NCT01780337|Oxytocics|oxytocics|mesh-ancestor
102533977|NCT01780337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102533978|NCT01780337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533979|NCT02251613|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
102533980|NCT02251613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102533981|NCT02251613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102533982|NCT02251613|Epinastine|epinastine|mesh-list
102533983|NCT02251613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102533984|NCT02251613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102533985|NCT02251613|Analgesics|analgesics|mesh-ancestor
102533986|NCT02251613|Sensory System Agents|sensory system agents|mesh-ancestor
102533987|NCT02251613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102533988|NCT02251613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102533989|NCT02251613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102533990|NCT02251613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102533991|NCT02251613|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102533992|NCT02251613|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102533993|NCT02251613|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102533994|NCT02251613|Histamine Antagonists|histamine antagonists|mesh-ancestor
102533995|NCT02251613|Histamine Agents|histamine agents|mesh-ancestor
102533996|NCT02251613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102533997|NCT02251613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102533998|NCT02865473|Pilocarpine|pilocarpine|mesh-list
102533999|NCT02865473|Miotics|miotics|mesh-ancestor
102534000|NCT02865473|Autonomic Agents|autonomic agents|mesh-ancestor
102534001|NCT02865473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102534002|NCT02865473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534003|NCT02865473|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102534004|NCT02865473|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102534005|NCT02865473|Cholinergic Agents|cholinergic agents|mesh-ancestor
102534006|NCT02865473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102534007|NCT02865473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534008|NCT02850419|Doxorubicin|doxorubicin|mesh-list
102534009|NCT02850419|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102534010|NCT02850419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102534011|NCT02850419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102534012|NCT02850419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102534013|NCT02850419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102534014|NCT02850419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102534015|NCT02850419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534016|NCT02841371|Edetic Acid|edetic acid|mesh-list
102534017|NCT02841371|Pentetic Acid|pentetic acid|mesh-list
102534018|NCT02841371|Antidotes|antidotes|mesh-ancestor
102534019|NCT02841371|Protective Agents|protective agents|mesh-ancestor
102534020|NCT02841371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534021|NCT02841371|Chelating Agents|chelating agents|mesh-ancestor
102534022|NCT02841371|Sequestering Agents|sequestering agents|mesh-ancestor
102534023|NCT02841371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534024|NCT02841371|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102534025|NCT02841371|Anticoagulants|anticoagulants|mesh-ancestor
102534026|NCT02841371|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102534027|NCT01783847|Prednisolone|prednisolone|mesh-list
102534028|NCT01783847|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102534029|NCT01783847|Methylprednisolone|methylprednisolone|mesh-list
102534030|NCT01783847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102534031|NCT01783847|Prednisolone acetate|prednisolone acetate|mesh-list
102534032|NCT01783847|Epoetin Alfa|epoetin alfa|mesh-list
102534033|NCT01783847|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102534034|NCT01783847|Prednisolone phosphate|prednisolone phosphate|mesh-list
102534035|NCT01783847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102534036|NCT01783847|Glucocorticoids|glucocorticoids|mesh-ancestor
102534037|NCT01783847|Hormones|hormones|mesh-ancestor
102534038|NCT01783847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102534039|NCT01783847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534040|NCT01783847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102534041|NCT01783847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102534042|NCT01783847|Antiemetics|antiemetics|mesh-ancestor
102534043|NCT01783847|Autonomic Agents|autonomic agents|mesh-ancestor
102534044|NCT01783847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102534045|NCT01783847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102534046|NCT01783847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102534047|NCT01783847|Protective Agents|protective agents|mesh-ancestor
102534048|NCT01783847|Hematinics|hematinics|mesh-ancestor
102534049|NCT02585375|Latanoprost|latanoprost|mesh-list
102534050|NCT02585375|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102534051|NCT02585375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102534052|NCT02516813|Peposertib|peposertib|mesh-list
102534053|NCT02516813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102534054|NCT02516813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102534055|NCT02516813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534056|NCT01785095|Hormones|hormones|mesh-list
102534057|NCT01785095|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102534058|NCT01785095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102534059|NCT01785095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534060|NCT01786343|Decitabine|decitabine|mesh-list
102534061|NCT01786343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102534062|NCT01786343|Antimetabolites|antimetabolites|mesh-ancestor
102534063|NCT01786343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534064|NCT01786343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102534065|NCT01786343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102534066|NCT03362775|Propofol|propofol|mesh-list
102534067|NCT03362775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102534068|NCT03362775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102534069|NCT03362775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534070|NCT03362775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102534071|NCT03362775|Anesthetics, General|anesthetics, general|mesh-ancestor
102534072|NCT03362775|Anesthetics|anesthetics|mesh-ancestor
102534073|NCT01786967|Fesoterodine|fesoterodine|mesh-list
102534074|NCT01786967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102534075|NCT01786967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102534076|NCT01786967|Cholinergic Agents|cholinergic agents|mesh-ancestor
102534077|NCT01786967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102534078|NCT01786967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534079|NCT01786967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534080|NCT01786967|Urological Agents|urological agents|mesh-ancestor
102534081|NCT02392871|Trametinib|trametinib|mesh-list
102534082|NCT02392871|Dabrafenib|dabrafenib|mesh-list
102534083|NCT02392871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102534084|NCT02392871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102534085|NCT02392871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102534086|NCT02392871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534087|NCT02382575|Rituximab|rituximab|mesh-list
102534088|NCT02382575|Tacrolimus|tacrolimus|mesh-list
102534089|NCT02382575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
102534090|NCT02382575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102534091|NCT02382575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102534092|NCT02382575|Immunologic Factors|immunologic factors|mesh-ancestor
102534093|NCT02382575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534094|NCT02382575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102534095|NCT02382575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102534096|NCT02382575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102534097|NCT02382575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534098|NCT01807871|Nicotine|nicotine|mesh-list
102534099|NCT01807871|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102345614|NCT05578976|Rituximab|rituximab|mesh-list
102534100|NCT01807871|Autonomic Agents|autonomic agents|mesh-ancestor
102534101|NCT01807871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102534102|NCT01807871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534103|NCT01807871|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102534104|NCT01807871|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102534105|NCT01807871|Cholinergic Agents|cholinergic agents|mesh-ancestor
102534106|NCT01807871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102534107|NCT01807871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534108|NCT01263938|Atorvastatin|atorvastatin|mesh-list
102534109|NCT01263938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102534110|NCT01263938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102534111|NCT01263938|Antimetabolites|antimetabolites|mesh-ancestor
102534112|NCT01263938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534113|NCT01263938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102534114|NCT01263938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102534115|NCT01263938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102534116|NCT02327741|Clopidogrel|clopidogrel|mesh-list
102534117|NCT02327741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102534118|NCT02327741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102534119|NCT02327741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102534120|NCT02327741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102534121|NCT02327741|Purinergic Agents|purinergic agents|mesh-ancestor
102534122|NCT02327741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102010451|NCT03792971|Dextromethorphan|dextromethorphan|mesh-list
102534123|NCT02327741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534124|NCT02327741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534125|NCT00367185|Thalidomide|thalidomide|mesh-list
102534126|NCT00367185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102534127|NCT00367185|Immunologic Factors|immunologic factors|mesh-ancestor
102534128|NCT00367185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534129|NCT00367185|Leprostatic Agents|leprostatic agents|mesh-ancestor
102534130|NCT00367185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102534131|NCT00367185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102534132|NCT00367185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102534133|NCT00367185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102534134|NCT00367185|Growth Substances|growth substances|mesh-ancestor
102534135|NCT00367185|Growth Inhibitors|growth inhibitors|mesh-ancestor
102534136|NCT00367185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102534137|NCT02635035|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102534138|NCT02635035|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102534139|NCT02635035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534140|NCT02635035|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102534141|NCT02635035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102534142|NCT02635035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102534143|NCT02635035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534144|NCT02635035|Dopamine Agents|dopamine agents|mesh-ancestor
102534145|NCT02635035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102534146|NCT03283137|Pembrolizumab|pembrolizumab|mesh-list
102534147|NCT03283137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102534148|NCT03283137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102534149|NCT03283137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102534150|NCT03283137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534151|NCT01267136|Acetaminophen|acetaminophen|mesh-list
102534152|NCT01267136|Tramadol|tramadol|mesh-list
102534153|NCT01267136|Codeine|codeine|mesh-list
102534154|NCT01267136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102534155|NCT01267136|Analgesics|analgesics|mesh-ancestor
102534156|NCT01267136|Sensory System Agents|sensory system agents|mesh-ancestor
102534157|NCT01267136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102534158|NCT01267136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534159|NCT01267136|Antipyretics|antipyretics|mesh-ancestor
102534160|NCT01267136|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102534161|NCT01267136|Narcotics|narcotics|mesh-ancestor
102534162|NCT01267136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102534163|NCT01267136|Antitussive Agents|antitussive agents|mesh-ancestor
102534164|NCT01267136|Respiratory System Agents|respiratory system agents|mesh-ancestor
102534165|NCT01370564|Diuretics|diuretics|mesh-list
102534166|NCT01370564|Natriuretic Agents|natriuretic agents|mesh-ancestor
102534167|NCT01370564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534168|NCT00367263|Ciclesonide|ciclesonide|mesh-list
102534169|NCT00367263|Glucocorticoids|glucocorticoids|mesh-ancestor
102534170|NCT00367263|Hormones|hormones|mesh-ancestor
102534171|NCT00367263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102534172|NCT00367263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534173|NCT00367263|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102534174|NCT02637999|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102534175|NCT02637999|Interferon alpha-2|interferon alpha-2|mesh-list
102534176|NCT02637999|Antiviral Agents|antiviral agents|mesh-ancestor
102534177|NCT02637999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102534178|NCT02637999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102534180|NCT01371110|Ketamine|ketamine|mesh-list
102534181|NCT01371110|Analgesics|analgesics|mesh-ancestor
102534182|NCT01371110|Sensory System Agents|sensory system agents|mesh-ancestor
102534183|NCT01371110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102534184|NCT01371110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534185|NCT01371110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102534186|NCT01371110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102534187|NCT01371110|Anesthetics, General|anesthetics, general|mesh-ancestor
102534188|NCT01371110|Anesthetics|anesthetics|mesh-ancestor
102534189|NCT01371110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102534190|NCT01371110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102534191|NCT01371110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102534192|NCT01371110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102534193|NCT01371110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010523|NCT02496910|Vasodilator Agents|vasodilator agents|mesh-ancestor
102534194|NCT01371110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102534195|NCT01371110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102534196|NCT01371110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102534197|NCT01371110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102534198|NCT01371110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102534199|NCT01371110|GABA Modulators|gaba modulators|mesh-ancestor
102534200|NCT01371110|GABA Agents|gaba agents|mesh-ancestor
102534201|NCT01791491|Abatacept|abatacept|mesh-list
102534202|NCT01791491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102534203|NCT01791491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534204|NCT01791491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102534205|NCT01791491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102534206|NCT01791491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102534207|NCT01791491|Immunologic Factors|immunologic factors|mesh-ancestor
102534208|NCT01791491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534209|NCT01791491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102534210|NCT00367419|Erythromycin|erythromycin|mesh-list
102534211|NCT00367419|Erythromycin Estolate|erythromycin estolate|mesh-list
102534212|NCT00367419|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
102534213|NCT00367419|Erythromycin stearate|erythromycin stearate|mesh-list
102534214|NCT00367419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102534215|NCT00367419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102534216|NCT00367419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102534217|NCT00367419|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102534218|NCT00367419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102534219|NCT00367419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534220|NCT01372202|Paclitaxel|paclitaxel|mesh-list
102534221|NCT01372202|Fluorouracil|fluorouracil|mesh-list
102534222|NCT01372202|Oxaliplatin|oxaliplatin|mesh-list
102534223|NCT01372202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102534224|NCT01372202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102534225|NCT01372202|Tubulin Modulators|tubulin modulators|mesh-ancestor
102534226|NCT01372202|Antimitotic Agents|antimitotic agents|mesh-ancestor
102534227|NCT01372202|Mitosis Modulators|mitosis modulators|mesh-ancestor
102534228|NCT01372202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534229|NCT01372202|Antimetabolites|antimetabolites|mesh-ancestor
102534230|NCT01372202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102534231|NCT01372202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102534232|NCT01372202|Immunologic Factors|immunologic factors|mesh-ancestor
102534233|NCT01372202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534234|NCT01811147|Norepinephrine|norepinephrine|mesh-list
102534235|NCT01811147|Serotonin|serotonin|mesh-list
102534236|NCT01811147|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
102534237|NCT01811147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102534238|NCT01811147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102534239|NCT01811147|Adrenergic Agents|adrenergic agents|mesh-ancestor
102534240|NCT01811147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102534241|NCT01811147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534242|NCT01811147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534243|NCT01811147|Sympathomimetics|sympathomimetics|mesh-ancestor
102534244|NCT01811147|Autonomic Agents|autonomic agents|mesh-ancestor
102534245|NCT01811147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102534246|NCT01811147|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102534247|NCT01811147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102534248|NCT01811147|Serotonin Agents|serotonin agents|mesh-ancestor
102534249|NCT01811147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102345762|NCT05421065|Ketamine|ketamine|mesh-list
102534250|NCT01811147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102534251|NCT01373450|Liraglutide|liraglutide|mesh-list
102534252|NCT01373450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102534253|NCT01373450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534254|NCT01373450|Incretins|incretins|mesh-ancestor
102534255|NCT01373450|Hormones|hormones|mesh-ancestor
102534256|NCT01373450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102534257|NCT01793285|Etanercept|etanercept|mesh-list
102534258|NCT01793285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102534259|NCT01793285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102534260|NCT01793285|Analgesics|analgesics|mesh-ancestor
102534261|NCT01793285|Sensory System Agents|sensory system agents|mesh-ancestor
102534262|NCT01793285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102534263|NCT01793285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534264|NCT01793285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102534265|NCT01793285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102534266|NCT01793285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102534267|NCT01793285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102534268|NCT01793285|Immunologic Factors|immunologic factors|mesh-ancestor
102534269|NCT05049525|Itraconazole|itraconazole|mesh-list
102534270|NCT05049525|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
102534271|NCT05049525|Terbinafine|terbinafine|mesh-list
102534272|NCT05049525|Antifungal Agents|antifungal agents|mesh-ancestor
102534273|NCT05049525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102534274|NCT05049525|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102534275|NCT05049525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102534276|NCT05049525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102534277|NCT05049525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534278|NCT05049525|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102534279|NCT05049525|Hormone Antagonists|hormone antagonists|mesh-ancestor
102534280|NCT05049525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102534281|NCT05049525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534282|NCT05049525|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102534283|NCT01811693|Nitroglycerin|nitroglycerin|mesh-list
102534284|NCT01811693|Vasodilator Agents|vasodilator agents|mesh-ancestor
102534285|NCT02639637|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102534286|NCT02639637|Valsartan|valsartan|mesh-list
102534287|NCT02639637|Enalaprilat|enalaprilat|mesh-list
102534288|NCT02639637|Enalapril|enalapril|mesh-list
102534289|NCT02639637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102534290|NCT02639637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534291|NCT02639637|Incretins|incretins|mesh-ancestor
102534292|NCT02639637|Hormones|hormones|mesh-ancestor
102534293|NCT02639637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102534294|NCT02639637|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102534295|NCT02639637|Protease Inhibitors|protease inhibitors|mesh-ancestor
102534296|NCT02639637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102534297|NCT02639637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534298|NCT02639637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102534299|NCT02639637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102534300|NCT02639637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102534301|NCT02639637|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102534302|NCT01332188|Cetirizine|cetirizine|mesh-list
102534303|NCT01332188|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102534304|NCT01332188|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102534305|NCT01332188|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102534306|NCT01332188|Histamine Antagonists|histamine antagonists|mesh-ancestor
102534307|NCT01332188|Histamine Agents|histamine agents|mesh-ancestor
102534308|NCT01332188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102534309|NCT01332188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534310|NCT01332188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534311|NCT01794455|Candesartan|candesartan|mesh-list
102534312|NCT01794455|Candesartan cilexetil|candesartan cilexetil|mesh-list
102534313|NCT01794455|Sertraline|sertraline|mesh-list
102534314|NCT01794455|Antidepressive Agents|antidepressive agents|mesh-ancestor
102534315|NCT01794455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102534316|NCT01794455|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102534317|NCT01794455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102534318|NCT01794455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102534319|NCT01794455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534320|NCT01794455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102534321|NCT01794455|Serotonin Agents|serotonin agents|mesh-ancestor
102345837|NCT05338671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534322|NCT01794455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534323|NCT01794455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102534324|NCT01794455|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102534325|NCT01794455|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102534327|NCT01332500|Sumatriptan|sumatriptan|mesh-list
102534328|NCT01332500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102534329|NCT01332500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102534330|NCT01332500|Analgesics|analgesics|mesh-ancestor
102534331|NCT01332500|Sensory System Agents|sensory system agents|mesh-ancestor
102534332|NCT01332500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102534333|NCT01332500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534334|NCT01332500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102534335|NCT01332500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102534336|NCT01332500|Gout Suppressants|gout suppressants|mesh-ancestor
102534337|NCT01332500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102534338|NCT01332500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102534339|NCT01332500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534340|NCT01332500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102534341|NCT01332500|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102534342|NCT01332500|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102534343|NCT01332500|Serotonin Agents|serotonin agents|mesh-ancestor
102534344|NCT01332500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102534345|NCT01812005|Rituximab|rituximab|mesh-list
102534346|NCT01812005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102534347|NCT01812005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102534348|NCT01812005|Immunologic Factors|immunologic factors|mesh-ancestor
102534349|NCT01812005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534350|NCT01812005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102534351|NCT01332578|Acetaminophen|acetaminophen|mesh-list
102534352|NCT01332578|Ascorbic Acid|ascorbic acid|mesh-list
102534353|NCT01332578|Phenylephrine|phenylephrine|mesh-list
102534354|NCT01332578|Oxymetazoline|oxymetazoline|mesh-list
102534355|NCT01332578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102534356|NCT01332578|Analgesics|analgesics|mesh-ancestor
102534357|NCT01332578|Sensory System Agents|sensory system agents|mesh-ancestor
102534358|NCT01332578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102534359|NCT01332578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534360|NCT01332578|Antipyretics|antipyretics|mesh-ancestor
102534361|NCT01332578|Antioxidants|antioxidants|mesh-ancestor
102534362|NCT01332578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534363|NCT01332578|Protective Agents|protective agents|mesh-ancestor
102534364|NCT01332578|Vitamins|vitamins|mesh-ancestor
102534365|NCT01332578|Micronutrients|micronutrients|mesh-ancestor
102534366|NCT01332578|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102534367|NCT01332578|Mydriatics|mydriatics|mesh-ancestor
102534368|NCT01332578|Autonomic Agents|autonomic agents|mesh-ancestor
102534369|NCT01332578|Sympathomimetics|sympathomimetics|mesh-ancestor
102534370|NCT01332578|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102534371|NCT01332578|Nasal Decongestants|nasal decongestants|mesh-ancestor
102534372|NCT01332578|Respiratory System Agents|respiratory system agents|mesh-ancestor
102534373|NCT01332578|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102534374|NCT01332578|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102534375|NCT01332578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102534376|NCT01332578|Adrenergic Agents|adrenergic agents|mesh-ancestor
102534377|NCT01332578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102534378|NCT01333592|Mitiglinide|mitiglinide|mesh-list
102534379|NCT01333592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102534380|NCT01333592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534381|NCT01375946|Contraceptive Agents|contraceptive agents|mesh-list
102534382|NCT01375946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102534383|NCT01375946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534384|NCT01267292|Buspirone|buspirone|mesh-list
102534385|NCT01267292|Methylphenidate|methylphenidate|mesh-list
102534386|NCT01267292|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102534387|NCT01267292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534388|NCT01267292|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102534389|NCT01267292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102534390|NCT01267292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102534391|NCT01267292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534392|NCT01267292|Dopamine Agents|dopamine agents|mesh-ancestor
102534393|NCT01267292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102534394|NCT01267292|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102534395|NCT01267292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102534396|NCT01267292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102534398|NCT01267292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102534399|NCT01267292|Serotonin Agents|serotonin agents|mesh-ancestor
102534400|NCT01734161|Dexamethasone|dexamethasone|mesh-list
102534401|NCT01734161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102534402|NCT01734161|Antiemetics|antiemetics|mesh-ancestor
102534403|NCT01734161|Autonomic Agents|autonomic agents|mesh-ancestor
102534404|NCT01734161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102534405|NCT01734161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534406|NCT01734161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102534407|NCT01734161|Glucocorticoids|glucocorticoids|mesh-ancestor
102534408|NCT01734161|Hormones|hormones|mesh-ancestor
101730493|NCT00794040|Citalopram|citalopram|mesh-list
102534409|NCT01734161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102534410|NCT01734161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102534411|NCT01734161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102534412|NCT01734239|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102534413|NCT01734239|Immunologic Factors|immunologic factors|mesh-ancestor
102534414|NCT01734239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534415|NCT01797575|Aspirin|aspirin|mesh-list
102534416|NCT01797575|Acetylcysteine|acetylcysteine|mesh-list
102534417|NCT01797575|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102534418|NCT01797575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102534419|NCT01797575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102534420|NCT01797575|Analgesics|analgesics|mesh-ancestor
102534421|NCT01797575|Sensory System Agents|sensory system agents|mesh-ancestor
102534422|NCT01797575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102534423|NCT01797575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534424|NCT01797575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102534425|NCT01797575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102534426|NCT01797575|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102534427|NCT01797575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102534428|NCT01797575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534429|NCT01797575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102534430|NCT01797575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102534431|NCT01797575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102534432|NCT01797575|Antipyretics|antipyretics|mesh-ancestor
102534433|NCT01797575|Antiviral Agents|antiviral agents|mesh-ancestor
102534434|NCT01797575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102534435|NCT01797575|Expectorants|expectorants|mesh-ancestor
102534436|NCT01797575|Respiratory System Agents|respiratory system agents|mesh-ancestor
102534437|NCT01797575|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102534438|NCT01797575|Antioxidants|antioxidants|mesh-ancestor
102534439|NCT01797575|Protective Agents|protective agents|mesh-ancestor
102534440|NCT01797575|Antidotes|antidotes|mesh-ancestor
102534441|NCT02641353|Thalidomide|thalidomide|mesh-list
102534442|NCT02641353|Apremilast|apremilast|mesh-list
102534443|NCT02641353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102534444|NCT02641353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102534445|NCT02641353|Analgesics|analgesics|mesh-ancestor
102534446|NCT02641353|Sensory System Agents|sensory system agents|mesh-ancestor
102534447|NCT02641353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102534448|NCT02641353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534449|NCT02641353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102534450|NCT02641353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102534451|NCT02641353|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102534452|NCT02641353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102534453|NCT02641353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102534454|NCT02641353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534455|NCT02641353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102534456|NCT02641353|Immunologic Factors|immunologic factors|mesh-ancestor
102534457|NCT02641353|Leprostatic Agents|leprostatic agents|mesh-ancestor
102534458|NCT02641353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102534459|NCT02641353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102534460|NCT02641353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102534461|NCT02641353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102534462|NCT02641353|Growth Substances|growth substances|mesh-ancestor
102534463|NCT02641353|Growth Inhibitors|growth inhibitors|mesh-ancestor
102534464|NCT02641353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102534465|NCT01378520|Ketoconazole|ketoconazole|mesh-list
102534466|NCT01378520|Antifungal Agents|antifungal agents|mesh-ancestor
102534467|NCT01378520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102534468|NCT01378520|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102534469|NCT01378520|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102534470|NCT01378520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102345986|NCT05130268|Dronedarone|dronedarone|mesh-list
102534471|NCT01378520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534472|NCT01378520|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102534473|NCT01378520|Hormone Antagonists|hormone antagonists|mesh-ancestor
102534474|NCT01378520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102534475|NCT01378520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534476|NCT01378520|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102534477|NCT01378988|Dexmedetomidine|dexmedetomidine|mesh-list
102534478|NCT01378988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102534479|NCT01378988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102534480|NCT01378988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534481|NCT01378988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102534482|NCT01378988|Analgesics|analgesics|mesh-ancestor
102534483|NCT01378988|Sensory System Agents|sensory system agents|mesh-ancestor
102534484|NCT01378988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102534485|NCT01378988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102534486|NCT01378988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102534487|NCT01378988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102534488|NCT01378988|Adrenergic Agents|adrenergic agents|mesh-ancestor
102534489|NCT01378988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102534490|NCT01378988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534491|NCT01335620|Tenofovir|tenofovir|mesh-list
102534492|NCT01335620|Emtricitabine|emtricitabine|mesh-list
102534493|NCT01335620|Raltegravir Potassium|raltegravir potassium|mesh-list
102534494|NCT01335620|Antiviral Agents|antiviral agents|mesh-ancestor
102534495|NCT01335620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102534496|NCT01335620|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102534497|NCT01335620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102534498|NCT01335620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102534499|NCT01335620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534500|NCT01335620|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102534501|NCT01335620|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102534502|NCT01335620|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102534503|NCT01335620|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102534504|NCT01335932|Ganciclovir|ganciclovir|mesh-list
102534505|NCT01335932|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102534506|NCT01335932|Antiviral Agents|antiviral agents|mesh-ancestor
102534507|NCT01335932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102534508|NCT01335932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102534509|NCT01335932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102534510|NCT01335932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534511|NCT01273766|Deferasirox|deferasirox|mesh-list
102534512|NCT01273766|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102534513|NCT01273766|Chelating Agents|chelating agents|mesh-ancestor
102534514|NCT01273766|Sequestering Agents|sequestering agents|mesh-ancestor
102534515|NCT01273766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534516|NCT01403246|Lenalidomide|lenalidomide|mesh-list
102534517|NCT01403246|Chlorambucil|chlorambucil|mesh-list
102534518|NCT01403246|Immunologic Factors|immunologic factors|mesh-ancestor
102534519|NCT01403246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534520|NCT01403246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102534521|NCT01403246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102534522|NCT01403246|Growth Substances|growth substances|mesh-ancestor
102534523|NCT01403246|Growth Inhibitors|growth inhibitors|mesh-ancestor
102534524|NCT01403246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102534525|NCT01403246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102534526|NCT01403246|Alkylating Agents|alkylating agents|mesh-ancestor
102534527|NCT01403246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534528|NCT01734551|Clonidine|clonidine|mesh-list
102534529|NCT01734551|Morphine|morphine|mesh-list
102534530|NCT01734551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102534531|NCT01734551|Narcotics|narcotics|mesh-ancestor
102534532|NCT01734551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102534533|NCT01734551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534534|NCT01734551|Analgesics|analgesics|mesh-ancestor
102534535|NCT01734551|Sensory System Agents|sensory system agents|mesh-ancestor
102534536|NCT01734551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102534537|NCT01734551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102534538|NCT01734551|Sympatholytics|sympatholytics|mesh-ancestor
102534539|NCT01734551|Autonomic Agents|autonomic agents|mesh-ancestor
102534540|NCT01734551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102534541|NCT01734551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102534542|NCT01734551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102534543|NCT01734551|Adrenergic Agents|adrenergic agents|mesh-ancestor
102534544|NCT01734551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102534545|NCT01734551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534546|NCT01404260|Carboplatin|carboplatin|mesh-list
102534547|NCT01404260|Gemcitabine|gemcitabine|mesh-list
102534548|NCT01404260|Gefitinib|gefitinib|mesh-list
102534549|NCT01404260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102534550|NCT01404260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102534551|NCT01404260|Antimetabolites|antimetabolites|mesh-ancestor
102534552|NCT01404260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534553|NCT01404260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102534554|NCT01404260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102534555|NCT02235909|Losartan|losartan|mesh-list
102534556|NCT02235909|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
102534557|NCT02235909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102534558|NCT02235909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102534559|NCT02235909|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102534560|NCT02235909|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102534561|NCT02235909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534562|NCT01404572|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102534563|NCT01404572|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102534564|NCT01404572|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102534565|NCT01404572|Protease Inhibitors|protease inhibitors|mesh-ancestor
102534566|NCT01404572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102534567|NCT01404572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534568|NCT01404572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102534569|NCT01404572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102534570|NCT01404572|Antiviral Agents|antiviral agents|mesh-ancestor
102534571|NCT01404572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102534572|NCT01381406|Tiotropium Bromide|tiotropium bromide|mesh-list
102534573|NCT01381406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102534574|NCT01381406|Autonomic Agents|autonomic agents|mesh-ancestor
102534575|NCT01381406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102534576|NCT01381406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534577|NCT01381406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102534578|NCT01381406|Respiratory System Agents|respiratory system agents|mesh-ancestor
102534579|NCT01381406|Parasympatholytics|parasympatholytics|mesh-ancestor
102534580|NCT01381406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102534581|NCT01381406|Cholinergic Agents|cholinergic agents|mesh-ancestor
102534582|NCT01381406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102534583|NCT01381406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534584|NCT01799213|Meloxicam|meloxicam|mesh-list
102534585|NCT01799213|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102534586|NCT01799213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102534587|NCT01799213|Analgesics|analgesics|mesh-ancestor
102534588|NCT01799213|Sensory System Agents|sensory system agents|mesh-ancestor
102534589|NCT01799213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102534590|NCT01799213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534591|NCT01799213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102010938|NCT03050060|Nelfinavir|nelfinavir|mesh-list
102534592|NCT01799213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102534593|NCT01799213|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102534594|NCT01799213|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102534595|NCT01799213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102534596|NCT01799213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534597|NCT01383200|Lidocaine|lidocaine|mesh-list
102534598|NCT01383200|Tetracaine|tetracaine|mesh-list
102534599|NCT01383200|Anesthetics, Local|anesthetics, local|mesh-ancestor
102534600|NCT01383200|Anesthetics|anesthetics|mesh-ancestor
102534601|NCT01383200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102534602|NCT01383200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534603|NCT01383200|Sensory System Agents|sensory system agents|mesh-ancestor
102534604|NCT01383200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102534605|NCT01383200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102534606|NCT01383200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102534607|NCT01383200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102534608|NCT01383200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102534609|NCT01383200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534610|NCT05588037|Dexamethasone|dexamethasone|mesh-list
102534611|NCT05588037|Dexamethasone acetate|dexamethasone acetate|mesh-list
102534612|NCT05588037|BB 1101|bb 1101|mesh-list
102534613|NCT05588037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102534614|NCT05588037|Antiemetics|antiemetics|mesh-ancestor
102534615|NCT05588037|Autonomic Agents|autonomic agents|mesh-ancestor
102534616|NCT05588037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102534617|NCT05588037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534618|NCT05588037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102534619|NCT05588037|Glucocorticoids|glucocorticoids|mesh-ancestor
102534620|NCT05588037|Hormones|hormones|mesh-ancestor
102534621|NCT05588037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102534622|NCT05588037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102534623|NCT05588037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102534624|NCT05588037|Protease Inhibitors|protease inhibitors|mesh-ancestor
102534625|NCT05588037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102534626|NCT05588037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534627|NCT02194088|Diclofenac|diclofenac|mesh-list
102534628|NCT02194088|Atropine|atropine|mesh-list
102534629|NCT02194088|Analgesics|analgesics|mesh-list
102534630|NCT02194088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102534631|NCT02194088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102534632|NCT02194088|Sensory System Agents|sensory system agents|mesh-ancestor
102534633|NCT02194088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102534634|NCT02194088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534635|NCT02194088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102534636|NCT02194088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102534637|NCT02194088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102534638|NCT02194088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102534639|NCT02194088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534640|NCT02194088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102534641|NCT02194088|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102534642|NCT02194088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102534643|NCT02194088|Autonomic Agents|autonomic agents|mesh-ancestor
102534644|NCT02194088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102534645|NCT02194088|Respiratory System Agents|respiratory system agents|mesh-ancestor
102534646|NCT02194088|Mydriatics|mydriatics|mesh-ancestor
102534647|NCT02194088|Parasympatholytics|parasympatholytics|mesh-ancestor
102534648|NCT02194088|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102534649|NCT02194088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102534650|NCT02194088|Cholinergic Agents|cholinergic agents|mesh-ancestor
102534651|NCT02194088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102534652|NCT02023593|Leucovorin|leucovorin|mesh-list
102534653|NCT02023593|Fluorouracil|fluorouracil|mesh-list
102534654|NCT02023593|Irinotecan|irinotecan|mesh-list
102534655|NCT02023593|Antimetabolites|antimetabolites|mesh-ancestor
102534656|NCT02023593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534657|NCT02023593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102534658|NCT02023593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102534659|NCT02023593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102534660|NCT02023593|Immunologic Factors|immunologic factors|mesh-ancestor
102534661|NCT02023593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534662|NCT02023593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102011002|NCT01305551|Metformin|metformin|mesh-list
102534663|NCT02023593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102534664|NCT02023593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102534665|NCT02023593|Antidotes|antidotes|mesh-ancestor
102534666|NCT02023593|Protective Agents|protective agents|mesh-ancestor
102534667|NCT02023593|Vitamin B Complex|vitamin b complex|mesh-ancestor
102534668|NCT02023593|Vitamins|vitamins|mesh-ancestor
102534669|NCT02023593|Micronutrients|micronutrients|mesh-ancestor
102534670|NCT01978431|Cocaine|cocaine|mesh-list
102534671|NCT01978431|Methylphenidate|methylphenidate|mesh-list
102534672|NCT01978431|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102534673|NCT01978431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534674|NCT01978431|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102534675|NCT01978431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102534676|NCT01978431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102534677|NCT01978431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534678|NCT01978431|Dopamine Agents|dopamine agents|mesh-ancestor
102534679|NCT01978431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102534680|NCT01978431|Anesthetics, Local|anesthetics, local|mesh-ancestor
102534681|NCT01978431|Anesthetics|anesthetics|mesh-ancestor
102534682|NCT01978431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102534683|NCT01978431|Sensory System Agents|sensory system agents|mesh-ancestor
102534684|NCT01978431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102534685|NCT01978431|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102534686|NCT01406444|Risedronic Acid|risedronic acid|mesh-list
102534687|NCT01406444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102534688|NCT01406444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102534689|NCT01406444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534690|NCT01406444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102534691|NCT01406444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534692|NCT01406444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102534693|NCT02685267|Prednisone|prednisone|mesh-list
102534694|NCT02685267|Docetaxel|docetaxel|mesh-list
102534695|NCT02685267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102534696|NCT02685267|Tubulin Modulators|tubulin modulators|mesh-ancestor
102534697|NCT02685267|Antimitotic Agents|antimitotic agents|mesh-ancestor
102534698|NCT02685267|Mitosis Modulators|mitosis modulators|mesh-ancestor
102534699|NCT02685267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534700|NCT02685267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102534701|NCT02685267|Glucocorticoids|glucocorticoids|mesh-ancestor
102534702|NCT02685267|Hormones|hormones|mesh-ancestor
102534703|NCT02685267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102534704|NCT02685267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534705|NCT02685267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102534706|NCT02257541|Imatinib Mesylate|imatinib mesylate|mesh-list
102534707|NCT02257541|Infigratinib|infigratinib|mesh-list
102534708|NCT02257541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102534709|NCT02257541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102534710|NCT02257541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102534711|NCT02257541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534712|NCT01817855|AZD7624|azd7624|mesh-list
102534713|NCT01817855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102534714|NCT01817855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102534715|NCT01817855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534716|NCT00368121|Dexamethasone|dexamethasone|mesh-list
102534717|NCT00368121|Cetuximab|cetuximab|mesh-list
102534718|NCT00368121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102534719|NCT00368121|Antiemetics|antiemetics|mesh-ancestor
102534720|NCT00368121|Autonomic Agents|autonomic agents|mesh-ancestor
102534721|NCT00368121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102534722|NCT00368121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534723|NCT00368121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102534724|NCT00368121|Glucocorticoids|glucocorticoids|mesh-ancestor
102534725|NCT00368121|Hormones|hormones|mesh-ancestor
102534726|NCT00368121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102534727|NCT00368121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102534728|NCT00368121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102534729|NCT00368121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102534730|NCT00367497|Cytarabine|cytarabine|mesh-list
102534731|NCT00367497|Methylprednisolone|methylprednisolone|mesh-list
102534732|NCT00367497|Rituximab|rituximab|mesh-list
102534733|NCT00367497|Etoposide|etoposide|mesh-list
102534734|NCT00367497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102534735|NCT00367497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102534736|NCT00367497|Immunologic Factors|immunologic factors|mesh-ancestor
102534737|NCT00367497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534738|NCT00367497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102534739|NCT00367497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102534740|NCT00367497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102534741|NCT00367497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102534742|NCT00367497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102534743|NCT00367497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534744|NCT00367497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102534745|NCT00367497|Antimetabolites|antimetabolites|mesh-ancestor
102534746|NCT00367497|Antiviral Agents|antiviral agents|mesh-ancestor
102534747|NCT00367497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102534748|NCT00367497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102534749|NCT00367497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102534750|NCT00367497|Antiemetics|antiemetics|mesh-ancestor
102534751|NCT00367497|Autonomic Agents|autonomic agents|mesh-ancestor
102534752|NCT00367497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102534753|NCT00367497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102534754|NCT00367497|Glucocorticoids|glucocorticoids|mesh-ancestor
102534755|NCT00367497|Hormones|hormones|mesh-ancestor
102534756|NCT00367497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102534757|NCT00367497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102534758|NCT00367497|Protective Agents|protective agents|mesh-ancestor
102534759|NCT01387178|Fluticasone|fluticasone|mesh-list
102534760|NCT01387178|Xhance|xhance|mesh-list
102534761|NCT01387178|Bromides|bromides|mesh-list
102534762|NCT01387178|Tiotropium Bromide|tiotropium bromide|mesh-list
102534763|NCT01387178|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102534764|NCT01387178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102534765|NCT01387178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102534766|NCT01387178|Autonomic Agents|autonomic agents|mesh-ancestor
102534767|NCT01387178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102534768|NCT01387178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534769|NCT01387178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102534770|NCT01387178|Respiratory System Agents|respiratory system agents|mesh-ancestor
102534771|NCT01387178|Dermatologic Agents|dermatologic agents|mesh-ancestor
102534772|NCT01387178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102534773|NCT01387178|Parasympatholytics|parasympatholytics|mesh-ancestor
102534774|NCT01387178|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102534775|NCT01387178|Cholinergic Agents|cholinergic agents|mesh-ancestor
102534776|NCT01387178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102534777|NCT01387178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534778|NCT01387178|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102534779|NCT01387178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102534780|NCT01387178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102534781|NCT01387178|Adrenergic Agents|adrenergic agents|mesh-ancestor
102534782|NCT01387178|Anticonvulsants|anticonvulsants|mesh-ancestor
102534783|NCT01805297|Aflibercept|aflibercept|mesh-list
102534784|NCT01805297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102534785|NCT01805297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102534786|NCT01805297|Growth Substances|growth substances|mesh-ancestor
102534787|NCT01805297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534788|NCT01805297|Growth Inhibitors|growth inhibitors|mesh-ancestor
102534789|NCT01805297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102534790|NCT01389284|Naproxen|naproxen|mesh-list
102534791|NCT01389284|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102534792|NCT01389284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102534793|NCT01389284|Analgesics|analgesics|mesh-ancestor
102534794|NCT01389284|Sensory System Agents|sensory system agents|mesh-ancestor
102534795|NCT01389284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102534796|NCT01389284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534797|NCT01389284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102534798|NCT01389284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102534799|NCT01389284|Gout Suppressants|gout suppressants|mesh-ancestor
102534800|NCT01389284|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102534801|NCT01389284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102534802|NCT01389284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534803|NCT01794143|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102534804|NCT01794143|Liraglutide|liraglutide|mesh-list
102534805|NCT01794143|Glimepiride|glimepiride|mesh-list
102534806|NCT01794143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
102534807|NCT01794143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102534808|NCT01794143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534809|NCT01794143|Incretins|incretins|mesh-ancestor
102534810|NCT01794143|Hormones|hormones|mesh-ancestor
102534811|NCT01794143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102534812|NCT01794143|Protease Inhibitors|protease inhibitors|mesh-ancestor
102534813|NCT01794143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102534814|NCT01794143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534815|NCT01794143|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102534816|NCT01794143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102534817|NCT01794143|Immunologic Factors|immunologic factors|mesh-ancestor
102534818|NCT01547741|Paclitaxel|paclitaxel|mesh-list
102534819|NCT01547741|Docetaxel|docetaxel|mesh-list
102534820|NCT01547741|Cyclophosphamide|cyclophosphamide|mesh-list
102534821|NCT01547741|Doxorubicin|doxorubicin|mesh-list
102534822|NCT01547741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102534823|NCT01547741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102534824|NCT01547741|Tubulin Modulators|tubulin modulators|mesh-ancestor
102534825|NCT01547741|Antimitotic Agents|antimitotic agents|mesh-ancestor
102534826|NCT01547741|Mitosis Modulators|mitosis modulators|mesh-ancestor
102534827|NCT01547741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534828|NCT01547741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102534829|NCT01547741|Immunologic Factors|immunologic factors|mesh-ancestor
102534830|NCT01547741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534831|NCT01547741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102534832|NCT01547741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102534833|NCT01547741|Alkylating Agents|alkylating agents|mesh-ancestor
102534834|NCT01547741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102534835|NCT01547741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102534836|NCT01547741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102534837|NCT01547741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102534838|NCT01547741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102534839|NCT01390064|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
102534840|NCT01390064|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102534841|NCT01390064|Immunologic Factors|immunologic factors|mesh-ancestor
102534842|NCT01390064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534843|NCT01473368|Amoxicillin|amoxicillin|mesh-list
102534844|NCT01473368|Clavulanic Acid|clavulanic acid|mesh-list
102534845|NCT01473368|Clavulanic Acids|clavulanic acids|mesh-list
102534846|NCT01473368|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102534847|NCT01473368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102534848|NCT01473368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102534849|NCT01473368|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102534850|NCT01473368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102534851|NCT01473368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534853|NCT04351490|Vitamin D|vitamin d|mesh-list
102534854|NCT04351490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102534855|NCT04351490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534856|NCT04351490|Vitamins|vitamins|mesh-ancestor
102534857|NCT04351490|Micronutrients|micronutrients|mesh-ancestor
102534858|NCT04351490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102534859|NCT01391312|Botulinum Toxins|botulinum toxins|mesh-list
102534860|NCT01391312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102534861|NCT01391312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102534862|NCT01391312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102534863|NCT01391312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102534864|NCT01391312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534865|NCT01391312|Cholinergic Agents|cholinergic agents|mesh-ancestor
102534866|NCT01391312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102534867|NCT01391312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534868|NCT01391312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102534869|NCT01391312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102534870|NCT03008252|Caseins|caseins|mesh-list
102534871|NCT03008252|Chelating Agents|chelating agents|mesh-ancestor
102534872|NCT03008252|Sequestering Agents|sequestering agents|mesh-ancestor
102534873|NCT03008252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534874|NCT05328635|Candesartan|candesartan|mesh-list
102534875|NCT05328635|Candesartan cilexetil|candesartan cilexetil|mesh-list
102534876|NCT05328635|Gabapentin|gabapentin|mesh-list
102534877|NCT05328635|Analgesics|analgesics|mesh-ancestor
102534878|NCT05328635|Sensory System Agents|sensory system agents|mesh-ancestor
102534879|NCT05328635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102534880|NCT05328635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534881|NCT05328635|Anticonvulsants|anticonvulsants|mesh-ancestor
102534882|NCT05328635|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102534883|NCT05328635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102534884|NCT05328635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102534885|NCT05328635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102534886|NCT05328635|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102534887|NCT05328635|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102534888|NCT05328635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102534889|NCT05328635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534890|NCT05328635|Antimanic Agents|antimanic agents|mesh-ancestor
102534891|NCT05328635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102534892|NCT05328635|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102534893|NCT05328635|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102534894|NCT01391858|Pregabalin|pregabalin|mesh-list
102534895|NCT01391858|Analgesics|analgesics|mesh-ancestor
102534896|NCT01391858|Sensory System Agents|sensory system agents|mesh-ancestor
102534897|NCT01391858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102534898|NCT01391858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534899|NCT01391858|Anticonvulsants|anticonvulsants|mesh-ancestor
102534900|NCT01391858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102534901|NCT01391858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102534902|NCT01391858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534903|NCT01391858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102534904|NCT01391858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102534905|NCT01391858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102534906|NCT01391858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102534907|NCT01391858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102534908|NCT05587257|Minoxidil|minoxidil|mesh-list
102534909|NCT05587257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102534910|NCT05587257|Vasodilator Agents|vasodilator agents|mesh-ancestor
102534911|NCT01825655|Cetirizine|cetirizine|mesh-list
102534912|NCT01825655|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102534913|NCT01825655|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102534914|NCT01825655|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102534915|NCT01825655|Histamine Antagonists|histamine antagonists|mesh-ancestor
102534916|NCT01825655|Histamine Agents|histamine agents|mesh-ancestor
102534917|NCT01825655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102534918|NCT01825655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534919|NCT01825655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534920|NCT02249663|Fluticasone|fluticasone|mesh-list
102534921|NCT02249663|Xhance|xhance|mesh-list
102534922|NCT02249663|Azelastine|azelastine|mesh-list
102534923|NCT02249663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102534924|NCT02249663|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102534925|NCT02249663|Autonomic Agents|autonomic agents|mesh-ancestor
102534926|NCT02249663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102534927|NCT02249663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534928|NCT02249663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102534929|NCT02249663|Respiratory System Agents|respiratory system agents|mesh-ancestor
102534930|NCT02249663|Dermatologic Agents|dermatologic agents|mesh-ancestor
102534931|NCT02249663|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102534932|NCT02249663|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
102534933|NCT02249663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102534934|NCT02249663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534935|NCT02249663|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102534936|NCT02249663|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102534937|NCT02249663|Histamine Antagonists|histamine antagonists|mesh-ancestor
102534938|NCT02249663|Histamine Agents|histamine agents|mesh-ancestor
102534939|NCT02249663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102534940|NCT04237623|Sargramostim|sargramostim|mesh-list
102534941|NCT04237623|Immunologic Factors|immunologic factors|mesh-ancestor
102534942|NCT04237623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534943|NCT01825889|Evacetrapib|evacetrapib|mesh-list
102534944|NCT01825889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102534945|NCT01825889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102534946|NCT01825889|Antimetabolites|antimetabolites|mesh-ancestor
102534947|NCT01825889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534948|NCT01825889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102534949|NCT02692755|Letrozole|letrozole|mesh-list
102534950|NCT02692755|Fulvestrant|fulvestrant|mesh-list
102534951|NCT02692755|Palbociclib|palbociclib|mesh-list
102534952|NCT02692755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102534953|NCT02692755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102534954|NCT02692755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102534955|NCT02692755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102534956|NCT02692755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534957|NCT02692755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102534958|NCT02692755|Hormone Antagonists|hormone antagonists|mesh-ancestor
102534959|NCT02692755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102534960|NCT02692755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534961|NCT02692755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102534962|NCT02692755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102534963|NCT02692755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102534964|NCT01829399|Epinephrine|epinephrine|mesh-list
102534965|NCT01829399|Bupivacaine|bupivacaine|mesh-list
102534966|NCT01829399|Anesthetics, Local|anesthetics, local|mesh-ancestor
102534967|NCT01829399|Anesthetics|anesthetics|mesh-ancestor
102534968|NCT01829399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102534969|NCT01829399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534970|NCT01829399|Sensory System Agents|sensory system agents|mesh-ancestor
102534971|NCT01829399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102534972|NCT01829399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102534973|NCT01829399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102534974|NCT01829399|Adrenergic Agents|adrenergic agents|mesh-ancestor
102534975|NCT01829399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102534976|NCT01829399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534977|NCT01829399|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102534978|NCT01829399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102534979|NCT01829399|Autonomic Agents|autonomic agents|mesh-ancestor
102534980|NCT01829399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102534981|NCT01829399|Respiratory System Agents|respiratory system agents|mesh-ancestor
102534982|NCT01829399|Mydriatics|mydriatics|mesh-ancestor
102534983|NCT01829399|Sympathomimetics|sympathomimetics|mesh-ancestor
102534984|NCT01829399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102534985|NCT01394510|Acetylcysteine|acetylcysteine|mesh-list
102534986|NCT01394510|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102534987|NCT01394510|Antiviral Agents|antiviral agents|mesh-ancestor
102534988|NCT01394510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102534989|NCT01394510|Expectorants|expectorants|mesh-ancestor
102534990|NCT01394510|Respiratory System Agents|respiratory system agents|mesh-ancestor
102534991|NCT01394510|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102534992|NCT01394510|Antioxidants|antioxidants|mesh-ancestor
102346515|NCT04186598|Nifedipine|nifedipine|mesh-list
102534993|NCT01394510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102534994|NCT01394510|Protective Agents|protective agents|mesh-ancestor
102534995|NCT01394510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102534996|NCT01394510|Antidotes|antidotes|mesh-ancestor
102534997|NCT05580549|Ethanol|ethanol|mesh-list
102534998|NCT05580549|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102534999|NCT05580549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102011344|NCT03722329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102535000|NCT05580549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102535001|NCT05580549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535002|NCT05327621|Pamiparib|pamiparib|mesh-list
102535003|NCT05327621|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102535004|NCT05327621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102535005|NCT05327621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535006|NCT05327621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102535007|NCT05327309|Bleomycin|bleomycin|mesh-list
102535008|NCT05327309|Propranolol|propranolol|mesh-list
102535009|NCT05327309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102535010|NCT05327309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102535011|NCT05327309|Adrenergic Agents|adrenergic agents|mesh-ancestor
102535012|NCT05327309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102535013|NCT05327309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535014|NCT05327309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535015|NCT05327309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102535016|NCT05327309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102535017|NCT05327309|Vasodilator Agents|vasodilator agents|mesh-ancestor
102535018|NCT05327309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102535019|NCT05327309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102535020|NCT00367731|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102535021|NCT00367731|Antiviral Agents|antiviral agents|mesh-ancestor
102535022|NCT00367731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102535023|NCT05326841|Vitamin D|vitamin d|mesh-list
102535024|NCT05326841|Cholecalciferol|cholecalciferol|mesh-list
102535025|NCT05326841|Vitamins|vitamins|mesh-ancestor
102535026|NCT05326841|Micronutrients|micronutrients|mesh-ancestor
102535027|NCT05326841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535028|NCT05326841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102535029|NCT05326841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102535030|NCT01412372|Mesalamine|mesalamine|mesh-list
102535031|NCT01412372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102535032|NCT01412372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102535033|NCT01412372|Analgesics|analgesics|mesh-ancestor
102535034|NCT01412372|Sensory System Agents|sensory system agents|mesh-ancestor
102535035|NCT01412372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102535036|NCT01412372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535037|NCT01412372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102535038|NCT01412372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102535039|NCT01414010|Amoxicillin|amoxicillin|mesh-list
102535040|NCT01414010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102535041|NCT01414010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102535042|NCT01415960|Leuprolide|leuprolide|mesh-list
102535043|NCT01415960|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102535044|NCT01415960|Fertility Agents|fertility agents|mesh-ancestor
102535045|NCT01415960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102535046|NCT01415960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535047|NCT01415960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102535048|NCT01415960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102535049|NCT01833845|Ribavirin|ribavirin|mesh-list
102535050|NCT01833845|Hydroxychloroquine|hydroxychloroquine|mesh-list
102535051|NCT01833845|Antimetabolites|antimetabolites|mesh-ancestor
102535052|NCT01833845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535053|NCT01833845|Antiviral Agents|antiviral agents|mesh-ancestor
102535054|NCT01833845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102535055|NCT01833845|Antimalarials|antimalarials|mesh-ancestor
102535056|NCT01833845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102535057|NCT01833845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102535058|NCT01833845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102535059|NCT01833845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102535060|NCT01416194|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
102535061|NCT01416194|Bazedoxifene|bazedoxifene|mesh-list
102535062|NCT01416194|Diphosphonates|diphosphonates|mesh-list
102535063|NCT01416194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102535064|NCT01416194|Hormone Antagonists|hormone antagonists|mesh-ancestor
102535065|NCT01416194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102535066|NCT01416194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346590|NCT04064840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102535067|NCT01416194|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102535068|NCT01416194|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102535069|NCT01416194|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102535071|NCT01416584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102535072|NCT01416584|Narcotics|narcotics|mesh-ancestor
102535073|NCT01416584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102535074|NCT01416584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535075|NCT01416584|Analgesics|analgesics|mesh-ancestor
102535076|NCT01416584|Sensory System Agents|sensory system agents|mesh-ancestor
102535077|NCT01416584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102535078|NCT01416584|Antitussive Agents|antitussive agents|mesh-ancestor
102535079|NCT01416584|Respiratory System Agents|respiratory system agents|mesh-ancestor
102535080|NCT02698215|Naltrexone|naltrexone|mesh-list
102535081|NCT02698215|Varenicline|varenicline|mesh-list
102535082|NCT02698215|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102535083|NCT02698215|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102535084|NCT02698215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535085|NCT02698215|Sensory System Agents|sensory system agents|mesh-ancestor
102535086|NCT02698215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102535087|NCT02698215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102535088|NCT02698215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102535089|NCT02698215|Cholinergic Agents|cholinergic agents|mesh-ancestor
102535090|NCT02698215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102535091|NCT02698215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535092|NCT04172961|Cyclosporine|cyclosporine|mesh-list
102535093|NCT04172961|Lifitegrast|lifitegrast|mesh-list
102535094|NCT04172961|Cyclosporins|cyclosporins|mesh-list
102535095|NCT04172961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102535096|NCT04172961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535097|NCT04172961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102535098|NCT04172961|Immunologic Factors|immunologic factors|mesh-ancestor
102535099|NCT04172961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535100|NCT04172961|Antifungal Agents|antifungal agents|mesh-ancestor
102535101|NCT04172961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102535102|NCT04172961|Dermatologic Agents|dermatologic agents|mesh-ancestor
102535103|NCT04172961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102535104|NCT04172961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102535105|NCT04172961|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102535106|NCT04172961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102535107|NCT01480232|Nicotine|nicotine|mesh-list
102535108|NCT01480232|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102535109|NCT01480232|Autonomic Agents|autonomic agents|mesh-ancestor
102535110|NCT01480232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102535111|NCT01480232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535112|NCT01480232|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102535113|NCT01480232|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102535114|NCT01480232|Cholinergic Agents|cholinergic agents|mesh-ancestor
102535115|NCT01480232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102535116|NCT01480232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535117|NCT04049799|Analgesics, Opioid|analgesics, opioid|mesh-list
102535118|NCT04049799|Narcotics|narcotics|mesh-ancestor
102535119|NCT04049799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102535120|NCT04049799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535121|NCT04049799|Analgesics|analgesics|mesh-ancestor
102535122|NCT04049799|Sensory System Agents|sensory system agents|mesh-ancestor
102535123|NCT04049799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102535124|NCT01399268|Hydrocortisone|hydrocortisone|mesh-list
102535125|NCT01399268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102535126|NCT03008876|Acetaminophen|acetaminophen|mesh-list
102535127|NCT03008876|Ibuprofen|ibuprofen|mesh-list
102535128|NCT03008876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102535129|NCT03008876|Analgesics|analgesics|mesh-ancestor
102535130|NCT03008876|Sensory System Agents|sensory system agents|mesh-ancestor
102535131|NCT03008876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102535132|NCT03008876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535133|NCT03008876|Antipyretics|antipyretics|mesh-ancestor
102535134|NCT03008876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102535135|NCT03008876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102535136|NCT03008876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102535137|NCT03008876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102535138|NCT03008876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102535139|NCT03008876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535140|NCT05414487|Ofatumumab|ofatumumab|mesh-list
102535141|NCT05414487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102535142|NCT02701257|Glucagon|glucagon|mesh-list
102535143|NCT02701257|Pancrelipase|pancrelipase|mesh-list
102535144|NCT02701257|Pancreatin|pancreatin|mesh-list
102535145|NCT02701257|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102535146|NCT02701257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102535147|NCT02701257|Hormones|hormones|mesh-ancestor
102535148|NCT02701257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102535149|NCT02701257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535150|NCT02701257|Incretins|incretins|mesh-ancestor
102535151|NCT01836029|Carboplatin|carboplatin|mesh-list
102535152|NCT01836029|Fluorouracil|fluorouracil|mesh-list
102535153|NCT01836029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102535154|NCT01836029|Antimetabolites|antimetabolites|mesh-ancestor
102535155|NCT01836029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535156|NCT01836029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102535157|NCT01836029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102535158|NCT01836029|Immunologic Factors|immunologic factors|mesh-ancestor
102535159|NCT01836029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535160|NCT02703909|Rocuronium|rocuronium|mesh-list
102535161|NCT02703909|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102535162|NCT02703909|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102535163|NCT02703909|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102535164|NCT02703909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102535165|NCT02703909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535166|NCT01836185|Evacetrapib|evacetrapib|mesh-list
102535167|NCT01836185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102535168|NCT01836185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102535169|NCT01836185|Antimetabolites|antimetabolites|mesh-ancestor
102535170|NCT01836185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535171|NCT01836185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102535172|NCT02706249|Enoxaparin|enoxaparin|mesh-list
102535173|NCT02706249|Anticoagulants|anticoagulants|mesh-ancestor
102535174|NCT02706249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102535175|NCT02706249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102535176|NCT02706249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535177|NCT04740021|Carboplatin|carboplatin|mesh-list
102535178|NCT04740021|Etoposide|etoposide|mesh-list
102535179|NCT04740021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102535180|NCT04740021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102535181|NCT04740021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102535182|NCT04740021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102535183|NCT04740021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102535184|NCT04740021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535185|NCT02708433|Lidocaine|lidocaine|mesh-list
102535186|NCT02708433|Anesthetics, Local|anesthetics, local|mesh-ancestor
102535187|NCT02708433|Anesthetics|anesthetics|mesh-ancestor
102535188|NCT02708433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102535189|NCT02708433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535190|NCT02708433|Sensory System Agents|sensory system agents|mesh-ancestor
102535191|NCT02708433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102535192|NCT02708433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102535193|NCT02708433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102535194|NCT02708433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102535195|NCT02708433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102535196|NCT02708433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535197|NCT03575013|Docetaxel|docetaxel|mesh-list
102535198|NCT03575013|Avelumab|avelumab|mesh-list
102535199|NCT03575013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102535200|NCT03575013|Tubulin Modulators|tubulin modulators|mesh-ancestor
102535201|NCT03575013|Antimitotic Agents|antimitotic agents|mesh-ancestor
102535202|NCT03575013|Mitosis Modulators|mitosis modulators|mesh-ancestor
102535203|NCT03575013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535204|NCT03575013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102535205|NCT00559637|Epoetin Alfa|epoetin alfa|mesh-list
102535206|NCT00559637|Hematinics|hematinics|mesh-ancestor
102535207|NCT03349281|Cytarabine|cytarabine|mesh-list
102535208|NCT03349281|Dexamethasone|dexamethasone|mesh-list
102535209|NCT03349281|Hydrocortisone|hydrocortisone|mesh-list
102535210|NCT03349281|Doxorubicin|doxorubicin|mesh-list
102535211|NCT03349281|Methotrexate|methotrexate|mesh-list
102535212|NCT03349281|Vincristine|vincristine|mesh-list
102535213|NCT03349281|Asparaginase|asparaginase|mesh-list
102535214|NCT03349281|Pegaspargase|pegaspargase|mesh-list
102535215|NCT03349281|Pevonedistat|pevonedistat|mesh-list
102535216|NCT03349281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102535217|NCT03349281|Antiemetics|antiemetics|mesh-ancestor
102535218|NCT03349281|Autonomic Agents|autonomic agents|mesh-ancestor
102535219|NCT03349281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102346740|NCT03691649|Timolol|timolol|mesh-list
102535220|NCT03349281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535221|NCT03349281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102535223|NCT03349281|Hormones|hormones|mesh-ancestor
102535224|NCT03349281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102535225|NCT03349281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102535226|NCT03349281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102535227|NCT03349281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102535228|NCT03349281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102535229|NCT03349281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102535230|NCT03349281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102535231|NCT03349281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535232|NCT03349281|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102535233|NCT03349281|Abortifacient Agents|abortifacient agents|mesh-ancestor
102535234|NCT03349281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102535235|NCT03349281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102535236|NCT03349281|Antimetabolites|antimetabolites|mesh-ancestor
102535237|NCT03349281|Dermatologic Agents|dermatologic agents|mesh-ancestor
102535238|NCT03349281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102535239|NCT03349281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102535240|NCT03349281|Immunologic Factors|immunologic factors|mesh-ancestor
102535241|NCT03349281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102535242|NCT03349281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102535243|NCT03349281|Antiviral Agents|antiviral agents|mesh-ancestor
102535244|NCT03349281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102535245|NCT03349281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102535246|NCT03349281|Tubulin Modulators|tubulin modulators|mesh-ancestor
102535247|NCT03349281|Antimitotic Agents|antimitotic agents|mesh-ancestor
102535248|NCT03349281|Mitosis Modulators|mitosis modulators|mesh-ancestor
102535249|NCT03206151|Leucovorin|leucovorin|mesh-list
102535250|NCT03206151|Folic Acid|folic acid|mesh-list
102535251|NCT03206151|Fluorouracil|fluorouracil|mesh-list
102535252|NCT03206151|Irinotecan|irinotecan|mesh-list
102535253|NCT03206151|Levoleucovorin|levoleucovorin|mesh-list
102535254|NCT03206151|Antimetabolites|antimetabolites|mesh-ancestor
102535255|NCT03206151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535256|NCT03206151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102535257|NCT03206151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102535258|NCT03206151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102535259|NCT03206151|Immunologic Factors|immunologic factors|mesh-ancestor
102535260|NCT03206151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535261|NCT03206151|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102535262|NCT03206151|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102535263|NCT03206151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102535264|NCT03206151|Antidotes|antidotes|mesh-ancestor
102535265|NCT03206151|Protective Agents|protective agents|mesh-ancestor
102535266|NCT03206151|Vitamin B Complex|vitamin b complex|mesh-ancestor
102535267|NCT03206151|Vitamins|vitamins|mesh-ancestor
102535268|NCT03206151|Micronutrients|micronutrients|mesh-ancestor
102535269|NCT03206151|Hematinics|hematinics|mesh-ancestor
102535270|NCT01841021|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102535271|NCT01841021|Immunoconjugates|immunoconjugates|mesh-list
102535272|NCT01841021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102535273|NCT01841021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102535274|NCT01841021|Immunotoxins|immunotoxins|mesh-ancestor
102535275|NCT01841021|Immunologic Factors|immunologic factors|mesh-ancestor
102535276|NCT01841021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535277|NCT02714283|Azithromycin|azithromycin|mesh-list
102535278|NCT02714283|Erythromycin|erythromycin|mesh-list
102535279|NCT02714283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102535280|NCT02714283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102535281|NCT02714283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102535282|NCT02714283|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102011614|NCT01334502|Hormones|hormones|mesh-ancestor
102535283|NCT02714283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102535284|NCT02714283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535285|NCT04810949|Vitamin D|vitamin d|mesh-list
102535286|NCT04810949|Cholecalciferol|cholecalciferol|mesh-list
102535287|NCT04810949|Vitamins|vitamins|mesh-ancestor
102535288|NCT04810949|Micronutrients|micronutrients|mesh-ancestor
102535289|NCT04810949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535290|NCT04810949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102535291|NCT04810949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102535292|NCT04795583|Prednisone|prednisone|mesh-list
102535293|NCT04795583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102535294|NCT04795583|Glucocorticoids|glucocorticoids|mesh-ancestor
102535295|NCT04795583|Hormones|hormones|mesh-ancestor
102535296|NCT04795583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102535297|NCT04795583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535298|NCT04795583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102535299|NCT04795583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102535300|NCT02722239|Metformin|metformin|mesh-list
102535301|NCT02722239|Dapagliflozin|dapagliflozin|mesh-list
102535302|NCT02722239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102535303|NCT02722239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535304|NCT02722239|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102535305|NCT02722239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535306|NCT02578641|Carboplatin|carboplatin|mesh-list
102535307|NCT02578641|Gemcitabine|gemcitabine|mesh-list
102535308|NCT02578641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102535309|NCT02578641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102535310|NCT02578641|Antimetabolites|antimetabolites|mesh-ancestor
102535311|NCT02578641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535312|NCT05084859|Prednisone|prednisone|mesh-list
102535313|NCT05084859|Docetaxel|docetaxel|mesh-list
102535314|NCT05084859|Panitumumab|panitumumab|mesh-list
102535315|NCT05084859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102535316|NCT05084859|Tubulin Modulators|tubulin modulators|mesh-ancestor
102535317|NCT05084859|Antimitotic Agents|antimitotic agents|mesh-ancestor
102535318|NCT05084859|Mitosis Modulators|mitosis modulators|mesh-ancestor
102535319|NCT05084859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535320|NCT05084859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102535321|NCT05084859|Glucocorticoids|glucocorticoids|mesh-ancestor
102535322|NCT05084859|Hormones|hormones|mesh-ancestor
102535323|NCT05084859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102535324|NCT05084859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535325|NCT05084859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102535326|NCT05084859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102535327|NCT01846871|Tivozanib|tivozanib|mesh-list
102535328|NCT01846871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102535329|NCT01846871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102535330|NCT01846871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535331|NCT02431260|INCB054329|incb054329|mesh-list
102535332|NCT02431260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102535333|NCT02055963|Minocycline|minocycline|mesh-list
102535334|NCT02055963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102535335|NCT02055963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102535336|NCT01848041|Phenylephrine|phenylephrine|mesh-list
102535337|NCT01848041|Oxymetazoline|oxymetazoline|mesh-list
102535338|NCT01848041|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102535339|NCT01848041|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102535340|NCT01848041|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102535341|NCT01848041|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102535342|NCT01848041|Adrenergic Agents|adrenergic agents|mesh-ancestor
102535343|NCT01848041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102535344|NCT01848041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535345|NCT01848041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535346|NCT01848041|Sympathomimetics|sympathomimetics|mesh-ancestor
102535347|NCT01848041|Autonomic Agents|autonomic agents|mesh-ancestor
102535348|NCT01848041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102535349|NCT01848041|Nasal Decongestants|nasal decongestants|mesh-ancestor
102535350|NCT01848041|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102535351|NCT01848041|Respiratory System Agents|respiratory system agents|mesh-ancestor
102535352|NCT01848041|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102535353|NCT01848041|Mydriatics|mydriatics|mesh-ancestor
102535354|NCT01848041|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102535355|NCT01848041|Protective Agents|protective agents|mesh-ancestor
102535356|NCT02724033|Dexamethasone|dexamethasone|mesh-list
102535357|NCT02724033|Ondansetron|ondansetron|mesh-list
102535358|NCT02724033|Antiemetics|antiemetics|mesh-list
102535359|NCT02724033|Bupivacaine|bupivacaine|mesh-list
102535360|NCT02724033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102535361|NCT02724033|Autonomic Agents|autonomic agents|mesh-ancestor
102535362|NCT02724033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102535363|NCT02724033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535364|NCT02724033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102535365|NCT02724033|Glucocorticoids|glucocorticoids|mesh-ancestor
102535366|NCT02724033|Hormones|hormones|mesh-ancestor
102535367|NCT02724033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102535368|NCT02724033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102535369|NCT02724033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102535370|NCT02724033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346886|NCT03509012|Durvalumab|durvalumab|mesh-list
102535371|NCT02724033|Anesthetics, Local|anesthetics, local|mesh-ancestor
102535372|NCT02724033|Anesthetics|anesthetics|mesh-ancestor
102535373|NCT02724033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102535374|NCT02724033|Sensory System Agents|sensory system agents|mesh-ancestor
102535375|NCT02724033|Antipruritics|antipruritics|mesh-ancestor
102535376|NCT02724033|Dermatologic Agents|dermatologic agents|mesh-ancestor
102535377|NCT02724033|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102535378|NCT02724033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102535379|NCT02724033|Serotonin Agents|serotonin agents|mesh-ancestor
102535380|NCT02724033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102535382|NCT02724423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102535383|NCT02724423|Anticonvulsants|anticonvulsants|mesh-ancestor
102535384|NCT02724423|Antiemetics|antiemetics|mesh-ancestor
102535385|NCT02724423|Autonomic Agents|autonomic agents|mesh-ancestor
102535386|NCT02724423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102535387|NCT02724423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535388|NCT02724423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102535389|NCT02724423|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102535390|NCT02724423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102535391|NCT02724423|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102535392|NCT02724423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102535393|NCT02724423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102535394|NCT02724423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102535395|NCT02724423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102535396|NCT02724423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102535397|NCT02724423|Anesthetics, General|anesthetics, general|mesh-ancestor
102535398|NCT02724423|Anesthetics|anesthetics|mesh-ancestor
102535399|NCT02724423|GABA Modulators|gaba modulators|mesh-ancestor
102535400|NCT02724423|GABA Agents|gaba agents|mesh-ancestor
102535401|NCT02724423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102535402|NCT02724423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535403|NCT02989259|Apatinib|apatinib|mesh-list
102535404|NCT02989259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102535405|NCT02989259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102535406|NCT02989259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102535407|NCT02989259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535408|NCT04950621|Propofol|propofol|mesh-list
102535409|NCT04950621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102535410|NCT04950621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102535411|NCT04950621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535412|NCT04950621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102535413|NCT04950621|Anesthetics, General|anesthetics, general|mesh-ancestor
102535414|NCT04950621|Anesthetics|anesthetics|mesh-ancestor
102535415|NCT01848899|Bivalirudin|bivalirudin|mesh-list
102535416|NCT01848899|Antithrombins|antithrombins|mesh-ancestor
102535417|NCT01848899|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102535418|NCT01848899|Protease Inhibitors|protease inhibitors|mesh-ancestor
102535419|NCT01848899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102535420|NCT01848899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535421|NCT01848899|Anticoagulants|anticoagulants|mesh-ancestor
102535422|NCT02731833|Fluorides|fluorides|mesh-list
102535423|NCT02731833|Tin Fluorides|tin fluorides|mesh-list
102535424|NCT02731833|Fluorophosphate|fluorophosphate|mesh-list
102535425|NCT02731833|Cariostatic Agents|cariostatic agents|mesh-ancestor
102535426|NCT02731833|Protective Agents|protective agents|mesh-ancestor
102535427|NCT02731833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535428|NCT01852019|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102535429|NCT01852019|Cangrelor|cangrelor|mesh-list
102535430|NCT01852019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102535431|NCT01852019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102011764|NCT02486848|Minoxidil|minoxidil|mesh-list
102535432|NCT01852019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102535433|NCT01852019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102535434|NCT01852019|Purinergic Agents|purinergic agents|mesh-ancestor
102535435|NCT01852019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102535436|NCT01852019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535437|NCT01852019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535438|NCT04457219|Hemostatics|hemostatics|mesh-list
102535439|NCT04457219|Coagulants|coagulants|mesh-ancestor
102535440|NCT01852175|Ticagrelor|ticagrelor|mesh-list
102535441|NCT01852175|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102535442|NCT01852175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102535443|NCT01852175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102535444|NCT01852175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102535445|NCT01852175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102535446|NCT01852175|Purinergic Agents|purinergic agents|mesh-ancestor
102535447|NCT01852175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102346963|NCT03292926|Glucocorticoids|glucocorticoids|mesh-ancestor
102535448|NCT01852175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535449|NCT01852175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535451|NCT02429934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102535452|NCT02429934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535453|NCT02429934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102535454|NCT02429934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102535455|NCT02429934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102535456|NCT02429934|Immunologic Factors|immunologic factors|mesh-ancestor
102535457|NCT02429934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535458|NCT02429934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102535459|NCT01852955|Acetaminophen|acetaminophen|mesh-list
102535460|NCT01852955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102535461|NCT01852955|Analgesics|analgesics|mesh-ancestor
102535462|NCT01852955|Sensory System Agents|sensory system agents|mesh-ancestor
102535463|NCT01852955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102535464|NCT01852955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535465|NCT01852955|Antipyretics|antipyretics|mesh-ancestor
102535466|NCT00558467|Pramipexole|pramipexole|mesh-list
102535467|NCT00558467|Antioxidants|antioxidants|mesh-ancestor
102535468|NCT00558467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535469|NCT00558467|Protective Agents|protective agents|mesh-ancestor
102535470|NCT00558467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535471|NCT00558467|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102535472|NCT00558467|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102535473|NCT00558467|Dopamine Agonists|dopamine agonists|mesh-ancestor
102535474|NCT00558467|Dopamine Agents|dopamine agents|mesh-ancestor
102535475|NCT00558467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102535476|NCT04226495|Sufentanil|sufentanil|mesh-list
102535477|NCT04226495|Dsuvia|dsuvia|mesh-list
102535478|NCT04226495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102535479|NCT04226495|Narcotics|narcotics|mesh-ancestor
102535480|NCT04226495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102535481|NCT04226495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535482|NCT04226495|Analgesics|analgesics|mesh-ancestor
102535483|NCT04226495|Sensory System Agents|sensory system agents|mesh-ancestor
102535484|NCT04226495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102535485|NCT04226495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102535486|NCT04226495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102535487|NCT04226495|Anesthetics, General|anesthetics, general|mesh-ancestor
102535488|NCT04226495|Anesthetics|anesthetics|mesh-ancestor
102535489|NCT02401230|Tenofovir|tenofovir|mesh-list
102535490|NCT02401230|Emtricitabine|emtricitabine|mesh-list
102535491|NCT02401230|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102535492|NCT02401230|Antiviral Agents|antiviral agents|mesh-ancestor
102535493|NCT02401230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102011843|NCT01306721|Ephedrine|ephedrine|mesh-list
102535494|NCT02401230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102535495|NCT02401230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102535496|NCT02401230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102535497|NCT02401230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535498|NCT02401230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102535499|NCT02401230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102535500|NCT01854359|Idebenone|idebenone|mesh-list
102535501|NCT01854359|Antioxidants|antioxidants|mesh-ancestor
102535502|NCT01854359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535503|NCT01854359|Protective Agents|protective agents|mesh-ancestor
102535504|NCT01854359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535505|NCT01854593|Bevacizumab|bevacizumab|mesh-list
102535506|NCT01854593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102535507|NCT01854593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102535508|NCT01854593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102535509|NCT01854593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102535510|NCT01854593|Growth Substances|growth substances|mesh-ancestor
102535511|NCT01854593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535512|NCT01854593|Growth Inhibitors|growth inhibitors|mesh-ancestor
102535513|NCT01855997|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102535514|NCT01855997|Interferon alpha-2|interferon alpha-2|mesh-list
102535515|NCT01855997|Antiviral Agents|antiviral agents|mesh-ancestor
102535516|NCT01855997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102535517|NCT01855997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102535518|NCT02734953|Nitric Oxide|nitric oxide|mesh-list
102535519|NCT02734953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102535520|NCT02734953|Autonomic Agents|autonomic agents|mesh-ancestor
102535521|NCT02734953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102535522|NCT02734953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535523|NCT02734953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102535524|NCT02734953|Respiratory System Agents|respiratory system agents|mesh-ancestor
102535525|NCT02734953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102535526|NCT02734953|Antioxidants|antioxidants|mesh-ancestor
102535527|NCT02734953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535528|NCT02734953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102535529|NCT02734953|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102535530|NCT02734953|Vasodilator Agents|vasodilator agents|mesh-ancestor
102535531|NCT02734953|Gasotransmitters|gasotransmitters|mesh-ancestor
102535532|NCT02734953|Protective Agents|protective agents|mesh-ancestor
102535533|NCT02428608|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102535534|NCT02428608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102535535|NCT02428608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102535536|NCT02428608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535537|NCT02428608|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102535538|NCT02428608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102535539|NCT02428608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535540|NCT02428608|Cholinergic Agents|cholinergic agents|mesh-ancestor
102535541|NCT02428608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102535542|NCT02735187|Vitamin D|vitamin d|mesh-list
102535543|NCT02735187|Vitamins|vitamins|mesh-ancestor
102535544|NCT02735187|Micronutrients|micronutrients|mesh-ancestor
102535545|NCT02735187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535546|NCT02735187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102535547|NCT02428296|Sirolimus|sirolimus|mesh-list
102535548|NCT02428296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102535549|NCT02428296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102535550|NCT02428296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102535551|NCT02428296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102535552|NCT02428296|Antifungal Agents|antifungal agents|mesh-ancestor
102535553|NCT02428296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102535554|NCT02428296|Immunologic Factors|immunologic factors|mesh-ancestor
102535555|NCT02428296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535556|NCT02643615|Propofol|propofol|mesh-list
102535557|NCT02643615|Desflurane|desflurane|mesh-list
102535558|NCT02643615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102535559|NCT02643615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102535560|NCT02643615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535561|NCT02643615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102535562|NCT02643615|Anesthetics, General|anesthetics, general|mesh-ancestor
102535563|NCT02643615|Anesthetics|anesthetics|mesh-ancestor
102535564|NCT02643615|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102535565|NCT02265341|Ponatinib|ponatinib|mesh-list
102535566|NCT02265341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102535567|NCT02265341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102535568|NCT02265341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102535569|NCT02265341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535570|NCT05679479|Meplazumab|meplazumab|mesh-list
102535571|NCT05679479|Antiviral Agents|antiviral agents|mesh-ancestor
102535572|NCT05679479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102535573|NCT01421186|Dexamethasone|dexamethasone|mesh-list
102535574|NCT01421186|Lenalidomide|lenalidomide|mesh-list
102535575|NCT01421186|Pomalidomide|pomalidomide|mesh-list
102535576|NCT01421186|Felzartamab|felzartamab|mesh-list
102535577|NCT01421186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102535578|NCT01421186|Antiemetics|antiemetics|mesh-ancestor
102535579|NCT01421186|Autonomic Agents|autonomic agents|mesh-ancestor
102535580|NCT01421186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102535581|NCT01421186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535582|NCT01421186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102535583|NCT01421186|Glucocorticoids|glucocorticoids|mesh-ancestor
102535584|NCT01421186|Hormones|hormones|mesh-ancestor
102535585|NCT01421186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102535586|NCT01421186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102535587|NCT01421186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102535588|NCT01421186|Immunologic Factors|immunologic factors|mesh-ancestor
102535589|NCT01421186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102535590|NCT01421186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102535591|NCT01421186|Growth Substances|growth substances|mesh-ancestor
102535592|NCT01421186|Growth Inhibitors|growth inhibitors|mesh-ancestor
102535593|NCT01860287|Buprenorphine|buprenorphine|mesh-list
102535594|NCT01860287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102535595|NCT01860287|Narcotics|narcotics|mesh-ancestor
102535596|NCT01860287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102535597|NCT01860287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535598|NCT01860287|Analgesics|analgesics|mesh-ancestor
102347112|NCT02858921|Trametinib|trametinib|mesh-list
102535599|NCT01860287|Sensory System Agents|sensory system agents|mesh-ancestor
102535600|NCT01860287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102535601|NCT01860287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102535602|NCT01421498|Lifitegrast|lifitegrast|mesh-list
102535603|NCT01421498|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102535604|NCT01421498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102535606|NCT01422200|Immunologic Factors|immunologic factors|mesh-ancestor
102535607|NCT01422200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535608|NCT01860521|Sufentanil|sufentanil|mesh-list
102535609|NCT01860521|Levobupivacaine|levobupivacaine|mesh-list
102535610|NCT01860521|Gemeprost|gemeprost|mesh-list
102535611|NCT01860521|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102535612|NCT01860521|Narcotics|narcotics|mesh-ancestor
102535613|NCT01860521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102535614|NCT01860521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535615|NCT01860521|Analgesics|analgesics|mesh-ancestor
102535616|NCT01860521|Sensory System Agents|sensory system agents|mesh-ancestor
102535617|NCT01860521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102535618|NCT01860521|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102535619|NCT01860521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102535620|NCT01860521|Anesthetics, General|anesthetics, general|mesh-ancestor
102535621|NCT01860521|Anesthetics|anesthetics|mesh-ancestor
102535622|NCT01860521|Anesthetics, Local|anesthetics, local|mesh-ancestor
102535623|NCT01860521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102535624|NCT01860521|Abortifacient Agents|abortifacient agents|mesh-ancestor
102535625|NCT01860521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102535626|NCT01400906|Fluticasone|fluticasone|mesh-list
102535627|NCT01400906|Xhance|xhance|mesh-list
102535628|NCT01400906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102535629|NCT01400906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102535630|NCT01400906|Autonomic Agents|autonomic agents|mesh-ancestor
102535631|NCT01400906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102535632|NCT01400906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535633|NCT01400906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102535634|NCT01400906|Respiratory System Agents|respiratory system agents|mesh-ancestor
102535635|NCT01400906|Dermatologic Agents|dermatologic agents|mesh-ancestor
102535636|NCT01400906|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102535637|NCT00367653|Azithromycin|azithromycin|mesh-list
102535638|NCT00367653|Chloroquine|chloroquine|mesh-list
102535639|NCT00367653|Mefloquine|mefloquine|mesh-list
102535640|NCT00367653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102535641|NCT00367653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102535642|NCT00367653|Amebicides|amebicides|mesh-ancestor
102535643|NCT00367653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102535644|NCT00367653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102535645|NCT00367653|Antimalarials|antimalarials|mesh-ancestor
102535646|NCT00367653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102535647|NCT01485380|Dexmedetomidine|dexmedetomidine|mesh-list
102535648|NCT01485380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102535649|NCT01485380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102535650|NCT01485380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535651|NCT01485380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102535652|NCT01485380|Analgesics|analgesics|mesh-ancestor
102535653|NCT01485380|Sensory System Agents|sensory system agents|mesh-ancestor
102535654|NCT01485380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102535655|NCT01485380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102535656|NCT01485380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102535657|NCT01485380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102535658|NCT01485380|Adrenergic Agents|adrenergic agents|mesh-ancestor
102535659|NCT01485380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102535660|NCT01485380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535661|NCT05445297|Amiodarone|amiodarone|mesh-list
102535662|NCT05445297|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102535663|NCT05445297|Vasodilator Agents|vasodilator agents|mesh-ancestor
102535664|NCT05445297|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102535665|NCT05445297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102535666|NCT05445297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535667|NCT05445297|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102535668|NCT05445297|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102535669|NCT05445297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102535670|NCT05445297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102535671|NCT05445297|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102535672|NCT05445297|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102535673|NCT05445297|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102347192|NCT02227199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102535674|NCT00556673|Fluticasone|fluticasone|mesh-list
102535675|NCT00556673|Mometasone Furoate|mometasone furoate|mesh-list
102535676|NCT00556673|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102535677|NCT00556673|Maleic acid|maleic acid|mesh-list
102535678|NCT00556673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102535679|NCT00556673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102535680|NCT00556673|Autonomic Agents|autonomic agents|mesh-ancestor
102535681|NCT00556673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102535682|NCT00556673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535683|NCT00556673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102535684|NCT00556673|Respiratory System Agents|respiratory system agents|mesh-ancestor
102535685|NCT00556673|Dermatologic Agents|dermatologic agents|mesh-ancestor
102535686|NCT00556673|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102535687|NCT00556673|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102535688|NCT00556673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102535689|NCT00556673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102535690|NCT00556673|Adrenergic Agents|adrenergic agents|mesh-ancestor
102535691|NCT00556673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102535692|NCT00556673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535693|NCT00556673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102535694|NCT05437029|Plant Lectins|plant lectins|mesh-list
102535695|NCT05437029|Agglutinins|agglutinins|mesh-ancestor
102535696|NCT05437029|Immunologic Factors|immunologic factors|mesh-ancestor
102535697|NCT05437029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535698|NCT05437029|Coagulants|coagulants|mesh-ancestor
102535699|NCT05437029|Hemagglutinins|hemagglutinins|mesh-ancestor
102535700|NCT01422434|Calcitriol|calcitriol|mesh-list
102535701|NCT01422434|Betamethasone|betamethasone|mesh-list
102535702|NCT01422434|Betamethasone Valerate|betamethasone valerate|mesh-list
102535703|NCT01422434|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102535704|NCT01422434|Betamethasone benzoate|betamethasone benzoate|mesh-list
102535705|NCT01422434|Calcipotriene|calcipotriene|mesh-list
102535706|NCT01422434|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102535707|NCT01422434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102535708|NCT01422434|Glucocorticoids|glucocorticoids|mesh-ancestor
102535709|NCT01422434|Hormones|hormones|mesh-ancestor
102535710|NCT01422434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102535711|NCT01422434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535712|NCT01422434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102535713|NCT01422434|Respiratory System Agents|respiratory system agents|mesh-ancestor
102535714|NCT01422434|Dermatologic Agents|dermatologic agents|mesh-ancestor
102535715|NCT01422434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102535716|NCT01422434|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102535717|NCT01422434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102535718|NCT01422434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535719|NCT01422434|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102535720|NCT01422434|Vitamins|vitamins|mesh-ancestor
102535721|NCT01422434|Micronutrients|micronutrients|mesh-ancestor
102535722|NCT01422434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102535723|NCT01861457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
102535724|NCT01861457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102535725|NCT02270255|Lidocaine|lidocaine|mesh-list
102535726|NCT02270255|Ropivacaine|ropivacaine|mesh-list
102535727|NCT02270255|Anesthetics, Local|anesthetics, local|mesh-ancestor
102535728|NCT02270255|Anesthetics|anesthetics|mesh-ancestor
102535729|NCT02270255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102535730|NCT02270255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535731|NCT02270255|Sensory System Agents|sensory system agents|mesh-ancestor
102535732|NCT02270255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102535733|NCT02270255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102535734|NCT02270255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102535735|NCT02270255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102535736|NCT02270255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102535737|NCT02270255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535738|NCT02651259|Vitamins|vitamins|mesh-list
102535739|NCT02651259|Pyridoxine|pyridoxine|mesh-list
102535740|NCT02651259|Pyridoxal|pyridoxal|mesh-list
102535741|NCT02651259|Vitamin B 6|vitamin b 6|mesh-list
102535742|NCT02651259|Vitamin B Complex|vitamin b complex|mesh-list
102535743|NCT02651259|Isoniazid|isoniazid|mesh-list
102535744|NCT02651259|Rifapentine|rifapentine|mesh-list
102535745|NCT02651259|Rifamycins|rifamycins|mesh-list
102535746|NCT02651259|Hydrazine|hydrazine|mesh-list
102535747|NCT02651259|Micronutrients|micronutrients|mesh-ancestor
102535748|NCT02651259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535749|NCT02651259|Antitubercular Agents|antitubercular agents|mesh-ancestor
102347267|NCT01858740|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102535750|NCT02651259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102535751|NCT02651259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102535752|NCT02651259|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102535754|NCT02651259|Antimetabolites|antimetabolites|mesh-ancestor
102535755|NCT02651259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535756|NCT02651259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102535757|NCT02651259|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102535758|NCT02651259|Leprostatic Agents|leprostatic agents|mesh-ancestor
102535759|NCT02651259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102535760|NCT02271425|Evacetrapib|evacetrapib|mesh-list
102535761|NCT02271425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102535762|NCT02271425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102535763|NCT02271425|Antimetabolites|antimetabolites|mesh-ancestor
102535764|NCT02271425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535765|NCT02271425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102535766|NCT05442411|Parecoxib|parecoxib|mesh-list
102535767|NCT05442411|Ropivacaine|ropivacaine|mesh-list
102535768|NCT05442411|Anesthetics, Local|anesthetics, local|mesh-ancestor
102535769|NCT05442411|Anesthetics|anesthetics|mesh-ancestor
102535770|NCT05442411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102535771|NCT05442411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535772|NCT05442411|Sensory System Agents|sensory system agents|mesh-ancestor
102535773|NCT05442411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102535774|NCT05442411|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102535775|NCT05442411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102535776|NCT05442411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102535777|NCT05442411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535778|NCT05442411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102535779|NCT05442411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102535780|NCT05442411|Analgesics|analgesics|mesh-ancestor
102535781|NCT05442411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102535782|NCT05442411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102535783|NCT05654363|Morphine|morphine|mesh-list
102535784|NCT05654363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102535785|NCT05654363|Narcotics|narcotics|mesh-ancestor
102535786|NCT05654363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102535787|NCT05654363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535788|NCT05654363|Analgesics|analgesics|mesh-ancestor
102535789|NCT05654363|Sensory System Agents|sensory system agents|mesh-ancestor
102535790|NCT05654363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102535791|NCT02651415|Perindopril|perindopril|mesh-list
102535792|NCT02651415|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102535793|NCT02651415|Protease Inhibitors|protease inhibitors|mesh-ancestor
102535794|NCT02651415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102535795|NCT02651415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535796|NCT02651415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102535797|NCT00555425|Buprenorphine|buprenorphine|mesh-list
102535798|NCT00555425|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102535799|NCT00555425|Naloxone|naloxone|mesh-list
102535800|NCT00555425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102535801|NCT00555425|Narcotics|narcotics|mesh-ancestor
102535802|NCT00555425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102535803|NCT00555425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535804|NCT00555425|Analgesics|analgesics|mesh-ancestor
102535805|NCT00555425|Sensory System Agents|sensory system agents|mesh-ancestor
102535806|NCT00555425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102535807|NCT00555425|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102535808|NCT05444673|Cisplatin|cisplatin|mesh-list
102535809|NCT05444673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102535810|NCT04338633|Calcium, Dietary|calcium, dietary|mesh-list
102535811|NCT04338633|Calcium|calcium|mesh-list
102535812|NCT04338633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102535813|NCT04338633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535814|NCT04338633|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102535815|NCT01488188|Vaccines|vaccines|mesh-list
102535816|NCT01488188|Immunologic Factors|immunologic factors|mesh-ancestor
102535817|NCT01488188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535818|NCT01489670|Bimatoprost|bimatoprost|mesh-list
102535819|NCT01489670|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102535820|NCT01489670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102535821|NCT01489670|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102535822|NCT01427504|Etravirine|etravirine|mesh-list
102535823|NCT01427504|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102535824|NCT01427504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102535825|NCT01427504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102535826|NCT01427504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535827|NCT01427504|Antiviral Agents|antiviral agents|mesh-ancestor
102535828|NCT01427504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102535829|NCT03169361|Ixazomib|ixazomib|mesh-list
102535830|NCT03169361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102535831|NCT03169361|Protease Inhibitors|protease inhibitors|mesh-ancestor
102535832|NCT03169361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102535833|NCT03169361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535834|NCT02265965|Nitroglycerin|nitroglycerin|mesh-list
102535835|NCT02265965|Vasodilator Agents|vasodilator agents|mesh-ancestor
102535836|NCT03021083|Fentanyl|fentanyl|mesh-list
102535837|NCT03021083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102535838|NCT03021083|Narcotics|narcotics|mesh-ancestor
102535839|NCT03021083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102535840|NCT03021083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535841|NCT03021083|Analgesics|analgesics|mesh-ancestor
102535842|NCT03021083|Sensory System Agents|sensory system agents|mesh-ancestor
102535843|NCT03021083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102535844|NCT03021083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102535845|NCT03021083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102535846|NCT03021083|Anesthetics, General|anesthetics, general|mesh-ancestor
102535847|NCT03021083|Anesthetics|anesthetics|mesh-ancestor
102535848|NCT03000257|Venetoclax|venetoclax|mesh-list
102154273|NCT03376191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154274|NCT03366597|Sevoflurane|sevoflurane|mesh-list
102154275|NCT03366597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102154276|NCT03366597|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102154277|NCT03366597|Anesthetics, General|anesthetics, general|mesh-ancestor
102154278|NCT03366597|Anesthetics|anesthetics|mesh-ancestor
102154279|NCT03366597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102154280|NCT03366597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154281|NCT03110120|Levobupivacaine|levobupivacaine|mesh-list
102154282|NCT03110120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102154283|NCT03110120|Anesthetics, Local|anesthetics, local|mesh-ancestor
102154284|NCT03110120|Anesthetics|anesthetics|mesh-ancestor
102154285|NCT03110120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102154286|NCT03110120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154287|NCT03110120|Sensory System Agents|sensory system agents|mesh-ancestor
102154288|NCT03110120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102154289|NCT03109886|Maleic acid|maleic acid|mesh-list
102154290|NCT03109886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102154291|NCT03109886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154292|NCT03110198|Hydrocortisone|hydrocortisone|mesh-list
102154293|NCT03110198|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102154294|NCT03110198|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102154295|NCT03110198|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102154296|NCT03110198|Mesalamine|mesalamine|mesh-list
102154297|NCT03110198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102154298|NCT03110198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102154299|NCT03110198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102154300|NCT03110198|Analgesics|analgesics|mesh-ancestor
102154301|NCT03110198|Sensory System Agents|sensory system agents|mesh-ancestor
102154302|NCT03110198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102154303|NCT03110198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154304|NCT03110198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102154305|NCT04460781|Vaccines|vaccines|mesh-list
102154306|NCT04460781|Immunologic Factors|immunologic factors|mesh-ancestor
102154307|NCT04460781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154308|NCT03371589|Dexamethasone|dexamethasone|mesh-list
102154309|NCT03371589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102154310|NCT03371589|Antiemetics|antiemetics|mesh-ancestor
102154311|NCT03371589|Autonomic Agents|autonomic agents|mesh-ancestor
102154312|NCT03371589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102154313|NCT03371589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154314|NCT03371589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102154315|NCT03371589|Glucocorticoids|glucocorticoids|mesh-ancestor
102154316|NCT03371589|Hormones|hormones|mesh-ancestor
102154317|NCT03371589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102154318|NCT03371589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102154319|NCT03371589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102154320|NCT03365817|Fentanyl|fentanyl|mesh-list
102154321|NCT03365817|Morphine|morphine|mesh-list
102154322|NCT03365817|Oxycodone|oxycodone|mesh-list
102154323|NCT03365817|Analgesics, Opioid|analgesics, opioid|mesh-list
102154324|NCT03365817|Tramadol|tramadol|mesh-list
102535849|NCT03000257|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
102535850|NCT03000257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102113590|NCT03365726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102113591|NCT03365726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113592|NCT03365726|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102113593|NCT03365726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102113594|NCT03365726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102113595|NCT03365726|Adrenergic Agents|adrenergic agents|mesh-ancestor
102113596|NCT03365726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102012246|NCT03777605|Nitroglycerin|nitroglycerin|mesh-list
102113597|NCT03365726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113598|NCT03365726|Protective Agents|protective agents|mesh-ancestor
102113599|NCT02303418|Oxytocin|oxytocin|mesh-list
102113600|NCT02303418|Carbetocin|carbetocin|mesh-list
102113601|NCT02303418|Oxytocics|oxytocics|mesh-ancestor
102113602|NCT02303418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102113603|NCT02303418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113604|NCT03510000|Empagliflozin|empagliflozin|mesh-list
102113605|NCT03510000|Pancrelipase|pancrelipase|mesh-list
102113606|NCT03510000|Hormones|hormones|mesh-list
102113607|NCT03510000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102113608|NCT03510000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113609|NCT03510000|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102113610|NCT03510000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113611|NCT03510000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102113612|NCT03510000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102113613|NCT03358082|Hydrocortisone|hydrocortisone|mesh-list
102113614|NCT03358082|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102113615|NCT03358082|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102113616|NCT03358082|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102113617|NCT03358082|Tacrolimus|tacrolimus|mesh-list
102113618|NCT03358082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102113619|NCT03358082|Immunologic Factors|immunologic factors|mesh-ancestor
102113620|NCT03358082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113621|NCT03358082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102113622|NCT03358082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102113623|NCT03358082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113624|NCT03358082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102113625|NCT03358004|Capecitabine|capecitabine|mesh-list
102113626|NCT03358004|Vinorelbine|vinorelbine|mesh-list
102113627|NCT03358004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102113628|NCT03358004|Antimetabolites|antimetabolites|mesh-ancestor
102113629|NCT03358004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113630|NCT03358004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102113631|NCT03358004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102113632|NCT03358004|Tubulin Modulators|tubulin modulators|mesh-ancestor
102113633|NCT03358004|Antimitotic Agents|antimitotic agents|mesh-ancestor
102113634|NCT03358004|Mitosis Modulators|mitosis modulators|mesh-ancestor
102113635|NCT03509922|Sarpogrelate|sarpogrelate|mesh-list
102113636|NCT03509922|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102113637|NCT03509922|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102113638|NCT03509922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113639|NCT03509922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102113640|NCT03509922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102113641|NCT03509922|Serotonin Agents|serotonin agents|mesh-ancestor
102113642|NCT03509922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102113643|NCT03509922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113644|NCT03365336|Oseltamivir|oseltamivir|mesh-list
102113645|NCT03365336|Antiviral Agents|antiviral agents|mesh-ancestor
102113646|NCT03365336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102113647|NCT03365336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102113648|NCT03365336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113649|NCT03362216|Diclofenac|diclofenac|mesh-list
102113650|NCT03362216|Salicylates|salicylates|mesh-list
102113651|NCT03362216|Methyl salicylate|methyl salicylate|mesh-list
102113652|NCT03362216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102113653|NCT03362216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102113654|NCT03362216|Analgesics|analgesics|mesh-ancestor
102113655|NCT03362216|Sensory System Agents|sensory system agents|mesh-ancestor
102113656|NCT03362216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102113657|NCT03362216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113658|NCT03362216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102113659|NCT03362216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102113660|NCT03362216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102113661|NCT03362216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102113662|NCT03362216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504519|NCT01246037|Bisoprolol|bisoprolol|mesh-list
102113663|NCT02312076|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102113664|NCT02312076|Luteolytic Agents|luteolytic agents|mesh-ancestor
102113665|NCT02312076|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102113666|NCT02312076|Contraceptive Agents|contraceptive agents|mesh-ancestor
102113667|NCT02312076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102113668|NCT02312076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113669|NCT02312076|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102113670|NCT02312076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102113671|NCT02312076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102113672|NCT02307396|Haloperidol|haloperidol|mesh-list
102113673|NCT02307396|Pimozide|pimozide|mesh-list
102113674|NCT02307396|Olanzapine|olanzapine|mesh-list
102113675|NCT02307396|Risperidone|risperidone|mesh-list
102113676|NCT02307396|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102113677|NCT02307396|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102113678|NCT02307396|Ziprasidone|ziprasidone|mesh-list
102113679|NCT02307396|Amisulpride|amisulpride|mesh-list
102113680|NCT02307396|Perphenazine|perphenazine|mesh-list
102113681|NCT02307396|Sertindole|sertindole|mesh-list
102113682|NCT02307396|Fluphenazine|fluphenazine|mesh-list
102113683|NCT02307396|Fluphenazine depot|fluphenazine depot|mesh-list
102113684|NCT02307396|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
102113685|NCT02307396|Sulpiride|sulpiride|mesh-list
102113686|NCT02307396|Thioridazine|thioridazine|mesh-list
102113687|NCT02307396|Clopenthixol|clopenthixol|mesh-list
102113688|NCT02307396|Fluspirilene|fluspirilene|mesh-list
102113689|NCT02307396|Benperidol|benperidol|mesh-list
102113690|NCT02307396|Bromperidol|bromperidol|mesh-list
102113691|NCT02307396|Perazine|perazine|mesh-list
102113692|NCT02307396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102113693|NCT02307396|Serotonin Agents|serotonin agents|mesh-ancestor
102113694|NCT02307396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102113695|NCT02307396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113696|NCT02307396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113697|NCT02307396|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102113698|NCT02307396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102113699|NCT02307396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102113700|NCT02307396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102113701|NCT02307396|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102113702|NCT02307396|Dopamine Agents|dopamine agents|mesh-ancestor
102113703|NCT02307396|Antiemetics|antiemetics|mesh-ancestor
102113704|NCT02307396|Autonomic Agents|autonomic agents|mesh-ancestor
102113705|NCT02307396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102113706|NCT02307396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102113707|NCT02307396|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102113708|NCT02307396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102113709|NCT02307396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102113710|NCT02307396|Antidepressive Agents|antidepressive agents|mesh-ancestor
102113711|NCT02307396|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102113712|NCT02307396|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102113713|NCT02307396|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102113714|NCT02307396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102113715|NCT03509688|Entecavir|entecavir|mesh-list
102113716|NCT03509688|Resveratrol|resveratrol|mesh-list
102113717|NCT03509688|Antiviral Agents|antiviral agents|mesh-ancestor
102113718|NCT03509688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102113719|NCT03509688|Antioxidants|antioxidants|mesh-ancestor
102113720|NCT03509688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113721|NCT03509688|Protective Agents|protective agents|mesh-ancestor
102113722|NCT03509688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113723|NCT03509688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102113724|NCT03509688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102113725|NCT02303730|Insulin Glargine|insulin glargine|mesh-list
102113726|NCT02303730|Exenatide|exenatide|mesh-list
102113727|NCT02303730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102113728|NCT02303730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113729|NCT02303730|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102113730|NCT02303730|Incretins|incretins|mesh-ancestor
102113731|NCT02303730|Hormones|hormones|mesh-ancestor
102113732|NCT02303730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102113733|NCT04524728|Letrozole|letrozole|mesh-list
102113734|NCT04524728|Fulvestrant|fulvestrant|mesh-list
102113735|NCT04524728|Palbociclib|palbociclib|mesh-list
102113736|NCT04524728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102113737|NCT04524728|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102113738|NCT04524728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102113739|NCT04524728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102113740|NCT04524728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113741|NCT04524728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102113742|NCT04524728|Hormone Antagonists|hormone antagonists|mesh-ancestor
102113743|NCT04524728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102113744|NCT04524728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113745|NCT04524728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102113746|NCT04524728|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102113747|NCT04524728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102113748|NCT04523792|Buprenorphine|buprenorphine|mesh-list
102113749|NCT04523792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102113750|NCT04523792|Narcotics|narcotics|mesh-ancestor
102113751|NCT04523792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102113752|NCT04523792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113753|NCT04523792|Analgesics|analgesics|mesh-ancestor
102113754|NCT04523792|Sensory System Agents|sensory system agents|mesh-ancestor
102113755|NCT04523792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102113756|NCT04523792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102113757|NCT02312232|Levodopa|levodopa|mesh-list
102113758|NCT02312232|Carbidopa|carbidopa|mesh-list
102113759|NCT02312232|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102113760|NCT02312232|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102113761|NCT02312232|Dopamine Agents|dopamine agents|mesh-ancestor
102113762|NCT02312232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102113763|NCT02312232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113764|NCT02312232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113765|NCT02312232|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102113766|NCT02312232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102113767|NCT02303886|Methylene Blue|methylene blue|mesh-list
102113768|NCT02303886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102113769|NCT02303886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113770|NCT02518958|Nivolumab|nivolumab|mesh-list
102113771|NCT02518958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102113772|NCT02518958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102113773|NCT02518958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102113774|NCT02518958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113775|NCT03506802|Aldesleukin|aldesleukin|mesh-list
102113776|NCT03506802|Plerixafor|plerixafor|mesh-list
102113777|NCT03506802|Lenalidomide|lenalidomide|mesh-list
102113778|NCT03506802|Melphalan|melphalan|mesh-list
102113779|NCT03506802|Interleukin-2|interleukin-2|mesh-list
102113780|NCT03506802|Mechlorethamine|mechlorethamine|mesh-list
102113781|NCT03506802|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102113782|NCT03506802|Lenograstim|lenograstim|mesh-list
102113783|NCT03506802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102113784|NCT03506802|Immunologic Factors|immunologic factors|mesh-ancestor
102113785|NCT03506802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113786|NCT03506802|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102113787|NCT03506802|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102113788|NCT03506802|Growth Substances|growth substances|mesh-ancestor
102113789|NCT03506802|Growth Inhibitors|growth inhibitors|mesh-ancestor
102113790|NCT03506802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102113791|NCT03506802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102113792|NCT03506802|Alkylating Agents|alkylating agents|mesh-ancestor
102113793|NCT03506802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113794|NCT03506802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102113795|NCT03506802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102113796|NCT03506802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102113797|NCT03506802|Analgesics|analgesics|mesh-ancestor
102113798|NCT03506802|Sensory System Agents|sensory system agents|mesh-ancestor
102012442|NCT01313585|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102113799|NCT03506802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102113800|NCT03506802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102113801|NCT03506802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102113802|NCT03506802|Antiviral Agents|antiviral agents|mesh-ancestor
102113803|NCT03506802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102113804|NCT02307864|Moxifloxacin|moxifloxacin|mesh-list
102113805|NCT02307864|Tramadol|tramadol|mesh-list
102113806|NCT02307864|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102113807|NCT02307864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102113808|NCT02307864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102113809|NCT02307864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102113810|NCT02307864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102113811|NCT02307864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102113812|NCT02307864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113813|NCT02307864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102113814|NCT02307864|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102113815|NCT02307864|Contraceptive Agents|contraceptive agents|mesh-ancestor
102113816|NCT02307864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102113817|NCT02307864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113818|NCT02307864|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102113819|NCT02307864|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102113820|NCT02307864|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102113821|NCT02307864|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102113823|NCT02307864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102113824|NCT02307864|Analgesics|analgesics|mesh-ancestor
102113825|NCT02307864|Sensory System Agents|sensory system agents|mesh-ancestor
102113826|NCT02307864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102113827|NCT02304042|Oxytocin|oxytocin|mesh-list
102113828|NCT02304042|Carbetocin|carbetocin|mesh-list
102113829|NCT02304042|Oxytocics|oxytocics|mesh-ancestor
102113830|NCT02304042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102113831|NCT02304042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113832|NCT02308098|Budesonide|budesonide|mesh-list
102113833|NCT02308098|Formoterol Fumarate|formoterol fumarate|mesh-list
102113834|NCT02308098|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
102113835|NCT02308098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102113836|NCT02308098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102113837|NCT02308098|Autonomic Agents|autonomic agents|mesh-ancestor
102113838|NCT02308098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102113839|NCT02308098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113840|NCT02308098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102113841|NCT02308098|Respiratory System Agents|respiratory system agents|mesh-ancestor
102113842|NCT02308098|Glucocorticoids|glucocorticoids|mesh-ancestor
102113843|NCT02308098|Hormones|hormones|mesh-ancestor
102113844|NCT02308098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102113845|NCT02308098|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102113846|NCT02308098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102113847|NCT02308098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102113848|NCT02308098|Adrenergic Agents|adrenergic agents|mesh-ancestor
102113849|NCT02308098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102113850|NCT02308098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113851|NCT03504072|Etanercept|etanercept|mesh-list
102113852|NCT03504072|Tofacitinib|tofacitinib|mesh-list
102113853|NCT03504072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102113854|NCT03504072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102113855|NCT03504072|Analgesics|analgesics|mesh-ancestor
102113856|NCT03504072|Sensory System Agents|sensory system agents|mesh-ancestor
102113857|NCT03504072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102113858|NCT03504072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113859|NCT03504072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102113860|NCT03504072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102113861|NCT03504072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102113862|NCT03504072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102113863|NCT03504072|Immunologic Factors|immunologic factors|mesh-ancestor
102113864|NCT03504072|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102113865|NCT03504072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102113866|NCT03504072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102113867|NCT03504072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113868|NCT03361280|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102113869|NCT03361280|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102113870|NCT03361280|Adrenergic Agents|adrenergic agents|mesh-ancestor
102113871|NCT03361280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102113872|NCT03361280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113873|NCT03361280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113874|NCT02308254|Lixisenatide|lixisenatide|mesh-list
102113875|NCT02308254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102113876|NCT02308254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113877|NCT03361124|Oxytocin|oxytocin|mesh-list
102113878|NCT03361124|Oxytocics|oxytocics|mesh-ancestor
102113879|NCT03361124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102113880|NCT03361124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113881|NCT03364088|Oxycodone|oxycodone|mesh-list
102113882|NCT03364088|Anesthetics|anesthetics|mesh-list
102113883|NCT03364088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102113884|NCT03364088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113885|NCT03364088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102113886|NCT03364088|Narcotics|narcotics|mesh-ancestor
102113887|NCT03364088|Analgesics|analgesics|mesh-ancestor
102113888|NCT03364088|Sensory System Agents|sensory system agents|mesh-ancestor
102113889|NCT03364088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102113890|NCT02304198|Udenafil|udenafil|mesh-list
102056625|NCT03564912|Capecitabine|capecitabine|mesh-list
101567444|NCT01251380|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102113892|NCT02304198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102113893|NCT02304198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102113894|NCT02304198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113895|NCT02304276|Calcium|calcium|mesh-list
102113896|NCT02304276|Fluorides|fluorides|mesh-list
102113897|NCT02304276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102113898|NCT02304276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113899|NCT02304276|Cariostatic Agents|cariostatic agents|mesh-ancestor
102113900|NCT02304276|Protective Agents|protective agents|mesh-ancestor
102113901|NCT04524260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102113902|NCT02308332|Tenofovir|tenofovir|mesh-list
102113903|NCT02308332|Emtricitabine|emtricitabine|mesh-list
102113904|NCT02308332|Rilpivirine|rilpivirine|mesh-list
102113905|NCT02308332|Antiviral Agents|antiviral agents|mesh-ancestor
102113906|NCT02308332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102113907|NCT02308332|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102113908|NCT02308332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102113909|NCT02308332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102113910|NCT02308332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113911|NCT02308332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102113912|NCT02308332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102113913|NCT03509298|Antibodies|antibodies|mesh-list
102113914|NCT03509298|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102113915|NCT03509298|Immunologic Factors|immunologic factors|mesh-ancestor
102113916|NCT03509298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113917|NCT03503994|Beclomethasone|beclomethasone|mesh-list
102113918|NCT03503994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102113919|NCT03503994|Glucocorticoids|glucocorticoids|mesh-ancestor
102113920|NCT03503994|Hormones|hormones|mesh-ancestor
102113921|NCT03503994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102113922|NCT03503994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113923|NCT03503994|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102113924|NCT03503994|Respiratory System Agents|respiratory system agents|mesh-ancestor
102113925|NCT01796002|Romidepsin|romidepsin|mesh-list
102113926|NCT01796002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102113927|NCT01796002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102113928|NCT01796002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102113929|NCT01796002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102113930|NCT01796002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113931|NCT03509142|Sirolimus|sirolimus|mesh-list
102113932|NCT03509142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102113933|NCT03509142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102113934|NCT03509142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102113935|NCT03509142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102113936|NCT03509142|Antifungal Agents|antifungal agents|mesh-ancestor
102113937|NCT03509142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102113938|NCT03509142|Immunologic Factors|immunologic factors|mesh-ancestor
102113939|NCT03509142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113940|NCT03356912|Prednisone|prednisone|mesh-list
102113941|NCT03356912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102113942|NCT03356912|Glucocorticoids|glucocorticoids|mesh-ancestor
102113943|NCT03356912|Hormones|hormones|mesh-ancestor
102113944|NCT03356912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102113945|NCT03356912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113946|NCT03356912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102113947|NCT03356912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102113948|NCT00102687|Azacitidine|azacitidine|mesh-list
102113949|NCT00102687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102113950|NCT00102687|Antimetabolites|antimetabolites|mesh-ancestor
102113951|NCT00102687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113952|NCT00102687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102113953|NCT00102687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102113954|NCT04509440|Triamcinolone|triamcinolone|mesh-list
102113955|NCT04509440|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102113956|NCT04509440|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102113957|NCT04509440|Anesthetics|anesthetics|mesh-list
102113958|NCT04509440|Mepivacaine|mepivacaine|mesh-list
102113959|NCT04509440|Anesthetics, Local|anesthetics, local|mesh-list
102113960|NCT04509440|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102113961|NCT04509440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102113962|NCT04509440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113963|NCT04509440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102113964|NCT04509440|Glucocorticoids|glucocorticoids|mesh-ancestor
102113965|NCT04509440|Hormones|hormones|mesh-ancestor
102113966|NCT04509440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102113967|NCT04509440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102113968|NCT04509440|Immunologic Factors|immunologic factors|mesh-ancestor
102113969|NCT04509440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102113970|NCT04509440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113971|NCT04509440|Sensory System Agents|sensory system agents|mesh-ancestor
102113972|NCT04509440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102113974|NCT02312544|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102113975|NCT02312544|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102113976|NCT02312544|Adrenergic Agents|adrenergic agents|mesh-ancestor
102113977|NCT02312544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102113978|NCT02312544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113979|NCT02312544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113980|NCT02312544|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102113981|NCT02312544|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102113982|NCT03360734|Cetuximab|cetuximab|mesh-list
102113983|NCT03360734|Panitumumab|panitumumab|mesh-list
102113984|NCT03360734|Necitumumab|necitumumab|mesh-list
102113985|NCT03360734|Antibodies|antibodies|mesh-list
102113986|NCT03360734|Immunologic Factors|immunologic factors|mesh-ancestor
102113987|NCT03360734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113988|NCT03360734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102113989|NCT03360734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102113990|NCT02308644|Bevacizumab|bevacizumab|mesh-list
102113991|NCT02308644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102113992|NCT02308644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102113993|NCT02308644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102113994|NCT02308644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102113995|NCT02308644|Growth Substances|growth substances|mesh-ancestor
102113996|NCT02308644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113997|NCT02308644|Growth Inhibitors|growth inhibitors|mesh-ancestor
102113998|NCT04510636|Pembrolizumab|pembrolizumab|mesh-list
102113999|NCT04510636|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102114000|NCT04510636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102114001|NCT04510636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102114002|NCT04510636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102114003|NCT04510636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114004|NCT04510636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102114005|NCT04510636|Alkylating Agents|alkylating agents|mesh-ancestor
102114006|NCT03540849|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102114007|NCT03540849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102114008|NCT03540849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102114009|NCT03540849|Immunotoxins|immunotoxins|mesh-ancestor
102114010|NCT03540849|Immunoconjugates|immunoconjugates|mesh-ancestor
102114011|NCT03540849|Immunologic Factors|immunologic factors|mesh-ancestor
102114012|NCT03540849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114013|NCT04520126|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
102114014|NCT04520126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102114015|NCT04520126|Antioxidants|antioxidants|mesh-ancestor
102114016|NCT04520126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114017|NCT04520126|Protective Agents|protective agents|mesh-ancestor
102114018|NCT04520126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114019|NCT04520126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102114020|NCT02304354|Rituximab|rituximab|mesh-list
102114021|NCT02304354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102114022|NCT02304354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102114023|NCT02304354|Immunologic Factors|immunologic factors|mesh-ancestor
102114024|NCT02304354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114025|NCT02304354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102114026|NCT03356600|Apatinib|apatinib|mesh-list
102114027|NCT03356600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102114028|NCT03356600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102114029|NCT03356600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102114030|NCT03356600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114031|NCT00102531|Cisplatin|cisplatin|mesh-list
102114032|NCT00102531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102114033|NCT05347654|Sulfadiazine|sulfadiazine|mesh-list
102114034|NCT05347654|Silver Sulfadiazine|silver sulfadiazine|mesh-list
102114035|NCT05347654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102114036|NCT05347654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102114037|NCT05347654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102114038|NCT05347654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102114039|NCT05347654|Coccidiostats|coccidiostats|mesh-ancestor
102114040|NCT05347654|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102535851|NCT03000257|Immunoconjugates|immunoconjugates|mesh-ancestor
102114041|NCT03360266|Listerine|listerine|mesh-list
102114042|NCT03360266|Fluorides|fluorides|mesh-list
102114043|NCT03360266|Sodium Fluoride|sodium fluoride|mesh-list
102114044|NCT03360266|Fluorides, Topical|fluorides, topical|mesh-list
102114045|NCT03360266|Cariostatic Agents|cariostatic agents|mesh-ancestor
102114046|NCT03360266|Protective Agents|protective agents|mesh-ancestor
102114047|NCT03360266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114048|NCT03360266|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102114049|NCT03360266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102114050|NCT02154789|Polidocanol|polidocanol|mesh-list
102114051|NCT02154789|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102114052|NCT02154789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102114053|NCT02771145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102114054|NCT03506256|Norfloxacin|norfloxacin|mesh-list
102114055|NCT03506256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102114056|NCT03506256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102114057|NCT03506256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102114058|NCT03506256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102114059|NCT03506256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102114060|NCT03506256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114061|NCT03506256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102114062|NCT03506256|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102114063|NCT03506256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102114064|NCT03356444|Docetaxel|docetaxel|mesh-list
102114065|NCT03356444|Abiraterone Acetate|abiraterone acetate|mesh-list
102114066|NCT03356444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102114067|NCT03356444|Tubulin Modulators|tubulin modulators|mesh-ancestor
102114068|NCT03356444|Antimitotic Agents|antimitotic agents|mesh-ancestor
102114069|NCT03356444|Mitosis Modulators|mitosis modulators|mesh-ancestor
102114070|NCT03356444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114071|NCT03356444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102114072|NCT03356444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102114073|NCT03356444|Hormone Antagonists|hormone antagonists|mesh-ancestor
102114074|NCT03356444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102114075|NCT03356444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114076|NCT03356444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102114077|NCT03503604|Leucovorin|leucovorin|mesh-list
102114078|NCT03503604|Paclitaxel|paclitaxel|mesh-list
102114079|NCT03503604|Carboplatin|carboplatin|mesh-list
102114080|NCT03503604|Gemcitabine|gemcitabine|mesh-list
102114081|NCT03503604|Fluorouracil|fluorouracil|mesh-list
102114082|NCT03503604|Oxaliplatin|oxaliplatin|mesh-list
102114083|NCT03503604|Irinotecan|irinotecan|mesh-list
102114084|NCT03503604|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102114085|NCT03503604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102114086|NCT03503604|Tubulin Modulators|tubulin modulators|mesh-ancestor
102114087|NCT03503604|Antimitotic Agents|antimitotic agents|mesh-ancestor
102114088|NCT03503604|Mitosis Modulators|mitosis modulators|mesh-ancestor
102114089|NCT03503604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114090|NCT03503604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102114091|NCT03503604|Antimetabolites|antimetabolites|mesh-ancestor
102114092|NCT03503604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102114093|NCT03503604|Immunologic Factors|immunologic factors|mesh-ancestor
102114094|NCT03503604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114095|NCT03503604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102114096|NCT03503604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102114097|NCT03503604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102114098|NCT03503604|Antidotes|antidotes|mesh-ancestor
102114099|NCT03503604|Protective Agents|protective agents|mesh-ancestor
102114100|NCT03503604|Vitamin B Complex|vitamin b complex|mesh-ancestor
102114101|NCT03503604|Vitamins|vitamins|mesh-ancestor
102114102|NCT03503604|Micronutrients|micronutrients|mesh-ancestor
102114103|NCT04508816|Cetuximab|cetuximab|mesh-list
102114104|NCT04508816|Nimotuzumab|nimotuzumab|mesh-list
102114105|NCT04508816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102114106|NCT04508816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102114107|NCT03359876|Warfarin|warfarin|mesh-list
102114108|NCT03359876|Rivaroxaban|rivaroxaban|mesh-list
102114109|NCT03359876|Anticoagulants|anticoagulants|mesh-ancestor
102114110|NCT03359876|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102114111|NCT03359876|Antithrombins|antithrombins|mesh-ancestor
102114112|NCT03359876|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102114113|NCT03359876|Protease Inhibitors|protease inhibitors|mesh-ancestor
102114114|NCT03359876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102114115|NCT03359876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114116|NCT05226832|Triamcinolone|triamcinolone|mesh-list
102535852|NCT03000257|Immunologic Factors|immunologic factors|mesh-ancestor
102114117|NCT05226832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102114118|NCT05226832|Glucocorticoids|glucocorticoids|mesh-ancestor
102114120|NCT05226832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102114121|NCT05226832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114122|NCT03354572|Acetylcysteine|acetylcysteine|mesh-list
102114123|NCT03354572|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102114124|NCT03354572|Antiviral Agents|antiviral agents|mesh-ancestor
102114125|NCT03354572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102114126|NCT03354572|Expectorants|expectorants|mesh-ancestor
102114127|NCT03354572|Respiratory System Agents|respiratory system agents|mesh-ancestor
102114128|NCT03354572|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102114129|NCT03354572|Antioxidants|antioxidants|mesh-ancestor
102114130|NCT03354572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114131|NCT03354572|Protective Agents|protective agents|mesh-ancestor
102114132|NCT03354572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114133|NCT03354572|Antidotes|antidotes|mesh-ancestor
102114134|NCT03359798|Narcotics|narcotics|mesh-list
102114135|NCT03359798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102114136|NCT03359798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114137|NCT03359798|Analgesics|analgesics|mesh-ancestor
102114138|NCT03359798|Sensory System Agents|sensory system agents|mesh-ancestor
102114139|NCT03359798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102114140|NCT02309346|Clindamycin|clindamycin|mesh-list
102114141|NCT02309346|Clindamycin palmitate|clindamycin palmitate|mesh-list
102114142|NCT02309346|Clindamycin phosphate|clindamycin phosphate|mesh-list
102114143|NCT02309346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102114144|NCT02309346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102114145|NCT02309346|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102114146|NCT02309346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102114147|NCT02309346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114148|NCT03356054|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102114149|NCT03356054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102114150|NCT03356054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102114151|NCT03356054|Immunotoxins|immunotoxins|mesh-ancestor
102114152|NCT03356054|Immunoconjugates|immunoconjugates|mesh-ancestor
102114153|NCT03356054|Immunologic Factors|immunologic factors|mesh-ancestor
102114154|NCT03356054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114155|NCT03354494|Desogestrel|desogestrel|mesh-list
102114156|NCT03354494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102114157|NCT03354494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102114158|NCT03354494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102114159|NCT03354494|Contraceptive Agents|contraceptive agents|mesh-ancestor
102114160|NCT03354494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102114161|NCT03354494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114162|NCT03354494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102114163|NCT03354494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102114164|NCT03354494|Progestins|progestins|mesh-ancestor
102114165|NCT03354494|Hormones|hormones|mesh-ancestor
102114166|NCT03354494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102114167|NCT05530954|Calcium|calcium|mesh-list
102114168|NCT05530954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102114169|NCT05530954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114170|NCT03354338|Amoxicillin|amoxicillin|mesh-list
102114171|NCT03354338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102114172|NCT03354338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102114173|NCT02304822|Ciprofloxacin|ciprofloxacin|mesh-list
102114174|NCT02304822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102114175|NCT02304822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102114176|NCT02304822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102114177|NCT02304822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102114178|NCT02304822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102114179|NCT02304822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114180|NCT02304822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102114181|NCT02304822|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102114182|NCT02304822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102114183|NCT02309424|Acetic Acid|acetic acid|mesh-list
102114184|NCT02309424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102114185|NCT02309424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102114186|NCT03506178|Phenylephrine|phenylephrine|mesh-list
102114187|NCT03506178|Oxymetazoline|oxymetazoline|mesh-list
102114188|NCT03506178|Menthol|menthol|mesh-list
102114189|NCT03506178|Antipruritics|antipruritics|mesh-ancestor
102114190|NCT03506178|Dermatologic Agents|dermatologic agents|mesh-ancestor
102114191|NCT03506178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101567747|NCT02437279|Nivolumab|nivolumab|mesh-list
102114192|NCT03506178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102114193|NCT03506178|Adrenergic Agents|adrenergic agents|mesh-ancestor
102114194|NCT03506178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102114195|NCT03506178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114196|NCT03506178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114197|NCT03506178|Sympathomimetics|sympathomimetics|mesh-ancestor
102114198|NCT03506178|Autonomic Agents|autonomic agents|mesh-ancestor
102114199|NCT03506178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102114200|NCT03506178|Nasal Decongestants|nasal decongestants|mesh-ancestor
102114201|NCT03506178|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102114202|NCT03506178|Respiratory System Agents|respiratory system agents|mesh-ancestor
102114203|NCT03506178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102114204|NCT03506178|Mydriatics|mydriatics|mesh-ancestor
102114205|NCT03506178|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102114206|NCT03506178|Protective Agents|protective agents|mesh-ancestor
102114207|NCT05210374|Copper|copper|mesh-list
102114208|NCT05210374|Doxorubicin|doxorubicin|mesh-list
102114209|NCT05210374|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102114210|NCT05210374|Disulfiram|disulfiram|mesh-list
102114211|NCT05210374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102114212|NCT05210374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102114213|NCT05210374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102114214|NCT05210374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102114215|NCT05210374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102114216|NCT05210374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114217|NCT05210374|Trace Elements|trace elements|mesh-ancestor
102114218|NCT05210374|Micronutrients|micronutrients|mesh-ancestor
102114219|NCT05210374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114220|NCT05210374|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102114221|NCT05210374|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
102114222|NCT02578186|Diphenhydramine|diphenhydramine|mesh-list
102114223|NCT02578186|Promethazine|promethazine|mesh-list
102114224|NCT02578186|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102114225|NCT02578186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102114226|NCT02578186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102114227|NCT02578186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114228|NCT02578186|Anesthetics, Local|anesthetics, local|mesh-ancestor
102114229|NCT02578186|Anesthetics|anesthetics|mesh-ancestor
102114230|NCT02578186|Sensory System Agents|sensory system agents|mesh-ancestor
102114231|NCT02578186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102114232|NCT02578186|Antiemetics|antiemetics|mesh-ancestor
102114233|NCT02578186|Autonomic Agents|autonomic agents|mesh-ancestor
102114234|NCT02578186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102114235|NCT02578186|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102114236|NCT02578186|Histamine Antagonists|histamine antagonists|mesh-ancestor
102114237|NCT02578186|Histamine Agents|histamine agents|mesh-ancestor
102114238|NCT02578186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102114239|NCT02578186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114240|NCT02578186|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102114241|NCT02578186|Antipruritics|antipruritics|mesh-ancestor
102114242|NCT02578186|Dermatologic Agents|dermatologic agents|mesh-ancestor
102114243|NCT04128436|Progesterone|progesterone|mesh-list
102114244|NCT04128436|Progestins|progestins|mesh-ancestor
102114245|NCT04128436|Hormones|hormones|mesh-ancestor
102114246|NCT04128436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102114247|NCT04128436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114248|NCT02309658|Cisplatin|cisplatin|mesh-list
102114249|NCT02309658|Gemcitabine|gemcitabine|mesh-list
102114250|NCT02309658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102114251|NCT02309658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102114252|NCT02309658|Antimetabolites|antimetabolites|mesh-ancestor
102114253|NCT02309658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114254|NCT05532280|Etoricoxib|etoricoxib|mesh-list
102114255|NCT05532280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102114256|NCT05532280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102114257|NCT05532280|Analgesics|analgesics|mesh-ancestor
102114258|NCT05532280|Sensory System Agents|sensory system agents|mesh-ancestor
102114259|NCT05532280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102114260|NCT05532280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114261|NCT05532280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102114262|NCT05532280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102114263|NCT05532280|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102114264|NCT05532280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102114265|NCT05532280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102114266|NCT05532280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114267|NCT04517162|Povidone|povidone|mesh-list
102114268|NCT04517162|Plasma Substitutes|plasma substitutes|mesh-ancestor
102114269|NCT04517162|Blood Substitutes|blood substitutes|mesh-ancestor
102114271|NCT02155023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102114272|NCT02155023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102114273|NCT02155023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114274|NCT02163213|Immunoglobulins|immunoglobulins|mesh-list
102114275|NCT02163213|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102114276|NCT02163213|Antibodies|antibodies|mesh-list
102114277|NCT02163213|Immunologic Factors|immunologic factors|mesh-ancestor
102114278|NCT02163213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114279|NCT04443920|Tranexamic Acid|tranexamic acid|mesh-list
102114280|NCT04443920|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102114281|NCT04443920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102114282|NCT04443920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114283|NCT04443920|Hemostatics|hemostatics|mesh-ancestor
102114284|NCT04443920|Coagulants|coagulants|mesh-ancestor
102114285|NCT03359018|Apatinib|apatinib|mesh-list
102114286|NCT03359018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102114287|NCT03359018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102114288|NCT03359018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102114289|NCT03359018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114290|NCT05530252|Minocycline|minocycline|mesh-list
102114291|NCT05530252|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102114292|NCT05530252|Anti-Infective Agents|anti-infective agents|mesh-list
102114293|NCT02163291|Paclitaxel|paclitaxel|mesh-list
102114294|NCT02163291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102114295|NCT02163291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102114296|NCT02163291|Tubulin Modulators|tubulin modulators|mesh-ancestor
102114297|NCT02163291|Antimitotic Agents|antimitotic agents|mesh-ancestor
102114298|NCT02163291|Mitosis Modulators|mitosis modulators|mesh-ancestor
102114299|NCT02163291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114300|NCT03505788|Acetazolamide|acetazolamide|mesh-list
102114301|NCT03505788|Anticonvulsants|anticonvulsants|mesh-ancestor
102114302|NCT03505788|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102114303|NCT03505788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102114304|NCT03505788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114305|NCT03505788|Diuretics|diuretics|mesh-ancestor
102114306|NCT03505788|Natriuretic Agents|natriuretic agents|mesh-ancestor
102114307|NCT03505788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114308|NCT02309970|Aspirin|aspirin|mesh-list
102114309|NCT02309970|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102114310|NCT02309970|Warfarin|warfarin|mesh-list
102114311|NCT02309970|Rivaroxaban|rivaroxaban|mesh-list
102114312|NCT02309970|Dabigatran|dabigatran|mesh-list
102114313|NCT02309970|Apixaban|apixaban|mesh-list
102114314|NCT02309970|Clopidogrel|clopidogrel|mesh-list
102114315|NCT02309970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102114316|NCT02309970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102114317|NCT02309970|Analgesics|analgesics|mesh-ancestor
102114318|NCT02309970|Sensory System Agents|sensory system agents|mesh-ancestor
102114319|NCT02309970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102114320|NCT02309970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114321|NCT02309970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102114322|NCT02309970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102114323|NCT02309970|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102114324|NCT02309970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102114325|NCT02309970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114326|NCT02309970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102114327|NCT02309970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102114328|NCT02309970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102114329|NCT02309970|Antipyretics|antipyretics|mesh-ancestor
102114330|NCT02309970|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102114331|NCT02309970|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102114332|NCT02309970|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102114333|NCT02309970|Purinergic Agents|purinergic agents|mesh-ancestor
102114334|NCT02309970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102114335|NCT02309970|Anticoagulants|anticoagulants|mesh-ancestor
102114336|NCT02309970|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102114337|NCT02309970|Antithrombins|antithrombins|mesh-ancestor
102114338|NCT02309970|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102114339|NCT02309970|Protease Inhibitors|protease inhibitors|mesh-ancestor
102114340|NCT03353948|Metformin|metformin|mesh-list
102114341|NCT03353948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102114342|NCT03353948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114343|NCT02161653|Pyridoxine|pyridoxine|mesh-list
102114344|NCT02161653|Prednisone|prednisone|mesh-list
102114345|NCT02161653|Pentoxifylline|pentoxifylline|mesh-list
102114346|NCT02161653|Metadoxine|metadoxine|mesh-list
102114347|NCT02161653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102114348|NCT02161653|Glucocorticoids|glucocorticoids|mesh-ancestor
102114349|NCT02161653|Hormones|hormones|mesh-ancestor
102114350|NCT02161653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102114351|NCT02161653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114352|NCT02161653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102114353|NCT02161653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102114354|NCT02161653|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102114355|NCT02161653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102114356|NCT02161653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114357|NCT02161653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102114358|NCT02161653|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102114359|NCT02161653|Protective Agents|protective agents|mesh-ancestor
102114360|NCT02161653|Vasodilator Agents|vasodilator agents|mesh-ancestor
102114361|NCT02161653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102114362|NCT02161653|Antioxidants|antioxidants|mesh-ancestor
102114363|NCT02161653|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102114364|NCT02161653|Vitamin B Complex|vitamin b complex|mesh-ancestor
102114365|NCT02161653|Vitamins|vitamins|mesh-ancestor
102114366|NCT02161653|Micronutrients|micronutrients|mesh-ancestor
102114367|NCT02576938|Triamcinolone|triamcinolone|mesh-list
102114368|NCT02576938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102114369|NCT02576938|Glucocorticoids|glucocorticoids|mesh-ancestor
102114370|NCT02576938|Hormones|hormones|mesh-ancestor
102114371|NCT02576938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102114372|NCT02576938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114373|NCT02305836|Donepezil|donepezil|mesh-list
102114374|NCT02305836|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102114375|NCT02305836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102114376|NCT02305836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114377|NCT02305836|Cholinergic Agents|cholinergic agents|mesh-ancestor
102114378|NCT02305836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102114379|NCT02305836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114380|NCT02305836|Nootropic Agents|nootropic agents|mesh-ancestor
102114381|NCT03503136|Cisplatin|cisplatin|mesh-list
102114382|NCT03503136|Docetaxel|docetaxel|mesh-list
102114383|NCT03503136|Fluorouracil|fluorouracil|mesh-list
102114384|NCT03503136|Capecitabine|capecitabine|mesh-list
102114385|NCT03503136|Nedaplatin|nedaplatin|mesh-list
102114386|NCT03503136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102114387|NCT03503136|Tubulin Modulators|tubulin modulators|mesh-ancestor
102114388|NCT03503136|Antimitotic Agents|antimitotic agents|mesh-ancestor
102114389|NCT03503136|Mitosis Modulators|mitosis modulators|mesh-ancestor
102114390|NCT03503136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114391|NCT03503136|Antimetabolites|antimetabolites|mesh-ancestor
102114392|NCT03503136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102114393|NCT03503136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102114394|NCT03503136|Immunologic Factors|immunologic factors|mesh-ancestor
102114395|NCT03503136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114396|NCT02305992|Bupivacaine|bupivacaine|mesh-list
102114397|NCT02305992|Anesthetics, Local|anesthetics, local|mesh-list
102114398|NCT02305992|Anesthetics|anesthetics|mesh-list
102114399|NCT02305992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102114400|NCT02305992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114401|NCT02305992|Sensory System Agents|sensory system agents|mesh-ancestor
102114402|NCT02305992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102114403|NCT03355352|Sufentanil|sufentanil|mesh-list
102114404|NCT03355352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102114405|NCT03355352|Narcotics|narcotics|mesh-ancestor
102114406|NCT03355352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102114407|NCT03355352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114408|NCT03355352|Analgesics|analgesics|mesh-ancestor
102114409|NCT03355352|Sensory System Agents|sensory system agents|mesh-ancestor
102114410|NCT03355352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102114411|NCT03355352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102114412|NCT03355352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102114413|NCT03355352|Anesthetics, General|anesthetics, general|mesh-ancestor
102114414|NCT03355352|Anesthetics|anesthetics|mesh-ancestor
102114415|NCT05529940|Folfirinox|folfirinox|mesh-list
102114416|NCT05529940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102114417|NCT04463784|Efavirenz|efavirenz|mesh-list
102114418|NCT04463784|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102114419|NCT04463784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102114420|NCT04463784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102114421|NCT04463784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535853|NCT03000257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114422|NCT04463784|Antiviral Agents|antiviral agents|mesh-ancestor
101505280|NCT00513201|Insulin|insulin|mesh-list
102114423|NCT04463784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102114424|NCT04463784|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102114425|NCT04463784|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102114426|NCT04463784|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102114427|NCT04463784|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102114428|NCT04463784|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102114429|NCT04463784|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102114430|NCT02310360|Fallypride|fallypride|mesh-list
102114431|NCT02310360|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102114432|NCT02310360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102114433|NCT02310360|Dopamine Agents|dopamine agents|mesh-ancestor
102114434|NCT02310360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102114435|NCT02310360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114436|NCT02310360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114437|NCT03353480|Azithromycin|azithromycin|mesh-list
102114438|NCT03353480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102114439|NCT03353480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102114440|NCT02306070|Metformin|metformin|mesh-list
102114441|NCT02306070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102114442|NCT02306070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114443|NCT03502824|Anti-Infective Agents|anti-infective agents|mesh-list
102114444|NCT03502824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102114445|NCT03353324|Bevacizumab|bevacizumab|mesh-list
102114446|NCT03353324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102114447|NCT03353324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102114448|NCT03353324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102114449|NCT03353324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102114450|NCT03353324|Growth Substances|growth substances|mesh-ancestor
102114451|NCT03353324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114452|NCT03353324|Growth Inhibitors|growth inhibitors|mesh-ancestor
102114453|NCT03354962|Nivolumab|nivolumab|mesh-list
102114454|NCT03354962|Ipilimumab|ipilimumab|mesh-list
102114455|NCT03354962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102114456|NCT03354962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102114457|NCT03354962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102013094|NCT02478424|Immunologic Factors|immunologic factors|mesh-ancestor
102114458|NCT03354962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114459|NCT04511468|Copper|copper|mesh-list
102114460|NCT04511468|Chromium|chromium|mesh-list
102114461|NCT04511468|Micronutrients|micronutrients|mesh-ancestor
102114462|NCT04511468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114463|NCT04511468|Trace Elements|trace elements|mesh-ancestor
102114464|NCT05531422|Fentanyl|fentanyl|mesh-list
102114465|NCT05531422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102114466|NCT05531422|Narcotics|narcotics|mesh-ancestor
102114467|NCT05531422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102114468|NCT05531422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114469|NCT05531422|Analgesics|analgesics|mesh-ancestor
102114470|NCT05531422|Sensory System Agents|sensory system agents|mesh-ancestor
102114471|NCT05531422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102114472|NCT05531422|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102114473|NCT05531422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102114474|NCT05531422|Anesthetics, General|anesthetics, general|mesh-ancestor
102114475|NCT05531422|Anesthetics|anesthetics|mesh-ancestor
102114476|NCT03354806|Analgesics|analgesics|mesh-list
102114477|NCT03354806|Sensory System Agents|sensory system agents|mesh-ancestor
102114478|NCT03354806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102114479|NCT03354806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114480|NCT05529082|Analgesics, Opioid|analgesics, opioid|mesh-list
102114481|NCT05529082|Narcotics|narcotics|mesh-ancestor
102114482|NCT05529082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102114483|NCT05529082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114484|NCT05529082|Analgesics|analgesics|mesh-ancestor
102114485|NCT05529082|Sensory System Agents|sensory system agents|mesh-ancestor
102114486|NCT05529082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102114487|NCT03350126|Nivolumab|nivolumab|mesh-list
102114488|NCT03350126|Ipilimumab|ipilimumab|mesh-list
102114489|NCT03350126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102114490|NCT03350126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102114491|NCT03350126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102114492|NCT03350126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114493|NCT05285878|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102114494|NCT05285878|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102114495|NCT05285878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114496|NCT05285878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102114497|NCT05285878|Immunologic Factors|immunologic factors|mesh-ancestor
102114498|NCT05285878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114500|NCT02314182|Capecitabine|capecitabine|mesh-list
102114501|NCT02314182|Oxaliplatin|oxaliplatin|mesh-list
102114502|NCT02314182|Irinotecan|irinotecan|mesh-list
102114503|NCT02314182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102114504|NCT02314182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102114505|NCT02314182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102114506|NCT02314182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102114507|NCT02314182|Growth Substances|growth substances|mesh-ancestor
102114508|NCT02314182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114509|NCT02314182|Growth Inhibitors|growth inhibitors|mesh-ancestor
102114510|NCT02314182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102114511|NCT02314182|Antimetabolites|antimetabolites|mesh-ancestor
102114512|NCT02314182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114513|NCT02314182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102114514|NCT02314182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102114515|NCT02314182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102114516|NCT05531344|Tamsulosin|tamsulosin|mesh-list
102114517|NCT05531344|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102114518|NCT05531344|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102114519|NCT05531344|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102114520|NCT05531344|Adrenergic Agents|adrenergic agents|mesh-ancestor
102114521|NCT05531344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102114522|NCT05531344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114523|NCT05531344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114524|NCT05531344|Urological Agents|urological agents|mesh-ancestor
102114525|NCT05531266|Glucocorticoids|glucocorticoids|mesh-list
102114526|NCT05531266|Hormones|hormones|mesh-ancestor
102114527|NCT05531266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102114528|NCT05531266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114529|NCT03349658|Anesthetics|anesthetics|mesh-list
102114530|NCT03349658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102114531|NCT03349658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114532|NCT03353012|Levonorgestrel|levonorgestrel|mesh-list
102114533|NCT03353012|Etonogestrel|etonogestrel|mesh-list
102114534|NCT03353012|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102114535|NCT03353012|Contraceptive Agents|contraceptive agents|mesh-ancestor
102114536|NCT03353012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102114537|NCT03353012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114538|NCT03353012|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102114539|NCT03353012|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102114540|NCT03353012|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102114541|NCT04462614|Heparin|heparin|mesh-list
102114542|NCT04462614|Anticoagulants|anticoagulants|mesh-ancestor
102114543|NCT04462614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102114544|NCT04462614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102114545|NCT04462614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114546|NCT03349424|Somatostatin|somatostatin|mesh-list
102114547|NCT03349424|Hormones|hormones|mesh-ancestor
102114548|NCT03349424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102114549|NCT03349424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114550|NCT03349346|Rituximab|rituximab|mesh-list
102114551|NCT03349346|Carboplatin|carboplatin|mesh-list
102114552|NCT03349346|Etoposide|etoposide|mesh-list
102114553|NCT03349346|Ifosfamide|ifosfamide|mesh-list
102114554|NCT03349346|Idelalisib|idelalisib|mesh-list
102114555|NCT03349346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102114556|NCT03349346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102114557|NCT03349346|Immunologic Factors|immunologic factors|mesh-ancestor
102114558|NCT03349346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114559|NCT03349346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102114560|NCT03349346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102114561|NCT03349346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102114562|NCT03349346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102114563|NCT03349346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102114564|NCT03349346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114565|NCT03349346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102114566|NCT03349346|Alkylating Agents|alkylating agents|mesh-ancestor
102114567|NCT03502434|Petrolatum|petrolatum|mesh-list
102114568|NCT03502434|Emollients|emollients|mesh-ancestor
102114569|NCT03502434|Dermatologic Agents|dermatologic agents|mesh-ancestor
102114570|NCT03352700|Dyclonine|dyclonine|mesh-list
102114571|NCT03352700|Anesthetics, Local|anesthetics, local|mesh-ancestor
102114572|NCT03352700|Anesthetics|anesthetics|mesh-ancestor
102114573|NCT03352700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102114574|NCT03352700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114575|NCT03352700|Sensory System Agents|sensory system agents|mesh-ancestor
102114576|NCT03352700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102114577|NCT05522998|Propofol|propofol|mesh-list
102114578|NCT05522998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102114579|NCT05522998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102114580|NCT05522998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114581|NCT05522998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102114582|NCT05522998|Anesthetics, General|anesthetics, general|mesh-ancestor
102114583|NCT05522998|Anesthetics|anesthetics|mesh-ancestor
102114584|NCT03349190|Ulipristal acetate|ulipristal acetate|mesh-list
102114585|NCT03349190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102114586|NCT03349190|Contraceptive Agents|contraceptive agents|mesh-ancestor
102114587|NCT03349190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102114588|NCT03349190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114589|NCT03349190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102114590|NCT03498534|Isoniazid|isoniazid|mesh-list
102114591|NCT03498534|Antitubercular Agents|antitubercular agents|mesh-ancestor
102114592|NCT03498534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102114593|NCT03498534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102114594|NCT03498534|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102114595|NCT03498534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102114596|NCT03498534|Antimetabolites|antimetabolites|mesh-ancestor
102114597|NCT03498534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114598|NCT03498534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102114599|NCT03502356|Azithromycin|azithromycin|mesh-list
102114600|NCT03502356|Cefazolin|cefazolin|mesh-list
102114601|NCT03502356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102114602|NCT03502356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102114603|NCT03498456|Amoxicillin|amoxicillin|mesh-list
102114604|NCT03498456|Clarithromycin|clarithromycin|mesh-list
102114605|NCT03498456|Lansoprazole|lansoprazole|mesh-list
102114606|NCT03498456|Dexlansoprazole|dexlansoprazole|mesh-list
102114607|NCT03498456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102114608|NCT03498456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102114609|NCT03498456|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102114610|NCT03498456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102114611|NCT03498456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114612|NCT03498456|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102114613|NCT03498456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102114614|NCT03498456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102114615|NCT03498456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102114616|NCT03498456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102114617|NCT02317146|Magnesium Sulfate|magnesium sulfate|mesh-list
102114618|NCT02317146|Analgesics|analgesics|mesh-ancestor
102114619|NCT02317146|Sensory System Agents|sensory system agents|mesh-ancestor
102114620|NCT02317146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102114621|NCT02317146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114622|NCT02317146|Anesthetics|anesthetics|mesh-ancestor
102114623|NCT02317146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102114624|NCT02317146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102114625|NCT02317146|Anticonvulsants|anticonvulsants|mesh-ancestor
102114626|NCT02317146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102114627|NCT02317146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102114628|NCT02317146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114629|NCT02317146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102114630|NCT02317146|Tocolytic Agents|tocolytic agents|mesh-ancestor
102114631|NCT02317146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102114632|NCT05528146|Psyllium|psyllium|mesh-list
102114633|NCT05528146|Cathartics|cathartics|mesh-ancestor
102114634|NCT05528146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102114635|NCT03349112|Lidocaine|lidocaine|mesh-list
102114636|NCT03349112|Anesthetics, Local|anesthetics, local|mesh-ancestor
102114637|NCT03349112|Anesthetics|anesthetics|mesh-ancestor
102114638|NCT03349112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102114639|NCT03349112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114640|NCT03349112|Sensory System Agents|sensory system agents|mesh-ancestor
102114641|NCT03349112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102114642|NCT03349112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102114643|NCT03349112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102114644|NCT03349112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102114645|NCT03349112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102114646|NCT03349112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114648|NCT03498222|Pemetrexed|pemetrexed|mesh-list
102535854|NCT02945813|Metformin|metformin|mesh-list
102114649|NCT03498222|Atezolizumab|atezolizumab|mesh-list
102114650|NCT03498222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102114651|NCT03498222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102114652|NCT03498222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114653|NCT03498222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102114654|NCT03498222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102114655|NCT03498222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102114656|NCT03498222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102114657|NCT02518022|Insulin|insulin|mesh-list
102114658|NCT02518022|Insulin Lispro|insulin lispro|mesh-list
102114659|NCT02518022|Insulin Aspart|insulin aspart|mesh-list
102114660|NCT02518022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102114661|NCT02518022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114662|NCT05504252|Fluorouracil|fluorouracil|mesh-list
102114663|NCT05504252|Oxaliplatin|oxaliplatin|mesh-list
102114664|NCT05504252|Nivolumab|nivolumab|mesh-list
102114665|NCT05504252|Antimetabolites|antimetabolites|mesh-ancestor
102114666|NCT05504252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114667|NCT05504252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102114668|NCT05504252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102114669|NCT05504252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102114670|NCT05504252|Immunologic Factors|immunologic factors|mesh-ancestor
102114671|NCT05504252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013300|NCT03772067|Insulin|insulin|mesh-list
102114672|NCT05504252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102114673|NCT05504252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102114674|NCT03497988|Oxytocin|oxytocin|mesh-list
102114675|NCT03497988|Oxytocics|oxytocics|mesh-ancestor
102114676|NCT03497988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102114677|NCT03497988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114678|NCT04610476|Sulfasalazine|sulfasalazine|mesh-list
102114679|NCT04610476|Prednisolone|prednisolone|mesh-list
102114680|NCT04610476|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102114681|NCT04610476|Methylprednisolone|methylprednisolone|mesh-list
102114682|NCT04610476|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102114683|NCT04610476|Prednisolone acetate|prednisolone acetate|mesh-list
102114684|NCT04610476|Adalimumab|adalimumab|mesh-list
102114685|NCT04610476|Infliximab|infliximab|mesh-list
102114686|NCT04610476|Etanercept|etanercept|mesh-list
102114687|NCT04610476|Apremilast|apremilast|mesh-list
102114688|NCT04610476|Golimumab|golimumab|mesh-list
102114689|NCT04610476|Certolizumab Pegol|certolizumab pegol|mesh-list
102114690|NCT04610476|Methotrexate|methotrexate|mesh-list
102114691|NCT04610476|Abatacept|abatacept|mesh-list
102114692|NCT04610476|Ustekinumab|ustekinumab|mesh-list
102114693|NCT04610476|Ixekizumab|ixekizumab|mesh-list
102114694|NCT04610476|Tofacitinib|tofacitinib|mesh-list
102114695|NCT04610476|Leflunomide|leflunomide|mesh-list
102114696|NCT04610476|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102114697|NCT04610476|Prednisolone phosphate|prednisolone phosphate|mesh-list
102114698|NCT04610476|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102114699|NCT04610476|Abortifacient Agents|abortifacient agents|mesh-ancestor
102114700|NCT04610476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102114701|NCT04610476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114702|NCT04610476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102114703|NCT04610476|Antimetabolites|antimetabolites|mesh-ancestor
102114704|NCT04610476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114705|NCT04610476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102114706|NCT04610476|Dermatologic Agents|dermatologic agents|mesh-ancestor
102114707|NCT04610476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102114708|NCT04610476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102114709|NCT04610476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102114710|NCT04610476|Immunologic Factors|immunologic factors|mesh-ancestor
102114711|NCT04610476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102114712|NCT04610476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102114713|NCT04610476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102114714|NCT04610476|Glucocorticoids|glucocorticoids|mesh-ancestor
102114715|NCT04610476|Hormones|hormones|mesh-ancestor
102114716|NCT04610476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102114717|NCT04610476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102114718|NCT04610476|Antiemetics|antiemetics|mesh-ancestor
102114719|NCT04610476|Autonomic Agents|autonomic agents|mesh-ancestor
102114720|NCT04610476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102114721|NCT04610476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102114722|NCT04610476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102114723|NCT04610476|Protective Agents|protective agents|mesh-ancestor
102114724|NCT04610476|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102114725|NCT04610476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102114726|NCT04610476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102114727|NCT04610476|Analgesics|analgesics|mesh-ancestor
102114728|NCT04610476|Sensory System Agents|sensory system agents|mesh-ancestor
102114729|NCT04610476|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102114730|NCT04610476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102114731|NCT04610476|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102114732|NCT04610476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102013374|NCT03770663|Tacrolimus|tacrolimus|mesh-list
102114733|NCT04610476|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102114734|NCT04610476|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102114735|NCT04610476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102114736|NCT03348800|Anesthetics|anesthetics|mesh-list
102114737|NCT03348800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102114738|NCT03348800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114739|NCT02314806|Clindamycin|clindamycin|mesh-list
102114740|NCT02314806|Clindamycin palmitate|clindamycin palmitate|mesh-list
102114741|NCT02314806|Clindamycin phosphate|clindamycin phosphate|mesh-list
102114742|NCT02314806|Gentamicins|gentamicins|mesh-list
102114743|NCT02314806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102114744|NCT02314806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102114745|NCT02314806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102114746|NCT02314806|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102114747|NCT02314806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102114748|NCT02314806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114749|NCT00709202|Betahistine|betahistine|mesh-list
102114750|NCT00709202|Vasodilator Agents|vasodilator agents|mesh-ancestor
102114751|NCT00709202|Histamine Agonists|histamine agonists|mesh-ancestor
102114752|NCT00709202|Histamine Agents|histamine agents|mesh-ancestor
102114753|NCT00709202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102114754|NCT00709202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114755|NCT00709202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114756|NCT05517538|Botulinum Toxins|botulinum toxins|mesh-list
102114757|NCT05517538|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102114758|NCT05517538|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102114759|NCT05517538|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102114760|NCT05517538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102114761|NCT05517538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114762|NCT05517538|Cholinergic Agents|cholinergic agents|mesh-ancestor
102114763|NCT05517538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102114764|NCT05517538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114765|NCT05517538|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102114766|NCT05517538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102114767|NCT02321280|Denosumab|denosumab|mesh-list
102114768|NCT02321280|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102114769|NCT02321280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114770|NCT05527444|Thalidomide|thalidomide|mesh-list
102114771|NCT05527444|Adalimumab|adalimumab|mesh-list
102114772|NCT05527444|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102114773|NCT05527444|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102114774|NCT05527444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102114775|NCT05527444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102114776|NCT05527444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102114777|NCT05527444|Immunologic Factors|immunologic factors|mesh-ancestor
102114778|NCT05527444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114779|NCT05527444|Leprostatic Agents|leprostatic agents|mesh-ancestor
102114780|NCT05527444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102114781|NCT05527444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102114782|NCT05527444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102114783|NCT05527444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102114784|NCT05527444|Growth Substances|growth substances|mesh-ancestor
102114785|NCT05527444|Growth Inhibitors|growth inhibitors|mesh-ancestor
102114786|NCT05527444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102114787|NCT05439902|Tamsulosin|tamsulosin|mesh-list
102114788|NCT05439902|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102114789|NCT05439902|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102114790|NCT05439902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102114791|NCT05439902|Adrenergic Agents|adrenergic agents|mesh-ancestor
102114792|NCT05439902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102114793|NCT05439902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114794|NCT05439902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114795|NCT05439902|Urological Agents|urological agents|mesh-ancestor
102114796|NCT02315118|Rituximab|rituximab|mesh-list
102114797|NCT02315118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102114798|NCT02315118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102114799|NCT02315118|Immunologic Factors|immunologic factors|mesh-ancestor
102114800|NCT02315118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114801|NCT02315118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102114802|NCT03122756|Dexamethasone|dexamethasone|mesh-list
102114803|NCT03122756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102114804|NCT03122756|Antiemetics|antiemetics|mesh-ancestor
102114805|NCT03122756|Autonomic Agents|autonomic agents|mesh-ancestor
102114806|NCT03122756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102114807|NCT03122756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114808|NCT03122756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102114809|NCT03122756|Glucocorticoids|glucocorticoids|mesh-ancestor
102114810|NCT03122756|Hormones|hormones|mesh-ancestor
102114811|NCT03122756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102114812|NCT03122756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102114813|NCT03122756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102114814|NCT03122678|Thiamine|thiamine|mesh-list
102114815|NCT03122678|Vitamins|vitamins|mesh-ancestor
102114816|NCT03122678|Micronutrients|micronutrients|mesh-ancestor
102114817|NCT03122678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114818|NCT03122678|Vitamin B Complex|vitamin b complex|mesh-ancestor
102114819|NCT02317770|Lidocaine|lidocaine|mesh-list
102114820|NCT02317770|Anesthetics, Local|anesthetics, local|mesh-ancestor
102114821|NCT02317770|Anesthetics|anesthetics|mesh-ancestor
102114822|NCT02317770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102114823|NCT02317770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114824|NCT02317770|Sensory System Agents|sensory system agents|mesh-ancestor
102114825|NCT02317770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102114826|NCT02317770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102114827|NCT02317770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102114828|NCT02317770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102114829|NCT02317770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102114830|NCT02317770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114831|NCT05527054|Diuretics|diuretics|mesh-list
102114832|NCT05527054|Natriuretic Agents|natriuretic agents|mesh-ancestor
102114833|NCT05527054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114834|NCT04506242|Apatinib|apatinib|mesh-list
102114835|NCT04506242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102114836|NCT04506242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102114837|NCT04506242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102114838|NCT04506242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114839|NCT05526898|Triamcinolone|triamcinolone|mesh-list
102114840|NCT05526898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102114841|NCT05526898|Glucocorticoids|glucocorticoids|mesh-ancestor
102114842|NCT05526898|Hormones|hormones|mesh-ancestor
102114843|NCT05526898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102114844|NCT05526898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114845|NCT05526820|Vaccines|vaccines|mesh-list
102114846|NCT05526820|Immunologic Factors|immunologic factors|mesh-ancestor
102114847|NCT05526820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114848|NCT03352076|Danazol|danazol|mesh-list
102114849|NCT03352076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102114850|NCT03352076|Hormone Antagonists|hormone antagonists|mesh-ancestor
102114851|NCT03352076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102114852|NCT03352076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114853|NCT03497442|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102114854|NCT03497442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102114855|NCT03497442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102114856|NCT03497442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102114857|NCT03497442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102114858|NCT03497442|Adrenergic Agents|adrenergic agents|mesh-ancestor
102114859|NCT03497442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102114860|NCT03497442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114861|NCT03497442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114862|NCT02738580|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
102114863|NCT02738580|Hormones|hormones|mesh-ancestor
102114864|NCT02738580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102114865|NCT02738580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114866|NCT03497364|Bupivacaine|bupivacaine|mesh-list
102114867|NCT03497364|Ropivacaine|ropivacaine|mesh-list
102114868|NCT03497364|Anesthetics, Local|anesthetics, local|mesh-ancestor
102114869|NCT03497364|Anesthetics|anesthetics|mesh-ancestor
102114870|NCT03497364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102114871|NCT03497364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114872|NCT03497364|Sensory System Agents|sensory system agents|mesh-ancestor
102114873|NCT03497364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102114875|NCT03348254|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102114876|NCT03348254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102114877|NCT03348254|Antitubercular Agents|antitubercular agents|mesh-ancestor
102114878|NCT05516446|Chromium|chromium|mesh-list
102114879|NCT05516446|Paclitaxel|paclitaxel|mesh-list
102114880|NCT05516446|Everolimus|everolimus|mesh-list
102114881|NCT05516446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102114882|NCT05516446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102114883|NCT05516446|Tubulin Modulators|tubulin modulators|mesh-ancestor
102114884|NCT05516446|Antimitotic Agents|antimitotic agents|mesh-ancestor
102114885|NCT05516446|Mitosis Modulators|mitosis modulators|mesh-ancestor
102114886|NCT05516446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114887|NCT05516446|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102114888|NCT05516446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102114889|NCT05516446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102114890|NCT05516446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102114891|NCT05516446|Immunologic Factors|immunologic factors|mesh-ancestor
102114892|NCT05516446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114893|NCT05516446|Trace Elements|trace elements|mesh-ancestor
102114894|NCT05516446|Micronutrients|micronutrients|mesh-ancestor
102114895|NCT02318082|Aldesleukin|aldesleukin|mesh-list
102114896|NCT02318082|Interleukin-2|interleukin-2|mesh-list
102114897|NCT02318082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102114898|NCT02318082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102114899|NCT02318082|Analgesics|analgesics|mesh-ancestor
102114900|NCT02318082|Sensory System Agents|sensory system agents|mesh-ancestor
102114901|NCT02318082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102114902|NCT02318082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114903|NCT02318082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102114904|NCT02318082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102114905|NCT02318082|Antiviral Agents|antiviral agents|mesh-ancestor
102114906|NCT02318082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102114907|NCT03348098|Paclitaxel|paclitaxel|mesh-list
102114908|NCT03348098|Apatinib|apatinib|mesh-list
102114909|NCT03348098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102114910|NCT03348098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102114911|NCT03348098|Tubulin Modulators|tubulin modulators|mesh-ancestor
102114912|NCT03348098|Antimitotic Agents|antimitotic agents|mesh-ancestor
102114913|NCT03348098|Mitosis Modulators|mitosis modulators|mesh-ancestor
102114914|NCT03348098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114915|NCT03348098|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102114916|NCT03348098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102114917|NCT03351842|Cisplatin|cisplatin|mesh-list
102114918|NCT03351842|Carboplatin|carboplatin|mesh-list
102114919|NCT03351842|Pemetrexed|pemetrexed|mesh-list
102114920|NCT03351842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102114921|NCT03351842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102114922|NCT03351842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114923|NCT03351842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102114924|NCT03351842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102114925|NCT02447406|Docetaxel|docetaxel|mesh-list
102114926|NCT02447406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102114927|NCT02447406|Tubulin Modulators|tubulin modulators|mesh-ancestor
102114928|NCT02447406|Antimitotic Agents|antimitotic agents|mesh-ancestor
102114929|NCT02447406|Mitosis Modulators|mitosis modulators|mesh-ancestor
102114930|NCT02447406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114931|NCT04505228|Atropine|atropine|mesh-list
102114932|NCT04505228|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102114933|NCT04505228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102114934|NCT04505228|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102114935|NCT04505228|Autonomic Agents|autonomic agents|mesh-ancestor
102114936|NCT04505228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102114937|NCT04505228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114938|NCT04505228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102114939|NCT04505228|Respiratory System Agents|respiratory system agents|mesh-ancestor
102114940|NCT04505228|Mydriatics|mydriatics|mesh-ancestor
102114941|NCT04505228|Parasympatholytics|parasympatholytics|mesh-ancestor
101505806|NCT04519463|Anesthetics|anesthetics|mesh-ancestor
102114942|NCT04505228|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102114943|NCT04505228|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102114944|NCT04505228|Cholinergic Agents|cholinergic agents|mesh-ancestor
102114945|NCT04505228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102114946|NCT04505228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568499|NCT01072149|Xhance|xhance|mesh-list
102114947|NCT05584826|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
102114949|NCT05584826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114950|NCT05584826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102114951|NCT05584826|Serotonin Agents|serotonin agents|mesh-ancestor
102114952|NCT05584826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102114953|NCT05584826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114954|NCT05584826|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102114955|NCT05584826|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102114956|NCT05584826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102114957|NCT05584826|Adrenergic Agents|adrenergic agents|mesh-ancestor
102114958|NCT03161028|Thioctic Acid|thioctic acid|mesh-list
102114959|NCT03161028|Antioxidants|antioxidants|mesh-ancestor
102114960|NCT03161028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114961|NCT03161028|Protective Agents|protective agents|mesh-ancestor
102114962|NCT03161028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114963|NCT03161028|Vitamin B Complex|vitamin b complex|mesh-ancestor
102114965|NCT03161028|Micronutrients|micronutrients|mesh-ancestor
102114966|NCT02322372|Bupivacaine|bupivacaine|mesh-list
102114967|NCT02322372|Anesthetics|anesthetics|mesh-ancestor
102114968|NCT02322372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102114969|NCT02322372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102114970|NCT02322372|Anesthetics, Local|anesthetics, local|mesh-ancestor
102114971|NCT02322372|Sensory System Agents|sensory system agents|mesh-ancestor
102114972|NCT02322372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102114973|NCT01376804|Valganciclovir|valganciclovir|mesh-list
102114974|NCT01376804|Antiviral Agents|antiviral agents|mesh-ancestor
102114975|NCT01376804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102114976|NCT05526118|Tenofovir|tenofovir|mesh-list
102114977|NCT05526118|Emtricitabine|emtricitabine|mesh-list
102114978|NCT05526118|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
102114979|NCT05526118|Antiviral Agents|antiviral agents|mesh-ancestor
102114980|NCT05526118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102114981|NCT05526118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102114982|NCT05526118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102114983|NCT05526118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102114984|NCT05526118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114985|NCT05526118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102114986|NCT05526118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102114987|NCT03122132|Ritonavir|ritonavir|mesh-list
102114988|NCT03122132|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102114989|NCT03122132|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102114990|NCT03122132|Protease Inhibitors|protease inhibitors|mesh-ancestor
102114991|NCT03122132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102114992|NCT03122132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102114993|NCT03122132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102114994|NCT03122132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102114995|NCT03122132|Antiviral Agents|antiviral agents|mesh-ancestor
102114996|NCT03122132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102114997|NCT03122132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102114998|NCT03122132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102114999|NCT03351686|Tranexamic Acid|tranexamic acid|mesh-list
102115000|NCT03351686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102115001|NCT03351686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102115002|NCT03351686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115003|NCT03351686|Hemostatics|hemostatics|mesh-ancestor
102115004|NCT03351686|Coagulants|coagulants|mesh-ancestor
102115005|NCT03347864|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
102115006|NCT03347864|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102115007|NCT03347864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115008|NCT02319018|Calcium, Dietary|calcium, dietary|mesh-list
102115009|NCT02319018|Leucovorin|leucovorin|mesh-list
102115010|NCT02319018|Folic Acid|folic acid|mesh-list
102115011|NCT02319018|Fluorouracil|fluorouracil|mesh-list
102115012|NCT02319018|Oxaliplatin|oxaliplatin|mesh-list
102115013|NCT02319018|Calcium|calcium|mesh-list
102115014|NCT02319018|Levoleucovorin|levoleucovorin|mesh-list
102115015|NCT02319018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102115016|NCT02319018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115017|NCT02319018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102115018|NCT02319018|Antimetabolites|antimetabolites|mesh-ancestor
102115019|NCT02319018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115020|NCT02319018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101568566|NCT04778787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102115021|NCT02319018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102115022|NCT02319018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102115023|NCT02319018|Immunologic Factors|immunologic factors|mesh-ancestor
102115024|NCT02319018|Antidotes|antidotes|mesh-ancestor
102115025|NCT02319018|Protective Agents|protective agents|mesh-ancestor
102115026|NCT02319018|Vitamin B Complex|vitamin b complex|mesh-ancestor
102115027|NCT02319018|Vitamins|vitamins|mesh-ancestor
102115028|NCT02319018|Micronutrients|micronutrients|mesh-ancestor
102115029|NCT02319018|Hematinics|hematinics|mesh-ancestor
102115030|NCT02574520|Bupivacaine|bupivacaine|mesh-list
102115031|NCT02574520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102115032|NCT02574520|Anesthetics, Local|anesthetics, local|mesh-ancestor
102115033|NCT02574520|Anesthetics|anesthetics|mesh-ancestor
102115034|NCT02574520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102115035|NCT02574520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115036|NCT02574520|Sensory System Agents|sensory system agents|mesh-ancestor
102115037|NCT02574520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102115038|NCT04425226|Pembrolizumab|pembrolizumab|mesh-list
102115039|NCT04425226|Lenvatinib|lenvatinib|mesh-list
102115040|NCT04425226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102115041|NCT04425226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102115042|NCT04425226|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102115043|NCT04425226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115044|NCT04425226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102115045|NCT04425226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102115046|NCT05520658|Fluorouracil|fluorouracil|mesh-list
102115047|NCT05520658|Digoxin|digoxin|mesh-list
102115048|NCT05520658|Furosemide|furosemide|mesh-list
102115049|NCT05520658|Antimetabolites|antimetabolites|mesh-ancestor
102115050|NCT05520658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115051|NCT05520658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102115052|NCT05520658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102115053|NCT05520658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102115054|NCT05520658|Immunologic Factors|immunologic factors|mesh-ancestor
102115055|NCT05520658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115056|NCT05520658|Diuretics|diuretics|mesh-ancestor
102115057|NCT05520658|Natriuretic Agents|natriuretic agents|mesh-ancestor
102115058|NCT05520658|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102115059|NCT05520658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102115060|NCT05520658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102115061|NCT05520658|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102115062|NCT05520658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102115063|NCT05520658|Protective Agents|protective agents|mesh-ancestor
102115064|NCT04462926|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102115065|NCT04462926|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102115066|NCT04462926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115067|NCT05140954|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
102115068|NCT05140954|Antiviral Agents|antiviral agents|mesh-ancestor
102115069|NCT05140954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102115070|NCT05140954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102115071|NCT05140954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102115072|NCT05140954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102115073|NCT05140954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115074|NCT05140954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102115075|NCT05140954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102115076|NCT03351062|Tamoxifen|tamoxifen|mesh-list
102115077|NCT03351062|Toremifene|toremifene|mesh-list
102115078|NCT03351062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102115079|NCT03351062|Hormone Antagonists|hormone antagonists|mesh-ancestor
102115080|NCT03351062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102013703|NCT04507763|Etanercept|etanercept|mesh-list
102115081|NCT03351062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115082|NCT03351062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102115083|NCT03351062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102115084|NCT03351062|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102115085|NCT03351062|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102115086|NCT03351062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102115087|NCT03496740|Bupivacaine|bupivacaine|mesh-list
102115088|NCT03496740|Anesthetics, Local|anesthetics, local|mesh-ancestor
102115089|NCT03496740|Anesthetics|anesthetics|mesh-ancestor
102115090|NCT03496740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102115091|NCT03496740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115092|NCT03496740|Sensory System Agents|sensory system agents|mesh-ancestor
102115093|NCT03496740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101505962|NCT01248468|Aspirin|aspirin|mesh-list
102115094|NCT05515822|Oxycodone|oxycodone|mesh-list
102115095|NCT05515822|Dezocine|dezocine|mesh-list
102115096|NCT05515822|Esketamine|esketamine|mesh-list
102115097|NCT05515822|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102115098|NCT05515822|Narcotics|narcotics|mesh-ancestor
102115099|NCT05515822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102115100|NCT05515822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535855|NCT02945813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102115101|NCT05515822|Analgesics|analgesics|mesh-ancestor
102115102|NCT05515822|Sensory System Agents|sensory system agents|mesh-ancestor
102115103|NCT05515822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102115104|NCT05515822|Antidepressive Agents|antidepressive agents|mesh-ancestor
102115105|NCT05515822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102115106|NCT04294654|Vortioxetine|vortioxetine|mesh-list
102115107|NCT04294654|Antidepressive Agents|antidepressive agents|mesh-ancestor
102115108|NCT04294654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102115109|NCT04294654|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102115110|NCT04294654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102115111|NCT04294654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102115112|NCT04294654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115113|NCT04294654|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102115114|NCT04294654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102115115|NCT04294654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102115116|NCT04294654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115117|NCT04294654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102115118|NCT04294654|Serotonin Agents|serotonin agents|mesh-ancestor
102115119|NCT04294654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102115120|NCT04294654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102115121|NCT04294654|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102115122|NCT04294654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102115123|NCT03496506|Selexipag|selexipag|mesh-list
102115124|NCT03496506|Clopidogrel|clopidogrel|mesh-list
102115125|NCT03496506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102115126|NCT03496506|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102115127|NCT03496506|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102115128|NCT03496506|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102115129|NCT03496506|Purinergic Agents|purinergic agents|mesh-ancestor
102115130|NCT03496506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102115131|NCT03496506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115132|NCT03496506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115133|NCT03496506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102115134|NCT04766684|Lidocaine|lidocaine|mesh-list
102115135|NCT04766684|Anesthetics, Local|anesthetics, local|mesh-ancestor
102115136|NCT04766684|Anesthetics|anesthetics|mesh-ancestor
102115137|NCT04766684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102115138|NCT04766684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115139|NCT04766684|Sensory System Agents|sensory system agents|mesh-ancestor
102115140|NCT04766684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102115141|NCT04766684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102115142|NCT04766684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102115143|NCT04766684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102115144|NCT04766684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102115145|NCT04766684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115146|NCT02325024|Nabiximols|nabiximols|mesh-list
102115147|NCT02325024|Analgesics|analgesics|mesh-ancestor
102115148|NCT02325024|Sensory System Agents|sensory system agents|mesh-ancestor
102115149|NCT02325024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102115150|NCT02325024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115151|NCT02319564|Beclomethasone|beclomethasone|mesh-list
102115152|NCT02319564|Albuterol|albuterol|mesh-list
102115153|NCT02319564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102115154|NCT02319564|Autonomic Agents|autonomic agents|mesh-ancestor
102115155|NCT02319564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102115156|NCT02319564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115157|NCT02319564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102115158|NCT02319564|Respiratory System Agents|respiratory system agents|mesh-ancestor
102115159|NCT02319564|Tocolytic Agents|tocolytic agents|mesh-ancestor
102115160|NCT02319564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102115161|NCT02319564|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102115162|NCT02319564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102115163|NCT02319564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102115164|NCT02319564|Adrenergic Agents|adrenergic agents|mesh-ancestor
102115165|NCT02319564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102115166|NCT02319564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115167|NCT02319564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102115168|NCT02319564|Glucocorticoids|glucocorticoids|mesh-ancestor
102115170|NCT02319564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102115171|NCT05056402|Vaccines|vaccines|mesh-list
102115172|NCT05056402|Immunologic Factors|immunologic factors|mesh-ancestor
102154325|NCT03365817|Methadone|methadone|mesh-list
102535856|NCT02945813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115173|NCT05056402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115174|NCT02325180|Lumefantrine|lumefantrine|mesh-list
102115175|NCT02325180|Artemether|artemether|mesh-list
102115176|NCT02325180|Piperaquine|piperaquine|mesh-list
102115177|NCT02325180|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102115178|NCT02325180|Artenimol|artenimol|mesh-list
102115179|NCT02325180|Antimalarials|antimalarials|mesh-ancestor
102115180|NCT02325180|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102115181|NCT02325180|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102115182|NCT02325180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102115183|NCT00709592|Mycophenolic Acid|mycophenolic acid|mesh-list
102115184|NCT00709592|Tacrolimus|tacrolimus|mesh-list
102115185|NCT00709592|Thymoglobulin|thymoglobulin|mesh-list
102115186|NCT00709592|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102115187|NCT00709592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102115188|NCT00709592|Immunologic Factors|immunologic factors|mesh-ancestor
102115189|NCT00709592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115190|NCT00709592|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102115191|NCT00709592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102115192|NCT00709592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115193|NCT00709592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102115194|NCT00709592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102115195|NCT00709592|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102115196|NCT00709592|Antitubercular Agents|antitubercular agents|mesh-ancestor
102115197|NCT00709592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102115198|NCT00709592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102115199|NCT05515354|Nicotine|nicotine|mesh-list
102115200|NCT05515354|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102115201|NCT05515354|Autonomic Agents|autonomic agents|mesh-ancestor
102115202|NCT05515354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102115203|NCT05515354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115204|NCT05515354|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102115205|NCT05515354|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102115206|NCT05515354|Cholinergic Agents|cholinergic agents|mesh-ancestor
102115207|NCT05515354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102115208|NCT05515354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115209|NCT02437370|Gemcitabine|gemcitabine|mesh-list
102115210|NCT02437370|Docetaxel|docetaxel|mesh-list
102115211|NCT02437370|Pembrolizumab|pembrolizumab|mesh-list
102115212|NCT02437370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102115213|NCT02437370|Antimetabolites|antimetabolites|mesh-ancestor
102115214|NCT02437370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115215|NCT02437370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102115216|NCT02437370|Tubulin Modulators|tubulin modulators|mesh-ancestor
102115217|NCT02437370|Antimitotic Agents|antimitotic agents|mesh-ancestor
102115218|NCT02437370|Mitosis Modulators|mitosis modulators|mesh-ancestor
102115219|NCT02437370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102115220|NCT02437370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102115221|NCT05515120|Aspirin|aspirin|mesh-list
102115222|NCT05515120|Vitamin K|vitamin k|mesh-list
102115223|NCT05515120|Rivaroxaban|rivaroxaban|mesh-list
102115224|NCT05515120|Acenocoumarol|acenocoumarol|mesh-list
102115225|NCT05515120|Vitamins|vitamins|mesh-ancestor
102115226|NCT05515120|Micronutrients|micronutrients|mesh-ancestor
102115227|NCT05515120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115228|NCT05515120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102115229|NCT05515120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102115230|NCT05515120|Analgesics|analgesics|mesh-ancestor
102115231|NCT05515120|Sensory System Agents|sensory system agents|mesh-ancestor
102115232|NCT05515120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102115233|NCT05515120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102115234|NCT05515120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102115235|NCT05515120|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102115236|NCT05515120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102115237|NCT05515120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115238|NCT05515120|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102115239|NCT05515120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102115240|NCT05515120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102115241|NCT05515120|Antipyretics|antipyretics|mesh-ancestor
102115242|NCT05515120|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101506099|NCT02950155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102115243|NCT05515120|Antithrombins|antithrombins|mesh-ancestor
102115244|NCT05515120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102115246|NCT05515120|Anticoagulants|anticoagulants|mesh-ancestor
102535857|NCT05442801|Tropicamide|tropicamide|mesh-list
102115247|NCT05515120|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102115248|NCT05515120|Hemostatics|hemostatics|mesh-ancestor
102115249|NCT05515120|Coagulants|coagulants|mesh-ancestor
102115250|NCT02323230|Cyclophosphamide|cyclophosphamide|mesh-list
102115251|NCT02323230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102115252|NCT02323230|Immunologic Factors|immunologic factors|mesh-ancestor
102115253|NCT02323230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115254|NCT02323230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102115255|NCT02323230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102115256|NCT02323230|Alkylating Agents|alkylating agents|mesh-ancestor
102115257|NCT02323230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115258|NCT02323230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102115259|NCT02323230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102115260|NCT05042128|Paclitaxel|paclitaxel|mesh-list
102115261|NCT05042128|Gemcitabine|gemcitabine|mesh-list
102115262|NCT05042128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102115263|NCT05042128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102115264|NCT05042128|Tubulin Modulators|tubulin modulators|mesh-ancestor
102115265|NCT05042128|Antimitotic Agents|antimitotic agents|mesh-ancestor
102115266|NCT05042128|Mitosis Modulators|mitosis modulators|mesh-ancestor
102115267|NCT05042128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115268|NCT05042128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102115269|NCT05042128|Antimetabolites|antimetabolites|mesh-ancestor
102115270|NCT03495804|Mannitol|mannitol|mesh-list
102115271|NCT03495804|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102115272|NCT03495804|Diuretics|diuretics|mesh-ancestor
102115273|NCT03495804|Natriuretic Agents|natriuretic agents|mesh-ancestor
102115274|NCT03495804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115275|NCT05519410|Lenvatinib|lenvatinib|mesh-list
102115276|NCT05519410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102115277|NCT05519410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102115278|NCT05519410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102115279|NCT05519410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115280|NCT05578586|Meropenem|meropenem|mesh-list
102115281|NCT05578586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102115282|NCT05578586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102115283|NCT02570074|Fosfomycin|fosfomycin|mesh-list
102115284|NCT02570074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102115285|NCT02570074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102115286|NCT02569996|Rituximab|rituximab|mesh-list
102115287|NCT02569996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102115288|NCT02569996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102115289|NCT02569996|Immunologic Factors|immunologic factors|mesh-ancestor
102115290|NCT02569996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115291|NCT02569996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102115292|NCT02325882|Fentanyl|fentanyl|mesh-list
102115293|NCT02325882|Dexmedetomidine|dexmedetomidine|mesh-list
102115294|NCT02325882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102115295|NCT02325882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102115296|NCT02325882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115297|NCT02325882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102115298|NCT02325882|Analgesics|analgesics|mesh-ancestor
102115299|NCT02325882|Sensory System Agents|sensory system agents|mesh-ancestor
102115300|NCT02325882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102115301|NCT02325882|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102115302|NCT02325882|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102115303|NCT02325882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102115304|NCT02325882|Adrenergic Agents|adrenergic agents|mesh-ancestor
102115305|NCT02325882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102115306|NCT02325882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115307|NCT02325882|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102115308|NCT02325882|Narcotics|narcotics|mesh-ancestor
102115309|NCT02325882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102115310|NCT02325882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102115311|NCT02325882|Anesthetics, General|anesthetics, general|mesh-ancestor
102115312|NCT02325882|Anesthetics|anesthetics|mesh-ancestor
102115313|NCT00708500|Interferons|interferons|mesh-list
102115314|NCT00708500|Ribavirin|ribavirin|mesh-list
102115315|NCT00708500|Interferon-alpha|interferon-alpha|mesh-list
102115316|NCT00708500|Interferon alpha-2|interferon alpha-2|mesh-list
102115317|NCT00708500|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102115318|NCT00708500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102115319|NCT00708500|Antiviral Agents|antiviral agents|mesh-ancestor
102115320|NCT00708500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102115321|NCT00708500|Antimetabolites|antimetabolites|mesh-ancestor
102115322|NCT00708500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115323|NCT00708500|Immunologic Factors|immunologic factors|mesh-ancestor
102115324|NCT00708500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115325|NCT05144100|Cisplatin|cisplatin|mesh-list
102058058|NCT04589351|Ezetimibe|ezetimibe|mesh-list
102115326|NCT05144100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102115327|NCT02320032|Aripiprazole|aripiprazole|mesh-list
102115328|NCT02320032|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
102115329|NCT02320032|Antidepressive Agents|antidepressive agents|mesh-ancestor
102115330|NCT02320032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102115331|NCT02320032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102115332|NCT02320032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102115333|NCT02320032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102115334|NCT02320032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115335|NCT02320032|Dopamine Agonists|dopamine agonists|mesh-ancestor
102115336|NCT02320032|Dopamine Agents|dopamine agents|mesh-ancestor
102115337|NCT02320032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102115338|NCT02320032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115339|NCT02320032|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102115340|NCT02320032|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102115341|NCT02320032|Serotonin Agents|serotonin agents|mesh-ancestor
102115342|NCT02320032|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102115343|NCT02320032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102115344|NCT02320032|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102115345|NCT02320032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102115346|NCT05514652|Analgesics, Opioid|analgesics, opioid|mesh-list
102115347|NCT05514652|Anesthetics|anesthetics|mesh-list
102115348|NCT05514652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102115349|NCT05514652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115350|NCT05514652|Narcotics|narcotics|mesh-ancestor
102115351|NCT05514652|Analgesics|analgesics|mesh-ancestor
102115352|NCT05514652|Sensory System Agents|sensory system agents|mesh-ancestor
102115353|NCT05514652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102115354|NCT00673244|Furosemide|furosemide|mesh-list
102115355|NCT00673244|Diuretics|diuretics|mesh-ancestor
102013987|NCT01341834|Everolimus|everolimus|mesh-list
102115356|NCT00673244|Natriuretic Agents|natriuretic agents|mesh-ancestor
102115357|NCT00673244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115358|NCT00673244|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102115359|NCT00673244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102115360|NCT00673244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115361|NCT02517788|Interferons|interferons|mesh-list
102115362|NCT02517788|Interferon-beta|interferon-beta|mesh-list
102115363|NCT02517788|Interferon beta-1a|interferon beta-1a|mesh-list
102115364|NCT02517788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102115365|NCT02517788|Antiviral Agents|antiviral agents|mesh-ancestor
102115366|NCT02517788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102115367|NCT02517788|Immunologic Factors|immunologic factors|mesh-ancestor
102115368|NCT02517788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115369|NCT02517788|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102115370|NCT04599790|Lenvatinib|lenvatinib|mesh-list
102115371|NCT04599790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102115372|NCT04599790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102115373|NCT04599790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102115374|NCT04599790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115375|NCT03132168|Anesthetics|anesthetics|mesh-list
102115376|NCT03132168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102115377|NCT03132168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115378|NCT04937062|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
102115379|NCT04937062|Glycerol|glycerol|mesh-list
102115380|NCT04937062|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102115381|NCT04937062|Protective Agents|protective agents|mesh-ancestor
102115382|NCT04937062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115383|NCT04937062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102115384|NCT02324010|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102115385|NCT02324010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102115386|NCT02324010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115387|NCT02324010|Incretins|incretins|mesh-ancestor
102115388|NCT02324010|Hormones|hormones|mesh-ancestor
102115389|NCT02324010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102115390|NCT02324010|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102115391|NCT02324010|Protease Inhibitors|protease inhibitors|mesh-ancestor
102115392|NCT02324010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102115393|NCT02324010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115394|NCT02320734|Rocuronium|rocuronium|mesh-list
102115395|NCT02320734|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102115396|NCT02320734|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102115397|NCT02320734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102115398|NCT02320734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102115399|NCT02320734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115400|NCT03346226|Dexmedetomidine|dexmedetomidine|mesh-list
102115401|NCT03346226|Propofol|propofol|mesh-list
102115402|NCT03346226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102115403|NCT03346226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102115404|NCT03346226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115405|NCT03346226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102115406|NCT03346226|Analgesics|analgesics|mesh-ancestor
102115407|NCT03346226|Sensory System Agents|sensory system agents|mesh-ancestor
102115408|NCT03346226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102115409|NCT03346226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102115410|NCT03346226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102115411|NCT03346226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102115412|NCT03346226|Adrenergic Agents|adrenergic agents|mesh-ancestor
102115413|NCT03346226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102115414|NCT03346226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115415|NCT03346226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102115416|NCT03346226|Anesthetics, General|anesthetics, general|mesh-ancestor
102115417|NCT03346226|Anesthetics|anesthetics|mesh-ancestor
102115418|NCT03347240|Baclofen|baclofen|mesh-list
102115419|NCT03347240|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102115420|NCT03347240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115421|NCT03347240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102115422|NCT03347240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102115423|NCT03347240|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102115424|NCT03347240|GABA Agonists|gaba agonists|mesh-ancestor
102115425|NCT03347240|GABA Agents|gaba agents|mesh-ancestor
102115426|NCT03347240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102115427|NCT03347240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115428|NCT02324088|Cyclophosphamide|cyclophosphamide|mesh-list
102115429|NCT02324088|Docetaxel|docetaxel|mesh-list
102115430|NCT02324088|Epirubicin|epirubicin|mesh-list
102115431|NCT02324088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102115432|NCT02324088|Immunologic Factors|immunologic factors|mesh-ancestor
102115433|NCT02324088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115434|NCT02324088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102115435|NCT02324088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102115436|NCT02324088|Alkylating Agents|alkylating agents|mesh-ancestor
102115437|NCT02324088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115438|NCT02324088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102115439|NCT02324088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102115440|NCT02324088|Tubulin Modulators|tubulin modulators|mesh-ancestor
102115441|NCT02324088|Antimitotic Agents|antimitotic agents|mesh-ancestor
102115442|NCT02324088|Mitosis Modulators|mitosis modulators|mesh-ancestor
102115443|NCT02324088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102115444|NCT02324088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102115445|NCT02324088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102115446|NCT02324088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102115447|NCT02324166|Cefazolin|cefazolin|mesh-list
102115448|NCT02324166|Lidocaine|lidocaine|mesh-list
102115449|NCT02324166|Anesthetics, Local|anesthetics, local|mesh-ancestor
102115450|NCT02324166|Anesthetics|anesthetics|mesh-ancestor
102115451|NCT02324166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102115452|NCT02324166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115453|NCT02324166|Sensory System Agents|sensory system agents|mesh-ancestor
102115454|NCT02324166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102115455|NCT02324166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102115456|NCT02324166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102115457|NCT02324166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102115458|NCT02324166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102115459|NCT02324166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115460|NCT02324166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102115461|NCT02324166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102115462|NCT03346538|Edaravone|edaravone|mesh-list
102115463|NCT03346538|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102115464|NCT03346538|Antioxidants|antioxidants|mesh-ancestor
102115465|NCT03346538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115466|NCT03346538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102115467|NCT03346538|Protective Agents|protective agents|mesh-ancestor
102115468|NCT03346538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506329|NCT00517764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102115470|NCT02513342|Endostar protein|endostar protein|mesh-list
102115471|NCT02513342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102115472|NCT02513342|Tubulin Modulators|tubulin modulators|mesh-ancestor
102115473|NCT02513342|Antimitotic Agents|antimitotic agents|mesh-ancestor
102115474|NCT02513342|Mitosis Modulators|mitosis modulators|mesh-ancestor
102535858|NCT05442801|Cyclopentolate|cyclopentolate|mesh-list
102115475|NCT02513342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115476|NCT02513342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102115477|NCT02513342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102115478|NCT02513342|Growth Substances|growth substances|mesh-ancestor
102115479|NCT02513342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115480|NCT02513342|Growth Inhibitors|growth inhibitors|mesh-ancestor
102115481|NCT03495024|Varenicline|varenicline|mesh-list
102115482|NCT03495024|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102115483|NCT03495024|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102115484|NCT03495024|Cholinergic Agents|cholinergic agents|mesh-ancestor
102115485|NCT03495024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102115486|NCT03495024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115487|NCT03495024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115488|NCT04188314|Desflurane|desflurane|mesh-list
102115489|NCT04188314|Isoflurane|isoflurane|mesh-list
102115490|NCT04188314|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102115491|NCT04188314|Anesthetics, General|anesthetics, general|mesh-ancestor
102115492|NCT04188314|Anesthetics|anesthetics|mesh-ancestor
102115493|NCT04188314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102115494|NCT04188314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115495|NCT05512780|Letrozole|letrozole|mesh-list
102115496|NCT05512780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102115497|NCT05512780|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102115498|NCT05512780|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102115499|NCT05512780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102115500|NCT05512780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115501|NCT05512780|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102115502|NCT05512780|Hormone Antagonists|hormone antagonists|mesh-ancestor
102115503|NCT05512780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102115504|NCT05512780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115505|NCT02517164|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
102115506|NCT02517164|Calcifediol|calcifediol|mesh-list
102115507|NCT02517164|Vitamins|vitamins|mesh-ancestor
102115508|NCT02517164|Micronutrients|micronutrients|mesh-ancestor
102115509|NCT02517164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115510|NCT02517164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102115511|NCT04834362|Insulin|insulin|mesh-list
102115512|NCT04834362|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102115513|NCT04834362|Insulin Glargine|insulin glargine|mesh-list
102115514|NCT04834362|Insulin Aspart|insulin aspart|mesh-list
102115515|NCT04834362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102115516|NCT04834362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115517|NCT05512702|Heparin|heparin|mesh-list
102115518|NCT05512702|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102115519|NCT05512702|Plasminogen|plasminogen|mesh-list
102115520|NCT05512702|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102115521|NCT05512702|Tinzaparin|tinzaparin|mesh-list
102115522|NCT05512702|Dalteparin|dalteparin|mesh-list
102115523|NCT05512702|Anticoagulants|anticoagulants|mesh-ancestor
102115524|NCT05512702|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102115525|NCT05512702|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102115526|NCT05512702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115527|NCT05512546|Aspirin|aspirin|mesh-list
102115528|NCT05512546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102115529|NCT05512546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102115530|NCT05512546|Analgesics|analgesics|mesh-ancestor
102115531|NCT05512546|Sensory System Agents|sensory system agents|mesh-ancestor
102115532|NCT05512546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102115533|NCT05512546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115534|NCT05512546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102115535|NCT05512546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102115536|NCT05512546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102115537|NCT05512546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102115538|NCT05512546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115539|NCT05512546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102115540|NCT05512546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102115541|NCT05512546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102115542|NCT05512546|Antipyretics|antipyretics|mesh-ancestor
102115543|NCT03345134|Pembrolizumab|pembrolizumab|mesh-list
102115544|NCT03345134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102115545|NCT03345134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102115546|NCT03345134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102115547|NCT03345134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115548|NCT02512562|Simeprevir|simeprevir|mesh-list
102115549|NCT02512562|Odalasvir|odalasvir|mesh-list
102115550|NCT02512562|Antiviral Agents|antiviral agents|mesh-ancestor
102115551|NCT02512562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102115552|NCT02512562|Protease Inhibitors|protease inhibitors|mesh-ancestor
102115553|NCT02512562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102115554|NCT02512562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115555|NCT02516774|Adalimumab|adalimumab|mesh-list
102115556|NCT02516774|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102115557|NCT02516774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102115558|NCT02516774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102115559|NCT05510986|Fentanyl|fentanyl|mesh-list
102115560|NCT05510986|Oxycodone|oxycodone|mesh-list
102115561|NCT05510986|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102115562|NCT05510986|Narcotics|narcotics|mesh-ancestor
102115563|NCT05510986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102115564|NCT05510986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115565|NCT05510986|Analgesics|analgesics|mesh-ancestor
102115566|NCT05510986|Sensory System Agents|sensory system agents|mesh-ancestor
102115567|NCT05510986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102115568|NCT05510986|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102115569|NCT05510986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102115570|NCT05510986|Anesthetics, General|anesthetics, general|mesh-ancestor
102115571|NCT05510986|Anesthetics|anesthetics|mesh-ancestor
102115572|NCT04872400|Vancomycin|vancomycin|mesh-list
102115573|NCT04872400|Tobramycin|tobramycin|mesh-list
102115574|NCT04872400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102115575|NCT04872400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102115576|NCT00101907|Gemcitabine|gemcitabine|mesh-list
102115577|NCT00101907|Panitumumab|panitumumab|mesh-list
102115578|NCT00101907|Motesanib diphosphate|motesanib diphosphate|mesh-list
102115579|NCT00101907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102115580|NCT00101907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102115581|NCT00101907|Antimetabolites|antimetabolites|mesh-ancestor
102115582|NCT00101907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115583|NCT00101907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102115584|NCT00101907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102115585|NCT00101907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102115586|NCT03491748|Cefpodoxime|cefpodoxime|mesh-list
102115587|NCT03491748|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
102115588|NCT03491748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102115589|NCT03491748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102115590|NCT04769206|Galantamine|galantamine|mesh-list
102115591|NCT04769206|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102115592|NCT04769206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102115593|NCT04769206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115594|NCT04769206|Cholinergic Agents|cholinergic agents|mesh-ancestor
102115595|NCT04769206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102115596|NCT04769206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115597|NCT04769206|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102115598|NCT04769206|Autonomic Agents|autonomic agents|mesh-ancestor
102115599|NCT04769206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102115600|NCT04769206|Nootropic Agents|nootropic agents|mesh-ancestor
102115601|NCT03492996|Delpazolid|delpazolid|mesh-list
102115602|NCT03492996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102115603|NCT03492996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102115604|NCT03492996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102115605|NCT03492996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102115606|NCT03492996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115607|NCT03772028|Cisplatin|cisplatin|mesh-list
102115608|NCT03772028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102115609|NCT02161965|Warfarin|warfarin|mesh-list
102115610|NCT02161965|Rivaroxaban|rivaroxaban|mesh-list
102115611|NCT02161965|Fluindione|fluindione|mesh-list
102115612|NCT02161965|Phenindione|phenindione|mesh-list
102115613|NCT02161965|Anticoagulants|anticoagulants|mesh-ancestor
102115614|NCT02161965|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102115615|NCT02161965|Antithrombins|antithrombins|mesh-ancestor
102115616|NCT02161965|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102115617|NCT02161965|Protease Inhibitors|protease inhibitors|mesh-ancestor
102115618|NCT02161965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102115619|NCT02161965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115620|NCT02050308|Nicotine|nicotine|mesh-list
102115621|NCT02050308|Varenicline|varenicline|mesh-list
102115622|NCT02050308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102115623|NCT02050308|Autonomic Agents|autonomic agents|mesh-ancestor
102115624|NCT02050308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102115625|NCT02050308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115626|NCT02050308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102115627|NCT02050308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102115628|NCT02050308|Cholinergic Agents|cholinergic agents|mesh-ancestor
102115629|NCT02050308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102115630|NCT02050308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115632|NCT02516618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102115633|NCT02516618|Analgesics|analgesics|mesh-ancestor
102115634|NCT02516618|Sensory System Agents|sensory system agents|mesh-ancestor
102115635|NCT02516618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102115636|NCT02516618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115637|NCT05507554|Analgesics|analgesics|mesh-list
102115638|NCT05507554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
102115639|NCT05507554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115640|NCT05507554|Sensory System Agents|sensory system agents|mesh-ancestor
102115641|NCT05507554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102115642|NCT02516462|Hormones|hormones|mesh-list
102115643|NCT02516462|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102115644|NCT02516462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102115645|NCT02516462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115646|NCT04650204|Anticonvulsants|anticonvulsants|mesh-list
102115647|NCT04501250|Insulin|insulin|mesh-list
102115648|NCT04501250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102115649|NCT04501250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102115650|NCT04501250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115651|NCT02761629|Interferons|interferons|mesh-list
102115652|NCT02761629|Ribavirin|ribavirin|mesh-list
102115653|NCT02761629|Interferon-alpha|interferon-alpha|mesh-list
102115654|NCT02761629|Interferon alpha-2|interferon alpha-2|mesh-list
102115655|NCT02761629|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102115656|NCT02761629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102115657|NCT02761629|Antiviral Agents|antiviral agents|mesh-ancestor
102115658|NCT02761629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102115659|NCT02761629|Antimetabolites|antimetabolites|mesh-ancestor
102115660|NCT02761629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115661|NCT02761629|Immunologic Factors|immunologic factors|mesh-ancestor
102115662|NCT02761629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115663|NCT03345992|Clarithromycin|clarithromycin|mesh-list
102115664|NCT03345992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102115665|NCT03345992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102115666|NCT03345992|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102115667|NCT03345992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102115668|NCT03345992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115669|NCT03345992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102115670|NCT03345992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102115671|NCT02162121|Ketorolac|ketorolac|mesh-list
102115672|NCT02162121|Buprenorphine|buprenorphine|mesh-list
102115673|NCT02162121|Anesthetics|anesthetics|mesh-list
102115674|NCT02162121|Ropivacaine|ropivacaine|mesh-list
102115675|NCT02162121|Levobupivacaine|levobupivacaine|mesh-list
102115676|NCT02162121|Mepivacaine|mepivacaine|mesh-list
102115677|NCT02162121|Anesthetics, Local|anesthetics, local|mesh-list
102115678|NCT02162121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102115679|NCT02162121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115680|NCT02162121|Sensory System Agents|sensory system agents|mesh-ancestor
102115681|NCT02162121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102115682|NCT02162121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102115683|NCT02162121|Narcotics|narcotics|mesh-ancestor
102115684|NCT02162121|Analgesics|analgesics|mesh-ancestor
102115685|NCT02162121|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102115686|NCT02162121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102115687|NCT02162121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102115688|NCT02162121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102115689|NCT02162121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102014315|NCT03303976|Immunologic Factors|immunologic factors|mesh-ancestor
102115690|NCT02162121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102115691|NCT02162121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102115692|NCT02162121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115693|NCT02511704|Nicotine|nicotine|mesh-list
102115694|NCT02511704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102115695|NCT02511704|Autonomic Agents|autonomic agents|mesh-ancestor
102115696|NCT02511704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102115697|NCT02511704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569232|NCT02845843|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102115698|NCT02511704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102115700|NCT02511704|Cholinergic Agents|cholinergic agents|mesh-ancestor
102115701|NCT02511704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102115702|NCT02511704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115703|NCT04500704|Carboplatin|carboplatin|mesh-list
102115704|NCT04500704|Pemetrexed|pemetrexed|mesh-list
102115705|NCT04500704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102115706|NCT04500704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102115707|NCT04500704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115708|NCT04500704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102115709|NCT04500704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102115710|NCT02164773|Magnesium Sulfate|magnesium sulfate|mesh-list
102115711|NCT02164773|Analgesics|analgesics|mesh-ancestor
102115712|NCT02164773|Sensory System Agents|sensory system agents|mesh-ancestor
102115713|NCT02164773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102115714|NCT02164773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115715|NCT02164773|Anesthetics|anesthetics|mesh-ancestor
102115716|NCT02164773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102115717|NCT02164773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102115718|NCT02164773|Anticonvulsants|anticonvulsants|mesh-ancestor
102115719|NCT02164773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102115720|NCT02164773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102115721|NCT02164773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115722|NCT02164773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102115723|NCT02164773|Tocolytic Agents|tocolytic agents|mesh-ancestor
102115724|NCT02164773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102115725|NCT00101439|Ezetimibe|ezetimibe|mesh-list
102115726|NCT00101439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102115727|NCT00101439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102115728|NCT00101439|Antimetabolites|antimetabolites|mesh-ancestor
102115729|NCT00101439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115730|NCT00101439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102115731|NCT03344822|Choline|choline|mesh-list
102115732|NCT03344822|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102115733|NCT03344822|Lipotropic Agents|lipotropic agents|mesh-ancestor
102115734|NCT03344822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102115735|NCT03344822|Antimetabolites|antimetabolites|mesh-ancestor
102115736|NCT03344822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115737|NCT03344822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102115738|NCT03344822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102115739|NCT03344822|Nootropic Agents|nootropic agents|mesh-ancestor
102115740|NCT03344822|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102115741|NCT02162745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102115742|NCT02506790|Toremifene|toremifene|mesh-list
102115743|NCT02506790|Metformin|metformin|mesh-list
102115744|NCT02506790|Melatonin|melatonin|mesh-list
102115745|NCT02506790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102115746|NCT02506790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115747|NCT02506790|Antioxidants|antioxidants|mesh-ancestor
102115748|NCT02506790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115749|NCT02506790|Protective Agents|protective agents|mesh-ancestor
102115750|NCT02506790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102115751|NCT02506790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102115752|NCT02506790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102115753|NCT02506790|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102115754|NCT02506790|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102115755|NCT02506790|Hormone Antagonists|hormone antagonists|mesh-ancestor
102115756|NCT02506790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102115757|NCT02506790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102115758|NCT04500002|Isoniazid|isoniazid|mesh-list
102115759|NCT04500002|Misoprostol|misoprostol|mesh-list
102115760|NCT04500002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102115761|NCT04500002|Abortifacient Agents|abortifacient agents|mesh-ancestor
102115762|NCT04500002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102115763|NCT04500002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115764|NCT04500002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102115765|NCT04500002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102115766|NCT04500002|Oxytocics|oxytocics|mesh-ancestor
102115767|NCT04500002|Antitubercular Agents|antitubercular agents|mesh-ancestor
102115768|NCT04500002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102115769|NCT04500002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102115770|NCT04500002|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102115771|NCT04500002|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102115772|NCT04500002|Antimetabolites|antimetabolites|mesh-ancestor
102115773|NCT04500002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115774|NCT04500002|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102115775|NCT02515682|Equol|equol|mesh-list
102115776|NCT02515682|Phytoestrogens|phytoestrogens|mesh-ancestor
102115777|NCT02515682|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102115778|NCT02515682|Estrogens|estrogens|mesh-ancestor
102115779|NCT02515682|Hormones|hormones|mesh-ancestor
102535859|NCT05442801|Mydriatics|mydriatics|mesh-ancestor
102115780|NCT02515682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102115781|NCT02515682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115782|NCT02515604|Misoprostol|misoprostol|mesh-list
102115783|NCT02515604|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102115784|NCT02515604|Abortifacient Agents|abortifacient agents|mesh-ancestor
102115785|NCT02515604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102115786|NCT02515604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115787|NCT02515604|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102115788|NCT02515604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102115789|NCT02515604|Oxytocics|oxytocics|mesh-ancestor
102115790|NCT02510534|Menotropins|menotropins|mesh-list
102115791|NCT02510534|Progesterone|progesterone|mesh-list
102115792|NCT02510534|Progestins|progestins|mesh-ancestor
102115793|NCT02510534|Hormones|hormones|mesh-ancestor
102115794|NCT02510534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102115795|NCT02510534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115796|NCT02510534|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102115797|NCT02510534|Fertility Agents|fertility agents|mesh-ancestor
102115798|NCT02510534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102115799|NCT02510612|Dexmedetomidine|dexmedetomidine|mesh-list
102115800|NCT02510612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102115801|NCT02510612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102115802|NCT02510612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115803|NCT02510612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102115804|NCT02510612|Analgesics|analgesics|mesh-ancestor
102115805|NCT02510612|Sensory System Agents|sensory system agents|mesh-ancestor
102115806|NCT02510612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102115807|NCT02510612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102115808|NCT02510612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102115809|NCT02510612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102115810|NCT02510612|Adrenergic Agents|adrenergic agents|mesh-ancestor
102115811|NCT02510612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102115812|NCT02510612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115813|NCT03749616|Acetaminophen|acetaminophen|mesh-list
102115814|NCT03749616|Ibuprofen|ibuprofen|mesh-list
102115815|NCT03749616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102115816|NCT03749616|Analgesics|analgesics|mesh-ancestor
102115817|NCT03749616|Sensory System Agents|sensory system agents|mesh-ancestor
102115818|NCT03749616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102115819|NCT03749616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115820|NCT03749616|Antipyretics|antipyretics|mesh-ancestor
102115821|NCT03749616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102115822|NCT03749616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102115823|NCT03749616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102115824|NCT03749616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102115825|NCT03749616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102115826|NCT03749616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115827|NCT04532502|Anesthetics|anesthetics|mesh-list
102115828|NCT04532502|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
102115829|NCT04532502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102115830|NCT04532502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115831|NCT04532502|Anesthetics, General|anesthetics, general|mesh-ancestor
102115832|NCT02515526|Tolbutamide|tolbutamide|mesh-list
102115833|NCT02515526|Ethanol|ethanol|mesh-list
102115834|NCT02515526|Digoxin|digoxin|mesh-list
102115835|NCT02515526|Midazolam|midazolam|mesh-list
102115836|NCT02515526|Dextromethorphan|dextromethorphan|mesh-list
102115837|NCT02515526|Caffeine|caffeine|mesh-list
102115838|NCT02515526|Omeprazole|omeprazole|mesh-list
102115839|NCT02515526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102115840|NCT02515526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102115841|NCT02515526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102115842|NCT02515526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115843|NCT02515526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102115844|NCT02515526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102115845|NCT02515526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102115846|NCT02515526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102115847|NCT02515526|Anesthetics, General|anesthetics, general|mesh-ancestor
102115848|NCT02515526|Anesthetics|anesthetics|mesh-ancestor
102115849|NCT02515526|GABA Modulators|gaba modulators|mesh-ancestor
102115851|NCT02515526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102115852|NCT02515526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115853|NCT02515526|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102115854|NCT02515526|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102115855|NCT02515526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102115856|NCT02515526|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102115857|NCT02515526|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102115858|NCT02515526|Purinergic Agents|purinergic agents|mesh-ancestor
102115859|NCT02515526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102115860|NCT02515526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102115861|NCT02515526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102115862|NCT02515526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102115863|NCT02515526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102115864|NCT02515526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102115865|NCT02515526|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102115866|NCT02515526|Protective Agents|protective agents|mesh-ancestor
102115867|NCT02515526|Antitussive Agents|antitussive agents|mesh-ancestor
102115868|NCT02515526|Respiratory System Agents|respiratory system agents|mesh-ancestor
102115869|NCT02515526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102115870|NCT02515526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102115871|NCT02515526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102115872|NCT02515448|Gentamicins|gentamicins|mesh-list
102115873|NCT02515448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102115874|NCT02515448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102115875|NCT02515448|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102115876|NCT02515448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102115877|NCT02515448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115878|NCT02170857|Hyaluronic Acid|hyaluronic acid|mesh-list
102115879|NCT02170857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102115880|NCT02170857|Immunologic Factors|immunologic factors|mesh-ancestor
102115881|NCT02170857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115882|NCT02170857|Viscosupplements|viscosupplements|mesh-ancestor
102115883|NCT02170857|Protective Agents|protective agents|mesh-ancestor
102115884|NCT04460820|Doxorubicin|doxorubicin|mesh-list
102115885|NCT04460820|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102115886|NCT04460820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102115887|NCT04460820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102115888|NCT04460820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102115889|NCT04460820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102115890|NCT04460820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102115891|NCT04460820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115892|NCT02170935|Dabigatran|dabigatran|mesh-list
102115893|NCT02170935|Antithrombins|antithrombins|mesh-ancestor
102115894|NCT02170935|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102115895|NCT02170935|Protease Inhibitors|protease inhibitors|mesh-ancestor
102115896|NCT02170935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102115897|NCT02170935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115898|NCT02170935|Anticoagulants|anticoagulants|mesh-ancestor
102115899|NCT03488316|Calcium|calcium|mesh-list
102115900|NCT03488316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102115901|NCT03488316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115902|NCT02510222|Magnesium Sulfate|magnesium sulfate|mesh-list
102115903|NCT02510222|Analgesics|analgesics|mesh-ancestor
102115904|NCT02510222|Sensory System Agents|sensory system agents|mesh-ancestor
102115905|NCT02510222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102115906|NCT02510222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115907|NCT02510222|Anesthetics|anesthetics|mesh-ancestor
102115908|NCT02510222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102115909|NCT02510222|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102115910|NCT02510222|Anticonvulsants|anticonvulsants|mesh-ancestor
102115911|NCT02510222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102115912|NCT02510222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102115913|NCT02510222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115914|NCT02510222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102115915|NCT02510222|Tocolytic Agents|tocolytic agents|mesh-ancestor
102115916|NCT02510222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102115917|NCT05100264|Acetic Acid|acetic acid|mesh-list
102115918|NCT05100264|Retinol acetate|retinol acetate|mesh-list
102115919|NCT05100264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102115920|NCT05100264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102115921|NCT05100264|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102115922|NCT05100264|Immunologic Factors|immunologic factors|mesh-ancestor
101569463|NCT00095017|Etoricoxib|etoricoxib|mesh-list
102115923|NCT05100264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115924|NCT05100264|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102115925|NCT05100264|Protective Agents|protective agents|mesh-ancestor
102115926|NCT05100264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102115927|NCT02505776|Bimatoprost|bimatoprost|mesh-list
102115928|NCT02505776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102115929|NCT02171013|Dabigatran|dabigatran|mesh-list
102115930|NCT02171013|Antithrombins|antithrombins|mesh-ancestor
102115931|NCT02171013|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102115932|NCT02171013|Protease Inhibitors|protease inhibitors|mesh-ancestor
102115933|NCT02171013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102115934|NCT02171013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115935|NCT02171013|Anticoagulants|anticoagulants|mesh-ancestor
102115937|NCT02167425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102115938|NCT02167425|Narcotics|narcotics|mesh-ancestor
102115939|NCT02167425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102115940|NCT02167425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115941|NCT02167425|Analgesics|analgesics|mesh-ancestor
102115942|NCT02167425|Sensory System Agents|sensory system agents|mesh-ancestor
102115943|NCT02167425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102115944|NCT02167425|Antitussive Agents|antitussive agents|mesh-ancestor
102115945|NCT02167425|Respiratory System Agents|respiratory system agents|mesh-ancestor
102115946|NCT03111732|Pembrolizumab|pembrolizumab|mesh-list
102115947|NCT03111732|Capecitabine|capecitabine|mesh-list
102115948|NCT03111732|Oxaliplatin|oxaliplatin|mesh-list
102115949|NCT03111732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102115950|NCT03111732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102115951|NCT03111732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102115952|NCT03111732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115953|NCT03111732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102115954|NCT03111732|Antimetabolites|antimetabolites|mesh-ancestor
102115955|NCT01663714|Tositumomab I-131|tositumomab i-131|mesh-list
102115956|NCT01663714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102115957|NCT02505386|Ertapenem|ertapenem|mesh-list
102115958|NCT02505386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102115959|NCT02505386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102115960|NCT05507086|Anti-Infective Agents|anti-infective agents|mesh-list
102115961|NCT05507086|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102115962|NCT02514980|Ketamine|ketamine|mesh-list
102115963|NCT02514980|Bupivacaine|bupivacaine|mesh-list
102115964|NCT02514980|Anesthetics, Local|anesthetics, local|mesh-ancestor
102115965|NCT02514980|Anesthetics|anesthetics|mesh-ancestor
102115966|NCT02514980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102115967|NCT02514980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115968|NCT02514980|Sensory System Agents|sensory system agents|mesh-ancestor
102115969|NCT02514980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102115970|NCT02514980|Analgesics|analgesics|mesh-ancestor
102115971|NCT02514980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102115972|NCT02514980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102115973|NCT02514980|Anesthetics, General|anesthetics, general|mesh-ancestor
102115974|NCT02514980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102115975|NCT02514980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102115976|NCT02514980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102115977|NCT02514980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115978|NCT02165475|Loperamide|loperamide|mesh-list
102115979|NCT02165475|Antidiarrheals|antidiarrheals|mesh-list
102115980|NCT02165475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102115981|NCT04862338|Niacinamide|niacinamide|mesh-list
102115982|NCT04862338|Niacin|niacin|mesh-list
102115983|NCT04862338|Nicotinic Acids|nicotinic acids|mesh-list
102115984|NCT04862338|Vitamin B Complex|vitamin b complex|mesh-ancestor
102115985|NCT04862338|Vitamins|vitamins|mesh-ancestor
102115986|NCT04862338|Micronutrients|micronutrients|mesh-ancestor
102115987|NCT04862338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102115988|NCT04862338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102115989|NCT04862338|Antimetabolites|antimetabolites|mesh-ancestor
102115990|NCT04862338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115991|NCT04862338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102115992|NCT04862338|Vasodilator Agents|vasodilator agents|mesh-ancestor
102115993|NCT02171325|Irinotecan|irinotecan|mesh-list
102115994|NCT02171325|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102115995|NCT02171325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102115996|NCT02171325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102115997|NCT02171325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102115998|NCT02171325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102115999|NCT02509286|Leucovorin|leucovorin|mesh-list
102116000|NCT02509286|Paclitaxel|paclitaxel|mesh-list
102116001|NCT02509286|Docetaxel|docetaxel|mesh-list
102116002|NCT02509286|Carboplatin|carboplatin|mesh-list
102116003|NCT02509286|Fluorouracil|fluorouracil|mesh-list
102116004|NCT02509286|Oxaliplatin|oxaliplatin|mesh-list
102116005|NCT02509286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102116006|NCT02509286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102116007|NCT02509286|Tubulin Modulators|tubulin modulators|mesh-ancestor
102116008|NCT02509286|Antimitotic Agents|antimitotic agents|mesh-ancestor
102116009|NCT02509286|Mitosis Modulators|mitosis modulators|mesh-ancestor
102116010|NCT02509286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116011|NCT02509286|Antimetabolites|antimetabolites|mesh-ancestor
102116012|NCT02509286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102116013|NCT02509286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102116014|NCT02509286|Immunologic Factors|immunologic factors|mesh-ancestor
102116015|NCT02509286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116016|NCT02509286|Antidotes|antidotes|mesh-ancestor
102116017|NCT02509286|Protective Agents|protective agents|mesh-ancestor
102116018|NCT02509286|Vitamin B Complex|vitamin b complex|mesh-ancestor
102116019|NCT02509286|Vitamins|vitamins|mesh-ancestor
102116020|NCT02509286|Micronutrients|micronutrients|mesh-ancestor
102116021|NCT03065244|Infliximab|infliximab|mesh-list
102116022|NCT03065244|Immunoglobulins|immunoglobulins|mesh-list
102116023|NCT03065244|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102116024|NCT03065244|gamma-Globulins|gamma-globulins|mesh-list
102116025|NCT03065244|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102116026|NCT03065244|Immunologic Factors|immunologic factors|mesh-ancestor
102116027|NCT03065244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116028|NCT03065244|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102116029|NCT03065244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102116030|NCT03065244|Dermatologic Agents|dermatologic agents|mesh-ancestor
102116031|NCT03065244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102116032|NCT03065244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102116033|NCT02171481|Dabigatran|dabigatran|mesh-list
102116034|NCT02171481|Antithrombins|antithrombins|mesh-ancestor
102116035|NCT02171481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102116036|NCT02171481|Protease Inhibitors|protease inhibitors|mesh-ancestor
102116037|NCT02171481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102116038|NCT02171481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116039|NCT02171481|Anticoagulants|anticoagulants|mesh-ancestor
102116040|NCT02171559|Enoxaparin|enoxaparin|mesh-list
102116041|NCT02171559|Dabigatran|dabigatran|mesh-list
102116042|NCT02171559|Anticoagulants|anticoagulants|mesh-ancestor
102116043|NCT02171559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102116044|NCT02171559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102116045|NCT02171559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116046|NCT02171559|Antithrombins|antithrombins|mesh-ancestor
102116047|NCT02171559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102116048|NCT02171559|Protease Inhibitors|protease inhibitors|mesh-ancestor
102116049|NCT02171559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102116050|NCT04901754|Apatinib|apatinib|mesh-list
102116051|NCT04901754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102116052|NCT04901754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102116053|NCT04901754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102116054|NCT04901754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116055|NCT02509208|Hemostatics|hemostatics|mesh-list
102116056|NCT02509208|Coagulants|coagulants|mesh-ancestor
102116057|NCT02504996|Acetaminophen|acetaminophen|mesh-list
102116058|NCT02504996|Morphine|morphine|mesh-list
102116059|NCT02504996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102116060|NCT02504996|Narcotics|narcotics|mesh-ancestor
102116061|NCT02504996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102116062|NCT02504996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116063|NCT02504996|Analgesics|analgesics|mesh-ancestor
102116064|NCT02504996|Sensory System Agents|sensory system agents|mesh-ancestor
102116065|NCT02504996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102116066|NCT02504996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102116067|NCT02504996|Antipyretics|antipyretics|mesh-ancestor
102116068|NCT02509052|Leflunomide|leflunomide|mesh-list
102116069|NCT02509052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102116070|NCT02509052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116071|NCT02509052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102116072|NCT02509052|Immunologic Factors|immunologic factors|mesh-ancestor
102116073|NCT02509052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116074|NCT00100815|Bevacizumab|bevacizumab|mesh-list
102116075|NCT00100815|Gemcitabine|gemcitabine|mesh-list
102116076|NCT00100815|Capecitabine|capecitabine|mesh-list
102116077|NCT00100815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102116078|NCT00100815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102116079|NCT00100815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102116080|NCT00100815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102116081|NCT00100815|Growth Substances|growth substances|mesh-ancestor
102116082|NCT00100815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116083|NCT00100815|Growth Inhibitors|growth inhibitors|mesh-ancestor
102116084|NCT00100815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102116085|NCT00100815|Antimetabolites|antimetabolites|mesh-ancestor
102116086|NCT00100815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116088|NCT00708422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102116089|NCT00708422|Latanoprost|latanoprost|mesh-list
102116090|NCT00708422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102116091|NCT00708422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102116092|NCT02514200|Riboflavin|riboflavin|mesh-list
102116093|NCT02514200|Vitamin B Complex|vitamin b complex|mesh-ancestor
102116094|NCT02514200|Vitamins|vitamins|mesh-ancestor
102116095|NCT02514200|Micronutrients|micronutrients|mesh-ancestor
102116096|NCT02514200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116097|NCT02514200|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102116098|NCT02514200|Dermatologic Agents|dermatologic agents|mesh-ancestor
102116099|NCT02504450|Haloperidol|haloperidol|mesh-list
102116100|NCT02504450|Ziprasidone|ziprasidone|mesh-list
102116101|NCT02504450|Loxapine|loxapine|mesh-list
102116102|NCT02504450|Antiemetics|antiemetics|mesh-ancestor
102116103|NCT02504450|Autonomic Agents|autonomic agents|mesh-ancestor
102116104|NCT02504450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102116105|NCT02504450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116106|NCT02504450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102116107|NCT02504450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102116108|NCT02504450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102116109|NCT02504450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102116110|NCT02504450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102116111|NCT02504450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102116112|NCT02504450|Dopamine Agents|dopamine agents|mesh-ancestor
102116113|NCT02504450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102116114|NCT02504450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116115|NCT02504450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102116116|NCT02504450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102116117|NCT02504450|Serotonin Agents|serotonin agents|mesh-ancestor
102116118|NCT02171637|Afatinib|afatinib|mesh-list
102116119|NCT02171637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102116120|NCT02171637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102116121|NCT02171637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102116122|NCT02171637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116123|NCT02171715|Afatinib|afatinib|mesh-list
102116124|NCT02171715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102116125|NCT02171715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102116126|NCT02171715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102116127|NCT02171715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116128|NCT02504372|Pembrolizumab|pembrolizumab|mesh-list
102116129|NCT02504372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102116130|NCT02504372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102116131|NCT02504372|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102116132|NCT02504372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116133|NCT02760069|Ondansetron|ondansetron|mesh-list
102116134|NCT02760069|Antiemetics|antiemetics|mesh-ancestor
102116135|NCT02760069|Autonomic Agents|autonomic agents|mesh-ancestor
102116136|NCT02760069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102116137|NCT02760069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116138|NCT02760069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102116139|NCT02760069|Antipruritics|antipruritics|mesh-ancestor
102116140|NCT02760069|Dermatologic Agents|dermatologic agents|mesh-ancestor
102116141|NCT02760069|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102116142|NCT02760069|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102116143|NCT02760069|Serotonin Agents|serotonin agents|mesh-ancestor
102116144|NCT02760069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102116145|NCT02760069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116146|NCT02504138|Anesthetics|anesthetics|mesh-list
102116147|NCT02504138|Propofol|propofol|mesh-list
102116148|NCT02504138|Desflurane|desflurane|mesh-list
102116149|NCT02504138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102116150|NCT02504138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116151|NCT02504138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102116152|NCT02504138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102116153|NCT02504138|Anesthetics, General|anesthetics, general|mesh-ancestor
102116154|NCT02504138|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102116155|NCT02508584|Antibodies|antibodies|mesh-list
102116156|NCT02508584|Immunologic Factors|immunologic factors|mesh-ancestor
102116157|NCT02508584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116158|NCT02171793|Olodaterol|olodaterol|mesh-list
102116159|NCT02171793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102116160|NCT02171793|Autonomic Agents|autonomic agents|mesh-ancestor
102116161|NCT02171793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102116162|NCT02171793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116163|NCT02171793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102116164|NCT02171793|Respiratory System Agents|respiratory system agents|mesh-ancestor
102116165|NCT02171871|Respiratory System Agents|respiratory system agents|mesh-list
102116167|NCT02508350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102116168|NCT02508350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102116169|NCT02503826|Midazolam|midazolam|mesh-list
102116170|NCT02503826|Sufentanil|sufentanil|mesh-list
102116171|NCT02503826|Dsuvia|dsuvia|mesh-list
102116172|NCT02503826|Propofol|propofol|mesh-list
102116173|NCT02503826|Cisatracurium|cisatracurium|mesh-list
102116174|NCT02503826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102116175|NCT02503826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102116176|NCT02503826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116177|NCT02503826|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102116178|NCT02503826|Anesthetics, General|anesthetics, general|mesh-ancestor
102116179|NCT02503826|Anesthetics|anesthetics|mesh-ancestor
102116180|NCT02503826|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102116181|NCT02503826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102116182|NCT02503826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102116183|NCT02503826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102116184|NCT02503826|GABA Modulators|gaba modulators|mesh-ancestor
102116185|NCT02503826|GABA Agents|gaba agents|mesh-ancestor
102116186|NCT02503826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102116187|NCT02503826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116188|NCT02503826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102116189|NCT02503826|Narcotics|narcotics|mesh-ancestor
102116190|NCT02503826|Analgesics|analgesics|mesh-ancestor
102116191|NCT02503826|Sensory System Agents|sensory system agents|mesh-ancestor
102116192|NCT02503826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102116193|NCT02503826|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102116194|NCT02503826|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102116195|NCT03121664|Itraconazole|itraconazole|mesh-list
102116196|NCT03121664|Antifungal Agents|antifungal agents|mesh-ancestor
102116197|NCT03121664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102116198|NCT03121664|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102116199|NCT03121664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102116200|NCT03121664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102116201|NCT03121664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116202|NCT03121664|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102116203|NCT03121664|Hormone Antagonists|hormone antagonists|mesh-ancestor
102014813|NCT05245006|Immunologic Factors|immunologic factors|mesh-ancestor
102116204|NCT03121664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102116205|NCT03121664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116206|NCT03121664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102116207|NCT02503904|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102116208|NCT02503904|Metronidazole|metronidazole|mesh-list
102116209|NCT02503904|Lidocaine|lidocaine|mesh-list
102116210|NCT02503904|Epinephrine|epinephrine|mesh-list
102116211|NCT02503904|Anesthetics, Local|anesthetics, local|mesh-ancestor
102116212|NCT02503904|Anesthetics|anesthetics|mesh-ancestor
102116213|NCT02503904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102116214|NCT02503904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116215|NCT02503904|Sensory System Agents|sensory system agents|mesh-ancestor
102116216|NCT02503904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102116217|NCT02503904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102116218|NCT02503904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102116219|NCT02503904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102116220|NCT02503904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102116221|NCT02503904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116222|NCT02503904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102116223|NCT02503904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102116224|NCT02503904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102116225|NCT02503904|Adrenergic Agents|adrenergic agents|mesh-ancestor
102116226|NCT02503904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102116227|NCT02503904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102116228|NCT02503904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102116229|NCT02503904|Autonomic Agents|autonomic agents|mesh-ancestor
102116230|NCT02503904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102116231|NCT02503904|Respiratory System Agents|respiratory system agents|mesh-ancestor
102116232|NCT02503904|Mydriatics|mydriatics|mesh-ancestor
102116234|NCT02503904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102116235|NCT02503904|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102116236|NCT02503904|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102116237|NCT02172105|Olodaterol|olodaterol|mesh-list
102116238|NCT02172105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102116239|NCT02172105|Autonomic Agents|autonomic agents|mesh-ancestor
102116240|NCT02172105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102535860|NCT05442801|Autonomic Agents|autonomic agents|mesh-ancestor
102116241|NCT02172105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116242|NCT02172105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102116243|NCT02172105|Respiratory System Agents|respiratory system agents|mesh-ancestor
102116244|NCT03121352|Paclitaxel|paclitaxel|mesh-list
102116245|NCT03121352|Carboplatin|carboplatin|mesh-list
102116246|NCT03121352|Pembrolizumab|pembrolizumab|mesh-list
102116247|NCT03121352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102116248|NCT03121352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102116249|NCT03121352|Tubulin Modulators|tubulin modulators|mesh-ancestor
102116250|NCT03121352|Antimitotic Agents|antimitotic agents|mesh-ancestor
102116251|NCT03121352|Mitosis Modulators|mitosis modulators|mesh-ancestor
102116252|NCT03121352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116253|NCT03121352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102116254|NCT03121352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102116255|NCT02513654|Lamotrigine|lamotrigine|mesh-list
102116256|NCT02513654|Anticonvulsants|anticonvulsants|mesh-ancestor
102116257|NCT02513654|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102116258|NCT02513654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102116259|NCT02513654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116260|NCT02513654|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102116261|NCT02513654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116262|NCT02513654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102116263|NCT02513654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102116264|NCT02513654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102116265|NCT02513654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102116266|NCT02513654|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102116267|NCT02513888|Vitamin D|vitamin d|mesh-list
102116268|NCT02513888|Vitamins|vitamins|mesh-ancestor
102116269|NCT02513888|Micronutrients|micronutrients|mesh-ancestor
102116270|NCT02513888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014883|NCT02718898|Ixekizumab|ixekizumab|mesh-list
102116271|NCT02513888|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102116272|NCT00101595|Dasatinib|dasatinib|mesh-list
102116273|NCT00101595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102116274|NCT00101595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102116275|NCT00101595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102116276|NCT00101595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116277|NCT02174757|Doxycycline|doxycycline|mesh-list
102116278|NCT02174757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102116279|NCT02174757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102116280|NCT02174757|Antimalarials|antimalarials|mesh-ancestor
102116281|NCT02174757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102116282|NCT02174757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102116283|NCT02168127|Methylphenidate|methylphenidate|mesh-list
102116284|NCT02168127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102116285|NCT02168127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116286|NCT02168127|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102116287|NCT02168127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102116288|NCT02168127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102116289|NCT02168127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116290|NCT02168127|Dopamine Agents|dopamine agents|mesh-ancestor
102116291|NCT02168127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102116292|NCT02255955|Acetaminophen|acetaminophen|mesh-list
102116293|NCT02255955|Naproxen|naproxen|mesh-list
102116294|NCT02255955|Codeine|codeine|mesh-list
102116295|NCT02255955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102116296|NCT02255955|Analgesics|analgesics|mesh-ancestor
102116297|NCT02255955|Sensory System Agents|sensory system agents|mesh-ancestor
102116298|NCT02255955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102116299|NCT02255955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116300|NCT02255955|Antipyretics|antipyretics|mesh-ancestor
102116301|NCT02255955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102116302|NCT02255955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102116303|NCT02255955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102116304|NCT02255955|Gout Suppressants|gout suppressants|mesh-ancestor
102116305|NCT02255955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102116306|NCT02255955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101507142|NCT05148689|Nasal Decongestants|nasal decongestants|mesh-ancestor
102116307|NCT02255955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116309|NCT02255955|Narcotics|narcotics|mesh-ancestor
102116310|NCT02255955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102116311|NCT02255955|Antitussive Agents|antitussive agents|mesh-ancestor
102116312|NCT02255955|Respiratory System Agents|respiratory system agents|mesh-ancestor
102116313|NCT02172261|Glimepiride|glimepiride|mesh-list
102116314|NCT02172261|Empagliflozin|empagliflozin|mesh-list
102116315|NCT02172261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102116316|NCT02172261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102116317|NCT02172261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116318|NCT02172261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102116319|NCT02172261|Immunologic Factors|immunologic factors|mesh-ancestor
102116320|NCT02172261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102116321|NCT02172261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116322|NCT02501564|Naproxen|naproxen|mesh-list
102116323|NCT02501564|Codeine|codeine|mesh-list
102116324|NCT02501564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102116325|NCT02501564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102116326|NCT02501564|Analgesics|analgesics|mesh-ancestor
102116327|NCT02501564|Sensory System Agents|sensory system agents|mesh-ancestor
102116328|NCT02501564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102116329|NCT02501564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116330|NCT02501564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102116331|NCT02501564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102116332|NCT02501564|Gout Suppressants|gout suppressants|mesh-ancestor
102116333|NCT02501564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102116334|NCT02501564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102116335|NCT02501564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116336|NCT02501564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102116337|NCT02501564|Narcotics|narcotics|mesh-ancestor
102116338|NCT02501564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102116339|NCT02501564|Antitussive Agents|antitussive agents|mesh-ancestor
102116340|NCT02501564|Respiratory System Agents|respiratory system agents|mesh-ancestor
102116341|NCT02172339|Tiotropium Bromide|tiotropium bromide|mesh-list
102116342|NCT02172339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102116343|NCT02172339|Autonomic Agents|autonomic agents|mesh-ancestor
102116344|NCT02172339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102116345|NCT02172339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116346|NCT02172339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102116347|NCT02172339|Respiratory System Agents|respiratory system agents|mesh-ancestor
102116348|NCT02172339|Parasympatholytics|parasympatholytics|mesh-ancestor
102116349|NCT02172339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102116350|NCT02172339|Cholinergic Agents|cholinergic agents|mesh-ancestor
102116351|NCT02172339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102116352|NCT02172339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116353|NCT02172417|Ranitidine|ranitidine|mesh-list
102116354|NCT02172417|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
102116355|NCT02172417|Cimetidine|cimetidine|mesh-list
102116356|NCT02172417|Tiotropium Bromide|tiotropium bromide|mesh-list
102116357|NCT02172417|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102116358|NCT02172417|Autonomic Agents|autonomic agents|mesh-ancestor
102116359|NCT02172417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102116360|NCT02172417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116361|NCT02172417|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102116362|NCT02172417|Respiratory System Agents|respiratory system agents|mesh-ancestor
102116363|NCT02172417|Parasympatholytics|parasympatholytics|mesh-ancestor
102116364|NCT02172417|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102116365|NCT02172417|Cholinergic Agents|cholinergic agents|mesh-ancestor
102116366|NCT02172417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102116367|NCT02172417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116368|NCT02172417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102116369|NCT02172417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102116370|NCT02172417|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102116371|NCT02172417|Histamine Antagonists|histamine antagonists|mesh-ancestor
102116372|NCT02172417|Histamine Agents|histamine agents|mesh-ancestor
102116373|NCT02172417|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102116374|NCT02172417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102116375|NCT02172417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102116376|NCT02168205|Pomalidomide|pomalidomide|mesh-list
102116377|NCT02168205|Caffeine|caffeine|mesh-list
102116378|NCT02168205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101507217|NCT05142098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101569911|NCT05333419|Latanoprost|latanoprost|mesh-list
102116379|NCT02168205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116380|NCT02168205|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102116382|NCT02168205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116383|NCT02168205|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102116384|NCT02168205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102116385|NCT02168205|Purinergic Agents|purinergic agents|mesh-ancestor
102116386|NCT02168205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102535861|NCT05442801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102116387|NCT02168205|Immunologic Factors|immunologic factors|mesh-ancestor
102116388|NCT02168205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102116389|NCT02168205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102116390|NCT02168205|Growth Substances|growth substances|mesh-ancestor
102116391|NCT02168205|Growth Inhibitors|growth inhibitors|mesh-ancestor
102116392|NCT02168205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102116393|NCT03343652|Nivolumab|nivolumab|mesh-list
102116394|NCT03343652|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102116395|NCT03343652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102116396|NCT03343652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102116397|NCT03343652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102116398|NCT03343652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116399|NCT03343652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102116400|NCT03343652|Alkylating Agents|alkylating agents|mesh-ancestor
102116401|NCT02175069|Ropivacaine|ropivacaine|mesh-list
102116402|NCT02175069|Anesthetics, Local|anesthetics, local|mesh-ancestor
102116403|NCT02175069|Anesthetics|anesthetics|mesh-ancestor
102116404|NCT02175069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102116405|NCT02175069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116406|NCT02175069|Sensory System Agents|sensory system agents|mesh-ancestor
102116407|NCT02175069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102116408|NCT04498520|Fulvestrant|fulvestrant|mesh-list
102116409|NCT04498520|Palbociclib|palbociclib|mesh-list
102116410|NCT04498520|Abexinostat|abexinostat|mesh-list
102116411|NCT04498520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102116412|NCT04498520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102116413|NCT04498520|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102116414|NCT04498520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102116415|NCT04498520|Hormone Antagonists|hormone antagonists|mesh-ancestor
102116416|NCT04498520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102116417|NCT04498520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116418|NCT04498520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102116419|NCT04498520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102116420|NCT04498520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116421|NCT04498520|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102116422|NCT02172495|Bromides|bromides|mesh-list
102116423|NCT02172495|Tiotropium Bromide|tiotropium bromide|mesh-list
102116424|NCT02172495|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102116425|NCT02172495|Autonomic Agents|autonomic agents|mesh-ancestor
102116426|NCT02172495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102116427|NCT02172495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116428|NCT02172495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102116429|NCT02172495|Respiratory System Agents|respiratory system agents|mesh-ancestor
102116430|NCT02172495|Parasympatholytics|parasympatholytics|mesh-ancestor
102116431|NCT02172495|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102116432|NCT02172495|Cholinergic Agents|cholinergic agents|mesh-ancestor
102116433|NCT02172495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102116434|NCT02172495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116435|NCT02172495|Anticonvulsants|anticonvulsants|mesh-ancestor
102116436|NCT02172573|Pramipexole|pramipexole|mesh-list
102116437|NCT02172573|Bromocriptine|bromocriptine|mesh-list
102116438|NCT02172573|Antioxidants|antioxidants|mesh-ancestor
102116439|NCT02172573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116440|NCT02172573|Protective Agents|protective agents|mesh-ancestor
102116441|NCT02172573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116442|NCT02172573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102116443|NCT02172573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102116444|NCT02172573|Dopamine Agonists|dopamine agonists|mesh-ancestor
102116445|NCT02172573|Dopamine Agents|dopamine agents|mesh-ancestor
102116446|NCT02172573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102116447|NCT02172573|Hormone Antagonists|hormone antagonists|mesh-ancestor
102116448|NCT02172573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102116449|NCT02175381|Carboplatin|carboplatin|mesh-list
102116450|NCT02175381|Gemcitabine|gemcitabine|mesh-list
102116451|NCT02175381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102116452|NCT02175381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102116453|NCT02175381|Antimetabolites|antimetabolites|mesh-ancestor
102116454|NCT02175381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116455|NCT03540225|Progesterone|progesterone|mesh-list
102116456|NCT03540225|Progestins|progestins|mesh-ancestor
102116457|NCT03540225|Hormones|hormones|mesh-ancestor
102116458|NCT03540225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102116459|NCT03540225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535862|NCT05442801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116460|NCT02507648|Oseltamivir|oseltamivir|mesh-list
102116461|NCT02507648|Antiviral Agents|antiviral agents|mesh-ancestor
102116462|NCT02507648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102116463|NCT02507648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102116464|NCT02507648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116465|NCT02172729|Lidocaine|lidocaine|mesh-list
102116466|NCT02172729|Anesthetics, Local|anesthetics, local|mesh-ancestor
102116467|NCT02172729|Anesthetics|anesthetics|mesh-ancestor
102116468|NCT02172729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102116469|NCT02172729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116470|NCT02172729|Sensory System Agents|sensory system agents|mesh-ancestor
102116471|NCT02172729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102116472|NCT02172729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102116473|NCT02172729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102116474|NCT02172729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102116475|NCT02172729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102116476|NCT02172729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116477|NCT02172807|Tiotropium Bromide|tiotropium bromide|mesh-list
102116478|NCT02172807|Oxitropium|oxitropium|mesh-list
102116479|NCT02172807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102116480|NCT02172807|Autonomic Agents|autonomic agents|mesh-ancestor
102116481|NCT02172807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102116482|NCT02172807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116483|NCT02172807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102116484|NCT02172807|Respiratory System Agents|respiratory system agents|mesh-ancestor
102116485|NCT02172807|Parasympatholytics|parasympatholytics|mesh-ancestor
102116486|NCT02172807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102116487|NCT02172807|Cholinergic Agents|cholinergic agents|mesh-ancestor
102116488|NCT02172807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102116489|NCT02172807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116490|NCT04568421|Immunosuppressive Agents|immunosuppressive agents|mesh-list
102116491|NCT04568421|Immunologic Factors|immunologic factors|mesh-ancestor
102116492|NCT04568421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116493|NCT02502968|Cytarabine|cytarabine|mesh-list
102116494|NCT02502968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102116495|NCT02502968|Antimetabolites|antimetabolites|mesh-ancestor
102116496|NCT02502968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116497|NCT02502968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102116498|NCT02502968|Antiviral Agents|antiviral agents|mesh-ancestor
102116499|NCT02502968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102116500|NCT02502968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102116501|NCT02502968|Immunologic Factors|immunologic factors|mesh-ancestor
102116502|NCT02502968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116503|NCT02168751|Propofol|propofol|mesh-list
102116504|NCT02168751|Sevoflurane|sevoflurane|mesh-list
102116505|NCT02168751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102116506|NCT02168751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102116507|NCT02168751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116508|NCT02168751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102116509|NCT02168751|Anesthetics, General|anesthetics, general|mesh-ancestor
102116510|NCT02168751|Anesthetics|anesthetics|mesh-ancestor
102116511|NCT02168751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102116512|NCT02168751|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102116513|NCT02507570|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
102116514|NCT02507570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102116515|NCT03344042|Fentanyl|fentanyl|mesh-list
102116516|NCT03344042|Sufentanil|sufentanil|mesh-list
102116517|NCT03344042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102116518|NCT03344042|Narcotics|narcotics|mesh-ancestor
102116519|NCT03344042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102116520|NCT03344042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116521|NCT03344042|Analgesics|analgesics|mesh-ancestor
102116522|NCT03344042|Sensory System Agents|sensory system agents|mesh-ancestor
102116523|NCT03344042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102116524|NCT03344042|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102116525|NCT03344042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102116526|NCT03344042|Anesthetics, General|anesthetics, general|mesh-ancestor
102116527|NCT03344042|Anesthetics|anesthetics|mesh-ancestor
102116528|NCT02175927|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102116529|NCT02175927|Amoxicillin|amoxicillin|mesh-list
102116530|NCT02175927|Metronidazole|metronidazole|mesh-list
102116531|NCT02175927|Tetracycline|tetracycline|mesh-list
102116532|NCT02175927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102116533|NCT02175927|Potassium Citrate|potassium citrate|mesh-list
102116534|NCT02175927|Lansoprazole|lansoprazole|mesh-list
102116535|NCT02175927|Bismuth|bismuth|mesh-list
102116536|NCT02175927|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
102116537|NCT02175927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116539|NCT02175927|Antitubercular Agents|antitubercular agents|mesh-ancestor
102116540|NCT02175927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102116541|NCT02175927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102116542|NCT02175927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102116543|NCT02175927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102116544|NCT02175927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102116545|NCT02175927|Antacids|antacids|mesh-ancestor
102015171|NCT01354470|Modafinil|modafinil|mesh-list
102116546|NCT02175927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102116547|NCT02175927|Diuretics|diuretics|mesh-ancestor
102116548|NCT02175927|Natriuretic Agents|natriuretic agents|mesh-ancestor
102116549|NCT02175927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116550|NCT02175927|Expectorants|expectorants|mesh-ancestor
102116551|NCT02175927|Respiratory System Agents|respiratory system agents|mesh-ancestor
102116552|NCT00707486|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
102116553|NCT00707486|Hemostatics|hemostatics|mesh-ancestor
102116554|NCT00707486|Coagulants|coagulants|mesh-ancestor
102116555|NCT02496182|Pirfenidone|pirfenidone|mesh-list
102116556|NCT02496182|Analgesics|analgesics|mesh-ancestor
102116557|NCT02496182|Sensory System Agents|sensory system agents|mesh-ancestor
102116558|NCT02496182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102116559|NCT02496182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116560|NCT02496182|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102116561|NCT02496182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102116562|NCT02496182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102116563|NCT02496182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102116564|NCT02496182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102116565|NCT02168907|Thioctic Acid|thioctic acid|mesh-list
102116566|NCT02168907|Rituximab|rituximab|mesh-list
102116567|NCT02168907|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102116568|NCT02168907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102116569|NCT02168907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102116570|NCT02168907|Immunologic Factors|immunologic factors|mesh-ancestor
102116571|NCT02168907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116572|NCT02168907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102116573|NCT02168907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102116574|NCT02168907|Alkylating Agents|alkylating agents|mesh-ancestor
102116575|NCT02168907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116576|NCT02168907|Antioxidants|antioxidants|mesh-ancestor
102116577|NCT02168907|Protective Agents|protective agents|mesh-ancestor
102116578|NCT02168907|Vitamin B Complex|vitamin b complex|mesh-ancestor
102116579|NCT02168907|Vitamins|vitamins|mesh-ancestor
102116580|NCT02168907|Micronutrients|micronutrients|mesh-ancestor
102116581|NCT02500784|Formoterol Fumarate|formoterol fumarate|mesh-list
102116582|NCT02500784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102116583|NCT02500784|Autonomic Agents|autonomic agents|mesh-ancestor
102116584|NCT02500784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102116585|NCT02500784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116586|NCT02500784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102116587|NCT02500784|Respiratory System Agents|respiratory system agents|mesh-ancestor
102116588|NCT02500784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102116589|NCT02500784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102116590|NCT02500784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102116591|NCT02500784|Adrenergic Agents|adrenergic agents|mesh-ancestor
102116592|NCT02500784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102116593|NCT02500784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116594|NCT02500940|Leucovorin|leucovorin|mesh-list
102116595|NCT02500940|Fluorouracil|fluorouracil|mesh-list
102116596|NCT02500940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102116597|NCT02500940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116598|NCT02500940|Antimetabolites|antimetabolites|mesh-ancestor
102116599|NCT02500940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116600|NCT02500940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102116601|NCT02500940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102116602|NCT02500940|Immunologic Factors|immunologic factors|mesh-ancestor
102116603|NCT02500940|Antidotes|antidotes|mesh-ancestor
102116604|NCT02500940|Protective Agents|protective agents|mesh-ancestor
102116605|NCT02500940|Vitamin B Complex|vitamin b complex|mesh-ancestor
102116607|NCT02500940|Micronutrients|micronutrients|mesh-ancestor
102116608|NCT02495636|Atezolizumab|atezolizumab|mesh-list
102116609|NCT02495636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102116610|NCT02495636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116611|NCT02495636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102116612|NCT02495636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102116614|NCT02169063|Fluorides|fluorides|mesh-list
102116615|NCT02169063|Sodium Fluoride|sodium fluoride|mesh-list
102116616|NCT02169063|Cariostatic Agents|cariostatic agents|mesh-ancestor
102116617|NCT02169063|Protective Agents|protective agents|mesh-ancestor
102116618|NCT02169063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116619|NCT02169063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102116620|NCT02169063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102116621|NCT04496882|Tenofovir|tenofovir|mesh-list
102116622|NCT04496882|Antiviral Agents|antiviral agents|mesh-ancestor
102116623|NCT04496882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102116624|NCT04496882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102116625|NCT04496882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102116626|NCT04496882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102116627|NCT04496882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116628|NCT04496882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102116629|NCT04496882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102116630|NCT02502500|Celecoxib|celecoxib|mesh-list
102116631|NCT02502500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102116632|NCT02502500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102116633|NCT02502500|Analgesics|analgesics|mesh-ancestor
102116634|NCT02502500|Sensory System Agents|sensory system agents|mesh-ancestor
102116635|NCT02502500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102116636|NCT02502500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116637|NCT02502500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102116638|NCT02502500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102116639|NCT02502500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102116640|NCT02502500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102116641|NCT02502500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102116642|NCT02502500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116643|NCT02173665|Linagliptin|linagliptin|mesh-list
102116644|NCT02173665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102116645|NCT02173665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116646|NCT02173665|Incretins|incretins|mesh-ancestor
102116647|NCT02173665|Hormones|hormones|mesh-ancestor
102116648|NCT02173665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102116649|NCT02173665|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102116650|NCT02173665|Protease Inhibitors|protease inhibitors|mesh-ancestor
102116651|NCT02173665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102116652|NCT02173665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116653|NCT02495324|Valsartan|valsartan|mesh-list
102116654|NCT02495324|Olmesartan|olmesartan|mesh-list
102116655|NCT02495324|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
102116656|NCT02495324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102116657|NCT02495324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102116658|NCT02495324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102116659|NCT02495324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116660|NCT02500238|Carbon Monoxide|carbon monoxide|mesh-list
102116661|NCT02500238|Antimetabolites|antimetabolites|mesh-ancestor
102116662|NCT02500238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116663|NCT02500238|Gasotransmitters|gasotransmitters|mesh-ancestor
102116664|NCT02500238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102116665|NCT02500238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116666|NCT04625283|Ketamine|ketamine|mesh-list
102116667|NCT04625283|Analgesics|analgesics|mesh-ancestor
102116668|NCT04625283|Sensory System Agents|sensory system agents|mesh-ancestor
102116669|NCT04625283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102116670|NCT04625283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116671|NCT04625283|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102116672|NCT04625283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102116673|NCT04625283|Anesthetics, General|anesthetics, general|mesh-ancestor
102116674|NCT04625283|Anesthetics|anesthetics|mesh-ancestor
102116675|NCT04625283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102116676|NCT04625283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102116677|NCT04625283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102116678|NCT04625283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102116679|NCT04625283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116680|NCT02256033|Istradefylline|istradefylline|mesh-list
102116681|NCT02256033|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
102116682|NCT02256033|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102116683|NCT02256033|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102116684|NCT02256033|Purinergic Agents|purinergic agents|mesh-ancestor
102116685|NCT02256033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102116686|NCT02256033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015304|NCT01347294|Bleomycin|bleomycin|mesh-list
102116687|NCT02256033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116688|NCT02502110|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102116689|NCT02502110|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102116690|NCT02502110|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102116691|NCT02502110|Antimetabolites|antimetabolites|mesh-ancestor
102116692|NCT02502110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116693|NCT02502110|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102116694|NCT02502110|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102116695|NCT02502110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102116696|NCT02502344|Metformin|metformin|mesh-list
102116697|NCT02502344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102116698|NCT02502344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116699|NCT02174211|Ranibizumab|ranibizumab|mesh-list
102116700|NCT02174211|Aflibercept|aflibercept|mesh-list
102116701|NCT02174211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102116702|NCT02174211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102116703|NCT02174211|Growth Substances|growth substances|mesh-ancestor
102116704|NCT02174211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116705|NCT02174211|Growth Inhibitors|growth inhibitors|mesh-ancestor
102116706|NCT02174211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102116707|NCT04496492|Tocotrienols|tocotrienols|mesh-list
102116708|NCT04496492|Vitamin E|vitamin e|mesh-list
102116709|NCT04496492|Tocopherols|tocopherols|mesh-list
102116710|NCT04496492|Antioxidants|antioxidants|mesh-ancestor
102116711|NCT04496492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116712|NCT04496492|Protective Agents|protective agents|mesh-ancestor
102116713|NCT04496492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116714|NCT04496492|Vitamins|vitamins|mesh-ancestor
102116715|NCT04496492|Micronutrients|micronutrients|mesh-ancestor
102116716|NCT02500004|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102116717|NCT02500004|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102116718|NCT02500004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116719|NCT02502032|Cisatracurium|cisatracurium|mesh-list
102116720|NCT02502032|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102116721|NCT02502032|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102116722|NCT02502032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102116723|NCT02502032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116724|NCT02494856|Naproxen|naproxen|mesh-list
102116725|NCT02494856|Esomeprazole|esomeprazole|mesh-list
102116726|NCT02494856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102116727|NCT02494856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102116728|NCT02494856|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102116729|NCT02494856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102116730|NCT02494856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116731|NCT02494856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102116732|NCT02494856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102116733|NCT02494856|Analgesics|analgesics|mesh-ancestor
102116734|NCT02494856|Sensory System Agents|sensory system agents|mesh-ancestor
102116735|NCT02494856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102116736|NCT02494856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116737|NCT02494856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102116738|NCT02494856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102116739|NCT02494856|Gout Suppressants|gout suppressants|mesh-ancestor
102116740|NCT02494856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102116741|NCT04495010|Nivolumab|nivolumab|mesh-list
102116742|NCT04495010|Ipilimumab|ipilimumab|mesh-list
102116743|NCT04495010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102116744|NCT04495010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102116745|NCT04495010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102116746|NCT04495010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116747|NCT03343418|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
102116748|NCT03343418|Hemostatics|hemostatics|mesh-ancestor
102116749|NCT03343418|Coagulants|coagulants|mesh-ancestor
102116750|NCT03343418|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102116751|NCT03343418|Natriuretic Agents|natriuretic agents|mesh-ancestor
101570288|NCT03122002|Clopidogrel|clopidogrel|mesh-list
102116752|NCT03343418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116753|NCT02501798|Methylphenidate|methylphenidate|mesh-list
102116754|NCT02501798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102116755|NCT02501798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116756|NCT02501798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102116757|NCT02501798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102015376|NCT01844856|Ertapenem|ertapenem|mesh-list
102116758|NCT02501798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102154326|NCT03365817|Narcotics|narcotics|mesh-ancestor
102116759|NCT02501798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116761|NCT02501798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102116762|NCT02169609|Interleukin-2|interleukin-2|mesh-list
102116763|NCT02169609|Dinutuximab|dinutuximab|mesh-list
102116764|NCT02169609|Isotretinoin|isotretinoin|mesh-list
102116765|NCT02169609|Sargramostim|sargramostim|mesh-list
102116766|NCT02169609|Immunologic Factors|immunologic factors|mesh-ancestor
102116767|NCT02169609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116768|NCT02169609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102116769|NCT02169609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102116770|NCT02169609|Analgesics|analgesics|mesh-ancestor
102116771|NCT02169609|Sensory System Agents|sensory system agents|mesh-ancestor
102116772|NCT02169609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102116773|NCT02169609|Dermatologic Agents|dermatologic agents|mesh-ancestor
102116774|NCT02499614|Crizotinib|crizotinib|mesh-list
102116775|NCT02499614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102116776|NCT02499614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102116777|NCT02499614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102116778|NCT02499614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116779|NCT02169843|Dexmedetomidine|dexmedetomidine|mesh-list
102116780|NCT02169843|Sevoflurane|sevoflurane|mesh-list
102116781|NCT02169843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102116782|NCT02169843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102116783|NCT02169843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116784|NCT02169843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102116785|NCT02169843|Analgesics|analgesics|mesh-ancestor
102116786|NCT02169843|Sensory System Agents|sensory system agents|mesh-ancestor
102116787|NCT02169843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102116788|NCT02169843|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102116789|NCT02169843|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102116790|NCT02169843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102116791|NCT02169843|Adrenergic Agents|adrenergic agents|mesh-ancestor
102116792|NCT02169843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102116793|NCT02169843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116794|NCT02169843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102116795|NCT02169843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102116796|NCT02169843|Anesthetics, General|anesthetics, general|mesh-ancestor
102116797|NCT02169843|Anesthetics|anesthetics|mesh-ancestor
102116798|NCT03341390|Aspirin|aspirin|mesh-list
102116799|NCT03341390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102116800|NCT03341390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102116801|NCT03341390|Analgesics|analgesics|mesh-ancestor
102116802|NCT03341390|Sensory System Agents|sensory system agents|mesh-ancestor
102116803|NCT03341390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102116804|NCT03341390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116805|NCT03341390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102116806|NCT03341390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102116807|NCT03341390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102116808|NCT03341390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102116809|NCT03341390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116810|NCT03341390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102116811|NCT03341390|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102116812|NCT03341390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102116813|NCT03341390|Antipyretics|antipyretics|mesh-ancestor
102116814|NCT02174445|Imatinib Mesylate|imatinib mesylate|mesh-list
102116815|NCT02174445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102116816|NCT02174445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102116817|NCT02174445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102116818|NCT02174445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116819|NCT00707174|Imiquimod|imiquimod|mesh-list
102116820|NCT00707174|Tazarotene|tazarotene|mesh-list
102116821|NCT00707174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102116822|NCT00707174|Immunologic Factors|immunologic factors|mesh-ancestor
102116823|NCT00707174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116824|NCT00707174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102116825|NCT00707174|Interferon Inducers|interferon inducers|mesh-ancestor
102116826|NCT00707174|Dermatologic Agents|dermatologic agents|mesh-ancestor
102116827|NCT00707174|Keratolytic Agents|keratolytic agents|mesh-ancestor
102116828|NCT03341234|Bupivacaine|bupivacaine|mesh-list
102116829|NCT03341234|Anesthetics, Local|anesthetics, local|mesh-ancestor
102116830|NCT03341234|Anesthetics|anesthetics|mesh-ancestor
102116831|NCT03341234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102116832|NCT03341234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116833|NCT03341234|Sensory System Agents|sensory system agents|mesh-ancestor
102116834|NCT03341234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102116835|NCT02499224|Monoclonal antibody YYB-101|monoclonal antibody yyb-101|mesh-list
102116837|NCT03120494|Tenofovir|tenofovir|mesh-list
102116838|NCT03120494|Emtricitabine|emtricitabine|mesh-list
102116839|NCT03120494|Antiviral Agents|antiviral agents|mesh-ancestor
102116840|NCT03120494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102116841|NCT03120494|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102116842|NCT03120494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102116843|NCT03120494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102116844|NCT03120494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116845|NCT03120494|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102116846|NCT03120494|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102116847|NCT03537573|Analgesics, Opioid|analgesics, opioid|mesh-list
102116848|NCT03537573|Narcotics|narcotics|mesh-ancestor
102116849|NCT03537573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102116850|NCT03537573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116851|NCT03537573|Analgesics|analgesics|mesh-ancestor
102116852|NCT03537573|Sensory System Agents|sensory system agents|mesh-ancestor
102116853|NCT03537573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102116854|NCT03120962|Famciclovir|famciclovir|mesh-list
102116855|NCT03120962|Oxycodone|oxycodone|mesh-list
102116856|NCT03120962|Gabapentin|gabapentin|mesh-list
102116857|NCT03120962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102116858|NCT03120962|Narcotics|narcotics|mesh-ancestor
102116859|NCT03120962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102116860|NCT03120962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116861|NCT03120962|Analgesics|analgesics|mesh-ancestor
102116862|NCT03120962|Sensory System Agents|sensory system agents|mesh-ancestor
102116863|NCT03120962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102116864|NCT03120962|Anticonvulsants|anticonvulsants|mesh-ancestor
102116865|NCT03120962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102116866|NCT03120962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102116867|NCT03120962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102116868|NCT03120962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102116869|NCT03120962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102116870|NCT03120962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102116871|NCT03120962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116872|NCT03120962|Antimanic Agents|antimanic agents|mesh-ancestor
102116873|NCT03120962|Antiviral Agents|antiviral agents|mesh-ancestor
102116874|NCT03120962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102116875|NCT03120962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102116876|NCT03120962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102116877|NCT02178813|Minocycline|minocycline|mesh-list
102116878|NCT02178813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102116879|NCT02178813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102116880|NCT03340922|Long-Acting Thyroid Stimulator|long-acting thyroid stimulator|mesh-list
102116881|NCT03340922|Immunologic Factors|immunologic factors|mesh-ancestor
102116882|NCT03340922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116883|NCT02177253|Bromides|bromides|mesh-list
102116884|NCT02177253|Albuterol|albuterol|mesh-list
102116885|NCT02177253|Ipratropium|ipratropium|mesh-list
102116886|NCT02177253|Anticonvulsants|anticonvulsants|mesh-ancestor
102116887|NCT02177253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102116888|NCT02177253|Autonomic Agents|autonomic agents|mesh-ancestor
102116889|NCT02177253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102116890|NCT02177253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116891|NCT02177253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102116892|NCT02177253|Respiratory System Agents|respiratory system agents|mesh-ancestor
102116893|NCT02177253|Tocolytic Agents|tocolytic agents|mesh-ancestor
102116894|NCT02177253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102116895|NCT02177253|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102116896|NCT02177253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102116897|NCT02177253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102116898|NCT02177253|Adrenergic Agents|adrenergic agents|mesh-ancestor
102116899|NCT02177253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102116900|NCT02177253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116901|NCT02177253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102116902|NCT02177253|Cholinergic Agents|cholinergic agents|mesh-ancestor
102116903|NCT02177331|Lacidipine|lacidipine|mesh-list
102116904|NCT02177331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102116905|NCT02177331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102116906|NCT02177331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102116907|NCT02177331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116908|NCT02177331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102116909|NCT02177331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116912|NCT02177409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102116913|NCT02177409|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102116914|NCT02177409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102116915|NCT02177409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116916|NCT02177409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102116917|NCT02177409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116918|NCT02177409|Vasodilator Agents|vasodilator agents|mesh-ancestor
102116919|NCT02177409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102116920|NCT02177409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102116921|NCT02170623|Pantoprazole|pantoprazole|mesh-list
102116922|NCT02170623|Dabigatran|dabigatran|mesh-list
102116923|NCT02170623|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102116924|NCT02170623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102116925|NCT02170623|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102116926|NCT02170623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102116927|NCT02170623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116928|NCT02170623|Antithrombins|antithrombins|mesh-ancestor
102116929|NCT02170623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102116930|NCT02170623|Protease Inhibitors|protease inhibitors|mesh-ancestor
102116931|NCT02170623|Anticoagulants|anticoagulants|mesh-ancestor
102116932|NCT02170701|Dabigatran|dabigatran|mesh-list
102116933|NCT02170701|Antithrombins|antithrombins|mesh-ancestor
102116934|NCT02170701|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102116935|NCT02170701|Protease Inhibitors|protease inhibitors|mesh-ancestor
102116936|NCT02170701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102116937|NCT02170701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116938|NCT02170701|Anticoagulants|anticoagulants|mesh-ancestor
102116939|NCT02498756|Ipilimumab|ipilimumab|mesh-list
102116940|NCT02498756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102116941|NCT02498756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102116942|NCT02498756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102116943|NCT02498756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116944|NCT03336632|Cyclosporine|cyclosporine|mesh-list
102116945|NCT03336632|Cyclophosphamide|cyclophosphamide|mesh-list
102116946|NCT03336632|Cyclosporins|cyclosporins|mesh-list
102116947|NCT03336632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102116948|NCT03336632|Immunologic Factors|immunologic factors|mesh-ancestor
102116949|NCT03336632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116950|NCT03336632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102116951|NCT03336632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102116952|NCT03336632|Alkylating Agents|alkylating agents|mesh-ancestor
102116953|NCT03336632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116954|NCT03336632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102116955|NCT03336632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102116956|NCT03336632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102116957|NCT03336632|Antifungal Agents|antifungal agents|mesh-ancestor
102116958|NCT03336632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102116959|NCT03336632|Dermatologic Agents|dermatologic agents|mesh-ancestor
102116960|NCT03336632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102116961|NCT02498288|Isotretinoin|isotretinoin|mesh-list
102116962|NCT02498288|Dermatologic Agents|dermatologic agents|mesh-ancestor
102116963|NCT02756403|Azithromycin|azithromycin|mesh-list
102116964|NCT02756403|Metronidazole|metronidazole|mesh-list
102116965|NCT02756403|Doxycycline|doxycycline|mesh-list
102116966|NCT02756403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102116967|NCT02756403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102116968|NCT02756403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102116969|NCT02756403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102116970|NCT02756403|Antimalarials|antimalarials|mesh-ancestor
102116971|NCT02494466|Montelukast|montelukast|mesh-list
102116972|NCT02494466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102116973|NCT02494466|Respiratory System Agents|respiratory system agents|mesh-ancestor
102116974|NCT02494466|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102116975|NCT02494466|Hormone Antagonists|hormone antagonists|mesh-ancestor
102116976|NCT02494466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102116977|NCT02494466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116978|NCT02494466|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102116979|NCT02494466|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102116980|NCT02494466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116981|NCT02177487|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102116982|NCT02177487|Telmisartan|telmisartan|mesh-list
102154327|NCT03365817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102116983|NCT02177487|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
102116984|NCT02177487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102116985|NCT02177487|Diuretics|diuretics|mesh-ancestor
102116986|NCT02177487|Natriuretic Agents|natriuretic agents|mesh-ancestor
102116987|NCT02177487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102116988|NCT02177487|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102116989|NCT02177487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102116990|NCT02177487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102116991|NCT02177487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102116992|NCT02177487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102116993|NCT02177643|Diacerein|diacerein|mesh-list
102116994|NCT02177643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102116995|NCT03340376|Doxorubicin|doxorubicin|mesh-list
102116996|NCT03340376|Atezolizumab|atezolizumab|mesh-list
102116997|NCT03340376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102116998|NCT03340376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102116999|NCT03340376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102117000|NCT03340376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102117001|NCT03340376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102117002|NCT03340376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117003|NCT03340376|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102117004|NCT03340376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102117005|NCT02182167|Acetylcysteine|acetylcysteine|mesh-list
102117006|NCT02182167|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102117007|NCT02182167|Antiviral Agents|antiviral agents|mesh-ancestor
102117008|NCT02182167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102117009|NCT02182167|Expectorants|expectorants|mesh-ancestor
102117010|NCT02182167|Respiratory System Agents|respiratory system agents|mesh-ancestor
102117011|NCT02182167|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102117012|NCT02182167|Antioxidants|antioxidants|mesh-ancestor
102117013|NCT02182167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117014|NCT02182167|Protective Agents|protective agents|mesh-ancestor
102117015|NCT02182167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117016|NCT02182167|Antidotes|antidotes|mesh-ancestor
102117017|NCT02182245|Paclitaxel|paclitaxel|mesh-list
102117018|NCT02182245|Carboplatin|carboplatin|mesh-list
102117019|NCT02182245|Nintedanib|nintedanib|mesh-list
102117020|NCT02182245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102117021|NCT02182245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102117022|NCT02182245|Tubulin Modulators|tubulin modulators|mesh-ancestor
102117023|NCT02182245|Antimitotic Agents|antimitotic agents|mesh-ancestor
102117024|NCT02182245|Mitosis Modulators|mitosis modulators|mesh-ancestor
102117025|NCT02182245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117026|NCT02182245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102117027|NCT02182245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102117028|NCT05233124|Aspirin|aspirin|mesh-list
102117029|NCT05233124|Rivaroxaban|rivaroxaban|mesh-list
102117030|NCT05233124|Clopidogrel|clopidogrel|mesh-list
102117031|NCT05233124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102117032|NCT05233124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102117033|NCT05233124|Analgesics|analgesics|mesh-ancestor
102117034|NCT05233124|Sensory System Agents|sensory system agents|mesh-ancestor
102117035|NCT05233124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102117036|NCT05233124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117037|NCT05233124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102117038|NCT05233124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102117039|NCT05233124|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102117040|NCT05233124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102117041|NCT05233124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117042|NCT05233124|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102117043|NCT05233124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102117044|NCT05233124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102117045|NCT05233124|Antipyretics|antipyretics|mesh-ancestor
102117046|NCT05233124|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102117047|NCT05233124|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102117048|NCT05233124|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102117049|NCT05233124|Purinergic Agents|purinergic agents|mesh-ancestor
102117050|NCT05233124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102117051|NCT05233124|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101507893|NCT02952599|Edoxaban|edoxaban|mesh-list
102117052|NCT05233124|Antithrombins|antithrombins|mesh-ancestor
102117053|NCT05233124|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102117054|NCT05233124|Protease Inhibitors|protease inhibitors|mesh-ancestor
102117055|NCT05233124|Anticoagulants|anticoagulants|mesh-ancestor
102117056|NCT03339752|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102117057|NCT03339752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102117058|NCT03339752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102117059|NCT03339752|Antimetabolites|antimetabolites|mesh-ancestor
102117060|NCT03339752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117061|NCT03339752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102117062|NCT03339752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102117063|NCT03339752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102117064|NCT03339362|Methylprednisolone|methylprednisolone|mesh-list
102117065|NCT03339362|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102117066|NCT03339362|Bupivacaine|bupivacaine|mesh-list
102117067|NCT03339362|Anesthetics, Local|anesthetics, local|mesh-ancestor
102117068|NCT03339362|Anesthetics|anesthetics|mesh-ancestor
102117069|NCT03339362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102117070|NCT03339362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117071|NCT03339362|Sensory System Agents|sensory system agents|mesh-ancestor
102117072|NCT03339362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102117073|NCT03339362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102117074|NCT03339362|Antiemetics|antiemetics|mesh-ancestor
102117075|NCT03339362|Autonomic Agents|autonomic agents|mesh-ancestor
102117076|NCT03339362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102117077|NCT03339362|Glucocorticoids|glucocorticoids|mesh-ancestor
102117079|NCT03339362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102117080|NCT03339362|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102117081|NCT03339362|Protective Agents|protective agents|mesh-ancestor
102117082|NCT02497820|Aspirin|aspirin|mesh-list
102117083|NCT02497820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102117084|NCT02497820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102117085|NCT02497820|Analgesics|analgesics|mesh-ancestor
102117086|NCT02497820|Sensory System Agents|sensory system agents|mesh-ancestor
102117087|NCT02497820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102117088|NCT02497820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117089|NCT02497820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102117090|NCT02497820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102117091|NCT02497820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102117092|NCT02497820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102117093|NCT02497820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117094|NCT02497820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102117095|NCT02497820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102117096|NCT02497820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102117097|NCT02497820|Antipyretics|antipyretics|mesh-ancestor
102117098|NCT02497508|Nivolumab|nivolumab|mesh-list
102117099|NCT02497508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102117100|NCT02497508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102117101|NCT02497508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102117102|NCT02497508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117103|NCT03338426|Atorvastatin|atorvastatin|mesh-list
102117104|NCT03338426|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102117105|NCT03338426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102117106|NCT03338426|Antimetabolites|antimetabolites|mesh-ancestor
102117107|NCT03338426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117108|NCT03338426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102117109|NCT03338426|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102117110|NCT03338426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102117111|NCT03338348|Azacitidine|azacitidine|mesh-list
102117112|NCT03338348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102117113|NCT03338348|Antimetabolites|antimetabolites|mesh-ancestor
102117114|NCT03338348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117115|NCT03338348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102117116|NCT03338348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102117117|NCT03334838|Nifurtimox|nifurtimox|mesh-list
102117118|NCT03334838|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102117119|NCT03334838|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102117120|NCT03334838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102117121|NCT03334838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102117122|NCT02497118|Vinorelbine|vinorelbine|mesh-list
102117123|NCT02497118|Endostatins|endostatins|mesh-list
102117124|NCT02497118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102117125|NCT02497118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102117126|NCT02497118|Tubulin Modulators|tubulin modulators|mesh-ancestor
102117127|NCT02497118|Antimitotic Agents|antimitotic agents|mesh-ancestor
102117128|NCT02497118|Mitosis Modulators|mitosis modulators|mesh-ancestor
102117129|NCT02497118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535863|NCT05442801|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102117130|NCT02497118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102117131|NCT02497118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102117132|NCT02497118|Growth Substances|growth substances|mesh-ancestor
102117133|NCT02497118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117134|NCT02497118|Growth Inhibitors|growth inhibitors|mesh-ancestor
102117135|NCT02496962|Atorvastatin|atorvastatin|mesh-list
102117136|NCT02496962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102117137|NCT02496962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102117138|NCT02496962|Antimetabolites|antimetabolites|mesh-ancestor
102117139|NCT02496962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117140|NCT02496962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102117141|NCT02496962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102117142|NCT02496962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102117143|NCT03334136|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
102117144|NCT03334136|Calcifediol|calcifediol|mesh-list
102117145|NCT03334136|Vitamins|vitamins|mesh-ancestor
102117146|NCT03334136|Micronutrients|micronutrients|mesh-ancestor
102117147|NCT03334136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117148|NCT03334136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102117149|NCT03120728|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102117150|NCT03120728|Etonogestrel|etonogestrel|mesh-list
102117151|NCT03120728|NuvaRing|nuvaring|mesh-list
102117152|NCT03120728|Contraceptive Agents|contraceptive agents|mesh-list
102117153|NCT03120728|Estradiol|estradiol|mesh-list
102117154|NCT03120728|Estrogens|estrogens|mesh-ancestor
102117155|NCT03120728|Hormones|hormones|mesh-ancestor
102117156|NCT03120728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102117157|NCT03120728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117158|NCT03120728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102117159|NCT03120728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102117160|NCT03120728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102117161|NCT03120728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102117162|NCT03120728|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102117163|NCT02496650|Dexmedetomidine|dexmedetomidine|mesh-list
102117164|NCT02496650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102117165|NCT02496650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102117166|NCT02496650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117167|NCT02496650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102117168|NCT02496650|Analgesics|analgesics|mesh-ancestor
102117169|NCT02496650|Sensory System Agents|sensory system agents|mesh-ancestor
102117170|NCT02496650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102117171|NCT02496650|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102117172|NCT02496650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102117173|NCT02496650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102117174|NCT02496650|Adrenergic Agents|adrenergic agents|mesh-ancestor
102117175|NCT02496650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102117176|NCT02496650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117177|NCT02492438|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102117178|NCT02492438|Immunologic Factors|immunologic factors|mesh-ancestor
102117179|NCT02492438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117180|NCT03342170|Thrombin|thrombin|mesh-list
102117181|NCT03342170|Hemostatics|hemostatics|mesh-ancestor
102117182|NCT03342170|Coagulants|coagulants|mesh-ancestor
102117183|NCT03333824|Midazolam|midazolam|mesh-list
102117184|NCT03333824|Granisetron|granisetron|mesh-list
102117185|NCT03333824|Caffeine|caffeine|mesh-list
102117186|NCT03333824|Omeprazole|omeprazole|mesh-list
102117187|NCT03333824|Adavosertib|adavosertib|mesh-list
102117188|NCT03333824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102117189|NCT03333824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102117190|NCT03333824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102117191|NCT03333824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117192|NCT03333824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102117193|NCT03333824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102117194|NCT03333824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102117195|NCT03333824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102117196|NCT03333824|Anesthetics, General|anesthetics, general|mesh-ancestor
102117197|NCT03333824|Anesthetics|anesthetics|mesh-ancestor
102117198|NCT03333824|GABA Modulators|gaba modulators|mesh-ancestor
102117199|NCT03333824|GABA Agents|gaba agents|mesh-ancestor
102117200|NCT03333824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102117201|NCT03333824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117202|NCT03333824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102117203|NCT03333824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102117204|NCT03333824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102117205|NCT03333824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102117206|NCT03333824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102117207|NCT03333824|Purinergic Agents|purinergic agents|mesh-ancestor
102117208|NCT03333824|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102117209|NCT03333824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102117210|NCT03333824|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102117211|NCT03333824|Antiemetics|antiemetics|mesh-ancestor
102117212|NCT03333824|Autonomic Agents|autonomic agents|mesh-ancestor
102117213|NCT03333824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102117214|NCT03333824|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102117215|NCT03333824|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102117216|NCT03333824|Serotonin Agents|serotonin agents|mesh-ancestor
102117217|NCT02496494|Tacrolimus|tacrolimus|mesh-list
102117218|NCT02496494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102117219|NCT02496494|Immunologic Factors|immunologic factors|mesh-ancestor
102117220|NCT02496494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117221|NCT02496494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102117222|NCT02496494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102117223|NCT02496494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117224|NCT03333278|Vitamins|vitamins|mesh-list
102117225|NCT03333278|Ascorbic Acid|ascorbic acid|mesh-list
102117226|NCT03333278|Thiamine|thiamine|mesh-list
102117227|NCT03333278|Hydrocortisone|hydrocortisone|mesh-list
102117228|NCT03333278|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102117229|NCT03333278|Micronutrients|micronutrients|mesh-ancestor
102117230|NCT03333278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117231|NCT03333278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102117232|NCT03333278|Antioxidants|antioxidants|mesh-ancestor
102117233|NCT03333278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117234|NCT03333278|Protective Agents|protective agents|mesh-ancestor
102117235|NCT03333278|Vitamin B Complex|vitamin b complex|mesh-ancestor
102117236|NCT04847596|Ofatumumab|ofatumumab|mesh-list
102117237|NCT04847596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102117238|NCT00706628|Nintedanib|nintedanib|mesh-list
102117239|NCT00706628|Afatinib|afatinib|mesh-list
102117240|NCT00706628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102117241|NCT00706628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102117242|NCT00706628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102117243|NCT00706628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117244|NCT05463614|Propranolol|propranolol|mesh-list
102117245|NCT05463614|Propafenone|propafenone|mesh-list
102117246|NCT05463614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102117247|NCT05463614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102117248|NCT05463614|Adrenergic Agents|adrenergic agents|mesh-ancestor
102117249|NCT05463614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102117250|NCT05463614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117251|NCT05463614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117252|NCT05463614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102117253|NCT05463614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102117254|NCT05463614|Vasodilator Agents|vasodilator agents|mesh-ancestor
102117255|NCT05463614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102117256|NCT05463614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102117257|NCT05463614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102117258|NCT03332888|Rituximab|rituximab|mesh-list
102117259|NCT03332888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102117260|NCT03332888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102117261|NCT03332888|Immunologic Factors|immunologic factors|mesh-ancestor
102117262|NCT03332888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117263|NCT03332888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102117264|NCT03332732|Metronidazole|metronidazole|mesh-list
102117265|NCT03332732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102117266|NCT03332732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102117267|NCT03332732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102117268|NCT03332732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102117269|NCT02492360|Cisplatin|cisplatin|mesh-list
102117270|NCT02492360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102117271|NCT02492282|Remifentanil|remifentanil|mesh-list
102117272|NCT02492282|Propofol|propofol|mesh-list
102117273|NCT02492282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102117274|NCT02492282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102117275|NCT02492282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117276|NCT02492282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102117277|NCT02492282|Anesthetics, General|anesthetics, general|mesh-ancestor
102117278|NCT02492282|Anesthetics|anesthetics|mesh-ancestor
102117279|NCT02492282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102117280|NCT02492282|Narcotics|narcotics|mesh-ancestor
102117281|NCT02492282|Analgesics|analgesics|mesh-ancestor
102117282|NCT02492282|Sensory System Agents|sensory system agents|mesh-ancestor
102117283|NCT02492282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102117284|NCT02492126|Citric Acid|citric acid|mesh-list
102117285|NCT02492126|Sodium Citrate|sodium citrate|mesh-list
102117286|NCT02492126|Anticoagulants|anticoagulants|mesh-ancestor
102117287|NCT02492126|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102117288|NCT02492126|Chelating Agents|chelating agents|mesh-ancestor
102117289|NCT02492126|Sequestering Agents|sequestering agents|mesh-ancestor
102117290|NCT02492126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117291|NCT05464862|Lidocaine|lidocaine|mesh-list
102117292|NCT05464862|Anesthetics, Local|anesthetics, local|mesh-ancestor
102117293|NCT05464862|Anesthetics|anesthetics|mesh-ancestor
102117294|NCT05464862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102117295|NCT05464862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117296|NCT05464862|Sensory System Agents|sensory system agents|mesh-ancestor
102117297|NCT05464862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102117298|NCT05464862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102117299|NCT05464862|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102117300|NCT05464862|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102117301|NCT05464862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102117302|NCT05464862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117303|NCT03324776|Insulin|insulin|mesh-list
102117304|NCT03324776|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102117305|NCT03324776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102117306|NCT03324776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117307|NCT02561806|Ustekinumab|ustekinumab|mesh-list
102117308|NCT02561806|Ixekizumab|ixekizumab|mesh-list
102117309|NCT02561806|Dermatologic Agents|dermatologic agents|mesh-ancestor
102117310|NCT03332576|Cyclophosphamide|cyclophosphamide|mesh-list
102117311|NCT03332576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102117312|NCT03332576|Immunologic Factors|immunologic factors|mesh-ancestor
102117313|NCT03332576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117314|NCT03332576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102117315|NCT03332576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102117316|NCT03332576|Alkylating Agents|alkylating agents|mesh-ancestor
102015935|NCT01359228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102117317|NCT03332576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117318|NCT03332576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102117319|NCT03332576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102117320|NCT03330860|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102117321|NCT03330860|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
102117322|NCT03330860|beta-Endorphin|beta-endorphin|mesh-list
102117323|NCT03330860|Hormones|hormones|mesh-ancestor
102117324|NCT03330860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102117325|NCT03330860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117326|NCT03330860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102117327|NCT03330860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117328|NCT03324542|Ranibizumab|ranibizumab|mesh-list
102117329|NCT03324542|Aflibercept|aflibercept|mesh-list
102117330|NCT03324542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102117331|NCT03324542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102117332|NCT03324542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102117333|NCT03324542|Growth Substances|growth substances|mesh-ancestor
102117334|NCT03324542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117335|NCT03324542|Growth Inhibitors|growth inhibitors|mesh-ancestor
102117336|NCT03330782|Remifentanil|remifentanil|mesh-list
102117337|NCT03330782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102117338|NCT03330782|Narcotics|narcotics|mesh-ancestor
102117339|NCT03330782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102117340|NCT03330782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117341|NCT03330782|Analgesics|analgesics|mesh-ancestor
102117342|NCT03330782|Sensory System Agents|sensory system agents|mesh-ancestor
102117343|NCT03330782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102117344|NCT05506462|Ketamine|ketamine|mesh-list
102117345|NCT05506462|Analgesics|analgesics|mesh-ancestor
102117346|NCT05506462|Sensory System Agents|sensory system agents|mesh-ancestor
102117347|NCT05506462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102117348|NCT05506462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117349|NCT05506462|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102117350|NCT05506462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102117351|NCT05506462|Anesthetics, General|anesthetics, general|mesh-ancestor
102117352|NCT05506462|Anesthetics|anesthetics|mesh-ancestor
102117353|NCT05506462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102117354|NCT05506462|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102117355|NCT05506462|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102117356|NCT05506462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102117357|NCT05506462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117358|NCT05501704|Tamoxifen|tamoxifen|mesh-list
102117359|NCT05501704|Anastrozole|anastrozole|mesh-list
102117360|NCT05501704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102117361|NCT05501704|Hormone Antagonists|hormone antagonists|mesh-ancestor
102117362|NCT05501704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102117363|NCT05501704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117364|NCT05501704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102117365|NCT05501704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102117366|NCT05501704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102117367|NCT05501704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102117368|NCT05501704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102117369|NCT05501704|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102117370|NCT05501704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102117371|NCT05501704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102117372|NCT05501704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117373|NCT05505994|Dapagliflozin|dapagliflozin|mesh-list
102117374|NCT05505994|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102117375|NCT05505994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117376|NCT05505994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102117377|NCT05505994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117378|NCT02491268|Cilostazol|cilostazol|mesh-list
102117379|NCT02491268|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102117380|NCT02491268|Autonomic Agents|autonomic agents|mesh-ancestor
102117381|NCT02491268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102117382|NCT02491268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117383|NCT02491268|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102016008|NCT04441918|Antibodies|antibodies|mesh-list
102117384|NCT02491268|Respiratory System Agents|respiratory system agents|mesh-ancestor
102117385|NCT02491268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102117386|NCT02491268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102117387|NCT02491268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117388|NCT02491268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102117389|NCT02491268|Vasodilator Agents|vasodilator agents|mesh-ancestor
102117390|NCT02491268|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102117391|NCT02491268|Protective Agents|protective agents|mesh-ancestor
102117392|NCT02491268|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102117393|NCT02491268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102117394|NCT02491268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102117395|NCT03323684|Acetaminophen|acetaminophen|mesh-list
102117396|NCT03323684|Ketorolac|ketorolac|mesh-list
102117397|NCT03323684|Fentanyl|fentanyl|mesh-list
102117398|NCT03323684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102117399|NCT03323684|Narcotics|narcotics|mesh-ancestor
102117400|NCT03323684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102117401|NCT03323684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117402|NCT03323684|Analgesics|analgesics|mesh-ancestor
102117403|NCT03323684|Sensory System Agents|sensory system agents|mesh-ancestor
102117404|NCT03323684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102117405|NCT03323684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102117406|NCT03323684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102117407|NCT03323684|Anesthetics, General|anesthetics, general|mesh-ancestor
102117408|NCT03323684|Anesthetics|anesthetics|mesh-ancestor
102117409|NCT03323684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102117410|NCT03323684|Antipyretics|antipyretics|mesh-ancestor
102117411|NCT03323684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102117412|NCT03323684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102117413|NCT03323684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102117414|NCT03323684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102117415|NCT03323684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102117416|NCT03323684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117417|NCT02182401|Tolbutamide|tolbutamide|mesh-list
102117418|NCT02182401|Midazolam|midazolam|mesh-list
102117419|NCT02182401|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102117420|NCT02182401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102117421|NCT02182401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102117422|NCT02182401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117423|NCT02182401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102117424|NCT02182401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102117425|NCT02182401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102117426|NCT02182401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102117427|NCT02182401|Anesthetics, General|anesthetics, general|mesh-ancestor
102117428|NCT02182401|Anesthetics|anesthetics|mesh-ancestor
102117430|NCT02182401|GABA Agents|gaba agents|mesh-ancestor
102117431|NCT02182401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102117432|NCT02182401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117433|NCT02182401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102117435|NCT04292080|Dermatologic Agents|dermatologic agents|mesh-ancestor
102117436|NCT04292080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102117437|NCT04292080|Immunologic Factors|immunologic factors|mesh-ancestor
102117438|NCT04292080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117439|NCT02177955|Midazolam|midazolam|mesh-list
102117440|NCT02177955|Diazepam|diazepam|mesh-list
102117441|NCT02177955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102117442|NCT02177955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102016078|NCT00702806|Ganirelix|ganirelix|mesh-list
102117443|NCT02177955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102117444|NCT02177955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117445|NCT02177955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102117446|NCT02177955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102117447|NCT02177955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102117448|NCT02177955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102117449|NCT02177955|Anesthetics, General|anesthetics, general|mesh-ancestor
102117450|NCT02177955|Anesthetics|anesthetics|mesh-ancestor
102117451|NCT02177955|GABA Modulators|gaba modulators|mesh-ancestor
102117452|NCT02177955|GABA Agents|gaba agents|mesh-ancestor
102117453|NCT02177955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102117454|NCT02177955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117455|NCT02177955|Anticonvulsants|anticonvulsants|mesh-ancestor
102117456|NCT02177955|Antiemetics|antiemetics|mesh-ancestor
102117457|NCT02177955|Autonomic Agents|autonomic agents|mesh-ancestor
102117458|NCT02177955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102117459|NCT02177955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102117460|NCT02177955|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102117461|NCT02177955|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102117462|NCT03323528|Benzalkonium Compounds|benzalkonium compounds|mesh-list
102117463|NCT03323528|Benzocaine|benzocaine|mesh-list
102117464|NCT03323528|Anesthetics, Local|anesthetics, local|mesh-ancestor
102117465|NCT03323528|Anesthetics|anesthetics|mesh-ancestor
102117466|NCT03323528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102117467|NCT03323528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117468|NCT03323528|Sensory System Agents|sensory system agents|mesh-ancestor
102117469|NCT03323528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102117470|NCT03323528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102117471|NCT03323528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102117472|NCT05501158|Tamoxifen|tamoxifen|mesh-list
102117473|NCT05501158|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102117474|NCT05501158|Hormone Antagonists|hormone antagonists|mesh-ancestor
102117475|NCT05501158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102117476|NCT05501158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117477|NCT05501158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102117478|NCT05501158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102117479|NCT05501158|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102117480|NCT05501158|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102117481|NCT05501158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102117482|NCT03537807|Riluzole|riluzole|mesh-list
102117483|NCT03537807|Anticonvulsants|anticonvulsants|mesh-ancestor
102117484|NCT03537807|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102117485|NCT03537807|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102117486|NCT03537807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102117487|NCT03537807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117488|NCT03537807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016140|NCT02278588|Rasagiline|rasagiline|mesh-list
102117489|NCT03537807|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102117490|NCT03537807|Protective Agents|protective agents|mesh-ancestor
102117491|NCT02182479|Fenoterol|fenoterol|mesh-list
102117492|NCT02182479|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
102117493|NCT02182479|Ipratropium|ipratropium|mesh-list
102117494|NCT02182479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102117495|NCT02182479|Autonomic Agents|autonomic agents|mesh-ancestor
102117496|NCT02182479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102117497|NCT02182479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117498|NCT02182479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102117499|NCT02182479|Respiratory System Agents|respiratory system agents|mesh-ancestor
102117500|NCT02182479|Sympathomimetics|sympathomimetics|mesh-ancestor
102117501|NCT02182479|Tocolytic Agents|tocolytic agents|mesh-ancestor
102117502|NCT02182479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101508350|NCT00513110|Caffeine|caffeine|mesh-list
102117503|NCT02182479|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102117504|NCT02182479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102117505|NCT02182479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102117506|NCT02182479|Adrenergic Agents|adrenergic agents|mesh-ancestor
102117507|NCT02182479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102117508|NCT02182479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117509|NCT02182479|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102117510|NCT02182479|Cholinergic Agents|cholinergic agents|mesh-ancestor
102117511|NCT02560558|Abatacept|abatacept|mesh-list
102117512|NCT02560558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102117513|NCT02560558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117514|NCT02560558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102117515|NCT02560558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102117516|NCT02560558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102117517|NCT02560558|Immunologic Factors|immunologic factors|mesh-ancestor
102117518|NCT02560558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117519|NCT02560558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102117520|NCT03329456|Ropivacaine|ropivacaine|mesh-list
102117521|NCT03329456|Anesthetics, Local|anesthetics, local|mesh-ancestor
102117522|NCT03329456|Anesthetics|anesthetics|mesh-ancestor
102117523|NCT03329456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102117524|NCT03329456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117525|NCT03329456|Sensory System Agents|sensory system agents|mesh-ancestor
102117526|NCT03329456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102117527|NCT02178033|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102117528|NCT02491736|Ketoprofen|ketoprofen|mesh-list
102117529|NCT02491736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102117530|NCT02491736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102117531|NCT02491736|Analgesics|analgesics|mesh-ancestor
102117532|NCT02491736|Sensory System Agents|sensory system agents|mesh-ancestor
102117533|NCT02491736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102117534|NCT02491736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117535|NCT02491736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102117536|NCT02491736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102117537|NCT02491736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102117538|NCT02491736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102117539|NCT02491736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117540|NCT05501080|Spironolactone|spironolactone|mesh-list
102117541|NCT05501080|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102117542|NCT05501080|Hormone Antagonists|hormone antagonists|mesh-ancestor
102117543|NCT05501080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102117544|NCT05501080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117545|NCT05501080|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102117546|NCT05501080|Diuretics|diuretics|mesh-ancestor
102117547|NCT05501080|Natriuretic Agents|natriuretic agents|mesh-ancestor
102117548|NCT02491970|Fluticasone|fluticasone|mesh-list
102117549|NCT02491970|Xhance|xhance|mesh-list
102117550|NCT02491970|Formoterol Fumarate|formoterol fumarate|mesh-list
102117551|NCT02491970|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102117552|NCT02491970|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102117553|NCT02491970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102117554|NCT02491970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102117555|NCT02491970|Autonomic Agents|autonomic agents|mesh-ancestor
102117556|NCT02491970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102117557|NCT02491970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117558|NCT02491970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102016184|NCT00398606|Antacids|antacids|mesh-ancestor
102117559|NCT02491970|Respiratory System Agents|respiratory system agents|mesh-ancestor
102117560|NCT02491970|Dermatologic Agents|dermatologic agents|mesh-ancestor
102117561|NCT02491970|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102117562|NCT02491970|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102117563|NCT02491970|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102117564|NCT02491970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102117565|NCT02491970|Adrenergic Agents|adrenergic agents|mesh-ancestor
102117566|NCT02491970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102117567|NCT02491970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117568|NCT02491970|Glucocorticoids|glucocorticoids|mesh-ancestor
102117569|NCT02491970|Hormones|hormones|mesh-ancestor
102117570|NCT02491970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102117571|NCT02491970|Sympathomimetics|sympathomimetics|mesh-ancestor
102117572|NCT02182557|Ketotifen|ketotifen|mesh-list
102117573|NCT02182557|Epinastine|epinastine|mesh-list
102117574|NCT02182557|Antipruritics|antipruritics|mesh-ancestor
102117575|NCT02182557|Dermatologic Agents|dermatologic agents|mesh-ancestor
102117576|NCT02182557|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102117577|NCT02182557|Histamine Antagonists|histamine antagonists|mesh-ancestor
102117578|NCT02182557|Histamine Agents|histamine agents|mesh-ancestor
102117579|NCT02182557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102117580|NCT02182557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117581|NCT02182557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535864|NCT05442801|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102117582|NCT02182557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102117583|NCT02182635|Oxitropium|oxitropium|mesh-list
102117584|NCT02182635|Parasympatholytics|parasympatholytics|mesh-ancestor
102117585|NCT02182635|Autonomic Agents|autonomic agents|mesh-ancestor
102117586|NCT02182635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102117587|NCT02182635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117588|NCT02182713|Bromides|bromides|mesh-list
102117589|NCT02182713|Albuterol|albuterol|mesh-list
102117590|NCT02182713|Ipratropium|ipratropium|mesh-list
102117591|NCT02182713|Anticonvulsants|anticonvulsants|mesh-ancestor
102117592|NCT02182713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102117593|NCT02182713|Autonomic Agents|autonomic agents|mesh-ancestor
102117594|NCT02182713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102117595|NCT02182713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117596|NCT02182713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102117597|NCT02182713|Respiratory System Agents|respiratory system agents|mesh-ancestor
102117598|NCT02182713|Tocolytic Agents|tocolytic agents|mesh-ancestor
102117599|NCT02182713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102117600|NCT02182713|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102117601|NCT02182713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102117602|NCT02182713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102117603|NCT02182713|Adrenergic Agents|adrenergic agents|mesh-ancestor
102117604|NCT02182713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102117605|NCT02182713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117606|NCT02182713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102117607|NCT02182713|Cholinergic Agents|cholinergic agents|mesh-ancestor
102117608|NCT03323372|Listerine|listerine|mesh-list
102117609|NCT03323372|Fluorides|fluorides|mesh-list
102117610|NCT03323372|Sodium Fluoride|sodium fluoride|mesh-list
102117611|NCT03323372|Cariostatic Agents|cariostatic agents|mesh-ancestor
102117612|NCT03323372|Protective Agents|protective agents|mesh-ancestor
102117613|NCT03323372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117614|NCT03323372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102117615|NCT03323372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102117616|NCT02180529|Methylphenidate|methylphenidate|mesh-list
102117617|NCT02180529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102117618|NCT02180529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117619|NCT02180529|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102117620|NCT02180529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102117621|NCT02180529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102117622|NCT02180529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117623|NCT02180529|Dopamine Agents|dopamine agents|mesh-ancestor
102117624|NCT02180529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102117625|NCT02182791|Nevirapine|nevirapine|mesh-list
102117626|NCT02182791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102117627|NCT02182791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102117628|NCT02182791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102016254|NCT02461888|Hormones|hormones|mesh-ancestor
102117629|NCT02182791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117630|NCT02182791|Antiviral Agents|antiviral agents|mesh-ancestor
102117631|NCT02182791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102117632|NCT02182791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102117633|NCT02182791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102117634|NCT02182791|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102117635|NCT02182791|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102117636|NCT03536325|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102117637|NCT03536325|Immunologic Factors|immunologic factors|mesh-ancestor
102117638|NCT03536325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117639|NCT03536637|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102117640|NCT03536637|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102117641|NCT03536637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102117642|NCT02488538|Fluoxetine|fluoxetine|mesh-list
102117643|NCT02488538|Contraceptive Agents|contraceptive agents|mesh-list
102117644|NCT02488538|Contraceptives, Oral|contraceptives, oral|mesh-list
102117645|NCT02488538|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
102117646|NCT02488538|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102117647|NCT02488538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102117648|NCT02488538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102117649|NCT02488538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117650|NCT02488538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102117652|NCT02488538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117653|NCT02488538|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102117654|NCT02488538|Antidepressive Agents|antidepressive agents|mesh-ancestor
102117655|NCT02488538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102117656|NCT02488538|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102117657|NCT02488538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102117658|NCT02488538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102117659|NCT02488538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102117660|NCT02488538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102117662|NCT02568046|Fluorouracil|fluorouracil|mesh-list
102117663|NCT02568046|Irinotecan|irinotecan|mesh-list
102117664|NCT02568046|Antimetabolites|antimetabolites|mesh-ancestor
102117665|NCT02568046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117666|NCT02568046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102117667|NCT02568046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102117668|NCT02568046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102117669|NCT02568046|Immunologic Factors|immunologic factors|mesh-ancestor
102117670|NCT02568046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117671|NCT02568046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102117672|NCT02568046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102117673|NCT02568046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102117674|NCT02568046|Antidotes|antidotes|mesh-ancestor
102117675|NCT02568046|Protective Agents|protective agents|mesh-ancestor
102117676|NCT02568046|Vitamin B Complex|vitamin b complex|mesh-ancestor
102117677|NCT02568046|Vitamins|vitamins|mesh-ancestor
102117678|NCT02568046|Micronutrients|micronutrients|mesh-ancestor
102117679|NCT03536481|Ensartinib|ensartinib|mesh-list
102117680|NCT03536481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102117681|NCT03536481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102117682|NCT03536481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102117683|NCT03536481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117684|NCT02488616|Insulin|insulin|mesh-list
102117685|NCT02488616|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102117686|NCT02488616|Hormones|hormones|mesh-list
102117687|NCT02488616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102117688|NCT02488616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117689|NCT02488616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102117690|NCT02256423|Ibuprofen|ibuprofen|mesh-list
102117691|NCT02256423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102117692|NCT02256423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102117693|NCT02256423|Analgesics|analgesics|mesh-ancestor
102117694|NCT02256423|Sensory System Agents|sensory system agents|mesh-ancestor
102117695|NCT02256423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102117696|NCT02256423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117697|NCT02256423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102117698|NCT02256423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102117699|NCT02256423|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102117700|NCT02256423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102117701|NCT02256423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117702|NCT03320486|Ketoconazole|ketoconazole|mesh-list
102117703|NCT03320486|Antifungal Agents|antifungal agents|mesh-ancestor
102117704|NCT03320486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102117705|NCT03320486|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102117706|NCT03320486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102117707|NCT03320486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102117708|NCT03320486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117709|NCT03320486|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102117710|NCT03320486|Hormone Antagonists|hormone antagonists|mesh-ancestor
102117711|NCT03320486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102117712|NCT03320486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117713|NCT03320486|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102117714|NCT02567656|Tenalisib|tenalisib|mesh-list
102117715|NCT02567656|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
102117716|NCT02567656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102117717|NCT02567656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117718|NCT02185833|Dirithromycin|dirithromycin|mesh-list
102117719|NCT02185833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102117720|NCT02185833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102117721|NCT02180997|Tamsulosin|tamsulosin|mesh-list
102117722|NCT02180997|Solifenacin Succinate|solifenacin succinate|mesh-list
102117723|NCT02180997|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102117724|NCT02180997|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102117725|NCT02180997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102117726|NCT02180997|Adrenergic Agents|adrenergic agents|mesh-ancestor
102117727|NCT02180997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102117728|NCT02180997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117729|NCT02180997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117730|NCT02180997|Urological Agents|urological agents|mesh-ancestor
102117731|NCT02180997|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102117732|NCT02180997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102117733|NCT02180997|Cholinergic Agents|cholinergic agents|mesh-ancestor
102117735|NCT02560012|Everolimus|everolimus|mesh-list
102117736|NCT02560012|Temsirolimus|temsirolimus|mesh-list
102117737|NCT02560012|MTOR Inhibitors|mtor inhibitors|mesh-list
102117738|NCT02560012|Sorafenib|sorafenib|mesh-list
102117739|NCT02560012|Sunitinib|sunitinib|mesh-list
102117740|NCT02560012|Axitinib|axitinib|mesh-list
102117741|NCT02560012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102117742|NCT02560012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102117743|NCT02560012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117744|NCT02560012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102117745|NCT02560012|Immunologic Factors|immunologic factors|mesh-ancestor
102117746|NCT02560012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117747|NCT02560012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102117748|NCT02560012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102117749|NCT02560012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102117750|NCT02560012|Growth Substances|growth substances|mesh-ancestor
102117751|NCT02560012|Growth Inhibitors|growth inhibitors|mesh-ancestor
102117752|NCT02560012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102117753|NCT02560012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102117754|NCT02560012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102117755|NCT02560012|Antifungal Agents|antifungal agents|mesh-ancestor
102117756|NCT03320174|Tafenoquine|tafenoquine|mesh-list
102117757|NCT03320174|Antimalarials|antimalarials|mesh-ancestor
102117758|NCT03320174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102117759|NCT03320174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102117760|NCT03320174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102117761|NCT03328364|Docetaxel|docetaxel|mesh-list
102117762|NCT03328364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102117763|NCT03328364|Tubulin Modulators|tubulin modulators|mesh-ancestor
102117764|NCT03328364|Antimitotic Agents|antimitotic agents|mesh-ancestor
102117765|NCT03328364|Mitosis Modulators|mitosis modulators|mesh-ancestor
102117766|NCT03328364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117767|NCT03328052|Antidepressive Agents|antidepressive agents|mesh-list
102117768|NCT03328052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102117769|NCT04514302|Immunoglobulins|immunoglobulins|mesh-list
102117770|NCT04514302|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102117771|NCT04514302|Antibodies|antibodies|mesh-list
102117772|NCT04514302|Immunologic Factors|immunologic factors|mesh-ancestor
102117773|NCT04514302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117774|NCT03319784|Triamcinolone|triamcinolone|mesh-list
102117775|NCT03319784|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102117776|NCT03319784|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102117777|NCT03319784|Ketorolac|ketorolac|mesh-list
102117778|NCT03319784|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102117779|NCT03319784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102117780|NCT03319784|Glucocorticoids|glucocorticoids|mesh-ancestor
102117781|NCT03319784|Hormones|hormones|mesh-ancestor
102117782|NCT03319784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102117783|NCT03319784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117784|NCT03319784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102117785|NCT03319784|Immunologic Factors|immunologic factors|mesh-ancestor
102117786|NCT03319784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102117787|NCT03319784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117788|NCT03319784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102117789|NCT03319784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102117790|NCT03319784|Analgesics|analgesics|mesh-ancestor
102117791|NCT03319784|Sensory System Agents|sensory system agents|mesh-ancestor
102117792|NCT03319784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102117793|NCT03319784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102117794|NCT03319784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102117795|NCT03319706|Olmesartan|olmesartan|mesh-list
102117796|NCT03319706|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
102117797|NCT03319706|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102117798|NCT03319706|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101571334|NCT00948766|Rivastigmine|rivastigmine|mesh-list
102117799|NCT03319706|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102117800|NCT03319706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117801|NCT03322358|Diphenhydramine|diphenhydramine|mesh-list
102117802|NCT03322358|Promethazine|promethazine|mesh-list
102117803|NCT03322358|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102117804|NCT03322358|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102117805|NCT03322358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102117806|NCT03322358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117807|NCT03322358|Anesthetics, Local|anesthetics, local|mesh-ancestor
102117808|NCT03322358|Anesthetics|anesthetics|mesh-ancestor
102117809|NCT03322358|Sensory System Agents|sensory system agents|mesh-ancestor
102117810|NCT03322358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102117811|NCT03322358|Antiemetics|antiemetics|mesh-ancestor
102117812|NCT03322358|Autonomic Agents|autonomic agents|mesh-ancestor
102117813|NCT03322358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102117814|NCT03322358|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102117815|NCT03322358|Histamine Antagonists|histamine antagonists|mesh-ancestor
102117816|NCT03322358|Histamine Agents|histamine agents|mesh-ancestor
102117817|NCT03322358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102117818|NCT03322358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117819|NCT03322358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102117820|NCT03322358|Antipruritics|antipruritics|mesh-ancestor
102117821|NCT03322358|Dermatologic Agents|dermatologic agents|mesh-ancestor
102117822|NCT05045170|Dexmedetomidine|dexmedetomidine|mesh-list
102117824|NCT05045170|Anesthetics|anesthetics|mesh-ancestor
102117825|NCT05045170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102117826|NCT05045170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117827|NCT05045170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102117828|NCT05045170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102117829|NCT05045170|Analgesics|analgesics|mesh-ancestor
102117830|NCT05045170|Sensory System Agents|sensory system agents|mesh-ancestor
102117831|NCT05045170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102117832|NCT05045170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102117833|NCT05045170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102117834|NCT05045170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102117835|NCT05045170|Adrenergic Agents|adrenergic agents|mesh-ancestor
102117836|NCT05045170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102117837|NCT05045170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117838|NCT05045170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102117839|NCT05045170|Anesthetics, General|anesthetics, general|mesh-ancestor
102117840|NCT05500690|Folic Acid|folic acid|mesh-list
102117841|NCT05500690|Hematinics|hematinics|mesh-ancestor
102117842|NCT05500690|Vitamin B Complex|vitamin b complex|mesh-ancestor
102117843|NCT05500690|Vitamins|vitamins|mesh-ancestor
102117844|NCT05500690|Micronutrients|micronutrients|mesh-ancestor
102117845|NCT05500690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117846|NCT03322124|Octenidine|octenidine|mesh-list
102117847|NCT03322124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102117848|NCT03322124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102117849|NCT04442984|Leucovorin|leucovorin|mesh-list
102117850|NCT04442984|Oxaliplatin|oxaliplatin|mesh-list
102117851|NCT04442984|Irinotecan|irinotecan|mesh-list
102117852|NCT04442984|Fluorouracil|fluorouracil|mesh-list
102117853|NCT04442984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102117854|NCT04442984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102117855|NCT04442984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102117856|NCT04442984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102117857|NCT04442984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117858|NCT04442984|Antidotes|antidotes|mesh-ancestor
102117859|NCT04442984|Protective Agents|protective agents|mesh-ancestor
102117860|NCT04442984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117861|NCT04442984|Vitamin B Complex|vitamin b complex|mesh-ancestor
102117862|NCT04442984|Vitamins|vitamins|mesh-ancestor
102117863|NCT04442984|Micronutrients|micronutrients|mesh-ancestor
102117864|NCT04442984|Antimetabolites|antimetabolites|mesh-ancestor
102117865|NCT04442984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102117866|NCT04442984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102117867|NCT04442984|Immunologic Factors|immunologic factors|mesh-ancestor
102117868|NCT03327506|Alprazolam|alprazolam|mesh-list
102117869|NCT03327506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102117870|NCT03327506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102117871|NCT03327506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117872|NCT03327506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102117873|NCT03327506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101508728|NCT00530907|Bevacizumab|bevacizumab|mesh-list
101571409|NCT01049217|Pregabalin|pregabalin|mesh-list
102117874|NCT03327506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102117875|NCT03327506|GABA Modulators|gaba modulators|mesh-ancestor
102117876|NCT03327506|GABA Agents|gaba agents|mesh-ancestor
102117877|NCT03327506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102117878|NCT03327506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117879|NCT02487914|Lidocaine|lidocaine|mesh-list
102117880|NCT02487914|Anesthetics, Local|anesthetics, local|mesh-ancestor
102117881|NCT02487914|Anesthetics|anesthetics|mesh-ancestor
102535865|NCT05442801|Cholinergic Agents|cholinergic agents|mesh-ancestor
102117882|NCT02487914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102117883|NCT02487914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117884|NCT02487914|Sensory System Agents|sensory system agents|mesh-ancestor
102117885|NCT02487914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102117886|NCT02487914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102117887|NCT02487914|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102117888|NCT02487914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102117889|NCT02487914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102117890|NCT02487914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117892|NCT02487680|Picolinic acid|picolinic acid|mesh-list
102117893|NCT02487680|Trace Elements|trace elements|mesh-ancestor
102117894|NCT02487680|Micronutrients|micronutrients|mesh-ancestor
102117895|NCT02487680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117896|NCT02487680|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102117897|NCT02487680|Chelating Agents|chelating agents|mesh-ancestor
102117898|NCT02487680|Sequestering Agents|sequestering agents|mesh-ancestor
102117899|NCT02487680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117900|NCT03319550|Caseins|caseins|mesh-list
102117901|NCT03319550|Chelating Agents|chelating agents|mesh-ancestor
102117902|NCT03319550|Sequestering Agents|sequestering agents|mesh-ancestor
102117903|NCT03319550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117904|NCT04442906|Fentanyl|fentanyl|mesh-list
102117905|NCT04442906|Dexmedetomidine|dexmedetomidine|mesh-list
102117906|NCT04442906|Bupivacaine|bupivacaine|mesh-list
102117907|NCT04442906|Anesthetics, Local|anesthetics, local|mesh-ancestor
102117908|NCT04442906|Anesthetics|anesthetics|mesh-ancestor
102117909|NCT04442906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102117910|NCT04442906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117911|NCT04442906|Sensory System Agents|sensory system agents|mesh-ancestor
102117912|NCT04442906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102117913|NCT04442906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102117914|NCT04442906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102117915|NCT04442906|Analgesics|analgesics|mesh-ancestor
102117916|NCT04442906|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102117917|NCT04442906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102117918|NCT04442906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102117919|NCT04442906|Adrenergic Agents|adrenergic agents|mesh-ancestor
102117920|NCT04442906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102117921|NCT04442906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117922|NCT04442906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102117923|NCT04442906|Narcotics|narcotics|mesh-ancestor
102117924|NCT04442906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102117925|NCT04442906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102117926|NCT04442906|Anesthetics, General|anesthetics, general|mesh-ancestor
102117927|NCT04510012|Complement System Proteins|complement system proteins|mesh-list
102117928|NCT04510012|Immunologic Factors|immunologic factors|mesh-ancestor
102117929|NCT04510012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117930|NCT03327350|Anticoagulants|anticoagulants|mesh-list
102117931|NCT03327272|Methylprednisolone|methylprednisolone|mesh-list
102117932|NCT03327272|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102117933|NCT03327272|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102117934|NCT03327272|Prednisolone|prednisolone|mesh-list
102117935|NCT03327272|Prednisolone acetate|prednisolone acetate|mesh-list
102117936|NCT03327272|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102117937|NCT03327272|Prednisolone phosphate|prednisolone phosphate|mesh-list
102117938|NCT03327272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102117939|NCT03327272|Antiemetics|antiemetics|mesh-ancestor
102117940|NCT03327272|Autonomic Agents|autonomic agents|mesh-ancestor
102117941|NCT03327272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102117942|NCT03327272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117943|NCT03327272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102117944|NCT03327272|Glucocorticoids|glucocorticoids|mesh-ancestor
102117945|NCT03327272|Hormones|hormones|mesh-ancestor
102117946|NCT03327272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102117947|NCT03327272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102117948|NCT03327272|Protective Agents|protective agents|mesh-ancestor
102117949|NCT03327272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102016568|NCT02616146|Hormones|hormones|mesh-ancestor
102117950|NCT03327272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102117951|NCT05508178|Vaccines|vaccines|mesh-list
102117952|NCT05508178|Immunologic Factors|immunologic factors|mesh-ancestor
102117953|NCT05508178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117954|NCT03327116|Methotrexate|methotrexate|mesh-list
102117955|NCT03327116|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102117956|NCT03327116|Abortifacient Agents|abortifacient agents|mesh-ancestor
102117957|NCT03327116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102117958|NCT03327116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117959|NCT03327116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102117960|NCT03327116|Antimetabolites|antimetabolites|mesh-ancestor
102117961|NCT03327116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117962|NCT03327116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102117963|NCT03327116|Dermatologic Agents|dermatologic agents|mesh-ancestor
102117964|NCT03327116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102117965|NCT03327116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102117966|NCT03327116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102117967|NCT03327116|Immunologic Factors|immunologic factors|mesh-ancestor
102117968|NCT03327116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102117969|NCT03327116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102117971|NCT03326960|Sevoflurane|sevoflurane|mesh-list
102117972|NCT03326960|Desflurane|desflurane|mesh-list
102117973|NCT03326960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102117974|NCT03326960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102117975|NCT03326960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117976|NCT03326960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102117977|NCT03326960|Anesthetics, General|anesthetics, general|mesh-ancestor
102117978|NCT03326960|Anesthetics|anesthetics|mesh-ancestor
102117979|NCT03326960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102117980|NCT03326960|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102117981|NCT03319238|Ketamine|ketamine|mesh-list
102117982|NCT03319238|Analgesics|analgesics|mesh-ancestor
102117983|NCT03319238|Sensory System Agents|sensory system agents|mesh-ancestor
102117984|NCT03319238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102117985|NCT03319238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102117986|NCT03319238|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102117987|NCT03319238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102117988|NCT03319238|Anesthetics, General|anesthetics, general|mesh-ancestor
102117989|NCT03319238|Anesthetics|anesthetics|mesh-ancestor
102117990|NCT03319238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102117991|NCT03319238|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102117992|NCT03319238|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102117993|NCT03319238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102117994|NCT03319238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102117995|NCT03321890|Prednisone|prednisone|mesh-list
102117996|NCT03321890|Cyclophosphamide|cyclophosphamide|mesh-list
102117997|NCT03321890|Methotrexate|methotrexate|mesh-list
102117998|NCT03321890|Etoposide|etoposide|mesh-list
102117999|NCT03321890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102118000|NCT03321890|Immunologic Factors|immunologic factors|mesh-ancestor
102118001|NCT03321890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118002|NCT03321890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102118003|NCT03321890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102118004|NCT03321890|Alkylating Agents|alkylating agents|mesh-ancestor
102118005|NCT03321890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118006|NCT03321890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102118007|NCT03321890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102118008|NCT03321890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102118009|NCT03321890|Glucocorticoids|glucocorticoids|mesh-ancestor
102118010|NCT03321890|Hormones|hormones|mesh-ancestor
102118011|NCT03321890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102118012|NCT03321890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102118013|NCT03321890|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102118014|NCT03321890|Abortifacient Agents|abortifacient agents|mesh-ancestor
102118015|NCT03321890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102118016|NCT03321890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102118017|NCT03321890|Antimetabolites|antimetabolites|mesh-ancestor
102118018|NCT03321890|Dermatologic Agents|dermatologic agents|mesh-ancestor
102118019|NCT03321890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102118020|NCT03321890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102016638|NCT04891172|Antibodies|antibodies|mesh-list
102118021|NCT03321890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102118022|NCT03321890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102118023|NCT03321890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102118024|NCT03321890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102118025|NCT05464394|Tranexamic Acid|tranexamic acid|mesh-list
102118027|NCT05464394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102118028|NCT05464394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118029|NCT05464394|Hemostatics|hemostatics|mesh-ancestor
102118030|NCT05464394|Coagulants|coagulants|mesh-ancestor
102118031|NCT05499598|Vitamin A|vitamin a|mesh-list
102118032|NCT05499598|Vitamins|vitamins|mesh-ancestor
102118033|NCT05499598|Micronutrients|micronutrients|mesh-ancestor
102118034|NCT05499598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118035|NCT03321734|Caffeine|caffeine|mesh-list
102118036|NCT03321734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102118037|NCT03321734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118038|NCT03321734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102118039|NCT03321734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102118040|NCT03321734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118041|NCT03321734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102118042|NCT03321734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102118043|NCT03321734|Purinergic Agents|purinergic agents|mesh-ancestor
102118044|NCT03321734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102118045|NCT04442750|Bupivacaine|bupivacaine|mesh-list
102118046|NCT04442750|Anesthetics, Local|anesthetics, local|mesh-ancestor
102118047|NCT04442750|Anesthetics|anesthetics|mesh-ancestor
102118048|NCT04442750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102118049|NCT04442750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118050|NCT04442750|Sensory System Agents|sensory system agents|mesh-ancestor
102118051|NCT04442750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102118052|NCT02753127|Leucovorin|leucovorin|mesh-list
102118053|NCT02753127|Bevacizumab|bevacizumab|mesh-list
102118054|NCT02753127|Fluorouracil|fluorouracil|mesh-list
102118055|NCT02753127|Irinotecan|irinotecan|mesh-list
102118056|NCT02753127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102118057|NCT02753127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102118058|NCT02753127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102118059|NCT02753127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102118060|NCT02753127|Growth Substances|growth substances|mesh-ancestor
102118061|NCT02753127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118062|NCT02753127|Growth Inhibitors|growth inhibitors|mesh-ancestor
102118063|NCT02753127|Antimetabolites|antimetabolites|mesh-ancestor
102118064|NCT02753127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118065|NCT02753127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102118066|NCT02753127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102118067|NCT02753127|Immunologic Factors|immunologic factors|mesh-ancestor
102118068|NCT02753127|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102118069|NCT02753127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102118070|NCT02753127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102118071|NCT02753127|Antidotes|antidotes|mesh-ancestor
102118072|NCT02753127|Protective Agents|protective agents|mesh-ancestor
102118073|NCT02753127|Vitamin B Complex|vitamin b complex|mesh-ancestor
102118074|NCT02753127|Vitamins|vitamins|mesh-ancestor
102118075|NCT02753127|Micronutrients|micronutrients|mesh-ancestor
102118076|NCT03326258|Nivolumab|nivolumab|mesh-list
102118077|NCT03326258|Ipilimumab|ipilimumab|mesh-list
102118078|NCT03326258|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
102118079|NCT03326258|Antibodies|antibodies|mesh-list
102118080|NCT03326258|Immunoglobulins|immunoglobulins|mesh-list
102118081|NCT03326258|Immunotoxins|immunotoxins|mesh-list
102118082|NCT03326258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102118083|NCT03326258|Immunoconjugates|immunoconjugates|mesh-list
102118084|NCT03326258|Immunologic Factors|immunologic factors|mesh-ancestor
102118085|NCT03326258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118086|NCT03326258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102118087|NCT03326258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102118088|NCT03326258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102118089|NCT03326258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118090|NCT03326102|Paclitaxel|paclitaxel|mesh-list
102118091|NCT03326102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102118092|NCT03326102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102118093|NCT03326102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102118094|NCT03326102|Tubulin Modulators|tubulin modulators|mesh-ancestor
102118095|NCT03326102|Antimitotic Agents|antimitotic agents|mesh-ancestor
102118096|NCT03326102|Mitosis Modulators|mitosis modulators|mesh-ancestor
102118097|NCT03326102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118098|NCT02487212|Clobetasol|clobetasol|mesh-list
102118099|NCT02487212|Petrolatum|petrolatum|mesh-list
102118100|NCT02487212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102118101|NCT02487212|Glucocorticoids|glucocorticoids|mesh-ancestor
102118102|NCT02487212|Hormones|hormones|mesh-ancestor
102118103|NCT02487212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102118104|NCT02487212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118105|NCT02487212|Emollients|emollients|mesh-ancestor
102118106|NCT02487212|Dermatologic Agents|dermatologic agents|mesh-ancestor
102118107|NCT04583488|Docetaxel|docetaxel|mesh-list
102118108|NCT04583488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102118109|NCT04583488|Tubulin Modulators|tubulin modulators|mesh-ancestor
102535866|NCT05442801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102118111|NCT04583488|Mitosis Modulators|mitosis modulators|mesh-ancestor
102118112|NCT04583488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118113|NCT03318536|Granisetron|granisetron|mesh-list
102118114|NCT03318536|Serotonin|serotonin|mesh-list
102118115|NCT03318536|Antiemetics|antiemetics|mesh-ancestor
102118116|NCT03318536|Autonomic Agents|autonomic agents|mesh-ancestor
102118117|NCT03318536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102118118|NCT03318536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118119|NCT03318536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102118120|NCT03318536|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102118121|NCT03318536|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102118122|NCT03318536|Serotonin Agents|serotonin agents|mesh-ancestor
102118123|NCT03318536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102118124|NCT03318536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118125|NCT03318536|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102118126|NCT03537027|Vitamin D|vitamin d|mesh-list
102118127|NCT03537027|Cholecalciferol|cholecalciferol|mesh-list
102118128|NCT03537027|Vitamins|vitamins|mesh-ancestor
102118129|NCT03537027|Micronutrients|micronutrients|mesh-ancestor
102118130|NCT03537027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118131|NCT03537027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102118132|NCT03537027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102118133|NCT02183025|Meloxicam|meloxicam|mesh-list
102118134|NCT02183025|Mefenamic Acid|mefenamic acid|mesh-list
102118135|NCT02183025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102118136|NCT02183025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102118137|NCT02183025|Analgesics|analgesics|mesh-ancestor
102118138|NCT02183025|Sensory System Agents|sensory system agents|mesh-ancestor
102118139|NCT02183025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102118140|NCT02183025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118141|NCT02183025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102118142|NCT02183025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102118143|NCT02183025|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102118144|NCT02183025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102118145|NCT02183025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102118146|NCT02183025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118147|NCT04282174|Cyclophosphamide|cyclophosphamide|mesh-list
102118148|NCT04282174|Melphalan|melphalan|mesh-list
102118149|NCT04282174|Busulfan|busulfan|mesh-list
102118150|NCT04282174|Thiotepa|thiotepa|mesh-list
102118151|NCT04282174|Fludarabine|fludarabine|mesh-list
102118152|NCT04282174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102118153|NCT04282174|Immunologic Factors|immunologic factors|mesh-ancestor
102118154|NCT04282174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118155|NCT04282174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102118156|NCT04282174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102118157|NCT04282174|Alkylating Agents|alkylating agents|mesh-ancestor
102118158|NCT04282174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118159|NCT04282174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102118160|NCT04282174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102118161|NCT02181309|Meloxicam|meloxicam|mesh-list
102118162|NCT02181309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102118163|NCT02181309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102118164|NCT02181309|Analgesics|analgesics|mesh-ancestor
102118165|NCT02181309|Sensory System Agents|sensory system agents|mesh-ancestor
102118166|NCT02181309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102118167|NCT02181309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118168|NCT02181309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102118169|NCT02181309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102118170|NCT02181309|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102118171|NCT02181309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102118172|NCT02181309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102118173|NCT02181309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118174|NCT02186145|Metronidazole|metronidazole|mesh-list
102118175|NCT02186145|Nystatin|nystatin|mesh-list
102118176|NCT02186145|Dexamethasone|dexamethasone|mesh-list
102118177|NCT02186145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102118178|NCT02186145|Antiemetics|antiemetics|mesh-ancestor
102118179|NCT02186145|Autonomic Agents|autonomic agents|mesh-ancestor
102118180|NCT02186145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102118181|NCT02186145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118182|NCT02186145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102118183|NCT02186145|Glucocorticoids|glucocorticoids|mesh-ancestor
102118184|NCT02186145|Hormones|hormones|mesh-ancestor
102060906|NCT02152514|Sufentanil|sufentanil|mesh-list
102118185|NCT02186145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102118186|NCT02186145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102118187|NCT02186145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102118188|NCT02186145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102118189|NCT02186145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102118191|NCT02186145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102118192|NCT02186145|Antifungal Agents|antifungal agents|mesh-ancestor
102118193|NCT02186145|Ionophores|ionophores|mesh-ancestor
102118194|NCT02186145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102118195|NCT02186145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118196|NCT03325868|Ulipristal acetate|ulipristal acetate|mesh-list
102118197|NCT03325868|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102118198|NCT03325868|Contraceptive Agents|contraceptive agents|mesh-ancestor
102118199|NCT03325868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102118200|NCT03325868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118201|NCT03325868|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102118202|NCT02183103|Meloxicam|meloxicam|mesh-list
102118203|NCT02183103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102118204|NCT02183103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102118205|NCT02183103|Analgesics|analgesics|mesh-ancestor
102118206|NCT02183103|Sensory System Agents|sensory system agents|mesh-ancestor
102118207|NCT02183103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102118208|NCT02183103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118209|NCT02183103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102118210|NCT02183103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102118211|NCT02183103|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102118212|NCT02183103|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102118213|NCT02183103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102118214|NCT02183103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118215|NCT03325790|Ebselen|ebselen|mesh-list
102118216|NCT03325790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102118217|NCT03325790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102118218|NCT03325790|Analgesics|analgesics|mesh-ancestor
102118219|NCT03325790|Sensory System Agents|sensory system agents|mesh-ancestor
102118220|NCT03325790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102118221|NCT03325790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118222|NCT03325790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102118223|NCT03325790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102118224|NCT03325790|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102016851|NCT03282136|Incretins|incretins|mesh-list
102118225|NCT03325790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102118226|NCT03325790|Antioxidants|antioxidants|mesh-ancestor
102118227|NCT03325790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118228|NCT03325790|Protective Agents|protective agents|mesh-ancestor
102118229|NCT03325790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102118230|NCT03325790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102118231|NCT03325790|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102118232|NCT02181543|Clonidine|clonidine|mesh-list
102118233|NCT02181543|Analgesics|analgesics|mesh-ancestor
102118234|NCT02181543|Sensory System Agents|sensory system agents|mesh-ancestor
102118235|NCT02181543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102118236|NCT02181543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118237|NCT02181543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102118238|NCT02181543|Sympatholytics|sympatholytics|mesh-ancestor
102118239|NCT02181543|Autonomic Agents|autonomic agents|mesh-ancestor
102118240|NCT02181543|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102118241|NCT02181543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102118242|NCT02181543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102118243|NCT02181543|Adrenergic Agents|adrenergic agents|mesh-ancestor
102118244|NCT02181543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102118245|NCT02181543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118246|NCT02181621|Cadexomer iodine|cadexomer iodine|mesh-list
102118247|NCT02181621|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102118248|NCT02181621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102118249|NCT02490176|Liraglutide|liraglutide|mesh-list
102118250|NCT02490176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102118251|NCT02490176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118252|NCT02490176|Incretins|incretins|mesh-ancestor
102118254|NCT02490176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102118255|NCT02183181|Meloxicam|meloxicam|mesh-list
102118256|NCT02183181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102118257|NCT02183181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102118258|NCT02183181|Analgesics|analgesics|mesh-ancestor
102118259|NCT02183181|Sensory System Agents|sensory system agents|mesh-ancestor
102118260|NCT02183181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102118261|NCT02183181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118262|NCT02183181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102118263|NCT02183181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102118264|NCT02183181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102118265|NCT02183181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102118266|NCT02183181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102118267|NCT02183181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118268|NCT02490098|Insulin|insulin|mesh-list
102118269|NCT02490098|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102118270|NCT02490098|Glucagon|glucagon|mesh-list
102118271|NCT02490098|Hormones|hormones|mesh-list
102118272|NCT02490098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102118273|NCT02490098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118274|NCT02490098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102118275|NCT02490098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102118276|NCT02486822|Oxytocin|oxytocin|mesh-list
102118277|NCT02486822|Oxytocics|oxytocics|mesh-ancestor
102118278|NCT02486822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102118279|NCT02486822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118280|NCT02186457|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102118281|NCT02186457|Polymyxins|polymyxins|mesh-list
102118282|NCT02186457|Polymyxin B|polymyxin b|mesh-list
102118283|NCT02186457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102118284|NCT02186535|Vitamin D|vitamin d|mesh-list
102118285|NCT02186535|Calcium|calcium|mesh-list
102118286|NCT02186535|Vitamins|vitamins|mesh-ancestor
102118287|NCT02186535|Micronutrients|micronutrients|mesh-ancestor
102118288|NCT02186535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118289|NCT02186535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102118290|NCT02186535|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102118291|NCT03325400|Fluorides|fluorides|mesh-list
102118292|NCT03325400|Cariostatic Agents|cariostatic agents|mesh-ancestor
102118293|NCT03325400|Protective Agents|protective agents|mesh-ancestor
102118294|NCT03325400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118295|NCT02181933|Lamivudine|lamivudine|mesh-list
102118296|NCT02181933|Zidovudine|zidovudine|mesh-list
102118297|NCT02181933|Nevirapine|nevirapine|mesh-list
102118298|NCT02181933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102118299|NCT02181933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102118300|NCT02181933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102118301|NCT02181933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118302|NCT02181933|Antiviral Agents|antiviral agents|mesh-ancestor
102118303|NCT02181933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102118304|NCT02181933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102118305|NCT02181933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102118306|NCT02181933|Antimetabolites|antimetabolites|mesh-ancestor
102118307|NCT02181933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102118308|NCT02181933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102118309|NCT02183337|Pioglitazone|pioglitazone|mesh-list
102118310|NCT02183337|Linagliptin|linagliptin|mesh-list
102118311|NCT02183337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102118312|NCT02183337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118313|NCT02183337|Incretins|incretins|mesh-ancestor
102118314|NCT02183337|Hormones|hormones|mesh-ancestor
102118315|NCT02183337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102118316|NCT02183337|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102118317|NCT02183337|Protease Inhibitors|protease inhibitors|mesh-ancestor
102118318|NCT02183337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102118319|NCT02183337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118320|NCT02489786|Digoxin|digoxin|mesh-list
102118321|NCT02489786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102118322|NCT02489786|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102118323|NCT02489786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102118324|NCT02489786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118325|NCT02489786|Protective Agents|protective agents|mesh-ancestor
102118326|NCT02489786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118327|NCT02489864|Terlipressin|terlipressin|mesh-list
102118328|NCT02489864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102118329|NCT02489864|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102118330|NCT02182011|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102118331|NCT02182011|Tenecteplase|tenecteplase|mesh-list
102118332|NCT02182011|Streptokinase|streptokinase|mesh-list
102118333|NCT02182011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102118334|NCT02182011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102118335|NCT02182011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118336|NCT02486744|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102118338|NCT02486744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102118339|NCT02486744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118340|NCT02186769|Risperidone|risperidone|mesh-list
102118341|NCT02186769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102118342|NCT02186769|Serotonin Agents|serotonin agents|mesh-ancestor
102118343|NCT02186769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102118344|NCT02186769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118345|NCT02186769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118346|NCT02186769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102118347|NCT02186769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102118348|NCT02186769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102118349|NCT02186769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102118350|NCT02186769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102118351|NCT02186769|Dopamine Agents|dopamine agents|mesh-ancestor
102118352|NCT02486432|Levodopa|levodopa|mesh-list
102118353|NCT02486432|Carbidopa|carbidopa|mesh-list
102118354|NCT02486432|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102118355|NCT02486432|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102118356|NCT02486432|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102118357|NCT02486432|Dopamine Agents|dopamine agents|mesh-ancestor
102118358|NCT02486432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102118359|NCT02486432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118360|NCT02486432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118361|NCT02486432|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102118362|NCT02486432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102118363|NCT02486432|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102118364|NCT02486432|Immunologic Factors|immunologic factors|mesh-ancestor
102118365|NCT02486432|Dopamine Agonists|dopamine agonists|mesh-ancestor
102118366|NCT02489240|Vitamin D|vitamin d|mesh-list
102118367|NCT02489240|Cholecalciferol|cholecalciferol|mesh-list
102118368|NCT02489240|Vitamins|vitamins|mesh-ancestor
102118369|NCT02489240|Micronutrients|micronutrients|mesh-ancestor
102118370|NCT02489240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118371|NCT02489240|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102118372|NCT02489240|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102118373|NCT02183415|Linagliptin|linagliptin|mesh-list
102118374|NCT02183415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102118375|NCT02183415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118376|NCT02183415|Incretins|incretins|mesh-ancestor
102118377|NCT02183415|Hormones|hormones|mesh-ancestor
102118378|NCT02183415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102118379|NCT02183415|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102118380|NCT02183415|Protease Inhibitors|protease inhibitors|mesh-ancestor
102118381|NCT02183415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102118382|NCT02183415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118383|NCT02486510|Maraviroc|maraviroc|mesh-list
102118384|NCT02486510|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102118385|NCT02486510|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102118386|NCT02486510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118387|NCT02486510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102118388|NCT02486510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102118389|NCT02486510|Antiviral Agents|antiviral agents|mesh-ancestor
102118390|NCT02486510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102118391|NCT02486510|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102118392|NCT04493528|Lidocaine|lidocaine|mesh-list
102118393|NCT04493528|Anesthetics, Local|anesthetics, local|mesh-ancestor
102118394|NCT04493528|Anesthetics|anesthetics|mesh-ancestor
102118395|NCT04493528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102118396|NCT04493528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118397|NCT04493528|Sensory System Agents|sensory system agents|mesh-ancestor
102118398|NCT04493528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102118399|NCT04493528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102118400|NCT04493528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102118401|NCT04493528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101571938|NCT02856568|Cisplatin|cisplatin|mesh-list
102118402|NCT04493528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102118403|NCT04493528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118404|NCT02183493|Linagliptin|linagliptin|mesh-list
102118405|NCT02183493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102118406|NCT02183493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118407|NCT02183493|Incretins|incretins|mesh-ancestor
102118408|NCT02183493|Hormones|hormones|mesh-ancestor
102118409|NCT02183493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102118410|NCT02183493|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102118411|NCT02183493|Protease Inhibitors|protease inhibitors|mesh-ancestor
102118412|NCT02183493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102118413|NCT02183493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118414|NCT02187081|Sorafenib|sorafenib|mesh-list
102118415|NCT02187081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102118416|NCT02187081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102118417|NCT02187081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102118418|NCT02187081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118419|NCT02485106|Rifaximin|rifaximin|mesh-list
102118420|NCT02485106|Pentoxifylline|pentoxifylline|mesh-list
102118421|NCT02485106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102118422|NCT02485106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102118423|NCT02485106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102118424|NCT02485106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102118425|NCT02485106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102118426|NCT02485106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118427|NCT02485106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102118428|NCT02485106|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102118429|NCT02485106|Protective Agents|protective agents|mesh-ancestor
102118430|NCT02485106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118431|NCT02485106|Vasodilator Agents|vasodilator agents|mesh-ancestor
102118432|NCT02485106|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102118433|NCT02485106|Antioxidants|antioxidants|mesh-ancestor
102118434|NCT02485028|Mirodenafil|mirodenafil|mesh-list
102118435|NCT02485028|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102118436|NCT02485028|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102118437|NCT02485028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102118438|NCT02485028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118439|NCT02183571|Metformin|metformin|mesh-list
102118440|NCT02183571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102118441|NCT02183571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118442|NCT03318146|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102118443|NCT03318146|Latanoprost|latanoprost|mesh-list
102118444|NCT03318146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102118445|NCT02183649|Carbetapentane|carbetapentane|mesh-list
102118446|NCT02183649|Antitussive Agents|antitussive agents|mesh-ancestor
102118447|NCT02183649|Respiratory System Agents|respiratory system agents|mesh-ancestor
102118448|NCT02187315|Cisplatin|cisplatin|mesh-list
102118449|NCT02187315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102118450|NCT02256735|Moxifloxacin|moxifloxacin|mesh-list
102118451|NCT02256735|p-Hydroxyamphetamine|p-hydroxyamphetamine|mesh-list
102118452|NCT02256735|Ritobegron|ritobegron|mesh-list
102118453|NCT02256735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102118454|NCT02256735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102118455|NCT02256735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102118456|NCT02256735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102118457|NCT02256735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102118458|NCT02256735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118459|NCT02256735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102118460|NCT02256735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118461|NCT02256735|Mydriatics|mydriatics|mesh-ancestor
102118462|NCT02256735|Autonomic Agents|autonomic agents|mesh-ancestor
102118463|NCT02256735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102118464|NCT02256735|Sympathomimetics|sympathomimetics|mesh-ancestor
102118465|NCT02256735|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102118466|NCT02256735|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102118467|NCT02256735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102118468|NCT02256735|Adrenergic Agents|adrenergic agents|mesh-ancestor
102118469|NCT02256735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102118470|NCT02183805|Cyclophosphamide|cyclophosphamide|mesh-list
102118471|NCT02183805|Carboplatin|carboplatin|mesh-list
102118472|NCT02183805|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102118473|NCT02183805|Paclitaxel|paclitaxel|mesh-list
102118474|NCT02183805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102118475|NCT02183805|Immunologic Factors|immunologic factors|mesh-ancestor
102118476|NCT02183805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118477|NCT02183805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102118478|NCT02183805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102118479|NCT02183805|Alkylating Agents|alkylating agents|mesh-ancestor
102118480|NCT02183805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118481|NCT02183805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102118482|NCT02183805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102118483|NCT02183805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102118485|NCT02183805|Antimitotic Agents|antimitotic agents|mesh-ancestor
102118486|NCT02183805|Mitosis Modulators|mitosis modulators|mesh-ancestor
102118487|NCT03316352|Bupivacaine|bupivacaine|mesh-list
102118488|NCT03316352|Anesthetics|anesthetics|mesh-list
102118489|NCT03316352|Anesthetics, Local|anesthetics, local|mesh-ancestor
102118490|NCT03316352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102118491|NCT03316352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118492|NCT03316352|Sensory System Agents|sensory system agents|mesh-ancestor
102118493|NCT03316352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102118494|NCT02187705|Telmisartan|telmisartan|mesh-list
102118495|NCT02187705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102118496|NCT02187705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102118497|NCT02187705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102118498|NCT02187705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118499|NCT03317912|Lidocaine|lidocaine|mesh-list
102118500|NCT03317912|Anesthetics, Local|anesthetics, local|mesh-ancestor
102118501|NCT03317912|Anesthetics|anesthetics|mesh-ancestor
102118502|NCT03317912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102017127|NCT03276598|Vasodilator Agents|vasodilator agents|mesh-ancestor
102118503|NCT03317912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118504|NCT03317912|Sensory System Agents|sensory system agents|mesh-ancestor
102118505|NCT03317912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102118506|NCT03317912|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102118507|NCT03317912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102118508|NCT03317912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102118509|NCT03317912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102118510|NCT03317912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118511|NCT03321110|Ubiquinone|ubiquinone|mesh-list
102118512|NCT03321110|Coenzyme Q10|coenzyme q10|mesh-list
102118513|NCT03321110|Micronutrients|micronutrients|mesh-ancestor
102118514|NCT03321110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118515|NCT03321110|Vitamins|vitamins|mesh-ancestor
102118516|NCT03317600|Lidocaine|lidocaine|mesh-list
102118517|NCT03317600|Anesthetics, Local|anesthetics, local|mesh-ancestor
102118518|NCT03317600|Anesthetics|anesthetics|mesh-ancestor
102118519|NCT03317600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102118520|NCT03317600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118521|NCT03317600|Sensory System Agents|sensory system agents|mesh-ancestor
102118522|NCT03317600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102118523|NCT03317600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102118524|NCT03317600|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102118525|NCT03317600|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102118526|NCT03317600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102118527|NCT03317600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118528|NCT02184117|Adenosine|adenosine|mesh-list
102118529|NCT02184117|Analgesics|analgesics|mesh-ancestor
102118530|NCT02184117|Sensory System Agents|sensory system agents|mesh-ancestor
102118531|NCT02184117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102118532|NCT02184117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118533|NCT02184117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102118534|NCT02184117|Vasodilator Agents|vasodilator agents|mesh-ancestor
102118535|NCT02184117|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102118536|NCT02184117|Purinergic Agonists|purinergic agonists|mesh-ancestor
102118537|NCT02184117|Purinergic Agents|purinergic agents|mesh-ancestor
102118538|NCT02184117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102118539|NCT02184117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118540|NCT02184273|Dipyrone|dipyrone|mesh-list
102118541|NCT02184273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102118542|NCT02184273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102118543|NCT02184273|Analgesics|analgesics|mesh-ancestor
102118544|NCT02184273|Sensory System Agents|sensory system agents|mesh-ancestor
102118545|NCT02184273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102118546|NCT02184273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118547|NCT02184273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102118548|NCT02184273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102118549|NCT02184273|Antipyretics|antipyretics|mesh-ancestor
101572085|NCT04273984|Abortifacient Agents|abortifacient agents|mesh-ancestor
102118550|NCT02486198|Oxaliplatin|oxaliplatin|mesh-list
102118551|NCT02486198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102118552|NCT02188173|Dexamethasone|dexamethasone|mesh-list
102118553|NCT02188173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102118554|NCT02188173|Antiemetics|antiemetics|mesh-ancestor
102118555|NCT02188173|Autonomic Agents|autonomic agents|mesh-ancestor
102118556|NCT02188173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102118557|NCT02188173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118558|NCT02188173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102118559|NCT02188173|Glucocorticoids|glucocorticoids|mesh-ancestor
102118560|NCT02188173|Hormones|hormones|mesh-ancestor
102118561|NCT02188173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102118562|NCT02188173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102118563|NCT02188173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102118564|NCT02184351|Clotrimazole|clotrimazole|mesh-list
102118565|NCT02184351|Miconazole|miconazole|mesh-list
102118566|NCT02184351|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102118567|NCT02184351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102118568|NCT02184351|Antifungal Agents|antifungal agents|mesh-ancestor
102118569|NCT02184351|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102118570|NCT02184351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102118571|NCT02184351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102118572|NCT02184351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118573|NCT02184351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102118574|NCT02184351|Hormone Antagonists|hormone antagonists|mesh-ancestor
102118575|NCT02184351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102118576|NCT02184351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118577|NCT02184351|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102118578|NCT02184351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102118579|NCT02184429|PF-06669571|pf-06669571|mesh-list
102118580|NCT02184429|Dopamine Agonists|dopamine agonists|mesh-ancestor
102118581|NCT02184429|Dopamine Agents|dopamine agents|mesh-ancestor
102118582|NCT02184429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102118583|NCT02184429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118584|NCT02184429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118585|NCT02484170|Mannitol|mannitol|mesh-list
102118586|NCT02484170|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102118587|NCT02484170|Diuretics|diuretics|mesh-ancestor
102118588|NCT02484170|Natriuretic Agents|natriuretic agents|mesh-ancestor
102118589|NCT02484170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118590|NCT02188407|Propofol|propofol|mesh-list
102118591|NCT02188407|Sevoflurane|sevoflurane|mesh-list
102118592|NCT02188407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102118593|NCT02188407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102118594|NCT02188407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118595|NCT02188407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102118596|NCT02188407|Anesthetics, General|anesthetics, general|mesh-ancestor
102118597|NCT02188407|Anesthetics|anesthetics|mesh-ancestor
102118598|NCT02188407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102118599|NCT02188407|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102118600|NCT03317210|Epoetin Alfa|epoetin alfa|mesh-list
102118601|NCT03317210|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102118602|NCT03317210|Hematinics|hematinics|mesh-ancestor
102118603|NCT02488694|Pemetrexed|pemetrexed|mesh-list
102118604|NCT02488694|Afatinib|afatinib|mesh-list
102118605|NCT02488694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102118606|NCT02488694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102118607|NCT02488694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118608|NCT02488694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102118609|NCT02488694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102118610|NCT02488694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102118611|NCT03316898|Memantine|memantine|mesh-list
102118612|NCT03316898|Donepezil|donepezil|mesh-list
102118613|NCT03316898|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102118614|NCT03316898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102118615|NCT03316898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118616|NCT03316898|Cholinergic Agents|cholinergic agents|mesh-ancestor
102118617|NCT03316898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102118618|NCT03316898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118619|NCT03316898|Nootropic Agents|nootropic agents|mesh-ancestor
102118620|NCT03316898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102118621|NCT03316898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102118622|NCT03316898|Dopamine Agents|dopamine agents|mesh-ancestor
102118623|NCT03316898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102118624|NCT03316898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102118625|NCT02188953|Calcium, Dietary|calcium, dietary|mesh-list
102118626|NCT02188953|Calcium Carbonate|calcium carbonate|mesh-list
102118627|NCT02188953|Calcium|calcium|mesh-list
102118628|NCT02188953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102118629|NCT02188953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118630|NCT02188953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102118631|NCT02188953|Antacids|antacids|mesh-ancestor
102612360|NCT00002423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102118632|NCT02188953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118633|NCT02188953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102118634|NCT02184819|Riboflavin|riboflavin|mesh-list
102118635|NCT02184819|Simendan|simendan|mesh-list
102118636|NCT02184819|Vitamin B Complex|vitamin b complex|mesh-ancestor
102118637|NCT02184819|Vitamins|vitamins|mesh-ancestor
102118638|NCT02184819|Micronutrients|micronutrients|mesh-ancestor
102118639|NCT02184819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118640|NCT02184819|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102118641|NCT02184819|Dermatologic Agents|dermatologic agents|mesh-ancestor
102118642|NCT02184819|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102118643|NCT02184819|Vasodilator Agents|vasodilator agents|mesh-ancestor
102118644|NCT02184819|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102118645|NCT02184819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102118646|NCT02184819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102118647|NCT02184819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118648|NCT02184819|Protective Agents|protective agents|mesh-ancestor
102118649|NCT02256813|Vitamin K|vitamin k|mesh-list
102118650|NCT02256813|Vitamin K 1|vitamin k 1|mesh-list
102118651|NCT02256813|Midazolam|midazolam|mesh-list
102118652|NCT02256813|Dextromethorphan|dextromethorphan|mesh-list
102118653|NCT02256813|Caffeine|caffeine|mesh-list
102118654|NCT02256813|Omeprazole|omeprazole|mesh-list
102118655|NCT02256813|Warfarin|warfarin|mesh-list
102118656|NCT02256813|Vitamins|vitamins|mesh-ancestor
102118657|NCT02256813|Micronutrients|micronutrients|mesh-ancestor
102118658|NCT02256813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118659|NCT02256813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102118660|NCT02256813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102118661|NCT02256813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102118662|NCT02256813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102118663|NCT02256813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102118664|NCT02256813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102118665|NCT02256813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102118666|NCT02256813|Anesthetics, General|anesthetics, general|mesh-ancestor
102118667|NCT02256813|Anesthetics|anesthetics|mesh-ancestor
102118668|NCT02256813|GABA Modulators|gaba modulators|mesh-ancestor
102118669|NCT02256813|GABA Agents|gaba agents|mesh-ancestor
102118670|NCT02256813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102118671|NCT02256813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118672|NCT02256813|Anticoagulants|anticoagulants|mesh-ancestor
102118673|NCT02256813|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102118674|NCT02256813|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102118675|NCT02256813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102118676|NCT02256813|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102118677|NCT02256813|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102118678|NCT02256813|Purinergic Agents|purinergic agents|mesh-ancestor
102118679|NCT02256813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102118680|NCT02256813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102118681|NCT02256813|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102118682|NCT02256813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102118683|NCT02256813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102118684|NCT02256813|Hemostatics|hemostatics|mesh-ancestor
102118685|NCT02256813|Coagulants|coagulants|mesh-ancestor
102118686|NCT02256813|Antitussive Agents|antitussive agents|mesh-ancestor
102118687|NCT02256813|Respiratory System Agents|respiratory system agents|mesh-ancestor
102118688|NCT02256813|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102118689|NCT02256813|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102118690|NCT02479958|Chlorhexidine|chlorhexidine|mesh-list
102118691|NCT02479958|Anti-Infective Agents|anti-infective agents|mesh-list
102118692|NCT02479958|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102118693|NCT02479958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102118694|NCT02479958|Disinfectants|disinfectants|mesh-ancestor
102118695|NCT02483624|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
102118696|NCT02483624|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102118697|NCT02483624|Protective Agents|protective agents|mesh-ancestor
102118698|NCT02483624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118699|NCT02483624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101572245|NCT02801227|Oxytocin|oxytocin|mesh-list
102118700|NCT02184897|Lenograstim|lenograstim|mesh-list
102118701|NCT02184897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102118702|NCT02184897|Immunologic Factors|immunologic factors|mesh-ancestor
102118703|NCT02184897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118704|NCT02184975|Hemostatics|hemostatics|mesh-list
102118705|NCT02184975|Coagulants|coagulants|mesh-ancestor
102118706|NCT02189343|Thalidomide|thalidomide|mesh-list
102118707|NCT02189343|Dexamethasone|dexamethasone|mesh-list
102118708|NCT02189343|Dexamethasone acetate|dexamethasone acetate|mesh-list
102118709|NCT02189343|Pomalidomide|pomalidomide|mesh-list
102118710|NCT02189343|Ricolinostat|ricolinostat|mesh-list
102118711|NCT02189343|BB 1101|bb 1101|mesh-list
102118712|NCT02189343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102118713|NCT02189343|Antiemetics|antiemetics|mesh-ancestor
102118714|NCT02189343|Autonomic Agents|autonomic agents|mesh-ancestor
102118715|NCT02189343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102118716|NCT02189343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118717|NCT02189343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102118718|NCT02189343|Glucocorticoids|glucocorticoids|mesh-ancestor
102118719|NCT02189343|Hormones|hormones|mesh-ancestor
102118720|NCT02189343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102118721|NCT02189343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102118722|NCT02189343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102118723|NCT02189343|Protease Inhibitors|protease inhibitors|mesh-ancestor
102118724|NCT02189343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102118725|NCT02189343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118726|NCT02189343|Immunologic Factors|immunologic factors|mesh-ancestor
102118727|NCT02189343|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102118728|NCT02189343|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102118729|NCT02189343|Growth Substances|growth substances|mesh-ancestor
102118730|NCT02189343|Growth Inhibitors|growth inhibitors|mesh-ancestor
102118731|NCT02189343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102118732|NCT02189343|Leprostatic Agents|leprostatic agents|mesh-ancestor
102118733|NCT02189343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102118734|NCT02189343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102118735|NCT02189343|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102118736|NCT03535701|Paclitaxel|paclitaxel|mesh-list
102118737|NCT03535701|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102118738|NCT03535701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102118739|NCT03535701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102118740|NCT03535701|Tubulin Modulators|tubulin modulators|mesh-ancestor
102118741|NCT03535701|Antimitotic Agents|antimitotic agents|mesh-ancestor
102118742|NCT03535701|Mitosis Modulators|mitosis modulators|mesh-ancestor
102118743|NCT03535701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118744|NCT02486276|Cilostazol|cilostazol|mesh-list
102118745|NCT02486276|Sumatriptan|sumatriptan|mesh-list
102118746|NCT02486276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102118747|NCT02486276|Autonomic Agents|autonomic agents|mesh-ancestor
102118748|NCT02486276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102118749|NCT02486276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118750|NCT02486276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102118751|NCT02486276|Respiratory System Agents|respiratory system agents|mesh-ancestor
102118752|NCT02486276|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102118753|NCT02486276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102118754|NCT02486276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118755|NCT02486276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102118756|NCT02486276|Vasodilator Agents|vasodilator agents|mesh-ancestor
102118757|NCT02486276|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102118758|NCT02486276|Protective Agents|protective agents|mesh-ancestor
102118759|NCT02486276|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102118760|NCT02486276|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102118761|NCT02486276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102118762|NCT02486276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102118763|NCT02486276|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102017386|NCT01360086|Vitamins|vitamins|mesh-ancestor
102118764|NCT02486276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102118765|NCT02486276|Serotonin Agents|serotonin agents|mesh-ancestor
102118766|NCT02486276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102118767|NCT02189577|Glycopyrrolate|glycopyrrolate|mesh-list
102118768|NCT02189577|Bromides|bromides|mesh-list
102118769|NCT02189577|Anticonvulsants|anticonvulsants|mesh-ancestor
102118770|NCT02189577|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102118771|NCT02189577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102118772|NCT02189577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102118773|NCT02189577|Cholinergic Agents|cholinergic agents|mesh-ancestor
102118774|NCT02189577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102118775|NCT02189577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118776|NCT02189577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118777|NCT02189655|Bupivacaine|bupivacaine|mesh-list
101572310|NCT02798653|Progestins|progestins|mesh-ancestor
102118778|NCT02189655|Anesthetics, Local|anesthetics, local|mesh-ancestor
102118779|NCT02189655|Anesthetics|anesthetics|mesh-ancestor
102118780|NCT02189655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102118781|NCT02189655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118782|NCT02189655|Sensory System Agents|sensory system agents|mesh-ancestor
102118783|NCT02189655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102118784|NCT04633863|Lubricant Eye Drops|lubricant eye drops|mesh-list
102118785|NCT04633863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102118786|NCT04633863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102118787|NCT02193633|Paclitaxel|paclitaxel|mesh-list
102118788|NCT02193633|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102118789|NCT02193633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102118790|NCT02193633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102118791|NCT02193633|Tubulin Modulators|tubulin modulators|mesh-ancestor
102118792|NCT02193633|Antimitotic Agents|antimitotic agents|mesh-ancestor
102118793|NCT02193633|Mitosis Modulators|mitosis modulators|mesh-ancestor
102118794|NCT02193633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118795|NCT03315338|Prednisone|prednisone|mesh-list
102118796|NCT03315338|Cortisone|cortisone|mesh-list
102118797|NCT03315338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102118798|NCT03315338|Glucocorticoids|glucocorticoids|mesh-ancestor
102118799|NCT03315338|Hormones|hormones|mesh-ancestor
102118800|NCT03315338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102118801|NCT03315338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118802|NCT03315338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102118803|NCT03315338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102118804|NCT02483156|Ribavirin|ribavirin|mesh-list
102118805|NCT02483156|Sofosbuvir|sofosbuvir|mesh-list
102118806|NCT02483156|Antimetabolites|antimetabolites|mesh-ancestor
102118807|NCT02483156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118808|NCT02483156|Antiviral Agents|antiviral agents|mesh-ancestor
102118809|NCT02483156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102118810|NCT00706004|Lubiprostone|lubiprostone|mesh-list
102118811|NCT00706004|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102118812|NCT00706004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102118813|NCT00706004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118814|NCT02485340|Isosorbide|isosorbide|mesh-list
102118815|NCT02485340|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
102118816|NCT02485340|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
102118817|NCT02485340|Sumatriptan|sumatriptan|mesh-list
102118818|NCT02485340|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102118819|NCT02485340|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102118820|NCT02485340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102118821|NCT02485340|Serotonin Agents|serotonin agents|mesh-ancestor
102118822|NCT02485340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102118823|NCT02485340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118824|NCT02485340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118825|NCT02485340|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102118826|NCT02485340|Diuretics|diuretics|mesh-ancestor
102118827|NCT02485340|Natriuretic Agents|natriuretic agents|mesh-ancestor
102118828|NCT02485340|Vasodilator Agents|vasodilator agents|mesh-ancestor
102118829|NCT02485340|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102118830|NCT04492514|Mavrilimumab|mavrilimumab|mesh-list
102118831|NCT04492514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102118832|NCT02485262|Sofosbuvir|sofosbuvir|mesh-list
102118833|NCT02485262|Simeprevir|simeprevir|mesh-list
102118834|NCT02485262|Antiviral Agents|antiviral agents|mesh-ancestor
102118835|NCT02485262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102118836|NCT02485262|Protease Inhibitors|protease inhibitors|mesh-ancestor
102118837|NCT02485262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102118838|NCT02485262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118839|NCT02479490|Prednisone|prednisone|mesh-list
102118840|NCT02479490|Everolimus|everolimus|mesh-list
102118841|NCT02479490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102118842|NCT02479490|Glucocorticoids|glucocorticoids|mesh-ancestor
102118843|NCT02479490|Hormones|hormones|mesh-ancestor
102118844|NCT02479490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102118845|NCT02479490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118846|NCT02479490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102118847|NCT02479490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102118848|NCT02479490|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102118849|NCT02479490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102118850|NCT02479490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102118851|NCT02479490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118852|NCT02479490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102118853|NCT02479490|Immunologic Factors|immunologic factors|mesh-ancestor
102118854|NCT02479256|Tamoxifen|tamoxifen|mesh-list
102118855|NCT02479256|Citric Acid|citric acid|mesh-list
102118856|NCT02479256|Sodium Citrate|sodium citrate|mesh-list
102118857|NCT02479256|Clomiphene|clomiphene|mesh-list
102118858|NCT02479256|Enclomiphene|enclomiphene|mesh-list
102118859|NCT02479256|Zuclomiphene|zuclomiphene|mesh-list
102118860|NCT02479256|Anticoagulants|anticoagulants|mesh-ancestor
102118861|NCT02479256|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102118862|NCT02479256|Chelating Agents|chelating agents|mesh-ancestor
102118863|NCT02479256|Sequestering Agents|sequestering agents|mesh-ancestor
102118864|NCT02479256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118865|NCT02479256|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102118866|NCT02479256|Hormone Antagonists|hormone antagonists|mesh-ancestor
102118867|NCT02479256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102118868|NCT02479256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118869|NCT02479256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102118870|NCT02479256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102118871|NCT02479256|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102118872|NCT02479256|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102118873|NCT02479256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102118874|NCT02479256|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102118875|NCT02479256|Fertility Agents|fertility agents|mesh-ancestor
102118876|NCT02479256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102118877|NCT02482766|Poractant alfa|poractant alfa|mesh-list
102118878|NCT02482766|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
102118879|NCT02482766|Respiratory System Agents|respiratory system agents|mesh-ancestor
102118880|NCT04492280|Hydrocortisone|hydrocortisone|mesh-list
102118881|NCT04492280|Fludrocortisone|fludrocortisone|mesh-list
102118882|NCT04492280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102118883|NCT02479178|Docetaxel|docetaxel|mesh-list
102118884|NCT02479178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102118885|NCT02479178|Tubulin Modulators|tubulin modulators|mesh-ancestor
102118886|NCT02479178|Antimitotic Agents|antimitotic agents|mesh-ancestor
102118887|NCT02479178|Mitosis Modulators|mitosis modulators|mesh-ancestor
102118888|NCT02479178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118889|NCT03314792|Oxycodone|oxycodone|mesh-list
102118890|NCT03314792|Tapentadol|tapentadol|mesh-list
102118891|NCT03314792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102118892|NCT03314792|Narcotics|narcotics|mesh-ancestor
102118893|NCT03314792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102118894|NCT03314792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118895|NCT03314792|Analgesics|analgesics|mesh-ancestor
102118896|NCT03314792|Sensory System Agents|sensory system agents|mesh-ancestor
102118897|NCT03314792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102118898|NCT03314792|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102118899|NCT03314792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102118900|NCT03314792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102118901|NCT03314792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118902|NCT03314792|Adrenergic Agents|adrenergic agents|mesh-ancestor
102118903|NCT03314792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102118904|NCT02476526|Acetylcysteine|acetylcysteine|mesh-list
102118905|NCT02476526|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102118906|NCT02476526|Antiviral Agents|antiviral agents|mesh-ancestor
102118907|NCT02476526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102118908|NCT02476526|Expectorants|expectorants|mesh-ancestor
102118909|NCT02476526|Respiratory System Agents|respiratory system agents|mesh-ancestor
102118910|NCT02476526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102118911|NCT02476526|Antioxidants|antioxidants|mesh-ancestor
102118912|NCT02476526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118913|NCT02476526|Protective Agents|protective agents|mesh-ancestor
102118914|NCT02476526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118915|NCT02476526|Antidotes|antidotes|mesh-ancestor
102118916|NCT02479022|Insulin|insulin|mesh-list
102118917|NCT02479022|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102118918|NCT02479022|Insulin Glargine|insulin glargine|mesh-list
102118919|NCT02479022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102118920|NCT02479022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118921|NCT02476760|Insulin|insulin|mesh-list
102118922|NCT02476760|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102118923|NCT02476760|Metformin|metformin|mesh-list
102118924|NCT02476760|Pioglitazone|pioglitazone|mesh-list
102118925|NCT02476760|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102118926|NCT02476760|Liraglutide|liraglutide|mesh-list
102118927|NCT02476760|Exenatide|exenatide|mesh-list
101509787|NCT02938182|Clopidogrel|clopidogrel|mesh-list
102118928|NCT02476760|Glimepiride|glimepiride|mesh-list
102118929|NCT02476760|Rosiglitazone|rosiglitazone|mesh-list
102118930|NCT02476760|Vildagliptin|vildagliptin|mesh-list
102118931|NCT02476760|Saxagliptin|saxagliptin|mesh-list
102118932|NCT02476760|Acarbose|acarbose|mesh-list
102118933|NCT02476760|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102118934|NCT02476760|Repaglinide|repaglinide|mesh-list
102118936|NCT02476760|Glipizide|glipizide|mesh-list
102118937|NCT02476760|Biguanides|biguanides|mesh-list
102118938|NCT02476760|Tolbutamide|tolbutamide|mesh-list
102118939|NCT02476760|Voglibose|voglibose|mesh-list
102118940|NCT02476760|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
102118941|NCT02476760|Nateglinide|nateglinide|mesh-list
102118942|NCT02476760|Miglitol|miglitol|mesh-list
102118943|NCT02476760|Meglitinide|meglitinide|mesh-list
102118944|NCT02476760|Troglitazone|troglitazone|mesh-list
102118945|NCT02476760|Acetohexamide|acetohexamide|mesh-list
102118946|NCT02476760|Buformin|buformin|mesh-list
102118947|NCT02476760|Chlorpropamide|chlorpropamide|mesh-list
102118948|NCT02476760|Phenformin|phenformin|mesh-list
102118949|NCT02476760|Gliquidone|gliquidone|mesh-list
102118950|NCT02476760|Carbutamide|carbutamide|mesh-list
102118951|NCT02476760|Tolazamide|tolazamide|mesh-list
102118952|NCT02476760|Glibornuride|glibornuride|mesh-list
102118953|NCT02476760|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
102118954|NCT02476760|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
102118955|NCT02476760|Incretins|incretins|mesh-list
102118956|NCT02476760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118957|NCT02476760|Hormones|hormones|mesh-ancestor
102118958|NCT02476760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102118959|NCT02476760|Protease Inhibitors|protease inhibitors|mesh-ancestor
102118960|NCT02476760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102118961|NCT02476760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118962|NCT02476760|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102118963|NCT02476760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102118964|NCT02476760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102118965|NCT02476760|Immunologic Factors|immunologic factors|mesh-ancestor
102118966|NCT05460338|Cholecalciferol|cholecalciferol|mesh-list
102118967|NCT05460338|Vitamin D|vitamin d|mesh-list
102118968|NCT05460338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102118969|NCT05460338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118970|NCT05460338|Vitamins|vitamins|mesh-ancestor
102118971|NCT05460338|Micronutrients|micronutrients|mesh-ancestor
102118972|NCT05460338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102118973|NCT02476136|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102118974|NCT02476136|Fluoxetine|fluoxetine|mesh-list
102118975|NCT02476136|Paroxetine|paroxetine|mesh-list
102118976|NCT02476136|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102118977|NCT02476136|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102118978|NCT02476136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102118979|NCT02476136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102118980|NCT02476136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102118981|NCT02476136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102118982|NCT02476136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102118983|NCT02476136|Analgesics|analgesics|mesh-ancestor
102118984|NCT02476136|Sensory System Agents|sensory system agents|mesh-ancestor
102118985|NCT02476136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102118986|NCT02476136|Antidepressive Agents|antidepressive agents|mesh-ancestor
102118987|NCT02476136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102118988|NCT02476136|Dopamine Agents|dopamine agents|mesh-ancestor
102118989|NCT02476136|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102118990|NCT02476136|Serotonin Agents|serotonin agents|mesh-ancestor
102118991|NCT02476136|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102118992|NCT02476136|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102118993|NCT02476136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102118994|NCT02476136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102118995|NCT05437094|Itraconazole|itraconazole|mesh-list
102118996|NCT05437094|Antifungal Agents|antifungal agents|mesh-ancestor
102118997|NCT05437094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102118998|NCT05437094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102118999|NCT05437094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102119000|NCT05437094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102119001|NCT05437094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119002|NCT05437094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102119003|NCT05437094|Hormone Antagonists|hormone antagonists|mesh-ancestor
102119004|NCT05437094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102119005|NCT05437094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509853|NCT02931357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102119006|NCT05437094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102119007|NCT05413772|Temocillin|temocillin|mesh-list
102119008|NCT05413772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102119009|NCT05413772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102119010|NCT05713292|Pirfenidone|pirfenidone|mesh-list
102119011|NCT05713292|Analgesics|analgesics|mesh-ancestor
102119012|NCT05713292|Sensory System Agents|sensory system agents|mesh-ancestor
102119013|NCT05713292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102119014|NCT05713292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119015|NCT05713292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102612361|NCT02973581|Acetaminophen|acetaminophen|mesh-list
102119016|NCT05713292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102119017|NCT05713292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102119018|NCT05713292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102119019|NCT05713292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102119020|NCT02475824|Midazolam|midazolam|mesh-list
102119021|NCT02475824|Meperidine|meperidine|mesh-list
102119022|NCT02475824|Dexmedetomidine|dexmedetomidine|mesh-list
102119023|NCT02475824|Propofol|propofol|mesh-list
102119024|NCT02475824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102119025|NCT02475824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102119026|NCT02475824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119027|NCT02475824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102119028|NCT02475824|Analgesics|analgesics|mesh-ancestor
102119029|NCT02475824|Sensory System Agents|sensory system agents|mesh-ancestor
102119030|NCT02475824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102119031|NCT02475824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102119032|NCT02475824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102119033|NCT02475824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102119034|NCT02475824|Adrenergic Agents|adrenergic agents|mesh-ancestor
102119035|NCT02475824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102119036|NCT02475824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119037|NCT02475824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102119038|NCT02475824|Anesthetics, General|anesthetics, general|mesh-ancestor
102119039|NCT02475824|Anesthetics|anesthetics|mesh-ancestor
102119040|NCT02475824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102119041|NCT02475824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102119042|NCT02475824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102119043|NCT02475824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102119044|NCT02475824|GABA Modulators|gaba modulators|mesh-ancestor
102119045|NCT02475824|GABA Agents|gaba agents|mesh-ancestor
102119046|NCT02475824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102119047|NCT02475824|Narcotics|narcotics|mesh-ancestor
102119048|NCT02478242|Nafamostat|nafamostat|mesh-list
102119049|NCT02478242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102119050|NCT02478242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102119051|NCT02478242|Analgesics|analgesics|mesh-ancestor
102119052|NCT02478242|Sensory System Agents|sensory system agents|mesh-ancestor
102119053|NCT02478242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102119054|NCT02478242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119055|NCT02478242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102119056|NCT02478242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102119057|NCT02478242|Anticoagulants|anticoagulants|mesh-ancestor
102119058|NCT02478242|Protease Inhibitors|protease inhibitors|mesh-ancestor
102119059|NCT02478242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102119060|NCT02478242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119061|NCT02478242|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102119062|NCT02478242|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102119063|NCT02478242|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102119064|NCT02478242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102119065|NCT02478242|Immunologic Factors|immunologic factors|mesh-ancestor
102119066|NCT02475746|Itraconazole|itraconazole|mesh-list
102119067|NCT02475746|PF-06372865|pf-06372865|mesh-list
102119068|NCT02475746|Antifungal Agents|antifungal agents|mesh-ancestor
102119069|NCT02475746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102119070|NCT02475746|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102119071|NCT02475746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102119072|NCT02475746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102119073|NCT02475746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119074|NCT02475746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102119075|NCT02475746|Hormone Antagonists|hormone antagonists|mesh-ancestor
102119076|NCT02475746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102119077|NCT02475746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119078|NCT02475746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102119079|NCT02475746|GABA Modulators|gaba modulators|mesh-ancestor
102119080|NCT02475746|GABA Agents|gaba agents|mesh-ancestor
102119081|NCT02475746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102119082|NCT05715164|Nicotine|nicotine|mesh-list
102119083|NCT05715164|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102119084|NCT05715164|Autonomic Agents|autonomic agents|mesh-ancestor
102119085|NCT05715164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102119086|NCT05715164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119087|NCT05715164|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102119088|NCT05715164|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102119089|NCT05715164|Cholinergic Agents|cholinergic agents|mesh-ancestor
102119090|NCT05715164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102119091|NCT05715164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119093|NCT02475356|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102119094|NCT02475356|Contraceptive Agents|contraceptive agents|mesh-ancestor
102119095|NCT02475356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102119096|NCT02475356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119097|NCT02475356|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102119098|NCT02475356|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102119099|NCT02475356|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102119100|NCT02480894|Maraviroc|maraviroc|mesh-list
102119101|NCT02480894|Fostemsavir|fostemsavir|mesh-list
102119102|NCT02480894|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102119103|NCT02480894|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102119104|NCT02480894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119105|NCT02480894|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102119106|NCT02480894|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102119107|NCT02480894|Antiviral Agents|antiviral agents|mesh-ancestor
102119108|NCT02480894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102119109|NCT02480894|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102119110|NCT02474654|Ketorolac|ketorolac|mesh-list
102119111|NCT02474654|Epinephrine|epinephrine|mesh-list
102119112|NCT02474654|Racepinephrine|racepinephrine|mesh-list
102119113|NCT02474654|Fentanyl|fentanyl|mesh-list
102119114|NCT02474654|Bupivacaine|bupivacaine|mesh-list
102119115|NCT02474654|Epinephryl borate|epinephryl borate|mesh-list
102119116|NCT02474654|Anesthetics, Local|anesthetics, local|mesh-ancestor
102119117|NCT02474654|Anesthetics|anesthetics|mesh-ancestor
102119118|NCT02474654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102119119|NCT02474654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119120|NCT02474654|Sensory System Agents|sensory system agents|mesh-ancestor
102119121|NCT02474654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102119122|NCT02474654|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102119123|NCT02474654|Narcotics|narcotics|mesh-ancestor
102119124|NCT02474654|Analgesics|analgesics|mesh-ancestor
102119125|NCT02474654|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102119126|NCT02474654|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102119127|NCT02474654|Anesthetics, General|anesthetics, general|mesh-ancestor
102119128|NCT02474654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102119129|NCT02474654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102119130|NCT02474654|Adrenergic Agents|adrenergic agents|mesh-ancestor
102119131|NCT02474654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102119132|NCT02474654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119133|NCT02474654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102119134|NCT02474654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102119135|NCT02474654|Autonomic Agents|autonomic agents|mesh-ancestor
102119136|NCT02474654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102119137|NCT02474654|Respiratory System Agents|respiratory system agents|mesh-ancestor
102119138|NCT02474654|Mydriatics|mydriatics|mesh-ancestor
102119139|NCT02474654|Sympathomimetics|sympathomimetics|mesh-ancestor
102119140|NCT02474654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102119141|NCT02474654|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102119142|NCT02474654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102119143|NCT02474654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102119144|NCT02474654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102119145|NCT02474654|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102119146|NCT02474654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102119147|NCT02477852|Rifampin|rifampin|mesh-list
102119148|NCT02477852|Isoniazid|isoniazid|mesh-list
102119149|NCT02477852|Pyrazinamide|pyrazinamide|mesh-list
102119150|NCT02477852|Ethambutol|ethambutol|mesh-list
102119151|NCT02477852|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102119152|NCT02477852|Antitubercular Agents|antitubercular agents|mesh-ancestor
102119153|NCT02477852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102119154|NCT02477852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102119155|NCT02477852|Leprostatic Agents|leprostatic agents|mesh-ancestor
102119156|NCT02477852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102119157|NCT02477852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102119158|NCT02477852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119159|NCT02477852|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102119160|NCT02477852|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102119161|NCT02477852|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102119162|NCT02477852|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102119163|NCT02477852|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102119164|NCT02477852|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102119165|NCT02477852|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102119166|NCT02477852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102119167|NCT02477852|Antimetabolites|antimetabolites|mesh-ancestor
102119168|NCT02477852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102119169|NCT02474810|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102119170|NCT02474810|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102119171|NCT02474810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102119172|NCT02474810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119173|NCT02725268|Paclitaxel|paclitaxel|mesh-list
102119174|NCT02725268|Serabelisib|serabelisib|mesh-list
102119175|NCT02725268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102119176|NCT02725268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102119177|NCT02725268|Tubulin Modulators|tubulin modulators|mesh-ancestor
102119178|NCT02725268|Antimitotic Agents|antimitotic agents|mesh-ancestor
102119179|NCT02725268|Mitosis Modulators|mitosis modulators|mesh-ancestor
102119180|NCT02725268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119181|NCT02725268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102119182|NCT05038592|Decitabine|decitabine|mesh-list
102119183|NCT05038592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102119184|NCT05038592|Antimetabolites|antimetabolites|mesh-ancestor
102119185|NCT05038592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119186|NCT05038592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102119187|NCT05038592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102119188|NCT00705536|Insulin|insulin|mesh-list
102119189|NCT00705536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102119190|NCT00705536|Insulin Lispro|insulin lispro|mesh-list
102119191|NCT00705536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102119192|NCT00705536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119193|NCT02474420|Amlodipine|amlodipine|mesh-list
102119194|NCT02474420|Deferasirox|deferasirox|mesh-list
102119195|NCT02474420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102119196|NCT02474420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102119197|NCT02474420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102119198|NCT02474420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119199|NCT02474420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102119200|NCT02474420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119201|NCT02474420|Vasodilator Agents|vasodilator agents|mesh-ancestor
102119202|NCT02474420|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102119203|NCT02474420|Chelating Agents|chelating agents|mesh-ancestor
102119204|NCT02474420|Sequestering Agents|sequestering agents|mesh-ancestor
102119205|NCT02474186|Paclitaxel|paclitaxel|mesh-list
102119206|NCT02474186|Docetaxel|docetaxel|mesh-list
102119207|NCT02474186|Capecitabine|capecitabine|mesh-list
102119208|NCT02474186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102119209|NCT02474186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102119210|NCT02474186|Tubulin Modulators|tubulin modulators|mesh-ancestor
102119211|NCT02474186|Antimitotic Agents|antimitotic agents|mesh-ancestor
102119212|NCT02474186|Mitosis Modulators|mitosis modulators|mesh-ancestor
102119213|NCT02474186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119214|NCT02474186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102119215|NCT02474186|Antimetabolites|antimetabolites|mesh-ancestor
102119216|NCT02477306|Rabeprazole|rabeprazole|mesh-list
102119217|NCT02477306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102119218|NCT02477306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102119219|NCT02477306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102119220|NCT02477306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102119221|NCT02477306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119222|NCT04868786|Mycophenolic Acid|mycophenolic acid|mesh-list
102119223|NCT04868786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102119224|NCT04868786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102119225|NCT04868786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102119226|NCT04868786|Antitubercular Agents|antitubercular agents|mesh-ancestor
102119227|NCT04868786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102119228|NCT04868786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102119229|NCT04868786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102119230|NCT04868786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119231|NCT02472626|Thioctic Acid|thioctic acid|mesh-list
102119232|NCT02472626|Cytarabine|cytarabine|mesh-list
102119233|NCT02472626|Daunorubicin|daunorubicin|mesh-list
102119234|NCT02472626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101510079|NCT00524615|Spironolactone|spironolactone|mesh-list
102119235|NCT02472626|Antimetabolites|antimetabolites|mesh-ancestor
102119236|NCT02472626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119237|NCT02472626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102119238|NCT02472626|Antiviral Agents|antiviral agents|mesh-ancestor
102119239|NCT02472626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102612362|NCT02973581|Dipyrone|dipyrone|mesh-list
102119240|NCT02472626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102119241|NCT02472626|Immunologic Factors|immunologic factors|mesh-ancestor
102119242|NCT02472626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119243|NCT02472626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102119244|NCT02472626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102119245|NCT02472626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102119246|NCT02472626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102119247|NCT02472626|Antioxidants|antioxidants|mesh-ancestor
102119248|NCT02472626|Protective Agents|protective agents|mesh-ancestor
102119249|NCT02472626|Vitamin B Complex|vitamin b complex|mesh-ancestor
102119250|NCT02472626|Vitamins|vitamins|mesh-ancestor
102119251|NCT02472626|Micronutrients|micronutrients|mesh-ancestor
102119252|NCT02472392|Cyclophosphamide|cyclophosphamide|mesh-list
102119253|NCT02472392|Melphalan|melphalan|mesh-list
102119254|NCT02472392|Busulfan|busulfan|mesh-list
102119255|NCT02472392|Fludarabine|fludarabine|mesh-list
102119256|NCT02472392|Thymoglobulin|thymoglobulin|mesh-list
102119257|NCT02472392|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102119258|NCT02472392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102119259|NCT02472392|Immunologic Factors|immunologic factors|mesh-ancestor
102119260|NCT02472392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119261|NCT02472392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102119262|NCT02472392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102119263|NCT02472392|Alkylating Agents|alkylating agents|mesh-ancestor
102119264|NCT02472392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119265|NCT02472392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102119266|NCT02472392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102119267|NCT02472158|Chlorhexidine|chlorhexidine|mesh-list
102119268|NCT02472158|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102119269|NCT02472158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102119270|NCT02472158|Disinfectants|disinfectants|mesh-ancestor
102119271|NCT02472080|Gemcitabine|gemcitabine|mesh-list
102119272|NCT02472080|Oxaliplatin|oxaliplatin|mesh-list
102119273|NCT02472080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102119274|NCT02472080|Antimetabolites|antimetabolites|mesh-ancestor
102119275|NCT02472080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119276|NCT02472080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102119277|NCT02473562|Varenicline|varenicline|mesh-list
102119278|NCT02473562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102119279|NCT02473562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102119280|NCT02473562|Cholinergic Agents|cholinergic agents|mesh-ancestor
102119281|NCT02473562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102119282|NCT02473562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119283|NCT02473562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119284|NCT02724020|Everolimus|everolimus|mesh-list
102119285|NCT02724020|Serabelisib|serabelisib|mesh-list
102119286|NCT02724020|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102119287|NCT02724020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102119288|NCT02724020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102119289|NCT02724020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119290|NCT02724020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102119291|NCT02724020|Immunologic Factors|immunologic factors|mesh-ancestor
102119292|NCT02724020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119293|NCT02724020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102119294|NCT02660034|Tislelizumab|tislelizumab|mesh-list
102119295|NCT02660034|Pamiparib|pamiparib|mesh-list
102119296|NCT02660034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102119297|NCT02660034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102119298|NCT02660034|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102119299|NCT02660034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102119300|NCT02660034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119301|NCT02816736|Valsartan|valsartan|mesh-list
102119302|NCT02816736|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102119303|NCT02816736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102119304|NCT02816736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102119305|NCT02816736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102119306|NCT02816736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119307|NCT02477072|Heparin|heparin|mesh-list
102119308|NCT02477072|Calcium heparin|calcium heparin|mesh-list
102119309|NCT02477072|Anticoagulants|anticoagulants|mesh-ancestor
102119310|NCT02477072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102119311|NCT02477072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102119312|NCT02477072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119313|NCT05103410|Aripiprazole|aripiprazole|mesh-list
102119314|NCT05103410|Antidepressive Agents|antidepressive agents|mesh-ancestor
102119315|NCT05103410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102119316|NCT05103410|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102119317|NCT05103410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102119318|NCT05103410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102119319|NCT05103410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119320|NCT05103410|Dopamine Agonists|dopamine agonists|mesh-ancestor
102119321|NCT05103410|Dopamine Agents|dopamine agents|mesh-ancestor
102119322|NCT05103410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102119323|NCT05103410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119324|NCT05103410|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102119325|NCT05103410|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102119326|NCT05103410|Serotonin Agents|serotonin agents|mesh-ancestor
102119327|NCT05103410|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102119328|NCT05103410|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102119329|NCT05103410|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102119330|NCT05103410|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102119331|NCT02472236|Digoxin|digoxin|mesh-list
102119332|NCT02472236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102119333|NCT02472236|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102119334|NCT02472236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102119335|NCT02472236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119336|NCT02472236|Protective Agents|protective agents|mesh-ancestor
102119337|NCT02472236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119338|NCT03108872|Anticoagulants|anticoagulants|mesh-list
102119339|NCT02194491|AS2471907|as2471907|mesh-list
102119340|NCT02194491|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102119341|NCT02194491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119342|NCT03487770|Aripiprazole|aripiprazole|mesh-list
102119343|NCT03487770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102119344|NCT03487770|Antidepressive Agents|antidepressive agents|mesh-ancestor
102119345|NCT03487770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102119346|NCT03487770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102119347|NCT03487770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102119348|NCT03487770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102119349|NCT03487770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119350|NCT03487770|Dopamine Agonists|dopamine agonists|mesh-ancestor
102119351|NCT03487770|Dopamine Agents|dopamine agents|mesh-ancestor
102119352|NCT03487770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102119353|NCT03487770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119354|NCT03487770|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102119355|NCT03487770|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102119356|NCT03487770|Serotonin Agents|serotonin agents|mesh-ancestor
102119357|NCT03487770|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102119358|NCT03487770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102119359|NCT03487770|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102119360|NCT03487770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102119361|NCT02473328|Ritonavir|ritonavir|mesh-list
102119362|NCT02473328|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102119363|NCT02473328|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102119364|NCT02473328|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102119365|NCT02473328|Protease Inhibitors|protease inhibitors|mesh-ancestor
102119366|NCT02473328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102119367|NCT02473328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119368|NCT02473328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102119369|NCT02473328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102119370|NCT02473328|Antiviral Agents|antiviral agents|mesh-ancestor
102119371|NCT02473328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102119372|NCT02473328|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102119373|NCT02473328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102119374|NCT02473406|Thymalfasin|thymalfasin|mesh-list
102119375|NCT02473406|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102119376|NCT02473406|Immunologic Factors|immunologic factors|mesh-ancestor
102119377|NCT02473406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119378|NCT02473094|Metformin|metformin|mesh-list
102119379|NCT02473094|Capecitabine|capecitabine|mesh-list
102119380|NCT02473094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102119381|NCT02473094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119382|NCT02473094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102119383|NCT02473094|Antimetabolites|antimetabolites|mesh-ancestor
102119384|NCT02473094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119385|NCT02473094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102119386|NCT03492138|Dexamethasone|dexamethasone|mesh-list
102119387|NCT03492138|Ixazomib|ixazomib|mesh-list
102119388|NCT03492138|TIC10 compound|tic10 compound|mesh-list
102119389|NCT03492138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102119390|NCT03492138|Antiemetics|antiemetics|mesh-ancestor
102119391|NCT03492138|Autonomic Agents|autonomic agents|mesh-ancestor
102119392|NCT03492138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102119393|NCT03492138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119394|NCT03492138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102119395|NCT03492138|Glucocorticoids|glucocorticoids|mesh-ancestor
102119396|NCT03492138|Hormones|hormones|mesh-ancestor
102119397|NCT03492138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102119398|NCT03492138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102119399|NCT03492138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102119400|NCT03492138|Protease Inhibitors|protease inhibitors|mesh-ancestor
102119401|NCT03492138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102119402|NCT03492138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119403|NCT02472938|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102119404|NCT02472938|Dermatologic Agents|dermatologic agents|mesh-ancestor
102119405|NCT02472938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102119406|NCT02472938|Immunologic Factors|immunologic factors|mesh-ancestor
102119407|NCT02472938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119408|NCT03131700|Bevacizumab|bevacizumab|mesh-list
102119409|NCT03131700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102119410|NCT03131700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102119411|NCT03131700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102119412|NCT03131700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102119413|NCT03131700|Growth Substances|growth substances|mesh-ancestor
102119414|NCT03131700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119415|NCT03131700|Growth Inhibitors|growth inhibitors|mesh-ancestor
102119416|NCT04706936|Cyclophosphamide|cyclophosphamide|mesh-list
102119417|NCT04706936|Fludarabine|fludarabine|mesh-list
102119418|NCT04706936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102119419|NCT04706936|Immunologic Factors|immunologic factors|mesh-ancestor
102119420|NCT04706936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119421|NCT04706936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102119422|NCT04706936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102119423|NCT04706936|Alkylating Agents|alkylating agents|mesh-ancestor
102119424|NCT04706936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119425|NCT04706936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102119426|NCT04706936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102119427|NCT02194881|Ivacaftor|ivacaftor|mesh-list
102119428|NCT02194881|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102119429|NCT02194881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102119430|NCT02194881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119431|NCT02194179|Nevirapine|nevirapine|mesh-list
102119432|NCT02194179|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102119433|NCT02194179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102119434|NCT02194179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102119435|NCT02194179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119436|NCT02194179|Antiviral Agents|antiviral agents|mesh-ancestor
102119437|NCT02194179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102119438|NCT02194179|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102119439|NCT02194179|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102119440|NCT02194179|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102119441|NCT02194179|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102119442|NCT02194257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102119443|NCT02194257|Ambroxol|ambroxol|mesh-list
102119444|NCT02194257|Expectorants|expectorants|mesh-ancestor
102119445|NCT02194257|Respiratory System Agents|respiratory system agents|mesh-ancestor
102119446|NCT02195115|Amitriptyline|amitriptyline|mesh-list
102119447|NCT02195115|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102119448|NCT02195115|Antidepressive Agents|antidepressive agents|mesh-ancestor
102119449|NCT02195115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102119450|NCT02195115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102119451|NCT02195115|Analgesics|analgesics|mesh-ancestor
102119452|NCT02195115|Sensory System Agents|sensory system agents|mesh-ancestor
102119453|NCT02195115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102119454|NCT02195115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119455|NCT02195115|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102119456|NCT02195115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102119457|NCT02195115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102119458|NCT02195115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119459|NCT02195115|Adrenergic Agents|adrenergic agents|mesh-ancestor
102119460|NCT02195115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102119461|NCT02194335|Olcegepant|olcegepant|mesh-list
102119462|NCT02194335|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
102119463|NCT02194335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119464|NCT02194335|Analgesics|analgesics|mesh-ancestor
102119465|NCT02194335|Sensory System Agents|sensory system agents|mesh-ancestor
102119466|NCT02194335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102119467|NCT02194335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119468|NCT02195973|Paclitaxel|paclitaxel|mesh-list
102119469|NCT02195973|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102119470|NCT02195973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102119471|NCT02195973|Tubulin Modulators|tubulin modulators|mesh-ancestor
102119472|NCT02195973|Antimitotic Agents|antimitotic agents|mesh-ancestor
102119473|NCT02195973|Mitosis Modulators|mitosis modulators|mesh-ancestor
102119474|NCT02195973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119475|NCT02196207|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102119476|NCT02196207|Immunologic Factors|immunologic factors|mesh-ancestor
102119477|NCT02196207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119478|NCT02195271|Melatonin|melatonin|mesh-list
102119479|NCT02195271|Antioxidants|antioxidants|mesh-ancestor
102119480|NCT02195271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119481|NCT02195271|Protective Agents|protective agents|mesh-ancestor
102119482|NCT02195271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119483|NCT02195271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102119484|NCT02196285|Vaccines|vaccines|mesh-list
102119485|NCT02196285|Immunologic Factors|immunologic factors|mesh-ancestor
102119486|NCT02196285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119487|NCT04229979|Cytarabine|cytarabine|mesh-list
102119488|NCT04229979|Azacitidine|azacitidine|mesh-list
102119489|NCT04229979|Decitabine|decitabine|mesh-list
102119490|NCT04229979|Venetoclax|venetoclax|mesh-list
102119491|NCT04229979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102119492|NCT04229979|Antimetabolites|antimetabolites|mesh-ancestor
102119493|NCT04229979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119494|NCT04229979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102119495|NCT04229979|Antiviral Agents|antiviral agents|mesh-ancestor
102119496|NCT04229979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102119497|NCT04229979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102119498|NCT04229979|Immunologic Factors|immunologic factors|mesh-ancestor
102119499|NCT04229979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119500|NCT04229979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102119501|NCT02196441|Bupivacaine|bupivacaine|mesh-list
102119502|NCT02196441|Anesthetics, Local|anesthetics, local|mesh-list
102119503|NCT02196441|Tetracaine|tetracaine|mesh-list
102119504|NCT02196441|Anesthetics|anesthetics|mesh-list
102119505|NCT02196441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102119506|NCT02196441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119507|NCT02196441|Sensory System Agents|sensory system agents|mesh-ancestor
102119508|NCT02196441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102119509|NCT02195661|Melatonin|melatonin|mesh-list
102119510|NCT02195661|Chloral Hydrate|chloral hydrate|mesh-list
102119511|NCT02195661|Antioxidants|antioxidants|mesh-ancestor
102119512|NCT02195661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119513|NCT02195661|Protective Agents|protective agents|mesh-ancestor
102119514|NCT02195661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119515|NCT02195661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102119516|NCT02195661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102119517|NCT03534297|Dapansutrile|dapansutrile|mesh-list
102119518|NCT03534297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102119519|NCT02195817|Nalmefene|nalmefene|mesh-list
102119520|NCT02195817|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102119521|NCT02195817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119522|NCT02195817|Sensory System Agents|sensory system agents|mesh-ancestor
102119523|NCT02195817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102119524|NCT03534063|Analgesics, Opioid|analgesics, opioid|mesh-list
102119525|NCT03534063|Narcotics|narcotics|mesh-ancestor
102119526|NCT03534063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102119527|NCT03534063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119528|NCT03534063|Analgesics|analgesics|mesh-ancestor
102119529|NCT03534063|Sensory System Agents|sensory system agents|mesh-ancestor
102119530|NCT03534063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102119531|NCT02197143|Esomeprazole|esomeprazole|mesh-list
102119532|NCT02197143|Ranitidine|ranitidine|mesh-list
102119533|NCT02197143|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
101573074|NCT05266417|Insulin|insulin|mesh-list
102119534|NCT02197143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102119535|NCT02197143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102119536|NCT02197143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102119537|NCT02197143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102119538|NCT02197143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119539|NCT02197143|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102119540|NCT02197143|Histamine Antagonists|histamine antagonists|mesh-ancestor
102119541|NCT02197143|Histamine Agents|histamine agents|mesh-ancestor
102119542|NCT02197143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102119543|NCT02197143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119544|NCT02096874|Bevacizumab|bevacizumab|mesh-list
102119545|NCT02096874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102119546|NCT02096874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102119547|NCT02096874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102119548|NCT02096874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102119549|NCT02096874|Growth Substances|growth substances|mesh-ancestor
102119550|NCT02096874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119551|NCT02096874|Growth Inhibitors|growth inhibitors|mesh-ancestor
102119552|NCT02198547|Magnesium Sulfate|magnesium sulfate|mesh-list
102119553|NCT02198547|Ropivacaine|ropivacaine|mesh-list
102119554|NCT02198547|Anesthetics, Local|anesthetics, local|mesh-ancestor
102119555|NCT02198547|Anesthetics|anesthetics|mesh-ancestor
102119556|NCT02198547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102119557|NCT02198547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119558|NCT02198547|Sensory System Agents|sensory system agents|mesh-ancestor
102119559|NCT02198547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102119560|NCT02198547|Analgesics|analgesics|mesh-ancestor
102119561|NCT02198547|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102119562|NCT02198547|Anticonvulsants|anticonvulsants|mesh-ancestor
102119563|NCT02198547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102119564|NCT02198547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102119565|NCT02198547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119566|NCT02198547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102119567|NCT02198547|Tocolytic Agents|tocolytic agents|mesh-ancestor
102119568|NCT02198547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102119569|NCT01024608|Beclomethasone|beclomethasone|mesh-list
102119570|NCT01024608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102119571|NCT01024608|Glucocorticoids|glucocorticoids|mesh-ancestor
102119572|NCT01024608|Hormones|hormones|mesh-ancestor
102119573|NCT01024608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102119574|NCT01024608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119575|NCT01024608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102119576|NCT01024608|Respiratory System Agents|respiratory system agents|mesh-ancestor
102119577|NCT03489798|Alprostadil|alprostadil|mesh-list
102119578|NCT03489798|Misoprostol|misoprostol|mesh-list
102119579|NCT03489798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102119580|NCT03489798|Abortifacient Agents|abortifacient agents|mesh-ancestor
102119581|NCT03489798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102119582|NCT03489798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119583|NCT03489798|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102119584|NCT03489798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102119585|NCT03489798|Oxytocics|oxytocics|mesh-ancestor
102119586|NCT03489798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102119587|NCT03489798|Vasodilator Agents|vasodilator agents|mesh-ancestor
102119588|NCT03489798|Urological Agents|urological agents|mesh-ancestor
102119589|NCT02031081|Prucalopride|prucalopride|mesh-list
102119590|NCT02031081|Laxatives|laxatives|mesh-ancestor
102119591|NCT02031081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102119592|NCT02031081|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
102119593|NCT02031081|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102119594|NCT02031081|Serotonin Agents|serotonin agents|mesh-ancestor
102119595|NCT02031081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102119596|NCT02031081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119597|NCT02031081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119598|NCT02198859|Lithium Carbonate|lithium carbonate|mesh-list
102119599|NCT02198859|Antidepressive Agents|antidepressive agents|mesh-ancestor
102119600|NCT02198859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102119601|NCT02198859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102119602|NCT02198859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119603|NCT02198859|Antimanic Agents|antimanic agents|mesh-ancestor
102119604|NCT02198859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102119605|NCT02198859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102119606|NCT02198859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119607|NCT02199171|Carboplatin|carboplatin|mesh-list
102119608|NCT02199171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102119609|NCT00910650|Aldesleukin|aldesleukin|mesh-list
102119610|NCT00910650|Interleukin-2|interleukin-2|mesh-list
102119611|NCT00910650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102119612|NCT00910650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102119613|NCT00910650|Analgesics|analgesics|mesh-ancestor
102119614|NCT00910650|Sensory System Agents|sensory system agents|mesh-ancestor
102119615|NCT00910650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102119616|NCT00910650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119617|NCT00910650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102119618|NCT00910650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102119619|NCT00910650|Antiviral Agents|antiviral agents|mesh-ancestor
102119620|NCT00910650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102119622|NCT02199327|Interferon-alpha|interferon-alpha|mesh-list
102119623|NCT02199327|Interferon alpha-2|interferon alpha-2|mesh-list
102119624|NCT02199327|Mitomycins|mitomycins|mesh-list
102119625|NCT02199327|Mitomycin|mitomycin|mesh-list
102119626|NCT02199327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102119627|NCT02199327|Antiviral Agents|antiviral agents|mesh-ancestor
102119628|NCT02199327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102119629|NCT02199327|Immunologic Factors|immunologic factors|mesh-ancestor
102119630|NCT02199327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119631|NCT02199327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102119632|NCT02199327|Alkylating Agents|alkylating agents|mesh-ancestor
102119633|NCT02199327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018258|NCT03244462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102119634|NCT02199327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102119635|NCT02199327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102119636|NCT00756288|Photosensitizing Agents|photosensitizing agents|mesh-list
102119637|NCT00756288|Dermatologic Agents|dermatologic agents|mesh-ancestor
102119638|NCT02198001|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102119639|NCT02198001|Amoxicillin|amoxicillin|mesh-list
102119640|NCT02198001|Clavulanic Acid|clavulanic acid|mesh-list
102119641|NCT02198001|Clavulanic Acids|clavulanic acids|mesh-list
102119642|NCT02198001|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102119643|NCT02198001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102119644|NCT02198001|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102119645|NCT02198001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102119646|NCT02198001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119647|NCT05116800|Gemcitabine|gemcitabine|mesh-list
102119648|NCT05116800|Docetaxel|docetaxel|mesh-list
102119649|NCT05116800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102119650|NCT05116800|Antimetabolites|antimetabolites|mesh-ancestor
102119651|NCT05116800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119652|NCT05116800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102119653|NCT05116800|Tubulin Modulators|tubulin modulators|mesh-ancestor
102119654|NCT05116800|Antimitotic Agents|antimitotic agents|mesh-ancestor
102119655|NCT05116800|Mitosis Modulators|mitosis modulators|mesh-ancestor
102119656|NCT04078737|Aspirin|aspirin|mesh-list
102119657|NCT04078737|Clopidogrel|clopidogrel|mesh-list
102119658|NCT04078737|Ticagrelor|ticagrelor|mesh-list
102119659|NCT04078737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102119660|NCT04078737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102119661|NCT04078737|Analgesics|analgesics|mesh-ancestor
102119662|NCT04078737|Sensory System Agents|sensory system agents|mesh-ancestor
102119663|NCT04078737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102119664|NCT04078737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119665|NCT04078737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102119666|NCT04078737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102119667|NCT04078737|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102119668|NCT04078737|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102119669|NCT04078737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119670|NCT04078737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102119671|NCT04078737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102119672|NCT04078737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102119673|NCT04078737|Antipyretics|antipyretics|mesh-ancestor
102119674|NCT04078737|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102119675|NCT04078737|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102119676|NCT04078737|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102119677|NCT04078737|Purinergic Agents|purinergic agents|mesh-ancestor
102119678|NCT04078737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102119679|NCT03491904|Fasinumab|fasinumab|mesh-list
102119680|NCT03491904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102119681|NCT03491904|Analgesics|analgesics|mesh-ancestor
102119682|NCT03491904|Sensory System Agents|sensory system agents|mesh-ancestor
102119683|NCT03491904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102119684|NCT03491904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573208|NCT02773147|Vitamins|vitamins|mesh-ancestor
102119686|NCT02199951|Artenimol|artenimol|mesh-list
102119687|NCT02199951|Antimalarials|antimalarials|mesh-ancestor
102119688|NCT02199951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102119689|NCT02199951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102119690|NCT02199951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102119691|NCT03533361|Lenvatinib|lenvatinib|mesh-list
102119692|NCT03533361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102119693|NCT03533361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102119694|NCT03533361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102119695|NCT03533361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119696|NCT01433328|Lidocaine|lidocaine|mesh-list
102119697|NCT01433328|Anesthetics, Local|anesthetics, local|mesh-ancestor
102119698|NCT01433328|Anesthetics|anesthetics|mesh-ancestor
102119699|NCT01433328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102119700|NCT01433328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119701|NCT01433328|Sensory System Agents|sensory system agents|mesh-ancestor
102119702|NCT01433328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102119703|NCT01433328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102119704|NCT01433328|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102119705|NCT01433328|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102119706|NCT01433328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102119707|NCT01433328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119708|NCT02198469|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
102119709|NCT02198469|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102119710|NCT02198469|Dermatologic Agents|dermatologic agents|mesh-ancestor
102119711|NCT02200185|Morphine|morphine|mesh-list
102119712|NCT02200185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102119713|NCT02200185|Narcotics|narcotics|mesh-ancestor
102119714|NCT02200185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102119715|NCT02200185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119716|NCT02200185|Analgesics|analgesics|mesh-ancestor
102119717|NCT02200185|Sensory System Agents|sensory system agents|mesh-ancestor
102119718|NCT02200185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102119719|NCT02201043|Thalidomide|thalidomide|mesh-list
102119720|NCT02201043|Tolnaftate|tolnaftate|mesh-list
102119721|NCT02201043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102119722|NCT02201043|Immunologic Factors|immunologic factors|mesh-ancestor
102119723|NCT02201043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119724|NCT02201043|Leprostatic Agents|leprostatic agents|mesh-ancestor
102119725|NCT02201043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102119726|NCT02201043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102119727|NCT02201043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102119728|NCT02201043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102119729|NCT02201043|Growth Substances|growth substances|mesh-ancestor
102119730|NCT02201043|Growth Inhibitors|growth inhibitors|mesh-ancestor
102119731|NCT02201043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102119732|NCT02201043|Antifungal Agents|antifungal agents|mesh-ancestor
102119733|NCT02201121|Phenylephrine|phenylephrine|mesh-list
102119734|NCT02201121|Dopamine|dopamine|mesh-list
102119735|NCT02201121|Oxymetazoline|oxymetazoline|mesh-list
102119736|NCT02201121|Ephedrine|ephedrine|mesh-list
102119737|NCT02201121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102119738|NCT02201121|Mydriatics|mydriatics|mesh-ancestor
102119739|NCT02201121|Autonomic Agents|autonomic agents|mesh-ancestor
102119740|NCT02201121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102119741|NCT02201121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119742|NCT02201121|Sympathomimetics|sympathomimetics|mesh-ancestor
102119743|NCT02201121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102119744|NCT02201121|Nasal Decongestants|nasal decongestants|mesh-ancestor
102119745|NCT02201121|Respiratory System Agents|respiratory system agents|mesh-ancestor
102119746|NCT02201121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102018368|NCT01352559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102119747|NCT02201121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102119748|NCT02201121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102119749|NCT02201121|Adrenergic Agents|adrenergic agents|mesh-ancestor
102119750|NCT02201121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102119751|NCT02201121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119752|NCT02201121|Protective Agents|protective agents|mesh-ancestor
102119753|NCT02201121|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102119754|NCT02201121|Dopamine Agents|dopamine agents|mesh-ancestor
102119755|NCT02200575|Telmisartan|telmisartan|mesh-list
102119756|NCT02200575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102119757|NCT02200575|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102119758|NCT02200575|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102119759|NCT02200575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119760|NCT02201199|Insulin|insulin|mesh-list
102119761|NCT02201199|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102119762|NCT02201199|Insulin Glargine|insulin glargine|mesh-list
102119763|NCT02201199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102119764|NCT02201199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119765|NCT02200653|Losartan|losartan|mesh-list
102119766|NCT02200653|Telmisartan|telmisartan|mesh-list
102612363|NCT02973581|Lidocaine|lidocaine|mesh-list
102119767|NCT02200653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102119768|NCT02200653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102119769|NCT02200653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102119770|NCT02200653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102119771|NCT02200653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119772|NCT03999411|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102119774|NCT03999411|Antiviral Agents|antiviral agents|mesh-ancestor
102119775|NCT03999411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102119776|NCT03999411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102119777|NCT03999411|Autonomic Agents|autonomic agents|mesh-ancestor
102119778|NCT03999411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102119779|NCT03999411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119780|NCT03999411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102119781|NCT03999411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102119782|NCT03999411|Cholinergic Agents|cholinergic agents|mesh-ancestor
102119783|NCT03999411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102119784|NCT03999411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119785|NCT05261997|Metformin|metformin|mesh-list
102119786|NCT05261997|Acarbose|acarbose|mesh-list
102119787|NCT05261997|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102119788|NCT05261997|Pancreatin|pancreatin|mesh-list
102119789|NCT05261997|Pancrelipase|pancrelipase|mesh-list
102018426|NCT03246880|Tadalafil|tadalafil|mesh-list
102119790|NCT05261997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119791|NCT05261997|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102119792|NCT05261997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102119793|NCT05261997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119794|NCT05261997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102119795|NCT02206425|Ascorbic Acid|ascorbic acid|mesh-list
102119796|NCT02206425|Dexamethasone|dexamethasone|mesh-list
102119797|NCT02206425|Dexamethasone acetate|dexamethasone acetate|mesh-list
102119798|NCT02206425|Prednisone|prednisone|mesh-list
102119799|NCT02206425|Cyclophosphamide|cyclophosphamide|mesh-list
102119800|NCT02206425|Melphalan|melphalan|mesh-list
102119801|NCT02206425|Doxorubicin|doxorubicin|mesh-list
102119802|NCT02206425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102119803|NCT02206425|Lenalidomide|lenalidomide|mesh-list
102119804|NCT02206425|Pomalidomide|pomalidomide|mesh-list
102119805|NCT02206425|BB 1101|bb 1101|mesh-list
102119806|NCT02206425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102119807|NCT02206425|Immunologic Factors|immunologic factors|mesh-ancestor
102119808|NCT02206425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119809|NCT02206425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102119810|NCT02206425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102119811|NCT02206425|Alkylating Agents|alkylating agents|mesh-ancestor
102119812|NCT02206425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119813|NCT02206425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102119814|NCT02206425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102119815|NCT02206425|Vitamins|vitamins|mesh-ancestor
102119816|NCT02206425|Micronutrients|micronutrients|mesh-ancestor
102119817|NCT02206425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102119818|NCT02206425|Antiemetics|antiemetics|mesh-ancestor
102119819|NCT02206425|Autonomic Agents|autonomic agents|mesh-ancestor
102119820|NCT02206425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102119821|NCT02206425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102119822|NCT02206425|Glucocorticoids|glucocorticoids|mesh-ancestor
102119823|NCT02206425|Hormones|hormones|mesh-ancestor
102119824|NCT02206425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102119825|NCT02206425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102119826|NCT02206425|Protease Inhibitors|protease inhibitors|mesh-ancestor
102119827|NCT02206425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102119828|NCT02206425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102119829|NCT02206425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102119830|NCT02206425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102119831|NCT02206425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102119832|NCT02206425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102119833|NCT02206425|Growth Substances|growth substances|mesh-ancestor
102119834|NCT02206425|Growth Inhibitors|growth inhibitors|mesh-ancestor
102119835|NCT02206425|Antioxidants|antioxidants|mesh-ancestor
102119836|NCT02206425|Protective Agents|protective agents|mesh-ancestor
101573357|NCT02767375|Immunologic Factors|immunologic factors|mesh-ancestor
102119837|NCT02201667|Aspirin|aspirin|mesh-list
102119838|NCT02201667|Clopidogrel|clopidogrel|mesh-list
102119839|NCT02201667|Ticagrelor|ticagrelor|mesh-list
102119840|NCT02201667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102119841|NCT02201667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102119842|NCT02201667|Analgesics|analgesics|mesh-ancestor
102119843|NCT02201667|Sensory System Agents|sensory system agents|mesh-ancestor
102062548|NCT02162966|Colistin|colistin|mesh-list
102119844|NCT02201667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102119845|NCT02201667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119846|NCT02201667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102119847|NCT02201667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102119848|NCT02201667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102119849|NCT02201667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102119850|NCT02201667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018468|NCT03241888|Megestrol|megestrol|mesh-list
102119851|NCT02201667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102119852|NCT02201667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102119853|NCT02201667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102119854|NCT02201667|Antipyretics|antipyretics|mesh-ancestor
102119855|NCT02201667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102119856|NCT02201667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102119857|NCT02201667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102119858|NCT02201667|Purinergic Agents|purinergic agents|mesh-ancestor
102119859|NCT02201667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102119860|NCT02206503|Dexamethasone|dexamethasone|mesh-list
102119861|NCT02206503|Cyclophosphamide|cyclophosphamide|mesh-list
102119862|NCT02206503|Lenalidomide|lenalidomide|mesh-list
102119863|NCT02206503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102119864|NCT02206503|Immunologic Factors|immunologic factors|mesh-ancestor
102119865|NCT02206503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119866|NCT02206503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102119867|NCT02206503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102119868|NCT02206503|Alkylating Agents|alkylating agents|mesh-ancestor
102119869|NCT02206503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119870|NCT02206503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102119871|NCT02206503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102119872|NCT02206503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102119873|NCT02206503|Antiemetics|antiemetics|mesh-ancestor
102119874|NCT02206503|Autonomic Agents|autonomic agents|mesh-ancestor
102119875|NCT02206503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102119876|NCT02206503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102119877|NCT02206503|Glucocorticoids|glucocorticoids|mesh-ancestor
102119878|NCT02206503|Hormones|hormones|mesh-ancestor
102119879|NCT02206503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102119880|NCT02206503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102119881|NCT02206503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102119882|NCT02206503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102119883|NCT02206503|Growth Substances|growth substances|mesh-ancestor
102119884|NCT02206503|Growth Inhibitors|growth inhibitors|mesh-ancestor
102119885|NCT02206659|Telmisartan|telmisartan|mesh-list
102119886|NCT02206659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102119887|NCT02206659|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102119888|NCT02206659|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102119889|NCT02206659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119890|NCT02206737|Nicotine|nicotine|mesh-list
102119891|NCT02206737|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102119892|NCT02206737|Autonomic Agents|autonomic agents|mesh-ancestor
102119893|NCT02206737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102119894|NCT02206737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119895|NCT02206737|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102119896|NCT02206737|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102119897|NCT02206737|Cholinergic Agents|cholinergic agents|mesh-ancestor
102119898|NCT02206737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102119899|NCT02206737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119900|NCT03533127|Bevacizumab|bevacizumab|mesh-list
102119901|NCT03533127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102119902|NCT03533127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102119903|NCT03533127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102119904|NCT03533127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102119905|NCT03533127|Growth Substances|growth substances|mesh-ancestor
102119906|NCT03533127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119907|NCT03533127|Growth Inhibitors|growth inhibitors|mesh-ancestor
102119908|NCT02207361|Paclitaxel|paclitaxel|mesh-list
102119909|NCT02207361|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102119910|NCT02207361|Carboplatin|carboplatin|mesh-list
102119911|NCT02207361|Epirubicin|epirubicin|mesh-list
102119912|NCT02207361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102119913|NCT02207361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102119914|NCT02207361|Tubulin Modulators|tubulin modulators|mesh-ancestor
102119915|NCT02207361|Antimitotic Agents|antimitotic agents|mesh-ancestor
102119916|NCT02207361|Mitosis Modulators|mitosis modulators|mesh-ancestor
102119917|NCT02207361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119918|NCT02207361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102119919|NCT02207361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102119920|NCT02207361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102119921|NCT02207361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102119922|NCT02202525|Telmisartan|telmisartan|mesh-list
102119923|NCT02202525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102119924|NCT02202525|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102119925|NCT02202525|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102119926|NCT02202525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119927|NCT02202603|Teriparatide|teriparatide|mesh-list
102119928|NCT02202603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102119929|NCT02202603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119930|NCT02202603|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102119931|NCT02202993|Mibefradil|mibefradil|mesh-list
102119932|NCT02202993|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102119933|NCT02202993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102119934|NCT02202993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102119935|NCT02202993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119936|NCT02202993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102119937|NCT02202993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119938|NCT02202993|Vasodilator Agents|vasodilator agents|mesh-ancestor
102119939|NCT02202993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102119940|NCT02202993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102119941|NCT02202993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102119942|NCT02190357|Rifaximin|rifaximin|mesh-list
102119943|NCT02190357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102119944|NCT02190357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102119945|NCT02190357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102119946|NCT02257671|Contraceptive Agents|contraceptive agents|mesh-list
102119947|NCT02257671|Levonorgestrel|levonorgestrel|mesh-list
102119948|NCT02257671|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102119949|NCT02257671|Contraceptives, Oral|contraceptives, oral|mesh-list
102119950|NCT02257671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102119951|NCT02257671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119952|NCT02257671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102119953|NCT02257671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102119954|NCT02257671|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102119955|NCT02257671|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102119956|NCT02257671|Estrogens|estrogens|mesh-ancestor
102119957|NCT02257671|Hormones|hormones|mesh-ancestor
102119958|NCT02257671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102119959|NCT01460160|Dasatinib|dasatinib|mesh-list
102119960|NCT01460160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102119961|NCT01460160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102119962|NCT01460160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102119963|NCT01460160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119964|NCT02203227|Turmeric extract|turmeric extract|mesh-list
102119965|NCT02203227|Antioxidants|antioxidants|mesh-ancestor
102119966|NCT02203227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102119967|NCT02203227|Protective Agents|protective agents|mesh-ancestor
102119968|NCT02203227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119969|NCT01170702|Ropivacaine|ropivacaine|mesh-list
102119970|NCT01170702|Anesthetics, Local|anesthetics, local|mesh-ancestor
102119971|NCT01170702|Anesthetics|anesthetics|mesh-ancestor
102119972|NCT01170702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102119973|NCT01170702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102119974|NCT01170702|Sensory System Agents|sensory system agents|mesh-ancestor
102119975|NCT01170702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102119976|NCT02203461|Ritonavir|ritonavir|mesh-list
102119977|NCT02203461|Lopinavir|lopinavir|mesh-list
102119978|NCT02203461|Darunavir|darunavir|mesh-list
102119979|NCT02203461|Tenofovir|tenofovir|mesh-list
102119980|NCT02203461|Emtricitabine|emtricitabine|mesh-list
102119981|NCT02203461|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102119982|NCT02203461|Cobicistat|cobicistat|mesh-list
102119983|NCT02203461|Elvitegravir|elvitegravir|mesh-list
102119984|NCT02203461|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101510834|NCT02924922|Mannitol|mannitol|mesh-list
101573508|NCT02770729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102119985|NCT02203461|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102119986|NCT02203461|Protease Inhibitors|protease inhibitors|mesh-ancestor
102119987|NCT02203461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102119988|NCT02203461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612364|NCT02973581|Bupivacaine|bupivacaine|mesh-list
102119989|NCT02203461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102119990|NCT02203461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102119991|NCT02203461|Antiviral Agents|antiviral agents|mesh-ancestor
102119992|NCT02203461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102119993|NCT02203461|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102119994|NCT02203461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102119995|NCT02203461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102119996|NCT02203461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102119997|NCT02203461|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102119998|NCT02191059|Docetaxel|docetaxel|mesh-list
102119999|NCT02191059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102120000|NCT02191059|Tubulin Modulators|tubulin modulators|mesh-ancestor
102120001|NCT02191059|Antimitotic Agents|antimitotic agents|mesh-ancestor
102120002|NCT02191059|Mitosis Modulators|mitosis modulators|mesh-ancestor
102120003|NCT02191059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120004|NCT02191215|Nevirapine|nevirapine|mesh-list
102120005|NCT02191215|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102120006|NCT02191215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102120007|NCT02191215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102120008|NCT02191215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120009|NCT02191215|Antiviral Agents|antiviral agents|mesh-ancestor
102120010|NCT02191215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102120011|NCT02191215|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102120012|NCT02191215|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102120013|NCT02191215|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102120014|NCT02191215|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102120015|NCT02209155|Verapamil|verapamil|mesh-list
102120016|NCT02209155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102120017|NCT02209155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102120018|NCT02209155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102120019|NCT02209155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120020|NCT02209155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102120021|NCT02209155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120022|NCT02209155|Vasodilator Agents|vasodilator agents|mesh-ancestor
102120023|NCT03485118|Rituximab|rituximab|mesh-list
102120024|NCT03485118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102120025|NCT03485118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102120026|NCT03485118|Immunologic Factors|immunologic factors|mesh-ancestor
102120027|NCT03485118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120028|NCT03485118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102120029|NCT02191293|Nevirapine|nevirapine|mesh-list
102120030|NCT02191293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102120031|NCT02191293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102120032|NCT02191293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102120033|NCT02191293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120034|NCT02191293|Antiviral Agents|antiviral agents|mesh-ancestor
102120035|NCT02191293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102120036|NCT02191293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102120037|NCT02191293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102120038|NCT02191293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102120039|NCT02191293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102120040|NCT02880540|Fentanyl|fentanyl|mesh-list
102120041|NCT02880540|Dexmedetomidine|dexmedetomidine|mesh-list
102120042|NCT02880540|Morphine|morphine|mesh-list
102120043|NCT02880540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102120044|NCT02880540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102120045|NCT02880540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018662|NCT00700570|Growth Substances|growth substances|mesh-ancestor
102120046|NCT02880540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102120047|NCT02880540|Analgesics|analgesics|mesh-ancestor
102120048|NCT02880540|Sensory System Agents|sensory system agents|mesh-ancestor
102120049|NCT02880540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102120050|NCT02880540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102120051|NCT02880540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102120052|NCT02880540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102120053|NCT02880540|Adrenergic Agents|adrenergic agents|mesh-ancestor
102120054|NCT02880540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102120055|NCT02880540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120056|NCT02880540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101510908|NCT01580501|Tadalafil|tadalafil|mesh-list
102120057|NCT02880540|Narcotics|narcotics|mesh-ancestor
102120058|NCT02880540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102120059|NCT02880540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102120060|NCT02880540|Anesthetics, General|anesthetics, general|mesh-ancestor
102120061|NCT02880540|Anesthetics|anesthetics|mesh-ancestor
102120062|NCT02191371|Propofol|propofol|mesh-list
102120063|NCT02191371|Desflurane|desflurane|mesh-list
102120064|NCT02191371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102120065|NCT02191371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102120066|NCT02191371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120067|NCT02191371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102120068|NCT02191371|Anesthetics, General|anesthetics, general|mesh-ancestor
102120069|NCT02191371|Anesthetics|anesthetics|mesh-ancestor
102120070|NCT02191371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102120071|NCT03532737|Pembrolizumab|pembrolizumab|mesh-list
102120072|NCT03532737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102120073|NCT03532737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102120074|NCT03532737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102120075|NCT03532737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120076|NCT02741388|Cytarabine|cytarabine|mesh-list
102120077|NCT02741388|Dexamethasone|dexamethasone|mesh-list
102120078|NCT02741388|Rituximab|rituximab|mesh-list
102120079|NCT02741388|Gemcitabine|gemcitabine|mesh-list
102120080|NCT02741388|Oxaliplatin|oxaliplatin|mesh-list
102120081|NCT02741388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102120082|NCT02741388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102120083|NCT02741388|Immunologic Factors|immunologic factors|mesh-ancestor
102120084|NCT02741388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120085|NCT02741388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102120086|NCT02741388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102120087|NCT02741388|Antiemetics|antiemetics|mesh-ancestor
102120088|NCT02741388|Autonomic Agents|autonomic agents|mesh-ancestor
102120089|NCT02741388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102120090|NCT02741388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102120091|NCT02741388|Glucocorticoids|glucocorticoids|mesh-ancestor
102120092|NCT02741388|Hormones|hormones|mesh-ancestor
102120093|NCT02741388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102120094|NCT02741388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102120095|NCT02741388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102120096|NCT02741388|Antimetabolites|antimetabolites|mesh-ancestor
102120097|NCT02741388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120098|NCT02741388|Antiviral Agents|antiviral agents|mesh-ancestor
102120099|NCT02741388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102120100|NCT02741388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102120101|NCT02191527|Chrysarobin|chrysarobin|mesh-list
102120102|NCT02191527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102120103|NCT02191527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102120104|NCT02191527|Analgesics|analgesics|mesh-ancestor
102120105|NCT02191527|Sensory System Agents|sensory system agents|mesh-ancestor
102120106|NCT02191527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102120107|NCT02191527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120108|NCT02191527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102120109|NCT02191527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102120110|NCT03484962|Antibodies|antibodies|mesh-list
102018725|NCT04486690|Propofol|propofol|mesh-list
102120111|NCT03484962|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102120112|NCT03484962|Immunologic Factors|immunologic factors|mesh-ancestor
102120113|NCT03484962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120114|NCT01331616|Bevacizumab|bevacizumab|mesh-list
102120115|NCT01331616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102120116|NCT01331616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102120117|NCT01331616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102120118|NCT01331616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102120119|NCT01331616|Growth Substances|growth substances|mesh-ancestor
102120120|NCT01331616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120121|NCT01331616|Growth Inhibitors|growth inhibitors|mesh-ancestor
102120122|NCT02209701|Porfiromycin|porfiromycin|mesh-list
102120123|NCT02209701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102120124|NCT02209701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102120125|NCT02191839|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
102120126|NCT02191839|Protein C Inhibitor|protein c inhibitor|mesh-list
102120127|NCT02191839|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102120128|NCT02191839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102120129|NCT02191839|Protease Inhibitors|protease inhibitors|mesh-ancestor
102120130|NCT02191839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102120131|NCT02191839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120132|NCT02204397|Ustekinumab|ustekinumab|mesh-list
102120133|NCT02204397|Dermatologic Agents|dermatologic agents|mesh-ancestor
102120134|NCT02192229|Vitamin D|vitamin d|mesh-list
102120135|NCT02192229|Cholecalciferol|cholecalciferol|mesh-list
102120136|NCT02192229|Vitamins|vitamins|mesh-ancestor
102120137|NCT02192229|Micronutrients|micronutrients|mesh-ancestor
102120138|NCT02192229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120139|NCT02192229|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102120140|NCT02192229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102120141|NCT02192463|Nevirapine|nevirapine|mesh-list
102120142|NCT02192463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102120143|NCT02192463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102120144|NCT02192463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102120145|NCT02192463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120146|NCT02192463|Antiviral Agents|antiviral agents|mesh-ancestor
102120147|NCT02192463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102120148|NCT02192463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102120149|NCT02192463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102120150|NCT02192463|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102120151|NCT02192463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102120152|NCT02204475|Interferons|interferons|mesh-list
102120153|NCT02204475|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102120154|NCT02204475|Grazoprevir|grazoprevir|mesh-list
102120155|NCT02204475|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
102120156|NCT02204475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102120157|NCT02204475|Antiviral Agents|antiviral agents|mesh-ancestor
102120158|NCT02204475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102120159|NCT02210169|Vancomycin|vancomycin|mesh-list
102120160|NCT02210169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102120161|NCT02210169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102120162|NCT02210949|Epoetin Alfa|epoetin alfa|mesh-list
102120163|NCT02210949|Hematinics|hematinics|mesh-ancestor
102120164|NCT02204553|Panobinostat|panobinostat|mesh-list
102120165|NCT02204553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102120166|NCT02204553|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102120167|NCT02204553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102120168|NCT02204553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120169|NCT01109004|Dexamethasone|dexamethasone|mesh-list
102120170|NCT01109004|Lenalidomide|lenalidomide|mesh-list
102120171|NCT01109004|Bortezomib|bortezomib|mesh-list
102120172|NCT01109004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102120173|NCT01109004|Antiemetics|antiemetics|mesh-ancestor
102120174|NCT01109004|Autonomic Agents|autonomic agents|mesh-ancestor
102120175|NCT01109004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102120176|NCT01109004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120177|NCT01109004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102120178|NCT01109004|Glucocorticoids|glucocorticoids|mesh-ancestor
102120179|NCT01109004|Hormones|hormones|mesh-ancestor
102120180|NCT01109004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102120181|NCT01109004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102120182|NCT01109004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102120183|NCT01109004|Immunologic Factors|immunologic factors|mesh-ancestor
102120184|NCT01109004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102120185|NCT01109004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102120186|NCT01109004|Growth Substances|growth substances|mesh-ancestor
102120187|NCT01109004|Growth Inhibitors|growth inhibitors|mesh-ancestor
102120188|NCT02211729|Azithromycin|azithromycin|mesh-list
102120189|NCT02211729|Pyrimethamine|pyrimethamine|mesh-list
102120190|NCT02211729|Sulfadoxine|sulfadoxine|mesh-list
102120191|NCT02211729|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
102120192|NCT02211729|Amodiaquine|amodiaquine|mesh-list
102120193|NCT02211729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102120194|NCT02211729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102120195|NCT02211729|Antimalarials|antimalarials|mesh-ancestor
102120196|NCT02211729|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102120197|NCT02211729|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102120198|NCT02211729|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102120199|NCT02211729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102120200|NCT02211729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120201|NCT02211729|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102120202|NCT05151510|Lidocaine|lidocaine|mesh-list
102120203|NCT05151510|Anesthetics, Local|anesthetics, local|mesh-ancestor
102120204|NCT05151510|Anesthetics|anesthetics|mesh-ancestor
102120205|NCT05151510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102120206|NCT05151510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120207|NCT05151510|Sensory System Agents|sensory system agents|mesh-ancestor
102120208|NCT05151510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102120209|NCT05151510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101573764|NCT02758327|Laxatives|laxatives|mesh-ancestor
102120210|NCT05151510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102120211|NCT05151510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102120212|NCT05151510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102120213|NCT05151510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120214|NCT02212119|Botulinum Toxins|botulinum toxins|mesh-list
102120215|NCT02212119|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102120216|NCT02212119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102120217|NCT02212119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120218|NCT02212119|Cholinergic Agents|cholinergic agents|mesh-ancestor
102120219|NCT02212119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102120220|NCT02212119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120221|NCT03484650|Lidocaine|lidocaine|mesh-list
102120222|NCT03484650|Anesthetics, Local|anesthetics, local|mesh-ancestor
102120223|NCT03484650|Anesthetics|anesthetics|mesh-ancestor
102120224|NCT03484650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102120225|NCT03484650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120226|NCT03484650|Sensory System Agents|sensory system agents|mesh-ancestor
102120227|NCT03484650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102120228|NCT03484650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102120229|NCT03484650|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102120230|NCT03484650|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102120231|NCT03484650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102120232|NCT03484650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120233|NCT02192697|Naquotinib|naquotinib|mesh-list
102120234|NCT02192697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102120235|NCT02192697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102120236|NCT02192697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102120237|NCT02192697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120238|NCT05153928|Norethindrone|norethindrone|mesh-list
102120239|NCT05153928|Norethindrone Acetate|norethindrone acetate|mesh-list
102120240|NCT05153928|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102120241|NCT05153928|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102120242|NCT05153928|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102120243|NCT05153928|Contraceptive Agents|contraceptive agents|mesh-ancestor
102120244|NCT05153928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102120245|NCT05153928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120246|NCT05153928|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102120247|NCT05153928|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102120248|NCT02214771|Fidaxomicin|fidaxomicin|mesh-list
102120249|NCT02214771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102120250|NCT02214771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102120251|NCT02192853|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102120252|NCT02192853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102120253|NCT02192853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120254|NCT02192853|Incretins|incretins|mesh-ancestor
102120255|NCT02192853|Hormones|hormones|mesh-ancestor
102120256|NCT02192853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102120257|NCT02192853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102120258|NCT02192853|Protease Inhibitors|protease inhibitors|mesh-ancestor
102120259|NCT02192853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102120260|NCT02192853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120261|NCT05151042|Salicylic Acid|salicylic acid|mesh-list
102120262|NCT05151042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102120263|NCT05151042|Antifungal Agents|antifungal agents|mesh-ancestor
102120264|NCT05151042|Keratolytic Agents|keratolytic agents|mesh-ancestor
102120265|NCT05151042|Dermatologic Agents|dermatologic agents|mesh-ancestor
102120266|NCT04574154|Anesthetics|anesthetics|mesh-list
102120267|NCT04574154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102120268|NCT04574154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120269|NCT03484416|Vitamin D|vitamin d|mesh-list
102120270|NCT03484416|Calcium Carbonate|calcium carbonate|mesh-list
102120271|NCT03484416|Calcium|calcium|mesh-list
102120272|NCT03484416|Vitamins|vitamins|mesh-ancestor
102120273|NCT03484416|Micronutrients|micronutrients|mesh-ancestor
102120274|NCT03484416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120275|NCT03484416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102120276|NCT03484416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102120277|NCT03484416|Antacids|antacids|mesh-ancestor
102120278|NCT03484416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120279|NCT03484416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102120280|NCT02205255|Azithromycin|azithromycin|mesh-list
102120281|NCT02205255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101573834|NCT00624546|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102120282|NCT02205255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102120283|NCT02220153|Rozanolixizumab|rozanolixizumab|mesh-list
102120284|NCT02220153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102120285|NCT02220153|Immunologic Factors|immunologic factors|mesh-ancestor
102120286|NCT02220153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120287|NCT03476772|Nalbuphine|nalbuphine|mesh-list
102120288|NCT03476772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102120289|NCT03476772|Narcotics|narcotics|mesh-ancestor
102120290|NCT03476772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102120291|NCT03476772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120292|NCT03476772|Analgesics|analgesics|mesh-ancestor
102120293|NCT03476772|Sensory System Agents|sensory system agents|mesh-ancestor
102120294|NCT03476772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102120295|NCT03535233|Triamcinolone|triamcinolone|mesh-list
102120296|NCT03535233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102120297|NCT03535233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102120298|NCT03535233|Clobetasol|clobetasol|mesh-list
102120299|NCT03535233|Minoxidil|minoxidil|mesh-list
102120300|NCT03535233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102120301|NCT03535233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102120302|NCT03535233|Glucocorticoids|glucocorticoids|mesh-ancestor
102120303|NCT03535233|Hormones|hormones|mesh-ancestor
102120304|NCT03535233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102120305|NCT03535233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120306|NCT03535233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102120307|NCT03535233|Immunologic Factors|immunologic factors|mesh-ancestor
102120308|NCT03535233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102120309|NCT03535233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120310|NCT03535233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102120311|NCT03535233|Vasodilator Agents|vasodilator agents|mesh-ancestor
102120312|NCT02205489|Cetirizine|cetirizine|mesh-list
102120313|NCT02205489|Acyclovir|acyclovir|mesh-list
102120314|NCT02205489|Ibuprofen|ibuprofen|mesh-list
102120315|NCT02205489|Methylprednisolone|methylprednisolone|mesh-list
102120316|NCT02205489|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102120317|NCT02205489|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102120318|NCT02205489|Prednisolone|prednisolone|mesh-list
102120319|NCT02205489|Prednisolone acetate|prednisolone acetate|mesh-list
102120320|NCT02205489|Alemtuzumab|alemtuzumab|mesh-list
102120321|NCT02205489|Esomeprazole|esomeprazole|mesh-list
102120322|NCT02205489|Ranitidine|ranitidine|mesh-list
102120323|NCT02205489|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102120324|NCT02205489|Prednisolone phosphate|prednisolone phosphate|mesh-list
102120325|NCT02205489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102120326|NCT02205489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102120327|NCT02205489|Analgesics|analgesics|mesh-ancestor
102120328|NCT02205489|Sensory System Agents|sensory system agents|mesh-ancestor
102120329|NCT02205489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102120330|NCT02205489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120331|NCT02205489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102120332|NCT02205489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102120333|NCT02205489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102120334|NCT02205489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102120335|NCT02205489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120336|NCT02205489|Antiemetics|antiemetics|mesh-ancestor
102120337|NCT02205489|Autonomic Agents|autonomic agents|mesh-ancestor
102120338|NCT02205489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102120339|NCT02205489|Glucocorticoids|glucocorticoids|mesh-ancestor
102120340|NCT02205489|Hormones|hormones|mesh-ancestor
102120341|NCT02205489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102120342|NCT02205489|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102120343|NCT02205489|Protective Agents|protective agents|mesh-ancestor
102120344|NCT02205489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102120345|NCT02205489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102120346|NCT02205489|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102120347|NCT02205489|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102120348|NCT02205489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102120349|NCT02205489|Antiviral Agents|antiviral agents|mesh-ancestor
102120350|NCT02205489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102120351|NCT02205489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102120352|NCT02205489|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102120353|NCT02205489|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102120354|NCT02205489|Histamine Antagonists|histamine antagonists|mesh-ancestor
102120355|NCT02205489|Histamine Agents|histamine agents|mesh-ancestor
102120356|NCT02205489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102120357|NCT02205489|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102120358|NCT02523846|Morphine|morphine|mesh-list
102120359|NCT02523846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102120360|NCT02523846|Narcotics|narcotics|mesh-ancestor
102120361|NCT02523846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102120362|NCT02523846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120363|NCT02523846|Analgesics|analgesics|mesh-ancestor
102120364|NCT02523846|Sensory System Agents|sensory system agents|mesh-ancestor
102120365|NCT02523846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102120366|NCT03484260|Testosterone|testosterone|mesh-list
102120367|NCT03484260|Androgens|androgens|mesh-ancestor
102120369|NCT03484260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102120370|NCT03484260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120371|NCT05195775|Tadalafil|tadalafil|mesh-list
102120372|NCT05195775|Vasodilator Agents|vasodilator agents|mesh-ancestor
102120373|NCT05195775|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102120374|NCT05195775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102120375|NCT05195775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102120376|NCT05195775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120377|NCT05195775|Urological Agents|urological agents|mesh-ancestor
102120378|NCT03480906|Latanoprost|latanoprost|mesh-list
102120379|NCT03480906|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102120380|NCT03480906|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102120381|NCT05262465|Azacitidine|azacitidine|mesh-list
102120382|NCT05262465|Venetoclax|venetoclax|mesh-list
102120383|NCT05262465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102120384|NCT05262465|Antimetabolites|antimetabolites|mesh-ancestor
102120385|NCT05262465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120386|NCT05262465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102120387|NCT05262465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102120388|NCT02220621|Hyaluronic Acid|hyaluronic acid|mesh-list
102120389|NCT02220621|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102120390|NCT02220621|Immunologic Factors|immunologic factors|mesh-ancestor
102120391|NCT02220621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120392|NCT02220621|Viscosupplements|viscosupplements|mesh-ancestor
102120393|NCT02220621|Protective Agents|protective agents|mesh-ancestor
102120394|NCT04370418|Fluorouracil|fluorouracil|mesh-list
102120395|NCT04370418|Antimetabolites|antimetabolites|mesh-ancestor
102120396|NCT04370418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120397|NCT04370418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102120398|NCT04370418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102120399|NCT04370418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102120400|NCT04370418|Immunologic Factors|immunologic factors|mesh-ancestor
102120401|NCT04370418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120402|NCT02220777|Omeprazole|omeprazole|mesh-list
102120403|NCT02220777|ASP8477|asp8477|mesh-list
102120404|NCT02220777|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102120405|NCT02220777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102120406|NCT02220777|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102120407|NCT02220777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102120408|NCT02220777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120409|NCT03476616|Valsartan|valsartan|mesh-list
102120410|NCT03476616|Eplerenone|eplerenone|mesh-list
102120411|NCT03476616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102120412|NCT03476616|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102120413|NCT03476616|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102120414|NCT03476616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120415|NCT03476616|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102120416|NCT03476616|Hormone Antagonists|hormone antagonists|mesh-ancestor
102120417|NCT03476616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102120418|NCT03476616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120419|NCT03476616|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102120420|NCT03476616|Diuretics|diuretics|mesh-ancestor
102120421|NCT03476616|Natriuretic Agents|natriuretic agents|mesh-ancestor
102120422|NCT02205879|Pregabalin|pregabalin|mesh-list
102120423|NCT02205879|Analgesics|analgesics|mesh-ancestor
102120424|NCT02205879|Sensory System Agents|sensory system agents|mesh-ancestor
102120425|NCT02205879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102120426|NCT02205879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120427|NCT02205879|Anticonvulsants|anticonvulsants|mesh-ancestor
102120428|NCT02205879|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102120429|NCT02205879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102120430|NCT02205879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120431|NCT02205879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102120432|NCT02205879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102120433|NCT02205879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102120434|NCT02205879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102120436|NCT03483948|Azacitidine|azacitidine|mesh-list
102120437|NCT03483948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102120438|NCT03483948|Antimetabolites|antimetabolites|mesh-ancestor
102120439|NCT03483948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612365|NCT02973581|Proxymetacaine|proxymetacaine|mesh-list
102120440|NCT03483948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102120441|NCT03483948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102120442|NCT03483870|Morphine|morphine|mesh-list
102120443|NCT03483870|Granisetron|granisetron|mesh-list
102120444|NCT03483870|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102120445|NCT03483870|Narcotics|narcotics|mesh-ancestor
102120446|NCT03483870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102120447|NCT03483870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120448|NCT03483870|Analgesics|analgesics|mesh-ancestor
102120449|NCT03483870|Sensory System Agents|sensory system agents|mesh-ancestor
102120450|NCT03483870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102120451|NCT03483870|Antiemetics|antiemetics|mesh-ancestor
102120452|NCT03483870|Autonomic Agents|autonomic agents|mesh-ancestor
102120453|NCT03483870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102120454|NCT03483870|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102120455|NCT03483870|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102120456|NCT03483870|Serotonin Agents|serotonin agents|mesh-ancestor
102120457|NCT03483870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102120458|NCT03483870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120459|NCT02221323|Insulin Lispro|insulin lispro|mesh-list
102120460|NCT02221323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102120461|NCT02221323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120462|NCT03480516|Fluorides|fluorides|mesh-list
102120463|NCT03480516|Sodium Fluoride|sodium fluoride|mesh-list
102120464|NCT03480516|Fluorides, Topical|fluorides, topical|mesh-list
102120465|NCT03480516|Cariostatic Agents|cariostatic agents|mesh-ancestor
102120466|NCT03480516|Protective Agents|protective agents|mesh-ancestor
102120467|NCT03480516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120468|NCT02221401|Metformin|metformin|mesh-list
102120469|NCT02221401|Linagliptin|linagliptin|mesh-list
102120470|NCT02221401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102120471|NCT02221401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120472|NCT02221401|Incretins|incretins|mesh-ancestor
102120473|NCT02221401|Hormones|hormones|mesh-ancestor
102120474|NCT02221401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102120475|NCT02221401|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102120476|NCT02221401|Protease Inhibitors|protease inhibitors|mesh-ancestor
102120477|NCT02221401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102120478|NCT02221401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120479|NCT03483636|Lemborexant|lemborexant|mesh-list
102120480|NCT03483636|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102120481|NCT03483636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102120482|NCT03483636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120483|NCT03483636|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102120484|NCT03483636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102120485|NCT03483636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102120486|NCT03483636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120487|NCT02221479|Plerixafor|plerixafor|mesh-list
102120488|NCT02221479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102120489|NCT02221479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102120490|NCT02221479|Antiviral Agents|antiviral agents|mesh-ancestor
102120491|NCT02221479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102120492|NCT02221635|Risperidone|risperidone|mesh-list
102120493|NCT02221635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102120494|NCT02221635|Serotonin Agents|serotonin agents|mesh-ancestor
102120495|NCT02221635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102120496|NCT02221635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120497|NCT02221635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120498|NCT02221635|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102120499|NCT02221635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102120500|NCT02221635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102120501|NCT02221635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102120502|NCT02221635|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102120503|NCT02221635|Dopamine Agents|dopamine agents|mesh-ancestor
102120504|NCT03480360|Mycophenolic Acid|mycophenolic acid|mesh-list
102120505|NCT03480360|Cyclophosphamide|cyclophosphamide|mesh-list
102120506|NCT03480360|Fludarabine|fludarabine|mesh-list
102120507|NCT03480360|Tacrolimus|tacrolimus|mesh-list
102120508|NCT03480360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102120509|NCT03480360|Immunologic Factors|immunologic factors|mesh-ancestor
102120510|NCT03480360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120511|NCT03480360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102120512|NCT03480360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102120513|NCT03480360|Alkylating Agents|alkylating agents|mesh-ancestor
102120514|NCT03480360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535867|NCT05442801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120515|NCT03480360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102120516|NCT03480360|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102120517|NCT03480360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102120518|NCT03480360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102120519|NCT03480360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102120520|NCT03480360|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102120521|NCT03480360|Antitubercular Agents|antitubercular agents|mesh-ancestor
102120522|NCT03480360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102120523|NCT03480360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102120524|NCT02723864|Veliparib|veliparib|mesh-list
102120525|NCT02723864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102120526|NCT02723864|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102120527|NCT02723864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102120528|NCT02723864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120529|NCT02471690|Oritavancin|oritavancin|mesh-list
102120530|NCT02471690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102120531|NCT02471690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102120532|NCT02225067|Calcium|calcium|mesh-list
102120533|NCT02225067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102120534|NCT02225067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120535|NCT03475758|Goserelin|goserelin|mesh-list
102120536|NCT03475758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102120537|NCT03475758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102120538|NCT02231385|Acetic Acid|acetic acid|mesh-list
102120539|NCT02231385|Retinol acetate|retinol acetate|mesh-list
102120540|NCT02231385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102120541|NCT02231385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102120542|NCT02231385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102120543|NCT02231385|Immunologic Factors|immunologic factors|mesh-ancestor
102120544|NCT02231385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120545|NCT02231385|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102120546|NCT02231385|Protective Agents|protective agents|mesh-ancestor
102120547|NCT02231385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102120548|NCT02523768|Basiliximab|basiliximab|mesh-list
102120549|NCT02523768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102120550|NCT02523768|Immunologic Factors|immunologic factors|mesh-ancestor
102120551|NCT02523768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120552|NCT03479736|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102120553|NCT03479736|Fluoroquinolones|fluoroquinolones|mesh-list
102120554|NCT03479736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102120555|NCT03479736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102120556|NCT03479736|Antitubercular Agents|antitubercular agents|mesh-ancestor
102120557|NCT03479736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102120558|NCT03479736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102120559|NCT03479736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120560|NCT03203642|XL647|xl647|mesh-list
102120561|NCT03203642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102120562|NCT03203642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102120563|NCT03203642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102120564|NCT03203642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120565|NCT03475680|Gentamicins|gentamicins|mesh-list
102120566|NCT03475680|Ornidazole|ornidazole|mesh-list
102120567|NCT03475680|Sennosides|sennosides|mesh-list
102120568|NCT03475680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102120569|NCT03475680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102120570|NCT03475680|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102120571|NCT03475680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102120572|NCT03475680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120573|NCT03475680|Laxatives|laxatives|mesh-ancestor
102120574|NCT03475680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102120575|NCT03475680|Amebicides|amebicides|mesh-ancestor
102120576|NCT03475680|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102120577|NCT03475680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102120578|NCT03475680|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
102120579|NCT04621136|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102120580|NCT04621136|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102120581|NCT03475524|Metformin|metformin|mesh-list
102120582|NCT03475524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102120583|NCT03475524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120584|NCT02259075|Botulinum Toxins|botulinum toxins|mesh-list
101574134|NCT02761291|Antimanic Agents|antimanic agents|mesh-ancestor
102120585|NCT02259075|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102120586|NCT02259075|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102120587|NCT02259075|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102120588|NCT02259075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102120589|NCT02259075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120590|NCT02259075|Cholinergic Agents|cholinergic agents|mesh-ancestor
102120591|NCT02259075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102120592|NCT02259075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120593|NCT02259075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102120594|NCT02259075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102120595|NCT02471846|Atezolizumab|atezolizumab|mesh-list
102019225|NCT04492475|Remdesivir|remdesivir|mesh-list
102120596|NCT02471846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102120597|NCT02471846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120598|NCT02471846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102120599|NCT02471846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102120600|NCT02472782|Teriparatide|teriparatide|mesh-list
102120601|NCT02472782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102120602|NCT02472782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120603|NCT02472782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102120604|NCT02258607|Trametinib|trametinib|mesh-list
102120605|NCT02258607|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
102120606|NCT02258607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102120607|NCT02258607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102120608|NCT02258607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102120609|NCT02258607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120610|NCT03792750|Nivolumab|nivolumab|mesh-list
102120611|NCT03792750|Linrodostat|linrodostat|mesh-list
102120612|NCT03792750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102120613|NCT03792750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102120614|NCT03792750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102120615|NCT03792750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120616|NCT03792750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102120617|NCT02258763|Amoxicillin|amoxicillin|mesh-list
102120618|NCT02258763|Clavulanic Acid|clavulanic acid|mesh-list
102120619|NCT02258763|Clavulanic Acids|clavulanic acids|mesh-list
102120620|NCT02258763|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102120621|NCT02258763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102120622|NCT02258763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102120623|NCT02258763|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102120624|NCT02258763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102120625|NCT02258763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120626|NCT02469974|Busulfan|busulfan|mesh-list
102120627|NCT02469974|Immunologic Factors|immunologic factors|mesh-ancestor
102120628|NCT02469974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120629|NCT02469974|Alkylating Agents|alkylating agents|mesh-ancestor
102120630|NCT02469974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120631|NCT02469974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102120632|NCT02469974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102120633|NCT02469974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102120634|NCT02469974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102120635|NCT02231931|Metformin|metformin|mesh-list
102120636|NCT02231931|Digoxin|digoxin|mesh-list
102120637|NCT02231931|Furosemide|furosemide|mesh-list
102120638|NCT02231931|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102120639|NCT02231931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102120640|NCT02231931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120641|NCT02231931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102120642|NCT02231931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102120643|NCT02231931|Antimetabolites|antimetabolites|mesh-ancestor
102120644|NCT02231931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120645|NCT02231931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102120646|NCT02231931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102120647|NCT02231931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102120648|NCT02231931|Diuretics|diuretics|mesh-ancestor
102120649|NCT02231931|Natriuretic Agents|natriuretic agents|mesh-ancestor
102120650|NCT02231931|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102120651|NCT02231931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102120652|NCT02231931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102120653|NCT02231931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102120654|NCT02231931|Protective Agents|protective agents|mesh-ancestor
102120655|NCT03131622|Coal Tar|coal tar|mesh-list
102120656|NCT03131622|Keratolytic Agents|keratolytic agents|mesh-ancestor
102120657|NCT03131622|Dermatologic Agents|dermatologic agents|mesh-ancestor
102120658|NCT03482544|Pregabalin|pregabalin|mesh-list
102120659|NCT03482544|Analgesics|analgesics|mesh-ancestor
102120660|NCT03482544|Sensory System Agents|sensory system agents|mesh-ancestor
102120661|NCT03482544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102120662|NCT03482544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120663|NCT03482544|Anticonvulsants|anticonvulsants|mesh-ancestor
102120664|NCT03482544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102019283|NCT03229954|Hematinics|hematinics|mesh-ancestor
102120665|NCT03482544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102120666|NCT03482544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120667|NCT03482544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102120668|NCT03482544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102120669|NCT03482544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102120670|NCT03482544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102120671|NCT03482544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102120672|NCT02750709|Nitisinone|nitisinone|mesh-list
102120673|NCT02750709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102120674|NCT02750709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120675|NCT02222649|Vitamin D|vitamin d|mesh-list
102120676|NCT02222649|Cholecalciferol|cholecalciferol|mesh-list
102120677|NCT02222649|Vitamins|vitamins|mesh-ancestor
102120678|NCT02222649|Micronutrients|micronutrients|mesh-ancestor
102120679|NCT02222649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120680|NCT02222649|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102120681|NCT02222649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102120682|NCT02222727|Donepezil|donepezil|mesh-list
102120683|NCT02222727|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102120684|NCT02222727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102120685|NCT02222727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120686|NCT02222727|Cholinergic Agents|cholinergic agents|mesh-ancestor
102120687|NCT02222727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102120688|NCT02222727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120689|NCT02222727|Nootropic Agents|nootropic agents|mesh-ancestor
102120690|NCT02723786|Mycophenolic Acid|mycophenolic acid|mesh-list
102120691|NCT02723786|Azathioprine|azathioprine|mesh-list
102120692|NCT02723786|Tacrolimus|tacrolimus|mesh-list
102120693|NCT02723786|Basiliximab|basiliximab|mesh-list
102120694|NCT02723786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102120695|NCT02723786|Immunologic Factors|immunologic factors|mesh-ancestor
102120696|NCT02723786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120697|NCT02723786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102120698|NCT02723786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102120699|NCT02723786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120700|NCT02723786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102120701|NCT02723786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102120702|NCT02723786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102120703|NCT02723786|Antitubercular Agents|antitubercular agents|mesh-ancestor
102120704|NCT02723786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102120705|NCT02723786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102120706|NCT02723786|Antimetabolites|antimetabolites|mesh-ancestor
102120707|NCT02723786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102120708|NCT02723786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102120709|NCT03310736|Hepcidins|hepcidins|mesh-list
102120710|NCT03310736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102120711|NCT02226783|Omeprazole|omeprazole|mesh-list
102120712|NCT02226783|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102120713|NCT02226783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102120714|NCT02226783|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102120715|NCT02226783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102120716|NCT02226783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120717|NCT03482232|Acetaminophen|acetaminophen|mesh-list
102120718|NCT03482232|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102120719|NCT03482232|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102120720|NCT03482232|Anti-Infective Agents|anti-infective agents|mesh-list
102120721|NCT03482232|Ibuprofen|ibuprofen|mesh-list
102120722|NCT03482232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
102120723|NCT03482232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102120724|NCT03482232|Hypolipidemic Agents|hypolipidemic agents|mesh-list
102120725|NCT03482232|Expectorants|expectorants|mesh-list
102120726|NCT03482232|Antitubercular Agents|antitubercular agents|mesh-ancestor
102120727|NCT03482232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102120728|NCT03482232|Analgesics|analgesics|mesh-ancestor
102120729|NCT03482232|Sensory System Agents|sensory system agents|mesh-ancestor
102120730|NCT03482232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102120731|NCT03482232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120732|NCT03482232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102120733|NCT03482232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102120734|NCT03482232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102120735|NCT03482232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120736|NCT03482232|Antipyretics|antipyretics|mesh-ancestor
102120737|NCT03482232|Antimetabolites|antimetabolites|mesh-ancestor
102120738|NCT03482232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102120739|NCT03482232|Respiratory System Agents|respiratory system agents|mesh-ancestor
102120740|NCT02227017|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102120741|NCT04542200|Antibodies|antibodies|mesh-list
102120742|NCT04542200|Immunologic Factors|immunologic factors|mesh-ancestor
102120743|NCT04542200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120744|NCT02227173|Flurbiprofen|flurbiprofen|mesh-list
102120745|NCT02227173|Digoxin|digoxin|mesh-list
102120746|NCT02227173|Montelukast|montelukast|mesh-list
102120747|NCT02227173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102120748|NCT02227173|Respiratory System Agents|respiratory system agents|mesh-ancestor
102120749|NCT02227173|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102120750|NCT02227173|Hormone Antagonists|hormone antagonists|mesh-ancestor
102120751|NCT02227173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102120752|NCT02227173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120753|NCT02227173|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102120754|NCT02227173|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102120755|NCT02227173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120756|NCT02227173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102120757|NCT02227173|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102120758|NCT02227173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102120759|NCT02227173|Protective Agents|protective agents|mesh-ancestor
102120760|NCT02227173|Analgesics|analgesics|mesh-ancestor
102120761|NCT02227173|Sensory System Agents|sensory system agents|mesh-ancestor
102120762|NCT02227173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102120763|NCT02227173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102120764|NCT02227173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102120765|NCT02227173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102120766|NCT02227173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102120767|NCT02227173|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102120768|NCT02469740|Clopidogrel|clopidogrel|mesh-list
102120769|NCT02469740|Ticagrelor|ticagrelor|mesh-list
102120770|NCT02469740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102120771|NCT02469740|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102120772|NCT02469740|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102120773|NCT02469740|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102120774|NCT02469740|Purinergic Agents|purinergic agents|mesh-ancestor
102120775|NCT02469740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102120776|NCT02469740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120777|NCT02469740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120778|NCT04432220|Apixaban|apixaban|mesh-list
102120779|NCT04432220|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102120780|NCT04432220|Antithrombins|antithrombins|mesh-ancestor
102120781|NCT04432220|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102120782|NCT04432220|Protease Inhibitors|protease inhibitors|mesh-ancestor
102120783|NCT04432220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102120784|NCT04432220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120785|NCT04432220|Anticoagulants|anticoagulants|mesh-ancestor
102120786|NCT04405622|Gemcitabine|gemcitabine|mesh-list
102120787|NCT04405622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102120788|NCT04405622|Antimetabolites|antimetabolites|mesh-ancestor
102120789|NCT04405622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120790|NCT04405622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102120791|NCT03481998|Letrozole|letrozole|mesh-list
102120792|NCT03481998|Fulvestrant|fulvestrant|mesh-list
102120793|NCT03481998|Anastrozole|anastrozole|mesh-list
102120794|NCT03481998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102120795|NCT03481998|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102120796|NCT03481998|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102120797|NCT03481998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102120798|NCT03481998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120799|NCT03481998|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102120800|NCT03481998|Hormone Antagonists|hormone antagonists|mesh-ancestor
102120801|NCT03481998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102120802|NCT03481998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120803|NCT03481998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102120804|NCT03481998|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102120805|NCT02723084|Ribavirin|ribavirin|mesh-list
102120806|NCT02723084|Sofosbuvir|sofosbuvir|mesh-list
102120814|NCT02750943|Cariostatic Agents|cariostatic agents|mesh-ancestor
102120815|NCT02750943|Protective Agents|protective agents|mesh-ancestor
102120816|NCT02750943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120817|NCT03481920|Avelumab|avelumab|mesh-list
102120818|NCT03481920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102120819|NCT03481920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102120820|NCT02227797|Voriconazole|voriconazole|mesh-list
102120821|NCT02227797|Antifungal Agents|antifungal agents|mesh-ancestor
102120822|NCT02227797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102120823|NCT02227797|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102120824|NCT02227797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102120825|NCT02227797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102120826|NCT02227797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120827|NCT02227797|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102120828|NCT02227797|Hormone Antagonists|hormone antagonists|mesh-ancestor
102120829|NCT02227797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102120830|NCT02227797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120831|NCT02227797|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102120832|NCT05784311|Metronidazole|metronidazole|mesh-list
102120833|NCT05784311|Cefuroxime|cefuroxime|mesh-list
102120834|NCT05784311|Cefuroxime axetil|cefuroxime axetil|mesh-list
102120835|NCT05784311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102120836|NCT05784311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102120837|NCT05784311|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102120838|NCT05784311|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102120839|NCT05783778|Testosterone|testosterone|mesh-list
102120840|NCT05783778|Androgens|androgens|mesh-ancestor
102120841|NCT05783778|Hormones|hormones|mesh-ancestor
102120842|NCT05783778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102120843|NCT05783778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120844|NCT05783661|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102120845|NCT05783661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102120852|NCT05783609|Rituximab|rituximab|mesh-list
102120853|NCT05783609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102120854|NCT05783609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102120855|NCT05783609|Immunologic Factors|immunologic factors|mesh-ancestor
102120856|NCT05783609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120857|NCT05783609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102120858|NCT05783557|Clevidipine|clevidipine|mesh-list
102120859|NCT05783557|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102120860|NCT05783557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102120861|NCT05783557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120862|NCT05783557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102120863|NCT05783557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120864|NCT05783518|Propofol|propofol|mesh-list
102120865|NCT05783518|Desflurane|desflurane|mesh-list
102120866|NCT05783518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102120867|NCT05783518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102120868|NCT05783518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120869|NCT05783518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102120870|NCT05783518|Anesthetics, General|anesthetics, general|mesh-ancestor
102120871|NCT05783518|Anesthetics|anesthetics|mesh-ancestor
102120872|NCT05783518|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102120873|NCT05783492|Ketamine|ketamine|mesh-list
102120874|NCT05783492|Analgesics|analgesics|mesh-ancestor
102120875|NCT05783492|Sensory System Agents|sensory system agents|mesh-ancestor
102120876|NCT05783492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102120877|NCT05783492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120878|NCT05783492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102120879|NCT05783492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102120880|NCT05783492|Anesthetics, General|anesthetics, general|mesh-ancestor
102120881|NCT05783492|Anesthetics|anesthetics|mesh-ancestor
102120882|NCT05783492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102120883|NCT05783492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102120884|NCT05783492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102120885|NCT05783492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102120886|NCT05783492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120888|NCT05783479|Hyaluronic Acid|hyaluronic acid|mesh-list
102120889|NCT05783479|Estrogens|estrogens|mesh-ancestor
102120890|NCT05783479|Hormones|hormones|mesh-ancestor
102120891|NCT05783479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102120892|NCT05783479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120893|NCT05783479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102120894|NCT05783479|Immunologic Factors|immunologic factors|mesh-ancestor
102120895|NCT05783479|Viscosupplements|viscosupplements|mesh-ancestor
102120896|NCT05783479|Protective Agents|protective agents|mesh-ancestor
102120897|NCT05783453|Emollients|emollients|mesh-list
102120898|NCT05783453|Dermatologic Agents|dermatologic agents|mesh-ancestor
102120899|NCT05782933|Rituximab|rituximab|mesh-list
102120900|NCT05782933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102120901|NCT05782933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102120902|NCT05782933|Immunologic Factors|immunologic factors|mesh-ancestor
102120903|NCT05782933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120904|NCT05782933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102120905|NCT05782920|Hyaluronic Acid|hyaluronic acid|mesh-list
102120906|NCT05782920|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102120907|NCT05782920|Immunologic Factors|immunologic factors|mesh-ancestor
102120908|NCT05782920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120909|NCT05782920|Viscosupplements|viscosupplements|mesh-ancestor
102120910|NCT05782920|Protective Agents|protective agents|mesh-ancestor
102120911|NCT05782777|Ezetimibe|ezetimibe|mesh-list
102120912|NCT05782777|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
102120913|NCT05782777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102120914|NCT05782777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102120915|NCT05782777|Antimetabolites|antimetabolites|mesh-ancestor
102120916|NCT05782777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120917|NCT05782777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102120918|NCT05782777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102120919|NCT05782764|Endostar protein|endostar protein|mesh-list
102120920|NCT05782764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102120921|NCT05782764|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102120922|NCT05782764|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102120923|NCT05782764|Growth Substances|growth substances|mesh-ancestor
102120924|NCT05782764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120925|NCT05782764|Growth Inhibitors|growth inhibitors|mesh-ancestor
102120926|NCT05782764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102120927|NCT05782764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120928|NCT05782764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102120929|NCT05782751|Mitogens|mitogens|mesh-list
102120930|NCT05782751|Mitosis Modulators|mitosis modulators|mesh-ancestor
102120931|NCT05782751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120932|NCT05781074|Lenvatinib|lenvatinib|mesh-list
102120933|NCT05781074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102120934|NCT05781074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102120935|NCT05781074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102120936|NCT05781074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120937|NCT05780541|Remdesivir|remdesivir|mesh-list
102120938|NCT05780541|Antimetabolites|antimetabolites|mesh-ancestor
102120939|NCT05780541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120940|NCT05780541|Antiviral Agents|antiviral agents|mesh-ancestor
102120941|NCT05780541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102120942|NCT05780463|Remdesivir|remdesivir|mesh-list
102120943|NCT05780463|Antimetabolites|antimetabolites|mesh-ancestor
102120944|NCT05780463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120945|NCT05780463|Antiviral Agents|antiviral agents|mesh-ancestor
102120946|NCT05780463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102120947|NCT05780281|Remdesivir|remdesivir|mesh-list
102120948|NCT05780281|Sotrovimab|sotrovimab|mesh-list
102120949|NCT05780281|Antimetabolites|antimetabolites|mesh-ancestor
102120950|NCT05780281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120951|NCT05780281|Antiviral Agents|antiviral agents|mesh-ancestor
102120952|NCT05780281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102120953|NCT05780268|Remdesivir|remdesivir|mesh-list
102120954|NCT05780268|Bamlanivimab|bamlanivimab|mesh-list
102120955|NCT05780268|Antimetabolites|antimetabolites|mesh-ancestor
102120956|NCT05780268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120958|NCT05780268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102120959|NCT05779657|Midazolam|midazolam|mesh-list
102120960|NCT05779657|Ketamine|ketamine|mesh-list
102120961|NCT05779657|Analgesics|analgesics|mesh-ancestor
102019567|NCT04454567|Antiviral Agents|antiviral agents|mesh-ancestor
102120962|NCT05779657|Sensory System Agents|sensory system agents|mesh-ancestor
102120963|NCT05779657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102120964|NCT05779657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120965|NCT05779657|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102120966|NCT05779657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102120967|NCT05779657|Anesthetics, General|anesthetics, general|mesh-ancestor
102120968|NCT05779657|Anesthetics|anesthetics|mesh-ancestor
102120969|NCT05779657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102120970|NCT05779657|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102120971|NCT05779657|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102120972|NCT05779657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102120973|NCT05779657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120974|NCT05779657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102120975|NCT05779657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102120976|NCT05779657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102120977|NCT05779657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102120978|NCT05779657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102120979|NCT05779657|GABA Modulators|gaba modulators|mesh-ancestor
102120980|NCT05779657|GABA Agents|gaba agents|mesh-ancestor
102120981|NCT05774054|Norepinephrine|norepinephrine|mesh-list
102120982|NCT05774054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102120983|NCT05774054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102120984|NCT05774054|Adrenergic Agents|adrenergic agents|mesh-ancestor
102120985|NCT05774054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102120986|NCT05774054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102120987|NCT05774054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120988|NCT05774054|Sympathomimetics|sympathomimetics|mesh-ancestor
102120989|NCT05774054|Autonomic Agents|autonomic agents|mesh-ancestor
102120990|NCT05774054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102120991|NCT05774054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102120992|NCT05751148|Bupivacaine|bupivacaine|mesh-list
102120993|NCT05751148|Prilocaine|prilocaine|mesh-list
102120994|NCT05751148|Anesthetics, Local|anesthetics, local|mesh-ancestor
102120995|NCT05751148|Anesthetics|anesthetics|mesh-ancestor
102120996|NCT05751148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102120997|NCT05751148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102120998|NCT05751148|Sensory System Agents|sensory system agents|mesh-ancestor
102120999|NCT05751148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102121000|NCT05711199|Nitroglycerin|nitroglycerin|mesh-list
102121001|NCT05711199|Vasodilator Agents|vasodilator agents|mesh-ancestor
102121002|NCT05703971|Atezolizumab|atezolizumab|mesh-list
102121003|NCT05703971|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102121004|NCT05703971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121005|NCT05703971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102121006|NCT05703971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121007|NCT05703074|Niacinamide|niacinamide|mesh-list
102121008|NCT05703074|Niacin|niacin|mesh-list
102121009|NCT05703074|Nicotinic Acids|nicotinic acids|mesh-list
102121010|NCT05703074|Vitamin B Complex|vitamin b complex|mesh-ancestor
102121011|NCT05703074|Vitamins|vitamins|mesh-ancestor
102121012|NCT05703074|Micronutrients|micronutrients|mesh-ancestor
102121013|NCT05703074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121014|NCT05703074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102121015|NCT05703074|Antimetabolites|antimetabolites|mesh-ancestor
102121016|NCT05703074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121017|NCT05703074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102121018|NCT05703074|Vasodilator Agents|vasodilator agents|mesh-ancestor
102121019|NCT05701865|Ethanol|ethanol|mesh-list
102121020|NCT05701865|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102121021|NCT05701865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102121022|NCT05701865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102121023|NCT05701865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121024|NCT05701345|Antidepressive Agents|antidepressive agents|mesh-list
102121025|NCT05701345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102121026|NCT05674721|Ibuprofen|ibuprofen|mesh-list
102121027|NCT05674721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102121028|NCT05674721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102121029|NCT05674721|Analgesics|analgesics|mesh-ancestor
102121030|NCT05674721|Sensory System Agents|sensory system agents|mesh-ancestor
102121031|NCT05674721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102121032|NCT05674721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121033|NCT05674721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102019638|NCT02451748|Analgesics|analgesics|mesh-ancestor
102121034|NCT05674721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102121035|NCT05674721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102121036|NCT05674721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102121037|NCT05674721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121038|NCT05664464|Sulfasalazine|sulfasalazine|mesh-list
102121039|NCT05664464|Temozolomide|temozolomide|mesh-list
102121040|NCT05664464|Gabapentin|gabapentin|mesh-list
102121041|NCT05664464|Memantine|memantine|mesh-list
102121042|NCT05664464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102121043|NCT05664464|Alkylating Agents|alkylating agents|mesh-ancestor
102121044|NCT05664464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121045|NCT05664464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121046|NCT05664464|Analgesics|analgesics|mesh-ancestor
102121047|NCT05664464|Sensory System Agents|sensory system agents|mesh-ancestor
102121048|NCT05664464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102121049|NCT05664464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121050|NCT05664464|Anticonvulsants|anticonvulsants|mesh-ancestor
102121051|NCT05664464|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102121052|NCT05664464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102121053|NCT05664464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102121054|NCT05664464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102121055|NCT05664464|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102121056|NCT05664464|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102121057|NCT05664464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102121058|NCT05664464|Antimanic Agents|antimanic agents|mesh-ancestor
102121059|NCT05664464|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102121060|NCT05664464|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102121061|NCT05664464|Dopamine Agents|dopamine agents|mesh-ancestor
102121062|NCT05664464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102121063|NCT05664464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102121064|NCT05664464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102121065|NCT05664464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102121066|NCT05664464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102121067|NCT05664464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102121068|NCT05657457|Tenecteplase|tenecteplase|mesh-list
102121069|NCT05657457|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102121070|NCT05657457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102121071|NCT05657457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121072|NCT05646316|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102121073|NCT05635344|Pembrolizumab|pembrolizumab|mesh-list
102121074|NCT05635344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102121075|NCT05635344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121076|NCT05635344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102121077|NCT05635344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121078|NCT05630989|Hydroxychloroquine|hydroxychloroquine|mesh-list
102121079|NCT05630989|Mitogens|mitogens|mesh-list
102121080|NCT05630989|Antimalarials|antimalarials|mesh-ancestor
102121081|NCT05630989|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102121082|NCT05630989|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102121083|NCT05630989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102121084|NCT05630989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102121085|NCT05630989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121086|NCT05630989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102121087|NCT05630989|Mitosis Modulators|mitosis modulators|mesh-ancestor
102121088|NCT05626530|Letermovir|letermovir|mesh-list
102121089|NCT05626530|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102121090|NCT05626530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102121091|NCT05626530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121092|NCT05626530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121093|NCT05626530|Antiviral Agents|antiviral agents|mesh-ancestor
102121094|NCT05626530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102121095|NCT05601674|Anesthetics|anesthetics|mesh-list
102121096|NCT05601674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102121097|NCT05601674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121098|NCT05527314|Fentanyl|fentanyl|mesh-list
102121099|NCT05527314|Remifentanil|remifentanil|mesh-list
102121100|NCT05527314|Sevoflurane|sevoflurane|mesh-list
102121101|NCT05527314|Cisatracurium|cisatracurium|mesh-list
102121102|NCT05527314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102121103|NCT05527314|Narcotics|narcotics|mesh-ancestor
102121104|NCT05527314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102121105|NCT05527314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121106|NCT05527314|Analgesics|analgesics|mesh-ancestor
102121107|NCT05527314|Sensory System Agents|sensory system agents|mesh-ancestor
101574672|NCT04589325|Ixekizumab|ixekizumab|mesh-list
102121108|NCT05527314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102121109|NCT05527314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102121110|NCT05527314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102121111|NCT05527314|Anesthetics, General|anesthetics, general|mesh-ancestor
102121112|NCT05527314|Anesthetics|anesthetics|mesh-ancestor
102121113|NCT05527314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102121114|NCT05527314|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102121115|NCT05527314|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102121116|NCT05527314|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102121117|NCT05517122|Niacinamide|niacinamide|mesh-list
102121119|NCT05517122|Nicotinic Acids|nicotinic acids|mesh-list
102121120|NCT05517122|Vitamin B Complex|vitamin b complex|mesh-ancestor
102121121|NCT05517122|Vitamins|vitamins|mesh-ancestor
102121122|NCT05517122|Micronutrients|micronutrients|mesh-ancestor
102121123|NCT05517122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121124|NCT05517122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102121125|NCT05517122|Antimetabolites|antimetabolites|mesh-ancestor
102121126|NCT05517122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121127|NCT05517122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102121128|NCT05517122|Vasodilator Agents|vasodilator agents|mesh-ancestor
102121129|NCT05484505|Nicotine|nicotine|mesh-list
102535868|NCT05442801|Parasympatholytics|parasympatholytics|mesh-ancestor
102121130|NCT05484505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102121131|NCT05484505|Autonomic Agents|autonomic agents|mesh-ancestor
102121132|NCT05484505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102121133|NCT05484505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121134|NCT05484505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102121135|NCT05484505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102121136|NCT05484505|Cholinergic Agents|cholinergic agents|mesh-ancestor
102121137|NCT05484505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102121138|NCT05484505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121139|NCT05478161|Fexofenadine|fexofenadine|mesh-list
102121140|NCT05478161|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102121141|NCT05478161|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102121142|NCT05478161|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102121143|NCT05478161|Histamine Antagonists|histamine antagonists|mesh-ancestor
102121144|NCT05478161|Histamine Agents|histamine agents|mesh-ancestor
102121145|NCT05478161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102121146|NCT05478161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121147|NCT05478161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121148|NCT05476822|Antibodies|antibodies|mesh-list
102121149|NCT05476822|Immunologic Factors|immunologic factors|mesh-ancestor
102121150|NCT05476822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121151|NCT05473364|Acetazolamide|acetazolamide|mesh-list
102121152|NCT05473364|Anticonvulsants|anticonvulsants|mesh-ancestor
102121153|NCT05473364|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102121154|NCT05473364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102121155|NCT05473364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121156|NCT05473364|Diuretics|diuretics|mesh-ancestor
102121157|NCT05473364|Natriuretic Agents|natriuretic agents|mesh-ancestor
102121158|NCT05473364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121159|NCT05413811|Fluorouracil|fluorouracil|mesh-list
102121160|NCT05413811|Antimetabolites|antimetabolites|mesh-ancestor
102121161|NCT05413811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121162|NCT05413811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102121163|NCT05413811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121164|NCT05413811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102121165|NCT05413811|Immunologic Factors|immunologic factors|mesh-ancestor
102121166|NCT05413811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121167|NCT05393804|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
102121168|NCT05393804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102121169|NCT05393804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121170|NCT05392608|Fulvestrant|fulvestrant|mesh-list
102121171|NCT05392608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102121172|NCT05392608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121173|NCT05392608|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102121174|NCT05392608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102121175|NCT05392608|Hormone Antagonists|hormone antagonists|mesh-ancestor
102121176|NCT05392608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102121177|NCT05392608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121178|NCT05382494|Mometasone Furoate|mometasone furoate|mesh-list
102121179|NCT05382494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102121180|NCT05382494|Dermatologic Agents|dermatologic agents|mesh-ancestor
102121181|NCT05382494|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102121182|NCT05351346|Prednisone|prednisone|mesh-list
102121183|NCT05351346|Cyclophosphamide|cyclophosphamide|mesh-list
102121184|NCT05351346|Rituximab|rituximab|mesh-list
102121185|NCT05351346|Doxorubicin|doxorubicin|mesh-list
102121186|NCT05351346|Vincristine|vincristine|mesh-list
102121187|NCT05351346|Lenalidomide|lenalidomide|mesh-list
102121188|NCT05351346|Decitabine|decitabine|mesh-list
102121189|NCT05351346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102121190|NCT05351346|Immunologic Factors|immunologic factors|mesh-ancestor
102121191|NCT05351346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121192|NCT05351346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102121193|NCT05351346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102121194|NCT05351346|Alkylating Agents|alkylating agents|mesh-ancestor
102121195|NCT05351346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121196|NCT05351346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121197|NCT05351346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102121198|NCT05351346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102121199|NCT05351346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102121200|NCT05351346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102121201|NCT05351346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102121202|NCT05351346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102121203|NCT05351346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102121204|NCT05351346|Glucocorticoids|glucocorticoids|mesh-ancestor
102535869|NCT05339373|Aceclofenac|aceclofenac|mesh-list
102121206|NCT05351346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102121207|NCT05351346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102121208|NCT05351346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102121209|NCT05351346|Tubulin Modulators|tubulin modulators|mesh-ancestor
102121210|NCT05351346|Antimitotic Agents|antimitotic agents|mesh-ancestor
102121211|NCT05351346|Mitosis Modulators|mitosis modulators|mesh-ancestor
102121212|NCT05351346|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102121213|NCT05351346|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102121214|NCT05351346|Growth Substances|growth substances|mesh-ancestor
102121215|NCT05351346|Growth Inhibitors|growth inhibitors|mesh-ancestor
102121216|NCT05351346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102121217|NCT05351346|Antimetabolites|antimetabolites|mesh-ancestor
102121218|NCT05323019|Ketamine|ketamine|mesh-list
102121219|NCT05323019|Esketamine|esketamine|mesh-list
102121220|NCT05323019|Analgesics|analgesics|mesh-ancestor
102121221|NCT05323019|Sensory System Agents|sensory system agents|mesh-ancestor
102121222|NCT05323019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102121223|NCT05323019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121224|NCT05323019|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102121225|NCT05323019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102121226|NCT05323019|Anesthetics, General|anesthetics, general|mesh-ancestor
102121227|NCT05323019|Anesthetics|anesthetics|mesh-ancestor
102121228|NCT05323019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102121229|NCT05323019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102121230|NCT05323019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102121231|NCT05323019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102121232|NCT05323019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121233|NCT05323019|Antidepressive Agents|antidepressive agents|mesh-ancestor
102121234|NCT05323019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102121235|NCT05280743|Oxycodone|oxycodone|mesh-list
102121236|NCT05280743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102121237|NCT05280743|Narcotics|narcotics|mesh-ancestor
102121238|NCT05280743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102121239|NCT05280743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121240|NCT05280743|Analgesics|analgesics|mesh-ancestor
102121241|NCT05280743|Sensory System Agents|sensory system agents|mesh-ancestor
102121242|NCT05280743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102121243|NCT05276258|Bupivacaine|bupivacaine|mesh-list
102121244|NCT05276258|Anesthetics, Local|anesthetics, local|mesh-ancestor
102121245|NCT05276258|Anesthetics|anesthetics|mesh-ancestor
102121246|NCT05276258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102121247|NCT05276258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121248|NCT05276258|Sensory System Agents|sensory system agents|mesh-ancestor
102121249|NCT05276258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102121250|NCT05233982|Olaparib|olaparib|mesh-list
102121251|NCT05233982|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102121252|NCT05233982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102121253|NCT05233982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121254|NCT05233982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121255|NCT05199493|Angiotensin II|angiotensin ii|mesh-list
102121256|NCT05199493|Giapreza|giapreza|mesh-list
102121257|NCT05199493|Angiotensinogen|angiotensinogen|mesh-list
102121258|NCT05199493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102121259|NCT05199493|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102121260|NCT05199493|Protease Inhibitors|protease inhibitors|mesh-ancestor
102121261|NCT05199493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102121262|NCT05199493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121263|NCT05169658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102121264|NCT05169658|Obinutuzumab|obinutuzumab|mesh-list
102121265|NCT05169658|Antibodies|antibodies|mesh-list
102121266|NCT05169658|Immunoglobulins|immunoglobulins|mesh-list
102121267|NCT05169658|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102121268|NCT05169658|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102121269|NCT05169658|Immunoconjugates|immunoconjugates|mesh-list
102121270|NCT05169658|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
102121271|NCT05169658|Immunologic Factors|immunologic factors|mesh-ancestor
102121272|NCT05169658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121273|NCT05169658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121274|NCT05112536|Paclitaxel|paclitaxel|mesh-list
102121275|NCT05112536|Carboplatin|carboplatin|mesh-list
102121276|NCT05112536|Doxorubicin|doxorubicin|mesh-list
102121277|NCT05112536|Pembrolizumab|pembrolizumab|mesh-list
102121278|NCT05112536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102121279|NCT05112536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121280|NCT05112536|Tubulin Modulators|tubulin modulators|mesh-ancestor
102121281|NCT05112536|Antimitotic Agents|antimitotic agents|mesh-ancestor
102121282|NCT05112536|Mitosis Modulators|mitosis modulators|mesh-ancestor
102121283|NCT05112536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121284|NCT05112536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102121285|NCT05112536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102121286|NCT05112536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102121287|NCT05112536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102121288|NCT05112536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102121289|NCT05112536|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102121290|NCT05109455|Proanthocyanidin|proanthocyanidin|mesh-list
102121291|NCT05109455|Procyanidin|procyanidin|mesh-list
102121292|NCT05109455|Antioxidants|antioxidants|mesh-ancestor
102121293|NCT05109455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121294|NCT05109455|Protective Agents|protective agents|mesh-ancestor
102121295|NCT05109455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121296|NCT05109455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102121297|NCT05109455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102121298|NCT05109455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102121299|NCT05098028|Rifaximin|rifaximin|mesh-list
102121300|NCT05098028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102121301|NCT05098028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102121302|NCT05098028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102121303|NCT05079360|Everolimus|everolimus|mesh-list
102121304|NCT05079360|Exemestane|exemestane|mesh-list
102121305|NCT05079360|Estrogens|estrogens|mesh-list
102121306|NCT05079360|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-list
102121307|NCT05079360|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
102121308|NCT05079360|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102121309|NCT05079360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102121310|NCT05079360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102121311|NCT05079360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121312|NCT05079360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102121313|NCT05079360|Immunologic Factors|immunologic factors|mesh-ancestor
102121314|NCT05079360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121315|NCT05079360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121316|NCT05079360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102121317|NCT05079360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102121318|NCT05079360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102121319|NCT05079360|Hormone Antagonists|hormone antagonists|mesh-ancestor
102121320|NCT05079360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102121321|NCT05079360|Hormones|hormones|mesh-ancestor
102121322|NCT05078060|Vaccines|vaccines|mesh-list
102121323|NCT05078060|Immunologic Factors|immunologic factors|mesh-ancestor
102121324|NCT05078060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121325|NCT05063786|Capecitabine|capecitabine|mesh-list
102121326|NCT05063786|Trastuzumab|trastuzumab|mesh-list
102121327|NCT05063786|Vinorelbine|vinorelbine|mesh-list
102121328|NCT05063786|Fulvestrant|fulvestrant|mesh-list
102121329|NCT05063786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102121330|NCT05063786|Antimetabolites|antimetabolites|mesh-ancestor
102121331|NCT05063786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121332|NCT05063786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121333|NCT05063786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102121334|NCT05063786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102121335|NCT05063786|Tubulin Modulators|tubulin modulators|mesh-ancestor
102121337|NCT05063786|Mitosis Modulators|mitosis modulators|mesh-ancestor
102121338|NCT05063786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102121339|NCT05063786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102121340|NCT05063786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102121341|NCT05063786|Hormone Antagonists|hormone antagonists|mesh-ancestor
102121342|NCT05063786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102121343|NCT05063786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121344|NCT05035836|Tamoxifen|tamoxifen|mesh-list
102121345|NCT05035836|Letrozole|letrozole|mesh-list
102121346|NCT05035836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121347|NCT05035836|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102121348|NCT05035836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102121349|NCT05035836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102121350|NCT05035836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121351|NCT05035836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102121352|NCT05035836|Hormone Antagonists|hormone antagonists|mesh-ancestor
102121353|NCT05035836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102121354|NCT05035836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121355|NCT05035836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102121356|NCT05035836|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102121357|NCT05035836|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102121358|NCT05035836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102121359|NCT05012787|Vaccines|vaccines|mesh-list
102121360|NCT05012787|1018 oligonucleotide|1018 oligonucleotide|mesh-list
102121361|NCT05012787|Immunologic Factors|immunologic factors|mesh-ancestor
102121362|NCT05012787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121363|NCT05012787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102121364|NCT05005260|Bupivacaine|bupivacaine|mesh-list
102121365|NCT05005260|Anesthetics, Local|anesthetics, local|mesh-ancestor
102121366|NCT05005260|Anesthetics|anesthetics|mesh-ancestor
102121367|NCT05005260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102121368|NCT05005260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121369|NCT05005260|Sensory System Agents|sensory system agents|mesh-ancestor
102121370|NCT05005260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102121371|NCT04990167|Bromides|bromides|mesh-list
102121372|NCT04990167|Tiotropium Bromide|tiotropium bromide|mesh-list
102121373|NCT04990167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102121374|NCT04990167|Autonomic Agents|autonomic agents|mesh-ancestor
102121375|NCT04990167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102121376|NCT04990167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121377|NCT04990167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102121378|NCT04990167|Respiratory System Agents|respiratory system agents|mesh-ancestor
102121379|NCT04990167|Parasympatholytics|parasympatholytics|mesh-ancestor
102121380|NCT04990167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102121381|NCT04990167|Cholinergic Agents|cholinergic agents|mesh-ancestor
102121382|NCT04990167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102019983|NCT02450188|Urological Agents|urological agents|mesh-ancestor
102121383|NCT04990167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121384|NCT04990167|Anticonvulsants|anticonvulsants|mesh-ancestor
102121385|NCT04918927|Nitazoxanide|nitazoxanide|mesh-list
102121386|NCT04918927|Favipiravir|favipiravir|mesh-list
102121387|NCT04918927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102121388|NCT04918927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102121389|NCT04918927|Antiviral Agents|antiviral agents|mesh-ancestor
102121390|NCT04907825|Warfarin|warfarin|mesh-list
102121391|NCT04907825|Anticoagulants|anticoagulants|mesh-list
102121392|NCT04907084|Fenofibrate|fenofibrate|mesh-list
102121393|NCT04907084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102121394|NCT04907084|Antimetabolites|antimetabolites|mesh-ancestor
102121395|NCT04907084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121396|NCT04907084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102121397|NCT04893356|Dacarbazine|dacarbazine|mesh-list
102121398|NCT04893356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102121399|NCT04893356|Alkylating Agents|alkylating agents|mesh-ancestor
102121400|NCT04893356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121401|NCT04893356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121402|NCT04857983|Memantine|memantine|mesh-list
102121403|NCT04857983|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102121404|NCT04857983|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102121405|NCT04857983|Dopamine Agents|dopamine agents|mesh-ancestor
102121406|NCT04857983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102121407|NCT04857983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121408|NCT04857983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830407|NCT05264883|Azacitidine|azacitidine|mesh-list
102121409|NCT04857983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102121410|NCT04857983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102121411|NCT04777708|Pembrolizumab|pembrolizumab|mesh-list
102121412|NCT04777708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102121413|NCT04777708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121414|NCT04777708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102121415|NCT04777708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121416|NCT04763512|Caseins|caseins|mesh-list
102121417|NCT04763512|Chelating Agents|chelating agents|mesh-ancestor
102121418|NCT04763512|Sequestering Agents|sequestering agents|mesh-ancestor
102121419|NCT04763512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121420|NCT04730349|Nivolumab|nivolumab|mesh-list
102121421|NCT04730349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102121422|NCT04730349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121423|NCT04730349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102121424|NCT04730349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121425|NCT04602117|Paclitaxel|paclitaxel|mesh-list
102121426|NCT04602117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102121427|NCT04602117|Trastuzumab|trastuzumab|mesh-list
102121428|NCT04602117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102121429|NCT04602117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121430|NCT04602117|Tubulin Modulators|tubulin modulators|mesh-ancestor
102121431|NCT04602117|Antimitotic Agents|antimitotic agents|mesh-ancestor
102121432|NCT04602117|Mitosis Modulators|mitosis modulators|mesh-ancestor
102121433|NCT04602117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121434|NCT04602117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102121436|NCT04601857|Futibatinib|futibatinib|mesh-list
102121437|NCT04601857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102121438|NCT04601857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121439|NCT04601857|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102121440|NCT04601857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121441|NCT04517396|Fenofibrate|fenofibrate|mesh-list
102121442|NCT04517396|Fenofibric acid|fenofibric acid|mesh-list
102121443|NCT04517396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102121444|NCT04517396|Antimetabolites|antimetabolites|mesh-ancestor
102121445|NCT04517396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121446|NCT04517396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102121447|NCT04517396|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102121448|NCT04382352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102121449|NCT04382352|Trastuzumab|trastuzumab|mesh-list
102121450|NCT04382352|Antibodies|antibodies|mesh-list
102121451|NCT04382352|Immunoglobulins|immunoglobulins|mesh-list
102121452|NCT04382352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102121453|NCT04382352|Immunologic Factors|immunologic factors|mesh-ancestor
102121454|NCT04382352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121455|NCT04382352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121456|NCT04311424|Tirzepatide|tirzepatide|mesh-list
102121457|NCT04311424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102121458|NCT04311424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121459|NCT04311424|Incretins|incretins|mesh-ancestor
102121460|NCT04311424|Hormones|hormones|mesh-ancestor
102121461|NCT04311424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102121462|NCT04301765|Testosterone|testosterone|mesh-list
102121463|NCT04301765|Androgens|androgens|mesh-ancestor
102121464|NCT04301765|Hormones|hormones|mesh-ancestor
102121465|NCT04301765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102121466|NCT04301765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121467|NCT04296396|Oxycodone|oxycodone|mesh-list
102121468|NCT04296396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102121469|NCT04296396|Narcotics|narcotics|mesh-ancestor
102121470|NCT04296396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102121471|NCT04296396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121472|NCT04296396|Analgesics|analgesics|mesh-ancestor
102121473|NCT04296396|Sensory System Agents|sensory system agents|mesh-ancestor
102121474|NCT04296396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102121475|NCT04291456|Minocycline|minocycline|mesh-list
102121476|NCT04291456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102121477|NCT04291456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102121478|NCT04266977|Dexamethasone|dexamethasone|mesh-list
102121479|NCT04266977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102121480|NCT04266977|Antiemetics|antiemetics|mesh-ancestor
102121481|NCT04266977|Autonomic Agents|autonomic agents|mesh-ancestor
102121482|NCT04266977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102121483|NCT04266977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121484|NCT04266977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102121485|NCT04266977|Glucocorticoids|glucocorticoids|mesh-ancestor
102121486|NCT04266977|Hormones|hormones|mesh-ancestor
102121487|NCT04266977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102121488|NCT04266977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102121489|NCT04266977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121490|NCT04195945|Cytarabine|cytarabine|mesh-list
102121491|NCT04195945|Daunorubicin|daunorubicin|mesh-list
102121492|NCT04195945|Mitoxantrone|mitoxantrone|mesh-list
102121493|NCT04195945|Cladribine|cladribine|mesh-list
102121494|NCT04195945|Lenograstim|lenograstim|mesh-list
102121495|NCT04195945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102121496|NCT04195945|Antimetabolites|antimetabolites|mesh-ancestor
102121497|NCT04195945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121498|NCT04195945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121499|NCT04195945|Antiviral Agents|antiviral agents|mesh-ancestor
102121500|NCT04195945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102121501|NCT04195945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102121502|NCT04195945|Immunologic Factors|immunologic factors|mesh-ancestor
102121503|NCT04195945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121504|NCT04195945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102121505|NCT04195945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102121533|NCT04139772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101830558|NCT04998500|Hormones|hormones|mesh-list
102121564|NCT04091204|Olaparib|olaparib|mesh-list
102121565|NCT04091204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102121566|NCT04091204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102121567|NCT04091204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121568|NCT04091204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121569|NCT04028245|Spartalizumab|spartalizumab|mesh-list
102121570|NCT04028245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102121571|NCT04028245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121572|NCT04028245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102121573|NCT04028245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121574|NCT04017650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102121575|NCT04017650|Nivolumab|nivolumab|mesh-list
102121576|NCT04017650|Cetuximab|cetuximab|mesh-list
102121577|NCT04017650|Antibodies|antibodies|mesh-list
102121578|NCT04017650|Immunoglobulins|immunoglobulins|mesh-list
102121579|NCT04017650|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102121580|NCT04017650|Immunologic Factors|immunologic factors|mesh-ancestor
102121581|NCT04017650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121582|NCT04017650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121583|NCT04017650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102121584|NCT04017650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121585|NCT03975114|Durvalumab|durvalumab|mesh-list
102121586|NCT03975114|Tremelimumab|tremelimumab|mesh-list
102121587|NCT03975114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102121588|NCT03975114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121589|NCT03955783|Venetoclax|venetoclax|mesh-list
102121590|NCT03955783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121591|NCT03942120|Ustekinumab|ustekinumab|mesh-list
102121592|NCT03942120|Dermatologic Agents|dermatologic agents|mesh-ancestor
102121593|NCT03940742|Tirzepatide|tirzepatide|mesh-list
102121594|NCT03940742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102121595|NCT03940742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121596|NCT03940742|Incretins|incretins|mesh-ancestor
102121597|NCT03940742|Hormones|hormones|mesh-ancestor
102121598|NCT03940742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102121599|NCT03893240|Antibodies|antibodies|mesh-list
102121600|NCT03893240|Antibodies, Blocking|antibodies, blocking|mesh-list
102121601|NCT03893240|Immunologic Factors|immunologic factors|mesh-ancestor
102121602|NCT03893240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121603|NCT03875274|Morphine|morphine|mesh-list
102121604|NCT03875274|Ropivacaine|ropivacaine|mesh-list
102121605|NCT03875274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102121606|NCT03875274|Narcotics|narcotics|mesh-ancestor
102121607|NCT03875274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102121608|NCT03875274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121609|NCT03875274|Analgesics|analgesics|mesh-ancestor
102121610|NCT03875274|Sensory System Agents|sensory system agents|mesh-ancestor
102121611|NCT03875274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102121612|NCT03875274|Anesthetics, Local|anesthetics, local|mesh-ancestor
102121613|NCT03875274|Anesthetics|anesthetics|mesh-ancestor
102121614|NCT03775850|Pembrolizumab|pembrolizumab|mesh-list
102121615|NCT03775850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102121616|NCT03775850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121617|NCT03775850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102121618|NCT03775850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121619|NCT03762109|Dantrolene|dantrolene|mesh-list
102121620|NCT03762109|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102121621|NCT03762109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121622|NCT03762109|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102121623|NCT03762109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102121624|NCT03732664|Pembrolizumab|pembrolizumab|mesh-list
102121625|NCT03732664|Nivolumab|nivolumab|mesh-list
102121626|NCT03732664|Durvalumab|durvalumab|mesh-list
102121627|NCT03732664|Tislelizumab|tislelizumab|mesh-list
102121628|NCT03732664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102121629|NCT03732664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121630|NCT03732664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102121631|NCT03732664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121632|NCT03620032|Vinorelbine|vinorelbine|mesh-list
102121633|NCT03620032|Nimotuzumab|nimotuzumab|mesh-list
102121634|NCT03620032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102121635|NCT03620032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121636|NCT03620032|Tubulin Modulators|tubulin modulators|mesh-ancestor
102121637|NCT03620032|Antimitotic Agents|antimitotic agents|mesh-ancestor
102121638|NCT03620032|Mitosis Modulators|mitosis modulators|mesh-ancestor
102121639|NCT03620032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121640|NCT03620032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102121641|NCT03410784|Paclitaxel|paclitaxel|mesh-list
102121642|NCT03410784|Carboplatin|carboplatin|mesh-list
102121643|NCT03410784|Pembrolizumab|pembrolizumab|mesh-list
102121644|NCT03410784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102121645|NCT03410784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121646|NCT03410784|Tubulin Modulators|tubulin modulators|mesh-ancestor
102121647|NCT03410784|Antimitotic Agents|antimitotic agents|mesh-ancestor
102121648|NCT03410784|Mitosis Modulators|mitosis modulators|mesh-ancestor
102121649|NCT03410784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121650|NCT03410784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102121651|NCT03410784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102121652|NCT03363841|Ibrexafungerp|ibrexafungerp|mesh-list
102121653|NCT03363841|Antifungal Agents|antifungal agents|mesh-ancestor
102121654|NCT03363841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102121655|NCT03355482|Methylprednisolone|methylprednisolone|mesh-list
102121656|NCT03355482|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102121657|NCT03355482|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102121658|NCT03355482|Prednisolone|prednisolone|mesh-list
102121659|NCT03355482|Prednisolone acetate|prednisolone acetate|mesh-list
102121660|NCT03355482|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102121661|NCT03355482|Prednisolone phosphate|prednisolone phosphate|mesh-list
102121662|NCT03355482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102121663|NCT03355482|Antiemetics|antiemetics|mesh-ancestor
102121664|NCT03355482|Autonomic Agents|autonomic agents|mesh-ancestor
102121665|NCT03355482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102121666|NCT03355482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121667|NCT03355482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102121668|NCT03355482|Glucocorticoids|glucocorticoids|mesh-ancestor
102121669|NCT03355482|Hormones|hormones|mesh-ancestor
102121670|NCT03355482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102121671|NCT03355482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102121672|NCT03355482|Protective Agents|protective agents|mesh-ancestor
102121673|NCT03355482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102121674|NCT03355482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121675|NCT03326921|Vidarabine|vidarabine|mesh-list
102121676|NCT03326921|Fludarabine|fludarabine|mesh-list
102121677|NCT03326921|Fludarabine phosphate|fludarabine phosphate|mesh-list
102121678|NCT03326921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121679|NCT03326921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102121680|NCT03326921|Antimetabolites|antimetabolites|mesh-ancestor
102121681|NCT03326921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121682|NCT03326921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102121683|NCT03326921|Immunologic Factors|immunologic factors|mesh-ancestor
102121684|NCT03326921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121685|NCT03326921|Antiviral Agents|antiviral agents|mesh-ancestor
102121686|NCT03326921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102121687|NCT03315260|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
102121688|NCT03315260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121689|NCT03310619|Nivolumab|nivolumab|mesh-list
102121690|NCT03310619|Durvalumab|durvalumab|mesh-list
102121691|NCT03310619|Relatlimab|relatlimab|mesh-list
102121692|NCT03310619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102121693|NCT03310619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121694|NCT03310619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102121695|NCT03310619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121696|NCT03190785|Benzoic Acid|benzoic acid|mesh-list
102121697|NCT03190785|Antifungal Agents|antifungal agents|mesh-ancestor
102121698|NCT03190785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102121699|NCT03093064|Natalizumab|natalizumab|mesh-list
102121700|NCT03093064|Immunologic Factors|immunologic factors|mesh-ancestor
102121701|NCT03093064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121702|NCT03060577|Evolocumab|evolocumab|mesh-list
102121703|NCT03060577|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102121704|NCT03060577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102121705|NCT03060577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102121706|NCT03060577|Antimetabolites|antimetabolites|mesh-ancestor
102121707|NCT03060577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121708|NCT03060577|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102121709|NCT03060577|Protease Inhibitors|protease inhibitors|mesh-ancestor
102121710|NCT03060577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102121711|NCT03060577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102121712|NCT02797275|Albuterol|albuterol|mesh-list
102121713|NCT02797275|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102121714|NCT02797275|Autonomic Agents|autonomic agents|mesh-ancestor
102121715|NCT02797275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102121716|NCT02797275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121717|NCT02797275|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102121718|NCT02797275|Respiratory System Agents|respiratory system agents|mesh-ancestor
102121719|NCT02797275|Tocolytic Agents|tocolytic agents|mesh-ancestor
102121720|NCT02797275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102121721|NCT02797275|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102121722|NCT02797275|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102121723|NCT02797275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102121724|NCT02797275|Adrenergic Agents|adrenergic agents|mesh-ancestor
102121725|NCT02797275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102121726|NCT02797275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121728|NCT02787005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102121729|NCT02787005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121730|NCT02787005|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102121731|NCT02787005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121732|NCT02734290|Paclitaxel|paclitaxel|mesh-list
102121733|NCT02734290|Pembrolizumab|pembrolizumab|mesh-list
102612366|NCT02973581|Anesthetics, Local|anesthetics, local|mesh-ancestor
102121734|NCT02734290|Capecitabine|capecitabine|mesh-list
102121735|NCT02734290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102121736|NCT02734290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121737|NCT02734290|Tubulin Modulators|tubulin modulators|mesh-ancestor
102121738|NCT02734290|Antimitotic Agents|antimitotic agents|mesh-ancestor
102121739|NCT02734290|Mitosis Modulators|mitosis modulators|mesh-ancestor
102121740|NCT02734290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121741|NCT02734290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102121742|NCT02734290|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102121743|NCT02734290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102121744|NCT02734290|Antimetabolites|antimetabolites|mesh-ancestor
102121745|NCT02673333|Pembrolizumab|pembrolizumab|mesh-list
102121746|NCT02673333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102121747|NCT02673333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121748|NCT02673333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102121749|NCT02673333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121750|NCT02633189|Bevacizumab|bevacizumab|mesh-list
102121751|NCT02633189|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102121752|NCT02633189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102121753|NCT02633189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121754|NCT02633189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102121755|NCT02633189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102121756|NCT02633189|Growth Substances|growth substances|mesh-ancestor
102121757|NCT02633189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121758|NCT02633189|Growth Inhibitors|growth inhibitors|mesh-ancestor
102121759|NCT02633189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102121760|NCT02633189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102121761|NCT02633189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121762|NCT02621242|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102121763|NCT02621242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102121764|NCT02621242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102121765|NCT02621242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102121766|NCT02621242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121767|NCT02621242|Antiviral Agents|antiviral agents|mesh-ancestor
102121768|NCT02621242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102121769|NCT02621242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102121770|NCT02621242|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102121771|NCT02601313|Cyclophosphamide|cyclophosphamide|mesh-list
102121772|NCT02601313|Fludarabine|fludarabine|mesh-list
102121773|NCT02601313|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
102121774|NCT02601313|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
102121775|NCT02601313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102121776|NCT02601313|Immunologic Factors|immunologic factors|mesh-ancestor
102121777|NCT02601313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121778|NCT02601313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102121779|NCT02601313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102121780|NCT02601313|Alkylating Agents|alkylating agents|mesh-ancestor
102121781|NCT02601313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121782|NCT02601313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121783|NCT02601313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102121784|NCT02601313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102121786|NCT02526368|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102121787|NCT02526368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102121788|NCT02514083|Fludarabine|fludarabine|mesh-list
102121789|NCT02514083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121790|NCT02500576|Aldesleukin|aldesleukin|mesh-list
102121791|NCT02500576|Cyclophosphamide|cyclophosphamide|mesh-list
102121792|NCT02500576|Pembrolizumab|pembrolizumab|mesh-list
102121793|NCT02500576|Fludarabine|fludarabine|mesh-list
102121794|NCT02500576|Fludarabine phosphate|fludarabine phosphate|mesh-list
102121795|NCT02500576|Interleukin-2|interleukin-2|mesh-list
102121796|NCT02500576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102121797|NCT02500576|Immunologic Factors|immunologic factors|mesh-ancestor
102121798|NCT02500576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121799|NCT02500576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102121800|NCT02500576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102121801|NCT02500576|Alkylating Agents|alkylating agents|mesh-ancestor
102121802|NCT02500576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121803|NCT02500576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121804|NCT02500576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102121805|NCT02500576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102121806|NCT02500576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102121807|NCT02500576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102121808|NCT02500576|Antimetabolites|antimetabolites|mesh-ancestor
102121809|NCT02500576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102121810|NCT02500576|Analgesics|analgesics|mesh-ancestor
102121811|NCT02500576|Sensory System Agents|sensory system agents|mesh-ancestor
102121812|NCT02500576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102121813|NCT02500576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102121814|NCT02500576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102121815|NCT02500576|Antiviral Agents|antiviral agents|mesh-ancestor
102121816|NCT02500576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102121817|NCT02395848|Fidaxomicin|fidaxomicin|mesh-list
102121818|NCT02395848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102121819|NCT02395848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102121820|NCT02214381|Paclitaxel|paclitaxel|mesh-list
102121821|NCT02214381|Cyclophosphamide|cyclophosphamide|mesh-list
102121822|NCT02214381|Doxorubicin|doxorubicin|mesh-list
102121823|NCT02214381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102121824|NCT02214381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121825|NCT02214381|Tubulin Modulators|tubulin modulators|mesh-ancestor
102121826|NCT02214381|Antimitotic Agents|antimitotic agents|mesh-ancestor
102121827|NCT02214381|Mitosis Modulators|mitosis modulators|mesh-ancestor
102121828|NCT02214381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121829|NCT02214381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102121830|NCT02214381|Immunologic Factors|immunologic factors|mesh-ancestor
102121831|NCT02214381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121832|NCT02214381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102121833|NCT02214381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102121834|NCT02214381|Alkylating Agents|alkylating agents|mesh-ancestor
102121835|NCT02214381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102121836|NCT02214381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102121837|NCT02214381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102121838|NCT02214381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102121839|NCT02214381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102121840|NCT02081326|BCG Vaccine|bcg vaccine|mesh-list
102121841|NCT02081326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102121842|NCT02081326|Immunologic Factors|immunologic factors|mesh-ancestor
102121843|NCT02081326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121844|NCT02061761|Nivolumab|nivolumab|mesh-list
102121845|NCT02061761|Relatlimab|relatlimab|mesh-list
102121846|NCT02061761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102121847|NCT02061761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121848|NCT02061761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102020387|NCT02727998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102121849|NCT02061761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121850|NCT01927068|Paclitaxel|paclitaxel|mesh-list
102121851|NCT01927068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102121852|NCT01927068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121853|NCT01927068|Tubulin Modulators|tubulin modulators|mesh-ancestor
102121854|NCT01927068|Antimitotic Agents|antimitotic agents|mesh-ancestor
102121855|NCT01927068|Mitosis Modulators|mitosis modulators|mesh-ancestor
102121856|NCT01927068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121857|NCT01898104|Capecitabine|capecitabine|mesh-list
102121858|NCT01898104|Valproic Acid|valproic acid|mesh-list
102121859|NCT01898104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102121860|NCT01898104|Antimetabolites|antimetabolites|mesh-ancestor
102121861|NCT01898104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121862|NCT01898104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121863|NCT01898104|Anticonvulsants|anticonvulsants|mesh-ancestor
102121864|NCT01898104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102121866|NCT01898104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102121867|NCT01898104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121868|NCT01898104|Antimanic Agents|antimanic agents|mesh-ancestor
102121869|NCT01898104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102121870|NCT01898104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102121871|NCT01898104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102121872|NCT01817452|Paclitaxel|paclitaxel|mesh-list
102121873|NCT01817452|Trastuzumab|trastuzumab|mesh-list
102121874|NCT01817452|Pertuzumab|pertuzumab|mesh-list
102121875|NCT01817452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102121876|NCT01817452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121877|NCT01817452|Tubulin Modulators|tubulin modulators|mesh-ancestor
102121878|NCT01817452|Antimitotic Agents|antimitotic agents|mesh-ancestor
102121879|NCT01817452|Mitosis Modulators|mitosis modulators|mesh-ancestor
102121880|NCT01817452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121881|NCT01817452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102121882|NCT01815242|Paclitaxel|paclitaxel|mesh-list
102121883|NCT01815242|Carboplatin|carboplatin|mesh-list
102612367|NCT02973581|Anesthetics|anesthetics|mesh-ancestor
102121884|NCT01815242|Gemcitabine|gemcitabine|mesh-list
102121885|NCT01815242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102121886|NCT01815242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121887|NCT01815242|Tubulin Modulators|tubulin modulators|mesh-ancestor
102121888|NCT01815242|Antimitotic Agents|antimitotic agents|mesh-ancestor
102121889|NCT01815242|Mitosis Modulators|mitosis modulators|mesh-ancestor
102121890|NCT01815242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121891|NCT01815242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102121892|NCT01815242|Antimetabolites|antimetabolites|mesh-ancestor
102121893|NCT01802749|Paclitaxel|paclitaxel|mesh-list
102121894|NCT01802749|Bevacizumab|bevacizumab|mesh-list
102121895|NCT01802749|Carboplatin|carboplatin|mesh-list
102121896|NCT01802749|Gemcitabine|gemcitabine|mesh-list
102121897|NCT01802749|Doxorubicin|doxorubicin|mesh-list
102121898|NCT01802749|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102121899|NCT01802749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102121900|NCT01802749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121901|NCT01802749|Tubulin Modulators|tubulin modulators|mesh-ancestor
102121902|NCT01802749|Antimitotic Agents|antimitotic agents|mesh-ancestor
102121903|NCT01802749|Mitosis Modulators|mitosis modulators|mesh-ancestor
102121904|NCT01802749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121905|NCT01802749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102121906|NCT01802749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102121907|NCT01802749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102121908|NCT01802749|Growth Substances|growth substances|mesh-ancestor
102121909|NCT01802749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121910|NCT01802749|Growth Inhibitors|growth inhibitors|mesh-ancestor
102121911|NCT01802749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102121912|NCT01802749|Antimetabolites|antimetabolites|mesh-ancestor
102121913|NCT01802749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102121914|NCT01802749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102121915|NCT01802749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102121916|NCT01802749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102121917|NCT01801904|Panitumumab|panitumumab|mesh-list
102121918|NCT01801904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102121919|NCT01801904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121920|NCT01779206|Paclitaxel|paclitaxel|mesh-list
102121921|NCT01779206|Docetaxel|docetaxel|mesh-list
102121922|NCT01779206|Cyclophosphamide|cyclophosphamide|mesh-list
102121923|NCT01779206|Epirubicin|epirubicin|mesh-list
102121924|NCT01779206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102121925|NCT01779206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121926|NCT01779206|Tubulin Modulators|tubulin modulators|mesh-ancestor
102121927|NCT01779206|Antimitotic Agents|antimitotic agents|mesh-ancestor
102121928|NCT01779206|Mitosis Modulators|mitosis modulators|mesh-ancestor
102121929|NCT01779206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121930|NCT01779206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102121931|NCT01779206|Immunologic Factors|immunologic factors|mesh-ancestor
102121932|NCT01779206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121933|NCT01779206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102121934|NCT01779206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102121935|NCT01779206|Alkylating Agents|alkylating agents|mesh-ancestor
102121936|NCT01779206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102121937|NCT01779206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102121938|NCT01779206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102121939|NCT01779206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102121940|NCT01779206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102121942|NCT01745965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102121943|NCT01745965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121944|NCT01706120|Paclitaxel|paclitaxel|mesh-list
102121945|NCT01706120|Bevacizumab|bevacizumab|mesh-list
102121946|NCT01706120|Carboplatin|carboplatin|mesh-list
102121947|NCT01706120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102121948|NCT01706120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121949|NCT01706120|Tubulin Modulators|tubulin modulators|mesh-ancestor
102121950|NCT01706120|Antimitotic Agents|antimitotic agents|mesh-ancestor
102121951|NCT01706120|Mitosis Modulators|mitosis modulators|mesh-ancestor
102121952|NCT01706120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121953|NCT01706120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102121954|NCT01706120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102121955|NCT01706120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102121956|NCT01706120|Growth Substances|growth substances|mesh-ancestor
102121957|NCT01706120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121958|NCT01706120|Growth Inhibitors|growth inhibitors|mesh-ancestor
102121959|NCT01682941|Phytoestrogens|phytoestrogens|mesh-list
102121960|NCT01682941|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102121961|NCT01682941|Estrogens|estrogens|mesh-ancestor
102121963|NCT01682941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102121964|NCT01682941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121965|NCT01656551|Gemcitabine|gemcitabine|mesh-list
102121966|NCT01656551|Pemetrexed|pemetrexed|mesh-list
102121967|NCT01656551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121968|NCT01656551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102121969|NCT01656551|Antimetabolites|antimetabolites|mesh-ancestor
102121970|NCT01656551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121971|NCT01656551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102121972|NCT01656551|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102121973|NCT01656551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102121974|NCT01649674|Magnesium citrate|magnesium citrate|mesh-list
102121975|NCT01649674|Picosulfate sodium|picosulfate sodium|mesh-list
102121976|NCT01649674|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102121977|NCT01649674|Cathartics|cathartics|mesh-ancestor
102121978|NCT01649674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102121979|NCT01628211|Leucovorin|leucovorin|mesh-list
102121980|NCT01628211|Folic Acid|folic acid|mesh-list
102121981|NCT01628211|Fluorouracil|fluorouracil|mesh-list
102121982|NCT01628211|Oxaliplatin|oxaliplatin|mesh-list
102121983|NCT01628211|Levoleucovorin|levoleucovorin|mesh-list
102121984|NCT01628211|Antimetabolites|antimetabolites|mesh-ancestor
102121985|NCT01628211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102121986|NCT01628211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102121987|NCT01628211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102121988|NCT01628211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102121989|NCT01628211|Immunologic Factors|immunologic factors|mesh-ancestor
102121990|NCT01628211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102121991|NCT01628211|Antidotes|antidotes|mesh-ancestor
102121992|NCT01628211|Protective Agents|protective agents|mesh-ancestor
102121993|NCT01628211|Vitamin B Complex|vitamin b complex|mesh-ancestor
102121994|NCT01628211|Vitamins|vitamins|mesh-ancestor
102121995|NCT01628211|Micronutrients|micronutrients|mesh-ancestor
102121996|NCT01628211|Hematinics|hematinics|mesh-ancestor
102121997|NCT01593488|Cytarabine|cytarabine|mesh-list
102020534|NCT05058404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102121998|NCT01593488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102121999|NCT01593488|Antimetabolites|antimetabolites|mesh-ancestor
102122000|NCT01593488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831002|NCT04400474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831016|NCT04328337|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101831017|NCT04328337|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101831018|NCT04328337|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101831019|NCT04328337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101831020|NCT04319627|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101831021|NCT04319627|Calcium|calcium|mesh-list
101831022|NCT04319627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101831023|NCT04319627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831024|NCT04319627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101831025|NCT04319627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101831026|NCT04319627|Antimetabolites|antimetabolites|mesh-ancestor
102122001|NCT01593488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102122002|NCT01593488|Antiviral Agents|antiviral agents|mesh-ancestor
102122003|NCT01593488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102122004|NCT01593488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102122005|NCT01593488|Immunologic Factors|immunologic factors|mesh-ancestor
102122006|NCT01593488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122007|NCT01405586|Gemcitabine|gemcitabine|mesh-list
102122008|NCT01405586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102122009|NCT01405586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102122010|NCT01405586|Antimetabolites|antimetabolites|mesh-ancestor
102122011|NCT01405586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122012|NCT01309230|Immunomodulating Agents|immunomodulating agents|mesh-list
102122013|NCT01309230|Immunologic Factors|immunologic factors|mesh-ancestor
102122014|NCT01309230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122015|NCT01238692|Rituximab|rituximab|mesh-list
102122016|NCT01238692|Panobinostat|panobinostat|mesh-list
102122017|NCT01238692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102122018|NCT01238692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102122019|NCT01238692|Immunologic Factors|immunologic factors|mesh-ancestor
102122020|NCT01238692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122021|NCT01238692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102122022|NCT01238692|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102122023|NCT01238692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102122024|NCT01238692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122025|NCT01209871|Immunoglobulins|immunoglobulins|mesh-list
102122026|NCT01209871|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102122028|NCT01209871|Immunologic Factors|immunologic factors|mesh-ancestor
102122029|NCT01209871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122030|NCT00996983|Ziconotide|ziconotide|mesh-list
102122031|NCT00996983|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102122032|NCT00996983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102122033|NCT00996983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122034|NCT00996983|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102122035|NCT00996983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122036|NCT00996983|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102122037|NCT00996983|Protective Agents|protective agents|mesh-ancestor
102122038|NCT00996983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102122039|NCT00996983|Analgesics|analgesics|mesh-ancestor
102122040|NCT00996983|Sensory System Agents|sensory system agents|mesh-ancestor
102122041|NCT00996983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102122042|NCT00660842|Paclitaxel|paclitaxel|mesh-list
102122043|NCT00660842|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102122044|NCT00660842|Carboplatin|carboplatin|mesh-list
102122045|NCT00660842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102122046|NCT00660842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102122047|NCT00660842|Tubulin Modulators|tubulin modulators|mesh-ancestor
102122048|NCT00660842|Antimitotic Agents|antimitotic agents|mesh-ancestor
102122049|NCT00660842|Mitosis Modulators|mitosis modulators|mesh-ancestor
102122050|NCT00660842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122051|NCT00657878|Paclitaxel|paclitaxel|mesh-list
102122052|NCT00657878|Carboplatin|carboplatin|mesh-list
102122053|NCT00657878|Gemcitabine|gemcitabine|mesh-list
102122054|NCT00657878|Doxorubicin|doxorubicin|mesh-list
102122055|NCT00657878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102122056|NCT00657878|Topotecan|topotecan|mesh-list
102122057|NCT00657878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102122058|NCT00657878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102122059|NCT00657878|Tubulin Modulators|tubulin modulators|mesh-ancestor
102122060|NCT00657878|Antimitotic Agents|antimitotic agents|mesh-ancestor
102122061|NCT00657878|Mitosis Modulators|mitosis modulators|mesh-ancestor
102122062|NCT00657878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122063|NCT00657878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102122064|NCT00657878|Antimetabolites|antimetabolites|mesh-ancestor
102122065|NCT00657878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102122066|NCT00657878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102122067|NCT00657878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102122068|NCT00657878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102122069|NCT00657878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102122070|NCT00642057|Tetrabenazine|tetrabenazine|mesh-list
102122071|NCT00642057|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102122072|NCT00642057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102122073|NCT00642057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102122074|NCT00642057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122075|NCT00642057|Adrenergic Agents|adrenergic agents|mesh-ancestor
102122076|NCT00642057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102122077|NCT00642057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122079|NCT00526396|Etoposide|etoposide|mesh-list
102122080|NCT00526396|Etoposide phosphate|etoposide phosphate|mesh-list
102122081|NCT00526396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102122082|NCT00526396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102122083|NCT00526396|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102122084|NCT00526396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102122085|NCT00526396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102122086|NCT00526396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122087|NCT00431704|Carboplatin|carboplatin|mesh-list
102122088|NCT00431704|Trastuzumab|trastuzumab|mesh-list
102122089|NCT00431704|Vinorelbine|vinorelbine|mesh-list
102122090|NCT00431704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102122091|NCT00431704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102122092|NCT00431704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102122093|NCT00431704|Tubulin Modulators|tubulin modulators|mesh-ancestor
102122094|NCT00431704|Antimitotic Agents|antimitotic agents|mesh-ancestor
102122095|NCT00431704|Mitosis Modulators|mitosis modulators|mesh-ancestor
102122096|NCT00431704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122097|NCT00412022|Tamoxifen|tamoxifen|mesh-list
102122098|NCT00412022|Zoledronic Acid|zoledronic acid|mesh-list
102122099|NCT00412022|Letrozole|letrozole|mesh-list
102122100|NCT00412022|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102122101|NCT00412022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102122102|NCT00412022|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102122103|NCT00412022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102122104|NCT00412022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102122105|NCT00412022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122106|NCT00412022|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102122107|NCT00412022|Hormone Antagonists|hormone antagonists|mesh-ancestor
102122108|NCT00412022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102122109|NCT00412022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122110|NCT00412022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102122111|NCT00412022|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102122112|NCT00412022|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102122113|NCT00412022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102122114|NCT00412022|Luteolytic Agents|luteolytic agents|mesh-ancestor
102122115|NCT00412022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102122116|NCT00412022|Contraceptive Agents|contraceptive agents|mesh-ancestor
102122117|NCT00412022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102122118|NCT00412022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102122119|NCT03474510|Bupivacaine|bupivacaine|mesh-list
102122120|NCT03474510|Ropivacaine|ropivacaine|mesh-list
102122121|NCT03474510|Anesthetics, Local|anesthetics, local|mesh-ancestor
102122122|NCT03474510|Anesthetics|anesthetics|mesh-ancestor
102122123|NCT03474510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102122124|NCT03474510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122125|NCT03474510|Sensory System Agents|sensory system agents|mesh-ancestor
102122126|NCT03474510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102122127|NCT02470832|Itraconazole|itraconazole|mesh-list
102122128|NCT02470832|Antifungal Agents|antifungal agents|mesh-ancestor
102122129|NCT02470832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102122130|NCT02470832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102122131|NCT02470832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102122132|NCT02470832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102122133|NCT02470832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122134|NCT02470832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102122135|NCT02470832|Hormone Antagonists|hormone antagonists|mesh-ancestor
102122136|NCT02470832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102122137|NCT02470832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122138|NCT02470832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102122139|NCT05258682|Acetylcysteine|acetylcysteine|mesh-list
102122140|NCT05258682|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102122141|NCT05258682|Antiviral Agents|antiviral agents|mesh-ancestor
102122142|NCT05258682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102122143|NCT05258682|Expectorants|expectorants|mesh-ancestor
102122144|NCT05258682|Respiratory System Agents|respiratory system agents|mesh-ancestor
102122145|NCT05258682|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102122146|NCT05258682|Antioxidants|antioxidants|mesh-ancestor
102122147|NCT05258682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122148|NCT05258682|Protective Agents|protective agents|mesh-ancestor
102122149|NCT05258682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122151|NCT02228031|Oxytocin|oxytocin|mesh-list
102122152|NCT02228031|Oxytocics|oxytocics|mesh-ancestor
102122153|NCT02228031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102122154|NCT02228031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122155|NCT04458948|Azithromycin|azithromycin|mesh-list
102122156|NCT04458948|Hydroxychloroquine|hydroxychloroquine|mesh-list
102122157|NCT04458948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102122158|NCT04458948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102122159|NCT04458948|Antimalarials|antimalarials|mesh-ancestor
102122160|NCT04458948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102122161|NCT04458948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102122162|NCT04458948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102122163|NCT04458948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122164|NCT04458948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102122165|NCT02232399|Simendan|simendan|mesh-list
102122166|NCT02232399|Milrinone|milrinone|mesh-list
102122167|NCT02232399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102122168|NCT02232399|Vasodilator Agents|vasodilator agents|mesh-ancestor
102122169|NCT02232399|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102122170|NCT02232399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102122171|NCT02232399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102122172|NCT02232399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122173|NCT02232399|Protective Agents|protective agents|mesh-ancestor
102122174|NCT02232399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122175|NCT02232399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102122177|NCT00704522|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102122178|NCT00704522|Antimetabolites|antimetabolites|mesh-ancestor
102122179|NCT00704522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122180|NCT00704522|Antiviral Agents|antiviral agents|mesh-ancestor
102122181|NCT00704522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102122182|NCT04458558|Mifepristone|mifepristone|mesh-list
102122183|NCT04458558|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102122184|NCT04458558|Abortifacient Agents|abortifacient agents|mesh-ancestor
102122185|NCT04458558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102122186|NCT04458558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122187|NCT04458558|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102122188|NCT04458558|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102122189|NCT04458558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102122190|NCT04458558|Contraceptive Agents|contraceptive agents|mesh-ancestor
102122191|NCT04458558|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102122192|NCT04458558|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102122193|NCT04458558|Hormone Antagonists|hormone antagonists|mesh-ancestor
102122194|NCT04458558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102122195|NCT04458558|Luteolytic Agents|luteolytic agents|mesh-ancestor
102122196|NCT04458558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102122197|NCT04458558|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102122198|NCT03478332|Nitroglycerin|nitroglycerin|mesh-list
102122199|NCT03478332|Vasodilator Agents|vasodilator agents|mesh-ancestor
102122200|NCT03930498|Antibodies|antibodies|mesh-list
102122201|NCT03930498|Antibodies, Blocking|antibodies, blocking|mesh-list
102122202|NCT03930498|Immunologic Factors|immunologic factors|mesh-ancestor
102122203|NCT03930498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122204|NCT03817554|Dopamine|dopamine|mesh-list
102122205|NCT03817554|Pramipexole|pramipexole|mesh-list
102122206|NCT03817554|Dopamine Agonists|dopamine agonists|mesh-list
102122207|NCT03817554|Antioxidants|antioxidants|mesh-ancestor
102122208|NCT03817554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122209|NCT03817554|Protective Agents|protective agents|mesh-ancestor
102122210|NCT03817554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122211|NCT03817554|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102122212|NCT03817554|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102122213|NCT03817554|Dopamine Agents|dopamine agents|mesh-ancestor
102122214|NCT03817554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102122215|NCT03817554|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102122216|NCT03817554|Sympathomimetics|sympathomimetics|mesh-ancestor
102122217|NCT03817554|Autonomic Agents|autonomic agents|mesh-ancestor
102122218|NCT03817554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102122219|NCT02223819|Crizotinib|crizotinib|mesh-list
102122220|NCT02223819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102122221|NCT02223819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102122222|NCT02223819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102122223|NCT02223819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122224|NCT02723630|Lenvatinib|lenvatinib|mesh-list
102122225|NCT02723630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102122226|NCT02723630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102122227|NCT02723630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102122228|NCT02723630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122229|NCT02866227|TOL-463|tol-463|mesh-list
102122230|NCT02866227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102122231|NCT05258136|Antibodies|antibodies|mesh-list
102122232|NCT05258136|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102122233|NCT05258136|Immunologic Factors|immunologic factors|mesh-ancestor
102122234|NCT05258136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122235|NCT04356326|Aspirin|aspirin|mesh-list
102122236|NCT04356326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102122237|NCT04356326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102122238|NCT04356326|Analgesics|analgesics|mesh-ancestor
102122239|NCT04356326|Sensory System Agents|sensory system agents|mesh-ancestor
102122240|NCT04356326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102122241|NCT04356326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122242|NCT04356326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102122243|NCT04356326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102122244|NCT04356326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102122245|NCT04356326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102122246|NCT04356326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122247|NCT04356326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102122248|NCT04356326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102122249|NCT04356326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102122250|NCT04356326|Antipyretics|antipyretics|mesh-ancestor
102122252|NCT02224131|Clopidogrel|clopidogrel|mesh-list
102122253|NCT02224131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102122254|NCT02224131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102122255|NCT02224131|Analgesics|analgesics|mesh-ancestor
102122256|NCT02224131|Sensory System Agents|sensory system agents|mesh-ancestor
102122257|NCT02224131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102122258|NCT02224131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122259|NCT02224131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102122260|NCT02224131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102122261|NCT02224131|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102122262|NCT02224131|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102122263|NCT02224131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122264|NCT02224131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102122265|NCT02224131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102122266|NCT02224131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102122267|NCT02224131|Antipyretics|antipyretics|mesh-ancestor
102122268|NCT02224131|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102122269|NCT02224131|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102122270|NCT02224131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102122271|NCT02224131|Purinergic Agents|purinergic agents|mesh-ancestor
102122272|NCT02224131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102122273|NCT02068586|Sunitinib|sunitinib|mesh-list
102122274|NCT02068586|Valproic Acid|valproic acid|mesh-list
102122275|NCT02068586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102122276|NCT02068586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102122277|NCT02068586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102122278|NCT02068586|Growth Substances|growth substances|mesh-ancestor
102122279|NCT02068586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122280|NCT02068586|Growth Inhibitors|growth inhibitors|mesh-ancestor
102122281|NCT02068586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102122282|NCT02068586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102122283|NCT02068586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122284|NCT02068586|Anticonvulsants|anticonvulsants|mesh-ancestor
102122285|NCT02068586|GABA Agents|gaba agents|mesh-ancestor
102122286|NCT02068586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102122287|NCT02068586|Antimanic Agents|antimanic agents|mesh-ancestor
102122288|NCT02068586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102122289|NCT02068586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102122290|NCT02068586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102122291|NCT03473964|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102122292|NCT03473964|Hormones|hormones|mesh-ancestor
102122293|NCT03473964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102122294|NCT03473964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122295|NCT03309644|Iodine|iodine|mesh-list
102122296|NCT03309644|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102122297|NCT03309644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102122298|NCT03309644|Trace Elements|trace elements|mesh-ancestor
102122299|NCT03309644|Micronutrients|micronutrients|mesh-ancestor
102122300|NCT03309644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122301|NCT03478020|Contraceptive Agents|contraceptive agents|mesh-list
102122302|NCT03478020|Contraceptives, Oral|contraceptives, oral|mesh-list
102122303|NCT03478020|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
102122304|NCT03478020|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102122305|NCT03478020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122306|NCT03478020|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102122307|NCT02008292|Physostigmine|physostigmine|mesh-list
102122308|NCT02008292|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102122309|NCT02008292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102122310|NCT02008292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122311|NCT02008292|Cholinergic Agents|cholinergic agents|mesh-ancestor
102122312|NCT02008292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102122313|NCT02008292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122314|NCT02008292|Miotics|miotics|mesh-ancestor
102122315|NCT02008292|Autonomic Agents|autonomic agents|mesh-ancestor
102122316|NCT02008292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102122317|NCT03477864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102122318|NCT03477864|Ipilimumab|ipilimumab|mesh-list
102122319|NCT03477864|Cemiplimab|cemiplimab|mesh-list
102122320|NCT03477864|Antibodies|antibodies|mesh-list
102122321|NCT03477864|Immunoglobulins|immunoglobulins|mesh-list
102122322|NCT03477864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102122323|NCT03477864|Immunologic Factors|immunologic factors|mesh-ancestor
102122324|NCT03477864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122325|NCT03477864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102122326|NCT03477864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102122327|NCT03477864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122328|NCT02229045|Paclitaxel|paclitaxel|mesh-list
102122329|NCT02229045|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102122330|NCT02229045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102122331|NCT02229045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102122332|NCT02229045|Tubulin Modulators|tubulin modulators|mesh-ancestor
102122333|NCT02229045|Antimitotic Agents|antimitotic agents|mesh-ancestor
102122334|NCT02229045|Mitosis Modulators|mitosis modulators|mesh-ancestor
102122335|NCT02229045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122336|NCT02229123|Levetiracetam|levetiracetam|mesh-list
102122337|NCT02229123|Anticonvulsants|anticonvulsants|mesh-ancestor
102122338|NCT02229123|Nootropic Agents|nootropic agents|mesh-ancestor
102122339|NCT02229201|Propofol|propofol|mesh-list
102122340|NCT02229201|Sevoflurane|sevoflurane|mesh-list
102122341|NCT02229201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102122342|NCT02229201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102122343|NCT02229201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122344|NCT02229201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102122345|NCT02229201|Anesthetics, General|anesthetics, general|mesh-ancestor
102122346|NCT02229201|Anesthetics|anesthetics|mesh-ancestor
102122347|NCT02229201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102122348|NCT02229201|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102122349|NCT02224443|Fentanyl|fentanyl|mesh-list
102122350|NCT02224443|Midazolam|midazolam|mesh-list
102122351|NCT02224443|Dexmedetomidine|dexmedetomidine|mesh-list
102122352|NCT02224443|Remifentanil|remifentanil|mesh-list
102122353|NCT02224443|Propofol|propofol|mesh-list
102122354|NCT02224443|Etomidate|etomidate|mesh-list
102122355|NCT02224443|Sevoflurane|sevoflurane|mesh-list
102122356|NCT02224443|Atracurium|atracurium|mesh-list
102122357|NCT02224443|Cisatracurium|cisatracurium|mesh-list
102122358|NCT02224443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102122359|NCT02224443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102122360|NCT02224443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122361|NCT02224443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102122362|NCT02224443|Analgesics|analgesics|mesh-ancestor
102122363|NCT02224443|Sensory System Agents|sensory system agents|mesh-ancestor
102122364|NCT02224443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102122365|NCT02224443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102122366|NCT02224443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102122367|NCT02224443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102122368|NCT02224443|Adrenergic Agents|adrenergic agents|mesh-ancestor
102122369|NCT02224443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102122370|NCT02224443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122371|NCT02224443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102122372|NCT02224443|Anesthetics, General|anesthetics, general|mesh-ancestor
102122373|NCT02224443|Anesthetics|anesthetics|mesh-ancestor
102122374|NCT02224443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102122375|NCT02224443|Narcotics|narcotics|mesh-ancestor
102122376|NCT02224443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102122377|NCT02224443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102122378|NCT02224443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102122379|NCT02224443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102122380|NCT02224443|GABA Modulators|gaba modulators|mesh-ancestor
102122381|NCT02224443|GABA Agents|gaba agents|mesh-ancestor
102122382|NCT02224443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102122383|NCT02224443|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102122384|NCT02224443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102122385|NCT02224443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102122386|NCT02224443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102122387|NCT02224443|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102122388|NCT02224443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102122389|NCT02224443|Cholinergic Agents|cholinergic agents|mesh-ancestor
102122390|NCT01944800|Ticagrelor|ticagrelor|mesh-list
102122391|NCT01944800|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102122392|NCT01944800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102122393|NCT01944800|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102122394|NCT01944800|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102122395|NCT01944800|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102122396|NCT01944800|Purinergic Agents|purinergic agents|mesh-ancestor
102122397|NCT01944800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102122398|NCT01944800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122399|NCT01944800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122400|NCT03617367|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102122401|NCT03617367|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102122402|NCT03617367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102122403|NCT03617367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102122404|NCT03617367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122405|NCT03617367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102122406|NCT03617367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102122407|NCT03617367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122408|NCT03617367|Cholinergic Agents|cholinergic agents|mesh-ancestor
102122409|NCT03617367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102122410|NCT02470676|Progesterone|progesterone|mesh-list
102122411|NCT02470676|Progestins|progestins|mesh-ancestor
102122412|NCT02470676|Hormones|hormones|mesh-ancestor
102122413|NCT02470676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102122414|NCT02470676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122415|NCT01933724|Prednisone|prednisone|mesh-list
102122416|NCT01933724|Glucocorticoids|glucocorticoids|mesh-list
102122417|NCT01933724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102122418|NCT01933724|Hormones|hormones|mesh-ancestor
102122419|NCT01933724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102122420|NCT01933724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122421|NCT01933724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102122422|NCT01933724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102122423|NCT02229747|Diclofenac|diclofenac|mesh-list
102122424|NCT02229747|Meloxicam|meloxicam|mesh-list
102122425|NCT02229747|Nimesulide|nimesulide|mesh-list
102122426|NCT02229747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102122427|NCT02229747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102122428|NCT02229747|Analgesics|analgesics|mesh-ancestor
102122429|NCT02229747|Sensory System Agents|sensory system agents|mesh-ancestor
102122430|NCT02229747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102122431|NCT02229747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122432|NCT02229747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102122433|NCT02229747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102122434|NCT02229747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102122435|NCT02229747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102122436|NCT02229747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122437|NCT02229747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102122438|NCT02232789|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
102122439|NCT02232789|Hallucinogens|hallucinogens|mesh-ancestor
102122440|NCT02232789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122441|NCT02232789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102122442|NCT02232789|Serotonin Agents|serotonin agents|mesh-ancestor
102122443|NCT02232789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102122444|NCT02232789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122445|NCT02232789|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102122446|NCT02232789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102122447|NCT02232789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102122448|NCT02232789|Adrenergic Agents|adrenergic agents|mesh-ancestor
102122449|NCT03030222|Empagliflozin|empagliflozin|mesh-list
101831451|NCT03283917|Dexamethasone|dexamethasone|mesh-list
102122450|NCT03030222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102122451|NCT03030222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122452|NCT03030222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102122453|NCT03030222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122454|NCT02232945|Oseltamivir|oseltamivir|mesh-list
102122455|NCT02232945|Antiviral Agents|antiviral agents|mesh-ancestor
102122456|NCT02232945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102122457|NCT02232945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102122458|NCT02232945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122459|NCT02546622|Factor VIII|factor viii|mesh-list
102122460|NCT02546622|Coagulants|coagulants|mesh-ancestor
102122461|NCT02229825|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102122462|NCT02229825|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102122463|NCT02229825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102122464|NCT02229825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102122465|NCT02229825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122466|NCT02229825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102122467|NCT02229825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122468|NCT02229825|Analgesics|analgesics|mesh-ancestor
102122469|NCT02229825|Sensory System Agents|sensory system agents|mesh-ancestor
102122470|NCT02229825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102122471|NCT02229825|Antidepressive Agents|antidepressive agents|mesh-ancestor
102122472|NCT02229825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102535870|NCT05339373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102122473|NCT02229825|Dopamine Agents|dopamine agents|mesh-ancestor
102122474|NCT03309566|Tenofovir|tenofovir|mesh-list
102122475|NCT03309566|Emtricitabine|emtricitabine|mesh-list
102122476|NCT03309566|Efavirenz|efavirenz|mesh-list
102122477|NCT03309566|Antiviral Agents|antiviral agents|mesh-ancestor
102122478|NCT03309566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102122479|NCT03309566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102122480|NCT03309566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102122481|NCT03309566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102122482|NCT03309566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122483|NCT03309566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102122484|NCT03309566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102122485|NCT03309566|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102122486|NCT03309566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102122487|NCT03309566|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102122488|NCT03309566|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102122489|NCT03309566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102122490|NCT03309566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102122492|NCT00735657|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102122493|NCT00735657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102122494|NCT00735657|Trace Elements|trace elements|mesh-ancestor
102122495|NCT00735657|Micronutrients|micronutrients|mesh-ancestor
102122496|NCT00735657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122497|NCT04030143|Aripiprazole|aripiprazole|mesh-list
102122498|NCT04030143|Antidepressive Agents|antidepressive agents|mesh-ancestor
102122499|NCT04030143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102122500|NCT04030143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102122501|NCT04030143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102122502|NCT04030143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102122503|NCT04030143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122504|NCT04030143|Dopamine Agonists|dopamine agonists|mesh-ancestor
102122505|NCT04030143|Dopamine Agents|dopamine agents|mesh-ancestor
102122506|NCT04030143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102122507|NCT04030143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122508|NCT04030143|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102122509|NCT04030143|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102122510|NCT04030143|Serotonin Agents|serotonin agents|mesh-ancestor
102122511|NCT04030143|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102122512|NCT04030143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102122513|NCT04030143|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102122514|NCT04030143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102122515|NCT02470442|Sevoflurane|sevoflurane|mesh-list
102122516|NCT02470442|Desflurane|desflurane|mesh-list
102122517|NCT02470442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102122518|NCT02470442|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102122519|NCT02470442|Anesthetics, General|anesthetics, general|mesh-ancestor
102122520|NCT02470442|Anesthetics|anesthetics|mesh-ancestor
102122521|NCT02470442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101831528|NCT03146962|Protective Agents|protective agents|mesh-ancestor
102122522|NCT02470442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122523|NCT01329939|Montelukast|montelukast|mesh-list
102122524|NCT01329939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102122525|NCT01329939|Respiratory System Agents|respiratory system agents|mesh-ancestor
102122526|NCT01329939|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102122527|NCT01329939|Hormone Antagonists|hormone antagonists|mesh-ancestor
102122528|NCT01329939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102122529|NCT01329939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122530|NCT01329939|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102122531|NCT01329939|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102122532|NCT01329939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122533|NCT02499900|Glatiramer Acetate|glatiramer acetate|mesh-list
102122534|NCT02499900|(T,G)-A-L|(t,g)-a-l|mesh-list
102122535|NCT02499900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102122536|NCT02499900|Immunologic Factors|immunologic factors|mesh-ancestor
102122537|NCT02499900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122538|NCT02499900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102122539|NCT02499900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102122540|NCT04554693|Metronidazole|metronidazole|mesh-list
102122541|NCT04554693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102122542|NCT04554693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102122543|NCT04554693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102122544|NCT04554693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102122545|NCT02230371|Granisetron|granisetron|mesh-list
102122546|NCT02230371|Antiemetics|antiemetics|mesh-ancestor
102122547|NCT02230371|Autonomic Agents|autonomic agents|mesh-ancestor
102122548|NCT02230371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102122549|NCT02230371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122550|NCT02230371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102122551|NCT02230371|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102122552|NCT02230371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102122553|NCT02230371|Serotonin Agents|serotonin agents|mesh-ancestor
102122554|NCT02230371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102122555|NCT02230371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122556|NCT03313934|Hyaluronic Acid|hyaluronic acid|mesh-list
102122557|NCT03313934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102122558|NCT03313934|Immunologic Factors|immunologic factors|mesh-ancestor
102122559|NCT03313934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122560|NCT03313934|Viscosupplements|viscosupplements|mesh-ancestor
102122561|NCT03313934|Protective Agents|protective agents|mesh-ancestor
102122562|NCT03313856|Magnesium Oxide|magnesium oxide|mesh-list
102122563|NCT03313856|Antacids|antacids|mesh-ancestor
102122564|NCT03313856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122565|NCT03313856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102122566|NCT05137626|Digoxin|digoxin|mesh-list
102122567|NCT05137626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102122568|NCT05137626|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102122569|NCT05137626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102122570|NCT05137626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122571|NCT05137626|Protective Agents|protective agents|mesh-ancestor
102122572|NCT05137626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122573|NCT02233023|Dopamine|dopamine|mesh-list
102122574|NCT02233023|Pramipexole|pramipexole|mesh-list
102122575|NCT02233023|Bromocriptine|bromocriptine|mesh-list
102122576|NCT02233023|Dopamine Agonists|dopamine agonists|mesh-list
102122577|NCT02233023|Antioxidants|antioxidants|mesh-ancestor
102122578|NCT02233023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122579|NCT02233023|Protective Agents|protective agents|mesh-ancestor
102122580|NCT02233023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122581|NCT02233023|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102122582|NCT02233023|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102122583|NCT02233023|Dopamine Agents|dopamine agents|mesh-ancestor
102122584|NCT02233023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102122585|NCT02233023|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102122586|NCT02233023|Sympathomimetics|sympathomimetics|mesh-ancestor
102122587|NCT02233023|Autonomic Agents|autonomic agents|mesh-ancestor
102122588|NCT02233023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102122589|NCT02233023|Hormone Antagonists|hormone antagonists|mesh-ancestor
102122590|NCT02233023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102122591|NCT03710642|Prazosin|prazosin|mesh-list
102122592|NCT03710642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102122593|NCT03710642|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102122594|NCT03710642|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102122595|NCT03710642|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101831604|NCT02813135|Cytarabine|cytarabine|mesh-list
102122596|NCT03710642|Adrenergic Agents|adrenergic agents|mesh-ancestor
102122597|NCT03710642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102122598|NCT03710642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122599|NCT03710642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122600|NCT02259309|Misoprostol|misoprostol|mesh-list
102122601|NCT02259309|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102122602|NCT02259309|Abortifacient Agents|abortifacient agents|mesh-ancestor
102122603|NCT02259309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102122604|NCT02259309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122605|NCT02259309|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102122606|NCT02259309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102122607|NCT02259309|Oxytocics|oxytocics|mesh-ancestor
102122608|NCT04459026|Ropivacaine|ropivacaine|mesh-list
102122609|NCT04459026|Anesthetics, Local|anesthetics, local|mesh-ancestor
102122610|NCT04459026|Anesthetics|anesthetics|mesh-ancestor
102122611|NCT04459026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102122612|NCT04459026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122613|NCT04459026|Sensory System Agents|sensory system agents|mesh-ancestor
102122614|NCT04459026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102122615|NCT03473418|Ketoconazole|ketoconazole|mesh-list
102122616|NCT03473418|Terconazole|terconazole|mesh-list
102122617|NCT03473418|Antifungal Agents|antifungal agents|mesh-ancestor
102122618|NCT03473418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102122619|NCT03473418|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102122620|NCT03473418|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102122621|NCT03473418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102122622|NCT03473418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122623|NCT03473418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102122624|NCT03473418|Hormone Antagonists|hormone antagonists|mesh-ancestor
102122625|NCT03473418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102122626|NCT03473418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122627|NCT03473418|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102122629|NCT04282278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102122630|NCT04282278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102122631|NCT04282278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102122632|NCT04282278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122633|NCT00705224|Interferons|interferons|mesh-list
102122634|NCT00705224|Ribavirin|ribavirin|mesh-list
102122635|NCT00705224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102122636|NCT00705224|Antiviral Agents|antiviral agents|mesh-ancestor
102122637|NCT00705224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102122638|NCT00705224|Antimetabolites|antimetabolites|mesh-ancestor
102122639|NCT00705224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122640|NCT02457156|Octreotide|octreotide|mesh-list
102122641|NCT02457156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102122642|NCT02457156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102122643|NCT02457156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102122644|NCT02523300|Methylprednisolone|methylprednisolone|mesh-list
102122645|NCT02523300|Glucocorticoids|glucocorticoids|mesh-list
102122646|NCT02523300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102122647|NCT02523300|Antiemetics|antiemetics|mesh-ancestor
102122648|NCT02523300|Autonomic Agents|autonomic agents|mesh-ancestor
102122649|NCT02523300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102122650|NCT02523300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122651|NCT02523300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102122652|NCT02523300|Hormones|hormones|mesh-ancestor
102122653|NCT02523300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102122654|NCT02523300|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102122655|NCT02523300|Protective Agents|protective agents|mesh-ancestor
102122656|NCT02325960|Insulin Glargine|insulin glargine|mesh-list
102122657|NCT02325960|Exenatide|exenatide|mesh-list
102122658|NCT02325960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102122659|NCT02325960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122660|NCT02325960|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102122661|NCT02325960|Incretins|incretins|mesh-ancestor
102122662|NCT02325960|Hormones|hormones|mesh-ancestor
102122663|NCT02325960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102122664|NCT05265650|Nivolumab|nivolumab|mesh-list
102122665|NCT05265650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102122666|NCT05265650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102122667|NCT05265650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102122668|NCT05265650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122669|NCT02234349|Pancrelipase|pancrelipase|mesh-list
102122670|NCT02234349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102122671|NCT04458636|Prednisolone|prednisolone|mesh-list
102122672|NCT04458636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102122673|NCT04458636|Glucocorticoids|glucocorticoids|mesh-ancestor
102122674|NCT04458636|Hormones|hormones|mesh-ancestor
102122675|NCT04458636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102122676|NCT04458636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122677|NCT04458636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102122678|NCT04458636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102122679|NCT03304652|Zaleplon|zaleplon|mesh-list
102122680|NCT03304652|Anticonvulsants|anticonvulsants|mesh-ancestor
102122681|NCT03304652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102122682|NCT03304652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102122683|NCT03304652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122684|NCT03304652|GABA Modulators|gaba modulators|mesh-ancestor
102122685|NCT03304652|GABA Agents|gaba agents|mesh-ancestor
102122686|NCT03304652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102122687|NCT03304652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122688|NCT03162783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102122689|NCT03162783|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102122690|NCT02523144|Dexmedetomidine|dexmedetomidine|mesh-list
102122691|NCT02523144|Chloral Hydrate|chloral hydrate|mesh-list
102122692|NCT02523144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102122693|NCT02523144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102122694|NCT02523144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122695|NCT02523144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102122696|NCT02523144|Analgesics|analgesics|mesh-ancestor
102122697|NCT02523144|Sensory System Agents|sensory system agents|mesh-ancestor
102122698|NCT02523144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102122699|NCT02523144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102122700|NCT02523144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102122701|NCT02523144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102122702|NCT02523144|Adrenergic Agents|adrenergic agents|mesh-ancestor
102122703|NCT02523144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102122704|NCT02523144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122705|NCT00704132|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102122706|NCT00704132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102122707|NCT00704132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122708|NCT00704132|Incretins|incretins|mesh-ancestor
102122709|NCT00704132|Hormones|hormones|mesh-ancestor
102122710|NCT00704132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102122711|NCT00704132|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102122712|NCT00704132|Protease Inhibitors|protease inhibitors|mesh-ancestor
102122713|NCT00704132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102122714|NCT00704132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122715|NCT03304496|Nitroglycerin|nitroglycerin|mesh-list
102122716|NCT03304496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102122717|NCT03304496|Vasodilator Agents|vasodilator agents|mesh-ancestor
102122718|NCT03840837|Rivastigmine|rivastigmine|mesh-list
102122719|NCT03840837|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102122720|NCT03840837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102122721|NCT03840837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122722|NCT03840837|Cholinergic Agents|cholinergic agents|mesh-ancestor
102122723|NCT03840837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102122724|NCT03840837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122725|NCT03840837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102122726|NCT03840837|Protective Agents|protective agents|mesh-ancestor
102122727|NCT03527238|Tacrolimus|tacrolimus|mesh-list
102122728|NCT03527238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102122729|NCT03527238|Immunologic Factors|immunologic factors|mesh-ancestor
102122730|NCT03527238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122731|NCT03527238|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102122732|NCT03527238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102122733|NCT03527238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122734|NCT03832179|Dexamethasone|dexamethasone|mesh-list
102122735|NCT03832179|Bevacizumab|bevacizumab|mesh-list
102122736|NCT03832179|Ranibizumab|ranibizumab|mesh-list
102122737|NCT03832179|Aflibercept|aflibercept|mesh-list
102122738|NCT03832179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102122739|NCT03832179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102122740|NCT03832179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102122741|NCT03832179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102122742|NCT03832179|Growth Substances|growth substances|mesh-ancestor
102122743|NCT03832179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122744|NCT03832179|Growth Inhibitors|growth inhibitors|mesh-ancestor
102122745|NCT03832179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102122746|NCT03832179|Antiemetics|antiemetics|mesh-ancestor
102122747|NCT03832179|Autonomic Agents|autonomic agents|mesh-ancestor
102122748|NCT03832179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102122749|NCT03832179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102122750|NCT03832179|Glucocorticoids|glucocorticoids|mesh-ancestor
102122751|NCT03832179|Hormones|hormones|mesh-ancestor
102122752|NCT03832179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102122753|NCT03832179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102122754|NCT03123783|Nivolumab|nivolumab|mesh-list
102122755|NCT03123783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102122756|NCT03123783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102122757|NCT03123783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102021312|NCT02436226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122758|NCT03123783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122759|NCT05154396|Loperamide|loperamide|mesh-list
102122760|NCT05154396|Antidiarrheals|antidiarrheals|mesh-ancestor
102122761|NCT05154396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102122762|NCT04740645|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
102122763|NCT04740645|Hemostatics|hemostatics|mesh-ancestor
102122764|NCT04740645|Coagulants|coagulants|mesh-ancestor
102122765|NCT04740645|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102122766|NCT04740645|Natriuretic Agents|natriuretic agents|mesh-ancestor
102122767|NCT04740645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122768|NCT04735185|Anesthetics|anesthetics|mesh-list
102122769|NCT04735185|Anesthetics, Local|anesthetics, local|mesh-list
102122770|NCT04735185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102122771|NCT04735185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122772|NCT04735185|Sensory System Agents|sensory system agents|mesh-ancestor
102122773|NCT04735185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102122775|NCT02802813|Piperaquine|piperaquine|mesh-list
102122776|NCT02802813|Artenimol|artenimol|mesh-list
102122777|NCT02802813|Artemisinins|artemisinins|mesh-list
102122778|NCT02802813|Antimalarials|antimalarials|mesh-ancestor
102122779|NCT02802813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102122780|NCT02802813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102122781|NCT02802813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102122782|NCT05134584|Lactulose|lactulose|mesh-list
102122783|NCT05134584|Linaclotide|linaclotide|mesh-list
102122784|NCT05134584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102122785|NCT05134584|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102122786|NCT05134584|Enzyme Activators|enzyme activators|mesh-ancestor
102122787|NCT05134584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122788|NCT05633277|Polidocanol|polidocanol|mesh-list
102122789|NCT05633277|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102122790|NCT05633277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102122791|NCT03312140|Choline|choline|mesh-list
102122792|NCT03312140|Lipotropic Agents|lipotropic agents|mesh-ancestor
102122793|NCT03312140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102122794|NCT03312140|Antimetabolites|antimetabolites|mesh-ancestor
102122795|NCT03312140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122796|NCT03312140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102122797|NCT03312140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102122798|NCT03312140|Nootropic Agents|nootropic agents|mesh-ancestor
102122799|NCT02233179|Calpastatin|calpastatin|mesh-list
102122800|NCT02233179|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
102122801|NCT02233179|Protease Inhibitors|protease inhibitors|mesh-ancestor
102122802|NCT02233179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102122803|NCT02233179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122804|NCT03311984|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102122805|NCT03311984|Dalteparin|dalteparin|mesh-list
102122806|NCT03311984|Anticoagulants|anticoagulants|mesh-ancestor
102122807|NCT03311984|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102122808|NCT03311984|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102122809|NCT03311984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122810|NCT03311906|Hyaluronic Acid|hyaluronic acid|mesh-list
102122811|NCT03311906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102122812|NCT03311906|Immunologic Factors|immunologic factors|mesh-ancestor
102122813|NCT03311906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122814|NCT03311906|Viscosupplements|viscosupplements|mesh-ancestor
102122815|NCT03311906|Protective Agents|protective agents|mesh-ancestor
102122816|NCT04554459|Ponatinib|ponatinib|mesh-list
102122817|NCT04554459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102122818|NCT04554459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102122819|NCT04554459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102122820|NCT04554459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831837|NCT01806571|Cytarabine|cytarabine|mesh-list
102122822|NCT03311750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102122823|NCT03311750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102122824|NCT03311672|Pembrolizumab|pembrolizumab|mesh-list
102122825|NCT03311672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102122826|NCT03311672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102122827|NCT03311672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102122828|NCT03311672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122829|NCT03311516|Insulin|insulin|mesh-list
102122830|NCT03311516|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102122831|NCT03311516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102122832|NCT03311516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122833|NCT04528329|Dexamethasone|dexamethasone|mesh-list
102122834|NCT04528329|Dexamethasone acetate|dexamethasone acetate|mesh-list
102122835|NCT04528329|BB 1101|bb 1101|mesh-list
102122836|NCT04528329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102122837|NCT04528329|Antiemetics|antiemetics|mesh-ancestor
102122838|NCT04528329|Autonomic Agents|autonomic agents|mesh-ancestor
102122839|NCT04528329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102122840|NCT04528329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122841|NCT04528329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102122842|NCT04528329|Glucocorticoids|glucocorticoids|mesh-ancestor
102122843|NCT04528329|Hormones|hormones|mesh-ancestor
102122844|NCT04528329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102122845|NCT04528329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102122846|NCT04528329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102122847|NCT04528329|Protease Inhibitors|protease inhibitors|mesh-ancestor
102065533|NCT02202512|Histamine Agents|histamine agents|mesh-ancestor
102122849|NCT04528329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122850|NCT02811939|Dronabinol|dronabinol|mesh-list
102122851|NCT02811939|Hallucinogens|hallucinogens|mesh-ancestor
102122852|NCT02811939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122853|NCT02811939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102122854|NCT02811939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102122855|NCT02811939|Analgesics|analgesics|mesh-ancestor
102122856|NCT02811939|Sensory System Agents|sensory system agents|mesh-ancestor
102122857|NCT02811939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102122858|NCT02811939|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102122859|NCT02811939|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102122860|NCT02811939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102122861|NCT02811939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122862|NCT02811939|Hormones|hormones|mesh-ancestor
102122863|NCT02811939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102122864|NCT01329549|Carboplatin|carboplatin|mesh-list
102122865|NCT01329549|Nintedanib|nintedanib|mesh-list
102122866|NCT01329549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102122867|NCT01329549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102122868|NCT01329549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102122869|NCT01329549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122870|NCT02234739|Voriconazole|voriconazole|mesh-list
102122871|NCT02234739|Antifungal Agents|antifungal agents|mesh-ancestor
102122872|NCT02234739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102122873|NCT02234739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102122874|NCT02234739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102122875|NCT02234739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102122876|NCT02234739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122877|NCT02234739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102122878|NCT02234739|Hormone Antagonists|hormone antagonists|mesh-ancestor
102122879|NCT02234739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102122880|NCT02234739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122881|NCT02234739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102122882|NCT02736474|Naltrexone|naltrexone|mesh-list
102122883|NCT02736474|Bupropion|bupropion|mesh-list
102122884|NCT02736474|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102122885|NCT02736474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102122886|NCT02736474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122887|NCT02736474|Sensory System Agents|sensory system agents|mesh-ancestor
102122888|NCT02736474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102122889|NCT02736474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102122890|NCT02736474|Antidepressive Agents|antidepressive agents|mesh-ancestor
102122891|NCT02736474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102122892|NCT02736474|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101831915|NCT00999037|Sevelamer|sevelamer|mesh-list
102122893|NCT02736474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102122894|NCT02736474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102122895|NCT02736474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122896|NCT02736474|Dopamine Agents|dopamine agents|mesh-ancestor
102122897|NCT02736474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102122898|NCT02736474|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102122899|NCT02736474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102122900|NCT02736474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102122902|NCT03302390|Epinephrine|epinephrine|mesh-list
102122903|NCT03302390|Anesthetics, Local|anesthetics, local|mesh-ancestor
102122904|NCT03302390|Anesthetics|anesthetics|mesh-ancestor
102122905|NCT03302390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102122906|NCT03302390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122907|NCT03302390|Sensory System Agents|sensory system agents|mesh-ancestor
102122908|NCT03302390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102122909|NCT03302390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102122910|NCT03302390|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102122911|NCT03302390|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102122912|NCT03302390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102122913|NCT03302390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122914|NCT03302390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102122915|NCT03302390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102122916|NCT03302390|Adrenergic Agents|adrenergic agents|mesh-ancestor
102122917|NCT03302390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102122918|NCT03302390|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102122919|NCT03302390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102122920|NCT03302390|Autonomic Agents|autonomic agents|mesh-ancestor
102122921|NCT03302390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102122922|NCT03302390|Respiratory System Agents|respiratory system agents|mesh-ancestor
102122923|NCT03302390|Mydriatics|mydriatics|mesh-ancestor
102122924|NCT03302390|Sympathomimetics|sympathomimetics|mesh-ancestor
102122925|NCT03302390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102122926|NCT03712371|Chitosan|chitosan|mesh-list
102122927|NCT03712371|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102122928|NCT03712371|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102122929|NCT03712371|Antimetabolites|antimetabolites|mesh-ancestor
102122930|NCT03712371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122931|NCT03712371|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102122932|NCT03712371|Chelating Agents|chelating agents|mesh-ancestor
102122933|NCT03712371|Sequestering Agents|sequestering agents|mesh-ancestor
102122934|NCT03712371|Hemostatics|hemostatics|mesh-ancestor
102122935|NCT03712371|Coagulants|coagulants|mesh-ancestor
102122936|NCT03472950|Ranolazine|ranolazine|mesh-list
102122937|NCT03472950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102122938|NCT03472950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102122939|NCT03472950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122940|NCT03706521|Lorecivivint|lorecivivint|mesh-list
102122941|NCT03706521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102122942|NCT02259543|Tetracycline|tetracycline|mesh-list
102122943|NCT02259543|Citric Acid|citric acid|mesh-list
102122944|NCT02259543|Sodium Citrate|sodium citrate|mesh-list
102122945|NCT02259543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102122946|NCT02259543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102122947|NCT02259543|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102122948|NCT02259543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102122949|NCT02259543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122950|NCT02259543|Anticoagulants|anticoagulants|mesh-ancestor
102122951|NCT02259543|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102122952|NCT02259543|Chelating Agents|chelating agents|mesh-ancestor
102122953|NCT02259543|Sequestering Agents|sequestering agents|mesh-ancestor
102122954|NCT03301454|Paclitaxel|paclitaxel|mesh-list
102122955|NCT03301454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102122956|NCT03301454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102122957|NCT03301454|Tubulin Modulators|tubulin modulators|mesh-ancestor
102122958|NCT03301454|Antimitotic Agents|antimitotic agents|mesh-ancestor
102122959|NCT03301454|Mitosis Modulators|mitosis modulators|mesh-ancestor
102122960|NCT03301454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122961|NCT04343235|Labetalol|labetalol|mesh-list
102122962|NCT04343235|Furosemide|furosemide|mesh-list
102122963|NCT04343235|Diuretics|diuretics|mesh-ancestor
102122964|NCT04343235|Natriuretic Agents|natriuretic agents|mesh-ancestor
102122965|NCT04343235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122966|NCT04343235|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102122967|NCT04343235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102122968|NCT04343235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122969|NCT04343235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102122970|NCT04343235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102122971|NCT04343235|Adrenergic Agents|adrenergic agents|mesh-ancestor
102122972|NCT04343235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102122973|NCT04343235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102122974|NCT04343235|Sympathomimetics|sympathomimetics|mesh-ancestor
102122975|NCT04343235|Autonomic Agents|autonomic agents|mesh-ancestor
102122976|NCT04343235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102122977|NCT04343235|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102122978|NCT04343235|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102122979|NCT05727410|Docetaxel|docetaxel|mesh-list
102122980|NCT05727410|Nivolumab|nivolumab|mesh-list
102122981|NCT05727410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102122982|NCT05727410|Tubulin Modulators|tubulin modulators|mesh-ancestor
102122983|NCT05727410|Antimitotic Agents|antimitotic agents|mesh-ancestor
102122984|NCT05727410|Mitosis Modulators|mitosis modulators|mesh-ancestor
102122985|NCT05727410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122986|NCT05727410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102122987|NCT05727410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102122988|NCT02467010|Dexamethasone|dexamethasone|mesh-list
102122989|NCT02467010|Cyclophosphamide|cyclophosphamide|mesh-list
102122990|NCT02467010|Bortezomib|bortezomib|mesh-list
102122991|NCT02467010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102122992|NCT02467010|Immunologic Factors|immunologic factors|mesh-ancestor
102122993|NCT02467010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102122994|NCT02467010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102122995|NCT02467010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102122996|NCT02467010|Alkylating Agents|alkylating agents|mesh-ancestor
102122997|NCT02467010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102122998|NCT02467010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102122999|NCT02467010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102123000|NCT02467010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102123001|NCT02467010|Antiemetics|antiemetics|mesh-ancestor
102123002|NCT02467010|Autonomic Agents|autonomic agents|mesh-ancestor
102123003|NCT02467010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102123004|NCT02467010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102123005|NCT02467010|Glucocorticoids|glucocorticoids|mesh-ancestor
102123006|NCT02467010|Hormones|hormones|mesh-ancestor
102123007|NCT02467010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102123008|NCT02467010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102123009|NCT02232555|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102123010|NCT02232555|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102123011|NCT02232555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102123012|NCT02232555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102123013|NCT02232555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123014|NCT02232555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102123015|NCT02232555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123016|NCT02232555|Analgesics|analgesics|mesh-ancestor
102123017|NCT02232555|Sensory System Agents|sensory system agents|mesh-ancestor
102123018|NCT02232555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102123019|NCT02232555|Antidepressive Agents|antidepressive agents|mesh-ancestor
102123020|NCT02232555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102123021|NCT02232555|Dopamine Agents|dopamine agents|mesh-ancestor
102123022|NCT02235519|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
102123023|NCT02235519|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102123024|NCT02235519|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102123025|NCT02235519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123026|NCT00702650|Testosterone|testosterone|mesh-list
102123027|NCT00702650|Androgens|androgens|mesh-ancestor
102123028|NCT00702650|Hormones|hormones|mesh-ancestor
102123029|NCT00702650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102123030|NCT00702650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123031|NCT03230916|Relebactam|relebactam|mesh-list
102123032|NCT03230916|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102123033|NCT03230916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102123034|NCT03230916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123035|NCT03230916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102123036|NCT03230916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102123037|NCT04210713|Minocycline|minocycline|mesh-list
102123038|NCT04210713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102123039|NCT04210713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101832062|NCT00530348|Immunologic Factors|immunologic factors|mesh-ancestor
102123040|NCT01337115|Ropivacaine|ropivacaine|mesh-list
102123041|NCT01337115|Anesthetics, Local|anesthetics, local|mesh-list
102123042|NCT01337115|Anesthetics|anesthetics|mesh-list
102123043|NCT01337115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102123044|NCT01337115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123045|NCT01337115|Sensory System Agents|sensory system agents|mesh-ancestor
102123046|NCT01337115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102123047|NCT03761784|Tretinoin|tretinoin|mesh-list
102123048|NCT03761784|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102123049|NCT03761784|Dermatologic Agents|dermatologic agents|mesh-ancestor
102123050|NCT03761784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102123051|NCT03761784|Keratolytic Agents|keratolytic agents|mesh-ancestor
102123052|NCT03300440|Vitamins|vitamins|mesh-list
102123054|NCT03300440|Vitamin B Complex|vitamin b complex|mesh-list
102123055|NCT03300440|Micronutrients|micronutrients|mesh-ancestor
102123056|NCT03300440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123057|NCT02236065|Lenograstim|lenograstim|mesh-list
102123058|NCT02236065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102123059|NCT02236065|Immunologic Factors|immunologic factors|mesh-ancestor
102123060|NCT02236065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123061|NCT02467556|Morphine|morphine|mesh-list
102123062|NCT02467556|Memantine|memantine|mesh-list
102123063|NCT02467556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102123064|NCT02467556|Narcotics|narcotics|mesh-ancestor
102123065|NCT02467556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102123066|NCT02467556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123067|NCT02467556|Analgesics|analgesics|mesh-ancestor
102123068|NCT02467556|Sensory System Agents|sensory system agents|mesh-ancestor
102123069|NCT02467556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102123071|NCT02467556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102123072|NCT02467556|Dopamine Agents|dopamine agents|mesh-ancestor
102123073|NCT02467556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102123074|NCT02467556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123075|NCT02467556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102123076|NCT02467556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102123077|NCT02262585|Telmisartan|telmisartan|mesh-list
102123078|NCT02262585|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102123079|NCT02262585|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102123080|NCT02262585|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102123081|NCT02262585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123082|NCT03309176|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102123083|NCT03309176|Medroxyprogesterone|medroxyprogesterone|mesh-list
102123084|NCT03309176|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102123085|NCT03309176|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102123086|NCT03309176|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102123087|NCT03309176|Contraceptive Agents|contraceptive agents|mesh-ancestor
102123088|NCT03309176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102123089|NCT03309176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123090|NCT03309176|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102123091|NCT03309176|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102123092|NCT03309176|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102123093|NCT03309176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102123094|NCT03309176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102123095|NCT02602353|Loxoprofen|loxoprofen|mesh-list
102123096|NCT02602353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102021664|NCT02800824|Budesonide|budesonide|mesh-list
102123097|NCT02602353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102123098|NCT02602353|Analgesics|analgesics|mesh-ancestor
102123099|NCT02602353|Sensory System Agents|sensory system agents|mesh-ancestor
102123100|NCT02602353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102123101|NCT02602353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123102|NCT02602353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102123103|NCT02602353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102123104|NCT04983498|Ondansetron|ondansetron|mesh-list
102123105|NCT04983498|Antiemetics|antiemetics|mesh-ancestor
102123106|NCT04983498|Autonomic Agents|autonomic agents|mesh-ancestor
102123107|NCT04983498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102123108|NCT04983498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123109|NCT04983498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102123110|NCT04983498|Antipruritics|antipruritics|mesh-ancestor
102123111|NCT04983498|Dermatologic Agents|dermatologic agents|mesh-ancestor
102123112|NCT04983498|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102123113|NCT04983498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102123114|NCT04983498|Serotonin Agents|serotonin agents|mesh-ancestor
102123115|NCT04983498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102123116|NCT04983498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123117|NCT03300362|Vaccines|vaccines|mesh-list
102123118|NCT03300362|Immunologic Factors|immunologic factors|mesh-ancestor
102123119|NCT03300362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123120|NCT02467400|Propranolol|propranolol|mesh-list
102123121|NCT02467400|Atenolol|atenolol|mesh-list
102123122|NCT02467400|Nebivolol|nebivolol|mesh-list
102123123|NCT02467400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102123124|NCT02467400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102123125|NCT02467400|Adrenergic Agents|adrenergic agents|mesh-ancestor
102123126|NCT02467400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102123127|NCT02467400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123128|NCT02467400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123129|NCT02467400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102123130|NCT02467400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102123131|NCT02467400|Vasodilator Agents|vasodilator agents|mesh-ancestor
102123132|NCT02467400|Sympatholytics|sympatholytics|mesh-ancestor
102123133|NCT02467400|Autonomic Agents|autonomic agents|mesh-ancestor
102123134|NCT02467400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102123135|NCT02467400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102123136|NCT02467400|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102123137|NCT02467400|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102123138|NCT02467400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102123139|NCT04002141|Letrozole|letrozole|mesh-list
102123140|NCT04002141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102123141|NCT04002141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102123142|NCT04002141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102123143|NCT04002141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102123144|NCT04002141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123145|NCT04002141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102123146|NCT04002141|Hormone Antagonists|hormone antagonists|mesh-ancestor
102123147|NCT04002141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102123148|NCT04002141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123149|NCT03308708|Norepinephrine|norepinephrine|mesh-list
102123150|NCT03308708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102123151|NCT03308708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102123152|NCT03308708|Adrenergic Agents|adrenergic agents|mesh-ancestor
102123153|NCT03308708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102123154|NCT03308708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123155|NCT03308708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123156|NCT03308708|Sympathomimetics|sympathomimetics|mesh-ancestor
102123157|NCT03308708|Autonomic Agents|autonomic agents|mesh-ancestor
102123158|NCT03308708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102123159|NCT03308708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102123160|NCT02262741|Durvalumab|durvalumab|mesh-list
102123161|NCT02262741|Tremelimumab|tremelimumab|mesh-list
102123162|NCT02262741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102123163|NCT02262741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102123164|NCT00250341|Beclomethasone|beclomethasone|mesh-list
102123165|NCT00250341|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102123166|NCT00250341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102123167|NCT00250341|Glucocorticoids|glucocorticoids|mesh-ancestor
102123168|NCT00250341|Hormones|hormones|mesh-ancestor
102123169|NCT00250341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102123170|NCT00250341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123171|NCT00250341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102123172|NCT00250341|Respiratory System Agents|respiratory system agents|mesh-ancestor
102123173|NCT00250341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102123174|NCT00250341|Autonomic Agents|autonomic agents|mesh-ancestor
102123175|NCT00250341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102123176|NCT00250341|Sympathomimetics|sympathomimetics|mesh-ancestor
102123177|NCT05156970|Carboplatin|carboplatin|mesh-list
102123178|NCT05156970|Docetaxel|docetaxel|mesh-list
102123179|NCT05156970|Apatinib|apatinib|mesh-list
102123180|NCT05156970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102123181|NCT05156970|Tubulin Modulators|tubulin modulators|mesh-ancestor
102123182|NCT05156970|Antimitotic Agents|antimitotic agents|mesh-ancestor
102123183|NCT05156970|Mitosis Modulators|mitosis modulators|mesh-ancestor
102123184|NCT05156970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123185|NCT05156970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102123186|NCT05156970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102123187|NCT02233881|Ipratropium|ipratropium|mesh-list
102123188|NCT02233881|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102123189|NCT02233881|Autonomic Agents|autonomic agents|mesh-ancestor
102123190|NCT02233881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102123191|NCT02233881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123192|NCT02233881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102123193|NCT02233881|Respiratory System Agents|respiratory system agents|mesh-ancestor
102123194|NCT02233881|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102123195|NCT02233881|Cholinergic Agents|cholinergic agents|mesh-ancestor
102123196|NCT02233881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102123197|NCT02233881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123198|NCT02234037|Decitabine|decitabine|mesh-list
102123199|NCT02234037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102123200|NCT02234037|Antimetabolites|antimetabolites|mesh-ancestor
102123201|NCT02234037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123202|NCT02234037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102123203|NCT02234037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102123204|NCT02234193|Lidocaine|lidocaine|mesh-list
102123205|NCT02234193|Epinephrine|epinephrine|mesh-list
102123206|NCT02234193|Anesthetics, Local|anesthetics, local|mesh-ancestor
102123207|NCT02234193|Anesthetics|anesthetics|mesh-ancestor
102123208|NCT02234193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102123209|NCT02234193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123210|NCT02234193|Sensory System Agents|sensory system agents|mesh-ancestor
102123211|NCT02234193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102123212|NCT02234193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102123213|NCT02234193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102123214|NCT02234193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102123215|NCT02234193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102123216|NCT02234193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123217|NCT02234193|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102123218|NCT02234193|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102123219|NCT02234193|Adrenergic Agents|adrenergic agents|mesh-ancestor
102123220|NCT02234193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102123221|NCT02234193|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102123222|NCT02234193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102123223|NCT02234193|Autonomic Agents|autonomic agents|mesh-ancestor
102123224|NCT02234193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102123225|NCT02234193|Respiratory System Agents|respiratory system agents|mesh-ancestor
102123226|NCT02234193|Mydriatics|mydriatics|mesh-ancestor
102123227|NCT02234193|Sympathomimetics|sympathomimetics|mesh-ancestor
102123228|NCT02234193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102123229|NCT04476459|Apatinib|apatinib|mesh-list
102123230|NCT04476459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102123231|NCT04476459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102123232|NCT04476459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102123233|NCT04476459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123234|NCT02262897|Paclitaxel|paclitaxel|mesh-list
102123235|NCT02262897|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102123236|NCT02262897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102123237|NCT02262897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102123238|NCT02262897|Tubulin Modulators|tubulin modulators|mesh-ancestor
102123239|NCT02262897|Antimitotic Agents|antimitotic agents|mesh-ancestor
102123240|NCT02262897|Mitosis Modulators|mitosis modulators|mesh-ancestor
102123241|NCT02262897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123242|NCT02723006|Nivolumab|nivolumab|mesh-list
102123243|NCT02723006|Ipilimumab|ipilimumab|mesh-list
102123244|NCT02723006|Vedolizumab|vedolizumab|mesh-list
102123245|NCT02723006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102123246|NCT02723006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102123247|NCT02723006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102123248|NCT02723006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123249|NCT02723006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102123250|NCT03308552|Paclitaxel|paclitaxel|mesh-list
102123251|NCT03308552|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102123252|NCT03308552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102123253|NCT03308552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102123254|NCT03308552|Tubulin Modulators|tubulin modulators|mesh-ancestor
102123255|NCT03308552|Antimitotic Agents|antimitotic agents|mesh-ancestor
102123256|NCT03308552|Mitosis Modulators|mitosis modulators|mesh-ancestor
102123257|NCT03308552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123258|NCT03308084|Dexamethasone|dexamethasone|mesh-list
102123259|NCT03308084|Methylprednisolone|methylprednisolone|mesh-list
102123260|NCT03308084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102123261|NCT03308084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102123262|NCT03308084|Prednisolone|prednisolone|mesh-list
102123263|NCT03308084|Prednisolone acetate|prednisolone acetate|mesh-list
102123264|NCT03308084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101832288|NCT00880529|Narcotics|narcotics|mesh-ancestor
102123265|NCT03308084|Prednisolone phosphate|prednisolone phosphate|mesh-list
102123266|NCT03308084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102123267|NCT03308084|Antiemetics|antiemetics|mesh-ancestor
102123268|NCT03308084|Autonomic Agents|autonomic agents|mesh-ancestor
102123269|NCT03308084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102123270|NCT03308084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123271|NCT03308084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102123272|NCT03308084|Glucocorticoids|glucocorticoids|mesh-ancestor
102123273|NCT03308084|Hormones|hormones|mesh-ancestor
102123274|NCT03308084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102123275|NCT03308084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102123276|NCT03308084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102123277|NCT03308084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102123278|NCT03308084|Protective Agents|protective agents|mesh-ancestor
102123279|NCT00702962|Carboplatin|carboplatin|mesh-list
102123280|NCT00702962|Etoposide|etoposide|mesh-list
102123281|NCT00702962|Vorinostat|vorinostat|mesh-list
102123282|NCT00702962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102123283|NCT00702962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102123284|NCT00702962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102123285|NCT00702962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102123286|NCT00702962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102123287|NCT00702962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123288|NCT00702962|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102123289|NCT01379508|Tenofovir|tenofovir|mesh-list
102123290|NCT01379508|Telbivudine|telbivudine|mesh-list
102123291|NCT01379508|Antiviral Agents|antiviral agents|mesh-ancestor
102123292|NCT01379508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102123293|NCT01379508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102123294|NCT01379508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102123295|NCT01379508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102021856|NCT02452554|Maytansine|maytansine|mesh-list
102021877|NCT03182374|Hylan|hylan|mesh-list
102123296|NCT01379508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123297|NCT01379508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102123298|NCT01379508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102123299|NCT05162430|Propofol|propofol|mesh-list
102123300|NCT05162430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102123301|NCT05162430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102123302|NCT05162430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123303|NCT05162430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102123304|NCT05162430|Anesthetics, General|anesthetics, general|mesh-ancestor
102123305|NCT05162430|Anesthetics|anesthetics|mesh-ancestor
102123306|NCT05031026|Dexmedetomidine|dexmedetomidine|mesh-list
102123307|NCT05031026|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102123308|NCT05031026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102123309|NCT05031026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123310|NCT05031026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102123311|NCT05031026|Analgesics|analgesics|mesh-ancestor
102123312|NCT05031026|Sensory System Agents|sensory system agents|mesh-ancestor
102123313|NCT05031026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102123314|NCT05031026|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102123315|NCT05031026|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102123316|NCT05031026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102123317|NCT05031026|Adrenergic Agents|adrenergic agents|mesh-ancestor
102123318|NCT05031026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102123319|NCT05031026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123320|NCT02264769|Carbetocin|carbetocin|mesh-list
102123321|NCT02264769|Oxytocics|oxytocics|mesh-ancestor
102123322|NCT02264769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102123323|NCT02264769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123324|NCT02264847|Clomiphene|clomiphene|mesh-list
102123325|NCT02264847|Enclomiphene|enclomiphene|mesh-list
102123326|NCT02264847|Zuclomiphene|zuclomiphene|mesh-list
102123327|NCT02264847|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102123328|NCT02264847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102123329|NCT02264847|Hormone Antagonists|hormone antagonists|mesh-ancestor
102123330|NCT02264847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102123331|NCT02264847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123332|NCT02264847|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102123333|NCT02264847|Fertility Agents|fertility agents|mesh-ancestor
102123334|NCT02264847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102123335|NCT02264847|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102123336|NCT02264847|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102123337|NCT04965506|Dulaglutide|dulaglutide|mesh-list
102123338|NCT04965506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102123339|NCT04965506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123340|NCT03469128|Sertraline|sertraline|mesh-list
102123341|NCT03469128|Antidepressive Agents|antidepressive agents|mesh-ancestor
102123342|NCT03469128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102123343|NCT03469128|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102123344|NCT03469128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102123345|NCT03469128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102123346|NCT03469128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123347|NCT03469128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102123348|NCT03469128|Serotonin Agents|serotonin agents|mesh-ancestor
102123349|NCT03469128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123350|NCT05161572|Oxaliplatin|oxaliplatin|mesh-list
102123351|NCT05161572|Tegafur|tegafur|mesh-list
102123352|NCT05161572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102123353|NCT05161572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102123354|NCT05161572|Antimetabolites|antimetabolites|mesh-ancestor
102123355|NCT05161572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123356|NCT03472170|Lactoferrin|lactoferrin|mesh-list
102123357|NCT03472170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102123358|NCT04156698|Docetaxel|docetaxel|mesh-list
102123359|NCT04156698|Capecitabine|capecitabine|mesh-list
102123360|NCT04156698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102123361|NCT04156698|Tubulin Modulators|tubulin modulators|mesh-ancestor
102123362|NCT04156698|Antimitotic Agents|antimitotic agents|mesh-ancestor
102123363|NCT04156698|Mitosis Modulators|mitosis modulators|mesh-ancestor
102021923|NCT04620252|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102123364|NCT04156698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123365|NCT04156698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102123366|NCT04156698|Antimetabolites|antimetabolites|mesh-ancestor
102123367|NCT03108326|Infliximab|infliximab|mesh-list
102123369|NCT03108326|Vedolizumab|vedolizumab|mesh-list
102123370|NCT03108326|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102123371|NCT03108326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102123372|NCT03108326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102123373|NCT03108326|Dermatologic Agents|dermatologic agents|mesh-ancestor
102123374|NCT03108326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102123375|NCT04964024|Antibodies|antibodies|mesh-list
102123376|NCT04964024|Immunologic Factors|immunologic factors|mesh-ancestor
102123377|NCT04964024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123378|NCT02466542|Esmolol|esmolol|mesh-list
102123379|NCT02466542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102123380|NCT02466542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102123381|NCT02466542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102123382|NCT02466542|Adrenergic Agents|adrenergic agents|mesh-ancestor
102123383|NCT02466542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102123384|NCT02466542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123385|NCT02466542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123386|NCT05067270|Insulin Lispro|insulin lispro|mesh-list
102123387|NCT05067270|Treprostinil|treprostinil|mesh-list
102123388|NCT05067270|Citric Acid|citric acid|mesh-list
102123389|NCT05067270|Sodium Citrate|sodium citrate|mesh-list
102123390|NCT05067270|Anticoagulants|anticoagulants|mesh-ancestor
102123391|NCT05067270|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102123392|NCT05067270|Chelating Agents|chelating agents|mesh-ancestor
102123393|NCT05067270|Sequestering Agents|sequestering agents|mesh-ancestor
102123394|NCT05067270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123395|NCT05067270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102123396|NCT05067270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123397|NCT05067270|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102123398|NCT01437735|Montelukast|montelukast|mesh-list
102123399|NCT01437735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102123400|NCT01437735|Respiratory System Agents|respiratory system agents|mesh-ancestor
102123401|NCT01437735|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102123402|NCT01437735|Hormone Antagonists|hormone antagonists|mesh-ancestor
102123403|NCT01437735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102123404|NCT01437735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123405|NCT01437735|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102123406|NCT01437735|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102123407|NCT01437735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123408|NCT02722304|Protease Inhibitors|protease inhibitors|mesh-list
102123409|NCT02722304|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
102123410|NCT02722304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102123411|NCT02722304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123412|NCT02722304|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102123413|NCT02722304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101832447|NCT00882323|Fludarabine|fludarabine|mesh-list
102123414|NCT03470610|Estradiol|estradiol|mesh-list
102123415|NCT03470610|Progesterone|progesterone|mesh-list
102123416|NCT03470610|Estrogens|estrogens|mesh-ancestor
102123417|NCT03470610|Hormones|hormones|mesh-ancestor
102123418|NCT03470610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102123419|NCT03470610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123420|NCT03470610|Progestins|progestins|mesh-ancestor
102123421|NCT02509845|Anti-Infective Agents|anti-infective agents|mesh-list
102123422|NCT02509845|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102123423|NCT03307148|Paclitaxel|paclitaxel|mesh-list
102123424|NCT03307148|Gemcitabine|gemcitabine|mesh-list
102123425|NCT03307148|Tretinoin|tretinoin|mesh-list
102123426|NCT03307148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102021995|NCT02417142|Exenatide|exenatide|mesh-list
102123427|NCT03307148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102123428|NCT03307148|Tubulin Modulators|tubulin modulators|mesh-ancestor
102123429|NCT03307148|Antimitotic Agents|antimitotic agents|mesh-ancestor
102123430|NCT03307148|Mitosis Modulators|mitosis modulators|mesh-ancestor
102123431|NCT03307148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123432|NCT03307148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102123433|NCT03307148|Antimetabolites|antimetabolites|mesh-ancestor
102123434|NCT03307148|Keratolytic Agents|keratolytic agents|mesh-ancestor
102123435|NCT03307148|Dermatologic Agents|dermatologic agents|mesh-ancestor
102123436|NCT03984591|Eplerenone|eplerenone|mesh-list
102123437|NCT03984591|Spironolactone|spironolactone|mesh-list
102123438|NCT03984591|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102123439|NCT03984591|Hormone Antagonists|hormone antagonists|mesh-ancestor
102123440|NCT03984591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102123441|NCT03984591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123442|NCT03984591|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102123443|NCT03984591|Diuretics|diuretics|mesh-ancestor
102123444|NCT03984591|Natriuretic Agents|natriuretic agents|mesh-ancestor
102123445|NCT03984591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102123446|NCT02503137|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102123447|NCT03470532|Epinephrine|epinephrine|mesh-list
102123448|NCT03470532|Racepinephrine|racepinephrine|mesh-list
102123449|NCT03470532|Mepivacaine|mepivacaine|mesh-list
102123451|NCT03470532|Epinephryl borate|epinephryl borate|mesh-list
102123452|NCT03470532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102123453|NCT03470532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102123454|NCT03470532|Adrenergic Agents|adrenergic agents|mesh-ancestor
102123455|NCT03470532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102123456|NCT03470532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123457|NCT03470532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123458|NCT03470532|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102123459|NCT03470532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102123460|NCT03470532|Autonomic Agents|autonomic agents|mesh-ancestor
102123461|NCT03470532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102123462|NCT03470532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102123463|NCT03470532|Respiratory System Agents|respiratory system agents|mesh-ancestor
102123464|NCT03470532|Mydriatics|mydriatics|mesh-ancestor
102123465|NCT03470532|Sympathomimetics|sympathomimetics|mesh-ancestor
102123466|NCT03470532|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102123467|NCT03470532|Anesthetics, Local|anesthetics, local|mesh-ancestor
102123468|NCT03470532|Anesthetics|anesthetics|mesh-ancestor
102123469|NCT03470532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102123470|NCT03470532|Sensory System Agents|sensory system agents|mesh-ancestor
102123471|NCT02502669|Finasteride|finasteride|mesh-list
102123472|NCT02502669|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102123473|NCT02502669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102123474|NCT02502669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102123475|NCT02502669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123476|NCT02502669|Hormone Antagonists|hormone antagonists|mesh-ancestor
102123477|NCT02502669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102123478|NCT02502669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123479|NCT02502669|Urological Agents|urological agents|mesh-ancestor
102123480|NCT03306914|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
102123481|NCT03306914|Plasma Substitutes|plasma substitutes|mesh-ancestor
102123482|NCT03306914|Blood Substitutes|blood substitutes|mesh-ancestor
102123483|NCT03306836|Heparin|heparin|mesh-list
102123484|NCT03306836|Calcium heparin|calcium heparin|mesh-list
102123485|NCT03306836|Anticoagulants|anticoagulants|mesh-ancestor
102123486|NCT03306836|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102123487|NCT03306836|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102123488|NCT03306836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123489|NCT04487145|Piperaquine|piperaquine|mesh-list
102123490|NCT04487145|Artenimol|artenimol|mesh-list
102123491|NCT04487145|Antimalarials|antimalarials|mesh-ancestor
102123492|NCT04487145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102123493|NCT04487145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102123494|NCT04487145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102123495|NCT04780568|Osimertinib|osimertinib|mesh-list
102123496|NCT04780568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102123497|NCT04780568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102123498|NCT04780568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102022056|NCT02428972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123499|NCT04780568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123501|NCT00709956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102123502|NCT00709956|Vasodilator Agents|vasodilator agents|mesh-ancestor
102123503|NCT02268201|Tacrolimus|tacrolimus|mesh-list
102123504|NCT02268201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102123505|NCT02268201|Immunologic Factors|immunologic factors|mesh-ancestor
102123506|NCT02268201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123507|NCT02268201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102123508|NCT02268201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102123509|NCT02268201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123510|NCT03306602|Z 350|z 350|mesh-list
102123511|NCT03306602|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102123512|NCT03306602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102123513|NCT03306602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102123514|NCT03306602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123515|NCT03306602|Hormone Antagonists|hormone antagonists|mesh-ancestor
102123516|NCT03306602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102123517|NCT03306602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123518|NCT02268279|Solithromycin|solithromycin|mesh-list
102123519|NCT02268279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102123520|NCT02268279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102123521|NCT02268357|Propranolol|propranolol|mesh-list
102123522|NCT02268357|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102123523|NCT02268357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102123524|NCT02268357|Adrenergic Agents|adrenergic agents|mesh-ancestor
102123525|NCT02268357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102123526|NCT02268357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123527|NCT02268357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123528|NCT02268357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102123529|NCT02268357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102123530|NCT02268357|Vasodilator Agents|vasodilator agents|mesh-ancestor
102123531|NCT02268435|Imatinib Mesylate|imatinib mesylate|mesh-list
102123532|NCT02268435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102123533|NCT02268435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102123534|NCT02268435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102123535|NCT02268435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123536|NCT02466464|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
102123537|NCT02466464|Hemostatics|hemostatics|mesh-ancestor
102123538|NCT02466464|Coagulants|coagulants|mesh-ancestor
102123539|NCT01423149|Fosbretabulin|fosbretabulin|mesh-list
102123540|NCT01423149|Combretastatin|combretastatin|mesh-list
102123541|NCT01423149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102123542|NCT01423149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102123543|NCT01423149|Tubulin Modulators|tubulin modulators|mesh-ancestor
102123544|NCT01423149|Antimitotic Agents|antimitotic agents|mesh-ancestor
102123545|NCT01423149|Mitosis Modulators|mitosis modulators|mesh-ancestor
102123546|NCT01423149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123547|NCT03470454|Linagliptin|linagliptin|mesh-list
102123548|NCT03470454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102123549|NCT03470454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123550|NCT03470454|Incretins|incretins|mesh-ancestor
102123551|NCT03470454|Hormones|hormones|mesh-ancestor
102123552|NCT03470454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102123553|NCT03470454|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102123554|NCT03470454|Protease Inhibitors|protease inhibitors|mesh-ancestor
102123555|NCT03470454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102123556|NCT03470454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123557|NCT03130842|Midazolam|midazolam|mesh-list
102123558|NCT03130842|Alprazolam|alprazolam|mesh-list
102123559|NCT03130842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102123560|NCT03130842|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102123561|NCT03130842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102123562|NCT03130842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123563|NCT03130842|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101832589|NCT00611975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102123564|NCT03130842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102123565|NCT03130842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102123566|NCT03130842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102123567|NCT03130842|Anesthetics, General|anesthetics, general|mesh-ancestor
102123568|NCT03130842|Anesthetics|anesthetics|mesh-ancestor
102123569|NCT03130842|GABA Modulators|gaba modulators|mesh-ancestor
102123570|NCT03130842|GABA Agents|gaba agents|mesh-ancestor
102123571|NCT03130842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102123572|NCT03130842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123573|NCT03130764|Durvalumab|durvalumab|mesh-list
102123574|NCT03130764|Tremelimumab|tremelimumab|mesh-list
102123575|NCT03130764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102123576|NCT03130764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102123577|NCT01234779|Olanzapine|olanzapine|mesh-list
102123578|NCT01234779|Antiemetics|antiemetics|mesh-ancestor
102123579|NCT01234779|Autonomic Agents|autonomic agents|mesh-ancestor
102123580|NCT01234779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102123581|NCT01234779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123582|NCT01234779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102123583|NCT01234779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102123584|NCT01234779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102123585|NCT01234779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102123586|NCT01234779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102123587|NCT01234779|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102123588|NCT01234779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102123589|NCT01234779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102535871|NCT05339373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102123590|NCT01234779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123591|NCT01234779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102123592|NCT01234779|Serotonin Agents|serotonin agents|mesh-ancestor
102123593|NCT03223350|Capsaicin|capsaicin|mesh-list
102123594|NCT03223350|Antipruritics|antipruritics|mesh-ancestor
102123595|NCT03223350|Dermatologic Agents|dermatologic agents|mesh-ancestor
102123596|NCT03223350|Sensory System Agents|sensory system agents|mesh-ancestor
102123597|NCT03223350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102123598|NCT03223350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123599|NCT03306368|Analgesics, Opioid|analgesics, opioid|mesh-list
102123600|NCT03306368|Narcotics|narcotics|mesh-ancestor
102123601|NCT03306368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102123602|NCT03306368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123603|NCT03306368|Analgesics|analgesics|mesh-ancestor
102123604|NCT03306368|Sensory System Agents|sensory system agents|mesh-ancestor
102123605|NCT03306368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102123606|NCT02840136|Meropenem|meropenem|mesh-list
102123607|NCT02840136|Tazobactam|tazobactam|mesh-list
102123608|NCT02840136|Piperacillin|piperacillin|mesh-list
102123609|NCT02840136|Ceftazidime|ceftazidime|mesh-list
102123610|NCT02840136|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102123611|NCT02840136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102123612|NCT02840136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102123613|NCT02840136|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102123614|NCT02840136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102123615|NCT02840136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123616|NCT03306290|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102123617|NCT03306290|Cefoxitin|cefoxitin|mesh-list
102123618|NCT03306290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102123619|NCT01616199|Vemurafenib|vemurafenib|mesh-list
102123620|NCT01616199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102022243|NCT03688958|Iodine|iodine|mesh-list
102123621|NCT01616199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102123622|NCT01616199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102123623|NCT01616199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123624|NCT03306212|Botulinum Toxins|botulinum toxins|mesh-list
102123625|NCT03306212|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102123626|NCT03306212|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102123627|NCT03306212|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102123628|NCT03306212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102123629|NCT03306212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123630|NCT03306212|Cholinergic Agents|cholinergic agents|mesh-ancestor
102123631|NCT03306212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102123632|NCT03306212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123633|NCT03306212|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102123634|NCT03306212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102123635|NCT04506138|Paclitaxel|paclitaxel|mesh-list
102123636|NCT04506138|Carboplatin|carboplatin|mesh-list
102123637|NCT04506138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102123638|NCT04506138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102123639|NCT04506138|Tubulin Modulators|tubulin modulators|mesh-ancestor
102123641|NCT04506138|Mitosis Modulators|mitosis modulators|mesh-ancestor
102123642|NCT04506138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123643|NCT01407003|Licogliflozin|licogliflozin|mesh-list
102123644|NCT01407003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102123645|NCT01407003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123646|NCT01407003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102123647|NCT01407003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123648|NCT05346302|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102123649|NCT05346302|Immunologic Factors|immunologic factors|mesh-ancestor
102123650|NCT05346302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123651|NCT01232595|Vancomycin|vancomycin|mesh-list
102123652|NCT01232595|LFF571|lff571|mesh-list
102123653|NCT01232595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102123654|NCT01232595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102123655|NCT01231347|Gemcitabine|gemcitabine|mesh-list
102123656|NCT01231347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102123657|NCT01231347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102123658|NCT01231347|Antimetabolites|antimetabolites|mesh-ancestor
102123659|NCT01231347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123660|NCT01231347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102123661|NCT01231347|Immunologic Factors|immunologic factors|mesh-ancestor
102123662|NCT01231347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123663|NCT01230957|Vaccines|vaccines|mesh-list
102123664|NCT01230957|Immunologic Factors|immunologic factors|mesh-ancestor
102123665|NCT01230957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123666|NCT01228383|Vaccines|vaccines|mesh-list
102123667|NCT01228383|Antibodies|antibodies|mesh-list
102123668|NCT01228383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102123669|NCT01228383|Immunoglobulins|immunoglobulins|mesh-list
102123670|NCT01228383|gamma-Globulins|gamma-globulins|mesh-list
102123671|NCT01228383|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102123672|NCT01228383|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102123673|NCT01228383|Immunologic Factors|immunologic factors|mesh-ancestor
102123674|NCT01228383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123675|NCT03305978|Ivermectin|ivermectin|mesh-list
102123676|NCT03305978|Selamectin|selamectin|mesh-list
102123677|NCT03305978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102123678|NCT03305978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102123679|NCT01594983|Fenofibrate|fenofibrate|mesh-list
102123680|NCT01594983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102123681|NCT01594983|Antimetabolites|antimetabolites|mesh-ancestor
102123682|NCT01594983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123683|NCT01594983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102123684|NCT03305510|Vitamin D|vitamin d|mesh-list
102123685|NCT03305510|Vitamins|vitamins|mesh-ancestor
102123686|NCT03305510|Micronutrients|micronutrients|mesh-ancestor
102123687|NCT03305510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022254|NCT03688568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102123688|NCT03305510|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102123689|NCT01224795|Peramivir|peramivir|mesh-list
102123690|NCT01224795|Antiviral Agents|antiviral agents|mesh-ancestor
102123691|NCT01224795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102123692|NCT01224795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102123693|NCT01224795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123694|NCT01402401|Trastuzumab|trastuzumab|mesh-list
102123695|NCT01402401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102123696|NCT01402401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102123697|NCT02720510|Dexamethasone|dexamethasone|mesh-list
102123698|NCT02720510|Lenalidomide|lenalidomide|mesh-list
102123699|NCT02720510|Bortezomib|bortezomib|mesh-list
102123700|NCT02720510|Panobinostat|panobinostat|mesh-list
102123701|NCT02720510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102123702|NCT02720510|Antiemetics|antiemetics|mesh-ancestor
102123703|NCT02720510|Autonomic Agents|autonomic agents|mesh-ancestor
102123704|NCT02720510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102123705|NCT02720510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123706|NCT02720510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102123707|NCT02720510|Glucocorticoids|glucocorticoids|mesh-ancestor
102123708|NCT02720510|Hormones|hormones|mesh-ancestor
102123709|NCT02720510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102123710|NCT02720510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102123711|NCT02720510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102123712|NCT02720510|Immunologic Factors|immunologic factors|mesh-ancestor
102123713|NCT02720510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102123714|NCT02720510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102123715|NCT02720510|Growth Substances|growth substances|mesh-ancestor
102123716|NCT02720510|Growth Inhibitors|growth inhibitors|mesh-ancestor
102123717|NCT02720510|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102123718|NCT02720510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102123719|NCT02720510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123721|NCT01220271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102123722|NCT01220271|Alkylating Agents|alkylating agents|mesh-ancestor
102123723|NCT01220271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123724|NCT01220271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102123725|NCT02468102|Rivaroxaban|rivaroxaban|mesh-list
102123726|NCT02468102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102123727|NCT02468102|Antithrombins|antithrombins|mesh-ancestor
102123728|NCT02468102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102123729|NCT02468102|Protease Inhibitors|protease inhibitors|mesh-ancestor
102123730|NCT02468102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102123731|NCT02468102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123732|NCT02468102|Anticoagulants|anticoagulants|mesh-ancestor
102123733|NCT01205061|Lidocaine|lidocaine|mesh-list
102123734|NCT01205061|Anesthetics, Local|anesthetics, local|mesh-ancestor
102123735|NCT01205061|Anesthetics|anesthetics|mesh-ancestor
102123736|NCT01205061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102123737|NCT01205061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123738|NCT01205061|Sensory System Agents|sensory system agents|mesh-ancestor
102123739|NCT01205061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102123740|NCT01205061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102123741|NCT01205061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102123742|NCT01205061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102123743|NCT01205061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102123744|NCT01205061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123745|NCT01204749|Paclitaxel|paclitaxel|mesh-list
102123746|NCT01204749|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102123747|NCT01204749|Trebananib|trebananib|mesh-list
102123748|NCT01204749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
102123749|NCT01204749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102123750|NCT01204749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102123751|NCT01204749|Tubulin Modulators|tubulin modulators|mesh-ancestor
102123752|NCT01204749|Antimitotic Agents|antimitotic agents|mesh-ancestor
102123753|NCT01204749|Mitosis Modulators|mitosis modulators|mesh-ancestor
102123754|NCT01204749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123755|NCT01204749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102123756|NCT01204749|Growth Substances|growth substances|mesh-ancestor
102123757|NCT01204749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123758|NCT01204749|Growth Inhibitors|growth inhibitors|mesh-ancestor
102123759|NCT02466698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102123760|NCT02466698|Metronidazole|metronidazole|mesh-list
102123761|NCT02466698|Vancomycin|vancomycin|mesh-list
102123762|NCT02466698|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102123763|NCT02466698|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
102123764|NCT02466698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102123765|NCT02466698|Antitubercular Agents|antitubercular agents|mesh-ancestor
102123766|NCT02466698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102123767|NCT02466698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102123768|NCT02466698|Laxatives|laxatives|mesh-ancestor
102123769|NCT02466698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102123770|NCT02720198|Milnacipran|milnacipran|mesh-list
102123771|NCT02720198|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102123772|NCT02720198|Levomilnacipran|levomilnacipran|mesh-list
102123773|NCT02720198|Antidepressive Agents|antidepressive agents|mesh-ancestor
102123774|NCT02720198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102123775|NCT02720198|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102123776|NCT02720198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102123777|NCT02720198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102123778|NCT02720198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123779|NCT02720198|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102123780|NCT02720198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102123781|NCT02720198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102123782|NCT02720198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123783|NCT02720198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102123784|NCT02720198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102123785|NCT02720198|Analgesics|analgesics|mesh-ancestor
102123786|NCT02720198|Sensory System Agents|sensory system agents|mesh-ancestor
102123787|NCT02720198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102123788|NCT01193361|Interferons|interferons|mesh-list
102123789|NCT01193361|Ribavirin|ribavirin|mesh-list
102123790|NCT01193361|Interferon-alpha|interferon-alpha|mesh-list
102123791|NCT01193361|Interferon alpha-2|interferon alpha-2|mesh-list
102123792|NCT01193361|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102123793|NCT01193361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102123794|NCT01193361|Antiviral Agents|antiviral agents|mesh-ancestor
102123795|NCT01193361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102123796|NCT01193361|Antimetabolites|antimetabolites|mesh-ancestor
102123797|NCT01193361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123798|NCT01193361|Immunologic Factors|immunologic factors|mesh-ancestor
102123799|NCT01193361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123800|NCT02263677|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102123801|NCT02263677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102123802|NCT02263677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123803|NCT02263677|Incretins|incretins|mesh-ancestor
102123804|NCT02263677|Hormones|hormones|mesh-ancestor
102123805|NCT02263677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102123806|NCT02263677|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102123807|NCT02263677|Protease Inhibitors|protease inhibitors|mesh-ancestor
102123808|NCT02263677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102123809|NCT02263677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123810|NCT01390545|Veltuzumab|veltuzumab|mesh-list
102123811|NCT01390545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102123812|NCT01591473|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
102123813|NCT01591473|Poly I-C|poly i-c|mesh-list
102123814|NCT01591473|Antiviral Agents|antiviral agents|mesh-ancestor
102123815|NCT01591473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102123816|NCT01591473|Interferon Inducers|interferon inducers|mesh-ancestor
102123817|NCT01591473|Immunologic Factors|immunologic factors|mesh-ancestor
102123818|NCT01591473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123819|NCT01192035|Ritonavir|ritonavir|mesh-list
102123820|NCT01192035|Lopinavir|lopinavir|mesh-list
102535872|NCT05339373|Analgesics|analgesics|mesh-ancestor
102123822|NCT01192035|Efavirenz|efavirenz|mesh-list
102123823|NCT01192035|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102123824|NCT01192035|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102123825|NCT01192035|Protease Inhibitors|protease inhibitors|mesh-ancestor
102123826|NCT01192035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102123827|NCT01192035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123828|NCT01192035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102123829|NCT01192035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102123830|NCT01192035|Antiviral Agents|antiviral agents|mesh-ancestor
102123831|NCT01192035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102123832|NCT01192035|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102123833|NCT01192035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102022395|NCT01375452|Letrozole|letrozole|mesh-list
102123834|NCT01192035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102123835|NCT01192035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102123836|NCT01192035|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102123837|NCT01192035|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102123838|NCT01192035|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102123839|NCT01192035|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102123840|NCT01192035|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102123841|NCT01384383|Ledipasvir|ledipasvir|mesh-list
102123842|NCT01384383|Antiviral Agents|antiviral agents|mesh-ancestor
102123843|NCT01384383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102123844|NCT01557777|Navitoclax|navitoclax|mesh-list
102123845|NCT01557777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102123846|NCT02268825|Pembrolizumab|pembrolizumab|mesh-list
102123847|NCT02268825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102123848|NCT02268825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102123849|NCT02268825|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102123850|NCT02268825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123851|NCT01381731|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102123852|NCT01381731|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102123853|NCT02268903|Furosemide|furosemide|mesh-list
102123854|NCT02268903|Diuretics|diuretics|mesh-list
102123855|NCT02268903|Natriuretic Agents|natriuretic agents|mesh-ancestor
102123856|NCT02268903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123857|NCT02268903|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102123858|NCT02268903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102123859|NCT02268903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123860|NCT01369095|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102123861|NCT01369095|Escitalopram|escitalopram|mesh-list
102123862|NCT01369095|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102123863|NCT01369095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102123864|NCT01369095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102123865|NCT01369095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123866|NCT01369095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102123867|NCT01369095|Serotonin Agents|serotonin agents|mesh-ancestor
102123868|NCT01369095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123869|NCT01369095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102123870|NCT01369095|Antidepressive Agents|antidepressive agents|mesh-ancestor
102123871|NCT01369095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102123872|NCT01369095|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102123873|NCT01369095|Analgesics|analgesics|mesh-ancestor
102123874|NCT01369095|Sensory System Agents|sensory system agents|mesh-ancestor
102123875|NCT01369095|Dopamine Agents|dopamine agents|mesh-ancestor
102123876|NCT02266173|Pertuzumab|pertuzumab|mesh-list
102123877|NCT02266173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102123878|NCT02266173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102123879|NCT01168713|Levofloxacin|levofloxacin|mesh-list
102123880|NCT01168713|Solithromycin|solithromycin|mesh-list
102123881|NCT01168713|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102123882|NCT01168713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102123883|NCT01168713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102123884|NCT01168713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102123885|NCT01168713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102123886|NCT01168713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102123887|NCT01168713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123888|NCT01168713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102123889|NCT01168713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102123890|NCT01168713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102123891|NCT02269293|Paclitaxel|paclitaxel|mesh-list
102123892|NCT02269293|Carboplatin|carboplatin|mesh-list
102123893|NCT02269293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102123894|NCT02269293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102123895|NCT02269293|Tubulin Modulators|tubulin modulators|mesh-ancestor
102123896|NCT02269293|Antimitotic Agents|antimitotic agents|mesh-ancestor
102123897|NCT02269293|Mitosis Modulators|mitosis modulators|mesh-ancestor
102123898|NCT02269293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123899|NCT01545453|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102123900|NCT01545453|Immunologic Factors|immunologic factors|mesh-ancestor
102123901|NCT01545453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123902|NCT01366131|Paclitaxel|paclitaxel|mesh-list
102123903|NCT01366131|Bevacizumab|bevacizumab|mesh-list
102123904|NCT01366131|Carboplatin|carboplatin|mesh-list
102123905|NCT01366131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102123906|NCT01366131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102123907|NCT01366131|Tubulin Modulators|tubulin modulators|mesh-ancestor
102123908|NCT01366131|Antimitotic Agents|antimitotic agents|mesh-ancestor
102123909|NCT01366131|Mitosis Modulators|mitosis modulators|mesh-ancestor
102123910|NCT01366131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123911|NCT01366131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102123912|NCT01366131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102123913|NCT01366131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102123914|NCT01366131|Growth Substances|growth substances|mesh-ancestor
102123915|NCT01366131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123916|NCT01366131|Growth Inhibitors|growth inhibitors|mesh-ancestor
102123917|NCT01365195|Ketamine|ketamine|mesh-list
102123918|NCT01365195|Analgesics|analgesics|mesh-ancestor
102123919|NCT01365195|Sensory System Agents|sensory system agents|mesh-ancestor
102123920|NCT01365195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102123921|NCT01365195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123922|NCT01365195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102123923|NCT01365195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102123924|NCT01365195|Anesthetics, General|anesthetics, general|mesh-ancestor
102123925|NCT01365195|Anesthetics|anesthetics|mesh-ancestor
102123926|NCT01365195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102123927|NCT01365195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102123928|NCT01365195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102123929|NCT01365195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102123930|NCT01365195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123931|NCT02269449|Hemostatics|hemostatics|mesh-list
102123932|NCT02269449|Coagulants|coagulants|mesh-ancestor
102123933|NCT01160601|Paclitaxel|paclitaxel|mesh-list
102123934|NCT01160601|Carboplatin|carboplatin|mesh-list
102123935|NCT01160601|Bavituximab|bavituximab|mesh-list
102123936|NCT01160601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102123937|NCT01160601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102123938|NCT01160601|Tubulin Modulators|tubulin modulators|mesh-ancestor
101832970|NCT00519428|Dexetimide|dexetimide|mesh-list
102123939|NCT01160601|Antimitotic Agents|antimitotic agents|mesh-ancestor
102123940|NCT01160601|Mitosis Modulators|mitosis modulators|mesh-ancestor
102123941|NCT01160601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123942|NCT01160601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102123943|NCT02269605|Bryostatin 1|bryostatin 1|mesh-list
102123944|NCT02269605|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102123945|NCT02269605|Immunologic Factors|immunologic factors|mesh-ancestor
102123946|NCT02269605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102123947|NCT02269605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102123948|NCT01356849|Atrasentan|atrasentan|mesh-list
102123949|NCT01356849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102123950|NCT01356849|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
102123951|NCT01356849|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102123952|NCT01356849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123953|NCT02266485|Pravastatin|pravastatin|mesh-list
102123954|NCT02266485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102123955|NCT02266485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102123956|NCT02266485|Antimetabolites|antimetabolites|mesh-ancestor
102123957|NCT02266485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123958|NCT02266485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102123959|NCT02266485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102123960|NCT02266485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102123961|NCT02263989|Telmisartan|telmisartan|mesh-list
102123962|NCT02263989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102123963|NCT02263989|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102123964|NCT02263989|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102123965|NCT02263989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123967|NCT01516203|Isoniazid|isoniazid|mesh-list
102123968|NCT01516203|Pyrazinamide|pyrazinamide|mesh-list
102123969|NCT01516203|Ethambutol|ethambutol|mesh-list
102123970|NCT01516203|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102123971|NCT01516203|Antitubercular Agents|antitubercular agents|mesh-ancestor
102123972|NCT01516203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102123973|NCT01516203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102123974|NCT01516203|Leprostatic Agents|leprostatic agents|mesh-ancestor
102123975|NCT01516203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102123976|NCT01516203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102123977|NCT01516203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123978|NCT01516203|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102123979|NCT01516203|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102123980|NCT01516203|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102123981|NCT01516203|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102123982|NCT01516203|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102123983|NCT01516203|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102123984|NCT01516203|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102123985|NCT01516203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102123986|NCT01516203|Antimetabolites|antimetabolites|mesh-ancestor
102123987|NCT01516203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102123988|NCT01321359|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
102123989|NCT01321359|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
102123990|NCT01321359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102123991|NCT01321359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123992|NCT00703118|Ribavirin|ribavirin|mesh-list
102123993|NCT00703118|Interferon alpha-2|interferon alpha-2|mesh-list
102123994|NCT00703118|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102123995|NCT00703118|Antimetabolites|antimetabolites|mesh-ancestor
102123996|NCT00703118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102123997|NCT00703118|Antiviral Agents|antiviral agents|mesh-ancestor
102123998|NCT00703118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102123999|NCT00703118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102124000|NCT01510119|Hydroxychloroquine|hydroxychloroquine|mesh-list
102124001|NCT01510119|Everolimus|everolimus|mesh-list
102124002|NCT01510119|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102124003|NCT01510119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102124004|NCT01510119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102124005|NCT01510119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124006|NCT01510119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102124007|NCT01510119|Immunologic Factors|immunologic factors|mesh-ancestor
102124008|NCT01510119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124009|NCT01510119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102124010|NCT01510119|Antimalarials|antimalarials|mesh-ancestor
101833043|NCT00525590|Carmustine|carmustine|mesh-list
102124012|NCT01510119|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102124013|NCT01510119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102124014|NCT01510119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102124015|NCT01150695|Vaccines|vaccines|mesh-list
102124016|NCT01150695|Immunologic Factors|immunologic factors|mesh-ancestor
102124017|NCT01150695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124018|NCT01302249|Timolol|timolol|mesh-list
102124019|NCT01302249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102124020|NCT01302249|Latanoprost|latanoprost|mesh-list
102124021|NCT01302249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102124022|NCT01302249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124023|NCT01302249|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102124024|NCT01302249|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102124025|NCT01302249|Adrenergic Agents|adrenergic agents|mesh-ancestor
102124026|NCT01302249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102124027|NCT01302249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124028|NCT01302249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102124029|NCT01302249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102124030|NCT02261636|Mesalamine|mesalamine|mesh-list
102124031|NCT02261636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102124032|NCT02261636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102124033|NCT02261636|Analgesics|analgesics|mesh-ancestor
102124034|NCT02261636|Sensory System Agents|sensory system agents|mesh-ancestor
102124035|NCT02261636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102124036|NCT02261636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124037|NCT02261636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102124038|NCT02261636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102124039|NCT05191706|Dexamethasone|dexamethasone|mesh-list
102124040|NCT05191706|Prednisolone|prednisolone|mesh-list
102124041|NCT05191706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102124042|NCT05191706|Methylprednisolone|methylprednisolone|mesh-list
102124043|NCT05191706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102124044|NCT05191706|Prednisolone acetate|prednisolone acetate|mesh-list
102124045|NCT05191706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102124046|NCT05191706|Prednisolone phosphate|prednisolone phosphate|mesh-list
102124047|NCT05191706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102124048|NCT05191706|Antiemetics|antiemetics|mesh-ancestor
102124049|NCT05191706|Autonomic Agents|autonomic agents|mesh-ancestor
102124050|NCT05191706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102124051|NCT05191706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124052|NCT05191706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102124053|NCT05191706|Glucocorticoids|glucocorticoids|mesh-ancestor
102124054|NCT05191706|Hormones|hormones|mesh-ancestor
102124055|NCT05191706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102124056|NCT05191706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102124057|NCT05191706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102124058|NCT05191706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102124059|NCT05191706|Protective Agents|protective agents|mesh-ancestor
102124060|NCT01493505|Paclitaxel|paclitaxel|mesh-list
102124061|NCT01493505|Carboplatin|carboplatin|mesh-list
102124062|NCT01493505|Trebananib|trebananib|mesh-list
102124063|NCT01493505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102124064|NCT01493505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102124065|NCT01493505|Tubulin Modulators|tubulin modulators|mesh-ancestor
102124066|NCT01493505|Antimitotic Agents|antimitotic agents|mesh-ancestor
102124067|NCT01493505|Mitosis Modulators|mitosis modulators|mesh-ancestor
102124068|NCT01493505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124069|NCT01493505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102124070|NCT01493505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102124071|NCT01493505|Growth Substances|growth substances|mesh-ancestor
102124072|NCT01493505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124073|NCT01493505|Growth Inhibitors|growth inhibitors|mesh-ancestor
102124074|NCT01301157|Calcipotriene|calcipotriene|mesh-list
102124075|NCT01301157|Dermatologic Agents|dermatologic agents|mesh-ancestor
102124076|NCT02264145|Norflurane|norflurane|mesh-list
102124077|NCT02264145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102124078|NCT02264145|Anesthetics|anesthetics|mesh-ancestor
102124079|NCT02264145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102124080|NCT02264145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124081|NCT02264301|Puerarin|puerarin|mesh-list
102124082|NCT02264301|Vasodilator Agents|vasodilator agents|mesh-ancestor
102124083|NCT02267109|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
102124084|NCT02267109|Antiviral Agents|antiviral agents|mesh-ancestor
102124085|NCT02267109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102124086|NCT04476069|Ibuprofen|ibuprofen|mesh-list
102124087|NCT04476069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102124088|NCT04476069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102124089|NCT04476069|Analgesics|analgesics|mesh-ancestor
102124090|NCT04476069|Sensory System Agents|sensory system agents|mesh-ancestor
102124091|NCT04476069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102124092|NCT04476069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124093|NCT04476069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102124094|NCT04476069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102124095|NCT04476069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102124096|NCT04476069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102124097|NCT04476069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124098|NCT01480479|Temozolomide|temozolomide|mesh-list
102124099|NCT01480479|Molgramostim|molgramostim|mesh-list
102124100|NCT01480479|Rindopepimut|rindopepimut|mesh-list
102124101|NCT01480479|Sargramostim|sargramostim|mesh-list
102124102|NCT01480479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102124103|NCT01480479|Alkylating Agents|alkylating agents|mesh-ancestor
102124104|NCT01480479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124105|NCT01480479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102124106|NCT01480479|Immunologic Factors|immunologic factors|mesh-ancestor
102124107|NCT01480479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124108|NCT01480479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102124109|NCT01116141|Folic Acid|folic acid|mesh-list
102124110|NCT01116141|Methotrexate|methotrexate|mesh-list
102124111|NCT01116141|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102124112|NCT01116141|Abortifacient Agents|abortifacient agents|mesh-ancestor
102124113|NCT01116141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102124114|NCT01116141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022683|NCT04995120|Paclitaxel|paclitaxel|mesh-list
102124115|NCT01116141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102124116|NCT01116141|Antimetabolites|antimetabolites|mesh-ancestor
102124117|NCT01116141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124118|NCT01116141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102124119|NCT01116141|Dermatologic Agents|dermatologic agents|mesh-ancestor
102124120|NCT01116141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102124121|NCT01116141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102124122|NCT01116141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102124123|NCT01116141|Immunologic Factors|immunologic factors|mesh-ancestor
102124124|NCT01116141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102124125|NCT01116141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102124126|NCT01116141|Hematinics|hematinics|mesh-ancestor
102124127|NCT01116141|Vitamin B Complex|vitamin b complex|mesh-ancestor
102124128|NCT01116141|Vitamins|vitamins|mesh-ancestor
102124129|NCT01116141|Micronutrients|micronutrients|mesh-ancestor
102124130|NCT01280565|Dacarbazine|dacarbazine|mesh-list
102124131|NCT01280565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102124132|NCT01280565|Alkylating Agents|alkylating agents|mesh-ancestor
102124133|NCT01280565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124134|NCT01280565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102124135|NCT05627739|Mycophenolic Acid|mycophenolic acid|mesh-list
102124136|NCT05627739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102124137|NCT05627739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102124138|NCT05627739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102124139|NCT05627739|Antitubercular Agents|antitubercular agents|mesh-ancestor
102124140|NCT05627739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102124141|NCT05627739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102124142|NCT05627739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102124143|NCT05627739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124144|NCT01113957|Doxorubicin|doxorubicin|mesh-list
102124145|NCT01113957|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102124146|NCT01113957|Temozolomide|temozolomide|mesh-list
102124147|NCT01113957|Veliparib|veliparib|mesh-list
102124148|NCT01113957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102124149|NCT01113957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102124150|NCT01113957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102124151|NCT01113957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102124152|NCT01113957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102124153|NCT01113957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124154|NCT01113957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102124155|NCT01113957|Alkylating Agents|alkylating agents|mesh-ancestor
102124156|NCT01113957|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102124157|NCT01111773|Lidocaine|lidocaine|mesh-list
102124158|NCT01111773|Tetracaine|tetracaine|mesh-list
102124159|NCT01111773|Anesthetics, Local|anesthetics, local|mesh-ancestor
102124160|NCT01111773|Anesthetics|anesthetics|mesh-ancestor
102124161|NCT01111773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102124162|NCT01111773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124163|NCT01111773|Sensory System Agents|sensory system agents|mesh-ancestor
102124164|NCT01111773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102124165|NCT01111773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102124166|NCT01111773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102124167|NCT01111773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102124168|NCT01111773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102124169|NCT01111773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124170|NCT01280331|Morphine|morphine|mesh-list
102124171|NCT01280331|Oxycodone|oxycodone|mesh-list
102124172|NCT01280331|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102124173|NCT01280331|Narcotics|narcotics|mesh-ancestor
102124174|NCT01280331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102124175|NCT01280331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124176|NCT01280331|Analgesics|analgesics|mesh-ancestor
102124177|NCT01280331|Sensory System Agents|sensory system agents|mesh-ancestor
102124178|NCT01280331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102124179|NCT01266525|Donepezil|donepezil|mesh-list
102124180|NCT01266525|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102124181|NCT01266525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102124182|NCT01266525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124183|NCT01266525|Cholinergic Agents|cholinergic agents|mesh-ancestor
102124184|NCT01266525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102124185|NCT01266525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124186|NCT01266525|Nootropic Agents|nootropic agents|mesh-ancestor
102124187|NCT01265901|Cyclophosphamide|cyclophosphamide|mesh-list
102124188|NCT01265901|Sunitinib|sunitinib|mesh-list
102124189|NCT01265901|Molgramostim|molgramostim|mesh-list
102124190|NCT01265901|Sargramostim|sargramostim|mesh-list
102124191|NCT01265901|Immunologic Factors|immunologic factors|mesh-ancestor
102124192|NCT01265901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124193|NCT01265901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102124194|NCT01265901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102124195|NCT01265901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102124196|NCT01265901|Alkylating Agents|alkylating agents|mesh-ancestor
102124197|NCT01265901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124198|NCT01265901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102124199|NCT01265901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102124200|NCT01265901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102124201|NCT01265901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102124202|NCT01265901|Growth Substances|growth substances|mesh-ancestor
102124203|NCT01265901|Growth Inhibitors|growth inhibitors|mesh-ancestor
102124204|NCT01265901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102124205|NCT01265901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102124207|NCT05231382|Fluorouracil|fluorouracil|mesh-list
102124208|NCT05231382|Raltitrexed|raltitrexed|mesh-list
102124209|NCT05231382|Oxaliplatin|oxaliplatin|mesh-list
102124210|NCT05231382|Antimetabolites|antimetabolites|mesh-ancestor
102124211|NCT05231382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124212|NCT05231382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102124213|NCT05231382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102124214|NCT05231382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102124215|NCT05231382|Immunologic Factors|immunologic factors|mesh-ancestor
102124216|NCT05231382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124217|NCT05231382|Antidotes|antidotes|mesh-ancestor
102124218|NCT05231382|Protective Agents|protective agents|mesh-ancestor
102124219|NCT05231382|Vitamin B Complex|vitamin b complex|mesh-ancestor
102124220|NCT05231382|Vitamins|vitamins|mesh-ancestor
102124221|NCT05231382|Micronutrients|micronutrients|mesh-ancestor
102124222|NCT05231382|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102124223|NCT05231382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102124224|NCT01262235|TKM-080301|tkm-080301|mesh-list
102124225|NCT01262235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102124226|NCT01262235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102124227|NCT01262235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124228|NCT01262001|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102124229|NCT01262001|Immunologic Factors|immunologic factors|mesh-ancestor
102124230|NCT01262001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124231|NCT01460511|Epinephrine|epinephrine|mesh-list
102124232|NCT01460511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102124233|NCT01460511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102124234|NCT01460511|Adrenergic Agents|adrenergic agents|mesh-ancestor
102124235|NCT01460511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102124236|NCT01460511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124237|NCT01460511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124238|NCT01460511|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102124239|NCT01460511|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102124240|NCT01460511|Autonomic Agents|autonomic agents|mesh-ancestor
102124241|NCT01460511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102124242|NCT01460511|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102124243|NCT01460511|Respiratory System Agents|respiratory system agents|mesh-ancestor
102124244|NCT01460511|Mydriatics|mydriatics|mesh-ancestor
102124245|NCT01460511|Sympathomimetics|sympathomimetics|mesh-ancestor
102124246|NCT01460511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102124247|NCT03135171|Trastuzumab|trastuzumab|mesh-list
102124248|NCT03135171|Pertuzumab|pertuzumab|mesh-list
102124249|NCT03135171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102124250|NCT03135171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102124251|NCT01449591|Metronidazole|metronidazole|mesh-list
102124252|NCT01449591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102124253|NCT01449591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102124254|NCT01449591|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102124255|NCT01449591|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102124256|NCT00909753|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102124257|NCT00909753|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102124258|NCT00909753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102124259|NCT01444365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
102124260|NCT01444365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102124261|NCT01444365|Analgesics|analgesics|mesh-ancestor
102124262|NCT01444365|Sensory System Agents|sensory system agents|mesh-ancestor
102124263|NCT01444365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102124264|NCT01444365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124265|NCT01444365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102124266|NCT01444365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102124267|NCT01098435|ALKS-33|alks-33|mesh-list
102535873|NCT05339373|Sensory System Agents|sensory system agents|mesh-ancestor
102124268|NCT01098435|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102124269|NCT01098435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124270|NCT01098435|Sensory System Agents|sensory system agents|mesh-ancestor
102124271|NCT01098435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102124272|NCT00909597|Pioglitazone|pioglitazone|mesh-list
102124273|NCT00909597|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102124274|NCT00909597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102124275|NCT00909597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124276|NCT00909597|Incretins|incretins|mesh-ancestor
102124277|NCT00909597|Hormones|hormones|mesh-ancestor
102124278|NCT00909597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102124279|NCT01077297|Tezosentan|tezosentan|mesh-list
102124280|NCT01077297|Vasodilator Agents|vasodilator agents|mesh-ancestor
102124281|NCT05653245|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
102124282|NCT05653245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102124283|NCT05379855|Atropine|atropine|mesh-list
102124284|NCT05379855|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102124285|NCT05379855|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102124286|NCT05379855|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102124287|NCT05379855|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102124288|NCT05379855|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102124289|NCT05379855|Autonomic Agents|autonomic agents|mesh-ancestor
102124290|NCT05379855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102124291|NCT05379855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124292|NCT05379855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102124293|NCT05379855|Respiratory System Agents|respiratory system agents|mesh-ancestor
102124294|NCT05379855|Mydriatics|mydriatics|mesh-ancestor
102124295|NCT05379855|Parasympatholytics|parasympatholytics|mesh-ancestor
102124296|NCT05379855|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102124297|NCT05379855|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102124298|NCT05379855|Cholinergic Agents|cholinergic agents|mesh-ancestor
102124299|NCT05379855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102124300|NCT05379855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124301|NCT02718326|Aflibercept|aflibercept|mesh-list
102124302|NCT02718326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102124303|NCT02718326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102124304|NCT02718326|Growth Substances|growth substances|mesh-ancestor
102124305|NCT02718326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124306|NCT02718326|Growth Inhibitors|growth inhibitors|mesh-ancestor
102124307|NCT02718326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102124308|NCT03691584|Dimercaprol|dimercaprol|mesh-list
102124309|NCT03691584|Chelating Agents|chelating agents|mesh-ancestor
102124310|NCT03691584|Sequestering Agents|sequestering agents|mesh-ancestor
102124311|NCT03691584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124312|NCT04655144|Dexamethasone|dexamethasone|mesh-list
102124313|NCT04655144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102124314|NCT04655144|Antiemetics|antiemetics|mesh-ancestor
102124315|NCT04655144|Autonomic Agents|autonomic agents|mesh-ancestor
102124316|NCT04655144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102124317|NCT04655144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124318|NCT04655144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102124319|NCT04655144|Glucocorticoids|glucocorticoids|mesh-ancestor
102124320|NCT04655144|Hormones|hormones|mesh-ancestor
102022891|NCT03394027|TIC10 compound|tic10 compound|mesh-list
102124321|NCT04655144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102124322|NCT04655144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102124323|NCT04655144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102124324|NCT03468972|Immunosuppressive Agents|immunosuppressive agents|mesh-list
102124325|NCT03468972|Immunologic Factors|immunologic factors|mesh-ancestor
102124326|NCT03468972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124327|NCT03600714|Interferons|interferons|mesh-list
102124328|NCT03600714|Ritonavir|ritonavir|mesh-list
102124329|NCT03600714|Lonafarnib|lonafarnib|mesh-list
102124330|NCT03600714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102124331|NCT03600714|Antiviral Agents|antiviral agents|mesh-ancestor
102124332|NCT03600714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102124333|NCT03600714|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102124334|NCT03600714|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102124335|NCT03600714|Protease Inhibitors|protease inhibitors|mesh-ancestor
102124336|NCT03600714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102124337|NCT03600714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124338|NCT03600714|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102124339|NCT03600714|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102124340|NCT03600714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102124341|NCT03600714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102124342|NCT04590326|Cemiplimab|cemiplimab|mesh-list
102124354|NCT05163366|Anesthetics|anesthetics|mesh-ancestor
102124355|NCT05163366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102124356|NCT05163366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102124357|NCT05163366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102124358|NCT05163366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102124359|NCT05163366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124360|NCT05163366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102124361|NCT05163366|Narcotics|narcotics|mesh-ancestor
102124362|NCT00900783|Valacyclovir|valacyclovir|mesh-list
102124363|NCT00900783|Antiviral Agents|antiviral agents|mesh-ancestor
102124364|NCT00900783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102124365|NCT01035879|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102124366|NCT01035879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102124367|NCT01035879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124368|NCT01035879|Incretins|incretins|mesh-ancestor
102124369|NCT01035879|Hormones|hormones|mesh-ancestor
102124370|NCT01035879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102124371|NCT01035879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102124372|NCT01035879|Protease Inhibitors|protease inhibitors|mesh-ancestor
102124373|NCT01035879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102124374|NCT01035879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124386|NCT01029873|Cisplatin|cisplatin|mesh-list
102124387|NCT01029873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102124388|NCT01024101|Paclitaxel|paclitaxel|mesh-list
102124389|NCT01024101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102124390|NCT01024101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102124391|NCT01024101|Tubulin Modulators|tubulin modulators|mesh-ancestor
102124392|NCT01024101|Antimitotic Agents|antimitotic agents|mesh-ancestor
102124393|NCT01024101|Mitosis Modulators|mitosis modulators|mesh-ancestor
102124394|NCT01024101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124395|NCT04489706|Arsenic Trioxide|arsenic trioxide|mesh-list
102124396|NCT04489706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102124397|NCT00818571|Vildagliptin|vildagliptin|mesh-list
102124398|NCT00818571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102124399|NCT00818571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124400|NCT00818571|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102124401|NCT00818571|Protease Inhibitors|protease inhibitors|mesh-ancestor
102124402|NCT00818571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102124403|NCT00818571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124404|NCT00818493|Acetaminophen|acetaminophen|mesh-list
102124405|NCT00818493|Morphine|morphine|mesh-list
102124406|NCT00818493|Oxycodone|oxycodone|mesh-list
102124407|NCT00818493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102124408|NCT00818493|Narcotics|narcotics|mesh-ancestor
102022957|NCT02424136|Gasotransmitters|gasotransmitters|mesh-ancestor
102124409|NCT00818493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102124410|NCT00818493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124411|NCT00818493|Analgesics|analgesics|mesh-ancestor
102124412|NCT00818493|Sensory System Agents|sensory system agents|mesh-ancestor
102124413|NCT00818493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102124414|NCT00818493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102124415|NCT00818493|Antipyretics|antipyretics|mesh-ancestor
102124416|NCT04455126|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102124417|NCT04455126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102124418|NCT00893139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102124419|NCT00893139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102124420|NCT01378962|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102124421|NCT01378962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102124422|NCT01378962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102124423|NCT01378962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102124424|NCT01378962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124425|NCT00892203|Sumatriptan|sumatriptan|mesh-list
102124426|NCT00892203|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102124427|NCT00892203|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102124428|NCT00892203|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102124429|NCT00892203|Serotonin Agents|serotonin agents|mesh-ancestor
102124430|NCT00892203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102124431|NCT00892203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124432|NCT00892203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124433|NCT00810147|BMS 708163|bms 708163|mesh-list
102124434|NCT00810147|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
102124435|NCT00810147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102124436|NCT00810147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124437|NCT04375956|Pembrolizumab|pembrolizumab|mesh-list
102124438|NCT04375956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102124439|NCT04375956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102124440|NCT04375956|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102124441|NCT04375956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124442|NCT04495478|Ramucirumab|ramucirumab|mesh-list
102124443|NCT04495478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102124444|NCT04495478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102124445|NCT04495478|Immunologic Factors|immunologic factors|mesh-ancestor
102124446|NCT04495478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124447|NCT04487444|Thymalfasin|thymalfasin|mesh-list
102124448|NCT04487444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102124449|NCT04487444|Immunologic Factors|immunologic factors|mesh-ancestor
102124450|NCT04487444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124451|NCT02717156|Pembrolizumab|pembrolizumab|mesh-list
102124452|NCT02717156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102124453|NCT02717156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102124454|NCT02717156|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102124455|NCT02717156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124456|NCT00884715|Octreotide|octreotide|mesh-list
102124457|NCT00884715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102124458|NCT00884715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102124459|NCT00884715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102124460|NCT03603080|Metformin|metformin|mesh-list
102124461|NCT03603080|Topiramate|topiramate|mesh-list
102124462|NCT03603080|Anti-Obesity Agents|anti-obesity agents|mesh-list
102124463|NCT03603080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102124464|NCT03603080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124465|NCT03603080|Anticonvulsants|anticonvulsants|mesh-ancestor
102124466|NCT01019187|Modafinil|modafinil|mesh-list
102124467|NCT01019187|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102124468|NCT01019187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124469|NCT01019187|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102124470|NCT01019187|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102124471|NCT01019187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102124472|NCT01019187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124473|NCT05088876|Acetaminophen|acetaminophen|mesh-list
102124474|NCT05088876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102124475|NCT05088876|Analgesics|analgesics|mesh-ancestor
102124476|NCT05088876|Sensory System Agents|sensory system agents|mesh-ancestor
102124477|NCT05088876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102124478|NCT05088876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124479|NCT05088876|Antipyretics|antipyretics|mesh-ancestor
102124480|NCT05084508|Vaccines|vaccines|mesh-list
102124481|NCT05084508|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102124482|NCT05084508|Immunologic Factors|immunologic factors|mesh-ancestor
102124483|NCT05084508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124484|NCT01018875|Donepezil|donepezil|mesh-list
102124485|NCT01018875|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102124486|NCT01018875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102124487|NCT01018875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124488|NCT01018875|Cholinergic Agents|cholinergic agents|mesh-ancestor
102124489|NCT01018875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102124490|NCT01018875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535874|NCT05339373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102124491|NCT01018875|Nootropic Agents|nootropic agents|mesh-ancestor
102124492|NCT05390736|Vitamin D|vitamin d|mesh-list
102124493|NCT05390736|Vitamins|vitamins|mesh-ancestor
102124494|NCT05390736|Micronutrients|micronutrients|mesh-ancestor
102124495|NCT05390736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124496|NCT05390736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102124497|NCT00806403|Reteplase|reteplase|mesh-list
102124498|NCT00806403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102124499|NCT00806403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102124500|NCT00806403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124501|NCT01007721|Fluticasone|fluticasone|mesh-list
102124503|NCT01007721|Montelukast|montelukast|mesh-list
102124504|NCT01007721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102124505|NCT01007721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102124506|NCT01007721|Autonomic Agents|autonomic agents|mesh-ancestor
102124507|NCT01007721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102124508|NCT01007721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124509|NCT01007721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102124510|NCT01007721|Respiratory System Agents|respiratory system agents|mesh-ancestor
102124511|NCT01007721|Dermatologic Agents|dermatologic agents|mesh-ancestor
102124512|NCT01007721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102124513|NCT01007721|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102124514|NCT01007721|Hormone Antagonists|hormone antagonists|mesh-ancestor
102124515|NCT01007721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102124516|NCT01007721|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102124517|NCT01007721|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102124518|NCT01007721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124519|NCT00701558|Gemcitabine|gemcitabine|mesh-list
102124520|NCT00701558|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102124521|NCT00701558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102124522|NCT00701558|Antimetabolites|antimetabolites|mesh-ancestor
102124523|NCT00701558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124524|NCT00701558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102124525|NCT00701558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102124526|NCT00701558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102124527|NCT03233828|Aldesleukin|aldesleukin|mesh-list
102124528|NCT03233828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102124529|NCT03233828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102124530|NCT03233828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102124531|NCT03233828|Antiviral Agents|antiviral agents|mesh-ancestor
102124532|NCT03233828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102124533|NCT03882177|Vitamin B 6|vitamin b 6|mesh-list
102124534|NCT03882177|Pyridoxal|pyridoxal|mesh-list
102124535|NCT03882177|Pyridoxine|pyridoxine|mesh-list
102124536|NCT03882177|Pravastatin|pravastatin|mesh-list
102124537|NCT03882177|Vitamins|vitamins|mesh-ancestor
102124538|NCT03882177|Micronutrients|micronutrients|mesh-ancestor
102124539|NCT03882177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124540|NCT03882177|Vitamin B Complex|vitamin b complex|mesh-ancestor
102124541|NCT03882177|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102124542|NCT03882177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102124543|NCT03882177|Antimetabolites|antimetabolites|mesh-ancestor
102124544|NCT03882177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124545|NCT03882177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102124546|NCT03882177|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102124547|NCT03882177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102124548|NCT01007097|Glimepiride|glimepiride|mesh-list
102124549|NCT01007097|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102124550|NCT01007097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102124551|NCT01007097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124552|NCT01007097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102124553|NCT01007097|Immunologic Factors|immunologic factors|mesh-ancestor
102124554|NCT01663402|Alirocumab|alirocumab|mesh-list
102124555|NCT01663402|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102124556|NCT01663402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102124557|NCT01663402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102124558|NCT01663402|Antimetabolites|antimetabolites|mesh-ancestor
102124559|NCT01663402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124560|NCT01663402|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102124561|NCT01663402|Protease Inhibitors|protease inhibitors|mesh-ancestor
102124562|NCT01663402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102124563|NCT01663402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102124564|NCT05115903|Adalimumab|adalimumab|mesh-list
102124565|NCT05115903|Infliximab|infliximab|mesh-list
102124566|NCT05115903|Golimumab|golimumab|mesh-list
102124567|NCT05115903|Certolizumab Pegol|certolizumab pegol|mesh-list
102124568|NCT05115903|Etanercept|etanercept|mesh-list
102124569|NCT05115903|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102124570|NCT05115903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102124571|NCT05115903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102124572|NCT05115903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102124573|NCT05115903|Dermatologic Agents|dermatologic agents|mesh-ancestor
102124574|NCT05115903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102124575|NCT05115903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102124576|NCT05115903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102124577|NCT05115903|Analgesics|analgesics|mesh-ancestor
102124578|NCT05115903|Sensory System Agents|sensory system agents|mesh-ancestor
102124579|NCT05115903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102124580|NCT05115903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124581|NCT05115903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102124582|NCT05115903|Immunologic Factors|immunologic factors|mesh-ancestor
102124583|NCT03223298|Botulinum Toxins|botulinum toxins|mesh-list
102124584|NCT03223298|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102124585|NCT03223298|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102124586|NCT03223298|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102124587|NCT03223298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102124588|NCT03223298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124589|NCT03223298|Cholinergic Agents|cholinergic agents|mesh-ancestor
102124590|NCT03223298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102023140|NCT01355991|Parasympatholytics|parasympatholytics|mesh-ancestor
102124591|NCT03223298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124592|NCT03223298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102124593|NCT03223298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102124594|NCT00869661|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102124595|NCT00869661|Interferon-alpha|interferon-alpha|mesh-list
102124596|NCT00869661|Ribavirin|ribavirin|mesh-list
102124597|NCT00869661|Antiviral Agents|antiviral agents|mesh-ancestor
102124598|NCT00869661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102124599|NCT00869661|Immunologic Factors|immunologic factors|mesh-ancestor
102124600|NCT00869661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124601|NCT00869661|Antimetabolites|antimetabolites|mesh-ancestor
102124602|NCT00869661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124603|NCT03192566|Acetaminophen|acetaminophen|mesh-list
102124604|NCT03192566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102124605|NCT03192566|Analgesics|analgesics|mesh-ancestor
102124606|NCT03192566|Sensory System Agents|sensory system agents|mesh-ancestor
102124607|NCT03192566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102124608|NCT03192566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124609|NCT03192566|Antipyretics|antipyretics|mesh-ancestor
102124610|NCT03296930|Ritonavir|ritonavir|mesh-list
102124611|NCT03296930|Ribavirin|ribavirin|mesh-list
102124612|NCT03296930|Sofosbuvir|sofosbuvir|mesh-list
102124613|NCT03296930|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102124614|NCT03296930|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102124615|NCT03296930|Protease Inhibitors|protease inhibitors|mesh-ancestor
102124616|NCT03296930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102124617|NCT03296930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124618|NCT03296930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102124619|NCT03296930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102124620|NCT03296930|Antiviral Agents|antiviral agents|mesh-ancestor
102124621|NCT03296930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102124622|NCT03296930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102124623|NCT03296930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102124624|NCT03296930|Antimetabolites|antimetabolites|mesh-ancestor
102124625|NCT04607772|Rituximab|rituximab|mesh-list
102124626|NCT04607772|Gemcitabine|gemcitabine|mesh-list
102124627|NCT04607772|Oxaliplatin|oxaliplatin|mesh-list
102124628|NCT04607772|Lenalidomide|lenalidomide|mesh-list
102124629|NCT04607772|Venetoclax|venetoclax|mesh-list
102124630|NCT04607772|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102124631|NCT04607772|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
102124632|NCT04607772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102124633|NCT04607772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102124634|NCT04607772|Immunologic Factors|immunologic factors|mesh-ancestor
102124635|NCT04607772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124636|NCT04607772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102124637|NCT04607772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102124638|NCT04607772|Antimetabolites|antimetabolites|mesh-ancestor
102124639|NCT04607772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124640|NCT04607772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102124641|NCT04607772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102124642|NCT04607772|Growth Substances|growth substances|mesh-ancestor
102124643|NCT04607772|Growth Inhibitors|growth inhibitors|mesh-ancestor
102124644|NCT04607772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102124645|NCT04607772|Alkylating Agents|alkylating agents|mesh-ancestor
102124646|NCT04607772|Immunoconjugates|immunoconjugates|mesh-ancestor
102124647|NCT02464124|Nitazoxanide|nitazoxanide|mesh-list
102124648|NCT02464124|Lactulose|lactulose|mesh-list
102124649|NCT02464124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102124650|NCT02464124|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102124651|NCT02464124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102124652|NCT00859521|Levetiracetam|levetiracetam|mesh-list
102124653|NCT00859521|Anticonvulsants|anticonvulsants|mesh-ancestor
102124654|NCT00859521|Nootropic Agents|nootropic agents|mesh-ancestor
102124655|NCT05398770|Vitamin D|vitamin d|mesh-list
102124656|NCT05398770|Vitamins|vitamins|mesh-ancestor
102124657|NCT05398770|Micronutrients|micronutrients|mesh-ancestor
102124658|NCT05398770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124659|NCT05398770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102124660|NCT00843687|Risperidone|risperidone|mesh-list
102124661|NCT00843687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102124662|NCT00843687|Serotonin Agents|serotonin agents|mesh-ancestor
102124663|NCT00843687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102124664|NCT00843687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124665|NCT00843687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124666|NCT00843687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102124667|NCT00843687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102124668|NCT00843687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102124669|NCT00843687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102124670|NCT00843687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102124671|NCT00843687|Dopamine Agents|dopamine agents|mesh-ancestor
102124672|NCT04642131|Caffeine|caffeine|mesh-list
102124673|NCT04642131|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102124674|NCT04642131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124675|NCT04642131|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102124676|NCT04642131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102124677|NCT04642131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124678|NCT04642131|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102124679|NCT04642131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102124680|NCT04642131|Purinergic Agents|purinergic agents|mesh-ancestor
102124681|NCT04642131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102124682|NCT01001715|Fasinumab|fasinumab|mesh-list
102124683|NCT01001715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102124684|NCT01001715|Analgesics|analgesics|mesh-ancestor
102124685|NCT01001715|Sensory System Agents|sensory system agents|mesh-ancestor
102124686|NCT01001715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102124687|NCT01001715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124688|NCT02463812|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102124689|NCT02463812|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102124690|NCT02463812|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102124691|NCT02463812|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102124692|NCT00789633|Gemcitabine|gemcitabine|mesh-list
102124693|NCT00789633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102124694|NCT00789633|Antimetabolites|antimetabolites|mesh-ancestor
102124695|NCT00789633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124696|NCT00789633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102124697|NCT00788541|Hydrocortisone|hydrocortisone|mesh-list
102124698|NCT00788541|Anecortave|anecortave|mesh-list
102124699|NCT00788541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102124700|NCT00788541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102124701|NCT00788541|Growth Substances|growth substances|mesh-ancestor
102124702|NCT00788541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124703|NCT00788541|Growth Inhibitors|growth inhibitors|mesh-ancestor
102124704|NCT00788541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102124705|NCT00788541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102124706|NCT03296540|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102124707|NCT03296540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102124708|NCT04489160|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
102124709|NCT04489160|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102124710|NCT04489160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102124711|NCT04489160|Immunologic Factors|immunologic factors|mesh-ancestor
102124712|NCT04489160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124713|NCT00786201|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102124714|NCT00786201|Immunologic Factors|immunologic factors|mesh-ancestor
102124715|NCT00786201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124716|NCT05514483|Ondansetron|ondansetron|mesh-list
102124717|NCT05514483|Antiemetics|antiemetics|mesh-ancestor
102124718|NCT05514483|Autonomic Agents|autonomic agents|mesh-ancestor
102124719|NCT05514483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102124720|NCT05514483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124721|NCT05514483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102124722|NCT05514483|Antipruritics|antipruritics|mesh-ancestor
102124723|NCT05514483|Dermatologic Agents|dermatologic agents|mesh-ancestor
102124724|NCT05514483|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102124725|NCT05514483|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102124726|NCT05514483|Serotonin Agents|serotonin agents|mesh-ancestor
102124727|NCT05514483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102124728|NCT05514483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124729|NCT00841815|Amlodipine|amlodipine|mesh-list
102124730|NCT00841815|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102124731|NCT00841815|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102124732|NCT00841815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102124733|NCT00841815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023279|NCT03710863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102124734|NCT00841815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102124735|NCT00841815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124736|NCT00841815|Vasodilator Agents|vasodilator agents|mesh-ancestor
102124737|NCT03296306|Cisplatin|cisplatin|mesh-list
102124738|NCT03296306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102124739|NCT04440280|Acetylcysteine|acetylcysteine|mesh-list
102124740|NCT04440280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102124741|NCT04440280|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102124742|NCT04440280|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102124743|NCT04440280|Antiviral Agents|antiviral agents|mesh-ancestor
102124744|NCT04440280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102124745|NCT04440280|Expectorants|expectorants|mesh-ancestor
102124746|NCT04440280|Respiratory System Agents|respiratory system agents|mesh-ancestor
102124747|NCT04440280|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102124748|NCT04440280|Antioxidants|antioxidants|mesh-ancestor
102124749|NCT04440280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124750|NCT04440280|Protective Agents|protective agents|mesh-ancestor
102124751|NCT04440280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124752|NCT04440280|Antidotes|antidotes|mesh-ancestor
102124753|NCT00841659|Paroxetine|paroxetine|mesh-list
102124754|NCT00841659|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102124755|NCT00841659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102124756|NCT00841659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102124757|NCT00841659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124758|NCT00841659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102124759|NCT00841659|Serotonin Agents|serotonin agents|mesh-ancestor
102124760|NCT00841659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124761|NCT00841659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102124762|NCT00841659|Antidepressive Agents|antidepressive agents|mesh-ancestor
102124763|NCT00841659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102124764|NCT00841659|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102124765|NCT00841659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102124766|NCT00841659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102124767|NCT04061252|Brodalumab|brodalumab|mesh-list
102124768|NCT04061252|Dermatologic Agents|dermatologic agents|mesh-ancestor
102124769|NCT04473417|Dapagliflozin|dapagliflozin|mesh-list
102124770|NCT04473417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102124771|NCT04473417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124772|NCT04473417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102124773|NCT04473417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124774|NCT01001091|Dexamethasone|dexamethasone|mesh-list
102124775|NCT01001091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102124776|NCT01001091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102124777|NCT01001091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102124778|NCT01001091|Antiemetics|antiemetics|mesh-ancestor
102124779|NCT01001091|Autonomic Agents|autonomic agents|mesh-ancestor
102124780|NCT01001091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102124781|NCT01001091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124782|NCT01001091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102124783|NCT01001091|Glucocorticoids|glucocorticoids|mesh-ancestor
102124784|NCT01001091|Hormones|hormones|mesh-ancestor
102124785|NCT01001091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102124786|NCT01001091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102124787|NCT01001091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102124788|NCT05076682|Cromolyn Sodium|cromolyn sodium|mesh-list
102124789|NCT05076682|Efavirenz|efavirenz|mesh-list
102124790|NCT05076682|Choline|choline|mesh-list
102124791|NCT05076682|Antibodies|antibodies|mesh-list
102124792|NCT05076682|Immunologic Factors|immunologic factors|mesh-ancestor
102124793|NCT05076682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124794|NCT05076682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102124795|NCT05076682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102124797|NCT05076682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124798|NCT05076682|Antiviral Agents|antiviral agents|mesh-ancestor
102124799|NCT05076682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102023350|NCT04583592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102124800|NCT05076682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102124801|NCT05076682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102124802|NCT05076682|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102124803|NCT05076682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102124804|NCT05076682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102124805|NCT05076682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102124806|NCT05076682|Lipotropic Agents|lipotropic agents|mesh-ancestor
102124807|NCT05076682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102124808|NCT05076682|Antimetabolites|antimetabolites|mesh-ancestor
102124809|NCT05076682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102124810|NCT05076682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102124811|NCT05076682|Nootropic Agents|nootropic agents|mesh-ancestor
102124812|NCT05076682|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
102124813|NCT05076682|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102124814|NCT05076682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102124815|NCT05076682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102124816|NCT05076682|Respiratory System Agents|respiratory system agents|mesh-ancestor
102124817|NCT00840879|Meloxicam|meloxicam|mesh-list
102124818|NCT00840879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102124819|NCT00840879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102124820|NCT00840879|Analgesics|analgesics|mesh-ancestor
102124821|NCT00840879|Sensory System Agents|sensory system agents|mesh-ancestor
102124822|NCT00840879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102124823|NCT00840879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124824|NCT00840879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102124825|NCT00840879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102124826|NCT00840879|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102124827|NCT00840879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102124828|NCT00840879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102124829|NCT00840879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124830|NCT02163434|Gabapentin|gabapentin|mesh-list
102124831|NCT02163434|Metoclopramide|metoclopramide|mesh-list
102124832|NCT02163434|Analgesics|analgesics|mesh-ancestor
102124833|NCT02163434|Sensory System Agents|sensory system agents|mesh-ancestor
102124834|NCT02163434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102124835|NCT02163434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124836|NCT02163434|Anticonvulsants|anticonvulsants|mesh-ancestor
102124837|NCT02163434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102124838|NCT02163434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102124839|NCT02163434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102124840|NCT02163434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102124841|NCT02163434|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102124842|NCT02163434|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102124843|NCT02163434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102124844|NCT02163434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124845|NCT02163434|Antimanic Agents|antimanic agents|mesh-ancestor
102124846|NCT02163434|Antiemetics|antiemetics|mesh-ancestor
102124847|NCT02163434|Autonomic Agents|autonomic agents|mesh-ancestor
102124848|NCT02163434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102124849|NCT02163434|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102124850|NCT02163434|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102124851|NCT02163434|Dopamine Agents|dopamine agents|mesh-ancestor
102124853|NCT04015622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102124854|NCT04015622|Tubulin Modulators|tubulin modulators|mesh-ancestor
102124855|NCT04015622|Antimitotic Agents|antimitotic agents|mesh-ancestor
102124856|NCT04015622|Mitosis Modulators|mitosis modulators|mesh-ancestor
102124857|NCT04015622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124858|NCT00840411|Clarithromycin|clarithromycin|mesh-list
102124859|NCT00840411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102124860|NCT00840411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102124861|NCT00840411|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102124862|NCT00840411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102124863|NCT00840411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124864|NCT00840411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102124865|NCT00840411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102124866|NCT00840099|Amoxicillin|amoxicillin|mesh-list
102124867|NCT00840099|Clavulanic Acid|clavulanic acid|mesh-list
102124868|NCT00840099|Clavulanic Acids|clavulanic acids|mesh-list
102124869|NCT00840099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102023419|NCT02930343|Analgesics|analgesics|mesh-ancestor
102124870|NCT00840099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102124871|NCT00840099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102124872|NCT00840099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102124873|NCT00840099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102124874|NCT00840099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124875|NCT03108248|Doxorubicin|doxorubicin|mesh-list
102124876|NCT03108248|Ethiodized Oil|ethiodized oil|mesh-list
102124877|NCT03108248|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
102124878|NCT03108248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102124879|NCT03108248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102124880|NCT03108248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102124881|NCT03108248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102124882|NCT03108248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102124883|NCT03108248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124884|NCT03108248|Hemostatics|hemostatics|mesh-ancestor
102124885|NCT03108248|Coagulants|coagulants|mesh-ancestor
102124886|NCT00836901|Amoxicillin|amoxicillin|mesh-list
102124887|NCT00836901|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102124888|NCT00836901|Clavulanic Acids|clavulanic acids|mesh-list
102124889|NCT00836901|Clavulanic Acid|clavulanic acid|mesh-list
102124890|NCT00836901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102124891|NCT00836901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102124892|NCT00836901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102124893|NCT00836901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102124894|NCT00836901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124895|NCT04460560|Terlipressin|terlipressin|mesh-list
102124896|NCT04460560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102124897|NCT04460560|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102124898|NCT04537689|Cyclosporine|cyclosporine|mesh-list
102124899|NCT04537689|Methotrexate|methotrexate|mesh-list
102124900|NCT04537689|Ixekizumab|ixekizumab|mesh-list
102124901|NCT04537689|Acitretin|acitretin|mesh-list
102124902|NCT04537689|Cyclosporins|cyclosporins|mesh-list
102124903|NCT04537689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102124904|NCT04537689|Abortifacient Agents|abortifacient agents|mesh-ancestor
102124905|NCT04537689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102124906|NCT04537689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124907|NCT04537689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102124908|NCT04537689|Antimetabolites|antimetabolites|mesh-ancestor
102124909|NCT04537689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124910|NCT04537689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102124911|NCT04537689|Dermatologic Agents|dermatologic agents|mesh-ancestor
102124912|NCT04537689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102124913|NCT04537689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102124914|NCT04537689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102124915|NCT04537689|Immunologic Factors|immunologic factors|mesh-ancestor
102124916|NCT04537689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102124917|NCT04537689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102124918|NCT04537689|Antifungal Agents|antifungal agents|mesh-ancestor
102124919|NCT04537689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102124920|NCT04537689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102124921|NCT04537689|Keratolytic Agents|keratolytic agents|mesh-ancestor
102124922|NCT03295760|Ubiquinone|ubiquinone|mesh-list
102124923|NCT03295760|Coenzyme Q10|coenzyme q10|mesh-list
102124924|NCT03295760|Micronutrients|micronutrients|mesh-ancestor
102124925|NCT03295760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124926|NCT03295760|Vitamins|vitamins|mesh-ancestor
102124927|NCT05563012|Capecitabine|capecitabine|mesh-list
102124928|NCT05563012|Oxaliplatin|oxaliplatin|mesh-list
102124929|NCT05563012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102124930|NCT05563012|Antimetabolites|antimetabolites|mesh-ancestor
102124931|NCT05563012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124932|NCT05563012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102124933|NCT04501653|Methylphenidate|methylphenidate|mesh-list
102124934|NCT04501653|Psilocybin|psilocybin|mesh-list
102124935|NCT04501653|Psilocin|psilocin|mesh-list
102124936|NCT04501653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102124937|NCT04501653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124938|NCT04501653|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102124939|NCT04501653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102124940|NCT04501653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102124941|NCT04501653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124942|NCT04501653|Dopamine Agents|dopamine agents|mesh-ancestor
102124943|NCT04501653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102124944|NCT04501653|Hallucinogens|hallucinogens|mesh-ancestor
102124945|NCT04501653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102124946|NCT04730206|Molnupiravir|molnupiravir|mesh-list
102124948|NCT04730206|Protease Inhibitors|protease inhibitors|mesh-ancestor
102124949|NCT04730206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102124950|NCT04730206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124951|NCT04730206|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102124952|NCT04730206|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102124953|NCT04730206|Antiviral Agents|antiviral agents|mesh-ancestor
102124954|NCT04730206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102124955|NCT00990327|Adenosine|adenosine|mesh-list
102124956|NCT00990327|Analgesics|analgesics|mesh-ancestor
102124957|NCT00990327|Sensory System Agents|sensory system agents|mesh-ancestor
102124958|NCT00990327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102124959|NCT00990327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124960|NCT00990327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102124961|NCT00990327|Vasodilator Agents|vasodilator agents|mesh-ancestor
102124962|NCT00990327|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102124963|NCT00990327|Purinergic Agonists|purinergic agonists|mesh-ancestor
102124964|NCT00990327|Purinergic Agents|purinergic agents|mesh-ancestor
102124965|NCT00990327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102124966|NCT00990327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124967|NCT03050814|Leucovorin|leucovorin|mesh-list
102124968|NCT03050814|Bevacizumab|bevacizumab|mesh-list
102124969|NCT03050814|Avelumab|avelumab|mesh-list
102124970|NCT03050814|Fluorouracil|fluorouracil|mesh-list
102124971|NCT03050814|Capecitabine|capecitabine|mesh-list
102124972|NCT03050814|Oxaliplatin|oxaliplatin|mesh-list
102124973|NCT03050814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102124974|NCT03050814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102124975|NCT03050814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102124976|NCT03050814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102124977|NCT03050814|Growth Substances|growth substances|mesh-ancestor
102124978|NCT03050814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124979|NCT03050814|Growth Inhibitors|growth inhibitors|mesh-ancestor
102124980|NCT03050814|Antimetabolites|antimetabolites|mesh-ancestor
102124981|NCT03050814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102124982|NCT03050814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102124983|NCT03050814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102124984|NCT03050814|Immunologic Factors|immunologic factors|mesh-ancestor
102124985|NCT03050814|Antidotes|antidotes|mesh-ancestor
102124986|NCT03050814|Protective Agents|protective agents|mesh-ancestor
102124987|NCT03050814|Vitamin B Complex|vitamin b complex|mesh-ancestor
102124988|NCT03050814|Vitamins|vitamins|mesh-ancestor
102124989|NCT03050814|Micronutrients|micronutrients|mesh-ancestor
102124990|NCT02462174|Ketamine|ketamine|mesh-list
102124991|NCT02462174|Bupivacaine|bupivacaine|mesh-list
102124992|NCT02462174|Anesthetics, Local|anesthetics, local|mesh-ancestor
102124993|NCT02462174|Anesthetics|anesthetics|mesh-ancestor
102124994|NCT02462174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102124995|NCT02462174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102124996|NCT02462174|Sensory System Agents|sensory system agents|mesh-ancestor
102124997|NCT02462174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102124998|NCT02462174|Analgesics|analgesics|mesh-ancestor
102124999|NCT02462174|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102125000|NCT02462174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102125001|NCT02462174|Anesthetics, General|anesthetics, general|mesh-ancestor
102125002|NCT02462174|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102125003|NCT02462174|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102125004|NCT02462174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102125005|NCT02462174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125006|NCT02564146|Paclitaxel|paclitaxel|mesh-list
102125007|NCT02564146|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102125008|NCT02564146|Gemcitabine|gemcitabine|mesh-list
102125009|NCT02564146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102125010|NCT02564146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102125011|NCT02564146|Tubulin Modulators|tubulin modulators|mesh-ancestor
102125012|NCT02564146|Antimitotic Agents|antimitotic agents|mesh-ancestor
102125013|NCT02564146|Mitosis Modulators|mitosis modulators|mesh-ancestor
102023555|NCT03116776|Viscosupplements|viscosupplements|mesh-ancestor
102125014|NCT02564146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125015|NCT02564146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102125016|NCT02564146|Antimetabolites|antimetabolites|mesh-ancestor
102125017|NCT00981357|Naproxen|naproxen|mesh-list
102125018|NCT00981357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102125019|NCT00981357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102125020|NCT00981357|Analgesics|analgesics|mesh-ancestor
102125021|NCT00981357|Sensory System Agents|sensory system agents|mesh-ancestor
102125022|NCT00981357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102125023|NCT00981357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125024|NCT00981357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102125025|NCT00981357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102125026|NCT00981357|Gout Suppressants|gout suppressants|mesh-ancestor
102125027|NCT00981357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102125028|NCT00981357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102125029|NCT00981357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125030|NCT02462252|Cyclosporine|cyclosporine|mesh-list
102125031|NCT02462252|Methylprednisolone|methylprednisolone|mesh-list
102125032|NCT02462252|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102125033|NCT02462252|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102125034|NCT02462252|Cyclosporins|cyclosporins|mesh-list
102125035|NCT02462252|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102125036|NCT02462252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102125037|NCT02462252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125038|NCT02462252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102125039|NCT02462252|Immunologic Factors|immunologic factors|mesh-ancestor
102125040|NCT02462252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125041|NCT02462252|Antifungal Agents|antifungal agents|mesh-ancestor
102125042|NCT02462252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102125043|NCT02462252|Dermatologic Agents|dermatologic agents|mesh-ancestor
102125044|NCT02462252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102125045|NCT02462252|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102125046|NCT02462252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102125047|NCT02462252|Antiemetics|antiemetics|mesh-ancestor
102125048|NCT02462252|Autonomic Agents|autonomic agents|mesh-ancestor
102125049|NCT02462252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102125050|NCT02462252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102125051|NCT02462252|Glucocorticoids|glucocorticoids|mesh-ancestor
102125052|NCT02462252|Hormones|hormones|mesh-ancestor
102125053|NCT02462252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102125054|NCT02462252|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102125055|NCT02462252|Protective Agents|protective agents|mesh-ancestor
102125056|NCT02462252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102125057|NCT02462252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102125058|NCT03130452|Amoxicillin|amoxicillin|mesh-list
102125059|NCT03130452|Metronidazole|metronidazole|mesh-list
102125060|NCT03130452|Clarithromycin|clarithromycin|mesh-list
102125061|NCT03130452|Lansoprazole|lansoprazole|mesh-list
102125062|NCT03130452|Dexlansoprazole|dexlansoprazole|mesh-list
102125063|NCT03130452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102125064|NCT03130452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102125065|NCT03130452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102125066|NCT03130452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102125067|NCT03130452|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102125068|NCT03130452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102125069|NCT03130452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125070|NCT03130452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102125071|NCT03130452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102125072|NCT03130452|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102125073|NCT03130452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102125074|NCT03130452|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102125075|NCT00979251|Oseltamivir|oseltamivir|mesh-list
102125076|NCT00979251|Amantadine|amantadine|mesh-list
102125077|NCT00979251|Antiviral Agents|antiviral agents|mesh-ancestor
102125078|NCT00979251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102125079|NCT00979251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102125080|NCT00979251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125081|NCT00979251|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102125082|NCT00979251|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102125083|NCT00979251|Dopamine Agents|dopamine agents|mesh-ancestor
102125084|NCT00979251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102125085|NCT00979251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125086|NCT00979251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102125087|NCT00979251|Analgesics|analgesics|mesh-ancestor
102125088|NCT00979251|Sensory System Agents|sensory system agents|mesh-ancestor
102125089|NCT00979251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102125090|NCT04551352|Adalimumab|adalimumab|mesh-list
102125091|NCT04551352|Obinutuzumab|obinutuzumab|mesh-list
102125092|NCT04551352|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102125093|NCT04551352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102125094|NCT04551352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102125095|NCT04551352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102125096|NCT04551352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102125097|NCT05398224|Rituximab|rituximab|mesh-list
102125098|NCT05398224|Methotrexate|methotrexate|mesh-list
102125099|NCT05398224|Zanubrutinib|zanubrutinib|mesh-list
102125100|NCT05398224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102125101|NCT05398224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102125102|NCT05398224|Immunologic Factors|immunologic factors|mesh-ancestor
102125103|NCT05398224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125104|NCT05398224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102125105|NCT05398224|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102125106|NCT05398224|Abortifacient Agents|abortifacient agents|mesh-ancestor
102125107|NCT05398224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102125108|NCT05398224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102125109|NCT05398224|Antimetabolites|antimetabolites|mesh-ancestor
102125110|NCT05398224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125111|NCT05398224|Dermatologic Agents|dermatologic agents|mesh-ancestor
102125112|NCT05398224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102125113|NCT05398224|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102125114|NCT05398224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102125115|NCT05398224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102125116|NCT05398224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102125117|NCT04542304|Metolazone|metolazone|mesh-list
102125118|NCT04542304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102125119|NCT04542304|Diuretics|diuretics|mesh-ancestor
102125120|NCT04542304|Natriuretic Agents|natriuretic agents|mesh-ancestor
102125121|NCT04542304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125122|NCT04542304|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102125123|NCT04542304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102125124|NCT04542304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125125|NCT02463110|Sertraline|sertraline|mesh-list
102125126|NCT02463110|Antidepressive Agents|antidepressive agents|mesh-ancestor
102125127|NCT02463110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102125128|NCT02463110|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102125129|NCT02463110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102125130|NCT02463110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102125131|NCT02463110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125132|NCT02463110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102125133|NCT02463110|Serotonin Agents|serotonin agents|mesh-ancestor
102125134|NCT02463110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125135|NCT05502952|Pentoxifylline|pentoxifylline|mesh-list
102125136|NCT05502952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102125137|NCT05502952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102125138|NCT05502952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125139|NCT05502952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102125140|NCT05502952|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102125141|NCT05502952|Protective Agents|protective agents|mesh-ancestor
102125142|NCT05502952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125143|NCT05502952|Vasodilator Agents|vasodilator agents|mesh-ancestor
102125144|NCT05502952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102125145|NCT05502952|Antioxidants|antioxidants|mesh-ancestor
102125146|NCT00835575|Mirtazapine|mirtazapine|mesh-list
102125147|NCT00835575|Antidepressive Agents|antidepressive agents|mesh-ancestor
102125148|NCT00835575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102125149|NCT00835575|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102125150|NCT00835575|Histamine Antagonists|histamine antagonists|mesh-ancestor
102125151|NCT00835575|Histamine Agents|histamine agents|mesh-ancestor
102125152|NCT00835575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102125153|NCT00835575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125154|NCT00835575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125155|NCT00835575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102125156|NCT00835575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102125157|NCT00835575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102125158|NCT00835575|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102125159|NCT00835575|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102125160|NCT00835575|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102125161|NCT00835575|Adrenergic Agents|adrenergic agents|mesh-ancestor
102125162|NCT00835575|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102125163|NCT00835575|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102125164|NCT00835575|Serotonin Agents|serotonin agents|mesh-ancestor
102125165|NCT00835575|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102125166|NCT00777309|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102125167|NCT00777309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102125168|NCT00777309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102125169|NCT00777309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102154328|NCT03365817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535875|NCT05339373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125170|NCT00777309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125172|NCT03295214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102125173|NCT03295214|Analgesics|analgesics|mesh-ancestor
102125174|NCT03295214|Sensory System Agents|sensory system agents|mesh-ancestor
102125175|NCT03295214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102125176|NCT03295214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125177|NCT03295214|Antipyretics|antipyretics|mesh-ancestor
102125178|NCT04604704|Niacinamide|niacinamide|mesh-list
102125179|NCT04604704|Naltrexone|naltrexone|mesh-list
102125180|NCT04604704|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102125181|NCT04604704|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102125182|NCT04604704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125183|NCT04604704|Sensory System Agents|sensory system agents|mesh-ancestor
102125184|NCT04604704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102125185|NCT04604704|Vitamin B Complex|vitamin b complex|mesh-ancestor
102125186|NCT04604704|Vitamins|vitamins|mesh-ancestor
102125187|NCT04604704|Micronutrients|micronutrients|mesh-ancestor
102125188|NCT00776373|Cytarabine|cytarabine|mesh-list
102125189|NCT00776373|Sirolimus|sirolimus|mesh-list
102125190|NCT00776373|Etoposide|etoposide|mesh-list
102125191|NCT00776373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102125192|NCT00776373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102125193|NCT00776373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102125194|NCT00776373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102125195|NCT00776373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102125196|NCT00776373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125197|NCT00776373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102125198|NCT00776373|Antimetabolites|antimetabolites|mesh-ancestor
102125199|NCT00776373|Antiviral Agents|antiviral agents|mesh-ancestor
102125200|NCT00776373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102125201|NCT00776373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102125202|NCT00776373|Immunologic Factors|immunologic factors|mesh-ancestor
102125203|NCT00776373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125204|NCT00776373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102125205|NCT00776373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102125206|NCT00776373|Antifungal Agents|antifungal agents|mesh-ancestor
102125207|NCT00772785|Buprenorphine|buprenorphine|mesh-list
102125208|NCT00772785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102125209|NCT00772785|Narcotics|narcotics|mesh-ancestor
102125210|NCT00772785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102125211|NCT00772785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125212|NCT00772785|Analgesics|analgesics|mesh-ancestor
102125213|NCT00772785|Sensory System Agents|sensory system agents|mesh-ancestor
102125214|NCT00772785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102125215|NCT00772785|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102125216|NCT02461706|Cannabidiol|cannabidiol|mesh-list
102125217|NCT02461706|Anticonvulsants|anticonvulsants|mesh-ancestor
102125218|NCT05497570|Tenoxicam|tenoxicam|mesh-list
102125219|NCT05497570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102125220|NCT05497570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102125221|NCT05497570|Analgesics|analgesics|mesh-ancestor
102125222|NCT05497570|Sensory System Agents|sensory system agents|mesh-ancestor
102125223|NCT05497570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102125224|NCT05497570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125225|NCT05497570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102125226|NCT05497570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102125227|NCT05497570|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102125228|NCT05497570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102125229|NCT05497570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125230|NCT00963885|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102125232|NCT00963885|Antiviral Agents|antiviral agents|mesh-ancestor
102125233|NCT00963885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102125234|NCT00963885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102125235|NCT05497492|Lidocaine|lidocaine|mesh-list
102125236|NCT05497492|Sufentanil|sufentanil|mesh-list
102125237|NCT05497492|Propofol|propofol|mesh-list
102125238|NCT05497492|Esketamine|esketamine|mesh-list
102125239|NCT05497492|Anesthetics, Local|anesthetics, local|mesh-ancestor
102125240|NCT05497492|Anesthetics|anesthetics|mesh-ancestor
102125241|NCT05497492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102125242|NCT05497492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125243|NCT05497492|Sensory System Agents|sensory system agents|mesh-ancestor
102125244|NCT05497492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102125245|NCT05497492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102125246|NCT05497492|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102125247|NCT05497492|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102125248|NCT05497492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102125249|NCT05497492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125250|NCT05497492|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102125251|NCT05497492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102125252|NCT05497492|Anesthetics, General|anesthetics, general|mesh-ancestor
102125253|NCT05497492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102125254|NCT05497492|Narcotics|narcotics|mesh-ancestor
102125255|NCT05497492|Analgesics|analgesics|mesh-ancestor
102125256|NCT05497492|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102125257|NCT05497492|Antidepressive Agents|antidepressive agents|mesh-ancestor
102125258|NCT05497492|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102125259|NCT00835497|Metformin|metformin|mesh-list
102125260|NCT00835497|Glipizide|glipizide|mesh-list
102125261|NCT00835497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102125262|NCT00835497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125263|NCT05005689|Fluorides|fluorides|mesh-list
102125264|NCT05005689|Sodium Fluoride|sodium fluoride|mesh-list
102125265|NCT05005689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125266|NCT05005689|Cariostatic Agents|cariostatic agents|mesh-ancestor
102125267|NCT05005689|Protective Agents|protective agents|mesh-ancestor
102125268|NCT00763503|Calcitriol|calcitriol|mesh-list
102125269|NCT00763503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102125270|NCT00763503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125271|NCT00763503|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102125272|NCT00763503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102125273|NCT00763503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125274|NCT00763503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102125275|NCT00763503|Vitamins|vitamins|mesh-ancestor
102125276|NCT00763503|Micronutrients|micronutrients|mesh-ancestor
102125277|NCT00763503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102125278|NCT00761709|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102125279|NCT00761709|Latanoprost|latanoprost|mesh-list
102125280|NCT00761709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102125281|NCT00760539|Timolol|timolol|mesh-list
102125282|NCT00760539|Travoprost|travoprost|mesh-list
102125283|NCT00760539|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102125284|NCT00760539|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102125285|NCT00760539|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102125286|NCT00760539|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102125287|NCT00760539|Adrenergic Agents|adrenergic agents|mesh-ancestor
102125288|NCT00760539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102125289|NCT00760539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125290|NCT00760539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125291|NCT00760539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102125292|NCT00760539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102125293|NCT04976049|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102125294|NCT04976049|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102125295|NCT04976049|Dermatologic Agents|dermatologic agents|mesh-ancestor
102125296|NCT00759135|Finasteride|finasteride|mesh-list
101834373|NCT00896519|Prednisone|prednisone|mesh-list
102125297|NCT00759135|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102125298|NCT00759135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102125299|NCT00759135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102125300|NCT00759135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125301|NCT00759135|Hormone Antagonists|hormone antagonists|mesh-ancestor
102125302|NCT00759135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102125303|NCT00759135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125304|NCT00759135|Urological Agents|urological agents|mesh-ancestor
102125305|NCT00835263|Lamotrigine|lamotrigine|mesh-list
102125306|NCT00835263|Anticonvulsants|anticonvulsants|mesh-ancestor
102125307|NCT00835263|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102125308|NCT00835263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102125309|NCT00835263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125310|NCT00835263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102125311|NCT00835263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125312|NCT00835263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102125313|NCT00835263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102125314|NCT00835263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102125315|NCT00835263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102125316|NCT00835263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102125317|NCT02639910|Venetoclax|venetoclax|mesh-list
102125318|NCT02639910|Idelalisib|idelalisib|mesh-list
102125319|NCT02639910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102125320|NCT02639910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102535876|NCT05339373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102154329|NCT03365817|Analgesics|analgesics|mesh-ancestor
102125321|NCT02639910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125322|NCT04454580|Azacitidine|azacitidine|mesh-list
102125323|NCT04454580|Decitabine|decitabine|mesh-list
102125324|NCT04454580|Venetoclax|venetoclax|mesh-list
102125325|NCT04454580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102125326|NCT04454580|Antimetabolites|antimetabolites|mesh-ancestor
102125327|NCT04454580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125328|NCT04454580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102125329|NCT04454580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102125330|NCT00948909|Donepezil|donepezil|mesh-list
102125331|NCT00948909|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102125332|NCT00948909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102125333|NCT00948909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125334|NCT00948909|Cholinergic Agents|cholinergic agents|mesh-ancestor
102125335|NCT00948909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102125336|NCT00948909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125337|NCT00948909|Nootropic Agents|nootropic agents|mesh-ancestor
102125338|NCT02522910|Docetaxel|docetaxel|mesh-list
102125339|NCT02522910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102125340|NCT02522910|Tubulin Modulators|tubulin modulators|mesh-ancestor
102125341|NCT02522910|Antimitotic Agents|antimitotic agents|mesh-ancestor
102125342|NCT02522910|Mitosis Modulators|mitosis modulators|mesh-ancestor
102125343|NCT02522910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125344|NCT00948753|Maraviroc|maraviroc|mesh-list
102125345|NCT00948753|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102125346|NCT00948753|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102125347|NCT00948753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125348|NCT00948753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102125349|NCT00948753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102125350|NCT00948753|Antiviral Agents|antiviral agents|mesh-ancestor
102125351|NCT00948753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102125352|NCT00948753|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102125353|NCT05397834|Fluticasone|fluticasone|mesh-list
102125354|NCT05397834|Xhance|xhance|mesh-list
102125355|NCT05397834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102125356|NCT05397834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102125357|NCT05397834|Autonomic Agents|autonomic agents|mesh-ancestor
102125358|NCT05397834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102125359|NCT05397834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125360|NCT05397834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102125361|NCT05397834|Respiratory System Agents|respiratory system agents|mesh-ancestor
102125362|NCT05397834|Dermatologic Agents|dermatologic agents|mesh-ancestor
102125363|NCT05397834|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102125364|NCT03134547|Sevoflurane|sevoflurane|mesh-list
102125365|NCT03134547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102125366|NCT03134547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102125367|NCT03134547|Anesthetics, General|anesthetics, general|mesh-ancestor
102125368|NCT03134547|Anesthetics|anesthetics|mesh-ancestor
102125369|NCT03134547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102125370|NCT03134547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125371|NCT01963208|Ganaxolone|ganaxolone|mesh-list
102125372|NCT01963208|Neurosteroids|neurosteroids|mesh-ancestor
102125373|NCT01963208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102125374|NCT01963208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125375|NCT01963208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125376|NCT01963208|GABA Modulators|gaba modulators|mesh-ancestor
102125377|NCT01963208|GABA Agents|gaba agents|mesh-ancestor
102125378|NCT00834873|Carvedilol|carvedilol|mesh-list
102125379|NCT00834873|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102125380|NCT00834873|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102125381|NCT00834873|Adrenergic Agents|adrenergic agents|mesh-ancestor
102125382|NCT00834873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102125383|NCT00834873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125384|NCT00834873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125385|NCT00834873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102125386|NCT00834873|Antioxidants|antioxidants|mesh-ancestor
102125387|NCT00834873|Protective Agents|protective agents|mesh-ancestor
102125388|NCT00834873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102125389|NCT00834873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102125390|NCT00834873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102125391|NCT00834873|Vasodilator Agents|vasodilator agents|mesh-ancestor
102125392|NCT00834873|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102125393|NCT00834873|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102125394|NCT01377480|Posaconazole|posaconazole|mesh-list
102125395|NCT01377480|Benzonidazole|benzonidazole|mesh-list
102125396|NCT01377480|Antifungal Agents|antifungal agents|mesh-ancestor
102125397|NCT01377480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102125398|NCT01377480|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102125399|NCT01377480|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102125400|NCT01377480|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102125401|NCT01377480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102125402|NCT01377480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102125403|NCT01377480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102125404|NCT01377480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125405|NCT01377480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102125406|NCT01377480|Hormone Antagonists|hormone antagonists|mesh-ancestor
102125407|NCT01377480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102125408|NCT01377480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125409|NCT01377480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102125410|NCT01377480|Immunologic Factors|immunologic factors|mesh-ancestor
102125411|NCT04263909|Sufentanil|sufentanil|mesh-list
102125412|NCT04263909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102125413|NCT04263909|Narcotics|narcotics|mesh-ancestor
102125414|NCT04263909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102125415|NCT04263909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125416|NCT04263909|Analgesics|analgesics|mesh-ancestor
102125417|NCT04263909|Sensory System Agents|sensory system agents|mesh-ancestor
102125418|NCT04263909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102125419|NCT04263909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102125420|NCT04263909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102125421|NCT04263909|Anesthetics, General|anesthetics, general|mesh-ancestor
102125422|NCT04263909|Anesthetics|anesthetics|mesh-ancestor
102125423|NCT01421264|Gabapentin|gabapentin|mesh-list
102125424|NCT01421264|Analgesics|analgesics|mesh-ancestor
102125425|NCT01421264|Sensory System Agents|sensory system agents|mesh-ancestor
102125426|NCT01421264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102125427|NCT01421264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023974|NCT02873754|Bupropion|bupropion|mesh-list
102125428|NCT01421264|Anticonvulsants|anticonvulsants|mesh-ancestor
102125429|NCT01421264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102125430|NCT01421264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102125431|NCT01421264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102125432|NCT01421264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102125433|NCT01421264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102125434|NCT01421264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102125435|NCT01421264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102125436|NCT01421264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125437|NCT01421264|Antimanic Agents|antimanic agents|mesh-ancestor
102125438|NCT04415840|Acetic Acid|acetic acid|mesh-list
102125439|NCT04415840|Retinol acetate|retinol acetate|mesh-list
102125440|NCT04415840|Lugol's solution|lugol's solution|mesh-list
102125441|NCT04415840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102125442|NCT04415840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102125443|NCT04415840|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102125444|NCT04415840|Immunologic Factors|immunologic factors|mesh-ancestor
102125445|NCT04415840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125446|NCT04415840|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101834498|NCT00892307|Adenosine|adenosine|mesh-list
102125447|NCT04415840|Protective Agents|protective agents|mesh-ancestor
102125448|NCT04415840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102125450|NCT04415840|Coagulants|coagulants|mesh-ancestor
102125451|NCT04488614|Zoledronic Acid|zoledronic acid|mesh-list
102125452|NCT04488614|Estrogens|estrogens|mesh-list
102125453|NCT04488614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102125454|NCT04488614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125455|NCT04488614|Hormones|hormones|mesh-ancestor
102125456|NCT04488614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102125457|NCT00834795|Carvedilol|carvedilol|mesh-list
102125458|NCT00834795|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102125459|NCT00834795|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102125460|NCT00834795|Adrenergic Agents|adrenergic agents|mesh-ancestor
102125461|NCT00834795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102125462|NCT00834795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125463|NCT00834795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125464|NCT00834795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102125465|NCT00834795|Antioxidants|antioxidants|mesh-ancestor
102125466|NCT00834795|Protective Agents|protective agents|mesh-ancestor
102125467|NCT00834795|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102125468|NCT00834795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102125469|NCT00834795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102125470|NCT00834795|Vasodilator Agents|vasodilator agents|mesh-ancestor
102125471|NCT00834795|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102125472|NCT00834795|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102125473|NCT00834717|Granisetron|granisetron|mesh-list
102125474|NCT00834717|Antiemetics|antiemetics|mesh-ancestor
102125475|NCT00834717|Autonomic Agents|autonomic agents|mesh-ancestor
102125476|NCT00834717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102125477|NCT00834717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125478|NCT00834717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102125479|NCT00834717|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102125480|NCT00834717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102125481|NCT00834717|Serotonin Agents|serotonin agents|mesh-ancestor
102125482|NCT00834717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102125483|NCT00834717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125484|NCT00834639|Valproic Acid|valproic acid|mesh-list
102125485|NCT00834639|Anticonvulsants|anticonvulsants|mesh-ancestor
102125486|NCT00834639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102125487|NCT00834639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125488|NCT00834639|GABA Agents|gaba agents|mesh-ancestor
102125489|NCT00834639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102125490|NCT00834639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125491|NCT00834639|Antimanic Agents|antimanic agents|mesh-ancestor
102125492|NCT00834639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102125493|NCT00834639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102125494|NCT00834639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102125495|NCT00834561|Lamotrigine|lamotrigine|mesh-list
102125496|NCT00834561|Anticonvulsants|anticonvulsants|mesh-ancestor
102125497|NCT00834561|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102125498|NCT00834561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102024045|NCT04046939|Antioxidants|antioxidants|mesh-ancestor
102125499|NCT00834561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125500|NCT00834561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102125501|NCT00834561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125502|NCT00834561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102125503|NCT00834561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102125504|NCT00834561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102125505|NCT00834561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102125506|NCT00834561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102125507|NCT00754221|Reboxetine|reboxetine|mesh-list
102125508|NCT00754221|Antidepressive Agents|antidepressive agents|mesh-ancestor
102125509|NCT00754221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102125510|NCT00754221|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102125511|NCT00754221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102125512|NCT00754221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102125513|NCT00754221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125514|NCT00754221|Adrenergic Agents|adrenergic agents|mesh-ancestor
102125515|NCT00754221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102125516|NCT00754221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125517|NCT00834405|Leflunomide|leflunomide|mesh-list
102125518|NCT00834405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102125519|NCT00834405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125520|NCT00834405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102125521|NCT00834405|Immunologic Factors|immunologic factors|mesh-ancestor
102125522|NCT00834405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125523|NCT00834249|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102125524|NCT00834249|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102125525|NCT00834249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102125526|NCT00834249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102125527|NCT00834249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125528|NCT00834249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102125529|NCT00834249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125530|NCT00834249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102125531|NCT00834249|Antidepressive Agents|antidepressive agents|mesh-ancestor
102125532|NCT00834249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102125533|NCT00751803|Eletriptan|eletriptan|mesh-list
102125534|NCT00751803|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102125535|NCT00751803|Serotonin Agents|serotonin agents|mesh-ancestor
102125536|NCT00751803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102125537|NCT00751803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125538|NCT00751803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125539|NCT05420961|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102125540|NCT05420961|Immunologic Factors|immunologic factors|mesh-ancestor
102125541|NCT05420961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125542|NCT05402397|Losartan|losartan|mesh-list
102535877|NCT05339373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102125543|NCT05402397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102125544|NCT05402397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102125545|NCT05402397|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102125546|NCT05402397|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102125547|NCT05402397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125549|NCT00833937|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102125550|NCT00833937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102125551|NCT00833937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102125552|NCT00833937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125553|NCT00833937|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102125554|NCT00833937|GABA Agonists|gaba agonists|mesh-ancestor
102125555|NCT00833937|GABA Agents|gaba agents|mesh-ancestor
102125556|NCT00833937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102125557|NCT00833937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125558|NCT00831051|Morphine|morphine|mesh-list
102125559|NCT00831051|Oxycodone|oxycodone|mesh-list
102125560|NCT00831051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102125561|NCT00831051|Narcotics|narcotics|mesh-ancestor
102125562|NCT00831051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102125563|NCT00831051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125564|NCT00831051|Analgesics|analgesics|mesh-ancestor
102125565|NCT00831051|Sensory System Agents|sensory system agents|mesh-ancestor
102125566|NCT00831051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102125567|NCT00750633|Moxifloxacin|moxifloxacin|mesh-list
102125568|NCT00750633|Dexamethasone|dexamethasone|mesh-list
102125569|NCT00750633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102125570|NCT00750633|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102125571|NCT00750633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102125572|NCT00750633|Antiemetics|antiemetics|mesh-ancestor
102125573|NCT00750633|Autonomic Agents|autonomic agents|mesh-ancestor
102125574|NCT00750633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102125575|NCT00750633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125576|NCT00750633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102125577|NCT00750633|Glucocorticoids|glucocorticoids|mesh-ancestor
102125578|NCT00750633|Hormones|hormones|mesh-ancestor
102125579|NCT00750633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102125580|NCT00750633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102125581|NCT00750633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102125582|NCT00750633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102125583|NCT00750633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102125584|NCT00750633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102125585|NCT00750633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102125586|NCT00750633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102125587|NCT00750633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125588|NCT00750243|Naproxen|naproxen|mesh-list
102125589|NCT00750243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102125590|NCT00750243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102125591|NCT00750243|Analgesics|analgesics|mesh-ancestor
102125592|NCT00750243|Sensory System Agents|sensory system agents|mesh-ancestor
102125593|NCT00750243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102024190|NCT03672812|Liraglutide|liraglutide|mesh-list
102125594|NCT00750243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125595|NCT00750243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102125596|NCT00750243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102125597|NCT00750243|Gout Suppressants|gout suppressants|mesh-ancestor
102125598|NCT00750243|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102125599|NCT00750243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102125600|NCT00750243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125601|NCT00924170|Cyclophosphamide|cyclophosphamide|mesh-list
102125602|NCT00924170|Fludarabine|fludarabine|mesh-list
102125603|NCT00924170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102125604|NCT00924170|Immunologic Factors|immunologic factors|mesh-ancestor
102125605|NCT00924170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125606|NCT00924170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102125607|NCT00924170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102125608|NCT00924170|Alkylating Agents|alkylating agents|mesh-ancestor
102125609|NCT00924170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125610|NCT00924170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102125611|NCT00924170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102125612|NCT04809285|Insulin|insulin|mesh-list
102125613|NCT04809285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102125614|NCT04809285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125615|NCT00920985|Contraceptive Agents|contraceptive agents|mesh-list
102125616|NCT00920985|Gestodene|gestodene|mesh-list
102125617|NCT00920985|Contraceptives, Oral|contraceptives, oral|mesh-list
102125618|NCT00920985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102125619|NCT00920985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125620|NCT00920985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102125621|NCT00920985|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102125622|NCT00920985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102125623|NCT00920985|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102125624|NCT00920985|Progestins|progestins|mesh-ancestor
102125625|NCT00920985|Hormones|hormones|mesh-ancestor
102125626|NCT00920985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102125627|NCT05388747|Cefuroxime|cefuroxime|mesh-list
102125628|NCT05388747|Cefuroxime axetil|cefuroxime axetil|mesh-list
102125629|NCT05388747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102125630|NCT05388747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102125631|NCT00828321|Ramipril|ramipril|mesh-list
102125632|NCT00828321|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102125633|NCT00828321|Protease Inhibitors|protease inhibitors|mesh-ancestor
102125634|NCT00828321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102125635|NCT00828321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125636|NCT00828321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102125637|NCT01352715|Ritonavir|ritonavir|mesh-list
102125638|NCT01352715|Lopinavir|lopinavir|mesh-list
102125639|NCT01352715|Tenofovir|tenofovir|mesh-list
102125640|NCT01352715|Lamivudine|lamivudine|mesh-list
102125641|NCT01352715|Emtricitabine|emtricitabine|mesh-list
102125642|NCT01352715|Zidovudine|zidovudine|mesh-list
102125643|NCT01352715|Raltegravir Potassium|raltegravir potassium|mesh-list
102125644|NCT01352715|Abacavir|abacavir|mesh-list
102125645|NCT01352715|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
102125646|NCT01352715|Dideoxynucleosides|dideoxynucleosides|mesh-list
102125647|NCT01352715|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102125648|NCT01352715|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102125649|NCT01352715|Protease Inhibitors|protease inhibitors|mesh-ancestor
102125650|NCT01352715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102125651|NCT01352715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125652|NCT01352715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102125653|NCT01352715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102125654|NCT01352715|Antiviral Agents|antiviral agents|mesh-ancestor
102125655|NCT01352715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102125656|NCT01352715|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102125657|NCT01352715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102125658|NCT01352715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102125659|NCT01352715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102125660|NCT01352715|Antimetabolites|antimetabolites|mesh-ancestor
102125661|NCT01352715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102125662|NCT01352715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102125663|NCT00743925|Atorvastatin|atorvastatin|mesh-list
102125664|NCT00743925|Varespladib methyl|varespladib methyl|mesh-list
102125665|NCT00743925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102125666|NCT00743925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102125667|NCT00743925|Antimetabolites|antimetabolites|mesh-ancestor
102125668|NCT00743925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125669|NCT00743925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102125670|NCT00743925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102125671|NCT00743925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102125672|NCT00743925|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
102125673|NCT00738387|Docetaxel|docetaxel|mesh-list
102125674|NCT00738387|Vadimezan|vadimezan|mesh-list
102125675|NCT00738387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102125676|NCT00738387|Tubulin Modulators|tubulin modulators|mesh-ancestor
102125677|NCT00738387|Antimitotic Agents|antimitotic agents|mesh-ancestor
102125678|NCT00738387|Mitosis Modulators|mitosis modulators|mesh-ancestor
102125679|NCT00738387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125680|NCT03710421|Cyclophosphamide|cyclophosphamide|mesh-list
102125681|NCT03710421|Fludarabine|fludarabine|mesh-list
102125682|NCT03710421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102125683|NCT03710421|Immunologic Factors|immunologic factors|mesh-ancestor
102125684|NCT03710421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125685|NCT03710421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102125686|NCT03710421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102125687|NCT03710421|Alkylating Agents|alkylating agents|mesh-ancestor
102125688|NCT03710421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125689|NCT03710421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102125690|NCT03710421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102125691|NCT00645177|Paclitaxel|paclitaxel|mesh-list
102125692|NCT00645177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102125693|NCT00645177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102125694|NCT00645177|Tubulin Modulators|tubulin modulators|mesh-ancestor
102125695|NCT00645177|Antimitotic Agents|antimitotic agents|mesh-ancestor
102125696|NCT00645177|Mitosis Modulators|mitosis modulators|mesh-ancestor
102125697|NCT00645177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125698|NCT00643383|Acetaminophen|acetaminophen|mesh-list
102125699|NCT00643383|Tramadol|tramadol|mesh-list
102125700|NCT00643383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102125701|NCT00643383|Analgesics|analgesics|mesh-ancestor
102125702|NCT00643383|Sensory System Agents|sensory system agents|mesh-ancestor
102125703|NCT00643383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102125704|NCT00643383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125705|NCT00643383|Antipyretics|antipyretics|mesh-ancestor
102125706|NCT00643383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102125707|NCT00643383|Narcotics|narcotics|mesh-ancestor
102125708|NCT00643383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102125709|NCT02559622|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102125710|NCT02559622|Immunologic Factors|immunologic factors|mesh-ancestor
102125711|NCT02559622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125712|NCT04285450|Vitamin K|vitamin k|mesh-list
102125713|NCT04285450|Vitamins|vitamins|mesh-ancestor
102125714|NCT04285450|Micronutrients|micronutrients|mesh-ancestor
102125715|NCT04285450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125716|NCT04285450|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102125717|NCT04285450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102125718|NCT04285450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125719|NCT04285450|Hemostatics|hemostatics|mesh-ancestor
102125720|NCT04285450|Coagulants|coagulants|mesh-ancestor
102125721|NCT05497102|Lenalidomide|lenalidomide|mesh-list
102125722|NCT05497102|Immunologic Factors|immunologic factors|mesh-ancestor
102125723|NCT05497102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125724|NCT05497102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102125725|NCT05497102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102125726|NCT05497102|Growth Substances|growth substances|mesh-ancestor
102125727|NCT05497102|Growth Inhibitors|growth inhibitors|mesh-ancestor
102125728|NCT05497102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102125729|NCT04017442|Morphine|morphine|mesh-list
102125730|NCT04017442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102125731|NCT04017442|Narcotics|narcotics|mesh-ancestor
102125732|NCT04017442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102125733|NCT04017442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125734|NCT04017442|Analgesics|analgesics|mesh-ancestor
102125735|NCT04017442|Sensory System Agents|sensory system agents|mesh-ancestor
102125736|NCT04017442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102125737|NCT04016818|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102125738|NCT04016818|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102125739|NCT04016818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125740|NCT05490160|Tranexamic Acid|tranexamic acid|mesh-list
102125741|NCT05490160|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102125742|NCT05490160|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102125743|NCT05490160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834781|NCT04034771|Melatonin|melatonin|mesh-list
102125744|NCT05490160|Hemostatics|hemostatics|mesh-ancestor
102125745|NCT05490160|Coagulants|coagulants|mesh-ancestor
102125746|NCT05495620|Dexamethasone|dexamethasone|mesh-list
102125747|NCT05495620|Lenalidomide|lenalidomide|mesh-list
102125748|NCT05495620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102125749|NCT05495620|Antiemetics|antiemetics|mesh-ancestor
102125750|NCT05495620|Autonomic Agents|autonomic agents|mesh-ancestor
102125751|NCT05495620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102125752|NCT05495620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125753|NCT05495620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102125754|NCT05495620|Glucocorticoids|glucocorticoids|mesh-ancestor
102125755|NCT05495620|Hormones|hormones|mesh-ancestor
102125756|NCT05495620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102125757|NCT05495620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102125758|NCT05495620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102125759|NCT05495620|Immunologic Factors|immunologic factors|mesh-ancestor
102125760|NCT05495620|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102125761|NCT05495620|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102125762|NCT05495620|Growth Substances|growth substances|mesh-ancestor
102125763|NCT05495620|Growth Inhibitors|growth inhibitors|mesh-ancestor
102125764|NCT05490082|Solifenacin Succinate|solifenacin succinate|mesh-list
102125765|NCT05490082|Mirabegron|mirabegron|mesh-list
102125766|NCT05490082|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102125767|NCT05490082|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102125768|NCT05490082|Cholinergic Agents|cholinergic agents|mesh-ancestor
102125769|NCT05490082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102125770|NCT05490082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125771|NCT05490082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125772|NCT05490082|Urological Agents|urological agents|mesh-ancestor
102125773|NCT05490082|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102125774|NCT05490082|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102125775|NCT05490082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102125776|NCT05490082|Adrenergic Agents|adrenergic agents|mesh-ancestor
102125777|NCT02559310|Moxifloxacin|moxifloxacin|mesh-list
102125778|NCT02559310|Linezolid|linezolid|mesh-list
102125779|NCT02559310|Lefamulin|lefamulin|mesh-list
102125780|NCT02559310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102125781|NCT02559310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102125782|NCT02559310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102125783|NCT02559310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102125784|NCT02559310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102125785|NCT02559310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125786|NCT02559310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102125787|NCT02559310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102125788|NCT05489926|Pamiparib|pamiparib|mesh-list
102125789|NCT05489926|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102125790|NCT05489926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102125791|NCT05489926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125792|NCT05489926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102125793|NCT05489848|Paclitaxel|paclitaxel|mesh-list
102125794|NCT05489848|Carboplatin|carboplatin|mesh-list
102125795|NCT05489848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102125796|NCT05489848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102125797|NCT05489848|Tubulin Modulators|tubulin modulators|mesh-ancestor
102125798|NCT05489848|Antimitotic Agents|antimitotic agents|mesh-ancestor
102125799|NCT05489848|Mitosis Modulators|mitosis modulators|mesh-ancestor
102125800|NCT05489848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125801|NCT03517449|Paclitaxel|paclitaxel|mesh-list
102125802|NCT03517449|Doxorubicin|doxorubicin|mesh-list
102125803|NCT03517449|Pembrolizumab|pembrolizumab|mesh-list
102125804|NCT03517449|Lenvatinib|lenvatinib|mesh-list
102125805|NCT03517449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102125806|NCT03517449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102125807|NCT03517449|Tubulin Modulators|tubulin modulators|mesh-ancestor
102125808|NCT03517449|Antimitotic Agents|antimitotic agents|mesh-ancestor
102125809|NCT03517449|Mitosis Modulators|mitosis modulators|mesh-ancestor
102125810|NCT03517449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125811|NCT03517449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102125812|NCT03517449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102125813|NCT03517449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102125814|NCT03517449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102125815|NCT03517449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102125816|NCT03517449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102125817|NCT03517449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102125818|NCT05489692|Leucovorin|leucovorin|mesh-list
102125819|NCT05489692|Fluorouracil|fluorouracil|mesh-list
102125820|NCT05489692|Oxaliplatin|oxaliplatin|mesh-list
102125821|NCT05489692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102125822|NCT05489692|Antimetabolites|antimetabolites|mesh-ancestor
102125823|NCT05489692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125824|NCT05489692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102125825|NCT05489692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102125826|NCT05489692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102125827|NCT05489692|Immunologic Factors|immunologic factors|mesh-ancestor
102125828|NCT05489692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125829|NCT05489692|Antidotes|antidotes|mesh-ancestor
102125830|NCT05489692|Protective Agents|protective agents|mesh-ancestor
102125831|NCT05489692|Vitamin B Complex|vitamin b complex|mesh-ancestor
102125832|NCT05489692|Vitamins|vitamins|mesh-ancestor
102125833|NCT05489692|Micronutrients|micronutrients|mesh-ancestor
102125834|NCT05489692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102125835|NCT00721695|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102125836|NCT00721695|Mydriatics|mydriatics|mesh-list
102125837|NCT00721695|Autonomic Agents|autonomic agents|mesh-ancestor
102125838|NCT00721695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102125839|NCT00721695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125840|NCT00625833|Reboxetine|reboxetine|mesh-list
102125841|NCT00625833|Antidepressive Agents|antidepressive agents|mesh-ancestor
102125842|NCT00625833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102125843|NCT00625833|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102125844|NCT00625833|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102125845|NCT00625833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102535878|NCT05439993|Paclitaxel|paclitaxel|mesh-list
102125846|NCT00625833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125847|NCT00625833|Adrenergic Agents|adrenergic agents|mesh-ancestor
102125848|NCT00625833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102125849|NCT00625833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125850|NCT03299036|Doxorubicin|doxorubicin|mesh-list
102125851|NCT03299036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102125852|NCT03299036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102125853|NCT03299036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102125854|NCT03299036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102125855|NCT03299036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102125856|NCT03299036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125857|NCT03290846|Secretin|secretin|mesh-list
102125858|NCT03290846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102125859|NCT03290846|Hormones|hormones|mesh-ancestor
102125860|NCT03290846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102125861|NCT03290846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125862|NCT03298958|Sirolimus|sirolimus|mesh-list
102125863|NCT03298958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102125864|NCT03298958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102125865|NCT03298958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102125866|NCT03298958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102125867|NCT03298958|Antifungal Agents|antifungal agents|mesh-ancestor
102125868|NCT03298958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102125869|NCT03298958|Immunologic Factors|immunologic factors|mesh-ancestor
102125870|NCT03298958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125871|NCT04488926|Palmidrol|palmidrol|mesh-list
102024423|NCT02915978|Anesthetics, General|anesthetics, general|mesh-ancestor
102125872|NCT04488926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102125873|NCT04488926|Analgesics|analgesics|mesh-ancestor
102125874|NCT04488926|Sensory System Agents|sensory system agents|mesh-ancestor
102125875|NCT04488926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102125876|NCT04488926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125877|NCT04488926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102125878|NCT04488926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102125879|NCT04488926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102125880|NCT04488926|Antiviral Agents|antiviral agents|mesh-ancestor
102125881|NCT04488926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102125882|NCT04488926|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102125883|NCT04488926|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102125884|NCT04488926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102125885|NCT04488926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125886|NCT04488926|Hormones|hormones|mesh-ancestor
102125887|NCT04488926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102125888|NCT04328714|Interferons|interferons|mesh-list
102125889|NCT04328714|Interferon-gamma|interferon-gamma|mesh-list
102125890|NCT04328714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102125891|NCT04328714|Antiviral Agents|antiviral agents|mesh-ancestor
102125892|NCT04328714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102125893|NCT03290456|Prednisone|prednisone|mesh-list
102125894|NCT03290456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102125895|NCT03290456|Glucocorticoids|glucocorticoids|mesh-ancestor
102125896|NCT03290456|Hormones|hormones|mesh-ancestor
102125897|NCT03290456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102125898|NCT03290456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125899|NCT03290456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102125900|NCT03290456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102125901|NCT02555878|Rivaroxaban|rivaroxaban|mesh-list
102125902|NCT02555878|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102125903|NCT02555878|Antithrombins|antithrombins|mesh-ancestor
102125904|NCT02555878|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102125905|NCT02555878|Protease Inhibitors|protease inhibitors|mesh-ancestor
102125906|NCT02555878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102125907|NCT02555878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125908|NCT02555878|Anticoagulants|anticoagulants|mesh-ancestor
102125909|NCT03298646|Diclofenac|diclofenac|mesh-list
102125910|NCT03298646|Lidocaine|lidocaine|mesh-list
102125911|NCT03298646|Anesthetics, Local|anesthetics, local|mesh-ancestor
102125912|NCT03298646|Anesthetics|anesthetics|mesh-ancestor
102125913|NCT03298646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102125914|NCT03298646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125915|NCT03298646|Sensory System Agents|sensory system agents|mesh-ancestor
102125916|NCT03298646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102125917|NCT03298646|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102125918|NCT03298646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102535879|NCT05439993|Tepotinib|tepotinib|mesh-list
102125919|NCT03298646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102125920|NCT03298646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102125921|NCT03298646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125922|NCT03298646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102125923|NCT03298646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102125925|NCT03298646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102125926|NCT03298646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102125927|NCT03298646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102125928|NCT03298646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102125929|NCT02460692|Dronabinol|dronabinol|mesh-list
102125930|NCT02460692|Hallucinogens|hallucinogens|mesh-ancestor
102125931|NCT02460692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125932|NCT02460692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102125933|NCT02460692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102125934|NCT02460692|Analgesics|analgesics|mesh-ancestor
102125935|NCT02460692|Sensory System Agents|sensory system agents|mesh-ancestor
102125936|NCT02460692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102125937|NCT02460692|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102125938|NCT02460692|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102125939|NCT02460692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102024493|NCT03175666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102125940|NCT02460692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125941|NCT02460692|Hormones|hormones|mesh-ancestor
102125942|NCT02460692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102125943|NCT05494060|Capecitabine|capecitabine|mesh-list
102125944|NCT05494060|Oxaliplatin|oxaliplatin|mesh-list
102125945|NCT05494060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102125946|NCT05494060|Antimetabolites|antimetabolites|mesh-ancestor
102125947|NCT05494060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125948|NCT05494060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102125949|NCT05488990|Calcitriol|calcitriol|mesh-list
102125950|NCT05488990|Calcipotriene|calcipotriene|mesh-list
102125951|NCT05488990|Dermatologic Agents|dermatologic agents|mesh-ancestor
102125952|NCT05488990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102125953|NCT05488990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125954|NCT05488990|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102125955|NCT05488990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102125956|NCT05488990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125957|NCT05488990|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102125958|NCT05488990|Vitamins|vitamins|mesh-ancestor
102125959|NCT05488990|Micronutrients|micronutrients|mesh-ancestor
102125960|NCT05488990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102125961|NCT03289520|Clopidogrel|clopidogrel|mesh-list
102125962|NCT03289520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102125963|NCT03289520|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102125964|NCT03289520|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102125965|NCT03289520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102125966|NCT03289520|Purinergic Agents|purinergic agents|mesh-ancestor
102125967|NCT03289520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102125968|NCT03289520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125969|NCT03289520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125971|NCT03293108|Denosumab|denosumab|mesh-list
102125972|NCT03293108|Calcium|calcium|mesh-list
102125973|NCT03293108|Vitamins|vitamins|mesh-ancestor
102125974|NCT03293108|Micronutrients|micronutrients|mesh-ancestor
102125975|NCT03293108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125976|NCT03293108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102125977|NCT03293108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102125978|NCT03292796|Bimatoprost|bimatoprost|mesh-list
102125979|NCT03292796|Latanoprost|latanoprost|mesh-list
102125980|NCT03292796|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102125981|NCT03292796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102125982|NCT03292796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102125983|NCT03288896|Ethanol|ethanol|mesh-list
102125984|NCT03288896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102125985|NCT03288896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102125986|NCT03288896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102125987|NCT03288896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102125988|NCT03288818|Mechlorethamine|mechlorethamine|mesh-list
102125989|NCT03288818|Alkylating Agents|alkylating agents|mesh-ancestor
102125990|NCT03288818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125991|NCT03288818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102125992|NCT03288818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102125993|NCT03292172|Atezolizumab|atezolizumab|mesh-list
102125994|NCT03292172|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102125995|NCT03292172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102125996|NCT03292172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102125997|NCT03292172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102125998|NCT02461004|Ezetimibe|ezetimibe|mesh-list
102125999|NCT02461004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102126000|NCT02461004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102126001|NCT02461004|Antimetabolites|antimetabolites|mesh-ancestor
102126002|NCT02461004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126003|NCT02461004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102126004|NCT03288428|Morphine|morphine|mesh-list
102126005|NCT03288428|Nalbuphine|nalbuphine|mesh-list
102126006|NCT03288428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102126007|NCT03288428|Narcotics|narcotics|mesh-ancestor
102126008|NCT03288428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102126009|NCT03288428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126010|NCT03288428|Analgesics|analgesics|mesh-ancestor
102126011|NCT03288428|Sensory System Agents|sensory system agents|mesh-ancestor
102126012|NCT03288428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102126013|NCT03288350|Avelumab|avelumab|mesh-list
102126014|NCT03288350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102126015|NCT03288350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102126016|NCT00003224|Vaccines|vaccines|mesh-list
102126017|NCT00003224|Freund's Adjuvant|freund's adjuvant|mesh-list
102126018|NCT00003224|Immunologic Factors|immunologic factors|mesh-ancestor
102126019|NCT00003224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126020|NCT00003224|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102126021|NCT03288038|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102126022|NCT03288038|Ezetimibe|ezetimibe|mesh-list
102126023|NCT03288038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102126024|NCT03288038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102126025|NCT03288038|Antimetabolites|antimetabolites|mesh-ancestor
102126026|NCT03288038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126027|NCT03288038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102126028|NCT03288038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102126029|NCT03288038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102126030|NCT03287882|Micronutrients|micronutrients|mesh-list
102126031|NCT03287882|Trace Elements|trace elements|mesh-list
102126032|NCT03287882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126033|NCT03291314|Avelumab|avelumab|mesh-list
102126034|NCT03291314|Axitinib|axitinib|mesh-list
102126035|NCT03291314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102126036|NCT03291314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102126037|NCT03291314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102126038|NCT03291314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102126039|NCT03291314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126040|NCT03291158|Minocycline|minocycline|mesh-list
102126041|NCT03291158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101835080|NCT00336544|Clarithromycin|clarithromycin|mesh-list
102126042|NCT03291158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102126043|NCT03283202|Prednisone|prednisone|mesh-list
102126044|NCT03283202|Prednisolone|prednisolone|mesh-list
102126046|NCT03283202|Rituximab|rituximab|mesh-list
102126047|NCT03283202|Vincristine|vincristine|mesh-list
102126048|NCT03283202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102126049|NCT03283202|Immunologic Factors|immunologic factors|mesh-ancestor
102126050|NCT03283202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126051|NCT03283202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102126052|NCT03283202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102126053|NCT03283202|Alkylating Agents|alkylating agents|mesh-ancestor
102126054|NCT03283202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126055|NCT03283202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102126056|NCT03283202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102126057|NCT03283202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102126058|NCT03283202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102126059|NCT03283202|Glucocorticoids|glucocorticoids|mesh-ancestor
102126060|NCT03283202|Hormones|hormones|mesh-ancestor
102126061|NCT03283202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102126062|NCT03283202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102126063|NCT03283202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102126064|NCT03283202|Tubulin Modulators|tubulin modulators|mesh-ancestor
102126065|NCT03283202|Antimitotic Agents|antimitotic agents|mesh-ancestor
102126066|NCT03283202|Mitosis Modulators|mitosis modulators|mesh-ancestor
102126067|NCT03283046|Dexamethasone|dexamethasone|mesh-list
102126068|NCT03283046|Nivolumab|nivolumab|mesh-list
102126069|NCT03283046|Lenalidomide|lenalidomide|mesh-list
102126071|NCT03283046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102126072|NCT03283046|Antiemetics|antiemetics|mesh-ancestor
102126073|NCT03283046|Autonomic Agents|autonomic agents|mesh-ancestor
102126074|NCT03283046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102126075|NCT03283046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126076|NCT03283046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102126077|NCT03283046|Glucocorticoids|glucocorticoids|mesh-ancestor
102126078|NCT03283046|Hormones|hormones|mesh-ancestor
102126079|NCT03283046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102126080|NCT03283046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102126081|NCT03283046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102126082|NCT03283046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102126083|NCT03283046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102126084|NCT03283046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126085|NCT03283046|Immunologic Factors|immunologic factors|mesh-ancestor
102126086|NCT03283046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102126087|NCT03283046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102126088|NCT03283046|Growth Substances|growth substances|mesh-ancestor
102126089|NCT03283046|Growth Inhibitors|growth inhibitors|mesh-ancestor
102126090|NCT03287180|Buprenorphine|buprenorphine|mesh-list
102126091|NCT03287180|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102126092|NCT03287180|Naloxone|naloxone|mesh-list
102126093|NCT03287180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102126094|NCT03287180|Narcotics|narcotics|mesh-ancestor
102126095|NCT03287180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102126096|NCT03287180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126097|NCT03287180|Analgesics|analgesics|mesh-ancestor
102126098|NCT03287180|Sensory System Agents|sensory system agents|mesh-ancestor
102126099|NCT03287180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102126100|NCT03287180|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102126101|NCT02460146|CXA-10|cxa-10|mesh-list
102126102|NCT02460146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102126103|NCT02460302|Progesterone|progesterone|mesh-list
102126104|NCT02460302|Progestins|progestins|mesh-ancestor
102126105|NCT02460302|Hormones|hormones|mesh-ancestor
102126106|NCT02460302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102126107|NCT02460302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126108|NCT03282188|Sargramostim|sargramostim|mesh-list
102126109|NCT03282188|Immunologic Factors|immunologic factors|mesh-ancestor
102126110|NCT03282188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126111|NCT03384212|Cytarabine|cytarabine|mesh-list
102126112|NCT03384212|Fludarabine|fludarabine|mesh-list
102126113|NCT03384212|Busulfan|busulfan|mesh-list
102126114|NCT03384212|Cladribine|cladribine|mesh-list
102126115|NCT03384212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102126116|NCT03384212|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102126117|NCT03384212|Antimetabolites|antimetabolites|mesh-ancestor
102126118|NCT03384212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126119|NCT03384212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102126120|NCT03384212|Immunologic Factors|immunologic factors|mesh-ancestor
102126121|NCT03384212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126122|NCT03384212|Antiviral Agents|antiviral agents|mesh-ancestor
102126123|NCT03384212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102126124|NCT03384212|Alkylating Agents|alkylating agents|mesh-ancestor
102126125|NCT03384212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102126126|NCT03384212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102126127|NCT02460068|Nivolumab|nivolumab|mesh-list
102126128|NCT02460068|Ipilimumab|ipilimumab|mesh-list
102126129|NCT02460068|Fotemustine|fotemustine|mesh-list
102126130|NCT02460068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102126131|NCT02460068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102126132|NCT02460068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102126133|NCT02460068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126134|NCT03286244|Paclitaxel|paclitaxel|mesh-list
102126135|NCT03286244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102126136|NCT03286244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102126137|NCT03286244|Tubulin Modulators|tubulin modulators|mesh-ancestor
102126138|NCT03286244|Antimitotic Agents|antimitotic agents|mesh-ancestor
102126139|NCT03286244|Mitosis Modulators|mitosis modulators|mesh-ancestor
102126140|NCT03286244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126141|NCT03282110|Citalopram|citalopram|mesh-list
102126142|NCT03282110|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102126143|NCT03282110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102126144|NCT03282110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102126145|NCT03282110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126146|NCT03282110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102126147|NCT03282110|Serotonin Agents|serotonin agents|mesh-ancestor
102126148|NCT03282110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126149|NCT03282110|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102126150|NCT03282110|Antidepressive Agents|antidepressive agents|mesh-ancestor
102126151|NCT03282110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102126152|NCT03269786|Bilirubin|bilirubin|mesh-list
102126153|NCT03269786|Antioxidants|antioxidants|mesh-ancestor
102126154|NCT03269786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126155|NCT03269786|Protective Agents|protective agents|mesh-ancestor
102126156|NCT03269786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126157|NCT02459600|Cyclopentolate|cyclopentolate|mesh-list
102126158|NCT02459600|Mydriatics|mydriatics|mesh-ancestor
102126159|NCT02459600|Autonomic Agents|autonomic agents|mesh-ancestor
102126160|NCT02459600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102126161|NCT02459600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126162|NCT02459600|Parasympatholytics|parasympatholytics|mesh-ancestor
102126163|NCT02459600|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102126164|NCT02459600|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102126165|NCT02459600|Cholinergic Agents|cholinergic agents|mesh-ancestor
102126166|NCT02459600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102126167|NCT02459600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126168|NCT03269318|Theophylline|theophylline|mesh-list
102126169|NCT03269318|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102126170|NCT03269318|Montelukast|montelukast|mesh-list
102126171|NCT03269318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102126172|NCT03269318|Autonomic Agents|autonomic agents|mesh-ancestor
102126173|NCT03269318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102126174|NCT03269318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126175|NCT03269318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102126176|NCT03269318|Respiratory System Agents|respiratory system agents|mesh-ancestor
102126177|NCT03269318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102126178|NCT03269318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102126179|NCT03269318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102126180|NCT03269318|Adrenergic Agents|adrenergic agents|mesh-ancestor
102126181|NCT03269318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102126182|NCT03269318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126183|NCT03269318|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102126184|NCT03269318|Hormone Antagonists|hormone antagonists|mesh-ancestor
102126185|NCT03269318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102126186|NCT03269318|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102126187|NCT03269318|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102126188|NCT03269318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102126189|NCT03269318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102126190|NCT03269318|Vasodilator Agents|vasodilator agents|mesh-ancestor
102126191|NCT03269318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102126192|NCT03269318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101835229|NCT00568061|Nitric Oxide|nitric oxide|mesh-list
102126212|NCT04172558|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102126213|NCT04172558|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102126214|NCT04172558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102126215|NCT04172558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126216|NCT04172558|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102126217|NCT04172558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102126218|NCT04172558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126219|NCT04172558|Cholinergic Agents|cholinergic agents|mesh-ancestor
102126220|NCT04172558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102126221|NCT03107858|Dopamine|dopamine|mesh-list
102126222|NCT03107858|Norepinephrine|norepinephrine|mesh-list
102126223|NCT03107858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102126224|NCT03107858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102126225|NCT03107858|Adrenergic Agents|adrenergic agents|mesh-ancestor
102126226|NCT03107858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102126227|NCT03107858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126228|NCT03107858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126229|NCT03107858|Sympathomimetics|sympathomimetics|mesh-ancestor
102126230|NCT03107858|Autonomic Agents|autonomic agents|mesh-ancestor
102126231|NCT03107858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102126232|NCT03107858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102126233|NCT03107858|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102126234|NCT03107858|Dopamine Agents|dopamine agents|mesh-ancestor
102535880|NCT05439993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102126235|NCT03107858|Protective Agents|protective agents|mesh-ancestor
102126236|NCT03269162|Docetaxel|docetaxel|mesh-list
102126237|NCT03269162|Pemetrexed|pemetrexed|mesh-list
102126238|NCT03269162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102126239|NCT03269162|Tubulin Modulators|tubulin modulators|mesh-ancestor
102126240|NCT03269162|Antimitotic Agents|antimitotic agents|mesh-ancestor
102126241|NCT03269162|Mitosis Modulators|mitosis modulators|mesh-ancestor
102126242|NCT03269162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126243|NCT03269162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102126244|NCT03269162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102126245|NCT03269162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102126246|NCT03284294|Cholecalciferol|cholecalciferol|mesh-list
102126247|NCT03284294|Vitamin D|vitamin d|mesh-list
102126248|NCT03284294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102126249|NCT03284294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126250|NCT03284294|Vitamins|vitamins|mesh-ancestor
102126251|NCT03284294|Micronutrients|micronutrients|mesh-ancestor
102126252|NCT03284294|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102126253|NCT02558296|Bexagliflozin|bexagliflozin|mesh-list
102126254|NCT02558296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102126255|NCT02558296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126256|NCT03268226|Beclomethasone|beclomethasone|mesh-list
102126257|NCT03268226|Glycopyrrolate|glycopyrrolate|mesh-list
102126258|NCT03268226|Formoterol Fumarate|formoterol fumarate|mesh-list
102126259|NCT03268226|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102126260|NCT03268226|Autonomic Agents|autonomic agents|mesh-ancestor
102126261|NCT03268226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102126262|NCT03268226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126263|NCT03268226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102126264|NCT03268226|Respiratory System Agents|respiratory system agents|mesh-ancestor
102126265|NCT03268226|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102126266|NCT03268226|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102126267|NCT03268226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102126268|NCT03268226|Adrenergic Agents|adrenergic agents|mesh-ancestor
102126269|NCT03268226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102126270|NCT03268226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126271|NCT03268226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102126272|NCT03268226|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102126273|NCT03268226|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102126274|NCT03268226|Cholinergic Agents|cholinergic agents|mesh-ancestor
102126275|NCT03268226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102126276|NCT03268226|Glucocorticoids|glucocorticoids|mesh-ancestor
102126278|NCT03268226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102126279|NCT02737475|Cyclophosphamide|cyclophosphamide|mesh-list
102126280|NCT02737475|Nivolumab|nivolumab|mesh-list
102126281|NCT02737475|Ipilimumab|ipilimumab|mesh-list
102126282|NCT02737475|Vaccines|vaccines|mesh-list
102126283|NCT02737475|Immunologic Factors|immunologic factors|mesh-ancestor
102126284|NCT02737475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126285|NCT02737475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102126286|NCT02737475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102126287|NCT02737475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102126288|NCT02737475|Alkylating Agents|alkylating agents|mesh-ancestor
102126289|NCT02737475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126290|NCT02737475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102126291|NCT02737475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102126292|NCT02737475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102126293|NCT02737475|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102126294|NCT02457806|Phenylephrine|phenylephrine|mesh-list
102126295|NCT02457806|Oxymetazoline|oxymetazoline|mesh-list
102126296|NCT02457806|Tetracaine|tetracaine|mesh-list
102126297|NCT02457806|Anesthetics, Local|anesthetics, local|mesh-ancestor
102126298|NCT02457806|Anesthetics|anesthetics|mesh-ancestor
102126299|NCT02457806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102126300|NCT02457806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126301|NCT02457806|Sensory System Agents|sensory system agents|mesh-ancestor
102126302|NCT02457806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102126303|NCT02457806|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102126304|NCT02457806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102126305|NCT02457806|Adrenergic Agents|adrenergic agents|mesh-ancestor
102126306|NCT02457806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102126307|NCT02457806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126308|NCT02457806|Sympathomimetics|sympathomimetics|mesh-ancestor
102126309|NCT02457806|Autonomic Agents|autonomic agents|mesh-ancestor
102126310|NCT02457806|Nasal Decongestants|nasal decongestants|mesh-ancestor
102126311|NCT02457806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102535881|NCT05439993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102126312|NCT02457806|Respiratory System Agents|respiratory system agents|mesh-ancestor
102126313|NCT02457806|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102126314|NCT02457806|Mydriatics|mydriatics|mesh-ancestor
102126315|NCT02457806|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102126316|NCT02457806|Protective Agents|protective agents|mesh-ancestor
102126317|NCT02459756|Citric Acid|citric acid|mesh-list
102126318|NCT02459756|Sodium Citrate|sodium citrate|mesh-list
102126319|NCT02459756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126320|NCT02459756|Anticoagulants|anticoagulants|mesh-ancestor
102126321|NCT02459756|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102126322|NCT02459756|Chelating Agents|chelating agents|mesh-ancestor
102126323|NCT02459756|Sequestering Agents|sequestering agents|mesh-ancestor
102126324|NCT02557672|Thrombin|thrombin|mesh-list
102126325|NCT02557672|Hemostatics|hemostatics|mesh-ancestor
102126326|NCT02557672|Coagulants|coagulants|mesh-ancestor
102126327|NCT02458196|Mycophenolic Acid|mycophenolic acid|mesh-list
102126328|NCT02458196|Prednisone|prednisone|mesh-list
102126329|NCT02458196|Prednisolone|prednisolone|mesh-list
102126330|NCT02458196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102126331|NCT02458196|Glucocorticoids|glucocorticoids|mesh-ancestor
102126332|NCT02458196|Hormones|hormones|mesh-ancestor
102126333|NCT02458196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102126334|NCT02458196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126335|NCT02458196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102126336|NCT02458196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102126337|NCT02458196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102126338|NCT02458196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102126339|NCT02458196|Antitubercular Agents|antitubercular agents|mesh-ancestor
102126340|NCT02458196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102126341|NCT02458196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102126342|NCT02458196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102126343|NCT02458196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126344|NCT05207735|Capecitabine|capecitabine|mesh-list
102126345|NCT05207735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102126346|NCT05207735|Antimetabolites|antimetabolites|mesh-ancestor
102126347|NCT05207735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126348|NCT05207735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102126349|NCT03264638|Cyproterone Acetate|cyproterone acetate|mesh-list
102126350|NCT03264638|Cyproterone|cyproterone|mesh-list
102126351|NCT03264638|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
102126352|NCT03264638|Androgen Antagonists|androgen antagonists|mesh-ancestor
102126353|NCT03264638|Hormone Antagonists|hormone antagonists|mesh-ancestor
102126354|NCT03264638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102126355|NCT03264638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126356|NCT03264638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102126357|NCT03264638|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102126358|NCT03264638|Contraceptive Agents|contraceptive agents|mesh-ancestor
102126359|NCT03264638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102126360|NCT04502381|Amphotericin B|amphotericin b|mesh-list
102126361|NCT04502381|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102126362|NCT04502381|Deoxycholic Acid|deoxycholic acid|mesh-list
102126363|NCT04502381|Amebicides|amebicides|mesh-ancestor
102126364|NCT04502381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102126365|NCT04502381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102126366|NCT04502381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102126367|NCT04502381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102126368|NCT04502381|Antifungal Agents|antifungal agents|mesh-ancestor
102126369|NCT04502381|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102126370|NCT04502381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102126371|NCT03264794|Gefitinib|gefitinib|mesh-list
102126372|NCT03264794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102126373|NCT03264794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102126374|NCT03264794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102126375|NCT03264794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126376|NCT02925923|Clopidogrel|clopidogrel|mesh-list
102126377|NCT02925923|Ticagrelor|ticagrelor|mesh-list
102126378|NCT02925923|Eptifibatide|eptifibatide|mesh-list
102126379|NCT02925923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102126380|NCT02925923|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102126381|NCT02925923|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102126382|NCT02925923|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102126383|NCT02925923|Purinergic Agents|purinergic agents|mesh-ancestor
102126384|NCT02925923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102126385|NCT02925923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126386|NCT02925923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126387|NCT03280316|Tolterodine Tartrate|tolterodine tartrate|mesh-list
102126388|NCT03280316|Botulinum Toxins|botulinum toxins|mesh-list
102126389|NCT03280316|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102126390|NCT03280316|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102126391|NCT03280316|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102126392|NCT03280316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102126393|NCT03280316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126394|NCT03280316|Cholinergic Agents|cholinergic agents|mesh-ancestor
102126395|NCT03280316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102126396|NCT03280316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126397|NCT03280316|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102126398|NCT03280316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102126399|NCT03280316|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102126400|NCT03280316|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102126401|NCT03280316|Urological Agents|urological agents|mesh-ancestor
102126402|NCT02410343|Hormones|hormones|mesh-list
102126403|NCT02410343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102126404|NCT02410343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126405|NCT05234840|Triamcinolone|triamcinolone|mesh-list
102126406|NCT05234840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102126407|NCT05234840|Glucocorticoids|glucocorticoids|mesh-ancestor
102126408|NCT05234840|Hormones|hormones|mesh-ancestor
102126409|NCT05234840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102126410|NCT05234840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126411|NCT03280004|Moxifloxacin|moxifloxacin|mesh-list
102126412|NCT03280004|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102126413|NCT03280004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102126414|NCT03280004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102126415|NCT03280004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102126416|NCT03280004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102126417|NCT03280004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102126418|NCT03280004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126419|NCT03280004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102126420|NCT03280004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102126421|NCT03280004|Contraceptive Agents|contraceptive agents|mesh-ancestor
102126422|NCT03280004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102126423|NCT03280004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126424|NCT03280004|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102126425|NCT03280004|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102126426|NCT03280004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102126427|NCT03434379|Bevacizumab|bevacizumab|mesh-list
102126428|NCT03434379|Atezolizumab|atezolizumab|mesh-list
102126429|NCT03434379|Sorafenib|sorafenib|mesh-list
102126430|NCT03434379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102126431|NCT03434379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102126432|NCT03434379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102126433|NCT03434379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102126434|NCT03434379|Growth Substances|growth substances|mesh-ancestor
102126435|NCT03434379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126436|NCT03434379|Growth Inhibitors|growth inhibitors|mesh-ancestor
102126437|NCT03434379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102126438|NCT03434379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102126439|NCT03434379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126440|NCT03434379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102126441|NCT02459288|Clopidogrel|clopidogrel|mesh-list
102126442|NCT02459288|Ticagrelor|ticagrelor|mesh-list
102126443|NCT02459288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102126444|NCT02459288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102126445|NCT02459288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102126446|NCT02459288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102126447|NCT02459288|Purinergic Agents|purinergic agents|mesh-ancestor
102126448|NCT02459288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102126449|NCT02459288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126450|NCT02459288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126451|NCT00734253|Pyridoxamine|pyridoxamine|mesh-list
102126452|NCT00734253|Vitamin B Complex|vitamin b complex|mesh-ancestor
102126453|NCT00734253|Vitamins|vitamins|mesh-ancestor
102126454|NCT00734253|Micronutrients|micronutrients|mesh-ancestor
102126455|NCT00734253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126456|NCT00730665|Esomeprazole|esomeprazole|mesh-list
102126457|NCT00730665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102126458|NCT00730665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102126459|NCT00730665|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102126460|NCT00730665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102126461|NCT00730665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126462|NCT00714597|Enoxaparin|enoxaparin|mesh-list
102126463|NCT00714597|Semuloparin|semuloparin|mesh-list
102126464|NCT00714597|Enoxaparin sodium|enoxaparin sodium|mesh-list
102126465|NCT00714597|Anticoagulants|anticoagulants|mesh-ancestor
102126466|NCT00714597|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102126467|NCT00714597|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102126468|NCT00714597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126469|NCT03265886|Bupivacaine|bupivacaine|mesh-list
102126470|NCT03265886|Anesthetics, Local|anesthetics, local|mesh-ancestor
102126471|NCT03265886|Anesthetics|anesthetics|mesh-ancestor
102126472|NCT03265886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102126473|NCT03265886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126474|NCT03265886|Sensory System Agents|sensory system agents|mesh-ancestor
102126475|NCT03265886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102126476|NCT00728091|Satavaptan|satavaptan|mesh-list
102126477|NCT00728091|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102126478|NCT00728091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126479|NCT00728091|Natriuretic Agents|natriuretic agents|mesh-ancestor
102126480|NCT00728091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126481|NCT03275090|SMOFlipid|smoflipid|mesh-list
102126482|NCT03275090|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102126483|NCT03275090|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102126484|NCT03275090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102126485|NCT03382821|Dexamethasone|dexamethasone|mesh-list
102126486|NCT03382821|Dexamethasone acetate|dexamethasone acetate|mesh-list
102126487|NCT03382821|Triamcinolone|triamcinolone|mesh-list
102126488|NCT03382821|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102126489|NCT03382821|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102126490|NCT03382821|Lidocaine|lidocaine|mesh-list
102126491|NCT03382821|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102126492|NCT03382821|BB 1101|bb 1101|mesh-list
102126493|NCT03382821|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102126494|NCT03382821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102126495|NCT03382821|Antiemetics|antiemetics|mesh-ancestor
102126496|NCT03382821|Autonomic Agents|autonomic agents|mesh-ancestor
102126497|NCT03382821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102126498|NCT03382821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126499|NCT03382821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102126500|NCT03382821|Glucocorticoids|glucocorticoids|mesh-ancestor
102126501|NCT03382821|Hormones|hormones|mesh-ancestor
102126502|NCT03382821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102126503|NCT03382821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102126504|NCT03382821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102126505|NCT03382821|Protease Inhibitors|protease inhibitors|mesh-ancestor
102126506|NCT03382821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102126507|NCT03382821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126508|NCT03382821|Anesthetics, Local|anesthetics, local|mesh-ancestor
102126509|NCT03382821|Anesthetics|anesthetics|mesh-ancestor
102126510|NCT03382821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102126511|NCT03382821|Sensory System Agents|sensory system agents|mesh-ancestor
102126512|NCT03382821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102126513|NCT03382821|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102126514|NCT03382821|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102126515|NCT03382821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102126516|NCT03382821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102126517|NCT03382821|Immunologic Factors|immunologic factors|mesh-ancestor
102126518|NCT03263624|Tazarotene|tazarotene|mesh-list
102126519|NCT03263624|Dermatologic Agents|dermatologic agents|mesh-ancestor
102126520|NCT03263624|Keratolytic Agents|keratolytic agents|mesh-ancestor
102126521|NCT00711555|Dexamethasone|dexamethasone|mesh-list
102126522|NCT00711555|Ondansetron|ondansetron|mesh-list
102126523|NCT00711555|Aprepitant|aprepitant|mesh-list
102126524|NCT00711555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102126525|NCT00711555|Antiemetics|antiemetics|mesh-ancestor
102126526|NCT00711555|Autonomic Agents|autonomic agents|mesh-ancestor
102126527|NCT00711555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102126528|NCT00711555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126529|NCT00711555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102126530|NCT00711555|Glucocorticoids|glucocorticoids|mesh-ancestor
102126531|NCT00711555|Hormones|hormones|mesh-ancestor
102126532|NCT00711555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102126533|NCT00711555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102126534|NCT00711555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102126535|NCT00711555|Antipruritics|antipruritics|mesh-ancestor
102126536|NCT00711555|Dermatologic Agents|dermatologic agents|mesh-ancestor
102126537|NCT00711555|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102126538|NCT00711555|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102126539|NCT00711555|Serotonin Agents|serotonin agents|mesh-ancestor
102126540|NCT00711555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102126541|NCT00711555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126542|NCT00711555|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102126543|NCT03263390|Anti-Obesity Agents|anti-obesity agents|mesh-list
102126544|NCT02280993|Dexamethasone|dexamethasone|mesh-list
102126545|NCT02280993|Cisplatin|cisplatin|mesh-list
102126546|NCT02280993|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102126547|NCT02280993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102126548|NCT02280993|Antiemetics|antiemetics|mesh-ancestor
102126549|NCT02280993|Autonomic Agents|autonomic agents|mesh-ancestor
102126550|NCT02280993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102126551|NCT02280993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126552|NCT02280993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102126553|NCT02280993|Glucocorticoids|glucocorticoids|mesh-ancestor
102126554|NCT02280993|Hormones|hormones|mesh-ancestor
102126555|NCT02280993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102126556|NCT02280993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102126557|NCT02280993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102126558|NCT02280993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102126559|NCT02280993|Immunotoxins|immunotoxins|mesh-ancestor
102126560|NCT02280993|Immunoconjugates|immunoconjugates|mesh-ancestor
102126561|NCT02280993|Immunologic Factors|immunologic factors|mesh-ancestor
102126562|NCT05488522|Bevacizumab|bevacizumab|mesh-list
102126563|NCT05488522|Atezolizumab|atezolizumab|mesh-list
102126564|NCT05488522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102126565|NCT05488522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102126566|NCT05488522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102126567|NCT05488522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102126568|NCT05488522|Growth Substances|growth substances|mesh-ancestor
102126569|NCT05488522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126570|NCT05488522|Growth Inhibitors|growth inhibitors|mesh-ancestor
102126571|NCT05488522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102025126|NCT04456608|Sensory System Agents|sensory system agents|mesh-ancestor
102126572|NCT05488522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126573|NCT05492968|Phenylephrine|phenylephrine|mesh-list
102126574|NCT05492968|Epinephrine|epinephrine|mesh-list
102126575|NCT05492968|Oxymetazoline|oxymetazoline|mesh-list
102126576|NCT05492968|Norepinephrine|norepinephrine|mesh-list
102126577|NCT05492968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102126578|NCT05492968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102126579|NCT05492968|Adrenergic Agents|adrenergic agents|mesh-ancestor
102126580|NCT05492968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102126581|NCT05492968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126582|NCT05492968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126583|NCT05492968|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102126584|NCT05492968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102126585|NCT05492968|Autonomic Agents|autonomic agents|mesh-ancestor
102126586|NCT05492968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102126587|NCT05492968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102126588|NCT05492968|Respiratory System Agents|respiratory system agents|mesh-ancestor
102126589|NCT05492968|Mydriatics|mydriatics|mesh-ancestor
102126590|NCT05492968|Sympathomimetics|sympathomimetics|mesh-ancestor
102126591|NCT05492968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102126592|NCT05492968|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102126593|NCT05492968|Nasal Decongestants|nasal decongestants|mesh-ancestor
102126594|NCT05492968|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102126595|NCT05492968|Protective Agents|protective agents|mesh-ancestor
102126596|NCT02457026|Triamcinolone|triamcinolone|mesh-list
102126597|NCT02457026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102126598|NCT02457026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102126599|NCT02457026|Aflibercept|aflibercept|mesh-list
102126600|NCT02457026|Verteporfin|verteporfin|mesh-list
102126601|NCT02457026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102126602|NCT02457026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102126603|NCT02457026|Glucocorticoids|glucocorticoids|mesh-ancestor
102126604|NCT02457026|Hormones|hormones|mesh-ancestor
102126605|NCT02457026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102126606|NCT02457026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126607|NCT02457026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102126608|NCT02457026|Immunologic Factors|immunologic factors|mesh-ancestor
102126609|NCT02457026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102126610|NCT02457026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126611|NCT02457026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102126612|NCT02457026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102126613|NCT02457026|Growth Substances|growth substances|mesh-ancestor
102126614|NCT02457026|Growth Inhibitors|growth inhibitors|mesh-ancestor
102126615|NCT02457026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102126616|NCT02457026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102126617|NCT02457026|Dermatologic Agents|dermatologic agents|mesh-ancestor
102126619|NCT03919526|Fludarabine|fludarabine|mesh-list
102126620|NCT03919526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102126621|NCT03919526|Immunologic Factors|immunologic factors|mesh-ancestor
102126622|NCT03919526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126623|NCT03919526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102126624|NCT03919526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102126625|NCT03919526|Alkylating Agents|alkylating agents|mesh-ancestor
102126626|NCT03919526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126627|NCT03919526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102126628|NCT03919526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102126629|NCT05492812|Melatonin|melatonin|mesh-list
102126630|NCT05492812|Chloral Hydrate|chloral hydrate|mesh-list
102126631|NCT05492812|Hydroxyzine|hydroxyzine|mesh-list
102126632|NCT05492812|Antioxidants|antioxidants|mesh-ancestor
102126633|NCT05492812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126634|NCT05492812|Protective Agents|protective agents|mesh-ancestor
102126635|NCT05492812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126636|NCT05492812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102126637|NCT05492812|Antipruritics|antipruritics|mesh-ancestor
102126638|NCT05492812|Dermatologic Agents|dermatologic agents|mesh-ancestor
102126639|NCT05492812|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102126640|NCT05492812|Histamine Antagonists|histamine antagonists|mesh-ancestor
102126641|NCT05492812|Histamine Agents|histamine agents|mesh-ancestor
102126642|NCT05492812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102126643|NCT05492812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102126644|NCT02458118|Secretin|secretin|mesh-list
102126645|NCT02458118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102126646|NCT02458118|Hormones|hormones|mesh-ancestor
102126647|NCT02458118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102126648|NCT02458118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126649|NCT05487742|Dexmedetomidine|dexmedetomidine|mesh-list
102126650|NCT05487742|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102126651|NCT05487742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102126652|NCT05487742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126653|NCT05487742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102126654|NCT05487742|Analgesics|analgesics|mesh-ancestor
102126655|NCT05487742|Sensory System Agents|sensory system agents|mesh-ancestor
102126656|NCT05487742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102126657|NCT05487742|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102126658|NCT05487742|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102126659|NCT05487742|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102126660|NCT05487742|Adrenergic Agents|adrenergic agents|mesh-ancestor
102126661|NCT05487742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102126662|NCT05487742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126663|NCT02457650|Cyclophosphamide|cyclophosphamide|mesh-list
102126664|NCT02457650|Fludarabine|fludarabine|mesh-list
102126665|NCT02457650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102126666|NCT02457650|Immunologic Factors|immunologic factors|mesh-ancestor
102126667|NCT02457650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126668|NCT02457650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102126669|NCT02457650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102126670|NCT02457650|Alkylating Agents|alkylating agents|mesh-ancestor
102126671|NCT02457650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126672|NCT02457650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102126673|NCT02457650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102126674|NCT02456948|Minocycline|minocycline|mesh-list
102126675|NCT02456948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102126676|NCT02456948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102126677|NCT05487508|Dexamethasone|dexamethasone|mesh-list
102126678|NCT05487508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102126679|NCT05487508|Antiemetics|antiemetics|mesh-ancestor
102126680|NCT05487508|Autonomic Agents|autonomic agents|mesh-ancestor
102126681|NCT05487508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102126682|NCT05487508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126683|NCT05487508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102126684|NCT05487508|Glucocorticoids|glucocorticoids|mesh-ancestor
102126685|NCT05487508|Hormones|hormones|mesh-ancestor
102126686|NCT05487508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102126687|NCT05487508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102126688|NCT05487508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102126689|NCT02713490|Bupivacaine|bupivacaine|mesh-list
102126690|NCT02713490|Anesthetics, Local|anesthetics, local|mesh-ancestor
102126691|NCT02713490|Anesthetics|anesthetics|mesh-ancestor
102126692|NCT02713490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102126693|NCT02713490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126694|NCT02713490|Sensory System Agents|sensory system agents|mesh-ancestor
102126695|NCT02713490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102126696|NCT05491720|Risperidone|risperidone|mesh-list
102126697|NCT05491720|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102126698|NCT05491720|Serotonin Agents|serotonin agents|mesh-ancestor
102126699|NCT05491720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102126700|NCT05491720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126701|NCT05491720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126702|NCT05491720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102126703|NCT05491720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102126704|NCT05491720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102126705|NCT05491720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102126706|NCT05491720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102126707|NCT05491720|Dopamine Agents|dopamine agents|mesh-ancestor
102126708|NCT05387954|Anticoagulants|anticoagulants|mesh-list
102126709|NCT05387954|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
102126710|NCT05387954|Antithrombins|antithrombins|mesh-ancestor
102126711|NCT05387954|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102126712|NCT05387954|Protease Inhibitors|protease inhibitors|mesh-ancestor
102126713|NCT05387954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102126714|NCT05387954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126715|NCT03262688|Bupivacaine|bupivacaine|mesh-list
102126716|NCT03262688|Anesthetics, Local|anesthetics, local|mesh-ancestor
102126717|NCT03262688|Anesthetics|anesthetics|mesh-ancestor
101835747|NCT01013532|Autonomic Agents|autonomic agents|mesh-ancestor
102126718|NCT03262688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102126719|NCT03262688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126720|NCT03262688|Sensory System Agents|sensory system agents|mesh-ancestor
102126721|NCT03262688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102126722|NCT05486884|Benzocaine|benzocaine|mesh-list
102126723|NCT05486884|Anesthetics, Local|anesthetics, local|mesh-ancestor
102126724|NCT05486884|Anesthetics|anesthetics|mesh-ancestor
102126725|NCT05486884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102126726|NCT05486884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126727|NCT05486884|Sensory System Agents|sensory system agents|mesh-ancestor
102126728|NCT05486884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102126729|NCT05485792|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102126730|NCT05485792|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102126731|NCT05485792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126732|NCT05485402|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
102126733|NCT05485402|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
102126734|NCT05485402|4-hydroxyphenylethanol|4-hydroxyphenylethanol|mesh-list
102126735|NCT05485402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102126736|NCT05485402|Antioxidants|antioxidants|mesh-ancestor
102126737|NCT05485402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126738|NCT05485402|Protective Agents|protective agents|mesh-ancestor
102126739|NCT05485402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126740|NCT05485402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102126741|NCT05485402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102126742|NCT05485402|Disinfectants|disinfectants|mesh-ancestor
102126743|NCT05485402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102126744|NCT03797924|Ropivacaine|ropivacaine|mesh-list
102126745|NCT03797924|Anesthetics, Local|anesthetics, local|mesh-ancestor
102126746|NCT03797924|Anesthetics|anesthetics|mesh-ancestor
102126747|NCT03797924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102126748|NCT03797924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126749|NCT03797924|Sensory System Agents|sensory system agents|mesh-ancestor
102126750|NCT03797924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102126751|NCT05486650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102126752|NCT05486650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126753|NCT05486650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102126754|NCT05486650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102126755|NCT05074628|Nitrofurantoin|nitrofurantoin|mesh-list
102126756|NCT05074628|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102126757|NCT05074628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102126758|NCT05074628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102126759|NCT04273516|Rivaroxaban|rivaroxaban|mesh-list
102126760|NCT04273516|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102126761|NCT04273516|Antithrombins|antithrombins|mesh-ancestor
102126762|NCT04273516|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102126763|NCT04273516|Protease Inhibitors|protease inhibitors|mesh-ancestor
102126764|NCT04273516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102126765|NCT04273516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126766|NCT04273516|Anticoagulants|anticoagulants|mesh-ancestor
102126767|NCT02458742|Morphine|morphine|mesh-list
102126768|NCT02458742|Bupivacaine|bupivacaine|mesh-list
102126769|NCT02458742|Anesthetics, Local|anesthetics, local|mesh-ancestor
102126770|NCT02458742|Anesthetics|anesthetics|mesh-ancestor
102126771|NCT02458742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102126772|NCT02458742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126773|NCT02458742|Sensory System Agents|sensory system agents|mesh-ancestor
102126774|NCT02458742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102126775|NCT02458742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102126776|NCT02458742|Narcotics|narcotics|mesh-ancestor
102126777|NCT02458742|Analgesics|analgesics|mesh-ancestor
102126778|NCT02403310|Cytarabine|cytarabine|mesh-list
102126779|NCT02403310|Daunorubicin|daunorubicin|mesh-list
102126780|NCT02403310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102126781|NCT02403310|Antimetabolites|antimetabolites|mesh-ancestor
102126782|NCT02403310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126783|NCT02403310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102126784|NCT02403310|Antiviral Agents|antiviral agents|mesh-ancestor
102126785|NCT02403310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102126786|NCT02403310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102126787|NCT02403310|Immunologic Factors|immunologic factors|mesh-ancestor
102126788|NCT02403310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126789|NCT02403310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102126790|NCT02403310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102126791|NCT02403310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102126792|NCT02403310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102126793|NCT01665274|Capecitabine|capecitabine|mesh-list
102126794|NCT01665274|Oxaliplatin|oxaliplatin|mesh-list
102126795|NCT01665274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102126796|NCT01665274|Antimetabolites|antimetabolites|mesh-ancestor
102126797|NCT01665274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126798|NCT01665274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102126799|NCT05387876|Vitamin D|vitamin d|mesh-list
102126800|NCT05387876|Vitamins|vitamins|mesh-ancestor
102126801|NCT05387876|Micronutrients|micronutrients|mesh-ancestor
102126802|NCT05387876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126803|NCT05387876|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102126804|NCT04560166|Irinotecan|irinotecan|mesh-list
102126805|NCT04560166|Temozolomide|temozolomide|mesh-list
102126806|NCT04560166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102126807|NCT04560166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102126808|NCT04560166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102126809|NCT04560166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126810|NCT04560166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102126811|NCT04560166|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102126812|NCT04560166|Alkylating Agents|alkylating agents|mesh-ancestor
102126813|NCT03262376|Vitamins|vitamins|mesh-list
102126814|NCT03262376|Micronutrients|micronutrients|mesh-ancestor
102126815|NCT03262376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126816|NCT02456714|Folfirinox|folfirinox|mesh-list
102126817|NCT02456714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102126818|NCT03258866|Rituximab|rituximab|mesh-list
102126819|NCT03258866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102126820|NCT03258866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102126821|NCT03258866|Immunologic Factors|immunologic factors|mesh-ancestor
102126822|NCT03258866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126823|NCT03258866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102126824|NCT03258476|Guanfacine|guanfacine|mesh-list
102126825|NCT03258476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102126826|NCT03258476|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102126827|NCT03258476|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102126828|NCT03258476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102126829|NCT03258476|Adrenergic Agents|adrenergic agents|mesh-ancestor
102126830|NCT03258476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102126831|NCT03258476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126832|NCT03258476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126833|NCT03258398|Avelumab|avelumab|mesh-list
102126834|NCT03258398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102126835|NCT03258398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102126836|NCT03261596|Mebendazole|mebendazole|mesh-list
102126838|NCT03261596|Piperazine citrate|piperazine citrate|mesh-list
102126839|NCT03261596|DMP 777|dmp 777|mesh-list
102126840|NCT03261596|Antinematodal Agents|antinematodal agents|mesh-ancestor
102126841|NCT03261596|Anthelmintics|anthelmintics|mesh-ancestor
102126842|NCT03261596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102126843|NCT03261596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102126844|NCT03261596|Tubulin Modulators|tubulin modulators|mesh-ancestor
102126845|NCT03261596|Antimitotic Agents|antimitotic agents|mesh-ancestor
102126846|NCT03261596|Mitosis Modulators|mitosis modulators|mesh-ancestor
102126847|NCT03261596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126848|NCT03261596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102126849|NCT03261596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102126850|NCT03825874|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102126851|NCT03825874|Amikacin|amikacin|mesh-list
102126852|NCT03825874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102126853|NCT03772574|Nicotine|nicotine|mesh-list
102126854|NCT03772574|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102126855|NCT03772574|Autonomic Agents|autonomic agents|mesh-ancestor
102126856|NCT03772574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102126857|NCT03772574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126858|NCT03772574|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102126859|NCT03772574|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102126860|NCT03772574|Cholinergic Agents|cholinergic agents|mesh-ancestor
102126861|NCT03772574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102126862|NCT03772574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126863|NCT02456558|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102126864|NCT02456558|Deferiprone|deferiprone|mesh-list
102126865|NCT02456558|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102126866|NCT02456558|Chelating Agents|chelating agents|mesh-ancestor
102126867|NCT02456558|Sequestering Agents|sequestering agents|mesh-ancestor
102126868|NCT02456558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126869|NCT03798080|Insulin|insulin|mesh-list
102126870|NCT03798080|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102126872|NCT03798080|Insulin Glargine|insulin glargine|mesh-list
102126873|NCT03798080|Lixisenatide|lixisenatide|mesh-list
102126874|NCT03798080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102126875|NCT03798080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126876|NCT03257930|Ethanol|ethanol|mesh-list
102126877|NCT03257930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102126878|NCT03257930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102126879|NCT03257930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102126880|NCT03257930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126881|NCT03257852|Methotrexate|methotrexate|mesh-list
102126882|NCT03257852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102126883|NCT03257852|Abortifacient Agents|abortifacient agents|mesh-ancestor
102126884|NCT03257852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102126885|NCT03257852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126886|NCT03257852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102126887|NCT03257852|Antimetabolites|antimetabolites|mesh-ancestor
102126888|NCT03257852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126889|NCT03257852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102126890|NCT03257852|Dermatologic Agents|dermatologic agents|mesh-ancestor
102126891|NCT03257852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102126892|NCT03257852|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102126893|NCT03257852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102126894|NCT03257852|Immunologic Factors|immunologic factors|mesh-ancestor
102126895|NCT03257852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102126896|NCT03257852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102126897|NCT05498896|Paclitaxel|paclitaxel|mesh-list
102126898|NCT05498896|Cyclophosphamide|cyclophosphamide|mesh-list
102126899|NCT05498896|Doxorubicin|doxorubicin|mesh-list
102126900|NCT05498896|Atezolizumab|atezolizumab|mesh-list
102126901|NCT05498896|Ipatasertib|ipatasertib|mesh-list
102126902|NCT05498896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102126903|NCT05498896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102126904|NCT05498896|Tubulin Modulators|tubulin modulators|mesh-ancestor
102126905|NCT05498896|Antimitotic Agents|antimitotic agents|mesh-ancestor
102126906|NCT05498896|Mitosis Modulators|mitosis modulators|mesh-ancestor
102126907|NCT05498896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126908|NCT05498896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102126909|NCT05498896|Immunologic Factors|immunologic factors|mesh-ancestor
102126910|NCT05498896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126911|NCT05498896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102126912|NCT05498896|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102069572|NCT05104138|Eplerenone|eplerenone|mesh-list
102126913|NCT05498896|Alkylating Agents|alkylating agents|mesh-ancestor
102126914|NCT05498896|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102126915|NCT05498896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102126916|NCT05498896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102126917|NCT05498896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102126918|NCT05498896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102126919|NCT05498896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102126920|NCT05498896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102126921|NCT05498896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102126922|NCT02743221|Trifluridine|trifluridine|mesh-list
102126923|NCT02743221|Bevacizumab|bevacizumab|mesh-list
102126924|NCT02743221|Capecitabine|capecitabine|mesh-list
102126925|NCT02743221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102126926|NCT02743221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102126927|NCT02743221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102126928|NCT02743221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102126929|NCT02743221|Growth Substances|growth substances|mesh-ancestor
102126930|NCT02743221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126931|NCT02743221|Growth Inhibitors|growth inhibitors|mesh-ancestor
102126932|NCT02743221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102126933|NCT02743221|Antimetabolites|antimetabolites|mesh-ancestor
102126934|NCT02743221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126935|NCT02743221|Antiviral Agents|antiviral agents|mesh-ancestor
102126936|NCT02743221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102126937|NCT03955887|Dimercaprol|dimercaprol|mesh-list
102126938|NCT03955887|Chelating Agents|chelating agents|mesh-ancestor
102126939|NCT03955887|Sequestering Agents|sequestering agents|mesh-ancestor
102126940|NCT03955887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126941|NCT03260972|Chloroprocaine|chloroprocaine|mesh-list
102126942|NCT03260972|Anesthetics, Local|anesthetics, local|mesh-ancestor
102126943|NCT03260972|Anesthetics|anesthetics|mesh-ancestor
102126944|NCT03260972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102126945|NCT03260972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126946|NCT03260972|Sensory System Agents|sensory system agents|mesh-ancestor
102126947|NCT03260972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102126948|NCT03370263|Belimumab|belimumab|mesh-list
102126949|NCT03370263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102126950|NCT03370263|Immunologic Factors|immunologic factors|mesh-ancestor
102126951|NCT03370263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126952|NCT00692445|Mecamylamine|mecamylamine|mesh-list
102126953|NCT00692445|Dexetimide|dexetimide|mesh-list
102126954|NCT00692445|Citalopram|citalopram|mesh-list
102126955|NCT00692445|Escitalopram|escitalopram|mesh-list
102126956|NCT00692445|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102126957|NCT00692445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102126958|NCT00692445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102126959|NCT00692445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126960|NCT00692445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102126961|NCT00692445|Serotonin Agents|serotonin agents|mesh-ancestor
102126962|NCT00692445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126963|NCT00692445|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102126964|NCT00692445|Antidepressive Agents|antidepressive agents|mesh-ancestor
102126965|NCT00692445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102126966|NCT00692445|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102126967|NCT00692445|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102126968|NCT00692445|Parasympatholytics|parasympatholytics|mesh-ancestor
102126969|NCT00692445|Autonomic Agents|autonomic agents|mesh-ancestor
102126970|NCT00692445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102126971|NCT00692445|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102126972|NCT00692445|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102126973|NCT00692445|Cholinergic Agents|cholinergic agents|mesh-ancestor
102126974|NCT00692445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102126975|NCT00692445|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
102126976|NCT00692445|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102126977|NCT03929757|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
102126978|NCT03929757|Antiviral Agents|antiviral agents|mesh-ancestor
102126979|NCT03929757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102126980|NCT03256292|Testosterone|testosterone|mesh-list
102126981|NCT03256292|Androgens|androgens|mesh-ancestor
102126982|NCT03256292|Hormones|hormones|mesh-ancestor
102126983|NCT03256292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102126984|NCT03256292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126985|NCT04473261|Iodine|iodine|mesh-list
102126986|NCT04473261|Cadexomer iodine|cadexomer iodine|mesh-list
102535882|NCT05439993|Tubulin Modulators|tubulin modulators|mesh-ancestor
102126987|NCT04473261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102126988|NCT04473261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102126989|NCT04473261|Trace Elements|trace elements|mesh-ancestor
102126990|NCT04473261|Micronutrients|micronutrients|mesh-ancestor
102126991|NCT04473261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102126992|NCT01358968|Gemcitabine|gemcitabine|mesh-list
102126993|NCT01358968|Pemetrexed|pemetrexed|mesh-list
102126994|NCT01358968|Desipramine|desipramine|mesh-list
102126995|NCT01358968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102126996|NCT01358968|Antimetabolites|antimetabolites|mesh-ancestor
102126997|NCT01358968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102126998|NCT01358968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102126999|NCT01358968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102127000|NCT01358968|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102127001|NCT01358968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102127002|NCT01358968|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102127003|NCT01358968|Antidepressive Agents|antidepressive agents|mesh-ancestor
102127004|NCT01358968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102127005|NCT01358968|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102127006|NCT01358968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102127007|NCT01358968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102127008|NCT01358968|Adrenergic Agents|adrenergic agents|mesh-ancestor
102127009|NCT01358968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102127010|NCT01358968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127011|NCT02281305|Colchicine|colchicine|mesh-list
102127012|NCT02281305|Gout Suppressants|gout suppressants|mesh-ancestor
102127013|NCT02281305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102127014|NCT02281305|Tubulin Modulators|tubulin modulators|mesh-ancestor
102127015|NCT02281305|Antimitotic Agents|antimitotic agents|mesh-ancestor
102127016|NCT02281305|Mitosis Modulators|mitosis modulators|mesh-ancestor
102127017|NCT02281305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127018|NCT02281305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102127019|NCT00624351|Epratuzumab|epratuzumab|mesh-list
102127020|NCT00624351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102127021|NCT00624351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102127022|NCT03251690|Tenofovir|tenofovir|mesh-list
102127023|NCT03251690|Emtricitabine|emtricitabine|mesh-list
102127024|NCT03251690|Efavirenz|efavirenz|mesh-list
102127025|NCT03251690|Rilpivirine|rilpivirine|mesh-list
102127026|NCT03251690|Antiviral Agents|antiviral agents|mesh-ancestor
102127027|NCT03251690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102127028|NCT03251690|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102127029|NCT03251690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102127030|NCT03251690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102127031|NCT03251690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127032|NCT03251690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102127033|NCT03251690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102127034|NCT03251690|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102127035|NCT03251690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102127036|NCT03251690|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102127037|NCT03251690|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102127038|NCT03251690|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102127039|NCT03251690|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102127040|NCT03251768|Lenograstim|lenograstim|mesh-list
102127041|NCT03251768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102127042|NCT03251768|Immunologic Factors|immunologic factors|mesh-ancestor
102127043|NCT03251768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127044|NCT00687687|Paclitaxel|paclitaxel|mesh-list
102127045|NCT00687687|Carboplatin|carboplatin|mesh-list
102127046|NCT00687687|Iniparib|iniparib|mesh-list
102127047|NCT00687687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102127048|NCT00687687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102127049|NCT00687687|Tubulin Modulators|tubulin modulators|mesh-ancestor
102127050|NCT00687687|Antimitotic Agents|antimitotic agents|mesh-ancestor
102127051|NCT00687687|Mitosis Modulators|mitosis modulators|mesh-ancestor
102127052|NCT00687687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127053|NCT00687687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102127054|NCT00687687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102127055|NCT00701090|Metformin|metformin|mesh-list
102127056|NCT00701090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102127057|NCT00701090|Glimepiride|glimepiride|mesh-list
102127058|NCT00701090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102127059|NCT00701090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127060|NCT00701090|Incretins|incretins|mesh-ancestor
102127061|NCT00701090|Hormones|hormones|mesh-ancestor
102535883|NCT05439993|Antimitotic Agents|antimitotic agents|mesh-ancestor
102127062|NCT00701090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102127063|NCT00701090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102127064|NCT00701090|Protease Inhibitors|protease inhibitors|mesh-ancestor
102127065|NCT00701090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102127066|NCT00701090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127067|NCT00701090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102127068|NCT00701090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102127069|NCT00701090|Immunologic Factors|immunologic factors|mesh-ancestor
102127070|NCT00614601|Vaccines|vaccines|mesh-list
102127071|NCT00614601|Immunologic Factors|immunologic factors|mesh-ancestor
102127072|NCT00614601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127073|NCT02283489|Paclitaxel|paclitaxel|mesh-list
102127074|NCT02283489|Endostatins|endostatins|mesh-list
102127075|NCT02283489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102127076|NCT02283489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102127077|NCT02283489|Tubulin Modulators|tubulin modulators|mesh-ancestor
102127078|NCT02283489|Antimitotic Agents|antimitotic agents|mesh-ancestor
102127079|NCT02283489|Mitosis Modulators|mitosis modulators|mesh-ancestor
102127080|NCT02283489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127081|NCT02283489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102127082|NCT02283489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102127083|NCT02283489|Growth Substances|growth substances|mesh-ancestor
102127084|NCT02283489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127085|NCT02283489|Growth Inhibitors|growth inhibitors|mesh-ancestor
102127086|NCT02455232|Lidocaine|lidocaine|mesh-list
102127087|NCT02455232|Anesthetics, Local|anesthetics, local|mesh-ancestor
102127088|NCT02455232|Anesthetics|anesthetics|mesh-ancestor
102127089|NCT02455232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102127090|NCT02455232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127091|NCT02455232|Sensory System Agents|sensory system agents|mesh-ancestor
102127092|NCT02455232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102127093|NCT02455232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102127094|NCT02455232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102127095|NCT02455232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102127096|NCT02455232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102127097|NCT02455232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127098|NCT03259958|Donepezil|donepezil|mesh-list
102127099|NCT03259958|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102127100|NCT03259958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102127101|NCT03259958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127102|NCT03259958|Cholinergic Agents|cholinergic agents|mesh-ancestor
102127103|NCT03259958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102127104|NCT03259958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127105|NCT03259958|Nootropic Agents|nootropic agents|mesh-ancestor
102127106|NCT02923947|Osimertinib|osimertinib|mesh-list
102127107|NCT02923947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102127108|NCT02923947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102127109|NCT02923947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102127110|NCT02923947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127111|NCT00679731|Methotrexate|methotrexate|mesh-list
102127112|NCT00679731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102127113|NCT00679731|Abortifacient Agents|abortifacient agents|mesh-ancestor
102127114|NCT00679731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102127115|NCT00679731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127116|NCT00679731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102127117|NCT00679731|Antimetabolites|antimetabolites|mesh-ancestor
102127118|NCT00679731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127119|NCT00679731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102127120|NCT00679731|Dermatologic Agents|dermatologic agents|mesh-ancestor
102127121|NCT00679731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102127122|NCT00679731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102127123|NCT00679731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102127124|NCT00679731|Immunologic Factors|immunologic factors|mesh-ancestor
102127125|NCT00679731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102127126|NCT00679731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102127127|NCT02455856|Itraconazole|itraconazole|mesh-list
102127128|NCT02455856|Antifungal Agents|antifungal agents|mesh-ancestor
102127129|NCT02455856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102127130|NCT02455856|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102127131|NCT02455856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102127132|NCT02455856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102069799|NCT05617508|Niacinamide|niacinamide|mesh-list
102535884|NCT05439993|Mitosis Modulators|mitosis modulators|mesh-ancestor
102127133|NCT02455856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127134|NCT02455856|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102127135|NCT02455856|Hormone Antagonists|hormone antagonists|mesh-ancestor
102127136|NCT02455856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102127137|NCT02455856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127138|NCT02455856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102127139|NCT02283645|Minoxidil|minoxidil|mesh-list
102127140|NCT02283645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102127141|NCT02283645|Vasodilator Agents|vasodilator agents|mesh-ancestor
102127142|NCT00602745|Fluorouracil|fluorouracil|mesh-list
102127143|NCT00602745|Antimetabolites|antimetabolites|mesh-ancestor
102127144|NCT00602745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127145|NCT00602745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102127146|NCT00602745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102127147|NCT00602745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102127148|NCT00602745|Immunologic Factors|immunologic factors|mesh-ancestor
102127149|NCT00602745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127150|NCT03251222|Dexmedetomidine|dexmedetomidine|mesh-list
102127151|NCT03251222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102127152|NCT03251222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102127153|NCT03251222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127154|NCT03251222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102127155|NCT03251222|Analgesics|analgesics|mesh-ancestor
102127156|NCT03251222|Sensory System Agents|sensory system agents|mesh-ancestor
102127157|NCT03251222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102127158|NCT03251222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102127159|NCT03251222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102127160|NCT03251222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102127161|NCT03251222|Adrenergic Agents|adrenergic agents|mesh-ancestor
102127162|NCT03251222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102127163|NCT03251222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127164|NCT04487834|Simethicone|simethicone|mesh-list
102127165|NCT04487834|Antifoaming Agents|antifoaming agents|mesh-ancestor
102127166|NCT04487834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127167|NCT04487834|Emollients|emollients|mesh-ancestor
102127168|NCT04487834|Dermatologic Agents|dermatologic agents|mesh-ancestor
102127169|NCT03250910|Ribavirin|ribavirin|mesh-list
102127170|NCT03250910|Sofosbuvir|sofosbuvir|mesh-list
102127171|NCT03250910|Velpatasvir|velpatasvir|mesh-list
102127172|NCT03250910|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102127173|NCT03250910|Antimetabolites|antimetabolites|mesh-ancestor
102127174|NCT03250910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127175|NCT03250910|Antiviral Agents|antiviral agents|mesh-ancestor
102127176|NCT03250910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102127177|NCT02283801|Lamotrigine|lamotrigine|mesh-list
102127178|NCT02283801|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102127179|NCT02283801|Anticonvulsants|anticonvulsants|mesh-ancestor
102127180|NCT02283801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102127181|NCT02283801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102127182|NCT02283801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127183|NCT02283801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102127184|NCT02283801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127185|NCT02283801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102127186|NCT02283801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102127187|NCT02283801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102127188|NCT02283801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102127189|NCT02283801|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102127190|NCT02283801|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102127191|NCT02455154|Letrozole|letrozole|mesh-list
102127192|NCT02455154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102127193|NCT02455154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102127194|NCT02455154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102127195|NCT02455154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102127196|NCT02455154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127197|NCT02455154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102127198|NCT02455154|Hormone Antagonists|hormone antagonists|mesh-ancestor
102127199|NCT02455154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102127200|NCT02455154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127201|NCT03254810|Adalimumab|adalimumab|mesh-list
102127202|NCT03254810|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102127203|NCT03254810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102127204|NCT03254810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102127205|NCT03255044|Atorvastatin|atorvastatin|mesh-list
102127206|NCT03255044|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102127207|NCT03255044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102127208|NCT03255044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102127209|NCT03255044|Antimetabolites|antimetabolites|mesh-ancestor
102127210|NCT03255044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127211|NCT03255044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102127212|NCT03255044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102127213|NCT03255044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102127215|NCT00677079|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102127216|NCT00677079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102127217|NCT00677079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127218|NCT00677079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102127219|NCT03245996|Atenolol|atenolol|mesh-list
102127220|NCT03245996|Nebivolol|nebivolol|mesh-list
102127221|NCT03245996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102127222|NCT03245996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102127223|NCT03245996|Sympatholytics|sympatholytics|mesh-ancestor
102127224|NCT03245996|Autonomic Agents|autonomic agents|mesh-ancestor
102127225|NCT03245996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102127226|NCT03245996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127227|NCT03245996|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102127228|NCT03245996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102127229|NCT03245996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102127230|NCT03245996|Adrenergic Agents|adrenergic agents|mesh-ancestor
102127231|NCT03245996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102127232|NCT03245996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127233|NCT03245996|Vasodilator Agents|vasodilator agents|mesh-ancestor
102127234|NCT03245996|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102127235|NCT03245996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102127236|NCT03245996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102127237|NCT02281929|Amoxicillin|amoxicillin|mesh-list
102127238|NCT02281929|Clavulanic Acids|clavulanic acids|mesh-list
102127239|NCT02281929|Clavulanic Acid|clavulanic acid|mesh-list
102127240|NCT02281929|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102127241|NCT02281929|Prednisolone|prednisolone|mesh-list
102127242|NCT02281929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102127243|NCT02281929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102127244|NCT02281929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102127245|NCT02281929|Glucocorticoids|glucocorticoids|mesh-ancestor
102127246|NCT02281929|Hormones|hormones|mesh-ancestor
102127247|NCT02281929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102127248|NCT02281929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127249|NCT02281929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102127250|NCT02281929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102127251|NCT02281929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102127252|NCT02281929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127253|NCT02281929|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102127254|NCT04424056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102127255|NCT04424056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102127256|NCT05478772|Fluconazole|fluconazole|mesh-list
102127257|NCT05478772|Antifungal Agents|antifungal agents|mesh-ancestor
102127258|NCT05478772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102127259|NCT05478772|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102127260|NCT05478772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102127261|NCT05478772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102127262|NCT05478772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127263|NCT05478772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102127264|NCT05478772|Hormone Antagonists|hormone antagonists|mesh-ancestor
102127265|NCT05478772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102127266|NCT05478772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127267|NCT05478772|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102127268|NCT05478772|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102127269|NCT02945852|Apatinib|apatinib|mesh-list
102127270|NCT02945852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102127271|NCT02945852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102127272|NCT02945852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102127273|NCT02945852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127274|NCT03245528|Angiotensin II|angiotensin ii|mesh-list
102127275|NCT03245528|Giapreza|giapreza|mesh-list
102127276|NCT03245528|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102127278|NCT00495885|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102127279|NCT00495885|Serotonin Agents|serotonin agents|mesh-ancestor
102127280|NCT00495885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102127281|NCT00495885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127282|NCT00495885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127283|NCT03254186|Propranolol|propranolol|mesh-list
102127284|NCT03254186|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102127285|NCT03254186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102127286|NCT03254186|Adrenergic Agents|adrenergic agents|mesh-ancestor
102127287|NCT03254186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102127288|NCT03254186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127289|NCT03254186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127290|NCT03254186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102127291|NCT03254186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102127292|NCT03254186|Vasodilator Agents|vasodilator agents|mesh-ancestor
102127293|NCT00589875|Valacyclovir|valacyclovir|mesh-list
102127294|NCT00589875|Antiviral Agents|antiviral agents|mesh-ancestor
102127295|NCT00589875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102127296|NCT03250598|Mitapivat|mitapivat|mesh-list
102127297|NCT03250598|Enzyme Activators|enzyme activators|mesh-ancestor
102127298|NCT03250598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127299|NCT05483062|Fluorides|fluorides|mesh-list
102127300|NCT05483062|Tin Fluorides|tin fluorides|mesh-list
102127301|NCT05483062|Cariostatic Agents|cariostatic agents|mesh-ancestor
102127302|NCT05483062|Protective Agents|protective agents|mesh-ancestor
102127303|NCT05483062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127304|NCT02282085|Olanzapine|olanzapine|mesh-list
102127305|NCT02282085|Risperidone|risperidone|mesh-list
102127306|NCT02282085|Aripiprazole|aripiprazole|mesh-list
102127307|NCT02282085|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102127308|NCT02282085|Ziprasidone|ziprasidone|mesh-list
102127309|NCT02282085|Antipsychotic Agents|antipsychotic agents|mesh-list
102127310|NCT02282085|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102127311|NCT02282085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102127312|NCT02282085|Serotonin Agents|serotonin agents|mesh-ancestor
102127313|NCT02282085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102127314|NCT02282085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836345|NCT00561821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102127315|NCT02282085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127316|NCT02282085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102127317|NCT02282085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102127318|NCT02282085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102127319|NCT02282085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102127320|NCT02282085|Dopamine Agents|dopamine agents|mesh-ancestor
102127321|NCT02282085|Antiemetics|antiemetics|mesh-ancestor
102127322|NCT02282085|Autonomic Agents|autonomic agents|mesh-ancestor
102127323|NCT02282085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102127324|NCT02282085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102127325|NCT02282085|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102127326|NCT02282085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102127327|NCT02282085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102127328|NCT02282085|Antidepressive Agents|antidepressive agents|mesh-ancestor
102127329|NCT02282085|Dopamine Agonists|dopamine agonists|mesh-ancestor
102127330|NCT02282085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102127331|NCT02282085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102127332|NCT02282085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102025891|NCT02697916|Aspirin|aspirin|mesh-list
102127333|NCT02282085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102127334|NCT02282085|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102127335|NCT02282085|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102127336|NCT02282085|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102127337|NCT02282085|Adrenergic Agents|adrenergic agents|mesh-ancestor
102127338|NCT03244592|Minocycline|minocycline|mesh-list
102127339|NCT03244592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102127340|NCT03244592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102127341|NCT03253328|Acetylcysteine|acetylcysteine|mesh-list
102127342|NCT03253328|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102127343|NCT03253328|Antiviral Agents|antiviral agents|mesh-ancestor
102127344|NCT03253328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102127345|NCT03253328|Expectorants|expectorants|mesh-ancestor
102127346|NCT03253328|Respiratory System Agents|respiratory system agents|mesh-ancestor
102127347|NCT03253328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102127348|NCT03253328|Antioxidants|antioxidants|mesh-ancestor
102127349|NCT03253328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127350|NCT03253328|Protective Agents|protective agents|mesh-ancestor
102127351|NCT03253328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127352|NCT03253328|Antidotes|antidotes|mesh-ancestor
102127353|NCT03253250|Tenofovir|tenofovir|mesh-list
102127354|NCT03253250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102127355|NCT03253250|Entecavir|entecavir|mesh-list
102127356|NCT03253250|Adefovir|adefovir|mesh-list
102127357|NCT03253250|Antiviral Agents|antiviral agents|mesh-ancestor
102127358|NCT03253250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102127359|NCT03253250|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102127360|NCT03253250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102127361|NCT03253250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102127362|NCT03253250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127363|NCT03253250|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102127364|NCT03253250|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102127365|NCT03253562|Metformin|metformin|mesh-list
102127366|NCT03253562|Vildagliptin|vildagliptin|mesh-list
102127367|NCT03253562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102127368|NCT03253562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127369|NCT03253562|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102127370|NCT03253562|Protease Inhibitors|protease inhibitors|mesh-ancestor
102127371|NCT03253562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102127372|NCT03253562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127373|NCT03250052|Linagliptin|linagliptin|mesh-list
102127374|NCT03250052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102127375|NCT03250052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127376|NCT03250052|Incretins|incretins|mesh-ancestor
102127377|NCT03250052|Hormones|hormones|mesh-ancestor
102127378|NCT03250052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102127379|NCT03250052|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102127380|NCT03250052|Protease Inhibitors|protease inhibitors|mesh-ancestor
102127381|NCT03250052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102127382|NCT03250052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127383|NCT05478382|Pregabalin|pregabalin|mesh-list
102127384|NCT05478382|Analgesics|analgesics|mesh-ancestor
102127385|NCT05478382|Sensory System Agents|sensory system agents|mesh-ancestor
102127386|NCT05478382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102127387|NCT05478382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127388|NCT05478382|Anticonvulsants|anticonvulsants|mesh-ancestor
102127389|NCT05478382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102127390|NCT05478382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102127391|NCT05478382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127392|NCT05478382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102127393|NCT05478382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102127394|NCT05478382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102127395|NCT05478382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102127396|NCT05478382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102127397|NCT03244358|Epalrestat|epalrestat|mesh-list
102127398|NCT03244358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102127399|NCT03244358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127400|NCT03249740|Sunitinib|sunitinib|mesh-list
102127401|NCT03249740|Aflibercept|aflibercept|mesh-list
102127402|NCT03249740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102127403|NCT03249740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102127404|NCT03249740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102127405|NCT03249740|Growth Substances|growth substances|mesh-ancestor
102127406|NCT03249740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127407|NCT03249740|Growth Inhibitors|growth inhibitors|mesh-ancestor
102127408|NCT03249740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102127409|NCT03249740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102127410|NCT03249740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127411|NCT03057977|Empagliflozin|empagliflozin|mesh-list
102127412|NCT03057977|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102127413|NCT03057977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127414|NCT03057977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102127415|NCT03057977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127416|NCT03249506|Dapagliflozin|dapagliflozin|mesh-list
102127417|NCT03249506|Empagliflozin|empagliflozin|mesh-list
102127418|NCT03249506|Canagliflozin|canagliflozin|mesh-list
102127419|NCT03249506|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
102127420|NCT03249506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
102127421|NCT03249506|Glucagon|glucagon|mesh-list
102127422|NCT03249506|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102127423|NCT03249506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102127424|NCT03249506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154330|NCT03365817|Sensory System Agents|sensory system agents|mesh-ancestor
102127425|NCT03249506|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102127426|NCT03249506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127427|NCT03249506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102127428|NCT03249506|Hormones|hormones|mesh-ancestor
102127429|NCT03249506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102127430|NCT03249506|Incretins|incretins|mesh-ancestor
102127431|NCT03249506|Protease Inhibitors|protease inhibitors|mesh-ancestor
102127432|NCT03249506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102127433|NCT03249662|Bupivacaine|bupivacaine|mesh-list
102127434|NCT03249662|Anesthetics, Local|anesthetics, local|mesh-ancestor
102127435|NCT03249662|Anesthetics|anesthetics|mesh-ancestor
102127436|NCT03249662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102127437|NCT03249662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127438|NCT03249662|Sensory System Agents|sensory system agents|mesh-ancestor
102127439|NCT03249662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102127440|NCT03249428|Nicotine|nicotine|mesh-list
102127441|NCT03249428|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102127442|NCT03249428|Autonomic Agents|autonomic agents|mesh-ancestor
102127443|NCT03249428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102127444|NCT03249428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127445|NCT03249428|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102127446|NCT03249428|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102127447|NCT03249428|Cholinergic Agents|cholinergic agents|mesh-ancestor
102127448|NCT03249428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102127449|NCT03249428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127450|NCT03243500|Lidocaine|lidocaine|mesh-list
102127451|NCT03243500|Bupivacaine|bupivacaine|mesh-list
102127452|NCT03243500|Atracurium|atracurium|mesh-list
102127453|NCT03243500|Anesthetics, Local|anesthetics, local|mesh-ancestor
102127454|NCT03243500|Anesthetics|anesthetics|mesh-ancestor
102127455|NCT03243500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102127456|NCT03243500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127457|NCT03243500|Sensory System Agents|sensory system agents|mesh-ancestor
102127458|NCT03243500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102127459|NCT03243500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102127460|NCT03243500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102127461|NCT03243500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102127462|NCT03243500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101836494|NCT00501852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102127463|NCT03243500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127464|NCT03243500|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102127465|NCT03243500|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102127466|NCT03243500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102127467|NCT03243500|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102127468|NCT03243500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102127469|NCT03243500|Cholinergic Agents|cholinergic agents|mesh-ancestor
102127470|NCT03243500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102127471|NCT03238898|Botulinum Toxins|botulinum toxins|mesh-list
102127472|NCT03238898|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102127473|NCT03238898|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102127474|NCT03238898|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102127475|NCT03238898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102127476|NCT03238898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127477|NCT03238898|Cholinergic Agents|cholinergic agents|mesh-ancestor
102127478|NCT03238898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102127479|NCT03238898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127480|NCT03238898|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102127481|NCT03238898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102127482|NCT03249194|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102127483|NCT03249194|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
102127484|NCT03249194|Antiviral Agents|antiviral agents|mesh-list
102127485|NCT03249194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102127486|NCT04486508|Heparin|heparin|mesh-list
102127487|NCT04486508|Calcium heparin|calcium heparin|mesh-list
102127488|NCT04486508|Enoxaparin|enoxaparin|mesh-list
102127489|NCT04486508|Enoxaparin sodium|enoxaparin sodium|mesh-list
102127490|NCT04486508|Atorvastatin|atorvastatin|mesh-list
102127491|NCT04486508|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
102127492|NCT04486508|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102127493|NCT04486508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102127494|NCT04486508|Antimetabolites|antimetabolites|mesh-ancestor
102127495|NCT04486508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127496|NCT04486508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102127497|NCT04486508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102127502|NCT02552212|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102127503|NCT02552212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102127504|NCT02552212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102127505|NCT02552212|Immunologic Factors|immunologic factors|mesh-ancestor
102127506|NCT02552212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127507|NCT02552212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102127508|NCT02454764|Interferons|interferons|mesh-list
102127509|NCT02454764|Tenofovir|tenofovir|mesh-list
102127510|NCT02454764|Interferon-alpha|interferon-alpha|mesh-list
102127511|NCT02454764|Interferon alpha-2|interferon alpha-2|mesh-list
102127512|NCT02454764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102127513|NCT02454764|Antiviral Agents|antiviral agents|mesh-ancestor
102127514|NCT02454764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102127515|NCT02454764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102127516|NCT02454764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102127517|NCT02454764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102127518|NCT02454764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127519|NCT02454764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102127520|NCT02454764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102127521|NCT02454764|Immunologic Factors|immunologic factors|mesh-ancestor
102127522|NCT02454764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127523|NCT00685919|Carbidopa|carbidopa|mesh-list
102127524|NCT00685919|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102127525|NCT00685919|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102127526|NCT00685919|Dopamine Agents|dopamine agents|mesh-ancestor
102127527|NCT00685919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102127528|NCT00685919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127529|NCT00685919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127530|NCT00685919|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102127531|NCT00685919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102127532|NCT03243344|Surgiflo|surgiflo|mesh-list
102127533|NCT03243344|Hemostatics|hemostatics|mesh-ancestor
102127534|NCT03243344|Coagulants|coagulants|mesh-ancestor
102127535|NCT03243032|Ibuprofen|ibuprofen|mesh-list
102127536|NCT03243032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102127537|NCT03243032|Anesthetics|anesthetics|mesh-list
102127538|NCT03243032|Anesthetics, Local|anesthetics, local|mesh-list
102127539|NCT03243032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102127540|NCT03243032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127541|NCT03243032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102127542|NCT03243032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102127543|NCT03243032|Analgesics|analgesics|mesh-ancestor
102127544|NCT03243032|Sensory System Agents|sensory system agents|mesh-ancestor
102127545|NCT03243032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102127546|NCT03243032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102127547|NCT03243032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102127548|NCT03243032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102127549|NCT03243032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127550|NCT03249038|Chrysarobin|chrysarobin|mesh-list
102127551|NCT03249038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102127552|NCT03249038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102127553|NCT03249038|Analgesics|analgesics|mesh-ancestor
102127554|NCT03249038|Sensory System Agents|sensory system agents|mesh-ancestor
102127555|NCT03249038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102127556|NCT03249038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127557|NCT03249038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102127558|NCT03249038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102127559|NCT03061331|Ivacaftor|ivacaftor|mesh-list
102127560|NCT03061331|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102127561|NCT03061331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102127562|NCT03061331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127563|NCT00700778|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102127564|NCT00700778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102127565|NCT00700778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127566|NCT05213585|Ivermectin|ivermectin|mesh-list
102127567|NCT05213585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102127568|NCT05213585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102127572|NCT05482282|Vaccines|vaccines|mesh-list
102127573|NCT05482282|Immunologic Factors|immunologic factors|mesh-ancestor
102127574|NCT05482282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127576|NCT05209529|Olaparib|olaparib|mesh-list
102127577|NCT05209529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102127578|NCT05209529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102127579|NCT05209529|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102127580|NCT05209529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102127581|NCT05209529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127582|NCT04424134|Spironolactone|spironolactone|mesh-list
102127583|NCT04424134|Bromhexine|bromhexine|mesh-list
102127584|NCT04424134|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102127585|NCT04424134|Hormone Antagonists|hormone antagonists|mesh-ancestor
102127586|NCT04424134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102127587|NCT04424134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127588|NCT04424134|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102127589|NCT04424134|Diuretics|diuretics|mesh-ancestor
102127590|NCT04424134|Natriuretic Agents|natriuretic agents|mesh-ancestor
102127591|NCT04424134|Expectorants|expectorants|mesh-ancestor
102127592|NCT04424134|Respiratory System Agents|respiratory system agents|mesh-ancestor
102127593|NCT04486430|Salicylates|salicylates|mesh-list
102127594|NCT04486430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102127595|NCT04486430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102127596|NCT04486430|Analgesics|analgesics|mesh-ancestor
102127597|NCT04486430|Sensory System Agents|sensory system agents|mesh-ancestor
102127598|NCT04486430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102127599|NCT04486430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127600|NCT04486430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102127601|NCT04486430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102127602|NCT04486430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102127603|NCT04486430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102127604|NCT04486430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127605|NCT03248726|Bisacodyl|bisacodyl|mesh-list
102127606|NCT03248726|Cathartics|cathartics|mesh-ancestor
102127607|NCT03248726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102127608|NCT03248726|Laxatives|laxatives|mesh-ancestor
102127609|NCT05208827|Vitamin D|vitamin d|mesh-list
102127610|NCT05208827|Ergocalciferols|ergocalciferols|mesh-list
102127611|NCT05208827|Cholecalciferol|cholecalciferol|mesh-list
102127612|NCT05208827|Vitamins|vitamins|mesh-list
102127613|NCT05208827|Micronutrients|micronutrients|mesh-ancestor
102127614|NCT05208827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127615|NCT05208827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102127616|NCT05208827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102127617|NCT04947059|Gemcitabine|gemcitabine|mesh-list
102127618|NCT04947059|Epirubicin|epirubicin|mesh-list
102127619|NCT04947059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102127620|NCT04947059|Antimetabolites|antimetabolites|mesh-ancestor
102127621|NCT04947059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127622|NCT04947059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102127623|NCT04947059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102127624|NCT04947059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102127625|NCT04947059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102127626|NCT04947059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102127627|NCT05481970|Dexamethasone|dexamethasone|mesh-list
102127628|NCT05481970|Lidocaine|lidocaine|mesh-list
102127629|NCT05481970|Fentanyl|fentanyl|mesh-list
102127630|NCT05481970|Dexmedetomidine|dexmedetomidine|mesh-list
102127631|NCT05481970|Ketamine|ketamine|mesh-list
102127632|NCT05481970|Propofol|propofol|mesh-list
102127633|NCT05481970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102127634|NCT05481970|Antiemetics|antiemetics|mesh-ancestor
102127635|NCT05481970|Autonomic Agents|autonomic agents|mesh-ancestor
102127636|NCT05481970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102127637|NCT05481970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127638|NCT05481970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102127639|NCT05481970|Glucocorticoids|glucocorticoids|mesh-ancestor
102127640|NCT05481970|Hormones|hormones|mesh-ancestor
102127641|NCT05481970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102127642|NCT05481970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102127643|NCT05481970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102127644|NCT05481970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127645|NCT05481970|Anesthetics, Local|anesthetics, local|mesh-ancestor
102127646|NCT05481970|Anesthetics|anesthetics|mesh-ancestor
102127647|NCT05481970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102127648|NCT05481970|Sensory System Agents|sensory system agents|mesh-ancestor
102127649|NCT05481970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102127650|NCT05481970|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102127651|NCT05481970|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102127652|NCT05481970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102127653|NCT05481970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102127654|NCT05481970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102127655|NCT05481970|Analgesics|analgesics|mesh-ancestor
102127656|NCT05481970|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102127657|NCT05481970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102127658|NCT05481970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102127659|NCT05481970|Adrenergic Agents|adrenergic agents|mesh-ancestor
102127660|NCT05481970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102127661|NCT05481970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102127662|NCT05481970|Anesthetics, General|anesthetics, general|mesh-ancestor
102127663|NCT05481970|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102127664|NCT05481970|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102127665|NCT05481970|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102127666|NCT05481970|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102127667|NCT05481970|Narcotics|narcotics|mesh-ancestor
102127668|NCT05481970|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102127669|NCT03248648|Ketamine|ketamine|mesh-list
102127670|NCT03248648|Neostigmine|neostigmine|mesh-list
102127671|NCT03248648|Analgesics|analgesics|mesh-ancestor
102127672|NCT03248648|Sensory System Agents|sensory system agents|mesh-ancestor
102127673|NCT03248648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102127674|NCT03248648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127675|NCT03248648|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102127676|NCT03248648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102127677|NCT03248648|Anesthetics, General|anesthetics, general|mesh-ancestor
102127678|NCT03248648|Anesthetics|anesthetics|mesh-ancestor
102127679|NCT03248648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102127680|NCT03248648|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102127681|NCT03248648|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102127682|NCT03248648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102127683|NCT03248648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127684|NCT03248648|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102127685|NCT03248648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102127686|NCT03248648|Cholinergic Agents|cholinergic agents|mesh-ancestor
102127687|NCT03248648|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101836718|NCT00307684|Dopamine Agents|dopamine agents|mesh-ancestor
102127689|NCT03241784|Interleukin-2|interleukin-2|mesh-list
102127690|NCT03241784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102127691|NCT03241784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102127692|NCT03241784|Analgesics|analgesics|mesh-ancestor
102127693|NCT03241784|Sensory System Agents|sensory system agents|mesh-ancestor
102127694|NCT03241784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102127695|NCT03241784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127696|NCT03242096|Sirolimus|sirolimus|mesh-list
102127697|NCT03242096|Paclitaxel|paclitaxel|mesh-list
102127698|NCT03242096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102127699|NCT03242096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102127700|NCT03242096|Tubulin Modulators|tubulin modulators|mesh-ancestor
102127701|NCT03242096|Antimitotic Agents|antimitotic agents|mesh-ancestor
102127702|NCT03242096|Mitosis Modulators|mitosis modulators|mesh-ancestor
102127703|NCT03242096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127704|NCT03242096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102127705|NCT03242096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102127706|NCT03242096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102127707|NCT03242096|Antifungal Agents|antifungal agents|mesh-ancestor
102127708|NCT03242096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102127709|NCT03242096|Immunologic Factors|immunologic factors|mesh-ancestor
102127710|NCT03242096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127711|NCT03241472|Letrozole|letrozole|mesh-list
102127712|NCT03241472|Clomiphene|clomiphene|mesh-list
102127713|NCT03241472|Enclomiphene|enclomiphene|mesh-list
102127714|NCT03241472|Zuclomiphene|zuclomiphene|mesh-list
102127715|NCT03241472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127716|NCT03241472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102127717|NCT03241472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102127718|NCT03241472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102127719|NCT03241472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102127720|NCT03241472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102127721|NCT03241472|Hormone Antagonists|hormone antagonists|mesh-ancestor
102127722|NCT03241472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102127723|NCT03241472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102612368|NCT02973581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102127724|NCT03241472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102127725|NCT03241472|Fertility Agents|fertility agents|mesh-ancestor
102127726|NCT03241472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102127727|NCT03241472|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102127728|NCT03241472|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102127729|NCT04313075|Leronlimab|leronlimab|mesh-list
102127730|NCT04313075|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102127731|NCT04313075|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102127732|NCT04313075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127733|NCT04313075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102127734|NCT04313075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102127735|NCT04313075|Antiviral Agents|antiviral agents|mesh-ancestor
102127736|NCT04313075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102127737|NCT03241550|Isavuconazole|isavuconazole|mesh-list
102127738|NCT03241550|Antifungal Agents|antifungal agents|mesh-ancestor
102127739|NCT03241550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102127740|NCT03241706|Glucagon|glucagon|mesh-list
102127741|NCT03241706|Somatostatin|somatostatin|mesh-list
102127742|NCT03241706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127743|NCT03241706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102127744|NCT03241706|Hormones|hormones|mesh-ancestor
102127745|NCT03241706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102127746|NCT03237416|Midazolam|midazolam|mesh-list
102127747|NCT03237416|Dabigatran|dabigatran|mesh-list
102127748|NCT03237416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102127749|NCT03237416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102127750|NCT03237416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102127751|NCT03237416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127752|NCT03237416|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102127753|NCT03237416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102127754|NCT03237416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102127755|NCT03237416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102127756|NCT03237416|Anesthetics, General|anesthetics, general|mesh-ancestor
102127757|NCT03237416|Anesthetics|anesthetics|mesh-ancestor
102127758|NCT03237416|GABA Modulators|gaba modulators|mesh-ancestor
102127759|NCT03237416|GABA Agents|gaba agents|mesh-ancestor
102127760|NCT03237416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102127761|NCT03237416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127762|NCT03237416|Antithrombins|antithrombins|mesh-ancestor
101836790|NCT00944723|Dermatologic Agents|dermatologic agents|mesh-ancestor
102127763|NCT03237416|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102127764|NCT03237416|Protease Inhibitors|protease inhibitors|mesh-ancestor
102127765|NCT03237416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102127766|NCT03237416|Anticoagulants|anticoagulants|mesh-ancestor
102127767|NCT05211011|Fosfomycin|fosfomycin|mesh-list
102127768|NCT05211011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102127769|NCT05211011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102127770|NCT03247868|Botulinum Toxins|botulinum toxins|mesh-list
102127771|NCT03247868|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102127772|NCT03247868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102127773|NCT03247868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127774|NCT03247868|Cholinergic Agents|cholinergic agents|mesh-ancestor
102127775|NCT03247868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102127776|NCT03247868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127777|NCT04094519|Digoxin|digoxin|mesh-list
102127778|NCT04094519|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102127779|NCT04094519|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102127780|NCT04094519|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102127781|NCT04094519|Antimetabolites|antimetabolites|mesh-ancestor
102127782|NCT04094519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127783|NCT04094519|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102127784|NCT04094519|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102127785|NCT04094519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102127786|NCT04094519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102127787|NCT04094519|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102127788|NCT04094519|Protective Agents|protective agents|mesh-ancestor
102127789|NCT04094519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127790|NCT02189798|Imidacloprid|imidacloprid|mesh-list
102127791|NCT02189798|Cholinergic Agents|cholinergic agents|mesh-ancestor
102127792|NCT02189798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102127793|NCT02189798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127794|NCT02189798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127795|NCT03107702|Melatonin|melatonin|mesh-list
102127796|NCT03107702|Antioxidants|antioxidants|mesh-ancestor
102154331|NCT03365817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102127797|NCT03107702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127798|NCT03107702|Protective Agents|protective agents|mesh-ancestor
102127799|NCT03107702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127800|NCT03107702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102127801|NCT02554318|Rifampin|rifampin|mesh-list
102127802|NCT02554318|Isoniazid|isoniazid|mesh-list
102127803|NCT02554318|Pyrazinamide|pyrazinamide|mesh-list
102127804|NCT02554318|Ethambutol|ethambutol|mesh-list
102127805|NCT02554318|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102127806|NCT02554318|Antitubercular Agents|antitubercular agents|mesh-ancestor
102127807|NCT02554318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102127808|NCT02554318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102127809|NCT02554318|Leprostatic Agents|leprostatic agents|mesh-ancestor
102127810|NCT02554318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102127811|NCT02554318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102127812|NCT02554318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127813|NCT02554318|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102127814|NCT02554318|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102127815|NCT02554318|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102127816|NCT02554318|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102127817|NCT02554318|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102127818|NCT02554318|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102127819|NCT02554318|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102127820|NCT02554318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102026371|NCT03338569|Antioxidants|antioxidants|mesh-ancestor
102127821|NCT02554318|Antimetabolites|antimetabolites|mesh-ancestor
102127822|NCT02554318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102127823|NCT03976973|Acetylcysteine|acetylcysteine|mesh-list
102127824|NCT03976973|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102127825|NCT03976973|Antiviral Agents|antiviral agents|mesh-ancestor
102127826|NCT03976973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102127827|NCT03976973|Expectorants|expectorants|mesh-ancestor
102127828|NCT03976973|Respiratory System Agents|respiratory system agents|mesh-ancestor
102127829|NCT03976973|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102127830|NCT03976973|Antioxidants|antioxidants|mesh-ancestor
102127831|NCT03976973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127832|NCT03976973|Protective Agents|protective agents|mesh-ancestor
102127833|NCT03976973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127834|NCT03976973|Antidotes|antidotes|mesh-ancestor
102127835|NCT04066751|Ivacaftor|ivacaftor|mesh-list
102127836|NCT04066751|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101836875|NCT01013012|Dexamethasone|dexamethasone|mesh-list
102127837|NCT04066751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102127838|NCT04066751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127840|NCT02550106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102127841|NCT02550106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102127842|NCT02550106|Respiratory System Agents|respiratory system agents|mesh-ancestor
102127843|NCT03237260|Vedolizumab|vedolizumab|mesh-list
102127844|NCT03237260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102127845|NCT03247400|Atorvastatin|atorvastatin|mesh-list
102127846|NCT03247400|Simvastatin|simvastatin|mesh-list
102127847|NCT03247400|Calcium|calcium|mesh-list
102127848|NCT03247400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102127849|NCT03247400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127850|NCT03247400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102127851|NCT03247400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102127852|NCT03247400|Antimetabolites|antimetabolites|mesh-ancestor
102127853|NCT03247400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127854|NCT03247400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102127855|NCT03247400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102127856|NCT03247400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102127857|NCT05480566|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
102127858|NCT05480566|Autonomic Agents|autonomic agents|mesh-ancestor
102127859|NCT05480566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102127860|NCT05480566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127861|NCT05480566|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102127862|NCT05480566|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102127863|NCT05480566|Respiratory System Agents|respiratory system agents|mesh-ancestor
102127864|NCT02453516|Epinephrine|epinephrine|mesh-list
102127865|NCT02453516|Ropivacaine|ropivacaine|mesh-list
102127866|NCT02453516|Anesthetics, Local|anesthetics, local|mesh-ancestor
102127867|NCT02453516|Anesthetics|anesthetics|mesh-ancestor
102127868|NCT02453516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102127869|NCT02453516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127870|NCT02453516|Sensory System Agents|sensory system agents|mesh-ancestor
102127871|NCT02453516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102127872|NCT02453516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102127873|NCT02453516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102127874|NCT02453516|Adrenergic Agents|adrenergic agents|mesh-ancestor
102127875|NCT02453516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102127876|NCT02453516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127877|NCT02453516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102127878|NCT02453516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102127879|NCT02453516|Autonomic Agents|autonomic agents|mesh-ancestor
102127880|NCT02453516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102127881|NCT02453516|Respiratory System Agents|respiratory system agents|mesh-ancestor
102127882|NCT02453516|Mydriatics|mydriatics|mesh-ancestor
102127883|NCT02453516|Sympathomimetics|sympathomimetics|mesh-ancestor
102127884|NCT02453516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102127885|NCT03716609|Magnesium citrate|magnesium citrate|mesh-list
102127886|NCT03716609|Citric Acid|citric acid|mesh-list
102127887|NCT03716609|Sodium Citrate|sodium citrate|mesh-list
102127888|NCT03716609|Anticoagulants|anticoagulants|mesh-ancestor
102127889|NCT03716609|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102127890|NCT03716609|Chelating Agents|chelating agents|mesh-ancestor
102127891|NCT03716609|Sequestering Agents|sequestering agents|mesh-ancestor
102127892|NCT03716609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127893|NCT03716609|Cathartics|cathartics|mesh-ancestor
102127894|NCT03716609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102127895|NCT03709355|Clarithromycin|clarithromycin|mesh-list
102127896|NCT03709355|Rifampin|rifampin|mesh-list
102127897|NCT03709355|Rifabutin|rifabutin|mesh-list
102127898|NCT03709355|Elsulfavirine|elsulfavirine|mesh-list
102127899|NCT03709355|Omeprazole|omeprazole|mesh-list
102127900|NCT03709355|Atorvastatin|atorvastatin|mesh-list
102127901|NCT03709355|Levonorgestrel|levonorgestrel|mesh-list
102127902|NCT03709355|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102127903|NCT03709355|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
102127904|NCT03709355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102127905|NCT03709355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102127906|NCT03709355|Antimetabolites|antimetabolites|mesh-ancestor
102127907|NCT03709355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127908|NCT03709355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102127909|NCT03709355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102127910|NCT03709355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102127911|NCT03709355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101836942|NCT03563157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102127912|NCT03709355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102127913|NCT03709355|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102127914|NCT03709355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102127915|NCT03709355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102127916|NCT03709355|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102127917|NCT03709355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102127918|NCT03709355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102127919|NCT03709355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102127920|NCT03709355|Contraceptive Agents|contraceptive agents|mesh-ancestor
102127921|NCT03709355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102127922|NCT03709355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127923|NCT03709355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102127924|NCT03709355|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102127925|NCT03709355|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102127926|NCT03709355|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102127927|NCT03709355|Antitubercular Agents|antitubercular agents|mesh-ancestor
102127928|NCT03709355|Leprostatic Agents|leprostatic agents|mesh-ancestor
102127929|NCT03709355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102127930|NCT03709355|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102127931|NCT03709355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102127932|NCT03709355|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102127933|NCT03709355|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102127934|NCT03709355|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102127935|NCT03709355|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102127936|NCT03709355|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102127937|NCT03709355|Estrogens|estrogens|mesh-ancestor
102127938|NCT03709355|Hormones|hormones|mesh-ancestor
102127939|NCT03709355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102127940|NCT03709355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102127941|NCT03709355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102127942|NCT03709355|Antiviral Agents|antiviral agents|mesh-ancestor
102127943|NCT03709355|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102127944|NCT05209217|Ketamine|ketamine|mesh-list
102127945|NCT05209217|Analgesics|analgesics|mesh-ancestor
102127946|NCT05209217|Sensory System Agents|sensory system agents|mesh-ancestor
102127947|NCT05209217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102127948|NCT05209217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127949|NCT05209217|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102127950|NCT05209217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102127951|NCT05209217|Anesthetics, General|anesthetics, general|mesh-ancestor
102127952|NCT05209217|Anesthetics|anesthetics|mesh-ancestor
102127953|NCT05209217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102127954|NCT05209217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102127955|NCT05209217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102127956|NCT05209217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102127957|NCT05209217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127958|NCT01662310|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102127959|NCT01662310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102127960|NCT01662310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102127961|NCT01662310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102127962|NCT01662310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127963|NCT01662310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102127964|NCT01662310|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102127965|NCT01662310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102127966|NCT01662310|Serotonin Agents|serotonin agents|mesh-ancestor
102127967|NCT01662310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102127968|NCT01662310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127969|NCT01662310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102127970|NCT01662310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102127971|NCT01662310|Dopamine Agents|dopamine agents|mesh-ancestor
102127972|NCT00700622|Insulin|insulin|mesh-list
102127973|NCT00700622|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102127974|NCT00700622|Insulin Glargine|insulin glargine|mesh-list
102127975|NCT00700622|Insulin Lispro|insulin lispro|mesh-list
102127976|NCT00700622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102127977|NCT00700622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127978|NCT03628625|Letrozole|letrozole|mesh-list
102127979|NCT03628625|Misoprostol|misoprostol|mesh-list
102127980|NCT03628625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102127981|NCT03628625|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102127982|NCT03628625|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102127983|NCT03628625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102127984|NCT03628625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102127985|NCT03628625|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102127986|NCT03628625|Hormone Antagonists|hormone antagonists|mesh-ancestor
102127987|NCT03628625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102127988|NCT03628625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102127989|NCT03628625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102127990|NCT03628625|Abortifacient Agents|abortifacient agents|mesh-ancestor
102127991|NCT03628625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102127992|NCT03628625|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102127993|NCT03628625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102127994|NCT03628625|Oxytocics|oxytocics|mesh-ancestor
102127995|NCT02553928|Memantine|memantine|mesh-list
102127996|NCT02553928|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102127997|NCT02553928|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102127998|NCT02553928|Dopamine Agents|dopamine agents|mesh-ancestor
102127999|NCT02553928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102128000|NCT02553928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128001|NCT02553928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128002|NCT02553928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102128003|NCT02553928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102128004|NCT03908255|Vitamins|vitamins|mesh-list
102128005|NCT03908255|Micronutrients|micronutrients|mesh-ancestor
102128006|NCT03908255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128007|NCT03246776|Triclosan|triclosan|mesh-list
102128008|NCT03246776|Halometasone|halometasone|mesh-list
102128009|NCT03246776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102128010|NCT03246776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102128011|NCT03246776|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102128012|NCT03246776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102128013|NCT03246776|Antimetabolites|antimetabolites|mesh-ancestor
102128014|NCT03246776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128015|NCT03246776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102128016|NCT03246776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102128017|NCT03246776|Dermatologic Agents|dermatologic agents|mesh-ancestor
102128018|NCT03246776|Glucocorticoids|glucocorticoids|mesh-ancestor
102128019|NCT03246776|Hormones|hormones|mesh-ancestor
102128020|NCT03246776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102128021|NCT03246776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128022|NCT03246386|Posaconazole|posaconazole|mesh-list
102128023|NCT03246386|Antifungal Agents|antifungal agents|mesh-ancestor
102128024|NCT03246386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102128025|NCT03246386|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102128026|NCT03246386|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102128027|NCT03246386|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102128028|NCT03246386|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102128029|NCT03246386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102128030|NCT03246386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102128031|NCT03246386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128032|NCT03246386|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102128033|NCT03246386|Hormone Antagonists|hormone antagonists|mesh-ancestor
102128034|NCT03246386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102128035|NCT03246386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128036|NCT03851081|Vincristine|vincristine|mesh-list
102128037|NCT03851081|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
102128038|NCT03851081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102128039|NCT03851081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102128040|NCT03851081|Tubulin Modulators|tubulin modulators|mesh-ancestor
102128041|NCT03851081|Antimitotic Agents|antimitotic agents|mesh-ancestor
102128042|NCT03851081|Mitosis Modulators|mitosis modulators|mesh-ancestor
102128043|NCT03851081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128044|NCT03851081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102128045|NCT03851081|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102128046|NCT03851081|Immunotoxins|immunotoxins|mesh-ancestor
102128047|NCT03851081|Immunoconjugates|immunoconjugates|mesh-ancestor
102128048|NCT03851081|Immunologic Factors|immunologic factors|mesh-ancestor
102128049|NCT03851081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128050|NCT03239600|Methotrexate|methotrexate|mesh-list
102128051|NCT03239600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102128052|NCT03239600|Abortifacient Agents|abortifacient agents|mesh-ancestor
102128053|NCT03239600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102128054|NCT03239600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128055|NCT03239600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102128056|NCT03239600|Antimetabolites|antimetabolites|mesh-ancestor
102128057|NCT03239600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128059|NCT03239600|Dermatologic Agents|dermatologic agents|mesh-ancestor
102128060|NCT03239600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102128061|NCT03239600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102128062|NCT03239600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102128063|NCT03239600|Immunologic Factors|immunologic factors|mesh-ancestor
102128064|NCT03239600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102128065|NCT03239600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102128066|NCT02966093|Lenvatinib|lenvatinib|mesh-list
102128067|NCT02966093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102128068|NCT02966093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102128069|NCT02966093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102128070|NCT02966093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128071|NCT03229616|Cyclophosphamide|cyclophosphamide|mesh-list
102128072|NCT03229616|Busulfan|busulfan|mesh-list
102128073|NCT03229616|Etoposide|etoposide|mesh-list
102128074|NCT03229616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102128075|NCT03229616|Immunologic Factors|immunologic factors|mesh-ancestor
102128076|NCT03229616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128077|NCT03229616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102128078|NCT03229616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102128079|NCT03229616|Alkylating Agents|alkylating agents|mesh-ancestor
102128080|NCT03229616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128081|NCT03229616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102128082|NCT03229616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102128083|NCT03229616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102128084|NCT03229616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102128085|NCT03229616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102128086|NCT03229616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102128087|NCT03234764|Immunomodulating Agents|immunomodulating agents|mesh-list
102128088|NCT03234764|Immunologic Factors|immunologic factors|mesh-ancestor
102128089|NCT03234764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128090|NCT03234842|Paclitaxel|paclitaxel|mesh-list
102128091|NCT03234842|Carboplatin|carboplatin|mesh-list
102128092|NCT03234842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102128093|NCT03234842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102128094|NCT03234842|Tubulin Modulators|tubulin modulators|mesh-ancestor
102128095|NCT03234842|Antimitotic Agents|antimitotic agents|mesh-ancestor
102128096|NCT03234842|Mitosis Modulators|mitosis modulators|mesh-ancestor
102128097|NCT03234842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128098|NCT03229148|Anesthetics|anesthetics|mesh-list
102128099|NCT03229148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102128100|NCT03229148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128101|NCT03228992|Ibuprofen|ibuprofen|mesh-list
102128102|NCT03228992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102128103|NCT03228992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102128104|NCT03228992|Analgesics|analgesics|mesh-ancestor
102128105|NCT03228992|Sensory System Agents|sensory system agents|mesh-ancestor
102128106|NCT03228992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102128107|NCT03228992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128108|NCT03228992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102128109|NCT03228992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102128110|NCT03228992|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102128111|NCT03228992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102128112|NCT03228992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128113|NCT02452502|Atorvastatin|atorvastatin|mesh-list
102128114|NCT02452502|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102128115|NCT02452502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102128116|NCT02452502|Antimetabolites|antimetabolites|mesh-ancestor
102128117|NCT02452502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128118|NCT02452502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102128119|NCT02452502|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102128120|NCT02452502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102128121|NCT03234296|Metronidazole|metronidazole|mesh-list
102128122|NCT03234296|Levofloxacin|levofloxacin|mesh-list
102128123|NCT03234296|Ertapenem|ertapenem|mesh-list
102128124|NCT03234296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102128125|NCT03234296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102128126|NCT03234296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102128127|NCT03234296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102128128|NCT03234296|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102128129|NCT03234296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102128130|NCT03234296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102128131|NCT03234296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102128132|NCT03234296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128133|NCT03234296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102128134|NCT03234296|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102128135|NCT03234296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102128136|NCT03228368|Atezolizumab|atezolizumab|mesh-list
102128137|NCT03228368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102128138|NCT03228368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128139|NCT03228368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102128140|NCT03228368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102128141|NCT03665129|Avdoralimab|avdoralimab|mesh-list
102128142|NCT03665129|Durvalumab|durvalumab|mesh-list
102128143|NCT03665129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102128144|NCT03665129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102128145|NCT03665129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102128146|NCT03665129|Antiviral Agents|antiviral agents|mesh-ancestor
102128147|NCT03665129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102128148|NCT03235700|Nicorandil|nicorandil|mesh-list
102128149|NCT03235700|Adenosine|adenosine|mesh-list
102128150|NCT03235700|Analgesics|analgesics|mesh-ancestor
102128151|NCT03235700|Sensory System Agents|sensory system agents|mesh-ancestor
102128152|NCT03235700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102128153|NCT03235700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128154|NCT03235700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102128155|NCT03235700|Vasodilator Agents|vasodilator agents|mesh-ancestor
102128156|NCT03235700|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102128157|NCT03235700|Purinergic Agonists|purinergic agonists|mesh-ancestor
102128158|NCT03235700|Purinergic Agents|purinergic agents|mesh-ancestor
102128159|NCT03235700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102128160|NCT03235700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128161|NCT03235700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102128162|NCT03235700|Vitamin B Complex|vitamin b complex|mesh-ancestor
102128163|NCT03235700|Vitamins|vitamins|mesh-ancestor
102128164|NCT03235700|Micronutrients|micronutrients|mesh-ancestor
102128165|NCT03234062|Choline|choline|mesh-list
102128166|NCT03234062|Lipotropic Agents|lipotropic agents|mesh-ancestor
102128167|NCT03234062|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102612369|NCT02973581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128169|NCT03234062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128170|NCT03234062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102128171|NCT03234062|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102128172|NCT03234062|Nootropic Agents|nootropic agents|mesh-ancestor
102128173|NCT05702879|Prednisolone|prednisolone|mesh-list
102128174|NCT05702879|Adalimumab|adalimumab|mesh-list
102128175|NCT05702879|Infliximab|infliximab|mesh-list
102128176|NCT05702879|Etanercept|etanercept|mesh-list
102128177|NCT05702879|Golimumab|golimumab|mesh-list
102128178|NCT05702879|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
102128179|NCT05702879|Ustekinumab|ustekinumab|mesh-list
102128180|NCT05702879|Vedolizumab|vedolizumab|mesh-list
102128181|NCT05702879|Ozanimod|ozanimod|mesh-list
102128182|NCT05702879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102128183|NCT05702879|Glucocorticoids|glucocorticoids|mesh-ancestor
102128184|NCT05702879|Hormones|hormones|mesh-ancestor
102128185|NCT05702879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102128186|NCT05702879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128187|NCT05702879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102128188|NCT05702879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102128189|NCT05702879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102128190|NCT05702879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102128191|NCT05702879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102128192|NCT05702879|Dermatologic Agents|dermatologic agents|mesh-ancestor
102128193|NCT05702879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102128194|NCT05702879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102128195|NCT05702879|Analgesics|analgesics|mesh-ancestor
102128196|NCT05702879|Sensory System Agents|sensory system agents|mesh-ancestor
102128197|NCT05702879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102128198|NCT05702879|Immunologic Factors|immunologic factors|mesh-ancestor
102128199|NCT05702879|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102128200|NCT05702879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128201|NCT03235778|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
102128202|NCT03235778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102128203|NCT03235778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102128204|NCT03235778|Analgesics|analgesics|mesh-ancestor
102128205|NCT03235778|Sensory System Agents|sensory system agents|mesh-ancestor
102128206|NCT03235778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102128207|NCT03235778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128208|NCT03235778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102128209|NCT03235778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102128210|NCT04439513|Hemostatics|hemostatics|mesh-list
102128211|NCT04439513|Coagulants|coagulants|mesh-ancestor
102128212|NCT02452970|Gemcitabine|gemcitabine|mesh-list
102128213|NCT02452970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102128214|NCT02452970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102128215|NCT02452970|Antimetabolites|antimetabolites|mesh-ancestor
102128216|NCT02452970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128217|NCT03227900|Lidocaine|lidocaine|mesh-list
102128218|NCT03227900|Anesthetics, Local|anesthetics, local|mesh-ancestor
102128219|NCT03227900|Anesthetics|anesthetics|mesh-ancestor
102128220|NCT03227900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102128221|NCT03227900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128222|NCT03227900|Sensory System Agents|sensory system agents|mesh-ancestor
102128223|NCT03227900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102128224|NCT03227900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102128225|NCT03227900|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102128226|NCT03227900|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102128227|NCT03227900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102128228|NCT03227900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128229|NCT03120182|Aspirin|aspirin|mesh-list
102128230|NCT03120182|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102128231|NCT03120182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102128232|NCT03120182|Analgesics|analgesics|mesh-ancestor
102128233|NCT03120182|Sensory System Agents|sensory system agents|mesh-ancestor
102128234|NCT03120182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102128235|NCT03120182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128236|NCT03120182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102128237|NCT03120182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102128238|NCT03120182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102128239|NCT03120182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102128240|NCT03120182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070912|NCT05202275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102128241|NCT03120182|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102128242|NCT03120182|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102128243|NCT03120182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102128244|NCT03120182|Antipyretics|antipyretics|mesh-ancestor
102128245|NCT02074436|Aminocaproic Acid|aminocaproic acid|mesh-list
102128246|NCT02074436|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102128247|NCT02074436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102128248|NCT02074436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128249|NCT02074436|Hemostatics|hemostatics|mesh-ancestor
102128250|NCT02074436|Coagulants|coagulants|mesh-ancestor
102128251|NCT03227432|Dexamethasone|dexamethasone|mesh-list
102128252|NCT03227432|Nivolumab|nivolumab|mesh-list
102128253|NCT03227432|Pomalidomide|pomalidomide|mesh-list
102128254|NCT03227432|Elotuzumab|elotuzumab|mesh-list
102128255|NCT03227432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102128256|NCT03227432|Antiemetics|antiemetics|mesh-ancestor
102128257|NCT03227432|Autonomic Agents|autonomic agents|mesh-ancestor
102128258|NCT03227432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102128259|NCT03227432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128260|NCT03227432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102128261|NCT03227432|Glucocorticoids|glucocorticoids|mesh-ancestor
102128262|NCT03227432|Hormones|hormones|mesh-ancestor
102128263|NCT03227432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102128264|NCT03227432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102128265|NCT03227432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102128266|NCT03227432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102128267|NCT03227432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102128268|NCT03227432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128269|NCT03227432|Immunologic Factors|immunologic factors|mesh-ancestor
102128270|NCT03227432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102128271|NCT03227432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102128272|NCT03227432|Growth Substances|growth substances|mesh-ancestor
102128273|NCT03227432|Growth Inhibitors|growth inhibitors|mesh-ancestor
102128274|NCT03222518|Acetaminophen|acetaminophen|mesh-list
102128275|NCT03222518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
102128276|NCT03222518|Piroxicam|piroxicam|mesh-list
102128277|NCT03222518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102128278|NCT03222518|Analgesics|analgesics|mesh-ancestor
102128279|NCT03222518|Sensory System Agents|sensory system agents|mesh-ancestor
102128280|NCT03222518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102128281|NCT03222518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128282|NCT03222518|Antipyretics|antipyretics|mesh-ancestor
102128283|NCT03222518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102128284|NCT03222518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102128285|NCT03222518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102128286|NCT03222518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102128287|NCT03222518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128288|NCT01750281|Docetaxel|docetaxel|mesh-list
102128289|NCT01750281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102026843|NCT03163420|Diclofenac|diclofenac|mesh-list
102128290|NCT01750281|Tubulin Modulators|tubulin modulators|mesh-ancestor
102128291|NCT01750281|Antimitotic Agents|antimitotic agents|mesh-ancestor
102128292|NCT01750281|Mitosis Modulators|mitosis modulators|mesh-ancestor
102128293|NCT01750281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128294|NCT03222206|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
102128295|NCT03222206|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102128296|NCT03222206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102128297|NCT03222206|Analgesics|analgesics|mesh-ancestor
102128298|NCT03222206|Sensory System Agents|sensory system agents|mesh-ancestor
102128299|NCT03222206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102128300|NCT03222206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128301|NCT03222206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102128302|NCT03222206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102128303|NCT03221816|Folic Acid|folic acid|mesh-list
102128304|NCT03221816|Pyridoxine|pyridoxine|mesh-list
102128305|NCT03221816|Vitamin B 12|vitamin b 12|mesh-list
102128306|NCT03221816|Hematinics|hematinics|mesh-ancestor
102128307|NCT03221816|Vitamin B Complex|vitamin b complex|mesh-ancestor
102128308|NCT03221816|Vitamins|vitamins|mesh-ancestor
102128309|NCT03221816|Micronutrients|micronutrients|mesh-ancestor
102128310|NCT03221816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128311|NCT03119636|Levodopa|levodopa|mesh-list
102128312|NCT03119636|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102128313|NCT03119636|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102128314|NCT03119636|Dopamine Agents|dopamine agents|mesh-ancestor
102128315|NCT03119636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102128316|NCT03119636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128317|NCT03119636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128319|NCT03226340|Amlodipine|amlodipine|mesh-list
102128320|NCT03226340|Telmisartan|telmisartan|mesh-list
102128321|NCT03226340|Chlorthalidone|chlorthalidone|mesh-list
102128322|NCT03226340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102128323|NCT03226340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102128324|NCT03226340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102128325|NCT03226340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128326|NCT03226340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102128327|NCT03226340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128328|NCT03226340|Vasodilator Agents|vasodilator agents|mesh-ancestor
102128329|NCT03226340|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102128330|NCT03226340|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102128331|NCT03226340|Diuretics|diuretics|mesh-ancestor
102128332|NCT03226340|Natriuretic Agents|natriuretic agents|mesh-ancestor
102128333|NCT03226340|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102128334|NCT03226340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102128335|NCT03226340|Antimetabolites|antimetabolites|mesh-ancestor
102128336|NCT03226340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102128337|NCT03226340|Vitamin B Complex|vitamin b complex|mesh-ancestor
102128338|NCT03226340|Vitamins|vitamins|mesh-ancestor
102128339|NCT03226340|Micronutrients|micronutrients|mesh-ancestor
102128340|NCT03221504|Oxymetazoline|oxymetazoline|mesh-list
102128341|NCT03221504|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102128342|NCT03221504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102128343|NCT03221504|Adrenergic Agents|adrenergic agents|mesh-ancestor
102128344|NCT03221504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102128345|NCT03221504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128346|NCT03221504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128347|NCT03221504|Sympathomimetics|sympathomimetics|mesh-ancestor
102128348|NCT03221504|Autonomic Agents|autonomic agents|mesh-ancestor
102128349|NCT03221504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102128350|NCT03221504|Nasal Decongestants|nasal decongestants|mesh-ancestor
102128351|NCT03221504|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102128352|NCT03221504|Respiratory System Agents|respiratory system agents|mesh-ancestor
102128353|NCT03221582|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
102128354|NCT03221582|Antiviral Agents|antiviral agents|mesh-ancestor
102128355|NCT03221582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102128356|NCT03232034|Calcium|calcium|mesh-list
102128357|NCT03232034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102128358|NCT03232034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128360|NCT03225950|Immunologic Factors|immunologic factors|mesh-ancestor
102128361|NCT03225950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128362|NCT03119948|Botulinum Toxins|botulinum toxins|mesh-list
102128363|NCT03119948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102128364|NCT03119948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102128365|NCT03119948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128366|NCT03119948|Cholinergic Agents|cholinergic agents|mesh-ancestor
102128367|NCT03119948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102128368|NCT03119948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128369|NCT03232112|Exenatide|exenatide|mesh-list
102128370|NCT03232112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102128371|NCT03232112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128372|NCT03232112|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102128373|NCT03232112|Incretins|incretins|mesh-ancestor
102128374|NCT03232112|Hormones|hormones|mesh-ancestor
102128375|NCT03232112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102128376|NCT03000569|Levodopa|levodopa|mesh-list
102128377|NCT03000569|Antiparkinson Agents|antiparkinson agents|mesh-list
102128378|NCT03000569|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102128379|NCT03000569|Dopamine Agents|dopamine agents|mesh-ancestor
102128380|NCT03000569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102128381|NCT03000569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128382|NCT03000569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128383|NCT02554786|Fluticasone|fluticasone|mesh-list
102128384|NCT02554786|Xhance|xhance|mesh-list
102128385|NCT02554786|Mometasone Furoate|mometasone furoate|mesh-list
102128386|NCT02554786|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102128387|NCT02554786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102128388|NCT02554786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102128389|NCT02554786|Autonomic Agents|autonomic agents|mesh-ancestor
102128390|NCT02554786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102128391|NCT02554786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128392|NCT02554786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102128393|NCT02554786|Respiratory System Agents|respiratory system agents|mesh-ancestor
102128394|NCT02554786|Dermatologic Agents|dermatologic agents|mesh-ancestor
102128395|NCT02554786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102128396|NCT02554786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102128397|NCT02554786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102128398|NCT02554786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102128399|NCT02554786|Adrenergic Agents|adrenergic agents|mesh-ancestor
102128400|NCT02554786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102128401|NCT02554786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128402|NCT05202314|Immunomodulating Agents|immunomodulating agents|mesh-list
102128403|NCT05202314|Immunologic Factors|immunologic factors|mesh-ancestor
102128404|NCT05202314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128406|NCT03225326|Anesthetics, Local|anesthetics, local|mesh-ancestor
102128407|NCT03225326|Anesthetics|anesthetics|mesh-ancestor
102128408|NCT03225326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102128409|NCT03225326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128410|NCT03225326|Sensory System Agents|sensory system agents|mesh-ancestor
102128411|NCT03225326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102128412|NCT03220880|Dexmedetomidine|dexmedetomidine|mesh-list
102128413|NCT03220880|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102128414|NCT03220880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102128415|NCT03220880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128416|NCT03220880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102128417|NCT03220880|Analgesics|analgesics|mesh-ancestor
102128418|NCT03220880|Sensory System Agents|sensory system agents|mesh-ancestor
102128419|NCT03220880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102128420|NCT03220880|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102128421|NCT03220880|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102128422|NCT03220880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102128423|NCT03220880|Adrenergic Agents|adrenergic agents|mesh-ancestor
102128424|NCT03220880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102128425|NCT03220880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128426|NCT02929589|Ibuprofen|ibuprofen|mesh-list
102128427|NCT02929589|Analgesics, Opioid|analgesics, opioid|mesh-list
102128428|NCT02929589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102128429|NCT02929589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102128430|NCT02929589|Analgesics|analgesics|mesh-ancestor
102128431|NCT02929589|Sensory System Agents|sensory system agents|mesh-ancestor
102128432|NCT02929589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102128433|NCT02929589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128434|NCT02929589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102128435|NCT02929589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102128436|NCT02929589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102128437|NCT02929589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102128438|NCT02929589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128440|NCT02929589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102128441|NCT02910635|Moxifloxacin|moxifloxacin|mesh-list
102128442|NCT02910635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102128443|NCT02910635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102128444|NCT02910635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102128445|NCT02910635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102128446|NCT02910635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102128447|NCT02910635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128448|NCT02910635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102128449|NCT02614547|Brexanolone|brexanolone|mesh-list
102128450|NCT02614547|Neurosteroids|neurosteroids|mesh-ancestor
102128451|NCT02614547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102128452|NCT02614547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128453|NCT02614547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128454|NCT02614547|GABA Modulators|gaba modulators|mesh-ancestor
102128455|NCT02614547|GABA Agents|gaba agents|mesh-ancestor
102128456|NCT04472481|Ergocalciferols|ergocalciferols|mesh-list
102128457|NCT04472481|Vitamin D|vitamin d|mesh-list
102128458|NCT04472481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102128459|NCT04472481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128460|NCT04472481|Vitamins|vitamins|mesh-ancestor
102128461|NCT04472481|Micronutrients|micronutrients|mesh-ancestor
102128462|NCT04472481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102128463|NCT01233297|Azithromycin|azithromycin|mesh-list
102128464|NCT01233297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102128465|NCT01233297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102128466|NCT04681079|Albuterol|albuterol|mesh-list
102128467|NCT04681079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102128468|NCT04681079|Autonomic Agents|autonomic agents|mesh-ancestor
102128469|NCT04681079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102128470|NCT04681079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027065|NCT02694718|Capecitabine|capecitabine|mesh-list
102128471|NCT04681079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102128472|NCT04681079|Respiratory System Agents|respiratory system agents|mesh-ancestor
102128473|NCT04681079|Tocolytic Agents|tocolytic agents|mesh-ancestor
102128474|NCT04681079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102128475|NCT04681079|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102128476|NCT04681079|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102128477|NCT04681079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102128478|NCT04681079|Adrenergic Agents|adrenergic agents|mesh-ancestor
102128479|NCT04681079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102128480|NCT04681079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128481|NCT00580125|Aripiprazole|aripiprazole|mesh-list
102128482|NCT00580125|Antidepressive Agents|antidepressive agents|mesh-ancestor
102128483|NCT00580125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102128484|NCT00580125|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102128485|NCT00580125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102128486|NCT00580125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102128487|NCT00580125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128488|NCT00580125|Dopamine Agonists|dopamine agonists|mesh-ancestor
102128489|NCT00580125|Dopamine Agents|dopamine agents|mesh-ancestor
102128490|NCT00580125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102128491|NCT00580125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128492|NCT00580125|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102128493|NCT00580125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102128494|NCT00580125|Serotonin Agents|serotonin agents|mesh-ancestor
102128495|NCT00580125|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102128496|NCT00580125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102128497|NCT00580125|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102128498|NCT00580125|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102128499|NCT01179009|Clonidine|clonidine|mesh-list
102128500|NCT01179009|Scopolamine|scopolamine|mesh-list
102128501|NCT01179009|Ketamine|ketamine|mesh-list
102128502|NCT01179009|Lorazepam|lorazepam|mesh-list
102128503|NCT01179009|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102128504|NCT01179009|Analgesics|analgesics|mesh-ancestor
102128505|NCT01179009|Sensory System Agents|sensory system agents|mesh-ancestor
102128506|NCT01179009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101837551|NCT00303628|Levoleucovorin|levoleucovorin|mesh-list
102128507|NCT01179009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128508|NCT01179009|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102128509|NCT01179009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102128510|NCT01179009|Anesthetics, General|anesthetics, general|mesh-ancestor
102128511|NCT01179009|Anesthetics|anesthetics|mesh-ancestor
102128512|NCT01179009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102128513|NCT01179009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102128514|NCT01179009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102128515|NCT01179009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102128516|NCT01179009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128517|NCT01179009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102128518|NCT01179009|Sympatholytics|sympatholytics|mesh-ancestor
102128519|NCT01179009|Autonomic Agents|autonomic agents|mesh-ancestor
102128520|NCT01179009|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102128521|NCT01179009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102128522|NCT01179009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102128523|NCT01179009|Adrenergic Agents|adrenergic agents|mesh-ancestor
102128524|NCT01179009|Anticonvulsants|anticonvulsants|mesh-ancestor
102128525|NCT01179009|Antiemetics|antiemetics|mesh-ancestor
102128526|NCT01179009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102128527|NCT01179009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102128528|NCT01179009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102128529|NCT01179009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102128530|NCT01179009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102128531|NCT01179009|GABA Modulators|gaba modulators|mesh-ancestor
102128532|NCT01179009|GABA Agents|gaba agents|mesh-ancestor
102128533|NCT01179009|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102128534|NCT01179009|Mydriatics|mydriatics|mesh-ancestor
102128535|NCT01179009|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102128536|NCT01179009|Cholinergic Agents|cholinergic agents|mesh-ancestor
102128537|NCT01179009|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102128538|NCT01179009|Parasympatholytics|parasympatholytics|mesh-ancestor
102128539|NCT00579189|Moxifloxacin|moxifloxacin|mesh-list
102128540|NCT00579189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102128541|NCT00579189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102128542|NCT00579189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102128543|NCT00579189|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102128544|NCT00579189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102128545|NCT00579189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102128546|NCT00579189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128547|NCT00579189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102128548|NCT00667953|Temozolomide|temozolomide|mesh-list
102128549|NCT00667953|Imatinib Mesylate|imatinib mesylate|mesh-list
102128550|NCT00667953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102128551|NCT00667953|Alkylating Agents|alkylating agents|mesh-ancestor
102128552|NCT00667953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128553|NCT00667953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102128554|NCT00667953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102128555|NCT00667953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102128556|NCT00578955|Azithromycin|azithromycin|mesh-list
102128557|NCT00578955|Dexamethasone|dexamethasone|mesh-list
102128558|NCT00578955|Dexamethasone acetate|dexamethasone acetate|mesh-list
102128559|NCT00578955|BB 1101|bb 1101|mesh-list
102128560|NCT00578955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102128561|NCT00578955|Antiemetics|antiemetics|mesh-ancestor
102128562|NCT00578955|Autonomic Agents|autonomic agents|mesh-ancestor
102128563|NCT00578955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102128564|NCT00578955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128565|NCT00578955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102128566|NCT00578955|Glucocorticoids|glucocorticoids|mesh-ancestor
102128567|NCT00578955|Hormones|hormones|mesh-ancestor
102128568|NCT00578955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102128569|NCT00578955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102128570|NCT00578955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102128571|NCT00578955|Protease Inhibitors|protease inhibitors|mesh-ancestor
102128572|NCT00578955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102128573|NCT00578955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128574|NCT00578955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102128575|NCT00578955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102128576|NCT00576537|Immunomodulating Agents|immunomodulating agents|mesh-list
102128577|NCT00576537|Immunologic Factors|immunologic factors|mesh-ancestor
102128578|NCT00576537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128579|NCT02282241|Melatonin|melatonin|mesh-list
102128580|NCT02282241|Antioxidants|antioxidants|mesh-ancestor
102128581|NCT02282241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128582|NCT02282241|Protective Agents|protective agents|mesh-ancestor
102128583|NCT02282241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128584|NCT02282241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102128585|NCT02424851|Thalidomide|thalidomide|mesh-list
102128586|NCT02424851|Dexamethasone|dexamethasone|mesh-list
102128588|NCT02424851|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102128589|NCT02424851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102128590|NCT02424851|Antiemetics|antiemetics|mesh-ancestor
102128591|NCT02424851|Autonomic Agents|autonomic agents|mesh-ancestor
102128592|NCT02424851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102128593|NCT02424851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128594|NCT02424851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102128595|NCT02424851|Glucocorticoids|glucocorticoids|mesh-ancestor
102128596|NCT02424851|Hormones|hormones|mesh-ancestor
102128597|NCT02424851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102128598|NCT02424851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102128599|NCT02424851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102128600|NCT02424851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102128601|NCT02424851|Alkylating Agents|alkylating agents|mesh-ancestor
102128602|NCT02424851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128603|NCT02424851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102128604|NCT02424851|Immunologic Factors|immunologic factors|mesh-ancestor
102128605|NCT02424851|Leprostatic Agents|leprostatic agents|mesh-ancestor
102128606|NCT02424851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102128607|NCT02424851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102128608|NCT02424851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102128609|NCT02424851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102128610|NCT02424851|Growth Substances|growth substances|mesh-ancestor
102128611|NCT02424851|Growth Inhibitors|growth inhibitors|mesh-ancestor
102128612|NCT02284035|Raltegravir Potassium|raltegravir potassium|mesh-list
102128613|NCT02284035|Lamivudine|lamivudine|mesh-list
102128614|NCT02284035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102128615|NCT02284035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102128616|NCT02284035|Antiviral Agents|antiviral agents|mesh-ancestor
102128617|NCT02284035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102128618|NCT02284035|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102128619|NCT02284035|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102128620|NCT02284035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102128621|NCT02284035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128622|NCT02284035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102128623|NCT02284035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102128624|NCT00484419|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102128625|NCT00484419|Rosiglitazone|rosiglitazone|mesh-list
102128626|NCT00484419|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
102128627|NCT00484419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102128628|NCT00484419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128629|NCT00484419|Incretins|incretins|mesh-ancestor
102128630|NCT00484419|Hormones|hormones|mesh-ancestor
102128631|NCT00484419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102128632|NCT00484419|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102128633|NCT00484419|Protease Inhibitors|protease inhibitors|mesh-ancestor
102128634|NCT00484419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102128635|NCT00484419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128636|NCT00484419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102128637|NCT00484419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102128638|NCT00484419|Antimetabolites|antimetabolites|mesh-ancestor
102128639|NCT00484419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102128640|NCT02273895|Scopolamine|scopolamine|mesh-list
102128641|NCT02273895|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102128642|NCT02273895|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102128643|NCT02273895|Antiemetics|antiemetics|mesh-ancestor
102128644|NCT02273895|Autonomic Agents|autonomic agents|mesh-ancestor
102128645|NCT02273895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102128646|NCT02273895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128647|NCT02273895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102128648|NCT02273895|Mydriatics|mydriatics|mesh-ancestor
102128649|NCT02273895|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102128650|NCT02273895|Cholinergic Agents|cholinergic agents|mesh-ancestor
102128651|NCT02273895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102128652|NCT02273895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128653|NCT02273895|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101837703|NCT01020630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102128654|NCT02273895|Parasympatholytics|parasympatholytics|mesh-ancestor
102128655|NCT00480831|Paclitaxel|paclitaxel|mesh-list
102128656|NCT00480831|Bevacizumab|bevacizumab|mesh-list
102128657|NCT00480831|Carboplatin|carboplatin|mesh-list
102128658|NCT00480831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102128659|NCT00480831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102128660|NCT00480831|Tubulin Modulators|tubulin modulators|mesh-ancestor
102128661|NCT00480831|Antimitotic Agents|antimitotic agents|mesh-ancestor
102027264|NCT03667352|Fentanyl|fentanyl|mesh-list
102128662|NCT00480831|Mitosis Modulators|mitosis modulators|mesh-ancestor
102128663|NCT00480831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128664|NCT00480831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102128665|NCT00480831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102128666|NCT00480831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102128667|NCT00480831|Growth Substances|growth substances|mesh-ancestor
102128668|NCT00480831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128669|NCT00480831|Growth Inhibitors|growth inhibitors|mesh-ancestor
102128670|NCT02549092|Levodopa|levodopa|mesh-list
102128671|NCT02549092|Carbidopa|carbidopa|mesh-list
102128672|NCT02549092|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102128673|NCT02549092|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102128674|NCT02549092|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102128675|NCT02549092|Dopamine Agents|dopamine agents|mesh-ancestor
102128676|NCT02549092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102128677|NCT02549092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128678|NCT02549092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128679|NCT02549092|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102128680|NCT02549092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102128681|NCT02549092|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102128682|NCT02549092|Immunologic Factors|immunologic factors|mesh-ancestor
102128683|NCT02549092|Dopamine Agonists|dopamine agonists|mesh-ancestor
102128684|NCT03220256|Lamotrigine|lamotrigine|mesh-list
102128685|NCT03220256|Anticonvulsants|anticonvulsants|mesh-ancestor
102128686|NCT03220256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102128687|NCT03220256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102128688|NCT03220256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128689|NCT03220256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102128690|NCT03220256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128691|NCT03220256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102128692|NCT03220256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102128693|NCT03220256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102128694|NCT03220256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102128695|NCT03220256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102128697|NCT03220490|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102128698|NCT03220490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102128699|NCT03220490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102128700|NCT03220490|Adrenergic Agents|adrenergic agents|mesh-ancestor
102128701|NCT03220490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102128702|NCT03220490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128703|NCT03220490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128704|NCT03220490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102128705|NCT03220490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102128706|NCT03220490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102128707|NCT03220490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102128708|NCT03220490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102128709|NCT02553772|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102128710|NCT02553772|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102128711|NCT02553772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102128712|NCT02553772|Laxatives|laxatives|mesh-ancestor
102128713|NCT02553772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102128714|NCT03119714|Pemirolast|pemirolast|mesh-list
102128715|NCT03119714|Histamine Antagonists|histamine antagonists|mesh-ancestor
102128716|NCT03119714|Histamine Agents|histamine agents|mesh-ancestor
102128717|NCT03119714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102128718|NCT03119714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128719|NCT03119714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128720|NCT00562887|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102128721|NCT00562887|Immunologic Factors|immunologic factors|mesh-ancestor
102128722|NCT00562887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128723|NCT05468554|Metformin|metformin|mesh-list
102128724|NCT05468554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102128725|NCT05468554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128726|NCT04617821|Paclitaxel|paclitaxel|mesh-list
102128727|NCT04617821|Gemcitabine|gemcitabine|mesh-list
102128728|NCT04617821|Folfirinox|folfirinox|mesh-list
102128729|NCT04617821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102128730|NCT04617821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102128731|NCT04617821|Tubulin Modulators|tubulin modulators|mesh-ancestor
102128732|NCT04617821|Antimitotic Agents|antimitotic agents|mesh-ancestor
102128733|NCT04617821|Mitosis Modulators|mitosis modulators|mesh-ancestor
102027308|NCT02573233|Hormones|hormones|mesh-ancestor
102128734|NCT04617821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128735|NCT04617821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102128736|NCT04617821|Antimetabolites|antimetabolites|mesh-ancestor
102128737|NCT03219008|Lithium Carbonate|lithium carbonate|mesh-list
102128738|NCT03219008|Mirtazapine|mirtazapine|mesh-list
102128739|NCT03219008|Fluvoxamine|fluvoxamine|mesh-list
102128740|NCT03219008|Fluoxetine|fluoxetine|mesh-list
102128741|NCT03219008|Bupropion|bupropion|mesh-list
102128742|NCT03219008|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
102128743|NCT03219008|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102128744|NCT03219008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102128745|NCT03219008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102128746|NCT03219008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128747|NCT03219008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102128748|NCT03219008|Serotonin Agents|serotonin agents|mesh-ancestor
102128749|NCT03219008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128750|NCT03219008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102128751|NCT03219008|Antidepressive Agents|antidepressive agents|mesh-ancestor
102128752|NCT03219008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102128753|NCT03219008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102128754|NCT03219008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102128755|NCT03219008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102128756|NCT03219008|Antimanic Agents|antimanic agents|mesh-ancestor
102128757|NCT03219008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102128758|NCT03219008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102128759|NCT03219008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102128760|NCT03219008|Histamine Antagonists|histamine antagonists|mesh-ancestor
102128761|NCT03219008|Histamine Agents|histamine agents|mesh-ancestor
102128762|NCT03219008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102128763|NCT03219008|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102128764|NCT03219008|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102128765|NCT03219008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102071441|NCT05202821|Fluorides|fluorides|mesh-list
102128766|NCT03219008|Adrenergic Agents|adrenergic agents|mesh-ancestor
102128767|NCT03219008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102128768|NCT03219008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102128769|NCT03219008|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102128770|NCT03219008|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102128771|NCT03219008|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102128772|NCT03219008|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102128773|NCT03219008|Dopamine Agents|dopamine agents|mesh-ancestor
102128774|NCT03218930|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102128775|NCT03218930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102128776|NCT03218930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102128777|NCT03218930|Antitubercular Agents|antitubercular agents|mesh-ancestor
102128778|NCT00562497|Remestemcel-l|remestemcel-l|mesh-list
102128779|NCT00562497|Prednisone|prednisone|mesh-list
102128780|NCT00562497|Methylprednisolone|methylprednisolone|mesh-list
102128781|NCT00562497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102128782|NCT00562497|Glucocorticoids|glucocorticoids|mesh-ancestor
102128783|NCT00562497|Hormones|hormones|mesh-ancestor
102128784|NCT00562497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102128785|NCT00562497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128786|NCT00562497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102128787|NCT00562497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102128788|NCT00562497|Antiemetics|antiemetics|mesh-ancestor
102128789|NCT00562497|Autonomic Agents|autonomic agents|mesh-ancestor
102128790|NCT00562497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102128791|NCT00562497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102128792|NCT00562497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102128793|NCT00562497|Protective Agents|protective agents|mesh-ancestor
102128794|NCT00562497|Antiviral Agents|antiviral agents|mesh-ancestor
102128795|NCT00562497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102128796|NCT00468975|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102128797|NCT00468975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102128798|NCT00468975|Autonomic Agents|autonomic agents|mesh-ancestor
102128799|NCT00468975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102128800|NCT00468975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128801|NCT00468975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102128802|NCT00468975|Respiratory System Agents|respiratory system agents|mesh-ancestor
102128803|NCT00468975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101837855|NCT01020708|Mesalamine|mesalamine|mesh-list
102128804|NCT00468975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102128805|NCT00468975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102128806|NCT00468975|Adrenergic Agents|adrenergic agents|mesh-ancestor
102128807|NCT00468975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102128808|NCT00468975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128809|NCT01503515|Fluconazole|fluconazole|mesh-list
102128810|NCT01503515|Voriconazole|voriconazole|mesh-list
102128811|NCT01503515|Caspofungin|caspofungin|mesh-list
102128812|NCT01503515|Antifungal Agents|antifungal agents|mesh-ancestor
102128813|NCT01503515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102128814|NCT01503515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102128815|NCT01503515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102128816|NCT01503515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102128817|NCT01503515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128818|NCT01503515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102128819|NCT01503515|Hormone Antagonists|hormone antagonists|mesh-ancestor
102128820|NCT01503515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102128821|NCT01503515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128822|NCT01503515|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102128823|NCT01503515|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102128824|NCT01503515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102128825|NCT00468273|Immunoglobulins|immunoglobulins|mesh-list
102128826|NCT00468273|Antibodies|antibodies|mesh-list
102128827|NCT00468273|gamma-Globulins|gamma-globulins|mesh-list
102128828|NCT00468273|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102128829|NCT00468273|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102128830|NCT00468273|Immunologic Factors|immunologic factors|mesh-ancestor
102128831|NCT00468273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128832|NCT03217916|polysaccharide-K|polysaccharide-k|mesh-list
102128833|NCT03217916|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102128834|NCT03217916|Immunologic Factors|immunologic factors|mesh-ancestor
102128835|NCT03217916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128836|NCT03217916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102128837|NCT03217916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102128838|NCT03217916|Antiviral Agents|antiviral agents|mesh-ancestor
102128839|NCT03217916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102128840|NCT03217916|Interferon Inducers|interferon inducers|mesh-ancestor
102128841|NCT03217916|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102128842|NCT03217916|Protective Agents|protective agents|mesh-ancestor
102128843|NCT00468117|Etanercept|etanercept|mesh-list
102128844|NCT00468117|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102128845|NCT00468117|Basiliximab|basiliximab|mesh-list
102128846|NCT00468117|Daclizumab|daclizumab|mesh-list
102128847|NCT00468117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102128848|NCT00468117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102128849|NCT00468117|Analgesics|analgesics|mesh-ancestor
102128850|NCT00468117|Sensory System Agents|sensory system agents|mesh-ancestor
102128851|NCT00468117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102128852|NCT00468117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128853|NCT00468117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102128854|NCT00468117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102128855|NCT00468117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102128856|NCT00468117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102128857|NCT00468117|Immunologic Factors|immunologic factors|mesh-ancestor
102128858|NCT00468039|Metformin|metformin|mesh-list
102128859|NCT00468039|Vildagliptin|vildagliptin|mesh-list
102128860|NCT00468039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102128861|NCT00468039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128862|NCT00468039|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102128863|NCT00468039|Protease Inhibitors|protease inhibitors|mesh-ancestor
102128864|NCT00468039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102128865|NCT00468039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128866|NCT02742519|Ivacaftor|ivacaftor|mesh-list
102128867|NCT02742519|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102128868|NCT02742519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102128869|NCT02742519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128870|NCT01375010|Vitamin D|vitamin d|mesh-list
102128871|NCT01375010|Cholecalciferol|cholecalciferol|mesh-list
102128872|NCT01375010|Vitamins|vitamins|mesh-list
102128873|NCT01375010|Micronutrients|micronutrients|mesh-ancestor
102027442|NCT01380600|Molgramostim|molgramostim|mesh-list
102128874|NCT01375010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128875|NCT01375010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102128876|NCT01375010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102128877|NCT03231176|Capecitabine|capecitabine|mesh-list
102128878|NCT03231176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102128879|NCT03231176|Antimetabolites|antimetabolites|mesh-ancestor
102128880|NCT03231176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128881|NCT03231176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102128882|NCT00467025|Sorafenib|sorafenib|mesh-list
102128883|NCT00467025|Trebananib|trebananib|mesh-list
102128884|NCT00467025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102128885|NCT00467025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102128886|NCT00467025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102128887|NCT00467025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128888|NCT00467025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102128889|NCT00467025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102128890|NCT00467025|Growth Substances|growth substances|mesh-ancestor
102128891|NCT00467025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128892|NCT00467025|Growth Inhibitors|growth inhibitors|mesh-ancestor
102128893|NCT03230786|Metformin|metformin|mesh-list
102128894|NCT03230786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102128895|NCT03230786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128896|NCT02451098|Atorvastatin|atorvastatin|mesh-list
102128897|NCT02451098|Ezetimibe|ezetimibe|mesh-list
102128898|NCT02451098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102128899|NCT02451098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102128900|NCT02451098|Antimetabolites|antimetabolites|mesh-ancestor
102128901|NCT02451098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128902|NCT02451098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102128903|NCT02451098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102128904|NCT02451098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102128905|NCT00546273|Vaccines|vaccines|mesh-list
102128906|NCT00546273|Immunologic Factors|immunologic factors|mesh-ancestor
102128907|NCT00546273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128908|NCT02452112|Lidocaine|lidocaine|mesh-list
102128909|NCT02452112|Anesthetics, Local|anesthetics, local|mesh-ancestor
102128910|NCT02452112|Anesthetics|anesthetics|mesh-ancestor
102128911|NCT02452112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102535885|NCT05439993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128912|NCT02452112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128913|NCT02452112|Sensory System Agents|sensory system agents|mesh-ancestor
102128914|NCT02452112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102128915|NCT02452112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102128916|NCT02452112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102128917|NCT02452112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102128918|NCT02452112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102128919|NCT02452112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128920|NCT00659061|Micronutrients|micronutrients|mesh-list
102128921|NCT00659061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128922|NCT02451956|Paclitaxel|paclitaxel|mesh-list
102128923|NCT02451956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102128924|NCT02451956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102128925|NCT02451956|Tubulin Modulators|tubulin modulators|mesh-ancestor
102128926|NCT02451956|Antimitotic Agents|antimitotic agents|mesh-ancestor
102128927|NCT02451956|Mitosis Modulators|mitosis modulators|mesh-ancestor
102128928|NCT02451956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128929|NCT02725372|Nitric Oxide|nitric oxide|mesh-list
102128930|NCT02725372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102128931|NCT02725372|Autonomic Agents|autonomic agents|mesh-ancestor
102128932|NCT02725372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102128933|NCT02725372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128934|NCT02725372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102128935|NCT02725372|Respiratory System Agents|respiratory system agents|mesh-ancestor
102128936|NCT02725372|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102128937|NCT02725372|Antioxidants|antioxidants|mesh-ancestor
102128938|NCT02725372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128939|NCT02725372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102128940|NCT02725372|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102128941|NCT02725372|Vasodilator Agents|vasodilator agents|mesh-ancestor
102128942|NCT02725372|Gasotransmitters|gasotransmitters|mesh-ancestor
102128943|NCT02725372|Protective Agents|protective agents|mesh-ancestor
102128944|NCT02450786|Donepezil|donepezil|mesh-list
102128945|NCT02450786|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102128946|NCT02450786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102128947|NCT02450786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128948|NCT02450786|Cholinergic Agents|cholinergic agents|mesh-ancestor
102128949|NCT02450786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102128950|NCT02450786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128951|NCT02450786|Nootropic Agents|nootropic agents|mesh-ancestor
102128952|NCT00539721|Ondansetron|ondansetron|mesh-list
102128953|NCT00539721|Rolapitant|rolapitant|mesh-list
102128954|NCT00539721|Antiemetics|antiemetics|mesh-ancestor
102128955|NCT00539721|Autonomic Agents|autonomic agents|mesh-ancestor
102128956|NCT00539721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102128957|NCT00539721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128958|NCT00539721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102128959|NCT00539721|Antipruritics|antipruritics|mesh-ancestor
102128960|NCT00539721|Dermatologic Agents|dermatologic agents|mesh-ancestor
102128961|NCT00539721|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102128962|NCT00539721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102128963|NCT00539721|Serotonin Agents|serotonin agents|mesh-ancestor
102128964|NCT00539721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102128965|NCT00539721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128966|NCT00539721|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102128967|NCT00464061|Volinanserin|volinanserin|mesh-list
102128968|NCT00464061|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102128969|NCT00464061|Serotonin Agents|serotonin agents|mesh-ancestor
102128970|NCT00464061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102128971|NCT00464061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128972|NCT00464061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128973|NCT03230630|Melatonin|melatonin|mesh-list
102128974|NCT03230630|Antioxidants|antioxidants|mesh-ancestor
102128975|NCT03230630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128976|NCT03230630|Protective Agents|protective agents|mesh-ancestor
102128977|NCT03230630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128978|NCT03230630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102128979|NCT00460941|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102128980|NCT00460941|Incretins|incretins|mesh-ancestor
102128981|NCT00460941|Hormones|hormones|mesh-ancestor
102128982|NCT00460941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102128983|NCT00460941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128984|NCT00460317|Paclitaxel|paclitaxel|mesh-list
102128985|NCT00460317|Carboplatin|carboplatin|mesh-list
102128986|NCT00460317|Motesanib diphosphate|motesanib diphosphate|mesh-list
102128987|NCT00460317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102128988|NCT00460317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102128989|NCT00460317|Tubulin Modulators|tubulin modulators|mesh-ancestor
102128990|NCT00460317|Antimitotic Agents|antimitotic agents|mesh-ancestor
102128991|NCT00460317|Mitosis Modulators|mitosis modulators|mesh-ancestor
102128992|NCT00460317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102128993|NCT00460317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102128994|NCT00460317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102128995|NCT03213548|Daminozide|daminozide|mesh-list
102128996|NCT03213548|Plant Growth Regulators|plant growth regulators|mesh-ancestor
102128997|NCT03213548|Growth Substances|growth substances|mesh-ancestor
102128998|NCT03213548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102128999|NCT00534027|Conatumumab|conatumumab|mesh-list
102129000|NCT00534027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102129001|NCT00534027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129002|NCT02548078|Vaccines|vaccines|mesh-list
102129003|NCT02548078|Immunologic Factors|immunologic factors|mesh-ancestor
102129004|NCT02548078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129005|NCT00532311|Atorvastatin|atorvastatin|mesh-list
102129006|NCT00532311|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102129007|NCT00532311|Simvastatin|simvastatin|mesh-list
102129008|NCT00532311|Pravastatin|pravastatin|mesh-list
102129009|NCT00532311|Lovastatin|lovastatin|mesh-list
102129010|NCT00532311|L 647318|l 647318|mesh-list
102129011|NCT00532311|Dihydromevinolin|dihydromevinolin|mesh-list
102129012|NCT00532311|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
102129013|NCT00532311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102129014|NCT00532311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102129015|NCT00532311|Antimetabolites|antimetabolites|mesh-ancestor
102129016|NCT00532311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129017|NCT00532311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102129018|NCT00532311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102129019|NCT03230474|Morphine|morphine|mesh-list
102129020|NCT03230474|Naloxone|naloxone|mesh-list
102129021|NCT03230474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102129022|NCT03230474|Narcotics|narcotics|mesh-ancestor
102129023|NCT03230474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102129024|NCT03230474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129025|NCT03230474|Analgesics|analgesics|mesh-ancestor
102129026|NCT03230474|Sensory System Agents|sensory system agents|mesh-ancestor
102129027|NCT03230474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102129028|NCT03230474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102129029|NCT02671435|Bevacizumab|bevacizumab|mesh-list
102129030|NCT02671435|Cetuximab|cetuximab|mesh-list
102129031|NCT02671435|Durvalumab|durvalumab|mesh-list
102129032|NCT02671435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102129033|NCT02671435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129034|NCT02671435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102129035|NCT02671435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102129036|NCT02671435|Growth Substances|growth substances|mesh-ancestor
102129037|NCT02671435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129038|NCT02671435|Growth Inhibitors|growth inhibitors|mesh-ancestor
102129039|NCT00529503|Rituximab|rituximab|mesh-list
102129040|NCT00529503|Dacetuzumab|dacetuzumab|mesh-list
102129041|NCT00529503|Carboplatin|carboplatin|mesh-list
102129042|NCT00529503|Etoposide|etoposide|mesh-list
102129043|NCT00529503|Ifosfamide|ifosfamide|mesh-list
102129044|NCT00529503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102129045|NCT00529503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129046|NCT00529503|Immunologic Factors|immunologic factors|mesh-ancestor
102129047|NCT00529503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129048|NCT00529503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102129049|NCT00529503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102129050|NCT00529503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102129051|NCT00529503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102129052|NCT00529503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102129053|NCT00529503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129054|NCT00529503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102129055|NCT00529503|Alkylating Agents|alkylating agents|mesh-ancestor
102129056|NCT05459194|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102129057|NCT05459194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102129058|NCT05459194|Autonomic Agents|autonomic agents|mesh-ancestor
102129059|NCT05459194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102129060|NCT05459194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129061|NCT05459194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102129062|NCT05459194|Respiratory System Agents|respiratory system agents|mesh-ancestor
102129063|NCT05459194|Glucocorticoids|glucocorticoids|mesh-ancestor
102129064|NCT05459194|Hormones|hormones|mesh-ancestor
102535886|NCT00554099|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102129065|NCT05459194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102129066|NCT05459194|Sympathomimetics|sympathomimetics|mesh-ancestor
102129068|NCT05476198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102129069|NCT05476198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129070|NCT02280057|Metformin|metformin|mesh-list
102129071|NCT02280057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102129072|NCT02280057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129073|NCT02279589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102129074|NCT02279589|Immunologic Factors|immunologic factors|mesh-ancestor
102129075|NCT02279589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129076|NCT02282709|Asunaprevir|asunaprevir|mesh-list
102129077|NCT02282709|Protease Inhibitors|protease inhibitors|mesh-ancestor
102129078|NCT02282709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102129079|NCT02282709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129080|NCT02282787|Dexmedetomidine|dexmedetomidine|mesh-list
102129081|NCT02282787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102129082|NCT02282787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102027650|NCT03110328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129083|NCT02282787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129084|NCT02282787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102129085|NCT02282787|Analgesics|analgesics|mesh-ancestor
102129086|NCT02282787|Sensory System Agents|sensory system agents|mesh-ancestor
102129087|NCT02282787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102129088|NCT02282787|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102129089|NCT02282787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102129090|NCT02282787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102129091|NCT02282787|Adrenergic Agents|adrenergic agents|mesh-ancestor
102129092|NCT02282787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102129093|NCT02282787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129094|NCT03223844|Dextroamphetamine|dextroamphetamine|mesh-list
102129095|NCT03223844|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102129096|NCT03223844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129097|NCT03223844|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102129098|NCT03223844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102129099|NCT03223844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102129100|NCT03223844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129101|NCT03223844|Dopamine Agents|dopamine agents|mesh-ancestor
102129102|NCT03223844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102129103|NCT00458601|Temozolomide|temozolomide|mesh-list
102129104|NCT00458601|Molgramostim|molgramostim|mesh-list
102129105|NCT00458601|Rindopepimut|rindopepimut|mesh-list
102129106|NCT00458601|Sargramostim|sargramostim|mesh-list
102129107|NCT00458601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102129108|NCT00458601|Alkylating Agents|alkylating agents|mesh-ancestor
102129109|NCT00458601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129110|NCT00458601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129111|NCT00458601|Immunologic Factors|immunologic factors|mesh-ancestor
102129112|NCT00458601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129113|NCT00458601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102129114|NCT00658047|Methotrexate|methotrexate|mesh-list
102129115|NCT00658047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102129116|NCT00658047|Abortifacient Agents|abortifacient agents|mesh-ancestor
102129117|NCT00658047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102129118|NCT00658047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129119|NCT00658047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102129120|NCT00658047|Antimetabolites|antimetabolites|mesh-ancestor
102129121|NCT00658047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129122|NCT00658047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129123|NCT00658047|Dermatologic Agents|dermatologic agents|mesh-ancestor
102129124|NCT00658047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102129125|NCT00658047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102129126|NCT00658047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102129127|NCT00658047|Immunologic Factors|immunologic factors|mesh-ancestor
102129128|NCT00658047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102129129|NCT00658047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102129130|NCT03230162|Heparin|heparin|mesh-list
102129131|NCT03230162|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102129132|NCT03230162|Tinzaparin|tinzaparin|mesh-list
102129133|NCT03230162|Dalteparin|dalteparin|mesh-list
102129134|NCT03230162|Sildenafil Citrate|sildenafil citrate|mesh-list
102129135|NCT03230162|Anticoagulants|anticoagulants|mesh-ancestor
102129136|NCT03230162|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102129137|NCT03230162|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102129138|NCT03230162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129139|NCT03230162|Vasodilator Agents|vasodilator agents|mesh-ancestor
102129140|NCT03230162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102129141|NCT03230162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102129142|NCT03230162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102129143|NCT03230162|Urological Agents|urological agents|mesh-ancestor
102129144|NCT00455559|Imatinib Mesylate|imatinib mesylate|mesh-list
102129145|NCT00455559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129146|NCT00455559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102129147|NCT00455559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102129148|NCT00455559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129149|NCT02916433|Octreotide|octreotide|mesh-list
102129150|NCT02916433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102129151|NCT02916433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102129152|NCT02916433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129153|NCT02284269|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102129154|NCT02284269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129155|NCT02284269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102129156|NCT02284269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129157|NCT04059523|Tretinoin|tretinoin|mesh-list
102129158|NCT04059523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129159|NCT04059523|Keratolytic Agents|keratolytic agents|mesh-ancestor
102129160|NCT04059523|Dermatologic Agents|dermatologic agents|mesh-ancestor
102129161|NCT00657501|Testosterone|testosterone|mesh-list
102129162|NCT00657501|Androgens|androgens|mesh-ancestor
102129163|NCT00657501|Hormones|hormones|mesh-ancestor
102129164|NCT00657501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102129165|NCT00657501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129166|NCT03675841|Carbamide Peroxide|carbamide peroxide|mesh-list
102129167|NCT03675841|Pazufloxacin|pazufloxacin|mesh-list
102129168|NCT03675841|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102129169|NCT03675841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102129170|NCT03675841|Antitubercular Agents|antitubercular agents|mesh-ancestor
102129171|NCT03675841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102129172|NCT03675841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102129173|NCT03675841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102129174|NCT03675841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102129175|NCT03675841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129176|NCT03675841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129177|NCT03229694|Bosentan|bosentan|mesh-list
101838227|NCT00493038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102129178|NCT03229694|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
102129179|NCT03229694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102129180|NCT03229694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129182|NCT03223064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102129183|NCT03223064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129184|NCT03209648|Itraconazole|itraconazole|mesh-list
102129185|NCT03209648|Antifungal Agents|antifungal agents|mesh-ancestor
102129186|NCT03209648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102129187|NCT03209648|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102129188|NCT03209648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102129189|NCT03209648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102129190|NCT03209648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129191|NCT03209648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102129192|NCT03209648|Hormone Antagonists|hormone antagonists|mesh-ancestor
102129193|NCT03209648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102129194|NCT03209648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129195|NCT03209648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102129196|NCT04058899|Dexmedetomidine|dexmedetomidine|mesh-list
102129197|NCT04058899|Nalbuphine|nalbuphine|mesh-list
102129198|NCT04058899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102129199|NCT04058899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102129200|NCT04058899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129201|NCT04058899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102129202|NCT04058899|Analgesics|analgesics|mesh-ancestor
102129203|NCT04058899|Sensory System Agents|sensory system agents|mesh-ancestor
102129204|NCT04058899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102129205|NCT04058899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102129206|NCT04058899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102129207|NCT04058899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102129208|NCT04058899|Adrenergic Agents|adrenergic agents|mesh-ancestor
102129209|NCT04058899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102129210|NCT04058899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129211|NCT04058899|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102129212|NCT04058899|Narcotics|narcotics|mesh-ancestor
102129213|NCT00657189|Sifalimumab|sifalimumab|mesh-list
102129214|NCT00657189|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102129215|NCT00657189|Immunologic Factors|immunologic factors|mesh-ancestor
102129216|NCT00657189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129218|NCT03209180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102129219|NCT03209180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102129220|NCT03209180|Adrenergic Agents|adrenergic agents|mesh-ancestor
102129221|NCT03209180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102129222|NCT03209180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129223|NCT03209180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129224|NCT03209180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102129225|NCT03209180|Antioxidants|antioxidants|mesh-ancestor
102129226|NCT03209180|Protective Agents|protective agents|mesh-ancestor
102129227|NCT03209180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102129228|NCT03209180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102129229|NCT03209180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102129230|NCT03209180|Vasodilator Agents|vasodilator agents|mesh-ancestor
102129231|NCT03209180|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102129232|NCT03209180|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102129233|NCT03215017|Loperamide|loperamide|mesh-list
102129234|NCT03215017|Sorbitol|sorbitol|mesh-list
102129235|NCT03215017|Antidiarrheals|antidiarrheals|mesh-ancestor
102129236|NCT03215017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102129237|NCT03215017|Cathartics|cathartics|mesh-ancestor
102129238|NCT02500849|Busulfan|busulfan|mesh-list
102129239|NCT02500849|Alkylating Agents|alkylating agents|mesh-ancestor
102129240|NCT02500849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129241|NCT02500849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102129242|NCT02500849|Immunologic Factors|immunologic factors|mesh-ancestor
102129243|NCT02500849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129244|NCT02500849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102129245|NCT02500849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129246|NCT02500849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102129247|NCT03209102|Hydrocortisone|hydrocortisone|mesh-list
102129248|NCT03209102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102129249|NCT02280447|Vaccines|vaccines|mesh-list
102129250|NCT02280447|Immunologic Factors|immunologic factors|mesh-ancestor
102129251|NCT02280447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129252|NCT00528333|Cytarabine|cytarabine|mesh-list
102129253|NCT00528333|Lintuzumab|lintuzumab|mesh-list
102129254|NCT00528333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102129255|NCT00528333|Antimetabolites|antimetabolites|mesh-ancestor
102129256|NCT00528333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129257|NCT00528333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129258|NCT00528333|Antiviral Agents|antiviral agents|mesh-ancestor
102129259|NCT00528333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102129260|NCT00528333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102129261|NCT00528333|Immunologic Factors|immunologic factors|mesh-ancestor
102129262|NCT00528333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129263|NCT00528333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102129264|NCT00526227|Clotrimazole|clotrimazole|mesh-list
102129265|NCT00526227|Miconazole|miconazole|mesh-list
102129266|NCT00526227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102129267|NCT00526227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102129268|NCT00526227|Antifungal Agents|antifungal agents|mesh-ancestor
102129269|NCT00526227|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102129270|NCT00526227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102129271|NCT00526227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102129272|NCT00526227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129273|NCT00526227|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102129274|NCT00526227|Hormone Antagonists|hormone antagonists|mesh-ancestor
102129275|NCT00526227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102129276|NCT00526227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129277|NCT00526227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102129278|NCT00526227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102129279|NCT02280603|Minoxidil|minoxidil|mesh-list
102129280|NCT02280603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102129281|NCT02280603|Vasodilator Agents|vasodilator agents|mesh-ancestor
102129282|NCT00524277|Molgramostim|molgramostim|mesh-list
102129283|NCT00524277|Vaccines|vaccines|mesh-list
102129284|NCT00524277|Sargramostim|sargramostim|mesh-list
102535887|NCT00554099|Mesalamine|mesalamine|mesh-list
102129285|NCT00524277|Immunologic Factors|immunologic factors|mesh-ancestor
102129286|NCT00524277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129287|NCT00524277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129288|NCT02284503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102129289|NCT02284503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102129290|NCT02284503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102129291|NCT02284503|Antimetabolites|antimetabolites|mesh-ancestor
102129292|NCT02284503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129293|NCT02284503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102129294|NCT02284503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102129295|NCT02284503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102129296|NCT00650949|Carboplatin|carboplatin|mesh-list
102129297|NCT00650949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129298|NCT00520923|Olanzapine|olanzapine|mesh-list
102129299|NCT00520923|Antiemetics|antiemetics|mesh-ancestor
102129300|NCT00520923|Autonomic Agents|autonomic agents|mesh-ancestor
102129301|NCT00520923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102129302|NCT00520923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129303|NCT00520923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102129304|NCT00520923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102129305|NCT00520923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102129306|NCT00520923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102129307|NCT00520923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102129308|NCT00520923|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102129309|NCT00520923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102129310|NCT00520923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102129311|NCT00520923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129312|NCT00520923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102129313|NCT00520923|Serotonin Agents|serotonin agents|mesh-ancestor
102129314|NCT02283177|Cytarabine|cytarabine|mesh-list
102129315|NCT02283177|Daunorubicin|daunorubicin|mesh-list
102129316|NCT02283177|Idarubicin|idarubicin|mesh-list
102129317|NCT02283177|Crenolanib|crenolanib|mesh-list
102129318|NCT02283177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102129319|NCT02283177|Antimetabolites|antimetabolites|mesh-ancestor
102129320|NCT02283177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129321|NCT02283177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129322|NCT02283177|Antiviral Agents|antiviral agents|mesh-ancestor
102129323|NCT02283177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102129324|NCT02283177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102129325|NCT02283177|Immunologic Factors|immunologic factors|mesh-ancestor
102129326|NCT02283177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129327|NCT02283177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102129328|NCT02283177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102129329|NCT02283177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102129330|NCT02283177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102129331|NCT00514371|Bortezomib|bortezomib|mesh-list
102129332|NCT00514371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129333|NCT02547766|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102129334|NCT02547766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102129335|NCT04470531|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102129336|NCT04470531|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102129337|NCT04470531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102129338|NCT04470531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102129339|NCT04470531|Antimalarials|antimalarials|mesh-ancestor
102129340|NCT04470531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102129341|NCT04470531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102129342|NCT02286453|Diclofenac|diclofenac|mesh-list
102129343|NCT02286453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102129344|NCT02286453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102129345|NCT02286453|Analgesics|analgesics|mesh-ancestor
102129346|NCT02286453|Sensory System Agents|sensory system agents|mesh-ancestor
102129347|NCT02286453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102129348|NCT02286453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129349|NCT02286453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102129350|NCT02286453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102129351|NCT02286453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102129352|NCT02286453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102129353|NCT02286453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129354|NCT00385515|Meclocycline|meclocycline|mesh-list
102129355|NCT00385515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102129356|NCT00385515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102129357|NCT02286609|Deflazacort|deflazacort|mesh-list
102129358|NCT02286609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102129359|NCT02286609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102129360|NCT02286609|Immunologic Factors|immunologic factors|mesh-ancestor
102129361|NCT02286609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129363|NCT00508989|Acetylcholine|acetylcholine|mesh-list
102129364|NCT00508989|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102129365|NCT00508989|Antimetabolites|antimetabolites|mesh-ancestor
102129366|NCT00508989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129367|NCT00508989|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102129368|NCT00508989|Vasodilator Agents|vasodilator agents|mesh-ancestor
102129369|NCT00508989|Vitamin B Complex|vitamin b complex|mesh-ancestor
102129371|NCT00508989|Micronutrients|micronutrients|mesh-ancestor
102129372|NCT00508989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129373|NCT00508989|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102129374|NCT00508989|Cholinergic Agents|cholinergic agents|mesh-ancestor
102129375|NCT00508989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102129376|NCT03104842|Dexamethasone|dexamethasone|mesh-list
102129377|NCT03104842|Lenalidomide|lenalidomide|mesh-list
102129378|NCT03104842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102129379|NCT03104842|Antiemetics|antiemetics|mesh-ancestor
102129380|NCT03104842|Autonomic Agents|autonomic agents|mesh-ancestor
102129381|NCT03104842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102129382|NCT03104842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129383|NCT03104842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102129384|NCT03104842|Glucocorticoids|glucocorticoids|mesh-ancestor
102129385|NCT03104842|Hormones|hormones|mesh-ancestor
102129386|NCT03104842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102129387|NCT03104842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102129388|NCT03104842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129389|NCT03104842|Immunologic Factors|immunologic factors|mesh-ancestor
102129390|NCT03104842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102129391|NCT03104842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102129392|NCT03104842|Growth Substances|growth substances|mesh-ancestor
102129393|NCT03104842|Growth Inhibitors|growth inhibitors|mesh-ancestor
102129394|NCT00436683|Sevelamer|sevelamer|mesh-list
102129395|NCT00436683|Chelating Agents|chelating agents|mesh-ancestor
102129396|NCT00436683|Sequestering Agents|sequestering agents|mesh-ancestor
102129397|NCT00436683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129398|NCT00434811|Sirolimus|sirolimus|mesh-list
102129399|NCT00434811|Etanercept|etanercept|mesh-list
102129400|NCT00434811|Tacrolimus|tacrolimus|mesh-list
102129401|NCT00434811|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102129402|NCT00434811|Basiliximab|basiliximab|mesh-list
102129403|NCT00434811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102129404|NCT00434811|Immunologic Factors|immunologic factors|mesh-ancestor
102129405|NCT00434811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129406|NCT00434811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102129407|NCT00434811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102129408|NCT00434811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129409|NCT00434811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102129410|NCT00434811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102129411|NCT00434811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102129412|NCT00434811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129413|NCT00434811|Antifungal Agents|antifungal agents|mesh-ancestor
102129414|NCT00434811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102129415|NCT00434811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102129416|NCT00434811|Analgesics|analgesics|mesh-ancestor
102129417|NCT00434811|Sensory System Agents|sensory system agents|mesh-ancestor
102129418|NCT00434811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102129419|NCT00434811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102129420|NCT00434811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102129421|NCT00434811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102129422|NCT03133845|Fentanyl|fentanyl|mesh-list
102129423|NCT03133845|Midazolam|midazolam|mesh-list
102129424|NCT03133845|Morphine|morphine|mesh-list
102129425|NCT03133845|Anesthetics|anesthetics|mesh-list
102129426|NCT03133845|Propofol|propofol|mesh-list
102129427|NCT03133845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102129428|NCT03133845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129429|NCT03133845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102129430|NCT03133845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102129431|NCT03133845|Anesthetics, General|anesthetics, general|mesh-ancestor
102129432|NCT03133845|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102129433|NCT03133845|Narcotics|narcotics|mesh-ancestor
102129434|NCT03133845|Analgesics|analgesics|mesh-ancestor
102129435|NCT03133845|Sensory System Agents|sensory system agents|mesh-ancestor
102129436|NCT03133845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102072108|NCT03314181|Daratumumab|daratumumab|mesh-list
102129437|NCT03133845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102129438|NCT03133845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102129439|NCT03133845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102129440|NCT03133845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102129441|NCT03133845|GABA Modulators|gaba modulators|mesh-ancestor
102129442|NCT03133845|GABA Agents|gaba agents|mesh-ancestor
102129443|NCT03133845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102129444|NCT03133845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129445|NCT00120393|Ritonavir|ritonavir|mesh-list
102129446|NCT00120393|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102129447|NCT00120393|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102129448|NCT00120393|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102129449|NCT00120393|Protease Inhibitors|protease inhibitors|mesh-ancestor
102129450|NCT00120393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102129451|NCT00120393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129452|NCT00120393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102129453|NCT00120393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102129454|NCT00120393|Antiviral Agents|antiviral agents|mesh-ancestor
102129455|NCT00120393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102129456|NCT00120393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102129457|NCT00120393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102129458|NCT05726019|Colchicine|colchicine|mesh-list
102129459|NCT05726019|Gout Suppressants|gout suppressants|mesh-ancestor
102129460|NCT05726019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102129461|NCT05726019|Tubulin Modulators|tubulin modulators|mesh-ancestor
102129462|NCT05726019|Antimitotic Agents|antimitotic agents|mesh-ancestor
102129463|NCT05726019|Mitosis Modulators|mitosis modulators|mesh-ancestor
102129464|NCT05726019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129465|NCT05726019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129466|NCT00116415|Lamivudine|lamivudine|mesh-list
102129467|NCT00116415|Efavirenz|efavirenz|mesh-list
102129468|NCT00116415|Didanosine|didanosine|mesh-list
102129469|NCT00116415|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102129470|NCT00116415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102129471|NCT00116415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102129472|NCT00116415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129473|NCT00116415|Antiviral Agents|antiviral agents|mesh-ancestor
102129474|NCT00116415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102129475|NCT00116415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102129476|NCT00116415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101838536|NCT00466440|Prednisone|prednisone|mesh-list
102129477|NCT00116415|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102129478|NCT00116415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102129479|NCT00116415|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102129480|NCT00116415|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102129481|NCT00116415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102129482|NCT00116415|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102129483|NCT00116415|Antimetabolites|antimetabolites|mesh-ancestor
102129484|NCT03207698|Metformin|metformin|mesh-list
102129485|NCT03207698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102129486|NCT03207698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129487|NCT03208712|Atezolizumab|atezolizumab|mesh-list
102129488|NCT03208712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102129489|NCT03208712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129490|NCT03208712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102129491|NCT03208712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129492|NCT03201380|Choline|choline|mesh-list
102129493|NCT03201380|Lipotropic Agents|lipotropic agents|mesh-ancestor
102129494|NCT03201380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102129495|NCT03201380|Antimetabolites|antimetabolites|mesh-ancestor
102129496|NCT03201380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129497|NCT03201380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102129498|NCT03201380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102129499|NCT03201380|Nootropic Agents|nootropic agents|mesh-ancestor
102129500|NCT03208556|Cyclophosphamide|cyclophosphamide|mesh-list
102129501|NCT03208556|Fludarabine|fludarabine|mesh-list
102129502|NCT03208556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102129503|NCT03208556|Immunologic Factors|immunologic factors|mesh-ancestor
102129504|NCT03208556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129505|NCT03208556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102129506|NCT03208556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102129507|NCT03208556|Alkylating Agents|alkylating agents|mesh-ancestor
102129508|NCT03208556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129509|NCT03208556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102535888|NCT00554099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102129510|NCT03208556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102129511|NCT00429429|Immunomodulating Agents|immunomodulating agents|mesh-list
102129512|NCT00429429|Immunologic Factors|immunologic factors|mesh-ancestor
102129513|NCT00429429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129514|NCT03201146|Cisplatin|cisplatin|mesh-list
102129515|NCT03201146|Carboplatin|carboplatin|mesh-list
102129516|NCT03201146|Pemetrexed|pemetrexed|mesh-list
102129517|NCT03201146|Apatinib|apatinib|mesh-list
102129518|NCT03201146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129519|NCT03201146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102129520|NCT03201146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129521|NCT03201146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102129522|NCT03201146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102129523|NCT03201146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102129524|NCT00370383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102129525|NCT00370383|Satraplatin|satraplatin|mesh-list
102129526|NCT00370383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129527|NCT00370383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102129528|NCT00370383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102129529|NCT00370383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129530|NCT00367887|Ribavirin|ribavirin|mesh-list
102129531|NCT00367887|Interferon alpha-2|interferon alpha-2|mesh-list
102129532|NCT00367887|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102129533|NCT00367887|Interferon-alpha|interferon-alpha|mesh-list
102129534|NCT00367887|Antimetabolites|antimetabolites|mesh-ancestor
102129535|NCT00367887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129536|NCT00367887|Antiviral Agents|antiviral agents|mesh-ancestor
102129537|NCT00367887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102129538|NCT00367887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129539|NCT00367887|Immunologic Factors|immunologic factors|mesh-ancestor
102129540|NCT00367887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129541|NCT02547220|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
102129542|NCT02547220|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102129543|NCT02547220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102129544|NCT02547220|Immunologic Factors|immunologic factors|mesh-ancestor
102129545|NCT02547220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129546|NCT03207308|Vitamin A|vitamin a|mesh-list
102129547|NCT03207308|Vitamins|vitamins|mesh-ancestor
102129548|NCT03207308|Micronutrients|micronutrients|mesh-ancestor
101838608|NCT00400179|Cisplatin|cisplatin|mesh-list
102129549|NCT03207308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129550|NCT00366795|Satavaptan|satavaptan|mesh-list
102129551|NCT00366795|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102129552|NCT00366795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129553|NCT00366795|Natriuretic Agents|natriuretic agents|mesh-ancestor
102129554|NCT00366795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129556|NCT00422019|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102028131|NCT03304873|Retapamulin|retapamulin|mesh-list
102129557|NCT00422019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102129558|NCT00422019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129559|NCT00422019|Immunologic Factors|immunologic factors|mesh-ancestor
102129560|NCT00422019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129561|NCT03207542|Daratumumab|daratumumab|mesh-list
102129562|NCT03207542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129563|NCT00360867|Motesanib diphosphate|motesanib diphosphate|mesh-list
102129564|NCT00360867|Imetelstat|imetelstat|mesh-list
102129565|NCT00360867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102129566|NCT00360867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102129567|NCT00360867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129568|NCT02287389|Mitomycins|mitomycins|mesh-list
102129569|NCT02287389|Mitomycin|mitomycin|mesh-list
102129570|NCT02287389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102129571|NCT02287389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129572|NCT02287389|Alkylating Agents|alkylating agents|mesh-ancestor
102129573|NCT02287389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129574|NCT02287389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102129575|NCT02287389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102129576|NCT00057993|Trastuzumab|trastuzumab|mesh-list
102129577|NCT00057993|Exemestane|exemestane|mesh-list
102129578|NCT00057993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102129579|NCT00057993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129580|NCT00057993|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102129581|NCT00057993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102129582|NCT00057993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102129583|NCT00057993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129584|NCT00057993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102129585|NCT00057993|Hormone Antagonists|hormone antagonists|mesh-ancestor
102129586|NCT00057993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102129587|NCT00057993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129588|NCT02284737|Sildenafil Citrate|sildenafil citrate|mesh-list
102129589|NCT02284737|Vasodilator Agents|vasodilator agents|mesh-ancestor
102129590|NCT02284737|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102129591|NCT02284737|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102129592|NCT02284737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102129593|NCT02284737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129594|NCT02284737|Urological Agents|urological agents|mesh-ancestor
102129596|NCT02448290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129597|NCT02448290|Tubulin Modulators|tubulin modulators|mesh-ancestor
102129598|NCT02448290|Antimitotic Agents|antimitotic agents|mesh-ancestor
102129599|NCT02448290|Mitosis Modulators|mitosis modulators|mesh-ancestor
102129600|NCT02448290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129601|NCT00357279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102129602|NCT04484558|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102129603|NCT04484558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102129604|NCT04484558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102129605|NCT04484558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129606|NCT00055575|Scopolamine|scopolamine|mesh-list
102129607|NCT00055575|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102129608|NCT00055575|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102129609|NCT00055575|Antiemetics|antiemetics|mesh-ancestor
102129610|NCT00055575|Autonomic Agents|autonomic agents|mesh-ancestor
102129611|NCT00055575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102129612|NCT00055575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129613|NCT00055575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102129614|NCT00055575|Mydriatics|mydriatics|mesh-ancestor
102129615|NCT00055575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102129616|NCT00055575|Cholinergic Agents|cholinergic agents|mesh-ancestor
102129617|NCT00055575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102129618|NCT00055575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129619|NCT00055575|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102129620|NCT00055575|Parasympatholytics|parasympatholytics|mesh-ancestor
102129621|NCT00051129|Hydrocortisone|hydrocortisone|mesh-list
102129622|NCT00051129|Anecortave|anecortave|mesh-list
102129623|NCT00051129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102129624|NCT00051129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102129625|NCT00051129|Growth Substances|growth substances|mesh-ancestor
102129626|NCT00051129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129627|NCT00051129|Growth Inhibitors|growth inhibitors|mesh-ancestor
102129628|NCT00051129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129629|NCT00051129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102129630|NCT03200600|Dexamethasone|dexamethasone|mesh-list
102129631|NCT03200600|Dexamethasone acetate|dexamethasone acetate|mesh-list
102129632|NCT03200600|Flurbiprofen|flurbiprofen|mesh-list
102129633|NCT03200600|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
102129634|NCT03200600|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102129635|NCT03200600|BB 1101|bb 1101|mesh-list
102129636|NCT03200600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102129637|NCT03200600|Antiemetics|antiemetics|mesh-ancestor
102129638|NCT03200600|Autonomic Agents|autonomic agents|mesh-ancestor
102129639|NCT03200600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102129640|NCT03200600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129641|NCT03200600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102129642|NCT03200600|Glucocorticoids|glucocorticoids|mesh-ancestor
102129643|NCT03200600|Hormones|hormones|mesh-ancestor
102129644|NCT03200600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102129645|NCT03200600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102129646|NCT03200600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129647|NCT03200600|Protease Inhibitors|protease inhibitors|mesh-ancestor
102129648|NCT03200600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102129649|NCT03200600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129650|NCT03200600|Analgesics|analgesics|mesh-ancestor
102129651|NCT03200600|Sensory System Agents|sensory system agents|mesh-ancestor
102129652|NCT03200600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102129653|NCT03200600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102129654|NCT03200600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102129655|NCT03200600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102129656|NCT02547454|Epoetin Alfa|epoetin alfa|mesh-list
102129657|NCT02547454|Hematinics|hematinics|mesh-ancestor
102129658|NCT01491893|Vaccines|vaccines|mesh-list
102129659|NCT01491893|Immunologic Factors|immunologic factors|mesh-ancestor
102129660|NCT01491893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129662|NCT00049959|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102129663|NCT00049959|Dermatologic Agents|dermatologic agents|mesh-ancestor
102129664|NCT03119324|Nimesulide|nimesulide|mesh-list
102129665|NCT03119324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102129666|NCT03119324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102129667|NCT03119324|Analgesics|analgesics|mesh-ancestor
102129668|NCT03119324|Sensory System Agents|sensory system agents|mesh-ancestor
102129669|NCT03119324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102129670|NCT03119324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129671|NCT03119324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102129672|NCT03119324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102129673|NCT03119324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102129674|NCT03119324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102129675|NCT03119324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129676|NCT00415623|Amlodipine|amlodipine|mesh-list
102129677|NCT00415623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102129678|NCT00415623|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102129679|NCT00415623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102129680|NCT00415623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129681|NCT00415623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102129682|NCT00415623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129683|NCT00415623|Vasodilator Agents|vasodilator agents|mesh-ancestor
102129684|NCT03133923|Vaccines|vaccines|mesh-list
102129685|NCT03133923|Immunologic Factors|immunologic factors|mesh-ancestor
102129686|NCT03133923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129687|NCT03134001|Analgesics|analgesics|mesh-list
102129688|NCT03134001|Sensory System Agents|sensory system agents|mesh-ancestor
102129689|NCT03134001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102129690|NCT03134001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129691|NCT01969409|Rituximab|rituximab|mesh-list
102129692|NCT01969409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102129693|NCT01969409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129694|NCT01969409|Immunologic Factors|immunologic factors|mesh-ancestor
102129695|NCT01969409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129696|NCT01969409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102129697|NCT05218577|Selenium|selenium|mesh-list
102129698|NCT05218577|Antioxidants|antioxidants|mesh-ancestor
102129699|NCT05218577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129700|NCT05218577|Protective Agents|protective agents|mesh-ancestor
102129701|NCT05218577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129702|NCT05218577|Trace Elements|trace elements|mesh-ancestor
102129703|NCT05218577|Micronutrients|micronutrients|mesh-ancestor
102129704|NCT00150813|Levetiracetam|levetiracetam|mesh-list
102129705|NCT00150813|Anticonvulsants|anticonvulsants|mesh-ancestor
102129706|NCT00150813|Nootropic Agents|nootropic agents|mesh-ancestor
102129707|NCT02712788|Milrinone|milrinone|mesh-list
102129708|NCT02712788|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102129709|NCT02712788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102129710|NCT02712788|Vasodilator Agents|vasodilator agents|mesh-ancestor
102129711|NCT02712788|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102129712|NCT02712788|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102129713|NCT02712788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102129714|NCT02712788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129715|NCT02712788|Protective Agents|protective agents|mesh-ancestor
102129716|NCT02712788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129717|NCT00035529|Abatacept|abatacept|mesh-list
102129718|NCT00035529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102129719|NCT00035529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129720|NCT00035529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102129721|NCT00035529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129722|NCT00035529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102129723|NCT00035529|Immunologic Factors|immunologic factors|mesh-ancestor
102129724|NCT00035529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129725|NCT00035529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102129726|NCT04470609|Vaccines|vaccines|mesh-list
102129727|NCT04470609|Immunologic Factors|immunologic factors|mesh-ancestor
102129728|NCT04470609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129729|NCT00356109|Insulin|insulin|mesh-list
102129730|NCT00356109|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102129731|NCT00356109|Insulin Glargine|insulin glargine|mesh-list
102129732|NCT00356109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102129733|NCT00356109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129734|NCT03206138|Imiquimod|imiquimod|mesh-list
102129735|NCT03206138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102129736|NCT03206138|Immunologic Factors|immunologic factors|mesh-ancestor
102129737|NCT03206138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129738|NCT03206138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129739|NCT03206138|Interferon Inducers|interferon inducers|mesh-ancestor
102129741|NCT04530305|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102129742|NCT04530305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102129743|NCT04530305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102129744|NCT04530305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129745|NCT04530305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102129746|NCT00006225|Flt3 ligand protein|flt3 ligand protein|mesh-list
102129747|NCT00006225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102129748|NCT00006225|Immunologic Factors|immunologic factors|mesh-ancestor
102129749|NCT00006225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129750|NCT00006225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102129751|NCT00006225|Protective Agents|protective agents|mesh-ancestor
102129752|NCT00005595|Arsenic Trioxide|arsenic trioxide|mesh-list
102129753|NCT00005595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129754|NCT02447822|Thymoglobulin|thymoglobulin|mesh-list
102129755|NCT02447822|Immunologic Factors|immunologic factors|mesh-ancestor
102129756|NCT02447822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129757|NCT02447822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102129758|NCT04477265|Solifenacin Succinate|solifenacin succinate|mesh-list
102129759|NCT04477265|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102129760|NCT04477265|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102129761|NCT04477265|Cholinergic Agents|cholinergic agents|mesh-ancestor
102129762|NCT04477265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102129763|NCT04477265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129764|NCT04477265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129765|NCT04477265|Urological Agents|urological agents|mesh-ancestor
102129766|NCT00353457|Capecitabine|capecitabine|mesh-list
102129767|NCT00353457|Oxaliplatin|oxaliplatin|mesh-list
102129768|NCT00353457|Cetuximab|cetuximab|mesh-list
102129769|NCT00353457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102129770|NCT00353457|Antimetabolites|antimetabolites|mesh-ancestor
102028341|NCT03657212|GABA Agonists|gaba agonists|mesh-ancestor
102129771|NCT00353457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129772|NCT00353457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129773|NCT00353457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102129774|NCT00411099|Agomelatine|agomelatine|mesh-list
102129775|NCT00411099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102129776|NCT00411099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102129777|NCT00411099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129778|NCT03195530|Propofol|propofol|mesh-list
102129779|NCT03195530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102129780|NCT03195530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102129781|NCT03195530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129782|NCT03195530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102129783|NCT03195530|Anesthetics, General|anesthetics, general|mesh-ancestor
102129785|NCT03195452|Raltegravir Potassium|raltegravir potassium|mesh-list
102129786|NCT03195452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
102129787|NCT03195452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102129788|NCT03195452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102129789|NCT03195452|Antiviral Agents|antiviral agents|mesh-ancestor
102129790|NCT03195452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102129791|NCT03195452|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102129792|NCT03195452|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102129793|NCT03195452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102129794|NCT03195452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129795|NCT03195452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102129796|NCT00406809|Navitoclax|navitoclax|mesh-list
102129797|NCT00406809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129798|NCT03200210|Febuxostat|febuxostat|mesh-list
102129799|NCT03200210|Gout Suppressants|gout suppressants|mesh-ancestor
102129800|NCT03200210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102129801|NCT00004899|Etoposide|etoposide|mesh-list
102129802|NCT00004899|Busulfan|busulfan|mesh-list
102129803|NCT00004899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102129804|NCT00004899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129805|NCT00004899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102129806|NCT00004899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102129807|NCT00004899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102129808|NCT00004899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129809|NCT00004899|Immunologic Factors|immunologic factors|mesh-ancestor
102129810|NCT00004899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072481|NCT00430508|Olmesartan|olmesartan|mesh-list
102129811|NCT00004899|Alkylating Agents|alkylating agents|mesh-ancestor
102129812|NCT00004899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102129813|NCT00004899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102129814|NCT00004899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102129815|NCT03199976|Fluticasone|fluticasone|mesh-list
102129816|NCT03199976|Xhance|xhance|mesh-list
102129817|NCT03199976|Bromides|bromides|mesh-list
102129818|NCT03199976|Albuterol|albuterol|mesh-list
102129819|NCT03199976|Tiotropium Bromide|tiotropium bromide|mesh-list
102129820|NCT03199976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102129821|NCT03199976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102129822|NCT03199976|Autonomic Agents|autonomic agents|mesh-ancestor
102129823|NCT03199976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102129824|NCT03199976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129825|NCT03199976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102129826|NCT03199976|Respiratory System Agents|respiratory system agents|mesh-ancestor
102129827|NCT03199976|Dermatologic Agents|dermatologic agents|mesh-ancestor
102129828|NCT03199976|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102129829|NCT03199976|Parasympatholytics|parasympatholytics|mesh-ancestor
102129830|NCT03199976|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102129831|NCT03199976|Cholinergic Agents|cholinergic agents|mesh-ancestor
102129832|NCT03199976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102028412|NCT03495232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102129833|NCT03199976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129834|NCT03199976|Anticonvulsants|anticonvulsants|mesh-ancestor
102129835|NCT03199976|Tocolytic Agents|tocolytic agents|mesh-ancestor
102129836|NCT03199976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102129837|NCT03199976|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102129838|NCT03199976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102129839|NCT03199976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102129840|NCT03199976|Adrenergic Agents|adrenergic agents|mesh-ancestor
102129841|NCT00369317|Cytarabine|cytarabine|mesh-list
102129842|NCT00369317|Etoposide|etoposide|mesh-list
102129843|NCT00369317|Daunorubicin|daunorubicin|mesh-list
102129844|NCT00369317|Etoposide phosphate|etoposide phosphate|mesh-list
102129845|NCT00369317|Asparaginase|asparaginase|mesh-list
102129846|NCT00369317|Thioguanine|thioguanine|mesh-list
102129847|NCT00369317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102129848|NCT00369317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129849|NCT00369317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102129850|NCT00369317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102129851|NCT00369317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102129852|NCT00369317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129853|NCT00369317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101838909|NCT00410163|Ofatumumab|ofatumumab|mesh-list
102129854|NCT00369317|Antimetabolites|antimetabolites|mesh-ancestor
102129855|NCT00369317|Antiviral Agents|antiviral agents|mesh-ancestor
102129856|NCT00369317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102129857|NCT00369317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102129858|NCT00369317|Immunologic Factors|immunologic factors|mesh-ancestor
102129859|NCT00369317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129860|NCT00369317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102129861|NCT02447666|Azacitidine|azacitidine|mesh-list
102129862|NCT02447666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102129863|NCT02447666|Antimetabolites|antimetabolites|mesh-ancestor
102129864|NCT02447666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129865|NCT02447666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129866|NCT02447666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102129867|NCT04469829|Methotrexate|methotrexate|mesh-list
102129868|NCT04469829|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102129869|NCT04469829|Abortifacient Agents|abortifacient agents|mesh-ancestor
102129870|NCT04469829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102129871|NCT04469829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129872|NCT04469829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102129873|NCT04469829|Antimetabolites|antimetabolites|mesh-ancestor
102129874|NCT04469829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129875|NCT04469829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129876|NCT04469829|Dermatologic Agents|dermatologic agents|mesh-ancestor
102129877|NCT04469829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102129878|NCT04469829|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102129879|NCT04469829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102129880|NCT04469829|Immunologic Factors|immunologic factors|mesh-ancestor
102129881|NCT04469829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102129882|NCT04469829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102129883|NCT00405951|Docetaxel|docetaxel|mesh-list
102129884|NCT00405951|Obatoclax|obatoclax|mesh-list
102129885|NCT00405951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129886|NCT00405951|Tubulin Modulators|tubulin modulators|mesh-ancestor
102129887|NCT00405951|Antimitotic Agents|antimitotic agents|mesh-ancestor
102129888|NCT00405951|Mitosis Modulators|mitosis modulators|mesh-ancestor
102129889|NCT00405951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129890|NCT00405951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102129891|NCT03194984|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102129892|NCT03194984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102129893|NCT03194984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102129894|NCT03669757|Betamethasone|betamethasone|mesh-list
102129895|NCT03669757|Betamethasone Valerate|betamethasone valerate|mesh-list
102129896|NCT03669757|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102129897|NCT03669757|Betamethasone benzoate|betamethasone benzoate|mesh-list
102129898|NCT03669757|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102129899|NCT03669757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102129900|NCT03669757|Glucocorticoids|glucocorticoids|mesh-ancestor
102129901|NCT03669757|Hormones|hormones|mesh-ancestor
102129902|NCT03669757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102129903|NCT03669757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129904|NCT03669757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102028470|NCT02387086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102129905|NCT03669757|Respiratory System Agents|respiratory system agents|mesh-ancestor
102129906|NCT02303821|Cytarabine|cytarabine|mesh-list
102129907|NCT02303821|Dexamethasone|dexamethasone|mesh-list
102129908|NCT02303821|Hydrocortisone|hydrocortisone|mesh-list
102129909|NCT02303821|Cyclophosphamide|cyclophosphamide|mesh-list
102129910|NCT02303821|Methotrexate|methotrexate|mesh-list
102129911|NCT02303821|Vincristine|vincristine|mesh-list
102129912|NCT02303821|Daunorubicin|daunorubicin|mesh-list
102129913|NCT02303821|Asparaginase|asparaginase|mesh-list
102129914|NCT02303821|Mitoxantrone|mitoxantrone|mesh-list
102129915|NCT02303821|Mercaptopurine|mercaptopurine|mesh-list
102129916|NCT02303821|Pegaspargase|pegaspargase|mesh-list
102129917|NCT02303821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102129918|NCT02303821|Immunologic Factors|immunologic factors|mesh-ancestor
102129919|NCT02303821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129920|NCT02303821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102129921|NCT02303821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102129922|NCT02303821|Alkylating Agents|alkylating agents|mesh-ancestor
102129923|NCT02303821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129924|NCT02303821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129925|NCT02303821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102129926|NCT02303821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102129927|NCT02303821|Antiemetics|antiemetics|mesh-ancestor
102129928|NCT02303821|Autonomic Agents|autonomic agents|mesh-ancestor
102129929|NCT02303821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102129930|NCT02303821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102129931|NCT02303821|Glucocorticoids|glucocorticoids|mesh-ancestor
102129932|NCT02303821|Hormones|hormones|mesh-ancestor
102129933|NCT02303821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102129934|NCT02303821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102129935|NCT02303821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102129936|NCT02303821|Abortifacient Agents|abortifacient agents|mesh-ancestor
102129937|NCT02303821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102129938|NCT02303821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102129939|NCT02303821|Antimetabolites|antimetabolites|mesh-ancestor
102129940|NCT02303821|Dermatologic Agents|dermatologic agents|mesh-ancestor
102129941|NCT02303821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102129942|NCT02303821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102129943|NCT02303821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102129944|NCT02303821|Antiviral Agents|antiviral agents|mesh-ancestor
102129945|NCT02303821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102129946|NCT02303821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102129947|NCT02303821|Tubulin Modulators|tubulin modulators|mesh-ancestor
102129948|NCT02303821|Antimitotic Agents|antimitotic agents|mesh-ancestor
102129949|NCT02303821|Mitosis Modulators|mitosis modulators|mesh-ancestor
102129950|NCT02303821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102129951|NCT02303821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102129952|NCT02303821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102129953|NCT02303821|Analgesics|analgesics|mesh-ancestor
102129954|NCT02303821|Sensory System Agents|sensory system agents|mesh-ancestor
102129955|NCT03913091|Bupivacaine|bupivacaine|mesh-list
102129956|NCT03913091|Anesthetics, Local|anesthetics, local|mesh-ancestor
102129957|NCT03913091|Anesthetics|anesthetics|mesh-ancestor
102129958|NCT03913091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102129959|NCT03913091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129960|NCT03913091|Sensory System Agents|sensory system agents|mesh-ancestor
102129961|NCT03913091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102129962|NCT00330369|Darusentan|darusentan|mesh-list
102129963|NCT00330369|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102129964|NCT00330369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129966|NCT03199664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102129967|NCT03199664|Immunologic Factors|immunologic factors|mesh-ancestor
102129968|NCT03199664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129969|NCT03199664|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102129970|NCT03199664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102129971|NCT03199664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129972|NCT02447510|Mitogens|mitogens|mesh-list
102129973|NCT02447510|Mitosis Modulators|mitosis modulators|mesh-ancestor
102129974|NCT02447510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129975|NCT05674643|Acetaminophen|acetaminophen|mesh-list
102129976|NCT05674643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102129977|NCT05674643|Analgesics|analgesics|mesh-ancestor
102129978|NCT05674643|Sensory System Agents|sensory system agents|mesh-ancestor
102028545|NCT02388490|Immunotoxins|immunotoxins|mesh-ancestor
102129979|NCT05674643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102129980|NCT05674643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102129981|NCT05674643|Antipyretics|antipyretics|mesh-ancestor
102129982|NCT02149537|Hydroxyurea|hydroxyurea|mesh-list
102129983|NCT02149537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129984|NCT02149537|Antisickling Agents|antisickling agents|mesh-ancestor
102129985|NCT02149537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102129986|NCT02149537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129987|NCT02149537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102129988|NCT03179917|Pembrolizumab|pembrolizumab|mesh-list
102129989|NCT03179917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102129990|NCT03179917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129991|NCT03179917|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102129992|NCT03179917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102129993|NCT05216237|Oxaliplatin|oxaliplatin|mesh-list
102129994|NCT05216237|Apatinib|apatinib|mesh-list
102129995|NCT05216237|Tegafur|tegafur|mesh-list
102129996|NCT05216237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102129997|NCT05216237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102129998|NCT05216237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102129999|NCT05216237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130000|NCT05216237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102130001|NCT05216237|Antimetabolites|antimetabolites|mesh-ancestor
102130002|NCT00322257|Insulin|insulin|mesh-list
102130003|NCT00322257|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102130004|NCT00322257|Insulin Aspart|insulin aspart|mesh-list
102130005|NCT00322257|Insulin Detemir|insulin detemir|mesh-list
102130006|NCT00322257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102130007|NCT00322257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130008|NCT03674671|Ketamine|ketamine|mesh-list
102130009|NCT03674671|Analgesics|analgesics|mesh-ancestor
102130010|NCT03674671|Sensory System Agents|sensory system agents|mesh-ancestor
102130011|NCT03674671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102130012|NCT03674671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130013|NCT03674671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102130014|NCT03674671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102130015|NCT03674671|Anesthetics, General|anesthetics, general|mesh-ancestor
102130016|NCT03674671|Anesthetics|anesthetics|mesh-ancestor
102130017|NCT03674671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102130018|NCT03674671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102130019|NCT03674671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102130020|NCT03674671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102130021|NCT03674671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130022|NCT00312975|Tremelimumab|tremelimumab|mesh-list
102130023|NCT00312975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130024|NCT03199820|Dinoprostone|dinoprostone|mesh-list
102130025|NCT03199820|Oxytocics|oxytocics|mesh-ancestor
102130026|NCT03199820|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102130027|NCT03199820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130028|NCT03199430|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
102130029|NCT03199430|Antioxidants|antioxidants|mesh-ancestor
102130030|NCT03199430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130031|NCT03199430|Protective Agents|protective agents|mesh-ancestor
102130032|NCT03199430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130033|NCT03199430|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
102130034|NCT03199430|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102130035|NCT03199430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130036|NCT03199430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102130037|NCT02287857|Tenofovir|tenofovir|mesh-list
102130038|NCT02287857|Antiviral Agents|antiviral agents|mesh-ancestor
102130039|NCT02287857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102130040|NCT02287857|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102130041|NCT02287857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102130042|NCT02287857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102130043|NCT02287857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130044|NCT02287857|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102130045|NCT02287857|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102130046|NCT01318499|Nepafenac|nepafenac|mesh-list
102130047|NCT01318499|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102130048|NCT01318499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102130049|NCT01318499|Analgesics|analgesics|mesh-ancestor
102130050|NCT01318499|Sensory System Agents|sensory system agents|mesh-ancestor
102130051|NCT01318499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102130052|NCT01318499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130053|NCT01318499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102130054|NCT01318499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102130055|NCT00397293|Topotecan|topotecan|mesh-list
102130056|NCT00397293|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102130057|NCT00397293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102130058|NCT00397293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102130059|NCT00397293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130060|NCT00397293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130061|NCT03628079|Mebendazole|mebendazole|mesh-list
102130062|NCT03628079|Antinematodal Agents|antinematodal agents|mesh-ancestor
102130063|NCT03628079|Anthelmintics|anthelmintics|mesh-ancestor
102130064|NCT03628079|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102130065|NCT03628079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102130066|NCT03628079|Tubulin Modulators|tubulin modulators|mesh-ancestor
102130067|NCT03628079|Antimitotic Agents|antimitotic agents|mesh-ancestor
102130068|NCT03628079|Mitosis Modulators|mitosis modulators|mesh-ancestor
102130069|NCT03628079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130070|NCT03628079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130071|NCT03204734|Capecitabine|capecitabine|mesh-list
102130072|NCT03204734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102130073|NCT03204734|Antimetabolites|antimetabolites|mesh-ancestor
102130074|NCT03204734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130075|NCT03204734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130076|NCT00396357|Metformin|metformin|mesh-list
102130077|NCT00396357|Vildagliptin|vildagliptin|mesh-list
102130078|NCT00396357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101836475|NCT01063816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130079|NCT00396357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130080|NCT00396357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102130082|NCT00396357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102130083|NCT00396357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130084|NCT00394563|Tanezumab|tanezumab|mesh-list
102130085|NCT00394563|Analgesics|analgesics|mesh-ancestor
102130086|NCT00394563|Sensory System Agents|sensory system agents|mesh-ancestor
102130087|NCT00394563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102130088|NCT00394563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130089|NCT02449538|Everolimus|everolimus|mesh-list
102130090|NCT02449538|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102130091|NCT02449538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102130092|NCT02449538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102130093|NCT02449538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130094|NCT02449538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102130095|NCT02449538|Immunologic Factors|immunologic factors|mesh-ancestor
102130096|NCT02449538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130097|NCT02449538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130098|NCT02446652|Paclitaxel|paclitaxel|mesh-list
102130099|NCT02446652|Carboplatin|carboplatin|mesh-list
102130100|NCT02446652|Hydralazine|hydralazine|mesh-list
102130101|NCT02446652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102130102|NCT02446652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130103|NCT02446652|Tubulin Modulators|tubulin modulators|mesh-ancestor
102130104|NCT02446652|Antimitotic Agents|antimitotic agents|mesh-ancestor
102130105|NCT02446652|Mitosis Modulators|mitosis modulators|mesh-ancestor
102130106|NCT02446652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130107|NCT02446652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102130108|NCT02446652|Vasodilator Agents|vasodilator agents|mesh-ancestor
102130109|NCT00299715|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102130110|NCT00299715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102130111|NCT00299715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102130112|NCT00299715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102130113|NCT00299715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130115|NCT00299715|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102130116|NCT00299715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102130117|NCT00299715|Serotonin Agents|serotonin agents|mesh-ancestor
102130118|NCT00299715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102130119|NCT00299715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130120|NCT00299715|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102130121|NCT00299715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102130122|NCT00299715|Dopamine Agents|dopamine agents|mesh-ancestor
102130123|NCT00299325|Rimonabant|rimonabant|mesh-list
102130124|NCT00299325|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102130125|NCT00299325|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
102130126|NCT00299325|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102130127|NCT00299325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102130128|NCT00299325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130129|NCT00299325|Hormones|hormones|mesh-ancestor
102130130|NCT00299325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102130131|NCT00299325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130132|NCT00391209|Insulin|insulin|mesh-list
102130133|NCT00391209|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102130134|NCT00391209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102130135|NCT00391209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130136|NCT02446574|Paclitaxel|paclitaxel|mesh-list
102130137|NCT02446574|Cisplatin|cisplatin|mesh-list
102130138|NCT02446574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102130139|NCT02446574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130140|NCT02446574|Tubulin Modulators|tubulin modulators|mesh-ancestor
102130141|NCT02446574|Antimitotic Agents|antimitotic agents|mesh-ancestor
102130142|NCT02446574|Mitosis Modulators|mitosis modulators|mesh-ancestor
102130143|NCT02446574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130144|NCT01775813|Metformin|metformin|mesh-list
102130145|NCT01775813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102130146|NCT01775813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130147|NCT00287547|Abatacept|abatacept|mesh-list
102130148|NCT00287547|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102130149|NCT00287547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130150|NCT00287547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102130151|NCT00287547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130152|NCT00287547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102130153|NCT00287547|Immunologic Factors|immunologic factors|mesh-ancestor
101839198|NCT00408993|Analgesics|analgesics|mesh-ancestor
102130154|NCT00287547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130155|NCT00287547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102130157|NCT03204578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102130158|NCT03204578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102130159|NCT03204578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102130160|NCT03204578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130161|NCT03204578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102130162|NCT03204578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102130163|NCT03204578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102130164|NCT03204578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102130165|NCT03204578|Anesthetics, General|anesthetics, general|mesh-ancestor
102130166|NCT03204578|Anesthetics|anesthetics|mesh-ancestor
102130167|NCT03204578|GABA Modulators|gaba modulators|mesh-ancestor
102130168|NCT03204578|GABA Agents|gaba agents|mesh-ancestor
102130169|NCT03204578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102130170|NCT03204578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130171|NCT01694069|Tazobactam|tazobactam|mesh-list
102130172|NCT01694069|Piperacillin|piperacillin|mesh-list
102130173|NCT01694069|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102130174|NCT01694069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102130175|NCT01694069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102130176|NCT01694069|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102130177|NCT01694069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102130178|NCT01694069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130179|NCT03204032|Thalidomide|thalidomide|mesh-list
102130180|NCT03204032|Temozolomide|temozolomide|mesh-list
102130181|NCT03204032|Tegafur|tegafur|mesh-list
102130182|NCT03204032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102130183|NCT03204032|Alkylating Agents|alkylating agents|mesh-ancestor
102130184|NCT03204032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130185|NCT03204032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130186|NCT03204032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102130187|NCT03204032|Immunologic Factors|immunologic factors|mesh-ancestor
102130188|NCT03204032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130190|NCT03204032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102130191|NCT03204032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102130192|NCT03204032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102130193|NCT03204032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102130194|NCT03204032|Growth Substances|growth substances|mesh-ancestor
102130195|NCT03204032|Growth Inhibitors|growth inhibitors|mesh-ancestor
102130196|NCT03204032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102130197|NCT03204032|Antimetabolites|antimetabolites|mesh-ancestor
102130198|NCT02285751|Aspirin|aspirin|mesh-list
102130199|NCT02285751|Clopidogrel|clopidogrel|mesh-list
102130200|NCT02285751|Ticagrelor|ticagrelor|mesh-list
102130201|NCT02285751|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102130202|NCT02285751|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102130203|NCT02285751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102130204|NCT02285751|Analgesics|analgesics|mesh-ancestor
102130205|NCT02285751|Sensory System Agents|sensory system agents|mesh-ancestor
102130206|NCT02285751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102130207|NCT02285751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130208|NCT02285751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102130209|NCT02285751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102130210|NCT02285751|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102130211|NCT02285751|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102130212|NCT02285751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130213|NCT02285751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102130214|NCT02285751|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102130215|NCT02285751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102130216|NCT02285751|Antipyretics|antipyretics|mesh-ancestor
102130217|NCT02285751|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102130218|NCT02285751|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102130219|NCT02285751|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102130220|NCT02285751|Purinergic Agents|purinergic agents|mesh-ancestor
102130221|NCT02285751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102130222|NCT02446730|Clopidogrel|clopidogrel|mesh-list
102130223|NCT02446730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102130224|NCT02446730|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102130225|NCT02446730|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102130226|NCT02446730|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102130227|NCT02446730|Purinergic Agents|purinergic agents|mesh-ancestor
101839270|NCT00494780|Prednisone|prednisone|mesh-list
102130228|NCT02446730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102130229|NCT02446730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130230|NCT02446730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130231|NCT05114915|Docetaxel|docetaxel|mesh-list
102130232|NCT05114915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130233|NCT05114915|Tubulin Modulators|tubulin modulators|mesh-ancestor
102130234|NCT05114915|Antimitotic Agents|antimitotic agents|mesh-ancestor
102130235|NCT05114915|Mitosis Modulators|mitosis modulators|mesh-ancestor
102130236|NCT05114915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130237|NCT03532035|Brincidofovir|brincidofovir|mesh-list
102130238|NCT03532035|Antiviral Agents|antiviral agents|mesh-ancestor
102130239|NCT03532035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102130240|NCT00282867|Insulin|insulin|mesh-list
102130241|NCT00282867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102130242|NCT00282867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130243|NCT03198338|Bupivacaine|bupivacaine|mesh-list
102130244|NCT03198338|Anesthetics, Local|anesthetics, local|mesh-ancestor
102130245|NCT03198338|Anesthetics|anesthetics|mesh-ancestor
102130246|NCT03198338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102130247|NCT03198338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130248|NCT03198338|Sensory System Agents|sensory system agents|mesh-ancestor
102130249|NCT03198338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102130250|NCT05222633|Ranibizumab|ranibizumab|mesh-list
102130251|NCT05222633|Aflibercept|aflibercept|mesh-list
102130252|NCT05222633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102130253|NCT05222633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102130254|NCT05222633|Growth Substances|growth substances|mesh-ancestor
102130255|NCT05222633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130256|NCT05222633|Growth Inhibitors|growth inhibitors|mesh-ancestor
102130257|NCT05222633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130258|NCT05222243|Calcium|calcium|mesh-list
102130259|NCT05222243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102130260|NCT05222243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130261|NCT04469283|Caffeine|caffeine|mesh-list
102130262|NCT04469283|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102130263|NCT04469283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130264|NCT04469283|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102130266|NCT04469283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130267|NCT04469283|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102130268|NCT04469283|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102130269|NCT04469283|Purinergic Agents|purinergic agents|mesh-ancestor
102130270|NCT04469283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102130271|NCT02285829|Bromides|bromides|mesh-list
102130272|NCT02285829|Rocuronium|rocuronium|mesh-list
102130273|NCT02285829|Cisatracurium|cisatracurium|mesh-list
102130274|NCT02285829|Anticonvulsants|anticonvulsants|mesh-ancestor
102130275|NCT02285829|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102130276|NCT02285829|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102130277|NCT02285829|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102130278|NCT02285829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102130279|NCT02285829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130281|NCT03203408|Viscosupplements|viscosupplements|mesh-ancestor
102130282|NCT03203408|Protective Agents|protective agents|mesh-ancestor
102130283|NCT03203408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130284|NCT02285985|Saxagliptin|saxagliptin|mesh-list
102130285|NCT02285985|Incretins|incretins|mesh-ancestor
102130286|NCT02285985|Hormones|hormones|mesh-ancestor
102130287|NCT02285985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102130288|NCT02285985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130289|NCT02285985|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102130290|NCT02285985|Protease Inhibitors|protease inhibitors|mesh-ancestor
102130291|NCT02285985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102130292|NCT02285985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130293|NCT02285985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102130294|NCT02445872|Dexamethasone|dexamethasone|mesh-list
102130295|NCT02445872|Aprepitant|aprepitant|mesh-list
102130296|NCT02445872|Palonosetron|palonosetron|mesh-list
102130297|NCT02445872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102130298|NCT02445872|Antiemetics|antiemetics|mesh-ancestor
102130299|NCT02445872|Autonomic Agents|autonomic agents|mesh-ancestor
102130300|NCT02445872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101839342|NCT00946673|Vorinostat|vorinostat|mesh-list
102130301|NCT02445872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130302|NCT02445872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102130303|NCT02445872|Glucocorticoids|glucocorticoids|mesh-ancestor
102130304|NCT02445872|Hormones|hormones|mesh-ancestor
102130305|NCT02445872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102130306|NCT02445872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102130307|NCT02445872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130308|NCT02445872|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102130309|NCT02445872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102130310|NCT02445872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130311|NCT02445872|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102130312|NCT02445872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102130313|NCT02445872|Serotonin Agents|serotonin agents|mesh-ancestor
102130314|NCT05221775|Lenvatinib|lenvatinib|mesh-list
102130315|NCT05221775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130316|NCT05221775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102130317|NCT05221775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102130318|NCT05221775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130319|NCT04700423|Ivermectin|ivermectin|mesh-list
102130320|NCT04700423|Albendazole|albendazole|mesh-list
102130321|NCT04700423|Moxidectin|moxidectin|mesh-list
102130322|NCT04700423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102130323|NCT04700423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102130324|NCT04700423|Anthelmintics|anthelmintics|mesh-ancestor
102130325|NCT04700423|Anticestodal Agents|anticestodal agents|mesh-ancestor
102130326|NCT04700423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102130327|NCT04700423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102130328|NCT04700423|Tubulin Modulators|tubulin modulators|mesh-ancestor
102130329|NCT04700423|Antimitotic Agents|antimitotic agents|mesh-ancestor
102130330|NCT04700423|Mitosis Modulators|mitosis modulators|mesh-ancestor
102130331|NCT04700423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130332|NCT04700423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130333|NCT04700423|Antinematodal Agents|antinematodal agents|mesh-ancestor
102130334|NCT02286219|Immunoglobulins|immunoglobulins|mesh-list
102130335|NCT02286219|Immunoglobulin G|immunoglobulin g|mesh-list
102130336|NCT02286219|Immunologic Factors|immunologic factors|mesh-ancestor
102130337|NCT02286219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130338|NCT02445716|Methyltestosterone|methyltestosterone|mesh-list
102130339|NCT02445716|Testosterone|testosterone|mesh-list
102130340|NCT02445716|Testosterone undecanoate|testosterone undecanoate|mesh-list
102130341|NCT02445716|Testosterone enanthate|testosterone enanthate|mesh-list
102130342|NCT02445716|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102130343|NCT02445716|Androgens|androgens|mesh-ancestor
102130344|NCT02445716|Hormones|hormones|mesh-ancestor
102130345|NCT02445716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102130346|NCT02445716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130347|NCT02445716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102130348|NCT02445716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130349|NCT02445716|Anabolic Agents|anabolic agents|mesh-ancestor
102130350|NCT03197636|Pembrolizumab|pembrolizumab|mesh-list
102130351|NCT03197636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102130352|NCT03197636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130353|NCT03197636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102130354|NCT03197636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130355|NCT05724381|Phenol|phenol|mesh-list
102130356|NCT05724381|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102130357|NCT05724381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102130358|NCT05724381|Disinfectants|disinfectants|mesh-ancestor
102130359|NCT05724381|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102130360|NCT05724381|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102130361|NCT03194594|Dexamethasone|dexamethasone|mesh-list
102130362|NCT03194594|Ketamine|ketamine|mesh-list
102130363|NCT03194594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102130364|NCT03194594|Antiemetics|antiemetics|mesh-ancestor
102130365|NCT03194594|Autonomic Agents|autonomic agents|mesh-ancestor
102130366|NCT03194594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102130367|NCT03194594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130368|NCT03194594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102130369|NCT03194594|Glucocorticoids|glucocorticoids|mesh-ancestor
102130370|NCT03194594|Hormones|hormones|mesh-ancestor
102130371|NCT03194594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102130372|NCT03194594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102130373|NCT03194594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130374|NCT03194594|Analgesics|analgesics|mesh-ancestor
102130375|NCT03194594|Sensory System Agents|sensory system agents|mesh-ancestor
102130376|NCT03194594|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102130377|NCT03194594|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101839415|NCT00946907|Antipyretics|antipyretics|mesh-ancestor
102130378|NCT03194594|Anesthetics, General|anesthetics, general|mesh-ancestor
102130379|NCT03194594|Anesthetics|anesthetics|mesh-ancestor
102130380|NCT03194594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102130381|NCT03194594|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102130382|NCT03194594|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102130383|NCT03194594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102130384|NCT03194594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130385|NCT04407377|Cyclobenzaprine|cyclobenzaprine|mesh-list
102130386|NCT04407377|Tolperisone|tolperisone|mesh-list
102130387|NCT04407377|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102130388|NCT04407377|Antidepressive Agents|antidepressive agents|mesh-ancestor
102130389|NCT04407377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102130390|NCT04407377|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102130391|NCT04407377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130392|NCT04407377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102130393|NCT04407377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102130394|NCT04407377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102130395|NCT04407377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102130396|NCT03203174|Botulinum Toxins|botulinum toxins|mesh-list
102130397|NCT03203174|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102130398|NCT03203174|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102130399|NCT03203174|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102130400|NCT03203174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102130401|NCT03203174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130402|NCT03203174|Cholinergic Agents|cholinergic agents|mesh-ancestor
102130403|NCT03203174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102130404|NCT03203174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130405|NCT03203174|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102130406|NCT03203174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102130407|NCT00257205|Temozolomide|temozolomide|mesh-list
102130408|NCT00257205|Dacarbazine|dacarbazine|mesh-list
102130409|NCT00257205|Tremelimumab|tremelimumab|mesh-list
102130410|NCT00257205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102130411|NCT00257205|Alkylating Agents|alkylating agents|mesh-ancestor
102130412|NCT00257205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130413|NCT00257205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130414|NCT03194204|Doxycycline|doxycycline|mesh-list
102130415|NCT03194204|Uric Acid|uric acid|mesh-list
102130416|NCT03194204|Rheumatoid Factor|rheumatoid factor|mesh-list
102130417|NCT03194204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102130418|NCT03194204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102130419|NCT03194204|Antimalarials|antimalarials|mesh-ancestor
102130420|NCT03194204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102130421|NCT03194204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102130422|NCT03194204|Antioxidants|antioxidants|mesh-ancestor
102130423|NCT03194204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130424|NCT03194204|Protective Agents|protective agents|mesh-ancestor
102130425|NCT03194204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130426|NCT03194204|Immunologic Factors|immunologic factors|mesh-ancestor
102130427|NCT04045301|Omalizumab|omalizumab|mesh-list
102130428|NCT04045301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102130429|NCT04045301|Immunologic Factors|immunologic factors|mesh-ancestor
102130430|NCT04045301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130431|NCT04045301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102130432|NCT04045301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102130433|NCT04045301|Respiratory System Agents|respiratory system agents|mesh-ancestor
102130434|NCT03197480|Aflibercept|aflibercept|mesh-list
102130435|NCT03197480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102130436|NCT03197480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102130437|NCT03197480|Growth Substances|growth substances|mesh-ancestor
102130438|NCT03197480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130439|NCT03197480|Growth Inhibitors|growth inhibitors|mesh-ancestor
102130440|NCT03197480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130441|NCT00151281|Thalidomide|thalidomide|mesh-list
102130442|NCT00151281|Prednisone|prednisone|mesh-list
102130443|NCT00151281|Cyclophosphamide|cyclophosphamide|mesh-list
102130444|NCT00151281|Rituximab|rituximab|mesh-list
102130445|NCT00151281|Etoposide|etoposide|mesh-list
102130446|NCT00151281|Procarbazine|procarbazine|mesh-list
102130447|NCT00151281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102130448|NCT00151281|Immunologic Factors|immunologic factors|mesh-ancestor
102130449|NCT00151281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130450|NCT00151281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102130451|NCT00151281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102130452|NCT00151281|Alkylating Agents|alkylating agents|mesh-ancestor
102130453|NCT00151281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130454|NCT00151281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130455|NCT00151281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102130456|NCT00151281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102130457|NCT00151281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102130458|NCT00151281|Glucocorticoids|glucocorticoids|mesh-ancestor
102130459|NCT00151281|Hormones|hormones|mesh-ancestor
102130460|NCT00151281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102130461|NCT00151281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102029027|NCT03130959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130462|NCT00151281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102130463|NCT00151281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102130464|NCT00151281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102130465|NCT00151281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102130466|NCT00151281|Leprostatic Agents|leprostatic agents|mesh-ancestor
102130467|NCT00151281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102130468|NCT00151281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102130469|NCT00151281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102130470|NCT00151281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102130471|NCT00151281|Growth Substances|growth substances|mesh-ancestor
102130472|NCT00151281|Growth Inhibitors|growth inhibitors|mesh-ancestor
102130473|NCT03202862|Fulvestrant|fulvestrant|mesh-list
102130474|NCT03202862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102130475|NCT03202862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130476|NCT03202862|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102130477|NCT03202862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102130478|NCT03202862|Hormone Antagonists|hormone antagonists|mesh-ancestor
102130479|NCT03202862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102130480|NCT03202862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130481|NCT00255099|Etravirine|etravirine|mesh-list
102130482|NCT00255099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102130483|NCT00255099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102130484|NCT00255099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102130485|NCT00255099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130486|NCT00255099|Antiviral Agents|antiviral agents|mesh-ancestor
102130487|NCT00255099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102130488|NCT00231153|Povidone-Iodine|povidone-iodine|mesh-list
102130489|NCT00231153|Povidone|povidone|mesh-list
102130490|NCT00231153|Plasma Substitutes|plasma substitutes|mesh-ancestor
102130491|NCT00231153|Blood Substitutes|blood substitutes|mesh-ancestor
102130492|NCT00231153|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102130493|NCT00231153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102130494|NCT03202784|Berotralstat|berotralstat|mesh-list
102130495|NCT03202784|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102130496|NCT03202784|Protease Inhibitors|protease inhibitors|mesh-ancestor
102130497|NCT03202784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102130498|NCT03202784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130499|NCT05220527|Triamcinolone|triamcinolone|mesh-list
102130500|NCT05220527|Hyaluronic Acid|hyaluronic acid|mesh-list
102130501|NCT05220527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102130502|NCT05220527|Glucocorticoids|glucocorticoids|mesh-ancestor
102130503|NCT05220527|Hormones|hormones|mesh-ancestor
102130504|NCT05220527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102130505|NCT05220527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130506|NCT05220527|Immunologic Factors|immunologic factors|mesh-ancestor
102130507|NCT05220527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102130508|NCT05220527|Viscosupplements|viscosupplements|mesh-ancestor
102130509|NCT05220527|Protective Agents|protective agents|mesh-ancestor
102130510|NCT03197402|Caseins|caseins|mesh-list
102130511|NCT03197402|Chelating Agents|chelating agents|mesh-ancestor
102130512|NCT03197402|Sequestering Agents|sequestering agents|mesh-ancestor
102130513|NCT03197402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130514|NCT05723991|Gemcitabine|gemcitabine|mesh-list
102130515|NCT05723991|Disitamab vedotin|disitamab vedotin|mesh-list
102130516|NCT05723991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102130517|NCT05723991|Antimetabolites|antimetabolites|mesh-ancestor
102130518|NCT05723991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130519|NCT05723991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130520|NCT05723991|Immunoconjugates|immunoconjugates|mesh-ancestor
102130521|NCT05723991|Immunologic Factors|immunologic factors|mesh-ancestor
102130522|NCT05723991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130523|NCT01318109|Metformin|metformin|mesh-list
102130524|NCT01318109|Alogliptin|alogliptin|mesh-list
101839565|NCT00374907|Metformin|metformin|mesh-list
102130525|NCT01318109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102130526|NCT01318109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130527|NCT01318109|Incretins|incretins|mesh-ancestor
102130528|NCT01318109|Hormones|hormones|mesh-ancestor
102130529|NCT01318109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102130530|NCT01318109|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102130531|NCT01318109|Protease Inhibitors|protease inhibitors|mesh-ancestor
102130532|NCT01318109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102130533|NCT01318109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130534|NCT05720871|Capsaicin|capsaicin|mesh-list
102130535|NCT05720871|Antipruritics|antipruritics|mesh-ancestor
102130536|NCT05720871|Dermatologic Agents|dermatologic agents|mesh-ancestor
102130537|NCT05720871|Sensory System Agents|sensory system agents|mesh-ancestor
102130538|NCT05720871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102130539|NCT05720871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130540|NCT05672927|Vaccines|vaccines|mesh-list
102130541|NCT05672927|Immunologic Factors|immunologic factors|mesh-ancestor
102130542|NCT05672927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130543|NCT05636267|Carboplatin|carboplatin|mesh-list
102130544|NCT05636267|Pemetrexed|pemetrexed|mesh-list
102130545|NCT05636267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130546|NCT05636267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102130547|NCT05636267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130548|NCT05636267|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102130549|NCT05636267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102130550|NCT03873311|Cytarabine|cytarabine|mesh-list
102130551|NCT03873311|Azacitidine|azacitidine|mesh-list
102130552|NCT03873311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102130553|NCT03873311|Antimetabolites|antimetabolites|mesh-ancestor
102130554|NCT03873311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130555|NCT03873311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130556|NCT03873311|Antiviral Agents|antiviral agents|mesh-ancestor
102130557|NCT03873311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102130558|NCT03873311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102130559|NCT03873311|Immunologic Factors|immunologic factors|mesh-ancestor
102130560|NCT03873311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102612370|NCT02973581|Sensory System Agents|sensory system agents|mesh-ancestor
102130561|NCT03873311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102130563|NCT00162279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102130564|NCT00162279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130565|NCT00162279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102130566|NCT00162279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130567|NCT00162279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102130568|NCT00162279|Immunologic Factors|immunologic factors|mesh-ancestor
102130569|NCT00162279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130570|NCT00162279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102130571|NCT00145431|Atorvastatin|atorvastatin|mesh-list
102130572|NCT00145431|Torcetrapib|torcetrapib|mesh-list
102130573|NCT00145431|Fenofibrate|fenofibrate|mesh-list
102130574|NCT00145431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102130575|NCT00145431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102130576|NCT00145431|Antimetabolites|antimetabolites|mesh-ancestor
102130577|NCT00145431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130578|NCT00145431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102130579|NCT00145431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102130580|NCT00145431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102130581|NCT00135369|Lamivudine|lamivudine|mesh-list
102130582|NCT00135369|Efavirenz|efavirenz|mesh-list
102130583|NCT00135369|Stavudine|stavudine|mesh-list
102130584|NCT00135369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102130585|NCT00135369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102130586|NCT00135369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102130587|NCT00135369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130588|NCT00135369|Antiviral Agents|antiviral agents|mesh-ancestor
102130589|NCT00135369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102130590|NCT00135369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102130591|NCT00135369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102130592|NCT00135369|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102130593|NCT00135369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102130594|NCT00135369|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102130595|NCT00135369|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102130596|NCT00135369|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102130597|NCT00135369|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102130598|NCT00135369|Antimetabolites|antimetabolites|mesh-ancestor
102130599|NCT03530319|Azithromycin|azithromycin|mesh-list
102130600|NCT03530319|Doxycycline|doxycycline|mesh-list
102130601|NCT03530319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102130602|NCT03530319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102130603|NCT03530319|Antimalarials|antimalarials|mesh-ancestor
102130604|NCT03530319|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102130605|NCT03530319|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102130606|NCT05726253|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102130607|NCT05726253|Amoxicillin|amoxicillin|mesh-list
102130608|NCT05726253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102130609|NCT02445404|Dexamethasone|dexamethasone|mesh-list
102130610|NCT02445404|Prednisone|prednisone|mesh-list
102130611|NCT02445404|Cyclophosphamide|cyclophosphamide|mesh-list
102130612|NCT02445404|Ifosfamide|ifosfamide|mesh-list
102130613|NCT02445404|Carboplatin|carboplatin|mesh-list
102130614|NCT02445404|Etoposide|etoposide|mesh-list
102130615|NCT02445404|Vincristine|vincristine|mesh-list
102130616|NCT02445404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102130617|NCT02445404|Immunologic Factors|immunologic factors|mesh-ancestor
102130618|NCT02445404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130619|NCT02445404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102130620|NCT02445404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102130621|NCT02445404|Alkylating Agents|alkylating agents|mesh-ancestor
102130622|NCT02445404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130623|NCT02445404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130624|NCT02445404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102130625|NCT02445404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102130626|NCT02445404|Antiemetics|antiemetics|mesh-ancestor
102130627|NCT02445404|Autonomic Agents|autonomic agents|mesh-ancestor
102130628|NCT02445404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102130629|NCT02445404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102130630|NCT02445404|Glucocorticoids|glucocorticoids|mesh-ancestor
102130631|NCT02445404|Hormones|hormones|mesh-ancestor
102130632|NCT02445404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102130633|NCT02445404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102130634|NCT02445404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102130635|NCT02445404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102073306|NCT02099604|Antiviral Agents|antiviral agents|mesh-ancestor
102130636|NCT02445404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102130637|NCT02445404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102130638|NCT02445404|Tubulin Modulators|tubulin modulators|mesh-ancestor
102130639|NCT02445404|Antimitotic Agents|antimitotic agents|mesh-ancestor
102130640|NCT02445404|Mitosis Modulators|mitosis modulators|mesh-ancestor
102130641|NCT05726175|Disitamab vedotin|disitamab vedotin|mesh-list
102130642|NCT05726175|Immunoconjugates|immunoconjugates|mesh-ancestor
102130643|NCT05726175|Immunologic Factors|immunologic factors|mesh-ancestor
102130644|NCT05726175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130646|NCT03530085|Busulfan|busulfan|mesh-list
102130647|NCT03530085|Decitabine|decitabine|mesh-list
102130648|NCT03530085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130649|NCT03530085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102130650|NCT03530085|Antimetabolites|antimetabolites|mesh-ancestor
102130651|NCT03530085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130652|NCT03530085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102130653|NCT03530085|Immunologic Factors|immunologic factors|mesh-ancestor
102130654|NCT03530085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130655|NCT03530085|Alkylating Agents|alkylating agents|mesh-ancestor
102130656|NCT03530085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102130657|NCT03530085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102130658|NCT03530085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102130659|NCT03196934|Cannabidiol|cannabidiol|mesh-list
102130660|NCT03196934|Anticonvulsants|anticonvulsants|mesh-ancestor
102130661|NCT03197012|Octreotide|octreotide|mesh-list
102130662|NCT03197012|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
102130663|NCT03197012|Edotreotide|edotreotide|mesh-list
102130664|NCT03197012|Chelating Agents|chelating agents|mesh-ancestor
102130665|NCT03197012|Sequestering Agents|sequestering agents|mesh-ancestor
102130666|NCT03197012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130667|NCT03197012|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102130668|NCT03197012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102130669|NCT03197012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102130670|NCT03197012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130671|NCT03530007|Ondansetron|ondansetron|mesh-list
102130672|NCT03530007|Antiemetics|antiemetics|mesh-ancestor
102130673|NCT03530007|Autonomic Agents|autonomic agents|mesh-ancestor
102130674|NCT03530007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102130675|NCT03530007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130676|NCT03530007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102130677|NCT03530007|Antipruritics|antipruritics|mesh-ancestor
101839709|NCT00943943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102130678|NCT03530007|Dermatologic Agents|dermatologic agents|mesh-ancestor
102130679|NCT03530007|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102130680|NCT03530007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102130681|NCT03530007|Serotonin Agents|serotonin agents|mesh-ancestor
102130682|NCT03530007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102130683|NCT03530007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130684|NCT03529929|Methylprednisolone|methylprednisolone|mesh-list
102130685|NCT03529929|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102130686|NCT03529929|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102130687|NCT03529929|Prednisolone|prednisolone|mesh-list
102130688|NCT03529929|Prednisolone acetate|prednisolone acetate|mesh-list
102130689|NCT03529929|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102130690|NCT03529929|Prednisolone phosphate|prednisolone phosphate|mesh-list
102130691|NCT03529929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102130692|NCT03529929|Antiemetics|antiemetics|mesh-ancestor
102130693|NCT03529929|Autonomic Agents|autonomic agents|mesh-ancestor
102130694|NCT03529929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102130695|NCT03529929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130696|NCT03529929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102130697|NCT03529929|Glucocorticoids|glucocorticoids|mesh-ancestor
102130698|NCT03529929|Hormones|hormones|mesh-ancestor
102130699|NCT03529929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102130700|NCT03529929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102130701|NCT03529929|Protective Agents|protective agents|mesh-ancestor
102130702|NCT03529929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102130703|NCT03529929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130704|NCT03052751|Rozanolixizumab|rozanolixizumab|mesh-list
102130705|NCT03052751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102130706|NCT03052751|Immunologic Factors|immunologic factors|mesh-ancestor
102130707|NCT03052751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130708|NCT03525561|Acetazolamide|acetazolamide|mesh-list
102130709|NCT03525561|Anticonvulsants|anticonvulsants|mesh-ancestor
102130710|NCT03525561|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102130711|NCT03525561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102130712|NCT03525561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130713|NCT03525561|Diuretics|diuretics|mesh-ancestor
102130714|NCT03525561|Natriuretic Agents|natriuretic agents|mesh-ancestor
102130715|NCT03525561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130716|NCT05696691|Ketamine|ketamine|mesh-list
102130717|NCT05696691|Analgesics|analgesics|mesh-ancestor
102130718|NCT05696691|Sensory System Agents|sensory system agents|mesh-ancestor
102130719|NCT05696691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102130720|NCT05696691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130721|NCT05696691|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102130722|NCT05696691|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102130723|NCT05696691|Anesthetics, General|anesthetics, general|mesh-ancestor
102130724|NCT05696691|Anesthetics|anesthetics|mesh-ancestor
102130725|NCT05696691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102130726|NCT05696691|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102130727|NCT05696691|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102130728|NCT05696691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102130729|NCT05696691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130730|NCT03527355|Vaccines|vaccines|mesh-list
102130731|NCT03527355|Immunologic Factors|immunologic factors|mesh-ancestor
102130732|NCT03527355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130733|NCT05707169|Lidocaine|lidocaine|mesh-list
102130734|NCT05707169|Epinephrine|epinephrine|mesh-list
102130735|NCT05707169|Racepinephrine|racepinephrine|mesh-list
102130736|NCT05707169|Levobupivacaine|levobupivacaine|mesh-list
102130737|NCT05707169|Epinephryl borate|epinephryl borate|mesh-list
102130738|NCT05707169|Anesthetics, Local|anesthetics, local|mesh-ancestor
102130739|NCT05707169|Anesthetics|anesthetics|mesh-ancestor
102130740|NCT05707169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102130741|NCT05707169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130742|NCT05707169|Sensory System Agents|sensory system agents|mesh-ancestor
102130743|NCT05707169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102130744|NCT05707169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102130745|NCT05707169|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102130746|NCT05707169|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102130747|NCT05707169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102130748|NCT05707169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130749|NCT05707169|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102130750|NCT05707169|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102130751|NCT05707169|Adrenergic Agents|adrenergic agents|mesh-ancestor
102130752|NCT05707169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102130753|NCT05707169|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102130754|NCT05707169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102130755|NCT05707169|Autonomic Agents|autonomic agents|mesh-ancestor
102130756|NCT05707169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102130757|NCT05707169|Respiratory System Agents|respiratory system agents|mesh-ancestor
102130758|NCT05707169|Mydriatics|mydriatics|mesh-ancestor
102130759|NCT05707169|Sympathomimetics|sympathomimetics|mesh-ancestor
102130760|NCT05707169|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102130761|NCT05052827|Caseins|caseins|mesh-list
102130762|NCT05052827|Chelating Agents|chelating agents|mesh-ancestor
102130763|NCT05052827|Sequestering Agents|sequestering agents|mesh-ancestor
102130764|NCT05052827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130765|NCT02712008|Aflibercept|aflibercept|mesh-list
102130766|NCT02712008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102130767|NCT02712008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102130768|NCT02712008|Growth Substances|growth substances|mesh-ancestor
102130769|NCT02712008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130770|NCT02712008|Growth Inhibitors|growth inhibitors|mesh-ancestor
102130771|NCT02712008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130772|NCT05130515|Niraparib|niraparib|mesh-list
102130773|NCT05130515|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102130774|NCT05130515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102130775|NCT05130515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130776|NCT05130515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130777|NCT03193814|Apatinib|apatinib|mesh-list
102130778|NCT03193814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130779|NCT03193814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102130780|NCT03193814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102130781|NCT03193814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130782|NCT02450084|Fentanyl|fentanyl|mesh-list
102130783|NCT02450084|Ropivacaine|ropivacaine|mesh-list
102130784|NCT02450084|Anesthetics, Local|anesthetics, local|mesh-ancestor
102535889|NCT00554099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102130785|NCT02450084|Anesthetics|anesthetics|mesh-ancestor
102130786|NCT02450084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102130787|NCT02450084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130788|NCT02450084|Sensory System Agents|sensory system agents|mesh-ancestor
102130789|NCT02450084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102130790|NCT02450084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102130791|NCT02450084|Narcotics|narcotics|mesh-ancestor
102130792|NCT02450084|Analgesics|analgesics|mesh-ancestor
102130793|NCT02450084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102130794|NCT02450084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102130795|NCT02450084|Anesthetics, General|anesthetics, general|mesh-ancestor
102130796|NCT03201770|Artesunate|artesunate|mesh-list
102130797|NCT03201770|Pyronaridine|pyronaridine|mesh-list
102130798|NCT03201770|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
102130799|NCT03201770|Antimalarials|antimalarials|mesh-ancestor
102130800|NCT03201770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102130801|NCT03201770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102130802|NCT03201770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102130803|NCT03201770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130804|NCT03201770|Antiviral Agents|antiviral agents|mesh-ancestor
102130805|NCT03201770|Schistosomicides|schistosomicides|mesh-ancestor
102130806|NCT03201770|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102130807|NCT03201770|Anthelmintics|anthelmintics|mesh-ancestor
102130808|NCT04213209|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102130809|NCT04213209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102130810|NCT04213209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130811|NCT04213209|Immunotoxins|immunotoxins|mesh-ancestor
102130812|NCT04213209|Immunoconjugates|immunoconjugates|mesh-ancestor
102130813|NCT04213209|Immunologic Factors|immunologic factors|mesh-ancestor
102130814|NCT04213209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130815|NCT04188405|Decitabine|decitabine|mesh-list
102130816|NCT04188405|Venetoclax|venetoclax|mesh-list
102130817|NCT04188405|Ponatinib|ponatinib|mesh-list
102130818|NCT04188405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102130819|NCT04188405|Antimetabolites|antimetabolites|mesh-ancestor
102130820|NCT04188405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130821|NCT04188405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130822|NCT04188405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102130823|NCT04188405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102130824|NCT04176393|Ivosidenib|ivosidenib|mesh-list
102130825|NCT04176393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130826|NCT04176393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102130827|NCT04176393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130828|NCT02449070|Nicorandil|nicorandil|mesh-list
102130829|NCT02449070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102130830|NCT02449070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102130831|NCT02449070|Vasodilator Agents|vasodilator agents|mesh-ancestor
102130832|NCT02449070|Vitamin B Complex|vitamin b complex|mesh-ancestor
102130834|NCT02449070|Micronutrients|micronutrients|mesh-ancestor
102130835|NCT02449070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130836|NCT03529149|Diltiazem|diltiazem|mesh-list
102130837|NCT03529149|Urapidil|urapidil|mesh-list
102130838|NCT03529149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102130839|NCT03529149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102130840|NCT03529149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102130841|NCT03529149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130842|NCT03529149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102130843|NCT03529149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130844|NCT03529149|Vasodilator Agents|vasodilator agents|mesh-ancestor
102130845|NCT03529149|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102130846|NCT03529149|Serotonin Agents|serotonin agents|mesh-ancestor
102130847|NCT03529149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102130848|NCT03529149|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102130849|NCT03529149|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102130850|NCT03529149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102130851|NCT03529149|Adrenergic Agents|adrenergic agents|mesh-ancestor
102130852|NCT03193502|Rivaroxaban|rivaroxaban|mesh-list
102130853|NCT03193502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102130854|NCT03193502|Antithrombins|antithrombins|mesh-ancestor
102130855|NCT03193502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102130856|NCT03193502|Protease Inhibitors|protease inhibitors|mesh-ancestor
102130857|NCT03193502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102130858|NCT03193502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130859|NCT03193502|Anticoagulants|anticoagulants|mesh-ancestor
102130860|NCT02711306|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
102130861|NCT02711306|Cathartics|cathartics|mesh-ancestor
102130862|NCT02711306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102130864|NCT03193112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102130865|NCT03193112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102130866|NCT03193112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130867|NCT03196154|Insulin|insulin|mesh-list
102130868|NCT03196154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102130869|NCT03196154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130870|NCT03193424|Docetaxel|docetaxel|mesh-list
102130871|NCT03193424|Apatinib|apatinib|mesh-list
102130872|NCT03193424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130873|NCT03193424|Tubulin Modulators|tubulin modulators|mesh-ancestor
102130874|NCT03193424|Antimitotic Agents|antimitotic agents|mesh-ancestor
102130875|NCT03193424|Mitosis Modulators|mitosis modulators|mesh-ancestor
102130876|NCT03193424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130877|NCT03193424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102130878|NCT03193424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102130879|NCT03193346|Botulinum Toxins|botulinum toxins|mesh-list
102130880|NCT03193346|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102130881|NCT03193346|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102130882|NCT03193346|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102130883|NCT03193346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102130884|NCT03193346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130885|NCT03193346|Cholinergic Agents|cholinergic agents|mesh-ancestor
102130886|NCT03193346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102130887|NCT03193346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130888|NCT03193346|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102130889|NCT03193346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102130890|NCT03118076|Dexmedetomidine|dexmedetomidine|mesh-list
102130891|NCT03118076|Ropivacaine|ropivacaine|mesh-list
102130892|NCT03118076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102130893|NCT03118076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102130894|NCT03118076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130895|NCT03118076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102130896|NCT03118076|Analgesics|analgesics|mesh-ancestor
102130897|NCT03118076|Sensory System Agents|sensory system agents|mesh-ancestor
102130898|NCT03118076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102130899|NCT03118076|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102130900|NCT03118076|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102130901|NCT03118076|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102130902|NCT03118076|Adrenergic Agents|adrenergic agents|mesh-ancestor
102130903|NCT03118076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102130904|NCT03118076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130905|NCT03118076|Anesthetics, Local|anesthetics, local|mesh-ancestor
102130906|NCT03118076|Anesthetics|anesthetics|mesh-ancestor
102130907|NCT03528915|Rifamycins|rifamycins|mesh-list
102130909|NCT03528915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102130910|NCT03528915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102130911|NCT03528915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102130912|NCT03192878|Infliximab|infliximab|mesh-list
102130913|NCT03192878|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102130914|NCT03192878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102130915|NCT03192878|Dermatologic Agents|dermatologic agents|mesh-ancestor
102130916|NCT03192878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102130917|NCT03192878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102130918|NCT00294320|Imiquimod|imiquimod|mesh-list
102130919|NCT00294320|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102130920|NCT00294320|Immunologic Factors|immunologic factors|mesh-ancestor
102130921|NCT00294320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130922|NCT00294320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130923|NCT00294320|Interferon Inducers|interferon inducers|mesh-ancestor
102130924|NCT03526575|Zaleplon|zaleplon|mesh-list
102130925|NCT03526575|Zolpidem|zolpidem|mesh-list
102130926|NCT03526575|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102130927|NCT03526575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102130928|NCT03526575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102130929|NCT03526575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130930|NCT03526575|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102130931|NCT03526575|GABA Agonists|gaba agonists|mesh-ancestor
102130932|NCT03526575|GABA Agents|gaba agents|mesh-ancestor
102130933|NCT03526575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102130934|NCT03526575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130935|NCT03526575|Anticonvulsants|anticonvulsants|mesh-ancestor
102130936|NCT03526575|GABA Modulators|gaba modulators|mesh-ancestor
102130937|NCT00189254|Imiquimod|imiquimod|mesh-list
102130938|NCT00189254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102130939|NCT00189254|Immunologic Factors|immunologic factors|mesh-ancestor
102130940|NCT00189254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130941|NCT00189254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130942|NCT00189254|Interferon Inducers|interferon inducers|mesh-ancestor
102130943|NCT03526419|Bupivacaine|bupivacaine|mesh-list
102130944|NCT03526419|Anesthetics, Local|anesthetics, local|mesh-ancestor
102130945|NCT03526419|Anesthetics|anesthetics|mesh-ancestor
102130946|NCT03526419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102130947|NCT03526419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130948|NCT03526419|Sensory System Agents|sensory system agents|mesh-ancestor
102130949|NCT03526419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102130950|NCT03192644|Leucovorin|leucovorin|mesh-list
102130951|NCT03192644|Oxaliplatin|oxaliplatin|mesh-list
102130952|NCT03192644|Ethiodized Oil|ethiodized oil|mesh-list
102130953|NCT03192644|Epirubicin|epirubicin|mesh-list
102130954|NCT03192644|Calcium|calcium|mesh-list
102130955|NCT03192644|Levoleucovorin|levoleucovorin|mesh-list
102130956|NCT03192644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102130957|NCT03192644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102130958|NCT03192644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130959|NCT03192644|Antidotes|antidotes|mesh-ancestor
102130960|NCT03192644|Protective Agents|protective agents|mesh-ancestor
102130961|NCT03192644|Vitamin B Complex|vitamin b complex|mesh-ancestor
102130962|NCT03192644|Vitamins|vitamins|mesh-ancestor
102130963|NCT03192644|Micronutrients|micronutrients|mesh-ancestor
102130964|NCT03192644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102130965|NCT03192644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102130966|NCT03192644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102130967|NCT03192644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102130968|NCT03192644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130969|NCT03110055|Grazoprevir|grazoprevir|mesh-list
102130970|NCT03110055|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
102130971|NCT03110055|Antiviral Agents|antiviral agents|mesh-ancestor
102130972|NCT03110055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102130973|NCT01190852|Fluticasone|fluticasone|mesh-list
102130974|NCT01190852|Azelastine|azelastine|mesh-list
102130975|NCT01190852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102130976|NCT01190852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102130977|NCT01190852|Autonomic Agents|autonomic agents|mesh-ancestor
102130978|NCT01190852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102130979|NCT01190852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130980|NCT01190852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102130981|NCT01190852|Respiratory System Agents|respiratory system agents|mesh-ancestor
102130982|NCT01190852|Dermatologic Agents|dermatologic agents|mesh-ancestor
102130983|NCT01190852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102130984|NCT01190852|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
102130985|NCT01190852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102130986|NCT01190852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102130987|NCT01190852|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102130988|NCT01190852|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102130989|NCT01190852|Histamine Antagonists|histamine antagonists|mesh-ancestor
102130990|NCT01190852|Histamine Agents|histamine agents|mesh-ancestor
102130991|NCT01190852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102130992|NCT02710214|Estrogens|estrogens|mesh-list
102130993|NCT02710214|Hormones|hormones|mesh-ancestor
102130994|NCT02710214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102130995|NCT02710214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102130996|NCT03782415|Temozolomide|temozolomide|mesh-list
102130997|NCT03782415|Ibudilast|ibudilast|mesh-list
102130998|NCT03782415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102130999|NCT03782415|Alkylating Agents|alkylating agents|mesh-ancestor
102131000|NCT03782415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131001|NCT03782415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102131002|NCT03782415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102131003|NCT03782415|Autonomic Agents|autonomic agents|mesh-ancestor
102131004|NCT03782415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102131005|NCT03782415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131006|NCT03782415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102131007|NCT03782415|Respiratory System Agents|respiratory system agents|mesh-ancestor
102131008|NCT03782415|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102131009|NCT03782415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102131010|NCT03782415|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102131011|NCT03782415|Vasodilator Agents|vasodilator agents|mesh-ancestor
102131012|NCT05561205|Methylphenidate|methylphenidate|mesh-list
102131013|NCT05561205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102131014|NCT05561205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131015|NCT05561205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102131016|NCT05561205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102131017|NCT05561205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102131018|NCT05561205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131019|NCT05561205|Dopamine Agents|dopamine agents|mesh-ancestor
102131020|NCT05561205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102131021|NCT03052517|Indoleacetic Acids|indoleacetic acids|mesh-list
102131022|NCT03052517|Plant Growth Regulators|plant growth regulators|mesh-ancestor
102131023|NCT03052517|Growth Substances|growth substances|mesh-ancestor
102131024|NCT03052517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131025|NCT02443844|Tamsulosin|tamsulosin|mesh-list
102131026|NCT02443844|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102131027|NCT02443844|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102131028|NCT02443844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102131029|NCT02443844|Adrenergic Agents|adrenergic agents|mesh-ancestor
102131030|NCT02443844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102131031|NCT02443844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131032|NCT02443844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131033|NCT02443844|Urological Agents|urological agents|mesh-ancestor
102131034|NCT02440100|Midazolam|midazolam|mesh-list
102131035|NCT02440100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102131036|NCT02440100|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102131037|NCT02440100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102131038|NCT02440100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131039|NCT02440100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102131040|NCT02440100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102131041|NCT02440100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102131042|NCT02440100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102131043|NCT02440100|Anesthetics, General|anesthetics, general|mesh-ancestor
102131044|NCT02440100|Anesthetics|anesthetics|mesh-ancestor
102131045|NCT02440100|GABA Modulators|gaba modulators|mesh-ancestor
102131046|NCT02440100|GABA Agents|gaba agents|mesh-ancestor
102131047|NCT02440100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102131048|NCT02440100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131049|NCT03524313|Carbon Monoxide|carbon monoxide|mesh-list
102131050|NCT03524313|Antimetabolites|antimetabolites|mesh-ancestor
102131051|NCT03524313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131052|NCT03524313|Gasotransmitters|gasotransmitters|mesh-ancestor
102131053|NCT03524313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102131054|NCT03524313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131055|NCT02439944|Nicotine|nicotine|mesh-list
102131056|NCT02439944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102131057|NCT02439944|Autonomic Agents|autonomic agents|mesh-ancestor
102131058|NCT02439944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102131059|NCT02439944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131060|NCT02439944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102131061|NCT02439944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102131062|NCT02439944|Cholinergic Agents|cholinergic agents|mesh-ancestor
102131063|NCT02439944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102131064|NCT02439944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131065|NCT03133065|Antiviral Agents|antiviral agents|mesh-list
102131066|NCT03133065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102131067|NCT03190616|Apatinib|apatinib|mesh-list
102131068|NCT03190616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102131069|NCT03190616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102131070|NCT03190616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102131071|NCT03190616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131072|NCT02443922|Metformin|metformin|mesh-list
102131073|NCT02443922|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102131074|NCT02443922|Glimepiride|glimepiride|mesh-list
102131075|NCT02443922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102131076|NCT02443922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131077|NCT02443922|Incretins|incretins|mesh-ancestor
102131078|NCT02443922|Hormones|hormones|mesh-ancestor
102131079|NCT02443922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102131080|NCT02443922|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102131081|NCT02443922|Protease Inhibitors|protease inhibitors|mesh-ancestor
102131082|NCT02443922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102131083|NCT02443922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131084|NCT02443922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102131085|NCT02443922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102131086|NCT02443922|Immunologic Factors|immunologic factors|mesh-ancestor
102131087|NCT04799847|Catumaxomab|catumaxomab|mesh-list
102131088|NCT04799847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102131089|NCT02439866|Methylprednisolone|methylprednisolone|mesh-list
102131090|NCT02439866|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102131091|NCT02439866|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102131092|NCT02439866|Prednisolone|prednisolone|mesh-list
102131093|NCT02439866|Prednisolone acetate|prednisolone acetate|mesh-list
102131094|NCT02439866|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102131095|NCT02439866|Prednisolone phosphate|prednisolone phosphate|mesh-list
102131096|NCT02439866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102131097|NCT02439866|Antiemetics|antiemetics|mesh-ancestor
102131098|NCT02439866|Autonomic Agents|autonomic agents|mesh-ancestor
102131099|NCT02439866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102131100|NCT02439866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131101|NCT02439866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102131102|NCT02439866|Glucocorticoids|glucocorticoids|mesh-ancestor
102131103|NCT02439866|Hormones|hormones|mesh-ancestor
102131104|NCT02439866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102131105|NCT02439866|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102131106|NCT02439866|Protective Agents|protective agents|mesh-ancestor
102131107|NCT02439866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102131108|NCT02439866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102131109|NCT02439788|Cyclophosphamide|cyclophosphamide|mesh-list
102131110|NCT02439788|Fludarabine|fludarabine|mesh-list
102131111|NCT02439788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102131112|NCT02439788|Immunologic Factors|immunologic factors|mesh-ancestor
102131113|NCT02439788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131114|NCT02439788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102131115|NCT02439788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102131116|NCT02439788|Alkylating Agents|alkylating agents|mesh-ancestor
102131117|NCT02439788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131118|NCT02439788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102131119|NCT02439788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102131120|NCT03188510|Mirikizumab|mirikizumab|mesh-list
102131121|NCT03188510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102131122|NCT03188510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102131123|NCT03188510|Analgesics|analgesics|mesh-ancestor
102131124|NCT03188510|Sensory System Agents|sensory system agents|mesh-ancestor
102131125|NCT03188510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102131126|NCT03188510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131127|NCT03188510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102131128|NCT03188510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102131129|NCT03188510|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102131130|NCT03188510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102131131|NCT03188198|Prednisone|prednisone|mesh-list
102131132|NCT03188198|Cyclophosphamide|cyclophosphamide|mesh-list
102131133|NCT03188198|Rituximab|rituximab|mesh-list
102131134|NCT03188198|Doxorubicin|doxorubicin|mesh-list
102131135|NCT03188198|Etoposide|etoposide|mesh-list
102131136|NCT03188198|Etoposide phosphate|etoposide phosphate|mesh-list
102131137|NCT03188198|Vincristine|vincristine|mesh-list
102131138|NCT03188198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102131139|NCT03188198|Immunologic Factors|immunologic factors|mesh-ancestor
102131140|NCT03188198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131141|NCT03188198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102131142|NCT03188198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102131143|NCT03188198|Alkylating Agents|alkylating agents|mesh-ancestor
102131144|NCT03188198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131145|NCT03188198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102131146|NCT03188198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102131147|NCT03188198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102131148|NCT03188198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102131149|NCT03188198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102131150|NCT03188198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102131151|NCT03188198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102131152|NCT03188198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102131153|NCT03188198|Glucocorticoids|glucocorticoids|mesh-ancestor
102131154|NCT03188198|Hormones|hormones|mesh-ancestor
102131155|NCT03188198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102131156|NCT03188198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102131157|NCT03188198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102131158|NCT03188198|Tubulin Modulators|tubulin modulators|mesh-ancestor
102131159|NCT03188198|Antimitotic Agents|antimitotic agents|mesh-ancestor
102131160|NCT03188198|Mitosis Modulators|mitosis modulators|mesh-ancestor
102131161|NCT03188276|Sofosbuvir|sofosbuvir|mesh-list
102131162|NCT03188276|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102131163|NCT03188276|Ledipasvir|ledipasvir|mesh-list
102131164|NCT03188276|Antiviral Agents|antiviral agents|mesh-ancestor
102131165|NCT03188276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102535890|NCT00554099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102131167|NCT03190304|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102131168|NCT03190304|Enzyme Inhibitors|enzyme inhibitors|mesh-list
102131169|NCT03190304|Protease Inhibitors|protease inhibitors|mesh-ancestor
102131170|NCT03190304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131171|NCT03190304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102131172|NCT02439632|Levofloxacin|levofloxacin|mesh-list
102131173|NCT02439632|Ofloxacin|ofloxacin|mesh-list
102131174|NCT02439632|Prulifloxacin|prulifloxacin|mesh-list
102131175|NCT02439632|Fluoroquinolones|fluoroquinolones|mesh-list
102131176|NCT02439632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102131177|NCT02439632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102131178|NCT02439632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102131179|NCT02439632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102131180|NCT02439632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102131181|NCT02439632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102131182|NCT02439632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131183|NCT02439632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102131184|NCT02439632|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102131185|NCT02439632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102131186|NCT02439632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102131187|NCT02443064|Vancomycin|vancomycin|mesh-list
102131188|NCT02443064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102131189|NCT02443064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102131190|NCT02741271|Mometasone Furoate|mometasone furoate|mesh-list
102131191|NCT02741271|Prednisone|prednisone|mesh-list
102131192|NCT02741271|Prednisolone|prednisolone|mesh-list
102131193|NCT02741271|Albuterol|albuterol|mesh-list
102131194|NCT02741271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102131195|NCT02741271|Glucocorticoids|glucocorticoids|mesh-ancestor
102131196|NCT02741271|Hormones|hormones|mesh-ancestor
102131197|NCT02741271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102131198|NCT02741271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131199|NCT02741271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102131200|NCT02741271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102131201|NCT02741271|Autonomic Agents|autonomic agents|mesh-ancestor
102131202|NCT02741271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102131203|NCT02741271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102131204|NCT02741271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102131205|NCT02741271|Respiratory System Agents|respiratory system agents|mesh-ancestor
102131206|NCT02741271|Tocolytic Agents|tocolytic agents|mesh-ancestor
102131207|NCT02741271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102131208|NCT02741271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102131209|NCT02741271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102131210|NCT02741271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102131211|NCT02741271|Adrenergic Agents|adrenergic agents|mesh-ancestor
102131212|NCT02741271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102131213|NCT02741271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131214|NCT02741271|Dermatologic Agents|dermatologic agents|mesh-ancestor
102131215|NCT02741271|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102131216|NCT02443142|Acetaminophen|acetaminophen|mesh-list
102131218|NCT02443142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102131219|NCT02443142|Analgesics|analgesics|mesh-ancestor
102131220|NCT02443142|Sensory System Agents|sensory system agents|mesh-ancestor
102131221|NCT02443142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102131222|NCT02443142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131223|NCT02443142|Antipyretics|antipyretics|mesh-ancestor
102131224|NCT02443142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102131225|NCT02443142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102131226|NCT02443142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102131227|NCT02443142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102131228|NCT02443142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102131229|NCT02443142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131230|NCT03524079|Ajmaline|ajmaline|mesh-list
102131231|NCT03524079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102131232|NCT03524079|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102131233|NCT03524079|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102131234|NCT03524079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102131235|NCT03524079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131236|NCT02438852|Ropivacaine|ropivacaine|mesh-list
102131237|NCT02438852|Anesthetics, Local|anesthetics, local|mesh-ancestor
102131238|NCT02438852|Anesthetics|anesthetics|mesh-ancestor
102131239|NCT02438852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102131240|NCT02438852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131241|NCT02438852|Sensory System Agents|sensory system agents|mesh-ancestor
102131242|NCT02438852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102131243|NCT02442674|Tolvaptan|tolvaptan|mesh-list
102131244|NCT02442674|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102131245|NCT02442674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131246|NCT02442674|Natriuretic Agents|natriuretic agents|mesh-ancestor
102131247|NCT02442674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131248|NCT02442752|Dexlansoprazole|dexlansoprazole|mesh-list
102131249|NCT02442752|Lansoprazole|lansoprazole|mesh-list
102131250|NCT02442752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102131251|NCT02442752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102131252|NCT02442752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102131253|NCT02442752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102131254|NCT02442752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131255|NCT02442362|Paclitaxel|paclitaxel|mesh-list
102131256|NCT02442362|Fluorouracil|fluorouracil|mesh-list
102131257|NCT02442362|Oxaliplatin|oxaliplatin|mesh-list
102131258|NCT02442362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102131259|NCT02442362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102131260|NCT02442362|Tubulin Modulators|tubulin modulators|mesh-ancestor
102131261|NCT02442362|Antimitotic Agents|antimitotic agents|mesh-ancestor
102131262|NCT02442362|Mitosis Modulators|mitosis modulators|mesh-ancestor
102131263|NCT02442362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131264|NCT02442362|Antimetabolites|antimetabolites|mesh-ancestor
102131265|NCT02442362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102131266|NCT02442362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102131267|NCT02442362|Immunologic Factors|immunologic factors|mesh-ancestor
102131268|NCT02442362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131269|NCT04440488|Protease Inhibitors|protease inhibitors|mesh-list
102131270|NCT04440488|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
102131271|NCT04440488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102131272|NCT04440488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131273|NCT04440488|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102131274|NCT04440488|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102131275|NCT02433860|Nicotine|nicotine|mesh-list
102131276|NCT02433860|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102131277|NCT02433860|Autonomic Agents|autonomic agents|mesh-ancestor
102131278|NCT02433860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102131279|NCT02433860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131280|NCT02433860|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102131281|NCT02433860|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102131282|NCT02433860|Cholinergic Agents|cholinergic agents|mesh-ancestor
102131283|NCT02433860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102131284|NCT02433860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131285|NCT03189914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102131286|NCT03189914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102131287|NCT03523455|Iron protein succinylate|iron protein succinylate|mesh-list
102131288|NCT03523455|Hematinics|hematinics|mesh-ancestor
102131289|NCT03189836|Rituximab|rituximab|mesh-list
102131290|NCT03189836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102131291|NCT03189836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102131292|NCT03189836|Immunologic Factors|immunologic factors|mesh-ancestor
102131293|NCT03189836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131294|NCT03189836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102131295|NCT04466943|Rocuronium|rocuronium|mesh-list
102131296|NCT04466943|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102131297|NCT04466943|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102131298|NCT04466943|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102131299|NCT04466943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102131300|NCT04466943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131301|NCT03212469|Durvalumab|durvalumab|mesh-list
102131302|NCT03212469|Tremelimumab|tremelimumab|mesh-list
102131303|NCT03212469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102131304|NCT03212469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102131305|NCT02442440|Anisodamine|anisodamine|mesh-list
102131306|NCT02442440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102131307|NCT02442440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102131308|NCT02442440|Adrenergic Agents|adrenergic agents|mesh-ancestor
102131309|NCT02442440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102131310|NCT02442440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131311|NCT02442440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131312|NCT02442440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102131313|NCT02442440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102131314|NCT02442440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102131315|NCT02442440|Analgesics|analgesics|mesh-ancestor
102131316|NCT02442440|Sensory System Agents|sensory system agents|mesh-ancestor
102131317|NCT02442440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102131318|NCT02442440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102131319|NCT02442440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102131320|NCT02442440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102131321|NCT02442440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102131322|NCT02442440|Parasympatholytics|parasympatholytics|mesh-ancestor
102131323|NCT02442440|Autonomic Agents|autonomic agents|mesh-ancestor
102131324|NCT02442440|Vasodilator Agents|vasodilator agents|mesh-ancestor
102131325|NCT02442440|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102131326|NCT02442440|Antioxidants|antioxidants|mesh-ancestor
102131327|NCT02442440|Protective Agents|protective agents|mesh-ancestor
102131328|NCT03187496|Midazolam|midazolam|mesh-list
102131329|NCT03187496|Caffeine|caffeine|mesh-list
102131330|NCT03187496|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102131331|NCT03187496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102131332|NCT03187496|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102131333|NCT03187496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102131334|NCT03187496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131335|NCT03187496|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102131336|NCT03187496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102131337|NCT03187496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102131338|NCT03187496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102131339|NCT03187496|Anesthetics, General|anesthetics, general|mesh-ancestor
102131340|NCT03187496|Anesthetics|anesthetics|mesh-ancestor
102131341|NCT03187496|GABA Modulators|gaba modulators|mesh-ancestor
102131342|NCT03187496|GABA Agents|gaba agents|mesh-ancestor
102131343|NCT03187496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102131344|NCT03187496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131345|NCT03187496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102131346|NCT03187496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102131347|NCT03187496|Antimetabolites|antimetabolites|mesh-ancestor
102131348|NCT03187496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102131349|NCT03187496|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102131350|NCT03187496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102131351|NCT03187496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102131352|NCT03187496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102131353|NCT03187496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102131354|NCT03187496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102131355|NCT03187496|Purinergic Agents|purinergic agents|mesh-ancestor
102131356|NCT02438072|Fexofenadine|fexofenadine|mesh-list
102131357|NCT02438072|Flurbiprofen|flurbiprofen|mesh-list
102131358|NCT02438072|Midazolam|midazolam|mesh-list
102131359|NCT02438072|Dextromethorphan|dextromethorphan|mesh-list
102131360|NCT02438072|Caffeine|caffeine|mesh-list
102131361|NCT02438072|Bupropion|bupropion|mesh-list
102131362|NCT02438072|Omeprazole|omeprazole|mesh-list
102131363|NCT02438072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102131364|NCT02438072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102131365|NCT02438072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102131366|NCT02438072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131367|NCT02438072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102131368|NCT02438072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102131369|NCT02438072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102131370|NCT02438072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102131371|NCT02438072|Anesthetics, General|anesthetics, general|mesh-ancestor
102131372|NCT02438072|Anesthetics|anesthetics|mesh-ancestor
102131373|NCT02438072|GABA Modulators|gaba modulators|mesh-ancestor
102131374|NCT02438072|GABA Agents|gaba agents|mesh-ancestor
102131375|NCT02438072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102131376|NCT02438072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131377|NCT02438072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102131378|NCT02438072|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102131379|NCT02438072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102131380|NCT02438072|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102131381|NCT02438072|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102131382|NCT02438072|Purinergic Agents|purinergic agents|mesh-ancestor
102131383|NCT02438072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102131384|NCT02438072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102131385|NCT02438072|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102131386|NCT02438072|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102131387|NCT02438072|Antidepressive Agents|antidepressive agents|mesh-ancestor
102131388|NCT02438072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102131389|NCT02438072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102131390|NCT02438072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102535891|NCT00554099|Analgesics|analgesics|mesh-ancestor
102131391|NCT02438072|Dopamine Agents|dopamine agents|mesh-ancestor
102131392|NCT02438072|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102131393|NCT02438072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102131394|NCT02438072|Antitussive Agents|antitussive agents|mesh-ancestor
102131395|NCT02438072|Respiratory System Agents|respiratory system agents|mesh-ancestor
102131396|NCT02438072|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102131397|NCT02438072|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102131399|NCT02438072|Sensory System Agents|sensory system agents|mesh-ancestor
102131400|NCT02438072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102131401|NCT02438072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102131402|NCT02438072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102131403|NCT02438072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102131404|NCT02438072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102131405|NCT02438072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102131406|NCT02438072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102131407|NCT02438072|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102131408|NCT02438072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102131409|NCT02438072|Histamine Antagonists|histamine antagonists|mesh-ancestor
102131410|NCT02438072|Histamine Agents|histamine agents|mesh-ancestor
102131411|NCT03522987|Escitalopram|escitalopram|mesh-list
102131412|NCT03522987|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102131413|NCT03522987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102131414|NCT03522987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102131415|NCT03522987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131416|NCT03522987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102131417|NCT03522987|Serotonin Agents|serotonin agents|mesh-ancestor
102131418|NCT03522987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131419|NCT02433626|Cisplatin|cisplatin|mesh-list
102131420|NCT02433626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102131421|NCT02442128|Fentanyl|fentanyl|mesh-list
102131422|NCT02442128|Propofol|propofol|mesh-list
102131423|NCT02442128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102131424|NCT02442128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102131425|NCT02442128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131426|NCT02442128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102131427|NCT02442128|Anesthetics, General|anesthetics, general|mesh-ancestor
102131428|NCT02442128|Anesthetics|anesthetics|mesh-ancestor
102131429|NCT02442128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102131430|NCT02442128|Narcotics|narcotics|mesh-ancestor
102131431|NCT02442128|Analgesics|analgesics|mesh-ancestor
102131432|NCT02442128|Sensory System Agents|sensory system agents|mesh-ancestor
102131433|NCT02442128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102131434|NCT02442128|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102131435|NCT04465773|Remifentanil|remifentanil|mesh-list
102131436|NCT04465773|Propofol|propofol|mesh-list
102131437|NCT04465773|Anesthetics|anesthetics|mesh-ancestor
102131438|NCT04465773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102131439|NCT04465773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131440|NCT04465773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102131441|NCT04465773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102131442|NCT04465773|Anesthetics, General|anesthetics, general|mesh-ancestor
102131443|NCT04465773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102131444|NCT04465773|Narcotics|narcotics|mesh-ancestor
102131445|NCT04465773|Analgesics|analgesics|mesh-ancestor
102131446|NCT04465773|Sensory System Agents|sensory system agents|mesh-ancestor
102131447|NCT04465773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102131448|NCT02709746|Vortioxetine|vortioxetine|mesh-list
102131449|NCT02709746|Fluoxetine|fluoxetine|mesh-list
102131450|NCT02709746|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102131451|NCT02709746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102131452|NCT02709746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102131453|NCT02709746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131454|NCT02709746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102131455|NCT02709746|Serotonin Agents|serotonin agents|mesh-ancestor
102131456|NCT02709746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131457|NCT02709746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102131458|NCT02709746|Antidepressive Agents|antidepressive agents|mesh-ancestor
102131459|NCT02709746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102131460|NCT02709746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102131461|NCT02709746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102131462|NCT02709746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102131463|NCT02709746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102131464|NCT02709746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102131465|NCT02709746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102131466|NCT02709746|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102131467|NCT02709746|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102131468|NCT02709746|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102131469|NCT02709746|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102131470|NCT02441894|Diphenhydramine|diphenhydramine|mesh-list
102131471|NCT02441894|Promethazine|promethazine|mesh-list
102131472|NCT02441894|Dexamethasone|dexamethasone|mesh-list
102131473|NCT02441894|Prednisolone|prednisolone|mesh-list
102131474|NCT02441894|Ondansetron|ondansetron|mesh-list
102131475|NCT02441894|Metoclopramide|metoclopramide|mesh-list
102131476|NCT02441894|Granisetron|granisetron|mesh-list
102131477|NCT02441894|Ranitidine|ranitidine|mesh-list
102131478|NCT02441894|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
102131479|NCT02441894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102131480|NCT02441894|Antiemetics|antiemetics|mesh-ancestor
102131481|NCT02441894|Autonomic Agents|autonomic agents|mesh-ancestor
102131482|NCT02441894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102131483|NCT02441894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131484|NCT02441894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102131485|NCT02441894|Glucocorticoids|glucocorticoids|mesh-ancestor
102131486|NCT02441894|Hormones|hormones|mesh-ancestor
102131487|NCT02441894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102131488|NCT02441894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102131489|NCT02441894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102131490|NCT02441894|Antipruritics|antipruritics|mesh-ancestor
102131491|NCT02441894|Dermatologic Agents|dermatologic agents|mesh-ancestor
102131492|NCT02441894|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102131493|NCT02441894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102131494|NCT02441894|Serotonin Agents|serotonin agents|mesh-ancestor
102131495|NCT02441894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102131496|NCT02441894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131497|NCT02441894|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102131498|NCT02441894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102131499|NCT02441894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102131500|NCT02441894|Anesthetics, Local|anesthetics, local|mesh-ancestor
102131501|NCT02441894|Anesthetics|anesthetics|mesh-ancestor
102131502|NCT02441894|Sensory System Agents|sensory system agents|mesh-ancestor
102131503|NCT02441894|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102131504|NCT02441894|Histamine Antagonists|histamine antagonists|mesh-ancestor
102131505|NCT02441894|Histamine Agents|histamine agents|mesh-ancestor
102131506|NCT02441894|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102131507|NCT02441894|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102131508|NCT02441894|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102131509|NCT02441894|Dopamine Agents|dopamine agents|mesh-ancestor
101840539|NCT01023360|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102131510|NCT02441894|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102131511|NCT02441894|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102131512|NCT02433704|Cefazolin|cefazolin|mesh-list
102131513|NCT02433704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102131514|NCT02433704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102131515|NCT05453825|Paclitaxel|paclitaxel|mesh-list
102131516|NCT05453825|Irinotecan|irinotecan|mesh-list
102131517|NCT05453825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102131518|NCT05453825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102131519|NCT05453825|Tubulin Modulators|tubulin modulators|mesh-ancestor
102131520|NCT05453825|Antimitotic Agents|antimitotic agents|mesh-ancestor
102131521|NCT05453825|Mitosis Modulators|mitosis modulators|mesh-ancestor
102131522|NCT05453825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131523|NCT05453825|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102131524|NCT05453825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102131525|NCT05453825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102131526|NCT02441816|Aflibercept|aflibercept|mesh-list
102131527|NCT02441816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102131528|NCT02441816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102131529|NCT02441816|Growth Substances|growth substances|mesh-ancestor
102131530|NCT02441816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131531|NCT02441816|Growth Inhibitors|growth inhibitors|mesh-ancestor
102131532|NCT02441816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102131533|NCT02433314|Brexanolone|brexanolone|mesh-list
102131534|NCT02433314|Neurosteroids|neurosteroids|mesh-ancestor
102131535|NCT02433314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102131536|NCT02433314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131537|NCT02433314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131538|NCT02433314|GABA Modulators|gaba modulators|mesh-ancestor
102131539|NCT02433314|GABA Agents|gaba agents|mesh-ancestor
102131540|NCT02290431|Dexamethasone|dexamethasone|mesh-list
102131541|NCT02290431|Bortezomib|bortezomib|mesh-list
102131542|NCT02290431|Panobinostat|panobinostat|mesh-list
102131543|NCT02290431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102131544|NCT02290431|Antiemetics|antiemetics|mesh-ancestor
102131545|NCT02290431|Autonomic Agents|autonomic agents|mesh-ancestor
102131546|NCT02290431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102131547|NCT02290431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131548|NCT02290431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102131549|NCT02290431|Glucocorticoids|glucocorticoids|mesh-ancestor
102131550|NCT02290431|Hormones|hormones|mesh-ancestor
102131551|NCT02290431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102131552|NCT02290431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102131553|NCT02290431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102131554|NCT02290431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102131555|NCT02290431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102131556|NCT02290431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131557|NCT02441270|Cyclophosphamide|cyclophosphamide|mesh-list
102131558|NCT02441270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102131559|NCT02441270|Immunologic Factors|immunologic factors|mesh-ancestor
102131560|NCT02441270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131561|NCT02441270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102131562|NCT02441270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102131563|NCT02441270|Alkylating Agents|alkylating agents|mesh-ancestor
102131564|NCT02441270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131565|NCT02441270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102131566|NCT02441270|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102131567|NCT02436980|Midazolam|midazolam|mesh-list
102131568|NCT02436980|Tramadol|tramadol|mesh-list
102131569|NCT02436980|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102131570|NCT02436980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102131571|NCT02436980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102131572|NCT02436980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131573|NCT02436980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102131574|NCT02436980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102131575|NCT02436980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102131576|NCT02436980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102131577|NCT02436980|Anesthetics, General|anesthetics, general|mesh-ancestor
102131578|NCT02436980|Anesthetics|anesthetics|mesh-ancestor
102131579|NCT02436980|GABA Modulators|gaba modulators|mesh-ancestor
102131580|NCT02436980|GABA Agents|gaba agents|mesh-ancestor
102131581|NCT02436980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102131582|NCT02436980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131583|NCT02436980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101840614|NCT00958139|Permethrin|permethrin|mesh-list
102131584|NCT02436980|Narcotics|narcotics|mesh-ancestor
102131585|NCT02436980|Analgesics|analgesics|mesh-ancestor
102131586|NCT02436980|Sensory System Agents|sensory system agents|mesh-ancestor
102131587|NCT02436980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102131589|NCT02436902|Chlorotrianisene|chlorotrianisene|mesh-list
102131590|NCT02436902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102131591|NCT02436902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102131592|NCT02436902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102131593|NCT02436902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131594|NCT02436902|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102131595|NCT02436902|Estrogens|estrogens|mesh-ancestor
102131596|NCT02436902|Hormones|hormones|mesh-ancestor
102131597|NCT02436902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102131598|NCT02436902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131599|NCT02436902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102131600|NCT02436512|Nitric Oxide|nitric oxide|mesh-list
102131601|NCT02436512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102131602|NCT02436512|Autonomic Agents|autonomic agents|mesh-ancestor
102131603|NCT02436512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102131604|NCT02436512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131605|NCT02436512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102131606|NCT02436512|Respiratory System Agents|respiratory system agents|mesh-ancestor
102131607|NCT02436512|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102131608|NCT02436512|Antioxidants|antioxidants|mesh-ancestor
102131609|NCT02436512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131610|NCT02436512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102131611|NCT02436512|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102131612|NCT02436512|Vasodilator Agents|vasodilator agents|mesh-ancestor
102131613|NCT02436512|Gasotransmitters|gasotransmitters|mesh-ancestor
102131614|NCT02436512|Protective Agents|protective agents|mesh-ancestor
102131615|NCT04466241|Ritonavir|ritonavir|mesh-list
102131616|NCT04466241|Lopinavir|lopinavir|mesh-list
102131617|NCT04466241|Telmisartan|telmisartan|mesh-list
102131618|NCT04466241|Atorvastatin|atorvastatin|mesh-list
102131619|NCT04466241|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102131620|NCT04466241|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102131621|NCT04466241|Antimetabolites|antimetabolites|mesh-ancestor
102131622|NCT04466241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131623|NCT04466241|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102131624|NCT04466241|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102131625|NCT04466241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102131626|NCT04466241|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102131627|NCT04466241|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102131628|NCT04466241|Protease Inhibitors|protease inhibitors|mesh-ancestor
102131629|NCT04466241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102131630|NCT04466241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102131631|NCT04466241|Antiviral Agents|antiviral agents|mesh-ancestor
102131632|NCT04466241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102131633|NCT04466241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102131634|NCT04466241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102131635|NCT04466241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102131636|NCT04466241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102131637|NCT04466241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102131638|NCT02440880|Dexamethasone|dexamethasone|mesh-list
102131639|NCT02440880|Dexamethasone acetate|dexamethasone acetate|mesh-list
102131640|NCT02440880|BB 1101|bb 1101|mesh-list
102131641|NCT02440880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102131642|NCT02440880|Antiemetics|antiemetics|mesh-ancestor
102131643|NCT02440880|Autonomic Agents|autonomic agents|mesh-ancestor
102131644|NCT02440880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102131645|NCT02440880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131646|NCT02440880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102131647|NCT02440880|Glucocorticoids|glucocorticoids|mesh-ancestor
102131648|NCT02440880|Hormones|hormones|mesh-ancestor
102131649|NCT02440880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102131650|NCT02440880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102131651|NCT02440880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102131652|NCT02440880|Protease Inhibitors|protease inhibitors|mesh-ancestor
102131653|NCT02440880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102131654|NCT02440880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131655|NCT03186482|Rifampin|rifampin|mesh-list
102131656|NCT03186482|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
102131657|NCT03186482|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102131658|NCT03186482|Antitubercular Agents|antitubercular agents|mesh-ancestor
101840701|NCT05352113|Serotonin Agents|serotonin agents|mesh-ancestor
102131659|NCT03186482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102131660|NCT03186482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102131661|NCT03186482|Leprostatic Agents|leprostatic agents|mesh-ancestor
102131662|NCT03186482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102131663|NCT03186482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102131664|NCT03186482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131665|NCT03186482|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102131666|NCT03186482|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102131667|NCT03186482|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102131668|NCT03186482|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102131669|NCT03186482|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102131670|NCT03186482|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102131671|NCT03186482|Antiviral Agents|antiviral agents|mesh-ancestor
102131672|NCT03186482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102131673|NCT03186482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102131674|NCT03186482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102131675|NCT03522207|Trazodone|trazodone|mesh-list
102131676|NCT03522207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102131677|NCT03522207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102131678|NCT03522207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102131679|NCT03522207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131680|NCT03522207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102131681|NCT03522207|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102131682|NCT03522207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102131683|NCT03522207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102131684|NCT03522207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131685|NCT03522207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102131686|NCT03522207|Serotonin Agents|serotonin agents|mesh-ancestor
102131687|NCT03522207|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102131688|NCT03522207|Antidepressive Agents|antidepressive agents|mesh-ancestor
102131689|NCT03528057|Hemostatics|hemostatics|mesh-list
102131690|NCT03528057|Coagulants|coagulants|mesh-ancestor
102131691|NCT05018273|Atezolizumab|atezolizumab|mesh-list
102131692|NCT05018273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102131693|NCT05018273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131694|NCT05018273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102131695|NCT05018273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102131696|NCT02707952|Ritonavir|ritonavir|mesh-list
102131697|NCT02707952|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102131698|NCT02707952|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102131699|NCT02707952|Protease Inhibitors|protease inhibitors|mesh-ancestor
102131700|NCT02707952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102131701|NCT02707952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131702|NCT02707952|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102131703|NCT02707952|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102131704|NCT02707952|Antiviral Agents|antiviral agents|mesh-ancestor
102131705|NCT02707952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102131706|NCT02707952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102131707|NCT02707952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102131708|NCT02291211|Cisplatin|cisplatin|mesh-list
102131709|NCT02291211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102131710|NCT05392101|Deferasirox|deferasirox|mesh-list
102131711|NCT05392101|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102131712|NCT05392101|Chelating Agents|chelating agents|mesh-ancestor
102131713|NCT05392101|Sequestering Agents|sequestering agents|mesh-ancestor
102131714|NCT05392101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131715|NCT02291367|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102131716|NCT02291367|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102131717|NCT02291367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102131718|NCT02291367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102131719|NCT02291367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131720|NCT02291367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102131721|NCT02291367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131722|NCT02291367|Analgesics|analgesics|mesh-ancestor
102131723|NCT02291367|Sensory System Agents|sensory system agents|mesh-ancestor
102131724|NCT02291367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102131725|NCT02291367|Antidepressive Agents|antidepressive agents|mesh-ancestor
102131726|NCT02291367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102131727|NCT02291367|Dopamine Agents|dopamine agents|mesh-ancestor
102131728|NCT02440958|Folfirinox|folfirinox|mesh-list
102131729|NCT02440958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102131730|NCT02432534|Atorvastatin|atorvastatin|mesh-list
102131731|NCT02432534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102131732|NCT02432534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102131733|NCT02432534|Antimetabolites|antimetabolites|mesh-ancestor
102131734|NCT02432534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131735|NCT02432534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102131736|NCT02432534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102131737|NCT02432534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102131738|NCT02432612|Nabiximols|nabiximols|mesh-list
102131739|NCT02432612|Analgesics|analgesics|mesh-ancestor
102131740|NCT02432612|Sensory System Agents|sensory system agents|mesh-ancestor
102131741|NCT02432612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102131742|NCT02432612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131743|NCT05705843|Vancomycin|vancomycin|mesh-list
102131744|NCT05705843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102131745|NCT05705843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102131746|NCT02436044|Leucovorin|leucovorin|mesh-list
102131747|NCT02436044|Fluorouracil|fluorouracil|mesh-list
102131748|NCT02436044|Oxaliplatin|oxaliplatin|mesh-list
102131749|NCT02436044|Levoleucovorin|levoleucovorin|mesh-list
102131750|NCT02436044|Antimetabolites|antimetabolites|mesh-ancestor
102131751|NCT02436044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131752|NCT02436044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102131753|NCT02436044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102131754|NCT02436044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102131755|NCT02436044|Immunologic Factors|immunologic factors|mesh-ancestor
102131756|NCT02436044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131757|NCT02436044|Antidotes|antidotes|mesh-ancestor
102131758|NCT02436044|Protective Agents|protective agents|mesh-ancestor
102131759|NCT02436044|Vitamin B Complex|vitamin b complex|mesh-ancestor
102131760|NCT02436044|Vitamins|vitamins|mesh-ancestor
102131761|NCT02436044|Micronutrients|micronutrients|mesh-ancestor
102131762|NCT02435732|Heparin|heparin|mesh-list
102131763|NCT02435732|Anticoagulants|anticoagulants|mesh-ancestor
102131764|NCT02435732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102131765|NCT02435732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102131766|NCT02435732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131767|NCT02435654|Olanzapine|olanzapine|mesh-list
102131768|NCT02435654|Antiemetics|antiemetics|mesh-ancestor
102131769|NCT02435654|Autonomic Agents|autonomic agents|mesh-ancestor
102131770|NCT02435654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102131771|NCT02435654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131772|NCT02435654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102131773|NCT02435654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102131774|NCT02435654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102131775|NCT02435654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102131776|NCT02435654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102131777|NCT02435654|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102131778|NCT02435654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102131779|NCT02435654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102131780|NCT02435654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131781|NCT02435654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102131782|NCT02435654|Serotonin Agents|serotonin agents|mesh-ancestor
102131783|NCT03191162|Benzonidazole|benzonidazole|mesh-list
102131784|NCT03191162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102131785|NCT03191162|Immunologic Factors|immunologic factors|mesh-ancestor
102131786|NCT03191162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131787|NCT03191162|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102131788|NCT03191162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102131789|NCT03191162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102131790|NCT03191162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102131791|NCT05571527|Hyaluronic Acid|hyaluronic acid|mesh-list
102131792|NCT05571527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102131793|NCT05571527|Immunologic Factors|immunologic factors|mesh-ancestor
102131794|NCT05571527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131795|NCT05571527|Viscosupplements|viscosupplements|mesh-ancestor
102131796|NCT05571527|Protective Agents|protective agents|mesh-ancestor
102131797|NCT02432066|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
102131798|NCT02432066|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102131799|NCT02432066|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102131800|NCT02432066|Cholinergic Agents|cholinergic agents|mesh-ancestor
102131801|NCT02432066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102131802|NCT02432066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840833|NCT01062958|Vitamins|vitamins|mesh-list
102131803|NCT02432066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131804|NCT04824599|Ropivacaine|ropivacaine|mesh-list
102131805|NCT04824599|Anesthetics, Local|anesthetics, local|mesh-list
102131806|NCT04824599|Anesthetics|anesthetics|mesh-list
102131807|NCT04824599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102131808|NCT04824599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131809|NCT04824599|Sensory System Agents|sensory system agents|mesh-ancestor
102131810|NCT04824599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102131811|NCT05233514|Metformin|metformin|mesh-list
102131812|NCT05233514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102131813|NCT05233514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131814|NCT02431832|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102131815|NCT02431832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102131816|NCT02431832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102131817|NCT02431832|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102131818|NCT02431832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102131819|NCT02431832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131820|NCT02435186|Paclitaxel|paclitaxel|mesh-list
102131821|NCT02435186|Cisplatin|cisplatin|mesh-list
102131822|NCT02435186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102131823|NCT02435186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102131824|NCT02435186|Tubulin Modulators|tubulin modulators|mesh-ancestor
102131825|NCT02435186|Antimitotic Agents|antimitotic agents|mesh-ancestor
102131826|NCT02435186|Mitosis Modulators|mitosis modulators|mesh-ancestor
102131827|NCT02435186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131828|NCT02435108|Crizotinib|crizotinib|mesh-list
102131829|NCT02435108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102131830|NCT02435108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102131831|NCT02435108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102131832|NCT02435108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131833|NCT02434952|Primaquine|primaquine|mesh-list
102131834|NCT02434952|Piperaquine|piperaquine|mesh-list
102131835|NCT02434952|Artenimol|artenimol|mesh-list
102131836|NCT02434952|Antimalarials|antimalarials|mesh-ancestor
102131837|NCT02434952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102131839|NCT02434952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102131840|NCT03117920|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
102131841|NCT03117920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102131842|NCT03117920|Alkylating Agents|alkylating agents|mesh-ancestor
102131843|NCT03117920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131844|NCT03117920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102131845|NCT03626753|Acetaminophen|acetaminophen|mesh-list
102131846|NCT03626753|Piroxicam|piroxicam|mesh-list
102131847|NCT03626753|Nefopam|nefopam|mesh-list
102131848|NCT03626753|Proroxan|proroxan|mesh-list
102131849|NCT03626753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102131850|NCT03626753|Analgesics|analgesics|mesh-ancestor
102131851|NCT03626753|Sensory System Agents|sensory system agents|mesh-ancestor
102131852|NCT03626753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102131853|NCT03626753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131854|NCT03626753|Antipyretics|antipyretics|mesh-ancestor
102131855|NCT03626753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102131856|NCT03626753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102131857|NCT03626753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102131858|NCT03626753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102131859|NCT03626753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102131860|NCT03626753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131861|NCT03626753|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102131862|NCT03626753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102131863|NCT03626753|Adrenergic Agents|adrenergic agents|mesh-ancestor
102131864|NCT03626753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102131865|NCT03626753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102131866|NCT02440256|Analgesics, Opioid|analgesics, opioid|mesh-list
102131867|NCT02440256|Narcotics|narcotics|mesh-ancestor
102131868|NCT02440256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102131869|NCT02440256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131870|NCT02440256|Analgesics|analgesics|mesh-ancestor
102131871|NCT02440256|Sensory System Agents|sensory system agents|mesh-ancestor
102131872|NCT02440256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102131873|NCT05157698|Naltrexone|naltrexone|mesh-list
102131874|NCT05157698|Bupropion|bupropion|mesh-list
102131875|NCT05157698|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102131876|NCT05157698|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102131877|NCT05157698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131878|NCT05157698|Sensory System Agents|sensory system agents|mesh-ancestor
102131879|NCT05157698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102131880|NCT05157698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102131881|NCT05157698|Antidepressive Agents|antidepressive agents|mesh-ancestor
102131882|NCT05157698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102131883|NCT05157698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102131884|NCT05157698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102131885|NCT05157698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102131886|NCT05157698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131888|NCT05157698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102131889|NCT05157698|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102131890|NCT05157698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102131891|NCT05157698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102131892|NCT03185624|Rifaximin|rifaximin|mesh-list
102131893|NCT03185624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102131894|NCT03185624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102131895|NCT03185624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102131896|NCT02707640|Acetylcysteine|acetylcysteine|mesh-list
102131897|NCT02707640|Pirfenidone|pirfenidone|mesh-list
102131898|NCT02707640|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102131899|NCT02707640|Antiviral Agents|antiviral agents|mesh-ancestor
102131900|NCT02707640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102131901|NCT02707640|Expectorants|expectorants|mesh-ancestor
102131902|NCT02707640|Respiratory System Agents|respiratory system agents|mesh-ancestor
102131903|NCT02707640|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102131904|NCT02707640|Antioxidants|antioxidants|mesh-ancestor
102131905|NCT02707640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131906|NCT02707640|Protective Agents|protective agents|mesh-ancestor
102131907|NCT02707640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131908|NCT02707640|Antidotes|antidotes|mesh-ancestor
102131909|NCT02707640|Analgesics|analgesics|mesh-ancestor
102131910|NCT02707640|Sensory System Agents|sensory system agents|mesh-ancestor
102131911|NCT02707640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102131912|NCT02707640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102131913|NCT02707640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102131914|NCT02707640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102131915|NCT02707640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102131916|NCT02707640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102131917|NCT03190694|Dapagliflozin|dapagliflozin|mesh-list
102131918|NCT03190694|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102131919|NCT03190694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131920|NCT03190694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102131921|NCT03190694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131922|NCT02430272|Glycopyrrolate|glycopyrrolate|mesh-list
102131923|NCT02430272|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102131924|NCT02430272|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102131925|NCT02430272|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102131926|NCT02430272|Cholinergic Agents|cholinergic agents|mesh-ancestor
102131927|NCT02430272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102131928|NCT02430272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131929|NCT02430272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131930|NCT03188978|Atorvastatin|atorvastatin|mesh-list
102131931|NCT03188978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102131932|NCT03188978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102131933|NCT03188978|Antimetabolites|antimetabolites|mesh-ancestor
102131934|NCT03188978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131935|NCT03188978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102131936|NCT03188978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102131937|NCT03188978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102131938|NCT02431286|Dexamethasone|dexamethasone|mesh-list
102131939|NCT02431286|Aprepitant|aprepitant|mesh-list
102131940|NCT02431286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102131941|NCT02431286|Antiemetics|antiemetics|mesh-ancestor
102131942|NCT02431286|Autonomic Agents|autonomic agents|mesh-ancestor
102131943|NCT02431286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102131944|NCT02431286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131945|NCT02431286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102131946|NCT02431286|Glucocorticoids|glucocorticoids|mesh-ancestor
102131947|NCT02431286|Hormones|hormones|mesh-ancestor
102131948|NCT02431286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102131949|NCT02431286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102131950|NCT02431286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102131951|NCT02431286|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102131952|NCT02431286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102131953|NCT02431286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840988|NCT03978988|Antipyretics|antipyretics|mesh-ancestor
102131954|NCT04579367|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
102131955|NCT04579367|Ezetimibe|ezetimibe|mesh-list
102131956|NCT04579367|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102131957|NCT04579367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102131958|NCT04579367|Antimetabolites|antimetabolites|mesh-ancestor
102131959|NCT04579367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131960|NCT04579367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102131961|NCT04579367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102131962|NCT04579367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102131963|NCT04579367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131964|NCT02431208|Dexamethasone|dexamethasone|mesh-list
102131965|NCT02431208|Lenalidomide|lenalidomide|mesh-list
102131966|NCT02431208|Atezolizumab|atezolizumab|mesh-list
102131967|NCT02431208|Daratumumab|daratumumab|mesh-list
102131968|NCT02431208|Pomalidomide|pomalidomide|mesh-list
102131969|NCT02431208|Antibodies|antibodies|mesh-list
102131970|NCT02431208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102131971|NCT02431208|Immunologic Factors|immunologic factors|mesh-ancestor
102131972|NCT02431208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131973|NCT02431208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102131974|NCT02431208|Antiemetics|antiemetics|mesh-ancestor
102131975|NCT02431208|Autonomic Agents|autonomic agents|mesh-ancestor
102131976|NCT02431208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102131977|NCT02431208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102131978|NCT02431208|Glucocorticoids|glucocorticoids|mesh-ancestor
102131979|NCT02431208|Hormones|hormones|mesh-ancestor
102131980|NCT02431208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102131981|NCT02431208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102131982|NCT02431208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102131983|NCT02431208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102131984|NCT02431208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102131985|NCT02431208|Growth Substances|growth substances|mesh-ancestor
102131986|NCT02431208|Growth Inhibitors|growth inhibitors|mesh-ancestor
102131987|NCT02431208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102131988|NCT02431208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102131989|NCT02431208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102131990|NCT03107078|Methylprednisolone|methylprednisolone|mesh-list
102131991|NCT03107078|Glucocorticoids|glucocorticoids|mesh-list
102131992|NCT03107078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102131993|NCT03107078|Antiemetics|antiemetics|mesh-ancestor
102131994|NCT03107078|Autonomic Agents|autonomic agents|mesh-ancestor
102131995|NCT03107078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102131996|NCT03107078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102131997|NCT03107078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102131998|NCT03107078|Hormones|hormones|mesh-ancestor
102131999|NCT03107078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102132000|NCT03107078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102132001|NCT03107078|Protective Agents|protective agents|mesh-ancestor
102132002|NCT02430350|Edaravone|edaravone|mesh-list
102132003|NCT02430350|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102132004|NCT02430350|Antioxidants|antioxidants|mesh-ancestor
102132005|NCT02430350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132006|NCT02430350|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102132007|NCT02430350|Protective Agents|protective agents|mesh-ancestor
102132008|NCT02430350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132009|NCT02429960|Remifentanil|remifentanil|mesh-list
102132010|NCT02429960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102132011|NCT02429960|Narcotics|narcotics|mesh-ancestor
102132012|NCT02429960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102132013|NCT02429960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132014|NCT02429960|Analgesics|analgesics|mesh-ancestor
102132015|NCT02429960|Sensory System Agents|sensory system agents|mesh-ancestor
102132016|NCT02429960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102132017|NCT02429804|Listerine|listerine|mesh-list
102132018|NCT02429804|Deoxyglucose|deoxyglucose|mesh-list
102132019|NCT02429804|Fluorides|fluorides|mesh-list
102132020|NCT02429804|Sodium Fluoride|sodium fluoride|mesh-list
102132021|NCT02429804|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102132022|NCT02429804|Cariostatic Agents|cariostatic agents|mesh-ancestor
102132023|NCT02429804|Protective Agents|protective agents|mesh-ancestor
102132024|NCT02429804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132025|NCT02429804|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102132026|NCT02429804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132027|NCT02429804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102132028|NCT02429804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102132029|NCT02429804|Antimetabolites|antimetabolites|mesh-ancestor
102132030|NCT02429804|Antiviral Agents|antiviral agents|mesh-ancestor
102132031|NCT03185156|Propofol|propofol|mesh-list
102132032|NCT03185156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102132033|NCT03185156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102132034|NCT03185156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132035|NCT03185156|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102132036|NCT03185156|Anesthetics, General|anesthetics, general|mesh-ancestor
102132037|NCT03185156|Anesthetics|anesthetics|mesh-ancestor
102132038|NCT02429726|Cisplatin|cisplatin|mesh-list
102132039|NCT02429726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102132040|NCT02429882|Brodalumab|brodalumab|mesh-list
102132041|NCT02429882|Dermatologic Agents|dermatologic agents|mesh-ancestor
102132042|NCT02430896|Methylphenidate|methylphenidate|mesh-list
102132043|NCT02430896|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102132044|NCT02430896|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102132045|NCT02430896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132046|NCT02430896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102132047|NCT02430896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102132048|NCT02430896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102132049|NCT02430896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132050|NCT02430896|Dopamine Agents|dopamine agents|mesh-ancestor
102132051|NCT02430896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102132052|NCT02430896|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102132053|NCT02430896|Adrenergic Agents|adrenergic agents|mesh-ancestor
102132054|NCT03184844|Thalidomide|thalidomide|mesh-list
102132055|NCT03184844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102132056|NCT03184844|Immunologic Factors|immunologic factors|mesh-ancestor
102132057|NCT03184844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132058|NCT03184844|Leprostatic Agents|leprostatic agents|mesh-ancestor
102132059|NCT03184844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102132060|NCT03184844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102132061|NCT03184844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102132062|NCT03184844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102132063|NCT03184844|Growth Substances|growth substances|mesh-ancestor
102132064|NCT03184844|Growth Inhibitors|growth inhibitors|mesh-ancestor
102132065|NCT03184844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102132066|NCT02425202|Ketamine|ketamine|mesh-list
102132067|NCT02425202|Analgesics|analgesics|mesh-ancestor
102132068|NCT02425202|Sensory System Agents|sensory system agents|mesh-ancestor
102132069|NCT02425202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102132070|NCT02425202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132071|NCT02425202|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102132072|NCT02425202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102132073|NCT02425202|Anesthetics, General|anesthetics, general|mesh-ancestor
102132074|NCT02425202|Anesthetics|anesthetics|mesh-ancestor
102132075|NCT02425202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102132076|NCT02425202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102132077|NCT02425202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102132078|NCT02425202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102132079|NCT02425202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132080|NCT03182504|Meropenem|meropenem|mesh-list
102132081|NCT03182504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102132082|NCT03182504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102132083|NCT02428946|Bromocriptine|bromocriptine|mesh-list
102132084|NCT02428946|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102132085|NCT02428946|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102132086|NCT02428946|Hormone Antagonists|hormone antagonists|mesh-ancestor
102132087|NCT02428946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102132088|NCT02428946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132089|NCT02428946|Dopamine Agonists|dopamine agonists|mesh-ancestor
102132090|NCT02428946|Dopamine Agents|dopamine agents|mesh-ancestor
102132091|NCT02428946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102132092|NCT02428946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132093|NCT02424656|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102132094|NCT02424656|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102132095|NCT02424656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132096|NCT02428868|Tranexamic Acid|tranexamic acid|mesh-list
102132097|NCT02428868|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102132098|NCT02428868|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102132099|NCT02428868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132100|NCT02428868|Hemostatics|hemostatics|mesh-ancestor
102132101|NCT02428868|Coagulants|coagulants|mesh-ancestor
102132102|NCT03181880|Bromides|bromides|mesh-list
102132103|NCT03181880|Formoterol Fumarate|formoterol fumarate|mesh-list
102132104|NCT03181880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102132105|NCT03181880|Autonomic Agents|autonomic agents|mesh-ancestor
102132106|NCT03181880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102132107|NCT03181880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132109|NCT03181880|Respiratory System Agents|respiratory system agents|mesh-ancestor
102132110|NCT03181880|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102132111|NCT03181880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102132112|NCT03181880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102132113|NCT03181880|Adrenergic Agents|adrenergic agents|mesh-ancestor
102132114|NCT03181880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102132115|NCT03181880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132116|NCT03181880|Anticonvulsants|anticonvulsants|mesh-ancestor
102132117|NCT03178994|Ketoconazole|ketoconazole|mesh-list
102132118|NCT03178994|Antifungal Agents|antifungal agents|mesh-ancestor
102132119|NCT03178994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102132120|NCT03178994|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102132121|NCT03178994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102132122|NCT03178994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102132123|NCT03178994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132124|NCT03178994|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102132125|NCT03178994|Hormone Antagonists|hormone antagonists|mesh-ancestor
102132126|NCT03178994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102132127|NCT03178994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132128|NCT03178994|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102132129|NCT03182114|Bupivacaine|bupivacaine|mesh-list
102132130|NCT03182114|Anesthetics, Local|anesthetics, local|mesh-ancestor
102132131|NCT03182114|Anesthetics|anesthetics|mesh-ancestor
102132132|NCT03182114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102132133|NCT03182114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132134|NCT03182114|Sensory System Agents|sensory system agents|mesh-ancestor
102132135|NCT03182114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102132136|NCT02428322|Vitamin D|vitamin d|mesh-list
102132137|NCT02428322|Cholecalciferol|cholecalciferol|mesh-list
102132138|NCT02428322|Vitamins|vitamins|mesh-ancestor
102132139|NCT02428322|Micronutrients|micronutrients|mesh-ancestor
102132140|NCT02428322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132141|NCT02428322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102132142|NCT02428322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102132143|NCT03053063|Selonsertib|selonsertib|mesh-list
102132144|NCT03053063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102132145|NCT03053063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102132146|NCT03053063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132147|NCT00702338|Hormones|hormones|mesh-list
102132148|NCT00702338|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102132149|NCT00702338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102132150|NCT00702338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132151|NCT05484557|Enoxaparin|enoxaparin|mesh-list
102132152|NCT05484557|Enoxaparin sodium|enoxaparin sodium|mesh-list
102132153|NCT05484557|Apixaban|apixaban|mesh-list
102132154|NCT05484557|Anticoagulants|anticoagulants|mesh-ancestor
102132155|NCT05484557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102132156|NCT05484557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102132157|NCT05484557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132158|NCT05484557|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102132159|NCT05484557|Antithrombins|antithrombins|mesh-ancestor
102132160|NCT05484557|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102132161|NCT05484557|Protease Inhibitors|protease inhibitors|mesh-ancestor
102132162|NCT05484557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102132163|NCT02427932|Gentamicins|gentamicins|mesh-list
102132164|NCT02427932|Ampicillin|ampicillin|mesh-list
102132165|NCT02427932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102132166|NCT02427932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102132167|NCT02427932|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102132168|NCT02427932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102132169|NCT02427932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132170|NCT03626519|Menthol|menthol|mesh-list
102132171|NCT03626519|Antipruritics|antipruritics|mesh-ancestor
102132172|NCT03626519|Dermatologic Agents|dermatologic agents|mesh-ancestor
102132173|NCT03184766|Ibuprofen|ibuprofen|mesh-list
102132174|NCT03184766|Pseudoephedrine|pseudoephedrine|mesh-list
102132175|NCT03184766|Ephedrine|ephedrine|mesh-list
102132176|NCT03184766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102132177|NCT03184766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102132178|NCT03184766|Analgesics|analgesics|mesh-ancestor
102132179|NCT03184766|Sensory System Agents|sensory system agents|mesh-ancestor
102132180|NCT03184766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102132181|NCT03184766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132183|NCT03184766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102132184|NCT03184766|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102132185|NCT03184766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102132186|NCT03184766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132187|NCT03184766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102132188|NCT03184766|Autonomic Agents|autonomic agents|mesh-ancestor
102132189|NCT03184766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102132190|NCT03184766|Respiratory System Agents|respiratory system agents|mesh-ancestor
102132191|NCT03184766|Nasal Decongestants|nasal decongestants|mesh-ancestor
102132192|NCT03184766|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102132193|NCT03184766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102132194|NCT03184766|Sympathomimetics|sympathomimetics|mesh-ancestor
102132195|NCT03184766|Adrenergic Agents|adrenergic agents|mesh-ancestor
102132196|NCT03184766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102132197|NCT03181646|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
102132198|NCT03181646|Nootropic Agents|nootropic agents|mesh-ancestor
102132199|NCT02420834|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102132200|NCT02420834|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102132201|NCT02420834|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102132202|NCT02420834|Laxatives|laxatives|mesh-ancestor
102132203|NCT02420834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102132204|NCT02423954|Sirolimus|sirolimus|mesh-list
102132205|NCT02423954|Capecitabine|capecitabine|mesh-list
102132206|NCT02423954|Nivolumab|nivolumab|mesh-list
102132207|NCT02423954|Irinotecan|irinotecan|mesh-list
102132208|NCT02423954|Temsirolimus|temsirolimus|mesh-list
102132209|NCT02423954|MTOR Inhibitors|mtor inhibitors|mesh-list
102132210|NCT02423954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102132211|NCT02423954|Antimetabolites|antimetabolites|mesh-ancestor
102132212|NCT02423954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132213|NCT02423954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102132214|NCT02423954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102132215|NCT02423954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102132216|NCT02423954|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102132217|NCT02423954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102132218|NCT02423954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102132219|NCT02423954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102132220|NCT02423954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102132221|NCT02423954|Immunologic Factors|immunologic factors|mesh-ancestor
102132222|NCT02423954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132223|NCT02423954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102132224|NCT02423954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102132225|NCT02423954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102132226|NCT02423954|Antifungal Agents|antifungal agents|mesh-ancestor
102132228|NCT04221503|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102132229|NCT04221503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102132230|NCT04221503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132231|NCT04221503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102132232|NCT02427308|Miltefosine|miltefosine|mesh-list
102132233|NCT02427308|Antifungal Agents|antifungal agents|mesh-ancestor
102132234|NCT02427308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102132235|NCT02427308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102132236|NCT02427308|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102132237|NCT02427308|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102132238|NCT03178292|Levofloxacin|levofloxacin|mesh-list
102132239|NCT03178292|Ofloxacin|ofloxacin|mesh-list
102132240|NCT03178292|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102132241|NCT03178292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102132242|NCT03178292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102132243|NCT03178292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102132244|NCT03178292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102132245|NCT03178292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102132246|NCT03178292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132247|NCT03178292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102132248|NCT03178292|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102132249|NCT03178292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102132250|NCT02427386|Estradiol|estradiol|mesh-list
102132251|NCT02427386|Estrogens|estrogens|mesh-list
102132252|NCT02427386|Hormones|hormones|mesh-ancestor
102132253|NCT02427386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101841292|NCT00963443|Antipyretics|antipyretics|mesh-ancestor
102132254|NCT02427386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132255|NCT03181178|Micronutrients|micronutrients|mesh-list
102132256|NCT03181178|Trace Elements|trace elements|mesh-list
102132257|NCT03181178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132258|NCT05478551|Botulinum Toxins|botulinum toxins|mesh-list
102132259|NCT05478551|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102132260|NCT05478551|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102132261|NCT05478551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102132262|NCT05478551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132263|NCT05478551|Cholinergic Agents|cholinergic agents|mesh-ancestor
102132264|NCT05478551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102132265|NCT05478551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132266|NCT02420444|BCG Vaccine|bcg vaccine|mesh-list
102132267|NCT02420444|Immunologic Factors|immunologic factors|mesh-ancestor
102132268|NCT02420444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132269|NCT02420444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102132270|NCT03180944|Lugol's solution|lugol's solution|mesh-list
102132271|NCT03180944|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102132272|NCT03180944|Hemostatics|hemostatics|mesh-ancestor
102132273|NCT03180944|Coagulants|coagulants|mesh-ancestor
102132274|NCT03180710|Insulin Lispro|insulin lispro|mesh-list
102132275|NCT03180710|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102132276|NCT03180710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132277|NCT04322669|Pidotimod|pidotimod|mesh-list
102132278|NCT04322669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102132279|NCT04322669|Immunologic Factors|immunologic factors|mesh-ancestor
102132280|NCT04322669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132281|NCT03180476|Apatinib|apatinib|mesh-list
102132282|NCT03180476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102132283|NCT03180476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102132284|NCT03180476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102132285|NCT03180476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132286|NCT03180632|Lorazepam|lorazepam|mesh-list
102132287|NCT03180632|Anticonvulsants|anticonvulsants|mesh-ancestor
102132288|NCT03180632|Antiemetics|antiemetics|mesh-ancestor
102132289|NCT03180632|Autonomic Agents|autonomic agents|mesh-ancestor
102132290|NCT03180632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102132291|NCT03180632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132292|NCT03180632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102132293|NCT03180632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102132294|NCT03180632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102132295|NCT03180632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102132296|NCT03180632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102132297|NCT03180632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102132298|NCT03180632|GABA Modulators|gaba modulators|mesh-ancestor
102132299|NCT03180632|GABA Agents|gaba agents|mesh-ancestor
102132300|NCT03180632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102132301|NCT03180632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132302|NCT02420132|Ranibizumab|ranibizumab|mesh-list
102132303|NCT02420132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102132304|NCT02420132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102132305|NCT02420132|Growth Substances|growth substances|mesh-ancestor
102132306|NCT02420132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132307|NCT02420132|Growth Inhibitors|growth inhibitors|mesh-ancestor
102132308|NCT02420132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102132309|NCT03183752|Metformin|metformin|mesh-list
102132310|NCT03183752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102132311|NCT03183752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132312|NCT03183674|Oxytocin|oxytocin|mesh-list
102132313|NCT03183674|Oxytocics|oxytocics|mesh-ancestor
102132314|NCT03183674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102132315|NCT03183674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132316|NCT03117530|Minocycline|minocycline|mesh-list
102132317|NCT03117530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102132318|NCT03117530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102132319|NCT03889925|Hyaluronic Acid|hyaluronic acid|mesh-list
102132320|NCT03889925|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102132321|NCT03889925|Immunologic Factors|immunologic factors|mesh-ancestor
102132322|NCT03889925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132323|NCT03889925|Viscosupplements|viscosupplements|mesh-ancestor
102132324|NCT03889925|Protective Agents|protective agents|mesh-ancestor
102132325|NCT05103254|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
102132326|NCT05103254|Ezetimibe|ezetimibe|mesh-list
102132327|NCT05103254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102132328|NCT05103254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102132329|NCT05103254|Antimetabolites|antimetabolites|mesh-ancestor
102132330|NCT05103254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132331|NCT05103254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102132332|NCT05103254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102132333|NCT05103254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102132334|NCT05103254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132335|NCT02426840|Calcium, Dietary|calcium, dietary|mesh-list
102132336|NCT02426840|Vitamin D|vitamin d|mesh-list
102132337|NCT02426840|Ergocalciferols|ergocalciferols|mesh-list
102132338|NCT02426840|Cholecalciferol|cholecalciferol|mesh-list
102132339|NCT02426840|Vitamins|vitamins|mesh-list
102132340|NCT02426840|Calcium|calcium|mesh-list
102132341|NCT02426840|Micronutrients|micronutrients|mesh-ancestor
102132342|NCT02426840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132343|NCT02426840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102132344|NCT02426840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102132345|NCT03178526|Lovastatin|lovastatin|mesh-list
102132346|NCT03178526|L 647318|l 647318|mesh-list
102132347|NCT03178526|Dihydromevinolin|dihydromevinolin|mesh-list
102132348|NCT03178526|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102132349|NCT03178526|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102132350|NCT03178526|Antimetabolites|antimetabolites|mesh-ancestor
102132351|NCT03178526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132352|NCT03178526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102132353|NCT03178526|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102132354|NCT03178526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102132355|NCT03857321|Insulin|insulin|mesh-list
102132356|NCT03857321|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102132357|NCT03857321|Insulin, Isophane|insulin, isophane|mesh-list
102132358|NCT03857321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102132359|NCT03857321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132360|NCT02423642|Heparin|heparin|mesh-list
102132361|NCT02423642|Anticoagulants|anticoagulants|mesh-ancestor
102132362|NCT02423642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132363|NCT02423642|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102132364|NCT02423642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102132365|NCT03180242|Trastuzumab|trastuzumab|mesh-list
102132366|NCT03180242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102132367|NCT03180242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102132368|NCT00709904|Semuloparin|semuloparin|mesh-list
102132369|NCT00709904|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102132370|NCT00709904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102132371|NCT00709904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102132372|NCT00709904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132373|NCT00709904|Anticoagulants|anticoagulants|mesh-ancestor
102132374|NCT04356989|Rivaroxaban|rivaroxaban|mesh-list
102132375|NCT04356989|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102132376|NCT04356989|Antithrombins|antithrombins|mesh-ancestor
102132377|NCT04356989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102132378|NCT04356989|Protease Inhibitors|protease inhibitors|mesh-ancestor
102132379|NCT04356989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102132380|NCT04356989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132381|NCT04356989|Anticoagulants|anticoagulants|mesh-ancestor
102132382|NCT03183596|Dexamethasone|dexamethasone|mesh-list
102132383|NCT03183596|Bupivacaine|bupivacaine|mesh-list
102132384|NCT03183596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102132385|NCT03183596|Antiemetics|antiemetics|mesh-ancestor
102132386|NCT03183596|Autonomic Agents|autonomic agents|mesh-ancestor
102132387|NCT03183596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102132388|NCT03183596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132389|NCT03183596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102132390|NCT03183596|Glucocorticoids|glucocorticoids|mesh-ancestor
102132391|NCT03183596|Hormones|hormones|mesh-ancestor
102132392|NCT03183596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102132393|NCT03183596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102132394|NCT03183596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102132395|NCT03183596|Anesthetics, Local|anesthetics, local|mesh-ancestor
102132396|NCT03183596|Anesthetics|anesthetics|mesh-ancestor
102132397|NCT03183596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102132398|NCT03183596|Sensory System Agents|sensory system agents|mesh-ancestor
102132399|NCT03117062|Salicylic Acid|salicylic acid|mesh-list
102132400|NCT03117062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102132401|NCT03117062|Antifungal Agents|antifungal agents|mesh-ancestor
102132402|NCT03117062|Keratolytic Agents|keratolytic agents|mesh-ancestor
102132403|NCT03117062|Dermatologic Agents|dermatologic agents|mesh-ancestor
102132404|NCT03620669|Durvalumab|durvalumab|mesh-list
102132405|NCT03620669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102132406|NCT03620669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102132407|NCT04325243|Sildenafil Citrate|sildenafil citrate|mesh-list
102132408|NCT04325243|Vasodilator Agents|vasodilator agents|mesh-ancestor
102132409|NCT04325243|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102132410|NCT04325243|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102132411|NCT04325243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102132412|NCT04325243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132413|NCT04325243|Urological Agents|urological agents|mesh-ancestor
102132414|NCT02419820|Aspirin|aspirin|mesh-list
102132415|NCT02419820|Clopidogrel|clopidogrel|mesh-list
102132417|NCT02419820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102132418|NCT02419820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102132419|NCT02419820|Analgesics|analgesics|mesh-ancestor
102132420|NCT02419820|Sensory System Agents|sensory system agents|mesh-ancestor
102132421|NCT02419820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102132422|NCT02419820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132423|NCT02419820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102132424|NCT02419820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102132425|NCT02419820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102132426|NCT02419820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102132427|NCT02419820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132428|NCT02419820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102132429|NCT02419820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102132430|NCT02419820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102132431|NCT02419820|Antipyretics|antipyretics|mesh-ancestor
102132432|NCT02419820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102132433|NCT02419820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102132434|NCT02419820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102132435|NCT02419820|Purinergic Agents|purinergic agents|mesh-ancestor
102132436|NCT02419820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102132437|NCT02419820|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102132438|NCT02419820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102132439|NCT02419820|Serotonin Agents|serotonin agents|mesh-ancestor
102132440|NCT05692739|Cyclosporine|cyclosporine|mesh-list
102132441|NCT05692739|Lubricant Eye Drops|lubricant eye drops|mesh-list
102132442|NCT05692739|Cyclosporins|cyclosporins|mesh-list
102132443|NCT05692739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132444|NCT05692739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102132445|NCT05692739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132446|NCT05692739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102132447|NCT05692739|Immunologic Factors|immunologic factors|mesh-ancestor
102132448|NCT05692739|Antifungal Agents|antifungal agents|mesh-ancestor
102132449|NCT05692739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102132450|NCT05692739|Dermatologic Agents|dermatologic agents|mesh-ancestor
102132451|NCT05692739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102132452|NCT05692739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102132453|NCT05692739|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102132454|NCT05692739|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102132456|NCT02419352|Neostigmine|neostigmine|mesh-list
102132457|NCT02419352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102132458|NCT02419352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102132459|NCT02419352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102132460|NCT02419352|Autonomic Agents|autonomic agents|mesh-ancestor
102132461|NCT02419352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102132462|NCT02419352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132463|NCT02419352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102132464|NCT02419352|Respiratory System Agents|respiratory system agents|mesh-ancestor
102132465|NCT02419352|Mydriatics|mydriatics|mesh-ancestor
102132466|NCT02419352|Parasympatholytics|parasympatholytics|mesh-ancestor
102132467|NCT02419352|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102132468|NCT02419352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102132469|NCT02419352|Cholinergic Agents|cholinergic agents|mesh-ancestor
102132470|NCT02419352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102132471|NCT02419352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132472|NCT02419352|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102132473|NCT02419352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102132474|NCT02419352|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102132475|NCT03365687|Vitamin D|vitamin d|mesh-list
102132476|NCT03365687|Cholecalciferol|cholecalciferol|mesh-list
102132477|NCT03365687|Vitamins|vitamins|mesh-ancestor
102132478|NCT03365687|Micronutrients|micronutrients|mesh-ancestor
102132479|NCT03365687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132480|NCT03365687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102132481|NCT03365687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102132482|NCT02419118|Dexamethasone|dexamethasone|mesh-list
102132483|NCT02419118|Lenalidomide|lenalidomide|mesh-list
102132484|NCT02419118|Daratumumab|daratumumab|mesh-list
102132486|NCT02419118|Antiemetics|antiemetics|mesh-ancestor
102132487|NCT02419118|Autonomic Agents|autonomic agents|mesh-ancestor
102132488|NCT02419118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102132489|NCT02419118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031042|NCT03148522|Serotonin Agents|serotonin agents|mesh-ancestor
102132490|NCT02419118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102132491|NCT02419118|Glucocorticoids|glucocorticoids|mesh-ancestor
102132492|NCT02419118|Hormones|hormones|mesh-ancestor
102132493|NCT02419118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102132494|NCT02419118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102132495|NCT02419118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102132496|NCT02419118|Immunologic Factors|immunologic factors|mesh-ancestor
102132497|NCT02419118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102132498|NCT02419118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102132499|NCT02419118|Growth Substances|growth substances|mesh-ancestor
102132500|NCT02419118|Growth Inhibitors|growth inhibitors|mesh-ancestor
102132501|NCT02426294|Pioglitazone|pioglitazone|mesh-list
102132502|NCT02426294|Glimepiride|glimepiride|mesh-list
102132503|NCT02426294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102132504|NCT02426294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132505|NCT02426294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102132506|NCT02426294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102132507|NCT02426294|Immunologic Factors|immunologic factors|mesh-ancestor
102132508|NCT02426450|Leucovorin|leucovorin|mesh-list
102132509|NCT02426450|Fluorouracil|fluorouracil|mesh-list
102132510|NCT02426450|Oxaliplatin|oxaliplatin|mesh-list
102132511|NCT02426450|Antimetabolites|antimetabolites|mesh-ancestor
102132512|NCT02426450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132513|NCT02426450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102132514|NCT02426450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102132515|NCT02426450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102132516|NCT02426450|Immunologic Factors|immunologic factors|mesh-ancestor
102132517|NCT02426450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132518|NCT02426450|Antidotes|antidotes|mesh-ancestor
102132519|NCT02426450|Protective Agents|protective agents|mesh-ancestor
102075182|NCT05258110|Midazolam|midazolam|mesh-list
102132520|NCT02426450|Vitamin B Complex|vitamin b complex|mesh-ancestor
102132521|NCT02426450|Vitamins|vitamins|mesh-ancestor
102132522|NCT02426450|Micronutrients|micronutrients|mesh-ancestor
102132523|NCT02426060|Warfarin|warfarin|mesh-list
102132524|NCT02426060|Anticoagulants|anticoagulants|mesh-ancestor
102132525|NCT02422784|Vitamin D|vitamin d|mesh-list
102132526|NCT02422784|Ergocalciferols|ergocalciferols|mesh-list
102132527|NCT02422784|Cholecalciferol|cholecalciferol|mesh-list
102132528|NCT02422784|Vitamins|vitamins|mesh-list
102132529|NCT02422784|Micronutrients|micronutrients|mesh-ancestor
102132530|NCT02422784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132531|NCT02422784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102132532|NCT02422784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102132533|NCT03740009|Bazedoxifene|bazedoxifene|mesh-list
102132534|NCT03740009|Estrogens|estrogens|mesh-list
102132535|NCT03740009|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
102132536|NCT03740009|Hormones|hormones|mesh-ancestor
102132537|NCT03740009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102132538|NCT03740009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132539|NCT03740009|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102132540|NCT03740009|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102132541|NCT03740009|Hormone Antagonists|hormone antagonists|mesh-ancestor
102132542|NCT03740009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102132543|NCT03179618|Vasodilator Agents|vasodilator agents|mesh-list
102132544|NCT03179618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
102132545|NCT03179618|Lipid Regulating Agents|lipid regulating agents|mesh-list
102132546|NCT03182894|Pembrolizumab|pembrolizumab|mesh-list
102132547|NCT03182894|Azacitidine|azacitidine|mesh-list
102132548|NCT03182894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102132549|NCT03182894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102132550|NCT03182894|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102132551|NCT03182894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132552|NCT03182894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102132553|NCT03182894|Antimetabolites|antimetabolites|mesh-ancestor
102132554|NCT03182894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102132555|NCT02418884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102132556|NCT02418884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102132557|NCT02418884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102132558|NCT02418884|Antimetabolites|antimetabolites|mesh-ancestor
102132559|NCT02418884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132560|NCT02418884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102132561|NCT02418884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102132562|NCT02418884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102132563|NCT02423096|Haloperidol|haloperidol|mesh-list
102132564|NCT02423096|Olanzapine|olanzapine|mesh-list
102132565|NCT02423096|Risperidone|risperidone|mesh-list
102132566|NCT02423096|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102132567|NCT02423096|Sulpiride|sulpiride|mesh-list
102132568|NCT02423096|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102132569|NCT02423096|Serotonin Agents|serotonin agents|mesh-ancestor
102132570|NCT02423096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102132571|NCT02423096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132572|NCT02423096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132573|NCT02423096|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102132574|NCT02423096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102132575|NCT02423096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102132576|NCT02423096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102132577|NCT02423096|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102132578|NCT02423096|Dopamine Agents|dopamine agents|mesh-ancestor
102132579|NCT02423096|Antiemetics|antiemetics|mesh-ancestor
102132580|NCT02423096|Autonomic Agents|autonomic agents|mesh-ancestor
102132581|NCT02423096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102132582|NCT02423096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102132583|NCT02423096|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102132584|NCT02423096|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102132585|NCT02423096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102132586|NCT02423096|Antidepressive Agents|antidepressive agents|mesh-ancestor
102132587|NCT02423096|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102132588|NCT02423096|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102132589|NCT03629951|Antipsychotic Agents|antipsychotic agents|mesh-list
102132590|NCT03629951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102132591|NCT03629951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102132592|NCT03629951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132593|NCT03629951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102132594|NCT02423018|Pregabalin|pregabalin|mesh-list
102132595|NCT02423018|Analgesics|analgesics|mesh-ancestor
102132596|NCT02423018|Sensory System Agents|sensory system agents|mesh-ancestor
102132597|NCT02423018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102132598|NCT02423018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132600|NCT02423018|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102132601|NCT02423018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102132602|NCT02423018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132603|NCT02423018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102132604|NCT02423018|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102132605|NCT02423018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102132606|NCT02423018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102132607|NCT02423018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102132608|NCT03179384|Ceftriaxone|ceftriaxone|mesh-list
102132609|NCT03179384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102132610|NCT03179384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102132611|NCT05691959|Calcium|calcium|mesh-list
102132612|NCT05691959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102132613|NCT05691959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132614|NCT02422706|Metronidazole|metronidazole|mesh-list
102132615|NCT02422706|Clarithromycin|clarithromycin|mesh-list
102132616|NCT02422706|Levofloxacin|levofloxacin|mesh-list
102132617|NCT02422706|Ofloxacin|ofloxacin|mesh-list
102132618|NCT02422706|Nitazoxanide|nitazoxanide|mesh-list
102132619|NCT02422706|Doxycycline|doxycycline|mesh-list
102132620|NCT02422706|Omeprazole|omeprazole|mesh-list
102132621|NCT02422706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102132622|NCT02422706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102132623|NCT02422706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102132624|NCT02422706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102132625|NCT02422706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102132626|NCT02422706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102132627|NCT02422706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102132628|NCT02422706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102132629|NCT02422706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132630|NCT02422706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102132631|NCT02422706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102132632|NCT02422706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102132633|NCT02422706|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102132634|NCT02422706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101841658|NCT00972257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102132635|NCT02422706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102132636|NCT02422706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102132637|NCT02422706|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102132638|NCT02422706|Antimalarials|antimalarials|mesh-ancestor
102132640|NCT03058757|Mitomycin|mitomycin|mesh-list
102132641|NCT03058757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102132642|NCT03058757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102132643|NCT03058757|Alkylating Agents|alkylating agents|mesh-ancestor
102132644|NCT03058757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132645|NCT03058757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102132646|NCT03058757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102132647|NCT03138889|Paclitaxel|paclitaxel|mesh-list
102132648|NCT03138889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102132649|NCT03138889|Carboplatin|carboplatin|mesh-list
102132650|NCT03138889|Pembrolizumab|pembrolizumab|mesh-list
102132651|NCT03138889|Pemetrexed|pemetrexed|mesh-list
102132652|NCT03138889|Atezolizumab|atezolizumab|mesh-list
102132653|NCT03138889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102132654|NCT03138889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102132655|NCT03138889|Tubulin Modulators|tubulin modulators|mesh-ancestor
102132656|NCT03138889|Antimitotic Agents|antimitotic agents|mesh-ancestor
102132657|NCT03138889|Mitosis Modulators|mitosis modulators|mesh-ancestor
102132658|NCT03138889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132659|NCT03138889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102132660|NCT03138889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102132661|NCT03138889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102132662|NCT03138889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102132663|NCT03138889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102132664|NCT01881763|Ketamine|ketamine|mesh-list
102132665|NCT01881763|Methohexital|methohexital|mesh-list
102132666|NCT01881763|Analgesics|analgesics|mesh-ancestor
102132667|NCT01881763|Sensory System Agents|sensory system agents|mesh-ancestor
102132668|NCT01881763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102132669|NCT01881763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132670|NCT01881763|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102132671|NCT01881763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102132672|NCT01881763|Anesthetics, General|anesthetics, general|mesh-ancestor
102132673|NCT01881763|Anesthetics|anesthetics|mesh-ancestor
102132674|NCT01881763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102132675|NCT01881763|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102132676|NCT01881763|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102132677|NCT01881763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102132678|NCT01881763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132679|NCT03669601|Gemcitabine|gemcitabine|mesh-list
102132680|NCT03669601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102132681|NCT03669601|Antimetabolites|antimetabolites|mesh-ancestor
102132682|NCT03669601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132683|NCT03669601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102132684|NCT02416388|Cytarabine|cytarabine|mesh-list
102132685|NCT02416388|Cyclosporine|cyclosporine|mesh-list
102132686|NCT02416388|Mycophenolic Acid|mycophenolic acid|mesh-list
102132687|NCT02416388|Dexamethasone|dexamethasone|mesh-list
102132688|NCT02416388|Methotrexate|methotrexate|mesh-list
102132689|NCT02416388|Daunorubicin|daunorubicin|mesh-list
102132690|NCT02416388|Venetoclax|venetoclax|mesh-list
102132691|NCT02416388|Idarubicin|idarubicin|mesh-list
102132692|NCT02416388|Cyclosporins|cyclosporins|mesh-list
102132693|NCT02416388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102132694|NCT02416388|Antiemetics|antiemetics|mesh-ancestor
102132695|NCT02416388|Autonomic Agents|autonomic agents|mesh-ancestor
102132696|NCT02416388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102132697|NCT02416388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132698|NCT02416388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102132699|NCT02416388|Glucocorticoids|glucocorticoids|mesh-ancestor
102132700|NCT02416388|Hormones|hormones|mesh-ancestor
102132701|NCT02416388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102132702|NCT02416388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102132703|NCT02416388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102132704|NCT02416388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102132705|NCT02416388|Abortifacient Agents|abortifacient agents|mesh-ancestor
102132706|NCT02416388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102132707|NCT02416388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102132708|NCT02416388|Antimetabolites|antimetabolites|mesh-ancestor
102132709|NCT02416388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132710|NCT02416388|Dermatologic Agents|dermatologic agents|mesh-ancestor
102132712|NCT02416388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102132713|NCT02416388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102132714|NCT02416388|Immunologic Factors|immunologic factors|mesh-ancestor
102132715|NCT02416388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102132716|NCT02416388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102132717|NCT02416388|Antiviral Agents|antiviral agents|mesh-ancestor
102132718|NCT02416388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102132719|NCT02416388|Antifungal Agents|antifungal agents|mesh-ancestor
102132720|NCT02416388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102132721|NCT02416388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102132722|NCT02416388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102132723|NCT02416388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102132724|NCT02416388|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102132725|NCT02416388|Antitubercular Agents|antitubercular agents|mesh-ancestor
102132726|NCT02416388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102132727|NCT02886065|Lenalidomide|lenalidomide|mesh-list
102132728|NCT02886065|Poly ICLC|poly iclc|mesh-list
102132729|NCT02886065|Citarinostat|citarinostat|mesh-list
102132730|NCT02886065|Immunologic Factors|immunologic factors|mesh-ancestor
102132731|NCT02886065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132732|NCT02886065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102132733|NCT02886065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102132734|NCT02886065|Growth Substances|growth substances|mesh-ancestor
102132735|NCT02886065|Growth Inhibitors|growth inhibitors|mesh-ancestor
102132736|NCT02886065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102132737|NCT02886065|Interferon Inducers|interferon inducers|mesh-ancestor
102132738|NCT02886065|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102132739|NCT02886065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102132740|NCT02886065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132741|NCT03392441|Insulin|insulin|mesh-list
102132742|NCT03392441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102132743|NCT03392441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132744|NCT03177824|Sildenafil Citrate|sildenafil citrate|mesh-list
102132745|NCT03177824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132746|NCT03177824|Vasodilator Agents|vasodilator agents|mesh-ancestor
102132747|NCT03177824|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102132748|NCT03177824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102132749|NCT03177824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102132750|NCT03177824|Urological Agents|urological agents|mesh-ancestor
102132751|NCT02416232|Trametinib|trametinib|mesh-list
102132752|NCT02416232|Dabrafenib|dabrafenib|mesh-list
102132753|NCT02416232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102132754|NCT02416232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102132755|NCT02416232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102132756|NCT02416232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132757|NCT04482842|Warfarin|warfarin|mesh-list
102132758|NCT04482842|Anticoagulants|anticoagulants|mesh-ancestor
102132759|NCT02767661|Capecitabine|capecitabine|mesh-list
102132760|NCT02767661|Letrozole|letrozole|mesh-list
102132761|NCT02767661|Anastrozole|anastrozole|mesh-list
102132762|NCT02767661|Exemestane|exemestane|mesh-list
102132763|NCT02767661|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102132764|NCT02767661|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102132765|NCT02767661|Antimetabolites|antimetabolites|mesh-ancestor
102132766|NCT02767661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132767|NCT02767661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102132768|NCT02767661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102132769|NCT02767661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102132770|NCT02767661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102132771|NCT02767661|Hormone Antagonists|hormone antagonists|mesh-ancestor
102132772|NCT02767661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102132773|NCT02767661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132774|NCT02767661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102132775|NCT02415920|Oxytocin|oxytocin|mesh-list
102132776|NCT02415920|Oxytocics|oxytocics|mesh-ancestor
102132777|NCT02415920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102132778|NCT02415920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132779|NCT03389243|Acetaminophen|acetaminophen|mesh-list
102132780|NCT03389243|Dipyrone|dipyrone|mesh-list
102132781|NCT03389243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102132782|NCT03389243|Analgesics|analgesics|mesh-ancestor
102132783|NCT03389243|Sensory System Agents|sensory system agents|mesh-ancestor
102132784|NCT03389243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102132785|NCT03389243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132786|NCT03389243|Antipyretics|antipyretics|mesh-ancestor
102132787|NCT03389243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102132788|NCT03389243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102132789|NCT03389243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102132790|NCT02421926|Imatinib Mesylate|imatinib mesylate|mesh-list
102132791|NCT02421926|Dasatinib|dasatinib|mesh-list
102132792|NCT02421926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102132793|NCT02421926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102132794|NCT02421926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102132795|NCT02421926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132796|NCT02410460|Lidocaine|lidocaine|mesh-list
102132797|NCT02410460|Clonidine|clonidine|mesh-list
102132798|NCT02410460|Midazolam|midazolam|mesh-list
102132799|NCT02410460|Glycopyrrolate|glycopyrrolate|mesh-list
102132800|NCT02410460|Scopolamine|scopolamine|mesh-list
102132801|NCT02410460|Ketamine|ketamine|mesh-list
102132802|NCT02410460|Ondansetron|ondansetron|mesh-list
102132803|NCT02410460|Metoclopramide|metoclopramide|mesh-list
102132804|NCT02410460|Bupivacaine|bupivacaine|mesh-list
102132805|NCT02410460|Propofol|propofol|mesh-list
102132806|NCT02410460|Sevoflurane|sevoflurane|mesh-list
102132807|NCT02410460|Desflurane|desflurane|mesh-list
102132808|NCT02410460|Famotidine|famotidine|mesh-list
102132809|NCT02410460|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102132810|NCT02410460|Anesthetics, Local|anesthetics, local|mesh-ancestor
102132811|NCT02410460|Anesthetics|anesthetics|mesh-ancestor
102132812|NCT02410460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102132813|NCT02410460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132814|NCT02410460|Sensory System Agents|sensory system agents|mesh-ancestor
102132815|NCT02410460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102132816|NCT02410460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102132817|NCT02410460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102132818|NCT02410460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102132819|NCT02410460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102132820|NCT02410460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132821|NCT02410460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102132822|NCT02410460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102132823|NCT02410460|Anesthetics, General|anesthetics, general|mesh-ancestor
102132824|NCT02410460|Analgesics|analgesics|mesh-ancestor
102132825|NCT02410460|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102132826|NCT02410460|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102132827|NCT02410460|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102132828|NCT02410460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102132829|NCT02410460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102132830|NCT02410460|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102132831|NCT02410460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102132832|NCT02410460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102132833|NCT02410460|GABA Modulators|gaba modulators|mesh-ancestor
102132834|NCT02410460|GABA Agents|gaba agents|mesh-ancestor
102132835|NCT02410460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102132836|NCT02410460|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102132837|NCT02410460|Antiemetics|antiemetics|mesh-ancestor
102132838|NCT02410460|Autonomic Agents|autonomic agents|mesh-ancestor
102132839|NCT02410460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102132840|NCT02410460|Antipruritics|antipruritics|mesh-ancestor
102132841|NCT02410460|Dermatologic Agents|dermatologic agents|mesh-ancestor
102132842|NCT02410460|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102132843|NCT02410460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102132844|NCT02410460|Serotonin Agents|serotonin agents|mesh-ancestor
102132845|NCT02410460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102132846|NCT02410460|Sympatholytics|sympatholytics|mesh-ancestor
102132847|NCT02410460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102132848|NCT02410460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102132849|NCT02410460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102132850|NCT02410460|Adrenergic Agents|adrenergic agents|mesh-ancestor
102132851|NCT02410460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102132852|NCT02410460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102132853|NCT02410460|Dopamine Agents|dopamine agents|mesh-ancestor
102132854|NCT02410460|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102132855|NCT02410460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102132856|NCT02410460|Cholinergic Agents|cholinergic agents|mesh-ancestor
102132857|NCT02410460|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102132858|NCT02410460|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102132859|NCT02410460|Histamine Antagonists|histamine antagonists|mesh-ancestor
102132860|NCT02410460|Histamine Agents|histamine agents|mesh-ancestor
102132861|NCT02410460|Mydriatics|mydriatics|mesh-ancestor
102132862|NCT02410460|Parasympatholytics|parasympatholytics|mesh-ancestor
102132863|NCT02410226|Anesthetics|anesthetics|mesh-list
102132864|NCT02410226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102132865|NCT02410226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132866|NCT03116672|Diclofenac|diclofenac|mesh-list
102132867|NCT03116672|Ketorolac|ketorolac|mesh-list
102132868|NCT03116672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102132869|NCT03116672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102132870|NCT03116672|Analgesics|analgesics|mesh-ancestor
102132871|NCT03116672|Sensory System Agents|sensory system agents|mesh-ancestor
102132872|NCT03116672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102132873|NCT03116672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132874|NCT03116672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102132875|NCT03116672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102132876|NCT03116672|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102132877|NCT03116672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102132878|NCT03116672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132879|NCT03174860|Diclofenac|diclofenac|mesh-list
102132880|NCT03174860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102132881|NCT03174860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102132882|NCT03174860|Analgesics|analgesics|mesh-ancestor
102132883|NCT03174860|Sensory System Agents|sensory system agents|mesh-ancestor
102132884|NCT03174860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102132885|NCT03174860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132886|NCT03174860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102132887|NCT03174860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102132888|NCT03174860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102132889|NCT03174860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102132890|NCT03174860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132891|NCT03174548|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
102132892|NCT03174548|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102132893|NCT03174548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132894|NCT03174548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102132895|NCT03174548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132896|NCT02417090|Metformin|metformin|mesh-list
102132897|NCT02417090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102132898|NCT02417090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132899|NCT00703820|Cytarabine|cytarabine|mesh-list
102132900|NCT00703820|Etoposide|etoposide|mesh-list
102132901|NCT00703820|Daunorubicin|daunorubicin|mesh-list
102132902|NCT00703820|Clofarabine|clofarabine|mesh-list
102132903|NCT00703820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102132904|NCT00703820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102132905|NCT00703820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102132906|NCT00703820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102132907|NCT00703820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102132908|NCT00703820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132909|NCT00703820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102132910|NCT00703820|Antimetabolites|antimetabolites|mesh-ancestor
102132911|NCT00703820|Antiviral Agents|antiviral agents|mesh-ancestor
102132912|NCT00703820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102132913|NCT00703820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102132914|NCT00703820|Immunologic Factors|immunologic factors|mesh-ancestor
102132915|NCT00703820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132916|NCT00703820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102132917|NCT03177980|Clonidine|clonidine|mesh-list
102132918|NCT03177980|Fentanyl|fentanyl|mesh-list
102132919|NCT03177980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102132920|NCT03177980|Narcotics|narcotics|mesh-ancestor
102132921|NCT03177980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102132922|NCT03177980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132923|NCT03177980|Analgesics|analgesics|mesh-ancestor
102132924|NCT03177980|Sensory System Agents|sensory system agents|mesh-ancestor
102132925|NCT03177980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102132926|NCT03177980|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102132927|NCT03177980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102132928|NCT03177980|Anesthetics, General|anesthetics, general|mesh-ancestor
102132929|NCT03177980|Anesthetics|anesthetics|mesh-ancestor
102132930|NCT03177980|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102132931|NCT03177980|Sympatholytics|sympatholytics|mesh-ancestor
102132932|NCT03177980|Autonomic Agents|autonomic agents|mesh-ancestor
102132933|NCT03177980|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102132934|NCT03177980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102132935|NCT03177980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102132936|NCT03177980|Adrenergic Agents|adrenergic agents|mesh-ancestor
102132937|NCT03177980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102132938|NCT03177980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132939|NCT03177434|Lactulose|lactulose|mesh-list
102132940|NCT03177434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102132941|NCT02587325|Sirolimus|sirolimus|mesh-list
102132942|NCT02587325|Temsirolimus|temsirolimus|mesh-list
102132943|NCT02587325|MTOR Inhibitors|mtor inhibitors|mesh-list
102132944|NCT02587325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102132945|NCT02587325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102132946|NCT02587325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102132947|NCT02587325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102132948|NCT02587325|Antifungal Agents|antifungal agents|mesh-ancestor
102132949|NCT02587325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102132950|NCT02587325|Immunologic Factors|immunologic factors|mesh-ancestor
102132951|NCT02587325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132952|NCT02587325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102132953|NCT02587325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102132954|NCT02587325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132955|NCT02414984|Golimumab|golimumab|mesh-list
102132956|NCT02414984|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102132957|NCT02414984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102132958|NCT02414984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102132959|NCT02414984|Immunologic Factors|immunologic factors|mesh-ancestor
102132960|NCT02414984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132961|NCT02415062|Donepezil|donepezil|mesh-list
102132962|NCT02415062|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102132963|NCT02415062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102132964|NCT02415062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132965|NCT02415062|Cholinergic Agents|cholinergic agents|mesh-ancestor
102132966|NCT02415062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102132967|NCT02415062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132968|NCT02415062|Nootropic Agents|nootropic agents|mesh-ancestor
102132969|NCT02408978|Naproxen|naproxen|mesh-list
102132970|NCT02408978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102132971|NCT02408978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102132972|NCT02408978|Analgesics|analgesics|mesh-ancestor
102132973|NCT02408978|Sensory System Agents|sensory system agents|mesh-ancestor
102132974|NCT02408978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102132975|NCT02408978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132976|NCT02408978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102132977|NCT02408978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102535892|NCT00554099|Sensory System Agents|sensory system agents|mesh-ancestor
102132978|NCT02408978|Gout Suppressants|gout suppressants|mesh-ancestor
102132979|NCT02408978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102132980|NCT02408978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102132981|NCT02408978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102132982|NCT02408744|Pirfenidone|pirfenidone|mesh-list
102132983|NCT02408744|Analgesics|analgesics|mesh-ancestor
102132984|NCT02408744|Sensory System Agents|sensory system agents|mesh-ancestor
102132985|NCT02408744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102132986|NCT02408744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132987|NCT02408744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102132988|NCT02408744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102132989|NCT02408744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102132990|NCT02408744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102132991|NCT02408744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102132992|NCT03174080|Fluorides|fluorides|mesh-list
102132993|NCT03174080|Cariostatic Agents|cariostatic agents|mesh-ancestor
102132994|NCT03174080|Protective Agents|protective agents|mesh-ancestor
102132995|NCT03174080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102132996|NCT03116516|Amlodipine|amlodipine|mesh-list
102132997|NCT03116516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102132998|NCT03116516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102132999|NCT03116516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102133000|NCT03116516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102133001|NCT03116516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133002|NCT03116516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102133003|NCT03116516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133004|NCT03116516|Vasodilator Agents|vasodilator agents|mesh-ancestor
102133005|NCT03116516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102133006|NCT03116516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102133007|NCT03116516|Antimetabolites|antimetabolites|mesh-ancestor
102133008|NCT03116516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102133009|NCT03116516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102133010|NCT03116516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102133011|NCT01564537|Dexamethasone|dexamethasone|mesh-list
102133012|NCT01564537|Lenalidomide|lenalidomide|mesh-list
102133013|NCT01564537|Ixazomib|ixazomib|mesh-list
101842025|NCT00980213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102133014|NCT01564537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102133015|NCT01564537|Antiemetics|antiemetics|mesh-ancestor
102133016|NCT01564537|Autonomic Agents|autonomic agents|mesh-ancestor
102133017|NCT01564537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102133018|NCT01564537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133019|NCT01564537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102133020|NCT01564537|Glucocorticoids|glucocorticoids|mesh-ancestor
102133021|NCT01564537|Hormones|hormones|mesh-ancestor
102133022|NCT01564537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102133023|NCT01564537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102133024|NCT01564537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102133025|NCT01564537|Immunologic Factors|immunologic factors|mesh-ancestor
102133026|NCT01564537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102133027|NCT01564537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102133028|NCT01564537|Growth Substances|growth substances|mesh-ancestor
102133029|NCT01564537|Growth Inhibitors|growth inhibitors|mesh-ancestor
102133030|NCT01564537|Protease Inhibitors|protease inhibitors|mesh-ancestor
102133031|NCT01564537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102133032|NCT01564537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133033|NCT03174236|Metronidazole|metronidazole|mesh-list
102133034|NCT03174236|Gentamicins|gentamicins|mesh-list
102133035|NCT03174236|Ceftriaxone|ceftriaxone|mesh-list
102133036|NCT03174236|Penicillins|penicillins|mesh-list
102133037|NCT03174236|Penicillin G|penicillin g|mesh-list
102133038|NCT03174236|Penicillin G Benzathine|penicillin g benzathine|mesh-list
102133039|NCT03174236|Penicillin G Procaine|penicillin g procaine|mesh-list
102133040|NCT03174236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102133041|NCT03174236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102133042|NCT03174236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102133043|NCT03174236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102133044|NCT03174236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102133045|NCT03174236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102133046|NCT03174236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133047|NCT03172052|Streptokinase|streptokinase|mesh-list
102133048|NCT03172052|Mesna|mesna|mesh-list
102031601|NCT02326168|BCG Vaccine|bcg vaccine|mesh-list
102133049|NCT03172052|Protective Agents|protective agents|mesh-ancestor
102133050|NCT03172052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133051|NCT03172052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102133052|NCT03172052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102133053|NCT03172052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133055|NCT03171818|Hematinics|hematinics|mesh-ancestor
102133056|NCT02408354|Glycerol|glycerol|mesh-list
102133057|NCT02408354|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102133058|NCT02408354|Protective Agents|protective agents|mesh-ancestor
102133059|NCT02408354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133060|NCT03176264|Bevacizumab|bevacizumab|mesh-list
102133061|NCT03176264|Spartalizumab|spartalizumab|mesh-list
102133062|NCT03176264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102133063|NCT03176264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102133064|NCT03176264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102133065|NCT03176264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102133066|NCT03176264|Growth Substances|growth substances|mesh-ancestor
102133067|NCT03176264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133068|NCT03176264|Growth Inhibitors|growth inhibitors|mesh-ancestor
102133069|NCT03176264|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102133070|NCT03176264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133071|NCT02406170|Paclitaxel|paclitaxel|mesh-list
102133072|NCT02406170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102133073|NCT02406170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102133074|NCT02406170|Tubulin Modulators|tubulin modulators|mesh-ancestor
102133075|NCT02406170|Antimitotic Agents|antimitotic agents|mesh-ancestor
102133076|NCT02406170|Mitosis Modulators|mitosis modulators|mesh-ancestor
102133077|NCT02406170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133078|NCT02413658|Phenytoin|phenytoin|mesh-list
102133079|NCT02413658|Anticonvulsants|anticonvulsants|mesh-ancestor
102133080|NCT02413658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102133081|NCT02413658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102133082|NCT02413658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102133083|NCT02413658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133084|NCT02413658|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102133085|NCT02413658|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102133086|NCT02406014|Diclofenac|diclofenac|mesh-list
102133087|NCT02406014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102133088|NCT02406014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102133089|NCT02406014|Analgesics|analgesics|mesh-ancestor
102133090|NCT02406014|Sensory System Agents|sensory system agents|mesh-ancestor
102133091|NCT02406014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102133092|NCT02406014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133093|NCT02406014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102133094|NCT02406014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102133095|NCT02406014|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102133096|NCT02406014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102133097|NCT02406014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133099|NCT02406092|Cyclophosphamide|cyclophosphamide|mesh-list
102133100|NCT02406092|Rituximab|rituximab|mesh-list
102133101|NCT02406092|Doxorubicin|doxorubicin|mesh-list
102133102|NCT02406092|Fludarabine|fludarabine|mesh-list
102133103|NCT02406092|Vincristine|vincristine|mesh-list
102133104|NCT02406092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102133105|NCT02406092|Immunologic Factors|immunologic factors|mesh-ancestor
102133106|NCT02406092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133107|NCT02406092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102133108|NCT02406092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102133109|NCT02406092|Alkylating Agents|alkylating agents|mesh-ancestor
102031672|NCT02330380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102133110|NCT02406092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133111|NCT02406092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102133112|NCT02406092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102133113|NCT02406092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102133114|NCT02406092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102133115|NCT02406092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102133116|NCT02406092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102133117|NCT02406092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102133118|NCT02406092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102133119|NCT02406092|Glucocorticoids|glucocorticoids|mesh-ancestor
102133120|NCT02406092|Hormones|hormones|mesh-ancestor
102133121|NCT02406092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102133122|NCT02406092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102133123|NCT02406092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102133124|NCT02406092|Tubulin Modulators|tubulin modulators|mesh-ancestor
102133125|NCT02406092|Antimitotic Agents|antimitotic agents|mesh-ancestor
102133126|NCT02406092|Mitosis Modulators|mitosis modulators|mesh-ancestor
102133127|NCT02413268|Nitroglycerin|nitroglycerin|mesh-list
102133128|NCT02413268|Vasodilator Agents|vasodilator agents|mesh-ancestor
102133129|NCT02405858|Prednisolone|prednisolone|mesh-list
102133130|NCT02405858|Abiraterone Acetate|abiraterone acetate|mesh-list
102133131|NCT02405858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102133132|NCT02405858|Glucocorticoids|glucocorticoids|mesh-ancestor
102133133|NCT02405858|Hormones|hormones|mesh-ancestor
102133134|NCT02405858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102133135|NCT02405858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133136|NCT02405858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102133137|NCT02405858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102133138|NCT02405858|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102133139|NCT02405858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102133140|NCT02405858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133141|NCT02405858|Hormone Antagonists|hormone antagonists|mesh-ancestor
102133142|NCT02405858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102133143|NCT03171740|Midazolam|midazolam|mesh-list
102133144|NCT03171740|Dexmedetomidine|dexmedetomidine|mesh-list
102133145|NCT03171740|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102133146|NCT03171740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102133147|NCT03171740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102133148|NCT03171740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133149|NCT03171740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102133150|NCT03171740|Analgesics|analgesics|mesh-ancestor
102133151|NCT03171740|Sensory System Agents|sensory system agents|mesh-ancestor
102133152|NCT03171740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102133153|NCT03171740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102133154|NCT03171740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102133155|NCT03171740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102133156|NCT03171740|Adrenergic Agents|adrenergic agents|mesh-ancestor
102133157|NCT03171740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102133158|NCT03171740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133159|NCT03171740|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102133160|NCT03171740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102133161|NCT03171740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102133162|NCT03171740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102133163|NCT03171740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102133164|NCT03171740|Anesthetics, General|anesthetics, general|mesh-ancestor
102133165|NCT03171740|Anesthetics|anesthetics|mesh-ancestor
102133166|NCT03171740|GABA Modulators|gaba modulators|mesh-ancestor
102133167|NCT03171740|GABA Agents|gaba agents|mesh-ancestor
102133168|NCT03176186|Xenon|xenon|mesh-list
102133169|NCT03176186|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102133170|NCT03176186|Anesthetics, General|anesthetics, general|mesh-ancestor
102133171|NCT03176186|Anesthetics|anesthetics|mesh-ancestor
102133172|NCT03176186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102133173|NCT03176186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133174|NCT04482764|Valproic Acid|valproic acid|mesh-list
102133175|NCT04482764|Anticonvulsants|anticonvulsants|mesh-ancestor
102133176|NCT04482764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102133177|NCT04482764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133178|NCT04482764|GABA Agents|gaba agents|mesh-ancestor
102133179|NCT04482764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102133180|NCT04482764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133181|NCT04482764|Antimanic Agents|antimanic agents|mesh-ancestor
102133182|NCT04482764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102133183|NCT04482764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102133184|NCT04482764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102133185|NCT02408042|Rituximab|rituximab|mesh-list
102133186|NCT02408042|Pembrolizumab|pembrolizumab|mesh-list
102133187|NCT02408042|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102133188|NCT02408042|Carboplatin|carboplatin|mesh-list
102133189|NCT02408042|Etoposide|etoposide|mesh-list
102133190|NCT02408042|Ifosfamide|ifosfamide|mesh-list
102133191|NCT02408042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102133192|NCT02408042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102133193|NCT02408042|Immunologic Factors|immunologic factors|mesh-ancestor
102133194|NCT02408042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133195|NCT02408042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102133196|NCT02408042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102133197|NCT02408042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133198|NCT02408042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102133199|NCT02408042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102133200|NCT02408042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102133201|NCT02408042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102133202|NCT02408042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102133203|NCT02408042|Alkylating Agents|alkylating agents|mesh-ancestor
102133205|NCT02408042|Immunoconjugates|immunoconjugates|mesh-ancestor
102133206|NCT03172988|Dexamethasone|dexamethasone|mesh-list
102133207|NCT03172988|Dexamethasone acetate|dexamethasone acetate|mesh-list
102133208|NCT03172988|Flurbiprofen|flurbiprofen|mesh-list
102133209|NCT03172988|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
102133210|NCT03172988|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102133211|NCT03172988|BB 1101|bb 1101|mesh-list
102133212|NCT03172988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102133213|NCT03172988|Antiemetics|antiemetics|mesh-ancestor
102133214|NCT03172988|Autonomic Agents|autonomic agents|mesh-ancestor
102133215|NCT03172988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102133216|NCT03172988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133217|NCT03172988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102133218|NCT03172988|Glucocorticoids|glucocorticoids|mesh-ancestor
102133219|NCT03172988|Hormones|hormones|mesh-ancestor
102133220|NCT03172988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102133221|NCT03172988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102133222|NCT03172988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102133223|NCT03172988|Protease Inhibitors|protease inhibitors|mesh-ancestor
102133224|NCT03172988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102133225|NCT03172988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133226|NCT03172988|Analgesics|analgesics|mesh-ancestor
102133227|NCT03172988|Sensory System Agents|sensory system agents|mesh-ancestor
102133228|NCT03172988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102133229|NCT03172988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102133230|NCT03172988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102133231|NCT03172988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102133232|NCT03042611|Apatinib|apatinib|mesh-list
102133233|NCT03042611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102133234|NCT03042611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102133235|NCT03042611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102133236|NCT03042611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133237|NCT03171584|Itraconazole|itraconazole|mesh-list
102133238|NCT03171584|Fluconazole|fluconazole|mesh-list
102133239|NCT03171584|Terbinafine|terbinafine|mesh-list
102133240|NCT03171584|Antifungal Agents|antifungal agents|mesh-ancestor
102133242|NCT03171584|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102133243|NCT03171584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102133244|NCT03171584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102031813|NCT04278404|GABA Agents|gaba agents|mesh-ancestor
102133245|NCT03171584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133246|NCT03171584|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102133247|NCT03171584|Hormone Antagonists|hormone antagonists|mesh-ancestor
102133248|NCT03171584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102133249|NCT03171584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133250|NCT03171584|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102133251|NCT03171584|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102133252|NCT03171584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102133253|NCT02950259|Indomethacin|indomethacin|mesh-list
102133254|NCT02950259|Cyclophosphamide|cyclophosphamide|mesh-list
102133255|NCT02950259|Omeprazole|omeprazole|mesh-list
102133256|NCT02950259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102133257|NCT02950259|Immunologic Factors|immunologic factors|mesh-ancestor
102133258|NCT02950259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133259|NCT02950259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102133260|NCT02950259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102133261|NCT02950259|Alkylating Agents|alkylating agents|mesh-ancestor
102133262|NCT02950259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133263|NCT02950259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102133264|NCT02950259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102133265|NCT02950259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102133266|NCT02950259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102133267|NCT02950259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102133268|NCT02950259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102133269|NCT02950259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102133270|NCT02950259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102133271|NCT02950259|Analgesics|analgesics|mesh-ancestor
102133272|NCT02950259|Sensory System Agents|sensory system agents|mesh-ancestor
102133273|NCT02950259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102133274|NCT02950259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102133275|NCT02950259|Gout Suppressants|gout suppressants|mesh-ancestor
102133276|NCT02950259|Tocolytic Agents|tocolytic agents|mesh-ancestor
102133277|NCT02950259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102133278|NCT02950259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102133279|NCT02349815|Levonorgestrel|levonorgestrel|mesh-list
102133280|NCT02349815|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102133281|NCT02349815|Contraceptive Agents|contraceptive agents|mesh-ancestor
102133282|NCT02349815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102133283|NCT02349815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133284|NCT02349815|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102133285|NCT02349815|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102133286|NCT02349815|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102133287|NCT02818517|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102133288|NCT02818517|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102133289|NCT02818517|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102133290|NCT02818517|Adrenergic Agents|adrenergic agents|mesh-ancestor
102133291|NCT02818517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102133292|NCT02818517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133293|NCT02818517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133294|NCT02818517|Protease Inhibitors|protease inhibitors|mesh-ancestor
102133295|NCT02818517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102133296|NCT02407340|Benzalkonium Compounds|benzalkonium compounds|mesh-list
102133297|NCT02407340|Oxytocin|oxytocin|mesh-list
102133298|NCT02407340|Oxytocics|oxytocics|mesh-ancestor
102133299|NCT02407340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102133300|NCT02407340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133301|NCT02407340|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102133302|NCT02407340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102133303|NCT02405156|Letrozole|letrozole|mesh-list
102133304|NCT02405156|Misoprostol|misoprostol|mesh-list
102133305|NCT02405156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102133306|NCT02405156|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102133307|NCT02405156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102133308|NCT02405156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102133309|NCT02405156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133310|NCT02405156|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102133311|NCT02405156|Hormone Antagonists|hormone antagonists|mesh-ancestor
101842310|NCT00293722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102133312|NCT02405156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102133313|NCT02405156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133314|NCT02405156|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102133315|NCT02405156|Abortifacient Agents|abortifacient agents|mesh-ancestor
102133316|NCT02405156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102133317|NCT02405156|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102133318|NCT02405156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102133319|NCT02405156|Oxytocics|oxytocics|mesh-ancestor
102133320|NCT02411942|Adapalene|adapalene|mesh-list
102133321|NCT02411942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102133322|NCT02411942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102133323|NCT02411942|Analgesics|analgesics|mesh-ancestor
102133324|NCT02411942|Sensory System Agents|sensory system agents|mesh-ancestor
102133325|NCT02411942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102133326|NCT02411942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133327|NCT02411942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102133328|NCT02411942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102133329|NCT02411942|Dermatologic Agents|dermatologic agents|mesh-ancestor
102133330|NCT02406950|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102133331|NCT02406950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102133332|NCT02406950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133333|NCT02406950|Incretins|incretins|mesh-ancestor
102133334|NCT02406950|Hormones|hormones|mesh-ancestor
102133335|NCT02406950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102133336|NCT02406950|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102133337|NCT02406950|Protease Inhibitors|protease inhibitors|mesh-ancestor
102133338|NCT02406950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102133339|NCT02406950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133340|NCT02406872|Propofol|propofol|mesh-list
102133341|NCT02406872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102133342|NCT02406872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102133343|NCT02406872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133344|NCT02406872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102133345|NCT02406872|Anesthetics, General|anesthetics, general|mesh-ancestor
102133346|NCT02406872|Anesthetics|anesthetics|mesh-ancestor
102133347|NCT03172676|Amoxicillin|amoxicillin|mesh-list
102133348|NCT03172676|Clarithromycin|clarithromycin|mesh-list
102535893|NCT00554099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102133349|NCT03172676|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
102133350|NCT03172676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102133351|NCT03172676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102133352|NCT03172676|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102133353|NCT03172676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102133354|NCT03172676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133355|NCT03172676|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102133356|NCT03172676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102133357|NCT02404844|Tamoxifen|tamoxifen|mesh-list
102133358|NCT02404844|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102133359|NCT02404844|Hormone Antagonists|hormone antagonists|mesh-ancestor
102133360|NCT02404844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102133361|NCT02404844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133362|NCT02404844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102133363|NCT02404844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102133364|NCT02404844|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102133365|NCT02404844|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102133366|NCT02404844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102133367|NCT04482296|Zinc Sulfate|zinc sulfate|mesh-list
102133368|NCT04482296|Astringents|astringents|mesh-ancestor
102133369|NCT04482296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133370|NCT04482296|Dermatologic Agents|dermatologic agents|mesh-ancestor
102133371|NCT03116282|Ethanol|ethanol|mesh-list
102133372|NCT03116282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102133373|NCT03116282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102133374|NCT03116282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102133375|NCT03116282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133376|NCT02404454|Hyaluronic Acid|hyaluronic acid|mesh-list
102133377|NCT02404454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102133378|NCT02404454|Immunologic Factors|immunologic factors|mesh-ancestor
102133379|NCT02404454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133380|NCT02404454|Viscosupplements|viscosupplements|mesh-ancestor
102133381|NCT02404454|Protective Agents|protective agents|mesh-ancestor
102133382|NCT03115892|Chlorhexidine|chlorhexidine|mesh-list
102133383|NCT03115892|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102133384|NCT03115892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102133385|NCT03115892|Disinfectants|disinfectants|mesh-ancestor
102133386|NCT02411786|Molgramostim|molgramostim|mesh-list
102133387|NCT02411786|Sargramostim|sargramostim|mesh-list
102133388|NCT02411786|Immunologic Factors|immunologic factors|mesh-ancestor
102133389|NCT02411786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133390|NCT02411786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102133391|NCT02404376|Exenatide|exenatide|mesh-list
102133392|NCT02404376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102133393|NCT02404376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133394|NCT02404376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102133395|NCT02404376|Incretins|incretins|mesh-ancestor
102133396|NCT02404376|Hormones|hormones|mesh-ancestor
102133397|NCT02404376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102133398|NCT04466085|Vaccines|vaccines|mesh-list
102133399|NCT04466085|Immunologic Factors|immunologic factors|mesh-ancestor
102133400|NCT04466085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133401|NCT03517995|Sulforaphane|sulforaphane|mesh-list
102133402|NCT03517995|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102133403|NCT03517995|Protective Agents|protective agents|mesh-ancestor
102133404|NCT03517995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133405|NCT03517995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102133406|NCT02411630|Tenofovir|tenofovir|mesh-list
102133407|NCT02411630|Emtricitabine|emtricitabine|mesh-list
102133408|NCT02411630|Antiviral Agents|antiviral agents|mesh-ancestor
102133409|NCT02411630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102133410|NCT02411630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102133411|NCT02411630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102133412|NCT02411630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102133413|NCT02411630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133414|NCT02411630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102133415|NCT02411630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102133416|NCT02411318|Ethanol|ethanol|mesh-list
102133417|NCT02411318|Caffeine|caffeine|mesh-list
102133418|NCT02411318|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102133419|NCT02411318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133420|NCT02411318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102133421|NCT02411318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102133422|NCT02411318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133423|NCT02411318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102133424|NCT02411318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102133425|NCT02411318|Purinergic Agents|purinergic agents|mesh-ancestor
102133426|NCT02411318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102133427|NCT02411318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102133428|NCT02411318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102133429|NCT02411318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102133430|NCT03133299|Vitamin D|vitamin d|mesh-list
102133431|NCT03133299|Glucocorticoids|glucocorticoids|mesh-list
102133432|NCT03133299|Vitamins|vitamins|mesh-ancestor
102133433|NCT03133299|Micronutrients|micronutrients|mesh-ancestor
102133434|NCT03133299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133435|NCT03133299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102133436|NCT03133299|Hormones|hormones|mesh-ancestor
102133437|NCT03133299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102133438|NCT04465695|Interferons|interferons|mesh-list
102133439|NCT04465695|Interferon-beta|interferon-beta|mesh-list
102133440|NCT04465695|Clofazimine|clofazimine|mesh-list
102133441|NCT04465695|Interferon beta-1b|interferon beta-1b|mesh-list
102133442|NCT04465695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102133443|NCT04465695|Antiviral Agents|antiviral agents|mesh-ancestor
102133444|NCT04465695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102133445|NCT04465695|Immunologic Factors|immunologic factors|mesh-ancestor
102133446|NCT04465695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133447|NCT04465695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102133448|NCT04465695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102133449|NCT04465695|Leprostatic Agents|leprostatic agents|mesh-ancestor
102133450|NCT04465695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102133451|NCT03115736|Tenofovir|tenofovir|mesh-list
102133452|NCT03115736|Antiviral Agents|antiviral agents|mesh-ancestor
102133453|NCT03115736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102133454|NCT03115736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102133455|NCT03115736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102133456|NCT03115736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102133457|NCT03115736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133458|NCT03115736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102133459|NCT03115736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102133460|NCT04465851|Curcumin|curcumin|mesh-list
102133461|NCT04465851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102133462|NCT04465851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102133464|NCT04465851|Sensory System Agents|sensory system agents|mesh-ancestor
102133465|NCT04465851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102133466|NCT04465851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133467|NCT04465851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102133468|NCT04465851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102133469|NCT04465851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102133470|NCT04465851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102133471|NCT04465851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133472|NCT04465539|Hydrocortisone|hydrocortisone|mesh-list
102133473|NCT04465539|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
102133474|NCT04465539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102133475|NCT04465539|Plasma Substitutes|plasma substitutes|mesh-ancestor
102133476|NCT04465539|Blood Substitutes|blood substitutes|mesh-ancestor
102133477|NCT02404142|Atracurium|atracurium|mesh-list
102133478|NCT02404142|Curare|curare|mesh-list
102133479|NCT02404142|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102133480|NCT02404142|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102133481|NCT02404142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102133482|NCT02404142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102133483|NCT02404142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133484|NCT02404142|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102133485|NCT02404142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102133486|NCT02404142|Cholinergic Agents|cholinergic agents|mesh-ancestor
102133487|NCT02404142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102133488|NCT02404142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133489|NCT03522051|Calcium|calcium|mesh-list
102133490|NCT03522051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102133491|NCT03522051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133492|NCT03171974|Dexamethasone|dexamethasone|mesh-list
102133493|NCT03171974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102133494|NCT03171974|Antiemetics|antiemetics|mesh-ancestor
102133495|NCT03171974|Autonomic Agents|autonomic agents|mesh-ancestor
102133496|NCT03171974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102133497|NCT03171974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133498|NCT03171974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102133499|NCT03171974|Glucocorticoids|glucocorticoids|mesh-ancestor
102133500|NCT03171974|Hormones|hormones|mesh-ancestor
102133501|NCT03171974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102133502|NCT03171974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102133503|NCT03171974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102133504|NCT02292069|Amlodipine|amlodipine|mesh-list
102133505|NCT02292069|Atorvastatin|atorvastatin|mesh-list
102133506|NCT02292069|Calcium|calcium|mesh-list
102133507|NCT02292069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102133508|NCT02292069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133509|NCT02292069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102133510|NCT02292069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102133511|NCT02292069|Antimetabolites|antimetabolites|mesh-ancestor
102133512|NCT02292069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133513|NCT02292069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102133514|NCT02292069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102133515|NCT02292069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102133516|NCT02292069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102133517|NCT02292069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102133518|NCT02292069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102133519|NCT02292069|Vasodilator Agents|vasodilator agents|mesh-ancestor
102133520|NCT02404064|Metronidazole|metronidazole|mesh-list
102133521|NCT02404064|Cefotaxime|cefotaxime|mesh-list
102133522|NCT02404064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102133523|NCT02404064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102133524|NCT02404064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102133525|NCT02404064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102133526|NCT02294643|Aspirin|aspirin|mesh-list
102133527|NCT02294643|Sarpogrelate|sarpogrelate|mesh-list
102133528|NCT02294643|Clopidogrel|clopidogrel|mesh-list
102133529|NCT02294643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102133530|NCT02294643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102133531|NCT02294643|Analgesics|analgesics|mesh-ancestor
102133532|NCT02294643|Sensory System Agents|sensory system agents|mesh-ancestor
102133533|NCT02294643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102133534|NCT02294643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133535|NCT02294643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102133536|NCT02294643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102133537|NCT02294643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102133538|NCT02294643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102133539|NCT02294643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133540|NCT02294643|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102133541|NCT02294643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102133542|NCT02294643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102133543|NCT02294643|Antipyretics|antipyretics|mesh-ancestor
102133544|NCT02294643|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102133545|NCT02294643|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102133546|NCT02294643|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102133547|NCT02294643|Purinergic Agents|purinergic agents|mesh-ancestor
102133548|NCT02294643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102133549|NCT02294643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102133550|NCT02294643|Serotonin Agents|serotonin agents|mesh-ancestor
102133551|NCT02410694|Thalidomide|thalidomide|mesh-list
102133552|NCT02410694|Dexamethasone|dexamethasone|mesh-list
102133554|NCT02410694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102133555|NCT02410694|Antiemetics|antiemetics|mesh-ancestor
102133556|NCT02410694|Autonomic Agents|autonomic agents|mesh-ancestor
102133557|NCT02410694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102133558|NCT02410694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133559|NCT02410694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102133560|NCT02410694|Glucocorticoids|glucocorticoids|mesh-ancestor
102133561|NCT02410694|Hormones|hormones|mesh-ancestor
102133562|NCT02410694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102133563|NCT02410694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102133564|NCT02410694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102133565|NCT02410694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102133566|NCT02410694|Immunologic Factors|immunologic factors|mesh-ancestor
102133567|NCT02410694|Leprostatic Agents|leprostatic agents|mesh-ancestor
102133568|NCT02410694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102133569|NCT02410694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102133570|NCT02410694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102133571|NCT02410694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102133572|NCT02410694|Growth Substances|growth substances|mesh-ancestor
102133573|NCT02410694|Growth Inhibitors|growth inhibitors|mesh-ancestor
102133574|NCT02410694|Protease Inhibitors|protease inhibitors|mesh-ancestor
102133575|NCT02410694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102133576|NCT02410694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133578|NCT03521895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102133579|NCT03521895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102133580|NCT03521895|Growth Substances|growth substances|mesh-ancestor
102133581|NCT03521895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133582|NCT03521895|Growth Inhibitors|growth inhibitors|mesh-ancestor
102133583|NCT03521895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102133584|NCT02401880|Empagliflozin|empagliflozin|mesh-list
102133585|NCT02401880|Linagliptin|linagliptin|mesh-list
102133586|NCT02401880|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102133587|NCT02401880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133588|NCT02401880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102133589|NCT02401880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133590|NCT02401880|Incretins|incretins|mesh-ancestor
102133591|NCT02401880|Hormones|hormones|mesh-ancestor
102133592|NCT02401880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102133593|NCT02401880|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102133594|NCT02401880|Protease Inhibitors|protease inhibitors|mesh-ancestor
102133595|NCT02401880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102133596|NCT03170726|Ibuprofen|ibuprofen|mesh-list
102133597|NCT03170726|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
102133598|NCT03170726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102133599|NCT03170726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102133600|NCT03170726|Analgesics|analgesics|mesh-ancestor
102133601|NCT03170726|Sensory System Agents|sensory system agents|mesh-ancestor
102133602|NCT03170726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102133603|NCT03170726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133604|NCT03170726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102133605|NCT03170726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102133606|NCT03170726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102133607|NCT03170726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102133608|NCT03170726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133609|NCT03175016|Irinotecan|irinotecan|mesh-list
102133610|NCT03175016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102133611|NCT03175016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102133612|NCT03175016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102133613|NCT03175016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133614|NCT03175016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102133615|NCT03174938|Flutemetamol|flutemetamol|mesh-list
102133616|NCT03174938|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102133617|NCT03174938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133618|NCT03520257|Apatinib|apatinib|mesh-list
102133619|NCT03520257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102133620|NCT03520257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102133621|NCT03520257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102133622|NCT03520257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133623|NCT02292303|Zinc|zinc|mesh-list
102133624|NCT02292303|Zinc Oxide|zinc oxide|mesh-list
102133625|NCT02292303|Trace Elements|trace elements|mesh-ancestor
102133626|NCT02292303|Micronutrients|micronutrients|mesh-ancestor
102133627|NCT02292303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133628|NCT02292303|Dermatologic Agents|dermatologic agents|mesh-ancestor
102133629|NCT02292303|Sunscreening Agents|sunscreening agents|mesh-ancestor
102133630|NCT02292303|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102133631|NCT02292303|Protective Agents|protective agents|mesh-ancestor
102133632|NCT02294955|Amiodarone|amiodarone|mesh-list
102133633|NCT02294955|Sotalol|sotalol|mesh-list
102133634|NCT02294955|Flecainide|flecainide|mesh-list
102133635|NCT02294955|Dronedarone|dronedarone|mesh-list
102133636|NCT02294955|Propafenone|propafenone|mesh-list
102133637|NCT02294955|Disopyramide|disopyramide|mesh-list
102133638|NCT02294955|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102133639|NCT02294955|Vasodilator Agents|vasodilator agents|mesh-ancestor
102133640|NCT02294955|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102133641|NCT02294955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102133642|NCT02294955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133643|NCT02294955|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102133644|NCT02294955|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102133645|NCT02294955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102133646|NCT02294955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102133647|NCT02294955|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102133648|NCT02294955|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102133649|NCT02294955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102133650|NCT02294955|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102133651|NCT02294955|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102133652|NCT02294955|Adrenergic Agents|adrenergic agents|mesh-ancestor
102133653|NCT02294955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102133654|NCT02294955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133655|NCT02294955|Sympatholytics|sympatholytics|mesh-ancestor
102133656|NCT02294955|Autonomic Agents|autonomic agents|mesh-ancestor
102133657|NCT02294955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102133658|NCT02294955|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102133659|NCT02396888|Insulin|insulin|mesh-list
102133660|NCT02396888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102133661|NCT02396888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133662|NCT03517683|Methamphetamine|methamphetamine|mesh-list
102133663|NCT03517683|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102133664|NCT03517683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133665|NCT03517683|Sympathomimetics|sympathomimetics|mesh-ancestor
102133666|NCT03517683|Autonomic Agents|autonomic agents|mesh-ancestor
102133667|NCT03517683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102133668|NCT03517683|Dopamine Agents|dopamine agents|mesh-ancestor
102133669|NCT03517683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102133670|NCT03517683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133671|NCT03517683|Adrenergic Agents|adrenergic agents|mesh-ancestor
102133672|NCT03517683|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102133673|NCT03517683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102133674|NCT03517683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102133675|NCT03517683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102133676|NCT02401334|Anti-Infective Agents|anti-infective agents|mesh-list
102133677|NCT02401334|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102133678|NCT02164643|Flutemetamol|flutemetamol|mesh-list
102133679|NCT02164643|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102133680|NCT02164643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133681|NCT02292459|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
102133682|NCT02292459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102133683|NCT02292459|Laxatives|laxatives|mesh-ancestor
102133684|NCT02292459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102133685|NCT04465071|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102133686|NCT04465071|Lubricant Eye Drops|lubricant eye drops|mesh-list
102133687|NCT04465071|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102133688|NCT03170336|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102133689|NCT03170336|Amiloride|amiloride|mesh-list
102133690|NCT03170336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102133691|NCT03170336|Diuretics|diuretics|mesh-ancestor
102133692|NCT03170336|Natriuretic Agents|natriuretic agents|mesh-ancestor
102133693|NCT03170336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133694|NCT03170336|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102133695|NCT03170336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102133696|NCT03170336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133697|NCT03170336|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
102133698|NCT03170336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102133699|NCT03170336|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
102133700|NCT03170336|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102133701|NCT02699684|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102133702|NCT02699684|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102133703|NCT02699684|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102133704|NCT02699684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102133705|NCT02295189|Triamcinolone|triamcinolone|mesh-list
102133706|NCT02295189|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102133707|NCT02295189|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102133708|NCT02295189|Ketorolac|ketorolac|mesh-list
102133709|NCT02295189|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102133710|NCT02295189|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102133711|NCT02295189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102133712|NCT02295189|Glucocorticoids|glucocorticoids|mesh-ancestor
102133713|NCT02295189|Hormones|hormones|mesh-ancestor
102133714|NCT02295189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102133730|NCT03519633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133731|NCT03519633|Cholinergic Agents|cholinergic agents|mesh-ancestor
102133732|NCT03519633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102133733|NCT03519633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133734|NCT03519633|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102133735|NCT03519633|Autonomic Agents|autonomic agents|mesh-ancestor
102133736|NCT03519633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102133737|NCT02289027|Vaccines|vaccines|mesh-list
102133738|NCT02289027|Immunologic Factors|immunologic factors|mesh-ancestor
102133739|NCT02289027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133740|NCT02396030|Magnesium Sulfate|magnesium sulfate|mesh-list
102133741|NCT02396030|Analgesics|analgesics|mesh-ancestor
102133742|NCT02396030|Sensory System Agents|sensory system agents|mesh-ancestor
102133743|NCT02396030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102133744|NCT02396030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133745|NCT02396030|Anesthetics|anesthetics|mesh-ancestor
102133746|NCT02396030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102133747|NCT02396030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102133748|NCT02396030|Anticonvulsants|anticonvulsants|mesh-ancestor
102133749|NCT02396030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102133750|NCT02396030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102133751|NCT02396030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133752|NCT02396030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102133753|NCT02396030|Tocolytic Agents|tocolytic agents|mesh-ancestor
102133754|NCT02396030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102133755|NCT02289261|Dexmedetomidine|dexmedetomidine|mesh-list
102133756|NCT02289261|Morphine|morphine|mesh-list
102133757|NCT02289261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102133758|NCT02289261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102133759|NCT02289261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133760|NCT02289261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102133762|NCT02289261|Sensory System Agents|sensory system agents|mesh-ancestor
102133763|NCT02289261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102133764|NCT02289261|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102133765|NCT02289261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102133766|NCT02289261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102133767|NCT02289261|Adrenergic Agents|adrenergic agents|mesh-ancestor
102133768|NCT02289261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102133769|NCT02289261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133770|NCT02289261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102133771|NCT02289261|Narcotics|narcotics|mesh-ancestor
102133772|NCT03168074|Lenvatinib|lenvatinib|mesh-list
102133773|NCT03168074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102133774|NCT03168074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102133775|NCT03168074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102133776|NCT03168074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133777|NCT02396108|Paclitaxel|paclitaxel|mesh-list
102133778|NCT02396108|Carboplatin|carboplatin|mesh-list
102133779|NCT02396108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102133780|NCT02396108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102133781|NCT02396108|Tubulin Modulators|tubulin modulators|mesh-ancestor
102133782|NCT02396108|Antimitotic Agents|antimitotic agents|mesh-ancestor
102133783|NCT02396108|Mitosis Modulators|mitosis modulators|mesh-ancestor
102133784|NCT02396108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133785|NCT02403596|Tranexamic Acid|tranexamic acid|mesh-list
102133786|NCT02403596|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102133787|NCT02403596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102133788|NCT02403596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133789|NCT02403596|Hemostatics|hemostatics|mesh-ancestor
102133790|NCT02403596|Coagulants|coagulants|mesh-ancestor
102133791|NCT02289495|Ritonavir|ritonavir|mesh-list
102133792|NCT02289495|GSK-2838232|gsk-2838232|mesh-list
102133793|NCT02289495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102133794|NCT02289495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102133795|NCT02289495|Protease Inhibitors|protease inhibitors|mesh-ancestor
102133796|NCT02289495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102133797|NCT02289495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133798|NCT02289495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102133799|NCT02289495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102133800|NCT02289495|Antiviral Agents|antiviral agents|mesh-ancestor
102133801|NCT02289495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102133802|NCT02289495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102133803|NCT02289495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102133804|NCT01774721|Gefitinib|gefitinib|mesh-list
102133805|NCT01774721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102133806|NCT01774721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102133807|NCT01774721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102133808|NCT01774721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133809|NCT02395952|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102133810|NCT02395952|Laxatives|laxatives|mesh-ancestor
102133811|NCT02395952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102133812|NCT03516903|Folic Acid|folic acid|mesh-list
102133813|NCT03516903|Methotrexate|methotrexate|mesh-list
102133814|NCT03516903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102133815|NCT03516903|Abortifacient Agents|abortifacient agents|mesh-ancestor
102133816|NCT03516903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102133817|NCT03516903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133818|NCT03516903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102133819|NCT03516903|Antimetabolites|antimetabolites|mesh-ancestor
102133820|NCT03516903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133821|NCT03516903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102133822|NCT03516903|Dermatologic Agents|dermatologic agents|mesh-ancestor
102133823|NCT03516903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102133824|NCT03516903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102133825|NCT03516903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102133826|NCT03516903|Immunologic Factors|immunologic factors|mesh-ancestor
102133827|NCT03516903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102133828|NCT03516903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102133829|NCT03516903|Hematinics|hematinics|mesh-ancestor
102133830|NCT03516903|Vitamin B Complex|vitamin b complex|mesh-ancestor
102133831|NCT03516903|Vitamins|vitamins|mesh-ancestor
102133832|NCT03516903|Micronutrients|micronutrients|mesh-ancestor
102133833|NCT03516747|Hormones|hormones|mesh-list
102133834|NCT03516747|Parathyroid Hormone|parathyroid hormone|mesh-list
102133835|NCT03516747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102133836|NCT03516747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133837|NCT03516747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102133838|NCT03516669|Amoxicillin|amoxicillin|mesh-list
102133839|NCT03516669|Clarithromycin|clarithromycin|mesh-list
102133840|NCT03516669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102133841|NCT03516669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102133842|NCT03516669|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102133843|NCT03516669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102133844|NCT03516669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133845|NCT03516669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102133846|NCT03516669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102133847|NCT02289807|Cisplatin|cisplatin|mesh-list
102133848|NCT02289807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102133849|NCT02298153|Atezolizumab|atezolizumab|mesh-list
102133850|NCT02298153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102133851|NCT02298153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133852|NCT02298153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102133853|NCT02298153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102133854|NCT02298387|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102133855|NCT02298387|Immunologic Factors|immunologic factors|mesh-ancestor
102133856|NCT02298387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133857|NCT02293551|Insulin Lispro|insulin lispro|mesh-list
102133858|NCT02293551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102133859|NCT02293551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133860|NCT02296047|Bromides|bromides|mesh-list
102133861|NCT02296047|Albuterol|albuterol|mesh-list
102133862|NCT02296047|Ipratropium|ipratropium|mesh-list
102133863|NCT02296047|Anticonvulsants|anticonvulsants|mesh-ancestor
102133864|NCT02296047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102133865|NCT02296047|Autonomic Agents|autonomic agents|mesh-ancestor
102133866|NCT02296047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102133867|NCT02296047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133868|NCT02296047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102133869|NCT02296047|Respiratory System Agents|respiratory system agents|mesh-ancestor
102133870|NCT02296047|Tocolytic Agents|tocolytic agents|mesh-ancestor
102133871|NCT02296047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102133872|NCT02296047|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102133873|NCT02296047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102133874|NCT02296047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102133875|NCT02296047|Adrenergic Agents|adrenergic agents|mesh-ancestor
102133876|NCT02296047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102133877|NCT02296047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133878|NCT02296047|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102133879|NCT02296047|Cholinergic Agents|cholinergic agents|mesh-ancestor
102133880|NCT02293785|Oxycodone|oxycodone|mesh-list
102133881|NCT02293785|Naloxone|naloxone|mesh-list
102133882|NCT02293785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102133883|NCT02293785|Narcotics|narcotics|mesh-ancestor
102133884|NCT02293785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102133885|NCT02293785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133886|NCT02293785|Analgesics|analgesics|mesh-ancestor
102133887|NCT02293785|Sensory System Agents|sensory system agents|mesh-ancestor
102133888|NCT02293785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102133889|NCT02293785|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102133890|NCT01162109|Zinc Sulfate|zinc sulfate|mesh-list
102133891|NCT01162109|Astringents|astringents|mesh-ancestor
102133892|NCT01162109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133893|NCT01162109|Dermatologic Agents|dermatologic agents|mesh-ancestor
102133894|NCT02296203|Irinotecan|irinotecan|mesh-list
102133895|NCT02296203|Cetuximab|cetuximab|mesh-list
102133896|NCT02296203|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102133897|NCT02296203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102133898|NCT02296203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102133899|NCT02296203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133900|NCT02296203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102133901|NCT02296203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102133902|NCT03514251|Parathyroid Hormone|parathyroid hormone|mesh-list
102133903|NCT03514251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102133904|NCT03514251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133905|NCT02296281|Pirfenidone|pirfenidone|mesh-list
102133906|NCT02296281|Analgesics|analgesics|mesh-ancestor
102133907|NCT02296281|Sensory System Agents|sensory system agents|mesh-ancestor
102133908|NCT02296281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102133909|NCT02296281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133910|NCT02296281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102133911|NCT02296281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102133912|NCT02296281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102133913|NCT02296281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102133914|NCT02296281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102133915|NCT02299245|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102133916|NCT02299245|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102133917|NCT02299245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102133918|NCT02299245|Antimetabolites|antimetabolites|mesh-ancestor
102133919|NCT02299245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133920|NCT02299245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102133921|NCT02299245|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102133922|NCT02299245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102133923|NCT03513549|Loxapine|loxapine|mesh-list
102133924|NCT03513549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102133925|NCT03513549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102133926|NCT03513549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102133927|NCT03513549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133928|NCT03513549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102133929|NCT03513549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102133930|NCT03513549|Dopamine Agents|dopamine agents|mesh-ancestor
102133931|NCT03513549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102133932|NCT03513549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133933|NCT03513471|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102133934|NCT03513471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102133935|NCT03513393|Velpatasvir|velpatasvir|mesh-list
102133936|NCT03513393|Omeprazole|omeprazole|mesh-list
102133937|NCT03513393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102133938|NCT03513393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102133939|NCT03513393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102133940|NCT03513393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102133941|NCT03513393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133942|NCT03513393|Antiviral Agents|antiviral agents|mesh-ancestor
102133943|NCT03513393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102133944|NCT02299401|Misoprostol|misoprostol|mesh-list
102133945|NCT02299401|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102133946|NCT02299401|Abortifacient Agents|abortifacient agents|mesh-ancestor
102133947|NCT02299401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102133948|NCT02299401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133949|NCT02299401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102133951|NCT02299401|Oxytocics|oxytocics|mesh-ancestor
102133952|NCT02699450|Ranibizumab|ranibizumab|mesh-list
102133953|NCT02699450|Faricimab|faricimab|mesh-list
102133954|NCT02699450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102133955|NCT02699450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102133956|NCT02699450|Growth Substances|growth substances|mesh-ancestor
102133957|NCT02699450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133958|NCT02699450|Growth Inhibitors|growth inhibitors|mesh-ancestor
102133959|NCT02699450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102133960|NCT02299557|Phenylephrine|phenylephrine|mesh-list
102133961|NCT02299557|Oxymetazoline|oxymetazoline|mesh-list
102133962|NCT02299557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102133963|NCT02299557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102133964|NCT02299557|Adrenergic Agents|adrenergic agents|mesh-ancestor
102133965|NCT02299557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102133966|NCT02299557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133967|NCT02299557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133968|NCT02299557|Sympathomimetics|sympathomimetics|mesh-ancestor
102133969|NCT02299557|Autonomic Agents|autonomic agents|mesh-ancestor
102133970|NCT02299557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102133971|NCT02299557|Nasal Decongestants|nasal decongestants|mesh-ancestor
102133972|NCT02299557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102133973|NCT02299557|Respiratory System Agents|respiratory system agents|mesh-ancestor
102133974|NCT02299557|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102133975|NCT02299557|Mydriatics|mydriatics|mesh-ancestor
102133976|NCT02299557|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102133977|NCT02299557|Protective Agents|protective agents|mesh-ancestor
102133978|NCT02302989|Ranibizumab|ranibizumab|mesh-list
102133979|NCT02302989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102133980|NCT02302989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102133981|NCT02302989|Growth Substances|growth substances|mesh-ancestor
102133982|NCT02302989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133983|NCT02302989|Growth Inhibitors|growth inhibitors|mesh-ancestor
102133984|NCT02302989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102133985|NCT02296671|Leucovorin|leucovorin|mesh-list
101842991|NCT00286234|Vitamins|vitamins|mesh-ancestor
102133986|NCT02296671|Fluorouracil|fluorouracil|mesh-list
102133987|NCT02296671|Oxaliplatin|oxaliplatin|mesh-list
102133988|NCT02296671|Pemetrexed|pemetrexed|mesh-list
102133989|NCT02296671|Antimetabolites|antimetabolites|mesh-ancestor
102133990|NCT02296671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102133991|NCT02296671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102133992|NCT02296671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102133993|NCT02296671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102133994|NCT02296671|Immunologic Factors|immunologic factors|mesh-ancestor
102133995|NCT02296671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102133996|NCT02296671|Antidotes|antidotes|mesh-ancestor
102133997|NCT02296671|Protective Agents|protective agents|mesh-ancestor
102133998|NCT02296671|Vitamin B Complex|vitamin b complex|mesh-ancestor
102133999|NCT02296671|Vitamins|vitamins|mesh-ancestor
102134000|NCT02296671|Micronutrients|micronutrients|mesh-ancestor
102134001|NCT02296671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102134002|NCT02296671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102134003|NCT02296671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102134004|NCT02296749|Sirolimus|sirolimus|mesh-list
102134005|NCT02296749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102134006|NCT02296749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102134007|NCT02296749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102134008|NCT02296749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102134009|NCT02296749|Antifungal Agents|antifungal agents|mesh-ancestor
102134010|NCT02296749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102134011|NCT02296749|Immunologic Factors|immunologic factors|mesh-ancestor
102134012|NCT02296749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134013|NCT04481750|Edaravone|edaravone|mesh-list
102134014|NCT04481750|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102134015|NCT04481750|Antioxidants|antioxidants|mesh-ancestor
102134016|NCT04481750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134017|NCT04481750|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102134018|NCT04481750|Protective Agents|protective agents|mesh-ancestor
102134019|NCT04481750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134020|NCT02303223|Propofol|propofol|mesh-list
102134021|NCT02303223|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102134022|NCT02303223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102134023|NCT02303223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134024|NCT02303223|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102134025|NCT02303223|Anesthetics, General|anesthetics, general|mesh-ancestor
102134026|NCT02303223|Anesthetics|anesthetics|mesh-ancestor
102134027|NCT03168698|Oxytocin|oxytocin|mesh-list
102134028|NCT03168698|Carbetocin|carbetocin|mesh-list
102134029|NCT03168698|Oxytocics|oxytocics|mesh-ancestor
102134030|NCT03168698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102134031|NCT03168698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134032|NCT04464135|Acetic Acid|acetic acid|mesh-list
102134033|NCT04464135|Retinol acetate|retinol acetate|mesh-list
102134034|NCT04464135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102134035|NCT04464135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102134036|NCT04464135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102134037|NCT04464135|Immunologic Factors|immunologic factors|mesh-ancestor
102134038|NCT04464135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134039|NCT04464135|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102134040|NCT04464135|Protective Agents|protective agents|mesh-ancestor
102134041|NCT04464135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102134042|NCT03510351|Tazobactam|tazobactam|mesh-list
102134043|NCT03510351|Ceftolozane|ceftolozane|mesh-list
102134044|NCT03510351|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
102134045|NCT03510351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102134046|NCT03510351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102134047|NCT03510351|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102134048|NCT03510351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102134049|NCT03510351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134050|NCT03510351|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102134051|NCT02403284|Liraglutide|liraglutide|mesh-list
102134052|NCT02403284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102134053|NCT02403284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134054|NCT02403284|Incretins|incretins|mesh-ancestor
102134055|NCT02403284|Hormones|hormones|mesh-ancestor
102134056|NCT02403284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102134057|NCT02400866|Olanzapine|olanzapine|mesh-list
102134058|NCT02400866|Antiemetics|antiemetics|mesh-ancestor
102134059|NCT02400866|Autonomic Agents|autonomic agents|mesh-ancestor
102134060|NCT02400866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102134061|NCT02400866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134062|NCT02400866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102134063|NCT02400866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102134064|NCT02400866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102134065|NCT02400866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102134066|NCT02400866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102134067|NCT02400866|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102134068|NCT02400866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102134069|NCT02400866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102134070|NCT02400866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134071|NCT02400866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102134072|NCT02400866|Serotonin Agents|serotonin agents|mesh-ancestor
102134073|NCT02400788|Sorafenib|sorafenib|mesh-list
102134074|NCT02400788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102134075|NCT02400788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102134076|NCT02400788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102134077|NCT02400788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134078|NCT02403128|Aflibercept|aflibercept|mesh-list
102134079|NCT02403128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102134080|NCT02403128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102134081|NCT02403128|Growth Substances|growth substances|mesh-ancestor
102134082|NCT02403128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134083|NCT02403128|Growth Inhibitors|growth inhibitors|mesh-ancestor
102134084|NCT02403128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102134085|NCT02297217|Paclitaxel|paclitaxel|mesh-list
102134086|NCT02297217|Carboplatin|carboplatin|mesh-list
102134087|NCT02297217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102134088|NCT02297217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102134089|NCT02297217|Tubulin Modulators|tubulin modulators|mesh-ancestor
102134090|NCT02297217|Antimitotic Agents|antimitotic agents|mesh-ancestor
102134091|NCT02297217|Mitosis Modulators|mitosis modulators|mesh-ancestor
102134092|NCT02297217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134093|NCT03515577|Edetic Acid|edetic acid|mesh-list
102134094|NCT03515577|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102134095|NCT03515577|Chelating Agents|chelating agents|mesh-ancestor
102134096|NCT03515577|Sequestering Agents|sequestering agents|mesh-ancestor
102134097|NCT03515577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134098|NCT03515577|Anticoagulants|anticoagulants|mesh-ancestor
102134099|NCT03515577|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102134100|NCT03515577|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102134101|NCT02300649|Dexmedetomidine|dexmedetomidine|mesh-list
102134102|NCT02300649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102134103|NCT02300649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102134104|NCT02300649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134105|NCT02300649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102134106|NCT02300649|Analgesics|analgesics|mesh-ancestor
102134107|NCT02300649|Sensory System Agents|sensory system agents|mesh-ancestor
102134108|NCT02300649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102134109|NCT02300649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102134110|NCT02300649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102134111|NCT02300649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102134112|NCT02300649|Adrenergic Agents|adrenergic agents|mesh-ancestor
102134113|NCT02300649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102134114|NCT02300649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134115|NCT02449161|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102134116|NCT02449161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102134117|NCT02449161|Contraceptive Agents|contraceptive agents|mesh-ancestor
102134118|NCT02449161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102134119|NCT02449161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134120|NCT02449161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102134121|NCT02449161|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102134122|NCT02449161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102134123|NCT02449161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102134124|NCT02297529|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
102134125|NCT02297529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102134126|NCT02297529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102134128|NCT02303769|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102134129|NCT02303769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102134130|NCT02303769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102134131|NCT02303769|Adrenergic Agents|adrenergic agents|mesh-ancestor
102134132|NCT02303769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102134133|NCT02303769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134134|NCT02303769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134135|NCT02303769|Urological Agents|urological agents|mesh-ancestor
102134136|NCT02303847|Ketamine|ketamine|mesh-list
102134137|NCT02303847|Analgesics|analgesics|mesh-ancestor
102134138|NCT02303847|Sensory System Agents|sensory system agents|mesh-ancestor
102134139|NCT02303847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102134140|NCT02303847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134141|NCT02303847|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102134142|NCT02303847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102134143|NCT02303847|Anesthetics, General|anesthetics, general|mesh-ancestor
102134144|NCT02303847|Anesthetics|anesthetics|mesh-ancestor
102134145|NCT02303847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102134146|NCT02303847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102134147|NCT02303847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102134148|NCT02303847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102134149|NCT02303847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134150|NCT02297763|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102134151|NCT02297763|Antidepressive Agents|antidepressive agents|mesh-ancestor
102134152|NCT02297763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102134153|NCT02297763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102134154|NCT02297763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102134155|NCT02297763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102134156|NCT02297763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134158|NCT03511833|Morphine|morphine|mesh-list
102134159|NCT03511833|Analgesics|analgesics|mesh-ancestor
102134160|NCT03511833|Sensory System Agents|sensory system agents|mesh-ancestor
102134161|NCT03511833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102134162|NCT03511833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134163|NCT03511833|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102134164|NCT03511833|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102134165|NCT03511833|Anesthetics, General|anesthetics, general|mesh-ancestor
102134166|NCT03511833|Anesthetics|anesthetics|mesh-ancestor
102134167|NCT03511833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102134168|NCT03511833|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102134169|NCT03511833|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102134170|NCT03511833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102134171|NCT03511833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134172|NCT03511833|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102134173|NCT03511833|Narcotics|narcotics|mesh-ancestor
102076843|NCT05285085|Lovastatin|lovastatin|mesh-list
102134175|NCT03511755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134176|NCT03511755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134177|NCT02696798|Ixekizumab|ixekizumab|mesh-list
102134178|NCT02696798|Dermatologic Agents|dermatologic agents|mesh-ancestor
102134179|NCT02304081|Saxagliptin|saxagliptin|mesh-list
102134180|NCT02304081|Incretins|incretins|mesh-ancestor
102134181|NCT02304081|Hormones|hormones|mesh-ancestor
102134182|NCT02304081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102134183|NCT02304081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134184|NCT02304081|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102134185|NCT02304081|Protease Inhibitors|protease inhibitors|mesh-ancestor
102134186|NCT02304081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102134187|NCT02304081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134188|NCT02304081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102134189|NCT02304237|Progesterone|progesterone|mesh-list
102134190|NCT02304237|Progestins|progestins|mesh-ancestor
102134191|NCT02304237|Hormones|hormones|mesh-ancestor
102134192|NCT02304237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102134193|NCT02304237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134194|NCT03515187|Bromides|bromides|mesh-list
102134195|NCT03515187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102134196|NCT03515187|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102134197|NCT03515187|Hyaluronic Acid|hyaluronic acid|mesh-list
102134198|NCT03515187|Anticonvulsants|anticonvulsants|mesh-ancestor
102134199|NCT03515187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102134200|NCT03515187|Immunologic Factors|immunologic factors|mesh-ancestor
102134201|NCT03515187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134202|NCT03515187|Viscosupplements|viscosupplements|mesh-ancestor
102134203|NCT03515187|Protective Agents|protective agents|mesh-ancestor
102134204|NCT02297997|Cetylpyridinium|cetylpyridinium|mesh-list
102134205|NCT02297997|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102134206|NCT02297997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102134207|NCT02395016|Gemcitabine|gemcitabine|mesh-list
102134208|NCT02395016|Nimotuzumab|nimotuzumab|mesh-list
102134209|NCT02395016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102134210|NCT02395016|Antimetabolites|antimetabolites|mesh-ancestor
101843208|NCT00266812|Temozolomide|temozolomide|mesh-list
102134211|NCT02395016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134212|NCT02395016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102134213|NCT02395016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102134215|NCT04480268|Gemcitabine|gemcitabine|mesh-list
102134216|NCT04480268|Capecitabine|capecitabine|mesh-list
102134217|NCT04480268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102134218|NCT04480268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102134219|NCT04480268|Tubulin Modulators|tubulin modulators|mesh-ancestor
102134220|NCT04480268|Antimitotic Agents|antimitotic agents|mesh-ancestor
102134221|NCT04480268|Mitosis Modulators|mitosis modulators|mesh-ancestor
102134222|NCT04480268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134223|NCT04480268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102134224|NCT04480268|Antimetabolites|antimetabolites|mesh-ancestor
102134225|NCT03510975|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
102134226|NCT03510975|Hemostatics|hemostatics|mesh-ancestor
102134227|NCT03510975|Coagulants|coagulants|mesh-ancestor
102134228|NCT03510975|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102134229|NCT03510975|Natriuretic Agents|natriuretic agents|mesh-ancestor
102134230|NCT03510975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134231|NCT03169790|Leucovorin|leucovorin|mesh-list
102134232|NCT03169790|Paclitaxel|paclitaxel|mesh-list
102134233|NCT03169790|Cyclophosphamide|cyclophosphamide|mesh-list
102134234|NCT03169790|Bevacizumab|bevacizumab|mesh-list
102134235|NCT03169790|Rituximab|rituximab|mesh-list
102134236|NCT03169790|Fluorouracil|fluorouracil|mesh-list
102134237|NCT03169790|Capecitabine|capecitabine|mesh-list
102134238|NCT03169790|Oxaliplatin|oxaliplatin|mesh-list
102134239|NCT03169790|Avelumab|avelumab|mesh-list
102134240|NCT03169790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102134241|NCT03169790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102134242|NCT03169790|Tubulin Modulators|tubulin modulators|mesh-ancestor
102134243|NCT03169790|Antimitotic Agents|antimitotic agents|mesh-ancestor
102134244|NCT03169790|Mitosis Modulators|mitosis modulators|mesh-ancestor
102134245|NCT03169790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134246|NCT03169790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102134247|NCT03169790|Immunologic Factors|immunologic factors|mesh-ancestor
102134248|NCT03169790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134249|NCT03169790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101836625|NCT00505934|Nootropic Agents|nootropic agents|mesh-ancestor
102134250|NCT03169790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102134251|NCT03169790|Alkylating Agents|alkylating agents|mesh-ancestor
102134252|NCT03169790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102134253|NCT03169790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102134254|NCT03169790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102134255|NCT03169790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102134256|NCT03169790|Growth Substances|growth substances|mesh-ancestor
102134257|NCT03169790|Growth Inhibitors|growth inhibitors|mesh-ancestor
102134258|NCT03169790|Antimetabolites|antimetabolites|mesh-ancestor
102134259|NCT03169790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102134260|NCT03169790|Antidotes|antidotes|mesh-ancestor
102134261|NCT03169790|Protective Agents|protective agents|mesh-ancestor
102134262|NCT03169790|Vitamin B Complex|vitamin b complex|mesh-ancestor
102134263|NCT03169790|Vitamins|vitamins|mesh-ancestor
102134264|NCT03169790|Micronutrients|micronutrients|mesh-ancestor
102134265|NCT02304393|Atezolizumab|atezolizumab|mesh-list
102134266|NCT02304393|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102134267|NCT02304393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134268|NCT02304393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102134269|NCT02304393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102134270|NCT02402972|Leucovorin|leucovorin|mesh-list
102134271|NCT02402972|Oxaliplatin|oxaliplatin|mesh-list
102134272|NCT02402972|Floxuridine|floxuridine|mesh-list
102134273|NCT02402972|Levoleucovorin|levoleucovorin|mesh-list
102134274|NCT02402972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102134275|NCT02402972|Antidotes|antidotes|mesh-ancestor
102134276|NCT02402972|Protective Agents|protective agents|mesh-ancestor
102134277|NCT02402972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134278|NCT02402972|Vitamin B Complex|vitamin b complex|mesh-ancestor
102134279|NCT02402972|Vitamins|vitamins|mesh-ancestor
102134280|NCT02402972|Micronutrients|micronutrients|mesh-ancestor
102134281|NCT02402972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102134282|NCT02402972|Antimetabolites|antimetabolites|mesh-ancestor
102134283|NCT02402972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134284|NCT02394470|Deuterium Oxide|deuterium oxide|mesh-list
101843275|NCT01019642|Vitamin D|vitamin d|mesh-list
102134285|NCT02394470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102134286|NCT02394470|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102134287|NCT02394470|Protective Agents|protective agents|mesh-ancestor
102134288|NCT02394470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134290|NCT02304627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102134291|NCT02304627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134292|NCT03508713|Antirheumatic Agents|antirheumatic agents|mesh-list
102134293|NCT02394158|Metformin|metformin|mesh-list
102134294|NCT02394158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102134295|NCT02394158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134296|NCT03508635|Prednisone|prednisone|mesh-list
102134297|NCT03508635|Cortisone|cortisone|mesh-list
102134298|NCT03508635|Mifepristone|mifepristone|mesh-list
102134299|NCT03508635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102134300|NCT03508635|Glucocorticoids|glucocorticoids|mesh-ancestor
102134301|NCT03508635|Hormones|hormones|mesh-ancestor
102134302|NCT03508635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102134303|NCT03508635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134304|NCT03508635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102134305|NCT03508635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102134306|NCT03508635|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102134307|NCT03508635|Abortifacient Agents|abortifacient agents|mesh-ancestor
102134308|NCT03508635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102134309|NCT03508635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102134310|NCT03508635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102134311|NCT03508635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102134312|NCT03508635|Contraceptive Agents|contraceptive agents|mesh-ancestor
102134313|NCT03508635|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102134314|NCT03508635|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102134315|NCT03508635|Hormone Antagonists|hormone antagonists|mesh-ancestor
102134316|NCT03508635|Luteolytic Agents|luteolytic agents|mesh-ancestor
102134317|NCT03508635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102134318|NCT03508635|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102134319|NCT04481282|Terbutaline|terbutaline|mesh-list
102134320|NCT04481282|Danazol|danazol|mesh-list
102134321|NCT04481282|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102134322|NCT04481282|Autonomic Agents|autonomic agents|mesh-ancestor
102134323|NCT04481282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102134324|NCT04481282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535894|NCT00554099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134325|NCT04481282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102134326|NCT04481282|Respiratory System Agents|respiratory system agents|mesh-ancestor
102134327|NCT04481282|Sympathomimetics|sympathomimetics|mesh-ancestor
102134328|NCT04481282|Tocolytic Agents|tocolytic agents|mesh-ancestor
102134329|NCT04481282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102134330|NCT04481282|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102134331|NCT04481282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102134332|NCT04481282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102134333|NCT04481282|Adrenergic Agents|adrenergic agents|mesh-ancestor
102134334|NCT04481282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102134335|NCT04481282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134336|NCT04481282|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102134337|NCT04481282|Hormone Antagonists|hormone antagonists|mesh-ancestor
102134338|NCT04481282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102134339|NCT02541604|Atezolizumab|atezolizumab|mesh-list
102134340|NCT02541604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102134341|NCT02541604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134342|NCT02541604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102134343|NCT02541604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102134344|NCT02393846|Ketoprofen|ketoprofen|mesh-list
102134345|NCT02393846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102134346|NCT02393846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102134347|NCT02393846|Analgesics|analgesics|mesh-ancestor
102134348|NCT02393846|Sensory System Agents|sensory system agents|mesh-ancestor
102134349|NCT02393846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102134350|NCT02393846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134351|NCT02393846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102134352|NCT02393846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102134353|NCT02393846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102134354|NCT02393846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102134355|NCT02393846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134356|NCT02302209|Oxytocin|oxytocin|mesh-list
102134357|NCT02302209|Oxytocics|oxytocics|mesh-ancestor
102134358|NCT02302209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102134359|NCT02302209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134360|NCT02394002|Propofol|propofol|mesh-list
102134361|NCT02394002|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102134362|NCT02394002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102134363|NCT02394002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134365|NCT02394002|Anesthetics, General|anesthetics, general|mesh-ancestor
102134366|NCT02394002|Anesthetics|anesthetics|mesh-ancestor
102134367|NCT02306577|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102134368|NCT02306577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102134369|NCT02306577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102134370|NCT02306577|Antiviral Agents|antiviral agents|mesh-ancestor
102134371|NCT02306577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102134372|NCT02402348|Metformin|metformin|mesh-list
102134373|NCT02402348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102134374|NCT02402348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134375|NCT02399462|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102134376|NCT02399462|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
102134377|NCT02399462|beta-Endorphin|beta-endorphin|mesh-list
102134378|NCT02399462|Hormones|hormones|mesh-ancestor
102134379|NCT02399462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102134380|NCT02399462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134381|NCT02399462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102134382|NCT02399462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134383|NCT02305173|Dexamethasone|dexamethasone|mesh-list
102134384|NCT02305173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102134385|NCT02305173|Antiemetics|antiemetics|mesh-ancestor
102134386|NCT02305173|Autonomic Agents|autonomic agents|mesh-ancestor
102134387|NCT02305173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102134388|NCT02305173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134389|NCT02305173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102134390|NCT02305173|Glucocorticoids|glucocorticoids|mesh-ancestor
102134391|NCT02305173|Hormones|hormones|mesh-ancestor
102134392|NCT02305173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102134393|NCT02305173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102134394|NCT02305173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102134395|NCT03505047|Copper|copper|mesh-list
102134396|NCT03505047|Trace Elements|trace elements|mesh-ancestor
102134397|NCT03505047|Micronutrients|micronutrients|mesh-ancestor
102134398|NCT03505047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535895|NCT00554099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102134399|NCT02402114|Hydrocortisone|hydrocortisone|mesh-list
102134400|NCT02402114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102134401|NCT02305485|Everolimus|everolimus|mesh-list
102134402|NCT02305485|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102134403|NCT02305485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102134404|NCT02305485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102134405|NCT02305485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134406|NCT02305485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102134407|NCT02305485|Immunologic Factors|immunologic factors|mesh-ancestor
102134408|NCT02305485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134409|NCT02305485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102134410|NCT02311569|Mirabegron|mirabegron|mesh-list
102134411|NCT02311569|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102134412|NCT02311569|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102134413|NCT02311569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102134414|NCT02311569|Adrenergic Agents|adrenergic agents|mesh-ancestor
102134415|NCT02311569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102134416|NCT02311569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134417|NCT02311569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134418|NCT02311569|Urological Agents|urological agents|mesh-ancestor
102134419|NCT02393456|Oxytocin|oxytocin|mesh-list
102134420|NCT02393456|Oxytocics|oxytocics|mesh-ancestor
102134421|NCT02393456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102134422|NCT02393456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134423|NCT02393612|Sarpogrelate|sarpogrelate|mesh-list
102134424|NCT02393612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102134425|NCT02393612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102134426|NCT02393612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134427|NCT02393612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102134428|NCT02393612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102134429|NCT02393612|Serotonin Agents|serotonin agents|mesh-ancestor
102134430|NCT02393612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102134431|NCT02393612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134432|NCT02306733|Oxytocin|oxytocin|mesh-list
102134433|NCT02306733|Ergonovine|ergonovine|mesh-list
102134434|NCT02306733|Oxytocics|oxytocics|mesh-ancestor
102134435|NCT02306733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102134436|NCT02306733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134437|NCT02698436|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102134438|NCT02698436|Dermatologic Agents|dermatologic agents|mesh-ancestor
102134439|NCT03507465|Capecitabine|capecitabine|mesh-list
102134440|NCT03507465|Letrozole|letrozole|mesh-list
102134441|NCT03507465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102134442|NCT03507465|Antimetabolites|antimetabolites|mesh-ancestor
102134443|NCT03507465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134444|NCT03507465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102134445|NCT03507465|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102134446|NCT03507465|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102134447|NCT03507465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102134448|NCT03507465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102134449|NCT03507465|Hormone Antagonists|hormone antagonists|mesh-ancestor
102134450|NCT03507465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102134451|NCT03507465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134452|NCT05476042|Epoetin Alfa|epoetin alfa|mesh-list
102134453|NCT05476042|Hematinics|hematinics|mesh-ancestor
102134454|NCT03507387|Phenylephrine|phenylephrine|mesh-list
102134455|NCT03507387|Oxymetazoline|oxymetazoline|mesh-list
102134456|NCT03507387|Bupivacaine|bupivacaine|mesh-list
102134457|NCT03507387|Anesthetics, Local|anesthetics, local|mesh-ancestor
102134458|NCT03507387|Anesthetics|anesthetics|mesh-ancestor
102134459|NCT03507387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102134460|NCT03507387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134461|NCT03507387|Sensory System Agents|sensory system agents|mesh-ancestor
102134462|NCT03507387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102134463|NCT03507387|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102134464|NCT03507387|Mydriatics|mydriatics|mesh-ancestor
102134465|NCT03507387|Autonomic Agents|autonomic agents|mesh-ancestor
102134466|NCT03507387|Sympathomimetics|sympathomimetics|mesh-ancestor
102134467|NCT03507387|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102134468|NCT03507387|Nasal Decongestants|nasal decongestants|mesh-ancestor
102134469|NCT03507387|Respiratory System Agents|respiratory system agents|mesh-ancestor
102134470|NCT03507387|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102134471|NCT03507387|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102134472|NCT03507387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102134473|NCT03507387|Adrenergic Agents|adrenergic agents|mesh-ancestor
102134474|NCT03507387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102535896|NCT00554099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102134475|NCT03507387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134476|NCT03507387|Protective Agents|protective agents|mesh-ancestor
102134477|NCT05454358|Letrozole|letrozole|mesh-list
102134478|NCT05454358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102134479|NCT05454358|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102134480|NCT05454358|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102134481|NCT05454358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102134482|NCT05454358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134483|NCT05454358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102134484|NCT05454358|Hormone Antagonists|hormone antagonists|mesh-ancestor
102134485|NCT05454358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102134486|NCT05454358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134487|NCT02694536|Gemcitabine|gemcitabine|mesh-list
102134488|NCT02694536|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102134489|NCT02694536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102134490|NCT02694536|Antimetabolites|antimetabolites|mesh-ancestor
102134491|NCT02694536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134492|NCT02694536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102134493|NCT02694536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102134494|NCT02694536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102134495|NCT02312037|Gemtuzumab|gemtuzumab|mesh-list
102134496|NCT02312037|Antibodies|antibodies|mesh-list
102134497|NCT02312037|Immunoconjugates|immunoconjugates|mesh-list
102134498|NCT02312037|Immunologic Factors|immunologic factors|mesh-ancestor
102134499|NCT02312037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134500|NCT02312037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102134501|NCT02312037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102134502|NCT02312037|Immunotoxins|immunotoxins|mesh-ancestor
102134503|NCT03167918|Calcium, Dietary|calcium, dietary|mesh-list
102134504|NCT03167918|Metformin|metformin|mesh-list
102134505|NCT03167918|Calcium Dobesilate|calcium dobesilate|mesh-list
102134506|NCT03167918|Calcium|calcium|mesh-list
102134507|NCT03167918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102134508|NCT03167918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134509|NCT03167918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102134510|NCT03167918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102134511|NCT03167918|Hemostatics|hemostatics|mesh-ancestor
102134512|NCT03167918|Coagulants|coagulants|mesh-ancestor
102134513|NCT05745818|Colchicine|colchicine|mesh-list
102134514|NCT05745818|Gout Suppressants|gout suppressants|mesh-ancestor
102134515|NCT05745818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102134516|NCT05745818|Tubulin Modulators|tubulin modulators|mesh-ancestor
102134517|NCT05745818|Antimitotic Agents|antimitotic agents|mesh-ancestor
102134518|NCT05745818|Mitosis Modulators|mitosis modulators|mesh-ancestor
102134519|NCT05745818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134520|NCT05745818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102134521|NCT02393300|Tranexamic Acid|tranexamic acid|mesh-list
102134522|NCT02393300|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102134523|NCT02393300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102134524|NCT02393300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134525|NCT02393300|Hemostatics|hemostatics|mesh-ancestor
102134526|NCT02393300|Coagulants|coagulants|mesh-ancestor
102134527|NCT03106610|Nivolumab|nivolumab|mesh-list
102134528|NCT03106610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102134529|NCT03106610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102134530|NCT03106610|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102134531|NCT03106610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134532|NCT02678884|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102134533|NCT02678884|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102134534|NCT02678884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134535|NCT03504735|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
102134536|NCT03504735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102134537|NCT03504735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102134538|NCT03504735|Antimetabolites|antimetabolites|mesh-ancestor
102134539|NCT03504735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134540|NCT03504735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102134541|NCT03504735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102134542|NCT03504735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102134543|NCT03504735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102134544|NCT03504735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102134545|NCT03504735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134546|NCT03504735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102134547|NCT03504735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102535897|NCT02664909|Tranexamic Acid|tranexamic acid|mesh-list
102134548|NCT05475886|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
102134549|NCT05475886|Plasma Substitutes|plasma substitutes|mesh-ancestor
102134550|NCT05475886|Blood Substitutes|blood substitutes|mesh-ancestor
102134552|NCT02312115|Diuretics|diuretics|mesh-ancestor
102134553|NCT02312115|Natriuretic Agents|natriuretic agents|mesh-ancestor
102134554|NCT02312115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134555|NCT02312115|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102134556|NCT02312115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102134557|NCT02312115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134558|NCT03106532|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102134559|NCT03106532|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102134560|NCT03026140|Celecoxib|celecoxib|mesh-list
102134561|NCT03026140|Nivolumab|nivolumab|mesh-list
102134562|NCT03026140|Ipilimumab|ipilimumab|mesh-list
102134563|NCT03026140|Relatlimab|relatlimab|mesh-list
102134564|NCT03026140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102134565|NCT03026140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102134566|NCT03026140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102134567|NCT03026140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134568|NCT03026140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102134569|NCT03026140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102134570|NCT03026140|Analgesics|analgesics|mesh-ancestor
102134571|NCT03026140|Sensory System Agents|sensory system agents|mesh-ancestor
102134572|NCT03026140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102134573|NCT03026140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134574|NCT03026140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102134575|NCT03026140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102134576|NCT03026140|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102134577|NCT03026140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102134578|NCT03026140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102134579|NCT02398994|Methylprednisolone|methylprednisolone|mesh-list
102134580|NCT02398994|Immunoglobulins|immunoglobulins|mesh-list
102134581|NCT02398994|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102134582|NCT02398994|gamma-Globulins|gamma-globulins|mesh-list
102134583|NCT02398994|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102134584|NCT02398994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102134585|NCT02398994|Antiemetics|antiemetics|mesh-ancestor
102134586|NCT02398994|Autonomic Agents|autonomic agents|mesh-ancestor
102134587|NCT02398994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102134588|NCT02398994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134589|NCT02398994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102134590|NCT02398994|Glucocorticoids|glucocorticoids|mesh-ancestor
102134591|NCT02398994|Hormones|hormones|mesh-ancestor
102134592|NCT02398994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102134593|NCT02398994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102134594|NCT02398994|Protective Agents|protective agents|mesh-ancestor
102134595|NCT02398994|Immunologic Factors|immunologic factors|mesh-ancestor
102134596|NCT02306889|Fenofibrate|fenofibrate|mesh-list
102134597|NCT02306889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102134598|NCT02306889|Antimetabolites|antimetabolites|mesh-ancestor
102134599|NCT02306889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134600|NCT02306889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102134601|NCT02393144|Meperidine|meperidine|mesh-list
102134602|NCT02393144|Analgesics, Opioid|analgesics, opioid|mesh-list
102134603|NCT02393144|Analgesics|analgesics|mesh-list
102134604|NCT02393144|Oxytocin|oxytocin|mesh-list
102134605|NCT02393144|Dinoprostone|dinoprostone|mesh-list
102134606|NCT02393144|Oxytocics|oxytocics|mesh-ancestor
102134607|NCT02393144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102134608|NCT02393144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134609|NCT02393144|Narcotics|narcotics|mesh-ancestor
102134610|NCT02393144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102134611|NCT02393144|Sensory System Agents|sensory system agents|mesh-ancestor
102134612|NCT02393144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102134613|NCT02393144|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102134614|NCT02306031|Diclofenac|diclofenac|mesh-list
102134615|NCT02306031|Lubricant Eye Drops|lubricant eye drops|mesh-list
102134616|NCT02306031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102134617|NCT02306031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102134618|NCT02306031|Analgesics|analgesics|mesh-ancestor
102134619|NCT02306031|Sensory System Agents|sensory system agents|mesh-ancestor
102134620|NCT02306031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102134621|NCT02306031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134622|NCT02306031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102134623|NCT02306031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102134624|NCT02306031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102134625|NCT02306031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102134626|NCT02306031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134627|NCT02306031|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102134628|NCT02306031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102134629|NCT02392910|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102134630|NCT02392910|Hematinics|hematinics|mesh-ancestor
102134631|NCT02307045|Nicotine|nicotine|mesh-list
102134632|NCT02307045|Varenicline|varenicline|mesh-list
102134633|NCT02307045|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102134634|NCT02307045|Autonomic Agents|autonomic agents|mesh-ancestor
102134635|NCT02307045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102134636|NCT02307045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134637|NCT02307045|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102134638|NCT02307045|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102134639|NCT02307045|Cholinergic Agents|cholinergic agents|mesh-ancestor
102134640|NCT02307045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102134641|NCT02307045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134642|NCT03167372|Imidacloprid|imidacloprid|mesh-list
102134643|NCT03167372|Cholinergic Agents|cholinergic agents|mesh-ancestor
102134644|NCT03167372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102134645|NCT03167372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134646|NCT03167372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134647|NCT03504345|Progesterone|progesterone|mesh-list
102134648|NCT03504345|Progestins|progestins|mesh-ancestor
102134649|NCT03504345|Hormones|hormones|mesh-ancestor
102134650|NCT03504345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102134651|NCT03504345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134652|NCT02307201|Magnesium Sulfate|magnesium sulfate|mesh-list
102134653|NCT02307201|Analgesics|analgesics|mesh-ancestor
102134654|NCT02307201|Sensory System Agents|sensory system agents|mesh-ancestor
102134655|NCT02307201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102134656|NCT02307201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134657|NCT02307201|Anesthetics|anesthetics|mesh-ancestor
102134658|NCT02307201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102134659|NCT02307201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102134660|NCT02307201|Anticonvulsants|anticonvulsants|mesh-ancestor
102134661|NCT02307201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102134662|NCT02307201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102134663|NCT02307201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134664|NCT02307201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102134665|NCT02307201|Tocolytic Agents|tocolytic agents|mesh-ancestor
102134666|NCT02307201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102134667|NCT02306187|Eldecalcitol|eldecalcitol|mesh-list
102134668|NCT02306187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102134669|NCT02306187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134670|NCT03167216|Cetirizine|cetirizine|mesh-list
102134671|NCT03167216|Cromolyn Sodium|cromolyn sodium|mesh-list
102134672|NCT03167216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102134673|NCT03167216|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102134674|NCT03167216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102134675|NCT03167216|Histamine Antagonists|histamine antagonists|mesh-ancestor
102134676|NCT03167216|Histamine Agents|histamine agents|mesh-ancestor
102134677|NCT03167216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102134678|NCT03167216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134679|NCT03167216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134680|NCT03167216|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
102134681|NCT03167216|Immunologic Factors|immunologic factors|mesh-ancestor
102134682|NCT03167216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102134683|NCT03167216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102134684|NCT03167216|Respiratory System Agents|respiratory system agents|mesh-ancestor
102134685|NCT02393066|Dexmedetomidine|dexmedetomidine|mesh-list
102134686|NCT02393066|Propofol|propofol|mesh-list
102134687|NCT02393066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102134688|NCT02393066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102134689|NCT02393066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134690|NCT02393066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102134691|NCT02393066|Analgesics|analgesics|mesh-ancestor
102134692|NCT02393066|Sensory System Agents|sensory system agents|mesh-ancestor
102134693|NCT02393066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102134694|NCT02393066|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102134695|NCT02393066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102134696|NCT02393066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102134697|NCT02393066|Adrenergic Agents|adrenergic agents|mesh-ancestor
102134698|NCT02393066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102134699|NCT02393066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134700|NCT02393066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102134701|NCT02393066|Anesthetics, General|anesthetics, general|mesh-ancestor
102134702|NCT02393066|Anesthetics|anesthetics|mesh-ancestor
102134703|NCT02398838|Misoprostol|misoprostol|mesh-list
102134704|NCT02398838|Mifepristone|mifepristone|mesh-list
101736712|NCT00916526|Mannitol|mannitol|mesh-list
102134705|NCT02398838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102134706|NCT02398838|Abortifacient Agents|abortifacient agents|mesh-ancestor
102134707|NCT02398838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102134708|NCT02398838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134709|NCT02398838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102134710|NCT02398838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102134711|NCT02398838|Oxytocics|oxytocics|mesh-ancestor
102134712|NCT02398838|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102134713|NCT02398838|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102134714|NCT02398838|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102134715|NCT02398838|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102134716|NCT02398838|Contraceptive Agents|contraceptive agents|mesh-ancestor
102134717|NCT02398838|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102134718|NCT02398838|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102134719|NCT02398838|Hormone Antagonists|hormone antagonists|mesh-ancestor
102134720|NCT02398838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102134721|NCT02398838|Luteolytic Agents|luteolytic agents|mesh-ancestor
102134722|NCT02398838|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102134723|NCT02398838|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102134724|NCT02398682|Tin Fluorides|tin fluorides|mesh-list
102134725|NCT02398682|Cariostatic Agents|cariostatic agents|mesh-ancestor
102134726|NCT02398682|Protective Agents|protective agents|mesh-ancestor
102134727|NCT02398682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134728|NCT02312427|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
102134729|NCT02312427|Protease Inhibitors|protease inhibitors|mesh-ancestor
102134730|NCT02312427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102134731|NCT02312427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134732|NCT02312427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102134733|NCT02312427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134735|NCT03504033|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102134736|NCT03504033|Anesthetics, General|anesthetics, general|mesh-ancestor
102134737|NCT03504033|Anesthetics|anesthetics|mesh-ancestor
102134738|NCT03504033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102134739|NCT03504033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134740|NCT03132519|Remifentanil|remifentanil|mesh-list
102134741|NCT03132519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102134742|NCT03132519|Narcotics|narcotics|mesh-ancestor
102134743|NCT03132519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102134744|NCT03132519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134745|NCT03132519|Analgesics|analgesics|mesh-ancestor
102134746|NCT03132519|Sensory System Agents|sensory system agents|mesh-ancestor
102134747|NCT03132519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102134748|NCT02398448|Allopurinol|allopurinol|mesh-list
102134749|NCT02398448|Antimetabolites|antimetabolites|mesh-ancestor
102134750|NCT02398448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134751|NCT02398448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102134752|NCT02398448|Gout Suppressants|gout suppressants|mesh-ancestor
102134753|NCT02398448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102134754|NCT02398448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102134755|NCT02398448|Antioxidants|antioxidants|mesh-ancestor
102134756|NCT02398448|Protective Agents|protective agents|mesh-ancestor
102134757|NCT02398448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134758|NCT02392520|Cetrorelix|cetrorelix|mesh-list
102134759|NCT02392520|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102134760|NCT02392520|Fertility Agents|fertility agents|mesh-ancestor
102134761|NCT02392520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102134762|NCT02392520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134763|NCT02392520|Hormone Antagonists|hormone antagonists|mesh-ancestor
102134764|NCT02392520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102134765|NCT02316249|Estradiol|estradiol|mesh-list
102134766|NCT02316249|Hormones|hormones|mesh-ancestor
102134767|NCT02316249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102134768|NCT02316249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134769|NCT02316249|Estrogens|estrogens|mesh-ancestor
102134770|NCT02696096|Buprenorphine|buprenorphine|mesh-list
102134771|NCT02696096|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102134772|NCT02696096|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102134773|NCT02696096|Narcotics|narcotics|mesh-ancestor
102134774|NCT02696096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102134775|NCT02696096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134776|NCT02696096|Analgesics|analgesics|mesh-ancestor
102134777|NCT02696096|Sensory System Agents|sensory system agents|mesh-ancestor
102134778|NCT02696096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102134779|NCT02696096|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102134780|NCT02316327|Bevacizumab|bevacizumab|mesh-list
102134781|NCT02316327|Gemcitabine|gemcitabine|mesh-list
102134782|NCT02316327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102134783|NCT02316327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102134784|NCT02316327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102134785|NCT02316327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102134786|NCT02316327|Growth Substances|growth substances|mesh-ancestor
102134787|NCT02316327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134788|NCT02316327|Growth Inhibitors|growth inhibitors|mesh-ancestor
102134789|NCT02316327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102134790|NCT02316327|Antimetabolites|antimetabolites|mesh-ancestor
102134791|NCT02316327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134792|NCT02695628|Misonidazole|misonidazole|mesh-list
102134793|NCT02695628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102134794|NCT02695628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102134795|NCT02695628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102134796|NCT02695628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102134797|NCT02392364|Aflibercept|aflibercept|mesh-list
102134798|NCT02392364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102134799|NCT02392364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102134800|NCT02392364|Growth Substances|growth substances|mesh-ancestor
102134801|NCT02392364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134802|NCT02392364|Growth Inhibitors|growth inhibitors|mesh-ancestor
102134803|NCT02392364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102134804|NCT02392676|Olaparib|olaparib|mesh-list
102134805|NCT02392676|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102134806|NCT02392676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102134807|NCT02392676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134808|NCT02392676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101843804|NCT04377503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102134809|NCT03106298|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102134810|NCT03106298|Hematinics|hematinics|mesh-ancestor
102134811|NCT02307591|Amiodarone|amiodarone|mesh-list
102134812|NCT02307591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102134813|NCT02307591|Vasodilator Agents|vasodilator agents|mesh-ancestor
102134814|NCT02307591|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102134815|NCT02307591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102134816|NCT02307591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134817|NCT02307591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102134818|NCT02307591|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102134819|NCT02307591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102134820|NCT02307591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102134821|NCT02307591|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102134822|NCT02307591|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102134823|NCT02307591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102134824|NCT03506997|Pembrolizumab|pembrolizumab|mesh-list
102134825|NCT03506997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102134826|NCT03506997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102134827|NCT03506997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102134828|NCT03506997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134829|NCT02398136|Midazolam|midazolam|mesh-list
102134830|NCT02398136|Ketamine|ketamine|mesh-list
102134831|NCT02398136|Analgesics|analgesics|mesh-ancestor
102134832|NCT02398136|Sensory System Agents|sensory system agents|mesh-ancestor
102134833|NCT02398136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102134834|NCT02398136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134835|NCT02398136|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102134836|NCT02398136|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102134837|NCT02398136|Anesthetics, General|anesthetics, general|mesh-ancestor
102134838|NCT02398136|Anesthetics|anesthetics|mesh-ancestor
102134839|NCT02398136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102134840|NCT02398136|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102134841|NCT02398136|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102134842|NCT02398136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102134843|NCT02398136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134844|NCT02398136|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102134845|NCT02398136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102134846|NCT02398136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102134847|NCT02398136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102134848|NCT02398136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102134849|NCT02398136|GABA Modulators|gaba modulators|mesh-ancestor
102134850|NCT02398136|GABA Agents|gaba agents|mesh-ancestor
102134851|NCT05745584|Mirabegron|mirabegron|mesh-list
102134852|NCT05745584|Cholinergic Antagonists|cholinergic antagonists|mesh-list
102134853|NCT05745584|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102134854|NCT05745584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102134855|NCT05745584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102134856|NCT05745584|Adrenergic Agents|adrenergic agents|mesh-ancestor
102134857|NCT05745584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102134858|NCT05745584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134859|NCT05745584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134860|NCT05745584|Urological Agents|urological agents|mesh-ancestor
102134861|NCT05745584|Cholinergic Agents|cholinergic agents|mesh-ancestor
102134862|NCT02312661|Metformin|metformin|mesh-list
102134863|NCT02312661|Paclitaxel|paclitaxel|mesh-list
102134864|NCT02312661|Carboplatin|carboplatin|mesh-list
102134865|NCT02312661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102134866|NCT02312661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102134867|NCT02312661|Tubulin Modulators|tubulin modulators|mesh-ancestor
102134868|NCT02312661|Antimitotic Agents|antimitotic agents|mesh-ancestor
102134869|NCT02312661|Mitosis Modulators|mitosis modulators|mesh-ancestor
102134870|NCT02312661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134871|NCT02312661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102134872|NCT02312661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134873|NCT02398058|Olaparib|olaparib|mesh-list
102134874|NCT02398058|Trabectedin|trabectedin|mesh-list
102134875|NCT02398058|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102134876|NCT02398058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102134877|NCT02398058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134878|NCT02398058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102134879|NCT02398058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102134880|NCT02398058|Alkylating Agents|alkylating agents|mesh-ancestor
102134881|NCT03501615|Immunotoxin HA22|immunotoxin ha22|mesh-list
102134882|NCT03501615|Immunotoxins|immunotoxins|mesh-ancestor
102134884|NCT03501615|Immunologic Factors|immunologic factors|mesh-ancestor
102134885|NCT03501615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134886|NCT03501615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102134887|NCT05745350|Pembrolizumab|pembrolizumab|mesh-list
102134888|NCT05745350|Etoposide|etoposide|mesh-list
102134889|NCT05745350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102134890|NCT05745350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102134891|NCT05745350|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102134892|NCT05745350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134893|NCT05745350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102134894|NCT05745350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102134895|NCT05745350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102134896|NCT05745350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102134897|NCT03506919|Allopurinol|allopurinol|mesh-list
102134898|NCT03506919|Antimetabolites|antimetabolites|mesh-ancestor
101736919|NCT00783224|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102134899|NCT03506919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134900|NCT03506919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102134901|NCT03506919|Gout Suppressants|gout suppressants|mesh-ancestor
102134902|NCT03506919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102134903|NCT03506919|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102134904|NCT03506919|Antioxidants|antioxidants|mesh-ancestor
102134905|NCT03506919|Protective Agents|protective agents|mesh-ancestor
102134906|NCT03506919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134907|NCT02545504|Leucovorin|leucovorin|mesh-list
102134908|NCT02545504|Fluorouracil|fluorouracil|mesh-list
102134909|NCT02545504|Oxaliplatin|oxaliplatin|mesh-list
102134910|NCT02545504|Antimetabolites|antimetabolites|mesh-ancestor
102134911|NCT02545504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134912|NCT02545504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102134913|NCT02545504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102134914|NCT02545504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102134915|NCT02545504|Immunologic Factors|immunologic factors|mesh-ancestor
102134916|NCT02545504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134917|NCT02545504|Antidotes|antidotes|mesh-ancestor
102134918|NCT02545504|Protective Agents|protective agents|mesh-ancestor
102134919|NCT02545504|Vitamin B Complex|vitamin b complex|mesh-ancestor
102134920|NCT02545504|Vitamins|vitamins|mesh-ancestor
102134921|NCT02545504|Micronutrients|micronutrients|mesh-ancestor
102134922|NCT03506841|Cerebrolysin|cerebrolysin|mesh-list
102134923|NCT03506841|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102134924|NCT03506841|Protective Agents|protective agents|mesh-ancestor
102134925|NCT03506841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134926|NCT03506841|Nootropic Agents|nootropic agents|mesh-ancestor
102134928|NCT02397512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102134929|NCT02313051|Everolimus|everolimus|mesh-list
102134930|NCT02313051|Letrozole|letrozole|mesh-list
102134931|NCT02313051|Goserelin|goserelin|mesh-list
102134932|NCT02313051|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102134933|NCT02313051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102134934|NCT02313051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102134935|NCT02313051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134936|NCT02313051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102134937|NCT02313051|Immunologic Factors|immunologic factors|mesh-ancestor
102134938|NCT02313051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134939|NCT02313051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102134940|NCT02313051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102134941|NCT02313051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102134942|NCT02313051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102134943|NCT02313051|Hormone Antagonists|hormone antagonists|mesh-ancestor
102134944|NCT02313051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102134945|NCT02313051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102134946|NCT02397590|Atorvastatin|atorvastatin|mesh-list
102134947|NCT02397590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102134948|NCT02397590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102134949|NCT02397590|Antimetabolites|antimetabolites|mesh-ancestor
101736986|NCT02587455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102134950|NCT02397590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134951|NCT02397590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102134952|NCT02397590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102134953|NCT02397590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102134954|NCT02397356|Ketamine|ketamine|mesh-list
102134955|NCT02397356|Analgesics|analgesics|mesh-ancestor
102134956|NCT02397356|Sensory System Agents|sensory system agents|mesh-ancestor
102134957|NCT02397356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102134958|NCT02397356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134959|NCT02397356|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102134960|NCT02397356|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102134961|NCT02397356|Anesthetics, General|anesthetics, general|mesh-ancestor
102134962|NCT02397356|Anesthetics|anesthetics|mesh-ancestor
102134963|NCT02397356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102134964|NCT02397356|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102134965|NCT02397356|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102134966|NCT02397356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102134967|NCT02397356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134968|NCT02307825|Azithromycin|azithromycin|mesh-list
102134969|NCT02307825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102134970|NCT02307825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102134971|NCT02540668|Warfarin|warfarin|mesh-list
102134972|NCT02540668|Anticoagulants|anticoagulants|mesh-ancestor
102134973|NCT03506763|Diclofenac|diclofenac|mesh-list
102134974|NCT03506763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102134975|NCT03506763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102134976|NCT03506763|Analgesics|analgesics|mesh-ancestor
102134977|NCT03506763|Sensory System Agents|sensory system agents|mesh-ancestor
102134978|NCT03506763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102134979|NCT03506763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134980|NCT03506763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102134981|NCT03506763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102134982|NCT03506763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102134983|NCT03506763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102134984|NCT03506763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134986|NCT02441439|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102134987|NCT02441439|Trace Elements|trace elements|mesh-ancestor
102134988|NCT02441439|Micronutrients|micronutrients|mesh-ancestor
102134989|NCT02441439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134990|NCT02441439|Hematinics|hematinics|mesh-ancestor
102134991|NCT02308137|Domperidone|domperidone|mesh-list
102134992|NCT02308137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102134993|NCT02308137|Antiemetics|antiemetics|mesh-ancestor
102134994|NCT02308137|Autonomic Agents|autonomic agents|mesh-ancestor
102134995|NCT02308137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102134996|NCT02308137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102134997|NCT02308137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102535898|NCT02664909|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102134998|NCT02308137|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102134999|NCT02308137|Dopamine Agents|dopamine agents|mesh-ancestor
102135000|NCT02308137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102135001|NCT03501459|Rituximab|rituximab|mesh-list
102135002|NCT03501459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102135003|NCT03501459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102135004|NCT03501459|Immunologic Factors|immunologic factors|mesh-ancestor
102135005|NCT03501459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135006|NCT03501459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102135007|NCT02317263|Testosterone|testosterone|mesh-list
102135008|NCT02317263|Androgens|androgens|mesh-ancestor
102135009|NCT02317263|Hormones|hormones|mesh-ancestor
102135010|NCT02317263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102135011|NCT02317263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135012|NCT02317341|Midazolam|midazolam|mesh-list
102135013|NCT02317341|Ketamine|ketamine|mesh-list
102135014|NCT02317341|Analgesics|analgesics|mesh-ancestor
102135015|NCT02317341|Sensory System Agents|sensory system agents|mesh-ancestor
102135016|NCT02317341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102135017|NCT02317341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135018|NCT02317341|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102135019|NCT02317341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102135020|NCT02317341|Anesthetics, General|anesthetics, general|mesh-ancestor
102135021|NCT02317341|Anesthetics|anesthetics|mesh-ancestor
102135022|NCT02317341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102135023|NCT02317341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102135024|NCT02317341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102135025|NCT02317341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102135026|NCT02317341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135027|NCT02317341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102135028|NCT02317341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102135029|NCT02317341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102135030|NCT02317341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102135031|NCT02317341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101844022|NCT00264238|Memantine|memantine|mesh-list
102135032|NCT02317341|GABA Modulators|gaba modulators|mesh-ancestor
102135033|NCT02317341|GABA Agents|gaba agents|mesh-ancestor
102135034|NCT02339740|Vitamins|vitamins|mesh-list
102135035|NCT02339740|Vitamin A|vitamin a|mesh-list
102135036|NCT02339740|Cytarabine|cytarabine|mesh-list
102135037|NCT02339740|Dexamethasone|dexamethasone|mesh-list
102135038|NCT02339740|Dexamethasone acetate|dexamethasone acetate|mesh-list
102135039|NCT02339740|Mitoxantrone|mitoxantrone|mesh-list
102135040|NCT02339740|Idarubicin|idarubicin|mesh-list
102135041|NCT02339740|Tretinoin|tretinoin|mesh-list
102135042|NCT02339740|Retinol palmitate|retinol palmitate|mesh-list
102135043|NCT02339740|Arsenic Trioxide|arsenic trioxide|mesh-list
102135044|NCT02339740|BB 1101|bb 1101|mesh-list
102135045|NCT02339740|Micronutrients|micronutrients|mesh-ancestor
102135046|NCT02339740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135047|NCT02339740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102135048|NCT02339740|Antiemetics|antiemetics|mesh-ancestor
102135049|NCT02339740|Autonomic Agents|autonomic agents|mesh-ancestor
102135050|NCT02339740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102135051|NCT02339740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102135052|NCT02339740|Glucocorticoids|glucocorticoids|mesh-ancestor
102135053|NCT02339740|Hormones|hormones|mesh-ancestor
102135054|NCT02339740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102135055|NCT02339740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102135056|NCT02339740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102135057|NCT02339740|Protease Inhibitors|protease inhibitors|mesh-ancestor
102135058|NCT02339740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102135059|NCT02339740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135060|NCT02339740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102135061|NCT02339740|Antimetabolites|antimetabolites|mesh-ancestor
102135062|NCT02339740|Antiviral Agents|antiviral agents|mesh-ancestor
102135063|NCT02339740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102135064|NCT02339740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102135065|NCT02339740|Immunologic Factors|immunologic factors|mesh-ancestor
102135066|NCT02339740|Analgesics|analgesics|mesh-ancestor
102135067|NCT02339740|Sensory System Agents|sensory system agents|mesh-ancestor
102135068|NCT02339740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102135069|NCT02339740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102135070|NCT02339740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102135071|NCT02339740|Keratolytic Agents|keratolytic agents|mesh-ancestor
102135072|NCT02339740|Dermatologic Agents|dermatologic agents|mesh-ancestor
102135073|NCT02339740|Antioxidants|antioxidants|mesh-ancestor
102135074|NCT02339740|Protective Agents|protective agents|mesh-ancestor
102135075|NCT02339740|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102135076|NCT02317419|Paclitaxel|paclitaxel|mesh-list
102135077|NCT02317419|Gemcitabine|gemcitabine|mesh-list
102135078|NCT02317419|LMB-100|lmb-100|mesh-list
102135079|NCT02317419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102135080|NCT02317419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102135081|NCT02317419|Tubulin Modulators|tubulin modulators|mesh-ancestor
102135082|NCT02317419|Antimitotic Agents|antimitotic agents|mesh-ancestor
102135083|NCT02317419|Mitosis Modulators|mitosis modulators|mesh-ancestor
102135084|NCT02317419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135085|NCT02317419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102135086|NCT02317419|Antimetabolites|antimetabolites|mesh-ancestor
102135087|NCT02317419|Immunoconjugates|immunoconjugates|mesh-ancestor
102135088|NCT02317419|Immunologic Factors|immunologic factors|mesh-ancestor
102135089|NCT02317419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135090|NCT02317497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
102135091|NCT02957968|Paclitaxel|paclitaxel|mesh-list
102135092|NCT02957968|Cyclophosphamide|cyclophosphamide|mesh-list
102135093|NCT02957968|Carboplatin|carboplatin|mesh-list
102135094|NCT02957968|Doxorubicin|doxorubicin|mesh-list
102135095|NCT02957968|Pembrolizumab|pembrolizumab|mesh-list
102135096|NCT02957968|Decitabine|decitabine|mesh-list
102135097|NCT02957968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102135098|NCT02957968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102135099|NCT02957968|Tubulin Modulators|tubulin modulators|mesh-ancestor
102135100|NCT02957968|Antimitotic Agents|antimitotic agents|mesh-ancestor
102135101|NCT02957968|Mitosis Modulators|mitosis modulators|mesh-ancestor
102135102|NCT02957968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135103|NCT02957968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102135104|NCT02957968|Immunologic Factors|immunologic factors|mesh-ancestor
102135105|NCT02957968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135106|NCT02957968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101844098|NCT01050699|Narcotics|narcotics|mesh-ancestor
102135107|NCT02957968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102135108|NCT02957968|Alkylating Agents|alkylating agents|mesh-ancestor
102135109|NCT02957968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102135110|NCT02957968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102135111|NCT02957968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102135112|NCT02957968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102135113|NCT02957968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102135114|NCT02957968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102135115|NCT02957968|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102135116|NCT02957968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102135117|NCT02957968|Antimetabolites|antimetabolites|mesh-ancestor
102135118|NCT05452174|Mirtazapine|mirtazapine|mesh-list
102135119|NCT05452174|Antidepressive Agents|antidepressive agents|mesh-ancestor
102135120|NCT05452174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102135121|NCT05452174|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102135122|NCT05452174|Histamine Antagonists|histamine antagonists|mesh-ancestor
102135123|NCT05452174|Histamine Agents|histamine agents|mesh-ancestor
102135124|NCT05452174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102135125|NCT05452174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135126|NCT05452174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135127|NCT05452174|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102135128|NCT05452174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102135129|NCT05452174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102135130|NCT05452174|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102135131|NCT05452174|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102135132|NCT05452174|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102135133|NCT05452174|Adrenergic Agents|adrenergic agents|mesh-ancestor
102135134|NCT05452174|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102135135|NCT05452174|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102135136|NCT05452174|Serotonin Agents|serotonin agents|mesh-ancestor
102135137|NCT05452174|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102135138|NCT03943888|Atropine|atropine|mesh-list
102135139|NCT03943888|Neostigmine|neostigmine|mesh-list
102135140|NCT03943888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102135141|NCT03943888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102135142|NCT03943888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102135143|NCT03943888|Autonomic Agents|autonomic agents|mesh-ancestor
102135144|NCT03943888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102135145|NCT03943888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135146|NCT03943888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102135147|NCT03943888|Respiratory System Agents|respiratory system agents|mesh-ancestor
102135148|NCT03943888|Mydriatics|mydriatics|mesh-ancestor
102135149|NCT03943888|Parasympatholytics|parasympatholytics|mesh-ancestor
102135150|NCT03943888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102135151|NCT03943888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102135152|NCT03943888|Cholinergic Agents|cholinergic agents|mesh-ancestor
102135153|NCT03943888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102135154|NCT03943888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135155|NCT03943888|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102135156|NCT03943888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102135157|NCT03943888|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102135158|NCT03502551|Ketamine|ketamine|mesh-list
102135159|NCT03502551|Analgesics|analgesics|mesh-ancestor
102135160|NCT03502551|Sensory System Agents|sensory system agents|mesh-ancestor
102135161|NCT03502551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102135162|NCT03502551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135163|NCT03502551|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102135164|NCT03502551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102135165|NCT03502551|Anesthetics, General|anesthetics, general|mesh-ancestor
102135166|NCT03502551|Anesthetics|anesthetics|mesh-ancestor
102135167|NCT03502551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102135168|NCT03502551|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102135169|NCT03502551|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102135170|NCT03502551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102135171|NCT03502551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135172|NCT02314377|Bevacizumab|bevacizumab|mesh-list
102135173|NCT02314377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102135174|NCT02314377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102135175|NCT02314377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102135176|NCT02314377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102135177|NCT02314377|Growth Substances|growth substances|mesh-ancestor
102135178|NCT02314377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135179|NCT02314377|Growth Inhibitors|growth inhibitors|mesh-ancestor
102135180|NCT02942290|Azacitidine|azacitidine|mesh-list
102135181|NCT02942290|Venetoclax|venetoclax|mesh-list
102135182|NCT02942290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102135183|NCT02942290|Antimetabolites|antimetabolites|mesh-ancestor
102135184|NCT02942290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135185|NCT02942290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102135186|NCT02942290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102135187|NCT02540356|Antibodies|antibodies|mesh-list
102135188|NCT02540356|Immunoglobulins|immunoglobulins|mesh-list
102135189|NCT02540356|Immunologic Factors|immunologic factors|mesh-ancestor
102135190|NCT02540356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135191|NCT05463094|Metformin|metformin|mesh-list
102135192|NCT05463094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102135193|NCT05463094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135194|NCT05431348|Hydrocortisone|hydrocortisone|mesh-list
102135195|NCT05431348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102135196|NCT05461378|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
102135197|NCT05461378|Antiviral Agents|antiviral agents|mesh-ancestor
102135198|NCT05461378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102135199|NCT02392130|Clobetasol|clobetasol|mesh-list
102135200|NCT02392130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102135201|NCT02392130|Glucocorticoids|glucocorticoids|mesh-ancestor
102135202|NCT02392130|Hormones|hormones|mesh-ancestor
102135203|NCT02392130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102135204|NCT02392130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135205|NCT05356091|Sevoflurane|sevoflurane|mesh-list
102135206|NCT05356091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102135207|NCT05356091|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102135208|NCT05356091|Anesthetics, General|anesthetics, general|mesh-ancestor
102135209|NCT05356091|Anesthetics|anesthetics|mesh-ancestor
102135210|NCT05356091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102135211|NCT05356091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135212|NCT05351021|Metformin|metformin|mesh-list
102135213|NCT05351021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102135214|NCT05351021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135215|NCT02688764|Calcium|calcium|mesh-list
102135216|NCT02688764|Calcium acetate|calcium acetate|mesh-list
102135217|NCT02688764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102135218|NCT02688764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135219|NCT02688764|Chelating Agents|chelating agents|mesh-ancestor
102135220|NCT02688764|Sequestering Agents|sequestering agents|mesh-ancestor
102135221|NCT02688764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135222|NCT02688608|Pembrolizumab|pembrolizumab|mesh-list
102135223|NCT02688608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102135224|NCT02688608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102135225|NCT02688608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102135226|NCT02688608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135227|NCT02688530|Dexamethasone|dexamethasone|mesh-list
101737253|NCT04101578|Hormones|hormones|mesh-ancestor
102135228|NCT02688530|Dexamethasone acetate|dexamethasone acetate|mesh-list
102135229|NCT02688530|BB 1101|bb 1101|mesh-list
102135230|NCT02688530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102135231|NCT02688530|Antiemetics|antiemetics|mesh-ancestor
102135232|NCT02688530|Autonomic Agents|autonomic agents|mesh-ancestor
102135233|NCT02688530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102135234|NCT02688530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135235|NCT02688530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102135236|NCT02688530|Glucocorticoids|glucocorticoids|mesh-ancestor
102135237|NCT02688530|Hormones|hormones|mesh-ancestor
102135238|NCT02688530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102135239|NCT02688530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102135240|NCT02688530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102135241|NCT02688530|Protease Inhibitors|protease inhibitors|mesh-ancestor
102135242|NCT02688530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102135243|NCT02688530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135244|NCT05744804|Aspirin|aspirin|mesh-list
102135245|NCT05744804|Rivaroxaban|rivaroxaban|mesh-list
102135246|NCT05744804|Clopidogrel|clopidogrel|mesh-list
102135247|NCT05744804|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102135248|NCT05744804|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102135249|NCT05744804|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102135250|NCT05744804|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102135251|NCT05744804|Purinergic Agents|purinergic agents|mesh-ancestor
102135252|NCT05744804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102135253|NCT05744804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135254|NCT05744804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135255|NCT05744804|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102135256|NCT05744804|Antithrombins|antithrombins|mesh-ancestor
102135257|NCT05744804|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102135258|NCT05744804|Protease Inhibitors|protease inhibitors|mesh-ancestor
102135259|NCT05744804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102135260|NCT05744804|Anticoagulants|anticoagulants|mesh-ancestor
102135261|NCT05744804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102135262|NCT05744804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102135263|NCT05744804|Analgesics|analgesics|mesh-ancestor
102135264|NCT05744804|Sensory System Agents|sensory system agents|mesh-ancestor
102135265|NCT05744804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102135266|NCT05744804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102135267|NCT05744804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102135268|NCT05744804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102135269|NCT05744804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102135270|NCT05744804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102135271|NCT05744804|Antipyretics|antipyretics|mesh-ancestor
102135272|NCT05744726|Bone wax|bone wax|mesh-list
102135273|NCT05744726|Hemostatics|hemostatics|mesh-ancestor
102135274|NCT05744726|Coagulants|coagulants|mesh-ancestor
102135275|NCT02467270|Ponatinib|ponatinib|mesh-list
102135276|NCT02467270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102135277|NCT02467270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102135278|NCT02467270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102135279|NCT02467270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135280|NCT05150795|Pregabalin|pregabalin|mesh-list
102135281|NCT05150795|Fentanyl|fentanyl|mesh-list
102135282|NCT05150795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102135283|NCT05150795|Narcotics|narcotics|mesh-ancestor
102135284|NCT05150795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102135285|NCT05150795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135286|NCT05150795|Analgesics|analgesics|mesh-ancestor
102135287|NCT05150795|Sensory System Agents|sensory system agents|mesh-ancestor
102135288|NCT05150795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102135289|NCT05150795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102135290|NCT05150795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102135291|NCT05150795|Anesthetics, General|anesthetics, general|mesh-ancestor
102135292|NCT05150795|Anesthetics|anesthetics|mesh-ancestor
102135293|NCT05150795|Anticonvulsants|anticonvulsants|mesh-ancestor
102135294|NCT05150795|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102135295|NCT05150795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102135296|NCT05150795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135297|NCT05150795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102135298|NCT05150795|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102135299|NCT05150795|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102135300|NCT05150795|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102135301|NCT03166280|Sofosbuvir|sofosbuvir|mesh-list
102135302|NCT03166280|Antiviral Agents|antiviral agents|mesh-ancestor
102135303|NCT03166280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102135304|NCT02533570|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102135305|NCT02533570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102135306|NCT02533570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102135307|NCT02533570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102135308|NCT02533570|Immunotoxins|immunotoxins|mesh-ancestor
102135309|NCT02533570|Immunoconjugates|immunoconjugates|mesh-ancestor
102135310|NCT02533570|Immunologic Factors|immunologic factors|mesh-ancestor
102135311|NCT02533570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135312|NCT02268448|Clonidine|clonidine|mesh-list
102135313|NCT02268448|Naltrexone|naltrexone|mesh-list
102135314|NCT02268448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102135315|NCT02268448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102135316|NCT02268448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135317|NCT02268448|Sensory System Agents|sensory system agents|mesh-ancestor
102135318|NCT02268448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102135319|NCT02268448|Analgesics|analgesics|mesh-ancestor
102135320|NCT02268448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102135321|NCT02268448|Sympatholytics|sympatholytics|mesh-ancestor
102135322|NCT02268448|Autonomic Agents|autonomic agents|mesh-ancestor
102135323|NCT02268448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102135324|NCT02268448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102135325|NCT02268448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102135326|NCT02268448|Adrenergic Agents|adrenergic agents|mesh-ancestor
102135327|NCT02268448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102135328|NCT02268448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135329|NCT05744570|Anesthetics|anesthetics|mesh-list
102135330|NCT05744570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102135331|NCT05744570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135332|NCT03036839|Sofosbuvir|sofosbuvir|mesh-list
102135333|NCT03036839|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102135334|NCT03036839|Ledipasvir|ledipasvir|mesh-list
102135335|NCT03036839|Antiviral Agents|antiviral agents|mesh-ancestor
102135336|NCT03036839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102135337|NCT04977791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102135338|NCT04977791|Antibodies|antibodies|mesh-list
102135339|NCT04977791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102135340|NCT04977791|Immunologic Factors|immunologic factors|mesh-ancestor
102135341|NCT04977791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135342|NCT04977791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135343|NCT04977791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102135344|NCT04977791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102135345|NCT03625739|Amoxicillin|amoxicillin|mesh-list
102135346|NCT03625739|Moxifloxacin|moxifloxacin|mesh-list
102135347|NCT03625739|Levofloxacin|levofloxacin|mesh-list
102135348|NCT03625739|Isoniazid|isoniazid|mesh-list
102135349|NCT03625739|Cycloserine|cycloserine|mesh-list
102135350|NCT03625739|Clavulanic Acid|clavulanic acid|mesh-list
102135351|NCT03625739|Imipenem|imipenem|mesh-list
102135352|NCT03625739|Amikacin|amikacin|mesh-list
102135353|NCT03625739|Pyrazinamide|pyrazinamide|mesh-list
102135354|NCT03625739|Ethambutol|ethambutol|mesh-list
102135355|NCT03625739|Bedaquiline|bedaquiline|mesh-list
102135356|NCT03625739|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102135357|NCT03625739|Clofazimine|clofazimine|mesh-list
102135358|NCT03625739|Gatifloxacin|gatifloxacin|mesh-list
102135359|NCT03625739|Aminosalicylic Acid|aminosalicylic acid|mesh-list
102135360|NCT03625739|Streptomycin|streptomycin|mesh-list
102135361|NCT03625739|Ethionamide|ethionamide|mesh-list
102135362|NCT03625739|Kanamycin|kanamycin|mesh-list
102135363|NCT03625739|Capreomycin|capreomycin|mesh-list
102135364|NCT03625739|Thioacetazone|thioacetazone|mesh-list
102135365|NCT03625739|Antitubercular Agents|antitubercular agents|mesh-list
102135366|NCT03625739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102135367|NCT03625739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102135368|NCT03625739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102135369|NCT03625739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102135370|NCT03625739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102135371|NCT03625739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135372|NCT03625739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102135373|NCT03625739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102135374|NCT03625739|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102135375|NCT03625739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102135376|NCT03625739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102135377|NCT03625739|Leprostatic Agents|leprostatic agents|mesh-ancestor
102135378|NCT03625739|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102135379|NCT03625739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102135380|NCT03625739|Antimetabolites|antimetabolites|mesh-ancestor
102135381|NCT03625739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102135382|NCT03625739|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102135383|NCT03625739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102135384|NCT03625739|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102135385|NCT03625739|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102135386|NCT03625739|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102135387|NCT03904199|Insulin|insulin|mesh-list
102135388|NCT03904199|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102135389|NCT03904199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102135390|NCT03904199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135391|NCT03902951|Leuprolide|leuprolide|mesh-list
102135392|NCT03902951|Abiraterone Acetate|abiraterone acetate|mesh-list
102135393|NCT03902951|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102135394|NCT03902951|Fertility Agents|fertility agents|mesh-ancestor
102135395|NCT03902951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102135396|NCT03902951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135397|NCT03902951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102135398|NCT03902951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102135399|NCT03902951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102135400|NCT03902951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102135401|NCT03902951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135402|NCT03902951|Hormone Antagonists|hormone antagonists|mesh-ancestor
102135403|NCT03902951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102135404|NCT03902951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102135405|NCT01286207|Rizatriptan|rizatriptan|mesh-list
102135406|NCT01286207|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102135407|NCT01286207|Serotonin Agents|serotonin agents|mesh-ancestor
102135408|NCT01286207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102135409|NCT01286207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135410|NCT01286207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135411|NCT05408026|Dexamethasone|dexamethasone|mesh-list
102135412|NCT05408026|Bortezomib|bortezomib|mesh-list
102135413|NCT05408026|Daratumumab|daratumumab|mesh-list
102135414|NCT05408026|Pomalidomide|pomalidomide|mesh-list
102135415|NCT05408026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102135416|NCT05408026|Antiemetics|antiemetics|mesh-ancestor
101844407|NCT02845271|Tramadol|tramadol|mesh-list
102135417|NCT05408026|Autonomic Agents|autonomic agents|mesh-ancestor
102135418|NCT05408026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102135419|NCT05408026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135420|NCT05408026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102135421|NCT05408026|Glucocorticoids|glucocorticoids|mesh-ancestor
102135422|NCT05408026|Hormones|hormones|mesh-ancestor
102135423|NCT05408026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102135424|NCT05408026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102135425|NCT05408026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102135426|NCT05408026|Immunologic Factors|immunologic factors|mesh-ancestor
102135427|NCT05408026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102135428|NCT05408026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102135429|NCT05408026|Growth Substances|growth substances|mesh-ancestor
102135430|NCT05408026|Growth Inhibitors|growth inhibitors|mesh-ancestor
102135431|NCT02170090|Gemcitabine|gemcitabine|mesh-list
102135432|NCT02170090|Capecitabine|capecitabine|mesh-list
102135433|NCT02170090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102135434|NCT02170090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102135435|NCT02170090|Antimetabolites|antimetabolites|mesh-ancestor
102135436|NCT02170090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135437|NCT04423510|Phenol|phenol|mesh-list
102135438|NCT04423510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101737457|NCT00437281|Pregabalin|pregabalin|mesh-list
102135439|NCT04423510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102135440|NCT04423510|Disinfectants|disinfectants|mesh-ancestor
102135441|NCT04423510|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102135442|NCT04423510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102135443|NCT00968201|Montelukast|montelukast|mesh-list
102135444|NCT00968201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102135445|NCT00968201|Respiratory System Agents|respiratory system agents|mesh-ancestor
102135446|NCT00968201|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102135447|NCT00968201|Hormone Antagonists|hormone antagonists|mesh-ancestor
102135448|NCT00968201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102135449|NCT00968201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135450|NCT00968201|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102135451|NCT00968201|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102135452|NCT00968201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135453|NCT00943397|Montelukast|montelukast|mesh-list
102135454|NCT00943397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102135455|NCT00943397|Respiratory System Agents|respiratory system agents|mesh-ancestor
102135456|NCT00943397|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102135457|NCT00943397|Hormone Antagonists|hormone antagonists|mesh-ancestor
102135458|NCT00943397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102135459|NCT00943397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135460|NCT00943397|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102135461|NCT00943397|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102135462|NCT00943397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135463|NCT00817817|Mometasone Furoate|mometasone furoate|mesh-list
102135464|NCT00817817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102135465|NCT00817817|Dermatologic Agents|dermatologic agents|mesh-ancestor
102135466|NCT00817817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102135467|NCT00702845|Hormones|hormones|mesh-list
102135468|NCT00702845|Progesterone|progesterone|mesh-list
102135469|NCT00702845|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102135470|NCT00702845|Ganirelix|ganirelix|mesh-list
102135471|NCT00702845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102135472|NCT00702845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135473|NCT00702845|Progestins|progestins|mesh-ancestor
102135474|NCT00702845|Hormone Antagonists|hormone antagonists|mesh-ancestor
102135475|NCT00647933|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102135476|NCT00647933|Lynestrenol|lynestrenol|mesh-list
102135477|NCT00647933|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102135478|NCT00647933|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102135479|NCT00647933|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102135480|NCT00647933|Contraceptive Agents|contraceptive agents|mesh-ancestor
102135481|NCT00647933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102135482|NCT00647933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135483|NCT00647933|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102135484|NCT00647933|Estrogens|estrogens|mesh-ancestor
102135485|NCT00647933|Hormones|hormones|mesh-ancestor
102135486|NCT00647933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102135487|NCT00647933|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102135488|NCT00641771|Cholecalciferol|cholecalciferol|mesh-list
102135489|NCT00641771|Vitamin D|vitamin d|mesh-list
102135490|NCT00641771|Alendronate|alendronate|mesh-list
102135491|NCT00641771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102135492|NCT00641771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135493|NCT00641771|Vitamins|vitamins|mesh-ancestor
102135494|NCT00641771|Micronutrients|micronutrients|mesh-ancestor
102135495|NCT00641771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102135496|NCT00519857|Tibolone|tibolone|mesh-list
102135497|NCT00519857|Androgen Antagonists|androgen antagonists|mesh-ancestor
102135498|NCT00519857|Hormone Antagonists|hormone antagonists|mesh-ancestor
102135499|NCT00519857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102135500|NCT00519857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135501|NCT00519857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102135502|NCT00519857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102135503|NCT00519857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102135504|NCT00519857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102135505|NCT00519857|Anabolic Agents|anabolic agents|mesh-ancestor
102135506|NCT00519857|Hormones|hormones|mesh-ancestor
102135507|NCT00431093|Tibolone|tibolone|mesh-list
102135508|NCT00431093|Estradiol|estradiol|mesh-list
102135509|NCT00431093|Estrogens|estrogens|mesh-ancestor
102135510|NCT00431093|Hormones|hormones|mesh-ancestor
102135511|NCT00431093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102135512|NCT00431093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135513|NCT00431093|Androgen Antagonists|androgen antagonists|mesh-ancestor
102135514|NCT00431093|Hormone Antagonists|hormone antagonists|mesh-ancestor
102135515|NCT00431093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102135516|NCT00431093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102135517|NCT00431093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102135518|NCT00431093|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102135519|NCT00431093|Anabolic Agents|anabolic agents|mesh-ancestor
102135520|NCT03665597|Pembrolizumab|pembrolizumab|mesh-list
102135521|NCT03665597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102135522|NCT03665597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102135523|NCT03665597|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102135524|NCT03665597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135525|NCT00092963|Rizatriptan|rizatriptan|mesh-list
102135526|NCT00092963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102135527|NCT00092963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135528|NCT00092963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135529|NCT00092963|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102135530|NCT00092963|Serotonin Agents|serotonin agents|mesh-ancestor
102135531|NCT00092885|Montelukast|montelukast|mesh-list
102135532|NCT00092885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102135533|NCT00092885|Respiratory System Agents|respiratory system agents|mesh-ancestor
102135534|NCT00092885|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102135535|NCT00092885|Hormone Antagonists|hormone antagonists|mesh-ancestor
102135536|NCT00092885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102135537|NCT00092885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135538|NCT00092885|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102135539|NCT00092885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102135540|NCT00092885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135541|NCT03673735|Durvalumab|durvalumab|mesh-list
102135542|NCT03673735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102135543|NCT03673735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102135544|NCT01272037|Tamoxifen|tamoxifen|mesh-list
102135545|NCT01272037|Letrozole|letrozole|mesh-list
102135546|NCT01272037|Anastrozole|anastrozole|mesh-list
102135547|NCT01272037|Exemestane|exemestane|mesh-list
102135548|NCT01272037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135549|NCT01272037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102135550|NCT01272037|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102135551|NCT01272037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102135552|NCT01272037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102135553|NCT01272037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102135554|NCT01272037|Hormone Antagonists|hormone antagonists|mesh-ancestor
102135555|NCT01272037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102135556|NCT01272037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135557|NCT01272037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102135558|NCT01272037|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102135559|NCT01272037|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102135560|NCT01272037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102135561|NCT00092105|Montelukast|montelukast|mesh-list
102135562|NCT00092105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102135563|NCT00092105|Respiratory System Agents|respiratory system agents|mesh-ancestor
102135564|NCT00092105|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102135565|NCT00092105|Hormone Antagonists|hormone antagonists|mesh-ancestor
102135566|NCT00092105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102135567|NCT00092105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135568|NCT00092105|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102135569|NCT00092105|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102135570|NCT00092105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135571|NCT00092027|Alendronate|alendronate|mesh-list
102135572|NCT00092027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135573|NCT00092027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102135574|NCT00076973|Montelukast|montelukast|mesh-list
102135575|NCT00076973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102135576|NCT00076973|Respiratory System Agents|respiratory system agents|mesh-ancestor
102135577|NCT00076973|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102135578|NCT00076973|Hormone Antagonists|hormone antagonists|mesh-ancestor
102135579|NCT00076973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102135580|NCT00076973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135581|NCT00076973|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102135582|NCT00076973|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102135583|NCT00076973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135584|NCT02314533|Fenofibrate|fenofibrate|mesh-list
102135585|NCT02314533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102135586|NCT02314533|Antimetabolites|antimetabolites|mesh-ancestor
102135587|NCT02314533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135588|NCT02314533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102135589|NCT03502395|Lidocaine|lidocaine|mesh-list
102135590|NCT03502395|Anesthetics, Local|anesthetics, local|mesh-ancestor
102135591|NCT03502395|Anesthetics|anesthetics|mesh-ancestor
102135592|NCT03502395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102135593|NCT03502395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135594|NCT03502395|Sensory System Agents|sensory system agents|mesh-ancestor
102135595|NCT03502395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102135596|NCT03502395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102135597|NCT03502395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102135598|NCT03502395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102135599|NCT03502395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102135600|NCT03502395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135601|NCT02318043|Fluticasone|fluticasone|mesh-list
102135602|NCT02318043|Budesonide|budesonide|mesh-list
102135603|NCT02318043|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102135604|NCT02318043|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102135605|NCT02318043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102135606|NCT02318043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102135607|NCT02318043|Autonomic Agents|autonomic agents|mesh-ancestor
102135608|NCT02318043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102135609|NCT02318043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135610|NCT02318043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102135611|NCT02318043|Respiratory System Agents|respiratory system agents|mesh-ancestor
102135612|NCT02318043|Dermatologic Agents|dermatologic agents|mesh-ancestor
102135613|NCT02318043|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102135614|NCT02318043|Glucocorticoids|glucocorticoids|mesh-ancestor
102135615|NCT02318043|Hormones|hormones|mesh-ancestor
102135616|NCT02318043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102135617|NCT02318043|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102135618|NCT02318043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102135619|NCT02318043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102135620|NCT02318043|Adrenergic Agents|adrenergic agents|mesh-ancestor
102135621|NCT02318043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102135622|NCT02318043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135623|NCT02318043|Sympathomimetics|sympathomimetics|mesh-ancestor
102135624|NCT03433313|Trastuzumab|trastuzumab|mesh-list
102135625|NCT03433313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102135626|NCT03433313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102135627|NCT02318121|Oxytocin|oxytocin|mesh-list
102135628|NCT02318121|Oxytocics|oxytocics|mesh-ancestor
102135629|NCT02318121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102135630|NCT02318121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135631|NCT02318199|Anesthetics|anesthetics|mesh-list
102135632|NCT02318199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102135633|NCT02318199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135634|NCT05225597|Carbachol|carbachol|mesh-list
102135635|NCT05225597|Epinephrine|epinephrine|mesh-list
102135636|NCT05225597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102135637|NCT05225597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102135638|NCT05225597|Adrenergic Agents|adrenergic agents|mesh-ancestor
102135639|NCT05225597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102135640|NCT05225597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135641|NCT05225597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135642|NCT05225597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102135643|NCT05225597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102135644|NCT05225597|Autonomic Agents|autonomic agents|mesh-ancestor
102135645|NCT05225597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102135646|NCT05225597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102135647|NCT05225597|Respiratory System Agents|respiratory system agents|mesh-ancestor
102135648|NCT05225597|Mydriatics|mydriatics|mesh-ancestor
102135649|NCT05225597|Sympathomimetics|sympathomimetics|mesh-ancestor
102135650|NCT05225597|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102135651|NCT05225597|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102135652|NCT05225597|Miotics|miotics|mesh-ancestor
102135653|NCT05225597|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102135654|NCT05225597|Cholinergic Agents|cholinergic agents|mesh-ancestor
102135655|NCT05225597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102135656|NCT05225597|Analgesics|analgesics|mesh-ancestor
102135657|NCT05225597|Sensory System Agents|sensory system agents|mesh-ancestor
102135658|NCT05225597|Protective Agents|protective agents|mesh-ancestor
102135659|NCT03070327|Cyclophosphamide|cyclophosphamide|mesh-list
102135660|NCT03070327|Lenalidomide|lenalidomide|mesh-list
102135661|NCT03070327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102135662|NCT03070327|Immunologic Factors|immunologic factors|mesh-ancestor
102135663|NCT03070327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135664|NCT03070327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102135665|NCT03070327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102135666|NCT03070327|Alkylating Agents|alkylating agents|mesh-ancestor
102135667|NCT03070327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135668|NCT03070327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102135669|NCT03070327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102135670|NCT03070327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102135671|NCT03070327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102135672|NCT03070327|Growth Substances|growth substances|mesh-ancestor
102135673|NCT03070327|Growth Inhibitors|growth inhibitors|mesh-ancestor
102135674|NCT00543127|Fulvestrant|fulvestrant|mesh-list
102135676|NCT00543127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102135677|NCT00543127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102135678|NCT00543127|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102135679|NCT00543127|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102135680|NCT00543127|Hormone Antagonists|hormone antagonists|mesh-ancestor
102135681|NCT00543127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102135682|NCT00543127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135683|NCT00543127|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102135684|NCT00543127|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102135685|NCT00543127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102135686|NCT00543127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135687|NCT00409435|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
102135688|NCT00409435|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102135689|NCT00409435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102135690|NCT00409435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135691|NCT00409435|Cholinergic Agents|cholinergic agents|mesh-ancestor
102135692|NCT00409435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102135693|NCT00409435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135694|NCT03673501|Sunitinib|sunitinib|mesh-list
102135695|NCT03673501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102135696|NCT03673501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102135697|NCT03673501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102135698|NCT03673501|Growth Substances|growth substances|mesh-ancestor
102135699|NCT03673501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135700|NCT03673501|Growth Inhibitors|growth inhibitors|mesh-ancestor
102135701|NCT03673501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102135702|NCT03673501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102135703|NCT03673501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135704|NCT02309385|Dexamethasone|dexamethasone|mesh-list
102135705|NCT02309385|Dexamethasone acetate|dexamethasone acetate|mesh-list
102135706|NCT02309385|Prednisolone|prednisolone|mesh-list
102135707|NCT02309385|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102135708|NCT02309385|Methylprednisolone|methylprednisolone|mesh-list
102135709|NCT02309385|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102135710|NCT02309385|Prednisolone acetate|prednisolone acetate|mesh-list
102135711|NCT02309385|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102135712|NCT02309385|Prednisolone phosphate|prednisolone phosphate|mesh-list
102135713|NCT02309385|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102135714|NCT02309385|BB 1101|bb 1101|mesh-list
102135715|NCT02309385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102135716|NCT02309385|Antiemetics|antiemetics|mesh-ancestor
102135717|NCT02309385|Autonomic Agents|autonomic agents|mesh-ancestor
102135718|NCT02309385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102135719|NCT02309385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135720|NCT02309385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102135721|NCT02309385|Glucocorticoids|glucocorticoids|mesh-ancestor
102135722|NCT02309385|Hormones|hormones|mesh-ancestor
102135723|NCT02309385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102135724|NCT02309385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102135725|NCT02309385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102135726|NCT02309385|Protease Inhibitors|protease inhibitors|mesh-ancestor
102135727|NCT02309385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102135728|NCT02309385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135729|NCT02309385|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102135730|NCT02309385|Protective Agents|protective agents|mesh-ancestor
102135731|NCT02315001|Liraglutide|liraglutide|mesh-list
102135732|NCT02315001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102135733|NCT02315001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135734|NCT02315001|Incretins|incretins|mesh-ancestor
102135735|NCT02315001|Hormones|hormones|mesh-ancestor
102135736|NCT02315001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102135737|NCT02315157|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102135738|NCT02315157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102135739|NCT02315157|Alkylating Agents|alkylating agents|mesh-ancestor
102135740|NCT02315157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135741|NCT02315157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102135742|NCT02309463|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
102135743|NCT02309463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135744|NCT03500367|Sirolimus|sirolimus|mesh-list
102135745|NCT03500367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102135746|NCT03500367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102078390|NCT05571514|Antacids|antacids|mesh-ancestor
102135747|NCT03500367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102135748|NCT03500367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102135749|NCT03500367|Antifungal Agents|antifungal agents|mesh-ancestor
102135750|NCT03500367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102135751|NCT03500367|Immunologic Factors|immunologic factors|mesh-ancestor
102135752|NCT03500367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135753|NCT02318433|Dexamethasone|dexamethasone|mesh-list
101737776|NCT04113941|Cholinergic Agents|cholinergic agents|mesh-ancestor
102135754|NCT02318433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102135755|NCT02318433|Antiemetics|antiemetics|mesh-ancestor
102135756|NCT02318433|Autonomic Agents|autonomic agents|mesh-ancestor
102135757|NCT02318433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102135758|NCT02318433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135759|NCT02318433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102135760|NCT02318433|Glucocorticoids|glucocorticoids|mesh-ancestor
102135761|NCT02318433|Hormones|hormones|mesh-ancestor
102135762|NCT02318433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102135763|NCT02318433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102135764|NCT02318433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102135765|NCT02318511|Hyaluronic Acid|hyaluronic acid|mesh-list
102135766|NCT02318511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102135767|NCT02318511|Immunologic Factors|immunologic factors|mesh-ancestor
102135768|NCT02318511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135769|NCT02318511|Viscosupplements|viscosupplements|mesh-ancestor
102135770|NCT02318511|Protective Agents|protective agents|mesh-ancestor
102135771|NCT02315391|Glycine|glycine|mesh-list
102135772|NCT02315391|Glycine Agents|glycine agents|mesh-ancestor
102135773|NCT02315391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102135774|NCT02315391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135775|NCT02315391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135776|NCT03022981|Sofosbuvir|sofosbuvir|mesh-list
102135777|NCT03022981|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102135778|NCT03022981|Velpatasvir|velpatasvir|mesh-list
102135779|NCT03022981|Antiviral Agents|antiviral agents|mesh-ancestor
102135780|NCT03022981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102135781|NCT03164967|Immunoglobulin G|immunoglobulin g|mesh-list
102135782|NCT03164967|Immunologic Factors|immunologic factors|mesh-ancestor
102135783|NCT03164967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135784|NCT03502005|Tenofovir|tenofovir|mesh-list
101844775|NCT00348933|Vitamins|vitamins|mesh-ancestor
102135785|NCT03502005|Emtricitabine|emtricitabine|mesh-list
102135786|NCT03502005|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
102135787|NCT03502005|Antiviral Agents|antiviral agents|mesh-ancestor
102135788|NCT03502005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102135789|NCT03502005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102135790|NCT03502005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102135791|NCT03502005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102135792|NCT03502005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135793|NCT03502005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102135794|NCT03502005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102135795|NCT02315547|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102135796|NCT02315547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102135797|NCT03669445|Dexamethasone|dexamethasone|mesh-list
102135798|NCT03669445|Lenalidomide|lenalidomide|mesh-list
102135799|NCT03669445|Daratumumab|daratumumab|mesh-list
102135800|NCT03669445|Ixazomib|ixazomib|mesh-list
102135801|NCT03669445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102135802|NCT03669445|Antiemetics|antiemetics|mesh-ancestor
102135803|NCT03669445|Autonomic Agents|autonomic agents|mesh-ancestor
102135804|NCT03669445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102135805|NCT03669445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135806|NCT03669445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102135807|NCT03669445|Glucocorticoids|glucocorticoids|mesh-ancestor
102135808|NCT03669445|Hormones|hormones|mesh-ancestor
102135809|NCT03669445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102135810|NCT03669445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102135811|NCT03669445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102135812|NCT03669445|Immunologic Factors|immunologic factors|mesh-ancestor
102135813|NCT03669445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102135814|NCT03669445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102135815|NCT03669445|Growth Substances|growth substances|mesh-ancestor
102135816|NCT03669445|Growth Inhibitors|growth inhibitors|mesh-ancestor
102135817|NCT03669445|Protease Inhibitors|protease inhibitors|mesh-ancestor
102135818|NCT03669445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241601|NCT04986735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135819|NCT03669445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135820|NCT03500133|Cytarabine|cytarabine|mesh-list
102135821|NCT03500133|Methylprednisolone|methylprednisolone|mesh-list
102135822|NCT03500133|Cisplatin|cisplatin|mesh-list
102135824|NCT03500133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102135825|NCT03500133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102135826|NCT03500133|Antimetabolites|antimetabolites|mesh-ancestor
102135827|NCT03500133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135828|NCT03500133|Antiviral Agents|antiviral agents|mesh-ancestor
102135829|NCT03500133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102135830|NCT03500133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102135831|NCT03500133|Immunologic Factors|immunologic factors|mesh-ancestor
102135832|NCT03500133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135833|NCT03500133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102135834|NCT03500133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102135835|NCT03500133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102135836|NCT03500133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102135837|NCT03500133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102135838|NCT03500133|Antiemetics|antiemetics|mesh-ancestor
102135839|NCT03500133|Autonomic Agents|autonomic agents|mesh-ancestor
102135840|NCT03500133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102135841|NCT03500133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102135842|NCT03500133|Glucocorticoids|glucocorticoids|mesh-ancestor
102135843|NCT03500133|Hormones|hormones|mesh-ancestor
102135844|NCT03500133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102135845|NCT03500133|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102135846|NCT03500133|Protective Agents|protective agents|mesh-ancestor
102135847|NCT04462809|Talazoparib|talazoparib|mesh-list
102135848|NCT04462809|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102135849|NCT04462809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102135850|NCT04462809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135851|NCT04462809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102135852|NCT02320773|Mirabegron|mirabegron|mesh-list
102135853|NCT02320773|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102135854|NCT02320773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102135855|NCT02320773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102135856|NCT02320773|Adrenergic Agents|adrenergic agents|mesh-ancestor
102135857|NCT02320773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102135858|NCT02320773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135859|NCT02320773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135860|NCT02320773|Urological Agents|urological agents|mesh-ancestor
102135862|NCT03377699|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102135863|NCT03377699|Insulin Aspart|insulin aspart|mesh-list
102135864|NCT03377699|Insulin Detemir|insulin detemir|mesh-list
102135865|NCT03377699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102135866|NCT03377699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135867|NCT04463901|Mitomycins|mitomycins|mesh-list
102135868|NCT04463901|Mitomycin|mitomycin|mesh-list
102135869|NCT04463901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102135870|NCT04463901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102135871|NCT04463901|Alkylating Agents|alkylating agents|mesh-ancestor
102135872|NCT04463901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135873|NCT04463901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102135874|NCT04463901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102135875|NCT01314443|Vitamin E|vitamin e|mesh-list
102135876|NCT01314443|Tocopherols|tocopherols|mesh-list
102135877|NCT01314443|Tocotrienols|tocotrienols|mesh-list
102135878|NCT01314443|alpha-Tocopherol|alpha-tocopherol|mesh-list
102135879|NCT01314443|gamma-Tocopherol|gamma-tocopherol|mesh-list
102135880|NCT01314443|Nicotine|nicotine|mesh-list
102135881|NCT01314443|Vitamins|vitamins|mesh-ancestor
102135882|NCT01314443|Micronutrients|micronutrients|mesh-ancestor
102135883|NCT01314443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135884|NCT01314443|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102135885|NCT01314443|Autonomic Agents|autonomic agents|mesh-ancestor
102135886|NCT01314443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102135887|NCT01314443|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102135888|NCT01314443|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102135889|NCT01314443|Cholinergic Agents|cholinergic agents|mesh-ancestor
102135890|NCT01314443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102135891|NCT01314443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135892|NCT01314443|Antioxidants|antioxidants|mesh-ancestor
102135893|NCT01314443|Protective Agents|protective agents|mesh-ancestor
102135894|NCT02310009|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102135895|NCT02310009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102135896|NCT03498417|Antibodies|antibodies|mesh-list
102135897|NCT03498417|Immunologic Factors|immunologic factors|mesh-ancestor
102135898|NCT03498417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135899|NCT03212651|Pembrolizumab|pembrolizumab|mesh-list
102135900|NCT03212651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102135901|NCT03212651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102135902|NCT03212651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102135903|NCT03212651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135904|NCT02319135|Cytarabine|cytarabine|mesh-list
102135905|NCT02319135|Fludarabine|fludarabine|mesh-list
102135906|NCT02319135|Lenograstim|lenograstim|mesh-list
102135907|NCT02319135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102135908|NCT02319135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102135909|NCT02319135|Antimetabolites|antimetabolites|mesh-ancestor
102135910|NCT02319135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135911|NCT02319135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102135912|NCT02319135|Immunologic Factors|immunologic factors|mesh-ancestor
102135913|NCT02319135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135914|NCT02319135|Antiviral Agents|antiviral agents|mesh-ancestor
102135915|NCT02319135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102135916|NCT02319135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102135917|NCT04738097|Clopidogrel|clopidogrel|mesh-list
102135918|NCT04738097|Ticagrelor|ticagrelor|mesh-list
102135919|NCT04738097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102135920|NCT04738097|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102135921|NCT04738097|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102135922|NCT04738097|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102135923|NCT04738097|Purinergic Agents|purinergic agents|mesh-ancestor
102135924|NCT04738097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102135925|NCT04738097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135926|NCT04738097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135927|NCT03499743|Celecoxib|celecoxib|mesh-list
102135928|NCT03499743|Scopolamine|scopolamine|mesh-list
102135929|NCT03499743|Bromides|bromides|mesh-list
102135930|NCT03499743|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102135931|NCT03499743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102135932|NCT03499743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102135933|NCT03499743|Analgesics|analgesics|mesh-ancestor
102135934|NCT03499743|Sensory System Agents|sensory system agents|mesh-ancestor
102135935|NCT03499743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101844932|NCT05357885|Antibodies|antibodies|mesh-list
102135936|NCT03499743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135937|NCT03499743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102135938|NCT03499743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102135939|NCT03499743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102135940|NCT03499743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102135941|NCT03499743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102135942|NCT03499743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135943|NCT03499743|Anticonvulsants|anticonvulsants|mesh-ancestor
102135944|NCT03499743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102135945|NCT03499743|Antiemetics|antiemetics|mesh-ancestor
102135946|NCT03499743|Autonomic Agents|autonomic agents|mesh-ancestor
102135947|NCT03499743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102135948|NCT03499743|Mydriatics|mydriatics|mesh-ancestor
102135949|NCT03499743|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101737976|NCT04115423|Adalimumab|adalimumab|mesh-list
102135950|NCT03499743|Cholinergic Agents|cholinergic agents|mesh-ancestor
102135951|NCT03499743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102135952|NCT03499743|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102135953|NCT03499743|Parasympatholytics|parasympatholytics|mesh-ancestor
102135954|NCT02310087|Vitamin E|vitamin e|mesh-list
102135955|NCT02310087|Vitamins|vitamins|mesh-ancestor
102135956|NCT02310087|Micronutrients|micronutrients|mesh-ancestor
102135957|NCT02310087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135958|NCT02310087|Antioxidants|antioxidants|mesh-ancestor
102135959|NCT02310087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135960|NCT02310087|Protective Agents|protective agents|mesh-ancestor
102135961|NCT02923921|Leucovorin|leucovorin|mesh-list
102135962|NCT02923921|Oxaliplatin|oxaliplatin|mesh-list
102135963|NCT02923921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102135964|NCT02923921|Antidotes|antidotes|mesh-ancestor
102135965|NCT02923921|Protective Agents|protective agents|mesh-ancestor
102135966|NCT02923921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135967|NCT02923921|Vitamin B Complex|vitamin b complex|mesh-ancestor
102135968|NCT02923921|Vitamins|vitamins|mesh-ancestor
102135969|NCT02923921|Micronutrients|micronutrients|mesh-ancestor
102135970|NCT02310243|Palbociclib|palbociclib|mesh-list
102135971|NCT02310243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102135972|NCT02310243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102135973|NCT02310243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102135974|NCT02310243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135975|NCT03497715|Ibuprofen|ibuprofen|mesh-list
102135976|NCT03497715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102135977|NCT03497715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102135979|NCT03497715|Sensory System Agents|sensory system agents|mesh-ancestor
102135980|NCT03497715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102135981|NCT03497715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135982|NCT03497715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102135983|NCT03497715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102135984|NCT03497715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102135985|NCT03497715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102135986|NCT03497715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102135987|NCT02321241|Aflibercept|aflibercept|mesh-list
102135988|NCT02321241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102135989|NCT02321241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102135990|NCT02321241|Growth Substances|growth substances|mesh-ancestor
102135991|NCT02321241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102135992|NCT02321241|Growth Inhibitors|growth inhibitors|mesh-ancestor
102135993|NCT02321241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102135994|NCT03583307|Sirolimus|sirolimus|mesh-list
102135995|NCT03583307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102135996|NCT03583307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102135997|NCT03583307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102135998|NCT03583307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102135999|NCT03583307|Antifungal Agents|antifungal agents|mesh-ancestor
102136000|NCT03583307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102136001|NCT03583307|Immunologic Factors|immunologic factors|mesh-ancestor
102136002|NCT03583307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136003|NCT03039023|Choline|choline|mesh-list
102136004|NCT03039023|Lipotropic Agents|lipotropic agents|mesh-ancestor
102136005|NCT03039023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102136006|NCT03039023|Antimetabolites|antimetabolites|mesh-ancestor
102136007|NCT03039023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136008|NCT03039023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102136009|NCT03039023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102136010|NCT03039023|Nootropic Agents|nootropic agents|mesh-ancestor
102136011|NCT02321397|Oxycodone|oxycodone|mesh-list
102136012|NCT02321397|Naloxone|naloxone|mesh-list
102136013|NCT02321397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102136014|NCT02321397|Narcotics|narcotics|mesh-ancestor
102136015|NCT02321397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102136016|NCT02321397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136017|NCT02321397|Analgesics|analgesics|mesh-ancestor
102136018|NCT02321397|Sensory System Agents|sensory system agents|mesh-ancestor
102136019|NCT02321397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102136020|NCT02321397|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102136021|NCT02319915|Tranexamic Acid|tranexamic acid|mesh-list
102136022|NCT02319915|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102136023|NCT02319915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102136024|NCT02319915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136025|NCT02319915|Hemostatics|hemostatics|mesh-ancestor
102136026|NCT02319915|Coagulants|coagulants|mesh-ancestor
102136027|NCT04898309|Complement C1s|complement c1s|mesh-list
102136028|NCT04898309|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
102136029|NCT04898309|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
102136030|NCT04898309|Immunologic Factors|immunologic factors|mesh-ancestor
102136031|NCT04898309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136032|NCT04898309|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102136033|NCT04898309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102136034|NCT03498963|Dimercaprol|dimercaprol|mesh-list
102136035|NCT03498963|Chelating Agents|chelating agents|mesh-ancestor
102136036|NCT03498963|Sequestering Agents|sequestering agents|mesh-ancestor
102136037|NCT03498963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136038|NCT02311101|Mitomycins|mitomycins|mesh-list
102136039|NCT02311101|Mitomycin|mitomycin|mesh-list
102136040|NCT02311101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102136041|NCT02311101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102136042|NCT02311101|Alkylating Agents|alkylating agents|mesh-ancestor
102136043|NCT02311101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136044|NCT02311101|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102136045|NCT02311101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102136046|NCT04620187|Cisplatin|cisplatin|mesh-list
102136047|NCT04620187|Carboplatin|carboplatin|mesh-list
102136048|NCT04620187|Trastuzumab|trastuzumab|mesh-list
102136049|NCT04620187|Maytansine|maytansine|mesh-list
102136050|NCT04620187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102136051|NCT04620187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102136052|NCT04620187|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102136053|NCT04620187|Tubulin Modulators|tubulin modulators|mesh-ancestor
102136054|NCT04620187|Antimitotic Agents|antimitotic agents|mesh-ancestor
102136055|NCT04620187|Mitosis Modulators|mitosis modulators|mesh-ancestor
102136056|NCT04620187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136057|NCT03668665|Hyaluronic Acid|hyaluronic acid|mesh-list
102136058|NCT03668665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102136059|NCT03668665|Immunologic Factors|immunologic factors|mesh-ancestor
102136060|NCT03668665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136061|NCT03668665|Viscosupplements|viscosupplements|mesh-ancestor
102136062|NCT03668665|Protective Agents|protective agents|mesh-ancestor
102136063|NCT02320383|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102136065|NCT02320383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102136066|NCT02320383|Alkylating Agents|alkylating agents|mesh-ancestor
102136067|NCT02320383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136068|NCT02320383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102136069|NCT02320383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102136070|NCT03704909|Epinephrine|epinephrine|mesh-list
102136071|NCT03704909|Racepinephrine|racepinephrine|mesh-list
102136072|NCT03704909|Ephedrine|ephedrine|mesh-list
102136073|NCT03704909|Epinephryl borate|epinephryl borate|mesh-list
102241602|NCT02475863|Warfarin|warfarin|mesh-list
102136074|NCT03704909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102136075|NCT03704909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102136076|NCT03704909|Adrenergic Agents|adrenergic agents|mesh-ancestor
102136077|NCT03704909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102136078|NCT03704909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136079|NCT03704909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136080|NCT03704909|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102136081|NCT03704909|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102136082|NCT03704909|Autonomic Agents|autonomic agents|mesh-ancestor
102136083|NCT03704909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102136084|NCT03704909|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102136085|NCT03704909|Respiratory System Agents|respiratory system agents|mesh-ancestor
102136086|NCT03704909|Mydriatics|mydriatics|mesh-ancestor
102136087|NCT03704909|Sympathomimetics|sympathomimetics|mesh-ancestor
102136088|NCT03704909|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102136089|NCT03704909|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102136090|NCT03704831|Anesthetics|anesthetics|mesh-list
102136092|NCT03704831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102136093|NCT03704831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136094|NCT03704831|Sensory System Agents|sensory system agents|mesh-ancestor
102136095|NCT03704831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102136096|NCT03704675|Vactosertib|vactosertib|mesh-list
102136097|NCT03704675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102136098|NCT03704675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102136099|NCT03704675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136100|NCT03494517|Magnesium Sulfate|magnesium sulfate|mesh-list
102136101|NCT03494517|Analgesics|analgesics|mesh-ancestor
102136102|NCT03494517|Sensory System Agents|sensory system agents|mesh-ancestor
102136103|NCT03494517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102136104|NCT03494517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136105|NCT03494517|Anesthetics|anesthetics|mesh-ancestor
102136106|NCT03494517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102136107|NCT03494517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102136108|NCT03494517|Anticonvulsants|anticonvulsants|mesh-ancestor
102136109|NCT03494517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102136110|NCT03494517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102136111|NCT03494517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136112|NCT03494517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102136113|NCT03494517|Tocolytic Agents|tocolytic agents|mesh-ancestor
102136114|NCT03494517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102136115|NCT04912427|Dexamethasone|dexamethasone|mesh-list
102136116|NCT04912427|Bortezomib|bortezomib|mesh-list
102136117|NCT04912427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102136118|NCT04912427|Antiemetics|antiemetics|mesh-ancestor
102136119|NCT04912427|Autonomic Agents|autonomic agents|mesh-ancestor
102136120|NCT04912427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102136121|NCT04912427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136122|NCT04912427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102136123|NCT04912427|Glucocorticoids|glucocorticoids|mesh-ancestor
102136124|NCT04912427|Hormones|hormones|mesh-ancestor
102136125|NCT04912427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102078769|NCT04116203|Metformin|metformin|mesh-list
102136126|NCT04912427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102136127|NCT04912427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102136128|NCT02322645|Eszopiclone|eszopiclone|mesh-list
102136129|NCT02322645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102136130|NCT02322645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102136131|NCT02322645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136132|NCT04050761|Nivolumab|nivolumab|mesh-list
102241603|NCT02475863|Anticoagulants|anticoagulants|mesh-ancestor
102136133|NCT04050761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102136134|NCT04050761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102136135|NCT04050761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102136136|NCT04050761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136137|NCT04785261|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102136138|NCT04785261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102136139|NCT03496389|Acetaminophen|acetaminophen|mesh-list
102136140|NCT03496389|Gabapentin|gabapentin|mesh-list
102136141|NCT03496389|Tramadol|tramadol|mesh-list
102136142|NCT03496389|Analgesics|analgesics|mesh-ancestor
102136143|NCT03496389|Sensory System Agents|sensory system agents|mesh-ancestor
102136144|NCT03496389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102136145|NCT03496389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136146|NCT03496389|Anticonvulsants|anticonvulsants|mesh-ancestor
102136147|NCT03496389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102136148|NCT03496389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102136149|NCT03496389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102136150|NCT03496389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102136151|NCT03496389|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102136152|NCT03496389|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102136153|NCT03496389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102136154|NCT03496389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136155|NCT03496389|Antimanic Agents|antimanic agents|mesh-ancestor
102136156|NCT03496389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102136157|NCT03496389|Narcotics|narcotics|mesh-ancestor
102136158|NCT03496389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102136159|NCT03496389|Antipyretics|antipyretics|mesh-ancestor
102136160|NCT03491709|Cetuximab|cetuximab|mesh-list
102136161|NCT03491709|Antibodies|antibodies|mesh-list
102136162|NCT03491709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102136163|NCT03491709|Immunologic Factors|immunologic factors|mesh-ancestor
102136164|NCT03491709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845160|NCT00438672|Hormones|hormones|mesh-ancestor
102136165|NCT03491709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102136166|NCT03491709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102136167|NCT02325063|Botulinum Toxins|botulinum toxins|mesh-list
102136168|NCT02325063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102136169|NCT02325063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102136170|NCT02325063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136171|NCT02325063|Cholinergic Agents|cholinergic agents|mesh-ancestor
102136172|NCT02325063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102136173|NCT02325063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136174|NCT02323191|Atezolizumab|atezolizumab|mesh-list
102136175|NCT02323191|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102136176|NCT02323191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136177|NCT02323191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102136178|NCT02323191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102136179|NCT02323269|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102136180|NCT02323269|Dermatologic Agents|dermatologic agents|mesh-ancestor
102136181|NCT02323269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102136182|NCT02323269|Immunologic Factors|immunologic factors|mesh-ancestor
102136183|NCT02323269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136184|NCT02323347|Progesterone|progesterone|mesh-list
102136185|NCT02323347|Progestins|progestins|mesh-ancestor
102136186|NCT02323347|Hormones|hormones|mesh-ancestor
102136187|NCT02323347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102136188|NCT02323347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136189|NCT03495765|Ranibizumab|ranibizumab|mesh-list
102136190|NCT03495765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102136191|NCT03495765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102136192|NCT03495765|Growth Substances|growth substances|mesh-ancestor
102136193|NCT03495765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136194|NCT03495765|Growth Inhibitors|growth inhibitors|mesh-ancestor
102136195|NCT03495765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102136196|NCT03495609|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102136197|NCT03495609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102136198|NCT03495609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136199|NCT03491475|Ajmaline|ajmaline|mesh-list
102136200|NCT03491475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102136201|NCT03491475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102136202|NCT03491475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102136203|NCT03491475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102136204|NCT03491475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136205|NCT03499119|Erenumab|erenumab|mesh-list
102136206|NCT03499119|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
102136207|NCT03499119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136208|NCT03499119|Analgesics|analgesics|mesh-ancestor
102136209|NCT03499119|Sensory System Agents|sensory system agents|mesh-ancestor
102136210|NCT03499119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102136211|NCT03499119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136212|NCT03328845|Insulin|insulin|mesh-list
102136213|NCT03328845|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102136214|NCT03328845|Insulin Lispro|insulin lispro|mesh-list
102136215|NCT03328845|Insulin Aspart|insulin aspart|mesh-list
102136216|NCT03328845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102136217|NCT03328845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136218|NCT02323737|Cisplatin|cisplatin|mesh-list
102136219|NCT02323737|Irinotecan|irinotecan|mesh-list
102136220|NCT02323737|Etoposide|etoposide|mesh-list
102136221|NCT02323737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102136222|NCT02323737|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102136223|NCT02323737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102136224|NCT02323737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102136225|NCT02323737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136226|NCT02323737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102136227|NCT02323737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102136228|NCT03037359|Immunoglobulin G|immunoglobulin g|mesh-list
102136229|NCT03037359|Immunologic Factors|immunologic factors|mesh-ancestor
102136230|NCT03037359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136231|NCT03491085|Amoxicillin|amoxicillin|mesh-list
102136232|NCT03491085|Clavulanic Acid|clavulanic acid|mesh-list
102136233|NCT03491085|Clavulanic Acids|clavulanic acids|mesh-list
102136234|NCT03491085|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102136235|NCT03491085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102136236|NCT03491085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102136237|NCT03491085|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102136238|NCT03491085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102136239|NCT03491085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136240|NCT02323971|Ticagrelor|ticagrelor|mesh-list
102136241|NCT02323971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102136242|NCT02323971|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102136243|NCT02323971|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102136244|NCT02323971|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102136245|NCT02323971|Purinergic Agents|purinergic agents|mesh-ancestor
102136246|NCT02323971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102136247|NCT02323971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136248|NCT02323971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136249|NCT03148899|Oxytocin|oxytocin|mesh-list
102136250|NCT03148899|Oxytocics|oxytocics|mesh-ancestor
102136251|NCT03148899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102136252|NCT03148899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136253|NCT03495063|Caffeine|caffeine|mesh-list
102136254|NCT03495063|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102136255|NCT03495063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136256|NCT03495063|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102136257|NCT03495063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102136258|NCT03495063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136259|NCT03495063|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102136260|NCT03495063|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102136261|NCT03495063|Purinergic Agents|purinergic agents|mesh-ancestor
102136262|NCT03495063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102136263|NCT03490617|Misoprostol|misoprostol|mesh-list
102136264|NCT03490617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102136265|NCT03490617|Abortifacient Agents|abortifacient agents|mesh-ancestor
102136266|NCT03490617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102136267|NCT03490617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136268|NCT03490617|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102136269|NCT03490617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102136270|NCT03490617|Oxytocics|oxytocics|mesh-ancestor
102136271|NCT03494907|Moxifloxacin|moxifloxacin|mesh-list
102136272|NCT03494907|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102136274|NCT03494907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102136275|NCT03494907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102136276|NCT03494907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102136277|NCT03494907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102136278|NCT03494907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136279|NCT03494907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102136280|NCT03494907|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102136281|NCT03494907|Contraceptive Agents|contraceptive agents|mesh-ancestor
102136282|NCT03494907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102136283|NCT03494907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136284|NCT03494907|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102136285|NCT03494907|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102136286|NCT03494907|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102136287|NCT03490539|Mycophenolic Acid|mycophenolic acid|mesh-list
102136288|NCT03490539|Azathioprine|azathioprine|mesh-list
102136289|NCT03490539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102136290|NCT03490539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102136291|NCT03490539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102136292|NCT03490539|Antitubercular Agents|antitubercular agents|mesh-ancestor
102136293|NCT03490539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102136294|NCT03490539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102136295|NCT03490539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102136296|NCT03490539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136297|NCT03490539|Antimetabolites|antimetabolites|mesh-ancestor
102136298|NCT03490539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102136299|NCT03490539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102136300|NCT03490539|Immunologic Factors|immunologic factors|mesh-ancestor
102136301|NCT03490539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136302|NCT03490539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102136303|NCT03493503|Albuterol|albuterol|mesh-list
102136304|NCT03493503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102136305|NCT03493503|Autonomic Agents|autonomic agents|mesh-ancestor
102136306|NCT03493503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102136307|NCT03493503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136308|NCT03493503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102136309|NCT03493503|Respiratory System Agents|respiratory system agents|mesh-ancestor
102136310|NCT03493503|Tocolytic Agents|tocolytic agents|mesh-ancestor
102136311|NCT03493503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102136312|NCT03493503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102136313|NCT03493503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102136314|NCT03493503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102136315|NCT03493503|Adrenergic Agents|adrenergic agents|mesh-ancestor
102136316|NCT03493503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102136317|NCT03493503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136318|NCT04791761|Acetaminophen|acetaminophen|mesh-list
102136319|NCT04791761|Ibuprofen|ibuprofen|mesh-list
102136320|NCT04791761|Oxycodone|oxycodone|mesh-list
102136321|NCT04791761|Analgesics, Opioid|analgesics, opioid|mesh-list
102136322|NCT04791761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102136323|NCT04791761|Analgesics|analgesics|mesh-ancestor
102136324|NCT04791761|Sensory System Agents|sensory system agents|mesh-ancestor
102136325|NCT04791761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102136326|NCT04791761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136327|NCT04791761|Antipyretics|antipyretics|mesh-ancestor
102136328|NCT04791761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102136329|NCT04791761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102136330|NCT04791761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102136331|NCT04791761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102136332|NCT04791761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102136333|NCT04791761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136334|NCT04791761|Narcotics|narcotics|mesh-ancestor
102136335|NCT04791761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102136336|NCT03667963|Lactulose|lactulose|mesh-list
102136337|NCT03667963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102136338|NCT03489837|Dipropizine|dipropizine|mesh-list
102136339|NCT03489837|Antitussive Agents|antitussive agents|mesh-ancestor
102136340|NCT03489837|Respiratory System Agents|respiratory system agents|mesh-ancestor
102136341|NCT03014479|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
102136342|NCT03014479|Protease Inhibitors|protease inhibitors|mesh-ancestor
102136343|NCT03014479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102136344|NCT03014479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136345|NCT03014479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102078996|NCT02799602|Hormones|hormones|mesh-ancestor
102136346|NCT03014479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136348|NCT03625505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102136349|NCT03493269|Midazolam|midazolam|mesh-list
102136350|NCT03493269|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102136351|NCT03493269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102136352|NCT03493269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102136353|NCT03493269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136354|NCT03493269|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102136355|NCT03493269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102136356|NCT03493269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102136357|NCT03493269|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102136358|NCT03493269|Anesthetics, General|anesthetics, general|mesh-ancestor
102136359|NCT03493269|Anesthetics|anesthetics|mesh-ancestor
102136360|NCT03493269|GABA Modulators|gaba modulators|mesh-ancestor
102136361|NCT03493269|GABA Agents|gaba agents|mesh-ancestor
102136362|NCT03493269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102136363|NCT03493269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136364|NCT04257682|Bupivacaine|bupivacaine|mesh-list
102136365|NCT04257682|Ropivacaine|ropivacaine|mesh-list
102136366|NCT04257682|Anesthetics, Local|anesthetics, local|mesh-list
102136367|NCT04257682|Mepivacaine|mepivacaine|mesh-list
102136368|NCT04257682|Anesthetics|anesthetics|mesh-list
102136369|NCT04257682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102136370|NCT04257682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136371|NCT04257682|Sensory System Agents|sensory system agents|mesh-ancestor
102136372|NCT04257682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102136373|NCT05426434|Pyrimethamine|pyrimethamine|mesh-list
102136374|NCT05426434|Piperaquine|piperaquine|mesh-list
102136375|NCT05426434|Sulfadoxine|sulfadoxine|mesh-list
102136376|NCT05426434|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
102136377|NCT05426434|Artenimol|artenimol|mesh-list
102136378|NCT05426434|Antimalarials|antimalarials|mesh-ancestor
102136379|NCT05426434|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102136380|NCT05426434|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102136381|NCT05426434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102136382|NCT05426434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102136383|NCT05426434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102136384|NCT05426434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136385|NCT05426434|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102136386|NCT05404906|Azacitidine|azacitidine|mesh-list
102136387|NCT05404906|Venetoclax|venetoclax|mesh-list
102136388|NCT05404906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102136390|NCT05404906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136391|NCT05404906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102136392|NCT05404906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102136393|NCT03020407|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102136394|NCT03020407|Dopamine|dopamine|mesh-list
102136395|NCT03020407|Epinephrine|epinephrine|mesh-list
102136396|NCT03020407|Norepinephrine|norepinephrine|mesh-list
102136397|NCT03020407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
102136398|NCT03020407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102136399|NCT03020407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102136400|NCT03020407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102136401|NCT03020407|Adrenergic Agents|adrenergic agents|mesh-ancestor
102136402|NCT03020407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102136403|NCT03020407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136404|NCT03020407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136405|NCT03020407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102136406|NCT03020407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102136407|NCT03020407|Autonomic Agents|autonomic agents|mesh-ancestor
102136408|NCT03020407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102136409|NCT03020407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102136410|NCT03020407|Respiratory System Agents|respiratory system agents|mesh-ancestor
102136411|NCT03020407|Mydriatics|mydriatics|mesh-ancestor
102136412|NCT03020407|Sympathomimetics|sympathomimetics|mesh-ancestor
102136413|NCT03020407|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102136414|NCT03020407|Dopamine Agents|dopamine agents|mesh-ancestor
102136415|NCT03020407|Protective Agents|protective agents|mesh-ancestor
102136416|NCT03624959|Itraconazole|itraconazole|mesh-list
102136417|NCT03624959|Rifampin|rifampin|mesh-list
102136418|NCT03624959|Gemfibrozil|gemfibrozil|mesh-list
102136419|NCT03624959|Ozanimod|ozanimod|mesh-list
102136420|NCT03624959|Antifungal Agents|antifungal agents|mesh-ancestor
102136421|NCT03624959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102136422|NCT03624959|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102136423|NCT03624959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102136424|NCT03624959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102136425|NCT03624959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136426|NCT03624959|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102136427|NCT03624959|Hormone Antagonists|hormone antagonists|mesh-ancestor
102136428|NCT03624959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102136429|NCT03624959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136430|NCT03624959|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102136431|NCT03624959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102136432|NCT03624959|Antitubercular Agents|antitubercular agents|mesh-ancestor
102136433|NCT03624959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102136434|NCT03624959|Leprostatic Agents|leprostatic agents|mesh-ancestor
102136435|NCT03624959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102136436|NCT03624959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102136437|NCT03624959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102136438|NCT03624959|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102136439|NCT03624959|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102136440|NCT03624959|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102136441|NCT03624959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102136442|NCT03624959|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102136443|NCT03624959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102136444|NCT03624959|Immunologic Factors|immunologic factors|mesh-ancestor
102136445|NCT03624959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102136446|NCT03624959|Antimetabolites|antimetabolites|mesh-ancestor
102136447|NCT03624959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102136448|NCT03624959|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102136449|NCT02536846|Olanzapine|olanzapine|mesh-list
102136450|NCT02536846|Antiemetics|antiemetics|mesh-ancestor
102136451|NCT02536846|Autonomic Agents|autonomic agents|mesh-ancestor
102136452|NCT02536846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102136453|NCT02536846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136454|NCT02536846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102136455|NCT02536846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102136456|NCT02536846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102136457|NCT02536846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102136458|NCT02536846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102136459|NCT02536846|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102136460|NCT02536846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102136461|NCT02536846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102136462|NCT02536846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136463|NCT02536846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102136464|NCT02536846|Serotonin Agents|serotonin agents|mesh-ancestor
102136465|NCT03014011|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102136466|NCT03014011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136467|NCT02293655|Methylphenidate|methylphenidate|mesh-list
102136468|NCT02293655|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102136469|NCT02293655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136470|NCT02293655|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102136471|NCT02293655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102136472|NCT02293655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102136473|NCT02293655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136474|NCT02293655|Dopamine Agents|dopamine agents|mesh-ancestor
102136475|NCT02293655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102136476|NCT01764191|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102136477|NCT01764191|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102136478|NCT01764191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136479|NCT05439460|Phenylephrine|phenylephrine|mesh-list
102136480|NCT05439460|Vasopressins|vasopressins|mesh-list
102136481|NCT05439460|Arginine Vasopressin|arginine vasopressin|mesh-list
102136482|NCT05439460|Epinephrine|epinephrine|mesh-list
102136483|NCT05439460|Racepinephrine|racepinephrine|mesh-list
102136484|NCT05439460|Oxymetazoline|oxymetazoline|mesh-list
102136485|NCT05439460|Epinephryl borate|epinephryl borate|mesh-list
102136486|NCT05439460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102136487|NCT05439460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102136488|NCT05439460|Adrenergic Agents|adrenergic agents|mesh-ancestor
102136489|NCT05439460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102136490|NCT05439460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136491|NCT05439460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136492|NCT05439460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102136493|NCT05439460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102136494|NCT05439460|Autonomic Agents|autonomic agents|mesh-ancestor
102136495|NCT05439460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102136497|NCT05439460|Respiratory System Agents|respiratory system agents|mesh-ancestor
102136498|NCT05439460|Mydriatics|mydriatics|mesh-ancestor
102136499|NCT05439460|Sympathomimetics|sympathomimetics|mesh-ancestor
102136500|NCT05439460|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102136501|NCT05439460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102136502|NCT05439460|Nasal Decongestants|nasal decongestants|mesh-ancestor
102136503|NCT05439460|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102136504|NCT05439460|Protective Agents|protective agents|mesh-ancestor
102136505|NCT05439460|Hemostatics|hemostatics|mesh-ancestor
102136506|NCT05439460|Coagulants|coagulants|mesh-ancestor
102136507|NCT05439460|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102136508|NCT05439460|Natriuretic Agents|natriuretic agents|mesh-ancestor
102136509|NCT01661140|Methotrexate|methotrexate|mesh-list
102136510|NCT01661140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102136511|NCT01661140|Abortifacient Agents|abortifacient agents|mesh-ancestor
102136512|NCT01661140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102136513|NCT01661140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136514|NCT01661140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102136515|NCT01661140|Antimetabolites|antimetabolites|mesh-ancestor
102136516|NCT01661140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136517|NCT01661140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102136518|NCT01661140|Dermatologic Agents|dermatologic agents|mesh-ancestor
102136519|NCT01661140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102136520|NCT01661140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102136521|NCT01661140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102136522|NCT01661140|Immunologic Factors|immunologic factors|mesh-ancestor
102136523|NCT01661140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102136524|NCT01661140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102136525|NCT03019549|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102136526|NCT03019549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102136527|NCT03019549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102136528|NCT03019549|Antimetabolites|antimetabolites|mesh-ancestor
102136529|NCT03019549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136530|NCT03019549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102136531|NCT03019549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102136532|NCT03019549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102136533|NCT05399602|Anesthetics|anesthetics|mesh-list
102136534|NCT05399602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102136535|NCT05399602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136536|NCT05397886|Propofol|propofol|mesh-list
102136537|NCT05397886|Flumazenil|flumazenil|mesh-list
102136538|NCT05397886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102136539|NCT05397886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102136540|NCT05397886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136541|NCT05397886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102136542|NCT05397886|Anesthetics, General|anesthetics, general|mesh-ancestor
102136543|NCT05397886|Anesthetics|anesthetics|mesh-ancestor
102136544|NCT05397886|Antidotes|antidotes|mesh-ancestor
102136545|NCT05397886|Protective Agents|protective agents|mesh-ancestor
102136546|NCT05397886|GABA Modulators|gaba modulators|mesh-ancestor
102136547|NCT05397886|GABA Agents|gaba agents|mesh-ancestor
102136548|NCT05397886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102136549|NCT05397886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136550|NCT05436886|Gabapentin|gabapentin|mesh-list
102136551|NCT05436886|Analgesics|analgesics|mesh-ancestor
102136552|NCT05436886|Sensory System Agents|sensory system agents|mesh-ancestor
102136553|NCT05436886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102136554|NCT05436886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136555|NCT05436886|Anticonvulsants|anticonvulsants|mesh-ancestor
102136556|NCT05436886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102136557|NCT05436886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102136558|NCT05436886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101738581|NCT00789581|Doxorubicin|doxorubicin|mesh-list
102136559|NCT05436886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102136560|NCT05436886|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102136561|NCT05436886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102136562|NCT05436886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102136563|NCT05436886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136564|NCT05436886|Antimanic Agents|antimanic agents|mesh-ancestor
102136565|NCT01373151|Adalimumab|adalimumab|mesh-list
102136566|NCT01373151|Methotrexate|methotrexate|mesh-list
102136567|NCT01373151|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102136568|NCT01373151|Abortifacient Agents|abortifacient agents|mesh-ancestor
102136569|NCT01373151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102136570|NCT01373151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136571|NCT01373151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102136572|NCT01373151|Antimetabolites|antimetabolites|mesh-ancestor
102136573|NCT01373151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136574|NCT01373151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102136575|NCT01373151|Dermatologic Agents|dermatologic agents|mesh-ancestor
102136576|NCT01373151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102136577|NCT01373151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102136578|NCT01373151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102136579|NCT01373151|Immunologic Factors|immunologic factors|mesh-ancestor
102136580|NCT01373151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102136581|NCT01373151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102136582|NCT01373151|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102136583|NCT01373151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102136585|NCT05436652|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102136586|NCT05436652|Methylprednisolone|methylprednisolone|mesh-list
102136587|NCT05436652|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102136588|NCT05436652|Prednisolone acetate|prednisolone acetate|mesh-list
102136589|NCT05436652|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102136590|NCT05436652|Prednisolone phosphate|prednisolone phosphate|mesh-list
102136591|NCT05436652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102136592|NCT05436652|Glucocorticoids|glucocorticoids|mesh-ancestor
102136593|NCT05436652|Hormones|hormones|mesh-ancestor
102136594|NCT05436652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102136595|NCT05436652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136596|NCT05436652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102136597|NCT05436652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102136598|NCT05436652|Antiemetics|antiemetics|mesh-ancestor
102136599|NCT05436652|Autonomic Agents|autonomic agents|mesh-ancestor
102136600|NCT05436652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102136601|NCT05436652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102136602|NCT05436652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102136603|NCT05436652|Protective Agents|protective agents|mesh-ancestor
102136604|NCT01660906|Dasatinib|dasatinib|mesh-list
102136605|NCT01660906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102136606|NCT01660906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102136607|NCT01660906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102136608|NCT01660906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136609|NCT05435014|Ethiodized Oil|ethiodized oil|mesh-list
102136610|NCT05435014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102136611|NCT03666949|Anesthetics|anesthetics|mesh-list
102136612|NCT03666949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102136613|NCT03666949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136614|NCT00886691|Bevacizumab|bevacizumab|mesh-list
102136615|NCT00886691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102136616|NCT00886691|Everolimus|everolimus|mesh-list
102136617|NCT00886691|Endothelial Growth Factors|endothelial growth factors|mesh-list
102136618|NCT00886691|Antibodies|antibodies|mesh-list
102136619|NCT00886691|Immunoglobulins|immunoglobulins|mesh-list
102136620|NCT00886691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102136621|NCT00886691|Immunoglobulin G|immunoglobulin g|mesh-list
102136622|NCT00886691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102136623|NCT00886691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102136624|NCT00886691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102136625|NCT00886691|Growth Substances|growth substances|mesh-ancestor
102136626|NCT00886691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136627|NCT00886691|Growth Inhibitors|growth inhibitors|mesh-ancestor
102136628|NCT00886691|Immunologic Factors|immunologic factors|mesh-ancestor
102136629|NCT00886691|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102136630|NCT00886691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102136631|NCT00886691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101738651|NCT03475953|Avelumab|avelumab|mesh-list
102136632|NCT00886691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136633|NCT00886691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102136634|NCT00960297|Paclitaxel|paclitaxel|mesh-list
102136635|NCT00960297|Bevacizumab|bevacizumab|mesh-list
102136636|NCT00960297|Carboplatin|carboplatin|mesh-list
102136637|NCT00960297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102136638|NCT00960297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102136639|NCT00960297|Tubulin Modulators|tubulin modulators|mesh-ancestor
102136640|NCT00960297|Antimitotic Agents|antimitotic agents|mesh-ancestor
102136641|NCT00960297|Mitosis Modulators|mitosis modulators|mesh-ancestor
102136642|NCT00960297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136643|NCT00960297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102136644|NCT00960297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102136645|NCT00960297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102136646|NCT00960297|Growth Substances|growth substances|mesh-ancestor
102136647|NCT00960297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136648|NCT00960297|Growth Inhibitors|growth inhibitors|mesh-ancestor
102136649|NCT05112861|Bevacizumab|bevacizumab|mesh-list
102136650|NCT05112861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102136651|NCT05112861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102136652|NCT05112861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102136653|NCT05112861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102136654|NCT05112861|Growth Substances|growth substances|mesh-ancestor
102136655|NCT05112861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136656|NCT05112861|Growth Inhibitors|growth inhibitors|mesh-ancestor
102136657|NCT03012061|Fluticasone|fluticasone|mesh-list
102136659|NCT03012061|Albuterol|albuterol|mesh-list
102136660|NCT03012061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102136661|NCT03012061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102136662|NCT03012061|Autonomic Agents|autonomic agents|mesh-ancestor
102136663|NCT03012061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102136664|NCT03012061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136665|NCT03012061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102136666|NCT03012061|Respiratory System Agents|respiratory system agents|mesh-ancestor
102136667|NCT03012061|Dermatologic Agents|dermatologic agents|mesh-ancestor
102136668|NCT03012061|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102136669|NCT03012061|Tocolytic Agents|tocolytic agents|mesh-ancestor
102136670|NCT03012061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102136671|NCT03012061|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102136672|NCT03012061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102136673|NCT03012061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102136674|NCT03012061|Adrenergic Agents|adrenergic agents|mesh-ancestor
102136675|NCT03012061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102136676|NCT03012061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136677|NCT00408863|Tibolone|tibolone|mesh-list
102136678|NCT00408863|Androgen Antagonists|androgen antagonists|mesh-ancestor
102136679|NCT00408863|Hormone Antagonists|hormone antagonists|mesh-ancestor
102136680|NCT00408863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102136681|NCT00408863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136682|NCT00408863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102136683|NCT00408863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102136684|NCT00408863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102136685|NCT00408863|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102136686|NCT00408863|Anabolic Agents|anabolic agents|mesh-ancestor
102136687|NCT00408863|Hormones|hormones|mesh-ancestor
102136688|NCT05085327|Sunscreening Agents|sunscreening agents|mesh-list
102136689|NCT05085327|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102136690|NCT05085327|Protective Agents|protective agents|mesh-ancestor
102136691|NCT05085327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136692|NCT05085327|Dermatologic Agents|dermatologic agents|mesh-ancestor
101738734|NCT04105985|Sympathomimetics|sympathomimetics|mesh-ancestor
102136693|NCT03666715|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102136694|NCT03666715|Antipsychotic Agents|antipsychotic agents|mesh-list
102136695|NCT03666715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102136696|NCT03666715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102136697|NCT03666715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136698|NCT03666715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102136699|NCT03666715|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102136700|NCT03666715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102136701|NCT03666715|Serotonin Agents|serotonin agents|mesh-ancestor
102136702|NCT03666715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102136703|NCT03666715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136704|NCT03666715|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102136705|NCT03666715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102136706|NCT03666715|Dopamine Agents|dopamine agents|mesh-ancestor
102136707|NCT04949399|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102136708|NCT04949399|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102136709|NCT04949399|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102136710|NCT04949399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102136711|NCT04949399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136712|NCT04949399|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102136713|NCT04949399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102136714|NCT04949399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136715|NCT04949399|Cholinergic Agents|cholinergic agents|mesh-ancestor
102136716|NCT04949399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102136717|NCT03131973|Leucovorin|leucovorin|mesh-list
102136718|NCT03131973|Flurbiprofen|flurbiprofen|mesh-list
102136719|NCT03131973|Methotrexate|methotrexate|mesh-list
102136720|NCT03131973|Digoxin|digoxin|mesh-list
102136721|NCT03131973|Midazolam|midazolam|mesh-list
102136723|NCT03131973|Omeprazole|omeprazole|mesh-list
102136724|NCT03131973|Pravastatin|pravastatin|mesh-list
102136725|NCT03131973|Montelukast|montelukast|mesh-list
102136726|NCT03131973|Branebrutinib|branebrutinib|mesh-list
102136727|NCT03131973|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102136728|NCT03131973|Abortifacient Agents|abortifacient agents|mesh-ancestor
102136729|NCT03131973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102136730|NCT03131973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136731|NCT03131973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102136732|NCT03131973|Antimetabolites|antimetabolites|mesh-ancestor
102136733|NCT03131973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136734|NCT03131973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102136735|NCT03131973|Dermatologic Agents|dermatologic agents|mesh-ancestor
102136736|NCT03131973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102136737|NCT03131973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102136738|NCT03131973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102136739|NCT03131973|Immunologic Factors|immunologic factors|mesh-ancestor
102136740|NCT03131973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102136741|NCT03131973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102136742|NCT03131973|Antidotes|antidotes|mesh-ancestor
102136743|NCT03131973|Protective Agents|protective agents|mesh-ancestor
102136744|NCT03131973|Vitamin B Complex|vitamin b complex|mesh-ancestor
102136745|NCT03131973|Vitamins|vitamins|mesh-ancestor
102136746|NCT03131973|Micronutrients|micronutrients|mesh-ancestor
102136747|NCT03131973|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102136748|NCT03131973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102136749|NCT03131973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102136750|NCT03131973|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102136751|NCT03131973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102136752|NCT03131973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102136753|NCT03131973|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102136754|NCT03131973|Anesthetics, General|anesthetics, general|mesh-ancestor
102136755|NCT03131973|Anesthetics|anesthetics|mesh-ancestor
102136756|NCT03131973|GABA Modulators|gaba modulators|mesh-ancestor
102136757|NCT03131973|GABA Agents|gaba agents|mesh-ancestor
102136758|NCT03131973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102136759|NCT03131973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102136760|NCT03131973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102136761|NCT03131973|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102136762|NCT03131973|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102136763|NCT03131973|Purinergic Agents|purinergic agents|mesh-ancestor
102136764|NCT03131973|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102136765|NCT03131973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102136766|NCT03131973|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102136767|NCT03131973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102136768|NCT03131973|Respiratory System Agents|respiratory system agents|mesh-ancestor
102136769|NCT03131973|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102136770|NCT03131973|Hormone Antagonists|hormone antagonists|mesh-ancestor
102136771|NCT03131973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102136772|NCT03131973|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102136773|NCT03131973|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102136774|NCT03131973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102136775|NCT03131973|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102136776|NCT03131973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102136777|NCT03131973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102136778|NCT03131973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102136779|NCT03131973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102136780|NCT03131973|Analgesics|analgesics|mesh-ancestor
102136781|NCT03131973|Sensory System Agents|sensory system agents|mesh-ancestor
102136782|NCT03131973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102136783|NCT03131973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102136784|NCT03131973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102136785|NCT03131973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102136786|NCT03131973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102136787|NCT03131973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102136788|NCT05078931|Pembrolizumab|pembrolizumab|mesh-list
102136789|NCT05078931|Lenvatinib|lenvatinib|mesh-list
102136790|NCT05078931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102136791|NCT05078931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102136792|NCT05078931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102136793|NCT05078931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136794|NCT05078931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102136795|NCT05078931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102136796|NCT04825197|Poractant alfa|poractant alfa|mesh-list
102136797|NCT04825197|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
102136798|NCT04825197|Respiratory System Agents|respiratory system agents|mesh-ancestor
102136799|NCT04187105|Cyclophosphamide|cyclophosphamide|mesh-list
102136801|NCT04187105|Tacrolimus|tacrolimus|mesh-list
102136802|NCT04187105|Complement Factor H|complement factor h|mesh-list
102136803|NCT04187105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102136804|NCT04187105|Immunologic Factors|immunologic factors|mesh-ancestor
102136805|NCT04187105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136806|NCT04187105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102136807|NCT04187105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102136808|NCT04187105|Alkylating Agents|alkylating agents|mesh-ancestor
102136809|NCT04187105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136810|NCT04187105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102136811|NCT04187105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102136812|NCT04187105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102136813|NCT04187105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102136814|NCT04187105|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102136815|NCT04703361|Niacin|niacin|mesh-list
102136816|NCT04703361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102136817|NCT04703361|Antimetabolites|antimetabolites|mesh-ancestor
102136818|NCT04703361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136819|NCT04703361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102136820|NCT04703361|Vasodilator Agents|vasodilator agents|mesh-ancestor
102136821|NCT04703361|Vitamin B Complex|vitamin b complex|mesh-ancestor
102136822|NCT04703361|Vitamins|vitamins|mesh-ancestor
102136823|NCT04703361|Micronutrients|micronutrients|mesh-ancestor
102136824|NCT04703361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136825|NCT03010423|Nicorandil|nicorandil|mesh-list
102136826|NCT03010423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102136827|NCT03010423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102136828|NCT03010423|Vasodilator Agents|vasodilator agents|mesh-ancestor
102136829|NCT03010423|Vitamin B Complex|vitamin b complex|mesh-ancestor
102136830|NCT03010423|Vitamins|vitamins|mesh-ancestor
102136831|NCT03010423|Micronutrients|micronutrients|mesh-ancestor
102136832|NCT03010423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136833|NCT05576597|Butyric Acid|butyric acid|mesh-list
102136834|NCT05576597|Histamine Antagonists|histamine antagonists|mesh-ancestor
102136835|NCT05576597|Histamine Agents|histamine agents|mesh-ancestor
102136836|NCT05576597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102136837|NCT05576597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136838|NCT05576597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136839|NCT03665779|Pyridoxine|pyridoxine|mesh-list
102136840|NCT03665779|Isosorbide|isosorbide|mesh-list
102136841|NCT03665779|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
102136842|NCT03665779|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
102136843|NCT03665779|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102136844|NCT03665779|Diuretics|diuretics|mesh-ancestor
102136845|NCT03665779|Natriuretic Agents|natriuretic agents|mesh-ancestor
102136846|NCT03665779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136847|NCT03665779|Vasodilator Agents|vasodilator agents|mesh-ancestor
102136848|NCT03665779|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102136849|NCT03665779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136850|NCT03665779|Vitamin B Complex|vitamin b complex|mesh-ancestor
102136851|NCT03665779|Vitamins|vitamins|mesh-ancestor
102136852|NCT03665779|Micronutrients|micronutrients|mesh-ancestor
102136853|NCT03703505|Mitapivat|mitapivat|mesh-list
102136854|NCT03703505|Enzyme Activators|enzyme activators|mesh-ancestor
102136855|NCT03703505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136856|NCT04946435|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102136857|NCT04946435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102136858|NCT04944017|Ketamine|ketamine|mesh-list
102136859|NCT04944017|Analgesics|analgesics|mesh-ancestor
102136860|NCT04944017|Sensory System Agents|sensory system agents|mesh-ancestor
102136861|NCT04944017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102136862|NCT04944017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136863|NCT04944017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102136864|NCT04944017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102136865|NCT04944017|Anesthetics, General|anesthetics, general|mesh-ancestor
102136866|NCT04944017|Anesthetics|anesthetics|mesh-ancestor
102136867|NCT04944017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102136868|NCT04944017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102136869|NCT04944017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102136870|NCT04944017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102136871|NCT04944017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136872|NCT03703427|Capecitabine|capecitabine|mesh-list
102136873|NCT03703427|Vinorelbine|vinorelbine|mesh-list
102136874|NCT03703427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102136876|NCT03703427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136877|NCT03703427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102136878|NCT03703427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102136879|NCT03703427|Tubulin Modulators|tubulin modulators|mesh-ancestor
102136880|NCT03703427|Antimitotic Agents|antimitotic agents|mesh-ancestor
102136881|NCT03703427|Mitosis Modulators|mitosis modulators|mesh-ancestor
102136882|NCT03703349|Magnesium Sulfate|magnesium sulfate|mesh-list
102136883|NCT03703349|Analgesics|analgesics|mesh-ancestor
102136884|NCT03703349|Sensory System Agents|sensory system agents|mesh-ancestor
102136885|NCT03703349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102136886|NCT03703349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136887|NCT03703349|Anesthetics|anesthetics|mesh-ancestor
102136888|NCT03703349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102136889|NCT03703349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102136890|NCT03703349|Anticonvulsants|anticonvulsants|mesh-ancestor
102136891|NCT03703349|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102136892|NCT03703349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101738933|NCT00443053|PENTA|penta|mesh-list
102136893|NCT03703349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136894|NCT03703349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102136895|NCT03703349|Tocolytic Agents|tocolytic agents|mesh-ancestor
102136896|NCT03703349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102136897|NCT03008005|Dronabinol|dronabinol|mesh-list
102136898|NCT03008005|Hallucinogens|hallucinogens|mesh-ancestor
102136899|NCT03008005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136900|NCT03008005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102136901|NCT03008005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102136902|NCT03008005|Analgesics|analgesics|mesh-ancestor
102136903|NCT03008005|Sensory System Agents|sensory system agents|mesh-ancestor
102136904|NCT03008005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102136905|NCT03008005|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102136906|NCT03008005|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102136907|NCT03008005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102136908|NCT03008005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136909|NCT03008005|Hormones|hormones|mesh-ancestor
102136910|NCT03008005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102136911|NCT03666325|Pembrolizumab|pembrolizumab|mesh-list
102136912|NCT03666325|Cetuximab|cetuximab|mesh-list
102136913|NCT03666325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102136914|NCT03666325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102136915|NCT03666325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102136916|NCT03666325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136918|NCT02440425|Pembrolizumab|pembrolizumab|mesh-list
102136919|NCT02440425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102136920|NCT02440425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102136921|NCT02440425|Tubulin Modulators|tubulin modulators|mesh-ancestor
102136922|NCT02440425|Antimitotic Agents|antimitotic agents|mesh-ancestor
102136923|NCT02440425|Mitosis Modulators|mitosis modulators|mesh-ancestor
102136924|NCT02440425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136925|NCT02440425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102136926|NCT02440425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102136927|NCT04931511|Betamethasone|betamethasone|mesh-list
102136928|NCT04931511|Betamethasone Valerate|betamethasone valerate|mesh-list
102136929|NCT04931511|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102136930|NCT04931511|Betamethasone benzoate|betamethasone benzoate|mesh-list
102136931|NCT04931511|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102136932|NCT04931511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102136933|NCT04931511|Glucocorticoids|glucocorticoids|mesh-ancestor
102136934|NCT04931511|Hormones|hormones|mesh-ancestor
102136935|NCT04931511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102136936|NCT04931511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136937|NCT04931511|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102136938|NCT04931511|Respiratory System Agents|respiratory system agents|mesh-ancestor
102136939|NCT04182321|Metformin|metformin|mesh-list
102136940|NCT04182321|Entecavir|entecavir|mesh-list
102136941|NCT04182321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102136942|NCT04182321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136943|NCT04182321|Antiviral Agents|antiviral agents|mesh-ancestor
102136944|NCT04182321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102136945|NCT03702959|Betamethasone|betamethasone|mesh-list
102136946|NCT03702959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102136947|NCT03702959|Glucocorticoids|glucocorticoids|mesh-ancestor
102136948|NCT03702959|Hormones|hormones|mesh-ancestor
102136949|NCT03702959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102136950|NCT03702959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136951|NCT03702959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102136952|NCT03702959|Respiratory System Agents|respiratory system agents|mesh-ancestor
102136953|NCT03001219|Methotrexate|methotrexate|mesh-list
102136954|NCT03001219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102136955|NCT03001219|Abortifacient Agents|abortifacient agents|mesh-ancestor
102136956|NCT03001219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102136957|NCT03001219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136958|NCT03001219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102136959|NCT03001219|Antimetabolites|antimetabolites|mesh-ancestor
102136960|NCT03001219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136961|NCT03001219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102136962|NCT03001219|Dermatologic Agents|dermatologic agents|mesh-ancestor
102136963|NCT03001219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102136964|NCT03001219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102136965|NCT03001219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102136966|NCT03001219|Immunologic Factors|immunologic factors|mesh-ancestor
102136967|NCT03001219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102136968|NCT03001219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102136969|NCT03702803|Alprazolam|alprazolam|mesh-list
102136970|NCT03702803|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102136971|NCT03702803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102136972|NCT03702803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136973|NCT03702803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102136974|NCT03702803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102136975|NCT03702803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102136976|NCT03702803|GABA Modulators|gaba modulators|mesh-ancestor
102136977|NCT03702803|GABA Agents|gaba agents|mesh-ancestor
102136978|NCT03702803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102136979|NCT03702803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102136980|NCT03487809|Budesonide|budesonide|mesh-list
102136981|NCT03487809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102136982|NCT03487809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102136983|NCT03487809|Autonomic Agents|autonomic agents|mesh-ancestor
102136984|NCT03487809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102136985|NCT03487809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136986|NCT03487809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102136987|NCT03487809|Respiratory System Agents|respiratory system agents|mesh-ancestor
102136988|NCT03487809|Glucocorticoids|glucocorticoids|mesh-ancestor
102136990|NCT03487809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102136991|NCT03702647|Ropivacaine|ropivacaine|mesh-list
102136992|NCT03702647|Anesthetics, Local|anesthetics, local|mesh-ancestor
102136993|NCT03702647|Anesthetics|anesthetics|mesh-ancestor
102136994|NCT03702647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102136995|NCT03702647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102136996|NCT03702647|Sensory System Agents|sensory system agents|mesh-ancestor
102136997|NCT03702647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102136998|NCT04583787|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
102136999|NCT04583787|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102137000|NCT04583787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137001|NCT03000673|Heparin|heparin|mesh-list
102137002|NCT03000673|Enoxaparin|enoxaparin|mesh-list
102137003|NCT03000673|Calcium heparin|calcium heparin|mesh-list
102137004|NCT03000673|Anticoagulants|anticoagulants|mesh-ancestor
102137005|NCT03000673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102137006|NCT03000673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102137007|NCT03000673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137008|NCT05423249|Ascorbic Acid|ascorbic acid|mesh-list
102137009|NCT05423249|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
102137010|NCT05423249|Antioxidants|antioxidants|mesh-ancestor
102137011|NCT05423249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137012|NCT05423249|Protective Agents|protective agents|mesh-ancestor
102137013|NCT05423249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137014|NCT05423249|Vitamins|vitamins|mesh-ancestor
102137015|NCT05423249|Micronutrients|micronutrients|mesh-ancestor
102137016|NCT05423249|Antidiarrheals|antidiarrheals|mesh-ancestor
102137017|NCT05423249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102137018|NCT02912455|Canagliflozin|canagliflozin|mesh-list
102137019|NCT02912455|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102137020|NCT02912455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137021|NCT02912455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102137022|NCT02912455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137023|NCT03702491|Oxaliplatin|oxaliplatin|mesh-list
102137024|NCT03702491|Apatinib|apatinib|mesh-list
102137025|NCT03702491|Tegafur|tegafur|mesh-list
102137026|NCT03702491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102137027|NCT03702491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102137028|NCT03702491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102137029|NCT03702491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137030|NCT03702491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102137031|NCT03702491|Antimetabolites|antimetabolites|mesh-ancestor
102137032|NCT03663751|Decitabine|decitabine|mesh-list
102137033|NCT03663751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102137034|NCT03663751|Antimetabolites|antimetabolites|mesh-ancestor
102137035|NCT03663751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137036|NCT03663751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102137037|NCT03663751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102137038|NCT04054687|Tranexamic Acid|tranexamic acid|mesh-list
102137039|NCT04054687|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102137040|NCT04054687|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102137041|NCT04054687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137042|NCT04054687|Hemostatics|hemostatics|mesh-ancestor
102137043|NCT04054687|Coagulants|coagulants|mesh-ancestor
102137044|NCT03492489|Cemiplimab|cemiplimab|mesh-list
102137045|NCT03492489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102137046|NCT03492489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102137047|NCT02531698|Vaccines|vaccines|mesh-list
102137048|NCT02531698|Immunologic Factors|immunologic factors|mesh-ancestor
102137049|NCT02531698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137050|NCT04308837|Diphenhydramine|diphenhydramine|mesh-list
102137051|NCT04308837|Promethazine|promethazine|mesh-list
102137052|NCT04308837|Dexamethasone|dexamethasone|mesh-list
102137053|NCT04308837|Paclitaxel|paclitaxel|mesh-list
102137054|NCT04308837|Carboplatin|carboplatin|mesh-list
102137055|NCT04308837|Palonosetron|palonosetron|mesh-list
102137056|NCT04308837|Famotidine|famotidine|mesh-list
102137057|NCT04308837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102137058|NCT04308837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102137059|NCT04308837|Tubulin Modulators|tubulin modulators|mesh-ancestor
102137060|NCT04308837|Antimitotic Agents|antimitotic agents|mesh-ancestor
102137061|NCT04308837|Mitosis Modulators|mitosis modulators|mesh-ancestor
102137062|NCT04308837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137063|NCT04308837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101846058|NCT00330681|Edaravone|edaravone|mesh-list
102137065|NCT04308837|Autonomic Agents|autonomic agents|mesh-ancestor
102137066|NCT04308837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102137067|NCT04308837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137068|NCT04308837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102137069|NCT04308837|Glucocorticoids|glucocorticoids|mesh-ancestor
102137070|NCT04308837|Hormones|hormones|mesh-ancestor
102137071|NCT04308837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102137072|NCT04308837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102137073|NCT04308837|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102137074|NCT04308837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102137075|NCT04308837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102137076|NCT04308837|Anesthetics, Local|anesthetics, local|mesh-ancestor
102137077|NCT04308837|Anesthetics|anesthetics|mesh-ancestor
102137078|NCT04308837|Sensory System Agents|sensory system agents|mesh-ancestor
102137079|NCT04308837|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102137080|NCT04308837|Histamine Antagonists|histamine antagonists|mesh-ancestor
102137081|NCT04308837|Histamine Agents|histamine agents|mesh-ancestor
102137082|NCT04308837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102137083|NCT04308837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102137084|NCT04308837|Antipruritics|antipruritics|mesh-ancestor
102137085|NCT04308837|Dermatologic Agents|dermatologic agents|mesh-ancestor
102137086|NCT04308837|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102137087|NCT04308837|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102137088|NCT04308837|Serotonin Agents|serotonin agents|mesh-ancestor
102137089|NCT04308837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102137090|NCT04308837|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102137091|NCT03664375|Botulinum Toxins|botulinum toxins|mesh-list
102137092|NCT03664375|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102137093|NCT03664375|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102137094|NCT03664375|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102137095|NCT03664375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102137096|NCT03664375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137097|NCT03664375|Cholinergic Agents|cholinergic agents|mesh-ancestor
102137098|NCT03664375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102137099|NCT03664375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137100|NCT03664375|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102137101|NCT03664375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102137102|NCT00403793|Methyltestosterone|methyltestosterone|mesh-list
102137103|NCT00403793|Etonogestrel|etonogestrel|mesh-list
102137104|NCT00403793|Testosterone|testosterone|mesh-list
102137105|NCT00403793|Testosterone undecanoate|testosterone undecanoate|mesh-list
102137106|NCT00403793|Testosterone enanthate|testosterone enanthate|mesh-list
102137107|NCT00403793|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102137108|NCT00403793|Androgens|androgens|mesh-ancestor
102137109|NCT00403793|Hormones|hormones|mesh-ancestor
102137110|NCT00403793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102137111|NCT00403793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137112|NCT00403793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102137113|NCT00403793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102137114|NCT00403793|Anabolic Agents|anabolic agents|mesh-ancestor
102137115|NCT00403793|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102137116|NCT00403793|Contraceptive Agents|contraceptive agents|mesh-ancestor
102137117|NCT00403793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102137118|NCT00403793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102137119|NCT05597098|Cantharidin|cantharidin|mesh-list
102137120|NCT05597098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102137121|NCT05597098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137122|NCT03034577|Neostigmine|neostigmine|mesh-list
102137123|NCT03034577|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102137124|NCT03034577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102137125|NCT03034577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137126|NCT03034577|Cholinergic Agents|cholinergic agents|mesh-ancestor
102137127|NCT03034577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102137128|NCT03034577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137129|NCT03034577|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102137130|NCT03034577|Autonomic Agents|autonomic agents|mesh-ancestor
102137131|NCT03034577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102137132|NCT04364997|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102137133|NCT04364997|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
102137134|NCT04364997|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102137135|NCT04364997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102137136|NCT04364997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102137137|NCT04364997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137138|NCT04364997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102137139|NCT04364997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137140|NCT04364997|Analgesics|analgesics|mesh-ancestor
102137141|NCT04364997|Sensory System Agents|sensory system agents|mesh-ancestor
102137142|NCT04364997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102137143|NCT04364997|Antidepressive Agents|antidepressive agents|mesh-ancestor
102137144|NCT04364997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102137145|NCT04364997|Dopamine Agents|dopamine agents|mesh-ancestor
102137146|NCT05417386|Leucovorin|leucovorin|mesh-list
102137147|NCT05417386|Fluorouracil|fluorouracil|mesh-list
101739184|NCT00436345|Propofol|propofol|mesh-list
102137148|NCT05417386|Capecitabine|capecitabine|mesh-list
102137149|NCT05417386|Oxaliplatin|oxaliplatin|mesh-list
102137150|NCT05417386|Irinotecan|irinotecan|mesh-list
102137151|NCT05417386|Camptothecin|camptothecin|mesh-list
102137152|NCT05417386|Folfirinox|folfirinox|mesh-list
102137153|NCT05417386|Levoleucovorin|levoleucovorin|mesh-list
102137154|NCT05417386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137155|NCT05417386|Antimetabolites|antimetabolites|mesh-ancestor
102137156|NCT05417386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137157|NCT05417386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102137158|NCT05417386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102137159|NCT05417386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102137160|NCT05417386|Immunologic Factors|immunologic factors|mesh-ancestor
102137161|NCT05417386|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102137162|NCT05417386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102137163|NCT05417386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102137164|NCT05417386|Antidotes|antidotes|mesh-ancestor
102137165|NCT05417386|Protective Agents|protective agents|mesh-ancestor
102137166|NCT05417386|Vitamin B Complex|vitamin b complex|mesh-ancestor
102137167|NCT05417386|Vitamins|vitamins|mesh-ancestor
102137168|NCT05417386|Micronutrients|micronutrients|mesh-ancestor
102137169|NCT05417386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102137170|NCT04005729|Cangrelor|cangrelor|mesh-list
102137171|NCT04005729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102137172|NCT04005729|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102137173|NCT04005729|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102137174|NCT04005729|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102137175|NCT04005729|Purinergic Agents|purinergic agents|mesh-ancestor
102137176|NCT04005729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102137177|NCT04005729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137178|NCT04005729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137179|NCT03487107|Sofosbuvir|sofosbuvir|mesh-list
102137180|NCT03487107|Yimitasvir|yimitasvir|mesh-list
102137181|NCT03487107|Antiviral Agents|antiviral agents|mesh-ancestor
102137182|NCT03487107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102137183|NCT02997163|Talazoparib|talazoparib|mesh-list
102137184|NCT02997163|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102137185|NCT02997163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102137186|NCT02997163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137187|NCT02997163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102137188|NCT03705065|Bupivacaine|bupivacaine|mesh-list
102137189|NCT03705065|Anesthetics, Local|anesthetics, local|mesh-ancestor
102137190|NCT03705065|Anesthetics|anesthetics|mesh-ancestor
102137191|NCT03705065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102137192|NCT03705065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137193|NCT03705065|Sensory System Agents|sensory system agents|mesh-ancestor
102137194|NCT03705065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102137195|NCT03702023|Acetaminophen|acetaminophen|mesh-list
102137196|NCT03702023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102137197|NCT03702023|Analgesics|analgesics|mesh-ancestor
102137198|NCT03702023|Sensory System Agents|sensory system agents|mesh-ancestor
102137199|NCT03702023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102137200|NCT03702023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137201|NCT03702023|Antipyretics|antipyretics|mesh-ancestor
102137202|NCT04259944|Capecitabine|capecitabine|mesh-list
102137203|NCT04259944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102137204|NCT04259944|Antimetabolites|antimetabolites|mesh-ancestor
102137205|NCT04259944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137206|NCT04259944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102137207|NCT03698513|Aspirin|aspirin|mesh-list
102137208|NCT03698513|Clopidogrel|clopidogrel|mesh-list
102137209|NCT03698513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102137210|NCT03698513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102137211|NCT03698513|Analgesics|analgesics|mesh-ancestor
102137212|NCT03698513|Sensory System Agents|sensory system agents|mesh-ancestor
102137213|NCT03698513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102137214|NCT03698513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137215|NCT03698513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102137216|NCT03698513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102137217|NCT03698513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102137218|NCT03698513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102137219|NCT03698513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137220|NCT03698513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102137221|NCT03698513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102137222|NCT03698513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102137223|NCT03698513|Antipyretics|antipyretics|mesh-ancestor
102137224|NCT03698513|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102137225|NCT03698513|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102137226|NCT03698513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102137227|NCT03698513|Purinergic Agents|purinergic agents|mesh-ancestor
102137228|NCT03698513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102137229|NCT03698435|Valganciclovir|valganciclovir|mesh-list
102137230|NCT03698435|Ganciclovir|ganciclovir|mesh-list
102137231|NCT03698435|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102137232|NCT03698435|Antiviral Agents|antiviral agents|mesh-ancestor
102137233|NCT03698435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102137234|NCT03698435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102137235|NCT03698435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102137236|NCT03698435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137238|NCT01652092|Cyclophosphamide|cyclophosphamide|mesh-list
102137239|NCT01652092|Melphalan|melphalan|mesh-list
102137240|NCT01652092|Busulfan|busulfan|mesh-list
102137241|NCT01652092|Fludarabine|fludarabine|mesh-list
102137242|NCT01652092|Fludarabine phosphate|fludarabine phosphate|mesh-list
102137243|NCT01652092|Alemtuzumab|alemtuzumab|mesh-list
102137244|NCT01652092|Mesna|mesna|mesh-list
102137245|NCT01652092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102137246|NCT01652092|Immunologic Factors|immunologic factors|mesh-ancestor
102137247|NCT01652092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137248|NCT01652092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102137249|NCT01652092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102137250|NCT01652092|Alkylating Agents|alkylating agents|mesh-ancestor
102137251|NCT01652092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137252|NCT01652092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102137253|NCT01652092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102137254|NCT01652092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102137255|NCT01652092|Antimetabolites|antimetabolites|mesh-ancestor
102137256|NCT01652092|Antiviral Agents|antiviral agents|mesh-ancestor
102137257|NCT01652092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102137258|NCT01652092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102137259|NCT01652092|Protective Agents|protective agents|mesh-ancestor
102137260|NCT04572815|Interleukin-12|interleukin-12|mesh-list
102137261|NCT04572815|Ustekinumab|ustekinumab|mesh-list
102137262|NCT04572815|Immunoglobulins|immunoglobulins|mesh-list
102137263|NCT04572815|Immunoglobulin G|immunoglobulin g|mesh-list
102137264|NCT04572815|Immunologic Factors|immunologic factors|mesh-ancestor
102137265|NCT04572815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137266|NCT04572815|Dermatologic Agents|dermatologic agents|mesh-ancestor
102137267|NCT04572815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102137268|NCT04572815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102137269|NCT04572815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102137270|NCT04572815|Growth Substances|growth substances|mesh-ancestor
102137271|NCT04572815|Growth Inhibitors|growth inhibitors|mesh-ancestor
102137272|NCT04572815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102137273|NCT03698045|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102137274|NCT03698045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102137276|NCT03697889|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102137277|NCT03697889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102137278|NCT03697889|Analgesics|analgesics|mesh-ancestor
102137279|NCT03697889|Sensory System Agents|sensory system agents|mesh-ancestor
102137280|NCT03697889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102137281|NCT03697889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137282|NCT03697889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102137283|NCT03697889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102137284|NCT03697889|Gout Suppressants|gout suppressants|mesh-ancestor
102137285|NCT03697889|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102137286|NCT03697889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846278|NCT00995033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137287|NCT03697889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137288|NCT03692819|Amoxicillin|amoxicillin|mesh-list
102137291|NCT03692819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102137292|NCT03692819|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102137293|NCT03692819|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102137294|NCT00458536|Molgramostim|molgramostim|mesh-list
102137295|NCT00458536|Sargramostim|sargramostim|mesh-list
102137296|NCT00458536|Immunologic Factors|immunologic factors|mesh-ancestor
102137297|NCT00458536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137298|NCT00458536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102137301|NCT05577364|Prednisone|prednisone|mesh-list
102137302|NCT05577364|Cyclophosphamide|cyclophosphamide|mesh-list
102137303|NCT05577364|Doxorubicin|doxorubicin|mesh-list
102137304|NCT05577364|Vincristine|vincristine|mesh-list
102137305|NCT05577364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102137306|NCT05577364|Immunologic Factors|immunologic factors|mesh-ancestor
102137307|NCT05577364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137308|NCT05577364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102137309|NCT05577364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102137310|NCT05577364|Alkylating Agents|alkylating agents|mesh-ancestor
102137311|NCT05577364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137312|NCT05577364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102137313|NCT05577364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102137314|NCT05577364|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102137315|NCT05577364|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102137316|NCT05577364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102137317|NCT05577364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102137318|NCT05577364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102137319|NCT05577364|Glucocorticoids|glucocorticoids|mesh-ancestor
102137320|NCT05577364|Hormones|hormones|mesh-ancestor
102137321|NCT05577364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102137322|NCT05577364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102137323|NCT05577364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102137324|NCT05577364|Tubulin Modulators|tubulin modulators|mesh-ancestor
102137325|NCT05577364|Antimitotic Agents|antimitotic agents|mesh-ancestor
102137326|NCT05577364|Mitosis Modulators|mitosis modulators|mesh-ancestor
102137327|NCT03697655|Daratumumab|daratumumab|mesh-list
102137328|NCT03697655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102137329|NCT03701321|Dexamethasone|dexamethasone|mesh-list
102137330|NCT03701321|Dexamethasone acetate|dexamethasone acetate|mesh-list
102137331|NCT03701321|Bortezomib|bortezomib|mesh-list
102137332|NCT03701321|Venetoclax|venetoclax|mesh-list
102137333|NCT03701321|Daratumumab|daratumumab|mesh-list
102137335|NCT03701321|BB 1101|bb 1101|mesh-list
102137336|NCT03701321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102137337|NCT03701321|Antiemetics|antiemetics|mesh-ancestor
102137338|NCT03701321|Autonomic Agents|autonomic agents|mesh-ancestor
102137339|NCT03701321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102137340|NCT03701321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137341|NCT03701321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102137342|NCT03701321|Glucocorticoids|glucocorticoids|mesh-ancestor
102137343|NCT03701321|Hormones|hormones|mesh-ancestor
102137344|NCT03701321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102137345|NCT03701321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102137346|NCT03701321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102137347|NCT03701321|Protease Inhibitors|protease inhibitors|mesh-ancestor
102137348|NCT03701321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102137349|NCT03701321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137350|NCT03701321|Dermatologic Agents|dermatologic agents|mesh-ancestor
102137351|NCT02526550|Vaccines|vaccines|mesh-list
102137352|NCT02526550|Immunologic Factors|immunologic factors|mesh-ancestor
102137353|NCT02526550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137354|NCT05565352|Ketamine|ketamine|mesh-list
102137355|NCT05565352|Analgesics|analgesics|mesh-ancestor
102137356|NCT05565352|Sensory System Agents|sensory system agents|mesh-ancestor
102137357|NCT05565352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102137358|NCT05565352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137359|NCT05565352|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102137360|NCT05565352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102137361|NCT05565352|Anesthetics, General|anesthetics, general|mesh-ancestor
102137362|NCT05565352|Anesthetics|anesthetics|mesh-ancestor
102137363|NCT05565352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102137364|NCT05565352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102137365|NCT05565352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102137366|NCT05565352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102137367|NCT05565352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137368|NCT04423276|Donepezil|donepezil|mesh-list
102137369|NCT04423276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102137370|NCT04423276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102137371|NCT04423276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137372|NCT04423276|Cholinergic Agents|cholinergic agents|mesh-ancestor
102137373|NCT04423276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102137374|NCT04423276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137375|NCT04423276|Nootropic Agents|nootropic agents|mesh-ancestor
102137376|NCT05564416|Atezolizumab|atezolizumab|mesh-list
102137377|NCT05564416|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102137378|NCT05564416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102137379|NCT05564416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137380|NCT05564416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102137381|NCT05564416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102137382|NCT05564416|Immunologic Factors|immunologic factors|mesh-ancestor
102137383|NCT05564416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137384|NCT03701087|Vitamin D|vitamin d|mesh-list
102137385|NCT03701087|Vitamins|vitamins|mesh-ancestor
102137386|NCT03701087|Micronutrients|micronutrients|mesh-ancestor
102137387|NCT03701087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137388|NCT03701087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102137389|NCT03697265|Pregnanolone|pregnanolone|mesh-list
102137390|NCT03697265|Anesthetics|anesthetics|mesh-ancestor
102137391|NCT03697265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102137392|NCT03697265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137393|NCT04523129|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102137394|NCT04523129|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102137395|NCT04513067|Pembrolizumab|pembrolizumab|mesh-list
102137396|NCT04513067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102137397|NCT04513067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102137398|NCT04513067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102137399|NCT04513067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137400|NCT04336943|Durvalumab|durvalumab|mesh-list
102137401|NCT04336943|Olaparib|olaparib|mesh-list
102137402|NCT04336943|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102137403|NCT04336943|Immunoglobulins|immunoglobulins|mesh-list
102137404|NCT04336943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102137405|NCT04336943|Immunoglobulin G|immunoglobulin g|mesh-list
102137406|NCT04336943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102137407|NCT04336943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102137408|NCT04336943|Immunologic Factors|immunologic factors|mesh-ancestor
102137409|NCT04336943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137410|NCT04336943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102137411|NCT04336943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137412|NCT03030989|Chlorhexidine|chlorhexidine|mesh-list
102137413|NCT03030989|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102137414|NCT03030989|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102137415|NCT03030989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102137416|NCT03030989|Disinfectants|disinfectants|mesh-ancestor
102137417|NCT03030989|Dermatologic Agents|dermatologic agents|mesh-ancestor
102137418|NCT03696641|Lithium Carbonate|lithium carbonate|mesh-list
102137419|NCT03696641|Antidepressive Agents|antidepressive agents|mesh-ancestor
102137420|NCT03696641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102137421|NCT03696641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102137422|NCT03696641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137423|NCT03696641|Antimanic Agents|antimanic agents|mesh-ancestor
102137424|NCT03696641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102137425|NCT03696641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102137426|NCT03696641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137427|NCT03696329|Tetrabenazine|tetrabenazine|mesh-list
102137428|NCT03696329|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102137429|NCT03696329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102137430|NCT03696329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102137431|NCT03696329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137432|NCT03696329|Adrenergic Agents|adrenergic agents|mesh-ancestor
102137433|NCT03696329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102137434|NCT03696329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137435|NCT03696095|Ropivacaine|ropivacaine|mesh-list
102137436|NCT03696095|Anesthetics, Local|anesthetics, local|mesh-ancestor
102137437|NCT03696095|Anesthetics|anesthetics|mesh-ancestor
102137438|NCT03696095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102137439|NCT03696095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137440|NCT03696095|Sensory System Agents|sensory system agents|mesh-ancestor
102137451|NCT03695861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137453|NCT03695705|Norfloxacin|norfloxacin|mesh-list
101739488|NCT00753896|Exenatide|exenatide|mesh-list
102137454|NCT03695705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102137455|NCT03695705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102137456|NCT03695705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102137457|NCT03695705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102137458|NCT03695705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102137459|NCT03695705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102137460|NCT03695705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137461|NCT03695705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102137462|NCT03695705|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102137463|NCT03695705|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102137464|NCT03699839|Vaccines|vaccines|mesh-list
102137465|NCT03699839|Immunologic Factors|immunologic factors|mesh-ancestor
102137466|NCT03699839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137467|NCT04050215|Edetic Acid|edetic acid|mesh-list
102137468|NCT04050215|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102137469|NCT04050215|Chelating Agents|chelating agents|mesh-ancestor
102137470|NCT04050215|Sequestering Agents|sequestering agents|mesh-ancestor
102137471|NCT04050215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137472|NCT04050215|Anticoagulants|anticoagulants|mesh-ancestor
102137473|NCT04050215|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102137474|NCT04050215|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102137486|NCT03699449|Paclitaxel|paclitaxel|mesh-list
102137487|NCT03699449|Durvalumab|durvalumab|mesh-list
102137488|NCT03699449|Olaparib|olaparib|mesh-list
102137489|NCT03699449|Tremelimumab|tremelimumab|mesh-list
102137490|NCT03699449|Cediranib|cediranib|mesh-list
102137491|NCT03699449|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102137492|NCT03699449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102137493|NCT03699449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102137494|NCT03699449|Tubulin Modulators|tubulin modulators|mesh-ancestor
102137495|NCT03699449|Antimitotic Agents|antimitotic agents|mesh-ancestor
102137496|NCT03699449|Mitosis Modulators|mitosis modulators|mesh-ancestor
102137497|NCT03699449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137498|NCT03699449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102137499|NCT03699449|Immunologic Factors|immunologic factors|mesh-ancestor
102137500|NCT03699449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137501|NCT03699449|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102137502|NCT03699449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102137503|NCT03699449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102137504|NCT04475939|Pembrolizumab|pembrolizumab|mesh-list
102137505|NCT04475939|Niraparib|niraparib|mesh-list
102137506|NCT04475939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102137507|NCT04475939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102137508|NCT04475939|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102137509|NCT04475939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137510|NCT04475939|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102137511|NCT04475939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102137512|NCT03699293|Aspirin|aspirin|mesh-list
102137513|NCT03699293|Celecoxib|celecoxib|mesh-list
102137514|NCT03699293|Naproxen|naproxen|mesh-list
102241604|NCT03071055|Ranibizumab|ranibizumab|mesh-list
102137515|NCT03699293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102137516|NCT03699293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102137517|NCT03699293|Analgesics|analgesics|mesh-ancestor
102137518|NCT03699293|Sensory System Agents|sensory system agents|mesh-ancestor
102137519|NCT03699293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102137520|NCT03699293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137521|NCT03699293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102137522|NCT03699293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102137523|NCT03699293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102137524|NCT03699293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102137525|NCT03699293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137526|NCT03699293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102137527|NCT03699293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102137528|NCT03699293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102137529|NCT03699293|Antipyretics|antipyretics|mesh-ancestor
102137530|NCT03699293|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102137531|NCT03699293|Gout Suppressants|gout suppressants|mesh-ancestor
102137532|NCT03029819|Nicotine|nicotine|mesh-list
102137533|NCT03029819|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102137534|NCT03029819|Autonomic Agents|autonomic agents|mesh-ancestor
102137535|NCT03029819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102137536|NCT03029819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137537|NCT03029819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102137538|NCT03029819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102137539|NCT03029819|Cholinergic Agents|cholinergic agents|mesh-ancestor
102137540|NCT03029819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102137541|NCT03029819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137542|NCT03105830|Acetaminophen|acetaminophen|mesh-list
102137543|NCT03105830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102137544|NCT03105830|Analgesics|analgesics|mesh-ancestor
102137545|NCT03105830|Sensory System Agents|sensory system agents|mesh-ancestor
102137546|NCT03105830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102137547|NCT03105830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137548|NCT03105830|Antipyretics|antipyretics|mesh-ancestor
102137549|NCT03691415|Deoxycholic Acid|deoxycholic acid|mesh-list
102137550|NCT03691415|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102137551|NCT03691415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102137552|NCT03699215|Simendan|simendan|mesh-list
102137553|NCT03699215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102137554|NCT03699215|Vasodilator Agents|vasodilator agents|mesh-ancestor
102137555|NCT03699215|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102137556|NCT03699215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102137557|NCT03699215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102137558|NCT03699215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137559|NCT03699215|Protective Agents|protective agents|mesh-ancestor
102137560|NCT03699215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137561|NCT03694535|Mitomycins|mitomycins|mesh-list
102137562|NCT03694535|Mitomycin|mitomycin|mesh-list
102137563|NCT03694535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102137564|NCT03694535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102137565|NCT03694535|Alkylating Agents|alkylating agents|mesh-ancestor
102137566|NCT03694535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137567|NCT03694535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102137568|NCT03694535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102137569|NCT03115034|Melatonin|melatonin|mesh-list
102137570|NCT03115034|Antioxidants|antioxidants|mesh-ancestor
102137571|NCT03115034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137572|NCT03115034|Protective Agents|protective agents|mesh-ancestor
102137573|NCT03115034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137574|NCT03115034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102137575|NCT05525546|Vaccines|vaccines|mesh-list
102137576|NCT05525546|Immunologic Factors|immunologic factors|mesh-ancestor
102137577|NCT05525546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137578|NCT03027557|Denosumab|denosumab|mesh-list
102137579|NCT03027557|Cinacalcet|cinacalcet|mesh-list
102137580|NCT03027557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102137581|NCT03027557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137582|NCT03027557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102137583|NCT03027557|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
102137584|NCT03027557|Hormone Antagonists|hormone antagonists|mesh-ancestor
102137585|NCT03027557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102137586|NCT03698825|Vactosertib|vactosertib|mesh-list
102137587|NCT03698825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102137588|NCT03698825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102137589|NCT03698825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137590|NCT02691572|Acetaminophen|acetaminophen|mesh-list
102137591|NCT02691572|Ketorolac|ketorolac|mesh-list
102137592|NCT02691572|Fentanyl|fentanyl|mesh-list
102137593|NCT02691572|Bupivacaine|bupivacaine|mesh-list
102137594|NCT02691572|Anesthetics, Local|anesthetics, local|mesh-ancestor
102137595|NCT02691572|Anesthetics|anesthetics|mesh-ancestor
102137596|NCT02691572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102137597|NCT02691572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137598|NCT02691572|Sensory System Agents|sensory system agents|mesh-ancestor
102137599|NCT02691572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102137600|NCT02691572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102137601|NCT02691572|Narcotics|narcotics|mesh-ancestor
102137602|NCT02691572|Analgesics|analgesics|mesh-ancestor
102137603|NCT02691572|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102137604|NCT02691572|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102137605|NCT02691572|Anesthetics, General|anesthetics, general|mesh-ancestor
102137606|NCT02691572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102137607|NCT02691572|Antipyretics|antipyretics|mesh-ancestor
102137608|NCT02691572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102137609|NCT02691572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102137610|NCT02691572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102137611|NCT02691572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102137612|NCT02691572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102137613|NCT02691572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137614|NCT05320172|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102137615|NCT05320172|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102137616|NCT03693833|Cannabidiol|cannabidiol|mesh-list
102137617|NCT03693833|Anticonvulsants|anticonvulsants|mesh-ancestor
102137618|NCT03693599|Carbetocin|carbetocin|mesh-list
102137619|NCT03693599|Syntometrine|syntometrine|mesh-list
102137620|NCT03693599|Oxytocics|oxytocics|mesh-ancestor
102137621|NCT03693599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102137622|NCT03693599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137623|NCT04277663|Interferons|interferons|mesh-list
102137624|NCT04277663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102137625|NCT04277663|Antiviral Agents|antiviral agents|mesh-ancestor
102137626|NCT04277663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102137627|NCT04270643|Vitamin D|vitamin d|mesh-list
102137628|NCT04270643|Cholecalciferol|cholecalciferol|mesh-list
102137629|NCT04270643|Vitamins|vitamins|mesh-ancestor
102137630|NCT04270643|Micronutrients|micronutrients|mesh-ancestor
102137631|NCT04270643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137632|NCT04270643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102137633|NCT04270643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102137634|NCT03693131|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
102137635|NCT03693131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102137636|NCT03693131|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102137637|NCT02677844|Loperamide|loperamide|mesh-list
102137638|NCT02677844|Antidiarrheals|antidiarrheals|mesh-list
102137639|NCT02677844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102137640|NCT03687905|Hydroxychloroquine|hydroxychloroquine|mesh-list
102137641|NCT03687905|Chloroquine|chloroquine|mesh-list
102137642|NCT03687905|Antimalarials|antimalarials|mesh-ancestor
102137643|NCT03687905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102137644|NCT03687905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102137645|NCT03687905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102137646|NCT03687905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102137647|NCT03687905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137648|NCT03687905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102137649|NCT03687905|Amebicides|amebicides|mesh-ancestor
102137650|NCT03687515|Prednisone|prednisone|mesh-list
102137651|NCT03687515|Budesonide|budesonide|mesh-list
102137652|NCT03687515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102137653|NCT03687515|Glucocorticoids|glucocorticoids|mesh-ancestor
102137654|NCT03687515|Hormones|hormones|mesh-ancestor
102137655|NCT03687515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102080267|NCT04774406|Fluzoparib|fluzoparib|mesh-list
102137656|NCT03687515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137657|NCT03687515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102137658|NCT03687515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102137659|NCT03687515|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102137660|NCT03687515|Autonomic Agents|autonomic agents|mesh-ancestor
102137661|NCT03687515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102137662|NCT03687515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102137663|NCT03687515|Respiratory System Agents|respiratory system agents|mesh-ancestor
102137664|NCT02691494|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102137665|NCT02691494|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102137666|NCT02691494|Norethindrone|norethindrone|mesh-list
101846648|NCT05734001|Hemostatics|hemostatics|mesh-list
102137667|NCT02691494|Norethindrone Acetate|norethindrone acetate|mesh-list
102137668|NCT02691494|Estradiol|estradiol|mesh-list
102137669|NCT02691494|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102137671|NCT02691494|Hormones|hormones|mesh-ancestor
102137672|NCT02691494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102137673|NCT02691494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137674|NCT02691494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102137675|NCT02691494|Contraceptive Agents|contraceptive agents|mesh-ancestor
102137676|NCT02691494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102137677|NCT02691494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102137678|NCT02691494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102137679|NCT02691494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102137680|NCT02691494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102137681|NCT02682602|Tacrine|tacrine|mesh-list
102137682|NCT02682602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102137683|NCT02682602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102137684|NCT02682602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137685|NCT02682602|Cholinergic Agents|cholinergic agents|mesh-ancestor
102137686|NCT02682602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102137687|NCT02682602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137688|NCT02682602|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102137689|NCT02682602|Autonomic Agents|autonomic agents|mesh-ancestor
102137690|NCT02682602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102137691|NCT02682602|Nootropic Agents|nootropic agents|mesh-ancestor
102137692|NCT03691337|Bupivacaine|bupivacaine|mesh-list
102137693|NCT03691337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102137694|NCT03691337|Anesthetics, Local|anesthetics, local|mesh-ancestor
102137695|NCT03691337|Anesthetics|anesthetics|mesh-ancestor
102137696|NCT03691337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102137697|NCT03691337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137698|NCT03691337|Sensory System Agents|sensory system agents|mesh-ancestor
102137699|NCT03691337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102137700|NCT02681510|Nicotine|nicotine|mesh-list
102137701|NCT02681510|Varenicline|varenicline|mesh-list
102137702|NCT02681510|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102137703|NCT02681510|Autonomic Agents|autonomic agents|mesh-ancestor
102137704|NCT02681510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102137705|NCT02681510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137706|NCT02681510|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102137707|NCT02681510|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102137708|NCT02681510|Cholinergic Agents|cholinergic agents|mesh-ancestor
102137709|NCT02681510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102137710|NCT02681510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137711|NCT03690323|Paclitaxel|paclitaxel|mesh-list
102137712|NCT03690323|Gemcitabine|gemcitabine|mesh-list
102137713|NCT03690323|Folfirinox|folfirinox|mesh-list
102137714|NCT03690323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102137715|NCT03690323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102137716|NCT03690323|Tubulin Modulators|tubulin modulators|mesh-ancestor
102137717|NCT03690323|Antimitotic Agents|antimitotic agents|mesh-ancestor
102137718|NCT03690323|Mitosis Modulators|mitosis modulators|mesh-ancestor
102137719|NCT03690323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137720|NCT03690323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102137721|NCT03690323|Antimetabolites|antimetabolites|mesh-ancestor
102137722|NCT03682211|Fentanyl|fentanyl|mesh-list
102137723|NCT03682211|Morphine|morphine|mesh-list
102137724|NCT03682211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102137725|NCT03682211|Narcotics|narcotics|mesh-ancestor
102137726|NCT03682211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102137727|NCT03682211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137728|NCT03682211|Analgesics|analgesics|mesh-ancestor
102137729|NCT03682211|Sensory System Agents|sensory system agents|mesh-ancestor
102137730|NCT03682211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102137731|NCT03682211|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102137732|NCT03682211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102137733|NCT03682211|Anesthetics, General|anesthetics, general|mesh-ancestor
102137735|NCT04132505|Hydroxychloroquine|hydroxychloroquine|mesh-list
102137736|NCT04132505|Antimalarials|antimalarials|mesh-ancestor
102137737|NCT04132505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102137738|NCT04132505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102137739|NCT04132505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102137740|NCT04132505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102137741|NCT04132505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846726|NCT01021358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102137742|NCT04132505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102137743|NCT02690714|Plasminogen|plasminogen|mesh-list
102137744|NCT02690714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102137745|NCT02690714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102137746|NCT02690714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137747|NCT03690167|Mitogens|mitogens|mesh-list
102137748|NCT03690167|Mitosis Modulators|mitosis modulators|mesh-ancestor
102137749|NCT03690167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137750|NCT03165890|Acetazolamide|acetazolamide|mesh-list
102137751|NCT03165890|Anticonvulsants|anticonvulsants|mesh-ancestor
102137752|NCT03165890|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102137753|NCT03165890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102137754|NCT03165890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137755|NCT03165890|Diuretics|diuretics|mesh-ancestor
102137756|NCT03165890|Natriuretic Agents|natriuretic agents|mesh-ancestor
102137757|NCT03165890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137758|NCT03681509|Pramipexole|pramipexole|mesh-list
102137759|NCT03681509|Antioxidants|antioxidants|mesh-ancestor
102137760|NCT03681509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137761|NCT03681509|Protective Agents|protective agents|mesh-ancestor
102137762|NCT03681509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137763|NCT03681509|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102137764|NCT03681509|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102137765|NCT03681509|Dopamine Agonists|dopamine agonists|mesh-ancestor
102137766|NCT03681509|Dopamine Agents|dopamine agents|mesh-ancestor
102137767|NCT03681509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102137768|NCT03686267|Lithium Carbonate|lithium carbonate|mesh-list
102137769|NCT03686267|Antidepressive Agents|antidepressive agents|mesh-ancestor
102137770|NCT03686267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102137771|NCT03686267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102137772|NCT03686267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137773|NCT03686267|Antimanic Agents|antimanic agents|mesh-ancestor
102137774|NCT03686267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102137775|NCT03686267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102137776|NCT03686267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137777|NCT03161210|Anesthetics|anesthetics|mesh-list
102137778|NCT03161210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102137779|NCT03161210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137780|NCT01898793|Aldesleukin|aldesleukin|mesh-list
102137781|NCT01898793|Cyclophosphamide|cyclophosphamide|mesh-list
102137782|NCT01898793|Fludarabine|fludarabine|mesh-list
102137783|NCT01898793|Fludarabine phosphate|fludarabine phosphate|mesh-list
102137784|NCT01898793|Interleukin-2|interleukin-2|mesh-list
102137785|NCT01898793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102137786|NCT01898793|Immunologic Factors|immunologic factors|mesh-ancestor
102137787|NCT01898793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137788|NCT01898793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102137789|NCT01898793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102137790|NCT01898793|Alkylating Agents|alkylating agents|mesh-ancestor
102137791|NCT01898793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137792|NCT01898793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102137793|NCT01898793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102137794|NCT01898793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102137795|NCT01898793|Antimetabolites|antimetabolites|mesh-ancestor
102137796|NCT01898793|Antiviral Agents|antiviral agents|mesh-ancestor
102137797|NCT01898793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102137798|NCT01898793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102137799|NCT01898793|Analgesics|analgesics|mesh-ancestor
102137800|NCT01898793|Sensory System Agents|sensory system agents|mesh-ancestor
102137801|NCT01898793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102137802|NCT01898793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102137803|NCT01898793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102137804|NCT03164096|Bupivacaine|bupivacaine|mesh-list
102137805|NCT03164096|Anesthetics, Local|anesthetics, local|mesh-ancestor
102137806|NCT03164096|Anesthetics|anesthetics|mesh-ancestor
102137807|NCT03164096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102137808|NCT03164096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137809|NCT03164096|Sensory System Agents|sensory system agents|mesh-ancestor
102137810|NCT03164096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102137812|NCT03164018|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102137813|NCT03164018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102137814|NCT03164018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137815|NCT03163784|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102137816|NCT03163784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102137817|NCT03163784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102137818|NCT03163784|Antitubercular Agents|antitubercular agents|mesh-ancestor
102137819|NCT03681431|Ceftriaxone|ceftriaxone|mesh-list
102137820|NCT03681431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102137821|NCT03681431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102137822|NCT03681197|Metformin|metformin|mesh-list
102137823|NCT03681197|Clomiphene|clomiphene|mesh-list
102137824|NCT03681197|Enclomiphene|enclomiphene|mesh-list
102137825|NCT03681197|Zuclomiphene|zuclomiphene|mesh-list
102137826|NCT03681197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102137827|NCT03681197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137828|NCT03681197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102137829|NCT03681197|Hormone Antagonists|hormone antagonists|mesh-ancestor
102137830|NCT03681197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102137831|NCT03681197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102137832|NCT03681197|Fertility Agents|fertility agents|mesh-ancestor
102137833|NCT03681197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101739841|NCT00719472|Glucocorticoids|glucocorticoids|mesh-ancestor
102137834|NCT03681197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102137835|NCT03681197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102137836|NCT03485703|Azithromycin|azithromycin|mesh-list
102137837|NCT03485703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102137838|NCT03485703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102137839|NCT03165344|Prednisone|prednisone|mesh-list
102137840|NCT03165344|Triamcinolone|triamcinolone|mesh-list
102137841|NCT03165344|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102137842|NCT03165344|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102137843|NCT03165344|Hydrocortisone|hydrocortisone|mesh-list
102137844|NCT03165344|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102137845|NCT03165344|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102137846|NCT03165344|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102137847|NCT03165344|Aluminum phosphate|aluminum phosphate|mesh-list
102137848|NCT03165344|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102137849|NCT03165344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102137850|NCT03165344|Glucocorticoids|glucocorticoids|mesh-ancestor
102137851|NCT03165344|Hormones|hormones|mesh-ancestor
102137852|NCT03165344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102137853|NCT03165344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137854|NCT03165344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102137855|NCT03165344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102137856|NCT03165344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102137857|NCT03165344|Immunologic Factors|immunologic factors|mesh-ancestor
102137858|NCT03165344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102137859|NCT03165344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137860|NCT03165344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102137861|NCT03165344|Antacids|antacids|mesh-ancestor
102137862|NCT03165344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102137863|NCT03487029|Oxymetazoline|oxymetazoline|mesh-list
102137864|NCT03487029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102137865|NCT03487029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102137866|NCT03487029|Adrenergic Agents|adrenergic agents|mesh-ancestor
102137867|NCT03487029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102137868|NCT03487029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137869|NCT03487029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137870|NCT03487029|Sympathomimetics|sympathomimetics|mesh-ancestor
102137871|NCT03487029|Autonomic Agents|autonomic agents|mesh-ancestor
102137872|NCT03487029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102137873|NCT03487029|Nasal Decongestants|nasal decongestants|mesh-ancestor
102137874|NCT03487029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102137875|NCT03487029|Respiratory System Agents|respiratory system agents|mesh-ancestor
102137876|NCT03689465|Cyclosporine|cyclosporine|mesh-list
102137877|NCT03689465|Mycophenolic Acid|mycophenolic acid|mesh-list
102137878|NCT03689465|Methotrexate|methotrexate|mesh-list
102137879|NCT03689465|Cyclosporins|cyclosporins|mesh-list
102137880|NCT03689465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102137881|NCT03689465|Abortifacient Agents|abortifacient agents|mesh-ancestor
102137882|NCT03689465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102137883|NCT03689465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137884|NCT03689465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102137885|NCT03689465|Antimetabolites|antimetabolites|mesh-ancestor
102137886|NCT03689465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137887|NCT03689465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102137888|NCT03689465|Dermatologic Agents|dermatologic agents|mesh-ancestor
102137889|NCT03689465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102137890|NCT03689465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102137891|NCT03689465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102137892|NCT03689465|Immunologic Factors|immunologic factors|mesh-ancestor
102137893|NCT03689465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102137894|NCT03689465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102137895|NCT03689465|Antifungal Agents|antifungal agents|mesh-ancestor
102137896|NCT03689465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102137897|NCT03689465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102137898|NCT03689465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102137899|NCT03689465|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102137900|NCT03689465|Antitubercular Agents|antitubercular agents|mesh-ancestor
102137901|NCT03689465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102137903|NCT03485625|Ketorolac|ketorolac|mesh-list
102137904|NCT03485625|Lidocaine|lidocaine|mesh-list
102137905|NCT03485625|Anesthetics, Local|anesthetics, local|mesh-ancestor
102137906|NCT03485625|Anesthetics|anesthetics|mesh-ancestor
102137907|NCT03485625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102137908|NCT03485625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137909|NCT03485625|Sensory System Agents|sensory system agents|mesh-ancestor
102137910|NCT03485625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102137911|NCT03485625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102137912|NCT03485625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102137913|NCT03485625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102137914|NCT03485625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102137915|NCT03485625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137916|NCT03485625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102137917|NCT03485625|Analgesics|analgesics|mesh-ancestor
102137918|NCT03485625|Antipyretics|antipyretics|mesh-ancestor
102137919|NCT03485625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102137920|NCT03485625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102137921|NCT03485625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102137922|NCT03485625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102137923|NCT03485625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102137924|NCT03680885|Lidocaine|lidocaine|mesh-list
102137925|NCT03680885|Anesthetics, Local|anesthetics, local|mesh-ancestor
102137926|NCT03680885|Anesthetics|anesthetics|mesh-ancestor
102137927|NCT03680885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102137928|NCT03680885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137929|NCT03680885|Sensory System Agents|sensory system agents|mesh-ancestor
102137930|NCT03680885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102137931|NCT03680885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102137932|NCT03680885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102137933|NCT03680885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102137934|NCT03680885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102137935|NCT03680885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137936|NCT03033069|Sertraline|sertraline|mesh-list
102137937|NCT03033069|Brexpiprazole|brexpiprazole|mesh-list
102137938|NCT03033069|Antidepressive Agents|antidepressive agents|mesh-ancestor
102137939|NCT03033069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102137940|NCT03033069|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102137941|NCT03033069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102137942|NCT03033069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102137943|NCT03033069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137944|NCT03033069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102137945|NCT03033069|Serotonin Agents|serotonin agents|mesh-ancestor
102137946|NCT03033069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137947|NCT03033069|Dopamine Agonists|dopamine agonists|mesh-ancestor
102137948|NCT03033069|Dopamine Agents|dopamine agents|mesh-ancestor
102137949|NCT03685409|Metformin|metformin|mesh-list
102137950|NCT03685409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102137951|NCT03685409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137952|NCT03165500|Midazolam|midazolam|mesh-list
102137953|NCT03165500|Diazepam|diazepam|mesh-list
102137954|NCT03165500|Nitrous Oxide|nitrous oxide|mesh-list
102535899|NCT02664909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102137955|NCT03165500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102137956|NCT03165500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102137957|NCT03165500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102137958|NCT03165500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137959|NCT03165500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102137960|NCT03165500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102137961|NCT03165500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102137962|NCT03165500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102137963|NCT03165500|Anesthetics, General|anesthetics, general|mesh-ancestor
102137964|NCT03165500|Anesthetics|anesthetics|mesh-ancestor
102137965|NCT03165500|GABA Modulators|gaba modulators|mesh-ancestor
102137966|NCT03165500|GABA Agents|gaba agents|mesh-ancestor
102137967|NCT03165500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102137968|NCT03165500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137969|NCT03165500|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102137970|NCT03165500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102137972|NCT03165500|Sensory System Agents|sensory system agents|mesh-ancestor
102137973|NCT03165500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102137974|NCT03165500|Anticonvulsants|anticonvulsants|mesh-ancestor
102137975|NCT03165500|Antiemetics|antiemetics|mesh-ancestor
102137976|NCT03165500|Autonomic Agents|autonomic agents|mesh-ancestor
102137977|NCT03165500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102137978|NCT03165500|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102137979|NCT03165500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102137980|NCT03163238|Dexmedetomidine|dexmedetomidine|mesh-list
102137981|NCT03163238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102137982|NCT03163238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102137983|NCT03163238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102137984|NCT03163238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102137985|NCT03163238|Analgesics|analgesics|mesh-ancestor
102137986|NCT03163238|Sensory System Agents|sensory system agents|mesh-ancestor
102137987|NCT03163238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102137988|NCT03163238|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102137989|NCT03163238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102137990|NCT03163238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102137991|NCT03163238|Adrenergic Agents|adrenergic agents|mesh-ancestor
102137992|NCT03163238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102137993|NCT03163238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137994|NCT03486561|Ranolazine|ranolazine|mesh-list
102137995|NCT03486561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102137996|NCT03486561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102137997|NCT03486561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102137998|NCT03680573|Allopurinol|allopurinol|mesh-list
102137999|NCT03680573|Nitroprusside|nitroprusside|mesh-list
102138000|NCT03680573|Nitroarginine|nitroarginine|mesh-list
102138001|NCT03680573|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
102138002|NCT03680573|Antimetabolites|antimetabolites|mesh-ancestor
102138003|NCT03680573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138004|NCT03680573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102138005|NCT03680573|Gout Suppressants|gout suppressants|mesh-ancestor
102138006|NCT03680573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102138007|NCT03680573|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102138008|NCT03680573|Antioxidants|antioxidants|mesh-ancestor
102138009|NCT03680573|Protective Agents|protective agents|mesh-ancestor
102138010|NCT03680573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138011|NCT03680573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102138012|NCT03680573|Vasodilator Agents|vasodilator agents|mesh-ancestor
102138013|NCT03680573|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102138014|NCT03689075|Tacrolimus|tacrolimus|mesh-list
102138015|NCT03689075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102138016|NCT03689075|Immunologic Factors|immunologic factors|mesh-ancestor
102138017|NCT03689075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138018|NCT03689075|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102138019|NCT03689075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102138020|NCT03689075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138021|NCT03680495|Methylprednisolone|methylprednisolone|mesh-list
102138022|NCT03680495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102138023|NCT03680495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102138024|NCT03680495|Prednisolone|prednisolone|mesh-list
102138025|NCT03680495|Prednisolone acetate|prednisolone acetate|mesh-list
102138026|NCT03680495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102138027|NCT03680495|Prednisolone phosphate|prednisolone phosphate|mesh-list
102138028|NCT03680495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102138029|NCT03680495|Antiemetics|antiemetics|mesh-ancestor
102138030|NCT03680495|Autonomic Agents|autonomic agents|mesh-ancestor
102138031|NCT03680495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102138032|NCT03680495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138033|NCT03680495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102138034|NCT03680495|Glucocorticoids|glucocorticoids|mesh-ancestor
102138035|NCT03680495|Hormones|hormones|mesh-ancestor
102138036|NCT03680495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102138037|NCT03680495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102138038|NCT03680495|Protective Agents|protective agents|mesh-ancestor
101740035|NCT04084158|Paclitaxel|paclitaxel|mesh-list
102138039|NCT03680495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102138040|NCT03680495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102138041|NCT03492255|Mycophenolic Acid|mycophenolic acid|mesh-list
102138042|NCT03492255|Prednisone|prednisone|mesh-list
102138043|NCT03492255|Methylprednisolone|methylprednisolone|mesh-list
102138044|NCT03492255|Cyclophosphamide|cyclophosphamide|mesh-list
102138045|NCT03492255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102138046|NCT03492255|Immunologic Factors|immunologic factors|mesh-ancestor
102138047|NCT03492255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138048|NCT03492255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102138049|NCT03492255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102138050|NCT03492255|Alkylating Agents|alkylating agents|mesh-ancestor
102138051|NCT03492255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138052|NCT03492255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102138053|NCT03492255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102138054|NCT03492255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102138055|NCT03492255|Glucocorticoids|glucocorticoids|mesh-ancestor
102138056|NCT03492255|Hormones|hormones|mesh-ancestor
102138057|NCT03492255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102138058|NCT03492255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102138059|NCT03492255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102138060|NCT03492255|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102138061|NCT03492255|Antitubercular Agents|antitubercular agents|mesh-ancestor
102138062|NCT03492255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102138063|NCT03492255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102138064|NCT03492255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102138065|NCT03492255|Antiemetics|antiemetics|mesh-ancestor
102138066|NCT03492255|Autonomic Agents|autonomic agents|mesh-ancestor
102138067|NCT03492255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102138068|NCT03492255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102138069|NCT03492255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102138070|NCT03492255|Protective Agents|protective agents|mesh-ancestor
102138071|NCT03684863|Capecitabine|capecitabine|mesh-list
102138072|NCT03684863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102138073|NCT03684863|Antimetabolites|antimetabolites|mesh-ancestor
102138074|NCT03684863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138075|NCT03684863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102138076|NCT03680339|Misoprostol|misoprostol|mesh-list
102138077|NCT03680339|Oxytocin|oxytocin|mesh-list
102138078|NCT03680339|Oxytocics|oxytocics|mesh-ancestor
102138079|NCT03680339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102138080|NCT03680339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138081|NCT03680339|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102138082|NCT03680339|Abortifacient Agents|abortifacient agents|mesh-ancestor
102138083|NCT03680339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102138084|NCT03680339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102138085|NCT03680183|Entecavir|entecavir|mesh-list
102138086|NCT03680183|Antiviral Agents|antiviral agents|mesh-ancestor
102138087|NCT03680183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102138088|NCT02136069|Infliximab|infliximab|mesh-list
102138089|NCT02136069|Etrolizumab|etrolizumab|mesh-list
102138090|NCT02136069|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102138091|NCT02136069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102138092|NCT02136069|Dermatologic Agents|dermatologic agents|mesh-ancestor
102138093|NCT02136069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102138094|NCT02136069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102138095|NCT02136069|Immunologic Factors|immunologic factors|mesh-ancestor
102138096|NCT02136069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138097|NCT02917031|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102138098|NCT02917031|Saxagliptin|saxagliptin|mesh-list
102138099|NCT02917031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102138100|NCT02917031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138101|NCT02917031|Incretins|incretins|mesh-ancestor
102138102|NCT02917031|Hormones|hormones|mesh-ancestor
102138103|NCT02917031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102138104|NCT02917031|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102138105|NCT02917031|Protease Inhibitors|protease inhibitors|mesh-ancestor
102138106|NCT02917031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102138107|NCT02917031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138108|NCT04460547|Interferons|interferons|mesh-list
102138109|NCT04460547|Interferon-beta|interferon-beta|mesh-list
102138110|NCT04460547|Interferon beta-1a|interferon beta-1a|mesh-list
102138111|NCT04460547|Hydroxychloroquine|hydroxychloroquine|mesh-list
102138112|NCT04460547|Ivermectin|ivermectin|mesh-list
102138113|NCT04460547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102138114|NCT04460547|Antiviral Agents|antiviral agents|mesh-ancestor
102138115|NCT04460547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102138116|NCT04460547|Antimalarials|antimalarials|mesh-ancestor
102138117|NCT04460547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102138118|NCT04460547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101847098|NCT01325415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102138119|NCT04460547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102138120|NCT04460547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138121|NCT04460547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102138122|NCT04460547|Immunologic Factors|immunologic factors|mesh-ancestor
102138123|NCT04460547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138124|NCT04460547|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102138125|NCT03132051|Triamcinolone|triamcinolone|mesh-list
102138126|NCT03132051|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102138127|NCT03132051|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102138128|NCT03132051|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102138129|NCT03132051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102138130|NCT03132051|Glucocorticoids|glucocorticoids|mesh-ancestor
102138131|NCT03132051|Hormones|hormones|mesh-ancestor
102138132|NCT03132051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102138133|NCT03132051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138134|NCT03132051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102138135|NCT03132051|Immunologic Factors|immunologic factors|mesh-ancestor
102138136|NCT03132051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102138137|NCT03132051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138138|NCT03684707|Metformin|metformin|mesh-list
102138139|NCT03684707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102138140|NCT03684707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138141|NCT01018563|Farletuzumab|farletuzumab|mesh-list
102138142|NCT01018563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102138143|NCT02528188|Tanezumab|tanezumab|mesh-list
102138144|NCT02528188|Analgesics|analgesics|mesh-ancestor
102138145|NCT02528188|Sensory System Agents|sensory system agents|mesh-ancestor
102138146|NCT02528188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102138147|NCT02528188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138148|NCT03684395|Warfarin|warfarin|mesh-list
102138149|NCT03684395|Rivaroxaban|rivaroxaban|mesh-list
102138150|NCT03684395|Dabigatran|dabigatran|mesh-list
102138151|NCT03684395|Apixaban|apixaban|mesh-list
102138152|NCT03684395|Anticoagulants|anticoagulants|mesh-ancestor
102138153|NCT03684395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102138154|NCT03684395|Antithrombins|antithrombins|mesh-ancestor
102138155|NCT03684395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102138156|NCT03684395|Protease Inhibitors|protease inhibitors|mesh-ancestor
102138157|NCT03684395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102138158|NCT03684395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138159|NCT04460001|Triamcinolone|triamcinolone|mesh-list
102138160|NCT04460001|Ranibizumab|ranibizumab|mesh-list
102138161|NCT04460001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102138162|NCT04460001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102138163|NCT04460001|Growth Substances|growth substances|mesh-ancestor
102138164|NCT04460001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138165|NCT04460001|Growth Inhibitors|growth inhibitors|mesh-ancestor
102138166|NCT04460001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102138167|NCT04460001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102138168|NCT04460001|Glucocorticoids|glucocorticoids|mesh-ancestor
102138169|NCT04460001|Hormones|hormones|mesh-ancestor
102138170|NCT04460001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102138171|NCT03484845|Ferrous fumarate|ferrous fumarate|mesh-list
102138172|NCT03484845|Lactoferrin|lactoferrin|mesh-list
102138173|NCT03484845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102138174|NCT03484845|Trace Elements|trace elements|mesh-ancestor
102138175|NCT03484845|Micronutrients|micronutrients|mesh-ancestor
102138176|NCT03484845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138177|NCT03679481|Tranexamic Acid|tranexamic acid|mesh-list
102138178|NCT03679481|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102138179|NCT03679481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102138180|NCT03679481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138181|NCT03679481|Hemostatics|hemostatics|mesh-ancestor
102138182|NCT03679481|Coagulants|coagulants|mesh-ancestor
102138183|NCT04461249|Travoprost|travoprost|mesh-list
102138184|NCT04461249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102138185|NCT04461249|Latanoprost|latanoprost|mesh-list
102138186|NCT04461249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102138187|NCT04461249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102138188|NCT05151549|Carboplatin|carboplatin|mesh-list
102138189|NCT05151549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102138190|NCT05151393|Vitamin D|vitamin d|mesh-list
102138191|NCT05151393|Cholecalciferol|cholecalciferol|mesh-list
102138192|NCT05151393|Vitamins|vitamins|mesh-ancestor
102138193|NCT05151393|Micronutrients|micronutrients|mesh-ancestor
102138194|NCT05151393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138195|NCT05151393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102138196|NCT05151393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102138197|NCT03484611|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102138198|NCT03484611|Cetrorelix|cetrorelix|mesh-list
102138199|NCT03484611|Menotropins|menotropins|mesh-list
102138201|NCT03484611|Progestins|progestins|mesh-ancestor
102138202|NCT03484611|Hormones|hormones|mesh-ancestor
102138203|NCT03484611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102138204|NCT03484611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138205|NCT03484611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102138206|NCT03484611|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102138207|NCT03484611|Fertility Agents|fertility agents|mesh-ancestor
102138208|NCT03484611|Hormone Antagonists|hormone antagonists|mesh-ancestor
102138209|NCT03679325|Vitamin D|vitamin d|mesh-list
102138210|NCT03679325|Vitamins|vitamins|mesh-ancestor
101740231|NCT04085562|Amlodipine|amlodipine|mesh-list
102138211|NCT03679325|Micronutrients|micronutrients|mesh-ancestor
102138212|NCT03679325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138213|NCT03679325|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102138214|NCT03878927|Gemtuzumab|gemtuzumab|mesh-list
102138215|NCT03878927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102138216|NCT03878927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102138217|NCT03878927|Immunotoxins|immunotoxins|mesh-ancestor
102138218|NCT03878927|Immunoconjugates|immunoconjugates|mesh-ancestor
102138219|NCT03878927|Immunologic Factors|immunologic factors|mesh-ancestor
102138220|NCT03878927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138221|NCT03623555|Hydrocortisone|hydrocortisone|mesh-list
102138222|NCT03623555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102138223|NCT03623711|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102138224|NCT03623711|Bupropion|bupropion|mesh-list
102138225|NCT03623711|Escitalopram|escitalopram|mesh-list
102138226|NCT03623711|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102138227|NCT03623711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102138228|NCT03623711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102138229|NCT03623711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138230|NCT03623711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102138231|NCT03623711|Serotonin Agents|serotonin agents|mesh-ancestor
102138232|NCT03623711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138233|NCT03623711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102138234|NCT03623711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102138235|NCT03623711|Antidepressive Agents|antidepressive agents|mesh-ancestor
102138236|NCT03623711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102138237|NCT03623711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102138238|NCT03623711|Dopamine Agents|dopamine agents|mesh-ancestor
102138239|NCT03623711|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102138240|NCT03623711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102138241|NCT03623711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102138242|NCT03623711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102138243|NCT03623711|Analgesics|analgesics|mesh-ancestor
102138244|NCT03623711|Sensory System Agents|sensory system agents|mesh-ancestor
102138245|NCT05368090|Epinephrine|epinephrine|mesh-list
102138246|NCT05368090|Racepinephrine|racepinephrine|mesh-list
102138247|NCT05368090|Epinephryl borate|epinephryl borate|mesh-list
102138248|NCT05368090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102138249|NCT05368090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102138250|NCT05368090|Adrenergic Agents|adrenergic agents|mesh-ancestor
102138251|NCT05368090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101740280|NCT00579345|Vaccines|vaccines|mesh-list
102138252|NCT05368090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138253|NCT05368090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138254|NCT05368090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102138255|NCT05368090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102138256|NCT05368090|Autonomic Agents|autonomic agents|mesh-ancestor
102138257|NCT05368090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102138258|NCT05368090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102138259|NCT05368090|Respiratory System Agents|respiratory system agents|mesh-ancestor
102138260|NCT05368090|Mydriatics|mydriatics|mesh-ancestor
102138261|NCT05368090|Sympathomimetics|sympathomimetics|mesh-ancestor
102138262|NCT05368090|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102138263|NCT05382442|Leucovorin|leucovorin|mesh-list
102138264|NCT05382442|Bevacizumab|bevacizumab|mesh-list
102138265|NCT05382442|Fluorouracil|fluorouracil|mesh-list
102138266|NCT05382442|Capecitabine|capecitabine|mesh-list
102138267|NCT05382442|Oxaliplatin|oxaliplatin|mesh-list
102138268|NCT05382442|Irinotecan|irinotecan|mesh-list
102138269|NCT05382442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102138270|NCT05382442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102138271|NCT05382442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102138272|NCT05382442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102138273|NCT05382442|Growth Substances|growth substances|mesh-ancestor
102138274|NCT05382442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138275|NCT05382442|Growth Inhibitors|growth inhibitors|mesh-ancestor
102138276|NCT05382442|Antimetabolites|antimetabolites|mesh-ancestor
102138277|NCT05382442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138278|NCT05382442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102138279|NCT05382442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102138280|NCT05382442|Immunologic Factors|immunologic factors|mesh-ancestor
102138281|NCT05382442|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102138282|NCT05382442|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102138283|NCT05382442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102138284|NCT05382442|Antidotes|antidotes|mesh-ancestor
102138285|NCT05382442|Protective Agents|protective agents|mesh-ancestor
102138286|NCT05382442|Vitamin B Complex|vitamin b complex|mesh-ancestor
102138288|NCT05382442|Micronutrients|micronutrients|mesh-ancestor
102138289|NCT05362474|Montelukast|montelukast|mesh-list
102138290|NCT05362474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102138291|NCT05362474|Respiratory System Agents|respiratory system agents|mesh-ancestor
102138292|NCT05362474|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102138293|NCT05362474|Hormone Antagonists|hormone antagonists|mesh-ancestor
102138294|NCT05362474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102138295|NCT05362474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138296|NCT05362474|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102138297|NCT05362474|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102138298|NCT05362474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138299|NCT05542342|Tislelizumab|tislelizumab|mesh-list
102138300|NCT05542342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102138301|NCT05542342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102138302|NCT05599516|Vaccines|vaccines|mesh-list
102138303|NCT05599516|Immunologic Factors|immunologic factors|mesh-ancestor
102138304|NCT05599516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138305|NCT05380024|Ensartinib|ensartinib|mesh-list
102138306|NCT05380024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102138307|NCT05380024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102138308|NCT05380024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102138309|NCT05380024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138310|NCT04251910|Dexmedetomidine|dexmedetomidine|mesh-list
102138311|NCT04251910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102138312|NCT04251910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102138313|NCT04251910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138314|NCT04251910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102138315|NCT04251910|Analgesics|analgesics|mesh-ancestor
102138316|NCT04251910|Sensory System Agents|sensory system agents|mesh-ancestor
102138317|NCT04251910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102138318|NCT04251910|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102138319|NCT04251910|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102138320|NCT04251910|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102138321|NCT04251910|Adrenergic Agents|adrenergic agents|mesh-ancestor
102138322|NCT04251910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102138323|NCT04251910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138324|NCT05342194|Gemcitabine|gemcitabine|mesh-list
102138325|NCT05342194|Oxaliplatin|oxaliplatin|mesh-list
102138326|NCT05342194|Lenvatinib|lenvatinib|mesh-list
102138327|NCT05342194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102138328|NCT05342194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102138329|NCT05342194|Antimetabolites|antimetabolites|mesh-ancestor
102138330|NCT05342194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138331|NCT05342194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102138332|NCT05342194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102138333|NCT03623789|Tranylcypromine|tranylcypromine|mesh-list
102138334|NCT03623789|Tranexamic Acid|tranexamic acid|mesh-list
102138335|NCT03623789|Hemostatics|hemostatics|mesh-list
102138336|NCT03623789|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102138337|NCT03623789|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102138338|NCT03623789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138339|NCT03623789|Coagulants|coagulants|mesh-ancestor
102138340|NCT03623789|Antidepressive Agents|antidepressive agents|mesh-ancestor
102138341|NCT03623789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102138342|NCT03623789|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102138343|NCT03623789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102138344|NCT03623789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102138345|NCT03623789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102138346|NCT03623789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102138347|NCT03623789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138348|NCT04247074|Botulinum Toxins|botulinum toxins|mesh-list
102138349|NCT04247074|Neurotransmitter Agents|neurotransmitter agents|mesh-list
102138350|NCT04247074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102138351|NCT04247074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102138352|NCT04247074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138353|NCT04247074|Cholinergic Agents|cholinergic agents|mesh-ancestor
102138354|NCT04247074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138356|NCT05306548|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102138357|NCT05306548|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102138358|NCT05306548|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102138359|NCT05306548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102138360|NCT05306548|Glucocorticoids|glucocorticoids|mesh-ancestor
102138361|NCT05306548|Hormones|hormones|mesh-ancestor
102138362|NCT05306548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102138363|NCT05306548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138364|NCT05306548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102138365|NCT05306548|Immunologic Factors|immunologic factors|mesh-ancestor
102138366|NCT05306548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102138367|NCT05306548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138368|NCT05306470|Lidocaine|lidocaine|mesh-list
102138369|NCT05306470|Ethyl Chloride|ethyl chloride|mesh-list
102138370|NCT05306470|Anesthetics, Local|anesthetics, local|mesh-ancestor
102138371|NCT05306470|Anesthetics|anesthetics|mesh-ancestor
102138372|NCT05306470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102138373|NCT05306470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138374|NCT05306470|Sensory System Agents|sensory system agents|mesh-ancestor
102138375|NCT05306470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102138376|NCT05306470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102138377|NCT05306470|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102138378|NCT05306470|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102138379|NCT05306470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102138380|NCT05306470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138381|NCT05340010|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102138382|NCT05340010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102138383|NCT05340010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138384|NCT05339386|Xenon|xenon|mesh-list
102138385|NCT05339386|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102138386|NCT05339386|Anesthetics, General|anesthetics, general|mesh-ancestor
102138387|NCT05339386|Anesthetics|anesthetics|mesh-ancestor
102138388|NCT05339386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102138389|NCT05339386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138390|NCT05339074|Ketamine|ketamine|mesh-list
102138391|NCT05339074|Analgesics|analgesics|mesh-ancestor
102138392|NCT05339074|Sensory System Agents|sensory system agents|mesh-ancestor
102138393|NCT05339074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102138394|NCT05339074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740388|NCT02589288|Anesthetics|anesthetics|mesh-ancestor
102138395|NCT05339074|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102138396|NCT05339074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102138397|NCT05339074|Anesthetics, General|anesthetics, general|mesh-ancestor
102138398|NCT05339074|Anesthetics|anesthetics|mesh-ancestor
102138399|NCT05339074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102138400|NCT05339074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102138401|NCT05339074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102138402|NCT05339074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102138403|NCT05339074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138404|NCT05560282|Fenfluramine|fenfluramine|mesh-list
102138405|NCT05560282|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102138406|NCT05560282|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102138407|NCT05560282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102138408|NCT05560282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138409|NCT05560282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102138410|NCT05560282|Serotonin Agents|serotonin agents|mesh-ancestor
102138411|NCT05560282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138412|NCT05338450|Clemastine|clemastine|mesh-list
102138413|NCT05338450|Antipruritics|antipruritics|mesh-ancestor
102138414|NCT05338450|Dermatologic Agents|dermatologic agents|mesh-ancestor
102138415|NCT05338450|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102138416|NCT05338450|Histamine Antagonists|histamine antagonists|mesh-ancestor
102138417|NCT05338450|Histamine Agents|histamine agents|mesh-ancestor
102138418|NCT05338450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102138419|NCT05338450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138420|NCT05338450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847408|NCT01064115|Cetirizine|cetirizine|mesh-list
102138421|NCT05338450|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102138422|NCT03677297|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102138423|NCT03677297|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102138424|NCT03677297|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102138425|NCT03677297|Antimetabolites|antimetabolites|mesh-ancestor
102138426|NCT03677297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138427|NCT03677297|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102138428|NCT03677297|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102138429|NCT03677297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102138430|NCT03676985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102138431|NCT03676985|Antibodies|antibodies|mesh-list
102138432|NCT03676985|Immunoglobulins|immunoglobulins|mesh-list
102138433|NCT03676985|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102138434|NCT03676985|Immunologic Factors|immunologic factors|mesh-ancestor
102138435|NCT03676985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138436|NCT03676985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102138437|NCT05348824|Sodium Hypochlorite|sodium hypochlorite|mesh-list
102138439|NCT05348824|Disinfectants|disinfectants|mesh-ancestor
102138440|NCT05348824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102138441|NCT02988401|Insulin|insulin|mesh-list
102138442|NCT02988401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102138443|NCT02988401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138444|NCT05266456|Vaccines|vaccines|mesh-list
102138445|NCT05266456|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102138446|NCT05266456|Immunologic Factors|immunologic factors|mesh-ancestor
102138447|NCT05266456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138448|NCT02269917|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
102138449|NCT02269917|Protease Inhibitors|protease inhibitors|mesh-list
102138450|NCT02269917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102138451|NCT02269917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138452|NCT02269917|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102138453|NCT02269917|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102138454|NCT02269917|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102138455|NCT02269917|Antiviral Agents|antiviral agents|mesh-ancestor
102138456|NCT02269917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102138457|NCT05293288|Anesthetics|anesthetics|mesh-list
102138458|NCT05293288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102138459|NCT05293288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138460|NCT03484221|Fluorouracil|fluorouracil|mesh-list
102138461|NCT03484221|Capecitabine|capecitabine|mesh-list
102138462|NCT03484221|Oxaliplatin|oxaliplatin|mesh-list
102138463|NCT03484221|Irinotecan|irinotecan|mesh-list
102138464|NCT03484221|Antimetabolites|antimetabolites|mesh-ancestor
102138465|NCT03484221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138466|NCT03484221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102138467|NCT03484221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102138468|NCT03484221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102138469|NCT03484221|Immunologic Factors|immunologic factors|mesh-ancestor
102138470|NCT03484221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138471|NCT03484221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102138472|NCT03484221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102138473|NCT03484221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102138474|NCT03857139|Nicotine|nicotine|mesh-list
102138475|NCT03857139|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102138476|NCT03857139|Autonomic Agents|autonomic agents|mesh-ancestor
102138477|NCT03857139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102138478|NCT03857139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138479|NCT03857139|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102138480|NCT03857139|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102138481|NCT03857139|Cholinergic Agents|cholinergic agents|mesh-ancestor
102138482|NCT03857139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102138483|NCT03857139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138484|NCT01658020|Moxifloxacin|moxifloxacin|mesh-list
102138485|NCT01658020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102138486|NCT01658020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102138487|NCT01658020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102138488|NCT01658020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102138489|NCT01658020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102138490|NCT01658020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138491|NCT01658020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102138492|NCT05255770|Benzocaine|benzocaine|mesh-list
102138493|NCT05255770|Anesthetics, Local|anesthetics, local|mesh-ancestor
102138494|NCT05255770|Anesthetics|anesthetics|mesh-ancestor
101847472|NCT00420342|Diuretics|diuretics|mesh-ancestor
102138495|NCT05255770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102138496|NCT05255770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138497|NCT05255770|Sensory System Agents|sensory system agents|mesh-ancestor
102138498|NCT05255770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102138499|NCT05322538|Vitamin D|vitamin d|mesh-list
102138500|NCT05322538|Ergocalciferols|ergocalciferols|mesh-list
102138501|NCT05322538|Cholecalciferol|cholecalciferol|mesh-list
102138502|NCT05322538|Vitamins|vitamins|mesh-list
102138503|NCT05322538|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
102138504|NCT05322538|Micronutrients|micronutrients|mesh-ancestor
102138505|NCT05322538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138506|NCT05322538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102138507|NCT05322538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102138508|NCT04965220|Trametinib|trametinib|mesh-list
102138509|NCT04965220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102138510|NCT04965220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102138511|NCT04965220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102138512|NCT04965220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138513|NCT05322070|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
102138514|NCT05322070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102138515|NCT05322070|Glucocorticoids|glucocorticoids|mesh-ancestor
102138516|NCT05322070|Hormones|hormones|mesh-ancestor
102138517|NCT05322070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102138518|NCT05322070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138519|NCT03483753|Vasopressins|vasopressins|mesh-list
102138520|NCT03483753|Arginine Vasopressin|arginine vasopressin|mesh-list
102138521|NCT03483753|Norepinephrine|norepinephrine|mesh-list
102138522|NCT03483753|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101740526|NCT00720135|Antibodies|antibodies|mesh-list
102138523|NCT03483753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102138524|NCT03483753|Adrenergic Agents|adrenergic agents|mesh-ancestor
102138525|NCT03483753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102138526|NCT03483753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138527|NCT03483753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138528|NCT03483753|Sympathomimetics|sympathomimetics|mesh-ancestor
102138529|NCT03483753|Autonomic Agents|autonomic agents|mesh-ancestor
102138530|NCT03483753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102138531|NCT03483753|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102138532|NCT03483753|Hemostatics|hemostatics|mesh-ancestor
102138533|NCT03483753|Coagulants|coagulants|mesh-ancestor
102138534|NCT03483753|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102138535|NCT03483753|Natriuretic Agents|natriuretic agents|mesh-ancestor
102138536|NCT03389477|Cisplatin|cisplatin|mesh-list
102138537|NCT03389477|Cetuximab|cetuximab|mesh-list
102138538|NCT03389477|Palbociclib|palbociclib|mesh-list
102138539|NCT03389477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102138540|NCT03389477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102138541|NCT03389477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102138542|NCT03389477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102138543|NCT03389477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138544|NCT02680574|Darbepoetin alfa|darbepoetin alfa|mesh-list
102138545|NCT02680574|Hematinics|hematinics|mesh-ancestor
102138546|NCT03672149|Cefazolin|cefazolin|mesh-list
102138547|NCT03672149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102138548|NCT03672149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102138549|NCT03672071|Ephedrine|ephedrine|mesh-list
102138550|NCT03672071|Pseudoephedrine|pseudoephedrine|mesh-list
102138551|NCT03672071|Norepinephrine|norepinephrine|mesh-list
102138552|NCT03672071|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102138553|NCT03672071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138554|NCT03672071|Sympathomimetics|sympathomimetics|mesh-ancestor
102138555|NCT03672071|Autonomic Agents|autonomic agents|mesh-ancestor
102138556|NCT03672071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102138557|NCT03672071|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102138558|NCT03672071|Adrenergic Agents|adrenergic agents|mesh-ancestor
102138559|NCT03672071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102138560|NCT03672071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138561|NCT03672071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102138562|NCT03672071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102138563|NCT03672071|Respiratory System Agents|respiratory system agents|mesh-ancestor
102138564|NCT03672071|Nasal Decongestants|nasal decongestants|mesh-ancestor
102138565|NCT03672071|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102138566|NCT03672071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102138567|NCT03480945|Nitroprusside|nitroprusside|mesh-list
102138568|NCT03480945|Serotonin|serotonin|mesh-list
102138569|NCT03480945|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102138570|NCT03480945|Serotonin Agents|serotonin agents|mesh-ancestor
102138571|NCT03480945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102138572|NCT03480945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138580|NCT03483207|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102138581|NCT03483207|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102138582|NCT03483207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138583|NCT05132985|Carboplatin|carboplatin|mesh-list
102138584|NCT05132985|Pemetrexed|pemetrexed|mesh-list
102138585|NCT05132985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102138586|NCT05132985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102138587|NCT05132985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138588|NCT05132985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102138589|NCT05132985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102138590|NCT03739593|Dexamethasone|dexamethasone|mesh-list
102138591|NCT03739593|Dexamethasone acetate|dexamethasone acetate|mesh-list
102138592|NCT03739593|BB 1101|bb 1101|mesh-list
102138593|NCT03739593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102138594|NCT03739593|Antiemetics|antiemetics|mesh-ancestor
102138595|NCT03739593|Autonomic Agents|autonomic agents|mesh-ancestor
102138596|NCT03739593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102138597|NCT03739593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138598|NCT03739593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102138599|NCT03739593|Glucocorticoids|glucocorticoids|mesh-ancestor
102138600|NCT03739593|Hormones|hormones|mesh-ancestor
102138601|NCT03739593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102138602|NCT03739593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102138603|NCT03739593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102138604|NCT03739593|Protease Inhibitors|protease inhibitors|mesh-ancestor
102138605|NCT03739593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102138606|NCT03739593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138607|NCT03480867|Temozolomide|temozolomide|mesh-list
102138608|NCT03480867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102138609|NCT03480867|Alkylating Agents|alkylating agents|mesh-ancestor
102138610|NCT03480867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138611|NCT03480867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102138612|NCT05254912|Sunscreening Agents|sunscreening agents|mesh-list
102138613|NCT05254912|Petrolatum|petrolatum|mesh-list
102138614|NCT05254912|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102138615|NCT05254912|Protective Agents|protective agents|mesh-ancestor
102138616|NCT05254912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138617|NCT05254912|Dermatologic Agents|dermatologic agents|mesh-ancestor
102138618|NCT05254912|Emollients|emollients|mesh-ancestor
102138619|NCT03480789|Dexmedetomidine|dexmedetomidine|mesh-list
102138620|NCT03480789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102138621|NCT03480789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102138622|NCT03480789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138623|NCT03480789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102138624|NCT03480789|Analgesics|analgesics|mesh-ancestor
102138625|NCT03480789|Sensory System Agents|sensory system agents|mesh-ancestor
102138626|NCT03480789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102138627|NCT03480789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102138628|NCT03480789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102138629|NCT03480789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102138630|NCT03480789|Adrenergic Agents|adrenergic agents|mesh-ancestor
102138631|NCT03480789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102138632|NCT03480789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138640|NCT03475407|Dexamethasone|dexamethasone|mesh-list
102138641|NCT03475407|Dexamethasone acetate|dexamethasone acetate|mesh-list
102138642|NCT03475407|BB 1101|bb 1101|mesh-list
102138643|NCT03475407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102138644|NCT03475407|Antiemetics|antiemetics|mesh-ancestor
102138645|NCT03475407|Autonomic Agents|autonomic agents|mesh-ancestor
102138646|NCT03475407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102138647|NCT03475407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138648|NCT03475407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102138649|NCT03475407|Glucocorticoids|glucocorticoids|mesh-ancestor
102138650|NCT03475407|Hormones|hormones|mesh-ancestor
102138651|NCT03475407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102612371|NCT02973581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102138652|NCT03475407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102138653|NCT03475407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102138654|NCT03475407|Protease Inhibitors|protease inhibitors|mesh-ancestor
102138655|NCT03475407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102138656|NCT03475407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138657|NCT03655197|Doxycycline|doxycycline|mesh-list
102138658|NCT03655197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102138659|NCT03655197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102138660|NCT03655197|Antimalarials|antimalarials|mesh-ancestor
102138661|NCT03655197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102138662|NCT03655197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102138663|NCT05317624|Methylprednisolone|methylprednisolone|mesh-list
102138664|NCT05317624|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102138665|NCT05317624|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102138666|NCT05317624|Prednisolone|prednisolone|mesh-list
102138667|NCT05317624|Prednisolone acetate|prednisolone acetate|mesh-list
102138668|NCT05317624|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102138669|NCT05317624|Prednisolone phosphate|prednisolone phosphate|mesh-list
102138670|NCT05317624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102138671|NCT05317624|Antiemetics|antiemetics|mesh-ancestor
102138672|NCT05317624|Autonomic Agents|autonomic agents|mesh-ancestor
102138673|NCT05317624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102138674|NCT05317624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138675|NCT05317624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102138676|NCT05317624|Glucocorticoids|glucocorticoids|mesh-ancestor
102138677|NCT05317624|Hormones|hormones|mesh-ancestor
102138678|NCT05317624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102138679|NCT05317624|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102138680|NCT05317624|Protective Agents|protective agents|mesh-ancestor
102138681|NCT05317624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102138682|NCT05317624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102138683|NCT03475017|Curcumin|curcumin|mesh-list
102138684|NCT03475017|Piperine|piperine|mesh-list
102138685|NCT03475017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102138686|NCT03475017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102138687|NCT03475017|Analgesics|analgesics|mesh-ancestor
102138688|NCT03475017|Sensory System Agents|sensory system agents|mesh-ancestor
102138689|NCT03475017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102138690|NCT03475017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138691|NCT03475017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102138692|NCT03475017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102138693|NCT03475017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102138694|NCT03475017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102138695|NCT03475017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138696|NCT03475017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102138697|NCT02674568|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
102138698|NCT02674568|Immunoconjugates|immunoconjugates|mesh-ancestor
102138699|NCT02674568|Immunologic Factors|immunologic factors|mesh-ancestor
102138700|NCT02674568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138701|NCT03474939|Midazolam|midazolam|mesh-list
102138702|NCT03474939|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102138703|NCT03474939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102138704|NCT03474939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102138705|NCT03474939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138706|NCT03474939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102138707|NCT03474939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102138708|NCT03474939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102138709|NCT03474939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102138710|NCT03474939|Anesthetics, General|anesthetics, general|mesh-ancestor
102138711|NCT03474939|Anesthetics|anesthetics|mesh-ancestor
102138712|NCT03474939|GABA Modulators|gaba modulators|mesh-ancestor
102138713|NCT03474939|GABA Agents|gaba agents|mesh-ancestor
102138714|NCT03474939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102138715|NCT03474939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138716|NCT03131583|Colchicine|colchicine|mesh-list
102138717|NCT03131583|Febuxostat|febuxostat|mesh-list
102138718|NCT03131583|Gout Suppressants|gout suppressants|mesh-ancestor
102138719|NCT03131583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102138720|NCT03131583|Tubulin Modulators|tubulin modulators|mesh-ancestor
102138721|NCT03131583|Antimitotic Agents|antimitotic agents|mesh-ancestor
102138722|NCT03131583|Mitosis Modulators|mitosis modulators|mesh-ancestor
102138723|NCT03131583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138724|NCT03131583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102138725|NCT04672928|Paclitaxel|paclitaxel|mesh-list
102138726|NCT04672928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102138727|NCT04672928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102138728|NCT04672928|Tubulin Modulators|tubulin modulators|mesh-ancestor
102138729|NCT04672928|Antimitotic Agents|antimitotic agents|mesh-ancestor
102138730|NCT04672928|Mitosis Modulators|mitosis modulators|mesh-ancestor
102138731|NCT04672928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138733|NCT03480321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102138734|NCT03480321|Autonomic Agents|autonomic agents|mesh-ancestor
102138735|NCT03480321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102138736|NCT03480321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138737|NCT03480321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102138738|NCT03480321|Respiratory System Agents|respiratory system agents|mesh-ancestor
102138739|NCT03480321|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102138740|NCT03480321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102138741|NCT03480321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740738|NCT00711789|Protease Inhibitors|protease inhibitors|mesh-ancestor
102138742|NCT03480321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102138743|NCT03480321|Vasodilator Agents|vasodilator agents|mesh-ancestor
102138744|NCT03480321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102138745|NCT03480321|Protective Agents|protective agents|mesh-ancestor
102138746|NCT03480321|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102138747|NCT03480321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102138748|NCT03480321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102138749|NCT04928950|Charcoal|charcoal|mesh-list
102138750|NCT04928950|Antidotes|antidotes|mesh-ancestor
102138751|NCT04928950|Protective Agents|protective agents|mesh-ancestor
102138752|NCT04928950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138753|NCT02986269|Anesthetics|anesthetics|mesh-list
102138754|NCT02986269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102138755|NCT02986269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138756|NCT05313256|Lidocaine|lidocaine|mesh-list
102138757|NCT05313256|Epinephrine|epinephrine|mesh-list
102138758|NCT05313256|Racepinephrine|racepinephrine|mesh-list
102138759|NCT05313256|Epinephryl borate|epinephryl borate|mesh-list
102138760|NCT05313256|Anesthetics, Local|anesthetics, local|mesh-ancestor
102138761|NCT05313256|Anesthetics|anesthetics|mesh-ancestor
102138762|NCT05313256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102138763|NCT05313256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138764|NCT05313256|Sensory System Agents|sensory system agents|mesh-ancestor
102138765|NCT05313256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102138766|NCT05313256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102138767|NCT05313256|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102138768|NCT05313256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102138769|NCT05313256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102138770|NCT05313256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138771|NCT05313256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102138772|NCT05313256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102138773|NCT05313256|Adrenergic Agents|adrenergic agents|mesh-ancestor
102138774|NCT05313256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102138775|NCT05313256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102138776|NCT05313256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102138777|NCT05313256|Autonomic Agents|autonomic agents|mesh-ancestor
102138778|NCT05313256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102138779|NCT05313256|Respiratory System Agents|respiratory system agents|mesh-ancestor
102138780|NCT05313256|Mydriatics|mydriatics|mesh-ancestor
102138781|NCT05313256|Sympathomimetics|sympathomimetics|mesh-ancestor
102138782|NCT05313256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102138783|NCT03474237|Hormones|hormones|mesh-list
102138784|NCT03474237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102138785|NCT03474237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138786|NCT03480165|Parecoxib|parecoxib|mesh-list
102138787|NCT03480165|Ropivacaine|ropivacaine|mesh-list
102138788|NCT03480165|Anesthetics, Local|anesthetics, local|mesh-ancestor
102138789|NCT03480165|Anesthetics|anesthetics|mesh-ancestor
102138790|NCT03480165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102138791|NCT03480165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138792|NCT03480165|Sensory System Agents|sensory system agents|mesh-ancestor
102138793|NCT03480165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102138794|NCT03480165|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102138795|NCT03480165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102138796|NCT03480165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102138797|NCT03480165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138798|NCT03480165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102138799|NCT03480165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102138800|NCT03480165|Analgesics|analgesics|mesh-ancestor
102138801|NCT03480165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102138803|NCT05311852|Palmidrol|palmidrol|mesh-list
102138804|NCT05311852|Antioxidants|antioxidants|mesh-list
102138805|NCT05311852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138806|NCT05311852|Protective Agents|protective agents|mesh-ancestor
102138807|NCT05311852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138808|NCT05311852|Analgesics|analgesics|mesh-ancestor
102138809|NCT05311852|Sensory System Agents|sensory system agents|mesh-ancestor
102138810|NCT05311852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102138811|NCT05311852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102138812|NCT05311852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102138813|NCT05311852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102138814|NCT05311852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102138815|NCT05311852|Antiviral Agents|antiviral agents|mesh-ancestor
102138816|NCT05311852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102138817|NCT05311852|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102138818|NCT05311852|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102138819|NCT05311852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102138820|NCT05311852|Hormones|hormones|mesh-ancestor
102138821|NCT05311852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102138822|NCT01373918|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102138823|NCT01373918|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102138824|NCT01373918|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102138825|NCT01373918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102138826|NCT03671915|Insulin|insulin|mesh-list
102138827|NCT03671915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102138828|NCT03671915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138829|NCT03302195|Heparin|heparin|mesh-list
102138830|NCT03302195|Anticoagulants|anticoagulants|mesh-ancestor
102138831|NCT03302195|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102138832|NCT03302195|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102138833|NCT03302195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138834|NCT02515773|Metformin|metformin|mesh-list
102138835|NCT02515773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102138836|NCT02515773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138837|NCT03114020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102138838|NCT03114020|Hyaluronic Acid|hyaluronic acid|mesh-list
102138839|NCT03114020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102138840|NCT03114020|Immunologic Factors|immunologic factors|mesh-ancestor
102138841|NCT03114020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138842|NCT03114020|Viscosupplements|viscosupplements|mesh-ancestor
102138843|NCT03114020|Protective Agents|protective agents|mesh-ancestor
102138844|NCT04460079|Lenograstim|lenograstim|mesh-list
102138845|NCT04460079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102138846|NCT04460079|Immunologic Factors|immunologic factors|mesh-ancestor
102138847|NCT04460079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138848|NCT03473691|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
102138849|NCT03473691|Immunoconjugates|immunoconjugates|mesh-ancestor
102138850|NCT03473691|Immunologic Factors|immunologic factors|mesh-ancestor
102138851|NCT03473691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138852|NCT03473691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102138853|NCT03473691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102138854|NCT03676361|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
102138855|NCT03676361|Hemostatics|hemostatics|mesh-ancestor
102138856|NCT03676361|Coagulants|coagulants|mesh-ancestor
102138857|NCT03676361|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102138858|NCT03676361|Natriuretic Agents|natriuretic agents|mesh-ancestor
102138859|NCT03676361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138860|NCT01712763|Goserelin|goserelin|mesh-list
102138861|NCT01712763|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102138862|NCT01712763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102138863|NCT01712763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102138864|NCT01712763|Luteolytic Agents|luteolytic agents|mesh-ancestor
102138865|NCT01712763|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102138866|NCT01712763|Contraceptive Agents|contraceptive agents|mesh-ancestor
102138867|NCT01712763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102138868|NCT01712763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138869|NCT01712763|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102138870|NCT05218486|Isotretinoin|isotretinoin|mesh-list
102138871|NCT05218486|Dermatologic Agents|dermatologic agents|mesh-ancestor
102138872|NCT05216770|Bupivacaine|bupivacaine|mesh-list
102138873|NCT05216770|Anesthetics, Local|anesthetics, local|mesh-ancestor
101847861|NCT00430638|Olmesartan|olmesartan|mesh-list
102138874|NCT05216770|Anesthetics|anesthetics|mesh-ancestor
102138875|NCT05216770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102081472|NCT02305160|Beractant|beractant|mesh-list
102138876|NCT05216770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138877|NCT05216770|Sensory System Agents|sensory system agents|mesh-ancestor
102138878|NCT05216770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102138879|NCT05236036|Mycophenolic Acid|mycophenolic acid|mesh-list
102138880|NCT05236036|Temozolomide|temozolomide|mesh-list
102138881|NCT05236036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102138882|NCT05236036|Alkylating Agents|alkylating agents|mesh-ancestor
102138883|NCT05236036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138884|NCT05236036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102138885|NCT05236036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102138886|NCT05236036|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102138887|NCT05236036|Antitubercular Agents|antitubercular agents|mesh-ancestor
102138888|NCT05236036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102138889|NCT05236036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102138890|NCT05236036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102138891|NCT02781779|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102138892|NCT02781779|Laxatives|laxatives|mesh-ancestor
102138893|NCT02781779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102138894|NCT05270200|Azacitidine|azacitidine|mesh-list
102138895|NCT05270200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102138896|NCT05270200|Antimetabolites|antimetabolites|mesh-ancestor
102138897|NCT05270200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138898|NCT05270200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102138899|NCT05270200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102138900|NCT04953104|Nivolumab|nivolumab|mesh-list
102138901|NCT04953104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102138902|NCT04953104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102138903|NCT04953104|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102138904|NCT04953104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138905|NCT03671057|Midazolam|midazolam|mesh-list
102138906|NCT03671057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102138907|NCT03671057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102138908|NCT03671057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102138909|NCT03671057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138910|NCT03671057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102138911|NCT03671057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102138912|NCT03671057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102138913|NCT03671057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102138914|NCT03671057|Anesthetics, General|anesthetics, general|mesh-ancestor
102138915|NCT03671057|Anesthetics|anesthetics|mesh-ancestor
102138916|NCT03671057|GABA Modulators|gaba modulators|mesh-ancestor
102138917|NCT03671057|GABA Agents|gaba agents|mesh-ancestor
102138918|NCT03671057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102138919|NCT03671057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138920|NCT03670901|Rituximab|rituximab|mesh-list
102138921|NCT03670901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102138922|NCT03670901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102138923|NCT03670901|Immunologic Factors|immunologic factors|mesh-ancestor
102138924|NCT03670901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138925|NCT03670901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102138926|NCT05166616|Osimertinib|osimertinib|mesh-list
102138927|NCT05166616|Triptolide|triptolide|mesh-list
102138928|NCT05166616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102138929|NCT05166616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102138930|NCT05166616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102138931|NCT05166616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138932|NCT05166616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102138933|NCT05166616|Alkylating Agents|alkylating agents|mesh-ancestor
102138934|NCT05166616|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
102138935|NCT05166616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138936|NCT05166616|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102138937|NCT05166616|Contraceptive Agents|contraceptive agents|mesh-ancestor
102138938|NCT05166616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102138939|NCT05166616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102138940|NCT05166616|Immunologic Factors|immunologic factors|mesh-ancestor
102138941|NCT05213728|Vaccines|vaccines|mesh-list
102138942|NCT05213728|Immunologic Factors|immunologic factors|mesh-ancestor
102138943|NCT05213728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138944|NCT05165836|Dexmedetomidine|dexmedetomidine|mesh-list
102138945|NCT05165836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102138946|NCT05165836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102138947|NCT05165836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138948|NCT05165836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102138949|NCT05165836|Analgesics|analgesics|mesh-ancestor
102138950|NCT05165836|Sensory System Agents|sensory system agents|mesh-ancestor
102138951|NCT05165836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102138952|NCT05165836|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102138953|NCT05165836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102138954|NCT05165836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102138955|NCT05165836|Adrenergic Agents|adrenergic agents|mesh-ancestor
102138956|NCT05165836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102138957|NCT05165836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138958|NCT04238416|Lactulose|lactulose|mesh-list
102138959|NCT04238416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102138960|NCT05162014|Empagliflozin|empagliflozin|mesh-list
102138961|NCT05162014|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102138962|NCT05162014|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102138963|NCT05162014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102138964|NCT05162014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138965|NCT05226754|Diacerein|diacerein|mesh-list
102138966|NCT05226754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102138967|NCT01657162|Alendronate|alendronate|mesh-list
102138968|NCT01657162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102138969|NCT01657162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138970|NCT05209906|Fentanyl|fentanyl|mesh-list
102138971|NCT05209906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102138972|NCT05209906|Narcotics|narcotics|mesh-ancestor
102138973|NCT05209906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102138974|NCT05209906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138975|NCT05209906|Analgesics|analgesics|mesh-ancestor
102138976|NCT05209906|Sensory System Agents|sensory system agents|mesh-ancestor
102138977|NCT05209906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102138978|NCT05209906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102138979|NCT05209906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102138980|NCT05209906|Anesthetics, General|anesthetics, general|mesh-ancestor
102138981|NCT05209906|Anesthetics|anesthetics|mesh-ancestor
102138982|NCT04422184|Potassium Citrate|potassium citrate|mesh-list
102138983|NCT04422184|Diuretics|diuretics|mesh-ancestor
102138984|NCT04422184|Natriuretic Agents|natriuretic agents|mesh-ancestor
102138985|NCT04422184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138986|NCT04422184|Expectorants|expectorants|mesh-ancestor
102138987|NCT04422184|Respiratory System Agents|respiratory system agents|mesh-ancestor
102138988|NCT05633810|Aspirin|aspirin|mesh-list
102138989|NCT05633810|Colchicine|colchicine|mesh-list
102138990|NCT05633810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102138991|NCT05633810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102138992|NCT05633810|Analgesics|analgesics|mesh-ancestor
102138993|NCT05633810|Sensory System Agents|sensory system agents|mesh-ancestor
102138994|NCT05633810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102138995|NCT05633810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102138996|NCT05633810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102138997|NCT05633810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102138998|NCT05633810|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102138999|NCT05633810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102139000|NCT05633810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139001|NCT05633810|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102139002|NCT05633810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102139003|NCT05633810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102139004|NCT05633810|Antipyretics|antipyretics|mesh-ancestor
102139005|NCT05633810|Gout Suppressants|gout suppressants|mesh-ancestor
102139006|NCT05633810|Tubulin Modulators|tubulin modulators|mesh-ancestor
102139007|NCT05633810|Antimitotic Agents|antimitotic agents|mesh-ancestor
102139008|NCT05633810|Mitosis Modulators|mitosis modulators|mesh-ancestor
102139009|NCT05633810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102139010|NCT05203822|Itraconazole|itraconazole|mesh-list
102139011|NCT05203822|Tepotinib|tepotinib|mesh-list
102139012|NCT05203822|Antifungal Agents|antifungal agents|mesh-ancestor
102139013|NCT05203822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102139014|NCT05203822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102139015|NCT05203822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102139016|NCT05203822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102139017|NCT05203822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139018|NCT05203822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102139019|NCT05203822|Hormone Antagonists|hormone antagonists|mesh-ancestor
102139020|NCT05203822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102139021|NCT05203822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139022|NCT05203822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101847991|NCT00428844|Oxacillin|oxacillin|mesh-list
102139023|NCT05203822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102612372|NCT02973581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102139024|NCT01373294|Lenalidomide|lenalidomide|mesh-list
102139025|NCT01373294|BCG Vaccine|bcg vaccine|mesh-list
102139026|NCT01373294|Immunologic Factors|immunologic factors|mesh-ancestor
102139027|NCT01373294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139028|NCT01373294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102139029|NCT01373294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102139030|NCT01373294|Growth Substances|growth substances|mesh-ancestor
102139031|NCT01373294|Growth Inhibitors|growth inhibitors|mesh-ancestor
102139032|NCT01373294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102139033|NCT01373294|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102139034|NCT05220358|Fostemsavir|fostemsavir|mesh-list
102139035|NCT05220358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102139036|NCT05220358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102139037|NCT05220358|Antiviral Agents|antiviral agents|mesh-ancestor
102139038|NCT05220358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102139039|NCT05220358|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102139040|NCT05220358|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102139041|NCT05220358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139042|NCT04422028|Desogestrel|desogestrel|mesh-list
102139043|NCT04422028|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102139044|NCT04422028|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102139045|NCT04422028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102139046|NCT04422028|Contraceptive Agents|contraceptive agents|mesh-ancestor
102139047|NCT04422028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102139048|NCT04422028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139049|NCT04422028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102139050|NCT04422028|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102139051|NCT04422028|Progestins|progestins|mesh-ancestor
102139052|NCT04422028|Hormones|hormones|mesh-ancestor
102139053|NCT04422028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102139054|NCT01656304|Bevacizumab|bevacizumab|mesh-list
102139055|NCT01656304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102139056|NCT01656304|Antibodies|antibodies|mesh-list
102139057|NCT01656304|Immunoglobulins|immunoglobulins|mesh-list
102139058|NCT01656304|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102139059|NCT01656304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102139060|NCT01656304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102139061|NCT01656304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102139062|NCT01656304|Growth Substances|growth substances|mesh-ancestor
102139063|NCT01656304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139064|NCT01656304|Growth Inhibitors|growth inhibitors|mesh-ancestor
102139065|NCT01656304|Immunologic Factors|immunologic factors|mesh-ancestor
102139066|NCT04421872|Anesthetics|anesthetics|mesh-list
102139067|NCT04421872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102139068|NCT04421872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139069|NCT04227028|Bevacizumab|bevacizumab|mesh-list
102139070|NCT04227028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102139071|NCT04227028|Endothelial Growth Factors|endothelial growth factors|mesh-list
102139072|NCT04227028|Antibodies|antibodies|mesh-list
102139073|NCT04227028|Immunoglobulins|immunoglobulins|mesh-list
102139074|NCT04227028|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102139075|NCT04227028|Immunoglobulin G|immunoglobulin g|mesh-list
102139076|NCT04227028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102139077|NCT04227028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102139078|NCT04227028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102139079|NCT04227028|Growth Substances|growth substances|mesh-ancestor
102139080|NCT04227028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139081|NCT04227028|Growth Inhibitors|growth inhibitors|mesh-ancestor
102139082|NCT04227028|Immunologic Factors|immunologic factors|mesh-ancestor
102139083|NCT03023423|Atezolizumab|atezolizumab|mesh-list
102139084|NCT03023423|Daratumumab|daratumumab|mesh-list
102139085|NCT03023423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102139086|NCT03023423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139087|NCT03023423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102139088|NCT03023423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102139089|NCT03675191|Orlistat|orlistat|mesh-list
102139090|NCT03675191|Phentermine|phentermine|mesh-list
102139091|NCT03675191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102139092|NCT03675191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139093|NCT03675191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102139094|NCT03675191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102139095|NCT03675191|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102139096|NCT03675191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139097|NCT03675191|Appetite Depressants|appetite depressants|mesh-ancestor
102139098|NCT03675191|Sympathomimetics|sympathomimetics|mesh-ancestor
102139099|NCT03675191|Autonomic Agents|autonomic agents|mesh-ancestor
102139100|NCT03675191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102139101|NCT03675191|Adrenergic Agents|adrenergic agents|mesh-ancestor
102139102|NCT03675191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102139103|NCT03198689|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102139104|NCT03198689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102139105|NCT03198689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102139106|NCT03198689|Immunotoxins|immunotoxins|mesh-ancestor
102139107|NCT03198689|Immunoconjugates|immunoconjugates|mesh-ancestor
102139108|NCT03198689|Immunologic Factors|immunologic factors|mesh-ancestor
102139109|NCT03198689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139110|NCT02635061|Nivolumab|nivolumab|mesh-list
102139111|NCT02635061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102139112|NCT02635061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102139113|NCT02635061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102139114|NCT02635061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139115|NCT05096728|Nifedipine|nifedipine|mesh-list
102139116|NCT05096728|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102139117|NCT05096728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102139118|NCT05096728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139119|NCT05096728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102139120|NCT05096728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139121|NCT05096728|Vasodilator Agents|vasodilator agents|mesh-ancestor
102139122|NCT05096728|Tocolytic Agents|tocolytic agents|mesh-ancestor
102139123|NCT05096728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102139124|NCT04421716|Ursolic acid|ursolic acid|mesh-list
102139125|NCT04421716|Curcumin|curcumin|mesh-list
102139126|NCT04421716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102139127|NCT04421716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102139128|NCT04421716|Analgesics|analgesics|mesh-ancestor
102139129|NCT04421716|Sensory System Agents|sensory system agents|mesh-ancestor
102139130|NCT04421716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102139131|NCT04421716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139132|NCT04421716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102139133|NCT04421716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102139134|NCT04421716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102139135|NCT04421716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102139136|NCT04421716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139137|NCT04421716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102139138|NCT04421716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102139139|NCT04421716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102139140|NCT05184868|Insulin Aspart|insulin aspart|mesh-list
102139141|NCT05184868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102139142|NCT05184868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139143|NCT04226950|Interferons|interferons|mesh-list
102139144|NCT04226950|Interferon-alpha|interferon-alpha|mesh-list
102139145|NCT04226950|Interferon alpha-2|interferon alpha-2|mesh-list
102139146|NCT04226950|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102139147|NCT04226950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102139148|NCT04226950|Antiviral Agents|antiviral agents|mesh-ancestor
102139149|NCT04226950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102139150|NCT04226950|Immunologic Factors|immunologic factors|mesh-ancestor
102139151|NCT04226950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139152|NCT05085574|Celecoxib|celecoxib|mesh-list
102139153|NCT05085574|Famotidine|famotidine|mesh-list
102139154|NCT05085574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102139155|NCT05085574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102139156|NCT05085574|Analgesics|analgesics|mesh-ancestor
102139157|NCT05085574|Sensory System Agents|sensory system agents|mesh-ancestor
102139158|NCT05085574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102139159|NCT05085574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139160|NCT05085574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102139161|NCT05085574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102139162|NCT05085574|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102139163|NCT05085574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102139164|NCT05085574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102139165|NCT05085574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139166|NCT05085574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102139167|NCT05085574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102139168|NCT05085574|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102139169|NCT05085574|Histamine Antagonists|histamine antagonists|mesh-ancestor
102139170|NCT05085574|Histamine Agents|histamine agents|mesh-ancestor
102139171|NCT05085574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102139172|NCT05085340|Pyrimethamine|pyrimethamine|mesh-list
101848144|NCT01039740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102139173|NCT05085340|Sulfadoxine|sulfadoxine|mesh-list
102139174|NCT05085340|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
102139175|NCT05085340|Antimalarials|antimalarials|mesh-ancestor
102139176|NCT05085340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102139177|NCT05085340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102139178|NCT05085340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102139179|NCT05085340|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102139180|NCT05085340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102139181|NCT05085340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139182|NCT05085340|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102139183|NCT02667236|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102139184|NCT01126749|Gemcitabine|gemcitabine|mesh-list
102139185|NCT01126749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102139186|NCT01126749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102139187|NCT01126749|Antimetabolites|antimetabolites|mesh-ancestor
102139188|NCT01126749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139189|NCT03674411|Mycophenolic Acid|mycophenolic acid|mesh-list
102139190|NCT03674411|Cyclophosphamide|cyclophosphamide|mesh-list
102139191|NCT03674411|Melphalan|melphalan|mesh-list
102139192|NCT03674411|Busulfan|busulfan|mesh-list
102139193|NCT03674411|Fludarabine|fludarabine|mesh-list
102139194|NCT03674411|Tacrolimus|tacrolimus|mesh-list
102139195|NCT03674411|Lenograstim|lenograstim|mesh-list
102139196|NCT03674411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102139197|NCT03674411|Immunologic Factors|immunologic factors|mesh-ancestor
102139198|NCT03674411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139199|NCT03674411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102139200|NCT03674411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102139201|NCT03674411|Alkylating Agents|alkylating agents|mesh-ancestor
102139202|NCT03674411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139203|NCT03674411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102139204|NCT03674411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102139205|NCT03674411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102139206|NCT03674411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102139207|NCT03674411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102139208|NCT03674411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102139209|NCT03674411|Antitubercular Agents|antitubercular agents|mesh-ancestor
102139210|NCT03674411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102139211|NCT03674411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102139212|NCT03674411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102139213|NCT03674333|Folic Acid|folic acid|mesh-list
102139214|NCT03674333|Hematinics|hematinics|mesh-ancestor
102139215|NCT03674333|Vitamin B Complex|vitamin b complex|mesh-ancestor
102139216|NCT03674333|Vitamins|vitamins|mesh-ancestor
102139217|NCT03674333|Micronutrients|micronutrients|mesh-ancestor
102139218|NCT03674333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139219|NCT03674099|Methylprednisolone|methylprednisolone|mesh-list
102139220|NCT03674099|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102139221|NCT03674099|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102139222|NCT03674099|Prednisolone|prednisolone|mesh-list
102139223|NCT03674099|Prednisolone acetate|prednisolone acetate|mesh-list
102139224|NCT03674099|Imatinib Mesylate|imatinib mesylate|mesh-list
102139225|NCT03674099|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102139226|NCT03674099|Prednisolone phosphate|prednisolone phosphate|mesh-list
102139227|NCT03674099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102139228|NCT03674099|Antiemetics|antiemetics|mesh-ancestor
102139229|NCT03674099|Autonomic Agents|autonomic agents|mesh-ancestor
102139230|NCT03674099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102139231|NCT03674099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139232|NCT03674099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102139233|NCT03674099|Glucocorticoids|glucocorticoids|mesh-ancestor
102139234|NCT03674099|Hormones|hormones|mesh-ancestor
102139235|NCT03674099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102139236|NCT03674099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102139237|NCT03674099|Protective Agents|protective agents|mesh-ancestor
102139238|NCT03674099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102139239|NCT03674099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102139240|NCT03674099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102139241|NCT03674099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102139242|NCT03674099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139243|NCT05124340|Vaccines|vaccines|mesh-list
102139244|NCT05124340|Immunologic Factors|immunologic factors|mesh-ancestor
102139245|NCT05124340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139246|NCT05084404|Guanabenz|guanabenz|mesh-list
102139247|NCT05084404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101848221|NCT01030016|Atenolol|atenolol|mesh-list
102139248|NCT05084404|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102139249|NCT05084404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102139251|NCT05084404|Adrenergic Agents|adrenergic agents|mesh-ancestor
102139252|NCT05084404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102139253|NCT05084404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139254|NCT05084404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139255|NCT03473613|Calcium, Dietary|calcium, dietary|mesh-list
102139256|NCT03473613|Cabergoline|cabergoline|mesh-list
102139257|NCT03473613|Calcium|calcium|mesh-list
102139258|NCT03473613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102139259|NCT03473613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139260|NCT03473613|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102139261|NCT03473613|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102139262|NCT03473613|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102139263|NCT03473613|Dopamine Agonists|dopamine agonists|mesh-ancestor
102139264|NCT03473613|Dopamine Agents|dopamine agents|mesh-ancestor
102139265|NCT03473613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102139266|NCT03473613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139267|NCT03670043|Metformin|metformin|mesh-list
102139268|NCT03670043|Psyllium|psyllium|mesh-list
102139269|NCT03670043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102139270|NCT03670043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139271|NCT03670043|Cathartics|cathartics|mesh-ancestor
102139272|NCT03670043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102139273|NCT05561660|Aspirin|aspirin|mesh-list
102139274|NCT05561660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102139275|NCT05561660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102139276|NCT05561660|Analgesics|analgesics|mesh-ancestor
102139277|NCT05561660|Sensory System Agents|sensory system agents|mesh-ancestor
102139278|NCT05561660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102139279|NCT05561660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139280|NCT05561660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102139281|NCT05561660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102139282|NCT05561660|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102139283|NCT05561660|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102139284|NCT05561660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139285|NCT05561660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102139286|NCT05561660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102139287|NCT05561660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102139288|NCT05561660|Antipyretics|antipyretics|mesh-ancestor
102139289|NCT03042819|Doxorubicin|doxorubicin|mesh-list
102139290|NCT03042819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102139291|NCT03042819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102139292|NCT03042819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102139293|NCT03042819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102139294|NCT03042819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102139295|NCT03042819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139296|NCT02832687|Acetaminophen|acetaminophen|mesh-list
102139297|NCT02832687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102139298|NCT02832687|Analgesics|analgesics|mesh-ancestor
102139299|NCT02832687|Sensory System Agents|sensory system agents|mesh-ancestor
102139300|NCT02832687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102139301|NCT02832687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139302|NCT02832687|Antipyretics|antipyretics|mesh-ancestor
102139303|NCT04372017|Vitamin D|vitamin d|mesh-list
102139304|NCT04372017|Hydroxychloroquine|hydroxychloroquine|mesh-list
102139305|NCT04372017|Vitamins|vitamins|mesh-ancestor
102139306|NCT04372017|Micronutrients|micronutrients|mesh-ancestor
102139307|NCT04372017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139308|NCT04372017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102139309|NCT04372017|Antimalarials|antimalarials|mesh-ancestor
102139310|NCT04372017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102139311|NCT04372017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102139312|NCT04372017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102139313|NCT04372017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102139314|NCT04372017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139315|NCT04372017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102139316|NCT05233358|Pembrolizumab|pembrolizumab|mesh-list
102139317|NCT05233358|Nivolumab|nivolumab|mesh-list
102139318|NCT05233358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102139319|NCT05233358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102139320|NCT05233358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102139321|NCT05233358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139322|NCT02387918|Dexamethasone|dexamethasone|mesh-list
102139323|NCT02387918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102139324|NCT02387918|Antiemetics|antiemetics|mesh-ancestor
102139326|NCT02387918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102139327|NCT02387918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139328|NCT02387918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102139329|NCT02387918|Glucocorticoids|glucocorticoids|mesh-ancestor
102139330|NCT02387918|Hormones|hormones|mesh-ancestor
102139331|NCT02387918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102139332|NCT02387918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102139333|NCT02387918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102139334|NCT04312971|Norepinephrine|norepinephrine|mesh-list
102139335|NCT04312971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102139336|NCT04312971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102139337|NCT04312971|Adrenergic Agents|adrenergic agents|mesh-ancestor
102139338|NCT04312971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102139339|NCT04312971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139340|NCT04312971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139341|NCT04312971|Sympathomimetics|sympathomimetics|mesh-ancestor
102139342|NCT04312971|Autonomic Agents|autonomic agents|mesh-ancestor
102139343|NCT04312971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102139344|NCT04312971|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102139345|NCT05231330|Fluorides|fluorides|mesh-list
102139346|NCT05231330|Cariostatic Agents|cariostatic agents|mesh-ancestor
102139347|NCT05231330|Protective Agents|protective agents|mesh-ancestor
102139348|NCT05231330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139349|NCT03179475|Oxycodone|oxycodone|mesh-list
102139350|NCT03179475|Naloxone|naloxone|mesh-list
102139351|NCT03179475|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102139352|NCT03179475|Narcotics|narcotics|mesh-ancestor
102139353|NCT03179475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102139354|NCT03179475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139355|NCT03179475|Analgesics|analgesics|mesh-ancestor
102139356|NCT03179475|Sensory System Agents|sensory system agents|mesh-ancestor
102139357|NCT03179475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102139358|NCT03179475|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102139359|NCT03105986|Probenecid|probenecid|mesh-list
102139360|NCT03105986|Uricosuric Agents|uricosuric agents|mesh-ancestor
102139361|NCT03105986|Gout Suppressants|gout suppressants|mesh-ancestor
102139362|NCT03105986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102139363|NCT03132129|Manganese|manganese|mesh-list
102139364|NCT03132129|Calcium|calcium|mesh-list
102139365|NCT03132129|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102139366|NCT03132129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139367|NCT03132129|Trace Elements|trace elements|mesh-ancestor
102139368|NCT03132129|Micronutrients|micronutrients|mesh-ancestor
102139369|NCT02391662|Paclitaxel|paclitaxel|mesh-list
102139370|NCT02391662|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102139371|NCT02391662|Gemcitabine|gemcitabine|mesh-list
102139372|NCT02391662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102139373|NCT02391662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102139374|NCT02391662|Tubulin Modulators|tubulin modulators|mesh-ancestor
102139375|NCT02391662|Antimitotic Agents|antimitotic agents|mesh-ancestor
102139376|NCT02391662|Mitosis Modulators|mitosis modulators|mesh-ancestor
102139377|NCT02391662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139378|NCT02391662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102139379|NCT02391662|Antimetabolites|antimetabolites|mesh-ancestor
102139380|NCT05076604|Cardioplegic Solutions|cardioplegic solutions|mesh-list
102139381|NCT05076604|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102139382|NCT05258955|Chlorhexidine|chlorhexidine|mesh-list
102139383|NCT05258955|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102139384|NCT05258955|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102139385|NCT05258955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102139386|NCT05258955|Disinfectants|disinfectants|mesh-ancestor
102139387|NCT05258955|Dermatologic Agents|dermatologic agents|mesh-ancestor
102139388|NCT05173324|Vaccines|vaccines|mesh-list
102139389|NCT05173324|Immunologic Factors|immunologic factors|mesh-ancestor
102139390|NCT05173324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139391|NCT04223518|Immunoglobulins|immunoglobulins|mesh-list
102139392|NCT04223518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102139393|NCT04223518|Antibodies|antibodies|mesh-list
102139394|NCT04223518|Immunologic Factors|immunologic factors|mesh-ancestor
102139395|NCT04223518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139396|NCT02387450|Sildenafil Citrate|sildenafil citrate|mesh-list
102139397|NCT02387450|Vasodilator Agents|vasodilator agents|mesh-ancestor
102139398|NCT02387450|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102139399|NCT02387450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102139400|NCT02387450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102154332|NCT03365817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102139401|NCT02387450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139402|NCT02387450|Urological Agents|urological agents|mesh-ancestor
102139404|NCT02390882|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102139405|NCT02390882|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102139406|NCT02390882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102139407|NCT02390882|Adrenergic Agents|adrenergic agents|mesh-ancestor
102139408|NCT02390882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102139409|NCT02390882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139410|NCT02390882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139411|NCT02390882|Urological Agents|urological agents|mesh-ancestor
102139412|NCT02387138|Oxaliplatin|oxaliplatin|mesh-list
102139413|NCT02387138|Irinotecan|irinotecan|mesh-list
102139414|NCT02387138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102139415|NCT02387138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102139416|NCT02387138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102139417|NCT02387138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102139418|NCT02387138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139419|NCT02387060|Fentanyl|fentanyl|mesh-list
102139420|NCT02387060|Bupivacaine|bupivacaine|mesh-list
102139421|NCT02387060|Anesthetics, Local|anesthetics, local|mesh-ancestor
102139422|NCT02387060|Anesthetics|anesthetics|mesh-ancestor
102139423|NCT02387060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102139424|NCT02387060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139425|NCT02387060|Sensory System Agents|sensory system agents|mesh-ancestor
102139426|NCT02387060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102139427|NCT02387060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102139428|NCT02387060|Narcotics|narcotics|mesh-ancestor
102139429|NCT02387060|Analgesics|analgesics|mesh-ancestor
102139430|NCT02387060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102139431|NCT02387060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102139432|NCT02387060|Anesthetics, General|anesthetics, general|mesh-ancestor
102139433|NCT01365052|Naproxen|naproxen|mesh-list
102139434|NCT01365052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102139435|NCT01365052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102139436|NCT01365052|Analgesics|analgesics|mesh-ancestor
102139437|NCT01365052|Sensory System Agents|sensory system agents|mesh-ancestor
102139438|NCT01365052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102139439|NCT01365052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139440|NCT01365052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102139441|NCT01365052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102139442|NCT01365052|Gout Suppressants|gout suppressants|mesh-ancestor
102139443|NCT01365052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102139444|NCT01365052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102139445|NCT01365052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139446|NCT05155215|Cyclophosphamide|cyclophosphamide|mesh-list
102139447|NCT05155215|Fludarabine|fludarabine|mesh-list
102139448|NCT05155215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102139449|NCT05155215|Immunologic Factors|immunologic factors|mesh-ancestor
102139450|NCT05155215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139451|NCT05155215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102139452|NCT05155215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102139453|NCT05155215|Alkylating Agents|alkylating agents|mesh-ancestor
102139454|NCT05155215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139455|NCT05155215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102139456|NCT05155215|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102139457|NCT03471585|Dronabinol|dronabinol|mesh-list
102139458|NCT03471585|Hallucinogens|hallucinogens|mesh-ancestor
102139459|NCT03471585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139460|NCT03471585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102139461|NCT03471585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102139462|NCT03471585|Analgesics|analgesics|mesh-ancestor
102139463|NCT03471585|Sensory System Agents|sensory system agents|mesh-ancestor
102139464|NCT03471585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102139465|NCT03471585|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102139466|NCT03471585|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102139467|NCT03471585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102139468|NCT03471585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139469|NCT03471585|Hormones|hormones|mesh-ancestor
102139470|NCT03471585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102139471|NCT05072782|Infliximab|infliximab|mesh-list
102139472|NCT05072782|Methotrexate|methotrexate|mesh-list
102139473|NCT05072782|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102139474|NCT05072782|Abortifacient Agents|abortifacient agents|mesh-ancestor
102139476|NCT05072782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139478|NCT05072782|Antimetabolites|antimetabolites|mesh-ancestor
102139479|NCT05072782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139480|NCT05072782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102139481|NCT05072782|Dermatologic Agents|dermatologic agents|mesh-ancestor
102139482|NCT05072782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102139483|NCT05072782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102139484|NCT05072782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102139485|NCT05072782|Immunologic Factors|immunologic factors|mesh-ancestor
102139486|NCT05072782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102139487|NCT05072782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102139488|NCT05072782|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102139489|NCT05072782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102139490|NCT05072782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102139491|NCT03379389|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102139492|NCT03379389|Methenamine hippurate|methenamine hippurate|mesh-list
102139493|NCT03379389|Methenamine mandelate|methenamine mandelate|mesh-list
102139494|NCT03379389|Methenamine|methenamine|mesh-list
102139495|NCT03379389|Acriflavine|acriflavine|mesh-list
102139496|NCT03379389|Methylene Blue|methylene blue|mesh-list
102139497|NCT03379389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102139498|NCT03379389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102139499|NCT03379389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139500|NCT03379389|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102139501|NCT03379389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102139502|NCT05170438|Paclitaxel|paclitaxel|mesh-list
102139503|NCT05170438|Lenvatinib|lenvatinib|mesh-list
102139504|NCT05170438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102139505|NCT05170438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102139506|NCT05170438|Tubulin Modulators|tubulin modulators|mesh-ancestor
102139507|NCT05170438|Antimitotic Agents|antimitotic agents|mesh-ancestor
102139508|NCT05170438|Mitosis Modulators|mitosis modulators|mesh-ancestor
102139509|NCT05170438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139510|NCT05170438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102139511|NCT05170438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102139512|NCT05109520|Insulin Glargine|insulin glargine|mesh-list
102139513|NCT05109520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102139514|NCT05109520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139515|NCT03478605|Dexamethasone|dexamethasone|mesh-list
102139516|NCT03478605|Ondansetron|ondansetron|mesh-list
102139517|NCT03478605|Olanzapine|olanzapine|mesh-list
102139518|NCT03478605|Aprepitant|aprepitant|mesh-list
102139519|NCT03478605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102139520|NCT03478605|Antiemetics|antiemetics|mesh-ancestor
102139521|NCT03478605|Autonomic Agents|autonomic agents|mesh-ancestor
102139522|NCT03478605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102139523|NCT03478605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139524|NCT03478605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102139525|NCT03478605|Glucocorticoids|glucocorticoids|mesh-ancestor
102139526|NCT03478605|Hormones|hormones|mesh-ancestor
102139527|NCT03478605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102139528|NCT03478605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102139529|NCT03478605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102139530|NCT03478605|Antipruritics|antipruritics|mesh-ancestor
102139531|NCT03478605|Dermatologic Agents|dermatologic agents|mesh-ancestor
102139532|NCT03478605|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102139533|NCT03478605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102139534|NCT03478605|Serotonin Agents|serotonin agents|mesh-ancestor
102139535|NCT03478605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102139536|NCT03478605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139537|NCT03478605|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101741529|NCT04620291|Antiviral Agents|antiviral agents|mesh-ancestor
102139538|NCT03478605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102139539|NCT03478605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102139540|NCT03478605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102139541|NCT03478605|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102139542|NCT03478605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102139543|NCT03478605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102139544|NCT03478605|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102139545|NCT05109364|Terazosin|terazosin|mesh-list
102139546|NCT05109364|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102139547|NCT05109364|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102139548|NCT05109364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102139549|NCT05109364|Adrenergic Agents|adrenergic agents|mesh-ancestor
102139550|NCT05109364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102139551|NCT05109364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139552|NCT05109364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139553|NCT05109364|Urological Agents|urological agents|mesh-ancestor
102139554|NCT05258799|Cytarabine|cytarabine|mesh-list
102139555|NCT05258799|Decitabine|decitabine|mesh-list
102139556|NCT05258799|Aclarubicin|aclarubicin|mesh-list
102139557|NCT05258799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102139558|NCT05258799|Antimetabolites|antimetabolites|mesh-ancestor
102139559|NCT05258799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139560|NCT05258799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102139561|NCT05258799|Antiviral Agents|antiviral agents|mesh-ancestor
102139562|NCT05258799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102139563|NCT05258799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102139564|NCT05258799|Immunologic Factors|immunologic factors|mesh-ancestor
102139565|NCT05258799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139566|NCT05258799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102139567|NCT05258799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102139568|NCT05258799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102139569|NCT05258799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102139570|NCT05053750|Paclitaxel|paclitaxel|mesh-list
102139571|NCT05053750|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102139572|NCT05053750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102139573|NCT05053750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102139574|NCT05053750|Tubulin Modulators|tubulin modulators|mesh-ancestor
102139575|NCT05053750|Antimitotic Agents|antimitotic agents|mesh-ancestor
102139576|NCT05053750|Mitosis Modulators|mitosis modulators|mesh-ancestor
102139577|NCT05053750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139578|NCT04233892|Estrogens|estrogens|mesh-list
102139579|NCT04233892|Hormones|hormones|mesh-ancestor
102139580|NCT04233892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102139581|NCT04233892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139582|NCT02386358|Benzonidazole|benzonidazole|mesh-list
102139583|NCT02386358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102139584|NCT02386358|Immunologic Factors|immunologic factors|mesh-ancestor
102139585|NCT02386358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139586|NCT02386358|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102139587|NCT02386358|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102139588|NCT02386358|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102139589|NCT02386358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102139590|NCT03283371|Natalizumab|natalizumab|mesh-list
102139591|NCT03283371|Immunologic Factors|immunologic factors|mesh-ancestor
102139592|NCT03283371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139593|NCT05069350|Bupivacaine|bupivacaine|mesh-list
102139594|NCT05069350|Anesthetics, Local|anesthetics, local|mesh-ancestor
102139595|NCT05069350|Anesthetics|anesthetics|mesh-ancestor
102139596|NCT05069350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102139597|NCT05069350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139598|NCT05069350|Sensory System Agents|sensory system agents|mesh-ancestor
102139599|NCT05069350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102139600|NCT03471351|Pembrolizumab|pembrolizumab|mesh-list
102139601|NCT03471351|Tenalisib|tenalisib|mesh-list
102139602|NCT03471351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102139603|NCT03471351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101741598|NCT04110275|Plasminogen|plasminogen|mesh-list
102139604|NCT03471351|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102139605|NCT03471351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139606|NCT03471351|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
102139607|NCT03471351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102139608|NCT02386592|Chlorhexidine|chlorhexidine|mesh-list
102139609|NCT02386592|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102139610|NCT02386592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102139611|NCT02386592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102139612|NCT02386592|Disinfectants|disinfectants|mesh-ancestor
102139613|NCT02386592|Dermatologic Agents|dermatologic agents|mesh-ancestor
102139614|NCT02390258|S66913|s66913|mesh-list
102139615|NCT02390258|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102139616|NCT02390258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102139617|NCT02390258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139618|NCT03891446|Bimatoprost|bimatoprost|mesh-list
102139619|NCT03891446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102139620|NCT03059511|Nalbuphine|nalbuphine|mesh-list
102139621|NCT03059511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102139622|NCT03059511|Narcotics|narcotics|mesh-ancestor
102139623|NCT03059511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102139624|NCT03059511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139625|NCT03059511|Analgesics|analgesics|mesh-ancestor
102139626|NCT03059511|Sensory System Agents|sensory system agents|mesh-ancestor
102139627|NCT03059511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102139628|NCT04439786|Lidocaine|lidocaine|mesh-list
102139629|NCT04439786|Anesthetics, Local|anesthetics, local|mesh-ancestor
102139630|NCT04439786|Anesthetics|anesthetics|mesh-ancestor
102139631|NCT04439786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102139632|NCT04439786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139633|NCT04439786|Sensory System Agents|sensory system agents|mesh-ancestor
102139634|NCT04439786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102139635|NCT04439786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102139636|NCT04439786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102139637|NCT04439786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102139638|NCT04439786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102139639|NCT04439786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139640|NCT02665286|Naproxen|naproxen|mesh-list
102139641|NCT02665286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
102139642|NCT02665286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102139643|NCT02665286|Orphenadrine|orphenadrine|mesh-list
102139644|NCT02665286|Methocarbamol|methocarbamol|mesh-list
102139645|NCT02665286|Cholinergic Antagonists|cholinergic antagonists|mesh-list
102139646|NCT02665286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102139647|NCT02665286|Analgesics|analgesics|mesh-ancestor
102139648|NCT02665286|Sensory System Agents|sensory system agents|mesh-ancestor
102139649|NCT02665286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102139650|NCT02665286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139651|NCT02665286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102139652|NCT02665286|Gout Suppressants|gout suppressants|mesh-ancestor
102139653|NCT02665286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102139654|NCT02665286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102139655|NCT02665286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139656|NCT02665286|Cholinergic Agents|cholinergic agents|mesh-ancestor
102139657|NCT02665286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102139658|NCT02665286|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101741670|NCT04110119|Diclofenac|diclofenac|mesh-list
102139659|NCT02665286|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102139660|NCT02665286|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102139661|NCT02665286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102139662|NCT02665286|Parasympatholytics|parasympatholytics|mesh-ancestor
102139663|NCT02665286|Autonomic Agents|autonomic agents|mesh-ancestor
102139664|NCT02665286|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102139665|NCT02665286|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
102139666|NCT02665286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102139667|NCT02390102|Epoetin Alfa|epoetin alfa|mesh-list
102139668|NCT02390102|Hematinics|hematinics|mesh-ancestor
102139669|NCT02134925|Poly ICLC|poly iclc|mesh-list
102139670|NCT02134925|Interferon Inducers|interferon inducers|mesh-ancestor
102139671|NCT02134925|Immunologic Factors|immunologic factors|mesh-ancestor
102139672|NCT02134925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139673|NCT03663673|Decanoic acid|decanoic acid|mesh-list
102139674|NCT03663673|Antifungal Agents|antifungal agents|mesh-ancestor
102139675|NCT03663673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102139676|NCT04058743|Cobalt|cobalt|mesh-list
102139677|NCT04058743|Chromium|chromium|mesh-list
102139678|NCT04058743|Nickel|nickel|mesh-list
102139679|NCT04058743|Trace Elements|trace elements|mesh-ancestor
102139680|NCT04058743|Micronutrients|micronutrients|mesh-ancestor
102139681|NCT04058743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139682|NCT03664063|Azithromycin|azithromycin|mesh-list
102139683|NCT03664063|Ivermectin|ivermectin|mesh-list
102139684|NCT03664063|Albendazole|albendazole|mesh-list
102139685|NCT03664063|Diethylcarbamazine|diethylcarbamazine|mesh-list
102139686|NCT03664063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102139687|NCT03664063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102139688|NCT03664063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102139689|NCT03664063|Anthelmintics|anthelmintics|mesh-ancestor
102139690|NCT03664063|Anticestodal Agents|anticestodal agents|mesh-ancestor
102139691|NCT03664063|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102139692|NCT03664063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102139693|NCT03664063|Tubulin Modulators|tubulin modulators|mesh-ancestor
102139694|NCT03664063|Antimitotic Agents|antimitotic agents|mesh-ancestor
102139695|NCT03664063|Mitosis Modulators|mitosis modulators|mesh-ancestor
102139696|NCT03664063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139697|NCT03664063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102139698|NCT03664063|Filaricides|filaricides|mesh-ancestor
102139699|NCT03664063|Antinematodal Agents|antinematodal agents|mesh-ancestor
102139700|NCT03664063|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
102139701|NCT03664063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102139702|NCT02911285|Acetylcysteine|acetylcysteine|mesh-list
102139714|NCT04997902|Tipifarnib|tipifarnib|mesh-list
102139715|NCT04997902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102139716|NCT01061515|Bevacizumab|bevacizumab|mesh-list
102139717|NCT01061515|Capecitabine|capecitabine|mesh-list
102139718|NCT01061515|Oxaliplatin|oxaliplatin|mesh-list
102139719|NCT01061515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102139720|NCT01061515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102139721|NCT01061515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102139722|NCT01061515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102139723|NCT01061515|Growth Substances|growth substances|mesh-ancestor
102139724|NCT01061515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139725|NCT01061515|Growth Inhibitors|growth inhibitors|mesh-ancestor
102139726|NCT01061515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102139727|NCT01061515|Antimetabolites|antimetabolites|mesh-ancestor
102139728|NCT01061515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139729|NCT01069939|Esomeprazole|esomeprazole|mesh-list
102139730|NCT01069939|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102139731|NCT01069939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102139732|NCT01069939|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102139733|NCT01069939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102139734|NCT01069939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139735|NCT01069705|Tobramycin|tobramycin|mesh-list
102139736|NCT01069705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102139737|NCT01069705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102139749|NCT01069627|Bevacizumab|bevacizumab|mesh-list
102139750|NCT01069627|Fotemustine|fotemustine|mesh-list
102139751|NCT01069627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102139752|NCT01069627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102139753|NCT01069627|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102139754|NCT01069627|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102139755|NCT01069627|Growth Substances|growth substances|mesh-ancestor
102139756|NCT01069627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139757|NCT01069627|Growth Inhibitors|growth inhibitors|mesh-ancestor
102139758|NCT04057261|Liraglutide|liraglutide|mesh-list
102139759|NCT04057261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102139760|NCT04057261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139761|NCT04057261|Incretins|incretins|mesh-ancestor
102139762|NCT04057261|Hormones|hormones|mesh-ancestor
102139763|NCT04057261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102139764|NCT01947023|Lapatinib|lapatinib|mesh-list
102139765|NCT01947023|Dabrafenib|dabrafenib|mesh-list
102139766|NCT01947023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102139767|NCT01947023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102139768|NCT01947023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102139769|NCT01947023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139770|NCT01064245|Mannitol|mannitol|mesh-list
102139771|NCT01064245|Methacholine Chloride|methacholine chloride|mesh-list
102139772|NCT01064245|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102139773|NCT01064245|Diuretics|diuretics|mesh-ancestor
102139774|NCT01064245|Natriuretic Agents|natriuretic agents|mesh-ancestor
102139775|NCT01064245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836476|NCT01063816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102139776|NCT01064245|Miotics|miotics|mesh-ancestor
102139777|NCT01064245|Autonomic Agents|autonomic agents|mesh-ancestor
102139778|NCT01064245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102139780|NCT01064245|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
102139781|NCT01064245|Respiratory System Agents|respiratory system agents|mesh-ancestor
102139782|NCT01064245|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102139783|NCT01064245|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102139784|NCT01064245|Cholinergic Agents|cholinergic agents|mesh-ancestor
102139785|NCT01064245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102139786|NCT01064245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139787|NCT04056949|Paclitaxel|paclitaxel|mesh-list
102139788|NCT04056949|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102139789|NCT04056949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102139790|NCT04056949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102139791|NCT04056949|Tubulin Modulators|tubulin modulators|mesh-ancestor
102139792|NCT04056949|Antimitotic Agents|antimitotic agents|mesh-ancestor
102139793|NCT04056949|Mitosis Modulators|mitosis modulators|mesh-ancestor
102139794|NCT04056949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139795|NCT03662425|Oxytocin|oxytocin|mesh-list
102139796|NCT03662425|Oxytocics|oxytocics|mesh-ancestor
102139797|NCT03662425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102139798|NCT03662425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139799|NCT03673163|Lidocaine|lidocaine|mesh-list
102139800|NCT03673163|Anesthetics, Local|anesthetics, local|mesh-ancestor
102139801|NCT03673163|Anesthetics|anesthetics|mesh-ancestor
102139802|NCT03673163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102139803|NCT03673163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139804|NCT03673163|Sensory System Agents|sensory system agents|mesh-ancestor
102139805|NCT03673163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102139806|NCT03673163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102139807|NCT03673163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102139808|NCT03673163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102139809|NCT03673163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102139810|NCT03673163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139811|NCT03662269|Indomethacin|indomethacin|mesh-list
102139812|NCT03662269|Omeprazole|omeprazole|mesh-list
102139813|NCT03662269|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102139814|NCT03662269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102139815|NCT03662269|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102139816|NCT03662269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102139817|NCT03662269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139818|NCT03662269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102139819|NCT03662269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102139820|NCT03662269|Analgesics|analgesics|mesh-ancestor
102139821|NCT03662269|Sensory System Agents|sensory system agents|mesh-ancestor
102139822|NCT03662269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102139823|NCT03662269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139824|NCT03662269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102139825|NCT03662269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102139826|NCT03662269|Gout Suppressants|gout suppressants|mesh-ancestor
102139827|NCT03662269|Tocolytic Agents|tocolytic agents|mesh-ancestor
102139828|NCT03662269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102139829|NCT03662269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102139830|NCT04056325|Ivermectin|ivermectin|mesh-list
102139831|NCT04056325|Moxidectin|moxidectin|mesh-list
102139832|NCT04056325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102139833|NCT04056325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102139834|NCT04056325|Anthelmintics|anthelmintics|mesh-ancestor
102139835|NCT04056325|Antinematodal Agents|antinematodal agents|mesh-ancestor
102139836|NCT03662971|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102139837|NCT03662971|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102139838|NCT03662893|Muscarinic Antagonists|muscarinic antagonists|mesh-list
102139839|NCT03662893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102139840|NCT03662893|Cholinergic Agents|cholinergic agents|mesh-ancestor
102139841|NCT03662893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102139842|NCT03662893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139843|NCT03662893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139844|NCT01624805|Cyclosporine|cyclosporine|mesh-list
102139845|NCT01624805|Methylprednisolone|methylprednisolone|mesh-list
102139846|NCT01624805|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102139847|NCT01624805|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102139848|NCT01624805|Prednisolone|prednisolone|mesh-list
102139849|NCT01624805|Prednisolone acetate|prednisolone acetate|mesh-list
102139850|NCT01624805|Lenograstim|lenograstim|mesh-list
102139851|NCT01624805|Cyclosporins|cyclosporins|mesh-list
102139852|NCT01624805|Thymoglobulin|thymoglobulin|mesh-list
102139853|NCT01624805|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102139854|NCT01624805|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102139855|NCT01624805|Prednisolone phosphate|prednisolone phosphate|mesh-list
102139856|NCT01624805|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102139857|NCT01624805|Immunologic Factors|immunologic factors|mesh-ancestor
102139858|NCT01624805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139859|NCT01624805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102139860|NCT01624805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139861|NCT01624805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102139862|NCT01624805|Antifungal Agents|antifungal agents|mesh-ancestor
102139863|NCT01624805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102139864|NCT01624805|Dermatologic Agents|dermatologic agents|mesh-ancestor
102139865|NCT01624805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102139866|NCT01624805|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102139867|NCT01624805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102139869|NCT01624805|Autonomic Agents|autonomic agents|mesh-ancestor
102139870|NCT01624805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102139871|NCT01624805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102139872|NCT01624805|Glucocorticoids|glucocorticoids|mesh-ancestor
102139873|NCT01624805|Hormones|hormones|mesh-ancestor
102139874|NCT01624805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102139875|NCT01624805|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102139876|NCT01624805|Protective Agents|protective agents|mesh-ancestor
102139877|NCT01624805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102139878|NCT01624805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102139879|NCT01585025|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
102139880|NCT01585025|Cathartics|cathartics|mesh-ancestor
102139881|NCT01585025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102139882|NCT00328653|Cyclosporine|cyclosporine|mesh-list
102139883|NCT00328653|Cyclosporins|cyclosporins|mesh-list
102139884|NCT00328653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102139885|NCT00328653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139886|NCT00328653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102139887|NCT00328653|Immunologic Factors|immunologic factors|mesh-ancestor
102139888|NCT00328653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139889|NCT00328653|Antifungal Agents|antifungal agents|mesh-ancestor
102139890|NCT00328653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102139891|NCT00328653|Dermatologic Agents|dermatologic agents|mesh-ancestor
102139892|NCT00328653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102139893|NCT00328653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102139894|NCT03662113|Domperidone|domperidone|mesh-list
102139895|NCT03662113|Simethicone|simethicone|mesh-list
102139896|NCT03662113|Antiemetics|antiemetics|mesh-ancestor
102139897|NCT03662113|Autonomic Agents|autonomic agents|mesh-ancestor
102139898|NCT03662113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102139899|NCT03662113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139900|NCT03662113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102139901|NCT03662113|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102139902|NCT03662113|Dopamine Agents|dopamine agents|mesh-ancestor
102139903|NCT03662113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102139904|NCT03662113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139905|NCT03662113|Antifoaming Agents|antifoaming agents|mesh-ancestor
102139906|NCT03662113|Emollients|emollients|mesh-ancestor
102139907|NCT03662113|Dermatologic Agents|dermatologic agents|mesh-ancestor
102139908|NCT03662035|Apatinib|apatinib|mesh-list
102139909|NCT03662035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102139910|NCT03662035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102139911|NCT03662035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102139912|NCT03662035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139913|NCT05798546|Cyclophosphamide|cyclophosphamide|mesh-list
102139914|NCT05798546|Fludarabine|fludarabine|mesh-list
102139915|NCT05798546|Interleukin-2|interleukin-2|mesh-list
102139916|NCT05798546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102139917|NCT05798546|Immunologic Factors|immunologic factors|mesh-ancestor
102139918|NCT05798546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139919|NCT05798546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102139920|NCT05798546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102139921|NCT05798546|Alkylating Agents|alkylating agents|mesh-ancestor
102139922|NCT05798546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139923|NCT05798546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102139924|NCT05798546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102139925|NCT05798546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102139926|NCT05798546|Analgesics|analgesics|mesh-ancestor
102139927|NCT05798546|Sensory System Agents|sensory system agents|mesh-ancestor
102139928|NCT05798546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102139929|NCT05798195|Dexamethasone|dexamethasone|mesh-list
102139930|NCT05798195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102139931|NCT05798195|Antiemetics|antiemetics|mesh-ancestor
102139932|NCT05798195|Autonomic Agents|autonomic agents|mesh-ancestor
102139933|NCT05798195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102139934|NCT05798195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139935|NCT05798195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102139936|NCT05798195|Glucocorticoids|glucocorticoids|mesh-ancestor
102139937|NCT05798195|Hormones|hormones|mesh-ancestor
102139938|NCT05798195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102139939|NCT05798195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102139940|NCT05798195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102139941|NCT05797948|Cyclophosphamide|cyclophosphamide|mesh-list
102139942|NCT05797948|Fludarabine|fludarabine|mesh-list
102139943|NCT05797948|Lenalidomide|lenalidomide|mesh-list
102139944|NCT05797948|Azacitidine|azacitidine|mesh-list
102139945|NCT05797948|Obinutuzumab|obinutuzumab|mesh-list
102139946|NCT05797948|Zanubrutinib|zanubrutinib|mesh-list
102139947|NCT05797948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102139948|NCT05797948|Immunologic Factors|immunologic factors|mesh-ancestor
102139949|NCT05797948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139950|NCT05797948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102139951|NCT05797948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102139952|NCT05797948|Alkylating Agents|alkylating agents|mesh-ancestor
102139953|NCT05797948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139954|NCT05797948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102139955|NCT05797948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102139956|NCT05797948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102139957|NCT05797948|Antimetabolites|antimetabolites|mesh-ancestor
102139958|NCT05797948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102139959|NCT05797948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102139960|NCT05797948|Growth Substances|growth substances|mesh-ancestor
102139961|NCT05797948|Growth Inhibitors|growth inhibitors|mesh-ancestor
102139962|NCT05797948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102139963|NCT05797948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102139964|NCT05797948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102139965|NCT05797818|Chlorhexidine|chlorhexidine|mesh-list
102139966|NCT05797818|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102139967|NCT05797818|Methylene Blue|methylene blue|mesh-list
102139968|NCT05797818|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102139969|NCT05797818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102139970|NCT05797818|Disinfectants|disinfectants|mesh-ancestor
102139971|NCT05797818|Dermatologic Agents|dermatologic agents|mesh-ancestor
102139972|NCT05797818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102139973|NCT05797818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139974|NCT05797805|Pembrolizumab|pembrolizumab|mesh-list
102139975|NCT05797805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102139976|NCT05797805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102139977|NCT05797805|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102139978|NCT05797805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139979|NCT05797792|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102139980|NCT05797792|Plasminogen|plasminogen|mesh-list
102139981|NCT05797792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102139982|NCT05797792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102139983|NCT05797792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139984|NCT05797753|Itraconazole|itraconazole|mesh-list
102139985|NCT05797753|Erythromycin|erythromycin|mesh-list
102139986|NCT05797753|Erythromycin Estolate|erythromycin estolate|mesh-list
102139987|NCT05797753|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
102139988|NCT05797753|Erythromycin stearate|erythromycin stearate|mesh-list
102139989|NCT05797753|Antifungal Agents|antifungal agents|mesh-ancestor
102139990|NCT05797753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102139991|NCT05797753|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102139992|NCT05797753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102139993|NCT05797753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102139994|NCT05797753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102139995|NCT05797753|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102139996|NCT05797753|Hormone Antagonists|hormone antagonists|mesh-ancestor
102139997|NCT05797753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102139998|NCT05797753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102139999|NCT05797753|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102140000|NCT05797753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102140001|NCT05797753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102140002|NCT05797753|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102140003|NCT05797740|Cladribine|cladribine|mesh-list
102140004|NCT05797740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102140005|NCT05797740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101836477|NCT01063816|Antimetabolites|antimetabolites|mesh-ancestor
102140007|NCT05797740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140008|NCT05797714|Tenofovir|tenofovir|mesh-list
102140009|NCT05797714|Antiviral Agents|antiviral agents|mesh-ancestor
102140010|NCT05797714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102140011|NCT05797714|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102140012|NCT05797714|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102140013|NCT05797714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102140014|NCT05797714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140015|NCT05797714|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102140016|NCT05797714|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102140017|NCT05797623|Cyclosporine|cyclosporine|mesh-list
102140018|NCT05797623|Cyclosporins|cyclosporins|mesh-list
102140019|NCT05797623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102140020|NCT05797623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140021|NCT05797623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102140022|NCT05797623|Immunologic Factors|immunologic factors|mesh-ancestor
102140023|NCT05797623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140024|NCT05797623|Antifungal Agents|antifungal agents|mesh-ancestor
102140025|NCT05797623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102140026|NCT05797623|Dermatologic Agents|dermatologic agents|mesh-ancestor
102140027|NCT05797623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102140028|NCT05797623|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102140029|NCT05797584|Dobutamine|dobutamine|mesh-list
102140030|NCT05797584|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102140031|NCT05797584|Sympathomimetics|sympathomimetics|mesh-ancestor
102140032|NCT05797584|Autonomic Agents|autonomic agents|mesh-ancestor
102140033|NCT05797584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102140034|NCT05797584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140035|NCT05797584|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102140036|NCT05797584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102140037|NCT05797584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102140038|NCT05797584|Adrenergic Agents|adrenergic agents|mesh-ancestor
102140039|NCT05797584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102140040|NCT05797584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140041|NCT05797584|Protective Agents|protective agents|mesh-ancestor
102140042|NCT05797493|Atezolizumab|atezolizumab|mesh-list
102140043|NCT05797493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102140044|NCT05797493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140045|NCT05797493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102140046|NCT05797493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102140047|NCT05797220|Diltiazem|diltiazem|mesh-list
102140048|NCT05797220|Botulinum Toxins|botulinum toxins|mesh-list
102140049|NCT05797220|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102140050|NCT05797220|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102140051|NCT05797220|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102140052|NCT05797220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102140053|NCT05797220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140054|NCT05797220|Cholinergic Agents|cholinergic agents|mesh-ancestor
102140055|NCT05797220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102140056|NCT05797220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140057|NCT05797220|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102140058|NCT05797220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102140059|NCT05797220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102140060|NCT05797220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102140061|NCT05797220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102140062|NCT05797220|Vasodilator Agents|vasodilator agents|mesh-ancestor
102140063|NCT05797077|Capecitabine|capecitabine|mesh-list
102140064|NCT05797077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102140065|NCT05797077|Antimetabolites|antimetabolites|mesh-ancestor
102140066|NCT05797077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140067|NCT05797077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102140068|NCT05797038|Tacrolimus|tacrolimus|mesh-list
102140069|NCT05797038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102140070|NCT05797038|Immunologic Factors|immunologic factors|mesh-ancestor
102140071|NCT05797038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140072|NCT05797038|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102140073|NCT05797038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102140074|NCT05797038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140075|NCT05795933|Vitamin D|vitamin d|mesh-list
102140076|NCT05795933|Cholecalciferol|cholecalciferol|mesh-list
102140077|NCT05795933|Vitamins|vitamins|mesh-ancestor
102140078|NCT05795933|Micronutrients|micronutrients|mesh-ancestor
101849041|NCT00434252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102140079|NCT05795933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140080|NCT05795933|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102140081|NCT05795933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102140083|NCT05792774|Anesthetics, Local|anesthetics, local|mesh-ancestor
102140084|NCT05792774|Anesthetics|anesthetics|mesh-ancestor
102140085|NCT05792774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102140086|NCT05792774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140087|NCT05792774|Sensory System Agents|sensory system agents|mesh-ancestor
102140088|NCT05792774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102140090|NCT05782127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102140091|NCT05703854|Cyclophosphamide|cyclophosphamide|mesh-list
102140092|NCT05703854|Fludarabine|fludarabine|mesh-list
102140093|NCT05703854|Fludarabine phosphate|fludarabine phosphate|mesh-list
102140094|NCT05703854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102140095|NCT05703854|Immunologic Factors|immunologic factors|mesh-ancestor
102140096|NCT05703854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140097|NCT05703854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102140098|NCT05703854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102140099|NCT05703854|Alkylating Agents|alkylating agents|mesh-ancestor
102140100|NCT05703854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140101|NCT05703854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102140102|NCT05703854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102140103|NCT05703854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102140104|NCT05703854|Antimetabolites|antimetabolites|mesh-ancestor
102140105|NCT05692999|Pembrolizumab|pembrolizumab|mesh-list
102140106|NCT05692999|Pemetrexed|pemetrexed|mesh-list
102140107|NCT05692999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102140108|NCT05692999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102140109|NCT05692999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102140110|NCT05692999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140111|NCT05692999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102140112|NCT05692999|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102140113|NCT05692999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102140114|NCT05665140|Dexamethasone|dexamethasone|mesh-list
102140115|NCT05665140|Lenalidomide|lenalidomide|mesh-list
102140116|NCT05665140|Bortezomib|bortezomib|mesh-list
102140117|NCT05665140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102140118|NCT05665140|Antiemetics|antiemetics|mesh-ancestor
102140119|NCT05665140|Autonomic Agents|autonomic agents|mesh-ancestor
102140120|NCT05665140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102140121|NCT05665140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140122|NCT05665140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102140123|NCT05665140|Glucocorticoids|glucocorticoids|mesh-ancestor
102140124|NCT05665140|Hormones|hormones|mesh-ancestor
102140125|NCT05665140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102140126|NCT05665140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102140127|NCT05665140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102140128|NCT05665140|Immunologic Factors|immunologic factors|mesh-ancestor
102140129|NCT05665140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102140130|NCT05665140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102140131|NCT05665140|Growth Substances|growth substances|mesh-ancestor
102140132|NCT05665140|Growth Inhibitors|growth inhibitors|mesh-ancestor
102140133|NCT05661591|Fluconazole|fluconazole|mesh-list
102140134|NCT05661591|Antifungal Agents|antifungal agents|mesh-ancestor
102140135|NCT05661591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102140136|NCT05661591|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102140137|NCT05661591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102140138|NCT05661591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102140139|NCT05661591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140140|NCT05661591|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102140141|NCT05661591|Hormone Antagonists|hormone antagonists|mesh-ancestor
102140142|NCT05661591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102140143|NCT05661591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140144|NCT05661591|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102140145|NCT05661591|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102140146|NCT05661201|Doxorubicin|doxorubicin|mesh-list
102140147|NCT05661201|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101742157|NCT00732693|Estradiol|estradiol|mesh-list
102140148|NCT05661201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102140149|NCT05661201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102140150|NCT05661201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102140151|NCT05661201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102140152|NCT05661201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140154|NCT05634148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102140155|NCT05634148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102140156|NCT05634148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140157|NCT05634148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102140158|NCT05634148|Analgesics|analgesics|mesh-ancestor
102140159|NCT05634148|Sensory System Agents|sensory system agents|mesh-ancestor
102140160|NCT05634148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102140161|NCT05634148|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102140162|NCT05634148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102140163|NCT05634148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102140164|NCT05634148|Adrenergic Agents|adrenergic agents|mesh-ancestor
102140165|NCT05634148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102140166|NCT05634148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140167|NCT05622123|Exenatide|exenatide|mesh-list
102140168|NCT05622123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102140169|NCT05622123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140170|NCT05622123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102140171|NCT05622123|Incretins|incretins|mesh-ancestor
102140172|NCT05622123|Hormones|hormones|mesh-ancestor
102140173|NCT05622123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102140174|NCT05594082|Trastuzumab|trastuzumab|mesh-list
102140175|NCT05594082|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
102140176|NCT05594082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102140177|NCT05594082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102140178|NCT05594082|Immunoconjugates|immunoconjugates|mesh-ancestor
102140179|NCT05594082|Immunologic Factors|immunologic factors|mesh-ancestor
102140180|NCT05594082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140181|NCT05574374|Fexuprazan|fexuprazan|mesh-list
102140182|NCT05574374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102140183|NCT05566639|Vaccines|vaccines|mesh-list
102140184|NCT05566639|Immunologic Factors|immunologic factors|mesh-ancestor
102140185|NCT05566639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140186|NCT05506787|Esketamine|esketamine|mesh-list
102140187|NCT05506787|Antidepressive Agents|antidepressive agents|mesh-ancestor
102140188|NCT05506787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102140189|NCT05503511|Bumetanide|bumetanide|mesh-list
102140190|NCT05503511|Diuretics|diuretics|mesh-ancestor
102140191|NCT05503511|Natriuretic Agents|natriuretic agents|mesh-ancestor
102140192|NCT05503511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140193|NCT05503511|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102140194|NCT05503511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102140195|NCT05503511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140196|NCT05503355|Venetoclax|venetoclax|mesh-list
102140197|NCT05503355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102140198|NCT05453851|Pancrelipase|pancrelipase|mesh-list
102140199|NCT05453851|Pancreatin|pancreatin|mesh-list
102140200|NCT05453851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102140201|NCT05453500|Prednisone|prednisone|mesh-list
102140202|NCT05453500|Cortisone|cortisone|mesh-list
102140203|NCT05453500|Cyclophosphamide|cyclophosphamide|mesh-list
102140204|NCT05453500|Rituximab|rituximab|mesh-list
102140205|NCT05453500|Doxorubicin|doxorubicin|mesh-list
102140206|NCT05453500|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102140207|NCT05453500|Etoposide|etoposide|mesh-list
102140208|NCT05453500|Vincristine|vincristine|mesh-list
102140209|NCT05453500|Etoposide phosphate|etoposide phosphate|mesh-list
102140210|NCT05453500|Daunorubicin|daunorubicin|mesh-list
102140211|NCT05453500|Podophyllotoxin|podophyllotoxin|mesh-list
102140212|NCT05453500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102140213|NCT05453500|Antibodies|antibodies|mesh-list
102140214|NCT05453500|Immunoglobulins|immunoglobulins|mesh-list
102140215|NCT05453500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102140216|NCT05453500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102140217|NCT05453500|Immunologic Factors|immunologic factors|mesh-ancestor
102140218|NCT05453500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140219|NCT05453500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102140220|NCT05453500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102140221|NCT05453500|Alkylating Agents|alkylating agents|mesh-ancestor
102140222|NCT05453500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140223|NCT05453500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102140224|NCT05453500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102140225|NCT05453500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102140226|NCT05453500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102140227|NCT05453500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102140228|NCT05453500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102140229|NCT05453500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102140231|NCT05453500|Hormones|hormones|mesh-ancestor
102140232|NCT05453500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102140233|NCT05453500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102140234|NCT05453500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102140235|NCT05453500|Tubulin Modulators|tubulin modulators|mesh-ancestor
102140236|NCT05453500|Antimitotic Agents|antimitotic agents|mesh-ancestor
102140237|NCT05453500|Mitosis Modulators|mitosis modulators|mesh-ancestor
102140238|NCT05453500|Keratolytic Agents|keratolytic agents|mesh-ancestor
102140239|NCT05453500|Dermatologic Agents|dermatologic agents|mesh-ancestor
102140240|NCT05445024|Sufentanil|sufentanil|mesh-list
102140241|NCT05445024|Nalbuphine|nalbuphine|mesh-list
102140242|NCT05445024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102140243|NCT05445024|Narcotics|narcotics|mesh-ancestor
102140244|NCT05445024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102140245|NCT05445024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140246|NCT05445024|Analgesics|analgesics|mesh-ancestor
102140247|NCT05445024|Sensory System Agents|sensory system agents|mesh-ancestor
102140248|NCT05445024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102140249|NCT05445024|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102140250|NCT05445024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102140251|NCT05445024|Anesthetics, General|anesthetics, general|mesh-ancestor
102140252|NCT05445024|Anesthetics|anesthetics|mesh-ancestor
102140253|NCT05429814|Menthol|menthol|mesh-list
102140254|NCT05429814|Antipruritics|antipruritics|mesh-ancestor
102140255|NCT05429814|Dermatologic Agents|dermatologic agents|mesh-ancestor
102140256|NCT05420337|Morphine|morphine|mesh-list
102140257|NCT05420337|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102140258|NCT05420337|Narcotics|narcotics|mesh-ancestor
102140259|NCT05420337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102140260|NCT05420337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140261|NCT05420337|Analgesics|analgesics|mesh-ancestor
102140262|NCT05420337|Sensory System Agents|sensory system agents|mesh-ancestor
102140263|NCT05420337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102140264|NCT05409872|Vitamin D|vitamin d|mesh-list
102140265|NCT05409872|Vitamins|vitamins|mesh-list
102140266|NCT05409872|Inositol|inositol|mesh-list
102140267|NCT05409872|Vitamin B 6|vitamin b 6|mesh-list
102140268|NCT05409872|Pyridoxal|pyridoxal|mesh-list
102140269|NCT05409872|Pyridoxine|pyridoxine|mesh-list
102140270|NCT05409872|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
102140271|NCT05409872|Micronutrients|micronutrients|mesh-ancestor
102140272|NCT05409872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140273|NCT05409872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102140274|NCT05409872|Vitamin B Complex|vitamin b complex|mesh-ancestor
102140275|NCT05409872|Antioxidants|antioxidants|mesh-ancestor
102140276|NCT05409872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140277|NCT05409872|Protective Agents|protective agents|mesh-ancestor
102140278|NCT05409872|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
102140279|NCT05409872|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102140280|NCT05409872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102140281|NCT05409872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102140282|NCT05390905|Tramadol|tramadol|mesh-list
102140283|NCT05390905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102140284|NCT05390905|Narcotics|narcotics|mesh-ancestor
102140285|NCT05390905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102140286|NCT05390905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140287|NCT05390905|Analgesics|analgesics|mesh-ancestor
102140288|NCT05390905|Sensory System Agents|sensory system agents|mesh-ancestor
102140289|NCT05390905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102140290|NCT05366621|Denosumab|denosumab|mesh-list
102140291|NCT05366621|Diphosphonates|diphosphonates|mesh-list
102140292|NCT05366621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140293|NCT05366621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102140294|NCT05359146|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
102140295|NCT05359146|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102140296|NCT05359146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140297|NCT05335252|Dronabinol|dronabinol|mesh-list
102140298|NCT05335252|Hallucinogens|hallucinogens|mesh-ancestor
102140299|NCT05335252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140300|NCT05335252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102140301|NCT05335252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102140302|NCT05335252|Analgesics|analgesics|mesh-ancestor
102140303|NCT05335252|Sensory System Agents|sensory system agents|mesh-ancestor
102140304|NCT05335252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102140305|NCT05335252|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102140306|NCT05335252|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102140307|NCT05335252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102140308|NCT05335252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140309|NCT05335252|Hormones|hormones|mesh-ancestor
102140321|NCT05289908|Vitamins|vitamins|mesh-ancestor
102140322|NCT05289908|Micronutrients|micronutrients|mesh-ancestor
102140323|NCT05289908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140324|NCT05289908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102140325|NCT05289908|Antiemetics|antiemetics|mesh-ancestor
102140326|NCT05289908|Autonomic Agents|autonomic agents|mesh-ancestor
102140327|NCT05289908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102140328|NCT05289908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102140329|NCT05289908|Glucocorticoids|glucocorticoids|mesh-ancestor
102140330|NCT05289908|Hormones|hormones|mesh-ancestor
102140331|NCT05289908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102140332|NCT05289908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102140333|NCT05289908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102140334|NCT05289908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102140335|NCT05289908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140336|NCT05289908|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102140337|NCT05289908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102140338|NCT05289908|Hematinics|hematinics|mesh-ancestor
102140339|NCT05289908|Vitamin B Complex|vitamin b complex|mesh-ancestor
102140340|NCT05284084|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
102140341|NCT05284084|Histamine Antagonists|histamine antagonists|mesh-ancestor
102140342|NCT05284084|Histamine Agents|histamine agents|mesh-ancestor
102140343|NCT05284084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102140344|NCT05284084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140345|NCT05284084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140356|NCT05226351|Dronabinol|dronabinol|mesh-list
102140357|NCT05226351|Hallucinogens|hallucinogens|mesh-ancestor
102140358|NCT05226351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140359|NCT05226351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102140360|NCT05226351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102140361|NCT05226351|Analgesics|analgesics|mesh-ancestor
102140362|NCT05226351|Sensory System Agents|sensory system agents|mesh-ancestor
102140363|NCT05226351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102140364|NCT05226351|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102140365|NCT05226351|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102140366|NCT05226351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102140367|NCT05226351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140368|NCT05226351|Hormones|hormones|mesh-ancestor
102140369|NCT05226351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102140370|NCT05215548|Afatinib|afatinib|mesh-list
102140371|NCT05215548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102140372|NCT05215548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102140373|NCT05215548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102140374|NCT05215548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140375|NCT05209555|Pilocarpine|pilocarpine|mesh-list
102140376|NCT05209555|Miotics|miotics|mesh-ancestor
102140377|NCT05209555|Autonomic Agents|autonomic agents|mesh-ancestor
102140378|NCT05209555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102140379|NCT05209555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140380|NCT05209555|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101849341|NCT01033058|Atorvastatin|atorvastatin|mesh-list
102140381|NCT05209555|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102140382|NCT05209555|Cholinergic Agents|cholinergic agents|mesh-ancestor
102082971|NCT03504423|Antidotes|antidotes|mesh-ancestor
102140384|NCT05209555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140385|NCT05202145|Cyclosporine|cyclosporine|mesh-list
102140386|NCT05202145|Tacrolimus|tacrolimus|mesh-list
102140387|NCT05202145|Cyclosporins|cyclosporins|mesh-list
102140388|NCT05202145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102140389|NCT05202145|Immunologic Factors|immunologic factors|mesh-ancestor
102140390|NCT05202145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140391|NCT05202145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102140392|NCT05202145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102140393|NCT05202145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140394|NCT05202145|Antifungal Agents|antifungal agents|mesh-ancestor
102140395|NCT05202145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102140396|NCT05202145|Dermatologic Agents|dermatologic agents|mesh-ancestor
102140397|NCT05202145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102140398|NCT05150938|Vitamin K|vitamin k|mesh-list
102140399|NCT05150938|Heparin|heparin|mesh-list
102140400|NCT05150938|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102140401|NCT05150938|Tinzaparin|tinzaparin|mesh-list
102140402|NCT05150938|Dalteparin|dalteparin|mesh-list
102140403|NCT05150938|Rivaroxaban|rivaroxaban|mesh-list
102140404|NCT05150938|Vitamins|vitamins|mesh-ancestor
102140405|NCT05150938|Micronutrients|micronutrients|mesh-ancestor
102140406|NCT05150938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140407|NCT05150938|Anticoagulants|anticoagulants|mesh-ancestor
102140408|NCT05150938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102140409|NCT05150938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102140410|NCT05150938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140411|NCT05150938|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102140412|NCT05150938|Antithrombins|antithrombins|mesh-ancestor
102140413|NCT05150938|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102140414|NCT05150938|Protease Inhibitors|protease inhibitors|mesh-ancestor
102140415|NCT05150938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102140416|NCT05150938|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102140417|NCT05150938|Hemostatics|hemostatics|mesh-ancestor
102140418|NCT05150938|Coagulants|coagulants|mesh-ancestor
102140419|NCT05142904|Iodine|iodine|mesh-list
102140420|NCT05142904|Cadexomer iodine|cadexomer iodine|mesh-list
102140421|NCT05142904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102140422|NCT05142904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102140423|NCT05142904|Trace Elements|trace elements|mesh-ancestor
102140424|NCT05142904|Micronutrients|micronutrients|mesh-ancestor
102140425|NCT05142904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140426|NCT05107856|Azacitidine|azacitidine|mesh-list
102140427|NCT05107856|Venetoclax|venetoclax|mesh-list
102140428|NCT05107856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102140429|NCT05107856|Antimetabolites|antimetabolites|mesh-ancestor
102140430|NCT05107856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140431|NCT05107856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102140432|NCT05107856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102140433|NCT05042648|Buprenorphine|buprenorphine|mesh-list
102140434|NCT05042648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102140435|NCT05042648|Narcotics|narcotics|mesh-ancestor
102140436|NCT05042648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102140437|NCT05042648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140438|NCT05042648|Analgesics|analgesics|mesh-ancestor
102140439|NCT05042648|Sensory System Agents|sensory system agents|mesh-ancestor
102140440|NCT05042648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102140441|NCT05042648|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102140442|NCT05036317|Empagliflozin|empagliflozin|mesh-list
102140443|NCT05036317|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102140444|NCT05036317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140445|NCT05036317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102140446|NCT05036317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140447|NCT04990388|Acetaminophen|acetaminophen|mesh-list
102140448|NCT04990388|Antipyretics|antipyretics|mesh-list
102140449|NCT04990388|Cetirizine|cetirizine|mesh-list
102140450|NCT04990388|Ibuprofen|ibuprofen|mesh-list
102140451|NCT04990388|Famotidine|famotidine|mesh-list
102140452|NCT04990388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102140453|NCT04990388|Analgesics|analgesics|mesh-ancestor
102140454|NCT04990388|Sensory System Agents|sensory system agents|mesh-ancestor
102140455|NCT04990388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102140456|NCT04990388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140457|NCT04990388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102140458|NCT04990388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102140459|NCT04990388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102140460|NCT04990388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102140465|NCT04990388|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102140466|NCT04990388|Histamine Antagonists|histamine antagonists|mesh-ancestor
102140468|NCT04990388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102140469|NCT04990388|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102140470|NCT04990388|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102140471|NCT04990388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102140472|NCT04916002|Cemiplimab|cemiplimab|mesh-list
102140473|NCT04916002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102140474|NCT04916002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102140475|NCT04896866|Anti-Infective Agents|anti-infective agents|mesh-list
102140476|NCT04896866|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102140477|NCT04871269|Dronabinol|dronabinol|mesh-list
102140478|NCT04871269|Hallucinogens|hallucinogens|mesh-ancestor
102140479|NCT04871269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140480|NCT04871269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102140481|NCT04871269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102140482|NCT04871269|Analgesics|analgesics|mesh-ancestor
102140483|NCT04871269|Sensory System Agents|sensory system agents|mesh-ancestor
102140484|NCT04871269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102140485|NCT04871269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102140486|NCT04871269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102140487|NCT04871269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102140488|NCT04871269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140489|NCT04871269|Hormones|hormones|mesh-ancestor
102140490|NCT04871269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102140491|NCT04837131|Ixazomib|ixazomib|mesh-list
102140492|NCT04837131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102140493|NCT04837131|Protease Inhibitors|protease inhibitors|mesh-ancestor
102140494|NCT04837131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102140495|NCT04837131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140496|NCT04768010|Misoprostol|misoprostol|mesh-list
102140497|NCT04768010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102140498|NCT04768010|Abortifacient Agents|abortifacient agents|mesh-ancestor
102140499|NCT04768010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102140500|NCT04768010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140501|NCT04768010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102140502|NCT04768010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102140503|NCT04768010|Oxytocics|oxytocics|mesh-ancestor
102140504|NCT04764214|Osimertinib|osimertinib|mesh-list
102140505|NCT04764214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102140506|NCT04764214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102140507|NCT04764214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102140508|NCT04764214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140513|NCT04675710|Pembrolizumab|pembrolizumab|mesh-list
102140514|NCT04675710|Trametinib|trametinib|mesh-list
102140515|NCT04675710|Dabrafenib|dabrafenib|mesh-list
102140516|NCT04675710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102140517|NCT04675710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102140518|NCT04675710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102140519|NCT04675710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140520|NCT04675710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102140521|NCT04675710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102140522|NCT04710030|Valacyclovir|valacyclovir|mesh-list
102140523|NCT04710030|Antiviral Agents|antiviral agents|mesh-ancestor
102140524|NCT04710030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102140525|NCT04653818|Sofosbuvir|sofosbuvir|mesh-list
102140526|NCT04653818|Velpatasvir|velpatasvir|mesh-list
102140527|NCT04653818|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102140528|NCT04653818|Antiviral Agents|antiviral agents|mesh-ancestor
102140529|NCT04653818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102140530|NCT04608955|Bedaquiline|bedaquiline|mesh-list
102140531|NCT04608955|Antitubercular Agents|antitubercular agents|mesh-ancestor
102140532|NCT04608955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102140533|NCT04608955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102140534|NCT04579848|Folic Acid|folic acid|mesh-list
102140535|NCT04579848|Methotrexate|methotrexate|mesh-list
102140536|NCT04579848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102140537|NCT04579848|Abortifacient Agents|abortifacient agents|mesh-ancestor
102140538|NCT04579848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102140539|NCT04579848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140540|NCT04579848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102140541|NCT04579848|Antimetabolites|antimetabolites|mesh-ancestor
102140542|NCT04579848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140543|NCT04579848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102140544|NCT04579848|Dermatologic Agents|dermatologic agents|mesh-ancestor
102140545|NCT04579848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102140546|NCT04579848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102140547|NCT04579848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102140548|NCT04579848|Immunologic Factors|immunologic factors|mesh-ancestor
102140549|NCT04579848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102140550|NCT04579848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102140551|NCT04579848|Hematinics|hematinics|mesh-ancestor
102140552|NCT04579848|Vitamin B Complex|vitamin b complex|mesh-ancestor
102140553|NCT04579848|Vitamins|vitamins|mesh-ancestor
102140554|NCT04579848|Micronutrients|micronutrients|mesh-ancestor
102140555|NCT04578652|Metformin|metformin|mesh-list
102140556|NCT04578652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102140557|NCT04578652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140558|NCT04570631|Dexamethasone|dexamethasone|mesh-list
102140559|NCT04570631|Bortezomib|bortezomib|mesh-list
102140560|NCT04570631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102140561|NCT04570631|Antiemetics|antiemetics|mesh-ancestor
102140562|NCT04570631|Autonomic Agents|autonomic agents|mesh-ancestor
102140563|NCT04570631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102140564|NCT04570631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140565|NCT04570631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102140566|NCT04570631|Glucocorticoids|glucocorticoids|mesh-ancestor
102140567|NCT04570631|Hormones|hormones|mesh-ancestor
102140568|NCT04570631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102140569|NCT04570631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102140570|NCT04570631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102140571|NCT04550832|Moxifloxacin|moxifloxacin|mesh-list
102140572|NCT04550832|Bedaquiline|bedaquiline|mesh-list
102140573|NCT04550832|Delpazolid|delpazolid|mesh-list
102140574|NCT04550832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102140575|NCT04550832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102140576|NCT04550832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102140577|NCT04550832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102140578|NCT04550832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102140579|NCT04550832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140580|NCT04550832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102140581|NCT04550832|Antitubercular Agents|antitubercular agents|mesh-ancestor
102140582|NCT04550832|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102140583|NCT04477629|Mycophenolic Acid|mycophenolic acid|mesh-list
102140584|NCT04477629|Abatacept|abatacept|mesh-list
102140585|NCT04477629|Tacrolimus|tacrolimus|mesh-list
102140586|NCT04477629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102140587|NCT04477629|Immunologic Factors|immunologic factors|mesh-ancestor
102140588|NCT04477629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140589|NCT04477629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102140590|NCT04477629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101742539|NCT02568111|Interferons|interferons|mesh-list
101742598|NCT00785291|Paclitaxel|paclitaxel|mesh-list
101742599|NCT00785291|Epothilones|epothilones|mesh-list
101742600|NCT00785291|Epothilone B|epothilone b|mesh-list
102140591|NCT04477629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140592|NCT04477629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102140593|NCT04477629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102140594|NCT04477629|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102140595|NCT04477629|Antitubercular Agents|antitubercular agents|mesh-ancestor
102140596|NCT04477629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102140597|NCT04477629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102140598|NCT04477629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102140599|NCT04477629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102140600|NCT04477629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102140601|NCT04476277|Biotin|biotin|mesh-list
102140602|NCT04476277|Vitamin B Complex|vitamin b complex|mesh-ancestor
102140603|NCT04476277|Vitamins|vitamins|mesh-ancestor
102140604|NCT04476277|Micronutrients|micronutrients|mesh-ancestor
102140605|NCT04476277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140606|NCT04430517|Niacinamide|niacinamide|mesh-list
102140607|NCT04430517|Niacin|niacin|mesh-list
102140608|NCT04430517|Nicotinic Acids|nicotinic acids|mesh-list
102140609|NCT04430517|Vitamin B Complex|vitamin b complex|mesh-ancestor
102140610|NCT04430517|Vitamins|vitamins|mesh-ancestor
102140611|NCT04430517|Micronutrients|micronutrients|mesh-ancestor
102140612|NCT04430517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140613|NCT04430517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102140614|NCT04430517|Antimetabolites|antimetabolites|mesh-ancestor
102140615|NCT04430517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140616|NCT04430517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102140617|NCT04430517|Vasodilator Agents|vasodilator agents|mesh-ancestor
102140618|NCT04414943|Ketamine|ketamine|mesh-list
102140619|NCT04414943|Esketamine|esketamine|mesh-list
102140620|NCT04414943|Analgesics|analgesics|mesh-ancestor
102140621|NCT04414943|Sensory System Agents|sensory system agents|mesh-ancestor
102140622|NCT04414943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102140623|NCT04414943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140624|NCT04414943|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102140625|NCT04414943|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102140626|NCT04414943|Anesthetics, General|anesthetics, general|mesh-ancestor
102140627|NCT04414943|Anesthetics|anesthetics|mesh-ancestor
102140628|NCT04414943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102140629|NCT04414943|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102140630|NCT04414943|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102140631|NCT04414943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102140632|NCT04414943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140633|NCT04414943|Antidepressive Agents|antidepressive agents|mesh-ancestor
102140634|NCT04414943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102140635|NCT04354025|Cytarabine|cytarabine|mesh-list
102140636|NCT04354025|Fludarabine|fludarabine|mesh-list
102140637|NCT04354025|Interleukin-2|interleukin-2|mesh-list
102140638|NCT04354025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102140639|NCT04354025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102140640|NCT04354025|Antimetabolites|antimetabolites|mesh-ancestor
102140641|NCT04354025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140642|NCT04354025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102140643|NCT04354025|Immunologic Factors|immunologic factors|mesh-ancestor
102140644|NCT04354025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140645|NCT04354025|Antiviral Agents|antiviral agents|mesh-ancestor
102140646|NCT04354025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102140647|NCT04354025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102140648|NCT04354025|Analgesics|analgesics|mesh-ancestor
102140649|NCT04354025|Sensory System Agents|sensory system agents|mesh-ancestor
102140650|NCT04354025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102140651|NCT04347720|Acetaminophen|acetaminophen|mesh-list
102140652|NCT04347720|Ibuprofen|ibuprofen|mesh-list
102140653|NCT04347720|Indomethacin|indomethacin|mesh-list
102140654|NCT04347720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102140655|NCT04347720|Analgesics|analgesics|mesh-ancestor
102140656|NCT04347720|Sensory System Agents|sensory system agents|mesh-ancestor
102140657|NCT04347720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102140658|NCT04347720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140659|NCT04347720|Antipyretics|antipyretics|mesh-ancestor
102140660|NCT04347720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101742601|NCT00785291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102140661|NCT04347720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102140662|NCT04347720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102140663|NCT04347720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102140664|NCT04347720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102140665|NCT04347720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140666|NCT04347720|Gout Suppressants|gout suppressants|mesh-ancestor
102140667|NCT04347720|Tocolytic Agents|tocolytic agents|mesh-ancestor
102140668|NCT04347720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102140669|NCT04325802|Naltrexone|naltrexone|mesh-list
102140670|NCT04325802|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102140671|NCT04325802|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102140672|NCT04325802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140673|NCT04325802|Sensory System Agents|sensory system agents|mesh-ancestor
102140674|NCT04325802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102140675|NCT04285346|Ganaxolone|ganaxolone|mesh-list
102140676|NCT04285346|Neurosteroids|neurosteroids|mesh-ancestor
102140677|NCT04285346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102140678|NCT04285346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140679|NCT04285346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140680|NCT04285346|GABA Modulators|gaba modulators|mesh-ancestor
102140681|NCT04285346|GABA Agents|gaba agents|mesh-ancestor
102140682|NCT04241562|Mitogens|mitogens|mesh-list
102140683|NCT04241562|Mitosis Modulators|mitosis modulators|mesh-ancestor
102140684|NCT04241562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140685|NCT04209192|Amikacin|amikacin|mesh-list
102140686|NCT04209192|Fosfomycin|fosfomycin|mesh-list
102140687|NCT04209192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102140688|NCT04209192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102140689|NCT04199468|Ketamine|ketamine|mesh-list
102140690|NCT04199468|Dronabinol|dronabinol|mesh-list
102140692|NCT04199468|Sensory System Agents|sensory system agents|mesh-ancestor
102140693|NCT04199468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102140694|NCT04199468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140695|NCT04199468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102140696|NCT04199468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102140697|NCT04199468|Anesthetics, General|anesthetics, general|mesh-ancestor
102140698|NCT04199468|Anesthetics|anesthetics|mesh-ancestor
102140699|NCT04199468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102140700|NCT04199468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102140701|NCT04199468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102140702|NCT04199468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102140703|NCT04199468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140704|NCT04199468|Hallucinogens|hallucinogens|mesh-ancestor
102140705|NCT04199468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102140706|NCT04199468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102140707|NCT04199468|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102140708|NCT04199468|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102140709|NCT04199468|Hormones|hormones|mesh-ancestor
102140710|NCT04199468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102140711|NCT04178148|Amikacin|amikacin|mesh-list
102140712|NCT04178148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102140713|NCT04178148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102140714|NCT04126681|Interferons|interferons|mesh-list
102140715|NCT04126681|Imatinib Mesylate|imatinib mesylate|mesh-list
102140716|NCT04126681|Dasatinib|dasatinib|mesh-list
102140717|NCT04126681|Hydroxyurea|hydroxyurea|mesh-list
102140718|NCT04126681|Homoharringtonine|homoharringtonine|mesh-list
102140719|NCT04126681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102140720|NCT04126681|Antiviral Agents|antiviral agents|mesh-ancestor
102140721|NCT04126681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102140722|NCT04126681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102140723|NCT04126681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102140724|NCT04126681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140725|NCT04126681|Antisickling Agents|antisickling agents|mesh-ancestor
102140726|NCT04126681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102140727|NCT04126681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102140728|NCT04126681|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102140729|NCT04118855|Axitinib|axitinib|mesh-list
102140730|NCT04118855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102140731|NCT04118855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102140732|NCT04118855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102140733|NCT04118855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140734|NCT04084860|Ketamine|ketamine|mesh-list
102140735|NCT04084860|Analgesics|analgesics|mesh-ancestor
102140736|NCT04084860|Sensory System Agents|sensory system agents|mesh-ancestor
102140737|NCT04084860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102140738|NCT04084860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140739|NCT04084860|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102140740|NCT04084860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102140741|NCT04084860|Anesthetics, General|anesthetics, general|mesh-ancestor
102140742|NCT04084860|Anesthetics|anesthetics|mesh-ancestor
102140743|NCT04084860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102140744|NCT04084860|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102140745|NCT04084860|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102140746|NCT04084860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102140747|NCT04084860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140748|NCT04011150|Fentanyl|fentanyl|mesh-list
102140749|NCT04011150|Ropivacaine|ropivacaine|mesh-list
102140750|NCT04011150|Anesthetics, Local|anesthetics, local|mesh-list
102140751|NCT04011150|Anesthetics|anesthetics|mesh-list
102140752|NCT04011150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102140753|NCT04011150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140754|NCT04011150|Sensory System Agents|sensory system agents|mesh-ancestor
102140755|NCT04011150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102140756|NCT04011150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102140757|NCT04011150|Narcotics|narcotics|mesh-ancestor
102140758|NCT04011150|Analgesics|analgesics|mesh-ancestor
102140759|NCT04011150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102140760|NCT04011150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102140761|NCT04011150|Anesthetics, General|anesthetics, general|mesh-ancestor
102140771|NCT03927378|Sensory System Agents|sensory system agents|mesh-ancestor
102140772|NCT03927378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102140773|NCT03927378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140774|NCT03927378|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102140775|NCT03927378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102140776|NCT03927378|Anesthetics, General|anesthetics, general|mesh-ancestor
102140777|NCT03927378|Anesthetics|anesthetics|mesh-ancestor
102140778|NCT03927378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102140779|NCT03927378|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102140780|NCT03927378|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102140781|NCT03927378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102140782|NCT03927378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140783|NCT03927378|Antidepressive Agents|antidepressive agents|mesh-ancestor
102140784|NCT03927378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102140785|NCT03875391|Oxytocin|oxytocin|mesh-list
102140786|NCT03875391|Oxytocics|oxytocics|mesh-ancestor
102140787|NCT03875391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102140788|NCT03875391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140789|NCT03836066|Bevacizumab|bevacizumab|mesh-list
102140790|NCT03836066|Atezolizumab|atezolizumab|mesh-list
102140791|NCT03836066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102140792|NCT03836066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102140793|NCT03836066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102140794|NCT03836066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102140795|NCT03836066|Growth Substances|growth substances|mesh-ancestor
102140796|NCT03836066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140797|NCT03836066|Growth Inhibitors|growth inhibitors|mesh-ancestor
102140798|NCT03836066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102140799|NCT03836066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140800|NCT03778242|Tranexamic Acid|tranexamic acid|mesh-list
102140801|NCT03778242|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102140802|NCT03778242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102140803|NCT03778242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140804|NCT03778242|Hemostatics|hemostatics|mesh-ancestor
102140805|NCT03778242|Coagulants|coagulants|mesh-ancestor
102140806|NCT03772613|Heparin|heparin|mesh-list
102140807|NCT03772613|Calcium heparin|calcium heparin|mesh-list
102140808|NCT03772613|Anticoagulants|anticoagulants|mesh-ancestor
102140809|NCT03772613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102140810|NCT03772613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102140811|NCT03772613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140812|NCT03730194|Melatonin|melatonin|mesh-list
102140813|NCT03730194|Antioxidants|antioxidants|mesh-ancestor
102140814|NCT03730194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140815|NCT03730194|Protective Agents|protective agents|mesh-ancestor
102140816|NCT03730194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140817|NCT03730194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102140818|NCT03698461|Leucovorin|leucovorin|mesh-list
102140819|NCT03698461|Bevacizumab|bevacizumab|mesh-list
102140820|NCT03698461|Atezolizumab|atezolizumab|mesh-list
102140821|NCT03698461|Fluorouracil|fluorouracil|mesh-list
102140822|NCT03698461|Oxaliplatin|oxaliplatin|mesh-list
102140823|NCT03698461|Levoleucovorin|levoleucovorin|mesh-list
102140824|NCT03698461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102140825|NCT03698461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102140826|NCT03698461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102140827|NCT03698461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102140828|NCT03698461|Growth Substances|growth substances|mesh-ancestor
102140829|NCT03698461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140830|NCT03698461|Growth Inhibitors|growth inhibitors|mesh-ancestor
102140831|NCT03698461|Antimetabolites|antimetabolites|mesh-ancestor
102140832|NCT03698461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140833|NCT03698461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102140834|NCT03698461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102140835|NCT03698461|Immunologic Factors|immunologic factors|mesh-ancestor
102140836|NCT03698461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102535902|NCT02664909|Coagulants|coagulants|mesh-ancestor
101849788|NCT01066689|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102140837|NCT03698461|Antidotes|antidotes|mesh-ancestor
102140838|NCT03698461|Protective Agents|protective agents|mesh-ancestor
102140839|NCT03698461|Vitamin B Complex|vitamin b complex|mesh-ancestor
102140840|NCT03698461|Vitamins|vitamins|mesh-ancestor
102140841|NCT03698461|Micronutrients|micronutrients|mesh-ancestor
102140843|NCT03601923|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102140844|NCT03601923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102140845|NCT03601923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140846|NCT03601923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102140847|NCT03590652|Dexamethasone|dexamethasone|mesh-list
102140848|NCT03590652|Daratumumab|daratumumab|mesh-list
102140849|NCT03590652|Pomalidomide|pomalidomide|mesh-list
102140850|NCT03590652|Ixazomib|ixazomib|mesh-list
102140851|NCT03590652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102140852|NCT03590652|Antiemetics|antiemetics|mesh-ancestor
102140853|NCT03590652|Autonomic Agents|autonomic agents|mesh-ancestor
102140854|NCT03590652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102140855|NCT03590652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140856|NCT03590652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102140857|NCT03590652|Glucocorticoids|glucocorticoids|mesh-ancestor
102140858|NCT03590652|Hormones|hormones|mesh-ancestor
102140859|NCT03590652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102140860|NCT03590652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102140861|NCT03590652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102140862|NCT03590652|Immunologic Factors|immunologic factors|mesh-ancestor
102140863|NCT03590652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102140864|NCT03590652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102140865|NCT03590652|Growth Substances|growth substances|mesh-ancestor
102140866|NCT03590652|Growth Inhibitors|growth inhibitors|mesh-ancestor
102140867|NCT03590652|Protease Inhibitors|protease inhibitors|mesh-ancestor
102140868|NCT03590652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102140869|NCT03590652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140870|NCT03535363|Osimertinib|osimertinib|mesh-list
102140871|NCT03535363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102140872|NCT03535363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102140873|NCT03535363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102140874|NCT03535363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140875|NCT03417284|Melphalan|melphalan|mesh-list
102140876|NCT03417284|Lenograstim|lenograstim|mesh-list
102140877|NCT03417284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102140878|NCT03417284|Immunologic Factors|immunologic factors|mesh-ancestor
102140879|NCT03417284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140880|NCT03417284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102140881|NCT03417284|Alkylating Agents|alkylating agents|mesh-ancestor
102140882|NCT03417284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140883|NCT03417284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102140884|NCT03417284|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102140885|NCT03417284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102140886|NCT03384836|Pembrolizumab|pembrolizumab|mesh-list
102140887|NCT03384836|Propranolol|propranolol|mesh-list
102140888|NCT03384836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102140889|NCT03384836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102140890|NCT03384836|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102140891|NCT03384836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140892|NCT03384836|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102140893|NCT03384836|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102140894|NCT03384836|Adrenergic Agents|adrenergic agents|mesh-ancestor
102140895|NCT03384836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102140896|NCT03384836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102140897|NCT03384836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102140898|NCT03384836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102140899|NCT03384836|Vasodilator Agents|vasodilator agents|mesh-ancestor
102140900|NCT03377179|Hydroxychloroquine|hydroxychloroquine|mesh-list
102140901|NCT03377179|Antimalarials|antimalarials|mesh-ancestor
102140902|NCT03377179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102140903|NCT03377179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102140904|NCT03377179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102140905|NCT03377179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102140906|NCT03377179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102140907|NCT03377179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102140908|NCT03290937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102140909|NCT03290937|Cetuximab|cetuximab|mesh-list
102140910|NCT03290937|Irinotecan|irinotecan|mesh-list
102140911|NCT03290937|Camptothecin|camptothecin|mesh-list
102140912|NCT03290937|Antibodies|antibodies|mesh-list
102140913|NCT03290937|Immunoglobulins|immunoglobulins|mesh-list
102140914|NCT03290937|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102141014|NCT02848131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102141016|NCT02848131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141017|NCT02848131|Antioxidants|antioxidants|mesh-ancestor
102141018|NCT02848131|Protective Agents|protective agents|mesh-ancestor
102141019|NCT02848131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141020|NCT02846376|Nivolumab|nivolumab|mesh-list
102141021|NCT02846376|Ipilimumab|ipilimumab|mesh-list
102141022|NCT02846376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102141023|NCT02846376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102141024|NCT02846376|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102141025|NCT02846376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141026|NCT02590601|Bromocriptine|bromocriptine|mesh-list
102141027|NCT02590601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102141028|NCT02590601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102141029|NCT02590601|Hormone Antagonists|hormone antagonists|mesh-ancestor
102141030|NCT02590601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102141031|NCT02590601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141032|NCT02590601|Dopamine Agonists|dopamine agonists|mesh-ancestor
102141033|NCT02590601|Dopamine Agents|dopamine agents|mesh-ancestor
102141034|NCT02590601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102141035|NCT02590601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141036|NCT02484443|Dinutuximab|dinutuximab|mesh-list
102141037|NCT02484443|Sargramostim|sargramostim|mesh-list
102141038|NCT02484443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102141039|NCT02484443|Immunologic Factors|immunologic factors|mesh-ancestor
102141040|NCT02484443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141041|NCT02484443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102141042|NCT02306161|Cyclophosphamide|cyclophosphamide|mesh-list
102141043|NCT02306161|Ifosfamide|ifosfamide|mesh-list
102141044|NCT02306161|Isophosphamide mustard|isophosphamide mustard|mesh-list
102141045|NCT02306161|Doxorubicin|doxorubicin|mesh-list
102141046|NCT02306161|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102141047|NCT02306161|Etoposide|etoposide|mesh-list
102141048|NCT02306161|Etoposide phosphate|etoposide phosphate|mesh-list
102141049|NCT02306161|Vincristine|vincristine|mesh-list
102141050|NCT02306161|Daunorubicin|daunorubicin|mesh-list
102141051|NCT02306161|Podophyllotoxin|podophyllotoxin|mesh-list
102141052|NCT02306161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102141053|NCT02306161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102141054|NCT02306161|Immunologic Factors|immunologic factors|mesh-ancestor
102141055|NCT02306161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141056|NCT02306161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102141057|NCT02306161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102141058|NCT02306161|Alkylating Agents|alkylating agents|mesh-ancestor
102141059|NCT02306161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141060|NCT02306161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102141061|NCT02306161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102141062|NCT02306161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102141063|NCT02306161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102141064|NCT02306161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102141065|NCT02306161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102141066|NCT02306161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102141067|NCT02306161|Tubulin Modulators|tubulin modulators|mesh-ancestor
102141068|NCT02306161|Antimitotic Agents|antimitotic agents|mesh-ancestor
102535903|NCT00368589|Atorvastatin|atorvastatin|mesh-list
102141069|NCT02306161|Mitosis Modulators|mitosis modulators|mesh-ancestor
102141070|NCT02306161|Keratolytic Agents|keratolytic agents|mesh-ancestor
102141071|NCT02306161|Dermatologic Agents|dermatologic agents|mesh-ancestor
102141072|NCT02254278|Cisplatin|cisplatin|mesh-list
102141073|NCT02254278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102141074|NCT02240498|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102141075|NCT02240498|Methylene Blue|methylene blue|mesh-list
102141076|NCT02240498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102141077|NCT02240498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141078|NCT02240498|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102141079|NCT02240498|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102141080|NCT02240498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102141081|NCT02178098|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
102141082|NCT02178098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102141083|NCT02178098|Antimetabolites|antimetabolites|mesh-ancestor
102141084|NCT02178098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141085|NCT02178098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102141086|NCT02178098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102141087|NCT02178098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102141088|NCT02178098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141089|NCT02101853|Calcium, Dietary|calcium, dietary|mesh-list
102141090|NCT02101853|Leucovorin|leucovorin|mesh-list
102141091|NCT02101853|Folic Acid|folic acid|mesh-list
102141092|NCT02101853|Cytarabine|cytarabine|mesh-list
102141093|NCT02101853|Dexamethasone|dexamethasone|mesh-list
102141094|NCT02101853|Dexamethasone acetate|dexamethasone acetate|mesh-list
102141095|NCT02101853|Hydrocortisone|hydrocortisone|mesh-list
102141096|NCT02101853|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102141097|NCT02101853|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102141098|NCT02101853|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102141099|NCT02101853|Cyclophosphamide|cyclophosphamide|mesh-list
102141100|NCT02101853|Methotrexate|methotrexate|mesh-list
102141101|NCT02101853|Etoposide|etoposide|mesh-list
102141102|NCT02101853|Vincristine|vincristine|mesh-list
102141103|NCT02101853|Etoposide phosphate|etoposide phosphate|mesh-list
102141104|NCT02101853|Asparaginase|asparaginase|mesh-list
102141105|NCT02101853|Mitoxantrone|mitoxantrone|mesh-list
102141106|NCT02101853|Mercaptopurine|mercaptopurine|mesh-list
102141107|NCT02101853|Podophyllotoxin|podophyllotoxin|mesh-list
102141108|NCT02101853|Pegaspargase|pegaspargase|mesh-list
102141109|NCT02101853|Thioguanine|thioguanine|mesh-list
102141110|NCT02101853|Blinatumomab|blinatumomab|mesh-list
102141111|NCT02101853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102141112|NCT02101853|Muromonab-CD3|muromonab-cd3|mesh-list
102141113|NCT02101853|Antibodies|antibodies|mesh-list
102141114|NCT02101853|Immunoglobulins|immunoglobulins|mesh-list
102141115|NCT02101853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102141116|NCT02101853|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102141117|NCT02101853|BB 1101|bb 1101|mesh-list
102141118|NCT02101853|Calcium|calcium|mesh-list
102141119|NCT02101853|2-Aminopurine|2-aminopurine|mesh-list
102141120|NCT02101853|Levoleucovorin|levoleucovorin|mesh-list
102141121|NCT02101853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102141122|NCT02101853|Immunologic Factors|immunologic factors|mesh-ancestor
102141123|NCT02101853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141124|NCT02101853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102141125|NCT02101853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102141126|NCT02101853|Alkylating Agents|alkylating agents|mesh-ancestor
102141127|NCT02101853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141128|NCT02101853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102141129|NCT02101853|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102141130|NCT02101853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102141131|NCT02101853|Antiemetics|antiemetics|mesh-ancestor
102141132|NCT02101853|Autonomic Agents|autonomic agents|mesh-ancestor
102141133|NCT02101853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102141134|NCT02101853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102141135|NCT02101853|Glucocorticoids|glucocorticoids|mesh-ancestor
102141136|NCT02101853|Hormones|hormones|mesh-ancestor
102141137|NCT02101853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102141138|NCT02101853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102141139|NCT02101853|Protease Inhibitors|protease inhibitors|mesh-ancestor
102141140|NCT02101853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102141141|NCT02101853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102141142|NCT02101853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102141143|NCT02101853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101850087|NCT00289887|Losartan|losartan|mesh-list
102141144|NCT02101853|Abortifacient Agents|abortifacient agents|mesh-ancestor
102141145|NCT02101853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102141146|NCT02101853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102141147|NCT02101853|Antimetabolites|antimetabolites|mesh-ancestor
102141148|NCT02101853|Dermatologic Agents|dermatologic agents|mesh-ancestor
102141149|NCT02101853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102141150|NCT02101853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102141151|NCT02101853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102141152|NCT02101853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102141153|NCT02101853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102141154|NCT02101853|Antiviral Agents|antiviral agents|mesh-ancestor
102141155|NCT02101853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102141156|NCT02101853|Antidotes|antidotes|mesh-ancestor
102141157|NCT02101853|Protective Agents|protective agents|mesh-ancestor
102141158|NCT02101853|Vitamin B Complex|vitamin b complex|mesh-ancestor
102141159|NCT02101853|Vitamins|vitamins|mesh-ancestor
102141160|NCT02101853|Micronutrients|micronutrients|mesh-ancestor
102141161|NCT02101853|Tubulin Modulators|tubulin modulators|mesh-ancestor
102141162|NCT02101853|Antimitotic Agents|antimitotic agents|mesh-ancestor
102141163|NCT02101853|Mitosis Modulators|mitosis modulators|mesh-ancestor
102141164|NCT02101853|Hematinics|hematinics|mesh-ancestor
102141165|NCT02101853|Analgesics|analgesics|mesh-ancestor
102141166|NCT02101853|Sensory System Agents|sensory system agents|mesh-ancestor
102141167|NCT02101853|Keratolytic Agents|keratolytic agents|mesh-ancestor
102141168|NCT01885689|Sirolimus|sirolimus|mesh-list
102141169|NCT01885689|Melphalan|melphalan|mesh-list
102141170|NCT01885689|Clofarabine|clofarabine|mesh-list
102141171|NCT01885689|Tacrolimus|tacrolimus|mesh-list
102141172|NCT01885689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102141173|NCT01885689|Immunologic Factors|immunologic factors|mesh-ancestor
102141174|NCT01885689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141175|NCT01885689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102141176|NCT01885689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102141177|NCT01885689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141178|NCT01885689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102141179|NCT01885689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102141180|NCT01885689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102141181|NCT01885689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102141182|NCT01885689|Antifungal Agents|antifungal agents|mesh-ancestor
102141183|NCT01885689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102141184|NCT01885689|Alkylating Agents|alkylating agents|mesh-ancestor
102141185|NCT01885689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102141186|NCT01885689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102141187|NCT01885689|Antimetabolites|antimetabolites|mesh-ancestor
102141188|NCT01798004|Cyclophosphamide|cyclophosphamide|mesh-list
102141189|NCT01798004|Melphalan|melphalan|mesh-list
102141190|NCT01798004|Busulfan|busulfan|mesh-list
102141191|NCT01798004|Mechlorethamine|mechlorethamine|mesh-list
102141192|NCT01798004|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102141193|NCT01798004|Cisplatin|cisplatin|mesh-list
102141194|NCT01798004|Doxorubicin|doxorubicin|mesh-list
102141195|NCT01798004|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102141196|NCT01798004|Etoposide|etoposide|mesh-list
102141197|NCT01798004|Vincristine|vincristine|mesh-list
102141198|NCT01798004|Etoposide phosphate|etoposide phosphate|mesh-list
102141199|NCT01798004|Topotecan|topotecan|mesh-list
102141200|NCT01798004|Podophyllotoxin|podophyllotoxin|mesh-list
102141201|NCT01798004|Lenograstim|lenograstim|mesh-list
102141202|NCT01798004|Mesna|mesna|mesh-list
102141203|NCT01798004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102141204|NCT01798004|Immunologic Factors|immunologic factors|mesh-ancestor
102141205|NCT01798004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141206|NCT01798004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102141207|NCT01798004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102141208|NCT01798004|Alkylating Agents|alkylating agents|mesh-ancestor
102141209|NCT01798004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141210|NCT01798004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102141211|NCT01798004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102141212|NCT01798004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102141213|NCT01798004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102141214|NCT01798004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102141215|NCT01798004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102141216|NCT01798004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102141217|NCT01798004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102141218|NCT01798004|Tubulin Modulators|tubulin modulators|mesh-ancestor
102141219|NCT01798004|Antimitotic Agents|antimitotic agents|mesh-ancestor
102141220|NCT01798004|Mitosis Modulators|mitosis modulators|mesh-ancestor
102141221|NCT01798004|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102141222|NCT01798004|Protective Agents|protective agents|mesh-ancestor
102141223|NCT01798004|Keratolytic Agents|keratolytic agents|mesh-ancestor
102141224|NCT01798004|Dermatologic Agents|dermatologic agents|mesh-ancestor
102141225|NCT01693380|Vaccines|vaccines|mesh-list
102141226|NCT01693380|Immunologic Factors|immunologic factors|mesh-ancestor
102141227|NCT01693380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141228|NCT01542879|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102141229|NCT01542879|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102141230|NCT01542879|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102141231|NCT01542879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141232|NCT01542879|Hematinics|hematinics|mesh-ancestor
102141233|NCT01542879|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102141234|NCT01542879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102141235|NCT01492972|Leuprolide|leuprolide|mesh-list
102141236|NCT01492972|Goserelin|goserelin|mesh-list
102141237|NCT01492972|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102141238|NCT01492972|Buserelin|buserelin|mesh-list
102141239|NCT01492972|Androgens|androgens|mesh-list
102141240|NCT01492972|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102141241|NCT01492972|Fertility Agents|fertility agents|mesh-ancestor
102141242|NCT01492972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102141243|NCT01492972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141244|NCT01492972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102141245|NCT01492972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102141246|NCT01492972|Hormones|hormones|mesh-ancestor
102141247|NCT01492972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102141248|NCT01492972|Luteolytic Agents|luteolytic agents|mesh-ancestor
102141249|NCT01492972|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102141250|NCT01492972|Contraceptive Agents|contraceptive agents|mesh-ancestor
102141251|NCT01492972|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102141252|NCT01256398|Calcium, Dietary|calcium, dietary|mesh-list
102141253|NCT01256398|Leucovorin|leucovorin|mesh-list
102141254|NCT01256398|Folic Acid|folic acid|mesh-list
102141255|NCT01256398|Cytarabine|cytarabine|mesh-list
102141256|NCT01256398|Dexamethasone|dexamethasone|mesh-list
102141257|NCT01256398|Dexamethasone acetate|dexamethasone acetate|mesh-list
102141258|NCT01256398|Cyclophosphamide|cyclophosphamide|mesh-list
102141259|NCT01256398|Melphalan|melphalan|mesh-list
102141260|NCT01256398|Mechlorethamine|mechlorethamine|mesh-list
102141261|NCT01256398|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102141262|NCT01256398|Methotrexate|methotrexate|mesh-list
102141263|NCT01256398|Fludarabine|fludarabine|mesh-list
102141264|NCT01256398|Fludarabine phosphate|fludarabine phosphate|mesh-list
102141265|NCT01256398|Etoposide|etoposide|mesh-list
102141266|NCT01256398|Vincristine|vincristine|mesh-list
102141267|NCT01256398|Daunorubicin|daunorubicin|mesh-list
102141268|NCT01256398|Dasatinib|dasatinib|mesh-list
102141269|NCT01256398|Mercaptopurine|mercaptopurine|mesh-list
102141270|NCT01256398|Alemtuzumab|alemtuzumab|mesh-list
102141271|NCT01256398|Etoposide phosphate|etoposide phosphate|mesh-list
102141272|NCT01256398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102141273|NCT01256398|Tacrolimus|tacrolimus|mesh-list
102141274|NCT01256398|Antibodies|antibodies|mesh-list
102141275|NCT01256398|Immunoglobulins|immunoglobulins|mesh-list
102141276|NCT01256398|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102141277|NCT01256398|Lenograstim|lenograstim|mesh-list
102141278|NCT01256398|BB 1101|bb 1101|mesh-list
102141279|NCT01256398|Calcium|calcium|mesh-list
102141280|NCT01256398|Levoleucovorin|levoleucovorin|mesh-list
102141281|NCT01256398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102141282|NCT01256398|Immunologic Factors|immunologic factors|mesh-ancestor
102141283|NCT01256398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141284|NCT01256398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102141285|NCT01256398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102141286|NCT01256398|Alkylating Agents|alkylating agents|mesh-ancestor
102141287|NCT01256398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141288|NCT01256398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102141289|NCT01256398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102141290|NCT01256398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102141291|NCT01256398|Antiemetics|antiemetics|mesh-ancestor
102141292|NCT01256398|Autonomic Agents|autonomic agents|mesh-ancestor
102141293|NCT01256398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102141294|NCT01256398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102141295|NCT01256398|Glucocorticoids|glucocorticoids|mesh-ancestor
102141296|NCT01256398|Hormones|hormones|mesh-ancestor
102141297|NCT01256398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102141298|NCT01256398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102141299|NCT01256398|Protease Inhibitors|protease inhibitors|mesh-ancestor
102141300|NCT01256398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102141301|NCT01256398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102141302|NCT01256398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102141303|NCT01256398|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102141304|NCT01256398|Abortifacient Agents|abortifacient agents|mesh-ancestor
102141305|NCT01256398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102141323|NCT01256398|Tubulin Modulators|tubulin modulators|mesh-ancestor
102141324|NCT01256398|Antimitotic Agents|antimitotic agents|mesh-ancestor
102141325|NCT01256398|Mitosis Modulators|mitosis modulators|mesh-ancestor
102141326|NCT01256398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102141327|NCT01256398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102141328|NCT01256398|Hematinics|hematinics|mesh-ancestor
102141329|NCT01175356|Vitamin A|vitamin a|mesh-list
102141330|NCT01175356|Cyclophosphamide|cyclophosphamide|mesh-list
102141331|NCT01175356|Melphalan|melphalan|mesh-list
102141332|NCT01175356|Busulfan|busulfan|mesh-list
102141333|NCT01175356|Mechlorethamine|mechlorethamine|mesh-list
102141334|NCT01175356|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102141335|NCT01175356|Cisplatin|cisplatin|mesh-list
102141336|NCT01175356|Doxorubicin|doxorubicin|mesh-list
102141337|NCT01175356|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102141338|NCT01175356|Etoposide|etoposide|mesh-list
102141339|NCT01175356|Vincristine|vincristine|mesh-list
102141340|NCT01175356|Topotecan|topotecan|mesh-list
102141341|NCT01175356|Tretinoin|tretinoin|mesh-list
102141342|NCT01175356|Etoposide phosphate|etoposide phosphate|mesh-list
102141343|NCT01175356|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
102141344|NCT01175356|Isotretinoin|isotretinoin|mesh-list
102141345|NCT01175356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102141346|NCT01175356|Immunologic Factors|immunologic factors|mesh-ancestor
102141347|NCT01175356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141348|NCT01175356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102141349|NCT01175356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102141350|NCT01175356|Alkylating Agents|alkylating agents|mesh-ancestor
102141351|NCT01175356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141352|NCT01175356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102141353|NCT01175356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102141354|NCT01175356|Vitamins|vitamins|mesh-ancestor
102141355|NCT01175356|Micronutrients|micronutrients|mesh-ancestor
102141356|NCT01175356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102141357|NCT01175356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102141358|NCT01175356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102141359|NCT01175356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102141360|NCT01175356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101743161|NCT02581176|Apixaban|apixaban|mesh-list
102141361|NCT01175356|Tubulin Modulators|tubulin modulators|mesh-ancestor
102141362|NCT01175356|Antimitotic Agents|antimitotic agents|mesh-ancestor
102141363|NCT01175356|Mitosis Modulators|mitosis modulators|mesh-ancestor
102141364|NCT01175356|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102141365|NCT01175356|Keratolytic Agents|keratolytic agents|mesh-ancestor
102141366|NCT01175356|Dermatologic Agents|dermatologic agents|mesh-ancestor
102141367|NCT01175356|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102141403|NCT00673010|Trace Elements|trace elements|mesh-ancestor
102141404|NCT00673010|Micronutrients|micronutrients|mesh-ancestor
102141405|NCT00673010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141406|NCT00587067|Floxuridine|floxuridine|mesh-list
102141407|NCT00587067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102141408|NCT00587067|Antimetabolites|antimetabolites|mesh-ancestor
102141409|NCT00587067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141410|NCT00587067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102141411|NCT00577278|Sirolimus|sirolimus|mesh-list
102141412|NCT00577278|Rituximab|rituximab|mesh-list
102141413|NCT00577278|Fludarabine|fludarabine|mesh-list
102141414|NCT00577278|Fludarabine phosphate|fludarabine phosphate|mesh-list
102141415|NCT00577278|Melphalan|melphalan|mesh-list
102141416|NCT00577278|Tacrolimus|tacrolimus|mesh-list
102141417|NCT00577278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102141418|NCT00577278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102141419|NCT00577278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102141420|NCT00577278|Immunologic Factors|immunologic factors|mesh-ancestor
102141421|NCT00577278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141422|NCT00577278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102141423|NCT00577278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102141424|NCT00577278|Antimetabolites|antimetabolites|mesh-ancestor
102141425|NCT00577278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141426|NCT00577278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102141427|NCT00577278|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102141428|NCT00577278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102141429|NCT00577278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102141430|NCT00577278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102141431|NCT00577278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102141432|NCT00577278|Antifungal Agents|antifungal agents|mesh-ancestor
102141433|NCT00577278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102141434|NCT00577278|Alkylating Agents|alkylating agents|mesh-ancestor
102141435|NCT00577278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102141436|NCT00453154|Cisplatin|cisplatin|mesh-list
102141437|NCT00453154|Carboplatin|carboplatin|mesh-list
102141438|NCT00453154|Etoposide|etoposide|mesh-list
102141439|NCT00453154|Etoposide phosphate|etoposide phosphate|mesh-list
102141440|NCT00453154|Sunitinib|sunitinib|mesh-list
102141441|NCT00453154|Podophyllotoxin|podophyllotoxin|mesh-list
102141442|NCT00453154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102141443|NCT00453154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102141444|NCT00453154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102141445|NCT00453154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102141446|NCT00453154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102141447|NCT00453154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141448|NCT00453154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102141449|NCT00453154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102141450|NCT00453154|Growth Substances|growth substances|mesh-ancestor
102141451|NCT00453154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141452|NCT00453154|Growth Inhibitors|growth inhibitors|mesh-ancestor
102141453|NCT00453154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102141454|NCT00453154|Keratolytic Agents|keratolytic agents|mesh-ancestor
102141455|NCT00453154|Dermatologic Agents|dermatologic agents|mesh-ancestor
102141456|NCT00453154|Tubulin Modulators|tubulin modulators|mesh-ancestor
102141457|NCT00453154|Antimitotic Agents|antimitotic agents|mesh-ancestor
102141458|NCT00453154|Mitosis Modulators|mitosis modulators|mesh-ancestor
102141459|NCT00334815|Bevacizumab|bevacizumab|mesh-list
102141460|NCT00334815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102141461|NCT00334815|Cisplatin|cisplatin|mesh-list
102141462|NCT00334815|Docetaxel|docetaxel|mesh-list
102141463|NCT00334815|Etoposide|etoposide|mesh-list
102141464|NCT00334815|Etoposide phosphate|etoposide phosphate|mesh-list
102141465|NCT00334815|Podophyllotoxin|podophyllotoxin|mesh-list
102141466|NCT00334815|Endothelial Growth Factors|endothelial growth factors|mesh-list
102141467|NCT00334815|Antibodies|antibodies|mesh-list
102141468|NCT00334815|Immunoglobulins|immunoglobulins|mesh-list
102141469|NCT00334815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102141470|NCT00334815|Lenograstim|lenograstim|mesh-list
102141471|NCT00334815|Immunoglobulin G|immunoglobulin g|mesh-list
101743228|NCT04137354|Trace Elements|trace elements|mesh-ancestor
102141472|NCT00334815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102141473|NCT00334815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102141474|NCT00334815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102141475|NCT00334815|Growth Substances|growth substances|mesh-ancestor
102141476|NCT00334815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141477|NCT00334815|Growth Inhibitors|growth inhibitors|mesh-ancestor
102141478|NCT00334815|Immunologic Factors|immunologic factors|mesh-ancestor
102141479|NCT00334815|Tubulin Modulators|tubulin modulators|mesh-ancestor
102141480|NCT00334815|Antimitotic Agents|antimitotic agents|mesh-ancestor
102141481|NCT00334815|Mitosis Modulators|mitosis modulators|mesh-ancestor
102141482|NCT00334815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141483|NCT00334815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102141484|NCT00334815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102141485|NCT00334815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102141486|NCT00334815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102141487|NCT00334815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102141488|NCT00334815|Keratolytic Agents|keratolytic agents|mesh-ancestor
102141489|NCT00334815|Dermatologic Agents|dermatologic agents|mesh-ancestor
102141490|NCT00309257|Valsartan|valsartan|mesh-list
102141491|NCT00309257|Benazepril|benazepril|mesh-list
102141492|NCT00309257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102141493|NCT00309257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102141494|NCT00309257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102141495|NCT00309257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141496|NCT00309257|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102141497|NCT00309257|Protease Inhibitors|protease inhibitors|mesh-ancestor
102141498|NCT00309257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102141499|NCT00258960|Cyclophosphamide|cyclophosphamide|mesh-list
102141500|NCT00258960|Doxorubicin|doxorubicin|mesh-list
102141501|NCT00258960|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102141502|NCT00258960|Trastuzumab|trastuzumab|mesh-list
102141503|NCT00258960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102141504|NCT00258960|Immunologic Factors|immunologic factors|mesh-ancestor
102141505|NCT00258960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141506|NCT00258960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102141507|NCT00258960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102141508|NCT00258960|Alkylating Agents|alkylating agents|mesh-ancestor
102141509|NCT00258960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141510|NCT00258960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102141511|NCT00258960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102141512|NCT00258960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102141513|NCT00258960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102141514|NCT00258960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102141515|NCT00258960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102141516|NCT00258960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102141517|NCT00121992|Cyclophosphamide|cyclophosphamide|mesh-list
102141518|NCT00121992|Docetaxel|docetaxel|mesh-list
102141519|NCT00121992|Doxorubicin|doxorubicin|mesh-list
102141520|NCT00121992|Fluorouracil|fluorouracil|mesh-list
102141521|NCT00121992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102141522|NCT00121992|Immunologic Factors|immunologic factors|mesh-ancestor
102141523|NCT00121992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141524|NCT00121992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102141525|NCT00121992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102141526|NCT00121992|Alkylating Agents|alkylating agents|mesh-ancestor
102141527|NCT00121992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141528|NCT00121992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102141529|NCT00121992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102141530|NCT00121992|Tubulin Modulators|tubulin modulators|mesh-ancestor
102141531|NCT00121992|Antimitotic Agents|antimitotic agents|mesh-ancestor
102141532|NCT00121992|Mitosis Modulators|mitosis modulators|mesh-ancestor
102141533|NCT00121992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102141534|NCT00121992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102141535|NCT00121992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102141536|NCT00121992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102141537|NCT00121992|Antimetabolites|antimetabolites|mesh-ancestor
102141538|NCT00121992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102141539|NCT00070564|Paclitaxel|paclitaxel|mesh-list
102141540|NCT00070564|Cyclophosphamide|cyclophosphamide|mesh-list
102141541|NCT00070564|Doxorubicin|doxorubicin|mesh-list
102141542|NCT00070564|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102141543|NCT00070564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102141544|NCT00070564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102141546|NCT00070564|Antimitotic Agents|antimitotic agents|mesh-ancestor
102141547|NCT00070564|Mitosis Modulators|mitosis modulators|mesh-ancestor
102141548|NCT00070564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141549|NCT00070564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102141550|NCT00070564|Immunologic Factors|immunologic factors|mesh-ancestor
102141551|NCT00070564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141552|NCT00070564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102141553|NCT00070564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102141554|NCT00070564|Alkylating Agents|alkylating agents|mesh-ancestor
102141555|NCT00070564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102141556|NCT00070564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102141557|NCT00070564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102141558|NCT00070564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102141559|NCT00070564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102141560|NCT05158647|Magnesium Sulfate|magnesium sulfate|mesh-list
102141561|NCT05158647|Analgesics|analgesics|mesh-ancestor
102141562|NCT05158647|Sensory System Agents|sensory system agents|mesh-ancestor
102141563|NCT05158647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102141564|NCT05158647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141565|NCT05158647|Anesthetics|anesthetics|mesh-ancestor
102141566|NCT05158647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102141567|NCT05158647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102141568|NCT05158647|Anticonvulsants|anticonvulsants|mesh-ancestor
102141569|NCT05158647|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102141570|NCT05158647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102141571|NCT05158647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141572|NCT05158647|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102141573|NCT05158647|Tocolytic Agents|tocolytic agents|mesh-ancestor
102141574|NCT05158647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102141575|NCT02738151|Insulin|insulin|mesh-list
102141576|NCT02738151|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102141577|NCT02738151|Insulin Glargine|insulin glargine|mesh-list
102141578|NCT02738151|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102141579|NCT02738151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141580|NCT05212389|Contraceptive Agents|contraceptive agents|mesh-list
102141581|NCT05212389|Contraceptives, Oral|contraceptives, oral|mesh-list
102141582|NCT05212389|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
102141583|NCT05212389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102141584|NCT05212389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141585|NCT05212389|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102141586|NCT03471039|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
102141587|NCT03471039|Growth Substances|growth substances|mesh-ancestor
102141588|NCT03471039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141589|NCT03471039|Vasodilator Agents|vasodilator agents|mesh-ancestor
102141590|NCT03471039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102141591|NCT03471039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141592|NCT03472677|Capsaicin|capsaicin|mesh-list
102141593|NCT03472677|Antipruritics|antipruritics|mesh-ancestor
102141594|NCT03472677|Dermatologic Agents|dermatologic agents|mesh-ancestor
102141595|NCT03472677|Sensory System Agents|sensory system agents|mesh-ancestor
102141596|NCT03472677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102141597|NCT03472677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141598|NCT02673567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102141599|NCT02673567|Antibodies|antibodies|mesh-list
102141600|NCT02673567|Immunoglobulins|immunoglobulins|mesh-list
102141601|NCT02673567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102141602|NCT02673567|Immunologic Factors|immunologic factors|mesh-ancestor
102141603|NCT02673567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141604|NCT02673567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102141605|NCT00702195|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102141606|NCT00702195|Hormones|hormones|mesh-ancestor
102141607|NCT00702195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102141608|NCT00702195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141609|NCT02993731|Paclitaxel|paclitaxel|mesh-list
102141610|NCT02993731|Gemcitabine|gemcitabine|mesh-list
102141611|NCT02993731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102141612|NCT02993731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102141613|NCT02993731|Tubulin Modulators|tubulin modulators|mesh-ancestor
102141614|NCT02993731|Antimitotic Agents|antimitotic agents|mesh-ancestor
102141615|NCT02993731|Mitosis Modulators|mitosis modulators|mesh-ancestor
102141616|NCT02993731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141617|NCT02993731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102141619|NCT02915159|Abatacept|abatacept|mesh-list
102141620|NCT02915159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102141621|NCT02915159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141622|NCT02915159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102141623|NCT02915159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102141624|NCT02915159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102141625|NCT02915159|Immunologic Factors|immunologic factors|mesh-ancestor
102141626|NCT02915159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141627|NCT02915159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102141628|NCT03669263|Fentanyl|fentanyl|mesh-list
102141629|NCT03669263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102141630|NCT03669263|Narcotics|narcotics|mesh-ancestor
102141631|NCT03669263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102141632|NCT03669263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141633|NCT03669263|Analgesics|analgesics|mesh-ancestor
102141634|NCT03669263|Sensory System Agents|sensory system agents|mesh-ancestor
102141635|NCT03669263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102141636|NCT03669263|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102141637|NCT03669263|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102141638|NCT03669263|Anesthetics, General|anesthetics, general|mesh-ancestor
102141639|NCT03669263|Anesthetics|anesthetics|mesh-ancestor
102141640|NCT02669264|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
102141641|NCT02669264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102141642|NCT02669264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102141643|NCT02521870|Pembrolizumab|pembrolizumab|mesh-list
102141644|NCT02521870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102141645|NCT02521870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102141646|NCT02521870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102141647|NCT02521870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141648|NCT02385656|Modafinil|modafinil|mesh-list
102141649|NCT02385656|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102141650|NCT02385656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141651|NCT02385656|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102141652|NCT02385656|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102141653|NCT02385656|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102141654|NCT02385656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141655|NCT02389868|Lovastatin|lovastatin|mesh-list
102141656|NCT02389868|L 647318|l 647318|mesh-list
102141657|NCT02389868|Dihydromevinolin|dihydromevinolin|mesh-list
102141658|NCT02389868|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102141659|NCT02389868|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102141660|NCT02389868|Antimetabolites|antimetabolites|mesh-ancestor
102141661|NCT02389868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141662|NCT02389868|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102141663|NCT02389868|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102141664|NCT02389868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102141665|NCT03623087|Dexamethasone|dexamethasone|mesh-list
102141666|NCT03623087|Gemcitabine|gemcitabine|mesh-list
102141667|NCT03623087|Etoposide|etoposide|mesh-list
102141668|NCT03623087|Asparaginase|asparaginase|mesh-list
102141669|NCT03623087|Ifosfamide|ifosfamide|mesh-list
102141670|NCT03623087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102141671|NCT03623087|Antiemetics|antiemetics|mesh-ancestor
102141672|NCT03623087|Autonomic Agents|autonomic agents|mesh-ancestor
102141673|NCT03623087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102141674|NCT03623087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141675|NCT03623087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102141676|NCT03623087|Glucocorticoids|glucocorticoids|mesh-ancestor
102141677|NCT03623087|Hormones|hormones|mesh-ancestor
102141678|NCT03623087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102141679|NCT03623087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102141680|NCT03623087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102141681|NCT03623087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102141682|NCT03623087|Antimetabolites|antimetabolites|mesh-ancestor
102141683|NCT03623087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141684|NCT03623087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102141685|NCT03623087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102141686|NCT03623087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102141687|NCT03623087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102141688|NCT03623087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102141689|NCT03623087|Alkylating Agents|alkylating agents|mesh-ancestor
102141690|NCT05420636|Paclitaxel|paclitaxel|mesh-list
102141691|NCT05420636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102141692|NCT05420636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102141693|NCT05420636|Tubulin Modulators|tubulin modulators|mesh-ancestor
102141694|NCT05420636|Antimitotic Agents|antimitotic agents|mesh-ancestor
102141695|NCT05420636|Mitosis Modulators|mitosis modulators|mesh-ancestor
102141696|NCT05420636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141697|NCT05066308|Cannabidiol|cannabidiol|mesh-list
102141698|NCT05066308|Anticonvulsants|anticonvulsants|mesh-ancestor
102141699|NCT03113396|Baclofen|baclofen|mesh-list
102141700|NCT03113396|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102141701|NCT03113396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141702|NCT03113396|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102141703|NCT03113396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102141704|NCT03113396|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102141705|NCT03113396|GABA Agonists|gaba agonists|mesh-ancestor
102141706|NCT03113396|GABA Agents|gaba agents|mesh-ancestor
102141707|NCT03113396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102141708|NCT03113396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141709|NCT03020615|Hydroxyurea|hydroxyurea|mesh-list
102141710|NCT03020615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102141711|NCT03020615|Antisickling Agents|antisickling agents|mesh-ancestor
102141712|NCT03020615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102141713|NCT03020615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141714|NCT03020615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102141715|NCT05063500|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
102141716|NCT05063500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102141717|NCT05063500|Antimetabolites|antimetabolites|mesh-ancestor
102141718|NCT05063500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141719|NCT05063500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102141720|NCT03693170|Cetuximab|cetuximab|mesh-list
102141721|NCT03693170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102141722|NCT03693170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102141723|NCT05062954|Proanthocyanidin|proanthocyanidin|mesh-list
102141724|NCT05062954|Procyanidin|procyanidin|mesh-list
102141725|NCT05062954|Antioxidants|antioxidants|mesh-ancestor
102141726|NCT05062954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141727|NCT05062954|Protective Agents|protective agents|mesh-ancestor
102141728|NCT05062954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141729|NCT05062954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102141730|NCT05062954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102141731|NCT05062954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102141732|NCT05048524|Leucovorin|leucovorin|mesh-list
102141733|NCT05048524|Gemcitabine|gemcitabine|mesh-list
102141734|NCT05048524|Oxaliplatin|oxaliplatin|mesh-list
102141735|NCT05048524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102141736|NCT05048524|Antimetabolites|antimetabolites|mesh-ancestor
102141737|NCT05048524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141738|NCT05048524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102141739|NCT05048524|Antidotes|antidotes|mesh-ancestor
102141740|NCT05048524|Protective Agents|protective agents|mesh-ancestor
102141741|NCT05048524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141742|NCT05048524|Vitamin B Complex|vitamin b complex|mesh-ancestor
102141743|NCT05048524|Vitamins|vitamins|mesh-ancestor
102141744|NCT05048524|Micronutrients|micronutrients|mesh-ancestor
102141745|NCT02389400|Methotrexate|methotrexate|mesh-list
102141746|NCT02389400|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102141747|NCT02389400|Abortifacient Agents|abortifacient agents|mesh-ancestor
102141748|NCT02389400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102141749|NCT02389400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141750|NCT02389400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102141751|NCT02389400|Antimetabolites|antimetabolites|mesh-ancestor
102141752|NCT02389400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141753|NCT02389400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102141754|NCT02389400|Dermatologic Agents|dermatologic agents|mesh-ancestor
102141755|NCT02389400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102141756|NCT02389400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102141757|NCT02389400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102141758|NCT02389400|Immunologic Factors|immunologic factors|mesh-ancestor
102141759|NCT02389400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102141760|NCT02389400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102141761|NCT02389322|BCG Vaccine|bcg vaccine|mesh-list
102141762|NCT02389322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102141763|NCT02389322|Immunologic Factors|immunologic factors|mesh-ancestor
102141764|NCT02389322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141765|NCT03669029|Golimumab|golimumab|mesh-list
102141766|NCT03669029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102141767|NCT03669029|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102141768|NCT03669029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102141769|NCT03669029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102141770|NCT03669029|Immunologic Factors|immunologic factors|mesh-ancestor
102141771|NCT03669029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141772|NCT03668015|Sorbitol|sorbitol|mesh-list
102141773|NCT03668015|Cathartics|cathartics|mesh-ancestor
102141774|NCT03668015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102141775|NCT02385734|Mitogens|mitogens|mesh-list
102141776|NCT02385734|Mitosis Modulators|mitosis modulators|mesh-ancestor
102141777|NCT02385734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141778|NCT02385500|Fesoterodine|fesoterodine|mesh-list
102141779|NCT02385500|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102141780|NCT02385500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102141781|NCT02385500|Cholinergic Agents|cholinergic agents|mesh-ancestor
102141782|NCT02385500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102141783|NCT02385500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141784|NCT02385500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141785|NCT02385500|Urological Agents|urological agents|mesh-ancestor
102141786|NCT05058976|Vitamin D|vitamin d|mesh-list
102141787|NCT05058976|Zoledronic Acid|zoledronic acid|mesh-list
102141788|NCT05058976|Calcium|calcium|mesh-list
102141789|NCT05058976|Vitamins|vitamins|mesh-ancestor
102141790|NCT05058976|Micronutrients|micronutrients|mesh-ancestor
102141791|NCT05058976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141792|NCT05058976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102141793|NCT05058976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102141794|NCT02385422|Propranolol|propranolol|mesh-list
102141795|NCT02385422|Carvedilol|carvedilol|mesh-list
102141796|NCT02385422|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102141797|NCT02385422|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102141798|NCT02385422|Adrenergic Agents|adrenergic agents|mesh-ancestor
102141799|NCT02385422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102141800|NCT02385422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141801|NCT02385422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141802|NCT02385422|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102141803|NCT02385422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102141804|NCT02385422|Vasodilator Agents|vasodilator agents|mesh-ancestor
102141805|NCT02385422|Antioxidants|antioxidants|mesh-ancestor
102141806|NCT02385422|Protective Agents|protective agents|mesh-ancestor
102141807|NCT02385422|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102141808|NCT02385422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102141809|NCT02385422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102141810|NCT02385422|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102141811|NCT02385422|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102141812|NCT02520388|Methylphenidate|methylphenidate|mesh-list
102141813|NCT02520388|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102141814|NCT02520388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141815|NCT02520388|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102141816|NCT02520388|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102141817|NCT02520388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102141818|NCT02520388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141819|NCT02520388|Dopamine Agents|dopamine agents|mesh-ancestor
102141820|NCT02520388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102141821|NCT03667937|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102141822|NCT03667937|Laxatives|laxatives|mesh-ancestor
102141823|NCT03667937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102141824|NCT03667235|Glutaral|glutaral|mesh-list
102141825|NCT03667235|Disinfectants|disinfectants|mesh-ancestor
102141826|NCT03667235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102141827|NCT02668640|Adalimumab|adalimumab|mesh-list
102141828|NCT02668640|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102141829|NCT02668640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102141830|NCT02668640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102141831|NCT05043766|Naltrexone|naltrexone|mesh-list
102141832|NCT05043766|Oxycodone|oxycodone|mesh-list
102141833|NCT05043766|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102141834|NCT05043766|Narcotics|narcotics|mesh-ancestor
102141835|NCT05043766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102141836|NCT05043766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141837|NCT05043766|Analgesics|analgesics|mesh-ancestor
102141838|NCT05043766|Sensory System Agents|sensory system agents|mesh-ancestor
102141839|NCT05043766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102141840|NCT05043766|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102141841|NCT05043766|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102535904|NCT00368589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101850749|NCT03742466|Methylprednisolone|methylprednisolone|mesh-list
102141842|NCT03462368|Anti-Infective Agents|anti-infective agents|mesh-list
102141843|NCT03462368|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102141845|NCT02383238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102141846|NCT02383238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141847|NCT02383238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102141848|NCT02383238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141849|NCT03011333|Epinephrine|epinephrine|mesh-list
102141850|NCT03011333|Bupivacaine|bupivacaine|mesh-list
102141851|NCT03011333|Anesthetics, Local|anesthetics, local|mesh-ancestor
102141852|NCT03011333|Anesthetics|anesthetics|mesh-ancestor
102141853|NCT03011333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102141854|NCT03011333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141855|NCT03011333|Sensory System Agents|sensory system agents|mesh-ancestor
102141856|NCT03011333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102141857|NCT03011333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102141858|NCT03011333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102141859|NCT03011333|Adrenergic Agents|adrenergic agents|mesh-ancestor
102141860|NCT03011333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102141861|NCT03011333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141862|NCT03011333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102141863|NCT03011333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102141864|NCT03011333|Autonomic Agents|autonomic agents|mesh-ancestor
102141865|NCT03011333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102141866|NCT03011333|Respiratory System Agents|respiratory system agents|mesh-ancestor
102141867|NCT03011333|Mydriatics|mydriatics|mesh-ancestor
102141868|NCT03011333|Sympathomimetics|sympathomimetics|mesh-ancestor
102141869|NCT03011333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102141870|NCT04570397|Ravulizumab|ravulizumab|mesh-list
102141871|NCT04570397|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102141872|NCT04570397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102141873|NCT04570397|Immunologic Factors|immunologic factors|mesh-ancestor
102141874|NCT04570397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743640|NCT04061655|Iron|iron|mesh-list
102141875|NCT02385188|Acetaminophen|acetaminophen|mesh-list
102141876|NCT02385188|Imiquimod|imiquimod|mesh-list
102141877|NCT02385188|Lidocaine|lidocaine|mesh-list
102141878|NCT02385188|Petrolatum|petrolatum|mesh-list
102141879|NCT02385188|Anesthetics, Local|anesthetics, local|mesh-ancestor
102141880|NCT02385188|Anesthetics|anesthetics|mesh-ancestor
102141881|NCT02385188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102141882|NCT02385188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141883|NCT02385188|Sensory System Agents|sensory system agents|mesh-ancestor
102141884|NCT02385188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102141885|NCT02385188|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102141886|NCT02385188|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102141887|NCT02385188|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102141888|NCT02385188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102141889|NCT02385188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141890|NCT02385188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102141891|NCT02385188|Analgesics|analgesics|mesh-ancestor
102141892|NCT02385188|Antipyretics|antipyretics|mesh-ancestor
102141893|NCT02385188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102141894|NCT02385188|Immunologic Factors|immunologic factors|mesh-ancestor
102141895|NCT02385188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102141896|NCT02385188|Interferon Inducers|interferon inducers|mesh-ancestor
102141897|NCT02385188|Emollients|emollients|mesh-ancestor
102141898|NCT02385188|Dermatologic Agents|dermatologic agents|mesh-ancestor
102141899|NCT02385032|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102141900|NCT02385032|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102141901|NCT02385032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102141902|NCT02384954|Rituximab|rituximab|mesh-list
102141903|NCT02384954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102141904|NCT02384954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102141905|NCT02384954|Immunologic Factors|immunologic factors|mesh-ancestor
102141906|NCT02384954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141907|NCT02384954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102141908|NCT02384876|Ephedrine|ephedrine|mesh-list
102141909|NCT02384876|Pseudoephedrine|pseudoephedrine|mesh-list
102141910|NCT02384876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102141911|NCT02384876|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102141912|NCT02384876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141913|NCT02384876|Sympathomimetics|sympathomimetics|mesh-ancestor
102141914|NCT02384876|Autonomic Agents|autonomic agents|mesh-ancestor
102141915|NCT02384876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102141916|NCT02384876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102141917|NCT02384876|Adrenergic Agents|adrenergic agents|mesh-ancestor
101850845|NCT01324596|Hormones|hormones|mesh-ancestor
102141918|NCT02384876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102141919|NCT02384876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141920|NCT02384876|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102141921|NCT02384876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102141922|NCT02384876|Respiratory System Agents|respiratory system agents|mesh-ancestor
102141924|NCT03013985|Insulin Glargine|insulin glargine|mesh-list
102141925|NCT03013985|Insulin glulisine|insulin glulisine|mesh-list
102141926|NCT03013985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102141927|NCT03013985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141928|NCT02377388|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102141929|NCT02377388|Saxagliptin|saxagliptin|mesh-list
102141930|NCT02377388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102141931|NCT02377388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141932|NCT02377388|Incretins|incretins|mesh-ancestor
102141933|NCT02377388|Hormones|hormones|mesh-ancestor
102141934|NCT02377388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102141935|NCT02377388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102141936|NCT02377388|Protease Inhibitors|protease inhibitors|mesh-ancestor
102141937|NCT02377388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102141938|NCT02377388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141939|NCT02382380|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
102141940|NCT02382380|Chelating Agents|chelating agents|mesh-ancestor
102141941|NCT02382380|Sequestering Agents|sequestering agents|mesh-ancestor
102141942|NCT02382380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141943|NCT02382146|Dexamethasone|dexamethasone|mesh-list
102141944|NCT02382146|Dexamethasone acetate|dexamethasone acetate|mesh-list
102141945|NCT02382146|Ondansetron|ondansetron|mesh-list
102141946|NCT02382146|BB 1101|bb 1101|mesh-list
102141947|NCT02382146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102141948|NCT02382146|Antiemetics|antiemetics|mesh-ancestor
102141949|NCT02382146|Autonomic Agents|autonomic agents|mesh-ancestor
102141950|NCT02382146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102141951|NCT02382146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141952|NCT02382146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102141953|NCT02382146|Glucocorticoids|glucocorticoids|mesh-ancestor
102141954|NCT02382146|Hormones|hormones|mesh-ancestor
102141955|NCT02382146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102141956|NCT02382146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102141957|NCT02382146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102141958|NCT02382146|Protease Inhibitors|protease inhibitors|mesh-ancestor
102141959|NCT02382146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102141960|NCT02382146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141961|NCT02382146|Antipruritics|antipruritics|mesh-ancestor
102141962|NCT02382146|Dermatologic Agents|dermatologic agents|mesh-ancestor
102141963|NCT02382146|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102141964|NCT02382146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102141965|NCT02382146|Serotonin Agents|serotonin agents|mesh-ancestor
102141966|NCT02382146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102141967|NCT02382068|Dexamethasone|dexamethasone|mesh-list
102141968|NCT02382068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102141969|NCT02382068|Antiemetics|antiemetics|mesh-ancestor
102141970|NCT02382068|Autonomic Agents|autonomic agents|mesh-ancestor
102141971|NCT02382068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102141972|NCT02382068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141973|NCT02382068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102141974|NCT02382068|Glucocorticoids|glucocorticoids|mesh-ancestor
102141975|NCT02382068|Hormones|hormones|mesh-ancestor
102141976|NCT02382068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102141977|NCT02382068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102141978|NCT02382068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102141979|NCT04731272|Dulaglutide|dulaglutide|mesh-list
102141980|NCT04731272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102141981|NCT04731272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141982|NCT02381600|Vitamin D|vitamin d|mesh-list
102141983|NCT02381600|Vitamins|vitamins|mesh-ancestor
102141984|NCT02381600|Micronutrients|micronutrients|mesh-ancestor
102141985|NCT02381600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141986|NCT02381600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102141987|NCT03113084|Heparin|heparin|mesh-list
102141988|NCT03113084|Calcium heparin|calcium heparin|mesh-list
102141989|NCT03113084|Anticoagulants|anticoagulants|mesh-ancestor
102535905|NCT00368589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102535906|NCT00368589|Antimetabolites|antimetabolites|mesh-ancestor
102141990|NCT03113084|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101850908|NCT00282087|Gemcitabine|gemcitabine|mesh-list
102141991|NCT03113084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102141992|NCT03113084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102141993|NCT02377076|Calcium, Dietary|calcium, dietary|mesh-list
102141994|NCT02377076|Calcium|calcium|mesh-list
102141995|NCT02377076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102141996|NCT02377076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102141997|NCT02377076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102141998|NCT04439474|Vitamin D|vitamin d|mesh-list
102141999|NCT04439474|Cholecalciferol|cholecalciferol|mesh-list
102142000|NCT04439474|Vitamins|vitamins|mesh-ancestor
102142001|NCT04439474|Micronutrients|micronutrients|mesh-ancestor
102142002|NCT04439474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142003|NCT04439474|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102142004|NCT04439474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102142005|NCT02662556|Sufentanil|sufentanil|mesh-list
102142006|NCT02662556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102142007|NCT02662556|Narcotics|narcotics|mesh-ancestor
102142008|NCT02662556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102142009|NCT02662556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142010|NCT02662556|Analgesics|analgesics|mesh-ancestor
102142011|NCT02662556|Sensory System Agents|sensory system agents|mesh-ancestor
102142012|NCT02662556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102142013|NCT02662556|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102142014|NCT02662556|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102142015|NCT02662556|Anesthetics, General|anesthetics, general|mesh-ancestor
102142016|NCT02662556|Anesthetics|anesthetics|mesh-ancestor
102142017|NCT02376452|Leucovorin|leucovorin|mesh-list
102142018|NCT02376452|Fluorouracil|fluorouracil|mesh-list
102142019|NCT02376452|Raltitrexed|raltitrexed|mesh-list
102142020|NCT02376452|Irinotecan|irinotecan|mesh-list
102142021|NCT02376452|Antimetabolites|antimetabolites|mesh-ancestor
102142022|NCT02376452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142023|NCT02376452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102142024|NCT02376452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102142025|NCT02376452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102142026|NCT02376452|Immunologic Factors|immunologic factors|mesh-ancestor
102142027|NCT02376452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142028|NCT02376452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102142029|NCT02376452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102142030|NCT02376452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102142031|NCT02376452|Antidotes|antidotes|mesh-ancestor
102142032|NCT02376452|Protective Agents|protective agents|mesh-ancestor
102142033|NCT02376452|Vitamin B Complex|vitamin b complex|mesh-ancestor
102142034|NCT02376452|Vitamins|vitamins|mesh-ancestor
102142035|NCT02376452|Micronutrients|micronutrients|mesh-ancestor
102142036|NCT02376452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102142037|NCT02516098|Scopolamine|scopolamine|mesh-list
102142038|NCT02516098|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102142039|NCT02516098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102142040|NCT02516098|Antiemetics|antiemetics|mesh-ancestor
102142041|NCT02516098|Autonomic Agents|autonomic agents|mesh-ancestor
102142042|NCT02516098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102142043|NCT02516098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142044|NCT02516098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102142045|NCT02516098|Mydriatics|mydriatics|mesh-ancestor
102142046|NCT02516098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102142047|NCT02516098|Cholinergic Agents|cholinergic agents|mesh-ancestor
102142048|NCT02516098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102142049|NCT02516098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142050|NCT02516098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102142051|NCT02516098|Parasympatholytics|parasympatholytics|mesh-ancestor
102142052|NCT02372318|Nalmefene|nalmefene|mesh-list
102142053|NCT02372318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102142054|NCT02372318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142055|NCT02372318|Sensory System Agents|sensory system agents|mesh-ancestor
102142056|NCT02372318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102142057|NCT03105674|Anesthetics|anesthetics|mesh-list
102142058|NCT03105674|Anesthetics, Local|anesthetics, local|mesh-list
102142059|NCT03105674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102142060|NCT03105674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142061|NCT03105674|Sensory System Agents|sensory system agents|mesh-ancestor
102142062|NCT03105674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102142063|NCT02380898|Ketorolac|ketorolac|mesh-list
102142064|NCT02380898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102142065|NCT02380898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102142067|NCT02380898|Sensory System Agents|sensory system agents|mesh-ancestor
102142068|NCT02380898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102142069|NCT02380898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142070|NCT02380898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102142071|NCT02380898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101743835|NCT00776555|Dopamine Agents|dopamine agents|mesh-ancestor
102142072|NCT02380898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102142073|NCT02380898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102142074|NCT02380898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142075|NCT02376296|Docetaxel|docetaxel|mesh-list
102142076|NCT02376296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102142077|NCT02376296|Tubulin Modulators|tubulin modulators|mesh-ancestor
102142078|NCT02376296|Antimitotic Agents|antimitotic agents|mesh-ancestor
102142079|NCT02376296|Mitosis Modulators|mitosis modulators|mesh-ancestor
102142080|NCT02376296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142081|NCT01364428|Insulin|insulin|mesh-list
102142082|NCT01364428|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102142083|NCT01364428|Insulin, Long-Acting|insulin, long-acting|mesh-list
102142084|NCT01364428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102142085|NCT01364428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142086|NCT02380586|Anesthetics|anesthetics|mesh-list
102142087|NCT02380586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102142088|NCT02380586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142089|NCT02375828|Glyburide|glyburide|mesh-list
102142090|NCT02375828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102142091|NCT02375828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142092|NCT02371226|Insulin|insulin|mesh-list
102142093|NCT02371226|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102142094|NCT02371226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102142095|NCT02371226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142096|NCT02371304|Capecitabine|capecitabine|mesh-list
102142097|NCT02371304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102142098|NCT02371304|Antimetabolites|antimetabolites|mesh-ancestor
102142099|NCT02371304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142100|NCT02371304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102142101|NCT02380352|Amoxicillin|amoxicillin|mesh-list
102142102|NCT02380352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102142103|NCT02380352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102142104|NCT02380118|Midazolam|midazolam|mesh-list
102142105|NCT02380118|Haloperidol|haloperidol|mesh-list
102142106|NCT02380118|Olanzapine|olanzapine|mesh-list
102142107|NCT02380118|Haloperidol decanoate|haloperidol decanoate|mesh-list
102142108|NCT02380118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102142109|NCT02380118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102142110|NCT02380118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102142111|NCT02380118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142112|NCT02380118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102142113|NCT02380118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102142114|NCT02380118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102142115|NCT02380118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102142116|NCT02380118|Anesthetics, General|anesthetics, general|mesh-ancestor
102142117|NCT02380118|Anesthetics|anesthetics|mesh-ancestor
102142118|NCT02380118|GABA Modulators|gaba modulators|mesh-ancestor
102142119|NCT02380118|GABA Agents|gaba agents|mesh-ancestor
102142120|NCT02380118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102142121|NCT02380118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142122|NCT02380118|Antiemetics|antiemetics|mesh-ancestor
102142123|NCT02380118|Autonomic Agents|autonomic agents|mesh-ancestor
102142124|NCT02380118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102142125|NCT02380118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102142126|NCT02380118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102142127|NCT02380118|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102142128|NCT02380118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102142129|NCT02380118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102142130|NCT02380118|Serotonin Agents|serotonin agents|mesh-ancestor
102142131|NCT02380118|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102142132|NCT02380118|Dopamine Agents|dopamine agents|mesh-ancestor
102142133|NCT02380118|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102142134|NCT03113708|Heparin|heparin|mesh-list
102142135|NCT03113708|Calcium heparin|calcium heparin|mesh-list
102142136|NCT03113708|Anticoagulants|anticoagulants|mesh-ancestor
102142137|NCT03113708|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102142138|NCT03113708|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102241605|NCT03071055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102142139|NCT03113708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142140|NCT02371148|Rituximab|rituximab|mesh-list
102142141|NCT02371148|Bortezomib|bortezomib|mesh-list
102142142|NCT02371148|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102142143|NCT02371148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102142144|NCT02371148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102142145|NCT02371148|Immunologic Factors|immunologic factors|mesh-ancestor
102142146|NCT02371148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142147|NCT02371148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102142148|NCT02371148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102142149|NCT02371148|Alkylating Agents|alkylating agents|mesh-ancestor
102142150|NCT02371148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142151|NCT02375360|Immunomodulating Agents|immunomodulating agents|mesh-list
102142152|NCT02375360|Immunologic Factors|immunologic factors|mesh-ancestor
102142153|NCT02375360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142154|NCT02370680|Aspirin|aspirin|mesh-list
102142155|NCT02370680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102142156|NCT02370680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102142157|NCT02370680|Analgesics|analgesics|mesh-ancestor
102142158|NCT02370680|Sensory System Agents|sensory system agents|mesh-ancestor
102142159|NCT02370680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102142160|NCT02370680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142161|NCT02370680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102142162|NCT02370680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102142163|NCT02370680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102142164|NCT02370680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102142165|NCT02370680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142166|NCT02370680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102142167|NCT02370680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102142168|NCT02370680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102142169|NCT02370680|Antipyretics|antipyretics|mesh-ancestor
102142170|NCT02370758|Valganciclovir|valganciclovir|mesh-list
102142171|NCT02370758|Ganciclovir|ganciclovir|mesh-list
102142172|NCT02370758|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102142173|NCT02370758|Antiviral Agents|antiviral agents|mesh-ancestor
102142174|NCT02370758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102142175|NCT02370758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102142176|NCT02370758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102142177|NCT02370758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142178|NCT02379026|Vitamin D|vitamin d|mesh-list
102142179|NCT02379026|Cholecalciferol|cholecalciferol|mesh-list
102142180|NCT02379026|Vitamins|vitamins|mesh-ancestor
102142181|NCT02379026|Micronutrients|micronutrients|mesh-ancestor
102142182|NCT02379026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142183|NCT02379026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102142184|NCT02379026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102142185|NCT02991859|Fluticasone|fluticasone|mesh-list
102142186|NCT02991859|Xhance|xhance|mesh-list
102142187|NCT02991859|Budesonide|budesonide|mesh-list
102142188|NCT02991859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102142189|NCT02991859|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102142190|NCT02991859|Autonomic Agents|autonomic agents|mesh-ancestor
102142191|NCT02991859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102142192|NCT02991859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142193|NCT02991859|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102142194|NCT02991859|Respiratory System Agents|respiratory system agents|mesh-ancestor
102142195|NCT02991859|Dermatologic Agents|dermatologic agents|mesh-ancestor
102142196|NCT02991859|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102142197|NCT02991859|Glucocorticoids|glucocorticoids|mesh-ancestor
102142198|NCT02991859|Hormones|hormones|mesh-ancestor
102142199|NCT02991859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102142200|NCT02374736|Immunoglobulins|immunoglobulins|mesh-list
102142201|NCT02374736|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102142202|NCT02374736|Antibodies|antibodies|mesh-list
102142203|NCT02374736|Immunoglobulin G|immunoglobulin g|mesh-list
102142204|NCT02374736|Immunologic Factors|immunologic factors|mesh-ancestor
102142205|NCT02374736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142206|NCT02369978|Benzonidazole|benzonidazole|mesh-list
102142207|NCT02369978|Nifurtimox|nifurtimox|mesh-list
102142208|NCT02369978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102142209|NCT02369978|Immunologic Factors|immunologic factors|mesh-ancestor
102142210|NCT02369978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743968|NCT00923637|Oxaliplatin|oxaliplatin|mesh-list
102142211|NCT02369978|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102142212|NCT02369978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102142213|NCT02369978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102142214|NCT02369978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102142215|NCT03661489|Propofol|propofol|mesh-list
102142216|NCT03661489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102142217|NCT03661489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102142218|NCT03661489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851126|NCT00423332|Cediranib|cediranib|mesh-list
102142222|NCT04056169|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102142223|NCT04056169|Ezetimibe|ezetimibe|mesh-list
102142224|NCT04056169|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102142225|NCT04056169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102142226|NCT04056169|Antimetabolites|antimetabolites|mesh-ancestor
102142227|NCT04056169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142228|NCT04056169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102142229|NCT04056169|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102142230|NCT04056169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102142231|NCT02988115|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
102142232|NCT02988115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102142233|NCT02988115|Antimetabolites|antimetabolites|mesh-ancestor
102142234|NCT02988115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142235|NCT02988115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102142236|NCT02988115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102142237|NCT02988115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102142238|NCT02988115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142241|NCT03008915|Aspirin|aspirin|mesh-list
102142242|NCT03008915|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
102142243|NCT03008915|Protein C Inhibitor|protein c inhibitor|mesh-list
102142244|NCT03008915|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102142245|NCT03008915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102142246|NCT03008915|Analgesics|analgesics|mesh-ancestor
102142247|NCT03008915|Sensory System Agents|sensory system agents|mesh-ancestor
102142248|NCT03008915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102142249|NCT03008915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142250|NCT03008915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102142251|NCT03008915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102142252|NCT03008915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102142253|NCT03008915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102142254|NCT03008915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142255|NCT03008915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102142256|NCT03008915|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102142257|NCT03008915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102142258|NCT03008915|Antipyretics|antipyretics|mesh-ancestor
102142259|NCT03008915|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102142260|NCT03008915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102142261|NCT03008915|Protease Inhibitors|protease inhibitors|mesh-ancestor
102142262|NCT03622489|Acetaminophen|acetaminophen|mesh-list
102142263|NCT03622489|Dipyrone|dipyrone|mesh-list
102142264|NCT03622489|Ibuprofen|ibuprofen|mesh-list
102142265|NCT03622489|Morphine|morphine|mesh-list
102142266|NCT03622489|Tramadol|tramadol|mesh-list
102142267|NCT03622489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102142268|NCT03622489|Narcotics|narcotics|mesh-ancestor
102142269|NCT03622489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102142270|NCT03622489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142271|NCT03622489|Analgesics|analgesics|mesh-ancestor
102142272|NCT03622489|Sensory System Agents|sensory system agents|mesh-ancestor
102142273|NCT03622489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102142274|NCT03622489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102142275|NCT03622489|Antipyretics|antipyretics|mesh-ancestor
102142276|NCT03622489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102142277|NCT03622489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102142278|NCT03622489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102142279|NCT03622489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102142280|NCT03622489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102142281|NCT03622489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142282|NCT03667001|Lidocaine|lidocaine|mesh-list
102142283|NCT03667001|Anesthetics, Local|anesthetics, local|mesh-ancestor
102142284|NCT03667001|Anesthetics|anesthetics|mesh-ancestor
102142285|NCT03667001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102142286|NCT03667001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142287|NCT03667001|Sensory System Agents|sensory system agents|mesh-ancestor
102142288|NCT03667001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102142289|NCT03667001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102142290|NCT03667001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102142291|NCT03667001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102142292|NCT03667001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102142293|NCT03667001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142294|NCT02379650|Hydroxychloroquine|hydroxychloroquine|mesh-list
102142295|NCT02379650|Antimalarials|antimalarials|mesh-ancestor
101851201|NCT01042704|Antiemetics|antiemetics|mesh-ancestor
102142296|NCT02379650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102142297|NCT02379650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102142298|NCT02379650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102142299|NCT02379650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102142300|NCT02379650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142301|NCT02379650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102142302|NCT03666299|Lidocaine|lidocaine|mesh-list
102142303|NCT03666299|Anesthetics, Local|anesthetics, local|mesh-ancestor
102142304|NCT03666299|Anesthetics|anesthetics|mesh-ancestor
102142305|NCT03666299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102142306|NCT03666299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142307|NCT03666299|Sensory System Agents|sensory system agents|mesh-ancestor
102142308|NCT03666299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102142309|NCT03666299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102142310|NCT03666299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102142311|NCT03666299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102142312|NCT03666299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102142313|NCT03666299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142314|NCT03660397|Antihypertensive Agents|antihypertensive agents|mesh-list
102142315|NCT03591380|Belimumab|belimumab|mesh-list
102142316|NCT03591380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102142317|NCT03591380|Immunologic Factors|immunologic factors|mesh-ancestor
102142318|NCT03591380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142319|NCT04057469|Tulobuterol|tulobuterol|mesh-list
102142320|NCT04057469|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102142321|NCT04057469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102142322|NCT04057469|Adrenergic Agents|adrenergic agents|mesh-ancestor
102142323|NCT04057469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102142324|NCT04057469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142325|NCT04057469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142326|NCT04057469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102142327|NCT04057469|Autonomic Agents|autonomic agents|mesh-ancestor
102142328|NCT04057469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102142329|NCT04057469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102142330|NCT04057469|Respiratory System Agents|respiratory system agents|mesh-ancestor
102142331|NCT03666221|Nimotuzumab|nimotuzumab|mesh-list
102142332|NCT03666221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102142333|NCT03666221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102142334|NCT03658291|Levofloxacin|levofloxacin|mesh-list
102142335|NCT03658291|Ofloxacin|ofloxacin|mesh-list
102142336|NCT03658291|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102142337|NCT03658291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102142338|NCT03658291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102142339|NCT03658291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102142340|NCT03658291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102142341|NCT03658291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102142342|NCT03658291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142343|NCT03658291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102142344|NCT03658291|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102142345|NCT03658291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102142346|NCT03658213|Goserelin|goserelin|mesh-list
102142347|NCT03658213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102142348|NCT03658213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102142349|NCT03006887|Pembrolizumab|pembrolizumab|mesh-list
102142350|NCT03006887|Lenvatinib|lenvatinib|mesh-list
102142351|NCT03006887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102142352|NCT03006887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102142353|NCT03006887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102142354|NCT03006887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142355|NCT03006887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102142356|NCT03006887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102142357|NCT02377856|Interferons|interferons|mesh-list
102142358|NCT02377856|Ribavirin|ribavirin|mesh-list
102142359|NCT02377856|Interferon-alpha|interferon-alpha|mesh-list
102142360|NCT02377856|Interferon alpha-2|interferon alpha-2|mesh-list
102142361|NCT02377856|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102142362|NCT02377856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102142363|NCT02377856|Antiviral Agents|antiviral agents|mesh-ancestor
102142364|NCT02377856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102142365|NCT02377856|Antimetabolites|antimetabolites|mesh-ancestor
102154333|NCT03365817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102142366|NCT02377856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142367|NCT02377856|Immunologic Factors|immunologic factors|mesh-ancestor
102142368|NCT02377856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142370|NCT02377778|Propofol|propofol|mesh-list
102142371|NCT02377778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102142372|NCT02377778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102142373|NCT02377778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142374|NCT02377778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102142375|NCT02377778|Anesthetics, General|anesthetics, general|mesh-ancestor
102142377|NCT02377778|Anticonvulsants|anticonvulsants|mesh-ancestor
102142378|NCT02377778|GABA Modulators|gaba modulators|mesh-ancestor
102142379|NCT02377778|GABA Agents|gaba agents|mesh-ancestor
102142380|NCT02377778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102142381|NCT02377778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142382|NCT02514772|Rituximab|rituximab|mesh-list
102142383|NCT02514772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102142384|NCT02514772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102142385|NCT02514772|Immunologic Factors|immunologic factors|mesh-ancestor
102142386|NCT02514772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142387|NCT02514772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102142388|NCT03658057|Rocuronium|rocuronium|mesh-list
102142389|NCT03658057|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102142390|NCT03658057|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102142391|NCT03658057|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102142392|NCT03658057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102142393|NCT03658057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142394|NCT03657979|Ropivacaine|ropivacaine|mesh-list
102142395|NCT03657979|Anesthetics, Local|anesthetics, local|mesh-ancestor
102142396|NCT03657979|Anesthetics|anesthetics|mesh-ancestor
102142397|NCT03657979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102142398|NCT03657979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142399|NCT03657979|Sensory System Agents|sensory system agents|mesh-ancestor
102142400|NCT03657979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102142401|NCT03659851|Simendan|simendan|mesh-list
102142402|NCT03659851|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102142403|NCT03659851|Vasodilator Agents|vasodilator agents|mesh-ancestor
102142404|NCT03659851|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102142405|NCT03659851|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102142406|NCT03659851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102142407|NCT03659851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142408|NCT03659851|Protective Agents|protective agents|mesh-ancestor
102142409|NCT03659851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142410|NCT03659383|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102142411|NCT03659383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142412|NCT02368730|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
102142413|NCT02368730|Hemostatics|hemostatics|mesh-ancestor
102142414|NCT02368730|Coagulants|coagulants|mesh-ancestor
102142415|NCT02368730|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102142416|NCT02368730|Natriuretic Agents|natriuretic agents|mesh-ancestor
102142417|NCT02368730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142418|NCT03659305|Bevacizumab|bevacizumab|mesh-list
102142419|NCT03659305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102142420|NCT03659305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102142421|NCT03659305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102142422|NCT03659305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102142423|NCT03659305|Growth Substances|growth substances|mesh-ancestor
102142424|NCT03659305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142425|NCT03659305|Growth Inhibitors|growth inhibitors|mesh-ancestor
102142426|NCT02788981|Paclitaxel|paclitaxel|mesh-list
102142427|NCT02788981|Mifepristone|mifepristone|mesh-list
102142428|NCT02788981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102142429|NCT02788981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102142430|NCT02788981|Tubulin Modulators|tubulin modulators|mesh-ancestor
102142431|NCT02788981|Antimitotic Agents|antimitotic agents|mesh-ancestor
102142432|NCT02788981|Mitosis Modulators|mitosis modulators|mesh-ancestor
102142433|NCT02788981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142434|NCT02788981|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102142435|NCT02788981|Abortifacient Agents|abortifacient agents|mesh-ancestor
102142436|NCT02788981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102142437|NCT02788981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142438|NCT02788981|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102142439|NCT02788981|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102142440|NCT02788981|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102142441|NCT02788981|Contraceptive Agents|contraceptive agents|mesh-ancestor
102142442|NCT02788981|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102142443|NCT02788981|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102142444|NCT02788981|Hormone Antagonists|hormone antagonists|mesh-ancestor
102142445|NCT02788981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102142446|NCT02788981|Luteolytic Agents|luteolytic agents|mesh-ancestor
102142447|NCT02788981|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102142448|NCT02788981|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102142449|NCT02368964|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102142450|NCT02368964|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102142451|NCT02368964|Luteolytic Agents|luteolytic agents|mesh-ancestor
102142452|NCT02368964|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102142453|NCT02368964|Contraceptive Agents|contraceptive agents|mesh-ancestor
102142454|NCT02368964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102142455|NCT02368964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142456|NCT02368964|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102142457|NCT02368964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102142458|NCT02368964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102142459|NCT02373722|Petrolatum|petrolatum|mesh-list
102142460|NCT02373722|Mineral Oil|mineral oil|mesh-list
102142461|NCT02373722|Emollients|emollients|mesh-ancestor
102142462|NCT02373722|Dermatologic Agents|dermatologic agents|mesh-ancestor
102142463|NCT03000179|Avelumab|avelumab|mesh-list
102142464|NCT03000179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102142465|NCT03000179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102142466|NCT03658993|Rifaximin|rifaximin|mesh-list
102142467|NCT03658993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102142468|NCT03658993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102142469|NCT03658993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102142470|NCT02373410|Bupivacaine|bupivacaine|mesh-list
102142471|NCT02373410|Anesthetics, Local|anesthetics, local|mesh-ancestor
102142472|NCT02373410|Anesthetics|anesthetics|mesh-ancestor
102142473|NCT02373410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102142474|NCT02373410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142475|NCT02373410|Sensory System Agents|sensory system agents|mesh-ancestor
102142476|NCT02373410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102142477|NCT02920177|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102142478|NCT02920177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102142479|NCT02920177|Glucocorticoids|glucocorticoids|mesh-ancestor
102142480|NCT02920177|Hormones|hormones|mesh-ancestor
102142481|NCT02920177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102142482|NCT02920177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142483|NCT02920177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102142484|NCT02920177|Immunologic Factors|immunologic factors|mesh-ancestor
102142485|NCT03006341|Telmisartan|telmisartan|mesh-list
102142486|NCT03006341|Warfarin|warfarin|mesh-list
102142487|NCT03006341|Dabigatran|dabigatran|mesh-list
102142488|NCT03006341|Anticoagulants|anticoagulants|mesh-ancestor
102142489|NCT03006341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102142490|NCT03006341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102142491|NCT03006341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102142492|NCT03006341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142493|NCT03006341|Antithrombins|antithrombins|mesh-ancestor
102142494|NCT03006341|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102142495|NCT03006341|Protease Inhibitors|protease inhibitors|mesh-ancestor
102142496|NCT03006341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102142497|NCT05022784|Nintedanib|nintedanib|mesh-list
102142498|NCT05022784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102142499|NCT05022784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102142500|NCT05022784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102142501|NCT05022784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142502|NCT04413799|Lidocaine|lidocaine|mesh-list
102142503|NCT04413799|Ketamine|ketamine|mesh-list
102142504|NCT04413799|Anesthetics, Local|anesthetics, local|mesh-ancestor
102142505|NCT04413799|Anesthetics|anesthetics|mesh-ancestor
102142506|NCT04413799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102142507|NCT04413799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142508|NCT04413799|Sensory System Agents|sensory system agents|mesh-ancestor
102142509|NCT04413799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102142510|NCT04413799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102142511|NCT04413799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102142512|NCT04413799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102142513|NCT04413799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102085068|NCT05001412|Carboplatin|carboplatin|mesh-list
102142514|NCT04413799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142516|NCT04413799|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102142517|NCT04413799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102142518|NCT04413799|Anesthetics, General|anesthetics, general|mesh-ancestor
102142519|NCT04413799|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102142520|NCT04413799|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102142521|NCT04413799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102142522|NCT03665753|Ketorolac|ketorolac|mesh-list
102142523|NCT03665753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102142524|NCT03665753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102142525|NCT03665753|Analgesics|analgesics|mesh-ancestor
102142526|NCT03665753|Sensory System Agents|sensory system agents|mesh-ancestor
102142527|NCT03665753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102142528|NCT03665753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142529|NCT03665753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102142530|NCT03665753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102142531|NCT03665753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102142532|NCT03665753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102142533|NCT03665753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142534|NCT02512042|Brinzolamide|brinzolamide|mesh-list
102142535|NCT02512042|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102142536|NCT02512042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102142537|NCT02512042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142538|NCT03665519|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102142539|NCT03665519|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102142540|NCT03665519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102142541|NCT04386746|Gemcitabine|gemcitabine|mesh-list
102142542|NCT04386746|Docetaxel|docetaxel|mesh-list
102142543|NCT04386746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102142544|NCT04386746|Antimetabolites|antimetabolites|mesh-ancestor
102142545|NCT04386746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142546|NCT04386746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102142547|NCT04386746|Tubulin Modulators|tubulin modulators|mesh-ancestor
102142548|NCT04386746|Antimitotic Agents|antimitotic agents|mesh-ancestor
102142549|NCT04386746|Mitosis Modulators|mitosis modulators|mesh-ancestor
102142550|NCT01066897|Pramipexole|pramipexole|mesh-list
102142551|NCT01066897|Antioxidants|antioxidants|mesh-ancestor
102142552|NCT01066897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142553|NCT01066897|Protective Agents|protective agents|mesh-ancestor
102142554|NCT01066897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142555|NCT01066897|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102142556|NCT01066897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102142557|NCT01066897|Dopamine Agonists|dopamine agonists|mesh-ancestor
102142558|NCT01066897|Dopamine Agents|dopamine agents|mesh-ancestor
102142559|NCT01066897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102142560|NCT02373254|Acetaminophen|acetaminophen|mesh-list
102142561|NCT02373254|Ibuprofen|ibuprofen|mesh-list
102142562|NCT02373254|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
102142563|NCT02373254|Hydrocodone|hydrocodone|mesh-list
102142564|NCT02373254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102142565|NCT02373254|Analgesics|analgesics|mesh-ancestor
102142566|NCT02373254|Sensory System Agents|sensory system agents|mesh-ancestor
102142567|NCT02373254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102142568|NCT02373254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142569|NCT02373254|Antipyretics|antipyretics|mesh-ancestor
102142570|NCT02373254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102142571|NCT02373254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102142572|NCT02373254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102142573|NCT02373254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102142574|NCT02373254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102142575|NCT02373254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142576|NCT02373254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102142577|NCT02373254|Narcotics|narcotics|mesh-ancestor
102142578|NCT02373254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102142579|NCT02373254|Antitussive Agents|antitussive agents|mesh-ancestor
102142580|NCT02373254|Respiratory System Agents|respiratory system agents|mesh-ancestor
102142581|NCT03657355|Zolpidem|zolpidem|mesh-list
102142582|NCT03657355|Suvorexant|suvorexant|mesh-list
102142583|NCT03657355|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102142584|NCT03657355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102142585|NCT03657355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102142586|NCT03657355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154334|NCT03365817|Anesthetics, General|anesthetics, general|mesh-ancestor
102142587|NCT03657355|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102142588|NCT03657355|GABA Agonists|gaba agonists|mesh-ancestor
102142589|NCT03657355|GABA Agents|gaba agents|mesh-ancestor
102142590|NCT03657355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102142591|NCT03657355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142592|NCT03657355|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102142593|NCT02985541|Levonorgestrel|levonorgestrel|mesh-list
102142594|NCT02985541|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102142595|NCT02985541|Contraceptive Agents|contraceptive agents|mesh-ancestor
102142596|NCT02985541|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102142597|NCT02985541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142598|NCT02985541|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102142599|NCT02985541|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102142600|NCT02985541|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102142601|NCT02365532|Dofetilide|dofetilide|mesh-list
102142602|NCT02365532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102142603|NCT02365532|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102142604|NCT02365532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102142605|NCT02365532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142606|NCT03113162|Cytarabine|cytarabine|mesh-list
102142607|NCT03113162|Etoposide|etoposide|mesh-list
102142608|NCT03113162|Melphalan|melphalan|mesh-list
102142609|NCT03113162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102142610|NCT03113162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102142611|NCT03113162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102142612|NCT03113162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102142613|NCT03113162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102142614|NCT03113162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142615|NCT03113162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102142616|NCT03113162|Antimetabolites|antimetabolites|mesh-ancestor
102142617|NCT03113162|Antiviral Agents|antiviral agents|mesh-ancestor
102142618|NCT03113162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102142619|NCT03113162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102142620|NCT03113162|Immunologic Factors|immunologic factors|mesh-ancestor
102142621|NCT03113162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142622|NCT03113162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102142623|NCT03113162|Alkylating Agents|alkylating agents|mesh-ancestor
102142624|NCT03113162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102142625|NCT02356705|Lidocaine|lidocaine|mesh-list
102142626|NCT02356705|Midazolam|midazolam|mesh-list
102142627|NCT02356705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102142628|NCT02356705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102142629|NCT02356705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102142630|NCT02356705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142631|NCT02356705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102142632|NCT02356705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102142633|NCT02356705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102142634|NCT02356705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102142635|NCT02356705|Anesthetics, General|anesthetics, general|mesh-ancestor
102142636|NCT02356705|Anesthetics|anesthetics|mesh-ancestor
102142637|NCT02356705|GABA Modulators|gaba modulators|mesh-ancestor
102142638|NCT02356705|GABA Agents|gaba agents|mesh-ancestor
102142639|NCT02356705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102142640|NCT02356705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142641|NCT02356705|Anesthetics, Local|anesthetics, local|mesh-ancestor
102142642|NCT02356705|Sensory System Agents|sensory system agents|mesh-ancestor
102142643|NCT02356705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102142644|NCT02356705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102142645|NCT02356705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102142646|NCT02356705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102142647|NCT02356705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102142648|NCT03541850|Ascorbic Acid|ascorbic acid|mesh-list
102142649|NCT03541850|Methyltestosterone|methyltestosterone|mesh-list
102142650|NCT03541850|Hormones|hormones|mesh-list
102142651|NCT03541850|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
102142652|NCT03541850|Androgens|androgens|mesh-list
102142653|NCT03541850|Androgen Antagonists|androgen antagonists|mesh-list
102142654|NCT03541850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102142655|NCT03541850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142656|NCT03541850|Antioxidants|antioxidants|mesh-ancestor
102142657|NCT03541850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142658|NCT03541850|Protective Agents|protective agents|mesh-ancestor
102142659|NCT03541850|Vitamins|vitamins|mesh-ancestor
102142660|NCT03541850|Micronutrients|micronutrients|mesh-ancestor
102535907|NCT00368589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142661|NCT03541850|Estrogens|estrogens|mesh-ancestor
102142662|NCT03541850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102142663|NCT03541850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102142664|NCT03541850|Anabolic Agents|anabolic agents|mesh-ancestor
102142665|NCT03541850|Hormone Antagonists|hormone antagonists|mesh-ancestor
102142666|NCT02511184|Pembrolizumab|pembrolizumab|mesh-list
102142667|NCT02511184|Crizotinib|crizotinib|mesh-list
101851572|NCT00371826|Hormones|hormones|mesh-ancestor
102142668|NCT02511184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102142669|NCT02511184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102142670|NCT02511184|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102142671|NCT02511184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142672|NCT02511184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102142673|NCT02511184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102142674|NCT02367560|Methylprednisolone|methylprednisolone|mesh-list
102142675|NCT02367560|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102142676|NCT02367560|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102142677|NCT02367560|Prednisolone|prednisolone|mesh-list
102142678|NCT02367560|Prednisolone acetate|prednisolone acetate|mesh-list
102142679|NCT02367560|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102142680|NCT02367560|Prednisolone phosphate|prednisolone phosphate|mesh-list
102142681|NCT02367560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102142682|NCT02367560|Antiemetics|antiemetics|mesh-ancestor
102142683|NCT02367560|Autonomic Agents|autonomic agents|mesh-ancestor
102142684|NCT02367560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102142685|NCT02367560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142686|NCT02367560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102142687|NCT02367560|Glucocorticoids|glucocorticoids|mesh-ancestor
102142688|NCT02367560|Hormones|hormones|mesh-ancestor
102142689|NCT02367560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102142690|NCT02367560|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102142691|NCT02367560|Protective Agents|protective agents|mesh-ancestor
102142692|NCT02367560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102142693|NCT02367560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102142694|NCT02372942|Progesterone|progesterone|mesh-list
102142695|NCT02372942|Progestins|progestins|mesh-ancestor
102142696|NCT02372942|Hormones|hormones|mesh-ancestor
102142697|NCT02372942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102142698|NCT02372942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142699|NCT02364986|Interferons|interferons|mesh-list
102142700|NCT02364986|Interferon-beta|interferon-beta|mesh-list
102142701|NCT02364986|Interferon beta-1a|interferon beta-1a|mesh-list
102142702|NCT02364986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102142703|NCT02364986|Antiviral Agents|antiviral agents|mesh-ancestor
102142704|NCT02364986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102142705|NCT02364986|Immunologic Factors|immunologic factors|mesh-ancestor
102142706|NCT02364986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142707|NCT02364986|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102142708|NCT02372786|Lidocaine|lidocaine|mesh-list
102142709|NCT02372786|Tetracaine|tetracaine|mesh-list
102142710|NCT02372786|Prilocaine|prilocaine|mesh-list
102142711|NCT02372786|Anesthetics, Local|anesthetics, local|mesh-ancestor
102142712|NCT02372786|Anesthetics|anesthetics|mesh-ancestor
102142713|NCT02372786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102142714|NCT02372786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142715|NCT02372786|Sensory System Agents|sensory system agents|mesh-ancestor
102142716|NCT02372786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102142717|NCT02372786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102142718|NCT02372786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102142719|NCT02372786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102142720|NCT02372786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102142721|NCT02372786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142722|NCT02367404|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102142723|NCT02367404|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102142724|NCT02367404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102142725|NCT02367404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102142726|NCT02367404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142727|NCT02367404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102142728|NCT02367404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142729|NCT02367404|Analgesics|analgesics|mesh-ancestor
102142730|NCT02367404|Sensory System Agents|sensory system agents|mesh-ancestor
102142731|NCT02367404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102142732|NCT02367404|Antidepressive Agents|antidepressive agents|mesh-ancestor
102142733|NCT02367404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102142734|NCT02367404|Dopamine Agents|dopamine agents|mesh-ancestor
102142735|NCT02367248|Deferoxamine|deferoxamine|mesh-list
102142736|NCT02367248|Siderophores|siderophores|mesh-ancestor
102142737|NCT02367248|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102142738|NCT02367248|Chelating Agents|chelating agents|mesh-ancestor
102142739|NCT02367248|Sequestering Agents|sequestering agents|mesh-ancestor
102142740|NCT02367248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142741|NCT03656965|Acyclovir|acyclovir|mesh-list
102142742|NCT03656965|Antiviral Agents|antiviral agents|mesh-ancestor
102142743|NCT03656965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102142744|NCT02384239|Tamoxifen|tamoxifen|mesh-list
102142745|NCT02384239|Fulvestrant|fulvestrant|mesh-list
102142746|NCT02384239|Palbociclib|palbociclib|mesh-list
102142747|NCT02384239|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102142748|NCT02384239|Hormone Antagonists|hormone antagonists|mesh-ancestor
102142749|NCT02384239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102142750|NCT02384239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142751|NCT02384239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102142752|NCT02384239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102142753|NCT02384239|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102142754|NCT02384239|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102142755|NCT02384239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102142756|NCT02384239|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102142757|NCT02384239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102142758|NCT02384239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102142759|NCT02384239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142760|NCT02364752|Diuretics|diuretics|mesh-list
102142761|NCT02364752|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
102142762|NCT02364752|Natriuretic Agents|natriuretic agents|mesh-ancestor
102142763|NCT02364752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142764|NCT02364752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102142765|NCT02364752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142766|NCT02372240|Dexamethasone|dexamethasone|mesh-list
102142767|NCT02372240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102142768|NCT02372240|Antiemetics|antiemetics|mesh-ancestor
102142769|NCT02372240|Autonomic Agents|autonomic agents|mesh-ancestor
102142770|NCT02372240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102142771|NCT02372240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142772|NCT02372240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102142773|NCT02372240|Glucocorticoids|glucocorticoids|mesh-ancestor
102142774|NCT02372240|Hormones|hormones|mesh-ancestor
102142775|NCT02372240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102142776|NCT02372240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102142777|NCT02372240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102142778|NCT02364206|Temozolomide|temozolomide|mesh-list
102142779|NCT02364206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102142780|NCT02364206|Alkylating Agents|alkylating agents|mesh-ancestor
102142781|NCT02364206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142782|NCT02364206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102142783|NCT02366546|Cyclophosphamide|cyclophosphamide|mesh-list
102142784|NCT02366546|Fludarabine|fludarabine|mesh-list
102142785|NCT02366546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102142786|NCT02366546|Immunologic Factors|immunologic factors|mesh-ancestor
102142787|NCT02366546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142788|NCT02366546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102142789|NCT02366546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102142790|NCT02366546|Alkylating Agents|alkylating agents|mesh-ancestor
102142791|NCT02366546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142792|NCT02366546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102142793|NCT02366546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102142794|NCT03029702|Metformin|metformin|mesh-list
102142795|NCT03029702|Glyburide|glyburide|mesh-list
102142796|NCT03029702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102142797|NCT03029702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142798|NCT02364362|Docetaxel|docetaxel|mesh-list
102142799|NCT02364362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102142800|NCT02364362|Tubulin Modulators|tubulin modulators|mesh-ancestor
102142801|NCT02364362|Antimitotic Agents|antimitotic agents|mesh-ancestor
102142802|NCT02364362|Mitosis Modulators|mitosis modulators|mesh-ancestor
102142803|NCT02364362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142804|NCT03004469|Finasteride|finasteride|mesh-list
102142805|NCT03004469|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102142806|NCT03004469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102142807|NCT03004469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102535908|NCT00368589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102142808|NCT03004469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142809|NCT03004469|Hormone Antagonists|hormone antagonists|mesh-ancestor
102142810|NCT03004469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102142811|NCT03004469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142812|NCT03004469|Urological Agents|urological agents|mesh-ancestor
102142813|NCT02358824|Amlodipine|amlodipine|mesh-list
102142814|NCT02358824|Telmisartan|telmisartan|mesh-list
102142815|NCT02358824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102142816|NCT02358824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102142817|NCT02358824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102142818|NCT02358824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142819|NCT02358824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102142820|NCT02358824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142821|NCT02358824|Vasodilator Agents|vasodilator agents|mesh-ancestor
102142822|NCT02358824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102142823|NCT02358824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102142824|NCT02359136|Epinephrine|epinephrine|mesh-list
102142825|NCT02359136|Analgesics|analgesics|mesh-list
102142826|NCT02359136|Anesthetics|anesthetics|mesh-list
102142827|NCT02359136|Ropivacaine|ropivacaine|mesh-list
102142828|NCT02359136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102142829|NCT02359136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142830|NCT02359136|Anesthetics, Local|anesthetics, local|mesh-ancestor
102142831|NCT02359136|Sensory System Agents|sensory system agents|mesh-ancestor
102142832|NCT02359136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102142833|NCT02359136|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102142834|NCT02359136|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102142835|NCT02359136|Adrenergic Agents|adrenergic agents|mesh-ancestor
102142836|NCT02359136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102142837|NCT02359136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142838|NCT02359136|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102142839|NCT02359136|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102142840|NCT02359136|Autonomic Agents|autonomic agents|mesh-ancestor
102142841|NCT02359136|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102142842|NCT02359136|Respiratory System Agents|respiratory system agents|mesh-ancestor
102142843|NCT02359136|Mydriatics|mydriatics|mesh-ancestor
102142844|NCT02359136|Sympathomimetics|sympathomimetics|mesh-ancestor
102142845|NCT02359136|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102142846|NCT02998151|Minocycline|minocycline|mesh-list
102142847|NCT02998151|Acamprosate|acamprosate|mesh-list
102142848|NCT02998151|Baclofen|baclofen|mesh-list
102142849|NCT02998151|Lovastatin|lovastatin|mesh-list
102142850|NCT02998151|L 647318|l 647318|mesh-list
102142851|NCT02998151|Dihydromevinolin|dihydromevinolin|mesh-list
102142852|NCT02998151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102142853|NCT02998151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102142854|NCT02998151|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102142855|NCT02998151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142856|NCT02998151|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102142857|NCT02998151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102142858|NCT02998151|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102142859|NCT02998151|GABA Agonists|gaba agonists|mesh-ancestor
102142860|NCT02998151|GABA Agents|gaba agents|mesh-ancestor
102142861|NCT02998151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102142862|NCT02998151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142863|NCT02998151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102142864|NCT02998151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102142865|NCT02998151|Antimetabolites|antimetabolites|mesh-ancestor
102142866|NCT02998151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102142867|NCT02998151|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102142868|NCT02998151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102142869|NCT02998151|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102142870|NCT01066819|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102142871|NCT01066819|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102142872|NCT01066819|Antiviral Agents|antiviral agents|mesh-ancestor
102142873|NCT01066819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102142874|NCT04057937|Apremilast|apremilast|mesh-list
102142875|NCT04057937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102142876|NCT04057937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102142877|NCT04057937|Analgesics|analgesics|mesh-ancestor
102142878|NCT04057937|Sensory System Agents|sensory system agents|mesh-ancestor
102142879|NCT04057937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102142880|NCT04057937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142881|NCT04057937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102142882|NCT04057937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102142883|NCT04057937|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102142884|NCT04057937|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102142886|NCT04057937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142887|NCT01069523|Guanfacine|guanfacine|mesh-list
102142888|NCT01069523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102142889|NCT01069523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102142890|NCT01069523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102142891|NCT01069523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102142892|NCT01069523|Adrenergic Agents|adrenergic agents|mesh-ancestor
102142893|NCT01069523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101744677|NCT00686517|Interferons|interferons|mesh-list
102142894|NCT01069523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142895|NCT01069523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142896|NCT01069289|Budesonide|budesonide|mesh-list
102142897|NCT01069289|Formoterol Fumarate|formoterol fumarate|mesh-list
102142898|NCT01069289|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
102142899|NCT01069289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102142900|NCT01069289|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102142901|NCT01069289|Autonomic Agents|autonomic agents|mesh-ancestor
102142902|NCT01069289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102142903|NCT01069289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142904|NCT01069289|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102142905|NCT01069289|Respiratory System Agents|respiratory system agents|mesh-ancestor
102142906|NCT01069289|Glucocorticoids|glucocorticoids|mesh-ancestor
102142907|NCT01069289|Hormones|hormones|mesh-ancestor
102142908|NCT01069289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102142909|NCT01069289|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102142910|NCT01069289|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102142911|NCT01069289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102142912|NCT01069289|Adrenergic Agents|adrenergic agents|mesh-ancestor
102142913|NCT01069289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102142914|NCT01069289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142915|NCT03303989|Mycophenolic Acid|mycophenolic acid|mesh-list
102142916|NCT03303989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102142917|NCT03303989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102142918|NCT03303989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102142919|NCT03303989|Antitubercular Agents|antitubercular agents|mesh-ancestor
102142920|NCT03303989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102142921|NCT03303989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102142922|NCT03303989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102142923|NCT03303989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142924|NCT02510794|Ranibizumab|ranibizumab|mesh-list
102142925|NCT02510794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102142926|NCT02510794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102142927|NCT02510794|Growth Substances|growth substances|mesh-ancestor
102142928|NCT02510794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142929|NCT02510794|Growth Inhibitors|growth inhibitors|mesh-ancestor
102142930|NCT02510794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102142931|NCT04056923|Methylene Blue|methylene blue|mesh-list
102142932|NCT04056923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102142933|NCT04056923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142934|NCT03664115|Itraconazole|itraconazole|mesh-list
102142935|NCT03664115|Antifungal Agents|antifungal agents|mesh-ancestor
102142936|NCT03664115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102142937|NCT03664115|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102142938|NCT03664115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102142939|NCT03664115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102142940|NCT03664115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142941|NCT03664115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102142942|NCT03664115|Hormone Antagonists|hormone antagonists|mesh-ancestor
102142943|NCT03664115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102142944|NCT03664115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142945|NCT03664115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102142946|NCT04056845|Acetaminophen|acetaminophen|mesh-list
102142947|NCT04056845|Diclofenac|diclofenac|mesh-list
102142948|NCT04056845|Analgesics|analgesics|mesh-list
102142949|NCT04056845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102142950|NCT04056845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102142951|NCT04056845|Sensory System Agents|sensory system agents|mesh-ancestor
102142952|NCT04056845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102142953|NCT04056845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142954|NCT04056845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102142956|NCT04056845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102142957|NCT04056845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102142958|NCT04056845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142959|NCT04056845|Antipyretics|antipyretics|mesh-ancestor
102142960|NCT02510014|Buprenorphine|buprenorphine|mesh-list
102142961|NCT02510014|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102142962|NCT02510014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102142963|NCT02510014|Narcotics|narcotics|mesh-ancestor
102142964|NCT02510014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102142965|NCT02510014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142966|NCT02510014|Analgesics|analgesics|mesh-ancestor
102142967|NCT02510014|Sensory System Agents|sensory system agents|mesh-ancestor
102142968|NCT02510014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102142969|NCT02510014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102142970|NCT02509312|Ketorolac|ketorolac|mesh-list
102142971|NCT02509312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102142972|NCT02509312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102142973|NCT02509312|Analgesics|analgesics|mesh-ancestor
102142974|NCT02509312|Sensory System Agents|sensory system agents|mesh-ancestor
102142975|NCT02509312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102142976|NCT02509312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102142977|NCT02509312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102142978|NCT02509312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102142979|NCT02509312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102142980|NCT02509312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102142981|NCT02509312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142982|NCT02362958|Capecitabine|capecitabine|mesh-list
102142983|NCT02362958|Vinorelbine|vinorelbine|mesh-list
102142984|NCT02362958|Lapatinib|lapatinib|mesh-list
102142985|NCT02362958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102142986|NCT02362958|Antimetabolites|antimetabolites|mesh-ancestor
102142987|NCT02362958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102142988|NCT02362958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102142989|NCT02362958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102142990|NCT02362958|Tubulin Modulators|tubulin modulators|mesh-ancestor
102142991|NCT02362958|Antimitotic Agents|antimitotic agents|mesh-ancestor
102142992|NCT02362958|Mitosis Modulators|mitosis modulators|mesh-ancestor
102142993|NCT02362958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102142994|NCT02362958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102142995|NCT04973800|Simvastatin|simvastatin|mesh-list
102142996|NCT04973800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102142997|NCT04973800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102142998|NCT04973800|Antimetabolites|antimetabolites|mesh-ancestor
102142999|NCT04973800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143000|NCT04973800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102143001|NCT04973800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102143002|NCT04973800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102143003|NCT05020522|Phenobarbital|phenobarbital|mesh-list
102143004|NCT05020522|Anticonvulsants|anticonvulsants|mesh-ancestor
102143005|NCT05020522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102143006|NCT05020522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102143007|NCT05020522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143008|NCT05020522|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102143009|NCT05020522|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102143010|NCT05020522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102143011|NCT05020522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143012|NCT05020522|GABA Modulators|gaba modulators|mesh-ancestor
102143013|NCT05020522|GABA Agents|gaba agents|mesh-ancestor
102143014|NCT05020522|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102143015|NCT05020522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102143016|NCT05020522|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102143017|NCT02519842|Dexamethasone|dexamethasone|mesh-list
102143018|NCT02519842|Ondansetron|ondansetron|mesh-list
102143019|NCT02519842|Fosaprepitant|fosaprepitant|mesh-list
102143020|NCT02519842|Aprepitant|aprepitant|mesh-list
102143021|NCT02519842|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
102143022|NCT02519842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102143023|NCT02519842|Antiemetics|antiemetics|mesh-ancestor
102143024|NCT02519842|Autonomic Agents|autonomic agents|mesh-ancestor
102143025|NCT02519842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102143026|NCT02519842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143027|NCT02519842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102143028|NCT02519842|Glucocorticoids|glucocorticoids|mesh-ancestor
102143030|NCT02519842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102143031|NCT02519842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102143032|NCT02519842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102143033|NCT02519842|Antipruritics|antipruritics|mesh-ancestor
102143034|NCT02519842|Dermatologic Agents|dermatologic agents|mesh-ancestor
101744807|NCT00718328|Simvastatin|simvastatin|mesh-list
102143035|NCT02519842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102143036|NCT02519842|Serotonin Agents|serotonin agents|mesh-ancestor
102143037|NCT02519842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102143038|NCT02519842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143039|NCT02519842|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102143040|NCT02509078|Cisatracurium|cisatracurium|mesh-list
102143041|NCT02509078|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102143042|NCT02509078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102143043|NCT02509078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102143044|NCT02509078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143045|NCT02993783|Vedolizumab|vedolizumab|mesh-list
102143046|NCT02993783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102143047|NCT03661775|Magnesium Sulfate|magnesium sulfate|mesh-list
102143048|NCT03661775|Analgesics|analgesics|mesh-ancestor
102143049|NCT03661775|Sensory System Agents|sensory system agents|mesh-ancestor
102143050|NCT03661775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102143051|NCT03661775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143052|NCT03661775|Anesthetics|anesthetics|mesh-ancestor
102143053|NCT03661775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102143054|NCT03661775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102143055|NCT03661775|Anticonvulsants|anticonvulsants|mesh-ancestor
102143056|NCT03661775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102143057|NCT03661775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102143058|NCT03661775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143059|NCT03661775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102143060|NCT03661775|Tocolytic Agents|tocolytic agents|mesh-ancestor
102143061|NCT03661775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102143062|NCT03660761|Apatinib|apatinib|mesh-list
102143063|NCT03660761|Temozolomide|temozolomide|mesh-list
102143064|NCT03660761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102143065|NCT03660761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102143066|NCT03660761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102143067|NCT03660761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143068|NCT03660761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102143069|NCT03660761|Alkylating Agents|alkylating agents|mesh-ancestor
102143070|NCT02993471|Vitamin K|vitamin k|mesh-list
102143071|NCT02993471|Midazolam|midazolam|mesh-list
102143072|NCT02993471|Dextromethorphan|dextromethorphan|mesh-list
102143073|NCT02993471|Caffeine|caffeine|mesh-list
102143074|NCT02993471|Ixekizumab|ixekizumab|mesh-list
102143075|NCT02993471|Omeprazole|omeprazole|mesh-list
102143076|NCT02993471|Warfarin|warfarin|mesh-list
102143077|NCT02993471|Vitamins|vitamins|mesh-ancestor
102143078|NCT02993471|Micronutrients|micronutrients|mesh-ancestor
102143079|NCT02993471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143080|NCT02993471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102143081|NCT02993471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102143082|NCT02993471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102143083|NCT02993471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102143084|NCT02993471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102143085|NCT02993471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102143086|NCT02993471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102143087|NCT02993471|Anesthetics, General|anesthetics, general|mesh-ancestor
102143088|NCT02993471|Anesthetics|anesthetics|mesh-ancestor
102143089|NCT02993471|GABA Modulators|gaba modulators|mesh-ancestor
102143090|NCT02993471|GABA Agents|gaba agents|mesh-ancestor
102143091|NCT02993471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102143092|NCT02993471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143093|NCT02993471|Anticoagulants|anticoagulants|mesh-ancestor
102143094|NCT02993471|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102143095|NCT02993471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102143096|NCT02993471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102143097|NCT02993471|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102143098|NCT02993471|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102143099|NCT02993471|Purinergic Agents|purinergic agents|mesh-ancestor
102143100|NCT02993471|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102143101|NCT02993471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102143102|NCT02993471|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102143103|NCT02993471|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102143104|NCT02993471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102143105|NCT02993471|Hemostatics|hemostatics|mesh-ancestor
102143106|NCT02993471|Coagulants|coagulants|mesh-ancestor
102143107|NCT02993471|Antitussive Agents|antitussive agents|mesh-ancestor
102143108|NCT02993471|Respiratory System Agents|respiratory system agents|mesh-ancestor
102143109|NCT02993471|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102143110|NCT02993471|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102143111|NCT02993471|Dermatologic Agents|dermatologic agents|mesh-ancestor
102143112|NCT01068743|Metformin|metformin|mesh-list
102143113|NCT01068743|Saxagliptin|saxagliptin|mesh-list
102143114|NCT01068743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102143115|NCT01068743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143116|NCT01068743|Incretins|incretins|mesh-ancestor
102143117|NCT01068743|Hormones|hormones|mesh-ancestor
102143118|NCT01068743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102143119|NCT01068743|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102143120|NCT01068743|Protease Inhibitors|protease inhibitors|mesh-ancestor
102143121|NCT01068743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102143122|NCT01068743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143123|NCT03622541|Sorafenib|sorafenib|mesh-list
102143124|NCT03622541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102143125|NCT03622541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102143126|NCT03622541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102143127|NCT03622541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143128|NCT03658733|Amoxicillin|amoxicillin|mesh-list
102143129|NCT03658733|Tetracycline|tetracycline|mesh-list
102143130|NCT03658733|Furazolidone|furazolidone|mesh-list
102143131|NCT03658733|Esomeprazole|esomeprazole|mesh-list
102143132|NCT03658733|Rabeprazole|rabeprazole|mesh-list
102143133|NCT03658733|Bismuth|bismuth|mesh-list
102143134|NCT03658733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102143135|NCT03658733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102143136|NCT03658733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102143137|NCT03658733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102143138|NCT03658733|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102143139|NCT03658733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102143140|NCT03658733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143141|NCT03658733|Antacids|antacids|mesh-ancestor
102143142|NCT03658733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102143143|NCT03658733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102143144|NCT03658733|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102143145|NCT03658733|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
102143146|NCT03658733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102143147|NCT03658733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102143148|NCT03658733|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102143149|NCT04056143|Rivaroxaban|rivaroxaban|mesh-list
102143150|NCT04056143|Apixaban|apixaban|mesh-list
102143151|NCT04056143|Edoxaban|edoxaban|mesh-list
102143152|NCT04056143|Dabigatran|dabigatran|mesh-list
102143153|NCT04056143|Thromboplastin|thromboplastin|mesh-list
102143154|NCT04056143|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102143155|NCT04056143|Antithrombins|antithrombins|mesh-ancestor
102143156|NCT04056143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102143157|NCT04056143|Protease Inhibitors|protease inhibitors|mesh-ancestor
102143158|NCT04056143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102143159|NCT04056143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143160|NCT04056143|Anticoagulants|anticoagulants|mesh-ancestor
102143161|NCT04056143|Hemostatics|hemostatics|mesh-ancestor
102143162|NCT04056143|Coagulants|coagulants|mesh-ancestor
102143163|NCT03661463|Aspirin|aspirin|mesh-list
102143164|NCT03661463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102143165|NCT03661463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102143166|NCT03661463|Analgesics|analgesics|mesh-ancestor
102143167|NCT03661463|Sensory System Agents|sensory system agents|mesh-ancestor
102143168|NCT03661463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102143169|NCT03661463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143170|NCT03661463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102143171|NCT03661463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102143172|NCT03661463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102143173|NCT03661463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102143174|NCT03661463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143175|NCT03661463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102143176|NCT03661463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102143177|NCT03661463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102143178|NCT03661463|Antipyretics|antipyretics|mesh-ancestor
102143179|NCT03658421|Dexmedetomidine|dexmedetomidine|mesh-list
102143180|NCT03658421|Morphine|morphine|mesh-list
102143181|NCT03658421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102143182|NCT03658421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102143183|NCT03658421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143184|NCT03658421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102143185|NCT03658421|Analgesics|analgesics|mesh-ancestor
102143186|NCT03658421|Sensory System Agents|sensory system agents|mesh-ancestor
102143187|NCT03658421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102143188|NCT03658421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102143189|NCT03658421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102143190|NCT03658421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102143191|NCT03658421|Adrenergic Agents|adrenergic agents|mesh-ancestor
102143192|NCT03658421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102143193|NCT03658421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143194|NCT03658421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102143195|NCT03658421|Narcotics|narcotics|mesh-ancestor
102143196|NCT03660293|Captopril|captopril|mesh-list
102143197|NCT03660293|Atorvastatin|atorvastatin|mesh-list
102143198|NCT03660293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102143199|NCT03660293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102143200|NCT03660293|Antimetabolites|antimetabolites|mesh-ancestor
102143201|NCT03660293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143202|NCT03660293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102143203|NCT03660293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102143204|NCT03660293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102143205|NCT03660293|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102143206|NCT03660293|Protease Inhibitors|protease inhibitors|mesh-ancestor
102143207|NCT03660293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102143208|NCT02986139|Etanercept|etanercept|mesh-list
102143209|NCT02986139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102143210|NCT02986139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102143211|NCT02986139|Analgesics|analgesics|mesh-ancestor
102143212|NCT02986139|Sensory System Agents|sensory system agents|mesh-ancestor
102143213|NCT02986139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102143214|NCT02986139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143215|NCT02986139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102143216|NCT02986139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102143217|NCT02986139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102143218|NCT02986139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102143219|NCT02986139|Immunologic Factors|immunologic factors|mesh-ancestor
102143220|NCT02906917|Insulin|insulin|mesh-list
102143221|NCT02906917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102143222|NCT02906917|Insulin Glargine|insulin glargine|mesh-list
102143223|NCT02906917|Insulin Aspart|insulin aspart|mesh-list
102143224|NCT02906917|Insulin, Long-Acting|insulin, long-acting|mesh-list
102143225|NCT02906917|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102143226|NCT02906917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102143227|NCT02906917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143228|NCT01066585|Ivermectin|ivermectin|mesh-list
102143229|NCT01066585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102143230|NCT01066585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102143231|NCT03654703|Cyclophosphamide|cyclophosphamide|mesh-list
102143232|NCT03654703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102143233|NCT03654703|Immunologic Factors|immunologic factors|mesh-ancestor
102143234|NCT03654703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143235|NCT03654703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102143236|NCT03654703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102143237|NCT03654703|Alkylating Agents|alkylating agents|mesh-ancestor
102143238|NCT03654703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143239|NCT03654703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102143240|NCT03654703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102143241|NCT02980783|Lidocaine|lidocaine|mesh-list
102143242|NCT02980783|Anesthetics, Local|anesthetics, local|mesh-ancestor
102143243|NCT02980783|Anesthetics|anesthetics|mesh-ancestor
102143244|NCT02980783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102143245|NCT02980783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143246|NCT02980783|Sensory System Agents|sensory system agents|mesh-ancestor
102143247|NCT02980783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102143248|NCT02980783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101950433|NCT03012529|Riboflavin|riboflavin|mesh-list
102143249|NCT02980783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102143250|NCT02980783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102143251|NCT02980783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102143252|NCT02980783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143253|NCT02989649|Metformin|metformin|mesh-list
102143254|NCT02989649|Pioglitazone|pioglitazone|mesh-list
102143255|NCT02989649|Alogliptin|alogliptin|mesh-list
102143256|NCT02989649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102143257|NCT02989649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143258|NCT02989649|Incretins|incretins|mesh-ancestor
102143259|NCT02989649|Hormones|hormones|mesh-ancestor
102143260|NCT02989649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102143261|NCT02989649|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102143262|NCT02989649|Protease Inhibitors|protease inhibitors|mesh-ancestor
102143263|NCT02989649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102143264|NCT02989649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143265|NCT03659435|Rivastigmine|rivastigmine|mesh-list
101852163|NCT01045928|Lenalidomide|lenalidomide|mesh-list
102143266|NCT03659435|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102143267|NCT03659435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102143268|NCT03659435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143269|NCT03659435|Cholinergic Agents|cholinergic agents|mesh-ancestor
102143270|NCT03659435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102143271|NCT03659435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143272|NCT03659435|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102143273|NCT03659435|Protective Agents|protective agents|mesh-ancestor
102143274|NCT01067339|Darapladib|darapladib|mesh-list
102143275|NCT01067339|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
102143276|NCT01067339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102143277|NCT01067339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143278|NCT04484675|Milrinone|milrinone|mesh-list
102143279|NCT04484675|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102143280|NCT04484675|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102143281|NCT04484675|Vasodilator Agents|vasodilator agents|mesh-ancestor
102143282|NCT04484675|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102143283|NCT04484675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102143284|NCT04484675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102143285|NCT04484675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143286|NCT04484675|Protective Agents|protective agents|mesh-ancestor
102143287|NCT04484675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143288|NCT03658109|Lidocaine|lidocaine|mesh-list
102143289|NCT03658109|Anesthetics, Local|anesthetics, local|mesh-ancestor
102143290|NCT03658109|Anesthetics|anesthetics|mesh-ancestor
102143291|NCT03658109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102143292|NCT03658109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143293|NCT03658109|Sensory System Agents|sensory system agents|mesh-ancestor
102143294|NCT03658109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102143295|NCT03658109|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102143296|NCT03658109|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102143297|NCT03658109|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102143298|NCT03658109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102143299|NCT03658109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143300|NCT03658031|Dapagliflozin|dapagliflozin|mesh-list
102143301|NCT03658031|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102143302|NCT03658031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143303|NCT03658031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102143304|NCT03658031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143305|NCT03660917|Riluzole|riluzole|mesh-list
102143306|NCT03660917|Anticonvulsants|anticonvulsants|mesh-ancestor
102143307|NCT03660917|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102143308|NCT03660917|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102143309|NCT03660917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102143310|NCT03660917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143311|NCT03660917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143312|NCT03660917|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102143313|NCT03660917|Protective Agents|protective agents|mesh-ancestor
102143314|NCT02977507|Sunscreening Agents|sunscreening agents|mesh-list
102143315|NCT02977507|Hydroquinone|hydroquinone|mesh-list
102143316|NCT02977507|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102143317|NCT02977507|Protective Agents|protective agents|mesh-ancestor
102143318|NCT02977507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143319|NCT02977507|Dermatologic Agents|dermatologic agents|mesh-ancestor
102143320|NCT02977507|Antioxidants|antioxidants|mesh-ancestor
102143321|NCT02977507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143322|NCT04471415|Atezolizumab|atezolizumab|mesh-list
102143323|NCT04471415|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102143324|NCT04471415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143325|NCT04471415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102143326|NCT04471415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102143327|NCT02976103|Analgesics|analgesics|mesh-list
102143328|NCT02976103|Sensory System Agents|sensory system agents|mesh-ancestor
102143329|NCT02976103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102143330|NCT02976103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143331|NCT05157243|Nitazoxanide|nitazoxanide|mesh-list
102143332|NCT05157243|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102143333|NCT05157243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102143334|NCT03653845|Epinephrine|epinephrine|mesh-list
102143335|NCT03653845|Racepinephrine|racepinephrine|mesh-list
102143336|NCT03653845|Epinephryl borate|epinephryl borate|mesh-list
102143337|NCT03653845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101852249|NCT00256282|Docetaxel|docetaxel|mesh-list
102143338|NCT03653845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102143339|NCT03653845|Adrenergic Agents|adrenergic agents|mesh-ancestor
102143340|NCT03653845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102143341|NCT03653845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143342|NCT03653845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143343|NCT03653845|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102143344|NCT03653845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102143345|NCT03653845|Autonomic Agents|autonomic agents|mesh-ancestor
102143346|NCT03653845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102143347|NCT03653845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102143348|NCT03653845|Respiratory System Agents|respiratory system agents|mesh-ancestor
102143349|NCT03653845|Mydriatics|mydriatics|mesh-ancestor
102143350|NCT03653845|Sympathomimetics|sympathomimetics|mesh-ancestor
102143351|NCT03653845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102143352|NCT03470961|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102143353|NCT03470961|Immunologic Factors|immunologic factors|mesh-ancestor
102143354|NCT03470961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143355|NCT03470961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102143356|NCT01066039|Bisoprolol|bisoprolol|mesh-list
102143357|NCT01066039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102143358|NCT01066039|Sympatholytics|sympatholytics|mesh-ancestor
102143359|NCT01066039|Autonomic Agents|autonomic agents|mesh-ancestor
102143360|NCT01066039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102143361|NCT01066039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143362|NCT01066039|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102143363|NCT01066039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102143364|NCT01066039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102143365|NCT01066039|Adrenergic Agents|adrenergic agents|mesh-ancestor
102143366|NCT01066039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102143367|NCT01066039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143368|NCT04217967|Lenalidomide|lenalidomide|mesh-list
102143369|NCT04217967|Ixazomib|ixazomib|mesh-list
102143370|NCT04217967|Immunologic Factors|immunologic factors|mesh-ancestor
102143371|NCT04217967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143372|NCT04217967|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102143373|NCT04217967|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102143374|NCT04217967|Growth Substances|growth substances|mesh-ancestor
102143375|NCT04217967|Growth Inhibitors|growth inhibitors|mesh-ancestor
102143376|NCT04217967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102143377|NCT04217967|Protease Inhibitors|protease inhibitors|mesh-ancestor
102143378|NCT04217967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102143379|NCT04217967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143380|NCT02919761|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102143381|NCT02919761|Hormones|hormones|mesh-ancestor
102143382|NCT02919761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102143383|NCT02919761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143384|NCT02910167|Acetaminophen|acetaminophen|mesh-list
102143385|NCT02910167|Scopolamine|scopolamine|mesh-list
102143386|NCT02910167|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102143387|NCT02910167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102143388|NCT02910167|Analgesics|analgesics|mesh-ancestor
102143389|NCT02910167|Sensory System Agents|sensory system agents|mesh-ancestor
102143390|NCT02910167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102143391|NCT02910167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143392|NCT02910167|Antipyretics|antipyretics|mesh-ancestor
102143393|NCT02910167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102143394|NCT02910167|Antiemetics|antiemetics|mesh-ancestor
102143395|NCT02910167|Autonomic Agents|autonomic agents|mesh-ancestor
102143396|NCT02910167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102143397|NCT02910167|Mydriatics|mydriatics|mesh-ancestor
102143398|NCT02910167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102143399|NCT02910167|Cholinergic Agents|cholinergic agents|mesh-ancestor
102143400|NCT02910167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102143401|NCT02910167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143402|NCT02910167|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102143403|NCT02910167|Parasympatholytics|parasympatholytics|mesh-ancestor
102143405|NCT04458285|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102143406|NCT04458285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102143407|NCT04458285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102143408|NCT04458285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102143409|NCT04458285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143410|NCT05156541|Interferons|interferons|mesh-list
102143411|NCT05156541|Interferon-gamma|interferon-gamma|mesh-list
102143412|NCT05156541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102143413|NCT05156541|Antiviral Agents|antiviral agents|mesh-ancestor
102143414|NCT05156541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102143415|NCT01067105|Ciclesonide|ciclesonide|mesh-list
102143416|NCT01067105|Glucocorticoids|glucocorticoids|mesh-ancestor
102143417|NCT01067105|Hormones|hormones|mesh-ancestor
102143418|NCT01067105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102143419|NCT01067105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143420|NCT01067105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102143421|NCT03470727|Dialysis Solutions|dialysis solutions|mesh-list
102143422|NCT03470727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102143423|NCT03470649|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
102143424|NCT03470649|Hematinics|hematinics|mesh-ancestor
102143425|NCT02910011|Doxycycline|doxycycline|mesh-list
102143426|NCT02910011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102143427|NCT02910011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102143428|NCT02910011|Antimalarials|antimalarials|mesh-ancestor
102143429|NCT02910011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102143430|NCT02910011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102143431|NCT04456803|Sevelamer|sevelamer|mesh-list
102143432|NCT04456803|Chelating Agents|chelating agents|mesh-ancestor
102143433|NCT04456803|Sequestering Agents|sequestering agents|mesh-ancestor
102143434|NCT04456803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143435|NCT02908529|Oxybutynin|oxybutynin|mesh-list
102143436|NCT02908529|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102143437|NCT02908529|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102143438|NCT02908529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102143439|NCT02908529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101745227|NCT00758199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102143440|NCT02908529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143441|NCT02908529|Adrenergic Agents|adrenergic agents|mesh-ancestor
102143442|NCT02908529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102143443|NCT02908529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143444|NCT02908529|Parasympatholytics|parasympatholytics|mesh-ancestor
102143445|NCT02908529|Autonomic Agents|autonomic agents|mesh-ancestor
102143446|NCT02908529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102143447|NCT02908529|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102143448|NCT02908529|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102143449|NCT02908529|Cholinergic Agents|cholinergic agents|mesh-ancestor
102143450|NCT02908529|Urological Agents|urological agents|mesh-ancestor
102143451|NCT03469557|Capecitabine|capecitabine|mesh-list
102143452|NCT03469557|Oxaliplatin|oxaliplatin|mesh-list
102143453|NCT03469557|Tislelizumab|tislelizumab|mesh-list
102143454|NCT03469557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102143455|NCT03469557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102143456|NCT03469557|Antimetabolites|antimetabolites|mesh-ancestor
102143457|NCT03469557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143458|NCT03469557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102143459|NCT02643381|Ketamine|ketamine|mesh-list
102143460|NCT02643381|Etomidate|etomidate|mesh-list
102143461|NCT02643381|Analgesics|analgesics|mesh-ancestor
102143462|NCT02643381|Sensory System Agents|sensory system agents|mesh-ancestor
102143463|NCT02643381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102143464|NCT02643381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143465|NCT02643381|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102143466|NCT02643381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102143467|NCT02643381|Anesthetics, General|anesthetics, general|mesh-ancestor
102143468|NCT02643381|Anesthetics|anesthetics|mesh-ancestor
102143469|NCT02643381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102143470|NCT02643381|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102143471|NCT02643381|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102143472|NCT02643381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102143473|NCT02643381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143474|NCT02643381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102143475|NCT04328961|Ascorbic Acid|ascorbic acid|mesh-list
102143476|NCT04328961|Hydroxychloroquine|hydroxychloroquine|mesh-list
102143477|NCT04328961|Antimalarials|antimalarials|mesh-ancestor
102143478|NCT04328961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102143479|NCT04328961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102143480|NCT04328961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102143481|NCT04328961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102143482|NCT04328961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143483|NCT04328961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102143484|NCT04328961|Antioxidants|antioxidants|mesh-ancestor
102143485|NCT04328961|Protective Agents|protective agents|mesh-ancestor
102143486|NCT04328961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143487|NCT04328961|Vitamins|vitamins|mesh-ancestor
102143488|NCT04328961|Micronutrients|micronutrients|mesh-ancestor
102143490|NCT00455403|Amebicides|amebicides|mesh-ancestor
102143491|NCT00455403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102143492|NCT00455403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102143493|NCT00455403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102143494|NCT00455403|Antimalarials|antimalarials|mesh-ancestor
102143495|NCT00455403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102143496|NCT03470337|Wobenzym|wobenzym|mesh-list
102143497|NCT03470337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102143498|NCT03470337|Immunologic Factors|immunologic factors|mesh-ancestor
102143499|NCT03470337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143500|NCT03576261|Polygeline|polygeline|mesh-list
102143501|NCT03576261|Plasma Substitutes|plasma substitutes|mesh-ancestor
102143502|NCT03576261|Blood Substitutes|blood substitutes|mesh-ancestor
102143503|NCT03469323|Succinylcholine|succinylcholine|mesh-list
102143504|NCT03469323|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
102143505|NCT03469323|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102143506|NCT03469323|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102143507|NCT03469323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102143508|NCT03469323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143509|NCT05160285|Nivolumab|nivolumab|mesh-list
102143510|NCT05160285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102143511|NCT05160285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102143512|NCT05160285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102143513|NCT05160285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143514|NCT05160051|FAPI-46|fapi-46|mesh-list
102143515|NCT05160051|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102143516|NCT05160051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143517|NCT03471819|Serotonin|serotonin|mesh-list
102143518|NCT03471819|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102143519|NCT03471819|Serotonin Agents|serotonin agents|mesh-ancestor
102143520|NCT03471819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102143521|NCT03471819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143522|NCT03471819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143523|NCT03618693|Anesthetics|anesthetics|mesh-list
102143524|NCT03618693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102143525|NCT03618693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143526|NCT01064167|Tranexamic Acid|tranexamic acid|mesh-list
102143527|NCT01064167|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102143528|NCT01064167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102143529|NCT01064167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143530|NCT01064167|Hemostatics|hemostatics|mesh-ancestor
102143531|NCT01064167|Coagulants|coagulants|mesh-ancestor
102143532|NCT04205305|Labetalol|labetalol|mesh-list
102143533|NCT04205305|Nicardipine|nicardipine|mesh-list
102143534|NCT04205305|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102143535|NCT04205305|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102143536|NCT04205305|Adrenergic Agents|adrenergic agents|mesh-ancestor
102143537|NCT04205305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102143538|NCT04205305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143539|NCT04205305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143540|NCT04205305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102143541|NCT04205305|Sympathomimetics|sympathomimetics|mesh-ancestor
102143542|NCT04205305|Autonomic Agents|autonomic agents|mesh-ancestor
102143543|NCT04205305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102143544|NCT04205305|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102143545|NCT04205305|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102143546|NCT04205305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102143547|NCT04205305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102143548|NCT04205305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102143549|NCT04205305|Vasodilator Agents|vasodilator agents|mesh-ancestor
102143550|NCT03470103|Aflibercept|aflibercept|mesh-list
102143551|NCT03470103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102143552|NCT03470103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102143553|NCT03470103|Growth Substances|growth substances|mesh-ancestor
102143554|NCT03470103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143555|NCT03470103|Growth Inhibitors|growth inhibitors|mesh-ancestor
102143556|NCT03470103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102143557|NCT01064947|Retapamulin|retapamulin|mesh-list
102143558|NCT01064947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102143559|NCT01064947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102143560|NCT03469947|Tranexamic Acid|tranexamic acid|mesh-list
102143561|NCT03469947|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102143562|NCT03469947|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101852472|NCT00251745|Lansoprazole|lansoprazole|mesh-list
102143563|NCT03469947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143564|NCT03469947|Hemostatics|hemostatics|mesh-ancestor
102143565|NCT03469947|Coagulants|coagulants|mesh-ancestor
102143566|NCT05157087|Omalizumab|omalizumab|mesh-list
102143567|NCT05157087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102143568|NCT05157087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102143569|NCT05157087|Respiratory System Agents|respiratory system agents|mesh-ancestor
102143570|NCT05163249|Osimertinib|osimertinib|mesh-list
102143571|NCT05163249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102143572|NCT05163249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102143573|NCT05163249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102143574|NCT05163249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143575|NCT04054063|Etomidate|etomidate|mesh-list
102143576|NCT04054063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102143577|NCT04054063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102143578|NCT04054063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143579|NCT04054063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102143580|NCT04054063|Anesthetics, General|anesthetics, general|mesh-ancestor
102143581|NCT04054063|Anesthetics|anesthetics|mesh-ancestor
102143582|NCT03652441|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102143583|NCT03652441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102143584|NCT03652441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102143585|NCT03652441|Immunotoxins|immunotoxins|mesh-ancestor
102143586|NCT03652441|Immunoconjugates|immunoconjugates|mesh-ancestor
102143587|NCT03652441|Immunologic Factors|immunologic factors|mesh-ancestor
102143588|NCT03652441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143589|NCT02918071|Benralizumab|benralizumab|mesh-list
102143590|NCT02918071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102143591|NCT02918071|Respiratory System Agents|respiratory system agents|mesh-ancestor
102143592|NCT05162625|Moxifloxacin|moxifloxacin|mesh-list
102143593|NCT05162625|Ciprofloxacin|ciprofloxacin|mesh-list
102143594|NCT05162625|Cefazolin|cefazolin|mesh-list
102143595|NCT05162625|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102143596|NCT05162625|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102143597|NCT05162625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102143598|NCT05162625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102143599|NCT05162625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102143600|NCT05162625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102143601|NCT05162625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102143602|NCT05162625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143603|NCT05162625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102143604|NCT05162625|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102143605|NCT05162625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102143606|NCT02506816|Olaparib|olaparib|mesh-list
102143607|NCT02506816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102143608|NCT02506816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102143609|NCT02506816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143610|NCT02506816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102143611|NCT05009901|Thioctic Acid|thioctic acid|mesh-list
102143612|NCT05009901|Antioxidants|antioxidants|mesh-ancestor
102143613|NCT05009901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143614|NCT05009901|Protective Agents|protective agents|mesh-ancestor
102143615|NCT05009901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143616|NCT05009901|Vitamin B Complex|vitamin b complex|mesh-ancestor
102143617|NCT05009901|Vitamins|vitamins|mesh-ancestor
102143618|NCT05009901|Micronutrients|micronutrients|mesh-ancestor
102143619|NCT01063855|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
102143620|NCT01063855|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102143621|NCT01063855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102143622|NCT01063855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143623|NCT05162001|Disulfiram|disulfiram|mesh-list
102143624|NCT05162001|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102143625|NCT05162001|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
102143626|NCT05162001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102143627|NCT05162001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143628|NCT03469167|Epinephrine|epinephrine|mesh-list
102143630|NCT03469167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102143631|NCT03469167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102143632|NCT03469167|Adrenergic Agents|adrenergic agents|mesh-ancestor
102143633|NCT03469167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102143634|NCT03469167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143635|NCT03469167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143636|NCT03469167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102143637|NCT03469167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102143638|NCT03469167|Autonomic Agents|autonomic agents|mesh-ancestor
102143639|NCT03469167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102143640|NCT03469167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102143641|NCT03469167|Respiratory System Agents|respiratory system agents|mesh-ancestor
102143642|NCT03469167|Mydriatics|mydriatics|mesh-ancestor
102143643|NCT03469167|Sympathomimetics|sympathomimetics|mesh-ancestor
102143644|NCT03469167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102143645|NCT03469167|Hemostatics|hemostatics|mesh-ancestor
102143646|NCT03469167|Coagulants|coagulants|mesh-ancestor
102143647|NCT01063153|Methylphenidate|methylphenidate|mesh-list
102143648|NCT01063153|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102143649|NCT01063153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143650|NCT01063153|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102143651|NCT01063153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102143652|NCT01063153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102143653|NCT01063153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143654|NCT01063153|Dopamine Agents|dopamine agents|mesh-ancestor
102143655|NCT01063153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102143656|NCT05161221|Acetaminophen|acetaminophen|mesh-list
102143657|NCT05161221|Naproxen|naproxen|mesh-list
102143658|NCT05161221|Oxycodone|oxycodone|mesh-list
102143659|NCT05161221|Bupivacaine|bupivacaine|mesh-list
102143660|NCT05161221|Anesthetics, Local|anesthetics, local|mesh-ancestor
102143661|NCT05161221|Anesthetics|anesthetics|mesh-ancestor
102143662|NCT05161221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102143663|NCT05161221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143664|NCT05161221|Sensory System Agents|sensory system agents|mesh-ancestor
102143665|NCT05161221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102143666|NCT05161221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102143667|NCT05161221|Narcotics|narcotics|mesh-ancestor
102143668|NCT05161221|Analgesics|analgesics|mesh-ancestor
102143669|NCT05161221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102143670|NCT05161221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102143671|NCT05161221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102143672|NCT05161221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102143673|NCT05161221|Gout Suppressants|gout suppressants|mesh-ancestor
102143674|NCT05161221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102143675|NCT05161221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102143676|NCT05161221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143677|NCT05161221|Antipyretics|antipyretics|mesh-ancestor
102143678|NCT02505334|Liraglutide|liraglutide|mesh-list
102143679|NCT02505334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102143680|NCT02505334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143681|NCT02505334|Incretins|incretins|mesh-ancestor
102143682|NCT02505334|Hormones|hormones|mesh-ancestor
102143683|NCT02505334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102143684|NCT03469089|Ketamine|ketamine|mesh-list
102143685|NCT03469089|Modafinil|modafinil|mesh-list
102143686|NCT03469089|Analgesics|analgesics|mesh-ancestor
102143687|NCT03469089|Sensory System Agents|sensory system agents|mesh-ancestor
102143688|NCT03469089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102143689|NCT03469089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143690|NCT03469089|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102143691|NCT03469089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102143692|NCT03469089|Anesthetics, General|anesthetics, general|mesh-ancestor
102143693|NCT03469089|Anesthetics|anesthetics|mesh-ancestor
102143694|NCT03469089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102143695|NCT03469089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102143696|NCT03469089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102143697|NCT03469089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102143698|NCT03469089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143699|NCT03469089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102143700|NCT03469089|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102143701|NCT03469089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102143702|NCT03469089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102143703|NCT04969510|Pramoxine|pramoxine|mesh-list
102143704|NCT04969510|Anesthetics, Local|anesthetics, local|mesh-ancestor
102143705|NCT04969510|Anesthetics|anesthetics|mesh-ancestor
102143706|NCT04969510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102143707|NCT04969510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143708|NCT04969510|Sensory System Agents|sensory system agents|mesh-ancestor
102143709|NCT04969510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102143710|NCT02504320|Febuxostat|febuxostat|mesh-list
102143711|NCT02504320|Gout Suppressants|gout suppressants|mesh-ancestor
102143712|NCT02504320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102143713|NCT05014516|Xenon|xenon|mesh-list
102143714|NCT05014516|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102143715|NCT05014516|Anesthetics, General|anesthetics, general|mesh-ancestor
102143717|NCT05014516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102143718|NCT05014516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143719|NCT01061671|Simvastatin|simvastatin|mesh-list
102143720|NCT01061671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102143721|NCT01061671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102143722|NCT01061671|Antimetabolites|antimetabolites|mesh-ancestor
102143723|NCT01061671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143724|NCT01061671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102143725|NCT01061671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102143726|NCT01061671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102143727|NCT04969120|Metoclopramide|metoclopramide|mesh-list
102143728|NCT04969120|Antiemetics|antiemetics|mesh-ancestor
102143729|NCT04969120|Autonomic Agents|autonomic agents|mesh-ancestor
102143730|NCT04969120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102143731|NCT04969120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143732|NCT04969120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102143733|NCT04969120|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102143734|NCT04969120|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102143735|NCT04969120|Dopamine Agents|dopamine agents|mesh-ancestor
102143736|NCT04969120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102143737|NCT04969120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143738|NCT00709995|Sunitinib|sunitinib|mesh-list
102143739|NCT00709995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102143740|NCT00709995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102143741|NCT00709995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102143742|NCT00709995|Growth Substances|growth substances|mesh-ancestor
102143743|NCT00709995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143744|NCT00709995|Growth Inhibitors|growth inhibitors|mesh-ancestor
102143745|NCT00709995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102143746|NCT00709995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102143747|NCT00709995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143748|NCT02503540|Aflibercept|aflibercept|mesh-list
102143749|NCT02503540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102143750|NCT02503540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102143751|NCT02503540|Growth Substances|growth substances|mesh-ancestor
102143752|NCT02503540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143753|NCT02503540|Growth Inhibitors|growth inhibitors|mesh-ancestor
102143754|NCT02503540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102143755|NCT04053985|Lenvatinib|lenvatinib|mesh-list
102143756|NCT04053985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102143757|NCT04053985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102143758|NCT04053985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102143759|NCT04053985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143760|NCT04455243|Acetylcysteine|acetylcysteine|mesh-list
102143761|NCT04455243|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102143762|NCT04455243|Antiviral Agents|antiviral agents|mesh-ancestor
102143763|NCT04455243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102143764|NCT04455243|Expectorants|expectorants|mesh-ancestor
102143765|NCT04455243|Respiratory System Agents|respiratory system agents|mesh-ancestor
102143766|NCT04455243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102143767|NCT04455243|Antioxidants|antioxidants|mesh-ancestor
102143768|NCT04455243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143769|NCT04455243|Protective Agents|protective agents|mesh-ancestor
102143770|NCT04455243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143771|NCT04455243|Antidotes|antidotes|mesh-ancestor
102143772|NCT04454775|Protein C|protein c|mesh-list
102143773|NCT04454775|Antithrombins|antithrombins|mesh-list
102143774|NCT04454775|Antithrombin III|antithrombin iii|mesh-list
102143775|NCT04454775|Protein S|protein s|mesh-list
102143776|NCT04454775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102143777|NCT04454775|Protease Inhibitors|protease inhibitors|mesh-ancestor
102143778|NCT04454775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102143779|NCT04454775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143780|NCT04454775|Anticoagulants|anticoagulants|mesh-ancestor
102143781|NCT04454775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102143782|NCT04454775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102143784|NCT03651661|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102143785|NCT03651661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102143786|NCT03651661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852690|NCT00189202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102143787|NCT01060111|Topiramate|topiramate|mesh-list
102143788|NCT01060111|Propranolol|propranolol|mesh-list
102143789|NCT01060111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102143790|NCT01060111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102143791|NCT01060111|Adrenergic Agents|adrenergic agents|mesh-ancestor
102143792|NCT01060111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102143793|NCT01060111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143794|NCT01060111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143795|NCT01060111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102143796|NCT01060111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102143797|NCT01060111|Vasodilator Agents|vasodilator agents|mesh-ancestor
102143798|NCT01060111|Anticonvulsants|anticonvulsants|mesh-ancestor
102143799|NCT01060111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102143800|NCT02969863|Pancrelipase|pancrelipase|mesh-list
102143801|NCT02969863|Pancreatin|pancreatin|mesh-list
102143802|NCT02969863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102143803|NCT03651427|Estradiol|estradiol|mesh-list
102143804|NCT03651427|Estrogens|estrogens|mesh-ancestor
102143805|NCT03651427|Hormones|hormones|mesh-ancestor
102143806|NCT03651427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102143807|NCT03651427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143808|NCT05285293|Vitamin A|vitamin a|mesh-list
102143809|NCT05285293|Vitamins|vitamins|mesh-ancestor
102143810|NCT05285293|Micronutrients|micronutrients|mesh-ancestor
102143811|NCT05285293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143812|NCT03650257|Temozolomide|temozolomide|mesh-list
102143813|NCT03650257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102143814|NCT03650257|Alkylating Agents|alkylating agents|mesh-ancestor
102143815|NCT03650257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143816|NCT03650257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102143817|NCT03649243|Propolis|propolis|mesh-list
102143818|NCT03649243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102143819|NCT03649165|Acetaminophen|acetaminophen|mesh-list
102143820|NCT03649165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102143821|NCT03649165|Analgesics|analgesics|mesh-ancestor
102143822|NCT03649165|Sensory System Agents|sensory system agents|mesh-ancestor
102143823|NCT03649165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102143824|NCT03649165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143825|NCT03649165|Antipyretics|antipyretics|mesh-ancestor
102143826|NCT03649009|Thiamine|thiamine|mesh-list
102143827|NCT03649009|Hydrocortisone|hydrocortisone|mesh-list
102143828|NCT03649009|Metoclopramide|metoclopramide|mesh-list
102143829|NCT03649009|Vitamins|vitamins|mesh-ancestor
102143830|NCT03649009|Micronutrients|micronutrients|mesh-ancestor
102143831|NCT03649009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143832|NCT03649009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102143833|NCT03649009|Vitamin B Complex|vitamin b complex|mesh-ancestor
102143834|NCT03649009|Antiemetics|antiemetics|mesh-ancestor
102143835|NCT03649009|Autonomic Agents|autonomic agents|mesh-ancestor
102143836|NCT03649009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102143837|NCT03649009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102143838|NCT03649009|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102143839|NCT03649009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102143840|NCT03649009|Dopamine Agents|dopamine agents|mesh-ancestor
102143841|NCT03649009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102143842|NCT03649009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143843|NCT03650023|Chitosan|chitosan|mesh-list
102143844|NCT03650023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102143845|NCT03650023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102143846|NCT03650023|Antimetabolites|antimetabolites|mesh-ancestor
102143847|NCT03650023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143848|NCT03650023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102143849|NCT03650023|Chelating Agents|chelating agents|mesh-ancestor
102143850|NCT03650023|Sequestering Agents|sequestering agents|mesh-ancestor
102143851|NCT03650023|Hemostatics|hemostatics|mesh-ancestor
102143852|NCT03650023|Coagulants|coagulants|mesh-ancestor
102143853|NCT04054999|Hydroxocobalamin|hydroxocobalamin|mesh-list
102143854|NCT04054999|Vitamin B 12|vitamin b 12|mesh-list
102143855|NCT04054999|Methylene Blue|methylene blue|mesh-list
102143856|NCT04054999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102143857|NCT04054999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143858|NCT04054999|Hematinics|hematinics|mesh-ancestor
102143859|NCT04054999|Vitamin B Complex|vitamin b complex|mesh-ancestor
102143860|NCT04054999|Vitamins|vitamins|mesh-ancestor
102143861|NCT04054999|Micronutrients|micronutrients|mesh-ancestor
102143862|NCT04054999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143863|NCT03649945|Docetaxel|docetaxel|mesh-list
102143864|NCT03649945|Endostar protein|endostar protein|mesh-list
102143865|NCT03649945|Nedaplatin|nedaplatin|mesh-list
101852764|NCT00219544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102143866|NCT03649945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102143867|NCT03649945|Tubulin Modulators|tubulin modulators|mesh-ancestor
102143868|NCT03649945|Antimitotic Agents|antimitotic agents|mesh-ancestor
102143869|NCT03649945|Mitosis Modulators|mitosis modulators|mesh-ancestor
102143870|NCT03649945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143871|NCT03649945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102143872|NCT03649945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102143873|NCT03649945|Growth Substances|growth substances|mesh-ancestor
102143874|NCT03649945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143875|NCT03649945|Growth Inhibitors|growth inhibitors|mesh-ancestor
102143877|NCT03650881|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102143878|NCT03650881|Dermatologic Agents|dermatologic agents|mesh-ancestor
102143879|NCT03650881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102143880|NCT03650881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102143881|NCT03650881|Analgesics|analgesics|mesh-ancestor
102143882|NCT03650881|Sensory System Agents|sensory system agents|mesh-ancestor
102143883|NCT03650881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102143884|NCT03650881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143885|NCT03650881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102143886|NCT03650881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102143887|NCT02904265|Acetazolamide|acetazolamide|mesh-list
102143888|NCT02904265|Diazepam|diazepam|mesh-list
102143889|NCT02904265|Anticonvulsants|anticonvulsants|mesh-ancestor
102143890|NCT02904265|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102143891|NCT02904265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102143892|NCT02904265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143893|NCT02904265|Diuretics|diuretics|mesh-ancestor
102143894|NCT02904265|Natriuretic Agents|natriuretic agents|mesh-ancestor
102143895|NCT02904265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143896|NCT02904265|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102143897|NCT02904265|Antiemetics|antiemetics|mesh-ancestor
102143898|NCT02904265|Autonomic Agents|autonomic agents|mesh-ancestor
102143899|NCT02904265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102143900|NCT02904265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102143901|NCT02904265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102143902|NCT02904265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102143903|NCT02904265|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102143904|NCT02904265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102143905|NCT02904265|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102143906|NCT02904265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102143907|NCT02904265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102143908|NCT02904265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102143909|NCT02904265|Anesthetics, General|anesthetics, general|mesh-ancestor
102143910|NCT02904265|Anesthetics|anesthetics|mesh-ancestor
102143911|NCT02904265|GABA Modulators|gaba modulators|mesh-ancestor
102143912|NCT02904265|GABA Agents|gaba agents|mesh-ancestor
102143913|NCT02904265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102143914|NCT03648229|Timolol|timolol|mesh-list
102143915|NCT03648229|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102143916|NCT03648229|Latanoprost|latanoprost|mesh-list
102143917|NCT03648229|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102143918|NCT03648229|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102143919|NCT03648229|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102143920|NCT03648229|Adrenergic Agents|adrenergic agents|mesh-ancestor
102143921|NCT03648229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102143922|NCT03648229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143923|NCT03648229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143924|NCT03648229|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102143925|NCT03648229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102143926|NCT03648697|Cyclophosphamide|cyclophosphamide|mesh-list
102143927|NCT03648697|Fludarabine|fludarabine|mesh-list
102143928|NCT03648697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102143929|NCT03648697|Immunologic Factors|immunologic factors|mesh-ancestor
102143930|NCT03648697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143931|NCT03648697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102143932|NCT03648697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102143933|NCT03648697|Alkylating Agents|alkylating agents|mesh-ancestor
102143934|NCT03648697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143935|NCT03648697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102143937|NCT04535037|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102143938|NCT04535037|Immunologic Factors|immunologic factors|mesh-ancestor
102143939|NCT04535037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143940|NCT02967679|Biotin|biotin|mesh-list
102143941|NCT02967679|Vitamin B Complex|vitamin b complex|mesh-ancestor
102143942|NCT02967679|Vitamins|vitamins|mesh-ancestor
102143943|NCT02967679|Micronutrients|micronutrients|mesh-ancestor
102143944|NCT02967679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143946|NCT04447053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102143947|NCT04447053|Immunologic Factors|immunologic factors|mesh-ancestor
102143948|NCT04447053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143949|NCT04361799|Insulin|insulin|mesh-list
102143950|NCT04361799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102143951|NCT04361799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143952|NCT05390073|Hormones|hormones|mesh-list
102143953|NCT05390073|Mitogens|mitogens|mesh-list
102143954|NCT05390073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143955|NCT05390073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102143956|NCT05390073|Mitosis Modulators|mitosis modulators|mesh-ancestor
102143957|NCT05390073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143958|NCT03647839|Nivolumab|nivolumab|mesh-list
102143959|NCT03647839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102143960|NCT03647839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102143961|NCT03647839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102143962|NCT03647839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143963|NCT04454619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102143964|NCT04454307|Tramadol|tramadol|mesh-list
102143965|NCT04454307|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102143966|NCT04454307|Narcotics|narcotics|mesh-ancestor
102143967|NCT04454307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102143968|NCT04454307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143969|NCT04454307|Analgesics|analgesics|mesh-ancestor
102143970|NCT04454307|Sensory System Agents|sensory system agents|mesh-ancestor
102143971|NCT04454307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102143972|NCT05388123|Rituximab|rituximab|mesh-list
102143973|NCT05388123|Vemurafenib|vemurafenib|mesh-list
102143974|NCT05388123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102143975|NCT05388123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102143976|NCT05388123|Immunologic Factors|immunologic factors|mesh-ancestor
102143977|NCT05388123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143978|NCT05388123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102143979|NCT05388123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102143980|NCT05388123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241606|NCT03071055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102143981|NCT05388123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143982|NCT04455711|Lidocaine|lidocaine|mesh-list
102143983|NCT04455711|Remifentanil|remifentanil|mesh-list
102143984|NCT04455711|Anesthetics, Local|anesthetics, local|mesh-ancestor
102143985|NCT04455711|Anesthetics|anesthetics|mesh-ancestor
102143986|NCT04455711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102143987|NCT04455711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102143988|NCT04455711|Sensory System Agents|sensory system agents|mesh-ancestor
102143989|NCT04455711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102143990|NCT04455711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102143991|NCT04455711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102143992|NCT04455711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102143993|NCT04455711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102143994|NCT04455711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102143995|NCT04455711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102143996|NCT04455711|Narcotics|narcotics|mesh-ancestor
102143997|NCT04455711|Analgesics|analgesics|mesh-ancestor
102143998|NCT03717987|Botulinum Toxins|botulinum toxins|mesh-list
102143999|NCT03717987|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102144000|NCT03717987|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102144001|NCT03717987|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102144002|NCT03717987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102144003|NCT03717987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144004|NCT03717987|Cholinergic Agents|cholinergic agents|mesh-ancestor
102144005|NCT03717987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102144006|NCT03717987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144007|NCT03717987|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102144008|NCT03717987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102144009|NCT04062669|Vaccines|vaccines|mesh-list
102144010|NCT04062669|Immunologic Factors|immunologic factors|mesh-ancestor
102144011|NCT04062669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144012|NCT05387967|Valsartan|valsartan|mesh-list
102144013|NCT05387967|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102144014|NCT05387967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
102144015|NCT05387967|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102144016|NCT05387967|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102144017|NCT05387967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144018|NCT03856359|Rifaximin|rifaximin|mesh-list
102144019|NCT03856359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102144020|NCT03856359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102144021|NCT03856359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102144022|NCT04052659|Azacitidine|azacitidine|mesh-list
102144023|NCT04052659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102144024|NCT04052659|Antimetabolites|antimetabolites|mesh-ancestor
102144025|NCT04052659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144026|NCT04052659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102144027|NCT04052659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102144028|NCT02964247|Liraglutide|liraglutide|mesh-list
102144029|NCT02964247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102144030|NCT02964247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144031|NCT02964247|Incretins|incretins|mesh-ancestor
102144032|NCT02964247|Hormones|hormones|mesh-ancestor
102144033|NCT02964247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102144034|NCT03654729|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
102144035|NCT03654729|Edetic Acid|edetic acid|mesh-list
102144036|NCT03654729|Anticoagulants|anticoagulants|mesh-ancestor
102144037|NCT03654729|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102144038|NCT03654729|Chelating Agents|chelating agents|mesh-ancestor
102144039|NCT03654729|Sequestering Agents|sequestering agents|mesh-ancestor
102144040|NCT03654729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144041|NCT03654729|Vitamin B Complex|vitamin b complex|mesh-ancestor
102144042|NCT03654729|Vitamins|vitamins|mesh-ancestor
102144043|NCT03654729|Micronutrients|micronutrients|mesh-ancestor
102144044|NCT03654729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144045|NCT04052269|Sildenafil Citrate|sildenafil citrate|mesh-list
102144046|NCT04052269|Tadalafil|tadalafil|mesh-list
102144047|NCT04052269|Vasodilator Agents|vasodilator agents|mesh-ancestor
102144048|NCT04052269|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102144049|NCT04052269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102144050|NCT04052269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102144051|NCT04052269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144052|NCT04052269|Urological Agents|urological agents|mesh-ancestor
102144053|NCT01377987|Acetazolamide|acetazolamide|mesh-list
102144054|NCT01377987|Anticonvulsants|anticonvulsants|mesh-ancestor
102144055|NCT01377987|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102144056|NCT01377987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102144057|NCT01377987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144058|NCT01377987|Diuretics|diuretics|mesh-ancestor
102144059|NCT01377987|Natriuretic Agents|natriuretic agents|mesh-ancestor
102144060|NCT01377987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144061|NCT03645187|Celecoxib|celecoxib|mesh-list
102144062|NCT03645187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102144063|NCT03645187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102144064|NCT03645187|Analgesics|analgesics|mesh-ancestor
102144065|NCT03645187|Sensory System Agents|sensory system agents|mesh-ancestor
102144066|NCT03645187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102144067|NCT03645187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144068|NCT03645187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102144069|NCT03645187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102144070|NCT03645187|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102144071|NCT03645187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102144072|NCT03645187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102144073|NCT03645187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144074|NCT03645109|Vitamin D|vitamin d|mesh-list
102144075|NCT03645109|Cholecalciferol|cholecalciferol|mesh-list
102144076|NCT03645109|Vitamins|vitamins|mesh-ancestor
102144077|NCT03645109|Micronutrients|micronutrients|mesh-ancestor
102144078|NCT03645109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144079|NCT03645109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102144080|NCT03645109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102144081|NCT04455555|Rotigotine|rotigotine|mesh-list
102144082|NCT04455555|Dopamine Agonists|dopamine agonists|mesh-ancestor
102144083|NCT04455555|Dopamine Agents|dopamine agents|mesh-ancestor
102144084|NCT04455555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102154335|NCT03365817|Anesthetics|anesthetics|mesh-ancestor
102144085|NCT04455555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144086|NCT04455555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144088|NCT02898259|Lenalidomide|lenalidomide|mesh-list
102144089|NCT02898259|Ixazomib|ixazomib|mesh-list
102144090|NCT02898259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102144091|NCT02898259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102144092|NCT02898259|Immunologic Factors|immunologic factors|mesh-ancestor
102144093|NCT02898259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144094|NCT02898259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102144095|NCT02898259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102144096|NCT02898259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102144097|NCT02898259|Growth Substances|growth substances|mesh-ancestor
102144098|NCT02898259|Growth Inhibitors|growth inhibitors|mesh-ancestor
102144099|NCT02898259|Protease Inhibitors|protease inhibitors|mesh-ancestor
102144100|NCT02898259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102144101|NCT02898259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144102|NCT03646357|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102144103|NCT03646357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102144104|NCT03646357|Adrenergic Agents|adrenergic agents|mesh-ancestor
102144105|NCT03646357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102144106|NCT03646357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144107|NCT03646357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144108|NCT02963935|Liraglutide|liraglutide|mesh-list
102144109|NCT02963935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102144110|NCT02963935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144111|NCT02963935|Incretins|incretins|mesh-ancestor
102144112|NCT02963935|Hormones|hormones|mesh-ancestor
102144113|NCT02963935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102144114|NCT03644641|Propofol|propofol|mesh-list
102144115|NCT03644641|Desflurane|desflurane|mesh-list
102144116|NCT03644641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102144117|NCT03644641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102144118|NCT03644641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144119|NCT03644641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102144120|NCT03644641|Anesthetics, General|anesthetics, general|mesh-ancestor
102144121|NCT03644641|Anesthetics|anesthetics|mesh-ancestor
102144122|NCT03644641|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102144123|NCT05283421|Estrogens|estrogens|mesh-list
102144124|NCT05283421|Hormones|hormones|mesh-ancestor
102144125|NCT05283421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102144126|NCT05283421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144127|NCT03630991|Calcium, Dietary|calcium, dietary|mesh-list
102144128|NCT03630991|Edetic Acid|edetic acid|mesh-list
102144129|NCT03630991|Calcium|calcium|mesh-list
102144130|NCT03630991|Pentetic Acid|pentetic acid|mesh-list
102144131|NCT03630991|Succimer|succimer|mesh-list
102144132|NCT03630991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144133|NCT03630991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102144134|NCT03630991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102144135|NCT03630991|Anticoagulants|anticoagulants|mesh-ancestor
102144136|NCT03630991|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102144137|NCT03630991|Chelating Agents|chelating agents|mesh-ancestor
102144138|NCT03630991|Sequestering Agents|sequestering agents|mesh-ancestor
102144139|NCT03630991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144140|NCT03630991|Antidotes|antidotes|mesh-ancestor
102144141|NCT03630991|Protective Agents|protective agents|mesh-ancestor
102144142|NCT03630991|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102144143|NCT02963701|Ibuprofen|ibuprofen|mesh-list
102144144|NCT02963701|Pseudoephedrine|pseudoephedrine|mesh-list
102144145|NCT02963701|Ephedrine|ephedrine|mesh-list
102144146|NCT02963701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102144147|NCT02963701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102144148|NCT02963701|Analgesics|analgesics|mesh-ancestor
102144149|NCT02963701|Sensory System Agents|sensory system agents|mesh-ancestor
102144150|NCT02963701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102144151|NCT02963701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144152|NCT02963701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102144153|NCT02963701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102144154|NCT02963701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102144155|NCT02963701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102144156|NCT02963701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144157|NCT02963701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102144158|NCT02963701|Autonomic Agents|autonomic agents|mesh-ancestor
102144159|NCT02963701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102144160|NCT02963701|Respiratory System Agents|respiratory system agents|mesh-ancestor
102144161|NCT02963701|Nasal Decongestants|nasal decongestants|mesh-ancestor
102144162|NCT02963701|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102144163|NCT02963701|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102144164|NCT02963701|Sympathomimetics|sympathomimetics|mesh-ancestor
102144165|NCT02963701|Adrenergic Agents|adrenergic agents|mesh-ancestor
102144166|NCT02963701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102144167|NCT02961751|Ciprofloxacin|ciprofloxacin|mesh-list
102144168|NCT02961751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102144169|NCT02961751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102144170|NCT02961751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102144171|NCT02961751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102144172|NCT02961751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102144173|NCT02961751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144174|NCT02961751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102144175|NCT02961751|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102144176|NCT02961751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102144177|NCT03643549|Temozolomide|temozolomide|mesh-list
102144178|NCT03643549|Bortezomib|bortezomib|mesh-list
102144179|NCT03643549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102144180|NCT03643549|Alkylating Agents|alkylating agents|mesh-ancestor
102144181|NCT03643549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144182|NCT03643549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102144183|NCT05262205|Anesthetics|anesthetics|mesh-list
102144184|NCT05262205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102144185|NCT05262205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144186|NCT03641053|Iodine|iodine|mesh-list
102144187|NCT03641053|Povidone-Iodine|povidone-iodine|mesh-list
102144188|NCT03641053|Povidone|povidone|mesh-list
102144189|NCT03641053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102144190|NCT03641053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102144191|NCT03641053|Trace Elements|trace elements|mesh-ancestor
102144192|NCT03641053|Micronutrients|micronutrients|mesh-ancestor
102144193|NCT03641053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144194|NCT03641053|Plasma Substitutes|plasma substitutes|mesh-ancestor
102144195|NCT03641053|Blood Substitutes|blood substitutes|mesh-ancestor
102144196|NCT04455477|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
102144197|NCT04455477|Natriuretic Agents|natriuretic agents|mesh-ancestor
102144198|NCT04455477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144199|NCT05165277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102144200|NCT03468777|Lansoprazole|lansoprazole|mesh-list
102144201|NCT03468777|Dexlansoprazole|dexlansoprazole|mesh-list
102144202|NCT03468777|Ranitidine|ranitidine|mesh-list
102144203|NCT03468777|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
102144204|NCT03468777|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102144205|NCT03468777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102144206|NCT03468777|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102144207|NCT03468777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102144208|NCT03468777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144209|NCT03468777|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102144210|NCT03468777|Histamine Antagonists|histamine antagonists|mesh-ancestor
102144211|NCT03468777|Histamine Agents|histamine agents|mesh-ancestor
102144212|NCT03468777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102144213|NCT03468777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144214|NCT03640377|Praziquantel|praziquantel|mesh-list
102144215|NCT03640377|Anthelmintics|anthelmintics|mesh-ancestor
102144216|NCT03640377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102144217|NCT03640377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102144218|NCT05323149|Tranexamic Acid|tranexamic acid|mesh-list
102144219|NCT05323149|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102144220|NCT05323149|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102144221|NCT05323149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144222|NCT05323149|Hemostatics|hemostatics|mesh-ancestor
102144223|NCT05323149|Coagulants|coagulants|mesh-ancestor
102144224|NCT05303805|Sevoflurane|sevoflurane|mesh-list
102144225|NCT05303805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102144226|NCT05303805|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102144227|NCT05303805|Anesthetics, General|anesthetics, general|mesh-ancestor
102144228|NCT05303805|Anesthetics|anesthetics|mesh-ancestor
102144229|NCT05303805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102144230|NCT05303805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144231|NCT03642847|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102144232|NCT03642847|Immunologic Factors|immunologic factors|mesh-ancestor
102144233|NCT03642847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144234|NCT03621163|Lithium Carbonate|lithium carbonate|mesh-list
102144235|NCT03621163|Antidepressive Agents|antidepressive agents|mesh-ancestor
102144236|NCT03621163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102144237|NCT03621163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102144238|NCT03621163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144239|NCT03621163|Antimanic Agents|antimanic agents|mesh-ancestor
102144240|NCT03621163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102144241|NCT03621163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102144242|NCT03621163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144244|NCT03632187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102144245|NCT03632187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144246|NCT03632187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102144247|NCT03632187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102144248|NCT03632187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102144249|NCT03632187|Immunologic Factors|immunologic factors|mesh-ancestor
102144250|NCT03632187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144251|NCT03632187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102144253|NCT05110209|Ranibizumab|ranibizumab|mesh-list
102144254|NCT05110209|Aflibercept|aflibercept|mesh-list
102144255|NCT05110209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102144256|NCT05110209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102144257|NCT05110209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102144258|NCT05110209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102144259|NCT05110209|Growth Substances|growth substances|mesh-ancestor
102144260|NCT05110209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144261|NCT05110209|Growth Inhibitors|growth inhibitors|mesh-ancestor
102144262|NCT04454151|Azithromycin|azithromycin|mesh-list
102144263|NCT04454151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102144264|NCT04454151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102144265|NCT05272683|Itraconazole|itraconazole|mesh-list
102144266|NCT05272683|Antifungal Agents|antifungal agents|mesh-ancestor
102144267|NCT05272683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102144268|NCT05272683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102144269|NCT05272683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102144270|NCT05272683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102144271|NCT05272683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144272|NCT05272683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102144273|NCT05272683|Hormone Antagonists|hormone antagonists|mesh-ancestor
102144274|NCT05272683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102144275|NCT05272683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144276|NCT05272683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102144277|NCT03934671|Antioxidants|antioxidants|mesh-list
102144278|NCT03934671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144279|NCT03934671|Protective Agents|protective agents|mesh-ancestor
102144280|NCT03934671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144281|NCT03130179|Nicotine|nicotine|mesh-list
102144282|NCT03130179|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102144283|NCT03130179|Autonomic Agents|autonomic agents|mesh-ancestor
102144284|NCT03130179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102144285|NCT03130179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144286|NCT03130179|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102144287|NCT03130179|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102144288|NCT03130179|Cholinergic Agents|cholinergic agents|mesh-ancestor
102144289|NCT03130179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102144290|NCT03130179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144291|NCT03466983|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
102144292|NCT03466983|Hematinics|hematinics|mesh-ancestor
102144293|NCT05439213|Epinephrine|epinephrine|mesh-list
102144294|NCT05439213|Racepinephrine|racepinephrine|mesh-list
102144295|NCT05439213|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102144296|NCT05439213|Epinephryl borate|epinephryl borate|mesh-list
102144297|NCT05439213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102144298|NCT05439213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102144299|NCT05439213|Adrenergic Agents|adrenergic agents|mesh-ancestor
102144300|NCT05439213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102144301|NCT05439213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144302|NCT05439213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144303|NCT05439213|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102144304|NCT05439213|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102144305|NCT05439213|Autonomic Agents|autonomic agents|mesh-ancestor
102144306|NCT05439213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102144307|NCT05439213|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102144308|NCT05439213|Respiratory System Agents|respiratory system agents|mesh-ancestor
102144309|NCT05439213|Mydriatics|mydriatics|mesh-ancestor
102144310|NCT05439213|Sympathomimetics|sympathomimetics|mesh-ancestor
102144311|NCT05439213|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102144313|NCT03466749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102144314|NCT03466749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102144315|NCT03466749|Tubulin Modulators|tubulin modulators|mesh-ancestor
102144316|NCT03466749|Antimitotic Agents|antimitotic agents|mesh-ancestor
102144317|NCT03466749|Mitosis Modulators|mitosis modulators|mesh-ancestor
101853212|NCT00184600|Insulin|insulin|mesh-list
102144318|NCT03466749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144319|NCT03466437|Methamphetamine|methamphetamine|mesh-list
102144320|NCT03466437|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102144321|NCT03466437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144322|NCT03466437|Sympathomimetics|sympathomimetics|mesh-ancestor
102144323|NCT03466437|Autonomic Agents|autonomic agents|mesh-ancestor
102144324|NCT03466437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102144325|NCT03466437|Dopamine Agents|dopamine agents|mesh-ancestor
102144326|NCT03466437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102144327|NCT03466437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144328|NCT03466437|Adrenergic Agents|adrenergic agents|mesh-ancestor
102144329|NCT03466437|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102144330|NCT03466437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102144331|NCT03466437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102144332|NCT03466437|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102144333|NCT03466359|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
102144334|NCT03466359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102144335|NCT03466359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144336|NCT01909245|Immunosuppressive Agents|immunosuppressive agents|mesh-list
102144337|NCT01909245|Gastrins|gastrins|mesh-list
102144338|NCT01909245|Immunologic Factors|immunologic factors|mesh-ancestor
102144339|NCT01909245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144340|NCT01909245|Hormones|hormones|mesh-ancestor
102144341|NCT01909245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102144342|NCT04459065|Nimotuzumab|nimotuzumab|mesh-list
102144343|NCT04459065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102144344|NCT04459065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102144345|NCT03465969|Tacrolimus|tacrolimus|mesh-list
102144346|NCT03465969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102144347|NCT03465969|Immunologic Factors|immunologic factors|mesh-ancestor
102144348|NCT03465969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144349|NCT03465969|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102144350|NCT03465969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102144351|NCT03465969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144352|NCT05397795|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102144353|NCT05397795|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102144354|NCT05397795|Luteolytic Agents|luteolytic agents|mesh-ancestor
102144355|NCT05397795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102144356|NCT05397795|Contraceptive Agents|contraceptive agents|mesh-ancestor
102144357|NCT05397795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102144358|NCT05397795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144359|NCT05397795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102144360|NCT05397795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102144361|NCT05397795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102144362|NCT03130101|Insulin|insulin|mesh-list
102144363|NCT03130101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102144364|NCT03130101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144365|NCT01067521|Glatiramer Acetate|glatiramer acetate|mesh-list
102144366|NCT01067521|(T,G)-A-L|(t,g)-a-l|mesh-list
102144367|NCT01067521|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102144368|NCT01067521|Immunologic Factors|immunologic factors|mesh-ancestor
102144369|NCT01067521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144370|NCT01067521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102144371|NCT01067521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102144372|NCT02735577|Disulfiram|disulfiram|mesh-list
102144373|NCT02735577|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102144374|NCT02735577|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
102144375|NCT02735577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102144376|NCT02735577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144377|NCT03642535|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102144378|NCT03642535|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102144379|NCT03642535|Dermatologic Agents|dermatologic agents|mesh-ancestor
102144380|NCT05171257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102144381|NCT05171257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102144382|NCT05171257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102144383|NCT05171257|Antitubercular Agents|antitubercular agents|mesh-ancestor
102144384|NCT01068613|Tiotropium Bromide|tiotropium bromide|mesh-list
102144385|NCT01068613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102144386|NCT01068613|Autonomic Agents|autonomic agents|mesh-ancestor
102144387|NCT01068613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102144388|NCT01068613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144389|NCT01068613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102144390|NCT01068613|Respiratory System Agents|respiratory system agents|mesh-ancestor
102144391|NCT01068613|Parasympatholytics|parasympatholytics|mesh-ancestor
102144392|NCT01068613|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102144393|NCT01068613|Cholinergic Agents|cholinergic agents|mesh-ancestor
102144394|NCT01068613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102144395|NCT01068613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144396|NCT05396937|Bevacizumab|bevacizumab|mesh-list
102144397|NCT05396937|Atezolizumab|atezolizumab|mesh-list
102144398|NCT05396937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102144399|NCT05396937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102144400|NCT05396937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102144401|NCT05396937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102144402|NCT05396937|Growth Substances|growth substances|mesh-ancestor
102144403|NCT05396937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144404|NCT05396937|Growth Inhibitors|growth inhibitors|mesh-ancestor
102144405|NCT05396937|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102144406|NCT05396937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144407|NCT05424315|Dapagliflozin|dapagliflozin|mesh-list
102144408|NCT05424315|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102144409|NCT05424315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144410|NCT05424315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102144411|NCT05424315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144412|NCT03642145|Deflazacort|deflazacort|mesh-list
102144413|NCT03642145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102144414|NCT03642145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102144415|NCT03642145|Immunologic Factors|immunologic factors|mesh-ancestor
102144416|NCT03642145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144417|NCT01064791|Mycophenolic Acid|mycophenolic acid|mesh-list
102144419|NCT01064791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102144420|NCT01064791|Immunologic Factors|immunologic factors|mesh-ancestor
102144421|NCT01064791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144422|NCT01064791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102144423|NCT01064791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102144424|NCT01064791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144425|NCT01064791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102144426|NCT01064791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102144427|NCT01064791|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102144428|NCT01064791|Antitubercular Agents|antitubercular agents|mesh-ancestor
102144429|NCT01064791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102144430|NCT01064791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102144431|NCT03465423|Propofol|propofol|mesh-list
102144432|NCT03465423|Anesthetics|anesthetics|mesh-ancestor
102144433|NCT03465423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102144434|NCT03465423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144435|NCT03465423|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102144436|NCT03465423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102144437|NCT03465423|Anesthetics, General|anesthetics, general|mesh-ancestor
102144438|NCT05161351|Vitamin D|vitamin d|mesh-list
102144439|NCT05161351|Cholecalciferol|cholecalciferol|mesh-list
102144440|NCT05161351|Baclofen|baclofen|mesh-list
102144441|NCT05161351|Vitamins|vitamins|mesh-ancestor
102144442|NCT05161351|Micronutrients|micronutrients|mesh-ancestor
102144443|NCT05161351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144444|NCT05161351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102144445|NCT05161351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102144446|NCT05161351|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102144447|NCT05161351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102144448|NCT05161351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102144449|NCT05161351|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102144450|NCT05161351|GABA Agonists|gaba agonists|mesh-ancestor
102144451|NCT05161351|GABA Agents|gaba agents|mesh-ancestor
102144452|NCT05161351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102144453|NCT05161351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144454|NCT03465345|Metformin|metformin|mesh-list
102144455|NCT03465345|Proanthocyanidin|proanthocyanidin|mesh-list
102144456|NCT03465345|Procyanidin|procyanidin|mesh-list
102087001|NCT03537534|Lidocaine|lidocaine|mesh-list
102144457|NCT03465345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102144458|NCT03465345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144460|NCT03465345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144461|NCT03465345|Protective Agents|protective agents|mesh-ancestor
102144462|NCT03465345|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102144463|NCT03465345|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102144464|NCT03465345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102144465|NCT02983799|Olaparib|olaparib|mesh-list
102144466|NCT02983799|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102144467|NCT02983799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102144468|NCT02983799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144469|NCT02983799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102144470|NCT05385705|Cyclophosphamide|cyclophosphamide|mesh-list
102144471|NCT05385705|Trastuzumab|trastuzumab|mesh-list
102144472|NCT05385705|Interleukin-2|interleukin-2|mesh-list
102144473|NCT05385705|Pertuzumab|pertuzumab|mesh-list
102144474|NCT05385705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102144475|NCT05385705|Immunologic Factors|immunologic factors|mesh-ancestor
102144476|NCT05385705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144477|NCT05385705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102144478|NCT05385705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102144479|NCT05385705|Alkylating Agents|alkylating agents|mesh-ancestor
102144480|NCT05385705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144481|NCT05385705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102144482|NCT05385705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102144483|NCT05385705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102144484|NCT05385705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102144485|NCT05385705|Analgesics|analgesics|mesh-ancestor
102144486|NCT05385705|Sensory System Agents|sensory system agents|mesh-ancestor
102144487|NCT05385705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102144488|NCT03912831|Cyclophosphamide|cyclophosphamide|mesh-list
102144489|NCT03912831|Fludarabine|fludarabine|mesh-list
102144490|NCT03912831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102144491|NCT03912831|Immunologic Factors|immunologic factors|mesh-ancestor
102144492|NCT03912831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144493|NCT03912831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102144494|NCT03912831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102144495|NCT03912831|Alkylating Agents|alkylating agents|mesh-ancestor
102144496|NCT03912831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144497|NCT03912831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102144498|NCT03912831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102144499|NCT02186847|Metformin|metformin|mesh-list
102144500|NCT02186847|Paclitaxel|paclitaxel|mesh-list
102144501|NCT02186847|Carboplatin|carboplatin|mesh-list
102144502|NCT02186847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102144503|NCT02186847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102144504|NCT02186847|Tubulin Modulators|tubulin modulators|mesh-ancestor
102144505|NCT02186847|Antimitotic Agents|antimitotic agents|mesh-ancestor
102144506|NCT02186847|Mitosis Modulators|mitosis modulators|mesh-ancestor
102144507|NCT02186847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144508|NCT02186847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102144509|NCT02186847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144510|NCT05274789|Dexmedetomidine|dexmedetomidine|mesh-list
102144511|NCT05274789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102144512|NCT05274789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102144513|NCT05274789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144514|NCT05274789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102144515|NCT05274789|Analgesics|analgesics|mesh-ancestor
102144516|NCT05274789|Sensory System Agents|sensory system agents|mesh-ancestor
102144517|NCT05274789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102144518|NCT05274789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102144519|NCT05274789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102144520|NCT05274789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102144521|NCT05274789|Adrenergic Agents|adrenergic agents|mesh-ancestor
102144522|NCT05274789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102144523|NCT05274789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144524|NCT02353247|Norethindrone|norethindrone|mesh-list
102144525|NCT02353247|Norethindrone Acetate|norethindrone acetate|mesh-list
102144526|NCT02353247|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102144527|NCT02353247|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102144528|NCT02353247|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102144529|NCT02353247|Contraceptive Agents|contraceptive agents|mesh-ancestor
102144530|NCT02353247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102144531|NCT02353247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144532|NCT02353247|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102144533|NCT02353247|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102144534|NCT04343651|Leronlimab|leronlimab|mesh-list
102144535|NCT04343651|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102144536|NCT04343651|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102144537|NCT04343651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144538|NCT04343651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102144539|NCT04343651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102144540|NCT04343651|Antiviral Agents|antiviral agents|mesh-ancestor
102144541|NCT04343651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102144542|NCT03343431|Tenofovir|tenofovir|mesh-list
102144543|NCT03343431|Antiviral Agents|antiviral agents|mesh-list
102144544|NCT03343431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102144545|NCT03343431|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102144546|NCT03343431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102144547|NCT03343431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102144548|NCT03343431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144549|NCT03343431|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102144550|NCT03343431|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102144551|NCT05226897|Metformin|metformin|mesh-list
102144552|NCT05226897|Dapagliflozin|dapagliflozin|mesh-list
102144553|NCT05226897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102144554|NCT05226897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144555|NCT05226897|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102144556|NCT05226897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144557|NCT04453761|Vitamin B Complex|vitamin b complex|mesh-list
102144558|NCT04453761|Vitamins|vitamins|mesh-ancestor
102144559|NCT04453761|Micronutrients|micronutrients|mesh-ancestor
102144560|NCT04453761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144561|NCT03463317|Aspirin|aspirin|mesh-list
102144562|NCT03463317|Warfarin|warfarin|mesh-list
102144563|NCT03463317|Rivaroxaban|rivaroxaban|mesh-list
102144564|NCT03463317|Dabigatran|dabigatran|mesh-list
102144565|NCT03463317|Apixaban|apixaban|mesh-list
102144566|NCT03463317|Edoxaban|edoxaban|mesh-list
102144567|NCT03463317|Phenprocoumon|phenprocoumon|mesh-list
102144568|NCT03463317|Clopidogrel|clopidogrel|mesh-list
102144569|NCT03463317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102144570|NCT03463317|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102144571|NCT03463317|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102144572|NCT03463317|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102144573|NCT03463317|Purinergic Agents|purinergic agents|mesh-ancestor
102144574|NCT03463317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102144575|NCT03463317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144576|NCT03463317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144577|NCT03463317|Anticoagulants|anticoagulants|mesh-ancestor
102144578|NCT03463317|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102144579|NCT03463317|Antithrombins|antithrombins|mesh-ancestor
102144580|NCT03463317|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102144581|NCT03463317|Protease Inhibitors|protease inhibitors|mesh-ancestor
102144582|NCT03463317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102144583|NCT03463317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102144584|NCT03463317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102144585|NCT03463317|Analgesics|analgesics|mesh-ancestor
102144586|NCT03463317|Sensory System Agents|sensory system agents|mesh-ancestor
102144587|NCT03463317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102144588|NCT03463317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102144589|NCT03463317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102144590|NCT03463317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102144591|NCT03463317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102144592|NCT03463317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102144593|NCT03463317|Antipyretics|antipyretics|mesh-ancestor
102144594|NCT02906579|Praliciguat|praliciguat|mesh-list
102144595|NCT02906579|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102144596|NCT02906579|Enzyme Activators|enzyme activators|mesh-ancestor
102144597|NCT02906579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144598|NCT02906579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102144599|NCT04975347|Naloxone|naloxone|mesh-list
102144600|NCT04975347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144601|NCT04975347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102144602|NCT04975347|Sensory System Agents|sensory system agents|mesh-ancestor
102144603|NCT04975347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102144604|NCT03463083|Fentanyl|fentanyl|mesh-list
102144605|NCT03463083|Dexmedetomidine|dexmedetomidine|mesh-list
102144606|NCT03463083|Bupivacaine|bupivacaine|mesh-list
102144607|NCT03463083|Anesthetics, Local|anesthetics, local|mesh-ancestor
102144608|NCT03463083|Anesthetics|anesthetics|mesh-ancestor
102144609|NCT03463083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102144610|NCT03463083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144611|NCT03463083|Sensory System Agents|sensory system agents|mesh-ancestor
102144612|NCT03463083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102144613|NCT03463083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102144614|NCT03463083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102144615|NCT03463083|Analgesics|analgesics|mesh-ancestor
102144616|NCT03463083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102144617|NCT03463083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102144618|NCT03463083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102144619|NCT03463083|Adrenergic Agents|adrenergic agents|mesh-ancestor
102144620|NCT03463083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102144621|NCT03463083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144622|NCT03463083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102144623|NCT03463083|Narcotics|narcotics|mesh-ancestor
102144624|NCT03463083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102144625|NCT03463083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102144626|NCT03463083|Anesthetics, General|anesthetics, general|mesh-ancestor
102144627|NCT04971837|Cannabidiol|cannabidiol|mesh-list
102144628|NCT04971837|Sorbitol|sorbitol|mesh-list
102144629|NCT04971837|Anticonvulsants|anticonvulsants|mesh-ancestor
102144630|NCT04971837|Cathartics|cathartics|mesh-ancestor
102144631|NCT04971837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102144632|NCT01328535|Temozolomide|temozolomide|mesh-list
102144633|NCT01328535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102144634|NCT01328535|Alkylating Agents|alkylating agents|mesh-ancestor
102144635|NCT01328535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144636|NCT01328535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102144637|NCT03463005|Propolis|propolis|mesh-list
102144638|NCT03463005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102144639|NCT02522169|Infliximab|infliximab|mesh-list
102144640|NCT02522169|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102144641|NCT02522169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102144642|NCT02522169|Dermatologic Agents|dermatologic agents|mesh-ancestor
102144643|NCT02522169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102144644|NCT02522169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102144645|NCT03656393|Carboplatin|carboplatin|mesh-list
102144646|NCT03656393|Vinorelbine|vinorelbine|mesh-list
102144647|NCT03656393|Gefitinib|gefitinib|mesh-list
102144648|NCT03656393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102144649|NCT03656393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102144650|NCT03656393|Tubulin Modulators|tubulin modulators|mesh-ancestor
102144651|NCT03656393|Antimitotic Agents|antimitotic agents|mesh-ancestor
102144652|NCT03656393|Mitosis Modulators|mitosis modulators|mesh-ancestor
102144653|NCT03656393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144654|NCT03656393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102144655|NCT03656393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102144656|NCT02979197|Celecoxib|celecoxib|mesh-list
102144657|NCT02979197|Amlodipine|amlodipine|mesh-list
102144658|NCT02979197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102144659|NCT02979197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102144660|NCT02979197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102144661|NCT02979197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144662|NCT02979197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102144663|NCT02979197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144664|NCT02979197|Vasodilator Agents|vasodilator agents|mesh-ancestor
102144665|NCT02979197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102144666|NCT02979197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102144667|NCT02979197|Analgesics|analgesics|mesh-ancestor
102144668|NCT02979197|Sensory System Agents|sensory system agents|mesh-ancestor
102144669|NCT02979197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102144670|NCT02979197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102144671|NCT02979197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102144672|NCT02979197|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102144673|NCT02979197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102144674|NCT02979197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102144675|NCT01837277|Efavirenz|efavirenz|mesh-list
102144676|NCT01837277|Dolutegravir|dolutegravir|mesh-list
102144677|NCT01837277|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102144678|NCT01837277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102144679|NCT01837277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102144680|NCT01837277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144681|NCT01837277|Antiviral Agents|antiviral agents|mesh-ancestor
102144682|NCT01837277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102154336|NCT03365817|Antitussive Agents|antitussive agents|mesh-ancestor
102144683|NCT01837277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102144684|NCT01837277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102144685|NCT01837277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102144686|NCT01837277|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102144687|NCT01837277|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102144688|NCT01837277|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102144689|NCT01837277|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102144690|NCT01837277|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102144691|NCT01837277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102144692|NCT01837277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102144694|NCT03655535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102144695|NCT03655535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144697|NCT03654365|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102144698|NCT03654365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144699|NCT03654365|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102144700|NCT03654365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102144701|NCT03654365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144702|NCT03654365|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102144703|NCT03654365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102144704|NCT03654365|Purinergic Agents|purinergic agents|mesh-ancestor
102144705|NCT03654365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102144706|NCT03655847|Dexmedetomidine|dexmedetomidine|mesh-list
102144707|NCT03655847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102144708|NCT03655847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102144709|NCT03655847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144710|NCT03655847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102144711|NCT03655847|Analgesics|analgesics|mesh-ancestor
102144712|NCT03655847|Sensory System Agents|sensory system agents|mesh-ancestor
102144713|NCT03655847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102144714|NCT03655847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102144715|NCT03655847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102144716|NCT03655847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102144717|NCT03655847|Adrenergic Agents|adrenergic agents|mesh-ancestor
102144718|NCT03655847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102144719|NCT03655847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144720|NCT03655457|Poractant alfa|poractant alfa|mesh-list
102144721|NCT03655457|Beractant|beractant|mesh-list
102144722|NCT03655457|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
102144723|NCT03655457|Respiratory System Agents|respiratory system agents|mesh-ancestor
102144724|NCT01066793|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102144725|NCT01066793|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102144726|NCT01066793|Antiviral Agents|antiviral agents|mesh-ancestor
102144727|NCT01066793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102144728|NCT04453371|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102144729|NCT04453371|Plasminogen|plasminogen|mesh-list
102144730|NCT04453371|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102144731|NCT04453371|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102144732|NCT04453371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144733|NCT02980523|Moxifloxacin|moxifloxacin|mesh-list
102144734|NCT02980523|Gatifloxacin|gatifloxacin|mesh-list
102144735|NCT02980523|Pazufloxacin|pazufloxacin|mesh-list
102144736|NCT02980523|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102144737|NCT02980523|Hyaluronic Acid|hyaluronic acid|mesh-list
102144738|NCT02980523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102144739|NCT02980523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102144740|NCT02980523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102144741|NCT02980523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102144742|NCT02980523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102144743|NCT02980523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102144744|NCT02980523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144745|NCT02980523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102144746|NCT02980523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144747|NCT02980523|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102144748|NCT02980523|Immunologic Factors|immunologic factors|mesh-ancestor
102144749|NCT02980523|Viscosupplements|viscosupplements|mesh-ancestor
102144750|NCT02980523|Protective Agents|protective agents|mesh-ancestor
102144751|NCT02980523|Antitubercular Agents|antitubercular agents|mesh-ancestor
102144752|NCT03468465|Solifenacin Succinate|solifenacin succinate|mesh-list
102144753|NCT03468465|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102144754|NCT03468465|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102144755|NCT03468465|Cholinergic Agents|cholinergic agents|mesh-ancestor
102144756|NCT03468465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102087314|NCT02256150|Mizoribine|mizoribine|mesh-list
102144757|NCT03468465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144758|NCT03468465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144759|NCT03468465|Urological Agents|urological agents|mesh-ancestor
102144760|NCT03460743|Hemagglutinins|hemagglutinins|mesh-list
102144761|NCT03460743|Vaccines|vaccines|mesh-list
102144762|NCT03460743|Immunologic Factors|immunologic factors|mesh-ancestor
102144763|NCT03460743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144764|NCT03460743|Agglutinins|agglutinins|mesh-ancestor
102144765|NCT03460743|Coagulants|coagulants|mesh-ancestor
102144766|NCT02980133|Fluticasone|fluticasone|mesh-list
102144767|NCT02980133|Xhance|xhance|mesh-list
102144768|NCT02980133|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102144769|NCT02980133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102144770|NCT02980133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102144771|NCT02980133|Autonomic Agents|autonomic agents|mesh-ancestor
102144772|NCT02980133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102144773|NCT02980133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144774|NCT02980133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102144775|NCT02980133|Respiratory System Agents|respiratory system agents|mesh-ancestor
102144776|NCT02980133|Dermatologic Agents|dermatologic agents|mesh-ancestor
102144777|NCT02980133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102144778|NCT02980133|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102144779|NCT02980133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102144780|NCT02980133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102144781|NCT02980133|Adrenergic Agents|adrenergic agents|mesh-ancestor
102144782|NCT02980133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102144783|NCT02980133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144784|NCT03653663|Simvastatin|simvastatin|mesh-list
102144785|NCT03653663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102144786|NCT03653663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102144787|NCT03653663|Antimetabolites|antimetabolites|mesh-ancestor
102144788|NCT03653663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144789|NCT03653663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102144790|NCT03653663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102144791|NCT03653663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102144792|NCT02979431|Gontivimab|gontivimab|mesh-list
102144793|NCT02979431|Antiviral Agents|antiviral agents|mesh-ancestor
102144794|NCT02979431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102144795|NCT03460275|Osimertinib|osimertinib|mesh-list
102144796|NCT03460275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102144797|NCT03460275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102144798|NCT03460275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102144799|NCT03460275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144800|NCT03468231|Leucovorin|leucovorin|mesh-list
102144801|NCT03468231|Fluorouracil|fluorouracil|mesh-list
102144802|NCT03468231|Oxaliplatin|oxaliplatin|mesh-list
102144803|NCT03468231|Sorafenib|sorafenib|mesh-list
102144804|NCT03468231|Antimetabolites|antimetabolites|mesh-ancestor
102144805|NCT03468231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144806|NCT03468231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102144807|NCT03468231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102144808|NCT03468231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102144809|NCT03468231|Immunologic Factors|immunologic factors|mesh-ancestor
102144810|NCT03468231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144811|NCT03468231|Antidotes|antidotes|mesh-ancestor
102144812|NCT03468231|Protective Agents|protective agents|mesh-ancestor
102144813|NCT03468231|Vitamin B Complex|vitamin b complex|mesh-ancestor
102144814|NCT03468231|Vitamins|vitamins|mesh-ancestor
102144815|NCT03468231|Micronutrients|micronutrients|mesh-ancestor
102144816|NCT03468231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102144817|NCT03468231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102144818|NCT03468153|Immunomodulating Agents|immunomodulating agents|mesh-list
102144819|NCT03468153|Immunologic Factors|immunologic factors|mesh-ancestor
102144820|NCT03468153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144821|NCT03460041|Magnesium Sulfate|magnesium sulfate|mesh-list
102144822|NCT03460041|Bupivacaine|bupivacaine|mesh-list
102144823|NCT03460041|Anesthetics, Local|anesthetics, local|mesh-ancestor
102144824|NCT03460041|Anesthetics|anesthetics|mesh-ancestor
102144825|NCT03460041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102144826|NCT03460041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144827|NCT03460041|Sensory System Agents|sensory system agents|mesh-ancestor
102144828|NCT03460041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102144829|NCT03460041|Analgesics|analgesics|mesh-ancestor
102144830|NCT03460041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102144831|NCT03460041|Anticonvulsants|anticonvulsants|mesh-ancestor
102144832|NCT03460041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102144833|NCT03460041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102144834|NCT03460041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144835|NCT03460041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102144837|NCT03460041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102144838|NCT02522013|Aminophylline|aminophylline|mesh-list
102144839|NCT02522013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102144840|NCT02522013|Autonomic Agents|autonomic agents|mesh-ancestor
102144841|NCT02522013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102144842|NCT02522013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144843|NCT02522013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101853754|NCT03490292|Paclitaxel|paclitaxel|mesh-list
102144844|NCT02522013|Respiratory System Agents|respiratory system agents|mesh-ancestor
102144845|NCT02522013|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102144846|NCT02522013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102144847|NCT02522013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102144848|NCT02522013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144849|NCT02522013|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102144850|NCT02522013|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102144851|NCT02522013|Purinergic Agents|purinergic agents|mesh-ancestor
102144852|NCT02522013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102144853|NCT02522013|Protective Agents|protective agents|mesh-ancestor
102144854|NCT02978417|Naltrexone|naltrexone|mesh-list
102144855|NCT02978417|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102144856|NCT02978417|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102144857|NCT02978417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144858|NCT02978417|Sensory System Agents|sensory system agents|mesh-ancestor
102144859|NCT02978417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102144860|NCT03458559|Etidronic Acid|etidronic acid|mesh-list
102144861|NCT03458559|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
102144862|NCT03458559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102144863|NCT03458559|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102144864|NCT03458559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144865|NCT03457467|Apatinib|apatinib|mesh-list
102144866|NCT03457467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102144867|NCT03457467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102144868|NCT03457467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102144869|NCT03457467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144870|NCT05191875|Doxycycline|doxycycline|mesh-list
102144871|NCT05191875|Furazolidone|furazolidone|mesh-list
102144872|NCT05191875|Bismuth|bismuth|mesh-list
102144873|NCT05191875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102144874|NCT05191875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102144875|NCT05191875|Antimalarials|antimalarials|mesh-ancestor
102144876|NCT05191875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102144877|NCT05191875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102144878|NCT05191875|Antacids|antacids|mesh-ancestor
102144879|NCT05191875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144880|NCT05191875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102144881|NCT05191875|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102144882|NCT05191875|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102144883|NCT05191875|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
102144884|NCT05191875|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102144885|NCT05191875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102144886|NCT04370145|Meropenem|meropenem|mesh-list
102144887|NCT04370145|Tinidazole|tinidazole|mesh-list
102144888|NCT04370145|Teicoplanin|teicoplanin|mesh-list
102144889|NCT04370145|Sulperazone|sulperazone|mesh-list
102144890|NCT04370145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102144891|NCT04370145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102144892|NCT04370145|Alkylating Agents|alkylating agents|mesh-ancestor
102144893|NCT04370145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144894|NCT04370145|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
102144895|NCT04370145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102144896|NCT04370145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102144897|NCT04370145|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102144898|NCT03453723|Lidocaine|lidocaine|mesh-list
102144899|NCT03453723|Anesthetics, Local|anesthetics, local|mesh-ancestor
102144900|NCT03453723|Anesthetics|anesthetics|mesh-ancestor
102144901|NCT03453723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102144902|NCT03453723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144903|NCT03453723|Sensory System Agents|sensory system agents|mesh-ancestor
102144904|NCT03453723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102144905|NCT03453723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102144906|NCT03453723|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102144907|NCT03453723|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102144908|NCT03453723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102144909|NCT03453723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144911|NCT04368429|Immunologic Factors|immunologic factors|mesh-ancestor
102144912|NCT04368429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144913|NCT04774965|Diphenhydramine|diphenhydramine|mesh-list
102144914|NCT04774965|Promethazine|promethazine|mesh-list
102144915|NCT04774965|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102144916|NCT04774965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102144917|NCT04774965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101853811|NCT00762554|Analgesics|analgesics|mesh-ancestor
102144918|NCT04774965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144919|NCT04774965|Anesthetics, Local|anesthetics, local|mesh-ancestor
102144921|NCT04774965|Sensory System Agents|sensory system agents|mesh-ancestor
102144922|NCT04774965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102144923|NCT04774965|Antiemetics|antiemetics|mesh-ancestor
102144924|NCT04774965|Autonomic Agents|autonomic agents|mesh-ancestor
102144925|NCT04774965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102144926|NCT04774965|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102144927|NCT04774965|Histamine Antagonists|histamine antagonists|mesh-ancestor
102144928|NCT04774965|Histamine Agents|histamine agents|mesh-ancestor
102144929|NCT04774965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102144930|NCT04774965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144931|NCT04774965|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102144932|NCT04774965|Antipruritics|antipruritics|mesh-ancestor
102144933|NCT04774965|Dermatologic Agents|dermatologic agents|mesh-ancestor
102144934|NCT03452553|Doxorubicin|doxorubicin|mesh-list
102144935|NCT03452553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102144936|NCT03452553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102144937|NCT03452553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102144938|NCT03452553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102144939|NCT03452553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102144940|NCT03452553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144941|NCT03452475|Lumefantrine|lumefantrine|mesh-list
102144942|NCT03452475|Artemether|artemether|mesh-list
102144943|NCT03452475|Piperaquine|piperaquine|mesh-list
102144944|NCT03452475|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102144945|NCT03452475|Mefloquine|mefloquine|mesh-list
102144946|NCT03452475|Antimalarials|antimalarials|mesh-ancestor
102144947|NCT03452475|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102144948|NCT03452475|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102144949|NCT03452475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102144950|NCT03451227|Dexmedetomidine|dexmedetomidine|mesh-list
102144951|NCT03451227|Remifentanil|remifentanil|mesh-list
102144952|NCT03451227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102144953|NCT03451227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102144954|NCT03451227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144955|NCT03451227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102144956|NCT03451227|Analgesics|analgesics|mesh-ancestor
102144957|NCT03451227|Sensory System Agents|sensory system agents|mesh-ancestor
102144958|NCT03451227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102144959|NCT03451227|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102144960|NCT03451227|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102144961|NCT03451227|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102144962|NCT03451227|Adrenergic Agents|adrenergic agents|mesh-ancestor
102144963|NCT03451227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102144964|NCT03451227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144965|NCT03451227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102144966|NCT03451227|Narcotics|narcotics|mesh-ancestor
102144967|NCT02529813|Cyclophosphamide|cyclophosphamide|mesh-list
102144968|NCT02529813|Fludarabine|fludarabine|mesh-list
102144969|NCT02529813|Fludarabine phosphate|fludarabine phosphate|mesh-list
102144970|NCT02529813|Tisagenlecleucel|tisagenlecleucel|mesh-list
102144971|NCT02529813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102144972|NCT02529813|Immunologic Factors|immunologic factors|mesh-ancestor
102144973|NCT02529813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144974|NCT02529813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102144975|NCT02529813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102144976|NCT02529813|Alkylating Agents|alkylating agents|mesh-ancestor
102144977|NCT02529813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102144978|NCT02529813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102144979|NCT02529813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102144980|NCT02529813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102144981|NCT02529813|Antimetabolites|antimetabolites|mesh-ancestor
102144982|NCT02529813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102144983|NCT05321511|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102144984|NCT05321511|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102144985|NCT05321511|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
102144986|NCT05321511|Hormones|hormones|mesh-ancestor
102241607|NCT03071055|Growth Substances|growth substances|mesh-ancestor
102144987|NCT05321511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102144988|NCT05321511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144989|NCT05321511|Luteolytic Agents|luteolytic agents|mesh-ancestor
102144990|NCT05321511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102144991|NCT05321511|Contraceptive Agents|contraceptive agents|mesh-ancestor
101853869|NCT01046942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102144992|NCT05321511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102144993|NCT05321511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102144994|NCT05321511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102144995|NCT05321511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102144996|NCT02417103|Liraglutide|liraglutide|mesh-list
102144997|NCT02417103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102144998|NCT02417103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102144999|NCT02417103|Incretins|incretins|mesh-ancestor
102145001|NCT02417103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102145002|NCT02097225|Trametinib|trametinib|mesh-list
102145003|NCT02097225|Dabrafenib|dabrafenib|mesh-list
102145004|NCT02097225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102145005|NCT02097225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102145006|NCT02097225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102145007|NCT02097225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145008|NCT02958865|PF-06700841|pf-06700841|mesh-list
102145009|NCT02958865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102145010|NCT02958865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102145011|NCT02958865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145012|NCT02501902|Paclitaxel|paclitaxel|mesh-list
102145013|NCT02501902|Palbociclib|palbociclib|mesh-list
102145014|NCT02501902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102145015|NCT02501902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102145016|NCT02501902|Tubulin Modulators|tubulin modulators|mesh-ancestor
102145017|NCT02501902|Antimitotic Agents|antimitotic agents|mesh-ancestor
102145018|NCT02501902|Mitosis Modulators|mitosis modulators|mesh-ancestor
102145019|NCT02501902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145020|NCT02501902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102145021|NCT02501902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102145022|NCT05320575|Zanubrutinib|zanubrutinib|mesh-list
102145023|NCT05320575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102145024|NCT05320575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102145025|NCT05320575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102145026|NCT05320575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145027|NCT03448731|Doxycycline|doxycycline|mesh-list
102145028|NCT03448731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102145029|NCT03448731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102145030|NCT03448731|Antimalarials|antimalarials|mesh-ancestor
102145031|NCT03448731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102145032|NCT03448731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102145033|NCT04452669|Epoprostenol|epoprostenol|mesh-list
102145034|NCT04452669|Tezosentan|tezosentan|mesh-list
102145035|NCT04452669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102145036|NCT04452669|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102145037|NCT04452669|Vasodilator Agents|vasodilator agents|mesh-ancestor
102145038|NCT03719001|Clevidipine|clevidipine|mesh-list
102145039|NCT03719001|Phenylephrine|phenylephrine|mesh-list
102145040|NCT03719001|Oxymetazoline|oxymetazoline|mesh-list
102145041|NCT03719001|Dexmedetomidine|dexmedetomidine|mesh-list
102145042|NCT03719001|Calcium|calcium|mesh-list
102145043|NCT03719001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102145044|NCT03719001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145045|NCT03719001|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102145046|NCT03719001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101746836|NCT00667251|Paclitaxel|paclitaxel|mesh-list
102145047|NCT03719001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102145048|NCT03719001|Analgesics|analgesics|mesh-ancestor
102145049|NCT03719001|Sensory System Agents|sensory system agents|mesh-ancestor
102145050|NCT03719001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102145051|NCT03719001|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102145052|NCT03719001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102145053|NCT03719001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102145054|NCT03719001|Adrenergic Agents|adrenergic agents|mesh-ancestor
102145055|NCT03719001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102145056|NCT03719001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145057|NCT03719001|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102145059|NCT03719001|Autonomic Agents|autonomic agents|mesh-ancestor
102145060|NCT03719001|Sympathomimetics|sympathomimetics|mesh-ancestor
102145061|NCT03719001|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102145062|NCT03719001|Nasal Decongestants|nasal decongestants|mesh-ancestor
102145063|NCT03719001|Respiratory System Agents|respiratory system agents|mesh-ancestor
102145064|NCT03719001|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102145065|NCT03719001|Protective Agents|protective agents|mesh-ancestor
101853946|NCT00390884|Vaccines|vaccines|mesh-list
102145066|NCT03719001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102145067|NCT03719001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102145068|NCT02500732|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102145069|NCT02500732|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102145070|NCT02500732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102145071|NCT02500732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102145072|NCT02500732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145073|NCT02500732|Adrenergic Agents|adrenergic agents|mesh-ancestor
102145074|NCT02500732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102145075|NCT02500732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145076|NCT04965064|Capecitabine|capecitabine|mesh-list
102145077|NCT04965064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102145078|NCT04965064|Antimetabolites|antimetabolites|mesh-ancestor
102145079|NCT04965064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145080|NCT04965064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102145081|NCT02499952|Pembrolizumab|pembrolizumab|mesh-list
102145082|NCT02499952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102145083|NCT02499952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102145084|NCT02499952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102145085|NCT02499952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145086|NCT02498392|JNJ-42165279|jnj-42165279|mesh-list
102145087|NCT02498392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102145088|NCT02498392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145089|NCT03205605|Mandelic Acids|mandelic acids|mesh-list
102145090|NCT03205605|Oxybutynin|oxybutynin|mesh-list
102145091|NCT03205605|Parasympatholytics|parasympatholytics|mesh-ancestor
102145092|NCT03205605|Autonomic Agents|autonomic agents|mesh-ancestor
102145093|NCT03205605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102145094|NCT03205605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145095|NCT03205605|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102145096|NCT03205605|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102145097|NCT03205605|Cholinergic Agents|cholinergic agents|mesh-ancestor
102145098|NCT03205605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102145099|NCT03205605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145100|NCT03205605|Urological Agents|urological agents|mesh-ancestor
102145101|NCT03205605|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102145102|NCT03205605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102145103|NCT05006638|Atropine|atropine|mesh-list
102145104|NCT05006638|Ondansetron|ondansetron|mesh-list
102145105|NCT05006638|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
102145106|NCT05006638|Obidoxime Chloride|obidoxime chloride|mesh-list
102145107|NCT05006638|Antiemetics|antiemetics|mesh-ancestor
102145108|NCT05006638|Autonomic Agents|autonomic agents|mesh-ancestor
102145109|NCT05006638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102145110|NCT05006638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145111|NCT05006638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102145112|NCT05006638|Antipruritics|antipruritics|mesh-ancestor
102145113|NCT05006638|Dermatologic Agents|dermatologic agents|mesh-ancestor
102145114|NCT05006638|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102145115|NCT05006638|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102145116|NCT05006638|Serotonin Agents|serotonin agents|mesh-ancestor
102145117|NCT05006638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102145118|NCT05006638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145119|NCT05006638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102145120|NCT05006638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102145121|NCT05006638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102145122|NCT05006638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102145123|NCT05006638|Respiratory System Agents|respiratory system agents|mesh-ancestor
102145124|NCT05006638|Mydriatics|mydriatics|mesh-ancestor
102145125|NCT05006638|Parasympatholytics|parasympatholytics|mesh-ancestor
102145126|NCT05006638|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102145127|NCT05006638|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102145128|NCT05006638|Cholinergic Agents|cholinergic agents|mesh-ancestor
102145129|NCT05006638|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102145130|NCT05006638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102145131|NCT05006638|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
102145132|NCT05006638|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
102145134|NCT02498236|Oxytocics|oxytocics|mesh-ancestor
102145135|NCT02498236|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102145136|NCT02498236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145137|NCT01283997|Minocycline|minocycline|mesh-list
102145138|NCT01283997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102145139|NCT01283997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102145140|NCT02496676|Magnesium Sulfate|magnesium sulfate|mesh-list
102145141|NCT02496676|Analgesics|analgesics|mesh-ancestor
102145142|NCT02496676|Sensory System Agents|sensory system agents|mesh-ancestor
102145143|NCT02496676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102145144|NCT02496676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145145|NCT02496676|Anesthetics|anesthetics|mesh-ancestor
102145146|NCT02496676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102145147|NCT02496676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102145148|NCT02496676|Anticonvulsants|anticonvulsants|mesh-ancestor
102145149|NCT02496676|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102145150|NCT02496676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102145151|NCT02496676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145152|NCT02496676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102145153|NCT02496676|Tocolytic Agents|tocolytic agents|mesh-ancestor
102145154|NCT02496676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102145155|NCT01160211|Trastuzumab|trastuzumab|mesh-list
102145157|NCT01160211|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102145158|NCT01160211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102145159|NCT01160211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102145160|NCT01160211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102145161|NCT01160211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102145162|NCT01160211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145163|NCT01160211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102145164|NCT01160211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102145165|NCT01160211|Hormone Antagonists|hormone antagonists|mesh-ancestor
102145166|NCT01160211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102145167|NCT01160211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145168|NCT03443271|Bupivacaine|bupivacaine|mesh-list
102145169|NCT03443271|Anesthetics, Local|anesthetics, local|mesh-ancestor
102145170|NCT03443271|Anesthetics|anesthetics|mesh-ancestor
102145171|NCT03443271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102145172|NCT03443271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145173|NCT03443271|Sensory System Agents|sensory system agents|mesh-ancestor
102145174|NCT03443271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102145175|NCT01064687|Metformin|metformin|mesh-list
102145176|NCT01064687|Pioglitazone|pioglitazone|mesh-list
102145177|NCT01064687|Exenatide|exenatide|mesh-list
102145178|NCT01064687|Dulaglutide|dulaglutide|mesh-list
102145179|NCT01064687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102145180|NCT01064687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145181|NCT01064687|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102145182|NCT01064687|Incretins|incretins|mesh-ancestor
102145183|NCT01064687|Hormones|hormones|mesh-ancestor
102145184|NCT01064687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102145185|NCT03447873|Lamivudine|lamivudine|mesh-list
102145186|NCT03447873|Cobicistat|cobicistat|mesh-list
102145187|NCT03447873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102145188|NCT03447873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102145189|NCT03447873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102145190|NCT03447873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145191|NCT03447873|Antiviral Agents|antiviral agents|mesh-ancestor
102145192|NCT03447873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102145193|NCT03447873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102145194|NCT03447873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102145195|NCT03447873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102145196|NCT03447873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102145197|NCT02493946|Botulinum Toxins|botulinum toxins|mesh-list
102145198|NCT02493946|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102145199|NCT02493946|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102145200|NCT02493946|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102145201|NCT02493946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102145202|NCT02493946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145203|NCT02493946|Cholinergic Agents|cholinergic agents|mesh-ancestor
102145204|NCT02493946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102087744|NCT02182518|Histamine Agents|histamine agents|mesh-ancestor
102145206|NCT02493946|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102145207|NCT02493946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102145208|NCT00740805|Cyclophosphamide|cyclophosphamide|mesh-list
102145209|NCT00740805|Doxorubicin|doxorubicin|mesh-list
102145210|NCT00740805|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102145211|NCT00740805|Veliparib|veliparib|mesh-list
102145212|NCT00740805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102145213|NCT00740805|Immunologic Factors|immunologic factors|mesh-ancestor
102145214|NCT00740805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145215|NCT00740805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102145216|NCT00740805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102145217|NCT00740805|Alkylating Agents|alkylating agents|mesh-ancestor
102145218|NCT00740805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145219|NCT00740805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102145220|NCT00740805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102145221|NCT00740805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102145222|NCT00740805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102145223|NCT00740805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102145224|NCT00740805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102145225|NCT00740805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102145226|NCT03621995|Catalase|catalase|mesh-list
102145227|NCT03621995|Antioxidants|antioxidants|mesh-ancestor
102145228|NCT03621995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145229|NCT03621995|Protective Agents|protective agents|mesh-ancestor
102145230|NCT03621995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145231|NCT03443037|Amantadine|amantadine|mesh-list
102145232|NCT03443037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102145233|NCT03443037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102145234|NCT03443037|Antiviral Agents|antiviral agents|mesh-ancestor
102145235|NCT03443037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102145236|NCT03443037|Dopamine Agents|dopamine agents|mesh-ancestor
102145237|NCT03443037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102145238|NCT03443037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145239|NCT03443037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145240|NCT03443037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102145241|NCT03443037|Analgesics|analgesics|mesh-ancestor
102145242|NCT03443037|Sensory System Agents|sensory system agents|mesh-ancestor
102145243|NCT03443037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102145244|NCT03442491|Hemostatics|hemostatics|mesh-list
102145245|NCT03442491|Coagulants|coagulants|mesh-ancestor
102145246|NCT02918279|Liraglutide|liraglutide|mesh-list
102145247|NCT02918279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102145248|NCT02918279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145249|NCT02918279|Incretins|incretins|mesh-ancestor
102145250|NCT02918279|Hormones|hormones|mesh-ancestor
102145251|NCT02918279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102145252|NCT02956837|Vaccines|vaccines|mesh-list
102145253|NCT02956837|Immunologic Factors|immunologic factors|mesh-ancestor
102145254|NCT02956837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145255|NCT03447093|Methimazole|methimazole|mesh-list
102145256|NCT03447093|Propylthiouracil|propylthiouracil|mesh-list
102145257|NCT03447093|Antithyroid Agents|antithyroid agents|mesh-ancestor
102145258|NCT03447093|Hormone Antagonists|hormone antagonists|mesh-ancestor
102145259|NCT03447093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102145260|NCT03447093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145261|NCT03447093|Antimetabolites|antimetabolites|mesh-ancestor
102145262|NCT03447093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145263|NCT03640351|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102145264|NCT03640351|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102145265|NCT03640351|Hyaluronic Acid|hyaluronic acid|mesh-list
102145266|NCT03640351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102145267|NCT03640351|Immunologic Factors|immunologic factors|mesh-ancestor
102145268|NCT03640351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145269|NCT03640351|Viscosupplements|viscosupplements|mesh-ancestor
102145270|NCT03640351|Protective Agents|protective agents|mesh-ancestor
102145271|NCT03640273|Loratadine|loratadine|mesh-list
102145272|NCT03640273|Antipruritics|antipruritics|mesh-ancestor
102145273|NCT03640273|Dermatologic Agents|dermatologic agents|mesh-ancestor
102145274|NCT03640273|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102145275|NCT03640273|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102145276|NCT03640273|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102145277|NCT03640273|Histamine Antagonists|histamine antagonists|mesh-ancestor
102145278|NCT03640273|Histamine Agents|histamine agents|mesh-ancestor
102145279|NCT03640273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102145281|NCT03640273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145282|NCT03442023|Chlorhexidine|chlorhexidine|mesh-list
102145283|NCT03442023|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102145284|NCT03442023|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102145285|NCT03442023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102145286|NCT03442023|Disinfectants|disinfectants|mesh-ancestor
102145287|NCT03442023|Dermatologic Agents|dermatologic agents|mesh-ancestor
102145288|NCT01063283|Bevacizumab|bevacizumab|mesh-list
102145289|NCT01063283|Carboplatin|carboplatin|mesh-list
102145290|NCT01063283|Pemetrexed|pemetrexed|mesh-list
101854173|NCT02531529|Fentanyl|fentanyl|mesh-list
102145292|NCT01063283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102145293|NCT01063283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102145294|NCT01063283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102145295|NCT01063283|Growth Substances|growth substances|mesh-ancestor
102145296|NCT01063283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145297|NCT01063283|Growth Inhibitors|growth inhibitors|mesh-ancestor
102145298|NCT01063283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102145299|NCT01063283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145300|NCT01063283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102145301|NCT01063283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102145302|NCT01062971|Timolol|timolol|mesh-list
102145303|NCT01062971|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102145304|NCT01062971|Dorzolamide|dorzolamide|mesh-list
102145305|NCT01062971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102145306|NCT01062971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102145307|NCT01062971|Adrenergic Agents|adrenergic agents|mesh-ancestor
102145308|NCT01062971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102145309|NCT01062971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145310|NCT01062971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145311|NCT01062971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102145312|NCT01062971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102145313|NCT01062971|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102145314|NCT01062971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102145315|NCT01062971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102145316|NCT01062971|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102145317|NCT01062971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102145318|NCT03446937|Dexamethasone|dexamethasone|mesh-list
102145319|NCT03446937|Betamethasone|betamethasone|mesh-list
102145320|NCT03446937|Betamethasone Valerate|betamethasone valerate|mesh-list
102145321|NCT03446937|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102145322|NCT03446937|Betamethasone benzoate|betamethasone benzoate|mesh-list
102145323|NCT03446937|Dexamethasone acetate|dexamethasone acetate|mesh-list
102145324|NCT03446937|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102145325|NCT03446937|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102145326|NCT03446937|BB 1101|bb 1101|mesh-list
102145327|NCT03446937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102145328|NCT03446937|Antiemetics|antiemetics|mesh-ancestor
102145329|NCT03446937|Autonomic Agents|autonomic agents|mesh-ancestor
102145330|NCT03446937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102145331|NCT03446937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145332|NCT03446937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102145333|NCT03446937|Glucocorticoids|glucocorticoids|mesh-ancestor
102145334|NCT03446937|Hormones|hormones|mesh-ancestor
102145335|NCT03446937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102145336|NCT03446937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102145337|NCT03446937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102145338|NCT03446937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102145339|NCT03446937|Respiratory System Agents|respiratory system agents|mesh-ancestor
102145340|NCT03446937|Protease Inhibitors|protease inhibitors|mesh-ancestor
102145341|NCT03446937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102145342|NCT03446937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145343|NCT03652493|Carboplatin|carboplatin|mesh-list
102145344|NCT03652493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102145345|NCT03652415|Lubricant Eye Drops|lubricant eye drops|mesh-list
102145346|NCT03652415|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102145347|NCT03652415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102145348|NCT02493868|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102145349|NCT02493868|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102145350|NCT02493868|Sertraline|sertraline|mesh-list
102145351|NCT02493868|Antidepressive Agents|antidepressive agents|mesh-list
102145352|NCT02493868|Esketamine|esketamine|mesh-list
102145353|NCT02493868|Escitalopram|escitalopram|mesh-list
102145354|NCT02493868|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102145356|NCT02493868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102145357|NCT02493868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145358|NCT02493868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102145359|NCT02493868|Serotonin Agents|serotonin agents|mesh-ancestor
102145360|NCT02493868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145361|NCT02493868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102145362|NCT02493868|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102145363|NCT02493868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102145364|NCT02493868|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102145365|NCT02493868|Analgesics|analgesics|mesh-ancestor
102145366|NCT02493868|Sensory System Agents|sensory system agents|mesh-ancestor
102145367|NCT02493868|Dopamine Agents|dopamine agents|mesh-ancestor
102145368|NCT03619057|Anesthetics|anesthetics|mesh-list
102145369|NCT03619057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102145370|NCT03619057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145372|NCT04451655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102145373|NCT04451655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145374|NCT03446625|Resveratrol|resveratrol|mesh-list
102145375|NCT03446625|Antioxidants|antioxidants|mesh-ancestor
102145376|NCT03446625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145377|NCT03446625|Protective Agents|protective agents|mesh-ancestor
102145378|NCT03446625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145379|NCT03446625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102145380|NCT03446625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102145381|NCT04594005|Paclitaxel|paclitaxel|mesh-list
102145382|NCT04594005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102145383|NCT04594005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102145384|NCT04594005|Tubulin Modulators|tubulin modulators|mesh-ancestor
102145385|NCT04594005|Antimitotic Agents|antimitotic agents|mesh-ancestor
102145386|NCT04594005|Mitosis Modulators|mitosis modulators|mesh-ancestor
102145387|NCT04594005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145388|NCT02516410|Ivacaftor|ivacaftor|mesh-list
102145389|NCT02516410|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102145390|NCT02516410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102241608|NCT03071055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145391|NCT02516410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145392|NCT02493712|Mesalamine|mesalamine|mesh-list
102145393|NCT02493712|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102145394|NCT02493712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102145395|NCT02493712|Analgesics|analgesics|mesh-ancestor
102145396|NCT02493712|Sensory System Agents|sensory system agents|mesh-ancestor
102145397|NCT02493712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102145398|NCT02493712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145399|NCT02493712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102145400|NCT02493712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102145401|NCT03446547|Durvalumab|durvalumab|mesh-list
102145402|NCT03446547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102145403|NCT03446547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102145404|NCT02516332|Escitalopram|escitalopram|mesh-list
102145405|NCT02516332|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102145406|NCT02516332|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102145407|NCT02516332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102145408|NCT02516332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145409|NCT02516332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102145410|NCT02516332|Serotonin Agents|serotonin agents|mesh-ancestor
102145411|NCT02516332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145412|NCT03437655|Eugenol|eugenol|mesh-list
102145413|NCT03437655|Zinc Oxide|zinc oxide|mesh-list
102145414|NCT03437655|Dermatologic Agents|dermatologic agents|mesh-ancestor
102145415|NCT03437655|Sunscreening Agents|sunscreening agents|mesh-ancestor
102145416|NCT03437655|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102145417|NCT03437655|Protective Agents|protective agents|mesh-ancestor
102145418|NCT03437655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145419|NCT03437655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102145420|NCT01062425|Temozolomide|temozolomide|mesh-list
102145421|NCT01062425|Cediranib|cediranib|mesh-list
102145422|NCT01062425|Maleic acid|maleic acid|mesh-list
102145423|NCT01062425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102145424|NCT01062425|Alkylating Agents|alkylating agents|mesh-ancestor
102145425|NCT01062425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145426|NCT01062425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102145427|NCT01062425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102145428|NCT01062425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102145429|NCT03437187|Analgesics|analgesics|mesh-list
102145430|NCT03437187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145431|NCT03437187|Sensory System Agents|sensory system agents|mesh-ancestor
102145432|NCT03437187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102145433|NCT02491684|Interferons|interferons|mesh-list
102145434|NCT02491684|Interferon-beta|interferon-beta|mesh-list
102145435|NCT02491684|Interferon beta-1a|interferon beta-1a|mesh-list
102145436|NCT02491684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102145437|NCT02491684|Antiviral Agents|antiviral agents|mesh-ancestor
101854321|NCT01048034|Hematinics|hematinics|mesh-ancestor
102145438|NCT02491684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102145439|NCT02491684|Immunologic Factors|immunologic factors|mesh-ancestor
102145440|NCT02491684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145441|NCT02491684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102145442|NCT03445611|Lidocaine|lidocaine|mesh-list
102145443|NCT03445611|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102145444|NCT03445611|Anesthetics, Local|anesthetics, local|mesh-ancestor
102145445|NCT03445611|Anesthetics|anesthetics|mesh-ancestor
102145446|NCT03445611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102145447|NCT03445611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145448|NCT03445611|Sensory System Agents|sensory system agents|mesh-ancestor
102145449|NCT03445611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102145450|NCT03445611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102145451|NCT03445611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102145452|NCT03445611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102145453|NCT03445611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102145454|NCT03445611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145455|NCT04360629|Tranexamic Acid|tranexamic acid|mesh-list
102145456|NCT04360629|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102145457|NCT04360629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102145458|NCT04360629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145459|NCT04360629|Hemostatics|hemostatics|mesh-ancestor
102145460|NCT04360629|Coagulants|coagulants|mesh-ancestor
102145461|NCT04727229|Bupivacaine|bupivacaine|mesh-list
102145462|NCT04727229|Anesthetics, Local|anesthetics, local|mesh-ancestor
102145463|NCT04727229|Anesthetics|anesthetics|mesh-ancestor
102145464|NCT04727229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102145465|NCT04727229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145466|NCT04727229|Sensory System Agents|sensory system agents|mesh-ancestor
102145467|NCT04727229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102145468|NCT03436719|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102145469|NCT03436719|Metronidazole|metronidazole|mesh-list
102145470|NCT03436719|Erythromycin|erythromycin|mesh-list
102145471|NCT03436719|Cefoperazone|cefoperazone|mesh-list
102145472|NCT03436719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102145473|NCT03436719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102145474|NCT03436719|Antitubercular Agents|antitubercular agents|mesh-ancestor
102145475|NCT03436719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102145476|NCT03436719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102145477|NCT03436719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102145478|NCT03436719|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102145479|NCT03436719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102145480|NCT03436719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145481|NCT01061333|Mometasone Furoate|mometasone furoate|mesh-list
102145482|NCT01061333|Nedocromil|nedocromil|mesh-list
102145483|NCT01061333|Montelukast|montelukast|mesh-list
102145484|NCT01061333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102145485|NCT01061333|Respiratory System Agents|respiratory system agents|mesh-ancestor
102145486|NCT01061333|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102145487|NCT01061333|Hormone Antagonists|hormone antagonists|mesh-ancestor
102145488|NCT01061333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102145489|NCT01061333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145490|NCT01061333|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102145491|NCT01061333|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102145492|NCT01061333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145493|NCT01061333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102145494|NCT01061333|Dermatologic Agents|dermatologic agents|mesh-ancestor
102145495|NCT01061333|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102145496|NCT01061333|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
102145497|NCT01061333|Immunologic Factors|immunologic factors|mesh-ancestor
102145498|NCT02489968|Empagliflozin|empagliflozin|mesh-list
102145499|NCT02489968|Linagliptin|linagliptin|mesh-list
102145500|NCT02489968|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102145501|NCT02489968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145502|NCT02489968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102145503|NCT02489968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145504|NCT02489968|Incretins|incretins|mesh-ancestor
102145505|NCT02489968|Hormones|hormones|mesh-ancestor
102145506|NCT02489968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102145507|NCT02489968|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102145508|NCT02489968|Protease Inhibitors|protease inhibitors|mesh-ancestor
102145509|NCT02489968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102145510|NCT03436173|Fluoxetine|fluoxetine|mesh-list
102145511|NCT03436173|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102145512|NCT03436173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102145513|NCT03436173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102145514|NCT03436173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145515|NCT03436173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102145516|NCT03436173|Serotonin Agents|serotonin agents|mesh-ancestor
102145517|NCT03436173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145518|NCT03436173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102145519|NCT03436173|Antidepressive Agents|antidepressive agents|mesh-ancestor
102145520|NCT03436173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102145521|NCT03436173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102145522|NCT03436173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102145523|NCT03436173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102145524|NCT03444831|Buspirone|buspirone|mesh-list
102145525|NCT03444831|Omeprazole|omeprazole|mesh-list
102145526|NCT03444831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102145527|NCT03444831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102145528|NCT03444831|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102145529|NCT03444831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102145530|NCT03444831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145531|NCT03444831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102145532|NCT03444831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102145533|NCT03444831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102145534|NCT03444831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145535|NCT03444831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102145536|NCT03444831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102145537|NCT03444831|Serotonin Agents|serotonin agents|mesh-ancestor
102145538|NCT03444831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102145539|NCT02481934|Lenalidomide|lenalidomide|mesh-list
102145540|NCT02481934|Bortezomib|bortezomib|mesh-list
102145541|NCT02481934|Immunologic Factors|immunologic factors|mesh-ancestor
102145542|NCT02481934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145543|NCT02481934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102145544|NCT02481934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102145545|NCT02481934|Growth Substances|growth substances|mesh-ancestor
102145546|NCT02481934|Growth Inhibitors|growth inhibitors|mesh-ancestor
102145547|NCT02481934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102145548|NCT03444519|Mannitol|mannitol|mesh-list
102145549|NCT03444519|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102145550|NCT03444519|Diuretics|diuretics|mesh-ancestor
102145551|NCT03444519|Natriuretic Agents|natriuretic agents|mesh-ancestor
102145552|NCT03444519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145553|NCT03129009|Anesthetics|anesthetics|mesh-list
102145554|NCT03129009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102145555|NCT03129009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145556|NCT02489500|Bortezomib|bortezomib|mesh-list
102145557|NCT02489500|Melphalan|melphalan|mesh-list
102145558|NCT02489500|Lenograstim|lenograstim|mesh-list
102145559|NCT02489500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102145560|NCT02489500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102145561|NCT02489500|Alkylating Agents|alkylating agents|mesh-ancestor
102145562|NCT02489500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145563|NCT02489500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102145564|NCT02489500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102145565|NCT02489500|Immunologic Factors|immunologic factors|mesh-ancestor
102145566|NCT02489500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145567|NCT02489500|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102145568|NCT04053959|Insulin|insulin|mesh-list
102145569|NCT04053959|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102145570|NCT04053959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102145571|NCT04053959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145572|NCT03652571|Nortriptyline|nortriptyline|mesh-list
102145573|NCT03652571|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102145574|NCT03652571|Antidepressive Agents|antidepressive agents|mesh-ancestor
102145575|NCT03652571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102145576|NCT03652571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102145577|NCT03652571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102145578|NCT03652571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102145579|NCT03652571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145580|NCT03652571|Adrenergic Agents|adrenergic agents|mesh-ancestor
102145581|NCT03652571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102145582|NCT03652571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145583|NCT03652103|Bupivacaine|bupivacaine|mesh-list
102145584|NCT03652103|Anesthetics, Local|anesthetics, local|mesh-ancestor
102145585|NCT03652103|Anesthetics|anesthetics|mesh-ancestor
102145586|NCT03652103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102145587|NCT03652103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145588|NCT03652103|Sensory System Agents|sensory system agents|mesh-ancestor
102145589|NCT03652103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102145590|NCT03651947|Denosumab|denosumab|mesh-list
102145591|NCT03651947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102145592|NCT03651947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145593|NCT03651557|Salicylates|salicylates|mesh-list
102145594|NCT03651557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102145595|NCT03651557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102145596|NCT03651557|Analgesics|analgesics|mesh-ancestor
102145597|NCT03651557|Sensory System Agents|sensory system agents|mesh-ancestor
102145598|NCT03651557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102145599|NCT03651557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145600|NCT03651557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102145601|NCT03651557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102145602|NCT03651557|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102145603|NCT03651557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102145604|NCT03651557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145605|NCT03432975|Povidone-Iodine|povidone-iodine|mesh-list
102145606|NCT03432975|Povidone|povidone|mesh-list
102145607|NCT03432975|Plasma Substitutes|plasma substitutes|mesh-ancestor
102145608|NCT03432975|Blood Substitutes|blood substitutes|mesh-ancestor
102145609|NCT03432975|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102145610|NCT03432975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102145611|NCT04953130|Vaccines|vaccines|mesh-list
102145612|NCT04953130|Immunologic Factors|immunologic factors|mesh-ancestor
102145613|NCT04953130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145614|NCT02488330|Bevacizumab|bevacizumab|mesh-list
102145615|NCT02488330|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102145616|NCT02488330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102145617|NCT02488330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102145618|NCT02488330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102145619|NCT02488330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102145620|NCT02488330|Growth Substances|growth substances|mesh-ancestor
102145621|NCT02488330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145622|NCT02488330|Growth Inhibitors|growth inhibitors|mesh-ancestor
102145623|NCT02488330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102145624|NCT02488330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102145625|NCT02488330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145626|NCT03432663|Amiodarone|amiodarone|mesh-list
102145627|NCT03432663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102145628|NCT03432663|Vasodilator Agents|vasodilator agents|mesh-ancestor
102145629|NCT03432663|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102145630|NCT03432663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102145631|NCT03432663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145632|NCT03432663|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102145633|NCT03432663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102145634|NCT03432663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102145635|NCT03432663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102145636|NCT03432663|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102145637|NCT03432663|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102145638|NCT03432663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102145639|NCT03432273|Nicotine|nicotine|mesh-list
102145640|NCT03432273|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102145641|NCT03432273|Autonomic Agents|autonomic agents|mesh-ancestor
102145642|NCT03432273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102145643|NCT03432273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145644|NCT03432273|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102145645|NCT03432273|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102145646|NCT03432273|Cholinergic Agents|cholinergic agents|mesh-ancestor
102145647|NCT03432273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102145648|NCT03432273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145649|NCT02481310|Cytarabine|cytarabine|mesh-list
102145651|NCT02481310|Hydrocortisone|hydrocortisone|mesh-list
102145652|NCT02481310|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102145653|NCT02481310|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102145654|NCT02481310|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102145655|NCT02481310|Cortisone|cortisone|mesh-list
102145656|NCT02481310|Cyclophosphamide|cyclophosphamide|mesh-list
102145657|NCT02481310|Rituximab|rituximab|mesh-list
102145658|NCT02481310|Doxorubicin|doxorubicin|mesh-list
102145659|NCT02481310|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102145660|NCT02481310|Methotrexate|methotrexate|mesh-list
102145661|NCT02481310|Etoposide|etoposide|mesh-list
102145662|NCT02481310|Vincristine|vincristine|mesh-list
102145663|NCT02481310|Etoposide phosphate|etoposide phosphate|mesh-list
102145664|NCT02481310|Ixazomib|ixazomib|mesh-list
102145665|NCT02481310|Podophyllotoxin|podophyllotoxin|mesh-list
102145666|NCT02481310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102145667|NCT02481310|Antibodies|antibodies|mesh-list
102145668|NCT02481310|Immunoglobulins|immunoglobulins|mesh-list
102145669|NCT02481310|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102145670|NCT02481310|Glycine|glycine|mesh-list
102145671|NCT02481310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102145672|NCT02481310|Immunologic Factors|immunologic factors|mesh-ancestor
102145673|NCT02481310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145674|NCT02481310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102145675|NCT02481310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102145676|NCT02481310|Alkylating Agents|alkylating agents|mesh-ancestor
102145677|NCT02481310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145678|NCT02481310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102145679|NCT02481310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102145680|NCT02481310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102145681|NCT02481310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102145682|NCT02481310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102145683|NCT02481310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102145684|NCT02481310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102145685|NCT02481310|Glucocorticoids|glucocorticoids|mesh-ancestor
102145686|NCT02481310|Hormones|hormones|mesh-ancestor
102145687|NCT02481310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102145688|NCT02481310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102145689|NCT02481310|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102145690|NCT02481310|Abortifacient Agents|abortifacient agents|mesh-ancestor
102145691|NCT02481310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102145692|NCT02481310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102145693|NCT02481310|Antimetabolites|antimetabolites|mesh-ancestor
102145694|NCT02481310|Dermatologic Agents|dermatologic agents|mesh-ancestor
102145695|NCT02481310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102145696|NCT02481310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102145697|NCT02481310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102145698|NCT02481310|Antiviral Agents|antiviral agents|mesh-ancestor
102145699|NCT02481310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102145700|NCT02481310|Tubulin Modulators|tubulin modulators|mesh-ancestor
102145701|NCT02481310|Antimitotic Agents|antimitotic agents|mesh-ancestor
102145702|NCT02481310|Mitosis Modulators|mitosis modulators|mesh-ancestor
102145703|NCT02481310|Protease Inhibitors|protease inhibitors|mesh-ancestor
102145704|NCT02481310|Keratolytic Agents|keratolytic agents|mesh-ancestor
102145705|NCT02481310|Glycine Agents|glycine agents|mesh-ancestor
102145706|NCT02481310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102145707|NCT03432195|Donepezil|donepezil|mesh-list
102145708|NCT03432195|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102145709|NCT03432195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102145710|NCT03432195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145711|NCT03432195|Cholinergic Agents|cholinergic agents|mesh-ancestor
102145712|NCT03432195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102145713|NCT03432195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145714|NCT03432195|Nootropic Agents|nootropic agents|mesh-ancestor
102145715|NCT03431961|Triamcinolone|triamcinolone|mesh-list
102145716|NCT03431961|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102145717|NCT03431961|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102145718|NCT03431961|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102145719|NCT03431961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102145720|NCT03431961|Glucocorticoids|glucocorticoids|mesh-ancestor
102145721|NCT03431961|Hormones|hormones|mesh-ancestor
102145722|NCT03431961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102145723|NCT03431961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145724|NCT03431961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102145725|NCT03431961|Immunologic Factors|immunologic factors|mesh-ancestor
102145726|NCT03431961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102145727|NCT03431961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145729|NCT02480764|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
102145730|NCT02480764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102145731|NCT02480764|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102145732|NCT02480764|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102145733|NCT02480764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145734|NCT03434691|Remifentanil|remifentanil|mesh-list
102145735|NCT03434691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102145736|NCT03434691|Narcotics|narcotics|mesh-ancestor
102145737|NCT03434691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102145738|NCT03434691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145740|NCT03434691|Sensory System Agents|sensory system agents|mesh-ancestor
102145741|NCT03434691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102145742|NCT03434613|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102145743|NCT03434613|Ezetimibe|ezetimibe|mesh-list
102145744|NCT03434613|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102145745|NCT03434613|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102145746|NCT03434613|Antimetabolites|antimetabolites|mesh-ancestor
102145747|NCT03434613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145748|NCT03434613|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102145749|NCT03434613|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102145750|NCT03434613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102145751|NCT04953052|Imatinib Mesylate|imatinib mesylate|mesh-list
102145752|NCT04953052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102145753|NCT04953052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102145754|NCT04953052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102145755|NCT04953052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145756|NCT03428685|Dydrogesterone|dydrogesterone|mesh-list
102145757|NCT03428685|Progestins|progestins|mesh-ancestor
102145758|NCT03428685|Hormones|hormones|mesh-ancestor
102145759|NCT03428685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102145760|NCT03428685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145761|NCT05665647|Ritonavir|ritonavir|mesh-list
102145762|NCT05665647|Itraconazole|itraconazole|mesh-list
102145763|NCT05665647|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
102145764|NCT05665647|Rifampin|rifampin|mesh-list
102145765|NCT05665647|Midazolam|midazolam|mesh-list
102145766|NCT05665647|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102145767|NCT05665647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102145768|NCT05665647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102145769|NCT05665647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145770|NCT05665647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102145771|NCT05665647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102145772|NCT05665647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102145773|NCT05665647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102145774|NCT05665647|Anesthetics, General|anesthetics, general|mesh-ancestor
102145775|NCT05665647|Anesthetics|anesthetics|mesh-ancestor
102145776|NCT05665647|GABA Modulators|gaba modulators|mesh-ancestor
102145777|NCT05665647|GABA Agents|gaba agents|mesh-ancestor
102145778|NCT05665647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102145779|NCT05665647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145780|NCT05665647|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102145781|NCT05665647|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102145782|NCT05665647|Protease Inhibitors|protease inhibitors|mesh-ancestor
102145783|NCT05665647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102145784|NCT05665647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102145785|NCT05665647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102145786|NCT05665647|Antiviral Agents|antiviral agents|mesh-ancestor
102145787|NCT05665647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102145788|NCT05665647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102145789|NCT05665647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102145790|NCT05665647|Antifungal Agents|antifungal agents|mesh-ancestor
102145791|NCT05665647|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102145792|NCT05665647|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102145793|NCT05665647|Hormone Antagonists|hormone antagonists|mesh-ancestor
102145794|NCT05665647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102145795|NCT05665647|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102145796|NCT05665647|Antitubercular Agents|antitubercular agents|mesh-ancestor
102145797|NCT05665647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102145798|NCT05665647|Leprostatic Agents|leprostatic agents|mesh-ancestor
102145799|NCT05665647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102145800|NCT05665647|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102145802|NCT05665647|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102145803|NCT05665647|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102145804|NCT05665647|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102145805|NCT05665647|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102145806|NCT03943173|Olaparib|olaparib|mesh-list
102145807|NCT03943173|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102145808|NCT03943173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102145809|NCT03943173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145810|NCT03943173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102145812|NCT04941196|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102145813|NCT04941196|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102145814|NCT04941196|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102145815|NCT04941196|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102145816|NCT04941196|Purinergic Agents|purinergic agents|mesh-ancestor
102145817|NCT04941196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102145818|NCT04941196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145819|NCT04941196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145820|NCT03431805|Tranexamic Acid|tranexamic acid|mesh-list
102145821|NCT03431805|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102145822|NCT03431805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102145823|NCT03431805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145824|NCT03431805|Hemostatics|hemostatics|mesh-ancestor
102145825|NCT03431805|Coagulants|coagulants|mesh-ancestor
102145826|NCT03428607|Olaparib|olaparib|mesh-list
102145827|NCT03428607|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102145828|NCT03428607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102145829|NCT03428607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145830|NCT03428607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102145831|NCT02521233|Losartan|losartan|mesh-list
102145832|NCT02521233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102145833|NCT02521233|Candesartan|candesartan|mesh-list
102145834|NCT02521233|Candesartan cilexetil|candesartan cilexetil|mesh-list
102145835|NCT02521233|Chlorthalidone|chlorthalidone|mesh-list
102145836|NCT02521233|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102145837|NCT02521233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102145838|NCT02521233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102145839|NCT02521233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102145840|NCT02521233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145841|NCT02521233|Diuretics|diuretics|mesh-ancestor
102145842|NCT02521233|Natriuretic Agents|natriuretic agents|mesh-ancestor
102145843|NCT02521233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145844|NCT02521233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102145845|NCT02521233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102145846|NCT03428529|Fluorouracil|fluorouracil|mesh-list
102145847|NCT03428529|Capecitabine|capecitabine|mesh-list
102145848|NCT03428529|Antimetabolites|antimetabolites|mesh-ancestor
102145849|NCT03428529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145850|NCT03428529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102145851|NCT03428529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102145852|NCT03428529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102145853|NCT03428529|Immunologic Factors|immunologic factors|mesh-ancestor
102145854|NCT03428529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145855|NCT03431649|Sildenafil Citrate|sildenafil citrate|mesh-list
102145856|NCT03431649|Beraprost|beraprost|mesh-list
102145857|NCT03431649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145858|NCT03431649|Vasodilator Agents|vasodilator agents|mesh-ancestor
102145859|NCT03431649|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102145860|NCT03431649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102145861|NCT03431649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102145862|NCT03431649|Urological Agents|urological agents|mesh-ancestor
102145863|NCT03431649|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102145864|NCT04450095|Ambrisentan|ambrisentan|mesh-list
102145865|NCT04450095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102145866|NCT03101475|Durvalumab|durvalumab|mesh-list
102145867|NCT03101475|Tremelimumab|tremelimumab|mesh-list
102145868|NCT03101475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102145869|NCT03101475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102145870|NCT01060007|Leucovorin|leucovorin|mesh-list
102145871|NCT01060007|Fluorouracil|fluorouracil|mesh-list
102145872|NCT01060007|Capecitabine|capecitabine|mesh-list
102145873|NCT01060007|Oxaliplatin|oxaliplatin|mesh-list
102145874|NCT01060007|Antimetabolites|antimetabolites|mesh-ancestor
102145875|NCT01060007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145876|NCT01060007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102145877|NCT01060007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102145878|NCT01060007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102145879|NCT01060007|Immunologic Factors|immunologic factors|mesh-ancestor
102145880|NCT01060007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145881|NCT01060007|Antidotes|antidotes|mesh-ancestor
102145882|NCT01060007|Protective Agents|protective agents|mesh-ancestor
102145883|NCT01060007|Vitamin B Complex|vitamin b complex|mesh-ancestor
102145884|NCT01060007|Vitamins|vitamins|mesh-ancestor
102145885|NCT01060007|Micronutrients|micronutrients|mesh-ancestor
102145886|NCT04175925|Famotidine|famotidine|mesh-list
102145887|NCT04175925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102145888|NCT04175925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102145889|NCT04175925|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102145890|NCT04175925|Histamine Antagonists|histamine antagonists|mesh-ancestor
102145891|NCT04175925|Histamine Agents|histamine agents|mesh-ancestor
102145892|NCT04175925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102145893|NCT04175925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145894|NCT04175925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145895|NCT02971007|Fluconazole|fluconazole|mesh-list
102145896|NCT02971007|Amphotericin B|amphotericin b|mesh-list
102145897|NCT02971007|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102145898|NCT02971007|Antifungal Agents|antifungal agents|mesh-ancestor
102145899|NCT02971007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102145900|NCT02971007|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102145901|NCT02971007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102145902|NCT02971007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102145903|NCT02971007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145904|NCT02971007|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102145905|NCT02971007|Hormone Antagonists|hormone antagonists|mesh-ancestor
102145906|NCT02971007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102145907|NCT02971007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145908|NCT02971007|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102145909|NCT02971007|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102145910|NCT02971007|Amebicides|amebicides|mesh-ancestor
102145911|NCT02971007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102145912|NCT02971007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102145913|NCT02971007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102145914|NCT03428139|Thioctic Acid|thioctic acid|mesh-list
102145915|NCT03428139|Antioxidants|antioxidants|mesh-ancestor
102145916|NCT03428139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145917|NCT03428139|Protective Agents|protective agents|mesh-ancestor
102145918|NCT03428139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747715|NCT02430194|Interferons|interferons|mesh-list
102145919|NCT03428139|Vitamin B Complex|vitamin b complex|mesh-ancestor
102145920|NCT03428139|Vitamins|vitamins|mesh-ancestor
102145921|NCT03428139|Micronutrients|micronutrients|mesh-ancestor
102145922|NCT03650543|Amoxicillin|amoxicillin|mesh-list
102145923|NCT03650543|Clarithromycin|clarithromycin|mesh-list
102145924|NCT03650543|Omeprazole|omeprazole|mesh-list
102145925|NCT03650543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102145926|NCT03650543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102145927|NCT03650543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102145928|NCT03650543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102145929|NCT03650543|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102145930|NCT03650543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102145931|NCT03650543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145932|NCT03650543|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102145933|NCT03650543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102145934|NCT03650543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102145935|NCT03650777|Warfarin|warfarin|mesh-list
102145936|NCT03650777|Anticoagulants|anticoagulants|mesh-ancestor
102145937|NCT02970305|Pimavanserin|pimavanserin|mesh-list
102145938|NCT02970305|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102145939|NCT02970305|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102145940|NCT02970305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102145941|NCT02970305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102145942|NCT02970305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102145943|NCT02970305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145944|NCT02970305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102145945|NCT02970305|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102145946|NCT02970305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102145947|NCT02970305|Serotonin Agents|serotonin agents|mesh-ancestor
102145948|NCT02970305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102145949|NCT02970305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145950|NCT03649763|Lidocaine|lidocaine|mesh-list
102145951|NCT03649763|Bupivacaine|bupivacaine|mesh-list
102145952|NCT03649763|Anesthetics, Local|anesthetics, local|mesh-ancestor
102145953|NCT03649763|Anesthetics|anesthetics|mesh-ancestor
102145954|NCT03649763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102145955|NCT03649763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145956|NCT03649763|Sensory System Agents|sensory system agents|mesh-ancestor
102145957|NCT03649763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102145958|NCT03649763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102145959|NCT03649763|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102145960|NCT03649763|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102145961|NCT03649763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102145962|NCT03649763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145963|NCT03427437|Epinephrine|epinephrine|mesh-list
102145964|NCT03427437|Racepinephrine|racepinephrine|mesh-list
102145965|NCT03427437|Bupivacaine|bupivacaine|mesh-list
102145966|NCT03427437|Epinephryl borate|epinephryl borate|mesh-list
102145967|NCT03427437|Anesthetics, Local|anesthetics, local|mesh-ancestor
102145968|NCT03427437|Anesthetics|anesthetics|mesh-ancestor
102145969|NCT03427437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102145970|NCT03427437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145971|NCT03427437|Sensory System Agents|sensory system agents|mesh-ancestor
102145972|NCT03427437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102145973|NCT03427437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102145974|NCT03427437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102145975|NCT03427437|Adrenergic Agents|adrenergic agents|mesh-ancestor
102145976|NCT03427437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102145977|NCT03427437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145978|NCT03427437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102145979|NCT03427437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102145980|NCT03427437|Autonomic Agents|autonomic agents|mesh-ancestor
102145981|NCT03427437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102145982|NCT03427437|Respiratory System Agents|respiratory system agents|mesh-ancestor
102145983|NCT03427437|Mydriatics|mydriatics|mesh-ancestor
102145984|NCT03427437|Sympathomimetics|sympathomimetics|mesh-ancestor
102145985|NCT03427437|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102145986|NCT03427359|Capecitabine|capecitabine|mesh-list
102145987|NCT03427359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102145988|NCT03427359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102145989|NCT03427359|Antimetabolites|antimetabolites|mesh-ancestor
102145990|NCT03427359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102145991|NCT05053659|Venetoclax|venetoclax|mesh-list
102145992|NCT05053659|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
102145993|NCT05053659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102145994|NCT05053659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102145995|NCT03423537|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102145996|NCT03423537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102145997|NCT03423537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102145998|NCT03649139|Immunomodulating Agents|immunomodulating agents|mesh-list
102145999|NCT03649139|Immunologic Factors|immunologic factors|mesh-ancestor
102146000|NCT03649139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146001|NCT03648125|Salicylic Acid|salicylic acid|mesh-list
102146002|NCT03648125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102146003|NCT03648125|Antifungal Agents|antifungal agents|mesh-ancestor
102146004|NCT03648125|Keratolytic Agents|keratolytic agents|mesh-ancestor
102146005|NCT03648125|Dermatologic Agents|dermatologic agents|mesh-ancestor
102146006|NCT03423225|Tacrolimus|tacrolimus|mesh-list
102146007|NCT03423225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102146008|NCT03423225|Immunologic Factors|immunologic factors|mesh-ancestor
102146009|NCT03423225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146010|NCT03423225|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102146011|NCT03423225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102146012|NCT03423225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146013|NCT02521077|Ascorbic Acid|ascorbic acid|mesh-list
102146014|NCT02521077|Vitamins|vitamins|mesh-ancestor
102146015|NCT02521077|Micronutrients|micronutrients|mesh-ancestor
102146016|NCT02521077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146017|NCT02521077|Antioxidants|antioxidants|mesh-ancestor
102146018|NCT02521077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146019|NCT02521077|Protective Agents|protective agents|mesh-ancestor
102146020|NCT03564093|Dexmedetomidine|dexmedetomidine|mesh-list
102146021|NCT03564093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102146022|NCT03564093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102146023|NCT03564093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146024|NCT03564093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102146025|NCT03564093|Analgesics|analgesics|mesh-ancestor
102146027|NCT03564093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102146028|NCT03564093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102146029|NCT03564093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102146030|NCT03564093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102146031|NCT03564093|Adrenergic Agents|adrenergic agents|mesh-ancestor
102146032|NCT03564093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102146033|NCT03564093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146034|NCT03429621|Simethicone|simethicone|mesh-list
102146036|NCT03429621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146037|NCT03429621|Emollients|emollients|mesh-ancestor
102146038|NCT03429621|Dermatologic Agents|dermatologic agents|mesh-ancestor
102146039|NCT03426969|Mycophenolic Acid|mycophenolic acid|mesh-list
102146040|NCT03426969|Cyclophosphamide|cyclophosphamide|mesh-list
102146041|NCT03426969|Melphalan|melphalan|mesh-list
102146042|NCT03426969|Mechlorethamine|mechlorethamine|mesh-list
102146043|NCT03426969|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102146044|NCT03426969|Fludarabine|fludarabine|mesh-list
102146045|NCT03426969|Fludarabine phosphate|fludarabine phosphate|mesh-list
102146046|NCT03426969|Tacrolimus|tacrolimus|mesh-list
102146047|NCT03426969|Lenograstim|lenograstim|mesh-list
102146048|NCT03426969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102146049|NCT03426969|Immunologic Factors|immunologic factors|mesh-ancestor
102146050|NCT03426969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146051|NCT03426969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102146052|NCT03426969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102146053|NCT03426969|Alkylating Agents|alkylating agents|mesh-ancestor
102146054|NCT03426969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146055|NCT03426969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102146056|NCT03426969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102146057|NCT03426969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102146058|NCT03426969|Antimetabolites|antimetabolites|mesh-ancestor
102146059|NCT03426969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102146060|NCT03426969|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102146061|NCT03426969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102146062|NCT03426969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102146063|NCT03426969|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102146064|NCT03426969|Antitubercular Agents|antitubercular agents|mesh-ancestor
102146065|NCT03426969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102146066|NCT03426969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102146067|NCT03422445|Temozolomide|temozolomide|mesh-list
102146068|NCT03422445|Apatinib|apatinib|mesh-list
102146069|NCT03422445|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102146070|NCT03422445|Alkylating Agents|alkylating agents|mesh-ancestor
102146071|NCT03422445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146072|NCT03422445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102146073|NCT03422445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102146074|NCT03422445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102146075|NCT03429309|Propofol|propofol|mesh-list
102146076|NCT03429309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102146077|NCT03429309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102146078|NCT03429309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146079|NCT03429309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102146080|NCT03429309|Anesthetics, General|anesthetics, general|mesh-ancestor
102146081|NCT03429309|Anesthetics|anesthetics|mesh-ancestor
102146082|NCT03429075|Psilocybin|psilocybin|mesh-list
102146083|NCT03429075|Escitalopram|escitalopram|mesh-list
102146084|NCT03429075|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102146085|NCT03429075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102146086|NCT03429075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102146087|NCT03429075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146088|NCT03429075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102146089|NCT03429075|Serotonin Agents|serotonin agents|mesh-ancestor
102146090|NCT03429075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146091|NCT03429075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102146092|NCT03429075|Hallucinogens|hallucinogens|mesh-ancestor
102146093|NCT03422289|Folic Acid|folic acid|mesh-list
102146094|NCT03422289|Vitamin B Complex|vitamin b complex|mesh-list
102146095|NCT03422289|Inositol|inositol|mesh-list
102146096|NCT03422289|Hematinics|hematinics|mesh-ancestor
102146097|NCT03422289|Vitamins|vitamins|mesh-ancestor
102146098|NCT03422289|Micronutrients|micronutrients|mesh-ancestor
102146099|NCT03422289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146100|NCT03422055|Fucoidan|fucoidan|mesh-list
102146101|NCT03422055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102146102|NCT03422055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102146104|NCT03422055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102146105|NCT04449471|Naproxen|naproxen|mesh-list
102146106|NCT04449471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102146107|NCT04449471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102146108|NCT04449471|Analgesics|analgesics|mesh-ancestor
102146109|NCT04449471|Sensory System Agents|sensory system agents|mesh-ancestor
102146110|NCT04449471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102146111|NCT04449471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146112|NCT04449471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102146113|NCT04449471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102146114|NCT04449471|Gout Suppressants|gout suppressants|mesh-ancestor
102146115|NCT04449471|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102146116|NCT04449471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102146117|NCT04449471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146119|NCT03127371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102146120|NCT03127371|Anesthetics, General|anesthetics, general|mesh-ancestor
102146121|NCT03127371|Anesthetics|anesthetics|mesh-ancestor
102146122|NCT03127371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102146123|NCT03127371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146124|NCT03127371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102146125|NCT03127371|Analgesics|analgesics|mesh-ancestor
102146126|NCT03127371|Sensory System Agents|sensory system agents|mesh-ancestor
102146127|NCT03127371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102146128|NCT03421821|Ropivacaine|ropivacaine|mesh-list
102146129|NCT03421821|Anesthetics, Local|anesthetics, local|mesh-ancestor
102146130|NCT03421821|Anesthetics|anesthetics|mesh-ancestor
102146131|NCT03421821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102146132|NCT03421821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747908|NCT00580970|Antimetabolites|antimetabolites|mesh-ancestor
102146133|NCT03421821|Sensory System Agents|sensory system agents|mesh-ancestor
102146134|NCT03421821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102146135|NCT03421743|Molgramostim|molgramostim|mesh-list
102146136|NCT03421743|Sargramostim|sargramostim|mesh-list
102146137|NCT03421743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102146138|NCT03421743|Immunologic Factors|immunologic factors|mesh-ancestor
102146139|NCT03421743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146140|NCT01103349|Montelukast|montelukast|mesh-list
102146141|NCT01103349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102146142|NCT01103349|Respiratory System Agents|respiratory system agents|mesh-ancestor
102146143|NCT01103349|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102146144|NCT01103349|Hormone Antagonists|hormone antagonists|mesh-ancestor
102146145|NCT01103349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102146146|NCT01103349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146147|NCT01103349|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102146148|NCT01103349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102146149|NCT01103349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146150|NCT03421275|Fentanyl|fentanyl|mesh-list
102146151|NCT03421275|Esketamine|esketamine|mesh-list
102146152|NCT03421275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102146153|NCT03421275|Narcotics|narcotics|mesh-ancestor
102146154|NCT03421275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102146155|NCT03421275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146156|NCT03421275|Analgesics|analgesics|mesh-ancestor
102146157|NCT03421275|Sensory System Agents|sensory system agents|mesh-ancestor
102146158|NCT03421275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102146159|NCT03421275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102146160|NCT03421275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102146161|NCT03421275|Anesthetics, General|anesthetics, general|mesh-ancestor
102146162|NCT03421275|Anesthetics|anesthetics|mesh-ancestor
102146163|NCT03421275|Antidepressive Agents|antidepressive agents|mesh-ancestor
102146164|NCT03421275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102146165|NCT03416517|Irinotecan|irinotecan|mesh-list
102146166|NCT03416517|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102146167|NCT03416517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102146168|NCT03416517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102146169|NCT03416517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146170|NCT03416517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102146171|NCT03421119|Insulin|insulin|mesh-list
102146172|NCT03421119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102146173|NCT03421119|Metformin|metformin|mesh-list
102146174|NCT03421119|Liraglutide|liraglutide|mesh-list
102146175|NCT03421119|Secretagogues|secretagogues|mesh-list
102146176|NCT03421119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102146177|NCT03421119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146178|NCT03421119|Incretins|incretins|mesh-ancestor
102146179|NCT03421119|Hormones|hormones|mesh-ancestor
102146180|NCT03421119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102146181|NCT03426033|Warfarin|warfarin|mesh-list
102146182|NCT03426033|Anticoagulants|anticoagulants|mesh-ancestor
102146183|NCT02432547|Aflibercept|aflibercept|mesh-list
102146184|NCT02432547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102146185|NCT02432547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102146186|NCT02432547|Growth Substances|growth substances|mesh-ancestor
102146187|NCT02432547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146188|NCT02432547|Growth Inhibitors|growth inhibitors|mesh-ancestor
102146189|NCT02432547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102146190|NCT02345733|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102146191|NCT02345733|Amoxicillin|amoxicillin|mesh-list
102146192|NCT02345733|Metronidazole|metronidazole|mesh-list
102146193|NCT02345733|Doxycycline|doxycycline|mesh-list
102146194|NCT02345733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102146195|NCT02345733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102146196|NCT02345733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102146197|NCT02345733|Antimalarials|antimalarials|mesh-ancestor
102146198|NCT03415269|Ambroxol|ambroxol|mesh-list
102146199|NCT03415269|Expectorants|expectorants|mesh-ancestor
102146200|NCT03415269|Respiratory System Agents|respiratory system agents|mesh-ancestor
102146201|NCT03618589|Pregabalin|pregabalin|mesh-list
102146202|NCT03618589|Analgesics|analgesics|mesh-ancestor
102146203|NCT03618589|Sensory System Agents|sensory system agents|mesh-ancestor
102146204|NCT03618589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102146205|NCT03618589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146206|NCT03618589|Anticonvulsants|anticonvulsants|mesh-ancestor
102146207|NCT03618589|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102146208|NCT03618589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102146209|NCT03618589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146210|NCT03618589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102146211|NCT03618589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102146212|NCT03618589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102146213|NCT03618589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102146214|NCT03618589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102146215|NCT03127449|Aflutinib|aflutinib|mesh-list
102146216|NCT03127449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102146217|NCT03127449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102146218|NCT03127449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146219|NCT02521155|Fenbendazole|fenbendazole|mesh-list
102146220|NCT02521155|Antinematodal Agents|antinematodal agents|mesh-ancestor
102146221|NCT02521155|Anthelmintics|anthelmintics|mesh-ancestor
102146222|NCT02521155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102146223|NCT02521155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102146224|NCT03415191|Ketamine|ketamine|mesh-list
102146225|NCT03415191|Analgesics|analgesics|mesh-ancestor
102146226|NCT03415191|Sensory System Agents|sensory system agents|mesh-ancestor
102146227|NCT03415191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102146228|NCT03415191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146229|NCT03415191|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102146230|NCT03415191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102146231|NCT03415191|Anesthetics, General|anesthetics, general|mesh-ancestor
102146232|NCT03415191|Anesthetics|anesthetics|mesh-ancestor
102146233|NCT03415191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102146234|NCT03415191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102146235|NCT03415191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102146236|NCT03415191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102146237|NCT03415191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146238|NCT03419949|Pregabalin|pregabalin|mesh-list
102146239|NCT03419949|Lamotrigine|lamotrigine|mesh-list
102146240|NCT03419949|Analgesics|analgesics|mesh-ancestor
102146241|NCT03419949|Sensory System Agents|sensory system agents|mesh-ancestor
102146242|NCT03419949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102146243|NCT03419949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146244|NCT03419949|Anticonvulsants|anticonvulsants|mesh-ancestor
102146245|NCT03419949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102146246|NCT03419949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102146247|NCT03419949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146248|NCT03419949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102146249|NCT03419949|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102146250|NCT03419949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102146251|NCT03419949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102146252|NCT03419949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102146253|NCT03419949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102146254|NCT03419949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102146255|NCT03414879|Lidocaine|lidocaine|mesh-list
102146256|NCT03414879|Ketamine|ketamine|mesh-list
102146257|NCT03414879|Anesthetics, Local|anesthetics, local|mesh-ancestor
102146258|NCT03414879|Anesthetics|anesthetics|mesh-ancestor
102146259|NCT03414879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101748039|NCT02598960|Nivolumab|nivolumab|mesh-list
102146260|NCT03414879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146261|NCT03414879|Sensory System Agents|sensory system agents|mesh-ancestor
102146262|NCT03414879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102146263|NCT03414879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102146264|NCT03414879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102146265|NCT03414879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102146266|NCT03414879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102146267|NCT03414879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146268|NCT03414879|Analgesics|analgesics|mesh-ancestor
102146269|NCT03414879|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102146270|NCT03414879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102146271|NCT03414879|Anesthetics, General|anesthetics, general|mesh-ancestor
102146272|NCT03414879|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102146273|NCT03414879|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102146274|NCT03414879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102146275|NCT03419715|Bimatoprost|bimatoprost|mesh-list
102146276|NCT03419715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102146277|NCT03618355|Sirolimus|sirolimus|mesh-list
102146278|NCT03618355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102146279|NCT03618355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102146280|NCT03618355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102146281|NCT03618355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102146282|NCT03618355|Antifungal Agents|antifungal agents|mesh-ancestor
102146283|NCT03618355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102146284|NCT03618355|Immunologic Factors|immunologic factors|mesh-ancestor
102146285|NCT03618355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146286|NCT04448457|Sufentanil|sufentanil|mesh-list
102146287|NCT04448457|Oxycodone|oxycodone|mesh-list
102146288|NCT04448457|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102146289|NCT04448457|Narcotics|narcotics|mesh-ancestor
102146290|NCT04448457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102146291|NCT04448457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146292|NCT04448457|Analgesics|analgesics|mesh-ancestor
102146293|NCT04448457|Sensory System Agents|sensory system agents|mesh-ancestor
102146294|NCT04448457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102146295|NCT04448457|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102146296|NCT04448457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102146297|NCT04448457|Anesthetics, General|anesthetics, general|mesh-ancestor
102146298|NCT04448457|Anesthetics|anesthetics|mesh-ancestor
102146299|NCT05384743|Rituximab|rituximab|mesh-list
102146300|NCT05384743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102146301|NCT05384743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102146302|NCT05384743|Immunologic Factors|immunologic factors|mesh-ancestor
102146303|NCT05384743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146304|NCT05384743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102146305|NCT03414333|Hormones|hormones|mesh-list
102146306|NCT03414333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102146307|NCT03414333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146308|NCT03617029|Ethiodized Oil|ethiodized oil|mesh-list
102146309|NCT03617029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102146310|NCT03616639|Morphine|morphine|mesh-list
102146311|NCT03616639|Oxycodone|oxycodone|mesh-list
102146312|NCT03616639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102146313|NCT03616639|Narcotics|narcotics|mesh-ancestor
102146314|NCT03616639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102146315|NCT03616639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146316|NCT03616639|Analgesics|analgesics|mesh-ancestor
102146317|NCT03616639|Sensory System Agents|sensory system agents|mesh-ancestor
102146318|NCT03616639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102146319|NCT03616561|Apremilast|apremilast|mesh-list
102146320|NCT03616561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102146321|NCT03616561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102146322|NCT03616561|Analgesics|analgesics|mesh-ancestor
102146323|NCT03616561|Sensory System Agents|sensory system agents|mesh-ancestor
102146324|NCT03616561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102146325|NCT03616561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146326|NCT03616561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102146327|NCT03616561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102146328|NCT03616561|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102146329|NCT03616561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102146330|NCT03616561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102154337|NCT03365817|Respiratory System Agents|respiratory system agents|mesh-ancestor
102146332|NCT03615313|Antibodies|antibodies|mesh-list
102146333|NCT03615313|Immunologic Factors|immunologic factors|mesh-ancestor
102146334|NCT03615313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146335|NCT03617575|Lactoferrin|lactoferrin|mesh-list
102146336|NCT03617575|Fesoterodine|fesoterodine|mesh-list
102146337|NCT03617575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102146338|NCT03617575|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102146339|NCT03617575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102146340|NCT03617575|Cholinergic Agents|cholinergic agents|mesh-ancestor
102146341|NCT03617575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102146342|NCT03617575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146343|NCT03617575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146344|NCT03617575|Urological Agents|urological agents|mesh-ancestor
102146345|NCT02983617|Obinutuzumab|obinutuzumab|mesh-list
102146346|NCT02983617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102146347|NCT02983617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102146348|NCT03616405|Amoxicillin|amoxicillin|mesh-list
102146349|NCT03616405|Tetracycline|tetracycline|mesh-list
102146350|NCT03616405|Furazolidone|furazolidone|mesh-list
102146351|NCT03616405|Rabeprazole|rabeprazole|mesh-list
102146352|NCT03616405|Bismuth|bismuth|mesh-list
102146353|NCT03616405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102146354|NCT03616405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102146355|NCT03616405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102146356|NCT03616405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102146357|NCT03616405|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102146358|NCT03616405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102146359|NCT03616405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146360|NCT03616405|Antacids|antacids|mesh-ancestor
102146361|NCT03616405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102146362|NCT03616405|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102146363|NCT03616405|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102146364|NCT03616405|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
102146365|NCT03616405|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102146366|NCT03616405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102146367|NCT03616405|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102146368|NCT03419559|Durvalumab|durvalumab|mesh-list
102146369|NCT03419559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102146370|NCT03419559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102146371|NCT02873689|Dexlansoprazole|dexlansoprazole|mesh-list
102146372|NCT02873689|Lansoprazole|lansoprazole|mesh-list
102146373|NCT02873689|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102146374|NCT02873689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102146375|NCT02873689|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102146376|NCT02873689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102146377|NCT02873689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146378|NCT02873377|Nicotine|nicotine|mesh-list
102146379|NCT02873377|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102146380|NCT02873377|Autonomic Agents|autonomic agents|mesh-ancestor
102146381|NCT02873377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102146382|NCT02873377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146383|NCT02873377|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102146384|NCT02873377|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102146385|NCT02873377|Cholinergic Agents|cholinergic agents|mesh-ancestor
102146386|NCT02873377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102146387|NCT02873377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146388|NCT03647579|Midazolam|midazolam|mesh-list
102146389|NCT03647579|Dexmedetomidine|dexmedetomidine|mesh-list
102146390|NCT03647579|Ketamine|ketamine|mesh-list
102146391|NCT03647579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102146392|NCT03647579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102146393|NCT03647579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146394|NCT03647579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102146395|NCT03647579|Analgesics|analgesics|mesh-ancestor
102146396|NCT03647579|Sensory System Agents|sensory system agents|mesh-ancestor
102146397|NCT03647579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102146398|NCT03647579|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102146399|NCT03647579|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102146400|NCT03647579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102146401|NCT03647579|Adrenergic Agents|adrenergic agents|mesh-ancestor
102146402|NCT03647579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102146403|NCT03647579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146404|NCT03647579|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102088937|NCT03703063|Vitamins|vitamins|mesh-ancestor
102146406|NCT03647579|Anesthetics, General|anesthetics, general|mesh-ancestor
102146407|NCT03647579|Anesthetics|anesthetics|mesh-ancestor
102146408|NCT03647579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102146409|NCT03647579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102146410|NCT03647579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102146411|NCT03647579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102146412|NCT03647579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102146413|NCT03647579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102146414|NCT03647579|GABA Modulators|gaba modulators|mesh-ancestor
102146415|NCT03647579|GABA Agents|gaba agents|mesh-ancestor
102146416|NCT04046861|Ascorbic Acid|ascorbic acid|mesh-list
102146417|NCT04046861|Vitamins|vitamins|mesh-ancestor
102146418|NCT04046861|Micronutrients|micronutrients|mesh-ancestor
102146419|NCT04046861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146420|NCT04046861|Antioxidants|antioxidants|mesh-ancestor
102146421|NCT04046861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146422|NCT04046861|Protective Agents|protective agents|mesh-ancestor
102146423|NCT02236741|Pramipexole|pramipexole|mesh-list
102146424|NCT02236741|Antioxidants|antioxidants|mesh-ancestor
102146425|NCT02236741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146426|NCT02236741|Protective Agents|protective agents|mesh-ancestor
102146427|NCT02236741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146428|NCT02236741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102146429|NCT02236741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102146430|NCT02236741|Dopamine Agonists|dopamine agonists|mesh-ancestor
102146431|NCT02236741|Dopamine Agents|dopamine agents|mesh-ancestor
102146432|NCT02236741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102146433|NCT03648671|Rasagiline|rasagiline|mesh-list
102146434|NCT03648671|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102146435|NCT03648671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102146436|NCT03648671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146437|NCT03648671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102146438|NCT03648671|Protective Agents|protective agents|mesh-ancestor
102146439|NCT03648671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146440|NCT03647423|Cyclophosphamide|cyclophosphamide|mesh-list
102146441|NCT03647423|Cetuximab|cetuximab|mesh-list
102146442|NCT03647423|Avelumab|avelumab|mesh-list
102146443|NCT03647423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102146444|NCT03647423|Immunologic Factors|immunologic factors|mesh-ancestor
102146445|NCT03647423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146446|NCT03647423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102146447|NCT03647423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102146448|NCT03647423|Alkylating Agents|alkylating agents|mesh-ancestor
102146449|NCT03647423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146450|NCT03647423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102146451|NCT03647423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102146452|NCT03647423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102146453|NCT04052711|Minocycline|minocycline|mesh-list
102146454|NCT04052711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102146455|NCT04052711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102146456|NCT03621683|Antioxidants|antioxidants|mesh-list
102146457|NCT03621683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146458|NCT03621683|Protective Agents|protective agents|mesh-ancestor
102146459|NCT03621683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146460|NCT03614065|Endostar protein|endostar protein|mesh-list
102146461|NCT03614065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
102146462|NCT03614065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102146463|NCT03614065|Growth Substances|growth substances|mesh-ancestor
102146464|NCT03614065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146465|NCT03614065|Growth Inhibitors|growth inhibitors|mesh-ancestor
102146466|NCT03614065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102146467|NCT03621527|Remifentanil|remifentanil|mesh-list
102146468|NCT03621527|Anesthetics|anesthetics|mesh-list
102146469|NCT03621527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102146470|NCT03621527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146471|NCT03621527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102146472|NCT03621527|Narcotics|narcotics|mesh-ancestor
102146473|NCT03621527|Analgesics|analgesics|mesh-ancestor
102146474|NCT03621527|Sensory System Agents|sensory system agents|mesh-ancestor
102146475|NCT03621527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102146476|NCT03646721|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102146477|NCT03646721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102146478|NCT03646721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146479|NCT03646721|Incretins|incretins|mesh-ancestor
102146480|NCT03646721|Hormones|hormones|mesh-ancestor
102146481|NCT03646721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102146482|NCT03646721|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102146483|NCT03646721|Protease Inhibitors|protease inhibitors|mesh-ancestor
102146484|NCT03646721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102146485|NCT03646721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146486|NCT03613753|Irinotecan|irinotecan|mesh-list
102146487|NCT03613753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102146488|NCT03613753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102146489|NCT03613753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102146490|NCT03613753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146491|NCT03613753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102146492|NCT04051853|Sorafenib|sorafenib|mesh-list
102146493|NCT04051853|Midazolam|midazolam|mesh-list
102146494|NCT04051853|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102146495|NCT04051853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102146496|NCT04051853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102146497|NCT04051853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146498|NCT04051853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102146499|NCT04051853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102146500|NCT04051853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102146501|NCT04051853|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102146502|NCT04051853|Anesthetics, General|anesthetics, general|mesh-ancestor
102146503|NCT04051853|Anesthetics|anesthetics|mesh-ancestor
102146504|NCT04051853|GABA Modulators|gaba modulators|mesh-ancestor
102146505|NCT04051853|GABA Agents|gaba agents|mesh-ancestor
102146506|NCT04051853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102146507|NCT04051853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146508|NCT04051853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102146509|NCT04051853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102146510|NCT04051853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102146511|NCT03643757|Bupivacaine|bupivacaine|mesh-list
102146512|NCT03643757|Anesthetics, Local|anesthetics, local|mesh-ancestor
102146513|NCT03643757|Anesthetics|anesthetics|mesh-ancestor
102146514|NCT03643757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102146515|NCT03643757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146516|NCT03643757|Sensory System Agents|sensory system agents|mesh-ancestor
102146517|NCT03643757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102146518|NCT03718793|Nitric Oxide|nitric oxide|mesh-list
102146519|NCT03718793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102146520|NCT03718793|Autonomic Agents|autonomic agents|mesh-ancestor
102146521|NCT03718793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102146522|NCT03718793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146523|NCT03718793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102146524|NCT03718793|Respiratory System Agents|respiratory system agents|mesh-ancestor
102146525|NCT03718793|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102146526|NCT03718793|Antioxidants|antioxidants|mesh-ancestor
102146527|NCT03718793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146528|NCT03718793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102146529|NCT03718793|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102146530|NCT03718793|Vasodilator Agents|vasodilator agents|mesh-ancestor
102146531|NCT03718793|Gasotransmitters|gasotransmitters|mesh-ancestor
102146532|NCT03718793|Protective Agents|protective agents|mesh-ancestor
102146533|NCT02962739|Tenofovir|tenofovir|mesh-list
102146534|NCT02962739|Emtricitabine|emtricitabine|mesh-list
102146535|NCT02962739|Antiviral Agents|antiviral agents|mesh-ancestor
102146536|NCT02962739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102146537|NCT02962739|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102146538|NCT02962739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102146539|NCT02962739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102146540|NCT02962739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146541|NCT02962739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102146542|NCT02962739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102146543|NCT01344629|Telmisartan|telmisartan|mesh-list
102146544|NCT01344629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102146545|NCT01344629|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102146546|NCT01344629|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102146547|NCT01344629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146548|NCT03642665|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102146549|NCT03642665|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102146550|NCT03642665|Estradiol|estradiol|mesh-list
102146551|NCT03642665|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102146552|NCT03642665|Progesterone|progesterone|mesh-list
102146553|NCT03642665|Estrogens|estrogens|mesh-ancestor
102146554|NCT03642665|Hormones|hormones|mesh-ancestor
102154338|NCT02852005|Vaccines|vaccines|mesh-list
102146555|NCT03642665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102146556|NCT03642665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146557|NCT03642665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102146558|NCT03642665|Contraceptive Agents|contraceptive agents|mesh-ancestor
102146559|NCT03642665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102146560|NCT03642665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102146561|NCT03642665|Progestins|progestins|mesh-ancestor
102146562|NCT03642509|Rivaroxaban|rivaroxaban|mesh-list
102146563|NCT03642509|Apixaban|apixaban|mesh-list
102146564|NCT03642509|Edoxaban|edoxaban|mesh-list
102146565|NCT03642509|Dabigatran|dabigatran|mesh-list
102146566|NCT03642509|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102146567|NCT03642509|Antithrombins|antithrombins|mesh-ancestor
102146568|NCT03642509|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102146569|NCT03642509|Protease Inhibitors|protease inhibitors|mesh-ancestor
102146570|NCT03642509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102146571|NCT03642509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146573|NCT03642353|Listerine|listerine|mesh-list
102146574|NCT03642353|Triclosan|triclosan|mesh-list
102146575|NCT03642353|Sodium Fluoride|sodium fluoride|mesh-list
102146576|NCT03642353|Cariostatic Agents|cariostatic agents|mesh-ancestor
102146577|NCT03642353|Protective Agents|protective agents|mesh-ancestor
102146578|NCT03642353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146579|NCT03642353|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102146580|NCT03642353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102146581|NCT03642353|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102146582|NCT03642353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102146583|NCT03642353|Antimetabolites|antimetabolites|mesh-ancestor
102146584|NCT03642353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146585|NCT03642353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102146586|NCT03424707|Eperisone|eperisone|mesh-list
102146587|NCT03424707|Anticonvulsants|anticonvulsants|mesh-ancestor
102146588|NCT03424707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102146589|NCT03424707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102146590|NCT03424707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146591|NCT03424707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102146592|NCT03424707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146593|NCT03424707|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102146594|NCT03424707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102146595|NCT03424707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102146596|NCT03424707|Parasympatholytics|parasympatholytics|mesh-ancestor
102146597|NCT03424707|Autonomic Agents|autonomic agents|mesh-ancestor
102146598|NCT03424707|Vasodilator Agents|vasodilator agents|mesh-ancestor
102146599|NCT05174351|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102146600|NCT05174351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102146601|NCT05174351|Adrenergic Agents|adrenergic agents|mesh-ancestor
102146602|NCT05174351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102146603|NCT05174351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146604|NCT05174351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146605|NCT03418935|Niacinamide|niacinamide|mesh-list
102146606|NCT03418935|Niacin|niacin|mesh-list
102146607|NCT03418935|Nicotinic Acids|nicotinic acids|mesh-list
102146608|NCT03418935|Vitamin B Complex|vitamin b complex|mesh-ancestor
102146609|NCT03418935|Vitamins|vitamins|mesh-ancestor
102146610|NCT03418935|Micronutrients|micronutrients|mesh-ancestor
102146611|NCT03418935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146612|NCT03418935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102146613|NCT03418935|Antimetabolites|antimetabolites|mesh-ancestor
102146614|NCT03418935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146615|NCT03418935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102146616|NCT03418935|Vasodilator Agents|vasodilator agents|mesh-ancestor
102146617|NCT03413319|Tilavonemab|tilavonemab|mesh-list
102146618|NCT03413319|Nootropic Agents|nootropic agents|mesh-ancestor
102146619|NCT03424629|Methotrexate|methotrexate|mesh-list
102146620|NCT03424629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102146621|NCT03424629|Abortifacient Agents|abortifacient agents|mesh-ancestor
102146622|NCT03424629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102146623|NCT03424629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146624|NCT03424629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102146625|NCT03424629|Antimetabolites|antimetabolites|mesh-ancestor
102146626|NCT03424629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146627|NCT03424629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102146628|NCT03424629|Dermatologic Agents|dermatologic agents|mesh-ancestor
102146629|NCT03424629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102146630|NCT03424629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102146631|NCT03424629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102146632|NCT03424629|Immunologic Factors|immunologic factors|mesh-ancestor
102146633|NCT03424629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102146634|NCT03424629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102146636|NCT03424473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102146637|NCT03424473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102146638|NCT03424473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102146639|NCT03424473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146640|NCT04448379|Osimertinib|osimertinib|mesh-list
102146641|NCT04448379|Afatinib|afatinib|mesh-list
102146642|NCT04448379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102146643|NCT04448379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102146644|NCT04448379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102146645|NCT04448379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146646|NCT04448223|Latanoprost|latanoprost|mesh-list
102146647|NCT04448223|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102146648|NCT04448223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102146649|NCT03644147|Acetaminophen|acetaminophen|mesh-list
102146650|NCT03644147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102146651|NCT03644147|Analgesics|analgesics|mesh-ancestor
102146652|NCT03644147|Sensory System Agents|sensory system agents|mesh-ancestor
102146653|NCT03644147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102146654|NCT03644147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146655|NCT03644147|Antipyretics|antipyretics|mesh-ancestor
102146656|NCT02743923|Paclitaxel|paclitaxel|mesh-list
102146657|NCT02743923|Bevacizumab|bevacizumab|mesh-list
102146658|NCT02743923|Carboplatin|carboplatin|mesh-list
102146659|NCT02743923|Pemetrexed|pemetrexed|mesh-list
102146660|NCT02743923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102146661|NCT02743923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102146662|NCT02743923|Tubulin Modulators|tubulin modulators|mesh-ancestor
102146663|NCT02743923|Antimitotic Agents|antimitotic agents|mesh-ancestor
102146664|NCT02743923|Mitosis Modulators|mitosis modulators|mesh-ancestor
102146665|NCT02743923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146666|NCT02743923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102146667|NCT02743923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102146668|NCT02743923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102146669|NCT02743923|Growth Substances|growth substances|mesh-ancestor
102146670|NCT02743923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146671|NCT02743923|Growth Inhibitors|growth inhibitors|mesh-ancestor
102146672|NCT02743923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102146673|NCT02743923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102146674|NCT02743923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102146675|NCT01065779|Alendronate|alendronate|mesh-list
102146676|NCT01065779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102146677|NCT01065779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146678|NCT02357966|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102146679|NCT02357966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102146680|NCT03570359|Interferons|interferons|mesh-list
102146681|NCT03570359|Interferon-beta|interferon-beta|mesh-list
102146682|NCT03570359|Interferon beta-1a|interferon beta-1a|mesh-list
102146683|NCT03570359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102146684|NCT03570359|Antiviral Agents|antiviral agents|mesh-ancestor
102146685|NCT03570359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102146686|NCT03570359|Immunologic Factors|immunologic factors|mesh-ancestor
102146687|NCT03570359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146688|NCT03570359|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102146689|NCT02358200|Paclitaxel|paclitaxel|mesh-list
102146690|NCT02358200|Carboplatin|carboplatin|mesh-list
102146691|NCT02358200|Talazoparib|talazoparib|mesh-list
102146692|NCT02358200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102146693|NCT02358200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102146694|NCT02358200|Tubulin Modulators|tubulin modulators|mesh-ancestor
102146695|NCT02358200|Antimitotic Agents|antimitotic agents|mesh-ancestor
102146696|NCT02358200|Mitosis Modulators|mitosis modulators|mesh-ancestor
102146697|NCT02358200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146698|NCT02358200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102146699|NCT02358200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102146700|NCT03413007|Antigen-Antibody Complex|antigen-antibody complex|mesh-list
102146701|NCT03413007|Immunologic Factors|immunologic factors|mesh-ancestor
102146702|NCT03413007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146703|NCT03127605|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
102146704|NCT03127605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102146705|NCT03127605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102146706|NCT03127605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102146707|NCT03127605|Immunotoxins|immunotoxins|mesh-ancestor
102146708|NCT03127605|Immunoconjugates|immunoconjugates|mesh-ancestor
102146709|NCT03127605|Immunologic Factors|immunologic factors|mesh-ancestor
102146710|NCT03127605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146712|NCT03112538|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102146713|NCT03112538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102146714|NCT03112538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146715|NCT05283551|Famciclovir|famciclovir|mesh-list
102146716|NCT05283551|Antiviral Agents|antiviral agents|mesh-ancestor
102146717|NCT05283551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102146718|NCT05283551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102146719|NCT05283551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102146720|NCT05283551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146722|NCT02357732|Trametinib|trametinib|mesh-list
102146723|NCT02357732|Dabrafenib|dabrafenib|mesh-list
102146724|NCT02357732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102146725|NCT02357732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102146726|NCT02357732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102146727|NCT02357732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146728|NCT02357732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102146729|NCT02357732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102146730|NCT03112148|Tofacitinib|tofacitinib|mesh-list
102146731|NCT03112148|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102146732|NCT03112148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102146733|NCT03112148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101748503|NCT00711620|Thymalfasin|thymalfasin|mesh-list
102146734|NCT03112148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146735|NCT03423849|Gemcitabine|gemcitabine|mesh-list
102146736|NCT03423849|Capecitabine|capecitabine|mesh-list
102146737|NCT03423849|Vinorelbine|vinorelbine|mesh-list
102146738|NCT03423849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102146739|NCT03423849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102146740|NCT03423849|Antimetabolites|antimetabolites|mesh-ancestor
102146741|NCT03423849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146742|NCT03423849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102146743|NCT03423849|Tubulin Modulators|tubulin modulators|mesh-ancestor
102146744|NCT03423849|Antimitotic Agents|antimitotic agents|mesh-ancestor
102146745|NCT03423849|Mitosis Modulators|mitosis modulators|mesh-ancestor
102146746|NCT02362490|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102146747|NCT02362490|Antiviral Agents|antiviral agents|mesh-ancestor
102146748|NCT02362490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102146749|NCT02362256|Clonidine|clonidine|mesh-list
102146750|NCT02362256|Naltrexone|naltrexone|mesh-list
102146751|NCT02362256|Lorazepam|lorazepam|mesh-list
102146752|NCT02362256|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102146753|NCT02362256|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102146754|NCT02362256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146755|NCT02362256|Sensory System Agents|sensory system agents|mesh-ancestor
102146756|NCT02362256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102146757|NCT02362256|Analgesics|analgesics|mesh-ancestor
102146758|NCT02362256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102146759|NCT02362256|Sympatholytics|sympatholytics|mesh-ancestor
102146760|NCT02362256|Autonomic Agents|autonomic agents|mesh-ancestor
102146761|NCT02362256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102146762|NCT02362256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102146763|NCT02362256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102146764|NCT02362256|Adrenergic Agents|adrenergic agents|mesh-ancestor
102146765|NCT02362256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102146766|NCT02362256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146767|NCT02362256|Anticonvulsants|anticonvulsants|mesh-ancestor
102146768|NCT02362256|Antiemetics|antiemetics|mesh-ancestor
102146769|NCT02362256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102146770|NCT02362256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102146771|NCT02362256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102146772|NCT02362256|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102146773|NCT02362256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102146774|NCT02362256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102146775|NCT02362256|GABA Modulators|gaba modulators|mesh-ancestor
102146776|NCT02362256|GABA Agents|gaba agents|mesh-ancestor
102146777|NCT03412305|Amoxicillin|amoxicillin|mesh-list
102146778|NCT03412305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102146779|NCT03412305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102146780|NCT02109081|Dexamethasone|dexamethasone|mesh-list
102146781|NCT02109081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102146782|NCT02109081|Antiemetics|antiemetics|mesh-ancestor
102146783|NCT02109081|Autonomic Agents|autonomic agents|mesh-ancestor
102146784|NCT02109081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102146785|NCT02109081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535909|NCT00368589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102146786|NCT02109081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102146787|NCT02109081|Glucocorticoids|glucocorticoids|mesh-ancestor
102146788|NCT02109081|Hormones|hormones|mesh-ancestor
102146789|NCT02109081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102146790|NCT02109081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102146791|NCT02109081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102146792|NCT04259996|Estradiol|estradiol|mesh-list
102146793|NCT04259996|Progesterone|progesterone|mesh-list
101855683|NCT03755765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102146794|NCT04259996|Estrogens|estrogens|mesh-ancestor
102146795|NCT04259996|Hormones|hormones|mesh-ancestor
102146796|NCT04259996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102146797|NCT04259996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146799|NCT03417453|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102146800|NCT03417453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102146801|NCT04795557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102146802|NCT03397875|Zinc Oxide|zinc oxide|mesh-list
102146803|NCT03397875|Dermatologic Agents|dermatologic agents|mesh-ancestor
102146804|NCT03397875|Sunscreening Agents|sunscreening agents|mesh-ancestor
102146805|NCT03397875|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102146806|NCT03397875|Protective Agents|protective agents|mesh-ancestor
102146807|NCT03397875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146808|NCT02362022|Morphine|morphine|mesh-list
102146809|NCT02362022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102146810|NCT02362022|Narcotics|narcotics|mesh-ancestor
102146811|NCT02362022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102146812|NCT02362022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146813|NCT02362022|Analgesics|analgesics|mesh-ancestor
102146814|NCT02362022|Sensory System Agents|sensory system agents|mesh-ancestor
102146815|NCT02362022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102146816|NCT03412071|Metronidazole|metronidazole|mesh-list
102146817|NCT03412071|Clindamycin|clindamycin|mesh-list
102146818|NCT03412071|Clindamycin palmitate|clindamycin palmitate|mesh-list
102146819|NCT03412071|Clindamycin phosphate|clindamycin phosphate|mesh-list
102146820|NCT03412071|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102146821|NCT03412071|Tinidazole|tinidazole|mesh-list
102146822|NCT03412071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102146823|NCT03412071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102146824|NCT03412071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102146825|NCT03412071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102146826|NCT03412071|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102146827|NCT03412071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102146828|NCT03412071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146829|NCT03412071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102146830|NCT03412071|Alkylating Agents|alkylating agents|mesh-ancestor
102146831|NCT03412071|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
102146832|NCT03397797|Rocuronium|rocuronium|mesh-list
102146833|NCT03397797|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102146834|NCT03397797|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102146835|NCT03397797|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102146836|NCT03397797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102146837|NCT03397797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146838|NCT05170581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102146839|NCT05170581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146840|NCT05170581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102146841|NCT05170581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102146842|NCT02351882|Nabilone|nabilone|mesh-list
102146843|NCT02351882|Antiemetics|antiemetics|mesh-ancestor
102146844|NCT02351882|Autonomic Agents|autonomic agents|mesh-ancestor
102146845|NCT02351882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102146846|NCT02351882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146847|NCT02351882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102146848|NCT02351882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102146849|NCT02351882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102146850|NCT02351882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102146851|NCT02351882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102146852|NCT02356640|Levobupivacaine|levobupivacaine|mesh-list
102146853|NCT02356640|Anesthetics, Local|anesthetics, local|mesh-ancestor
101748636|NCT03015792|BB 1101|bb 1101|mesh-list
102146854|NCT02356640|Anesthetics|anesthetics|mesh-ancestor
102146855|NCT02356640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102146856|NCT02356640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146857|NCT02356640|Sensory System Agents|sensory system agents|mesh-ancestor
102146858|NCT02356640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102146859|NCT05169801|Paclitaxel|paclitaxel|mesh-list
102146860|NCT05169801|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102146861|NCT05169801|Carboplatin|carboplatin|mesh-list
102146862|NCT05169801|Bevacizumab|bevacizumab|mesh-list
102146863|NCT05169801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102146864|NCT05169801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102146865|NCT05169801|Tubulin Modulators|tubulin modulators|mesh-ancestor
102146866|NCT05169801|Antimitotic Agents|antimitotic agents|mesh-ancestor
102146867|NCT05169801|Mitosis Modulators|mitosis modulators|mesh-ancestor
102146868|NCT05169801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146869|NCT05169801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102146870|NCT05169801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102146871|NCT05169801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102146872|NCT05169801|Growth Substances|growth substances|mesh-ancestor
102146873|NCT05169801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146874|NCT05169801|Growth Inhibitors|growth inhibitors|mesh-ancestor
102146875|NCT04447443|Loperamide|loperamide|mesh-list
102146876|NCT04447443|Antidiarrheals|antidiarrheals|mesh-list
102146877|NCT04447443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102146878|NCT02356328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102146879|NCT02356328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102146880|NCT01345253|Belimumab|belimumab|mesh-list
102146881|NCT01345253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102146882|NCT01345253|Immunologic Factors|immunologic factors|mesh-ancestor
102146883|NCT01345253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146884|NCT03397329|Mitapivat|mitapivat|mesh-list
102146885|NCT03397329|Enzyme Activators|enzyme activators|mesh-ancestor
102146886|NCT03397329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146887|NCT03150134|Cyclosporine|cyclosporine|mesh-list
102146888|NCT03150134|Cyclosporins|cyclosporins|mesh-list
102146889|NCT03150134|Immunosuppressive Agents|immunosuppressive agents|mesh-list
102146890|NCT03150134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102146891|NCT03150134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146892|NCT03150134|Immunologic Factors|immunologic factors|mesh-ancestor
102146893|NCT03150134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146894|NCT03150134|Antifungal Agents|antifungal agents|mesh-ancestor
102146895|NCT03150134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102146896|NCT03150134|Dermatologic Agents|dermatologic agents|mesh-ancestor
102146897|NCT03150134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102146898|NCT03150134|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102146899|NCT03411369|Vitamins|vitamins|mesh-list
102146900|NCT03411369|Micronutrients|micronutrients|mesh-ancestor
102146901|NCT03411369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146902|NCT04653207|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102146903|NCT02351804|Dexamethasone|dexamethasone|mesh-list
102146904|NCT02351804|Ropivacaine|ropivacaine|mesh-list
102146905|NCT02351804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102146906|NCT02351804|Antiemetics|antiemetics|mesh-ancestor
102146907|NCT02351804|Autonomic Agents|autonomic agents|mesh-ancestor
102146908|NCT02351804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102146909|NCT02351804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146910|NCT02351804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102146911|NCT02351804|Glucocorticoids|glucocorticoids|mesh-ancestor
102146912|NCT02351804|Hormones|hormones|mesh-ancestor
102146913|NCT02351804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102146914|NCT02351804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102146915|NCT02351804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102146916|NCT02351804|Anesthetics, Local|anesthetics, local|mesh-ancestor
102146917|NCT02351804|Anesthetics|anesthetics|mesh-ancestor
102146918|NCT02351804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102146919|NCT02351804|Sensory System Agents|sensory system agents|mesh-ancestor
102146920|NCT03640403|Artesunate|artesunate|mesh-list
102146921|NCT03640403|Piperaquine|piperaquine|mesh-list
102146922|NCT03640403|Amodiaquine|amodiaquine|mesh-list
102146923|NCT03640403|Artenimol|artenimol|mesh-list
102146924|NCT03640403|Antimalarials|antimalarials|mesh-ancestor
102146925|NCT03640403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102146926|NCT03640403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102146927|NCT03640403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102146928|NCT03640403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102146929|NCT03640403|Antiviral Agents|antiviral agents|mesh-ancestor
102146930|NCT03640403|Schistosomicides|schistosomicides|mesh-ancestor
102146931|NCT03640403|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102146932|NCT03640403|Anthelmintics|anthelmintics|mesh-ancestor
102146933|NCT02355938|Vancomycin|vancomycin|mesh-list
102146934|NCT02355938|Fidaxomicin|fidaxomicin|mesh-list
102146935|NCT02355938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102146936|NCT02355938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102146937|NCT03397173|Ascorbic Acid|ascorbic acid|mesh-list
102146938|NCT03397173|Azacitidine|azacitidine|mesh-list
102146939|NCT03397173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102146940|NCT03397173|Antimetabolites|antimetabolites|mesh-ancestor
102146941|NCT03397173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146942|NCT03397173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102146943|NCT03397173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102146944|NCT03397173|Antioxidants|antioxidants|mesh-ancestor
102146945|NCT03397173|Protective Agents|protective agents|mesh-ancestor
102146946|NCT03397173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146947|NCT03397173|Vitamins|vitamins|mesh-ancestor
102146948|NCT03397173|Micronutrients|micronutrients|mesh-ancestor
102146949|NCT03640247|Acetaminophen|acetaminophen|mesh-list
102146950|NCT03640247|Ibuprofen|ibuprofen|mesh-list
102146953|NCT03640247|Hydrocodone|hydrocodone|mesh-list
102146954|NCT03640247|Narcotics|narcotics|mesh-list
102146955|NCT03640247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102146956|NCT03640247|Analgesics|analgesics|mesh-ancestor
102146957|NCT03640247|Sensory System Agents|sensory system agents|mesh-ancestor
102146958|NCT03640247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102146959|NCT03640247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146960|NCT03640247|Antipyretics|antipyretics|mesh-ancestor
102146961|NCT03640247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102146962|NCT03640247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102146963|NCT03640247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102146964|NCT03640247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102146965|NCT03640247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102146966|NCT03640247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146967|NCT03640247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102146968|NCT03640247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102146969|NCT03640247|Antitussive Agents|antitussive agents|mesh-ancestor
102146970|NCT03640247|Respiratory System Agents|respiratory system agents|mesh-ancestor
102146971|NCT03394131|Insulin|insulin|mesh-list
102146972|NCT03394131|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102146973|NCT03394131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102146974|NCT03394131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146975|NCT02360618|Metformin|metformin|mesh-list
102146976|NCT02360618|Simvastatin|simvastatin|mesh-list
102146977|NCT02360618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102146978|NCT02360618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146979|NCT02360618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102146980|NCT02360618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102146981|NCT02360618|Antimetabolites|antimetabolites|mesh-ancestor
102146982|NCT02360618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102146983|NCT02360618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102146984|NCT02360618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102146985|NCT02360618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102146986|NCT05214183|Rituximab|rituximab|mesh-list
102146987|NCT05214183|Acalabrutinib|acalabrutinib|mesh-list
102146988|NCT05214183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102146989|NCT05214183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102146990|NCT05214183|Immunologic Factors|immunologic factors|mesh-ancestor
102146991|NCT05214183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146992|NCT05214183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102146993|NCT01344161|Vitamin D|vitamin d|mesh-list
102146994|NCT01344161|Cholecalciferol|cholecalciferol|mesh-list
102146995|NCT01344161|Vitamins|vitamins|mesh-ancestor
102146996|NCT01344161|Micronutrients|micronutrients|mesh-ancestor
102146997|NCT01344161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102146998|NCT01344161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102146999|NCT01344161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102147000|NCT02451358|Vaccines|vaccines|mesh-list
102147001|NCT02451358|Immunologic Factors|immunologic factors|mesh-ancestor
102147002|NCT02451358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147003|NCT02360384|Linaclotide|linaclotide|mesh-list
102147004|NCT02360384|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102147005|NCT02360384|Enzyme Activators|enzyme activators|mesh-ancestor
102147006|NCT02360384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147007|NCT02360384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102147008|NCT03396861|Aflibercept|aflibercept|mesh-list
102147009|NCT03396861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102147010|NCT03396861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102147011|NCT03396861|Growth Substances|growth substances|mesh-ancestor
102147012|NCT03396861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147013|NCT03396861|Growth Inhibitors|growth inhibitors|mesh-ancestor
102147014|NCT03396861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102147015|NCT02749721|Vortioxetine|vortioxetine|mesh-list
102147016|NCT02749721|Antidepressive Agents|antidepressive agents|mesh-ancestor
102147017|NCT02749721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102147018|NCT02749721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102147019|NCT02749721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102147020|NCT02749721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102147021|NCT02749721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147022|NCT02749721|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102147023|NCT02749721|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102147024|NCT02749721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101855906|NCT03649841|Ascorbic Acid|ascorbic acid|mesh-list
102147025|NCT02749721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147026|NCT02749721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102147028|NCT02749721|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102147029|NCT02749721|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102147030|NCT02749721|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102147031|NCT02749721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102147032|NCT02351102|Valacyclovir|valacyclovir|mesh-list
102147033|NCT02351102|Antiviral Agents|antiviral agents|mesh-ancestor
102147034|NCT02351102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102147035|NCT02351024|Naproxen|naproxen|mesh-list
102147036|NCT02351024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102147037|NCT02351024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102147038|NCT02351024|Analgesics|analgesics|mesh-ancestor
102147039|NCT02351024|Sensory System Agents|sensory system agents|mesh-ancestor
102147040|NCT02351024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102147041|NCT02351024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147042|NCT02351024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102147043|NCT02351024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102147044|NCT02351024|Gout Suppressants|gout suppressants|mesh-ancestor
102147045|NCT02351024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102147046|NCT02351024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102147047|NCT02351024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147048|NCT02355704|Atorvastatin|atorvastatin|mesh-list
102147049|NCT02355704|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102147050|NCT02355704|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102147051|NCT02355704|Antimetabolites|antimetabolites|mesh-ancestor
102147052|NCT02355704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147053|NCT02355704|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102147054|NCT02355704|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102147055|NCT02355704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102147056|NCT03396393|Artenimol|artenimol|mesh-list
102147057|NCT03396393|Antimalarials|antimalarials|mesh-ancestor
102147058|NCT03396393|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102147059|NCT03396393|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102147060|NCT03396393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102147061|NCT03393819|Ethanol|ethanol|mesh-list
102147062|NCT03393819|Chlorhexidine|chlorhexidine|mesh-list
102147063|NCT03393819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102147064|NCT03393819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102147065|NCT03393819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102147066|NCT03393819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147067|NCT03393819|Disinfectants|disinfectants|mesh-ancestor
102147068|NCT03393507|Apatinib|apatinib|mesh-list
102147069|NCT03393507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102147070|NCT03393507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102147071|NCT03393507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102147072|NCT03393507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147073|NCT01348139|AZD-3199|azd-3199|mesh-list
102147074|NCT01348139|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102147075|NCT01348139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102147076|NCT01348139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102147077|NCT01348139|Adrenergic Agents|adrenergic agents|mesh-ancestor
102147078|NCT01348139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102147079|NCT01348139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147080|NCT01348139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147081|NCT02355236|Celecoxib|celecoxib|mesh-list
102147082|NCT02355236|Naproxen|naproxen|mesh-list
102147083|NCT02355236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102147084|NCT02355236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102147085|NCT02355236|Analgesics|analgesics|mesh-ancestor
102147086|NCT02355236|Sensory System Agents|sensory system agents|mesh-ancestor
102147087|NCT02355236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102147088|NCT02355236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147089|NCT02355236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102147090|NCT02355236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102147091|NCT02355236|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102535910|NCT00368589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102147092|NCT02355236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102147093|NCT02355236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102147094|NCT02355236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147095|NCT02355236|Gout Suppressants|gout suppressants|mesh-ancestor
102147096|NCT05169255|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102147097|NCT05169255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102147098|NCT02359604|Esomeprazole|esomeprazole|mesh-list
102147100|NCT02359604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102147101|NCT02359604|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102147102|NCT02359604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102147103|NCT02359604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147105|NCT03410511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102147106|NCT03410511|Autonomic Agents|autonomic agents|mesh-ancestor
102147107|NCT03410511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102147108|NCT03410511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147109|NCT03410511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102147110|NCT03410511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102147111|NCT03410511|Cholinergic Agents|cholinergic agents|mesh-ancestor
102147112|NCT03410511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102147113|NCT03410511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147114|NCT05169021|Folic Acid|folic acid|mesh-list
102147115|NCT05169021|Vitamin B Complex|vitamin b complex|mesh-list
102147116|NCT05169021|Amlodipine|amlodipine|mesh-list
102147117|NCT05169021|Antihypertensive Agents|antihypertensive agents|mesh-list
102147118|NCT05169021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102147119|NCT05169021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102147120|NCT05169021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147121|NCT05169021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102147122|NCT05169021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147123|NCT05169021|Vasodilator Agents|vasodilator agents|mesh-ancestor
102147124|NCT05169021|Hematinics|hematinics|mesh-ancestor
102147125|NCT05169021|Vitamins|vitamins|mesh-ancestor
102147126|NCT05169021|Micronutrients|micronutrients|mesh-ancestor
102147127|NCT02359292|Charcoal|charcoal|mesh-list
102147128|NCT02359292|Antidotes|antidotes|mesh-ancestor
102147129|NCT02359292|Protective Agents|protective agents|mesh-ancestor
102147130|NCT02359292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147131|NCT05168787|Valsartan|valsartan|mesh-list
102147132|NCT05168787|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102147133|NCT05168787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102147134|NCT05168787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102147135|NCT05168787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102147136|NCT05168787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147137|NCT02359214|Vitamin D|vitamin d|mesh-list
102147138|NCT02359214|Cholecalciferol|cholecalciferol|mesh-list
102147139|NCT02359214|Vitamins|vitamins|mesh-ancestor
102147140|NCT02359214|Micronutrients|micronutrients|mesh-ancestor
102147141|NCT02359214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147142|NCT02359214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102147143|NCT02359214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102147144|NCT02359370|Lidocaine|lidocaine|mesh-list
102147145|NCT02359370|Magnesium Sulfate|magnesium sulfate|mesh-list
102147146|NCT02359370|Anesthetics, Local|anesthetics, local|mesh-ancestor
102147147|NCT02359370|Anesthetics|anesthetics|mesh-ancestor
102147148|NCT02359370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102147149|NCT02359370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147150|NCT02359370|Sensory System Agents|sensory system agents|mesh-ancestor
102147151|NCT02359370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102147152|NCT02359370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102147153|NCT02359370|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102147154|NCT02359370|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102147155|NCT02359370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102147156|NCT02359370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147157|NCT02359370|Analgesics|analgesics|mesh-ancestor
102147158|NCT02359370|Anticonvulsants|anticonvulsants|mesh-ancestor
102147159|NCT02359370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102147160|NCT02359370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102147161|NCT02359370|Tocolytic Agents|tocolytic agents|mesh-ancestor
102147162|NCT02359370|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102147163|NCT02359448|Melatonin|melatonin|mesh-list
102147164|NCT02359448|Antioxidants|antioxidants|mesh-ancestor
102147165|NCT02359448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147166|NCT02359448|Protective Agents|protective agents|mesh-ancestor
102147167|NCT02359448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147168|NCT02359448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102147169|NCT02359526|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
102147170|NCT02359526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102147171|NCT02359526|Glucocorticoids|glucocorticoids|mesh-ancestor
102147173|NCT02359526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102147174|NCT02359526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147175|NCT03618953|Atezolizumab|atezolizumab|mesh-list
102147176|NCT03618953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102147177|NCT03618953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147178|NCT03618953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102147179|NCT03618953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102147180|NCT02354768|Lanreotide|lanreotide|mesh-list
102147181|NCT02354768|Loperamide|loperamide|mesh-list
102147182|NCT02354768|Antidiarrheals|antidiarrheals|mesh-list
102147183|NCT02354768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102147184|NCT02354768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102147185|NCT00000125|Antihypertensive Agents|antihypertensive agents|mesh-list
102147186|NCT00000125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102147187|NCT00000125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102147188|NCT02354612|Bevacizumab|bevacizumab|mesh-list
102147189|NCT02354612|Capecitabine|capecitabine|mesh-list
102147190|NCT02354612|Axitinib|axitinib|mesh-list
102147191|NCT02354612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102147192|NCT02354612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102147193|NCT02354612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102147194|NCT02354612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102147195|NCT02354612|Growth Substances|growth substances|mesh-ancestor
102147196|NCT02354612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147197|NCT02354612|Growth Inhibitors|growth inhibitors|mesh-ancestor
102147198|NCT02354612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102147199|NCT02354612|Antimetabolites|antimetabolites|mesh-ancestor
102147200|NCT02354612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147201|NCT02354612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102147202|NCT02354612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102147203|NCT02348450|Irinotecan|irinotecan|mesh-list
102147204|NCT02348450|Etoposide|etoposide|mesh-list
102147205|NCT02348450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102147206|NCT02348450|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102147207|NCT02348450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102147208|NCT02348450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102147209|NCT02348450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147210|NCT02348450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102147211|NCT02348450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102147212|NCT03393273|Elotuzumab|elotuzumab|mesh-list
102147213|NCT03393273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102147214|NCT03613597|Etoposide|etoposide|mesh-list
102147215|NCT03613597|Etoposide phosphate|etoposide phosphate|mesh-list
102147216|NCT03613597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102147217|NCT03613597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102147218|NCT03613597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102147219|NCT03613597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102147220|NCT03613597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102147221|NCT03613597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147222|NCT02348372|Glycine|glycine|mesh-list
102147223|NCT02348372|Glycine Agents|glycine agents|mesh-ancestor
102147224|NCT02348372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102147225|NCT02348372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147226|NCT02348372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147227|NCT02031731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102147228|NCT02031731|Immunologic Factors|immunologic factors|mesh-ancestor
102147229|NCT02031731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147230|NCT03614533|Vaccines|vaccines|mesh-list
102147231|NCT03614533|Immunologic Factors|immunologic factors|mesh-ancestor
102147232|NCT03614533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147233|NCT03147404|Avelumab|avelumab|mesh-list
102147234|NCT03147404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102147235|NCT03147404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102147236|NCT03614455|Itraconazole|itraconazole|mesh-list
102147237|NCT03614455|Posaconazole|posaconazole|mesh-list
102147238|NCT03614455|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-list
102147239|NCT03614455|Antifungal Agents|antifungal agents|mesh-ancestor
102147240|NCT03614455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102154339|NCT02852005|Immunologic Factors|immunologic factors|mesh-ancestor
102147241|NCT03614455|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102147242|NCT03614455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102147243|NCT03614455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102147244|NCT03614455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147245|NCT03614455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102147246|NCT03614455|Hormone Antagonists|hormone antagonists|mesh-ancestor
101856144|NCT00110890|Cinacalcet|cinacalcet|mesh-list
102147247|NCT03614455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102147248|NCT03614455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147249|NCT03614455|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102147250|NCT03614455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102147251|NCT03614455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102147252|NCT03393117|Narcotics|narcotics|mesh-list
102147253|NCT03393117|Bupivacaine|bupivacaine|mesh-list
102147254|NCT03393117|Anesthetics, Local|anesthetics, local|mesh-ancestor
102147255|NCT03393117|Anesthetics|anesthetics|mesh-ancestor
102147256|NCT03393117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102147257|NCT03393117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147258|NCT03393117|Sensory System Agents|sensory system agents|mesh-ancestor
102147259|NCT03393117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102147260|NCT03393117|Analgesics|analgesics|mesh-ancestor
102147261|NCT02032303|Ticagrelor|ticagrelor|mesh-list
102147262|NCT02032303|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102147263|NCT02032303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102147264|NCT02032303|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102147265|NCT02032303|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102147266|NCT02032303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102147267|NCT02032303|Purinergic Agents|purinergic agents|mesh-ancestor
102147268|NCT02032303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102147269|NCT02032303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147270|NCT02032303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147271|NCT04297293|Ramosetron|ramosetron|mesh-list
102147272|NCT04297293|Antiemetics|antiemetics|mesh-ancestor
102147273|NCT04297293|Autonomic Agents|autonomic agents|mesh-ancestor
102147274|NCT04297293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102147275|NCT04297293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147276|NCT04297293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102147277|NCT04297293|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102147278|NCT04297293|Serotonin Agents|serotonin agents|mesh-ancestor
102147279|NCT04297293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102147280|NCT04297293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147281|NCT03392961|Insulin|insulin|mesh-list
102147282|NCT03392961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102147283|NCT03392961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147284|NCT02350946|Oxytocin|oxytocin|mesh-list
102147285|NCT02350946|Oxytocics|oxytocics|mesh-ancestor
102147286|NCT02350946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102147287|NCT02350946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147288|NCT00000371|Cycloserine|cycloserine|mesh-list
102147289|NCT00000371|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102147290|NCT00000371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102147291|NCT00000371|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102147292|NCT00000371|Antitubercular Agents|antitubercular agents|mesh-ancestor
102147293|NCT00000371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102147294|NCT00000371|Antimetabolites|antimetabolites|mesh-ancestor
102147295|NCT00000371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147296|NCT02350712|Carboplatin|carboplatin|mesh-list
102147297|NCT02350712|Cetuximab|cetuximab|mesh-list
102147298|NCT02350712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102147299|NCT02350712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102147300|NCT02867995|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102147301|NCT02867995|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102147302|NCT03618797|Fenofibrate|fenofibrate|mesh-list
102147303|NCT03618797|Pitavastatin|pitavastatin|mesh-list
102147304|NCT03618797|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102147305|NCT03618797|Antimetabolites|antimetabolites|mesh-ancestor
102147306|NCT03618797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147307|NCT03618797|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102147308|NCT03618797|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102147309|NCT03618797|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102147310|NCT03618797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102147311|NCT03149432|Gabapentin|gabapentin|mesh-list
102147312|NCT03149432|Analgesics|analgesics|mesh-ancestor
102147313|NCT03149432|Sensory System Agents|sensory system agents|mesh-ancestor
102147314|NCT03149432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102147315|NCT03149432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147316|NCT03149432|Anticonvulsants|anticonvulsants|mesh-ancestor
102147317|NCT03149432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102147318|NCT03149432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102147319|NCT03149432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102147320|NCT03149432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102147321|NCT03149432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102147323|NCT03149432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102147324|NCT03149432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147325|NCT03149432|Antimanic Agents|antimanic agents|mesh-ancestor
102147326|NCT05384483|Cariprazine|cariprazine|mesh-list
102147327|NCT05384483|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102147328|NCT05384483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102147329|NCT05384483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102147330|NCT05384483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147331|NCT05384483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102147332|NCT05061563|Esomeprazole|esomeprazole|mesh-list
102147333|NCT05061563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102147334|NCT05061563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102147335|NCT05061563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102147336|NCT05061563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102147337|NCT05061563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147338|NCT03147092|Losartan|losartan|mesh-list
102147339|NCT03147092|Atenolol|atenolol|mesh-list
102147340|NCT03147092|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102147341|NCT03147092|Clonidine|clonidine|mesh-list
102147342|NCT03147092|Captopril|captopril|mesh-list
102147343|NCT03147092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102147344|NCT03147092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102147345|NCT03147092|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102147346|NCT03147092|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102147347|NCT03147092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147348|NCT03147092|Diuretics|diuretics|mesh-ancestor
102147349|NCT03147092|Natriuretic Agents|natriuretic agents|mesh-ancestor
102147350|NCT03147092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147351|NCT03147092|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102147352|NCT03147092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102147353|NCT03147092|Analgesics|analgesics|mesh-ancestor
102147354|NCT03147092|Sensory System Agents|sensory system agents|mesh-ancestor
102147355|NCT03147092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102147356|NCT03147092|Sympatholytics|sympatholytics|mesh-ancestor
102147357|NCT03147092|Autonomic Agents|autonomic agents|mesh-ancestor
102147358|NCT03147092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102147359|NCT03147092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102147360|NCT03147092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102147361|NCT03147092|Adrenergic Agents|adrenergic agents|mesh-ancestor
102147362|NCT03147092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102147363|NCT03147092|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102147364|NCT03147092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102147365|NCT03147092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102147366|NCT03147092|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102147367|NCT03147092|Protease Inhibitors|protease inhibitors|mesh-ancestor
102147368|NCT03147092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102147369|NCT03149588|Propofol|propofol|mesh-list
102147370|NCT03149588|Sevoflurane|sevoflurane|mesh-list
102147371|NCT03149588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102147372|NCT03149588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102147373|NCT03149588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147374|NCT03149588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102147375|NCT03149588|Anesthetics, General|anesthetics, general|mesh-ancestor
102147376|NCT03149588|Anesthetics|anesthetics|mesh-ancestor
102147377|NCT03149588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102147378|NCT03149588|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102147379|NCT03613207|Lidocaine|lidocaine|mesh-list
102147380|NCT03613207|Prilocaine|prilocaine|mesh-list
102147381|NCT03613207|Anesthetics, Local|anesthetics, local|mesh-ancestor
102147382|NCT03613207|Anesthetics|anesthetics|mesh-ancestor
102147383|NCT03613207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102147384|NCT03613207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147385|NCT03613207|Sensory System Agents|sensory system agents|mesh-ancestor
102147386|NCT03613207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102147387|NCT03613207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102147388|NCT03613207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102147389|NCT03613207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102147390|NCT03613207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102147391|NCT03613207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147392|NCT03612739|Azacitidine|azacitidine|mesh-list
102147393|NCT03612739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102147394|NCT03612739|Antimetabolites|antimetabolites|mesh-ancestor
101856281|NCT00110266|Chelating Agents|chelating agents|mesh-ancestor
102147395|NCT03612739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147396|NCT03612739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102147397|NCT03612739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102147399|NCT02350400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102147400|NCT02350400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102147401|NCT02350400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102147402|NCT02350400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147403|NCT02350400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102147405|NCT03612817|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102147406|NCT03612817|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102147407|NCT03612817|Adrenergic Agents|adrenergic agents|mesh-ancestor
102147408|NCT03612817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102147409|NCT03612817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241609|NCT03071055|Growth Inhibitors|growth inhibitors|mesh-ancestor
102147410|NCT03612817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147411|NCT03612817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102147412|NCT03612817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102147413|NCT02347904|Oxaliplatin|oxaliplatin|mesh-list
102147414|NCT02347904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102147415|NCT03612349|Menthol|menthol|mesh-list
102147416|NCT03612349|Antipruritics|antipruritics|mesh-ancestor
102147417|NCT03612349|Dermatologic Agents|dermatologic agents|mesh-ancestor
102147418|NCT03146858|Enoxaparin|enoxaparin|mesh-list
102147419|NCT03146858|Anticoagulants|anticoagulants|mesh-ancestor
102147420|NCT03146858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102147421|NCT03146858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102147422|NCT03146858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147423|NCT03408405|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102147424|NCT03408405|Hormones|hormones|mesh-ancestor
102147425|NCT03408405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102147426|NCT03408405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147427|NCT03408093|Interferons|interferons|mesh-list
102147428|NCT03408093|Interferon-beta|interferon-beta|mesh-list
102147429|NCT03408093|Interferon beta-1b|interferon beta-1b|mesh-list
102147430|NCT03408093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102147431|NCT03408093|Antiviral Agents|antiviral agents|mesh-ancestor
102147432|NCT03408093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102147433|NCT03408093|Immunologic Factors|immunologic factors|mesh-ancestor
102147434|NCT03408093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147435|NCT03408093|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102147436|NCT04679623|Midazolam|midazolam|mesh-list
102147437|NCT04679623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102147438|NCT04679623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102147439|NCT04679623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102147440|NCT04679623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147441|NCT04679623|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102147442|NCT04679623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102147443|NCT04679623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102147444|NCT04679623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102147445|NCT04679623|Anesthetics, General|anesthetics, general|mesh-ancestor
102147446|NCT04679623|Anesthetics|anesthetics|mesh-ancestor
102147447|NCT04679623|GABA Modulators|gaba modulators|mesh-ancestor
102147448|NCT04679623|GABA Agents|gaba agents|mesh-ancestor
102147449|NCT04679623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102147450|NCT04679623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147451|NCT02353988|Bicalutamide|bicalutamide|mesh-list
102147452|NCT02353988|Androgen Antagonists|androgen antagonists|mesh-ancestor
102147453|NCT02353988|Hormone Antagonists|hormone antagonists|mesh-ancestor
102147454|NCT02353988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102147455|NCT02353988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147456|NCT02353988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102147457|NCT03392571|Paclitaxel|paclitaxel|mesh-list
102147458|NCT03392571|Cisplatin|cisplatin|mesh-list
102147459|NCT03392571|Gemcitabine|gemcitabine|mesh-list
102147460|NCT03392571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102147461|NCT03392571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102147462|NCT03392571|Tubulin Modulators|tubulin modulators|mesh-ancestor
102147463|NCT03392571|Antimitotic Agents|antimitotic agents|mesh-ancestor
102147464|NCT03392571|Mitosis Modulators|mitosis modulators|mesh-ancestor
102147465|NCT03392571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147466|NCT03392571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102147467|NCT03392571|Antimetabolites|antimetabolites|mesh-ancestor
102147468|NCT04656067|Tranexamic Acid|tranexamic acid|mesh-list
102147469|NCT04656067|Ethamsylate|ethamsylate|mesh-list
102147470|NCT04656067|Oxytocin|oxytocin|mesh-list
102147472|NCT04656067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102147473|NCT04656067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147474|NCT04656067|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102147475|NCT04656067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102147476|NCT04656067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147477|NCT04656067|Hemostatics|hemostatics|mesh-ancestor
102147478|NCT04656067|Coagulants|coagulants|mesh-ancestor
102147479|NCT03612037|Thioctic Acid|thioctic acid|mesh-list
102147480|NCT03612037|Antioxidants|antioxidants|mesh-ancestor
102147481|NCT03612037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147482|NCT03612037|Protective Agents|protective agents|mesh-ancestor
102147483|NCT03612037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147484|NCT03612037|Vitamin B Complex|vitamin b complex|mesh-ancestor
102147485|NCT03612037|Vitamins|vitamins|mesh-ancestor
102147486|NCT03612037|Micronutrients|micronutrients|mesh-ancestor
102147487|NCT04447209|Chrysarobin|chrysarobin|mesh-list
102147488|NCT04447209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102147489|NCT04447209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102147490|NCT04447209|Analgesics|analgesics|mesh-ancestor
102147491|NCT04447209|Sensory System Agents|sensory system agents|mesh-ancestor
102147492|NCT04447209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102147493|NCT04447209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147494|NCT04447209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102147495|NCT04447209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102147496|NCT04199624|Omeprazole|omeprazole|mesh-list
102147497|NCT04199624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147498|NCT04199624|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102147499|NCT04199624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102147500|NCT04199624|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102147501|NCT04199624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102147502|NCT03611491|Lidocaine|lidocaine|mesh-list
102147503|NCT03611491|Anesthetics, Local|anesthetics, local|mesh-ancestor
102147504|NCT03611491|Anesthetics|anesthetics|mesh-ancestor
102147505|NCT03611491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102147506|NCT03611491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147507|NCT03611491|Sensory System Agents|sensory system agents|mesh-ancestor
102147508|NCT03611491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102147509|NCT03611491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102147510|NCT03611491|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102147511|NCT03611491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102147512|NCT03611491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102147513|NCT03611491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147514|NCT02748863|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102147515|NCT02748863|Immunologic Factors|immunologic factors|mesh-ancestor
102147516|NCT02748863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147517|NCT03611179|Bevacizumab|bevacizumab|mesh-list
102147518|NCT03611179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102147519|NCT03611179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102147520|NCT03611179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102147521|NCT03611179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102147522|NCT03611179|Growth Substances|growth substances|mesh-ancestor
102147523|NCT03611179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147524|NCT03611179|Growth Inhibitors|growth inhibitors|mesh-ancestor
102147525|NCT03126123|Acetic Acid|acetic acid|mesh-list
102147526|NCT03126123|Retinol acetate|retinol acetate|mesh-list
102147527|NCT03126123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102147528|NCT03126123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102147529|NCT03126123|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102147530|NCT03126123|Immunologic Factors|immunologic factors|mesh-ancestor
102147531|NCT03126123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147532|NCT03126123|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102147533|NCT03126123|Protective Agents|protective agents|mesh-ancestor
102147534|NCT03126123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102147535|NCT02353676|Bupivacaine|bupivacaine|mesh-list
102147536|NCT02353676|Anesthetics, Local|anesthetics, local|mesh-ancestor
102147537|NCT02353676|Anesthetics|anesthetics|mesh-ancestor
102147538|NCT02353676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102147539|NCT02353676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147540|NCT02353676|Sensory System Agents|sensory system agents|mesh-ancestor
102147541|NCT02353676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102147542|NCT03617471|Acetaminophen|acetaminophen|mesh-list
102147543|NCT03617471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101856430|NCT03964324|Vasodilator Agents|vasodilator agents|mesh-ancestor
102147544|NCT03617471|Analgesics|analgesics|mesh-ancestor
102147545|NCT03617471|Sensory System Agents|sensory system agents|mesh-ancestor
102147546|NCT03617471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102147547|NCT03617471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147548|NCT03617471|Antipyretics|antipyretics|mesh-ancestor
102147549|NCT05168007|Cariprazine|cariprazine|mesh-list
102147550|NCT05168007|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102147551|NCT05168007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102147552|NCT05168007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102147553|NCT05168007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147554|NCT05168007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102147555|NCT02032927|Acetaminophen|acetaminophen|mesh-list
102147556|NCT02032927|Oxycodone|oxycodone|mesh-list
102147557|NCT02032927|Codeine|codeine|mesh-list
102147558|NCT02032927|Naloxone|naloxone|mesh-list
102147559|NCT02032927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102147560|NCT02032927|Analgesics|analgesics|mesh-ancestor
102147561|NCT02032927|Sensory System Agents|sensory system agents|mesh-ancestor
102147562|NCT02032927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102147563|NCT02032927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147564|NCT02032927|Antipyretics|antipyretics|mesh-ancestor
102147565|NCT02032927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102147566|NCT02032927|Narcotics|narcotics|mesh-ancestor
102147567|NCT02032927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102147568|NCT02032927|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102147569|NCT02032927|Antitussive Agents|antitussive agents|mesh-ancestor
102147570|NCT02032927|Respiratory System Agents|respiratory system agents|mesh-ancestor
102147571|NCT02353598|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102147572|NCT02353598|Immunologic Factors|immunologic factors|mesh-ancestor
102147573|NCT02353598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147574|NCT03392103|Raltitrexed|raltitrexed|mesh-list
102147575|NCT03392103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102147576|NCT03392103|Antimetabolites|antimetabolites|mesh-ancestor
102147577|NCT03392103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147578|NCT03392103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102147579|NCT03392103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102147580|NCT03392103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102147581|NCT03610945|Fluconazole|fluconazole|mesh-list
102147582|NCT03610945|Quinidine|quinidine|mesh-list
102147583|NCT03610945|Antifungal Agents|antifungal agents|mesh-ancestor
102147584|NCT03610945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102147585|NCT03610945|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102147586|NCT03610945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102147587|NCT03610945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102147588|NCT03610945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147589|NCT03610945|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102147590|NCT03610945|Hormone Antagonists|hormone antagonists|mesh-ancestor
102147591|NCT03610945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102147592|NCT03610945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147593|NCT03610945|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102147594|NCT03610945|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102147595|NCT03610945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102147596|NCT03610945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102147597|NCT03610945|Adrenergic Agents|adrenergic agents|mesh-ancestor
102147598|NCT03610945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102147599|NCT03610945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102147600|NCT03610945|Antimalarials|antimalarials|mesh-ancestor
102147601|NCT03610945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102147602|NCT03610945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102147603|NCT03610945|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102147604|NCT03610945|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102147605|NCT03610945|Cholinergic Agents|cholinergic agents|mesh-ancestor
102147606|NCT03610945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102147607|NCT03610945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102147608|NCT03610945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102147609|NCT03610945|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102147610|NCT03616769|Antihypertensive Agents|antihypertensive agents|mesh-list
102147611|NCT03616769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
102147612|NCT05167851|Lazertinib|lazertinib|mesh-list
102147613|NCT05167851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102147614|NCT05167851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102147615|NCT05167851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147616|NCT02236715|Ipratropium|ipratropium|mesh-list
102147617|NCT02236715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102147618|NCT02236715|Autonomic Agents|autonomic agents|mesh-ancestor
101856503|NCT00104572|Vitamin D|vitamin d|mesh-list
102147619|NCT02236715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102147620|NCT02236715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147621|NCT02236715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102147622|NCT02236715|Respiratory System Agents|respiratory system agents|mesh-ancestor
102147623|NCT02236715|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102147624|NCT02236715|Cholinergic Agents|cholinergic agents|mesh-ancestor
102147625|NCT02236715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102147626|NCT02236715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147628|NCT03823365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102147629|NCT03616691|Bevacizumab|bevacizumab|mesh-list
102147630|NCT03616691|Atezolizumab|atezolizumab|mesh-list
102147631|NCT03616691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102147632|NCT03616691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102147633|NCT03616691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102147634|NCT03616691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102147635|NCT03616691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102147636|NCT03616691|Growth Substances|growth substances|mesh-ancestor
102147637|NCT03616691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147638|NCT03616691|Growth Inhibitors|growth inhibitors|mesh-ancestor
102147639|NCT03616691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102147640|NCT03616691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147641|NCT03616691|Immunologic Factors|immunologic factors|mesh-ancestor
102147642|NCT03158168|Zinc Sulfate|zinc sulfate|mesh-list
102147643|NCT03158168|Astringents|astringents|mesh-ancestor
102147644|NCT03158168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147645|NCT03158168|Dermatologic Agents|dermatologic agents|mesh-ancestor
102147646|NCT02865499|Acarbose|acarbose|mesh-list
102147647|NCT02865499|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102147648|NCT02865499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102147649|NCT02865499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147650|NCT02865499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102147651|NCT02865499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147652|NCT03156062|Salicylic Acid|salicylic acid|mesh-list
102147653|NCT03156062|Salicylates|salicylates|mesh-list
102147654|NCT03156062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102147655|NCT03156062|Antifungal Agents|antifungal agents|mesh-ancestor
102147656|NCT03156062|Keratolytic Agents|keratolytic agents|mesh-ancestor
102147657|NCT03156062|Dermatologic Agents|dermatologic agents|mesh-ancestor
102147658|NCT03156062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102147659|NCT03156062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102147660|NCT03156062|Analgesics|analgesics|mesh-ancestor
102147661|NCT03156062|Sensory System Agents|sensory system agents|mesh-ancestor
102147662|NCT03156062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102147663|NCT03156062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147664|NCT03156062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102147665|NCT03156062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102147666|NCT03156062|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102147667|NCT03156062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102147668|NCT03156062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147669|NCT03404739|Ceftazidime|ceftazidime|mesh-list
102147670|NCT03404739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102147671|NCT03404739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102147672|NCT02031965|Dexamethasone|dexamethasone|mesh-list
102147673|NCT02031965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102147674|NCT02031965|Antiemetics|antiemetics|mesh-ancestor
102147675|NCT02031965|Autonomic Agents|autonomic agents|mesh-ancestor
102147676|NCT02031965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102147677|NCT02031965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147678|NCT02031965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102147679|NCT02031965|Glucocorticoids|glucocorticoids|mesh-ancestor
102147680|NCT02031965|Hormones|hormones|mesh-ancestor
102147681|NCT02031965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102147682|NCT02031965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102147683|NCT02031965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102147684|NCT03149120|Nivolumab|nivolumab|mesh-list
102147685|NCT03149120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102147686|NCT03149120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102147687|NCT03149120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102147688|NCT03149120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147689|NCT04849325|Sirolimus|sirolimus|mesh-list
102147690|NCT04849325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102147691|NCT04849325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102147692|NCT04849325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102147693|NCT04849325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102147694|NCT04849325|Antifungal Agents|antifungal agents|mesh-ancestor
102147695|NCT04849325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102147696|NCT04849325|Immunologic Factors|immunologic factors|mesh-ancestor
102147697|NCT04849325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147698|NCT03403023|Cyclosporine|cyclosporine|mesh-list
102147699|NCT03403023|Cyclosporins|cyclosporins|mesh-list
102147700|NCT03403023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102147701|NCT03403023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147702|NCT03403023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102147703|NCT03403023|Immunologic Factors|immunologic factors|mesh-ancestor
102147704|NCT03403023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147705|NCT03403023|Antifungal Agents|antifungal agents|mesh-ancestor
102147706|NCT03403023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102147707|NCT03403023|Dermatologic Agents|dermatologic agents|mesh-ancestor
102147708|NCT03403023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102147709|NCT03403023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102147710|NCT02864407|Tiotropium Bromide|tiotropium bromide|mesh-list
102147712|NCT02864407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102147713|NCT02864407|Autonomic Agents|autonomic agents|mesh-ancestor
102147714|NCT02864407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102147715|NCT02864407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147716|NCT02864407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102147717|NCT02864407|Respiratory System Agents|respiratory system agents|mesh-ancestor
102147718|NCT02864407|Parasympatholytics|parasympatholytics|mesh-ancestor
102147719|NCT02864407|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102147720|NCT02864407|Cholinergic Agents|cholinergic agents|mesh-ancestor
102147721|NCT02864407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102147722|NCT02864407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147723|NCT03616301|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102147724|NCT03616301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102147725|NCT03616301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102147726|NCT03616301|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102147727|NCT03616301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102147728|NCT03616301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147729|NCT03394989|Fluticasone|fluticasone|mesh-list
102147730|NCT03394989|Xhance|xhance|mesh-list
102147731|NCT03394989|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102147732|NCT03394989|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102147733|NCT03394989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101749510|NCT00620776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102147734|NCT03394989|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102147735|NCT03394989|Autonomic Agents|autonomic agents|mesh-ancestor
102147736|NCT03394989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102147737|NCT03394989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147738|NCT03394989|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102147739|NCT03394989|Respiratory System Agents|respiratory system agents|mesh-ancestor
102147740|NCT03394989|Dermatologic Agents|dermatologic agents|mesh-ancestor
102147741|NCT03394989|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102147742|NCT03394989|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102147743|NCT03394989|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102147744|NCT03394989|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102147745|NCT03394989|Adrenergic Agents|adrenergic agents|mesh-ancestor
102147746|NCT03394989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102147747|NCT03394989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147748|NCT03394989|Glucocorticoids|glucocorticoids|mesh-ancestor
102147749|NCT03394989|Hormones|hormones|mesh-ancestor
102147750|NCT03394989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102147751|NCT03394989|Sympathomimetics|sympathomimetics|mesh-ancestor
102147752|NCT02033239|Insulin|insulin|mesh-list
102147753|NCT02033239|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102147754|NCT02033239|Insulin Aspart|insulin aspart|mesh-list
102147755|NCT02033239|Insulin, Long-Acting|insulin, long-acting|mesh-list
102147756|NCT02033239|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102147757|NCT02033239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102147758|NCT02033239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147759|NCT02486302|Etanercept|etanercept|mesh-list
102147760|NCT02486302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102147761|NCT02486302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102147762|NCT02486302|Analgesics|analgesics|mesh-ancestor
102147763|NCT02486302|Sensory System Agents|sensory system agents|mesh-ancestor
102147764|NCT02486302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102147765|NCT02486302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147766|NCT02486302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102147767|NCT02486302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102147768|NCT02486302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102147769|NCT02486302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102147770|NCT02486302|Immunologic Factors|immunologic factors|mesh-ancestor
102147771|NCT02034097|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102147772|NCT02034097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102147773|NCT02034097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102147774|NCT02034097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102147775|NCT02034097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147776|NCT03615833|Vitamin D|vitamin d|mesh-list
102147777|NCT03615833|Cholecalciferol|cholecalciferol|mesh-list
102147778|NCT03615833|Vitamins|vitamins|mesh-ancestor
102147779|NCT03615833|Micronutrients|micronutrients|mesh-ancestor
102147780|NCT03615833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147781|NCT03615833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102147782|NCT03615833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102147783|NCT02747875|Fentanyl|fentanyl|mesh-list
102147784|NCT02747875|Methadone|methadone|mesh-list
102147785|NCT02747875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102147786|NCT02747875|Narcotics|narcotics|mesh-ancestor
102147787|NCT02747875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102147788|NCT02747875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147789|NCT02747875|Analgesics|analgesics|mesh-ancestor
102147790|NCT02747875|Sensory System Agents|sensory system agents|mesh-ancestor
102147791|NCT02747875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102147792|NCT02747875|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102147793|NCT02747875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102147794|NCT02747875|Anesthetics, General|anesthetics, general|mesh-ancestor
102147795|NCT02747875|Anesthetics|anesthetics|mesh-ancestor
102147796|NCT02747875|Antitussive Agents|antitussive agents|mesh-ancestor
102147797|NCT02747875|Respiratory System Agents|respiratory system agents|mesh-ancestor
102147798|NCT03394833|Polygeline|polygeline|mesh-list
101749568|NCT00764465|Ritonavir|ritonavir|mesh-list
102147799|NCT03394833|Plasma Substitutes|plasma substitutes|mesh-ancestor
102147800|NCT03394833|Blood Substitutes|blood substitutes|mesh-ancestor
102147801|NCT02347358|Plasminogen|plasminogen|mesh-list
102147802|NCT02347358|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102147803|NCT02347358|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102147804|NCT02347358|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102147805|NCT02347358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147806|NCT03610321|Gefarnate|gefarnate|mesh-list
102147807|NCT03610321|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102147808|NCT03610321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102147809|NCT02236793|Becaplermin|becaplermin|mesh-list
102147810|NCT02236793|Anticoagulants|anticoagulants|mesh-ancestor
102147811|NCT02236793|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
102147812|NCT02236793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102147813|NCT02236793|Growth Substances|growth substances|mesh-ancestor
102147814|NCT02236793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147815|NCT02347046|Dotinurad|dotinurad|mesh-list
102147816|NCT02347046|Uricosuric Agents|uricosuric agents|mesh-ancestor
102147817|NCT02347046|Gout Suppressants|gout suppressants|mesh-ancestor
102147818|NCT02347046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102147819|NCT03391245|Vitamin D|vitamin d|mesh-list
102147820|NCT03391245|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
102147821|NCT03391245|Calcifediol|calcifediol|mesh-list
102147822|NCT03391245|Vitamins|vitamins|mesh-ancestor
102147823|NCT03391245|Micronutrients|micronutrients|mesh-ancestor
102147824|NCT03391245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147825|NCT03391245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102147826|NCT03401619|Vitamin D|vitamin d|mesh-list
102147827|NCT03401619|Calcitonin|calcitonin|mesh-list
102147828|NCT03401619|Salmon calcitonin|salmon calcitonin|mesh-list
102147829|NCT03401619|Diphosphonates|diphosphonates|mesh-list
102147830|NCT03401619|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
102147831|NCT03401619|Katacalcin|katacalcin|mesh-list
102147832|NCT03401619|Vitamins|vitamins|mesh-ancestor
102147833|NCT03401619|Micronutrients|micronutrients|mesh-ancestor
102147834|NCT03401619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147835|NCT03401619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102147836|NCT03401619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102147837|NCT03401619|Vasodilator Agents|vasodilator agents|mesh-ancestor
102147838|NCT03399903|Mesalamine|mesalamine|mesh-list
102147839|NCT03399903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102147840|NCT03399903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102147841|NCT03399903|Analgesics|analgesics|mesh-ancestor
102147842|NCT03399903|Sensory System Agents|sensory system agents|mesh-ancestor
102147843|NCT03399903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102147844|NCT03399903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147845|NCT03399903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102147846|NCT03399903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102147847|NCT03146468|Nivolumab|nivolumab|mesh-list
102147848|NCT03146468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102147849|NCT03146468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102147850|NCT03146468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102147851|NCT03146468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147852|NCT02353130|Memantine|memantine|mesh-list
102147853|NCT02353130|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102147854|NCT02353130|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102147855|NCT02353130|Dopamine Agents|dopamine agents|mesh-ancestor
102147856|NCT02353130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102147857|NCT02353130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147858|NCT02353130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147859|NCT02353130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102147860|NCT02353130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102147861|NCT02033551|Paclitaxel|paclitaxel|mesh-list
102147862|NCT02033551|Carboplatin|carboplatin|mesh-list
102147863|NCT02033551|Veliparib|veliparib|mesh-list
102147864|NCT02033551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102147865|NCT02033551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102147866|NCT02033551|Tubulin Modulators|tubulin modulators|mesh-ancestor
102147867|NCT02033551|Antimitotic Agents|antimitotic agents|mesh-ancestor
102147868|NCT02033551|Mitosis Modulators|mitosis modulators|mesh-ancestor
102147869|NCT02033551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749629|NCT00842140|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102147870|NCT02033551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102147871|NCT02033551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102147872|NCT02450578|Atovaquone|atovaquone|mesh-list
102147873|NCT02450578|Proguanil|proguanil|mesh-list
102147874|NCT02450578|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
102147875|NCT02450578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102147876|NCT02450578|Antimalarials|antimalarials|mesh-ancestor
102147877|NCT02450578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102147878|NCT02450578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102147879|NCT02450578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102147880|NCT02450578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147881|NCT02450578|Antimetabolites|antimetabolites|mesh-ancestor
102147882|NCT02346890|Sevelamer|sevelamer|mesh-list
102147883|NCT02346890|Chelating Agents|chelating agents|mesh-ancestor
102147884|NCT02346890|Sequestering Agents|sequestering agents|mesh-ancestor
102147885|NCT02346890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147886|NCT03146390|Listerine|listerine|mesh-list
102147887|NCT03146390|Sodium Fluoride|sodium fluoride|mesh-list
102147888|NCT03146390|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102147889|NCT03146390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102147890|NCT03146390|Cariostatic Agents|cariostatic agents|mesh-ancestor
102147891|NCT03146390|Protective Agents|protective agents|mesh-ancestor
102147892|NCT03146390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147893|NCT02859415|Plicamycin|plicamycin|mesh-list
102147894|NCT02859415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102147895|NCT02859415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147896|NCT02859415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102147897|NCT02859415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102147898|NCT02859415|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102147899|NCT02859415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102147900|NCT02859415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147901|NCT02859415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102147902|NCT02871791|Everolimus|everolimus|mesh-list
102147903|NCT02871791|Palbociclib|palbociclib|mesh-list
102147904|NCT02871791|Exemestane|exemestane|mesh-list
102147905|NCT02871791|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102147906|NCT02871791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102147907|NCT02871791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102147908|NCT02871791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147909|NCT02871791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102147910|NCT02871791|Immunologic Factors|immunologic factors|mesh-ancestor
102147911|NCT02871791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147912|NCT02871791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102147913|NCT02871791|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102147914|NCT02871791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102147915|NCT02871791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102147916|NCT02871791|Hormone Antagonists|hormone antagonists|mesh-ancestor
102147917|NCT02871791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102147918|NCT02346578|Flutamide|flutamide|mesh-list
102147919|NCT02346578|Androgen Antagonists|androgen antagonists|mesh-ancestor
102147920|NCT02346578|Hormone Antagonists|hormone antagonists|mesh-ancestor
102147921|NCT02346578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102147922|NCT02346578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147923|NCT02346578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102147924|NCT02346578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102147927|NCT03112382|Retinol palmitate|retinol palmitate|mesh-list
102147928|NCT03112382|Micronutrients|micronutrients|mesh-ancestor
102147929|NCT03112382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147930|NCT03112382|Antioxidants|antioxidants|mesh-ancestor
102147931|NCT03112382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147932|NCT03112382|Protective Agents|protective agents|mesh-ancestor
102147933|NCT03112382|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102147934|NCT03112382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102147935|NCT03399669|Gefitinib|gefitinib|mesh-list
102147936|NCT03399669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102147937|NCT03399669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102147938|NCT03399669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102147939|NCT03399669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147940|NCT03148574|Misoprostol|misoprostol|mesh-list
102147941|NCT03148574|Oxytocin|oxytocin|mesh-list
102147942|NCT03148574|Oxytocics|oxytocics|mesh-ancestor
102147943|NCT03148574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102147944|NCT03148574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147945|NCT03148574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102147946|NCT03148574|Abortifacient Agents|abortifacient agents|mesh-ancestor
102147947|NCT03148574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102147948|NCT03148574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102147949|NCT02343536|Prednisone|prednisone|mesh-list
102147950|NCT02343536|Cyclophosphamide|cyclophosphamide|mesh-list
102147951|NCT02343536|Rituximab|rituximab|mesh-list
102147952|NCT02343536|Vincristine|vincristine|mesh-list
102147953|NCT02343536|Azacitidine|azacitidine|mesh-list
102147954|NCT02343536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102147955|NCT02343536|Immunologic Factors|immunologic factors|mesh-ancestor
102147956|NCT02343536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147957|NCT02343536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102147958|NCT02343536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102147959|NCT02343536|Alkylating Agents|alkylating agents|mesh-ancestor
102147960|NCT02343536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147961|NCT02343536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102147962|NCT02343536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102147963|NCT02343536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102147964|NCT02343536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102147965|NCT02343536|Glucocorticoids|glucocorticoids|mesh-ancestor
102147966|NCT02343536|Hormones|hormones|mesh-ancestor
102147967|NCT02343536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102147968|NCT02343536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102147969|NCT02343536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102147970|NCT02343536|Tubulin Modulators|tubulin modulators|mesh-ancestor
102147971|NCT02343536|Antimitotic Agents|antimitotic agents|mesh-ancestor
102147972|NCT02343536|Mitosis Modulators|mitosis modulators|mesh-ancestor
102147973|NCT02343536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102147974|NCT02343536|Antimetabolites|antimetabolites|mesh-ancestor
102147975|NCT02343536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102147976|NCT02343614|Celecoxib|celecoxib|mesh-list
102147977|NCT02343614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102147978|NCT02343614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102147979|NCT02343614|Analgesics|analgesics|mesh-ancestor
102147980|NCT02343614|Sensory System Agents|sensory system agents|mesh-ancestor
102147981|NCT02343614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102147982|NCT02343614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102147983|NCT02343614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102147984|NCT02343614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102147985|NCT02343614|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102147986|NCT02343614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102147987|NCT02343614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102147988|NCT02343614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147989|NCT02871635|Adalimumab|adalimumab|mesh-list
102147990|NCT02871635|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102147991|NCT02871635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102147992|NCT02871635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102147993|NCT03390465|Amlodipine|amlodipine|mesh-list
102147994|NCT03390465|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102147995|NCT03390465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102147996|NCT03390465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102147997|NCT03390465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102147998|NCT03390465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102147999|NCT03390465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102148000|NCT03390465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148001|NCT03390465|Vasodilator Agents|vasodilator agents|mesh-ancestor
102148003|NCT03390465|Natriuretic Agents|natriuretic agents|mesh-ancestor
102148004|NCT03390465|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102148005|NCT03390387|Dexamethasone|dexamethasone|mesh-list
102148006|NCT03390387|Dexamethasone acetate|dexamethasone acetate|mesh-list
102148007|NCT03390387|Methylprednisolone|methylprednisolone|mesh-list
102148008|NCT03390387|Bortezomib|bortezomib|mesh-list
102148009|NCT03390387|Daunorubicin|daunorubicin|mesh-list
102148010|NCT03390387|Idarubicin|idarubicin|mesh-list
102148011|NCT03390387|BB 1101|bb 1101|mesh-list
102148012|NCT03390387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102148013|NCT03390387|Antiemetics|antiemetics|mesh-ancestor
102148014|NCT03390387|Autonomic Agents|autonomic agents|mesh-ancestor
102148015|NCT03390387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102148016|NCT03390387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148017|NCT03390387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102148018|NCT03390387|Glucocorticoids|glucocorticoids|mesh-ancestor
102148019|NCT03390387|Hormones|hormones|mesh-ancestor
102148020|NCT03390387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102148021|NCT03390387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102148022|NCT03390387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102148023|NCT03390387|Protease Inhibitors|protease inhibitors|mesh-ancestor
102148024|NCT03390387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102148025|NCT03390387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148026|NCT03390387|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102148027|NCT03390387|Protective Agents|protective agents|mesh-ancestor
102148028|NCT03390387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102148029|NCT03390387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102148030|NCT03390387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102148031|NCT03146000|Meloxicam|meloxicam|mesh-list
102148032|NCT03146000|Lidocaine|lidocaine|mesh-list
102148033|NCT03146000|Prilocaine|prilocaine|mesh-list
102148034|NCT03146000|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
102148035|NCT03146000|Anesthetics, Local|anesthetics, local|mesh-ancestor
102148036|NCT03146000|Anesthetics|anesthetics|mesh-ancestor
102148037|NCT03146000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102148038|NCT03146000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148039|NCT03146000|Sensory System Agents|sensory system agents|mesh-ancestor
102148040|NCT03146000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102148041|NCT03146000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102148042|NCT03146000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102148043|NCT03146000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102148044|NCT03146000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102148045|NCT03146000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148046|NCT03146000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102148047|NCT03146000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102148048|NCT03146000|Analgesics|analgesics|mesh-ancestor
102148049|NCT03146000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102148050|NCT03146000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102148051|NCT03146000|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102148052|NCT03146000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102148053|NCT03146000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102148054|NCT03146000|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
102148055|NCT02346188|Ferrous fumarate|ferrous fumarate|mesh-list
102148056|NCT02346188|Zinc Oxide|zinc oxide|mesh-list
102148057|NCT02346188|Trace Elements|trace elements|mesh-ancestor
102148058|NCT02346188|Micronutrients|micronutrients|mesh-ancestor
102148059|NCT02346188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148060|NCT02346188|Dermatologic Agents|dermatologic agents|mesh-ancestor
102148061|NCT02346188|Sunscreening Agents|sunscreening agents|mesh-ancestor
102148062|NCT02346188|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101749815|NCT00709436|Anesthetics|anesthetics|mesh-ancestor
102148063|NCT02346188|Protective Agents|protective agents|mesh-ancestor
102148064|NCT02477332|Omalizumab|omalizumab|mesh-list
102148065|NCT02477332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102148066|NCT02477332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102148067|NCT02477332|Respiratory System Agents|respiratory system agents|mesh-ancestor
102148068|NCT02346110|Dexamethasone|dexamethasone|mesh-list
102148069|NCT02346110|Epinephrine|epinephrine|mesh-list
101856950|NCT01010243|Antiemetics|antiemetics|mesh-ancestor
102148070|NCT02346110|Racepinephrine|racepinephrine|mesh-list
102148071|NCT02346110|Bupivacaine|bupivacaine|mesh-list
102148073|NCT02346110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102148074|NCT02346110|Antiemetics|antiemetics|mesh-ancestor
102148075|NCT02346110|Autonomic Agents|autonomic agents|mesh-ancestor
102148076|NCT02346110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102148077|NCT02346110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148078|NCT02346110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102148079|NCT02346110|Glucocorticoids|glucocorticoids|mesh-ancestor
102148080|NCT02346110|Hormones|hormones|mesh-ancestor
102148081|NCT02346110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102148082|NCT02346110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102148083|NCT02346110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102148084|NCT02346110|Anesthetics, Local|anesthetics, local|mesh-ancestor
102148085|NCT02346110|Anesthetics|anesthetics|mesh-ancestor
102148086|NCT02346110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102148087|NCT02346110|Sensory System Agents|sensory system agents|mesh-ancestor
102148088|NCT02346110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102148089|NCT02346110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102148090|NCT02346110|Adrenergic Agents|adrenergic agents|mesh-ancestor
102148091|NCT02346110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102148092|NCT02346110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148093|NCT02346110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102148094|NCT02346110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102148095|NCT02346110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102148096|NCT02346110|Respiratory System Agents|respiratory system agents|mesh-ancestor
102148097|NCT02346110|Mydriatics|mydriatics|mesh-ancestor
102148098|NCT02346110|Sympathomimetics|sympathomimetics|mesh-ancestor
102148099|NCT02346110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102148100|NCT02348528|Dexamethasone|dexamethasone|mesh-list
102148101|NCT02348528|Lenalidomide|lenalidomide|mesh-list
102148102|NCT02348528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102148103|NCT02348528|Antiemetics|antiemetics|mesh-ancestor
102148104|NCT02348528|Autonomic Agents|autonomic agents|mesh-ancestor
102148105|NCT02348528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102148106|NCT02348528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148107|NCT02348528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102148108|NCT02348528|Glucocorticoids|glucocorticoids|mesh-ancestor
102148109|NCT02348528|Hormones|hormones|mesh-ancestor
102148110|NCT02348528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102148111|NCT02348528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102148112|NCT02348528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102148113|NCT02348528|Immunologic Factors|immunologic factors|mesh-ancestor
102148114|NCT02348528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101749890|NCT00716846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102148115|NCT02348528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102148116|NCT02348528|Growth Substances|growth substances|mesh-ancestor
102148117|NCT02348528|Growth Inhibitors|growth inhibitors|mesh-ancestor
102148118|NCT02342600|Trametinib|trametinib|mesh-list
102148119|NCT02342600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102148120|NCT02342600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102148121|NCT02342600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102148122|NCT02342600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148123|NCT03147638|Warfarin|warfarin|mesh-list
102148124|NCT03147638|Anticoagulants|anticoagulants|mesh-ancestor
102148125|NCT02342366|Sodium Oxybate|sodium oxybate|mesh-list
102148126|NCT02342366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102148127|NCT02342366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102148128|NCT02342366|Anesthetics, General|anesthetics, general|mesh-ancestor
102148129|NCT02342366|Anesthetics|anesthetics|mesh-ancestor
102148130|NCT02342366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102148131|NCT02342366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148132|NCT02862535|Oxaliplatin|oxaliplatin|mesh-list
102148133|NCT02862535|Nivolumab|nivolumab|mesh-list
102148134|NCT02862535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102148135|NCT02862535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102148136|NCT02862535|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102148137|NCT02862535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148138|NCT02033707|Scopolamine|scopolamine|mesh-list
102148139|NCT02033707|Hallucinogens|hallucinogens|mesh-list
102148140|NCT02033707|Nicotine|nicotine|mesh-list
102148141|NCT02033707|Histamine Antagonists|histamine antagonists|mesh-list
102148142|NCT02033707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102148143|NCT02033707|Autonomic Agents|autonomic agents|mesh-ancestor
102148144|NCT02033707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102148145|NCT02033707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148146|NCT02033707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102148147|NCT02033707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102148148|NCT02033707|Cholinergic Agents|cholinergic agents|mesh-ancestor
102148149|NCT02033707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102148150|NCT02033707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148151|NCT02033707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102148152|NCT02033707|Antiemetics|antiemetics|mesh-ancestor
102148153|NCT02033707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102148154|NCT02033707|Mydriatics|mydriatics|mesh-ancestor
102148155|NCT02033707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102148156|NCT02033707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102148157|NCT02033707|Histamine Agents|histamine agents|mesh-ancestor
102148158|NCT02033707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102148159|NCT02039336|Docetaxel|docetaxel|mesh-list
102148160|NCT02039336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102148161|NCT02039336|Tubulin Modulators|tubulin modulators|mesh-ancestor
102148162|NCT02039336|Antimitotic Agents|antimitotic agents|mesh-ancestor
102148163|NCT02039336|Mitosis Modulators|mitosis modulators|mesh-ancestor
102148164|NCT02039336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148165|NCT04935476|Dapsone|dapsone|mesh-list
102148166|NCT04935476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102148167|NCT04935476|Antimalarials|antimalarials|mesh-ancestor
102148168|NCT04935476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102148169|NCT04935476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102148170|NCT04935476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102148171|NCT04935476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102148172|NCT04935476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148173|NCT04935476|Leprostatic Agents|leprostatic agents|mesh-ancestor
102148174|NCT04935476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102148175|NCT02476006|Atorvastatin|atorvastatin|mesh-list
102148176|NCT02476006|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102148177|NCT02476006|Simvastatin|simvastatin|mesh-list
102148178|NCT02476006|Ezetimibe|ezetimibe|mesh-list
102148179|NCT02476006|Alirocumab|alirocumab|mesh-list
102148180|NCT02476006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102148181|NCT02476006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102148182|NCT02476006|Antimetabolites|antimetabolites|mesh-ancestor
102148183|NCT02476006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148184|NCT02476006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102148185|NCT02476006|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102148186|NCT02476006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102148187|NCT02476006|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102148188|NCT02476006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102148189|NCT02476006|Protease Inhibitors|protease inhibitors|mesh-ancestor
102148190|NCT02344940|Tamoxifen|tamoxifen|mesh-list
102148191|NCT02344940|Toremifene|toremifene|mesh-list
102148192|NCT02344940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102148193|NCT02344940|Hormone Antagonists|hormone antagonists|mesh-ancestor
102148194|NCT02344940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102148195|NCT02344940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148196|NCT02344940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102148197|NCT02344940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102148198|NCT02344940|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102148199|NCT02344940|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102148200|NCT02344940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102148201|NCT03615677|Esomeprazole|esomeprazole|mesh-list
102148202|NCT03615677|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102148203|NCT03615677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102148204|NCT03615677|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102148205|NCT03615677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102148206|NCT03615677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148207|NCT02344862|Dotinurad|dotinurad|mesh-list
102148208|NCT02344862|Uricosuric Agents|uricosuric agents|mesh-ancestor
102148209|NCT02344862|Gout Suppressants|gout suppressants|mesh-ancestor
102148210|NCT02344862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102148211|NCT03614429|Chlorhexidine|chlorhexidine|mesh-list
102148212|NCT03614429|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102148213|NCT03614429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102148214|NCT03614429|Disinfectants|disinfectants|mesh-ancestor
102148215|NCT03614273|Epinephrine|epinephrine|mesh-list
102148216|NCT03614273|Racepinephrine|racepinephrine|mesh-list
102148217|NCT03614273|Epinephryl borate|epinephryl borate|mesh-list
102148218|NCT03614273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102148219|NCT03614273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102148220|NCT03614273|Adrenergic Agents|adrenergic agents|mesh-ancestor
102148221|NCT03614273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102148222|NCT03614273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148223|NCT03614273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148224|NCT03614273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102148225|NCT03614273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102148226|NCT03614273|Autonomic Agents|autonomic agents|mesh-ancestor
102148227|NCT03614273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102148228|NCT03614273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102148229|NCT03614273|Respiratory System Agents|respiratory system agents|mesh-ancestor
102148230|NCT03614273|Mydriatics|mydriatics|mesh-ancestor
102148231|NCT03614273|Sympathomimetics|sympathomimetics|mesh-ancestor
102148232|NCT03614273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102148233|NCT02336984|Trastuzumab|trastuzumab|mesh-list
102148234|NCT02336984|Pertuzumab|pertuzumab|mesh-list
102148235|NCT02336984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102148236|NCT02336984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102148237|NCT03145610|Triclosan|triclosan|mesh-list
102148238|NCT03145610|Fluorides|fluorides|mesh-list
102148239|NCT03145610|Cariostatic Agents|cariostatic agents|mesh-ancestor
102148240|NCT03145610|Protective Agents|protective agents|mesh-ancestor
102148241|NCT03145610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148242|NCT03145610|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102148243|NCT03145610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102148244|NCT03145610|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102148245|NCT03145610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102148246|NCT03145610|Antimetabolites|antimetabolites|mesh-ancestor
102148247|NCT03145610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148248|NCT03145610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102148249|NCT02341586|Iron|iron|mesh-list
102148250|NCT02341586|Trace Elements|trace elements|mesh-ancestor
102148251|NCT02341586|Micronutrients|micronutrients|mesh-ancestor
102148252|NCT02341586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148253|NCT02336906|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
102148254|NCT02336906|Laxatives|laxatives|mesh-ancestor
102148255|NCT02336906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102148256|NCT03613961|Anesthetics|anesthetics|mesh-list
102148257|NCT03613961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102148258|NCT03613961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148259|NCT02341352|Fluorides|fluorides|mesh-list
102148260|NCT02341352|Fluorides, Topical|fluorides, topical|mesh-list
102148261|NCT02341352|Immunoglobulins|immunoglobulins|mesh-list
102148262|NCT02341352|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102148263|NCT02341352|Antibodies|antibodies|mesh-list
102148264|NCT02341352|Cariostatic Agents|cariostatic agents|mesh-ancestor
102148265|NCT02341352|Protective Agents|protective agents|mesh-ancestor
102148266|NCT02341352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148267|NCT02341352|Immunologic Factors|immunologic factors|mesh-ancestor
102148268|NCT02344550|Everolimus|everolimus|mesh-list
102148269|NCT02344550|Letrozole|letrozole|mesh-list
102148270|NCT02344550|Leuprolide|leuprolide|mesh-list
102148271|NCT02344550|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102148272|NCT02344550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102148273|NCT02344550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102148274|NCT02344550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148275|NCT02344550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102148276|NCT02344550|Immunologic Factors|immunologic factors|mesh-ancestor
102148277|NCT02344550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148278|NCT02344550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102148279|NCT02344550|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102148280|NCT02344550|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102148281|NCT02344550|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102148282|NCT02344550|Hormone Antagonists|hormone antagonists|mesh-ancestor
102148283|NCT02344550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102148284|NCT02344550|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102148285|NCT02344550|Fertility Agents|fertility agents|mesh-ancestor
102148286|NCT02344550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102148287|NCT02344550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102148288|NCT02419612|Dapagliflozin|dapagliflozin|mesh-list
102148289|NCT02419612|Glimepiride|glimepiride|mesh-list
102148290|NCT02419612|Saxagliptin|saxagliptin|mesh-list
102148291|NCT02419612|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102148292|NCT02419612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148293|NCT02419612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102148294|NCT02419612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148295|NCT02419612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102148296|NCT02419612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102148297|NCT02419612|Immunologic Factors|immunologic factors|mesh-ancestor
102148298|NCT02419612|Incretins|incretins|mesh-ancestor
102535911|NCT00553319|Amphetamine|amphetamine|mesh-list
102148299|NCT02419612|Hormones|hormones|mesh-ancestor
102148300|NCT02419612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102535912|NCT00553319|Adderall|adderall|mesh-list
102148301|NCT02419612|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102148303|NCT02419612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102148304|NCT03612947|Magnesium Sulfate|magnesium sulfate|mesh-list
102148305|NCT03612947|Bupivacaine|bupivacaine|mesh-list
102148306|NCT03612947|Anesthetics, Local|anesthetics, local|mesh-ancestor
102148307|NCT03612947|Anesthetics|anesthetics|mesh-ancestor
102148308|NCT03612947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102148309|NCT03612947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148310|NCT03612947|Sensory System Agents|sensory system agents|mesh-ancestor
102148311|NCT03612947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102148312|NCT03612947|Analgesics|analgesics|mesh-ancestor
102148313|NCT03612947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102148314|NCT03612947|Anticonvulsants|anticonvulsants|mesh-ancestor
102148315|NCT03612947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102148316|NCT03612947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102148317|NCT03612947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148318|NCT03612947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102148319|NCT03612947|Tocolytic Agents|tocolytic agents|mesh-ancestor
102148320|NCT03612947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102148321|NCT02344784|Methylphenidate|methylphenidate|mesh-list
102148322|NCT02344784|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102148323|NCT02344784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148324|NCT02344784|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102148325|NCT02344784|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102148326|NCT02344784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102148327|NCT02344784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148328|NCT02344784|Dopamine Agents|dopamine agents|mesh-ancestor
102148329|NCT02344784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102148330|NCT02447848|Sufentanil|sufentanil|mesh-list
102148331|NCT02447848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102148332|NCT02447848|Narcotics|narcotics|mesh-ancestor
102148333|NCT02447848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102148334|NCT02447848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148335|NCT02447848|Analgesics|analgesics|mesh-ancestor
102148336|NCT02447848|Sensory System Agents|sensory system agents|mesh-ancestor
102148337|NCT02447848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102148338|NCT02447848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102148339|NCT02447848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102148340|NCT02447848|Anesthetics, General|anesthetics, general|mesh-ancestor
102148341|NCT02447848|Anesthetics|anesthetics|mesh-ancestor
102148342|NCT02336516|Azithromycin|azithromycin|mesh-list
102148343|NCT02336516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102148344|NCT02336516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102148345|NCT05254652|Pregabalin|pregabalin|mesh-list
102148346|NCT05254652|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102148347|NCT05254652|Analgesics|analgesics|mesh-ancestor
102148348|NCT05254652|Sensory System Agents|sensory system agents|mesh-ancestor
102148349|NCT05254652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102148350|NCT05254652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148351|NCT05254652|Anticonvulsants|anticonvulsants|mesh-ancestor
102148352|NCT05254652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102148353|NCT05254652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102148354|NCT05254652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148355|NCT05254652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102148356|NCT05254652|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102148357|NCT05254652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102148358|NCT05254652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102148359|NCT05254652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102148360|NCT05254652|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102148361|NCT05254652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102148362|NCT05254652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102148363|NCT05254652|Antidepressive Agents|antidepressive agents|mesh-ancestor
102148364|NCT05254652|Dopamine Agents|dopamine agents|mesh-ancestor
102148365|NCT02343926|Metformin|metformin|mesh-list
102148366|NCT02343926|Vildagliptin|vildagliptin|mesh-list
102148367|NCT02343926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102148368|NCT02343926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148369|NCT02343926|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102148370|NCT02343926|Protease Inhibitors|protease inhibitors|mesh-ancestor
102148371|NCT02343926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102148372|NCT02343926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148373|NCT03112226|Estradiol|estradiol|mesh-list
101857248|NCT00381680|Micronutrients|micronutrients|mesh-ancestor
102148374|NCT03112226|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
102535913|NCT00553319|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102148375|NCT03112226|Estrogens|estrogens|mesh-ancestor
102148376|NCT03112226|Hormones|hormones|mesh-ancestor
102148377|NCT03112226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102148378|NCT03112226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148379|NCT03112226|Hormone Antagonists|hormone antagonists|mesh-ancestor
102148380|NCT02343692|Pancrelipase|pancrelipase|mesh-list
102148381|NCT02343692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102148382|NCT02332616|Methylprednisolone|methylprednisolone|mesh-list
102148383|NCT02332616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102148384|NCT02332616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102148385|NCT02332616|Prednisolone|prednisolone|mesh-list
102148386|NCT02332616|Prednisolone acetate|prednisolone acetate|mesh-list
102148387|NCT02332616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102148388|NCT02332616|Prednisolone phosphate|prednisolone phosphate|mesh-list
102148389|NCT02332616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102148390|NCT02332616|Antiemetics|antiemetics|mesh-ancestor
102148391|NCT02332616|Autonomic Agents|autonomic agents|mesh-ancestor
102148392|NCT02332616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102148393|NCT02332616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148394|NCT02332616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102148395|NCT02332616|Glucocorticoids|glucocorticoids|mesh-ancestor
102148396|NCT02332616|Hormones|hormones|mesh-ancestor
102148397|NCT02332616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102148398|NCT02332616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102148399|NCT02332616|Protective Agents|protective agents|mesh-ancestor
102148400|NCT02332616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102148401|NCT02332616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102148402|NCT03345173|Ketamine|ketamine|mesh-list
102148403|NCT03345173|Analgesics|analgesics|mesh-ancestor
102148404|NCT03345173|Sensory System Agents|sensory system agents|mesh-ancestor
102148405|NCT03345173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102148406|NCT03345173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148407|NCT03345173|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102148408|NCT03345173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102148409|NCT03345173|Anesthetics, General|anesthetics, general|mesh-ancestor
102148410|NCT03345173|Anesthetics|anesthetics|mesh-ancestor
102148411|NCT03345173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102148412|NCT03345173|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102148413|NCT03345173|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102148414|NCT03345173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102148415|NCT03345173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148416|NCT03618173|Dexamethasone|dexamethasone|mesh-list
102148417|NCT03618173|Dexamethasone acetate|dexamethasone acetate|mesh-list
102148418|NCT03618173|BB 1101|bb 1101|mesh-list
102148419|NCT03618173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102148420|NCT03618173|Antiemetics|antiemetics|mesh-ancestor
102148421|NCT03618173|Autonomic Agents|autonomic agents|mesh-ancestor
102148422|NCT03618173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102148423|NCT03618173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148424|NCT03618173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102148425|NCT03618173|Glucocorticoids|glucocorticoids|mesh-ancestor
102148426|NCT03618173|Hormones|hormones|mesh-ancestor
102148427|NCT03618173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102148428|NCT03618173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102148429|NCT03618173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102148430|NCT03618173|Protease Inhibitors|protease inhibitors|mesh-ancestor
102148431|NCT03618173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102148432|NCT03618173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148433|NCT02336048|Obinutuzumab|obinutuzumab|mesh-list
102148434|NCT02336048|Chlorambucil|chlorambucil|mesh-list
102148435|NCT02336048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102148436|NCT02336048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102148437|NCT02336048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102148438|NCT02336048|Alkylating Agents|alkylating agents|mesh-ancestor
102148439|NCT02336048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148440|NCT03612401|Mirabegron|mirabegron|mesh-list
102148441|NCT03612401|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102148442|NCT03612401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102148443|NCT03612401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102148444|NCT03612401|Adrenergic Agents|adrenergic agents|mesh-ancestor
102148445|NCT03612401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102148446|NCT03612401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148447|NCT03612401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148448|NCT03612401|Urological Agents|urological agents|mesh-ancestor
102148450|NCT03612323|Carticaine|carticaine|mesh-list
102148451|NCT03612323|Anesthetics, Local|anesthetics, local|mesh-ancestor
102148452|NCT03612323|Anesthetics|anesthetics|mesh-ancestor
102148453|NCT03612323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102148454|NCT03612323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148455|NCT03612323|Sensory System Agents|sensory system agents|mesh-ancestor
102148456|NCT03612323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102148457|NCT03612323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102148458|NCT03612323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102148459|NCT03612323|Analgesics|analgesics|mesh-ancestor
102148460|NCT03612323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102148461|NCT03612323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102148462|NCT03612323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102148463|NCT03612323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102148464|NCT03612323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148465|NCT02994719|Amantadine|amantadine|mesh-list
102148466|NCT02994719|Levodopa|levodopa|mesh-list
102148467|NCT02994719|Carbidopa|carbidopa|mesh-list
102148468|NCT02994719|Pramipexole|pramipexole|mesh-list
102148469|NCT02994719|Ropinirole|ropinirole|mesh-list
102148470|NCT02994719|Entacapone|entacapone|mesh-list
102148471|NCT02994719|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102148472|NCT02994719|Tolcapone|tolcapone|mesh-list
102148473|NCT02994719|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102148474|NCT02994719|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102148475|NCT02994719|Dopamine Agents|dopamine agents|mesh-ancestor
102148476|NCT02994719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102148477|NCT02994719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148478|NCT02994719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148479|NCT02994719|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102148480|NCT02994719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102148481|NCT02994719|Antioxidants|antioxidants|mesh-ancestor
102148482|NCT02994719|Protective Agents|protective agents|mesh-ancestor
102148483|NCT02994719|Dopamine Agonists|dopamine agonists|mesh-ancestor
102148484|NCT02994719|Antiviral Agents|antiviral agents|mesh-ancestor
102148485|NCT02994719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102148486|NCT02994719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102148487|NCT02994719|Analgesics|analgesics|mesh-ancestor
102148488|NCT02994719|Sensory System Agents|sensory system agents|mesh-ancestor
102148489|NCT02994719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102148490|NCT02994719|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102148491|NCT02994719|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102148492|NCT02994719|Immunologic Factors|immunologic factors|mesh-ancestor
102148493|NCT04356638|Midazolam|midazolam|mesh-list
102148494|NCT04356638|Dexmedetomidine|dexmedetomidine|mesh-list
102148495|NCT04356638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102148496|NCT04356638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102148497|NCT04356638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148498|NCT04356638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102148499|NCT04356638|Analgesics|analgesics|mesh-ancestor
102148500|NCT04356638|Sensory System Agents|sensory system agents|mesh-ancestor
102148501|NCT04356638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102148502|NCT04356638|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102148503|NCT04356638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102148504|NCT04356638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102148505|NCT04356638|Adrenergic Agents|adrenergic agents|mesh-ancestor
102148506|NCT04356638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102148507|NCT04356638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148508|NCT04356638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102148509|NCT04356638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102148510|NCT04356638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102148511|NCT04356638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102148512|NCT04356638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102148513|NCT04356638|Anesthetics, General|anesthetics, general|mesh-ancestor
102148514|NCT04356638|Anesthetics|anesthetics|mesh-ancestor
102148515|NCT04356638|GABA Modulators|gaba modulators|mesh-ancestor
102148516|NCT04356638|GABA Agents|gaba agents|mesh-ancestor
102148517|NCT04346108|Immunoglobulins|immunoglobulins|mesh-list
102148518|NCT04346108|Antibodies|antibodies|mesh-list
102148519|NCT04346108|gamma-Globulins|gamma-globulins|mesh-list
102148520|NCT04346108|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102148521|NCT04346108|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102148522|NCT04346108|Immunoglobulin G|immunoglobulin g|mesh-list
102148523|NCT04346108|Immunologic Factors|immunologic factors|mesh-ancestor
102148524|NCT04346108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148525|NCT02335736|Cetrorelix|cetrorelix|mesh-list
102148526|NCT02335736|Hormones|hormones|mesh-list
102148527|NCT02335736|Hormone Antagonists|hormone antagonists|mesh-list
102148528|NCT02335736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102148529|NCT02335736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148530|NCT02335736|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102148531|NCT02335736|Fertility Agents|fertility agents|mesh-ancestor
102148532|NCT02335736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102148533|NCT03613259|Alovudine|alovudine|mesh-list
102148534|NCT03613259|Antiviral Agents|antiviral agents|mesh-ancestor
102148535|NCT03613259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102148536|NCT02032355|Anesthetics|anesthetics|mesh-list
102148537|NCT02032355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102148538|NCT02032355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148539|NCT03095456|Tiotropium Bromide|tiotropium bromide|mesh-list
102148540|NCT03095456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102148541|NCT03095456|Autonomic Agents|autonomic agents|mesh-ancestor
102148542|NCT03095456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102148543|NCT03095456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148544|NCT03095456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102148545|NCT03095456|Respiratory System Agents|respiratory system agents|mesh-ancestor
102148546|NCT03095456|Parasympatholytics|parasympatholytics|mesh-ancestor
102148547|NCT03095456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102148548|NCT03095456|Cholinergic Agents|cholinergic agents|mesh-ancestor
102148549|NCT03095456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102148550|NCT03095456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148551|NCT03612557|Penicillins|penicillins|mesh-list
102148552|NCT03612557|Penicillin G|penicillin g|mesh-list
102148553|NCT03612557|Penicillin G Benzathine|penicillin g benzathine|mesh-list
102148554|NCT03612557|Penicillin G Procaine|penicillin g procaine|mesh-list
102148555|NCT03612557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101750300|NCT01033279|Warfarin|warfarin|mesh-list
102148556|NCT03612557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102148557|NCT03067844|Alirocumab|alirocumab|mesh-list
102148558|NCT03067844|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102148559|NCT03067844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102148560|NCT03067844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102148561|NCT03067844|Antimetabolites|antimetabolites|mesh-ancestor
102148562|NCT03067844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148563|NCT03067844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102148564|NCT03067844|Protease Inhibitors|protease inhibitors|mesh-ancestor
102148565|NCT03067844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102148566|NCT03067844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102148567|NCT02340182|Metronidazole|metronidazole|mesh-list
102148568|NCT02340182|Vancomycin|vancomycin|mesh-list
102148569|NCT02340182|Ciprofloxacin|ciprofloxacin|mesh-list
102148570|NCT02340182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102148571|NCT02340182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102148572|NCT02340182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102148573|NCT02340182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102148574|NCT02340182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102148575|NCT02340182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102148576|NCT02340182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102148577|NCT02340182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148578|NCT02340182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102148579|NCT02340182|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102148580|NCT02340182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102148581|NCT02339714|Loratadine|loratadine|mesh-list
102148582|NCT02339714|Antipruritics|antipruritics|mesh-ancestor
102148583|NCT02339714|Dermatologic Agents|dermatologic agents|mesh-ancestor
102148584|NCT02339714|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102148585|NCT02339714|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102148586|NCT02339714|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102148587|NCT02339714|Histamine Antagonists|histamine antagonists|mesh-ancestor
102148588|NCT02339714|Histamine Agents|histamine agents|mesh-ancestor
102148589|NCT02339714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102148590|NCT02339714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148591|NCT02339714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148592|NCT02335190|Lidocaine|lidocaine|mesh-list
102148593|NCT02335190|Anesthetics, Local|anesthetics, local|mesh-ancestor
102148594|NCT02335190|Anesthetics|anesthetics|mesh-ancestor
102148595|NCT02335190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102148596|NCT02335190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091106|NCT05742438|Analgesics|analgesics|mesh-ancestor
102148597|NCT02335190|Sensory System Agents|sensory system agents|mesh-ancestor
101857483|NCT00160563|Levocetirizine|levocetirizine|mesh-list
102148598|NCT02335190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102148599|NCT02335190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102148600|NCT02335190|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102148601|NCT02335190|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102148602|NCT02335190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102148603|NCT02335190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148604|NCT02339324|Interferons|interferons|mesh-list
102148605|NCT02339324|Interferon-alpha|interferon-alpha|mesh-list
102148606|NCT02339324|Interferon alpha-2|interferon alpha-2|mesh-list
102148607|NCT02339324|Pembrolizumab|pembrolizumab|mesh-list
102148608|NCT02339324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102148609|NCT02339324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102148610|NCT02339324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102148611|NCT02339324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148612|NCT02339324|Antiviral Agents|antiviral agents|mesh-ancestor
102148613|NCT02339324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102148614|NCT02339324|Immunologic Factors|immunologic factors|mesh-ancestor
102148615|NCT02339324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148616|NCT02418754|Aflibercept|aflibercept|mesh-list
102148617|NCT02418754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102148618|NCT02418754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102148619|NCT02418754|Growth Substances|growth substances|mesh-ancestor
102148620|NCT02418754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148621|NCT02418754|Growth Inhibitors|growth inhibitors|mesh-ancestor
102148622|NCT02418754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102148623|NCT02334488|Mycophenolic Acid|mycophenolic acid|mesh-list
102148624|NCT02334488|Everolimus|everolimus|mesh-list
102148625|NCT02334488|Tacrolimus|tacrolimus|mesh-list
102148626|NCT02334488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102148627|NCT02334488|Immunologic Factors|immunologic factors|mesh-ancestor
102148628|NCT02334488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148629|NCT02334488|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102148630|NCT02334488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102148631|NCT02334488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148632|NCT02334488|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102148633|NCT02334488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102148634|NCT02334488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102148635|NCT02334488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102148636|NCT02334488|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102148637|NCT02334488|Antitubercular Agents|antitubercular agents|mesh-ancestor
102148638|NCT02334488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102148639|NCT02334488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102148640|NCT02862457|Paclitaxel|paclitaxel|mesh-list
102148641|NCT02862457|Cisplatin|cisplatin|mesh-list
102148642|NCT02862457|Carboplatin|carboplatin|mesh-list
102148643|NCT02862457|Pembrolizumab|pembrolizumab|mesh-list
102148644|NCT02862457|Pemetrexed|pemetrexed|mesh-list
102148645|NCT02862457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102148646|NCT02862457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102148647|NCT02862457|Tubulin Modulators|tubulin modulators|mesh-ancestor
102148648|NCT02862457|Antimitotic Agents|antimitotic agents|mesh-ancestor
102148649|NCT02862457|Mitosis Modulators|mitosis modulators|mesh-ancestor
102148650|NCT02862457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148651|NCT02862457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102148652|NCT02862457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102148653|NCT02862457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102148654|NCT02862457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102148655|NCT02862457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102148656|NCT02334254|Warfarin|warfarin|mesh-list
102148657|NCT02334254|Rivaroxaban|rivaroxaban|mesh-list
102148658|NCT02334254|Clopidogrel|clopidogrel|mesh-list
102148659|NCT02334254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102148660|NCT02334254|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102148661|NCT02334254|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102148662|NCT02334254|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102148663|NCT02334254|Purinergic Agents|purinergic agents|mesh-ancestor
102148664|NCT02334254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102148665|NCT02334254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148666|NCT02334254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148667|NCT02334254|Anticoagulants|anticoagulants|mesh-ancestor
102148668|NCT02334254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102148669|NCT02334254|Antithrombins|antithrombins|mesh-ancestor
102148670|NCT02334254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102148671|NCT02334254|Protease Inhibitors|protease inhibitors|mesh-ancestor
102148672|NCT02334254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102148673|NCT02331602|Rivaroxaban|rivaroxaban|mesh-list
101857565|NCT01050608|Ethanol|ethanol|mesh-list
102148675|NCT02331602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102148676|NCT02331602|Antithrombins|antithrombins|mesh-ancestor
101263506|NCT01762332|Narcotics|narcotics|mesh-ancestor
102148677|NCT02331602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102148678|NCT02331602|Protease Inhibitors|protease inhibitors|mesh-ancestor
102148679|NCT02331602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102148680|NCT02331602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148681|NCT02331602|Anticoagulants|anticoagulants|mesh-ancestor
102148682|NCT02338934|Vitamin D|vitamin d|mesh-list
102148683|NCT02338934|Cinacalcet|cinacalcet|mesh-list
102148684|NCT02338934|Vitamins|vitamins|mesh-ancestor
102148685|NCT02338934|Micronutrients|micronutrients|mesh-ancestor
102148686|NCT02338934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148687|NCT02338934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102148688|NCT02338934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102148689|NCT02338934|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
102148690|NCT02338934|Hormone Antagonists|hormone antagonists|mesh-ancestor
102148691|NCT02338934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102148692|NCT03861039|Tirzepatide|tirzepatide|mesh-list
102148693|NCT03861039|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102148694|NCT03861039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148695|NCT03861039|Incretins|incretins|mesh-ancestor
102148696|NCT03861039|Hormones|hormones|mesh-ancestor
102148697|NCT03861039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102148698|NCT02334176|Lidocaine|lidocaine|mesh-list
102148699|NCT02334176|Epinephrine|epinephrine|mesh-list
102148700|NCT02334176|Anesthetics, Local|anesthetics, local|mesh-ancestor
102148701|NCT02334176|Anesthetics|anesthetics|mesh-ancestor
102148702|NCT02334176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102148703|NCT02334176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148704|NCT02334176|Sensory System Agents|sensory system agents|mesh-ancestor
102148705|NCT02334176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102148706|NCT02334176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102148707|NCT02334176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102148708|NCT02334176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102148709|NCT02334176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102148710|NCT02334176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148711|NCT02334176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102148712|NCT02334176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102148713|NCT02334176|Adrenergic Agents|adrenergic agents|mesh-ancestor
102148714|NCT02334176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102148715|NCT02334176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102148716|NCT02334176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102148717|NCT02334176|Autonomic Agents|autonomic agents|mesh-ancestor
102148718|NCT02334176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102148719|NCT02334176|Respiratory System Agents|respiratory system agents|mesh-ancestor
102148720|NCT02334176|Mydriatics|mydriatics|mesh-ancestor
102148721|NCT02334176|Sympathomimetics|sympathomimetics|mesh-ancestor
102148722|NCT02334176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102148723|NCT02338856|Beta-lapachone|beta-lapachone|mesh-list
102148724|NCT02338856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102148725|NCT02338856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102148726|NCT02338856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102148727|NCT02338856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102148728|NCT02338856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148729|NCT02338856|Antiviral Agents|antiviral agents|mesh-ancestor
102148730|NCT03609307|Bevacizumab|bevacizumab|mesh-list
102148731|NCT03609307|Propranolol|propranolol|mesh-list
102148732|NCT03609307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102148733|NCT03609307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102148734|NCT03609307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102148735|NCT03609307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102148736|NCT03609307|Growth Substances|growth substances|mesh-ancestor
102148737|NCT03609307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148738|NCT03609307|Growth Inhibitors|growth inhibitors|mesh-ancestor
102148739|NCT03609307|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102148740|NCT03609307|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102148741|NCT03609307|Adrenergic Agents|adrenergic agents|mesh-ancestor
102148742|NCT03609307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102148743|NCT03609307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148744|NCT03609307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102148745|NCT03609307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102148746|NCT03609307|Vasodilator Agents|vasodilator agents|mesh-ancestor
102148747|NCT03399435|Epinephrine|epinephrine|mesh-list
102148748|NCT03399435|Racepinephrine|racepinephrine|mesh-list
102148749|NCT03399435|Bupivacaine|bupivacaine|mesh-list
102148750|NCT03399435|Epinephryl borate|epinephryl borate|mesh-list
102148751|NCT03399435|Neosaxitoxin|neosaxitoxin|mesh-list
102148752|NCT03399435|Anesthetics, Local|anesthetics, local|mesh-ancestor
102148753|NCT03399435|Anesthetics|anesthetics|mesh-ancestor
102148754|NCT03399435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102148755|NCT03399435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148756|NCT03399435|Sensory System Agents|sensory system agents|mesh-ancestor
102148757|NCT03399435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102148758|NCT03399435|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102148759|NCT03399435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102148760|NCT03399435|Adrenergic Agents|adrenergic agents|mesh-ancestor
102148761|NCT03399435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102148762|NCT03399435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148763|NCT03399435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102148764|NCT03399435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102148765|NCT03399435|Autonomic Agents|autonomic agents|mesh-ancestor
102148766|NCT03399435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102148767|NCT03399435|Respiratory System Agents|respiratory system agents|mesh-ancestor
102148768|NCT03399435|Mydriatics|mydriatics|mesh-ancestor
102148769|NCT03399435|Sympathomimetics|sympathomimetics|mesh-ancestor
102148770|NCT03399435|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102148771|NCT03399435|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102148772|NCT03399435|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102148773|NCT01936688|Etanercept|etanercept|mesh-list
102148774|NCT01936688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102148775|NCT01936688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102148776|NCT01936688|Analgesics|analgesics|mesh-ancestor
102148777|NCT01936688|Sensory System Agents|sensory system agents|mesh-ancestor
102148778|NCT01936688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102148779|NCT01936688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148780|NCT01936688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102148781|NCT01936688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102148782|NCT01936688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102148783|NCT01936688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102148784|NCT01936688|Immunologic Factors|immunologic factors|mesh-ancestor
102148785|NCT02338544|Adapalene|adapalene|mesh-list
102148786|NCT02338544|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102148787|NCT02338544|Dermatologic Agents|dermatologic agents|mesh-ancestor
102148788|NCT02338544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102148789|NCT02338544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102148790|NCT02338544|Analgesics|analgesics|mesh-ancestor
102148791|NCT02338544|Sensory System Agents|sensory system agents|mesh-ancestor
102148792|NCT02338544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102148793|NCT02338544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148794|NCT02338544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102148795|NCT02338544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102148796|NCT04446663|Paclitaxel|paclitaxel|mesh-list
102148797|NCT04446663|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102148798|NCT04446663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102148799|NCT04446663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102148800|NCT04446663|Tubulin Modulators|tubulin modulators|mesh-ancestor
102148801|NCT04446663|Antimitotic Agents|antimitotic agents|mesh-ancestor
102148802|NCT04446663|Mitosis Modulators|mitosis modulators|mesh-ancestor
102148803|NCT04446663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148804|NCT01861496|Cisplatin|cisplatin|mesh-list
102148805|NCT01861496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102148806|NCT02520219|Endostar protein|endostar protein|mesh-list
102148807|NCT02520219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102148808|NCT02520219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102148809|NCT02520219|Growth Substances|growth substances|mesh-ancestor
102148810|NCT02520219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148811|NCT02520219|Growth Inhibitors|growth inhibitors|mesh-ancestor
102148812|NCT02520219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102148813|NCT03394287|Apatinib|apatinib|mesh-list
102148814|NCT03394287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102148815|NCT03394287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102148816|NCT03394287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102148817|NCT03394287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148818|NCT02338622|Olaparib|olaparib|mesh-list
102148819|NCT02338622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102148820|NCT02338622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102148821|NCT02338622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857701|NCT01015547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102148822|NCT02338622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102148823|NCT02338466|Tenecteplase|tenecteplase|mesh-list
102148824|NCT02338466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102148825|NCT02338466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102148826|NCT02338466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148827|NCT03394209|Oseltamivir|oseltamivir|mesh-list
102148828|NCT03394209|Favipiravir|favipiravir|mesh-list
102148829|NCT03394209|Antiviral Agents|antiviral agents|mesh-ancestor
102148830|NCT03394209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102148831|NCT03394209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102148832|NCT03394209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148833|NCT03399201|Anesthetics|anesthetics|mesh-list
102148834|NCT03399201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102148835|NCT03399201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148836|NCT02520453|Durvalumab|durvalumab|mesh-list
102148837|NCT02520453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102148838|NCT02520453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102148839|NCT03389763|Remifentanil|remifentanil|mesh-list
102148840|NCT03389763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102148841|NCT03389763|Narcotics|narcotics|mesh-ancestor
102148842|NCT03389763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102148843|NCT03389763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148844|NCT03389763|Analgesics|analgesics|mesh-ancestor
102148845|NCT03389763|Sensory System Agents|sensory system agents|mesh-ancestor
102148846|NCT03389763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102148847|NCT02866175|Vitamin K|vitamin k|mesh-list
102148848|NCT02866175|Edoxaban|edoxaban|mesh-list
102148849|NCT02866175|Clopidogrel|clopidogrel|mesh-list
102148850|NCT02866175|Ticagrelor|ticagrelor|mesh-list
102148851|NCT02866175|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102148852|NCT02866175|Vitamins|vitamins|mesh-ancestor
102148853|NCT02866175|Micronutrients|micronutrients|mesh-ancestor
102148854|NCT02866175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148855|NCT02866175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102148856|NCT02866175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102148857|NCT02866175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102148858|NCT02866175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102148859|NCT02866175|Purinergic Agents|purinergic agents|mesh-ancestor
102148860|NCT02866175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102148861|NCT02866175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148862|NCT02866175|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102148863|NCT02866175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102148864|NCT02866175|Hemostatics|hemostatics|mesh-ancestor
102148865|NCT02866175|Coagulants|coagulants|mesh-ancestor
102148866|NCT02866175|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102148867|NCT02866175|Antithrombins|antithrombins|mesh-ancestor
102148868|NCT02866175|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102148869|NCT02866175|Protease Inhibitors|protease inhibitors|mesh-ancestor
102148870|NCT02866175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102148871|NCT02866175|Anticoagulants|anticoagulants|mesh-ancestor
102148872|NCT02330822|Hyaluronic Acid|hyaluronic acid|mesh-list
102148873|NCT02330822|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102148874|NCT02330822|Immunologic Factors|immunologic factors|mesh-ancestor
102148875|NCT02330822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148876|NCT02330822|Viscosupplements|viscosupplements|mesh-ancestor
102148877|NCT02330822|Protective Agents|protective agents|mesh-ancestor
102148878|NCT02338310|Letrozole|letrozole|mesh-list
102148879|NCT02338310|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102148880|NCT02338310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102148881|NCT02338310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102148882|NCT02338310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102148883|NCT02338310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148884|NCT02338310|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102148885|NCT02338310|Hormone Antagonists|hormone antagonists|mesh-ancestor
102148886|NCT02338310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102148887|NCT02338310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148888|NCT03389607|Anesthetics|anesthetics|mesh-list
102148889|NCT03389607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102148890|NCT03389607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148891|NCT02817789|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
102148892|NCT02817789|Clopidogrel|clopidogrel|mesh-list
102148893|NCT02817789|Ticagrelor|ticagrelor|mesh-list
102148894|NCT02817789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102148895|NCT02817789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102148896|NCT02817789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102148897|NCT02817789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102148898|NCT02817789|Purinergic Agents|purinergic agents|mesh-ancestor
102148899|NCT02817789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102148900|NCT02817789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148901|NCT02817789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148903|NCT02817789|Sensory System Agents|sensory system agents|mesh-ancestor
102148904|NCT02817789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102148905|NCT02817789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102148906|NCT02817789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102148907|NCT02817789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102148908|NCT02817789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102148909|NCT02817789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102148910|NCT02817789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102148911|NCT05383625|Vaccines|vaccines|mesh-list
102148912|NCT05383625|Immunologic Factors|immunologic factors|mesh-ancestor
102148913|NCT05383625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148914|NCT02926859|Cannabidiol|cannabidiol|mesh-list
102148915|NCT02926859|Anticonvulsants|anticonvulsants|mesh-ancestor
102148916|NCT03389451|Edetic Acid|edetic acid|mesh-list
102148917|NCT03389451|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102148918|NCT03389451|Chelating Agents|chelating agents|mesh-ancestor
102148919|NCT03389451|Sequestering Agents|sequestering agents|mesh-ancestor
102148920|NCT03389451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148921|NCT03389451|Anticoagulants|anticoagulants|mesh-ancestor
102148922|NCT03389451|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102148923|NCT03389451|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102148924|NCT03385395|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
102148925|NCT03385395|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102148926|NCT03385395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102148927|NCT03385395|Protease Inhibitors|protease inhibitors|mesh-ancestor
102148928|NCT03385395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102148929|NCT03385395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148930|NCT02330120|Dexmedetomidine|dexmedetomidine|mesh-list
102148931|NCT02330120|Propofol|propofol|mesh-list
102148932|NCT02330120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102148933|NCT02330120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102148934|NCT02330120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148935|NCT02330120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102148936|NCT02330120|Analgesics|analgesics|mesh-ancestor
102148937|NCT02330120|Sensory System Agents|sensory system agents|mesh-ancestor
102148938|NCT02330120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102148939|NCT02330120|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102148940|NCT02330120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102148941|NCT02330120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102148942|NCT02330120|Adrenergic Agents|adrenergic agents|mesh-ancestor
102148943|NCT02330120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102148944|NCT02330120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148945|NCT02330120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102148946|NCT02330120|Anesthetics, General|anesthetics, general|mesh-ancestor
102148947|NCT02330120|Anesthetics|anesthetics|mesh-ancestor
102148948|NCT03389295|Cisplatin|cisplatin|mesh-list
102148949|NCT03389295|Docetaxel|docetaxel|mesh-list
102148950|NCT03389295|Fluorouracil|fluorouracil|mesh-list
102148951|NCT03389295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102148952|NCT03389295|Tubulin Modulators|tubulin modulators|mesh-ancestor
102148953|NCT03389295|Antimitotic Agents|antimitotic agents|mesh-ancestor
102148954|NCT03389295|Mitosis Modulators|mitosis modulators|mesh-ancestor
102148955|NCT03389295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102148956|NCT03389295|Antimetabolites|antimetabolites|mesh-ancestor
102148957|NCT03389295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102148958|NCT03389295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102148959|NCT03389295|Immunologic Factors|immunologic factors|mesh-ancestor
102148960|NCT03389295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148961|NCT03398811|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102148962|NCT03398811|Etonogestrel|etonogestrel|mesh-list
102148963|NCT03398811|Desogestrel|desogestrel|mesh-list
102148964|NCT03398811|Medroxyprogesterone|medroxyprogesterone|mesh-list
102148965|NCT03398811|Progesterone|progesterone|mesh-list
102148966|NCT03398811|Progestins|progestins|mesh-ancestor
102148967|NCT03398811|Hormones|hormones|mesh-ancestor
102148968|NCT03398811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102148969|NCT03398811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148970|NCT03398811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102148971|NCT03398811|Contraceptive Agents|contraceptive agents|mesh-ancestor
102091498|NCT05214287|Nitrox|nitrox|mesh-list
102148973|NCT03398811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102148974|NCT03398811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102148975|NCT03398811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102148976|NCT03398811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102148977|NCT03398811|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102148978|NCT03398811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102148979|NCT03398811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102148980|NCT01300143|Chlorotrianisene|chlorotrianisene|mesh-list
102148981|NCT01300143|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102148982|NCT01300143|Estrogens|estrogens|mesh-ancestor
102148983|NCT01300143|Hormones|hormones|mesh-ancestor
102148984|NCT01300143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102148985|NCT01300143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148986|NCT01300143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102148987|NCT01300143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102148988|NCT01336205|Naloxegol|naloxegol|mesh-list
102148989|NCT01336205|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102148990|NCT01336205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102148991|NCT01336205|Sensory System Agents|sensory system agents|mesh-ancestor
102148992|NCT01336205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102148993|NCT02333240|Antihypertensive Agents|antihypertensive agents|mesh-list
102148994|NCT03610685|Prednisolone|prednisolone|mesh-list
102148995|NCT03610685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102148996|NCT03610685|Glucocorticoids|glucocorticoids|mesh-ancestor
102148997|NCT03610685|Hormones|hormones|mesh-ancestor
102148998|NCT03610685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102148999|NCT03610685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149000|NCT03610685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102149001|NCT03610685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102149002|NCT02327234|Ibuprofen|ibuprofen|mesh-list
102149003|NCT02327234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102149004|NCT02327234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102149005|NCT02327234|Analgesics|analgesics|mesh-ancestor
102149006|NCT02327234|Sensory System Agents|sensory system agents|mesh-ancestor
102149007|NCT02327234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102149008|NCT02327234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149009|NCT02327234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102149010|NCT02327234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102149011|NCT02327234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102149012|NCT02327234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102149013|NCT02327234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149014|NCT01123707|Aripiprazole|aripiprazole|mesh-list
102149015|NCT01123707|Escitalopram|escitalopram|mesh-list
102149016|NCT01123707|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102149017|NCT01123707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102149018|NCT01123707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101750787|NCT05610800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102149019|NCT01123707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149020|NCT01123707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102149021|NCT01123707|Serotonin Agents|serotonin agents|mesh-ancestor
102149022|NCT01123707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149023|NCT01123707|Antidepressive Agents|antidepressive agents|mesh-ancestor
102149024|NCT01123707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102149025|NCT01123707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102149026|NCT01123707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102149027|NCT01123707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102149028|NCT01123707|Dopamine Agonists|dopamine agonists|mesh-ancestor
102149029|NCT01123707|Dopamine Agents|dopamine agents|mesh-ancestor
102149030|NCT01123707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102149031|NCT01123707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102149032|NCT01123707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102149033|NCT01123707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102149034|NCT01123707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102149035|NCT01123707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102149036|NCT01258803|Mometasone Furoate|mometasone furoate|mesh-list
102149037|NCT01258803|Formoterol Fumarate|formoterol fumarate|mesh-list
102149038|NCT01258803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102149039|NCT01258803|Autonomic Agents|autonomic agents|mesh-ancestor
102149040|NCT01258803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102149041|NCT01258803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149042|NCT01258803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102149043|NCT01258803|Respiratory System Agents|respiratory system agents|mesh-ancestor
102149044|NCT01258803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102149045|NCT01258803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102149046|NCT01258803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102149047|NCT01258803|Adrenergic Agents|adrenergic agents|mesh-ancestor
102149048|NCT01258803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102149049|NCT01258803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149050|NCT01258803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102149051|NCT01258803|Dermatologic Agents|dermatologic agents|mesh-ancestor
102149052|NCT01258803|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102149053|NCT02327156|Dexmedetomidine|dexmedetomidine|mesh-list
102149054|NCT02327156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102149055|NCT02327156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102149056|NCT02327156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149057|NCT02327156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102149059|NCT02327156|Sensory System Agents|sensory system agents|mesh-ancestor
102149060|NCT02327156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101750860|NCT05408091|Antibodies|antibodies|mesh-list
102149061|NCT02327156|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102149062|NCT02327156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102149063|NCT02327156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102149064|NCT02327156|Adrenergic Agents|adrenergic agents|mesh-ancestor
102149065|NCT02327156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102149066|NCT02327156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149067|NCT02039804|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102149068|NCT02039804|Hyaluronic Acid|hyaluronic acid|mesh-list
102149069|NCT02039804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102149070|NCT02039804|Immunologic Factors|immunologic factors|mesh-ancestor
102149071|NCT02039804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149072|NCT02039804|Viscosupplements|viscosupplements|mesh-ancestor
102149073|NCT02039804|Protective Agents|protective agents|mesh-ancestor
102149074|NCT02039804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102149075|NCT03385161|Ethanol|ethanol|mesh-list
102149076|NCT03385161|Botulinum Toxins|botulinum toxins|mesh-list
102149077|NCT03385161|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102149078|NCT03385161|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102149079|NCT03385161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102149080|NCT03385161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102149081|NCT03385161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149082|NCT03385161|Cholinergic Agents|cholinergic agents|mesh-ancestor
102149083|NCT03385161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102149084|NCT03385161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149085|NCT03385161|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102149086|NCT03385161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102149087|NCT03385161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102149088|NCT03385161|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102149089|NCT03385161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102149090|NCT02327000|Pregabalin|pregabalin|mesh-list
102149091|NCT02327000|Analgesics|analgesics|mesh-ancestor
102149092|NCT02327000|Sensory System Agents|sensory system agents|mesh-ancestor
102149093|NCT02327000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102149094|NCT02327000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149095|NCT02327000|Anticonvulsants|anticonvulsants|mesh-ancestor
102149096|NCT02327000|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102149097|NCT02327000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102149098|NCT02327000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149099|NCT02327000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102149100|NCT02327000|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102149101|NCT02327000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102149102|NCT02327000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102149103|NCT02327000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102149104|NCT02033603|Ropivacaine|ropivacaine|mesh-list
102149105|NCT02033603|Anesthetics, Local|anesthetics, local|mesh-ancestor
102149106|NCT02033603|Anesthetics|anesthetics|mesh-ancestor
102149107|NCT02033603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102149108|NCT02033603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149109|NCT02033603|Sensory System Agents|sensory system agents|mesh-ancestor
102149110|NCT02033603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102149111|NCT02326922|Levonorgestrel|levonorgestrel|mesh-list
102149112|NCT02326922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102149113|NCT02326922|Contraceptive Agents|contraceptive agents|mesh-ancestor
102149114|NCT02326922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102149115|NCT02326922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091637|NCT05008809|Vitamins|vitamins|mesh-ancestor
102149116|NCT02326922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102149117|NCT02326922|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102149118|NCT02326922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102149120|NCT00862251|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102149121|NCT00862251|Simvastatin|simvastatin|mesh-list
102149122|NCT00862251|Ezetimibe|ezetimibe|mesh-list
102149124|NCT00862251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102149125|NCT00862251|Antimetabolites|antimetabolites|mesh-ancestor
102149126|NCT00862251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149127|NCT00862251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102149128|NCT00862251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102149129|NCT00862251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102149130|NCT00885963|Sapacitabine|sapacitabine|mesh-list
102149131|NCT00885963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102149132|NCT00725127|Aspirin|aspirin|mesh-list
102149133|NCT00725127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102149134|NCT00725127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102149135|NCT00725127|Analgesics|analgesics|mesh-ancestor
102149136|NCT00725127|Sensory System Agents|sensory system agents|mesh-ancestor
102149137|NCT00725127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102149138|NCT00725127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149139|NCT00725127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102149140|NCT00725127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102149141|NCT00725127|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102149142|NCT00725127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102149143|NCT00725127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149144|NCT00725127|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102149145|NCT00725127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102149146|NCT00725127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102149147|NCT00725127|Antipyretics|antipyretics|mesh-ancestor
102149148|NCT02328950|Cytarabine|cytarabine|mesh-list
102149149|NCT02328950|Cyclophosphamide|cyclophosphamide|mesh-list
102149150|NCT02328950|Busulfan|busulfan|mesh-list
102149151|NCT02328950|Fludarabine|fludarabine|mesh-list
102149152|NCT02328950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102149153|NCT02328950|Immunologic Factors|immunologic factors|mesh-ancestor
102149154|NCT02328950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149155|NCT02328950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102149156|NCT02328950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102149157|NCT02328950|Alkylating Agents|alkylating agents|mesh-ancestor
102149158|NCT02328950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149159|NCT02328950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102149160|NCT02328950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102149161|NCT02328950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102149162|NCT02328950|Antimetabolites|antimetabolites|mesh-ancestor
102149163|NCT02328950|Antiviral Agents|antiviral agents|mesh-ancestor
102149164|NCT02328950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102149165|NCT03398577|Dapagliflozin|dapagliflozin|mesh-list
102149166|NCT03398577|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102149167|NCT03398577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149168|NCT03398577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102149169|NCT03398577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149170|NCT03389061|Sofosbuvir|sofosbuvir|mesh-list
102149171|NCT03389061|Velpatasvir|velpatasvir|mesh-list
102149172|NCT03389061|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102149173|NCT03389061|Antiviral Agents|antiviral agents|mesh-ancestor
102149174|NCT03389061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102149175|NCT05078138|Epoetin Alfa|epoetin alfa|mesh-list
102149176|NCT05078138|Hematinics|hematinics|mesh-ancestor
102149177|NCT02038868|Tamsulosin|tamsulosin|mesh-list
102149178|NCT02038868|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102149179|NCT02038868|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102149180|NCT02038868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102149181|NCT02038868|Adrenergic Agents|adrenergic agents|mesh-ancestor
102149182|NCT02038868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102149183|NCT02038868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149184|NCT02038868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149185|NCT02038868|Urological Agents|urological agents|mesh-ancestor
102149186|NCT02328794|Varenicline|varenicline|mesh-list
102149187|NCT02328794|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102149188|NCT02328794|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102149189|NCT02328794|Cholinergic Agents|cholinergic agents|mesh-ancestor
102149190|NCT02328794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102149191|NCT02328794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149192|NCT02328794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149193|NCT03388827|Misoprostol|misoprostol|mesh-list
102149194|NCT03388827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102149195|NCT03388827|Abortifacient Agents|abortifacient agents|mesh-ancestor
102149196|NCT03388827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102149197|NCT03388827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149198|NCT03388827|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102149199|NCT03388827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102149200|NCT03388827|Oxytocics|oxytocics|mesh-ancestor
102149201|NCT02328716|Cisplatin|cisplatin|mesh-list
102149202|NCT02328716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102149203|NCT00445107|Montelukast|montelukast|mesh-list
102149204|NCT00445107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102149205|NCT00445107|Respiratory System Agents|respiratory system agents|mesh-ancestor
102149206|NCT00445107|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102149207|NCT00445107|Hormone Antagonists|hormone antagonists|mesh-ancestor
102149208|NCT00445107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102149209|NCT00445107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149210|NCT00445107|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102149211|NCT00445107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102149212|NCT00445107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149213|NCT05077592|Povidone-Iodine|povidone-iodine|mesh-list
102149214|NCT05077592|Povidone|povidone|mesh-list
102149215|NCT05077592|Plasma Substitutes|plasma substitutes|mesh-ancestor
102149216|NCT05077592|Blood Substitutes|blood substitutes|mesh-ancestor
102149217|NCT05077592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102149218|NCT05077592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102149219|NCT00038727|Metformin|metformin|mesh-list
102149220|NCT00038727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102149221|NCT00038727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149222|NCT02864381|Nivolumab|nivolumab|mesh-list
102149223|NCT02864381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102149224|NCT02864381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102149225|NCT02864381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102149226|NCT02864381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149227|NCT05230472|Simvastatin|simvastatin|mesh-list
102149228|NCT05230472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102149229|NCT05230472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102149230|NCT05230472|Antimetabolites|antimetabolites|mesh-ancestor
102149231|NCT05230472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149232|NCT05230472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102149233|NCT05230472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102149234|NCT05230472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102149235|NCT03398031|Magnesium Oxide|magnesium oxide|mesh-list
102149236|NCT03398031|Antacids|antacids|mesh-ancestor
102149237|NCT03398031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149238|NCT03398031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102149239|NCT02039960|Bupropion|bupropion|mesh-list
102149240|NCT02039960|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102149241|NCT02039960|Antidepressive Agents|antidepressive agents|mesh-ancestor
102149242|NCT02039960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102149243|NCT02039960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102149244|NCT02039960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102149245|NCT02039960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102149246|NCT02039960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149247|NCT02039960|Dopamine Agents|dopamine agents|mesh-ancestor
102149248|NCT02039960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102149249|NCT02039960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149250|NCT02039960|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102149251|NCT02039960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102149252|NCT02039960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102149253|NCT05383313|Midazolam|midazolam|mesh-list
102149254|NCT05383313|Ketamine|ketamine|mesh-list
102149255|NCT05383313|Psilocybin|psilocybin|mesh-list
102149256|NCT05383313|Analgesics|analgesics|mesh-ancestor
102149257|NCT05383313|Sensory System Agents|sensory system agents|mesh-ancestor
102149258|NCT05383313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102149259|NCT05383313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149260|NCT05383313|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102149261|NCT05383313|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102149262|NCT05383313|Anesthetics, General|anesthetics, general|mesh-ancestor
102149263|NCT05383313|Anesthetics|anesthetics|mesh-ancestor
102149264|NCT05383313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102149265|NCT05383313|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102149266|NCT05383313|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102149267|NCT05383313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102149268|NCT05383313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858146|NCT00321906|Antimetabolites|antimetabolites|mesh-ancestor
102149269|NCT05383313|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102149270|NCT05383313|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102149271|NCT05383313|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102149272|NCT05383313|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102149273|NCT05383313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102149274|NCT05383313|GABA Modulators|gaba modulators|mesh-ancestor
102149275|NCT05383313|GABA Agents|gaba agents|mesh-ancestor
102149276|NCT05383313|Hallucinogens|hallucinogens|mesh-ancestor
102149277|NCT02033681|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102149278|NCT03144128|Vitamin D|vitamin d|mesh-list
102149279|NCT03144128|Vitamins|vitamins|mesh-ancestor
102149280|NCT03144128|Micronutrients|micronutrients|mesh-ancestor
102149281|NCT03144128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149282|NCT03144128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102149283|NCT02326610|Hormones|hormones|mesh-list
102149284|NCT02326610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102149285|NCT02326610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149286|NCT00409773|Atorvastatin|atorvastatin|mesh-list
102149287|NCT00409773|Simvastatin|simvastatin|mesh-list
102149288|NCT00409773|Ezetimibe|ezetimibe|mesh-list
102149289|NCT00409773|Calcium|calcium|mesh-list
102149290|NCT00409773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102149291|NCT00409773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149292|NCT00409773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102149293|NCT00409773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101751092|NCT04977830|Xenon|xenon|mesh-list
102149294|NCT00409773|Antimetabolites|antimetabolites|mesh-ancestor
102149295|NCT00409773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149296|NCT00409773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102149297|NCT00409773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102149298|NCT00409773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102149299|NCT02326376|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102149300|NCT02326376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102149301|NCT02034422|Antioxidants|antioxidants|mesh-list
102149302|NCT02034422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149303|NCT02034422|Protective Agents|protective agents|mesh-ancestor
102149304|NCT02034422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149305|NCT02325986|Fluorouracil|fluorouracil|mesh-list
102149306|NCT02325986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102149307|NCT02325986|Antimetabolites|antimetabolites|mesh-ancestor
102149308|NCT02325986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149309|NCT02325986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102149310|NCT02325986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102149311|NCT02325986|Immunologic Factors|immunologic factors|mesh-ancestor
102149312|NCT02325986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149313|NCT00398151|Montelukast|montelukast|mesh-list
102149314|NCT00398151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102149315|NCT00398151|Respiratory System Agents|respiratory system agents|mesh-ancestor
102149316|NCT00398151|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102149317|NCT00398151|Hormone Antagonists|hormone antagonists|mesh-ancestor
102149318|NCT00398151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102149319|NCT00398151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149320|NCT00398151|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102149321|NCT00398151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102149322|NCT00398151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149323|NCT03610139|Vitamin D|vitamin d|mesh-list
102149324|NCT03610139|Cholecalciferol|cholecalciferol|mesh-list
102149325|NCT03610139|Vitamins|vitamins|mesh-ancestor
102149326|NCT03610139|Micronutrients|micronutrients|mesh-ancestor
102149327|NCT03610139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149328|NCT03610139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102149329|NCT03610139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102149330|NCT02327624|Clopidogrel|clopidogrel|mesh-list
102149331|NCT02327624|Ticagrelor|ticagrelor|mesh-list
102149332|NCT02327624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102149333|NCT02327624|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102149334|NCT02327624|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102149335|NCT02327624|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102149336|NCT02327624|Purinergic Agents|purinergic agents|mesh-ancestor
102149337|NCT02327624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102154340|NCT02852005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149338|NCT02327624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149339|NCT02327624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149340|NCT03388671|Bupivacaine|bupivacaine|mesh-list
102149341|NCT03388671|Anesthetics, Local|anesthetics, local|mesh-ancestor
102149342|NCT03388671|Anesthetics|anesthetics|mesh-ancestor
102149343|NCT03388671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102149344|NCT03388671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149345|NCT03388671|Sensory System Agents|sensory system agents|mesh-ancestor
102149346|NCT03388671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102149347|NCT02327936|Fesoterodine|fesoterodine|mesh-list
102149348|NCT02327936|Oxybutynin|oxybutynin|mesh-list
102149349|NCT02327936|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102149350|NCT02327936|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102149351|NCT02327936|Cholinergic Agents|cholinergic agents|mesh-ancestor
102149352|NCT02327936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102149353|NCT02327936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149354|NCT02327936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149355|NCT02327936|Urological Agents|urological agents|mesh-ancestor
102149356|NCT02327936|Parasympatholytics|parasympatholytics|mesh-ancestor
102149357|NCT02327936|Autonomic Agents|autonomic agents|mesh-ancestor
102149358|NCT02327936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102149359|NCT03609827|Melphalan|melphalan|mesh-list
102149360|NCT03609827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102149361|NCT03609827|Alkylating Agents|alkylating agents|mesh-ancestor
102149362|NCT03609827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149363|NCT03609827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102149364|NCT03609827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102149365|NCT03609827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102149366|NCT03609827|Immunologic Factors|immunologic factors|mesh-ancestor
102149367|NCT03609827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149368|NCT02858401|Vesatolimod|vesatolimod|mesh-list
102149369|NCT02858401|Antiviral Agents|antiviral agents|mesh-ancestor
102149370|NCT02858401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102149371|NCT03144596|Tamsulosin|tamsulosin|mesh-list
102149372|NCT03144596|Alfuzosin|alfuzosin|mesh-list
102149373|NCT03144596|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102149374|NCT03144596|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102149375|NCT03144596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102149376|NCT03144596|Adrenergic Agents|adrenergic agents|mesh-ancestor
102149377|NCT03144596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102149378|NCT03144596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149379|NCT03144596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149380|NCT03144596|Urological Agents|urological agents|mesh-ancestor
102149381|NCT00127647|Montelukast|montelukast|mesh-list
102149382|NCT00127647|Pranlukast|pranlukast|mesh-list
102149383|NCT00127647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102149384|NCT00127647|Respiratory System Agents|respiratory system agents|mesh-ancestor
102149385|NCT00127647|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102149386|NCT00127647|Hormone Antagonists|hormone antagonists|mesh-ancestor
102149387|NCT00127647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102149388|NCT00127647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149389|NCT00127647|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102149390|NCT00127647|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102149391|NCT00127647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149392|NCT03111446|Anesthetics|anesthetics|mesh-list
102149393|NCT03111446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102149394|NCT03111446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149395|NCT02034071|Diazoxide|diazoxide|mesh-list
102149396|NCT02034071|Choline|choline|mesh-list
102149397|NCT02034071|Lipotropic Agents|lipotropic agents|mesh-ancestor
102149398|NCT02034071|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102149399|NCT02034071|Antimetabolites|antimetabolites|mesh-ancestor
102149400|NCT02034071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149401|NCT02034071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102149402|NCT02034071|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102149403|NCT02034071|Nootropic Agents|nootropic agents|mesh-ancestor
102149404|NCT02034071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102149405|NCT02034071|Vasodilator Agents|vasodilator agents|mesh-ancestor
102149406|NCT03609359|Pembrolizumab|pembrolizumab|mesh-list
102149407|NCT03609359|Lenvatinib|lenvatinib|mesh-list
102149408|NCT03609359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102149409|NCT03609359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102149410|NCT03609359|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102149411|NCT03609359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149412|NCT03609359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102149413|NCT03609359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102149414|NCT04833764|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102149415|NCT04833764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102149416|NCT04833764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102149417|NCT04833764|Antimetabolites|antimetabolites|mesh-ancestor
101751182|NCT04690608|Glucocorticoids|glucocorticoids|mesh-ancestor
102149418|NCT04833764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149419|NCT04833764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102149420|NCT04833764|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102149421|NCT04833764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102149422|NCT03388125|Ethanolamine oleate|ethanolamine oleate|mesh-list
102149423|NCT03388125|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102149424|NCT03388125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102149425|NCT04822376|Ansuvimab|ansuvimab|mesh-list
102149426|NCT04822376|Antiviral Agents|antiviral agents|mesh-ancestor
102149427|NCT04822376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102149428|NCT05173545|Mitoxantrone|mitoxantrone|mesh-list
102149429|NCT05173545|Analgesics|analgesics|mesh-ancestor
102149430|NCT05173545|Sensory System Agents|sensory system agents|mesh-ancestor
102149431|NCT05173545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102149432|NCT05173545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149433|NCT05173545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102149434|NCT05173545|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102149435|NCT05173545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102149436|NCT05173545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102149437|NCT05173545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149438|NCT05383183|Choline|choline|mesh-list
102149439|NCT05383183|Lipotropic Agents|lipotropic agents|mesh-ancestor
102149440|NCT05383183|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102149441|NCT05383183|Antimetabolites|antimetabolites|mesh-ancestor
102149442|NCT05383183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149443|NCT05383183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102149444|NCT05383183|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102149445|NCT05383183|Nootropic Agents|nootropic agents|mesh-ancestor
102149446|NCT02327702|Emtricitabine|emtricitabine|mesh-list
102149447|NCT02327702|Antiviral Agents|antiviral agents|mesh-ancestor
102149448|NCT02327702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102149449|NCT02327702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102149450|NCT02327702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102149451|NCT02327702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102149452|NCT02327702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149453|NCT02327702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102149454|NCT02327702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102149455|NCT03609775|Ethanol|ethanol|mesh-list
102149456|NCT03609775|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102149457|NCT03609775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102149458|NCT03609775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102149459|NCT03609775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149460|NCT03690765|Dydrogesterone|dydrogesterone|mesh-list
102149461|NCT03690765|Progestins|progestins|mesh-ancestor
102149462|NCT03690765|Hormones|hormones|mesh-ancestor
102149463|NCT03690765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102149464|NCT03690765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149465|NCT02033941|Phenol|phenol|mesh-list
102149466|NCT02033941|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102149467|NCT02033941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102149468|NCT02033941|Disinfectants|disinfectants|mesh-ancestor
102149469|NCT02033941|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102149470|NCT02033941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102149471|NCT03143972|Dexmedetomidine|dexmedetomidine|mesh-list
102149472|NCT03143972|Remifentanil|remifentanil|mesh-list
102149473|NCT03143972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102149474|NCT03143972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102149475|NCT03143972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149476|NCT03143972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102149477|NCT03143972|Analgesics|analgesics|mesh-ancestor
102149478|NCT03143972|Sensory System Agents|sensory system agents|mesh-ancestor
102149479|NCT03143972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102149480|NCT03143972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102149481|NCT03143972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102149482|NCT03143972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102149483|NCT03143972|Adrenergic Agents|adrenergic agents|mesh-ancestor
102149484|NCT03143972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102149485|NCT03143972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149486|NCT03143972|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102149487|NCT03143972|Narcotics|narcotics|mesh-ancestor
102149488|NCT02237027|Tenofovir|tenofovir|mesh-list
102149489|NCT02237027|Emtricitabine|emtricitabine|mesh-list
102149490|NCT02237027|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102149491|NCT02237027|Antiviral Agents|antiviral agents|mesh-ancestor
102149492|NCT02237027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102149493|NCT02237027|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102149494|NCT02237027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102149495|NCT02237027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102149496|NCT02237027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149497|NCT02237027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102149498|NCT02237027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102149499|NCT03609125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102149500|NCT03609125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102149501|NCT03143738|Anesthetics|anesthetics|mesh-list
102149502|NCT03143738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102149503|NCT03143738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149504|NCT04393753|Avelumab|avelumab|mesh-list
102149505|NCT04393753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102149506|NCT04393753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102149507|NCT04647903|Amphetamine|amphetamine|mesh-list
102149508|NCT04647903|Dextroamphetamine|dextroamphetamine|mesh-list
102149509|NCT04647903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102149510|NCT04647903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149511|NCT04647903|Sympathomimetics|sympathomimetics|mesh-ancestor
102149512|NCT04647903|Autonomic Agents|autonomic agents|mesh-ancestor
102149513|NCT04647903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102149514|NCT04647903|Dopamine Agents|dopamine agents|mesh-ancestor
102149515|NCT04647903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102149516|NCT04647903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149517|NCT04647903|Adrenergic Agents|adrenergic agents|mesh-ancestor
102149518|NCT04647903|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102149519|NCT04647903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102149520|NCT04647903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102149521|NCT04647903|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102149522|NCT03142256|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102149523|NCT03142256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102149524|NCT03142256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102149525|NCT03142256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102149526|NCT03142256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149527|NCT03142256|Antiviral Agents|antiviral agents|mesh-ancestor
102149528|NCT03142256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102149529|NCT03142256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102149530|NCT03142256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102149531|NCT03380403|Ciprofloxacin|ciprofloxacin|mesh-list
102149532|NCT03380403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102149533|NCT03380403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102149534|NCT03380403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102149535|NCT03380403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102149536|NCT03380403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102149537|NCT03380403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149538|NCT03380403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102149539|NCT03380403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102149540|NCT03380403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102149541|NCT03380325|Iloprost|iloprost|mesh-list
102149542|NCT03380325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102149543|NCT03380325|Vasodilator Agents|vasodilator agents|mesh-ancestor
102149544|NCT02237053|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102149545|NCT02237053|Octreotide|octreotide|mesh-list
102149546|NCT02237053|Glucagon|glucagon|mesh-list
102149547|NCT02237053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149548|NCT02237053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102149549|NCT02237053|Hormones|hormones|mesh-ancestor
102149550|NCT02237053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102149551|NCT02237053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102149552|NCT02237053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102149553|NCT02237131|Contraceptive Agents|contraceptive agents|mesh-list
102149554|NCT02237131|Contraceptives, Oral|contraceptives, oral|mesh-list
102149555|NCT02237131|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
102149556|NCT02237131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102149557|NCT02237131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149558|NCT02237131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102535914|NCT00553319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149559|NCT04997174|Celecoxib|celecoxib|mesh-list
102149560|NCT04997174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102149561|NCT04997174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102149562|NCT04997174|Analgesics|analgesics|mesh-ancestor
101836478|NCT01063816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149563|NCT04997174|Sensory System Agents|sensory system agents|mesh-ancestor
102149564|NCT04997174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102149565|NCT04997174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149566|NCT04997174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102149567|NCT04997174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102149568|NCT04997174|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102149569|NCT04997174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102149570|NCT04997174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102149571|NCT04997174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149572|NCT02237209|Vaccines|vaccines|mesh-list
102149573|NCT02237209|Immunologic Factors|immunologic factors|mesh-ancestor
102149574|NCT02237209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149575|NCT03387111|Leucovorin|leucovorin|mesh-list
102149576|NCT03387111|Paclitaxel|paclitaxel|mesh-list
102149577|NCT03387111|Cyclophosphamide|cyclophosphamide|mesh-list
102149578|NCT03387111|Bevacizumab|bevacizumab|mesh-list
102149579|NCT03387111|Fluorouracil|fluorouracil|mesh-list
102149580|NCT03387111|Capecitabine|capecitabine|mesh-list
102149581|NCT03387111|Cetuximab|cetuximab|mesh-list
102149582|NCT03387111|Avelumab|avelumab|mesh-list
102149583|NCT03387111|Necitumumab|necitumumab|mesh-list
102149584|NCT03387111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102149585|NCT03387111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102149586|NCT03387111|Tubulin Modulators|tubulin modulators|mesh-ancestor
102149587|NCT03387111|Antimitotic Agents|antimitotic agents|mesh-ancestor
102149588|NCT03387111|Mitosis Modulators|mitosis modulators|mesh-ancestor
102149589|NCT03387111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149590|NCT03387111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102149591|NCT03387111|Immunologic Factors|immunologic factors|mesh-ancestor
102149592|NCT03387111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149593|NCT03387111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102149594|NCT03387111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102149595|NCT03387111|Alkylating Agents|alkylating agents|mesh-ancestor
102149596|NCT03387111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102149597|NCT03387111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102149598|NCT03387111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102149599|NCT03387111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102149600|NCT03387111|Growth Substances|growth substances|mesh-ancestor
102149601|NCT03387111|Growth Inhibitors|growth inhibitors|mesh-ancestor
102149602|NCT03387111|Antimetabolites|antimetabolites|mesh-ancestor
102149603|NCT03387111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102149604|NCT03387111|Antidotes|antidotes|mesh-ancestor
102149605|NCT03387111|Protective Agents|protective agents|mesh-ancestor
102149606|NCT03387111|Vitamin B Complex|vitamin b complex|mesh-ancestor
102149607|NCT03387111|Vitamins|vitamins|mesh-ancestor
102149608|NCT03387111|Micronutrients|micronutrients|mesh-ancestor
102149609|NCT03608293|Dimercaprol|dimercaprol|mesh-list
102149610|NCT03608293|Chelating Agents|chelating agents|mesh-ancestor
102149611|NCT03608293|Sequestering Agents|sequestering agents|mesh-ancestor
102149612|NCT03608293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149613|NCT03608501|Thalidomide|thalidomide|mesh-list
102149614|NCT03608501|Dexamethasone|dexamethasone|mesh-list
102149615|NCT03608501|Ixazomib|ixazomib|mesh-list
102149616|NCT03608501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102149617|NCT03608501|Antiemetics|antiemetics|mesh-ancestor
102149618|NCT03608501|Autonomic Agents|autonomic agents|mesh-ancestor
102149619|NCT03608501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102149620|NCT03608501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149621|NCT03608501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102149622|NCT03608501|Glucocorticoids|glucocorticoids|mesh-ancestor
102149623|NCT03608501|Hormones|hormones|mesh-ancestor
102149624|NCT03608501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102149625|NCT03608501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102149626|NCT03608501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102149627|NCT03608501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149628|NCT03608501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102149629|NCT03608501|Immunologic Factors|immunologic factors|mesh-ancestor
102149630|NCT03608501|Leprostatic Agents|leprostatic agents|mesh-ancestor
102149631|NCT03608501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102149632|NCT03608501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102149633|NCT03608501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102149634|NCT03608501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102149635|NCT03608501|Growth Substances|growth substances|mesh-ancestor
102149636|NCT03608501|Growth Inhibitors|growth inhibitors|mesh-ancestor
102149637|NCT03608501|Protease Inhibitors|protease inhibitors|mesh-ancestor
102149638|NCT03608501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102149639|NCT03608761|Rebamipide|rebamipide|mesh-list
102149640|NCT03608761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102149641|NCT03608761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102149642|NCT03608761|Antioxidants|antioxidants|mesh-ancestor
102149643|NCT03608761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149644|NCT03608761|Protective Agents|protective agents|mesh-ancestor
102149645|NCT03608761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149646|NCT03608761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102149648|NCT04554836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102149649|NCT04554836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102149650|NCT04536272|Heparin|heparin|mesh-list
102149651|NCT04536272|Calcium heparin|calcium heparin|mesh-list
102149652|NCT04536272|Enoxaparin|enoxaparin|mesh-list
102149653|NCT04536272|Nadroparin|nadroparin|mesh-list
102149654|NCT04536272|Anticoagulants|anticoagulants|mesh-ancestor
102149655|NCT04536272|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102149656|NCT04536272|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102149657|NCT04536272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149658|NCT02731131|Ribavirin|ribavirin|mesh-list
102149659|NCT02731131|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102149660|NCT02731131|Antimetabolites|antimetabolites|mesh-ancestor
102149661|NCT02731131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149662|NCT02731131|Antiviral Agents|antiviral agents|mesh-ancestor
102149663|NCT02731131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102149664|NCT04585724|Palbociclib|palbociclib|mesh-list
102149665|NCT04585724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102149666|NCT04585724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102149667|NCT04585724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102149668|NCT04585724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149669|NCT02237261|Prednisone|prednisone|mesh-list
102149670|NCT02237261|Bortezomib|bortezomib|mesh-list
102149671|NCT02237261|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102149672|NCT02237261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102149673|NCT02237261|Glucocorticoids|glucocorticoids|mesh-ancestor
102149674|NCT02237261|Hormones|hormones|mesh-ancestor
102149675|NCT02237261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102149676|NCT02237261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149677|NCT02237261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102149678|NCT02237261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102149679|NCT02237261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101751463|NCT04168112|Hormones|hormones|mesh-ancestor
102149680|NCT02237261|Alkylating Agents|alkylating agents|mesh-ancestor
102149681|NCT02237261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149682|NCT03386643|Clobetasol|clobetasol|mesh-list
102149683|NCT03386643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102149684|NCT03386643|Glucocorticoids|glucocorticoids|mesh-ancestor
102149685|NCT03386643|Hormones|hormones|mesh-ancestor
102149686|NCT03386643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102149687|NCT03386643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149688|NCT05171985|Dexmedetomidine|dexmedetomidine|mesh-list
102149689|NCT05171985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102149690|NCT05171985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102149691|NCT05171985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149692|NCT05171985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102149693|NCT05171985|Analgesics|analgesics|mesh-ancestor
102149694|NCT05171985|Sensory System Agents|sensory system agents|mesh-ancestor
102149695|NCT05171985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102149696|NCT05171985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102149697|NCT05171985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102149698|NCT05171985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102149699|NCT05171985|Adrenergic Agents|adrenergic agents|mesh-ancestor
102149700|NCT05171985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102149701|NCT05171985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149702|NCT02237365|Aspirin|aspirin|mesh-list
102149703|NCT02237365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102149704|NCT02237365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102149705|NCT02237365|Analgesics|analgesics|mesh-ancestor
102149706|NCT02237365|Sensory System Agents|sensory system agents|mesh-ancestor
102149707|NCT02237365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102149708|NCT02237365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149709|NCT02237365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102149710|NCT02237365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102149711|NCT02237365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102149712|NCT02237365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102149713|NCT02237365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858593|NCT00350792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102149714|NCT02237365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102149715|NCT02237365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102149716|NCT02237365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102149717|NCT02237365|Antipyretics|antipyretics|mesh-ancestor
102149718|NCT03383367|TEMPO|tempo|mesh-list
102149719|NCT03383367|Antioxidants|antioxidants|mesh-ancestor
102149720|NCT03383367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149721|NCT03383367|Protective Agents|protective agents|mesh-ancestor
102149722|NCT03383367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149723|NCT02856113|Alogliptin|alogliptin|mesh-list
102149724|NCT02856113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102149725|NCT02856113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149726|NCT02856113|Incretins|incretins|mesh-ancestor
102149727|NCT02856113|Hormones|hormones|mesh-ancestor
102149728|NCT02856113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102149729|NCT02856113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102149730|NCT02856113|Protease Inhibitors|protease inhibitors|mesh-ancestor
102149731|NCT02856113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102149732|NCT02856113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149733|NCT03386565|Lidocaine|lidocaine|mesh-list
102149734|NCT03386565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102149735|NCT03386565|Anesthetics, Local|anesthetics, local|mesh-ancestor
102149736|NCT03386565|Anesthetics|anesthetics|mesh-ancestor
102149737|NCT03386565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102149738|NCT03386565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149739|NCT03386565|Sensory System Agents|sensory system agents|mesh-ancestor
102149740|NCT03386565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102149741|NCT03386565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102149742|NCT03386565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102149743|NCT03386565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102149744|NCT03386565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101751522|NCT03945448|Fluconazole|fluconazole|mesh-list
102149745|NCT03386565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149746|NCT02237339|Allopurinol|allopurinol|mesh-list
102149747|NCT02237339|Antimetabolites|antimetabolites|mesh-ancestor
102149748|NCT02237339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149749|NCT02237339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102149750|NCT02237339|Gout Suppressants|gout suppressants|mesh-ancestor
102149751|NCT02237339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102149752|NCT02237339|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102149753|NCT02237339|Antioxidants|antioxidants|mesh-ancestor
102149754|NCT02237339|Protective Agents|protective agents|mesh-ancestor
102149755|NCT02237339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149756|NCT05171751|Octreotide|octreotide|mesh-list
102149757|NCT05171751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102149758|NCT05171751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102149759|NCT05171751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102149760|NCT03971084|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
102149761|NCT03971084|Caseins|caseins|mesh-list
102149762|NCT03971084|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102149763|NCT03971084|Serotonin Agents|serotonin agents|mesh-ancestor
102149764|NCT03971084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102149765|NCT03971084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149766|NCT03971084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149767|NCT03971084|Chelating Agents|chelating agents|mesh-ancestor
102149768|NCT03971084|Sequestering Agents|sequestering agents|mesh-ancestor
102149769|NCT03379779|Dimercaprol|dimercaprol|mesh-list
102149770|NCT03379779|Chelating Agents|chelating agents|mesh-ancestor
102149771|NCT03379779|Sequestering Agents|sequestering agents|mesh-ancestor
102149772|NCT03379779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149773|NCT04083014|Bortezomib|bortezomib|mesh-list
102149774|NCT04083014|Antibodies|antibodies|mesh-list
102149775|NCT04083014|Immunologic Factors|immunologic factors|mesh-ancestor
102149776|NCT04083014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149777|NCT04083014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102149778|NCT03563066|Benralizumab|benralizumab|mesh-list
102149779|NCT03563066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102149780|NCT03563066|Respiratory System Agents|respiratory system agents|mesh-ancestor
102149781|NCT03140384|Misoprostol|misoprostol|mesh-list
102149782|NCT03140384|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102149783|NCT03140384|Abortifacient Agents|abortifacient agents|mesh-ancestor
102149784|NCT03140384|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102149785|NCT03140384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149786|NCT03140384|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101858668|NCT03982134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102149787|NCT03140384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102149788|NCT03140384|Oxytocics|oxytocics|mesh-ancestor
102149789|NCT05117307|Bupivacaine|bupivacaine|mesh-list
102149790|NCT05117307|Anesthetics, Local|anesthetics, local|mesh-ancestor
102149791|NCT05117307|Anesthetics|anesthetics|mesh-ancestor
102149792|NCT05117307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102149793|NCT05117307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149794|NCT05117307|Sensory System Agents|sensory system agents|mesh-ancestor
102149795|NCT05117307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102149796|NCT03739268|Sevelamer|sevelamer|mesh-list
102149797|NCT03739268|Chelating Agents|chelating agents|mesh-ancestor
102149798|NCT03739268|Sequestering Agents|sequestering agents|mesh-ancestor
102149799|NCT03739268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149800|NCT02787590|Simvastatin|simvastatin|mesh-list
102149801|NCT02787590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102149802|NCT02787590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102149803|NCT02787590|Antimetabolites|antimetabolites|mesh-ancestor
102149804|NCT02787590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149805|NCT02787590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102149806|NCT02787590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102149807|NCT02787590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102149808|NCT04445571|Pulmonary Surfactants|pulmonary surfactants|mesh-list
102149809|NCT04445571|Respiratory System Agents|respiratory system agents|mesh-ancestor
102149810|NCT03382743|Lidocaine|lidocaine|mesh-list
102149811|NCT03382743|Anesthetics, Local|anesthetics, local|mesh-ancestor
102149812|NCT03382743|Anesthetics|anesthetics|mesh-ancestor
102149813|NCT03382743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102149814|NCT03382743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149815|NCT03382743|Sensory System Agents|sensory system agents|mesh-ancestor
102149816|NCT03382743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102149817|NCT03382743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102149818|NCT03382743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102149819|NCT03382743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102149820|NCT03382743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102149821|NCT03382743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149822|NCT02854631|Prednisolone|prednisolone|mesh-list
102149823|NCT02854631|Selonsertib|selonsertib|mesh-list
102149824|NCT02854631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102149825|NCT02854631|Glucocorticoids|glucocorticoids|mesh-ancestor
102149826|NCT02854631|Hormones|hormones|mesh-ancestor
102149827|NCT02854631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102149828|NCT02854631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149829|NCT02854631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102149830|NCT02854631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102149831|NCT02854631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102149832|NCT02854631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102149833|NCT02854631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149834|NCT03607643|Leucovorin|leucovorin|mesh-list
102149835|NCT03607643|Bevacizumab|bevacizumab|mesh-list
102149836|NCT03607643|Gemcitabine|gemcitabine|mesh-list
102149837|NCT03607643|Oxaliplatin|oxaliplatin|mesh-list
102149838|NCT03607643|Irinotecan|irinotecan|mesh-list
102149839|NCT03607643|Temozolomide|temozolomide|mesh-list
102149840|NCT03607643|Bortezomib|bortezomib|mesh-list
102149841|NCT03607643|Cannabidiol|cannabidiol|mesh-list
102149842|NCT03607643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102149843|NCT03607643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102149844|NCT03607643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102149845|NCT03607643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102149846|NCT03607643|Growth Substances|growth substances|mesh-ancestor
102149847|NCT03607643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149848|NCT03607643|Growth Inhibitors|growth inhibitors|mesh-ancestor
102149849|NCT03607643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102149850|NCT03607643|Antimetabolites|antimetabolites|mesh-ancestor
102149851|NCT03607643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149852|NCT03607643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102149853|NCT03607643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102149854|NCT03607643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102149855|NCT03607643|Antidotes|antidotes|mesh-ancestor
102149856|NCT03607643|Protective Agents|protective agents|mesh-ancestor
102149857|NCT03607643|Vitamin B Complex|vitamin b complex|mesh-ancestor
102149858|NCT03607643|Vitamins|vitamins|mesh-ancestor
102149859|NCT03607643|Micronutrients|micronutrients|mesh-ancestor
102149860|NCT03607643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102149861|NCT03607643|Alkylating Agents|alkylating agents|mesh-ancestor
101858749|NCT00335972|Remifentanil|remifentanil|mesh-list
102149862|NCT03607643|Anticonvulsants|anticonvulsants|mesh-ancestor
102149863|NCT02855359|Prednisone|prednisone|mesh-list
102149864|NCT02855359|Cyclophosphamide|cyclophosphamide|mesh-list
102149865|NCT02855359|Rituximab|rituximab|mesh-list
102149866|NCT02855359|Doxorubicin|doxorubicin|mesh-list
102149867|NCT02855359|Vincristine|vincristine|mesh-list
102149868|NCT02855359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102149869|NCT02855359|Immunologic Factors|immunologic factors|mesh-ancestor
102149870|NCT02855359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149871|NCT02855359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102149872|NCT02855359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102149873|NCT02855359|Alkylating Agents|alkylating agents|mesh-ancestor
102149874|NCT02855359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149875|NCT02855359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102149876|NCT02855359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102149877|NCT02855359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102149878|NCT02855359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102149879|NCT02855359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102149880|NCT02855359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102149881|NCT02855359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102149882|NCT02855359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102149883|NCT02855359|Glucocorticoids|glucocorticoids|mesh-ancestor
102149884|NCT02855359|Hormones|hormones|mesh-ancestor
102149885|NCT02855359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102149886|NCT02855359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102149887|NCT02855359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102149888|NCT02855359|Tubulin Modulators|tubulin modulators|mesh-ancestor
102149889|NCT02855359|Antimitotic Agents|antimitotic agents|mesh-ancestor
102149890|NCT02855359|Mitosis Modulators|mitosis modulators|mesh-ancestor
102149891|NCT05084456|Docetaxel|docetaxel|mesh-list
102149892|NCT05084456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102149893|NCT05084456|Tubulin Modulators|tubulin modulators|mesh-ancestor
102149894|NCT05084456|Antimitotic Agents|antimitotic agents|mesh-ancestor
102149895|NCT05084456|Mitosis Modulators|mitosis modulators|mesh-ancestor
102149896|NCT05084456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149897|NCT03607903|Adalimumab|adalimumab|mesh-list
102149898|NCT03607903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102149899|NCT03607903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102149900|NCT03607903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102149901|NCT04438850|Ivermectin|ivermectin|mesh-list
102149902|NCT04438850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102149903|NCT04438850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102149904|NCT03385863|Pulmonary Surfactants|pulmonary surfactants|mesh-list
102149905|NCT03385863|Poractant alfa|poractant alfa|mesh-list
102149906|NCT03385863|Respiratory System Agents|respiratory system agents|mesh-ancestor
102149907|NCT03939026|Cyclophosphamide|cyclophosphamide|mesh-list
102149908|NCT03939026|Fludarabine|fludarabine|mesh-list
102149909|NCT03939026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102149910|NCT03939026|Immunologic Factors|immunologic factors|mesh-ancestor
102149911|NCT03939026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149912|NCT03939026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102149913|NCT03939026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102149914|NCT03939026|Alkylating Agents|alkylating agents|mesh-ancestor
102149915|NCT03939026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149916|NCT03939026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102149917|NCT03939026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102149918|NCT03382431|PC-786|pc-786|mesh-list
102149919|NCT03382431|Antiviral Agents|antiviral agents|mesh-ancestor
102149920|NCT03382431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102149921|NCT03382431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102149922|NCT03382431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149923|NCT03141632|Dulaglutide|dulaglutide|mesh-list
102149924|NCT03141632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102149925|NCT03141632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149926|NCT04282239|Lidocaine|lidocaine|mesh-list
102149927|NCT04282239|Epinephrine|epinephrine|mesh-list
102149928|NCT04282239|Dexmedetomidine|dexmedetomidine|mesh-list
102149929|NCT04282239|Ropivacaine|ropivacaine|mesh-list
102149930|NCT04282239|Anesthetics, Local|anesthetics, local|mesh-ancestor
102149931|NCT04282239|Anesthetics|anesthetics|mesh-ancestor
102149932|NCT04282239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102149933|NCT04282239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149934|NCT04282239|Sensory System Agents|sensory system agents|mesh-ancestor
102149935|NCT04282239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102149936|NCT04282239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102149937|NCT04282239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101858816|NCT00345878|Vaccines|vaccines|mesh-list
102149938|NCT04282239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102149939|NCT04282239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102149940|NCT04282239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149941|NCT04282239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102149942|NCT04282239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102149944|NCT04282239|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102149945|NCT04282239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102149946|NCT04282239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102149947|NCT04282239|Adrenergic Agents|adrenergic agents|mesh-ancestor
102149948|NCT04282239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102149949|NCT04282239|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102149950|NCT04282239|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102149951|NCT04282239|Autonomic Agents|autonomic agents|mesh-ancestor
102149952|NCT04282239|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102149953|NCT04282239|Respiratory System Agents|respiratory system agents|mesh-ancestor
102149954|NCT04282239|Mydriatics|mydriatics|mesh-ancestor
102149955|NCT04282239|Sympathomimetics|sympathomimetics|mesh-ancestor
102149956|NCT04282239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102149957|NCT03605173|Vitamin D|vitamin d|mesh-list
102149958|NCT03605173|Ergocalciferols|ergocalciferols|mesh-list
102149959|NCT03605173|Cholecalciferol|cholecalciferol|mesh-list
102149960|NCT03605173|Vitamins|vitamins|mesh-list
102149961|NCT03605173|Micronutrients|micronutrients|mesh-ancestor
102149962|NCT03605173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149963|NCT03605173|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102149964|NCT03605173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102149965|NCT03605095|Nitroglycerin|nitroglycerin|mesh-list
102149966|NCT03605095|Vasodilator Agents|vasodilator agents|mesh-ancestor
102149967|NCT03382275|Iron|iron|mesh-list
102149968|NCT03382275|Ferric maltol|ferric maltol|mesh-list
102149969|NCT03382275|Trace Elements|trace elements|mesh-ancestor
102149970|NCT03382275|Micronutrients|micronutrients|mesh-ancestor
102149971|NCT03382275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149972|NCT03382275|Hematinics|hematinics|mesh-ancestor
102149973|NCT05080478|Clopidogrel|clopidogrel|mesh-list
102149974|NCT05080478|Ticagrelor|ticagrelor|mesh-list
102149975|NCT05080478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102149976|NCT05080478|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102149977|NCT05080478|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102149978|NCT05080478|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102149979|NCT05080478|Purinergic Agents|purinergic agents|mesh-ancestor
102149980|NCT05080478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102149981|NCT05080478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149982|NCT05080478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149983|NCT05082974|Varenicline|varenicline|mesh-list
102149984|NCT05082974|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102149985|NCT05082974|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102149986|NCT05082974|Cholinergic Agents|cholinergic agents|mesh-ancestor
102149987|NCT05082974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102149988|NCT05082974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751792|NCT02891278|Cytarabine|cytarabine|mesh-list
102149989|NCT05082974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102149990|NCT03604471|Atorvastatin|atorvastatin|mesh-list
102149991|NCT03604471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102149992|NCT03604471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102149993|NCT03604471|Antimetabolites|antimetabolites|mesh-ancestor
102149994|NCT03604471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102149995|NCT03604471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102149996|NCT03604471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102149997|NCT03604471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102149998|NCT03757130|Liraglutide|liraglutide|mesh-list
102149999|NCT03757130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102150000|NCT03757130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150001|NCT03757130|Incretins|incretins|mesh-ancestor
102150002|NCT03757130|Hormones|hormones|mesh-ancestor
102150003|NCT03757130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102150004|NCT02237443|Bromides|bromides|mesh-list
102150005|NCT02237443|Rocuronium|rocuronium|mesh-list
102150006|NCT02237443|Vecuronium Bromide|vecuronium bromide|mesh-list
102150007|NCT02237443|Succinylcholine|succinylcholine|mesh-list
102150008|NCT02237443|Anticonvulsants|anticonvulsants|mesh-ancestor
102150009|NCT02237443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102150010|NCT02237443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102150011|NCT02237443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102150012|NCT02237443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102150013|NCT02237443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858892|NCT01059422|Antiviral Agents|antiviral agents|mesh-ancestor
102150014|NCT02237443|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
102150015|NCT02237443|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102150016|NCT02237443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102150017|NCT02237443|Cholinergic Agents|cholinergic agents|mesh-ancestor
102150018|NCT02237443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102150019|NCT02237443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150020|NCT03141398|Pancrelipase|pancrelipase|mesh-list
102150021|NCT03141398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102150022|NCT03733418|Vitamin D|vitamin d|mesh-list
102150023|NCT03733418|Cholecalciferol|cholecalciferol|mesh-list
102150024|NCT03733418|Vitamins|vitamins|mesh-ancestor
102150025|NCT03733418|Micronutrients|micronutrients|mesh-ancestor
102150026|NCT03733418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150027|NCT03733418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102150028|NCT03733418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102150029|NCT03607331|Citalopram|citalopram|mesh-list
102150030|NCT03607331|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102150031|NCT03607331|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102150032|NCT03607331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102150033|NCT03607331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150034|NCT03607331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102150035|NCT03607331|Serotonin Agents|serotonin agents|mesh-ancestor
102150036|NCT03607331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150037|NCT03607331|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102150038|NCT03607331|Antidepressive Agents|antidepressive agents|mesh-ancestor
102150039|NCT03607331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102150040|NCT05082896|Anesthetics|anesthetics|mesh-list
102150041|NCT05082896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102150042|NCT05082896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150043|NCT03607955|Paclitaxel|paclitaxel|mesh-list
102150044|NCT03607955|Carboplatin|carboplatin|mesh-list
102150045|NCT03607955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102150046|NCT03607955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102150047|NCT03607955|Tubulin Modulators|tubulin modulators|mesh-ancestor
102150048|NCT03607955|Antimitotic Agents|antimitotic agents|mesh-ancestor
102150049|NCT03607955|Mitosis Modulators|mitosis modulators|mesh-ancestor
102150050|NCT03607955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150051|NCT02067975|Tryptophan|tryptophan|mesh-list
102150052|NCT02067975|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102150053|NCT02067975|Antidepressive Agents|antidepressive agents|mesh-ancestor
102150054|NCT02067975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102150055|NCT03143036|Thalidomide|thalidomide|mesh-list
102150056|NCT03143036|Dexamethasone|dexamethasone|mesh-list
102150057|NCT03143036|Daratumumab|daratumumab|mesh-list
102150058|NCT03143036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102150059|NCT03143036|Antiemetics|antiemetics|mesh-ancestor
102150060|NCT03143036|Autonomic Agents|autonomic agents|mesh-ancestor
102150061|NCT03143036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102150062|NCT03143036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150063|NCT03143036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102150064|NCT03143036|Glucocorticoids|glucocorticoids|mesh-ancestor
102150065|NCT03143036|Hormones|hormones|mesh-ancestor
102150066|NCT03143036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102150067|NCT03143036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102150068|NCT03143036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102150069|NCT03143036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102150070|NCT03143036|Immunologic Factors|immunologic factors|mesh-ancestor
102150071|NCT03143036|Leprostatic Agents|leprostatic agents|mesh-ancestor
102150072|NCT03143036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102150073|NCT03143036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102150074|NCT03143036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102150075|NCT03143036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102150076|NCT03143036|Growth Substances|growth substances|mesh-ancestor
102150077|NCT03143036|Growth Inhibitors|growth inhibitors|mesh-ancestor
102150078|NCT05082662|Diclofenac|diclofenac|mesh-list
102150079|NCT05082662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102150080|NCT05082662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102150081|NCT05082662|Analgesics|analgesics|mesh-ancestor
102150082|NCT05082662|Sensory System Agents|sensory system agents|mesh-ancestor
102150083|NCT05082662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102154341|NCT03601741|Anti-Infective Agents|anti-infective agents|mesh-list
102150084|NCT05082662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150085|NCT05082662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102150086|NCT05082662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102150087|NCT05082662|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102150088|NCT05082662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102150089|NCT05082662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150090|NCT05080010|Carboplatin|carboplatin|mesh-list
102150091|NCT05080010|Etoposide|etoposide|mesh-list
102150092|NCT05080010|Vincristine|vincristine|mesh-list
102150093|NCT05080010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102150094|NCT05080010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102150095|NCT05080010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101751908|NCT01805804|Valsartan|valsartan|mesh-list
102150096|NCT05080010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102150097|NCT05080010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102150098|NCT05080010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150099|NCT05080010|Tubulin Modulators|tubulin modulators|mesh-ancestor
102150100|NCT05080010|Antimitotic Agents|antimitotic agents|mesh-ancestor
102150101|NCT05080010|Mitosis Modulators|mitosis modulators|mesh-ancestor
102150102|NCT03385551|Estradiol|estradiol|mesh-list
102150103|NCT03385551|Estrogens|estrogens|mesh-ancestor
102150104|NCT03385551|Hormones|hormones|mesh-ancestor
102150105|NCT03385551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102150106|NCT03385551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150107|NCT03606473|Amphetamine|amphetamine|mesh-list
102150108|NCT03606473|Dextroamphetamine|dextroamphetamine|mesh-list
102150109|NCT03606473|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102150110|NCT03606473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150111|NCT03606473|Sympathomimetics|sympathomimetics|mesh-ancestor
102150112|NCT03606473|Autonomic Agents|autonomic agents|mesh-ancestor
102150113|NCT03606473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102150114|NCT03606473|Dopamine Agents|dopamine agents|mesh-ancestor
102150115|NCT03606473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102150116|NCT03606473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150117|NCT03606473|Adrenergic Agents|adrenergic agents|mesh-ancestor
102150118|NCT03606473|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102150119|NCT03606473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102150120|NCT03606473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102150121|NCT03606473|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102150122|NCT03316274|Nivolumab|nivolumab|mesh-list
102150123|NCT03316274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102150124|NCT03316274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102150125|NCT03316274|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102150126|NCT03316274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150127|NCT03252626|Alprostadil|alprostadil|mesh-list
102150128|NCT03252626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102150129|NCT03252626|Vasodilator Agents|vasodilator agents|mesh-ancestor
102150130|NCT03252626|Urological Agents|urological agents|mesh-ancestor
102150131|NCT05072054|Atorvastatin|atorvastatin|mesh-list
102150132|NCT05072054|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102150133|NCT05072054|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102150134|NCT05072054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102150135|NCT05072054|Antimetabolites|antimetabolites|mesh-ancestor
102150136|NCT05072054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150137|NCT05072054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102150138|NCT05072054|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102150139|NCT05072054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102150140|NCT03142880|Ropivacaine|ropivacaine|mesh-list
102150141|NCT03142880|Anesthetics, Local|anesthetics, local|mesh-ancestor
102150142|NCT03142880|Anesthetics|anesthetics|mesh-ancestor
102150143|NCT03142880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102150144|NCT03142880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150145|NCT03142880|Sensory System Agents|sensory system agents|mesh-ancestor
102150146|NCT03142880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102150147|NCT03605537|Mometasone Furoate|mometasone furoate|mesh-list
102150148|NCT03605537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102150149|NCT03605537|Dermatologic Agents|dermatologic agents|mesh-ancestor
102150150|NCT03605537|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102150151|NCT03381495|Sufentanil|sufentanil|mesh-list
102150152|NCT03381495|Ropivacaine|ropivacaine|mesh-list
102150153|NCT03381495|Anesthetics, Local|anesthetics, local|mesh-ancestor
102150154|NCT03381495|Anesthetics|anesthetics|mesh-ancestor
102150155|NCT03381495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102150156|NCT03381495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150157|NCT03381495|Sensory System Agents|sensory system agents|mesh-ancestor
102154342|NCT03601741|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102150158|NCT03381495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102150159|NCT03381495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102150160|NCT03381495|Narcotics|narcotics|mesh-ancestor
102150161|NCT03381495|Analgesics|analgesics|mesh-ancestor
102150162|NCT03381495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102150163|NCT03381495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102150164|NCT03381495|Anesthetics, General|anesthetics, general|mesh-ancestor
102150165|NCT03059498|Bupivacaine|bupivacaine|mesh-list
102150166|NCT03059498|Anesthetics, Local|anesthetics, local|mesh-ancestor
102150167|NCT03059498|Anesthetics|anesthetics|mesh-ancestor
102150168|NCT03059498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102150169|NCT03059498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150170|NCT03059498|Sensory System Agents|sensory system agents|mesh-ancestor
102150171|NCT03059498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102150172|NCT03142646|Cyclophosphamide|cyclophosphamide|mesh-list
102150173|NCT03142646|Fludarabine|fludarabine|mesh-list
102150174|NCT03142646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102150175|NCT03142646|Immunologic Factors|immunologic factors|mesh-ancestor
102150176|NCT03142646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150177|NCT03142646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102150178|NCT03142646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102150179|NCT03142646|Alkylating Agents|alkylating agents|mesh-ancestor
102150180|NCT03142646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150181|NCT03142646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102150182|NCT03142646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102150183|NCT03541083|Blinatumomab|blinatumomab|mesh-list
102150184|NCT03541083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102150185|NCT04962230|Ritonavir|ritonavir|mesh-list
102150186|NCT04962230|Nirmatrelvir|nirmatrelvir|mesh-list
102150187|NCT04962230|Carbamazepine|carbamazepine|mesh-list
102150188|NCT04962230|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102150189|NCT04962230|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102150190|NCT04962230|Protease Inhibitors|protease inhibitors|mesh-ancestor
102150191|NCT04962230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102150192|NCT04962230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150193|NCT04962230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102150194|NCT04962230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102150195|NCT04962230|Antiviral Agents|antiviral agents|mesh-ancestor
102150196|NCT04962230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102150197|NCT04962230|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102150198|NCT04962230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102150199|NCT04962230|Anticonvulsants|anticonvulsants|mesh-ancestor
102150200|NCT04962230|Antimanic Agents|antimanic agents|mesh-ancestor
102150201|NCT04962230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102150202|NCT04962230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102150203|NCT04962230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150204|NCT04962230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102150205|NCT04962230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102150206|NCT04962230|Analgesics|analgesics|mesh-ancestor
102150207|NCT04962230|Sensory System Agents|sensory system agents|mesh-ancestor
102150208|NCT04962230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102150209|NCT04962230|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102150210|NCT04962230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102150211|NCT04962230|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102150212|NCT04962230|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102150213|NCT03602027|Gefitinib|gefitinib|mesh-list
102150214|NCT03602027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102150215|NCT03602027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102150216|NCT03602027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102150217|NCT03602027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150218|NCT03141476|Cefuroxime|cefuroxime|mesh-list
102150219|NCT03141476|Cefuroxime axetil|cefuroxime axetil|mesh-list
102150220|NCT03141476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101752045|NCT00114530|Cyclophosphamide|cyclophosphamide|mesh-list
102150221|NCT03141476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102150222|NCT03601871|Thalidomide|thalidomide|mesh-list
102150223|NCT03601871|Dexamethasone|dexamethasone|mesh-list
102150224|NCT03601871|Palonosetron|palonosetron|mesh-list
102150225|NCT03601871|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
102150226|NCT03601871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102150227|NCT03601871|Antiemetics|antiemetics|mesh-ancestor
102150228|NCT03601871|Autonomic Agents|autonomic agents|mesh-ancestor
102150229|NCT03601871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102150230|NCT03601871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150231|NCT03601871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102150232|NCT03601871|Glucocorticoids|glucocorticoids|mesh-ancestor
102150233|NCT03601871|Hormones|hormones|mesh-ancestor
102154343|NCT03365115|Fentanyl|fentanyl|mesh-list
102535915|NCT00553319|Sympathomimetics|sympathomimetics|mesh-ancestor
102150234|NCT03601871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102150235|NCT03601871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102150236|NCT03601871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102150237|NCT03601871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102150238|NCT03601871|Immunologic Factors|immunologic factors|mesh-ancestor
102150239|NCT03601871|Leprostatic Agents|leprostatic agents|mesh-ancestor
102150240|NCT03601871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102150241|NCT03601871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102150242|NCT03601871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102150243|NCT03601871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102150244|NCT03601871|Growth Substances|growth substances|mesh-ancestor
102150245|NCT03601871|Growth Inhibitors|growth inhibitors|mesh-ancestor
102150246|NCT03601871|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102150247|NCT03601871|Serotonin Agents|serotonin agents|mesh-ancestor
102150248|NCT03601871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102150249|NCT03601871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150250|NCT03380949|Remifentanil|remifentanil|mesh-list
102150251|NCT03380949|Analgesics, Opioid|analgesics, opioid|mesh-list
102150252|NCT03380949|Narcotics|narcotics|mesh-ancestor
102150253|NCT03380949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102150254|NCT03380949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150255|NCT03380949|Analgesics|analgesics|mesh-ancestor
102150256|NCT03380949|Sensory System Agents|sensory system agents|mesh-ancestor
102150257|NCT03380949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102150258|NCT03604757|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102150259|NCT03604757|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102150260|NCT03604757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150261|NCT03604679|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102150262|NCT03604679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102150263|NCT03604679|Alkylating Agents|alkylating agents|mesh-ancestor
102150264|NCT03604679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150265|NCT03604679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102150266|NCT05078372|Midazolam|midazolam|mesh-list
102150267|NCT05078372|Ropivacaine|ropivacaine|mesh-list
102150268|NCT05078372|Anesthetics, Local|anesthetics, local|mesh-ancestor
102150269|NCT05078372|Anesthetics|anesthetics|mesh-ancestor
102150270|NCT05078372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102150271|NCT05078372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150272|NCT05078372|Sensory System Agents|sensory system agents|mesh-ancestor
102150273|NCT05078372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102150274|NCT05078372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102150275|NCT05078372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102150276|NCT05078372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102150277|NCT05078372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102150278|NCT05078372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102150279|NCT05078372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102150280|NCT05078372|Anesthetics, General|anesthetics, general|mesh-ancestor
102150281|NCT05078372|GABA Modulators|gaba modulators|mesh-ancestor
102150282|NCT05078372|GABA Agents|gaba agents|mesh-ancestor
102150283|NCT05078372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102150284|NCT05078372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150285|NCT03380871|Carboplatin|carboplatin|mesh-list
102150286|NCT03380871|Pembrolizumab|pembrolizumab|mesh-list
102150287|NCT03380871|Pemetrexed|pemetrexed|mesh-list
102150288|NCT03380871|Poly ICLC|poly iclc|mesh-list
102150289|NCT03380871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102150290|NCT03380871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102150291|NCT03380871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102150292|NCT03380871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150293|NCT03380871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102150294|NCT03380871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102150295|NCT03380871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102150296|NCT03380871|Interferon Inducers|interferon inducers|mesh-ancestor
102150297|NCT03380871|Immunologic Factors|immunologic factors|mesh-ancestor
102150298|NCT03380871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150299|NCT02237495|Dexmedetomidine|dexmedetomidine|mesh-list
102150300|NCT02237495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102150301|NCT02237495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102150302|NCT02237495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150303|NCT02237495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102150304|NCT02237495|Analgesics|analgesics|mesh-ancestor
102150305|NCT02237495|Sensory System Agents|sensory system agents|mesh-ancestor
102150306|NCT02237495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102535916|NCT00553319|Autonomic Agents|autonomic agents|mesh-ancestor
102150307|NCT02237495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102150308|NCT02237495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102150309|NCT02237495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102150310|NCT02237495|Adrenergic Agents|adrenergic agents|mesh-ancestor
102150311|NCT02237495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102150312|NCT02237495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150313|NCT02486666|Enoxaparin|enoxaparin|mesh-list
102150314|NCT02486666|Enoxaparin sodium|enoxaparin sodium|mesh-list
102150315|NCT02486666|Anticoagulants|anticoagulants|mesh-ancestor
102150316|NCT02486666|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102150317|NCT02486666|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102150318|NCT02486666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150319|NCT02237807|Dirithromycin|dirithromycin|mesh-list
102150320|NCT02237807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102150321|NCT02237807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102150323|NCT03125187|Calcium heparin|calcium heparin|mesh-list
102150324|NCT03125187|Anticoagulants|anticoagulants|mesh-ancestor
102150325|NCT03125187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102150326|NCT03125187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102150327|NCT03125187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150328|NCT02038946|Nivolumab|nivolumab|mesh-list
102150329|NCT02038946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102150330|NCT02038946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102150331|NCT02038946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102150332|NCT02038946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150333|NCT03377907|Lidocaine|lidocaine|mesh-list
102150334|NCT03377907|Ketamine|ketamine|mesh-list
102150335|NCT03377907|Anesthetics, Local|anesthetics, local|mesh-ancestor
102150336|NCT03377907|Anesthetics|anesthetics|mesh-ancestor
102150337|NCT03377907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102150338|NCT03377907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150339|NCT03377907|Sensory System Agents|sensory system agents|mesh-ancestor
102150340|NCT03377907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102150341|NCT03377907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101752169|NCT00852046|Dexmedetomidine|dexmedetomidine|mesh-list
102150342|NCT03377907|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102150343|NCT03377907|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102150344|NCT03377907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102150345|NCT03377907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150346|NCT03377907|Analgesics|analgesics|mesh-ancestor
102150347|NCT03377907|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102150348|NCT03377907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102150349|NCT03377907|Anesthetics, General|anesthetics, general|mesh-ancestor
102150350|NCT03377907|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102150351|NCT03377907|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102150352|NCT03377907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102150353|NCT03141554|Chlorhexidine|chlorhexidine|mesh-list
102150354|NCT03141554|Povidone-Iodine|povidone-iodine|mesh-list
102150355|NCT03141554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102150356|NCT03141554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102150357|NCT03141554|Disinfectants|disinfectants|mesh-ancestor
102150358|NCT03369795|Methotrexate|methotrexate|mesh-list
102150359|NCT03369795|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102150360|NCT03369795|Abortifacient Agents|abortifacient agents|mesh-ancestor
102150361|NCT03369795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102150362|NCT03369795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150363|NCT03369795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102150364|NCT03369795|Antimetabolites|antimetabolites|mesh-ancestor
102150365|NCT03369795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150366|NCT03369795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102150367|NCT03369795|Dermatologic Agents|dermatologic agents|mesh-ancestor
102150368|NCT03369795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102150369|NCT03369795|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102150370|NCT03369795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102150371|NCT03369795|Immunologic Factors|immunologic factors|mesh-ancestor
102150372|NCT03369795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102150373|NCT03369795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102150374|NCT03374709|Oxcarbazepine|oxcarbazepine|mesh-list
102150375|NCT03374709|Anticonvulsants|anticonvulsants|mesh-ancestor
102150376|NCT03374709|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102150377|NCT03374709|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102150378|NCT03374709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102150379|NCT03374709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150380|NCT03374709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102150381|NCT03374709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102150383|NCT05393414|Ketorolac|ketorolac|mesh-list
102150384|NCT05393414|Morphine|morphine|mesh-list
102150385|NCT05393414|Analgesics, Opioid|analgesics, opioid|mesh-list
102150386|NCT05393414|Narcotics|narcotics|mesh-ancestor
102150387|NCT05393414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102150388|NCT05393414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150390|NCT05393414|Sensory System Agents|sensory system agents|mesh-ancestor
102150391|NCT05393414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102150392|NCT05393414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102150393|NCT05393414|Antipyretics|antipyretics|mesh-ancestor
102150394|NCT05393414|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102150395|NCT05393414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102150396|NCT05393414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102150397|NCT05393414|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102150398|NCT05393414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102150399|NCT05393414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150400|NCT03369327|Sofosbuvir|sofosbuvir|mesh-list
102150401|NCT03369327|Antiviral Agents|antiviral agents|mesh-ancestor
102150402|NCT03369327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102150403|NCT02034500|Vaccines|vaccines|mesh-list
102150404|NCT02034500|Immunologic Factors|immunologic factors|mesh-ancestor
102150405|NCT02034500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150406|NCT03377283|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102150407|NCT03377283|Thymoglobulin|thymoglobulin|mesh-list
102150408|NCT03377283|Immunologic Factors|immunologic factors|mesh-ancestor
102150409|NCT03377283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150410|NCT03377283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102150411|NCT03955640|Olaparib|olaparib|mesh-list
102150412|NCT03955640|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102150413|NCT03955640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102150414|NCT03955640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150415|NCT03955640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102150416|NCT03369093|Amoxicillin|amoxicillin|mesh-list
102150417|NCT03369093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102150418|NCT03369093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102150419|NCT03369015|Amphetamine|amphetamine|mesh-list
102150420|NCT03369015|Dextroamphetamine|dextroamphetamine|mesh-list
102150421|NCT03369015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102150422|NCT03369015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150423|NCT03369015|Sympathomimetics|sympathomimetics|mesh-ancestor
102150424|NCT03369015|Autonomic Agents|autonomic agents|mesh-ancestor
102150425|NCT03369015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102150426|NCT03369015|Dopamine Agents|dopamine agents|mesh-ancestor
102150427|NCT03369015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102150428|NCT03369015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150429|NCT03369015|Adrenergic Agents|adrenergic agents|mesh-ancestor
102150430|NCT03369015|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102150431|NCT03369015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102150432|NCT03369015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102150433|NCT03369015|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102150434|NCT03890744|Docetaxel|docetaxel|mesh-list
102150435|NCT03890744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102150436|NCT03890744|Tubulin Modulators|tubulin modulators|mesh-ancestor
102150437|NCT03890744|Antimitotic Agents|antimitotic agents|mesh-ancestor
102150438|NCT03890744|Mitosis Modulators|mitosis modulators|mesh-ancestor
102150439|NCT03890744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150440|NCT03374163|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102150441|NCT03374163|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102150442|NCT03374163|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102150443|NCT03374163|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102150444|NCT03374007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102150445|NCT03374007|Antibodies|antibodies|mesh-list
102150446|NCT03374007|Immunoglobulins|immunoglobulins|mesh-list
102150447|NCT03374007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102150448|NCT03374007|Immunologic Factors|immunologic factors|mesh-ancestor
102150449|NCT03374007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150450|NCT03374007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102150451|NCT04525521|Hand Sanitizers|hand sanitizers|mesh-list
102150452|NCT04525521|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102150453|NCT04525521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102150454|NCT04525521|Disinfectants|disinfectants|mesh-ancestor
102150455|NCT05392166|Calcium|calcium|mesh-list
102150456|NCT05392166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102150457|NCT05392166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150459|NCT02853331|Sunitinib|sunitinib|mesh-list
102150460|NCT02853331|Axitinib|axitinib|mesh-list
102150461|NCT02853331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102150462|NCT02853331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102150463|NCT02853331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102150464|NCT02853331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150465|NCT02853331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102150466|NCT02853331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102150467|NCT02853331|Growth Substances|growth substances|mesh-ancestor
102150468|NCT02853331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150469|NCT02853331|Growth Inhibitors|growth inhibitors|mesh-ancestor
102150470|NCT02853331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102150471|NCT02853331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102150472|NCT03136640|Docetaxel|docetaxel|mesh-list
102150473|NCT03136640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102150474|NCT03136640|Tubulin Modulators|tubulin modulators|mesh-ancestor
102150475|NCT03136640|Antimitotic Agents|antimitotic agents|mesh-ancestor
102150476|NCT03136640|Mitosis Modulators|mitosis modulators|mesh-ancestor
102150477|NCT03136640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150478|NCT02675439|Ipilimumab|ipilimumab|mesh-list
102150479|NCT02675439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102150480|NCT02675439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102150481|NCT02675439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102150482|NCT02675439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150483|NCT03604003|Losartan|losartan|mesh-list
102150484|NCT03604003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102150485|NCT03604003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102150486|NCT03604003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102150487|NCT03604003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102150488|NCT03604003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150489|NCT03368391|Lidocaine|lidocaine|mesh-list
102150490|NCT03368391|Phenylephrine|phenylephrine|mesh-list
102150491|NCT03368391|Epinephrine|epinephrine|mesh-list
102150492|NCT03368391|Racepinephrine|racepinephrine|mesh-list
102150493|NCT03368391|Oxymetazoline|oxymetazoline|mesh-list
102150494|NCT03368391|Tetracaine|tetracaine|mesh-list
102150495|NCT03368391|Mepivacaine|mepivacaine|mesh-list
102150496|NCT03368391|Epinephryl borate|epinephryl borate|mesh-list
102150497|NCT03368391|Anesthetics, Local|anesthetics, local|mesh-ancestor
102150498|NCT03368391|Anesthetics|anesthetics|mesh-ancestor
102150499|NCT03368391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102150500|NCT03368391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150501|NCT03368391|Sensory System Agents|sensory system agents|mesh-ancestor
102150502|NCT03368391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102150503|NCT03368391|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102150504|NCT03368391|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102150505|NCT03368391|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102150506|NCT03368391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102150507|NCT03368391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150508|NCT03368391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102150509|NCT03368391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102150510|NCT03368391|Adrenergic Agents|adrenergic agents|mesh-ancestor
102150511|NCT03368391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102150512|NCT03368391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102150513|NCT03368391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102150514|NCT03368391|Autonomic Agents|autonomic agents|mesh-ancestor
102150515|NCT03368391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102150516|NCT03368391|Respiratory System Agents|respiratory system agents|mesh-ancestor
102150517|NCT03368391|Mydriatics|mydriatics|mesh-ancestor
102150518|NCT03368391|Sympathomimetics|sympathomimetics|mesh-ancestor
102150519|NCT03368391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102150520|NCT03368391|Nasal Decongestants|nasal decongestants|mesh-ancestor
102150521|NCT03368391|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102150522|NCT03368391|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102150523|NCT03368391|Protective Agents|protective agents|mesh-ancestor
102150524|NCT03373305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102150525|NCT03373305|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102150526|NCT03373305|Lenalidomide|lenalidomide|mesh-list
102150527|NCT03373305|Piperidine|piperidine|mesh-list
102150528|NCT03373305|Antibodies|antibodies|mesh-list
102150529|NCT03373305|Immunoglobulins|immunoglobulins|mesh-list
102150530|NCT03373305|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102150531|NCT03373305|Immunoconjugates|immunoconjugates|mesh-list
102150532|NCT03373305|Immunologic Factors|immunologic factors|mesh-ancestor
102150533|NCT03373305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150534|NCT03373305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102150535|NCT03373305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102150536|NCT03373305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102150537|NCT03373305|Growth Substances|growth substances|mesh-ancestor
102150538|NCT03373305|Growth Inhibitors|growth inhibitors|mesh-ancestor
102150539|NCT03373305|Immunotoxins|immunotoxins|mesh-ancestor
102150541|NCT03373305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102150542|NCT03373305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150543|NCT03373305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102150544|NCT03376737|Pemetrexed|pemetrexed|mesh-list
102150545|NCT03376737|Apatinib|apatinib|mesh-list
102150546|NCT03376737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102150547|NCT03376737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102150548|NCT03376737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150549|NCT03376737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102150550|NCT03376737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102150551|NCT03376737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102150552|NCT03373227|Tacrolimus|tacrolimus|mesh-list
102150553|NCT03373227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102150554|NCT03373227|Immunologic Factors|immunologic factors|mesh-ancestor
102150555|NCT03373227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150556|NCT03373227|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102150557|NCT03373227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102150558|NCT03373227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150559|NCT02484716|Timolol|timolol|mesh-list
102150560|NCT02484716|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102150561|NCT02484716|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102150562|NCT02484716|Adrenergic Agents|adrenergic agents|mesh-ancestor
102150563|NCT02484716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102150564|NCT02484716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150565|NCT02484716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150566|NCT02484716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102150567|NCT02484716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102150568|NCT03373149|Hormones|hormones|mesh-list
102150569|NCT03373149|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
102150570|NCT03373149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102150571|NCT03373149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150572|NCT05386784|Cholecalciferol|cholecalciferol|mesh-list
102150573|NCT05386784|Vitamin D|vitamin d|mesh-list
102150574|NCT05386784|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
102150575|NCT05386784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102150576|NCT05386784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150577|NCT05386784|Vitamins|vitamins|mesh-ancestor
102150578|NCT05386784|Micronutrients|micronutrients|mesh-ancestor
102150579|NCT05386784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102150580|NCT05386784|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102150581|NCT05386784|Hormone Antagonists|hormone antagonists|mesh-ancestor
102150582|NCT05386784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102150583|NCT05386784|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102150584|NCT05386784|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102150585|NCT03602287|Lidocaine|lidocaine|mesh-list
102150586|NCT03602287|Anesthetics, Local|anesthetics, local|mesh-ancestor
102150587|NCT03602287|Anesthetics|anesthetics|mesh-ancestor
102150588|NCT03602287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102150589|NCT03602287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150590|NCT03602287|Sensory System Agents|sensory system agents|mesh-ancestor
102150591|NCT03602287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102150592|NCT03602287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102150593|NCT03602287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102150594|NCT03602287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102150595|NCT03602287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102150596|NCT03602287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150597|NCT03137498|Ketorolac|ketorolac|mesh-list
102150598|NCT03137498|Lidocaine|lidocaine|mesh-list
102150599|NCT03137498|Prilocaine|prilocaine|mesh-list
102150600|NCT03137498|Anesthetics, Local|anesthetics, local|mesh-ancestor
102150601|NCT03137498|Anesthetics|anesthetics|mesh-ancestor
102150602|NCT03137498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102150603|NCT03137498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150604|NCT03137498|Sensory System Agents|sensory system agents|mesh-ancestor
102150605|NCT03137498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102154344|NCT03365115|Morphine|morphine|mesh-list
102150606|NCT03137498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102150607|NCT03137498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102150608|NCT03137498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102150609|NCT03137498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102150610|NCT03137498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150611|NCT03137498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102150612|NCT03137498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102150614|NCT03137498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102150615|NCT03137498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102150616|NCT03137498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102150617|NCT03137498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102150618|NCT03602209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102150619|NCT03602209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102150620|NCT03367377|Insulin Glargine|insulin glargine|mesh-list
102150621|NCT03367377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102150622|NCT03367377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150623|NCT03602131|Gemcitabine|gemcitabine|mesh-list
102150624|NCT03602131|Busulfan|busulfan|mesh-list
102150625|NCT03602131|Cladribine|cladribine|mesh-list
102150626|NCT03602131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102150627|NCT03602131|Antimetabolites|antimetabolites|mesh-ancestor
102150628|NCT03602131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150629|NCT03602131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102150630|NCT03602131|Alkylating Agents|alkylating agents|mesh-ancestor
102150631|NCT03602131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102150632|NCT03602131|Immunologic Factors|immunologic factors|mesh-ancestor
102150633|NCT03602131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150634|NCT03602131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102150635|NCT03602131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102150636|NCT05851547|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102150637|NCT05851547|Androgens|androgens|mesh-list
102150638|NCT05851547|Hormones|hormones|mesh-ancestor
102150639|NCT05851547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102150640|NCT05851547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150641|NCT05851547|Luteolytic Agents|luteolytic agents|mesh-ancestor
102150642|NCT05851547|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102150643|NCT05851547|Contraceptive Agents|contraceptive agents|mesh-ancestor
102150644|NCT05851547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102150645|NCT05851547|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102150646|NCT05851547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102150647|NCT05851547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102150648|NCT05851508|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102150649|NCT05851508|Methylprednisolone|methylprednisolone|mesh-list
102150650|NCT05851508|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102150651|NCT05851508|Prednisolone|prednisolone|mesh-list
102150652|NCT05851508|Prednisolone acetate|prednisolone acetate|mesh-list
102150653|NCT05851508|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102150654|NCT05851508|Prednisolone phosphate|prednisolone phosphate|mesh-list
102150655|NCT05851508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102150656|NCT05851508|Antiemetics|antiemetics|mesh-ancestor
102150657|NCT05851508|Autonomic Agents|autonomic agents|mesh-ancestor
102150658|NCT05851508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102150659|NCT05851508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150660|NCT05851508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102150661|NCT05851508|Glucocorticoids|glucocorticoids|mesh-ancestor
102150662|NCT05851508|Hormones|hormones|mesh-ancestor
102150663|NCT05851508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102150664|NCT05851508|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102150665|NCT05851508|Protective Agents|protective agents|mesh-ancestor
102150666|NCT05851508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102150667|NCT05851508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102150668|NCT05851391|Anesthetics|anesthetics|mesh-list
102150669|NCT05851391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102150670|NCT05851391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150671|NCT05851352|Antibodies|antibodies|mesh-list
102150672|NCT05851352|Immunologic Factors|immunologic factors|mesh-ancestor
102150673|NCT05851352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150674|NCT05851014|Letrozole|letrozole|mesh-list
102150675|NCT05851014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102150676|NCT05851014|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102150677|NCT05851014|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102150678|NCT05851014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102150679|NCT05851014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150692|NCT05850871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150694|NCT05850832|Esmolol|esmolol|mesh-list
102150695|NCT05850832|Analgesics|analgesics|mesh-ancestor
102150696|NCT05850832|Sensory System Agents|sensory system agents|mesh-ancestor
102150697|NCT05850832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102150698|NCT05850832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150699|NCT05850832|Anesthetics|anesthetics|mesh-ancestor
102150700|NCT05850832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102150701|NCT05850832|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102150702|NCT05850832|Anticonvulsants|anticonvulsants|mesh-ancestor
102150703|NCT05850832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102150704|NCT05850832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102150705|NCT05850832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150706|NCT05850832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102150707|NCT05850832|Tocolytic Agents|tocolytic agents|mesh-ancestor
102150708|NCT05850832|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102150709|NCT05850832|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102150710|NCT05850832|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102150711|NCT05850832|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102150712|NCT05850832|Adrenergic Agents|adrenergic agents|mesh-ancestor
102150713|NCT05850832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102150714|NCT05850702|Lidocaine|lidocaine|mesh-list
102150715|NCT05850702|Anesthetics, Local|anesthetics, local|mesh-ancestor
102150716|NCT05850702|Anesthetics|anesthetics|mesh-ancestor
102150717|NCT05850702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102150718|NCT05850702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150719|NCT05850702|Sensory System Agents|sensory system agents|mesh-ancestor
102150720|NCT05850702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102150721|NCT05850702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102150722|NCT05850702|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102150723|NCT05850702|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102150724|NCT05850702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102150725|NCT05850702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150726|NCT05850559|Mitogens|mitogens|mesh-list
102150727|NCT05850559|Mitosis Modulators|mitosis modulators|mesh-ancestor
102150728|NCT05850559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150742|NCT05850507|Vaccines|vaccines|mesh-list
102150743|NCT05850507|Immunologic Factors|immunologic factors|mesh-ancestor
102150744|NCT05850507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150745|NCT05850468|Lidocaine|lidocaine|mesh-list
102150746|NCT05850468|Fentanyl|fentanyl|mesh-list
102150747|NCT05850468|Anesthetics|anesthetics|mesh-list
102150748|NCT05850468|Anesthetics, Local|anesthetics, local|mesh-ancestor
102150749|NCT05850468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102150750|NCT05850468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150751|NCT05850468|Sensory System Agents|sensory system agents|mesh-ancestor
102150752|NCT05850468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102150753|NCT05850468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102150754|NCT05850468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102150755|NCT05850468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102150756|NCT05850468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102150757|NCT05850468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150758|NCT05850468|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102150759|NCT05850468|Narcotics|narcotics|mesh-ancestor
102150760|NCT05850468|Analgesics|analgesics|mesh-ancestor
102150761|NCT05850468|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102150762|NCT05850468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102150763|NCT05850468|Anesthetics, General|anesthetics, general|mesh-ancestor
102150764|NCT05850455|Lidocaine|lidocaine|mesh-list
102150765|NCT05850455|Dexmedetomidine|dexmedetomidine|mesh-list
102150766|NCT05850455|Bupivacaine|bupivacaine|mesh-list
102150767|NCT05850455|Anesthetics, Local|anesthetics, local|mesh-ancestor
102150768|NCT05850455|Anesthetics|anesthetics|mesh-ancestor
102150769|NCT05850455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102150770|NCT05850455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150771|NCT05850455|Sensory System Agents|sensory system agents|mesh-ancestor
102150772|NCT05850455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102150773|NCT05850455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102150774|NCT05850455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102150775|NCT05850455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102150776|NCT05850455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102150777|NCT05850455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150778|NCT05850455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102150779|NCT05850455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102150780|NCT05850455|Analgesics|analgesics|mesh-ancestor
102150781|NCT05850455|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102150782|NCT05850455|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102150783|NCT05850455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102150784|NCT05850455|Adrenergic Agents|adrenergic agents|mesh-ancestor
102150785|NCT05850455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102150786|NCT05850377|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102150787|NCT05850377|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102150788|NCT05850377|Dermatologic Agents|dermatologic agents|mesh-ancestor
102150789|NCT05850143|Dexamethasone|dexamethasone|mesh-list
102150790|NCT05850143|Prednisolone|prednisolone|mesh-list
102150791|NCT05850143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102150792|NCT05850143|Antiemetics|antiemetics|mesh-ancestor
102150793|NCT05850143|Autonomic Agents|autonomic agents|mesh-ancestor
102150794|NCT05850143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102150795|NCT05850143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150796|NCT05850143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102150797|NCT05850143|Glucocorticoids|glucocorticoids|mesh-ancestor
102150798|NCT05850143|Hormones|hormones|mesh-ancestor
102150799|NCT05850143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102150800|NCT05850143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102150801|NCT05850143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102150802|NCT05850117|Amoxicillin|amoxicillin|mesh-list
102150803|NCT05850117|Metronidazole|metronidazole|mesh-list
102150804|NCT05850117|Levofloxacin|levofloxacin|mesh-list
102150805|NCT05850117|Ofloxacin|ofloxacin|mesh-list
102150806|NCT05850117|Tetracycline|tetracycline|mesh-list
102150807|NCT05850117|Esomeprazole|esomeprazole|mesh-list
102150808|NCT05850117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102150809|NCT05850117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102150810|NCT05850117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102150811|NCT05850117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102150812|NCT05850117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102150813|NCT05850117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102150814|NCT05850117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102150815|NCT05850117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102150816|NCT05850117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150817|NCT05850117|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102150818|NCT05850117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102150819|NCT05850117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102150820|NCT05850117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102150821|NCT05850117|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102150822|NCT05850117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102150823|NCT05850117|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102150824|NCT05850091|Colchicine|colchicine|mesh-list
102150825|NCT05850091|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102150826|NCT05850091|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102150827|NCT05850091|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102150828|NCT05850091|Antimetabolites|antimetabolites|mesh-ancestor
102150829|NCT05850091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150830|NCT05850091|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102150831|NCT05850091|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102150832|NCT05850091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102150833|NCT05850091|Gout Suppressants|gout suppressants|mesh-ancestor
102150834|NCT05850091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102150835|NCT05850091|Tubulin Modulators|tubulin modulators|mesh-ancestor
102150836|NCT05850091|Antimitotic Agents|antimitotic agents|mesh-ancestor
102150837|NCT05850091|Mitosis Modulators|mitosis modulators|mesh-ancestor
102150838|NCT05850091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102150840|NCT05849883|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102150841|NCT05849883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102150842|NCT05849883|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102150843|NCT05849883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102150844|NCT05849883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150845|NCT05849857|Dexamethasone|dexamethasone|mesh-list
102150846|NCT05849857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102150847|NCT05849857|Antiemetics|antiemetics|mesh-ancestor
102150848|NCT05849857|Autonomic Agents|autonomic agents|mesh-ancestor
102150849|NCT05849857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102150850|NCT05849857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150851|NCT05849857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102150852|NCT05849857|Glucocorticoids|glucocorticoids|mesh-ancestor
102150853|NCT05849857|Hormones|hormones|mesh-ancestor
102150854|NCT05849857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102150855|NCT05849857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102150856|NCT05849857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102150857|NCT05849766|Dapagliflozin|dapagliflozin|mesh-list
102150858|NCT05849766|Carvedilol|carvedilol|mesh-list
102150859|NCT05849766|Ramipril|ramipril|mesh-list
102150860|NCT05849766|Spironolactone|spironolactone|mesh-list
102150861|NCT05849766|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102150862|NCT05849766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150863|NCT05849766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102150864|NCT05849766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150865|NCT05849766|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102150866|NCT05849766|Hormone Antagonists|hormone antagonists|mesh-ancestor
102150867|NCT05849766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102150868|NCT05849766|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102150869|NCT05849766|Diuretics|diuretics|mesh-ancestor
102150870|NCT05849766|Natriuretic Agents|natriuretic agents|mesh-ancestor
102150871|NCT05849766|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102150872|NCT05849766|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102150873|NCT05849766|Adrenergic Agents|adrenergic agents|mesh-ancestor
102150874|NCT05849766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102150875|NCT05849766|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102150876|NCT05849766|Antioxidants|antioxidants|mesh-ancestor
102150877|NCT05849766|Protective Agents|protective agents|mesh-ancestor
102150878|NCT05849766|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102150879|NCT05849766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102150880|NCT05849766|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102150881|NCT05849766|Vasodilator Agents|vasodilator agents|mesh-ancestor
102150882|NCT05849766|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102150883|NCT05849766|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102150884|NCT05849766|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102150885|NCT05849766|Protease Inhibitors|protease inhibitors|mesh-ancestor
102150886|NCT05849766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102150887|NCT05849662|Cytarabine|cytarabine|mesh-list
102150888|NCT05849662|Fludarabine|fludarabine|mesh-list
102150889|NCT05849662|Azacitidine|azacitidine|mesh-list
102150890|NCT05849662|Trametinib|trametinib|mesh-list
102150891|NCT05849662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102150892|NCT05849662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102150893|NCT05849662|Antimetabolites|antimetabolites|mesh-ancestor
102150894|NCT05849662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150895|NCT05849662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102150896|NCT05849662|Immunologic Factors|immunologic factors|mesh-ancestor
102150897|NCT05849662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150898|NCT05849662|Antiviral Agents|antiviral agents|mesh-ancestor
102150899|NCT05849662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102150900|NCT05849662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102150901|NCT05849662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102150902|NCT05849597|Dexmedetomidine|dexmedetomidine|mesh-list
102150903|NCT05849597|Propofol|propofol|mesh-list
102150904|NCT05849597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102150905|NCT05849597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102150906|NCT05849597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150907|NCT05849597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102150908|NCT05849597|Analgesics|analgesics|mesh-ancestor
102150909|NCT05849597|Sensory System Agents|sensory system agents|mesh-ancestor
102150910|NCT05849597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102150911|NCT05849597|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102150912|NCT05849597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102150914|NCT05849597|Adrenergic Agents|adrenergic agents|mesh-ancestor
102150915|NCT05849597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102150916|NCT05849597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150917|NCT05849597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102150918|NCT05849597|Anesthetics, General|anesthetics, general|mesh-ancestor
102150919|NCT05849597|Anesthetics|anesthetics|mesh-ancestor
102150920|NCT05847283|Dydrogesterone|dydrogesterone|mesh-list
102150921|NCT05847283|Progestins|progestins|mesh-ancestor
102150922|NCT05847283|Hormones|hormones|mesh-ancestor
102150923|NCT05847283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102150924|NCT05847283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150925|NCT05846724|Pembrolizumab|pembrolizumab|mesh-list
102150926|NCT05846724|Lenvatinib|lenvatinib|mesh-list
102150927|NCT05846724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102150928|NCT05846724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102150929|NCT05846724|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102150930|NCT05846724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150931|NCT05846724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102150932|NCT05846724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102150933|NCT05846620|Dimercaprol|dimercaprol|mesh-list
102150934|NCT05846620|Chelating Agents|chelating agents|mesh-ancestor
102150935|NCT05846620|Sequestering Agents|sequestering agents|mesh-ancestor
102150936|NCT05846620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150937|NCT05845580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
102150938|NCT05845580|Red yeast rice|red yeast rice|mesh-list
102150939|NCT05845580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102150940|NCT05845580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102150941|NCT05845580|Antimetabolites|antimetabolites|mesh-ancestor
102150942|NCT05845580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150943|NCT05845580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102150944|NCT05845580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102150945|NCT05845099|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
102150946|NCT05845099|Vasodilator Agents|vasodilator agents|mesh-ancestor
102150947|NCT05845099|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
102150948|NCT05845099|Protective Agents|protective agents|mesh-ancestor
102150949|NCT05845099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150950|NCT05843968|Mycophenolic Acid|mycophenolic acid|mesh-list
102150951|NCT05843968|Rituximab|rituximab|mesh-list
102150952|NCT05843968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102150953|NCT05843968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102150954|NCT05843968|Immunologic Factors|immunologic factors|mesh-ancestor
102150955|NCT05843968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150956|NCT05843968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102150957|NCT05843968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102150958|NCT05843968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102150959|NCT05843968|Antitubercular Agents|antitubercular agents|mesh-ancestor
102150960|NCT05843968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102150961|NCT05843968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102150962|NCT05843968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102150963|NCT05843968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150964|NCT05841134|Capecitabine|capecitabine|mesh-list
102150965|NCT05841134|Oxaliplatin|oxaliplatin|mesh-list
102150966|NCT05841134|Tislelizumab|tislelizumab|mesh-list
102150967|NCT05841134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102150968|NCT05841134|Antimetabolites|antimetabolites|mesh-ancestor
102150969|NCT05841134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150970|NCT05841134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102150971|NCT05841134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102150972|NCT05837013|Anesthetics|anesthetics|mesh-list
102150973|NCT05837013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102150974|NCT05837013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150975|NCT05831878|Disitamab vedotin|disitamab vedotin|mesh-list
102150976|NCT05831878|Immunoconjugates|immunoconjugates|mesh-ancestor
102150977|NCT05831878|Immunologic Factors|immunologic factors|mesh-ancestor
102150978|NCT05831878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150979|NCT05827705|Ephedrine|ephedrine|mesh-list
102150980|NCT05827705|Pseudoephedrine|pseudoephedrine|mesh-list
102150981|NCT05827705|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102150982|NCT05827705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102150983|NCT05827705|Sympathomimetics|sympathomimetics|mesh-ancestor
102150984|NCT05827705|Autonomic Agents|autonomic agents|mesh-ancestor
102150985|NCT05827705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102150986|NCT05827705|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102150987|NCT05827705|Adrenergic Agents|adrenergic agents|mesh-ancestor
102150988|NCT05827705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102150989|NCT05827705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150990|NCT05827705|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102150991|NCT05827705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102150992|NCT05827705|Respiratory System Agents|respiratory system agents|mesh-ancestor
102150993|NCT05827705|Nasal Decongestants|nasal decongestants|mesh-ancestor
102150995|NCT05816746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102150996|NCT05816746|Antimetabolites|antimetabolites|mesh-ancestor
102150997|NCT05816746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102150998|NCT05816746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102150999|NCT05816746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102151000|NCT05949229|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102151001|NCT05949229|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102151002|NCT05949229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102151003|NCT05949229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102151004|NCT05949229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151005|NCT05949229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102151006|NCT05949229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151007|NCT05949229|Analgesics|analgesics|mesh-ancestor
102151008|NCT05949229|Sensory System Agents|sensory system agents|mesh-ancestor
102151009|NCT05949229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102151010|NCT05949229|Antidepressive Agents|antidepressive agents|mesh-ancestor
102151011|NCT05949229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102151012|NCT05949229|Dopamine Agents|dopamine agents|mesh-ancestor
102151013|NCT05949203|Cabotegravir|cabotegravir|mesh-list
102151014|NCT05949203|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102151015|NCT05949203|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102151016|NCT05949203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102151017|NCT05949203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151018|NCT05949203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102151019|NCT05949203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102151020|NCT05949203|Antiviral Agents|antiviral agents|mesh-ancestor
102151021|NCT05949203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102151022|NCT05949021|Doxorubicin|doxorubicin|mesh-list
102151023|NCT05949021|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102151024|NCT05949021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102151025|NCT05949021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151026|NCT05949021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102151027|NCT05949021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102151028|NCT05949021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102151029|NCT05949021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151030|NCT05948891|Beclomethasone|beclomethasone|mesh-list
102151031|NCT05948891|Glycopyrrolate|glycopyrrolate|mesh-list
102151032|NCT05948891|Formoterol Fumarate|formoterol fumarate|mesh-list
102151033|NCT05948891|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102151034|NCT05948891|Autonomic Agents|autonomic agents|mesh-ancestor
102151035|NCT05948891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102151036|NCT05948891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151037|NCT05948891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102151038|NCT05948891|Respiratory System Agents|respiratory system agents|mesh-ancestor
102151039|NCT05948891|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102151040|NCT05948891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102151041|NCT05948891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102151042|NCT05948891|Adrenergic Agents|adrenergic agents|mesh-ancestor
102151043|NCT05948891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102151044|NCT05948891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151045|NCT05948891|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102151046|NCT05948891|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102151047|NCT05948891|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102151048|NCT05948891|Cholinergic Agents|cholinergic agents|mesh-ancestor
102151049|NCT05948891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102151050|NCT05948891|Glucocorticoids|glucocorticoids|mesh-ancestor
102151051|NCT05948891|Hormones|hormones|mesh-ancestor
102151052|NCT05948891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102151054|NCT05948813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151055|NCT05948813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102151056|NCT05948813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102151057|NCT05948813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151058|NCT05948449|Oxaliplatin|oxaliplatin|mesh-list
102151059|NCT05948449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151060|NCT05948267|Lidocaine|lidocaine|mesh-list
102151061|NCT05948267|Fentanyl|fentanyl|mesh-list
102151062|NCT05948267|Ketamine|ketamine|mesh-list
102151063|NCT05948267|Propofol|propofol|mesh-list
102151064|NCT05948267|Anesthetics, Local|anesthetics, local|mesh-ancestor
102151065|NCT05948267|Anesthetics|anesthetics|mesh-ancestor
102151066|NCT05948267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102151067|NCT05948267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151068|NCT05948267|Sensory System Agents|sensory system agents|mesh-ancestor
102151069|NCT05948267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102151070|NCT05948267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102151071|NCT05948267|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102151072|NCT05948267|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102151073|NCT05948267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102151074|NCT05948267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151075|NCT05948267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102151076|NCT05948267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102151077|NCT05948267|Anesthetics, General|anesthetics, general|mesh-ancestor
102151078|NCT05948267|Analgesics|analgesics|mesh-ancestor
102151079|NCT05948267|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102151080|NCT05948267|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102151081|NCT05948267|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102151082|NCT05948267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102151083|NCT05948267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102151084|NCT05948267|Narcotics|narcotics|mesh-ancestor
102151085|NCT05948267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102151086|NCT05948228|Fluorides|fluorides|mesh-list
102151087|NCT05948228|Cariostatic Agents|cariostatic agents|mesh-ancestor
102151088|NCT05948228|Protective Agents|protective agents|mesh-ancestor
102151089|NCT05948228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151090|NCT05948072|Cetuximab|cetuximab|mesh-list
102151091|NCT05948072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102151092|NCT05948072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151093|NCT05947825|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102151094|NCT05947825|Paclitaxel|paclitaxel|mesh-list
102151095|NCT05947825|Gemcitabine|gemcitabine|mesh-list
102151096|NCT05947825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102151097|NCT05947825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151098|NCT05947825|Tubulin Modulators|tubulin modulators|mesh-ancestor
102151099|NCT05947825|Antimitotic Agents|antimitotic agents|mesh-ancestor
102151100|NCT05947825|Mitosis Modulators|mitosis modulators|mesh-ancestor
102151101|NCT05947825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151102|NCT05947825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102151103|NCT05947825|Antimetabolites|antimetabolites|mesh-ancestor
102151104|NCT05947825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102151105|NCT05947825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151106|NCT05947825|Incretins|incretins|mesh-ancestor
102151107|NCT05947825|Hormones|hormones|mesh-ancestor
102151108|NCT05947825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102151109|NCT05947825|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102151110|NCT05947825|Protease Inhibitors|protease inhibitors|mesh-ancestor
102151111|NCT05947825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102151112|NCT05947812|Tafenoquine|tafenoquine|mesh-list
102151113|NCT05947812|Antimalarials|antimalarials|mesh-ancestor
102151114|NCT05947812|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102151115|NCT05947812|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102151116|NCT05947812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102151117|NCT05947760|Magnesium Sulfate|magnesium sulfate|mesh-list
102151118|NCT05947760|Analgesics|analgesics|mesh-ancestor
102151119|NCT05947760|Sensory System Agents|sensory system agents|mesh-ancestor
102151120|NCT05947760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102151121|NCT05947760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151122|NCT05947760|Anesthetics|anesthetics|mesh-ancestor
102151123|NCT05947760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102151124|NCT05947760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102151125|NCT05947760|Anticonvulsants|anticonvulsants|mesh-ancestor
102151126|NCT05947760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102151127|NCT05947760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102154345|NCT03365115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102151128|NCT05947760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151129|NCT05947760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102151130|NCT05947760|Tocolytic Agents|tocolytic agents|mesh-ancestor
102151131|NCT05947760|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102151132|NCT05947708|Dialysis Solutions|dialysis solutions|mesh-list
102151133|NCT05947708|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102151135|NCT05947669|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102151136|NCT05947669|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102151137|NCT05947669|Prednisolone|prednisolone|mesh-list
102151138|NCT05947669|Prednisolone acetate|prednisolone acetate|mesh-list
102151139|NCT05947669|Infliximab|infliximab|mesh-list
102151140|NCT05947669|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102151141|NCT05947669|Prednisolone phosphate|prednisolone phosphate|mesh-list
102151142|NCT05947669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102151143|NCT05947669|Antiemetics|antiemetics|mesh-ancestor
102151144|NCT05947669|Autonomic Agents|autonomic agents|mesh-ancestor
102151145|NCT05947669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102151146|NCT05947669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151147|NCT05947669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102151148|NCT05947669|Glucocorticoids|glucocorticoids|mesh-ancestor
102151149|NCT05947669|Hormones|hormones|mesh-ancestor
102151150|NCT05947669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101752948|NCT04067102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102151151|NCT05947669|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102151152|NCT05947669|Protective Agents|protective agents|mesh-ancestor
102151153|NCT05947669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102151154|NCT05947669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151155|NCT05947669|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102151156|NCT05947669|Dermatologic Agents|dermatologic agents|mesh-ancestor
102151157|NCT05947669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102151158|NCT05947643|Theophylline|theophylline|mesh-list
102151159|NCT05947643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102151160|NCT05947643|Autonomic Agents|autonomic agents|mesh-ancestor
102151161|NCT05947643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102151162|NCT05947643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151163|NCT05947643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102151164|NCT05947643|Respiratory System Agents|respiratory system agents|mesh-ancestor
102151165|NCT05947643|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102151166|NCT05947643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102151167|NCT05947643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151168|NCT05947643|Vasodilator Agents|vasodilator agents|mesh-ancestor
102151169|NCT05947643|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102151170|NCT05947643|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102151171|NCT05947643|Purinergic Agents|purinergic agents|mesh-ancestor
102151172|NCT05947643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102151173|NCT05947604|Midazolam|midazolam|mesh-list
102151174|NCT05947604|Dextromethorphan|dextromethorphan|mesh-list
102151175|NCT05947604|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102151176|NCT05947604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102151177|NCT05947604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102151178|NCT05947604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151179|NCT05947604|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102151180|NCT05947604|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102151181|NCT05947604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102151182|NCT05947604|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102151183|NCT05947604|Anesthetics, General|anesthetics, general|mesh-ancestor
102151184|NCT05947604|Anesthetics|anesthetics|mesh-ancestor
102151185|NCT05947604|GABA Modulators|gaba modulators|mesh-ancestor
102151186|NCT05947604|GABA Agents|gaba agents|mesh-ancestor
102151187|NCT05947604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102151188|NCT05947604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151189|NCT05947604|Antitussive Agents|antitussive agents|mesh-ancestor
102151190|NCT05947604|Respiratory System Agents|respiratory system agents|mesh-ancestor
102151191|NCT05947604|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102151192|NCT05947604|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102151193|NCT05947513|Curcumin|curcumin|mesh-list
102151194|NCT05947513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102151195|NCT05947513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102151196|NCT05947513|Analgesics|analgesics|mesh-ancestor
102151197|NCT05947513|Sensory System Agents|sensory system agents|mesh-ancestor
102151198|NCT05947513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102151199|NCT05947513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151200|NCT05947513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102151201|NCT05947513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102151202|NCT05947513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151203|NCT05947513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102151204|NCT05947513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151206|NCT05947500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102151207|NCT05947500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101860089|NCT00304356|Nitazoxanide|nitazoxanide|mesh-list
102151208|NCT05947500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151209|NCT05947500|Immunologic Factors|immunologic factors|mesh-ancestor
102151210|NCT05947500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151212|NCT05947461|Indomethacin|indomethacin|mesh-list
102151213|NCT05947461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102151214|NCT05947461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102151215|NCT05947461|Analgesics|analgesics|mesh-ancestor
102151216|NCT05947461|Sensory System Agents|sensory system agents|mesh-ancestor
102151217|NCT05947461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102151218|NCT05947461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151219|NCT05947461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102151220|NCT05947461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102151221|NCT05947461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102151222|NCT05947461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102151223|NCT05947461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151224|NCT05947461|Gout Suppressants|gout suppressants|mesh-ancestor
102151225|NCT05947461|Tocolytic Agents|tocolytic agents|mesh-ancestor
102151226|NCT05947461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102151227|NCT05947383|Psilocybin|psilocybin|mesh-list
102151228|NCT05947383|Hallucinogens|hallucinogens|mesh-ancestor
102151229|NCT05947383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151230|NCT05947383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102151231|NCT05947162|Nicotine|nicotine|mesh-list
102151232|NCT05947162|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102151233|NCT05947162|Autonomic Agents|autonomic agents|mesh-ancestor
102151234|NCT05947162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102151235|NCT05947162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151236|NCT05947162|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102151237|NCT05947162|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102151238|NCT05947162|Cholinergic Agents|cholinergic agents|mesh-ancestor
102151239|NCT05947162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102151240|NCT05947162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151241|NCT05947071|Vaccines|vaccines|mesh-list
102151242|NCT05947071|Immunologic Factors|immunologic factors|mesh-ancestor
102151243|NCT05947071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151244|NCT05944445|Linezolid|linezolid|mesh-list
102151245|NCT05944445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102151246|NCT05944445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102151247|NCT05944445|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102151248|NCT05944445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102151249|NCT05944445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151250|NCT05944055|Vitamin D|vitamin d|mesh-list
102151251|NCT05944055|Vitamins|vitamins|mesh-ancestor
102151252|NCT05944055|Micronutrients|micronutrients|mesh-ancestor
102151253|NCT05944055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151254|NCT05944055|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102151255|NCT05941858|Nicotine|nicotine|mesh-list
102151256|NCT05941858|Carbon Monoxide|carbon monoxide|mesh-list
102151257|NCT05941858|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102151258|NCT05941858|Autonomic Agents|autonomic agents|mesh-ancestor
102151259|NCT05941858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102151260|NCT05941858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151261|NCT05941858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102151262|NCT05941858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102151263|NCT05941858|Cholinergic Agents|cholinergic agents|mesh-ancestor
102151264|NCT05941858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102241610|NCT03071055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151265|NCT05941858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151266|NCT05941858|Antimetabolites|antimetabolites|mesh-ancestor
102151267|NCT05941858|Gasotransmitters|gasotransmitters|mesh-ancestor
102151268|NCT05940961|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
102151269|NCT05940961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102151270|NCT05940961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151271|NCT05940961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102151272|NCT05940961|Immunotoxins|immunotoxins|mesh-ancestor
102151273|NCT05940961|Immunoconjugates|immunoconjugates|mesh-ancestor
102151274|NCT05940961|Immunologic Factors|immunologic factors|mesh-ancestor
102151275|NCT05940961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151276|NCT05937854|Tadalafil|tadalafil|mesh-list
102151277|NCT05937854|Vasodilator Agents|vasodilator agents|mesh-ancestor
102151278|NCT05937854|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102093834|NCT03061006|Dabigatran|dabigatran|mesh-list
102151285|NCT05933057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102151286|NCT05933057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151287|NCT05925049|Natalizumab|natalizumab|mesh-list
102151288|NCT05925049|Immunologic Factors|immunologic factors|mesh-ancestor
102151289|NCT05925049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151297|NCT05906459|Antibodies|antibodies|mesh-list
102151298|NCT05906459|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
102151299|NCT05906459|Immunologic Factors|immunologic factors|mesh-ancestor
102151300|NCT05906459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151301|NCT05895747|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
102151302|NCT05895747|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102151303|NCT05895747|Antidepressive Agents|antidepressive agents|mesh-ancestor
102151304|NCT05895747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102151305|NCT05862168|Paclitaxel|paclitaxel|mesh-list
102151306|NCT05862168|Fluorouracil|fluorouracil|mesh-list
102151307|NCT05862168|Tislelizumab|tislelizumab|mesh-list
102151308|NCT05862168|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102151309|NCT05862168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151310|NCT05862168|Tubulin Modulators|tubulin modulators|mesh-ancestor
102151311|NCT05862168|Antimitotic Agents|antimitotic agents|mesh-ancestor
102151312|NCT05862168|Mitosis Modulators|mitosis modulators|mesh-ancestor
102151313|NCT05862168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151314|NCT05862168|Antimetabolites|antimetabolites|mesh-ancestor
102151315|NCT05862168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102151316|NCT05862168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102151317|NCT05862168|Immunologic Factors|immunologic factors|mesh-ancestor
102151318|NCT05862168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151319|NCT05862168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102151320|NCT05855876|Ketamine|ketamine|mesh-list
102151321|NCT05855876|Analgesics|analgesics|mesh-ancestor
102151322|NCT05855876|Sensory System Agents|sensory system agents|mesh-ancestor
102151323|NCT05855876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102151324|NCT05855876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151325|NCT05855876|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102151326|NCT05855876|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102151327|NCT05855876|Anesthetics, General|anesthetics, general|mesh-ancestor
102151328|NCT05855876|Anesthetics|anesthetics|mesh-ancestor
102151329|NCT05855876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102151330|NCT05855876|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102151331|NCT05855876|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102151332|NCT05855876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102151333|NCT05855876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151334|NCT05838287|Pioglitazone|pioglitazone|mesh-list
102151335|NCT05838287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102151336|NCT05838287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151337|NCT05832047|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102151338|NCT05831124|Vaccines|vaccines|mesh-list
102151339|NCT05831124|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102151340|NCT05831124|Immunologic Factors|immunologic factors|mesh-ancestor
102151341|NCT05831124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151342|NCT05827978|Vaccines|vaccines|mesh-list
102151343|NCT05827978|Immunologic Factors|immunologic factors|mesh-ancestor
102151344|NCT05827978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151345|NCT05825066|Paclitaxel|paclitaxel|mesh-list
102151346|NCT05825066|Gemcitabine|gemcitabine|mesh-list
102151347|NCT05825066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102151348|NCT05825066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151349|NCT05825066|Tubulin Modulators|tubulin modulators|mesh-ancestor
102151350|NCT05825066|Antimitotic Agents|antimitotic agents|mesh-ancestor
102151351|NCT05825066|Mitosis Modulators|mitosis modulators|mesh-ancestor
102151352|NCT05825066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151353|NCT05825066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102151354|NCT05825066|Antimetabolites|antimetabolites|mesh-ancestor
102151355|NCT05808010|Hydrotalcite|hydrotalcite|mesh-list
101860238|NCT03978156|Analgesics|analgesics|mesh-ancestor
102151356|NCT05808010|Antacids|antacids|mesh-ancestor
102151357|NCT05808010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151358|NCT05808010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102151359|NCT05799378|Hydroxychloroquine|hydroxychloroquine|mesh-list
102151360|NCT05799378|Antimalarials|antimalarials|mesh-ancestor
102151361|NCT05799378|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102151362|NCT05799378|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102151363|NCT05799378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102151364|NCT05799378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102151365|NCT05799378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151366|NCT05799378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102151367|NCT05794958|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
102151368|NCT05794958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102151369|NCT05794958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151370|NCT05775159|Bevacizumab|bevacizumab|mesh-list
102151371|NCT05775159|Gemcitabine|gemcitabine|mesh-list
102151372|NCT05775159|Lenvatinib|lenvatinib|mesh-list
102151373|NCT05775159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102151374|NCT05775159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151375|NCT05775159|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102151376|NCT05775159|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102151377|NCT05775159|Growth Substances|growth substances|mesh-ancestor
102151378|NCT05775159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151379|NCT05775159|Growth Inhibitors|growth inhibitors|mesh-ancestor
102151380|NCT05775159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102151381|NCT05775159|Antimetabolites|antimetabolites|mesh-ancestor
102151382|NCT05775159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151383|NCT05775159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102151384|NCT05775159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102151385|NCT05774951|Tamoxifen|tamoxifen|mesh-list
102151386|NCT05774951|Letrozole|letrozole|mesh-list
102151387|NCT05774951|Anastrozole|anastrozole|mesh-list
102151388|NCT05774951|Exemestane|exemestane|mesh-list
102151389|NCT05774951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151390|NCT05774951|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102151391|NCT05774951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102151392|NCT05774951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102151393|NCT05774951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151394|NCT05774951|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102151395|NCT05774951|Hormone Antagonists|hormone antagonists|mesh-ancestor
102151396|NCT05774951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102151397|NCT05774951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151398|NCT05774951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102151399|NCT05774951|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102151400|NCT05774951|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102151401|NCT05774951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102151402|NCT05760313|Linaclotide|linaclotide|mesh-list
102151403|NCT05760313|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102151404|NCT05760313|Enzyme Activators|enzyme activators|mesh-ancestor
102151405|NCT05760313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151406|NCT05760313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102151407|NCT05756777|Ivosidenib|ivosidenib|mesh-list
102151408|NCT05756777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151409|NCT05756777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102151410|NCT05756777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151411|NCT05754203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102151412|NCT05754203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151413|NCT05754203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102151414|NCT05754203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151415|NCT05748665|Etomidate|etomidate|mesh-list
102151416|NCT05748665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102151417|NCT05748665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102151418|NCT05748665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151419|NCT05748665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102151420|NCT05748665|Anesthetics, General|anesthetics, general|mesh-ancestor
102151421|NCT05748665|Anesthetics|anesthetics|mesh-ancestor
102151422|NCT05724329|Dasatinib|dasatinib|mesh-list
102151423|NCT05724329|Tislelizumab|tislelizumab|mesh-list
102151424|NCT05724329|Quercetin|quercetin|mesh-list
102151425|NCT05724329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151426|NCT05724329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102151427|NCT05724329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102151428|NCT05724329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151429|NCT05724329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102151430|NCT05724329|Antioxidants|antioxidants|mesh-ancestor
102151431|NCT05724329|Protective Agents|protective agents|mesh-ancestor
102151432|NCT05724329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151433|NCT05718466|Bevacizumab|bevacizumab|mesh-list
102151434|NCT05718466|Carboplatin|carboplatin|mesh-list
102151435|NCT05718466|Irinotecan|irinotecan|mesh-list
102151436|NCT05718466|Etoposide|etoposide|mesh-list
102151437|NCT05718466|Temozolomide|temozolomide|mesh-list
102151438|NCT05718466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102151439|NCT05718466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151440|NCT05718466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102151441|NCT05718466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102151442|NCT05718466|Growth Substances|growth substances|mesh-ancestor
102151443|NCT05718466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151444|NCT05718466|Growth Inhibitors|growth inhibitors|mesh-ancestor
102151445|NCT05718466|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102151446|NCT05718466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102151447|NCT05718466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102151448|NCT05718466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151449|NCT05718466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102151450|NCT05718466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102151451|NCT05718466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102151452|NCT05718466|Alkylating Agents|alkylating agents|mesh-ancestor
102151453|NCT05715216|Nivolumab|nivolumab|mesh-list
102151454|NCT05715216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102151455|NCT05715216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151456|NCT05715216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102151457|NCT05715216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151458|NCT05680129|Metformin|metformin|mesh-list
102151459|NCT05680129|Dulaglutide|dulaglutide|mesh-list
102151460|NCT05680129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102151461|NCT05680129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151462|NCT05647122|Osimertinib|osimertinib|mesh-list
102151463|NCT05647122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151464|NCT05647122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102151465|NCT05647122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102151466|NCT05647122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151467|NCT05640934|Melatonin|melatonin|mesh-list
102151468|NCT05640934|Antioxidants|antioxidants|mesh-ancestor
102151469|NCT05640934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151470|NCT05640934|Protective Agents|protective agents|mesh-ancestor
102151471|NCT05640934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151472|NCT05640934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102151473|NCT05640180|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102151474|NCT05640180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151475|NCT05640180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102151476|NCT05640180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151477|NCT05514054|Tamoxifen|tamoxifen|mesh-list
102151478|NCT05514054|Letrozole|letrozole|mesh-list
102151479|NCT05514054|Anastrozole|anastrozole|mesh-list
102151480|NCT05514054|Exemestane|exemestane|mesh-list
102151481|NCT05514054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151482|NCT05514054|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102151483|NCT05514054|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102151484|NCT05514054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102151485|NCT05514054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151486|NCT05514054|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102151487|NCT05514054|Hormone Antagonists|hormone antagonists|mesh-ancestor
102151488|NCT05514054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102151489|NCT05514054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151490|NCT05514054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102151491|NCT05514054|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102151492|NCT05514054|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102151493|NCT05514054|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102151494|NCT05508009|Cyclophosphamide|cyclophosphamide|mesh-list
102151495|NCT05508009|Melphalan|melphalan|mesh-list
102151496|NCT05508009|Rituximab|rituximab|mesh-list
102151497|NCT05508009|Fludarabine|fludarabine|mesh-list
102151498|NCT05508009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102151499|NCT05508009|Immunologic Factors|immunologic factors|mesh-ancestor
102151500|NCT05508009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151501|NCT05508009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102151502|NCT05508009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102151504|NCT05508009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151506|NCT05508009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102151507|NCT05508009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102151508|NCT05498272|Olaparib|olaparib|mesh-list
102151509|NCT05498272|Leuprolide|leuprolide|mesh-list
102151510|NCT05498272|Goserelin|goserelin|mesh-list
102151511|NCT05498272|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102151512|NCT05498272|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102151513|NCT05498272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102151514|NCT05498272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151515|NCT05498272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151516|NCT05498272|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102151517|NCT05498272|Fertility Agents|fertility agents|mesh-ancestor
102151518|NCT05498272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102151519|NCT05498272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151520|NCT05498272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102151521|NCT05498272|Luteolytic Agents|luteolytic agents|mesh-ancestor
102151522|NCT05498272|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102151523|NCT05498272|Contraceptive Agents|contraceptive agents|mesh-ancestor
102151524|NCT05498272|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102151525|NCT05471830|Apixaban|apixaban|mesh-list
102151526|NCT05471830|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102151527|NCT05471830|Antithrombins|antithrombins|mesh-ancestor
102151528|NCT05471830|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102151529|NCT05471830|Protease Inhibitors|protease inhibitors|mesh-ancestor
102151530|NCT05471830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102151531|NCT05471830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151532|NCT05471830|Anticoagulants|anticoagulants|mesh-ancestor
102151533|NCT05459298|Vitamin D|vitamin d|mesh-list
102151534|NCT05459298|Cholecalciferol|cholecalciferol|mesh-list
102151535|NCT05459298|Vitamins|vitamins|mesh-ancestor
102151536|NCT05459298|Micronutrients|micronutrients|mesh-ancestor
102151537|NCT05459298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151538|NCT05459298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102151539|NCT05459298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102151540|NCT05407662|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
102151541|NCT05407662|Mineralocorticoids|mineralocorticoids|mesh-list
102151542|NCT05407662|Hormone Antagonists|hormone antagonists|mesh-ancestor
102151543|NCT05407662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102151544|NCT05407662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151545|NCT05407662|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102151546|NCT05407662|Diuretics|diuretics|mesh-ancestor
102151547|NCT05407662|Natriuretic Agents|natriuretic agents|mesh-ancestor
102151548|NCT05407662|Hormones|hormones|mesh-ancestor
102151549|NCT05401565|Balovaptan|balovaptan|mesh-list
102151550|NCT05401565|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102151551|NCT05401565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151552|NCT05401565|Natriuretic Agents|natriuretic agents|mesh-ancestor
102151553|NCT05401565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151554|NCT05400577|Sotorasib|sotorasib|mesh-list
102151555|NCT05400577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102151556|NCT05400577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151557|NCT05400577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102151558|NCT05400577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151559|NCT05304390|Carbon Monoxide|carbon monoxide|mesh-list
102151560|NCT05304390|Antimetabolites|antimetabolites|mesh-ancestor
102151561|NCT05304390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151562|NCT05304390|Gasotransmitters|gasotransmitters|mesh-ancestor
102151563|NCT05304390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102151564|NCT05304390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151565|NCT05295589|Paclitaxel|paclitaxel|mesh-list
102151566|NCT05295589|Doxorubicin|doxorubicin|mesh-list
102151567|NCT05295589|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102151568|NCT05295589|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102151569|NCT05295589|Topotecan|topotecan|mesh-list
102151570|NCT05295589|Olaparib|olaparib|mesh-list
102151571|NCT05295589|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102151572|NCT05295589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102151573|NCT05295589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151574|NCT05295589|Tubulin Modulators|tubulin modulators|mesh-ancestor
102151575|NCT05295589|Antimitotic Agents|antimitotic agents|mesh-ancestor
102151576|NCT05295589|Mitosis Modulators|mitosis modulators|mesh-ancestor
102151577|NCT05295589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151578|NCT05295589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102151579|NCT05295589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102151580|NCT05295589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102151581|NCT05295589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102151582|NCT05295589|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102151583|NCT05288777|Capecitabine|capecitabine|mesh-list
102151584|NCT05288777|Trastuzumab|trastuzumab|mesh-list
102151585|NCT05288777|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102151586|NCT05288777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102151587|NCT05288777|Antimetabolites|antimetabolites|mesh-ancestor
102151588|NCT05288777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151589|NCT05288777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151590|NCT05288777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102151591|NCT05288777|Tubulin Modulators|tubulin modulators|mesh-ancestor
102151592|NCT05288777|Antimitotic Agents|antimitotic agents|mesh-ancestor
102151593|NCT05288777|Mitosis Modulators|mitosis modulators|mesh-ancestor
102151594|NCT05288777|Immunotoxins|immunotoxins|mesh-ancestor
102151595|NCT05288777|Immunoconjugates|immunoconjugates|mesh-ancestor
102151596|NCT05288777|Immunologic Factors|immunologic factors|mesh-ancestor
102151597|NCT05288777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151598|NCT05269381|Cyclophosphamide|cyclophosphamide|mesh-list
102151599|NCT05269381|Pembrolizumab|pembrolizumab|mesh-list
102151600|NCT05269381|Sargramostim|sargramostim|mesh-list
102151601|NCT05269381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102151602|NCT05269381|Immunologic Factors|immunologic factors|mesh-ancestor
102151603|NCT05269381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151604|NCT05269381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102151605|NCT05269381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102151606|NCT05269381|Alkylating Agents|alkylating agents|mesh-ancestor
102151607|NCT05269381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151608|NCT05269381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151609|NCT05269381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102151610|NCT05269381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102151611|NCT05269381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102151613|NCT05261269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102151614|NCT05261269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102151615|NCT05261269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151616|NCT05261269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151617|NCT05228496|Tislelizumab|tislelizumab|mesh-list
102241612|NCT04433559|Vasodilator Agents|vasodilator agents|mesh-ancestor
102151618|NCT05228496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102151619|NCT05228496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151620|NCT05194397|Niacinamide|niacinamide|mesh-list
102151621|NCT05194397|Niacin|niacin|mesh-list
102151622|NCT05194397|Nicotinic Acids|nicotinic acids|mesh-list
102151623|NCT05194397|Vitamin B Complex|vitamin b complex|mesh-ancestor
102151624|NCT05194397|Vitamins|vitamins|mesh-ancestor
102151625|NCT05194397|Micronutrients|micronutrients|mesh-ancestor
102151626|NCT05194397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151627|NCT05194397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102151628|NCT05194397|Antimetabolites|antimetabolites|mesh-ancestor
102151629|NCT05194397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151630|NCT05194397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102151631|NCT05194397|Vasodilator Agents|vasodilator agents|mesh-ancestor
102151632|NCT05156281|Teriflunomide|teriflunomide|mesh-list
102151633|NCT05156281|Remibrutinib|remibrutinib|mesh-list
102151634|NCT05156281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102151635|NCT05156281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102151636|NCT05156281|Analgesics|analgesics|mesh-ancestor
102151637|NCT05156281|Sensory System Agents|sensory system agents|mesh-ancestor
102151638|NCT05156281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102151639|NCT05156281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151640|NCT05156281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102151641|NCT05156281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102151642|NCT05156281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102151643|NCT05156281|Immunologic Factors|immunologic factors|mesh-ancestor
102151644|NCT05156281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102151645|NCT05156281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102151646|NCT05156281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151647|NCT05153174|Sulforaphane|sulforaphane|mesh-list
102151648|NCT05153174|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102151649|NCT05153174|Protective Agents|protective agents|mesh-ancestor
102151650|NCT05153174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151651|NCT05153174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151652|NCT05147662|Factor VIII|factor viii|mesh-list
102151653|NCT05147662|Coagulants|coagulants|mesh-ancestor
102151654|NCT05101746|Nitric Oxide|nitric oxide|mesh-list
102151655|NCT05101746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102151656|NCT05101746|Autonomic Agents|autonomic agents|mesh-ancestor
102151657|NCT05101746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102151658|NCT05101746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151659|NCT05101746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102151660|NCT05101746|Respiratory System Agents|respiratory system agents|mesh-ancestor
102151661|NCT05101746|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102151662|NCT05101746|Antioxidants|antioxidants|mesh-ancestor
102151663|NCT05101746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151664|NCT05101746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102151665|NCT05101746|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102151666|NCT05101746|Vasodilator Agents|vasodilator agents|mesh-ancestor
102151667|NCT05101746|Gasotransmitters|gasotransmitters|mesh-ancestor
102151668|NCT05101746|Protective Agents|protective agents|mesh-ancestor
102151669|NCT05098210|Poly I-C|poly i-c|mesh-list
102151670|NCT05098210|Nivolumab|nivolumab|mesh-list
102151671|NCT05098210|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102151672|NCT05098210|Poly ICLC|poly iclc|mesh-list
102151673|NCT05098210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102151674|NCT05098210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151675|NCT05098210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102151676|NCT05098210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151677|NCT05098210|Interferon Inducers|interferon inducers|mesh-ancestor
102151678|NCT05098210|Immunologic Factors|immunologic factors|mesh-ancestor
102151679|NCT05098210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151680|NCT05098210|Laxatives|laxatives|mesh-ancestor
102151681|NCT05098210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102151682|NCT05098210|Antiviral Agents|antiviral agents|mesh-ancestor
102151683|NCT05098210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102151684|NCT05069597|Pancrelipase|pancrelipase|mesh-list
102151685|NCT05069597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102151686|NCT04985916|Botulinum Toxins|botulinum toxins|mesh-list
102151687|NCT04985916|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102151688|NCT04985916|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102151689|NCT04985916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102151690|NCT04985916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102151691|NCT04985916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151692|NCT04985916|Cholinergic Agents|cholinergic agents|mesh-ancestor
102151693|NCT04985916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102151694|NCT04985916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151695|NCT04985916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102151696|NCT04985916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102151697|NCT04951492|Olaparib|olaparib|mesh-list
102151698|NCT04951492|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102151699|NCT04951492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102151700|NCT04951492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151701|NCT04951492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151702|NCT04938453|Nintedanib|nintedanib|mesh-list
102151703|NCT04938453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151704|NCT04938453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102151705|NCT04938453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102151706|NCT04938453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151707|NCT04926818|Ofatumumab|ofatumumab|mesh-list
102151708|NCT04926818|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102151709|NCT04926818|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102151710|NCT04926818|Siponimod|siponimod|mesh-list
102151711|NCT04926818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151712|NCT04926818|Immunologic Factors|immunologic factors|mesh-ancestor
102151713|NCT04926818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151714|NCT04926818|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102151715|NCT04926818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151716|NCT04926818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102151717|NCT04887285|Anesthetics|anesthetics|mesh-list
102151718|NCT04887285|Anesthetics, Local|anesthetics, local|mesh-list
102151719|NCT04887285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102151720|NCT04887285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151721|NCT04887285|Sensory System Agents|sensory system agents|mesh-ancestor
102151722|NCT04887285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102151723|NCT04877821|Paclitaxel|paclitaxel|mesh-list
102151724|NCT04877821|Cyclophosphamide|cyclophosphamide|mesh-list
102151725|NCT04877821|Carboplatin|carboplatin|mesh-list
102151726|NCT04877821|Epirubicin|epirubicin|mesh-list
102151727|NCT04877821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102151728|NCT04877821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151729|NCT04877821|Tubulin Modulators|tubulin modulators|mesh-ancestor
102151731|NCT04877821|Mitosis Modulators|mitosis modulators|mesh-ancestor
102151732|NCT04877821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151733|NCT04877821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102151734|NCT04877821|Immunologic Factors|immunologic factors|mesh-ancestor
102151735|NCT04877821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151736|NCT04877821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102151737|NCT04877821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102151738|NCT04877821|Alkylating Agents|alkylating agents|mesh-ancestor
102151739|NCT04877821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102151740|NCT04877821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102151741|NCT04877821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102151742|NCT04877821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102151743|NCT04877821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102151744|NCT04827576|Docetaxel|docetaxel|mesh-list
102151745|NCT04827576|Magrolimab|magrolimab|mesh-list
102151746|NCT04827576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151747|NCT04827576|Tubulin Modulators|tubulin modulators|mesh-ancestor
102151748|NCT04827576|Antimitotic Agents|antimitotic agents|mesh-ancestor
102151749|NCT04827576|Mitosis Modulators|mitosis modulators|mesh-ancestor
101753542|NCT00655629|Vasodilator Agents|vasodilator agents|mesh-ancestor
102151750|NCT04827576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151751|NCT04827576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102151752|NCT04809766|Cyclophosphamide|cyclophosphamide|mesh-list
102151753|NCT04809766|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102151754|NCT04809766|Fludarabine|fludarabine|mesh-list
102151755|NCT04809766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102151756|NCT04809766|Immunologic Factors|immunologic factors|mesh-ancestor
102151757|NCT04809766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151758|NCT04809766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102151759|NCT04809766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102151760|NCT04809766|Alkylating Agents|alkylating agents|mesh-ancestor
102151761|NCT04809766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151762|NCT04809766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151763|NCT04809766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102151764|NCT04778982|Fulvestrant|fulvestrant|mesh-list
102151765|NCT04778982|Palbociclib|palbociclib|mesh-list
102151766|NCT04778982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102151767|NCT04778982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151768|NCT04778982|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102151769|NCT04778982|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102151770|NCT04778982|Hormone Antagonists|hormone antagonists|mesh-ancestor
102151771|NCT04778982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102151772|NCT04778982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151773|NCT04778982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102151774|NCT04778982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102151775|NCT04778982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151776|NCT04772781|Ibuprofen|ibuprofen|mesh-list
102151777|NCT04772781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102151778|NCT04772781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102151779|NCT04772781|Analgesics|analgesics|mesh-ancestor
102151780|NCT04772781|Sensory System Agents|sensory system agents|mesh-ancestor
102151781|NCT04772781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102151782|NCT04772781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151783|NCT04772781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102151784|NCT04772781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102151785|NCT04772781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102151786|NCT04772781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102151787|NCT04772781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151788|NCT04699591|Domperidone|domperidone|mesh-list
102151789|NCT04699591|Antiemetics|antiemetics|mesh-ancestor
102151790|NCT04699591|Autonomic Agents|autonomic agents|mesh-ancestor
102151791|NCT04699591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102151792|NCT04699591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151793|NCT04699591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102151794|NCT04699591|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102151795|NCT04699591|Dopamine Agents|dopamine agents|mesh-ancestor
102151796|NCT04699591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102151797|NCT04699591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151798|NCT04679948|Midazolam|midazolam|mesh-list
102151799|NCT04679948|Caffeine|caffeine|mesh-list
102151800|NCT04679948|Omeprazole|omeprazole|mesh-list
102151801|NCT04679948|Warfarin|warfarin|mesh-list
102151802|NCT04679948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102154346|NCT03365115|Narcotics|narcotics|mesh-ancestor
102151804|NCT04679948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102151805|NCT04679948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151807|NCT04679948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102151808|NCT04679948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102151809|NCT04679948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102151810|NCT04679948|Anesthetics, General|anesthetics, general|mesh-ancestor
102151811|NCT04679948|Anesthetics|anesthetics|mesh-ancestor
102151812|NCT04679948|GABA Modulators|gaba modulators|mesh-ancestor
102151813|NCT04679948|GABA Agents|gaba agents|mesh-ancestor
102151814|NCT04679948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102151815|NCT04679948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151816|NCT04679948|Anticoagulants|anticoagulants|mesh-ancestor
102151817|NCT04679948|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102151818|NCT04679948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102151819|NCT04679948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102151820|NCT04679948|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102151821|NCT04679948|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102151822|NCT04679948|Purinergic Agents|purinergic agents|mesh-ancestor
102151823|NCT04679948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102151824|NCT04679948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102151825|NCT04679948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102151826|NCT04663308|Volixibat|volixibat|mesh-list
102151827|NCT04663308|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102151828|NCT04660344|Atezolizumab|atezolizumab|mesh-list
102151829|NCT04660344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102151830|NCT04660344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151831|NCT04660344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102151832|NCT04660344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151833|NCT04647435|Tramadol|tramadol|mesh-list
102151834|NCT04647435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102151835|NCT04647435|Narcotics|narcotics|mesh-ancestor
102151836|NCT04647435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102151837|NCT04647435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151838|NCT04647435|Analgesics|analgesics|mesh-ancestor
102151839|NCT04647435|Sensory System Agents|sensory system agents|mesh-ancestor
102151840|NCT04647435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102151841|NCT04637529|Ibuprofen|ibuprofen|mesh-list
102151842|NCT04637529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102151843|NCT04637529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102151844|NCT04637529|Analgesics|analgesics|mesh-ancestor
102151845|NCT04637529|Sensory System Agents|sensory system agents|mesh-ancestor
102151846|NCT04637529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102151847|NCT04637529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151848|NCT04637529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102151849|NCT04637529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102151850|NCT04637529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102151851|NCT04637529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102151852|NCT04637529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151853|NCT04625803|Apatinib|apatinib|mesh-list
102151854|NCT04625803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151855|NCT04625803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102151856|NCT04625803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102151857|NCT04625803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151858|NCT04621526|Dexmedetomidine|dexmedetomidine|mesh-list
102151859|NCT04621526|Ketamine|ketamine|mesh-list
102151860|NCT04621526|Propofol|propofol|mesh-list
102151861|NCT04621526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102151862|NCT04621526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102151863|NCT04621526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151864|NCT04621526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102151865|NCT04621526|Analgesics|analgesics|mesh-ancestor
102151866|NCT04621526|Sensory System Agents|sensory system agents|mesh-ancestor
102151867|NCT04621526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102151868|NCT04621526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102151869|NCT04621526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102151870|NCT04621526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102151871|NCT04621526|Adrenergic Agents|adrenergic agents|mesh-ancestor
102151872|NCT04621526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102151873|NCT04621526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151874|NCT04621526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102151875|NCT04621526|Anesthetics, General|anesthetics, general|mesh-ancestor
102151876|NCT04621526|Anesthetics|anesthetics|mesh-ancestor
102151877|NCT04621526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102151878|NCT04621526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102151879|NCT04621526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102151880|NCT04620759|Psilocybin|psilocybin|mesh-list
102151881|NCT04620759|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
102151882|NCT04620759|Hallucinogens|hallucinogens|mesh-ancestor
102151883|NCT04620759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151884|NCT04620759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102151885|NCT04620759|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102151886|NCT04620759|Serotonin Agents|serotonin agents|mesh-ancestor
102151887|NCT04620759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102151888|NCT04620759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151889|NCT04620759|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102151890|NCT04590937|Metformin|metformin|mesh-list
102151891|NCT04590937|Digoxin|digoxin|mesh-list
102151892|NCT04590937|Furosemide|furosemide|mesh-list
102151893|NCT04590937|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102151894|NCT04590937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102151895|NCT04590937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151896|NCT04590937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102151897|NCT04590937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102151898|NCT04590937|Antimetabolites|antimetabolites|mesh-ancestor
102151899|NCT04590937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151900|NCT04590937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102151901|NCT04590937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102151902|NCT04590937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102151903|NCT04590937|Diuretics|diuretics|mesh-ancestor
102151904|NCT04590937|Natriuretic Agents|natriuretic agents|mesh-ancestor
102151905|NCT04590937|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102151906|NCT04590937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102151907|NCT04590937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102151908|NCT04590937|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102151909|NCT04590937|Protective Agents|protective agents|mesh-ancestor
102151910|NCT04586010|Teriflunomide|teriflunomide|mesh-list
102151911|NCT04586010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102151912|NCT04586010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102151913|NCT04586010|Analgesics|analgesics|mesh-ancestor
102151914|NCT04586010|Sensory System Agents|sensory system agents|mesh-ancestor
102151915|NCT04586010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102151916|NCT04586010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151917|NCT04586010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102151918|NCT04586010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102151919|NCT04586010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102151920|NCT04586010|Immunologic Factors|immunologic factors|mesh-ancestor
102151921|NCT04577755|Pomalidomide|pomalidomide|mesh-list
102151922|NCT04577755|Immunologic Factors|immunologic factors|mesh-ancestor
102151923|NCT04577755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151924|NCT04577755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102151925|NCT04577755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102151926|NCT04577755|Growth Substances|growth substances|mesh-ancestor
102151927|NCT04577755|Growth Inhibitors|growth inhibitors|mesh-ancestor
102151928|NCT04577755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151929|NCT04544189|Fulvestrant|fulvestrant|mesh-list
102151930|NCT04544189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102151931|NCT04544189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151932|NCT04544189|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102151933|NCT04544189|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102151934|NCT04544189|Hormone Antagonists|hormone antagonists|mesh-ancestor
102151935|NCT04544189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102151936|NCT04544189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151937|NCT04491084|Antibodies|antibodies|mesh-list
102151938|NCT04491084|Flt3 ligand protein|flt3 ligand protein|mesh-list
102151939|NCT04491084|Immunologic Factors|immunologic factors|mesh-ancestor
102151940|NCT04491084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151941|NCT04491084|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102151942|NCT04491084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102151943|NCT04491084|Protective Agents|protective agents|mesh-ancestor
102151944|NCT04446117|Prednisone|prednisone|mesh-list
102151945|NCT04446117|Atezolizumab|atezolizumab|mesh-list
102151946|NCT04446117|Abiraterone Acetate|abiraterone acetate|mesh-list
102151947|NCT04446117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102151948|NCT04446117|Glucocorticoids|glucocorticoids|mesh-ancestor
102151949|NCT04446117|Hormones|hormones|mesh-ancestor
102151950|NCT04446117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102151951|NCT04446117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151952|NCT04446117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102151954|NCT04446117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102151955|NCT04446117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151956|NCT04446117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102151957|NCT04446117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102151958|NCT04446117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102151959|NCT04446117|Hormone Antagonists|hormone antagonists|mesh-ancestor
102151960|NCT04446117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102151961|NCT04435600|Ustekinumab|ustekinumab|mesh-list
102151962|NCT04435600|Dermatologic Agents|dermatologic agents|mesh-ancestor
102151963|NCT04431635|Rituximab|rituximab|mesh-list
102151964|NCT04431635|Nivolumab|nivolumab|mesh-list
102151965|NCT04431635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102151966|NCT04431635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151967|NCT04431635|Immunologic Factors|immunologic factors|mesh-ancestor
102151968|NCT04431635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151969|NCT04431635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102151970|NCT04431635|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102151971|NCT04431635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151972|NCT04397003|Durvalumab|durvalumab|mesh-list
102151973|NCT04397003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102151974|NCT04397003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151975|NCT04329065|Paclitaxel|paclitaxel|mesh-list
102151976|NCT04329065|Trastuzumab|trastuzumab|mesh-list
102151977|NCT04329065|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102151978|NCT04329065|Pertuzumab|pertuzumab|mesh-list
102151979|NCT04329065|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
102151980|NCT04329065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102151981|NCT04329065|Vaccines|vaccines|mesh-list
102151982|NCT04329065|Antibodies|antibodies|mesh-list
102151983|NCT04329065|Immunoglobulins|immunoglobulins|mesh-list
102151984|NCT04329065|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102151985|NCT04329065|Immunoglobulin G|immunoglobulin g|mesh-list
102151986|NCT04329065|Immunologic Factors|immunologic factors|mesh-ancestor
102151987|NCT04329065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102151988|NCT04329065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102151989|NCT04329065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151990|NCT04329065|Tubulin Modulators|tubulin modulators|mesh-ancestor
102151991|NCT04329065|Antimitotic Agents|antimitotic agents|mesh-ancestor
102151992|NCT04329065|Mitosis Modulators|mitosis modulators|mesh-ancestor
102151993|NCT04329065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102151994|NCT04326257|Nivolumab|nivolumab|mesh-list
102151995|NCT04326257|Ipilimumab|ipilimumab|mesh-list
102151996|NCT04326257|Relatlimab|relatlimab|mesh-list
102151997|NCT04326257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102151998|NCT04326257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102151999|NCT04326257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102152000|NCT04326257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152001|NCT04249401|Warfarin|warfarin|mesh-list
102152002|NCT04249401|Rivaroxaban|rivaroxaban|mesh-list
102152003|NCT04249401|Dabigatran|dabigatran|mesh-list
102152004|NCT04249401|Apixaban|apixaban|mesh-list
102152005|NCT04249401|Anticoagulants|anticoagulants|mesh-ancestor
102152006|NCT04249401|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102152007|NCT04249401|Antithrombins|antithrombins|mesh-ancestor
102152008|NCT04249401|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102152009|NCT04249401|Protease Inhibitors|protease inhibitors|mesh-ancestor
102152010|NCT04249401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102152011|NCT04249401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152012|NCT04222972|Paclitaxel|paclitaxel|mesh-list
102152013|NCT04222972|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102152014|NCT04222972|Carboplatin|carboplatin|mesh-list
102152015|NCT04222972|Gemcitabine|gemcitabine|mesh-list
102152016|NCT04222972|Pembrolizumab|pembrolizumab|mesh-list
102152017|NCT04222972|Pemetrexed|pemetrexed|mesh-list
102152018|NCT04222972|Pralsetinib|pralsetinib|mesh-list
102152019|NCT04222972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101753806|NCT02553603|Hormones|hormones|mesh-list
102152020|NCT04222972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152021|NCT04222972|Tubulin Modulators|tubulin modulators|mesh-ancestor
102152022|NCT04222972|Antimitotic Agents|antimitotic agents|mesh-ancestor
102152023|NCT04222972|Mitosis Modulators|mitosis modulators|mesh-ancestor
102152024|NCT04222972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152025|NCT04222972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102152026|NCT04222972|Antimetabolites|antimetabolites|mesh-ancestor
102152027|NCT04222972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101860912|NCT00474539|Vaccines|vaccines|mesh-list
102152028|NCT04222972|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102152029|NCT04222972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102152046|NCT04147260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152047|NCT04147260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152048|NCT04147260|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102152049|NCT04147260|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102152051|NCT04114136|Rosiglitazone|rosiglitazone|mesh-list
102152052|NCT04114136|Pembrolizumab|pembrolizumab|mesh-list
102152054|NCT04114136|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102152055|NCT04114136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152056|NCT04114136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102152057|NCT04114136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152058|NCT04114136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102152059|NCT04114136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152060|NCT04112043|Niacinamide|niacinamide|mesh-list
102152061|NCT04112043|Niacin|niacin|mesh-list
102152062|NCT04112043|Nicotinic Acids|nicotinic acids|mesh-list
102152063|NCT04112043|Vitamin B Complex|vitamin b complex|mesh-ancestor
102152064|NCT04112043|Vitamins|vitamins|mesh-ancestor
102152065|NCT04112043|Micronutrients|micronutrients|mesh-ancestor
102152066|NCT04112043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152067|NCT04112043|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102152068|NCT04112043|Antimetabolites|antimetabolites|mesh-ancestor
102152069|NCT04112043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152070|NCT04112043|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102152071|NCT04112043|Vasodilator Agents|vasodilator agents|mesh-ancestor
102152072|NCT04092673|Trastuzumab|trastuzumab|mesh-list
102152073|NCT04092673|Sotorasib|sotorasib|mesh-list
102152074|NCT04092673|Fulvestrant|fulvestrant|mesh-list
102152075|NCT04092673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102152076|NCT04092673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152077|NCT04092673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102152078|NCT04092673|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102152079|NCT04092673|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102152080|NCT04092673|Hormone Antagonists|hormone antagonists|mesh-ancestor
102152081|NCT04092673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102152082|NCT04092673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152083|NCT04092673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102152084|NCT04092673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152085|NCT04071236|Avelumab|avelumab|mesh-list
102152086|NCT04071236|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
102152087|NCT04071236|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102152088|NCT04071236|Peposertib|peposertib|mesh-list
102152089|NCT04071236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102152090|NCT04071236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152091|NCT04071236|Immunologic Factors|immunologic factors|mesh-ancestor
102152092|NCT04071236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152093|NCT04071236|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102152094|NCT04071236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102152095|NCT04071236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152101|NCT03997968|Rituximab|rituximab|mesh-list
101861000|NCT00495677|PF 232798|pf 232798|mesh-list
102152102|NCT03997968|Gemcitabine|gemcitabine|mesh-list
102152103|NCT03997968|Capecitabine|capecitabine|mesh-list
102152105|NCT03997968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102152106|NCT03997968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152107|NCT03997968|Immunologic Factors|immunologic factors|mesh-ancestor
102152108|NCT03997968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152109|NCT03997968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102152110|NCT03997968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102152111|NCT03997968|Antimetabolites|antimetabolites|mesh-ancestor
102152112|NCT03997968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152113|NCT03997968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102152114|NCT03997968|Alkylating Agents|alkylating agents|mesh-ancestor
102152115|NCT03995706|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
102152116|NCT03995706|Immunoconjugates|immunoconjugates|mesh-ancestor
102152117|NCT03995706|Immunologic Factors|immunologic factors|mesh-ancestor
102152118|NCT03995706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152119|NCT03984097|Dexamethasone|dexamethasone|mesh-list
102152120|NCT03984097|Lenalidomide|lenalidomide|mesh-list
102152121|NCT03984097|Bortezomib|bortezomib|mesh-list
102152122|NCT03984097|Pomalidomide|pomalidomide|mesh-list
102152123|NCT03984097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102152124|NCT03984097|Antiemetics|antiemetics|mesh-ancestor
102152125|NCT03984097|Autonomic Agents|autonomic agents|mesh-ancestor
102094655|NCT05690204|Colchicine|colchicine|mesh-list
102152126|NCT03984097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102152127|NCT03984097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152128|NCT03984097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102152129|NCT03984097|Glucocorticoids|glucocorticoids|mesh-ancestor
102152130|NCT03984097|Hormones|hormones|mesh-ancestor
102152131|NCT03984097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102152132|NCT03984097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102152133|NCT03984097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152134|NCT03984097|Immunologic Factors|immunologic factors|mesh-ancestor
102152135|NCT03984097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102152136|NCT03984097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102152137|NCT03984097|Growth Substances|growth substances|mesh-ancestor
102152138|NCT03984097|Growth Inhibitors|growth inhibitors|mesh-ancestor
102152139|NCT03887377|Botulinum Toxins|botulinum toxins|mesh-list
102152140|NCT03887377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102152141|NCT03887377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102152142|NCT03887377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102152143|NCT03887377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152144|NCT03887377|Cholinergic Agents|cholinergic agents|mesh-ancestor
102152145|NCT03887377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102152146|NCT03887377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152147|NCT03876769|Tisagenlecleucel|tisagenlecleucel|mesh-list
102152148|NCT03876769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102152149|NCT03876769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152150|NCT03833154|Durvalumab|durvalumab|mesh-list
102152151|NCT03833154|Osimertinib|osimertinib|mesh-list
102152152|NCT03833154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102152153|NCT03833154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152154|NCT03833154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102152155|NCT03833154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102152156|NCT03833154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152157|NCT03780894|Tranexamic Acid|tranexamic acid|mesh-list
102152158|NCT03780894|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102152159|NCT03780894|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102152160|NCT03780894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152161|NCT03780894|Hemostatics|hemostatics|mesh-ancestor
102152162|NCT03780894|Coagulants|coagulants|mesh-ancestor
102152163|NCT03741478|Insulin|insulin|mesh-list
102152164|NCT03741478|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102152165|NCT03741478|Insulin Lispro|insulin lispro|mesh-list
102152166|NCT03741478|Olanzapine|olanzapine|mesh-list
102152167|NCT03741478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102152168|NCT03741478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152169|NCT03741478|Antiemetics|antiemetics|mesh-ancestor
102152170|NCT03741478|Autonomic Agents|autonomic agents|mesh-ancestor
102152171|NCT03741478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102152172|NCT03741478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102152173|NCT03741478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102152174|NCT03741478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102152175|NCT03741478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102152176|NCT03741478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102152177|NCT03741478|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101861059|NCT00291642|Cetirizine|cetirizine|mesh-list
102152178|NCT03741478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102152179|NCT03741478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102152180|NCT03741478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152181|NCT03741478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102152183|NCT03669367|Abatacept|abatacept|mesh-list
102152184|NCT03669367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102152185|NCT03669367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152186|NCT03669367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102152187|NCT03669367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152188|NCT03669367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102152189|NCT03669367|Immunologic Factors|immunologic factors|mesh-ancestor
102152190|NCT03669367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152191|NCT03669367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102152192|NCT03650114|Ofatumumab|ofatumumab|mesh-list
102152193|NCT03650114|Vaccines|vaccines|mesh-list
102152194|NCT03650114|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102152195|NCT03650114|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
102152196|NCT03650114|Immunologic Factors|immunologic factors|mesh-ancestor
102152197|NCT03650114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152198|NCT03650114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102535917|NCT00553319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102152199|NCT03650114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102152200|NCT03630081|Ciprofloxacin|ciprofloxacin|mesh-list
102152201|NCT03630081|Meropenem|meropenem|mesh-list
102152202|NCT03630081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102152203|NCT03630081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102152204|NCT03630081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102152205|NCT03630081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102152206|NCT03630081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102152207|NCT03630081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152208|NCT03630081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152209|NCT03630081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102152210|NCT03630081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102152211|NCT03522688|Dexmedetomidine|dexmedetomidine|mesh-list
102152212|NCT03522688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102152213|NCT03522688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102152214|NCT03522688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152215|NCT03522688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102152216|NCT03522688|Analgesics|analgesics|mesh-ancestor
102152217|NCT03522688|Sensory System Agents|sensory system agents|mesh-ancestor
102152218|NCT03522688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102152219|NCT03522688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102152220|NCT03522688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102152221|NCT03522688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102152222|NCT03522688|Adrenergic Agents|adrenergic agents|mesh-ancestor
102152223|NCT03522688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102152224|NCT03522688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152225|NCT03511118|Metformin|metformin|mesh-list
102152226|NCT03511118|Topiramate|topiramate|mesh-list
102152227|NCT03511118|Azithromycin|azithromycin|mesh-list
102152228|NCT03511118|Doxycycline|doxycycline|mesh-list
102152229|NCT03511118|Ciprofloxacin|ciprofloxacin|mesh-list
102152230|NCT03511118|Levofloxacin|levofloxacin|mesh-list
102152231|NCT03511118|Clindamycin|clindamycin|mesh-list
102152232|NCT03511118|Valganciclovir|valganciclovir|mesh-list
102152233|NCT03511118|Remdesivir|remdesivir|mesh-list
102152234|NCT03511118|Hydroxyurea|hydroxyurea|mesh-list
101754009|NCT00862108|Dopamine Agents|dopamine agents|mesh-ancestor
102152235|NCT03511118|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102152236|NCT03511118|Verapamil|verapamil|mesh-list
102152237|NCT03511118|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102152238|NCT03511118|Labetalol|labetalol|mesh-list
102152239|NCT03511118|Nifedipine|nifedipine|mesh-list
102152240|NCT03511118|Furosemide|furosemide|mesh-list
102152241|NCT03511118|Sumatriptan|sumatriptan|mesh-list
102152242|NCT03511118|Oxycodone|oxycodone|mesh-list
102152243|NCT03511118|Gabapentin|gabapentin|mesh-list
102152244|NCT03511118|Ondansetron|ondansetron|mesh-list
102152245|NCT03511118|Fluvoxamine|fluvoxamine|mesh-list
102152246|NCT03511118|Trazodone|trazodone|mesh-list
102152247|NCT03511118|Cyclobenzaprine|cyclobenzaprine|mesh-list
102152248|NCT03511118|Methylphenidate|methylphenidate|mesh-list
102152249|NCT03511118|Citalopram|citalopram|mesh-list
102152250|NCT03511118|Sertraline|sertraline|mesh-list
102152251|NCT03511118|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102152252|NCT03511118|Tranexamic Acid|tranexamic acid|mesh-list
102152253|NCT03511118|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102152254|NCT03511118|Escitalopram|escitalopram|mesh-list
102152255|NCT03511118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102152256|NCT03511118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152257|NCT03511118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102152258|NCT03511118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102152259|NCT03511118|Antimetabolites|antimetabolites|mesh-ancestor
102152260|NCT03511118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152261|NCT03511118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102152262|NCT03511118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102152263|NCT03511118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102152264|NCT03511118|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102152265|NCT03511118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102152266|NCT03511118|Hemostatics|hemostatics|mesh-ancestor
102152267|NCT03511118|Coagulants|coagulants|mesh-ancestor
102152268|NCT03511118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102152269|NCT03511118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102152270|NCT03511118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102152271|NCT03511118|Narcotics|narcotics|mesh-ancestor
102152272|NCT03511118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102152273|NCT03511118|Analgesics|analgesics|mesh-ancestor
102152274|NCT03511118|Sensory System Agents|sensory system agents|mesh-ancestor
102152275|NCT03511118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102152276|NCT03511118|Anticonvulsants|anticonvulsants|mesh-ancestor
102152277|NCT03511118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102152278|NCT03511118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102152279|NCT03511118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102535918|NCT00553319|Dopamine Agents|dopamine agents|mesh-ancestor
102152280|NCT03511118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102152281|NCT03511118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102152282|NCT03511118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102152283|NCT03511118|Antimanic Agents|antimanic agents|mesh-ancestor
102152284|NCT03511118|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102152285|NCT03511118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102152286|NCT03511118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102152287|NCT03511118|Serotonin Agents|serotonin agents|mesh-ancestor
102152288|NCT03511118|Autonomic Agents|autonomic agents|mesh-ancestor
102152289|NCT03511118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102152290|NCT03511118|Antidepressive Agents|antidepressive agents|mesh-ancestor
102152291|NCT03511118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102152292|NCT03511118|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102152293|NCT03511118|Dopamine Agents|dopamine agents|mesh-ancestor
102152294|NCT03511118|Antiemetics|antiemetics|mesh-ancestor
102152295|NCT03511118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102152296|NCT03511118|Antipruritics|antipruritics|mesh-ancestor
102152297|NCT03511118|Dermatologic Agents|dermatologic agents|mesh-ancestor
102152298|NCT03511118|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102152299|NCT03511118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102152300|NCT03511118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102152301|NCT03511118|Diuretics|diuretics|mesh-ancestor
102152302|NCT03511118|Natriuretic Agents|natriuretic agents|mesh-ancestor
102152303|NCT03511118|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102152304|NCT03511118|Antimalarials|antimalarials|mesh-ancestor
102152305|NCT03511118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102152306|NCT03511118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102152307|NCT03511118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102152308|NCT03511118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102152309|NCT03511118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152310|NCT03511118|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102152311|NCT03511118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102152312|NCT03511118|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102152313|NCT03511118|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102152314|NCT03511118|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102152315|NCT03511118|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102152316|NCT03511118|Antisickling Agents|antisickling agents|mesh-ancestor
102152317|NCT03511118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102152318|NCT03511118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102152319|NCT03511118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102152320|NCT03511118|Vasodilator Agents|vasodilator agents|mesh-ancestor
102152321|NCT03511118|Tocolytic Agents|tocolytic agents|mesh-ancestor
102152322|NCT03511118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102152323|NCT03511118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102152324|NCT03511118|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102152325|NCT03511118|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102152326|NCT03511118|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102152327|NCT03511118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102152328|NCT03511118|Antiviral Agents|antiviral agents|mesh-ancestor
102152329|NCT03511118|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102152330|NCT03511118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102152331|NCT03511118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102152332|NCT03511118|Adrenergic Agents|adrenergic agents|mesh-ancestor
102152333|NCT03511118|Sympathomimetics|sympathomimetics|mesh-ancestor
102152334|NCT03511118|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102152335|NCT03511118|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102152336|NCT03511118|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102152337|NCT03511118|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102152338|NCT03511118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102152339|NCT03493919|Vaccines|vaccines|mesh-list
102152340|NCT03493919|Immunologic Factors|immunologic factors|mesh-ancestor
102152341|NCT03493919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152342|NCT03396575|Cyclophosphamide|cyclophosphamide|mesh-list
102152343|NCT03396575|Fludarabine|fludarabine|mesh-list
102152344|NCT03396575|Vaccines|vaccines|mesh-list
102152345|NCT03396575|Immunologic Factors|immunologic factors|mesh-ancestor
102152346|NCT03396575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152347|NCT03396575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102152348|NCT03396575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102152349|NCT03396575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102152350|NCT03396575|Alkylating Agents|alkylating agents|mesh-ancestor
102152351|NCT03396575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152352|NCT03396575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152353|NCT03396575|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102152354|NCT03340506|Trametinib|trametinib|mesh-list
102152355|NCT03340506|Dabrafenib|dabrafenib|mesh-list
102152356|NCT03340506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152357|NCT03340506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102152358|NCT03340506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102152359|NCT03340506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152360|NCT03326128|Bupropion|bupropion|mesh-list
102152361|NCT03326128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102152362|NCT03326128|Antidepressive Agents|antidepressive agents|mesh-ancestor
102152363|NCT03326128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102152364|NCT03326128|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102152365|NCT03326128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102152366|NCT03326128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102241613|NCT04433559|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102152367|NCT03326128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152368|NCT03326128|Dopamine Agents|dopamine agents|mesh-ancestor
102152369|NCT03326128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102152370|NCT03326128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152371|NCT03326128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102152372|NCT03326128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102152373|NCT03326128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102152374|NCT03277924|Doxorubicin|doxorubicin|mesh-list
102152375|NCT03277924|Nivolumab|nivolumab|mesh-list
102152376|NCT03277924|Methotrexate|methotrexate|mesh-list
102152377|NCT03277924|Sunitinib|sunitinib|mesh-list
102152378|NCT03277924|Epirubicin|epirubicin|mesh-list
102152379|NCT03277924|Ifosfamide|ifosfamide|mesh-list
102152380|NCT03277924|Dacarbazine|dacarbazine|mesh-list
102152381|NCT03277924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152382|NCT03277924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102152383|NCT03277924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102152384|NCT03277924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102152385|NCT03277924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102152386|NCT03277924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152387|NCT03277924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102152388|NCT03277924|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102152389|NCT03277924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102152390|NCT03277924|Abortifacient Agents|abortifacient agents|mesh-ancestor
102152391|NCT03277924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102152392|NCT03277924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152393|NCT03277924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102152394|NCT03277924|Antimetabolites|antimetabolites|mesh-ancestor
102152395|NCT03277924|Dermatologic Agents|dermatologic agents|mesh-ancestor
102152396|NCT03277924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102152397|NCT03277924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102152398|NCT03277924|Immunologic Factors|immunologic factors|mesh-ancestor
102152399|NCT03277924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102152400|NCT03277924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102152401|NCT03277924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102152402|NCT03277924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102152403|NCT03277924|Growth Substances|growth substances|mesh-ancestor
101861285|NCT00279708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102152404|NCT03277924|Growth Inhibitors|growth inhibitors|mesh-ancestor
102152405|NCT03277924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102152406|NCT03277924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102152407|NCT03277924|Alkylating Agents|alkylating agents|mesh-ancestor
102152408|NCT03176134|Tedizolid|tedizolid|mesh-list
102152409|NCT03176134|Tedizolid phosphate|tedizolid phosphate|mesh-list
102152410|NCT03176134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102152411|NCT03176134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102152412|NCT03152786|Propranolol|propranolol|mesh-list
102152413|NCT03152786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102152414|NCT03152786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102152415|NCT03152786|Adrenergic Agents|adrenergic agents|mesh-ancestor
102152416|NCT03152786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102152417|NCT03152786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152418|NCT03152786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152419|NCT03152786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102152420|NCT03152786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102152421|NCT03152786|Vasodilator Agents|vasodilator agents|mesh-ancestor
102152422|NCT03004443|Infliximab|infliximab|mesh-list
102152423|NCT03004443|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102152424|NCT03004443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102152425|NCT03004443|Dermatologic Agents|dermatologic agents|mesh-ancestor
102152426|NCT03004443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102152427|NCT03004443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102152428|NCT02996773|Cyclophosphamide|cyclophosphamide|mesh-list
102152429|NCT02996773|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102152430|NCT02996773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102152431|NCT02996773|Immunologic Factors|immunologic factors|mesh-ancestor
102152432|NCT02996773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152433|NCT02996773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102152434|NCT02996773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102152435|NCT02996773|Alkylating Agents|alkylating agents|mesh-ancestor
102152436|NCT02996773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152437|NCT02996773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152438|NCT02996773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102152440|NCT02748018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102152441|NCT02748018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152442|NCT02739035|Dexamethasone|dexamethasone|mesh-list
102152443|NCT02739035|Celecoxib|celecoxib|mesh-list
102152444|NCT02739035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102152445|NCT02739035|Antiemetics|antiemetics|mesh-ancestor
102152446|NCT02739035|Autonomic Agents|autonomic agents|mesh-ancestor
102152447|NCT02739035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102152448|NCT02739035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152449|NCT02739035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102152450|NCT02739035|Glucocorticoids|glucocorticoids|mesh-ancestor
102152451|NCT02739035|Hormones|hormones|mesh-ancestor
102152452|NCT02739035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102152453|NCT02739035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102152454|NCT02739035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152455|NCT02739035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102152456|NCT02739035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102152457|NCT02739035|Analgesics|analgesics|mesh-ancestor
102152458|NCT02739035|Sensory System Agents|sensory system agents|mesh-ancestor
102152459|NCT02739035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102152460|NCT02739035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102152461|NCT02739035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102152462|NCT02739035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102152463|NCT02739035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152464|NCT02538484|Letrozole|letrozole|mesh-list
102152465|NCT02538484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152466|NCT02538484|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102152467|NCT02538484|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102152468|NCT02538484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102152469|NCT02538484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152470|NCT02538484|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102152471|NCT02538484|Hormone Antagonists|hormone antagonists|mesh-ancestor
102152472|NCT02538484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102152473|NCT02538484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152474|NCT02484391|Thioctic Acid|thioctic acid|mesh-list
102152475|NCT02484391|Cytarabine|cytarabine|mesh-list
102152476|NCT02484391|Mitoxantrone|mitoxantrone|mesh-list
101754247|NCT00726570|Heparin|heparin|mesh-list
102152477|NCT02484391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102152478|NCT02484391|Antimetabolites|antimetabolites|mesh-ancestor
102152479|NCT02484391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152480|NCT02484391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152481|NCT02484391|Antiviral Agents|antiviral agents|mesh-ancestor
102152482|NCT02484391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102152483|NCT02484391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102152484|NCT02484391|Immunologic Factors|immunologic factors|mesh-ancestor
102152485|NCT02484391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152486|NCT02484391|Analgesics|analgesics|mesh-ancestor
102152487|NCT02484391|Sensory System Agents|sensory system agents|mesh-ancestor
102152488|NCT02484391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102152489|NCT02484391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102152490|NCT02484391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102152491|NCT02484391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102152492|NCT02484391|Antioxidants|antioxidants|mesh-ancestor
102152493|NCT02484391|Protective Agents|protective agents|mesh-ancestor
102152494|NCT02484391|Vitamin B Complex|vitamin b complex|mesh-ancestor
102152496|NCT02484391|Micronutrients|micronutrients|mesh-ancestor
102152497|NCT02478320|Ilorasertib|ilorasertib|mesh-list
102152498|NCT02478320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152499|NCT02478320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102152500|NCT02478320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102535919|NCT00553319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102152501|NCT02478320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152502|NCT02311998|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
102152503|NCT02311998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102152504|NCT02311998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152505|NCT02311998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102152506|NCT02311998|Immunotoxins|immunotoxins|mesh-ancestor
102152507|NCT02311998|Immunoconjugates|immunoconjugates|mesh-ancestor
102152508|NCT02311998|Immunologic Factors|immunologic factors|mesh-ancestor
102152509|NCT02311998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152510|NCT02252042|Docetaxel|docetaxel|mesh-list
102152511|NCT02252042|Pembrolizumab|pembrolizumab|mesh-list
102152512|NCT02252042|Methotrexate|methotrexate|mesh-list
102152513|NCT02252042|Cetuximab|cetuximab|mesh-list
102152514|NCT02252042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152515|NCT02252042|Tubulin Modulators|tubulin modulators|mesh-ancestor
102152516|NCT02252042|Antimitotic Agents|antimitotic agents|mesh-ancestor
102152517|NCT02252042|Mitosis Modulators|mitosis modulators|mesh-ancestor
102152518|NCT02252042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152519|NCT02252042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102152520|NCT02252042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102152521|NCT02252042|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102152522|NCT02252042|Abortifacient Agents|abortifacient agents|mesh-ancestor
102152523|NCT02252042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102152524|NCT02252042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152525|NCT02252042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102152526|NCT02252042|Antimetabolites|antimetabolites|mesh-ancestor
102152527|NCT02252042|Dermatologic Agents|dermatologic agents|mesh-ancestor
102152528|NCT02252042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102152529|NCT02252042|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102152530|NCT02252042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102152531|NCT02252042|Immunologic Factors|immunologic factors|mesh-ancestor
102152532|NCT02252042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102152533|NCT02252042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102152534|NCT02248597|Mycophenolic Acid|mycophenolic acid|mesh-list
102152535|NCT02248597|Cyclophosphamide|cyclophosphamide|mesh-list
102152536|NCT02248597|Busulfan|busulfan|mesh-list
102152537|NCT02248597|Fludarabine|fludarabine|mesh-list
102152538|NCT02248597|Fludarabine phosphate|fludarabine phosphate|mesh-list
102152539|NCT02248597|Tacrolimus|tacrolimus|mesh-list
102152540|NCT02248597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102152541|NCT02248597|Immunologic Factors|immunologic factors|mesh-ancestor
102152542|NCT02248597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152543|NCT02248597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102152544|NCT02248597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102152545|NCT02248597|Alkylating Agents|alkylating agents|mesh-ancestor
102152546|NCT02248597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152547|NCT02248597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152548|NCT02248597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102152549|NCT02248597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102152550|NCT02248597|Antimetabolites|antimetabolites|mesh-ancestor
102152551|NCT02248597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102152552|NCT02248597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102152553|NCT02248597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102152554|NCT02248597|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102152555|NCT02248597|Antitubercular Agents|antitubercular agents|mesh-ancestor
102152556|NCT02248597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102152557|NCT02248597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102152558|NCT02157324|Acalabrutinib|acalabrutinib|mesh-list
102152559|NCT02157324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152560|NCT02099058|Nivolumab|nivolumab|mesh-list
102152561|NCT02099058|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102152562|NCT02099058|Osimertinib|osimertinib|mesh-list
102152563|NCT02099058|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102152564|NCT02099058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102152565|NCT02099058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152566|NCT02099058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102152567|NCT02099058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152568|NCT02099058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102152569|NCT02099058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102152570|NCT02099058|Immunologic Factors|immunologic factors|mesh-ancestor
102152571|NCT02099058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152572|NCT01900847|Ketamine|ketamine|mesh-list
102152573|NCT01900847|Morphine|morphine|mesh-list
102152574|NCT01900847|Analgesics|analgesics|mesh-ancestor
102152575|NCT01900847|Sensory System Agents|sensory system agents|mesh-ancestor
102152576|NCT01900847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102152577|NCT01900847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152578|NCT01900847|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102152579|NCT01900847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102152580|NCT01900847|Anesthetics, General|anesthetics, general|mesh-ancestor
102152581|NCT01900847|Anesthetics|anesthetics|mesh-ancestor
102152582|NCT01900847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102152583|NCT01900847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102152584|NCT01900847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102152585|NCT01900847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102152586|NCT01900847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152587|NCT01900847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102152588|NCT01900847|Narcotics|narcotics|mesh-ancestor
102152589|NCT01710007|Atorvastatin|atorvastatin|mesh-list
102152590|NCT01710007|Pitavastatin|pitavastatin|mesh-list
102152591|NCT01710007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102152592|NCT01710007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102152593|NCT01710007|Antimetabolites|antimetabolites|mesh-ancestor
102152594|NCT01710007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152595|NCT01710007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102152596|NCT01710007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102152597|NCT01710007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102152598|NCT01357772|Tamoxifen|tamoxifen|mesh-list
102152599|NCT01357772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102152600|NCT01357772|Hormone Antagonists|hormone antagonists|mesh-ancestor
102152601|NCT01357772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102152602|NCT01357772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152603|NCT01357772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102152604|NCT01357772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152605|NCT01357772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102152606|NCT01357772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102152607|NCT01357772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102152608|NCT00378482|Tremelimumab|tremelimumab|mesh-list
102152609|NCT00378482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152610|NCT05813860|Infliximab|infliximab|mesh-list
102152611|NCT05813860|Azathioprine|azathioprine|mesh-list
102152612|NCT05813860|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102152613|NCT05813860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102152614|NCT05813860|Dermatologic Agents|dermatologic agents|mesh-ancestor
102152615|NCT05813860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102152616|NCT05813860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102152617|NCT05813860|Antimetabolites|antimetabolites|mesh-ancestor
102152618|NCT05813860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152619|NCT05813860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102152620|NCT05813860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152621|NCT05813860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102152622|NCT05813860|Immunologic Factors|immunologic factors|mesh-ancestor
102152623|NCT05813860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152624|NCT05795517|Ezetimibe|ezetimibe|mesh-list
102152625|NCT05795517|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102152626|NCT05795517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102152627|NCT05795517|Antimetabolites|antimetabolites|mesh-ancestor
102152628|NCT05795517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861521|NCT00293462|Sargramostim|sargramostim|mesh-list
102152629|NCT05795517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102152630|NCT05788276|Dapagliflozin|dapagliflozin|mesh-list
102152631|NCT05788276|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102152632|NCT05788276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152633|NCT05788276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102152634|NCT05788276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152635|NCT05759754|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102152636|NCT05759754|Protease Inhibitors|protease inhibitors|mesh-ancestor
102152637|NCT05759754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102152638|NCT05759754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152639|NCT05759572|Apatinib|apatinib|mesh-list
102152640|NCT05759572|Fulvestrant|fulvestrant|mesh-list
102152641|NCT05759572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152642|NCT05759572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102152643|NCT05759572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102152644|NCT05759572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152645|NCT05759572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102152646|NCT05759572|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102152647|NCT05759572|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102152648|NCT05759572|Hormone Antagonists|hormone antagonists|mesh-ancestor
102152649|NCT05759572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102152650|NCT05759572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152651|NCT05738694|Axitinib|axitinib|mesh-list
102152652|NCT05738694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152653|NCT05738694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101754444|NCT00799149|Etoricoxib|etoricoxib|mesh-list
102152654|NCT05738694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102152655|NCT05738694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152656|NCT05737199|Pembrolizumab|pembrolizumab|mesh-list
102152657|NCT05737199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102152658|NCT05737199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152659|NCT05737199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102152660|NCT05737199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152661|NCT05731986|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
102152662|NCT05731986|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102152663|NCT05731986|Immunologic Factors|immunologic factors|mesh-ancestor
102152664|NCT05731986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152665|NCT05725499|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
102152666|NCT05725499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102152667|NCT05725499|Immunologic Factors|immunologic factors|mesh-ancestor
102152668|NCT05725499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152669|NCT05708521|Hydromorphone|hydromorphone|mesh-list
102152670|NCT05708521|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102152671|NCT05708521|Narcotics|narcotics|mesh-ancestor
102152672|NCT05708521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102152673|NCT05708521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152674|NCT05708521|Analgesics|analgesics|mesh-ancestor
102152675|NCT05708521|Sensory System Agents|sensory system agents|mesh-ancestor
102152676|NCT05708521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102152677|NCT05707234|Midazolam|midazolam|mesh-list
102152678|NCT05707234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102152679|NCT05707234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102152680|NCT05707234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102152681|NCT05707234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152682|NCT05707234|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102152683|NCT05707234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102152684|NCT05707234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102152685|NCT05707234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102152686|NCT05707234|Anesthetics, General|anesthetics, general|mesh-ancestor
102152687|NCT05707234|Anesthetics|anesthetics|mesh-ancestor
102152688|NCT05707234|GABA Modulators|gaba modulators|mesh-ancestor
102152689|NCT05707234|GABA Agents|gaba agents|mesh-ancestor
102152690|NCT05707234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102152691|NCT05707234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152692|NCT05703672|Varenicline|varenicline|mesh-list
102152693|NCT05703672|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102152694|NCT05703672|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102152695|NCT05703672|Cholinergic Agents|cholinergic agents|mesh-ancestor
102152696|NCT05703672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102152697|NCT05703672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152698|NCT05703672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152699|NCT05702359|Vitamin D|vitamin d|mesh-list
102152700|NCT05702359|Ergocalciferols|ergocalciferols|mesh-list
102152701|NCT05702359|Cholecalciferol|cholecalciferol|mesh-list
102152703|NCT05702359|Micronutrients|micronutrients|mesh-ancestor
102152704|NCT05702359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152705|NCT05702359|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102152706|NCT05702359|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102152707|NCT05702073|Insulin Glargine|insulin glargine|mesh-list
102152708|NCT05702073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102152709|NCT05702073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152711|NCT05690282|Ibuprofen|ibuprofen|mesh-list
102152712|NCT05690282|Gabapentin|gabapentin|mesh-list
102152713|NCT05690282|Bupivacaine|bupivacaine|mesh-list
102152714|NCT05690282|Anesthetics, Local|anesthetics, local|mesh-ancestor
102152715|NCT05690282|Anesthetics|anesthetics|mesh-ancestor
102152716|NCT05690282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102152717|NCT05690282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152718|NCT05690282|Sensory System Agents|sensory system agents|mesh-ancestor
102152719|NCT05690282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102152720|NCT05690282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102152721|NCT05690282|Analgesics|analgesics|mesh-ancestor
102152722|NCT05690282|Antipyretics|antipyretics|mesh-ancestor
102152723|NCT05690282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102152724|NCT05690282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102152725|NCT05690282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102152726|NCT05690282|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102152727|NCT05690282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102152728|NCT05690282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152729|NCT05690282|Anticonvulsants|anticonvulsants|mesh-ancestor
102152730|NCT05690282|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102152731|NCT05690282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102152732|NCT05690282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102152733|NCT05690282|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102152734|NCT05690282|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102152735|NCT05690282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102152736|NCT05690282|Antimanic Agents|antimanic agents|mesh-ancestor
102152737|NCT05677334|Insulin|insulin|mesh-list
102152738|NCT05677334|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102152739|NCT05677334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102152740|NCT05677334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152741|NCT05676645|Lumefantrine|lumefantrine|mesh-list
102152742|NCT05676645|Artemether|artemether|mesh-list
102152743|NCT05676645|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102152744|NCT05676645|Antimalarials|antimalarials|mesh-ancestor
102152745|NCT05676645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102152746|NCT05676645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102152747|NCT05676645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102152748|NCT05591651|Hyaluronic Acid|hyaluronic acid|mesh-list
102152749|NCT05591651|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102152750|NCT05591651|Immunologic Factors|immunologic factors|mesh-ancestor
102152751|NCT05591651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152752|NCT05591651|Viscosupplements|viscosupplements|mesh-ancestor
102152753|NCT05591651|Protective Agents|protective agents|mesh-ancestor
102152754|NCT05574504|Avelumab|avelumab|mesh-list
102152755|NCT05574504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102152756|NCT05574504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102152757|NCT05574504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152758|NCT05574504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152759|NCT05570409|Mycophenolic Acid|mycophenolic acid|mesh-list
102152760|NCT05570409|Prednisolone|prednisolone|mesh-list
102152761|NCT05570409|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102152762|NCT05570409|Methylprednisolone|methylprednisolone|mesh-list
102152763|NCT05570409|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102152764|NCT05570409|Prednisolone acetate|prednisolone acetate|mesh-list
102152765|NCT05570409|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102152766|NCT05570409|Prednisolone phosphate|prednisolone phosphate|mesh-list
102152767|NCT05570409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102152768|NCT05570409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152769|NCT05570409|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102152770|NCT05570409|Antitubercular Agents|antitubercular agents|mesh-ancestor
102152771|NCT05570409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102152772|NCT05570409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102152773|NCT05570409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102152774|NCT05570409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152775|NCT05570409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102152776|NCT05570409|Glucocorticoids|glucocorticoids|mesh-ancestor
102152777|NCT05570409|Hormones|hormones|mesh-ancestor
102152778|NCT05570409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102152779|NCT05570409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152780|NCT05570409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102152781|NCT05570409|Antiemetics|antiemetics|mesh-ancestor
102152782|NCT05570409|Autonomic Agents|autonomic agents|mesh-ancestor
102152783|NCT05570409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102152784|NCT05570409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102152785|NCT05570409|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102152786|NCT05570409|Protective Agents|protective agents|mesh-ancestor
102152787|NCT05545670|Allopurinol|allopurinol|mesh-list
102152788|NCT05545670|Antimetabolites|antimetabolites|mesh-ancestor
102152789|NCT05545670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152790|NCT05545670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102152791|NCT05545670|Gout Suppressants|gout suppressants|mesh-ancestor
102152792|NCT05545670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102152793|NCT05545670|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102152794|NCT05545670|Antioxidants|antioxidants|mesh-ancestor
102152795|NCT05545670|Protective Agents|protective agents|mesh-ancestor
102152796|NCT05545670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152797|NCT05514106|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
102152798|NCT05514106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152799|NCT05514106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102152800|NCT05514106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152801|NCT05514106|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102152802|NCT05487794|Methyltestosterone|methyltestosterone|mesh-list
102152804|NCT05487794|Testosterone undecanoate|testosterone undecanoate|mesh-list
102152805|NCT05487794|Testosterone enanthate|testosterone enanthate|mesh-list
102152806|NCT05487794|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102152807|NCT05487794|Androgens|androgens|mesh-ancestor
102152808|NCT05487794|Hormones|hormones|mesh-ancestor
102152809|NCT05487794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102152810|NCT05487794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152811|NCT05487794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102152812|NCT05487794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152813|NCT05487794|Anabolic Agents|anabolic agents|mesh-ancestor
102152814|NCT05481684|Progesterone|progesterone|mesh-list
102152815|NCT05481684|Progestins|progestins|mesh-ancestor
102152816|NCT05481684|Hormones|hormones|mesh-ancestor
102152817|NCT05481684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102152818|NCT05481684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152819|NCT05481528|Moxifloxacin|moxifloxacin|mesh-list
102152820|NCT05481528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102152821|NCT05481528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102152822|NCT05481528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102152823|NCT05481528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102152824|NCT05481528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102152825|NCT05481528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152826|NCT05481528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152827|NCT05461131|Azithromycin|azithromycin|mesh-list
102152828|NCT05461131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102152829|NCT05461131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102152830|NCT05458674|Trastuzumab|trastuzumab|mesh-list
102152831|NCT05458674|Tucatinib|tucatinib|mesh-list
102152832|NCT05458674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102152833|NCT05458674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152834|NCT05458674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102152835|NCT05458674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102152836|NCT05458674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152837|NCT05429489|Morphine|morphine|mesh-list
102152838|NCT05429489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101754625|NCT00734318|Xhance|xhance|mesh-list
102152839|NCT05429489|Narcotics|narcotics|mesh-ancestor
102152840|NCT05429489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102152841|NCT05429489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152842|NCT05429489|Analgesics|analgesics|mesh-ancestor
102152843|NCT05429489|Sensory System Agents|sensory system agents|mesh-ancestor
102152844|NCT05429489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102152845|NCT05413863|Insulin|insulin|mesh-list
102152846|NCT05413863|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102152847|NCT05413863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102152848|NCT05413863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152849|NCT05412914|Propofol|propofol|mesh-list
102152850|NCT05412914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102152851|NCT05412914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102152852|NCT05412914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152853|NCT05412914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102152854|NCT05412914|Anesthetics, General|anesthetics, general|mesh-ancestor
102152855|NCT05412914|Anesthetics|anesthetics|mesh-ancestor
102152856|NCT05374499|Epinephrine|epinephrine|mesh-list
102152857|NCT05374499|Bupivacaine|bupivacaine|mesh-list
102152858|NCT05374499|Anesthetics, Local|anesthetics, local|mesh-ancestor
102152859|NCT05374499|Anesthetics|anesthetics|mesh-ancestor
102152860|NCT05374499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102152861|NCT05374499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152862|NCT05374499|Sensory System Agents|sensory system agents|mesh-ancestor
102152863|NCT05374499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102152864|NCT05374499|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102152865|NCT05374499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102152866|NCT05374499|Adrenergic Agents|adrenergic agents|mesh-ancestor
102152867|NCT05374499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102152868|NCT05374499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152869|NCT05374499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102152870|NCT05374499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102152871|NCT05374499|Autonomic Agents|autonomic agents|mesh-ancestor
102152872|NCT05374499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102152873|NCT05374499|Respiratory System Agents|respiratory system agents|mesh-ancestor
102152874|NCT05374499|Mydriatics|mydriatics|mesh-ancestor
102152875|NCT05374499|Sympathomimetics|sympathomimetics|mesh-ancestor
102152876|NCT05374499|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102152877|NCT05373264|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102535920|NCT00553319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152878|NCT05373264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102152879|NCT05373264|Diuretics|diuretics|mesh-ancestor
102152880|NCT05373264|Natriuretic Agents|natriuretic agents|mesh-ancestor
102152881|NCT05373264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152882|NCT05373264|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102152883|NCT05373264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102152884|NCT05373264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152885|NCT05367492|Varenicline|varenicline|mesh-list
102152886|NCT05367492|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102152887|NCT05367492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102152888|NCT05367492|Cholinergic Agents|cholinergic agents|mesh-ancestor
102152889|NCT05367492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102152890|NCT05367492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152891|NCT05367492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152893|NCT05358704|Fluorouracil|fluorouracil|mesh-list
102152894|NCT05358704|Capecitabine|capecitabine|mesh-list
102152895|NCT05358704|Oxaliplatin|oxaliplatin|mesh-list
102152896|NCT05358704|Irinotecan|irinotecan|mesh-list
102152897|NCT05358704|Antimetabolites|antimetabolites|mesh-ancestor
102152898|NCT05358704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152899|NCT05358704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102152900|NCT05358704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152901|NCT05358704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102152902|NCT05358704|Immunologic Factors|immunologic factors|mesh-ancestor
102152903|NCT05358704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152904|NCT05358704|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102152905|NCT05358704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102152906|NCT05358704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102152907|NCT05358704|Antidotes|antidotes|mesh-ancestor
102152908|NCT05358704|Protective Agents|protective agents|mesh-ancestor
102152909|NCT05358704|Vitamin B Complex|vitamin b complex|mesh-ancestor
102152910|NCT05358704|Vitamins|vitamins|mesh-ancestor
102152911|NCT05358704|Micronutrients|micronutrients|mesh-ancestor
102152912|NCT05358691|Durvalumab|durvalumab|mesh-list
102152913|NCT05358691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102152914|NCT05358691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152915|NCT05357690|Bupivacaine|bupivacaine|mesh-list
102152916|NCT05357690|Anesthetics, Local|anesthetics, local|mesh-ancestor
102152917|NCT05357690|Anesthetics|anesthetics|mesh-ancestor
102152918|NCT05357690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102152919|NCT05357690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152920|NCT05357690|Sensory System Agents|sensory system agents|mesh-ancestor
102152921|NCT05357690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102152922|NCT05341154|Dexmedetomidine|dexmedetomidine|mesh-list
102152923|NCT05341154|Ketamine|ketamine|mesh-list
102152924|NCT05341154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102152925|NCT05341154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102152926|NCT05341154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861816|NCT01082458|Lidocaine|lidocaine|mesh-list
102152927|NCT05341154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102152928|NCT05341154|Analgesics|analgesics|mesh-ancestor
102152929|NCT05341154|Sensory System Agents|sensory system agents|mesh-ancestor
102152930|NCT05341154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102152931|NCT05341154|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102152932|NCT05341154|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102152933|NCT05341154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102152934|NCT05341154|Adrenergic Agents|adrenergic agents|mesh-ancestor
102152935|NCT05341154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102152936|NCT05341154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152937|NCT05341154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102152938|NCT05341154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102152939|NCT05341154|Anesthetics, General|anesthetics, general|mesh-ancestor
102152940|NCT05341154|Anesthetics|anesthetics|mesh-ancestor
102152941|NCT05341154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102152942|NCT05341154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102152943|NCT05330858|Rabeprazole|rabeprazole|mesh-list
102152944|NCT05330858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102152945|NCT05330858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102152946|NCT05330858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102152947|NCT05330858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102152948|NCT05330858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152949|NCT05328102|Lenalidomide|lenalidomide|mesh-list
102152950|NCT05328102|Immunologic Factors|immunologic factors|mesh-ancestor
102152951|NCT05328102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152952|NCT05328102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102152953|NCT05328102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102152954|NCT05328102|Growth Substances|growth substances|mesh-ancestor
102152955|NCT05328102|Growth Inhibitors|growth inhibitors|mesh-ancestor
102152956|NCT05328102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152957|NCT05317676|Palmidrol|palmidrol|mesh-list
102152958|NCT05317676|Analgesics|analgesics|mesh-ancestor
102152959|NCT05317676|Sensory System Agents|sensory system agents|mesh-ancestor
102152960|NCT05317676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102152961|NCT05317676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152962|NCT05317676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102152963|NCT05317676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102152964|NCT05317676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102152965|NCT05317676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102152966|NCT05317676|Antiviral Agents|antiviral agents|mesh-ancestor
102152967|NCT05317676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102152968|NCT05317676|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102152969|NCT05317676|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102152970|NCT05317676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102152971|NCT05317676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152972|NCT05317676|Hormones|hormones|mesh-ancestor
102152973|NCT05317676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102152974|NCT05312268|Rasburicase|rasburicase|mesh-list
102152975|NCT05312268|Gout Suppressants|gout suppressants|mesh-ancestor
102152976|NCT05312268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102152977|NCT05295927|Prednisone|prednisone|mesh-list
102152978|NCT05295927|Prednisolone|prednisolone|mesh-list
102152979|NCT05295927|Abiraterone Acetate|abiraterone acetate|mesh-list
102152980|NCT05295927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102152981|NCT05295927|Glucocorticoids|glucocorticoids|mesh-ancestor
102152982|NCT05295927|Hormones|hormones|mesh-ancestor
102152983|NCT05295927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102152984|NCT05295927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152985|NCT05295927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102152986|NCT05295927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102152987|NCT05295927|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102152988|NCT05295927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102152989|NCT05295927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102152990|NCT05295927|Hormone Antagonists|hormone antagonists|mesh-ancestor
102152991|NCT05295927|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102152992|NCT05288673|Ravulizumab|ravulizumab|mesh-list
102152993|NCT05288673|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102152994|NCT05288673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102152995|NCT05288673|Immunologic Factors|immunologic factors|mesh-ancestor
102152996|NCT05288673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102152997|NCT05288660|Ravulizumab|ravulizumab|mesh-list
102152998|NCT05288660|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102152999|NCT05288660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102153000|NCT05288660|Immunologic Factors|immunologic factors|mesh-ancestor
102153001|NCT05288660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153002|NCT05284812|Vaccines|vaccines|mesh-list
102153003|NCT05284812|Immunologic Factors|immunologic factors|mesh-ancestor
102153004|NCT05284812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153005|NCT05283226|Paclitaxel|paclitaxel|mesh-list
102153006|NCT05283226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102153007|NCT05283226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153008|NCT05283226|Tubulin Modulators|tubulin modulators|mesh-ancestor
102153009|NCT05283226|Antimitotic Agents|antimitotic agents|mesh-ancestor
102153010|NCT05283226|Mitosis Modulators|mitosis modulators|mesh-ancestor
102153011|NCT05283226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153012|NCT05257460|Insulin|insulin|mesh-list
102153013|NCT05257460|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102153014|NCT05257460|Insulin Lispro|insulin lispro|mesh-list
102153015|NCT05257460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102153016|NCT05257460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153017|NCT05254626|Pioglitazone|pioglitazone|mesh-list
102153018|NCT05254626|Dapagliflozin|dapagliflozin|mesh-list
102153019|NCT05254626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102153020|NCT05254626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153021|NCT05254626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102153022|NCT05254626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153023|NCT05246085|Hydrocortisone|hydrocortisone|mesh-list
102153024|NCT05246085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102153025|NCT05243550|Mitomycins|mitomycins|mesh-list
102535921|NCT00553319|Adrenergic Agents|adrenergic agents|mesh-ancestor
102153026|NCT05243550|Mitomycin|mitomycin|mesh-list
102153027|NCT05243550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102153028|NCT05243550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153029|NCT05243550|Alkylating Agents|alkylating agents|mesh-ancestor
102153030|NCT05243550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153031|NCT05243550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102153032|NCT05243550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102153033|NCT05223335|Clopidogrel|clopidogrel|mesh-list
102153034|NCT05223335|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101754799|NCT00738842|Ticagrelor|ticagrelor|mesh-list
102153035|NCT05223335|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102153036|NCT05223335|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102153037|NCT05223335|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102153038|NCT05223335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102153039|NCT05223335|Purinergic Agents|purinergic agents|mesh-ancestor
102153040|NCT05223335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102153041|NCT05223335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153042|NCT05223335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153043|NCT05216653|Capecitabine|capecitabine|mesh-list
102153044|NCT05216653|Oxaliplatin|oxaliplatin|mesh-list
102153045|NCT05216653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102153046|NCT05216653|Antimetabolites|antimetabolites|mesh-ancestor
102153047|NCT05216653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153048|NCT05216653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153049|NCT05211791|Anesthetics|anesthetics|mesh-list
102153050|NCT05211791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102153051|NCT05211791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153052|NCT05166811|Magnesium Sulfate|magnesium sulfate|mesh-list
102153053|NCT05166811|Analgesics|analgesics|mesh-ancestor
102153054|NCT05166811|Sensory System Agents|sensory system agents|mesh-ancestor
102153055|NCT05166811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102153056|NCT05166811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153057|NCT05166811|Anesthetics|anesthetics|mesh-ancestor
102153058|NCT05166811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102153059|NCT05166811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102153060|NCT05166811|Anticonvulsants|anticonvulsants|mesh-ancestor
102153061|NCT05166811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102153062|NCT05166811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102153063|NCT05166811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153064|NCT05166811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102153065|NCT05166811|Tocolytic Agents|tocolytic agents|mesh-ancestor
102153066|NCT05166811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102153067|NCT05165225|Cyclophosphamide|cyclophosphamide|mesh-list
102153068|NCT05165225|Docetaxel|docetaxel|mesh-list
102153069|NCT05165225|Epirubicin|epirubicin|mesh-list
102153070|NCT05165225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102153071|NCT05165225|Immunologic Factors|immunologic factors|mesh-ancestor
102153072|NCT05165225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153073|NCT05165225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102153074|NCT05165225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102153075|NCT05165225|Alkylating Agents|alkylating agents|mesh-ancestor
102153076|NCT05165225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153077|NCT05165225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153078|NCT05165225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102153079|NCT05165225|Tubulin Modulators|tubulin modulators|mesh-ancestor
102153080|NCT05165225|Antimitotic Agents|antimitotic agents|mesh-ancestor
102153081|NCT05165225|Mitosis Modulators|mitosis modulators|mesh-ancestor
102153082|NCT05165225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102153083|NCT05165225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102153084|NCT05165225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102153085|NCT05165225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102153086|NCT05150587|Rifaximin|rifaximin|mesh-list
102153087|NCT05150587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102153088|NCT05150587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102153089|NCT05150587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102153090|NCT05143229|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
102153091|NCT05143229|Immunoconjugates|immunoconjugates|mesh-ancestor
102153092|NCT05143229|Immunologic Factors|immunologic factors|mesh-ancestor
102153093|NCT05143229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153094|NCT05120596|Pembrolizumab|pembrolizumab|mesh-list
102153095|NCT05120596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102153096|NCT05120596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153097|NCT05120596|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102153098|NCT05120596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153099|NCT05099055|Dexmedetomidine|dexmedetomidine|mesh-list
102153100|NCT05099055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102153101|NCT05099055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102153102|NCT05099055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153103|NCT05099055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102153104|NCT05099055|Analgesics|analgesics|mesh-ancestor
102153105|NCT05099055|Sensory System Agents|sensory system agents|mesh-ancestor
102153106|NCT05099055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102153107|NCT05099055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102153108|NCT05099055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102153109|NCT05099055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102153110|NCT05099055|Adrenergic Agents|adrenergic agents|mesh-ancestor
102153111|NCT05099055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102153112|NCT05099055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153113|NCT05024344|Dexamethasone|dexamethasone|mesh-list
102153114|NCT05024344|Ropivacaine|ropivacaine|mesh-list
102153115|NCT05024344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102153116|NCT05024344|Antiemetics|antiemetics|mesh-ancestor
102153117|NCT05024344|Autonomic Agents|autonomic agents|mesh-ancestor
102153118|NCT05024344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102153119|NCT05024344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153120|NCT05024344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102153121|NCT05024344|Glucocorticoids|glucocorticoids|mesh-ancestor
102153122|NCT05024344|Hormones|hormones|mesh-ancestor
102153123|NCT05024344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102153124|NCT05024344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102153125|NCT05024344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153126|NCT05024344|Anesthetics, Local|anesthetics, local|mesh-ancestor
102153127|NCT05024344|Anesthetics|anesthetics|mesh-ancestor
102153128|NCT05024344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102153129|NCT05024344|Sensory System Agents|sensory system agents|mesh-ancestor
102153130|NCT04997304|Albuterol|albuterol|mesh-list
102153131|NCT04997304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102153132|NCT04997304|Autonomic Agents|autonomic agents|mesh-ancestor
102153133|NCT04997304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102153134|NCT04997304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153135|NCT04997304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102153136|NCT04997304|Respiratory System Agents|respiratory system agents|mesh-ancestor
102153137|NCT04997304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102153138|NCT04997304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102153139|NCT04997304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102153140|NCT04997304|Adrenergic Agents|adrenergic agents|mesh-ancestor
102153141|NCT04997304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102153142|NCT04997304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153143|NCT04997304|Tocolytic Agents|tocolytic agents|mesh-ancestor
102153144|NCT04997304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102153145|NCT04993027|Vancomycin|vancomycin|mesh-list
102153146|NCT04993027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102153147|NCT04993027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101862038|NCT01021943|Spironolactone|spironolactone|mesh-list
102153148|NCT04991324|Vitamin D|vitamin d|mesh-list
102153149|NCT04991324|Cholecalciferol|cholecalciferol|mesh-list
102153150|NCT04991324|Vitamins|vitamins|mesh-ancestor
102153151|NCT04991324|Micronutrients|micronutrients|mesh-ancestor
101754933|NCT00729170|Calcium|calcium|mesh-list
102153152|NCT04991324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153153|NCT04991324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102153154|NCT04991324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102153156|NCT04984616|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102153157|NCT04984616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102153158|NCT04984616|Antimetabolites|antimetabolites|mesh-ancestor
102153159|NCT04984616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153160|NCT04984616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102153161|NCT04984616|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102153162|NCT04984616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102153163|NCT04966481|Cetuximab|cetuximab|mesh-list
102153164|NCT04966481|Palbociclib|palbociclib|mesh-list
102153165|NCT04966481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102153166|NCT04966481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153167|NCT04966481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102153168|NCT04966481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102153169|NCT04966481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153170|NCT04957329|Latanoprost|latanoprost|mesh-list
102153171|NCT04957329|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102153172|NCT04957329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102153173|NCT04937881|Tenofovir|tenofovir|mesh-list
102153174|NCT04937881|Antiviral Agents|antiviral agents|mesh-ancestor
102153175|NCT04937881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102153176|NCT04937881|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102153177|NCT04937881|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102153178|NCT04937881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102153179|NCT04937881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153180|NCT04937881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102153181|NCT04937881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102153182|NCT04907721|Glucagon|glucagon|mesh-list
102153183|NCT04907721|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102153184|NCT04907721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102153185|NCT04907721|Hormones|hormones|mesh-ancestor
102153186|NCT04907721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102153187|NCT04907721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153188|NCT04907721|Incretins|incretins|mesh-ancestor
102153189|NCT04905810|Azacitidine|azacitidine|mesh-list
102153190|NCT04905810|Decitabine|decitabine|mesh-list
102153191|NCT04905810|Venetoclax|venetoclax|mesh-list
102153192|NCT04905810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102153193|NCT04905810|Antimetabolites|antimetabolites|mesh-ancestor
102153194|NCT04905810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153195|NCT04905810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153196|NCT04905810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102153197|NCT04871412|Vitamin D|vitamin d|mesh-list
102153198|NCT04871412|Ergocalciferols|ergocalciferols|mesh-list
102153199|NCT04871412|Cholecalciferol|cholecalciferol|mesh-list
102153200|NCT04871412|Vitamins|vitamins|mesh-list
102153201|NCT04871412|Curcumin|curcumin|mesh-list
102153202|NCT04871412|Micronutrients|micronutrients|mesh-ancestor
102153203|NCT04871412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153204|NCT04871412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102153205|NCT04871412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102153206|NCT04871412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102153207|NCT04871412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102153208|NCT04871412|Analgesics|analgesics|mesh-ancestor
102153209|NCT04871412|Sensory System Agents|sensory system agents|mesh-ancestor
102153210|NCT04871412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102153211|NCT04871412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102153212|NCT04871412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102153213|NCT04871412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153214|NCT04871412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102153215|NCT04871412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153216|NCT04868877|Osimertinib|osimertinib|mesh-list
102153217|NCT04868877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153218|NCT04868877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102153219|NCT04868877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102153220|NCT04868877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153221|NCT04818086|Buprenorphine|buprenorphine|mesh-list
102153222|NCT04818086|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102153223|NCT04818086|Lemborexant|lemborexant|mesh-list
102153224|NCT04818086|Naloxone|naloxone|mesh-list
102153225|NCT04818086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102153226|NCT04818086|Narcotics|narcotics|mesh-ancestor
102153227|NCT04818086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102153228|NCT04818086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153229|NCT04818086|Analgesics|analgesics|mesh-ancestor
102153230|NCT04818086|Sensory System Agents|sensory system agents|mesh-ancestor
102153231|NCT04818086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102153232|NCT04818086|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102153233|NCT04818086|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102153234|NCT04818086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102153235|NCT04818086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153236|NCT04818086|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102153237|NCT04818086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102153239|NCT04799431|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102153240|NCT04799431|Poly ICLC|poly iclc|mesh-list
102153241|NCT04799431|Interferon Inducers|interferon inducers|mesh-ancestor
102153242|NCT04799431|Immunologic Factors|immunologic factors|mesh-ancestor
102153243|NCT04799431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153244|NCT04799431|Laxatives|laxatives|mesh-ancestor
102153245|NCT04799431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102153246|NCT04799431|Antiviral Agents|antiviral agents|mesh-ancestor
102153247|NCT04799431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102153248|NCT04745832|Prednisone|prednisone|mesh-list
102153249|NCT04745832|Cyclophosphamide|cyclophosphamide|mesh-list
102153250|NCT04745832|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102153251|NCT04745832|Rituximab|rituximab|mesh-list
102153252|NCT04745832|Vincristine|vincristine|mesh-list
102153253|NCT04745832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102153254|NCT04745832|Immunologic Factors|immunologic factors|mesh-ancestor
102153255|NCT04745832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153256|NCT04745832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102153257|NCT04745832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102153258|NCT04745832|Alkylating Agents|alkylating agents|mesh-ancestor
102153259|NCT04745832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153260|NCT04745832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153261|NCT04745832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102153262|NCT04745832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102153263|NCT04745832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102153264|NCT04745832|Glucocorticoids|glucocorticoids|mesh-ancestor
102153265|NCT04745832|Hormones|hormones|mesh-ancestor
102153266|NCT04745832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102153267|NCT04745832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102153268|NCT04745832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102153269|NCT04745832|Tubulin Modulators|tubulin modulators|mesh-ancestor
102153270|NCT04745832|Antimitotic Agents|antimitotic agents|mesh-ancestor
102153271|NCT04745832|Mitosis Modulators|mitosis modulators|mesh-ancestor
102153272|NCT04724668|Melatonin|melatonin|mesh-list
102153273|NCT04724668|Antioxidants|antioxidants|mesh-ancestor
102153274|NCT04724668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153275|NCT04724668|Protective Agents|protective agents|mesh-ancestor
102153276|NCT04724668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153277|NCT04724668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102153278|NCT04685772|Methylprednisolone|methylprednisolone|mesh-list
102153279|NCT04685772|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102153280|NCT04685772|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102153281|NCT04685772|Prednisolone|prednisolone|mesh-list
102153282|NCT04685772|Prednisolone acetate|prednisolone acetate|mesh-list
102153283|NCT04685772|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102153284|NCT04685772|Prednisolone phosphate|prednisolone phosphate|mesh-list
102153285|NCT04685772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102153286|NCT04685772|Antiemetics|antiemetics|mesh-ancestor
102153287|NCT04685772|Autonomic Agents|autonomic agents|mesh-ancestor
102153288|NCT04685772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102153289|NCT04685772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153290|NCT04685772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102153291|NCT04685772|Glucocorticoids|glucocorticoids|mesh-ancestor
102153292|NCT04685772|Hormones|hormones|mesh-ancestor
102153293|NCT04685772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102153294|NCT04685772|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102153295|NCT04685772|Protective Agents|protective agents|mesh-ancestor
102153296|NCT04685772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102153297|NCT04685772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153298|NCT04609189|Vitamin D|vitamin d|mesh-list
102153299|NCT04609189|Cholecalciferol|cholecalciferol|mesh-list
102153300|NCT04609189|Calcium Carbonate|calcium carbonate|mesh-list
102153301|NCT04609189|Calcium|calcium|mesh-list
102153302|NCT04609189|Vitamins|vitamins|mesh-ancestor
102153304|NCT04609189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153305|NCT04609189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102153306|NCT04609189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102153307|NCT04609189|Antacids|antacids|mesh-ancestor
102153308|NCT04609189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153309|NCT04609189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102153310|NCT04604795|Itraconazole|itraconazole|mesh-list
102153311|NCT04604795|Antifungal Agents|antifungal agents|mesh-ancestor
102153312|NCT04604795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102153313|NCT04604795|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102153314|NCT04604795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102153315|NCT04604795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102153316|NCT04604795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153317|NCT04604795|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102153318|NCT04604795|Hormone Antagonists|hormone antagonists|mesh-ancestor
102153319|NCT04604795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102153320|NCT04604795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153321|NCT04604795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102153322|NCT04588233|Melatonin|melatonin|mesh-list
102153323|NCT04588233|Antioxidants|antioxidants|mesh-ancestor
102153324|NCT04588233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153325|NCT04588233|Protective Agents|protective agents|mesh-ancestor
102153326|NCT04588233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153327|NCT04588233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102153328|NCT04587128|Irinotecan|irinotecan|mesh-list
102153329|NCT04587128|Cetuximab|cetuximab|mesh-list
102153330|NCT04587128|Panitumumab|panitumumab|mesh-list
102153331|NCT04587128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102153332|NCT04587128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102153333|NCT04587128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102153334|NCT04587128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153335|NCT04587128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153336|NCT04587128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102153337|NCT04570150|Neostigmine|neostigmine|mesh-list
102153338|NCT04570150|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102153339|NCT04570150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102153340|NCT04570150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153341|NCT04570150|Cholinergic Agents|cholinergic agents|mesh-ancestor
102153342|NCT04570150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102153343|NCT04570150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153344|NCT04570150|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102153345|NCT04570150|Autonomic Agents|autonomic agents|mesh-ancestor
102153346|NCT04570150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102153347|NCT04563273|Vaccines|vaccines|mesh-list
102153348|NCT04563273|BCG Vaccine|bcg vaccine|mesh-list
102153349|NCT04563273|Immunologic Factors|immunologic factors|mesh-ancestor
102153350|NCT04563273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153351|NCT04563273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102153352|NCT04552782|Ethanol|ethanol|mesh-list
102153353|NCT04552782|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102153354|NCT04552782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102153355|NCT04552782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102153356|NCT04552782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153357|NCT04545762|Cyclophosphamide|cyclophosphamide|mesh-list
102153358|NCT04545762|Fludarabine|fludarabine|mesh-list
102153359|NCT04545762|Fludarabine phosphate|fludarabine phosphate|mesh-list
102153360|NCT04545762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102153361|NCT04545762|Immunologic Factors|immunologic factors|mesh-ancestor
102153362|NCT04545762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153363|NCT04545762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102153364|NCT04545762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102153365|NCT04545762|Alkylating Agents|alkylating agents|mesh-ancestor
102153366|NCT04545762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153367|NCT04545762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153368|NCT04545762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102153369|NCT04545762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102153370|NCT04545762|Antimetabolites|antimetabolites|mesh-ancestor
102153371|NCT04539977|Carboplatin|carboplatin|mesh-list
102153372|NCT04539977|Etoposide|etoposide|mesh-list
102153373|NCT04539977|Etoposide phosphate|etoposide phosphate|mesh-list
102153374|NCT04539977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153375|NCT04539977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102153376|NCT04539977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102153377|NCT04539977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102153378|NCT04539977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102153379|NCT04539977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153380|NCT04535141|Olanzapine|olanzapine|mesh-list
102153381|NCT04535141|Antiemetics|antiemetics|mesh-ancestor
102153382|NCT04535141|Autonomic Agents|autonomic agents|mesh-ancestor
102153383|NCT04535141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102153384|NCT04535141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153385|NCT04535141|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102153386|NCT04535141|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102153387|NCT04535141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102153388|NCT04535141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102153389|NCT04535141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102153390|NCT04535141|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102153391|NCT04535141|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102153392|NCT04535141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102153393|NCT04535141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153394|NCT04535141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102153395|NCT04535141|Serotonin Agents|serotonin agents|mesh-ancestor
102153396|NCT04534023|Idebenone|idebenone|mesh-list
102153397|NCT04534023|Antioxidants|antioxidants|mesh-ancestor
102153398|NCT04534023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153399|NCT04534023|Protective Agents|protective agents|mesh-ancestor
102153400|NCT04534023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153401|NCT04527393|Morphine|morphine|mesh-list
101755176|NCT05575440|Fluorides|fluorides|mesh-list
102153402|NCT04527393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102153403|NCT04527393|Narcotics|narcotics|mesh-ancestor
102153404|NCT04527393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102153405|NCT04527393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153406|NCT04527393|Analgesics|analgesics|mesh-ancestor
102153407|NCT04527393|Sensory System Agents|sensory system agents|mesh-ancestor
102153408|NCT04527393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102153409|NCT04510506|Pancrelipase|pancrelipase|mesh-list
102153410|NCT04510506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102153411|NCT04480918|Ketamine|ketamine|mesh-list
102153412|NCT04480918|Esketamine|esketamine|mesh-list
102153413|NCT04480918|Analgesics|analgesics|mesh-ancestor
102153414|NCT04480918|Sensory System Agents|sensory system agents|mesh-ancestor
102153415|NCT04480918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102153416|NCT04480918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153417|NCT04480918|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102153418|NCT04480918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102153419|NCT04480918|Anesthetics, General|anesthetics, general|mesh-ancestor
102153420|NCT04480918|Anesthetics|anesthetics|mesh-ancestor
102153421|NCT04480918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102153422|NCT04480918|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102153423|NCT04480918|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102153424|NCT04480918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102153425|NCT04480918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153426|NCT04480918|Antidepressive Agents|antidepressive agents|mesh-ancestor
102153427|NCT04480918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102153428|NCT04465487|Cemiplimab|cemiplimab|mesh-list
102153429|NCT04465487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102153430|NCT04465487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153431|NCT04419909|Tisagenlecleucel|tisagenlecleucel|mesh-list
102153432|NCT04419909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102153433|NCT04419909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153434|NCT04374500|Verapamil|verapamil|mesh-list
102153435|NCT04374500|Nitroprusside|nitroprusside|mesh-list
102153436|NCT04374500|Acetylcholine|acetylcholine|mesh-list
102153437|NCT04374500|Vasodilator Agents|vasodilator agents|mesh-list
102153438|NCT04374500|Bradykinin|bradykinin|mesh-list
102153439|NCT04374500|Substance P|substance p|mesh-list
102153440|NCT04374500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102153441|NCT04374500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102153442|NCT04374500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102153443|NCT04374500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153444|NCT04374500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102153445|NCT04374500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153446|NCT04374500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102153447|NCT04374500|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102153448|NCT04374500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102153449|NCT04374500|Cholinergic Agents|cholinergic agents|mesh-ancestor
101862332|NCT00452699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102153450|NCT04374500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102153451|NCT04340947|Nicotine|nicotine|mesh-list
102153452|NCT04340947|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102153453|NCT04340947|Autonomic Agents|autonomic agents|mesh-ancestor
102153454|NCT04340947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102153455|NCT04340947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153456|NCT04340947|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102153457|NCT04340947|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102153458|NCT04340947|Cholinergic Agents|cholinergic agents|mesh-ancestor
102153459|NCT04340947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102153460|NCT04340947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153461|NCT04326283|Trametinib|trametinib|mesh-list
102153462|NCT04326283|Riluzole|riluzole|mesh-list
102153463|NCT04326283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153464|NCT04326283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102153465|NCT04326283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102153466|NCT04326283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153467|NCT04326283|Anticonvulsants|anticonvulsants|mesh-ancestor
102153468|NCT04326283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102153469|NCT04326283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102153470|NCT04326283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102153471|NCT04326283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153472|NCT04326283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102153473|NCT04326283|Protective Agents|protective agents|mesh-ancestor
102153474|NCT04280965|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102535922|NCT00553319|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102153475|NCT04280965|Antidepressive Agents|antidepressive agents|mesh-ancestor
102153476|NCT04280965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102153477|NCT04280965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102153478|NCT04280965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102153479|NCT04280965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102153480|NCT04280965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153481|NCT04266353|Resveratrol|resveratrol|mesh-list
102153482|NCT04266353|Antioxidants|antioxidants|mesh-ancestor
102153483|NCT04266353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153484|NCT04266353|Protective Agents|protective agents|mesh-ancestor
102153485|NCT04266353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153486|NCT04266353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102153487|NCT04266353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102153489|NCT04231643|Cannabidiol|cannabidiol|mesh-list
102153490|NCT04231643|Hallucinogens|hallucinogens|mesh-ancestor
102153491|NCT04231643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153492|NCT04231643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102153493|NCT04231643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102153494|NCT04231643|Analgesics|analgesics|mesh-ancestor
102153495|NCT04231643|Sensory System Agents|sensory system agents|mesh-ancestor
102153496|NCT04231643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102153497|NCT04231643|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102153498|NCT04231643|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102153499|NCT04231643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102153500|NCT04231643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153501|NCT04231643|Hormones|hormones|mesh-ancestor
102153502|NCT04231643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102153503|NCT04231643|Anticonvulsants|anticonvulsants|mesh-ancestor
102153504|NCT04207190|Talazoparib|talazoparib|mesh-list
102153505|NCT04207190|Gemtuzumab|gemtuzumab|mesh-list
102153506|NCT04207190|Calicheamicins|calicheamicins|mesh-list
102153507|NCT04207190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102153508|NCT04207190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102153509|NCT04207190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153510|NCT04207190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153511|NCT04207190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102153512|NCT04207190|Immunotoxins|immunotoxins|mesh-ancestor
102153513|NCT04207190|Immunoconjugates|immunoconjugates|mesh-ancestor
102153514|NCT04207190|Immunologic Factors|immunologic factors|mesh-ancestor
102153515|NCT04207190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153516|NCT04207190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102153517|NCT04174196|Lenalidomide|lenalidomide|mesh-list
102153519|NCT04174196|Immunologic Factors|immunologic factors|mesh-ancestor
102153520|NCT04174196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153521|NCT04174196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102153522|NCT04174196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102153523|NCT04174196|Growth Substances|growth substances|mesh-ancestor
102153524|NCT04174196|Growth Inhibitors|growth inhibitors|mesh-ancestor
102153525|NCT04174196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153526|NCT04171167|Fluticasone|fluticasone|mesh-list
102153527|NCT04171167|Xhance|xhance|mesh-list
102153528|NCT04171167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102153529|NCT04171167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102153530|NCT04171167|Autonomic Agents|autonomic agents|mesh-ancestor
102153531|NCT04171167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102153532|NCT04171167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153533|NCT04171167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102153534|NCT04171167|Respiratory System Agents|respiratory system agents|mesh-ancestor
102153535|NCT04171167|Dermatologic Agents|dermatologic agents|mesh-ancestor
102153536|NCT04171167|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102153537|NCT04129060|Cholinergic Agents|cholinergic agents|mesh-list
102153538|NCT04129060|Cholinergic Antagonists|cholinergic antagonists|mesh-list
102153539|NCT04129060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102153540|NCT04129060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153541|NCT04129060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153542|NCT04119284|Terephthalic acid|terephthalic acid|mesh-list
102153543|NCT04119284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102153544|NCT04119284|Antioxidants|antioxidants|mesh-ancestor
102153545|NCT04119284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153546|NCT04119284|Protective Agents|protective agents|mesh-ancestor
102153547|NCT04119284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153548|NCT04117763|Empagliflozin|empagliflozin|mesh-list
102153549|NCT04117763|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102153550|NCT04117763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153551|NCT04117763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102153552|NCT04117763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153553|NCT04078880|Ascorbic Acid|ascorbic acid|mesh-list
102153554|NCT04078880|Antioxidants|antioxidants|mesh-ancestor
102153555|NCT04078880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153556|NCT04078880|Protective Agents|protective agents|mesh-ancestor
102153557|NCT04078880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153558|NCT04078880|Vitamins|vitamins|mesh-ancestor
102153559|NCT04078880|Micronutrients|micronutrients|mesh-ancestor
102153560|NCT04077437|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
102153561|NCT04077437|Hallucinogens|hallucinogens|mesh-ancestor
102153562|NCT04077437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153563|NCT04077437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102153564|NCT04077437|Serotonin Agents|serotonin agents|mesh-ancestor
102153565|NCT04077437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102153566|NCT04077437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153567|NCT04077437|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102153568|NCT04077437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102153569|NCT04077437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102153570|NCT04077437|Adrenergic Agents|adrenergic agents|mesh-ancestor
102153571|NCT04071574|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102153572|NCT04071574|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102153573|NCT04071574|Cetrorelix|cetrorelix|mesh-list
102153574|NCT04071574|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
102153575|NCT04071574|Hormones|hormones|mesh-ancestor
102153576|NCT04071574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102153577|NCT04071574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153578|NCT04071574|Luteolytic Agents|luteolytic agents|mesh-ancestor
102153579|NCT04071574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102153580|NCT04071574|Contraceptive Agents|contraceptive agents|mesh-ancestor
102153581|NCT04071574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101755357|NCT00732576|Vitamins|vitamins|mesh-ancestor
102153582|NCT04071574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102153583|NCT04071574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102153584|NCT04071574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153585|NCT04071574|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102153586|NCT04071574|Fertility Agents|fertility agents|mesh-ancestor
102153587|NCT04071574|Hormone Antagonists|hormone antagonists|mesh-ancestor
102153588|NCT04023669|Cyclophosphamide|cyclophosphamide|mesh-list
102153589|NCT04023669|Gemcitabine|gemcitabine|mesh-list
102153590|NCT04023669|Lenograstim|lenograstim|mesh-list
102153591|NCT04023669|Prexasertib|prexasertib|mesh-list
102153592|NCT04023669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102153593|NCT04023669|Immunologic Factors|immunologic factors|mesh-ancestor
102153594|NCT04023669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153595|NCT04023669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102153596|NCT04023669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102153597|NCT04023669|Alkylating Agents|alkylating agents|mesh-ancestor
102153598|NCT04023669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153600|NCT04023669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102153601|NCT04023669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102153602|NCT04023669|Antimetabolites|antimetabolites|mesh-ancestor
102153603|NCT04023669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102153604|NCT04023669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102153605|NCT04023669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102153606|NCT04002362|Triamcinolone|triamcinolone|mesh-list
102153607|NCT04002362|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102153608|NCT04002362|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102153609|NCT04002362|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102153610|NCT04002362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102153611|NCT04002362|Glucocorticoids|glucocorticoids|mesh-ancestor
102153612|NCT04002362|Hormones|hormones|mesh-ancestor
102153613|NCT04002362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102153614|NCT04002362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153615|NCT04002362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102153616|NCT04002362|Immunologic Factors|immunologic factors|mesh-ancestor
102153617|NCT04002362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102153618|NCT04002362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153619|NCT03992196|Rotigotine|rotigotine|mesh-list
102153620|NCT03992196|Dopamine Agonists|dopamine agonists|mesh-ancestor
102153621|NCT03992196|Dopamine Agents|dopamine agents|mesh-ancestor
102153622|NCT03992196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102153623|NCT03992196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153624|NCT03992196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153625|NCT03982381|Metformin|metformin|mesh-list
102153626|NCT03982381|Dapagliflozin|dapagliflozin|mesh-list
102153627|NCT03982381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102153628|NCT03982381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153629|NCT03982381|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101755415|NCT00617734|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102153630|NCT03982381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153631|NCT03982186|JNJ-56136379|jnj-56136379|mesh-list
102153632|NCT03982186|Antiviral Agents|antiviral agents|mesh-ancestor
102153633|NCT03982186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102153634|NCT03970252|Calcium, Dietary|calcium, dietary|mesh-list
102153635|NCT03970252|Leucovorin|leucovorin|mesh-list
102153636|NCT03970252|Folic Acid|folic acid|mesh-list
102153637|NCT03970252|Fluorouracil|fluorouracil|mesh-list
102153638|NCT03970252|Oxaliplatin|oxaliplatin|mesh-list
102153639|NCT03970252|Nivolumab|nivolumab|mesh-list
102153640|NCT03970252|Irinotecan|irinotecan|mesh-list
102153641|NCT03970252|Camptothecin|camptothecin|mesh-list
102153642|NCT03970252|Calcium|calcium|mesh-list
102153643|NCT03970252|Levoleucovorin|levoleucovorin|mesh-list
102153644|NCT03970252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102153645|NCT03970252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153646|NCT03970252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102153647|NCT03970252|Antimetabolites|antimetabolites|mesh-ancestor
102153648|NCT03970252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153649|NCT03970252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102153650|NCT03970252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153651|NCT03970252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102153652|NCT03970252|Immunologic Factors|immunologic factors|mesh-ancestor
102153653|NCT03970252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102153654|NCT03970252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102153655|NCT03970252|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102153656|NCT03970252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102153657|NCT03970252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102153658|NCT03970252|Antidotes|antidotes|mesh-ancestor
102153659|NCT03970252|Protective Agents|protective agents|mesh-ancestor
102153660|NCT03970252|Vitamin B Complex|vitamin b complex|mesh-ancestor
102153661|NCT03970252|Vitamins|vitamins|mesh-ancestor
102153662|NCT03970252|Micronutrients|micronutrients|mesh-ancestor
102153663|NCT03970252|Hematinics|hematinics|mesh-ancestor
102153664|NCT03970252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102153665|NCT03969004|Cemiplimab|cemiplimab|mesh-list
102153666|NCT03969004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102153667|NCT03969004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153668|NCT03932409|Paclitaxel|paclitaxel|mesh-list
102153669|NCT03932409|Carboplatin|carboplatin|mesh-list
102153670|NCT03932409|Pembrolizumab|pembrolizumab|mesh-list
102153671|NCT03932409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102153672|NCT03932409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153673|NCT03932409|Tubulin Modulators|tubulin modulators|mesh-ancestor
102153674|NCT03932409|Antimitotic Agents|antimitotic agents|mesh-ancestor
102153675|NCT03932409|Mitosis Modulators|mitosis modulators|mesh-ancestor
102153676|NCT03932409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153677|NCT03932409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102153678|NCT03932409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102153679|NCT03915613|Insulin|insulin|mesh-list
102153680|NCT03915613|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102153681|NCT03915613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102153682|NCT03915613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153683|NCT03907852|Cyclophosphamide|cyclophosphamide|mesh-list
102153684|NCT03907852|Nivolumab|nivolumab|mesh-list
102153685|NCT03907852|Fludarabine|fludarabine|mesh-list
102153686|NCT03907852|Ipilimumab|ipilimumab|mesh-list
102153687|NCT03907852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102153688|NCT03907852|Immunologic Factors|immunologic factors|mesh-ancestor
102153689|NCT03907852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153690|NCT03907852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102153691|NCT03907852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102153692|NCT03907852|Alkylating Agents|alkylating agents|mesh-ancestor
102153693|NCT03907852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153694|NCT03907852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153695|NCT03907852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102153696|NCT03907852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102153697|NCT03907852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102153698|NCT03896633|Brinzolamide|brinzolamide|mesh-list
102153699|NCT03896633|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102153700|NCT03896633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102153701|NCT03896633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153702|NCT03890731|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102153703|NCT03890731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102153704|NCT03890731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102153705|NCT03890731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153706|NCT03872180|Venetoclax|venetoclax|mesh-list
102153707|NCT03872180|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102153708|NCT03872180|Obinutuzumab|obinutuzumab|mesh-list
102153709|NCT03872180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153710|NCT03872180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102153711|NCT03872180|Alkylating Agents|alkylating agents|mesh-ancestor
102153712|NCT03872180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153713|NCT03872180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102153714|NCT03847649|Prednisone|prednisone|mesh-list
102153715|NCT03847649|Durvalumab|durvalumab|mesh-list
102153716|NCT03847649|Tremelimumab|tremelimumab|mesh-list
102153717|NCT03847649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102153718|NCT03847649|Glucocorticoids|glucocorticoids|mesh-ancestor
102153719|NCT03847649|Hormones|hormones|mesh-ancestor
102153720|NCT03847649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102153721|NCT03847649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153722|NCT03847649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102153723|NCT03847649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153724|NCT03847649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102153725|NCT03847311|Sulfasalazine|sulfasalazine|mesh-list
102153726|NCT03847311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102153727|NCT03847311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102153728|NCT03847311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102153729|NCT03847311|Analgesics|analgesics|mesh-ancestor
102153730|NCT03847311|Sensory System Agents|sensory system agents|mesh-ancestor
102153731|NCT03847311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102153732|NCT03847311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153733|NCT03847311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102153734|NCT03847311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102153735|NCT03847311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102153736|NCT03845543|Paclitaxel|paclitaxel|mesh-list
102153737|NCT03845543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102153738|NCT03845543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153739|NCT03845543|Tubulin Modulators|tubulin modulators|mesh-ancestor
102153740|NCT03845543|Antimitotic Agents|antimitotic agents|mesh-ancestor
102153741|NCT03845543|Mitosis Modulators|mitosis modulators|mesh-ancestor
102153742|NCT03845543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153743|NCT03827889|Fluorides|fluorides|mesh-list
102153744|NCT03827889|Fluorides, Topical|fluorides, topical|mesh-list
102153745|NCT03827889|Cariostatic Agents|cariostatic agents|mesh-ancestor
102153746|NCT03827889|Protective Agents|protective agents|mesh-ancestor
102153747|NCT03827889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153748|NCT03826563|Melatonin|melatonin|mesh-list
102153749|NCT03826563|Antioxidants|antioxidants|mesh-ancestor
101862633|NCT00290498|Prednisone|prednisone|mesh-list
102153750|NCT03826563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153752|NCT03826563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153753|NCT03826563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102153754|NCT03825796|Cytarabine|cytarabine|mesh-list
102153755|NCT03825796|Daunorubicin|daunorubicin|mesh-list
102153756|NCT03825796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102153757|NCT03825796|Antimetabolites|antimetabolites|mesh-ancestor
102153758|NCT03825796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153759|NCT03825796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153760|NCT03825796|Antiviral Agents|antiviral agents|mesh-ancestor
102153761|NCT03825796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102153762|NCT03825796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102153763|NCT03825796|Immunologic Factors|immunologic factors|mesh-ancestor
102153764|NCT03825796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153765|NCT03825796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102153766|NCT03825796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102153767|NCT03825796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102153768|NCT03825796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102153769|NCT03823131|Pembrolizumab|pembrolizumab|mesh-list
102153770|NCT03823131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102153771|NCT03823131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153772|NCT03823131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102153773|NCT03823131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153774|NCT03822091|Terlipressin|terlipressin|mesh-list
102153775|NCT03822091|Norepinephrine|norepinephrine|mesh-list
102153776|NCT03822091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102153777|NCT03822091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102153778|NCT03822091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102153780|NCT03822091|Adrenergic Agents|adrenergic agents|mesh-ancestor
102153781|NCT03822091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102153782|NCT03822091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153783|NCT03822091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153784|NCT03822091|Sympathomimetics|sympathomimetics|mesh-ancestor
102153785|NCT03822091|Autonomic Agents|autonomic agents|mesh-ancestor
102153786|NCT03822091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102153787|NCT03739619|Gemcitabine|gemcitabine|mesh-list
102153788|NCT03739619|Nivolumab|nivolumab|mesh-list
102153789|NCT03739619|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102153790|NCT03739619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102153791|NCT03739619|Antimetabolites|antimetabolites|mesh-ancestor
102153792|NCT03739619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153793|NCT03739619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153794|NCT03739619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102153795|NCT03739619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102153796|NCT03739619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102153797|NCT03739619|Alkylating Agents|alkylating agents|mesh-ancestor
102153798|NCT03664544|Edaravone|edaravone|mesh-list
102153799|NCT03664544|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102153800|NCT03664544|Antioxidants|antioxidants|mesh-ancestor
102153801|NCT03664544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153802|NCT03664544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102153803|NCT03664544|Protective Agents|protective agents|mesh-ancestor
102153804|NCT03664544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153805|NCT03537495|Linezolid|linezolid|mesh-list
102153806|NCT03537495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102153807|NCT03537495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102153808|NCT03537495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102153809|NCT03537495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102153810|NCT03537495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153811|NCT03535259|Sorafenib|sorafenib|mesh-list
102153812|NCT03535259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153813|NCT03535259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102153814|NCT03535259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102153815|NCT03535259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153816|NCT03521570|Nivolumab|nivolumab|mesh-list
102153817|NCT03521570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102153818|NCT03521570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153819|NCT03521570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102153820|NCT03521570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153821|NCT03484299|Gemcitabine|gemcitabine|mesh-list
102153822|NCT03484299|Folfirinox|folfirinox|mesh-list
102153823|NCT03484299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102153824|NCT03484299|Antimetabolites|antimetabolites|mesh-ancestor
102153825|NCT03484299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153826|NCT03484299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153827|NCT03468218|Pembrolizumab|pembrolizumab|mesh-list
102153828|NCT03468218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102153829|NCT03468218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153830|NCT03468218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102153831|NCT03468218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153832|NCT03408574|Mecamylamine|mecamylamine|mesh-list
102153833|NCT03408574|Nicotine|nicotine|mesh-list
102153834|NCT03408574|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102153835|NCT03408574|Autonomic Agents|autonomic agents|mesh-ancestor
102153836|NCT03408574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102153837|NCT03408574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153838|NCT03408574|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102153839|NCT03408574|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102153840|NCT03408574|Cholinergic Agents|cholinergic agents|mesh-ancestor
102153841|NCT03408574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102153842|NCT03408574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153843|NCT03408574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102153844|NCT03408574|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
102153845|NCT03408574|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102153846|NCT03408574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102153847|NCT03341520|Obinutuzumab|obinutuzumab|mesh-list
102153848|NCT03341520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102153849|NCT03341520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153850|NCT03222570|Serotonin|serotonin|mesh-list
102154347|NCT03365115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102153851|NCT03222570|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
102153852|NCT03222570|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102153853|NCT03222570|Serotonin Agents|serotonin agents|mesh-ancestor
102153854|NCT03222570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102153855|NCT03222570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153856|NCT03222570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153857|NCT03222570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102153858|NCT03222570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102153859|NCT03136328|Edotreotide|edotreotide|mesh-list
102153860|NCT03136328|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102153861|NCT03136328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153862|NCT03072771|Cytarabine|cytarabine|mesh-list
102153863|NCT03072771|Etoposide|etoposide|mesh-list
102153864|NCT03072771|Melphalan|melphalan|mesh-list
102153865|NCT03072771|Carmustine|carmustine|mesh-list
102153866|NCT03072771|Blinatumomab|blinatumomab|mesh-list
102153867|NCT03072771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102153868|NCT03072771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153869|NCT03072771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102153870|NCT03072771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102153871|NCT03072771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102153872|NCT03072771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153873|NCT03072771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102153874|NCT03072771|Antimetabolites|antimetabolites|mesh-ancestor
102153875|NCT03072771|Antiviral Agents|antiviral agents|mesh-ancestor
102153876|NCT03072771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102153877|NCT03072771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102153878|NCT03072771|Immunologic Factors|immunologic factors|mesh-ancestor
102153879|NCT03072771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153880|NCT03072771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102153881|NCT03072771|Alkylating Agents|alkylating agents|mesh-ancestor
102153882|NCT03072771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102153883|NCT03067272|Contraceptive Agents|contraceptive agents|mesh-list
102153884|NCT03067272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102153885|NCT03067272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153886|NCT02966782|Azacitidine|azacitidine|mesh-list
102153887|NCT02966782|Venetoclax|venetoclax|mesh-list
102153888|NCT02966782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102153889|NCT02966782|Antimetabolites|antimetabolites|mesh-ancestor
102153890|NCT02966782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153891|NCT02966782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153892|NCT02966782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102153893|NCT02925650|Phenserine|phenserine|mesh-list
102153894|NCT02925650|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102153895|NCT02925650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102153896|NCT02925650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153897|NCT02925650|Cholinergic Agents|cholinergic agents|mesh-ancestor
102153898|NCT02925650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102153899|NCT02925650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153900|NCT02914938|Rituximab|rituximab|mesh-list
102153901|NCT02914938|Zanubrutinib|zanubrutinib|mesh-list
102153902|NCT02914938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102153903|NCT02914938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153904|NCT02914938|Immunologic Factors|immunologic factors|mesh-ancestor
102153905|NCT02914938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153906|NCT02914938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102153907|NCT02914938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102153908|NCT02914938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102153909|NCT02914938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153910|NCT02849457|Vigabatrin|vigabatrin|mesh-list
102153911|NCT02849457|Anticonvulsants|anticonvulsants|mesh-ancestor
102153912|NCT02849457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102153913|NCT02849457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153914|NCT02849457|GABA Agents|gaba agents|mesh-ancestor
101755681|NCT00573430|Candesartan|candesartan|mesh-list
102153915|NCT02849457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102153916|NCT02849457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153917|NCT02802631|Minocycline|minocycline|mesh-list
102153918|NCT02802631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102153919|NCT02802631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102153920|NCT02757898|Biotin|biotin|mesh-list
102153921|NCT02757898|Vitamin B Complex|vitamin b complex|mesh-ancestor
102153922|NCT02757898|Vitamins|vitamins|mesh-ancestor
102153923|NCT02757898|Micronutrients|micronutrients|mesh-ancestor
102153924|NCT02757898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535923|NCT00553319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102153925|NCT02730546|Calcium, Dietary|calcium, dietary|mesh-list
102153927|NCT02730546|Folic Acid|folic acid|mesh-list
102153928|NCT02730546|Paclitaxel|paclitaxel|mesh-list
102153929|NCT02730546|Carboplatin|carboplatin|mesh-list
102153930|NCT02730546|Pembrolizumab|pembrolizumab|mesh-list
102153931|NCT02730546|Fluorouracil|fluorouracil|mesh-list
102153932|NCT02730546|Oxaliplatin|oxaliplatin|mesh-list
102153933|NCT02730546|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102153934|NCT02730546|Calcium|calcium|mesh-list
102153935|NCT02730546|Levoleucovorin|levoleucovorin|mesh-list
102153936|NCT02730546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102153937|NCT02730546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153938|NCT02730546|Tubulin Modulators|tubulin modulators|mesh-ancestor
102153939|NCT02730546|Antimitotic Agents|antimitotic agents|mesh-ancestor
102153940|NCT02730546|Mitosis Modulators|mitosis modulators|mesh-ancestor
102153941|NCT02730546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153942|NCT02730546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102153943|NCT02730546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102153944|NCT02730546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102153945|NCT02730546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153946|NCT02730546|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102153947|NCT02730546|Antimetabolites|antimetabolites|mesh-ancestor
102153948|NCT02730546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102153949|NCT02730546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102153950|NCT02730546|Immunologic Factors|immunologic factors|mesh-ancestor
102153951|NCT02730546|Antidotes|antidotes|mesh-ancestor
102153952|NCT02730546|Protective Agents|protective agents|mesh-ancestor
102153953|NCT02730546|Vitamin B Complex|vitamin b complex|mesh-ancestor
102153954|NCT02730546|Vitamins|vitamins|mesh-ancestor
102153955|NCT02730546|Micronutrients|micronutrients|mesh-ancestor
102153956|NCT02730546|Hematinics|hematinics|mesh-ancestor
102153957|NCT02672098|Carboplatin|carboplatin|mesh-list
102153958|NCT02672098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153959|NCT02649335|Propranolol|propranolol|mesh-list
102153960|NCT02649335|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102153961|NCT02649335|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102153962|NCT02649335|Adrenergic Agents|adrenergic agents|mesh-ancestor
102153963|NCT02649335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102153964|NCT02649335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153965|NCT02649335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153966|NCT02649335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102153967|NCT02649335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102153968|NCT02649335|Vasodilator Agents|vasodilator agents|mesh-ancestor
102153969|NCT02609386|Zinc|zinc|mesh-list
102153970|NCT02609386|Indomethacin|indomethacin|mesh-list
102153971|NCT02609386|Cyclophosphamide|cyclophosphamide|mesh-list
102153972|NCT02609386|Omeprazole|omeprazole|mesh-list
102153973|NCT02609386|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101862862|NCT01026311|Ubiquinone|ubiquinone|mesh-list
102153974|NCT02609386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102153975|NCT02609386|Immunologic Factors|immunologic factors|mesh-ancestor
102153976|NCT02609386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102153977|NCT02609386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102153978|NCT02609386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102153979|NCT02609386|Alkylating Agents|alkylating agents|mesh-ancestor
102153980|NCT02609386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102153981|NCT02609386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102153982|NCT02609386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102153983|NCT02609386|Micronutrients|micronutrients|mesh-ancestor
102153984|NCT02609386|Trace Elements|trace elements|mesh-ancestor
102153985|NCT02609386|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102153986|NCT02609386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102153987|NCT02609386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102153988|NCT02609386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102153989|NCT02609386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102153990|NCT02609386|Analgesics|analgesics|mesh-ancestor
102153991|NCT02609386|Sensory System Agents|sensory system agents|mesh-ancestor
102153992|NCT02609386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102153993|NCT02609386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102153994|NCT02609386|Gout Suppressants|gout suppressants|mesh-ancestor
102153995|NCT02609386|Tocolytic Agents|tocolytic agents|mesh-ancestor
102153996|NCT02609386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102153997|NCT02609386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102153998|NCT02589496|Pembrolizumab|pembrolizumab|mesh-list
102153999|NCT02589496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102154000|NCT02589496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102154001|NCT02589496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102154002|NCT02589496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154004|NCT02213575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102154005|NCT02213575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102154006|NCT02148796|Broncho-Vaxom|broncho-vaxom|mesh-list
102154007|NCT02148796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102154008|NCT02148796|Immunologic Factors|immunologic factors|mesh-ancestor
102154009|NCT02148796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154010|NCT02133872|Minocycline|minocycline|mesh-list
102154011|NCT02133872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102154012|NCT02133872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102154013|NCT01958593|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
102154014|NCT01958593|Hallucinogens|hallucinogens|mesh-ancestor
102154015|NCT01958593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154016|NCT01958593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102154017|NCT01958593|Serotonin Agents|serotonin agents|mesh-ancestor
102154018|NCT01958593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102154019|NCT01958593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154020|NCT01958593|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102154021|NCT01958593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102154022|NCT01958593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102154023|NCT01958593|Adrenergic Agents|adrenergic agents|mesh-ancestor
102154024|NCT01820858|Paclitaxel|paclitaxel|mesh-list
102154025|NCT01820858|Carboplatin|carboplatin|mesh-list
102154026|NCT01820858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102154027|NCT01820858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102154028|NCT01820858|Tubulin Modulators|tubulin modulators|mesh-ancestor
102154029|NCT01820858|Antimitotic Agents|antimitotic agents|mesh-ancestor
102154030|NCT01820858|Mitosis Modulators|mitosis modulators|mesh-ancestor
102154031|NCT01820858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154032|NCT01755897|Paclitaxel|paclitaxel|mesh-list
102154033|NCT01755897|Cisplatin|cisplatin|mesh-list
102154034|NCT01755897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102154035|NCT01755897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102154036|NCT01755897|Tubulin Modulators|tubulin modulators|mesh-ancestor
102154037|NCT01755897|Antimitotic Agents|antimitotic agents|mesh-ancestor
102154038|NCT01755897|Mitosis Modulators|mitosis modulators|mesh-ancestor
102154039|NCT01755897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154040|NCT01738607|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102154041|NCT01738607|Psyllium|psyllium|mesh-list
102154042|NCT01738607|Laxatives|laxatives|mesh-ancestor
102154043|NCT01738607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102154044|NCT01738607|Cathartics|cathartics|mesh-ancestor
102154045|NCT01728259|Dexamethasone|dexamethasone|mesh-list
102154046|NCT01728259|Bortezomib|bortezomib|mesh-list
102154047|NCT01728259|Pomalidomide|pomalidomide|mesh-list
102154048|NCT01728259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102154049|NCT01728259|Antiemetics|antiemetics|mesh-ancestor
102154050|NCT01728259|Autonomic Agents|autonomic agents|mesh-ancestor
102154051|NCT01728259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102154052|NCT01728259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154053|NCT01728259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102154054|NCT01728259|Glucocorticoids|glucocorticoids|mesh-ancestor
102154056|NCT01728259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102154057|NCT01728259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102154058|NCT01728259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102154059|NCT01728259|Immunologic Factors|immunologic factors|mesh-ancestor
102154060|NCT01728259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102154061|NCT01728259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102154062|NCT01728259|Growth Substances|growth substances|mesh-ancestor
102154063|NCT01728259|Growth Inhibitors|growth inhibitors|mesh-ancestor
102154064|NCT01722604|Brinzolamide|brinzolamide|mesh-list
102154065|NCT01722604|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102154066|NCT01722604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102154067|NCT01722604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154068|NCT01689740|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
102154069|NCT01689740|Hallucinogens|hallucinogens|mesh-ancestor
102154070|NCT01689740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154071|NCT01689740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102154072|NCT01689740|Serotonin Agents|serotonin agents|mesh-ancestor
102154073|NCT01689740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102154074|NCT01689740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154075|NCT01689740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102154076|NCT01689740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102154077|NCT01689740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102154078|NCT01689740|Adrenergic Agents|adrenergic agents|mesh-ancestor
102154079|NCT01567800|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
102154080|NCT01567800|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102154081|NCT01567800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154082|NCT01305499|Azacitidine|azacitidine|mesh-list
102154083|NCT01305499|Entinostat|entinostat|mesh-list
102154084|NCT01305499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102154085|NCT01305499|Antimetabolites|antimetabolites|mesh-ancestor
102154086|NCT01305499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154087|NCT01305499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102154088|NCT01305499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102154089|NCT01305499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102154090|NCT01202994|Flutemetamol|flutemetamol|mesh-list
102154091|NCT01202994|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102154092|NCT01202994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154093|NCT00930943|Oxymorphone|oxymorphone|mesh-list
102154094|NCT00930943|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102154095|NCT00930943|Narcotics|narcotics|mesh-ancestor
102154096|NCT00930943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102154097|NCT00930943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154098|NCT00930943|Analgesics|analgesics|mesh-ancestor
102154099|NCT00930943|Sensory System Agents|sensory system agents|mesh-ancestor
102154100|NCT00930943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102154101|NCT00930943|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102154102|NCT00670670|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
102154103|NCT00670670|Caseins|caseins|mesh-list
102154104|NCT00670670|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102154105|NCT00670670|Serotonin Agents|serotonin agents|mesh-ancestor
102154106|NCT00670670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102154107|NCT00670670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154108|NCT00670670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154109|NCT00670670|Chelating Agents|chelating agents|mesh-ancestor
101755887|NCT00879892|Anesthetics|anesthetics|mesh-ancestor
102154110|NCT00670670|Sequestering Agents|sequestering agents|mesh-ancestor
102154111|NCT00670618|Fluorides|fluorides|mesh-list
102154112|NCT00670618|Cariostatic Agents|cariostatic agents|mesh-ancestor
102154113|NCT00670618|Protective Agents|protective agents|mesh-ancestor
102154114|NCT00670618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154115|NCT00620425|Sumatriptan|sumatriptan|mesh-list
102154116|NCT00620425|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102154117|NCT00620425|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102154118|NCT00620425|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102154119|NCT00620425|Serotonin Agents|serotonin agents|mesh-ancestor
102154120|NCT00620425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102154121|NCT00620425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154122|NCT00620425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154123|NCT00515281|Nitric Oxide|nitric oxide|mesh-list
102154124|NCT00515281|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102154125|NCT00515281|Autonomic Agents|autonomic agents|mesh-ancestor
102154126|NCT00515281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102154127|NCT00515281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154128|NCT00515281|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102154129|NCT00515281|Respiratory System Agents|respiratory system agents|mesh-ancestor
102154130|NCT00515281|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102154131|NCT00515281|Antioxidants|antioxidants|mesh-ancestor
102535924|NCT00553319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102535925|NCT00553319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102535926|NCT00369291|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
102535927|NCT00369291|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102535928|NCT00369291|Immunologic Factors|immunologic factors|mesh-ancestor
102535929|NCT00369291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535930|NCT01868633|Dexamethasone|dexamethasone|mesh-list
102535931|NCT01868633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102535932|NCT01868633|Antiemetics|antiemetics|mesh-ancestor
102535933|NCT01868633|Autonomic Agents|autonomic agents|mesh-ancestor
102535934|NCT01868633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102535935|NCT01868633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535936|NCT01868633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102535937|NCT01868633|Glucocorticoids|glucocorticoids|mesh-ancestor
102535938|NCT01868633|Hormones|hormones|mesh-ancestor
102535939|NCT01868633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102535940|NCT01868633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102535941|NCT01868633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102535942|NCT04738773|Naltrexone|naltrexone|mesh-list
102535943|NCT04738773|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102535944|NCT04738773|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102535945|NCT04738773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535946|NCT04738773|Sensory System Agents|sensory system agents|mesh-ancestor
102535947|NCT04738773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102535948|NCT03833063|Botulinum Toxins|botulinum toxins|mesh-list
102535949|NCT03833063|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102535950|NCT03833063|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102535951|NCT03833063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102535952|NCT03833063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102535953|NCT03833063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535954|NCT03833063|Cholinergic Agents|cholinergic agents|mesh-ancestor
102535955|NCT03833063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102535956|NCT03833063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535957|NCT03833063|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102535958|NCT03833063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102535959|NCT02676375|Bupropion|bupropion|mesh-list
102535960|NCT02676375|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102535961|NCT02676375|Antidepressive Agents|antidepressive agents|mesh-ancestor
102535962|NCT02676375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102535963|NCT02676375|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102535964|NCT02676375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102535965|NCT02676375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102535966|NCT02676375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535967|NCT02676375|Dopamine Agents|dopamine agents|mesh-ancestor
102535968|NCT02676375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102535969|NCT02676375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535970|NCT02676375|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102535971|NCT02676375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102535972|NCT02676375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102535973|NCT01871441|Mycophenolic Acid|mycophenolic acid|mesh-list
102535974|NCT01871441|Cyclophosphamide|cyclophosphamide|mesh-list
102535975|NCT01871441|Tacrolimus|tacrolimus|mesh-list
102535976|NCT01871441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102535977|NCT01871441|Immunologic Factors|immunologic factors|mesh-ancestor
102535978|NCT01871441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102535979|NCT01871441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102535980|NCT01871441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102535981|NCT01871441|Alkylating Agents|alkylating agents|mesh-ancestor
102535982|NCT01871441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535983|NCT01871441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102535984|NCT01871441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102535985|NCT01871441|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102535986|NCT01871441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102535987|NCT01871441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102535988|NCT01871441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102535989|NCT01871441|Antitubercular Agents|antitubercular agents|mesh-ancestor
102535990|NCT01871441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102535991|NCT01871441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102535992|NCT04338711|Tofacitinib|tofacitinib|mesh-list
102535993|NCT04338711|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102535994|NCT04338711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102535995|NCT04338711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102535996|NCT04338711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102535997|NCT01874951|Naltrexone|naltrexone|mesh-list
102535998|NCT01874951|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102535999|NCT01874951|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102536000|NCT01874951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536001|NCT01874951|Sensory System Agents|sensory system agents|mesh-ancestor
102536002|NCT01874951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102536003|NCT04739241|Insulin|insulin|mesh-list
102536004|NCT04739241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102536005|NCT04739241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102536006|NCT04739241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536007|NCT03024437|Bevacizumab|bevacizumab|mesh-list
102536008|NCT03024437|Atezolizumab|atezolizumab|mesh-list
102536009|NCT03024437|Entinostat|entinostat|mesh-list
102536010|NCT03024437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102536011|NCT03024437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102536012|NCT03024437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102536013|NCT03024437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102536014|NCT03024437|Growth Substances|growth substances|mesh-ancestor
102536015|NCT03024437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536016|NCT03024437|Growth Inhibitors|growth inhibitors|mesh-ancestor
101567225|NCT01253408|Dronabinol|dronabinol|mesh-list
102536017|NCT03024437|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102536018|NCT03024437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536019|NCT03024437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102536020|NCT03024437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102536021|NCT01489826|HU 211|hu 211|mesh-list
102536022|NCT01489826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102536023|NCT01489826|Antiemetics|antiemetics|mesh-ancestor
102536024|NCT01489826|Autonomic Agents|autonomic agents|mesh-ancestor
102536025|NCT01489826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102536026|NCT01489826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536027|NCT01489826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102536028|NCT01489826|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102536029|NCT01489826|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102536030|NCT01489826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102536031|NCT01489826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536032|NCT01489826|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102536033|NCT01489826|Protective Agents|protective agents|mesh-ancestor
102536034|NCT02677623|Mannitol|mannitol|mesh-list
102536035|NCT02677623|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102536036|NCT02677623|Diuretics|diuretics|mesh-ancestor
102536037|NCT02677623|Natriuretic Agents|natriuretic agents|mesh-ancestor
102536038|NCT02677623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536039|NCT02677701|Azithromycin|azithromycin|mesh-list
102536040|NCT02677701|Tobramycin|tobramycin|mesh-list
102536041|NCT02677701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102536042|NCT02677701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102536043|NCT01543178|Rifaximin|rifaximin|mesh-list
102536044|NCT01543178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102536045|NCT01543178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102536046|NCT01543178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102536047|NCT01649856|Rituximab|rituximab|mesh-list
102536048|NCT01649856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102536049|NCT01649856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102536050|NCT01649856|Immunologic Factors|immunologic factors|mesh-ancestor
102536051|NCT01649856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536052|NCT01649856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102536053|NCT01543568|Aflibercept|aflibercept|mesh-list
102536054|NCT01543568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102536055|NCT01543568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102536056|NCT01543568|Growth Substances|growth substances|mesh-ancestor
102536057|NCT01543568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536058|NCT01543568|Growth Inhibitors|growth inhibitors|mesh-ancestor
102536059|NCT01543568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102536060|NCT02681757|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102536061|NCT02681757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102536062|NCT02375724|Bromides|bromides|mesh-list
102536063|NCT02375724|Anticonvulsants|anticonvulsants|mesh-ancestor
102536064|NCT02398188|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102536065|NCT02398188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102536066|NCT02398188|Autonomic Agents|autonomic agents|mesh-ancestor
102536067|NCT02398188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102536068|NCT02398188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536069|NCT02398188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102536070|NCT02398188|Respiratory System Agents|respiratory system agents|mesh-ancestor
102536071|NCT02398188|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102536072|NCT02398188|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102536073|NCT02398188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102536074|NCT02398188|Adrenergic Agents|adrenergic agents|mesh-ancestor
102536075|NCT02398188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102536076|NCT02398188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536077|NCT02425098|Vaccines|vaccines|mesh-list
102536078|NCT02425098|Immunologic Factors|immunologic factors|mesh-ancestor
102536079|NCT02425098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536080|NCT02424630|Ropivacaine|ropivacaine|mesh-list
102536081|NCT02424630|Anesthetics, Local|anesthetics, local|mesh-ancestor
102536082|NCT02424630|Anesthetics|anesthetics|mesh-ancestor
102536083|NCT02424630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102536084|NCT02424630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536085|NCT02424630|Sensory System Agents|sensory system agents|mesh-ancestor
102536086|NCT02424630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102536087|NCT02397408|Choline|choline|mesh-list
102536088|NCT02397408|Lipotropic Agents|lipotropic agents|mesh-ancestor
102536089|NCT02397408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102154348|NCT03365115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536090|NCT02397408|Antimetabolites|antimetabolites|mesh-ancestor
102536091|NCT02397408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536092|NCT02397408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102536093|NCT02397408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102536094|NCT02397408|Nootropic Agents|nootropic agents|mesh-ancestor
102536095|NCT02397096|Ritonavir|ritonavir|mesh-list
102536096|NCT02397096|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
102536097|NCT02397096|Tenofovir|tenofovir|mesh-list
102536098|NCT02397096|Lamivudine|lamivudine|mesh-list
102536099|NCT02397096|Cobicistat|cobicistat|mesh-list
102536100|NCT02397096|Elvitegravir|elvitegravir|mesh-list
102536101|NCT02397096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
102536102|NCT02397096|Protease Inhibitors|protease inhibitors|mesh-list
102536103|NCT02397096|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102536104|NCT02397096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102536105|NCT02397096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536106|NCT02397096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102536107|NCT02397096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102536108|NCT02397096|Antiviral Agents|antiviral agents|mesh-ancestor
102536109|NCT02397096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102536110|NCT02397096|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102536111|NCT02397096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102536112|NCT02397096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102536113|NCT02397096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102536114|NCT02396316|Aflibercept|aflibercept|mesh-list
102536115|NCT02396316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102536116|NCT02396316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102536117|NCT02396316|Growth Substances|growth substances|mesh-ancestor
102536118|NCT02396316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536119|NCT02396316|Growth Inhibitors|growth inhibitors|mesh-ancestor
102536120|NCT02396316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102536121|NCT02682381|Teduglutide|teduglutide|mesh-list
102536122|NCT02682381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102536123|NCT02682381|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102536124|NCT02682381|Protective Agents|protective agents|mesh-ancestor
102536125|NCT02682381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536126|NCT04915950|APD791|apd791|mesh-list
102536127|NCT04915950|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102536128|NCT04915950|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102536129|NCT04915950|Serotonin Agents|serotonin agents|mesh-ancestor
102536130|NCT04915950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102536131|NCT04915950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536132|NCT04915950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536133|NCT04976595|Testosterone|testosterone|mesh-list
102536134|NCT04976595|Androgens|androgens|mesh-ancestor
102536135|NCT04976595|Hormones|hormones|mesh-ancestor
102536136|NCT04976595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102536137|NCT04976595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536138|NCT00367965|Eszopiclone|eszopiclone|mesh-list
102536139|NCT00367965|Zopiclone|zopiclone|mesh-list
102536140|NCT00367965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102536141|NCT00367965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102536142|NCT00367965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536143|NCT02683161|Varenicline|varenicline|mesh-list
102536144|NCT02683161|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102536145|NCT02683161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102536146|NCT02683161|Cholinergic Agents|cholinergic agents|mesh-ancestor
102536147|NCT02683161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102536148|NCT02683161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536149|NCT02683161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536150|NCT02683707|Lidocaine|lidocaine|mesh-list
102536151|NCT02683707|Fentanyl|fentanyl|mesh-list
102536152|NCT02683707|Midazolam|midazolam|mesh-list
102536153|NCT02683707|Anesthetics, Local|anesthetics, local|mesh-ancestor
102536154|NCT02683707|Anesthetics|anesthetics|mesh-ancestor
102536155|NCT02683707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102536156|NCT02683707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536157|NCT02683707|Sensory System Agents|sensory system agents|mesh-ancestor
102536158|NCT02683707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102536159|NCT02683707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102536160|NCT02683707|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102536161|NCT02683707|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102536162|NCT02683707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102536163|NCT02683707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536164|NCT02683707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102536165|NCT02683707|Narcotics|narcotics|mesh-ancestor
102536166|NCT02683707|Analgesics|analgesics|mesh-ancestor
102536167|NCT02683707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102536169|NCT02683707|Anesthetics, General|anesthetics, general|mesh-ancestor
102536170|NCT02683707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102536171|NCT02683707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102536172|NCT02683707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102536173|NCT02683707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102536174|NCT02683707|GABA Modulators|gaba modulators|mesh-ancestor
102536175|NCT02683707|GABA Agents|gaba agents|mesh-ancestor
102536176|NCT02683707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102536177|NCT02371980|Vortioxetine|vortioxetine|mesh-list
102536178|NCT02371980|Antidepressive Agents|antidepressive agents|mesh-ancestor
102536179|NCT02371980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102536180|NCT02371980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102536181|NCT02371980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102536182|NCT02371980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102536183|NCT02371980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536184|NCT02371980|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102536185|NCT02371980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102536186|NCT02371980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101756165|NCT01608451|Progestins|progestins|mesh-ancestor
102536187|NCT02371980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536188|NCT02371980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102536189|NCT02371980|Serotonin Agents|serotonin agents|mesh-ancestor
102536190|NCT02371980|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102536191|NCT02371980|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102536192|NCT02371980|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102536193|NCT02371980|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102536194|NCT02867865|Gemcitabine|gemcitabine|mesh-list
102536195|NCT02867865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102536196|NCT02867865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102536197|NCT02867865|Antimetabolites|antimetabolites|mesh-ancestor
102536198|NCT02867865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536199|NCT05447949|Levobupivacaine|levobupivacaine|mesh-list
102536200|NCT05447949|Anesthetics, Local|anesthetics, local|mesh-ancestor
102536201|NCT05447949|Anesthetics|anesthetics|mesh-ancestor
102536202|NCT05447949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102536203|NCT05447949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536204|NCT05447949|Sensory System Agents|sensory system agents|mesh-ancestor
102536205|NCT05447949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102536206|NCT05447871|Bupivacaine|bupivacaine|mesh-list
102536207|NCT05447871|Anesthetics, Local|anesthetics, local|mesh-ancestor
102536208|NCT05447871|Anesthetics|anesthetics|mesh-ancestor
102536209|NCT05447871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102536210|NCT05447871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536211|NCT05447871|Sensory System Agents|sensory system agents|mesh-ancestor
102536212|NCT05447871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102536213|NCT00369447|Nimotuzumab|nimotuzumab|mesh-list
102536214|NCT00369447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102536215|NCT00369447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102536216|NCT04772235|Osimertinib|osimertinib|mesh-list
102536217|NCT04772235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102536218|NCT04772235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102536219|NCT04772235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102536220|NCT04772235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536221|NCT04766463|Morphine|morphine|mesh-list
102536222|NCT04766463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102536223|NCT04766463|Narcotics|narcotics|mesh-ancestor
102536224|NCT04766463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102536225|NCT04766463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536226|NCT04766463|Analgesics|analgesics|mesh-ancestor
102536227|NCT04766463|Sensory System Agents|sensory system agents|mesh-ancestor
102536228|NCT04766463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102536229|NCT00823563|Adenosine|adenosine|mesh-list
102536230|NCT00823563|Nitroglycerin|nitroglycerin|mesh-list
102536231|NCT00823563|Vasodilator Agents|vasodilator agents|mesh-ancestor
102536232|NCT00823563|Analgesics|analgesics|mesh-ancestor
102536233|NCT00823563|Sensory System Agents|sensory system agents|mesh-ancestor
102536234|NCT00823563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102536235|NCT00823563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536236|NCT00823563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102536237|NCT00823563|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102536238|NCT00823563|Purinergic Agonists|purinergic agonists|mesh-ancestor
102536239|NCT00823563|Purinergic Agents|purinergic agents|mesh-ancestor
102536240|NCT00823563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101567453|NCT01251146|Atenolol|atenolol|mesh-list
102536241|NCT00823563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154132|NCT00515281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536242|NCT05447169|Antibodies|antibodies|mesh-list
102536243|NCT05447169|Immunologic Factors|immunologic factors|mesh-ancestor
102536244|NCT05447169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536245|NCT04652193|Anesthetics|anesthetics|mesh-list
102536246|NCT04652193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102536247|NCT04652193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536248|NCT05451147|Metformin|metformin|mesh-list
102536249|NCT05451147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101756224|NCT00737256|Dopamine Agents|dopamine agents|mesh-ancestor
102536250|NCT05451147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536251|NCT04553367|Meropenem|meropenem|mesh-list
102536252|NCT04553367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102536253|NCT04553367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102536254|NCT00369837|Clevidipine|clevidipine|mesh-list
102536255|NCT00369837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102536256|NCT00369837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102536257|NCT00369837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536258|NCT00369837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102536259|NCT00369837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536260|NCT05449899|Cyclophosphamide|cyclophosphamide|mesh-list
102536261|NCT05449899|Busulfan|busulfan|mesh-list
102536262|NCT05449899|Fludarabine|fludarabine|mesh-list
102536263|NCT05449899|Decitabine|decitabine|mesh-list
102536264|NCT05449899|Lenograstim|lenograstim|mesh-list
102536265|NCT05449899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102536266|NCT05449899|Immunologic Factors|immunologic factors|mesh-ancestor
102536267|NCT05449899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536268|NCT05449899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102536269|NCT05449899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102536270|NCT05449899|Alkylating Agents|alkylating agents|mesh-ancestor
102536271|NCT05449899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536272|NCT05449899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102536273|NCT05449899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102536274|NCT05449899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102536275|NCT05449899|Antimetabolites|antimetabolites|mesh-ancestor
102536276|NCT05449899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102536277|NCT05449899|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102536278|NCT05441631|Insulin|insulin|mesh-list
102536279|NCT05441631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102536280|NCT05441631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102536281|NCT05441631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536282|NCT01546454|Leuprolide|leuprolide|mesh-list
102536283|NCT01546454|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102536284|NCT01546454|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102536285|NCT01546454|Levonorgestrel|levonorgestrel|mesh-list
102536286|NCT01546454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102536287|NCT01546454|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
102536288|NCT01546454|Estradiol|estradiol|mesh-list
102536289|NCT01546454|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102536290|NCT01546454|Progesterone|progesterone|mesh-list
102536291|NCT01546454|Estrogens|estrogens|mesh-ancestor
102536292|NCT01546454|Hormones|hormones|mesh-ancestor
102536293|NCT01546454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102536294|NCT01546454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536295|NCT01546454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102536296|NCT01546454|Contraceptive Agents|contraceptive agents|mesh-ancestor
102536297|NCT01546454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101413717|NCT02274181|Enclomiphene|enclomiphene|mesh-list
102536298|NCT01546454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102536299|NCT01546454|Progestins|progestins|mesh-ancestor
102536300|NCT01546454|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102536301|NCT01546454|Fertility Agents|fertility agents|mesh-ancestor
102536302|NCT01546454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102536303|NCT01546454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102536304|NCT01546454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102536305|NCT01546454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102536306|NCT01546454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102536307|NCT01546454|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102536308|NCT00368901|Darbepoetin alfa|darbepoetin alfa|mesh-list
102536309|NCT00368901|Hematinics|hematinics|mesh-ancestor
102536310|NCT05430867|Memantine|memantine|mesh-list
102536311|NCT05430867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102536312|NCT05430867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102536313|NCT05430867|Dopamine Agents|dopamine agents|mesh-ancestor
102536314|NCT05430867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102536315|NCT05430867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536316|NCT05430867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536317|NCT05430867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102536318|NCT05430867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102536319|NCT05448885|Cisplatin|cisplatin|mesh-list
102536320|NCT05448885|Gemcitabine|gemcitabine|mesh-list
102536321|NCT05448885|Tislelizumab|tislelizumab|mesh-list
102536322|NCT05448885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102536323|NCT05448885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102536324|NCT05448885|Antimetabolites|antimetabolites|mesh-ancestor
102536325|NCT05448885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536326|NCT05448885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102536327|NCT01547000|Guanfacine|guanfacine|mesh-list
102536328|NCT01547000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102536329|NCT01547000|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102536330|NCT01547000|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102536331|NCT01547000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102536332|NCT01547000|Adrenergic Agents|adrenergic agents|mesh-ancestor
102536333|NCT01547000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102536334|NCT01547000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536335|NCT01547000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536336|NCT02980016|Isoniazid|isoniazid|mesh-list
102536337|NCT02980016|Rifapentine|rifapentine|mesh-list
102536338|NCT02980016|Rifampin|rifampin|mesh-list
102536339|NCT02980016|Antitubercular Agents|antitubercular agents|mesh-ancestor
102536340|NCT02980016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102536341|NCT02980016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102536342|NCT02980016|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102536343|NCT02980016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102536344|NCT02980016|Antimetabolites|antimetabolites|mesh-ancestor
102536345|NCT02980016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536346|NCT02980016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102536347|NCT02980016|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102536348|NCT02980016|Leprostatic Agents|leprostatic agents|mesh-ancestor
102536349|NCT02980016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102536350|NCT02980016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102536351|NCT02980016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102536352|NCT02980016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102536353|NCT02980016|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102536354|NCT02980016|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102536355|NCT02980016|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102536356|NCT02980016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102536357|NCT01493180|Rebamipide|rebamipide|mesh-list
102536358|NCT01493180|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102536359|NCT01493180|Hyaluronic Acid|hyaluronic acid|mesh-list
102536360|NCT01493180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102536361|NCT01493180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102536362|NCT01493180|Immunologic Factors|immunologic factors|mesh-ancestor
102536363|NCT01493180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536364|NCT01493180|Viscosupplements|viscosupplements|mesh-ancestor
102536365|NCT01493180|Protective Agents|protective agents|mesh-ancestor
102536366|NCT01493180|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102536367|NCT01493180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102536368|NCT01493180|Antioxidants|antioxidants|mesh-ancestor
102536369|NCT01493180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536370|NCT01493180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102536371|NCT01431014|Dexamethasone|dexamethasone|mesh-list
102536372|NCT01431014|Dexamethasone acetate|dexamethasone acetate|mesh-list
102536373|NCT01431014|BB 1101|bb 1101|mesh-list
102536374|NCT01431014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102536375|NCT01431014|Antiemetics|antiemetics|mesh-ancestor
102536376|NCT01431014|Autonomic Agents|autonomic agents|mesh-ancestor
102536377|NCT01431014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102536378|NCT01431014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536379|NCT01431014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102536380|NCT01431014|Glucocorticoids|glucocorticoids|mesh-ancestor
102536381|NCT01431014|Hormones|hormones|mesh-ancestor
102536382|NCT01431014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102536383|NCT01431014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102536384|NCT01431014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102536385|NCT01431014|Protease Inhibitors|protease inhibitors|mesh-ancestor
102536386|NCT01431014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102536387|NCT01431014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567598|NCT01091259|Bevacizumab|bevacizumab|mesh-list
102536388|NCT01431170|Trimethoprim|trimethoprim|mesh-list
102536389|NCT01431170|Polymyxins|polymyxins|mesh-list
102154133|NCT00515281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102536390|NCT01431170|Polymyxin B|polymyxin b|mesh-list
102536391|NCT01431170|Besifloxacin|besifloxacin|mesh-list
102536392|NCT01431170|Fluoroquinolones|fluoroquinolones|mesh-list
102536393|NCT01431170|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102536394|NCT01431170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102536395|NCT01431170|Antimalarials|antimalarials|mesh-ancestor
102536396|NCT01431170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102536397|NCT01431170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102536398|NCT01431170|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102536399|NCT01431170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102536400|NCT01431170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536401|NCT01431170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102536402|NCT01431170|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102536403|NCT01431170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102536404|NCT01431170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102536405|NCT01431170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102536406|NCT01431170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102536407|NCT01431170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102536408|NCT01431170|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102536409|NCT05448183|Gemcitabine|gemcitabine|mesh-list
102536410|NCT05448183|Oxaliplatin|oxaliplatin|mesh-list
102536411|NCT05448183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102536412|NCT05448183|Antimetabolites|antimetabolites|mesh-ancestor
101756408|NCT04721626|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102536413|NCT05448183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536414|NCT05448183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102536415|NCT04732455|Lidocaine|lidocaine|mesh-list
102536416|NCT04732455|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102536417|NCT04732455|Anesthetics, Local|anesthetics, local|mesh-ancestor
102536418|NCT04732455|Anesthetics|anesthetics|mesh-ancestor
102536419|NCT04732455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102536420|NCT04732455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536421|NCT04732455|Sensory System Agents|sensory system agents|mesh-ancestor
102536422|NCT04732455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102536423|NCT04732455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102536424|NCT04732455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102536425|NCT04732455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102536426|NCT04732455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102536427|NCT04732455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536428|NCT04732455|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102536429|NCT04732455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102536430|NCT04732455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102536431|NCT04732455|Analgesics|analgesics|mesh-ancestor
102536432|NCT04732455|Antidepressive Agents|antidepressive agents|mesh-ancestor
102536433|NCT04732455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102536434|NCT04732455|Dopamine Agents|dopamine agents|mesh-ancestor
102536435|NCT04306965|Apremilast|apremilast|mesh-list
102536436|NCT04306965|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102536437|NCT04306965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102536438|NCT04306965|Analgesics|analgesics|mesh-ancestor
102536439|NCT04306965|Sensory System Agents|sensory system agents|mesh-ancestor
102536440|NCT04306965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102536441|NCT04306965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536442|NCT04306965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102536443|NCT04306965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102536444|NCT04306965|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102536445|NCT04306965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102536446|NCT04306965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102536447|NCT04306965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536448|NCT02371746|Travoprost|travoprost|mesh-list
102536449|NCT02371746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102536450|NCT01431794|Paclitaxel|paclitaxel|mesh-list
102536451|NCT01431794|Gemcitabine|gemcitabine|mesh-list
102536452|NCT01431794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102536453|NCT01431794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102536454|NCT01431794|Tubulin Modulators|tubulin modulators|mesh-ancestor
102536455|NCT01431794|Antimitotic Agents|antimitotic agents|mesh-ancestor
102536456|NCT01431794|Mitosis Modulators|mitosis modulators|mesh-ancestor
102536457|NCT01431794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536458|NCT01431794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102536459|NCT01431794|Antimetabolites|antimetabolites|mesh-ancestor
102536460|NCT01497860|Vinorelbine|vinorelbine|mesh-list
102536461|NCT01497860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101567667|NCT01198548|Vitamin D|vitamin d|mesh-list
102536462|NCT01497860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102536463|NCT01497860|Tubulin Modulators|tubulin modulators|mesh-ancestor
102536464|NCT01497860|Antimitotic Agents|antimitotic agents|mesh-ancestor
102536465|NCT01497860|Mitosis Modulators|mitosis modulators|mesh-ancestor
102536466|NCT01497860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536468|NCT02213900|Haloperidol decanoate|haloperidol decanoate|mesh-list
102536469|NCT02213900|Antiemetics|antiemetics|mesh-ancestor
102536470|NCT02213900|Autonomic Agents|autonomic agents|mesh-ancestor
102536471|NCT02213900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102536472|NCT02213900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536473|NCT02213900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102536474|NCT02213900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102536475|NCT02213900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102536476|NCT02213900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102536477|NCT02213900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102536478|NCT02213900|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102536479|NCT02213900|Dopamine Agents|dopamine agents|mesh-ancestor
102536480|NCT02213900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102536481|NCT02213900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536482|NCT02213900|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102536483|NCT02370888|Lenalidomide|lenalidomide|mesh-list
102536484|NCT02370888|Immunologic Factors|immunologic factors|mesh-ancestor
102536485|NCT02370888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536486|NCT02370888|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102536487|NCT02370888|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102536488|NCT02370888|Growth Substances|growth substances|mesh-ancestor
102536489|NCT02370888|Growth Inhibitors|growth inhibitors|mesh-ancestor
102536490|NCT02370888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102536491|NCT05358873|Antibodies|antibodies|mesh-list
102536492|NCT05358873|Immunologic Factors|immunologic factors|mesh-ancestor
102536493|NCT05358873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536494|NCT02214290|Caffeine|caffeine|mesh-list
102536495|NCT02214290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102536496|NCT02214290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536497|NCT02214290|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102536498|NCT02214290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102536499|NCT02214290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536500|NCT02214290|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102536501|NCT02214290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102536502|NCT02214290|Purinergic Agents|purinergic agents|mesh-ancestor
102536503|NCT02214290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102536504|NCT03160911|Hemostatics|hemostatics|mesh-list
102536505|NCT03160911|Coagulants|coagulants|mesh-ancestor
102536506|NCT04685499|Pembrolizumab|pembrolizumab|mesh-list
102536507|NCT04685499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102536508|NCT04685499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102536509|NCT04685499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102536510|NCT04685499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536511|NCT04678869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102536512|NCT04678869|Ciprofloxacin|ciprofloxacin|mesh-list
102536513|NCT04678869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102536514|NCT04678869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102536515|NCT04678869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102536516|NCT04678869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102536517|NCT04678869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536518|NCT04678869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102536519|NCT04678869|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102536520|NCT04678869|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102536521|NCT00369603|Donepezil|donepezil|mesh-list
102536522|NCT00369603|Galantamine|galantamine|mesh-list
102536523|NCT00369603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102536524|NCT00369603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241614|NCT04433559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102536525|NCT00369603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536526|NCT00369603|Cholinergic Agents|cholinergic agents|mesh-ancestor
102536527|NCT00369603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102536528|NCT00369603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536529|NCT00369603|Nootropic Agents|nootropic agents|mesh-ancestor
102536530|NCT00369603|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102536531|NCT00369603|Autonomic Agents|autonomic agents|mesh-ancestor
102536532|NCT00369603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102536533|NCT01551056|Cetirizine|cetirizine|mesh-list
102536534|NCT01551056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102536535|NCT01551056|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102536536|NCT01551056|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102536537|NCT01551056|Histamine Antagonists|histamine antagonists|mesh-ancestor
102536538|NCT01551056|Histamine Agents|histamine agents|mesh-ancestor
102536539|NCT01551056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102536540|NCT01551056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536541|NCT01551056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536542|NCT05227131|Capecitabine|capecitabine|mesh-list
102536543|NCT05227131|Tucatinib|tucatinib|mesh-list
102536544|NCT05227131|Margetuximab|margetuximab|mesh-list
102536545|NCT05227131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102536546|NCT05227131|Antimetabolites|antimetabolites|mesh-ancestor
102536547|NCT05227131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536548|NCT05227131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102536549|NCT05227131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102536550|NCT05227131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102536551|NCT01499498|Sildenafil Citrate|sildenafil citrate|mesh-list
102536552|NCT01499498|Vasodilator Agents|vasodilator agents|mesh-ancestor
102536553|NCT01499498|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102536554|NCT01499498|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102536555|NCT01499498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102536556|NCT01499498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536557|NCT01499498|Urological Agents|urological agents|mesh-ancestor
102536558|NCT01499654|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
102536559|NCT01499654|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102536560|NCT01499654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536561|NCT02421588|Doxorubicin|doxorubicin|mesh-list
102536562|NCT02421588|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102536563|NCT02421588|Topotecan|topotecan|mesh-list
102536564|NCT02421588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102536565|NCT02421588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102536566|NCT02421588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102536567|NCT02421588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102536568|NCT02421588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102536569|NCT02421588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536570|NCT02421588|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102536571|NCT02768727|Xenon|xenon|mesh-list
102536572|NCT02768727|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102536573|NCT02768727|Anesthetics, General|anesthetics, general|mesh-ancestor
102536574|NCT02768727|Anesthetics|anesthetics|mesh-ancestor
102536575|NCT02768727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102536576|NCT02768727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536577|NCT02688309|Dexamethasone|dexamethasone|mesh-list
102536578|NCT02688309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102536579|NCT02688309|Antiemetics|antiemetics|mesh-ancestor
102536580|NCT02688309|Autonomic Agents|autonomic agents|mesh-ancestor
102536581|NCT02688309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102536582|NCT02688309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536583|NCT02688309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102536584|NCT02688309|Glucocorticoids|glucocorticoids|mesh-ancestor
102536585|NCT02688309|Hormones|hormones|mesh-ancestor
102536586|NCT02688309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102536587|NCT02688309|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102536588|NCT02688309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102536589|NCT00370851|Bevacizumab|bevacizumab|mesh-list
102536590|NCT00370851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102536591|NCT00370851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102536592|NCT00370851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102536593|NCT00370851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102536594|NCT00370851|Growth Substances|growth substances|mesh-ancestor
102536595|NCT00370851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536596|NCT00370851|Growth Inhibitors|growth inhibitors|mesh-ancestor
102536597|NCT05124171|Vaccines|vaccines|mesh-list
102536598|NCT05124171|Immunologic Factors|immunologic factors|mesh-ancestor
102536599|NCT05124171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536600|NCT00370305|Rosiglitazone|rosiglitazone|mesh-list
102536601|NCT00370305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102536602|NCT00370305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536603|NCT00371007|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102536604|NCT00371007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102536605|NCT00371007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536606|NCT00371007|Incretins|incretins|mesh-ancestor
102536607|NCT00371007|Hormones|hormones|mesh-ancestor
102536608|NCT00371007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102536609|NCT00371007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102536610|NCT00371007|Protease Inhibitors|protease inhibitors|mesh-ancestor
102536611|NCT00371007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102536612|NCT00371007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536613|NCT02421510|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
102536614|NCT02421510|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102536615|NCT02421510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536616|NCT02421510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102536617|NCT02421510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536618|NCT00552617|Rocuronium|rocuronium|mesh-list
102536619|NCT00552617|Vecuronium Bromide|vecuronium bromide|mesh-list
102536620|NCT00552617|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102536621|NCT00552617|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102536622|NCT00552617|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102536623|NCT00552617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102536624|NCT00552617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536625|NCT00552617|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102536626|NCT00552617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102536627|NCT00552617|Cholinergic Agents|cholinergic agents|mesh-ancestor
102536628|NCT00552617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102536629|NCT00552617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536630|NCT04387305|Tranexamic Acid|tranexamic acid|mesh-list
102536631|NCT04387305|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102536632|NCT04387305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102536633|NCT04387305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536634|NCT04387305|Hemostatics|hemostatics|mesh-ancestor
102536635|NCT04387305|Coagulants|coagulants|mesh-ancestor
102536636|NCT02421120|Tazobactam|tazobactam|mesh-list
102536637|NCT02421120|Ceftolozane|ceftolozane|mesh-list
102536638|NCT02421120|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
102536639|NCT02421120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102536640|NCT02421120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102536641|NCT02421120|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102536642|NCT02421120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102536643|NCT02421120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536644|NCT02421120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102536645|NCT03022877|Simendan|simendan|mesh-list
102536646|NCT03022877|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102536647|NCT03022877|Vasodilator Agents|vasodilator agents|mesh-ancestor
102536648|NCT03022877|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102536649|NCT03022877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102536650|NCT03022877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102536651|NCT03022877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536652|NCT03022877|Protective Agents|protective agents|mesh-ancestor
102536653|NCT03022877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536654|NCT02420262|Insulin|insulin|mesh-list
102536655|NCT02420262|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102536656|NCT02420262|Insulin Glargine|insulin glargine|mesh-list
102536657|NCT02420262|Insulin Aspart|insulin aspart|mesh-list
102536658|NCT02420262|Liraglutide|liraglutide|mesh-list
102536659|NCT02420262|Xultophy|xultophy|mesh-list
102536660|NCT02420262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102536661|NCT02420262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536662|NCT02420262|Incretins|incretins|mesh-ancestor
102536663|NCT02420262|Hormones|hormones|mesh-ancestor
102536664|NCT02420262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102536665|NCT00369993|Fluticasone|fluticasone|mesh-list
102536666|NCT00369993|Xhance|xhance|mesh-list
102536667|NCT00369993|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102536668|NCT00369993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102536669|NCT00369993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102536670|NCT00369993|Autonomic Agents|autonomic agents|mesh-ancestor
102536671|NCT00369993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102536672|NCT00369993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536673|NCT00369993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102536674|NCT00369993|Respiratory System Agents|respiratory system agents|mesh-ancestor
102536675|NCT00369993|Dermatologic Agents|dermatologic agents|mesh-ancestor
102536676|NCT00369993|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102536677|NCT00369993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102536678|NCT00369993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102536679|NCT00369993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102536680|NCT00369993|Adrenergic Agents|adrenergic agents|mesh-ancestor
102536681|NCT00369993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102536682|NCT00369993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154349|NCT03365115|Analgesics|analgesics|mesh-ancestor
102536684|NCT00552305|Anticonvulsants|anticonvulsants|mesh-ancestor
102536685|NCT00552305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102536686|NCT00552305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102536687|NCT00552305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102536688|NCT00552305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536689|NCT02278887|Cyclophosphamide|cyclophosphamide|mesh-list
102536690|NCT02278887|Fludarabine|fludarabine|mesh-list
102536691|NCT02278887|Ipilimumab|ipilimumab|mesh-list
102536692|NCT02278887|Interleukin-2|interleukin-2|mesh-list
102536693|NCT02278887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102536694|NCT02278887|Immunologic Factors|immunologic factors|mesh-ancestor
102536695|NCT02278887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536696|NCT02278887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102536697|NCT02278887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102536698|NCT02278887|Alkylating Agents|alkylating agents|mesh-ancestor
102536699|NCT02278887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536700|NCT02278887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102536701|NCT02278887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102536702|NCT02278887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102536703|NCT02278887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102536704|NCT02278887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102536705|NCT02278887|Analgesics|analgesics|mesh-ancestor
102536706|NCT02278887|Sensory System Agents|sensory system agents|mesh-ancestor
102536707|NCT02278887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102536708|NCT04168203|Apixaban|apixaban|mesh-list
102536709|NCT04168203|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102536710|NCT04168203|Antithrombins|antithrombins|mesh-ancestor
102536711|NCT04168203|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102536712|NCT04168203|Protease Inhibitors|protease inhibitors|mesh-ancestor
102536713|NCT04168203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102536714|NCT04168203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536715|NCT04168203|Anticoagulants|anticoagulants|mesh-ancestor
102536716|NCT04135989|Everolimus|everolimus|mesh-list
102536717|NCT04135989|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102536718|NCT04135989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102536719|NCT04135989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102536720|NCT04135989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536721|NCT04135989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102536722|NCT04135989|Immunologic Factors|immunologic factors|mesh-ancestor
102536723|NCT04135989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536724|NCT04135989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102536725|NCT01854255|Cisplatin|cisplatin|mesh-list
102536726|NCT01854255|Doxorubicin|doxorubicin|mesh-list
102536727|NCT01854255|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102536728|NCT01854255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102536729|NCT01854255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102536730|NCT01854255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102536731|NCT01854255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102536732|NCT01854255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102536733|NCT01854255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536734|NCT01555281|Nelfinavir|nelfinavir|mesh-list
102536735|NCT01555281|Dexamethasone|dexamethasone|mesh-list
102536736|NCT01555281|Lenalidomide|lenalidomide|mesh-list
102536737|NCT01555281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102536738|NCT01555281|Antiemetics|antiemetics|mesh-ancestor
102536739|NCT01555281|Autonomic Agents|autonomic agents|mesh-ancestor
102536740|NCT01555281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102536741|NCT01555281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536742|NCT01555281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102536743|NCT01555281|Glucocorticoids|glucocorticoids|mesh-ancestor
102536744|NCT01555281|Hormones|hormones|mesh-ancestor
102536745|NCT01555281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102536746|NCT01555281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102536747|NCT01555281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102536748|NCT01555281|Immunologic Factors|immunologic factors|mesh-ancestor
102536749|NCT01555281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102536750|NCT01555281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102536751|NCT01555281|Growth Substances|growth substances|mesh-ancestor
102536752|NCT01555281|Growth Inhibitors|growth inhibitors|mesh-ancestor
102536753|NCT01555281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102536754|NCT01555281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102536755|NCT01555281|Protease Inhibitors|protease inhibitors|mesh-ancestor
102536756|NCT01555281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102536757|NCT01555281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536758|NCT01555281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102536759|NCT01555281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102536760|NCT01555281|Antiviral Agents|antiviral agents|mesh-ancestor
102536761|NCT01555281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102536762|NCT00370539|Triamcinolone|triamcinolone|mesh-list
102536763|NCT00370539|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102536764|NCT00370539|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102536765|NCT00370539|Bevacizumab|bevacizumab|mesh-list
102536766|NCT00370539|Verteporfin|verteporfin|mesh-list
102536767|NCT00370539|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102536768|NCT00370539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102536769|NCT00370539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102536770|NCT00370539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102536771|NCT00370539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102536772|NCT00370539|Growth Substances|growth substances|mesh-ancestor
102536773|NCT00370539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536774|NCT00370539|Growth Inhibitors|growth inhibitors|mesh-ancestor
102536775|NCT00370539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102536776|NCT00370539|Glucocorticoids|glucocorticoids|mesh-ancestor
102536777|NCT00370539|Hormones|hormones|mesh-ancestor
102536778|NCT00370539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102536779|NCT00370539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102536780|NCT00370539|Immunologic Factors|immunologic factors|mesh-ancestor
102536781|NCT00370539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102536782|NCT00370539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536783|NCT00370539|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102536784|NCT00370539|Dermatologic Agents|dermatologic agents|mesh-ancestor
102536785|NCT03996057|Methenamine|methenamine|mesh-list
102536786|NCT03996057|Methenamine hippurate|methenamine hippurate|mesh-list
102536787|NCT03996057|Methenamine mandelate|methenamine mandelate|mesh-list
102536788|NCT03996057|Estrogens|estrogens|mesh-list
102536789|NCT03996057|Hormones|hormones|mesh-ancestor
102536790|NCT03996057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102536791|NCT03996057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536792|NCT03996057|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102536793|NCT03996057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102536794|NCT03996057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102536795|NCT03150875|Docetaxel|docetaxel|mesh-list
102536796|NCT03150875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102536797|NCT03150875|Tubulin Modulators|tubulin modulators|mesh-ancestor
102536798|NCT03150875|Antimitotic Agents|antimitotic agents|mesh-ancestor
102536799|NCT03150875|Mitosis Modulators|mitosis modulators|mesh-ancestor
102536800|NCT03150875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536801|NCT00552071|Octreotide|octreotide|mesh-list
102536802|NCT00552071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102536803|NCT00552071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102536804|NCT00552071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102536805|NCT00673335|Letrozole|letrozole|mesh-list
102536806|NCT00673335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102536807|NCT00673335|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102536808|NCT00673335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102536809|NCT00673335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102536810|NCT00673335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536811|NCT00673335|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102536812|NCT00673335|Hormone Antagonists|hormone antagonists|mesh-ancestor
102536813|NCT00673335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102536814|NCT00673335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536815|NCT04880889|Pantothenic Acid|pantothenic acid|mesh-list
102536816|NCT04880889|Thiamine|thiamine|mesh-list
102536817|NCT04880889|Vitamin B Complex|vitamin b complex|mesh-ancestor
102536818|NCT04880889|Vitamins|vitamins|mesh-ancestor
102536819|NCT04880889|Micronutrients|micronutrients|mesh-ancestor
102536820|NCT04880889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536821|NCT03833427|Pembrolizumab|pembrolizumab|mesh-list
102536822|NCT03833427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102536823|NCT03833427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102536824|NCT03833427|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102536825|NCT03833427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536826|NCT04849377|Cisplatin|cisplatin|mesh-list
102536827|NCT04849377|Carboplatin|carboplatin|mesh-list
102536828|NCT04849377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102536829|NCT05511779|Brincidofovir|brincidofovir|mesh-list
102536830|NCT05511779|Antiviral Agents|antiviral agents|mesh-ancestor
102536831|NCT05511779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102536832|NCT00551525|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
102536833|NCT00551525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102536834|NCT00551525|Analgesics|analgesics|mesh-ancestor
102536835|NCT00551525|Sensory System Agents|sensory system agents|mesh-ancestor
102536836|NCT00551525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102536837|NCT00551525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536838|NCT04802031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102536839|NCT04802031|Immunologic Factors|immunologic factors|mesh-ancestor
102536840|NCT04802031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536841|NCT05454345|Moxifloxacin|moxifloxacin|mesh-list
102536842|NCT05454345|Rifampin|rifampin|mesh-list
102536843|NCT05454345|Isoniazid|isoniazid|mesh-list
102536844|NCT05454345|Pyrazinamide|pyrazinamide|mesh-list
102536845|NCT05454345|Ethambutol|ethambutol|mesh-list
102536846|NCT05454345|Rifapentine|rifapentine|mesh-list
102536847|NCT05454345|Sitafloxacin|sitafloxacin|mesh-list
102536848|NCT05454345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102536849|NCT05454345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102536850|NCT05454345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102536851|NCT05454345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102536852|NCT05454345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102536853|NCT05454345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536854|NCT05454345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102536855|NCT05454345|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102536856|NCT05454345|Antitubercular Agents|antitubercular agents|mesh-ancestor
102536857|NCT05454345|Leprostatic Agents|leprostatic agents|mesh-ancestor
102536858|NCT05454345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102536859|NCT05454345|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102536860|NCT05454345|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102536861|NCT05454345|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102536862|NCT05454345|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102536863|NCT05454345|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102536864|NCT05454345|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102536865|NCT05454345|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102536866|NCT05454345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102536867|NCT05454345|Antimetabolites|antimetabolites|mesh-ancestor
102536868|NCT05454345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102536869|NCT04459611|Paclitaxel|paclitaxel|mesh-list
102536870|NCT04459611|Carboplatin|carboplatin|mesh-list
102536871|NCT04459611|Pemetrexed|pemetrexed|mesh-list
102536872|NCT04459611|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102536873|NCT04459611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102536874|NCT04459611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102536875|NCT04459611|Tubulin Modulators|tubulin modulators|mesh-ancestor
102536876|NCT04459611|Antimitotic Agents|antimitotic agents|mesh-ancestor
102536877|NCT04459611|Mitosis Modulators|mitosis modulators|mesh-ancestor
102536878|NCT04459611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536879|NCT04459611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102536880|NCT04459611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102536881|NCT04459611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102536882|NCT00370617|Metformin|metformin|mesh-list
102536883|NCT00370617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102536884|NCT00370617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536885|NCT01553708|Sulfadiazine|sulfadiazine|mesh-list
102536886|NCT01553708|Silver Sulfadiazine|silver sulfadiazine|mesh-list
102536887|NCT01553708|Mitogens|mitogens|mesh-list
102536888|NCT01553708|Mitosis Modulators|mitosis modulators|mesh-ancestor
102536889|NCT01553708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536890|NCT01553708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102536891|NCT01553708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102536892|NCT01553708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102536893|NCT01553708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102536894|NCT01553708|Coccidiostats|coccidiostats|mesh-ancestor
102536895|NCT01553708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102536896|NCT02370498|Paclitaxel|paclitaxel|mesh-list
102536897|NCT02370498|Pembrolizumab|pembrolizumab|mesh-list
102536898|NCT02370498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102536899|NCT02370498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102536900|NCT02370498|Tubulin Modulators|tubulin modulators|mesh-ancestor
102536901|NCT02370498|Antimitotic Agents|antimitotic agents|mesh-ancestor
102536902|NCT02370498|Mitosis Modulators|mitosis modulators|mesh-ancestor
102536903|NCT02370498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536904|NCT02370498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102536905|NCT02370498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102536906|NCT01554488|Fluticasone|fluticasone|mesh-list
102536907|NCT01554488|Xhance|xhance|mesh-list
102536908|NCT01554488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102536909|NCT01554488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102536910|NCT01554488|Autonomic Agents|autonomic agents|mesh-ancestor
102536911|NCT01554488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102536912|NCT01554488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536913|NCT01554488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102536914|NCT01554488|Respiratory System Agents|respiratory system agents|mesh-ancestor
102536915|NCT01554488|Dermatologic Agents|dermatologic agents|mesh-ancestor
102536916|NCT01554488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102536917|NCT02347332|Methotrexate|methotrexate|mesh-list
102536918|NCT02347332|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102536919|NCT02347332|Abortifacient Agents|abortifacient agents|mesh-ancestor
102536920|NCT02347332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102536921|NCT02347332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536922|NCT02347332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102536923|NCT02347332|Antimetabolites|antimetabolites|mesh-ancestor
102536924|NCT02347332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536925|NCT02347332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102536926|NCT02347332|Dermatologic Agents|dermatologic agents|mesh-ancestor
102536927|NCT02347332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102536928|NCT02347332|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102536929|NCT02347332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102536930|NCT02347332|Immunologic Factors|immunologic factors|mesh-ancestor
102536931|NCT02347332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102536932|NCT02347332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102536934|NCT01502306|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102536935|NCT01502306|Autonomic Agents|autonomic agents|mesh-ancestor
102536936|NCT01502306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102536937|NCT01502306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536938|NCT01502306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102536939|NCT01502306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102536940|NCT01502306|Cholinergic Agents|cholinergic agents|mesh-ancestor
102536941|NCT01502306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102536942|NCT01502306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536943|NCT03325959|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102536944|NCT03325959|Analgesics|analgesics|mesh-ancestor
102536945|NCT03325959|Sensory System Agents|sensory system agents|mesh-ancestor
102536946|NCT03325959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102536947|NCT03325959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536948|NCT03325959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102536949|NCT03325959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536950|NCT03325959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102536951|NCT03325959|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102536952|NCT03325959|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102536953|NCT03325959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102536954|NCT03325959|Antidepressive Agents|antidepressive agents|mesh-ancestor
102536955|NCT03325959|Dopamine Agents|dopamine agents|mesh-ancestor
102536956|NCT02347176|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102536957|NCT02347176|Immunologic Factors|immunologic factors|mesh-ancestor
102536958|NCT02347176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536959|NCT05451381|Dexmedetomidine|dexmedetomidine|mesh-list
102536960|NCT05451381|Propofol|propofol|mesh-list
102536961|NCT05451381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102536962|NCT05451381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102536963|NCT05451381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536964|NCT05451381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102536965|NCT05451381|Analgesics|analgesics|mesh-ancestor
102536966|NCT05451381|Sensory System Agents|sensory system agents|mesh-ancestor
102536967|NCT05451381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102536968|NCT05451381|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102536969|NCT05451381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102536970|NCT05451381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102536971|NCT05451381|Adrenergic Agents|adrenergic agents|mesh-ancestor
102536972|NCT05451381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102536973|NCT05451381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536974|NCT05451381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102536975|NCT05451381|Anesthetics, General|anesthetics, general|mesh-ancestor
102536976|NCT05451381|Anesthetics|anesthetics|mesh-ancestor
102536977|NCT05450913|Lidocaine|lidocaine|mesh-list
102536978|NCT05450913|Anesthetics, Local|anesthetics, local|mesh-list
102536979|NCT05450913|Anesthetics|anesthetics|mesh-list
102536980|NCT05450913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102536981|NCT05450913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102536982|NCT05450913|Sensory System Agents|sensory system agents|mesh-ancestor
102536983|NCT05450913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102536984|NCT05450913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102536985|NCT05450913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102536986|NCT05450913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102536987|NCT05450913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102536988|NCT05450913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536989|NCT05446779|Hydrocortisone|hydrocortisone|mesh-list
102536990|NCT05446779|Epinephrine|epinephrine|mesh-list
102536991|NCT05446779|Racepinephrine|racepinephrine|mesh-list
102536992|NCT05446779|Epinephryl borate|epinephryl borate|mesh-list
102536993|NCT05446779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102536994|NCT05446779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102536995|NCT05446779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102536996|NCT05446779|Adrenergic Agents|adrenergic agents|mesh-ancestor
102536997|NCT05446779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102536998|NCT05446779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102536999|NCT05446779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537000|NCT05446779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102537001|NCT05446779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102537002|NCT05446779|Autonomic Agents|autonomic agents|mesh-ancestor
102537003|NCT05446779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102537004|NCT05446779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102537005|NCT05446779|Respiratory System Agents|respiratory system agents|mesh-ancestor
102537006|NCT05446779|Mydriatics|mydriatics|mesh-ancestor
102537007|NCT05446779|Sympathomimetics|sympathomimetics|mesh-ancestor
102537008|NCT05446779|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102537009|NCT02215070|Pasireotide|pasireotide|mesh-list
102537010|NCT02215070|Hormones|hormones|mesh-ancestor
102537011|NCT02215070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102537012|NCT02215070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537013|NCT04000737|Sorafenib|sorafenib|mesh-list
102537014|NCT04000737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102537015|NCT04000737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102537016|NCT04000737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102537017|NCT04000737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537018|NCT02347098|Atorvastatin|atorvastatin|mesh-list
102537019|NCT02347098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
102537020|NCT02347098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102537021|NCT02347098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102537022|NCT02347098|Antimetabolites|antimetabolites|mesh-ancestor
102537023|NCT02347098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537024|NCT02347098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102537025|NCT02347098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102537026|NCT03708237|Gabapentin|gabapentin|mesh-list
102537027|NCT03708237|Ropinirole|ropinirole|mesh-list
102537028|NCT03708237|Analgesics|analgesics|mesh-ancestor
102537029|NCT03708237|Sensory System Agents|sensory system agents|mesh-ancestor
102537030|NCT03708237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102537031|NCT03708237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537032|NCT03708237|Anticonvulsants|anticonvulsants|mesh-ancestor
102537033|NCT03708237|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102537034|NCT03708237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102537035|NCT03708237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102537036|NCT03708237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102537037|NCT03708237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102537038|NCT03708237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102537039|NCT03708237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102537040|NCT03708237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537041|NCT03708237|Antimanic Agents|antimanic agents|mesh-ancestor
102537042|NCT03708237|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102537043|NCT03708237|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102537044|NCT03708237|Dopamine Agonists|dopamine agonists|mesh-ancestor
102537045|NCT03708237|Dopamine Agents|dopamine agents|mesh-ancestor
102537046|NCT01556594|Glucagon|glucagon|mesh-list
102537047|NCT01556594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102537048|NCT01556594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102537049|NCT01556594|Hormones|hormones|mesh-ancestor
102537050|NCT01556594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102537051|NCT01556594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537052|NCT01556594|Incretins|incretins|mesh-ancestor
102537053|NCT00371319|Mycophenolic Acid|mycophenolic acid|mesh-list
102537054|NCT00371319|Tacrolimus|tacrolimus|mesh-list
102537055|NCT00371319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102537056|NCT00371319|Immunologic Factors|immunologic factors|mesh-ancestor
102537057|NCT00371319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537058|NCT00371319|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102537059|NCT00371319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102537060|NCT00371319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537061|NCT00371319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102537062|NCT00371319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102537063|NCT00371319|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102537064|NCT00371319|Antitubercular Agents|antitubercular agents|mesh-ancestor
102537065|NCT00371319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102537066|NCT00371319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102537067|NCT01439672|Insulin|insulin|mesh-list
102537068|NCT01439672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102537069|NCT01439672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537070|NCT03465111|Hormones|hormones|mesh-list
102537071|NCT03465111|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102537072|NCT03465111|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
102537073|NCT03465111|beta-Endorphin|beta-endorphin|mesh-list
102537074|NCT03465111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102537075|NCT03465111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537076|NCT03465111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102537077|NCT03465111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537078|NCT01440764|Furosemide|furosemide|mesh-list
102537079|NCT01440764|Diuretics|diuretics|mesh-ancestor
102537080|NCT01440764|Natriuretic Agents|natriuretic agents|mesh-ancestor
102537081|NCT01440764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241615|NCT04433559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102537082|NCT01440764|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102537083|NCT01440764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102537084|NCT01440764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537085|NCT01557452|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
102537086|NCT01557452|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102537087|NCT01557452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102537088|NCT01557452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537089|NCT05283837|Pertuzumab|pertuzumab|mesh-list
102537090|NCT05283837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102537091|NCT05283837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102537092|NCT02209610|Fentanyl|fentanyl|mesh-list
102537093|NCT02209610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102537094|NCT02209610|Narcotics|narcotics|mesh-ancestor
102537095|NCT02209610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102537096|NCT02209610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537097|NCT02209610|Analgesics|analgesics|mesh-ancestor
102537098|NCT02209610|Sensory System Agents|sensory system agents|mesh-ancestor
102537099|NCT02209610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102537100|NCT02209610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102537101|NCT02209610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102537102|NCT02209610|Anesthetics, General|anesthetics, general|mesh-ancestor
102537103|NCT02209610|Anesthetics|anesthetics|mesh-ancestor
102537104|NCT01441076|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102537105|NCT01441076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102537106|NCT05244993|Paclitaxel|paclitaxel|mesh-list
102537107|NCT05244993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102537108|NCT05244993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102537109|NCT05244993|Tubulin Modulators|tubulin modulators|mesh-ancestor
102537110|NCT05244993|Antimitotic Agents|antimitotic agents|mesh-ancestor
102537111|NCT05244993|Mitosis Modulators|mitosis modulators|mesh-ancestor
102537112|NCT05244993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537113|NCT03289299|Dexamethasone|dexamethasone|mesh-list
102537114|NCT03289299|Lenalidomide|lenalidomide|mesh-list
102537115|NCT03289299|Daratumumab|daratumumab|mesh-list
102537116|NCT03289299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102537117|NCT03289299|Antiemetics|antiemetics|mesh-ancestor
102537118|NCT03289299|Autonomic Agents|autonomic agents|mesh-ancestor
102537119|NCT03289299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102537120|NCT03289299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537121|NCT03289299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102537122|NCT03289299|Glucocorticoids|glucocorticoids|mesh-ancestor
102537123|NCT03289299|Hormones|hormones|mesh-ancestor
102537124|NCT03289299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102537125|NCT03289299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102537126|NCT03289299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102537127|NCT03289299|Immunologic Factors|immunologic factors|mesh-ancestor
102537128|NCT03289299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102537129|NCT03289299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102537130|NCT03289299|Growth Substances|growth substances|mesh-ancestor
101568359|NCT04319549|Eusol|eusol|mesh-list
102537131|NCT03289299|Growth Inhibitors|growth inhibitors|mesh-ancestor
102537132|NCT01558700|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102537133|NCT01558700|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102537134|NCT01558700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102537135|NCT01558700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102241635|NCT03070665|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102537136|NCT01558700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537137|NCT01558700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102537138|NCT01558700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537139|NCT01558700|Analgesics|analgesics|mesh-ancestor
102537140|NCT01558700|Sensory System Agents|sensory system agents|mesh-ancestor
102537141|NCT01558700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102537142|NCT01558700|Antidepressive Agents|antidepressive agents|mesh-ancestor
102537143|NCT01558700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102537144|NCT01558700|Dopamine Agents|dopamine agents|mesh-ancestor
102537145|NCT02757105|Ondansetron|ondansetron|mesh-list
102537146|NCT02757105|Antiemetics|antiemetics|mesh-ancestor
102537147|NCT02757105|Autonomic Agents|autonomic agents|mesh-ancestor
102537148|NCT02757105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102537149|NCT02757105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537150|NCT02757105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102537151|NCT02757105|Antipruritics|antipruritics|mesh-ancestor
102537152|NCT02757105|Dermatologic Agents|dermatologic agents|mesh-ancestor
102537153|NCT02757105|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102537154|NCT02757105|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102537155|NCT02757105|Serotonin Agents|serotonin agents|mesh-ancestor
102537156|NCT02757105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102537157|NCT02757105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537158|NCT05083845|Anesthetics|anesthetics|mesh-list
102537159|NCT05083845|Anesthetics, Local|anesthetics, local|mesh-list
102537160|NCT05083845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102537161|NCT05083845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537162|NCT05083845|Sensory System Agents|sensory system agents|mesh-ancestor
102537163|NCT05083845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102537164|NCT00371553|Sunitinib|sunitinib|mesh-list
102537165|NCT00371553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102537166|NCT00371553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102537167|NCT00371553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102537168|NCT00371553|Growth Substances|growth substances|mesh-ancestor
102537169|NCT00371553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537170|NCT00371553|Growth Inhibitors|growth inhibitors|mesh-ancestor
102537171|NCT00371553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102537172|NCT00371553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102537173|NCT00371553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537174|NCT02892201|Pembrolizumab|pembrolizumab|mesh-list
102537175|NCT02892201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102537176|NCT02892201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102537177|NCT02892201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102537178|NCT02892201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537179|NCT01507220|Morphine|morphine|mesh-list
102537180|NCT01507220|Bupivacaine|bupivacaine|mesh-list
102537181|NCT01507220|Anesthetics, Local|anesthetics, local|mesh-ancestor
102537182|NCT01507220|Anesthetics|anesthetics|mesh-ancestor
102537183|NCT01507220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102537184|NCT01507220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537185|NCT01507220|Sensory System Agents|sensory system agents|mesh-ancestor
102537186|NCT01507220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102537187|NCT01507220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102537188|NCT01507220|Narcotics|narcotics|mesh-ancestor
102537189|NCT01507220|Analgesics|analgesics|mesh-ancestor
102537190|NCT01509404|Valganciclovir|valganciclovir|mesh-list
102537191|NCT01509404|Antiviral Agents|antiviral agents|mesh-ancestor
102537192|NCT01509404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102537193|NCT01562132|Fluconazole|fluconazole|mesh-list
102537194|NCT01562132|Flucytosine|flucytosine|mesh-list
102537195|NCT01562132|Antifungal Agents|antifungal agents|mesh-ancestor
102537196|NCT01562132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102537197|NCT01562132|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102537198|NCT01562132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102537199|NCT01562132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102537200|NCT01562132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537201|NCT01562132|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102537202|NCT01562132|Hormone Antagonists|hormone antagonists|mesh-ancestor
102537203|NCT01562132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102537204|NCT01562132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537205|NCT01562132|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102537206|NCT01562132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102537207|NCT01562132|Antimetabolites|antimetabolites|mesh-ancestor
102537208|NCT02762331|Ascorbic Acid|ascorbic acid|mesh-list
102537209|NCT02762331|Vitamins|vitamins|mesh-ancestor
102537210|NCT02762331|Micronutrients|micronutrients|mesh-ancestor
102537211|NCT02762331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537212|NCT02762331|Antioxidants|antioxidants|mesh-ancestor
102537213|NCT02762331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537214|NCT02762331|Protective Agents|protective agents|mesh-ancestor
102537215|NCT02762799|Lenograstim|lenograstim|mesh-list
102537216|NCT02762799|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102537217|NCT02762799|Immunologic Factors|immunologic factors|mesh-ancestor
102537218|NCT02762799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537219|NCT01447706|Paclitaxel|paclitaxel|mesh-list
102537220|NCT01447706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102537221|NCT01447706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102537222|NCT01447706|Tubulin Modulators|tubulin modulators|mesh-ancestor
102537223|NCT01447706|Antimitotic Agents|antimitotic agents|mesh-ancestor
102537224|NCT01447706|Mitosis Modulators|mitosis modulators|mesh-ancestor
102537225|NCT01447706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537226|NCT01509638|Bupivacaine|bupivacaine|mesh-list
102537227|NCT01509638|Anesthetics, Local|anesthetics, local|mesh-ancestor
102537228|NCT01509638|Anesthetics|anesthetics|mesh-ancestor
102537229|NCT01509638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102537230|NCT01509638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537231|NCT01509638|Sensory System Agents|sensory system agents|mesh-ancestor
102537232|NCT01509638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102537233|NCT04336917|Lidocaine|lidocaine|mesh-list
102537234|NCT04336917|Bupivacaine|bupivacaine|mesh-list
102537235|NCT04336917|Anesthetics, Local|anesthetics, local|mesh-list
102537236|NCT04336917|Anesthetics|anesthetics|mesh-list
102537237|NCT04336917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102537238|NCT04336917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537239|NCT04336917|Sensory System Agents|sensory system agents|mesh-ancestor
102537240|NCT04336917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102537241|NCT04336917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102537242|NCT04336917|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102537243|NCT04336917|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102537244|NCT04336917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102537245|NCT04336917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537246|NCT01448486|Raltegravir Potassium|raltegravir potassium|mesh-list
102537247|NCT01448486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102537248|NCT01448486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102537249|NCT01448486|Antiviral Agents|antiviral agents|mesh-ancestor
102537250|NCT01448486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102537251|NCT01448486|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102537252|NCT01448486|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102537253|NCT01448486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102537254|NCT01448486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537255|NCT01562678|Liraglutide|liraglutide|mesh-list
102537256|NCT01562678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102537257|NCT01562678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537258|NCT01562678|Incretins|incretins|mesh-ancestor
102537259|NCT01562678|Hormones|hormones|mesh-ancestor
102537260|NCT01562678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102537261|NCT02767869|Magnesium Oxide|magnesium oxide|mesh-list
102537262|NCT02767869|Antacids|antacids|mesh-ancestor
102537263|NCT02767869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537264|NCT02767869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102537265|NCT01449266|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
102537266|NCT01449266|Chelating Agents|chelating agents|mesh-ancestor
102537267|NCT01449266|Sequestering Agents|sequestering agents|mesh-ancestor
102537268|NCT01449266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537269|NCT02767947|Luliconazole|luliconazole|mesh-list
102537270|NCT02767947|Antifungal Agents|antifungal agents|mesh-ancestor
102537271|NCT02767947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102537272|NCT02770365|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102537273|NCT02770365|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102537274|NCT02770365|Estradiol|estradiol|mesh-list
102537275|NCT02770365|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101568494|NCT01075815|Hormones|hormones|mesh-list
102537277|NCT02770365|Hormones|hormones|mesh-ancestor
102537278|NCT02770365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102537279|NCT02770365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537280|NCT02770365|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102537281|NCT02770365|Contraceptive Agents|contraceptive agents|mesh-ancestor
102537282|NCT02770365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102537283|NCT02770365|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102537284|NCT02770521|Insulin Lispro|insulin lispro|mesh-list
102537285|NCT02770521|Treprostinil|treprostinil|mesh-list
102537286|NCT02770521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102537287|NCT02770521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537288|NCT02770521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102537289|NCT02346240|Etanercept|etanercept|mesh-list
102537290|NCT02346240|Certolizumab Pegol|certolizumab pegol|mesh-list
102537291|NCT02346240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102537292|NCT02346240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102537293|NCT02346240|Analgesics|analgesics|mesh-ancestor
102537294|NCT02346240|Sensory System Agents|sensory system agents|mesh-ancestor
102537295|NCT02346240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102537296|NCT02346240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537297|NCT02346240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102537298|NCT02346240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102537299|NCT02346240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102537300|NCT02346240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102537301|NCT02346240|Immunologic Factors|immunologic factors|mesh-ancestor
102537302|NCT02346240|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102537303|NCT01511978|Amifampridine|amifampridine|mesh-list
102537304|NCT01511978|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102537305|NCT01511978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102537306|NCT01511978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537307|NCT01511978|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102537308|NCT01511978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102537309|NCT01511978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537310|NCT02772783|Insulin|insulin|mesh-list
102537311|NCT02772783|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102537312|NCT02772783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102537313|NCT02772783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537314|NCT02774343|Pioglitazone|pioglitazone|mesh-list
102537315|NCT02774343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102537316|NCT02774343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537317|NCT05349045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
102537318|NCT05349045|Antibodies|antibodies|mesh-list
102537319|NCT05349045|Immunologic Factors|immunologic factors|mesh-ancestor
102537320|NCT05349045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537321|NCT05349045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102537322|NCT05349045|Growth Substances|growth substances|mesh-ancestor
102537323|NCT05349045|Growth Inhibitors|growth inhibitors|mesh-ancestor
102537324|NCT05349045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102537325|NCT02392104|Warfarin|warfarin|mesh-list
102537326|NCT02392104|Anticoagulants|anticoagulants|mesh-ancestor
102537327|NCT04336605|Analgesics|analgesics|mesh-list
102537328|NCT04336605|Sensory System Agents|sensory system agents|mesh-ancestor
102537329|NCT04336605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102537330|NCT04336605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537331|NCT01450826|Ondansetron|ondansetron|mesh-list
102537332|NCT01450826|Aprepitant|aprepitant|mesh-list
102537333|NCT01450826|Antiemetics|antiemetics|mesh-ancestor
102537334|NCT01450826|Autonomic Agents|autonomic agents|mesh-ancestor
102537335|NCT01450826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102537336|NCT01450826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537337|NCT01450826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102537338|NCT01450826|Antipruritics|antipruritics|mesh-ancestor
102537339|NCT01450826|Dermatologic Agents|dermatologic agents|mesh-ancestor
102537340|NCT01450826|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102537341|NCT01450826|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102537342|NCT01450826|Serotonin Agents|serotonin agents|mesh-ancestor
102537343|NCT01450826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102537344|NCT01450826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537345|NCT01450826|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102537346|NCT05349903|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
102537347|NCT05349903|Antioxidants|antioxidants|mesh-ancestor
102537348|NCT05349903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537349|NCT05349903|Protective Agents|protective agents|mesh-ancestor
102154135|NCT00515281|Vasodilator Agents|vasodilator agents|mesh-ancestor
102537350|NCT05349903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537351|NCT05349903|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
102537352|NCT05349903|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102537353|NCT05349903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102537354|NCT05349903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102537355|NCT05349825|Losartan|losartan|mesh-list
102537356|NCT05349825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102537357|NCT05349825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102537358|NCT05349825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102537359|NCT05349825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102537360|NCT05349825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537361|NCT01451996|Loratadine|loratadine|mesh-list
102537362|NCT01451996|Antipruritics|antipruritics|mesh-ancestor
102537363|NCT01451996|Dermatologic Agents|dermatologic agents|mesh-ancestor
102537364|NCT01451996|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102537365|NCT01451996|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102537366|NCT01451996|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102537367|NCT01451996|Histamine Antagonists|histamine antagonists|mesh-ancestor
102537368|NCT01451996|Histamine Agents|histamine agents|mesh-ancestor
102537369|NCT01451996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102537370|NCT01451996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537371|NCT01451996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537372|NCT01512446|Alendronate|alendronate|mesh-list
102537373|NCT01512446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102537374|NCT01512446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537375|NCT04334967|Ascorbic Acid|ascorbic acid|mesh-list
102537376|NCT04334967|Hydroxychloroquine|hydroxychloroquine|mesh-list
102537377|NCT04334967|Vitamins|vitamins|mesh-ancestor
102537378|NCT04334967|Micronutrients|micronutrients|mesh-ancestor
102537379|NCT04334967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537380|NCT04334967|Antimalarials|antimalarials|mesh-ancestor
102537381|NCT04334967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102537382|NCT04334967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102537383|NCT04334967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102537384|NCT04334967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102537385|NCT04334967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537386|NCT04334967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102537387|NCT04334967|Antioxidants|antioxidants|mesh-ancestor
102537388|NCT04334967|Protective Agents|protective agents|mesh-ancestor
102537389|NCT04335123|Losartan|losartan|mesh-list
102537390|NCT04335123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102537391|NCT04335123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102537392|NCT04335123|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102537393|NCT04335123|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102537394|NCT04335123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537395|NCT05453565|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
102537396|NCT02742987|Clopidogrel|clopidogrel|mesh-list
102537397|NCT02742987|Ticagrelor|ticagrelor|mesh-list
102537398|NCT02742987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102537399|NCT02742987|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102537400|NCT02742987|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102537401|NCT02742987|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102537402|NCT02742987|Purinergic Agents|purinergic agents|mesh-ancestor
102537403|NCT02742987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102537404|NCT02742987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537405|NCT02742987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537406|NCT05450055|Lidocaine|lidocaine|mesh-list
102537407|NCT05450055|Analgesics|analgesics|mesh-list
102537408|NCT05450055|Anesthetics, Local|anesthetics, local|mesh-ancestor
102537409|NCT05450055|Anesthetics|anesthetics|mesh-ancestor
102537410|NCT05450055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102537411|NCT05450055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537412|NCT05450055|Sensory System Agents|sensory system agents|mesh-ancestor
102537413|NCT05450055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102537414|NCT05450055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102537415|NCT05450055|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102537416|NCT05450055|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102537417|NCT05450055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102537418|NCT05450055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537419|NCT02743377|Rolipram|rolipram|mesh-list
102537420|NCT02743377|Antidepressive Agents|antidepressive agents|mesh-ancestor
102537421|NCT02743377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102537422|NCT02743377|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102537423|NCT02743377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102537424|NCT02743377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102537425|NCT02743377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537426|NCT05437965|Glucocorticoids|glucocorticoids|mesh-list
102537427|NCT05437965|Immunosuppressive Agents|immunosuppressive agents|mesh-list
102537428|NCT05437965|Hormones|hormones|mesh-ancestor
102537429|NCT05437965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102537430|NCT05437965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537431|NCT05437965|Immunologic Factors|immunologic factors|mesh-ancestor
102537432|NCT00372099|Calcitonin|calcitonin|mesh-list
102537433|NCT00372099|Salmon calcitonin|salmon calcitonin|mesh-list
102537434|NCT00372099|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
102537435|NCT00372099|Katacalcin|katacalcin|mesh-list
102537436|NCT00372099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102537437|NCT00372099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537438|NCT00372099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102537439|NCT00372099|Vasodilator Agents|vasodilator agents|mesh-ancestor
102537440|NCT02748525|Cholecystokinin|cholecystokinin|mesh-list
102537441|NCT02748525|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102537442|NCT02748525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102537443|NCT01454414|Permethrin|permethrin|mesh-list
102537444|NCT01454414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102537445|NCT01454414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537446|NCT04335513|Insulin|insulin|mesh-list
102537447|NCT04335513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102537448|NCT04335513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537449|NCT01568528|Oxytocin|oxytocin|mesh-list
102537450|NCT01568528|Oxytocics|oxytocics|mesh-ancestor
102537451|NCT01568528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102537452|NCT01568528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537453|NCT05013255|Pioglitazone|pioglitazone|mesh-list
102537454|NCT05013255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102537455|NCT05013255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537456|NCT01461668|Retapamulin|retapamulin|mesh-list
102537457|NCT01461668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102537458|NCT01461668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102537459|NCT00372177|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
102537460|NCT00372177|Immunologic Factors|immunologic factors|mesh-ancestor
102537461|NCT00372177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537462|NCT05177991|Bupivacaine|bupivacaine|mesh-list
102537463|NCT05177991|Anesthetics, Local|anesthetics, local|mesh-ancestor
102537464|NCT05177991|Anesthetics|anesthetics|mesh-ancestor
102537465|NCT05177991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102537466|NCT05177991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537467|NCT05177991|Sensory System Agents|sensory system agents|mesh-ancestor
102537468|NCT05177991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102537469|NCT01461824|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102537470|NCT01461824|Medroxyprogesterone|medroxyprogesterone|mesh-list
102537471|NCT01461824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102537472|NCT01461824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102537473|NCT01461824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102537474|NCT01461824|Contraceptive Agents|contraceptive agents|mesh-ancestor
102537475|NCT01461824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102537476|NCT01461824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537477|NCT01461824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102537478|NCT01461824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102537479|NCT01461824|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102537480|NCT01461824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102537481|NCT01461824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102537482|NCT04080843|Capecitabine|capecitabine|mesh-list
102537483|NCT04080843|Oxaliplatin|oxaliplatin|mesh-list
102537484|NCT04080843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102537485|NCT04080843|Antimetabolites|antimetabolites|mesh-ancestor
102537486|NCT04080843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537487|NCT04080843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102537488|NCT04737837|Lacosamide|lacosamide|mesh-list
102537489|NCT04737837|Anticonvulsants|anticonvulsants|mesh-ancestor
102537490|NCT04737837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102537491|NCT04737837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102537492|NCT04737837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102537493|NCT04737837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537494|NCT05456763|Butyric Acid|butyric acid|mesh-list
101568718|NCT00626769|Genistein|genistein|mesh-list
102537495|NCT05456763|Histamine Antagonists|histamine antagonists|mesh-ancestor
102537496|NCT05456763|Histamine Agents|histamine agents|mesh-ancestor
102537497|NCT05456763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102537498|NCT05456763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537499|NCT05456763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537500|NCT05456061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102537501|NCT05456061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102537502|NCT02369874|Durvalumab|durvalumab|mesh-list
102537503|NCT02369874|Tremelimumab|tremelimumab|mesh-list
101757510|NCT00420511|Metformin|metformin|mesh-list
102537504|NCT02369874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102537505|NCT02369874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102537506|NCT02369874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102537507|NCT02369874|Immunologic Factors|immunologic factors|mesh-ancestor
102537508|NCT02369874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537509|NCT00372645|Folic Acid|folic acid|mesh-list
102537510|NCT00372645|Hematinics|hematinics|mesh-ancestor
102537511|NCT00372645|Vitamin B Complex|vitamin b complex|mesh-ancestor
102537512|NCT00372645|Vitamins|vitamins|mesh-ancestor
102537513|NCT00372645|Micronutrients|micronutrients|mesh-ancestor
102537514|NCT00372645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537515|NCT00372723|Infliximab|infliximab|mesh-list
102537516|NCT00372723|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102537517|NCT00372723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102537518|NCT00372723|Dermatologic Agents|dermatologic agents|mesh-ancestor
102537519|NCT00372723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102537520|NCT00372723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102537521|NCT00372801|Ibuprofen|ibuprofen|mesh-list
102537522|NCT00372801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102537523|NCT00372801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102537524|NCT00372801|Analgesics|analgesics|mesh-ancestor
102537525|NCT00372801|Sensory System Agents|sensory system agents|mesh-ancestor
102537526|NCT00372801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102537527|NCT00372801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537528|NCT00372801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102537529|NCT00372801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102537530|NCT00372801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102537531|NCT00372801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102537532|NCT00372801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537533|NCT04797429|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102537534|NCT04797429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537535|NCT05455359|Famotidine|famotidine|mesh-list
102537536|NCT05455359|Prucalopride|prucalopride|mesh-list
102537537|NCT05455359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102537538|NCT05455359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102537539|NCT05455359|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102537540|NCT05455359|Histamine Antagonists|histamine antagonists|mesh-ancestor
102537541|NCT05455359|Histamine Agents|histamine agents|mesh-ancestor
102537542|NCT05455359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102537543|NCT05455359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537544|NCT05455359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537545|NCT05455359|Laxatives|laxatives|mesh-ancestor
102537546|NCT05455359|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
102537547|NCT05455359|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102537548|NCT05455359|Serotonin Agents|serotonin agents|mesh-ancestor
102537549|NCT00373503|Lofexidine|lofexidine|mesh-list
102537550|NCT00373503|Dronabinol|dronabinol|mesh-list
102537551|NCT00373503|Hallucinogens|hallucinogens|mesh-ancestor
102537552|NCT00373503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537553|NCT00373503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102537554|NCT00373503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102537555|NCT00373503|Analgesics|analgesics|mesh-ancestor
102537556|NCT00373503|Sensory System Agents|sensory system agents|mesh-ancestor
102537557|NCT00373503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102537558|NCT00373503|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102537559|NCT00373503|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102537560|NCT00373503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102537561|NCT00373503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537562|NCT00373503|Hormones|hormones|mesh-ancestor
102537563|NCT00373503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102537564|NCT00373503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102537565|NCT00373503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102537566|NCT00373503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102537567|NCT00373503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102537568|NCT00373503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102537569|NCT00373503|Adrenergic Agents|adrenergic agents|mesh-ancestor
102537570|NCT01515176|Ofatumumab|ofatumumab|mesh-list
102537571|NCT01515176|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102537572|NCT01515176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102537573|NCT01515176|Immunologic Factors|immunologic factors|mesh-ancestor
102537574|NCT01515176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537575|NCT01515410|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102537576|NCT01515410|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102537577|NCT01515410|Immunologic Factors|immunologic factors|mesh-ancestor
102537578|NCT01515410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537579|NCT01515410|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102537580|NCT01515410|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102537581|NCT01515410|Dopamine Agonists|dopamine agonists|mesh-ancestor
102537582|NCT01515410|Dopamine Agents|dopamine agents|mesh-ancestor
102537583|NCT01515410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102537584|NCT01515410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537585|NCT01515566|Fentanyl|fentanyl|mesh-list
102537586|NCT01515566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102537587|NCT01515566|Narcotics|narcotics|mesh-ancestor
102537588|NCT01515566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102537589|NCT01515566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537590|NCT01515566|Analgesics|analgesics|mesh-ancestor
102537591|NCT01515566|Sensory System Agents|sensory system agents|mesh-ancestor
102537592|NCT01515566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102537593|NCT01515566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102537594|NCT01515566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102537595|NCT01515566|Anesthetics, General|anesthetics, general|mesh-ancestor
102537596|NCT01515566|Anesthetics|anesthetics|mesh-ancestor
102537597|NCT00708045|Deoxyglucose|deoxyglucose|mesh-list
102537598|NCT00708045|Antimetabolites|antimetabolites|mesh-ancestor
102537599|NCT00708045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537600|NCT00708045|Antiviral Agents|antiviral agents|mesh-ancestor
102537601|NCT00708045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102537602|NCT01516268|Sufentanil|sufentanil|mesh-list
102537603|NCT01516268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102537604|NCT01516268|Narcotics|narcotics|mesh-ancestor
102537605|NCT01516268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102537606|NCT01516268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537607|NCT01516268|Analgesics|analgesics|mesh-ancestor
102537608|NCT01516268|Sensory System Agents|sensory system agents|mesh-ancestor
102537609|NCT01516268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102537610|NCT01516268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102537611|NCT01516268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102537612|NCT01516268|Anesthetics, General|anesthetics, general|mesh-ancestor
102537613|NCT01516268|Anesthetics|anesthetics|mesh-ancestor
102537614|NCT05440968|Chrysarobin|chrysarobin|mesh-list
102537615|NCT05440968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102537616|NCT05440968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102537617|NCT05440968|Analgesics|analgesics|mesh-ancestor
102537618|NCT05440968|Sensory System Agents|sensory system agents|mesh-ancestor
102537619|NCT05440968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102537620|NCT05440968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537621|NCT05440968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102537622|NCT05440968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102537623|NCT01516424|Risperidone|risperidone|mesh-list
102537624|NCT01516424|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102537625|NCT01516424|Serotonin Agents|serotonin agents|mesh-ancestor
102537626|NCT01516424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102537627|NCT01516424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537628|NCT01516424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537629|NCT01516424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102537630|NCT01516424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102537631|NCT01516424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102537632|NCT01516424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102537633|NCT01516424|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102537634|NCT01516424|Dopamine Agents|dopamine agents|mesh-ancestor
102537635|NCT02368314|Enoxaparin|enoxaparin|mesh-list
102537636|NCT02368314|Enoxaparin sodium|enoxaparin sodium|mesh-list
102537637|NCT02368314|Anticoagulants|anticoagulants|mesh-ancestor
102537638|NCT02368314|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102537639|NCT02368314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102537640|NCT02368314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537641|NCT01463384|Minocycline|minocycline|mesh-list
102537642|NCT01463384|Tetracycline|tetracycline|mesh-list
102537643|NCT01463384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102537644|NCT01463384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102537645|NCT01463384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102537646|NCT01463384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101568862|NCT03866200|Antioxidants|antioxidants|mesh-ancestor
102537647|NCT01463384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537648|NCT02785185|Clobetasol|clobetasol|mesh-list
102537649|NCT02785185|Halobetasol|halobetasol|mesh-list
102537650|NCT02785185|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102537651|NCT02785185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102537652|NCT02785185|Glucocorticoids|glucocorticoids|mesh-ancestor
102537653|NCT02785185|Hormones|hormones|mesh-ancestor
102537654|NCT02785185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102537655|NCT02785185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537656|NCT02787057|Moxifloxacin|moxifloxacin|mesh-list
102537657|NCT02787057|Vancomycin|vancomycin|mesh-list
102537658|NCT02787057|Ceftazidime|ceftazidime|mesh-list
102537659|NCT02787057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102537660|NCT02787057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102537661|NCT02787057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102537662|NCT02787057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102537663|NCT02787057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102537664|NCT02787057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537665|NCT02787057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102537666|NCT01468532|Prednisone|prednisone|mesh-list
102537667|NCT01468532|Docetaxel|docetaxel|mesh-list
102537668|NCT01468532|Pasireotide|pasireotide|mesh-list
102537669|NCT01468532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102537670|NCT01468532|Tubulin Modulators|tubulin modulators|mesh-ancestor
102537671|NCT01468532|Antimitotic Agents|antimitotic agents|mesh-ancestor
102537672|NCT01468532|Mitosis Modulators|mitosis modulators|mesh-ancestor
102537673|NCT01468532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537674|NCT01468532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102537675|NCT01468532|Glucocorticoids|glucocorticoids|mesh-ancestor
102537676|NCT01468532|Hormones|hormones|mesh-ancestor
102537677|NCT01468532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102537678|NCT01468532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537679|NCT01468532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102537680|NCT05062317|Leucovorin|leucovorin|mesh-list
102537681|NCT05062317|Bevacizumab|bevacizumab|mesh-list
102537682|NCT05062317|Fluorouracil|fluorouracil|mesh-list
102537683|NCT05062317|Capecitabine|capecitabine|mesh-list
102537684|NCT05062317|Oxaliplatin|oxaliplatin|mesh-list
102537685|NCT05062317|Irinotecan|irinotecan|mesh-list
102537686|NCT05062317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102537687|NCT05062317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102537688|NCT05062317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102537689|NCT05062317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102537690|NCT05062317|Growth Substances|growth substances|mesh-ancestor
102537691|NCT05062317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537692|NCT05062317|Growth Inhibitors|growth inhibitors|mesh-ancestor
102537693|NCT05062317|Antimetabolites|antimetabolites|mesh-ancestor
102537694|NCT05062317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537695|NCT05062317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102537696|NCT05062317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102537697|NCT05062317|Immunologic Factors|immunologic factors|mesh-ancestor
102537698|NCT05062317|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102537699|NCT05062317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102537700|NCT05062317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102537701|NCT05062317|Antidotes|antidotes|mesh-ancestor
102537702|NCT05062317|Protective Agents|protective agents|mesh-ancestor
102537703|NCT05062317|Vitamin B Complex|vitamin b complex|mesh-ancestor
102537704|NCT05062317|Vitamins|vitamins|mesh-ancestor
102537705|NCT05062317|Micronutrients|micronutrients|mesh-ancestor
102537706|NCT01469234|Loratadine|loratadine|mesh-list
102537707|NCT01469234|Fexofenadine|fexofenadine|mesh-list
102537708|NCT01469234|Terfenadine|terfenadine|mesh-list
102537709|NCT01469234|Antipruritics|antipruritics|mesh-ancestor
102537710|NCT01469234|Dermatologic Agents|dermatologic agents|mesh-ancestor
102537711|NCT01469234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102537712|NCT01469234|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102537713|NCT01469234|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102537714|NCT01469234|Histamine Antagonists|histamine antagonists|mesh-ancestor
102537715|NCT01469234|Histamine Agents|histamine agents|mesh-ancestor
102537716|NCT01469234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102537717|NCT01469234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537718|NCT01469234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537719|NCT05045937|Vitamin D|vitamin d|mesh-list
102537720|NCT05045937|Vitamins|vitamins|mesh-list
102537721|NCT05045937|Ivermectin|ivermectin|mesh-list
102537722|NCT05045937|Remdesivir|remdesivir|mesh-list
102537723|NCT05045937|Ibuprofen|ibuprofen|mesh-list
102537724|NCT05045937|Budesonide|budesonide|mesh-list
102537725|NCT05045937|Melatonin|melatonin|mesh-list
102537726|NCT05045937|Albuterol|albuterol|mesh-list
102537727|NCT05045937|Quercetin|quercetin|mesh-list
102537728|NCT05045937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537729|NCT05045937|Micronutrients|micronutrients|mesh-ancestor
102537730|NCT05045937|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102537731|NCT05045937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102537732|NCT05045937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102537733|NCT05045937|Analgesics|analgesics|mesh-ancestor
102537734|NCT05045937|Sensory System Agents|sensory system agents|mesh-ancestor
102537735|NCT05045937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102537736|NCT05045937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102537737|NCT05045937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102537738|NCT05045937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537739|NCT05045937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102537740|NCT05045937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102537741|NCT05045937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102537742|NCT05045937|Autonomic Agents|autonomic agents|mesh-ancestor
102537743|NCT05045937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102537744|NCT05045937|Respiratory System Agents|respiratory system agents|mesh-ancestor
102537745|NCT05045937|Glucocorticoids|glucocorticoids|mesh-ancestor
102537746|NCT05045937|Hormones|hormones|mesh-ancestor
102537747|NCT05045937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102537748|NCT05045937|Antioxidants|antioxidants|mesh-ancestor
102537749|NCT05045937|Protective Agents|protective agents|mesh-ancestor
102241636|NCT04891809|Dexamethasone|dexamethasone|mesh-list
102537750|NCT05045937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102537751|NCT05045937|Tocolytic Agents|tocolytic agents|mesh-ancestor
102537752|NCT05045937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102537753|NCT05045937|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102537754|NCT05045937|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102537755|NCT05045937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102537756|NCT05045937|Adrenergic Agents|adrenergic agents|mesh-ancestor
102537757|NCT05045937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102537758|NCT05045937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102537759|NCT05045937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102537760|NCT05045937|Antimetabolites|antimetabolites|mesh-ancestor
102537761|NCT05045937|Antiviral Agents|antiviral agents|mesh-ancestor
102537762|NCT00373581|Cocaine|cocaine|mesh-list
102537763|NCT00373581|Vigabatrin|vigabatrin|mesh-list
102537764|NCT00373581|Anesthetics, Local|anesthetics, local|mesh-ancestor
102537765|NCT00373581|Anesthetics|anesthetics|mesh-ancestor
102537766|NCT00373581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102537767|NCT00373581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537768|NCT00373581|Sensory System Agents|sensory system agents|mesh-ancestor
102537769|NCT00373581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102537770|NCT00373581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102537771|NCT00373581|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102537772|NCT00373581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102537773|NCT00373581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102537774|NCT00373581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537775|NCT00373581|Dopamine Agents|dopamine agents|mesh-ancestor
102537776|NCT00373581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102537777|NCT00373581|Anticonvulsants|anticonvulsants|mesh-ancestor
102537778|NCT00373581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102537779|NCT00373581|GABA Agents|gaba agents|mesh-ancestor
102537780|NCT01470170|Alfentanil|alfentanil|mesh-list
102537781|NCT01470170|Propofol|propofol|mesh-list
102537782|NCT01470170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102537783|NCT01470170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102537784|NCT01470170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537785|NCT01470170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102537786|NCT01470170|Anesthetics, General|anesthetics, general|mesh-ancestor
102537787|NCT01470170|Anesthetics|anesthetics|mesh-ancestor
102537788|NCT01470170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102537789|NCT01470170|Narcotics|narcotics|mesh-ancestor
102537790|NCT01470170|Analgesics|analgesics|mesh-ancestor
102537791|NCT01470170|Sensory System Agents|sensory system agents|mesh-ancestor
102537792|NCT01470170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102537793|NCT04311567|Methotrexate|methotrexate|mesh-list
102537794|NCT04311567|Tofacitinib|tofacitinib|mesh-list
102537795|NCT04311567|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102537796|NCT04311567|Abortifacient Agents|abortifacient agents|mesh-ancestor
102537797|NCT04311567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102537798|NCT04311567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537799|NCT04311567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102537800|NCT04311567|Antimetabolites|antimetabolites|mesh-ancestor
102537801|NCT04311567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537802|NCT04311567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102537803|NCT04311567|Dermatologic Agents|dermatologic agents|mesh-ancestor
102537804|NCT04311567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102537805|NCT04311567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102537806|NCT04311567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102537807|NCT04311567|Immunologic Factors|immunologic factors|mesh-ancestor
102537808|NCT04311567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102537809|NCT04311567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102537810|NCT04311567|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102537811|NCT04311567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102537812|NCT04259775|Insulin|insulin|mesh-list
102537813|NCT04259775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102537814|NCT04259775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537815|NCT05037825|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102537816|NCT05037825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537817|NCT05037825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102537818|NCT05037825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102537819|NCT01573052|Chlordiazepoxide|chlordiazepoxide|mesh-list
102537820|NCT01573052|Gabapentin|gabapentin|mesh-list
102537821|NCT01573052|Analgesics|analgesics|mesh-ancestor
102537822|NCT01573052|Sensory System Agents|sensory system agents|mesh-ancestor
102537823|NCT01573052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102537824|NCT01573052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537825|NCT01573052|Anticonvulsants|anticonvulsants|mesh-ancestor
102537826|NCT01573052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102537827|NCT01573052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102537828|NCT01573052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102537829|NCT01573052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102537830|NCT01573052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102537831|NCT01573052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102537832|NCT01573052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102537833|NCT01573052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537834|NCT01573052|Antimanic Agents|antimanic agents|mesh-ancestor
102537835|NCT01573052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102537836|NCT01573052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102537837|NCT01573052|GABA Modulators|gaba modulators|mesh-ancestor
102537838|NCT01573052|GABA Agents|gaba agents|mesh-ancestor
102537839|NCT01521260|Chlorhexidine|chlorhexidine|mesh-list
102537840|NCT01521260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102537841|NCT01521260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102537842|NCT01521260|Disinfectants|disinfectants|mesh-ancestor
102537843|NCT01523834|Panobinostat|panobinostat|mesh-list
102537844|NCT01523834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102537845|NCT01523834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102537846|NCT01523834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102537847|NCT01523834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537848|NCT01472432|Vildagliptin|vildagliptin|mesh-list
102537849|NCT01472432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102537850|NCT01472432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537851|NCT01472432|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102537852|NCT01472432|Protease Inhibitors|protease inhibitors|mesh-ancestor
102537853|NCT01472432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102537854|NCT01472432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537855|NCT01524302|Levofloxacin|levofloxacin|mesh-list
102537856|NCT01524302|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
102537857|NCT01524302|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102537858|NCT01524302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102537859|NCT01524302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102537860|NCT01524302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102537861|NCT01524302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102537862|NCT01524302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102537863|NCT01524302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537864|NCT01524302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102537865|NCT01524302|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102537866|NCT01524302|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102537867|NCT02802111|Albuterol|albuterol|mesh-list
102537868|NCT02802111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102537869|NCT02802111|Autonomic Agents|autonomic agents|mesh-ancestor
102537870|NCT02802111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102537871|NCT02802111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537872|NCT02802111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102537873|NCT02802111|Respiratory System Agents|respiratory system agents|mesh-ancestor
102537874|NCT02802111|Tocolytic Agents|tocolytic agents|mesh-ancestor
102537875|NCT02802111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102537876|NCT02802111|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102537877|NCT02802111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102537878|NCT02802111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102537879|NCT02802111|Adrenergic Agents|adrenergic agents|mesh-ancestor
102537880|NCT02802111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102537881|NCT02802111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537882|NCT01576874|Oxytocin|oxytocin|mesh-list
102537883|NCT01576874|Oxytocics|oxytocics|mesh-ancestor
102537884|NCT01576874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102537885|NCT01576874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537886|NCT01576952|Bromfenac|bromfenac|mesh-list
102537887|NCT01576952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102537888|NCT01576952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102537889|NCT01576952|Analgesics|analgesics|mesh-ancestor
102537890|NCT01576952|Sensory System Agents|sensory system agents|mesh-ancestor
102537891|NCT01576952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102537892|NCT01576952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537893|NCT01576952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102537894|NCT01576952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102537895|NCT01577966|Sulfasalazine|sulfasalazine|mesh-list
102537896|NCT01577966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102537897|NCT01577966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102537898|NCT01577966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102537899|NCT01577966|Analgesics|analgesics|mesh-ancestor
102537900|NCT01577966|Sensory System Agents|sensory system agents|mesh-ancestor
102537901|NCT01577966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102537902|NCT01577966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537903|NCT01577966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102537904|NCT01577966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102537905|NCT01577966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102537906|NCT02345226|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102537907|NCT02345226|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102537908|NCT02345226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102537909|NCT02345226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102537910|NCT02345226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537911|NCT02345226|Antiviral Agents|antiviral agents|mesh-ancestor
102537912|NCT02345226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102537913|NCT02345226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102537914|NCT02345226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102537915|NCT02802501|Piperaquine|piperaquine|mesh-list
102537916|NCT02802501|Primaquine|primaquine|mesh-list
102537917|NCT02802501|Artenimol|artenimol|mesh-list
102537918|NCT02802501|Tafenoquine|tafenoquine|mesh-list
102537919|NCT02802501|Antimalarials|antimalarials|mesh-ancestor
102537920|NCT02802501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102537921|NCT02802501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102537922|NCT02802501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102537923|NCT01528592|Levodopa|levodopa|mesh-list
102537924|NCT01528592|Carbidopa|carbidopa|mesh-list
102537925|NCT01528592|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102537926|NCT01528592|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102537927|NCT01528592|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102537928|NCT01528592|Dopamine Agents|dopamine agents|mesh-ancestor
102537929|NCT01528592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102537930|NCT01528592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537931|NCT01528592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537932|NCT01528592|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102537933|NCT01528592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102537934|NCT01528592|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102537935|NCT01528592|Immunologic Factors|immunologic factors|mesh-ancestor
102537936|NCT01528592|Dopamine Agonists|dopamine agonists|mesh-ancestor
102537937|NCT01578278|Fluticasone|fluticasone|mesh-list
102537938|NCT01578278|Xhance|xhance|mesh-list
102537939|NCT01578278|Bepotastine besilate|bepotastine besilate|mesh-list
102537940|NCT01578278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102537941|NCT01578278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102537942|NCT01578278|Autonomic Agents|autonomic agents|mesh-ancestor
102537943|NCT01578278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102537944|NCT01578278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537945|NCT01578278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102537946|NCT01578278|Respiratory System Agents|respiratory system agents|mesh-ancestor
102537947|NCT01578278|Dermatologic Agents|dermatologic agents|mesh-ancestor
102537948|NCT01578278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102537949|NCT02803749|Buspirone|buspirone|mesh-list
102537950|NCT02803749|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102537951|NCT02803749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102537952|NCT02803749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102537953|NCT02803749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154136|NCT00515281|Gasotransmitters|gasotransmitters|mesh-ancestor
102537954|NCT02803749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102154137|NCT00515281|Protective Agents|protective agents|mesh-ancestor
102537955|NCT02803749|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102537957|NCT02803749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102537958|NCT02803749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537959|NCT01578980|Pancrelipase|pancrelipase|mesh-list
102537960|NCT01578980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102537961|NCT01529060|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
102537962|NCT01529060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102537963|NCT00372879|Vitamin E|vitamin e|mesh-list
102537964|NCT00372879|Vitamins|vitamins|mesh-ancestor
102537965|NCT00372879|Micronutrients|micronutrients|mesh-ancestor
102537966|NCT00372879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537967|NCT00372879|Antioxidants|antioxidants|mesh-ancestor
102537968|NCT00372879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537969|NCT00372879|Protective Agents|protective agents|mesh-ancestor
102537970|NCT02806869|Ibuprofen|ibuprofen|mesh-list
102537971|NCT02806869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102537972|NCT02806869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102537973|NCT02806869|Analgesics|analgesics|mesh-ancestor
102537974|NCT02806869|Sensory System Agents|sensory system agents|mesh-ancestor
102537975|NCT02806869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102537976|NCT02806869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537977|NCT02806869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102537978|NCT02806869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102537979|NCT02806869|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102537980|NCT02806869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102537981|NCT02806869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537982|NCT03910101|Botulinum Toxins|botulinum toxins|mesh-list
102537983|NCT03910101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102537984|NCT03910101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102537985|NCT03910101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102537986|NCT03910101|Cholinergic Agents|cholinergic agents|mesh-ancestor
102537987|NCT03910101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102537988|NCT03910101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537989|NCT02813265|Loteprednol Etabonate|loteprednol etabonate|mesh-list
102537990|NCT02813265|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102537991|NCT05564858|Antibodies|antibodies|mesh-list
102537992|NCT05564858|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102537993|NCT05564858|Immunoconjugates|immunoconjugates|mesh-list
102537994|NCT05564858|Immunologic Factors|immunologic factors|mesh-ancestor
102537995|NCT05564858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102537996|NCT02814279|Dipyrone|dipyrone|mesh-list
102537997|NCT02814279|Chlorhexidine|chlorhexidine|mesh-list
102537998|NCT02814279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102537999|NCT02814279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102538000|NCT02814279|Disinfectants|disinfectants|mesh-ancestor
102538001|NCT02814279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102538002|NCT02814279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102538003|NCT02814279|Analgesics|analgesics|mesh-ancestor
102538004|NCT02814279|Sensory System Agents|sensory system agents|mesh-ancestor
102538005|NCT02814279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102538006|NCT02814279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538007|NCT02814279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102538008|NCT02814279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102538009|NCT02814279|Antipyretics|antipyretics|mesh-ancestor
102538010|NCT00373659|Ranibizumab|ranibizumab|mesh-list
102538011|NCT00373659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102538012|NCT00373659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102538013|NCT00373659|Growth Substances|growth substances|mesh-ancestor
102538014|NCT00373659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538015|NCT00373659|Growth Inhibitors|growth inhibitors|mesh-ancestor
102538016|NCT00373659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102538017|NCT02885025|Fluticasone|fluticasone|mesh-list
102538018|NCT02885025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102538019|NCT02885025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102538020|NCT02885025|Autonomic Agents|autonomic agents|mesh-ancestor
102538021|NCT02885025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102538022|NCT02885025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538023|NCT02885025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102538024|NCT02885025|Respiratory System Agents|respiratory system agents|mesh-ancestor
102538025|NCT02885025|Dermatologic Agents|dermatologic agents|mesh-ancestor
102538026|NCT02885025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102538027|NCT01580618|Tenecteplase|tenecteplase|mesh-list
102538028|NCT01580618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101569241|NCT02845999|Cetuximab|cetuximab|mesh-list
102538029|NCT01580618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102538030|NCT01580618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538031|NCT01581710|Montelukast|montelukast|mesh-list
102538032|NCT01581710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102538033|NCT01581710|Respiratory System Agents|respiratory system agents|mesh-ancestor
102538034|NCT01581710|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102538035|NCT01581710|Hormone Antagonists|hormone antagonists|mesh-ancestor
102538036|NCT01581710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102538037|NCT01581710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538038|NCT01581710|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102538039|NCT01581710|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102538040|NCT01581710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538041|NCT01582490|Bupivacaine|bupivacaine|mesh-list
102538042|NCT01582490|Anesthetics, Local|anesthetics, local|mesh-ancestor
102538043|NCT01582490|Anesthetics|anesthetics|mesh-ancestor
102538044|NCT01582490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102538045|NCT01582490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538046|NCT01582490|Sensory System Agents|sensory system agents|mesh-ancestor
102538047|NCT01582490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102538048|NCT01582880|Riboflavin|riboflavin|mesh-list
102538049|NCT01582880|Vitamins|vitamins|mesh-ancestor
102538050|NCT01582880|Micronutrients|micronutrients|mesh-ancestor
102538051|NCT01582880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538052|NCT01582880|Vitamin B Complex|vitamin b complex|mesh-ancestor
102538053|NCT01582880|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102538054|NCT01582880|Dermatologic Agents|dermatologic agents|mesh-ancestor
102538055|NCT02889393|Teduglutide|teduglutide|mesh-list
102538056|NCT02889393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102538057|NCT02889393|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102538058|NCT02889393|Protective Agents|protective agents|mesh-ancestor
102538059|NCT02889393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538060|NCT02818569|Dexmedetomidine|dexmedetomidine|mesh-list
102538061|NCT02818569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102538062|NCT02818569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102538063|NCT02818569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538064|NCT02818569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102538065|NCT02818569|Analgesics|analgesics|mesh-ancestor
102538066|NCT02818569|Sensory System Agents|sensory system agents|mesh-ancestor
102538067|NCT02818569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102538068|NCT02818569|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102538069|NCT02818569|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102538070|NCT02818569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102538071|NCT02818569|Adrenergic Agents|adrenergic agents|mesh-ancestor
102538072|NCT02818569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102538073|NCT02818569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538074|NCT03581409|Aspirin|aspirin|mesh-list
102538075|NCT03581409|Cilostazol|cilostazol|mesh-list
102538076|NCT03581409|Clopidogrel|clopidogrel|mesh-list
102538077|NCT03581409|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102538078|NCT03581409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102538079|NCT03581409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102538080|NCT03581409|Analgesics|analgesics|mesh-ancestor
102538081|NCT03581409|Sensory System Agents|sensory system agents|mesh-ancestor
102538082|NCT03581409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102538083|NCT03581409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538084|NCT03581409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102538085|NCT03581409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102538086|NCT03581409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102538087|NCT03581409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102538088|NCT03581409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538089|NCT03581409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102538090|NCT03581409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102538091|NCT03581409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102538092|NCT03581409|Antipyretics|antipyretics|mesh-ancestor
102538093|NCT03581409|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102538094|NCT03581409|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102538095|NCT03581409|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102538096|NCT03581409|Purinergic Agents|purinergic agents|mesh-ancestor
102538097|NCT03581409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102538098|NCT03581409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102538099|NCT03581409|Autonomic Agents|autonomic agents|mesh-ancestor
102538100|NCT03581409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102538101|NCT03581409|Respiratory System Agents|respiratory system agents|mesh-ancestor
101569328|NCT00968968|Trastuzumab|trastuzumab|mesh-list
102538102|NCT03581409|Vasodilator Agents|vasodilator agents|mesh-ancestor
102538103|NCT03581409|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102538104|NCT03581409|Protective Agents|protective agents|mesh-ancestor
102538105|NCT03581409|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102538106|NCT03581409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102538107|NCT03566667|Metoprolol|metoprolol|mesh-list
102538108|NCT03566667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102538109|NCT03566667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102538110|NCT03566667|Sympatholytics|sympatholytics|mesh-ancestor
102538111|NCT03566667|Autonomic Agents|autonomic agents|mesh-ancestor
101758105|NCT00892918|Moxifloxacin|moxifloxacin|mesh-list
102538112|NCT03566667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102538113|NCT03566667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538114|NCT03566667|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102538115|NCT03566667|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102538116|NCT03566667|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102538117|NCT03566667|Adrenergic Agents|adrenergic agents|mesh-ancestor
102538118|NCT03566667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102538119|NCT03566667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538120|NCT01533116|Levodopa|levodopa|mesh-list
102538121|NCT01533116|Carbidopa|carbidopa|mesh-list
102538122|NCT01533116|Opicapone|opicapone|mesh-list
102538123|NCT01533116|Benserazide|benserazide|mesh-list
102538124|NCT01533116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102538125|NCT01533116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102538126|NCT01533116|Dopamine Agents|dopamine agents|mesh-ancestor
102538127|NCT01533116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102538128|NCT01533116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538129|NCT01533116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538130|NCT01533116|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102538131|NCT01533116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102538132|NCT01533116|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102538133|NCT03510741|Acetylcysteine|acetylcysteine|mesh-list
102538134|NCT03510741|Sodium Benzoate|sodium benzoate|mesh-list
102538135|NCT03510741|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102538136|NCT03510741|Antiviral Agents|antiviral agents|mesh-ancestor
102538137|NCT03510741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102538138|NCT03510741|Expectorants|expectorants|mesh-ancestor
102538139|NCT03510741|Respiratory System Agents|respiratory system agents|mesh-ancestor
102538140|NCT03510741|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102538141|NCT03510741|Antioxidants|antioxidants|mesh-ancestor
102538142|NCT03510741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538143|NCT03510741|Protective Agents|protective agents|mesh-ancestor
102538144|NCT03510741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538145|NCT03510741|Antidotes|antidotes|mesh-ancestor
102538146|NCT03510741|Antifungal Agents|antifungal agents|mesh-ancestor
102538147|NCT05556044|Empagliflozin|empagliflozin|mesh-list
102538148|NCT05556044|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102538149|NCT05556044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538150|NCT05556044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102538151|NCT05556044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538152|NCT01584518|Furosemide|furosemide|mesh-list
102538153|NCT01584518|Diuretics|diuretics|mesh-ancestor
102538154|NCT01584518|Natriuretic Agents|natriuretic agents|mesh-ancestor
102538155|NCT01584518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538156|NCT01584518|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102538157|NCT01584518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102538158|NCT01584518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538159|NCT02901249|Lithium Carbonate|lithium carbonate|mesh-list
102538160|NCT02901249|Sertraline|sertraline|mesh-list
102538161|NCT02901249|Nortriptyline|nortriptyline|mesh-list
102538162|NCT02901249|Antidepressive Agents|antidepressive agents|mesh-ancestor
102538163|NCT02901249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102538164|NCT02901249|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102538165|NCT02901249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102538166|NCT02901249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102538167|NCT02901249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538168|NCT02901249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102538169|NCT02901249|Serotonin Agents|serotonin agents|mesh-ancestor
102538170|NCT02901249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538171|NCT02901249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102538172|NCT02901249|Antimanic Agents|antimanic agents|mesh-ancestor
102538173|NCT02901249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102538174|NCT02901249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102154138|NCT00504582|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102538175|NCT02901249|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102538176|NCT02901249|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102538177|NCT02901249|Adrenergic Agents|adrenergic agents|mesh-ancestor
102538178|NCT02212028|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102538179|NCT02212028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102538180|NCT00373815|Everolimus|everolimus|mesh-list
102538181|NCT00373815|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102538182|NCT00373815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102538183|NCT00373815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102538184|NCT00373815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538185|NCT00373815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102538186|NCT00373815|Immunologic Factors|immunologic factors|mesh-ancestor
102538187|NCT00373815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538188|NCT00373815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102538189|NCT01586312|Hyaluronic Acid|hyaluronic acid|mesh-list
102538190|NCT01586312|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102538191|NCT01586312|Immunologic Factors|immunologic factors|mesh-ancestor
102538192|NCT01586312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538193|NCT01586312|Viscosupplements|viscosupplements|mesh-ancestor
102538194|NCT01586312|Protective Agents|protective agents|mesh-ancestor
102538195|NCT00373893|Lidocaine|lidocaine|mesh-list
102538196|NCT00373893|Anesthetics, Local|anesthetics, local|mesh-ancestor
102538197|NCT00373893|Anesthetics|anesthetics|mesh-ancestor
102538198|NCT00373893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102538199|NCT00373893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538200|NCT00373893|Sensory System Agents|sensory system agents|mesh-ancestor
102538201|NCT00373893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102538202|NCT00373893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102538203|NCT00373893|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102538204|NCT00373893|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102538205|NCT00373893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102538206|NCT00373893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538207|NCT02977299|Aripiprazole|aripiprazole|mesh-list
102538208|NCT02977299|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102538209|NCT02977299|Antidepressive Agents|antidepressive agents|mesh-ancestor
102538210|NCT02977299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102538211|NCT02977299|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102538212|NCT02977299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102538213|NCT02977299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102538214|NCT02977299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538215|NCT02977299|Dopamine Agonists|dopamine agonists|mesh-ancestor
102538216|NCT02977299|Dopamine Agents|dopamine agents|mesh-ancestor
102538217|NCT02977299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102538218|NCT02977299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538219|NCT02977299|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102538220|NCT02977299|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102538221|NCT02977299|Serotonin Agents|serotonin agents|mesh-ancestor
102538222|NCT02977299|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102538223|NCT02977299|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102538224|NCT02977299|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102538225|NCT02977299|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102538226|NCT02977299|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102538227|NCT02977299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102538228|NCT02977299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102538229|NCT02977299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102538230|NCT02212106|Vaccines|vaccines|mesh-list
102538231|NCT02212106|Immunologic Factors|immunologic factors|mesh-ancestor
102538232|NCT02212106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538233|NCT02903121|Tamoxifen|tamoxifen|mesh-list
102538234|NCT02903121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102538235|NCT02903121|Hormone Antagonists|hormone antagonists|mesh-ancestor
102538236|NCT02903121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102538237|NCT02903121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538238|NCT02903121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102538239|NCT02903121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102538240|NCT02903121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102538241|NCT02903121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102538242|NCT02903121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102538243|NCT02904915|Lidocaine|lidocaine|mesh-list
102538244|NCT02904915|Anesthetics, Local|anesthetics, local|mesh-ancestor
102538245|NCT02904915|Anesthetics|anesthetics|mesh-ancestor
102538246|NCT02904915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102538247|NCT02904915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538248|NCT02904915|Sensory System Agents|sensory system agents|mesh-ancestor
102538249|NCT02904915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102538250|NCT02904915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102538251|NCT02904915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102538252|NCT02904915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102538253|NCT02904915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102538254|NCT02904915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538255|NCT02907489|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102538256|NCT02907489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102538257|NCT02907489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102538258|NCT01535924|Gemcitabine|gemcitabine|mesh-list
102538259|NCT01535924|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102538260|NCT01535924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102538261|NCT01535924|Antimetabolites|antimetabolites|mesh-ancestor
102538262|NCT01535924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538263|NCT01535924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102538264|NCT01535924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102538265|NCT01535924|Alkylating Agents|alkylating agents|mesh-ancestor
102538266|NCT02909439|Neostigmine|neostigmine|mesh-list
102538267|NCT02909439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102538268|NCT02909439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102538269|NCT02909439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538270|NCT02909439|Cholinergic Agents|cholinergic agents|mesh-ancestor
102538271|NCT02909439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102538272|NCT02909439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538273|NCT02909439|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102538274|NCT02909439|Autonomic Agents|autonomic agents|mesh-ancestor
102538275|NCT02909439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102538276|NCT01536938|Calcitriol|calcitriol|mesh-list
102538277|NCT01536938|Betamethasone|betamethasone|mesh-list
102538278|NCT01536938|Betamethasone Valerate|betamethasone valerate|mesh-list
102538279|NCT01536938|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102538280|NCT01536938|Betamethasone benzoate|betamethasone benzoate|mesh-list
102538281|NCT01536938|Calcipotriene|calcipotriene|mesh-list
102538282|NCT01536938|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102538283|NCT01536938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102538284|NCT01536938|Glucocorticoids|glucocorticoids|mesh-ancestor
102538285|NCT01536938|Hormones|hormones|mesh-ancestor
102538286|NCT01536938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102538287|NCT01536938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538288|NCT01536938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102538289|NCT01536938|Respiratory System Agents|respiratory system agents|mesh-ancestor
102538290|NCT01536938|Dermatologic Agents|dermatologic agents|mesh-ancestor
102538291|NCT01536938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101758293|NCT01039363|Immunotoxins|immunotoxins|mesh-ancestor
102538292|NCT01536938|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102538293|NCT01536938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102538294|NCT01536938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538295|NCT01536938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102538296|NCT01536938|Vitamins|vitamins|mesh-ancestor
102538297|NCT01536938|Micronutrients|micronutrients|mesh-ancestor
102538298|NCT01536938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102538299|NCT01588418|Exenatide|exenatide|mesh-list
102538300|NCT01588418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102538301|NCT01588418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538302|NCT01588418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102538303|NCT01588418|Incretins|incretins|mesh-ancestor
102538304|NCT01588418|Hormones|hormones|mesh-ancestor
102538305|NCT01588418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102538306|NCT03007160|Potassium Citrate|potassium citrate|mesh-list
102538307|NCT03007160|Diuretics|diuretics|mesh-ancestor
102538308|NCT03007160|Natriuretic Agents|natriuretic agents|mesh-ancestor
102538309|NCT03007160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538310|NCT03007160|Expectorants|expectorants|mesh-ancestor
102538311|NCT03007160|Respiratory System Agents|respiratory system agents|mesh-ancestor
102538312|NCT03007004|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
102538313|NCT03007004|Botulinum Toxins|botulinum toxins|mesh-list
102538314|NCT03007004|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102538315|NCT03007004|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102538316|NCT03007004|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102538317|NCT03007004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102538318|NCT03007004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538319|NCT03007004|Cholinergic Agents|cholinergic agents|mesh-ancestor
101569532|NCT00897715|Rilonacept|rilonacept|mesh-list
102538320|NCT03007004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102538321|NCT03007004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538322|NCT03007004|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102538323|NCT03007004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102538324|NCT03007004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102538325|NCT02914119|Rocuronium|rocuronium|mesh-list
102538326|NCT02914119|Mivacurium|mivacurium|mesh-list
102538327|NCT02914119|Cisatracurium|cisatracurium|mesh-list
102538328|NCT02914119|Succinylcholine|succinylcholine|mesh-list
102538329|NCT02914119|Neostigmine|neostigmine|mesh-list
102538330|NCT02914119|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102538331|NCT02914119|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102538332|NCT02914119|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102538333|NCT02914119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102538334|NCT02914119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538335|NCT02914119|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102538336|NCT02914119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102538337|NCT02914119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538338|NCT02914119|Cholinergic Agents|cholinergic agents|mesh-ancestor
102538339|NCT02914119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102538340|NCT02914119|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102538341|NCT02914119|Autonomic Agents|autonomic agents|mesh-ancestor
102538342|NCT02914119|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
102538343|NCT01589510|Bimatoprost|bimatoprost|mesh-list
102538344|NCT01589510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102538345|NCT01589510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102538346|NCT01589510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102538347|NCT02914509|Travoprost|travoprost|mesh-list
102538348|NCT02914509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102538349|NCT02840097|Tranexamic Acid|tranexamic acid|mesh-list
102538350|NCT02840097|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102538351|NCT02840097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102538352|NCT02840097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538353|NCT02840097|Hemostatics|hemostatics|mesh-ancestor
102538354|NCT02840097|Coagulants|coagulants|mesh-ancestor
102538355|NCT02841033|Daratumumab|daratumumab|mesh-list
102538356|NCT02841033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102538357|NCT02988089|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102538358|NCT02988089|Amoxicillin|amoxicillin|mesh-list
102538359|NCT02988089|Metronidazole|metronidazole|mesh-list
102538360|NCT02988089|Clarithromycin|clarithromycin|mesh-list
102538361|NCT02988089|Levofloxacin|levofloxacin|mesh-list
102538362|NCT02988089|Ofloxacin|ofloxacin|mesh-list
102538363|NCT02988089|Tetracycline|tetracycline|mesh-list
102538364|NCT02988089|Tinidazole|tinidazole|mesh-list
102538365|NCT02988089|Furazolidone|furazolidone|mesh-list
102538366|NCT02988089|Bismuth|bismuth|mesh-list
102538367|NCT02988089|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
102538368|NCT02988089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102538369|NCT02988089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102538370|NCT02988089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102538371|NCT02988089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102538372|NCT02988089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102538373|NCT02988089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538374|NCT02988089|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102538375|NCT02988089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102538376|NCT02988089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102538377|NCT02988089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102538378|NCT02988089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102538379|NCT02988089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102538380|NCT02988089|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102538381|NCT02988089|Antacids|antacids|mesh-ancestor
102538382|NCT02988089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102538383|NCT02988089|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102538384|NCT02988089|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
102538385|NCT02988089|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102538386|NCT02988089|Alkylating Agents|alkylating agents|mesh-ancestor
102538387|NCT02430233|Progesterone|progesterone|mesh-list
102538388|NCT02430233|Progestins|progestins|mesh-ancestor
102538389|NCT02430233|Hormones|hormones|mesh-ancestor
102538390|NCT02430233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102538391|NCT02430233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538392|NCT01589978|Aspirin|aspirin|mesh-list
102538393|NCT01589978|Salicylic Acid|salicylic acid|mesh-list
102538394|NCT01589978|Salicylates|salicylates|mesh-list
102538395|NCT01589978|Ticlopidine|ticlopidine|mesh-list
102538396|NCT01589978|Clopidogrel|clopidogrel|mesh-list
102538397|NCT01589978|Ticagrelor|ticagrelor|mesh-list
102538398|NCT01589978|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102538399|NCT01589978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102538400|NCT01589978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102538401|NCT01589978|Analgesics|analgesics|mesh-ancestor
102538402|NCT01589978|Sensory System Agents|sensory system agents|mesh-ancestor
102538403|NCT01589978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102538404|NCT01589978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538405|NCT01589978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102538406|NCT01589978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102538407|NCT01589978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102538408|NCT01589978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102538409|NCT01589978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538410|NCT01589978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102538411|NCT01589978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102538412|NCT01589978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102538413|NCT01589978|Antipyretics|antipyretics|mesh-ancestor
102538414|NCT01589978|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102538415|NCT01589978|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102538416|NCT01589978|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102538417|NCT01589978|Purinergic Agents|purinergic agents|mesh-ancestor
102538418|NCT01589978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102538419|NCT01589978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102538420|NCT01589978|Antifungal Agents|antifungal agents|mesh-ancestor
102538421|NCT01589978|Keratolytic Agents|keratolytic agents|mesh-ancestor
102538422|NCT01589978|Dermatologic Agents|dermatologic agents|mesh-ancestor
102538423|NCT01589978|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102538424|NCT01589978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102538425|NCT01592006|Ribavirin|ribavirin|mesh-list
102538426|NCT01592006|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102538427|NCT01592006|Antimetabolites|antimetabolites|mesh-ancestor
102538428|NCT01592006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538429|NCT01592006|Antiviral Agents|antiviral agents|mesh-ancestor
102538430|NCT01592006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102538431|NCT00551291|Mycophenolic Acid|mycophenolic acid|mesh-list
102538432|NCT00551291|Prednisone|prednisone|mesh-list
102538433|NCT00551291|Epoetin Alfa|epoetin alfa|mesh-list
102538434|NCT00551291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102538435|NCT00551291|Glucocorticoids|glucocorticoids|mesh-ancestor
102538436|NCT00551291|Hormones|hormones|mesh-ancestor
102538437|NCT00551291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102538438|NCT00551291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538439|NCT00551291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102538440|NCT00551291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102538441|NCT00551291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102538442|NCT00551291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102538443|NCT00551291|Antitubercular Agents|antitubercular agents|mesh-ancestor
102538444|NCT00551291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102538445|NCT00551291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102538446|NCT00551291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102538447|NCT00551291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538448|NCT00551291|Hematinics|hematinics|mesh-ancestor
102538449|NCT02981264|Lidocaine|lidocaine|mesh-list
102538450|NCT02981264|Anesthetics, Local|anesthetics, local|mesh-ancestor
102538451|NCT02981264|Anesthetics|anesthetics|mesh-ancestor
102538452|NCT02981264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102538453|NCT02981264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538454|NCT02981264|Sensory System Agents|sensory system agents|mesh-ancestor
102538455|NCT02981264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102538456|NCT02981264|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102538457|NCT02981264|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102538458|NCT02981264|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102538459|NCT02981264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102538460|NCT02981264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538461|NCT05470985|Ozanimod|ozanimod|mesh-list
102538462|NCT05470985|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102538463|NCT05470985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538464|NCT05470985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102538465|NCT05470985|Immunologic Factors|immunologic factors|mesh-ancestor
102538466|NCT05470985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538467|NCT01593722|Ivermectin|ivermectin|mesh-list
102538468|NCT01593722|Diethylcarbamazine|diethylcarbamazine|mesh-list
102538469|NCT01593722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102538470|NCT01593722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102538471|NCT01593722|Filaricides|filaricides|mesh-ancestor
101569690|NCT00895453|Iron|iron|mesh-list
102538472|NCT01593722|Antinematodal Agents|antinematodal agents|mesh-ancestor
102538473|NCT01593722|Anthelmintics|anthelmintics|mesh-ancestor
102538474|NCT01593722|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
102538475|NCT01593722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102538476|NCT01593722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538477|NCT01594424|Immunoglobulins|immunoglobulins|mesh-list
102538478|NCT01594424|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102538479|NCT01594424|Antibodies|antibodies|mesh-list
102538480|NCT01594424|gamma-Globulins|gamma-globulins|mesh-list
102538481|NCT01594424|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102538482|NCT01594424|Immunologic Factors|immunologic factors|mesh-ancestor
102538483|NCT01594424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538484|NCT01595282|Ibuprofen|ibuprofen|mesh-list
102538485|NCT01595282|Ketorolac|ketorolac|mesh-list
102538486|NCT01595282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102538487|NCT01595282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102538488|NCT01595282|Analgesics|analgesics|mesh-ancestor
102538489|NCT01595282|Sensory System Agents|sensory system agents|mesh-ancestor
102538490|NCT01595282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102538491|NCT01595282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538492|NCT01595282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102538493|NCT01595282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102538494|NCT01595282|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102538495|NCT01595282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102538496|NCT01595282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538497|NCT01595516|Metoprolol|metoprolol|mesh-list
102538498|NCT01595516|Nebivolol|nebivolol|mesh-list
102538499|NCT01595516|Bradykinin|bradykinin|mesh-list
102538500|NCT01595516|Kininogens|kininogens|mesh-list
102538501|NCT01595516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538502|NCT01595516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538503|NCT01595516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102538504|NCT01595516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102538505|NCT01595516|Sympatholytics|sympatholytics|mesh-ancestor
102538506|NCT01595516|Autonomic Agents|autonomic agents|mesh-ancestor
102538507|NCT01595516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102538508|NCT01595516|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102538509|NCT01595516|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102538510|NCT01595516|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102538511|NCT01595516|Adrenergic Agents|adrenergic agents|mesh-ancestor
102538512|NCT01595516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102538513|NCT01595516|Vasodilator Agents|vasodilator agents|mesh-ancestor
102538514|NCT01595516|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102538515|NCT01595516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102538516|NCT01595516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102538517|NCT01595516|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
102538518|NCT01595516|Protease Inhibitors|protease inhibitors|mesh-ancestor
102538519|NCT01595516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102538520|NCT01596842|Cholecalciferol|cholecalciferol|mesh-list
102538521|NCT01596842|Vitamin D|vitamin d|mesh-list
102538522|NCT01596842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102538523|NCT01596842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538524|NCT01596842|Vitamins|vitamins|mesh-ancestor
102538525|NCT01596842|Micronutrients|micronutrients|mesh-ancestor
102538526|NCT01596842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102538527|NCT02217800|Octreotide|octreotide|mesh-list
102538528|NCT02217800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102538529|NCT02217800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102538530|NCT02217800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102538531|NCT02218190|Alvimopan|alvimopan|mesh-list
102538532|NCT02218190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102538533|NCT03006614|Cisplatin|cisplatin|mesh-list
102538534|NCT03006614|Gemcitabine|gemcitabine|mesh-list
102538535|NCT03006614|Docetaxel|docetaxel|mesh-list
102538536|NCT03006614|Capecitabine|capecitabine|mesh-list
102538537|NCT03006614|Trastuzumab|trastuzumab|mesh-list
102538538|NCT03006614|Vinorelbine|vinorelbine|mesh-list
102538539|NCT03006614|Epirubicin|epirubicin|mesh-list
102538540|NCT03006614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102538541|NCT03006614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102538542|NCT03006614|Antimetabolites|antimetabolites|mesh-ancestor
102538543|NCT03006614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538544|NCT03006614|Tubulin Modulators|tubulin modulators|mesh-ancestor
102538545|NCT03006614|Antimitotic Agents|antimitotic agents|mesh-ancestor
102538546|NCT03006614|Mitosis Modulators|mitosis modulators|mesh-ancestor
102538547|NCT03006614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102538548|NCT03006614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102538549|NCT03006614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102538550|NCT03006614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102538551|NCT03006614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102538552|NCT03006614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102538553|NCT03001466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102538554|NCT03001466|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102538555|NCT03006380|Oxytocin|oxytocin|mesh-list
102538556|NCT03006380|Oxytocics|oxytocics|mesh-ancestor
102538557|NCT03006380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102538558|NCT03006380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538559|NCT02981030|Misoprostol|misoprostol|mesh-list
102538560|NCT02981030|Mifepristone|mifepristone|mesh-list
102538561|NCT02981030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102538562|NCT02981030|Abortifacient Agents|abortifacient agents|mesh-ancestor
102538563|NCT02981030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102538564|NCT02981030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538565|NCT02981030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102538566|NCT02981030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102538567|NCT02981030|Oxytocics|oxytocics|mesh-ancestor
102538568|NCT02981030|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102538569|NCT02981030|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102538570|NCT02981030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102538571|NCT02981030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102538572|NCT02981030|Contraceptive Agents|contraceptive agents|mesh-ancestor
102538573|NCT02981030|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102538574|NCT02981030|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102538575|NCT02981030|Hormone Antagonists|hormone antagonists|mesh-ancestor
102538576|NCT02981030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102538577|NCT02981030|Luteolytic Agents|luteolytic agents|mesh-ancestor
102538578|NCT02981030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102538579|NCT02981030|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102538580|NCT03006146|Molgramostim|molgramostim|mesh-list
102538581|NCT03006146|Sargramostim|sargramostim|mesh-list
102538582|NCT03006146|Immunologic Factors|immunologic factors|mesh-ancestor
102538583|NCT03006146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538584|NCT03006146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102538585|NCT00551213|Capecitabine|capecitabine|mesh-list
102538586|NCT00551213|Irinotecan|irinotecan|mesh-list
102538587|NCT00551213|Cetuximab|cetuximab|mesh-list
102538588|NCT00551213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102538589|NCT00551213|Antimetabolites|antimetabolites|mesh-ancestor
102538590|NCT00551213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538591|NCT00551213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102538592|NCT00551213|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102538593|NCT00551213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102538594|NCT00551213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102538595|NCT00551213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102538596|NCT01999361|Mycophenolic Acid|mycophenolic acid|mesh-list
102538597|NCT01999361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102538598|NCT01999361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102538599|NCT01999361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102538600|NCT01999361|Antitubercular Agents|antitubercular agents|mesh-ancestor
102538601|NCT01999361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102538602|NCT01999361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102538603|NCT01999361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102538604|NCT01999361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538605|NCT03006471|Dapagliflozin|dapagliflozin|mesh-list
102538606|NCT03006471|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102538607|NCT03006471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538608|NCT03006471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102538609|NCT03006471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538610|NCT01684397|Bevacizumab|bevacizumab|mesh-list
102538611|NCT01684397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102538612|NCT01684397|Endothelial Growth Factors|endothelial growth factors|mesh-list
102538613|NCT01684397|Antibodies|antibodies|mesh-list
102538614|NCT01684397|Immunoglobulins|immunoglobulins|mesh-list
102538615|NCT01684397|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102538616|NCT01684397|Immunoglobulin G|immunoglobulin g|mesh-list
102538617|NCT01684397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102538618|NCT01684397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102538619|NCT01684397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102538620|NCT01684397|Growth Substances|growth substances|mesh-ancestor
102538621|NCT01684397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538622|NCT01684397|Growth Inhibitors|growth inhibitors|mesh-ancestor
102154139|NCT00504582|Hemostatics|hemostatics|mesh-ancestor
102538623|NCT01684397|Immunologic Factors|immunologic factors|mesh-ancestor
102538624|NCT03005678|Denosumab|denosumab|mesh-list
102538625|NCT03005678|Alendronate|alendronate|mesh-list
102538626|NCT03005678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102538627|NCT03005678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538628|NCT03008889|Acetylcysteine|acetylcysteine|mesh-list
102538629|NCT03008889|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102538630|NCT03008889|Antiviral Agents|antiviral agents|mesh-ancestor
102538631|NCT03008889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102538632|NCT03008889|Expectorants|expectorants|mesh-ancestor
102538633|NCT03008889|Respiratory System Agents|respiratory system agents|mesh-ancestor
102538634|NCT03008889|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102538635|NCT03008889|Antioxidants|antioxidants|mesh-ancestor
102241637|NCT04891809|Lenalidomide|lenalidomide|mesh-list
102538636|NCT03008889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538637|NCT03008889|Protective Agents|protective agents|mesh-ancestor
102538638|NCT03008889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538639|NCT03008889|Antidotes|antidotes|mesh-ancestor
102538640|NCT04980482|Interferons|interferons|mesh-list
102538641|NCT04980482|Interferon-alpha|interferon-alpha|mesh-list
102538642|NCT04980482|Interferon alpha-2|interferon alpha-2|mesh-list
102538643|NCT04980482|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102538644|NCT04980482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102538645|NCT04980482|Antiviral Agents|antiviral agents|mesh-ancestor
102538646|NCT04980482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102538647|NCT04980482|Immunologic Factors|immunologic factors|mesh-ancestor
102538648|NCT04980482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538649|NCT03005210|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102538650|NCT03005210|Antiviral Agents|antiviral agents|mesh-ancestor
102538651|NCT03005210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102538652|NCT03000218|Metformin|metformin|mesh-list
102538653|NCT03000218|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102538654|NCT03000218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102538655|NCT03000218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538656|NCT03000218|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102538657|NCT03000218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102538658|NCT03010683|Metformin|metformin|mesh-list
102538659|NCT03010683|Liraglutide|liraglutide|mesh-list
102538660|NCT03010683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102538661|NCT03010683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538662|NCT03010683|Incretins|incretins|mesh-ancestor
102538663|NCT03010683|Hormones|hormones|mesh-ancestor
102538664|NCT03010683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102538665|NCT04877678|Bepotastine besilate|bepotastine besilate|mesh-list
102538666|NCT04877678|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102538667|NCT02918097|Risperidone|risperidone|mesh-list
102538668|NCT02918097|Lithium Carbonate|lithium carbonate|mesh-list
102538669|NCT02918097|Sertraline|sertraline|mesh-list
102538670|NCT02918097|Nortriptyline|nortriptyline|mesh-list
102538671|NCT02918097|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102538672|NCT02918097|Serotonin Agents|serotonin agents|mesh-ancestor
102538673|NCT02918097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102538674|NCT02918097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538675|NCT02918097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538676|NCT02918097|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102538677|NCT02918097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102538678|NCT02918097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102538679|NCT02918097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102538680|NCT02918097|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102538681|NCT02918097|Dopamine Agents|dopamine agents|mesh-ancestor
102538682|NCT02918097|Antidepressive Agents|antidepressive agents|mesh-ancestor
102538683|NCT02918097|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102538684|NCT02918097|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102538685|NCT02918097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102538686|NCT02918097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102538687|NCT02918097|Antimanic Agents|antimanic agents|mesh-ancestor
102538688|NCT02918097|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102538689|NCT02918097|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102538690|NCT02918097|Adrenergic Agents|adrenergic agents|mesh-ancestor
102538691|NCT05408585|Anesthetics|anesthetics|mesh-list
102538692|NCT05408585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102538693|NCT05408585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538694|NCT02999204|Vitamin D|vitamin d|mesh-list
102538695|NCT02999204|Cholecalciferol|cholecalciferol|mesh-list
102538696|NCT02999204|Vitamins|vitamins|mesh-ancestor
102538697|NCT02999204|Micronutrients|micronutrients|mesh-ancestor
102538698|NCT02999204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569914|NCT02836795|Antibodies|antibodies|mesh-list
101758692|NCT00895804|Pindolol|pindolol|mesh-list
102538699|NCT02999204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102538700|NCT02999204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102538701|NCT03012477|Adavosertib|adavosertib|mesh-list
102538702|NCT03012477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102538703|NCT03012477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538704|NCT02919111|Edetic Acid|edetic acid|mesh-list
102538705|NCT02919111|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102538706|NCT02919111|Chelating Agents|chelating agents|mesh-ancestor
102538707|NCT02919111|Sequestering Agents|sequestering agents|mesh-ancestor
102538708|NCT02919111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538709|NCT02919111|Anticoagulants|anticoagulants|mesh-ancestor
102538710|NCT02919111|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102538711|NCT02919111|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102538712|NCT02999126|Remifentanil|remifentanil|mesh-list
102538713|NCT02999126|Propofol|propofol|mesh-list
102538714|NCT02999126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102538715|NCT02999126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102538716|NCT02999126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538717|NCT02999126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102538718|NCT02999126|Anesthetics, General|anesthetics, general|mesh-ancestor
102538719|NCT02999126|Anesthetics|anesthetics|mesh-ancestor
102538720|NCT02999126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102538721|NCT02999126|Narcotics|narcotics|mesh-ancestor
102538722|NCT02999126|Analgesics|analgesics|mesh-ancestor
102538723|NCT02999126|Sensory System Agents|sensory system agents|mesh-ancestor
102538724|NCT02999126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102538725|NCT03019887|Methotrimeprazine|methotrimeprazine|mesh-list
102538726|NCT03019887|Haloperidol|haloperidol|mesh-list
102538727|NCT03019887|Olanzapine|olanzapine|mesh-list
102538728|NCT03019887|Risperidone|risperidone|mesh-list
102538729|NCT03019887|Aripiprazole|aripiprazole|mesh-list
102538730|NCT03019887|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102538731|NCT03019887|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102538732|NCT03019887|Haloperidol decanoate|haloperidol decanoate|mesh-list
102538733|NCT03019887|Perphenazine|perphenazine|mesh-list
102538734|NCT03019887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102538735|NCT03019887|Serotonin Agents|serotonin agents|mesh-ancestor
102538736|NCT03019887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102538737|NCT03019887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538738|NCT03019887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538739|NCT03019887|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102538740|NCT03019887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102538741|NCT03019887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102538742|NCT03019887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102538743|NCT03019887|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102538744|NCT03019887|Dopamine Agents|dopamine agents|mesh-ancestor
102538745|NCT03019887|Antiemetics|antiemetics|mesh-ancestor
102538746|NCT03019887|Autonomic Agents|autonomic agents|mesh-ancestor
102538747|NCT03019887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102538748|NCT03019887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102538749|NCT03019887|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102538750|NCT03019887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102538751|NCT03019887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102538752|NCT03019887|Antidepressive Agents|antidepressive agents|mesh-ancestor
102538753|NCT03019887|Dopamine Agonists|dopamine agonists|mesh-ancestor
102538754|NCT03019887|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102538755|NCT03019887|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102538756|NCT03019887|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102538757|NCT03019887|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102538758|NCT03019887|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102538759|NCT03019887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102538760|NCT03019887|Analgesics|analgesics|mesh-ancestor
102538761|NCT03019887|Sensory System Agents|sensory system agents|mesh-ancestor
102538762|NCT02998970|Empagliflozin|empagliflozin|mesh-list
102538763|NCT02998970|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102538764|NCT02998970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538765|NCT02998970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102538766|NCT02998970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538767|NCT05406752|Acetaminophen|acetaminophen|mesh-list
102538768|NCT05406752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102538769|NCT05406752|Analgesics|analgesics|mesh-ancestor
102538770|NCT05406752|Sensory System Agents|sensory system agents|mesh-ancestor
102538771|NCT05406752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102538772|NCT05406752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538773|NCT05406752|Antipyretics|antipyretics|mesh-ancestor
102538774|NCT02247362|Hemagglutinins|hemagglutinins|mesh-list
102538775|NCT02247362|Vaccines|vaccines|mesh-list
102538776|NCT02247362|Immunologic Factors|immunologic factors|mesh-ancestor
102538777|NCT02247362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538779|NCT02247362|Coagulants|coagulants|mesh-ancestor
102538780|NCT02920749|Anesthetics|anesthetics|mesh-list
102538781|NCT02920749|Propofol|propofol|mesh-list
102538782|NCT02920749|Sevoflurane|sevoflurane|mesh-list
102538783|NCT02920749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102538784|NCT02920749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538785|NCT02920749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102538786|NCT02920749|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102538787|NCT02920749|Anesthetics, General|anesthetics, general|mesh-ancestor
102538788|NCT02920749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102538789|NCT02920749|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102538790|NCT02248142|Pramipexole|pramipexole|mesh-list
102538791|NCT02248142|Antioxidants|antioxidants|mesh-ancestor
102538792|NCT02248142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538793|NCT02248142|Protective Agents|protective agents|mesh-ancestor
102538794|NCT02248142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538795|NCT02248142|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102538796|NCT02248142|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102538797|NCT02248142|Dopamine Agonists|dopamine agonists|mesh-ancestor
102538798|NCT02248142|Dopamine Agents|dopamine agents|mesh-ancestor
102538799|NCT02248142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102538800|NCT04667780|Colchicine|colchicine|mesh-list
102538801|NCT04667780|Gout Suppressants|gout suppressants|mesh-ancestor
102538802|NCT04667780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102538803|NCT04667780|Tubulin Modulators|tubulin modulators|mesh-ancestor
102538804|NCT04667780|Antimitotic Agents|antimitotic agents|mesh-ancestor
102538805|NCT04667780|Mitosis Modulators|mitosis modulators|mesh-ancestor
102538806|NCT04667780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538807|NCT04667780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102538808|NCT02248220|Pramipexole|pramipexole|mesh-list
102538809|NCT02248220|Antioxidants|antioxidants|mesh-ancestor
102538810|NCT02248220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538811|NCT02248220|Protective Agents|protective agents|mesh-ancestor
102538812|NCT02248220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538813|NCT02248220|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102538814|NCT02248220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102538815|NCT02248220|Dopamine Agonists|dopamine agonists|mesh-ancestor
102538816|NCT02248220|Dopamine Agents|dopamine agents|mesh-ancestor
102538817|NCT02248220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102538818|NCT02921061|Cytarabine|cytarabine|mesh-list
102538819|NCT02921061|Decitabine|decitabine|mesh-list
102538820|NCT02921061|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
102538821|NCT02921061|Mitoxantrone|mitoxantrone|mesh-list
102538822|NCT02921061|Cladribine|cladribine|mesh-list
102538823|NCT02921061|Lenograstim|lenograstim|mesh-list
102538824|NCT02921061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102538825|NCT02921061|Antimetabolites|antimetabolites|mesh-ancestor
102538826|NCT02921061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538827|NCT02921061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102538828|NCT02921061|Antiviral Agents|antiviral agents|mesh-ancestor
102538829|NCT02921061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102538830|NCT02921061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102538831|NCT02921061|Immunologic Factors|immunologic factors|mesh-ancestor
102538832|NCT02921061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538833|NCT02921061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102538834|NCT02921061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102538835|NCT02921061|Analgesics|analgesics|mesh-ancestor
102538836|NCT02921061|Sensory System Agents|sensory system agents|mesh-ancestor
102538837|NCT02921061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102538838|NCT02921061|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102538839|NCT02921061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102538840|NCT05310422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102538841|NCT05310422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102538842|NCT03004118|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102538843|NCT03004118|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102538844|NCT03004118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102538845|NCT03004196|Chlorhexidine|chlorhexidine|mesh-list
102538846|NCT03004196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102538847|NCT03004196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102538848|NCT03004196|Disinfectants|disinfectants|mesh-ancestor
102538849|NCT02281409|Mogamulizumab|mogamulizumab|mesh-list
102538850|NCT02281409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102538851|NCT05200442|Cetuximab|cetuximab|mesh-list
102538852|NCT05200442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102538853|NCT05200442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102538854|NCT02859441|Ranibizumab|ranibizumab|mesh-list
102538855|NCT02859441|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102538856|NCT02859441|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102538857|NCT02859441|Growth Substances|growth substances|mesh-ancestor
102538858|NCT02859441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538859|NCT02859441|Growth Inhibitors|growth inhibitors|mesh-ancestor
102538860|NCT02859441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102538861|NCT01880099|Galantamine|galantamine|mesh-list
102538862|NCT01880099|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
102538863|NCT01880099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102538864|NCT01880099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538865|NCT01880099|Cholinergic Agents|cholinergic agents|mesh-ancestor
102538866|NCT01880099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102538867|NCT01880099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538868|NCT01880099|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102538869|NCT01880099|Autonomic Agents|autonomic agents|mesh-ancestor
102538870|NCT01880099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102538871|NCT01880099|Nootropic Agents|nootropic agents|mesh-ancestor
102538872|NCT05183204|Metformin|metformin|mesh-list
102538873|NCT05183204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102538874|NCT05183204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538875|NCT04287803|Methoxyflurane|methoxyflurane|mesh-list
102538876|NCT04287803|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102538877|NCT04287803|Anesthetics, General|anesthetics, general|mesh-ancestor
102538878|NCT04287803|Anesthetics|anesthetics|mesh-ancestor
102538879|NCT04287803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102538880|NCT04287803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538881|NCT02860845|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102538882|NCT02860845|Clindamycin|clindamycin|mesh-list
102538883|NCT02860845|Clindamycin palmitate|clindamycin palmitate|mesh-list
102538884|NCT02860845|Clindamycin phosphate|clindamycin phosphate|mesh-list
102538885|NCT02860845|Clotrimazole|clotrimazole|mesh-list
102538886|NCT02860845|Miconazole|miconazole|mesh-list
102538887|NCT02860845|Antifungal Agents|antifungal agents|mesh-list
102538888|NCT02860845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102538889|NCT02860845|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102538890|NCT02860845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102538891|NCT02860845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538892|NCT02860845|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102538893|NCT02860845|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102538894|NCT02860845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102538895|NCT02860845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102538896|NCT02860845|Hormone Antagonists|hormone antagonists|mesh-ancestor
102538897|NCT02860845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102538898|NCT02860845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538899|NCT02860845|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102538900|NCT02860845|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102538901|NCT03003884|Propofol|propofol|mesh-list
102538902|NCT03003884|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102538903|NCT03003884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102538904|NCT03003884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538905|NCT03003884|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102538906|NCT03003884|Anesthetics, General|anesthetics, general|mesh-ancestor
102538907|NCT03003884|Anesthetics|anesthetics|mesh-ancestor
102538908|NCT01880723|Albuterol|albuterol|mesh-list
102538909|NCT01880723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102538910|NCT01880723|Autonomic Agents|autonomic agents|mesh-ancestor
102538911|NCT01880723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102538912|NCT01880723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538913|NCT01880723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102538914|NCT01880723|Respiratory System Agents|respiratory system agents|mesh-ancestor
102538915|NCT01880723|Tocolytic Agents|tocolytic agents|mesh-ancestor
102538916|NCT01880723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102538917|NCT01880723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102538918|NCT01880723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102538919|NCT01880723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102538920|NCT01880723|Adrenergic Agents|adrenergic agents|mesh-ancestor
102538921|NCT01880723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102538922|NCT01880723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538923|NCT02248454|Insulin Lispro|insulin lispro|mesh-list
102538924|NCT02248454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102538925|NCT02248454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538926|NCT04466618|Heparin|heparin|mesh-list
102538927|NCT04466618|Calcium heparin|calcium heparin|mesh-list
102538928|NCT04466618|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102538929|NCT04466618|Anticoagulants|anticoagulants|mesh-ancestor
102154140|NCT00504582|Coagulants|coagulants|mesh-ancestor
102538930|NCT04466618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102538931|NCT04466618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102538932|NCT04466618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538933|NCT04466618|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102538934|NCT04466618|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102538935|NCT04466618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102538936|NCT01881113|Cetirizine|cetirizine|mesh-list
102538937|NCT01881113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102538938|NCT01881113|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102538939|NCT01881113|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102538940|NCT01881113|Histamine Antagonists|histamine antagonists|mesh-ancestor
102538941|NCT01881113|Histamine Agents|histamine agents|mesh-ancestor
102538942|NCT01881113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102538943|NCT01881113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538944|NCT01881113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538945|NCT05140694|Empagliflozin|empagliflozin|mesh-list
102538946|NCT05140694|Dulaglutide|dulaglutide|mesh-list
102538947|NCT05140694|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
102538948|NCT05140694|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102538949|NCT05140694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538950|NCT05140694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102538951|NCT05140694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538952|NCT05140694|Immunologic Factors|immunologic factors|mesh-ancestor
102538953|NCT02987699|Leucovorin|leucovorin|mesh-list
102538954|NCT02987699|Oxaliplatin|oxaliplatin|mesh-list
102538955|NCT02987699|Fluorouracil|fluorouracil|mesh-list
102538956|NCT02987699|Levoleucovorin|levoleucovorin|mesh-list
102538957|NCT02987699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102538958|NCT02987699|Antidotes|antidotes|mesh-ancestor
102538959|NCT02987699|Protective Agents|protective agents|mesh-ancestor
102538960|NCT02987699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538961|NCT02987699|Vitamin B Complex|vitamin b complex|mesh-ancestor
102538962|NCT02987699|Vitamins|vitamins|mesh-ancestor
102538963|NCT02987699|Micronutrients|micronutrients|mesh-ancestor
102538964|NCT02987699|Antimetabolites|antimetabolites|mesh-ancestor
102538965|NCT02987699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538966|NCT02987699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102538967|NCT02987699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102538968|NCT02987699|Immunologic Factors|immunologic factors|mesh-ancestor
102538969|NCT03003728|Melphalan|melphalan|mesh-list
102538970|NCT03003728|Elotuzumab|elotuzumab|mesh-list
102538971|NCT03003728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102538972|NCT03003728|Alkylating Agents|alkylating agents|mesh-ancestor
102538973|NCT03003728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538974|NCT03003728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102538975|NCT03003728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102538976|NCT03003728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102538977|NCT03003728|Immunologic Factors|immunologic factors|mesh-ancestor
102538978|NCT03003728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538979|NCT05672810|Fibrin fragment D|fibrin fragment d|mesh-list
102538980|NCT05672810|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102538981|NCT05672810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102538982|NCT05672810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538983|NCT05672810|Hemostatics|hemostatics|mesh-ancestor
102538984|NCT05672810|Coagulants|coagulants|mesh-ancestor
102538985|NCT00559247|Asunaprevir|asunaprevir|mesh-list
102538986|NCT00559247|Protease Inhibitors|protease inhibitors|mesh-ancestor
102538987|NCT00559247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102538988|NCT00559247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102538989|NCT03003416|Dexamethasone|dexamethasone|mesh-list
102538990|NCT03003416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102538991|NCT03003416|Antiemetics|antiemetics|mesh-ancestor
102538992|NCT03003416|Autonomic Agents|autonomic agents|mesh-ancestor
102538993|NCT03003416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102538994|NCT03003416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102538995|NCT03003416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102538996|NCT03003416|Glucocorticoids|glucocorticoids|mesh-ancestor
102538997|NCT03003416|Hormones|hormones|mesh-ancestor
102538998|NCT03003416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102538999|NCT03003416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102539000|NCT03003416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102539001|NCT02988869|Formoterol Fumarate|formoterol fumarate|mesh-list
102539002|NCT02988869|Tiotropium Bromide|tiotropium bromide|mesh-list
102539003|NCT02988869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102154141|NCT00436254|Molgramostim|molgramostim|mesh-list
101570228|NCT04283110|Midazolam|midazolam|mesh-list
102539004|NCT02988869|Autonomic Agents|autonomic agents|mesh-ancestor
102539005|NCT02988869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102539006|NCT02988869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539007|NCT02988869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102539008|NCT02988869|Respiratory System Agents|respiratory system agents|mesh-ancestor
102539009|NCT02988869|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102539010|NCT02988869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102539011|NCT02988869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102539012|NCT02988869|Adrenergic Agents|adrenergic agents|mesh-ancestor
102539013|NCT02988869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102539014|NCT02988869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539015|NCT02988869|Parasympatholytics|parasympatholytics|mesh-ancestor
102539016|NCT02988869|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102539017|NCT02988869|Cholinergic Agents|cholinergic agents|mesh-ancestor
102539018|NCT03028467|Folic Acid|folic acid|mesh-list
102539019|NCT03028467|Methotrexate|methotrexate|mesh-list
102539020|NCT03028467|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102539021|NCT03028467|Abortifacient Agents|abortifacient agents|mesh-ancestor
102539022|NCT03028467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102539023|NCT03028467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539024|NCT03028467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102539025|NCT03028467|Antimetabolites|antimetabolites|mesh-ancestor
102539026|NCT03028467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539027|NCT03028467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102539028|NCT03028467|Dermatologic Agents|dermatologic agents|mesh-ancestor
102539029|NCT03028467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102539030|NCT03028467|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102539031|NCT03028467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102539032|NCT03028467|Immunologic Factors|immunologic factors|mesh-ancestor
102539033|NCT03028467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102539034|NCT03028467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102539035|NCT03028467|Hematinics|hematinics|mesh-ancestor
102539036|NCT03028467|Vitamin B Complex|vitamin b complex|mesh-ancestor
102539037|NCT03028467|Vitamins|vitamins|mesh-ancestor
102539038|NCT03028467|Micronutrients|micronutrients|mesh-ancestor
102539039|NCT04327310|Meplazumab|meplazumab|mesh-list
102539040|NCT04327310|Antiviral Agents|antiviral agents|mesh-ancestor
102539041|NCT04327310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102539042|NCT02222870|Vaccines|vaccines|mesh-list
102539043|NCT02222870|Immunologic Factors|immunologic factors|mesh-ancestor
102539044|NCT02222870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539045|NCT02223260|Dabigatran|dabigatran|mesh-list
102539046|NCT02223260|Antithrombins|antithrombins|mesh-ancestor
102539047|NCT02223260|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102539048|NCT02223260|Protease Inhibitors|protease inhibitors|mesh-ancestor
102539049|NCT02223260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102539050|NCT02223260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539051|NCT02223260|Anticoagulants|anticoagulants|mesh-ancestor
102539052|NCT02863263|Povidone-Iodine|povidone-iodine|mesh-list
102539053|NCT02863263|Povidone|povidone|mesh-list
102539054|NCT02863263|Plasma Substitutes|plasma substitutes|mesh-ancestor
102539055|NCT02863263|Blood Substitutes|blood substitutes|mesh-ancestor
102539056|NCT02863263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102539057|NCT02863263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102539058|NCT02223338|Ciprofloxacin|ciprofloxacin|mesh-list
102539059|NCT02223338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102539060|NCT02223338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102539061|NCT02223338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102539062|NCT02223338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102539063|NCT02223338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102539064|NCT02223338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539065|NCT02223338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102539066|NCT02223338|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102539067|NCT02223338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102539068|NCT01887587|Dexamethasone|dexamethasone|mesh-list
102539069|NCT01887587|Doxorubicin|doxorubicin|mesh-list
102539070|NCT01887587|Vincristine|vincristine|mesh-list
102539071|NCT01887587|Ixazomib|ixazomib|mesh-list
102539072|NCT01887587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102539073|NCT01887587|Antiemetics|antiemetics|mesh-ancestor
102539074|NCT01887587|Autonomic Agents|autonomic agents|mesh-ancestor
102539075|NCT01887587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102539076|NCT01887587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539077|NCT01887587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102539078|NCT01887587|Glucocorticoids|glucocorticoids|mesh-ancestor
102539079|NCT01887587|Hormones|hormones|mesh-ancestor
102539080|NCT01887587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102539081|NCT01887587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102539082|NCT01887587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102539083|NCT01887587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102539084|NCT01887587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102539085|NCT01887587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102539086|NCT01887587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102539087|NCT01887587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539088|NCT01887587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102539089|NCT01887587|Tubulin Modulators|tubulin modulators|mesh-ancestor
102539090|NCT01887587|Antimitotic Agents|antimitotic agents|mesh-ancestor
102539091|NCT01887587|Mitosis Modulators|mitosis modulators|mesh-ancestor
102539092|NCT01887587|Protease Inhibitors|protease inhibitors|mesh-ancestor
102539093|NCT03029091|Losartan|losartan|mesh-list
102539094|NCT03029091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102539095|NCT03029091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102539096|NCT03029091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102539097|NCT03029091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102539098|NCT03029091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539099|NCT02997410|Salicylic Acid|salicylic acid|mesh-list
102539100|NCT02997410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102539101|NCT02997410|Antifungal Agents|antifungal agents|mesh-ancestor
102539102|NCT02997410|Keratolytic Agents|keratolytic agents|mesh-ancestor
102539103|NCT02997410|Dermatologic Agents|dermatologic agents|mesh-ancestor
102539104|NCT00374205|Artesunate|artesunate|mesh-list
102539105|NCT00374205|Lumefantrine|lumefantrine|mesh-list
102539106|NCT00374205|Artemether|artemether|mesh-list
102539107|NCT00374205|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102539108|NCT00374205|Amodiaquine|amodiaquine|mesh-list
102539109|NCT00374205|Antimalarials|antimalarials|mesh-ancestor
102539110|NCT00374205|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102539111|NCT00374205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102539112|NCT00374205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102539113|NCT00374205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102539114|NCT00374205|Antiviral Agents|antiviral agents|mesh-ancestor
102539115|NCT00374205|Schistosomicides|schistosomicides|mesh-ancestor
102539116|NCT00374205|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102539117|NCT00374205|Anthelmintics|anthelmintics|mesh-ancestor
102539118|NCT02248844|Botulinum Toxins|botulinum toxins|mesh-list
102539119|NCT02248844|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102539120|NCT02248844|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102539121|NCT02248844|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102539122|NCT02248844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102539123|NCT02248844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539124|NCT02248844|Cholinergic Agents|cholinergic agents|mesh-ancestor
102539125|NCT02248844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102539126|NCT02248844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539127|NCT02248844|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102539128|NCT02248844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102539129|NCT03029715|Dexmedetomidine|dexmedetomidine|mesh-list
102539130|NCT03029715|Remifentanil|remifentanil|mesh-list
102539131|NCT03029715|Propofol|propofol|mesh-list
102539132|NCT03029715|Desflurane|desflurane|mesh-list
102539133|NCT03029715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102539134|NCT03029715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102539135|NCT03029715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539136|NCT03029715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102539137|NCT03029715|Analgesics|analgesics|mesh-ancestor
102539138|NCT03029715|Sensory System Agents|sensory system agents|mesh-ancestor
102539139|NCT03029715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102539140|NCT03029715|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102539141|NCT03029715|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102539142|NCT03029715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102539143|NCT03029715|Adrenergic Agents|adrenergic agents|mesh-ancestor
102539144|NCT03029715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102539145|NCT03029715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539146|NCT03029715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102539147|NCT03029715|Anesthetics, General|anesthetics, general|mesh-ancestor
102539148|NCT03029715|Anesthetics|anesthetics|mesh-ancestor
102539149|NCT03029715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102539150|NCT03029715|Narcotics|narcotics|mesh-ancestor
102539151|NCT03029715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102539152|NCT00555035|Dolutegravir|dolutegravir|mesh-list
102539153|NCT00555035|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102539154|NCT00555035|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102539155|NCT00555035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102539156|NCT00555035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539157|NCT00555035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102539158|NCT00555035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102539159|NCT00555035|Antiviral Agents|antiviral agents|mesh-ancestor
102539160|NCT00555035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102539161|NCT03035955|Azelaic acid|azelaic acid|mesh-list
102539162|NCT03035955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102539163|NCT03035955|Dermatologic Agents|dermatologic agents|mesh-ancestor
102539164|NCT03830060|Hydrocortisone|hydrocortisone|mesh-list
102539165|NCT03830060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102539166|NCT02927223|Atropine|atropine|mesh-list
102539167|NCT02927223|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102539168|NCT02927223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102539169|NCT02927223|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102539170|NCT02927223|Autonomic Agents|autonomic agents|mesh-ancestor
102539171|NCT02927223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102539172|NCT02927223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539173|NCT02927223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102539174|NCT02927223|Respiratory System Agents|respiratory system agents|mesh-ancestor
102539175|NCT02927223|Mydriatics|mydriatics|mesh-ancestor
102539176|NCT02927223|Parasympatholytics|parasympatholytics|mesh-ancestor
102539177|NCT02927223|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102539178|NCT02927223|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102539179|NCT02927223|Cholinergic Agents|cholinergic agents|mesh-ancestor
102539180|NCT02927223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102539181|NCT02927223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539182|NCT03002792|Anesthetics|anesthetics|mesh-list
102539183|NCT03002792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102539184|NCT03002792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539185|NCT02927457|GSK2646264|gsk2646264|mesh-list
102539186|NCT02927457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102539187|NCT02927457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102539188|NCT02927457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539189|NCT01891331|Fluconazole|fluconazole|mesh-list
102539190|NCT01891331|Antifungal Agents|antifungal agents|mesh-ancestor
102539191|NCT01891331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102539192|NCT01891331|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102539193|NCT01891331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102539194|NCT01891331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102539195|NCT01891331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539196|NCT01891331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102539197|NCT01891331|Hormone Antagonists|hormone antagonists|mesh-ancestor
102539198|NCT01891331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102539199|NCT01891331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539200|NCT01891331|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102539201|NCT01891331|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102539202|NCT02247518|Tadalafil|tadalafil|mesh-list
102539203|NCT02247518|Tamsulosin|tamsulosin|mesh-list
102539204|NCT02247518|Vasodilator Agents|vasodilator agents|mesh-ancestor
102539205|NCT02247518|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102539206|NCT02247518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102539207|NCT02247518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102539208|NCT02247518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539209|NCT02247518|Urological Agents|urological agents|mesh-ancestor
102539210|NCT02247518|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102539211|NCT02247518|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102539212|NCT02247518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102539213|NCT02247518|Adrenergic Agents|adrenergic agents|mesh-ancestor
102539214|NCT02247518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102539215|NCT02247518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539216|NCT02867163|Tranexamic Acid|tranexamic acid|mesh-list
102539217|NCT02867163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102539218|NCT02867163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102539219|NCT02867163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539220|NCT02867163|Hemostatics|hemostatics|mesh-ancestor
102539221|NCT02867163|Coagulants|coagulants|mesh-ancestor
102539222|NCT04067609|Dexamethasone|dexamethasone|mesh-list
102539223|NCT04067609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102539224|NCT04067609|Antiemetics|antiemetics|mesh-ancestor
102539225|NCT04067609|Autonomic Agents|autonomic agents|mesh-ancestor
102539226|NCT04067609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102539227|NCT04067609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539228|NCT04067609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102539229|NCT04067609|Glucocorticoids|glucocorticoids|mesh-ancestor
102539230|NCT04067609|Hormones|hormones|mesh-ancestor
102539231|NCT04067609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102539232|NCT04067609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102539233|NCT04067609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102539234|NCT03022097|Bromides|bromides|mesh-list
102539235|NCT03022097|Formoterol Fumarate|formoterol fumarate|mesh-list
102539236|NCT03022097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102539237|NCT03022097|Autonomic Agents|autonomic agents|mesh-ancestor
102539238|NCT03022097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102539239|NCT03022097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539240|NCT03022097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102539241|NCT03022097|Respiratory System Agents|respiratory system agents|mesh-ancestor
102539242|NCT03022097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102539243|NCT03022097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102539244|NCT03022097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102539245|NCT03022097|Adrenergic Agents|adrenergic agents|mesh-ancestor
102539246|NCT03022097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102539247|NCT03022097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539248|NCT03022097|Anticonvulsants|anticonvulsants|mesh-ancestor
102539249|NCT03002636|Anesthetics|anesthetics|mesh-list
102539250|NCT03002636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102539251|NCT03002636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539252|NCT03039543|Rocuronium|rocuronium|mesh-list
102539253|NCT03039543|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102539254|NCT03039543|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102539255|NCT03039543|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102539256|NCT03039543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102539257|NCT03039543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539258|NCT04047875|Norethindrone|norethindrone|mesh-list
102539259|NCT04047875|Norethindrone Acetate|norethindrone acetate|mesh-list
102539260|NCT04047875|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102539261|NCT04047875|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102539262|NCT04047875|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102539263|NCT04047875|Contraceptive Agents|contraceptive agents|mesh-ancestor
102539264|NCT04047875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102539265|NCT04047875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539266|NCT04047875|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102539267|NCT04047875|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102539268|NCT03002090|Iron|iron|mesh-list
102539269|NCT03002090|Trace Elements|trace elements|mesh-ancestor
102539270|NCT03002090|Micronutrients|micronutrients|mesh-ancestor
102539271|NCT03002090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539272|NCT02328755|Methotrexate|methotrexate|mesh-list
102539273|NCT02328755|Tacrolimus|tacrolimus|mesh-list
102539274|NCT02328755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102539275|NCT02328755|Abortifacient Agents|abortifacient agents|mesh-ancestor
102539276|NCT02328755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102539277|NCT02328755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539278|NCT02328755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102539279|NCT02328755|Antimetabolites|antimetabolites|mesh-ancestor
102539280|NCT02328755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539281|NCT02328755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102539282|NCT02328755|Dermatologic Agents|dermatologic agents|mesh-ancestor
102539283|NCT02328755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102539284|NCT02328755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102539285|NCT02328755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102539286|NCT02328755|Immunologic Factors|immunologic factors|mesh-ancestor
102539287|NCT02328755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102539288|NCT02328755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102539289|NCT02328755|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102539290|NCT02870283|Carbamazepine|carbamazepine|mesh-list
102539291|NCT02870283|Valproic Acid|valproic acid|mesh-list
102539292|NCT02870283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102539293|NCT02870283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102539294|NCT02870283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539295|NCT02870283|Antimanic Agents|antimanic agents|mesh-ancestor
102539296|NCT02870283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102539297|NCT02870283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102539298|NCT02870283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539299|NCT02870283|Anticonvulsants|anticonvulsants|mesh-ancestor
102539300|NCT02870283|GABA Agents|gaba agents|mesh-ancestor
102539301|NCT02870283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102539302|NCT02870283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102539303|NCT02870283|Analgesics|analgesics|mesh-ancestor
102539304|NCT02870283|Sensory System Agents|sensory system agents|mesh-ancestor
102154143|NCT00436254|Immunologic Factors|immunologic factors|mesh-ancestor
102539305|NCT02870283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102539306|NCT02870283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102539307|NCT02870283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102539308|NCT02870283|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102539309|NCT02870283|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102539310|NCT02931045|Clopidogrel|clopidogrel|mesh-list
102539311|NCT02931045|Ticagrelor|ticagrelor|mesh-list
102539312|NCT02931045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102539313|NCT02931045|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102539314|NCT02931045|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102539315|NCT02931045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102539316|NCT02931045|Purinergic Agents|purinergic agents|mesh-ancestor
102539317|NCT02931045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102539318|NCT02931045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539319|NCT02931045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539320|NCT03040011|Dexamethasone|dexamethasone|mesh-list
102539321|NCT03040011|Bupivacaine|bupivacaine|mesh-list
102539322|NCT03040011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102539323|NCT03040011|Antiemetics|antiemetics|mesh-ancestor
102539324|NCT03040011|Autonomic Agents|autonomic agents|mesh-ancestor
102539325|NCT03040011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102539326|NCT03040011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539327|NCT03040011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102539328|NCT03040011|Glucocorticoids|glucocorticoids|mesh-ancestor
102539329|NCT03040011|Hormones|hormones|mesh-ancestor
102539330|NCT03040011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102539331|NCT03040011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102539332|NCT03040011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102539333|NCT03040011|Anesthetics, Local|anesthetics, local|mesh-ancestor
102539334|NCT03040011|Anesthetics|anesthetics|mesh-ancestor
102539335|NCT03040011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102539336|NCT03040011|Sensory System Agents|sensory system agents|mesh-ancestor
102539337|NCT02225132|Hydroxyurea|hydroxyurea|mesh-list
102539338|NCT02225132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102539339|NCT02225132|Antisickling Agents|antisickling agents|mesh-ancestor
102539340|NCT02225132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102539341|NCT02225132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539342|NCT02225132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102539343|NCT03040479|Lasmiditan|lasmiditan|mesh-list
102539344|NCT03040479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102539345|NCT03040479|Serotonin Agents|serotonin agents|mesh-ancestor
102539346|NCT03040479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102539347|NCT03040479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539348|NCT03040479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539349|NCT02872857|Galantamine|galantamine|mesh-list
102539350|NCT02872857|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102539351|NCT02872857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102539352|NCT02872857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539353|NCT02872857|Cholinergic Agents|cholinergic agents|mesh-ancestor
102539354|NCT02872857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102539355|NCT02872857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539356|NCT02872857|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102539357|NCT02872857|Autonomic Agents|autonomic agents|mesh-ancestor
102539358|NCT02872857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102539359|NCT02872857|Nootropic Agents|nootropic agents|mesh-ancestor
102539360|NCT02996318|Sirolimus|sirolimus|mesh-list
102539361|NCT02996318|Paclitaxel|paclitaxel|mesh-list
102539362|NCT02996318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102539363|NCT02996318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102539364|NCT02996318|Tubulin Modulators|tubulin modulators|mesh-ancestor
102539365|NCT02996318|Antimitotic Agents|antimitotic agents|mesh-ancestor
102539366|NCT02996318|Mitosis Modulators|mitosis modulators|mesh-ancestor
102241638|NCT04891809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102539367|NCT02996318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539368|NCT02996318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102539369|NCT02996318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102539370|NCT02996318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102539371|NCT02996318|Antifungal Agents|antifungal agents|mesh-ancestor
102539372|NCT02996318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102539373|NCT02996318|Immunologic Factors|immunologic factors|mesh-ancestor
102539374|NCT02996318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539375|NCT05197751|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102539376|NCT05197751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101570590|NCT00886795|Abatacept|abatacept|mesh-list
102539377|NCT05197751|Immunologic Factors|immunologic factors|mesh-ancestor
102539378|NCT05197751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539379|NCT05197751|Antacids|antacids|mesh-ancestor
102539380|NCT05197751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539381|NCT05197751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102539382|NCT02994602|ST 1435|st 1435|mesh-list
102539383|NCT02994602|Testosterone|testosterone|mesh-list
102539384|NCT02994602|Androgens|androgens|mesh-ancestor
102539385|NCT02994602|Hormones|hormones|mesh-ancestor
102539386|NCT02994602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102539387|NCT02994602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539388|NCT02994602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102539389|NCT02994602|Contraceptive Agents|contraceptive agents|mesh-ancestor
102539390|NCT02994602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102539391|NCT02994602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102539392|NCT03297710|Trifluridine|trifluridine|mesh-list
102539393|NCT03297710|Antimetabolites|antimetabolites|mesh-ancestor
102539394|NCT03297710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539395|NCT03297710|Antiviral Agents|antiviral agents|mesh-ancestor
102539396|NCT03297710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102539397|NCT04350671|Interferons|interferons|mesh-list
102539398|NCT04350671|Ritonavir|ritonavir|mesh-list
102539399|NCT04350671|Lopinavir|lopinavir|mesh-list
102539400|NCT04350671|Interferon-beta|interferon-beta|mesh-list
102539401|NCT04350671|Interferon beta-1a|interferon beta-1a|mesh-list
102539402|NCT04350671|Hydroxychloroquine|hydroxychloroquine|mesh-list
102539403|NCT04350671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102539404|NCT04350671|Antiviral Agents|antiviral agents|mesh-ancestor
102539405|NCT04350671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102539406|NCT04350671|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102539407|NCT04350671|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102539408|NCT04350671|Protease Inhibitors|protease inhibitors|mesh-ancestor
102539409|NCT04350671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102539410|NCT04350671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539411|NCT04350671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102539412|NCT04350671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102539413|NCT04350671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102539414|NCT04350671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102539415|NCT04350671|Antimalarials|antimalarials|mesh-ancestor
102539416|NCT04350671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102539417|NCT04350671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102539418|NCT04350671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102539419|NCT04350671|Immunologic Factors|immunologic factors|mesh-ancestor
102539420|NCT04350671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539421|NCT04350671|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102539422|NCT04850846|Metformin|metformin|mesh-list
102539423|NCT04850846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102539424|NCT04850846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539425|NCT05166083|Testosterone|testosterone|mesh-list
102539426|NCT05166083|Androgens|androgens|mesh-ancestor
102539427|NCT05166083|Hormones|hormones|mesh-ancestor
102539428|NCT05166083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102539429|NCT05166083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539430|NCT04707794|Sevoflurane|sevoflurane|mesh-list
102539431|NCT04707794|Desflurane|desflurane|mesh-list
102539432|NCT04707794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102539433|NCT04707794|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102539434|NCT04707794|Anesthetics, General|anesthetics, general|mesh-ancestor
102539435|NCT04707794|Anesthetics|anesthetics|mesh-ancestor
102539436|NCT04707794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102539437|NCT04707794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539438|NCT04667312|Durvalumab|durvalumab|mesh-list
102539439|NCT04667312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102539440|NCT04667312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102539441|NCT02759588|Bevacizumab|bevacizumab|mesh-list
102539442|NCT02759588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102539443|NCT02759588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102539444|NCT02759588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102539445|NCT02759588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102539446|NCT02759588|Growth Substances|growth substances|mesh-ancestor
102539447|NCT02759588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539448|NCT02759588|Growth Inhibitors|growth inhibitors|mesh-ancestor
102539449|NCT03045861|Cobicistat|cobicistat|mesh-list
101570676|NCT02826343|Hormones|hormones|mesh-ancestor
102539450|NCT03045861|GSK-2838232|gsk-2838232|mesh-list
102539451|NCT03045861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102539452|NCT03045861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102539453|NCT03045861|Antiviral Agents|antiviral agents|mesh-ancestor
102539454|NCT03045861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102539455|NCT03045861|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102539456|NCT03045861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102539457|NCT03045861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102539458|NCT03045861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539459|NCT02249078|Quetmolimab|quetmolimab|mesh-list
102539460|NCT02249078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102539461|NCT01903265|Cyclobenzaprine|cyclobenzaprine|mesh-list
102539462|NCT01903265|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102539463|NCT01903265|Antidepressive Agents|antidepressive agents|mesh-ancestor
102539464|NCT01903265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102539465|NCT01903265|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102539466|NCT01903265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539467|NCT01903265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102539468|NCT01903265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102539469|NCT01903265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102539470|NCT01903265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102539471|NCT01907321|Capsaicin|capsaicin|mesh-list
102539472|NCT01907321|Antipruritics|antipruritics|mesh-ancestor
102539473|NCT01907321|Dermatologic Agents|dermatologic agents|mesh-ancestor
102539474|NCT01907321|Sensory System Agents|sensory system agents|mesh-ancestor
102539475|NCT01907321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102539476|NCT01907321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539477|NCT02219516|Verinurad|verinurad|mesh-list
102539478|NCT02219516|Gout Suppressants|gout suppressants|mesh-ancestor
102539479|NCT02219516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102539480|NCT04976777|Dexamethasone|dexamethasone|mesh-list
102539481|NCT04976777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102539482|NCT04976777|Antiemetics|antiemetics|mesh-ancestor
102539483|NCT04976777|Autonomic Agents|autonomic agents|mesh-ancestor
102539484|NCT04976777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102539485|NCT04976777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539486|NCT04976777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102539487|NCT04976777|Glucocorticoids|glucocorticoids|mesh-ancestor
102539488|NCT04976777|Hormones|hormones|mesh-ancestor
102539489|NCT04976777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102539490|NCT04976777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102539491|NCT04976777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102539492|NCT02247596|Resveratrol|resveratrol|mesh-list
102539493|NCT02247596|Antioxidants|antioxidants|mesh-ancestor
102539494|NCT02247596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539495|NCT02247596|Protective Agents|protective agents|mesh-ancestor
102539496|NCT02247596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539497|NCT02247596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102539498|NCT02247596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102539499|NCT03686657|Metformin|metformin|mesh-list
102539500|NCT03686657|Celecoxib|celecoxib|mesh-list
102539501|NCT03686657|Valsartan|valsartan|mesh-list
102539502|NCT03686657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102539503|NCT03686657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539504|NCT03686657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102539505|NCT03686657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102539506|NCT03686657|Analgesics|analgesics|mesh-ancestor
102539507|NCT03686657|Sensory System Agents|sensory system agents|mesh-ancestor
102539508|NCT03686657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102539509|NCT03686657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102539510|NCT03686657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102539511|NCT03686657|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102539512|NCT03686657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102539513|NCT03686657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102539514|NCT03686657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539515|NCT03686657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102539516|NCT03686657|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102539517|NCT03686657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102539518|NCT02476058|Diphenhydramine|diphenhydramine|mesh-list
102539519|NCT02476058|Promethazine|promethazine|mesh-list
102539520|NCT02476058|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102539521|NCT02476058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102539522|NCT02476058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102539523|NCT02476058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539524|NCT02476058|Anesthetics, Local|anesthetics, local|mesh-ancestor
102539525|NCT02476058|Anesthetics|anesthetics|mesh-ancestor
102539526|NCT02476058|Sensory System Agents|sensory system agents|mesh-ancestor
102539527|NCT02476058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102539528|NCT02476058|Antiemetics|antiemetics|mesh-ancestor
102539529|NCT02476058|Autonomic Agents|autonomic agents|mesh-ancestor
102539530|NCT02476058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102539531|NCT02476058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102539532|NCT02476058|Histamine Antagonists|histamine antagonists|mesh-ancestor
102539533|NCT02476058|Histamine Agents|histamine agents|mesh-ancestor
102539534|NCT02476058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102539535|NCT02476058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539536|NCT02476058|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102539537|NCT02476058|Antipruritics|antipruritics|mesh-ancestor
102539538|NCT02476058|Dermatologic Agents|dermatologic agents|mesh-ancestor
102539539|NCT02143466|Durvalumab|durvalumab|mesh-list
102539540|NCT02143466|Osimertinib|osimertinib|mesh-list
102539541|NCT02143466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102539542|NCT02143466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102539543|NCT02143466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102539544|NCT02143466|Immunologic Factors|immunologic factors|mesh-ancestor
102539545|NCT02143466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539546|NCT02143466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102539547|NCT02143466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102539548|NCT02143466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539549|NCT03050619|Empagliflozin|empagliflozin|mesh-list
102539550|NCT03050619|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102539551|NCT03050619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539552|NCT03050619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102539553|NCT03050619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539554|NCT02071394|Xenon|xenon|mesh-list
102539555|NCT02071394|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101759542|NCT02548533|Autonomic Agents|autonomic agents|mesh-ancestor
102539556|NCT02071394|Anesthetics, General|anesthetics, general|mesh-ancestor
102539557|NCT02071394|Anesthetics|anesthetics|mesh-ancestor
102539558|NCT02071394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102539559|NCT02071394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539560|NCT01911065|Vaccines|vaccines|mesh-list
102539561|NCT01911065|Immunologic Factors|immunologic factors|mesh-ancestor
102539562|NCT01911065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539563|NCT02995772|Tamoxifen|tamoxifen|mesh-list
102539564|NCT02995772|Fluorouracil|fluorouracil|mesh-list
102539565|NCT02995772|Letrozole|letrozole|mesh-list
102539566|NCT02995772|Anastrozole|anastrozole|mesh-list
102539567|NCT02995772|Exemestane|exemestane|mesh-list
102539568|NCT02995772|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102539569|NCT02995772|Antimetabolites|antimetabolites|mesh-ancestor
102539570|NCT02995772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539571|NCT02995772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102539572|NCT02995772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102539573|NCT02995772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102539574|NCT02995772|Immunologic Factors|immunologic factors|mesh-ancestor
102539575|NCT02995772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539576|NCT02995772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102539577|NCT02995772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102539578|NCT02995772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102539579|NCT02995772|Hormone Antagonists|hormone antagonists|mesh-ancestor
102539580|NCT02995772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102539581|NCT02995772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102539582|NCT02995772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102539583|NCT02995772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102539584|NCT02995772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102539585|NCT02987465|Norepinephrine|norepinephrine|mesh-list
102539586|NCT02987465|Acetylcholine|acetylcholine|mesh-list
102539587|NCT02987465|Darbepoetin alfa|darbepoetin alfa|mesh-list
102539588|NCT02987465|Hematinics|hematinics|mesh-ancestor
102539589|NCT02987465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102539590|NCT02987465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102539591|NCT02987465|Adrenergic Agents|adrenergic agents|mesh-ancestor
102539592|NCT02987465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102539593|NCT02987465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539594|NCT02987465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539595|NCT02987465|Sympathomimetics|sympathomimetics|mesh-ancestor
102539596|NCT02987465|Autonomic Agents|autonomic agents|mesh-ancestor
102539597|NCT02987465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102539598|NCT02987465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102539599|NCT02987465|Vasodilator Agents|vasodilator agents|mesh-ancestor
102539600|NCT02987465|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102539601|NCT02987465|Cholinergic Agents|cholinergic agents|mesh-ancestor
102539602|NCT04895579|Durvalumab|durvalumab|mesh-list
102539603|NCT04895579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102539604|NCT04895579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102539606|NCT02227316|Ibuprofen|ibuprofen|mesh-list
102539607|NCT02227316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102539608|NCT02227316|Analgesics|analgesics|mesh-ancestor
102539609|NCT02227316|Sensory System Agents|sensory system agents|mesh-ancestor
102539610|NCT02227316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102539611|NCT02227316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539612|NCT02227316|Antipyretics|antipyretics|mesh-ancestor
102539613|NCT02227316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102539614|NCT02227316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102539615|NCT02227316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102539616|NCT02227316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102539617|NCT02227316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102539618|NCT02227316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539619|NCT00555971|Omalizumab|omalizumab|mesh-list
102539620|NCT00555971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102539621|NCT00555971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102539622|NCT00555971|Respiratory System Agents|respiratory system agents|mesh-ancestor
102539623|NCT02943213|Chlorpromazine|chlorpromazine|mesh-list
102539624|NCT02943213|Antiemetics|antiemetics|mesh-ancestor
102539625|NCT02943213|Autonomic Agents|autonomic agents|mesh-ancestor
102539626|NCT02943213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102539627|NCT02943213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539628|NCT02943213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102539629|NCT02943213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102539630|NCT02943213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102539631|NCT02943213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102539632|NCT02943213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102539633|NCT02943213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102539634|NCT02943213|Dopamine Agents|dopamine agents|mesh-ancestor
102539635|NCT02943213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102539636|NCT02943213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539637|NCT01850108|Mycophenolic Acid|mycophenolic acid|mesh-list
102539638|NCT01850108|Sirolimus|sirolimus|mesh-list
102539639|NCT01850108|Cyclophosphamide|cyclophosphamide|mesh-list
102539640|NCT01850108|Fludarabine|fludarabine|mesh-list
102539641|NCT01850108|Thymoglobulin|thymoglobulin|mesh-list
102539642|NCT01850108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102539643|NCT01850108|Immunologic Factors|immunologic factors|mesh-ancestor
102539644|NCT01850108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539645|NCT01850108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102539646|NCT01850108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102539647|NCT01850108|Alkylating Agents|alkylating agents|mesh-ancestor
102539648|NCT01850108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539649|NCT01850108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102539650|NCT01850108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102539651|NCT01850108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102539652|NCT01850108|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102539653|NCT01850108|Antitubercular Agents|antitubercular agents|mesh-ancestor
102539654|NCT01850108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102539655|NCT01850108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102539656|NCT01850108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102539657|NCT01850108|Antifungal Agents|antifungal agents|mesh-ancestor
102539658|NCT01822652|Cyclophosphamide|cyclophosphamide|mesh-list
102539659|NCT01822652|Pembrolizumab|pembrolizumab|mesh-list
102539660|NCT01822652|Fludarabine|fludarabine|mesh-list
102539661|NCT01822652|Fludarabine phosphate|fludarabine phosphate|mesh-list
102539662|NCT01822652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102539663|NCT01822652|Immunologic Factors|immunologic factors|mesh-ancestor
102539664|NCT01822652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539665|NCT01822652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102539666|NCT01822652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102539667|NCT01822652|Alkylating Agents|alkylating agents|mesh-ancestor
102539668|NCT01822652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539669|NCT01822652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102539670|NCT01822652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102539671|NCT01822652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102539672|NCT01822652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102539673|NCT01822652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102539674|NCT01822652|Antimetabolites|antimetabolites|mesh-ancestor
102539675|NCT02249234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102539676|NCT02249234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102539677|NCT02249234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101759659|NCT00909454|Vitamins|vitamins|mesh-list
102539678|NCT02249234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539679|NCT02249234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102539680|NCT02249234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102539681|NCT02249234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539682|NCT02249234|Cholinergic Agents|cholinergic agents|mesh-ancestor
102539683|NCT02249234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102539684|NCT01338740|Adalimumab|adalimumab|mesh-list
102539685|NCT01338740|Infliximab|infliximab|mesh-list
102539686|NCT01338740|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102539687|NCT01338740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102539688|NCT01338740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102539689|NCT01338740|Dermatologic Agents|dermatologic agents|mesh-ancestor
102539690|NCT01338740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102539691|NCT02944461|Dapsone|dapsone|mesh-list
102539692|NCT02944461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102539693|NCT02944461|Antimalarials|antimalarials|mesh-ancestor
102539694|NCT02944461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102539695|NCT02944461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102539696|NCT02944461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102539697|NCT02944461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102539698|NCT02944461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539699|NCT02944461|Leprostatic Agents|leprostatic agents|mesh-ancestor
102539700|NCT02944461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102539701|NCT05376722|Prednisone|prednisone|mesh-list
102539702|NCT05376722|Pamiparib|pamiparib|mesh-list
102539703|NCT05376722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102539704|NCT05376722|Glucocorticoids|glucocorticoids|mesh-ancestor
102539705|NCT05376722|Hormones|hormones|mesh-ancestor
102539706|NCT05376722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102539707|NCT05376722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539708|NCT05376722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102539709|NCT05376722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102539710|NCT05376722|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102539711|NCT05376722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102539712|NCT05376722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539713|NCT04737057|Fluorides|fluorides|mesh-list
102539714|NCT04737057|Cariostatic Agents|cariostatic agents|mesh-ancestor
102539715|NCT04737057|Protective Agents|protective agents|mesh-ancestor
102539716|NCT04737057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539717|NCT03111381|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102539718|NCT03111381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102539719|NCT03111381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102539720|NCT03111381|Analgesics|analgesics|mesh-ancestor
102539721|NCT03111381|Sensory System Agents|sensory system agents|mesh-ancestor
102539722|NCT03111381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102539723|NCT03111381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539724|NCT03111381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102539725|NCT03111381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102539726|NCT03111381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102539727|NCT03111381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102539728|NCT03111381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539729|NCT02946489|Ketamine|ketamine|mesh-list
102539730|NCT02946489|Analgesics|analgesics|mesh-ancestor
102539731|NCT02946489|Sensory System Agents|sensory system agents|mesh-ancestor
102539732|NCT02946489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102241639|NCT04891809|Antiemetics|antiemetics|mesh-ancestor
102539733|NCT02946489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539734|NCT02946489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102539735|NCT02946489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102539736|NCT02946489|Anesthetics, General|anesthetics, general|mesh-ancestor
102539737|NCT02946489|Anesthetics|anesthetics|mesh-ancestor
102539738|NCT02946489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102539739|NCT02946489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102539740|NCT02946489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102539741|NCT02946489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102539742|NCT02946489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539743|NCT02949921|Lidocaine|lidocaine|mesh-list
102539744|NCT02949921|Anesthetics, Local|anesthetics, local|mesh-ancestor
102539745|NCT02949921|Anesthetics|anesthetics|mesh-ancestor
102539746|NCT02949921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102539747|NCT02949921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539748|NCT02949921|Sensory System Agents|sensory system agents|mesh-ancestor
102539749|NCT02949921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102539750|NCT02949921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102539751|NCT02949921|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102539752|NCT02949921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102539753|NCT02949921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102539754|NCT02949921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539755|NCT02227706|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102539756|NCT02227706|Hemostatics|hemostatics|mesh-ancestor
102539757|NCT02227706|Coagulants|coagulants|mesh-ancestor
102539758|NCT03112863|Vitamin A|vitamin a|mesh-list
102539759|NCT03112863|Retinol palmitate|retinol palmitate|mesh-list
102539760|NCT03112863|Vitamins|vitamins|mesh-ancestor
102539761|NCT03112863|Micronutrients|micronutrients|mesh-ancestor
102539762|NCT03112863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539763|NCT03112863|Antioxidants|antioxidants|mesh-ancestor
102539764|NCT03112863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539765|NCT03112863|Protective Agents|protective agents|mesh-ancestor
102539766|NCT03112863|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102539767|NCT03112863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102539768|NCT02950467|Psilocybin|psilocybin|mesh-list
102539769|NCT02950467|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
102539770|NCT02950467|Hallucinogens|hallucinogens|mesh-ancestor
102539771|NCT02950467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539772|NCT02950467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102539773|NCT02950467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102539774|NCT02950467|Serotonin Agents|serotonin agents|mesh-ancestor
102539775|NCT02950467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102539776|NCT02950467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539777|NCT02950467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102539778|NCT01930487|Antioxidants|antioxidants|mesh-list
102539779|NCT01930487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539780|NCT01930487|Protective Agents|protective agents|mesh-ancestor
102539781|NCT01930487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539782|NCT03864068|Inositol|inositol|mesh-list
102539783|NCT03864068|Vitamin B Complex|vitamin b complex|mesh-ancestor
102539784|NCT03864068|Vitamins|vitamins|mesh-ancestor
102539785|NCT03864068|Micronutrients|micronutrients|mesh-ancestor
102539786|NCT03864068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539787|NCT03063255|Anesthetics|anesthetics|mesh-list
102539788|NCT03063255|Mepivacaine|mepivacaine|mesh-list
102539789|NCT03063255|Rocuronium|rocuronium|mesh-list
102539790|NCT03063255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102539791|NCT03063255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539792|NCT03063255|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102539793|NCT03063255|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102539794|NCT03063255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102539795|NCT03063255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102539796|NCT03063255|Anesthetics, Local|anesthetics, local|mesh-ancestor
102539797|NCT03063255|Sensory System Agents|sensory system agents|mesh-ancestor
102539798|NCT05249114|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102539799|NCT05249114|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102539800|NCT05249114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539801|NCT05245292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102539802|NCT05245292|Antibodies|antibodies|mesh-list
102539803|NCT05245292|Immunoglobulins|immunoglobulins|mesh-list
102539804|NCT05245292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102539805|NCT05245292|Antibodies, Blocking|antibodies, blocking|mesh-list
102539806|NCT05245292|Immunologic Factors|immunologic factors|mesh-ancestor
102539807|NCT05245292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539808|NCT05245292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102539809|NCT03115827|Carbidopa|carbidopa|mesh-list
102539810|NCT03115827|Droxidopa|droxidopa|mesh-list
102539811|NCT03115827|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102539812|NCT03115827|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102539813|NCT03115827|Dopamine Agents|dopamine agents|mesh-ancestor
102539814|NCT03115827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102539815|NCT03115827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539816|NCT03115827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539817|NCT03115827|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102539818|NCT03115827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102539819|NCT01915823|Fluticasone|fluticasone|mesh-list
102539820|NCT01915823|Xhance|xhance|mesh-list
102539821|NCT01915823|Azelastine|azelastine|mesh-list
102539822|NCT01915823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102539823|NCT01915823|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102539824|NCT01915823|Autonomic Agents|autonomic agents|mesh-ancestor
102539825|NCT01915823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102539826|NCT01915823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539827|NCT01915823|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102539828|NCT01915823|Respiratory System Agents|respiratory system agents|mesh-ancestor
102539829|NCT01915823|Dermatologic Agents|dermatologic agents|mesh-ancestor
102539830|NCT01915823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102539831|NCT01915823|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
102539832|NCT01915823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102539833|NCT01915823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539834|NCT01915823|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102539835|NCT01915823|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102539836|NCT01915823|Histamine Antagonists|histamine antagonists|mesh-ancestor
102539837|NCT01915823|Histamine Agents|histamine agents|mesh-ancestor
102539838|NCT01915823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102539839|NCT05199194|Tenecteplase|tenecteplase|mesh-list
102539840|NCT05199194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102539841|NCT05199194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102539842|NCT05199194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539843|NCT01916681|Misoprostol|misoprostol|mesh-list
102539844|NCT01916681|Oxytocin|oxytocin|mesh-list
102539845|NCT01916681|Oxytocics|oxytocics|mesh-ancestor
102539846|NCT01916681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102539847|NCT01916681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539848|NCT01916681|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102539849|NCT01916681|Abortifacient Agents|abortifacient agents|mesh-ancestor
102539850|NCT01916681|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102539851|NCT01916681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102539852|NCT05735951|Stiripentol|stiripentol|mesh-list
102539853|NCT05735951|Anticonvulsants|anticonvulsants|mesh-ancestor
102539854|NCT01917773|Octreotide|octreotide|mesh-list
102539855|NCT01917773|Bisacodyl|bisacodyl|mesh-list
102539856|NCT01917773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102539857|NCT01917773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102539858|NCT01917773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102539859|NCT01917773|Cathartics|cathartics|mesh-ancestor
102539860|NCT01917773|Laxatives|laxatives|mesh-ancestor
102539861|NCT02283749|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
102539862|NCT02283749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102539863|NCT01934231|Amoxicillin|amoxicillin|mesh-list
102539864|NCT01934231|Clavulanic Acid|clavulanic acid|mesh-list
102539865|NCT01934231|Clavulanic Acids|clavulanic acids|mesh-list
102539866|NCT01934231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102539867|NCT01934231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102539868|NCT01934231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102539869|NCT01934231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102539870|NCT01934231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102539871|NCT01934231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539872|NCT01935791|Glucagon|glucagon|mesh-list
102539873|NCT01935791|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102539874|NCT01935791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102539875|NCT01935791|Hormones|hormones|mesh-ancestor
102539876|NCT01935791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102539877|NCT01935791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539878|NCT01935791|Incretins|incretins|mesh-ancestor
102539879|NCT03074409|Oxytocin|oxytocin|mesh-list
102539880|NCT03074409|Oxytocics|oxytocics|mesh-ancestor
102539881|NCT03074409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102539882|NCT03074409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539883|NCT02955147|Prednisone|prednisone|mesh-list
102539884|NCT02955147|Ustekinumab|ustekinumab|mesh-list
102539885|NCT02955147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102539886|NCT02955147|Glucocorticoids|glucocorticoids|mesh-ancestor
102539887|NCT02955147|Hormones|hormones|mesh-ancestor
102539888|NCT02955147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102539889|NCT02955147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539890|NCT02955147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102539891|NCT02955147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102539892|NCT02955147|Dermatologic Agents|dermatologic agents|mesh-ancestor
102539893|NCT03119181|Lidocaine|lidocaine|mesh-list
102539894|NCT03119181|Epinephrine|epinephrine|mesh-list
102539895|NCT03119181|Racepinephrine|racepinephrine|mesh-list
102539896|NCT03119181|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102539897|NCT03119181|Epinephryl borate|epinephryl borate|mesh-list
102539898|NCT03119181|Anesthetics, Local|anesthetics, local|mesh-ancestor
102539899|NCT03119181|Anesthetics|anesthetics|mesh-ancestor
102539900|NCT03119181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102539901|NCT03119181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539902|NCT03119181|Sensory System Agents|sensory system agents|mesh-ancestor
102539903|NCT03119181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102539904|NCT03119181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102539905|NCT03119181|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101571110|NCT05517590|Coagulants|coagulants|mesh-ancestor
102539906|NCT03119181|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102539907|NCT03119181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102539908|NCT03119181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539909|NCT03119181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102539910|NCT03119181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102539911|NCT03119181|Adrenergic Agents|adrenergic agents|mesh-ancestor
102539912|NCT03119181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102539913|NCT03119181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102539914|NCT03119181|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102539915|NCT03119181|Autonomic Agents|autonomic agents|mesh-ancestor
102539916|NCT03119181|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102539917|NCT03119181|Respiratory System Agents|respiratory system agents|mesh-ancestor
102539918|NCT03119181|Mydriatics|mydriatics|mesh-ancestor
102539919|NCT03119181|Sympathomimetics|sympathomimetics|mesh-ancestor
102539920|NCT03119181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102539921|NCT01691534|Pyrazinamide|pyrazinamide|mesh-list
102539922|NCT01691534|Clofazimine|clofazimine|mesh-list
102539923|NCT01691534|Antitubercular Agents|antitubercular agents|mesh-ancestor
102539924|NCT01691534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102539925|NCT01691534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102539926|NCT01691534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102539927|NCT01691534|Leprostatic Agents|leprostatic agents|mesh-ancestor
102539928|NCT01691690|Acetaminophen|acetaminophen|mesh-list
102539929|NCT01691690|Dexamethasone|dexamethasone|mesh-list
102539930|NCT01691690|Midazolam|midazolam|mesh-list
102539931|NCT01691690|Morphine|morphine|mesh-list
102539932|NCT01691690|Nitrous Oxide|nitrous oxide|mesh-list
102539933|NCT01691690|Ondansetron|ondansetron|mesh-list
102539934|NCT01691690|Propofol|propofol|mesh-list
102539935|NCT01691690|Sevoflurane|sevoflurane|mesh-list
102539936|NCT01691690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102539937|NCT01691690|Antiemetics|antiemetics|mesh-ancestor
102539938|NCT01691690|Autonomic Agents|autonomic agents|mesh-ancestor
102539939|NCT01691690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102539940|NCT01691690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539941|NCT01691690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102539942|NCT01691690|Glucocorticoids|glucocorticoids|mesh-ancestor
102539943|NCT01691690|Hormones|hormones|mesh-ancestor
102539944|NCT01691690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102539945|NCT01691690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102539946|NCT01691690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102539947|NCT01691690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102539948|NCT01691690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102539949|NCT01691690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102539950|NCT01691690|Anesthetics, General|anesthetics, general|mesh-ancestor
102539951|NCT01691690|Anesthetics|anesthetics|mesh-ancestor
102539952|NCT01691690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102539953|NCT01691690|Narcotics|narcotics|mesh-ancestor
102539954|NCT01691690|Analgesics|analgesics|mesh-ancestor
102539955|NCT01691690|Sensory System Agents|sensory system agents|mesh-ancestor
102539956|NCT01691690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102539957|NCT01691690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102539958|NCT01691690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102539959|NCT01691690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102539960|NCT01691690|GABA Modulators|gaba modulators|mesh-ancestor
102539961|NCT01691690|GABA Agents|gaba agents|mesh-ancestor
102539962|NCT01691690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102539963|NCT01691690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539964|NCT01691690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102539965|NCT01691690|Antipyretics|antipyretics|mesh-ancestor
102539966|NCT01691690|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102539967|NCT01691690|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102539968|NCT01691690|Antipruritics|antipruritics|mesh-ancestor
102539969|NCT01691690|Dermatologic Agents|dermatologic agents|mesh-ancestor
102539970|NCT01691690|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102539971|NCT01691690|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102539972|NCT01691690|Serotonin Agents|serotonin agents|mesh-ancestor
102539973|NCT01694108|BCG Vaccine|bcg vaccine|mesh-list
102539974|NCT01694108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102539975|NCT01694108|Immunologic Factors|immunologic factors|mesh-ancestor
102539976|NCT01694108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539977|NCT02283827|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102539978|NCT02283827|Phenytoin|phenytoin|mesh-list
102539979|NCT02283827|Anticonvulsants|anticonvulsants|mesh-ancestor
102539980|NCT02283827|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102539981|NCT02283827|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102539982|NCT02283827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102539983|NCT02283827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539984|NCT02283827|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102539985|NCT02283827|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102539986|NCT01626092|Cyclosporine|cyclosporine|mesh-list
102539987|NCT01626092|Mycophenolic Acid|mycophenolic acid|mesh-list
102539988|NCT01626092|Melphalan|melphalan|mesh-list
102539989|NCT01626092|Alemtuzumab|alemtuzumab|mesh-list
102539990|NCT01626092|Clofarabine|clofarabine|mesh-list
102539991|NCT01626092|Cyclosporins|cyclosporins|mesh-list
102539992|NCT01626092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102539993|NCT01626092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102539994|NCT01626092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102539995|NCT01626092|Immunologic Factors|immunologic factors|mesh-ancestor
102539996|NCT01626092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102539997|NCT01626092|Antifungal Agents|antifungal agents|mesh-ancestor
102539998|NCT01626092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102539999|NCT01626092|Dermatologic Agents|dermatologic agents|mesh-ancestor
102540000|NCT01626092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102540001|NCT01626092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102540002|NCT01626092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102540003|NCT01626092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102540004|NCT01626092|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102540005|NCT01626092|Antitubercular Agents|antitubercular agents|mesh-ancestor
102540006|NCT01626092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102540007|NCT01626092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102540008|NCT01626092|Alkylating Agents|alkylating agents|mesh-ancestor
102540009|NCT01626092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102540010|NCT01626092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102540011|NCT01626092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102540012|NCT01626092|Antimetabolites|antimetabolites|mesh-ancestor
102540013|NCT01694966|Methylene Blue|methylene blue|mesh-list
102540014|NCT01694966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102540015|NCT01694966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540016|NCT01937975|Grazoprevir|grazoprevir|mesh-list
102540017|NCT01937975|Antiviral Agents|antiviral agents|mesh-ancestor
102540018|NCT01937975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102540019|NCT01628588|Bimatoprost|bimatoprost|mesh-list
102540020|NCT01628588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102540021|NCT00374985|Docetaxel|docetaxel|mesh-list
102540022|NCT00374985|Oxaliplatin|oxaliplatin|mesh-list
102540023|NCT00374985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102540024|NCT00374985|Tubulin Modulators|tubulin modulators|mesh-ancestor
102540025|NCT00374985|Antimitotic Agents|antimitotic agents|mesh-ancestor
102540026|NCT00374985|Mitosis Modulators|mitosis modulators|mesh-ancestor
102540027|NCT00374985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540028|NCT01695668|Loteprednol Etabonate|loteprednol etabonate|mesh-list
102540029|NCT01695668|Cyclosporine|cyclosporine|mesh-list
102540030|NCT01695668|Cyclosporins|cyclosporins|mesh-list
102540031|NCT01695668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102540032|NCT01695668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540033|NCT01695668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102540034|NCT01695668|Immunologic Factors|immunologic factors|mesh-ancestor
102540035|NCT01695668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540036|NCT01695668|Antifungal Agents|antifungal agents|mesh-ancestor
102540037|NCT01695668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102540038|NCT01695668|Dermatologic Agents|dermatologic agents|mesh-ancestor
102540039|NCT01695668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102540040|NCT01695668|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102540041|NCT01695668|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102540042|NCT03270020|Denosumab|denosumab|mesh-list
102540043|NCT03270020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102540044|NCT03270020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540045|NCT01921751|Paclitaxel|paclitaxel|mesh-list
102540046|NCT01921751|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102540047|NCT01921751|Gemcitabine|gemcitabine|mesh-list
102540048|NCT01921751|Capecitabine|capecitabine|mesh-list
102540049|NCT01921751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102540050|NCT01921751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102540051|NCT01921751|Tubulin Modulators|tubulin modulators|mesh-ancestor
102540052|NCT01921751|Antimitotic Agents|antimitotic agents|mesh-ancestor
102540053|NCT01921751|Mitosis Modulators|mitosis modulators|mesh-ancestor
102540054|NCT01921751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540055|NCT01921751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102540056|NCT01921751|Antimetabolites|antimetabolites|mesh-ancestor
102540057|NCT02958345|Vaccines|vaccines|mesh-list
102540058|NCT02958345|Immunologic Factors|immunologic factors|mesh-ancestor
101571263|NCT04237987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102540059|NCT02958345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540060|NCT01629134|Hyaluronic Acid|hyaluronic acid|mesh-list
102540061|NCT01629134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102540062|NCT01629134|Immunologic Factors|immunologic factors|mesh-ancestor
102540063|NCT01629134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540064|NCT01629134|Viscosupplements|viscosupplements|mesh-ancestor
102540065|NCT01629134|Protective Agents|protective agents|mesh-ancestor
102540066|NCT01629290|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
102540067|NCT01629290|Cariostatic Agents|cariostatic agents|mesh-ancestor
102540068|NCT01629290|Protective Agents|protective agents|mesh-ancestor
102540069|NCT01629290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540071|NCT01696760|Enoxaparin|enoxaparin|mesh-list
102540072|NCT01696760|Enoxaparin sodium|enoxaparin sodium|mesh-list
102540073|NCT01696760|Anticoagulants|anticoagulants|mesh-ancestor
102540074|NCT01696760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102540075|NCT01696760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102540076|NCT01696760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540077|NCT01696760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102540078|NCT01696760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102540079|NCT01696760|Analgesics|analgesics|mesh-ancestor
102540080|NCT01696760|Sensory System Agents|sensory system agents|mesh-ancestor
102540081|NCT01696760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102540082|NCT01696760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540083|NCT01696760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102540084|NCT01696760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102540085|NCT01696760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102540086|NCT01696760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102540087|NCT01696760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102540088|NCT01696760|Antipyretics|antipyretics|mesh-ancestor
102540089|NCT01924169|Lenalidomide|lenalidomide|mesh-list
102540090|NCT01924169|Vaccines|vaccines|mesh-list
102540091|NCT01924169|Immunologic Factors|immunologic factors|mesh-ancestor
102540092|NCT01924169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540093|NCT01924169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102540094|NCT01924169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102540095|NCT01924169|Growth Substances|growth substances|mesh-ancestor
102540096|NCT01924169|Growth Inhibitors|growth inhibitors|mesh-ancestor
102540097|NCT01924169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102540098|NCT02958969|Apixaban|apixaban|mesh-list
102540099|NCT02958969|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102540100|NCT02958969|Antithrombins|antithrombins|mesh-ancestor
102540101|NCT02958969|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102540102|NCT02958969|Protease Inhibitors|protease inhibitors|mesh-ancestor
102540103|NCT02958969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102540104|NCT02958969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540105|NCT02958969|Anticoagulants|anticoagulants|mesh-ancestor
102540106|NCT01924871|Remifentanil|remifentanil|mesh-list
102540107|NCT01924871|Desflurane|desflurane|mesh-list
102540108|NCT01924871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102540109|NCT01924871|Narcotics|narcotics|mesh-ancestor
102540110|NCT01924871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102540111|NCT01924871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540112|NCT01924871|Analgesics|analgesics|mesh-ancestor
102540113|NCT01924871|Sensory System Agents|sensory system agents|mesh-ancestor
102540114|NCT01924871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102540115|NCT01924871|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102540116|NCT01924871|Anesthetics, General|anesthetics, general|mesh-ancestor
102540117|NCT01924871|Anesthetics|anesthetics|mesh-ancestor
102540118|NCT01698710|Paclitaxel|paclitaxel|mesh-list
102540119|NCT01698710|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102540120|NCT01698710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102540121|NCT01698710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102540122|NCT01698710|Tubulin Modulators|tubulin modulators|mesh-ancestor
102540123|NCT01698710|Antimitotic Agents|antimitotic agents|mesh-ancestor
102540124|NCT01698710|Mitosis Modulators|mitosis modulators|mesh-ancestor
102540125|NCT01698710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540126|NCT01924949|Sofosbuvir|sofosbuvir|mesh-list
102540127|NCT01924949|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102540128|NCT01924949|Ledipasvir|ledipasvir|mesh-list
102540129|NCT01924949|Antiviral Agents|antiviral agents|mesh-ancestor
102540130|NCT01924949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102540131|NCT01938989|Methamphetamine|methamphetamine|mesh-list
102540132|NCT01938989|beta-Endorphin|beta-endorphin|mesh-list
102540133|NCT01938989|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102540134|NCT01938989|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
102540135|NCT01938989|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102540136|NCT01938989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540137|NCT01938989|Sympathomimetics|sympathomimetics|mesh-ancestor
102540138|NCT01938989|Autonomic Agents|autonomic agents|mesh-ancestor
102540139|NCT01938989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102540140|NCT01938989|Dopamine Agents|dopamine agents|mesh-ancestor
102540141|NCT01938989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102540142|NCT01938989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540143|NCT01938989|Adrenergic Agents|adrenergic agents|mesh-ancestor
102540144|NCT01938989|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102540145|NCT01938989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102540146|NCT01938989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102540147|NCT01938989|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102540148|NCT01938989|Hormones|hormones|mesh-ancestor
102540149|NCT01938989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102540150|NCT01939301|Nitric Oxide|nitric oxide|mesh-list
102540151|NCT01939301|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102540152|NCT01939301|Autonomic Agents|autonomic agents|mesh-ancestor
102540153|NCT01939301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102540154|NCT01939301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540155|NCT01939301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102540156|NCT01939301|Respiratory System Agents|respiratory system agents|mesh-ancestor
102540157|NCT01939301|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102540158|NCT01939301|Antioxidants|antioxidants|mesh-ancestor
102540159|NCT01939301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540160|NCT01939301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102540161|NCT01939301|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102540162|NCT01939301|Vasodilator Agents|vasodilator agents|mesh-ancestor
102540163|NCT01939301|Gasotransmitters|gasotransmitters|mesh-ancestor
102540164|NCT01939301|Protective Agents|protective agents|mesh-ancestor
102540165|NCT03078075|Naltrexone|naltrexone|mesh-list
102540166|NCT03078075|Bupropion|bupropion|mesh-list
102540167|NCT03078075|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102540168|NCT03078075|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102540169|NCT03078075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540170|NCT03078075|Sensory System Agents|sensory system agents|mesh-ancestor
102540171|NCT03078075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102540172|NCT03078075|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102540173|NCT03078075|Antidepressive Agents|antidepressive agents|mesh-ancestor
102540174|NCT03078075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102540175|NCT03078075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102540176|NCT03078075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102540177|NCT03078075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102540178|NCT03078075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540179|NCT03078075|Dopamine Agents|dopamine agents|mesh-ancestor
102540180|NCT03078075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102540181|NCT03078075|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102540182|NCT03078075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102540183|NCT03078075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102540184|NCT01926977|Ranibizumab|ranibizumab|mesh-list
102540185|NCT01926977|Aflibercept|aflibercept|mesh-list
102540186|NCT01926977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102540187|NCT01926977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102540188|NCT01926977|Growth Substances|growth substances|mesh-ancestor
102540189|NCT01926977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540190|NCT01926977|Growth Inhibitors|growth inhibitors|mesh-ancestor
102540191|NCT01926977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102540192|NCT01928693|Moxifloxacin|moxifloxacin|mesh-list
102540193|NCT01928693|Gatifloxacin|gatifloxacin|mesh-list
102540194|NCT01928693|Besifloxacin|besifloxacin|mesh-list
102540195|NCT01928693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102540196|NCT01928693|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102540197|NCT01928693|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102540198|NCT01928693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102540199|NCT01928693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102540200|NCT01928693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102540201|NCT01928693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102540202|NCT01928693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102540203|NCT01928693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540204|NCT01928693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102540205|NCT01928693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102540206|NCT01928693|Contraceptive Agents|contraceptive agents|mesh-ancestor
102540207|NCT01928693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102540208|NCT01928693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540209|NCT01928693|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102540210|NCT01928693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102540211|NCT01928693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102540212|NCT01928849|Valproic Acid|valproic acid|mesh-list
102540213|NCT01928849|Anticonvulsants|anticonvulsants|mesh-ancestor
102540214|NCT01928849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102540215|NCT01928849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540216|NCT01928849|GABA Agents|gaba agents|mesh-ancestor
102540217|NCT01928849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102540218|NCT01928849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540219|NCT01928849|Antimanic Agents|antimanic agents|mesh-ancestor
102540220|NCT01928849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102540221|NCT01928849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102540222|NCT01928849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102540223|NCT01631552|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
102540224|NCT01631552|Immunoconjugates|immunoconjugates|mesh-ancestor
102540225|NCT01631552|Immunologic Factors|immunologic factors|mesh-ancestor
102540226|NCT01631552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540227|NCT03081117|Insulin|insulin|mesh-list
102540228|NCT03081117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102540229|NCT03081117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540230|NCT01944293|Midazolam|midazolam|mesh-list
102540231|NCT01944293|Ketamine|ketamine|mesh-list
102540232|NCT01944293|Analgesics|analgesics|mesh-ancestor
102540233|NCT01944293|Sensory System Agents|sensory system agents|mesh-ancestor
102540234|NCT01944293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102540235|NCT01944293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540236|NCT01944293|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102540237|NCT01944293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102540238|NCT01944293|Anesthetics, General|anesthetics, general|mesh-ancestor
102540239|NCT01944293|Anesthetics|anesthetics|mesh-ancestor
102540240|NCT01944293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102540241|NCT01944293|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102540242|NCT01944293|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102540243|NCT01944293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102540244|NCT01944293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540245|NCT01944293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102540246|NCT01944293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102540247|NCT01944293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102540248|NCT01944293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102540249|NCT01944293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102540250|NCT01944293|GABA Modulators|gaba modulators|mesh-ancestor
102540251|NCT01944293|GABA Agents|gaba agents|mesh-ancestor
102540252|NCT01944371|Disulfiram|disulfiram|mesh-list
102540253|NCT01944371|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102540254|NCT01944371|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
102540255|NCT01944371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102540256|NCT01944371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540257|NCT02343120|Zanubrutinib|zanubrutinib|mesh-list
102540258|NCT02343120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102540259|NCT02343120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102540260|NCT02343120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102540261|NCT02343120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540262|NCT01631630|Pioglitazone|pioglitazone|mesh-list
102540263|NCT01631630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102540264|NCT01631630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540265|NCT03837860|Oxycodone|oxycodone|mesh-list
102540266|NCT03837860|Risperidone|risperidone|mesh-list
102540267|NCT03837860|Ziprasidone|ziprasidone|mesh-list
102540268|NCT03837860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102540269|NCT03837860|Narcotics|narcotics|mesh-ancestor
102540270|NCT03837860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102540271|NCT03837860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540272|NCT03837860|Analgesics|analgesics|mesh-ancestor
102540273|NCT03837860|Sensory System Agents|sensory system agents|mesh-ancestor
102540274|NCT03837860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102540275|NCT03837860|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102540276|NCT03837860|Serotonin Agents|serotonin agents|mesh-ancestor
102540277|NCT03837860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102540278|NCT03837860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540279|NCT03837860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102540280|NCT03837860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102540281|NCT03837860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102540282|NCT03837860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102540283|NCT03837860|Dopamine Agents|dopamine agents|mesh-ancestor
102540284|NCT02289989|Hydrocortisone|hydrocortisone|mesh-list
102540285|NCT02289989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102540286|NCT03076112|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102540287|NCT03076112|Ipragliflozin|ipragliflozin|mesh-list
102540288|NCT03076112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102540289|NCT03076112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540290|NCT03076112|Incretins|incretins|mesh-ancestor
102540291|NCT03076112|Hormones|hormones|mesh-ancestor
102540292|NCT03076112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102540293|NCT03076112|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102540294|NCT03076112|Protease Inhibitors|protease inhibitors|mesh-ancestor
102540295|NCT03076112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102540296|NCT03076112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540297|NCT03076112|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102540298|NCT03129945|Indomethacin|indomethacin|mesh-list
102540299|NCT03129945|Nifedipine|nifedipine|mesh-list
102540300|NCT03129945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102540301|NCT03129945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102540302|NCT03129945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540303|NCT03129945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102540304|NCT03129945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540305|NCT03129945|Vasodilator Agents|vasodilator agents|mesh-ancestor
102540306|NCT03129945|Tocolytic Agents|tocolytic agents|mesh-ancestor
102540307|NCT03129945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102540308|NCT03129945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102540309|NCT03129945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102540310|NCT03129945|Analgesics|analgesics|mesh-ancestor
102540311|NCT03129945|Sensory System Agents|sensory system agents|mesh-ancestor
102540312|NCT03129945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102540313|NCT03129945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102540314|NCT03129945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102540315|NCT03129945|Gout Suppressants|gout suppressants|mesh-ancestor
102540316|NCT03129945|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102540317|NCT03129945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102540318|NCT01700036|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
102540319|NCT01700036|Protein C Inhibitor|protein c inhibitor|mesh-list
102540320|NCT01700036|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102540321|NCT01700036|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102540322|NCT01700036|Protease Inhibitors|protease inhibitors|mesh-ancestor
102540323|NCT01700036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241640|NCT04891809|Autonomic Agents|autonomic agents|mesh-ancestor
102540324|NCT01700036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540325|NCT01950299|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102540326|NCT01950299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102540327|NCT03093207|Aspirin|aspirin|mesh-list
102540328|NCT03093207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102540329|NCT03093207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102540330|NCT03093207|Analgesics|analgesics|mesh-ancestor
102540331|NCT03093207|Sensory System Agents|sensory system agents|mesh-ancestor
102540332|NCT03093207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102540333|NCT03093207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540334|NCT03093207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102540335|NCT03093207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102540336|NCT03093207|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102540337|NCT03093207|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102540338|NCT03093207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540339|NCT03093207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102540340|NCT03093207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102540341|NCT03093207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102540342|NCT03093207|Antipyretics|antipyretics|mesh-ancestor
102540343|NCT05482451|Nivolumab|nivolumab|mesh-list
102540344|NCT05482451|Tretinoin|tretinoin|mesh-list
102540345|NCT05482451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102540346|NCT05482451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102540347|NCT05482451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102540348|NCT05482451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540349|NCT05482451|Keratolytic Agents|keratolytic agents|mesh-ancestor
102540350|NCT05482451|Dermatologic Agents|dermatologic agents|mesh-ancestor
102540351|NCT02228408|Hydralazine|hydralazine|mesh-list
102540352|NCT02228408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102540353|NCT02228408|Vasodilator Agents|vasodilator agents|mesh-ancestor
102540354|NCT01951391|Benzalkonium Compounds|benzalkonium compounds|mesh-list
102540355|NCT01951391|Triclocarban|triclocarban|mesh-list
102540356|NCT01951391|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102540357|NCT01951391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102540358|NCT02342886|Moxifloxacin|moxifloxacin|mesh-list
102540359|NCT02342886|Rifampin|rifampin|mesh-list
102540360|NCT02342886|Isoniazid|isoniazid|mesh-list
102540361|NCT02342886|Pyrazinamide|pyrazinamide|mesh-list
102540362|NCT02342886|Ethambutol|ethambutol|mesh-list
102540363|NCT02342886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102540364|NCT02342886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102540365|NCT02342886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102540366|NCT02342886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102540367|NCT02342886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102540368|NCT02342886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540369|NCT02342886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102540370|NCT02342886|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102540371|NCT02342886|Antitubercular Agents|antitubercular agents|mesh-ancestor
102540372|NCT02342886|Leprostatic Agents|leprostatic agents|mesh-ancestor
102540373|NCT02342886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102540374|NCT02342886|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102540375|NCT02342886|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102540376|NCT02342886|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102540377|NCT02342886|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102540378|NCT02342886|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102540379|NCT02342886|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102540380|NCT02342886|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102540381|NCT02342886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102540382|NCT02342886|Antimetabolites|antimetabolites|mesh-ancestor
102540383|NCT02342886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102540384|NCT04350281|Interferons|interferons|mesh-list
102540385|NCT04350281|Interferon-beta|interferon-beta|mesh-list
102540386|NCT04350281|Hydroxychloroquine|hydroxychloroquine|mesh-list
102540387|NCT04350281|Interferon beta-1b|interferon beta-1b|mesh-list
102540388|NCT04350281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102540389|NCT04350281|Antiviral Agents|antiviral agents|mesh-ancestor
102540390|NCT04350281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102540391|NCT04350281|Antimalarials|antimalarials|mesh-ancestor
102540392|NCT04350281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102540393|NCT04350281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102540394|NCT04350281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102540395|NCT04350281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540396|NCT04350281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102540397|NCT04350281|Immunologic Factors|immunologic factors|mesh-ancestor
102540398|NCT04350281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540399|NCT04350281|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102540400|NCT02389998|Hyoscyamine|hyoscyamine|mesh-list
102540401|NCT02389998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102540402|NCT02389998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102540403|NCT02389998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102540404|NCT02389998|Autonomic Agents|autonomic agents|mesh-ancestor
102540405|NCT02389998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102540406|NCT02389998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540407|NCT02389998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102540408|NCT02389998|Respiratory System Agents|respiratory system agents|mesh-ancestor
102540409|NCT02389998|Mydriatics|mydriatics|mesh-ancestor
102540410|NCT02389998|Parasympatholytics|parasympatholytics|mesh-ancestor
102540411|NCT02389998|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102540412|NCT02389998|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102540413|NCT02389998|Cholinergic Agents|cholinergic agents|mesh-ancestor
102540414|NCT02389998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102540415|NCT02389998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540416|NCT02389764|Nintedanib|nintedanib|mesh-list
102540417|NCT02389764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102540418|NCT02389764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102540419|NCT02389764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102540420|NCT02389764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540421|NCT04903470|Bisacodyl|bisacodyl|mesh-list
102540422|NCT04903470|Cathartics|cathartics|mesh-ancestor
102540423|NCT04903470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102540424|NCT04903470|Laxatives|laxatives|mesh-ancestor
102540425|NCT01647932|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102540426|NCT01647932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102540427|NCT01647932|Diuretics|diuretics|mesh-ancestor
102540428|NCT01647932|Natriuretic Agents|natriuretic agents|mesh-ancestor
102540429|NCT01647932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540430|NCT01647932|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102540431|NCT01647932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102540432|NCT01647932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540433|NCT04903002|Oxytocin|oxytocin|mesh-list
102540434|NCT04903002|Oxytocics|oxytocics|mesh-ancestor
102540435|NCT04903002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102540436|NCT04903002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540437|NCT02366130|Denosumab|denosumab|mesh-list
102540438|NCT02366130|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
102540439|NCT02366130|Hormones|hormones|mesh-list
102540440|NCT02366130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102540441|NCT02366130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540442|NCT02366130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102540443|NCT02366130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102540444|NCT01635062|Calcitriol|calcitriol|mesh-list
102540445|NCT01635062|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
102540446|NCT01635062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102540447|NCT01635062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540448|NCT01635062|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102540449|NCT01635062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102540450|NCT01635062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540451|NCT01635062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102540452|NCT01635062|Vitamins|vitamins|mesh-ancestor
102540453|NCT01635062|Micronutrients|micronutrients|mesh-ancestor
102540454|NCT01635062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102540455|NCT01637090|Everolimus|everolimus|mesh-list
102540456|NCT01637090|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102540457|NCT01637090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102540458|NCT01637090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102540459|NCT01637090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540460|NCT01637090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102540461|NCT01637090|Immunologic Factors|immunologic factors|mesh-ancestor
102540462|NCT01637090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540463|NCT01637090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102540464|NCT02389452|Hylan|hylan|mesh-list
102540465|NCT02389452|Viscosupplements|viscosupplements|mesh-ancestor
102540466|NCT02389452|Protective Agents|protective agents|mesh-ancestor
102540467|NCT02389452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540468|NCT02365584|Lanreotide|lanreotide|mesh-list
102540469|NCT02365584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102540470|NCT02342418|Tedizolid|tedizolid|mesh-list
102540471|NCT02342418|Tedizolid phosphate|tedizolid phosphate|mesh-list
102540472|NCT02342418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102540473|NCT02342418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102540474|NCT05727449|Anesthetics|anesthetics|mesh-list
102540475|NCT05727449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102540476|NCT05727449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540477|NCT03102645|Imipramine|imipramine|mesh-list
102540478|NCT03102645|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102540479|NCT03102645|Antidepressive Agents|antidepressive agents|mesh-ancestor
102540480|NCT03102645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102540481|NCT03102645|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102540482|NCT03102645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101760488|NCT00838227|Modafinil|modafinil|mesh-list
102540483|NCT03102645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102540484|NCT03102645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540485|NCT03102645|Adrenergic Agents|adrenergic agents|mesh-ancestor
102540486|NCT03102645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102540487|NCT03102645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540488|NCT01639352|Pasireotide|pasireotide|mesh-list
102540489|NCT01639352|Hormones|hormones|mesh-ancestor
102540490|NCT01639352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102540491|NCT01639352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540492|NCT01705496|Fialuridine|fialuridine|mesh-list
102540493|NCT01705496|Antiviral Agents|antiviral agents|mesh-ancestor
102540494|NCT01705496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102540495|NCT01705496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102540496|NCT01705496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102540497|NCT01705496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540498|NCT02287415|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102540499|NCT02287415|Warfarin|warfarin|mesh-list
102540500|NCT02287415|Anticoagulants|anticoagulants|mesh-ancestor
102540501|NCT02287415|Anticonvulsants|anticonvulsants|mesh-ancestor
102540502|NCT02287415|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102540503|NCT02287415|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102540504|NCT02287415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102540505|NCT02287415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540506|NCT02312934|Nicotine|nicotine|mesh-list
102540507|NCT02312934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102540508|NCT02312934|Autonomic Agents|autonomic agents|mesh-ancestor
102540509|NCT02312934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102540510|NCT02312934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540511|NCT02312934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102540512|NCT02312934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102540513|NCT02312934|Cholinergic Agents|cholinergic agents|mesh-ancestor
102540514|NCT02312934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102540515|NCT02312934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540516|NCT04707027|Aflibercept|aflibercept|mesh-list
102540517|NCT04707027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102540518|NCT04707027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102540519|NCT04707027|Growth Substances|growth substances|mesh-ancestor
102540520|NCT04707027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540521|NCT04707027|Growth Inhibitors|growth inhibitors|mesh-ancestor
102540522|NCT04707027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102540523|NCT01602068|Dexamethasone|dexamethasone|mesh-list
102540524|NCT01602068|Citric Acid|citric acid|mesh-list
102540525|NCT01602068|Sodium Citrate|sodium citrate|mesh-list
102540526|NCT01602068|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102540527|NCT01602068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102540528|NCT01602068|Antiemetics|antiemetics|mesh-ancestor
102540529|NCT01602068|Autonomic Agents|autonomic agents|mesh-ancestor
102540530|NCT01602068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102540531|NCT01602068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540532|NCT01602068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102540533|NCT01602068|Glucocorticoids|glucocorticoids|mesh-ancestor
102540534|NCT01602068|Hormones|hormones|mesh-ancestor
102540535|NCT01602068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102540536|NCT01602068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102540537|NCT01602068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102540538|NCT01602068|Anticoagulants|anticoagulants|mesh-ancestor
102540539|NCT01602068|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102540540|NCT01602068|Chelating Agents|chelating agents|mesh-ancestor
102540541|NCT01602068|Sequestering Agents|sequestering agents|mesh-ancestor
102540542|NCT01602068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540543|NCT02978157|Amoxicillin|amoxicillin|mesh-list
102540544|NCT02978157|Levofloxacin|levofloxacin|mesh-list
102540545|NCT02978157|Ofloxacin|ofloxacin|mesh-list
102540546|NCT02978157|Tetracycline|tetracycline|mesh-list
102540547|NCT02978157|Esomeprazole|esomeprazole|mesh-list
102540548|NCT02978157|Bismuth|bismuth|mesh-list
102540549|NCT02978157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102540550|NCT02978157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102540551|NCT02978157|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102540552|NCT02978157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102540553|NCT02978157|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102540554|NCT02978157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102540555|NCT02978157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540556|NCT02978157|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102540557|NCT02978157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102540558|NCT02978157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102540559|NCT02978157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102540560|NCT02978157|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102540561|NCT02978157|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102540562|NCT02978157|Antacids|antacids|mesh-ancestor
102540563|NCT02978157|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102540564|NCT01705964|Epinephrine|epinephrine|mesh-list
102540565|NCT01705964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102540566|NCT01705964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102540567|NCT01705964|Adrenergic Agents|adrenergic agents|mesh-ancestor
102540568|NCT01705964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102540569|NCT01705964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540570|NCT01705964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540571|NCT01705964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102540572|NCT01705964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102540573|NCT01705964|Autonomic Agents|autonomic agents|mesh-ancestor
102540574|NCT01705964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102540575|NCT01705964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102540576|NCT01705964|Respiratory System Agents|respiratory system agents|mesh-ancestor
102540577|NCT01705964|Mydriatics|mydriatics|mesh-ancestor
102540578|NCT01705964|Sympathomimetics|sympathomimetics|mesh-ancestor
102540579|NCT01705964|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102540580|NCT02341482|Itraconazole|itraconazole|mesh-list
102540581|NCT02341482|Antifungal Agents|antifungal agents|mesh-ancestor
102540582|NCT02341482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102540583|NCT02341482|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101760560|NCT01046383|Caseins|caseins|mesh-list
102540584|NCT02341482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102540585|NCT02341482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102540586|NCT02341482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540587|NCT02341482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101571794|NCT00955474|Citalopram|citalopram|mesh-list
102540588|NCT02341482|Hormone Antagonists|hormone antagonists|mesh-ancestor
102540589|NCT02341482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102540590|NCT02341482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540591|NCT02341482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102540593|NCT03140631|Heparin Antagonists|heparin antagonists|mesh-ancestor
102540594|NCT03140631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540595|NCT03140631|Coagulants|coagulants|mesh-ancestor
102540596|NCT04420260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
102540597|NCT04420260|Immunologic Factors|immunologic factors|mesh-ancestor
102540598|NCT04420260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540599|NCT00422643|Hyaluronic Acid|hyaluronic acid|mesh-list
102540600|NCT00422643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102540601|NCT00422643|Immunologic Factors|immunologic factors|mesh-ancestor
102540602|NCT00422643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540603|NCT00422643|Viscosupplements|viscosupplements|mesh-ancestor
102540604|NCT00422643|Protective Agents|protective agents|mesh-ancestor
102540605|NCT05405907|Hemostatics|hemostatics|mesh-list
102540606|NCT05405907|Coagulants|coagulants|mesh-ancestor
102540607|NCT01706588|Diclofenac|diclofenac|mesh-list
102540608|NCT01706588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102540609|NCT01706588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102540610|NCT01706588|Analgesics|analgesics|mesh-ancestor
102540611|NCT01706588|Sensory System Agents|sensory system agents|mesh-ancestor
102540612|NCT01706588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102540613|NCT01706588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540614|NCT01706588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102540615|NCT01706588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102540616|NCT01706588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102540617|NCT01706588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102540618|NCT01706588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540619|NCT01602692|Lidocaine|lidocaine|mesh-list
102540620|NCT01602692|Epinephrine|epinephrine|mesh-list
102540621|NCT01602692|Racepinephrine|racepinephrine|mesh-list
102540622|NCT01602692|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102540623|NCT01602692|Epinephryl borate|epinephryl borate|mesh-list
102540624|NCT01602692|Anesthetics, Local|anesthetics, local|mesh-ancestor
102540625|NCT01602692|Anesthetics|anesthetics|mesh-ancestor
102540626|NCT01602692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102540627|NCT01602692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540628|NCT01602692|Sensory System Agents|sensory system agents|mesh-ancestor
102540629|NCT01602692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102540630|NCT01602692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102540631|NCT01602692|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102540632|NCT01602692|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102540633|NCT01602692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102540634|NCT01602692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540635|NCT01602692|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102540636|NCT01602692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102540637|NCT01602692|Adrenergic Agents|adrenergic agents|mesh-ancestor
102540638|NCT01602692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102540639|NCT01602692|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102540640|NCT01602692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102540641|NCT01602692|Autonomic Agents|autonomic agents|mesh-ancestor
102540642|NCT01602692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102540643|NCT01602692|Respiratory System Agents|respiratory system agents|mesh-ancestor
102540644|NCT01602692|Mydriatics|mydriatics|mesh-ancestor
102540645|NCT01602692|Sympathomimetics|sympathomimetics|mesh-ancestor
102540646|NCT01602692|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102540647|NCT01603940|Losartan|losartan|mesh-list
102540648|NCT01603940|Benazepril|benazepril|mesh-list
102540649|NCT01603940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102540650|NCT01603940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102540651|NCT01603940|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102540652|NCT01603940|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102540653|NCT01603940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540654|NCT01603940|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102540655|NCT01603940|Protease Inhibitors|protease inhibitors|mesh-ancestor
102540656|NCT01603940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102540657|NCT01605032|Bortezomib|bortezomib|mesh-list
102540658|NCT01605032|Melphalan|melphalan|mesh-list
102540659|NCT01605032|Busulfan|busulfan|mesh-list
102540660|NCT01605032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102540661|NCT01605032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102540662|NCT01605032|Alkylating Agents|alkylating agents|mesh-ancestor
102540663|NCT01605032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540664|NCT01605032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102540665|NCT01605032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102540666|NCT01605032|Immunologic Factors|immunologic factors|mesh-ancestor
102540667|NCT01605032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540668|NCT01706666|Dexamethasone|dexamethasone|mesh-list
102540669|NCT01706666|Cyclophosphamide|cyclophosphamide|mesh-list
102540670|NCT01706666|Lenalidomide|lenalidomide|mesh-list
102540671|NCT01706666|Bortezomib|bortezomib|mesh-list
102540672|NCT01706666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102540673|NCT01706666|Immunologic Factors|immunologic factors|mesh-ancestor
102540674|NCT01706666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540675|NCT01706666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102540676|NCT01706666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102540677|NCT01706666|Alkylating Agents|alkylating agents|mesh-ancestor
102540678|NCT01706666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540679|NCT01706666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102540680|NCT01706666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102540681|NCT01706666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101760676|NCT02548923|Propofol|propofol|mesh-list
102540682|NCT01706666|Antiemetics|antiemetics|mesh-ancestor
102540683|NCT01706666|Autonomic Agents|autonomic agents|mesh-ancestor
102540684|NCT01706666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102540685|NCT01706666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102540686|NCT01706666|Glucocorticoids|glucocorticoids|mesh-ancestor
102540687|NCT01706666|Hormones|hormones|mesh-ancestor
102540688|NCT01706666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102540689|NCT01706666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102540690|NCT01706666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102540691|NCT01706666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102540692|NCT01706666|Growth Substances|growth substances|mesh-ancestor
102540693|NCT01706666|Growth Inhibitors|growth inhibitors|mesh-ancestor
102540694|NCT03149991|Ketamine|ketamine|mesh-list
102540695|NCT03149991|Brexpiprazole|brexpiprazole|mesh-list
102540696|NCT03149991|Analgesics|analgesics|mesh-ancestor
102540697|NCT03149991|Sensory System Agents|sensory system agents|mesh-ancestor
102540698|NCT03149991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102540699|NCT03149991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540700|NCT03149991|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102540701|NCT03149991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102540702|NCT03149991|Anesthetics, General|anesthetics, general|mesh-ancestor
102540703|NCT03149991|Anesthetics|anesthetics|mesh-ancestor
102540704|NCT03149991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102540705|NCT03149991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102540706|NCT03149991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102540707|NCT03149991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102540708|NCT03149991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540709|NCT03149991|Serotonin Agents|serotonin agents|mesh-ancestor
102540710|NCT03149991|Dopamine Agonists|dopamine agonists|mesh-ancestor
102540711|NCT03149991|Dopamine Agents|dopamine agents|mesh-ancestor
102540712|NCT05704439|Antihypertensive Agents|antihypertensive agents|mesh-list
102540713|NCT05400993|Cyclophosphamide|cyclophosphamide|mesh-list
102540714|NCT05400993|Docetaxel|docetaxel|mesh-list
102540715|NCT05400993|Epirubicin|epirubicin|mesh-list
102540716|NCT05400993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102540717|NCT05400993|Immunologic Factors|immunologic factors|mesh-ancestor
102540718|NCT05400993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540719|NCT05400993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102540720|NCT05400993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102540721|NCT05400993|Alkylating Agents|alkylating agents|mesh-ancestor
102540722|NCT05400993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540723|NCT05400993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102540724|NCT05400993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102540725|NCT05400993|Tubulin Modulators|tubulin modulators|mesh-ancestor
102540726|NCT05400993|Antimitotic Agents|antimitotic agents|mesh-ancestor
102540727|NCT05400993|Mitosis Modulators|mitosis modulators|mesh-ancestor
102540728|NCT05400993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102540729|NCT05400993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102540730|NCT05400993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102540731|NCT05400993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102540732|NCT01605890|Tenofovir|tenofovir|mesh-list
102540733|NCT01605890|Emtricitabine|emtricitabine|mesh-list
102540734|NCT01605890|Raltegravir Potassium|raltegravir potassium|mesh-list
102540735|NCT01605890|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102540736|NCT01605890|Antiviral Agents|antiviral agents|mesh-ancestor
102540737|NCT01605890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101571947|NCT04081831|Aspirin|aspirin|mesh-list
102540738|NCT01605890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101760718|NCT00839397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102540739|NCT01605890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102540740|NCT01605890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102540741|NCT01605890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540742|NCT01605890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102540743|NCT01605890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102540744|NCT01605890|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102540745|NCT01605890|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102540746|NCT02288273|Exenatide|exenatide|mesh-list
102540747|NCT02288273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102540748|NCT02288273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540749|NCT02288273|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102540750|NCT02288273|Incretins|incretins|mesh-ancestor
102540751|NCT02288273|Hormones|hormones|mesh-ancestor
102540752|NCT02288273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102540753|NCT01606124|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
102540754|NCT01606124|Antioxidants|antioxidants|mesh-ancestor
102540755|NCT01606124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540756|NCT01606124|Protective Agents|protective agents|mesh-ancestor
102540757|NCT01606124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540758|NCT01606124|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
102540759|NCT01606124|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102540760|NCT01606124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102540761|NCT01606124|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102540762|NCT01607450|Glucagon|glucagon|mesh-list
102540763|NCT01607450|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102540764|NCT01607450|Incretins|incretins|mesh-ancestor
102540765|NCT01607450|Hormones|hormones|mesh-ancestor
102540766|NCT01607450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102540767|NCT01607450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540768|NCT01607450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102540769|NCT05738993|Pertuzumab|pertuzumab|mesh-list
102540770|NCT05738993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102540771|NCT05738993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102540772|NCT01709474|Vitamin D|vitamin d|mesh-list
102540773|NCT01709474|Ergocalciferols|ergocalciferols|mesh-list
102540774|NCT01709474|Cholecalciferol|cholecalciferol|mesh-list
102540775|NCT01709474|Vitamins|vitamins|mesh-list
102540776|NCT01709474|Micronutrients|micronutrients|mesh-ancestor
102540777|NCT01709474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540778|NCT01709474|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102540779|NCT01709474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102540780|NCT02992808|Menotropins|menotropins|mesh-list
102540781|NCT02992808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102540782|NCT02992808|Fertility Agents|fertility agents|mesh-ancestor
102540783|NCT02992808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102540784|NCT02992808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540785|NCT02992886|Raltitrexed|raltitrexed|mesh-list
102540786|NCT02992886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102540787|NCT02992886|Antimetabolites|antimetabolites|mesh-ancestor
102540788|NCT02992886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540789|NCT02992886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102540790|NCT02992886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102540791|NCT02992886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102540792|NCT02331095|Warfarin|warfarin|mesh-list
102540793|NCT02331095|Rivaroxaban|rivaroxaban|mesh-list
102540794|NCT02331095|Atorvastatin|atorvastatin|mesh-list
102540795|NCT02331095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102540796|NCT02331095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102540797|NCT02331095|Antimetabolites|antimetabolites|mesh-ancestor
102540798|NCT02331095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540799|NCT02331095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102540800|NCT02331095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102540801|NCT02331095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102540802|NCT02331095|Anticoagulants|anticoagulants|mesh-ancestor
102540803|NCT02331095|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102540804|NCT02331095|Antithrombins|antithrombins|mesh-ancestor
102540805|NCT02331095|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102540806|NCT02331095|Protease Inhibitors|protease inhibitors|mesh-ancestor
102540807|NCT01640834|Glucagon|glucagon|mesh-list
102540808|NCT01640834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102540809|NCT01640834|Hormones|hormones|mesh-ancestor
102540810|NCT01640834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102540811|NCT01640834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540812|NCT03029273|Cyclophosphamide|cyclophosphamide|mesh-list
102154144|NCT00436254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540813|NCT03029273|Fludarabine|fludarabine|mesh-list
102540814|NCT03029273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102540815|NCT03029273|Immunologic Factors|immunologic factors|mesh-ancestor
102540816|NCT03029273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540817|NCT03029273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102540818|NCT03029273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102540819|NCT03029273|Alkylating Agents|alkylating agents|mesh-ancestor
102540820|NCT03029273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540821|NCT03029273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102540822|NCT03029273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102540823|NCT05316935|Letrozole|letrozole|mesh-list
102540824|NCT05316935|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102540825|NCT05316935|Cyproterone|cyproterone|mesh-list
102540826|NCT05316935|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
102540827|NCT05316935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102540828|NCT05316935|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102540829|NCT05316935|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102540830|NCT05316935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102540831|NCT05316935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540832|NCT05316935|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102540833|NCT05316935|Hormone Antagonists|hormone antagonists|mesh-ancestor
102540834|NCT05316935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102540835|NCT05316935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540836|NCT05316935|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102540837|NCT05316935|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102540838|NCT05316935|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102540839|NCT05316935|Contraceptive Agents|contraceptive agents|mesh-ancestor
102540840|NCT05316935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102540841|NCT05316935|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102540842|NCT05316935|Estrogens|estrogens|mesh-ancestor
102540843|NCT05316935|Hormones|hormones|mesh-ancestor
102540844|NCT05316935|Androgen Antagonists|androgen antagonists|mesh-ancestor
102540845|NCT05738759|Anesthetics|anesthetics|mesh-list
102540846|NCT05738759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102540847|NCT05738759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540848|NCT05738681|Acetylcysteine|acetylcysteine|mesh-list
102540849|NCT05738681|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102540850|NCT05738681|Antiviral Agents|antiviral agents|mesh-ancestor
102540851|NCT05738681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102540852|NCT05738681|Expectorants|expectorants|mesh-ancestor
102540853|NCT05738681|Respiratory System Agents|respiratory system agents|mesh-ancestor
102540854|NCT05738681|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102540855|NCT05738681|Antioxidants|antioxidants|mesh-ancestor
102540856|NCT05738681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540857|NCT05738681|Protective Agents|protective agents|mesh-ancestor
102540858|NCT05738681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540859|NCT05738681|Antidotes|antidotes|mesh-ancestor
102540860|NCT01642082|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
102540861|NCT01642082|Immunologic Factors|immunologic factors|mesh-ancestor
102540862|NCT01642082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540863|NCT02288819|Diuretics|diuretics|mesh-list
102540864|NCT02288819|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
102540865|NCT02288819|Natriuretic Agents|natriuretic agents|mesh-ancestor
102540866|NCT02288819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540867|NCT02288819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102540868|NCT02288819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540869|NCT01642238|Aspirin|aspirin|mesh-list
102540870|NCT01642238|Hirudins|hirudins|mesh-list
102540871|NCT01642238|Bivalirudin|bivalirudin|mesh-list
102540872|NCT01642238|Clopidogrel|clopidogrel|mesh-list
102540873|NCT01642238|Ticagrelor|ticagrelor|mesh-list
102540874|NCT01642238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102540875|NCT01642238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102540876|NCT01642238|Analgesics|analgesics|mesh-ancestor
102540877|NCT01642238|Sensory System Agents|sensory system agents|mesh-ancestor
102540878|NCT01642238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102540879|NCT01642238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540880|NCT01642238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102540881|NCT01642238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102540882|NCT01642238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102540883|NCT01642238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102540884|NCT01642238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540885|NCT01642238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102540886|NCT01642238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102540887|NCT01642238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102540888|NCT01642238|Antipyretics|antipyretics|mesh-ancestor
102540889|NCT01642238|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102540890|NCT01642238|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102540891|NCT01642238|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102540892|NCT01642238|Purinergic Agents|purinergic agents|mesh-ancestor
102540893|NCT01642238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102540894|NCT01642238|Antithrombins|antithrombins|mesh-ancestor
102540895|NCT01642238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102540896|NCT01642238|Protease Inhibitors|protease inhibitors|mesh-ancestor
102540897|NCT01642238|Anticoagulants|anticoagulants|mesh-ancestor
102540898|NCT05259995|Oxymetazoline|oxymetazoline|mesh-list
102540899|NCT05259995|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102540900|NCT05259995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102540901|NCT05259995|Adrenergic Agents|adrenergic agents|mesh-ancestor
102540902|NCT05259995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102540903|NCT05259995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540904|NCT05259995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540905|NCT05259995|Sympathomimetics|sympathomimetics|mesh-ancestor
102540906|NCT05259995|Autonomic Agents|autonomic agents|mesh-ancestor
102540907|NCT05259995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102540908|NCT05259995|Nasal Decongestants|nasal decongestants|mesh-ancestor
102540909|NCT05259995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102540910|NCT05259995|Respiratory System Agents|respiratory system agents|mesh-ancestor
102540911|NCT03028883|Buprenorphine|buprenorphine|mesh-list
102540912|NCT03028883|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102540913|NCT03028883|Narcotics|narcotics|mesh-ancestor
102540914|NCT03028883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102540915|NCT03028883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540916|NCT03028883|Analgesics|analgesics|mesh-ancestor
102540917|NCT03028883|Sensory System Agents|sensory system agents|mesh-ancestor
102540918|NCT03028883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102540919|NCT03028883|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102540920|NCT05238467|Antibodies|antibodies|mesh-list
102540921|NCT05238467|Immunologic Factors|immunologic factors|mesh-ancestor
102540922|NCT05238467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540923|NCT02290613|Ambrisentan|ambrisentan|mesh-list
102540924|NCT02290613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102540925|NCT02986685|Rabeprazole|rabeprazole|mesh-list
102540926|NCT02986685|Trimebutine|trimebutine|mesh-list
102540927|NCT02986685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102540928|NCT02986685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540929|NCT02986685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102540930|NCT02986685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102540931|NCT02986685|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102540932|NCT02986685|Parasympatholytics|parasympatholytics|mesh-ancestor
102540933|NCT02986685|Autonomic Agents|autonomic agents|mesh-ancestor
102540934|NCT02986685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102540935|NCT02986685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540936|NCT01610570|Plicamycin|plicamycin|mesh-list
102540937|NCT01610570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102540938|NCT01610570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540939|NCT01610570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102540940|NCT01610570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102540941|NCT01610570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102540942|NCT01610570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102540943|NCT01610570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540944|NCT01610570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102540945|NCT01611662|Gemcitabine|gemcitabine|mesh-list
102540946|NCT01611662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102540947|NCT01611662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102540948|NCT01611662|Antimetabolites|antimetabolites|mesh-ancestor
102540949|NCT01611662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540950|NCT05200481|Carboplatin|carboplatin|mesh-list
102540951|NCT05200481|Pemetrexed|pemetrexed|mesh-list
102540952|NCT05200481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102540953|NCT05200481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102540954|NCT05200481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540955|NCT05200481|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102540956|NCT05200481|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102540957|NCT01615484|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102540958|NCT05139563|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102540959|NCT05139563|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102540960|NCT05139563|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101572175|NCT02805049|Caspofungin|caspofungin|mesh-list
102540961|NCT05139563|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102540963|NCT01646762|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102540964|NCT01646762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102540965|NCT01646762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102540966|NCT01646762|Tubulin Modulators|tubulin modulators|mesh-ancestor
102540967|NCT01646762|Antimitotic Agents|antimitotic agents|mesh-ancestor
102540968|NCT01646762|Mitosis Modulators|mitosis modulators|mesh-ancestor
102540969|NCT01646762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540970|NCT04997525|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102540971|NCT04997525|Estradiol|estradiol|mesh-list
102540972|NCT04997525|Progesterone|progesterone|mesh-list
102540973|NCT04997525|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102540974|NCT04997525|Estrogens|estrogens|mesh-ancestor
102540975|NCT04997525|Hormones|hormones|mesh-ancestor
102540976|NCT04997525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102540977|NCT04997525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540978|NCT04997525|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102540979|NCT04997525|Progestins|progestins|mesh-ancestor
102540980|NCT01649180|Axitinib|axitinib|mesh-list
102540981|NCT01649180|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102540982|NCT01649180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102540983|NCT01649180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102540984|NCT01649180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102540985|NCT01649180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102540986|NCT04408313|Naltrexone|naltrexone|mesh-list
102540987|NCT04408313|Buprenorphine|buprenorphine|mesh-list
102540988|NCT04408313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102540989|NCT04408313|Narcotics|narcotics|mesh-ancestor
102540990|NCT04408313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102540991|NCT04408313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102540992|NCT04408313|Analgesics|analgesics|mesh-ancestor
102540993|NCT04408313|Sensory System Agents|sensory system agents|mesh-ancestor
102540994|NCT04408313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102540995|NCT04408313|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102540996|NCT04408313|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102540997|NCT01619774|Trametinib|trametinib|mesh-list
102540998|NCT01619774|Dabrafenib|dabrafenib|mesh-list
102540999|NCT01619774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102541000|NCT01619774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102541001|NCT01619774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102541002|NCT01619774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541003|NCT01651442|Zolpidem|zolpidem|mesh-list
102541004|NCT01651442|Trazodone|trazodone|mesh-list
102541005|NCT01651442|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102541006|NCT01651442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102541007|NCT01651442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102541008|NCT01651442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541009|NCT01651442|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102541010|NCT01651442|GABA Agonists|gaba agonists|mesh-ancestor
102541011|NCT01651442|GABA Agents|gaba agents|mesh-ancestor
102541012|NCT01651442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102541013|NCT01651442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541014|NCT01651442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102541015|NCT01651442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102541016|NCT01651442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102541017|NCT01651442|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102541018|NCT01651442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102541019|NCT01651442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102541020|NCT01651442|Serotonin Agents|serotonin agents|mesh-ancestor
102541021|NCT01651442|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102541022|NCT01651442|Antidepressive Agents|antidepressive agents|mesh-ancestor
102541023|NCT04901975|Spironolactone|spironolactone|mesh-list
102541024|NCT04901975|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102541025|NCT04901975|Hormone Antagonists|hormone antagonists|mesh-ancestor
102541026|NCT04901975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102541027|NCT04901975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541028|NCT04901975|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102541029|NCT04901975|Diuretics|diuretics|mesh-ancestor
102541030|NCT04901975|Natriuretic Agents|natriuretic agents|mesh-ancestor
102541031|NCT05421416|Loratadine|loratadine|mesh-list
102541032|NCT05421416|Antipruritics|antipruritics|mesh-ancestor
102541033|NCT05421416|Dermatologic Agents|dermatologic agents|mesh-ancestor
102541034|NCT05421416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102541035|NCT05421416|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102541036|NCT05421416|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102541037|NCT05421416|Histamine Antagonists|histamine antagonists|mesh-ancestor
102541038|NCT05421416|Histamine Agents|histamine agents|mesh-ancestor
102541039|NCT05421416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102541040|NCT05421416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541041|NCT05421416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541042|NCT04868045|Hormones|hormones|mesh-list
102541043|NCT04868045|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
102541044|NCT04868045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102541045|NCT04868045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541046|NCT04803539|Capecitabine|capecitabine|mesh-list
102541047|NCT04803539|Apatinib|apatinib|mesh-list
102541048|NCT04803539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102541049|NCT04803539|Antimetabolites|antimetabolites|mesh-ancestor
102541050|NCT04803539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541051|NCT04803539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102541052|NCT04803539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102541053|NCT04803539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102541054|NCT04799015|Dexamethasone|dexamethasone|mesh-list
102541055|NCT04799015|Metoclopramide|metoclopramide|mesh-list
102541056|NCT04799015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102541057|NCT04799015|Antiemetics|antiemetics|mesh-ancestor
102541058|NCT04799015|Autonomic Agents|autonomic agents|mesh-ancestor
102541059|NCT04799015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102541060|NCT04799015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541061|NCT04799015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102541062|NCT04799015|Glucocorticoids|glucocorticoids|mesh-ancestor
102541063|NCT04799015|Hormones|hormones|mesh-ancestor
102541064|NCT04799015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102541065|NCT04799015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102541066|NCT04799015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102541067|NCT04799015|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102541068|NCT04799015|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102541069|NCT04799015|Dopamine Agents|dopamine agents|mesh-ancestor
102541070|NCT04799015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102541071|NCT04799015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541072|NCT01658228|Donepezil|donepezil|mesh-list
102541073|NCT01658228|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102541074|NCT01658228|Citalopram|citalopram|mesh-list
102541075|NCT01658228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102541076|NCT01658228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102541077|NCT01658228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541078|NCT01658228|Cholinergic Agents|cholinergic agents|mesh-ancestor
102541079|NCT01658228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102541080|NCT01658228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541081|NCT01658228|Nootropic Agents|nootropic agents|mesh-ancestor
102541082|NCT01658228|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102541083|NCT01658228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102541084|NCT01658228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102541085|NCT01658228|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102541086|NCT01658228|Antidepressive Agents|antidepressive agents|mesh-ancestor
102541087|NCT01658228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102241641|NCT04891809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102541088|NCT01658228|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102541089|NCT01658228|Serotonin Agents|serotonin agents|mesh-ancestor
102541090|NCT05709938|Insulin|insulin|mesh-list
102541091|NCT05709938|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102541092|NCT05709938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102541093|NCT05709938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541094|NCT01659866|Ciprofloxacin|ciprofloxacin|mesh-list
102541095|NCT01659866|Gentamicins|gentamicins|mesh-list
102541096|NCT01659866|Ceftriaxone|ceftriaxone|mesh-list
102541097|NCT01659866|Imipenem|imipenem|mesh-list
102541098|NCT01659866|Amikacin|amikacin|mesh-list
102541099|NCT01659866|Cefuroxime|cefuroxime|mesh-list
102541100|NCT01659866|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102541101|NCT01659866|Aztreonam|aztreonam|mesh-list
102541102|NCT01659866|Trimethoprim|trimethoprim|mesh-list
102541103|NCT01659866|Sulfamethoxazole|sulfamethoxazole|mesh-list
102541104|NCT01659866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102541105|NCT01659866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102541106|NCT01659866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102541107|NCT01659866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102541108|NCT01659866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102541109|NCT01659866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572325|NCT04233463|Hormones|hormones|mesh-ancestor
102541110|NCT01659866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102541111|NCT01659866|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102541112|NCT01659866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102541113|NCT01659866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102541114|NCT01659866|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102541115|NCT01659866|Antimalarials|antimalarials|mesh-ancestor
102541116|NCT01659866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102541117|NCT01659866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102541118|NCT01659866|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102541119|NCT01659866|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102541120|NCT01659866|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102541121|NCT02249702|Gemcitabine|gemcitabine|mesh-list
102541122|NCT02249702|Docetaxel|docetaxel|mesh-list
102541123|NCT02249702|Trabectedin|trabectedin|mesh-list
102541124|NCT02249702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102541125|NCT02249702|Antimetabolites|antimetabolites|mesh-ancestor
102541126|NCT02249702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541127|NCT02249702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102541128|NCT02249702|Tubulin Modulators|tubulin modulators|mesh-ancestor
102541129|NCT02249702|Antimitotic Agents|antimitotic agents|mesh-ancestor
102541130|NCT02249702|Mitosis Modulators|mitosis modulators|mesh-ancestor
102541131|NCT02249702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102541132|NCT02249702|Alkylating Agents|alkylating agents|mesh-ancestor
102541133|NCT02947529|Tranexamic Acid|tranexamic acid|mesh-list
102541134|NCT02947529|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102541135|NCT02947529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102541136|NCT02947529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541137|NCT02947529|Hemostatics|hemostatics|mesh-ancestor
102541138|NCT02947529|Coagulants|coagulants|mesh-ancestor
102541139|NCT01660802|Dexamethasone|dexamethasone|mesh-list
102541140|NCT01660802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102541141|NCT01660802|Antiemetics|antiemetics|mesh-ancestor
102541142|NCT01660802|Autonomic Agents|autonomic agents|mesh-ancestor
102541143|NCT01660802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102541144|NCT01660802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541145|NCT01660802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102541146|NCT01660802|Glucocorticoids|glucocorticoids|mesh-ancestor
102541147|NCT01660802|Hormones|hormones|mesh-ancestor
102541148|NCT01660802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102541149|NCT01660802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102541150|NCT01660802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102541151|NCT02899325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102541152|NCT02899325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102541153|NCT02899325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541154|NCT01661114|Gemcitabine|gemcitabine|mesh-list
102541155|NCT01661114|Fluorouracil|fluorouracil|mesh-list
102541156|NCT01661114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102541157|NCT01661114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102541158|NCT01661114|Antimetabolites|antimetabolites|mesh-ancestor
102541159|NCT01661114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541160|NCT01661114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102541161|NCT01661114|Immunologic Factors|immunologic factors|mesh-ancestor
102541162|NCT01661114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541163|NCT02683265|Methylphenidate|methylphenidate|mesh-list
102541164|NCT02683265|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102541165|NCT02683265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541166|NCT02683265|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102541167|NCT02683265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102541168|NCT02683265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102541169|NCT02683265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541170|NCT02683265|Dopamine Agents|dopamine agents|mesh-ancestor
102541171|NCT02683265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102541172|NCT02987829|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
102541173|NCT02987829|Androgen Antagonists|androgen antagonists|mesh-ancestor
102541174|NCT02987829|Hormone Antagonists|hormone antagonists|mesh-ancestor
102541175|NCT02987829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102541176|NCT02987829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541177|NCT02988843|Bevacizumab|bevacizumab|mesh-list
102541178|NCT02988843|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102541179|NCT02988843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102541180|NCT02988843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102541181|NCT02988843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102541182|NCT02988843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102541183|NCT02988843|Growth Substances|growth substances|mesh-ancestor
102541184|NCT02988843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541185|NCT02988843|Growth Inhibitors|growth inhibitors|mesh-ancestor
102541186|NCT02988843|Immunotoxins|immunotoxins|mesh-ancestor
102541187|NCT02988843|Immunoconjugates|immunoconjugates|mesh-ancestor
102541188|NCT02988843|Immunologic Factors|immunologic factors|mesh-ancestor
102541189|NCT01661270|Aflibercept|aflibercept|mesh-list
102541190|NCT01661270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102541191|NCT01661270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102541192|NCT01661270|Growth Substances|growth substances|mesh-ancestor
102541193|NCT01661270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541194|NCT01661270|Growth Inhibitors|growth inhibitors|mesh-ancestor
102541195|NCT01661270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102541196|NCT03000309|Apremilast|apremilast|mesh-list
102541197|NCT03000309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102541198|NCT03000309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102541199|NCT03000309|Analgesics|analgesics|mesh-ancestor
102541200|NCT03000309|Sensory System Agents|sensory system agents|mesh-ancestor
102541201|NCT03000309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102541202|NCT03000309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541203|NCT03000309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102541204|NCT03000309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102541205|NCT03000309|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102541206|NCT03000309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102541207|NCT03000309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102541208|NCT03000309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541209|NCT02992028|Vitamins|vitamins|mesh-list
102541210|NCT02992028|Micronutrients|micronutrients|mesh-ancestor
102541211|NCT02992028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541212|NCT03165981|Vaccines|vaccines|mesh-list
102541213|NCT03165981|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102541214|NCT03165981|Immunologic Factors|immunologic factors|mesh-ancestor
102541215|NCT03165981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541216|NCT02249780|Parathyroid Hormone|parathyroid hormone|mesh-list
102541217|NCT02249780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102541218|NCT02249780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541219|NCT03170661|Rocuronium|rocuronium|mesh-list
102541220|NCT03170661|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102541221|NCT03170661|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102541222|NCT03170661|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102541223|NCT03170661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102541224|NCT03170661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541225|NCT03175731|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
102541226|NCT03175731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102541227|NCT03175731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541228|NCT01662908|Heparin|heparin|mesh-list
102541229|NCT01662908|Enoxaparin|enoxaparin|mesh-list
102541230|NCT01662908|Calcium heparin|calcium heparin|mesh-list
102541231|NCT01662908|Warfarin|warfarin|mesh-list
102541232|NCT01662908|Edoxaban|edoxaban|mesh-list
102541233|NCT01662908|Anticoagulants|anticoagulants|mesh-ancestor
102541234|NCT01662908|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102541235|NCT01662908|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102541236|NCT01662908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541237|NCT01662908|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102541238|NCT01662908|Antithrombins|antithrombins|mesh-ancestor
102541239|NCT01662908|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102541240|NCT01662908|Protease Inhibitors|protease inhibitors|mesh-ancestor
102541241|NCT01662908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102541242|NCT00375297|Sildenafil Citrate|sildenafil citrate|mesh-list
102541243|NCT00375297|Vasodilator Agents|vasodilator agents|mesh-ancestor
102541244|NCT00375297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102541245|NCT00375297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102541246|NCT00375297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102541247|NCT00375297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541248|NCT00375297|Urological Agents|urological agents|mesh-ancestor
102541249|NCT02234570|Oxfendazole|oxfendazole|mesh-list
102541250|NCT02234570|Anthelmintics|anthelmintics|mesh-ancestor
102541251|NCT02234570|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102541252|NCT02234570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102541253|NCT02234570|Antinematodal Agents|antinematodal agents|mesh-ancestor
102541254|NCT04525599|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102541255|NCT04525599|Immunologic Factors|immunologic factors|mesh-ancestor
102541256|NCT04525599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572474|NCT02797015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102541257|NCT02240030|Levodopa|levodopa|mesh-list
102541258|NCT02240030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102541259|NCT02240030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102541260|NCT02240030|Dopamine Agents|dopamine agents|mesh-ancestor
102541261|NCT02240030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102541262|NCT02240030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541263|NCT02240030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541264|NCT03180489|Dapagliflozin|dapagliflozin|mesh-list
102541265|NCT03180489|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102541266|NCT03180489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541267|NCT03180489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102541268|NCT03180489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541269|NCT03471663|Palbociclib|palbociclib|mesh-list
102541270|NCT03471663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102541271|NCT03471663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102541272|NCT03471663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102541273|NCT03471663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541274|NCT01664858|Calcium|calcium|mesh-list
102541275|NCT01664858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102541276|NCT01664858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541277|NCT04348695|Simvastatin|simvastatin|mesh-list
102541278|NCT04348695|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102541279|NCT04348695|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102541280|NCT04348695|Antimetabolites|antimetabolites|mesh-ancestor
102541281|NCT04348695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541282|NCT04348695|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102541283|NCT04348695|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102541284|NCT04348695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102541285|NCT04316871|Morphine|morphine|mesh-list
102541286|NCT04316871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102541287|NCT04316871|Narcotics|narcotics|mesh-ancestor
102541288|NCT04316871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102541289|NCT04316871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541290|NCT04316871|Analgesics|analgesics|mesh-ancestor
102541291|NCT04316871|Sensory System Agents|sensory system agents|mesh-ancestor
102541292|NCT04316871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102541293|NCT05364567|Vitamin D|vitamin d|mesh-list
102541294|NCT05364567|Cholecalciferol|cholecalciferol|mesh-list
102541295|NCT05364567|Vitamins|vitamins|mesh-ancestor
102541296|NCT05364567|Micronutrients|micronutrients|mesh-ancestor
102541297|NCT05364567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541298|NCT05364567|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102541299|NCT05364567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102541300|NCT00375765|Dutasteride|dutasteride|mesh-list
102541301|NCT00375765|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102541302|NCT00375765|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102541303|NCT00375765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102541304|NCT00375765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541305|NCT00375765|Hormone Antagonists|hormone antagonists|mesh-ancestor
102541306|NCT00375765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102541307|NCT00375765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541308|NCT03325647|Methyltestosterone|methyltestosterone|mesh-list
102541309|NCT03325647|Testosterone|testosterone|mesh-list
102541310|NCT03325647|Testosterone undecanoate|testosterone undecanoate|mesh-list
102541311|NCT03325647|Testosterone enanthate|testosterone enanthate|mesh-list
102541312|NCT03325647|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102541313|NCT03325647|Androgens|androgens|mesh-ancestor
102541314|NCT03325647|Hormones|hormones|mesh-ancestor
102541315|NCT03325647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102541316|NCT03325647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541317|NCT03325647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102541318|NCT03325647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102541319|NCT03325647|Anabolic Agents|anabolic agents|mesh-ancestor
102541320|NCT01665950|Simvastatin|simvastatin|mesh-list
102541321|NCT01665950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102541322|NCT01665950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102541323|NCT01665950|Antimetabolites|antimetabolites|mesh-ancestor
102541324|NCT01665950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541325|NCT01665950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102541326|NCT01665950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102541327|NCT01665950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102541328|NCT01667978|Ritonavir|ritonavir|mesh-list
102541329|NCT01667978|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102541330|NCT01667978|Norethindrone|norethindrone|mesh-list
102541331|NCT01667978|Norethindrone Acetate|norethindrone acetate|mesh-list
102541332|NCT01667978|Protease Inhibitors|protease inhibitors|mesh-list
102541333|NCT01667978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102541334|NCT01667978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102541335|NCT01667978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102541336|NCT01667978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541338|NCT01667978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102541339|NCT01667978|Antiviral Agents|antiviral agents|mesh-ancestor
102541340|NCT01667978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102541341|NCT01667978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102541342|NCT01667978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102541343|NCT01667978|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102541344|NCT01667978|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102541345|NCT01667978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102541346|NCT01667978|Contraceptive Agents|contraceptive agents|mesh-ancestor
102541347|NCT01667978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102541348|NCT01667978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541349|NCT01667978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102541350|NCT01667978|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102541351|NCT03282669|Morphine|morphine|mesh-list
102541352|NCT03282669|Hydromorphone|hydromorphone|mesh-list
102541353|NCT03282669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102541354|NCT03282669|Narcotics|narcotics|mesh-ancestor
102541355|NCT03282669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102541356|NCT03282669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541357|NCT03282669|Analgesics|analgesics|mesh-ancestor
102541358|NCT03282669|Sensory System Agents|sensory system agents|mesh-ancestor
102541359|NCT03282669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102541360|NCT00375843|Sertraline|sertraline|mesh-list
102541361|NCT00375843|Escitalopram|escitalopram|mesh-list
102541362|NCT00375843|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102541363|NCT00375843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102541364|NCT00375843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102541365|NCT00375843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541366|NCT00375843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102541367|NCT00375843|Serotonin Agents|serotonin agents|mesh-ancestor
102541368|NCT00375843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541369|NCT00375843|Antidepressive Agents|antidepressive agents|mesh-ancestor
102541370|NCT00375843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102541371|NCT03247569|Edoxaban|edoxaban|mesh-list
102541372|NCT03247569|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102541373|NCT03247569|Antithrombins|antithrombins|mesh-ancestor
102541374|NCT03247569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102541375|NCT03247569|Protease Inhibitors|protease inhibitors|mesh-ancestor
102541376|NCT03247569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102541377|NCT03247569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541378|NCT03247569|Anticoagulants|anticoagulants|mesh-ancestor
102541379|NCT01668836|Resveratrol|resveratrol|mesh-list
102541380|NCT01668836|Antioxidants|antioxidants|mesh-ancestor
102541381|NCT01668836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541382|NCT01668836|Protective Agents|protective agents|mesh-ancestor
102541383|NCT01668836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541384|NCT01668836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102541385|NCT01668836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102541386|NCT03744663|Buprenorphine|buprenorphine|mesh-list
102541387|NCT03744663|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102541388|NCT03744663|Naloxone|naloxone|mesh-list
102541389|NCT03744663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102541390|NCT03744663|Narcotics|narcotics|mesh-ancestor
102541391|NCT03744663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102541392|NCT03744663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541393|NCT03744663|Analgesics|analgesics|mesh-ancestor
102541394|NCT03744663|Sensory System Agents|sensory system agents|mesh-ancestor
102541395|NCT03744663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102541396|NCT03744663|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102541397|NCT01669538|Galantamine|galantamine|mesh-list
101761379|NCT02563782|Mycophenolic Acid|mycophenolic acid|mesh-list
102541398|NCT01669538|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102541399|NCT01669538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102541400|NCT01669538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541401|NCT01669538|Cholinergic Agents|cholinergic agents|mesh-ancestor
102541402|NCT01669538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102541403|NCT01669538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541404|NCT01669538|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102541405|NCT01669538|Autonomic Agents|autonomic agents|mesh-ancestor
102541406|NCT01669538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102541408|NCT00375375|Lactulose|lactulose|mesh-list
102541409|NCT00375375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102541410|NCT04333095|Bupivacaine|bupivacaine|mesh-list
102541411|NCT04333095|Anesthetics, Local|anesthetics, local|mesh-ancestor
102541412|NCT04333095|Anesthetics|anesthetics|mesh-ancestor
102541413|NCT04333095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102541414|NCT04333095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541415|NCT04333095|Sensory System Agents|sensory system agents|mesh-ancestor
102541416|NCT04333095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102541417|NCT05045144|Vaccines|vaccines|mesh-list
102541418|NCT05045144|Immunologic Factors|immunologic factors|mesh-ancestor
102541419|NCT05045144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541420|NCT00375687|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102541421|NCT00375687|Luteolytic Agents|luteolytic agents|mesh-ancestor
102541422|NCT00375687|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102541423|NCT00375687|Contraceptive Agents|contraceptive agents|mesh-ancestor
102541424|NCT00375687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102541425|NCT00375687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541426|NCT00375687|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102541427|NCT00375687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102541428|NCT00375687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102541429|NCT01658241|Panobinostat|panobinostat|mesh-list
102541430|NCT01658241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102541431|NCT01658241|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102541432|NCT01658241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102541433|NCT01658241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541434|NCT01455051|Ofatumumab|ofatumumab|mesh-list
102541435|NCT01455051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102541436|NCT01673828|Pregnanolone|pregnanolone|mesh-list
102541437|NCT01673828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102541438|NCT01673828|Anesthetics|anesthetics|mesh-ancestor
102541439|NCT01673828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102541440|NCT01673828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541441|NCT05325099|Azacitidine|azacitidine|mesh-list
102541442|NCT05325099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102541443|NCT05325099|Antimetabolites|antimetabolites|mesh-ancestor
102541444|NCT05325099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541445|NCT05325099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102541446|NCT05325099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102541447|NCT05293509|Cyclosporine|cyclosporine|mesh-list
102541448|NCT05293509|Mycophenolic Acid|mycophenolic acid|mesh-list
102541449|NCT05293509|Dexamethasone|dexamethasone|mesh-list
102541450|NCT05293509|Cyclophosphamide|cyclophosphamide|mesh-list
102541451|NCT05293509|Busulfan|busulfan|mesh-list
102541452|NCT05293509|Rituximab|rituximab|mesh-list
102541453|NCT05293509|Fludarabine|fludarabine|mesh-list
102541454|NCT05293509|Bortezomib|bortezomib|mesh-list
102541455|NCT05293509|Tacrolimus|tacrolimus|mesh-list
102541456|NCT05293509|Cyclosporins|cyclosporins|mesh-list
102541457|NCT05293509|Thymoglobulin|thymoglobulin|mesh-list
102541458|NCT05293509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102541459|NCT05293509|Immunologic Factors|immunologic factors|mesh-ancestor
102541460|NCT05293509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541461|NCT05293509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102541462|NCT05293509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102541463|NCT05293509|Alkylating Agents|alkylating agents|mesh-ancestor
101761446|NCT00744354|Doxorubicin|doxorubicin|mesh-list
102541464|NCT05293509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541465|NCT05293509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102541466|NCT05293509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102541467|NCT05293509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102541468|NCT05293509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102541469|NCT05293509|Antiemetics|antiemetics|mesh-ancestor
102541470|NCT05293509|Autonomic Agents|autonomic agents|mesh-ancestor
102541471|NCT05293509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102541472|NCT05293509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102541473|NCT05293509|Glucocorticoids|glucocorticoids|mesh-ancestor
102541474|NCT05293509|Hormones|hormones|mesh-ancestor
102541475|NCT05293509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102541476|NCT05293509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102541477|NCT05293509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102541478|NCT05293509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101572697|NCT02782273|Analgesics|analgesics|mesh-ancestor
102541479|NCT05293509|Antifungal Agents|antifungal agents|mesh-ancestor
102541480|NCT05293509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102541481|NCT05293509|Dermatologic Agents|dermatologic agents|mesh-ancestor
101572768|NCT02689843|Cyproterone Acetate|cyproterone acetate|mesh-list
102541482|NCT05293509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102541483|NCT05293509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102541484|NCT05293509|Antitubercular Agents|antitubercular agents|mesh-ancestor
102541485|NCT05293509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102541486|NCT02296775|Rituximab|rituximab|mesh-list
102541487|NCT02296775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102541488|NCT02296775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102541489|NCT02296775|Immunologic Factors|immunologic factors|mesh-ancestor
102541490|NCT02296775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541491|NCT02296775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102541492|NCT01675778|Hydromorphone|hydromorphone|mesh-list
102541493|NCT01675778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102541494|NCT01675778|Narcotics|narcotics|mesh-ancestor
102541495|NCT01675778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102541496|NCT01675778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541497|NCT01675778|Analgesics|analgesics|mesh-ancestor
102541498|NCT01675778|Sensory System Agents|sensory system agents|mesh-ancestor
102541499|NCT01675778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102541500|NCT04736589|Sirolimus|sirolimus|mesh-list
102541501|NCT04736589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102541502|NCT04736589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102541503|NCT04736589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102541504|NCT04736589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102541505|NCT04736589|Antifungal Agents|antifungal agents|mesh-ancestor
102541506|NCT04736589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102541507|NCT04736589|Immunologic Factors|immunologic factors|mesh-ancestor
102541508|NCT04736589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541509|NCT05201859|Capecitabine|capecitabine|mesh-list
102541510|NCT05201859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102541511|NCT05201859|Antimetabolites|antimetabolites|mesh-ancestor
102541512|NCT05201859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541513|NCT05201859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102541514|NCT02594111|Colchicine|colchicine|mesh-list
102541515|NCT02594111|Gout Suppressants|gout suppressants|mesh-ancestor
102541516|NCT02594111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102541517|NCT02594111|Tubulin Modulators|tubulin modulators|mesh-ancestor
102541518|NCT02594111|Antimitotic Agents|antimitotic agents|mesh-ancestor
102541519|NCT02594111|Mitosis Modulators|mitosis modulators|mesh-ancestor
102541520|NCT02594111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541521|NCT02594111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102541522|NCT03186261|Chlorhexidine|chlorhexidine|mesh-list
102541523|NCT03186261|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102541524|NCT03186261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102541525|NCT03186261|Fluorides|fluorides|mesh-list
102541526|NCT03186261|Cariostatic Agents|cariostatic agents|mesh-ancestor
102541527|NCT03186261|Protective Agents|protective agents|mesh-ancestor
102541528|NCT03186261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541529|NCT03186261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102541530|NCT03186261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102541531|NCT03186261|Disinfectants|disinfectants|mesh-ancestor
102541532|NCT03186261|Dermatologic Agents|dermatologic agents|mesh-ancestor
102541533|NCT02589353|Acarbose|acarbose|mesh-list
102541534|NCT02589353|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102541535|NCT02589353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102541536|NCT02589353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541537|NCT02589353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102541538|NCT02589353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541539|NCT02986607|Parathyroid Hormone|parathyroid hormone|mesh-list
102541540|NCT02986607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102541541|NCT02986607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541542|NCT01678976|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102541543|NCT01678976|Oxcarbazepine|oxcarbazepine|mesh-list
102541544|NCT01678976|Anticonvulsants|anticonvulsants|mesh-ancestor
102541545|NCT01678976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102541546|NCT01678976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102541547|NCT01678976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102541548|NCT01678976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541549|NCT01678976|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102541550|NCT01678976|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102541551|NCT04645667|Tacrolimus|tacrolimus|mesh-list
102541552|NCT04645667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102541553|NCT04645667|Immunologic Factors|immunologic factors|mesh-ancestor
102541554|NCT04645667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541555|NCT04645667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102541556|NCT04645667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102541557|NCT04645667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541558|NCT02249936|Omeprazole|omeprazole|mesh-list
102541559|NCT02249936|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102541560|NCT02249936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102541561|NCT02249936|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102541562|NCT02249936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102541563|NCT02249936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541564|NCT03190005|Clopidogrel|clopidogrel|mesh-list
102541565|NCT03190005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102541566|NCT03190005|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102541567|NCT03190005|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102541568|NCT03190005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102541569|NCT03190005|Purinergic Agents|purinergic agents|mesh-ancestor
102541570|NCT03190005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102541571|NCT03190005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541572|NCT03190005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541573|NCT04816214|Carboplatin|carboplatin|mesh-list
102541574|NCT04816214|Pemetrexed|pemetrexed|mesh-list
102541575|NCT04816214|Osimertinib|osimertinib|mesh-list
102541576|NCT04816214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102541577|NCT04816214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102541578|NCT04816214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541579|NCT04816214|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102541580|NCT04816214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102541581|NCT04816214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102541582|NCT01461915|Paclitaxel|paclitaxel|mesh-list
102541583|NCT01461915|Gemcitabine|gemcitabine|mesh-list
102541584|NCT01461915|Heparin|heparin|mesh-list
102541585|NCT01461915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102541586|NCT01461915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102541587|NCT01461915|Tubulin Modulators|tubulin modulators|mesh-ancestor
102541588|NCT01461915|Antimitotic Agents|antimitotic agents|mesh-ancestor
102541589|NCT01461915|Mitosis Modulators|mitosis modulators|mesh-ancestor
102541590|NCT01461915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541591|NCT01461915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102541592|NCT01461915|Antimetabolites|antimetabolites|mesh-ancestor
102541593|NCT01461915|Anticoagulants|anticoagulants|mesh-ancestor
102541594|NCT01461915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102541595|NCT01461915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102541596|NCT01682642|Goserelin|goserelin|mesh-list
102541597|NCT01682642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102541598|NCT01682642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102541599|NCT01683422|Gemcitabine|gemcitabine|mesh-list
102541600|NCT01683422|Capecitabine|capecitabine|mesh-list
102541601|NCT01683422|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102541602|NCT01683422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102541603|NCT01683422|Antimetabolites|antimetabolites|mesh-ancestor
102541604|NCT01683422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541605|NCT01683422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102541606|NCT01683422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102541607|NCT01683422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102541608|NCT03194373|Carboplatin|carboplatin|mesh-list
102541609|NCT03194373|Palbociclib|palbociclib|mesh-list
102541610|NCT03194373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102541611|NCT03194373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102541612|NCT03194373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102541613|NCT03194373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541614|NCT05066061|Analgesics|analgesics|mesh-list
102541615|NCT05066061|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
102541616|NCT05066061|Sensory System Agents|sensory system agents|mesh-ancestor
102541617|NCT05066061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102541618|NCT05066061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541619|NCT05066061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102541620|NCT05066061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102541621|NCT05066061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102541622|NCT04781673|Lidocaine|lidocaine|mesh-list
102541623|NCT04781673|Ketamine|ketamine|mesh-list
102541624|NCT04781673|Anesthetics, Local|anesthetics, local|mesh-ancestor
102541625|NCT04781673|Anesthetics|anesthetics|mesh-ancestor
102541626|NCT04781673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102541627|NCT04781673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541628|NCT04781673|Sensory System Agents|sensory system agents|mesh-ancestor
102541629|NCT04781673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102541630|NCT04781673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102541631|NCT04781673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102541632|NCT04781673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102541633|NCT04781673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102541634|NCT04781673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541635|NCT04781673|Analgesics|analgesics|mesh-ancestor
102541636|NCT04781673|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102541637|NCT04781673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102541638|NCT04781673|Anesthetics, General|anesthetics, general|mesh-ancestor
102541639|NCT04781673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102541640|NCT04781673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102541641|NCT04781673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102541642|NCT03197025|Aldesleukin|aldesleukin|mesh-list
102541643|NCT03197025|Interleukin-2|interleukin-2|mesh-list
102541644|NCT03197025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102541645|NCT03197025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102541646|NCT03197025|Analgesics|analgesics|mesh-ancestor
102541647|NCT03197025|Sensory System Agents|sensory system agents|mesh-ancestor
102541648|NCT03197025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102541649|NCT03197025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541650|NCT03197025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102541651|NCT03197025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102541652|NCT03197025|Antiviral Agents|antiviral agents|mesh-ancestor
102541653|NCT03197025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102541654|NCT02249546|Amoxicillin|amoxicillin|mesh-list
102541655|NCT02249546|Clarithromycin|clarithromycin|mesh-list
102541656|NCT02249546|Acetylcysteine|acetylcysteine|mesh-list
102541657|NCT02249546|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102541658|NCT02249546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102541659|NCT02249546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102541660|NCT02249546|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102541661|NCT02249546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102541662|NCT02249546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541663|NCT02249546|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102541664|NCT02249546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102541665|NCT02249546|Antiviral Agents|antiviral agents|mesh-ancestor
102541666|NCT02249546|Expectorants|expectorants|mesh-ancestor
102541667|NCT02249546|Respiratory System Agents|respiratory system agents|mesh-ancestor
102541668|NCT02249546|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102541669|NCT02249546|Antioxidants|antioxidants|mesh-ancestor
102541670|NCT02249546|Protective Agents|protective agents|mesh-ancestor
102541671|NCT02249546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541672|NCT02249546|Antidotes|antidotes|mesh-ancestor
102541673|NCT02303093|gamma-Globulins|gamma-globulins|mesh-list
102541674|NCT02303093|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102541675|NCT02303093|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102541676|NCT02303093|Immunologic Factors|immunologic factors|mesh-ancestor
102541677|NCT02303093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541678|NCT04960215|Ubiquinone|ubiquinone|mesh-list
102541679|NCT04960215|Coenzyme Q10|coenzyme q10|mesh-list
102541680|NCT04960215|Micronutrients|micronutrients|mesh-ancestor
102541681|NCT04960215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541682|NCT04960215|Vitamins|vitamins|mesh-ancestor
102541683|NCT02333045|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102541684|NCT02333045|Maraviroc|maraviroc|mesh-list
102541685|NCT02333045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102541686|NCT02333045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102541687|NCT02333045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101761667|NCT00738296|Ezetimibe|ezetimibe|mesh-list
102541688|NCT02333045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541689|NCT02333045|Antiviral Agents|antiviral agents|mesh-ancestor
102541690|NCT02333045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102541691|NCT02333045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102541692|NCT02333045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102541693|NCT02333045|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102541694|NCT02333045|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102541695|NCT02333045|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102541696|NCT01684748|Olmesartan|olmesartan|mesh-list
102541697|NCT01684748|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
102541698|NCT01684748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102541699|NCT01684748|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102541700|NCT01684748|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102541701|NCT01684748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541702|NCT04028063|Doxorubicin|doxorubicin|mesh-list
102541703|NCT04028063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102541704|NCT04028063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102541705|NCT04028063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102541706|NCT04028063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102541707|NCT04028063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102541708|NCT04028063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541709|NCT01685684|Oxycodone|oxycodone|mesh-list
102541710|NCT01685684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102541711|NCT01685684|Narcotics|narcotics|mesh-ancestor
102541712|NCT01685684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102541713|NCT01685684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541714|NCT01685684|Analgesics|analgesics|mesh-ancestor
102541715|NCT01685684|Sensory System Agents|sensory system agents|mesh-ancestor
102541716|NCT01685684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102541717|NCT03978767|Acetaminophen|acetaminophen|mesh-list
102541718|NCT03978767|Ibuprofen|ibuprofen|mesh-list
102541719|NCT03978767|Ketorolac|ketorolac|mesh-list
102541720|NCT03978767|Oxycodone|oxycodone|mesh-list
102541721|NCT03978767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102541722|NCT03978767|Analgesics|analgesics|mesh-ancestor
102541723|NCT03978767|Sensory System Agents|sensory system agents|mesh-ancestor
102541724|NCT03978767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102541725|NCT03978767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541726|NCT03978767|Antipyretics|antipyretics|mesh-ancestor
102541727|NCT03978767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102541728|NCT03978767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102541729|NCT03978767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102541730|NCT03978767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102541731|NCT03978767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102541732|NCT03978767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541733|NCT03978767|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102541734|NCT03978767|Narcotics|narcotics|mesh-ancestor
102541735|NCT03978767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102541736|NCT04436133|Vaccines|vaccines|mesh-list
102541737|NCT04436133|Immunologic Factors|immunologic factors|mesh-ancestor
102541738|NCT04436133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541739|NCT01685996|Zonisamide|zonisamide|mesh-list
102541740|NCT01685996|Anticonvulsants|anticonvulsants|mesh-ancestor
102541741|NCT01685996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102541742|NCT01685996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102541743|NCT01685996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541744|NCT01685996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102541745|NCT01685996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541746|NCT03207399|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102541747|NCT03207399|Antiviral Agents|antiviral agents|mesh-ancestor
102541748|NCT03207399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102541749|NCT04543409|Benralizumab|benralizumab|mesh-list
102541750|NCT04543409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102541751|NCT04543409|Respiratory System Agents|respiratory system agents|mesh-ancestor
102541752|NCT02196155|Cortisone|cortisone|mesh-list
102541753|NCT02196155|Botulinum Toxins|botulinum toxins|mesh-list
102541754|NCT02196155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102541755|NCT02196155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102541756|NCT02196155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102541757|NCT02196155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102541758|NCT02196155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541759|NCT02196155|Cholinergic Agents|cholinergic agents|mesh-ancestor
102541760|NCT02196155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102541761|NCT02196155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541762|NCT02196155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102541763|NCT02196155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102541764|NCT02196155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102541765|NCT02175173|Rufinamide|rufinamide|mesh-list
102541766|NCT02175173|Anticonvulsants|anticonvulsants|mesh-ancestor
102541767|NCT02175173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102541768|NCT02175173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102541769|NCT02175173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102541770|NCT02175173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541771|NCT04121403|Rituximab|rituximab|mesh-list
102541772|NCT04121403|Cladribine|cladribine|mesh-list
102541773|NCT04121403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102541774|NCT04121403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102541775|NCT04121403|Immunologic Factors|immunologic factors|mesh-ancestor
102541776|NCT04121403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541777|NCT04121403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102541778|NCT04121403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102541779|NCT02049515|Ofatumumab|ofatumumab|mesh-list
102541780|NCT02049515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102541781|NCT03224403|Acetaminophen|acetaminophen|mesh-list
102541782|NCT03224403|Ibuprofen|ibuprofen|mesh-list
102541783|NCT03224403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102541784|NCT03224403|Analgesics|analgesics|mesh-ancestor
102541785|NCT03224403|Sensory System Agents|sensory system agents|mesh-ancestor
102541786|NCT03224403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102541787|NCT03224403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541788|NCT03224403|Antipyretics|antipyretics|mesh-ancestor
102541789|NCT03224403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102541790|NCT03224403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102541791|NCT03224403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102541792|NCT03224403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102541793|NCT03224403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102541794|NCT03224403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541795|NCT02334059|Ketamine|ketamine|mesh-list
102541796|NCT02334059|Analgesics|analgesics|mesh-ancestor
102541797|NCT02334059|Sensory System Agents|sensory system agents|mesh-ancestor
102541798|NCT02334059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102541799|NCT02334059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541800|NCT02334059|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102541801|NCT02334059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102541802|NCT02334059|Anesthetics, General|anesthetics, general|mesh-ancestor
102541803|NCT02334059|Anesthetics|anesthetics|mesh-ancestor
102541804|NCT02334059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102541805|NCT02334059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102541806|NCT02334059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102541807|NCT02334059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102541808|NCT02334059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541809|NCT04501523|Capecitabine|capecitabine|mesh-list
102541810|NCT04501523|Tislelizumab|tislelizumab|mesh-list
102541811|NCT04501523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102541812|NCT04501523|Antimetabolites|antimetabolites|mesh-ancestor
102541813|NCT04501523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541814|NCT04501523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102541815|NCT04501523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102541816|NCT04499573|Cytarabine|cytarabine|mesh-list
102541817|NCT04499573|Dexamethasone|dexamethasone|mesh-list
102541818|NCT04499573|Cyclophosphamide|cyclophosphamide|mesh-list
102541819|NCT04499573|Fludarabine|fludarabine|mesh-list
102541820|NCT04499573|Etoposide|etoposide|mesh-list
102541821|NCT04499573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102541822|NCT04499573|Immunologic Factors|immunologic factors|mesh-ancestor
102541823|NCT04499573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541824|NCT04499573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102541825|NCT04499573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102541826|NCT04499573|Alkylating Agents|alkylating agents|mesh-ancestor
102541827|NCT04499573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541828|NCT04499573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102541829|NCT04499573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102541830|NCT04499573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102541831|NCT04499573|Antiemetics|antiemetics|mesh-ancestor
102541832|NCT04499573|Autonomic Agents|autonomic agents|mesh-ancestor
102541833|NCT04499573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102541834|NCT04499573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102541835|NCT04499573|Glucocorticoids|glucocorticoids|mesh-ancestor
102541836|NCT04499573|Hormones|hormones|mesh-ancestor
102541837|NCT04499573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102541838|NCT04499573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102541839|NCT04499573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102541840|NCT04499573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102541841|NCT04499573|Antimetabolites|antimetabolites|mesh-ancestor
102541842|NCT04499573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102541843|NCT04499573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102541844|NCT04499573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102541845|NCT04499573|Antiviral Agents|antiviral agents|mesh-ancestor
102541846|NCT04499573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102541847|NCT03425097|Fexofenadine|fexofenadine|mesh-list
102541848|NCT03425097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102541849|NCT03425097|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102541850|NCT03425097|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102541851|NCT03425097|Histamine Antagonists|histamine antagonists|mesh-ancestor
102541852|NCT03425097|Histamine Agents|histamine agents|mesh-ancestor
102541853|NCT03425097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102541854|NCT03425097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541855|NCT03425097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541857|NCT01926041|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102541858|NCT01926041|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102541859|NCT01926041|Cholinergic Agents|cholinergic agents|mesh-ancestor
102541860|NCT01926041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102541861|NCT01926041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541862|NCT01926041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541863|NCT01769027|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102541864|NCT01769027|Azithromycin|azithromycin|mesh-list
102541865|NCT01769027|Penicillins|penicillins|mesh-list
102541866|NCT01769027|Sertraline|sertraline|mesh-list
102541867|NCT01769027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102541868|NCT01769027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102541869|NCT01769027|Antidepressive Agents|antidepressive agents|mesh-ancestor
102541870|NCT01769027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102541871|NCT01769027|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102541872|NCT01769027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101761858|NCT00939718|Vitamins|vitamins|mesh-ancestor
102541873|NCT01769027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102541874|NCT01769027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541875|NCT01769027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102541876|NCT01769027|Serotonin Agents|serotonin agents|mesh-ancestor
102541877|NCT01769027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541878|NCT01769027|Immunologic Factors|immunologic factors|mesh-ancestor
102541879|NCT04706637|Dapagliflozin|dapagliflozin|mesh-list
102541880|NCT04706637|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102541881|NCT04706637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541882|NCT04706637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102541883|NCT04706637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541884|NCT04706949|Carboplatin|carboplatin|mesh-list
102541885|NCT04706949|Pemetrexed|pemetrexed|mesh-list
102541886|NCT04706949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102541887|NCT04706949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102541888|NCT04706949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541889|NCT04706949|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102541890|NCT04706949|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102541891|NCT02299349|Epinephrine|epinephrine|mesh-list
102541892|NCT02299349|Racepinephrine|racepinephrine|mesh-list
102541893|NCT02299349|Morphine|morphine|mesh-list
102541894|NCT02299349|Bupivacaine|bupivacaine|mesh-list
102541895|NCT02299349|Epinephryl borate|epinephryl borate|mesh-list
102541896|NCT02299349|Anesthetics, Local|anesthetics, local|mesh-ancestor
102541897|NCT02299349|Anesthetics|anesthetics|mesh-ancestor
102541898|NCT02299349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102541899|NCT02299349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541900|NCT02299349|Sensory System Agents|sensory system agents|mesh-ancestor
102541901|NCT02299349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102541902|NCT02299349|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102541903|NCT02299349|Narcotics|narcotics|mesh-ancestor
102541904|NCT02299349|Analgesics|analgesics|mesh-ancestor
102541905|NCT02299349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102541906|NCT02299349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102541907|NCT02299349|Adrenergic Agents|adrenergic agents|mesh-ancestor
102541908|NCT02299349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102541909|NCT02299349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541910|NCT02299349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102541911|NCT02299349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102541912|NCT02299349|Autonomic Agents|autonomic agents|mesh-ancestor
102541913|NCT02299349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102541914|NCT02299349|Respiratory System Agents|respiratory system agents|mesh-ancestor
102541915|NCT02299349|Mydriatics|mydriatics|mesh-ancestor
102541916|NCT02299349|Sympathomimetics|sympathomimetics|mesh-ancestor
102541917|NCT02299349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102541918|NCT03296163|Paclitaxel|paclitaxel|mesh-list
102541919|NCT03296163|Bevacizumab|bevacizumab|mesh-list
102541920|NCT03296163|Carboplatin|carboplatin|mesh-list
102541921|NCT03296163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102541922|NCT03296163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102541923|NCT03296163|Tubulin Modulators|tubulin modulators|mesh-ancestor
102541924|NCT03296163|Antimitotic Agents|antimitotic agents|mesh-ancestor
102541925|NCT03296163|Mitosis Modulators|mitosis modulators|mesh-ancestor
102541926|NCT03296163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541927|NCT03296163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102541928|NCT03296163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102541929|NCT03296163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102541930|NCT03296163|Growth Substances|growth substances|mesh-ancestor
102541931|NCT03296163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541932|NCT03296163|Growth Inhibitors|growth inhibitors|mesh-ancestor
102541933|NCT00376155|Pyrimethamine|pyrimethamine|mesh-list
102541934|NCT00376155|Sulfadoxine|sulfadoxine|mesh-list
102541935|NCT00376155|Amodiaquine|amodiaquine|mesh-list
102541936|NCT00376155|Antimalarials|antimalarials|mesh-ancestor
102541937|NCT00376155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102541938|NCT00376155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102541939|NCT00376155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102541940|NCT00376155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102541941|NCT00376155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102541942|NCT00376155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541943|NCT00376155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102541944|NCT01989221|Granisetron|granisetron|mesh-list
102541945|NCT01989221|Antiemetics|antiemetics|mesh-ancestor
102541946|NCT01989221|Autonomic Agents|autonomic agents|mesh-ancestor
102541947|NCT01989221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102541948|NCT01989221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541949|NCT01989221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102541950|NCT01989221|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102541951|NCT01989221|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102541952|NCT01989221|Serotonin Agents|serotonin agents|mesh-ancestor
102541953|NCT01989221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102541954|NCT01989221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541955|NCT03226899|Colchicine|colchicine|mesh-list
102541956|NCT03226899|Allopurinol|allopurinol|mesh-list
102541957|NCT03226899|Febuxostat|febuxostat|mesh-list
102541958|NCT03226899|Lesinurad|lesinurad|mesh-list
102541959|NCT03226899|Gout Suppressants|gout suppressants|mesh-ancestor
102541960|NCT03226899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102541961|NCT03226899|Tubulin Modulators|tubulin modulators|mesh-ancestor
102541962|NCT03226899|Antimitotic Agents|antimitotic agents|mesh-ancestor
102541963|NCT03226899|Mitosis Modulators|mitosis modulators|mesh-ancestor
102541964|NCT03226899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541965|NCT03226899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102541966|NCT03226899|Antimetabolites|antimetabolites|mesh-ancestor
102541967|NCT03226899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102541968|NCT03226899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102541969|NCT03226899|Antioxidants|antioxidants|mesh-ancestor
102541970|NCT03226899|Protective Agents|protective agents|mesh-ancestor
102541971|NCT03226899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541972|NCT03226899|Uricosuric Agents|uricosuric agents|mesh-ancestor
102541973|NCT01990703|Levonorgestrel|levonorgestrel|mesh-list
102541974|NCT01990703|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102541975|NCT01990703|Contraceptive Agents|contraceptive agents|mesh-ancestor
102541976|NCT01990703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102541977|NCT01990703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541978|NCT01990703|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102541979|NCT01990703|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102541980|NCT01990703|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102541981|NCT03230175|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102541982|NCT03230175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102541983|NCT01992185|Sunscreening Agents|sunscreening agents|mesh-list
102541984|NCT01992185|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102541985|NCT01992185|Protective Agents|protective agents|mesh-ancestor
102541986|NCT01992185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541987|NCT01992185|Dermatologic Agents|dermatologic agents|mesh-ancestor
102541988|NCT04332627|Neostigmine|neostigmine|mesh-list
102541989|NCT04332627|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102541990|NCT04332627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102541991|NCT04332627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102541992|NCT04332627|Cholinergic Agents|cholinergic agents|mesh-ancestor
102541993|NCT04332627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102541994|NCT04332627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102541995|NCT04332627|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102541996|NCT04332627|Autonomic Agents|autonomic agents|mesh-ancestor
102541997|NCT04332627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102541998|NCT03440229|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102541999|NCT03440229|Laxatives|laxatives|mesh-ancestor
102542000|NCT03440229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102542001|NCT01963091|Oxytocin|oxytocin|mesh-list
102542002|NCT01963091|Oxytocics|oxytocics|mesh-ancestor
102542003|NCT01963091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102542004|NCT01963091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542005|NCT02306759|Ketamine|ketamine|mesh-list
101573236|NCT04771741|Ketorolac|ketorolac|mesh-list
102542006|NCT02306759|Analgesics|analgesics|mesh-ancestor
102542007|NCT02306759|Sensory System Agents|sensory system agents|mesh-ancestor
102542008|NCT02306759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102542009|NCT02306759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542010|NCT02306759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102542011|NCT02306759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102542012|NCT02306759|Anesthetics, General|anesthetics, general|mesh-ancestor
102542014|NCT02306759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102542015|NCT02306759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102542016|NCT02306759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102542017|NCT02306759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102542018|NCT02306759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542019|NCT03298113|Protective Agents|protective agents|mesh-list
102542020|NCT03298113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542021|NCT03232749|Methylprednisolone|methylprednisolone|mesh-list
102542022|NCT03232749|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102542023|NCT03232749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102542024|NCT03232749|Antiemetics|antiemetics|mesh-ancestor
102542025|NCT03232749|Autonomic Agents|autonomic agents|mesh-ancestor
102542026|NCT03232749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102542027|NCT03232749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542028|NCT03232749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102542029|NCT03232749|Glucocorticoids|glucocorticoids|mesh-ancestor
102542030|NCT03232749|Hormones|hormones|mesh-ancestor
102542031|NCT03232749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102542032|NCT03232749|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102542033|NCT03232749|Protective Agents|protective agents|mesh-ancestor
102542034|NCT01687400|Decitabine|decitabine|mesh-list
102542035|NCT01687400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102542036|NCT01687400|Antimetabolites|antimetabolites|mesh-ancestor
102542037|NCT01687400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542038|NCT01687400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102542039|NCT01687400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102542040|NCT01688102|Vitamin D|vitamin d|mesh-list
102542041|NCT01688102|Cholecalciferol|cholecalciferol|mesh-list
102542042|NCT01688102|Vitamins|vitamins|mesh-ancestor
102542043|NCT01688102|Micronutrients|micronutrients|mesh-ancestor
102542044|NCT01688102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542045|NCT01688102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102542046|NCT01688102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102542047|NCT01994993|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102542048|NCT01994993|Metronidazole|metronidazole|mesh-list
102542049|NCT01994993|Clindamycin|clindamycin|mesh-list
102542050|NCT01994993|Clindamycin palmitate|clindamycin palmitate|mesh-list
102542051|NCT01994993|Clindamycin phosphate|clindamycin phosphate|mesh-list
102542052|NCT01994993|Gentamicins|gentamicins|mesh-list
102542053|NCT01994993|Tazobactam|tazobactam|mesh-list
102542054|NCT01994993|Piperacillin|piperacillin|mesh-list
102542055|NCT01994993|Ampicillin|ampicillin|mesh-list
102542056|NCT01994993|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102542057|NCT01994993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102542058|NCT01994993|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102542059|NCT01994993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102542060|NCT01994993|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102542061|NCT01994993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102542062|NCT01994993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542063|NCT01994993|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102542064|NCT01688336|Leucovorin|leucovorin|mesh-list
102542065|NCT01688336|Oxaliplatin|oxaliplatin|mesh-list
102542066|NCT01688336|Irinotecan|irinotecan|mesh-list
102542067|NCT01688336|Folfirinox|folfirinox|mesh-list
102542068|NCT01688336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102542069|NCT01688336|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102542070|NCT01688336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102542071|NCT01688336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102542072|NCT01688336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542073|NCT01688336|Antidotes|antidotes|mesh-ancestor
102542074|NCT01688336|Protective Agents|protective agents|mesh-ancestor
102542075|NCT01688336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542076|NCT01688336|Vitamin B Complex|vitamin b complex|mesh-ancestor
102542077|NCT01688336|Vitamins|vitamins|mesh-ancestor
102542078|NCT01688336|Micronutrients|micronutrients|mesh-ancestor
102542079|NCT01963481|Cyclophosphamide|cyclophosphamide|mesh-list
102542080|NCT01963481|Exemestane|exemestane|mesh-list
102542081|NCT01963481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102542082|NCT01963481|Immunologic Factors|immunologic factors|mesh-ancestor
102542083|NCT01963481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542084|NCT01963481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102542085|NCT01963481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102542086|NCT01963481|Alkylating Agents|alkylating agents|mesh-ancestor
102542087|NCT01963481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542088|NCT01963481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102542089|NCT01963481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102542090|NCT01963481|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101762094|NCT00561574|Adrenergic Agents|adrenergic agents|mesh-ancestor
101762139|NCT00742404|Dexamethasone|dexamethasone|mesh-list
101762140|NCT00742404|Doxorubicin|doxorubicin|mesh-list
101762141|NCT00742404|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101762142|NCT00742404|Bortezomib|bortezomib|mesh-list
101762143|NCT00742404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101762144|NCT00742404|Antiemetics|antiemetics|mesh-ancestor
101762145|NCT00742404|Autonomic Agents|autonomic agents|mesh-ancestor
102542091|NCT01963481|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102542092|NCT01963481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102542093|NCT01963481|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102542094|NCT01963481|Hormone Antagonists|hormone antagonists|mesh-ancestor
102542095|NCT01963481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102542096|NCT04436744|Palbociclib|palbociclib|mesh-list
102542097|NCT04436744|Anastrozole|anastrozole|mesh-list
102542098|NCT04436744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102542099|NCT04436744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102542100|NCT04436744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102542101|NCT04436744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542102|NCT04436744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102542103|NCT04436744|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102542104|NCT04436744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102542105|NCT04436744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102542106|NCT04436744|Hormone Antagonists|hormone antagonists|mesh-ancestor
102542107|NCT04436744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102542108|NCT04436744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542109|NCT01963793|Aprepitant|aprepitant|mesh-list
102542110|NCT01963793|Fosaprepitant|fosaprepitant|mesh-list
102542111|NCT01963793|Antiemetics|antiemetics|mesh-ancestor
102542112|NCT01963793|Autonomic Agents|autonomic agents|mesh-ancestor
102542113|NCT01963793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102542114|NCT01963793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542115|NCT01963793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102542116|NCT01963793|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102542117|NCT01963793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102542118|NCT01963793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542119|NCT03449433|Insulin|insulin|mesh-list
102542120|NCT03449433|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102542121|NCT03449433|Insulin Aspart|insulin aspart|mesh-list
102542122|NCT03449433|Insulin, Long-Acting|insulin, long-acting|mesh-list
102542123|NCT03449433|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102542124|NCT03449433|Insulin Lispro|insulin lispro|mesh-list
102542125|NCT03449433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102542126|NCT03449433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542127|NCT03241485|Morphine|morphine|mesh-list
102542128|NCT03241485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102542129|NCT03241485|Narcotics|narcotics|mesh-ancestor
102542130|NCT03241485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102542131|NCT03241485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542132|NCT03241485|Analgesics|analgesics|mesh-ancestor
102542133|NCT03241485|Sensory System Agents|sensory system agents|mesh-ancestor
102542134|NCT03241485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102542135|NCT04313504|Niraparib|niraparib|mesh-list
102542136|NCT04313504|Dostarlimab|dostarlimab|mesh-list
102542137|NCT04313504|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102542138|NCT04313504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102542139|NCT04313504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542140|NCT04313504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102542141|NCT01996943|Ethanol|ethanol|mesh-list
102542142|NCT01996943|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102542143|NCT01996943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102542144|NCT01996943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102542145|NCT01996943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542146|NCT04812626|Triamcinolone|triamcinolone|mesh-list
102542147|NCT04812626|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102542148|NCT04812626|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101762146|NCT00742404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102542149|NCT04812626|Fluorouracil|fluorouracil|mesh-list
102542150|NCT04812626|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102542151|NCT04812626|Antimetabolites|antimetabolites|mesh-ancestor
102542152|NCT04812626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542153|NCT04812626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102542154|NCT04812626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102542155|NCT04812626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102542156|NCT04812626|Immunologic Factors|immunologic factors|mesh-ancestor
102542157|NCT04812626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542158|NCT04812626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102542159|NCT04812626|Glucocorticoids|glucocorticoids|mesh-ancestor
102542160|NCT04812626|Hormones|hormones|mesh-ancestor
102542161|NCT04812626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102542162|NCT04812626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102542163|NCT04197986|Infigratinib|infigratinib|mesh-list
102542164|NCT04197986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102542165|NCT01997411|Glucagon|glucagon|mesh-list
102542166|NCT01997411|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102542167|NCT01997411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102542168|NCT01997411|Hormones|hormones|mesh-ancestor
102542169|NCT01997411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102542170|NCT01997411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542171|NCT01997411|Incretins|incretins|mesh-ancestor
102542172|NCT03534635|Pembrolizumab|pembrolizumab|mesh-list
102542173|NCT03534635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102542174|NCT03534635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102542175|NCT03534635|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102542176|NCT03534635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542177|NCT01999517|Nitroglycerin|nitroglycerin|mesh-list
102542178|NCT01999517|Vasodilator Agents|vasodilator agents|mesh-ancestor
102542179|NCT02657486|Infigratinib|infigratinib|mesh-list
102542180|NCT02657486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102542181|NCT02385110|Dexamethasone|dexamethasone|mesh-list
102542182|NCT02385110|Methotrexate|methotrexate|mesh-list
102542183|NCT02385110|Etoposide|etoposide|mesh-list
102542184|NCT02385110|Alemtuzumab|alemtuzumab|mesh-list
102542185|NCT02385110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102542186|NCT02385110|Antiemetics|antiemetics|mesh-ancestor
102542187|NCT02385110|Autonomic Agents|autonomic agents|mesh-ancestor
102542188|NCT02385110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102542189|NCT02385110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542190|NCT02385110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102542191|NCT02385110|Glucocorticoids|glucocorticoids|mesh-ancestor
102542192|NCT02385110|Hormones|hormones|mesh-ancestor
102542193|NCT02385110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102542194|NCT02385110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102542195|NCT02385110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102542196|NCT02385110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102542197|NCT02385110|Abortifacient Agents|abortifacient agents|mesh-ancestor
102542198|NCT02385110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102542199|NCT02385110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102542200|NCT02385110|Antimetabolites|antimetabolites|mesh-ancestor
102542201|NCT02385110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542202|NCT02385110|Dermatologic Agents|dermatologic agents|mesh-ancestor
102542203|NCT02385110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102542204|NCT02385110|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102542205|NCT02385110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102542206|NCT02385110|Immunologic Factors|immunologic factors|mesh-ancestor
102542207|NCT02385110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102542208|NCT02385110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102542209|NCT02385110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102542210|NCT02385110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102542211|NCT02385110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102542212|NCT02385110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102542213|NCT01999985|Dasatinib|dasatinib|mesh-list
102542214|NCT01999985|Afatinib|afatinib|mesh-list
102542215|NCT01999985|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102542216|NCT01999985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102542217|NCT01999985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102542218|NCT01999985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102542219|NCT01999985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542220|NCT01968317|Metformin|metformin|mesh-list
102542221|NCT01968317|Megestrol|megestrol|mesh-list
102542222|NCT01968317|Megestrol Acetate|megestrol acetate|mesh-list
102542223|NCT01968317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102542224|NCT01968317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542225|NCT01968317|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102542226|NCT01968317|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102542227|NCT01968317|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102542228|NCT01968317|Contraceptive Agents|contraceptive agents|mesh-ancestor
102542229|NCT01968317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102542230|NCT01968317|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102542231|NCT01968317|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102542232|NCT01968317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102542233|NCT01968317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101573528|NCT02769793|Levodopa|levodopa|mesh-list
102542234|NCT01968317|Appetite Stimulants|appetite stimulants|mesh-ancestor
102542235|NCT01968317|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102542236|NCT01971593|Eplerenone|eplerenone|mesh-list
102542237|NCT01971593|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102542238|NCT01971593|Hormone Antagonists|hormone antagonists|mesh-ancestor
102542239|NCT01971593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102542240|NCT01971593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542241|NCT01971593|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102542242|NCT01971593|Diuretics|diuretics|mesh-ancestor
102542243|NCT01971593|Natriuretic Agents|natriuretic agents|mesh-ancestor
102542244|NCT01971593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102542245|NCT02986451|Clarithromycin|clarithromycin|mesh-list
102542246|NCT02986451|Dexamethasone|dexamethasone|mesh-list
102542247|NCT02986451|Lenalidomide|lenalidomide|mesh-list
102542248|NCT02986451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102542249|NCT02986451|Antiemetics|antiemetics|mesh-ancestor
102542250|NCT02986451|Autonomic Agents|autonomic agents|mesh-ancestor
102542251|NCT02986451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102542252|NCT02986451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542253|NCT02986451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102542254|NCT02986451|Glucocorticoids|glucocorticoids|mesh-ancestor
102542255|NCT02986451|Hormones|hormones|mesh-ancestor
102542256|NCT02986451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102542257|NCT02986451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102542258|NCT02986451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102542259|NCT02986451|Immunologic Factors|immunologic factors|mesh-ancestor
102542260|NCT02986451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102542261|NCT02986451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102542262|NCT02986451|Growth Substances|growth substances|mesh-ancestor
102542263|NCT02986451|Growth Inhibitors|growth inhibitors|mesh-ancestor
102542264|NCT02986451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102542265|NCT02986451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102542266|NCT02986451|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102542267|NCT02986451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102542268|NCT02986451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542269|NCT02986451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102542270|NCT02986451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102542271|NCT03245463|Hyaluronic Acid|hyaluronic acid|mesh-list
102542272|NCT03245463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102542273|NCT03245463|Immunologic Factors|immunologic factors|mesh-ancestor
102542274|NCT03245463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542275|NCT03245463|Viscosupplements|viscosupplements|mesh-ancestor
102542276|NCT03245463|Protective Agents|protective agents|mesh-ancestor
102542277|NCT01974245|Cholecalciferol|cholecalciferol|mesh-list
102542278|NCT01974245|Vitamin D|vitamin d|mesh-list
102542279|NCT01974245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102542280|NCT01974245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542281|NCT01974245|Vitamins|vitamins|mesh-ancestor
102542282|NCT01974245|Micronutrients|micronutrients|mesh-ancestor
102542283|NCT01974245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102542284|NCT03307005|Zolpidem|zolpidem|mesh-list
102542285|NCT03307005|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102542286|NCT03307005|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102542287|NCT03307005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102542288|NCT03307005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542289|NCT03307005|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102542290|NCT03307005|GABA Agonists|gaba agonists|mesh-ancestor
102542291|NCT03307005|GABA Agents|gaba agents|mesh-ancestor
102542292|NCT03307005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102542293|NCT03307005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542294|NCT02005601|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102542295|NCT02005601|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102542296|NCT02005601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102542297|NCT02005601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102542298|NCT02005601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542299|NCT02005601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102542300|NCT02005601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542301|NCT02005601|Analgesics|analgesics|mesh-ancestor
102542302|NCT02005601|Sensory System Agents|sensory system agents|mesh-ancestor
102542303|NCT02005601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102542304|NCT02005601|Antidepressive Agents|antidepressive agents|mesh-ancestor
102542305|NCT02005601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102542306|NCT02005601|Dopamine Agents|dopamine agents|mesh-ancestor
102542307|NCT02007863|Fludarabine|fludarabine|mesh-list
102542308|NCT02007863|Melphalan|melphalan|mesh-list
102542309|NCT02007863|Busulfan|busulfan|mesh-list
102542310|NCT02007863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102542311|NCT02007863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542312|NCT02007863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102542313|NCT02007863|Immunologic Factors|immunologic factors|mesh-ancestor
102542314|NCT02007863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542315|NCT02007863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102542316|NCT02007863|Alkylating Agents|alkylating agents|mesh-ancestor
102542317|NCT02007863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102542318|NCT03460899|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102542319|NCT03460899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542320|NCT02305277|Opicapone|opicapone|mesh-list
102542321|NCT02305277|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102542322|NCT02305277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102542323|NCT02305277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542324|NCT02305277|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102542325|NCT02305277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102542326|NCT03309657|Tazobactam|tazobactam|mesh-list
102542327|NCT03309657|Ceftolozane|ceftolozane|mesh-list
102542328|NCT03309657|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
102542329|NCT03309657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102542330|NCT03309657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102542331|NCT03309657|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102542332|NCT03309657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102542333|NCT03309657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542334|NCT03309657|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102542335|NCT03463161|Pembrolizumab|pembrolizumab|mesh-list
102542336|NCT03463161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102542337|NCT03463161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102542338|NCT03463161|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102542339|NCT03463161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542340|NCT03467685|Anesthetics|anesthetics|mesh-list
102542341|NCT03467685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102542342|NCT03467685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542343|NCT03468075|Ascorbic Acid|ascorbic acid|mesh-list
102542344|NCT03468075|Gemcitabine|gemcitabine|mesh-list
102542345|NCT03468075|Vitamins|vitamins|mesh-ancestor
102542346|NCT03468075|Micronutrients|micronutrients|mesh-ancestor
102542347|NCT03468075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542348|NCT03468075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102542349|NCT03468075|Antimetabolites|antimetabolites|mesh-ancestor
102542350|NCT03468075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542351|NCT03468075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102542352|NCT03468075|Antioxidants|antioxidants|mesh-ancestor
102542353|NCT03468075|Protective Agents|protective agents|mesh-ancestor
102542354|NCT03468933|Plasminogen|plasminogen|mesh-list
102542355|NCT03468933|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102542356|NCT03468933|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102542357|NCT03468933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102542358|NCT03468933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542359|NCT03472287|Diacerein|diacerein|mesh-list
102542360|NCT03472287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102542361|NCT02219984|Anticoagulants|anticoagulants|mesh-list
102542362|NCT02067416|Paclitaxel|paclitaxel|mesh-list
102542363|NCT02067416|Docetaxel|docetaxel|mesh-list
102542364|NCT02067416|Epirubicin|epirubicin|mesh-list
102542365|NCT02067416|Taxane|taxane|mesh-list
102542366|NCT02067416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102542367|NCT02067416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102542368|NCT02067416|Tubulin Modulators|tubulin modulators|mesh-ancestor
102542369|NCT02067416|Antimitotic Agents|antimitotic agents|mesh-ancestor
102542370|NCT02067416|Mitosis Modulators|mitosis modulators|mesh-ancestor
102542371|NCT02067416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542372|NCT02067416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102542373|NCT02067416|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102542374|NCT02067416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102542375|NCT02067416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102542376|NCT03258645|Dabigatran|dabigatran|mesh-list
102542377|NCT03258645|Antithrombins|antithrombins|mesh-ancestor
102542378|NCT03258645|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102542379|NCT03258645|Protease Inhibitors|protease inhibitors|mesh-ancestor
102542380|NCT03258645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101762366|NCT00560794|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102542381|NCT03258645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542382|NCT03258645|Anticoagulants|anticoagulants|mesh-ancestor
102542383|NCT03482583|Nicotine|nicotine|mesh-list
102542384|NCT03482583|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102542385|NCT03482583|Autonomic Agents|autonomic agents|mesh-ancestor
102542386|NCT03482583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102542387|NCT03482583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542388|NCT03482583|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102542389|NCT03482583|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102542390|NCT03482583|Cholinergic Agents|cholinergic agents|mesh-ancestor
102542391|NCT03482583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102542392|NCT03482583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542393|NCT02010203|BCG Vaccine|bcg vaccine|mesh-list
102542394|NCT02010203|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102542395|NCT02010203|Immunologic Factors|immunologic factors|mesh-ancestor
102542396|NCT02010203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542397|NCT03261999|Leuprolide|leuprolide|mesh-list
102542398|NCT03261999|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102542399|NCT03261999|Fertility Agents|fertility agents|mesh-ancestor
102542400|NCT03261999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102542401|NCT03261999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542402|NCT03261999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102542403|NCT03261999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102542404|NCT03482973|Bupivacaine|bupivacaine|mesh-list
102542405|NCT03482973|Anesthetics, Local|anesthetics, local|mesh-ancestor
102542406|NCT03482973|Anesthetics|anesthetics|mesh-ancestor
102542407|NCT03482973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102542408|NCT03482973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542409|NCT03482973|Sensory System Agents|sensory system agents|mesh-ancestor
102542410|NCT03482973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102542411|NCT01602380|Fulvestrant|fulvestrant|mesh-list
102542412|NCT01602380|Anastrozole|anastrozole|mesh-list
102542413|NCT01602380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102542414|NCT01602380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102542415|NCT01602380|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102542416|NCT01602380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102542417|NCT01602380|Hormone Antagonists|hormone antagonists|mesh-ancestor
102542418|NCT01602380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102542419|NCT01602380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542420|NCT01602380|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102542421|NCT01602380|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102542422|NCT01602380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102542423|NCT01602380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542424|NCT03483675|Immunosuppressive Agents|immunosuppressive agents|mesh-list
102542425|NCT03483675|Immunologic Factors|immunologic factors|mesh-ancestor
102542426|NCT03483675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542427|NCT03327051|Omeprazole|omeprazole|mesh-list
102542428|NCT03327051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102542429|NCT03327051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102542430|NCT03327051|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102542431|NCT03327051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102542432|NCT03327051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542433|NCT02057939|Leuprolide|leuprolide|mesh-list
102542434|NCT02057939|Androgens|androgens|mesh-list
102542435|NCT02057939|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102542436|NCT02057939|Fertility Agents|fertility agents|mesh-ancestor
102542437|NCT02057939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102542438|NCT02057939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542439|NCT02057939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102542440|NCT02057939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102542441|NCT02057939|Hormones|hormones|mesh-ancestor
102542442|NCT02057939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102542443|NCT03496467|Nepafenac|nepafenac|mesh-list
102542444|NCT03496467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101762422|NCT00848991|Propofol|propofol|mesh-list
102542445|NCT03496467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102542446|NCT03496467|Analgesics|analgesics|mesh-ancestor
102542447|NCT03496467|Sensory System Agents|sensory system agents|mesh-ancestor
102542448|NCT03496467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102542449|NCT03496467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542450|NCT03496467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102542451|NCT03496467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102542452|NCT00482690|Nicotine|nicotine|mesh-list
102542453|NCT00482690|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102542454|NCT00482690|Autonomic Agents|autonomic agents|mesh-ancestor
102542455|NCT00482690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102542456|NCT00482690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542457|NCT00482690|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102542458|NCT00482690|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102542459|NCT00482690|Cholinergic Agents|cholinergic agents|mesh-ancestor
102542460|NCT00482690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102542461|NCT00482690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542462|NCT02058251|Oxytocin|oxytocin|mesh-list
102542463|NCT02058251|Oxytocics|oxytocics|mesh-ancestor
102542464|NCT02058251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102542465|NCT02058251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542466|NCT03329937|Niraparib|niraparib|mesh-list
102542467|NCT03329937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102542468|NCT03329937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102542469|NCT03329937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542470|NCT03329937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102542471|NCT01710254|Regadenoson|regadenoson|mesh-list
102542472|NCT01710254|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
102542473|NCT01710254|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102542474|NCT01710254|Purinergic Agonists|purinergic agonists|mesh-ancestor
102542475|NCT01710254|Purinergic Agents|purinergic agents|mesh-ancestor
102542476|NCT01710254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102542477|NCT01710254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542478|NCT01710254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542479|NCT03496545|Acetaminophen|acetaminophen|mesh-list
102542480|NCT03496545|Bromocriptine|bromocriptine|mesh-list
102542481|NCT03496545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102542482|NCT03496545|Analgesics|analgesics|mesh-ancestor
102542483|NCT03496545|Sensory System Agents|sensory system agents|mesh-ancestor
102542484|NCT03496545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102542485|NCT03496545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542486|NCT03496545|Antipyretics|antipyretics|mesh-ancestor
102542487|NCT03496545|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102542488|NCT03496545|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102542489|NCT03496545|Hormone Antagonists|hormone antagonists|mesh-ancestor
102542490|NCT03496545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102542491|NCT03496545|Dopamine Agonists|dopamine agonists|mesh-ancestor
102542492|NCT03496545|Dopamine Agents|dopamine agents|mesh-ancestor
102542493|NCT03496545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102542494|NCT03496545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542495|NCT01710332|Aflibercept|aflibercept|mesh-list
102542496|NCT01710332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102542497|NCT01710332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102542498|NCT01710332|Growth Substances|growth substances|mesh-ancestor
102542499|NCT01710332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542500|NCT01710332|Growth Inhibitors|growth inhibitors|mesh-ancestor
102542501|NCT01710332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102542502|NCT02311907|Paclitaxel|paclitaxel|mesh-list
102542503|NCT02311907|Carboplatin|carboplatin|mesh-list
102542504|NCT02311907|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102542505|NCT02311907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102542506|NCT02311907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102542507|NCT02311907|Tubulin Modulators|tubulin modulators|mesh-ancestor
102542508|NCT02311907|Antimitotic Agents|antimitotic agents|mesh-ancestor
102542509|NCT02311907|Mitosis Modulators|mitosis modulators|mesh-ancestor
102542510|NCT02311907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542511|NCT02013245|Vaccines|vaccines|mesh-list
102542512|NCT02013245|Immunologic Factors|immunologic factors|mesh-ancestor
102542513|NCT02013245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542514|NCT01980485|Carbon Monoxide|carbon monoxide|mesh-list
102542515|NCT01980485|Antimetabolites|antimetabolites|mesh-ancestor
102542516|NCT01980485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542517|NCT01980485|Gasotransmitters|gasotransmitters|mesh-ancestor
102542518|NCT01980485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102542519|NCT01980485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542520|NCT01981967|Vaccines|vaccines|mesh-list
102542521|NCT01981967|Immunologic Factors|immunologic factors|mesh-ancestor
102542522|NCT01981967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542523|NCT01982123|Edetic Acid|edetic acid|mesh-list
102542524|NCT01982123|Pentetic Acid|pentetic acid|mesh-list
102542525|NCT01982123|Technetium Tc 99m Pentetate|technetium tc 99m pentetate|mesh-list
102542526|NCT01982123|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
102542527|NCT01982123|Antidotes|antidotes|mesh-ancestor
102542528|NCT01982123|Protective Agents|protective agents|mesh-ancestor
102542529|NCT01982123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542530|NCT01982123|Chelating Agents|chelating agents|mesh-ancestor
102542531|NCT01982123|Sequestering Agents|sequestering agents|mesh-ancestor
102542532|NCT01982123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542533|NCT01982123|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102542534|NCT01982123|Anticoagulants|anticoagulants|mesh-ancestor
102542535|NCT01982123|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102542536|NCT01982123|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102542538|NCT02061683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102542539|NCT01711658|Lapatinib|lapatinib|mesh-list
102542540|NCT01711658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102542541|NCT01711658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102542542|NCT01711658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102542543|NCT01711658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542544|NCT01712360|Naftifine|naftifine|mesh-list
102542545|NCT01712360|Antifungal Agents|antifungal agents|mesh-ancestor
102542546|NCT01712360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102542547|NCT02396147|Relugolix|relugolix|mesh-list
102542548|NCT02396147|Androgen Antagonists|androgen antagonists|mesh-ancestor
102542549|NCT02396147|Hormone Antagonists|hormone antagonists|mesh-ancestor
102542550|NCT02396147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102542551|NCT02396147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542552|NCT01713608|Artefenomel|artefenomel|mesh-list
102542553|NCT01713608|Antimalarials|antimalarials|mesh-ancestor
102542554|NCT01713608|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102542555|NCT01713608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102542556|NCT01713608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102542557|NCT02018627|Glucagon|glucagon|mesh-list
102542558|NCT02018627|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102542559|NCT02018627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102542560|NCT02018627|Hormones|hormones|mesh-ancestor
102542561|NCT02018627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102542562|NCT02018627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542563|NCT02018627|Incretins|incretins|mesh-ancestor
102542564|NCT03476330|Quercetin|quercetin|mesh-list
102542565|NCT03476330|Antioxidants|antioxidants|mesh-ancestor
102542566|NCT03476330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542567|NCT03476330|Protective Agents|protective agents|mesh-ancestor
102542568|NCT03476330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542569|NCT04413344|Bromocriptine|bromocriptine|mesh-list
102542570|NCT04413344|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102542571|NCT04413344|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102542572|NCT04413344|Hormone Antagonists|hormone antagonists|mesh-ancestor
102542573|NCT04413344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102542574|NCT04413344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542575|NCT04413344|Dopamine Agonists|dopamine agonists|mesh-ancestor
102542576|NCT04413344|Dopamine Agents|dopamine agents|mesh-ancestor
102542577|NCT04413344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102542578|NCT04413344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542579|NCT01717742|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102542580|NCT01717742|Plasminogen|plasminogen|mesh-list
102542581|NCT01717742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102542582|NCT01717742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102542583|NCT01717742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542584|NCT01717898|Prednisone|prednisone|mesh-list
102542585|NCT01717898|Abiraterone Acetate|abiraterone acetate|mesh-list
102542586|NCT01717898|Dactolisib|dactolisib|mesh-list
102542587|NCT01717898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102542588|NCT01717898|Glucocorticoids|glucocorticoids|mesh-ancestor
102542589|NCT01717898|Hormones|hormones|mesh-ancestor
102542590|NCT01717898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102542591|NCT01717898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542592|NCT01717898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102542593|NCT01717898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102542594|NCT01717898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102542595|NCT01717898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102542596|NCT01717898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542597|NCT01717898|Hormone Antagonists|hormone antagonists|mesh-ancestor
102542598|NCT01717898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102542599|NCT01737944|Methotrexate|methotrexate|mesh-list
102542600|NCT01737944|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102542601|NCT01737944|Abortifacient Agents|abortifacient agents|mesh-ancestor
102542602|NCT01737944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102542603|NCT01737944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542604|NCT01737944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102542605|NCT01737944|Antimetabolites|antimetabolites|mesh-ancestor
102542606|NCT01737944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542607|NCT01737944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102542608|NCT01737944|Dermatologic Agents|dermatologic agents|mesh-ancestor
102542609|NCT01737944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102542610|NCT01737944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102542611|NCT01737944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102542612|NCT01737944|Immunologic Factors|immunologic factors|mesh-ancestor
102542613|NCT01737944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102542614|NCT01737944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102542615|NCT01740206|Methylphenidate|methylphenidate|mesh-list
102542616|NCT01740206|Amphetamine|amphetamine|mesh-list
102542617|NCT01740206|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102542618|NCT01740206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542619|NCT01740206|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102542620|NCT01740206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102542621|NCT01740206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102542622|NCT01740206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542623|NCT01740206|Dopamine Agents|dopamine agents|mesh-ancestor
102542624|NCT01740206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102542625|NCT01740206|Sympathomimetics|sympathomimetics|mesh-ancestor
102542626|NCT01740206|Autonomic Agents|autonomic agents|mesh-ancestor
102542627|NCT01740206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102542628|NCT01740206|Adrenergic Agents|adrenergic agents|mesh-ancestor
102542629|NCT01740206|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102542630|NCT01740362|Tofacitinib|tofacitinib|mesh-list
102542631|NCT01740362|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102542632|NCT01740362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102542633|NCT01740362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102542634|NCT01740362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542635|NCT02068157|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
102542636|NCT02068157|Trioxsalen|trioxsalen|mesh-list
102542637|NCT02068157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102542638|NCT02068157|Dermatologic Agents|dermatologic agents|mesh-ancestor
102542639|NCT02068157|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102542640|NCT01741454|Tamsulosin|tamsulosin|mesh-list
102542641|NCT01741454|Tolterodine Tartrate|tolterodine tartrate|mesh-list
102542642|NCT01741454|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102542643|NCT01741454|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102542644|NCT01741454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102542645|NCT01741454|Adrenergic Agents|adrenergic agents|mesh-ancestor
102542646|NCT01741454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102542647|NCT01741454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542648|NCT01741454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542649|NCT01741454|Urological Agents|urological agents|mesh-ancestor
102542650|NCT01741454|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102542651|NCT01741454|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102542652|NCT01741454|Cholinergic Agents|cholinergic agents|mesh-ancestor
102542653|NCT01720316|Glycine|glycine|mesh-list
102542654|NCT01720316|Glycine Agents|glycine agents|mesh-ancestor
102542655|NCT01720316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102542656|NCT01720316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542657|NCT01720316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542658|NCT02399345|Ritonavir|ritonavir|mesh-list
102542659|NCT02399345|Ribavirin|ribavirin|mesh-list
102542660|NCT02399345|Sofosbuvir|sofosbuvir|mesh-list
102542661|NCT02399345|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102542662|NCT02399345|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102542663|NCT02399345|Protease Inhibitors|protease inhibitors|mesh-ancestor
102542664|NCT02399345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102542665|NCT02399345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542666|NCT02399345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102542667|NCT02399345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102542668|NCT02399345|Antiviral Agents|antiviral agents|mesh-ancestor
102542669|NCT02399345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102542670|NCT02399345|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102542671|NCT02399345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102542672|NCT02399345|Antimetabolites|antimetabolites|mesh-ancestor
102542673|NCT02400437|Dexamethasone|dexamethasone|mesh-list
102542674|NCT02400437|Rituximab|rituximab|mesh-list
102542675|NCT02400437|Ixazomib|ixazomib|mesh-list
102542676|NCT02400437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102542677|NCT02400437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102542678|NCT02400437|Immunologic Factors|immunologic factors|mesh-ancestor
102542679|NCT02400437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542680|NCT02400437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102542681|NCT02400437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102542682|NCT02400437|Antiemetics|antiemetics|mesh-ancestor
102542683|NCT02400437|Autonomic Agents|autonomic agents|mesh-ancestor
102542684|NCT02400437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102542685|NCT02400437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102542686|NCT02400437|Glucocorticoids|glucocorticoids|mesh-ancestor
102542687|NCT02400437|Hormones|hormones|mesh-ancestor
101762672|NCT00850161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102542688|NCT02400437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102542689|NCT02400437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102542690|NCT02400437|Protease Inhibitors|protease inhibitors|mesh-ancestor
102542691|NCT02400437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102542692|NCT02400437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542693|NCT02024477|Saxagliptin|saxagliptin|mesh-list
102542694|NCT02024477|Incretins|incretins|mesh-ancestor
102542695|NCT02024477|Hormones|hormones|mesh-ancestor
102542696|NCT02024477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102542697|NCT02024477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542698|NCT02024477|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102542699|NCT02024477|Protease Inhibitors|protease inhibitors|mesh-ancestor
102542700|NCT02024477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102542701|NCT02024477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542702|NCT02024477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102542703|NCT02024711|Hyaluronic Acid|hyaluronic acid|mesh-list
102542704|NCT02024711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102542705|NCT02024711|Immunologic Factors|immunologic factors|mesh-ancestor
102542706|NCT02024711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542707|NCT02024711|Viscosupplements|viscosupplements|mesh-ancestor
102542708|NCT02024711|Protective Agents|protective agents|mesh-ancestor
102542709|NCT02071823|Opicapone|opicapone|mesh-list
102542710|NCT02071823|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102542711|NCT02071823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102542712|NCT02071823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542713|NCT02071823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102542714|NCT02071823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102542715|NCT02029703|Hylan|hylan|mesh-list
102542716|NCT02029703|Viscosupplements|viscosupplements|mesh-ancestor
102542717|NCT02029703|Protective Agents|protective agents|mesh-ancestor
102542718|NCT02029703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542719|NCT02406443|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102542720|NCT02406443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102542721|NCT02406443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542722|NCT02406443|Incretins|incretins|mesh-ancestor
102542723|NCT02406443|Hormones|hormones|mesh-ancestor
102542724|NCT02406443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102542725|NCT02406443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102542726|NCT02406443|Protease Inhibitors|protease inhibitors|mesh-ancestor
102542727|NCT02406443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102542728|NCT02406443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542729|NCT02032433|Naltrexone|naltrexone|mesh-list
102542730|NCT02032433|Buprenorphine|buprenorphine|mesh-list
102542731|NCT02032433|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102542732|NCT02032433|Naloxone|naloxone|mesh-list
102542733|NCT02032433|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102542734|NCT02032433|Narcotics|narcotics|mesh-ancestor
102542735|NCT02032433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102542736|NCT02032433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542737|NCT02032433|Analgesics|analgesics|mesh-ancestor
102542738|NCT02032433|Sensory System Agents|sensory system agents|mesh-ancestor
102542739|NCT02032433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102542740|NCT02032433|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102542741|NCT02032433|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102542742|NCT02342015|Atorvastatin|atorvastatin|mesh-list
102542743|NCT02342015|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102542744|NCT02342015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102542745|NCT02342015|Antimetabolites|antimetabolites|mesh-ancestor
102542746|NCT02342015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542747|NCT02342015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102542748|NCT02342015|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102542749|NCT02342015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102542750|NCT02342327|Menthol|menthol|mesh-list
102542751|NCT02342327|Antipruritics|antipruritics|mesh-ancestor
102542752|NCT02342327|Dermatologic Agents|dermatologic agents|mesh-ancestor
102542753|NCT01721564|Bosentan|bosentan|mesh-list
102542754|NCT01721564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102542755|NCT01721564|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102542756|NCT01721564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542757|NCT02342561|Anti-Infective Agents|anti-infective agents|mesh-list
102542758|NCT02342561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102542759|NCT02343575|Valproic Acid|valproic acid|mesh-list
102542760|NCT02343575|Haloperidol|haloperidol|mesh-list
102542761|NCT02343575|Haloperidol decanoate|haloperidol decanoate|mesh-list
102542762|NCT02343575|Antiemetics|antiemetics|mesh-ancestor
102542763|NCT02343575|Autonomic Agents|autonomic agents|mesh-ancestor
102542764|NCT02343575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102542765|NCT02343575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542766|NCT02343575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102542767|NCT02343575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102542768|NCT02343575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102542769|NCT02343575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102542770|NCT02343575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102542771|NCT02343575|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102542772|NCT02343575|Dopamine Agents|dopamine agents|mesh-ancestor
102542773|NCT02343575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102542774|NCT02343575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542775|NCT02343575|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102542776|NCT02343575|Anticonvulsants|anticonvulsants|mesh-ancestor
102542777|NCT02343575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102542778|NCT02343575|GABA Agents|gaba agents|mesh-ancestor
102542779|NCT02343575|Antimanic Agents|antimanic agents|mesh-ancestor
102542780|NCT01744574|Progesterone|progesterone|mesh-list
102542781|NCT01744574|Progestins|progestins|mesh-ancestor
102542782|NCT01744574|Hormones|hormones|mesh-ancestor
102542783|NCT01744574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102542784|NCT01744574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542785|NCT01744730|Clindamycin|clindamycin|mesh-list
102542786|NCT01744730|Clindamycin palmitate|clindamycin palmitate|mesh-list
102542787|NCT01744730|Clindamycin phosphate|clindamycin phosphate|mesh-list
102542788|NCT01744730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102542789|NCT01744730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102542790|NCT01744730|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102542791|NCT01744730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102542792|NCT01744730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542793|NCT00354965|Amoxicillin|amoxicillin|mesh-list
102542794|NCT00354965|Clavulanic Acid|clavulanic acid|mesh-list
102542795|NCT00354965|Clavulanic Acids|clavulanic acids|mesh-list
102542796|NCT00354965|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102542797|NCT00354965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102542798|NCT00354965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102542799|NCT00354965|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102542800|NCT00354965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102542801|NCT00354965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542802|NCT02037425|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102542803|NCT02037425|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102542804|NCT02037425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102542805|NCT02037425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102542806|NCT02037425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542807|NCT02037425|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101762793|NCT00750048|Antipyretics|antipyretics|mesh-ancestor
102542808|NCT02037425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102542809|NCT02037425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542810|NCT02037425|Cholinergic Agents|cholinergic agents|mesh-ancestor
102542811|NCT02037425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102542812|NCT00355043|Zinc Sulfate|zinc sulfate|mesh-list
102542813|NCT00355043|Astringents|astringents|mesh-ancestor
102542814|NCT00355043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542815|NCT00355043|Dermatologic Agents|dermatologic agents|mesh-ancestor
102542816|NCT02037893|Antipyrine|antipyrine|mesh-list
102542817|NCT02037893|Benzocaine|benzocaine|mesh-list
102542818|NCT02037893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102542819|NCT02037893|Anesthetics, Local|anesthetics, local|mesh-ancestor
102542820|NCT02037893|Anesthetics|anesthetics|mesh-ancestor
102542821|NCT02037893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102542822|NCT02037893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542823|NCT02037893|Sensory System Agents|sensory system agents|mesh-ancestor
102542824|NCT02037893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102542825|NCT02037893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102542826|NCT02037893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102542827|NCT02037893|Analgesics|analgesics|mesh-ancestor
102542828|NCT02037893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102542829|NCT02037893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102542830|NCT02040623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102542831|NCT02040623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102542832|NCT02041325|Lenalidomide|lenalidomide|mesh-list
102542833|NCT02041325|Immunologic Factors|immunologic factors|mesh-ancestor
102542834|NCT02041325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542835|NCT02041325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102542836|NCT02041325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102542837|NCT02041325|Growth Substances|growth substances|mesh-ancestor
102542838|NCT02041325|Growth Inhibitors|growth inhibitors|mesh-ancestor
102542839|NCT02041325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102542840|NCT01723514|Erenumab|erenumab|mesh-list
102542841|NCT01723514|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
102542842|NCT01723514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542843|NCT01723514|Analgesics|analgesics|mesh-ancestor
102542844|NCT01723514|Sensory System Agents|sensory system agents|mesh-ancestor
102542845|NCT01723514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102542846|NCT01723514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542847|NCT02044367|Dabigatran|dabigatran|mesh-list
102542848|NCT02044367|Antithrombins|antithrombins|mesh-ancestor
102542849|NCT02044367|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102542850|NCT02044367|Protease Inhibitors|protease inhibitors|mesh-ancestor
102542851|NCT02044367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102542852|NCT02044367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542853|NCT02044367|Anticoagulants|anticoagulants|mesh-ancestor
102542854|NCT01745822|Tenofovir|tenofovir|mesh-list
102542855|NCT01745822|Antiviral Agents|antiviral agents|mesh-ancestor
102542856|NCT01745822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102542857|NCT01745822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102542858|NCT01745822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102542859|NCT01745822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102542860|NCT01745822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542861|NCT01745822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102542862|NCT01745822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102542863|NCT05718869|Zanubrutinib|zanubrutinib|mesh-list
102542864|NCT05718869|Immunoglobulins|immunoglobulins|mesh-list
102542865|NCT05718869|Immunologic Factors|immunologic factors|mesh-ancestor
102542866|NCT05718869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542867|NCT05718869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102542868|NCT05718869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102542869|NCT05718869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102542870|NCT05718869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542871|NCT02354339|Magnesium Oxide|magnesium oxide|mesh-list
102542872|NCT02354339|Antacids|antacids|mesh-ancestor
102542873|NCT02354339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542874|NCT02354339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102542875|NCT01747850|Ethanol|ethanol|mesh-list
102542876|NCT01747850|Nabiximols|nabiximols|mesh-list
102542877|NCT01747850|Dronabinol|dronabinol|mesh-list
102542878|NCT01747850|Cannabidiol|cannabidiol|mesh-list
102542879|NCT01747850|Peppermint oil|peppermint oil|mesh-list
102542880|NCT01747850|Anticonvulsants|anticonvulsants|mesh-ancestor
102542881|NCT01747850|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102542882|NCT01747850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102542883|NCT01747850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102542884|NCT01747850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542885|NCT01747850|Analgesics|analgesics|mesh-ancestor
102542886|NCT01747850|Sensory System Agents|sensory system agents|mesh-ancestor
102542887|NCT01747850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102542888|NCT01747850|Hallucinogens|hallucinogens|mesh-ancestor
102542889|NCT01747850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102542890|NCT01747850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102542891|NCT01747850|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102542892|NCT01747850|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102542893|NCT01747850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102542894|NCT01747850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542895|NCT01747850|Hormones|hormones|mesh-ancestor
102542896|NCT01747850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102542897|NCT01747850|Antiemetics|antiemetics|mesh-ancestor
102542898|NCT01747850|Autonomic Agents|autonomic agents|mesh-ancestor
102542899|NCT01747850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102542900|NCT01747850|Parasympatholytics|parasympatholytics|mesh-ancestor
102542901|NCT01727414|Methylphenidate|methylphenidate|mesh-list
102542902|NCT01727414|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102542903|NCT01727414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542904|NCT01727414|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102542905|NCT01727414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102542906|NCT01727414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102542907|NCT01727414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542908|NCT01727414|Dopamine Agents|dopamine agents|mesh-ancestor
102542909|NCT01727414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102542910|NCT02048891|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102542911|NCT02048891|Progesterone|progesterone|mesh-list
102542912|NCT02048891|Progestins|progestins|mesh-ancestor
102542913|NCT02048891|Hormones|hormones|mesh-ancestor
102542914|NCT02048891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102542915|NCT02048891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542916|NCT02048891|Luteolytic Agents|luteolytic agents|mesh-ancestor
102542917|NCT02048891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102542918|NCT02048891|Contraceptive Agents|contraceptive agents|mesh-ancestor
102542919|NCT02048891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102542920|NCT02048891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102542921|NCT02048891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102542922|NCT02048891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102542923|NCT01727726|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102542924|NCT01727726|Brexpiprazole|brexpiprazole|mesh-list
102542925|NCT01727726|Antidepressive Agents|antidepressive agents|mesh-ancestor
102542926|NCT01727726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102542927|NCT01727726|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102542928|NCT01727726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102542929|NCT01727726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102542930|NCT01727726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542931|NCT01727726|Serotonin Agents|serotonin agents|mesh-ancestor
102542932|NCT01727726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102542933|NCT01727726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542934|NCT01727726|Dopamine Agonists|dopamine agonists|mesh-ancestor
102542935|NCT01727726|Dopamine Agents|dopamine agents|mesh-ancestor
102542936|NCT02355821|Bisoprolol|bisoprolol|mesh-list
102542937|NCT02355821|Moxonidine|moxonidine|mesh-list
102542938|NCT02355821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102542939|NCT02355821|Sympatholytics|sympatholytics|mesh-ancestor
102542940|NCT02355821|Autonomic Agents|autonomic agents|mesh-ancestor
102542941|NCT02355821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102542942|NCT02355821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542943|NCT02355821|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102542944|NCT02355821|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102542945|NCT02355821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102542946|NCT02355821|Adrenergic Agents|adrenergic agents|mesh-ancestor
102542947|NCT02355821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102542948|NCT02355821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542949|NCT01748240|Azacitidine|azacitidine|mesh-list
102542950|NCT01748240|Vorinostat|vorinostat|mesh-list
102542951|NCT01748240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102542952|NCT01748240|Antimetabolites|antimetabolites|mesh-ancestor
102542953|NCT01748240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542954|NCT01748240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102542955|NCT01748240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102542956|NCT01748240|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102542957|NCT01748942|Dexamethasone|dexamethasone|mesh-list
102542958|NCT01748942|Dexamethasone acetate|dexamethasone acetate|mesh-list
102542959|NCT01748942|Ichthammol|ichthammol|mesh-list
102542960|NCT01748942|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102542961|NCT01748942|BB 1101|bb 1101|mesh-list
102542962|NCT01748942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102542963|NCT01748942|Antiemetics|antiemetics|mesh-ancestor
102542964|NCT01748942|Autonomic Agents|autonomic agents|mesh-ancestor
102542965|NCT01748942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102542966|NCT01748942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542967|NCT01748942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102542968|NCT01748942|Glucocorticoids|glucocorticoids|mesh-ancestor
102542969|NCT01748942|Hormones|hormones|mesh-ancestor
102542970|NCT01748942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102542971|NCT01748942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102542972|NCT01748942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102542973|NCT01748942|Protease Inhibitors|protease inhibitors|mesh-ancestor
102542974|NCT01748942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102542975|NCT01748942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542976|NCT01748942|Dermatologic Agents|dermatologic agents|mesh-ancestor
102542977|NCT02355977|Minocycline|minocycline|mesh-list
102542978|NCT02355977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102542979|NCT02355977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102542980|NCT01749410|Botulinum Toxins|botulinum toxins|mesh-list
102542981|NCT01749410|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102542982|NCT01749410|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102542983|NCT01749410|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102542984|NCT01749410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102542985|NCT01749410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542986|NCT01749410|Cholinergic Agents|cholinergic agents|mesh-ancestor
102542987|NCT01749410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102542988|NCT01749410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542989|NCT01749410|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102542990|NCT01749410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102542991|NCT01729598|Valproic Acid|valproic acid|mesh-list
102542992|NCT01729598|Anticonvulsants|anticonvulsants|mesh-ancestor
102542993|NCT01729598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102542994|NCT01729598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102542995|NCT01729598|GABA Agents|gaba agents|mesh-ancestor
102542996|NCT01729598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102542997|NCT01729598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102542998|NCT01729598|Antimanic Agents|antimanic agents|mesh-ancestor
102542999|NCT01729598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102543000|NCT01729598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102543001|NCT01729598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102543002|NCT05718011|Dexmedetomidine|dexmedetomidine|mesh-list
102543003|NCT05718011|Ketamine|ketamine|mesh-list
102543004|NCT05718011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102543005|NCT05718011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102543006|NCT05718011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543007|NCT05718011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102543008|NCT05718011|Analgesics|analgesics|mesh-ancestor
102543009|NCT05718011|Sensory System Agents|sensory system agents|mesh-ancestor
102543010|NCT05718011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102543011|NCT05718011|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102543012|NCT05718011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102543013|NCT05718011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102543014|NCT05718011|Adrenergic Agents|adrenergic agents|mesh-ancestor
102543015|NCT05718011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102543016|NCT05718011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543017|NCT05718011|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102543018|NCT05718011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102543019|NCT05718011|Anesthetics, General|anesthetics, general|mesh-ancestor
102543020|NCT05718011|Anesthetics|anesthetics|mesh-ancestor
102543021|NCT05718011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102543022|NCT05718011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102543023|NCT05717933|Hormones|hormones|mesh-list
102543024|NCT05717933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102543025|NCT05717933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543026|NCT01730846|Doxazosin|doxazosin|mesh-list
102543027|NCT01730846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102543028|NCT01730846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102543029|NCT01730846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102543030|NCT01730846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102543031|NCT01730846|Adrenergic Agents|adrenergic agents|mesh-ancestor
102543032|NCT01730846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102543033|NCT01730846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543034|NCT01730846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543035|NCT02314403|Rituximab|rituximab|mesh-list
102543036|NCT02314403|Abatacept|abatacept|mesh-list
102543037|NCT02314403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102543038|NCT02314403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102543039|NCT02314403|Immunologic Factors|immunologic factors|mesh-ancestor
102543040|NCT02314403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543041|NCT02314403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102543042|NCT02314403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102543043|NCT02314403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543044|NCT02314403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102543045|NCT02052557|Bupivacaine|bupivacaine|mesh-list
102543046|NCT02052557|Anesthetics, Local|anesthetics, local|mesh-ancestor
102543047|NCT02052557|Anesthetics|anesthetics|mesh-ancestor
102543048|NCT02052557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102543049|NCT02052557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543050|NCT02052557|Sensory System Agents|sensory system agents|mesh-ancestor
102543051|NCT02052557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102543052|NCT02052635|Clopidogrel|clopidogrel|mesh-list
102543053|NCT02052635|Ticagrelor|ticagrelor|mesh-list
102543054|NCT02052635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102543055|NCT02052635|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102543056|NCT02052635|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102543057|NCT02052635|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102543058|NCT02052635|Purinergic Agents|purinergic agents|mesh-ancestor
102543059|NCT02052635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102543060|NCT02052635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543061|NCT02052635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543062|NCT01732718|Atorvastatin|atorvastatin|mesh-list
102543063|NCT01732718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102543064|NCT01732718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102543065|NCT01732718|Antimetabolites|antimetabolites|mesh-ancestor
102543066|NCT01732718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543067|NCT01732718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102543068|NCT01732718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102543069|NCT01732718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102543070|NCT02362373|Levonorgestrel|levonorgestrel|mesh-list
102543071|NCT02362373|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102543072|NCT02362373|Contraceptive Agents|contraceptive agents|mesh-ancestor
102543073|NCT02362373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102543074|NCT02362373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543075|NCT02362373|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102543076|NCT02362373|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102543077|NCT02362373|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102543078|NCT02363621|Ranibizumab|ranibizumab|mesh-list
102543079|NCT02363621|Aflibercept|aflibercept|mesh-list
102543080|NCT02363621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102543081|NCT02363621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102543082|NCT02363621|Growth Substances|growth substances|mesh-ancestor
102543083|NCT02363621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543084|NCT02363621|Growth Inhibitors|growth inhibitors|mesh-ancestor
102543085|NCT02363621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102543086|NCT01749956|Leucovorin|leucovorin|mesh-list
102543087|NCT01749956|Fluorouracil|fluorouracil|mesh-list
102543088|NCT01749956|Oxaliplatin|oxaliplatin|mesh-list
102543089|NCT01749956|Aflibercept|aflibercept|mesh-list
102543090|NCT01749956|Antimetabolites|antimetabolites|mesh-ancestor
102543091|NCT01749956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543092|NCT01749956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102543093|NCT01749956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102543094|NCT01749956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102543095|NCT01749956|Immunologic Factors|immunologic factors|mesh-ancestor
102543096|NCT01749956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543097|NCT01749956|Antidotes|antidotes|mesh-ancestor
102543098|NCT01749956|Protective Agents|protective agents|mesh-ancestor
102543099|NCT01749956|Vitamin B Complex|vitamin b complex|mesh-ancestor
102543100|NCT01749956|Vitamins|vitamins|mesh-ancestor
102543101|NCT01749956|Micronutrients|micronutrients|mesh-ancestor
102543102|NCT01749956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102543103|NCT01749956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102543104|NCT01749956|Growth Substances|growth substances|mesh-ancestor
102543105|NCT01749956|Growth Inhibitors|growth inhibitors|mesh-ancestor
102543106|NCT02365961|Clonidine|clonidine|mesh-list
102543107|NCT02365961|Epinephrine|epinephrine|mesh-list
102543108|NCT02365961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102543109|NCT02365961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102543110|NCT02365961|Adrenergic Agents|adrenergic agents|mesh-ancestor
102543111|NCT02365961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102543112|NCT02365961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543113|NCT02365961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543114|NCT02365961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102543115|NCT02365961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102543116|NCT02365961|Autonomic Agents|autonomic agents|mesh-ancestor
102543117|NCT02365961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102543118|NCT02365961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102543119|NCT02365961|Respiratory System Agents|respiratory system agents|mesh-ancestor
102543120|NCT02365961|Mydriatics|mydriatics|mesh-ancestor
102543121|NCT02365961|Sympathomimetics|sympathomimetics|mesh-ancestor
102543122|NCT02365961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102543123|NCT02365961|Analgesics|analgesics|mesh-ancestor
102543124|NCT02365961|Sensory System Agents|sensory system agents|mesh-ancestor
102543125|NCT02365961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102543126|NCT02365961|Sympatholytics|sympatholytics|mesh-ancestor
102543127|NCT02365961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102543128|NCT05532059|Cisplatin|cisplatin|mesh-list
102543129|NCT05532059|Gemcitabine|gemcitabine|mesh-list
102543130|NCT05532059|Lenvatinib|lenvatinib|mesh-list
102543131|NCT05532059|Tislelizumab|tislelizumab|mesh-list
102543132|NCT05532059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102543133|NCT05532059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102543134|NCT05532059|Antimetabolites|antimetabolites|mesh-ancestor
102543135|NCT05532059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543136|NCT05532059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102543137|NCT05532059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102543138|NCT05532059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102543139|NCT03809234|Ondansetron|ondansetron|mesh-list
102543140|NCT03809234|Antiemetics|antiemetics|mesh-ancestor
102543141|NCT03809234|Autonomic Agents|autonomic agents|mesh-ancestor
102543142|NCT03809234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102543143|NCT03809234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543144|NCT03809234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102543145|NCT03809234|Antipruritics|antipruritics|mesh-ancestor
102543146|NCT03809234|Dermatologic Agents|dermatologic agents|mesh-ancestor
102543147|NCT03809234|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102543148|NCT03809234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102543149|NCT03809234|Serotonin Agents|serotonin agents|mesh-ancestor
102543150|NCT03809234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101763136|NCT00947596|Atropine|atropine|mesh-list
102543151|NCT03809234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543152|NCT03711188|Nivolumab|nivolumab|mesh-list
102543153|NCT03711188|Ipilimumab|ipilimumab|mesh-list
102543154|NCT03711188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102543155|NCT03711188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102543156|NCT03711188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102543157|NCT03711188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543158|NCT02366663|Cytarabine|cytarabine|mesh-list
102543159|NCT02366663|Rituximab|rituximab|mesh-list
102543160|NCT02366663|Etoposide|etoposide|mesh-list
102543161|NCT02366663|Melphalan|melphalan|mesh-list
102543162|NCT02366663|Carmustine|carmustine|mesh-list
102543163|NCT02366663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102543164|NCT02366663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102543165|NCT02366663|Immunologic Factors|immunologic factors|mesh-ancestor
102543166|NCT02366663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543167|NCT02366663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102543168|NCT02366663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102543169|NCT02366663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102543170|NCT02366663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102543171|NCT02366663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102543172|NCT02366663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543173|NCT02366663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102543174|NCT02366663|Antimetabolites|antimetabolites|mesh-ancestor
102543175|NCT02366663|Antiviral Agents|antiviral agents|mesh-ancestor
102543176|NCT02366663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102543177|NCT02366663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102543178|NCT02366663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102543179|NCT02366663|Alkylating Agents|alkylating agents|mesh-ancestor
102543180|NCT02366663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102543181|NCT01754480|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102543182|NCT01754480|Hemostatics|hemostatics|mesh-ancestor
102543183|NCT01754480|Coagulants|coagulants|mesh-ancestor
102543184|NCT02367599|Vitamin D|vitamin d|mesh-list
102543185|NCT02367599|Vitamins|vitamins|mesh-ancestor
102543186|NCT02367599|Micronutrients|micronutrients|mesh-ancestor
102543187|NCT02367599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543188|NCT02367599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102543189|NCT02368457|Tocopherols|tocopherols|mesh-list
102543190|NCT02368457|Vitamin E|vitamin e|mesh-list
102543191|NCT02368457|Tocotrienols|tocotrienols|mesh-list
102543192|NCT02368457|alpha-Tocopherol|alpha-tocopherol|mesh-list
102543193|NCT02368457|Pentoxifylline|pentoxifylline|mesh-list
102543194|NCT02368457|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102543195|NCT02368457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102543196|NCT02368457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543197|NCT02368457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102543198|NCT02368457|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102543199|NCT02368457|Protective Agents|protective agents|mesh-ancestor
102543200|NCT02368457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543201|NCT02368457|Vasodilator Agents|vasodilator agents|mesh-ancestor
102543202|NCT02368457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102543203|NCT02368457|Antioxidants|antioxidants|mesh-ancestor
102543204|NCT02368457|Vitamins|vitamins|mesh-ancestor
102543205|NCT02368457|Micronutrients|micronutrients|mesh-ancestor
102543206|NCT02371187|Dapagliflozin|dapagliflozin|mesh-list
102543207|NCT02371187|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101574454|NCT05381428|Indomethacin|indomethacin|mesh-list
102543208|NCT02371187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543209|NCT02371187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102543210|NCT02371187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543211|NCT02373137|Ofloxacin|ofloxacin|mesh-list
102543212|NCT02373137|Prednisolone|prednisolone|mesh-list
102543213|NCT02373137|Phenylephrine|phenylephrine|mesh-list
102543214|NCT02373137|Oxymetazoline|oxymetazoline|mesh-list
102543215|NCT02373137|Tropicamide|tropicamide|mesh-list
102543216|NCT02373137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102543217|NCT02373137|Glucocorticoids|glucocorticoids|mesh-ancestor
102543218|NCT02373137|Hormones|hormones|mesh-ancestor
102543219|NCT02373137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102543220|NCT02373137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543221|NCT02373137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102543222|NCT02373137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102543223|NCT02373137|Autonomic Agents|autonomic agents|mesh-ancestor
102543224|NCT02373137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102543225|NCT02373137|Protective Agents|protective agents|mesh-ancestor
102543226|NCT02373137|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102543227|NCT02373137|Mydriatics|mydriatics|mesh-ancestor
102543228|NCT02373137|Sympathomimetics|sympathomimetics|mesh-ancestor
102543229|NCT02373137|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102543230|NCT02373137|Nasal Decongestants|nasal decongestants|mesh-ancestor
102543231|NCT02373137|Respiratory System Agents|respiratory system agents|mesh-ancestor
102543232|NCT02373137|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102543233|NCT02373137|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102543234|NCT02373137|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102543235|NCT02373137|Adrenergic Agents|adrenergic agents|mesh-ancestor
102543236|NCT02373137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102543237|NCT02373137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543238|NCT02373137|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102543239|NCT02373137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102543240|NCT02373137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102543241|NCT02373137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102543242|NCT02373137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102543243|NCT02373137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102543244|NCT02373137|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102543245|NCT02373137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102543246|NCT02373137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102543247|NCT02373137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102543248|NCT02373137|Cholinergic Agents|cholinergic agents|mesh-ancestor
102543249|NCT05488067|Atorvastatin|atorvastatin|mesh-list
102543250|NCT05488067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102543251|NCT05488067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102543252|NCT05488067|Antimetabolites|antimetabolites|mesh-ancestor
102543253|NCT05488067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543254|NCT05488067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102543255|NCT05488067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102543256|NCT05488067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102543257|NCT02373371|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
102543258|NCT02373371|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102543259|NCT02373371|Dermatologic Agents|dermatologic agents|mesh-ancestor
102543260|NCT00354653|Lamivudine|lamivudine|mesh-list
102543261|NCT00354653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102543262|NCT00354653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102543263|NCT00354653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102543264|NCT00354653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543265|NCT00354653|Antiviral Agents|antiviral agents|mesh-ancestor
102543266|NCT00354653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102543267|NCT00354653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102543268|NCT00354653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102543269|NCT00354731|Pentoxifylline|pentoxifylline|mesh-list
102543270|NCT00354731|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102543271|NCT00354731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102543272|NCT00354731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543273|NCT00354731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102543274|NCT00354731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102543275|NCT00354731|Protective Agents|protective agents|mesh-ancestor
102543276|NCT00354731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543277|NCT00354731|Vasodilator Agents|vasodilator agents|mesh-ancestor
102543278|NCT00354731|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102543279|NCT00354731|Antioxidants|antioxidants|mesh-ancestor
102543280|NCT00354809|Casopitant|casopitant|mesh-list
102543281|NCT00354809|Antiemetics|antiemetics|mesh-ancestor
102543282|NCT00354809|Autonomic Agents|autonomic agents|mesh-ancestor
102543283|NCT00354809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102543284|NCT00354809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543285|NCT00354809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102543286|NCT00354809|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102543287|NCT00354809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102543288|NCT00354809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543289|NCT04769258|Vaccines|vaccines|mesh-list
102543290|NCT04769258|Immunologic Factors|immunologic factors|mesh-ancestor
102543291|NCT04769258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543292|NCT01762904|Ethanol|ethanol|mesh-list
102543293|NCT01762904|Chlorhexidine|chlorhexidine|mesh-list
102543294|NCT01762904|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102543295|NCT01762904|Triclosan|triclosan|mesh-list
102543296|NCT01762904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
102543297|NCT01762904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102543298|NCT01762904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102543299|NCT01762904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543300|NCT01762904|Disinfectants|disinfectants|mesh-ancestor
102543301|NCT01762904|Dermatologic Agents|dermatologic agents|mesh-ancestor
102543302|NCT01762904|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102543303|NCT01762904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102543304|NCT01762904|Antimetabolites|antimetabolites|mesh-ancestor
102543305|NCT01762904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543306|NCT01762904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102543307|NCT02376257|Cycloserine|cycloserine|mesh-list
102543308|NCT02376257|Modafinil|modafinil|mesh-list
102543309|NCT02376257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102543310|NCT02376257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543311|NCT02376257|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102543312|NCT02376257|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102543313|NCT02376257|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102543314|NCT02376257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543315|NCT02376257|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102543316|NCT02376257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102543317|NCT02376257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102543318|NCT02376257|Antitubercular Agents|antitubercular agents|mesh-ancestor
102543319|NCT02376257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102543320|NCT02376257|Antimetabolites|antimetabolites|mesh-ancestor
102543321|NCT01762982|Benzalkonium Compounds|benzalkonium compounds|mesh-list
102543322|NCT01762982|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102543323|NCT01762982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102543324|NCT03211286|Tranexamic Acid|tranexamic acid|mesh-list
102543325|NCT03211286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102543326|NCT03211286|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102543327|NCT03211286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102543328|NCT03211286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543329|NCT03211286|Hemostatics|hemostatics|mesh-ancestor
102543330|NCT03211286|Coagulants|coagulants|mesh-ancestor
102543331|NCT01763606|Aspirin|aspirin|mesh-list
102543332|NCT01763606|Enoxaparin|enoxaparin|mesh-list
102543333|NCT01763606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102543334|NCT01763606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102543335|NCT01763606|Analgesics|analgesics|mesh-ancestor
102543336|NCT01763606|Sensory System Agents|sensory system agents|mesh-ancestor
102543337|NCT01763606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102543338|NCT01763606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543339|NCT01763606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102543340|NCT01763606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102543341|NCT01763606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102543342|NCT01763606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102543343|NCT01763606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543344|NCT01763606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102543345|NCT01763606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102543346|NCT01763606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102543347|NCT01763606|Antipyretics|antipyretics|mesh-ancestor
102543348|NCT01763606|Anticoagulants|anticoagulants|mesh-ancestor
102543349|NCT03161756|Denosumab|denosumab|mesh-list
102543350|NCT03161756|Nivolumab|nivolumab|mesh-list
102543351|NCT03161756|Ipilimumab|ipilimumab|mesh-list
102543352|NCT03161756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102543353|NCT03161756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102543354|NCT03161756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102543355|NCT03161756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543356|NCT03161756|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102543357|NCT03161756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574609|NCT01034631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102543358|NCT01766024|Interferons|interferons|mesh-list
102543359|NCT01766024|Interferon-beta|interferon-beta|mesh-list
102543360|NCT01766024|Interferon beta-1a|interferon beta-1a|mesh-list
102543361|NCT01766024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102543362|NCT01766024|Antiviral Agents|antiviral agents|mesh-ancestor
102543363|NCT01766024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102543364|NCT01766024|Immunologic Factors|immunologic factors|mesh-ancestor
102543365|NCT01766024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543366|NCT01766024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102543367|NCT01767506|Azithromycin|azithromycin|mesh-list
102543368|NCT01767506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102543369|NCT01767506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102543370|NCT02383043|Cocaine|cocaine|mesh-list
102543371|NCT02383043|Amphetamine|amphetamine|mesh-list
102543372|NCT02383043|Dextroamphetamine|dextroamphetamine|mesh-list
102543373|NCT02383043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102543374|NCT02383043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543375|NCT02383043|Sympathomimetics|sympathomimetics|mesh-ancestor
102543376|NCT02383043|Autonomic Agents|autonomic agents|mesh-ancestor
102543377|NCT02383043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102543378|NCT02383043|Dopamine Agents|dopamine agents|mesh-ancestor
102543379|NCT02383043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102543380|NCT02383043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543381|NCT02383043|Adrenergic Agents|adrenergic agents|mesh-ancestor
102543382|NCT02383043|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102543383|NCT02383043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102543384|NCT02383043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102543385|NCT02383043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102543386|NCT02383043|Anesthetics, Local|anesthetics, local|mesh-ancestor
102543387|NCT02383043|Anesthetics|anesthetics|mesh-ancestor
102543388|NCT02383043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102543389|NCT02383043|Sensory System Agents|sensory system agents|mesh-ancestor
102543390|NCT02383043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102543391|NCT01768520|Celecoxib|celecoxib|mesh-list
102543392|NCT01768520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102543393|NCT01768520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102543394|NCT01768520|Analgesics|analgesics|mesh-ancestor
102543395|NCT01768520|Sensory System Agents|sensory system agents|mesh-ancestor
102543396|NCT01768520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102543397|NCT01768520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543398|NCT01768520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102543399|NCT01768520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102543400|NCT01768520|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102543401|NCT01768520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102543402|NCT01768520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102543403|NCT01768520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543404|NCT00355589|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102543405|NCT00355589|Ramipril|ramipril|mesh-list
102543406|NCT00355589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102543407|NCT00355589|Diuretics|diuretics|mesh-ancestor
102543408|NCT00355589|Natriuretic Agents|natriuretic agents|mesh-ancestor
102543409|NCT00355589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543410|NCT00355589|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102543411|NCT00355589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102543412|NCT00355589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543413|NCT00355589|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102543414|NCT00355589|Protease Inhibitors|protease inhibitors|mesh-ancestor
102543415|NCT00355589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102543416|NCT01769222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102543417|NCT01769222|Ipilimumab|ipilimumab|mesh-list
102543418|NCT01769222|Antibodies|antibodies|mesh-list
102543419|NCT01769222|Immunoglobulins|immunoglobulins|mesh-list
102543420|NCT01769222|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102543421|NCT01769222|Immunologic Factors|immunologic factors|mesh-ancestor
102543422|NCT01769222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543423|NCT01769222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102543424|NCT01769222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102543425|NCT01769222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543426|NCT02386319|Melatonin|melatonin|mesh-list
102543427|NCT02386319|Antioxidants|antioxidants|mesh-ancestor
102543428|NCT02386319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543429|NCT02386319|Protective Agents|protective agents|mesh-ancestor
102543430|NCT02386319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543431|NCT02386319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102543432|NCT02240888|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102543433|NCT02240888|Immunologic Factors|immunologic factors|mesh-ancestor
102543434|NCT02240888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543435|NCT02387801|Ixekizumab|ixekizumab|mesh-list
102543436|NCT02387801|Dermatologic Agents|dermatologic agents|mesh-ancestor
102543437|NCT02259608|BCG Vaccine|bcg vaccine|mesh-list
102543438|NCT02259608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102543439|NCT02259608|Immunologic Factors|immunologic factors|mesh-ancestor
102543440|NCT02259608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543441|NCT05284097|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
102543442|NCT05284097|Antiviral Agents|antiviral agents|mesh-ancestor
102543443|NCT05284097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102543444|NCT02326844|Talazoparib|talazoparib|mesh-list
102543445|NCT02326844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102543446|NCT02326844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102543447|NCT02326844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543448|NCT02326844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102543449|NCT02239874|Vitamin D|vitamin d|mesh-list
102543450|NCT02239874|Ergocalciferols|ergocalciferols|mesh-list
102543451|NCT02239874|Cholecalciferol|cholecalciferol|mesh-list
102543452|NCT02239874|Vitamins|vitamins|mesh-list
102543453|NCT02239874|Micronutrients|micronutrients|mesh-ancestor
102543454|NCT02239874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543455|NCT02239874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102543456|NCT02239874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102543457|NCT01771952|Hyaluronic Acid|hyaluronic acid|mesh-list
102543458|NCT01771952|Hylan|hylan|mesh-list
102543459|NCT01771952|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102543460|NCT01771952|Immunologic Factors|immunologic factors|mesh-ancestor
102543461|NCT01771952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543462|NCT01771952|Viscosupplements|viscosupplements|mesh-ancestor
102543463|NCT01771952|Protective Agents|protective agents|mesh-ancestor
102543464|NCT02389361|Acetaminophen|acetaminophen|mesh-list
102543465|NCT02389361|Tramadol|tramadol|mesh-list
102543466|NCT02389361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102543467|NCT02389361|Analgesics|analgesics|mesh-ancestor
102543468|NCT02389361|Sensory System Agents|sensory system agents|mesh-ancestor
102543469|NCT02389361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102543470|NCT02389361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543471|NCT02389361|Antipyretics|antipyretics|mesh-ancestor
102543472|NCT02389361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102543473|NCT02389361|Narcotics|narcotics|mesh-ancestor
102543474|NCT02389361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102543475|NCT02252354|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102543476|NCT02252354|Relugolix|relugolix|mesh-list
102543477|NCT02252354|Androgen Antagonists|androgen antagonists|mesh-ancestor
102543478|NCT02252354|Hormone Antagonists|hormone antagonists|mesh-ancestor
102543479|NCT02252354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102543480|NCT02252354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543481|NCT02393339|Acetaminophen|acetaminophen|mesh-list
102543482|NCT02393339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102543483|NCT02393339|Analgesics|analgesics|mesh-ancestor
102543484|NCT02393339|Sensory System Agents|sensory system agents|mesh-ancestor
102543485|NCT02393339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102543486|NCT02393339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543487|NCT02393339|Antipyretics|antipyretics|mesh-ancestor
102543488|NCT05235191|Methadone|methadone|mesh-list
102543489|NCT05235191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102543490|NCT05235191|Narcotics|narcotics|mesh-ancestor
102543491|NCT05235191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102543492|NCT05235191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543493|NCT05235191|Analgesics|analgesics|mesh-ancestor
102543494|NCT05235191|Sensory System Agents|sensory system agents|mesh-ancestor
102543495|NCT05235191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102543496|NCT05235191|Antitussive Agents|antitussive agents|mesh-ancestor
102543497|NCT05235191|Respiratory System Agents|respiratory system agents|mesh-ancestor
102543498|NCT01774604|Indomethacin|indomethacin|mesh-list
102543499|NCT01774604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102543500|NCT01774604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102543501|NCT01774604|Analgesics|analgesics|mesh-ancestor
102543502|NCT01774604|Sensory System Agents|sensory system agents|mesh-ancestor
102543503|NCT01774604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102543504|NCT01774604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543505|NCT01774604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102543506|NCT01774604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102543507|NCT01774604|Gout Suppressants|gout suppressants|mesh-ancestor
102543508|NCT01774604|Tocolytic Agents|tocolytic agents|mesh-ancestor
102543509|NCT01774604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102543510|NCT01774604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102543511|NCT01774604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102543512|NCT01774604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543513|NCT01777412|Bevacizumab|bevacizumab|mesh-list
102543514|NCT01777412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102543515|NCT01777412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102543516|NCT01777412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102543517|NCT01777412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102543518|NCT01777412|Growth Substances|growth substances|mesh-ancestor
102543519|NCT01777412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543520|NCT01777412|Growth Inhibitors|growth inhibitors|mesh-ancestor
102543521|NCT02236910|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
102543522|NCT02236910|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102543523|NCT02236910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543524|NCT04873349|Oleuropein|oleuropein|mesh-list
102543525|NCT04873349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102543526|NCT04873349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102543527|NCT04873349|Vasodilator Agents|vasodilator agents|mesh-ancestor
102543528|NCT01780454|Rituximab|rituximab|mesh-list
102543529|NCT01780454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102543530|NCT01780454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102543531|NCT01780454|Immunologic Factors|immunologic factors|mesh-ancestor
102543532|NCT01780454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543533|NCT01780454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102543534|NCT04869449|Ketoconazole|ketoconazole|mesh-list
102543535|NCT04869449|Antifungal Agents|antifungal agents|mesh-ancestor
102543536|NCT04869449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102543537|NCT04869449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102543538|NCT04869449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102543539|NCT04869449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102543540|NCT04869449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543541|NCT04869449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102543542|NCT04869449|Hormone Antagonists|hormone antagonists|mesh-ancestor
102543543|NCT04869449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102543544|NCT04869449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543545|NCT04869449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102543546|NCT00355901|Visilizumab|visilizumab|mesh-list
102543547|NCT00355901|Immunologic Factors|immunologic factors|mesh-ancestor
102543548|NCT00355901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543549|NCT00355667|Furosemide|furosemide|mesh-list
102543550|NCT00355667|Azosemide|azosemide|mesh-list
102543551|NCT00355667|Diuretics|diuretics|mesh-ancestor
102543552|NCT00355667|Natriuretic Agents|natriuretic agents|mesh-ancestor
102543553|NCT00355667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543554|NCT00355667|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102543555|NCT00355667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102543556|NCT00355667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543557|NCT02364336|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102543558|NCT02364336|Antiviral Agents|antiviral agents|mesh-ancestor
102543559|NCT02364336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102543560|NCT04419948|Ibuprofen|ibuprofen|mesh-list
102543561|NCT04419948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102543562|NCT04419948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102543563|NCT04419948|Analgesics|analgesics|mesh-ancestor
102543564|NCT04419948|Sensory System Agents|sensory system agents|mesh-ancestor
102543565|NCT04419948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102543566|NCT04419948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543567|NCT04419948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102543568|NCT04419948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102543569|NCT04419948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102543570|NCT04419948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102543571|NCT04419948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543572|NCT01312922|Dexetimide|dexetimide|mesh-list
102543573|NCT01312922|Pipamperone|pipamperone|mesh-list
102543574|NCT01312922|Citalopram|citalopram|mesh-list
102543575|NCT01312922|Escitalopram|escitalopram|mesh-list
102543576|NCT01312922|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102543577|NCT01312922|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102543578|NCT01312922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102543579|NCT01312922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543580|NCT01312922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102543581|NCT01312922|Serotonin Agents|serotonin agents|mesh-ancestor
102543582|NCT01312922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543583|NCT01312922|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102543584|NCT01312922|Antidepressive Agents|antidepressive agents|mesh-ancestor
102543585|NCT01312922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102543586|NCT01312922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102543587|NCT01312922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102543588|NCT01312922|Parasympatholytics|parasympatholytics|mesh-ancestor
102543589|NCT01312922|Autonomic Agents|autonomic agents|mesh-ancestor
102543590|NCT01312922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102543591|NCT01312922|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102543592|NCT01312922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102543593|NCT01312922|Cholinergic Agents|cholinergic agents|mesh-ancestor
102543594|NCT01312922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102543595|NCT01312922|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102543596|NCT01312922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102543597|NCT01312922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102543598|NCT01783574|Methyltestosterone|methyltestosterone|mesh-list
102543599|NCT01783574|Testosterone|testosterone|mesh-list
102543600|NCT01783574|Testosterone undecanoate|testosterone undecanoate|mesh-list
102543601|NCT01783574|Testosterone enanthate|testosterone enanthate|mesh-list
102543602|NCT01783574|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102543603|NCT01783574|Androgens|androgens|mesh-ancestor
102543604|NCT01783574|Hormones|hormones|mesh-ancestor
102543605|NCT01783574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102543606|NCT01783574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543607|NCT01783574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102543608|NCT01783574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102543609|NCT01783574|Anabolic Agents|anabolic agents|mesh-ancestor
102543610|NCT03656783|Tenofovir|tenofovir|mesh-list
102543611|NCT03656783|Emtricitabine|emtricitabine|mesh-list
102543612|NCT03656783|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
102543613|NCT03656783|Antiviral Agents|antiviral agents|mesh-ancestor
102543614|NCT03656783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102543615|NCT03656783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102543616|NCT03656783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102543617|NCT03656783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102543618|NCT03656783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543619|NCT03656783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102543620|NCT03656783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102543621|NCT01784666|Isradipine|isradipine|mesh-list
102543622|NCT01784666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102543623|NCT01784666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102543624|NCT01784666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102543625|NCT01784666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543626|NCT01784666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102543627|NCT01784666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543628|NCT01784666|Vasodilator Agents|vasodilator agents|mesh-ancestor
102543629|NCT04296695|Tenofovir|tenofovir|mesh-list
102543630|NCT04296695|Efavirenz|efavirenz|mesh-list
102543631|NCT04296695|Antiviral Agents|antiviral agents|mesh-ancestor
102543632|NCT04296695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102543633|NCT04296695|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102543634|NCT04296695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102543635|NCT04296695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102543636|NCT04296695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543637|NCT04296695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102543638|NCT04296695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102543639|NCT04296695|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102543640|NCT04296695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102543641|NCT04296695|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102543642|NCT04296695|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102543643|NCT04296695|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102543644|NCT04296695|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102543645|NCT04259645|Bupivacaine|bupivacaine|mesh-list
102543646|NCT04259645|Anesthetics, Local|anesthetics, local|mesh-ancestor
102543647|NCT04259645|Anesthetics|anesthetics|mesh-ancestor
102543648|NCT04259645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102543649|NCT04259645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543650|NCT04259645|Sensory System Agents|sensory system agents|mesh-ancestor
102543651|NCT04259645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102543652|NCT01787006|Fluorouracil|fluorouracil|mesh-list
102543653|NCT01787006|Cetuximab|cetuximab|mesh-list
102543654|NCT01787006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102543655|NCT01787006|Antimetabolites|antimetabolites|mesh-ancestor
102543656|NCT01787006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543657|NCT01787006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102543658|NCT01787006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102543659|NCT01787006|Immunologic Factors|immunologic factors|mesh-ancestor
102543660|NCT01787006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543661|NCT01787006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102543662|NCT02260622|Aspirin|aspirin|mesh-list
102543663|NCT02260622|Rivaroxaban|rivaroxaban|mesh-list
102543664|NCT02260622|Clopidogrel|clopidogrel|mesh-list
102543665|NCT02260622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102543666|NCT02260622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102543667|NCT02260622|Analgesics|analgesics|mesh-ancestor
102543668|NCT02260622|Sensory System Agents|sensory system agents|mesh-ancestor
102543669|NCT02260622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102543670|NCT02260622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543671|NCT02260622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102543672|NCT02260622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102543673|NCT02260622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102543674|NCT02260622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102543675|NCT02260622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543676|NCT02260622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102543677|NCT02260622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102543678|NCT02260622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102543679|NCT02260622|Antipyretics|antipyretics|mesh-ancestor
102543680|NCT02260622|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102543681|NCT02260622|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102543682|NCT02260622|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102543683|NCT02260622|Purinergic Agents|purinergic agents|mesh-ancestor
102543684|NCT02260622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102543685|NCT02260622|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102543686|NCT02260622|Antithrombins|antithrombins|mesh-ancestor
102543687|NCT02260622|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102543688|NCT02260622|Protease Inhibitors|protease inhibitors|mesh-ancestor
102543689|NCT02260622|Anticoagulants|anticoagulants|mesh-ancestor
102543690|NCT03186209|Benralizumab|benralizumab|mesh-list
102543691|NCT03186209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102543692|NCT03186209|Respiratory System Agents|respiratory system agents|mesh-ancestor
102543693|NCT02261948|Simendan|simendan|mesh-list
102543694|NCT02261948|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102543695|NCT02261948|Vasodilator Agents|vasodilator agents|mesh-ancestor
102543696|NCT02261948|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102543697|NCT02261948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102543698|NCT02261948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102543699|NCT02261948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543700|NCT02261948|Protective Agents|protective agents|mesh-ancestor
102543701|NCT02261948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543702|NCT01787240|Escitalopram|escitalopram|mesh-list
102543703|NCT01787240|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102543704|NCT01787240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102543705|NCT01787240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102543706|NCT01787240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543707|NCT01787240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102543708|NCT01787240|Serotonin Agents|serotonin agents|mesh-ancestor
102543709|NCT01787240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543710|NCT00357149|Cisplatin|cisplatin|mesh-list
102543711|NCT00357149|Docetaxel|docetaxel|mesh-list
102543712|NCT00357149|Fluorouracil|fluorouracil|mesh-list
102543713|NCT00357149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102543714|NCT00357149|Tubulin Modulators|tubulin modulators|mesh-ancestor
102543715|NCT00357149|Antimitotic Agents|antimitotic agents|mesh-ancestor
102543716|NCT00357149|Mitosis Modulators|mitosis modulators|mesh-ancestor
102543717|NCT00357149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543718|NCT00357149|Antimetabolites|antimetabolites|mesh-ancestor
102543719|NCT00357149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102543720|NCT00357149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102543721|NCT00357149|Immunologic Factors|immunologic factors|mesh-ancestor
102543722|NCT00357149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543723|NCT04903652|Vinorelbine|vinorelbine|mesh-list
102543724|NCT04903652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102543725|NCT04903652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102543726|NCT04903652|Tubulin Modulators|tubulin modulators|mesh-ancestor
102543727|NCT04903652|Antimitotic Agents|antimitotic agents|mesh-ancestor
102543728|NCT04903652|Mitosis Modulators|mitosis modulators|mesh-ancestor
102543729|NCT04903652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543730|NCT04071821|Cetirizine|cetirizine|mesh-list
102543731|NCT04071821|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102543732|NCT04071821|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102543733|NCT04071821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102543734|NCT04071821|Histamine Antagonists|histamine antagonists|mesh-ancestor
102543735|NCT04071821|Histamine Agents|histamine agents|mesh-ancestor
102543736|NCT04071821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102543737|NCT04071821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543738|NCT04071821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543740|NCT03064295|Regadenoson|regadenoson|mesh-list
102543741|NCT03064295|Analgesics|analgesics|mesh-ancestor
102543742|NCT03064295|Sensory System Agents|sensory system agents|mesh-ancestor
102543743|NCT03064295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102543744|NCT03064295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543745|NCT03064295|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102543746|NCT03064295|Vasodilator Agents|vasodilator agents|mesh-ancestor
102543747|NCT03064295|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102543748|NCT03064295|Purinergic Agonists|purinergic agonists|mesh-ancestor
102543749|NCT03064295|Purinergic Agents|purinergic agents|mesh-ancestor
102543750|NCT03064295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102543751|NCT03064295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543752|NCT03064295|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
102543753|NCT01789814|Clopidogrel|clopidogrel|mesh-list
102543754|NCT01789814|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102543755|NCT01789814|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102543756|NCT01789814|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102543757|NCT01789814|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102543758|NCT01789814|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102543759|NCT01789814|Purinergic Agents|purinergic agents|mesh-ancestor
102543760|NCT01789814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102543761|NCT01789814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543762|NCT01789814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543763|NCT00356447|Estradiol|estradiol|mesh-list
102543764|NCT00356447|Estrogens|estrogens|mesh-ancestor
102543765|NCT00356447|Hormones|hormones|mesh-ancestor
102543766|NCT00356447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102543767|NCT00356447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543768|NCT01736852|Oxytocin|oxytocin|mesh-list
102543769|NCT01736852|Oxytocics|oxytocics|mesh-ancestor
102543770|NCT01736852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102543771|NCT01736852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543772|NCT01810952|Insulin|insulin|mesh-list
102543773|NCT01810952|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102543774|NCT01810952|Insulin Glargine|insulin glargine|mesh-list
102543775|NCT01810952|Insulin, Isophane|insulin, isophane|mesh-list
102543776|NCT01810952|Isophane Insulin, Human|isophane insulin, human|mesh-list
102543777|NCT01810952|Isophane insulin, beef|isophane insulin, beef|mesh-list
102543778|NCT01810952|Insulin Lispro|insulin lispro|mesh-list
102543779|NCT01810952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102543780|NCT01810952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543781|NCT04059887|Atezolizumab|atezolizumab|mesh-list
102543782|NCT04059887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102543783|NCT04059887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543784|NCT04059887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102543785|NCT04059887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102543786|NCT01877642|Lorazepam|lorazepam|mesh-list
102543787|NCT01877642|Loxapine|loxapine|mesh-list
102543788|NCT01877642|Anticonvulsants|anticonvulsants|mesh-ancestor
102543789|NCT01877642|Antiemetics|antiemetics|mesh-ancestor
102543790|NCT01877642|Autonomic Agents|autonomic agents|mesh-ancestor
102543791|NCT01877642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102543792|NCT01877642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543793|NCT01877642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102543794|NCT01877642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102543795|NCT01877642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102543796|NCT01877642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102543797|NCT01877642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102543798|NCT01877642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102543799|NCT01877642|GABA Modulators|gaba modulators|mesh-ancestor
102543800|NCT01877642|GABA Agents|gaba agents|mesh-ancestor
102543801|NCT01877642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102543802|NCT01877642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543803|NCT01877642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102543804|NCT01877642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102543805|NCT01877642|Dopamine Agents|dopamine agents|mesh-ancestor
102543806|NCT02819843|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
102543807|NCT02819843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102543808|NCT02819843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102543809|NCT01878656|Sevoflurane|sevoflurane|mesh-list
102543810|NCT01878656|Desflurane|desflurane|mesh-list
102543811|NCT01878656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102543812|NCT01878656|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102543813|NCT01878656|Anesthetics, General|anesthetics, general|mesh-ancestor
102543814|NCT01878656|Anesthetics|anesthetics|mesh-ancestor
102543815|NCT01878656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102543816|NCT01878656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543817|NCT01811654|Hyaluronic Acid|hyaluronic acid|mesh-list
102543818|NCT01811654|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102543819|NCT01811654|Immunologic Factors|immunologic factors|mesh-ancestor
102543820|NCT01811654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543821|NCT01811654|Viscosupplements|viscosupplements|mesh-ancestor
102543822|NCT01811654|Protective Agents|protective agents|mesh-ancestor
102543823|NCT02266472|Metformin|metformin|mesh-list
102543824|NCT02266472|Empagliflozin|empagliflozin|mesh-list
102543825|NCT02266472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102543826|NCT02266472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543827|NCT02266472|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102543828|NCT02266472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543829|NCT03500289|Midazolam|midazolam|mesh-list
102543830|NCT03500289|Ketamine|ketamine|mesh-list
102543831|NCT03500289|Analgesics|analgesics|mesh-ancestor
102543832|NCT03500289|Sensory System Agents|sensory system agents|mesh-ancestor
102543833|NCT03500289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102543834|NCT03500289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543835|NCT03500289|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102543836|NCT03500289|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102543837|NCT03500289|Anesthetics, General|anesthetics, general|mesh-ancestor
102543838|NCT03500289|Anesthetics|anesthetics|mesh-ancestor
102543839|NCT03500289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102543840|NCT03500289|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102543841|NCT03500289|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102543842|NCT03500289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102543843|NCT03500289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543844|NCT03500289|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102543845|NCT03500289|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102543846|NCT03500289|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102543847|NCT03500289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102543848|NCT03500289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102543849|NCT03500289|GABA Modulators|gaba modulators|mesh-ancestor
102543850|NCT03500289|GABA Agents|gaba agents|mesh-ancestor
102543851|NCT01812044|Lidocaine|lidocaine|mesh-list
102543852|NCT01812044|Bupivacaine|bupivacaine|mesh-list
102543853|NCT01812044|Anesthetics, Local|anesthetics, local|mesh-list
102543854|NCT01812044|Anesthetics|anesthetics|mesh-list
102543855|NCT01812044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102543856|NCT01812044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543857|NCT01812044|Sensory System Agents|sensory system agents|mesh-ancestor
102543858|NCT01812044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102543859|NCT01812044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102543860|NCT01812044|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102543861|NCT01812044|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102543862|NCT01812044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102543863|NCT01812044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543864|NCT03974789|Dexamethasone|dexamethasone|mesh-list
102543865|NCT03974789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102543866|NCT03974789|Antiemetics|antiemetics|mesh-ancestor
102543867|NCT03974789|Autonomic Agents|autonomic agents|mesh-ancestor
102543868|NCT03974789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102543869|NCT03974789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543870|NCT03974789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102543871|NCT03974789|Glucocorticoids|glucocorticoids|mesh-ancestor
102543872|NCT03974789|Hormones|hormones|mesh-ancestor
102543873|NCT03974789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102543874|NCT03974789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102543875|NCT03974789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102543876|NCT01812668|Fluorides|fluorides|mesh-list
102543877|NCT01812668|Cariostatic Agents|cariostatic agents|mesh-ancestor
102543878|NCT01812668|Protective Agents|protective agents|mesh-ancestor
102543879|NCT01812668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543880|NCT02570477|Vancomycin|vancomycin|mesh-list
102543881|NCT02570477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102543882|NCT02570477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102543883|NCT04344821|Calcium|calcium|mesh-list
102543884|NCT04344821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102543885|NCT04344821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543886|NCT04351100|Diacerein|diacerein|mesh-list
102543887|NCT04351100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102543888|NCT05328674|Mitogens|mitogens|mesh-list
102543889|NCT05328674|Mitosis Modulators|mitosis modulators|mesh-ancestor
102543890|NCT05328674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543891|NCT01798316|Acetaminophen|acetaminophen|mesh-list
102543892|NCT01798316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102543893|NCT01798316|Analgesics|analgesics|mesh-ancestor
102543894|NCT01798316|Sensory System Agents|sensory system agents|mesh-ancestor
102543895|NCT01798316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102543896|NCT01798316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543897|NCT01798316|Antipyretics|antipyretics|mesh-ancestor
102543898|NCT03883763|Bupivacaine|bupivacaine|mesh-list
102543899|NCT03883763|Anesthetics, Local|anesthetics, local|mesh-ancestor
102543900|NCT03883763|Anesthetics|anesthetics|mesh-ancestor
102543901|NCT03883763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102543902|NCT03883763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543903|NCT03883763|Sensory System Agents|sensory system agents|mesh-ancestor
102543904|NCT03883763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102543905|NCT01798394|Progesterone|progesterone|mesh-list
102543906|NCT01798394|Progestins|progestins|mesh-ancestor
102543907|NCT01798394|Hormones|hormones|mesh-ancestor
102543908|NCT01798394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102543909|NCT01798394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543910|NCT01798550|Enoxaparin|enoxaparin|mesh-list
102543911|NCT01798550|Anticoagulants|anticoagulants|mesh-ancestor
102543912|NCT01798550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102543913|NCT01798550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102543914|NCT01798550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543915|NCT00357305|Cytarabine|cytarabine|mesh-list
102543916|NCT00357305|Etoposide|etoposide|mesh-list
102543917|NCT00357305|Etoposide phosphate|etoposide phosphate|mesh-list
102543918|NCT00357305|Vorinostat|vorinostat|mesh-list
102543919|NCT00357305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102543920|NCT00357305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102543921|NCT00357305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102543922|NCT00357305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102543923|NCT00357305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102543924|NCT00357305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543925|NCT00357305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102543926|NCT00357305|Antimetabolites|antimetabolites|mesh-ancestor
102543927|NCT00357305|Antiviral Agents|antiviral agents|mesh-ancestor
102543928|NCT00357305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102543929|NCT00357305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102543930|NCT00357305|Immunologic Factors|immunologic factors|mesh-ancestor
102543931|NCT00357305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543932|NCT00357305|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102543933|NCT02340000|Amoxicillin|amoxicillin|mesh-list
102543934|NCT02340000|Clavulanic Acid|clavulanic acid|mesh-list
102543935|NCT02340000|Clavulanic Acids|clavulanic acids|mesh-list
102543936|NCT02340000|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102543937|NCT02340000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102543938|NCT02340000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102543939|NCT02340000|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102543940|NCT02340000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102543941|NCT02340000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543942|NCT01813214|Vemurafenib|vemurafenib|mesh-list
102543943|NCT01813214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102543944|NCT01813214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102543945|NCT01813214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102543946|NCT01813214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543947|NCT01815008|Aspirin|aspirin|mesh-list
102543948|NCT01815008|Clopidogrel|clopidogrel|mesh-list
102543949|NCT01815008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102543950|NCT01815008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102543951|NCT01815008|Analgesics|analgesics|mesh-ancestor
102543952|NCT01815008|Sensory System Agents|sensory system agents|mesh-ancestor
102543953|NCT01815008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102543954|NCT01815008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543955|NCT01815008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102543956|NCT01815008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102543957|NCT01815008|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102543958|NCT01815008|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102543959|NCT01815008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543960|NCT01815008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102543961|NCT01815008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102543962|NCT01815008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102543963|NCT01815008|Antipyretics|antipyretics|mesh-ancestor
102543964|NCT01815008|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102543965|NCT01815008|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102543966|NCT01815008|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102543967|NCT01815008|Purinergic Agents|purinergic agents|mesh-ancestor
102543968|NCT01815008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102543969|NCT01801124|Bupivacaine|bupivacaine|mesh-list
102543970|NCT01801124|Anesthetics, Local|anesthetics, local|mesh-ancestor
102543971|NCT01801124|Anesthetics|anesthetics|mesh-ancestor
102543972|NCT01801124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102543973|NCT01801124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543974|NCT01801124|Sensory System Agents|sensory system agents|mesh-ancestor
102543975|NCT01801124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102543976|NCT00357461|Ipilimumab|ipilimumab|mesh-list
102543977|NCT00357461|Vaccines|vaccines|mesh-list
102543978|NCT00357461|Freund's Adjuvant|freund's adjuvant|mesh-list
102543979|NCT00357461|Immunologic Factors|immunologic factors|mesh-ancestor
102543980|NCT00357461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543981|NCT00357461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102543982|NCT00357461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102543983|NCT00357461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102543984|NCT00357461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102543985|NCT00357461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102543986|NCT00357539|Azithromycin|azithromycin|mesh-list
102543987|NCT00357539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102543988|NCT00357539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102543989|NCT03331965|Metoclopramide|metoclopramide|mesh-list
102543990|NCT03331965|Antiemetics|antiemetics|mesh-ancestor
102543991|NCT03331965|Autonomic Agents|autonomic agents|mesh-ancestor
102543992|NCT03331965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102543993|NCT03331965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102543994|NCT03331965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102543995|NCT03331965|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102543996|NCT03331965|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102543997|NCT03331965|Dopamine Agents|dopamine agents|mesh-ancestor
102543998|NCT03331965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102543999|NCT03331965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544000|NCT03278223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102544001|NCT03279237|Leucovorin|leucovorin|mesh-list
102544002|NCT03279237|Paclitaxel|paclitaxel|mesh-list
102544003|NCT03279237|Carboplatin|carboplatin|mesh-list
102544004|NCT03279237|Fluorouracil|fluorouracil|mesh-list
102544005|NCT03279237|Oxaliplatin|oxaliplatin|mesh-list
102544006|NCT03279237|Irinotecan|irinotecan|mesh-list
102544007|NCT03279237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102544008|NCT03279237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102544009|NCT03279237|Tubulin Modulators|tubulin modulators|mesh-ancestor
102544010|NCT03279237|Antimitotic Agents|antimitotic agents|mesh-ancestor
102544011|NCT03279237|Mitosis Modulators|mitosis modulators|mesh-ancestor
102544012|NCT03279237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544013|NCT03279237|Antimetabolites|antimetabolites|mesh-ancestor
102544014|NCT03279237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102544015|NCT03279237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102544016|NCT03279237|Immunologic Factors|immunologic factors|mesh-ancestor
102544017|NCT03279237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544018|NCT03279237|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102544019|NCT03279237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102544020|NCT03279237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102544021|NCT03279237|Antidotes|antidotes|mesh-ancestor
102544022|NCT03279237|Protective Agents|protective agents|mesh-ancestor
102544023|NCT03279237|Vitamin B Complex|vitamin b complex|mesh-ancestor
102544024|NCT03279237|Vitamins|vitamins|mesh-ancestor
102544025|NCT03279237|Micronutrients|micronutrients|mesh-ancestor
102544026|NCT03282591|Serlopitant|serlopitant|mesh-list
102544027|NCT03282591|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102544028|NCT03282591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102544029|NCT03282591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544030|NCT03282591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544031|NCT03509883|Apixaban|apixaban|mesh-list
102544032|NCT03509883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102544033|NCT03509883|Antithrombins|antithrombins|mesh-ancestor
102544034|NCT03509883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102544035|NCT03509883|Protease Inhibitors|protease inhibitors|mesh-ancestor
102544036|NCT03509883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102544037|NCT03509883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544038|NCT03509883|Anticoagulants|anticoagulants|mesh-ancestor
102544039|NCT03336645|Midazolam|midazolam|mesh-list
102544040|NCT03336645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102544041|NCT03336645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102544042|NCT03336645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102544043|NCT03336645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544044|NCT03336645|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102544045|NCT03336645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102544046|NCT03336645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102544047|NCT03336645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102544048|NCT03336645|Anesthetics, General|anesthetics, general|mesh-ancestor
102544049|NCT03336645|Anesthetics|anesthetics|mesh-ancestor
102544050|NCT03336645|GABA Modulators|gaba modulators|mesh-ancestor
102544051|NCT03336645|GABA Agents|gaba agents|mesh-ancestor
102544052|NCT03336645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102544053|NCT03336645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544054|NCT00376311|Calcitonin|calcitonin|mesh-list
102544055|NCT00376311|Salmon calcitonin|salmon calcitonin|mesh-list
102544056|NCT00376311|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
102544057|NCT00376311|Katacalcin|katacalcin|mesh-list
102544058|NCT00376311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102544059|NCT00376311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544060|NCT00376311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102544061|NCT00376311|Vasodilator Agents|vasodilator agents|mesh-ancestor
102544062|NCT03511521|Insulin|insulin|mesh-list
102544063|NCT03511521|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102544064|NCT03511521|Insulin Aspart|insulin aspart|mesh-list
102544065|NCT03511521|Insulin, Isophane|insulin, isophane|mesh-list
102544066|NCT03511521|Isophane Insulin, Human|isophane insulin, human|mesh-list
102544067|NCT03511521|Isophane insulin, beef|isophane insulin, beef|mesh-list
102544068|NCT03511521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102544069|NCT03511521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544070|NCT00376077|Methylprednisolone|methylprednisolone|mesh-list
102544071|NCT00376077|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102544072|NCT00376077|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102544073|NCT00376077|gamma-Globulins|gamma-globulins|mesh-list
102544074|NCT00376077|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102544075|NCT00376077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102544076|NCT00376077|Antiemetics|antiemetics|mesh-ancestor
102544077|NCT00376077|Autonomic Agents|autonomic agents|mesh-ancestor
102544078|NCT00376077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102544079|NCT00376077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544080|NCT00376077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102544081|NCT00376077|Glucocorticoids|glucocorticoids|mesh-ancestor
102544082|NCT00376077|Hormones|hormones|mesh-ancestor
102544083|NCT00376077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102544084|NCT00376077|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102544085|NCT00376077|Protective Agents|protective agents|mesh-ancestor
102544086|NCT00376077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102544087|NCT00376077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102544088|NCT00376077|Immunologic Factors|immunologic factors|mesh-ancestor
102544089|NCT03519243|Darbepoetin alfa|darbepoetin alfa|mesh-list
102544090|NCT03519243|Hematinics|hematinics|mesh-ancestor
102544091|NCT03577275|Moxifloxacin|moxifloxacin|mesh-list
102544092|NCT03577275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102544093|NCT03577275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102544094|NCT03577275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102544095|NCT03577275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102544096|NCT03577275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102544097|NCT03577275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544098|NCT03577275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102544099|NCT03521505|Dexmedetomidine|dexmedetomidine|mesh-list
102544100|NCT03521505|Propofol|propofol|mesh-list
102544101|NCT03521505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102544102|NCT03521505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102544103|NCT03521505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544104|NCT03521505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102544105|NCT03521505|Analgesics|analgesics|mesh-ancestor
102544106|NCT03521505|Sensory System Agents|sensory system agents|mesh-ancestor
102544107|NCT03521505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101830803|NCT04630145|Rifampin|rifampin|mesh-list
102544108|NCT03521505|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102544109|NCT03521505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102544110|NCT03521505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102544111|NCT03521505|Adrenergic Agents|adrenergic agents|mesh-ancestor
102544112|NCT03521505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102544113|NCT03521505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544114|NCT03521505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102544115|NCT03521505|Anesthetics, General|anesthetics, general|mesh-ancestor
102544116|NCT03521505|Anesthetics|anesthetics|mesh-ancestor
102544117|NCT03522441|Clindamycin|clindamycin|mesh-list
102544118|NCT03522441|Clindamycin palmitate|clindamycin palmitate|mesh-list
102544119|NCT03522441|Clindamycin phosphate|clindamycin phosphate|mesh-list
102544120|NCT03522441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102544121|NCT03522441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102544122|NCT03522441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102544123|NCT03522441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102544124|NCT03522441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544125|NCT03530631|Adderall|adderall|mesh-list
102544126|NCT03530631|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101764117|NCT00742976|Insulin|insulin|mesh-list
102544127|NCT03530631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544128|NCT03350217|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
102544129|NCT03350217|Plasma Substitutes|plasma substitutes|mesh-ancestor
102544130|NCT03350217|Blood Substitutes|blood substitutes|mesh-ancestor
102544131|NCT03351933|Immunoglobulins|immunoglobulins|mesh-list
102544132|NCT03351933|Antibodies|antibodies|mesh-list
102544133|NCT03351933|gamma-Globulins|gamma-globulins|mesh-list
102544134|NCT03351933|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102544135|NCT03351933|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102544136|NCT03351933|Immunologic Factors|immunologic factors|mesh-ancestor
102544137|NCT03351933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544138|NCT03594045|Apixaban|apixaban|mesh-list
102544139|NCT03594045|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102544140|NCT03594045|Antithrombins|antithrombins|mesh-ancestor
102544141|NCT03594045|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102544142|NCT03594045|Protease Inhibitors|protease inhibitors|mesh-ancestor
102544143|NCT03594045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102544144|NCT03594045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544145|NCT03594045|Anticoagulants|anticoagulants|mesh-ancestor
102544146|NCT03595449|Lidocaine|lidocaine|mesh-list
102544147|NCT03595449|Anesthetics, Local|anesthetics, local|mesh-ancestor
102544148|NCT03595449|Anesthetics|anesthetics|mesh-ancestor
102544149|NCT03595449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102544150|NCT03595449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544151|NCT03595449|Sensory System Agents|sensory system agents|mesh-ancestor
102544152|NCT03595449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102544153|NCT03595449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102544154|NCT03595449|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102544155|NCT03595449|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102544156|NCT03595449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102544157|NCT03595449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544158|NCT03597009|Nivolumab|nivolumab|mesh-list
102544159|NCT03597009|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
102544160|NCT03597009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102544161|NCT03597009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102544162|NCT03597009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102544163|NCT03597009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544164|NCT03352323|Phenylephrine|phenylephrine|mesh-list
102544165|NCT03352323|Oxymetazoline|oxymetazoline|mesh-list
102544166|NCT03352323|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102544167|NCT03352323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102544168|NCT03352323|Adrenergic Agents|adrenergic agents|mesh-ancestor
102544169|NCT03352323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102544170|NCT03352323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544171|NCT03352323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544172|NCT03352323|Sympathomimetics|sympathomimetics|mesh-ancestor
102544173|NCT03352323|Autonomic Agents|autonomic agents|mesh-ancestor
102544174|NCT03352323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102544175|NCT03352323|Nasal Decongestants|nasal decongestants|mesh-ancestor
102544176|NCT03352323|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102544177|NCT03352323|Respiratory System Agents|respiratory system agents|mesh-ancestor
102544178|NCT03352323|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102544179|NCT03352323|Mydriatics|mydriatics|mesh-ancestor
102544180|NCT03352323|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101764185|NCT03387085|Vitamins|vitamins|mesh-ancestor
102544181|NCT03352323|Protective Agents|protective agents|mesh-ancestor
102544182|NCT04734639|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
102544183|NCT04734639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102544184|NCT04734639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544185|NCT03357393|Midazolam|midazolam|mesh-list
102544186|NCT03357393|Glycopyrrolate|glycopyrrolate|mesh-list
102544187|NCT03357393|Scopolamine|scopolamine|mesh-list
102544188|NCT03357393|Morphine|morphine|mesh-list
102544189|NCT03357393|Propofol|propofol|mesh-list
102544190|NCT03357393|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102544191|NCT03357393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102544192|NCT03357393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102544193|NCT03357393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544194|NCT03357393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102544195|NCT03357393|Anesthetics, General|anesthetics, general|mesh-ancestor
102544196|NCT03357393|Anesthetics|anesthetics|mesh-ancestor
102544197|NCT03357393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102544198|NCT03357393|Narcotics|narcotics|mesh-ancestor
102544199|NCT03357393|Analgesics|analgesics|mesh-ancestor
102544200|NCT03357393|Sensory System Agents|sensory system agents|mesh-ancestor
102544201|NCT03357393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102544202|NCT03357393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102544203|NCT03357393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102544204|NCT03357393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102544205|NCT03357393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102544206|NCT03357393|GABA Modulators|gaba modulators|mesh-ancestor
102544207|NCT03357393|GABA Agents|gaba agents|mesh-ancestor
102544208|NCT03357393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102544209|NCT03357393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544210|NCT03357393|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102544211|NCT03357393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102544212|NCT03357393|Cholinergic Agents|cholinergic agents|mesh-ancestor
102544213|NCT03357393|Antiemetics|antiemetics|mesh-ancestor
102544214|NCT03357393|Autonomic Agents|autonomic agents|mesh-ancestor
102544215|NCT03357393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102544216|NCT03357393|Mydriatics|mydriatics|mesh-ancestor
102544217|NCT03357393|Parasympatholytics|parasympatholytics|mesh-ancestor
102544218|NCT03541941|Bupivacaine|bupivacaine|mesh-list
102544219|NCT03541941|Anesthetics, Local|anesthetics, local|mesh-ancestor
102544220|NCT03541941|Anesthetics|anesthetics|mesh-ancestor
102544221|NCT03541941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102544222|NCT03541941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544223|NCT03541941|Sensory System Agents|sensory system agents|mesh-ancestor
102544224|NCT03541941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102544225|NCT00376467|Imatinib Mesylate|imatinib mesylate|mesh-list
102544226|NCT00376467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102544227|NCT00376467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102544228|NCT00376467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102544229|NCT00376467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544230|NCT03556761|Furosemide|furosemide|mesh-list
102544231|NCT03556761|Diuretics|diuretics|mesh-ancestor
102544232|NCT03556761|Natriuretic Agents|natriuretic agents|mesh-ancestor
102544233|NCT03556761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544234|NCT03556761|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102544235|NCT03556761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102544236|NCT03556761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544237|NCT03559179|Analgesics, Opioid|analgesics, opioid|mesh-list
102544238|NCT03559179|Narcotics|narcotics|mesh-ancestor
102544239|NCT03559179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102544240|NCT03559179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544241|NCT03559179|Analgesics|analgesics|mesh-ancestor
102544242|NCT03559179|Sensory System Agents|sensory system agents|mesh-ancestor
102544243|NCT03559179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102544244|NCT03366207|Ciprofloxacin|ciprofloxacin|mesh-list
102544245|NCT03366207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102544246|NCT03366207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102544247|NCT03366207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102544248|NCT03366207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102544249|NCT03366207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102544250|NCT03366207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544251|NCT03366207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102544252|NCT03366207|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102544253|NCT03366207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102544254|NCT03368235|Prednisolone|prednisolone|mesh-list
102544255|NCT03368235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102544256|NCT03368235|Glucocorticoids|glucocorticoids|mesh-ancestor
102544257|NCT03368235|Hormones|hormones|mesh-ancestor
102544258|NCT03368235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101830947|NCT04510051|Immunologic Factors|immunologic factors|mesh-ancestor
102544259|NCT03368235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544260|NCT03368235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102544261|NCT03368235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102544262|NCT02310750|PF-06700841|pf-06700841|mesh-list
102544263|NCT02310750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102544264|NCT02310750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102544265|NCT02310750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544266|NCT03615807|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102544267|NCT03615807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102544268|NCT02310672|Macitentan|macitentan|mesh-list
102544269|NCT02310672|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
102544270|NCT02310672|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102544271|NCT02310672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544272|NCT02310672|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
102544273|NCT03626415|Abrocitinib|abrocitinib|mesh-list
102544274|NCT03626415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102544275|NCT03626415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102544276|NCT03626415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544277|NCT04373421|Chlorhexidine|chlorhexidine|mesh-list
102544278|NCT04373421|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102544279|NCT04373421|Benzydamine|benzydamine|mesh-list
102544280|NCT04373421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102544281|NCT04373421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102544282|NCT04373421|Disinfectants|disinfectants|mesh-ancestor
102544283|NCT04373421|Dermatologic Agents|dermatologic agents|mesh-ancestor
102544284|NCT04373421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102544285|NCT03632109|Gentamicins|gentamicins|mesh-list
102544286|NCT03632109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102544287|NCT03632109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102544288|NCT03632109|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102544289|NCT03632109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102544290|NCT03632109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544291|NCT02363946|Diphenhydramine|diphenhydramine|mesh-list
102544292|NCT02363946|Promethazine|promethazine|mesh-list
102544293|NCT02363946|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102544294|NCT02363946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102544295|NCT02363946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102544296|NCT02363946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544297|NCT02363946|Anesthetics, Local|anesthetics, local|mesh-ancestor
102544298|NCT02363946|Anesthetics|anesthetics|mesh-ancestor
102544299|NCT02363946|Sensory System Agents|sensory system agents|mesh-ancestor
102544300|NCT02363946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102544301|NCT02363946|Antiemetics|antiemetics|mesh-ancestor
102544302|NCT02363946|Autonomic Agents|autonomic agents|mesh-ancestor
102544303|NCT02363946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102544304|NCT02363946|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102544305|NCT02363946|Histamine Antagonists|histamine antagonists|mesh-ancestor
102544306|NCT02363946|Histamine Agents|histamine agents|mesh-ancestor
102544307|NCT02363946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102544308|NCT02363946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544309|NCT02363946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102544310|NCT02363946|Antipruritics|antipruritics|mesh-ancestor
102544311|NCT02363946|Dermatologic Agents|dermatologic agents|mesh-ancestor
102544312|NCT02363478|Buspirone|buspirone|mesh-list
102544313|NCT02363478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102544314|NCT02363478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102544315|NCT02363478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102544316|NCT02363478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544317|NCT02363478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102544318|NCT02363478|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102544319|NCT02363478|Serotonin Agents|serotonin agents|mesh-ancestor
102544320|NCT02363478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102544321|NCT02363478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544322|NCT02338362|Fluticasone|fluticasone|mesh-list
102544323|NCT02338362|Xhance|xhance|mesh-list
102544324|NCT02338362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102544325|NCT02338362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102544326|NCT02338362|Autonomic Agents|autonomic agents|mesh-ancestor
102544327|NCT02338362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102544328|NCT02338362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544329|NCT02338362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102544330|NCT02338362|Respiratory System Agents|respiratory system agents|mesh-ancestor
102544331|NCT02338362|Dermatologic Agents|dermatologic agents|mesh-ancestor
102544332|NCT02338362|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102544333|NCT01803074|Ritonavir|ritonavir|mesh-list
102544334|NCT01803074|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102544335|NCT01803074|Tenofovir|tenofovir|mesh-list
102544336|NCT01803074|Emtricitabine|emtricitabine|mesh-list
102544337|NCT01803074|BMS-955176|bms-955176|mesh-list
102544338|NCT01803074|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102544339|NCT01803074|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102544340|NCT01803074|Protease Inhibitors|protease inhibitors|mesh-ancestor
102544341|NCT01803074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102544342|NCT01803074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544343|NCT01803074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102544344|NCT01803074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102544345|NCT01803074|Antiviral Agents|antiviral agents|mesh-ancestor
102544346|NCT01803074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102544347|NCT01803074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102544348|NCT01803074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102544349|NCT01803074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102544350|NCT01803074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102544351|NCT05327894|Blinatumomab|blinatumomab|mesh-list
102544352|NCT05327894|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102544353|NCT05327894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102544354|NCT05327894|Immunologic Factors|immunologic factors|mesh-ancestor
102544355|NCT05327894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544356|NCT05327660|Carbon Monoxide|carbon monoxide|mesh-list
102544357|NCT05327660|Antimetabolites|antimetabolites|mesh-ancestor
102544358|NCT05327660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544359|NCT05327660|Gasotransmitters|gasotransmitters|mesh-ancestor
102544360|NCT05327660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102544361|NCT05327660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544362|NCT01822886|Gemcitabine|gemcitabine|mesh-list
102544363|NCT01822886|Romidepsin|romidepsin|mesh-list
102544364|NCT01822886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102544365|NCT01822886|Antimetabolites|antimetabolites|mesh-ancestor
102544366|NCT01822886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544367|NCT01822886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102544368|NCT01822886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102544369|NCT01822886|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102544370|NCT01822886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102544371|NCT01823510|Aspirin|aspirin|mesh-list
102544372|NCT01823510|Clopidogrel|clopidogrel|mesh-list
102544373|NCT01823510|Ticagrelor|ticagrelor|mesh-list
101764361|NCT04444804|Protease Inhibitors|protease inhibitors|mesh-ancestor
102544374|NCT01823510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102544375|NCT01823510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102544376|NCT01823510|Analgesics|analgesics|mesh-ancestor
102544377|NCT01823510|Sensory System Agents|sensory system agents|mesh-ancestor
102544378|NCT01823510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102544379|NCT01823510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544380|NCT01823510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102544381|NCT01823510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102544382|NCT01823510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102544383|NCT01823510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102544384|NCT01823510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544385|NCT01823510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102544386|NCT01823510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102544387|NCT01823510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102544388|NCT01823510|Antipyretics|antipyretics|mesh-ancestor
102544389|NCT01823510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102544390|NCT01823510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102544391|NCT01823510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102544392|NCT01823510|Purinergic Agents|purinergic agents|mesh-ancestor
102544393|NCT01823510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102544394|NCT05327582|Paclitaxel|paclitaxel|mesh-list
102544395|NCT05327582|Durvalumab|durvalumab|mesh-list
102544396|NCT05327582|Lenvatinib|lenvatinib|mesh-list
102544397|NCT05327582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102544398|NCT05327582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102544399|NCT05327582|Tubulin Modulators|tubulin modulators|mesh-ancestor
102544400|NCT05327582|Antimitotic Agents|antimitotic agents|mesh-ancestor
102544401|NCT05327582|Mitosis Modulators|mitosis modulators|mesh-ancestor
102544402|NCT05327582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544403|NCT05327582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102544404|NCT05327582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102544405|NCT05327582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102544406|NCT02271698|Dexamethasone|dexamethasone|mesh-list
102544407|NCT02271698|Dexamethasone acetate|dexamethasone acetate|mesh-list
102544408|NCT02271698|BB 1101|bb 1101|mesh-list
102544409|NCT02271698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102544410|NCT02271698|Antiemetics|antiemetics|mesh-ancestor
101831120|NCT04036305|Sensory System Agents|sensory system agents|mesh-ancestor
102544411|NCT02271698|Autonomic Agents|autonomic agents|mesh-ancestor
102544412|NCT02271698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102544413|NCT02271698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544414|NCT02271698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102544415|NCT02271698|Glucocorticoids|glucocorticoids|mesh-ancestor
102544416|NCT02271698|Hormones|hormones|mesh-ancestor
102544417|NCT02271698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102544418|NCT02271698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102544419|NCT02271698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102544420|NCT02271698|Protease Inhibitors|protease inhibitors|mesh-ancestor
102544421|NCT02271698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102544422|NCT02271698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544423|NCT02328404|Vitamin D|vitamin d|mesh-list
102544424|NCT02328404|Cholecalciferol|cholecalciferol|mesh-list
102544425|NCT02328404|Vitamins|vitamins|mesh-ancestor
102544426|NCT02328404|Micronutrients|micronutrients|mesh-ancestor
102544427|NCT02328404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544428|NCT02328404|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102544429|NCT02328404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102544430|NCT05748236|Lamotrigine|lamotrigine|mesh-list
102544431|NCT05748236|Carbamazepine|carbamazepine|mesh-list
102544432|NCT05748236|Anticonvulsants|anticonvulsants|mesh-ancestor
102544433|NCT05748236|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102544434|NCT05748236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102544435|NCT05748236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544436|NCT05748236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102544437|NCT05748236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544438|NCT05748236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102544439|NCT05748236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102544440|NCT05748236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102544441|NCT05748236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102544442|NCT05748236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102544443|NCT05748236|Antimanic Agents|antimanic agents|mesh-ancestor
102544444|NCT05748236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102544445|NCT05748236|Analgesics|analgesics|mesh-ancestor
102544446|NCT05748236|Sensory System Agents|sensory system agents|mesh-ancestor
102544447|NCT05748236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102544448|NCT05748236|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102544449|NCT05748236|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102544450|NCT01829516|Oxytocin|oxytocin|mesh-list
102544451|NCT01829516|Oxytocics|oxytocics|mesh-ancestor
102544452|NCT01829516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102544453|NCT01829516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544454|NCT01830140|Bimatoprost|bimatoprost|mesh-list
102544455|NCT01830140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102544456|NCT01830842|Nicotine|nicotine|mesh-list
102544457|NCT01830842|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102544458|NCT01830842|Autonomic Agents|autonomic agents|mesh-ancestor
102544459|NCT01830842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102544460|NCT01830842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544461|NCT01830842|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102544462|NCT01830842|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102544463|NCT01830842|Cholinergic Agents|cholinergic agents|mesh-ancestor
102544464|NCT01830842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102544465|NCT01830842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544466|NCT01831232|Cytarabine|cytarabine|mesh-list
102544467|NCT01831232|Idarubicin|idarubicin|mesh-list
102544468|NCT01831232|Pravastatin|pravastatin|mesh-list
102544469|NCT01831232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102544470|NCT01831232|Antimetabolites|antimetabolites|mesh-ancestor
102544471|NCT01831232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544472|NCT01831232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102544473|NCT01831232|Antiviral Agents|antiviral agents|mesh-ancestor
102544474|NCT01831232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102544475|NCT01831232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102544476|NCT01831232|Immunologic Factors|immunologic factors|mesh-ancestor
102544477|NCT01831232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544478|NCT01831232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102544479|NCT01831232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102544480|NCT01831232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102544481|NCT01831232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102544482|NCT01831232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102544483|NCT01831232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102544484|NCT01831232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102544485|NCT01831232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101831198|NCT03870919|Palbociclib|palbociclib|mesh-list
102544487|NCT01831934|Immunologic Factors|immunologic factors|mesh-ancestor
102544488|NCT01831934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544489|NCT01833026|Albuterol|albuterol|mesh-list
102544490|NCT01833026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102544491|NCT01833026|Autonomic Agents|autonomic agents|mesh-ancestor
102544492|NCT01833026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102544493|NCT01833026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544494|NCT01833026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102544495|NCT01833026|Respiratory System Agents|respiratory system agents|mesh-ancestor
102544496|NCT01833026|Tocolytic Agents|tocolytic agents|mesh-ancestor
102544497|NCT01833026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102544498|NCT01833026|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102544499|NCT01833026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102544500|NCT01833026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102544501|NCT01833026|Adrenergic Agents|adrenergic agents|mesh-ancestor
102544502|NCT01833026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102544503|NCT01833026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544504|NCT03383523|Praziquantel|praziquantel|mesh-list
102544505|NCT03383523|Emodepside|emodepside|mesh-list
102544506|NCT03383523|Toltrazuril|toltrazuril|mesh-list
102544507|NCT03383523|Anthelmintics|anthelmintics|mesh-ancestor
102544508|NCT03383523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102544509|NCT03383523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102544510|NCT03383523|Coccidiostats|coccidiostats|mesh-ancestor
102544511|NCT03383523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102544512|NCT00377091|PENTA|penta|mesh-list
102544513|NCT00377091|Fondaparinux|fondaparinux|mesh-list
102544514|NCT00377091|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102544515|NCT00377091|Antithrombins|antithrombins|mesh-ancestor
102544516|NCT00377091|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102544517|NCT00377091|Protease Inhibitors|protease inhibitors|mesh-ancestor
102544518|NCT00377091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102544519|NCT00377091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544520|NCT00377091|Anticoagulants|anticoagulants|mesh-ancestor
102544521|NCT00377091|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102544522|NCT00377091|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102544523|NCT01835912|Citric Acid|citric acid|mesh-list
102544524|NCT01835912|Sodium Citrate|sodium citrate|mesh-list
102544525|NCT01835912|Anticoagulants|anticoagulants|mesh-ancestor
102544526|NCT01835912|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102544527|NCT01835912|Chelating Agents|chelating agents|mesh-ancestor
102544528|NCT01835912|Sequestering Agents|sequestering agents|mesh-ancestor
102544529|NCT01835912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544530|NCT05747768|Midazolam|midazolam|mesh-list
102544531|NCT05747768|Dabigatran|dabigatran|mesh-list
102544532|NCT05747768|Atorvastatin|atorvastatin|mesh-list
102544533|NCT05747768|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102544534|NCT05747768|Pitavastatin|pitavastatin|mesh-list
102544535|NCT05747768|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102544536|NCT05747768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102544537|NCT05747768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102544538|NCT05747768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544539|NCT05747768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102544540|NCT05747768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102544541|NCT05747768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102544542|NCT05747768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102544543|NCT05747768|Anesthetics, General|anesthetics, general|mesh-ancestor
102544544|NCT05747768|Anesthetics|anesthetics|mesh-ancestor
102544545|NCT05747768|GABA Modulators|gaba modulators|mesh-ancestor
102544546|NCT05747768|GABA Agents|gaba agents|mesh-ancestor
102544547|NCT05747768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102544548|NCT05747768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544549|NCT05747768|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102544550|NCT05747768|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102544551|NCT05747768|Antimetabolites|antimetabolites|mesh-ancestor
102544552|NCT05747768|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102544553|NCT05747768|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102544554|NCT05747768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102544555|NCT05747768|Antithrombins|antithrombins|mesh-ancestor
102544556|NCT05747768|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102544557|NCT05747768|Protease Inhibitors|protease inhibitors|mesh-ancestor
102544558|NCT05747768|Anticoagulants|anticoagulants|mesh-ancestor
102544559|NCT04410159|Povidone-Iodine|povidone-iodine|mesh-list
102544560|NCT04410159|Listerine|listerine|mesh-list
102544561|NCT04410159|Povidone|povidone|mesh-list
102544562|NCT04410159|Plasma Substitutes|plasma substitutes|mesh-ancestor
102544563|NCT04410159|Blood Substitutes|blood substitutes|mesh-ancestor
102544564|NCT04410159|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102544565|NCT04410159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102544566|NCT03398421|Itraconazole|itraconazole|mesh-list
102544567|NCT03398421|Nemiralisib|nemiralisib|mesh-list
102544568|NCT03398421|Antifungal Agents|antifungal agents|mesh-ancestor
102544569|NCT03398421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102544570|NCT03398421|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102544571|NCT03398421|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102544572|NCT03398421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102544573|NCT03398421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544574|NCT03398421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102544575|NCT03398421|Hormone Antagonists|hormone antagonists|mesh-ancestor
101764559|NCT03680352|Enmetazobactam|enmetazobactam|mesh-list
102544576|NCT03398421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102544577|NCT03398421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544578|NCT03398421|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102544579|NCT03398421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102544580|NCT01839110|Ranolazine|ranolazine|mesh-list
102544581|NCT01839110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102544582|NCT01839110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102544583|NCT01839110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544584|NCT00559754|Bevacizumab|bevacizumab|mesh-list
102544585|NCT00559754|Docetaxel|docetaxel|mesh-list
102544586|NCT00559754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102544587|NCT00559754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102544588|NCT00559754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102544589|NCT00559754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102544590|NCT00559754|Growth Substances|growth substances|mesh-ancestor
102544591|NCT00559754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544592|NCT00559754|Growth Inhibitors|growth inhibitors|mesh-ancestor
102544593|NCT00559754|Tubulin Modulators|tubulin modulators|mesh-ancestor
102544594|NCT00559754|Antimitotic Agents|antimitotic agents|mesh-ancestor
102544595|NCT00559754|Mitosis Modulators|mitosis modulators|mesh-ancestor
102544596|NCT00559754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544597|NCT03402243|Menthol|menthol|mesh-list
102544598|NCT03402243|Antipruritics|antipruritics|mesh-ancestor
102544599|NCT03402243|Dermatologic Agents|dermatologic agents|mesh-ancestor
102544600|NCT01841606|Ondansetron|ondansetron|mesh-list
102544601|NCT01841606|Antiemetics|antiemetics|mesh-ancestor
102544602|NCT01841606|Autonomic Agents|autonomic agents|mesh-ancestor
102544603|NCT01841606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102544604|NCT01841606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544605|NCT01841606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102544606|NCT01841606|Antipruritics|antipruritics|mesh-ancestor
102544607|NCT01841606|Dermatologic Agents|dermatologic agents|mesh-ancestor
102544608|NCT01841606|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102544609|NCT01841606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102544610|NCT01841606|Serotonin Agents|serotonin agents|mesh-ancestor
102544611|NCT01841606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102544612|NCT01841606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544613|NCT04392141|Colchicine|colchicine|mesh-list
102544614|NCT04392141|Gout Suppressants|gout suppressants|mesh-ancestor
102544615|NCT04392141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102544616|NCT04392141|Tubulin Modulators|tubulin modulators|mesh-ancestor
102544617|NCT04392141|Antimitotic Agents|antimitotic agents|mesh-ancestor
102544618|NCT04392141|Mitosis Modulators|mitosis modulators|mesh-ancestor
102544619|NCT04392141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544620|NCT04392141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102544621|NCT04838054|Chlorine dioxide|chlorine dioxide|mesh-list
102544622|NCT04838054|Dental Disinfectants|dental disinfectants|mesh-ancestor
102544623|NCT04838054|Disinfectants|disinfectants|mesh-ancestor
102544624|NCT04838054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102544625|NCT00559364|Omeprazole|omeprazole|mesh-list
102544626|NCT00559364|Pancrelipase|pancrelipase|mesh-list
102544627|NCT00559364|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
102544628|NCT00559364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102544629|NCT00559364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102544630|NCT00559364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102544631|NCT00559364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544632|NCT05746676|Hyaluronic Acid|hyaluronic acid|mesh-list
102544633|NCT05746676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544634|NCT05746676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101764632|NCT00864591|Adenosine|adenosine|mesh-list
102544635|NCT05746676|Immunologic Factors|immunologic factors|mesh-ancestor
102544636|NCT05746676|Viscosupplements|viscosupplements|mesh-ancestor
102544637|NCT05746676|Protective Agents|protective agents|mesh-ancestor
102544638|NCT05746598|Cisplatin|cisplatin|mesh-list
102544639|NCT05746598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831345|NCT03514108|Metformin|metformin|mesh-list
102544640|NCT05745974|Fibrin fragment D|fibrin fragment d|mesh-list
102544641|NCT05745974|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102544642|NCT05745974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102544643|NCT05745974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544644|NCT05745974|Hemostatics|hemostatics|mesh-ancestor
102544645|NCT05745974|Coagulants|coagulants|mesh-ancestor
102544646|NCT02306850|Pembrolizumab|pembrolizumab|mesh-list
102544647|NCT02306850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102544648|NCT02306850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102544649|NCT02306850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102544650|NCT02306850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544651|NCT02306694|Factor VIII|factor viii|mesh-list
102544652|NCT02306694|Coagulants|coagulants|mesh-ancestor
102544653|NCT01648140|Interferons|interferons|mesh-list
102544654|NCT01648140|Ribavirin|ribavirin|mesh-list
102544655|NCT01648140|Interferon-alpha|interferon-alpha|mesh-list
102544656|NCT01648140|Interferon alpha-2|interferon alpha-2|mesh-list
102544657|NCT01648140|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102544658|NCT01648140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102544659|NCT01648140|Antiviral Agents|antiviral agents|mesh-ancestor
102544660|NCT01648140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102544661|NCT01648140|Antimetabolites|antimetabolites|mesh-ancestor
102544662|NCT01648140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544663|NCT01648140|Immunologic Factors|immunologic factors|mesh-ancestor
102544664|NCT01648140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544665|NCT02335242|Sildenafil Citrate|sildenafil citrate|mesh-list
102544666|NCT02335242|Vasodilator Agents|vasodilator agents|mesh-ancestor
102544667|NCT02335242|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102544668|NCT02335242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102544669|NCT02335242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102544670|NCT02335242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544671|NCT02335242|Urological Agents|urological agents|mesh-ancestor
102544672|NCT04883892|Hyaluronic Acid|hyaluronic acid|mesh-list
102544673|NCT04883892|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102544674|NCT04883892|Immunologic Factors|immunologic factors|mesh-ancestor
102544675|NCT04883892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544676|NCT04883892|Viscosupplements|viscosupplements|mesh-ancestor
102544677|NCT04883892|Protective Agents|protective agents|mesh-ancestor
102544678|NCT02334384|Anti-Infective Agents|anti-infective agents|mesh-list
102544679|NCT02334384|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102544680|NCT02305758|Bevacizumab|bevacizumab|mesh-list
102544681|NCT02305758|Fluorouracil|fluorouracil|mesh-list
102544682|NCT02305758|Veliparib|veliparib|mesh-list
102544683|NCT02305758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102544684|NCT02305758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102544685|NCT02305758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102544686|NCT02305758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102544687|NCT02305758|Growth Substances|growth substances|mesh-ancestor
102544688|NCT02305758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544689|NCT02305758|Growth Inhibitors|growth inhibitors|mesh-ancestor
102544690|NCT02305758|Antimetabolites|antimetabolites|mesh-ancestor
102544691|NCT02305758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544692|NCT02305758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102544693|NCT02305758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102544694|NCT02305758|Immunologic Factors|immunologic factors|mesh-ancestor
102544695|NCT02305758|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101764692|NCT02559102|Anesthetics|anesthetics|mesh-list
102544696|NCT02305758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102544697|NCT04392219|Molnupiravir|molnupiravir|mesh-list
102544698|NCT04392219|Antiviral Agents|antiviral agents|mesh-ancestor
102544699|NCT04392219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102544700|NCT04365153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102544701|NCT04365153|Immunologic Factors|immunologic factors|mesh-ancestor
102544702|NCT04365153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544703|NCT03654417|Lidocaine|lidocaine|mesh-list
102544704|NCT03654417|Anesthetics, Local|anesthetics, local|mesh-ancestor
102544705|NCT03654417|Anesthetics|anesthetics|mesh-ancestor
102544706|NCT03654417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102544707|NCT03654417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544708|NCT03654417|Sensory System Agents|sensory system agents|mesh-ancestor
102544709|NCT03654417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102544710|NCT03654417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102544711|NCT03654417|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102544712|NCT03654417|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102544713|NCT03654417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102544714|NCT03654417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544716|NCT00376701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102544717|NCT00376701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102544718|NCT00376701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102544719|NCT00376701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102544720|NCT00376701|Growth Substances|growth substances|mesh-ancestor
102544721|NCT00376701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544722|NCT00376701|Growth Inhibitors|growth inhibitors|mesh-ancestor
102544723|NCT04358991|Ceftazidime|ceftazidime|mesh-list
102544724|NCT04358991|Avibactam|avibactam|mesh-list
102544725|NCT04358991|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
102544726|NCT04358991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102544727|NCT04358991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102544728|NCT04358991|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102544729|NCT04358991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102544730|NCT04358991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544731|NCT04338009|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102544732|NCT04338009|Protease Inhibitors|protease inhibitors|mesh-ancestor
102544733|NCT04338009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102544734|NCT04338009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544735|NCT02303574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102544736|NCT02354976|Fenofibrate|fenofibrate|mesh-list
102544737|NCT02354976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102544738|NCT02354976|Antimetabolites|antimetabolites|mesh-ancestor
102544739|NCT02354976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544740|NCT02354976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102544741|NCT02303262|Gemcitabine|gemcitabine|mesh-list
102544742|NCT02303262|Mocetinostat|mocetinostat|mesh-list
102544743|NCT02303262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102544744|NCT02303262|Antimetabolites|antimetabolites|mesh-ancestor
102544745|NCT02303262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544746|NCT02303262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102544747|NCT02303262|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102544748|NCT02303262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102544749|NCT00558896|Dexamethasone|dexamethasone|mesh-list
102544750|NCT00558896|Pomalidomide|pomalidomide|mesh-list
102544751|NCT00558896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102544752|NCT00558896|Antiemetics|antiemetics|mesh-ancestor
102544753|NCT00558896|Autonomic Agents|autonomic agents|mesh-ancestor
102544754|NCT00558896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102544755|NCT00558896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544756|NCT00558896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102544757|NCT00558896|Glucocorticoids|glucocorticoids|mesh-ancestor
102544758|NCT00558896|Hormones|hormones|mesh-ancestor
102544759|NCT00558896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102544760|NCT00558896|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102544761|NCT00558896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102544762|NCT00558896|Immunologic Factors|immunologic factors|mesh-ancestor
102544763|NCT00558896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102544764|NCT00558896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102544765|NCT00558896|Growth Substances|growth substances|mesh-ancestor
102544766|NCT00558896|Growth Inhibitors|growth inhibitors|mesh-ancestor
102544767|NCT01857362|Nitisinone|nitisinone|mesh-list
102544768|NCT01857362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102544769|NCT01857362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544770|NCT02265224|Acetylcysteine|acetylcysteine|mesh-list
102544771|NCT02265224|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102544772|NCT02265224|Antiviral Agents|antiviral agents|mesh-ancestor
102544773|NCT02265224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102544774|NCT02265224|Expectorants|expectorants|mesh-ancestor
102544775|NCT02265224|Respiratory System Agents|respiratory system agents|mesh-ancestor
102544776|NCT02265224|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102544777|NCT02265224|Antioxidants|antioxidants|mesh-ancestor
102544778|NCT02265224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544779|NCT02265224|Protective Agents|protective agents|mesh-ancestor
102544780|NCT02265224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544781|NCT02265224|Antidotes|antidotes|mesh-ancestor
102544782|NCT01859078|Digoxin|digoxin|mesh-list
102544783|NCT01859078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102544784|NCT01859078|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102544785|NCT01859078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102544786|NCT01859078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544787|NCT01859078|Protective Agents|protective agents|mesh-ancestor
101831579|NCT02879695|Nivolumab|nivolumab|mesh-list
102544788|NCT01859078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544789|NCT00558428|Amlodipine|amlodipine|mesh-list
102544790|NCT00558428|Telmisartan|telmisartan|mesh-list
102544791|NCT00558428|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
102544792|NCT00558428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102544793|NCT00558428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102544794|NCT00558428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102544795|NCT00558428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544796|NCT00558428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102544797|NCT00558428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544798|NCT00558428|Vasodilator Agents|vasodilator agents|mesh-ancestor
102544799|NCT00558428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102544800|NCT00558428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102544801|NCT05314725|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102544802|NCT05314725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544803|NCT05314725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102544804|NCT05314725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544805|NCT04310085|Lumefantrine|lumefantrine|mesh-list
102544806|NCT04310085|Artemether|artemether|mesh-list
102544807|NCT04310085|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102544808|NCT04310085|Antimalarials|antimalarials|mesh-ancestor
102544809|NCT04310085|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102544810|NCT04310085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102544811|NCT04310085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102544812|NCT00558272|Zoledronic Acid|zoledronic acid|mesh-list
102544813|NCT00558272|Saracatinib|saracatinib|mesh-list
102544814|NCT00558272|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102544815|NCT00558272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544816|NCT00558272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102544817|NCT00558272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102544818|NCT00558272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544819|NCT01859312|Hydrocortisone|hydrocortisone|mesh-list
102544820|NCT01859312|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102544821|NCT01859312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102544822|NCT03407625|Misoprostol|misoprostol|mesh-list
102544823|NCT03407625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102544824|NCT03407625|Abortifacient Agents|abortifacient agents|mesh-ancestor
102544825|NCT03407625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102544826|NCT03407625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544827|NCT03407625|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102544828|NCT03407625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102544829|NCT03407625|Oxytocics|oxytocics|mesh-ancestor
102544830|NCT03666663|Lidocaine|lidocaine|mesh-list
102544831|NCT03666663|Bupivacaine|bupivacaine|mesh-list
102544832|NCT03666663|Ropivacaine|ropivacaine|mesh-list
102544833|NCT03666663|Anesthetics, Local|anesthetics, local|mesh-ancestor
102544834|NCT03666663|Anesthetics|anesthetics|mesh-ancestor
102544835|NCT03666663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102544836|NCT03666663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544837|NCT03666663|Sensory System Agents|sensory system agents|mesh-ancestor
102544838|NCT03666663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102544839|NCT03666663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102544840|NCT03666663|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102544841|NCT03666663|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102544842|NCT03666663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102544843|NCT03666663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544844|NCT05692154|Fexofenadine|fexofenadine|mesh-list
102544845|NCT05692154|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102544846|NCT05692154|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102544847|NCT05692154|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102544848|NCT05692154|Histamine Antagonists|histamine antagonists|mesh-ancestor
102544849|NCT05692154|Histamine Agents|histamine agents|mesh-ancestor
102544850|NCT05692154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102544851|NCT05692154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544852|NCT05692154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544853|NCT01863134|Eptifibatide|eptifibatide|mesh-list
102544854|NCT01863134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102544855|NCT03415581|Oxycodone|oxycodone|mesh-list
102544856|NCT03415581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102544857|NCT03415581|Narcotics|narcotics|mesh-ancestor
102544858|NCT03415581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102544859|NCT03415581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544860|NCT03415581|Analgesics|analgesics|mesh-ancestor
102544861|NCT03415581|Sensory System Agents|sensory system agents|mesh-ancestor
102544862|NCT03415581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102544863|NCT00557492|Bevacizumab|bevacizumab|mesh-list
102544864|NCT00557492|Gemcitabine|gemcitabine|mesh-list
102544865|NCT00557492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102544866|NCT00557492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102544867|NCT00557492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102544868|NCT00557492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102544869|NCT00557492|Growth Substances|growth substances|mesh-ancestor
102544870|NCT00557492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544871|NCT00557492|Growth Inhibitors|growth inhibitors|mesh-ancestor
102544872|NCT00557492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102544873|NCT00557492|Antimetabolites|antimetabolites|mesh-ancestor
102544874|NCT00557492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544875|NCT01865708|Ethanol|ethanol|mesh-list
102544876|NCT01865708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102544877|NCT01865708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102544878|NCT01865708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102544879|NCT01865708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544880|NCT04203225|Lidocaine|lidocaine|mesh-list
102544881|NCT04203225|Epinephrine|epinephrine|mesh-list
102544882|NCT04203225|Tetracaine|tetracaine|mesh-list
102544883|NCT04203225|Anesthetics, Local|anesthetics, local|mesh-ancestor
102544884|NCT04203225|Anesthetics|anesthetics|mesh-ancestor
102544885|NCT04203225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102544886|NCT04203225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544887|NCT04203225|Sensory System Agents|sensory system agents|mesh-ancestor
102544888|NCT04203225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102544889|NCT04203225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101764876|NCT00872235|Quinapril|quinapril|mesh-list
102544890|NCT04203225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102544891|NCT04203225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102544892|NCT04203225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102544893|NCT04203225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544894|NCT04203225|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102544895|NCT04203225|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102544896|NCT04203225|Adrenergic Agents|adrenergic agents|mesh-ancestor
102544897|NCT04203225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102544898|NCT04203225|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102544899|NCT04203225|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102544900|NCT04203225|Autonomic Agents|autonomic agents|mesh-ancestor
102544901|NCT04203225|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102544902|NCT04203225|Respiratory System Agents|respiratory system agents|mesh-ancestor
102544903|NCT04203225|Mydriatics|mydriatics|mesh-ancestor
102544904|NCT04203225|Sympathomimetics|sympathomimetics|mesh-ancestor
102544905|NCT04203225|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102544906|NCT05314257|Granisetron|granisetron|mesh-list
102544907|NCT05314257|Antiemetics|antiemetics|mesh-ancestor
102544908|NCT05314257|Autonomic Agents|autonomic agents|mesh-ancestor
102544909|NCT05314257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102544910|NCT05314257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544911|NCT05314257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102544912|NCT05314257|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102544913|NCT05314257|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102544914|NCT05314257|Serotonin Agents|serotonin agents|mesh-ancestor
102544915|NCT05314257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102544916|NCT05314257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544917|NCT02354586|Niraparib|niraparib|mesh-list
102544918|NCT02354586|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102544919|NCT02354586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102544920|NCT02354586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544921|NCT02354586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102544922|NCT01866410|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102544923|NCT01866410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102544924|NCT01866410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102544925|NCT01866410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102544926|NCT01866410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544927|NCT00377325|Cyclosporine|cyclosporine|mesh-list
102544928|NCT00377325|Cyclosporins|cyclosporins|mesh-list
102544929|NCT00377325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102544930|NCT00377325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544931|NCT00377325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102544932|NCT00377325|Immunologic Factors|immunologic factors|mesh-ancestor
102544933|NCT00377325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831649|NCT02732288|Protective Agents|protective agents|mesh-ancestor
102544934|NCT00377325|Antifungal Agents|antifungal agents|mesh-ancestor
102544935|NCT00377325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102544936|NCT00377325|Dermatologic Agents|dermatologic agents|mesh-ancestor
102544937|NCT00377325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102544938|NCT00377325|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102544939|NCT02332824|Candesartan|candesartan|mesh-list
102544940|NCT02332824|Candesartan cilexetil|candesartan cilexetil|mesh-list
102544941|NCT02332824|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
102544942|NCT02332824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102544943|NCT02332824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102544944|NCT02332824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102544945|NCT02332824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764946|NCT00676650|Prednisone|prednisone|mesh-list
102544946|NCT02332824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102544947|NCT03701061|Vaccines|vaccines|mesh-list
102544948|NCT03701061|Immunologic Factors|immunologic factors|mesh-ancestor
102544949|NCT03701061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544950|NCT03420014|Doxorubicin|doxorubicin|mesh-list
102544951|NCT03420014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102544952|NCT03420014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102544953|NCT03420014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102544954|NCT03420014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102544955|NCT03420014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102544956|NCT03420014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102544957|NCT03420014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544958|NCT03705273|Dexamethasone|dexamethasone|mesh-list
102544959|NCT03705273|Dexamethasone acetate|dexamethasone acetate|mesh-list
102544960|NCT03705273|BB 1101|bb 1101|mesh-list
102544961|NCT03705273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102544962|NCT03705273|Antiemetics|antiemetics|mesh-ancestor
102544963|NCT03705273|Autonomic Agents|autonomic agents|mesh-ancestor
102544964|NCT03705273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102544965|NCT03705273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544966|NCT03705273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102544967|NCT03705273|Glucocorticoids|glucocorticoids|mesh-ancestor
102544968|NCT03705273|Hormones|hormones|mesh-ancestor
102544969|NCT03705273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102544970|NCT03705273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102544971|NCT03705273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102544972|NCT03705273|Protease Inhibitors|protease inhibitors|mesh-ancestor
102544973|NCT03705273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102544974|NCT03705273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544975|NCT04184271|Fluorides|fluorides|mesh-list
102544976|NCT04184271|Cariostatic Agents|cariostatic agents|mesh-ancestor
102544977|NCT04184271|Protective Agents|protective agents|mesh-ancestor
102544978|NCT04184271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544979|NCT03936387|Ropivacaine|ropivacaine|mesh-list
102544980|NCT03936387|Anesthetics, Local|anesthetics, local|mesh-ancestor
102544981|NCT03936387|Anesthetics|anesthetics|mesh-ancestor
102544982|NCT03936387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102544983|NCT03936387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544984|NCT03936387|Sensory System Agents|sensory system agents|mesh-ancestor
102544985|NCT03936387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102544986|NCT04173429|Nadroparin|nadroparin|mesh-list
102544987|NCT04173429|Warfarin|warfarin|mesh-list
102544988|NCT04173429|Calcium|calcium|mesh-list
102544989|NCT04173429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102544990|NCT04173429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102544991|NCT04173429|Anticoagulants|anticoagulants|mesh-ancestor
102544992|NCT04173429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102544993|NCT04173429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102544994|NCT04173429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102544995|NCT03710187|Hydrocortisone|hydrocortisone|mesh-list
102544996|NCT03710187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102544997|NCT04167189|Lidocaine|lidocaine|mesh-list
102544998|NCT04167189|Anesthetics, Local|anesthetics, local|mesh-ancestor
102544999|NCT04167189|Anesthetics|anesthetics|mesh-ancestor
102545000|NCT04167189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102545001|NCT04167189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545002|NCT04167189|Sensory System Agents|sensory system agents|mesh-ancestor
102545003|NCT04167189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102545004|NCT04167189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102545005|NCT04167189|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102545006|NCT04167189|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102545007|NCT04167189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102545008|NCT04167189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545009|NCT03929367|Oxytocin|oxytocin|mesh-list
102545010|NCT03929367|Oxytocics|oxytocics|mesh-ancestor
102545011|NCT03929367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102545012|NCT03929367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545013|NCT04149405|Diphosphonates|diphosphonates|mesh-list
102545014|NCT04149405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102545015|NCT04149405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545016|NCT00556712|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102545017|NCT00556712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102545018|NCT00556712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102545019|NCT00556712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102545020|NCT00556712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545021|NCT03717051|Nicotine|nicotine|mesh-list
102545022|NCT03717051|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102545023|NCT03717051|Autonomic Agents|autonomic agents|mesh-ancestor
102545024|NCT03717051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102545025|NCT03717051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545026|NCT03717051|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102545027|NCT03717051|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102545028|NCT03717051|Cholinergic Agents|cholinergic agents|mesh-ancestor
102545029|NCT03717051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102545030|NCT03717051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545031|NCT04350320|Colchicine|colchicine|mesh-list
102545032|NCT04350320|Gout Suppressants|gout suppressants|mesh-ancestor
102545033|NCT04350320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102545034|NCT04350320|Tubulin Modulators|tubulin modulators|mesh-ancestor
102545035|NCT04350320|Antimitotic Agents|antimitotic agents|mesh-ancestor
102545036|NCT04350320|Mitosis Modulators|mitosis modulators|mesh-ancestor
102545037|NCT04350320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545038|NCT04350320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102545039|NCT03920865|Risdiplam|risdiplam|mesh-list
102545040|NCT03920865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102545041|NCT03920865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102545042|NCT03920865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545043|NCT00556322|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102545044|NCT00556322|Docetaxel|docetaxel|mesh-list
102545045|NCT00556322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102545046|NCT00556322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102545047|NCT00556322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102545048|NCT00556322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545049|NCT00556322|Tubulin Modulators|tubulin modulators|mesh-ancestor
102545050|NCT00556322|Antimitotic Agents|antimitotic agents|mesh-ancestor
102545051|NCT00556322|Mitosis Modulators|mitosis modulators|mesh-ancestor
102545052|NCT04137627|Melatonin|melatonin|mesh-list
102545053|NCT04137627|Antioxidants|antioxidants|mesh-ancestor
102545054|NCT04137627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545055|NCT04137627|Protective Agents|protective agents|mesh-ancestor
102545056|NCT04137627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545057|NCT04137627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102545058|NCT04136145|Belimumab|belimumab|mesh-list
102545059|NCT04136145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102545060|NCT04136145|Immunologic Factors|immunologic factors|mesh-ancestor
102545061|NCT04136145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545062|NCT01869686|Denosumab|denosumab|mesh-list
102545063|NCT01869686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102545064|NCT01869686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545065|NCT03360890|Docetaxel|docetaxel|mesh-list
102545066|NCT03360890|Pembrolizumab|pembrolizumab|mesh-list
102545067|NCT03360890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102545068|NCT03360890|Tubulin Modulators|tubulin modulators|mesh-ancestor
102545069|NCT03360890|Antimitotic Agents|antimitotic agents|mesh-ancestor
102545070|NCT03360890|Mitosis Modulators|mitosis modulators|mesh-ancestor
102545071|NCT03360890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545072|NCT03360890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102545073|NCT03360890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102545074|NCT03862755|Heparin|heparin|mesh-list
102545075|NCT03862755|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102545076|NCT03862755|Tinzaparin|tinzaparin|mesh-list
102545077|NCT03862755|Dalteparin|dalteparin|mesh-list
102545078|NCT03862755|Anticoagulants|anticoagulants|mesh-ancestor
102545079|NCT03862755|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102545080|NCT03862755|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102545081|NCT03862755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545082|NCT02332590|Adalimumab|adalimumab|mesh-list
102545083|NCT02332590|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102545084|NCT02332590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102545085|NCT02332590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102545086|NCT04076787|Sunitinib|sunitinib|mesh-list
102545087|NCT04076787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102545088|NCT04076787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102545089|NCT04076787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102545090|NCT04076787|Growth Substances|growth substances|mesh-ancestor
102545091|NCT04076787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545092|NCT04076787|Growth Inhibitors|growth inhibitors|mesh-ancestor
102545093|NCT04076787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102545094|NCT04076787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102545095|NCT04076787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545096|NCT00554840|Varenicline|varenicline|mesh-list
102545097|NCT00554840|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102545098|NCT00554840|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102545099|NCT00554840|Cholinergic Agents|cholinergic agents|mesh-ancestor
102545100|NCT00554840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102545101|NCT00554840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545102|NCT00554840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545103|NCT04069221|Cobicistat|cobicistat|mesh-list
102545104|NCT04069221|Artefenomel|artefenomel|mesh-list
102545105|NCT04069221|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102545106|NCT04069221|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102545107|NCT04069221|Antiviral Agents|antiviral agents|mesh-ancestor
102545108|NCT04069221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102545109|NCT04069221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102545110|NCT04069221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102545111|NCT04069221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102545112|NCT04069221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545113|NCT04069221|Antimalarials|antimalarials|mesh-ancestor
102545114|NCT04069221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102545115|NCT04069221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102545116|NCT03054038|Afatinib|afatinib|mesh-list
102545117|NCT03054038|Necitumumab|necitumumab|mesh-list
102545118|NCT03054038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102545119|NCT03054038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102545120|NCT03054038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102545121|NCT03054038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545122|NCT03054038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102545123|NCT02302716|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102545124|NCT02302716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545125|NCT03958071|Pirfenidone|pirfenidone|mesh-list
102545126|NCT03958071|Nintedanib|nintedanib|mesh-list
102545127|NCT03958071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102545128|NCT03958071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102545129|NCT03958071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102545130|NCT03958071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545131|NCT03958071|Analgesics|analgesics|mesh-ancestor
102545132|NCT03958071|Sensory System Agents|sensory system agents|mesh-ancestor
102545133|NCT03958071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102545134|NCT03958071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545135|NCT03958071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102545136|NCT03958071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102545137|NCT03958071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102545138|NCT03958071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102545139|NCT04066647|Dexamethasone|dexamethasone|mesh-list
102545140|NCT04066647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102545141|NCT04066647|Antiemetics|antiemetics|mesh-ancestor
102545142|NCT04066647|Autonomic Agents|autonomic agents|mesh-ancestor
102545143|NCT04066647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102545144|NCT04066647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545145|NCT04066647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102545146|NCT04066647|Glucocorticoids|glucocorticoids|mesh-ancestor
102545147|NCT04066647|Hormones|hormones|mesh-ancestor
102545148|NCT04066647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102545149|NCT04066647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102545150|NCT04066647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102545151|NCT04041453|Ivermectin|ivermectin|mesh-list
102545152|NCT04041453|Albendazole|albendazole|mesh-list
102545153|NCT04041453|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102545154|NCT04041453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102545155|NCT04041453|Anthelmintics|anthelmintics|mesh-ancestor
102545156|NCT04041453|Anticestodal Agents|anticestodal agents|mesh-ancestor
101831878|NCT01409200|Estrogens|estrogens|mesh-ancestor
102545157|NCT04041453|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102545158|NCT04041453|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102545159|NCT04041453|Tubulin Modulators|tubulin modulators|mesh-ancestor
102545161|NCT04041453|Mitosis Modulators|mitosis modulators|mesh-ancestor
102545162|NCT04041453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545163|NCT04041453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102545164|NCT02354508|Pasireotide|pasireotide|mesh-list
102545165|NCT02354508|Hormones|hormones|mesh-ancestor
102545166|NCT02354508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102545167|NCT02354508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545168|NCT00554216|Topiramate|topiramate|mesh-list
102545169|NCT00554216|Phentermine|phentermine|mesh-list
102545170|NCT00554216|Anticonvulsants|anticonvulsants|mesh-ancestor
102545171|NCT00554216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102545172|NCT00554216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545173|NCT00554216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102545174|NCT00554216|Appetite Depressants|appetite depressants|mesh-ancestor
102545175|NCT00554216|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102545176|NCT00554216|Sympathomimetics|sympathomimetics|mesh-ancestor
102545177|NCT00554216|Autonomic Agents|autonomic agents|mesh-ancestor
102545178|NCT00554216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102545179|NCT00554216|Adrenergic Agents|adrenergic agents|mesh-ancestor
102545180|NCT00554216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102545181|NCT00554216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545182|NCT02353572|Dexamethasone|dexamethasone|mesh-list
102545183|NCT02353572|Bortezomib|bortezomib|mesh-list
102545184|NCT02353572|Melphalan|melphalan|mesh-list
102545185|NCT02353572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102545186|NCT02353572|Antiemetics|antiemetics|mesh-ancestor
102545187|NCT02353572|Autonomic Agents|autonomic agents|mesh-ancestor
102545188|NCT02353572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102545189|NCT02353572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545190|NCT02353572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102545191|NCT02353572|Glucocorticoids|glucocorticoids|mesh-ancestor
102545192|NCT02353572|Hormones|hormones|mesh-ancestor
102545193|NCT02353572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102545194|NCT02353572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102545195|NCT02353572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102545196|NCT02353572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102545197|NCT02353572|Alkylating Agents|alkylating agents|mesh-ancestor
102545198|NCT02353572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545199|NCT02353572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102545200|NCT02353572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102545201|NCT02353572|Immunologic Factors|immunologic factors|mesh-ancestor
102545202|NCT03886701|Isoniazid|isoniazid|mesh-list
102545203|NCT03886701|Rifapentine|rifapentine|mesh-list
102545204|NCT03886701|Antitubercular Agents|antitubercular agents|mesh-ancestor
102545205|NCT03886701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102545206|NCT03886701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102545207|NCT03886701|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102545208|NCT03886701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102545209|NCT03886701|Antimetabolites|antimetabolites|mesh-ancestor
102545210|NCT03886701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545211|NCT03886701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102545212|NCT03886701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102545213|NCT03886701|Leprostatic Agents|leprostatic agents|mesh-ancestor
102545214|NCT00552578|Buprenorphine|buprenorphine|mesh-list
102545215|NCT00552578|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102545216|NCT00552578|Naloxone|naloxone|mesh-list
102545217|NCT00552578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102545218|NCT00552578|Narcotics|narcotics|mesh-ancestor
102545219|NCT00552578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102545220|NCT00552578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545221|NCT00552578|Analgesics|analgesics|mesh-ancestor
102545222|NCT00552578|Sensory System Agents|sensory system agents|mesh-ancestor
102545223|NCT00552578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102545224|NCT00552578|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102545225|NCT02301936|Sofosbuvir|sofosbuvir|mesh-list
102545226|NCT02301936|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102545227|NCT02301936|Ledipasvir|ledipasvir|mesh-list
102545228|NCT02301936|Antiviral Agents|antiviral agents|mesh-ancestor
102545229|NCT02301936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102545230|NCT03881163|Acetylcysteine|acetylcysteine|mesh-list
102545231|NCT03881163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102545232|NCT03881163|Antiviral Agents|antiviral agents|mesh-ancestor
102545233|NCT03881163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102545234|NCT03881163|Expectorants|expectorants|mesh-ancestor
102545235|NCT03881163|Respiratory System Agents|respiratory system agents|mesh-ancestor
102545236|NCT03881163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102545237|NCT03881163|Antioxidants|antioxidants|mesh-ancestor
102545238|NCT03881163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545239|NCT03881163|Protective Agents|protective agents|mesh-ancestor
102545240|NCT03881163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545241|NCT03881163|Antidotes|antidotes|mesh-ancestor
102545242|NCT03848871|Betamethasone|betamethasone|mesh-list
102545243|NCT03848871|Betamethasone Valerate|betamethasone valerate|mesh-list
102545244|NCT03848871|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102545245|NCT03848871|Betamethasone benzoate|betamethasone benzoate|mesh-list
102545246|NCT03848871|Calcipotriene|calcipotriene|mesh-list
102545247|NCT03848871|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102545248|NCT03848871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102545249|NCT03848871|Glucocorticoids|glucocorticoids|mesh-ancestor
102545250|NCT03848871|Hormones|hormones|mesh-ancestor
102545251|NCT03848871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102545252|NCT03848871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545253|NCT03848871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102545254|NCT03848871|Respiratory System Agents|respiratory system agents|mesh-ancestor
102545255|NCT03848871|Dermatologic Agents|dermatologic agents|mesh-ancestor
102545256|NCT04032327|Bupivacaine|bupivacaine|mesh-list
102545257|NCT04032327|Anesthetics, Local|anesthetics, local|mesh-ancestor
102545258|NCT04032327|Anesthetics|anesthetics|mesh-ancestor
102545259|NCT04032327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102545260|NCT04032327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545261|NCT04032327|Sensory System Agents|sensory system agents|mesh-ancestor
102545262|NCT04032327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102545263|NCT04041219|Tacrolimus|tacrolimus|mesh-list
102545264|NCT04041219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102545265|NCT04041219|Immunologic Factors|immunologic factors|mesh-ancestor
102545266|NCT04041219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545267|NCT04041219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102545268|NCT04041219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102545269|NCT04041219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545270|NCT00552344|Certolizumab Pegol|certolizumab pegol|mesh-list
102545271|NCT00552344|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102545272|NCT00552344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102545273|NCT00552344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102545274|NCT00552344|Immunologic Factors|immunologic factors|mesh-ancestor
102545275|NCT00552344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545276|NCT00552344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102545277|NCT02814968|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102545278|NCT02814968|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102545279|NCT02814968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545280|NCT03879603|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102545281|NCT03879603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102545282|NCT03879603|Immunologic Factors|immunologic factors|mesh-ancestor
102545283|NCT03879603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545284|NCT03879603|Antacids|antacids|mesh-ancestor
102545285|NCT03879603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545286|NCT03879603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102545287|NCT00553514|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102545288|NCT00553514|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102545289|NCT00553514|Hormones|hormones|mesh-ancestor
102545290|NCT00553514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102545291|NCT00553514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545292|NCT00553514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102545293|NCT02813642|Mitogens|mitogens|mesh-list
102545294|NCT02813642|Mitosis Modulators|mitosis modulators|mesh-ancestor
102545295|NCT02813642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545296|NCT03852537|Methylprednisolone|methylprednisolone|mesh-list
102545297|NCT03852537|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102545298|NCT03852537|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102545299|NCT03852537|Prednisolone|prednisolone|mesh-list
102545300|NCT03852537|Prednisolone acetate|prednisolone acetate|mesh-list
102545301|NCT03852537|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102545302|NCT03852537|Prednisolone phosphate|prednisolone phosphate|mesh-list
102545303|NCT03852537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102545304|NCT03852537|Antiemetics|antiemetics|mesh-ancestor
102545305|NCT03852537|Autonomic Agents|autonomic agents|mesh-ancestor
102545306|NCT03852537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102545307|NCT03852537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545308|NCT03852537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102545309|NCT03852537|Glucocorticoids|glucocorticoids|mesh-ancestor
102545310|NCT03852537|Hormones|hormones|mesh-ancestor
102545311|NCT03852537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102545312|NCT03852537|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102545313|NCT03852537|Protective Agents|protective agents|mesh-ancestor
102545314|NCT03852537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102545315|NCT03852537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102545316|NCT03875859|Benzoic Acid|benzoic acid|mesh-list
102545317|NCT03875859|Antifungal Agents|antifungal agents|mesh-ancestor
102545318|NCT03875859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102545319|NCT00553202|Cyclosporine|cyclosporine|mesh-list
102545320|NCT00553202|Methylprednisolone|methylprednisolone|mesh-list
102545321|NCT00553202|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102545322|NCT00553202|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102545323|NCT00553202|Prednisolone|prednisolone|mesh-list
102545324|NCT00553202|Prednisolone acetate|prednisolone acetate|mesh-list
102545325|NCT00553202|Cyclophosphamide|cyclophosphamide|mesh-list
102545327|NCT00553202|Methotrexate|methotrexate|mesh-list
102545328|NCT00553202|Tacrolimus|tacrolimus|mesh-list
102545329|NCT00553202|Cyclosporins|cyclosporins|mesh-list
102545330|NCT00553202|Thymoglobulin|thymoglobulin|mesh-list
102545331|NCT00553202|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102545332|NCT00553202|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102545333|NCT00553202|Prednisolone phosphate|prednisolone phosphate|mesh-list
102545334|NCT00553202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102545335|NCT00553202|Immunologic Factors|immunologic factors|mesh-ancestor
102545336|NCT00553202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545337|NCT00553202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102545338|NCT00553202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102545339|NCT00553202|Alkylating Agents|alkylating agents|mesh-ancestor
102545340|NCT00553202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545341|NCT00553202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102545342|NCT00553202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102545343|NCT00553202|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102545344|NCT00553202|Abortifacient Agents|abortifacient agents|mesh-ancestor
102545345|NCT00553202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102545346|NCT00553202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102545347|NCT00553202|Antimetabolites|antimetabolites|mesh-ancestor
102545348|NCT00553202|Dermatologic Agents|dermatologic agents|mesh-ancestor
102545349|NCT00553202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102545350|NCT00553202|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102545351|NCT00553202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102545352|NCT00553202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102545353|NCT00553202|Antifungal Agents|antifungal agents|mesh-ancestor
102545354|NCT00553202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101765351|NCT00880815|Antimetabolites|antimetabolites|mesh-ancestor
102545355|NCT00553202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102545356|NCT00553202|Antiemetics|antiemetics|mesh-ancestor
102545357|NCT00553202|Autonomic Agents|autonomic agents|mesh-ancestor
102545358|NCT00553202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102545359|NCT00553202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102545360|NCT00553202|Glucocorticoids|glucocorticoids|mesh-ancestor
102545361|NCT00553202|Hormones|hormones|mesh-ancestor
102545362|NCT00553202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102545363|NCT00553202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102545364|NCT00553202|Protective Agents|protective agents|mesh-ancestor
102545365|NCT00553202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102545366|NCT00552188|Atreleuton|atreleuton|mesh-list
102545367|NCT00552188|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
102545368|NCT00552188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102545369|NCT00552188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545370|NCT00377793|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
102545371|NCT00377793|Vasodilator Agents|vasodilator agents|mesh-ancestor
102545372|NCT00377793|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102545373|NCT00377793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102545374|NCT00377793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102545375|NCT00377793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545376|NCT00377793|Urological Agents|urological agents|mesh-ancestor
102545377|NCT04027803|Eculizumab|eculizumab|mesh-list
102545378|NCT04027803|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102545379|NCT04027803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102545380|NCT04027803|Immunologic Factors|immunologic factors|mesh-ancestor
102545381|NCT04027803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545382|NCT00552110|Mometasone Furoate|mometasone furoate|mesh-list
102545383|NCT00552110|Phenylephrine|phenylephrine|mesh-list
102545384|NCT00552110|Oxymetazoline|oxymetazoline|mesh-list
102545385|NCT00552110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102545386|NCT00552110|Dermatologic Agents|dermatologic agents|mesh-ancestor
102545388|NCT00552110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102545389|NCT00552110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102545390|NCT00552110|Adrenergic Agents|adrenergic agents|mesh-ancestor
102545391|NCT00552110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102545392|NCT00552110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545393|NCT00552110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545394|NCT00552110|Sympathomimetics|sympathomimetics|mesh-ancestor
102545395|NCT00552110|Autonomic Agents|autonomic agents|mesh-ancestor
102545396|NCT00552110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102545397|NCT00552110|Nasal Decongestants|nasal decongestants|mesh-ancestor
102545398|NCT00552110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102545399|NCT00552110|Respiratory System Agents|respiratory system agents|mesh-ancestor
102545400|NCT00552110|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102545401|NCT00552110|Mydriatics|mydriatics|mesh-ancestor
102545402|NCT00552110|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102545403|NCT00552110|Protective Agents|protective agents|mesh-ancestor
102545404|NCT02301624|Eculizumab|eculizumab|mesh-list
102545405|NCT02301624|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102545406|NCT02301624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102545407|NCT02301624|Immunologic Factors|immunologic factors|mesh-ancestor
102545408|NCT02301624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545409|NCT02007122|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
102545410|NCT02007122|Cephalosporins|cephalosporins|mesh-list
102545411|NCT02007122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102545412|NCT02007122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102545413|NCT03250520|Titanium dioxide|titanium dioxide|mesh-list
102545414|NCT03250520|Sunscreening Agents|sunscreening agents|mesh-ancestor
102545415|NCT03250520|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102545416|NCT03250520|Protective Agents|protective agents|mesh-ancestor
102545417|NCT03250520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545418|NCT03250520|Dermatologic Agents|dermatologic agents|mesh-ancestor
102545419|NCT03250520|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102545420|NCT03847389|Clobetasol|clobetasol|mesh-list
102545421|NCT03847389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102545422|NCT03847389|Glucocorticoids|glucocorticoids|mesh-ancestor
102545423|NCT03847389|Hormones|hormones|mesh-ancestor
102545424|NCT03847389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102545425|NCT03847389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545426|NCT02351934|Celecoxib|celecoxib|mesh-list
102545427|NCT02351934|Furosemide|furosemide|mesh-list
102545428|NCT02351934|Gabapentin|gabapentin|mesh-list
102545429|NCT02351934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102545430|NCT02351934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102545431|NCT02351934|Analgesics|analgesics|mesh-ancestor
102545432|NCT02351934|Sensory System Agents|sensory system agents|mesh-ancestor
102545433|NCT02351934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102545434|NCT02351934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545435|NCT02351934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102545436|NCT02351934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102545437|NCT02351934|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102545438|NCT02351934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102545439|NCT02351934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102545440|NCT02351934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545441|NCT02351934|Anticonvulsants|anticonvulsants|mesh-ancestor
102545442|NCT02351934|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102545443|NCT02351934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102545444|NCT02351934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102545445|NCT02351934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102545446|NCT02351934|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102545447|NCT02351934|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102545448|NCT02351934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102545449|NCT02351934|Antimanic Agents|antimanic agents|mesh-ancestor
102545450|NCT02351934|Diuretics|diuretics|mesh-ancestor
102545451|NCT02351934|Natriuretic Agents|natriuretic agents|mesh-ancestor
102545452|NCT02351934|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102545453|NCT02351934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102545454|NCT00377481|Darbepoetin alfa|darbepoetin alfa|mesh-list
102545455|NCT00377481|Hematinics|hematinics|mesh-ancestor
102545456|NCT00377559|Docetaxel|docetaxel|mesh-list
102545457|NCT00377559|Doxorubicin|doxorubicin|mesh-list
102545458|NCT00377559|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102545459|NCT00377559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102545460|NCT00377559|Tubulin Modulators|tubulin modulators|mesh-ancestor
102545461|NCT00377559|Antimitotic Agents|antimitotic agents|mesh-ancestor
102545462|NCT00377559|Mitosis Modulators|mitosis modulators|mesh-ancestor
102545463|NCT00377559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545464|NCT00377559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102545465|NCT00377559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102545466|NCT00377559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102545467|NCT00377559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102545468|NCT03026348|Aluminum phosphate|aluminum phosphate|mesh-list
102545470|NCT03026348|Immunologic Factors|immunologic factors|mesh-ancestor
102545471|NCT03026348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545472|NCT03026348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102545473|NCT03026348|Antacids|antacids|mesh-ancestor
102545474|NCT03026348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545475|NCT03026348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102545476|NCT04763408|Sorafenib|sorafenib|mesh-list
102545477|NCT04763408|Lenvatinib|lenvatinib|mesh-list
102545478|NCT04763408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102545479|NCT04763408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102545480|NCT04763408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102545481|NCT04763408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545482|NCT03825939|Tranexamic Acid|tranexamic acid|mesh-list
102545483|NCT03825939|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102545484|NCT03825939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102545485|NCT03825939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545486|NCT03825939|Hemostatics|hemostatics|mesh-ancestor
102545487|NCT03825939|Coagulants|coagulants|mesh-ancestor
102545488|NCT03988647|Pembrolizumab|pembrolizumab|mesh-list
102545489|NCT03988647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102545490|NCT03988647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102545491|NCT03988647|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102545492|NCT03988647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545493|NCT00551642|Nitric Oxide|nitric oxide|mesh-list
102545494|NCT00551642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102545495|NCT00551642|Autonomic Agents|autonomic agents|mesh-ancestor
102545496|NCT00551642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102545497|NCT00551642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545498|NCT00551642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102545499|NCT00551642|Respiratory System Agents|respiratory system agents|mesh-ancestor
102545500|NCT00551642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102545501|NCT00551642|Antioxidants|antioxidants|mesh-ancestor
102545502|NCT00551642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545503|NCT00551642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102545504|NCT00551642|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102545505|NCT00551642|Vasodilator Agents|vasodilator agents|mesh-ancestor
102545506|NCT00551642|Gasotransmitters|gasotransmitters|mesh-ancestor
102545507|NCT00551642|Protective Agents|protective agents|mesh-ancestor
102545508|NCT02799212|Somatostatin|somatostatin|mesh-list
102545509|NCT02799212|Hormones|hormones|mesh-ancestor
102545510|NCT02799212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102545511|NCT02799212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545512|NCT04690322|Factor VIII|factor viii|mesh-list
102545513|NCT04690322|BAX 855|bax 855|mesh-list
102545514|NCT04690322|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102545515|NCT04690322|Coagulants|coagulants|mesh-ancestor
102545516|NCT04690322|Immunologic Factors|immunologic factors|mesh-ancestor
102545517|NCT04690322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545518|NCT02648282|Cyclophosphamide|cyclophosphamide|mesh-list
102545519|NCT02648282|Pembrolizumab|pembrolizumab|mesh-list
102545520|NCT02648282|Vaccines|vaccines|mesh-list
102545521|NCT02648282|Immunologic Factors|immunologic factors|mesh-ancestor
102545522|NCT02648282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545523|NCT02648282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102545524|NCT02648282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102545525|NCT02648282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102545526|NCT02648282|Alkylating Agents|alkylating agents|mesh-ancestor
102545527|NCT02648282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545528|NCT02648282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102545529|NCT02648282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102545530|NCT02648282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102545531|NCT02648282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102545532|NCT04004481|Morphine|morphine|mesh-list
102545533|NCT04004481|Tramadol|tramadol|mesh-list
102545534|NCT04004481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102545535|NCT04004481|Narcotics|narcotics|mesh-ancestor
102545536|NCT04004481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102545537|NCT04004481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154146|NCT00353938|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
102545539|NCT04004481|Sensory System Agents|sensory system agents|mesh-ancestor
102545540|NCT04004481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102545541|NCT03997851|Acetaminophen|acetaminophen|mesh-list
102545542|NCT03997851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102545543|NCT03997851|Analgesics|analgesics|mesh-ancestor
102545544|NCT03997851|Sensory System Agents|sensory system agents|mesh-ancestor
102545545|NCT03997851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102545546|NCT03997851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545547|NCT03997851|Antipyretics|antipyretics|mesh-ancestor
102545548|NCT03989427|Listerine|listerine|mesh-list
102545549|NCT03989427|Sodium Fluoride|sodium fluoride|mesh-list
102545550|NCT03989427|Cariostatic Agents|cariostatic agents|mesh-ancestor
102545551|NCT03989427|Protective Agents|protective agents|mesh-ancestor
102545552|NCT03989427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545553|NCT03989427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102545554|NCT03989427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102545555|NCT03007719|Fluorides|fluorides|mesh-list
102545556|NCT03007719|Cariostatic Agents|cariostatic agents|mesh-ancestor
102545557|NCT03007719|Protective Agents|protective agents|mesh-ancestor
102545558|NCT03007719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545559|NCT02985801|Pancrelipase|pancrelipase|mesh-list
102545560|NCT02985801|Pancreatin|pancreatin|mesh-list
102545561|NCT02985801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102545562|NCT02988362|Amlodipine|amlodipine|mesh-list
102545563|NCT02988362|Candesartan|candesartan|mesh-list
102545564|NCT02988362|Candesartan cilexetil|candesartan cilexetil|mesh-list
102545565|NCT02988362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102545566|NCT02988362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102545567|NCT02988362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101765552|NCT00547300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102545568|NCT02988362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545569|NCT02988362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102545570|NCT02988362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545571|NCT02988362|Vasodilator Agents|vasodilator agents|mesh-ancestor
102545572|NCT02988362|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102545573|NCT02988362|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102545574|NCT02988440|Sorafenib|sorafenib|mesh-list
102545575|NCT02988440|Spartalizumab|spartalizumab|mesh-list
102545576|NCT02988440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102545577|NCT02988440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102545578|NCT02988440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102545579|NCT02988440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545580|NCT02988440|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102545581|NCT02988440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102545582|NCT05405192|Dostarlimab|dostarlimab|mesh-list
102545583|NCT05405192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102545584|NCT00550550|Fluticasone|fluticasone|mesh-list
102545585|NCT00550550|Mometasone Furoate|mometasone furoate|mesh-list
102545586|NCT00550550|Loratadine|loratadine|mesh-list
102545587|NCT00550550|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
102545588|NCT00550550|Prednisone|prednisone|mesh-list
102545589|NCT00550550|Albuterol|albuterol|mesh-list
102545590|NCT00550550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102545591|NCT00550550|Glucocorticoids|glucocorticoids|mesh-ancestor
102545592|NCT00550550|Hormones|hormones|mesh-ancestor
102545593|NCT00550550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102545594|NCT00550550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545595|NCT00550550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102545596|NCT00550550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102545597|NCT00550550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102545598|NCT00550550|Autonomic Agents|autonomic agents|mesh-ancestor
102545599|NCT00550550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102545600|NCT00550550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102545601|NCT00550550|Respiratory System Agents|respiratory system agents|mesh-ancestor
102545602|NCT00550550|Dermatologic Agents|dermatologic agents|mesh-ancestor
102545603|NCT00550550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102545604|NCT00550550|Tocolytic Agents|tocolytic agents|mesh-ancestor
102545605|NCT00550550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102545606|NCT00550550|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102545607|NCT00550550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102545608|NCT00550550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102545609|NCT00550550|Adrenergic Agents|adrenergic agents|mesh-ancestor
102545610|NCT00550550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102545611|NCT00550550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545612|NCT00550550|Antipruritics|antipruritics|mesh-ancestor
102545613|NCT00550550|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102545614|NCT00550550|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102545615|NCT00550550|Histamine Antagonists|histamine antagonists|mesh-ancestor
102545616|NCT00550550|Histamine Agents|histamine agents|mesh-ancestor
102545617|NCT00550550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102545618|NCT00550550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102545620|NCT00550550|Sensory System Agents|sensory system agents|mesh-ancestor
102545621|NCT00550550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102545622|NCT01590680|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
102545623|NCT01590680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102545624|NCT01590680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102545625|NCT01590680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545626|NCT01590680|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102545627|NCT02971839|Ivacaftor|ivacaftor|mesh-list
102545628|NCT02971839|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102545629|NCT02971839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102545630|NCT02971839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545631|NCT02974803|Trametinib|trametinib|mesh-list
102545632|NCT02974803|Dabrafenib|dabrafenib|mesh-list
102545633|NCT02974803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102545634|NCT02974803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102545635|NCT02974803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102545636|NCT02974803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545637|NCT02281136|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102545638|NCT02281136|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102545639|NCT02281136|Dermatologic Agents|dermatologic agents|mesh-ancestor
102545640|NCT00558038|Lactulose|lactulose|mesh-list
102545641|NCT00558038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102545642|NCT01507233|Morphine|morphine|mesh-list
102545643|NCT01507233|Bupivacaine|bupivacaine|mesh-list
102545644|NCT01507233|Anesthetics, Local|anesthetics, local|mesh-ancestor
102545645|NCT01507233|Anesthetics|anesthetics|mesh-ancestor
102545646|NCT01507233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102545647|NCT01507233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545648|NCT01507233|Sensory System Agents|sensory system agents|mesh-ancestor
102545649|NCT01507233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102545650|NCT01507233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102545651|NCT01507233|Narcotics|narcotics|mesh-ancestor
102545652|NCT01507233|Analgesics|analgesics|mesh-ancestor
102545653|NCT02301390|Amiodarone|amiodarone|mesh-list
102545654|NCT02301390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102545655|NCT02301390|Vasodilator Agents|vasodilator agents|mesh-ancestor
102545656|NCT02301390|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102545657|NCT02301390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102545658|NCT02301390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545659|NCT02301390|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102545660|NCT02301390|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102545661|NCT02301390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102545662|NCT02301390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102545663|NCT02301390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102545664|NCT02301390|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102545665|NCT02301390|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102545666|NCT02278562|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102545667|NCT02278562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102545668|NCT00378417|Vaccines|vaccines|mesh-list
102545669|NCT00378417|Immunologic Factors|immunologic factors|mesh-ancestor
102545670|NCT00378417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545671|NCT01487499|Cisplatin|cisplatin|mesh-list
102545672|NCT01487499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102545673|NCT01483209|Botulinum Toxins|botulinum toxins|mesh-list
102545674|NCT01483209|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102545675|NCT01483209|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102545676|NCT01483209|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102545677|NCT01483209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102545678|NCT01483209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545679|NCT01483209|Cholinergic Agents|cholinergic agents|mesh-ancestor
102545680|NCT01483209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102545681|NCT01483209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545682|NCT01483209|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102545683|NCT01483209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102545684|NCT02281448|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102545685|NCT02281448|Contraceptive Agents|contraceptive agents|mesh-list
102545686|NCT02281448|Contraceptives, Oral|contraceptives, oral|mesh-list
102545687|NCT02281448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
102545688|NCT02281448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102545689|NCT02281448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545690|NCT02281448|Anticonvulsants|anticonvulsants|mesh-ancestor
102545691|NCT02281448|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102545692|NCT02281448|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102545693|NCT02281448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101765697|NCT04722718|Antimitotic Agents|antimitotic agents|mesh-ancestor
102545694|NCT02281448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545695|NCT02281448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102545696|NCT00378729|Metformin|metformin|mesh-list
102545697|NCT00378729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102545698|NCT00378729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545699|NCT00378495|Miltefosine|miltefosine|mesh-list
102545700|NCT00378495|Antifungal Agents|antifungal agents|mesh-ancestor
102545701|NCT00378495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102545702|NCT00378495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102545703|NCT00378495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102545704|NCT00378495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102545705|NCT02281526|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102545706|NCT02281526|Anticonvulsants|anticonvulsants|mesh-ancestor
102545707|NCT02281526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102545708|NCT02281526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102545709|NCT02281526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102545710|NCT02281526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545711|NCT03802227|Oxycodone|oxycodone|mesh-list
102545712|NCT03802227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102545713|NCT03802227|Narcotics|narcotics|mesh-ancestor
102545714|NCT03802227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102545715|NCT03802227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545716|NCT03802227|Analgesics|analgesics|mesh-ancestor
102545717|NCT03802227|Sensory System Agents|sensory system agents|mesh-ancestor
102545718|NCT03802227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102545719|NCT02749617|Apixaban|apixaban|mesh-list
102545720|NCT02749617|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102545721|NCT02749617|Antithrombins|antithrombins|mesh-ancestor
102545722|NCT02749617|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102545723|NCT02749617|Protease Inhibitors|protease inhibitors|mesh-ancestor
102545724|NCT02749617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102545725|NCT02749617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545726|NCT02749617|Anticoagulants|anticoagulants|mesh-ancestor
102545727|NCT02749227|Pasireotide|pasireotide|mesh-list
102545728|NCT02749227|Hormones|hormones|mesh-ancestor
102545729|NCT02749227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102545730|NCT02749227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545731|NCT02746263|Acetaminophen|acetaminophen|mesh-list
102545732|NCT02746263|Morphine|morphine|mesh-list
102545733|NCT02746263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102545734|NCT02746263|Narcotics|narcotics|mesh-ancestor
102545735|NCT02746263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102545736|NCT02746263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545737|NCT02746263|Analgesics|analgesics|mesh-ancestor
102545738|NCT02746263|Sensory System Agents|sensory system agents|mesh-ancestor
102545739|NCT02746263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102545740|NCT02746263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102545741|NCT02746263|Antipyretics|antipyretics|mesh-ancestor
102545742|NCT01394211|Anastrozole|anastrozole|mesh-list
102545743|NCT01394211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102545744|NCT01394211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102545745|NCT01394211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102545746|NCT01394211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102545747|NCT01394211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102545748|NCT01394211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545749|NCT01394211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102545750|NCT01394211|Hormone Antagonists|hormone antagonists|mesh-ancestor
102545751|NCT01394211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102545752|NCT01394211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545753|NCT02717949|Ribavirin|ribavirin|mesh-list
102545754|NCT02717949|Sofosbuvir|sofosbuvir|mesh-list
102545755|NCT02717949|Ledipasvir|ledipasvir|mesh-list
101765755|NCT00963976|Enalapril|enalapril|mesh-list
102545756|NCT02717949|Antimetabolites|antimetabolites|mesh-ancestor
102545757|NCT02717949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545758|NCT02717949|Antiviral Agents|antiviral agents|mesh-ancestor
102545759|NCT02717949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102545760|NCT02300610|Cisplatin|cisplatin|mesh-list
102545761|NCT02300610|Gemcitabine|gemcitabine|mesh-list
102154147|NCT00353938|Hallucinogens|hallucinogens|mesh-ancestor
102545762|NCT02300610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102545763|NCT02300610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102545764|NCT02300610|Antimetabolites|antimetabolites|mesh-ancestor
102545765|NCT02300610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545767|NCT01880840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102545768|NCT01880840|Autonomic Agents|autonomic agents|mesh-ancestor
102545769|NCT01880840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102545770|NCT01880840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545771|NCT01880840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102545772|NCT01880840|Respiratory System Agents|respiratory system agents|mesh-ancestor
102545773|NCT01880840|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
102545774|NCT01880840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102545775|NCT01880840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545776|NCT01880840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102545777|NCT01880840|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102545778|NCT01880840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102545779|NCT01880840|Histamine Antagonists|histamine antagonists|mesh-ancestor
102545780|NCT01880840|Histamine Agents|histamine agents|mesh-ancestor
102545781|NCT01880840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102545782|NCT01377441|Ibuprofen|ibuprofen|mesh-list
102545783|NCT01377441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
102545784|NCT01377441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102545785|NCT01377441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102545786|NCT01377441|Analgesics|analgesics|mesh-ancestor
102545787|NCT01377441|Sensory System Agents|sensory system agents|mesh-ancestor
102545788|NCT01377441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102545789|NCT01377441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545790|NCT01377441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102545791|NCT01377441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102545792|NCT01377441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102545793|NCT01377441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545794|NCT01882868|Leucovorin|leucovorin|mesh-list
102545795|NCT01882868|Irinotecan|irinotecan|mesh-list
102545796|NCT01882868|Aflibercept|aflibercept|mesh-list
102545797|NCT01882868|Levoleucovorin|levoleucovorin|mesh-list
102545798|NCT01882868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102545799|NCT01882868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102545800|NCT01882868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102545801|NCT01882868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545802|NCT01882868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102545803|NCT01882868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102545804|NCT01882868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102545805|NCT01882868|Growth Substances|growth substances|mesh-ancestor
102545806|NCT01882868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545807|NCT01882868|Growth Inhibitors|growth inhibitors|mesh-ancestor
102545808|NCT01882868|Antidotes|antidotes|mesh-ancestor
102545809|NCT01882868|Protective Agents|protective agents|mesh-ancestor
102545810|NCT01882868|Vitamin B Complex|vitamin b complex|mesh-ancestor
102545811|NCT01882868|Vitamins|vitamins|mesh-ancestor
102545812|NCT01882868|Micronutrients|micronutrients|mesh-ancestor
102545813|NCT01383447|Imatinib Mesylate|imatinib mesylate|mesh-list
102545814|NCT01383447|Entinostat|entinostat|mesh-list
102545815|NCT01383447|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
102545816|NCT01383447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102545817|NCT01383447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102545818|NCT01383447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102545819|NCT01383447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545820|NCT02300298|Docetaxel|docetaxel|mesh-list
102545821|NCT02300298|Nintedanib|nintedanib|mesh-list
102545822|NCT02300298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102545823|NCT02300298|Tubulin Modulators|tubulin modulators|mesh-ancestor
102545824|NCT02300298|Antimitotic Agents|antimitotic agents|mesh-ancestor
102545825|NCT02300298|Mitosis Modulators|mitosis modulators|mesh-ancestor
102545826|NCT02300298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545827|NCT02300298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102545828|NCT02300298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102545829|NCT02300220|Ciprofloxacin|ciprofloxacin|mesh-list
102545830|NCT02300220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102545831|NCT02300220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102545832|NCT02300220|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102545833|NCT02300220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102545834|NCT02300220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102545835|NCT02300220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545836|NCT02300220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102545837|NCT02300220|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102545838|NCT02300220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102545840|NCT01379469|Anticonvulsants|anticonvulsants|mesh-ancestor
102545841|NCT01379469|Antimanic Agents|antimanic agents|mesh-ancestor
102545842|NCT01379469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102545843|NCT01379469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102545844|NCT01379469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545845|NCT01379469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102545846|NCT01379469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102545847|NCT01379469|Analgesics|analgesics|mesh-ancestor
102545848|NCT01379469|Sensory System Agents|sensory system agents|mesh-ancestor
102545849|NCT01379469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102545850|NCT01379469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102545851|NCT01379469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102545852|NCT01379469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545853|NCT01379469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102545854|NCT01379469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102545855|NCT01309581|Ketamine|ketamine|mesh-list
102545856|NCT01309581|Methohexital|methohexital|mesh-list
102545857|NCT01309581|Analgesics|analgesics|mesh-ancestor
102545858|NCT01309581|Sensory System Agents|sensory system agents|mesh-ancestor
102545859|NCT01309581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102545860|NCT01309581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545861|NCT01309581|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102545862|NCT01309581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102545863|NCT01309581|Anesthetics, General|anesthetics, general|mesh-ancestor
102545864|NCT01309581|Anesthetics|anesthetics|mesh-ancestor
102545865|NCT01309581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102545866|NCT01309581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102545867|NCT01309581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102545868|NCT01309581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102545869|NCT01309581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545870|NCT05289050|Ketamine|ketamine|mesh-list
102545871|NCT05289050|Esketamine|esketamine|mesh-list
102545872|NCT05289050|Analgesics|analgesics|mesh-ancestor
102545873|NCT05289050|Sensory System Agents|sensory system agents|mesh-ancestor
102545874|NCT05289050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102545875|NCT05289050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545876|NCT05289050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102545877|NCT05289050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102545878|NCT05289050|Anesthetics, General|anesthetics, general|mesh-ancestor
102545879|NCT05289050|Anesthetics|anesthetics|mesh-ancestor
102545880|NCT05289050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102545881|NCT05289050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102545882|NCT05289050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102545883|NCT05289050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102545884|NCT05289050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545885|NCT05289050|Antidepressive Agents|antidepressive agents|mesh-ancestor
102545886|NCT05289050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102545887|NCT02987738|Dapagliflozin|dapagliflozin|mesh-list
102545888|NCT02987738|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102545889|NCT02987738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545890|NCT02987738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102545891|NCT02987738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545892|NCT01292265|Certolizumab Pegol|certolizumab pegol|mesh-list
102545893|NCT01292265|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102545894|NCT01292265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102545895|NCT01292265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102545896|NCT01292265|Immunologic Factors|immunologic factors|mesh-ancestor
102545897|NCT01292265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545898|NCT01292265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102545899|NCT01885910|Doxycycline|doxycycline|mesh-list
102545900|NCT01885910|Dapsone|dapsone|mesh-list
102545901|NCT01885910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102545902|NCT01885910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102545903|NCT01885910|Antimalarials|antimalarials|mesh-ancestor
102545904|NCT01885910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102545905|NCT01885910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102545906|NCT01885910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102545907|NCT01885910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102545908|NCT01885910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154148|NCT00353938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545909|NCT01885910|Leprostatic Agents|leprostatic agents|mesh-ancestor
102545910|NCT02658357|Risperidone|risperidone|mesh-list
102545911|NCT02658357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102545912|NCT02658357|Serotonin Agents|serotonin agents|mesh-ancestor
102545913|NCT02658357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102545914|NCT02658357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545915|NCT02658357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545916|NCT02658357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102545917|NCT02658357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102545918|NCT02658357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102545919|NCT02658357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102545920|NCT02658357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102545921|NCT02658357|Dopamine Agents|dopamine agents|mesh-ancestor
102545922|NCT02988908|Donepezil|donepezil|mesh-list
102545923|NCT02988908|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102545924|NCT02988908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102545925|NCT02988908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545926|NCT02988908|Cholinergic Agents|cholinergic agents|mesh-ancestor
102545927|NCT02988908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102545928|NCT02988908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545929|NCT02988908|Nootropic Agents|nootropic agents|mesh-ancestor
102545930|NCT02326272|Certolizumab Pegol|certolizumab pegol|mesh-list
102545931|NCT02326272|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102545932|NCT02326272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102545933|NCT02326272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102545934|NCT02326272|Immunologic Factors|immunologic factors|mesh-ancestor
102545935|NCT02326272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545936|NCT02326272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102545937|NCT02325414|Zoledronic Acid|zoledronic acid|mesh-list
102545938|NCT02325414|Diphosphonates|diphosphonates|mesh-list
102545939|NCT02325414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102545940|NCT02325414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545941|NCT02349048|Sofosbuvir|sofosbuvir|mesh-list
102545942|NCT02349048|Simeprevir|simeprevir|mesh-list
102545943|NCT02349048|Antiviral Agents|antiviral agents|mesh-ancestor
102545944|NCT02349048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102545945|NCT02349048|Protease Inhibitors|protease inhibitors|mesh-ancestor
102545946|NCT02349048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102545947|NCT02349048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545948|NCT01280643|Leucovorin|leucovorin|mesh-list
102545949|NCT01280643|Bevacizumab|bevacizumab|mesh-list
102545950|NCT01280643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102545951|NCT01280643|Cetuximab|cetuximab|mesh-list
102545952|NCT01280643|Fluorouracil|fluorouracil|mesh-list
102545953|NCT01280643|Capecitabine|capecitabine|mesh-list
102545954|NCT01280643|Oxaliplatin|oxaliplatin|mesh-list
102545955|NCT01280643|Irinotecan|irinotecan|mesh-list
102545956|NCT01280643|Antibodies|antibodies|mesh-list
102545957|NCT01280643|Immunoglobulins|immunoglobulins|mesh-list
102545958|NCT01280643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102545959|NCT01280643|Levoleucovorin|levoleucovorin|mesh-list
102545960|NCT01280643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102545961|NCT01280643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102545962|NCT01280643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102545963|NCT01280643|Growth Substances|growth substances|mesh-ancestor
102545964|NCT01280643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545965|NCT01280643|Growth Inhibitors|growth inhibitors|mesh-ancestor
102545966|NCT01280643|Immunologic Factors|immunologic factors|mesh-ancestor
102545967|NCT01280643|Antimetabolites|antimetabolites|mesh-ancestor
102545968|NCT01280643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545969|NCT01280643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102545970|NCT01280643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102545971|NCT01280643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102545972|NCT01280643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102545973|NCT01280643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102545974|NCT01280643|Antidotes|antidotes|mesh-ancestor
102545975|NCT01280643|Protective Agents|protective agents|mesh-ancestor
102545976|NCT01280643|Vitamin B Complex|vitamin b complex|mesh-ancestor
102545977|NCT01280643|Vitamins|vitamins|mesh-ancestor
102545978|NCT01280643|Micronutrients|micronutrients|mesh-ancestor
102545979|NCT01888952|Prednisone|prednisone|mesh-list
102545980|NCT01888952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102545981|NCT01888952|Glucocorticoids|glucocorticoids|mesh-ancestor
102545982|NCT01888952|Hormones|hormones|mesh-ancestor
102545983|NCT01888952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102545984|NCT01888952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545985|NCT01888952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102545986|NCT01888952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102545988|NCT02299206|Dermatologic Agents|dermatologic agents|mesh-ancestor
102545989|NCT02299206|Sunscreening Agents|sunscreening agents|mesh-ancestor
102545990|NCT02299206|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102545991|NCT02299206|Protective Agents|protective agents|mesh-ancestor
102545992|NCT02299206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102545993|NCT02640573|Hydroxyurea|hydroxyurea|mesh-list
102545994|NCT02640573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102545995|NCT02640573|Antisickling Agents|antisickling agents|mesh-ancestor
102545996|NCT02640573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102545997|NCT02640573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102545998|NCT02640573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102545999|NCT02298192|Liraglutide|liraglutide|mesh-list
102546000|NCT02298192|Xultophy|xultophy|mesh-list
102546001|NCT02298192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102546002|NCT02298192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546003|NCT02298192|Incretins|incretins|mesh-ancestor
102546004|NCT02298192|Hormones|hormones|mesh-ancestor
102546005|NCT02298192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102546006|NCT01893632|Gabapentin|gabapentin|mesh-list
102546007|NCT01893632|Analgesics|analgesics|mesh-ancestor
102546008|NCT01893632|Sensory System Agents|sensory system agents|mesh-ancestor
102546009|NCT01893632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102546010|NCT01893632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546011|NCT01893632|Anticonvulsants|anticonvulsants|mesh-ancestor
102546012|NCT01893632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102546013|NCT01893632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102546014|NCT01893632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102546015|NCT01893632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102546016|NCT01893632|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102546017|NCT01893632|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102546018|NCT01893632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102546019|NCT01893632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546020|NCT01893632|Antimanic Agents|antimanic agents|mesh-ancestor
102546021|NCT01272141|Everolimus|everolimus|mesh-list
102546022|NCT01272141|Lapatinib|lapatinib|mesh-list
102546023|NCT01272141|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102546024|NCT01272141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102546025|NCT01272141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102546026|NCT01272141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546027|NCT01272141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102546028|NCT01272141|Immunologic Factors|immunologic factors|mesh-ancestor
102546029|NCT01272141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546030|NCT01272141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102546031|NCT01895036|Naltrexone|naltrexone|mesh-list
102546032|NCT01895036|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102546033|NCT01895036|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102546034|NCT01895036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546035|NCT01895036|Sensory System Agents|sensory system agents|mesh-ancestor
102546036|NCT01895036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102546037|NCT03781479|Amifampridine|amifampridine|mesh-list
102546038|NCT03781479|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102546039|NCT03781479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102546040|NCT03781479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546041|NCT03781479|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102546042|NCT03781479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102546043|NCT03781479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546044|NCT01223001|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102546045|NCT01223001|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102546046|NCT01223001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102546047|NCT01223001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102546048|NCT01223001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546049|NCT01223001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102546050|NCT01223001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546051|NCT01223001|Analgesics|analgesics|mesh-ancestor
102546052|NCT01223001|Sensory System Agents|sensory system agents|mesh-ancestor
102546053|NCT01223001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102546054|NCT01223001|Antidepressive Agents|antidepressive agents|mesh-ancestor
102546055|NCT01223001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102546056|NCT01223001|Dopamine Agents|dopamine agents|mesh-ancestor
102546057|NCT02608905|Dapagliflozin|dapagliflozin|mesh-list
102546058|NCT02608905|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102154149|NCT00353938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102546059|NCT02608905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546060|NCT02608905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102546061|NCT02608905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546062|NCT01213329|Alemtuzumab|alemtuzumab|mesh-list
102546063|NCT01213329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102546064|NCT01213329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102546065|NCT03964532|Avelumab|avelumab|mesh-list
102546066|NCT03964532|Talazoparib|talazoparib|mesh-list
102546067|NCT03964532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102546068|NCT03964532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102546069|NCT03964532|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102546070|NCT03964532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102546071|NCT03964532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546072|NCT01189071|Darifenacin|darifenacin|mesh-list
102546073|NCT01189071|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102546074|NCT01189071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102546075|NCT01189071|Cholinergic Agents|cholinergic agents|mesh-ancestor
102546076|NCT01189071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102546077|NCT01189071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546078|NCT01189071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546079|NCT01189071|Urological Agents|urological agents|mesh-ancestor
102546080|NCT02515851|Bupivacaine|bupivacaine|mesh-list
102546081|NCT02515851|Anesthetics, Local|anesthetics, local|mesh-ancestor
102546082|NCT02515851|Anesthetics|anesthetics|mesh-ancestor
102546083|NCT02515851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102546084|NCT02515851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546085|NCT02515851|Sensory System Agents|sensory system agents|mesh-ancestor
102546086|NCT02515851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102546087|NCT02492295|Propofol|propofol|mesh-list
102546088|NCT02492295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102546089|NCT02492295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102546090|NCT02492295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546091|NCT02492295|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102546092|NCT02492295|Anesthetics, General|anesthetics, general|mesh-ancestor
102546093|NCT02492295|Anesthetics|anesthetics|mesh-ancestor
102546094|NCT02468583|Triamcinolone|triamcinolone|mesh-list
102546095|NCT02468583|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102546096|NCT02468583|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102546097|NCT02468583|FX006|fx006|mesh-list
102546098|NCT02468583|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102546099|NCT02468583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102546100|NCT02468583|Glucocorticoids|glucocorticoids|mesh-ancestor
102546101|NCT02468583|Hormones|hormones|mesh-ancestor
102546102|NCT02468583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102546103|NCT02468583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546104|NCT02468583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102546105|NCT02468583|Immunologic Factors|immunologic factors|mesh-ancestor
102546106|NCT02468583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102546107|NCT02468583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546108|NCT03763929|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
102546109|NCT03763929|Antioxidants|antioxidants|mesh-ancestor
102546110|NCT03763929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546111|NCT03763929|Protective Agents|protective agents|mesh-ancestor
102546112|NCT03763929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546113|NCT03763929|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102546114|NCT03763929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102546115|NCT01118013|Mycophenolic Acid|mycophenolic acid|mesh-list
102546116|NCT01118013|Methotrexate|methotrexate|mesh-list
102546117|NCT01118013|Fludarabine phosphate|fludarabine phosphate|mesh-list
102546118|NCT01118013|Fludarabine|fludarabine|mesh-list
102546119|NCT01118013|Busulfan|busulfan|mesh-list
102546120|NCT01118013|Tacrolimus|tacrolimus|mesh-list
102546121|NCT01118013|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102546122|NCT01118013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102546123|NCT01118013|Abortifacient Agents|abortifacient agents|mesh-ancestor
102546124|NCT01118013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102546125|NCT01118013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546126|NCT01118013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102546127|NCT01118013|Antimetabolites|antimetabolites|mesh-ancestor
102546128|NCT01118013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546129|NCT01118013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102546130|NCT01118013|Dermatologic Agents|dermatologic agents|mesh-ancestor
102546131|NCT01118013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102546132|NCT01118013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102546133|NCT01118013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102546134|NCT01118013|Immunologic Factors|immunologic factors|mesh-ancestor
102546135|NCT01118013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102546136|NCT01118013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102546137|NCT01118013|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102546138|NCT01118013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102546139|NCT01118013|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102546140|NCT01118013|Antitubercular Agents|antitubercular agents|mesh-ancestor
102546141|NCT01118013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102546142|NCT01118013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102546143|NCT01118013|Alkylating Agents|alkylating agents|mesh-ancestor
102546144|NCT01118013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102546145|NCT01118013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102546146|NCT00378027|PENTA|penta|mesh-list
102546147|NCT00378027|Fondaparinux|fondaparinux|mesh-list
102546148|NCT00378027|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102546149|NCT00378027|Antithrombins|antithrombins|mesh-ancestor
102546150|NCT00378027|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102546151|NCT00378027|Protease Inhibitors|protease inhibitors|mesh-ancestor
102546152|NCT00378027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102546153|NCT00378027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546154|NCT00378027|Anticoagulants|anticoagulants|mesh-ancestor
102546155|NCT00378027|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102546156|NCT00378027|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102546157|NCT00552032|Mometasone Furoate|mometasone furoate|mesh-list
102546158|NCT00552032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102546159|NCT00552032|Dermatologic Agents|dermatologic agents|mesh-ancestor
102546160|NCT00552032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102546161|NCT02429583|Vaccines|vaccines|mesh-list
102546162|NCT02429583|Immunologic Factors|immunologic factors|mesh-ancestor
102546163|NCT02429583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546164|NCT02413047|Methotrexate|methotrexate|mesh-list
102546165|NCT02413047|Mercaptopurine|mercaptopurine|mesh-list
102546166|NCT02413047|Azathioprine|azathioprine|mesh-list
102546167|NCT02413047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102546168|NCT02413047|Abortifacient Agents|abortifacient agents|mesh-ancestor
102546169|NCT02413047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102546170|NCT02413047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546171|NCT02413047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102546172|NCT02413047|Antimetabolites|antimetabolites|mesh-ancestor
102546173|NCT02413047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546174|NCT02413047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102546175|NCT02413047|Dermatologic Agents|dermatologic agents|mesh-ancestor
102546176|NCT02413047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102546177|NCT02413047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102546178|NCT02413047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102546179|NCT02413047|Immunologic Factors|immunologic factors|mesh-ancestor
102546180|NCT02413047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102546181|NCT02413047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102546182|NCT02277548|Pregabalin|pregabalin|mesh-list
102546183|NCT02277548|Analgesics|analgesics|mesh-ancestor
102546184|NCT02277548|Sensory System Agents|sensory system agents|mesh-ancestor
102546185|NCT02277548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102546186|NCT02277548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546187|NCT02277548|Anticonvulsants|anticonvulsants|mesh-ancestor
102546188|NCT02277548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102546189|NCT02277548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102546190|NCT02277548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546191|NCT02277548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102546192|NCT02277548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102546193|NCT02277548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102546194|NCT02277548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102546195|NCT02277548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102546196|NCT02411643|Calcipotriene|calcipotriene|mesh-list
102546197|NCT02411643|Dermatologic Agents|dermatologic agents|mesh-ancestor
102546198|NCT01085643|Lubiprostone|lubiprostone|mesh-list
102546199|NCT01085643|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102546200|NCT01085643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102546201|NCT01085643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546202|NCT03028766|Adavosertib|adavosertib|mesh-list
102546203|NCT03028766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102546204|NCT03028766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546205|NCT01071993|Atorvastatin|atorvastatin|mesh-list
102546206|NCT01071993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102546207|NCT01071993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102546208|NCT01071993|Antimetabolites|antimetabolites|mesh-ancestor
101832950|NCT00519896|Sunitinib|sunitinib|mesh-list
102241642|NCT04891809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546209|NCT01071993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546210|NCT01071993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102546211|NCT01071993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102546212|NCT01071993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102546213|NCT03756818|Paclitaxel|paclitaxel|mesh-list
102546214|NCT03756818|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102546215|NCT03756818|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102546216|NCT03756818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102546217|NCT03756818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102546218|NCT03756818|Tubulin Modulators|tubulin modulators|mesh-ancestor
102546219|NCT03756818|Antimitotic Agents|antimitotic agents|mesh-ancestor
102546220|NCT03756818|Mitosis Modulators|mitosis modulators|mesh-ancestor
102546221|NCT03756818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546222|NCT03756818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102546223|NCT03756818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102546224|NCT01065051|Riociguat|riociguat|mesh-list
102546225|NCT01065051|Enzyme Activators|enzyme activators|mesh-ancestor
102546226|NCT01065051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546227|NCT02379585|Paclitaxel|paclitaxel|mesh-list
102546228|NCT02379585|Docetaxel|docetaxel|mesh-list
102546229|NCT02379585|Cyclophosphamide|cyclophosphamide|mesh-list
102546230|NCT02379585|Doxorubicin|doxorubicin|mesh-list
102546231|NCT02379585|Trastuzumab|trastuzumab|mesh-list
102546232|NCT02379585|Pertuzumab|pertuzumab|mesh-list
102546233|NCT02379585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102546234|NCT02379585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102546235|NCT02379585|Tubulin Modulators|tubulin modulators|mesh-ancestor
102546236|NCT02379585|Antimitotic Agents|antimitotic agents|mesh-ancestor
102546237|NCT02379585|Mitosis Modulators|mitosis modulators|mesh-ancestor
102546238|NCT02379585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546239|NCT02379585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102546240|NCT02379585|Immunologic Factors|immunologic factors|mesh-ancestor
102546241|NCT02379585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546242|NCT02379585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102546243|NCT02379585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102546244|NCT02379585|Alkylating Agents|alkylating agents|mesh-ancestor
102546245|NCT02379585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102546246|NCT02379585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102546247|NCT02379585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102546248|NCT02379585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102546249|NCT02379585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102546250|NCT02379585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102546251|NCT01048125|Nitroprusside|nitroprusside|mesh-list
102546252|NCT01048125|Phenylephrine|phenylephrine|mesh-list
102546253|NCT01048125|Oxymetazoline|oxymetazoline|mesh-list
102546254|NCT01048125|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102546255|NCT01048125|Mydriatics|mydriatics|mesh-ancestor
102546256|NCT01048125|Autonomic Agents|autonomic agents|mesh-ancestor
102546257|NCT01048125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102546258|NCT01048125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546259|NCT01048125|Sympathomimetics|sympathomimetics|mesh-ancestor
102546260|NCT01048125|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102546261|NCT01048125|Nasal Decongestants|nasal decongestants|mesh-ancestor
102546262|NCT01048125|Respiratory System Agents|respiratory system agents|mesh-ancestor
102546263|NCT01048125|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102546264|NCT01048125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102546265|NCT01048125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102546266|NCT01048125|Adrenergic Agents|adrenergic agents|mesh-ancestor
102546267|NCT01048125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102546268|NCT01048125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546269|NCT01048125|Protective Agents|protective agents|mesh-ancestor
102546270|NCT01048125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102546271|NCT01048125|Vasodilator Agents|vasodilator agents|mesh-ancestor
102546272|NCT01048125|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102546273|NCT01901588|Dexmedetomidine|dexmedetomidine|mesh-list
102546274|NCT01901588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102546275|NCT01901588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102546276|NCT01901588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546277|NCT01901588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102546278|NCT01901588|Analgesics|analgesics|mesh-ancestor
102546279|NCT01901588|Sensory System Agents|sensory system agents|mesh-ancestor
102546280|NCT01901588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102546281|NCT01901588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102546282|NCT01901588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102546283|NCT01901588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102154150|NCT00353938|Serotonin Agents|serotonin agents|mesh-ancestor
102546284|NCT01901588|Adrenergic Agents|adrenergic agents|mesh-ancestor
102546285|NCT01901588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102546286|NCT01901588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546287|NCT03673124|Letrozole|letrozole|mesh-list
102546288|NCT03673124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102546289|NCT03673124|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102546290|NCT03673124|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102546291|NCT03673124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102546292|NCT03673124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546293|NCT03673124|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102546294|NCT03673124|Hormone Antagonists|hormone antagonists|mesh-ancestor
102546295|NCT03673124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102546296|NCT03673124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546297|NCT01025271|Daptomycin|daptomycin|mesh-list
102546298|NCT01025271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102546299|NCT01025271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102546300|NCT01902758|Ambrisentan|ambrisentan|mesh-list
102546301|NCT01902758|Theophylline|theophylline|mesh-list
102546302|NCT01902758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102546303|NCT01902758|Autonomic Agents|autonomic agents|mesh-ancestor
102546304|NCT01902758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102546305|NCT01902758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546306|NCT01902758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102546307|NCT01902758|Respiratory System Agents|respiratory system agents|mesh-ancestor
102546308|NCT01902758|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102546309|NCT01902758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102546310|NCT01902758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546311|NCT01902758|Vasodilator Agents|vasodilator agents|mesh-ancestor
102546312|NCT01902758|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102546313|NCT01902758|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102546314|NCT01902758|Purinergic Agents|purinergic agents|mesh-ancestor
102546315|NCT01902758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102546316|NCT01902758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102546317|NCT01020903|Aprepitant|aprepitant|mesh-list
102546318|NCT01020903|Antiemetics|antiemetics|mesh-ancestor
102546319|NCT01020903|Autonomic Agents|autonomic agents|mesh-ancestor
102546320|NCT01020903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102546321|NCT01020903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546322|NCT01020903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102546323|NCT01020903|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102546324|NCT01020903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102546325|NCT01020903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546326|NCT02318901|Pembrolizumab|pembrolizumab|mesh-list
102546327|NCT02318901|Trastuzumab|trastuzumab|mesh-list
102546328|NCT02318901|Cetuximab|cetuximab|mesh-list
102546329|NCT02318901|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102546330|NCT02318901|Maytansine|maytansine|mesh-list
102546331|NCT02318901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102546332|NCT02318901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102546333|NCT02318901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102546334|NCT02318901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546335|NCT02318901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102546336|NCT02318901|Tubulin Modulators|tubulin modulators|mesh-ancestor
102546337|NCT02318901|Antimitotic Agents|antimitotic agents|mesh-ancestor
102546338|NCT02318901|Mitosis Modulators|mitosis modulators|mesh-ancestor
102546339|NCT02318901|Immunotoxins|immunotoxins|mesh-ancestor
102546340|NCT02318901|Immunoconjugates|immunoconjugates|mesh-ancestor
102546341|NCT02318901|Immunologic Factors|immunologic factors|mesh-ancestor
102546342|NCT02318901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546343|NCT01904864|Iron|iron|mesh-list
102546344|NCT01904864|Micronutrients|micronutrients|mesh-ancestor
102546345|NCT01904864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546346|NCT01904864|Trace Elements|trace elements|mesh-ancestor
102546347|NCT01016847|Montelukast|montelukast|mesh-list
102546348|NCT01016847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102546349|NCT01016847|Respiratory System Agents|respiratory system agents|mesh-ancestor
102546350|NCT01016847|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102546351|NCT01016847|Hormone Antagonists|hormone antagonists|mesh-ancestor
102546352|NCT01016847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102546353|NCT01016847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546354|NCT01016847|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102546355|NCT01016847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102546356|NCT01016847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546357|NCT00989937|Oxytocin|oxytocin|mesh-list
102546358|NCT00989937|Oxytocics|oxytocics|mesh-ancestor
102546359|NCT00989937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102546360|NCT00989937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546361|NCT00982995|Palonosetron|palonosetron|mesh-list
102546362|NCT00982995|Antiemetics|antiemetics|mesh-ancestor
102546363|NCT00982995|Autonomic Agents|autonomic agents|mesh-ancestor
102546364|NCT00982995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102546365|NCT00982995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546366|NCT00982995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102546367|NCT00982995|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102546368|NCT00982995|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102546369|NCT00982995|Serotonin Agents|serotonin agents|mesh-ancestor
102546370|NCT00982995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102546371|NCT00982995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546372|NCT00965055|Atorvastatin|atorvastatin|mesh-list
102546373|NCT00965055|Ezetimibe|ezetimibe|mesh-list
102546374|NCT00965055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102546375|NCT00965055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102546376|NCT00965055|Antimetabolites|antimetabolites|mesh-ancestor
102546377|NCT00965055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546378|NCT00965055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102546379|NCT00965055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102546380|NCT00965055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102546381|NCT02266797|Dexamethasone|dexamethasone|mesh-list
102546382|NCT02266797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102546383|NCT02266797|Antiemetics|antiemetics|mesh-ancestor
102546384|NCT02266797|Autonomic Agents|autonomic agents|mesh-ancestor
102546385|NCT02266797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102546386|NCT02266797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546387|NCT02266797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102546388|NCT02266797|Glucocorticoids|glucocorticoids|mesh-ancestor
102546389|NCT02266797|Hormones|hormones|mesh-ancestor
102546390|NCT02266797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102546391|NCT02266797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102546392|NCT02266797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102546393|NCT00378183|Risperidone|risperidone|mesh-list
102546394|NCT00378183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102546395|NCT00378183|Serotonin Agents|serotonin agents|mesh-ancestor
102546396|NCT00378183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102546397|NCT00378183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546398|NCT00378183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546399|NCT00378183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102546400|NCT00378183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102546401|NCT00378183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102546402|NCT00378183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102546403|NCT00378183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102546404|NCT00378183|Dopamine Agents|dopamine agents|mesh-ancestor
102546405|NCT01906658|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102546406|NCT01906658|Hormones|hormones|mesh-ancestor
102546407|NCT01906658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102546408|NCT01906658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546409|NCT01908062|Naltrexone|naltrexone|mesh-list
102546410|NCT01908062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102546411|NCT01908062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102546412|NCT01908062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546413|NCT01908062|Sensory System Agents|sensory system agents|mesh-ancestor
102546414|NCT01908062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102546415|NCT00924807|Sorafenib|sorafenib|mesh-list
102546416|NCT00924807|Leuprolide|leuprolide|mesh-list
102546417|NCT00924807|Bicalutamide|bicalutamide|mesh-list
102546418|NCT00924807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102546419|NCT00924807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102546420|NCT00924807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102546421|NCT00924807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546422|NCT00924807|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102546423|NCT00924807|Fertility Agents|fertility agents|mesh-ancestor
102546424|NCT00924807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102546425|NCT00924807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546426|NCT00924807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102546427|NCT00924807|Androgen Antagonists|androgen antagonists|mesh-ancestor
102546428|NCT00924807|Hormone Antagonists|hormone antagonists|mesh-ancestor
102546429|NCT00924807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102546430|NCT00896025|Acetylcysteine|acetylcysteine|mesh-list
102546431|NCT00896025|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102546432|NCT00896025|Antiviral Agents|antiviral agents|mesh-ancestor
102546433|NCT00896025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102546434|NCT00896025|Expectorants|expectorants|mesh-ancestor
102546435|NCT00896025|Respiratory System Agents|respiratory system agents|mesh-ancestor
102546436|NCT00896025|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102546437|NCT00896025|Antioxidants|antioxidants|mesh-ancestor
102546438|NCT00896025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546439|NCT00896025|Protective Agents|protective agents|mesh-ancestor
102546440|NCT00896025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546441|NCT00896025|Antidotes|antidotes|mesh-ancestor
102546442|NCT02162979|Sildenafil Citrate|sildenafil citrate|mesh-list
102546443|NCT02162979|Vasodilator Agents|vasodilator agents|mesh-ancestor
102546444|NCT02162979|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102546445|NCT02162979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102546446|NCT02162979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102546447|NCT02162979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546448|NCT02162979|Urological Agents|urological agents|mesh-ancestor
102546449|NCT03734601|Mycophenolic Acid|mycophenolic acid|mesh-list
102546450|NCT03734601|Tacrolimus|tacrolimus|mesh-list
102546451|NCT03734601|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101766477|NCT05750966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102546452|NCT03734601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102546453|NCT03734601|Immunologic Factors|immunologic factors|mesh-ancestor
102546454|NCT03734601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546455|NCT03734601|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102546456|NCT03734601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102546457|NCT03734601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546458|NCT03734601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102546459|NCT03734601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102546460|NCT03734601|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102546461|NCT03734601|Antitubercular Agents|antitubercular agents|mesh-ancestor
102546462|NCT03734601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102546463|NCT03734601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102546464|NCT01908842|Buprenorphine|buprenorphine|mesh-list
102546465|NCT01908842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102546466|NCT01908842|Narcotics|narcotics|mesh-ancestor
102546467|NCT01908842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102546468|NCT01908842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546469|NCT01908842|Analgesics|analgesics|mesh-ancestor
102546470|NCT01908842|Sensory System Agents|sensory system agents|mesh-ancestor
102546471|NCT01908842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102546472|NCT01908842|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102546473|NCT00833859|Gemcitabine|gemcitabine|mesh-list
102546474|NCT00833859|Capecitabine|capecitabine|mesh-list
102546475|NCT00833859|Docetaxel|docetaxel|mesh-list
102546476|NCT00833859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102546477|NCT00833859|Antimetabolites|antimetabolites|mesh-ancestor
102546478|NCT00833859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546479|NCT00833859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102546480|NCT00833859|Tubulin Modulators|tubulin modulators|mesh-ancestor
102546481|NCT00833859|Antimitotic Agents|antimitotic agents|mesh-ancestor
102546482|NCT00833859|Mitosis Modulators|mitosis modulators|mesh-ancestor
102546483|NCT00832299|Leucovorin|leucovorin|mesh-list
102546484|NCT00832299|Fluorouracil|fluorouracil|mesh-list
102546485|NCT00832299|Oxaliplatin|oxaliplatin|mesh-list
102546486|NCT00832299|Antimetabolites|antimetabolites|mesh-ancestor
102546487|NCT00832299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546488|NCT00832299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102546489|NCT00832299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102546490|NCT00832299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102546491|NCT00832299|Immunologic Factors|immunologic factors|mesh-ancestor
102546492|NCT00832299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546493|NCT00832299|Antidotes|antidotes|mesh-ancestor
102546494|NCT00832299|Protective Agents|protective agents|mesh-ancestor
102546495|NCT00832299|Vitamin B Complex|vitamin b complex|mesh-ancestor
102546496|NCT00832299|Vitamins|vitamins|mesh-ancestor
102546497|NCT00832299|Micronutrients|micronutrients|mesh-ancestor
102546498|NCT03723447|Dexamethasone|dexamethasone|mesh-list
102546499|NCT03723447|Epinephrine|epinephrine|mesh-list
102546500|NCT03723447|Bupivacaine|bupivacaine|mesh-list
102546501|NCT03723447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102546502|NCT03723447|Antiemetics|antiemetics|mesh-ancestor
102546503|NCT03723447|Autonomic Agents|autonomic agents|mesh-ancestor
102546504|NCT03723447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102546505|NCT03723447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546506|NCT03723447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102546507|NCT03723447|Glucocorticoids|glucocorticoids|mesh-ancestor
102546508|NCT03723447|Hormones|hormones|mesh-ancestor
102612373|NCT02973581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102546509|NCT03723447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102546510|NCT03723447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102546511|NCT03723447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102546512|NCT03723447|Anesthetics, Local|anesthetics, local|mesh-ancestor
102546513|NCT03723447|Anesthetics|anesthetics|mesh-ancestor
102546514|NCT03723447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102546515|NCT03723447|Sensory System Agents|sensory system agents|mesh-ancestor
102546516|NCT03723447|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102546517|NCT03723447|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102546518|NCT03723447|Adrenergic Agents|adrenergic agents|mesh-ancestor
102546519|NCT03723447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102546520|NCT03723447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546521|NCT03723447|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102546522|NCT03723447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102546523|NCT03723447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102546524|NCT03723447|Respiratory System Agents|respiratory system agents|mesh-ancestor
102546525|NCT03723447|Mydriatics|mydriatics|mesh-ancestor
102546526|NCT03723447|Sympathomimetics|sympathomimetics|mesh-ancestor
102546527|NCT03723447|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102546528|NCT00836355|Minocycline|minocycline|mesh-list
102546529|NCT00836355|Enoxaparin|enoxaparin|mesh-list
102546530|NCT00836355|Anticoagulants|anticoagulants|mesh-ancestor
102546531|NCT00836355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102546532|NCT00836355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102546533|NCT00836355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546534|NCT00836355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102546535|NCT00836355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102546536|NCT00816777|Irinotecan|irinotecan|mesh-list
102546537|NCT00816777|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102546538|NCT00816777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102546539|NCT00816777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102546540|NCT00816777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546541|NCT00816777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102546542|NCT00823095|Nitric Oxide|nitric oxide|mesh-list
102546543|NCT00823095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102546544|NCT00823095|Autonomic Agents|autonomic agents|mesh-ancestor
102546545|NCT00823095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102546546|NCT00823095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546547|NCT00823095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102546548|NCT00823095|Respiratory System Agents|respiratory system agents|mesh-ancestor
102546549|NCT00823095|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102546550|NCT00823095|Antioxidants|antioxidants|mesh-ancestor
102546551|NCT00823095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546552|NCT00823095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102546553|NCT00823095|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102546554|NCT00823095|Vasodilator Agents|vasodilator agents|mesh-ancestor
102546555|NCT00823095|Gasotransmitters|gasotransmitters|mesh-ancestor
102546556|NCT00823095|Protective Agents|protective agents|mesh-ancestor
102546557|NCT00803283|Morphine|morphine|mesh-list
102546558|NCT00803283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102546559|NCT00803283|Narcotics|narcotics|mesh-ancestor
102546560|NCT00803283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102546561|NCT00803283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546562|NCT00803283|Analgesics|analgesics|mesh-ancestor
102546563|NCT00803283|Sensory System Agents|sensory system agents|mesh-ancestor
102546564|NCT00803283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102546565|NCT03701295|Azacitidine|azacitidine|mesh-list
102546566|NCT03701295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102546567|NCT03701295|Antimetabolites|antimetabolites|mesh-ancestor
102546568|NCT03701295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546569|NCT03701295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102546570|NCT03701295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102546571|NCT00799773|Rituximab|rituximab|mesh-list
102546572|NCT00799773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102546573|NCT00799773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102546574|NCT00799773|Immunologic Factors|immunologic factors|mesh-ancestor
102546575|NCT00799773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546576|NCT00799773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102546577|NCT00760461|Domperidone|domperidone|mesh-list
102546578|NCT00760461|Antiemetics|antiemetics|mesh-ancestor
102546579|NCT00760461|Autonomic Agents|autonomic agents|mesh-ancestor
102546580|NCT00760461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102546581|NCT00760461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546582|NCT00760461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102546583|NCT00760461|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102546584|NCT00760461|Dopamine Agents|dopamine agents|mesh-ancestor
102546585|NCT00760461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102546586|NCT00760461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546587|NCT00750555|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102546588|NCT00750555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102546589|NCT00750555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102546590|NCT00750555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102546591|NCT00750555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546592|NCT01941615|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
102546593|NCT01941615|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
102546594|NCT01941615|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102546595|NCT01941615|Contraceptive Agents|contraceptive agents|mesh-ancestor
102546596|NCT01941615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102546597|NCT01941615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546598|NCT01941615|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102546599|NCT01941615|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102546600|NCT01941615|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102546601|NCT01941615|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102546602|NCT01941615|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102546603|NCT01941615|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
102546604|NCT01941615|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102546605|NCT01941615|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102546606|NCT01901679|Celecoxib|celecoxib|mesh-list
102546607|NCT01901679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102546608|NCT01901679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102546609|NCT01901679|Analgesics|analgesics|mesh-ancestor
102546610|NCT01901679|Sensory System Agents|sensory system agents|mesh-ancestor
102546611|NCT01901679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102546612|NCT01901679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546613|NCT01901679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102546614|NCT01901679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102546615|NCT01901679|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102546616|NCT01901679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102546617|NCT01901679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102546618|NCT01901679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546619|NCT00688935|Melatonin|melatonin|mesh-list
102546620|NCT00688935|Antioxidants|antioxidants|mesh-ancestor
102546621|NCT00688935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546622|NCT00688935|Protective Agents|protective agents|mesh-ancestor
102546623|NCT00688935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546624|NCT00688935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102546625|NCT00684255|Fludarabine|fludarabine|mesh-list
102546626|NCT00684255|Busulfan|busulfan|mesh-list
102546627|NCT00684255|Alemtuzumab|alemtuzumab|mesh-list
102546628|NCT00684255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102546629|NCT00684255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546630|NCT00684255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102546631|NCT00684255|Immunologic Factors|immunologic factors|mesh-ancestor
102546632|NCT00684255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546633|NCT00684255|Alkylating Agents|alkylating agents|mesh-ancestor
102546634|NCT00684255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102546635|NCT00684255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102546636|NCT00684255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102546637|NCT00668265|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102546638|NCT00668265|Antidepressive Agents|antidepressive agents|mesh-ancestor
102546639|NCT00668265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102546640|NCT00668265|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102546641|NCT00668265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102546642|NCT00668265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102546643|NCT00668265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546644|NCT01856361|Ramipril|ramipril|mesh-list
102546645|NCT01856361|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102546646|NCT01856361|Protease Inhibitors|protease inhibitors|mesh-ancestor
102546647|NCT01856361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102546648|NCT01856361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546649|NCT01856361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102546650|NCT00642603|Bevacizumab|bevacizumab|mesh-list
102546651|NCT00642603|Capecitabine|capecitabine|mesh-list
102546652|NCT00642603|Oxaliplatin|oxaliplatin|mesh-list
102546653|NCT00642603|Irinotecan|irinotecan|mesh-list
102546654|NCT00642603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101833392|NCT03991312|Itraconazole|itraconazole|mesh-list
102546656|NCT00642603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102546657|NCT00642603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102546658|NCT00642603|Growth Substances|growth substances|mesh-ancestor
102546659|NCT00642603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546660|NCT00642603|Growth Inhibitors|growth inhibitors|mesh-ancestor
102546661|NCT00642603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102546662|NCT00642603|Antimetabolites|antimetabolites|mesh-ancestor
102546663|NCT00642603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546664|NCT00642603|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102546665|NCT00642603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102546666|NCT00642603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102546667|NCT01841931|Buprenorphine|buprenorphine|mesh-list
102546668|NCT01841931|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102546669|NCT01841931|Naloxone|naloxone|mesh-list
102546670|NCT01841931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102546671|NCT01841931|Narcotics|narcotics|mesh-ancestor
102546672|NCT01841931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102546673|NCT01841931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546674|NCT01841931|Analgesics|analgesics|mesh-ancestor
102546675|NCT01841931|Sensory System Agents|sensory system agents|mesh-ancestor
102546676|NCT01841931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102546677|NCT01841931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102546678|NCT00633087|Deoxyglucose|deoxyglucose|mesh-list
102546679|NCT00633087|Antimetabolites|antimetabolites|mesh-ancestor
102546680|NCT00633087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546681|NCT00633087|Antiviral Agents|antiviral agents|mesh-ancestor
102546682|NCT00633087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102546683|NCT04713891|Atezolizumab|atezolizumab|mesh-list
102546684|NCT04713891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102546685|NCT04713891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102546686|NCT04713891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546687|NCT04713891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102546688|NCT04713891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102546689|NCT04713891|Immunologic Factors|immunologic factors|mesh-ancestor
102546690|NCT04713891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546691|NCT00379509|Lapatinib|lapatinib|mesh-list
102546692|NCT00379509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102546693|NCT00379509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102546694|NCT00379509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102546695|NCT00379509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546696|NCT04706247|Anesthetics|anesthetics|mesh-list
102546697|NCT04706247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102546698|NCT04706247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546699|NCT00597909|Sodium Benzoate|sodium benzoate|mesh-list
102546700|NCT00597909|Phenylacetic acid|phenylacetic acid|mesh-list
102546701|NCT00597909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102546702|NCT00597909|Antimetabolites|antimetabolites|mesh-ancestor
102546703|NCT00597909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546704|NCT00597909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102546705|NCT00597909|Antifungal Agents|antifungal agents|mesh-ancestor
102546706|NCT00597909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102546707|NCT00422955|Rosiglitazone|rosiglitazone|mesh-list
102546708|NCT00422955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102546709|NCT00422955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546710|NCT00588471|Simvastatin|simvastatin|mesh-list
102546711|NCT00588471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102546712|NCT00588471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102546713|NCT00588471|Antimetabolites|antimetabolites|mesh-ancestor
102546714|NCT00588471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546715|NCT00588471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102546716|NCT00588471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102546717|NCT00588471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102546718|NCT05600673|Bimatoprost|bimatoprost|mesh-list
102546719|NCT05600673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102546720|NCT01784991|Morphine|morphine|mesh-list
102546721|NCT01784991|Hydromorphone|hydromorphone|mesh-list
102546722|NCT01784991|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102546723|NCT01784991|Narcotics|narcotics|mesh-ancestor
102546724|NCT01784991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102546725|NCT01784991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546726|NCT01784991|Analgesics|analgesics|mesh-ancestor
102546727|NCT01784991|Sensory System Agents|sensory system agents|mesh-ancestor
102546728|NCT01784991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102546729|NCT01760889|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102546730|NCT01760889|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102546731|NCT01760889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546732|NCT01760889|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102546733|NCT01760889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102546734|NCT01760889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102546735|NCT01760889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546736|NCT01760889|Dopamine Agents|dopamine agents|mesh-ancestor
102546737|NCT01760889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102546738|NCT05600517|Fluorides|fluorides|mesh-list
102546739|NCT05600517|Cariostatic Agents|cariostatic agents|mesh-ancestor
102546740|NCT05600517|Protective Agents|protective agents|mesh-ancestor
102546741|NCT05600517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546742|NCT01745913|Fludarabine|fludarabine|mesh-list
102546743|NCT01745913|Melphalan|melphalan|mesh-list
102546744|NCT01745913|Thymoglobulin|thymoglobulin|mesh-list
102546745|NCT01745913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102546746|NCT01745913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546747|NCT01745913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102546748|NCT01745913|Immunologic Factors|immunologic factors|mesh-ancestor
102546749|NCT01745913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546750|NCT01745913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102546751|NCT01745913|Alkylating Agents|alkylating agents|mesh-ancestor
102546752|NCT01745913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102546753|NCT05600127|Avelumab|avelumab|mesh-list
102546754|NCT05600127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102546755|NCT05600127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102546756|NCT01691079|Bromides|bromides|mesh-list
102546757|NCT01691079|Ipratropium|ipratropium|mesh-list
102546758|NCT01691079|Anticonvulsants|anticonvulsants|mesh-ancestor
102546759|NCT01691079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102546760|NCT01691079|Autonomic Agents|autonomic agents|mesh-ancestor
102546761|NCT01691079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102546762|NCT01691079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546763|NCT01691079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102546764|NCT01691079|Respiratory System Agents|respiratory system agents|mesh-ancestor
102546765|NCT01691079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102546766|NCT01691079|Cholinergic Agents|cholinergic agents|mesh-ancestor
102546767|NCT01691079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102546768|NCT01691079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546769|NCT01673061|Lidocaine|lidocaine|mesh-list
102546770|NCT01673061|Epinephrine|epinephrine|mesh-list
102546771|NCT01673061|Norflurane|norflurane|mesh-list
102546772|NCT01673061|Anesthetics, Local|anesthetics, local|mesh-ancestor
102546773|NCT01673061|Anesthetics|anesthetics|mesh-ancestor
102546774|NCT01673061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102546775|NCT01673061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546776|NCT01673061|Sensory System Agents|sensory system agents|mesh-ancestor
102546777|NCT01673061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102546778|NCT01673061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102546779|NCT01673061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102546780|NCT01673061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102546781|NCT01673061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102546782|NCT01673061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546783|NCT01673061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102546784|NCT01673061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102546785|NCT01673061|Adrenergic Agents|adrenergic agents|mesh-ancestor
102546786|NCT01673061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102546787|NCT01673061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102546788|NCT01673061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102546789|NCT01673061|Autonomic Agents|autonomic agents|mesh-ancestor
102546790|NCT01673061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102546791|NCT01673061|Respiratory System Agents|respiratory system agents|mesh-ancestor
102546792|NCT01673061|Mydriatics|mydriatics|mesh-ancestor
102546793|NCT01673061|Sympathomimetics|sympathomimetics|mesh-ancestor
102546794|NCT01673061|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102546795|NCT05599347|Azithromycin|azithromycin|mesh-list
102546796|NCT05599347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102546797|NCT05599347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102546798|NCT01621737|Oxytocin|oxytocin|mesh-list
102546799|NCT01621737|Oxytocics|oxytocics|mesh-ancestor
102546800|NCT01621737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102546801|NCT01621737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546802|NCT00379665|Cisplatin|cisplatin|mesh-list
102546803|NCT00379665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102546804|NCT00357383|Azithromycin|azithromycin|mesh-list
102546805|NCT00357383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102546806|NCT00357383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102546807|NCT01598025|Fludarabine|fludarabine|mesh-list
102546808|NCT01598025|Fludarabine phosphate|fludarabine phosphate|mesh-list
102546809|NCT01598025|Melphalan|melphalan|mesh-list
102546810|NCT01598025|Thiotepa|thiotepa|mesh-list
102546811|NCT01598025|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102546812|NCT01598025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102546813|NCT01598025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102546814|NCT01598025|Antimetabolites|antimetabolites|mesh-ancestor
102546815|NCT01598025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546816|NCT01598025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102546817|NCT01598025|Immunologic Factors|immunologic factors|mesh-ancestor
102546818|NCT01598025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546819|NCT01598025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102546820|NCT01598025|Alkylating Agents|alkylating agents|mesh-ancestor
102546821|NCT01598025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102546822|NCT01587963|Ascorbic Acid|ascorbic acid|mesh-list
102546823|NCT01587963|Antioxidants|antioxidants|mesh-ancestor
102546824|NCT01587963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546825|NCT01587963|Protective Agents|protective agents|mesh-ancestor
102546826|NCT01587963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546827|NCT01587963|Vitamins|vitamins|mesh-ancestor
102546828|NCT01587963|Micronutrients|micronutrients|mesh-ancestor
102546829|NCT01648751|Estrogens|estrogens|mesh-list
102546830|NCT01648751|Hormones|hormones|mesh-ancestor
102546831|NCT01648751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102546832|NCT01648751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546833|NCT05550519|Tenofovir|tenofovir|mesh-list
102546834|NCT05550519|Entecavir|entecavir|mesh-list
102546835|NCT05550519|Antiviral Agents|antiviral agents|mesh-ancestor
102546836|NCT05550519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102546837|NCT05550519|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102546838|NCT05550519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102546839|NCT05550519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102546840|NCT05550519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546841|NCT05550519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102546842|NCT05550519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102546843|NCT01203371|Naftopidil|naftopidil|mesh-list
102546844|NCT01203371|Tamsulosin|tamsulosin|mesh-list
102546845|NCT01203371|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102546846|NCT01203371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102546847|NCT01203371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102546848|NCT01203371|Adrenergic Agents|adrenergic agents|mesh-ancestor
102546849|NCT01203371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102546850|NCT01203371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546851|NCT01203371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546852|NCT01203371|Urological Agents|urological agents|mesh-ancestor
102546853|NCT01203371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102546854|NCT01203371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102546855|NCT01203371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102546856|NCT01203371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102546857|NCT01203371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102546858|NCT01549977|Febuxostat|febuxostat|mesh-list
102546859|NCT01549977|Gout Suppressants|gout suppressants|mesh-ancestor
102546860|NCT01549977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102546861|NCT00357617|Celecoxib|celecoxib|mesh-list
102546862|NCT00357617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102546863|NCT00357617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102546864|NCT00357617|Analgesics|analgesics|mesh-ancestor
102546865|NCT00357617|Sensory System Agents|sensory system agents|mesh-ancestor
102546866|NCT00357617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102546867|NCT00357617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546868|NCT00357617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102546869|NCT00357617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102546870|NCT00357617|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102546871|NCT00357617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102546872|NCT00357617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102546873|NCT00357617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546874|NCT01548651|Saxagliptin|saxagliptin|mesh-list
102546875|NCT01548651|Incretins|incretins|mesh-ancestor
102546876|NCT01548651|Hormones|hormones|mesh-ancestor
101833617|NCT00523718|Anticonvulsants|anticonvulsants|mesh-ancestor
102546877|NCT01548651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102546878|NCT01548651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546879|NCT01548651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102546880|NCT01548651|Protease Inhibitors|protease inhibitors|mesh-ancestor
102546881|NCT01548651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102546882|NCT01548651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546883|NCT01548651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102546884|NCT01533753|Gabapentin|gabapentin|mesh-list
102546885|NCT01533753|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102546886|NCT01533753|Analgesics|analgesics|mesh-ancestor
102546887|NCT01533753|Sensory System Agents|sensory system agents|mesh-ancestor
102546888|NCT01533753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102546889|NCT01533753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546890|NCT01533753|Anticonvulsants|anticonvulsants|mesh-ancestor
102546891|NCT01533753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102546892|NCT01533753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102546893|NCT01533753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102546894|NCT01533753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102546895|NCT01533753|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102546896|NCT01533753|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102546897|NCT01533753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102546898|NCT01533753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546899|NCT01533753|Antimanic Agents|antimanic agents|mesh-ancestor
102546900|NCT01533753|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102546901|NCT01533753|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102546902|NCT01533753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102546903|NCT01533753|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102546904|NCT01533753|Antidepressive Agents|antidepressive agents|mesh-ancestor
102546905|NCT05722301|Methyltestosterone|methyltestosterone|mesh-list
102546906|NCT05722301|Testosterone|testosterone|mesh-list
102546907|NCT05722301|Testosterone undecanoate|testosterone undecanoate|mesh-list
102546908|NCT05722301|Testosterone enanthate|testosterone enanthate|mesh-list
102546909|NCT05722301|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102546910|NCT05722301|Androgens|androgens|mesh-ancestor
102546911|NCT05722301|Hormones|hormones|mesh-ancestor
102546912|NCT05722301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102546913|NCT05722301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546914|NCT05722301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102546915|NCT05722301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102546916|NCT05722301|Anabolic Agents|anabolic agents|mesh-ancestor
102546917|NCT01534143|Sirolimus|sirolimus|mesh-list
102546918|NCT01534143|Fludarabine|fludarabine|mesh-list
102546919|NCT01534143|Fludarabine phosphate|fludarabine phosphate|mesh-list
102546920|NCT01534143|Bortezomib|bortezomib|mesh-list
102546921|NCT01534143|Busulfan|busulfan|mesh-list
102546922|NCT01534143|Tacrolimus|tacrolimus|mesh-list
102546923|NCT01534143|Thymoglobulin|thymoglobulin|mesh-list
102546924|NCT01534143|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102546925|NCT01534143|Immunoglobulins|immunoglobulins|mesh-list
102546926|NCT01534143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102546927|NCT01534143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102546928|NCT01534143|Antimetabolites|antimetabolites|mesh-ancestor
102546929|NCT01534143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546930|NCT01534143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102546931|NCT01534143|Immunologic Factors|immunologic factors|mesh-ancestor
102546932|NCT01534143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546933|NCT01534143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102546934|NCT01534143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102546935|NCT01534143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102546936|NCT01534143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102546937|NCT01534143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102546938|NCT01534143|Antifungal Agents|antifungal agents|mesh-ancestor
102546939|NCT01534143|Alkylating Agents|alkylating agents|mesh-ancestor
102546940|NCT01534143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102546941|NCT01534143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102546942|NCT05722067|Calcium|calcium|mesh-list
102546943|NCT05722067|Ionophores|ionophores|mesh-list
102546944|NCT05722067|Calcium Ionophores|calcium ionophores|mesh-list
102546945|NCT05722067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102546946|NCT05722067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546947|NCT05722067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102546948|NCT05722067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546949|NCT01692171|Heparin|heparin|mesh-list
102546950|NCT01692171|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102546951|NCT01692171|Tinzaparin|tinzaparin|mesh-list
102546952|NCT01692171|Dalteparin|dalteparin|mesh-list
102546953|NCT01692171|Anticoagulants|anticoagulants|mesh-ancestor
101833697|NCT00515216|Leucovorin|leucovorin|mesh-list
102154151|NCT00353938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102546954|NCT01692171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102546955|NCT01692171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102546956|NCT01692171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546957|NCT05723315|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
102546958|NCT05723315|Natriuretic Agents|natriuretic agents|mesh-ancestor
102546959|NCT05723315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546960|NCT00570531|Paclitaxel|paclitaxel|mesh-list
102546961|NCT00570531|Bevacizumab|bevacizumab|mesh-list
102546962|NCT00570531|Fluorouracil|fluorouracil|mesh-list
102546963|NCT00570531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102546964|NCT00570531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102546965|NCT00570531|Tubulin Modulators|tubulin modulators|mesh-ancestor
102546966|NCT00570531|Antimitotic Agents|antimitotic agents|mesh-ancestor
102546967|NCT00570531|Mitosis Modulators|mitosis modulators|mesh-ancestor
102241643|NCT04891809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102546968|NCT00570531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546969|NCT00570531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102546970|NCT00570531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102546971|NCT00570531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102546972|NCT00570531|Growth Substances|growth substances|mesh-ancestor
102546973|NCT00570531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546974|NCT00570531|Growth Inhibitors|growth inhibitors|mesh-ancestor
102546975|NCT00570531|Antimetabolites|antimetabolites|mesh-ancestor
102546976|NCT00570531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102546977|NCT00570531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102546978|NCT00570531|Immunologic Factors|immunologic factors|mesh-ancestor
102546979|NCT05258565|Plasminogen|plasminogen|mesh-list
102546980|NCT05258565|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102546981|NCT05258565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102546982|NCT05258565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102546983|NCT05258565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102546984|NCT05715437|Ketamine|ketamine|mesh-list
102546985|NCT05715437|Bupivacaine|bupivacaine|mesh-list
102546986|NCT05715437|Anesthetics, Local|anesthetics, local|mesh-ancestor
102546987|NCT05715437|Anesthetics|anesthetics|mesh-ancestor
102546988|NCT05715437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102546989|NCT05715437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102546990|NCT05715437|Sensory System Agents|sensory system agents|mesh-ancestor
102546991|NCT05715437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102546992|NCT05715437|Analgesics|analgesics|mesh-ancestor
102546993|NCT05715437|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102546994|NCT05715437|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102546995|NCT05715437|Anesthetics, General|anesthetics, general|mesh-ancestor
102546996|NCT05715437|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102546997|NCT05715437|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102546998|NCT05715437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102546999|NCT05715437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547000|NCT05721443|Cetuximab|cetuximab|mesh-list
102547001|NCT05721443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102547002|NCT05721443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102547003|NCT00523809|Bevacizumab|bevacizumab|mesh-list
102547004|NCT00523809|Fludarabine|fludarabine|mesh-list
102547005|NCT00523809|Fludarabine phosphate|fludarabine phosphate|mesh-list
102547006|NCT00523809|Melphalan|melphalan|mesh-list
102547007|NCT00523809|Thymoglobulin|thymoglobulin|mesh-list
102547008|NCT00523809|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102547009|NCT00523809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102547010|NCT00523809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102547011|NCT00523809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102547012|NCT00523809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102547013|NCT00523809|Growth Substances|growth substances|mesh-ancestor
102547014|NCT00523809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547015|NCT00523809|Growth Inhibitors|growth inhibitors|mesh-ancestor
102547016|NCT00523809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102547017|NCT00523809|Antimetabolites|antimetabolites|mesh-ancestor
102547018|NCT00523809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547019|NCT00523809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102547020|NCT00523809|Immunologic Factors|immunologic factors|mesh-ancestor
102547021|NCT00523809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102547022|NCT00523809|Alkylating Agents|alkylating agents|mesh-ancestor
102547023|NCT00523809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102547024|NCT00501345|Aspirin|aspirin|mesh-list
102547025|NCT00501345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102547026|NCT00501345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102547027|NCT00501345|Analgesics|analgesics|mesh-ancestor
102547028|NCT00501345|Sensory System Agents|sensory system agents|mesh-ancestor
102547029|NCT00501345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102547030|NCT00501345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547031|NCT00501345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102547032|NCT00501345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102547033|NCT00501345|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102547034|NCT00501345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102547035|NCT00501345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547036|NCT00501345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102547037|NCT00501345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102547038|NCT00501345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102547039|NCT00501345|Antipyretics|antipyretics|mesh-ancestor
102547040|NCT00357773|Azithromycin|azithromycin|mesh-list
102547041|NCT00357773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102547042|NCT00357773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102547043|NCT00487461|Simvastatin|simvastatin|mesh-list
102547044|NCT00487461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102547045|NCT00487461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102547046|NCT00487461|Antimetabolites|antimetabolites|mesh-ancestor
102547047|NCT00487461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547048|NCT00487461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102547049|NCT00487461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102547050|NCT00487461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102547051|NCT04972383|Hyaluronic Acid|hyaluronic acid|mesh-list
102547052|NCT04972383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102547053|NCT04972383|Immunologic Factors|immunologic factors|mesh-ancestor
102547054|NCT04972383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547055|NCT04972383|Viscosupplements|viscosupplements|mesh-ancestor
102547056|NCT04972383|Protective Agents|protective agents|mesh-ancestor
102547057|NCT00356187|Propranolol|propranolol|mesh-list
102547058|NCT00356187|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102547059|NCT00356187|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102547060|NCT00356187|Adrenergic Agents|adrenergic agents|mesh-ancestor
102547061|NCT00356187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102547062|NCT00356187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547063|NCT00356187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547064|NCT00356187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102547065|NCT00356187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102547066|NCT00356187|Vasodilator Agents|vasodilator agents|mesh-ancestor
102547067|NCT02224729|Dexamethasone|dexamethasone|mesh-list
102547068|NCT02224729|Bortezomib|bortezomib|mesh-list
102547069|NCT02224729|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102547070|NCT02224729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102547071|NCT02224729|Antiemetics|antiemetics|mesh-ancestor
102547072|NCT02224729|Autonomic Agents|autonomic agents|mesh-ancestor
102547073|NCT02224729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102547074|NCT02224729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547075|NCT02224729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102547076|NCT02224729|Glucocorticoids|glucocorticoids|mesh-ancestor
102547077|NCT02224729|Hormones|hormones|mesh-ancestor
102547078|NCT02224729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102547079|NCT02224729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102547080|NCT02224729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102547081|NCT02224729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102547082|NCT02224729|Alkylating Agents|alkylating agents|mesh-ancestor
102547083|NCT02224729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547084|NCT00305643|Celecoxib|celecoxib|mesh-list
102547085|NCT00305643|Capecitabine|capecitabine|mesh-list
102547086|NCT00305643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102547087|NCT00305643|Antimetabolites|antimetabolites|mesh-ancestor
102547088|NCT00305643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547089|NCT00305643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102547090|NCT00305643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102547091|NCT00305643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102547092|NCT00305643|Analgesics|analgesics|mesh-ancestor
102547093|NCT00305643|Sensory System Agents|sensory system agents|mesh-ancestor
102547094|NCT00305643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102547095|NCT00305643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547096|NCT00305643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102547097|NCT00305643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102547098|NCT00305643|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102547099|NCT00305643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102547100|NCT00305643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102547101|NCT03004105|Durvalumab|durvalumab|mesh-list
102154350|NCT03365115|Sensory System Agents|sensory system agents|mesh-ancestor
102547102|NCT03004105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102547103|NCT03004105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102547104|NCT00271011|Irinotecan|irinotecan|mesh-list
102547105|NCT00271011|Cetuximab|cetuximab|mesh-list
102547106|NCT00271011|Mitomycins|mitomycins|mesh-list
102547107|NCT00271011|Mitomycin|mitomycin|mesh-list
102547108|NCT00271011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102547109|NCT00271011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102547110|NCT00271011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102547111|NCT00271011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547112|NCT00271011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102547113|NCT00271011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102547114|NCT00271011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102547115|NCT00271011|Alkylating Agents|alkylating agents|mesh-ancestor
102547116|NCT00271011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102547117|NCT03312530|Atezolizumab|atezolizumab|mesh-list
102547118|NCT03312530|Venetoclax|venetoclax|mesh-list
102547119|NCT03312530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102547120|NCT03312530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547121|NCT03312530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102547122|NCT03312530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102547123|NCT05697965|Vancomycin|vancomycin|mesh-list
102547124|NCT05697965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102547125|NCT05697965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102547126|NCT00179127|Insulin Glargine|insulin glargine|mesh-list
102547127|NCT00179127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102547128|NCT00179127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547129|NCT05720273|Calcitriol|calcitriol|mesh-list
102547130|NCT05720273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102547131|NCT05720273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547132|NCT05720273|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102547133|NCT05720273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102547134|NCT05720273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547135|NCT05720273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102547136|NCT05720273|Vitamins|vitamins|mesh-ancestor
102547137|NCT05720273|Micronutrients|micronutrients|mesh-ancestor
102547138|NCT05720273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102547139|NCT00183963|Tamoxifen|tamoxifen|mesh-list
102547140|NCT00183963|Fulvestrant|fulvestrant|mesh-list
102547141|NCT00183963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102547142|NCT00183963|Hormone Antagonists|hormone antagonists|mesh-ancestor
102547143|NCT00183963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102547144|NCT00183963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547145|NCT00183963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102547146|NCT00183963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102547147|NCT00183963|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102547148|NCT00183963|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102547149|NCT00183963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102547150|NCT00183963|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102547151|NCT00176631|Docetaxel|docetaxel|mesh-list
102547152|NCT00176631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102547153|NCT00176631|Tubulin Modulators|tubulin modulators|mesh-ancestor
102547154|NCT00176631|Antimitotic Agents|antimitotic agents|mesh-ancestor
102547155|NCT00176631|Mitosis Modulators|mitosis modulators|mesh-ancestor
102547156|NCT00176631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547157|NCT05719961|Insulin|insulin|mesh-list
102547158|NCT05719961|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102547159|NCT05719961|Insulin Aspart|insulin aspart|mesh-list
102547160|NCT05719961|Insulin, Long-Acting|insulin, long-acting|mesh-list
102547161|NCT05719961|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102547162|NCT05719961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102547163|NCT05719961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547164|NCT01910636|Sofosbuvir|sofosbuvir|mesh-list
102547165|NCT01910636|Antiviral Agents|antiviral agents|mesh-ancestor
102547166|NCT01910636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102547167|NCT04317807|Levetiracetam|levetiracetam|mesh-list
102547168|NCT04317807|Anticonvulsants|anticonvulsants|mesh-ancestor
102547169|NCT04317807|Nootropic Agents|nootropic agents|mesh-ancestor
102547170|NCT00118053|Carboplatin|carboplatin|mesh-list
102547171|NCT00118053|Docetaxel|docetaxel|mesh-list
102547172|NCT00118053|Trastuzumab|trastuzumab|mesh-list
102547173|NCT00118053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102547174|NCT00118053|Tubulin Modulators|tubulin modulators|mesh-ancestor
102547175|NCT00118053|Antimitotic Agents|antimitotic agents|mesh-ancestor
102547176|NCT00118053|Mitosis Modulators|mitosis modulators|mesh-ancestor
102547177|NCT00118053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547178|NCT00118053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102547179|NCT04225611|Dexamethasone|dexamethasone|mesh-list
102547180|NCT04225611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102547181|NCT04225611|Antiemetics|antiemetics|mesh-ancestor
102547182|NCT04225611|Autonomic Agents|autonomic agents|mesh-ancestor
102547183|NCT04225611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102547184|NCT04225611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547185|NCT04225611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102547186|NCT04225611|Glucocorticoids|glucocorticoids|mesh-ancestor
102547187|NCT04225611|Hormones|hormones|mesh-ancestor
102547188|NCT04225611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102547189|NCT04225611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102547190|NCT04225611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102547191|NCT00379977|Vaccines|vaccines|mesh-list
102547192|NCT00379977|Immunologic Factors|immunologic factors|mesh-ancestor
102547193|NCT00379977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547194|NCT05669885|Sildenafil Citrate|sildenafil citrate|mesh-list
102547195|NCT05669885|Vasodilator Agents|vasodilator agents|mesh-ancestor
102547196|NCT05669885|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102547197|NCT05669885|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102547198|NCT05669885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102547199|NCT05669885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547200|NCT05669885|Urological Agents|urological agents|mesh-ancestor
102547201|NCT00955929|Sildenafil Citrate|sildenafil citrate|mesh-list
102547202|NCT00955929|Alprostadil|alprostadil|mesh-list
102547203|NCT00955929|Vasodilator Agents|vasodilator agents|mesh-ancestor
102547204|NCT00955929|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102547205|NCT00955929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102547206|NCT00955929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102547207|NCT00955929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547208|NCT00955929|Urological Agents|urological agents|mesh-ancestor
102547209|NCT00955929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102547210|NCT00357851|Aprotinin|aprotinin|mesh-list
102547211|NCT00357851|Hemostatics|hemostatics|mesh-ancestor
102547212|NCT00357851|Coagulants|coagulants|mesh-ancestor
102547213|NCT00357851|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102547214|NCT00357851|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102547215|NCT00357851|Protease Inhibitors|protease inhibitors|mesh-ancestor
102547216|NCT00357851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102547217|NCT00357851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547218|NCT00358319|Valproic Acid|valproic acid|mesh-list
102547219|NCT00358319|Anticonvulsants|anticonvulsants|mesh-ancestor
102547220|NCT00358319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102547221|NCT00358319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547222|NCT00358319|GABA Agents|gaba agents|mesh-ancestor
102547223|NCT00358319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102547224|NCT00358319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547225|NCT00358319|Antimanic Agents|antimanic agents|mesh-ancestor
102547226|NCT00358319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102547227|NCT00358319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102547228|NCT00358319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102547229|NCT05663801|Magnesium Sulfate|magnesium sulfate|mesh-list
102547230|NCT05663801|Ketamine|ketamine|mesh-list
102547231|NCT05663801|Bupivacaine|bupivacaine|mesh-list
102547232|NCT05663801|Anesthetics, Local|anesthetics, local|mesh-ancestor
102547233|NCT05663801|Anesthetics|anesthetics|mesh-ancestor
102547234|NCT05663801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102241644|NCT04891809|Glucocorticoids|glucocorticoids|mesh-ancestor
102547235|NCT05663801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547236|NCT05663801|Sensory System Agents|sensory system agents|mesh-ancestor
102547237|NCT05663801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102547238|NCT05663801|Analgesics|analgesics|mesh-ancestor
102547239|NCT05663801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102547240|NCT05663801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102547241|NCT05663801|Anesthetics, General|anesthetics, general|mesh-ancestor
102547242|NCT05663801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102547243|NCT05663801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102547244|NCT05663801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102547245|NCT05663801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547246|NCT05663801|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102547247|NCT05663801|Anticonvulsants|anticonvulsants|mesh-ancestor
102547248|NCT05663801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102547249|NCT05663801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102547250|NCT05663801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102547251|NCT05663801|Tocolytic Agents|tocolytic agents|mesh-ancestor
102547252|NCT05663801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102547254|NCT03866499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102547255|NCT03866499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102547256|NCT03866499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102547257|NCT03866499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547258|NCT00000105|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
102547259|NCT00000105|Freund's Adjuvant|freund's adjuvant|mesh-list
102547260|NCT00000105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102547261|NCT00000105|Immunologic Factors|immunologic factors|mesh-ancestor
102547262|NCT00000105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547263|NCT00000117|Immunoglobulins|immunoglobulins|mesh-list
102547264|NCT00000117|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102547265|NCT00000117|Antibodies|antibodies|mesh-list
102547266|NCT00000117|Immunologic Factors|immunologic factors|mesh-ancestor
102547267|NCT00000117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547268|NCT00000123|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
102547269|NCT00000123|Vasodilator Agents|vasodilator agents|mesh-ancestor
102547270|NCT00000123|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
102547271|NCT00000123|Protective Agents|protective agents|mesh-ancestor
102547272|NCT00000123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547273|NCT00380133|Prednisolone|prednisolone|mesh-list
102547274|NCT00380133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102547275|NCT00380133|Glucocorticoids|glucocorticoids|mesh-ancestor
102547276|NCT00380133|Hormones|hormones|mesh-ancestor
102547277|NCT00380133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102547278|NCT00380133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547279|NCT00380133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102547280|NCT00380133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102547281|NCT02959229|Lactoferrin|lactoferrin|mesh-list
102547282|NCT02959229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102547283|NCT02953665|Liraglutide|liraglutide|mesh-list
102547284|NCT02953665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102547285|NCT02953665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547286|NCT02953665|Incretins|incretins|mesh-ancestor
102547287|NCT02953665|Hormones|hormones|mesh-ancestor
102547288|NCT02953665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102547289|NCT00000189|Gepirone|gepirone|mesh-list
102547290|NCT00000189|Antidepressive Agents|antidepressive agents|mesh-ancestor
102547291|NCT00000189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102547292|NCT00000189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102547293|NCT00000189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102547294|NCT00000189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102547295|NCT00000189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547296|NCT00000189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102547297|NCT00000189|Serotonin Agents|serotonin agents|mesh-ancestor
102547298|NCT00000189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102547299|NCT00000189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547300|NCT02681211|Diphenhydramine|diphenhydramine|mesh-list
102547301|NCT02681211|Promethazine|promethazine|mesh-list
102547302|NCT02681211|Ketorolac|ketorolac|mesh-list
102547303|NCT02681211|Metoclopramide|metoclopramide|mesh-list
102547304|NCT02681211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102241645|NCT04891809|Hormones|hormones|mesh-ancestor
102547305|NCT02681211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102547306|NCT02681211|Analgesics|analgesics|mesh-ancestor
102547307|NCT02681211|Sensory System Agents|sensory system agents|mesh-ancestor
102547308|NCT02681211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102547309|NCT02681211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547310|NCT02681211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102547311|NCT02681211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102547312|NCT02681211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102547313|NCT02681211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102547314|NCT02681211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547315|NCT02681211|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102547316|NCT02681211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102547317|NCT02681211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102547318|NCT02681211|Anesthetics, Local|anesthetics, local|mesh-ancestor
102547319|NCT02681211|Anesthetics|anesthetics|mesh-ancestor
102547320|NCT02681211|Antiemetics|antiemetics|mesh-ancestor
102547321|NCT02681211|Autonomic Agents|autonomic agents|mesh-ancestor
102547322|NCT02681211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102547323|NCT02681211|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102547324|NCT02681211|Histamine Antagonists|histamine antagonists|mesh-ancestor
102547325|NCT02681211|Histamine Agents|histamine agents|mesh-ancestor
102547326|NCT02681211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101834076|NCT00893477|Rituximab|rituximab|mesh-list
102547327|NCT02681211|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102547328|NCT02681211|Antipruritics|antipruritics|mesh-ancestor
102547329|NCT02681211|Dermatologic Agents|dermatologic agents|mesh-ancestor
102547330|NCT02681211|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102547331|NCT02681211|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102547332|NCT02681211|Dopamine Agents|dopamine agents|mesh-ancestor
102547333|NCT00000195|Naltrexone|naltrexone|mesh-list
102547334|NCT00000195|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102547335|NCT00000195|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102547336|NCT00000195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547337|NCT00000195|Sensory System Agents|sensory system agents|mesh-ancestor
102547338|NCT00000195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102547339|NCT00000201|Selegiline|selegiline|mesh-list
102547340|NCT00000201|Antidepressive Agents|antidepressive agents|mesh-ancestor
102547341|NCT00000201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102547342|NCT00000201|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102547343|NCT00000201|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102547344|NCT00000201|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102547345|NCT00000201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102547346|NCT00000201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547347|NCT00000201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102547348|NCT00000201|Protective Agents|protective agents|mesh-ancestor
102547349|NCT00000201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547350|NCT00000207|Buprenorphine|buprenorphine|mesh-list
102547351|NCT00000207|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102547352|NCT00000207|Narcotics|narcotics|mesh-ancestor
102547353|NCT00000207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102547354|NCT00000207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547355|NCT00000207|Analgesics|analgesics|mesh-ancestor
102547356|NCT00000207|Sensory System Agents|sensory system agents|mesh-ancestor
102547357|NCT00000207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102547358|NCT00000207|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102547359|NCT02295774|Methylene Blue|methylene blue|mesh-list
102547360|NCT02295774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102547361|NCT02295774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547362|NCT01807611|Mycophenolic Acid|mycophenolic acid|mesh-list
102547363|NCT01807611|Cyclophosphamide|cyclophosphamide|mesh-list
102547364|NCT01807611|Melphalan|melphalan|mesh-list
102547365|NCT01807611|Mechlorethamine|mechlorethamine|mesh-list
102547366|NCT01807611|Thiotepa|thiotepa|mesh-list
102547367|NCT01807611|Fludarabine|fludarabine|mesh-list
102547368|NCT01807611|Lenograstim|lenograstim|mesh-list
102547369|NCT01807611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102547370|NCT01807611|Immunologic Factors|immunologic factors|mesh-ancestor
102547371|NCT01807611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547372|NCT01807611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102547373|NCT01807611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102547374|NCT01807611|Alkylating Agents|alkylating agents|mesh-ancestor
102547375|NCT01807611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547376|NCT01807611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102547377|NCT01807611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102547378|NCT01807611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102547379|NCT01807611|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102547380|NCT01807611|Antitubercular Agents|antitubercular agents|mesh-ancestor
102547381|NCT01807611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102547382|NCT01807611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102547383|NCT01807611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102547384|NCT01807611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102547385|NCT02977949|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
102547386|NCT02977949|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102547387|NCT02977949|Hormone Antagonists|hormone antagonists|mesh-ancestor
102547388|NCT02977949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102547389|NCT02977949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547390|NCT02977949|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102547391|NCT02977949|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102547392|NCT02977949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102547393|NCT02294682|Gepotidacin|gepotidacin|mesh-list
102547394|NCT02294682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102547395|NCT02294682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102547396|NCT02294682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547397|NCT02294682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102547398|NCT01692717|Losartan|losartan|mesh-list
102547399|NCT01692717|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102547400|NCT01692717|Atorvastatin|atorvastatin|mesh-list
101834151|NCT01058902|Aspirin|aspirin|mesh-list
102547401|NCT01692717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102547402|NCT01692717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102547403|NCT01692717|Antimetabolites|antimetabolites|mesh-ancestor
102547404|NCT01692717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547405|NCT01692717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102547406|NCT01692717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102547407|NCT01692717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102547408|NCT01692717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102547409|NCT01692717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102547410|NCT01692717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102547411|NCT01692717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102547412|NCT01692717|Diuretics|diuretics|mesh-ancestor
102547413|NCT01692717|Natriuretic Agents|natriuretic agents|mesh-ancestor
102547414|NCT01692717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547415|NCT01692717|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102547416|NCT01692717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102547417|NCT00355277|Amitriptyline|amitriptyline|mesh-list
102547418|NCT00355277|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102547419|NCT00355277|Antidepressive Agents|antidepressive agents|mesh-ancestor
102547420|NCT00355277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102547421|NCT00355277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102547422|NCT00355277|Analgesics|analgesics|mesh-ancestor
102547423|NCT00355277|Sensory System Agents|sensory system agents|mesh-ancestor
102547424|NCT00355277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102547425|NCT00355277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547426|NCT00355277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102547427|NCT00355277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102547428|NCT00355277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102547429|NCT00355277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547430|NCT00355277|Adrenergic Agents|adrenergic agents|mesh-ancestor
102547431|NCT00355277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102547432|NCT00000735|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
102547433|NCT00000735|Antiviral Agents|antiviral agents|mesh-ancestor
102547434|NCT00000735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102547435|NCT00000213|Fluoxetine|fluoxetine|mesh-list
102547436|NCT00000213|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102547437|NCT00000213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102547438|NCT00000213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102547439|NCT00000213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547440|NCT00000213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102547441|NCT00000213|Serotonin Agents|serotonin agents|mesh-ancestor
102547442|NCT00000213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547443|NCT00000213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102547444|NCT00000213|Antidepressive Agents|antidepressive agents|mesh-ancestor
102547445|NCT00000213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102547446|NCT00000213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102547447|NCT00000213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102547448|NCT00000213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102547449|NCT00000219|Buprenorphine|buprenorphine|mesh-list
102547450|NCT00000219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102547451|NCT00000219|Narcotics|narcotics|mesh-ancestor
102547452|NCT00000219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102547453|NCT00000219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547454|NCT00000219|Analgesics|analgesics|mesh-ancestor
102547455|NCT00000219|Sensory System Agents|sensory system agents|mesh-ancestor
102547456|NCT00000219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102547457|NCT00000219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102547458|NCT00000225|Buprenorphine|buprenorphine|mesh-list
102547459|NCT00000225|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102547460|NCT00000225|Narcotics|narcotics|mesh-ancestor
102547461|NCT00000225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102547462|NCT00000225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547463|NCT00000225|Analgesics|analgesics|mesh-ancestor
102547464|NCT00000225|Sensory System Agents|sensory system agents|mesh-ancestor
102547465|NCT00000225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102547466|NCT00000225|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102547467|NCT02294604|Chlorhexidine|chlorhexidine|mesh-list
102547468|NCT02294604|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102547469|NCT02294604|Povidone-Iodine|povidone-iodine|mesh-list
102547470|NCT02294604|Povidone|povidone|mesh-list
102547471|NCT02294604|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102547472|NCT02294604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102547473|NCT02294604|Disinfectants|disinfectants|mesh-ancestor
102547474|NCT02294604|Dermatologic Agents|dermatologic agents|mesh-ancestor
101834222|NCT00891605|Paclitaxel|paclitaxel|mesh-list
102547475|NCT02294604|Plasma Substitutes|plasma substitutes|mesh-ancestor
102547476|NCT02294604|Blood Substitutes|blood substitutes|mesh-ancestor
102547477|NCT01645176|Hydroxychloroquine|hydroxychloroquine|mesh-list
102547478|NCT01645176|Atorvastatin|atorvastatin|mesh-list
102547479|NCT01645176|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102547480|NCT01645176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102547481|NCT01645176|Antimetabolites|antimetabolites|mesh-ancestor
102547482|NCT01645176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547483|NCT01645176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102547484|NCT01645176|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102547485|NCT01645176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102547486|NCT01645176|Antimalarials|antimalarials|mesh-ancestor
102547487|NCT01645176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102547488|NCT01645176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102547489|NCT01645176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102547490|NCT01645176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102547491|NCT03465735|Heparin|heparin|mesh-list
102547492|NCT03465735|Enoxaparin|enoxaparin|mesh-list
102547493|NCT03465735|Dalteparin|dalteparin|mesh-list
102547494|NCT03465735|Warfarin|warfarin|mesh-list
102547495|NCT03465735|Rivaroxaban|rivaroxaban|mesh-list
102547496|NCT03465735|Dabigatran|dabigatran|mesh-list
102547497|NCT03465735|Apixaban|apixaban|mesh-list
102547498|NCT03465735|Edoxaban|edoxaban|mesh-list
102547499|NCT03465735|Anticoagulants|anticoagulants|mesh-ancestor
102547500|NCT03465735|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102547501|NCT03465735|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102547502|NCT03465735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547503|NCT03465735|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102547504|NCT03465735|Antithrombins|antithrombins|mesh-ancestor
102547505|NCT03465735|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102547506|NCT03465735|Protease Inhibitors|protease inhibitors|mesh-ancestor
102547507|NCT03465735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102547508|NCT05637671|Paroxetine|paroxetine|mesh-list
102547509|NCT05637671|Oxybutynin|oxybutynin|mesh-list
102547510|NCT05637671|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102547511|NCT05637671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102547512|NCT05637671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102547513|NCT05637671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547514|NCT05637671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102547515|NCT05637671|Serotonin Agents|serotonin agents|mesh-ancestor
102547516|NCT05637671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547517|NCT05637671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102547518|NCT05637671|Antidepressive Agents|antidepressive agents|mesh-ancestor
102547519|NCT05637671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102547520|NCT05637671|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102547521|NCT05637671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102547522|NCT05637671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102547523|NCT05637671|Parasympatholytics|parasympatholytics|mesh-ancestor
102547524|NCT05637671|Autonomic Agents|autonomic agents|mesh-ancestor
102547525|NCT05637671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102547526|NCT05637671|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102547527|NCT05637671|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102547528|NCT05637671|Cholinergic Agents|cholinergic agents|mesh-ancestor
102547529|NCT05637671|Urological Agents|urological agents|mesh-ancestor
102547530|NCT02322216|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
102547531|NCT02322216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102547532|NCT02322216|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102547533|NCT02322216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102547534|NCT02322216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102547535|NCT02322216|Analgesics|analgesics|mesh-ancestor
102547536|NCT02322216|Sensory System Agents|sensory system agents|mesh-ancestor
102547537|NCT02322216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102547538|NCT02322216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547539|NCT02322216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102547540|NCT02322216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102547541|NCT02322216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102547542|NCT02322216|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102547543|NCT02322216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102547544|NCT02322216|Histamine Antagonists|histamine antagonists|mesh-ancestor
102547545|NCT02322216|Histamine Agents|histamine agents|mesh-ancestor
102547546|NCT02322216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102547547|NCT02322216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547548|NCT03447639|Povidone-Iodine|povidone-iodine|mesh-list
102547549|NCT03447639|Povidone|povidone|mesh-list
102547550|NCT03447639|Plasma Substitutes|plasma substitutes|mesh-ancestor
102547551|NCT03447639|Blood Substitutes|blood substitutes|mesh-ancestor
102547552|NCT03447639|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102547553|NCT03447639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102547554|NCT03425799|Tranexamic Acid|tranexamic acid|mesh-list
102547555|NCT03425799|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102547556|NCT03425799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102547557|NCT03425799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547558|NCT03425799|Hemostatics|hemostatics|mesh-ancestor
102547559|NCT03425799|Coagulants|coagulants|mesh-ancestor
102547560|NCT03363633|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
102547561|NCT03363633|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102547562|NCT03363633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102547563|NCT03360903|Caffeine|caffeine|mesh-list
102547564|NCT03360903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102547565|NCT03360903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547566|NCT03360903|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102547567|NCT03360903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102547568|NCT03360903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547569|NCT03360903|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102547570|NCT03360903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102547571|NCT03360903|Purinergic Agents|purinergic agents|mesh-ancestor
102547572|NCT03360903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102547573|NCT00000231|Buprenorphine|buprenorphine|mesh-list
102547574|NCT00000231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102547575|NCT00000231|Narcotics|narcotics|mesh-ancestor
102547576|NCT00000231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102547577|NCT00000231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547578|NCT00000231|Analgesics|analgesics|mesh-ancestor
102547579|NCT00000231|Sensory System Agents|sensory system agents|mesh-ancestor
102547580|NCT00000231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102547581|NCT00000231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102547582|NCT00000237|Buprenorphine|buprenorphine|mesh-list
102547583|NCT00000237|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102547584|NCT00000237|Narcotics|narcotics|mesh-ancestor
102547585|NCT00000237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102547586|NCT00000237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547587|NCT00000237|Analgesics|analgesics|mesh-ancestor
102547588|NCT00000237|Sensory System Agents|sensory system agents|mesh-ancestor
102547589|NCT00000237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102547590|NCT00000237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102547591|NCT00000765|Zidovudine|zidovudine|mesh-list
102547592|NCT00000765|Antimetabolites|antimetabolites|mesh-ancestor
102547593|NCT00000765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547594|NCT00000765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102547595|NCT00000765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102547596|NCT00000765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102547597|NCT00000765|Antiviral Agents|antiviral agents|mesh-ancestor
102547598|NCT00000765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102547599|NCT00000765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102547600|NCT00000765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102547601|NCT00000243|Buprenorphine|buprenorphine|mesh-list
102547602|NCT00000243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102547603|NCT00000243|Narcotics|narcotics|mesh-ancestor
102547604|NCT00000243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102547605|NCT00000243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547606|NCT00000243|Analgesics|analgesics|mesh-ancestor
102547607|NCT00000243|Sensory System Agents|sensory system agents|mesh-ancestor
102547608|NCT00000243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102547609|NCT00000243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102547610|NCT00000771|Paromomycin|paromomycin|mesh-list
102547611|NCT00000771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102547612|NCT00000771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102547613|NCT00000771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102547614|NCT00000771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102547615|NCT05575505|Pentoxifylline|pentoxifylline|mesh-list
102547616|NCT05575505|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102547617|NCT05575505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102547618|NCT05575505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547619|NCT05575505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102547620|NCT05575505|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102547621|NCT05575505|Protective Agents|protective agents|mesh-ancestor
102547622|NCT05575505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547623|NCT05575505|Vasodilator Agents|vasodilator agents|mesh-ancestor
102547624|NCT05575505|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102547625|NCT05575505|Antioxidants|antioxidants|mesh-ancestor
102547626|NCT00000249|Nitrous Oxide|nitrous oxide|mesh-list
102547627|NCT00000249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102547628|NCT00000249|Anesthetics, General|anesthetics, general|mesh-ancestor
102547629|NCT00000249|Anesthetics|anesthetics|mesh-ancestor
102547630|NCT00000249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102547631|NCT00000249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547632|NCT00000249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102547633|NCT00000249|Analgesics|analgesics|mesh-ancestor
102547634|NCT00000249|Sensory System Agents|sensory system agents|mesh-ancestor
102547635|NCT00000249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102547636|NCT00000261|Nitrous Oxide|nitrous oxide|mesh-list
102547637|NCT00000261|Sevoflurane|sevoflurane|mesh-list
102547638|NCT00000261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102547639|NCT00000261|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102547640|NCT00000261|Anesthetics, General|anesthetics, general|mesh-ancestor
102547641|NCT00000261|Anesthetics|anesthetics|mesh-ancestor
102547642|NCT00000261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102547643|NCT00000261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547644|NCT00000261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102547645|NCT00000261|Analgesics|analgesics|mesh-ancestor
102547646|NCT00000261|Sensory System Agents|sensory system agents|mesh-ancestor
102547647|NCT00000261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102547648|NCT00000801|Cytarabine|cytarabine|mesh-list
102547649|NCT00000801|Dexamethasone|dexamethasone|mesh-list
102547650|NCT00000801|Cyclophosphamide|cyclophosphamide|mesh-list
102547651|NCT00000801|Doxorubicin|doxorubicin|mesh-list
102547652|NCT00000801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102547653|NCT00000801|Vincristine|vincristine|mesh-list
102547654|NCT00000801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102547655|NCT00000801|Immunologic Factors|immunologic factors|mesh-ancestor
102547656|NCT00000801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547657|NCT00000801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102547658|NCT00000801|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102547659|NCT00000801|Alkylating Agents|alkylating agents|mesh-ancestor
102547660|NCT00000801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547661|NCT00000801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102547662|NCT00000801|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102547663|NCT00000801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102547664|NCT00000801|Antiemetics|antiemetics|mesh-ancestor
102547665|NCT00000801|Autonomic Agents|autonomic agents|mesh-ancestor
102547666|NCT00000801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102547667|NCT00000801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102547668|NCT00000801|Glucocorticoids|glucocorticoids|mesh-ancestor
102547669|NCT00000801|Hormones|hormones|mesh-ancestor
102547670|NCT00000801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102547671|NCT00000801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102547672|NCT00000801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102547673|NCT00000801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102547674|NCT00000801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102547675|NCT00000801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102547676|NCT00000801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102547677|NCT00000801|Antimetabolites|antimetabolites|mesh-ancestor
102547678|NCT00000801|Antiviral Agents|antiviral agents|mesh-ancestor
102547679|NCT00000801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102547680|NCT00000801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102547681|NCT00000801|Tubulin Modulators|tubulin modulators|mesh-ancestor
102547682|NCT00000801|Antimitotic Agents|antimitotic agents|mesh-ancestor
102547683|NCT00000801|Mitosis Modulators|mitosis modulators|mesh-ancestor
102547684|NCT00000267|Risperidone|risperidone|mesh-list
102547685|NCT00000267|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102547686|NCT00000267|Serotonin Agents|serotonin agents|mesh-ancestor
102547687|NCT00000267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102547688|NCT00000267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547689|NCT00000267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547690|NCT00000267|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102547691|NCT00000267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102547692|NCT00000267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102547693|NCT00000267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102547694|NCT00000267|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102547695|NCT00000267|Dopamine Agents|dopamine agents|mesh-ancestor
102547696|NCT00000807|Etoposide|etoposide|mesh-list
102547697|NCT00000807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102547698|NCT00000807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102547699|NCT00000807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102547700|NCT00000807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102547701|NCT00000807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102547702|NCT00000807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547703|NCT00001677|Methotrexate|methotrexate|mesh-list
102547704|NCT00001677|Fludarabine|fludarabine|mesh-list
102547705|NCT00001677|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102547706|NCT00001677|Abortifacient Agents|abortifacient agents|mesh-ancestor
102547707|NCT00001677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102547708|NCT00001677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547709|NCT00001677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102547710|NCT00001677|Antimetabolites|antimetabolites|mesh-ancestor
102547711|NCT00001677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547712|NCT00001677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102547713|NCT00001677|Dermatologic Agents|dermatologic agents|mesh-ancestor
102547714|NCT00001677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102547715|NCT00001677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102547716|NCT00001677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102547717|NCT00001677|Immunologic Factors|immunologic factors|mesh-ancestor
102547718|NCT00001677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102547719|NCT00001677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102547720|NCT00001689|Vincristine|vincristine|mesh-list
102547721|NCT00001689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102547722|NCT00001689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102547723|NCT00001689|Tubulin Modulators|tubulin modulators|mesh-ancestor
102547724|NCT00001689|Antimitotic Agents|antimitotic agents|mesh-ancestor
102547725|NCT00001689|Mitosis Modulators|mitosis modulators|mesh-ancestor
102547726|NCT00001689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547727|NCT00001713|Heparin|heparin|mesh-list
102547728|NCT00001713|Plasminogen|plasminogen|mesh-list
102547729|NCT00001713|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102547730|NCT00001713|Warfarin|warfarin|mesh-list
102547731|NCT00001713|Anticoagulants|anticoagulants|mesh-ancestor
102547732|NCT00001713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102547733|NCT00001713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102547734|NCT00001713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547735|NCT00000273|Fentanyl|fentanyl|mesh-list
102547736|NCT00000273|Morphine|morphine|mesh-list
102547737|NCT00000273|Oxycodone|oxycodone|mesh-list
102547738|NCT00000273|Buprenorphine|buprenorphine|mesh-list
102547739|NCT00000273|Methadone|methadone|mesh-list
102547740|NCT00000273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102547741|NCT00000273|Narcotics|narcotics|mesh-ancestor
102547742|NCT00000273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102547743|NCT00000273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547744|NCT00000273|Analgesics|analgesics|mesh-ancestor
102547745|NCT00000273|Sensory System Agents|sensory system agents|mesh-ancestor
102547746|NCT00000273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102547747|NCT00000273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102547748|NCT00000273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102547749|NCT00000273|Anesthetics, General|anesthetics, general|mesh-ancestor
102547750|NCT00000273|Anesthetics|anesthetics|mesh-ancestor
102547751|NCT00000273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102547752|NCT00000273|Antitussive Agents|antitussive agents|mesh-ancestor
102547753|NCT00000273|Respiratory System Agents|respiratory system agents|mesh-ancestor
102547754|NCT00000819|Prednisone|prednisone|mesh-list
102547755|NCT00000819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102547756|NCT00000819|Glucocorticoids|glucocorticoids|mesh-ancestor
102547757|NCT00000819|Hormones|hormones|mesh-ancestor
102547758|NCT00000819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102547759|NCT00000819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547760|NCT00000819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102547761|NCT00000819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102547762|NCT00000279|Clonidine|clonidine|mesh-list
102547763|NCT00000279|Analgesics|analgesics|mesh-ancestor
102547764|NCT00000279|Sensory System Agents|sensory system agents|mesh-ancestor
102547765|NCT00000279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102547766|NCT00000279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547767|NCT00000279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102547768|NCT00000279|Sympatholytics|sympatholytics|mesh-ancestor
102547769|NCT00000279|Autonomic Agents|autonomic agents|mesh-ancestor
102547770|NCT00000279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102547771|NCT00000279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102547772|NCT00000279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102547773|NCT00000279|Adrenergic Agents|adrenergic agents|mesh-ancestor
102547774|NCT00000279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102547775|NCT00000279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547776|NCT00000825|Aldesleukin|aldesleukin|mesh-list
102547777|NCT00000825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102547778|NCT00000825|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102547779|NCT00000825|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102547780|NCT00000825|Antiviral Agents|antiviral agents|mesh-ancestor
102547781|NCT00000825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102547782|NCT00000285|Phenytoin|phenytoin|mesh-list
102547783|NCT00000285|Anticonvulsants|anticonvulsants|mesh-ancestor
102547784|NCT00000285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102547785|NCT00000285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102547786|NCT00000285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102547787|NCT00000285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547788|NCT00000285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101767831|NCT01267604|Melatonin|melatonin|mesh-list
102547789|NCT00000285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102547790|NCT00001737|Cyclosporine|cyclosporine|mesh-list
102547791|NCT00001737|Cyclosporins|cyclosporins|mesh-list
102547792|NCT00001737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102547793|NCT00001737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547794|NCT00001737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102547795|NCT00001737|Immunologic Factors|immunologic factors|mesh-ancestor
102547796|NCT00001737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547797|NCT00001737|Antifungal Agents|antifungal agents|mesh-ancestor
102547798|NCT00001737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102547799|NCT00001737|Dermatologic Agents|dermatologic agents|mesh-ancestor
102547800|NCT00001737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102547801|NCT00001737|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102547802|NCT00000843|Adefovir|adefovir|mesh-list
102547803|NCT00000843|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
102547804|NCT00000843|Antiviral Agents|antiviral agents|mesh-ancestor
102547805|NCT00000843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102547806|NCT00000843|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102547807|NCT00000843|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102547808|NCT00000843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102547809|NCT00000843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547810|NCT05362487|Bromides|bromides|mesh-list
102547811|NCT05362487|Tiotropium Bromide|tiotropium bromide|mesh-list
102547812|NCT05362487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102547813|NCT05362487|Autonomic Agents|autonomic agents|mesh-ancestor
102547814|NCT05362487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102547815|NCT05362487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547816|NCT05362487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102547817|NCT05362487|Respiratory System Agents|respiratory system agents|mesh-ancestor
102547818|NCT05362487|Parasympatholytics|parasympatholytics|mesh-ancestor
102547819|NCT05362487|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102547820|NCT05362487|Cholinergic Agents|cholinergic agents|mesh-ancestor
102547821|NCT05362487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102547822|NCT05362487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547823|NCT05362487|Anticonvulsants|anticonvulsants|mesh-ancestor
102547824|NCT00000291|Labetalol|labetalol|mesh-list
102547825|NCT00000291|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102547826|NCT00000291|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102547827|NCT00000291|Adrenergic Agents|adrenergic agents|mesh-ancestor
102547828|NCT00000291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102547829|NCT00000291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547830|NCT00000291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547831|NCT00000291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102547832|NCT00000291|Sympathomimetics|sympathomimetics|mesh-ancestor
102547833|NCT00000291|Autonomic Agents|autonomic agents|mesh-ancestor
102547834|NCT00000291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102547835|NCT00000291|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102547836|NCT00000291|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102547837|NCT00000861|Indinavir|indinavir|mesh-list
102547838|NCT00000861|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102547839|NCT00000861|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102547840|NCT00000861|Protease Inhibitors|protease inhibitors|mesh-ancestor
102547841|NCT00000861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102547842|NCT00000861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547843|NCT00000861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102547844|NCT00000861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102547845|NCT00000861|Antiviral Agents|antiviral agents|mesh-ancestor
102547846|NCT00000861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102547847|NCT00000297|Labetalol|labetalol|mesh-list
102547848|NCT00000297|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102547849|NCT00000297|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102547850|NCT00000297|Adrenergic Agents|adrenergic agents|mesh-ancestor
102547851|NCT00000297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102547852|NCT00000297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547853|NCT00000297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547854|NCT00000297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102547855|NCT00000297|Sympathomimetics|sympathomimetics|mesh-ancestor
101767923|NCT00546052|Losartan|losartan|mesh-list
102547856|NCT00000297|Autonomic Agents|autonomic agents|mesh-ancestor
102547857|NCT00000297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102547858|NCT00000297|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102547859|NCT00000297|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102547860|NCT00359879|Exenatide|exenatide|mesh-list
102547861|NCT00359879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102547862|NCT00359879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547863|NCT00359879|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102547864|NCT00359879|Incretins|incretins|mesh-ancestor
102547865|NCT00359879|Hormones|hormones|mesh-ancestor
102547866|NCT00359879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102547867|NCT00000303|Baclofen|baclofen|mesh-list
102547868|NCT00000303|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102547869|NCT00000303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547870|NCT00000303|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102547871|NCT00000303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102547872|NCT00000303|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102547873|NCT00000303|GABA Agonists|gaba agonists|mesh-ancestor
102547874|NCT00000303|GABA Agents|gaba agents|mesh-ancestor
102547875|NCT00000303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102547876|NCT00000303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547877|NCT00001785|Interferons|interferons|mesh-list
102547878|NCT00001785|Interferon-beta|interferon-beta|mesh-list
102547879|NCT00001785|Interferon beta-1a|interferon beta-1a|mesh-list
102547880|NCT00001785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102547881|NCT00001785|Antiviral Agents|antiviral agents|mesh-ancestor
102547882|NCT00001785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102547883|NCT00001785|Immunologic Factors|immunologic factors|mesh-ancestor
102547884|NCT00001785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547885|NCT00001785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102547886|NCT00001827|Aldesleukin|aldesleukin|mesh-list
102547887|NCT00001827|Sargramostim|sargramostim|mesh-list
102547888|NCT00001827|Freund's Adjuvant|freund's adjuvant|mesh-list
102547889|NCT00001827|Immunologic Factors|immunologic factors|mesh-ancestor
102547890|NCT00001827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547891|NCT00001827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102547892|NCT00001827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102547893|NCT00001827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102547894|NCT00001827|Antiviral Agents|antiviral agents|mesh-ancestor
102547895|NCT00001827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102547896|NCT00001827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102547897|NCT01647516|Ozanimod|ozanimod|mesh-list
102547898|NCT01647516|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102547899|NCT01647516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547900|NCT01647516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102547901|NCT01647516|Immunologic Factors|immunologic factors|mesh-ancestor
102547902|NCT01647516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547903|NCT00001839|Cyclosporine|cyclosporine|mesh-list
102547904|NCT00001839|Cyclosporins|cyclosporins|mesh-list
102547905|NCT00001839|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102547906|NCT00001839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102547907|NCT00001839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547908|NCT00001839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102547909|NCT00001839|Immunologic Factors|immunologic factors|mesh-ancestor
102547910|NCT00001839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547911|NCT00001839|Antifungal Agents|antifungal agents|mesh-ancestor
102547912|NCT00001839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102547913|NCT00001839|Dermatologic Agents|dermatologic agents|mesh-ancestor
102547914|NCT00001839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102547915|NCT00001839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102547916|NCT00000885|Lamivudine|lamivudine|mesh-list
102547917|NCT00000885|Zidovudine|zidovudine|mesh-list
102547918|NCT00000885|Efavirenz|efavirenz|mesh-list
102547919|NCT00000885|Abacavir|abacavir|mesh-list
102547920|NCT00000885|Stavudine|stavudine|mesh-list
102547921|NCT00000885|Didanosine|didanosine|mesh-list
102547922|NCT00000885|Adefovir|adefovir|mesh-list
102547923|NCT00000885|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
102547924|NCT00000885|Nelfinavir|nelfinavir|mesh-list
102547925|NCT00000885|Indinavir|indinavir|mesh-list
102547926|NCT00000885|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102547927|NCT00000885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102547928|NCT00000885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102547929|NCT00000885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547930|NCT00000885|Antiviral Agents|antiviral agents|mesh-ancestor
102547931|NCT00000885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102547932|NCT00000885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102547933|NCT00000885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102547934|NCT00000885|Antimetabolites|antimetabolites|mesh-ancestor
102547935|NCT00000885|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102547936|NCT00000885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102547937|NCT00000885|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102547938|NCT00000885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102547939|NCT00000885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102547940|NCT00000885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102547941|NCT00000885|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102547942|NCT00000885|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102547943|NCT00000885|Protease Inhibitors|protease inhibitors|mesh-ancestor
102547944|NCT01647282|Minocycline|minocycline|mesh-list
102547945|NCT01647282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102547946|NCT01647282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102547947|NCT00000897|Zidovudine|zidovudine|mesh-list
102547948|NCT00000897|Antimetabolites|antimetabolites|mesh-ancestor
102547949|NCT00000897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547950|NCT00000897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102547951|NCT00000897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102547952|NCT00000897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102547953|NCT00000897|Antiviral Agents|antiviral agents|mesh-ancestor
102547954|NCT00000897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102547955|NCT00000897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102547956|NCT00000897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102547957|NCT05347979|Dabigatran|dabigatran|mesh-list
102547958|NCT05347979|Antithrombins|antithrombins|mesh-ancestor
102547959|NCT05347979|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102547960|NCT05347979|Protease Inhibitors|protease inhibitors|mesh-ancestor
102547961|NCT05347979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102547962|NCT05347979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547963|NCT05347979|Anticoagulants|anticoagulants|mesh-ancestor
102547964|NCT00000909|Aldesleukin|aldesleukin|mesh-list
102547965|NCT00000909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102547966|NCT00000909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102547967|NCT00000909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102547968|NCT00000909|Antiviral Agents|antiviral agents|mesh-ancestor
102547969|NCT00000909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102547970|NCT05444699|Prednisolone|prednisolone|mesh-list
102547971|NCT05444699|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102547972|NCT05444699|Methylprednisolone|methylprednisolone|mesh-list
102547973|NCT05444699|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102547974|NCT05444699|Prednisolone acetate|prednisolone acetate|mesh-list
102547975|NCT05444699|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102547976|NCT05444699|Prednisolone phosphate|prednisolone phosphate|mesh-list
102547977|NCT05444699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102547978|NCT05444699|Glucocorticoids|glucocorticoids|mesh-ancestor
102547979|NCT05444699|Hormones|hormones|mesh-ancestor
102547980|NCT05444699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102547981|NCT05444699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547982|NCT05444699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102547983|NCT05444699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102547984|NCT05444699|Antiemetics|antiemetics|mesh-ancestor
102547985|NCT05444699|Autonomic Agents|autonomic agents|mesh-ancestor
102547986|NCT05444699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102547987|NCT05444699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102547988|NCT05444699|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102547989|NCT05444699|Protective Agents|protective agents|mesh-ancestor
102547990|NCT00001863|Leflunomide|leflunomide|mesh-list
102547991|NCT00001863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102547992|NCT00001863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102547993|NCT00001863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102547994|NCT00001863|Immunologic Factors|immunologic factors|mesh-ancestor
102547995|NCT00001863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102547996|NCT00000921|Prednisone|prednisone|mesh-list
102547997|NCT00000921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102547998|NCT00000921|Glucocorticoids|glucocorticoids|mesh-ancestor
102547999|NCT00000921|Hormones|hormones|mesh-ancestor
102548000|NCT00000921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102548001|NCT00000921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548002|NCT00000921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102548003|NCT00000921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102548004|NCT02321436|Botulinum Toxins|botulinum toxins|mesh-list
102548005|NCT02321436|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102548006|NCT02321436|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102548007|NCT02321436|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101834747|NCT00605813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102548008|NCT02321436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102548009|NCT02321436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548010|NCT02321436|Cholinergic Agents|cholinergic agents|mesh-ancestor
102548011|NCT02321436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102548012|NCT02321436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548013|NCT02321436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102548014|NCT02321436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102548015|NCT05325515|Alendronate|alendronate|mesh-list
102548016|NCT05325515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102548017|NCT05325515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548018|NCT00000939|Efavirenz|efavirenz|mesh-list
102548019|NCT00000939|Stavudine|stavudine|mesh-list
102548020|NCT00000939|Didanosine|didanosine|mesh-list
102548021|NCT00000939|Hydroxyurea|hydroxyurea|mesh-list
102548022|NCT00000939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102548023|NCT00000939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102548024|NCT00000939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548025|NCT00000939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548026|NCT00000939|Antiviral Agents|antiviral agents|mesh-ancestor
102548027|NCT00000939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548028|NCT00000939|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102548029|NCT00000939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102548030|NCT00000939|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102548031|NCT00000939|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102548032|NCT00000939|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102548033|NCT00000939|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102548034|NCT00000939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102548035|NCT00000939|Antisickling Agents|antisickling agents|mesh-ancestor
102548036|NCT00000939|Antimetabolites|antimetabolites|mesh-ancestor
102548037|NCT00000939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102548038|NCT00000939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102548039|NCT00000945|Cidofovir|cidofovir|mesh-list
102548040|NCT00000945|Probenecid|probenecid|mesh-list
102548041|NCT00000945|Uricosuric Agents|uricosuric agents|mesh-ancestor
102548042|NCT00000945|Gout Suppressants|gout suppressants|mesh-ancestor
102548043|NCT00000945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102548044|NCT00000945|Antiviral Agents|antiviral agents|mesh-ancestor
102548045|NCT00000945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548046|NCT00000945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548047|NCT00000945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548048|NCT04344041|Cholecalciferol|cholecalciferol|mesh-list
102548049|NCT04344041|Vitamin D|vitamin d|mesh-list
102548050|NCT04344041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102548051|NCT04344041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548052|NCT04344041|Vitamins|vitamins|mesh-ancestor
102548053|NCT04344041|Micronutrients|micronutrients|mesh-ancestor
102548054|NCT04344041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102548055|NCT00000963|Didanosine|didanosine|mesh-list
102548056|NCT00000963|Antimetabolites|antimetabolites|mesh-ancestor
102548057|NCT00000963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548058|NCT00000963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102548059|NCT00000963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102548060|NCT00000963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548061|NCT00000963|Antiviral Agents|antiviral agents|mesh-ancestor
102548062|NCT00000963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548063|NCT00000963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102548064|NCT00000963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102548065|NCT02319642|Certolizumab Pegol|certolizumab pegol|mesh-list
102548066|NCT02319642|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102548067|NCT02319642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101768097|NCT00888303|Glucocorticoids|glucocorticoids|mesh-ancestor
102548068|NCT02319642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102548069|NCT02319642|Immunologic Factors|immunologic factors|mesh-ancestor
102548070|NCT02319642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548071|NCT02319642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102548072|NCT00001893|Etanercept|etanercept|mesh-list
102548073|NCT00001893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102548074|NCT00001893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102548075|NCT00001893|Analgesics|analgesics|mesh-ancestor
102548076|NCT00001893|Sensory System Agents|sensory system agents|mesh-ancestor
102548077|NCT00001893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102548078|NCT00001893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548079|NCT00001893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102548080|NCT00001893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102548081|NCT00001893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102548082|NCT00001893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102548083|NCT00001893|Immunologic Factors|immunologic factors|mesh-ancestor
102548084|NCT00000981|Fiacitabine|fiacitabine|mesh-list
102548085|NCT00000981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102548086|NCT00000981|Antiviral Agents|antiviral agents|mesh-ancestor
102548087|NCT00000981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548088|NCT02280096|4-Aminopyridine|4-aminopyridine|mesh-list
102548089|NCT02280096|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102548090|NCT02280096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102548091|NCT02280096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548092|NCT00001905|Interferons|interferons|mesh-list
102548093|NCT00001905|Interferon-gamma|interferon-gamma|mesh-list
102548094|NCT00001905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102548095|NCT00001905|Antiviral Agents|antiviral agents|mesh-ancestor
102548096|NCT00001905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548097|NCT00000987|Zidovudine|zidovudine|mesh-list
102548098|NCT00000987|Doxorubicin|doxorubicin|mesh-list
102548099|NCT00000987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102548100|NCT00000987|Bleomycin|bleomycin|mesh-list
102548101|NCT00000987|Vincristine|vincristine|mesh-list
102548102|NCT00000987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102548103|NCT00000987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102548104|NCT00000987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102548105|NCT00000987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102548106|NCT00000987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548107|NCT00000987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548108|NCT00000987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102548109|NCT00000987|Tubulin Modulators|tubulin modulators|mesh-ancestor
102548110|NCT00000987|Antimitotic Agents|antimitotic agents|mesh-ancestor
102548111|NCT00000987|Mitosis Modulators|mitosis modulators|mesh-ancestor
102548112|NCT00000987|Antimetabolites|antimetabolites|mesh-ancestor
102548113|NCT00000987|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102548114|NCT00000987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102548115|NCT00000987|Antiviral Agents|antiviral agents|mesh-ancestor
102548116|NCT00000987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548117|NCT00000987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102548118|NCT00000987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102548119|NCT00001911|Interleukin-12|interleukin-12|mesh-list
102548120|NCT00001911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102548121|NCT00001911|Immunologic Factors|immunologic factors|mesh-ancestor
102548122|NCT00001911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548123|NCT00001911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102548124|NCT00001911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102548125|NCT00001911|Growth Substances|growth substances|mesh-ancestor
102548126|NCT00001911|Growth Inhibitors|growth inhibitors|mesh-ancestor
102548127|NCT00001911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102548128|NCT00001929|Eliprodil|eliprodil|mesh-list
102548129|NCT00001929|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102548130|NCT00001929|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102548131|NCT00001929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102548132|NCT00001929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548133|NCT00001929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548134|NCT00001929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102548135|NCT00001929|Protective Agents|protective agents|mesh-ancestor
102548136|NCT00358553|Insulin|insulin|mesh-list
102548137|NCT00358553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101768172|NCT01051219|Losartan|losartan|mesh-list
102548138|NCT00358553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548139|NCT00000993|Zidovudine|zidovudine|mesh-list
102548140|NCT00000993|Antimetabolites|antimetabolites|mesh-ancestor
102548141|NCT00000993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548142|NCT00000993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102548143|NCT00000993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102548144|NCT00000993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548145|NCT00000993|Antiviral Agents|antiviral agents|mesh-ancestor
102548146|NCT00000993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548147|NCT00000993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102548148|NCT00000993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102548149|NCT00359177|Casopitant|casopitant|mesh-list
102548150|NCT00359177|Antiemetics|antiemetics|mesh-ancestor
102548151|NCT00359177|Autonomic Agents|autonomic agents|mesh-ancestor
102548152|NCT00359177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102548153|NCT00359177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548154|NCT00359177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102548155|NCT00359177|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102548156|NCT00359177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102548157|NCT00359177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548158|NCT00001017|Fluconazole|fluconazole|mesh-list
102548159|NCT00001017|Amphotericin B|amphotericin b|mesh-list
102548160|NCT00001017|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102548161|NCT00001017|Antifungal Agents|antifungal agents|mesh-ancestor
102548162|NCT00001017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548163|NCT00001017|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102548164|NCT00001017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102548165|NCT00001017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548166|NCT00001017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548167|NCT00001017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102548168|NCT00001017|Hormone Antagonists|hormone antagonists|mesh-ancestor
102548169|NCT00001017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102548170|NCT00001017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548171|NCT00001017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102548172|NCT00001017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102548173|NCT00001017|Amebicides|amebicides|mesh-ancestor
102548174|NCT00001017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102548175|NCT00001017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102548176|NCT00001017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102548177|NCT02279862|Ipilimumab|ipilimumab|mesh-list
102548178|NCT02279862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102548179|NCT02279862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102548180|NCT02279862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102548181|NCT02279862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548182|NCT00001965|Cyclosporine|cyclosporine|mesh-list
102548183|NCT00001965|Cyclosporins|cyclosporins|mesh-list
102548184|NCT00001965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548185|NCT00001965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548186|NCT00001965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102548187|NCT00001965|Immunologic Factors|immunologic factors|mesh-ancestor
102548188|NCT00001965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548189|NCT00001965|Antifungal Agents|antifungal agents|mesh-ancestor
102548190|NCT00001965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548191|NCT00001965|Dermatologic Agents|dermatologic agents|mesh-ancestor
102548192|NCT00001965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102548193|NCT00001965|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102548194|NCT00001023|Azithromycin|azithromycin|mesh-list
102548195|NCT00001023|Clarithromycin|clarithromycin|mesh-list
102548196|NCT00001023|Rifabutin|rifabutin|mesh-list
102548197|NCT00001023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102548198|NCT00001023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548199|NCT00001023|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102548200|NCT00001023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548201|NCT00001023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548202|NCT00001023|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102548203|NCT00001023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102548204|NCT00001023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102548205|NCT00001023|Antitubercular Agents|antitubercular agents|mesh-ancestor
102548206|NCT00001035|Interferons|interferons|mesh-list
102548207|NCT00001035|Interferon-alpha|interferon-alpha|mesh-list
102548208|NCT00001035|Interferon alpha-2|interferon alpha-2|mesh-list
102548209|NCT00001035|Zidovudine|zidovudine|mesh-list
102548210|NCT00001035|Didanosine|didanosine|mesh-list
102548211|NCT00001035|Zalcitabine|zalcitabine|mesh-list
102548212|NCT00001035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102548213|NCT00001035|Antiviral Agents|antiviral agents|mesh-ancestor
102548214|NCT00001035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548215|NCT00001035|Immunologic Factors|immunologic factors|mesh-ancestor
102548216|NCT00001035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548217|NCT00001035|Antimetabolites|antimetabolites|mesh-ancestor
102548218|NCT00001035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548219|NCT00001035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102548220|NCT00001035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102548221|NCT00001035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548222|NCT00001035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102548223|NCT00001035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102548224|NCT05503901|Timolol|timolol|mesh-list
102548225|NCT05503901|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102548226|NCT05503901|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102548227|NCT05503901|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102548228|NCT05503901|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102548229|NCT05503901|Adrenergic Agents|adrenergic agents|mesh-ancestor
102548230|NCT05503901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102548231|NCT05503901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548232|NCT05503901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548233|NCT05503901|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102548234|NCT05503901|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102548235|NCT00001053|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102548236|NCT00001053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102548237|NCT00001053|Immunologic Factors|immunologic factors|mesh-ancestor
102548238|NCT00001053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548239|NCT00001053|Antacids|antacids|mesh-ancestor
102548240|NCT00001053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548241|NCT00001053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102548242|NCT00001989|Zidovudine|zidovudine|mesh-list
102548243|NCT00001989|Trichosanthin|trichosanthin|mesh-list
102548244|NCT00001989|Antimetabolites|antimetabolites|mesh-ancestor
102548245|NCT00001989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548246|NCT00001989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102548247|NCT00001989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102548248|NCT00001989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548249|NCT00001989|Antiviral Agents|antiviral agents|mesh-ancestor
102548250|NCT00001989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548251|NCT00001989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102548252|NCT00001989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102548253|NCT00001989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102548254|NCT00001989|Abortifacient Agents|abortifacient agents|mesh-ancestor
102548255|NCT00001989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102548256|NCT00001989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548257|NCT00001989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102548258|NCT00001989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102548259|NCT00001059|Doxorubicin|doxorubicin|mesh-list
102548260|NCT00001059|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102548261|NCT00001059|Bleomycin|bleomycin|mesh-list
102548262|NCT00001059|Vincristine|vincristine|mesh-list
102548263|NCT00001059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102548264|NCT00001059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102548265|NCT00001059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102548266|NCT00001059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102548267|NCT00001059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548268|NCT00001059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548269|NCT00001059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102548270|NCT00001059|Tubulin Modulators|tubulin modulators|mesh-ancestor
102548271|NCT00001059|Antimitotic Agents|antimitotic agents|mesh-ancestor
102548272|NCT00001059|Mitosis Modulators|mitosis modulators|mesh-ancestor
102548273|NCT00001065|Amphotericin B|amphotericin b|mesh-list
102548274|NCT00001065|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102548275|NCT00001065|Amebicides|amebicides|mesh-ancestor
102548276|NCT00001065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102548277|NCT00001065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102548278|NCT00001065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548279|NCT00001065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102548280|NCT00001065|Antifungal Agents|antifungal agents|mesh-ancestor
102548281|NCT02977637|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102548282|NCT02977637|Hematinics|hematinics|mesh-ancestor
102548283|NCT02977637|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102548284|NCT02977637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102548285|NCT00001995|Rifabutin|rifabutin|mesh-list
102548286|NCT00001995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102548287|NCT00001995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548288|NCT00001995|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102548289|NCT00001995|Antitubercular Agents|antitubercular agents|mesh-ancestor
102548290|NCT05501483|Pioglitazone|pioglitazone|mesh-list
102548291|NCT05501483|Empagliflozin|empagliflozin|mesh-list
102548292|NCT05501483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102548293|NCT05501483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548294|NCT05501483|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102548295|NCT05501483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548296|NCT00002001|Zidovudine|zidovudine|mesh-list
102548297|NCT00002001|Didanosine|didanosine|mesh-list
102548298|NCT00002001|Zalcitabine|zalcitabine|mesh-list
102548299|NCT00002001|Antimetabolites|antimetabolites|mesh-ancestor
102548300|NCT00002001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548301|NCT00002001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102548302|NCT00002001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102548303|NCT00002001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548304|NCT00002001|Antiviral Agents|antiviral agents|mesh-ancestor
102548305|NCT00002001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548306|NCT00002001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102548307|NCT00002001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102548308|NCT00002007|Zidovudine|zidovudine|mesh-list
102548309|NCT00002007|Sargramostim|sargramostim|mesh-list
102548310|NCT00002007|Antimetabolites|antimetabolites|mesh-ancestor
102548311|NCT00002007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548312|NCT00002007|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102548313|NCT00002007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102548314|NCT00002007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548315|NCT00002007|Antiviral Agents|antiviral agents|mesh-ancestor
102548316|NCT00002007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548317|NCT00002007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102548318|NCT00002007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102548319|NCT00002007|Immunologic Factors|immunologic factors|mesh-ancestor
102548320|NCT00002007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548322|NCT00001095|Zidovudine|zidovudine|mesh-list
102548323|NCT00001095|Nevirapine|nevirapine|mesh-list
102548324|NCT00001095|Stavudine|stavudine|mesh-list
102548325|NCT00001095|Indinavir|indinavir|mesh-list
102548326|NCT00001095|Amprenavir|amprenavir|mesh-list
102548327|NCT00001095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102548328|NCT00001095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102548329|NCT00001095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548330|NCT00001095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548331|NCT00001095|Antiviral Agents|antiviral agents|mesh-ancestor
102548332|NCT00001095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548333|NCT00001095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102548334|NCT00001095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102548335|NCT00001095|Antimetabolites|antimetabolites|mesh-ancestor
102548336|NCT00001095|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102548337|NCT00001095|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102548338|NCT00001095|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102548339|NCT00001095|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102548340|NCT00001095|Protease Inhibitors|protease inhibitors|mesh-ancestor
102548341|NCT00001095|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102548342|NCT00001095|Antitubercular Agents|antitubercular agents|mesh-ancestor
102548343|NCT00001095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102548344|NCT02294058|Interferons|interferons|mesh-list
102548345|NCT02294058|Interferon-beta|interferon-beta|mesh-list
102548346|NCT02294058|Interferon beta-1a|interferon beta-1a|mesh-list
102548347|NCT02294058|Ozanimod|ozanimod|mesh-list
102548348|NCT02294058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102548349|NCT02294058|Antiviral Agents|antiviral agents|mesh-ancestor
102548350|NCT02294058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548351|NCT02294058|Immunologic Factors|immunologic factors|mesh-ancestor
102548352|NCT02294058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548353|NCT02294058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102548354|NCT02294058|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102548355|NCT02294058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548356|NCT02294058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102548357|NCT00002013|Zidovudine|zidovudine|mesh-list
102548358|NCT00002013|Antimetabolites|antimetabolites|mesh-ancestor
102548359|NCT00002013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548360|NCT00002013|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102548361|NCT00002013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102548362|NCT00002013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548363|NCT00002013|Antiviral Agents|antiviral agents|mesh-ancestor
102548364|NCT00002013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548365|NCT00002013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102548366|NCT00002013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102548367|NCT00359333|Gemcitabine|gemcitabine|mesh-list
102548368|NCT00359333|Docetaxel|docetaxel|mesh-list
102548369|NCT00359333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102548370|NCT00359333|Antimetabolites|antimetabolites|mesh-ancestor
102548371|NCT00359333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548372|NCT00359333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102548373|NCT00359333|Tubulin Modulators|tubulin modulators|mesh-ancestor
102548374|NCT00359333|Antimitotic Agents|antimitotic agents|mesh-ancestor
102548375|NCT00359333|Mitosis Modulators|mitosis modulators|mesh-ancestor
102548376|NCT00001101|Doxycycline|doxycycline|mesh-list
102548377|NCT00001101|Ceftriaxone|ceftriaxone|mesh-list
102548378|NCT00001101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102548379|NCT00001101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548380|NCT00001101|Antimalarials|antimalarials|mesh-ancestor
102548381|NCT00001101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102548382|NCT00001101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102548383|NCT00001107|Fluconazole|fluconazole|mesh-list
102548384|NCT00001107|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102548385|NCT00001107|Antifungal Agents|antifungal agents|mesh-ancestor
102548386|NCT00001107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548387|NCT00001107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102548388|NCT00001107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102548389|NCT00001107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548390|NCT00001107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548391|NCT00001107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102548392|NCT00001107|Hormone Antagonists|hormone antagonists|mesh-ancestor
102548393|NCT00001107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102548394|NCT00001107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548395|NCT00001107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102548396|NCT00001107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102548397|NCT00001107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102548398|NCT00001107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102548400|NCT00002019|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102548401|NCT00002019|Amebicides|amebicides|mesh-ancestor
102548402|NCT00002019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102548403|NCT00002019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102548404|NCT00002019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548405|NCT00002019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102548406|NCT00002019|Antifungal Agents|antifungal agents|mesh-ancestor
102548407|NCT00002025|Ganciclovir|ganciclovir|mesh-list
102548408|NCT00002025|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102548409|NCT00002025|Antiviral Agents|antiviral agents|mesh-ancestor
102548410|NCT00002025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548411|NCT00002025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102548412|NCT00002025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548413|NCT00002025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548414|NCT00001131|Aldesleukin|aldesleukin|mesh-list
102548415|NCT00001131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102548416|NCT00001131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102548417|NCT00001131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102548418|NCT00001131|Antiviral Agents|antiviral agents|mesh-ancestor
102548419|NCT00001131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548420|NCT00001155|Cyclophosphamide|cyclophosphamide|mesh-list
102548421|NCT00001155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102548422|NCT00001155|Immunologic Factors|immunologic factors|mesh-ancestor
102548423|NCT00001155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548424|NCT00001155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102548425|NCT00001155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102548426|NCT00001155|Alkylating Agents|alkylating agents|mesh-ancestor
102548427|NCT00001155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548428|NCT00001155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102548429|NCT00001155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102548430|NCT00002037|Trifluridine|trifluridine|mesh-list
102548431|NCT00002037|Antimetabolites|antimetabolites|mesh-ancestor
102548432|NCT00002037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548433|NCT00002037|Antiviral Agents|antiviral agents|mesh-ancestor
102548434|NCT00002037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548435|NCT00001197|Hydroxyurea|hydroxyurea|mesh-list
102548436|NCT00001197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102548437|NCT00001197|Antisickling Agents|antisickling agents|mesh-ancestor
102548438|NCT00001197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548439|NCT00001197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548440|NCT00001197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102548441|NCT05270057|Prednisone|prednisone|mesh-list
102548442|NCT05270057|Cyclophosphamide|cyclophosphamide|mesh-list
102548443|NCT05270057|Rituximab|rituximab|mesh-list
102548444|NCT05270057|Doxorubicin|doxorubicin|mesh-list
102548445|NCT05270057|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102548446|NCT05270057|Etoposide|etoposide|mesh-list
102548447|NCT05270057|Vincristine|vincristine|mesh-list
102548448|NCT05270057|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
102548449|NCT05270057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102548450|NCT05270057|Immunologic Factors|immunologic factors|mesh-ancestor
102548451|NCT05270057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548452|NCT05270057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102548453|NCT05270057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102548454|NCT05270057|Alkylating Agents|alkylating agents|mesh-ancestor
102548455|NCT05270057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548456|NCT05270057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102548457|NCT05270057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102548458|NCT05270057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102548459|NCT05270057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102548460|NCT05270057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102548461|NCT05270057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102548462|NCT05270057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548463|NCT05270057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102548464|NCT05270057|Glucocorticoids|glucocorticoids|mesh-ancestor
102548465|NCT05270057|Hormones|hormones|mesh-ancestor
102548466|NCT05270057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102548467|NCT05270057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102548468|NCT05270057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102548469|NCT05270057|Tubulin Modulators|tubulin modulators|mesh-ancestor
102548470|NCT05270057|Antimitotic Agents|antimitotic agents|mesh-ancestor
102548471|NCT05270057|Mitosis Modulators|mitosis modulators|mesh-ancestor
102548472|NCT00002043|Dapsone|dapsone|mesh-list
102548473|NCT00002043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548474|NCT00002043|Antimalarials|antimalarials|mesh-ancestor
102548475|NCT00002043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102548476|NCT00002043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102548477|NCT00002043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102548478|NCT00002043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548479|NCT00002043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548480|NCT00002043|Leprostatic Agents|leprostatic agents|mesh-ancestor
102548481|NCT00002043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102548482|NCT00001209|Cyclophosphamide|cyclophosphamide|mesh-list
102548483|NCT00001209|Ifosfamide|ifosfamide|mesh-list
102548484|NCT00001209|Vincristine|vincristine|mesh-list
102548485|NCT00001209|Doxorubicin|doxorubicin|mesh-list
102548486|NCT00001209|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102548487|NCT00001209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102548488|NCT00001209|Immunologic Factors|immunologic factors|mesh-ancestor
102548489|NCT00001209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548490|NCT00001209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102548491|NCT00001209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102548492|NCT00001209|Alkylating Agents|alkylating agents|mesh-ancestor
102548493|NCT00001209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548494|NCT00001209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102548495|NCT00001209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102548496|NCT00001209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102548497|NCT00001209|Tubulin Modulators|tubulin modulators|mesh-ancestor
102548498|NCT00001209|Antimitotic Agents|antimitotic agents|mesh-ancestor
102548499|NCT00001209|Mitosis Modulators|mitosis modulators|mesh-ancestor
102548500|NCT00001209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102548501|NCT00001209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102548502|NCT00001209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102548503|NCT00001209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548504|NCT00002049|Thymopentin|thymopentin|mesh-list
102548505|NCT00002049|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102548506|NCT00002049|Immunologic Factors|immunologic factors|mesh-ancestor
102548507|NCT00002049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548508|NCT05044637|Primaquine|primaquine|mesh-list
102548509|NCT05044637|Antimalarials|antimalarials|mesh-ancestor
102548510|NCT05044637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102548511|NCT05044637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102548512|NCT05044637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548513|NCT05043077|Phenylephrine|phenylephrine|mesh-list
102548514|NCT05043077|Oxymetazoline|oxymetazoline|mesh-list
102548515|NCT05043077|Tropicamide|tropicamide|mesh-list
102548516|NCT05043077|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102548517|NCT05043077|Mydriatics|mydriatics|mesh-ancestor
102548518|NCT05043077|Autonomic Agents|autonomic agents|mesh-ancestor
102548519|NCT05043077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102548520|NCT05043077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548521|NCT05043077|Sympathomimetics|sympathomimetics|mesh-ancestor
102548522|NCT05043077|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102548523|NCT05043077|Nasal Decongestants|nasal decongestants|mesh-ancestor
102548524|NCT05043077|Respiratory System Agents|respiratory system agents|mesh-ancestor
102548525|NCT05043077|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102548526|NCT05043077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102548527|NCT05043077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102548528|NCT05043077|Adrenergic Agents|adrenergic agents|mesh-ancestor
102548529|NCT05043077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102548530|NCT05043077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548531|NCT05043077|Protective Agents|protective agents|mesh-ancestor
102548532|NCT05043077|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102548533|NCT05043077|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102548534|NCT05043077|Cholinergic Agents|cholinergic agents|mesh-ancestor
102548535|NCT00002055|Pentamidine|pentamidine|mesh-list
102548536|NCT00002055|Antifungal Agents|antifungal agents|mesh-ancestor
102548537|NCT00002055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548538|NCT00002055|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102548539|NCT00002055|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102548540|NCT00002055|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102548541|NCT05031455|Aspirin|aspirin|mesh-list
102548542|NCT05031455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102548543|NCT05031455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102548544|NCT05031455|Analgesics|analgesics|mesh-ancestor
102548545|NCT05031455|Sensory System Agents|sensory system agents|mesh-ancestor
102548546|NCT05031455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102548547|NCT05031455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548548|NCT05031455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102548549|NCT05031455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102548550|NCT05031455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102548551|NCT05031455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102548552|NCT05031455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768579|NCT00974428|Wobenzym|wobenzym|mesh-list
102548553|NCT05031455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102548554|NCT05031455|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102548555|NCT05031455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548556|NCT05031455|Antipyretics|antipyretics|mesh-ancestor
102548557|NCT05029973|Bevacizumab|bevacizumab|mesh-list
102548558|NCT05029973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102548559|NCT05029973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102548560|NCT05029973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102548561|NCT05029973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102548562|NCT05029973|Growth Substances|growth substances|mesh-ancestor
102548563|NCT05029973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548564|NCT05029973|Growth Inhibitors|growth inhibitors|mesh-ancestor
102548565|NCT00002061|Inosine Pranobex|inosine pranobex|mesh-list
102548566|NCT00002061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102548567|NCT00002061|Immunologic Factors|immunologic factors|mesh-ancestor
102548568|NCT00002061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548569|NCT00002061|Antiviral Agents|antiviral agents|mesh-ancestor
102548570|NCT00002061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548571|NCT00002067|Megestrol|megestrol|mesh-list
102548572|NCT00002067|Megestrol Acetate|megestrol acetate|mesh-list
102548573|NCT00002067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102548574|NCT00002067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102548575|NCT00002067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102548576|NCT00002067|Contraceptive Agents|contraceptive agents|mesh-ancestor
102548577|NCT00002067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102548578|NCT00002067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548579|NCT00002067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102548580|NCT00002067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102548581|NCT00002067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102548582|NCT00002067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102548583|NCT00002067|Appetite Stimulants|appetite stimulants|mesh-ancestor
102548584|NCT00002067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102548585|NCT00380835|Amrubicin|amrubicin|mesh-list
102548586|NCT00380835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102548587|NCT00001311|Heparin|heparin|mesh-list
102548588|NCT00001311|Anticoagulants|anticoagulants|mesh-ancestor
102548589|NCT00001311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102548590|NCT00001311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102548591|NCT00001311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548592|NCT05016713|Chlorhexidine|chlorhexidine|mesh-list
102548593|NCT05016713|Fluorides|fluorides|mesh-list
102548594|NCT05016713|Cariostatic Agents|cariostatic agents|mesh-ancestor
102548595|NCT05016713|Protective Agents|protective agents|mesh-ancestor
102548596|NCT05016713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548597|NCT05016713|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102548598|NCT05016713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548599|NCT05016713|Disinfectants|disinfectants|mesh-ancestor
102548600|NCT00002073|Epoetin Alfa|epoetin alfa|mesh-list
102548601|NCT00002073|Hematinics|hematinics|mesh-ancestor
102548602|NCT00001317|Interferons|interferons|mesh-list
102548603|NCT00001317|Interferon-gamma|interferon-gamma|mesh-list
102548604|NCT00001317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102548605|NCT00001317|Antiviral Agents|antiviral agents|mesh-ancestor
102548606|NCT00001317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548607|NCT00001335|Topotecan|topotecan|mesh-list
102548608|NCT00001335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102548609|NCT00001335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102548610|NCT00001335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548611|NCT00001335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548612|NCT00001335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102548613|NCT00002079|Miglustat|miglustat|mesh-list
101835340|NCT00924755|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102548615|NCT00002079|Antimetabolites|antimetabolites|mesh-ancestor
102548616|NCT00002079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548617|NCT00002079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102548618|NCT00002079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102548619|NCT00002079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548620|NCT00002079|Antiviral Agents|antiviral agents|mesh-ancestor
102548621|NCT00002079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548622|NCT00002079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102548623|NCT00002079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102548624|NCT00002079|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102548625|NCT00002079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102548626|NCT00002079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548627|NCT00002085|Azithromycin|azithromycin|mesh-list
102548628|NCT00002085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102548629|NCT00002085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548630|NCT00001383|Paclitaxel|paclitaxel|mesh-list
102548631|NCT00001383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102548632|NCT00001383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102548633|NCT00001383|Tubulin Modulators|tubulin modulators|mesh-ancestor
102548634|NCT00001383|Antimitotic Agents|antimitotic agents|mesh-ancestor
102548635|NCT00001383|Mitosis Modulators|mitosis modulators|mesh-ancestor
102548636|NCT00001383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548637|NCT00002091|Pentoxifylline|pentoxifylline|mesh-list
102548638|NCT00002091|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102548639|NCT00002091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548640|NCT00002091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548641|NCT00002091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102548642|NCT00002091|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102548643|NCT00002091|Protective Agents|protective agents|mesh-ancestor
102548644|NCT00002091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548645|NCT00002091|Vasodilator Agents|vasodilator agents|mesh-ancestor
102548646|NCT00002091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102548647|NCT00002091|Antioxidants|antioxidants|mesh-ancestor
102548648|NCT00001407|Interferons|interferons|mesh-list
102548649|NCT00001407|Interferon-gamma|interferon-gamma|mesh-list
102548650|NCT00001407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102548651|NCT00001407|Antiviral Agents|antiviral agents|mesh-ancestor
102548652|NCT00001407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548653|NCT00002097|Nystatin|nystatin|mesh-list
102548654|NCT00002097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102548655|NCT00002097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548656|NCT00002097|Antifungal Agents|antifungal agents|mesh-ancestor
102548657|NCT00002097|Ionophores|ionophores|mesh-ancestor
102548658|NCT00002097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102548659|NCT00002097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548660|NCT00001431|Gemcitabine|gemcitabine|mesh-list
102548661|NCT00001431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102548662|NCT00001431|Antimetabolites|antimetabolites|mesh-ancestor
102548663|NCT00001431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548664|NCT00001431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102548665|NCT05428007|Nivolumab|nivolumab|mesh-list
102548666|NCT05428007|Ipilimumab|ipilimumab|mesh-list
102548667|NCT05428007|Relatlimab|relatlimab|mesh-list
102548668|NCT05428007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102548669|NCT05428007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102548670|NCT05428007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102548671|NCT05428007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548672|NCT00002103|Leucovorin|leucovorin|mesh-list
102548673|NCT00002103|Trimetrexate|trimetrexate|mesh-list
102548674|NCT00002103|Calcium|calcium|mesh-list
102548675|NCT00002103|Levoleucovorin|levoleucovorin|mesh-list
102548676|NCT00002103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102548677|NCT00002103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548678|NCT00002103|Antidotes|antidotes|mesh-ancestor
102548679|NCT00002103|Protective Agents|protective agents|mesh-ancestor
102548680|NCT00002103|Vitamin B Complex|vitamin b complex|mesh-ancestor
102548681|NCT00002103|Vitamins|vitamins|mesh-ancestor
102548682|NCT00002103|Micronutrients|micronutrients|mesh-ancestor
102548683|NCT00002103|Antifungal Agents|antifungal agents|mesh-ancestor
102548684|NCT00002103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548685|NCT00002103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102548686|NCT00002103|Antimetabolites|antimetabolites|mesh-ancestor
102548687|NCT00002103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548688|NCT00002103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101768713|NCT00770406|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102548689|NCT00002103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102548690|NCT00002103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548692|NCT00001437|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102548693|NCT00001437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548694|NCT00001437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548695|NCT00001437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102548696|NCT00001437|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102548697|NCT00001437|Protective Agents|protective agents|mesh-ancestor
102548698|NCT00001437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548699|NCT00001437|Vasodilator Agents|vasodilator agents|mesh-ancestor
102548700|NCT00001437|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102548701|NCT00001437|Antioxidants|antioxidants|mesh-ancestor
102548702|NCT00360191|Buspirone|buspirone|mesh-list
102548703|NCT00360191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102548704|NCT00360191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102548705|NCT00360191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102548706|NCT00360191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548707|NCT00360191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102548708|NCT00360191|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102548709|NCT00360191|Serotonin Agents|serotonin agents|mesh-ancestor
102548710|NCT00360191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102548711|NCT00360191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548712|NCT00001443|Indinavir|indinavir|mesh-list
102548713|NCT00001443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102548714|NCT00001443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102548715|NCT00001443|Protease Inhibitors|protease inhibitors|mesh-ancestor
102548716|NCT00001443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548717|NCT00001443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548718|NCT00001443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102548719|NCT00001443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102548720|NCT00001443|Antiviral Agents|antiviral agents|mesh-ancestor
102548721|NCT00001443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548722|NCT00001449|Leucovorin|leucovorin|mesh-list
102548723|NCT00001449|Gemcitabine|gemcitabine|mesh-list
102548724|NCT00001449|Floxuridine|floxuridine|mesh-list
102548725|NCT00001449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102548726|NCT00001449|Antimetabolites|antimetabolites|mesh-ancestor
102548727|NCT00001449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548728|NCT00001449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102548729|NCT00001449|Antidotes|antidotes|mesh-ancestor
102548730|NCT00001449|Protective Agents|protective agents|mesh-ancestor
102548731|NCT00001449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548732|NCT00001449|Vitamin B Complex|vitamin b complex|mesh-ancestor
102548733|NCT00001449|Vitamins|vitamins|mesh-ancestor
102548734|NCT00001449|Micronutrients|micronutrients|mesh-ancestor
102548735|NCT00002109|Zidovudine|zidovudine|mesh-list
102548736|NCT00002109|Stavudine|stavudine|mesh-list
102548737|NCT00002109|Didanosine|didanosine|mesh-list
102548738|NCT00002109|Zalcitabine|zalcitabine|mesh-list
102548739|NCT00002109|Thymopentin|thymopentin|mesh-list
102548740|NCT00002109|Antimetabolites|antimetabolites|mesh-ancestor
102548741|NCT00002109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548742|NCT00002109|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102548743|NCT00002109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102548744|NCT00002109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548745|NCT00002109|Antiviral Agents|antiviral agents|mesh-ancestor
102548746|NCT00002109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548747|NCT00002109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102548748|NCT00002109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102548749|NCT00002109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102548750|NCT00002109|Immunologic Factors|immunologic factors|mesh-ancestor
102548751|NCT00002109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548752|NCT00359567|Palonosetron|palonosetron|mesh-list
102548753|NCT00359567|Granisetron|granisetron|mesh-list
102548754|NCT00359567|Antiemetics|antiemetics|mesh-ancestor
102548755|NCT00359567|Autonomic Agents|autonomic agents|mesh-ancestor
102548756|NCT00359567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102548757|NCT00359567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548758|NCT00359567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102548759|NCT00359567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102548760|NCT00359567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102548761|NCT00359567|Serotonin Agents|serotonin agents|mesh-ancestor
101835489|NCT00492726|Ertapenem|ertapenem|mesh-list
102548762|NCT00359567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102548763|NCT00359567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548764|NCT00381147|Clarithromycin|clarithromycin|mesh-list
102548765|NCT00381147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102548766|NCT00381147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548767|NCT00381147|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102548768|NCT00381147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548769|NCT00381147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548770|NCT00381147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102548771|NCT00381147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102548772|NCT05210465|Dobutamine|dobutamine|mesh-list
102548773|NCT05210465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102548774|NCT05210465|Sympathomimetics|sympathomimetics|mesh-ancestor
102548775|NCT05210465|Autonomic Agents|autonomic agents|mesh-ancestor
102548776|NCT05210465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102548777|NCT05210465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548778|NCT05210465|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102548779|NCT05210465|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102548780|NCT05210465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102548781|NCT05210465|Adrenergic Agents|adrenergic agents|mesh-ancestor
102548782|NCT05210465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102548783|NCT05210465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548784|NCT05210465|Protective Agents|protective agents|mesh-ancestor
102548785|NCT00002115|Adefovir|adefovir|mesh-list
102548786|NCT00002115|Antiviral Agents|antiviral agents|mesh-ancestor
102548787|NCT00002115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548788|NCT00002115|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102548789|NCT00002115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102548790|NCT00002115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548791|NCT00002115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548792|NCT04983407|Paclitaxel|paclitaxel|mesh-list
102548793|NCT04983407|Gemcitabine|gemcitabine|mesh-list
102548794|NCT04983407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102548795|NCT04983407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102548796|NCT04983407|Tubulin Modulators|tubulin modulators|mesh-ancestor
102548797|NCT04983407|Antimitotic Agents|antimitotic agents|mesh-ancestor
102548798|NCT04983407|Mitosis Modulators|mitosis modulators|mesh-ancestor
102548799|NCT04983407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548800|NCT04983407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102548801|NCT04983407|Antimetabolites|antimetabolites|mesh-ancestor
102548802|NCT00001569|Paclitaxel|paclitaxel|mesh-list
102548803|NCT00001569|Cisplatin|cisplatin|mesh-list
102548804|NCT00001569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102548805|NCT00001569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102548806|NCT00001569|Tubulin Modulators|tubulin modulators|mesh-ancestor
102548807|NCT00001569|Antimitotic Agents|antimitotic agents|mesh-ancestor
102548808|NCT00001569|Mitosis Modulators|mitosis modulators|mesh-ancestor
102548809|NCT00001569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548810|NCT00001587|Melphalan|melphalan|mesh-list
102548811|NCT00001587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102548812|NCT00001587|Alkylating Agents|alkylating agents|mesh-ancestor
102548813|NCT00001587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548814|NCT00001587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102548815|NCT00001587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102548816|NCT00001587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102548817|NCT00001587|Immunologic Factors|immunologic factors|mesh-ancestor
102548818|NCT00001587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548819|NCT00002127|Thalidomide|thalidomide|mesh-list
102548820|NCT00002127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102548821|NCT00002127|Immunologic Factors|immunologic factors|mesh-ancestor
102548822|NCT00002127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548823|NCT00002127|Leprostatic Agents|leprostatic agents|mesh-ancestor
102548824|NCT00002127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102548825|NCT00002127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548826|NCT00002127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102548827|NCT00002127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102548828|NCT00002127|Growth Substances|growth substances|mesh-ancestor
102548829|NCT00002127|Growth Inhibitors|growth inhibitors|mesh-ancestor
102548830|NCT00002127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102548831|NCT00001599|Thalidomide|thalidomide|mesh-list
102548832|NCT00001599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102548833|NCT00001599|Immunologic Factors|immunologic factors|mesh-ancestor
102548834|NCT00001599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548835|NCT00001599|Leprostatic Agents|leprostatic agents|mesh-ancestor
102548836|NCT00001599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102548837|NCT00001599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548838|NCT00001599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102548839|NCT00001599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102548840|NCT00001599|Growth Substances|growth substances|mesh-ancestor
102548841|NCT00001599|Growth Inhibitors|growth inhibitors|mesh-ancestor
102548842|NCT00001599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102548843|NCT00380913|Nabilone|nabilone|mesh-list
102548844|NCT00380913|Antiemetics|antiemetics|mesh-ancestor
102548845|NCT00380913|Autonomic Agents|autonomic agents|mesh-ancestor
102548846|NCT00380913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102548847|NCT00380913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548848|NCT00380913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102548849|NCT00380913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102548850|NCT00380913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102548851|NCT00380913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102548852|NCT00380913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102548853|NCT00002133|Itraconazole|itraconazole|mesh-list
102548854|NCT00002133|Antifungal Agents|antifungal agents|mesh-ancestor
102548855|NCT00002133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548856|NCT00002133|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102548857|NCT00002133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102548858|NCT00002133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548859|NCT00002133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548860|NCT00002133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102548861|NCT00002133|Hormone Antagonists|hormone antagonists|mesh-ancestor
102548862|NCT00002133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102548863|NCT00002133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548864|NCT00002133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102548865|NCT00001629|Angiotensin II|angiotensin ii|mesh-list
102548866|NCT00001629|Giapreza|giapreza|mesh-list
102548867|NCT00001629|Angiotensinogen|angiotensinogen|mesh-list
102548868|NCT00001629|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
102548869|NCT00001629|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102548870|NCT00001629|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102548871|NCT00001629|Protease Inhibitors|protease inhibitors|mesh-ancestor
102548872|NCT00001629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548873|NCT00001629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548874|NCT00001629|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102548875|NCT00002139|Azithromycin|azithromycin|mesh-list
102548876|NCT00002139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102548877|NCT00002139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548878|NCT00002295|Inosine Pranobex|inosine pranobex|mesh-list
102548879|NCT00002295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102548880|NCT00002295|Immunologic Factors|immunologic factors|mesh-ancestor
102548881|NCT00002295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548882|NCT00002295|Antiviral Agents|antiviral agents|mesh-ancestor
102548883|NCT00002295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548884|NCT00002145|Foscarnet|foscarnet|mesh-list
102548885|NCT00002145|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
102548886|NCT00002145|Antiviral Agents|antiviral agents|mesh-ancestor
102548887|NCT00002145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548888|NCT00002145|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102548889|NCT00002145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102548890|NCT00002145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548891|NCT00002145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548892|NCT00002301|Foscarnet|foscarnet|mesh-list
102548893|NCT00002301|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
102548894|NCT00002301|Antiviral Agents|antiviral agents|mesh-ancestor
102548895|NCT00002301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548896|NCT00002301|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102548897|NCT00002301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102548898|NCT00002301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101768919|NCT00378703|Sirolimus|sirolimus|mesh-list
102548899|NCT00002301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548900|NCT00002307|Zidovudine|zidovudine|mesh-list
102548901|NCT00002307|Stavudine|stavudine|mesh-list
102548902|NCT00002307|Antimetabolites|antimetabolites|mesh-ancestor
102548903|NCT00002307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548904|NCT00002307|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102548905|NCT00002307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102548906|NCT00002307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548907|NCT00002307|Antiviral Agents|antiviral agents|mesh-ancestor
102548908|NCT00002307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548909|NCT00002307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102548910|NCT00002307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102548911|NCT00002313|Didanosine|didanosine|mesh-list
102548912|NCT00002313|Nystatin|nystatin|mesh-list
102548913|NCT00002313|Antimetabolites|antimetabolites|mesh-ancestor
102548914|NCT00002313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548915|NCT00002313|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102548916|NCT00002313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102548917|NCT00002313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548918|NCT00002313|Antiviral Agents|antiviral agents|mesh-ancestor
102548919|NCT00002313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548920|NCT00002313|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102548921|NCT00002313|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102548922|NCT00002313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102548923|NCT00002313|Antifungal Agents|antifungal agents|mesh-ancestor
102548924|NCT00002313|Ionophores|ionophores|mesh-ancestor
102548925|NCT00002313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102548926|NCT00002157|Thalidomide|thalidomide|mesh-list
102548927|NCT00002157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102548928|NCT00002157|Immunologic Factors|immunologic factors|mesh-ancestor
102548929|NCT00002157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548930|NCT00002157|Leprostatic Agents|leprostatic agents|mesh-ancestor
102548931|NCT00002157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102548932|NCT00002157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548933|NCT00002157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102548934|NCT00002157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102548935|NCT00002157|Growth Substances|growth substances|mesh-ancestor
102548936|NCT00002157|Growth Inhibitors|growth inhibitors|mesh-ancestor
102548937|NCT00002157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102548938|NCT00002319|Doxorubicin|doxorubicin|mesh-list
102548939|NCT00002319|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102548940|NCT00002319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102548941|NCT00002319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102548942|NCT00002319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102548943|NCT00002319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102548944|NCT00002319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548945|NCT00002319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548946|NCT00002163|Abacavir|abacavir|mesh-list
102548947|NCT00002163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102548948|NCT00002163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102548949|NCT00002163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548950|NCT00002163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548951|NCT00002163|Antiviral Agents|antiviral agents|mesh-ancestor
102548952|NCT00002163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548953|NCT00002163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102548954|NCT00002163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102548955|NCT00002325|Fluconazole|fluconazole|mesh-list
102548956|NCT00002325|Antifungal Agents|antifungal agents|mesh-ancestor
102548957|NCT00002325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548958|NCT00002325|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102548959|NCT00002325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102548960|NCT00002325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548961|NCT00002325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548962|NCT00002325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102548963|NCT00002325|Hormone Antagonists|hormone antagonists|mesh-ancestor
102548964|NCT00002325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102548965|NCT00002325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548966|NCT00002325|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102548967|NCT00002325|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102548968|NCT00002331|Clarithromycin|clarithromycin|mesh-list
102548969|NCT00002331|Ethambutol|ethambutol|mesh-list
102548970|NCT00002331|Clofazimine|clofazimine|mesh-list
102548971|NCT00002331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102548972|NCT00002331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102548973|NCT00002331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102548974|NCT00002331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548975|NCT00002331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548976|NCT00002331|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102548977|NCT00002331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102548978|NCT00002331|Antitubercular Agents|antitubercular agents|mesh-ancestor
102548979|NCT00002331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102548980|NCT00002331|Leprostatic Agents|leprostatic agents|mesh-ancestor
102548981|NCT00002337|Vesnarinone|vesnarinone|mesh-list
102548982|NCT00002337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102548983|NCT00002337|Immunologic Factors|immunologic factors|mesh-ancestor
102548984|NCT00002337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102548985|NCT00002337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102548986|NCT00002337|Antiviral Agents|antiviral agents|mesh-ancestor
102548987|NCT00002337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101835709|NCT01015482|GABA Agents|gaba agents|mesh-ancestor
102548988|NCT00002337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102548989|NCT00002337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102548990|NCT00002337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548991|NCT00002337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548992|NCT00002337|Protective Agents|protective agents|mesh-ancestor
102548994|NCT00002169|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102548995|NCT00002169|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102548996|NCT00002169|Protease Inhibitors|protease inhibitors|mesh-ancestor
102548997|NCT00002169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102548998|NCT00002169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102548999|NCT00002169|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102549000|NCT00002169|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102549001|NCT00002169|Antiviral Agents|antiviral agents|mesh-ancestor
102549002|NCT00002169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549003|NCT02293902|Folic Acid|folic acid|mesh-list
102549004|NCT02293902|Methotrexate|methotrexate|mesh-list
102549005|NCT02293902|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102549006|NCT02293902|Abortifacient Agents|abortifacient agents|mesh-ancestor
102549007|NCT02293902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102549008|NCT02293902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102549009|NCT02293902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102549010|NCT02293902|Antimetabolites|antimetabolites|mesh-ancestor
102549011|NCT02293902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549012|NCT02293902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102549013|NCT02293902|Dermatologic Agents|dermatologic agents|mesh-ancestor
102549014|NCT02293902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549015|NCT02293902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102549016|NCT02293902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102549017|NCT02293902|Immunologic Factors|immunologic factors|mesh-ancestor
102549018|NCT02293902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102549019|NCT02293902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102549020|NCT02293902|Hematinics|hematinics|mesh-ancestor
102549021|NCT02293902|Vitamin B Complex|vitamin b complex|mesh-ancestor
102549022|NCT02293902|Vitamins|vitamins|mesh-ancestor
102549023|NCT02293902|Micronutrients|micronutrients|mesh-ancestor
102549024|NCT00002343|Ethambutol|ethambutol|mesh-list
102549025|NCT00002343|Rifabutin|rifabutin|mesh-list
102549026|NCT00002343|Antitubercular Agents|antitubercular agents|mesh-ancestor
102549027|NCT00002343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102549028|NCT00002343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549029|NCT00002343|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102549030|NCT05168735|Ketamine|ketamine|mesh-list
102549031|NCT05168735|Analgesics|analgesics|mesh-ancestor
102549032|NCT05168735|Sensory System Agents|sensory system agents|mesh-ancestor
102549033|NCT05168735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102549034|NCT05168735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102549035|NCT05168735|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102549036|NCT05168735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102549037|NCT05168735|Anesthetics, General|anesthetics, general|mesh-ancestor
102549038|NCT05168735|Anesthetics|anesthetics|mesh-ancestor
102549039|NCT05168735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102549040|NCT05168735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102549041|NCT05168735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102549042|NCT05168735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102549043|NCT05168735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549044|NCT00002349|Stavudine|stavudine|mesh-list
102549045|NCT00002349|Antimetabolites|antimetabolites|mesh-ancestor
102549046|NCT00002349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549047|NCT00002349|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102549048|NCT00002349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102549049|NCT00002349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549050|NCT00002349|Antiviral Agents|antiviral agents|mesh-ancestor
102549051|NCT00002349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549052|NCT00002349|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102549053|NCT00002349|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102549054|NCT04706013|Pyridoxal|pyridoxal|mesh-list
102549055|NCT04706013|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
102549056|NCT04706013|Vitamin B Complex|vitamin b complex|mesh-ancestor
102549057|NCT04706013|Vitamins|vitamins|mesh-ancestor
102549058|NCT04706013|Micronutrients|micronutrients|mesh-ancestor
102549059|NCT04706013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102549060|NCT00002355|Fomivirsen|fomivirsen|mesh-list
102549061|NCT00002355|Antiviral Agents|antiviral agents|mesh-ancestor
102549062|NCT00002355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549063|NCT02278614|Timolol|timolol|mesh-list
101835791|NCT00926705|Narcotics|narcotics|mesh-ancestor
102549065|NCT02278614|Latanoprost|latanoprost|mesh-list
102549066|NCT02278614|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102549067|NCT02278614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102549068|NCT02278614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102549069|NCT02278614|Adrenergic Agents|adrenergic agents|mesh-ancestor
102549070|NCT02278614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102549071|NCT02278614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549072|NCT02278614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102549073|NCT02278614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102549074|NCT02278614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102549075|NCT00002361|Ritonavir|ritonavir|mesh-list
102549076|NCT00002361|Indinavir|indinavir|mesh-list
102549077|NCT00002361|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102549078|NCT00002361|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102549079|NCT00002361|Protease Inhibitors|protease inhibitors|mesh-ancestor
102549080|NCT00002361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549081|NCT00002361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549082|NCT00002361|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102549083|NCT00002361|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102549084|NCT00002361|Antiviral Agents|antiviral agents|mesh-ancestor
102549085|NCT00002361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549086|NCT00002361|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102549087|NCT00002361|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102549088|NCT00002181|Cidofovir|cidofovir|mesh-list
102549089|NCT00002181|Antiviral Agents|antiviral agents|mesh-ancestor
102549090|NCT00002181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549091|NCT00002181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549092|NCT00002181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549093|NCT00002367|Lamivudine|lamivudine|mesh-list
102549094|NCT00002367|Zidovudine|zidovudine|mesh-list
102549095|NCT00002367|Saquinavir|saquinavir|mesh-list
102549096|NCT00002367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102549097|NCT00002367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102549098|NCT00002367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549099|NCT00002367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549100|NCT00002367|Antiviral Agents|antiviral agents|mesh-ancestor
102549101|NCT00002367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549102|NCT00002367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102549103|NCT00002367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102549104|NCT00002367|Antimetabolites|antimetabolites|mesh-ancestor
102549105|NCT00002367|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102549106|NCT00002367|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102549107|NCT00002367|Protease Inhibitors|protease inhibitors|mesh-ancestor
102549108|NCT00002367|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102549109|NCT00002367|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102549110|NCT00002187|Fomivirsen|fomivirsen|mesh-list
102549111|NCT00002187|Antiviral Agents|antiviral agents|mesh-ancestor
102549112|NCT00002187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549113|NCT00002373|Maribavir|maribavir|mesh-list
102549114|NCT00002373|Antiviral Agents|antiviral agents|mesh-ancestor
102549115|NCT00002373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549116|NCT00002379|Lamivudine|lamivudine|mesh-list
102549117|NCT00002379|Zidovudine|zidovudine|mesh-list
102549118|NCT00002379|Stavudine|stavudine|mesh-list
102549119|NCT00002379|Adefovir|adefovir|mesh-list
102549120|NCT00002379|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
102549121|NCT00002379|Indinavir|indinavir|mesh-list
102549122|NCT00002379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102549123|NCT00002379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102549124|NCT00002379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549125|NCT00002379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549126|NCT00002379|Antiviral Agents|antiviral agents|mesh-ancestor
102549127|NCT00002379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549128|NCT00002379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102549129|NCT00002379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102549130|NCT00002379|Antimetabolites|antimetabolites|mesh-ancestor
102549131|NCT00002379|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102549132|NCT00002379|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102549133|NCT00002379|Protease Inhibitors|protease inhibitors|mesh-ancestor
102549134|NCT00359723|Methylphenidate|methylphenidate|mesh-list
102549135|NCT00359723|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102549136|NCT00359723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102549137|NCT00359723|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102549138|NCT00359723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102549139|NCT00359723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102549140|NCT00359723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549141|NCT00359723|Dopamine Agents|dopamine agents|mesh-ancestor
102549142|NCT00359723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102549143|NCT00002193|Amprenavir|amprenavir|mesh-list
102549144|NCT00002193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102549145|NCT00002193|Antitubercular Agents|antitubercular agents|mesh-ancestor
102549146|NCT00002193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102549147|NCT00002193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549148|NCT00002193|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102549149|NCT00002193|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102549150|NCT00002193|Protease Inhibitors|protease inhibitors|mesh-ancestor
102549151|NCT00002193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549152|NCT00002193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549153|NCT00002193|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102549154|NCT00002193|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102549155|NCT00002193|Antiviral Agents|antiviral agents|mesh-ancestor
102549156|NCT00002391|Lamivudine|lamivudine|mesh-list
102549157|NCT00002391|Zidovudine|zidovudine|mesh-list
102549158|NCT00002391|Abacavir|abacavir|mesh-list
102549159|NCT00002391|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102549160|NCT00002391|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102549161|NCT00002391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549162|NCT00002391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549163|NCT00002391|Antiviral Agents|antiviral agents|mesh-ancestor
102549164|NCT00002391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549165|NCT00002391|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102549166|NCT00002391|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102549167|NCT00002391|Antimetabolites|antimetabolites|mesh-ancestor
102549168|NCT00002199|Lamivudine|lamivudine|mesh-list
102549169|NCT00002199|Zidovudine|zidovudine|mesh-list
102549170|NCT00002199|Abacavir|abacavir|mesh-list
102549171|NCT00002199|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
102549172|NCT00002199|Indinavir|indinavir|mesh-list
102549173|NCT00002199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102549174|NCT00002199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102549175|NCT00002199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549176|NCT00002199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549177|NCT00002199|Antiviral Agents|antiviral agents|mesh-ancestor
102549178|NCT00002199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549179|NCT00002199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102549180|NCT00002199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102549181|NCT00002199|Antimetabolites|antimetabolites|mesh-ancestor
102549182|NCT00002199|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102549183|NCT00002199|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102549184|NCT00002199|Protease Inhibitors|protease inhibitors|mesh-ancestor
102549185|NCT00002397|Lamivudine|lamivudine|mesh-list
102549186|NCT00002397|Stavudine|stavudine|mesh-list
102549187|NCT00002397|Nelfinavir|nelfinavir|mesh-list
102549188|NCT00002397|Saquinavir|saquinavir|mesh-list
102549189|NCT00002397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102549190|NCT00002397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102549191|NCT00002397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549192|NCT00002397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549193|NCT00002397|Antiviral Agents|antiviral agents|mesh-ancestor
102549194|NCT00002397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549195|NCT00002397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102549196|NCT00002397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102549197|NCT00002397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102549198|NCT00002397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102549199|NCT00002397|Protease Inhibitors|protease inhibitors|mesh-ancestor
102549200|NCT00002397|Antimetabolites|antimetabolites|mesh-ancestor
102549201|NCT00002397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102549202|NCT00002397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102549203|NCT00002205|Abacavir|abacavir|mesh-list
102549204|NCT00002205|Amprenavir|amprenavir|mesh-list
102549205|NCT00002205|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102549206|NCT00002205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102549207|NCT00002205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549208|NCT00002205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549209|NCT00002205|Antiviral Agents|antiviral agents|mesh-ancestor
102549210|NCT00002205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549211|NCT00002205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102549212|NCT00002205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102549213|NCT00002205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102549214|NCT00002205|Antitubercular Agents|antitubercular agents|mesh-ancestor
102549215|NCT00002205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102549216|NCT00002205|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102549217|NCT00002205|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102549218|NCT00002205|Protease Inhibitors|protease inhibitors|mesh-ancestor
102549220|NCT02977169|Carboplatin|carboplatin|mesh-list
102549221|NCT02977169|Pemetrexed|pemetrexed|mesh-list
102549222|NCT02977169|Vinorelbine|vinorelbine|mesh-list
102549223|NCT02977169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102549224|NCT02977169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549225|NCT02977169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549226|NCT02977169|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102549227|NCT02977169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102549228|NCT02977169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102549229|NCT02977169|Tubulin Modulators|tubulin modulators|mesh-ancestor
102549230|NCT02977169|Antimitotic Agents|antimitotic agents|mesh-ancestor
101769282|NCT00378079|Methadone|methadone|mesh-list
102549231|NCT02977169|Mitosis Modulators|mitosis modulators|mesh-ancestor
102549232|NCT00002409|Lamivudine|lamivudine|mesh-list
102549233|NCT00002409|Zidovudine|zidovudine|mesh-list
102549234|NCT00002409|Abacavir|abacavir|mesh-list
102549235|NCT00002409|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
102549236|NCT00002409|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102549237|NCT00002409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102549238|NCT00002409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549239|NCT00002409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549240|NCT00002409|Antiviral Agents|antiviral agents|mesh-ancestor
102549241|NCT00002409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549242|NCT00002409|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102549243|NCT00002409|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102549244|NCT00002409|Antimetabolites|antimetabolites|mesh-ancestor
102549245|NCT00002211|Nelfinavir|nelfinavir|mesh-list
102549246|NCT00002211|Stavudine|stavudine|mesh-list
102549247|NCT00002211|Didanosine|didanosine|mesh-list
102549248|NCT00002211|Delavirdine|delavirdine|mesh-list
102549249|NCT00002211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102549250|NCT00002211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102549251|NCT00002211|Protease Inhibitors|protease inhibitors|mesh-ancestor
102549252|NCT00002211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549253|NCT00002211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549254|NCT00002211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102549255|NCT00002211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102549256|NCT00002211|Antiviral Agents|antiviral agents|mesh-ancestor
102549257|NCT00002211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549258|NCT00002211|Antimetabolites|antimetabolites|mesh-ancestor
102549259|NCT00002211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102549260|NCT00002211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102549261|NCT00002415|Tenofovir|tenofovir|mesh-list
102549262|NCT00002415|Antiviral Agents|antiviral agents|mesh-ancestor
102549263|NCT00002415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549264|NCT00002415|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102549265|NCT00002415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102549266|NCT00002415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549267|NCT00002415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549268|NCT00002415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102549269|NCT00002415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102549270|NCT00381537|Carbamazepine|carbamazepine|mesh-list
102549271|NCT00381537|Phenobarbital|phenobarbital|mesh-list
102549272|NCT00381537|Anticonvulsants|anticonvulsants|mesh-ancestor
102549273|NCT00381537|Antimanic Agents|antimanic agents|mesh-ancestor
102549274|NCT00381537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102549275|NCT00381537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102549276|NCT00381537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102549277|NCT00381537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102549278|NCT00381537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102549279|NCT00381537|Analgesics|analgesics|mesh-ancestor
102549280|NCT00381537|Sensory System Agents|sensory system agents|mesh-ancestor
102549281|NCT00381537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102549282|NCT00381537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102549283|NCT00381537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102549284|NCT00381537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549285|NCT00381537|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102549286|NCT00381537|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102549287|NCT00381537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102549288|NCT00381537|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102549289|NCT00381537|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102549290|NCT00381537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102549291|NCT00381537|GABA Modulators|gaba modulators|mesh-ancestor
102549292|NCT00381537|GABA Agents|gaba agents|mesh-ancestor
102549293|NCT00381537|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102549294|NCT00002427|Stavudine|stavudine|mesh-list
102549295|NCT00002427|Didanosine|didanosine|mesh-list
102549296|NCT00002427|Hydroxyurea|hydroxyurea|mesh-list
102549297|NCT00002427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102549298|NCT00002427|Antisickling Agents|antisickling agents|mesh-ancestor
102549299|NCT00002427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549300|NCT00002427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549301|NCT00002427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102549302|NCT00002427|Antimetabolites|antimetabolites|mesh-ancestor
102549303|NCT00002427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102549304|NCT00002427|Antiviral Agents|antiviral agents|mesh-ancestor
102549305|NCT00002427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549306|NCT00002427|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102549307|NCT00002427|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102549308|NCT00002223|Ritonavir|ritonavir|mesh-list
102549309|NCT00002223|Indinavir|indinavir|mesh-list
102549310|NCT00002223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102549311|NCT00002223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102549312|NCT00002223|Protease Inhibitors|protease inhibitors|mesh-ancestor
102549313|NCT00002223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549314|NCT00002223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549315|NCT00002223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102549316|NCT00002223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102549317|NCT00002223|Antiviral Agents|antiviral agents|mesh-ancestor
102549318|NCT00002223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549319|NCT00002223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102549320|NCT00002223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102549321|NCT00002433|Interferons|interferons|mesh-list
102549322|NCT00002433|Interferon-gamma|interferon-gamma|mesh-list
102549323|NCT00002433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102549324|NCT00002433|Antiviral Agents|antiviral agents|mesh-ancestor
102549325|NCT00002433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549326|NCT00002439|Alitretinoin|alitretinoin|mesh-list
102549327|NCT00002439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102549328|NCT00002439|Dermatologic Agents|dermatologic agents|mesh-ancestor
102549329|NCT00002229|Saquinavir|saquinavir|mesh-list
102549330|NCT00002229|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102549331|NCT00002229|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102549332|NCT00002229|Protease Inhibitors|protease inhibitors|mesh-ancestor
102549333|NCT00002229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549334|NCT00002229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549335|NCT00002229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102549336|NCT00002229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102549337|NCT00002229|Antiviral Agents|antiviral agents|mesh-ancestor
102549338|NCT00002229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549339|NCT00002229|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102549340|NCT00002229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102549341|NCT04963673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
102549342|NCT04963673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549343|NCT04963673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549344|NCT00002451|Ritonavir|ritonavir|mesh-list
102549345|NCT00002451|Indinavir|indinavir|mesh-list
102549346|NCT00002451|Lamivudine|lamivudine|mesh-list
102549347|NCT00002451|Stavudine|stavudine|mesh-list
102549348|NCT00002451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102549349|NCT00002451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102549350|NCT00002451|Protease Inhibitors|protease inhibitors|mesh-ancestor
102549351|NCT00002451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549352|NCT00002451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549353|NCT00002451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102549354|NCT00002451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102549355|NCT00002451|Antiviral Agents|antiviral agents|mesh-ancestor
102549356|NCT00002451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549357|NCT00002451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102549358|NCT00002451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102549359|NCT00002451|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102549360|NCT00002451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102549361|NCT00002451|Antimetabolites|antimetabolites|mesh-ancestor
102549362|NCT00002235|Efavirenz|efavirenz|mesh-list
102549363|NCT00002235|Nelfinavir|nelfinavir|mesh-list
102549364|NCT00002235|Indinavir|indinavir|mesh-list
102549365|NCT00002235|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102549366|NCT00002235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102549367|NCT00002235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549368|NCT00002235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549369|NCT00002235|Antiviral Agents|antiviral agents|mesh-ancestor
102549370|NCT00002235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549371|NCT00002235|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102549372|NCT00002235|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102549373|NCT00002235|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102549374|NCT00002235|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102549375|NCT00002235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102549376|NCT00002235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102549377|NCT00002235|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102549378|NCT00002235|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102549379|NCT00002235|Protease Inhibitors|protease inhibitors|mesh-ancestor
102549380|NCT00002235|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102549381|NCT00002235|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102549382|NCT00002463|Leucovorin|leucovorin|mesh-list
102549383|NCT00002463|Prednisone|prednisone|mesh-list
102549384|NCT00002463|Methotrexate|methotrexate|mesh-list
102549385|NCT00002463|Vincristine|vincristine|mesh-list
102549386|NCT00002463|Procarbazine|procarbazine|mesh-list
102549387|NCT00002463|Mechlorethamine|mechlorethamine|mesh-list
102549388|NCT00002463|Calcium|calcium|mesh-list
102549389|NCT00002463|Levoleucovorin|levoleucovorin|mesh-list
102549390|NCT00002463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102549391|NCT00002463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102549392|NCT00002463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102549393|NCT00002463|Glucocorticoids|glucocorticoids|mesh-ancestor
102549394|NCT00002463|Hormones|hormones|mesh-ancestor
102549395|NCT00002463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102549396|NCT00002463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102549397|NCT00002463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102549398|NCT00002463|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102549399|NCT00002463|Abortifacient Agents|abortifacient agents|mesh-ancestor
102549400|NCT00002463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102549401|NCT00002463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102549402|NCT00002463|Antimetabolites|antimetabolites|mesh-ancestor
102549403|NCT00002463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549404|NCT00002463|Dermatologic Agents|dermatologic agents|mesh-ancestor
102549405|NCT00002463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549406|NCT00002463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102549407|NCT00002463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102549408|NCT00002463|Immunologic Factors|immunologic factors|mesh-ancestor
102549409|NCT00002463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102549410|NCT00002463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102549411|NCT00002463|Antidotes|antidotes|mesh-ancestor
102549412|NCT00002463|Protective Agents|protective agents|mesh-ancestor
102549413|NCT00002463|Vitamin B Complex|vitamin b complex|mesh-ancestor
102549414|NCT00002463|Vitamins|vitamins|mesh-ancestor
102549415|NCT00002463|Micronutrients|micronutrients|mesh-ancestor
102549416|NCT00002463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102549417|NCT00002463|Tubulin Modulators|tubulin modulators|mesh-ancestor
102549418|NCT00002463|Antimitotic Agents|antimitotic agents|mesh-ancestor
102549419|NCT00002463|Mitosis Modulators|mitosis modulators|mesh-ancestor
102549420|NCT00002463|Alkylating Agents|alkylating agents|mesh-ancestor
102549421|NCT00002463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102549422|NCT00002247|Ganciclovir|ganciclovir|mesh-list
102549423|NCT00002247|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102549424|NCT00002247|Antiviral Agents|antiviral agents|mesh-ancestor
102549425|NCT00002247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549426|NCT00002247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102549427|NCT00002247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549428|NCT00002247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549429|NCT00002475|Interferons|interferons|mesh-list
102549430|NCT00002475|Interferon-alpha|interferon-alpha|mesh-list
102549431|NCT00002475|Interferon-gamma|interferon-gamma|mesh-list
102549432|NCT00002475|Cyclophosphamide|cyclophosphamide|mesh-list
102549433|NCT00002475|Vaccines|vaccines|mesh-list
102549434|NCT00002475|Sargramostim|sargramostim|mesh-list
102549435|NCT00002475|Immunologic Factors|immunologic factors|mesh-ancestor
102549436|NCT00002475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102549437|NCT00002475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102549438|NCT00002475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102549439|NCT00002475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102549440|NCT00002475|Alkylating Agents|alkylating agents|mesh-ancestor
102549441|NCT00002475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549442|NCT00002475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102549443|NCT00002475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102549444|NCT00002475|Antiviral Agents|antiviral agents|mesh-ancestor
102549445|NCT00002475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549446|NCT00002481|Cytarabine|cytarabine|mesh-list
102549447|NCT00002481|Dexamethasone|dexamethasone|mesh-list
102549448|NCT00002481|Cyclophosphamide|cyclophosphamide|mesh-list
102549449|NCT00002481|Etoposide|etoposide|mesh-list
102549450|NCT00002481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102549451|NCT00002481|Immunologic Factors|immunologic factors|mesh-ancestor
102549452|NCT00002481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102549453|NCT00002481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102549454|NCT00002481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102549455|NCT00002481|Alkylating Agents|alkylating agents|mesh-ancestor
102549456|NCT00002481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549457|NCT00002481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102549458|NCT00002481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102549459|NCT00002481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102549460|NCT00002481|Antiemetics|antiemetics|mesh-ancestor
102549461|NCT00002481|Autonomic Agents|autonomic agents|mesh-ancestor
102549462|NCT00002481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102549463|NCT00002481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102549464|NCT00002481|Glucocorticoids|glucocorticoids|mesh-ancestor
102549465|NCT00002481|Hormones|hormones|mesh-ancestor
102549466|NCT00002481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102549467|NCT00002481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102549468|NCT00002481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102549469|NCT00002481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102549470|NCT00002481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102549471|NCT00002481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549472|NCT00002481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102549473|NCT00002481|Antimetabolites|antimetabolites|mesh-ancestor
102549474|NCT00002481|Antiviral Agents|antiviral agents|mesh-ancestor
102549475|NCT00002481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549476|NCT00002253|Octreotide|octreotide|mesh-list
102549477|NCT00002253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102549478|NCT00002253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102549479|NCT00002253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102549480|NCT04862585|Diphenhydramine|diphenhydramine|mesh-list
102549481|NCT04862585|Promethazine|promethazine|mesh-list
102549482|NCT04862585|Dexamethasone|dexamethasone|mesh-list
102549483|NCT04862585|Dexamethasone acetate|dexamethasone acetate|mesh-list
102549484|NCT04862585|Paclitaxel|paclitaxel|mesh-list
102549485|NCT04862585|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102549486|NCT04862585|Famotidine|famotidine|mesh-list
102549487|NCT04862585|Ranitidine|ranitidine|mesh-list
102549488|NCT04862585|Cimetidine|cimetidine|mesh-list
102549489|NCT04862585|BB 1101|bb 1101|mesh-list
102549490|NCT04862585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102549491|NCT04862585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102549492|NCT04862585|Tubulin Modulators|tubulin modulators|mesh-ancestor
102549493|NCT04862585|Antimitotic Agents|antimitotic agents|mesh-ancestor
102549494|NCT04862585|Mitosis Modulators|mitosis modulators|mesh-ancestor
102549495|NCT04862585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549496|NCT04862585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102549497|NCT04862585|Antiemetics|antiemetics|mesh-ancestor
102549498|NCT04862585|Autonomic Agents|autonomic agents|mesh-ancestor
102549499|NCT04862585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102549500|NCT04862585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102549501|NCT04862585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102549502|NCT04862585|Glucocorticoids|glucocorticoids|mesh-ancestor
102549503|NCT04862585|Hormones|hormones|mesh-ancestor
102549504|NCT04862585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102549505|NCT04862585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102549506|NCT04862585|Protease Inhibitors|protease inhibitors|mesh-ancestor
102549507|NCT04862585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549508|NCT04862585|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102549509|NCT04862585|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102549510|NCT04862585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102549511|NCT04862585|Anesthetics, Local|anesthetics, local|mesh-ancestor
102549512|NCT04862585|Anesthetics|anesthetics|mesh-ancestor
102549513|NCT04862585|Sensory System Agents|sensory system agents|mesh-ancestor
102549514|NCT04862585|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102549515|NCT04862585|Histamine Antagonists|histamine antagonists|mesh-ancestor
102549516|NCT04862585|Histamine Agents|histamine agents|mesh-ancestor
102549517|NCT04862585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102549518|NCT04862585|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102549519|NCT04862585|Antipruritics|antipruritics|mesh-ancestor
102549520|NCT04862585|Dermatologic Agents|dermatologic agents|mesh-ancestor
102549521|NCT04862585|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101836229|NCT00940667|Losartan|losartan|mesh-list
102549522|NCT04862585|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102549523|NCT04862585|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102549524|NCT04862585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102549525|NCT00002487|Methotrexate|methotrexate|mesh-list
102549526|NCT00002487|Dipyridamole|dipyridamole|mesh-list
102549527|NCT00002487|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102549528|NCT00002487|Abortifacient Agents|abortifacient agents|mesh-ancestor
102549529|NCT00002487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102549530|NCT00002487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102549531|NCT00002487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102549532|NCT00002487|Antimetabolites|antimetabolites|mesh-ancestor
102549533|NCT00002487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549534|NCT00002487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102549535|NCT00002487|Dermatologic Agents|dermatologic agents|mesh-ancestor
102549536|NCT00002487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549537|NCT00002487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102549538|NCT00002487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102549539|NCT00002487|Immunologic Factors|immunologic factors|mesh-ancestor
102549540|NCT00002487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102549541|NCT00002487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102549542|NCT00002487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102549543|NCT00002487|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102549544|NCT00002487|Vasodilator Agents|vasodilator agents|mesh-ancestor
102549545|NCT00002493|Doxorubicin|doxorubicin|mesh-list
102549546|NCT00002493|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102549547|NCT00002493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102549548|NCT00002493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102549549|NCT00002493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102549550|NCT00002493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102549551|NCT00002493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549552|NCT00002493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549553|NCT00002259|Mitoxantrone|mitoxantrone|mesh-list
102549554|NCT00002259|Analgesics|analgesics|mesh-ancestor
102549555|NCT00002259|Sensory System Agents|sensory system agents|mesh-ancestor
102549556|NCT00002259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102549557|NCT00002259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102549558|NCT00002259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102549559|NCT00002259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102549560|NCT00002259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102549561|NCT00002259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549562|NCT00002259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549563|NCT00002499|Cytarabine|cytarabine|mesh-list
102549564|NCT00002499|Dexamethasone|dexamethasone|mesh-list
102549565|NCT00002499|Prednisone|prednisone|mesh-list
102549566|NCT00002499|Methotrexate|methotrexate|mesh-list
102549567|NCT00002499|Vincristine|vincristine|mesh-list
102549568|NCT00002499|Daunorubicin|daunorubicin|mesh-list
102549569|NCT00002499|Asparaginase|asparaginase|mesh-list
102549570|NCT00002499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102549571|NCT00002499|Antiemetics|antiemetics|mesh-ancestor
102549572|NCT00002499|Autonomic Agents|autonomic agents|mesh-ancestor
102549573|NCT00002499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102549574|NCT00002499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102549575|NCT00002499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102549576|NCT00002499|Glucocorticoids|glucocorticoids|mesh-ancestor
102549577|NCT00002499|Hormones|hormones|mesh-ancestor
102549578|NCT00002499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102549579|NCT00002499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102549580|NCT00002499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102549581|NCT00002499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102549582|NCT00002499|Abortifacient Agents|abortifacient agents|mesh-ancestor
102549583|NCT00002499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102549584|NCT00002499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102549585|NCT00002499|Antimetabolites|antimetabolites|mesh-ancestor
102549586|NCT00002499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549587|NCT00002499|Dermatologic Agents|dermatologic agents|mesh-ancestor
102549588|NCT00002499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549589|NCT00002499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102549590|NCT00002499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102549591|NCT00002499|Immunologic Factors|immunologic factors|mesh-ancestor
102549592|NCT00002499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102549593|NCT00002499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102549594|NCT00002499|Antiviral Agents|antiviral agents|mesh-ancestor
102549595|NCT00002499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549596|NCT00002499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102549597|NCT00002499|Tubulin Modulators|tubulin modulators|mesh-ancestor
102549598|NCT00002499|Antimitotic Agents|antimitotic agents|mesh-ancestor
102549599|NCT00002499|Mitosis Modulators|mitosis modulators|mesh-ancestor
102549600|NCT00002499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102549601|NCT00002499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102549602|NCT00002499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102549603|NCT00002505|Interferons|interferons|mesh-list
102549604|NCT00002505|Interferon-gamma|interferon-gamma|mesh-list
102549605|NCT00002505|Vaccines|vaccines|mesh-list
102549606|NCT00002505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102549607|NCT00002505|Antiviral Agents|antiviral agents|mesh-ancestor
102549608|NCT00002505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549609|NCT00002505|Immunologic Factors|immunologic factors|mesh-ancestor
102549610|NCT00002505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102549611|NCT00002265|Zalcitabine|zalcitabine|mesh-list
102549612|NCT00002265|Antimetabolites|antimetabolites|mesh-ancestor
102549613|NCT00002265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549614|NCT00002265|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102549615|NCT00002265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102549616|NCT00002265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549617|NCT00002265|Antiviral Agents|antiviral agents|mesh-ancestor
102549618|NCT00002265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549619|NCT00002265|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102549620|NCT00002265|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102549621|NCT04933331|Silver Nitrate|silver nitrate|mesh-list
102549622|NCT04933331|Fluorides|fluorides|mesh-list
102549623|NCT04933331|Fluorides, Topical|fluorides, topical|mesh-list
102549624|NCT04933331|Cariostatic Agents|cariostatic agents|mesh-ancestor
102549625|NCT04933331|Protective Agents|protective agents|mesh-ancestor
102549626|NCT04933331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102549627|NCT04933331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102549628|NCT04933331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549629|NCT00002271|Alovudine|alovudine|mesh-list
102549630|NCT00002271|Antiviral Agents|antiviral agents|mesh-ancestor
102549631|NCT00002271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549632|NCT00002517|Cytarabine|cytarabine|mesh-list
102549633|NCT00002517|Dexamethasone|dexamethasone|mesh-list
102549634|NCT00002517|Etoposide|etoposide|mesh-list
102549635|NCT00002517|Daunorubicin|daunorubicin|mesh-list
102549636|NCT00002517|Mitoxantrone|mitoxantrone|mesh-list
102549637|NCT00002517|Idarubicin|idarubicin|mesh-list
102549638|NCT00002517|Thioguanine|thioguanine|mesh-list
102549639|NCT00002517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102549640|NCT00002517|Antiemetics|antiemetics|mesh-ancestor
102549641|NCT00002517|Autonomic Agents|autonomic agents|mesh-ancestor
102549642|NCT00002517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102549643|NCT00002517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102549644|NCT00002517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101769655|NCT00367237|Infliximab|infliximab|mesh-list
102549645|NCT00002517|Glucocorticoids|glucocorticoids|mesh-ancestor
102549646|NCT00002517|Hormones|hormones|mesh-ancestor
102549647|NCT00002517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102549648|NCT00002517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102549649|NCT00002517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102549650|NCT00002517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102549651|NCT00002517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102549652|NCT00002517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102549653|NCT00002517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549654|NCT00002517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549655|NCT00002517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102549656|NCT00002517|Antimetabolites|antimetabolites|mesh-ancestor
102549657|NCT00002517|Antiviral Agents|antiviral agents|mesh-ancestor
102549658|NCT00002517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549659|NCT00002517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102549660|NCT00002517|Immunologic Factors|immunologic factors|mesh-ancestor
102549661|NCT00002517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102549662|NCT00002517|Analgesics|analgesics|mesh-ancestor
102549663|NCT00002517|Sensory System Agents|sensory system agents|mesh-ancestor
102549664|NCT00002277|Fluconazole|fluconazole|mesh-list
102549665|NCT00002277|Amphotericin B|amphotericin b|mesh-list
102549666|NCT00002277|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102549667|NCT00002277|Antifungal Agents|antifungal agents|mesh-ancestor
102549668|NCT00002277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549669|NCT00002277|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101836379|NCT00335452|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102549670|NCT00002277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102549671|NCT00002277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549672|NCT00002277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549673|NCT00002277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102549674|NCT00002277|Hormone Antagonists|hormone antagonists|mesh-ancestor
102549675|NCT00002277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102549676|NCT00002277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102549677|NCT00002277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102549678|NCT00002277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102549679|NCT00002277|Amebicides|amebicides|mesh-ancestor
102549680|NCT00002277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102549681|NCT00002277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102549682|NCT00002277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102549683|NCT04469075|Clindamycin|clindamycin|mesh-list
102549684|NCT04469075|Clindamycin palmitate|clindamycin palmitate|mesh-list
102549685|NCT04469075|Clindamycin phosphate|clindamycin phosphate|mesh-list
102549686|NCT04469075|Triamcinolone|triamcinolone|mesh-list
102549687|NCT04469075|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102549688|NCT04469075|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102549689|NCT04469075|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102549690|NCT04469075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102549691|NCT04469075|Glucocorticoids|glucocorticoids|mesh-ancestor
102549692|NCT04469075|Hormones|hormones|mesh-ancestor
102549693|NCT04469075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102549694|NCT04469075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102549695|NCT04469075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102549696|NCT04469075|Immunologic Factors|immunologic factors|mesh-ancestor
102549697|NCT04469075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549698|NCT04469075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549699|NCT04469075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102549700|NCT04469075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549701|NCT04469075|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102549702|NCT00002523|Leucovorin|leucovorin|mesh-list
102549703|NCT00002523|Fluorouracil|fluorouracil|mesh-list
102549704|NCT00002523|Calcium|calcium|mesh-list
102549705|NCT00002523|Levoleucovorin|levoleucovorin|mesh-list
102549706|NCT00002523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102549707|NCT00002523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102549708|NCT00002523|Antimetabolites|antimetabolites|mesh-ancestor
102549709|NCT00002523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549710|NCT00002523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102549711|NCT00002523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102549712|NCT00002523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102549713|NCT00002523|Immunologic Factors|immunologic factors|mesh-ancestor
102549714|NCT00002523|Antidotes|antidotes|mesh-ancestor
102549715|NCT00002523|Protective Agents|protective agents|mesh-ancestor
102549716|NCT00002523|Vitamin B Complex|vitamin b complex|mesh-ancestor
102549717|NCT00002523|Vitamins|vitamins|mesh-ancestor
102549718|NCT00002523|Micronutrients|micronutrients|mesh-ancestor
102549719|NCT00002529|Tamoxifen|tamoxifen|mesh-list
102549720|NCT00002529|Toremifene|toremifene|mesh-list
102549721|NCT00002529|Cyclophosphamide|cyclophosphamide|mesh-list
102549722|NCT00002529|Doxorubicin|doxorubicin|mesh-list
102549723|NCT00002529|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102549724|NCT00002529|Epirubicin|epirubicin|mesh-list
102549725|NCT00002529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102549726|NCT00002529|Immunologic Factors|immunologic factors|mesh-ancestor
102549727|NCT00002529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102549728|NCT00002529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102549729|NCT00002529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102549730|NCT00002529|Alkylating Agents|alkylating agents|mesh-ancestor
102549731|NCT00002529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549732|NCT00002529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102549733|NCT00002529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102549734|NCT00002529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102549735|NCT00002529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102549736|NCT00002529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102549737|NCT00002529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549738|NCT00002529|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102549739|NCT00002529|Hormone Antagonists|hormone antagonists|mesh-ancestor
102549740|NCT00002529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102549741|NCT00002529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102549742|NCT00002529|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102549743|NCT00002529|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102549744|NCT00002529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102549745|NCT04832087|Teduglutide|teduglutide|mesh-list
102549746|NCT04832087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102549747|NCT04832087|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102549748|NCT04832087|Protective Agents|protective agents|mesh-ancestor
102549749|NCT04832087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102549750|NCT00002217|Lamivudine|lamivudine|mesh-list
102549751|NCT00002217|Zidovudine|zidovudine|mesh-list
102549752|NCT00002217|Abacavir|abacavir|mesh-list
102549753|NCT00002217|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
102549754|NCT00002217|Amprenavir|amprenavir|mesh-list
102549755|NCT00002217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102549756|NCT00002217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102549757|NCT00002217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549758|NCT00002217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549759|NCT00002217|Antiviral Agents|antiviral agents|mesh-ancestor
102549760|NCT00002217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549761|NCT00002217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102549762|NCT00002217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102549763|NCT00002217|Antimetabolites|antimetabolites|mesh-ancestor
102549764|NCT00002217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102549765|NCT00002217|Antitubercular Agents|antitubercular agents|mesh-ancestor
102549766|NCT00002217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102549767|NCT00002217|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102549768|NCT00002217|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102549769|NCT00002217|Protease Inhibitors|protease inhibitors|mesh-ancestor
102549770|NCT00002283|Trimethoprim|trimethoprim|mesh-list
102549771|NCT00002283|Dapsone|dapsone|mesh-list
102549772|NCT00002283|Sulfamethoxazole|sulfamethoxazole|mesh-list
102549773|NCT00002283|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102549774|NCT00002283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549775|NCT00002283|Antimalarials|antimalarials|mesh-ancestor
102549776|NCT00002283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102549777|NCT00002283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102549778|NCT00002283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102549779|NCT00002283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549780|NCT00002283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549781|NCT00002283|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102549782|NCT00002283|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102549783|NCT00002283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102549784|NCT00002283|Leprostatic Agents|leprostatic agents|mesh-ancestor
102549785|NCT00002283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102549786|NCT04826237|Dexamethasone|dexamethasone|mesh-list
102549787|NCT04826237|Methylprednisolone|methylprednisolone|mesh-list
102549788|NCT04826237|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102549789|NCT04826237|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102549790|NCT04826237|Prednisolone|prednisolone|mesh-list
102549791|NCT04826237|Prednisolone acetate|prednisolone acetate|mesh-list
102549792|NCT04826237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
102549793|NCT04826237|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102549794|NCT04826237|Prednisolone phosphate|prednisolone phosphate|mesh-list
102549795|NCT04826237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102549796|NCT04826237|Antiemetics|antiemetics|mesh-ancestor
102549797|NCT04826237|Autonomic Agents|autonomic agents|mesh-ancestor
102549798|NCT04826237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102549799|NCT04826237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102549800|NCT04826237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102549801|NCT04826237|Glucocorticoids|glucocorticoids|mesh-ancestor
102549802|NCT04826237|Hormones|hormones|mesh-ancestor
102549803|NCT04826237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102549804|NCT04826237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102549805|NCT04826237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102549806|NCT04826237|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102549807|NCT04826237|Protective Agents|protective agents|mesh-ancestor
102549808|NCT04826237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102549809|NCT04826237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102549810|NCT04826237|Antimetabolites|antimetabolites|mesh-ancestor
102549811|NCT04826237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549812|NCT04826237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549813|NCT04826237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102549814|NCT00002535|Aldesleukin|aldesleukin|mesh-list
102549815|NCT00002535|Indomethacin|indomethacin|mesh-list
102549816|NCT00002535|Cyclophosphamide|cyclophosphamide|mesh-list
102549817|NCT00002535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102549818|NCT00002535|Immunologic Factors|immunologic factors|mesh-ancestor
102549819|NCT00002535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102549820|NCT00002535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102549821|NCT00002535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102549822|NCT00002535|Alkylating Agents|alkylating agents|mesh-ancestor
102549823|NCT00002535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096866|NCT03470480|Methamphetamine|methamphetamine|mesh-list
102549824|NCT00002535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102549825|NCT00002535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102549826|NCT00002535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102549827|NCT00002535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102549828|NCT00002535|Antiviral Agents|antiviral agents|mesh-ancestor
102549829|NCT00002535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549830|NCT00002535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102549831|NCT00002535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102549832|NCT00002535|Analgesics|analgesics|mesh-ancestor
102549833|NCT00002535|Sensory System Agents|sensory system agents|mesh-ancestor
102549834|NCT00002535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102549835|NCT00002535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102549836|NCT00002535|Gout Suppressants|gout suppressants|mesh-ancestor
102549837|NCT00002535|Tocolytic Agents|tocolytic agents|mesh-ancestor
102549838|NCT00002535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102549839|NCT00002535|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102549840|NCT00002535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549841|NCT00002547|Cytarabine|cytarabine|mesh-list
102549842|NCT00002547|Cyclosporine|cyclosporine|mesh-list
102549843|NCT00002547|Cyclophosphamide|cyclophosphamide|mesh-list
102549844|NCT00002547|Busulfan|busulfan|mesh-list
102549845|NCT00002547|Methotrexate|methotrexate|mesh-list
102549846|NCT00002547|Cyclosporins|cyclosporins|mesh-list
102549847|NCT00002547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102549848|NCT00002547|Immunologic Factors|immunologic factors|mesh-ancestor
101769857|NCT00902187|Fesoterodine|fesoterodine|mesh-list
102549849|NCT00002547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102549850|NCT00002547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102549851|NCT00002547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102549852|NCT00002547|Alkylating Agents|alkylating agents|mesh-ancestor
102549853|NCT00002547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549854|NCT00002547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102549855|NCT00002547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102549856|NCT00002547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102549857|NCT00002547|Abortifacient Agents|abortifacient agents|mesh-ancestor
102549858|NCT00002547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102549859|NCT00002547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102549860|NCT00002547|Antimetabolites|antimetabolites|mesh-ancestor
102549861|NCT00002547|Dermatologic Agents|dermatologic agents|mesh-ancestor
102549862|NCT00002547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549863|NCT00002547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102549864|NCT00002547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102549865|NCT00002547|Antiviral Agents|antiviral agents|mesh-ancestor
102549866|NCT00002547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549867|NCT00002547|Antifungal Agents|antifungal agents|mesh-ancestor
102549868|NCT00002547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102549869|NCT00002289|Thymopentin|thymopentin|mesh-list
102549870|NCT00002289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102549871|NCT00002289|Immunologic Factors|immunologic factors|mesh-ancestor
102549872|NCT00002289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102549873|NCT00002553|Cobalt|cobalt|mesh-list
102549874|NCT00002553|Cyclophosphamide|cyclophosphamide|mesh-list
102549875|NCT00002553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102549876|NCT00002553|Immunologic Factors|immunologic factors|mesh-ancestor
102549877|NCT00002553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102549878|NCT00002553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102549879|NCT00002553|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102549880|NCT00002553|Alkylating Agents|alkylating agents|mesh-ancestor
102549881|NCT00002553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549882|NCT00002553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102549883|NCT00002553|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102549884|NCT00002553|Trace Elements|trace elements|mesh-ancestor
102549885|NCT00002553|Micronutrients|micronutrients|mesh-ancestor
102549886|NCT00002559|Paclitaxel|paclitaxel|mesh-list
102549887|NCT00002559|Ifosfamide|ifosfamide|mesh-list
102549888|NCT00002559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102549889|NCT00002559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102549890|NCT00002559|Tubulin Modulators|tubulin modulators|mesh-ancestor
102549891|NCT00002559|Antimitotic Agents|antimitotic agents|mesh-ancestor
102549892|NCT00002559|Mitosis Modulators|mitosis modulators|mesh-ancestor
102549893|NCT00002559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549894|NCT00002559|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102549895|NCT00002559|Alkylating Agents|alkylating agents|mesh-ancestor
102549896|NCT00002565|Cytarabine|cytarabine|mesh-list
102549897|NCT00002565|Prednisone|prednisone|mesh-list
102549898|NCT00002565|Methylprednisolone|methylprednisolone|mesh-list
102549899|NCT00002565|Cyclophosphamide|cyclophosphamide|mesh-list
102549900|NCT00002565|Ifosfamide|ifosfamide|mesh-list
102549901|NCT00002565|Doxorubicin|doxorubicin|mesh-list
102549902|NCT00002565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102549903|NCT00002565|Etoposide|etoposide|mesh-list
102549904|NCT00002565|Vincristine|vincristine|mesh-list
102549905|NCT00002565|Mitoxantrone|mitoxantrone|mesh-list
102549906|NCT00002565|Idarubicin|idarubicin|mesh-list
102549907|NCT00002565|Bleomycin|bleomycin|mesh-list
102549908|NCT00002565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102549909|NCT00002565|Immunologic Factors|immunologic factors|mesh-ancestor
102549910|NCT00002565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102549911|NCT00002565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102549912|NCT00002565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102549913|NCT00002565|Alkylating Agents|alkylating agents|mesh-ancestor
102549914|NCT00002565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549915|NCT00002565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102549916|NCT00002565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102549917|NCT00002565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102549918|NCT00002565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102549919|NCT00002565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102549920|NCT00002565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549921|NCT00002565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102549922|NCT00002565|Glucocorticoids|glucocorticoids|mesh-ancestor
102549923|NCT00002565|Hormones|hormones|mesh-ancestor
102549924|NCT00002565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102549925|NCT00002565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102549926|NCT00002565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102549927|NCT00002565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102549928|NCT00002565|Antimetabolites|antimetabolites|mesh-ancestor
102549929|NCT00002565|Antiviral Agents|antiviral agents|mesh-ancestor
102549930|NCT00002565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549931|NCT00002565|Tubulin Modulators|tubulin modulators|mesh-ancestor
102549932|NCT00002565|Antimitotic Agents|antimitotic agents|mesh-ancestor
102549933|NCT00002565|Mitosis Modulators|mitosis modulators|mesh-ancestor
102549934|NCT00002565|Antiemetics|antiemetics|mesh-ancestor
102549935|NCT00002565|Autonomic Agents|autonomic agents|mesh-ancestor
102549936|NCT00002565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102549937|NCT00002565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102549938|NCT00002565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102549939|NCT00002565|Protective Agents|protective agents|mesh-ancestor
102549940|NCT00002565|Analgesics|analgesics|mesh-ancestor
102549941|NCT00002565|Sensory System Agents|sensory system agents|mesh-ancestor
102549942|NCT00002571|Leucovorin|leucovorin|mesh-list
102549943|NCT00002571|Cytarabine|cytarabine|mesh-list
102549944|NCT00002571|Trimethoprim|trimethoprim|mesh-list
102549945|NCT00002571|Sulfamethoxazole|sulfamethoxazole|mesh-list
102549946|NCT00002571|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102549947|NCT00002571|Prednisone|prednisone|mesh-list
102549948|NCT00002571|Cyclophosphamide|cyclophosphamide|mesh-list
102549949|NCT00002571|Doxorubicin|doxorubicin|mesh-list
102549950|NCT00002571|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102549951|NCT00002571|Methotrexate|methotrexate|mesh-list
102549952|NCT00002571|Etoposide|etoposide|mesh-list
102549953|NCT00002571|Vincristine|vincristine|mesh-list
102549954|NCT00002571|Bleomycin|bleomycin|mesh-list
102549955|NCT00002571|Levoleucovorin|levoleucovorin|mesh-list
102549956|NCT00002571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102549957|NCT00002571|Immunologic Factors|immunologic factors|mesh-ancestor
102549958|NCT00002571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102549959|NCT00002571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102549960|NCT00002571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102549961|NCT00002571|Alkylating Agents|alkylating agents|mesh-ancestor
102549962|NCT00002571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102549963|NCT00002571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102549964|NCT00002571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102549965|NCT00002571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102549966|NCT00002571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102549967|NCT00002571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102549968|NCT00002571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102549969|NCT00002571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102549970|NCT00002571|Glucocorticoids|glucocorticoids|mesh-ancestor
102549971|NCT00002571|Hormones|hormones|mesh-ancestor
102549972|NCT00002571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102549973|NCT00002571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102549974|NCT00002571|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102549975|NCT00002571|Abortifacient Agents|abortifacient agents|mesh-ancestor
102549976|NCT00002571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102549977|NCT00002571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102549978|NCT00002571|Antimetabolites|antimetabolites|mesh-ancestor
102097016|NCT03782636|Aldesleukin|aldesleukin|mesh-list
102549979|NCT00002571|Dermatologic Agents|dermatologic agents|mesh-ancestor
102549980|NCT00002571|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102549981|NCT00002571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102549982|NCT00002571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102549983|NCT00002571|Antiviral Agents|antiviral agents|mesh-ancestor
102549984|NCT00002571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102549985|NCT00002571|Antidotes|antidotes|mesh-ancestor
102549986|NCT00002571|Protective Agents|protective agents|mesh-ancestor
102549987|NCT00002571|Vitamin B Complex|vitamin b complex|mesh-ancestor
102549988|NCT00002571|Vitamins|vitamins|mesh-ancestor
102549989|NCT00002571|Micronutrients|micronutrients|mesh-ancestor
102549990|NCT00002571|Tubulin Modulators|tubulin modulators|mesh-ancestor
102549991|NCT00002571|Antimitotic Agents|antimitotic agents|mesh-ancestor
102549992|NCT00002571|Mitosis Modulators|mitosis modulators|mesh-ancestor
102549993|NCT00002571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102549994|NCT00002571|Antimalarials|antimalarials|mesh-ancestor
102549995|NCT00002571|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102549996|NCT00002571|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102549997|NCT00002571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102549998|NCT00002571|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102549999|NCT00002571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102550000|NCT00002571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102550001|NCT00360815|Insulin|insulin|mesh-list
102550002|NCT00360815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102550003|NCT00360815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550004|NCT00002583|Vinorelbine|vinorelbine|mesh-list
102550005|NCT00002583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550006|NCT00002583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102550007|NCT00002583|Tubulin Modulators|tubulin modulators|mesh-ancestor
102550008|NCT00002583|Antimitotic Agents|antimitotic agents|mesh-ancestor
102550009|NCT00002583|Mitosis Modulators|mitosis modulators|mesh-ancestor
102550010|NCT00002583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550011|NCT00002589|Aldesleukin|aldesleukin|mesh-list
102550012|NCT00002589|Muromonab-CD3|muromonab-cd3|mesh-list
102550013|NCT00002589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550014|NCT00002589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102550015|NCT00002589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102550016|NCT00002589|Antiviral Agents|antiviral agents|mesh-ancestor
102550017|NCT00002589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102550018|NCT00002589|Immunologic Factors|immunologic factors|mesh-ancestor
102550019|NCT00002589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550020|NCT00002589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102550021|NCT02223871|Lumefantrine|lumefantrine|mesh-list
102550022|NCT02223871|Artemether|artemether|mesh-list
102550023|NCT02223871|Primaquine|primaquine|mesh-list
102550024|NCT02223871|Antimalarials|antimalarials|mesh-ancestor
102550025|NCT02223871|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102550026|NCT02223871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102550027|NCT02223871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102550028|NCT00002595|Toremifene|toremifene|mesh-list
102550029|NCT00002595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102550030|NCT00002595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550031|NCT00002595|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102550032|NCT00002595|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102550033|NCT00002595|Hormone Antagonists|hormone antagonists|mesh-ancestor
102550034|NCT00002595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102550035|NCT00002595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550036|NCT00002595|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102550037|NCT03004339|Betamethasone|betamethasone|mesh-list
102550038|NCT03004339|Betamethasone Valerate|betamethasone valerate|mesh-list
102550039|NCT03004339|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102550040|NCT03004339|Betamethasone benzoate|betamethasone benzoate|mesh-list
102550041|NCT03004339|Calcipotriene|calcipotriene|mesh-list
102550042|NCT03004339|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102550043|NCT03004339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102550044|NCT03004339|Glucocorticoids|glucocorticoids|mesh-ancestor
102550045|NCT03004339|Hormones|hormones|mesh-ancestor
102550046|NCT03004339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102550047|NCT03004339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550048|NCT03004339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102550049|NCT03004339|Respiratory System Agents|respiratory system agents|mesh-ancestor
102550050|NCT03004339|Dermatologic Agents|dermatologic agents|mesh-ancestor
102550051|NCT00002619|Carboplatin|carboplatin|mesh-list
102550052|NCT00002619|Thiotepa|thiotepa|mesh-list
102550053|NCT00002619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102097090|NCT04914598|Cisplatin|cisplatin|mesh-list
102550054|NCT00002619|Immunologic Factors|immunologic factors|mesh-ancestor
102550055|NCT00002619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550056|NCT00002619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102550057|NCT00002619|Alkylating Agents|alkylating agents|mesh-ancestor
102550058|NCT00002619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550059|NCT00002619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102550060|NCT00002619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102550061|NCT00002625|Topotecan|topotecan|mesh-list
102550062|NCT00002625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102550063|NCT00002625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102550064|NCT00002625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102550065|NCT00002625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550066|NCT00002625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550067|NCT00360737|Antitoxins|antitoxins|mesh-list
102550068|NCT00360737|Botulinum Antitoxin|botulinum antitoxin|mesh-list
102550069|NCT00360737|Immunologic Factors|immunologic factors|mesh-ancestor
102550070|NCT00360737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550071|NCT05752305|Dexamethasone|dexamethasone|mesh-list
102550072|NCT05752305|Methylprednisolone|methylprednisolone|mesh-list
102550073|NCT05752305|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102550074|NCT05752305|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102550075|NCT05752305|Prednisolone|prednisolone|mesh-list
102550076|NCT05752305|Prednisolone acetate|prednisolone acetate|mesh-list
102550077|NCT05752305|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102550078|NCT05752305|Prednisolone phosphate|prednisolone phosphate|mesh-list
102550079|NCT05752305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102550080|NCT05752305|Antiemetics|antiemetics|mesh-ancestor
102550081|NCT05752305|Autonomic Agents|autonomic agents|mesh-ancestor
102550082|NCT05752305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102550083|NCT05752305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550084|NCT05752305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102550085|NCT05752305|Glucocorticoids|glucocorticoids|mesh-ancestor
102550086|NCT05752305|Hormones|hormones|mesh-ancestor
102550087|NCT05752305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102550088|NCT05752305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102550089|NCT05752305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550090|NCT05752305|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102550091|NCT05752305|Protective Agents|protective agents|mesh-ancestor
102550092|NCT04343729|Methylprednisolone|methylprednisolone|mesh-list
102550093|NCT04343729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102550094|NCT04343729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102550095|NCT04343729|Prednisolone|prednisolone|mesh-list
102550096|NCT04343729|Prednisolone acetate|prednisolone acetate|mesh-list
102550097|NCT04343729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102550098|NCT04343729|Prednisolone phosphate|prednisolone phosphate|mesh-list
102550099|NCT04343729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102550100|NCT04343729|Antiemetics|antiemetics|mesh-ancestor
102550101|NCT04343729|Autonomic Agents|autonomic agents|mesh-ancestor
102550102|NCT04343729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102550103|NCT04343729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550104|NCT04343729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102550105|NCT04343729|Glucocorticoids|glucocorticoids|mesh-ancestor
102550106|NCT04343729|Hormones|hormones|mesh-ancestor
102550107|NCT04343729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102550108|NCT04343729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102550109|NCT04343729|Protective Agents|protective agents|mesh-ancestor
102550110|NCT04343729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102550111|NCT04343729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550112|NCT00002631|Fluorouracil|fluorouracil|mesh-list
102550113|NCT00002631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550114|NCT00002631|Antimetabolites|antimetabolites|mesh-ancestor
102550115|NCT00002631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550116|NCT00002631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102550117|NCT00002631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102550118|NCT00002631|Immunologic Factors|immunologic factors|mesh-ancestor
102550119|NCT00002631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550120|NCT00002637|Interferons|interferons|mesh-list
102550121|NCT00002637|Aldesleukin|aldesleukin|mesh-list
102550122|NCT00002637|Interferon-gamma|interferon-gamma|mesh-list
102550123|NCT00002637|Vaccines|vaccines|mesh-list
102550124|NCT00002637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550125|NCT00002637|Antiviral Agents|antiviral agents|mesh-ancestor
102550126|NCT00002637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102550127|NCT00002637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102550128|NCT00002637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102550129|NCT00002637|Immunologic Factors|immunologic factors|mesh-ancestor
102550130|NCT00002637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550131|NCT02977013|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102550132|NCT02977013|Dalteparin|dalteparin|mesh-list
102550133|NCT02977013|Anticoagulants|anticoagulants|mesh-ancestor
102550134|NCT02977013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102550135|NCT02977013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102550136|NCT02977013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550137|NCT05806918|Interferons|interferons|mesh-list
102550138|NCT05806918|Interferon alpha-2|interferon alpha-2|mesh-list
102550139|NCT05806918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550140|NCT05806918|Antiviral Agents|antiviral agents|mesh-ancestor
102550141|NCT05806918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102550142|NCT00002241|Ritonavir|ritonavir|mesh-list
102550143|NCT00002241|Indinavir|indinavir|mesh-list
102550144|NCT00002241|Lamivudine|lamivudine|mesh-list
102550145|NCT00002241|Stavudine|stavudine|mesh-list
102550146|NCT00002241|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102550147|NCT00002241|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102550148|NCT00002241|Protease Inhibitors|protease inhibitors|mesh-ancestor
102550149|NCT00002241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102550150|NCT00002241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550151|NCT00002241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102550152|NCT00002241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102550153|NCT00002241|Antiviral Agents|antiviral agents|mesh-ancestor
102550154|NCT00002241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102550155|NCT00002241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102550156|NCT00002241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102550157|NCT00002241|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102550158|NCT00002241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102550159|NCT00002241|Antimetabolites|antimetabolites|mesh-ancestor
102550160|NCT05806853|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102550161|NCT05806853|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102550162|NCT05806853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550163|NCT05806723|Atorvastatin|atorvastatin|mesh-list
102550164|NCT05806723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102550165|NCT05806723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102550166|NCT05806723|Antimetabolites|antimetabolites|mesh-ancestor
102550167|NCT05806723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550168|NCT05806723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102550169|NCT05806723|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102550170|NCT05806723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102550171|NCT05806697|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102550172|NCT05806697|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102550173|NCT05806697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550174|NCT05806671|Fulvestrant|fulvestrant|mesh-list
102550175|NCT05806671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102550176|NCT05806671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550177|NCT05806671|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102550178|NCT05806671|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102550179|NCT05806671|Hormone Antagonists|hormone antagonists|mesh-ancestor
102550180|NCT05806671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102550181|NCT05806671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550182|NCT05806515|Carboplatin|carboplatin|mesh-list
102550183|NCT05806515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550184|NCT05806476|Caffeine|caffeine|mesh-list
102550185|NCT05806476|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102550186|NCT05806476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550187|NCT05806476|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102550188|NCT05806476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102550189|NCT05806476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550190|NCT05806476|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102550191|NCT05806476|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102550192|NCT05806476|Purinergic Agents|purinergic agents|mesh-ancestor
102550193|NCT05806476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102550194|NCT05806385|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102550195|NCT05806385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550196|NCT05806385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102550197|NCT05806385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550198|NCT05806307|Vasopressins|vasopressins|mesh-list
102550199|NCT05806307|Arginine Vasopressin|arginine vasopressin|mesh-list
102550200|NCT05806307|Epinephrine|epinephrine|mesh-list
102550201|NCT05806307|Bupivacaine|bupivacaine|mesh-list
102550202|NCT05806307|Misoprostol|misoprostol|mesh-list
102550203|NCT05806307|Ethamsylate|ethamsylate|mesh-list
102550204|NCT05806307|Oxytocin|oxytocin|mesh-list
102550205|NCT05806307|Carbetocin|carbetocin|mesh-list
102550206|NCT05806307|Anesthetics, Local|anesthetics, local|mesh-ancestor
102550207|NCT05806307|Anesthetics|anesthetics|mesh-ancestor
102550208|NCT05806307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102550209|NCT05806307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550210|NCT05806307|Sensory System Agents|sensory system agents|mesh-ancestor
102550211|NCT05806307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102550212|NCT05806307|Oxytocics|oxytocics|mesh-ancestor
102550213|NCT05806307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102550214|NCT05806307|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102550215|NCT05806307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102550216|NCT05806307|Adrenergic Agents|adrenergic agents|mesh-ancestor
102550217|NCT05806307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102550218|NCT05806307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550219|NCT05806307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102550220|NCT05806307|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102550221|NCT05806307|Autonomic Agents|autonomic agents|mesh-ancestor
102550222|NCT05806307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102550223|NCT05806307|Respiratory System Agents|respiratory system agents|mesh-ancestor
102550224|NCT05806307|Mydriatics|mydriatics|mesh-ancestor
102550225|NCT05806307|Sympathomimetics|sympathomimetics|mesh-ancestor
102550226|NCT05806307|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102550227|NCT05806307|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102550228|NCT05806307|Abortifacient Agents|abortifacient agents|mesh-ancestor
102550229|NCT05806307|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102550230|NCT05806307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102550231|NCT05806307|Hemostatics|hemostatics|mesh-ancestor
102550232|NCT05806307|Coagulants|coagulants|mesh-ancestor
102550233|NCT05806307|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102550234|NCT05806307|Natriuretic Agents|natriuretic agents|mesh-ancestor
102550235|NCT05806047|Fulvestrant|fulvestrant|mesh-list
102550236|NCT05806047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102550237|NCT05806047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550238|NCT05806047|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102550239|NCT05806047|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102550240|NCT05806047|Hormone Antagonists|hormone antagonists|mesh-ancestor
102550241|NCT05806047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102550242|NCT05806047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550243|NCT05805930|Prednisone|prednisone|mesh-list
102550244|NCT05805930|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102550245|NCT05805930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102550246|NCT05805930|Glucocorticoids|glucocorticoids|mesh-ancestor
102550247|NCT05805930|Hormones|hormones|mesh-ancestor
102550248|NCT05805930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102550249|NCT05805930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550250|NCT05805930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102550251|NCT05805930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550252|NCT05805930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102550253|NCT05805800|Dexamethasone|dexamethasone|mesh-list
102550254|NCT05805800|Olanzapine|olanzapine|mesh-list
102550255|NCT05805800|Serotonin|serotonin|mesh-list
102550256|NCT05805800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102550257|NCT05805800|Antiemetics|antiemetics|mesh-ancestor
102550258|NCT05805800|Autonomic Agents|autonomic agents|mesh-ancestor
102550259|NCT05805800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102550260|NCT05805800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550261|NCT05805800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102550262|NCT05805800|Glucocorticoids|glucocorticoids|mesh-ancestor
102550263|NCT05805800|Hormones|hormones|mesh-ancestor
102550264|NCT05805800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102550265|NCT05805800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102550266|NCT05805800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550267|NCT05805800|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102550268|NCT05805800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102550269|NCT05805800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102550270|NCT05805800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102550271|NCT05805800|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102550272|NCT05805800|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102550273|NCT05805800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102550274|NCT05805800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550275|NCT05805800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102550276|NCT05805800|Serotonin Agents|serotonin agents|mesh-ancestor
102550277|NCT05805800|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102550278|NCT05805631|Pemetrexed|pemetrexed|mesh-list
102550279|NCT05805631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550280|NCT05805631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102550281|NCT05805631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550282|NCT05805631|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102550283|NCT05805631|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102550284|NCT05805553|Nandrolone Decanoate|nandrolone decanoate|mesh-list
102550285|NCT05805553|Propranolol|propranolol|mesh-list
102550286|NCT05805553|Nandrolone|nandrolone|mesh-list
102550287|NCT05805553|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
102550288|NCT05805553|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102550289|NCT05805553|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102550290|NCT05805553|Adrenergic Agents|adrenergic agents|mesh-ancestor
102550291|NCT05805553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102550292|NCT05805553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550293|NCT05805553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770291|NCT01055821|Interferons|interferons|mesh-list
102550294|NCT05805553|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102550295|NCT05805553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102550296|NCT05805553|Vasodilator Agents|vasodilator agents|mesh-ancestor
102550297|NCT05805553|Androgens|androgens|mesh-ancestor
102550298|NCT05805553|Hormones|hormones|mesh-ancestor
102550299|NCT05805553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102550300|NCT05805553|Anabolic Agents|anabolic agents|mesh-ancestor
102550301|NCT05805553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102550302|NCT05804747|Edoxaban|edoxaban|mesh-list
102550303|NCT05804747|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102550304|NCT05804747|Antithrombins|antithrombins|mesh-ancestor
102550305|NCT05804747|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102550306|NCT05804747|Protease Inhibitors|protease inhibitors|mesh-ancestor
102550307|NCT05804747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102550308|NCT05804747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550309|NCT05804747|Anticoagulants|anticoagulants|mesh-ancestor
102550310|NCT05800938|Isosorbide|isosorbide|mesh-list
102550311|NCT05800938|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102550312|NCT05800938|Diuretics|diuretics|mesh-ancestor
102550313|NCT05800938|Natriuretic Agents|natriuretic agents|mesh-ancestor
102550314|NCT05800938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550315|NCT05797935|Dapagliflozin|dapagliflozin|mesh-list
102550316|NCT05797935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102550317|NCT05797935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550318|NCT05797935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102550319|NCT05797935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550320|NCT05775237|Vitamins|vitamins|mesh-list
102550321|NCT05775237|Ascorbic Acid|ascorbic acid|mesh-list
102550322|NCT05775237|Curcumin|curcumin|mesh-list
102550323|NCT05775237|Micronutrients|micronutrients|mesh-ancestor
102550324|NCT05775237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550325|NCT05775237|Antioxidants|antioxidants|mesh-ancestor
102550326|NCT05775237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550327|NCT05775237|Protective Agents|protective agents|mesh-ancestor
102550328|NCT05775237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102550329|NCT05775237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102550330|NCT05775237|Analgesics|analgesics|mesh-ancestor
102550331|NCT05775237|Sensory System Agents|sensory system agents|mesh-ancestor
102550332|NCT05775237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102550333|NCT05775237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102550334|NCT05775237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102550335|NCT05775237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550336|NCT05775237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102550337|NCT05751044|Cytarabine|cytarabine|mesh-list
102550338|NCT05751044|Dexamethasone|dexamethasone|mesh-list
102550339|NCT05751044|Cyclophosphamide|cyclophosphamide|mesh-list
102550340|NCT05751044|Venetoclax|venetoclax|mesh-list
102550341|NCT05751044|Dasatinib|dasatinib|mesh-list
102550342|NCT05751044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102550343|NCT05751044|Immunologic Factors|immunologic factors|mesh-ancestor
102550344|NCT05751044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550345|NCT05751044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102550346|NCT05751044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102550347|NCT05751044|Alkylating Agents|alkylating agents|mesh-ancestor
102550348|NCT05751044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550349|NCT05751044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550350|NCT05751044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102550351|NCT05751044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102550352|NCT05751044|Antiemetics|antiemetics|mesh-ancestor
102550353|NCT05751044|Autonomic Agents|autonomic agents|mesh-ancestor
102550354|NCT05751044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102550355|NCT05751044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102550356|NCT05751044|Glucocorticoids|glucocorticoids|mesh-ancestor
102550357|NCT05751044|Hormones|hormones|mesh-ancestor
102612374|NCT02973581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102550358|NCT05751044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102550359|NCT05751044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102550360|NCT05751044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102550362|NCT05751044|Antiviral Agents|antiviral agents|mesh-ancestor
102550363|NCT05751044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102550364|NCT05751044|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102550365|NCT05751044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102550366|NCT05709093|Azacitidine|azacitidine|mesh-list
102550367|NCT05709093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102550368|NCT05709093|Antimetabolites|antimetabolites|mesh-ancestor
102550369|NCT05709093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550370|NCT05709093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550371|NCT05709093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102550372|NCT05690646|Ritonavir|ritonavir|mesh-list
102550373|NCT05690646|Nirmatrelvir|nirmatrelvir|mesh-list
102550374|NCT05690646|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
102550375|NCT05690646|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102550376|NCT05690646|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102550377|NCT05690646|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102550378|NCT05690646|Protease Inhibitors|protease inhibitors|mesh-ancestor
102550379|NCT05690646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102550380|NCT05690646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550381|NCT05690646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102550382|NCT05690646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102550383|NCT05690646|Antiviral Agents|antiviral agents|mesh-ancestor
102550384|NCT05690646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102550385|NCT05690646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102550386|NCT05690646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102550387|NCT05690646|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102550388|NCT05690646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102550389|NCT05648201|Raltegravir Potassium|raltegravir potassium|mesh-list
102550390|NCT05648201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102550391|NCT05648201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102550392|NCT05648201|Antiviral Agents|antiviral agents|mesh-ancestor
102550393|NCT05648201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102550394|NCT05648201|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102550395|NCT05648201|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102550396|NCT05648201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102550397|NCT05648201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550398|NCT05607004|Exemestane|exemestane|mesh-list
102550399|NCT05607004|Goserelin|goserelin|mesh-list
102550400|NCT05607004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550401|NCT05607004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102550402|NCT05607004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102550403|NCT05607004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102550404|NCT05607004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550405|NCT05607004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102550406|NCT05607004|Hormone Antagonists|hormone antagonists|mesh-ancestor
102550407|NCT05607004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102550408|NCT05607004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550409|NCT05607004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102550410|NCT05604300|Vitamin E|vitamin e|mesh-list
102550411|NCT05604300|Vitamins|vitamins|mesh-ancestor
102550412|NCT05604300|Micronutrients|micronutrients|mesh-ancestor
102550413|NCT05604300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550414|NCT05604300|Antioxidants|antioxidants|mesh-ancestor
102550415|NCT05604300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550416|NCT05604300|Protective Agents|protective agents|mesh-ancestor
102550417|NCT05593497|Abiraterone Acetate|abiraterone acetate|mesh-list
102550418|NCT05593497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550419|NCT05593497|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102550420|NCT05593497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102550421|NCT05593497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550422|NCT05593497|Hormone Antagonists|hormone antagonists|mesh-ancestor
102550423|NCT05593497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102550424|NCT05593497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550425|NCT05593497|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102550426|NCT05511870|Etripamil|etripamil|mesh-list
102550427|NCT05511870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102550428|NCT05511870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102550429|NCT05511870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550430|NCT05511870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101770422|NCT00336505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102550431|NCT05511870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550432|NCT05492851|Hylan|hylan|mesh-list
102550433|NCT05492851|Viscosupplements|viscosupplements|mesh-ancestor
102550434|NCT05492851|Protective Agents|protective agents|mesh-ancestor
102550435|NCT05492851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550436|NCT05486104|Hemay005|hemay005|mesh-list
102550437|NCT05486104|Dermatologic Agents|dermatologic agents|mesh-ancestor
102550438|NCT05486104|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102550439|NCT05486104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102550440|NCT05486104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102550441|NCT05486104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550442|NCT05423535|Fibrin Foam|fibrin foam|mesh-list
102550443|NCT05423535|Hemostatics|hemostatics|mesh-ancestor
102550444|NCT05423535|Coagulants|coagulants|mesh-ancestor
102550445|NCT05414409|Metformin|metformin|mesh-list
102550446|NCT05414409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102550447|NCT05414409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550448|NCT05411575|Plerixafor|plerixafor|mesh-list
102550449|NCT05411575|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102550450|NCT05411575|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102550451|NCT05411575|Antiviral Agents|antiviral agents|mesh-ancestor
102550452|NCT05411575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102550453|NCT05367401|Azacitidine|azacitidine|mesh-list
102550454|NCT05367401|Magrolimab|magrolimab|mesh-list
102550455|NCT05367401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102550456|NCT05367401|Antimetabolites|antimetabolites|mesh-ancestor
102550457|NCT05367401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550458|NCT05367401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550459|NCT05367401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102550460|NCT05367401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102550461|NCT05297448|Rifaximin|rifaximin|mesh-list
102550462|NCT05297448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102550463|NCT05297448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102550464|NCT05297448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102550465|NCT05161156|Bromides|bromides|mesh-list
102550466|NCT05161156|Tiotropium Bromide|tiotropium bromide|mesh-list
102550467|NCT05161156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102550468|NCT05161156|Autonomic Agents|autonomic agents|mesh-ancestor
102550469|NCT05161156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102550470|NCT05161156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550471|NCT05161156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102550472|NCT05161156|Respiratory System Agents|respiratory system agents|mesh-ancestor
102550473|NCT05161156|Parasympatholytics|parasympatholytics|mesh-ancestor
102550474|NCT05161156|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102550475|NCT05161156|Cholinergic Agents|cholinergic agents|mesh-ancestor
102550476|NCT05161156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102550477|NCT05161156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550478|NCT05161156|Anticonvulsants|anticonvulsants|mesh-ancestor
102550479|NCT05132101|Palbociclib|palbociclib|mesh-list
102550480|NCT05132101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550481|NCT05132101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102550482|NCT05132101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102550483|NCT05132101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550484|NCT05062395|Deoxyglucose|deoxyglucose|mesh-list
102550485|NCT05062395|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102550486|NCT05062395|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102550487|NCT05062395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550488|NCT05062395|Antimetabolites|antimetabolites|mesh-ancestor
102550489|NCT05062395|Antiviral Agents|antiviral agents|mesh-ancestor
102550490|NCT05062395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102550491|NCT05045950|Memantine|memantine|mesh-list
102550492|NCT05045950|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102550493|NCT05045950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102550494|NCT05045950|Dopamine Agents|dopamine agents|mesh-ancestor
102550495|NCT05045950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102550496|NCT05045950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550497|NCT05045950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550498|NCT05045950|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101770494|NCT01060189|Coagulants|coagulants|mesh-ancestor
102550499|NCT05045950|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102550500|NCT04947514|Tranexamic Acid|tranexamic acid|mesh-list
102550501|NCT04947514|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102550502|NCT04947514|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102550503|NCT04947514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550504|NCT04947514|Hemostatics|hemostatics|mesh-ancestor
102550505|NCT04947514|Coagulants|coagulants|mesh-ancestor
102550506|NCT04924101|Cisplatin|cisplatin|mesh-list
102550507|NCT04924101|Carboplatin|carboplatin|mesh-list
102550508|NCT04924101|Pembrolizumab|pembrolizumab|mesh-list
102550509|NCT04924101|Etoposide|etoposide|mesh-list
102550510|NCT04924101|Etoposide phosphate|etoposide phosphate|mesh-list
102550511|NCT04924101|Lenvatinib|lenvatinib|mesh-list
102550512|NCT04924101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550513|NCT04924101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102550514|NCT04924101|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102550515|NCT04924101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550516|NCT04924101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102550517|NCT04924101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102550518|NCT04924101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102550519|NCT04924101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102550520|NCT04924101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102550521|NCT04860011|Dapagliflozin|dapagliflozin|mesh-list
102550522|NCT04860011|Metolazone|metolazone|mesh-list
102550523|NCT04860011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102550524|NCT04860011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550525|NCT04860011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102550526|NCT04860011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550527|NCT04860011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102550528|NCT04860011|Diuretics|diuretics|mesh-ancestor
102550529|NCT04860011|Natriuretic Agents|natriuretic agents|mesh-ancestor
102550530|NCT04860011|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102550531|NCT04860011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102550532|NCT04827745|Blinatumomab|blinatumomab|mesh-list
102550533|NCT04827745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550534|NCT04735978|Nivolumab|nivolumab|mesh-list
102550535|NCT04735978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102550536|NCT04735978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550537|NCT04735978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102550538|NCT04735978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550539|NCT04704050|Dronedarone|dronedarone|mesh-list
102550540|NCT04704050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102550541|NCT04669210|Mycophenolic Acid|mycophenolic acid|mesh-list
102550542|NCT04669210|Tacrolimus|tacrolimus|mesh-list
102550543|NCT04669210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102550544|NCT04669210|Immunologic Factors|immunologic factors|mesh-ancestor
102550545|NCT04669210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550546|NCT04669210|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102550547|NCT04669210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102550548|NCT04669210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550549|NCT04669210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102550550|NCT04669210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550551|NCT04669210|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102550552|NCT04669210|Antitubercular Agents|antitubercular agents|mesh-ancestor
102550553|NCT04669210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102550554|NCT04669210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102550555|NCT04655157|Nivolumab|nivolumab|mesh-list
102550556|NCT04655157|Ipilimumab|ipilimumab|mesh-list
102550557|NCT04655157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102550558|NCT04655157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550559|NCT04655157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102550560|NCT04655157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550561|NCT04650269|Emtricitabine|emtricitabine|mesh-list
102550562|NCT04650269|Antiviral Agents|antiviral agents|mesh-ancestor
102550563|NCT04650269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102550564|NCT04650269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102550565|NCT04650269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102550566|NCT04650269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102550567|NCT04650269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550568|NCT04650269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102550569|NCT04650269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102550570|NCT04629196|Ustekinumab|ustekinumab|mesh-list
102550571|NCT04629196|Dermatologic Agents|dermatologic agents|mesh-ancestor
102550572|NCT04617002|TIC10 compound|tic10 compound|mesh-list
102550573|NCT04617002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550574|NCT04591808|Perindopril|perindopril|mesh-list
102550575|NCT04591808|Atorvastatin|atorvastatin|mesh-list
102550576|NCT04591808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102550577|NCT04591808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102550578|NCT04591808|Antimetabolites|antimetabolites|mesh-ancestor
102550579|NCT04591808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550580|NCT04591808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102550581|NCT04591808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102550582|NCT04591808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102550583|NCT04591808|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102550584|NCT04591808|Protease Inhibitors|protease inhibitors|mesh-ancestor
102550585|NCT04591808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102550586|NCT04587687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102550587|NCT04587687|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102550588|NCT04587687|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102550589|NCT04587687|Antibodies|antibodies|mesh-list
102550590|NCT04587687|Immunoglobulins|immunoglobulins|mesh-list
102550591|NCT04587687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102550592|NCT04587687|Immunoconjugates|immunoconjugates|mesh-list
102550593|NCT04587687|Immunologic Factors|immunologic factors|mesh-ancestor
102550594|NCT04587687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550595|NCT04587687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550596|NCT04587687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102550597|NCT04587687|Alkylating Agents|alkylating agents|mesh-ancestor
102550598|NCT04587687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550599|NCT04587687|Immunotoxins|immunotoxins|mesh-ancestor
102550600|NCT04585750|Pembrolizumab|pembrolizumab|mesh-list
102550601|NCT04585750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102550602|NCT04585750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550603|NCT04585750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102550604|NCT04585750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550605|NCT04578600|Lenalidomide|lenalidomide|mesh-list
102550606|NCT04578600|Azacitidine|azacitidine|mesh-list
102550607|NCT04578600|Obinutuzumab|obinutuzumab|mesh-list
102550608|NCT04578600|Immunologic Factors|immunologic factors|mesh-ancestor
102550609|NCT04578600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550610|NCT04578600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102550611|NCT04578600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102550612|NCT04578600|Growth Substances|growth substances|mesh-ancestor
102550613|NCT04578600|Growth Inhibitors|growth inhibitors|mesh-ancestor
102550614|NCT04578600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550615|NCT04578600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102550616|NCT04578600|Antimetabolites|antimetabolites|mesh-ancestor
102550617|NCT04578600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550618|NCT04578600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102550619|NCT04578600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102550620|NCT04471987|Interleukin-12|interleukin-12|mesh-list
102550621|NCT04471987|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102550622|NCT04471987|Immunologic Factors|immunologic factors|mesh-ancestor
102550623|NCT04471987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550624|NCT04471987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102550625|NCT04471987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102550626|NCT04471987|Growth Substances|growth substances|mesh-ancestor
102550627|NCT04471987|Growth Inhibitors|growth inhibitors|mesh-ancestor
102550628|NCT04471987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550629|NCT04405037|Alvimopan|alvimopan|mesh-list
102550630|NCT04405037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102550631|NCT04389177|Paclitaxel|paclitaxel|mesh-list
102550632|NCT04389177|Cisplatin|cisplatin|mesh-list
102550633|NCT04389177|Pembrolizumab|pembrolizumab|mesh-list
102550634|NCT04389177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102550635|NCT04389177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550636|NCT04389177|Tubulin Modulators|tubulin modulators|mesh-ancestor
102550637|NCT04389177|Antimitotic Agents|antimitotic agents|mesh-ancestor
102550638|NCT04389177|Mitosis Modulators|mitosis modulators|mesh-ancestor
102550639|NCT04389177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550640|NCT04389177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102550641|NCT04389177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102550642|NCT04368988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102550643|NCT04365257|Prazosin|prazosin|mesh-list
102550644|NCT04365257|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-list
102550645|NCT04365257|Adrenergic Antagonists|adrenergic antagonists|mesh-list
102550646|NCT04365257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102550647|NCT04365257|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102550648|NCT04365257|Adrenergic Agents|adrenergic agents|mesh-ancestor
102550649|NCT04365257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102550650|NCT04365257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550651|NCT04365257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550652|NCT04341545|Letrozole|letrozole|mesh-list
102550653|NCT04341545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550654|NCT04341545|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102550655|NCT04341545|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102550656|NCT04341545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102550657|NCT04341545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550658|NCT04341545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102550659|NCT04341545|Hormone Antagonists|hormone antagonists|mesh-ancestor
102550660|NCT04341545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102550661|NCT04341545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550662|NCT04220021|Metformin|metformin|mesh-list
102550663|NCT04220021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102550664|NCT04220021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550665|NCT04219722|Hyaluronic Acid|hyaluronic acid|mesh-list
102550666|NCT04219722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102550667|NCT04219722|Immunologic Factors|immunologic factors|mesh-ancestor
102550668|NCT04219722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550669|NCT04219722|Viscosupplements|viscosupplements|mesh-ancestor
102550670|NCT04219722|Protective Agents|protective agents|mesh-ancestor
102550671|NCT04191304|Benralizumab|benralizumab|mesh-list
102550672|NCT04191304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102550673|NCT04191304|Respiratory System Agents|respiratory system agents|mesh-ancestor
102550674|NCT04186299|Clonidine|clonidine|mesh-list
102550675|NCT04186299|Epinephrine|epinephrine|mesh-list
102550676|NCT04186299|Carticaine|carticaine|mesh-list
102550677|NCT04186299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102550678|NCT04186299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102550679|NCT04186299|Adrenergic Agents|adrenergic agents|mesh-ancestor
102550680|NCT04186299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102550681|NCT04186299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550682|NCT04186299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550683|NCT04186299|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102550684|NCT04186299|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102550685|NCT04186299|Autonomic Agents|autonomic agents|mesh-ancestor
102550686|NCT04186299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102550687|NCT04186299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102550688|NCT04186299|Respiratory System Agents|respiratory system agents|mesh-ancestor
102550689|NCT04186299|Mydriatics|mydriatics|mesh-ancestor
102550690|NCT04186299|Sympathomimetics|sympathomimetics|mesh-ancestor
102550691|NCT04186299|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102550692|NCT04186299|Analgesics|analgesics|mesh-ancestor
102550693|NCT04186299|Sensory System Agents|sensory system agents|mesh-ancestor
102550694|NCT04186299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102550695|NCT04186299|Sympatholytics|sympatholytics|mesh-ancestor
102550696|NCT04186299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102550697|NCT04186299|Anesthetics, Local|anesthetics, local|mesh-ancestor
102550698|NCT04186299|Anesthetics|anesthetics|mesh-ancestor
102550699|NCT04186299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102550700|NCT04165096|Acetaminophen|acetaminophen|mesh-list
102550701|NCT04165096|Diphenhydramine|diphenhydramine|mesh-list
102550702|NCT04165096|Promethazine|promethazine|mesh-list
102550703|NCT04165096|Pembrolizumab|pembrolizumab|mesh-list
102550704|NCT04165096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102550705|NCT04165096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550706|NCT04165096|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102550707|NCT04165096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550708|NCT04165096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102550709|NCT04165096|Analgesics|analgesics|mesh-ancestor
102550710|NCT04165096|Sensory System Agents|sensory system agents|mesh-ancestor
102550711|NCT04165096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102550712|NCT04165096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550713|NCT04165096|Antipyretics|antipyretics|mesh-ancestor
102550714|NCT04165096|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102550715|NCT04165096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102550716|NCT04165096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102550717|NCT04165096|Anesthetics, Local|anesthetics, local|mesh-ancestor
102550718|NCT04165096|Anesthetics|anesthetics|mesh-ancestor
102550719|NCT04165096|Antiemetics|antiemetics|mesh-ancestor
102550720|NCT04165096|Autonomic Agents|autonomic agents|mesh-ancestor
102550721|NCT04165096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102550722|NCT04165096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102550723|NCT04165096|Histamine Antagonists|histamine antagonists|mesh-ancestor
102550724|NCT04165096|Histamine Agents|histamine agents|mesh-ancestor
102550725|NCT04165096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102550726|NCT04165096|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102550727|NCT04165096|Antipruritics|antipruritics|mesh-ancestor
102550728|NCT04165096|Dermatologic Agents|dermatologic agents|mesh-ancestor
102550729|NCT04145700|Gemcitabine|gemcitabine|mesh-list
102550730|NCT04145700|Docetaxel|docetaxel|mesh-list
102550731|NCT04145700|Ramucirumab|ramucirumab|mesh-list
102097759|NCT03106688|Carfentanil|carfentanil|mesh-list
102550732|NCT04145700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102550733|NCT04145700|Antimetabolites|antimetabolites|mesh-ancestor
102550734|NCT04145700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550735|NCT04145700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550736|NCT04145700|Tubulin Modulators|tubulin modulators|mesh-ancestor
102550737|NCT04145700|Antimitotic Agents|antimitotic agents|mesh-ancestor
102550738|NCT04145700|Mitosis Modulators|mitosis modulators|mesh-ancestor
102550740|NCT04068753|Dostarlimab|dostarlimab|mesh-list
102550741|NCT04068753|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102550742|NCT04068753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102550743|NCT04068753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550744|NCT04068753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550745|NCT04005690|Olaparib|olaparib|mesh-list
102550746|NCT04005690|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102550747|NCT04005690|Onvansertib|onvansertib|mesh-list
102550748|NCT04005690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102550749|NCT04005690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550750|NCT04005690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550751|NCT04005690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102550752|NCT03927222|Temozolomide|temozolomide|mesh-list
102550753|NCT03927222|Molgramostim|molgramostim|mesh-list
102550754|NCT03927222|Sargramostim|sargramostim|mesh-list
102550755|NCT03927222|Immunologic Factors|immunologic factors|mesh-ancestor
102550756|NCT03927222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550757|NCT03927222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102550758|NCT03927222|Alkylating Agents|alkylating agents|mesh-ancestor
102550759|NCT03927222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550760|NCT03927222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550761|NCT03869892|Trifluridine|trifluridine|mesh-list
102550762|NCT03869892|Bevacizumab|bevacizumab|mesh-list
102550763|NCT03869892|Capecitabine|capecitabine|mesh-list
102550764|NCT03869892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102550765|NCT03869892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550766|NCT03869892|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102550767|NCT03869892|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102550768|NCT03869892|Growth Substances|growth substances|mesh-ancestor
102550769|NCT03869892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550770|NCT03869892|Growth Inhibitors|growth inhibitors|mesh-ancestor
102550771|NCT03869892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102550772|NCT03869892|Antimetabolites|antimetabolites|mesh-ancestor
102550773|NCT03869892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770783|NCT00986284|Gefitinib|gefitinib|mesh-list
102550774|NCT03869892|Antiviral Agents|antiviral agents|mesh-ancestor
102550775|NCT03869892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102550776|NCT03822663|Caffeine|caffeine|mesh-list
102550777|NCT03822663|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102550778|NCT03822663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550779|NCT03822663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102550780|NCT03822663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102550781|NCT03822663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550782|NCT03822663|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102550783|NCT03822663|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102550784|NCT03822663|Purinergic Agents|purinergic agents|mesh-ancestor
102550785|NCT03822663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102550786|NCT03801525|Venetoclax|venetoclax|mesh-list
102550787|NCT03801525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550788|NCT03778957|Bevacizumab|bevacizumab|mesh-list
102550789|NCT03778957|Durvalumab|durvalumab|mesh-list
102550790|NCT03778957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102550791|NCT03778957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550792|NCT03778957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102550793|NCT03778957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102550794|NCT03778957|Growth Substances|growth substances|mesh-ancestor
102550795|NCT03778957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550796|NCT03778957|Growth Inhibitors|growth inhibitors|mesh-ancestor
102550797|NCT03767933|Acetaminophen|acetaminophen|mesh-list
102550798|NCT03767933|Ibuprofen|ibuprofen|mesh-list
102550799|NCT03767933|Hydromorphone|hydromorphone|mesh-list
102550800|NCT03767933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102550801|NCT03767933|Analgesics|analgesics|mesh-ancestor
102550802|NCT03767933|Sensory System Agents|sensory system agents|mesh-ancestor
102550803|NCT03767933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102550804|NCT03767933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550805|NCT03767933|Antipyretics|antipyretics|mesh-ancestor
102550806|NCT03767933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102550807|NCT03767933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102097833|NCT04885660|Lisinopril|lisinopril|mesh-list
102550808|NCT03767933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102550809|NCT03767933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102550810|NCT03767933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102550811|NCT03767933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550812|NCT03767933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102550813|NCT03767933|Narcotics|narcotics|mesh-ancestor
102550814|NCT03767933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102550815|NCT03701919|Botulinum Toxins|botulinum toxins|mesh-list
102550816|NCT03701919|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102550817|NCT03701919|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102550818|NCT03701919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102550819|NCT03701919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550820|NCT03701919|Cholinergic Agents|cholinergic agents|mesh-ancestor
102550821|NCT03701919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102550822|NCT03701919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550823|NCT03701919|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102550824|NCT03701919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102550825|NCT03636152|Hydroxychloroquine|hydroxychloroquine|mesh-list
102550826|NCT03636152|Chloroquine|chloroquine|mesh-list
102550827|NCT03636152|Antimalarials|antimalarials|mesh-ancestor
102550828|NCT03636152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102550829|NCT03636152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102550830|NCT03636152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102550831|NCT03636152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102550832|NCT03636152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550833|NCT03636152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102550834|NCT03636152|Amebicides|amebicides|mesh-ancestor
102550835|NCT03633604|HBOC 201|hboc 201|mesh-list
102550836|NCT03633604|Blood Substitutes|blood substitutes|mesh-ancestor
102550837|NCT03555916|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102550838|NCT03555916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102550839|NCT03555916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102550840|NCT03555916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550841|NCT03555916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102550842|NCT03555916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101770838|NCT00333775|Bevacizumab|bevacizumab|mesh-list
102550843|NCT03555916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550844|NCT03555916|Cholinergic Agents|cholinergic agents|mesh-ancestor
102550845|NCT03555916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102550846|NCT03474497|Pembrolizumab|pembrolizumab|mesh-list
102550847|NCT03474497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102550848|NCT03474497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550849|NCT03474497|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102550850|NCT03474497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550851|NCT03395223|Methylene Blue|methylene blue|mesh-list
102550852|NCT03395223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102550853|NCT03395223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550854|NCT03289650|Tacrolimus|tacrolimus|mesh-list
102550855|NCT03289650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102550856|NCT03289650|Immunologic Factors|immunologic factors|mesh-ancestor
102550857|NCT03289650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550858|NCT03289650|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102550859|NCT03289650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102550860|NCT03289650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550861|NCT03255070|Immunoconjugates|immunoconjugates|mesh-list
102550862|NCT03255070|Immunologic Factors|immunologic factors|mesh-ancestor
102550863|NCT03255070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550864|NCT03192397|Mycophenolic Acid|mycophenolic acid|mesh-list
102550865|NCT03192397|Sirolimus|sirolimus|mesh-list
102550866|NCT03192397|Cyclophosphamide|cyclophosphamide|mesh-list
102550867|NCT03192397|Melphalan|melphalan|mesh-list
102550868|NCT03192397|Fludarabine|fludarabine|mesh-list
102550869|NCT03192397|Fludarabine phosphate|fludarabine phosphate|mesh-list
102550870|NCT03192397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102550871|NCT03192397|Immunologic Factors|immunologic factors|mesh-ancestor
102550872|NCT03192397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550873|NCT03192397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102550874|NCT03192397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102550875|NCT03192397|Alkylating Agents|alkylating agents|mesh-ancestor
102550876|NCT03192397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550877|NCT03192397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550878|NCT03192397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102550879|NCT03192397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102550880|NCT03192397|Antimetabolites|antimetabolites|mesh-ancestor
102097908|NCT04872322|Anesthetics, Local|anesthetics, local|mesh-ancestor
102550881|NCT03192397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102550882|NCT03192397|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102550883|NCT03192397|Antitubercular Agents|antitubercular agents|mesh-ancestor
102550884|NCT03192397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102550885|NCT03192397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102550886|NCT03192397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102550887|NCT03192397|Antifungal Agents|antifungal agents|mesh-ancestor
102550888|NCT02975492|Vitamin D|vitamin d|mesh-list
102550889|NCT02975492|Ergocalciferols|ergocalciferols|mesh-list
102550890|NCT02975492|Cholecalciferol|cholecalciferol|mesh-list
102550891|NCT02975492|Vitamins|vitamins|mesh-list
102550892|NCT02975492|Micronutrients|micronutrients|mesh-ancestor
102550893|NCT02975492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550894|NCT02975492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102550895|NCT02975492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102550896|NCT02867267|Thymalfasin|thymalfasin|mesh-list
102550897|NCT02867267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102550898|NCT02867267|Immunologic Factors|immunologic factors|mesh-ancestor
102550899|NCT02867267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550900|NCT02821832|Rifampin|rifampin|mesh-list
102550901|NCT02821832|Isoniazid|isoniazid|mesh-list
102550902|NCT02821832|Pyrazinamide|pyrazinamide|mesh-list
102550903|NCT02821832|Ethambutol|ethambutol|mesh-list
102550904|NCT02821832|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102550905|NCT02821832|Antitubercular Agents|antitubercular agents|mesh-ancestor
102550906|NCT02821832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102550907|NCT02821832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102550908|NCT02821832|Leprostatic Agents|leprostatic agents|mesh-ancestor
102550909|NCT02821832|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102550910|NCT02821832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102550911|NCT02821832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770909|NCT00983398|Melphalan|melphalan|mesh-list
102550912|NCT02821832|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102550913|NCT02821832|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102550914|NCT02821832|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102550915|NCT02821832|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102550916|NCT02821832|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102550917|NCT02821832|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102550918|NCT02821832|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102550919|NCT02821832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102550920|NCT02821832|Antimetabolites|antimetabolites|mesh-ancestor
102550921|NCT02821832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102550922|NCT02813148|Naloxegol|naloxegol|mesh-list
102550923|NCT02813148|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102550924|NCT02813148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550925|NCT02813148|Sensory System Agents|sensory system agents|mesh-ancestor
102550926|NCT02813148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102550927|NCT02756611|Venetoclax|venetoclax|mesh-list
102550928|NCT02756611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550929|NCT02673359|Progesterone|progesterone|mesh-list
102550930|NCT02673359|Progestins|progestins|mesh-ancestor
102550931|NCT02673359|Hormones|hormones|mesh-ancestor
102550932|NCT02673359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102550933|NCT02673359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550934|NCT02629809|Cyclophosphamide|cyclophosphamide|mesh-list
102550935|NCT02629809|Fludarabine|fludarabine|mesh-list
102550936|NCT02629809|Fludarabine phosphate|fludarabine phosphate|mesh-list
102550937|NCT02629809|Obinutuzumab|obinutuzumab|mesh-list
102550938|NCT02629809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102550939|NCT02629809|Immunologic Factors|immunologic factors|mesh-ancestor
102550940|NCT02629809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550941|NCT02629809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102550942|NCT02629809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102550943|NCT02629809|Alkylating Agents|alkylating agents|mesh-ancestor
102550944|NCT02629809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550945|NCT02629809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550946|NCT02629809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102550947|NCT02629809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102550948|NCT02629809|Antimetabolites|antimetabolites|mesh-ancestor
102550949|NCT02629809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102550950|NCT02624518|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
102550951|NCT02624518|Bombesin|bombesin|mesh-list
102550952|NCT02624518|Gastrins|gastrins|mesh-list
102550953|NCT02624518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102550954|NCT02624518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550955|NCT02624518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550956|NCT02624518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102550957|NCT02624518|Hormones|hormones|mesh-ancestor
102550958|NCT02624518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102550959|NCT02542657|Clarithromycin|clarithromycin|mesh-list
102550960|NCT02542657|Dexamethasone|dexamethasone|mesh-list
102550961|NCT02542657|Pomalidomide|pomalidomide|mesh-list
102550962|NCT02542657|Ixazomib|ixazomib|mesh-list
102550963|NCT02542657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102550964|NCT02542657|Antiemetics|antiemetics|mesh-ancestor
102550965|NCT02542657|Autonomic Agents|autonomic agents|mesh-ancestor
102550966|NCT02542657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102550967|NCT02542657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550968|NCT02542657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102550969|NCT02542657|Glucocorticoids|glucocorticoids|mesh-ancestor
102550970|NCT02542657|Hormones|hormones|mesh-ancestor
102550971|NCT02542657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102550972|NCT02542657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102550973|NCT02542657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102550974|NCT02542657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550975|NCT02542657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102550976|NCT02542657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102550977|NCT02542657|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102550978|NCT02542657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102550979|NCT02542657|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102550980|NCT02542657|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102550981|NCT02542657|Immunologic Factors|immunologic factors|mesh-ancestor
102550982|NCT02542657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102550983|NCT02542657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102550984|NCT02542657|Growth Substances|growth substances|mesh-ancestor
102550985|NCT02542657|Growth Inhibitors|growth inhibitors|mesh-ancestor
102550986|NCT02542657|Protease Inhibitors|protease inhibitors|mesh-ancestor
102550987|NCT02303171|Enoxaparin|enoxaparin|mesh-list
102550988|NCT02303171|Warfarin|warfarin|mesh-list
102550989|NCT02303171|Anticoagulants|anticoagulants|mesh-ancestor
102550990|NCT02303171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102550991|NCT02303171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102550992|NCT02303171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102550993|NCT02287623|Bupivacaine|bupivacaine|mesh-list
102550994|NCT02287623|Anesthetics, Local|anesthetics, local|mesh-ancestor
102550995|NCT02287623|Anesthetics|anesthetics|mesh-ancestor
102550996|NCT02287623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102550997|NCT02287623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102550998|NCT02287623|Sensory System Agents|sensory system agents|mesh-ancestor
102550999|NCT02287623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102551000|NCT02266329|Prazosin|prazosin|mesh-list
102551001|NCT02266329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102551002|NCT02266329|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102551003|NCT02266329|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102551004|NCT02266329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102551005|NCT02266329|Adrenergic Agents|adrenergic agents|mesh-ancestor
102551006|NCT02266329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102551007|NCT02266329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551008|NCT02266329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551009|NCT01794520|Dexamethasone|dexamethasone|mesh-list
102551010|NCT01794520|Venetoclax|venetoclax|mesh-list
102551011|NCT01794520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102551012|NCT01794520|Antiemetics|antiemetics|mesh-ancestor
102551013|NCT01794520|Autonomic Agents|autonomic agents|mesh-ancestor
102551014|NCT01794520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102551015|NCT01794520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551016|NCT01794520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102551017|NCT01794520|Glucocorticoids|glucocorticoids|mesh-ancestor
102551018|NCT01794520|Hormones|hormones|mesh-ancestor
102551019|NCT01794520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102551020|NCT01794520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102551021|NCT01794520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102551022|NCT01653678|Vitamin D|vitamin d|mesh-list
102551023|NCT01653678|Ergocalciferols|ergocalciferols|mesh-list
102551024|NCT01653678|Cholecalciferol|cholecalciferol|mesh-list
102551025|NCT01653678|Vitamins|vitamins|mesh-list
102551026|NCT01653678|Micronutrients|micronutrients|mesh-ancestor
102551027|NCT01653678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551028|NCT01653678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102551029|NCT01653678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102551030|NCT01370811|Mandelic Acids|mandelic acids|mesh-list
102551031|NCT01370811|Clonidine|clonidine|mesh-list
102551032|NCT01370811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102551033|NCT01370811|Oxybutynin|oxybutynin|mesh-list
102551034|NCT01370811|Analgesics|analgesics|mesh-ancestor
102551035|NCT01370811|Sensory System Agents|sensory system agents|mesh-ancestor
102551036|NCT01370811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102551037|NCT01370811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551038|NCT01370811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102551039|NCT01370811|Sympatholytics|sympatholytics|mesh-ancestor
102551040|NCT01370811|Autonomic Agents|autonomic agents|mesh-ancestor
102551041|NCT01370811|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102551042|NCT01370811|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102551043|NCT01370811|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102551044|NCT01370811|Adrenergic Agents|adrenergic agents|mesh-ancestor
102551045|NCT01370811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102551046|NCT01370811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551047|NCT01370811|Parasympatholytics|parasympatholytics|mesh-ancestor
102551048|NCT01370811|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102551049|NCT01370811|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102551050|NCT01370811|Cholinergic Agents|cholinergic agents|mesh-ancestor
102551051|NCT01370811|Urological Agents|urological agents|mesh-ancestor
102551052|NCT01370811|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102551053|NCT01370811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102551054|NCT01323569|Nabiximols|nabiximols|mesh-list
102551055|NCT01323569|Dronabinol|dronabinol|mesh-list
102551056|NCT01323569|Analgesics|analgesics|mesh-ancestor
102551057|NCT01323569|Sensory System Agents|sensory system agents|mesh-ancestor
102551058|NCT01323569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102551059|NCT01323569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551060|NCT01323569|Hallucinogens|hallucinogens|mesh-ancestor
102551061|NCT01323569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102551062|NCT01323569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102551063|NCT01323569|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102551064|NCT01323569|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102551065|NCT01323569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102551066|NCT01323569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551067|NCT01323569|Hormones|hormones|mesh-ancestor
102551068|NCT01323569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102551069|NCT01323465|Rifampin|rifampin|mesh-list
102551070|NCT01323465|Ketoconazole|ketoconazole|mesh-list
102551071|NCT01323465|Nabiximols|nabiximols|mesh-list
102551072|NCT01323465|Omeprazole|omeprazole|mesh-list
102551073|NCT01323465|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102551074|NCT01323465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102551075|NCT01323465|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102551076|NCT01323465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102551077|NCT01323465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551078|NCT01323465|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102551079|NCT01323465|Antitubercular Agents|antitubercular agents|mesh-ancestor
102551080|NCT01323465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102551081|NCT01323465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102551082|NCT01323465|Leprostatic Agents|leprostatic agents|mesh-ancestor
102551083|NCT01323465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102551084|NCT01323465|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102551085|NCT01323465|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102551086|NCT01323465|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102551087|NCT01323465|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102551088|NCT01323465|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102551089|NCT01323465|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102551090|NCT01323465|Antifungal Agents|antifungal agents|mesh-ancestor
102551091|NCT01323465|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102551092|NCT01323465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102551093|NCT01323465|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102551094|NCT01323465|Hormone Antagonists|hormone antagonists|mesh-ancestor
102551095|NCT01323465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102551096|NCT01323465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551097|NCT01323465|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102551098|NCT01323465|Analgesics|analgesics|mesh-ancestor
102551099|NCT01323465|Sensory System Agents|sensory system agents|mesh-ancestor
102551100|NCT01323465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102551101|NCT01322464|Nabiximols|nabiximols|mesh-list
102551102|NCT01322464|Analgesics|analgesics|mesh-ancestor
102551103|NCT01322464|Sensory System Agents|sensory system agents|mesh-ancestor
102551104|NCT01322464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102551105|NCT01322464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551106|NCT01322139|Moxifloxacin|moxifloxacin|mesh-list
102551108|NCT01322139|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102551109|NCT01322139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102551110|NCT01322139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102551111|NCT01322139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102551112|NCT01322139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102551113|NCT01322139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102551114|NCT01322139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551115|NCT01322139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102551116|NCT01322139|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102551117|NCT01322139|Contraceptive Agents|contraceptive agents|mesh-ancestor
102551118|NCT01322139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102551119|NCT01322139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551120|NCT01322139|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102551121|NCT01322139|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102551122|NCT01322139|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102551123|NCT01322139|Analgesics|analgesics|mesh-ancestor
102551124|NCT01322139|Sensory System Agents|sensory system agents|mesh-ancestor
102551125|NCT01322139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102551126|NCT01169259|Vitamin D|vitamin d|mesh-list
102551127|NCT01169259|Ergocalciferols|ergocalciferols|mesh-list
102551128|NCT01169259|Cholecalciferol|cholecalciferol|mesh-list
102551129|NCT01169259|Vitamins|vitamins|mesh-list
102551130|NCT01169259|Micronutrients|micronutrients|mesh-ancestor
102551131|NCT01169259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551132|NCT01169259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102551133|NCT01169259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102551134|NCT01165632|Fluorides|fluorides|mesh-list
102551135|NCT01165632|Cariostatic Agents|cariostatic agents|mesh-ancestor
102551136|NCT01165632|Protective Agents|protective agents|mesh-ancestor
102551137|NCT01165632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551138|NCT01019850|Vorinostat|vorinostat|mesh-list
102551139|NCT01019850|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
102551140|NCT01019850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102551141|NCT01019850|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102551142|NCT01019850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102551143|NCT01019850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551144|NCT01019850|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102551145|NCT00885326|Zoledronic Acid|zoledronic acid|mesh-list
102551146|NCT00885326|Cyclophosphamide|cyclophosphamide|mesh-list
102551147|NCT00885326|Bevacizumab|bevacizumab|mesh-list
102551148|NCT00885326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102551149|NCT00885326|Immunologic Factors|immunologic factors|mesh-ancestor
102551150|NCT00885326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551151|NCT00885326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102551152|NCT00885326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102551153|NCT00885326|Alkylating Agents|alkylating agents|mesh-ancestor
102551154|NCT00885326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551155|NCT00885326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102551156|NCT00885326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102551157|NCT00885326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102551158|NCT00885326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102551159|NCT00885326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102551160|NCT00885326|Growth Substances|growth substances|mesh-ancestor
102551161|NCT00885326|Growth Inhibitors|growth inhibitors|mesh-ancestor
102551162|NCT00885326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102551163|NCT00606138|Ranibizumab|ranibizumab|mesh-list
102551164|NCT00606138|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102551165|NCT00606138|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102551166|NCT00606138|Growth Substances|growth substances|mesh-ancestor
102551167|NCT00606138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551168|NCT00606138|Growth Inhibitors|growth inhibitors|mesh-ancestor
102551169|NCT00606138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102551170|NCT00005835|Melphalan|melphalan|mesh-list
102551171|NCT00005835|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
102551172|NCT00005835|Immunologic Factors|immunologic factors|mesh-ancestor
102551173|NCT00005835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551174|NCT00005835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102551175|NCT00005835|Alkylating Agents|alkylating agents|mesh-ancestor
102551176|NCT00005835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551177|NCT00005835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102551178|NCT00005835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102551179|NCT00005835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102551180|NCT00005835|Antimetabolites|antimetabolites|mesh-ancestor
102551181|NCT00005835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102551182|NCT00005835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102551183|NCT00005835|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102551184|NCT00005835|Protective Agents|protective agents|mesh-ancestor
102551185|NCT04401995|Nivolumab|nivolumab|mesh-list
102551186|NCT04401995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102551187|NCT04401995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102551188|NCT04401995|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102551189|NCT04401995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551191|NCT00002643|Cyclophosphamide|cyclophosphamide|mesh-list
102551192|NCT00002643|Ifosfamide|ifosfamide|mesh-list
102551193|NCT00002643|Doxorubicin|doxorubicin|mesh-list
102551194|NCT00002643|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102551195|NCT00002643|Etoposide|etoposide|mesh-list
102551196|NCT00002643|Vincristine|vincristine|mesh-list
102551197|NCT00002643|Topotecan|topotecan|mesh-list
102551198|NCT00002643|Amifostine|amifostine|mesh-list
102551199|NCT00002643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102551200|NCT00002643|Immunologic Factors|immunologic factors|mesh-ancestor
102551201|NCT00002643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551202|NCT00002643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102551203|NCT00002643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102551204|NCT00002643|Alkylating Agents|alkylating agents|mesh-ancestor
102551205|NCT00002643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551206|NCT00002643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102551207|NCT00002643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102551208|NCT00002643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102551209|NCT00002643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102551210|NCT00002643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102551211|NCT00002643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102551212|NCT00002643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102551213|NCT00002643|Tubulin Modulators|tubulin modulators|mesh-ancestor
102551214|NCT00002643|Antimitotic Agents|antimitotic agents|mesh-ancestor
102551215|NCT00002643|Mitosis Modulators|mitosis modulators|mesh-ancestor
102551216|NCT00002643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102551217|NCT00002643|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102551218|NCT00002643|Protective Agents|protective agents|mesh-ancestor
102551219|NCT00002643|Trace Elements|trace elements|mesh-ancestor
102551220|NCT00002643|Micronutrients|micronutrients|mesh-ancestor
102551221|NCT00002649|Aldesleukin|aldesleukin|mesh-list
102551222|NCT00002649|Cyclophosphamide|cyclophosphamide|mesh-list
102551223|NCT00002649|Etoposide|etoposide|mesh-list
102551224|NCT00002649|Etoposide phosphate|etoposide phosphate|mesh-list
102551225|NCT00002649|Interleukin-2|interleukin-2|mesh-list
102551226|NCT00002649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102551227|NCT00002649|Immunologic Factors|immunologic factors|mesh-ancestor
102551228|NCT00002649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551229|NCT00002649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102551230|NCT00002649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102551231|NCT00002649|Alkylating Agents|alkylating agents|mesh-ancestor
102551232|NCT00002649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551233|NCT00002649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102551234|NCT00002649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102551235|NCT00002649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102551236|NCT00002649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102551237|NCT00002649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102551238|NCT00002649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102551239|NCT00002649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102551240|NCT00002649|Analgesics|analgesics|mesh-ancestor
102551241|NCT00002649|Sensory System Agents|sensory system agents|mesh-ancestor
102551242|NCT00002649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102551243|NCT00002649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102551244|NCT00002649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102551245|NCT00002649|Antiviral Agents|antiviral agents|mesh-ancestor
102551246|NCT00002649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102551247|NCT01151605|Insulin|insulin|mesh-list
102551248|NCT01151605|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102551249|NCT01151605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102551250|NCT01151605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551251|NCT03003871|Chlorhexidine|chlorhexidine|mesh-list
102551252|NCT03003871|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102551253|NCT03003871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102551254|NCT03003871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102551255|NCT03003871|Disinfectants|disinfectants|mesh-ancestor
102551256|NCT03003871|Dermatologic Agents|dermatologic agents|mesh-ancestor
102551257|NCT00995059|Sirolimus|sirolimus|mesh-list
102551258|NCT00995059|Bortezomib|bortezomib|mesh-list
102551259|NCT00995059|Melphalan|melphalan|mesh-list
102551260|NCT00995059|Tacrolimus|tacrolimus|mesh-list
102551261|NCT00995059|Thymoglobulin|thymoglobulin|mesh-list
102551262|NCT00995059|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102551263|NCT00995059|Immunoglobulins|immunoglobulins|mesh-list
102551264|NCT00995059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102551265|NCT00995059|Immunologic Factors|immunologic factors|mesh-ancestor
102551266|NCT00995059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551267|NCT00995059|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102551268|NCT00995059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102551269|NCT00995059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551270|NCT00995059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102551271|NCT00995059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102551272|NCT00995059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102551273|NCT00995059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102551274|NCT00995059|Antifungal Agents|antifungal agents|mesh-ancestor
102551275|NCT00995059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102551276|NCT00995059|Alkylating Agents|alkylating agents|mesh-ancestor
102551277|NCT00995059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102551278|NCT02249299|Nabiximols|nabiximols|mesh-list
102551279|NCT02249299|Analgesics|analgesics|mesh-ancestor
102551280|NCT02249299|Sensory System Agents|sensory system agents|mesh-ancestor
102551281|NCT02249299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102551282|NCT02249299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551283|NCT00002679|Tamoxifen|tamoxifen|mesh-list
102551284|NCT00002679|Paclitaxel|paclitaxel|mesh-list
102551285|NCT00002679|Cyclophosphamide|cyclophosphamide|mesh-list
102551286|NCT00002679|Doxorubicin|doxorubicin|mesh-list
102551287|NCT00002679|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102551288|NCT00002679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102551289|NCT00002679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102551290|NCT00002679|Tubulin Modulators|tubulin modulators|mesh-ancestor
102551291|NCT00002679|Antimitotic Agents|antimitotic agents|mesh-ancestor
102551292|NCT00002679|Mitosis Modulators|mitosis modulators|mesh-ancestor
102551293|NCT00002679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551294|NCT00002679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102551295|NCT00002679|Immunologic Factors|immunologic factors|mesh-ancestor
102551296|NCT00002679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551297|NCT00002679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102551298|NCT00002679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102551299|NCT00002679|Alkylating Agents|alkylating agents|mesh-ancestor
102551300|NCT00002679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102551301|NCT00002679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102551302|NCT00002679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102551303|NCT00002679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102551304|NCT00002679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102551305|NCT00002679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102551306|NCT00002679|Hormone Antagonists|hormone antagonists|mesh-ancestor
102551307|NCT00002679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102551308|NCT00002679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102551309|NCT00002679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102551310|NCT00002679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102551311|NCT00002679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102551312|NCT00002691|Leucovorin|leucovorin|mesh-list
102551313|NCT00002691|Cytarabine|cytarabine|mesh-list
102551314|NCT00002691|Dexamethasone|dexamethasone|mesh-list
102551315|NCT00002691|Cyclophosphamide|cyclophosphamide|mesh-list
102551316|NCT00002691|Methotrexate|methotrexate|mesh-list
102551317|NCT00002691|Etoposide|etoposide|mesh-list
102551318|NCT00002691|Vincristine|vincristine|mesh-list
102551319|NCT00002691|Daunorubicin|daunorubicin|mesh-list
102551320|NCT00002691|Asparaginase|asparaginase|mesh-list
102551321|NCT00002691|Levoleucovorin|levoleucovorin|mesh-list
102551322|NCT00002691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102551323|NCT00002691|Immunologic Factors|immunologic factors|mesh-ancestor
102551324|NCT00002691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551325|NCT00002691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102551326|NCT00002691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102551327|NCT00002691|Alkylating Agents|alkylating agents|mesh-ancestor
102551328|NCT00002691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551329|NCT00002691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102551330|NCT00002691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102551331|NCT00002691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102551332|NCT00002691|Antiemetics|antiemetics|mesh-ancestor
102098361|NCT04870060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102551333|NCT00002691|Autonomic Agents|autonomic agents|mesh-ancestor
102551334|NCT00002691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102551335|NCT00002691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102551337|NCT00002691|Hormones|hormones|mesh-ancestor
102551338|NCT00002691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102551339|NCT00002691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102551340|NCT00002691|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102551341|NCT00002691|Abortifacient Agents|abortifacient agents|mesh-ancestor
102551342|NCT00002691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102551343|NCT00002691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102551344|NCT00002691|Antimetabolites|antimetabolites|mesh-ancestor
102551345|NCT00002691|Dermatologic Agents|dermatologic agents|mesh-ancestor
102551346|NCT00002691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102551347|NCT00002691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102551348|NCT00002691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102551349|NCT00002691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102551350|NCT00002691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102551351|NCT00002691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102551352|NCT00002691|Antiviral Agents|antiviral agents|mesh-ancestor
102551353|NCT00002691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102551354|NCT00002691|Antidotes|antidotes|mesh-ancestor
102551355|NCT00002691|Protective Agents|protective agents|mesh-ancestor
102551356|NCT00002691|Vitamin B Complex|vitamin b complex|mesh-ancestor
102551357|NCT00002691|Vitamins|vitamins|mesh-ancestor
102551358|NCT00002691|Micronutrients|micronutrients|mesh-ancestor
102551359|NCT00002691|Tubulin Modulators|tubulin modulators|mesh-ancestor
102551360|NCT00002691|Antimitotic Agents|antimitotic agents|mesh-ancestor
102551361|NCT00002691|Mitosis Modulators|mitosis modulators|mesh-ancestor
102551362|NCT00002691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102551363|NCT03003637|Nivolumab|nivolumab|mesh-list
102551364|NCT03003637|Ipilimumab|ipilimumab|mesh-list
102551365|NCT03003637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102551366|NCT03003637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102551367|NCT03003637|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102551368|NCT03003637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551369|NCT04054115|Alprostadil|alprostadil|mesh-list
102551370|NCT04054115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102551371|NCT04054115|Vasodilator Agents|vasodilator agents|mesh-ancestor
102551372|NCT04054115|Urological Agents|urological agents|mesh-ancestor
102551373|NCT00002697|Carboplatin|carboplatin|mesh-list
102551374|NCT00002697|Etoposide|etoposide|mesh-list
102551375|NCT00002697|Ifosfamide|ifosfamide|mesh-list
102551376|NCT00002697|Sargramostim|sargramostim|mesh-list
102551377|NCT00002697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102551378|NCT00002697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101771393|NCT00987766|Gemcitabine|gemcitabine|mesh-list
102551379|NCT00002697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102551380|NCT00002697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102551381|NCT00002697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102551382|NCT00002697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551383|NCT00002697|Immunologic Factors|immunologic factors|mesh-ancestor
102551384|NCT00002697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551385|NCT00002697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102551386|NCT00002697|Alkylating Agents|alkylating agents|mesh-ancestor
102551387|NCT04488601|Sirolimus|sirolimus|mesh-list
102551388|NCT04488601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102551389|NCT04488601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102551390|NCT04488601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102551391|NCT04488601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102551392|NCT04488601|Antifungal Agents|antifungal agents|mesh-ancestor
102551393|NCT04488601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102551394|NCT04488601|Immunologic Factors|immunologic factors|mesh-ancestor
102551395|NCT04488601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551396|NCT05032807|Cannabidiol|cannabidiol|mesh-list
102551397|NCT05032807|Anticonvulsants|anticonvulsants|mesh-ancestor
102551398|NCT00002715|Prednisone|prednisone|mesh-list
102551399|NCT00002715|Doxorubicin|doxorubicin|mesh-list
102551400|NCT00002715|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102551401|NCT00002715|Bleomycin|bleomycin|mesh-list
102551402|NCT00002715|Etoposide|etoposide|mesh-list
102551403|NCT00002715|Vincristine|vincristine|mesh-list
102551404|NCT00002715|Vinblastine|vinblastine|mesh-list
102551405|NCT00002715|Mechlorethamine|mechlorethamine|mesh-list
102551406|NCT00002715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102551407|NCT00002715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102551408|NCT00002715|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102551409|NCT00002715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102551410|NCT00002715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102551411|NCT00002715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551412|NCT00002715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102551413|NCT00002715|Glucocorticoids|glucocorticoids|mesh-ancestor
102551414|NCT00002715|Hormones|hormones|mesh-ancestor
102551415|NCT00002715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102551416|NCT00002715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551417|NCT00002715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102551418|NCT00002715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102551419|NCT00002715|Tubulin Modulators|tubulin modulators|mesh-ancestor
102551420|NCT00002715|Antimitotic Agents|antimitotic agents|mesh-ancestor
102551421|NCT00002715|Mitosis Modulators|mitosis modulators|mesh-ancestor
102551422|NCT00002715|Alkylating Agents|alkylating agents|mesh-ancestor
102551423|NCT00002715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102551424|NCT04972513|Nitric Oxide|nitric oxide|mesh-list
102551425|NCT04972513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102551426|NCT04972513|Autonomic Agents|autonomic agents|mesh-ancestor
102551427|NCT04972513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102551428|NCT04972513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551429|NCT04972513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102551430|NCT04972513|Respiratory System Agents|respiratory system agents|mesh-ancestor
102551431|NCT04972513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102551432|NCT04972513|Antioxidants|antioxidants|mesh-ancestor
102551433|NCT04972513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551434|NCT04972513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102551435|NCT04972513|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102551436|NCT04972513|Vasodilator Agents|vasodilator agents|mesh-ancestor
102551437|NCT04972513|Gasotransmitters|gasotransmitters|mesh-ancestor
102551438|NCT04972513|Protective Agents|protective agents|mesh-ancestor
102551439|NCT02976467|Fulacimstat|fulacimstat|mesh-list
102551440|NCT02976467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102551441|NCT02976467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551442|NCT02981095|Bupivacaine|bupivacaine|mesh-list
102551443|NCT02981095|Anesthetics, Local|anesthetics, local|mesh-ancestor
102551444|NCT02981095|Anesthetics|anesthetics|mesh-ancestor
102551445|NCT02981095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102551446|NCT02981095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551447|NCT02981095|Sensory System Agents|sensory system agents|mesh-ancestor
102551448|NCT02981095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102551449|NCT00002721|Doxorubicin|doxorubicin|mesh-list
102551450|NCT00002721|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102551451|NCT00002721|Estramustine|estramustine|mesh-list
102551452|NCT00002721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102551453|NCT00002721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102551454|NCT00002721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102551455|NCT00002721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102551456|NCT00002721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102551457|NCT00002721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551458|NCT00002721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102551459|NCT00002721|Alkylating Agents|alkylating agents|mesh-ancestor
102551460|NCT00002721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102551461|NCT04739345|Pentoxifylline|pentoxifylline|mesh-list
102551462|NCT04739345|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102551463|NCT04739345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102551464|NCT04739345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551465|NCT04739345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102551466|NCT04739345|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102551467|NCT04739345|Protective Agents|protective agents|mesh-ancestor
102551468|NCT04739345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551469|NCT04739345|Vasodilator Agents|vasodilator agents|mesh-ancestor
102551470|NCT04739345|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102551471|NCT04739345|Antioxidants|antioxidants|mesh-ancestor
102551472|NCT01625455|Aprepitant|aprepitant|mesh-list
102551473|NCT01625455|Antiemetics|antiemetics|mesh-ancestor
102551474|NCT01625455|Autonomic Agents|autonomic agents|mesh-ancestor
102551475|NCT01625455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102551476|NCT01625455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551477|NCT01625455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102551478|NCT01625455|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102551479|NCT01625455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102551480|NCT01625455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551481|NCT05751681|Cetrorelix|cetrorelix|mesh-list
102551482|NCT05751681|Dydrogesterone|dydrogesterone|mesh-list
102551483|NCT05751681|Progestins|progestins|mesh-list
102551484|NCT05751681|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102551485|NCT05751681|Fertility Agents|fertility agents|mesh-ancestor
102098519|NCT03046108|Hormones|hormones|mesh-ancestor
102551486|NCT05751681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102551487|NCT05751681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551488|NCT05751681|Hormone Antagonists|hormone antagonists|mesh-ancestor
102551489|NCT05751681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102551491|NCT02976623|Metronidazole|metronidazole|mesh-list
102551492|NCT02976623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102551493|NCT02976623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102551494|NCT02976623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102551495|NCT02976623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102551496|NCT00002733|Interferons|interferons|mesh-list
102551497|NCT00002733|Interferon-alpha|interferon-alpha|mesh-list
102551498|NCT00002733|Aldesleukin|aldesleukin|mesh-list
102551499|NCT00002733|Cimetidine|cimetidine|mesh-list
102551500|NCT00002733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102551501|NCT00002733|Antiviral Agents|antiviral agents|mesh-ancestor
102551502|NCT00002733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102551503|NCT00002733|Immunologic Factors|immunologic factors|mesh-ancestor
102551504|NCT00002733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551505|NCT00002733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102551506|NCT00002733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102551507|NCT00002733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102551508|NCT00002733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102551509|NCT00002733|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102551510|NCT00002733|Histamine Antagonists|histamine antagonists|mesh-ancestor
102551511|NCT00002733|Histamine Agents|histamine agents|mesh-ancestor
102551512|NCT00002733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102551513|NCT00002733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551514|NCT00002733|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102551515|NCT00002733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102551516|NCT00002733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102551517|NCT01625923|Olanzapine|olanzapine|mesh-list
102551518|NCT01625923|Antiemetics|antiemetics|mesh-ancestor
102551519|NCT01625923|Autonomic Agents|autonomic agents|mesh-ancestor
102551520|NCT01625923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102551521|NCT01625923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551522|NCT01625923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102551523|NCT01625923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102551524|NCT01625923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102551525|NCT01625923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102551526|NCT01625923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102551527|NCT01625923|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102551528|NCT01625923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102551529|NCT01625923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102551530|NCT01625923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551531|NCT01625923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102551532|NCT01625923|Serotonin Agents|serotonin agents|mesh-ancestor
102551533|NCT00002751|Antibodies|antibodies|mesh-list
102551534|NCT00002751|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102551535|NCT00002751|Immunologic Factors|immunologic factors|mesh-ancestor
102551536|NCT00002751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551537|NCT00002757|Cytarabine|cytarabine|mesh-list
102551538|NCT00002757|Prednisone|prednisone|mesh-list
102551539|NCT00002757|Prednisolone|prednisolone|mesh-list
102551540|NCT00002757|Hydrocortisone|hydrocortisone|mesh-list
102551541|NCT00002757|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102551542|NCT00002757|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102551543|NCT00002757|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102551544|NCT00002757|Cyclophosphamide|cyclophosphamide|mesh-list
102551545|NCT00002757|Doxorubicin|doxorubicin|mesh-list
102551546|NCT00002757|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102551547|NCT00002757|Methotrexate|methotrexate|mesh-list
102551548|NCT00002757|Etoposide|etoposide|mesh-list
102551549|NCT00002757|Vincristine|vincristine|mesh-list
102551550|NCT00002757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102551551|NCT00002757|Immunologic Factors|immunologic factors|mesh-ancestor
102551552|NCT00002757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551553|NCT00002757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102551554|NCT00002757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102551555|NCT00002757|Alkylating Agents|alkylating agents|mesh-ancestor
102551556|NCT00002757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551557|NCT00002757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102551558|NCT00002757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102098587|NCT04869046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102551559|NCT00002757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102551560|NCT00002757|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102551561|NCT00002757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102551562|NCT00002757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102551563|NCT00002757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102551564|NCT00002757|Glucocorticoids|glucocorticoids|mesh-ancestor
102551565|NCT00002757|Hormones|hormones|mesh-ancestor
102551566|NCT00002757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102551567|NCT00002757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102551568|NCT00002757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102551569|NCT00002757|Abortifacient Agents|abortifacient agents|mesh-ancestor
102551570|NCT00002757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102551571|NCT00002757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102551572|NCT00002757|Antimetabolites|antimetabolites|mesh-ancestor
102551573|NCT00002757|Dermatologic Agents|dermatologic agents|mesh-ancestor
102551574|NCT00002757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102551575|NCT00002757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102551576|NCT00002757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102551577|NCT00002757|Antiviral Agents|antiviral agents|mesh-ancestor
102551578|NCT00002757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102551579|NCT00002757|Tubulin Modulators|tubulin modulators|mesh-ancestor
102551580|NCT00002757|Antimitotic Agents|antimitotic agents|mesh-ancestor
102551581|NCT00002757|Mitosis Modulators|mitosis modulators|mesh-ancestor
102551582|NCT00002763|Interferons|interferons|mesh-list
102551583|NCT00002763|Interferon-alpha|interferon-alpha|mesh-list
102551584|NCT00002763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102551585|NCT00002763|Antiviral Agents|antiviral agents|mesh-ancestor
102551586|NCT00002763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102551587|NCT00002763|Immunologic Factors|immunologic factors|mesh-ancestor
102551588|NCT00002763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551589|NCT00002775|Docetaxel|docetaxel|mesh-list
102551590|NCT00002775|Estramustine|estramustine|mesh-list
102551591|NCT00002775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102551592|NCT00002775|Tubulin Modulators|tubulin modulators|mesh-ancestor
102551593|NCT00002775|Antimitotic Agents|antimitotic agents|mesh-ancestor
102551594|NCT00002775|Mitosis Modulators|mitosis modulators|mesh-ancestor
102551595|NCT00002775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551596|NCT00002775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102551597|NCT00002775|Alkylating Agents|alkylating agents|mesh-ancestor
102551598|NCT00002775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102551599|NCT01631149|Rocuronium|rocuronium|mesh-list
102551600|NCT01631149|Atracurium|atracurium|mesh-list
102551601|NCT01631149|Mivacurium|mivacurium|mesh-list
102551602|NCT01631149|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102551603|NCT01631149|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102551604|NCT01631149|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102551605|NCT01631149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102551606|NCT01631149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551607|NCT01631149|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102551608|NCT01631149|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102551609|NCT01631149|Cholinergic Agents|cholinergic agents|mesh-ancestor
102551610|NCT01631149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102551611|NCT01631149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551612|NCT00002787|Aldesleukin|aldesleukin|mesh-list
102551613|NCT00002787|Interleukin-2|interleukin-2|mesh-list
102551614|NCT00002787|Vaccines|vaccines|mesh-list
102551615|NCT00002787|Immunoglobulins|immunoglobulins|mesh-list
102551616|NCT00002787|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102551617|NCT00002787|Antibodies|antibodies|mesh-list
102551618|NCT00002787|Sargramostim|sargramostim|mesh-list
102551619|NCT00002787|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
102551620|NCT00002787|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
102551621|NCT00002787|Immunologic Factors|immunologic factors|mesh-ancestor
102551622|NCT00002787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551623|NCT00002787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102551624|NCT00002787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102551625|NCT00002787|Analgesics|analgesics|mesh-ancestor
102551626|NCT00002787|Sensory System Agents|sensory system agents|mesh-ancestor
102551627|NCT00002787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102551628|NCT00002787|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102551629|NCT00002787|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102551630|NCT00002787|Antiviral Agents|antiviral agents|mesh-ancestor
102551631|NCT00002787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102551632|NCT00002787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102551633|NCT02975453|Rivaroxaban|rivaroxaban|mesh-list
102551634|NCT02975453|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102551635|NCT02975453|Antithrombins|antithrombins|mesh-ancestor
102551636|NCT02975453|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102551637|NCT02975453|Protease Inhibitors|protease inhibitors|mesh-ancestor
102551638|NCT02975453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102551639|NCT02975453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551641|NCT00002793|Leucovorin|leucovorin|mesh-list
102551642|NCT00002793|Fluorouracil|fluorouracil|mesh-list
102551643|NCT00002793|Calcium|calcium|mesh-list
102551644|NCT00002793|Levoleucovorin|levoleucovorin|mesh-list
102551645|NCT00002793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102551646|NCT00002793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551647|NCT00002793|Antimetabolites|antimetabolites|mesh-ancestor
102551648|NCT00002793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551649|NCT00002793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102551650|NCT00002793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102551651|NCT00002793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102551652|NCT00002793|Immunologic Factors|immunologic factors|mesh-ancestor
102551653|NCT00002793|Antidotes|antidotes|mesh-ancestor
102551654|NCT00002793|Protective Agents|protective agents|mesh-ancestor
102551655|NCT00002793|Vitamin B Complex|vitamin b complex|mesh-ancestor
102551656|NCT00002793|Vitamins|vitamins|mesh-ancestor
102551657|NCT00002793|Micronutrients|micronutrients|mesh-ancestor
102551658|NCT01632709|Bupivacaine|bupivacaine|mesh-list
102551659|NCT01632709|Anesthetics, Local|anesthetics, local|mesh-ancestor
102551660|NCT01632709|Anesthetics|anesthetics|mesh-ancestor
102551661|NCT01632709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102551662|NCT01632709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551663|NCT01632709|Sensory System Agents|sensory system agents|mesh-ancestor
102551664|NCT01632709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102551665|NCT05751291|Bupivacaine|bupivacaine|mesh-list
102551666|NCT05751291|Anesthetics, Local|anesthetics, local|mesh-ancestor
102551667|NCT05751291|Anesthetics|anesthetics|mesh-ancestor
102551668|NCT05751291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102551669|NCT05751291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551670|NCT05751291|Sensory System Agents|sensory system agents|mesh-ancestor
102551671|NCT05751291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102551672|NCT01634191|Apremilast|apremilast|mesh-list
102551673|NCT01634191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102551674|NCT01634191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102551675|NCT01634191|Analgesics|analgesics|mesh-ancestor
102551676|NCT01634191|Sensory System Agents|sensory system agents|mesh-ancestor
102551677|NCT01634191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102551678|NCT01634191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551679|NCT01634191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102551680|NCT01634191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102551681|NCT01634191|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102551682|NCT01634191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102551683|NCT01634191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102551684|NCT01634191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551685|NCT04005443|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
102551686|NCT04005443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551687|NCT04003649|Nivolumab|nivolumab|mesh-list
102551688|NCT04003649|Ipilimumab|ipilimumab|mesh-list
102551689|NCT04003649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102551690|NCT04003649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102551691|NCT04003649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102551692|NCT04003649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551693|NCT05713851|Dapagliflozin|dapagliflozin|mesh-list
102551694|NCT05713851|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102551695|NCT05713851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551696|NCT05713851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102551697|NCT05713851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551698|NCT00361907|Insulin|insulin|mesh-list
102551699|NCT00361907|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102551700|NCT00361907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102551701|NCT00361907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551702|NCT05710185|Deucravacitinib|deucravacitinib|mesh-list
102551703|NCT05710185|Dermatologic Agents|dermatologic agents|mesh-ancestor
102551704|NCT05710185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102551705|NCT05710185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102551706|NCT05710185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551707|NCT04276493|Docetaxel|docetaxel|mesh-list
102551708|NCT04276493|Capecitabine|capecitabine|mesh-list
102551709|NCT04276493|Oxaliplatin|oxaliplatin|mesh-list
102551710|NCT04276493|Tislelizumab|tislelizumab|mesh-list
102551711|NCT04276493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102551712|NCT04276493|Tubulin Modulators|tubulin modulators|mesh-ancestor
102551713|NCT04276493|Antimitotic Agents|antimitotic agents|mesh-ancestor
102551714|NCT04276493|Mitosis Modulators|mitosis modulators|mesh-ancestor
102551715|NCT04276493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551716|NCT04276493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102551717|NCT04276493|Antimetabolites|antimetabolites|mesh-ancestor
102551718|NCT04276493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102551719|NCT05670795|Clomiphene|clomiphene|mesh-list
102551720|NCT05670795|Enclomiphene|enclomiphene|mesh-list
102551721|NCT05670795|Zuclomiphene|zuclomiphene|mesh-list
102551722|NCT05670795|Hormones|hormones|mesh-list
102551723|NCT05670795|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102551724|NCT05670795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102551725|NCT05670795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551726|NCT05670795|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102551727|NCT05670795|Hormone Antagonists|hormone antagonists|mesh-ancestor
102551728|NCT05670795|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102551729|NCT05670795|Fertility Agents|fertility agents|mesh-ancestor
102551730|NCT05670795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102551731|NCT05670795|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102551732|NCT05670795|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102551733|NCT04266197|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
102551734|NCT04266197|Vasodilator Agents|vasodilator agents|mesh-ancestor
102551735|NCT04266197|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102551736|NCT04266197|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102551737|NCT04266197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102551738|NCT04266197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551739|NCT04266197|Urological Agents|urological agents|mesh-ancestor
102551740|NCT05669313|Rivaroxaban|rivaroxaban|mesh-list
102551741|NCT05669313|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102551742|NCT05669313|Antithrombins|antithrombins|mesh-ancestor
102551743|NCT05669313|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102551744|NCT05669313|Protease Inhibitors|protease inhibitors|mesh-ancestor
102551745|NCT05669313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102551746|NCT05669313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551747|NCT05669313|Anticoagulants|anticoagulants|mesh-ancestor
102551748|NCT04343963|Bromides|bromides|mesh-list
102551749|NCT04343963|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
102551750|NCT04343963|Anticonvulsants|anticonvulsants|mesh-ancestor
102551751|NCT04343963|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102551752|NCT04343963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102551753|NCT04343963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551754|NCT04343963|Cholinergic Agents|cholinergic agents|mesh-ancestor
102551755|NCT04343963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102551756|NCT04343963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551757|NCT04248179|Sufentanil|sufentanil|mesh-list
102551758|NCT04248179|Ropivacaine|ropivacaine|mesh-list
102551759|NCT04248179|Anesthetics, Local|anesthetics, local|mesh-ancestor
102551760|NCT04248179|Anesthetics|anesthetics|mesh-ancestor
102551761|NCT04248179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102551762|NCT04248179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551763|NCT04248179|Sensory System Agents|sensory system agents|mesh-ancestor
102551764|NCT04248179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102551765|NCT04248179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102551766|NCT04248179|Narcotics|narcotics|mesh-ancestor
102551767|NCT04248179|Analgesics|analgesics|mesh-ancestor
102551768|NCT04248179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102551769|NCT04248179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102551770|NCT04248179|Anesthetics, General|anesthetics, general|mesh-ancestor
102551771|NCT00361517|Amphotericin B|amphotericin b|mesh-list
102551772|NCT00361517|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102551773|NCT00361517|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
102551774|NCT00361517|Deoxycholic Acid|deoxycholic acid|mesh-list
102551775|NCT00361517|Amebicides|amebicides|mesh-ancestor
102551776|NCT00361517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102551777|NCT00361517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102551778|NCT00361517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102551779|NCT00361517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102551780|NCT00361517|Antifungal Agents|antifungal agents|mesh-ancestor
102551781|NCT00361517|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102551782|NCT00361517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102551783|NCT03920267|Deucravacitinib|deucravacitinib|mesh-list
102551784|NCT03920267|Dermatologic Agents|dermatologic agents|mesh-ancestor
102551785|NCT03920267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102551786|NCT03920267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102098822|NCT04867252|Vitamins|vitamins|mesh-ancestor
102551787|NCT03920267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551788|NCT05447507|Dexmedetomidine|dexmedetomidine|mesh-list
102551789|NCT05447507|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102551790|NCT05447507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101771785|NCT00329719|Temsirolimus|temsirolimus|mesh-list
102551791|NCT05447507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551792|NCT05447507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102551793|NCT05447507|Analgesics|analgesics|mesh-ancestor
102551794|NCT05447507|Sensory System Agents|sensory system agents|mesh-ancestor
102551795|NCT05447507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102551796|NCT05447507|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102551797|NCT05447507|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102551798|NCT05447507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102551799|NCT05447507|Adrenergic Agents|adrenergic agents|mesh-ancestor
102551800|NCT05447507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102551801|NCT05447507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551802|NCT01635439|Dinoprostone|dinoprostone|mesh-list
102551803|NCT01635439|Oxytocics|oxytocics|mesh-ancestor
102551804|NCT01635439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102551805|NCT01635439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551806|NCT01636063|Misoprostol|misoprostol|mesh-list
102551807|NCT01636063|Mifepristone|mifepristone|mesh-list
102551808|NCT01636063|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102551809|NCT01636063|Abortifacient Agents|abortifacient agents|mesh-ancestor
102551810|NCT01636063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102551811|NCT01636063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551812|NCT01636063|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102551813|NCT01636063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102551814|NCT01636063|Oxytocics|oxytocics|mesh-ancestor
102551815|NCT01636063|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102551816|NCT01636063|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102551817|NCT01636063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102551818|NCT01636063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102551819|NCT01636063|Contraceptive Agents|contraceptive agents|mesh-ancestor
102551820|NCT01636063|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102551821|NCT01636063|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102551822|NCT01636063|Hormone Antagonists|hormone antagonists|mesh-ancestor
102551823|NCT01636063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102551824|NCT01636063|Luteolytic Agents|luteolytic agents|mesh-ancestor
102551825|NCT01636063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102551826|NCT01636063|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102551827|NCT05635305|Zoliflodacin|zoliflodacin|mesh-list
102551828|NCT05635305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102551829|NCT05635305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102551830|NCT05635305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102551831|NCT05635305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551832|NCT05635305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102551833|NCT05749575|Paclitaxel|paclitaxel|mesh-list
102551834|NCT05749575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102551835|NCT05749575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102551836|NCT05749575|Tubulin Modulators|tubulin modulators|mesh-ancestor
102551837|NCT05749575|Antimitotic Agents|antimitotic agents|mesh-ancestor
102551838|NCT05749575|Mitosis Modulators|mitosis modulators|mesh-ancestor
102551839|NCT05749575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551840|NCT04387201|Vitamin B 12|vitamin b 12|mesh-list
102551841|NCT04387201|Hydroxocobalamin|hydroxocobalamin|mesh-list
102551842|NCT04387201|Dulaglutide|dulaglutide|mesh-list
102551843|NCT04387201|Vitamins|vitamins|mesh-ancestor
102551844|NCT04387201|Micronutrients|micronutrients|mesh-ancestor
102551845|NCT04387201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551846|NCT04387201|Vitamin B Complex|vitamin b complex|mesh-ancestor
102551847|NCT04387201|Hematinics|hematinics|mesh-ancestor
102551848|NCT04387201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102551849|NCT04178005|Cladribine|cladribine|mesh-list
102551850|NCT04178005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102551851|NCT04178005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102551852|NCT04178005|Immunologic Factors|immunologic factors|mesh-ancestor
102551853|NCT04178005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551854|NCT05623761|Fluorides|fluorides|mesh-list
102551855|NCT05623761|Cariostatic Agents|cariostatic agents|mesh-ancestor
102551856|NCT05623761|Protective Agents|protective agents|mesh-ancestor
102551857|NCT05623761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551858|NCT04231331|Ertugliflozin|ertugliflozin|mesh-list
102551859|NCT04231331|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102551860|NCT04231331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551861|NCT04231331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102551862|NCT04231331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551863|NCT00361985|Esomeprazole|esomeprazole|mesh-list
102551864|NCT00361985|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102551865|NCT00361985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102551866|NCT00361985|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102551867|NCT00361985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102551868|NCT00361985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551869|NCT00362063|Hormones|hormones|mesh-list
102551870|NCT00362063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102551871|NCT00362063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551872|NCT00382239|Exenatide|exenatide|mesh-list
102551873|NCT00382239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102551874|NCT00382239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551875|NCT00382239|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102551876|NCT00382239|Incretins|incretins|mesh-ancestor
102551877|NCT00382239|Hormones|hormones|mesh-ancestor
102551878|NCT00382239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102551879|NCT04004845|Misoprostol|misoprostol|mesh-list
102551880|NCT04004845|Oxytocin|oxytocin|mesh-list
102551881|NCT04004845|Oxytocics|oxytocics|mesh-ancestor
102551882|NCT04004845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102551883|NCT04004845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551884|NCT04004845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102551885|NCT04004845|Abortifacient Agents|abortifacient agents|mesh-ancestor
102551886|NCT04004845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102551887|NCT04004845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102551888|NCT01637935|Pioglitazone|pioglitazone|mesh-list
102551889|NCT01637935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102551890|NCT01637935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551891|NCT00382083|Acetaminophen|acetaminophen|mesh-list
102551892|NCT00382083|Ibuprofen|ibuprofen|mesh-list
102551893|NCT00382083|Lidocaine|lidocaine|mesh-list
102551894|NCT00382083|Anesthetics, Local|anesthetics, local|mesh-ancestor
102551895|NCT00382083|Anesthetics|anesthetics|mesh-ancestor
102551896|NCT00382083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102551897|NCT00382083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551898|NCT00382083|Sensory System Agents|sensory system agents|mesh-ancestor
102551899|NCT00382083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102551900|NCT00382083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102551901|NCT00382083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102551902|NCT00382083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102551903|NCT00382083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102551904|NCT00382083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551905|NCT00382083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102551906|NCT00382083|Analgesics|analgesics|mesh-ancestor
102551907|NCT00382083|Antipyretics|antipyretics|mesh-ancestor
102551908|NCT00382083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102551909|NCT00382083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102551910|NCT00382083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102551911|NCT00382083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102551912|NCT00382083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102551913|NCT01640197|Resveratrol|resveratrol|mesh-list
102551914|NCT01640197|Antioxidants|antioxidants|mesh-ancestor
102551915|NCT01640197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551916|NCT01640197|Protective Agents|protective agents|mesh-ancestor
102551917|NCT01640197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551918|NCT01640197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102551919|NCT01640197|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102551920|NCT01641445|Topiramate|topiramate|mesh-list
102551921|NCT01641445|Anticonvulsants|anticonvulsants|mesh-ancestor
102551922|NCT01641445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102551923|NCT01641445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551924|NCT04185311|Nivolumab|nivolumab|mesh-list
102551925|NCT04185311|Ipilimumab|ipilimumab|mesh-list
102551926|NCT04185311|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
102551927|NCT04185311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102551928|NCT04185311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102551929|NCT04185311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102551930|NCT04185311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551931|NCT05513937|Amlodipine|amlodipine|mesh-list
102551932|NCT05513937|Nebivolol|nebivolol|mesh-list
102551933|NCT05513937|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102551934|NCT05513937|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102551935|NCT05513937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102551936|NCT05513937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551937|NCT05513937|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102551938|NCT05513937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551939|NCT05513937|Vasodilator Agents|vasodilator agents|mesh-ancestor
102551940|NCT05513937|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102551941|NCT05513937|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102551942|NCT05513937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102551943|NCT05513937|Adrenergic Agents|adrenergic agents|mesh-ancestor
102551944|NCT05513937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102551945|NCT01642147|Anesthetics|anesthetics|mesh-list
102551946|NCT01642147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102551947|NCT01642147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551948|NCT04584749|Lidocaine|lidocaine|mesh-list
102551949|NCT04584749|Anesthetics, Local|anesthetics, local|mesh-ancestor
102551950|NCT04584749|Anesthetics|anesthetics|mesh-ancestor
102551951|NCT04584749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102551952|NCT04584749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551953|NCT04584749|Sensory System Agents|sensory system agents|mesh-ancestor
102551954|NCT04584749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102551955|NCT04584749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102551956|NCT04584749|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102551957|NCT04584749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102551958|NCT04584749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102551959|NCT04584749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551960|NCT01644331|Tolvaptan|tolvaptan|mesh-list
102551961|NCT01644331|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102551962|NCT01644331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551963|NCT01644331|Natriuretic Agents|natriuretic agents|mesh-ancestor
102551964|NCT01644331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551965|NCT00362141|Levetiracetam|levetiracetam|mesh-list
102551966|NCT00362141|Anticonvulsants|anticonvulsants|mesh-ancestor
102551967|NCT00362141|Nootropic Agents|nootropic agents|mesh-ancestor
102551968|NCT05733897|Hydroxychloroquine|hydroxychloroquine|mesh-list
102551969|NCT05733897|Antimalarials|antimalarials|mesh-ancestor
102551970|NCT05733897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102551971|NCT05733897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102551972|NCT05733897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102551973|NCT05733897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102551974|NCT05733897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551975|NCT05733897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102551976|NCT01646671|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102551977|NCT01646671|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102551978|NCT01646671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551979|NCT03561259|Vorinostat|vorinostat|mesh-list
102551980|NCT03561259|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
102551981|NCT03561259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102551982|NCT03561259|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102551983|NCT03561259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102551984|NCT03561259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102551985|NCT03561259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102551986|NCT03002935|Coenzyme Q10|coenzyme q10|mesh-list
102551987|NCT03002935|Micronutrients|micronutrients|mesh-ancestor
102551988|NCT03002935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551989|NCT03002935|Vitamins|vitamins|mesh-ancestor
102551990|NCT03788291|Rituximab|rituximab|mesh-list
102551991|NCT03788291|Acalabrutinib|acalabrutinib|mesh-list
102551992|NCT03788291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102551993|NCT03788291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102551994|NCT03788291|Immunologic Factors|immunologic factors|mesh-ancestor
102551995|NCT03788291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102551996|NCT03788291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102551997|NCT04593459|Metformin|metformin|mesh-list
102551998|NCT04593459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102551999|NCT04593459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552000|NCT04120883|Hydroxychloroquine|hydroxychloroquine|mesh-list
102552001|NCT04120883|Antimalarials|antimalarials|mesh-ancestor
102552002|NCT04120883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102552003|NCT04120883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102552004|NCT04120883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102552005|NCT04120883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102552006|NCT04120883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552007|NCT04120883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102552008|NCT03775109|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102552009|NCT03775109|Immunologic Factors|immunologic factors|mesh-ancestor
102552010|NCT03775109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099045|NCT03045016|Prazosin|prazosin|mesh-list
102552011|NCT03251924|Nivolumab|nivolumab|mesh-list
102552012|NCT03251924|Ipilimumab|ipilimumab|mesh-list
102552013|NCT03251924|Antibodies|antibodies|mesh-list
102552014|NCT03251924|Immunoglobulins|immunoglobulins|mesh-list
102552015|NCT03251924|Antibodies, Blocking|antibodies, blocking|mesh-list
101772035|NCT00776802|Hormones|hormones|mesh-ancestor
102552016|NCT03251924|Immunologic Factors|immunologic factors|mesh-ancestor
102552017|NCT03251924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552018|NCT03251924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102552019|NCT03251924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102552020|NCT03251924|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102552021|NCT03251924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552022|NCT01651351|Protease Inhibitors|protease inhibitors|mesh-list
102552023|NCT01651351|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
102552024|NCT01651351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102552025|NCT01651351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552026|NCT01651351|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102552027|NCT01651351|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102552028|NCT03762317|Clonidine|clonidine|mesh-list
102552029|NCT03762317|Analgesics|analgesics|mesh-ancestor
102552030|NCT03762317|Sensory System Agents|sensory system agents|mesh-ancestor
102552031|NCT03762317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102552032|NCT03762317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552033|NCT03762317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102552034|NCT03762317|Sympatholytics|sympatholytics|mesh-ancestor
102552035|NCT03762317|Autonomic Agents|autonomic agents|mesh-ancestor
102552036|NCT03762317|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102552037|NCT03762317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102552038|NCT03762317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102552039|NCT03762317|Adrenergic Agents|adrenergic agents|mesh-ancestor
102552040|NCT03762317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102552041|NCT03762317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552042|NCT04383639|Locust bean gum|locust bean gum|mesh-list
102552043|NCT04383639|Antidiarrheals|antidiarrheals|mesh-ancestor
102552044|NCT04383639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102552045|NCT03083431|Propranolol|propranolol|mesh-list
102552046|NCT03083431|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102552047|NCT03083431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102552048|NCT03083431|Adrenergic Agents|adrenergic agents|mesh-ancestor
102552049|NCT03083431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102552050|NCT03083431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552051|NCT03083431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552052|NCT03083431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102552053|NCT03083431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102552054|NCT03083431|Vasodilator Agents|vasodilator agents|mesh-ancestor
102552055|NCT02975921|Povidone-Iodine|povidone-iodine|mesh-list
102552056|NCT02975921|Povidone|povidone|mesh-list
102552057|NCT02975921|Plasma Substitutes|plasma substitutes|mesh-ancestor
102552058|NCT02975921|Blood Substitutes|blood substitutes|mesh-ancestor
102552059|NCT02975921|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102552060|NCT02975921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102552061|NCT05452785|Minocycline|minocycline|mesh-list
102552062|NCT05452785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102552063|NCT05452785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102552064|NCT03002545|Magnesium citrate|magnesium citrate|mesh-list
102552065|NCT03002545|Cathartics|cathartics|mesh-ancestor
102552066|NCT03002545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102552067|NCT04517747|Ramucirumab|ramucirumab|mesh-list
102552068|NCT04517747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102552069|NCT02219581|Dexamethasone|dexamethasone|mesh-list
102552070|NCT02219581|Dexamethasone acetate|dexamethasone acetate|mesh-list
102552071|NCT02219581|BB 1101|bb 1101|mesh-list
102552072|NCT02219581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102552073|NCT02219581|Antiemetics|antiemetics|mesh-ancestor
102552074|NCT02219581|Autonomic Agents|autonomic agents|mesh-ancestor
102552075|NCT02219581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102552076|NCT02219581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552077|NCT02219581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102552078|NCT02219581|Glucocorticoids|glucocorticoids|mesh-ancestor
102552079|NCT02219581|Hormones|hormones|mesh-ancestor
102552080|NCT02219581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102552081|NCT02219581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102552082|NCT02219581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102552083|NCT02219581|Protease Inhibitors|protease inhibitors|mesh-ancestor
102552084|NCT02219581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102552085|NCT02219581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552086|NCT01437709|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102552087|NCT01437709|Ofatumumab|ofatumumab|mesh-list
102552088|NCT01437709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102552089|NCT01437709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102552090|NCT01437709|Alkylating Agents|alkylating agents|mesh-ancestor
102552091|NCT01437709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552092|NCT01437709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102552093|NCT01437709|Immunologic Factors|immunologic factors|mesh-ancestor
102552094|NCT01437709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552095|NCT03740165|Paclitaxel|paclitaxel|mesh-list
102552096|NCT03740165|Docetaxel|docetaxel|mesh-list
102552097|NCT03740165|Bevacizumab|bevacizumab|mesh-list
102552098|NCT03740165|Carboplatin|carboplatin|mesh-list
102552099|NCT03740165|Pembrolizumab|pembrolizumab|mesh-list
102552100|NCT03740165|Olaparib|olaparib|mesh-list
102552101|NCT03740165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102552102|NCT03740165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102552103|NCT03740165|Tubulin Modulators|tubulin modulators|mesh-ancestor
102552104|NCT03740165|Antimitotic Agents|antimitotic agents|mesh-ancestor
102552105|NCT03740165|Mitosis Modulators|mitosis modulators|mesh-ancestor
102552106|NCT03740165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552107|NCT03740165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102552108|NCT03740165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102552109|NCT03740165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102552110|NCT03740165|Growth Substances|growth substances|mesh-ancestor
102552111|NCT03740165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552112|NCT03740165|Growth Inhibitors|growth inhibitors|mesh-ancestor
102552113|NCT03740165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102552114|NCT03740165|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102552115|NCT03740165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102552116|NCT01912274|Azacitidine|azacitidine|mesh-list
102552117|NCT01912274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102552118|NCT01912274|Antimetabolites|antimetabolites|mesh-ancestor
102552119|NCT01912274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552120|NCT01912274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102552121|NCT01912274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102552122|NCT01654861|Ascorbic Acid|ascorbic acid|mesh-list
102552123|NCT01654861|Gemcitabine|gemcitabine|mesh-list
102552124|NCT01654861|Vitamins|vitamins|mesh-ancestor
102552125|NCT01654861|Micronutrients|micronutrients|mesh-ancestor
102552126|NCT01654861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552127|NCT01654861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102552128|NCT01654861|Antimetabolites|antimetabolites|mesh-ancestor
102552129|NCT01654861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552130|NCT01654861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102552131|NCT01654861|Antioxidants|antioxidants|mesh-ancestor
102552132|NCT01654861|Protective Agents|protective agents|mesh-ancestor
102552133|NCT01934582|Treprostinil|treprostinil|mesh-list
102552134|NCT01934582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102552135|NCT05735834|Rituximab|rituximab|mesh-list
102552136|NCT05735834|Zanubrutinib|zanubrutinib|mesh-list
102552137|NCT05735834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102552138|NCT05735834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102552139|NCT05735834|Immunologic Factors|immunologic factors|mesh-ancestor
102552140|NCT05735834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552141|NCT05735834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102552142|NCT05735834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102552143|NCT05735834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102552144|NCT05735834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552145|NCT05184777|Estradiol|estradiol|mesh-list
102552146|NCT05184777|Progesterone|progesterone|mesh-list
102552147|NCT05184777|Estrogens|estrogens|mesh-ancestor
102552148|NCT05184777|Hormones|hormones|mesh-ancestor
102552149|NCT05184777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102552150|NCT05184777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552151|NCT05184777|Progestins|progestins|mesh-ancestor
102552152|NCT01912352|Methylphenidate|methylphenidate|mesh-list
102552153|NCT01912352|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102552154|NCT01912352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552155|NCT01912352|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102552156|NCT01912352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102552157|NCT01912352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102552158|NCT01912352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552159|NCT01912352|Dopamine Agents|dopamine agents|mesh-ancestor
102552160|NCT01912352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102552161|NCT02975843|Beclomethasone|beclomethasone|mesh-list
102552162|NCT02975843|Glycopyrrolate|glycopyrrolate|mesh-list
102552163|NCT02975843|Formoterol Fumarate|formoterol fumarate|mesh-list
102552164|NCT02975843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102552165|NCT02975843|Autonomic Agents|autonomic agents|mesh-ancestor
102552166|NCT02975843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102552167|NCT02975843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552168|NCT02975843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102552169|NCT02975843|Respiratory System Agents|respiratory system agents|mesh-ancestor
102552170|NCT02975843|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102552171|NCT02975843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102552172|NCT02975843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102552173|NCT02975843|Adrenergic Agents|adrenergic agents|mesh-ancestor
102552174|NCT02975843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102552175|NCT02975843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552176|NCT02975843|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102552177|NCT02975843|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102552178|NCT02975843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102552179|NCT02975843|Cholinergic Agents|cholinergic agents|mesh-ancestor
102552180|NCT02975843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102552181|NCT02975843|Glucocorticoids|glucocorticoids|mesh-ancestor
102552182|NCT02975843|Hormones|hormones|mesh-ancestor
102552183|NCT02975843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102552184|NCT01655563|Tacrolimus|tacrolimus|mesh-list
102552185|NCT01655563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102552186|NCT01655563|Immunologic Factors|immunologic factors|mesh-ancestor
102552187|NCT01655563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552188|NCT01655563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102552189|NCT01655563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102552190|NCT01655563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552191|NCT01655719|Pioglitazone|pioglitazone|mesh-list
102552192|NCT01655719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102552193|NCT01655719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552194|NCT05735756|Citalopram|citalopram|mesh-list
102552195|NCT05735756|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102552196|NCT05735756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102552197|NCT05735756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102552198|NCT05735756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552199|NCT05735756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102552200|NCT05735756|Serotonin Agents|serotonin agents|mesh-ancestor
102552201|NCT05735756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552202|NCT05735756|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102552203|NCT05735756|Antidepressive Agents|antidepressive agents|mesh-ancestor
102552204|NCT05735756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102552205|NCT01936844|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102552206|NCT01936844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102552207|NCT02987348|Insulin|insulin|mesh-list
102552208|NCT02987348|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102552209|NCT02987348|Exenatide|exenatide|mesh-list
102552210|NCT02987348|Insulin, Long-Acting|insulin, long-acting|mesh-list
102552211|NCT02987348|Glucagon|glucagon|mesh-list
102552212|NCT02987348|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102552213|NCT02987348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102552214|NCT02987348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552215|NCT02987348|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102552216|NCT02987348|Incretins|incretins|mesh-ancestor
102552217|NCT02987348|Hormones|hormones|mesh-ancestor
102552218|NCT02987348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102552219|NCT02987348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102552220|NCT01656031|Cytarabine|cytarabine|mesh-list
102552221|NCT01656031|Clofarabine|clofarabine|mesh-list
102552222|NCT01656031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102552223|NCT01656031|Antimetabolites|antimetabolites|mesh-ancestor
102552224|NCT01656031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552225|NCT01656031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102552226|NCT01656031|Antiviral Agents|antiviral agents|mesh-ancestor
102552227|NCT01656031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102552228|NCT01656031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102552229|NCT01656031|Immunologic Factors|immunologic factors|mesh-ancestor
102552230|NCT01656031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552231|NCT01656187|Memantine|memantine|mesh-list
102552232|NCT01656187|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102552233|NCT01656187|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102552234|NCT01656187|Dopamine Agents|dopamine agents|mesh-ancestor
102552235|NCT01656187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102552236|NCT01656187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552237|NCT01656187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552238|NCT01656187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102552239|NCT01656187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102552241|NCT01658839|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102552242|NCT01658839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102552243|NCT01658839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102552244|NCT01658995|Doxycycline|doxycycline|mesh-list
102552245|NCT01658995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102552246|NCT01658995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102552247|NCT01658995|Antimalarials|antimalarials|mesh-ancestor
102552248|NCT01658995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102552249|NCT01658995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102552250|NCT01350141|Bococizumab|bococizumab|mesh-list
102552251|NCT01350141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102552252|NCT01350141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102552253|NCT01350141|Antimetabolites|antimetabolites|mesh-ancestor
102552254|NCT01350141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552255|NCT01350141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102552256|NCT01662115|Nicotine|nicotine|mesh-list
102552257|NCT01662115|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102552258|NCT01662115|Autonomic Agents|autonomic agents|mesh-ancestor
102552259|NCT01662115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102552260|NCT01662115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552261|NCT01662115|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102552262|NCT01662115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102552263|NCT01662115|Cholinergic Agents|cholinergic agents|mesh-ancestor
102552264|NCT01662115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102552265|NCT01662115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552266|NCT01598545|Hydromorphone|hydromorphone|mesh-list
102552267|NCT01598545|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102552268|NCT01598545|Narcotics|narcotics|mesh-ancestor
102552269|NCT01598545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102552270|NCT01598545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552271|NCT01598545|Analgesics|analgesics|mesh-ancestor
102552272|NCT01598545|Sensory System Agents|sensory system agents|mesh-ancestor
102552273|NCT01598545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102552274|NCT01598701|Acetaminophen|acetaminophen|mesh-list
102552275|NCT01598701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102552276|NCT01598701|Analgesics|analgesics|mesh-ancestor
102552277|NCT01598701|Sensory System Agents|sensory system agents|mesh-ancestor
102552278|NCT01598701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102552279|NCT01598701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552280|NCT01598701|Antipyretics|antipyretics|mesh-ancestor
102552281|NCT00000309|Risperidone|risperidone|mesh-list
102552282|NCT00000309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102552283|NCT00000309|Serotonin Agents|serotonin agents|mesh-ancestor
102552284|NCT00000309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102552285|NCT00000309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552286|NCT00000309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552287|NCT00000309|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102552288|NCT00000309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102552289|NCT00000309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102552290|NCT00000309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102552291|NCT00000309|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102552292|NCT00000309|Dopamine Agents|dopamine agents|mesh-ancestor
102552293|NCT00000315|Cocaine|cocaine|mesh-list
102552294|NCT00000315|Anesthetics, Local|anesthetics, local|mesh-ancestor
102552295|NCT00000315|Anesthetics|anesthetics|mesh-ancestor
102552296|NCT00000315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102552297|NCT00000315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552298|NCT00000315|Sensory System Agents|sensory system agents|mesh-ancestor
102552299|NCT00000315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102552300|NCT00000315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102552301|NCT00000315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102552302|NCT00000315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102552303|NCT00000315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102552304|NCT00000315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552305|NCT00000315|Dopamine Agents|dopamine agents|mesh-ancestor
102552306|NCT00000315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102552307|NCT00000321|Desipramine|desipramine|mesh-list
102552308|NCT00000321|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102552309|NCT00000321|Antidepressive Agents|antidepressive agents|mesh-ancestor
102552310|NCT00000321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102552311|NCT00000321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102552312|NCT00000321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552313|NCT00000321|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102552314|NCT00000321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102552316|NCT00000321|Adrenergic Agents|adrenergic agents|mesh-ancestor
102552317|NCT00000321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102552318|NCT00000321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552319|NCT05125029|Botulinum Toxins|botulinum toxins|mesh-list
102552320|NCT05125029|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102552321|NCT05125029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102552322|NCT05125029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552323|NCT05125029|Cholinergic Agents|cholinergic agents|mesh-ancestor
102552324|NCT05125029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102552325|NCT05125029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552326|NCT01940276|Prednisone|prednisone|mesh-list
102552327|NCT01940276|Abiraterone Acetate|abiraterone acetate|mesh-list
102552328|NCT01940276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102552329|NCT01940276|Glucocorticoids|glucocorticoids|mesh-ancestor
102552330|NCT01940276|Hormones|hormones|mesh-ancestor
102552331|NCT01940276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102552332|NCT01940276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552333|NCT01940276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102552334|NCT01940276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102552335|NCT01940276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102552336|NCT01940276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102552337|NCT01940276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552338|NCT01940276|Hormone Antagonists|hormone antagonists|mesh-ancestor
102552339|NCT01940276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102552340|NCT00000327|Heroin|heroin|mesh-list
102552341|NCT00000327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102552342|NCT00000327|Narcotics|narcotics|mesh-ancestor
102552343|NCT00000327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102552344|NCT00000327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552345|NCT00000327|Analgesics|analgesics|mesh-ancestor
102552346|NCT00000327|Sensory System Agents|sensory system agents|mesh-ancestor
102552347|NCT00000327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102552348|NCT01919216|Citalopram|citalopram|mesh-list
102552349|NCT01919216|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102552350|NCT01919216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102552351|NCT01919216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102552352|NCT01919216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552353|NCT01919216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102552354|NCT01919216|Serotonin Agents|serotonin agents|mesh-ancestor
102552355|NCT01919216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552356|NCT01919216|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102552357|NCT01919216|Antidepressive Agents|antidepressive agents|mesh-ancestor
102552358|NCT01919216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102552359|NCT01940510|Rifampin|rifampin|mesh-list
102552360|NCT01940510|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102552361|NCT01940510|Antitubercular Agents|antitubercular agents|mesh-ancestor
102552362|NCT01940510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102552363|NCT01940510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102552364|NCT01940510|Leprostatic Agents|leprostatic agents|mesh-ancestor
102552365|NCT01940510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102552366|NCT01940510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102552367|NCT01940510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552368|NCT01940510|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102552369|NCT01940510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102552370|NCT01940510|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102552371|NCT01940510|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102552372|NCT01940510|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102552373|NCT01940510|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102552374|NCT00380289|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102552375|NCT00380289|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102552376|NCT00380289|Adrenergic Agents|adrenergic agents|mesh-ancestor
102552377|NCT00380289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102552378|NCT00380289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552379|NCT00380289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552380|NCT05364645|Carboplatin|carboplatin|mesh-list
102552381|NCT05364645|Pemetrexed|pemetrexed|mesh-list
102552382|NCT05364645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102552383|NCT05364645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102099411|NCT03041506|Midazolam|midazolam|mesh-list
102552384|NCT05364645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552385|NCT05364645|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102552386|NCT05364645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102552387|NCT01919450|Regadenoson|regadenoson|mesh-list
102552388|NCT01919450|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
102552389|NCT01919450|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102552390|NCT01919450|Purinergic Agonists|purinergic agonists|mesh-ancestor
102552391|NCT01919450|Purinergic Agents|purinergic agents|mesh-ancestor
102552392|NCT01919450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102552393|NCT01919450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552394|NCT01919450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552395|NCT01602679|Progesterone|progesterone|mesh-list
102552396|NCT01602679|Progestins|progestins|mesh-ancestor
102552397|NCT01602679|Hormones|hormones|mesh-ancestor
102552398|NCT01602679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102552399|NCT01602679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552400|NCT01919606|Bupivacaine|bupivacaine|mesh-list
102552401|NCT01919606|Anesthetics, Local|anesthetics, local|mesh-ancestor
102552402|NCT01919606|Anesthetics|anesthetics|mesh-ancestor
102552403|NCT01919606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102552404|NCT01919606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552405|NCT01919606|Sensory System Agents|sensory system agents|mesh-ancestor
102552406|NCT01919606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102552407|NCT01919996|Azithromycin|azithromycin|mesh-list
102552408|NCT01919996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102552409|NCT01919996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102552410|NCT05735132|Lidocaine|lidocaine|mesh-list
102552411|NCT05735132|Anesthetics, Local|anesthetics, local|mesh-ancestor
102552412|NCT05735132|Anesthetics|anesthetics|mesh-ancestor
102552413|NCT05735132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102552414|NCT05735132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552415|NCT05735132|Sensory System Agents|sensory system agents|mesh-ancestor
102552416|NCT05735132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102552417|NCT05735132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102552418|NCT05735132|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102552419|NCT05735132|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102552420|NCT05735132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102552421|NCT05735132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552422|NCT01667029|Sulfasalazine|sulfasalazine|mesh-list
102552423|NCT01667029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102552424|NCT01667029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102552425|NCT01667029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102552426|NCT01667029|Analgesics|analgesics|mesh-ancestor
102552427|NCT01667029|Sensory System Agents|sensory system agents|mesh-ancestor
102552428|NCT01667029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102552429|NCT01667029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552430|NCT01667029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102552431|NCT01667029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102552432|NCT01667029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102552433|NCT01943864|Trametinib|trametinib|mesh-list
102552434|NCT01943864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102552435|NCT01943864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102552436|NCT01943864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102552437|NCT01943864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552438|NCT01607203|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102552439|NCT01607203|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102552440|NCT01607203|Luteolytic Agents|luteolytic agents|mesh-ancestor
102552441|NCT01607203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102552442|NCT01607203|Contraceptive Agents|contraceptive agents|mesh-ancestor
102552443|NCT01607203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102552444|NCT01607203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552445|NCT01607203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102552446|NCT01607203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102552447|NCT01607203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102552448|NCT00000333|Benztropine|benztropine|mesh-list
102552449|NCT00000333|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102552450|NCT00000333|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102552451|NCT00000333|Parasympatholytics|parasympatholytics|mesh-ancestor
102552452|NCT00000333|Autonomic Agents|autonomic agents|mesh-ancestor
102552453|NCT00000333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102552454|NCT00000333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552455|NCT00000333|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102552456|NCT00000333|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102552457|NCT00000333|Cholinergic Agents|cholinergic agents|mesh-ancestor
102552458|NCT00000333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102552459|NCT00000333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552460|NCT00000333|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102552461|NCT00000333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102552462|NCT00000333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102552464|NCT00000339|Risperidone|risperidone|mesh-list
102552465|NCT00000339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102552466|NCT00000339|Serotonin Agents|serotonin agents|mesh-ancestor
102552467|NCT00000339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102552468|NCT00000339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552469|NCT00000339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552470|NCT00000339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102552471|NCT00000339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102552472|NCT00000339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102552473|NCT00000339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102552474|NCT00000339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102552475|NCT00000339|Dopamine Agents|dopamine agents|mesh-ancestor
102552476|NCT00000345|Lofexidine|lofexidine|mesh-list
102552477|NCT00000345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102552478|NCT00000345|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102552479|NCT00000345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552480|NCT00000345|Sensory System Agents|sensory system agents|mesh-ancestor
102552481|NCT00000345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102552482|NCT00000345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102552483|NCT00000345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102552484|NCT00000345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102552485|NCT00000345|Adrenergic Agents|adrenergic agents|mesh-ancestor
102552486|NCT00000345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102552487|NCT00000345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552488|NCT00000357|Buprenorphine|buprenorphine|mesh-list
102552489|NCT00000357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102552490|NCT00000357|Narcotics|narcotics|mesh-ancestor
102552491|NCT00000357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102552492|NCT00000357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552493|NCT00000357|Analgesics|analgesics|mesh-ancestor
102552494|NCT00000357|Sensory System Agents|sensory system agents|mesh-ancestor
102552495|NCT00000357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102552496|NCT00000357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102552497|NCT05095311|Cetirizine|cetirizine|mesh-list
102552498|NCT05095311|Nedocromil|nedocromil|mesh-list
102552499|NCT05095311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102552500|NCT05095311|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102552501|NCT05095311|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102552502|NCT05095311|Histamine Antagonists|histamine antagonists|mesh-ancestor
102552503|NCT05095311|Histamine Agents|histamine agents|mesh-ancestor
102552504|NCT05095311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102552505|NCT05095311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552506|NCT05095311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552507|NCT05095311|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
102552508|NCT05095311|Immunologic Factors|immunologic factors|mesh-ancestor
102552509|NCT05095311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102552510|NCT05095311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102552511|NCT05095311|Respiratory System Agents|respiratory system agents|mesh-ancestor
102552512|NCT01922336|Infliximab|infliximab|mesh-list
102552513|NCT01922336|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102552514|NCT01922336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102552515|NCT01922336|Dermatologic Agents|dermatologic agents|mesh-ancestor
102552516|NCT01922336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102552517|NCT01922336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102552518|NCT04330755|Magnesium Sulfate|magnesium sulfate|mesh-list
102552519|NCT04330755|Simendan|simendan|mesh-list
102552520|NCT04330755|Analgesics|analgesics|mesh-ancestor
102552521|NCT04330755|Sensory System Agents|sensory system agents|mesh-ancestor
102552522|NCT04330755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102552523|NCT04330755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552524|NCT04330755|Anesthetics|anesthetics|mesh-ancestor
102552525|NCT04330755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102552526|NCT04330755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102552527|NCT04330755|Anticonvulsants|anticonvulsants|mesh-ancestor
102552528|NCT04330755|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102552529|NCT04330755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102552530|NCT04330755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552531|NCT04330755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102552532|NCT04330755|Tocolytic Agents|tocolytic agents|mesh-ancestor
102552533|NCT04330755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102552534|NCT04330755|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102552535|NCT04330755|Vasodilator Agents|vasodilator agents|mesh-ancestor
102552536|NCT04330755|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102552537|NCT04330755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102552538|NCT04330755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102552539|NCT04330755|Protective Agents|protective agents|mesh-ancestor
102552540|NCT01608295|Paroxetine|paroxetine|mesh-list
102552541|NCT01608295|Antidepressive Agents|antidepressive agents|mesh-list
102552542|NCT01608295|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
102552543|NCT01608295|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102552544|NCT01608295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102552545|NCT01608295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102552546|NCT01608295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552547|NCT01608295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102552548|NCT01608295|Serotonin Agents|serotonin agents|mesh-ancestor
102552549|NCT01608295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552550|NCT01608295|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102552551|NCT01608295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102552552|NCT01608295|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102552553|NCT01608295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102552554|NCT01608295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102552555|NCT01608295|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102552556|NCT01608295|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102552557|NCT04713189|Fentanyl|fentanyl|mesh-list
102552558|NCT04713189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102552559|NCT04713189|Narcotics|narcotics|mesh-ancestor
102552560|NCT04713189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102552561|NCT04713189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552562|NCT04713189|Analgesics|analgesics|mesh-ancestor
102552563|NCT04713189|Sensory System Agents|sensory system agents|mesh-ancestor
102552564|NCT04713189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102552565|NCT04713189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102552566|NCT04713189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102552567|NCT04713189|Anesthetics, General|anesthetics, general|mesh-ancestor
102552568|NCT04713189|Anesthetics|anesthetics|mesh-ancestor
102552569|NCT01610011|Glycine|glycine|mesh-list
102552570|NCT01610011|Glycine Agents|glycine agents|mesh-ancestor
102552571|NCT01610011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102552572|NCT01610011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552573|NCT01610011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552574|NCT00000399|Hormones|hormones|mesh-list
102552575|NCT00000399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102552576|NCT00000399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552577|NCT02237989|Acetaminophen|acetaminophen|mesh-list
102552578|NCT02237989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102552579|NCT02237989|Analgesics|analgesics|mesh-ancestor
102552580|NCT02237989|Sensory System Agents|sensory system agents|mesh-ancestor
102552581|NCT02237989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102552582|NCT02237989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552583|NCT02237989|Antipyretics|antipyretics|mesh-ancestor
102552584|NCT00000429|Calcium Carbonate|calcium carbonate|mesh-list
102552585|NCT00000429|Calcium|calcium|mesh-list
102552586|NCT00000429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102552587|NCT00000429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552588|NCT00000429|Antacids|antacids|mesh-ancestor
102552589|NCT00000429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552590|NCT00000429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102552591|NCT01673191|Dexamethasone|dexamethasone|mesh-list
102552592|NCT01673191|Prednisolone acetate|prednisolone acetate|mesh-list
102552593|NCT01673191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102552594|NCT01673191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102552595|NCT01673191|Antiemetics|antiemetics|mesh-ancestor
102552596|NCT01673191|Autonomic Agents|autonomic agents|mesh-ancestor
102552597|NCT01673191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102552598|NCT01673191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552599|NCT01673191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102552600|NCT01673191|Glucocorticoids|glucocorticoids|mesh-ancestor
102552601|NCT01673191|Hormones|hormones|mesh-ancestor
102552602|NCT01673191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102552603|NCT01673191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102099634|NCT02784288|Paclitaxel|paclitaxel|mesh-list
102552604|NCT01673191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102552605|NCT01673191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102552606|NCT01925144|Omeprazole|omeprazole|mesh-list
102552607|NCT01925144|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102552608|NCT01925144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102552609|NCT01925144|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102552610|NCT01925144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102552611|NCT01925144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552612|NCT00000441|Carbamazepine|carbamazepine|mesh-list
102552613|NCT00000441|Lorazepam|lorazepam|mesh-list
102552614|NCT00000441|Anticonvulsants|anticonvulsants|mesh-ancestor
102552615|NCT00000441|Antiemetics|antiemetics|mesh-ancestor
102552616|NCT00000441|Autonomic Agents|autonomic agents|mesh-ancestor
102552617|NCT00000441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102552618|NCT00000441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552619|NCT00000441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102552620|NCT00000441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102552621|NCT00000441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102552622|NCT00000441|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102552623|NCT00000441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102552624|NCT00000441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102552625|NCT00000441|GABA Modulators|gaba modulators|mesh-ancestor
102552626|NCT00000441|GABA Agents|gaba agents|mesh-ancestor
102552627|NCT00000441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102552628|NCT00000441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552629|NCT00000441|Antimanic Agents|antimanic agents|mesh-ancestor
102552630|NCT00000441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102552631|NCT00000441|Analgesics|analgesics|mesh-ancestor
102552632|NCT00000441|Sensory System Agents|sensory system agents|mesh-ancestor
102552633|NCT00000441|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102552634|NCT00000441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102552635|NCT00000441|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102552636|NCT00000441|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102552637|NCT00000447|Naltrexone|naltrexone|mesh-list
102552638|NCT00000447|Nicotine|nicotine|mesh-list
102552639|NCT00000447|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102552640|NCT00000447|Autonomic Agents|autonomic agents|mesh-ancestor
102552641|NCT00000447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102552642|NCT00000447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552643|NCT00000447|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102552644|NCT00000447|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102552645|NCT00000447|Cholinergic Agents|cholinergic agents|mesh-ancestor
102552646|NCT00000447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102552647|NCT00000447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552648|NCT00000447|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102552649|NCT00000447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102552650|NCT00000447|Sensory System Agents|sensory system agents|mesh-ancestor
102552651|NCT01927718|Thalidomide|thalidomide|mesh-list
102552652|NCT01927718|Lenalidomide|lenalidomide|mesh-list
102552653|NCT01927718|Immunologic Factors|immunologic factors|mesh-ancestor
102552654|NCT01927718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552655|NCT01927718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102552656|NCT01927718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102552657|NCT01927718|Growth Substances|growth substances|mesh-ancestor
102552658|NCT01927718|Growth Inhibitors|growth inhibitors|mesh-ancestor
102552659|NCT01927718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102552660|NCT01927718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102552661|NCT01927718|Leprostatic Agents|leprostatic agents|mesh-ancestor
102552662|NCT01927718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102552663|NCT01927718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102552664|NCT05066607|Dexamethasone|dexamethasone|mesh-list
102552665|NCT05066607|Pomalidomide|pomalidomide|mesh-list
102552666|NCT05066607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102552667|NCT05066607|Antiemetics|antiemetics|mesh-ancestor
102552668|NCT05066607|Autonomic Agents|autonomic agents|mesh-ancestor
102552669|NCT05066607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102552670|NCT05066607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552671|NCT05066607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102552672|NCT05066607|Glucocorticoids|glucocorticoids|mesh-ancestor
102552673|NCT05066607|Hormones|hormones|mesh-ancestor
102552674|NCT05066607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102552675|NCT05066607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102552676|NCT05066607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102552677|NCT05066607|Immunologic Factors|immunologic factors|mesh-ancestor
102552678|NCT05066607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102552679|NCT05066607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102552680|NCT05066607|Growth Substances|growth substances|mesh-ancestor
102552681|NCT05066607|Growth Inhibitors|growth inhibitors|mesh-ancestor
102552682|NCT01948310|Ranolazine|ranolazine|mesh-list
102552683|NCT01948310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102552684|NCT01948310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102552685|NCT01948310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552686|NCT01948388|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102552687|NCT01948388|Hormones|hormones|mesh-ancestor
102552688|NCT01948388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102552689|NCT01948388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552690|NCT01675297|Cholecalciferol|cholecalciferol|mesh-list
102552691|NCT01675297|Vitamin D|vitamin d|mesh-list
102552692|NCT01675297|Risedronic Acid|risedronic acid|mesh-list
102552693|NCT01675297|Etidronic Acid|etidronic acid|mesh-list
102552694|NCT01675297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102552695|NCT01675297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552696|NCT01675297|Vitamins|vitamins|mesh-ancestor
102552697|NCT01675297|Micronutrients|micronutrients|mesh-ancestor
102552698|NCT01675297|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102552699|NCT01675297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102552700|NCT01675297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102552701|NCT01675297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552702|NCT05295537|Liver Extracts|liver extracts|mesh-list
102552703|NCT05295537|Hematinics|hematinics|mesh-ancestor
102552704|NCT02287376|Diclofenac|diclofenac|mesh-list
102552705|NCT02287376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102552706|NCT02287376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102552707|NCT02287376|Analgesics|analgesics|mesh-ancestor
102552708|NCT02287376|Sensory System Agents|sensory system agents|mesh-ancestor
102552709|NCT02287376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102552710|NCT02287376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552711|NCT02287376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102552712|NCT02287376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102552713|NCT02287376|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102552714|NCT02287376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102552715|NCT02287376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552716|NCT01928186|Alovudine|alovudine|mesh-list
102552717|NCT01928186|Antiviral Agents|antiviral agents|mesh-ancestor
102552718|NCT01928186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102552719|NCT01611571|Teriparatide|teriparatide|mesh-list
102552720|NCT01611571|Risedronic Acid|risedronic acid|mesh-list
102552721|NCT01611571|Etidronic Acid|etidronic acid|mesh-list
102552722|NCT01611571|Parathyroid Hormone|parathyroid hormone|mesh-list
102552723|NCT01611571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102552724|NCT01611571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552725|NCT01611571|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102552726|NCT01611571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101430152|NCT00151346|Analgesics|analgesics|mesh-ancestor
102552727|NCT01611571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102552728|NCT01611571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552729|NCT00000477|Lovastatin|lovastatin|mesh-list
102552730|NCT00000477|L 647318|l 647318|mesh-list
102552731|NCT00000477|Dihydromevinolin|dihydromevinolin|mesh-list
102552732|NCT00000477|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102552733|NCT00000477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102552734|NCT00000477|Antimetabolites|antimetabolites|mesh-ancestor
102552735|NCT00000477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552736|NCT00000477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102552737|NCT00000477|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102552738|NCT00000477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102552739|NCT00000483|Niacin|niacin|mesh-list
102552740|NCT00000483|Clofibrate|clofibrate|mesh-list
102552741|NCT00000483|Estrogens|estrogens|mesh-list
102552742|NCT00000483|Hormones|hormones|mesh-ancestor
102552743|NCT00000483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102552744|NCT00000483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552745|NCT00000483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102552746|NCT00000483|Antimetabolites|antimetabolites|mesh-ancestor
102552747|NCT00000483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552748|NCT00000483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102552749|NCT00000483|Vasodilator Agents|vasodilator agents|mesh-ancestor
102552750|NCT00000483|Vitamin B Complex|vitamin b complex|mesh-ancestor
102552751|NCT00000483|Vitamins|vitamins|mesh-ancestor
102552752|NCT00000483|Micronutrients|micronutrients|mesh-ancestor
102552753|NCT00000483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102552754|NCT00000507|Streptokinase|streptokinase|mesh-list
102552755|NCT00000507|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102099784|NCT04850950|Tenofovir|tenofovir|mesh-list
102552756|NCT00000507|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102552757|NCT00000507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552758|NCT00380445|Vildagliptin|vildagliptin|mesh-list
102552759|NCT00380445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102552760|NCT00380445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552761|NCT00380445|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102552762|NCT00380445|Protease Inhibitors|protease inhibitors|mesh-ancestor
102552763|NCT00380445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102552764|NCT00380445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552765|NCT01950260|Hormones|hormones|mesh-list
102552766|NCT01950260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102552767|NCT01950260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552768|NCT01676311|Huperzine A|huperzine a|mesh-list
102552769|NCT01676311|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102552770|NCT01676311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102552771|NCT01676311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552772|NCT01676311|Cholinergic Agents|cholinergic agents|mesh-ancestor
102552773|NCT01676311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102552774|NCT01676311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552775|NCT01676311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102552776|NCT01676311|Protective Agents|protective agents|mesh-ancestor
102552777|NCT01951118|Donepezil|donepezil|mesh-list
102552778|NCT01951118|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102552779|NCT01951118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102552780|NCT01951118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552781|NCT01951118|Cholinergic Agents|cholinergic agents|mesh-ancestor
102552782|NCT01951118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102552783|NCT01951118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552784|NCT01951118|Nootropic Agents|nootropic agents|mesh-ancestor
102552785|NCT01951820|Lidocaine|lidocaine|mesh-list
102552786|NCT01951820|Tetracaine|tetracaine|mesh-list
102552787|NCT01951820|Carticaine|carticaine|mesh-list
102552788|NCT01951820|Benzocaine|benzocaine|mesh-list
102552789|NCT01951820|Anesthetics, Local|anesthetics, local|mesh-ancestor
102552790|NCT01951820|Anesthetics|anesthetics|mesh-ancestor
102552791|NCT01951820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102552792|NCT01951820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552793|NCT01951820|Sensory System Agents|sensory system agents|mesh-ancestor
102552794|NCT01951820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102552795|NCT01951820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102552796|NCT01951820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102552797|NCT01951820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102552798|NCT01951820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102552799|NCT01951820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552800|NCT01952444|Ciprofloxacin|ciprofloxacin|mesh-list
102552801|NCT01952444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102552802|NCT01952444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102552803|NCT01952444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102552804|NCT01952444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102552805|NCT01952444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102552806|NCT01952444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552807|NCT01952444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102552808|NCT01952444|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102552809|NCT01952444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102552810|NCT01614847|Lubricant Eye Drops|lubricant eye drops|mesh-list
102552811|NCT01614847|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102552812|NCT01614847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102552813|NCT00382629|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
102552814|NCT00382629|Antioxidants|antioxidants|mesh-ancestor
102552815|NCT00382629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552816|NCT00382629|Protective Agents|protective agents|mesh-ancestor
102552817|NCT00382629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552818|NCT00000513|Atenolol|atenolol|mesh-list
102552819|NCT00000513|Chlorthalidone|chlorthalidone|mesh-list
102552820|NCT00000513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102552821|NCT00000513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102552822|NCT00000513|Sympatholytics|sympatholytics|mesh-ancestor
102552823|NCT00000513|Autonomic Agents|autonomic agents|mesh-ancestor
102552824|NCT00000513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102552825|NCT00000513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552826|NCT00000513|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102552827|NCT00000513|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102552828|NCT00000513|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102552829|NCT00000513|Adrenergic Agents|adrenergic agents|mesh-ancestor
102552830|NCT00000513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102552831|NCT00000513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552832|NCT00000513|Diuretics|diuretics|mesh-ancestor
102552833|NCT00000513|Natriuretic Agents|natriuretic agents|mesh-ancestor
102552834|NCT00000513|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102552835|NCT00000513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102552836|NCT00000543|Calcium|calcium|mesh-list
102552837|NCT00000543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102552838|NCT00000543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552839|NCT00000549|Hormones|hormones|mesh-list
102552840|NCT00000549|Estrogens|estrogens|mesh-list
102552841|NCT00000549|Progestins|progestins|mesh-list
102552842|NCT00000549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102552843|NCT00000549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552844|NCT01617577|Lenograstim|lenograstim|mesh-list
102552845|NCT01617577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102552846|NCT01617577|Immunologic Factors|immunologic factors|mesh-ancestor
102552847|NCT01617577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552848|NCT01701037|Trametinib|trametinib|mesh-list
102552849|NCT01701037|Dabrafenib|dabrafenib|mesh-list
102552850|NCT01701037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102552851|NCT01701037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102552852|NCT01701037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102552853|NCT01701037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552854|NCT00000585|Penicillins|penicillins|mesh-list
102552855|NCT00000585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102552856|NCT00000585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102552857|NCT01701115|Bupivacaine|bupivacaine|mesh-list
102552858|NCT01701115|Anesthetics, Local|anesthetics, local|mesh-list
102552859|NCT01701115|Mepivacaine|mepivacaine|mesh-list
102552860|NCT01701115|Anesthetics|anesthetics|mesh-list
102552861|NCT01701115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102552862|NCT01701115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552863|NCT01701115|Sensory System Agents|sensory system agents|mesh-ancestor
102552864|NCT01701115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102552865|NCT00000597|Nandrolone Decanoate|nandrolone decanoate|mesh-list
102552866|NCT00000597|Nandrolone|nandrolone|mesh-list
102552867|NCT00000597|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
102552868|NCT00000597|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102552869|NCT00000597|Androgens|androgens|mesh-ancestor
102552870|NCT00000597|Hormones|hormones|mesh-ancestor
102552871|NCT00000597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102552872|NCT00000597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552873|NCT00000597|Anabolic Agents|anabolic agents|mesh-ancestor
102552874|NCT00000597|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102552875|NCT00000597|Immunologic Factors|immunologic factors|mesh-ancestor
102552876|NCT00000597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102552877|NCT01621009|Bupropion|bupropion|mesh-list
102552878|NCT01621009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102552879|NCT01621009|Antidepressive Agents|antidepressive agents|mesh-ancestor
102552880|NCT01621009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102552881|NCT01621009|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102552882|NCT01621009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102552883|NCT01621009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102552884|NCT01621009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552885|NCT01621009|Dopamine Agents|dopamine agents|mesh-ancestor
102552886|NCT01621009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102552887|NCT01621009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552888|NCT01621009|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102552889|NCT01621009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102552890|NCT01621009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102552891|NCT04830969|Chlorhexidine|chlorhexidine|mesh-list
102552892|NCT04830969|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102552893|NCT04830969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102552894|NCT04830969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102552895|NCT04830969|Disinfectants|disinfectants|mesh-ancestor
102552896|NCT04830969|Dermatologic Agents|dermatologic agents|mesh-ancestor
102552897|NCT01683331|Insulin|insulin|mesh-list
102552898|NCT01683331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102552899|NCT01683331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552900|NCT02986880|Botulinum Toxins|botulinum toxins|mesh-list
102552901|NCT02986880|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102552902|NCT02986880|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102552903|NCT02986880|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102099970|NCT04823260|Niacin|niacin|mesh-list
102552904|NCT02986880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102552905|NCT02986880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552907|NCT02986880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102552908|NCT02986880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552909|NCT02986880|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102552910|NCT02986880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102552911|NCT02290106|Pitavastatin|pitavastatin|mesh-list
102552912|NCT02290106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102552913|NCT02290106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102552914|NCT02290106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102552915|NCT02290106|Antimetabolites|antimetabolites|mesh-ancestor
102552916|NCT02290106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552917|NCT02290106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102552918|NCT02290106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102552919|NCT00000621|Tretinoin|tretinoin|mesh-list
102552920|NCT00000621|Isotretinoin|isotretinoin|mesh-list
102552921|NCT00000621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102552922|NCT00000621|Keratolytic Agents|keratolytic agents|mesh-ancestor
102552923|NCT00000621|Dermatologic Agents|dermatologic agents|mesh-ancestor
102552924|NCT04818957|Vitamin D|vitamin d|mesh-list
102552925|NCT04818957|Cholecalciferol|cholecalciferol|mesh-list
102552926|NCT04818957|Vitamins|vitamins|mesh-ancestor
102552927|NCT04818957|Micronutrients|micronutrients|mesh-ancestor
102552928|NCT04818957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552929|NCT04818957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102552930|NCT04818957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102552931|NCT01621477|Cytarabine|cytarabine|mesh-list
102552932|NCT01621477|Plerixafor|plerixafor|mesh-list
102552933|NCT01621477|Mycophenolic Acid|mycophenolic acid|mesh-list
102552934|NCT01621477|Cyclophosphamide|cyclophosphamide|mesh-list
102552935|NCT01621477|Busulfan|busulfan|mesh-list
102552936|NCT01621477|Clofarabine|clofarabine|mesh-list
102552937|NCT01621477|Tacrolimus|tacrolimus|mesh-list
102552938|NCT01621477|Thymoglobulin|thymoglobulin|mesh-list
102552939|NCT01621477|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102552940|NCT01621477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102552941|NCT01621477|Immunologic Factors|immunologic factors|mesh-ancestor
102552942|NCT01621477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552943|NCT01621477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102552944|NCT01621477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102552945|NCT01621477|Alkylating Agents|alkylating agents|mesh-ancestor
102552946|NCT01621477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552947|NCT01621477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102552948|NCT01621477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102552949|NCT01621477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102552950|NCT01621477|Antimetabolites|antimetabolites|mesh-ancestor
102552951|NCT01621477|Antiviral Agents|antiviral agents|mesh-ancestor
102552952|NCT01621477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102552953|NCT01621477|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102552954|NCT01621477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102552955|NCT01621477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102552956|NCT01621477|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102552957|NCT01621477|Antitubercular Agents|antitubercular agents|mesh-ancestor
102552958|NCT01621477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102552959|NCT01621477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102552960|NCT01621477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102552961|NCT00000627|Fluconazole|fluconazole|mesh-list
102552962|NCT00000627|Antifungal Agents|antifungal agents|mesh-ancestor
102552963|NCT00000627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102552964|NCT00000627|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102552965|NCT00000627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102552966|NCT00000627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102552967|NCT00000627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552968|NCT00000627|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102552969|NCT00000627|Hormone Antagonists|hormone antagonists|mesh-ancestor
102552970|NCT00000627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102552971|NCT00000627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552972|NCT00000627|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102552973|NCT00000627|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102552974|NCT00000633|Vaccines|vaccines|mesh-list
102552975|NCT00000633|Immunologic Factors|immunologic factors|mesh-ancestor
102552976|NCT00000633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552977|NCT01621633|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102552978|NCT01621633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102552979|NCT01621633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552980|NCT05479214|Metformin|metformin|mesh-list
102552981|NCT05479214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102552982|NCT05479214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102552983|NCT00000657|Zidovudine|zidovudine|mesh-list
102552984|NCT00000657|Didanosine|didanosine|mesh-list
102552985|NCT00000657|Antimetabolites|antimetabolites|mesh-ancestor
102552986|NCT00000657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102552987|NCT00000657|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102552988|NCT00000657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102552989|NCT00000657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102552990|NCT00000657|Antiviral Agents|antiviral agents|mesh-ancestor
102552991|NCT00000657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102552992|NCT00000657|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102552993|NCT00000657|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102552994|NCT01701505|Phenylephrine|phenylephrine|mesh-list
102552995|NCT01701505|Oxymetazoline|oxymetazoline|mesh-list
102552996|NCT01701505|Tetracaine|tetracaine|mesh-list
102552997|NCT01701505|Anesthetics, Local|anesthetics, local|mesh-ancestor
102552998|NCT01701505|Anesthetics|anesthetics|mesh-ancestor
102552999|NCT01701505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102553000|NCT01701505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553001|NCT01701505|Sensory System Agents|sensory system agents|mesh-ancestor
102553002|NCT01701505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102553003|NCT01701505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102553004|NCT01701505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102553005|NCT01701505|Adrenergic Agents|adrenergic agents|mesh-ancestor
102553006|NCT01701505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102553007|NCT01701505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553008|NCT01701505|Sympathomimetics|sympathomimetics|mesh-ancestor
102553009|NCT01701505|Autonomic Agents|autonomic agents|mesh-ancestor
102553010|NCT01701505|Nasal Decongestants|nasal decongestants|mesh-ancestor
102553011|NCT01701505|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102553012|NCT01701505|Respiratory System Agents|respiratory system agents|mesh-ancestor
102553013|NCT01701505|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102553014|NCT01701505|Mydriatics|mydriatics|mesh-ancestor
102553015|NCT01701505|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102553016|NCT01701505|Protective Agents|protective agents|mesh-ancestor
102553017|NCT00000663|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
102553018|NCT00000663|Immunologic Factors|immunologic factors|mesh-ancestor
102553019|NCT00000663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553020|NCT00000669|Didanosine|didanosine|mesh-list
102553021|NCT00000669|Antimetabolites|antimetabolites|mesh-ancestor
102553022|NCT00000669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553023|NCT00000669|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102553024|NCT00000669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102553025|NCT00000669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102553026|NCT00000669|Antiviral Agents|antiviral agents|mesh-ancestor
102553027|NCT00000669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102553028|NCT00000669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102553029|NCT00000669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102553030|NCT01622257|Metformin|metformin|mesh-list
102553031|NCT01622257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102553032|NCT01622257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553033|NCT04942899|Capecitabine|capecitabine|mesh-list
102553034|NCT04942899|Letrozole|letrozole|mesh-list
102553035|NCT04942899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102553036|NCT04942899|Antimetabolites|antimetabolites|mesh-ancestor
102553037|NCT04942899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553038|NCT04942899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102553039|NCT04942899|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102553040|NCT04942899|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102553041|NCT04942899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102553042|NCT04942899|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102553043|NCT04942899|Hormone Antagonists|hormone antagonists|mesh-ancestor
102553044|NCT04942899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102553045|NCT04942899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553046|NCT00000693|Zidovudine|zidovudine|mesh-list
102553047|NCT00000693|Acyclovir|acyclovir|mesh-list
102553048|NCT00000693|Antimetabolites|antimetabolites|mesh-ancestor
102553049|NCT00000693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553050|NCT00000693|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102553051|NCT00000693|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102553052|NCT00000693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102553053|NCT00000693|Antiviral Agents|antiviral agents|mesh-ancestor
102553054|NCT00000693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102553055|NCT00000693|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102553056|NCT00000693|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102553057|NCT04752033|Morphine|morphine|mesh-list
102553058|NCT04752033|Hydromorphone|hydromorphone|mesh-list
102553059|NCT04752033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102553060|NCT04752033|Narcotics|narcotics|mesh-ancestor
102553061|NCT04752033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102553062|NCT04752033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553063|NCT04752033|Analgesics|analgesics|mesh-ancestor
102553064|NCT04752033|Sensory System Agents|sensory system agents|mesh-ancestor
102553065|NCT04752033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102553066|NCT02987270|Piperaquine|piperaquine|mesh-list
102553067|NCT02987270|Artenimol|artenimol|mesh-list
102553068|NCT02987270|Antimalarials|antimalarials|mesh-ancestor
102553069|NCT02987270|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102553070|NCT02987270|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102553071|NCT02987270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102553072|NCT00000699|Ribavirin|ribavirin|mesh-list
102553073|NCT00000699|Inosine Pranobex|inosine pranobex|mesh-list
102553074|NCT00000699|Antimetabolites|antimetabolites|mesh-ancestor
102553075|NCT00000699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553076|NCT00000699|Antiviral Agents|antiviral agents|mesh-ancestor
102553077|NCT00000699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102553078|NCT00000699|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102553079|NCT00000699|Immunologic Factors|immunologic factors|mesh-ancestor
102553080|NCT00000699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553081|NCT04931979|Pembrolizumab|pembrolizumab|mesh-list
102553082|NCT04931979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102553083|NCT04931979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102553084|NCT04931979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102553085|NCT04931979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553086|NCT00000723|Leucovorin|leucovorin|mesh-list
102553087|NCT00000723|Zidovudine|zidovudine|mesh-list
102553088|NCT00000723|Dexamethasone|dexamethasone|mesh-list
102553089|NCT00000723|Methotrexate|methotrexate|mesh-list
102553090|NCT00000723|Calcium|calcium|mesh-list
102553091|NCT00000723|Levoleucovorin|levoleucovorin|mesh-list
102553092|NCT00000723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102553093|NCT00000723|Antiemetics|antiemetics|mesh-ancestor
102553094|NCT00000723|Autonomic Agents|autonomic agents|mesh-ancestor
102553095|NCT00000723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102553096|NCT00000723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553097|NCT00000723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102553098|NCT00000723|Glucocorticoids|glucocorticoids|mesh-ancestor
102553099|NCT00000723|Hormones|hormones|mesh-ancestor
102553100|NCT00000723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102553101|NCT00000723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102553102|NCT00000723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102553103|NCT00000723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102553104|NCT00000723|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102553105|NCT00000723|Abortifacient Agents|abortifacient agents|mesh-ancestor
102553106|NCT00000723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102553107|NCT00000723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102553108|NCT00000723|Antimetabolites|antimetabolites|mesh-ancestor
102553109|NCT00000723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553110|NCT00000723|Dermatologic Agents|dermatologic agents|mesh-ancestor
102553111|NCT00000723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102553112|NCT00000723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102553113|NCT00000723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102553114|NCT00000723|Immunologic Factors|immunologic factors|mesh-ancestor
102553115|NCT00000723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102553116|NCT00000723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102553117|NCT00000723|Antidotes|antidotes|mesh-ancestor
102553118|NCT00000723|Protective Agents|protective agents|mesh-ancestor
102553119|NCT00000723|Vitamin B Complex|vitamin b complex|mesh-ancestor
102553120|NCT00000723|Vitamins|vitamins|mesh-ancestor
102553121|NCT00000723|Micronutrients|micronutrients|mesh-ancestor
102553122|NCT00000723|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102553123|NCT00000723|Antiviral Agents|antiviral agents|mesh-ancestor
102553124|NCT00000723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102553125|NCT00000723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102553126|NCT00000723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102553127|NCT02329964|Neostigmine|neostigmine|mesh-list
102553128|NCT02329964|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
102553129|NCT02329964|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102553130|NCT02329964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102553131|NCT02329964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553132|NCT02329964|Cholinergic Agents|cholinergic agents|mesh-ancestor
102553133|NCT02329964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102553134|NCT02329964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553135|NCT02329964|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102553136|NCT02329964|Autonomic Agents|autonomic agents|mesh-ancestor
102553137|NCT02329964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102553138|NCT04750395|Haloperidol|haloperidol|mesh-list
102553139|NCT04750395|Olanzapine|olanzapine|mesh-list
102553140|NCT04750395|Haloperidol decanoate|haloperidol decanoate|mesh-list
102553141|NCT04750395|Antiemetics|antiemetics|mesh-ancestor
102553142|NCT04750395|Autonomic Agents|autonomic agents|mesh-ancestor
102553143|NCT04750395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102553144|NCT04750395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553145|NCT04750395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102553146|NCT04750395|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102553147|NCT04750395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102553148|NCT04750395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102553149|NCT04750395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102553150|NCT04750395|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102553151|NCT04750395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102553152|NCT04750395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102553153|NCT04750395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553154|NCT04750395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102553155|NCT04750395|Serotonin Agents|serotonin agents|mesh-ancestor
102553156|NCT04750395|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102553157|NCT04750395|Dopamine Agents|dopamine agents|mesh-ancestor
102553158|NCT04750395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102553159|NCT00000729|Foscarnet|foscarnet|mesh-list
102553160|NCT00000729|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
102553161|NCT00000729|Antiviral Agents|antiviral agents|mesh-ancestor
102553162|NCT00000729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102553163|NCT00000729|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102553164|NCT00000729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102553165|NCT00000729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102553166|NCT00000729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553167|NCT03438773|Tacrolimus|tacrolimus|mesh-list
102553168|NCT03438773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102553169|NCT03438773|Immunologic Factors|immunologic factors|mesh-ancestor
102553170|NCT03438773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553171|NCT03438773|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102553172|NCT03438773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102553173|NCT03438773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553174|NCT02974985|Hyaluronic Acid|hyaluronic acid|mesh-list
102553175|NCT02974985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102553176|NCT02974985|Immunologic Factors|immunologic factors|mesh-ancestor
102553177|NCT02974985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553178|NCT02974985|Viscosupplements|viscosupplements|mesh-ancestor
102553179|NCT02974985|Protective Agents|protective agents|mesh-ancestor
102553180|NCT01704781|Lenalidomide|lenalidomide|mesh-list
102553181|NCT01704781|Immunologic Factors|immunologic factors|mesh-ancestor
102553182|NCT01704781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553183|NCT01704781|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102553184|NCT01704781|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102553185|NCT01704781|Growth Substances|growth substances|mesh-ancestor
102553186|NCT01704781|Growth Inhibitors|growth inhibitors|mesh-ancestor
102553187|NCT01704781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102553188|NCT02288156|Capsaicin|capsaicin|mesh-list
102553189|NCT02288156|Antipruritics|antipruritics|mesh-ancestor
102553190|NCT02288156|Dermatologic Agents|dermatologic agents|mesh-ancestor
102553191|NCT02288156|Sensory System Agents|sensory system agents|mesh-ancestor
102553192|NCT02288156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102553193|NCT02288156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553194|NCT04699383|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
102553195|NCT04699383|Allopurinol|allopurinol|mesh-list
102553196|NCT04699383|Antimetabolites|antimetabolites|mesh-ancestor
102553197|NCT04699383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553198|NCT04699383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102553199|NCT04699383|Gout Suppressants|gout suppressants|mesh-ancestor
102553200|NCT04699383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102553201|NCT04699383|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102553202|NCT04699383|Antioxidants|antioxidants|mesh-ancestor
102553203|NCT04699383|Protective Agents|protective agents|mesh-ancestor
102553204|NCT04699383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553205|NCT04699383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102553206|NCT04699383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102553207|NCT04699383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102553208|NCT04699383|Schistosomicides|schistosomicides|mesh-ancestor
102553209|NCT04699383|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102553210|NCT04699383|Anthelmintics|anthelmintics|mesh-ancestor
102553211|NCT05700266|Aspirin|aspirin|mesh-list
102553212|NCT05700266|Rivaroxaban|rivaroxaban|mesh-list
102553213|NCT05700266|Clopidogrel|clopidogrel|mesh-list
102553214|NCT05700266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102553215|NCT05700266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102553216|NCT05700266|Analgesics|analgesics|mesh-ancestor
102553217|NCT05700266|Sensory System Agents|sensory system agents|mesh-ancestor
102553218|NCT05700266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102553219|NCT05700266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553220|NCT05700266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102553221|NCT05700266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102553222|NCT05700266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102553223|NCT05700266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102553224|NCT05700266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553225|NCT05700266|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102553226|NCT05700266|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102553227|NCT05700266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102553228|NCT05700266|Antipyretics|antipyretics|mesh-ancestor
102553229|NCT05700266|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102553230|NCT05700266|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102553231|NCT05700266|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102553232|NCT05700266|Purinergic Agents|purinergic agents|mesh-ancestor
102553233|NCT05700266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102553234|NCT05700266|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102553235|NCT05700266|Antithrombins|antithrombins|mesh-ancestor
102553236|NCT05700266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102553237|NCT05700266|Protease Inhibitors|protease inhibitors|mesh-ancestor
102553238|NCT05700266|Anticoagulants|anticoagulants|mesh-ancestor
102553239|NCT05423132|Ropivacaine|ropivacaine|mesh-list
102553240|NCT05423132|Anesthetics, Local|anesthetics, local|mesh-ancestor
102553241|NCT05423132|Anesthetics|anesthetics|mesh-ancestor
102553242|NCT05423132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102553243|NCT05423132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553244|NCT05423132|Sensory System Agents|sensory system agents|mesh-ancestor
102553245|NCT05423132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102553246|NCT02975219|Bevacizumab|bevacizumab|mesh-list
102553247|NCT02975219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102553248|NCT02975219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102553249|NCT02975219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102553250|NCT02975219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102553251|NCT02975219|Growth Substances|growth substances|mesh-ancestor
102553252|NCT02975219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553253|NCT02975219|Growth Inhibitors|growth inhibitors|mesh-ancestor
102553254|NCT01686451|Simvastatin|simvastatin|mesh-list
102553255|NCT01686451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102553256|NCT01686451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102553257|NCT01686451|Antimetabolites|antimetabolites|mesh-ancestor
102553258|NCT01686451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553259|NCT01686451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102553260|NCT01686451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102553261|NCT01686451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102553262|NCT00361751|Fenofibrate|fenofibrate|mesh-list
102553263|NCT00361751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102553264|NCT00361751|Antimetabolites|antimetabolites|mesh-ancestor
102553265|NCT00361751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553266|NCT00361751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102553267|NCT05681702|Aspirin|aspirin|mesh-list
102553268|NCT05681702|Clopidogrel|clopidogrel|mesh-list
102553269|NCT05681702|Ticagrelor|ticagrelor|mesh-list
102553270|NCT05681702|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102553271|NCT05681702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102553272|NCT05681702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102553273|NCT05681702|Analgesics|analgesics|mesh-ancestor
102553274|NCT05681702|Sensory System Agents|sensory system agents|mesh-ancestor
102553275|NCT05681702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102553276|NCT05681702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553277|NCT05681702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102553278|NCT05681702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102553279|NCT05681702|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102553280|NCT05681702|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102553281|NCT05681702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553282|NCT05681702|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102553283|NCT05681702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102553284|NCT05681702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102553285|NCT05681702|Antipyretics|antipyretics|mesh-ancestor
102553286|NCT05681702|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102553287|NCT05681702|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102553288|NCT05681702|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102553289|NCT05681702|Purinergic Agents|purinergic agents|mesh-ancestor
102553290|NCT05681702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102553291|NCT04675983|Fluorouracil|fluorouracil|mesh-list
102553292|NCT04675983|Capecitabine|capecitabine|mesh-list
102553293|NCT04675983|Oxaliplatin|oxaliplatin|mesh-list
102553294|NCT04675983|Ramucirumab|ramucirumab|mesh-list
102553295|NCT04675983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102553296|NCT04675983|Antimetabolites|antimetabolites|mesh-ancestor
102553297|NCT04675983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553298|NCT04675983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102553299|NCT04675983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102553300|NCT04675983|Immunologic Factors|immunologic factors|mesh-ancestor
102553301|NCT04675983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553302|NCT03668951|Dexmedetomidine|dexmedetomidine|mesh-list
102553303|NCT03668951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102553304|NCT03668951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102553305|NCT03668951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553306|NCT03668951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102553307|NCT03668951|Analgesics|analgesics|mesh-ancestor
102553308|NCT03668951|Sensory System Agents|sensory system agents|mesh-ancestor
102553309|NCT03668951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102553310|NCT03668951|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102553311|NCT03668951|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102553312|NCT03668951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102553313|NCT03668951|Adrenergic Agents|adrenergic agents|mesh-ancestor
102553314|NCT03668951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102553315|NCT03668951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553316|NCT04889703|Salicylic Acid|salicylic acid|mesh-list
102553317|NCT04889703|Salicylates|salicylates|mesh-list
102553318|NCT04889703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102553319|NCT04889703|Antifungal Agents|antifungal agents|mesh-ancestor
102553320|NCT04889703|Keratolytic Agents|keratolytic agents|mesh-ancestor
102553321|NCT04889703|Dermatologic Agents|dermatologic agents|mesh-ancestor
102553322|NCT04889703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102553323|NCT04889703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102553324|NCT04889703|Analgesics|analgesics|mesh-ancestor
102553325|NCT04889703|Sensory System Agents|sensory system agents|mesh-ancestor
102553326|NCT04889703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102553327|NCT04889703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553328|NCT04889703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102553329|NCT04889703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102553330|NCT04889703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102553331|NCT04889703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102553332|NCT04889703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553333|NCT00421811|Melphalan|melphalan|mesh-list
102553334|NCT00421811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102553335|NCT00421811|Alkylating Agents|alkylating agents|mesh-ancestor
102553336|NCT00421811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553337|NCT00421811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102553338|NCT00421811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102553339|NCT00421811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102553340|NCT00421811|Immunologic Factors|immunologic factors|mesh-ancestor
102553341|NCT00421811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553342|NCT03363893|Fulvestrant|fulvestrant|mesh-list
102553343|NCT03363893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102553344|NCT03363893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102553345|NCT03363893|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102553346|NCT03363893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102553347|NCT03363893|Hormone Antagonists|hormone antagonists|mesh-ancestor
102553348|NCT03363893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102553349|NCT03363893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553350|NCT01687387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102553351|NCT01706263|Salicylic Acid|salicylic acid|mesh-list
102553352|NCT01706263|Salicylates|salicylates|mesh-list
102553353|NCT01706263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102553354|NCT01706263|Antifungal Agents|antifungal agents|mesh-ancestor
102553355|NCT01706263|Keratolytic Agents|keratolytic agents|mesh-ancestor
102553356|NCT01706263|Dermatologic Agents|dermatologic agents|mesh-ancestor
102553357|NCT01706263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102553358|NCT01706263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102553359|NCT01706263|Analgesics|analgesics|mesh-ancestor
102553360|NCT01706263|Sensory System Agents|sensory system agents|mesh-ancestor
102553361|NCT01706263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102553362|NCT01706263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553363|NCT01706263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102553364|NCT01706263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102553365|NCT01706263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102553366|NCT01706263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102553367|NCT01706263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553368|NCT05738798|Immunomodulating Agents|immunomodulating agents|mesh-list
102553369|NCT05738798|Immunologic Factors|immunologic factors|mesh-ancestor
102553370|NCT05738798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553371|NCT04342247|Methyltestosterone|methyltestosterone|mesh-list
102553372|NCT04342247|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102553373|NCT04342247|Testosterone|testosterone|mesh-list
102553374|NCT04342247|Testosterone undecanoate|testosterone undecanoate|mesh-list
102553375|NCT04342247|Testosterone enanthate|testosterone enanthate|mesh-list
102553376|NCT04342247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102553377|NCT04342247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102553378|NCT04342247|Anabolic Agents|anabolic agents|mesh-ancestor
102553379|NCT04342247|Hormones|hormones|mesh-ancestor
102553380|NCT04342247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102553381|NCT04342247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553382|NCT04342247|Androgens|androgens|mesh-ancestor
102553383|NCT05738642|Thrombin|thrombin|mesh-list
102553384|NCT05738642|Hemostatics|hemostatics|mesh-ancestor
102553385|NCT05738642|Coagulants|coagulants|mesh-ancestor
102553386|NCT01690663|Dexamethasone|dexamethasone|mesh-list
102553387|NCT01690663|Bupivacaine|bupivacaine|mesh-list
102553388|NCT01690663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102553389|NCT01690663|Antiemetics|antiemetics|mesh-ancestor
102553390|NCT01690663|Autonomic Agents|autonomic agents|mesh-ancestor
102553391|NCT01690663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102553392|NCT01690663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553393|NCT01690663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102553394|NCT01690663|Glucocorticoids|glucocorticoids|mesh-ancestor
102553395|NCT01690663|Hormones|hormones|mesh-ancestor
102553396|NCT01690663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102553397|NCT01690663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102553398|NCT01690663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102553399|NCT01690663|Anesthetics, Local|anesthetics, local|mesh-ancestor
102553400|NCT01690663|Anesthetics|anesthetics|mesh-ancestor
102553401|NCT01690663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102553402|NCT01690663|Sensory System Agents|sensory system agents|mesh-ancestor
102553403|NCT05738564|Lidocaine|lidocaine|mesh-list
102553404|NCT05738564|Epinephrine|epinephrine|mesh-list
102553405|NCT05738564|Oxymetazoline|oxymetazoline|mesh-list
102553406|NCT05738564|Anesthetics, Local|anesthetics, local|mesh-ancestor
102553407|NCT05738564|Anesthetics|anesthetics|mesh-ancestor
102553408|NCT05738564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102553409|NCT05738564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553410|NCT05738564|Sensory System Agents|sensory system agents|mesh-ancestor
102553411|NCT05738564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102553412|NCT05738564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102553413|NCT05738564|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102553414|NCT05738564|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102553415|NCT05738564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102553416|NCT05738564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553417|NCT05738564|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102553418|NCT05738564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102553419|NCT05738564|Adrenergic Agents|adrenergic agents|mesh-ancestor
102553420|NCT05738564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102553421|NCT05738564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102553422|NCT05738564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102553423|NCT05738564|Autonomic Agents|autonomic agents|mesh-ancestor
102553424|NCT05738564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102553425|NCT05738564|Respiratory System Agents|respiratory system agents|mesh-ancestor
102553426|NCT05738564|Mydriatics|mydriatics|mesh-ancestor
102553427|NCT05738564|Sympathomimetics|sympathomimetics|mesh-ancestor
102553428|NCT05738564|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102553429|NCT05738564|Nasal Decongestants|nasal decongestants|mesh-ancestor
102553430|NCT05343572|Plerixafor|plerixafor|mesh-list
102553431|NCT05343572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102553432|NCT05343572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102553433|NCT05343572|Antiviral Agents|antiviral agents|mesh-ancestor
102553434|NCT05343572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102553435|NCT04350086|Dexmedetomidine|dexmedetomidine|mesh-list
102553436|NCT04350086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102553437|NCT04350086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102553438|NCT04350086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553439|NCT04350086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102553440|NCT04350086|Analgesics|analgesics|mesh-ancestor
102553441|NCT04350086|Sensory System Agents|sensory system agents|mesh-ancestor
102553442|NCT04350086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102553443|NCT04350086|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102553444|NCT04350086|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102553445|NCT04350086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102553446|NCT04350086|Adrenergic Agents|adrenergic agents|mesh-ancestor
102553447|NCT04350086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102553448|NCT04350086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553449|NCT05738408|Nicotine|nicotine|mesh-list
102553450|NCT05738408|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102553451|NCT05738408|Autonomic Agents|autonomic agents|mesh-ancestor
102553452|NCT05738408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102553453|NCT05738408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553454|NCT05738408|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102553455|NCT05738408|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102553456|NCT05738408|Cholinergic Agents|cholinergic agents|mesh-ancestor
102553457|NCT05738408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102553458|NCT05738408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553459|NCT01352117|Tenofovir|tenofovir|mesh-list
102553460|NCT01352117|Emtricitabine|emtricitabine|mesh-list
102553461|NCT01352117|Efavirenz|efavirenz|mesh-list
102553462|NCT01352117|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102553463|NCT01352117|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102553464|NCT01352117|Etoposide|etoposide|mesh-list
102553465|NCT01352117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102553466|NCT01352117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102553467|NCT01352117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102553468|NCT01352117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102553469|NCT01352117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102553470|NCT01352117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553471|NCT01352117|Antiviral Agents|antiviral agents|mesh-ancestor
102553472|NCT01352117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102553473|NCT01352117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102553474|NCT01352117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102553475|NCT01352117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102553476|NCT01352117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102553477|NCT01352117|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102553478|NCT01352117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102553479|NCT01352117|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102553480|NCT01352117|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102553481|NCT01352117|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102553482|NCT01352117|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102553483|NCT03379207|Dimercaprol|dimercaprol|mesh-list
102553484|NCT03379207|Chelating Agents|chelating agents|mesh-ancestor
102553485|NCT03379207|Sequestering Agents|sequestering agents|mesh-ancestor
102553486|NCT03379207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553487|NCT02974439|Amlodipine|amlodipine|mesh-list
102553488|NCT02974439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102553489|NCT02974439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102553490|NCT02974439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102553491|NCT02974439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553492|NCT02974439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102553493|NCT02974439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553494|NCT02974439|Vasodilator Agents|vasodilator agents|mesh-ancestor
102553495|NCT03340727|Caffeine|caffeine|mesh-list
102553496|NCT03340727|Caffeine citrate|caffeine citrate|mesh-list
102553497|NCT03340727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553498|NCT03340727|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102553499|NCT03340727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553500|NCT03340727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102553501|NCT03340727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102553502|NCT03340727|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102553503|NCT03340727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102553504|NCT03340727|Purinergic Agents|purinergic agents|mesh-ancestor
102553505|NCT03340727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102553506|NCT04612179|Sirolimus|sirolimus|mesh-list
102553507|NCT04612179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102553508|NCT04612179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102553509|NCT04612179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102553510|NCT04612179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102553511|NCT04612179|Antifungal Agents|antifungal agents|mesh-ancestor
102553512|NCT04612179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102553513|NCT04612179|Immunologic Factors|immunologic factors|mesh-ancestor
102553514|NCT04612179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553515|NCT05578820|Ganciclovir|ganciclovir|mesh-list
102553516|NCT05578820|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102553517|NCT05578820|Antiviral Agents|antiviral agents|mesh-ancestor
102553518|NCT05578820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102553519|NCT05578820|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102553520|NCT05578820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102553521|NCT05578820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553522|NCT01707043|Calcitriol|calcitriol|mesh-list
102553523|NCT01707043|Betamethasone|betamethasone|mesh-list
102553524|NCT01707043|Betamethasone Valerate|betamethasone valerate|mesh-list
102553525|NCT01707043|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102553526|NCT01707043|Betamethasone benzoate|betamethasone benzoate|mesh-list
102553527|NCT01707043|Calcipotriene|calcipotriene|mesh-list
102553528|NCT01707043|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102553529|NCT01707043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102553530|NCT01707043|Glucocorticoids|glucocorticoids|mesh-ancestor
102553531|NCT01707043|Hormones|hormones|mesh-ancestor
102553532|NCT01707043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102553533|NCT01707043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553534|NCT01707043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102553535|NCT01707043|Respiratory System Agents|respiratory system agents|mesh-ancestor
102553536|NCT01707043|Dermatologic Agents|dermatologic agents|mesh-ancestor
102553537|NCT01707043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102553538|NCT01707043|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102553539|NCT01707043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102553540|NCT01707043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553541|NCT01707043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102553542|NCT01707043|Vitamins|vitamins|mesh-ancestor
102553543|NCT01707043|Micronutrients|micronutrients|mesh-ancestor
102553544|NCT01707043|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102553545|NCT04258839|Brexpiprazole|brexpiprazole|mesh-list
102553546|NCT04258839|Serotonin Agents|serotonin agents|mesh-ancestor
102553547|NCT04258839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102553548|NCT04258839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553549|NCT04258839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553550|NCT04258839|Dopamine Agonists|dopamine agonists|mesh-ancestor
102553551|NCT04258839|Dopamine Agents|dopamine agents|mesh-ancestor
102553552|NCT01708525|Deuterium Oxide|deuterium oxide|mesh-list
102553553|NCT01708525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102553554|NCT01708525|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102553555|NCT01708525|Protective Agents|protective agents|mesh-ancestor
102553556|NCT01708525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100609|NCT01198626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102100610|NCT01198626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100611|NCT01198626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102100612|NCT01194960|Docetaxel|docetaxel|mesh-list
102100613|NCT01194960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102100614|NCT01194960|Tubulin Modulators|tubulin modulators|mesh-ancestor
102100615|NCT01194960|Antimitotic Agents|antimitotic agents|mesh-ancestor
102100616|NCT01194960|Mitosis Modulators|mitosis modulators|mesh-ancestor
102100617|NCT01194960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100618|NCT01331850|Ritonavir|ritonavir|mesh-list
102100619|NCT01331850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102100620|NCT01331850|Interferon-alpha|interferon-alpha|mesh-list
102100621|NCT01331850|Ribavirin|ribavirin|mesh-list
102100622|NCT01331850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102100623|NCT01331850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102100624|NCT01331850|Protease Inhibitors|protease inhibitors|mesh-ancestor
102100625|NCT01331850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102100626|NCT01331850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100627|NCT01331850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102100628|NCT01331850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102100629|NCT01331850|Antiviral Agents|antiviral agents|mesh-ancestor
102100630|NCT01331850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102553557|NCT03634917|Calcium, Dietary|calcium, dietary|mesh-list
102553558|NCT03634917|Acamprosate|acamprosate|mesh-list
102553559|NCT03634917|Calcium Carbonate|calcium carbonate|mesh-list
102553561|NCT03634917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102553562|NCT03634917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553563|NCT03634917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102553564|NCT03634917|Antacids|antacids|mesh-ancestor
102553565|NCT03634917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553566|NCT03634917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102553567|NCT03634917|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102553568|NCT05058872|Levonorgestrel|levonorgestrel|mesh-list
102553569|NCT05058872|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102553570|NCT05058872|Estradiol|estradiol|mesh-list
102553571|NCT05058872|Estrogens|estrogens|mesh-ancestor
102553572|NCT05058872|Hormones|hormones|mesh-ancestor
102553573|NCT05058872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102553574|NCT05058872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553575|NCT05058872|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102553576|NCT05058872|Contraceptive Agents|contraceptive agents|mesh-ancestor
102553577|NCT05058872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102553578|NCT05058872|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102553579|NCT05058872|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102553580|NCT05058872|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102553581|NCT05058872|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102553582|NCT04595565|Carboplatin|carboplatin|mesh-list
102553583|NCT04595565|Capecitabine|capecitabine|mesh-list
102553584|NCT04595565|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
102553585|NCT04595565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102553586|NCT04595565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102553587|NCT04595565|Antimetabolites|antimetabolites|mesh-ancestor
102553588|NCT04595565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553589|NCT04595565|Immunoconjugates|immunoconjugates|mesh-ancestor
102553590|NCT04595565|Immunologic Factors|immunologic factors|mesh-ancestor
102553591|NCT04595565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553592|NCT02284880|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102553593|NCT02284880|Anticonvulsants|anticonvulsants|mesh-ancestor
102553594|NCT02284880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102553595|NCT02284880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102553596|NCT02284880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102553597|NCT02284880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553598|NCT03538899|Busulfan|busulfan|mesh-list
102553599|NCT03538899|Alkylating Agents|alkylating agents|mesh-ancestor
102553600|NCT03538899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553601|NCT03538899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102553602|NCT03538899|Immunologic Factors|immunologic factors|mesh-ancestor
102553603|NCT03538899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553604|NCT03538899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102553605|NCT03538899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102553606|NCT03538899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102553607|NCT04230681|Fentanyl|fentanyl|mesh-list
102553608|NCT04230681|Hydromorphone|hydromorphone|mesh-list
102553609|NCT04230681|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102553610|NCT04230681|Narcotics|narcotics|mesh-ancestor
102553611|NCT04230681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102553612|NCT04230681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553613|NCT04230681|Analgesics|analgesics|mesh-ancestor
102553614|NCT04230681|Sensory System Agents|sensory system agents|mesh-ancestor
102553615|NCT04230681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102553616|NCT04230681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102553617|NCT04230681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102553618|NCT04230681|Anesthetics, General|anesthetics, general|mesh-ancestor
102553619|NCT04230681|Anesthetics|anesthetics|mesh-ancestor
102553620|NCT01708603|Ustekinumab|ustekinumab|mesh-list
102553621|NCT01708603|Brodalumab|brodalumab|mesh-list
102553622|NCT01708603|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102553623|NCT01708603|Dermatologic Agents|dermatologic agents|mesh-ancestor
102553624|NCT01708603|Immunologic Factors|immunologic factors|mesh-ancestor
102553625|NCT01708603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553626|NCT03523221|Dexamethasone|dexamethasone|mesh-list
102553627|NCT03523221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102553628|NCT03523221|Antiemetics|antiemetics|mesh-ancestor
102553629|NCT03523221|Autonomic Agents|autonomic agents|mesh-ancestor
102553630|NCT03523221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102553631|NCT03523221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100693|NCT05222828|Mepivacaine|mepivacaine|mesh-list
102553632|NCT03523221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102553634|NCT03523221|Hormones|hormones|mesh-ancestor
102553635|NCT03523221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102553636|NCT03523221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102553637|NCT03523221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102553638|NCT03590171|Bortezomib|bortezomib|mesh-list
102553639|NCT03590171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102553640|NCT00362765|Metformin|metformin|mesh-list
102553641|NCT00362765|Fenofibrate|fenofibrate|mesh-list
102553642|NCT00362765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102553643|NCT00362765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553644|NCT00362765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102553645|NCT00362765|Antimetabolites|antimetabolites|mesh-ancestor
102553646|NCT00362765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553647|NCT00362765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102553648|NCT03430011|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102553649|NCT03430011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102553650|NCT03543839|Belimumab|belimumab|mesh-list
102553651|NCT03543839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102553652|NCT03543839|Immunologic Factors|immunologic factors|mesh-ancestor
102553653|NCT03543839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553654|NCT04173507|Avelumab|avelumab|mesh-list
102553655|NCT04173507|Talazoparib|talazoparib|mesh-list
102553656|NCT04173507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102553657|NCT04173507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102553658|NCT04173507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101773682|NCT00990028|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102553659|NCT04173507|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102553660|NCT04173507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102553661|NCT04173507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553662|NCT04173507|Immunologic Factors|immunologic factors|mesh-ancestor
102553663|NCT04173507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553664|NCT05033756|Pembrolizumab|pembrolizumab|mesh-list
102553665|NCT05033756|Olaparib|olaparib|mesh-list
102553666|NCT05033756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102553667|NCT05033756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102553668|NCT05033756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102553669|NCT05033756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553670|NCT05033756|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102553671|NCT05033756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102553672|NCT03522077|Hemostatics|hemostatics|mesh-list
102553673|NCT03522077|Coagulants|coagulants|mesh-ancestor
102553674|NCT02980562|Bisacodyl|bisacodyl|mesh-list
102553675|NCT02980562|Cathartics|cathartics|mesh-ancestor
102553676|NCT02980562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102553677|NCT02980562|Laxatives|laxatives|mesh-ancestor
102553678|NCT03266393|Tacrolimus|tacrolimus|mesh-list
102553679|NCT03266393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102553680|NCT03266393|Immunologic Factors|immunologic factors|mesh-ancestor
102553681|NCT03266393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553682|NCT03266393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102553683|NCT03266393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102553684|NCT03266393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553685|NCT00421967|Ketorolac|ketorolac|mesh-list
102553686|NCT00421967|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102553687|NCT00421967|Epinephrine|epinephrine|mesh-list
102553688|NCT00421967|Racepinephrine|racepinephrine|mesh-list
102553689|NCT00421967|Ropivacaine|ropivacaine|mesh-list
102553690|NCT00421967|Epinephryl borate|epinephryl borate|mesh-list
102553691|NCT00421967|Anesthetics, Local|anesthetics, local|mesh-ancestor
102553692|NCT00421967|Anesthetics|anesthetics|mesh-ancestor
102553693|NCT00421967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102553694|NCT00421967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553695|NCT00421967|Sensory System Agents|sensory system agents|mesh-ancestor
102553696|NCT00421967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102553697|NCT00421967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102553698|NCT00421967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102553699|NCT00421967|Analgesics|analgesics|mesh-ancestor
102553700|NCT00421967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102553701|NCT00421967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102553702|NCT00421967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102553703|NCT00421967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102553704|NCT00421967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553705|NCT00421967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102553706|NCT00421967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102100762|NCT05370716|Pregabalin|pregabalin|mesh-list
102553708|NCT00421967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102553709|NCT00421967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102553710|NCT00421967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102553711|NCT00421967|Autonomic Agents|autonomic agents|mesh-ancestor
102553712|NCT00421967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102553713|NCT00421967|Respiratory System Agents|respiratory system agents|mesh-ancestor
102553714|NCT00421967|Mydriatics|mydriatics|mesh-ancestor
102553715|NCT00421967|Sympathomimetics|sympathomimetics|mesh-ancestor
102553716|NCT00421967|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102553717|NCT03209687|Menotropins|menotropins|mesh-list
102553718|NCT03209687|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102553719|NCT03209687|Fertility Agents|fertility agents|mesh-ancestor
102553720|NCT03209687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102553721|NCT03209687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553722|NCT04997798|Trastuzumab|trastuzumab|mesh-list
102553723|NCT04997798|Exemestane|exemestane|mesh-list
102553724|NCT04997798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102553725|NCT04997798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102553726|NCT04997798|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102553727|NCT04997798|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102553728|NCT04997798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102553729|NCT04997798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553730|NCT04997798|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102553731|NCT04997798|Hormone Antagonists|hormone antagonists|mesh-ancestor
102553732|NCT04997798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102553733|NCT04997798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553734|NCT00362531|Prednisone|prednisone|mesh-list
102553735|NCT00362531|Tacrolimus|tacrolimus|mesh-list
102553736|NCT00362531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102553737|NCT00362531|Glucocorticoids|glucocorticoids|mesh-ancestor
102553738|NCT00362531|Hormones|hormones|mesh-ancestor
102553739|NCT00362531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102553740|NCT00362531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553741|NCT00362531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102553742|NCT00362531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102553743|NCT00362531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102553744|NCT00362531|Immunologic Factors|immunologic factors|mesh-ancestor
102553745|NCT00362531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102553746|NCT00362531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102553747|NCT00362531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553748|NCT04330443|Pulmonary Surfactants|pulmonary surfactants|mesh-list
102553749|NCT04330443|Respiratory System Agents|respiratory system agents|mesh-ancestor
102553750|NCT04330677|Oxytocin|oxytocin|mesh-list
102553751|NCT04330677|Estrogens|estrogens|mesh-list
102553752|NCT04330677|Oxytocics|oxytocics|mesh-ancestor
102553753|NCT04330677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102553754|NCT04330677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553755|NCT04330677|Hormones|hormones|mesh-ancestor
102553756|NCT04330677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102553757|NCT04965116|Contraceptive Agents|contraceptive agents|mesh-list
102553758|NCT04965116|Progestins|progestins|mesh-list
102553759|NCT04965116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102553760|NCT04965116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553761|NCT04965116|Hormones|hormones|mesh-ancestor
102553762|NCT04965116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102553763|NCT05114486|Pilocarpine|pilocarpine|mesh-list
102553764|NCT05114486|Miotics|miotics|mesh-ancestor
102553765|NCT05114486|Autonomic Agents|autonomic agents|mesh-ancestor
102553766|NCT05114486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102553767|NCT05114486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553768|NCT05114486|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102553769|NCT05114486|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102553770|NCT05114486|Cholinergic Agents|cholinergic agents|mesh-ancestor
102553771|NCT05114486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102553772|NCT05114486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553773|NCT03200847|Pembrolizumab|pembrolizumab|mesh-list
102553774|NCT03200847|Tretinoin|tretinoin|mesh-list
102553775|NCT03200847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102553776|NCT03200847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102553777|NCT03200847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102553778|NCT03200847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553779|NCT03200847|Keratolytic Agents|keratolytic agents|mesh-ancestor
102553780|NCT03200847|Dermatologic Agents|dermatologic agents|mesh-ancestor
102553781|NCT02259517|Guanfacine|guanfacine|mesh-list
102553783|NCT02259517|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102553784|NCT02259517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553785|NCT02259517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102553786|NCT02259517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102553787|NCT02259517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102553788|NCT02259517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553789|NCT02259517|Dopamine Agents|dopamine agents|mesh-ancestor
102553790|NCT02259517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102553791|NCT02259517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102553792|NCT02259517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102553793|NCT02259517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102553794|NCT02259517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102553795|NCT02259517|Adrenergic Agents|adrenergic agents|mesh-ancestor
102553796|NCT04358588|Nitric Oxide|nitric oxide|mesh-list
102553797|NCT04358588|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102553798|NCT04358588|Autonomic Agents|autonomic agents|mesh-ancestor
102553799|NCT04358588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102553800|NCT04358588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553801|NCT04358588|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102553802|NCT04358588|Respiratory System Agents|respiratory system agents|mesh-ancestor
102553803|NCT04358588|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102553804|NCT04358588|Antioxidants|antioxidants|mesh-ancestor
102553805|NCT04358588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553806|NCT04358588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102553807|NCT04358588|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102553808|NCT04358588|Vasodilator Agents|vasodilator agents|mesh-ancestor
102553809|NCT04358588|Gasotransmitters|gasotransmitters|mesh-ancestor
102553810|NCT04358588|Protective Agents|protective agents|mesh-ancestor
102553811|NCT03166761|Dexamethasone|dexamethasone|mesh-list
102553812|NCT03166761|Triamcinolone|triamcinolone|mesh-list
102553813|NCT03166761|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102553814|NCT03166761|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102553815|NCT03166761|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102553816|NCT03166761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102553817|NCT03166761|Antiemetics|antiemetics|mesh-ancestor
102553818|NCT03166761|Autonomic Agents|autonomic agents|mesh-ancestor
102553819|NCT03166761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102553820|NCT03166761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553821|NCT03166761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102553822|NCT03166761|Glucocorticoids|glucocorticoids|mesh-ancestor
102553823|NCT03166761|Hormones|hormones|mesh-ancestor
102553824|NCT03166761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102553825|NCT03166761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102553826|NCT03166761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102553827|NCT03166761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102553828|NCT03166761|Immunologic Factors|immunologic factors|mesh-ancestor
102553829|NCT03166761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102553830|NCT03166761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553831|NCT04042155|Rivaroxaban|rivaroxaban|mesh-list
102553832|NCT04042155|Apixaban|apixaban|mesh-list
102553833|NCT04042155|Edoxaban|edoxaban|mesh-list
102553834|NCT04042155|Dabigatran|dabigatran|mesh-list
102553835|NCT04042155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102553836|NCT04042155|Antithrombins|antithrombins|mesh-ancestor
102553837|NCT04042155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102553838|NCT04042155|Protease Inhibitors|protease inhibitors|mesh-ancestor
102553839|NCT04042155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102553840|NCT04042155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553841|NCT04042155|Anticoagulants|anticoagulants|mesh-ancestor
102553842|NCT04195256|Dexmedetomidine|dexmedetomidine|mesh-list
102553843|NCT04195256|Ketamine|ketamine|mesh-list
102553844|NCT04195256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102553845|NCT04195256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102553846|NCT04195256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553847|NCT04195256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102553848|NCT04195256|Analgesics|analgesics|mesh-ancestor
102553849|NCT04195256|Sensory System Agents|sensory system agents|mesh-ancestor
102553850|NCT04195256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102553851|NCT04195256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102553852|NCT04195256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102553853|NCT04195256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102553854|NCT04195256|Adrenergic Agents|adrenergic agents|mesh-ancestor
102553855|NCT04195256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101773879|NCT00687440|Mitosis Modulators|mitosis modulators|mesh-ancestor
102553856|NCT04195256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553857|NCT04195256|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102553858|NCT04195256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102553859|NCT04195256|Anesthetics, General|anesthetics, general|mesh-ancestor
102553860|NCT04195256|Anesthetics|anesthetics|mesh-ancestor
102553861|NCT04195256|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102553862|NCT04195256|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102553863|NCT00002901|Docetaxel|docetaxel|mesh-list
102553864|NCT00002901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102553865|NCT00002901|Tubulin Modulators|tubulin modulators|mesh-ancestor
102553866|NCT00002901|Antimitotic Agents|antimitotic agents|mesh-ancestor
102553867|NCT00002901|Mitosis Modulators|mitosis modulators|mesh-ancestor
102553868|NCT00002901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553869|NCT00002907|Bryostatin 1|bryostatin 1|mesh-list
102553870|NCT00002907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102553871|NCT00002907|Immunologic Factors|immunologic factors|mesh-ancestor
102553872|NCT00002907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553873|NCT00002907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102553874|NCT01710787|Phenylephrine|phenylephrine|mesh-list
102553875|NCT01710787|Oxymetazoline|oxymetazoline|mesh-list
102553876|NCT01710787|Tetracaine|tetracaine|mesh-list
102553877|NCT01710787|Anesthetics, Local|anesthetics, local|mesh-ancestor
102553878|NCT01710787|Anesthetics|anesthetics|mesh-ancestor
102553879|NCT01710787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102553880|NCT01710787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553881|NCT01710787|Sensory System Agents|sensory system agents|mesh-ancestor
102553882|NCT01710787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102553883|NCT01710787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102553884|NCT01710787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102553885|NCT01710787|Adrenergic Agents|adrenergic agents|mesh-ancestor
102553886|NCT01710787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102553887|NCT01710787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553888|NCT01710787|Sympathomimetics|sympathomimetics|mesh-ancestor
102553889|NCT01710787|Autonomic Agents|autonomic agents|mesh-ancestor
102553890|NCT01710787|Nasal Decongestants|nasal decongestants|mesh-ancestor
102553891|NCT01710787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102553892|NCT01710787|Respiratory System Agents|respiratory system agents|mesh-ancestor
102553893|NCT01710787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102553894|NCT01710787|Mydriatics|mydriatics|mesh-ancestor
102553895|NCT01710787|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102553896|NCT01710787|Protective Agents|protective agents|mesh-ancestor
102553897|NCT01711177|Travoprost|travoprost|mesh-list
102553898|NCT01711177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102553899|NCT02277990|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102553900|NCT02277990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102553901|NCT01715233|Leucovorin|leucovorin|mesh-list
102553902|NCT01715233|Carboplatin|carboplatin|mesh-list
102553903|NCT01715233|Docetaxel|docetaxel|mesh-list
102553904|NCT01715233|Fluorouracil|fluorouracil|mesh-list
102553905|NCT01715233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102553906|NCT01715233|Tubulin Modulators|tubulin modulators|mesh-ancestor
102553907|NCT01715233|Antimitotic Agents|antimitotic agents|mesh-ancestor
102553908|NCT01715233|Mitosis Modulators|mitosis modulators|mesh-ancestor
102553909|NCT01715233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553910|NCT01715233|Antimetabolites|antimetabolites|mesh-ancestor
102553911|NCT01715233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102553912|NCT01715233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102553913|NCT01715233|Immunologic Factors|immunologic factors|mesh-ancestor
102553914|NCT01715233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553915|NCT01715233|Antidotes|antidotes|mesh-ancestor
102553916|NCT01715233|Protective Agents|protective agents|mesh-ancestor
102553917|NCT01715233|Vitamin B Complex|vitamin b complex|mesh-ancestor
102553918|NCT01715233|Vitamins|vitamins|mesh-ancestor
102553919|NCT01715233|Micronutrients|micronutrients|mesh-ancestor
102553920|NCT05145283|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
102553921|NCT05145283|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102553922|NCT05145283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102553923|NCT05145283|Immunologic Factors|immunologic factors|mesh-ancestor
102553924|NCT05145283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553925|NCT04826588|Methylprednisolone|methylprednisolone|mesh-list
102553926|NCT04826588|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102553927|NCT04826588|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102553928|NCT04826588|Prednisolone|prednisolone|mesh-list
102553929|NCT04826588|Prednisolone acetate|prednisolone acetate|mesh-list
102553930|NCT04826588|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102553931|NCT04826588|Prednisolone phosphate|prednisolone phosphate|mesh-list
102553932|NCT04826588|Immunoglobulins|immunoglobulins|mesh-list
102553933|NCT04826588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102553934|NCT04826588|Antiemetics|antiemetics|mesh-ancestor
102553935|NCT04826588|Autonomic Agents|autonomic agents|mesh-ancestor
102553936|NCT04826588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102553937|NCT04826588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553938|NCT04826588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102553939|NCT04826588|Glucocorticoids|glucocorticoids|mesh-ancestor
102553940|NCT04826588|Hormones|hormones|mesh-ancestor
102553941|NCT04826588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102553942|NCT04826588|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102553943|NCT04826588|Protective Agents|protective agents|mesh-ancestor
102553944|NCT04826588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102553945|NCT04826588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102553946|NCT04826588|Immunologic Factors|immunologic factors|mesh-ancestor
102553947|NCT01719367|Atenolol|atenolol|mesh-list
102553948|NCT01719367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102553949|NCT01719367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102553950|NCT01719367|Sympatholytics|sympatholytics|mesh-ancestor
102553951|NCT01719367|Autonomic Agents|autonomic agents|mesh-ancestor
102553952|NCT01719367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102553953|NCT01719367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553954|NCT01719367|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102553955|NCT01719367|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102553956|NCT01719367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102553957|NCT01719367|Adrenergic Agents|adrenergic agents|mesh-ancestor
102553958|NCT01719367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102553959|NCT01719367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553960|NCT02276040|Bupivacaine|bupivacaine|mesh-list
102553961|NCT02276040|Anesthetics, Local|anesthetics, local|mesh-ancestor
102553962|NCT02276040|Anesthetics|anesthetics|mesh-ancestor
102553963|NCT02276040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102553964|NCT02276040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553965|NCT02276040|Sensory System Agents|sensory system agents|mesh-ancestor
102553966|NCT02276040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102553967|NCT02250703|Midazolam|midazolam|mesh-list
102553968|NCT02250703|Dexmedetomidine|dexmedetomidine|mesh-list
102553969|NCT02250703|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102553970|NCT02250703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102553971|NCT02250703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553972|NCT02250703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102553973|NCT02250703|Analgesics|analgesics|mesh-ancestor
102553974|NCT02250703|Sensory System Agents|sensory system agents|mesh-ancestor
102553975|NCT02250703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102553976|NCT02250703|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102553977|NCT02250703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102553978|NCT02250703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102553979|NCT02250703|Adrenergic Agents|adrenergic agents|mesh-ancestor
102553980|NCT02250703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102553981|NCT02250703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102553982|NCT02250703|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102553983|NCT02250703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102553984|NCT02250703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102553985|NCT02250703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102553986|NCT02250703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102553987|NCT02250703|Anesthetics, General|anesthetics, general|mesh-ancestor
102553988|NCT02250703|Anesthetics|anesthetics|mesh-ancestor
102553989|NCT02250703|GABA Modulators|gaba modulators|mesh-ancestor
102553990|NCT02250703|GABA Agents|gaba agents|mesh-ancestor
102553991|NCT02314728|Misoprostol|misoprostol|mesh-list
102553992|NCT02314728|Oxytocin|oxytocin|mesh-list
102553993|NCT02314728|Oxytocics|oxytocics|mesh-ancestor
102553994|NCT02314728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102553995|NCT02314728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102553996|NCT02314728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102553997|NCT02314728|Abortifacient Agents|abortifacient agents|mesh-ancestor
102553998|NCT02314728|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102553999|NCT02314728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102554000|NCT03135860|Nitric Oxide|nitric oxide|mesh-list
102554001|NCT03135860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102554002|NCT03135860|Autonomic Agents|autonomic agents|mesh-ancestor
102554003|NCT03135860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102554004|NCT03135860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554005|NCT03135860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102554006|NCT03135860|Respiratory System Agents|respiratory system agents|mesh-ancestor
102554007|NCT03135860|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102554008|NCT03135860|Antioxidants|antioxidants|mesh-ancestor
102101064|NCT05628558|Hemostatics|hemostatics|mesh-ancestor
102554009|NCT03135860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554010|NCT03135860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102554011|NCT03135860|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102554013|NCT03135860|Gasotransmitters|gasotransmitters|mesh-ancestor
102554014|NCT03135860|Protective Agents|protective agents|mesh-ancestor
102554015|NCT02275338|Lanreotide|lanreotide|mesh-list
102554016|NCT02275338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554017|NCT01646268|Rotigotine|rotigotine|mesh-list
102554018|NCT01646268|Dopamine Agonists|dopamine agonists|mesh-ancestor
102554019|NCT01646268|Dopamine Agents|dopamine agents|mesh-ancestor
102554020|NCT01646268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102554021|NCT01646268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554022|NCT01646268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554023|NCT03988634|Valsartan|valsartan|mesh-list
102554024|NCT03988634|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102554025|NCT03988634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102554026|NCT03988634|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102554027|NCT03988634|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102554028|NCT03988634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554029|NCT02294630|Pulmonary Surfactants|pulmonary surfactants|mesh-list
102554030|NCT02294630|Respiratory System Agents|respiratory system agents|mesh-ancestor
102554031|NCT01722487|Chlorambucil|chlorambucil|mesh-list
102554032|NCT01722487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102554033|NCT01722487|Alkylating Agents|alkylating agents|mesh-ancestor
102554034|NCT01722487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554035|NCT01722487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554036|NCT02795858|Octreotide|octreotide|mesh-list
102554037|NCT02795858|Ramucirumab|ramucirumab|mesh-list
102554038|NCT02795858|Lanreotide|lanreotide|mesh-list
102554039|NCT02795858|Somatostatin|somatostatin|mesh-list
102554040|NCT02795858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102554041|NCT02795858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102554042|NCT02795858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554043|NCT02795858|Hormones|hormones|mesh-ancestor
102554044|NCT02795858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102554045|NCT02795858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554046|NCT02730962|Vancomycin|vancomycin|mesh-list
102554047|NCT02730962|Clindamycin|clindamycin|mesh-list
102554048|NCT02730962|Clindamycin palmitate|clindamycin palmitate|mesh-list
102554049|NCT02730962|Clindamycin phosphate|clindamycin phosphate|mesh-list
102554050|NCT02730962|Neomycin|neomycin|mesh-list
102554051|NCT02730962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102554052|NCT02730962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102554053|NCT02730962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102554054|NCT02730962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102554055|NCT02730962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554056|NCT02296346|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102554057|NCT02296346|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102554058|NCT02296346|Methylprednisolone|methylprednisolone|mesh-list
102554059|NCT02296346|Prednisolone|prednisolone|mesh-list
102554060|NCT02296346|Prednisolone acetate|prednisolone acetate|mesh-list
102554061|NCT02296346|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102554062|NCT02296346|Prednisolone phosphate|prednisolone phosphate|mesh-list
102554063|NCT02296346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102554064|NCT02296346|Glucocorticoids|glucocorticoids|mesh-ancestor
102554065|NCT02296346|Hormones|hormones|mesh-ancestor
102554066|NCT02296346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102554067|NCT02296346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554068|NCT02296346|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102554069|NCT02296346|Protective Agents|protective agents|mesh-ancestor
102554070|NCT02296346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102554071|NCT02296346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554072|NCT02296346|Antiemetics|antiemetics|mesh-ancestor
102554073|NCT02296346|Autonomic Agents|autonomic agents|mesh-ancestor
102554074|NCT02296346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102554075|NCT02296346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102554076|NCT01726621|Insulin|insulin|mesh-list
102554077|NCT01726621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102554078|NCT01726621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554079|NCT02372630|Linagliptin|linagliptin|mesh-list
102554080|NCT02372630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102554081|NCT02372630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554082|NCT02372630|Incretins|incretins|mesh-ancestor
102554083|NCT02372630|Hormones|hormones|mesh-ancestor
102554084|NCT02372630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102554085|NCT02372630|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102554086|NCT02372630|Protease Inhibitors|protease inhibitors|mesh-ancestor
102554087|NCT02372630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102554088|NCT02372630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554089|NCT02318654|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
102554090|NCT02318654|Anesthetics, Local|anesthetics, local|mesh-ancestor
102554091|NCT02318654|Anesthetics|anesthetics|mesh-ancestor
102554092|NCT02318654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102554093|NCT02318654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554094|NCT02318654|Sensory System Agents|sensory system agents|mesh-ancestor
102554095|NCT02318654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102554096|NCT02318654|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
102554097|NCT04349930|Cannabidiol|cannabidiol|mesh-list
102554098|NCT04349930|Anticonvulsants|anticonvulsants|mesh-ancestor
102554099|NCT02303990|Pembrolizumab|pembrolizumab|mesh-list
102554100|NCT02303990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102554101|NCT02303990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554102|NCT02303990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102554103|NCT02303990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554104|NCT01727089|Bevacizumab|bevacizumab|mesh-list
102554105|NCT01727089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102554106|NCT01727089|Endothelial Growth Factors|endothelial growth factors|mesh-list
102554107|NCT01727089|Antibodies|antibodies|mesh-list
102554108|NCT01727089|Immunoglobulins|immunoglobulins|mesh-list
102554109|NCT01727089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102554110|NCT01727089|Immunoglobulin G|immunoglobulin g|mesh-list
102554111|NCT01727089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554112|NCT01727089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102554113|NCT01727089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102554114|NCT01727089|Growth Substances|growth substances|mesh-ancestor
102554115|NCT01727089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554116|NCT01727089|Growth Inhibitors|growth inhibitors|mesh-ancestor
102554117|NCT01727089|Immunologic Factors|immunologic factors|mesh-ancestor
102554118|NCT01727791|Pregabalin|pregabalin|mesh-list
102554119|NCT01727791|Analgesics|analgesics|mesh-ancestor
102554120|NCT01727791|Sensory System Agents|sensory system agents|mesh-ancestor
102554121|NCT01727791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102554122|NCT01727791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554123|NCT01727791|Anticonvulsants|anticonvulsants|mesh-ancestor
102554124|NCT01727791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102554125|NCT01727791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102554126|NCT01727791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554127|NCT01727791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102554128|NCT01727791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102554129|NCT01727791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102554130|NCT01727791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102554131|NCT01727791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102554132|NCT01728337|Botulinum Toxins|botulinum toxins|mesh-list
102554133|NCT01728337|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102554134|NCT01728337|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102554135|NCT01728337|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102554136|NCT01728337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102554137|NCT01728337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554138|NCT01728337|Cholinergic Agents|cholinergic agents|mesh-ancestor
102554139|NCT01728337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102554140|NCT01728337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554141|NCT01728337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102554142|NCT01728337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102554143|NCT02247193|Botulinum Toxins|botulinum toxins|mesh-list
102554144|NCT02247193|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102554145|NCT02247193|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102554146|NCT02247193|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102554147|NCT02247193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102554148|NCT02247193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554149|NCT02247193|Cholinergic Agents|cholinergic agents|mesh-ancestor
102554150|NCT02247193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102554151|NCT02247193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554152|NCT02247193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102554153|NCT02247193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102554154|NCT02245087|Atorvastatin|atorvastatin|mesh-list
102101212|NCT01120470|Prednisone|prednisone|mesh-list
102554155|NCT02245087|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102554156|NCT02245087|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102554157|NCT02245087|Antimetabolites|antimetabolites|mesh-ancestor
102554158|NCT02245087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554159|NCT02245087|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101774210|NCT03827473|Vitamins|vitamins|mesh-ancestor
102554160|NCT02245087|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102554161|NCT02245087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102554162|NCT04726969|Ivermectin|ivermectin|mesh-list
102554163|NCT04726969|Albendazole|albendazole|mesh-list
102554164|NCT04726969|Moxidectin|moxidectin|mesh-list
102554165|NCT04726969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102554166|NCT04726969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102554167|NCT04726969|Anthelmintics|anthelmintics|mesh-ancestor
102554168|NCT04726969|Anticestodal Agents|anticestodal agents|mesh-ancestor
102554169|NCT04726969|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102554170|NCT04726969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102554171|NCT04726969|Tubulin Modulators|tubulin modulators|mesh-ancestor
102554172|NCT04726969|Antimitotic Agents|antimitotic agents|mesh-ancestor
102554173|NCT04726969|Mitosis Modulators|mitosis modulators|mesh-ancestor
102554174|NCT04726969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554175|NCT04726969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554176|NCT04726969|Antinematodal Agents|antinematodal agents|mesh-ancestor
102554177|NCT03174275|Paclitaxel|paclitaxel|mesh-list
102554178|NCT03174275|Carboplatin|carboplatin|mesh-list
102554179|NCT03174275|Durvalumab|durvalumab|mesh-list
102554180|NCT03174275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102554181|NCT03174275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554182|NCT03174275|Tubulin Modulators|tubulin modulators|mesh-ancestor
102554183|NCT03174275|Antimitotic Agents|antimitotic agents|mesh-ancestor
102554184|NCT03174275|Mitosis Modulators|mitosis modulators|mesh-ancestor
102554185|NCT03174275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554186|NCT03174275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102554187|NCT01731691|Protease Inhibitors|protease inhibitors|mesh-list
102554188|NCT01731691|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
102554189|NCT01731691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102554190|NCT01731691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554191|NCT01731691|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102554192|NCT01731691|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102554193|NCT02247739|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
102554194|NCT02247739|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102554195|NCT02247739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102554196|NCT02247739|Immunologic Factors|immunologic factors|mesh-ancestor
102554197|NCT02247739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554198|NCT02975141|Paclitaxel|paclitaxel|mesh-list
102554199|NCT02975141|Gemcitabine|gemcitabine|mesh-list
102554200|NCT02975141|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102554201|NCT02975141|Afatinib|afatinib|mesh-list
102554202|NCT02975141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102554203|NCT02975141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554204|NCT02975141|Tubulin Modulators|tubulin modulators|mesh-ancestor
102554205|NCT02975141|Antimitotic Agents|antimitotic agents|mesh-ancestor
102554206|NCT02975141|Mitosis Modulators|mitosis modulators|mesh-ancestor
102554207|NCT02975141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554208|NCT02975141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102554209|NCT02975141|Antimetabolites|antimetabolites|mesh-ancestor
102554210|NCT02975141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102554211|NCT02975141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102554212|NCT03452891|Simvastatin|simvastatin|mesh-list
102554213|NCT03452891|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102554214|NCT03452891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102554215|NCT03452891|Antimetabolites|antimetabolites|mesh-ancestor
102554216|NCT03452891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554217|NCT03452891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102554218|NCT03452891|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102554219|NCT03452891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102554220|NCT04341935|Linagliptin|linagliptin|mesh-list
102554221|NCT04341935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102554222|NCT04341935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554223|NCT04341935|Incretins|incretins|mesh-ancestor
102554224|NCT04341935|Hormones|hormones|mesh-ancestor
102554225|NCT04341935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102554226|NCT04341935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102554227|NCT04341935|Protease Inhibitors|protease inhibitors|mesh-ancestor
102554228|NCT04341935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102554229|NCT04341935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554230|NCT05317039|Calcium|calcium|mesh-list
102554231|NCT05317039|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102554232|NCT05317039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554233|NCT05316883|Clozapine|clozapine|mesh-list
102554234|NCT05316883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102554235|NCT05316883|Serotonin Agents|serotonin agents|mesh-ancestor
102554236|NCT05316883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102554237|NCT05316883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554238|NCT05316883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554239|NCT05316883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102554240|NCT05316883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102554241|NCT05316883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102554242|NCT05316883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102554243|NCT05316883|GABA Antagonists|gaba antagonists|mesh-ancestor
102554244|NCT05316883|GABA Agents|gaba agents|mesh-ancestor
102554245|NCT05316649|Chrysarobin|chrysarobin|mesh-list
102554246|NCT05316649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102554247|NCT05316649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102554248|NCT05316649|Analgesics|analgesics|mesh-ancestor
102554249|NCT05316649|Sensory System Agents|sensory system agents|mesh-ancestor
102554250|NCT05316649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102554251|NCT05316649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554252|NCT05316649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102554253|NCT05316649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102554254|NCT03990363|Allopurinol|allopurinol|mesh-list
102554255|NCT03990363|Verinurad|verinurad|mesh-list
102554256|NCT03990363|Antimetabolites|antimetabolites|mesh-ancestor
102554257|NCT03990363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554258|NCT03990363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102554259|NCT03990363|Gout Suppressants|gout suppressants|mesh-ancestor
102554260|NCT03990363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102554261|NCT03990363|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102554262|NCT03990363|Antioxidants|antioxidants|mesh-ancestor
102554263|NCT03990363|Protective Agents|protective agents|mesh-ancestor
102554264|NCT03990363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554265|NCT04341857|Antibodies|antibodies|mesh-list
102554266|NCT04341857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102554267|NCT04341857|Immunologic Factors|immunologic factors|mesh-ancestor
102554268|NCT04341857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554269|NCT00002913|Paclitaxel|paclitaxel|mesh-list
102554270|NCT00002913|Topotecan|topotecan|mesh-list
102554271|NCT00002913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102554272|NCT00002913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554273|NCT00002913|Tubulin Modulators|tubulin modulators|mesh-ancestor
102554274|NCT00002913|Antimitotic Agents|antimitotic agents|mesh-ancestor
102554275|NCT00002913|Mitosis Modulators|mitosis modulators|mesh-ancestor
102554276|NCT00002913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554277|NCT00002913|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102554278|NCT00002913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102554279|NCT00002913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102554280|NCT00002919|Doxorubicin|doxorubicin|mesh-list
102554281|NCT00002919|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102554282|NCT00002919|Methotrexate|methotrexate|mesh-list
102554283|NCT00002919|Vinblastine|vinblastine|mesh-list
102554284|NCT00002919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554285|NCT00002919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102554286|NCT00002919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102554287|NCT00002919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102554288|NCT00002919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102554289|NCT00002919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554290|NCT00002919|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102554291|NCT00002919|Abortifacient Agents|abortifacient agents|mesh-ancestor
102554292|NCT00002919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102554293|NCT00002919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554294|NCT00002919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102554295|NCT00002919|Antimetabolites|antimetabolites|mesh-ancestor
102554296|NCT00002919|Dermatologic Agents|dermatologic agents|mesh-ancestor
102554297|NCT00002919|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102554298|NCT00002919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102554299|NCT00002919|Immunologic Factors|immunologic factors|mesh-ancestor
102554300|NCT00002919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102554301|NCT00002919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102554302|NCT00002919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102554303|NCT00002919|Tubulin Modulators|tubulin modulators|mesh-ancestor
102554304|NCT00002919|Antimitotic Agents|antimitotic agents|mesh-ancestor
102554305|NCT00002919|Mitosis Modulators|mitosis modulators|mesh-ancestor
102554306|NCT03083405|Opipramol|opipramol|mesh-list
102554307|NCT03083405|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102554308|NCT03083405|Antidepressive Agents|antidepressive agents|mesh-ancestor
102554309|NCT03083405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102554310|NCT03083405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102554311|NCT03083405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102554312|NCT03083405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102554313|NCT03083405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554314|NCT03083405|Adrenergic Agents|adrenergic agents|mesh-ancestor
102554315|NCT03083405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102554316|NCT03083405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554317|NCT00383799|Amiodarone|amiodarone|mesh-list
102554318|NCT00383799|Procainamide|procainamide|mesh-list
102554319|NCT00383799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102554320|NCT00383799|Vasodilator Agents|vasodilator agents|mesh-ancestor
102554321|NCT00383799|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102554322|NCT00383799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102554323|NCT00383799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554324|NCT00383799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102554325|NCT00383799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102554326|NCT00383799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102554327|NCT00383799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102554328|NCT00383799|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102554329|NCT00383799|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102554330|NCT00383799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102554331|NCT00383799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102554332|NCT04635241|Heparin|heparin|mesh-list
102554333|NCT04635241|Calcium heparin|calcium heparin|mesh-list
102554334|NCT04635241|Anticoagulants|anticoagulants|mesh-ancestor
102554335|NCT04635241|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102554336|NCT04635241|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102554337|NCT04635241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554338|NCT03954483|Triazolam|triazolam|mesh-list
102554339|NCT03954483|Buspirone|buspirone|mesh-list
102554340|NCT03954483|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102554341|NCT03954483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102554342|NCT03954483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102554343|NCT03954483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554344|NCT03954483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102554345|NCT03954483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102554346|NCT03954483|Serotonin Agents|serotonin agents|mesh-ancestor
102554347|NCT03954483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102554348|NCT03954483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554349|NCT03954483|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102554350|NCT03954483|GABA Modulators|gaba modulators|mesh-ancestor
102554351|NCT03954483|GABA Agents|gaba agents|mesh-ancestor
102554352|NCT04545541|Heparin|heparin|mesh-list
102554353|NCT04545541|Calcium heparin|calcium heparin|mesh-list
102554354|NCT04545541|Anticoagulants|anticoagulants|mesh-ancestor
102554355|NCT04545541|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102554356|NCT04545541|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102554357|NCT04545541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554358|NCT00002925|Aldesleukin|aldesleukin|mesh-list
102554359|NCT00002925|Etoposide|etoposide|mesh-list
102554360|NCT00002925|Daunorubicin|daunorubicin|mesh-list
102554361|NCT00002925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102554362|NCT00002925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554363|NCT00002925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102554364|NCT00002925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102554365|NCT00002925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102554366|NCT00002925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554367|NCT00002925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102554368|NCT00002925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102554369|NCT00002925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102554370|NCT00002925|Antiviral Agents|antiviral agents|mesh-ancestor
102554371|NCT00002925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102554372|NCT00002937|Paclitaxel|paclitaxel|mesh-list
102554373|NCT00002937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102554374|NCT00002937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554375|NCT00002937|Tubulin Modulators|tubulin modulators|mesh-ancestor
102554376|NCT00002937|Antimitotic Agents|antimitotic agents|mesh-ancestor
102554377|NCT00002937|Mitosis Modulators|mitosis modulators|mesh-ancestor
102554378|NCT00002937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554379|NCT02922777|Docetaxel|docetaxel|mesh-list
102554380|NCT02922777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554382|NCT02922777|Antimitotic Agents|antimitotic agents|mesh-ancestor
102554383|NCT02922777|Mitosis Modulators|mitosis modulators|mesh-ancestor
102554384|NCT02922777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554385|NCT02918955|Cisplatin|cisplatin|mesh-list
102554386|NCT02918955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554387|NCT00002943|Cyclophosphamide|cyclophosphamide|mesh-list
102554388|NCT00002943|Carboplatin|carboplatin|mesh-list
102554389|NCT00002943|Etoposide|etoposide|mesh-list
102554390|NCT00002943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102554391|NCT00002943|Immunologic Factors|immunologic factors|mesh-ancestor
102554392|NCT00002943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554393|NCT00002943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102554394|NCT00002943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102554395|NCT00002943|Alkylating Agents|alkylating agents|mesh-ancestor
102554396|NCT00002943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554397|NCT00002943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554398|NCT00002943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102554399|NCT00002943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102554400|NCT00002943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102554401|NCT00002943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102554402|NCT00002943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102554403|NCT00002949|Paclitaxel|paclitaxel|mesh-list
102554404|NCT00002949|Vinorelbine|vinorelbine|mesh-list
102554405|NCT00002949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102554406|NCT00002949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554407|NCT00002949|Tubulin Modulators|tubulin modulators|mesh-ancestor
102554408|NCT00002949|Antimitotic Agents|antimitotic agents|mesh-ancestor
102554409|NCT00002949|Mitosis Modulators|mitosis modulators|mesh-ancestor
102554410|NCT00002949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554411|NCT05315557|Terlipressin|terlipressin|mesh-list
102554412|NCT05315557|Vasopressins|vasopressins|mesh-list
102554413|NCT05315557|Arginine Vasopressin|arginine vasopressin|mesh-list
102554414|NCT05315557|Hemostatics|hemostatics|mesh-ancestor
102554415|NCT05315557|Coagulants|coagulants|mesh-ancestor
102554416|NCT05315557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102554417|NCT05315557|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102554418|NCT05315557|Natriuretic Agents|natriuretic agents|mesh-ancestor
102554419|NCT05315557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554420|NCT05315557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102554421|NCT00002955|Leucovorin|leucovorin|mesh-list
102554422|NCT00002955|Trimetrexate|trimetrexate|mesh-list
102554423|NCT00002955|Fluorouracil|fluorouracil|mesh-list
102554424|NCT00002955|Calcium|calcium|mesh-list
102554425|NCT00002955|Levoleucovorin|levoleucovorin|mesh-list
102554426|NCT00002955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102554427|NCT00002955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554428|NCT00002955|Antimetabolites|antimetabolites|mesh-ancestor
102554429|NCT00002955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554430|NCT00002955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102554431|NCT00002955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554432|NCT00002955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102554433|NCT00002955|Immunologic Factors|immunologic factors|mesh-ancestor
102554434|NCT00002955|Antidotes|antidotes|mesh-ancestor
102554435|NCT00002955|Protective Agents|protective agents|mesh-ancestor
102554436|NCT00002955|Vitamin B Complex|vitamin b complex|mesh-ancestor
102554437|NCT00002955|Vitamins|vitamins|mesh-ancestor
102554438|NCT00002955|Micronutrients|micronutrients|mesh-ancestor
102554439|NCT00002955|Antifungal Agents|antifungal agents|mesh-ancestor
102554440|NCT00002955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102554441|NCT00002955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102554442|NCT00002955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102554443|NCT00002961|Cyclosporine|cyclosporine|mesh-list
102554444|NCT00002961|Cyclophosphamide|cyclophosphamide|mesh-list
102554445|NCT00002961|Busulfan|busulfan|mesh-list
102554446|NCT00002961|Methotrexate|methotrexate|mesh-list
102554447|NCT00002961|Etoposide|etoposide|mesh-list
102101503|NCT00805350|Serotonin Agents|serotonin agents|mesh-ancestor
102101504|NCT00805350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102101505|NCT00805350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101511|NCT03462836|Lidocaine|lidocaine|mesh-list
102101512|NCT03462836|Ketamine|ketamine|mesh-list
102101513|NCT03462836|Anesthetics, Local|anesthetics, local|mesh-ancestor
102554448|NCT00002961|Etoposide phosphate|etoposide phosphate|mesh-list
102554449|NCT00002961|Cyclosporins|cyclosporins|mesh-list
102554450|NCT00002961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102554451|NCT00002961|Immunologic Factors|immunologic factors|mesh-ancestor
102554452|NCT00002961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554453|NCT00002961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102554454|NCT00002961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102554455|NCT00002961|Alkylating Agents|alkylating agents|mesh-ancestor
102554456|NCT00002961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554457|NCT00002961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554458|NCT00002961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102554459|NCT00002961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102554460|NCT00002961|Abortifacient Agents|abortifacient agents|mesh-ancestor
102554461|NCT00002961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102554462|NCT00002961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102554463|NCT00002961|Antimetabolites|antimetabolites|mesh-ancestor
102554464|NCT00002961|Dermatologic Agents|dermatologic agents|mesh-ancestor
102554465|NCT00002961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102554466|NCT00002961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102554467|NCT00002961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102554468|NCT00002961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102554469|NCT00002961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102554470|NCT00002961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102554471|NCT00002961|Antifungal Agents|antifungal agents|mesh-ancestor
102554472|NCT00002961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102554473|NCT00002961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102554474|NCT00002967|Tamoxifen|tamoxifen|mesh-list
102554475|NCT00002967|Cyclophosphamide|cyclophosphamide|mesh-list
102554476|NCT00002967|Doxorubicin|doxorubicin|mesh-list
102554477|NCT00002967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102554478|NCT00002967|Octreotide|octreotide|mesh-list
102554479|NCT00002967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102554480|NCT00002967|Immunologic Factors|immunologic factors|mesh-ancestor
102554481|NCT00002967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554482|NCT00002967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102554483|NCT00002967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102554484|NCT00002967|Alkylating Agents|alkylating agents|mesh-ancestor
102554485|NCT00002967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554486|NCT00002967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554487|NCT00002967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102554488|NCT00002967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102554489|NCT00002967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102554490|NCT00002967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102554491|NCT00002967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102554492|NCT00002967|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102554493|NCT00002967|Hormone Antagonists|hormone antagonists|mesh-ancestor
102554494|NCT00002967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102554495|NCT00002967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102554496|NCT00002967|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102554497|NCT00002967|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102554498|NCT00002967|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102554499|NCT00002967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102554500|NCT04246177|Pembrolizumab|pembrolizumab|mesh-list
102554501|NCT04246177|Lenvatinib|lenvatinib|mesh-list
102554502|NCT04246177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102554503|NCT04246177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554504|NCT04246177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102554505|NCT04246177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554506|NCT04246177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102554507|NCT04246177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102554508|NCT00002973|Melphalan|melphalan|mesh-list
102554509|NCT00002973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102554510|NCT00002973|Alkylating Agents|alkylating agents|mesh-ancestor
102554511|NCT00002973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554512|NCT00002973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554513|NCT00002973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102554514|NCT00002973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102554515|NCT00002973|Immunologic Factors|immunologic factors|mesh-ancestor
102554516|NCT00002973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554517|NCT00002985|Doxorubicin|doxorubicin|mesh-list
102554518|NCT00002985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102554519|NCT00002985|Daunorubicin|daunorubicin|mesh-list
102554520|NCT00002985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102554521|NCT00002985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554522|NCT00002985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102554523|NCT00002985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102554524|NCT00002985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102554525|NCT00002985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554526|NCT02767557|Paclitaxel|paclitaxel|mesh-list
102554527|NCT02767557|Gemcitabine|gemcitabine|mesh-list
102554528|NCT02767557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102554529|NCT02767557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554530|NCT02767557|Tubulin Modulators|tubulin modulators|mesh-ancestor
102554531|NCT02767557|Antimitotic Agents|antimitotic agents|mesh-ancestor
102554532|NCT02767557|Mitosis Modulators|mitosis modulators|mesh-ancestor
102554533|NCT02767557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554534|NCT02767557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102554535|NCT02767557|Antimetabolites|antimetabolites|mesh-ancestor
102554536|NCT00363389|Misoprostol|misoprostol|mesh-list
102554537|NCT00363389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102554538|NCT00363389|Abortifacient Agents|abortifacient agents|mesh-ancestor
102554539|NCT00363389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102554540|NCT00363389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554541|NCT00363389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102554542|NCT00363389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102554543|NCT00363389|Oxytocics|oxytocics|mesh-ancestor
102554544|NCT03057431|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102554545|NCT03057431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102554546|NCT03057431|Diuretics|diuretics|mesh-ancestor
102554547|NCT03057431|Natriuretic Agents|natriuretic agents|mesh-ancestor
102554548|NCT03057431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554549|NCT03057431|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102554550|NCT03057431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102554551|NCT03057431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554552|NCT00003003|Mitoxantrone|mitoxantrone|mesh-list
102554553|NCT00003003|Mitomycins|mitomycins|mesh-list
102554554|NCT00003003|Mitomycin|mitomycin|mesh-list
102554555|NCT00003003|Sargramostim|sargramostim|mesh-list
102554556|NCT00003003|Immunologic Factors|immunologic factors|mesh-ancestor
102554557|NCT00003003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554558|NCT00003003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554559|NCT00003003|Analgesics|analgesics|mesh-ancestor
102554560|NCT00003003|Sensory System Agents|sensory system agents|mesh-ancestor
102554561|NCT00003003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102554562|NCT00003003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102554563|NCT00003003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102554564|NCT00003003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102554565|NCT00003003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554566|NCT00003003|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102554567|NCT00003003|Alkylating Agents|alkylating agents|mesh-ancestor
102554568|NCT00003003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102554569|NCT00003009|Aldesleukin|aldesleukin|mesh-list
102554570|NCT00003009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554571|NCT00003009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102554572|NCT00003009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102554573|NCT00003009|Antiviral Agents|antiviral agents|mesh-ancestor
102554574|NCT00003009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102554575|NCT00003015|Carboplatin|carboplatin|mesh-list
102554576|NCT00003015|Vincristine|vincristine|mesh-list
102554577|NCT00003015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554578|NCT00003015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102554579|NCT00003015|Tubulin Modulators|tubulin modulators|mesh-ancestor
102554580|NCT00003015|Antimitotic Agents|antimitotic agents|mesh-ancestor
102554581|NCT00003015|Mitosis Modulators|mitosis modulators|mesh-ancestor
102554582|NCT00003015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554583|NCT04204837|Nivolumab|nivolumab|mesh-list
102554584|NCT04204837|Relatlimab|relatlimab|mesh-list
102554585|NCT04204837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102554586|NCT04204837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554587|NCT04204837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102554588|NCT04204837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554589|NCT00003021|Bizelesin|bizelesin|mesh-list
102554590|NCT00003021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102554591|NCT00003021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554592|NCT00003021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102554593|NCT00003021|Alkylating Agents|alkylating agents|mesh-ancestor
102554594|NCT00003021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554595|NCT00003039|Alvocidib|alvocidib|mesh-list
102554596|NCT00003039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554597|NCT00003039|Growth Inhibitors|growth inhibitors|mesh-ancestor
102554598|NCT00003039|Growth Substances|growth substances|mesh-ancestor
102554599|NCT00003039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554600|NCT00003039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102554601|NCT00003039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102554602|NCT00003039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554603|NCT00383877|Insulin|insulin|mesh-list
102554604|NCT00383877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102554605|NCT00383877|Insulin Detemir|insulin detemir|mesh-list
102554606|NCT00383877|Isophane Insulin, Human|isophane insulin, human|mesh-list
102554607|NCT00383877|Insulin, Isophane|insulin, isophane|mesh-list
102554608|NCT00383877|Isophane insulin, beef|isophane insulin, beef|mesh-list
102554609|NCT00383877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102554610|NCT00383877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554611|NCT00003063|Leucovorin|leucovorin|mesh-list
102554612|NCT00003063|Interferons|interferons|mesh-list
102554613|NCT00003063|Interferon-alpha|interferon-alpha|mesh-list
102554614|NCT00003063|Levamisole|levamisole|mesh-list
102554615|NCT00003063|Fluorouracil|fluorouracil|mesh-list
102554616|NCT00003063|Calcium|calcium|mesh-list
102554617|NCT00003063|Levoleucovorin|levoleucovorin|mesh-list
102554618|NCT00003063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102554619|NCT00003063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554620|NCT00003063|Antimetabolites|antimetabolites|mesh-ancestor
102554621|NCT00003063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554622|NCT00003063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102554623|NCT00003063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554624|NCT00003063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102554625|NCT00003063|Immunologic Factors|immunologic factors|mesh-ancestor
102554626|NCT00003063|Antiviral Agents|antiviral agents|mesh-ancestor
102554627|NCT00003063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102554628|NCT00003063|Antidotes|antidotes|mesh-ancestor
102554629|NCT00003063|Protective Agents|protective agents|mesh-ancestor
102554630|NCT00003063|Vitamin B Complex|vitamin b complex|mesh-ancestor
102554631|NCT00003063|Vitamins|vitamins|mesh-ancestor
102554632|NCT00003063|Micronutrients|micronutrients|mesh-ancestor
102554633|NCT00003063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102554634|NCT00003063|Antinematodal Agents|antinematodal agents|mesh-ancestor
102554635|NCT00003063|Anthelmintics|anthelmintics|mesh-ancestor
102554636|NCT00003063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102554637|NCT00003063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102554638|NCT00003075|Fenretinide|fenretinide|mesh-list
102554639|NCT00003075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554640|NCT00003075|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102554641|NCT00003075|Protective Agents|protective agents|mesh-ancestor
102554642|NCT00003075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554643|NCT00003081|Melphalan|melphalan|mesh-list
102554644|NCT00003081|Busulfan|busulfan|mesh-list
102554645|NCT00003081|Thiotepa|thiotepa|mesh-list
102554646|NCT00003081|Immunologic Factors|immunologic factors|mesh-ancestor
102554647|NCT00003081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554648|NCT00003081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102554649|NCT00003081|Alkylating Agents|alkylating agents|mesh-ancestor
102554650|NCT00003081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554651|NCT00003081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554652|NCT00003081|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102554653|NCT00003081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102554654|NCT02348385|Amphetamine|amphetamine|mesh-list
102554655|NCT02348385|Dextroamphetamine|dextroamphetamine|mesh-list
102554656|NCT02348385|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102554657|NCT02348385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554658|NCT02348385|Sympathomimetics|sympathomimetics|mesh-ancestor
102554659|NCT02348385|Autonomic Agents|autonomic agents|mesh-ancestor
102554660|NCT02348385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102554661|NCT02348385|Dopamine Agents|dopamine agents|mesh-ancestor
102554662|NCT02348385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102554663|NCT02348385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554664|NCT02348385|Adrenergic Agents|adrenergic agents|mesh-ancestor
102554665|NCT02348385|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102554666|NCT02348385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102554667|NCT02348385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102554668|NCT02348385|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102554669|NCT00003087|Paclitaxel|paclitaxel|mesh-list
102554670|NCT00003087|Cisplatin|cisplatin|mesh-list
102554671|NCT00003087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102554672|NCT00003087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554673|NCT00003087|Tubulin Modulators|tubulin modulators|mesh-ancestor
102554674|NCT00003087|Antimitotic Agents|antimitotic agents|mesh-ancestor
102554675|NCT00003087|Mitosis Modulators|mitosis modulators|mesh-ancestor
102554676|NCT00003087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554677|NCT00003093|Cyclophosphamide|cyclophosphamide|mesh-list
102554678|NCT00003093|Carboplatin|carboplatin|mesh-list
102554679|NCT00003093|Doxorubicin|doxorubicin|mesh-list
102554680|NCT00003093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102554682|NCT00003093|Molgramostim|molgramostim|mesh-list
102554683|NCT00003093|Lenograstim|lenograstim|mesh-list
102554684|NCT00003093|Sargramostim|sargramostim|mesh-list
102554685|NCT00003093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102554686|NCT00003093|Immunologic Factors|immunologic factors|mesh-ancestor
102554687|NCT00003093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554688|NCT00003093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102554689|NCT00003093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102554690|NCT00003093|Alkylating Agents|alkylating agents|mesh-ancestor
102554691|NCT00003093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554692|NCT00003093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554693|NCT00003093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102554694|NCT00003093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102554695|NCT00003093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102554696|NCT00003093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102554697|NCT00003093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102554698|NCT00003093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102554699|NCT00003093|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102554700|NCT00003099|Tamoxifen|tamoxifen|mesh-list
102554701|NCT00003099|Fenretinide|fenretinide|mesh-list
102554702|NCT00003099|Retinamide|retinamide|mesh-list
102554703|NCT00003099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102554704|NCT00003099|Hormone Antagonists|hormone antagonists|mesh-ancestor
102554705|NCT00003099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102554706|NCT00003099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554707|NCT00003099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102554708|NCT00003099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554709|NCT00003099|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102554710|NCT00003099|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102554711|NCT00003099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102554712|NCT00003099|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102554713|NCT00003099|Protective Agents|protective agents|mesh-ancestor
102554714|NCT00003105|Paclitaxel|paclitaxel|mesh-list
102554715|NCT00003105|Gemcitabine|gemcitabine|mesh-list
102554716|NCT00003105|Doxorubicin|doxorubicin|mesh-list
102554717|NCT00003105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102554718|NCT00003105|Ifosfamide|ifosfamide|mesh-list
102554719|NCT00003105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102554720|NCT00003105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554721|NCT00003105|Tubulin Modulators|tubulin modulators|mesh-ancestor
102554722|NCT00003105|Antimitotic Agents|antimitotic agents|mesh-ancestor
102554723|NCT00003105|Mitosis Modulators|mitosis modulators|mesh-ancestor
102554724|NCT00003105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554725|NCT00003105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102554726|NCT00003105|Antimetabolites|antimetabolites|mesh-ancestor
102554727|NCT00003105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102554728|NCT00003105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102554729|NCT00003105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102554730|NCT00003105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102554731|NCT00003105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102554732|NCT00003105|Alkylating Agents|alkylating agents|mesh-ancestor
102554733|NCT00003111|Paclitaxel|paclitaxel|mesh-list
102554734|NCT00003111|Carboplatin|carboplatin|mesh-list
102554735|NCT00003111|Irinotecan|irinotecan|mesh-list
102554736|NCT00003111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102554737|NCT00003111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554738|NCT00003111|Tubulin Modulators|tubulin modulators|mesh-ancestor
102554739|NCT00003111|Antimitotic Agents|antimitotic agents|mesh-ancestor
102554740|NCT00003111|Mitosis Modulators|mitosis modulators|mesh-ancestor
102554741|NCT00003111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554742|NCT00003111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102554743|NCT00003111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102554744|NCT00003111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102554745|NCT05709301|Donepezil|donepezil|mesh-list
102554746|NCT05709301|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102554747|NCT05709301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102554748|NCT05709301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554749|NCT05709301|Cholinergic Agents|cholinergic agents|mesh-ancestor
102554750|NCT05709301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102554751|NCT05709301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554752|NCT05709301|Nootropic Agents|nootropic agents|mesh-ancestor
102101798|NCT00836004|Clindamycin|clindamycin|mesh-list
102554753|NCT00003117|Paclitaxel|paclitaxel|mesh-list
102554754|NCT00003117|Carboplatin|carboplatin|mesh-list
102554755|NCT00003117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102554756|NCT00003117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554757|NCT00003117|Tubulin Modulators|tubulin modulators|mesh-ancestor
102554758|NCT00003117|Antimitotic Agents|antimitotic agents|mesh-ancestor
102554759|NCT00003117|Mitosis Modulators|mitosis modulators|mesh-ancestor
102554760|NCT00003117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554761|NCT02240329|Capsaicin|capsaicin|mesh-list
102554762|NCT02240329|Antipruritics|antipruritics|mesh-ancestor
102554763|NCT02240329|Dermatologic Agents|dermatologic agents|mesh-ancestor
102554764|NCT02240329|Sensory System Agents|sensory system agents|mesh-ancestor
102554765|NCT02240329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102554766|NCT02240329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554767|NCT00003123|Amifostine|amifostine|mesh-list
102554768|NCT00003123|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102554769|NCT00003123|Protective Agents|protective agents|mesh-ancestor
102554770|NCT00003123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554771|NCT03981523|Benzonidazole|benzonidazole|mesh-list
102554772|NCT03981523|Nifurtimox|nifurtimox|mesh-list
102554773|NCT03981523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102554774|NCT03981523|Immunologic Factors|immunologic factors|mesh-ancestor
102554775|NCT03981523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554776|NCT03981523|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102554777|NCT03981523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102554778|NCT03981523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102554779|NCT03981523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102554780|NCT03965923|Tenofovir|tenofovir|mesh-list
102554781|NCT03965923|Emtricitabine|emtricitabine|mesh-list
102554782|NCT03965923|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102554783|NCT03965923|Dapivirine|dapivirine|mesh-list
102554784|NCT03965923|Antiviral Agents|antiviral agents|mesh-ancestor
102554785|NCT03965923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102554786|NCT03965923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102554787|NCT03965923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102554788|NCT03965923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102554789|NCT03965923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554790|NCT03965923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102554791|NCT03965923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102554792|NCT03962725|Dexmedetomidine|dexmedetomidine|mesh-list
102554793|NCT03962725|Ketamine|ketamine|mesh-list
102554794|NCT03962725|Propofol|propofol|mesh-list
102554795|NCT03962725|Anesthetics|anesthetics|mesh-list
102554796|NCT03962725|Rocuronium|rocuronium|mesh-list
102554797|NCT03962725|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
102554798|NCT03962725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102554799|NCT03962725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102554800|NCT03962725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554801|NCT03962725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102554802|NCT03962725|Analgesics|analgesics|mesh-ancestor
102554803|NCT03962725|Sensory System Agents|sensory system agents|mesh-ancestor
102554804|NCT03962725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102554805|NCT03962725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102554806|NCT03962725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102554807|NCT03962725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102554808|NCT03962725|Adrenergic Agents|adrenergic agents|mesh-ancestor
102554809|NCT03962725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102554810|NCT03962725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554811|NCT03962725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102554812|NCT03962725|Anesthetics, General|anesthetics, general|mesh-ancestor
102554813|NCT03962725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102554814|NCT03962725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102554815|NCT03962725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102554816|NCT03962725|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102554817|NCT03962725|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102554818|NCT05699473|Calcium, Dietary|calcium, dietary|mesh-list
102554819|NCT05699473|Tetrahydrofolates|tetrahydrofolates|mesh-list
102554820|NCT05699473|Calcium|calcium|mesh-list
102554821|NCT05699473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102554822|NCT05699473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554823|NCT05699473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102554824|NCT05699473|Vitamin B Complex|vitamin b complex|mesh-ancestor
102554825|NCT05699473|Vitamins|vitamins|mesh-ancestor
102554826|NCT05699473|Micronutrients|micronutrients|mesh-ancestor
102554827|NCT02210559|Paclitaxel|paclitaxel|mesh-list
102554828|NCT02210559|Gemcitabine|gemcitabine|mesh-list
102101873|NCT04356664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554829|NCT02210559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102554830|NCT02210559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554831|NCT02210559|Tubulin Modulators|tubulin modulators|mesh-ancestor
102554832|NCT02210559|Antimitotic Agents|antimitotic agents|mesh-ancestor
102554833|NCT02210559|Mitosis Modulators|mitosis modulators|mesh-ancestor
102554834|NCT02210559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554835|NCT02210559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102554836|NCT02210559|Antimetabolites|antimetabolites|mesh-ancestor
102554837|NCT00003135|Doxorubicin|doxorubicin|mesh-list
102554838|NCT00003135|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102554839|NCT00003135|Fluorouracil|fluorouracil|mesh-list
102554840|NCT00003135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102554841|NCT00003135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554842|NCT00003135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102554843|NCT00003135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102554844|NCT00003135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102554845|NCT00003135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554846|NCT00003135|Antimetabolites|antimetabolites|mesh-ancestor
102554847|NCT00003135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102554848|NCT00003135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102554849|NCT00003135|Immunologic Factors|immunologic factors|mesh-ancestor
102554850|NCT00003135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554852|NCT03439891|Sorafenib|sorafenib|mesh-list
102554853|NCT03439891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102554854|NCT03439891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554855|NCT03439891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102554856|NCT03439891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554857|NCT03439891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102554858|NCT03439891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102554859|NCT00003141|Cyclophosphamide|cyclophosphamide|mesh-list
102554860|NCT00003141|Thiotepa|thiotepa|mesh-list
102554861|NCT00003141|Cisplatin|cisplatin|mesh-list
102554862|NCT00003141|Carboplatin|carboplatin|mesh-list
102554863|NCT00003141|Etoposide|etoposide|mesh-list
102554864|NCT00003141|Vincristine|vincristine|mesh-list
102554865|NCT00003141|Lenograstim|lenograstim|mesh-list
102554866|NCT00003141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102554867|NCT00003141|Immunologic Factors|immunologic factors|mesh-ancestor
102554868|NCT00003141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554869|NCT00003141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102554870|NCT00003141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102554871|NCT00003141|Alkylating Agents|alkylating agents|mesh-ancestor
102554872|NCT00003141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554873|NCT00003141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554874|NCT00003141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102554875|NCT00003141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102554876|NCT00003141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102554877|NCT00003141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102554878|NCT00003141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102554879|NCT00003141|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102554880|NCT00003141|Tubulin Modulators|tubulin modulators|mesh-ancestor
102554881|NCT00003141|Antimitotic Agents|antimitotic agents|mesh-ancestor
102554882|NCT00003141|Mitosis Modulators|mitosis modulators|mesh-ancestor
102554883|NCT04867135|Amikacin|amikacin|mesh-list
102554884|NCT04867135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102554885|NCT04867135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102554886|NCT01740817|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102554887|NCT01740817|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102554888|NCT01740817|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102554889|NCT01740817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102554890|NCT04728217|Factor VIII|factor viii|mesh-list
102554891|NCT04728217|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
102554892|NCT04728217|Coagulants|coagulants|mesh-ancestor
102554893|NCT04728217|Immunologic Factors|immunologic factors|mesh-ancestor
102554894|NCT04728217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554895|NCT04581343|Paclitaxel|paclitaxel|mesh-list
102554896|NCT04581343|Gemcitabine|gemcitabine|mesh-list
102554897|NCT04581343|Spartalizumab|spartalizumab|mesh-list
102554898|NCT04581343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102554899|NCT04581343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554900|NCT04581343|Tubulin Modulators|tubulin modulators|mesh-ancestor
102554901|NCT04581343|Antimitotic Agents|antimitotic agents|mesh-ancestor
102554902|NCT04581343|Mitosis Modulators|mitosis modulators|mesh-ancestor
102554903|NCT04581343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554904|NCT04581343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102101948|NCT02602288|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102554905|NCT04581343|Antimetabolites|antimetabolites|mesh-ancestor
102554906|NCT04581343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102554907|NCT04581343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102554908|NCT01743859|Lenalidomide|lenalidomide|mesh-list
102554909|NCT01743859|Azacitidine|azacitidine|mesh-list
102554910|NCT01743859|Immunologic Factors|immunologic factors|mesh-ancestor
102554911|NCT01743859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554912|NCT01743859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102554913|NCT01743859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102554914|NCT01743859|Growth Substances|growth substances|mesh-ancestor
102554915|NCT01743859|Growth Inhibitors|growth inhibitors|mesh-ancestor
102554916|NCT01743859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554917|NCT01743859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102554918|NCT01743859|Antimetabolites|antimetabolites|mesh-ancestor
102554919|NCT01743859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554920|NCT01743859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102554921|NCT01746043|Minocycline|minocycline|mesh-list
102554922|NCT01746043|Modafinil|modafinil|mesh-list
102554923|NCT01746043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102554924|NCT01746043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102554925|NCT01746043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102554926|NCT01746043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554927|NCT01746043|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102554928|NCT01746043|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102554929|NCT01746043|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102554930|NCT01746043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554931|NCT05635903|Diazepam|diazepam|mesh-list
102554932|NCT05635903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102554933|NCT05635903|Anticonvulsants|anticonvulsants|mesh-ancestor
102554934|NCT05635903|Antiemetics|antiemetics|mesh-ancestor
102554935|NCT05635903|Autonomic Agents|autonomic agents|mesh-ancestor
102554936|NCT05635903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102554937|NCT05635903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554938|NCT05635903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102554939|NCT05635903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102554940|NCT05635903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102554941|NCT05635903|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102554942|NCT05635903|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102554943|NCT05635903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102554944|NCT05635903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102554945|NCT05635903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102554946|NCT05635903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102554947|NCT05635903|Anesthetics, General|anesthetics, general|mesh-ancestor
102554948|NCT05635903|Anesthetics|anesthetics|mesh-ancestor
102554949|NCT05635903|GABA Modulators|gaba modulators|mesh-ancestor
102554950|NCT05635903|GABA Agents|gaba agents|mesh-ancestor
102554951|NCT05635903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102554952|NCT05635903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554953|NCT01746511|Glycerol|glycerol|mesh-list
102554954|NCT01746511|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102554955|NCT01746511|Protective Agents|protective agents|mesh-ancestor
102554956|NCT01746511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554957|NCT01746979|Gemcitabine|gemcitabine|mesh-list
102554958|NCT01746979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102554959|NCT01746979|Antimetabolites|antimetabolites|mesh-ancestor
102554960|NCT01746979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554961|NCT01746979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554962|NCT05614453|Tislelizumab|tislelizumab|mesh-list
102554963|NCT05614453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102554964|NCT05614453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554965|NCT01754389|Sirolimus|sirolimus|mesh-list
102554966|NCT01754389|Methotrexate|methotrexate|mesh-list
102554967|NCT01754389|Bortezomib|bortezomib|mesh-list
102554968|NCT01754389|Tacrolimus|tacrolimus|mesh-list
102554969|NCT01754389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102554970|NCT01754389|Abortifacient Agents|abortifacient agents|mesh-ancestor
102554971|NCT01754389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102554972|NCT01754389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102554973|NCT01754389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102554974|NCT01754389|Antimetabolites|antimetabolites|mesh-ancestor
102554975|NCT01754389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554976|NCT01754389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554977|NCT01754389|Dermatologic Agents|dermatologic agents|mesh-ancestor
102554978|NCT01754389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102554979|NCT01754389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102554980|NCT01754389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102554981|NCT01754389|Immunologic Factors|immunologic factors|mesh-ancestor
102554982|NCT01754389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102554983|NCT01754389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102554984|NCT01754389|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102554985|NCT01754389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102554986|NCT01754389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102554987|NCT01754389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102554988|NCT01754389|Antifungal Agents|antifungal agents|mesh-ancestor
102554989|NCT01754623|Gemcitabine|gemcitabine|mesh-list
102554990|NCT01754623|Fluorouracil|fluorouracil|mesh-list
102554991|NCT01754623|Capecitabine|capecitabine|mesh-list
102554992|NCT01754623|Docetaxel|docetaxel|mesh-list
102554993|NCT01754623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102554994|NCT01754623|Antimetabolites|antimetabolites|mesh-ancestor
102554995|NCT01754623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102554996|NCT01754623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102554997|NCT01754623|Tubulin Modulators|tubulin modulators|mesh-ancestor
102554998|NCT01754623|Antimitotic Agents|antimitotic agents|mesh-ancestor
102554999|NCT01754623|Mitosis Modulators|mitosis modulators|mesh-ancestor
102555000|NCT01754623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102555001|NCT01754623|Immunologic Factors|immunologic factors|mesh-ancestor
102555002|NCT01754623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555003|NCT01755169|Ketamine|ketamine|mesh-list
102555004|NCT01755169|Analgesics|analgesics|mesh-ancestor
102555005|NCT01755169|Sensory System Agents|sensory system agents|mesh-ancestor
102555006|NCT01755169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102555007|NCT01755169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555008|NCT01755169|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102555009|NCT01755169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102555010|NCT01755169|Anesthetics, General|anesthetics, general|mesh-ancestor
102555011|NCT01755169|Anesthetics|anesthetics|mesh-ancestor
102555012|NCT01755169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102555013|NCT01755169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102555014|NCT01755169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102555015|NCT01755169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102555016|NCT01755169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555017|NCT01755949|Colchicine|colchicine|mesh-list
102555018|NCT01755949|Gout Suppressants|gout suppressants|mesh-ancestor
102555019|NCT01755949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102555020|NCT01755949|Tubulin Modulators|tubulin modulators|mesh-ancestor
102555021|NCT01755949|Antimitotic Agents|antimitotic agents|mesh-ancestor
102555022|NCT01755949|Mitosis Modulators|mitosis modulators|mesh-ancestor
102555023|NCT01755949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555024|NCT01755949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102555025|NCT01756885|Varenicline|varenicline|mesh-list
102555026|NCT01756885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102555027|NCT01756885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102555028|NCT01756885|Cholinergic Agents|cholinergic agents|mesh-ancestor
102555029|NCT01756885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102555030|NCT01756885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555031|NCT01756885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555032|NCT04172701|Cholinergic Agents|cholinergic agents|mesh-list
102555033|NCT04172701|Muscarinic Antagonists|muscarinic antagonists|mesh-list
102555034|NCT04172701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102555035|NCT04172701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555036|NCT04172701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555037|NCT04172701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102555038|NCT01760785|Valproic Acid|valproic acid|mesh-list
102555039|NCT01760785|Anticonvulsants|anticonvulsants|mesh-ancestor
102555040|NCT01760785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102555041|NCT01760785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555042|NCT01760785|GABA Agents|gaba agents|mesh-ancestor
102555043|NCT01760785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102555044|NCT01760785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555045|NCT01760785|Antimanic Agents|antimanic agents|mesh-ancestor
102555046|NCT01760785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102555047|NCT01760785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102555048|NCT01760785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102555049|NCT04062097|Vitamin K|vitamin k|mesh-list
102555050|NCT04062097|Dabigatran|dabigatran|mesh-list
102555051|NCT04062097|Vitamins|vitamins|mesh-ancestor
102555052|NCT04062097|Micronutrients|micronutrients|mesh-ancestor
102555053|NCT04062097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555054|NCT04062097|Antithrombins|antithrombins|mesh-ancestor
102555055|NCT04062097|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102555056|NCT04062097|Protease Inhibitors|protease inhibitors|mesh-ancestor
102555057|NCT04062097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102555058|NCT04062097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555059|NCT04062097|Anticoagulants|anticoagulants|mesh-ancestor
102555060|NCT04062097|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102555061|NCT04062097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102555062|NCT04062097|Hemostatics|hemostatics|mesh-ancestor
102555063|NCT04062097|Coagulants|coagulants|mesh-ancestor
102555064|NCT02241655|Anesthetics|anesthetics|mesh-list
102555065|NCT02241655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102555066|NCT02241655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555068|NCT04005079|Prednisolone|prednisolone|mesh-list
102555069|NCT04005079|Pilocarpine|pilocarpine|mesh-list
102555070|NCT04005079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102555071|NCT04005079|Glucocorticoids|glucocorticoids|mesh-ancestor
102555072|NCT04005079|Hormones|hormones|mesh-ancestor
102555073|NCT04005079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102555074|NCT04005079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555075|NCT04005079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102555076|NCT04005079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102555077|NCT04005079|Autonomic Agents|autonomic agents|mesh-ancestor
102555078|NCT04005079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102555079|NCT04005079|Miotics|miotics|mesh-ancestor
102555080|NCT04005079|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102555081|NCT04005079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102555082|NCT04005079|Cholinergic Agents|cholinergic agents|mesh-ancestor
102555083|NCT04005079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102555084|NCT04005079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555085|NCT04005079|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102555086|NCT04005079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102555087|NCT04005079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102555088|NCT04005079|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102555089|NCT04005079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102555090|NCT04005079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102555091|NCT04005079|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102555092|NCT04005079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102555093|NCT01762501|Amlodipine|amlodipine|mesh-list
102555094|NCT01762501|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
102555095|NCT01762501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102555096|NCT01762501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102555097|NCT01762501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102555098|NCT01762501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555099|NCT01762501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102555100|NCT01762501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555101|NCT01762501|Vasodilator Agents|vasodilator agents|mesh-ancestor
102555102|NCT01762501|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102555103|NCT01762501|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102555104|NCT01764607|Sirolimus|sirolimus|mesh-list
102555105|NCT01764607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102555106|NCT01764607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102555107|NCT01764607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102555108|NCT01764607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102555109|NCT01764607|Antifungal Agents|antifungal agents|mesh-ancestor
102555110|NCT01764607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102555111|NCT01764607|Immunologic Factors|immunologic factors|mesh-ancestor
102555112|NCT01764607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555113|NCT01764685|Topiramate|topiramate|mesh-list
101775153|NCT00805662|Oxytocin|oxytocin|mesh-list
102555114|NCT01764685|Anticonvulsants|anticonvulsants|mesh-ancestor
102555115|NCT01764685|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102555116|NCT01764685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555117|NCT05115409|Rituximab|rituximab|mesh-list
102555118|NCT05115409|Antibodies|antibodies|mesh-list
102555119|NCT05115409|Immunologic Factors|immunologic factors|mesh-ancestor
102555120|NCT05115409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555121|NCT05115409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102555122|NCT05115409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102555123|NCT05115409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102555124|NCT01766713|Ezetimibe|ezetimibe|mesh-list
102555125|NCT01766713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102555126|NCT01766713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102555127|NCT01766713|Antimetabolites|antimetabolites|mesh-ancestor
102555128|NCT01766713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555129|NCT01766713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102555130|NCT01767103|Deferiprone|deferiprone|mesh-list
102555131|NCT01767103|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102555133|NCT01767103|Sequestering Agents|sequestering agents|mesh-ancestor
102555134|NCT01767103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555135|NCT01769209|Cytarabine|cytarabine|mesh-list
102555136|NCT01769209|Dexamethasone|dexamethasone|mesh-list
102555137|NCT01769209|Doxorubicin|doxorubicin|mesh-list
102555138|NCT01769209|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102555139|NCT01769209|Methotrexate|methotrexate|mesh-list
102555140|NCT01769209|Vincristine|vincristine|mesh-list
102555141|NCT01769209|Bortezomib|bortezomib|mesh-list
102555142|NCT01769209|Asparaginase|asparaginase|mesh-list
102555143|NCT01769209|Pegaspargase|pegaspargase|mesh-list
102555144|NCT01769209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102555145|NCT01769209|Antiemetics|antiemetics|mesh-ancestor
102555146|NCT01769209|Autonomic Agents|autonomic agents|mesh-ancestor
102555147|NCT01769209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102555148|NCT01769209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555149|NCT01769209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102555150|NCT01769209|Glucocorticoids|glucocorticoids|mesh-ancestor
102555151|NCT01769209|Hormones|hormones|mesh-ancestor
102555152|NCT01769209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102555153|NCT01769209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102555154|NCT01769209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102555155|NCT01769209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102555156|NCT01769209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102555157|NCT01769209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102555158|NCT01769209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102555159|NCT01769209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555160|NCT01769209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102555161|NCT01769209|Abortifacient Agents|abortifacient agents|mesh-ancestor
102555162|NCT01769209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102555163|NCT01769209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102555164|NCT01769209|Antimetabolites|antimetabolites|mesh-ancestor
102555165|NCT01769209|Dermatologic Agents|dermatologic agents|mesh-ancestor
102555166|NCT01769209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102555167|NCT01769209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102555168|NCT01769209|Immunologic Factors|immunologic factors|mesh-ancestor
102555169|NCT01769209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102555170|NCT01769209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102555171|NCT01769209|Antiviral Agents|antiviral agents|mesh-ancestor
102555172|NCT01769209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102555173|NCT01769209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102555174|NCT01769209|Tubulin Modulators|tubulin modulators|mesh-ancestor
102555175|NCT01769209|Antimitotic Agents|antimitotic agents|mesh-ancestor
102555176|NCT01769209|Mitosis Modulators|mitosis modulators|mesh-ancestor
102555177|NCT01769365|Amoxicillin|amoxicillin|mesh-list
102555178|NCT01769365|Metronidazole|metronidazole|mesh-list
102555179|NCT01769365|Clarithromycin|clarithromycin|mesh-list
102555180|NCT01769365|Pantoprazole|pantoprazole|mesh-list
102555181|NCT01769365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102555182|NCT01769365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102555183|NCT01769365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102555184|NCT01769365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102555185|NCT01769365|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102555186|NCT01769365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102555187|NCT01769365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555188|NCT01769365|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102555189|NCT01769365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102555190|NCT01769365|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102555191|NCT01769365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102555192|NCT01769365|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102555193|NCT01771627|Nicotine|nicotine|mesh-list
102555194|NCT01771627|Varenicline|varenicline|mesh-list
102555195|NCT01771627|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102555196|NCT01771627|Autonomic Agents|autonomic agents|mesh-ancestor
102555197|NCT01771627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102555198|NCT01771627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555199|NCT01771627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102555200|NCT01771627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102555201|NCT01771627|Cholinergic Agents|cholinergic agents|mesh-ancestor
102555202|NCT01771627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102555203|NCT01771627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555204|NCT03749629|Psychotropic Drugs|psychotropic drugs|mesh-list
102555205|NCT03682393|Hydrocortisone|hydrocortisone|mesh-list
102555206|NCT03682393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102555207|NCT03499483|Tenofovir|tenofovir|mesh-list
102555208|NCT03499483|Emtricitabine|emtricitabine|mesh-list
102555209|NCT03499483|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
102555210|NCT03499483|Antiviral Agents|antiviral agents|mesh-ancestor
102555211|NCT03499483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102555212|NCT03499483|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102555213|NCT03499483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102555214|NCT03499483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102555215|NCT03499483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555216|NCT03499483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102555217|NCT03499483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102555218|NCT04350931|BCG Vaccine|bcg vaccine|mesh-list
102555219|NCT04350931|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102555220|NCT04350931|Immunologic Factors|immunologic factors|mesh-ancestor
102555221|NCT04350931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555222|NCT01673867|Docetaxel|docetaxel|mesh-list
102555223|NCT01673867|Nivolumab|nivolumab|mesh-list
102555224|NCT01673867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102555225|NCT01673867|Tubulin Modulators|tubulin modulators|mesh-ancestor
102555226|NCT01673867|Antimitotic Agents|antimitotic agents|mesh-ancestor
102555227|NCT01673867|Mitosis Modulators|mitosis modulators|mesh-ancestor
102555228|NCT01673867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555229|NCT01673867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102555230|NCT01673867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102555231|NCT01777945|Docetaxel|docetaxel|mesh-list
102555232|NCT01777945|Capecitabine|capecitabine|mesh-list
102555233|NCT01777945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102555234|NCT01777945|Tubulin Modulators|tubulin modulators|mesh-ancestor
102555235|NCT01777945|Antimitotic Agents|antimitotic agents|mesh-ancestor
102555236|NCT01777945|Mitosis Modulators|mitosis modulators|mesh-ancestor
102555237|NCT01777945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555238|NCT01777945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102555239|NCT01777945|Antimetabolites|antimetabolites|mesh-ancestor
102555240|NCT03012581|Nivolumab|nivolumab|mesh-list
102555241|NCT03012581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102555242|NCT03012581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102555243|NCT03012581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102555244|NCT03012581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555245|NCT05451043|Paclitaxel|paclitaxel|mesh-list
102555246|NCT05451043|Gemcitabine|gemcitabine|mesh-list
102555247|NCT05451043|Durvalumab|durvalumab|mesh-list
102555248|NCT05451043|Tremelimumab|tremelimumab|mesh-list
102555249|NCT05451043|Propranolol|propranolol|mesh-list
102555250|NCT05451043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102555251|NCT05451043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102555252|NCT05451043|Tubulin Modulators|tubulin modulators|mesh-ancestor
102555253|NCT05451043|Antimitotic Agents|antimitotic agents|mesh-ancestor
102555254|NCT05451043|Mitosis Modulators|mitosis modulators|mesh-ancestor
102555255|NCT05451043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555256|NCT05451043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102555257|NCT05451043|Antimetabolites|antimetabolites|mesh-ancestor
102555258|NCT05451043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102555259|NCT05451043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102555260|NCT05451043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102555261|NCT05451043|Adrenergic Agents|adrenergic agents|mesh-ancestor
102555262|NCT05451043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102555263|NCT05451043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555264|NCT05451043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102555265|NCT05451043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102555266|NCT05451043|Vasodilator Agents|vasodilator agents|mesh-ancestor
102555267|NCT02652169|Amikacin|amikacin|mesh-list
102555268|NCT02652169|Teicoplanin|teicoplanin|mesh-list
102555269|NCT02652169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102555270|NCT02652169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102555271|NCT02478775|Cetrorelix|cetrorelix|mesh-list
102555272|NCT02478775|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102555273|NCT02478775|Fertility Agents|fertility agents|mesh-ancestor
102555274|NCT02478775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102555275|NCT02478775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555276|NCT02478775|Hormone Antagonists|hormone antagonists|mesh-ancestor
102555277|NCT02478775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102555278|NCT01783561|Caffeine|caffeine|mesh-list
102555279|NCT01783561|Caffeine citrate|caffeine citrate|mesh-list
102555280|NCT01783561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555281|NCT01783561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102555282|NCT01783561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102322|NCT05016518|Propofol|propofol|mesh-list
102555283|NCT01783561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102555284|NCT01783561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102555285|NCT01783561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102555286|NCT01783561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102555287|NCT01783561|Purinergic Agents|purinergic agents|mesh-ancestor
102555288|NCT01783561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102555290|NCT02452931|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102555291|NCT02452931|Fertility Agents|fertility agents|mesh-ancestor
102555292|NCT02452931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102555293|NCT02452931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555294|NCT02452931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102555295|NCT02452931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102555296|NCT04744727|Acetaminophen|acetaminophen|mesh-list
102555297|NCT04744727|Meperidine|meperidine|mesh-list
102555298|NCT04744727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102555299|NCT04744727|Analgesics|analgesics|mesh-ancestor
102555300|NCT04744727|Sensory System Agents|sensory system agents|mesh-ancestor
102555301|NCT04744727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102555302|NCT04744727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555303|NCT04744727|Antipyretics|antipyretics|mesh-ancestor
102555304|NCT04744727|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102555305|NCT04744727|Narcotics|narcotics|mesh-ancestor
102555306|NCT04744727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102555307|NCT04744727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102555308|NCT02454179|Pembrolizumab|pembrolizumab|mesh-list
102555309|NCT02454179|Acalabrutinib|acalabrutinib|mesh-list
102555310|NCT02454179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102555311|NCT02454179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102555312|NCT02454179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102555313|NCT02454179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555314|NCT02041533|Paclitaxel|paclitaxel|mesh-list
102555315|NCT02041533|Carboplatin|carboplatin|mesh-list
102555316|NCT02041533|Gemcitabine|gemcitabine|mesh-list
102555317|NCT02041533|Nivolumab|nivolumab|mesh-list
102555318|NCT02041533|Pemetrexed|pemetrexed|mesh-list
102555319|NCT02041533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102555320|NCT02041533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102555321|NCT02041533|Tubulin Modulators|tubulin modulators|mesh-ancestor
102555322|NCT02041533|Antimitotic Agents|antimitotic agents|mesh-ancestor
102555323|NCT02041533|Mitosis Modulators|mitosis modulators|mesh-ancestor
102555324|NCT02041533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555325|NCT02041533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102555326|NCT02041533|Antimetabolites|antimetabolites|mesh-ancestor
102555327|NCT02041533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102555328|NCT02041533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102555329|NCT02041533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102555330|NCT02041533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102555331|NCT02041533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102555332|NCT02260531|Trastuzumab|trastuzumab|mesh-list
102555333|NCT02260531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102555334|NCT02260531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102555335|NCT02458235|Azacitidine|azacitidine|mesh-list
102555336|NCT02458235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102555337|NCT02458235|Antimetabolites|antimetabolites|mesh-ancestor
102555338|NCT02458235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555339|NCT02458235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102555340|NCT02458235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102555341|NCT02115997|Prednisone|prednisone|mesh-list
102555342|NCT02115997|Methylprednisolone|methylprednisolone|mesh-list
102555343|NCT02115997|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102555344|NCT02115997|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102555345|NCT02115997|Prednisolone|prednisolone|mesh-list
102555346|NCT02115997|Prednisolone acetate|prednisolone acetate|mesh-list
102555347|NCT02115997|Rituximab|rituximab|mesh-list
102555348|NCT02115997|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102555349|NCT02115997|Prednisolone phosphate|prednisolone phosphate|mesh-list
102555350|NCT02115997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102555351|NCT02115997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102555352|NCT02115997|Immunologic Factors|immunologic factors|mesh-ancestor
102555353|NCT02115997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555354|NCT02115997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102555355|NCT02115997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102555356|NCT02115997|Glucocorticoids|glucocorticoids|mesh-ancestor
102555357|NCT02115997|Hormones|hormones|mesh-ancestor
102555358|NCT02115997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102555359|NCT02115997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102555360|NCT02115997|Antiemetics|antiemetics|mesh-ancestor
102555361|NCT02115997|Autonomic Agents|autonomic agents|mesh-ancestor
102555362|NCT02115997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102555363|NCT02115997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102555364|NCT02115997|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102555365|NCT02115997|Protective Agents|protective agents|mesh-ancestor
102555366|NCT01805323|Dexamethasone|dexamethasone|mesh-list
102555367|NCT01805323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102555368|NCT01805323|Antiemetics|antiemetics|mesh-ancestor
102555369|NCT01805323|Autonomic Agents|autonomic agents|mesh-ancestor
102555370|NCT01805323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101575205|NCT02749747|Sulpiride|sulpiride|mesh-list
102555371|NCT01805323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555372|NCT01805323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102555373|NCT01805323|Glucocorticoids|glucocorticoids|mesh-ancestor
102555374|NCT01805323|Hormones|hormones|mesh-ancestor
102555375|NCT01805323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102555376|NCT01805323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102555377|NCT01805323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102555378|NCT01641055|Caseins|caseins|mesh-list
102555379|NCT01641055|Chelating Agents|chelating agents|mesh-ancestor
102555380|NCT01641055|Sequestering Agents|sequestering agents|mesh-ancestor
102555381|NCT01641055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555382|NCT01788631|Regadenoson|regadenoson|mesh-list
102555383|NCT01788631|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
102555384|NCT01788631|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102555385|NCT01788631|Purinergic Agonists|purinergic agonists|mesh-ancestor
102555386|NCT01788631|Purinergic Agents|purinergic agents|mesh-ancestor
102555387|NCT01788631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102555388|NCT01788631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555389|NCT01788631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555390|NCT00907283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102555391|NCT00907283|Deferiprone|deferiprone|mesh-list
102555392|NCT00907283|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102555393|NCT00907283|Chelating Agents|chelating agents|mesh-ancestor
102555394|NCT00907283|Sequestering Agents|sequestering agents|mesh-ancestor
102555395|NCT00907283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555396|NCT01789255|Cyclosporine|cyclosporine|mesh-list
102555397|NCT01789255|Methotrexate|methotrexate|mesh-list
102555398|NCT01789255|Vorinostat|vorinostat|mesh-list
102555399|NCT01789255|Tacrolimus|tacrolimus|mesh-list
102555400|NCT01789255|Cyclosporins|cyclosporins|mesh-list
102555401|NCT01789255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102555402|NCT01789255|Abortifacient Agents|abortifacient agents|mesh-ancestor
102555403|NCT01789255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102555404|NCT01789255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555405|NCT01789255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102555406|NCT01789255|Antimetabolites|antimetabolites|mesh-ancestor
102555407|NCT01789255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555408|NCT01789255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102555409|NCT01789255|Dermatologic Agents|dermatologic agents|mesh-ancestor
102555410|NCT01789255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102555411|NCT01789255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102555412|NCT01789255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102555413|NCT01789255|Immunologic Factors|immunologic factors|mesh-ancestor
102555414|NCT01789255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102555415|NCT01789255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102555416|NCT01789255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102555417|NCT01789255|Antifungal Agents|antifungal agents|mesh-ancestor
102555418|NCT01789255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102555419|NCT01789255|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102555420|NCT02464163|Hemagglutinins|hemagglutinins|mesh-list
102555421|NCT02464163|Agglutinins|agglutinins|mesh-ancestor
102555422|NCT02464163|Immunologic Factors|immunologic factors|mesh-ancestor
102555423|NCT02464163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555424|NCT02464163|Coagulants|coagulants|mesh-ancestor
102555425|NCT01808755|Trimethoprim|trimethoprim|mesh-list
102555426|NCT01808755|Sulfamethoxazole|sulfamethoxazole|mesh-list
102555427|NCT01808755|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102555428|NCT01808755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102555429|NCT01808755|Antimalarials|antimalarials|mesh-ancestor
102555430|NCT01808755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102555431|NCT01808755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102555432|NCT01808755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102555433|NCT01808755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102555434|NCT01808755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555435|NCT01808755|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102555436|NCT01808755|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102555437|NCT01808755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102555439|NCT02694809|Estrogens|estrogens|mesh-list
102555440|NCT02694809|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
102555441|NCT02694809|Hormones|hormones|mesh-ancestor
102555442|NCT02694809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102555443|NCT02694809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555444|NCT02694809|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102555445|NCT02694809|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102555446|NCT02694809|Hormone Antagonists|hormone antagonists|mesh-ancestor
102555447|NCT02694809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102555448|NCT00568997|Pimecrolimus|pimecrolimus|mesh-list
102555449|NCT00568997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102555450|NCT00568997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102555451|NCT00568997|Analgesics|analgesics|mesh-ancestor
102555452|NCT00568997|Sensory System Agents|sensory system agents|mesh-ancestor
102555453|NCT00568997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102555454|NCT00568997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555455|NCT00568997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102555456|NCT00568997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102555457|NCT00568997|Dermatologic Agents|dermatologic agents|mesh-ancestor
102555458|NCT00568997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102555459|NCT00568997|Immunologic Factors|immunologic factors|mesh-ancestor
102555460|NCT00568997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102555461|NCT00568997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102555462|NCT00568997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555463|NCT00362687|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102555464|NCT00362687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102555465|NCT00362687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102555466|NCT00362687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102555467|NCT00362687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555468|NCT00362687|Antiviral Agents|antiviral agents|mesh-ancestor
102555469|NCT00362687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102555470|NCT00362687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102555471|NCT00362687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102555472|NCT01790659|Gentamicins|gentamicins|mesh-list
102555473|NCT01790659|Paromomycin|paromomycin|mesh-list
102555474|NCT01790659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102555475|NCT01790659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102555476|NCT01790659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102555477|NCT01790659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102555478|NCT01790659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555479|NCT01790659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102555480|NCT01790659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102555481|NCT02469701|Nivolumab|nivolumab|mesh-list
102555482|NCT02469701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102555483|NCT02469701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102555484|NCT02469701|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102555485|NCT02469701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555486|NCT01733953|Atorvastatin|atorvastatin|mesh-list
102555487|NCT01733953|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102555488|NCT01733953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102555489|NCT01733953|Antimetabolites|antimetabolites|mesh-ancestor
102555490|NCT01733953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555491|NCT01733953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102555492|NCT01733953|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102555493|NCT01733953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102555494|NCT00362921|Carmustine|carmustine|mesh-list
102555495|NCT00362921|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
102555496|NCT00362921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102555497|NCT00362921|Alkylating Agents|alkylating agents|mesh-ancestor
102555498|NCT00362921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575312|NCT01015833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102555499|NCT00362921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102555500|NCT00362921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102555501|NCT01734889|Nitisinone|nitisinone|mesh-list
102555502|NCT01734889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102555503|NCT01734889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555504|NCT01736527|Loteprednol Etabonate|loteprednol etabonate|mesh-list
102555505|NCT01736527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102555506|NCT01796665|Clindamycin|clindamycin|mesh-list
102555507|NCT01796665|Clindamycin palmitate|clindamycin palmitate|mesh-list
102555508|NCT01796665|Clindamycin phosphate|clindamycin phosphate|mesh-list
102555509|NCT01796665|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102555510|NCT01796665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102555511|NCT01796665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102555512|NCT01796665|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102555513|NCT01796665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102555514|NCT01796665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555515|NCT01796665|Dermatologic Agents|dermatologic agents|mesh-ancestor
102555516|NCT01798225|Doxycycline|doxycycline|mesh-list
102555517|NCT01798225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102555518|NCT01798225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102555519|NCT01798225|Antimalarials|antimalarials|mesh-ancestor
102555520|NCT01798225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102555521|NCT01798225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102555522|NCT01800877|Phenylephrine|phenylephrine|mesh-list
102555524|NCT01800877|Vasopressins|vasopressins|mesh-list
102555525|NCT01800877|Epinephrine|epinephrine|mesh-list
102555526|NCT01800877|Norepinephrine|norepinephrine|mesh-list
102555527|NCT01800877|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
102555528|NCT01800877|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102555529|NCT01800877|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102555530|NCT01800877|Adrenergic Agents|adrenergic agents|mesh-ancestor
102555531|NCT01800877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102555532|NCT01800877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555533|NCT01800877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555534|NCT01800877|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102555535|NCT01800877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102555536|NCT01800877|Autonomic Agents|autonomic agents|mesh-ancestor
102555537|NCT01800877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102555538|NCT01800877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102555539|NCT01800877|Respiratory System Agents|respiratory system agents|mesh-ancestor
102555540|NCT01800877|Mydriatics|mydriatics|mesh-ancestor
102555541|NCT01800877|Sympathomimetics|sympathomimetics|mesh-ancestor
102555542|NCT01800877|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102555543|NCT01800877|Nasal Decongestants|nasal decongestants|mesh-ancestor
102555544|NCT01800877|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102555545|NCT01800877|Protective Agents|protective agents|mesh-ancestor
102555546|NCT01800877|Hemostatics|hemostatics|mesh-ancestor
102555547|NCT01800877|Coagulants|coagulants|mesh-ancestor
102555548|NCT01800877|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102555549|NCT01800877|Natriuretic Agents|natriuretic agents|mesh-ancestor
102555550|NCT01800877|Dopamine Agents|dopamine agents|mesh-ancestor
102555551|NCT02471651|Dexamethasone|dexamethasone|mesh-list
102555552|NCT02471651|Ranibizumab|ranibizumab|mesh-list
102555553|NCT02471651|Aflibercept|aflibercept|mesh-list
102555554|NCT02471651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102555555|NCT02471651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102555556|NCT02471651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102555557|NCT02471651|Growth Substances|growth substances|mesh-ancestor
102555558|NCT02471651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555559|NCT02471651|Growth Inhibitors|growth inhibitors|mesh-ancestor
102555560|NCT02471651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102555561|NCT02471651|Antiemetics|antiemetics|mesh-ancestor
102555562|NCT02471651|Autonomic Agents|autonomic agents|mesh-ancestor
102555563|NCT02471651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102555564|NCT02471651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102555565|NCT02471651|Glucocorticoids|glucocorticoids|mesh-ancestor
102555566|NCT02471651|Hormones|hormones|mesh-ancestor
102555567|NCT02471651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102555568|NCT02471651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102555569|NCT02477423|Gentamicins|gentamicins|mesh-list
102555570|NCT02477423|Ampicillin|ampicillin|mesh-list
102555571|NCT02477423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102555572|NCT02477423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102555573|NCT02477423|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102555574|NCT02477423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102555575|NCT02477423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555576|NCT00363701|Esomeprazole|esomeprazole|mesh-list
102555577|NCT00363701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102555578|NCT00363701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102154351|NCT03365115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102555579|NCT00363701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102555580|NCT00363701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102555581|NCT00363701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555582|NCT04744571|Aspirin|aspirin|mesh-list
102555583|NCT04744571|Metoprolol|metoprolol|mesh-list
102555584|NCT04744571|Clopidogrel|clopidogrel|mesh-list
102555585|NCT04744571|Ticagrelor|ticagrelor|mesh-list
102555586|NCT04744571|Atorvastatin|atorvastatin|mesh-list
102555587|NCT04744571|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102555588|NCT04744571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102555589|NCT04744571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102555590|NCT04744571|Analgesics|analgesics|mesh-ancestor
102555591|NCT04744571|Sensory System Agents|sensory system agents|mesh-ancestor
102555592|NCT04744571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102555593|NCT04744571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555594|NCT04744571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102555595|NCT04744571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102555596|NCT04744571|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102555597|NCT04744571|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102555598|NCT04744571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555599|NCT04744571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102555600|NCT04744571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102555601|NCT04744571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102555602|NCT04744571|Antipyretics|antipyretics|mesh-ancestor
102555603|NCT04744571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102555604|NCT04744571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102555605|NCT04744571|Antimetabolites|antimetabolites|mesh-ancestor
102555606|NCT04744571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102555607|NCT04744571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102555608|NCT04744571|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102555609|NCT04744571|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102555610|NCT04744571|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102555611|NCT04744571|Purinergic Agents|purinergic agents|mesh-ancestor
102555612|NCT04744571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102555613|NCT04744571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102555614|NCT04744571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102555615|NCT04744571|Sympatholytics|sympatholytics|mesh-ancestor
102555616|NCT04744571|Autonomic Agents|autonomic agents|mesh-ancestor
102555617|NCT04744571|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102555618|NCT04744571|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102555619|NCT04744571|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102555620|NCT04744571|Adrenergic Agents|adrenergic agents|mesh-ancestor
102555621|NCT00363155|KRN 7000|krn 7000|mesh-list
102555622|NCT00363155|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102555623|NCT00363155|Immunologic Factors|immunologic factors|mesh-ancestor
102555624|NCT00363155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555625|NCT00363155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102555626|NCT02519387|Buprenorphine|buprenorphine|mesh-list
102555627|NCT02519387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102555628|NCT02519387|Narcotics|narcotics|mesh-ancestor
102555629|NCT02519387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102555630|NCT02519387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555631|NCT02519387|Analgesics|analgesics|mesh-ancestor
102555632|NCT02519387|Sensory System Agents|sensory system agents|mesh-ancestor
102555633|NCT02519387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102555634|NCT02519387|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102555635|NCT02257957|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102555636|NCT02257957|Hyaluronic Acid|hyaluronic acid|mesh-list
102555637|NCT02257957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102555638|NCT02257957|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102555639|NCT02257957|Immunologic Factors|immunologic factors|mesh-ancestor
102555640|NCT02257957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555641|NCT02257957|Viscosupplements|viscosupplements|mesh-ancestor
102555642|NCT02257957|Protective Agents|protective agents|mesh-ancestor
102555643|NCT02524769|Estrogens|estrogens|mesh-list
102555644|NCT02524769|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
102555645|NCT02524769|Hormones|hormones|mesh-ancestor
102555646|NCT02524769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102555647|NCT02524769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555648|NCT02525549|Adapalene|adapalene|mesh-list
102555649|NCT02525549|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102555650|NCT02525549|Dermatologic Agents|dermatologic agents|mesh-ancestor
102555651|NCT02525549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102555652|NCT02525549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102555653|NCT02525549|Analgesics|analgesics|mesh-ancestor
102555654|NCT02525549|Sensory System Agents|sensory system agents|mesh-ancestor
102555655|NCT02525549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102555656|NCT02525549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555657|NCT02525549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102555658|NCT02525549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102555659|NCT01878799|Sofosbuvir|sofosbuvir|mesh-list
102555660|NCT01878799|Ledipasvir|ledipasvir|mesh-list
102555661|NCT01878799|Antiviral Agents|antiviral agents|mesh-ancestor
102555662|NCT01878799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102555663|NCT02527265|Insulin|insulin|mesh-list
102555664|NCT02527265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102555665|NCT02527265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555666|NCT01879345|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102555667|NCT01879345|Anticonvulsants|anticonvulsants|mesh-ancestor
102555668|NCT01879345|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102555669|NCT01879345|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102555670|NCT01879345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102555671|NCT01879345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555672|NCT01804075|Morphine|morphine|mesh-list
102555673|NCT01804075|Methadone|methadone|mesh-list
102555674|NCT01804075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102555675|NCT01804075|Narcotics|narcotics|mesh-ancestor
102555676|NCT01804075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102555677|NCT01804075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555678|NCT01804075|Analgesics|analgesics|mesh-ancestor
102555679|NCT01804075|Sensory System Agents|sensory system agents|mesh-ancestor
102555680|NCT01804075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102555681|NCT01804075|Antitussive Agents|antitussive agents|mesh-ancestor
102555682|NCT01804075|Respiratory System Agents|respiratory system agents|mesh-ancestor
102555683|NCT02416193|Vitamin D|vitamin d|mesh-list
102555684|NCT02416193|Ergocalciferols|ergocalciferols|mesh-list
102555685|NCT02416193|Cholecalciferol|cholecalciferol|mesh-list
102555686|NCT02416193|Vitamins|vitamins|mesh-list
102555687|NCT02416193|Micronutrients|micronutrients|mesh-ancestor
102555688|NCT02416193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555689|NCT02416193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102555690|NCT02416193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102555691|NCT02530151|Clonidine|clonidine|mesh-list
102555692|NCT02530151|Morphine|morphine|mesh-list
102555693|NCT02530151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102555694|NCT02530151|Narcotics|narcotics|mesh-ancestor
102555695|NCT02530151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102555696|NCT02530151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555697|NCT02530151|Analgesics|analgesics|mesh-ancestor
102555698|NCT02530151|Sensory System Agents|sensory system agents|mesh-ancestor
102555699|NCT02530151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102555700|NCT02530151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102555701|NCT02530151|Sympatholytics|sympatholytics|mesh-ancestor
102555702|NCT02530151|Autonomic Agents|autonomic agents|mesh-ancestor
102555703|NCT02530151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102555704|NCT02530151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102555705|NCT02530151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102555706|NCT02530151|Adrenergic Agents|adrenergic agents|mesh-ancestor
102555707|NCT02530151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102555708|NCT02530151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555709|NCT02530541|Chlorhexidine|chlorhexidine|mesh-list
102555710|NCT02530541|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102555711|NCT02530541|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102555712|NCT02530541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102555713|NCT02530541|Disinfectants|disinfectants|mesh-ancestor
102555714|NCT02530541|Dermatologic Agents|dermatologic agents|mesh-ancestor
102555715|NCT01804465|Ipilimumab|ipilimumab|mesh-list
102555716|NCT01804465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102555717|NCT01804465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102555718|NCT01804465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102555719|NCT01804465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555720|NCT02531321|Levonorgestrel|levonorgestrel|mesh-list
102555721|NCT02531321|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102555722|NCT02531321|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
102555723|NCT02531321|Estradiol|estradiol|mesh-list
102555724|NCT02531321|Estrogens|estrogens|mesh-ancestor
102555725|NCT02531321|Hormones|hormones|mesh-ancestor
102555726|NCT02531321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102555727|NCT02531321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555728|NCT02531321|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102555729|NCT02531321|Contraceptive Agents|contraceptive agents|mesh-ancestor
102555730|NCT02531321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102555731|NCT02531321|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102555732|NCT02531321|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102555733|NCT02531321|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102555734|NCT02531321|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102555735|NCT02531321|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102555736|NCT01805089|Melatonin|melatonin|mesh-list
102555737|NCT01805089|Antioxidants|antioxidants|mesh-ancestor
102555738|NCT01805089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555739|NCT01805089|Protective Agents|protective agents|mesh-ancestor
102555740|NCT01805089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555741|NCT01805089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102555742|NCT02417129|Rituximab|rituximab|mesh-list
102555743|NCT02417129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102555744|NCT02417129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102555745|NCT02417129|Immunologic Factors|immunologic factors|mesh-ancestor
102555746|NCT02417129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555747|NCT02417129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102555748|NCT01879735|Cholylsarcosine|cholylsarcosine|mesh-list
102555749|NCT01879735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102555750|NCT02417831|Tamsulosin|tamsulosin|mesh-list
102555751|NCT02417831|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102555752|NCT02417831|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102555753|NCT02417831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102555754|NCT02417831|Adrenergic Agents|adrenergic agents|mesh-ancestor
102555755|NCT02417831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102555756|NCT02417831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555757|NCT02417831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555758|NCT02417831|Urological Agents|urological agents|mesh-ancestor
102555759|NCT02419547|Fentanyl|fentanyl|mesh-list
102555760|NCT02419547|Midazolam|midazolam|mesh-list
102555761|NCT02419547|Propofol|propofol|mesh-list
102555762|NCT02419547|Sevoflurane|sevoflurane|mesh-list
102555763|NCT02419547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102555764|NCT02419547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102555765|NCT02419547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555766|NCT02419547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102555767|NCT02419547|Anesthetics, General|anesthetics, general|mesh-ancestor
102555768|NCT02419547|Anesthetics|anesthetics|mesh-ancestor
102555769|NCT02419547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102555770|NCT02419547|Narcotics|narcotics|mesh-ancestor
102555771|NCT02419547|Analgesics|analgesics|mesh-ancestor
102555772|NCT02419547|Sensory System Agents|sensory system agents|mesh-ancestor
102555773|NCT02419547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102555774|NCT02419547|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102555775|NCT02419547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102555776|NCT02419547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102555777|NCT02419547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102555778|NCT02419547|GABA Modulators|gaba modulators|mesh-ancestor
102555779|NCT02419547|GABA Agents|gaba agents|mesh-ancestor
102555780|NCT02419547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102555781|NCT02419547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555782|NCT02419547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102555783|NCT02419547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102555784|NCT02533427|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102555785|NCT02533427|Norgestimate|norgestimate|mesh-list
102555786|NCT02533427|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102555787|NCT02533427|Estradiol|estradiol|mesh-list
102555788|NCT02533427|Estrogens|estrogens|mesh-ancestor
102555789|NCT02533427|Hormones|hormones|mesh-ancestor
102555790|NCT02533427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102555791|NCT02533427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555792|NCT02533427|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102555793|NCT02533427|Contraceptive Agents|contraceptive agents|mesh-ancestor
102555794|NCT02533427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102555795|NCT02533427|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102555796|NCT02533427|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102555797|NCT02533427|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102555798|NCT02533427|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102555799|NCT02533427|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102555800|NCT05328817|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102555801|NCT05328817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102555802|NCT05328817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102555803|NCT05328817|Antitubercular Agents|antitubercular agents|mesh-ancestor
102555804|NCT05328427|Tin Fluorides|tin fluorides|mesh-list
102555805|NCT05328427|Cariostatic Agents|cariostatic agents|mesh-ancestor
102555806|NCT05328427|Protective Agents|protective agents|mesh-ancestor
102555807|NCT05328427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555808|NCT02533505|Budesonide|budesonide|mesh-list
102555809|NCT02533505|Formoterol Fumarate|formoterol fumarate|mesh-list
102555810|NCT02533505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102555811|NCT02533505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102555812|NCT02533505|Autonomic Agents|autonomic agents|mesh-ancestor
102555813|NCT02533505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102555814|NCT02533505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555815|NCT02533505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102555816|NCT02533505|Respiratory System Agents|respiratory system agents|mesh-ancestor
102555817|NCT02533505|Glucocorticoids|glucocorticoids|mesh-ancestor
102555818|NCT02533505|Hormones|hormones|mesh-ancestor
102555819|NCT02533505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102555820|NCT02533505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102555821|NCT02533505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102555822|NCT02533505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102555823|NCT02533505|Adrenergic Agents|adrenergic agents|mesh-ancestor
102555824|NCT02533505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102555825|NCT02533505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555826|NCT02420015|Bupropion|bupropion|mesh-list
102555827|NCT02420015|Nicotine|nicotine|mesh-list
102555828|NCT02420015|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102555829|NCT02420015|Autonomic Agents|autonomic agents|mesh-ancestor
102555830|NCT02420015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102555831|NCT02420015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555832|NCT02420015|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102555833|NCT02420015|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102555834|NCT02420015|Cholinergic Agents|cholinergic agents|mesh-ancestor
102555835|NCT02420015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102555836|NCT02420015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555837|NCT02420015|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102555838|NCT02420015|Antidepressive Agents|antidepressive agents|mesh-ancestor
102555839|NCT02420015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102555840|NCT02420015|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102555841|NCT02420015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102555842|NCT02420015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102555843|NCT02420015|Dopamine Agents|dopamine agents|mesh-ancestor
102555844|NCT02420015|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102555845|NCT02420015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102555846|NCT02420015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102555847|NCT05326867|Lidocaine|lidocaine|mesh-list
102555848|NCT05326867|Anesthetics, Local|anesthetics, local|mesh-ancestor
102555849|NCT05326867|Anesthetics|anesthetics|mesh-ancestor
102555850|NCT05326867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102555851|NCT05326867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555852|NCT05326867|Sensory System Agents|sensory system agents|mesh-ancestor
102555853|NCT05326867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102555854|NCT05326867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102555855|NCT05326867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102555856|NCT05326867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102555857|NCT05326867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102555858|NCT05326867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555859|NCT05324995|Celecoxib|celecoxib|mesh-list
102555860|NCT05324995|Epinephrine|epinephrine|mesh-list
102555861|NCT05324995|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102555862|NCT05324995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102555863|NCT05324995|Adrenergic Agents|adrenergic agents|mesh-ancestor
102555864|NCT05324995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102555865|NCT05324995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555866|NCT05324995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555867|NCT05324995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102555868|NCT05324995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102555869|NCT05324995|Autonomic Agents|autonomic agents|mesh-ancestor
102555870|NCT05324995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102555871|NCT05324995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102555872|NCT05324995|Respiratory System Agents|respiratory system agents|mesh-ancestor
102555873|NCT05324995|Mydriatics|mydriatics|mesh-ancestor
102555874|NCT05324995|Sympathomimetics|sympathomimetics|mesh-ancestor
102555875|NCT05324995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102555876|NCT05324995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102555877|NCT05324995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102555878|NCT05324995|Analgesics|analgesics|mesh-ancestor
102555879|NCT05324995|Sensory System Agents|sensory system agents|mesh-ancestor
102555880|NCT05324995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102555881|NCT05324995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102555882|NCT05324995|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102555883|NCT05324995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102555884|NCT05324995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102555885|NCT05318521|Ibuprofen|ibuprofen|mesh-list
102555886|NCT05318521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102555887|NCT05318521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102555888|NCT05318521|Analgesics|analgesics|mesh-ancestor
102555889|NCT05318521|Sensory System Agents|sensory system agents|mesh-ancestor
102555890|NCT05318521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102555891|NCT05318521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555892|NCT05318521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102555893|NCT05318521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102555894|NCT05318521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102555895|NCT05318521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102555896|NCT05318521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555897|NCT02420873|Maytansine|maytansine|mesh-list
102555898|NCT02420873|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
102555899|NCT02420873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102555900|NCT02420873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102555901|NCT02420873|Tubulin Modulators|tubulin modulators|mesh-ancestor
102555902|NCT02420873|Antimitotic Agents|antimitotic agents|mesh-ancestor
102555903|NCT02420873|Mitosis Modulators|mitosis modulators|mesh-ancestor
102555904|NCT02420873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555905|NCT02420873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102555906|NCT02420873|Immunotoxins|immunotoxins|mesh-ancestor
102555907|NCT02420873|Immunoconjugates|immunoconjugates|mesh-ancestor
102555908|NCT02420873|Immunologic Factors|immunologic factors|mesh-ancestor
102555909|NCT02420873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555910|NCT02534129|Petrolatum|petrolatum|mesh-list
102555911|NCT02534129|Emollients|emollients|mesh-ancestor
102555912|NCT02534129|Dermatologic Agents|dermatologic agents|mesh-ancestor
102555913|NCT02420951|Bupivacaine|bupivacaine|mesh-list
102555914|NCT02420951|Anesthetics, Local|anesthetics, local|mesh-ancestor
102555915|NCT02420951|Anesthetics|anesthetics|mesh-ancestor
102555916|NCT02420951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102555917|NCT02420951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555918|NCT02420951|Sensory System Agents|sensory system agents|mesh-ancestor
102555919|NCT02420951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102555920|NCT02267083|Doxorubicin|doxorubicin|mesh-list
102555921|NCT02267083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102555922|NCT02267083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102555923|NCT02267083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102555924|NCT02267083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102555925|NCT02267083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102555926|NCT02267083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555927|NCT05748145|Metronidazole|metronidazole|mesh-list
102555928|NCT05748145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102555929|NCT05748145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102555930|NCT05748145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102555931|NCT05748145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102555932|NCT02535611|Memantine|memantine|mesh-list
102555933|NCT02535611|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102555934|NCT02535611|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102555935|NCT02535611|Dopamine Agents|dopamine agents|mesh-ancestor
102555936|NCT02535611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102555937|NCT02535611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555938|NCT02535611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555939|NCT02535611|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102555940|NCT02535611|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102555941|NCT01823497|Morphine|morphine|mesh-list
102555942|NCT01823497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102555943|NCT01823497|Narcotics|narcotics|mesh-ancestor
102555944|NCT01823497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102555945|NCT01823497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555946|NCT01823497|Analgesics|analgesics|mesh-ancestor
102555947|NCT01823497|Sensory System Agents|sensory system agents|mesh-ancestor
102555948|NCT01823497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102555949|NCT00363935|Dexmedetomidine|dexmedetomidine|mesh-list
102555950|NCT00363935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102555951|NCT00363935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102555952|NCT00363935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555953|NCT00363935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102555954|NCT00363935|Analgesics|analgesics|mesh-ancestor
102555955|NCT00363935|Sensory System Agents|sensory system agents|mesh-ancestor
102555956|NCT00363935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102555957|NCT00363935|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102555958|NCT00363935|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102555959|NCT00363935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102555961|NCT00363935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102555962|NCT00363935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555963|NCT05747521|Doxorubicin|doxorubicin|mesh-list
102555964|NCT05747521|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102555965|NCT05747521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102555966|NCT05747521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102555967|NCT05747521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102555968|NCT05747521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102555969|NCT05747521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102555970|NCT05747521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555971|NCT02537873|Cocaine|cocaine|mesh-list
102555972|NCT02537873|Anesthetics, Local|anesthetics, local|mesh-ancestor
102555973|NCT02537873|Anesthetics|anesthetics|mesh-ancestor
102555974|NCT02537873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102555975|NCT02537873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555976|NCT02537873|Sensory System Agents|sensory system agents|mesh-ancestor
102555977|NCT02537873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102555978|NCT02537873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102555979|NCT02537873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102555980|NCT02537873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102555981|NCT02537873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102555982|NCT02537873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102555983|NCT02537873|Dopamine Agents|dopamine agents|mesh-ancestor
102555984|NCT02537873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102555985|NCT02537951|Lidocaine|lidocaine|mesh-list
102555986|NCT02537951|Prilocaine|prilocaine|mesh-list
102555987|NCT02537951|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
102555988|NCT02537951|Capsaicin|capsaicin|mesh-list
102555989|NCT02537951|Anesthetics, Local|anesthetics, local|mesh-ancestor
102555990|NCT02537951|Anesthetics|anesthetics|mesh-ancestor
102555991|NCT02537951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102555992|NCT02537951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102555993|NCT02537951|Sensory System Agents|sensory system agents|mesh-ancestor
102555994|NCT02537951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102555995|NCT02537951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102555996|NCT02537951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102555997|NCT02537951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102555998|NCT02537951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102555999|NCT02537951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556000|NCT02537951|Antipruritics|antipruritics|mesh-ancestor
102556001|NCT02537951|Dermatologic Agents|dermatologic agents|mesh-ancestor
102556002|NCT02537951|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
102556003|NCT02487485|Sirolimus|sirolimus|mesh-list
102556004|NCT02487485|Ketamine|ketamine|mesh-list
102556005|NCT02487485|Analgesics|analgesics|mesh-ancestor
102556006|NCT02487485|Sensory System Agents|sensory system agents|mesh-ancestor
102556007|NCT02487485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102556008|NCT02487485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556009|NCT02487485|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102556010|NCT02487485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102556011|NCT02487485|Anesthetics, General|anesthetics, general|mesh-ancestor
102556012|NCT02487485|Anesthetics|anesthetics|mesh-ancestor
102556013|NCT02487485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102556014|NCT02487485|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102556015|NCT02487485|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102556016|NCT02487485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102556017|NCT02487485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556018|NCT02487485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102556019|NCT02487485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102556020|NCT02487485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102556021|NCT02487485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102556022|NCT02487485|Antifungal Agents|antifungal agents|mesh-ancestor
102556023|NCT02487485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102556024|NCT02487485|Immunologic Factors|immunologic factors|mesh-ancestor
102556025|NCT02487563|Decitabine|decitabine|mesh-list
102556026|NCT02487563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102556027|NCT02487563|Antimetabolites|antimetabolites|mesh-ancestor
102556028|NCT02487563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556029|NCT02487563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102556030|NCT02487563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102556031|NCT02427737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
101863237|NCT00292370|Serotonin Agents|serotonin agents|mesh-ancestor
102556032|NCT02427737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102556033|NCT02427737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556035|NCT02489357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102556036|NCT02489357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102556037|NCT02489357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102556038|NCT02489357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556039|NCT02490293|Cephalosporins|cephalosporins|mesh-list
102556040|NCT02490293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102556041|NCT02490293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102556042|NCT02539511|Ketamine|ketamine|mesh-list
102556043|NCT02539511|Analgesics|analgesics|mesh-ancestor
102556044|NCT02539511|Sensory System Agents|sensory system agents|mesh-ancestor
102556045|NCT02539511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102556046|NCT02539511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556047|NCT02539511|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102556048|NCT02539511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102556049|NCT02539511|Anesthetics, General|anesthetics, general|mesh-ancestor
102556050|NCT02539511|Anesthetics|anesthetics|mesh-ancestor
102556051|NCT02539511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102556052|NCT02539511|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102556053|NCT02539511|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102556054|NCT02539511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102556055|NCT02539511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556056|NCT02493257|Ethanol|ethanol|mesh-list
102556057|NCT02493257|Capsaicin|capsaicin|mesh-list
102556058|NCT02493257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102556059|NCT02493257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102556060|NCT02493257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102556061|NCT02493257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556062|NCT02493257|Antipruritics|antipruritics|mesh-ancestor
102556063|NCT02493257|Dermatologic Agents|dermatologic agents|mesh-ancestor
102556064|NCT02493257|Sensory System Agents|sensory system agents|mesh-ancestor
102556065|NCT02493257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102556066|NCT02430389|Remifentanil|remifentanil|mesh-list
102556067|NCT02430389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102556068|NCT02430389|Narcotics|narcotics|mesh-ancestor
102556069|NCT02430389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102556070|NCT02430389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556071|NCT02430389|Analgesics|analgesics|mesh-ancestor
102556072|NCT02430389|Sensory System Agents|sensory system agents|mesh-ancestor
102556073|NCT02430389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102556074|NCT02431637|Piperaquine|piperaquine|mesh-list
102556075|NCT02431637|Antimalarials|antimalarials|mesh-ancestor
102556076|NCT02431637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102556077|NCT02431637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102556078|NCT02431637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102556079|NCT02545907|Thalidomide|thalidomide|mesh-list
102556080|NCT02545907|Dexamethasone|dexamethasone|mesh-list
102556081|NCT02545907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102556082|NCT02545907|Antiemetics|antiemetics|mesh-ancestor
102556083|NCT02545907|Autonomic Agents|autonomic agents|mesh-ancestor
102556084|NCT02545907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102556085|NCT02545907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556086|NCT02545907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102556087|NCT02545907|Glucocorticoids|glucocorticoids|mesh-ancestor
102556088|NCT02545907|Hormones|hormones|mesh-ancestor
102556089|NCT02545907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102556090|NCT02545907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102556091|NCT02545907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102556092|NCT02545907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102556093|NCT02545907|Immunologic Factors|immunologic factors|mesh-ancestor
102556094|NCT02545907|Leprostatic Agents|leprostatic agents|mesh-ancestor
102556095|NCT02545907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102556096|NCT02545907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102556097|NCT02545907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102556098|NCT02545907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102556099|NCT02545907|Growth Substances|growth substances|mesh-ancestor
102556100|NCT02545907|Growth Inhibitors|growth inhibitors|mesh-ancestor
102556101|NCT02495831|Diclofenac|diclofenac|mesh-list
102556102|NCT02495831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102556103|NCT02495831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102556104|NCT02495831|Analgesics|analgesics|mesh-ancestor
102556105|NCT02495831|Sensory System Agents|sensory system agents|mesh-ancestor
102556106|NCT02495831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102556107|NCT02495831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556108|NCT02495831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102556109|NCT02495831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102556110|NCT02495831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102556111|NCT02495831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102556112|NCT02495831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556113|NCT02498483|Acetaminophen|acetaminophen|mesh-list
102556114|NCT02498483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102556115|NCT02498483|Analgesics|analgesics|mesh-ancestor
102556116|NCT02498483|Sensory System Agents|sensory system agents|mesh-ancestor
102556117|NCT02498483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102556118|NCT02498483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556119|NCT02498483|Antipyretics|antipyretics|mesh-ancestor
102556120|NCT02547623|Dexamethasone|dexamethasone|mesh-list
102556121|NCT02547623|Prednisolone|prednisolone|mesh-list
102556122|NCT02547623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102556123|NCT02547623|Antiemetics|antiemetics|mesh-ancestor
102556124|NCT02547623|Autonomic Agents|autonomic agents|mesh-ancestor
102556125|NCT02547623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102556126|NCT02547623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556127|NCT02547623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102556128|NCT02547623|Glucocorticoids|glucocorticoids|mesh-ancestor
102556129|NCT02547623|Hormones|hormones|mesh-ancestor
102556130|NCT02547623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102556131|NCT02547623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102556132|NCT02547623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102556133|NCT02547779|Plasma-lyte 148|plasma-lyte 148|mesh-list
102556134|NCT02547779|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102556135|NCT02547779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102556136|NCT00559585|Abatacept|abatacept|mesh-list
102556137|NCT00559585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102556138|NCT00559585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556139|NCT00559585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102556140|NCT00559585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102556141|NCT00559585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102556142|NCT00559585|Immunologic Factors|immunologic factors|mesh-ancestor
102556143|NCT00559585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556144|NCT00559585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102556145|NCT01824901|Docetaxel|docetaxel|mesh-list
102556146|NCT01824901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102556147|NCT01824901|Tubulin Modulators|tubulin modulators|mesh-ancestor
102556148|NCT01824901|Antimitotic Agents|antimitotic agents|mesh-ancestor
102556149|NCT01824901|Mitosis Modulators|mitosis modulators|mesh-ancestor
102556150|NCT01824901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556151|NCT00559507|Saracatinib|saracatinib|mesh-list
102556152|NCT00559507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102556153|NCT00559507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102556154|NCT00559507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556155|NCT04969627|Metformin|metformin|mesh-list
102556156|NCT04969627|Exenatide|exenatide|mesh-list
102556157|NCT04969627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102556158|NCT04969627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556159|NCT04969627|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102556160|NCT04969627|Incretins|incretins|mesh-ancestor
102556161|NCT04969627|Hormones|hormones|mesh-ancestor
102556162|NCT04969627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102556163|NCT04953325|Vaccines|vaccines|mesh-list
102556164|NCT04953325|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102556165|NCT04953325|Immunologic Factors|immunologic factors|mesh-ancestor
102556166|NCT04953325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556167|NCT01826851|Bupivacaine|bupivacaine|mesh-list
102556168|NCT01826851|Anesthetics, Local|anesthetics, local|mesh-ancestor
102556169|NCT01826851|Anesthetics|anesthetics|mesh-ancestor
102556170|NCT01826851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102556171|NCT01826851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556172|NCT01826851|Sensory System Agents|sensory system agents|mesh-ancestor
102556173|NCT01826851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102556174|NCT02499497|Androgens|androgens|mesh-list
102556175|NCT02499497|Hormones|hormones|mesh-ancestor
102556176|NCT02499497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102556177|NCT02499497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556178|NCT01827475|Acetaminophen|acetaminophen|mesh-list
102556179|NCT01827475|Ibuprofen|ibuprofen|mesh-list
102556180|NCT01827475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102556181|NCT01827475|Analgesics|analgesics|mesh-ancestor
102556182|NCT01827475|Sensory System Agents|sensory system agents|mesh-ancestor
102556183|NCT01827475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102556184|NCT01827475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556185|NCT01827475|Antipyretics|antipyretics|mesh-ancestor
102556186|NCT01827475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102556187|NCT01827475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102556188|NCT01827475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102556189|NCT01827475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102556190|NCT01827475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102556191|NCT01827475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556192|NCT02434523|Amitriptyline|amitriptyline|mesh-list
102556193|NCT02434523|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102556194|NCT02434523|Antidepressive Agents|antidepressive agents|mesh-ancestor
102556195|NCT02434523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102556196|NCT02434523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102556197|NCT02434523|Analgesics|analgesics|mesh-ancestor
102556198|NCT02434523|Sensory System Agents|sensory system agents|mesh-ancestor
102556199|NCT02434523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102556200|NCT02434523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556201|NCT02434523|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102556202|NCT02434523|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102556203|NCT02434523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102556204|NCT02434523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556205|NCT02434523|Adrenergic Agents|adrenergic agents|mesh-ancestor
102556206|NCT02434523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102556207|NCT02501135|Bupivacaine|bupivacaine|mesh-list
102556208|NCT02501135|Ropivacaine|ropivacaine|mesh-list
102556209|NCT02501135|Anesthetics, Local|anesthetics, local|mesh-ancestor
102556210|NCT02501135|Anesthetics|anesthetics|mesh-ancestor
102556211|NCT02501135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102556212|NCT02501135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556213|NCT02501135|Sensory System Agents|sensory system agents|mesh-ancestor
102556214|NCT02501135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102556215|NCT02550743|Capecitabine|capecitabine|mesh-list
102556216|NCT02550743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102556217|NCT02550743|Antimetabolites|antimetabolites|mesh-ancestor
102556218|NCT02550743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556219|NCT02550743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102556220|NCT02437253|Adalimumab|adalimumab|mesh-list
102556221|NCT02437253|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102556222|NCT02437253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102556223|NCT02437253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102556224|NCT01829503|Cytarabine|cytarabine|mesh-list
102556225|NCT01829503|Decitabine|decitabine|mesh-list
102556226|NCT01829503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102556227|NCT01829503|Antimetabolites|antimetabolites|mesh-ancestor
102556228|NCT01829503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556229|NCT01829503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102556230|NCT01829503|Antiviral Agents|antiviral agents|mesh-ancestor
102556231|NCT01829503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102556232|NCT01829503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102556233|NCT01829503|Immunologic Factors|immunologic factors|mesh-ancestor
102556234|NCT01829503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556235|NCT01829503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102556236|NCT05742763|Acetaminophen|acetaminophen|mesh-list
102556237|NCT05742763|Ibuprofen|ibuprofen|mesh-list
102556238|NCT05742763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102556239|NCT05742763|Analgesics|analgesics|mesh-ancestor
102556240|NCT05742763|Sensory System Agents|sensory system agents|mesh-ancestor
102556241|NCT05742763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102556242|NCT05742763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556243|NCT05742763|Antipyretics|antipyretics|mesh-ancestor
102556244|NCT05742763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102556245|NCT05742763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102556246|NCT05742763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102556247|NCT05742763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102556248|NCT05742763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102556249|NCT05742763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556250|NCT02504723|Carvedilol|carvedilol|mesh-list
102556251|NCT02504723|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102556252|NCT02504723|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102556253|NCT02504723|Adrenergic Agents|adrenergic agents|mesh-ancestor
102556254|NCT02504723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102556255|NCT02504723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556256|NCT02504723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556257|NCT02504723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102556258|NCT02504723|Antioxidants|antioxidants|mesh-ancestor
102556259|NCT02504723|Protective Agents|protective agents|mesh-ancestor
102556260|NCT02504723|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102556261|NCT02504723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102556262|NCT02504723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102556263|NCT02504723|Vasodilator Agents|vasodilator agents|mesh-ancestor
102556264|NCT02504723|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102556265|NCT02504723|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102556266|NCT02439281|Clonidine|clonidine|mesh-list
102556267|NCT02439281|Ropivacaine|ropivacaine|mesh-list
102556268|NCT02439281|Anesthetics, Local|anesthetics, local|mesh-ancestor
102556269|NCT02439281|Anesthetics|anesthetics|mesh-ancestor
102556270|NCT02439281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102556271|NCT02439281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556272|NCT02439281|Sensory System Agents|sensory system agents|mesh-ancestor
102556273|NCT02439281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102556274|NCT02439281|Analgesics|analgesics|mesh-ancestor
102556275|NCT02439281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102556276|NCT02439281|Sympatholytics|sympatholytics|mesh-ancestor
102556277|NCT02439281|Autonomic Agents|autonomic agents|mesh-ancestor
102556278|NCT02439281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102556279|NCT02439281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102556280|NCT02439281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102556281|NCT02439281|Adrenergic Agents|adrenergic agents|mesh-ancestor
102556282|NCT02439281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102556283|NCT02439281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556284|NCT02505269|Doxorubicin|doxorubicin|mesh-list
102556285|NCT02505269|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102556286|NCT02505269|Dacarbazine|dacarbazine|mesh-list
102556287|NCT02505269|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102556288|NCT02505269|Imidazole|imidazole|mesh-list
102556289|NCT02505269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102556290|NCT02505269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102556291|NCT02505269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102556292|NCT02505269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102556293|NCT02505269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102556294|NCT02505269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556295|NCT02505269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102556296|NCT02505269|Alkylating Agents|alkylating agents|mesh-ancestor
102556297|NCT02505269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102556298|NCT02505269|Immunotoxins|immunotoxins|mesh-ancestor
102556299|NCT02505269|Immunoconjugates|immunoconjugates|mesh-ancestor
102556300|NCT02505269|Immunologic Factors|immunologic factors|mesh-ancestor
102556301|NCT02505269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556302|NCT00422123|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102556303|NCT00422123|Antidepressive Agents|antidepressive agents|mesh-ancestor
102556304|NCT00422123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102556305|NCT00422123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102556306|NCT00422123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102556307|NCT00422123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102556308|NCT00422123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556309|NCT00559273|Darbepoetin alfa|darbepoetin alfa|mesh-list
102556310|NCT00559273|Hematinics|hematinics|mesh-ancestor
102556311|NCT02506673|Midazolam|midazolam|mesh-list
102556312|NCT02506673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102556313|NCT02506673|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102556314|NCT02506673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102556315|NCT02506673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556316|NCT02506673|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102556317|NCT02506673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102556318|NCT02506673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102556319|NCT02506673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102556320|NCT02506673|Anesthetics, General|anesthetics, general|mesh-ancestor
102556321|NCT02506673|Anesthetics|anesthetics|mesh-ancestor
102556322|NCT02506673|GABA Modulators|gaba modulators|mesh-ancestor
102556323|NCT02506673|GABA Agents|gaba agents|mesh-ancestor
102556324|NCT02506673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102556325|NCT02506673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556326|NCT02508077|Calcium, Dietary|calcium, dietary|mesh-list
102556327|NCT02508077|Leucovorin|leucovorin|mesh-list
102556328|NCT02508077|Folic Acid|folic acid|mesh-list
102556329|NCT02508077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102556330|NCT02508077|Panitumumab|panitumumab|mesh-list
102556331|NCT02508077|Fluorouracil|fluorouracil|mesh-list
102556332|NCT02508077|Irinotecan|irinotecan|mesh-list
102103332|NCT02792517|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102556333|NCT02508077|Camptothecin|camptothecin|mesh-list
102556334|NCT02508077|Antibodies|antibodies|mesh-list
102556335|NCT02508077|Immunoglobulins|immunoglobulins|mesh-list
102556336|NCT02508077|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102556337|NCT02508077|Calcium|calcium|mesh-list
102556338|NCT02508077|Levoleucovorin|levoleucovorin|mesh-list
102556339|NCT02508077|Immunologic Factors|immunologic factors|mesh-ancestor
102556340|NCT02508077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556341|NCT02508077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102556342|NCT02508077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102556343|NCT02508077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102556344|NCT02508077|Antimetabolites|antimetabolites|mesh-ancestor
102556345|NCT02508077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556346|NCT02508077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102556347|NCT02508077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102556348|NCT02508077|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102556349|NCT02508077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102556350|NCT02508077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102556351|NCT02508077|Antidotes|antidotes|mesh-ancestor
102556352|NCT02508077|Protective Agents|protective agents|mesh-ancestor
102556353|NCT02508077|Vitamin B Complex|vitamin b complex|mesh-ancestor
102556354|NCT02508077|Vitamins|vitamins|mesh-ancestor
102556355|NCT02508077|Micronutrients|micronutrients|mesh-ancestor
102556356|NCT02508077|Hematinics|hematinics|mesh-ancestor
102556357|NCT02508077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102556358|NCT00558259|Dabigatran|dabigatran|mesh-list
102556359|NCT00558259|Antithrombins|antithrombins|mesh-ancestor
102556360|NCT00558259|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102556361|NCT00558259|Protease Inhibitors|protease inhibitors|mesh-ancestor
102556362|NCT00558259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102556363|NCT00558259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556364|NCT00558259|Anticoagulants|anticoagulants|mesh-ancestor
102556365|NCT02508389|Avasopasem manganese|avasopasem manganese|mesh-list
102556366|NCT02508389|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102556367|NCT02508389|Antioxidants|antioxidants|mesh-ancestor
102556368|NCT02508389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556369|NCT02508389|Protective Agents|protective agents|mesh-ancestor
102556370|NCT02508389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556371|NCT02509481|Ivermectin|ivermectin|mesh-list
102556372|NCT02509481|Albendazole|albendazole|mesh-list
102556373|NCT02509481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102556374|NCT02509481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102556375|NCT02509481|Anthelmintics|anthelmintics|mesh-ancestor
102556376|NCT02509481|Anticestodal Agents|anticestodal agents|mesh-ancestor
102556377|NCT02509481|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102556378|NCT02509481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102556379|NCT02509481|Tubulin Modulators|tubulin modulators|mesh-ancestor
102556380|NCT02509481|Antimitotic Agents|antimitotic agents|mesh-ancestor
102556381|NCT02509481|Mitosis Modulators|mitosis modulators|mesh-ancestor
102556382|NCT02509481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556383|NCT02509481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102556384|NCT04341077|Fluzoparib|fluzoparib|mesh-list
102556385|NCT04341077|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102556386|NCT04341077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102556387|NCT04341077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556388|NCT04341077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102556389|NCT02561897|Warfarin|warfarin|mesh-list
102556390|NCT02561897|Edoxaban|edoxaban|mesh-list
102556391|NCT02561897|Anticoagulants|anticoagulants|mesh-ancestor
102556392|NCT02561897|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102556393|NCT02561897|Antithrombins|antithrombins|mesh-ancestor
102556394|NCT02561897|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102556395|NCT02561897|Protease Inhibitors|protease inhibitors|mesh-ancestor
102556396|NCT02561897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102556397|NCT02561897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556398|NCT02512679|Cyclophosphamide|cyclophosphamide|mesh-list
102556399|NCT02512679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102556400|NCT02512679|Immunologic Factors|immunologic factors|mesh-ancestor
102556401|NCT02512679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556402|NCT02512679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102556403|NCT02512679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102556404|NCT02512679|Alkylating Agents|alkylating agents|mesh-ancestor
102556405|NCT02512679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556406|NCT02512679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102556407|NCT02512679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102556408|NCT02562521|Nicotine|nicotine|mesh-list
102556409|NCT02562521|Varenicline|varenicline|mesh-list
102556410|NCT02562521|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102556412|NCT02562521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102556413|NCT02562521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556414|NCT02562521|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102556415|NCT02562521|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102556416|NCT02562521|Cholinergic Agents|cholinergic agents|mesh-ancestor
102556417|NCT02562521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102556418|NCT02562521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556419|NCT02562755|Sorafenib|sorafenib|mesh-list
102556420|NCT02562755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102556421|NCT02562755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102556422|NCT02562755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102556423|NCT02562755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556424|NCT05446883|Paclitaxel|paclitaxel|mesh-list
102556425|NCT05446883|Carboplatin|carboplatin|mesh-list
101576225|NCT02723383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102556426|NCT05446883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102556427|NCT05446883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102556428|NCT05446883|Tubulin Modulators|tubulin modulators|mesh-ancestor
102556429|NCT05446883|Antimitotic Agents|antimitotic agents|mesh-ancestor
102556430|NCT05446883|Mitosis Modulators|mitosis modulators|mesh-ancestor
102556431|NCT05446883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556432|NCT00363857|Ropinirole|ropinirole|mesh-list
102556433|NCT00363857|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102556434|NCT00363857|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102556435|NCT00363857|Dopamine Agonists|dopamine agonists|mesh-ancestor
102556436|NCT00363857|Dopamine Agents|dopamine agents|mesh-ancestor
102556437|NCT00363857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102556438|NCT00363857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556439|NCT00363857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556440|NCT04563923|Avdoralimab|avdoralimab|mesh-list
102556441|NCT04563923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102556442|NCT04563923|Antiviral Agents|antiviral agents|mesh-ancestor
102556443|NCT04563923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102556444|NCT00558103|Lapatinib|lapatinib|mesh-list
102556445|NCT00558103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102556446|NCT00558103|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102556447|NCT00558103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102556448|NCT00558103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556449|NCT02974361|Ibuprofen|ibuprofen|mesh-list
102556450|NCT02974361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102556451|NCT02974361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102556452|NCT02974361|Analgesics|analgesics|mesh-ancestor
102556453|NCT02974361|Sensory System Agents|sensory system agents|mesh-ancestor
102556454|NCT02974361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102556455|NCT02974361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556456|NCT02974361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102556457|NCT02974361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102556458|NCT02974361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102556459|NCT02974361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102556460|NCT02974361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556461|NCT05690815|Tenofovir|tenofovir|mesh-list
102556462|NCT05690815|Emtricitabine|emtricitabine|mesh-list
102556463|NCT05690815|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
102556464|NCT05690815|Antiviral Agents|antiviral agents|mesh-ancestor
102556465|NCT05690815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102556466|NCT05690815|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102556467|NCT05690815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102556468|NCT05690815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102556469|NCT05690815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556470|NCT05690815|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102556471|NCT05690815|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102556472|NCT02569541|Fusidic Acid|fusidic acid|mesh-list
102556473|NCT02569541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102556474|NCT02569541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102556475|NCT02569541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102556476|NCT02569541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102556477|NCT02569541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556478|NCT04477733|Butorphanol|butorphanol|mesh-list
102556479|NCT04477733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102556480|NCT04477733|Narcotics|narcotics|mesh-ancestor
102556481|NCT04477733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102556482|NCT04477733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556483|NCT04477733|Analgesics|analgesics|mesh-ancestor
102556484|NCT04477733|Sensory System Agents|sensory system agents|mesh-ancestor
102556485|NCT04477733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102556486|NCT04477733|Antitussive Agents|antitussive agents|mesh-ancestor
102556487|NCT04477733|Respiratory System Agents|respiratory system agents|mesh-ancestor
102556488|NCT04477733|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102556489|NCT00558025|Pramipexole|pramipexole|mesh-list
102556490|NCT00558025|Antioxidants|antioxidants|mesh-ancestor
102556491|NCT00558025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556492|NCT00558025|Protective Agents|protective agents|mesh-ancestor
102556493|NCT00558025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556494|NCT00558025|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102556495|NCT00558025|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102556496|NCT00558025|Dopamine Agonists|dopamine agonists|mesh-ancestor
102556497|NCT00558025|Dopamine Agents|dopamine agents|mesh-ancestor
102556498|NCT00558025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102556499|NCT02576249|Methylprednisolone|methylprednisolone|mesh-list
102556500|NCT02576249|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102556501|NCT02576249|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102556502|NCT02576249|Prednisolone|prednisolone|mesh-list
102556503|NCT02576249|Prednisolone acetate|prednisolone acetate|mesh-list
102556504|NCT02576249|Ropivacaine|ropivacaine|mesh-list
102556505|NCT02576249|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102556506|NCT02576249|Prednisolone phosphate|prednisolone phosphate|mesh-list
102556507|NCT02576249|Anesthetics, Local|anesthetics, local|mesh-ancestor
102556508|NCT02576249|Anesthetics|anesthetics|mesh-ancestor
102556509|NCT02576249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102556510|NCT02576249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556511|NCT02576249|Sensory System Agents|sensory system agents|mesh-ancestor
102556512|NCT02576249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102556513|NCT02576249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102556514|NCT02576249|Antiemetics|antiemetics|mesh-ancestor
102556515|NCT02576249|Autonomic Agents|autonomic agents|mesh-ancestor
102556516|NCT02576249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102556517|NCT02576249|Glucocorticoids|glucocorticoids|mesh-ancestor
102556518|NCT02576249|Hormones|hormones|mesh-ancestor
102556519|NCT02576249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102556520|NCT02576249|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102556521|NCT02576249|Protective Agents|protective agents|mesh-ancestor
102556522|NCT02576249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102556523|NCT02576249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102556524|NCT03868657|Moxifloxacin|moxifloxacin|mesh-list
102556525|NCT03868657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102556526|NCT03868657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102556527|NCT03868657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102556528|NCT03868657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102556529|NCT03868657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102556530|NCT03868657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556531|NCT03868657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102556532|NCT01834261|Oxytocin|oxytocin|mesh-list
102556533|NCT01834261|Oxytocics|oxytocics|mesh-ancestor
102556534|NCT01834261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102556535|NCT01834261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556536|NCT02578901|Tranexamic Acid|tranexamic acid|mesh-list
102556537|NCT02578901|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102556538|NCT02578901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102556539|NCT02578901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556540|NCT02578901|Hemostatics|hemostatics|mesh-ancestor
102556541|NCT02578901|Coagulants|coagulants|mesh-ancestor
102556542|NCT02579057|Furosemide|furosemide|mesh-list
102556543|NCT02579057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102556544|NCT02579057|Diuretics|diuretics|mesh-ancestor
102556545|NCT02579057|Natriuretic Agents|natriuretic agents|mesh-ancestor
102556546|NCT02579057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556547|NCT02579057|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102556548|NCT02579057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102556549|NCT02579057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556550|NCT00557245|Tenofovir|tenofovir|mesh-list
102556551|NCT00557245|Emtricitabine|emtricitabine|mesh-list
102556552|NCT00557245|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102556553|NCT00557245|Antiviral Agents|antiviral agents|mesh-ancestor
102556554|NCT00557245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102556555|NCT00557245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102556556|NCT00557245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102556557|NCT00557245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102556558|NCT00557245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556559|NCT00557245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102556560|NCT00557245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102556561|NCT00364091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102556562|NCT00364091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102556563|NCT04743011|Heparin|heparin|mesh-list
102556564|NCT04743011|Calcium heparin|calcium heparin|mesh-list
102556565|NCT04743011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102556566|NCT04743011|Anticoagulants|anticoagulants|mesh-ancestor
102556567|NCT04743011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102556568|NCT04743011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102556569|NCT04743011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556570|NCT03528941|Lamivudine|lamivudine|mesh-list
102556571|NCT03528941|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102556572|NCT03528941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102556573|NCT03528941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102556574|NCT03528941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556575|NCT03528941|Antiviral Agents|antiviral agents|mesh-ancestor
102556576|NCT03528941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102556577|NCT03528941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102556578|NCT03528941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102556579|NCT01836133|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102556580|NCT01836133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102556581|NCT01836133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102556582|NCT01836133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102556583|NCT01836133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556584|NCT00365183|Pemetrexed|pemetrexed|mesh-list
102556585|NCT00365183|Motexafin gadolinium|motexafin gadolinium|mesh-list
102556586|NCT00365183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102556587|NCT00365183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102556588|NCT00365183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556589|NCT00365183|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102556590|NCT00365183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102556591|NCT00365183|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102556592|NCT00365183|Dermatologic Agents|dermatologic agents|mesh-ancestor
102556593|NCT01837069|Metoprolol|metoprolol|mesh-list
102556594|NCT01837069|Lisinopril|lisinopril|mesh-list
102556595|NCT01837069|Atorvastatin|atorvastatin|mesh-list
102556596|NCT01837069|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102556597|NCT01837069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102556598|NCT01837069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102556599|NCT01837069|Antimetabolites|antimetabolites|mesh-ancestor
102556600|NCT01837069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556601|NCT01837069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102556602|NCT01837069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102556603|NCT01837069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102556604|NCT01837069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102556605|NCT01837069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102556606|NCT01837069|Sympatholytics|sympatholytics|mesh-ancestor
102556607|NCT01837069|Autonomic Agents|autonomic agents|mesh-ancestor
102556608|NCT01837069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102556609|NCT01837069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556610|NCT01837069|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102556611|NCT01837069|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102556612|NCT01837069|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102556613|NCT01837069|Adrenergic Agents|adrenergic agents|mesh-ancestor
102556614|NCT01837069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102556615|NCT01837069|Protease Inhibitors|protease inhibitors|mesh-ancestor
102556616|NCT01837069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102556617|NCT01837069|Protective Agents|protective agents|mesh-ancestor
102556618|NCT02289690|Carboplatin|carboplatin|mesh-list
102556619|NCT02289690|Etoposide|etoposide|mesh-list
102556620|NCT02289690|Veliparib|veliparib|mesh-list
102556621|NCT02289690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102556622|NCT02289690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102556623|NCT02289690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102556624|NCT02289690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102556625|NCT02289690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102556626|NCT02289690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556627|NCT02289690|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102556628|NCT02268955|Ibuprofen|ibuprofen|mesh-list
102556629|NCT02268955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102556630|NCT02268955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102556631|NCT02268955|Analgesics|analgesics|mesh-ancestor
102556632|NCT02268955|Sensory System Agents|sensory system agents|mesh-ancestor
102556633|NCT02268955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102556634|NCT02268955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556635|NCT02268955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102556636|NCT02268955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102556637|NCT02268955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102556638|NCT02268955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102556639|NCT02268955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556640|NCT02585843|Spironolactone|spironolactone|mesh-list
102556641|NCT02585843|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102556642|NCT02585843|Hormone Antagonists|hormone antagonists|mesh-ancestor
102556643|NCT02585843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102556644|NCT02585843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556645|NCT02585843|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102556646|NCT02585843|Diuretics|diuretics|mesh-ancestor
102556647|NCT02585843|Natriuretic Agents|natriuretic agents|mesh-ancestor
102556648|NCT01838317|Pioglitazone|pioglitazone|mesh-list
102556649|NCT01838317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102556650|NCT01838317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556651|NCT05249231|Fluorides|fluorides|mesh-list
102556652|NCT05249231|Cariostatic Agents|cariostatic agents|mesh-ancestor
102556653|NCT05249231|Protective Agents|protective agents|mesh-ancestor
102556654|NCT05249231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556655|NCT05249153|Sufentanil|sufentanil|mesh-list
102556656|NCT05249153|Dexmedetomidine|dexmedetomidine|mesh-list
102556657|NCT05249153|Dsuvia|dsuvia|mesh-list
102556658|NCT05249153|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102556659|NCT05249153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102556660|NCT05249153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556661|NCT05249153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102556662|NCT05249153|Analgesics|analgesics|mesh-ancestor
102556663|NCT05249153|Sensory System Agents|sensory system agents|mesh-ancestor
102556664|NCT05249153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102556665|NCT05249153|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102556666|NCT05249153|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102556667|NCT05249153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102556668|NCT05249153|Adrenergic Agents|adrenergic agents|mesh-ancestor
102556669|NCT05249153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102556670|NCT05249153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556671|NCT05249153|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102556672|NCT05249153|Narcotics|narcotics|mesh-ancestor
102556673|NCT05249153|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102556674|NCT05249153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102556675|NCT05249153|Anesthetics, General|anesthetics, general|mesh-ancestor
102556676|NCT05249153|Anesthetics|anesthetics|mesh-ancestor
102556677|NCT02961257|Prednisone|prednisone|mesh-list
102556678|NCT02961257|Lenograstim|lenograstim|mesh-list
102556679|NCT02961257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102556680|NCT02961257|Glucocorticoids|glucocorticoids|mesh-ancestor
102556681|NCT02961257|Hormones|hormones|mesh-ancestor
102556682|NCT02961257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102556683|NCT02961257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556684|NCT02961257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101576509|NCT02708173|Vaccines|vaccines|mesh-list
102556685|NCT02961257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102556686|NCT02961257|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102556687|NCT02961257|Immunologic Factors|immunologic factors|mesh-ancestor
102556688|NCT02271217|4-Aminopyridine|4-aminopyridine|mesh-list
102556689|NCT02271217|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102556690|NCT02271217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102556691|NCT02271217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556692|NCT02989519|Progesterone|progesterone|mesh-list
102556693|NCT02989519|Dydrogesterone|dydrogesterone|mesh-list
102556694|NCT02989519|Progestins|progestins|mesh-ancestor
102556695|NCT02989519|Hormones|hormones|mesh-ancestor
102556696|NCT02989519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102556697|NCT02989519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556698|NCT02429375|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102556699|NCT02429375|Mocetinostat|mocetinostat|mesh-list
102556700|NCT02429375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102556701|NCT02429375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102556702|NCT02429375|Immunotoxins|immunotoxins|mesh-ancestor
102556703|NCT02429375|Immunoconjugates|immunoconjugates|mesh-ancestor
102556704|NCT02429375|Immunologic Factors|immunologic factors|mesh-ancestor
102556705|NCT02429375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556706|NCT02429375|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102556707|NCT02429375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102556708|NCT02429375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556709|NCT02289456|Paclitaxel|paclitaxel|mesh-list
102556710|NCT02289456|Carboplatin|carboplatin|mesh-list
102556711|NCT02289456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102556712|NCT02289456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102556713|NCT02289456|Tubulin Modulators|tubulin modulators|mesh-ancestor
102556714|NCT02289456|Antimitotic Agents|antimitotic agents|mesh-ancestor
102556715|NCT02289456|Mitosis Modulators|mitosis modulators|mesh-ancestor
102556716|NCT02289456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556717|NCT02589977|Regadenoson|regadenoson|mesh-list
102556718|NCT02589977|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
102556719|NCT02589977|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102556720|NCT02589977|Purinergic Agonists|purinergic agonists|mesh-ancestor
102556721|NCT02589977|Purinergic Agents|purinergic agents|mesh-ancestor
102556722|NCT02589977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102556723|NCT02589977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556724|NCT02589977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556725|NCT02274948|Metformin|metformin|mesh-list
102556726|NCT02274948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102556727|NCT02274948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556728|NCT02274792|Etanercept|etanercept|mesh-list
102556729|NCT02274792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102556730|NCT02274792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102556731|NCT02274792|Analgesics|analgesics|mesh-ancestor
102556732|NCT02274792|Sensory System Agents|sensory system agents|mesh-ancestor
102556733|NCT02274792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102556734|NCT02274792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556735|NCT02274792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102556736|NCT02274792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102556737|NCT02274792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102556738|NCT02274792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102556739|NCT02274792|Immunologic Factors|immunologic factors|mesh-ancestor
102556740|NCT05432466|Celiprolol|celiprolol|mesh-list
101576565|NCT03820531|Pancrelipase|pancrelipase|mesh-list
102556741|NCT05432466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102556742|NCT05432466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102556743|NCT05432466|Sympathomimetics|sympathomimetics|mesh-ancestor
102556744|NCT05432466|Autonomic Agents|autonomic agents|mesh-ancestor
102556745|NCT05432466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102556746|NCT05432466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556747|NCT05432466|Vasodilator Agents|vasodilator agents|mesh-ancestor
102556748|NCT05432466|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102556749|NCT05432466|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102556750|NCT05432466|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102556751|NCT05432466|Adrenergic Agents|adrenergic agents|mesh-ancestor
102556752|NCT05432466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102556753|NCT05432466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556754|NCT02592629|Triamcinolone|triamcinolone|mesh-list
102556755|NCT02592629|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102556756|NCT02592629|Lidocaine|lidocaine|mesh-list
102556757|NCT02592629|Ethyl Chloride|ethyl chloride|mesh-list
102556758|NCT02592629|Anesthetics, Local|anesthetics, local|mesh-ancestor
102556759|NCT02592629|Anesthetics|anesthetics|mesh-ancestor
102556760|NCT02592629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102556761|NCT02592629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556762|NCT02592629|Sensory System Agents|sensory system agents|mesh-ancestor
102556763|NCT02592629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102556764|NCT02592629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102556765|NCT02592629|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102556766|NCT02592629|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102556767|NCT02592629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102556768|NCT02592629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556769|NCT02592629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102556770|NCT02592629|Glucocorticoids|glucocorticoids|mesh-ancestor
102556771|NCT02592629|Hormones|hormones|mesh-ancestor
102556772|NCT02592629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102556773|NCT02592629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102556774|NCT02592629|Immunologic Factors|immunologic factors|mesh-ancestor
102556775|NCT02596451|Diclofenac|diclofenac|mesh-list
102556776|NCT02596451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102556777|NCT02596451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102556778|NCT02596451|Analgesics|analgesics|mesh-ancestor
102556779|NCT02596451|Sensory System Agents|sensory system agents|mesh-ancestor
102556780|NCT02596451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102556781|NCT02596451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556782|NCT02596451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102556783|NCT02596451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102556784|NCT02596451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102556785|NCT02596451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102556786|NCT02596451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556788|NCT01839799|Gemcitabine|gemcitabine|mesh-list
102556789|NCT01839799|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102556790|NCT01839799|Folfirinox|folfirinox|mesh-list
102556791|NCT01839799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102556792|NCT01839799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102556793|NCT01839799|Tubulin Modulators|tubulin modulators|mesh-ancestor
102556794|NCT01839799|Antimitotic Agents|antimitotic agents|mesh-ancestor
102556795|NCT01839799|Mitosis Modulators|mitosis modulators|mesh-ancestor
102556796|NCT01839799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556797|NCT01839799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102556798|NCT01839799|Antimetabolites|antimetabolites|mesh-ancestor
102556799|NCT03062059|Gemcitabine|gemcitabine|mesh-list
102556800|NCT03062059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102556801|NCT03062059|Antimetabolites|antimetabolites|mesh-ancestor
102556802|NCT03062059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556803|NCT03062059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102556804|NCT02597543|Regadenoson|regadenoson|mesh-list
102556805|NCT02597543|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
102556806|NCT02597543|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102556807|NCT02597543|Purinergic Agonists|purinergic agonists|mesh-ancestor
102556808|NCT02597543|Purinergic Agents|purinergic agents|mesh-ancestor
102556809|NCT02597543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102556810|NCT02597543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556811|NCT02597543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556812|NCT00553501|Rituximab|rituximab|mesh-list
102556813|NCT00553501|Epratuzumab|epratuzumab|mesh-list
102556814|NCT00553501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102556815|NCT00553501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102556816|NCT00553501|Immunologic Factors|immunologic factors|mesh-ancestor
102556817|NCT00553501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556818|NCT00553501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102556819|NCT02599649|Nivolumab|nivolumab|mesh-list
102556820|NCT02599649|Azacitidine|azacitidine|mesh-list
102556821|NCT02599649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102556822|NCT02599649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102556823|NCT02599649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102556824|NCT02599649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556825|NCT02599649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102556826|NCT02599649|Antimetabolites|antimetabolites|mesh-ancestor
102556827|NCT02599649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102556828|NCT01840345|Acetylcysteine|acetylcysteine|mesh-list
102556829|NCT01840345|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102556830|NCT01840345|Antiviral Agents|antiviral agents|mesh-ancestor
102556831|NCT01840345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102556832|NCT01840345|Expectorants|expectorants|mesh-ancestor
102556833|NCT01840345|Respiratory System Agents|respiratory system agents|mesh-ancestor
102556834|NCT01840345|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102556835|NCT01840345|Antioxidants|antioxidants|mesh-ancestor
102556836|NCT01840345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556837|NCT01840345|Protective Agents|protective agents|mesh-ancestor
102556838|NCT01840345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556839|NCT01840345|Antidotes|antidotes|mesh-ancestor
102556840|NCT00364481|Omeprazole|omeprazole|mesh-list
102556841|NCT00364481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102556842|NCT00364481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102556843|NCT00364481|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102556844|NCT00364481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102556845|NCT00364481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556846|NCT02601833|Fluorides|fluorides|mesh-list
102556847|NCT02601833|Cariostatic Agents|cariostatic agents|mesh-ancestor
102556848|NCT02601833|Protective Agents|protective agents|mesh-ancestor
102556849|NCT02601833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556850|NCT00553267|Amlodipine|amlodipine|mesh-list
102556851|NCT00553267|Telmisartan|telmisartan|mesh-list
102556852|NCT00553267|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
102556853|NCT00553267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101557329|NCT03295240|Rituximab|rituximab|mesh-list
102556854|NCT00553267|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102556855|NCT00553267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102556856|NCT00553267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556857|NCT00553267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102556859|NCT00553267|Vasodilator Agents|vasodilator agents|mesh-ancestor
102556860|NCT00553267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102556861|NCT00553267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102556862|NCT00364559|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102556863|NCT00364559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102556864|NCT00364559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102556865|NCT00364559|Antimetabolites|antimetabolites|mesh-ancestor
102556866|NCT00364559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556867|NCT00364559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102556868|NCT00364559|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102556869|NCT00364559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102556870|NCT02271984|Praziquantel|praziquantel|mesh-list
102556871|NCT02271984|Anthelmintics|anthelmintics|mesh-ancestor
102556872|NCT02271984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102556873|NCT02271984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102556874|NCT02604173|Budesonide|budesonide|mesh-list
102556875|NCT02604173|Acetazolamide|acetazolamide|mesh-list
102556876|NCT02604173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102556877|NCT02604173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102556878|NCT02604173|Autonomic Agents|autonomic agents|mesh-ancestor
102556879|NCT02604173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102556880|NCT02604173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556881|NCT02604173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102556882|NCT02604173|Respiratory System Agents|respiratory system agents|mesh-ancestor
102556883|NCT02604173|Glucocorticoids|glucocorticoids|mesh-ancestor
102556884|NCT02604173|Hormones|hormones|mesh-ancestor
102556885|NCT02604173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102556886|NCT02604173|Anticonvulsants|anticonvulsants|mesh-ancestor
102556887|NCT02604173|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102556888|NCT02604173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102556889|NCT02604173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556890|NCT02604173|Diuretics|diuretics|mesh-ancestor
102556891|NCT02604173|Natriuretic Agents|natriuretic agents|mesh-ancestor
102556892|NCT02287038|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102556893|NCT02287038|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102556894|NCT02287038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102556895|NCT02287038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102556896|NCT02287038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556897|NCT02287038|Adrenergic Agents|adrenergic agents|mesh-ancestor
102556898|NCT02287038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102556899|NCT02287038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556900|NCT00365339|Ritonavir|ritonavir|mesh-list
102556901|NCT00365339|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102556902|NCT00365339|Tenofovir|tenofovir|mesh-list
102556903|NCT00365339|Aripiprazole|aripiprazole|mesh-list
102556904|NCT00365339|Famotidine|famotidine|mesh-list
102556905|NCT00365339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102556906|NCT00365339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102556907|NCT00365339|Protease Inhibitors|protease inhibitors|mesh-ancestor
102556908|NCT00365339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102556909|NCT00365339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556910|NCT00365339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102556911|NCT00365339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102556912|NCT00365339|Antiviral Agents|antiviral agents|mesh-ancestor
102556913|NCT00365339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102556914|NCT00365339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102556915|NCT00365339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102556916|NCT00365339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102556917|NCT00365339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102556918|NCT00365339|Antidepressive Agents|antidepressive agents|mesh-ancestor
102556919|NCT00365339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102556920|NCT00365339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102556921|NCT00365339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102556922|NCT00365339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102556923|NCT00365339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556924|NCT00365339|Dopamine Agonists|dopamine agonists|mesh-ancestor
102556925|NCT00365339|Dopamine Agents|dopamine agents|mesh-ancestor
102556926|NCT00365339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102556927|NCT00365339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102556928|NCT00365339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102556929|NCT00365339|Serotonin Agents|serotonin agents|mesh-ancestor
102556930|NCT00365339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102556931|NCT00365339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102556932|NCT00365339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102556933|NCT00365339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102556934|NCT00365339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102556935|NCT00365339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102556936|NCT00365339|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102556937|NCT00365339|Histamine Antagonists|histamine antagonists|mesh-ancestor
102556938|NCT00365339|Histamine Agents|histamine agents|mesh-ancestor
102556939|NCT02815033|Choline|choline|mesh-list
101576755|NCT02706535|Rifampin|rifampin|mesh-list
102556940|NCT02815033|Lipotropic Agents|lipotropic agents|mesh-ancestor
102556941|NCT02815033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102556942|NCT02815033|Antimetabolites|antimetabolites|mesh-ancestor
102556943|NCT02815033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556944|NCT02815033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102556945|NCT02815033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102556946|NCT02815033|Nootropic Agents|nootropic agents|mesh-ancestor
102556947|NCT00366119|Ramipril|ramipril|mesh-list
102556948|NCT00366119|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102556949|NCT00366119|Protease Inhibitors|protease inhibitors|mesh-ancestor
102556950|NCT00366119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102556951|NCT00366119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556952|NCT00366119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102556953|NCT05371301|Paclitaxel|paclitaxel|mesh-list
102556954|NCT05371301|Carboplatin|carboplatin|mesh-list
102556955|NCT05371301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102556956|NCT05371301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102556957|NCT05371301|Tubulin Modulators|tubulin modulators|mesh-ancestor
102556958|NCT05371301|Antimitotic Agents|antimitotic agents|mesh-ancestor
102556959|NCT05371301|Mitosis Modulators|mitosis modulators|mesh-ancestor
102556960|NCT05371301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556961|NCT02285166|Hypolipidemic Agents|hypolipidemic agents|mesh-list
102556962|NCT02285166|Antimetabolites|antimetabolites|mesh-ancestor
102556963|NCT02285166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556964|NCT02285166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102556965|NCT02605187|Acetaminophen|acetaminophen|mesh-list
102556966|NCT02605187|Ibuprofen|ibuprofen|mesh-list
102556967|NCT02605187|Morphine|morphine|mesh-list
102556968|NCT02605187|Gabapentin|gabapentin|mesh-list
102556969|NCT02605187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102556970|NCT02605187|Narcotics|narcotics|mesh-ancestor
102556971|NCT02605187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102556972|NCT02605187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102556973|NCT02605187|Analgesics|analgesics|mesh-ancestor
102556974|NCT02605187|Sensory System Agents|sensory system agents|mesh-ancestor
102556975|NCT02605187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102556976|NCT02605187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102556977|NCT02605187|Antipyretics|antipyretics|mesh-ancestor
102556978|NCT02605187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102556979|NCT02605187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102556980|NCT02605187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102556981|NCT02605187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102556982|NCT02605187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102556983|NCT02605187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556984|NCT02605187|Anticonvulsants|anticonvulsants|mesh-ancestor
102556985|NCT02605187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102556986|NCT02605187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102556987|NCT02605187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102556988|NCT02605187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102556989|NCT02605187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102556990|NCT02605187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102556991|NCT02605187|Antimanic Agents|antimanic agents|mesh-ancestor
102556992|NCT05592197|Lenvatinib|lenvatinib|mesh-list
102556993|NCT05592197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102556994|NCT05592197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102556995|NCT05592197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102556996|NCT05592197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102556997|NCT02989207|Mitomycins|mitomycins|mesh-list
102556998|NCT02989207|Mitomycin|mitomycin|mesh-list
102556999|NCT02989207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102557000|NCT02989207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102557001|NCT02989207|Alkylating Agents|alkylating agents|mesh-ancestor
102557002|NCT02989207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557003|NCT02989207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102557004|NCT02989207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102557005|NCT02647099|Aspirin|aspirin|mesh-list
102557006|NCT02647099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102557007|NCT02647099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102557008|NCT02647099|Analgesics|analgesics|mesh-ancestor
102557009|NCT02647099|Sensory System Agents|sensory system agents|mesh-ancestor
102557010|NCT02647099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102557011|NCT02647099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557012|NCT02647099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102557013|NCT02647099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102557014|NCT02647099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102557015|NCT02647099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102557016|NCT02647099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557017|NCT02647099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102557018|NCT02647099|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102557019|NCT02647099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102557020|NCT02647099|Antipyretics|antipyretics|mesh-ancestor
102557021|NCT01843621|Vaccines|vaccines|mesh-list
102557022|NCT01843621|Immunologic Factors|immunologic factors|mesh-ancestor
102557023|NCT01843621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557024|NCT02608229|Paclitaxel|paclitaxel|mesh-list
102557025|NCT02608229|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102557026|NCT02608229|Gemcitabine|gemcitabine|mesh-list
102557027|NCT02608229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102557028|NCT02608229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102557029|NCT02608229|Tubulin Modulators|tubulin modulators|mesh-ancestor
102557030|NCT02608229|Antimitotic Agents|antimitotic agents|mesh-ancestor
102557031|NCT02608229|Mitosis Modulators|mitosis modulators|mesh-ancestor
102557032|NCT02608229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557033|NCT02608229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102557034|NCT02608229|Antimetabolites|antimetabolites|mesh-ancestor
102557035|NCT00555061|Retapamulin|retapamulin|mesh-list
102557036|NCT00555061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102557037|NCT00555061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102557038|NCT01642212|Budesonide|budesonide|mesh-list
102557039|NCT01642212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102557040|NCT01642212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102557041|NCT01642212|Autonomic Agents|autonomic agents|mesh-ancestor
102557042|NCT01642212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102557043|NCT01642212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557044|NCT01642212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102557045|NCT01642212|Respiratory System Agents|respiratory system agents|mesh-ancestor
102557046|NCT01642212|Glucocorticoids|glucocorticoids|mesh-ancestor
102557047|NCT01642212|Hormones|hormones|mesh-ancestor
102557048|NCT01642212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102557049|NCT05649618|Cyclophosphamide|cyclophosphamide|mesh-list
102557050|NCT05649618|Fludarabine|fludarabine|mesh-list
102557051|NCT05649618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102557052|NCT05649618|Immunologic Factors|immunologic factors|mesh-ancestor
102557053|NCT05649618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557054|NCT05649618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102557055|NCT05649618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102557056|NCT05649618|Alkylating Agents|alkylating agents|mesh-ancestor
102557057|NCT05649618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557058|NCT05649618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102557059|NCT05649618|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102557060|NCT00552175|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102557061|NCT00552175|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102557062|NCT00552175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102557063|NCT00552175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102557064|NCT00552175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557065|NCT00552175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102557066|NCT00552175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557067|NCT00552175|Analgesics|analgesics|mesh-ancestor
102557068|NCT00552175|Sensory System Agents|sensory system agents|mesh-ancestor
102557069|NCT00552175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102557070|NCT00552175|Antidepressive Agents|antidepressive agents|mesh-ancestor
102557071|NCT00552175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102557072|NCT00552175|Dopamine Agents|dopamine agents|mesh-ancestor
102557073|NCT01644474|Ezetimibe|ezetimibe|mesh-list
102557074|NCT01644474|Alirocumab|alirocumab|mesh-list
102557075|NCT01644474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102557076|NCT01644474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102557077|NCT01644474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102557078|NCT01644474|Antimetabolites|antimetabolites|mesh-ancestor
102557079|NCT01644474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557080|NCT01644474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102557081|NCT01644474|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102557082|NCT01644474|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102557083|NCT01644474|Protease Inhibitors|protease inhibitors|mesh-ancestor
102557084|NCT01644474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102557085|NCT01644474|Immunologic Factors|immunologic factors|mesh-ancestor
102557086|NCT01644474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557087|NCT02989129|Quercetin|quercetin|mesh-list
102557088|NCT02989129|Antioxidants|antioxidants|mesh-ancestor
102557089|NCT02989129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557090|NCT02989129|Protective Agents|protective agents|mesh-ancestor
102557091|NCT02989129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557092|NCT01847131|Phenylephrine|phenylephrine|mesh-list
102557093|NCT01847131|Oxymetazoline|oxymetazoline|mesh-list
102557094|NCT01847131|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102557095|NCT01847131|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102557096|NCT01847131|Adrenergic Agents|adrenergic agents|mesh-ancestor
102557097|NCT01847131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102557098|NCT01847131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557099|NCT01847131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557100|NCT01847131|Sympathomimetics|sympathomimetics|mesh-ancestor
102557101|NCT01847131|Autonomic Agents|autonomic agents|mesh-ancestor
102557102|NCT01847131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102557103|NCT01847131|Nasal Decongestants|nasal decongestants|mesh-ancestor
102557104|NCT01847131|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102557105|NCT01847131|Respiratory System Agents|respiratory system agents|mesh-ancestor
102557106|NCT01847131|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102557107|NCT01847131|Mydriatics|mydriatics|mesh-ancestor
102557108|NCT01847131|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102557109|NCT01847131|Protective Agents|protective agents|mesh-ancestor
102557110|NCT02285010|Pregabalin|pregabalin|mesh-list
102557111|NCT02285010|Analgesics|analgesics|mesh-ancestor
102557112|NCT02285010|Sensory System Agents|sensory system agents|mesh-ancestor
102557113|NCT02285010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102557114|NCT02285010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557115|NCT02285010|Anticonvulsants|anticonvulsants|mesh-ancestor
102557116|NCT02285010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102557117|NCT02285010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102557118|NCT02285010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557119|NCT02285010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102557120|NCT02285010|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102557121|NCT02285010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102557122|NCT02285010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102557123|NCT02285010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102557124|NCT02617667|Cyclosporine|cyclosporine|mesh-list
102557125|NCT02617667|Cyclosporins|cyclosporins|mesh-list
102557126|NCT02617667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102557127|NCT02617667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557128|NCT02617667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102557129|NCT02617667|Immunologic Factors|immunologic factors|mesh-ancestor
102557130|NCT02617667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557131|NCT02617667|Antifungal Agents|antifungal agents|mesh-ancestor
102557132|NCT02617667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102557133|NCT02617667|Dermatologic Agents|dermatologic agents|mesh-ancestor
102557134|NCT02617667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102557135|NCT02617667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102557136|NCT03023449|Nitric Oxide|nitric oxide|mesh-list
102557137|NCT03023449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102557138|NCT03023449|Autonomic Agents|autonomic agents|mesh-ancestor
102557139|NCT03023449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102557140|NCT03023449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557141|NCT03023449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102557142|NCT03023449|Respiratory System Agents|respiratory system agents|mesh-ancestor
102557143|NCT03023449|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102557144|NCT03023449|Antioxidants|antioxidants|mesh-ancestor
102557145|NCT03023449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557146|NCT03023449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102557147|NCT03023449|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102557148|NCT03023449|Vasodilator Agents|vasodilator agents|mesh-ancestor
102557149|NCT03023449|Gasotransmitters|gasotransmitters|mesh-ancestor
102557150|NCT03023449|Protective Agents|protective agents|mesh-ancestor
102557151|NCT01848067|Prednisone|prednisone|mesh-list
102557152|NCT01848067|Abiraterone Acetate|abiraterone acetate|mesh-list
102557153|NCT01848067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102557154|NCT01848067|Glucocorticoids|glucocorticoids|mesh-ancestor
102557155|NCT01848067|Hormones|hormones|mesh-ancestor
102557156|NCT01848067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102557157|NCT01848067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557158|NCT01848067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102557159|NCT01848067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102557160|NCT01848067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102557161|NCT01848067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102557162|NCT01848067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557163|NCT01848067|Hormone Antagonists|hormone antagonists|mesh-ancestor
102557164|NCT01848067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102557165|NCT05731973|Sufentanil|sufentanil|mesh-list
102557166|NCT05731973|Oxycodone|oxycodone|mesh-list
102557167|NCT05731973|Analgesics, Opioid|analgesics, opioid|mesh-list
102557168|NCT05731973|Bupivacaine|bupivacaine|mesh-list
102557169|NCT05731973|Anesthetics, Local|anesthetics, local|mesh-ancestor
102557170|NCT05731973|Anesthetics|anesthetics|mesh-ancestor
102557171|NCT05731973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102557172|NCT05731973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557173|NCT05731973|Sensory System Agents|sensory system agents|mesh-ancestor
102557174|NCT05731973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102557175|NCT05731973|Narcotics|narcotics|mesh-ancestor
102557176|NCT05731973|Analgesics|analgesics|mesh-ancestor
102557177|NCT05731973|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102557178|NCT05731973|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102557179|NCT05731973|Anesthetics, General|anesthetics, general|mesh-ancestor
102557180|NCT05068349|3-n-butylphthalide|3-n-butylphthalide|mesh-list
102557181|NCT05068349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102557182|NCT05068349|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102557183|NCT05068349|Protective Agents|protective agents|mesh-ancestor
102557184|NCT05068349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557185|NCT05452577|Estazolam|estazolam|mesh-list
102557186|NCT05452577|Anticonvulsants|anticonvulsants|mesh-ancestor
102557187|NCT05452577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102557188|NCT05452577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102557189|NCT05452577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102557190|NCT05452577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557191|NCT05452577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102557192|NCT05452577|GABA Modulators|gaba modulators|mesh-ancestor
102557193|NCT05452577|GABA Agents|gaba agents|mesh-ancestor
102557194|NCT05452577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102557195|NCT05452577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557196|NCT05464615|Amoxicillin|amoxicillin|mesh-list
102557197|NCT05464615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102557198|NCT05464615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102557199|NCT00364871|Naltrexone|naltrexone|mesh-list
102557200|NCT00364871|Bupropion|bupropion|mesh-list
102557201|NCT00364871|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102557202|NCT00364871|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102557203|NCT00364871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557204|NCT00364871|Sensory System Agents|sensory system agents|mesh-ancestor
102557205|NCT00364871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102557206|NCT00364871|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102557207|NCT00364871|Antidepressive Agents|antidepressive agents|mesh-ancestor
102557208|NCT00364871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102557209|NCT00364871|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102557210|NCT00364871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102557211|NCT00364871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102557212|NCT00364871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557213|NCT00364871|Dopamine Agents|dopamine agents|mesh-ancestor
102557214|NCT00364871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102557215|NCT00364871|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102557216|NCT00364871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102557217|NCT00364871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102557218|NCT00551161|Memantine|memantine|mesh-list
102557219|NCT00551161|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102557220|NCT00551161|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102557221|NCT00551161|Dopamine Agents|dopamine agents|mesh-ancestor
102557222|NCT00551161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102557223|NCT00551161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557224|NCT00551161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557225|NCT00551161|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102557226|NCT00551161|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102557227|NCT00550771|Paclitaxel|paclitaxel|mesh-list
102557228|NCT00550771|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102557229|NCT00550771|Cyclophosphamide|cyclophosphamide|mesh-list
102557230|NCT00550771|Doxorubicin|doxorubicin|mesh-list
102557232|NCT00550771|Trastuzumab|trastuzumab|mesh-list
102557233|NCT00550771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102557234|NCT00550771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102557235|NCT00550771|Tubulin Modulators|tubulin modulators|mesh-ancestor
102557236|NCT00550771|Antimitotic Agents|antimitotic agents|mesh-ancestor
102557237|NCT00550771|Mitosis Modulators|mitosis modulators|mesh-ancestor
102557238|NCT00550771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557239|NCT00550771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102557240|NCT00550771|Immunologic Factors|immunologic factors|mesh-ancestor
102557241|NCT00550771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557242|NCT00550771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102557243|NCT00550771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102557244|NCT00550771|Alkylating Agents|alkylating agents|mesh-ancestor
102557245|NCT00550771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102557246|NCT00550771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102557247|NCT00550771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102557248|NCT00550771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102557249|NCT00550771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102557250|NCT00550771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102557251|NCT01852669|Furosemide|furosemide|mesh-list
102557252|NCT01852669|Diuretics|diuretics|mesh-ancestor
102557253|NCT01852669|Natriuretic Agents|natriuretic agents|mesh-ancestor
102557254|NCT01852669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557255|NCT01852669|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102557256|NCT01852669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102557257|NCT01852669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557258|NCT04741295|Heparin|heparin|mesh-list
102557259|NCT04741295|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102557260|NCT04741295|Tinzaparin|tinzaparin|mesh-list
102557261|NCT04741295|Dalteparin|dalteparin|mesh-list
102557262|NCT04741295|Anticoagulants|anticoagulants|mesh-ancestor
102557263|NCT04741295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102557264|NCT04741295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102557265|NCT04741295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557266|NCT00550537|Paclitaxel|paclitaxel|mesh-list
102557267|NCT00550537|Bevacizumab|bevacizumab|mesh-list
102557268|NCT00550537|Carboplatin|carboplatin|mesh-list
102557269|NCT00550537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102557270|NCT00550537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102557271|NCT00550537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102557272|NCT00550537|Tubulin Modulators|tubulin modulators|mesh-ancestor
102557273|NCT00550537|Antimitotic Agents|antimitotic agents|mesh-ancestor
102557274|NCT00550537|Mitosis Modulators|mitosis modulators|mesh-ancestor
102557275|NCT00550537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557276|NCT00550537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102557277|NCT00550537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102557278|NCT00550537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102557279|NCT00550537|Growth Substances|growth substances|mesh-ancestor
102557280|NCT00550537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557281|NCT00550537|Growth Inhibitors|growth inhibitors|mesh-ancestor
102557282|NCT00550537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102557283|NCT00550537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102557284|NCT04801043|Imipenem|imipenem|mesh-list
102557285|NCT04801043|Cilastatin|cilastatin|mesh-list
102557286|NCT04801043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102557287|NCT04801043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102557288|NCT04801043|Protease Inhibitors|protease inhibitors|mesh-ancestor
102557289|NCT04801043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102557290|NCT04801043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557291|NCT05706701|Nicotine|nicotine|mesh-list
102557292|NCT05706701|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102557293|NCT05706701|Autonomic Agents|autonomic agents|mesh-ancestor
102557294|NCT05706701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102557295|NCT05706701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557296|NCT05706701|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102557297|NCT05706701|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102557298|NCT05706701|Cholinergic Agents|cholinergic agents|mesh-ancestor
102557299|NCT05706701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102557300|NCT05706701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557301|NCT04734197|Cyclosporine|cyclosporine|mesh-list
102557302|NCT04734197|Mycophenolic Acid|mycophenolic acid|mesh-list
102557303|NCT04734197|Betamethasone|betamethasone|mesh-list
102557304|NCT04734197|Betamethasone Valerate|betamethasone valerate|mesh-list
102104276|NCT02604550|Narcotics|narcotics|mesh-ancestor
102557305|NCT04734197|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102557306|NCT04734197|Betamethasone benzoate|betamethasone benzoate|mesh-list
102557307|NCT04734197|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102557308|NCT04734197|Lifitegrast|lifitegrast|mesh-list
102557309|NCT04734197|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102557310|NCT04734197|Cyclosporins|cyclosporins|mesh-list
102557311|NCT04734197|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102557312|NCT04734197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102557313|NCT04734197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557314|NCT04734197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102557315|NCT04734197|Immunologic Factors|immunologic factors|mesh-ancestor
102557316|NCT04734197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557317|NCT04734197|Antifungal Agents|antifungal agents|mesh-ancestor
102557318|NCT04734197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102557319|NCT04734197|Dermatologic Agents|dermatologic agents|mesh-ancestor
102557320|NCT04734197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102557321|NCT04734197|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102557322|NCT04734197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102557323|NCT04734197|Glucocorticoids|glucocorticoids|mesh-ancestor
102557324|NCT04734197|Hormones|hormones|mesh-ancestor
102557325|NCT04734197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102557326|NCT04734197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102557327|NCT04734197|Respiratory System Agents|respiratory system agents|mesh-ancestor
102557328|NCT04734197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102557329|NCT04734197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102557330|NCT04734197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102557331|NCT04734197|Antitubercular Agents|antitubercular agents|mesh-ancestor
102557332|NCT04734197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102557333|NCT00550147|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102557334|NCT00550147|Methylphenidate|methylphenidate|mesh-list
102557335|NCT00550147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102557336|NCT00550147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557337|NCT00550147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102557338|NCT00550147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102557339|NCT00550147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102557340|NCT00550147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557341|NCT00550147|Dopamine Agents|dopamine agents|mesh-ancestor
102557342|NCT00550147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102557343|NCT00550147|Antidepressive Agents|antidepressive agents|mesh-ancestor
102557344|NCT00550147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102557345|NCT00550147|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102557346|NCT00550147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102557347|NCT00550147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102557348|NCT05688215|Calcium, Dietary|calcium, dietary|mesh-list
102557349|NCT05688215|Leucovorin|leucovorin|mesh-list
102557350|NCT05688215|Folic Acid|folic acid|mesh-list
102557351|NCT05688215|Fluorouracil|fluorouracil|mesh-list
102557352|NCT05688215|Oxaliplatin|oxaliplatin|mesh-list
102557353|NCT05688215|Irinotecan|irinotecan|mesh-list
102557354|NCT05688215|Quemliclustat|quemliclustat|mesh-list
102557355|NCT05688215|Calcium|calcium|mesh-list
102557356|NCT05688215|Levoleucovorin|levoleucovorin|mesh-list
102557357|NCT05688215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102557358|NCT05688215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557359|NCT05688215|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102557360|NCT05688215|Antimetabolites|antimetabolites|mesh-ancestor
102557361|NCT05688215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557362|NCT05688215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102557363|NCT05688215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102557364|NCT05688215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102557365|NCT05688215|Immunologic Factors|immunologic factors|mesh-ancestor
102557366|NCT05688215|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102557367|NCT05688215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102557368|NCT05688215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102557369|NCT05688215|Antidotes|antidotes|mesh-ancestor
102557370|NCT05688215|Protective Agents|protective agents|mesh-ancestor
102557371|NCT05688215|Vitamin B Complex|vitamin b complex|mesh-ancestor
102557372|NCT05688215|Vitamins|vitamins|mesh-ancestor
102557373|NCT05688215|Micronutrients|micronutrients|mesh-ancestor
102557374|NCT05688215|Hematinics|hematinics|mesh-ancestor
102557375|NCT05688215|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102557376|NCT05688215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102557377|NCT00557401|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
102557378|NCT00557401|Baclofen|baclofen|mesh-list
102557379|NCT00557401|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102557380|NCT00557401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557381|NCT00557401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102557382|NCT00557401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102557383|NCT00557401|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102557385|NCT00557401|GABA Agents|gaba agents|mesh-ancestor
102557386|NCT00557401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102557387|NCT00557401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557388|NCT02264353|Donepezil|donepezil|mesh-list
102557389|NCT02264353|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102557390|NCT02264353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102557391|NCT02264353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557392|NCT02264353|Cholinergic Agents|cholinergic agents|mesh-ancestor
102557393|NCT02264353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102557394|NCT02264353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557395|NCT02264353|Nootropic Agents|nootropic agents|mesh-ancestor
102557396|NCT02265913|Acyclovir|acyclovir|mesh-list
102557397|NCT02265913|Antiviral Agents|antiviral agents|mesh-ancestor
102557398|NCT02265913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102557399|NCT02624843|Ethanol|ethanol|mesh-list
102557400|NCT02624843|Benzyl Alcohol|benzyl alcohol|mesh-list
102557401|NCT02624843|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102557402|NCT02624843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102557403|NCT02624843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102557404|NCT02624843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557405|NCT02624843|Anesthetics, Local|anesthetics, local|mesh-ancestor
102557406|NCT02624843|Anesthetics|anesthetics|mesh-ancestor
102557407|NCT02624843|Sensory System Agents|sensory system agents|mesh-ancestor
102557408|NCT02624843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102557409|NCT02279641|Allopurinol|allopurinol|mesh-list
102557410|NCT02279641|Verinurad|verinurad|mesh-list
102557411|NCT02279641|Antimetabolites|antimetabolites|mesh-ancestor
102557412|NCT02279641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557413|NCT02279641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102557414|NCT02279641|Gout Suppressants|gout suppressants|mesh-ancestor
102557415|NCT02279641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102557416|NCT02279641|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102557417|NCT02279641|Antioxidants|antioxidants|mesh-ancestor
102557418|NCT02279641|Protective Agents|protective agents|mesh-ancestor
102557419|NCT02279641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557420|NCT02629991|Oxytocin|oxytocin|mesh-list
102557421|NCT02629991|Oxytocics|oxytocics|mesh-ancestor
102557422|NCT02629991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102557423|NCT02629991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557424|NCT00553657|Tolterodine Tartrate|tolterodine tartrate|mesh-list
102557425|NCT00553657|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102557426|NCT00553657|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102557427|NCT00553657|Cholinergic Agents|cholinergic agents|mesh-ancestor
102557428|NCT00553657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102557429|NCT00553657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557430|NCT00553657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557431|NCT00553657|Urological Agents|urological agents|mesh-ancestor
102557432|NCT05142709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102557433|NCT05142709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557434|NCT05142709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102557435|NCT05142709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102557436|NCT04992143|Sorafenib|sorafenib|mesh-list
102557437|NCT04992143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102557438|NCT04992143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102557439|NCT04992143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102557440|NCT04992143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557441|NCT04485065|Azacitidine|azacitidine|mesh-list
102557442|NCT04485065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102557443|NCT04485065|Antimetabolites|antimetabolites|mesh-ancestor
102557444|NCT04485065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557445|NCT04485065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102557446|NCT04485065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102557447|NCT03769129|Pembrolizumab|pembrolizumab|mesh-list
102557448|NCT03769129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102557449|NCT03769129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102557450|NCT03769129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102557451|NCT03769129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557452|NCT00367445|Insulin|insulin|mesh-list
102557453|NCT00367445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102557454|NCT00367445|Insulin Glargine|insulin glargine|mesh-list
102104430|NCT00116298|Lamivudine|lamivudine|mesh-list
102557455|NCT00367445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102557456|NCT00367445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557457|NCT01866943|Tranexamic Acid|tranexamic acid|mesh-list
102557458|NCT01866943|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102557459|NCT01866943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102557460|NCT01866943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557461|NCT01866943|Hemostatics|hemostatics|mesh-ancestor
102557462|NCT01866943|Coagulants|coagulants|mesh-ancestor
102557463|NCT01868425|Acetaminophen|acetaminophen|mesh-list
102557464|NCT01868425|Ketamine|ketamine|mesh-list
102557465|NCT01868425|Gabapentin|gabapentin|mesh-list
102557466|NCT01868425|Bupivacaine|bupivacaine|mesh-list
102557467|NCT01868425|Anesthetics, Local|anesthetics, local|mesh-ancestor
102557468|NCT01868425|Anesthetics|anesthetics|mesh-ancestor
102557469|NCT01868425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102557470|NCT01868425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557471|NCT01868425|Sensory System Agents|sensory system agents|mesh-ancestor
102557472|NCT01868425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102557473|NCT01868425|Analgesics|analgesics|mesh-ancestor
102557474|NCT01868425|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102557475|NCT01868425|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102557476|NCT01868425|Anesthetics, General|anesthetics, general|mesh-ancestor
102557477|NCT01868425|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102557478|NCT01868425|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102557479|NCT01868425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102557480|NCT01868425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557481|NCT01868425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102557482|NCT01868425|Antipyretics|antipyretics|mesh-ancestor
102557483|NCT01868425|Anticonvulsants|anticonvulsants|mesh-ancestor
102557484|NCT01868425|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102557485|NCT01868425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102557486|NCT01868425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102557487|NCT01868425|Antimanic Agents|antimanic agents|mesh-ancestor
102557488|NCT00550459|Tolvaptan|tolvaptan|mesh-list
102557489|NCT00550459|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102557490|NCT00550459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557491|NCT00550459|Natriuretic Agents|natriuretic agents|mesh-ancestor
102557492|NCT00550459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557493|NCT01871077|Ketorolac|ketorolac|mesh-list
102557494|NCT01871077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102557495|NCT01871077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102557496|NCT01871077|Analgesics|analgesics|mesh-ancestor
102557497|NCT01871077|Sensory System Agents|sensory system agents|mesh-ancestor
102557498|NCT01871077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102557499|NCT01871077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557500|NCT01871077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102557501|NCT01871077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102557502|NCT01871077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102557503|NCT01871077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102557504|NCT01871077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557505|NCT01874119|Fosaprepitant|fosaprepitant|mesh-list
102557506|NCT01874119|Aprepitant|aprepitant|mesh-list
102557507|NCT01874119|Antiemetics|antiemetics|mesh-ancestor
102557508|NCT01874119|Autonomic Agents|autonomic agents|mesh-ancestor
102557509|NCT01874119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102557510|NCT01874119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557511|NCT01874119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102557512|NCT01874119|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102557513|NCT01874119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102557514|NCT01874119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557515|NCT02823145|Fenfluramine|fenfluramine|mesh-list
102557516|NCT02823145|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102557517|NCT02823145|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102557518|NCT02823145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102557519|NCT02823145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557520|NCT02823145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102557521|NCT02823145|Serotonin Agents|serotonin agents|mesh-ancestor
102557522|NCT02823145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557523|NCT02280811|Aldesleukin|aldesleukin|mesh-list
102557524|NCT02280811|Cyclophosphamide|cyclophosphamide|mesh-list
102557525|NCT02280811|Fludarabine|fludarabine|mesh-list
102557526|NCT02280811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102557527|NCT02280811|Immunologic Factors|immunologic factors|mesh-ancestor
102557528|NCT02280811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558011|NCT00335140|Antimetabolites|antimetabolites|mesh-ancestor
102557529|NCT02280811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102557530|NCT02280811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102557531|NCT02280811|Alkylating Agents|alkylating agents|mesh-ancestor
102557532|NCT02280811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557533|NCT02280811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101577349|NCT01009203|Sirolimus|sirolimus|mesh-list
102557534|NCT02280811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102557535|NCT02280811|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102557536|NCT02280811|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102557537|NCT02280811|Antiviral Agents|antiviral agents|mesh-ancestor
102557538|NCT02280811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102557539|NCT01930747|Remifentanil|remifentanil|mesh-list
102557540|NCT01930747|Sevoflurane|sevoflurane|mesh-list
102557541|NCT01930747|Rocuronium|rocuronium|mesh-list
102557542|NCT01930747|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102557543|NCT01930747|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102557544|NCT01930747|Anesthetics, General|anesthetics, general|mesh-ancestor
102557545|NCT01930747|Anesthetics|anesthetics|mesh-ancestor
102557546|NCT01930747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102557547|NCT01930747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557548|NCT01930747|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102557549|NCT01930747|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102557550|NCT01930747|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102557551|NCT01930747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102557552|NCT01930747|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102557553|NCT01930747|Narcotics|narcotics|mesh-ancestor
102557554|NCT01930747|Analgesics|analgesics|mesh-ancestor
102557555|NCT01930747|Sensory System Agents|sensory system agents|mesh-ancestor
102557556|NCT01931527|Rasburicase|rasburicase|mesh-list
102557557|NCT01931527|Gout Suppressants|gout suppressants|mesh-ancestor
102557558|NCT01931527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102557559|NCT02639429|Misoprostol|misoprostol|mesh-list
102557560|NCT02639429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102557561|NCT02639429|Abortifacient Agents|abortifacient agents|mesh-ancestor
102557562|NCT02639429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102557563|NCT02639429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557564|NCT02639429|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102557565|NCT02639429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102557566|NCT02639429|Oxytocics|oxytocics|mesh-ancestor
102557567|NCT01936363|Niacinamide|niacinamide|mesh-list
102557568|NCT01936363|Vitamin B Complex|vitamin b complex|mesh-ancestor
102557569|NCT01936363|Vitamins|vitamins|mesh-ancestor
102557570|NCT01936363|Micronutrients|micronutrients|mesh-ancestor
102557571|NCT01936363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557572|NCT04893629|Digoxin|digoxin|mesh-list
102557573|NCT04893629|Captopril|captopril|mesh-list
102557574|NCT04893629|Furosemide|furosemide|mesh-list
102557575|NCT04893629|Diuretics|diuretics|mesh-ancestor
102557576|NCT04893629|Natriuretic Agents|natriuretic agents|mesh-ancestor
102557577|NCT04893629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577418|NCT04735861|Growth Inhibitors|growth inhibitors|mesh-ancestor
102557578|NCT04893629|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102557579|NCT04893629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102557580|NCT04893629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557581|NCT04893629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102557582|NCT04893629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102557583|NCT04893629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102557584|NCT04893629|Protective Agents|protective agents|mesh-ancestor
102557585|NCT04893629|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102557586|NCT04893629|Protease Inhibitors|protease inhibitors|mesh-ancestor
102557587|NCT04893629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102557588|NCT04891991|Infliximab|infliximab|mesh-list
102557589|NCT04891991|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102557590|NCT04891991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102557591|NCT04891991|Dermatologic Agents|dermatologic agents|mesh-ancestor
102557592|NCT04891991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102557593|NCT04891991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102557594|NCT01936519|Cyclosporine|cyclosporine|mesh-list
102557595|NCT01936519|Mycophenolic Acid|mycophenolic acid|mesh-list
102557596|NCT01936519|Everolimus|everolimus|mesh-list
102557597|NCT01936519|Tacrolimus|tacrolimus|mesh-list
102557598|NCT01936519|Cyclosporins|cyclosporins|mesh-list
102557599|NCT01936519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
102557600|NCT01936519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102557601|NCT01936519|Immunologic Factors|immunologic factors|mesh-ancestor
102557602|NCT01936519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557603|NCT01936519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102557604|NCT01936519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557605|NCT01936519|Antifungal Agents|antifungal agents|mesh-ancestor
102557606|NCT01936519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102557607|NCT01936519|Dermatologic Agents|dermatologic agents|mesh-ancestor
102557608|NCT01936519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102557609|NCT01936519|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102557610|NCT01936519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102557611|NCT01936519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102557612|NCT01936519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102557613|NCT01936519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102557614|NCT01936519|Antitubercular Agents|antitubercular agents|mesh-ancestor
102557615|NCT01936519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102557616|NCT04507841|Niraparib|niraparib|mesh-list
102557617|NCT04507841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102557618|NCT04507841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102557619|NCT04507841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557620|NCT04507841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102557621|NCT01936909|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102557622|NCT01936909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102557623|NCT01938079|Ketamine|ketamine|mesh-list
102557624|NCT01938079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
102557625|NCT01938079|Analgesics|analgesics|mesh-ancestor
102557626|NCT01938079|Sensory System Agents|sensory system agents|mesh-ancestor
102557627|NCT01938079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102557628|NCT01938079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557629|NCT01938079|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102557630|NCT01938079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102557631|NCT01938079|Anesthetics, General|anesthetics, general|mesh-ancestor
102557632|NCT01938079|Anesthetics|anesthetics|mesh-ancestor
102557633|NCT01938079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102557634|NCT01938079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102557635|NCT01938079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102557636|NCT01938079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102557637|NCT01938079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557638|NCT02641691|Leucovorin|leucovorin|mesh-list
102557639|NCT02641691|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
102557640|NCT02641691|Tetrahydrofolates|tetrahydrofolates|mesh-list
102557641|NCT02641691|Fluorouracil|fluorouracil|mesh-list
102557642|NCT02641691|Oxaliplatin|oxaliplatin|mesh-list
102557643|NCT02641691|Levoleucovorin|levoleucovorin|mesh-list
102557644|NCT02641691|Antimetabolites|antimetabolites|mesh-ancestor
102557645|NCT02641691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557646|NCT02641691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102557647|NCT02641691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102557648|NCT02641691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102557649|NCT02641691|Immunologic Factors|immunologic factors|mesh-ancestor
102557650|NCT02641691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557651|NCT02641691|Antidotes|antidotes|mesh-ancestor
102557652|NCT02641691|Protective Agents|protective agents|mesh-ancestor
102557653|NCT02641691|Vitamin B Complex|vitamin b complex|mesh-ancestor
102557654|NCT02641691|Vitamins|vitamins|mesh-ancestor
102557655|NCT02641691|Micronutrients|micronutrients|mesh-ancestor
102557656|NCT04047251|Topotecan|topotecan|mesh-list
102557657|NCT04047251|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102557658|NCT04047251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102557659|NCT04047251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102557660|NCT04047251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557661|NCT04047251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102557662|NCT04045613|Atezolizumab|atezolizumab|mesh-list
102557663|NCT04045613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102557664|NCT04045613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102557665|NCT04045613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557666|NCT04045613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102557667|NCT04045613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102557668|NCT04045613|Immunologic Factors|immunologic factors|mesh-ancestor
102557669|NCT04045613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557670|NCT05588999|Salicylic Acid|salicylic acid|mesh-list
102557671|NCT05588999|Salicylates|salicylates|mesh-list
102557672|NCT05588999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102557673|NCT05588999|Antifungal Agents|antifungal agents|mesh-ancestor
102557674|NCT05588999|Keratolytic Agents|keratolytic agents|mesh-ancestor
102557675|NCT05588999|Dermatologic Agents|dermatologic agents|mesh-ancestor
102557676|NCT05588999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102557677|NCT05588999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102557678|NCT05588999|Analgesics|analgesics|mesh-ancestor
102557679|NCT05588999|Sensory System Agents|sensory system agents|mesh-ancestor
102557680|NCT05588999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102557681|NCT05588999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557682|NCT05588999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102557683|NCT05588999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102557684|NCT05588999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102557685|NCT05588999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102557686|NCT05588999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557687|NCT01643928|Rituximab|rituximab|mesh-list
102557688|NCT01643928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102557689|NCT01643928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102557690|NCT01643928|Immunologic Factors|immunologic factors|mesh-ancestor
102557691|NCT01643928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557692|NCT01643928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102557693|NCT04234997|Suvorexant|suvorexant|mesh-list
102557694|NCT04234997|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102557695|NCT04234997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102557696|NCT04234997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102557697|NCT04234997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557698|NCT04234997|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102557699|NCT04234997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101577542|NCT02430181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102557700|NCT04234997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557701|NCT03750071|Avelumab|avelumab|mesh-list
102557702|NCT03750071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102557703|NCT03750071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102557704|NCT03635567|Paclitaxel|paclitaxel|mesh-list
102557705|NCT03635567|Bevacizumab|bevacizumab|mesh-list
102557706|NCT03635567|Carboplatin|carboplatin|mesh-list
102557707|NCT03635567|Pembrolizumab|pembrolizumab|mesh-list
102557708|NCT03635567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102557709|NCT03635567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102557710|NCT03635567|Tubulin Modulators|tubulin modulators|mesh-ancestor
102557711|NCT03635567|Antimitotic Agents|antimitotic agents|mesh-ancestor
102557712|NCT03635567|Mitosis Modulators|mitosis modulators|mesh-ancestor
102557713|NCT03635567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557714|NCT03635567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102557715|NCT03635567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102557716|NCT03635567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102557717|NCT03635567|Growth Substances|growth substances|mesh-ancestor
102557718|NCT03635567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557719|NCT03635567|Growth Inhibitors|growth inhibitors|mesh-ancestor
102557720|NCT03635567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102557721|NCT05588531|Cefepime|cefepime|mesh-list
102557722|NCT05588531|Avibactam|avibactam|mesh-list
102557723|NCT05588531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102557724|NCT05588531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102557725|NCT05588531|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102557726|NCT05588531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102557727|NCT05588531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557728|NCT05588297|Bevacizumab|bevacizumab|mesh-list
102557729|NCT05588297|Nivolumab|nivolumab|mesh-list
102557730|NCT05588297|Capecitabine|capecitabine|mesh-list
102557731|NCT05588297|Oxaliplatin|oxaliplatin|mesh-list
102557732|NCT05588297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102557733|NCT05588297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102557734|NCT05588297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102557735|NCT05588297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102557736|NCT05588297|Growth Substances|growth substances|mesh-ancestor
102557737|NCT05588297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557738|NCT05588297|Growth Inhibitors|growth inhibitors|mesh-ancestor
102557739|NCT05588297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102557740|NCT05588297|Antimetabolites|antimetabolites|mesh-ancestor
102557741|NCT05588297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557742|NCT05588297|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102557743|NCT05588219|Cisplatin|cisplatin|mesh-list
102557744|NCT05588219|Tislelizumab|tislelizumab|mesh-list
102557745|NCT05588219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102557746|NCT05588219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102557747|NCT05588219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102557748|NCT05588219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557749|NCT02303405|Pioglitazone|pioglitazone|mesh-list
102557750|NCT02303405|Hydroxychloroquine|hydroxychloroquine|mesh-list
102557751|NCT02303405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102557752|NCT02303405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557753|NCT02303405|Antimalarials|antimalarials|mesh-ancestor
102557754|NCT02303405|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102104722|NCT02087007|Respiratory System Agents|respiratory system agents|mesh-ancestor
102557755|NCT02303405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102557756|NCT02303405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102557757|NCT02303405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102557758|NCT02303405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557759|NCT02303405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102557760|NCT02164955|Pomalidomide|pomalidomide|mesh-list
102557761|NCT02164955|Immunologic Factors|immunologic factors|mesh-ancestor
102557762|NCT02164955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557763|NCT02164955|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102557764|NCT02164955|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102557765|NCT02164955|Growth Substances|growth substances|mesh-ancestor
102557766|NCT02164955|Growth Inhibitors|growth inhibitors|mesh-ancestor
102557767|NCT02164955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102557768|NCT05587361|Propranolol|propranolol|mesh-list
102557769|NCT05587361|Nicotine|nicotine|mesh-list
102557770|NCT05587361|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102557771|NCT05587361|Autonomic Agents|autonomic agents|mesh-ancestor
102557772|NCT05587361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102557773|NCT05587361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557774|NCT05587361|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102557775|NCT05587361|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102557776|NCT05587361|Cholinergic Agents|cholinergic agents|mesh-ancestor
102557777|NCT05587361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102557778|NCT05587361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557779|NCT05587361|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102557780|NCT05587361|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102557781|NCT05587361|Adrenergic Agents|adrenergic agents|mesh-ancestor
102557782|NCT05587361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102557783|NCT05587361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102557784|NCT05587361|Vasodilator Agents|vasodilator agents|mesh-ancestor
102557785|NCT01943461|Avelumab|avelumab|mesh-list
102557786|NCT01943461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102557787|NCT01943461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102557788|NCT01943461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102557789|NCT01943461|Immunologic Factors|immunologic factors|mesh-ancestor
102557790|NCT01943461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557791|NCT00422435|Paclitaxel|paclitaxel|mesh-list
102557792|NCT00422435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102557793|NCT00422435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102557794|NCT00422435|Tubulin Modulators|tubulin modulators|mesh-ancestor
102557795|NCT00422435|Antimitotic Agents|antimitotic agents|mesh-ancestor
102557796|NCT00422435|Mitosis Modulators|mitosis modulators|mesh-ancestor
102557797|NCT00422435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557798|NCT00702481|Nimotuzumab|nimotuzumab|mesh-list
102557799|NCT00702481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102557800|NCT00702481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102557801|NCT03559049|Carboplatin|carboplatin|mesh-list
102557802|NCT03559049|Pembrolizumab|pembrolizumab|mesh-list
102557803|NCT03559049|Pemetrexed|pemetrexed|mesh-list
102557804|NCT03559049|Rucaparib|rucaparib|mesh-list
102557805|NCT03559049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102557806|NCT03559049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102557807|NCT03559049|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102557808|NCT03559049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557809|NCT03559049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102557810|NCT03559049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102557811|NCT03559049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102557812|NCT03559049|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102557813|NCT05559437|Bupivacaine|bupivacaine|mesh-list
102557814|NCT05559437|Levobupivacaine|levobupivacaine|mesh-list
102557815|NCT05559437|Anesthetics, Local|anesthetics, local|mesh-ancestor
102557816|NCT05559437|Anesthetics|anesthetics|mesh-ancestor
102557817|NCT05559437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102557818|NCT05559437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557819|NCT05559437|Sensory System Agents|sensory system agents|mesh-ancestor
102557820|NCT05559437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102557821|NCT00367211|Naproxen|naproxen|mesh-list
102557822|NCT00367211|Omeprazole|omeprazole|mesh-list
102557823|NCT00367211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102557824|NCT00367211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102557825|NCT00367211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102557826|NCT00367211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102557827|NCT00367211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557828|NCT00367211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102557829|NCT00367211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102557830|NCT00367211|Analgesics|analgesics|mesh-ancestor
102104801|NCT03557229|Expectorants|expectorants|mesh-ancestor
102557831|NCT00367211|Sensory System Agents|sensory system agents|mesh-ancestor
102557832|NCT00367211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102557833|NCT00367211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557834|NCT00367211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102557835|NCT00367211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102557836|NCT00367211|Gout Suppressants|gout suppressants|mesh-ancestor
102557837|NCT00367211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102557839|NCT02646449|Antidepressive Agents|antidepressive agents|mesh-ancestor
102557840|NCT02646449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102557841|NCT02646449|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102557842|NCT02646449|Histamine Antagonists|histamine antagonists|mesh-ancestor
102557843|NCT02646449|Histamine Agents|histamine agents|mesh-ancestor
102557844|NCT02646449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102557845|NCT02646449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557846|NCT02646449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557847|NCT02646449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102557848|NCT02646449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102557849|NCT02646449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102557850|NCT02646449|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102557851|NCT02646449|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102557852|NCT02646449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102557853|NCT02646449|Adrenergic Agents|adrenergic agents|mesh-ancestor
102557854|NCT02646449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102557855|NCT02646449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102557856|NCT02646449|Serotonin Agents|serotonin agents|mesh-ancestor
102557857|NCT02646449|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102557858|NCT04339361|Lidocaine|lidocaine|mesh-list
102557859|NCT04339361|Dinoprostone|dinoprostone|mesh-list
102557860|NCT04339361|Anesthetics, Local|anesthetics, local|mesh-ancestor
102557861|NCT04339361|Anesthetics|anesthetics|mesh-ancestor
102557862|NCT04339361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102557863|NCT04339361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557864|NCT04339361|Sensory System Agents|sensory system agents|mesh-ancestor
102557865|NCT04339361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102557866|NCT04339361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102557867|NCT04339361|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102557868|NCT04339361|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102557869|NCT04339361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102557870|NCT04339361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557871|NCT04339361|Oxytocics|oxytocics|mesh-ancestor
102557872|NCT04339361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102557873|NCT05369351|Mirabegron|mirabegron|mesh-list
102557874|NCT05369351|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102557875|NCT05369351|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102557876|NCT05369351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102557877|NCT05369351|Adrenergic Agents|adrenergic agents|mesh-ancestor
102557878|NCT05369351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102557879|NCT05369351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557880|NCT05369351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557881|NCT05369351|Urological Agents|urological agents|mesh-ancestor
102557882|NCT02653391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102557883|NCT02653391|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102557884|NCT05303987|Dexmedetomidine|dexmedetomidine|mesh-list
102557885|NCT05303987|Propofol|propofol|mesh-list
102557886|NCT05303987|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102557887|NCT05303987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102557888|NCT05303987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557889|NCT05303987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102557890|NCT05303987|Analgesics|analgesics|mesh-ancestor
102557891|NCT05303987|Sensory System Agents|sensory system agents|mesh-ancestor
102557892|NCT05303987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102557893|NCT05303987|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102557894|NCT05303987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102557895|NCT05303987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102557896|NCT05303987|Adrenergic Agents|adrenergic agents|mesh-ancestor
102557897|NCT05303987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102557898|NCT05303987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557899|NCT05303987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102557900|NCT05303987|Anesthetics, General|anesthetics, general|mesh-ancestor
102557901|NCT05303987|Anesthetics|anesthetics|mesh-ancestor
102557902|NCT02654483|Serlopitant|serlopitant|mesh-list
101577719|NCT02698969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102557903|NCT02654483|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102557904|NCT02654483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102557905|NCT02654483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557906|NCT02654483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557907|NCT02655653|Tranexamic Acid|tranexamic acid|mesh-list
102557908|NCT02655653|Aminocaproic Acid|aminocaproic acid|mesh-list
102557909|NCT02655653|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102557910|NCT02655653|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102557911|NCT02655653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557912|NCT02655653|Hemostatics|hemostatics|mesh-ancestor
102557913|NCT02655653|Coagulants|coagulants|mesh-ancestor
102557914|NCT03081143|Paclitaxel|paclitaxel|mesh-list
102557915|NCT03081143|Ramucirumab|ramucirumab|mesh-list
102557916|NCT03081143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102557917|NCT03081143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102557918|NCT03081143|Tubulin Modulators|tubulin modulators|mesh-ancestor
102557919|NCT03081143|Antimitotic Agents|antimitotic agents|mesh-ancestor
102557920|NCT03081143|Mitosis Modulators|mitosis modulators|mesh-ancestor
102557921|NCT03081143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557922|NCT02658461|Trastuzumab|trastuzumab|mesh-list
102557923|NCT02658461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102557924|NCT02658461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102557925|NCT00367913|Clarithromycin|clarithromycin|mesh-list
102557926|NCT00367913|Ciprofloxacin|ciprofloxacin|mesh-list
102557927|NCT00367913|Rifampin|rifampin|mesh-list
102557928|NCT00367913|Ethambutol|ethambutol|mesh-list
102557929|NCT00367913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102557930|NCT00367913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102557931|NCT00367913|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102557932|NCT00367913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102557933|NCT00367913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557934|NCT00367913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102557935|NCT00367913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102557936|NCT00367913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102557937|NCT00367913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102557938|NCT00367913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102557939|NCT00367913|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102557940|NCT00367913|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102557941|NCT00367913|Antitubercular Agents|antitubercular agents|mesh-ancestor
102557942|NCT00367913|Leprostatic Agents|leprostatic agents|mesh-ancestor
102557943|NCT00367913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102557944|NCT00367913|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102557945|NCT00367913|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102557946|NCT00367913|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102557947|NCT00367913|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102557948|NCT00367913|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102557949|NCT00367913|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102557950|NCT02659787|Buprenorphine|buprenorphine|mesh-list
102557951|NCT02659787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102557952|NCT02659787|Narcotics|narcotics|mesh-ancestor
102557953|NCT02659787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102557954|NCT02659787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557955|NCT02659787|Analgesics|analgesics|mesh-ancestor
102557956|NCT02659787|Sensory System Agents|sensory system agents|mesh-ancestor
102557957|NCT02659787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102557958|NCT02659787|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102557959|NCT05044871|Paclitaxel|paclitaxel|mesh-list
102557960|NCT05044871|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102557961|NCT05044871|Bevacizumab|bevacizumab|mesh-list
102557962|NCT05044871|Tislelizumab|tislelizumab|mesh-list
102557963|NCT05044871|Pamiparib|pamiparib|mesh-list
102557964|NCT05044871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102557965|NCT05044871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102557966|NCT05044871|Tubulin Modulators|tubulin modulators|mesh-ancestor
102557967|NCT05044871|Antimitotic Agents|antimitotic agents|mesh-ancestor
102557968|NCT05044871|Mitosis Modulators|mitosis modulators|mesh-ancestor
102557969|NCT05044871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557970|NCT05044871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102557971|NCT05044871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102557972|NCT05044871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102557973|NCT05044871|Growth Substances|growth substances|mesh-ancestor
102557974|NCT05044871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557975|NCT05044871|Growth Inhibitors|growth inhibitors|mesh-ancestor
102557976|NCT05044871|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102557977|NCT05044871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102557978|NCT04931693|Acetaminophen|acetaminophen|mesh-list
102557979|NCT04931693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102557980|NCT04931693|Analgesics|analgesics|mesh-ancestor
102557981|NCT04931693|Sensory System Agents|sensory system agents|mesh-ancestor
102557982|NCT04931693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102557983|NCT04931693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557984|NCT04931693|Antipyretics|antipyretics|mesh-ancestor
102557985|NCT02271594|Insulin|insulin|mesh-list
102557986|NCT02271594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102557987|NCT02271594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557988|NCT04817969|Cimetidine|cimetidine|mesh-list
102557989|NCT04817969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102557990|NCT04817969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102557991|NCT04817969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102557992|NCT04817969|Histamine Antagonists|histamine antagonists|mesh-ancestor
102557993|NCT04817969|Histamine Agents|histamine agents|mesh-ancestor
102557994|NCT04817969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102557995|NCT04817969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102557996|NCT04817969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102557997|NCT04817969|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102557998|NCT04817969|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102557999|NCT04817969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102558000|NCT05649228|Capsaicin|capsaicin|mesh-list
102558001|NCT05649228|Antipruritics|antipruritics|mesh-ancestor
102558002|NCT05649228|Dermatologic Agents|dermatologic agents|mesh-ancestor
102558003|NCT05649228|Sensory System Agents|sensory system agents|mesh-ancestor
102558004|NCT05649228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102558005|NCT05649228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558006|NCT02350517|Paclitaxel|paclitaxel|mesh-list
102558007|NCT02350517|Endostar protein|endostar protein|mesh-list
102558008|NCT02350517|Endostatins|endostatins|mesh-list
102558009|NCT02350517|Nedaplatin|nedaplatin|mesh-list
102558010|NCT02350517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102558011|NCT02350517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102558012|NCT02350517|Tubulin Modulators|tubulin modulators|mesh-ancestor
102558013|NCT02350517|Antimitotic Agents|antimitotic agents|mesh-ancestor
102558014|NCT02350517|Mitosis Modulators|mitosis modulators|mesh-ancestor
102558015|NCT02350517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558016|NCT02350517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102558017|NCT02350517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102558018|NCT02350517|Growth Substances|growth substances|mesh-ancestor
102558019|NCT02350517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558020|NCT02350517|Growth Inhibitors|growth inhibitors|mesh-ancestor
102558021|NCT02270736|Botulinum Toxins|botulinum toxins|mesh-list
102558022|NCT02270736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102558023|NCT02270736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102558024|NCT02270736|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102558025|NCT02270736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102558026|NCT02270736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102558027|NCT02270736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558028|NCT02270736|Cholinergic Agents|cholinergic agents|mesh-ancestor
102558029|NCT02270736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102558030|NCT02270736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558031|NCT02270736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102558032|NCT02270736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102558033|NCT02205047|Fluorouracil|fluorouracil|mesh-list
102558034|NCT02205047|Capecitabine|capecitabine|mesh-list
102558035|NCT02205047|Trastuzumab|trastuzumab|mesh-list
102558036|NCT02205047|Pertuzumab|pertuzumab|mesh-list
102558037|NCT02205047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102558038|NCT02205047|Antimetabolites|antimetabolites|mesh-ancestor
102558039|NCT02205047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558040|NCT02205047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102558041|NCT02205047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102558042|NCT02205047|Immunologic Factors|immunologic factors|mesh-ancestor
102558043|NCT02205047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558044|NCT02205047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102558045|NCT04878198|Melatonin|melatonin|mesh-list
102558046|NCT04878198|Antioxidants|antioxidants|mesh-ancestor
102558047|NCT04878198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558048|NCT04878198|Protective Agents|protective agents|mesh-ancestor
102558049|NCT04878198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558050|NCT04878198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102558051|NCT04651595|Morphine|morphine|mesh-list
102558052|NCT04651595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102105025|NCT03425708|Febuxostat|febuxostat|mesh-list
102558054|NCT04651595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102558055|NCT04651595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558056|NCT04651595|Analgesics|analgesics|mesh-ancestor
102558057|NCT04651595|Sensory System Agents|sensory system agents|mesh-ancestor
102558058|NCT04651595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102558059|NCT02669615|Melphalan|melphalan|mesh-list
102558060|NCT02669615|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102558061|NCT02669615|Alkylating Agents|alkylating agents|mesh-ancestor
102558062|NCT02669615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558063|NCT02669615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102558064|NCT02669615|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102558065|NCT02669615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102558066|NCT02669615|Immunologic Factors|immunologic factors|mesh-ancestor
102558067|NCT02669615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558068|NCT02672111|Buprenorphine|buprenorphine|mesh-list
102558069|NCT02672111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102558070|NCT02672111|Narcotics|narcotics|mesh-ancestor
102558071|NCT02672111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102558072|NCT02672111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558073|NCT02672111|Analgesics|analgesics|mesh-ancestor
102558074|NCT02672111|Sensory System Agents|sensory system agents|mesh-ancestor
102558075|NCT02672111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102558076|NCT02672111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102558077|NCT00586391|Ipilimumab|ipilimumab|mesh-list
102558078|NCT00586391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102558079|NCT00586391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102558080|NCT00586391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102558081|NCT00586391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558082|NCT05432843|Pregabalin|pregabalin|mesh-list
102558083|NCT05432843|Analgesics|analgesics|mesh-ancestor
102558084|NCT05432843|Sensory System Agents|sensory system agents|mesh-ancestor
102558085|NCT05432843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102558086|NCT05432843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558087|NCT05432843|Anticonvulsants|anticonvulsants|mesh-ancestor
102558088|NCT05432843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102558089|NCT05432843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102558090|NCT05432843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558091|NCT05432843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102558092|NCT05432843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101577912|NCT01007253|Histamine Agents|histamine agents|mesh-ancestor
102558093|NCT05432843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102558094|NCT05432843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102558095|NCT05432843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102558096|NCT05411471|Vaccines|vaccines|mesh-list
102558097|NCT05411471|Immunologic Factors|immunologic factors|mesh-ancestor
102558098|NCT05411471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558099|NCT02677493|Vaccines|vaccines|mesh-list
102558100|NCT02677493|Immunologic Factors|immunologic factors|mesh-ancestor
102558101|NCT02677493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558102|NCT02679911|Ciclopirox|ciclopirox|mesh-list
102558103|NCT02679911|Amorolfine|amorolfine|mesh-list
102558104|NCT02679911|Antifungal Agents|antifungal agents|mesh-ancestor
102558105|NCT02679911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102558106|NCT02680301|Triamcinolone|triamcinolone|mesh-list
102558107|NCT02680301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102558108|NCT02680301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102558109|NCT02680301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102558110|NCT02680301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102558111|NCT02680301|Glucocorticoids|glucocorticoids|mesh-ancestor
102558112|NCT02680301|Hormones|hormones|mesh-ancestor
102558113|NCT02680301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102558114|NCT02680301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558115|NCT02680301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102558116|NCT02680301|Immunologic Factors|immunologic factors|mesh-ancestor
102558117|NCT02680301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102558118|NCT02680301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558119|NCT02680457|Insulin|insulin|mesh-list
102558120|NCT02680457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102558121|NCT02680457|Insulin Glargine|insulin glargine|mesh-list
102558122|NCT02680457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102558123|NCT02680457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558124|NCT02283762|Riociguat|riociguat|mesh-list
102558125|NCT02283762|Enzyme Activators|enzyme activators|mesh-ancestor
102558126|NCT02283762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558127|NCT02692391|Indomethacin|indomethacin|mesh-list
102558128|NCT02692391|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102558129|NCT02692391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102558130|NCT02692391|Analgesics|analgesics|mesh-ancestor
102558131|NCT02692391|Sensory System Agents|sensory system agents|mesh-ancestor
102558132|NCT02692391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102558133|NCT02692391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558134|NCT02692391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102558135|NCT02692391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102558136|NCT02692391|Gout Suppressants|gout suppressants|mesh-ancestor
102558137|NCT02692391|Tocolytic Agents|tocolytic agents|mesh-ancestor
102558138|NCT02692391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102558139|NCT02692391|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102558140|NCT02692391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102558141|NCT02692391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558142|NCT02696291|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102558143|NCT02682563|Dapagliflozin|dapagliflozin|mesh-list
102558144|NCT02682563|Gliclazide|gliclazide|mesh-list
102558145|NCT02682563|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102558146|NCT02682563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558147|NCT02682563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102558148|NCT02682563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558149|NCT02697071|Ketamine|ketamine|mesh-list
102558150|NCT02697071|Analgesics|analgesics|mesh-ancestor
102558151|NCT02697071|Sensory System Agents|sensory system agents|mesh-ancestor
102558152|NCT02697071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102558153|NCT02697071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558154|NCT02697071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102558155|NCT02697071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102558156|NCT02697071|Anesthetics, General|anesthetics, general|mesh-ancestor
102558157|NCT02697071|Anesthetics|anesthetics|mesh-ancestor
102558158|NCT02697071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102558159|NCT02697071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102558160|NCT02697071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102558161|NCT02697071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102558162|NCT02697071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558163|NCT02283294|Warfarin|warfarin|mesh-list
102558164|NCT02283294|Apixaban|apixaban|mesh-list
102558165|NCT02283294|Anticoagulants|anticoagulants|mesh-ancestor
102558166|NCT02283294|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102558167|NCT02283294|Antithrombins|antithrombins|mesh-ancestor
102558168|NCT02283294|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102558169|NCT02283294|Protease Inhibitors|protease inhibitors|mesh-ancestor
102558170|NCT02283294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102558171|NCT02283294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558172|NCT05648994|Paclitaxel|paclitaxel|mesh-list
102558173|NCT05648994|Cyclophosphamide|cyclophosphamide|mesh-list
102558174|NCT05648994|Fludarabine|fludarabine|mesh-list
102558175|NCT05648994|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102558176|NCT05648994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102558177|NCT05648994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102558178|NCT05648994|Tubulin Modulators|tubulin modulators|mesh-ancestor
102558179|NCT05648994|Antimitotic Agents|antimitotic agents|mesh-ancestor
102558180|NCT05648994|Mitosis Modulators|mitosis modulators|mesh-ancestor
102558181|NCT05648994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558182|NCT05648994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102558183|NCT05648994|Immunologic Factors|immunologic factors|mesh-ancestor
102558184|NCT05648994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558185|NCT05648994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102558186|NCT05648994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102558187|NCT05648994|Alkylating Agents|alkylating agents|mesh-ancestor
102558188|NCT05648994|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102558189|NCT04869306|Hyaluronic Acid|hyaluronic acid|mesh-list
102558190|NCT04869306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102558191|NCT04869306|Immunologic Factors|immunologic factors|mesh-ancestor
102558192|NCT04869306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558193|NCT04869306|Viscosupplements|viscosupplements|mesh-ancestor
102558194|NCT04869306|Protective Agents|protective agents|mesh-ancestor
102558195|NCT02268864|Simeprevir|simeprevir|mesh-list
102558196|NCT02268864|Antiviral Agents|antiviral agents|mesh-ancestor
102558197|NCT02268864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102558198|NCT02268864|Protease Inhibitors|protease inhibitors|mesh-ancestor
102558199|NCT02268864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102558200|NCT02268864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558201|NCT02703779|Plerixafor|plerixafor|mesh-list
102558202|NCT02703779|Bortezomib|bortezomib|mesh-list
102558203|NCT02703779|Lenograstim|lenograstim|mesh-list
102558204|NCT02703779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102558205|NCT02703779|Immunologic Factors|immunologic factors|mesh-ancestor
102558206|NCT02703779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558207|NCT02703779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102558208|NCT02703779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102558209|NCT02703779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102558210|NCT02703779|Antiviral Agents|antiviral agents|mesh-ancestor
102558211|NCT02703779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102558212|NCT04738955|Micafungin|micafungin|mesh-list
102558213|NCT04738955|Antifungal Agents|antifungal agents|mesh-ancestor
102558214|NCT04738955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102558215|NCT02268396|Glycopyrrolate|glycopyrrolate|mesh-list
102558216|NCT02268396|Formoterol Fumarate|formoterol fumarate|mesh-list
102558217|NCT02268396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102558218|NCT02268396|Autonomic Agents|autonomic agents|mesh-ancestor
102558219|NCT02268396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102558220|NCT02268396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558221|NCT02268396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102558222|NCT02268396|Respiratory System Agents|respiratory system agents|mesh-ancestor
102558223|NCT02268396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102558224|NCT02268396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102558225|NCT02268396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102558226|NCT02268396|Adrenergic Agents|adrenergic agents|mesh-ancestor
102558227|NCT02268396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102558228|NCT02268396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558229|NCT02268396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102558230|NCT02268396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102558231|NCT02268396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102558232|NCT02268396|Cholinergic Agents|cholinergic agents|mesh-ancestor
102558233|NCT05648526|Ketamine|ketamine|mesh-list
102558234|NCT05648526|Analgesics|analgesics|mesh-ancestor
102558235|NCT05648526|Sensory System Agents|sensory system agents|mesh-ancestor
102558236|NCT05648526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102558237|NCT05648526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558238|NCT05648526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102558239|NCT05648526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102558240|NCT05648526|Anesthetics, General|anesthetics, general|mesh-ancestor
102558241|NCT05648526|Anesthetics|anesthetics|mesh-ancestor
102558242|NCT05648526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102558243|NCT05648526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102558244|NCT05648526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102558245|NCT05648526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102558246|NCT05648526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558247|NCT02705807|Epoprostenol|epoprostenol|mesh-list
102558248|NCT02705807|Tezosentan|tezosentan|mesh-list
102558249|NCT02705807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102558250|NCT02705807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102558251|NCT02705807|Vasodilator Agents|vasodilator agents|mesh-ancestor
102558252|NCT01643772|Oxycodone|oxycodone|mesh-list
102558253|NCT01643772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102558254|NCT01643772|Narcotics|narcotics|mesh-ancestor
102558255|NCT01643772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102558256|NCT01643772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558257|NCT01643772|Analgesics|analgesics|mesh-ancestor
102558258|NCT01643772|Sensory System Agents|sensory system agents|mesh-ancestor
102558259|NCT01643772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102558260|NCT02707523|Azithromycin|azithromycin|mesh-list
102558261|NCT02707523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102558262|NCT02707523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102558263|NCT02712047|Fluticasone|fluticasone|mesh-list
102558264|NCT02712047|Xhance|xhance|mesh-list
102558265|NCT02712047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102558266|NCT02712047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102558267|NCT02712047|Autonomic Agents|autonomic agents|mesh-ancestor
102558268|NCT02712047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102558269|NCT02712047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558270|NCT02712047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102558271|NCT02712047|Respiratory System Agents|respiratory system agents|mesh-ancestor
102558272|NCT02712047|Dermatologic Agents|dermatologic agents|mesh-ancestor
102558273|NCT02712047|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102558274|NCT02717273|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102558275|NCT02717273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102558276|NCT02717273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102558277|NCT02717273|Antitubercular Agents|antitubercular agents|mesh-ancestor
102558278|NCT00369239|Risperidone|risperidone|mesh-list
102558279|NCT00369239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102558280|NCT00369239|Serotonin Agents|serotonin agents|mesh-ancestor
102558281|NCT00369239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102558282|NCT00369239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558283|NCT00369239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558284|NCT00369239|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102558285|NCT00369239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102558286|NCT00369239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102558287|NCT00369239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102558288|NCT00369239|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102558289|NCT00369239|Dopamine Agents|dopamine agents|mesh-ancestor
102558290|NCT03833921|Prednisone|prednisone|mesh-list
102558291|NCT03833921|Abiraterone Acetate|abiraterone acetate|mesh-list
102558292|NCT03833921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102558293|NCT03833921|Glucocorticoids|glucocorticoids|mesh-ancestor
102558294|NCT03833921|Hormones|hormones|mesh-ancestor
101578111|NCT04214665|Thioctic Acid|thioctic acid|mesh-list
102558295|NCT03833921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102558296|NCT03833921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558297|NCT03833921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102558298|NCT03833921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102558299|NCT03833921|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102558300|NCT03833921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102558301|NCT03833921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558302|NCT03833921|Hormone Antagonists|hormone antagonists|mesh-ancestor
102558303|NCT03833921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102558304|NCT05215925|Carboplatin|carboplatin|mesh-list
102558305|NCT05215925|Docetaxel|docetaxel|mesh-list
102558306|NCT05215925|Pemetrexed|pemetrexed|mesh-list
102558307|NCT05215925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102558308|NCT05215925|Tubulin Modulators|tubulin modulators|mesh-ancestor
102558309|NCT05215925|Antimitotic Agents|antimitotic agents|mesh-ancestor
102558310|NCT05215925|Mitosis Modulators|mitosis modulators|mesh-ancestor
102558311|NCT05215925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558312|NCT05215925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102558313|NCT05215925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102558314|NCT05215925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102558315|NCT05159687|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102558316|NCT05159687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102558317|NCT05159687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102558318|NCT05159687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102558319|NCT05159687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558320|NCT05159687|Adrenergic Agents|adrenergic agents|mesh-ancestor
102558321|NCT05159687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102558322|NCT05159687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558323|NCT02721017|Fentanyl|fentanyl|mesh-list
102558324|NCT02721017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102558325|NCT02721017|Narcotics|narcotics|mesh-ancestor
102558326|NCT02721017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102558327|NCT02721017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558328|NCT02721017|Analgesics|analgesics|mesh-ancestor
102558329|NCT02721017|Sensory System Agents|sensory system agents|mesh-ancestor
102558330|NCT02721017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102558331|NCT02721017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102558332|NCT02721017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102558333|NCT02721017|Anesthetics, General|anesthetics, general|mesh-ancestor
102558334|NCT02721017|Anesthetics|anesthetics|mesh-ancestor
102558335|NCT02721641|Trastuzumab|trastuzumab|mesh-list
102558336|NCT02721641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102558337|NCT02721641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102558338|NCT03649061|Etanercept|etanercept|mesh-list
102558339|NCT03649061|Leflunomide|leflunomide|mesh-list
102558340|NCT03649061|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102558341|NCT03649061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102558342|NCT03649061|Analgesics|analgesics|mesh-ancestor
102558343|NCT03649061|Sensory System Agents|sensory system agents|mesh-ancestor
102558344|NCT03649061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102558345|NCT03649061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558346|NCT03649061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102558347|NCT03649061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102558348|NCT03649061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102105318|NCT05816694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102105319|NCT05816694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102105320|NCT05816694|Alkylating Agents|alkylating agents|mesh-ancestor
102105321|NCT05816694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102105322|NCT05816694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102105324|NCT05816694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102558349|NCT03649061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102558350|NCT03649061|Immunologic Factors|immunologic factors|mesh-ancestor
102558351|NCT03649061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102558352|NCT03649061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558353|NCT02265744|Antibodies|antibodies|mesh-list
102558354|NCT02265744|Immunologic Factors|immunologic factors|mesh-ancestor
101578174|NCT02700685|Antioxidants|antioxidants|mesh-ancestor
102558355|NCT02265744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558356|NCT05109143|Indomethacin|indomethacin|mesh-list
102558357|NCT05109143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102558358|NCT05109143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102558359|NCT05109143|Analgesics|analgesics|mesh-ancestor
102558360|NCT05109143|Sensory System Agents|sensory system agents|mesh-ancestor
102558361|NCT05109143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102558362|NCT05109143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558363|NCT05109143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102558364|NCT05109143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102558365|NCT05109143|Gout Suppressants|gout suppressants|mesh-ancestor
102558366|NCT05109143|Tocolytic Agents|tocolytic agents|mesh-ancestor
102558367|NCT05109143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102558368|NCT05109143|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102558369|NCT05109143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102558370|NCT05109143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558371|NCT03614663|Cannabidiol|cannabidiol|mesh-list
102558372|NCT03614663|Anticonvulsants|anticonvulsants|mesh-ancestor
102558373|NCT00085735|Cyclophosphamide|cyclophosphamide|mesh-list
102558374|NCT00085735|Lomustine|lomustine|mesh-list
102558375|NCT00085735|Cisplatin|cisplatin|mesh-list
102558376|NCT00085735|Vincristine|vincristine|mesh-list
102558377|NCT00085735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102558378|NCT00085735|Immunologic Factors|immunologic factors|mesh-ancestor
102558379|NCT00085735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558380|NCT00085735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102558381|NCT00085735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102558382|NCT00085735|Alkylating Agents|alkylating agents|mesh-ancestor
102558383|NCT00085735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558384|NCT00085735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102558385|NCT00085735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102558386|NCT00085735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102558387|NCT00085735|Tubulin Modulators|tubulin modulators|mesh-ancestor
102558388|NCT00085735|Antimitotic Agents|antimitotic agents|mesh-ancestor
102558389|NCT00085735|Mitosis Modulators|mitosis modulators|mesh-ancestor
102558390|NCT03578783|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
102558391|NCT03578783|Anesthetics, Local|anesthetics, local|mesh-ancestor
102558392|NCT03578783|Anesthetics|anesthetics|mesh-ancestor
102558393|NCT03578783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102558394|NCT03578783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558395|NCT03578783|Sensory System Agents|sensory system agents|mesh-ancestor
102558396|NCT03578783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102558397|NCT03578783|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
102558398|NCT05544786|Ritonavir|ritonavir|mesh-list
102558399|NCT05544786|Nirmatrelvir|nirmatrelvir|mesh-list
102558400|NCT05544786|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
102558401|NCT05544786|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102558402|NCT05544786|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102558403|NCT05544786|Protease Inhibitors|protease inhibitors|mesh-ancestor
102558404|NCT05544786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102558405|NCT05544786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558406|NCT05544786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102558407|NCT05544786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102558408|NCT05544786|Antiviral Agents|antiviral agents|mesh-ancestor
102558409|NCT05544786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102558410|NCT05544786|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102558411|NCT05544786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102558412|NCT02726789|Interferons|interferons|mesh-list
102558413|NCT02726789|Interferon-alpha|interferon-alpha|mesh-list
102558414|NCT02726789|Interferon alpha-2|interferon alpha-2|mesh-list
102558415|NCT02726789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102558416|NCT02726789|Entecavir|entecavir|mesh-list
102558417|NCT02726789|REP 2139|rep 2139|mesh-list
102558418|NCT02726789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102558419|NCT02726789|Antiviral Agents|antiviral agents|mesh-ancestor
102558420|NCT02726789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102558421|NCT02726789|Immunologic Factors|immunologic factors|mesh-ancestor
102558422|NCT02726789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558423|NCT02731313|Trastuzumab|trastuzumab|mesh-list
102558424|NCT02731313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102558425|NCT02731313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102558426|NCT02281591|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102558427|NCT02281591|Anticonvulsants|anticonvulsants|mesh-ancestor
102558428|NCT02281591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102558429|NCT02281591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102558430|NCT02281591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102558431|NCT02281591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558432|NCT02731469|Darbepoetin alfa|darbepoetin alfa|mesh-list
102558433|NCT02731469|Hematinics|hematinics|mesh-ancestor
102558434|NCT01944319|Meropenem|meropenem|mesh-list
102558435|NCT01944319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102558436|NCT01944319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102558437|NCT00368303|Paroxetine|paroxetine|mesh-list
102558438|NCT00368303|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102558439|NCT00368303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102558440|NCT00368303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102558441|NCT00368303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558442|NCT00368303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102558443|NCT00368303|Serotonin Agents|serotonin agents|mesh-ancestor
102558444|NCT00368303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558445|NCT00368303|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102558446|NCT00368303|Antidepressive Agents|antidepressive agents|mesh-ancestor
102558447|NCT00368303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102558448|NCT00368303|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102558449|NCT00368303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102558450|NCT00368303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102558451|NCT00368381|Hydrocortisone|hydrocortisone|mesh-list
102558452|NCT00368381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102558453|NCT05020145|Vaccines|vaccines|mesh-list
102558454|NCT05020145|Immunologic Factors|immunologic factors|mesh-ancestor
102558455|NCT05020145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558456|NCT02734355|Amlodipine|amlodipine|mesh-list
102558457|NCT02734355|Telmisartan|telmisartan|mesh-list
102558458|NCT02734355|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
102558459|NCT02734355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102558460|NCT02734355|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102558461|NCT02734355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102558462|NCT02734355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558463|NCT02734355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102558464|NCT02734355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558465|NCT02734355|Vasodilator Agents|vasodilator agents|mesh-ancestor
102558466|NCT02734355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102558467|NCT02734355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102558468|NCT00369395|Volociximab|volociximab|mesh-list
102558469|NCT00369395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102558470|NCT00369395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102558471|NCT00369395|Growth Substances|growth substances|mesh-ancestor
102558472|NCT00369395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558473|NCT00369395|Growth Inhibitors|growth inhibitors|mesh-ancestor
102558474|NCT00369395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102558475|NCT01947907|Hormones|hormones|mesh-list
102558476|NCT01947907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102558477|NCT01947907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558478|NCT01948141|Nintedanib|nintedanib|mesh-list
102558479|NCT01948141|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102558480|NCT01948141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102558481|NCT01948141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102558482|NCT01948141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102558483|NCT01948141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558484|NCT04938323|BCG Vaccine|bcg vaccine|mesh-list
102558485|NCT04938323|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102558486|NCT04938323|Immunologic Factors|immunologic factors|mesh-ancestor
102558487|NCT04938323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558488|NCT05446493|Tadalafil|tadalafil|mesh-list
102558489|NCT05446493|Vasodilator Agents|vasodilator agents|mesh-ancestor
102558490|NCT05446493|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102558491|NCT05446493|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102558492|NCT05446493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102558493|NCT05446493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558494|NCT05446493|Urological Agents|urological agents|mesh-ancestor
102558495|NCT02863055|Nintedanib|nintedanib|mesh-list
102558496|NCT02863055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102558497|NCT02863055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102558498|NCT02863055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102558499|NCT02863055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558500|NCT05445479|Doxycycline|doxycycline|mesh-list
102558501|NCT05445479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102558502|NCT05445479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102558503|NCT05445479|Antimalarials|antimalarials|mesh-ancestor
102558504|NCT05445479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102558505|NCT05445479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102558506|NCT02711735|Vaccines|vaccines|mesh-list
102558507|NCT02711735|Immunologic Factors|immunologic factors|mesh-ancestor
102558508|NCT02711735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558509|NCT05445011|Cyclophosphamide|cyclophosphamide|mesh-list
102558510|NCT05445011|Fludarabine|fludarabine|mesh-list
102558511|NCT05445011|Fludarabine phosphate|fludarabine phosphate|mesh-list
102558512|NCT05445011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102558513|NCT05445011|Immunologic Factors|immunologic factors|mesh-ancestor
102558514|NCT05445011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558515|NCT05445011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102558516|NCT05445011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102558517|NCT05445011|Alkylating Agents|alkylating agents|mesh-ancestor
102558518|NCT05445011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558519|NCT05445011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102558520|NCT05445011|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102558521|NCT05445011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102558522|NCT05445011|Antimetabolites|antimetabolites|mesh-ancestor
102558523|NCT04770155|Bosentan|bosentan|mesh-list
102558524|NCT04770155|Sildenafil Citrate|sildenafil citrate|mesh-list
102558525|NCT04770155|Vasodilator Agents|vasodilator agents|mesh-ancestor
102558526|NCT04770155|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102558527|NCT04770155|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102558528|NCT04770155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102558529|NCT04770155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558530|NCT04770155|Urological Agents|urological agents|mesh-ancestor
102558531|NCT04770155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102558532|NCT04770155|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102558533|NCT04744181|Folic Acid|folic acid|mesh-list
102558534|NCT04744181|Vitamin B Complex|vitamin b complex|mesh-list
102558535|NCT04744181|Vitamins|vitamins|mesh-ancestor
102558536|NCT04744181|Micronutrients|micronutrients|mesh-ancestor
102558537|NCT04744181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558538|NCT04744181|Hematinics|hematinics|mesh-ancestor
102558539|NCT01970345|Mecasermin|mecasermin|mesh-list
102558540|NCT01970345|Growth Substances|growth substances|mesh-ancestor
102558541|NCT01970345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558542|NCT00619931|APD791|apd791|mesh-list
102558543|NCT00619931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102558544|NCT00619931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102558545|NCT00619931|Serotonin Agents|serotonin agents|mesh-ancestor
102558546|NCT00619931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102558547|NCT00619931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558548|NCT00619931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558549|NCT04739111|Antibodies|antibodies|mesh-list
102558550|NCT04739111|Immunoglobulins|immunoglobulins|mesh-list
102558551|NCT04739111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102558552|NCT04739111|Immunologic Factors|immunologic factors|mesh-ancestor
102558553|NCT04739111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558554|NCT04768231|Rifampin|rifampin|mesh-list
102558555|NCT04768231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102558556|NCT04768231|Antitubercular Agents|antitubercular agents|mesh-ancestor
102558557|NCT04768231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102558558|NCT04768231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102558559|NCT04768231|Leprostatic Agents|leprostatic agents|mesh-ancestor
102558560|NCT04768231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102558561|NCT04768231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102558562|NCT04768231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558563|NCT04768231|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102558564|NCT04768231|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102558565|NCT04768231|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102558566|NCT04768231|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102558567|NCT04768231|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102558568|NCT04768231|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102558569|NCT05452187|Immunosuppressive Agents|immunosuppressive agents|mesh-list
102558570|NCT05452187|Immunologic Factors|immunologic factors|mesh-ancestor
102558571|NCT05452187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558572|NCT01889797|Rituximab|rituximab|mesh-list
102558573|NCT01889797|Obinutuzumab|obinutuzumab|mesh-list
102558574|NCT01889797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102558575|NCT01889797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102558576|NCT01889797|Immunologic Factors|immunologic factors|mesh-ancestor
102558577|NCT01889797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558578|NCT01889797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102558580|NCT00369551|Bevacizumab|bevacizumab|mesh-list
102558581|NCT00369551|Carboplatin|carboplatin|mesh-list
102558582|NCT00369551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102558583|NCT00369551|Antibodies|antibodies|mesh-list
102558584|NCT00369551|Immunoglobulins|immunoglobulins|mesh-list
102558585|NCT00369551|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102558586|NCT00369551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102558587|NCT00369551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102558588|NCT00369551|Tubulin Modulators|tubulin modulators|mesh-ancestor
102558589|NCT00369551|Antimitotic Agents|antimitotic agents|mesh-ancestor
102558590|NCT00369551|Mitosis Modulators|mitosis modulators|mesh-ancestor
102558591|NCT00369551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558592|NCT00369551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102558593|NCT00369551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102558594|NCT00369551|Growth Substances|growth substances|mesh-ancestor
102558595|NCT00369551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558596|NCT00369551|Growth Inhibitors|growth inhibitors|mesh-ancestor
102558597|NCT00369551|Immunologic Factors|immunologic factors|mesh-ancestor
102558598|NCT04537793|Ivacaftor|ivacaftor|mesh-list
102558599|NCT04537793|Elexacaftor|elexacaftor|mesh-list
102558600|NCT04537793|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102558601|NCT04537793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102558602|NCT04537793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558603|NCT05451173|Durvalumab|durvalumab|mesh-list
102558604|NCT05451173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102558605|NCT05451173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102558606|NCT05437601|Carotenoids|carotenoids|mesh-list
102558607|NCT05437601|Antioxidants|antioxidants|mesh-ancestor
102558608|NCT05437601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558609|NCT05437601|Protective Agents|protective agents|mesh-ancestor
102558610|NCT05437601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558611|NCT05449145|Vitamin D|vitamin d|mesh-list
102558612|NCT05449145|Vitamins|vitamins|mesh-ancestor
102558613|NCT05449145|Micronutrients|micronutrients|mesh-ancestor
102558614|NCT05449145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558615|NCT05449145|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102558616|NCT05447039|Montelukast|montelukast|mesh-list
102558617|NCT05447039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102558618|NCT05447039|Respiratory System Agents|respiratory system agents|mesh-ancestor
102558619|NCT05447039|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102558620|NCT05447039|Hormone Antagonists|hormone antagonists|mesh-ancestor
102558621|NCT05447039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102558622|NCT05447039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558623|NCT05447039|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102558624|NCT05447039|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102558625|NCT05447039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558626|NCT05446805|Corticosterone|corticosterone|mesh-list
102558627|NCT05446805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102558628|NCT05446415|Glucagon|glucagon|mesh-list
102558629|NCT05446415|Incretins|incretins|mesh-list
102558630|NCT05446415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102558631|NCT05446415|Hormones|hormones|mesh-ancestor
102558632|NCT05446415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102558633|NCT05446415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558634|NCT05448365|Vitamin D|vitamin d|mesh-list
102558635|NCT05448365|Vitamins|vitamins|mesh-list
102558636|NCT05448365|Inositol|inositol|mesh-list
102558637|NCT05448365|Vitamin B 6|vitamin b 6|mesh-list
102558638|NCT05448365|Pyridoxal|pyridoxal|mesh-list
102558639|NCT05448365|Pyridoxine|pyridoxine|mesh-list
102558640|NCT05448365|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
102558641|NCT05448365|Micronutrients|micronutrients|mesh-ancestor
102558642|NCT05448365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558643|NCT05448365|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102558644|NCT05448365|Vitamin B Complex|vitamin b complex|mesh-ancestor
102558645|NCT05448365|Antioxidants|antioxidants|mesh-ancestor
102558646|NCT05448365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558647|NCT05448365|Protective Agents|protective agents|mesh-ancestor
102558648|NCT05448365|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
102558649|NCT05448365|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102558650|NCT05448365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102558651|NCT05448365|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102558652|NCT00370799|Betamethasone|betamethasone|mesh-list
102558653|NCT00370799|Betamethasone Valerate|betamethasone valerate|mesh-list
102558654|NCT00370799|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102558655|NCT00370799|Betamethasone benzoate|betamethasone benzoate|mesh-list
102558656|NCT00370799|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102558657|NCT00370799|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102558658|NCT00370799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102558659|NCT00370799|Glucocorticoids|glucocorticoids|mesh-ancestor
102558660|NCT00370799|Hormones|hormones|mesh-ancestor
102558661|NCT00370799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102558662|NCT00370799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558663|NCT00370799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102558664|NCT00370799|Respiratory System Agents|respiratory system agents|mesh-ancestor
102558665|NCT02661971|Leucovorin|leucovorin|mesh-list
102558666|NCT02661971|Docetaxel|docetaxel|mesh-list
102558667|NCT02661971|Fluorouracil|fluorouracil|mesh-list
102558668|NCT02661971|Oxaliplatin|oxaliplatin|mesh-list
102558669|NCT02661971|Ramucirumab|ramucirumab|mesh-list
102558670|NCT02661971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102558671|NCT02661971|Tubulin Modulators|tubulin modulators|mesh-ancestor
102558672|NCT02661971|Antimitotic Agents|antimitotic agents|mesh-ancestor
102558673|NCT02661971|Mitosis Modulators|mitosis modulators|mesh-ancestor
102558674|NCT02661971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558675|NCT02661971|Antimetabolites|antimetabolites|mesh-ancestor
102558676|NCT02661971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102558677|NCT02661971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102558678|NCT02661971|Immunologic Factors|immunologic factors|mesh-ancestor
102558679|NCT02661971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558680|NCT02661971|Antidotes|antidotes|mesh-ancestor
102558681|NCT02661971|Protective Agents|protective agents|mesh-ancestor
102558682|NCT02661971|Vitamin B Complex|vitamin b complex|mesh-ancestor
102558683|NCT02661971|Vitamins|vitamins|mesh-ancestor
102558684|NCT02661971|Micronutrients|micronutrients|mesh-ancestor
102558685|NCT05442905|Anesthetics|anesthetics|mesh-list
102558686|NCT05442905|Propofol|propofol|mesh-list
102558687|NCT05442905|Sevoflurane|sevoflurane|mesh-list
102558688|NCT05442905|Atracurium|atracurium|mesh-list
102558689|NCT05442905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102558690|NCT05442905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558691|NCT05442905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102558692|NCT05442905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102558693|NCT05442905|Anesthetics, General|anesthetics, general|mesh-ancestor
102558694|NCT05442905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102558695|NCT05442905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102558696|NCT05442905|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102558697|NCT05442905|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102558698|NCT05442905|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102558699|NCT05442905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102558700|NCT05442905|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102558701|NCT05442905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102558702|NCT05442905|Cholinergic Agents|cholinergic agents|mesh-ancestor
102558703|NCT05442905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102558704|NCT05442905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558705|NCT00369863|Triamcinolone|triamcinolone|mesh-list
102558706|NCT00369863|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102558707|NCT00369863|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102558708|NCT00369863|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102558709|NCT00369863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102558710|NCT00369863|Glucocorticoids|glucocorticoids|mesh-ancestor
102558711|NCT00369863|Hormones|hormones|mesh-ancestor
102558712|NCT00369863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102558713|NCT00369863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558714|NCT00369863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102558715|NCT00369863|Immunologic Factors|immunologic factors|mesh-ancestor
102558716|NCT00369863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102558717|NCT00369863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558718|NCT01890343|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102558719|NCT01890343|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102558720|NCT01890343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558721|NCT02588027|Ibuprofen|ibuprofen|mesh-list
102558722|NCT02588027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102558723|NCT02588027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102558724|NCT02588027|Analgesics|analgesics|mesh-ancestor
102558725|NCT02588027|Sensory System Agents|sensory system agents|mesh-ancestor
102558726|NCT02588027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102558727|NCT02588027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558728|NCT02588027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102558729|NCT02588027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102558730|NCT02588027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102558731|NCT02588027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102558732|NCT02588027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558733|NCT04449965|Povidone-Iodine|povidone-iodine|mesh-list
102558734|NCT04449965|Povidone|povidone|mesh-list
102558735|NCT04449965|Plasma Substitutes|plasma substitutes|mesh-ancestor
102558736|NCT04449965|Blood Substitutes|blood substitutes|mesh-ancestor
102558737|NCT04449965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102558738|NCT04449965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102558739|NCT05431673|Doxycycline|doxycycline|mesh-list
102558740|NCT05431673|Ciprofloxacin|ciprofloxacin|mesh-list
102558741|NCT05431673|Rifampin|rifampin|mesh-list
102558742|NCT05431673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102558743|NCT05431673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102558744|NCT05431673|Antimalarials|antimalarials|mesh-ancestor
102558745|NCT05431673|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102558746|NCT05431673|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102558747|NCT05431673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102558748|NCT05431673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102558749|NCT05431673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102558750|NCT05431673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558751|NCT05431673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102558752|NCT05431673|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102558753|NCT05431673|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102558754|NCT05431673|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102558755|NCT05431673|Antitubercular Agents|antitubercular agents|mesh-ancestor
102558756|NCT05431673|Leprostatic Agents|leprostatic agents|mesh-ancestor
102558757|NCT05431673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102558758|NCT05431673|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102558759|NCT05431673|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102558760|NCT05431673|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102558761|NCT05431673|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102558762|NCT05431673|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102558763|NCT05431673|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102558764|NCT01951651|Exenatide|exenatide|mesh-list
102558765|NCT01951651|Glipizide|glipizide|mesh-list
102558766|NCT01951651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102558767|NCT01951651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558768|NCT01951651|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102558769|NCT01951651|Incretins|incretins|mesh-ancestor
102558770|NCT01951651|Hormones|hormones|mesh-ancestor
102558771|NCT01951651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102558772|NCT02466581|Hydroxychloroquine|hydroxychloroquine|mesh-list
102558773|NCT02466581|Sulfasalazine|sulfasalazine|mesh-list
102558774|NCT02466581|Prednisolone|prednisolone|mesh-list
102558775|NCT02466581|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102558776|NCT02466581|Methylprednisolone|methylprednisolone|mesh-list
102558777|NCT02466581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102558778|NCT02466581|Prednisolone acetate|prednisolone acetate|mesh-list
102558779|NCT02466581|Certolizumab Pegol|certolizumab pegol|mesh-list
102558780|NCT02466581|Abatacept|abatacept|mesh-list
102558781|NCT02466581|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102558782|NCT02466581|Prednisolone phosphate|prednisolone phosphate|mesh-list
102558783|NCT02466581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102558784|NCT02466581|Glucocorticoids|glucocorticoids|mesh-ancestor
102558785|NCT02466581|Hormones|hormones|mesh-ancestor
102558786|NCT02466581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102558787|NCT02466581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558788|NCT02466581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102558789|NCT02466581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102558790|NCT02466581|Antiemetics|antiemetics|mesh-ancestor
102558791|NCT02466581|Autonomic Agents|autonomic agents|mesh-ancestor
102558792|NCT02466581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102558793|NCT02466581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102558794|NCT02466581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102558795|NCT02466581|Protective Agents|protective agents|mesh-ancestor
102558796|NCT02466581|Antimalarials|antimalarials|mesh-ancestor
102558797|NCT02466581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102558798|NCT02466581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102558799|NCT02466581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102558800|NCT02466581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612375|NCT02973581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102558801|NCT02466581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558802|NCT02466581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102558803|NCT02466581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102558804|NCT02466581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102558805|NCT02466581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102558806|NCT02466581|Immunologic Factors|immunologic factors|mesh-ancestor
102558807|NCT02466581|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102558808|NCT02466581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102558809|NCT02466581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102558810|NCT02466581|Analgesics|analgesics|mesh-ancestor
102558811|NCT02466581|Sensory System Agents|sensory system agents|mesh-ancestor
102558812|NCT01951963|Ketamine|ketamine|mesh-list
102558813|NCT01951963|Morphine|morphine|mesh-list
102558814|NCT01951963|Analgesics|analgesics|mesh-ancestor
102558815|NCT01951963|Sensory System Agents|sensory system agents|mesh-ancestor
102558816|NCT01951963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102558817|NCT01951963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558818|NCT01951963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102558819|NCT01951963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102558820|NCT01951963|Anesthetics, General|anesthetics, general|mesh-ancestor
102558821|NCT01951963|Anesthetics|anesthetics|mesh-ancestor
102558822|NCT01951963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102558823|NCT01951963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102558824|NCT01951963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102558825|NCT01951963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102558826|NCT01951963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558827|NCT01951963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102558828|NCT01951963|Narcotics|narcotics|mesh-ancestor
102558829|NCT02377271|Bosentan|bosentan|mesh-list
102558830|NCT02377271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102558831|NCT02377271|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102558832|NCT02377271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558833|NCT01894555|Aspirin|aspirin|mesh-list
102558834|NCT01894555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102558835|NCT01894555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102558836|NCT01894555|Analgesics|analgesics|mesh-ancestor
102558837|NCT01894555|Sensory System Agents|sensory system agents|mesh-ancestor
102558838|NCT01894555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102558839|NCT01894555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558840|NCT01894555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102558841|NCT01894555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102558842|NCT01894555|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102558843|NCT01894555|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102558844|NCT01894555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558845|NCT01894555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102558846|NCT01894555|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102558847|NCT01894555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102558848|NCT01894555|Antipyretics|antipyretics|mesh-ancestor
102558849|NCT01953211|Contraceptive Agents|contraceptive agents|mesh-list
102558850|NCT01953211|Norinyl|norinyl|mesh-list
102558851|NCT01953211|Contraceptives, Oral|contraceptives, oral|mesh-list
102558852|NCT01953211|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
102558853|NCT01953211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102558854|NCT01953211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558855|NCT01953211|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102558856|NCT01953211|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102558857|NCT01953211|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102558858|NCT02028221|Metformin|metformin|mesh-list
102558859|NCT02028221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102558860|NCT02028221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558861|NCT05735197|Dapagliflozin|dapagliflozin|mesh-list
102558862|NCT05735197|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102558863|NCT05735197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558864|NCT05735197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102558865|NCT05735197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558866|NCT00370097|Fluticasone|fluticasone|mesh-list
102558867|NCT00370097|Xhance|xhance|mesh-list
102558868|NCT00370097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102558869|NCT00370097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102558870|NCT00370097|Autonomic Agents|autonomic agents|mesh-ancestor
102558871|NCT00370097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102558872|NCT00370097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558873|NCT00370097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102558874|NCT00370097|Respiratory System Agents|respiratory system agents|mesh-ancestor
102558875|NCT00370097|Dermatologic Agents|dermatologic agents|mesh-ancestor
102558876|NCT00370097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102558877|NCT01897285|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102558878|NCT01897285|Laxatives|laxatives|mesh-ancestor
102558879|NCT01897285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102558880|NCT00370253|Terlipressin|terlipressin|mesh-list
102558881|NCT00370253|Norepinephrine|norepinephrine|mesh-list
102558882|NCT00370253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102558883|NCT00370253|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102558884|NCT00370253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102558885|NCT00370253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102558886|NCT00370253|Adrenergic Agents|adrenergic agents|mesh-ancestor
102558887|NCT00370253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102558888|NCT00370253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558889|NCT00370253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558890|NCT00370253|Sympathomimetics|sympathomimetics|mesh-ancestor
102558891|NCT00370253|Autonomic Agents|autonomic agents|mesh-ancestor
102558892|NCT00370253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102558893|NCT01491815|Abatacept|abatacept|mesh-list
102558894|NCT01491815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102558895|NCT01491815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558896|NCT01491815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102558897|NCT01491815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102558898|NCT01491815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102558899|NCT01491815|Immunologic Factors|immunologic factors|mesh-ancestor
102558900|NCT01491815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558901|NCT01491815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102558902|NCT04359953|Azithromycin|azithromycin|mesh-list
102558903|NCT04359953|Hydroxychloroquine|hydroxychloroquine|mesh-list
102558904|NCT04359953|Telmisartan|telmisartan|mesh-list
102558905|NCT04359953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102558906|NCT04359953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102558907|NCT04359953|Antimalarials|antimalarials|mesh-ancestor
102558908|NCT04359953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102558909|NCT04359953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102558910|NCT04359953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102558911|NCT04359953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558912|NCT04359953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102558913|NCT04359953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102558914|NCT04359953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102558915|NCT04359953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102558916|NCT05364515|Clobetasol|clobetasol|mesh-list
102558917|NCT05364515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102558918|NCT05364515|Glucocorticoids|glucocorticoids|mesh-ancestor
102558919|NCT05364515|Hormones|hormones|mesh-ancestor
102558920|NCT05364515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102558921|NCT05364515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558922|NCT01438073|Hormones|hormones|mesh-list
102558923|NCT01438073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102558924|NCT01438073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558925|NCT04338191|Leucovorin|leucovorin|mesh-list
102558926|NCT04338191|Fluorouracil|fluorouracil|mesh-list
102558927|NCT04338191|Oxaliplatin|oxaliplatin|mesh-list
102558928|NCT04338191|Irinotecan|irinotecan|mesh-list
102558929|NCT04338191|Levoleucovorin|levoleucovorin|mesh-list
102558930|NCT04338191|Antimetabolites|antimetabolites|mesh-ancestor
102558931|NCT04338191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558932|NCT04338191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102558933|NCT04338191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102558934|NCT04338191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102558935|NCT04338191|Immunologic Factors|immunologic factors|mesh-ancestor
102558936|NCT04338191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558937|NCT04338191|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102558938|NCT04338191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102558939|NCT04338191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102558940|NCT04338191|Antidotes|antidotes|mesh-ancestor
102558941|NCT04338191|Protective Agents|protective agents|mesh-ancestor
102558942|NCT04338191|Vitamin B Complex|vitamin b complex|mesh-ancestor
102558943|NCT04338191|Vitamins|vitamins|mesh-ancestor
102558944|NCT04338191|Micronutrients|micronutrients|mesh-ancestor
102558945|NCT00371033|Pregabalin|pregabalin|mesh-list
102558946|NCT00371033|Analgesics|analgesics|mesh-ancestor
102558947|NCT00371033|Sensory System Agents|sensory system agents|mesh-ancestor
102105934|NCT04627753|Rituximab|rituximab|mesh-list
102558948|NCT00371033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101578754|NCT01002573|Antipyretics|antipyretics|mesh-ancestor
102558949|NCT00371033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558950|NCT00371033|Anticonvulsants|anticonvulsants|mesh-ancestor
102558952|NCT00371033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102558953|NCT00371033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558954|NCT00371033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102558955|NCT00371033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102558956|NCT00371033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102558957|NCT00371033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102558958|NCT00371033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102558959|NCT00371111|Triamcinolone|triamcinolone|mesh-list
102558960|NCT00371111|Bevacizumab|bevacizumab|mesh-list
102558961|NCT00371111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102558962|NCT00371111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102558963|NCT00371111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102558964|NCT00371111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102558965|NCT00371111|Growth Substances|growth substances|mesh-ancestor
102558966|NCT00371111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558967|NCT00371111|Growth Inhibitors|growth inhibitors|mesh-ancestor
102558968|NCT00371111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102558969|NCT00371111|Glucocorticoids|glucocorticoids|mesh-ancestor
102558970|NCT00371111|Hormones|hormones|mesh-ancestor
102558971|NCT00371111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102558972|NCT05454683|Melatonin|melatonin|mesh-list
102558973|NCT05454683|Antioxidants|antioxidants|mesh-ancestor
102558974|NCT05454683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558975|NCT05454683|Protective Agents|protective agents|mesh-ancestor
102558976|NCT05454683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558977|NCT05454683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102558978|NCT05139095|Apatinib|apatinib|mesh-list
102558979|NCT05139095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102558980|NCT05139095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102558981|NCT05139095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102558982|NCT05139095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558983|NCT04108247|Fluzoparib|fluzoparib|mesh-list
102558984|NCT04108247|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102558985|NCT04108247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102558986|NCT04108247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558987|NCT04108247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102558988|NCT05453435|Entecavir|entecavir|mesh-list
102558989|NCT05453435|Antiviral Agents|antiviral agents|mesh-ancestor
102558990|NCT05453435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102558991|NCT03029845|Propranolol|propranolol|mesh-list
102558992|NCT03029845|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102558993|NCT03029845|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102558994|NCT03029845|Adrenergic Agents|adrenergic agents|mesh-ancestor
102558995|NCT03029845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102558996|NCT03029845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102558997|NCT03029845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102558998|NCT03029845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102558999|NCT03029845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102559000|NCT03029845|Vasodilator Agents|vasodilator agents|mesh-ancestor
102559001|NCT05451719|Capecitabine|capecitabine|mesh-list
102559002|NCT05451719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102559003|NCT05451719|Antimetabolites|antimetabolites|mesh-ancestor
102559004|NCT05451719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559005|NCT05451719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102559006|NCT01955629|Capecitabine|capecitabine|mesh-list
102559007|NCT01955629|Oxaliplatin|oxaliplatin|mesh-list
102559008|NCT01955629|Aflibercept|aflibercept|mesh-list
102559009|NCT01955629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102559010|NCT01955629|Antimetabolites|antimetabolites|mesh-ancestor
102559011|NCT01955629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559012|NCT01955629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102559013|NCT01955629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102559014|NCT01955629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102559015|NCT01955629|Growth Substances|growth substances|mesh-ancestor
102559016|NCT01955629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559017|NCT01955629|Growth Inhibitors|growth inhibitors|mesh-ancestor
102559018|NCT01898689|Ropivacaine|ropivacaine|mesh-list
102559019|NCT01898689|Anesthetics, Local|anesthetics, local|mesh-ancestor
102559020|NCT01898689|Anesthetics|anesthetics|mesh-ancestor
102559021|NCT01898689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102559022|NCT01898689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559023|NCT01898689|Sensory System Agents|sensory system agents|mesh-ancestor
102559024|NCT01898689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102559025|NCT04021121|Linezolid|linezolid|mesh-list
102559026|NCT04021121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102559027|NCT04021121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102559028|NCT04021121|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102559029|NCT04021121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102559030|NCT04021121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559031|NCT05062577|Buprenorphine|buprenorphine|mesh-list
102559032|NCT05062577|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102559033|NCT05062577|ASP8062|asp8062|mesh-list
102559034|NCT05062577|Naloxone|naloxone|mesh-list
102559035|NCT05062577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102559036|NCT05062577|Narcotics|narcotics|mesh-ancestor
102559037|NCT05062577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102559038|NCT05062577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559039|NCT05062577|Analgesics|analgesics|mesh-ancestor
102559040|NCT05062577|Sensory System Agents|sensory system agents|mesh-ancestor
102559041|NCT05062577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102559042|NCT05062577|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102559043|NCT05062577|GABA Modulators|gaba modulators|mesh-ancestor
102559044|NCT05062577|GABA Agents|gaba agents|mesh-ancestor
102559045|NCT05062577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102559046|NCT05062577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559047|NCT05448989|Atropine|atropine|mesh-list
102559048|NCT05448989|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102559049|NCT05448989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102559050|NCT05448989|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102559051|NCT05448989|Autonomic Agents|autonomic agents|mesh-ancestor
102559052|NCT05448989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102559053|NCT05448989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559054|NCT05448989|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102559055|NCT05448989|Respiratory System Agents|respiratory system agents|mesh-ancestor
102559056|NCT05448989|Mydriatics|mydriatics|mesh-ancestor
102559057|NCT05448989|Parasympatholytics|parasympatholytics|mesh-ancestor
102559058|NCT05448989|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102559059|NCT05448989|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102559060|NCT05448989|Cholinergic Agents|cholinergic agents|mesh-ancestor
102559061|NCT05448989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102559062|NCT05448989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559063|NCT00370565|Insulin|insulin|mesh-list
102559064|NCT00370565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102559065|NCT00370565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102559066|NCT00370565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559067|NCT05039723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102559068|NCT05039723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102559069|NCT05039723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102559070|NCT05039723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559071|NCT05039723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102559072|NCT05039723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102559073|NCT05039723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559074|NCT05039723|Cholinergic Agents|cholinergic agents|mesh-ancestor
102559075|NCT05039723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102559076|NCT00370019|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102559077|NCT00370019|Medroxyprogesterone|medroxyprogesterone|mesh-list
102559078|NCT00370019|Estradiol|estradiol|mesh-list
102559079|NCT00370019|Estrogens|estrogens|mesh-ancestor
102559080|NCT00370019|Hormones|hormones|mesh-ancestor
102559081|NCT00370019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102559082|NCT00370019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559083|NCT00370019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102559084|NCT00370019|Contraceptive Agents|contraceptive agents|mesh-ancestor
102559085|NCT00370019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102559086|NCT00370019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102559087|NCT00370019|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102559088|NCT00370019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102559089|NCT00370019|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102559090|NCT00370019|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102559091|NCT00370019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102559092|NCT00370019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102559093|NCT03888131|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
102559094|NCT03888131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102559095|NCT03888131|Respiratory System Agents|respiratory system agents|mesh-ancestor
102559096|NCT01900249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102559097|NCT01900249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102559098|NCT04969211|Iloperidone|iloperidone|mesh-list
102559099|NCT04969211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102559100|NCT04969211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102559101|NCT04969211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102559102|NCT04969211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559103|NCT04969211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102559104|NCT01901575|Remifentanil|remifentanil|mesh-list
102559105|NCT01901575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102559106|NCT01901575|Narcotics|narcotics|mesh-ancestor
102559107|NCT01901575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102559108|NCT01901575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559109|NCT01901575|Analgesics|analgesics|mesh-ancestor
102559110|NCT01901575|Sensory System Agents|sensory system agents|mesh-ancestor
102559111|NCT01901575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102559112|NCT03754049|Dexamethasone|dexamethasone|mesh-list
102559113|NCT03754049|Dexamethasone acetate|dexamethasone acetate|mesh-list
102559114|NCT03754049|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102559115|NCT03754049|BB 1101|bb 1101|mesh-list
102559116|NCT03754049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102559117|NCT03754049|Antiemetics|antiemetics|mesh-ancestor
102559118|NCT03754049|Autonomic Agents|autonomic agents|mesh-ancestor
102559119|NCT03754049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102559120|NCT03754049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559121|NCT03754049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102559122|NCT03754049|Glucocorticoids|glucocorticoids|mesh-ancestor
102559123|NCT03754049|Hormones|hormones|mesh-ancestor
102559124|NCT03754049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102559125|NCT03754049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102559126|NCT03754049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102559127|NCT03754049|Protease Inhibitors|protease inhibitors|mesh-ancestor
102559128|NCT03754049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102559129|NCT03754049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559130|NCT01901809|Dopamine|dopamine|mesh-list
102559131|NCT01901809|Furosemide|furosemide|mesh-list
102559132|NCT01901809|Diuretics|diuretics|mesh-ancestor
102559133|NCT01901809|Natriuretic Agents|natriuretic agents|mesh-ancestor
102559134|NCT01901809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559135|NCT01901809|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102559136|NCT01901809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102559137|NCT01901809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559138|NCT01901809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102559139|NCT01901809|Sympathomimetics|sympathomimetics|mesh-ancestor
102559140|NCT01901809|Autonomic Agents|autonomic agents|mesh-ancestor
102559141|NCT01901809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102559142|NCT01901809|Dopamine Agents|dopamine agents|mesh-ancestor
102559143|NCT01901809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102559144|NCT01901809|Protective Agents|protective agents|mesh-ancestor
102559145|NCT03029533|Leuprolide|leuprolide|mesh-list
102559146|NCT03029533|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102559147|NCT03029533|Fertility Agents|fertility agents|mesh-ancestor
102559148|NCT03029533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102559149|NCT03029533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559150|NCT03029533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102559151|NCT03029533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102559152|NCT04921007|Bupivacaine|bupivacaine|mesh-list
102559153|NCT04921007|Anesthetics, Local|anesthetics, local|mesh-ancestor
102559154|NCT04921007|Anesthetics|anesthetics|mesh-ancestor
102559155|NCT04921007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102559156|NCT04921007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559157|NCT04921007|Sensory System Agents|sensory system agents|mesh-ancestor
102559158|NCT04921007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102559159|NCT01904071|Morphine|morphine|mesh-list
102559160|NCT01904071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102559161|NCT01904071|Narcotics|narcotics|mesh-ancestor
102559162|NCT01904071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102559163|NCT01904071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559164|NCT01904071|Analgesics|analgesics|mesh-ancestor
102559165|NCT01904071|Sensory System Agents|sensory system agents|mesh-ancestor
102559166|NCT01904071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102559167|NCT01907113|Empagliflozin|empagliflozin|mesh-list
102559168|NCT01907113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102559169|NCT01907113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559170|NCT01907113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102559171|NCT01907113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559172|NCT00370643|Insulin|insulin|mesh-list
102559173|NCT00370643|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102559174|NCT00370643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102559175|NCT00370643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559176|NCT01908127|Salicylic Acid|salicylic acid|mesh-list
102559177|NCT01908127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102559178|NCT01908127|Antifungal Agents|antifungal agents|mesh-ancestor
102559179|NCT01908127|Keratolytic Agents|keratolytic agents|mesh-ancestor
102559180|NCT01908127|Dermatologic Agents|dermatologic agents|mesh-ancestor
102559181|NCT04679831|Praziquantel|praziquantel|mesh-list
102559182|NCT04679831|Anthelmintics|anthelmintics|mesh-ancestor
102559183|NCT04679831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102559184|NCT04679831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102559185|NCT01908751|Vitamin D|vitamin d|mesh-list
102559186|NCT01908751|Ergocalciferols|ergocalciferols|mesh-list
102559187|NCT01908751|Cholecalciferol|cholecalciferol|mesh-list
102559188|NCT01908751|Vitamins|vitamins|mesh-list
102559189|NCT01908751|Micronutrients|micronutrients|mesh-ancestor
102559190|NCT01908751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559191|NCT01908751|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102559192|NCT01908751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102559193|NCT00370721|Bevacizumab|bevacizumab|mesh-list
102559194|NCT00370721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102559195|NCT00370721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102559196|NCT00370721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102559197|NCT00370721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102559198|NCT00370721|Growth Substances|growth substances|mesh-ancestor
102559199|NCT00370721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559200|NCT00370721|Growth Inhibitors|growth inhibitors|mesh-ancestor
102559201|NCT01909141|Metformin|metformin|mesh-list
102559202|NCT01909141|Pioglitazone|pioglitazone|mesh-list
102559203|NCT01909141|Carbamide Peroxide|carbamide peroxide|mesh-list
102559204|NCT01909141|Letrozole|letrozole|mesh-list
102559205|NCT01909141|Clomiphene|clomiphene|mesh-list
102559206|NCT01909141|Enclomiphene|enclomiphene|mesh-list
102559207|NCT01909141|Zuclomiphene|zuclomiphene|mesh-list
102559208|NCT01909141|Hormones|hormones|mesh-list
102559209|NCT01909141|Estradiol|estradiol|mesh-list
102559210|NCT01909141|Testosterone|testosterone|mesh-list
102559211|NCT01909141|Progesterone|progesterone|mesh-list
102559212|NCT01909141|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102559213|NCT01909141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102559214|NCT01909141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559215|NCT01909141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559216|NCT01909141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102559217|NCT01909141|Estrogens|estrogens|mesh-ancestor
102559218|NCT01909141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102559219|NCT01909141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102559220|NCT01909141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102559221|NCT01909141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102559222|NCT01909141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102559223|NCT01909141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102559224|NCT01909141|Hormone Antagonists|hormone antagonists|mesh-ancestor
102559225|NCT01909141|Androgens|androgens|mesh-ancestor
102559226|NCT01909141|Progestins|progestins|mesh-ancestor
102559227|NCT01909141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102559228|NCT01909141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102559229|NCT01909141|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102559230|NCT01909141|Fertility Agents|fertility agents|mesh-ancestor
102559231|NCT01909141|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102559232|NCT01909141|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102559233|NCT04486859|Rivaroxaban|rivaroxaban|mesh-list
102559234|NCT04486859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102559235|NCT04486859|Antithrombins|antithrombins|mesh-ancestor
102559236|NCT04486859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102559237|NCT04486859|Protease Inhibitors|protease inhibitors|mesh-ancestor
102559238|NCT04486859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102559239|NCT04486859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559240|NCT04486859|Anticoagulants|anticoagulants|mesh-ancestor
102559241|NCT01910311|Rifampin|rifampin|mesh-list
102559242|NCT01910311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102559243|NCT01910311|Antitubercular Agents|antitubercular agents|mesh-ancestor
102559244|NCT01910311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102559245|NCT01910311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102559246|NCT01910311|Leprostatic Agents|leprostatic agents|mesh-ancestor
102559247|NCT01910311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102559248|NCT01910311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102559249|NCT01910311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559250|NCT01910311|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102559251|NCT01910311|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102559252|NCT01910311|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102559253|NCT01910311|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102559254|NCT01910311|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102559255|NCT01910311|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102559256|NCT04404959|Ropivacaine|ropivacaine|mesh-list
102559257|NCT04404959|Anesthetics|anesthetics|mesh-list
102559258|NCT04404959|Anesthetics, Local|anesthetics, local|mesh-ancestor
102559259|NCT04404959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102559260|NCT04404959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559261|NCT04404959|Sensory System Agents|sensory system agents|mesh-ancestor
102559262|NCT04404959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102559263|NCT04403711|Dexmedetomidine|dexmedetomidine|mesh-list
102559264|NCT04403711|Anesthetics|anesthetics|mesh-list
102559265|NCT04403711|Anesthetics, Local|anesthetics, local|mesh-list
102559266|NCT04403711|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102559267|NCT04403711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102559268|NCT04403711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559269|NCT04403711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102559270|NCT04403711|Analgesics|analgesics|mesh-ancestor
102559271|NCT04403711|Sensory System Agents|sensory system agents|mesh-ancestor
102559272|NCT04403711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102559273|NCT04403711|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102559274|NCT04403711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102559275|NCT04403711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102559276|NCT04403711|Adrenergic Agents|adrenergic agents|mesh-ancestor
102559277|NCT04403711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102559278|NCT04403711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559280|NCT01911169|Cholecalciferol|cholecalciferol|mesh-list
102559281|NCT01911169|Vitamins|vitamins|mesh-list
102559282|NCT01911169|Micronutrients|micronutrients|mesh-ancestor
102559283|NCT01911169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559284|NCT01911169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102559285|NCT01911169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102559286|NCT04403087|Trimebutine|trimebutine|mesh-list
102559287|NCT04403087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102559288|NCT04403087|Parasympatholytics|parasympatholytics|mesh-ancestor
102559289|NCT04403087|Autonomic Agents|autonomic agents|mesh-ancestor
102559290|NCT04403087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102559291|NCT04403087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559292|NCT04358393|Azacitidine|azacitidine|mesh-list
102559293|NCT04358393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102559294|NCT04358393|Antimetabolites|antimetabolites|mesh-ancestor
102559295|NCT04358393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559296|NCT04358393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102559297|NCT04358393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102559298|NCT04748887|Superoxide Dismutase|superoxide dismutase|mesh-list
102559299|NCT04748887|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102559300|NCT04748887|Antioxidants|antioxidants|mesh-ancestor
102559301|NCT04748887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559302|NCT04748887|Protective Agents|protective agents|mesh-ancestor
102559303|NCT04748887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559304|NCT01916629|Sunscreening Agents|sunscreening agents|mesh-list
102559305|NCT01916629|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102559306|NCT01916629|Protective Agents|protective agents|mesh-ancestor
102559307|NCT01916629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559308|NCT01916629|Dermatologic Agents|dermatologic agents|mesh-ancestor
102559309|NCT01916941|Prazosin|prazosin|mesh-list
102559310|NCT01916941|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102559311|NCT01916941|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102559312|NCT01916941|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102559313|NCT01916941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102559314|NCT01916941|Adrenergic Agents|adrenergic agents|mesh-ancestor
102559315|NCT01916941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101579146|NCT02697331|Progesterone|progesterone|mesh-list
102559316|NCT01916941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559317|NCT01916941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559318|NCT04768985|Acalabrutinib|acalabrutinib|mesh-list
102559319|NCT04768985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102559320|NCT04210037|Paclitaxel|paclitaxel|mesh-list
102559321|NCT04210037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102559322|NCT04210037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102559323|NCT04210037|Tubulin Modulators|tubulin modulators|mesh-ancestor
102106288|NCT03582033|Antiemetics|antiemetics|mesh-ancestor
102559324|NCT04210037|Antimitotic Agents|antimitotic agents|mesh-ancestor
102559325|NCT04210037|Mitosis Modulators|mitosis modulators|mesh-ancestor
102559326|NCT04210037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559327|NCT00371501|Aspirin|aspirin|mesh-list
102559328|NCT00371501|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102559329|NCT00371501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102559330|NCT00371501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102559331|NCT00371501|Analgesics|analgesics|mesh-ancestor
102559332|NCT00371501|Sensory System Agents|sensory system agents|mesh-ancestor
102559333|NCT00371501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102559334|NCT00371501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559335|NCT00371501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102559336|NCT00371501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102559337|NCT00371501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102559338|NCT00371501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102559339|NCT00371501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559340|NCT00371501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102559341|NCT00371501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102559342|NCT00371501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102559343|NCT00371501|Antipyretics|antipyretics|mesh-ancestor
102559344|NCT00371501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102559345|NCT00371501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102559346|NCT00371501|Antimetabolites|antimetabolites|mesh-ancestor
102559347|NCT00371501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102559348|NCT00371501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102559349|NCT03251651|Dexmedetomidine|dexmedetomidine|mesh-list
102559350|NCT03251651|Propofol|propofol|mesh-list
102559351|NCT03251651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102559352|NCT03251651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102559353|NCT03251651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559354|NCT03251651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102559355|NCT03251651|Analgesics|analgesics|mesh-ancestor
102559356|NCT03251651|Sensory System Agents|sensory system agents|mesh-ancestor
102559357|NCT03251651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102559358|NCT03251651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102559359|NCT03251651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102559360|NCT03251651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102559361|NCT03251651|Adrenergic Agents|adrenergic agents|mesh-ancestor
102559362|NCT03251651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102559363|NCT03251651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559364|NCT03251651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102559365|NCT03251651|Anesthetics, General|anesthetics, general|mesh-ancestor
102559366|NCT03251651|Anesthetics|anesthetics|mesh-ancestor
102559367|NCT05738707|Vaccines|vaccines|mesh-list
102559368|NCT05738707|Immunologic Factors|immunologic factors|mesh-ancestor
102559369|NCT05738707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559370|NCT05738629|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102559371|NCT05738629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102559372|NCT05349071|Methylprednisolone|methylprednisolone|mesh-list
102559373|NCT05349071|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102559374|NCT05349071|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102559375|NCT05349071|Prednisolone|prednisolone|mesh-list
102559376|NCT05349071|Prednisolone acetate|prednisolone acetate|mesh-list
102559377|NCT05349071|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102559378|NCT05349071|Prednisolone phosphate|prednisolone phosphate|mesh-list
102559379|NCT05349071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102559380|NCT05349071|Antiemetics|antiemetics|mesh-ancestor
102559381|NCT05349071|Autonomic Agents|autonomic agents|mesh-ancestor
102559382|NCT05349071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102559383|NCT05349071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559384|NCT05349071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102559385|NCT05349071|Glucocorticoids|glucocorticoids|mesh-ancestor
102559386|NCT05349071|Hormones|hormones|mesh-ancestor
102559387|NCT05349071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102559388|NCT05349071|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102559389|NCT05349071|Protective Agents|protective agents|mesh-ancestor
102559390|NCT05349071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102559391|NCT05349071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102559392|NCT01929889|Iloperidone|iloperidone|mesh-list
102559393|NCT01929889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102559394|NCT01929889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102559395|NCT01929889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102559396|NCT01929889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559397|NCT01929889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102106363|NCT03497923|Anticonvulsants|anticonvulsants|mesh-ancestor
102559398|NCT05738473|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102559399|NCT05738473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102559401|NCT05725135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102559402|NCT05725135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102559403|NCT05725135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559404|NCT05725135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102559405|NCT05725135|Anesthetics, General|anesthetics, general|mesh-ancestor
102559406|NCT05725135|Anesthetics|anesthetics|mesh-ancestor
102559407|NCT05738317|Paclitaxel|paclitaxel|mesh-list
102559408|NCT05738317|Bevacizumab|bevacizumab|mesh-list
102559409|NCT05738317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102559410|NCT05738317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102559411|NCT05738317|Tubulin Modulators|tubulin modulators|mesh-ancestor
102559412|NCT05738317|Antimitotic Agents|antimitotic agents|mesh-ancestor
102559413|NCT05738317|Mitosis Modulators|mitosis modulators|mesh-ancestor
102559414|NCT05738317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559415|NCT05738317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102559416|NCT05738317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102559417|NCT05738317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102559418|NCT05738317|Growth Substances|growth substances|mesh-ancestor
102559419|NCT05738317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559420|NCT05738317|Growth Inhibitors|growth inhibitors|mesh-ancestor
102559421|NCT02284555|Mupirocin|mupirocin|mesh-list
102559422|NCT02284555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102559423|NCT02284555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102559424|NCT02284555|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102559425|NCT02284555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102559426|NCT02284555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559427|NCT03029689|Raltegravir Potassium|raltegravir potassium|mesh-list
102559428|NCT03029689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102559429|NCT03029689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102559430|NCT03029689|Antiviral Agents|antiviral agents|mesh-ancestor
102559431|NCT03029689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102559432|NCT03029689|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102559433|NCT03029689|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102559434|NCT03029689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102559435|NCT03029689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559436|NCT02287909|Clopidogrel|clopidogrel|mesh-list
102559437|NCT02287909|Ticagrelor|ticagrelor|mesh-list
102559438|NCT02287909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102559439|NCT02287909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102559440|NCT02287909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102559441|NCT02287909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102559442|NCT02287909|Purinergic Agents|purinergic agents|mesh-ancestor
102559443|NCT02287909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102559444|NCT02287909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559445|NCT02287909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559446|NCT00371579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102559447|NCT00371579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102559448|NCT00371579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102559449|NCT00371579|Antimetabolites|antimetabolites|mesh-ancestor
102559450|NCT00371579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559451|NCT00371579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102559452|NCT00371579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102559453|NCT00371579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102559454|NCT02833805|Mycophenolic Acid|mycophenolic acid|mesh-list
102559455|NCT02833805|Cyclophosphamide|cyclophosphamide|mesh-list
102559456|NCT02833805|Fludarabine|fludarabine|mesh-list
102559457|NCT02833805|Tacrolimus|tacrolimus|mesh-list
102559458|NCT02833805|Thymoglobulin|thymoglobulin|mesh-list
102559459|NCT02833805|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102559460|NCT02833805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102559461|NCT02833805|Immunologic Factors|immunologic factors|mesh-ancestor
102559462|NCT02833805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559463|NCT02833805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102559464|NCT02833805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102559465|NCT02833805|Alkylating Agents|alkylating agents|mesh-ancestor
102559466|NCT02833805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559467|NCT02833805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102559468|NCT02833805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102559469|NCT02833805|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102559470|NCT02833805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102559471|NCT02833805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102559472|NCT02833805|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102559474|NCT02833805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102559475|NCT02833805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102559476|NCT02327195|Methylphenidate|methylphenidate|mesh-list
102559477|NCT02327195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102559478|NCT02327195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559479|NCT02327195|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102559480|NCT02327195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102559481|NCT02327195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102559482|NCT02327195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559483|NCT02327195|Dopamine Agents|dopamine agents|mesh-ancestor
102559484|NCT02327195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102559485|NCT04768465|Prednisone|prednisone|mesh-list
102559486|NCT04768465|Bromides|bromides|mesh-list
102559487|NCT04768465|Tacrolimus|tacrolimus|mesh-list
102559488|NCT04768465|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
102559489|NCT04768465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102559490|NCT04768465|Glucocorticoids|glucocorticoids|mesh-ancestor
102559491|NCT04768465|Hormones|hormones|mesh-ancestor
102559492|NCT04768465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102559493|NCT04768465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559494|NCT04768465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102559495|NCT04768465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102559496|NCT04768465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102559497|NCT04768465|Immunologic Factors|immunologic factors|mesh-ancestor
102559498|NCT04768465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102559499|NCT04768465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102559500|NCT04768465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559501|NCT04768465|Anticonvulsants|anticonvulsants|mesh-ancestor
102559502|NCT04768465|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102559503|NCT04768465|Cholinergic Agents|cholinergic agents|mesh-ancestor
102559504|NCT04768465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102559505|NCT01614665|Tacrolimus|tacrolimus|mesh-list
102559506|NCT01614665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102559507|NCT01614665|Immunologic Factors|immunologic factors|mesh-ancestor
102559508|NCT01614665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559509|NCT01614665|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102559510|NCT01614665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102559511|NCT01614665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559512|NCT05691829|Pembrolizumab|pembrolizumab|mesh-list
102559513|NCT05691829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102559514|NCT05691829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102559515|NCT05691829|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102559516|NCT05691829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559517|NCT00371735|Artesunate|artesunate|mesh-list
102559518|NCT00371735|Dapsone|dapsone|mesh-list
102559519|NCT00371735|Chlorproguanil|chlorproguanil|mesh-list
102559520|NCT00371735|Proguanil|proguanil|mesh-list
102559521|NCT00371735|Antimalarials|antimalarials|mesh-ancestor
102559522|NCT00371735|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102559523|NCT00371735|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102559524|NCT00371735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102559525|NCT00371735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102559526|NCT00371735|Antiviral Agents|antiviral agents|mesh-ancestor
102559527|NCT00371735|Schistosomicides|schistosomicides|mesh-ancestor
102559528|NCT00371735|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102559529|NCT00371735|Anthelmintics|anthelmintics|mesh-ancestor
102559530|NCT00371735|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102559531|NCT00371735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102559532|NCT00371735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559533|NCT00371735|Leprostatic Agents|leprostatic agents|mesh-ancestor
102559534|NCT00371735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102559535|NCT00371735|Antimetabolites|antimetabolites|mesh-ancestor
102559536|NCT05052307|Vaccines|vaccines|mesh-list
102559537|NCT05052307|Immunologic Factors|immunologic factors|mesh-ancestor
102559538|NCT05052307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559539|NCT05332457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102559540|NCT05332457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102559541|NCT05332457|Adrenergic Agents|adrenergic agents|mesh-ancestor
102559542|NCT05332457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102559543|NCT05332457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559544|NCT05332457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559545|NCT05417659|Niacin|niacin|mesh-list
102559546|NCT05417659|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102559547|NCT05417659|Antimetabolites|antimetabolites|mesh-ancestor
102559548|NCT05417659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559549|NCT05417659|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102559550|NCT05417659|Vasodilator Agents|vasodilator agents|mesh-ancestor
102559551|NCT05417659|Vitamin B Complex|vitamin b complex|mesh-ancestor
102559552|NCT05417659|Vitamins|vitamins|mesh-ancestor
102559553|NCT05417659|Micronutrients|micronutrients|mesh-ancestor
102559554|NCT05417659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559555|NCT02762513|Axitinib|axitinib|mesh-list
102559556|NCT02762513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102559557|NCT02762513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102559558|NCT02762513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102559559|NCT02762513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559560|NCT02958761|Hyaluronic Acid|hyaluronic acid|mesh-list
102559561|NCT02958761|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102559562|NCT02958761|Immunologic Factors|immunologic factors|mesh-ancestor
102559563|NCT02958761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559564|NCT02958761|Viscosupplements|viscosupplements|mesh-ancestor
102559565|NCT02958761|Protective Agents|protective agents|mesh-ancestor
102559566|NCT05215535|Liver Extracts|liver extracts|mesh-list
102559567|NCT05215535|Hematinics|hematinics|mesh-ancestor
102559568|NCT02767271|Luliconazole|luliconazole|mesh-list
102559569|NCT02767271|Antifungal Agents|antifungal agents|mesh-ancestor
102559570|NCT02767271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102559571|NCT05647993|Azithromycin|azithromycin|mesh-list
102559572|NCT05647993|Cefazolin|cefazolin|mesh-list
102559573|NCT05647993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102559574|NCT05647993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102559575|NCT02741687|Insulin|insulin|mesh-list
102559576|NCT02741687|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102559577|NCT02741687|Insulin Glargine|insulin glargine|mesh-list
102559578|NCT02741687|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102559579|NCT02741687|Insulin Aspart|insulin aspart|mesh-list
102559580|NCT02741687|Insulin Lispro|insulin lispro|mesh-list
102559581|NCT02741687|Insulin Detemir|insulin detemir|mesh-list
102559582|NCT02741687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102559583|NCT02741687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559584|NCT02741687|Incretins|incretins|mesh-ancestor
102559585|NCT02741687|Hormones|hormones|mesh-ancestor
102559586|NCT02741687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102559587|NCT02741687|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102559588|NCT02741687|Protease Inhibitors|protease inhibitors|mesh-ancestor
102559589|NCT02741687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102559590|NCT02741687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559591|NCT05361499|Amoxicillin|amoxicillin|mesh-list
102559592|NCT05361499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102559593|NCT05361499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102559594|NCT04337099|Tempol|tempol|mesh-list
102559595|NCT04337099|TEMPO|tempo|mesh-list
102559596|NCT04337099|TEMPOL-H|tempol-h|mesh-list
102559597|NCT04337099|Antioxidants|antioxidants|mesh-ancestor
102559598|NCT04337099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559599|NCT04337099|Protective Agents|protective agents|mesh-ancestor
102559600|NCT04337099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559601|NCT04337099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102559602|NCT04337099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102559603|NCT04337099|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102559604|NCT04337099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102559605|NCT05630677|Rabeprazole|rabeprazole|mesh-list
102559606|NCT05630677|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102559607|NCT05630677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102559608|NCT05630677|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102559609|NCT05630677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102559610|NCT05630677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559611|NCT05627791|Oxytocin|oxytocin|mesh-list
102559612|NCT05627791|Oxytocics|oxytocics|mesh-ancestor
102559613|NCT05627791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102559614|NCT05627791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559615|NCT02771093|Alogliptin|alogliptin|mesh-list
102559616|NCT02771093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102559617|NCT02771093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559618|NCT02771093|Incretins|incretins|mesh-ancestor
102559619|NCT02771093|Hormones|hormones|mesh-ancestor
102559620|NCT02771093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102559621|NCT02771093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102559622|NCT02771093|Protease Inhibitors|protease inhibitors|mesh-ancestor
102559623|NCT02771093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102559624|NCT02771093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579449|NCT01200329|Melphalan|melphalan|mesh-list
102559625|NCT05306587|Daratumumab|daratumumab|mesh-list
102559626|NCT05306587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102559627|NCT04337879|Oxaliplatin|oxaliplatin|mesh-list
102559628|NCT04337879|Irinotecan|irinotecan|mesh-list
102559629|NCT04337879|Calcium|calcium|mesh-list
102559630|NCT04337879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102559631|NCT04337879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559632|NCT04337879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102559633|NCT04337879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102559634|NCT04337879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102559635|NCT04337879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102559636|NCT04337879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559637|NCT02745353|Naloxegol|naloxegol|mesh-list
102559638|NCT02745353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102559639|NCT02745353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559640|NCT02745353|Sensory System Agents|sensory system agents|mesh-ancestor
102559641|NCT02745353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102559642|NCT04778839|Paclitaxel|paclitaxel|mesh-list
102559643|NCT04778839|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102559644|NCT04778839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102559645|NCT04778839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102559646|NCT04778839|Tubulin Modulators|tubulin modulators|mesh-ancestor
102559647|NCT04778839|Antimitotic Agents|antimitotic agents|mesh-ancestor
102559648|NCT04778839|Mitosis Modulators|mitosis modulators|mesh-ancestor
102559649|NCT04778839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559650|NCT05602207|Abrocitinib|abrocitinib|mesh-list
102559651|NCT05602207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102559652|NCT05602207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102559653|NCT05602207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559654|NCT05598619|Ascorbic Acid|ascorbic acid|mesh-list
102559655|NCT05598619|Vitamins|vitamins|mesh-ancestor
102559656|NCT05598619|Micronutrients|micronutrients|mesh-ancestor
102559657|NCT05598619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559658|NCT05598619|Antioxidants|antioxidants|mesh-ancestor
102559659|NCT05598619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559660|NCT05598619|Protective Agents|protective agents|mesh-ancestor
102559661|NCT02746991|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
102559662|NCT02746991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102559663|NCT02746991|Glucocorticoids|glucocorticoids|mesh-ancestor
102559664|NCT02746991|Hormones|hormones|mesh-ancestor
102559665|NCT02746991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102559666|NCT02746991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559667|NCT02747615|Tranexamic Acid|tranexamic acid|mesh-list
102559668|NCT02747615|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102559669|NCT02747615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102559670|NCT02747615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559671|NCT02747615|Hemostatics|hemostatics|mesh-ancestor
102559672|NCT02747615|Coagulants|coagulants|mesh-ancestor
102559673|NCT02775617|Azithromycin|azithromycin|mesh-list
102559674|NCT02775617|Ivermectin|ivermectin|mesh-list
102559675|NCT02775617|Permethrin|permethrin|mesh-list
102559676|NCT02775617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102559677|NCT02775617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102559678|NCT02775617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102559679|NCT02775617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102559680|NCT02775617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559681|NCT00371813|Varenicline|varenicline|mesh-list
102559682|NCT00371813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102559683|NCT00371813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102559684|NCT00371813|Cholinergic Agents|cholinergic agents|mesh-ancestor
102559685|NCT00371813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102559686|NCT00371813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559687|NCT00371813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559688|NCT02748785|Methotrexate|methotrexate|mesh-list
102559689|NCT02748785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102559690|NCT02748785|Abortifacient Agents|abortifacient agents|mesh-ancestor
102559691|NCT02748785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102559692|NCT02748785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559693|NCT02748785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102559694|NCT02748785|Antimetabolites|antimetabolites|mesh-ancestor
101579514|NCT00640081|Antidotes|antidotes|mesh-ancestor
102559695|NCT02748785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559696|NCT02748785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102559697|NCT02748785|Dermatologic Agents|dermatologic agents|mesh-ancestor
102559698|NCT02748785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102559699|NCT02748785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102559700|NCT02748785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102559701|NCT02748785|Immunologic Factors|immunologic factors|mesh-ancestor
102559702|NCT02748785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102559703|NCT02748785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102559704|NCT02295553|Ketamine|ketamine|mesh-list
102559705|NCT02295553|Propofol|propofol|mesh-list
102559706|NCT02295553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102559707|NCT02295553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102559708|NCT02295553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559709|NCT02295553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102559710|NCT02295553|Anesthetics, General|anesthetics, general|mesh-ancestor
102559711|NCT02295553|Anesthetics|anesthetics|mesh-ancestor
102559712|NCT02295553|Analgesics|analgesics|mesh-ancestor
102559713|NCT02295553|Sensory System Agents|sensory system agents|mesh-ancestor
102559714|NCT02295553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102559715|NCT02295553|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102559716|NCT02295553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102559717|NCT02295553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102559718|NCT02295553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102559719|NCT02295553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559720|NCT02296099|Bupivacaine|bupivacaine|mesh-list
102559721|NCT02296099|Anesthetics, Local|anesthetics, local|mesh-ancestor
102559722|NCT02296099|Anesthetics|anesthetics|mesh-ancestor
102559723|NCT02296099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102559724|NCT02296099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559725|NCT02296099|Sensory System Agents|sensory system agents|mesh-ancestor
102559726|NCT02296099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102559727|NCT05455073|Folic Acid|folic acid|mesh-list
102559728|NCT05455073|Hematinics|hematinics|mesh-ancestor
102559729|NCT05455073|Vitamin B Complex|vitamin b complex|mesh-ancestor
102559730|NCT05455073|Vitamins|vitamins|mesh-ancestor
102559731|NCT05455073|Micronutrients|micronutrients|mesh-ancestor
102559732|NCT05455073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559733|NCT04334993|Blinatumomab|blinatumomab|mesh-list
102559734|NCT04334993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102559735|NCT05349929|Ibuprofen|ibuprofen|mesh-list
102559736|NCT05349929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102559737|NCT05349929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102559738|NCT05349929|Analgesics|analgesics|mesh-ancestor
102559739|NCT05349929|Sensory System Agents|sensory system agents|mesh-ancestor
102559740|NCT05349929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102559741|NCT05349929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559742|NCT05349929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102559743|NCT05349929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102559744|NCT05349929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102559745|NCT05349929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102559746|NCT05349929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559747|NCT04669171|Rituximab|rituximab|mesh-list
102559748|NCT04669171|Lenalidomide|lenalidomide|mesh-list
102559749|NCT04669171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102559750|NCT04669171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102559751|NCT04669171|Immunologic Factors|immunologic factors|mesh-ancestor
102559752|NCT04669171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559753|NCT04669171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102559754|NCT04669171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102559755|NCT04669171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102559756|NCT04669171|Growth Substances|growth substances|mesh-ancestor
102559757|NCT04669171|Growth Inhibitors|growth inhibitors|mesh-ancestor
102559758|NCT04757675|Dexmedetomidine|dexmedetomidine|mesh-list
102559759|NCT04757675|Ketamine|ketamine|mesh-list
102559760|NCT04757675|Esketamine|esketamine|mesh-list
102559761|NCT04757675|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102559762|NCT04757675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102559763|NCT04757675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559764|NCT04757675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102559765|NCT04757675|Analgesics|analgesics|mesh-ancestor
102559766|NCT04757675|Sensory System Agents|sensory system agents|mesh-ancestor
102559767|NCT04757675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102559768|NCT04757675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102559769|NCT04757675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102559770|NCT04757675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102559771|NCT04757675|Adrenergic Agents|adrenergic agents|mesh-ancestor
102559772|NCT04757675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102559773|NCT04757675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559774|NCT04757675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102559775|NCT04757675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102559776|NCT04757675|Anesthetics, General|anesthetics, general|mesh-ancestor
102559777|NCT04757675|Anesthetics|anesthetics|mesh-ancestor
102559778|NCT04757675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102559779|NCT04757675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102559780|NCT04757675|Antidepressive Agents|antidepressive agents|mesh-ancestor
102559781|NCT04757675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102559782|NCT04611529|Ibuprofen|ibuprofen|mesh-list
102559783|NCT04611529|Diclofenac|diclofenac|mesh-list
102559784|NCT04611529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102559785|NCT04611529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102559786|NCT04611529|Analgesics|analgesics|mesh-ancestor
102559787|NCT04611529|Sensory System Agents|sensory system agents|mesh-ancestor
102559788|NCT04611529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102559789|NCT04611529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559790|NCT04611529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102559791|NCT04611529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102559792|NCT04611529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102559793|NCT04611529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102559794|NCT04611529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559795|NCT05323721|Pyrimethamine|pyrimethamine|mesh-list
102559796|NCT05323721|Piperaquine|piperaquine|mesh-list
102559797|NCT05323721|Sulfadoxine|sulfadoxine|mesh-list
102559798|NCT05323721|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
102559799|NCT05323721|Amodiaquine|amodiaquine|mesh-list
102559800|NCT05323721|Artenimol|artenimol|mesh-list
102559801|NCT05323721|Antimalarials|antimalarials|mesh-ancestor
102559802|NCT05323721|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102559803|NCT05323721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102559804|NCT05323721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102559805|NCT05323721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102559806|NCT05323721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102559807|NCT05323721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559808|NCT05323721|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102559809|NCT05288075|Glycopyrrolate|glycopyrrolate|mesh-list
102559810|NCT05288075|Charcoal|charcoal|mesh-list
102559811|NCT05288075|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102559812|NCT05288075|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102559813|NCT05288075|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102559814|NCT05288075|Cholinergic Agents|cholinergic agents|mesh-ancestor
102559815|NCT05288075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102559816|NCT05288075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559817|NCT05288075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559818|NCT05288075|Antidotes|antidotes|mesh-ancestor
102559819|NCT05288075|Protective Agents|protective agents|mesh-ancestor
102559820|NCT05272787|Sunscreening Agents|sunscreening agents|mesh-list
102559821|NCT05272787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102559822|NCT05272787|Protective Agents|protective agents|mesh-ancestor
102559823|NCT05272787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559824|NCT05272787|Dermatologic Agents|dermatologic agents|mesh-ancestor
102559825|NCT05145569|Paclitaxel|paclitaxel|mesh-list
102559826|NCT05145569|Carboplatin|carboplatin|mesh-list
102559827|NCT05145569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102559828|NCT05145569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102559829|NCT05145569|Tubulin Modulators|tubulin modulators|mesh-ancestor
102559830|NCT05145569|Antimitotic Agents|antimitotic agents|mesh-ancestor
102559831|NCT05145569|Mitosis Modulators|mitosis modulators|mesh-ancestor
102559832|NCT05145569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559833|NCT04566991|Deferoxamine|deferoxamine|mesh-list
102559834|NCT04566991|Siderophores|siderophores|mesh-ancestor
102559835|NCT04566991|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102559836|NCT04566991|Chelating Agents|chelating agents|mesh-ancestor
102559837|NCT04566991|Sequestering Agents|sequestering agents|mesh-ancestor
102559838|NCT04566991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559839|NCT03763175|Lovastatin|lovastatin|mesh-list
102559840|NCT03763175|L 647318|l 647318|mesh-list
102559841|NCT03763175|Dihydromevinolin|dihydromevinolin|mesh-list
102559842|NCT03763175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102559843|NCT03763175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102559844|NCT03763175|Antimetabolites|antimetabolites|mesh-ancestor
102559845|NCT03763175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559846|NCT03763175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102559847|NCT03763175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102559848|NCT03763175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102559849|NCT04365049|Paclitaxel|paclitaxel|mesh-list
102559850|NCT04365049|Gemcitabine|gemcitabine|mesh-list
102559851|NCT04365049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102559852|NCT04365049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102559853|NCT04365049|Tubulin Modulators|tubulin modulators|mesh-ancestor
102559854|NCT04365049|Antimitotic Agents|antimitotic agents|mesh-ancestor
102559855|NCT04365049|Mitosis Modulators|mitosis modulators|mesh-ancestor
102559856|NCT04365049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559857|NCT04365049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102559858|NCT04365049|Antimetabolites|antimetabolites|mesh-ancestor
102559859|NCT03092011|Clonidine|clonidine|mesh-list
102559860|NCT03092011|Morphine|morphine|mesh-list
102559861|NCT03092011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102559862|NCT03092011|Narcotics|narcotics|mesh-ancestor
102559863|NCT03092011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102559864|NCT03092011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559865|NCT03092011|Analgesics|analgesics|mesh-ancestor
102559866|NCT03092011|Sensory System Agents|sensory system agents|mesh-ancestor
102559867|NCT03092011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102559868|NCT03092011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102559869|NCT03092011|Sympatholytics|sympatholytics|mesh-ancestor
102559870|NCT03092011|Autonomic Agents|autonomic agents|mesh-ancestor
102559871|NCT03092011|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102559872|NCT03092011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102559873|NCT03092011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102559874|NCT03092011|Adrenergic Agents|adrenergic agents|mesh-ancestor
102559875|NCT03092011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102559876|NCT03092011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559877|NCT00372515|Gefitinib|gefitinib|mesh-list
102559878|NCT00372515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102559879|NCT00372515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102559880|NCT00372515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102559881|NCT00372515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559882|NCT04448119|Favipiravir|favipiravir|mesh-list
102559883|NCT04448119|Antiviral Agents|antiviral agents|mesh-ancestor
102559884|NCT04448119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102559885|NCT03047473|Avelumab|avelumab|mesh-list
102559886|NCT03047473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102559887|NCT03047473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102559888|NCT03069131|Rifaximin|rifaximin|mesh-list
102559889|NCT03069131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102559890|NCT03069131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102559891|NCT03069131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102559892|NCT02990845|Pembrolizumab|pembrolizumab|mesh-list
102559893|NCT02990845|Leuprolide|leuprolide|mesh-list
102559894|NCT02990845|Exemestane|exemestane|mesh-list
102559895|NCT02990845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102559896|NCT02990845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102559897|NCT02990845|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102559898|NCT02990845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559899|NCT02990845|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102559900|NCT02990845|Fertility Agents|fertility agents|mesh-ancestor
102559901|NCT02990845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102559902|NCT02990845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559903|NCT02990845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102559904|NCT02990845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102559905|NCT02990845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102559906|NCT02990845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102559907|NCT02990845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102559908|NCT02990845|Hormone Antagonists|hormone antagonists|mesh-ancestor
102559909|NCT02990845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102559910|NCT04438213|Ertugliflozin|ertugliflozin|mesh-list
102559911|NCT04438213|Metolazone|metolazone|mesh-list
102559912|NCT04438213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102559913|NCT04438213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559914|NCT04438213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102559915|NCT04438213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559916|NCT04438213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102559917|NCT04438213|Diuretics|diuretics|mesh-ancestor
102559918|NCT04438213|Natriuretic Agents|natriuretic agents|mesh-ancestor
102559919|NCT04438213|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102559920|NCT04438213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102559921|NCT01987219|Bromides|bromides|mesh-list
102559922|NCT01987219|Albuterol|albuterol|mesh-list
102559923|NCT01987219|Ipratropium|ipratropium|mesh-list
102559924|NCT01987219|Anticonvulsants|anticonvulsants|mesh-ancestor
102559925|NCT01987219|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102559926|NCT01987219|Autonomic Agents|autonomic agents|mesh-ancestor
102559927|NCT01987219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102559928|NCT01987219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106888|NCT02099877|Fentanyl|fentanyl|mesh-list
102559929|NCT01987219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102559930|NCT01987219|Respiratory System Agents|respiratory system agents|mesh-ancestor
102559931|NCT01987219|Tocolytic Agents|tocolytic agents|mesh-ancestor
102559932|NCT01987219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102559933|NCT01987219|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102559934|NCT01987219|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102559935|NCT01987219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102559936|NCT01987219|Adrenergic Agents|adrenergic agents|mesh-ancestor
102559937|NCT01987219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102559938|NCT01987219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559939|NCT01987219|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102559940|NCT01987219|Cholinergic Agents|cholinergic agents|mesh-ancestor
102559941|NCT04265053|Ketorolac|ketorolac|mesh-list
102559942|NCT04265053|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102559943|NCT04265053|Estradiol|estradiol|mesh-list
102559944|NCT04265053|Testosterone|testosterone|mesh-list
102559945|NCT04265053|Ganirelix|ganirelix|mesh-list
102559946|NCT04265053|Estrogens|estrogens|mesh-ancestor
102559947|NCT04265053|Hormones|hormones|mesh-ancestor
102559948|NCT04265053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102559949|NCT04265053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559950|NCT04265053|Androgens|androgens|mesh-ancestor
102559951|NCT04265053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102559952|NCT04265053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102559953|NCT04265053|Analgesics|analgesics|mesh-ancestor
102559954|NCT04265053|Sensory System Agents|sensory system agents|mesh-ancestor
102559955|NCT04265053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102559956|NCT04265053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102559957|NCT04265053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102559958|NCT04265053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102559959|NCT04265053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102559960|NCT04265053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559961|NCT04265053|Hormone Antagonists|hormone antagonists|mesh-ancestor
102559962|NCT04332497|Ibuprofen|ibuprofen|mesh-list
102559963|NCT04332497|Fentanyl|fentanyl|mesh-list
102559964|NCT04332497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102559965|NCT04332497|Narcotics|narcotics|mesh-ancestor
102559966|NCT04332497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102559967|NCT04332497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559968|NCT04332497|Analgesics|analgesics|mesh-ancestor
102559969|NCT04332497|Sensory System Agents|sensory system agents|mesh-ancestor
102559970|NCT04332497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102559971|NCT04332497|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102559972|NCT04332497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102559973|NCT04332497|Anesthetics, General|anesthetics, general|mesh-ancestor
102559974|NCT04332497|Anesthetics|anesthetics|mesh-ancestor
102559975|NCT04332497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102559976|NCT04332497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102559977|NCT04332497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102559978|NCT04332497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102559979|NCT04332497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102559980|NCT04332497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102559981|NCT04332497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559982|NCT02633137|Cytarabine|cytarabine|mesh-list
102559983|NCT02633137|Lenalidomide|lenalidomide|mesh-list
102559984|NCT02633137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102559985|NCT02633137|Antimetabolites|antimetabolites|mesh-ancestor
102559986|NCT02633137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102559987|NCT02633137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102559988|NCT02633137|Antiviral Agents|antiviral agents|mesh-ancestor
102559989|NCT02633137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102559990|NCT02633137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102559991|NCT02633137|Immunologic Factors|immunologic factors|mesh-ancestor
102559992|NCT02633137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102559993|NCT02633137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102559994|NCT02633137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102559995|NCT02633137|Growth Substances|growth substances|mesh-ancestor
102559996|NCT02633137|Growth Inhibitors|growth inhibitors|mesh-ancestor
102559997|NCT04258397|Pirfenidone|pirfenidone|mesh-list
102559998|NCT04258397|Analgesics|analgesics|mesh-ancestor
102559999|NCT04258397|Sensory System Agents|sensory system agents|mesh-ancestor
102560000|NCT04258397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102560001|NCT04258397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560002|NCT04258397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102560003|NCT04258397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102106960|NCT03415646|Morphine|morphine|mesh-list
102560004|NCT04258397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102560005|NCT04258397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102560006|NCT04258397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102560007|NCT04707209|Sirolimus|sirolimus|mesh-list
102560008|NCT04707209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102560009|NCT04707209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102560010|NCT04707209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102560011|NCT04707209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102560012|NCT04707209|Antifungal Agents|antifungal agents|mesh-ancestor
102560013|NCT04707209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102560014|NCT04707209|Immunologic Factors|immunologic factors|mesh-ancestor
102560015|NCT04707209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560016|NCT01989793|Losartan|losartan|mesh-list
102560017|NCT01989793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102560018|NCT01989793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102560019|NCT01989793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101579862|NCT02846545|Golimumab|golimumab|mesh-list
102560020|NCT01989793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102560021|NCT01989793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560022|NCT01992523|Ticagrelor|ticagrelor|mesh-list
102560023|NCT01992523|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102560024|NCT01992523|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102560025|NCT01992523|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102560026|NCT01992523|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102560027|NCT01992523|Purinergic Agents|purinergic agents|mesh-ancestor
102560028|NCT01992523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102560029|NCT01992523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560030|NCT01992523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560031|NCT04186247|Azithromycin|azithromycin|mesh-list
102560032|NCT04186247|Metronidazole|metronidazole|mesh-list
102560033|NCT04186247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102560034|NCT04186247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102560035|NCT04186247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102560036|NCT04186247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102560037|NCT04181255|Poractant alfa|poractant alfa|mesh-list
102560038|NCT04181255|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
102560039|NCT04181255|Respiratory System Agents|respiratory system agents|mesh-ancestor
102560040|NCT00373373|Sorafenib|sorafenib|mesh-list
102560041|NCT00373373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102560042|NCT00373373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102560043|NCT00373373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102560044|NCT00373373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560045|NCT00373451|Heparin|heparin|mesh-list
102560046|NCT00373451|Calcium heparin|calcium heparin|mesh-list
102560047|NCT00373451|Bivalirudin|bivalirudin|mesh-list
102560048|NCT00373451|Abciximab|abciximab|mesh-list
102560049|NCT00373451|Anticoagulants|anticoagulants|mesh-ancestor
102560050|NCT00373451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102560051|NCT00373451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102560052|NCT00373451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560053|NCT00373451|Antithrombins|antithrombins|mesh-ancestor
102560054|NCT00373451|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102560055|NCT00373451|Protease Inhibitors|protease inhibitors|mesh-ancestor
102560056|NCT00373451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102560057|NCT00373451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102560058|NCT01387763|Interferons|interferons|mesh-list
102560059|NCT01387763|Interferon-alpha|interferon-alpha|mesh-list
102560060|NCT01387763|Interferon alpha-2|interferon alpha-2|mesh-list
102560061|NCT01387763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102560062|NCT01387763|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102560063|NCT01387763|Hydroxyurea|hydroxyurea|mesh-list
102560064|NCT01387763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102560065|NCT01387763|Antiviral Agents|antiviral agents|mesh-ancestor
102560066|NCT01387763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102560067|NCT01387763|Immunologic Factors|immunologic factors|mesh-ancestor
102560068|NCT01387763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560069|NCT01387763|Antisickling Agents|antisickling agents|mesh-ancestor
102560070|NCT01387763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102560071|NCT01387763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560072|NCT01387763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102560073|NCT00373061|Omalizumab|omalizumab|mesh-list
102560074|NCT00373061|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102560075|NCT00373061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102560076|NCT00373061|Respiratory System Agents|respiratory system agents|mesh-ancestor
102560077|NCT00707213|Deoxyglucose|deoxyglucose|mesh-list
102560078|NCT00707213|Antimetabolites|antimetabolites|mesh-ancestor
102560079|NCT00707213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560080|NCT00707213|Antiviral Agents|antiviral agents|mesh-ancestor
102560081|NCT00707213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102560082|NCT01993849|Acetylcysteine|acetylcysteine|mesh-list
102560083|NCT01993849|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102560084|NCT01993849|Antiviral Agents|antiviral agents|mesh-ancestor
102560085|NCT01993849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102560086|NCT01993849|Expectorants|expectorants|mesh-ancestor
102560087|NCT01993849|Respiratory System Agents|respiratory system agents|mesh-ancestor
102560088|NCT01993849|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102560089|NCT01993849|Antioxidants|antioxidants|mesh-ancestor
102560090|NCT01993849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560091|NCT01993849|Protective Agents|protective agents|mesh-ancestor
102560092|NCT01993849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560093|NCT01993849|Antidotes|antidotes|mesh-ancestor
102560094|NCT02778113|Glucagon|glucagon|mesh-list
102560095|NCT02778113|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102560096|NCT02778113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102560097|NCT02778113|Hormones|hormones|mesh-ancestor
102560098|NCT02778113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102560099|NCT02778113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560100|NCT02778113|Incretins|incretins|mesh-ancestor
102560101|NCT04982237|Paclitaxel|paclitaxel|mesh-list
102560102|NCT04982237|Bevacizumab|bevacizumab|mesh-list
102560103|NCT04982237|Carboplatin|carboplatin|mesh-list
102560104|NCT04982237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102560105|NCT04982237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102560106|NCT04982237|Tubulin Modulators|tubulin modulators|mesh-ancestor
102560107|NCT04982237|Antimitotic Agents|antimitotic agents|mesh-ancestor
102560108|NCT04982237|Mitosis Modulators|mitosis modulators|mesh-ancestor
102560109|NCT04982237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560110|NCT04982237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102560111|NCT04982237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102560112|NCT04982237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102560113|NCT04982237|Growth Substances|growth substances|mesh-ancestor
102560114|NCT04982237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560115|NCT04982237|Growth Inhibitors|growth inhibitors|mesh-ancestor
102560116|NCT01996657|Warfarin|warfarin|mesh-list
102560117|NCT01996657|Anticoagulants|anticoagulants|mesh-ancestor
102560118|NCT02316379|Xenon|xenon|mesh-list
102560119|NCT02316379|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102560120|NCT02316379|Anesthetics, General|anesthetics, general|mesh-ancestor
102560121|NCT02316379|Anesthetics|anesthetics|mesh-ancestor
102560122|NCT02316379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102560123|NCT02316379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560124|NCT02303977|Gemcitabine|gemcitabine|mesh-list
102560125|NCT02303977|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102560126|NCT02303977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102560127|NCT02303977|Antimetabolites|antimetabolites|mesh-ancestor
102560128|NCT02303977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560129|NCT02303977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102560130|NCT01997515|Ketamine|ketamine|mesh-list
102560131|NCT01997515|Analgesics|analgesics|mesh-ancestor
102560132|NCT01997515|Sensory System Agents|sensory system agents|mesh-ancestor
102560133|NCT01997515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102560134|NCT01997515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560135|NCT01997515|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102560136|NCT01997515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102560137|NCT01997515|Anesthetics, General|anesthetics, general|mesh-ancestor
102560138|NCT01997515|Anesthetics|anesthetics|mesh-ancestor
102560139|NCT01997515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102560140|NCT01997515|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102560141|NCT01997515|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102560142|NCT01997515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102560143|NCT01997515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560144|NCT04333823|Dapagliflozin|dapagliflozin|mesh-list
102560145|NCT04333823|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102560146|NCT04333823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560147|NCT04333823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102560148|NCT04333823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560149|NCT01997905|Protein S|protein s|mesh-list
102560150|NCT01997905|Anticoagulants|anticoagulants|mesh-ancestor
102560151|NCT02788019|Ropivacaine|ropivacaine|mesh-list
102560152|NCT02788019|Anesthetics, Local|anesthetics, local|mesh-ancestor
102560153|NCT02788019|Anesthetics|anesthetics|mesh-ancestor
102560154|NCT02788019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102560155|NCT02788019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560156|NCT02788019|Sensory System Agents|sensory system agents|mesh-ancestor
102560157|NCT02788019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102560158|NCT02788097|Progesterone|progesterone|mesh-list
102560159|NCT02788097|Progestins|progestins|mesh-ancestor
102560161|NCT02788097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102560162|NCT02788097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560163|NCT02789033|Isosorbide|isosorbide|mesh-list
102560164|NCT02789033|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
102560165|NCT02789033|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
102560166|NCT02789033|Chitosan|chitosan|mesh-list
102560167|NCT02789033|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102560168|NCT02789033|Diuretics|diuretics|mesh-ancestor
102560169|NCT02789033|Natriuretic Agents|natriuretic agents|mesh-ancestor
102560170|NCT02789033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560171|NCT02789033|Vasodilator Agents|vasodilator agents|mesh-ancestor
102560172|NCT02789033|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102560173|NCT02789033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560174|NCT02789033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102560175|NCT02789033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102560176|NCT02789033|Antimetabolites|antimetabolites|mesh-ancestor
102560177|NCT02789033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102560178|NCT02789033|Chelating Agents|chelating agents|mesh-ancestor
102560179|NCT02789033|Sequestering Agents|sequestering agents|mesh-ancestor
102560180|NCT02789033|Hemostatics|hemostatics|mesh-ancestor
102560181|NCT02789033|Coagulants|coagulants|mesh-ancestor
102560182|NCT00372827|Travoprost|travoprost|mesh-list
102560183|NCT00372827|Brinzolamide|brinzolamide|mesh-list
102560184|NCT00372827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102560185|NCT00372827|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102560186|NCT00372827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102560187|NCT00372827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560188|NCT02278315|Dexamethasone|dexamethasone|mesh-list
102560189|NCT02278315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102560190|NCT02278315|Antiemetics|antiemetics|mesh-ancestor
102560191|NCT02278315|Autonomic Agents|autonomic agents|mesh-ancestor
102560192|NCT02278315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102560193|NCT02278315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560194|NCT02278315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102560195|NCT02278315|Glucocorticoids|glucocorticoids|mesh-ancestor
102560196|NCT02278315|Hormones|hormones|mesh-ancestor
102560197|NCT02278315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102560198|NCT02278315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102560199|NCT02278315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102560200|NCT02795117|Ivermectin|ivermectin|mesh-list
102560201|NCT02795117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102560202|NCT02795117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102560203|NCT02882633|Bupivacaine|bupivacaine|mesh-list
102560204|NCT02882633|Anesthetics, Local|anesthetics, local|mesh-ancestor
102560205|NCT02882633|Anesthetics|anesthetics|mesh-ancestor
102560206|NCT02882633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102560207|NCT02882633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560208|NCT02882633|Sensory System Agents|sensory system agents|mesh-ancestor
102560209|NCT02882633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102560210|NCT00373607|Artesunate|artesunate|mesh-list
102560211|NCT00373607|Piperaquine|piperaquine|mesh-list
102560212|NCT00373607|Mefloquine|mefloquine|mesh-list
102560213|NCT00373607|Antimalarials|antimalarials|mesh-ancestor
102560214|NCT00373607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102560215|NCT00373607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102560216|NCT00373607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102560217|NCT00373607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102560218|NCT00373607|Antiviral Agents|antiviral agents|mesh-ancestor
102560219|NCT00373607|Schistosomicides|schistosomicides|mesh-ancestor
102560220|NCT00373607|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102560221|NCT00373607|Anthelmintics|anthelmintics|mesh-ancestor
102560222|NCT02882711|Ketamine|ketamine|mesh-list
102560223|NCT02882711|Analgesics|analgesics|mesh-ancestor
102560224|NCT02882711|Sensory System Agents|sensory system agents|mesh-ancestor
102560225|NCT02882711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102560226|NCT02882711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560227|NCT02882711|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102560228|NCT02882711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102560229|NCT02882711|Anesthetics, General|anesthetics, general|mesh-ancestor
102560230|NCT02882711|Anesthetics|anesthetics|mesh-ancestor
102560231|NCT02882711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102560232|NCT02882711|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102560233|NCT02882711|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102560234|NCT02882711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101580049|NCT01195103|Fentanyl|fentanyl|mesh-list
102560235|NCT02882711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560236|NCT02794337|Sorafenib|sorafenib|mesh-list
102560237|NCT02794337|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102560238|NCT02794337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102560239|NCT02794337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102560240|NCT02794337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102560241|NCT02794337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560242|NCT02590523|Moxifloxacin|moxifloxacin|mesh-list
102560243|NCT02590523|Vancomycin|vancomycin|mesh-list
102560244|NCT02590523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102560245|NCT02590523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102560246|NCT02590523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102560247|NCT02590523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102560248|NCT02590523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102560249|NCT02590523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560250|NCT02590523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102560251|NCT02895035|Ketorolac|ketorolac|mesh-list
102560252|NCT02895035|Phenylephrine|phenylephrine|mesh-list
102560253|NCT02895035|Epinephrine|epinephrine|mesh-list
102560254|NCT02895035|Oxymetazoline|oxymetazoline|mesh-list
102560255|NCT02895035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102560256|NCT02895035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102560257|NCT02895035|Adrenergic Agents|adrenergic agents|mesh-ancestor
102560258|NCT02895035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102560259|NCT02895035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560260|NCT02895035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560261|NCT02895035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102560262|NCT02895035|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102560263|NCT02895035|Autonomic Agents|autonomic agents|mesh-ancestor
102560264|NCT02895035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102560265|NCT02895035|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102560266|NCT02895035|Respiratory System Agents|respiratory system agents|mesh-ancestor
102560267|NCT02895035|Mydriatics|mydriatics|mesh-ancestor
102560268|NCT02895035|Sympathomimetics|sympathomimetics|mesh-ancestor
102560269|NCT02895035|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102560270|NCT02895035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102560271|NCT02895035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102560272|NCT02895035|Analgesics|analgesics|mesh-ancestor
102560273|NCT02895035|Sensory System Agents|sensory system agents|mesh-ancestor
102560274|NCT02895035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102560275|NCT02895035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102560276|NCT02895035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102560277|NCT02895035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102560278|NCT02895035|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102560279|NCT02895035|Nasal Decongestants|nasal decongestants|mesh-ancestor
102560280|NCT02895035|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102560281|NCT02895035|Protective Agents|protective agents|mesh-ancestor
102560282|NCT02802449|Vitamin D|vitamin d|mesh-list
102560283|NCT02802449|Ergocalciferols|ergocalciferols|mesh-list
102560284|NCT02802449|Cholecalciferol|cholecalciferol|mesh-list
102560285|NCT02802449|Calcifediol|calcifediol|mesh-list
102560286|NCT02802449|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
102560287|NCT02802449|Vitamins|vitamins|mesh-list
102560288|NCT02802449|Micronutrients|micronutrients|mesh-ancestor
102560289|NCT02802449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560290|NCT02802449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102560291|NCT02802449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102560292|NCT02803229|Amphetamine|amphetamine|mesh-list
102560293|NCT02803229|Adderall|adderall|mesh-list
102560294|NCT02803229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102560295|NCT02803229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560296|NCT02803229|Sympathomimetics|sympathomimetics|mesh-ancestor
102560297|NCT02803229|Autonomic Agents|autonomic agents|mesh-ancestor
102560298|NCT02803229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102560299|NCT02803229|Dopamine Agents|dopamine agents|mesh-ancestor
102560300|NCT02803229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102560301|NCT02803229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560302|NCT02803229|Adrenergic Agents|adrenergic agents|mesh-ancestor
102560303|NCT02803229|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102560304|NCT02803229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102560305|NCT02803229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102560306|NCT02803229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102107257|NCT03414164|Protective Agents|protective agents|mesh-ancestor
102560307|NCT01938001|Rituximab|rituximab|mesh-list
102560308|NCT01938001|Lenalidomide|lenalidomide|mesh-list
102560309|NCT01938001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102560310|NCT01938001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102560311|NCT01938001|Immunologic Factors|immunologic factors|mesh-ancestor
102560312|NCT01938001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560313|NCT01938001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102560314|NCT01938001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102560315|NCT01938001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102560316|NCT01938001|Growth Substances|growth substances|mesh-ancestor
102560317|NCT01938001|Growth Inhibitors|growth inhibitors|mesh-ancestor
102560318|NCT02805179|Temozolomide|temozolomide|mesh-list
102560319|NCT02805179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102560320|NCT02805179|Alkylating Agents|alkylating agents|mesh-ancestor
102560321|NCT02805179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560322|NCT02805179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102560323|NCT02896595|Anesthetics|anesthetics|mesh-list
102560324|NCT02896595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102560325|NCT02896595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560326|NCT02003911|Azithromycin|azithromycin|mesh-list
102560327|NCT02003911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102560328|NCT02003911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102560329|NCT04147351|Bevacizumab|bevacizumab|mesh-list
102560330|NCT04147351|Atezolizumab|atezolizumab|mesh-list
102560331|NCT04147351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102560332|NCT04147351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102560333|NCT04147351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102560334|NCT04147351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102560335|NCT04147351|Growth Substances|growth substances|mesh-ancestor
102560336|NCT04147351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560337|NCT04147351|Growth Inhibitors|growth inhibitors|mesh-ancestor
102560338|NCT04147351|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102560339|NCT04147351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560340|NCT02004613|Dexmedetomidine|dexmedetomidine|mesh-list
102560341|NCT02004613|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102560342|NCT02004613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102560343|NCT02004613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560344|NCT02004613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102560345|NCT02004613|Analgesics|analgesics|mesh-ancestor
102560346|NCT02004613|Sensory System Agents|sensory system agents|mesh-ancestor
102560347|NCT02004613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102560348|NCT02004613|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102560349|NCT02004613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102560350|NCT02004613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102560351|NCT02004613|Adrenergic Agents|adrenergic agents|mesh-ancestor
102560352|NCT02004613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102560353|NCT02004613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560354|NCT01754779|Potassium Citrate|potassium citrate|mesh-list
102560355|NCT01754779|Citric Acid|citric acid|mesh-list
102560356|NCT01754779|Sodium Citrate|sodium citrate|mesh-list
102560357|NCT01754779|Anticoagulants|anticoagulants|mesh-ancestor
102560358|NCT01754779|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102560359|NCT01754779|Chelating Agents|chelating agents|mesh-ancestor
102560360|NCT01754779|Sequestering Agents|sequestering agents|mesh-ancestor
102560361|NCT01754779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560362|NCT01754779|Diuretics|diuretics|mesh-ancestor
102560363|NCT01754779|Natriuretic Agents|natriuretic agents|mesh-ancestor
102560364|NCT01754779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560365|NCT01754779|Expectorants|expectorants|mesh-ancestor
102560366|NCT01754779|Respiratory System Agents|respiratory system agents|mesh-ancestor
102560367|NCT02149277|Lenograstim|lenograstim|mesh-list
102560368|NCT02149277|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102560369|NCT02149277|Immunologic Factors|immunologic factors|mesh-ancestor
102560370|NCT02149277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560371|NCT02896907|Calcium, Dietary|calcium, dietary|mesh-list
102560372|NCT02896907|Vitamins|vitamins|mesh-list
102560373|NCT02896907|Leucovorin|leucovorin|mesh-list
102560374|NCT02896907|Ascorbic Acid|ascorbic acid|mesh-list
102560375|NCT02896907|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
102560376|NCT02896907|Tetrahydrofolates|tetrahydrofolates|mesh-list
102560377|NCT02896907|Fluorouracil|fluorouracil|mesh-list
102560378|NCT02896907|Oxaliplatin|oxaliplatin|mesh-list
102560379|NCT02896907|Irinotecan|irinotecan|mesh-list
102560380|NCT02896907|Camptothecin|camptothecin|mesh-list
102560381|NCT02896907|Calcium|calcium|mesh-list
102560382|NCT02896907|Levoleucovorin|levoleucovorin|mesh-list
102560383|NCT02896907|Micronutrients|micronutrients|mesh-ancestor
102560384|NCT02896907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560385|NCT02896907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102560386|NCT02896907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102560387|NCT02896907|Antimetabolites|antimetabolites|mesh-ancestor
102560388|NCT02896907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560389|NCT02896907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102560390|NCT02896907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102560391|NCT02896907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102560392|NCT02896907|Immunologic Factors|immunologic factors|mesh-ancestor
102560393|NCT02896907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102560394|NCT02896907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102560395|NCT02896907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102560396|NCT02896907|Antidotes|antidotes|mesh-ancestor
102560397|NCT02896907|Protective Agents|protective agents|mesh-ancestor
102560398|NCT02896907|Vitamin B Complex|vitamin b complex|mesh-ancestor
102560399|NCT02896907|Antioxidants|antioxidants|mesh-ancestor
102560400|NCT02896907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102560401|NCT02005549|Bevacizumab|bevacizumab|mesh-list
102560402|NCT02005549|Docetaxel|docetaxel|mesh-list
102560403|NCT02005549|Capecitabine|capecitabine|mesh-list
102560404|NCT02005549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102560405|NCT02005549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102560406|NCT02005549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102560407|NCT02005549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102560408|NCT02005549|Growth Substances|growth substances|mesh-ancestor
102560409|NCT02005549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560410|NCT02005549|Growth Inhibitors|growth inhibitors|mesh-ancestor
102560411|NCT02005549|Tubulin Modulators|tubulin modulators|mesh-ancestor
102560412|NCT02005549|Antimitotic Agents|antimitotic agents|mesh-ancestor
102560413|NCT02005549|Mitosis Modulators|mitosis modulators|mesh-ancestor
102560414|NCT02005549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560415|NCT02005549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102560416|NCT02005549|Antimetabolites|antimetabolites|mesh-ancestor
102560417|NCT04349696|Mitiglinide|mitiglinide|mesh-list
102560418|NCT04349696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102560419|NCT04349696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560420|NCT02810873|Copper|copper|mesh-list
102560421|NCT02810873|Deoxyglucose|deoxyglucose|mesh-list
102560422|NCT02810873|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102560423|NCT02810873|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102560424|NCT02810873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560425|NCT02810873|Trace Elements|trace elements|mesh-ancestor
102560426|NCT02810873|Micronutrients|micronutrients|mesh-ancestor
102560427|NCT02810873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560428|NCT02810873|Antimetabolites|antimetabolites|mesh-ancestor
102560429|NCT02810873|Antiviral Agents|antiviral agents|mesh-ancestor
102560430|NCT02810873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102560431|NCT04492358|Prednisone|prednisone|mesh-list
102560432|NCT04492358|Colchicine|colchicine|mesh-list
102560433|NCT04492358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102560434|NCT04492358|Glucocorticoids|glucocorticoids|mesh-ancestor
102560435|NCT04492358|Hormones|hormones|mesh-ancestor
102560436|NCT04492358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102560437|NCT04492358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560438|NCT04492358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102560439|NCT04492358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102560440|NCT04492358|Gout Suppressants|gout suppressants|mesh-ancestor
102560441|NCT04492358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102560442|NCT04492358|Tubulin Modulators|tubulin modulators|mesh-ancestor
102560443|NCT04492358|Antimitotic Agents|antimitotic agents|mesh-ancestor
102560444|NCT04492358|Mitosis Modulators|mitosis modulators|mesh-ancestor
102560445|NCT04492358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560446|NCT03488420|Edoxaban|edoxaban|mesh-list
102560447|NCT03488420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102560448|NCT03488420|Antithrombins|antithrombins|mesh-ancestor
102560449|NCT03488420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102560450|NCT03488420|Protease Inhibitors|protease inhibitors|mesh-ancestor
102560451|NCT03488420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102560452|NCT03488420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560453|NCT03488420|Anticoagulants|anticoagulants|mesh-ancestor
102560454|NCT01066663|Pyrimethamine|pyrimethamine|mesh-list
102560455|NCT01066663|Antimalarials|antimalarials|mesh-ancestor
102560456|NCT01066663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102560457|NCT01066663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102560458|NCT01066663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102560459|NCT01066663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102107419|NCT03413150|Amiodarone|amiodarone|mesh-list
102560460|NCT01066663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102560461|NCT01066663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560462|NCT01959685|Enclomiphene|enclomiphene|mesh-list
102560463|NCT01959685|Clomiphene|clomiphene|mesh-list
102560464|NCT01959685|Zuclomiphene|zuclomiphene|mesh-list
102560465|NCT01959685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102560466|NCT01959685|Hormone Antagonists|hormone antagonists|mesh-ancestor
102560467|NCT01959685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102560468|NCT01959685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560469|NCT01959685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102560470|NCT01959685|Fertility Agents|fertility agents|mesh-ancestor
102560471|NCT01959685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102560472|NCT01959685|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102560473|NCT01959685|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102560474|NCT02901899|Pembrolizumab|pembrolizumab|mesh-list
102560475|NCT02901899|Guadecitabine|guadecitabine|mesh-list
102560476|NCT02901899|Azacitidine|azacitidine|mesh-list
102560477|NCT02901899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102560478|NCT02901899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102560479|NCT02901899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102560480|NCT02901899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560481|NCT02901899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102560482|NCT02901899|Antimetabolites|antimetabolites|mesh-ancestor
102560483|NCT02901899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102560484|NCT04333589|Favipiravir|favipiravir|mesh-list
102560485|NCT04333589|Antiviral Agents|antiviral agents|mesh-ancestor
102560486|NCT04333589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102560487|NCT02902913|Ibuprofen|ibuprofen|mesh-list
102560488|NCT02902913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102560489|NCT02902913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102560490|NCT02902913|Analgesics|analgesics|mesh-ancestor
102560491|NCT02902913|Sensory System Agents|sensory system agents|mesh-ancestor
102560492|NCT02902913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102560493|NCT02902913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560494|NCT02902913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102560495|NCT02902913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102560496|NCT02902913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102560497|NCT02902913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102560498|NCT02902913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560499|NCT03417986|Thiethylperazine|thiethylperazine|mesh-list
102560500|NCT03417986|Antiemetics|antiemetics|mesh-ancestor
102560501|NCT03417986|Autonomic Agents|autonomic agents|mesh-ancestor
102560502|NCT03417986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102560503|NCT03417986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560504|NCT03417986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102560505|NCT03417986|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102560506|NCT03417986|Dopamine Agents|dopamine agents|mesh-ancestor
102560507|NCT03417986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102560508|NCT03417986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560509|NCT04349228|Hydroxychloroquine|hydroxychloroquine|mesh-list
102560510|NCT04349228|Antimalarials|antimalarials|mesh-ancestor
102560511|NCT04349228|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102560512|NCT04349228|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102560513|NCT04349228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102560514|NCT04349228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102560515|NCT04349228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560516|NCT04349228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102560517|NCT02301416|Topiramate|topiramate|mesh-list
102560518|NCT02301416|Phentermine|phentermine|mesh-list
102560519|NCT02301416|Anticonvulsants|anticonvulsants|mesh-ancestor
102560520|NCT02301416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102560521|NCT02301416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560522|NCT02301416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102560523|NCT02301416|Appetite Depressants|appetite depressants|mesh-ancestor
102560524|NCT02301416|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102560525|NCT02301416|Sympathomimetics|sympathomimetics|mesh-ancestor
102560526|NCT02301416|Autonomic Agents|autonomic agents|mesh-ancestor
102560527|NCT02301416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102560528|NCT02301416|Adrenergic Agents|adrenergic agents|mesh-ancestor
102560529|NCT02301416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102560530|NCT02301416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560531|NCT02815709|Morphine|morphine|mesh-list
102560532|NCT02815709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102560533|NCT02815709|Narcotics|narcotics|mesh-ancestor
102560534|NCT02815709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102560535|NCT02815709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560536|NCT02815709|Analgesics|analgesics|mesh-ancestor
102560537|NCT02815709|Sensory System Agents|sensory system agents|mesh-ancestor
102560538|NCT02815709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102560540|NCT02912195|Morphine|morphine|mesh-list
102560541|NCT02912195|Anesthetics, Local|anesthetics, local|mesh-ancestor
102560542|NCT02912195|Anesthetics|anesthetics|mesh-ancestor
102560543|NCT02912195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102560544|NCT02912195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560545|NCT02912195|Sensory System Agents|sensory system agents|mesh-ancestor
102560546|NCT02912195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102560547|NCT02912195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102560548|NCT02912195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102560549|NCT02912195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102560550|NCT02912195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102560551|NCT02912195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560552|NCT02912195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102560553|NCT02912195|Narcotics|narcotics|mesh-ancestor
102560554|NCT02912195|Analgesics|analgesics|mesh-ancestor
102560555|NCT01960075|Fosphenytoin|fosphenytoin|mesh-list
102560556|NCT01960075|Levetiracetam|levetiracetam|mesh-list
102560557|NCT01960075|Valproic Acid|valproic acid|mesh-list
102560558|NCT01960075|Anticonvulsants|anticonvulsants|mesh-ancestor
102560559|NCT01960075|Nootropic Agents|nootropic agents|mesh-ancestor
102560560|NCT01960075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102560561|NCT01960075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560562|NCT01960075|GABA Agents|gaba agents|mesh-ancestor
102560563|NCT01960075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102560564|NCT01960075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560565|NCT01960075|Antimanic Agents|antimanic agents|mesh-ancestor
102560566|NCT01960075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102560567|NCT01960075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102560568|NCT01960075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102560569|NCT01960075|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102560570|NCT01960075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102560571|NCT01988246|Aflibercept|aflibercept|mesh-list
102560572|NCT01988246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102560573|NCT01988246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102560574|NCT01988246|Growth Substances|growth substances|mesh-ancestor
102560575|NCT01988246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560576|NCT01988246|Growth Inhibitors|growth inhibitors|mesh-ancestor
102560577|NCT01988246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102560578|NCT01990898|Cyclosporine|cyclosporine|mesh-list
102560579|NCT01990898|Cyclosporins|cyclosporins|mesh-list
102560580|NCT01990898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102560581|NCT01990898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560582|NCT01990898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102560583|NCT01990898|Immunologic Factors|immunologic factors|mesh-ancestor
102560584|NCT01990898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560585|NCT01990898|Antifungal Agents|antifungal agents|mesh-ancestor
102560586|NCT01990898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102560587|NCT01990898|Dermatologic Agents|dermatologic agents|mesh-ancestor
102560588|NCT01990898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102560589|NCT01990898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102560590|NCT01960387|Cytarabine|cytarabine|mesh-list
102560591|NCT01960387|Clofarabine|clofarabine|mesh-list
102560592|NCT01960387|Antimetabolites|antimetabolites|mesh-list
102560593|NCT01960387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102560594|NCT01960387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560595|NCT01960387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102560596|NCT01960387|Antiviral Agents|antiviral agents|mesh-ancestor
102560597|NCT01960387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102560598|NCT01960387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102560599|NCT01960387|Immunologic Factors|immunologic factors|mesh-ancestor
102560600|NCT01960387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560601|NCT02823431|Lidocaine|lidocaine|mesh-list
102560602|NCT02823431|Anesthetics, Local|anesthetics, local|mesh-ancestor
102560603|NCT02823431|Anesthetics|anesthetics|mesh-ancestor
101580418|NCT00625014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102560604|NCT02823431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102560605|NCT02823431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560606|NCT02823431|Sensory System Agents|sensory system agents|mesh-ancestor
102560607|NCT02823431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101580484|NCT00979953|Analgesics|analgesics|mesh-ancestor
102560608|NCT02823431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102560609|NCT02823431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102560610|NCT02823431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102560611|NCT02823431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102560612|NCT02823431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560613|NCT02824913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102560614|NCT02824913|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102560615|NCT03008213|Palonosetron|palonosetron|mesh-list
102560616|NCT03008213|Antiemetics|antiemetics|mesh-ancestor
102560617|NCT03008213|Autonomic Agents|autonomic agents|mesh-ancestor
102560618|NCT03008213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102560619|NCT03008213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560620|NCT03008213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102560621|NCT03008213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102560622|NCT03008213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102560623|NCT03008213|Serotonin Agents|serotonin agents|mesh-ancestor
102560624|NCT03008213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102560625|NCT03008213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560626|NCT02059070|Bupivacaine|bupivacaine|mesh-list
102560627|NCT02059070|Ropivacaine|ropivacaine|mesh-list
102560628|NCT02059070|Anesthetics, Local|anesthetics, local|mesh-ancestor
102560629|NCT02059070|Anesthetics|anesthetics|mesh-ancestor
102560630|NCT02059070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102560631|NCT02059070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560632|NCT02059070|Sensory System Agents|sensory system agents|mesh-ancestor
102560633|NCT02059070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102560634|NCT01962961|Acetylcysteine|acetylcysteine|mesh-list
102560635|NCT01962961|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102560636|NCT01962961|Antiviral Agents|antiviral agents|mesh-ancestor
102560637|NCT01962961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102560638|NCT01962961|Expectorants|expectorants|mesh-ancestor
102560639|NCT01962961|Respiratory System Agents|respiratory system agents|mesh-ancestor
102560640|NCT01962961|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102560641|NCT01962961|Antioxidants|antioxidants|mesh-ancestor
102560642|NCT01962961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560643|NCT01962961|Protective Agents|protective agents|mesh-ancestor
102560644|NCT01962961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560645|NCT01962961|Antidotes|antidotes|mesh-ancestor
102560646|NCT03010631|Lubiprostone|lubiprostone|mesh-list
102560647|NCT03010631|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102560648|NCT03010631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102560649|NCT03010631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560650|NCT00374621|Isosorbide|isosorbide|mesh-list
102560651|NCT00374621|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
102560652|NCT00374621|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
102560653|NCT00374621|Misoprostol|misoprostol|mesh-list
102560654|NCT00374621|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102560655|NCT00374621|Abortifacient Agents|abortifacient agents|mesh-ancestor
102560656|NCT00374621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102560657|NCT00374621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560658|NCT00374621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102560659|NCT00374621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102560660|NCT00374621|Oxytocics|oxytocics|mesh-ancestor
102560661|NCT00374621|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102560662|NCT00374621|Diuretics|diuretics|mesh-ancestor
102560663|NCT00374621|Natriuretic Agents|natriuretic agents|mesh-ancestor
102560664|NCT00374621|Vasodilator Agents|vasodilator agents|mesh-ancestor
102560665|NCT00374621|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102560666|NCT00374621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560667|NCT03012191|Gentamicins|gentamicins|mesh-list
102560668|NCT03012191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102560669|NCT03012191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102560670|NCT03012191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102560671|NCT03012191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102560672|NCT03012191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560673|NCT01994486|Sofosbuvir|sofosbuvir|mesh-list
102560674|NCT01994486|Antiviral Agents|antiviral agents|mesh-ancestor
102560675|NCT01994486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102560676|NCT01967641|Buprenorphine|buprenorphine|mesh-list
102560677|NCT01967641|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102560678|NCT01967641|Naloxone|naloxone|mesh-list
102560679|NCT01967641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102560680|NCT01967641|Narcotics|narcotics|mesh-ancestor
102560681|NCT01967641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102560682|NCT01967641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560683|NCT01967641|Analgesics|analgesics|mesh-ancestor
102560684|NCT01967641|Sensory System Agents|sensory system agents|mesh-ancestor
102560685|NCT01967641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102560686|NCT01967641|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102560687|NCT01968421|Broncho-Vaxom|broncho-vaxom|mesh-list
102560688|NCT01968421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102560689|NCT01968421|Immunologic Factors|immunologic factors|mesh-ancestor
102560690|NCT01968421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560692|NCT02913521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102560693|NCT02913521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102560694|NCT02913521|Analgesics|analgesics|mesh-ancestor
102560695|NCT02913521|Sensory System Agents|sensory system agents|mesh-ancestor
102560696|NCT02913521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102560697|NCT02913521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560698|NCT02913521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102560699|NCT02913521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102560700|NCT02913521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102560701|NCT02913521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102560702|NCT02913521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560703|NCT01969201|Hormones|hormones|mesh-list
102560704|NCT01969201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102560705|NCT01969201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560706|NCT01962428|Ticagrelor|ticagrelor|mesh-list
102560707|NCT01962428|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102560708|NCT01962428|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102560709|NCT01962428|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102560710|NCT01962428|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102560711|NCT01962428|Purinergic Agents|purinergic agents|mesh-ancestor
102560712|NCT01962428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102560713|NCT01962428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560714|NCT01962428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560715|NCT01999400|Mesalamine|mesalamine|mesh-list
102560716|NCT01999400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102560717|NCT01999400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102560718|NCT01999400|Analgesics|analgesics|mesh-ancestor
102560719|NCT01999400|Sensory System Agents|sensory system agents|mesh-ancestor
102560720|NCT01999400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102560721|NCT01999400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560722|NCT01999400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102560723|NCT01999400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102560724|NCT01969435|Cytarabine|cytarabine|mesh-list
102560725|NCT01969435|Etoposide|etoposide|mesh-list
102560726|NCT01969435|Melphalan|melphalan|mesh-list
102560727|NCT01969435|Carmustine|carmustine|mesh-list
102560728|NCT01969435|Etoposide phosphate|etoposide phosphate|mesh-list
102560729|NCT01969435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102560730|NCT01969435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102560731|NCT01969435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102560732|NCT01969435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102560733|NCT01969435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102560734|NCT01969435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560735|NCT01969435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102560736|NCT01969435|Antimetabolites|antimetabolites|mesh-ancestor
102560737|NCT01969435|Antiviral Agents|antiviral agents|mesh-ancestor
102560738|NCT01969435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102560739|NCT01969435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102560740|NCT01969435|Immunologic Factors|immunologic factors|mesh-ancestor
102560741|NCT01969435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560742|NCT01969435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102560743|NCT01969435|Alkylating Agents|alkylating agents|mesh-ancestor
102560744|NCT01969435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102560745|NCT01965002|Aspirin|aspirin|mesh-list
102560746|NCT01965002|Enoxaparin|enoxaparin|mesh-list
102560747|NCT01965002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102560748|NCT01965002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102560749|NCT01965002|Analgesics|analgesics|mesh-ancestor
102560750|NCT01965002|Sensory System Agents|sensory system agents|mesh-ancestor
102560751|NCT01965002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102560752|NCT01965002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560753|NCT01965002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102560754|NCT01965002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102560755|NCT01965002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102560756|NCT01965002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102560757|NCT01965002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560758|NCT01965002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102560759|NCT01965002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102560760|NCT01965002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102560761|NCT01965002|Antipyretics|antipyretics|mesh-ancestor
102107703|NCT03385382|Hormones|hormones|mesh-ancestor
102560762|NCT01965002|Anticoagulants|anticoagulants|mesh-ancestor
102560763|NCT02304757|Alendronate|alendronate|mesh-list
102560764|NCT02304757|Methylene diphosphonate|methylene diphosphonate|mesh-list
102560765|NCT02304757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102560766|NCT02304757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560767|NCT01969747|Empagliflozin|empagliflozin|mesh-list
102560768|NCT01969747|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102560769|NCT01969747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560770|NCT01969747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102560771|NCT01969747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560772|NCT02002832|Risperidone|risperidone|mesh-list
102560773|NCT02002832|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102560774|NCT02002832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102560775|NCT02002832|Serotonin Agents|serotonin agents|mesh-ancestor
102560776|NCT02002832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102560777|NCT02002832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560778|NCT02002832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560779|NCT02002832|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102560780|NCT02002832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102560781|NCT02002832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102560782|NCT02002832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102560783|NCT02002832|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102560784|NCT02002832|Dopamine Agents|dopamine agents|mesh-ancestor
102560785|NCT02002832|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102560786|NCT02002832|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102560787|NCT02002832|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102560788|NCT02002832|Adrenergic Agents|adrenergic agents|mesh-ancestor
102560789|NCT02002832|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102560790|NCT02002832|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102560791|NCT01966718|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102560792|NCT01966718|Hormones|hormones|mesh-ancestor
102560793|NCT01966718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102560794|NCT01966718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560795|NCT02308501|Alcaftadine|alcaftadine|mesh-list
102560796|NCT02308501|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102560797|NCT02308501|Histamine Antagonists|histamine antagonists|mesh-ancestor
102560798|NCT02308501|Histamine Agents|histamine agents|mesh-ancestor
102560799|NCT02308501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102560800|NCT02308501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560801|NCT02308501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560802|NCT02006108|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102560803|NCT02006108|Hematinics|hematinics|mesh-ancestor
102560804|NCT02006108|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102560805|NCT02006108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102560806|NCT02006342|Insulin|insulin|mesh-list
102560807|NCT02006342|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102560808|NCT02006342|Insulin Glargine|insulin glargine|mesh-list
102560809|NCT02006342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102560810|NCT02006342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560811|NCT01968356|Ethanol|ethanol|mesh-list
102560812|NCT01968356|Chlorhexidine|chlorhexidine|mesh-list
102560813|NCT01968356|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102560814|NCT01968356|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102560815|NCT01968356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102560816|NCT01968356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102560817|NCT01968356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560818|NCT01968356|Disinfectants|disinfectants|mesh-ancestor
102560819|NCT01968356|Dermatologic Agents|dermatologic agents|mesh-ancestor
102560820|NCT02008682|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102560821|NCT02008682|Liraglutide|liraglutide|mesh-list
102560822|NCT02008682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102560823|NCT02008682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560824|NCT02008682|Incretins|incretins|mesh-ancestor
102560825|NCT02008682|Hormones|hormones|mesh-ancestor
102560826|NCT02008682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102560827|NCT02008682|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102560828|NCT02008682|Protease Inhibitors|protease inhibitors|mesh-ancestor
102560829|NCT02008682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102560830|NCT02008682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560831|NCT01969916|Regadenoson|regadenoson|mesh-list
102560832|NCT01969916|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
102560833|NCT01969916|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102560834|NCT01969916|Purinergic Agonists|purinergic agonists|mesh-ancestor
102560835|NCT01969916|Purinergic Agents|purinergic agents|mesh-ancestor
102560836|NCT01969916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102560837|NCT01969916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560838|NCT01969916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560839|NCT00373919|Erythromycin|erythromycin|mesh-list
102560840|NCT00373919|Erythromycin Estolate|erythromycin estolate|mesh-list
102560841|NCT00373919|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
102560842|NCT00373919|Erythromycin stearate|erythromycin stearate|mesh-list
102560843|NCT00373919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102560844|NCT00373919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102560845|NCT00373919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102560846|NCT00373919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102560847|NCT00373919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102560848|NCT00373919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560849|NCT02916407|Sevoflurane|sevoflurane|mesh-list
102560850|NCT02916407|Desflurane|desflurane|mesh-list
102560851|NCT02916407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102560852|NCT02916407|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102560853|NCT02916407|Anesthetics, General|anesthetics, general|mesh-ancestor
102560854|NCT02916407|Anesthetics|anesthetics|mesh-ancestor
102560855|NCT02916407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102560856|NCT02916407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560857|NCT02918357|Edetic Acid|edetic acid|mesh-list
102560858|NCT02918357|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102560859|NCT02918357|Chelating Agents|chelating agents|mesh-ancestor
102560860|NCT02918357|Sequestering Agents|sequestering agents|mesh-ancestor
102560861|NCT02918357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560862|NCT02918357|Anticoagulants|anticoagulants|mesh-ancestor
102560863|NCT02918357|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102560864|NCT02918357|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102560865|NCT02829983|Clarithromycin|clarithromycin|mesh-list
102560866|NCT02829983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102560867|NCT02829983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102560868|NCT02829983|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102560869|NCT02829983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102560870|NCT02829983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560871|NCT02829983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102560872|NCT02829983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102560873|NCT02012192|Paclitaxel|paclitaxel|mesh-list
102560874|NCT02012192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102560875|NCT02012192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102560876|NCT02012192|Tubulin Modulators|tubulin modulators|mesh-ancestor
102560877|NCT02012192|Antimitotic Agents|antimitotic agents|mesh-ancestor
102560878|NCT02012192|Mitosis Modulators|mitosis modulators|mesh-ancestor
102560879|NCT02012192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560880|NCT02066792|Cycloserine|cycloserine|mesh-list
102560881|NCT02066792|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102560882|NCT02066792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102560883|NCT02066792|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102560884|NCT02066792|Antitubercular Agents|antitubercular agents|mesh-ancestor
102560885|NCT02066792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102560886|NCT02066792|Antimetabolites|antimetabolites|mesh-ancestor
102560887|NCT02066792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560888|NCT02922959|Naloxone|naloxone|mesh-list
102560889|NCT02922959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560890|NCT02922959|Sensory System Agents|sensory system agents|mesh-ancestor
102560891|NCT02922959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102560892|NCT02922959|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102560893|NCT02014363|Amitriptyline|amitriptyline|mesh-list
102560894|NCT02014363|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102560895|NCT02014363|Antidepressive Agents|antidepressive agents|mesh-ancestor
102560896|NCT02014363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102560897|NCT02014363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102560898|NCT02014363|Analgesics|analgesics|mesh-ancestor
102560899|NCT02014363|Sensory System Agents|sensory system agents|mesh-ancestor
102560900|NCT02014363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102560901|NCT02014363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560902|NCT02014363|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102560903|NCT02014363|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102560904|NCT02014363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102560905|NCT02014363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560906|NCT02014363|Adrenergic Agents|adrenergic agents|mesh-ancestor
102560907|NCT02014363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102560908|NCT02067806|Chloroprocaine|chloroprocaine|mesh-list
102560909|NCT02067806|Anesthetics, Local|anesthetics, local|mesh-ancestor
102560910|NCT02067806|Anesthetics|anesthetics|mesh-ancestor
102560911|NCT02067806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102560912|NCT02067806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560913|NCT02067806|Sensory System Agents|sensory system agents|mesh-ancestor
102560914|NCT02067806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102560916|NCT02833415|Glycerol|glycerol|mesh-list
102560917|NCT02833415|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102560918|NCT02833415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560919|NCT02833415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102560920|NCT02833415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560921|NCT02833415|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102560922|NCT02833415|Protective Agents|protective agents|mesh-ancestor
102560923|NCT02012348|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102560924|NCT02012348|Benzalkonium Compounds|benzalkonium compounds|mesh-list
102560925|NCT02012348|Triclocarban|triclocarban|mesh-list
102560926|NCT02012348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102560927|NCT02012348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102560928|NCT02834663|Ranibizumab|ranibizumab|mesh-list
102560929|NCT02834663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102560930|NCT02834663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102560931|NCT02834663|Growth Substances|growth substances|mesh-ancestor
102560932|NCT02834663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560933|NCT02834663|Growth Inhibitors|growth inhibitors|mesh-ancestor
102560934|NCT02834663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102560935|NCT01973036|Oxytocin|oxytocin|mesh-list
102560936|NCT01973036|Oxytocics|oxytocics|mesh-ancestor
102560937|NCT01973036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102560938|NCT01973036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560939|NCT02017327|Bimatoprost|bimatoprost|mesh-list
102560940|NCT02017327|Latanoprost|latanoprost|mesh-list
102560941|NCT02017327|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102560942|NCT02017327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102560943|NCT02017327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102560944|NCT02837237|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
102560945|NCT02837237|Mineralocorticoids|mineralocorticoids|mesh-list
102560946|NCT02837237|Hormone Antagonists|hormone antagonists|mesh-ancestor
102560947|NCT02837237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102560948|NCT02837237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560949|NCT02837237|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102560950|NCT02837237|Diuretics|diuretics|mesh-ancestor
102560951|NCT02837237|Natriuretic Agents|natriuretic agents|mesh-ancestor
102560952|NCT02837237|Hormones|hormones|mesh-ancestor
102560953|NCT02018107|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102560954|NCT02018107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102560955|NCT02018107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560956|NCT02018653|Calcium, Dietary|calcium, dietary|mesh-list
102560957|NCT02018653|Antidiarrheals|antidiarrheals|mesh-list
102560958|NCT02018653|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
102560959|NCT02018653|Calcium|calcium|mesh-list
102560960|NCT02018653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102560961|NCT02018653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560962|NCT02018653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102560963|NCT02018653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102560964|NCT02923895|Fluorides|fluorides|mesh-list
102560965|NCT02923895|Tin Fluorides|tin fluorides|mesh-list
102560966|NCT02923895|Fluorophosphate|fluorophosphate|mesh-list
102560967|NCT02923895|Cariostatic Agents|cariostatic agents|mesh-ancestor
102560968|NCT02923895|Protective Agents|protective agents|mesh-ancestor
102560969|NCT02923895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560970|NCT01973348|Methamphetamine|methamphetamine|mesh-list
102560971|NCT01973348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102560972|NCT01973348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560973|NCT01973348|Sympathomimetics|sympathomimetics|mesh-ancestor
102560974|NCT01973348|Autonomic Agents|autonomic agents|mesh-ancestor
102560975|NCT01973348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102560976|NCT01973348|Dopamine Agents|dopamine agents|mesh-ancestor
102560977|NCT01973348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102560978|NCT01973348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102560979|NCT01973348|Adrenergic Agents|adrenergic agents|mesh-ancestor
102560980|NCT01973348|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102560981|NCT01973348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102560982|NCT01973348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102560983|NCT01973348|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102560984|NCT02839889|Naloxegol|naloxegol|mesh-list
102560985|NCT02839889|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102560986|NCT02839889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560987|NCT02839889|Sensory System Agents|sensory system agents|mesh-ancestor
102560988|NCT02839889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102560989|NCT01971385|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102560990|NCT01971385|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
102560991|NCT01971385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102560992|NCT01971385|Immunologic Factors|immunologic factors|mesh-ancestor
102560993|NCT01971385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102560994|NCT02925611|Desflurane|desflurane|mesh-list
102560995|NCT02925611|Isoflurane|isoflurane|mesh-list
102560996|NCT02925611|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102560997|NCT02925611|Anesthetics, General|anesthetics, general|mesh-ancestor
102560998|NCT02925611|Anesthetics|anesthetics|mesh-ancestor
101580817|NCT00640705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102560999|NCT02925611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102561000|NCT02925611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561001|NCT01973335|Spironolactone|spironolactone|mesh-list
102561002|NCT01973335|Acetazolamide|acetazolamide|mesh-list
102561003|NCT01973335|Bumetanide|bumetanide|mesh-list
102561004|NCT01973335|Diuretics|diuretics|mesh-list
102561005|NCT01973335|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
102561006|NCT01973335|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102561007|NCT01973335|Hormone Antagonists|hormone antagonists|mesh-ancestor
102561008|NCT01973335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102561009|NCT01973335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561010|NCT01973335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102561011|NCT01973335|Natriuretic Agents|natriuretic agents|mesh-ancestor
102561012|NCT01973335|Anticonvulsants|anticonvulsants|mesh-ancestor
102561013|NCT01973335|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102561014|NCT01973335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102561015|NCT01973335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561016|NCT01973335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102561017|NCT01973413|Insulin|insulin|mesh-list
102561018|NCT01973413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102561019|NCT01973413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561020|NCT02021461|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102561021|NCT02021461|Anticonvulsants|anticonvulsants|mesh-ancestor
102561022|NCT02021461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102561023|NCT02021461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102561024|NCT02021461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102561025|NCT02021461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561026|NCT02929667|Fluoxetine|fluoxetine|mesh-list
102561027|NCT02929667|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102561028|NCT02929667|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102561029|NCT02929667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102561030|NCT02929667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561031|NCT02929667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102561032|NCT02929667|Serotonin Agents|serotonin agents|mesh-ancestor
102561033|NCT02929667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561034|NCT02929667|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102561035|NCT02929667|Antidepressive Agents|antidepressive agents|mesh-ancestor
102561036|NCT02929667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102561037|NCT02929667|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102561038|NCT02929667|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102561039|NCT02929667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102561040|NCT02021929|Sorafenib|sorafenib|mesh-list
102561041|NCT02021929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102561042|NCT02021929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102561043|NCT02021929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102561044|NCT02021929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561045|NCT02929823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102561046|NCT02929823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102561047|NCT02023411|Teriparatide|teriparatide|mesh-list
102561048|NCT02023411|Hormones|hormones|mesh-list
102561049|NCT02023411|Parathyroid Hormone|parathyroid hormone|mesh-list
102561050|NCT02023411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102561051|NCT02023411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561052|NCT02023411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102561053|NCT02023411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102561054|NCT02068820|Fluorophosphate|fluorophosphate|mesh-list
102561055|NCT02068820|Cariostatic Agents|cariostatic agents|mesh-ancestor
101580886|NCT00625092|Vitamins|vitamins|mesh-ancestor
102561056|NCT02068820|Protective Agents|protective agents|mesh-ancestor
102561057|NCT02068820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561058|NCT01975519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102561059|NCT01975519|Immunologic Factors|immunologic factors|mesh-ancestor
102561060|NCT01975519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561061|NCT02934191|Acetaminophen|acetaminophen|mesh-list
102561062|NCT02934191|Celecoxib|celecoxib|mesh-list
102561063|NCT02934191|Oxycodone|oxycodone|mesh-list
102561064|NCT02934191|Calcium Carbonate|calcium carbonate|mesh-list
102561065|NCT02934191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561066|NCT02934191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102561067|NCT02934191|Analgesics|analgesics|mesh-ancestor
102561068|NCT02934191|Sensory System Agents|sensory system agents|mesh-ancestor
102561069|NCT02934191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102561070|NCT02934191|Antipyretics|antipyretics|mesh-ancestor
102561071|NCT02934191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102561072|NCT02934191|Narcotics|narcotics|mesh-ancestor
102561073|NCT02934191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102561074|NCT02934191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102561075|NCT02934191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102561076|NCT02934191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102561077|NCT02934191|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102561078|NCT02934191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102561079|NCT02934191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102561080|NCT02934191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561081|NCT02934191|Antacids|antacids|mesh-ancestor
102561082|NCT02934191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102561083|NCT02937623|Calcium|calcium|mesh-list
102561084|NCT02937623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102561085|NCT02937623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561086|NCT01977781|Methylprednisolone|methylprednisolone|mesh-list
102561087|NCT01977781|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102561088|NCT01977781|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102561089|NCT01977781|Prednisolone|prednisolone|mesh-list
102561090|NCT01977781|Prednisolone acetate|prednisolone acetate|mesh-list
102561091|NCT01977781|Tacrolimus|tacrolimus|mesh-list
102561092|NCT01977781|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102561093|NCT01977781|Prednisolone phosphate|prednisolone phosphate|mesh-list
102561094|NCT01977781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102561095|NCT01977781|Immunologic Factors|immunologic factors|mesh-ancestor
102561096|NCT01977781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561097|NCT01977781|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102561098|NCT01977781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102561099|NCT01977781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561100|NCT01977781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102561101|NCT01977781|Antiemetics|antiemetics|mesh-ancestor
102561102|NCT01977781|Autonomic Agents|autonomic agents|mesh-ancestor
102561103|NCT01977781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102561104|NCT01977781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102561105|NCT01977781|Glucocorticoids|glucocorticoids|mesh-ancestor
102561106|NCT01977781|Hormones|hormones|mesh-ancestor
102561107|NCT01977781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102561108|NCT01977781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102561109|NCT01977781|Protective Agents|protective agents|mesh-ancestor
102561110|NCT01977781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102561111|NCT01977781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102561112|NCT02070302|Botulinum Toxins|botulinum toxins|mesh-list
102561113|NCT02070302|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102561114|NCT02070302|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102561115|NCT02070302|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102561116|NCT02070302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102561117|NCT02070302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561118|NCT02070302|Cholinergic Agents|cholinergic agents|mesh-ancestor
102561119|NCT02070302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102561120|NCT02070302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561121|NCT02070302|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102561122|NCT02070302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102561123|NCT02938949|Alirocumab|alirocumab|mesh-list
102561124|NCT02938949|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102561125|NCT02938949|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102561126|NCT02938949|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102561127|NCT02938949|Antimetabolites|antimetabolites|mesh-ancestor
102561128|NCT02938949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561129|NCT02938949|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102561130|NCT02938949|Protease Inhibitors|protease inhibitors|mesh-ancestor
102561131|NCT02938949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102561132|NCT02938949|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102561133|NCT02025439|Amantadine|amantadine|mesh-list
102561134|NCT02025439|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102561135|NCT02025439|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102561136|NCT02025439|Antiviral Agents|antiviral agents|mesh-ancestor
102561137|NCT02025439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102561138|NCT02025439|Dopamine Agents|dopamine agents|mesh-ancestor
102561139|NCT02025439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102561140|NCT02025439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561141|NCT02025439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561142|NCT02025439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102561143|NCT02025439|Analgesics|analgesics|mesh-ancestor
102561144|NCT02025439|Sensory System Agents|sensory system agents|mesh-ancestor
102561145|NCT02025439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102561146|NCT02939651|Pembrolizumab|pembrolizumab|mesh-list
102561147|NCT02939651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102561148|NCT02939651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102561149|NCT02939651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102561150|NCT02939651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561151|NCT02026297|Tranexamic Acid|tranexamic acid|mesh-list
102561152|NCT02026297|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102561153|NCT02026297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102561154|NCT02026297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561155|NCT02026297|Hemostatics|hemostatics|mesh-ancestor
102561156|NCT02026297|Coagulants|coagulants|mesh-ancestor
102561157|NCT02070692|Tamoxifen|tamoxifen|mesh-list
102561158|NCT02070692|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102561159|NCT02070692|Hormone Antagonists|hormone antagonists|mesh-ancestor
102561160|NCT02070692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102561161|NCT02070692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561162|NCT02070692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102561163|NCT02070692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102561164|NCT02070692|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102561165|NCT02070692|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102561166|NCT02070692|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102561167|NCT02015234|Cyclobenzaprine|cyclobenzaprine|mesh-list
102561168|NCT02015234|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102561169|NCT02015234|Antidepressive Agents|antidepressive agents|mesh-ancestor
102561170|NCT02015234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102561171|NCT02015234|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102561172|NCT02015234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561173|NCT02015234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102561174|NCT02015234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102561175|NCT02015234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102561176|NCT02015234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102561177|NCT02869451|Bupropion|bupropion|mesh-list
102561178|NCT02869451|Nicotine|nicotine|mesh-list
101581013|NCT02677597|Paclitaxel|paclitaxel|mesh-list
102561179|NCT02869451|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102561180|NCT02869451|Autonomic Agents|autonomic agents|mesh-ancestor
102561181|NCT02869451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102561182|NCT02869451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561183|NCT02869451|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102561184|NCT02869451|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102561185|NCT02869451|Cholinergic Agents|cholinergic agents|mesh-ancestor
102561186|NCT02869451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102561187|NCT02869451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561188|NCT02869451|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102561189|NCT02869451|Antidepressive Agents|antidepressive agents|mesh-ancestor
102561190|NCT02869451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102561191|NCT02869451|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102561192|NCT02869451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102561193|NCT02869451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102561194|NCT02869451|Dopamine Agents|dopamine agents|mesh-ancestor
102561195|NCT02869451|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102561196|NCT02869451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102561197|NCT02869451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102561198|NCT02305316|Opicapone|opicapone|mesh-list
102561199|NCT02305316|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102561200|NCT02305316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102561201|NCT02305316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561202|NCT02305316|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102561203|NCT02305316|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102561204|NCT02944565|Daratumumab|daratumumab|mesh-list
102561205|NCT02944565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102561206|NCT02870309|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
102561207|NCT02870309|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102561208|NCT02870309|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102561209|NCT02870309|Protease Inhibitors|protease inhibitors|mesh-ancestor
102561210|NCT02870309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102561211|NCT02870309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561212|NCT01979276|Dexamethasone|dexamethasone|mesh-list
102561213|NCT01979276|Pomalidomide|pomalidomide|mesh-list
102561214|NCT01979276|Romidepsin|romidepsin|mesh-list
102561215|NCT01979276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102561216|NCT01979276|Antiemetics|antiemetics|mesh-ancestor
102561217|NCT01979276|Autonomic Agents|autonomic agents|mesh-ancestor
102561218|NCT01979276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102561219|NCT01979276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561220|NCT01979276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102561221|NCT01979276|Glucocorticoids|glucocorticoids|mesh-ancestor
102561222|NCT01979276|Hormones|hormones|mesh-ancestor
102561223|NCT01979276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102561224|NCT01979276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102561225|NCT01979276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102561226|NCT01979276|Immunologic Factors|immunologic factors|mesh-ancestor
102561227|NCT01979276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102561228|NCT01979276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102561229|NCT01979276|Growth Substances|growth substances|mesh-ancestor
102561230|NCT01979276|Growth Inhibitors|growth inhibitors|mesh-ancestor
102561231|NCT01979276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102561232|NCT01979276|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102561233|NCT01979276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102561234|NCT01979276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561235|NCT02871011|Nitric Oxide|nitric oxide|mesh-list
102561236|NCT02871011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102561237|NCT02871011|Autonomic Agents|autonomic agents|mesh-ancestor
102561238|NCT02871011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102561239|NCT02871011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561240|NCT02871011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102561241|NCT02871011|Respiratory System Agents|respiratory system agents|mesh-ancestor
102561242|NCT02871011|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102561243|NCT02871011|Antioxidants|antioxidants|mesh-ancestor
102561244|NCT02871011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561245|NCT02871011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102561246|NCT02871011|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102561247|NCT02871011|Vasodilator Agents|vasodilator agents|mesh-ancestor
102561248|NCT02871011|Gasotransmitters|gasotransmitters|mesh-ancestor
102561249|NCT02871011|Protective Agents|protective agents|mesh-ancestor
102561250|NCT02344238|Riboflavin|riboflavin|mesh-list
102561251|NCT02344238|Vitamin B Complex|vitamin b complex|mesh-ancestor
102561252|NCT02344238|Vitamins|vitamins|mesh-ancestor
102561253|NCT02344238|Micronutrients|micronutrients|mesh-ancestor
102561254|NCT02344238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561255|NCT02344238|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102561256|NCT02344238|Dermatologic Agents|dermatologic agents|mesh-ancestor
102561257|NCT02344316|Melatonin|melatonin|mesh-list
102561258|NCT02344316|Antioxidants|antioxidants|mesh-ancestor
102561259|NCT02344316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561260|NCT02344316|Protective Agents|protective agents|mesh-ancestor
102561261|NCT02344316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561262|NCT02344316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102561263|NCT02344628|Azithromycin|azithromycin|mesh-list
102561264|NCT02344628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102561265|NCT02344628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102561266|NCT02345486|Plasma-lyte 148|plasma-lyte 148|mesh-list
102561267|NCT02345486|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102561268|NCT02345486|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102561269|NCT02019758|Fluticasone|fluticasone|mesh-list
102561270|NCT02019758|Budesonide|budesonide|mesh-list
102561271|NCT02019758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102561272|NCT02019758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102561273|NCT02019758|Autonomic Agents|autonomic agents|mesh-ancestor
102561274|NCT02019758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102561275|NCT02019758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561276|NCT02019758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102561277|NCT02019758|Respiratory System Agents|respiratory system agents|mesh-ancestor
102561278|NCT02019758|Dermatologic Agents|dermatologic agents|mesh-ancestor
102561279|NCT02019758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102561280|NCT02019758|Glucocorticoids|glucocorticoids|mesh-ancestor
102561281|NCT02019758|Hormones|hormones|mesh-ancestor
102561282|NCT02019758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102561283|NCT01980589|Dexamethasone|dexamethasone|mesh-list
102561284|NCT01980589|Cyclophosphamide|cyclophosphamide|mesh-list
102561285|NCT01980589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102561286|NCT01980589|Immunologic Factors|immunologic factors|mesh-ancestor
102561287|NCT01980589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561288|NCT01980589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102561289|NCT01980589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102561290|NCT01980589|Alkylating Agents|alkylating agents|mesh-ancestor
102561291|NCT01980589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561292|NCT01980589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102561293|NCT01980589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102561294|NCT01980589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102561295|NCT01980589|Antiemetics|antiemetics|mesh-ancestor
102561296|NCT01980589|Autonomic Agents|autonomic agents|mesh-ancestor
102561297|NCT01980589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102561298|NCT01980589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102561299|NCT01980589|Glucocorticoids|glucocorticoids|mesh-ancestor
102561300|NCT01980589|Hormones|hormones|mesh-ancestor
102561301|NCT01980589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102561302|NCT01980589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102561303|NCT02021942|Pasireotide|pasireotide|mesh-list
102561304|NCT02021942|Hormones|hormones|mesh-ancestor
102561305|NCT02021942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102561306|NCT02021942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561307|NCT01981759|Cycloserine|cycloserine|mesh-list
102561308|NCT01981759|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102561309|NCT01981759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102561310|NCT01981759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102561311|NCT01981759|Antitubercular Agents|antitubercular agents|mesh-ancestor
102561312|NCT01981759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102561313|NCT01981759|Antimetabolites|antimetabolites|mesh-ancestor
102561314|NCT01981759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561315|NCT01980524|Acipimox|acipimox|mesh-list
102561316|NCT01980524|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102561317|NCT01980524|Antimetabolites|antimetabolites|mesh-ancestor
102561318|NCT01980524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561319|NCT01980524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102561320|NCT01982539|Diclofenac|diclofenac|mesh-list
102561321|NCT01982539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102561322|NCT01982539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102561323|NCT01982539|Analgesics|analgesics|mesh-ancestor
102561324|NCT01982539|Sensory System Agents|sensory system agents|mesh-ancestor
102561325|NCT01982539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102561326|NCT01982539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561327|NCT01982539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102561328|NCT01982539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102561329|NCT01982539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102561330|NCT01982539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102561331|NCT01982539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561332|NCT01982695|Losartan|losartan|mesh-list
102561333|NCT01982695|Lisinopril|lisinopril|mesh-list
102561334|NCT01982695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102561335|NCT01982695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102561336|NCT01982695|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102561337|NCT01982695|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102561338|NCT01982695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561339|NCT01982695|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102561340|NCT01982695|Protease Inhibitors|protease inhibitors|mesh-ancestor
102561341|NCT01982695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102561342|NCT01982695|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102561343|NCT01982695|Protective Agents|protective agents|mesh-ancestor
102561344|NCT01982695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561345|NCT01981772|Lidocaine|lidocaine|mesh-list
102561346|NCT01981772|Epinephrine|epinephrine|mesh-list
102561347|NCT01981772|Racepinephrine|racepinephrine|mesh-list
102561348|NCT01981772|Epinephryl borate|epinephryl borate|mesh-list
102561349|NCT01981772|Anesthetics, Local|anesthetics, local|mesh-ancestor
102561350|NCT01981772|Anesthetics|anesthetics|mesh-ancestor
102561351|NCT01981772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102561352|NCT01981772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561353|NCT01981772|Sensory System Agents|sensory system agents|mesh-ancestor
102561354|NCT01981772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102561355|NCT01981772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102561356|NCT01981772|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102561357|NCT01981772|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102561358|NCT01981772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102561359|NCT01981772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561360|NCT01981772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102561361|NCT01981772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102561362|NCT01981772|Adrenergic Agents|adrenergic agents|mesh-ancestor
102561363|NCT01981772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102561364|NCT01981772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102561365|NCT01981772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102561366|NCT01981772|Autonomic Agents|autonomic agents|mesh-ancestor
102561367|NCT01981772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102561368|NCT01981772|Respiratory System Agents|respiratory system agents|mesh-ancestor
102561369|NCT01981772|Mydriatics|mydriatics|mesh-ancestor
102561370|NCT01981772|Sympathomimetics|sympathomimetics|mesh-ancestor
102561371|NCT01981772|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102561373|NCT01982240|Plecanatide|plecanatide|mesh-list
102561374|NCT01982240|Cathartics|cathartics|mesh-ancestor
102561375|NCT01982240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102561376|NCT01982240|Laxatives|laxatives|mesh-ancestor
102561377|NCT01982240|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102561378|NCT01982240|Enzyme Activators|enzyme activators|mesh-ancestor
102561379|NCT01982240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561380|NCT02029495|Brodalumab|brodalumab|mesh-list
102561381|NCT02029495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102561382|NCT02029495|Dermatologic Agents|dermatologic agents|mesh-ancestor
102561383|NCT02029495|Immunologic Factors|immunologic factors|mesh-ancestor
102561384|NCT02029495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561385|NCT01985425|Colchicine|colchicine|mesh-list
102561386|NCT01985425|Gout Suppressants|gout suppressants|mesh-ancestor
101581209|NCT04178785|Analgesics|analgesics|mesh-ancestor
102561387|NCT01985425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102561388|NCT01985425|Tubulin Modulators|tubulin modulators|mesh-ancestor
102561389|NCT01985425|Antimitotic Agents|antimitotic agents|mesh-ancestor
102561390|NCT01985425|Mitosis Modulators|mitosis modulators|mesh-ancestor
102561391|NCT01985425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561392|NCT01985425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102561393|NCT02348918|Bevacizumab|bevacizumab|mesh-list
102561394|NCT02348918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102561395|NCT02348918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102561396|NCT02348918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102561397|NCT02348918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102561398|NCT02348918|Growth Substances|growth substances|mesh-ancestor
102561399|NCT02348918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561400|NCT02348918|Growth Inhibitors|growth inhibitors|mesh-ancestor
102561401|NCT01985581|Guanfacine|guanfacine|mesh-list
102561402|NCT01985581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102561403|NCT01985581|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102561404|NCT01985581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102561405|NCT01985581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102561406|NCT01985581|Adrenergic Agents|adrenergic agents|mesh-ancestor
102561407|NCT01985581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102561408|NCT01985581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561409|NCT01985581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561410|NCT02024204|Fluticasone|fluticasone|mesh-list
102561411|NCT02024204|Xhance|xhance|mesh-list
102561412|NCT02024204|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102561413|NCT02024204|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102561414|NCT02024204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102561415|NCT02024204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102561416|NCT02024204|Autonomic Agents|autonomic agents|mesh-ancestor
102561417|NCT02024204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102561418|NCT02024204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561419|NCT02024204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102561420|NCT02024204|Respiratory System Agents|respiratory system agents|mesh-ancestor
102561421|NCT02024204|Dermatologic Agents|dermatologic agents|mesh-ancestor
102561422|NCT02024204|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102561423|NCT02024204|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102561424|NCT02024204|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102561425|NCT02024204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102561426|NCT02024204|Adrenergic Agents|adrenergic agents|mesh-ancestor
102561427|NCT02024204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102561428|NCT02024204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561429|NCT02024204|Glucocorticoids|glucocorticoids|mesh-ancestor
102561430|NCT02024204|Hormones|hormones|mesh-ancestor
102561431|NCT02024204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102561432|NCT02024204|Sympathomimetics|sympathomimetics|mesh-ancestor
102561434|NCT03930745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102561435|NCT02034019|Dexamethasone|dexamethasone|mesh-list
102561436|NCT02034019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102561437|NCT02034019|Antiemetics|antiemetics|mesh-ancestor
102561438|NCT02034019|Autonomic Agents|autonomic agents|mesh-ancestor
102561439|NCT02034019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102561440|NCT02034019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561441|NCT02034019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102561442|NCT02034019|Glucocorticoids|glucocorticoids|mesh-ancestor
102561443|NCT02034019|Hormones|hormones|mesh-ancestor
102561444|NCT02034019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102561445|NCT02034019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102561446|NCT02034019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102561447|NCT02349152|Fentanyl|fentanyl|mesh-list
102561448|NCT02349152|Remifentanil|remifentanil|mesh-list
102561449|NCT02349152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102561450|NCT02349152|Narcotics|narcotics|mesh-ancestor
102561451|NCT02349152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102561452|NCT02349152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561453|NCT02349152|Analgesics|analgesics|mesh-ancestor
102561454|NCT02349152|Sensory System Agents|sensory system agents|mesh-ancestor
102561455|NCT02349152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102561456|NCT02349152|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102561457|NCT02349152|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102561458|NCT02349152|Anesthetics, General|anesthetics, general|mesh-ancestor
102561459|NCT02349152|Anesthetics|anesthetics|mesh-ancestor
102561460|NCT02035345|Carboplatin|carboplatin|mesh-list
102561461|NCT02035345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102561462|NCT01986361|Flurbiprofen|flurbiprofen|mesh-list
102561463|NCT01986361|Analgesics|analgesics|mesh-ancestor
102561464|NCT01986361|Sensory System Agents|sensory system agents|mesh-ancestor
102561465|NCT01986361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102561466|NCT01986361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561467|NCT01986361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102561468|NCT01986361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102561469|NCT01986361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102561470|NCT01986361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102561471|NCT01986361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102561472|NCT01986361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102561473|NCT01986361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561474|NCT01983020|Lidocaine|lidocaine|mesh-list
102561475|NCT01983020|Ketamine|ketamine|mesh-list
102561476|NCT01983020|Anesthetics, Local|anesthetics, local|mesh-ancestor
102561477|NCT01983020|Anesthetics|anesthetics|mesh-ancestor
102561478|NCT01983020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102561479|NCT01983020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561480|NCT01983020|Sensory System Agents|sensory system agents|mesh-ancestor
102561481|NCT01983020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102561482|NCT01983020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102561483|NCT01983020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102561484|NCT01983020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102561485|NCT01983020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102561486|NCT01983020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561487|NCT01983020|Analgesics|analgesics|mesh-ancestor
102561488|NCT01983020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102561489|NCT01983020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102561490|NCT01983020|Anesthetics, General|anesthetics, general|mesh-ancestor
102561491|NCT01983020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102561492|NCT01983020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102561493|NCT01983020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102561494|NCT02058511|Anesthetics|anesthetics|mesh-list
102561495|NCT02058511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102561496|NCT02058511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561497|NCT01983566|Omeprazole|omeprazole|mesh-list
102561498|NCT01983566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102561499|NCT01983566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102561500|NCT01983566|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102561501|NCT01983566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102561502|NCT01983566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561503|NCT01983878|Ramucirumab|ramucirumab|mesh-list
102561504|NCT01983878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102561505|NCT02396732|Aspirin|aspirin|mesh-list
102561506|NCT02396732|Enoxaparin|enoxaparin|mesh-list
101836462|NCT00483756|Antifungal Agents|antifungal agents|mesh-ancestor
102561507|NCT02396732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102561508|NCT02396732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102561509|NCT02396732|Analgesics|analgesics|mesh-ancestor
102561510|NCT02396732|Sensory System Agents|sensory system agents|mesh-ancestor
102561511|NCT02396732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102561512|NCT02396732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561513|NCT02396732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102561514|NCT02396732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102561515|NCT02396732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102561516|NCT02396732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102561517|NCT02396732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561518|NCT02396732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102561519|NCT02396732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102561520|NCT02396732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102561521|NCT02396732|Antipyretics|antipyretics|mesh-ancestor
102561522|NCT02396732|Anticoagulants|anticoagulants|mesh-ancestor
102561523|NCT02352974|Vitamin D|vitamin d|mesh-list
102561524|NCT02352974|Vitamins|vitamins|mesh-ancestor
102561525|NCT02352974|Micronutrients|micronutrients|mesh-ancestor
102561526|NCT02352974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561527|NCT02352974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102561528|NCT02353754|Morphine|morphine|mesh-list
102561529|NCT02353754|Bupivacaine|bupivacaine|mesh-list
102561530|NCT02353754|Anesthetics, Local|anesthetics, local|mesh-ancestor
102561531|NCT02353754|Anesthetics|anesthetics|mesh-ancestor
102561532|NCT02353754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102561533|NCT02353754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561534|NCT02353754|Sensory System Agents|sensory system agents|mesh-ancestor
102561535|NCT02353754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102561536|NCT02353754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102561537|NCT02353754|Narcotics|narcotics|mesh-ancestor
102561538|NCT02353754|Analgesics|analgesics|mesh-ancestor
102561539|NCT02354378|Dexmedetomidine|dexmedetomidine|mesh-list
102561540|NCT02354378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102561541|NCT02354378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102561542|NCT02354378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561543|NCT02354378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102561544|NCT02354378|Analgesics|analgesics|mesh-ancestor
102561545|NCT02354378|Sensory System Agents|sensory system agents|mesh-ancestor
102561546|NCT02354378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102561547|NCT02354378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102561548|NCT02354378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102561549|NCT02354378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102561550|NCT02354378|Adrenergic Agents|adrenergic agents|mesh-ancestor
102561551|NCT02354378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102561552|NCT02354378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561553|NCT02059213|Palbociclib|palbociclib|mesh-list
102561554|NCT02059213|Leuprolide|leuprolide|mesh-list
102561555|NCT02059213|Goserelin|goserelin|mesh-list
102561556|NCT02059213|Bicalutamide|bicalutamide|mesh-list
102561557|NCT02059213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102561558|NCT02059213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102561559|NCT02059213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102561560|NCT02059213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561561|NCT02059213|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102561562|NCT02059213|Fertility Agents|fertility agents|mesh-ancestor
102561563|NCT02059213|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102561564|NCT02059213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561565|NCT02059213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102561566|NCT02059213|Androgen Antagonists|androgen antagonists|mesh-ancestor
102561567|NCT02059213|Hormone Antagonists|hormone antagonists|mesh-ancestor
102561568|NCT02059213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102561569|NCT02037061|Bupivacaine|bupivacaine|mesh-list
102561570|NCT02037061|Anesthetics, Local|anesthetics, local|mesh-ancestor
102561571|NCT02037061|Anesthetics|anesthetics|mesh-ancestor
102561572|NCT02037061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102561573|NCT02037061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561574|NCT02037061|Sensory System Agents|sensory system agents|mesh-ancestor
102561575|NCT02037061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102561576|NCT02354534|Artesunate|artesunate|mesh-list
102561577|NCT02354534|Antimalarials|antimalarials|mesh-ancestor
102561578|NCT02354534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102561579|NCT02354534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102561580|NCT02354534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102108522|NCT02120859|Paclitaxel|paclitaxel|mesh-list
102561581|NCT02354534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102561583|NCT02354534|Schistosomicides|schistosomicides|mesh-ancestor
102561584|NCT02354534|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102561585|NCT02354534|Anthelmintics|anthelmintics|mesh-ancestor
102561586|NCT02355158|Clonidine|clonidine|mesh-list
102561587|NCT02355158|Analgesics|analgesics|mesh-ancestor
102561588|NCT02355158|Sensory System Agents|sensory system agents|mesh-ancestor
102561589|NCT02355158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102561590|NCT02355158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561591|NCT02355158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102561592|NCT02355158|Sympatholytics|sympatholytics|mesh-ancestor
102561593|NCT02355158|Autonomic Agents|autonomic agents|mesh-ancestor
102561594|NCT02355158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102561595|NCT02355158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102561596|NCT02355158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102561597|NCT02355158|Adrenergic Agents|adrenergic agents|mesh-ancestor
102561598|NCT02355158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102561599|NCT02355158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561600|NCT02033876|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102561601|NCT02033876|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102561602|NCT02033876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102561603|NCT02061397|Sirolimus|sirolimus|mesh-list
102561604|NCT02061397|Everolimus|everolimus|mesh-list
102561605|NCT02061397|Simvastatin|simvastatin|mesh-list
102561606|NCT02061397|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102561607|NCT02061397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102561608|NCT02061397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102561609|NCT02061397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561610|NCT02061397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102561611|NCT02061397|Immunologic Factors|immunologic factors|mesh-ancestor
102561612|NCT02061397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561613|NCT02061397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102561614|NCT02061397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102561615|NCT02061397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102561616|NCT02061397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102561617|NCT02061397|Antifungal Agents|antifungal agents|mesh-ancestor
102561618|NCT02061397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102561619|NCT02061397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102561620|NCT02061397|Antimetabolites|antimetabolites|mesh-ancestor
102561621|NCT02061397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102561622|NCT02061397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102561623|NCT02062177|Midazolam|midazolam|mesh-list
102561624|NCT02062177|Propofol|propofol|mesh-list
102561625|NCT02062177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102561626|NCT02062177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102561627|NCT02062177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561628|NCT02062177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102561629|NCT02062177|Anesthetics, General|anesthetics, general|mesh-ancestor
102561630|NCT02062177|Anesthetics|anesthetics|mesh-ancestor
102561631|NCT02062177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102561632|NCT02062177|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102561633|NCT02062177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102561634|NCT02062177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102561635|NCT02062177|GABA Modulators|gaba modulators|mesh-ancestor
102561636|NCT02062177|GABA Agents|gaba agents|mesh-ancestor
102561637|NCT02062177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102561638|NCT02062177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561639|NCT02034578|Apixaban|apixaban|mesh-list
102561640|NCT02034578|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102561641|NCT02034578|Antithrombins|antithrombins|mesh-ancestor
102561642|NCT02034578|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102561643|NCT02034578|Protease Inhibitors|protease inhibitors|mesh-ancestor
102561644|NCT02034578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102561645|NCT02034578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561646|NCT02034578|Anticoagulants|anticoagulants|mesh-ancestor
102561647|NCT02403830|Morphine|morphine|mesh-list
101581483|NCT05911126|Antiemetics|antiemetics|mesh-ancestor
102561648|NCT02403830|Methylnaltrexone|methylnaltrexone|mesh-list
102561649|NCT02403830|Ticagrelor|ticagrelor|mesh-list
102561650|NCT02403830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102561651|NCT02403830|Narcotics|narcotics|mesh-ancestor
102561652|NCT02403830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102561653|NCT02403830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561654|NCT02403830|Analgesics|analgesics|mesh-ancestor
102561655|NCT02403830|Sensory System Agents|sensory system agents|mesh-ancestor
102561656|NCT02403830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102561657|NCT02403830|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102108597|NCT00332748|Taxane|taxane|mesh-list
102561658|NCT02403830|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102561659|NCT02403830|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102561660|NCT02403830|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102561661|NCT02403830|Purinergic Agents|purinergic agents|mesh-ancestor
102561662|NCT02403830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102561663|NCT02403830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561664|NCT02403830|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102561665|NCT02036840|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102561666|NCT02036840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102561667|NCT02951195|Ivacaftor|ivacaftor|mesh-list
102561668|NCT02951195|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102561669|NCT02951195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102561670|NCT02951195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561671|NCT02037230|Gemcitabine|gemcitabine|mesh-list
102561672|NCT02037230|Adavosertib|adavosertib|mesh-list
102561673|NCT02037230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102561674|NCT02037230|Antimetabolites|antimetabolites|mesh-ancestor
102561675|NCT02037230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561676|NCT02037230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102561677|NCT02037230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102561678|NCT02312882|Tofacitinib|tofacitinib|mesh-list
102561679|NCT02312882|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102561680|NCT02312882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102561681|NCT02312882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102561682|NCT02312882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561683|NCT02877095|Furosemide|furosemide|mesh-list
102561684|NCT02877095|Diuretics|diuretics|mesh-ancestor
102561685|NCT02877095|Natriuretic Agents|natriuretic agents|mesh-ancestor
102561686|NCT02877095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561687|NCT02877095|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102561688|NCT02877095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102561689|NCT02877095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561690|NCT02877485|Triamcinolone|triamcinolone|mesh-list
102561691|NCT02877485|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102561692|NCT02877485|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102561693|NCT02877485|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102561694|NCT02877485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102561695|NCT02877485|Glucocorticoids|glucocorticoids|mesh-ancestor
102561696|NCT02877485|Hormones|hormones|mesh-ancestor
102561697|NCT02877485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102561698|NCT02877485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561699|NCT02877485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102561700|NCT02877485|Immunologic Factors|immunologic factors|mesh-ancestor
102561701|NCT02877485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102561702|NCT02877485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561703|NCT00374387|NuvaRing|nuvaring|mesh-list
102561704|NCT00374387|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102561705|NCT00374387|Contraceptive Agents|contraceptive agents|mesh-ancestor
102561706|NCT00374387|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102561707|NCT00374387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561708|NCT03023891|Prednisone|prednisone|mesh-list
102561709|NCT03023891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102561710|NCT03023891|Glucocorticoids|glucocorticoids|mesh-ancestor
102561711|NCT03023891|Hormones|hormones|mesh-ancestor
102561712|NCT03023891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102561713|NCT03023891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561714|NCT03023891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102561715|NCT03023891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102561716|NCT03028025|Hemostatics|hemostatics|mesh-list
102561717|NCT03028025|Coagulants|coagulants|mesh-ancestor
102561718|NCT02955329|Nicotine|nicotine|mesh-list
102561719|NCT02955329|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102561720|NCT02955329|Autonomic Agents|autonomic agents|mesh-ancestor
102561721|NCT02955329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102561722|NCT02955329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561723|NCT02955329|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102561724|NCT02955329|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102561725|NCT02955329|Cholinergic Agents|cholinergic agents|mesh-ancestor
102561726|NCT02955329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102561727|NCT02955329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561728|NCT02359058|Capecitabine|capecitabine|mesh-list
102561729|NCT02359058|Oxaliplatin|oxaliplatin|mesh-list
102561730|NCT02359058|Ramucirumab|ramucirumab|mesh-list
102108671|NCT00325650|Rimonabant|rimonabant|mesh-list
102561731|NCT02359058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102561732|NCT02359058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102561733|NCT02359058|Antimetabolites|antimetabolites|mesh-ancestor
102561734|NCT02359058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561736|NCT02404610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
102561737|NCT02404610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102561738|NCT02404610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561739|NCT02404610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102561740|NCT02404610|Anesthetics, General|anesthetics, general|mesh-ancestor
102561741|NCT02404610|Anesthetics|anesthetics|mesh-ancestor
102561742|NCT03110003|Bupivacaine|bupivacaine|mesh-list
102561743|NCT03110003|Anesthetics, Local|anesthetics, local|mesh-ancestor
102561744|NCT03110003|Anesthetics|anesthetics|mesh-ancestor
102561745|NCT03110003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102561746|NCT03110003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561747|NCT03110003|Sensory System Agents|sensory system agents|mesh-ancestor
102561748|NCT03110003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102561749|NCT03114995|Tirofiban|tirofiban|mesh-list
102561750|NCT03114995|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102561751|NCT03114995|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102561752|NCT03114995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561753|NCT03114995|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102561754|NCT02959853|Anastrozole|anastrozole|mesh-list
102561755|NCT02959853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102561756|NCT02959853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101581598|NCT05907486|Expectorants|expectorants|mesh-ancestor
102561757|NCT02959853|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102561758|NCT02959853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102561759|NCT02959853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102561760|NCT02959853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561761|NCT02959853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102561762|NCT02959853|Hormone Antagonists|hormone antagonists|mesh-ancestor
102561763|NCT02959853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102561764|NCT02959853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561765|NCT00374465|Verapamil|verapamil|mesh-list
102561766|NCT00374465|Carvedilol|carvedilol|mesh-list
102561767|NCT00374465|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102561768|NCT00374465|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102561769|NCT00374465|Adrenergic Agents|adrenergic agents|mesh-ancestor
102561770|NCT00374465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102561771|NCT00374465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561772|NCT00374465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561773|NCT00374465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102561774|NCT00374465|Antioxidants|antioxidants|mesh-ancestor
102561775|NCT00374465|Protective Agents|protective agents|mesh-ancestor
102561776|NCT00374465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102561777|NCT00374465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102561778|NCT00374465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102561779|NCT00374465|Vasodilator Agents|vasodilator agents|mesh-ancestor
102561780|NCT00374465|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102561781|NCT00374465|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102561782|NCT00374465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102561783|NCT02040116|Rituximab|rituximab|mesh-list
102561784|NCT02040116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102561785|NCT02040116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102561786|NCT02040116|Immunologic Factors|immunologic factors|mesh-ancestor
102561787|NCT02040116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561788|NCT02040116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102561789|NCT02360774|Canagliflozin|canagliflozin|mesh-list
102561790|NCT02360774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102561791|NCT02360774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561792|NCT02360774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102561793|NCT02360774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561794|NCT02361476|Clonidine|clonidine|mesh-list
102561795|NCT02361476|Analgesics|analgesics|mesh-ancestor
102561796|NCT02361476|Sensory System Agents|sensory system agents|mesh-ancestor
102561797|NCT02361476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102561798|NCT02361476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561799|NCT02361476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102561800|NCT02361476|Sympatholytics|sympatholytics|mesh-ancestor
102561801|NCT02361476|Autonomic Agents|autonomic agents|mesh-ancestor
102561802|NCT02361476|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102108744|NCT02127489|Anesthetics|anesthetics|mesh-ancestor
102561803|NCT02361476|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102561804|NCT02361476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102561805|NCT02361476|Adrenergic Agents|adrenergic agents|mesh-ancestor
102561806|NCT02361476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102561807|NCT02361476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561808|NCT02363270|Ketamine|ketamine|mesh-list
102561809|NCT02363270|Analgesics|analgesics|mesh-ancestor
102561810|NCT02363270|Sensory System Agents|sensory system agents|mesh-ancestor
102561811|NCT02363270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102561812|NCT02363270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561813|NCT02363270|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102561814|NCT02363270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102561815|NCT02363270|Anesthetics, General|anesthetics, general|mesh-ancestor
102561816|NCT02363270|Anesthetics|anesthetics|mesh-ancestor
102561817|NCT02363270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102561818|NCT02363270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102561819|NCT02363270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102561820|NCT02363270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102561821|NCT02363270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561822|NCT02042534|Warfarin|warfarin|mesh-list
102561823|NCT02042534|Rivaroxaban|rivaroxaban|mesh-list
102561824|NCT02042534|Anticoagulants|anticoagulants|mesh-ancestor
102561825|NCT02042534|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102561826|NCT02042534|Antithrombins|antithrombins|mesh-ancestor
102561827|NCT02042534|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102561828|NCT02042534|Protease Inhibitors|protease inhibitors|mesh-ancestor
102561829|NCT02042534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102561830|NCT02042534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561831|NCT02043704|Acetaminophen|acetaminophen|mesh-list
102561832|NCT02043704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102561833|NCT02043704|Analgesics|analgesics|mesh-ancestor
102561834|NCT02043704|Sensory System Agents|sensory system agents|mesh-ancestor
102561835|NCT02043704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102561836|NCT02043704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561837|NCT02043704|Antipyretics|antipyretics|mesh-ancestor
102561838|NCT02410382|Dexamethasone|dexamethasone|mesh-list
102561839|NCT02410382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102561840|NCT02410382|Antiemetics|antiemetics|mesh-ancestor
102561841|NCT02410382|Autonomic Agents|autonomic agents|mesh-ancestor
102561842|NCT02410382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102561843|NCT02410382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561844|NCT02410382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102561845|NCT02410382|Glucocorticoids|glucocorticoids|mesh-ancestor
102561846|NCT02410382|Hormones|hormones|mesh-ancestor
102561847|NCT02410382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102561848|NCT02410382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102561849|NCT02410382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102561850|NCT03038867|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102561851|NCT03038867|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102561852|NCT03038867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102561853|NCT03038867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102561854|NCT03038867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561855|NCT03038867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102561856|NCT03038867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561857|NCT03038867|Analgesics|analgesics|mesh-ancestor
102561858|NCT03038867|Sensory System Agents|sensory system agents|mesh-ancestor
102561859|NCT03038867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102561860|NCT03038867|Antidepressive Agents|antidepressive agents|mesh-ancestor
102561861|NCT03038867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102561862|NCT03038867|Dopamine Agents|dopamine agents|mesh-ancestor
102561863|NCT03119831|Ethanol|ethanol|mesh-list
102561864|NCT03119831|Chlorhexidine|chlorhexidine|mesh-list
102561865|NCT03119831|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102561866|NCT03119831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102561867|NCT03119831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102561868|NCT03119831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102561869|NCT03119831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561870|NCT03119831|Disinfectants|disinfectants|mesh-ancestor
102561871|NCT03119831|Dermatologic Agents|dermatologic agents|mesh-ancestor
102561872|NCT02965781|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
102561873|NCT02965781|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102561874|NCT02965781|Immunologic Factors|immunologic factors|mesh-ancestor
102561875|NCT02965781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561876|NCT03124121|Golimumab|golimumab|mesh-list
102108819|NCT02128191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102561877|NCT03124121|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102561878|NCT03124121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102561879|NCT03124121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102561880|NCT03124121|Immunologic Factors|immunologic factors|mesh-ancestor
102561881|NCT03124121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561882|NCT03042299|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
102561883|NCT03042299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102561884|NCT03042299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102561885|NCT03042299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561886|NCT00374699|Bortezomib|bortezomib|mesh-list
102561887|NCT00374699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102561888|NCT00374777|Nitrazepam|nitrazepam|mesh-list
102561889|NCT00374777|Zolpidem|zolpidem|mesh-list
102561890|NCT00374777|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102561891|NCT00374777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102561892|NCT00374777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102561893|NCT00374777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561894|NCT00374777|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102561895|NCT00374777|GABA Agonists|gaba agonists|mesh-ancestor
102561896|NCT00374777|GABA Agents|gaba agents|mesh-ancestor
102561897|NCT00374777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102561898|NCT00374777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561899|NCT00374777|Anticonvulsants|anticonvulsants|mesh-ancestor
102561900|NCT00374777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102561901|NCT00374777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102561902|NCT00374777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102561903|NCT00374777|GABA Modulators|gaba modulators|mesh-ancestor
102561904|NCT02044796|Cytarabine|cytarabine|mesh-list
102561905|NCT02044796|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
102561906|NCT02044796|Mitoxantrone|mitoxantrone|mesh-list
102561907|NCT02044796|Cladribine|cladribine|mesh-list
102561908|NCT02044796|Lenograstim|lenograstim|mesh-list
102561909|NCT02044796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102561910|NCT02044796|Antimetabolites|antimetabolites|mesh-ancestor
102561911|NCT02044796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561912|NCT02044796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102561913|NCT02044796|Antiviral Agents|antiviral agents|mesh-ancestor
102561914|NCT02044796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102561915|NCT02044796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102561916|NCT02044796|Immunologic Factors|immunologic factors|mesh-ancestor
102561917|NCT02044796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561918|NCT02044796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102561919|NCT02044796|Analgesics|analgesics|mesh-ancestor
102561920|NCT02044796|Sensory System Agents|sensory system agents|mesh-ancestor
102561921|NCT02044796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102561922|NCT02044796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102561923|NCT02044796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102561924|NCT02044796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102561925|NCT02973503|Grazoprevir|grazoprevir|mesh-list
102561926|NCT02973503|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
102561927|NCT02973503|Antiviral Agents|antiviral agents|mesh-ancestor
102561928|NCT02973503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102561929|NCT03127943|Lidocaine|lidocaine|mesh-list
102561930|NCT03127943|Anesthetics, Local|anesthetics, local|mesh-ancestor
102561931|NCT03127943|Anesthetics|anesthetics|mesh-ancestor
102561932|NCT03127943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102561933|NCT03127943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561934|NCT03127943|Sensory System Agents|sensory system agents|mesh-ancestor
102561935|NCT03127943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102561936|NCT03127943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102561937|NCT03127943|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102561938|NCT03127943|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102561939|NCT03127943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102561940|NCT03127943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561941|NCT03048383|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102561942|NCT03048383|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102561943|NCT03048383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102561944|NCT03048383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102561945|NCT03048383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561946|NCT03048383|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102561947|NCT03048383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102561948|NCT03048383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561949|NCT03048383|Cholinergic Agents|cholinergic agents|mesh-ancestor
102561950|NCT03048383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102561951|NCT02045264|Icatibant|icatibant|mesh-list
102561952|NCT02045264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102561953|NCT02045264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102561954|NCT02045264|Analgesics|analgesics|mesh-ancestor
102561955|NCT02045264|Sensory System Agents|sensory system agents|mesh-ancestor
102561956|NCT02045264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102561957|NCT02045264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561958|NCT02045264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102561959|NCT02045264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102561960|NCT02045264|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
102561961|NCT02045264|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
102561962|NCT02045264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561963|NCT02045264|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102561964|NCT02045264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102561965|NCT02045264|Immunologic Factors|immunologic factors|mesh-ancestor
102561966|NCT02975297|Exenatide|exenatide|mesh-list
102561967|NCT02975297|Nicotine|nicotine|mesh-list
102561968|NCT02975297|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102561969|NCT02975297|Autonomic Agents|autonomic agents|mesh-ancestor
102561970|NCT02975297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102561971|NCT02975297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561972|NCT02975297|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102561973|NCT02975297|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102561974|NCT02975297|Cholinergic Agents|cholinergic agents|mesh-ancestor
102561975|NCT02975297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102561976|NCT02975297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102561977|NCT02975297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102561978|NCT02975297|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102561979|NCT02975297|Incretins|incretins|mesh-ancestor
102561980|NCT02975297|Hormones|hormones|mesh-ancestor
102561981|NCT02975297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102561982|NCT02046200|Ethanol|ethanol|mesh-list
102561983|NCT02046200|Ivermectin|ivermectin|mesh-list
102561984|NCT02046200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102561985|NCT02046200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102561986|NCT02046200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102561987|NCT02046200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561988|NCT02046200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102561989|NCT02978339|Curcumin|curcumin|mesh-list
102561990|NCT02978339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102561991|NCT02978339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102561992|NCT02978339|Analgesics|analgesics|mesh-ancestor
102561993|NCT02978339|Sensory System Agents|sensory system agents|mesh-ancestor
102561994|NCT02978339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102561995|NCT02978339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102561996|NCT02978339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102561997|NCT02978339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102561998|NCT02978339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102561999|NCT02978339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102562000|NCT02978339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562001|NCT02367872|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
102562002|NCT02367872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102562003|NCT02367872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562004|NCT00374855|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102562005|NCT00374855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102562006|NCT00374855|Diuretics|diuretics|mesh-ancestor
102562007|NCT00374855|Natriuretic Agents|natriuretic agents|mesh-ancestor
102562008|NCT00374855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562009|NCT00374855|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102562010|NCT00374855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102562011|NCT00374855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562012|NCT02412644|Apremilast|apremilast|mesh-list
102562013|NCT02412644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102562014|NCT02412644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102562015|NCT02412644|Analgesics|analgesics|mesh-ancestor
102562016|NCT02412644|Sensory System Agents|sensory system agents|mesh-ancestor
102562017|NCT02412644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102562018|NCT02412644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562019|NCT02412644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102562020|NCT02412644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102562021|NCT02412644|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102562022|NCT02412644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102562023|NCT02412644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102562024|NCT02412644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562026|NCT02413034|Cefazolin|cefazolin|mesh-list
102562027|NCT02413034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101581876|NCT05465941|Irinotecan|irinotecan|mesh-list
102562028|NCT02413034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102562029|NCT04737473|Anesthetics|anesthetics|mesh-list
102562030|NCT04737473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102562031|NCT04737473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562032|NCT02369900|Esmolol|esmolol|mesh-list
102562033|NCT02369900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102562034|NCT02369900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102562035|NCT02369900|Adrenergic Agents|adrenergic agents|mesh-ancestor
102562036|NCT02369900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102562037|NCT02369900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562038|NCT02369900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562039|NCT02369900|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102562040|NCT03054857|Dexmedetomidine|dexmedetomidine|mesh-list
102562041|NCT03054857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102562042|NCT03054857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102562043|NCT03054857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562044|NCT03054857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102562045|NCT03054857|Analgesics|analgesics|mesh-ancestor
102562046|NCT03054857|Sensory System Agents|sensory system agents|mesh-ancestor
102562047|NCT03054857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102562048|NCT03054857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102562049|NCT03054857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102562050|NCT03054857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102562051|NCT03054857|Adrenergic Agents|adrenergic agents|mesh-ancestor
102562052|NCT03054857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102562053|NCT03054857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562054|NCT02414204|Sildenafil Citrate|sildenafil citrate|mesh-list
102562055|NCT02414204|Vasodilator Agents|vasodilator agents|mesh-ancestor
102562056|NCT02414204|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102562057|NCT02414204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102562058|NCT02414204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102562059|NCT02414204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562060|NCT02414204|Urological Agents|urological agents|mesh-ancestor
102562061|NCT02989493|Doxazosin|doxazosin|mesh-list
102562062|NCT02989493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102562063|NCT02989493|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102562064|NCT02989493|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102562065|NCT02989493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102562066|NCT02989493|Adrenergic Agents|adrenergic agents|mesh-ancestor
102562067|NCT02989493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102562068|NCT02989493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562069|NCT02989493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562070|NCT02050334|Caffeic acid|caffeic acid|mesh-list
102562071|NCT02050334|Antioxidants|antioxidants|mesh-ancestor
102562072|NCT02050334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562073|NCT02050334|Protective Agents|protective agents|mesh-ancestor
102562074|NCT02050334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562075|NCT02371850|Nicotine|nicotine|mesh-list
102562076|NCT02371850|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102562077|NCT02371850|Autonomic Agents|autonomic agents|mesh-ancestor
102562078|NCT02371850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102562079|NCT02371850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562080|NCT02371850|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102562081|NCT02371850|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102562082|NCT02371850|Cholinergic Agents|cholinergic agents|mesh-ancestor
102562083|NCT02371850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101581934|NCT05332444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101581996|NCT05074355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581997|NCT05074355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101581998|NCT05074355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102562084|NCT02371850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562085|NCT03144635|Grazoprevir|grazoprevir|mesh-list
102562086|NCT03144635|Antiviral Agents|antiviral agents|mesh-ancestor
102562087|NCT03144635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102562088|NCT03145259|Diclofenac|diclofenac|mesh-list
102562089|NCT03145259|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
102562090|NCT03145259|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102562091|NCT03145259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102562092|NCT03145259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102562093|NCT03145259|Analgesics|analgesics|mesh-ancestor
102562094|NCT03145259|Sensory System Agents|sensory system agents|mesh-ancestor
102562095|NCT03145259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102562096|NCT03145259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562097|NCT03145259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102562098|NCT03145259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102562099|NCT03145259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102562100|NCT03145259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102562101|NCT03145259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562102|NCT00354692|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102562103|NCT00354692|Ferric gluconate|ferric gluconate|mesh-list
102562104|NCT00354692|Hematinics|hematinics|mesh-ancestor
102562105|NCT02989727|Lamotrigine|lamotrigine|mesh-list
102562106|NCT02989727|Anticonvulsants|anticonvulsants|mesh-ancestor
102562107|NCT02989727|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102562108|NCT02989727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102562109|NCT02989727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562110|NCT02989727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102562111|NCT02989727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562112|NCT02989727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102562113|NCT02989727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102562114|NCT02989727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102562115|NCT02989727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102562116|NCT02989727|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102562117|NCT02039947|Trametinib|trametinib|mesh-list
102562118|NCT02039947|Dabrafenib|dabrafenib|mesh-list
102562119|NCT02039947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102562120|NCT02039947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102562121|NCT02039947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102562122|NCT02039947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562123|NCT02052752|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102562124|NCT02052752|Dermatologic Agents|dermatologic agents|mesh-ancestor
102562125|NCT02996591|Dexamethasone|dexamethasone|mesh-list
102562126|NCT02996591|Dexamethasone acetate|dexamethasone acetate|mesh-list
102562127|NCT02996591|Midazolam|midazolam|mesh-list
102562128|NCT02996591|Glycopyrrolate|glycopyrrolate|mesh-list
102562129|NCT02996591|Ketamine|ketamine|mesh-list
102562130|NCT02996591|Bupivacaine|bupivacaine|mesh-list
102562131|NCT02996591|Mepivacaine|mepivacaine|mesh-list
102562132|NCT02996591|Anesthetics|anesthetics|mesh-list
102562133|NCT02996591|Propofol|propofol|mesh-list
102562134|NCT02996591|Sevoflurane|sevoflurane|mesh-list
102562135|NCT02996591|BB 1101|bb 1101|mesh-list
102562136|NCT02996591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102562137|NCT02996591|Antiemetics|antiemetics|mesh-ancestor
102562138|NCT02996591|Autonomic Agents|autonomic agents|mesh-ancestor
102562139|NCT02996591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102562140|NCT02996591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562141|NCT02996591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102562142|NCT02996591|Glucocorticoids|glucocorticoids|mesh-ancestor
102562143|NCT02996591|Hormones|hormones|mesh-ancestor
102562144|NCT02996591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102562145|NCT02996591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102562146|NCT02996591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102562147|NCT02996591|Protease Inhibitors|protease inhibitors|mesh-ancestor
102562148|NCT02996591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102562149|NCT02996591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562150|NCT02996591|Anesthetics, Local|anesthetics, local|mesh-ancestor
102562151|NCT02996591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102562152|NCT02996591|Sensory System Agents|sensory system agents|mesh-ancestor
102562153|NCT02996591|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102562154|NCT02996591|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102562155|NCT02996591|Anesthetics, General|anesthetics, general|mesh-ancestor
102562156|NCT02996591|Analgesics|analgesics|mesh-ancestor
102562157|NCT02996591|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102562158|NCT02996591|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102562159|NCT02996591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102562160|NCT02996591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102562161|NCT02996591|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102562162|NCT02996591|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102562163|NCT02996591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102562164|NCT02996591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102562165|NCT02996591|GABA Modulators|gaba modulators|mesh-ancestor
102562166|NCT02996591|GABA Agents|gaba agents|mesh-ancestor
102562167|NCT02996591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102562168|NCT02996591|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102562169|NCT02996591|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102562170|NCT02996591|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102562171|NCT02996591|Cholinergic Agents|cholinergic agents|mesh-ancestor
102562172|NCT03066947|Interferons|interferons|mesh-list
102562173|NCT03066947|Interferon-alpha|interferon-alpha|mesh-list
102562174|NCT03066947|Interferon alpha-2|interferon alpha-2|mesh-list
102562175|NCT03066947|Cyclophosphamide|cyclophosphamide|mesh-list
102562177|NCT03066947|Immunologic Factors|immunologic factors|mesh-ancestor
102562178|NCT03066947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562179|NCT03066947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102562180|NCT03066947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102562181|NCT03066947|Alkylating Agents|alkylating agents|mesh-ancestor
102562182|NCT03066947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562183|NCT03066947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102562184|NCT03066947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102562185|NCT03066947|Antiviral Agents|antiviral agents|mesh-ancestor
102562186|NCT03066947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102562187|NCT02043145|Botulinum Toxins|botulinum toxins|mesh-list
102562188|NCT02043145|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102562189|NCT02043145|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102562190|NCT02043145|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102562191|NCT02043145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102562192|NCT02043145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562193|NCT02043145|Cholinergic Agents|cholinergic agents|mesh-ancestor
102562194|NCT02043145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102562195|NCT02043145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562196|NCT02043145|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102562197|NCT02043145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102562198|NCT02062801|Ephedrine|ephedrine|mesh-list
102562199|NCT02062801|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102562200|NCT02062801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562201|NCT02062801|Sympathomimetics|sympathomimetics|mesh-ancestor
102562202|NCT02062801|Autonomic Agents|autonomic agents|mesh-ancestor
102562203|NCT02062801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102562204|NCT02062801|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102562205|NCT02062801|Adrenergic Agents|adrenergic agents|mesh-ancestor
102562206|NCT02062801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102562207|NCT02062801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562208|NCT03152591|Licogliflozin|licogliflozin|mesh-list
102562209|NCT03152591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102562210|NCT03152591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562211|NCT03152591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102562212|NCT03152591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562213|NCT02063035|Tranexamic Acid|tranexamic acid|mesh-list
102562214|NCT02063035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102562215|NCT02063035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102562216|NCT02063035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562217|NCT02063035|Hemostatics|hemostatics|mesh-ancestor
102562218|NCT02063035|Coagulants|coagulants|mesh-ancestor
102562219|NCT00375245|Sirolimus|sirolimus|mesh-list
102562220|NCT00375245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102562221|NCT00375245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102562222|NCT00375245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102562223|NCT00375245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102562224|NCT00375245|Antifungal Agents|antifungal agents|mesh-ancestor
102562225|NCT00375245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102562226|NCT00375245|Immunologic Factors|immunologic factors|mesh-ancestor
102562227|NCT00375245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562228|NCT02043379|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102562229|NCT02043379|Immunologic Factors|immunologic factors|mesh-ancestor
102562230|NCT02043379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562231|NCT02054156|Azithromycin|azithromycin|mesh-list
102562232|NCT02054156|Tobramycin|tobramycin|mesh-list
102562233|NCT02054156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102562234|NCT02054156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102562235|NCT03159143|Docetaxel|docetaxel|mesh-list
102562236|NCT03159143|Oxaliplatin|oxaliplatin|mesh-list
102562237|NCT03159143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102562238|NCT03159143|Tubulin Modulators|tubulin modulators|mesh-ancestor
102562239|NCT03159143|Antimitotic Agents|antimitotic agents|mesh-ancestor
102562240|NCT03159143|Mitosis Modulators|mitosis modulators|mesh-ancestor
102562241|NCT03159143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562242|NCT03068897|Ibuprofen|ibuprofen|mesh-list
102562243|NCT03068897|Tizanidine|tizanidine|mesh-list
102562244|NCT03068897|Baclofen|baclofen|mesh-list
102562245|NCT03068897|Metaxalone|metaxalone|mesh-list
102562246|NCT03068897|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102562247|NCT03068897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102562248|NCT03068897|Analgesics|analgesics|mesh-ancestor
102562249|NCT03068897|Sensory System Agents|sensory system agents|mesh-ancestor
102109195|NCT02741310|Analgesics|analgesics|mesh-ancestor
102562250|NCT03068897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102562251|NCT03068897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562252|NCT03068897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102562253|NCT03068897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102562254|NCT03068897|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102562255|NCT03068897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102562256|NCT03068897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562257|NCT03068897|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102562258|NCT03068897|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102562259|NCT03068897|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102562260|NCT03068897|GABA Agonists|gaba agonists|mesh-ancestor
102562262|NCT03068897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102562263|NCT03068897|Anticonvulsants|anticonvulsants|mesh-ancestor
102562264|NCT03068897|Parasympatholytics|parasympatholytics|mesh-ancestor
102562265|NCT03068897|Autonomic Agents|autonomic agents|mesh-ancestor
102562266|NCT03068897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102562267|NCT03068897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102562268|NCT03068897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102562269|NCT03068897|Adrenergic Agents|adrenergic agents|mesh-ancestor
102562270|NCT02049476|Dexamethasone|dexamethasone|mesh-list
101582188|NCT04205838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101582189|NCT04196530|Atezolizumab|atezolizumab|mesh-list
101582190|NCT04196530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101582191|NCT04196530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582192|NCT04196530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102562271|NCT02049476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102562272|NCT02049476|Antiemetics|antiemetics|mesh-ancestor
102562273|NCT02049476|Autonomic Agents|autonomic agents|mesh-ancestor
102562274|NCT02049476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102562275|NCT02049476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562276|NCT02049476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102562277|NCT02049476|Glucocorticoids|glucocorticoids|mesh-ancestor
102562278|NCT02049476|Hormones|hormones|mesh-ancestor
102562279|NCT02049476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102562280|NCT02049476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102562281|NCT02049476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102562282|NCT02299297|Tofacitinib|tofacitinib|mesh-list
102562283|NCT02299297|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102562284|NCT02299297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102562285|NCT02299297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102562286|NCT02299297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562287|NCT03069677|Midazolam|midazolam|mesh-list
102562288|NCT03069677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102562289|NCT03069677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102562290|NCT03069677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102562291|NCT03069677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562292|NCT03069677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102562293|NCT03069677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102562294|NCT03069677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102562295|NCT03069677|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102562296|NCT03069677|Anesthetics, General|anesthetics, general|mesh-ancestor
102562297|NCT03069677|Anesthetics|anesthetics|mesh-ancestor
102562298|NCT03069677|GABA Modulators|gaba modulators|mesh-ancestor
102562299|NCT03069677|GABA Agents|gaba agents|mesh-ancestor
102562300|NCT03069677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102562301|NCT03069677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562302|NCT02044393|Itraconazole|itraconazole|mesh-list
102562303|NCT02044393|Antifungal Agents|antifungal agents|mesh-ancestor
102562304|NCT02044393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102562305|NCT02044393|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102562306|NCT02044393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102562307|NCT02044393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102562308|NCT02044393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562309|NCT02044393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102562310|NCT02044393|Hormone Antagonists|hormone antagonists|mesh-ancestor
102562311|NCT02044393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102562312|NCT02044393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562313|NCT02044393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102562314|NCT05405465|Golimumab|golimumab|mesh-list
102562315|NCT05405465|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102562316|NCT05405465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102562317|NCT05405465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102562318|NCT05405465|Immunologic Factors|immunologic factors|mesh-ancestor
102562319|NCT05405465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562320|NCT02064907|Dexlansoprazole|dexlansoprazole|mesh-list
102562321|NCT02064907|Lansoprazole|lansoprazole|mesh-list
102562322|NCT02064907|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102562323|NCT02064907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102562324|NCT02064907|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102562325|NCT02064907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102562326|NCT02064907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562327|NCT02064985|Ticagrelor|ticagrelor|mesh-list
102562328|NCT02064985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102562329|NCT02064985|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102562330|NCT02064985|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102562331|NCT02064985|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102562332|NCT02064985|Purinergic Agents|purinergic agents|mesh-ancestor
102562333|NCT02064985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102562334|NCT02064985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562335|NCT02064985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562336|NCT03170219|Furosemide|furosemide|mesh-list
102562337|NCT03170219|Diuretics|diuretics|mesh-ancestor
102562338|NCT03170219|Natriuretic Agents|natriuretic agents|mesh-ancestor
102562339|NCT03170219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562340|NCT03170219|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102562341|NCT03170219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102562342|NCT03170219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562343|NCT00375557|Valproic Acid|valproic acid|mesh-list
102562344|NCT00375557|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102562345|NCT00375557|Antidepressive Agents|antidepressive agents|mesh-ancestor
102562346|NCT00375557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102562347|NCT00375557|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102562348|NCT00375557|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102562349|NCT00375557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102562350|NCT00375557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562351|NCT00375557|Anticonvulsants|anticonvulsants|mesh-ancestor
102562352|NCT00375557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102562353|NCT00375557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562354|NCT00375557|GABA Agents|gaba agents|mesh-ancestor
102562355|NCT00375557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102562356|NCT00375557|Antimanic Agents|antimanic agents|mesh-ancestor
102562357|NCT03177395|Acetylcysteine|acetylcysteine|mesh-list
102562358|NCT03177395|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102562359|NCT03177395|Antiviral Agents|antiviral agents|mesh-ancestor
102562360|NCT03177395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102562361|NCT03177395|Expectorants|expectorants|mesh-ancestor
102562362|NCT03177395|Respiratory System Agents|respiratory system agents|mesh-ancestor
102562363|NCT03177395|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102562364|NCT03177395|Antioxidants|antioxidants|mesh-ancestor
102562365|NCT03177395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562366|NCT03177395|Protective Agents|protective agents|mesh-ancestor
102562367|NCT03177395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562368|NCT03177395|Antidotes|antidotes|mesh-ancestor
102562369|NCT05159999|Antihypertensive Agents|antihypertensive agents|mesh-list
102562370|NCT03179345|Pregabalin|pregabalin|mesh-list
102562371|NCT03179345|Gabapentin|gabapentin|mesh-list
102562372|NCT03179345|Analgesics|analgesics|mesh-ancestor
102562373|NCT03179345|Sensory System Agents|sensory system agents|mesh-ancestor
102562374|NCT03179345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102562375|NCT03179345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562376|NCT03179345|Anticonvulsants|anticonvulsants|mesh-ancestor
102562377|NCT03179345|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102562378|NCT03179345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102562379|NCT03179345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562380|NCT03179345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102562381|NCT03179345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102562382|NCT03179345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102562383|NCT03179345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102562384|NCT03179345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102562385|NCT03179345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102562386|NCT03179345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101582261|NCT04016389|Paclitaxel|paclitaxel|mesh-list
102562387|NCT03179345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102562388|NCT03179345|Antimanic Agents|antimanic agents|mesh-ancestor
102562389|NCT03086213|Lidocaine|lidocaine|mesh-list
102562390|NCT03086213|Sufentanil|sufentanil|mesh-list
102562391|NCT03086213|Dexmedetomidine|dexmedetomidine|mesh-list
102562392|NCT03086213|Dsuvia|dsuvia|mesh-list
102562393|NCT03086213|Ropivacaine|ropivacaine|mesh-list
102562394|NCT03086213|Propofol|propofol|mesh-list
102562395|NCT03086213|Anesthetics, Local|anesthetics, local|mesh-ancestor
102562396|NCT03086213|Anesthetics|anesthetics|mesh-ancestor
102562397|NCT03086213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102562398|NCT03086213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109344|NCT05242029|Psilocybin|psilocybin|mesh-list
102562399|NCT03086213|Sensory System Agents|sensory system agents|mesh-ancestor
102562400|NCT03086213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102562401|NCT03086213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102562402|NCT03086213|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102562403|NCT03086213|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102562404|NCT03086213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102562405|NCT03086213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562406|NCT03086213|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102562407|NCT03086213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102562408|NCT03086213|Analgesics|analgesics|mesh-ancestor
102562409|NCT03086213|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102562410|NCT03086213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102562411|NCT03086213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102562412|NCT03086213|Adrenergic Agents|adrenergic agents|mesh-ancestor
102562413|NCT03086213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102562414|NCT03086213|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102562415|NCT03086213|Anesthetics, General|anesthetics, general|mesh-ancestor
102562416|NCT03086213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102562417|NCT03086213|Narcotics|narcotics|mesh-ancestor
102562418|NCT03086213|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102562419|NCT02378714|Varenicline|varenicline|mesh-list
102562420|NCT02378714|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102562421|NCT02378714|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102562422|NCT02378714|Cholinergic Agents|cholinergic agents|mesh-ancestor
102562423|NCT02378714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102562424|NCT02378714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562425|NCT02378714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562426|NCT03091673|Glucagon|glucagon|mesh-list
102562427|NCT03091673|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102562428|NCT03091673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102562429|NCT03091673|Hormones|hormones|mesh-ancestor
102562430|NCT03091673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102562431|NCT03091673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562432|NCT03091673|Incretins|incretins|mesh-ancestor
102562433|NCT02382848|Prazosin|prazosin|mesh-list
102562434|NCT02382848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102562435|NCT02382848|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102562436|NCT02382848|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102562437|NCT02382848|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102562438|NCT02382848|Adrenergic Agents|adrenergic agents|mesh-ancestor
102562439|NCT02382848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102562440|NCT02382848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562441|NCT02382848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562442|NCT02065687|Metformin|metformin|mesh-list
102562443|NCT02065687|Paclitaxel|paclitaxel|mesh-list
102562444|NCT02065687|Carboplatin|carboplatin|mesh-list
102562445|NCT02065687|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102562446|NCT02065687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102562447|NCT02065687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102562448|NCT02065687|Tubulin Modulators|tubulin modulators|mesh-ancestor
102562449|NCT02065687|Antimitotic Agents|antimitotic agents|mesh-ancestor
102562450|NCT02065687|Mitosis Modulators|mitosis modulators|mesh-ancestor
102562451|NCT02065687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562452|NCT02065687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102562453|NCT02065687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562454|NCT03096353|Naloxone|naloxone|mesh-list
102562455|NCT03096353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102562456|NCT03096353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562457|NCT03096353|Sensory System Agents|sensory system agents|mesh-ancestor
102562458|NCT03096353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102562459|NCT03098615|Efinaconazole|efinaconazole|mesh-list
102562460|NCT03098615|Antifungal Agents|antifungal agents|mesh-ancestor
102562461|NCT03098615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102562462|NCT05363501|Naloxone|naloxone|mesh-list
102562463|NCT05363501|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102562464|NCT05363501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562465|NCT05363501|Sensory System Agents|sensory system agents|mesh-ancestor
102562466|NCT05363501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102562467|NCT04736927|Midazolam|midazolam|mesh-list
102562468|NCT04736927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102562469|NCT04736927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102562470|NCT04736927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102562471|NCT04736927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109419|NCT05726370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102562472|NCT04736927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102562473|NCT04736927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102562474|NCT04736927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102562475|NCT04736927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102562476|NCT04736927|Anesthetics, General|anesthetics, general|mesh-ancestor
102562477|NCT04736927|Anesthetics|anesthetics|mesh-ancestor
102562478|NCT04736927|GABA Modulators|gaba modulators|mesh-ancestor
102562479|NCT04736927|GABA Agents|gaba agents|mesh-ancestor
102562480|NCT04736927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102562481|NCT04736927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562482|NCT03810703|Amphetamine|amphetamine|mesh-list
102562483|NCT03810703|Dextroamphetamine|dextroamphetamine|mesh-list
102562484|NCT03810703|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102562485|NCT03810703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562486|NCT03810703|Sympathomimetics|sympathomimetics|mesh-ancestor
102562487|NCT03810703|Autonomic Agents|autonomic agents|mesh-ancestor
102562488|NCT03810703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102562489|NCT03810703|Dopamine Agents|dopamine agents|mesh-ancestor
102562490|NCT03810703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102562491|NCT03810703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562492|NCT03810703|Adrenergic Agents|adrenergic agents|mesh-ancestor
102562493|NCT03810703|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102562494|NCT03810703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102562495|NCT03810703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102562496|NCT03810703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102562497|NCT02389088|Letrozole|letrozole|mesh-list
102562498|NCT02389088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102562499|NCT02389088|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102562500|NCT02389088|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102562501|NCT02389088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102562502|NCT02389088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562503|NCT02389088|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102562504|NCT02389088|Hormone Antagonists|hormone antagonists|mesh-ancestor
102562505|NCT02389088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102562506|NCT02389088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562507|NCT02068027|Clonidine|clonidine|mesh-list
102562508|NCT02068027|Analgesics|analgesics|mesh-ancestor
102562509|NCT02068027|Sensory System Agents|sensory system agents|mesh-ancestor
102562510|NCT02068027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102562511|NCT02068027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562512|NCT02068027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102562513|NCT02068027|Sympatholytics|sympatholytics|mesh-ancestor
102562514|NCT02068027|Autonomic Agents|autonomic agents|mesh-ancestor
102562515|NCT02068027|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102562516|NCT02068027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102562517|NCT02068027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102562518|NCT02068027|Adrenergic Agents|adrenergic agents|mesh-ancestor
102562519|NCT02068027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102562520|NCT02068027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562521|NCT02392208|Telavancin|telavancin|mesh-list
102562522|NCT02392208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102562523|NCT02392208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102562524|NCT05185583|Methylphenidate|methylphenidate|mesh-list
102562525|NCT05185583|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101582376|NCT03712098|Hormones|hormones|mesh-ancestor
102562526|NCT05185583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562527|NCT05185583|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102562528|NCT05185583|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102562529|NCT05185583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102562530|NCT05185583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562531|NCT05185583|Dopamine Agents|dopamine agents|mesh-ancestor
102562532|NCT05185583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102562533|NCT04645121|Carbon Monoxide|carbon monoxide|mesh-list
102562534|NCT04645121|Antimetabolites|antimetabolites|mesh-ancestor
102562535|NCT04645121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562536|NCT04645121|Gasotransmitters|gasotransmitters|mesh-ancestor
102562537|NCT04645121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102562538|NCT04645121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562539|NCT04603937|Aflibercept|aflibercept|mesh-list
102562540|NCT04603937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102562541|NCT04603937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102562542|NCT04603937|Growth Substances|growth substances|mesh-ancestor
102562543|NCT04603937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562544|NCT04603937|Growth Inhibitors|growth inhibitors|mesh-ancestor
102562545|NCT04603937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102562546|NCT02392286|Prednisone|prednisone|mesh-list
102562547|NCT02392286|Methylprednisolone|methylprednisolone|mesh-list
102562548|NCT02392286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102562549|NCT02392286|Glucocorticoids|glucocorticoids|mesh-ancestor
102562550|NCT02392286|Hormones|hormones|mesh-ancestor
102562551|NCT02392286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102562552|NCT02392286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562553|NCT02392286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102562554|NCT02392286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102562555|NCT02392286|Antiemetics|antiemetics|mesh-ancestor
102562556|NCT02392286|Autonomic Agents|autonomic agents|mesh-ancestor
102562557|NCT02392286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102562558|NCT02392286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102562559|NCT02392286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102562560|NCT02392286|Protective Agents|protective agents|mesh-ancestor
102562561|NCT04586153|Meplazumab|meplazumab|mesh-list
102562562|NCT04586153|Antiviral Agents|antiviral agents|mesh-ancestor
102562563|NCT04586153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102562564|NCT05717738|Bevacizumab|bevacizumab|mesh-list
102562565|NCT05717738|Atezolizumab|atezolizumab|mesh-list
102562566|NCT05717738|Sorafenib|sorafenib|mesh-list
102562567|NCT05717738|Apatinib|apatinib|mesh-list
102562568|NCT05717738|Lenvatinib|lenvatinib|mesh-list
102562569|NCT05717738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102562570|NCT05717738|Antibodies|antibodies|mesh-list
102562571|NCT05717738|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102562572|NCT05717738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102562573|NCT05717738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102562574|NCT05717738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102562575|NCT05717738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102562576|NCT05717738|Growth Substances|growth substances|mesh-ancestor
102562577|NCT05717738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562578|NCT05717738|Growth Inhibitors|growth inhibitors|mesh-ancestor
102562579|NCT05717738|Immunologic Factors|immunologic factors|mesh-ancestor
102562580|NCT05717738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102562581|NCT05717738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102562582|NCT05717738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562583|NCT02393378|Folic Acid|folic acid|mesh-list
102562584|NCT02393378|Adalimumab|adalimumab|mesh-list
102562585|NCT02393378|Methotrexate|methotrexate|mesh-list
102562586|NCT02393378|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102562587|NCT02393378|Abortifacient Agents|abortifacient agents|mesh-ancestor
102562588|NCT02393378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102562589|NCT02393378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562590|NCT02393378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102562591|NCT02393378|Antimetabolites|antimetabolites|mesh-ancestor
102562592|NCT02393378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562593|NCT02393378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102562594|NCT02393378|Dermatologic Agents|dermatologic agents|mesh-ancestor
102562595|NCT02393378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102562596|NCT02393378|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102562597|NCT02393378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102562598|NCT02393378|Immunologic Factors|immunologic factors|mesh-ancestor
102562599|NCT02393378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102562600|NCT02393378|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102562601|NCT02393378|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102562602|NCT02393378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102562603|NCT02393378|Hematinics|hematinics|mesh-ancestor
102562604|NCT02393378|Vitamin B Complex|vitamin b complex|mesh-ancestor
102562605|NCT02393378|Vitamins|vitamins|mesh-ancestor
102562606|NCT02393378|Micronutrients|micronutrients|mesh-ancestor
102562607|NCT04949477|Acetaminophen|acetaminophen|mesh-list
102562608|NCT04949477|Dexmedetomidine|dexmedetomidine|mesh-list
102562609|NCT04949477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102562610|NCT04949477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102562611|NCT04949477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562612|NCT04949477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102562613|NCT04949477|Analgesics|analgesics|mesh-ancestor
102562614|NCT04949477|Sensory System Agents|sensory system agents|mesh-ancestor
102562615|NCT04949477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102562616|NCT04949477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102562617|NCT04949477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102562618|NCT04949477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102562619|NCT04949477|Adrenergic Agents|adrenergic agents|mesh-ancestor
102562620|NCT04949477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102562621|NCT04949477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562622|NCT04949477|Antipyretics|antipyretics|mesh-ancestor
102109567|NCT02133105|Simendan|simendan|mesh-list
102562623|NCT04873895|Hydroxychloroquine|hydroxychloroquine|mesh-list
102562624|NCT04873895|Axitinib|axitinib|mesh-list
102562625|NCT04873895|Antimalarials|antimalarials|mesh-ancestor
102562626|NCT04873895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102562627|NCT04873895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102562628|NCT04873895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102562629|NCT04873895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102562630|NCT04873895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562631|NCT04873895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102562632|NCT04873895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102562633|NCT04873895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102562634|NCT05717582|Androgens|androgens|mesh-list
102562635|NCT05717582|Hormones|hormones|mesh-ancestor
102562636|NCT05717582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102562637|NCT05717582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562638|NCT03101033|Betamethasone|betamethasone|mesh-list
102562639|NCT03101033|Betamethasone Valerate|betamethasone valerate|mesh-list
102562640|NCT03101033|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102562641|NCT03101033|Betamethasone benzoate|betamethasone benzoate|mesh-list
102562642|NCT03101033|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102562643|NCT03101033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102562644|NCT03101033|Glucocorticoids|glucocorticoids|mesh-ancestor
102562645|NCT03101033|Hormones|hormones|mesh-ancestor
102562646|NCT03101033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102562647|NCT03101033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562648|NCT03101033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102562649|NCT03101033|Respiratory System Agents|respiratory system agents|mesh-ancestor
102562650|NCT02069041|Leucovorin|leucovorin|mesh-list
102562651|NCT02069041|Fluorouracil|fluorouracil|mesh-list
102562652|NCT02069041|Oxaliplatin|oxaliplatin|mesh-list
102562653|NCT02069041|Ramucirumab|ramucirumab|mesh-list
102562654|NCT02069041|Antimetabolites|antimetabolites|mesh-ancestor
102562655|NCT02069041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562656|NCT02069041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102562657|NCT02069041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102562658|NCT02069041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102562659|NCT02069041|Immunologic Factors|immunologic factors|mesh-ancestor
102562660|NCT02069041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562661|NCT02069041|Antidotes|antidotes|mesh-ancestor
102562662|NCT02069041|Protective Agents|protective agents|mesh-ancestor
102562663|NCT02069041|Vitamin B Complex|vitamin b complex|mesh-ancestor
102562664|NCT02069041|Vitamins|vitamins|mesh-ancestor
102562665|NCT02069041|Micronutrients|micronutrients|mesh-ancestor
102562666|NCT04920344|Cisplatin|cisplatin|mesh-list
102562667|NCT04920344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102562668|NCT03101111|Vaccines|vaccines|mesh-list
102562669|NCT03101111|Immunologic Factors|immunologic factors|mesh-ancestor
102562670|NCT03101111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562671|NCT05423834|Tenofovir|tenofovir|mesh-list
102562672|NCT05423834|Entecavir|entecavir|mesh-list
102562673|NCT05423834|Antiviral Agents|antiviral agents|mesh-ancestor
102562674|NCT05423834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102562675|NCT05423834|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102562676|NCT05423834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102562677|NCT05423834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102562678|NCT05423834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562679|NCT05423834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102562680|NCT05423834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102562681|NCT03103061|Regadenoson|regadenoson|mesh-list
102562682|NCT03103061|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
102562683|NCT03103061|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102562684|NCT03103061|Purinergic Agonists|purinergic agonists|mesh-ancestor
102562685|NCT03103061|Purinergic Agents|purinergic agents|mesh-ancestor
102562686|NCT03103061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102562687|NCT03103061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562688|NCT03103061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562689|NCT03105479|Vancomycin|vancomycin|mesh-list
102562690|NCT03105479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102562691|NCT03105479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102562692|NCT00355862|Cyclosporine|cyclosporine|mesh-list
102562693|NCT00355862|Sirolimus|sirolimus|mesh-list
102562694|NCT00355862|Prednisolone|prednisolone|mesh-list
102562695|NCT00355862|Temsirolimus|temsirolimus|mesh-list
102562696|NCT00355862|Azathioprine|azathioprine|mesh-list
102562697|NCT00355862|MTOR Inhibitors|mtor inhibitors|mesh-list
102109641|NCT02137161|Glucocorticoids|glucocorticoids|mesh-ancestor
102562698|NCT00355862|Tacrolimus|tacrolimus|mesh-list
102562699|NCT00355862|Cyclosporins|cyclosporins|mesh-list
102562700|NCT00355862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102562701|NCT00355862|Immunologic Factors|immunologic factors|mesh-ancestor
102562702|NCT00355862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562703|NCT00355862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102562704|NCT00355862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102562705|NCT00355862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562706|NCT00355862|Antifungal Agents|antifungal agents|mesh-ancestor
102562707|NCT00355862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102562708|NCT00355862|Dermatologic Agents|dermatologic agents|mesh-ancestor
102562709|NCT00355862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102562710|NCT00355862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102562711|NCT00355862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102562712|NCT00355862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102562713|NCT00355862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102562714|NCT00355862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102562715|NCT00355862|Glucocorticoids|glucocorticoids|mesh-ancestor
102562716|NCT00355862|Hormones|hormones|mesh-ancestor
101582579|NCT02636322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102562717|NCT00355862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102562718|NCT00355862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102562719|NCT00355862|Antimetabolites|antimetabolites|mesh-ancestor
102562720|NCT00355862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102562721|NCT02049151|Cyclophosphamide|cyclophosphamide|mesh-list
102562722|NCT02049151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102562723|NCT02049151|Immunologic Factors|immunologic factors|mesh-ancestor
102562724|NCT02049151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562725|NCT02049151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102562726|NCT02049151|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102562727|NCT02049151|Alkylating Agents|alkylating agents|mesh-ancestor
102562728|NCT02049151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562729|NCT02049151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102562730|NCT02049151|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102562731|NCT02049307|Losartan|losartan|mesh-list
102562732|NCT02049307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102562733|NCT02049307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102562734|NCT02049307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102562735|NCT02049307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102562736|NCT02049307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562737|NCT00355628|Fentanyl|fentanyl|mesh-list
102562738|NCT00355628|Citric Acid|citric acid|mesh-list
102562739|NCT00355628|Sodium Citrate|sodium citrate|mesh-list
102562740|NCT00355628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102562741|NCT00355628|Narcotics|narcotics|mesh-ancestor
102562742|NCT00355628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102562743|NCT00355628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562744|NCT00355628|Analgesics|analgesics|mesh-ancestor
102562745|NCT00355628|Sensory System Agents|sensory system agents|mesh-ancestor
102562746|NCT00355628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102562747|NCT00355628|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102562748|NCT00355628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102562749|NCT00355628|Anesthetics, General|anesthetics, general|mesh-ancestor
102562750|NCT00355628|Anesthetics|anesthetics|mesh-ancestor
102562751|NCT00355628|Anticoagulants|anticoagulants|mesh-ancestor
102562752|NCT00355628|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102562753|NCT00355628|Chelating Agents|chelating agents|mesh-ancestor
102562754|NCT00355628|Sequestering Agents|sequestering agents|mesh-ancestor
102562755|NCT00355628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562756|NCT02049385|Diazoxide|diazoxide|mesh-list
102562757|NCT02049385|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102562758|NCT02049385|Vasodilator Agents|vasodilator agents|mesh-ancestor
102562759|NCT03717155|Carboplatin|carboplatin|mesh-list
102562760|NCT03717155|Gemcitabine|gemcitabine|mesh-list
102562761|NCT03717155|Cetuximab|cetuximab|mesh-list
102562762|NCT03717155|Avelumab|avelumab|mesh-list
102562763|NCT03717155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102562764|NCT03717155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102562765|NCT03717155|Antimetabolites|antimetabolites|mesh-ancestor
102562766|NCT03717155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562767|NCT03717155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102562768|NCT03789097|Pembrolizumab|pembrolizumab|mesh-list
102562769|NCT03789097|Poly ICLC|poly iclc|mesh-list
102562770|NCT03789097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102562771|NCT03789097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102562772|NCT03789097|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102109718|NCT04468542|Immunologic Factors|immunologic factors|mesh-ancestor
102562773|NCT03789097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562774|NCT03789097|Interferon Inducers|interferon inducers|mesh-ancestor
102562775|NCT03789097|Immunologic Factors|immunologic factors|mesh-ancestor
102562776|NCT03789097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562778|NCT03655613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102562779|NCT03655613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102562780|NCT03655613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102562781|NCT03655613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562782|NCT04820036|Insulin|insulin|mesh-list
102562783|NCT04820036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102562784|NCT04820036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562785|NCT03286829|Metoprolol|metoprolol|mesh-list
102562786|NCT03286829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102562787|NCT03286829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102562788|NCT03286829|Sympatholytics|sympatholytics|mesh-ancestor
102562789|NCT03286829|Autonomic Agents|autonomic agents|mesh-ancestor
102562790|NCT03286829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102562791|NCT03286829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562792|NCT03286829|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102562793|NCT03286829|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102562794|NCT03286829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102562795|NCT03286829|Adrenergic Agents|adrenergic agents|mesh-ancestor
102562796|NCT03286829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102562797|NCT03286829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562798|NCT02051335|Scopolamine|scopolamine|mesh-list
102562799|NCT02051335|Donepezil|donepezil|mesh-list
102562800|NCT02051335|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102562801|NCT02051335|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102562802|NCT02051335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102562803|NCT02051335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562804|NCT02051335|Cholinergic Agents|cholinergic agents|mesh-ancestor
102562805|NCT02051335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102562806|NCT02051335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562807|NCT02051335|Nootropic Agents|nootropic agents|mesh-ancestor
102562808|NCT02051335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102562809|NCT02051335|Antiemetics|antiemetics|mesh-ancestor
102562810|NCT02051335|Autonomic Agents|autonomic agents|mesh-ancestor
102562811|NCT02051335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102562812|NCT02051335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102562813|NCT02051335|Mydriatics|mydriatics|mesh-ancestor
102562814|NCT02051335|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102562815|NCT02051335|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102562816|NCT02051335|Parasympatholytics|parasympatholytics|mesh-ancestor
102562817|NCT03290027|Tazarotene|tazarotene|mesh-list
102562818|NCT03290027|Dermatologic Agents|dermatologic agents|mesh-ancestor
102562819|NCT03290027|Keratolytic Agents|keratolytic agents|mesh-ancestor
102562820|NCT02300077|Fentanyl|fentanyl|mesh-list
102562821|NCT02300077|Morphine|morphine|mesh-list
102562822|NCT02300077|Methadone|methadone|mesh-list
102562823|NCT02300077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102562824|NCT02300077|Narcotics|narcotics|mesh-ancestor
102562825|NCT02300077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102562826|NCT02300077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562827|NCT02300077|Analgesics|analgesics|mesh-ancestor
102562828|NCT02300077|Sensory System Agents|sensory system agents|mesh-ancestor
102562829|NCT02300077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102562830|NCT02300077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102562831|NCT02300077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102562832|NCT02300077|Anesthetics, General|anesthetics, general|mesh-ancestor
102562833|NCT02300077|Anesthetics|anesthetics|mesh-ancestor
102562834|NCT02300077|Antitussive Agents|antitussive agents|mesh-ancestor
102562835|NCT02300077|Respiratory System Agents|respiratory system agents|mesh-ancestor
102562836|NCT05272826|Dexamethasone|dexamethasone|mesh-list
102562837|NCT05272826|Bortezomib|bortezomib|mesh-list
102562838|NCT05272826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102562839|NCT05272826|Antiemetics|antiemetics|mesh-ancestor
102562840|NCT05272826|Autonomic Agents|autonomic agents|mesh-ancestor
102562841|NCT05272826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102562842|NCT05272826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562843|NCT05272826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102562844|NCT05272826|Glucocorticoids|glucocorticoids|mesh-ancestor
102562845|NCT05272826|Hormones|hormones|mesh-ancestor
102562846|NCT05272826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102562847|NCT05272826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102562848|NCT05272826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102562849|NCT03458429|Lenograstim|lenograstim|mesh-list
102562850|NCT03458429|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102562851|NCT03458429|Immunologic Factors|immunologic factors|mesh-ancestor
102562852|NCT03458429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562853|NCT03291197|Bupivacaine|bupivacaine|mesh-list
102562854|NCT03291197|Anesthetics, Local|anesthetics, local|mesh-ancestor
102562855|NCT03291197|Anesthetics|anesthetics|mesh-ancestor
102562856|NCT03291197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102562857|NCT03291197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562858|NCT03291197|Sensory System Agents|sensory system agents|mesh-ancestor
102562859|NCT03291197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102562860|NCT05638880|Empagliflozin|empagliflozin|mesh-list
102562861|NCT05638880|Valsartan|valsartan|mesh-list
102562862|NCT05638880|Levocetirizine|levocetirizine|mesh-list
102562863|NCT05638880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102562864|NCT05638880|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102562865|NCT05638880|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102562866|NCT05638880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562867|NCT05638880|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102562868|NCT05638880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102562869|NCT05638880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562870|NCT05638880|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102562871|NCT05638880|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102562872|NCT05638880|Histamine Antagonists|histamine antagonists|mesh-ancestor
102562873|NCT05638880|Histamine Agents|histamine agents|mesh-ancestor
102562874|NCT05638880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102562875|NCT00356096|Pramipexole|pramipexole|mesh-list
102562876|NCT00356096|Antioxidants|antioxidants|mesh-ancestor
102562877|NCT00356096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562878|NCT00356096|Protective Agents|protective agents|mesh-ancestor
102562879|NCT00356096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562880|NCT00356096|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102562881|NCT00356096|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102562882|NCT00356096|Dopamine Agonists|dopamine agonists|mesh-ancestor
102562883|NCT00356096|Dopamine Agents|dopamine agents|mesh-ancestor
102562884|NCT00356096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102562885|NCT05637086|Phenytoin|phenytoin|mesh-list
102562886|NCT05637086|Pentoxifylline|pentoxifylline|mesh-list
102562887|NCT05637086|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102562888|NCT05637086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102562889|NCT05637086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562890|NCT05637086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102562891|NCT05637086|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102562892|NCT05637086|Protective Agents|protective agents|mesh-ancestor
102562893|NCT05637086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562894|NCT05637086|Vasodilator Agents|vasodilator agents|mesh-ancestor
102562895|NCT05637086|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102562896|NCT05637086|Antioxidants|antioxidants|mesh-ancestor
102562897|NCT05637086|Anticonvulsants|anticonvulsants|mesh-ancestor
102562898|NCT05637086|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102562899|NCT05637086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102562900|NCT05637086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102562901|NCT05637086|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102562902|NCT05637086|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102562903|NCT03243461|Temozolomide|temozolomide|mesh-list
102562904|NCT03243461|Valproic Acid|valproic acid|mesh-list
102562905|NCT03243461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102562906|NCT03243461|Alkylating Agents|alkylating agents|mesh-ancestor
102562907|NCT03243461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562908|NCT03243461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102562909|NCT03243461|Anticonvulsants|anticonvulsants|mesh-ancestor
102562910|NCT03243461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102562911|NCT03243461|GABA Agents|gaba agents|mesh-ancestor
102562912|NCT03243461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102562913|NCT03243461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562914|NCT03243461|Antimanic Agents|antimanic agents|mesh-ancestor
102562915|NCT03243461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102562916|NCT03243461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102562917|NCT03243461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102562918|NCT03296345|Ketamine|ketamine|mesh-list
102562919|NCT03296345|Analgesics|analgesics|mesh-ancestor
102562920|NCT03296345|Sensory System Agents|sensory system agents|mesh-ancestor
102562921|NCT03296345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102562922|NCT03296345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562923|NCT03296345|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101582786|NCT00052884|Alkylating Agents|alkylating agents|mesh-ancestor
102562924|NCT03296345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102562925|NCT03296345|Anesthetics, General|anesthetics, general|mesh-ancestor
102562926|NCT03296345|Anesthetics|anesthetics|mesh-ancestor
102562927|NCT03296345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102562928|NCT03296345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102562929|NCT03296345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102562930|NCT03296345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102562931|NCT03296345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562932|NCT00421694|Bicalutamide|bicalutamide|mesh-list
102562933|NCT00421694|Androgen Antagonists|androgen antagonists|mesh-ancestor
102562934|NCT00421694|Hormone Antagonists|hormone antagonists|mesh-ancestor
102562935|NCT00421694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102562936|NCT00421694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562937|NCT00421694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102562938|NCT00376181|Pioglitazone|pioglitazone|mesh-list
102562939|NCT00376181|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
102562940|NCT00376181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102562941|NCT00376181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562942|NCT00376181|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102562943|NCT00376181|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102562944|NCT00376181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562945|NCT04736693|Zoledronic Acid|zoledronic acid|mesh-list
102562946|NCT04736693|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
102562947|NCT04736693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102562948|NCT04736693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562949|NCT04736693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102562950|NCT04736693|Hormone Antagonists|hormone antagonists|mesh-ancestor
102562951|NCT04736693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102562952|NCT04736693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102562953|NCT04736693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102562955|NCT04652414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102562956|NCT04652414|Glucocorticoids|glucocorticoids|mesh-ancestor
102562957|NCT04652414|Hormones|hormones|mesh-ancestor
102562958|NCT04652414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102562959|NCT04652414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562960|NCT04652414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102562961|NCT04652414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102562962|NCT04630964|Niacin|niacin|mesh-list
102562963|NCT04630964|Psilocybin|psilocybin|mesh-list
102562964|NCT04630964|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102562965|NCT04630964|Antimetabolites|antimetabolites|mesh-ancestor
102562966|NCT04630964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562967|NCT04630964|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102562968|NCT04630964|Vasodilator Agents|vasodilator agents|mesh-ancestor
102562969|NCT04630964|Vitamin B Complex|vitamin b complex|mesh-ancestor
102562970|NCT04630964|Vitamins|vitamins|mesh-ancestor
102562971|NCT04630964|Micronutrients|micronutrients|mesh-ancestor
102562972|NCT04630964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562973|NCT04630964|Hallucinogens|hallucinogens|mesh-ancestor
102562974|NCT04630964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102562975|NCT04736381|Mycophenolic Acid|mycophenolic acid|mesh-list
102562976|NCT04736381|Abatacept|abatacept|mesh-list
102562977|NCT04736381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102562978|NCT04736381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102562979|NCT04736381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102562980|NCT04736381|Antitubercular Agents|antitubercular agents|mesh-ancestor
102562981|NCT04736381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102562982|NCT04736381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102562983|NCT04736381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102562984|NCT04736381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562985|NCT04736381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102562986|NCT04736381|Immunologic Factors|immunologic factors|mesh-ancestor
102562987|NCT04736381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102562988|NCT04736381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102562989|NCT04736381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102562990|NCT04736381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102562991|NCT03302741|Botulinum Toxins|botulinum toxins|mesh-list
102562992|NCT03302741|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101582848|NCT00003266|Dopamine Agents|dopamine agents|mesh-ancestor
102562993|NCT03302741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102562994|NCT03302741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102562995|NCT03302741|Cholinergic Agents|cholinergic agents|mesh-ancestor
102562996|NCT03302741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102562997|NCT03302741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109944|NCT05578287|Celecoxib|celecoxib|mesh-list
102562999|NCT02792465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102563000|NCT02792465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102563001|NCT02792465|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102563002|NCT02792465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102563003|NCT02792465|Hormone Antagonists|hormone antagonists|mesh-ancestor
102563004|NCT02792465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102563005|NCT02792465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563006|NCT05573828|Parathyroid Hormone|parathyroid hormone|mesh-list
102563007|NCT05573828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102563008|NCT05573828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563009|NCT02769611|Ruboxistaurin|ruboxistaurin|mesh-list
102563010|NCT02769611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102563011|NCT02769611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563012|NCT04525820|Vitamin D|vitamin d|mesh-list
102563013|NCT04525820|Ergocalciferols|ergocalciferols|mesh-list
102563014|NCT04525820|Cholecalciferol|cholecalciferol|mesh-list
102563015|NCT04525820|Vitamins|vitamins|mesh-list
102563016|NCT04525820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102563017|NCT04525820|Micronutrients|micronutrients|mesh-ancestor
102563018|NCT04525820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563019|NCT04525820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102563020|NCT04525820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102563021|NCT05570708|Psilocybin|psilocybin|mesh-list
102563022|NCT05570708|Hallucinogens|hallucinogens|mesh-ancestor
102563023|NCT05570708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563024|NCT05570708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102563025|NCT03305159|Chlorhexidine|chlorhexidine|mesh-list
102563026|NCT03305159|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102563027|NCT03305159|Povidone-Iodine|povidone-iodine|mesh-list
102563028|NCT03305159|Povidone|povidone|mesh-list
102563029|NCT03305159|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102563030|NCT03305159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102563031|NCT03305159|Disinfectants|disinfectants|mesh-ancestor
102563032|NCT03305159|Dermatologic Agents|dermatologic agents|mesh-ancestor
102563033|NCT03305159|Plasma Substitutes|plasma substitutes|mesh-ancestor
102563034|NCT03305159|Blood Substitutes|blood substitutes|mesh-ancestor
102563035|NCT05552144|Listerine|listerine|mesh-list
102563036|NCT05552144|Sodium Fluoride|sodium fluoride|mesh-list
102563037|NCT05552144|Cariostatic Agents|cariostatic agents|mesh-ancestor
102563038|NCT05552144|Protective Agents|protective agents|mesh-ancestor
102563039|NCT05552144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563040|NCT05552144|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102563041|NCT05552144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102563042|NCT03308669|Topiramate|topiramate|mesh-list
102563043|NCT03308669|Lasmiditan|lasmiditan|mesh-list
102563044|NCT03308669|Anticonvulsants|anticonvulsants|mesh-ancestor
102563045|NCT03308669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102563046|NCT03308669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563047|NCT03308669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102563048|NCT03308669|Serotonin Agents|serotonin agents|mesh-ancestor
102563049|NCT03308669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102563050|NCT03308669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563051|NCT00356252|Carotenoids|carotenoids|mesh-list
102563052|NCT00356252|Antioxidants|antioxidants|mesh-ancestor
102563053|NCT00356252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563054|NCT00356252|Protective Agents|protective agents|mesh-ancestor
101582921|NCT00002514|Mitosis Modulators|mitosis modulators|mesh-ancestor
102563055|NCT00356252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563056|NCT02056171|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102563057|NCT02056171|Antidepressive Agents|antidepressive agents|mesh-ancestor
102563058|NCT02056171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102563059|NCT02056171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102563060|NCT02056171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102563061|NCT02056171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102563062|NCT02056171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563063|NCT03312023|Sofosbuvir|sofosbuvir|mesh-list
102563064|NCT03312023|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102563065|NCT03312023|Ledipasvir|ledipasvir|mesh-list
102563066|NCT03312023|Antiviral Agents|antiviral agents|mesh-ancestor
102563067|NCT03312023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102563068|NCT02342197|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102563069|NCT02342197|Luteolytic Agents|luteolytic agents|mesh-ancestor
102563070|NCT02342197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102563071|NCT02342197|Contraceptive Agents|contraceptive agents|mesh-ancestor
102563072|NCT02342197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102563073|NCT02342197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563074|NCT02342197|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102563075|NCT02342197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102563076|NCT02342197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102563077|NCT02344225|Ibuprofen|ibuprofen|mesh-list
102563078|NCT02344225|Ketorolac|ketorolac|mesh-list
102563079|NCT02344225|Caffeine|caffeine|mesh-list
102563080|NCT02344225|Caffeine citrate|caffeine citrate|mesh-list
102563081|NCT02344225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563082|NCT02344225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102563083|NCT02344225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102563084|NCT02344225|Analgesics|analgesics|mesh-ancestor
102563085|NCT02344225|Sensory System Agents|sensory system agents|mesh-ancestor
102563086|NCT02344225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102563087|NCT02344225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563088|NCT02344225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102563089|NCT02344225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102563090|NCT02344225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102563091|NCT02344225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102563092|NCT02344225|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102563093|NCT02344225|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102563094|NCT02344225|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102563095|NCT02344225|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102563096|NCT02344225|Purinergic Agents|purinergic agents|mesh-ancestor
102563097|NCT02344225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102563098|NCT04319588|Anesthetics|anesthetics|mesh-list
102563099|NCT04319588|Anesthetics, Local|anesthetics, local|mesh-list
102563100|NCT04319588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102563101|NCT04319588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563102|NCT04319588|Sensory System Agents|sensory system agents|mesh-ancestor
102563103|NCT04319588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102563104|NCT03769844|Molgramostim|molgramostim|mesh-list
102563105|NCT03769844|Sargramostim|sargramostim|mesh-list
102563106|NCT03769844|Immunologic Factors|immunologic factors|mesh-ancestor
102563107|NCT03769844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563108|NCT03769844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102563109|NCT02347345|Sofosbuvir|sofosbuvir|mesh-list
102563110|NCT02347345|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102563111|NCT02347345|Ledipasvir|ledipasvir|mesh-list
102563112|NCT02347345|Antiviral Agents|antiviral agents|mesh-ancestor
102563113|NCT02347345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102563114|NCT03319277|Opiate Alkaloids|opiate alkaloids|mesh-list
102563115|NCT03319277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102563116|NCT03319277|Narcotics|narcotics|mesh-ancestor
102563117|NCT03319277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102563118|NCT03319277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563119|NCT03319277|Analgesics|analgesics|mesh-ancestor
102563120|NCT03319277|Sensory System Agents|sensory system agents|mesh-ancestor
102563121|NCT03319277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102563122|NCT03768440|Ropivacaine|ropivacaine|mesh-list
102563123|NCT03768440|Anesthetics, Local|anesthetics, local|mesh-ancestor
102563124|NCT03768440|Anesthetics|anesthetics|mesh-ancestor
102563125|NCT03768440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102563126|NCT03768440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563127|NCT03768440|Sensory System Agents|sensory system agents|mesh-ancestor
102563128|NCT03768440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102563129|NCT04624295|Aspirin|aspirin|mesh-list
102563130|NCT04624295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102563131|NCT04624295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102563132|NCT04624295|Analgesics|analgesics|mesh-ancestor
102563133|NCT04624295|Sensory System Agents|sensory system agents|mesh-ancestor
102563134|NCT04624295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102563135|NCT04624295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563136|NCT04624295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102563137|NCT04624295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102563138|NCT04624295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102563139|NCT04624295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102563140|NCT04624295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563141|NCT04624295|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102563142|NCT04624295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102563143|NCT04624295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102563144|NCT04624295|Antipyretics|antipyretics|mesh-ancestor
102563145|NCT03323801|Tretinoin|tretinoin|mesh-list
102563146|NCT03323801|Isotretinoin|isotretinoin|mesh-list
102563147|NCT03323801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102563148|NCT03323801|Keratolytic Agents|keratolytic agents|mesh-ancestor
102563149|NCT03323801|Dermatologic Agents|dermatologic agents|mesh-ancestor
102563150|NCT04450355|Nefopam|nefopam|mesh-list
102563151|NCT04450355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102563152|NCT04450355|Analgesics|analgesics|mesh-ancestor
102563153|NCT04450355|Sensory System Agents|sensory system agents|mesh-ancestor
102563154|NCT04450355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102563155|NCT04450355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563156|NCT02349685|Anti-Infective Agents|anti-infective agents|mesh-list
102563157|NCT02349685|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102563158|NCT02352259|Bleomycin|bleomycin|mesh-list
102563159|NCT02352259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102563160|NCT02352259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102563161|NCT03326999|Bupivacaine|bupivacaine|mesh-list
102563162|NCT03326999|Anesthetics, Local|anesthetics, local|mesh-ancestor
102563163|NCT03326999|Anesthetics|anesthetics|mesh-ancestor
102563164|NCT03326999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102563165|NCT03326999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563166|NCT03326999|Sensory System Agents|sensory system agents|mesh-ancestor
102563167|NCT03326999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102563168|NCT02397265|Insulin|insulin|mesh-list
102563169|NCT02397265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102563170|NCT02397265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563171|NCT00356720|Azithromycin|azithromycin|mesh-list
102563172|NCT00356720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102563173|NCT00356720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102563174|NCT04121780|Hormones|hormones|mesh-list
102563175|NCT04121780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102563176|NCT04121780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563177|NCT00375869|Darbepoetin alfa|darbepoetin alfa|mesh-list
102563178|NCT00375869|Hematinics|hematinics|mesh-ancestor
102563179|NCT03198221|Picosulfate sodium|picosulfate sodium|mesh-list
102563180|NCT03198221|Magnesium Oxide|magnesium oxide|mesh-list
102563181|NCT03198221|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
102563182|NCT03198221|Citric Acid|citric acid|mesh-list
102563183|NCT03198221|Cathartics|cathartics|mesh-ancestor
102563184|NCT03198221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102563185|NCT03198221|Anticoagulants|anticoagulants|mesh-ancestor
102563186|NCT03198221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102563187|NCT03198221|Chelating Agents|chelating agents|mesh-ancestor
102563188|NCT03198221|Sequestering Agents|sequestering agents|mesh-ancestor
102563189|NCT03198221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563190|NCT03198221|Antacids|antacids|mesh-ancestor
102563191|NCT03198221|Laxatives|laxatives|mesh-ancestor
102563192|NCT03203681|Methyltestosterone|methyltestosterone|mesh-list
102563193|NCT03203681|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102563194|NCT03203681|Testosterone|testosterone|mesh-list
102563195|NCT03203681|Testosterone undecanoate|testosterone undecanoate|mesh-list
102563196|NCT03203681|Testosterone enanthate|testosterone enanthate|mesh-list
102563197|NCT03203681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102563198|NCT03203681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102563199|NCT03203681|Anabolic Agents|anabolic agents|mesh-ancestor
102563200|NCT03203681|Hormones|hormones|mesh-ancestor
102563201|NCT03203681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102563202|NCT03203681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563203|NCT03203681|Androgens|androgens|mesh-ancestor
102563204|NCT05993949|Dasatinib|dasatinib|mesh-list
102563205|NCT05993949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102563206|NCT05993949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102563207|NCT05993949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102563208|NCT05993949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563209|NCT05993858|Cetuximab|cetuximab|mesh-list
102563210|NCT05993858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102563211|NCT05993858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102563212|NCT05993767|Tenofovir|tenofovir|mesh-list
102563213|NCT05993767|Emtricitabine|emtricitabine|mesh-list
102563214|NCT05993767|Dolutegravir|dolutegravir|mesh-list
102563215|NCT05993767|Antiviral Agents|antiviral agents|mesh-ancestor
102563216|NCT05993767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102563217|NCT05993767|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102563218|NCT05993767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102563219|NCT05993767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102563220|NCT05993767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563221|NCT05993767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102563222|NCT05993767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102563223|NCT05993767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102563224|NCT05993767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102563225|NCT05993611|Immunoglobulins|immunoglobulins|mesh-list
102563226|NCT05993611|Immunologic Factors|immunologic factors|mesh-ancestor
102563227|NCT05993611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563228|NCT05993455|Panitumumab|panitumumab|mesh-list
102563229|NCT05993455|Sotorasib|sotorasib|mesh-list
102563230|NCT05993455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102563231|NCT05993455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102563232|NCT05993455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102563233|NCT05993455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563234|NCT05993390|Neostigmine|neostigmine|mesh-list
102563235|NCT05993390|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102563236|NCT05993390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102563237|NCT05993390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563238|NCT05993390|Cholinergic Agents|cholinergic agents|mesh-ancestor
102563239|NCT05993390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102563240|NCT05993390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563241|NCT05993390|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102563242|NCT05993390|Autonomic Agents|autonomic agents|mesh-ancestor
102563243|NCT05993390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102563244|NCT05993234|Trastuzumab|trastuzumab|mesh-list
102563245|NCT05993234|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
102563246|NCT05993234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102563247|NCT05993234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102563248|NCT05993234|Immunoconjugates|immunoconjugates|mesh-ancestor
102563249|NCT05993234|Immunologic Factors|immunologic factors|mesh-ancestor
102563250|NCT05993234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563251|NCT05993182|Ephedrine|ephedrine|mesh-list
102563252|NCT05993182|Pseudoephedrine|pseudoephedrine|mesh-list
102563253|NCT05993182|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102563254|NCT05993182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563255|NCT05993182|Sympathomimetics|sympathomimetics|mesh-ancestor
102563256|NCT05993182|Autonomic Agents|autonomic agents|mesh-ancestor
102563257|NCT05993182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102563258|NCT05993182|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102563259|NCT05993182|Adrenergic Agents|adrenergic agents|mesh-ancestor
102563260|NCT05993182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102563261|NCT05993182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563262|NCT05993182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102563263|NCT05993182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102563264|NCT05993182|Respiratory System Agents|respiratory system agents|mesh-ancestor
102563265|NCT05993182|Nasal Decongestants|nasal decongestants|mesh-ancestor
102563266|NCT05993143|Ivermectin|ivermectin|mesh-list
102563267|NCT05993143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102563268|NCT05993143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102563269|NCT05992987|Adenosine|adenosine|mesh-list
102563270|NCT05992987|Antibodies|antibodies|mesh-list
102563271|NCT05992987|Immunologic Factors|immunologic factors|mesh-ancestor
102563272|NCT05992987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563273|NCT05992987|Analgesics|analgesics|mesh-ancestor
102563274|NCT05992987|Sensory System Agents|sensory system agents|mesh-ancestor
102563275|NCT05992987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102563276|NCT05992987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102563277|NCT05992987|Vasodilator Agents|vasodilator agents|mesh-ancestor
102563278|NCT05992987|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102563279|NCT05992987|Purinergic Agonists|purinergic agonists|mesh-ancestor
102563280|NCT05992987|Purinergic Agents|purinergic agents|mesh-ancestor
102563281|NCT05992987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102563282|NCT05992987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563283|NCT05992922|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102563284|NCT05992922|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102563285|NCT05992896|Bupivacaine|bupivacaine|mesh-list
102563286|NCT05992896|Anesthetics, Local|anesthetics, local|mesh-ancestor
102563287|NCT05992896|Anesthetics|anesthetics|mesh-ancestor
102563288|NCT05992896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102563289|NCT05992896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563290|NCT05992896|Sensory System Agents|sensory system agents|mesh-ancestor
102563291|NCT05992896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102563292|NCT05992883|Triamcinolone|triamcinolone|mesh-list
102563293|NCT05992883|Ketorolac|ketorolac|mesh-list
102563294|NCT05992883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102563295|NCT05992883|Glucocorticoids|glucocorticoids|mesh-ancestor
102563296|NCT05992883|Hormones|hormones|mesh-ancestor
102563297|NCT05992883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102563298|NCT05992883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563299|NCT05992883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102563300|NCT05992883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563301|NCT05992883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102563302|NCT05992883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102563303|NCT05992883|Analgesics|analgesics|mesh-ancestor
102563304|NCT05992883|Sensory System Agents|sensory system agents|mesh-ancestor
102563305|NCT05992883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102563306|NCT05992883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102563307|NCT05992883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102563308|NCT05992610|Paclitaxel|paclitaxel|mesh-list
102563309|NCT05992610|Carboplatin|carboplatin|mesh-list
102563310|NCT05992610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102563311|NCT05992610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102563312|NCT05992610|Tubulin Modulators|tubulin modulators|mesh-ancestor
102563313|NCT05992610|Antimitotic Agents|antimitotic agents|mesh-ancestor
102563314|NCT05992610|Mitosis Modulators|mitosis modulators|mesh-ancestor
102563315|NCT05992610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563316|NCT05992584|Lenvatinib|lenvatinib|mesh-list
102563317|NCT05992584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102563318|NCT05992584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102563319|NCT05992584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102563320|NCT05992584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563321|NCT05992311|Montelukast|montelukast|mesh-list
102563322|NCT05992311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102563323|NCT05992311|Respiratory System Agents|respiratory system agents|mesh-ancestor
102563324|NCT05992311|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102563325|NCT05992311|Hormone Antagonists|hormone antagonists|mesh-ancestor
102563326|NCT05992311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102563327|NCT05992311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563328|NCT05992311|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102563329|NCT05992311|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102563330|NCT05992311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563331|NCT05992220|Bevacizumab|bevacizumab|mesh-list
102563332|NCT05992220|Atezolizumab|atezolizumab|mesh-list
102563333|NCT05992220|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102563334|NCT05992220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102563335|NCT05992220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102563336|NCT05992220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102563337|NCT05992220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102563338|NCT05992220|Growth Substances|growth substances|mesh-ancestor
102563339|NCT05992220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563340|NCT05992220|Growth Inhibitors|growth inhibitors|mesh-ancestor
102563341|NCT05992220|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102563342|NCT05992220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563343|NCT05992220|Immunologic Factors|immunologic factors|mesh-ancestor
102563344|NCT05992077|Sofosbuvir|sofosbuvir|mesh-list
102563345|NCT05992077|Antiviral Agents|antiviral agents|mesh-ancestor
102563346|NCT05992077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102563347|NCT05991908|Vidarabine|vidarabine|mesh-list
102563348|NCT05991908|Fludarabine|fludarabine|mesh-list
102563349|NCT05991908|Fludarabine phosphate|fludarabine phosphate|mesh-list
102563350|NCT05991908|Melphalan|melphalan|mesh-list
102563351|NCT05991908|Busulfan|busulfan|mesh-list
102563352|NCT05991908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102563353|NCT05991908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102563354|NCT05991908|Antimetabolites|antimetabolites|mesh-ancestor
102563355|NCT05991908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563356|NCT05991908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102563357|NCT05991908|Immunologic Factors|immunologic factors|mesh-ancestor
102563358|NCT05991908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563359|NCT05991908|Antiviral Agents|antiviral agents|mesh-ancestor
102563360|NCT05991908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102563361|NCT05991908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102563362|NCT05991908|Alkylating Agents|alkylating agents|mesh-ancestor
101583221|NCT04259476|Anesthetics|anesthetics|mesh-ancestor
102563363|NCT05991908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102563364|NCT05991856|Antihypertensive Agents|antihypertensive agents|mesh-list
102563365|NCT05991830|Anesthetics|anesthetics|mesh-list
102563366|NCT05991830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102563367|NCT05991830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563368|NCT05991817|Anesthetics|anesthetics|mesh-list
102563369|NCT05991817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102563370|NCT05991817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563371|NCT05990894|Methylprednisolone|methylprednisolone|mesh-list
102563372|NCT05990894|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102563373|NCT05990894|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102563374|NCT05990894|Prednisolone|prednisolone|mesh-list
102563375|NCT05990894|Prednisolone acetate|prednisolone acetate|mesh-list
102563376|NCT05990894|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102154352|NCT03365115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102563377|NCT05990894|Prednisolone phosphate|prednisolone phosphate|mesh-list
102563378|NCT05990894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102563379|NCT05990894|Antiemetics|antiemetics|mesh-ancestor
102563380|NCT05990894|Autonomic Agents|autonomic agents|mesh-ancestor
102563381|NCT05990894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102563382|NCT05990894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563383|NCT05990894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102563384|NCT05990894|Glucocorticoids|glucocorticoids|mesh-ancestor
102563385|NCT05990894|Hormones|hormones|mesh-ancestor
102563386|NCT05990894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102563387|NCT05990894|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102563388|NCT05990894|Protective Agents|protective agents|mesh-ancestor
102563389|NCT05990894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102563390|NCT05990894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102563391|NCT05990790|Propofol|propofol|mesh-list
102563392|NCT05990790|Sevoflurane|sevoflurane|mesh-list
102563393|NCT05990790|Desflurane|desflurane|mesh-list
102563394|NCT05990790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102563395|NCT05990790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102563396|NCT05990790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563397|NCT05990790|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102563398|NCT05990790|Anesthetics, General|anesthetics, general|mesh-ancestor
102563399|NCT05990790|Anesthetics|anesthetics|mesh-ancestor
102563400|NCT05990790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102563401|NCT05990790|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102563402|NCT05989386|Povidone-Iodine|povidone-iodine|mesh-list
102563403|NCT05989386|Povidone|povidone|mesh-list
102563404|NCT05989386|Plasma Substitutes|plasma substitutes|mesh-ancestor
102563405|NCT05989386|Blood Substitutes|blood substitutes|mesh-ancestor
102563406|NCT05989386|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102563407|NCT05989386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102563408|NCT05989347|Dapagliflozin|dapagliflozin|mesh-list
102563409|NCT05989347|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102563410|NCT05989347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563411|NCT05989347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102563412|NCT05989347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563413|NCT05989217|Salicylic Acid|salicylic acid|mesh-list
102563414|NCT05989217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102563415|NCT05989217|Antifungal Agents|antifungal agents|mesh-ancestor
102563416|NCT05989217|Keratolytic Agents|keratolytic agents|mesh-ancestor
102563417|NCT05989217|Dermatologic Agents|dermatologic agents|mesh-ancestor
102563418|NCT05989165|Minoxidil|minoxidil|mesh-list
102563419|NCT05989165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102563420|NCT05989165|Vasodilator Agents|vasodilator agents|mesh-ancestor
102563421|NCT05989126|Aflibercept|aflibercept|mesh-list
102563422|NCT05989126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102563423|NCT05989126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102563424|NCT05989126|Growth Substances|growth substances|mesh-ancestor
102563425|NCT05989126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563426|NCT05989126|Growth Inhibitors|growth inhibitors|mesh-ancestor
102563427|NCT05989126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102563428|NCT05988983|Contraceptive Agents|contraceptive agents|mesh-list
102563429|NCT05988983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102563430|NCT05988983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563431|NCT05988814|Folfirinox|folfirinox|mesh-list
102563432|NCT05988814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102563433|NCT05988788|Sodium Hypochlorite|sodium hypochlorite|mesh-list
102563434|NCT05988788|Eusol|eusol|mesh-list
102563435|NCT05988788|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
102563436|NCT05988788|Disinfectants|disinfectants|mesh-ancestor
102563437|NCT05988788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102563438|NCT05988788|Antioxidants|antioxidants|mesh-ancestor
102563439|NCT05988788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563440|NCT05988788|Protective Agents|protective agents|mesh-ancestor
102563441|NCT05988788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563442|NCT05988788|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
102563443|NCT05988788|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102563444|NCT05988788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102563445|NCT05988788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102563446|NCT05988710|Oxycodone|oxycodone|mesh-list
102563447|NCT05988710|Buprenorphine|buprenorphine|mesh-list
102563448|NCT05988710|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102563449|NCT05988710|Narcotics|narcotics|mesh-ancestor
102563450|NCT05988710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102563451|NCT05988710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563452|NCT05988710|Analgesics|analgesics|mesh-ancestor
102563453|NCT05988710|Sensory System Agents|sensory system agents|mesh-ancestor
102563454|NCT05988710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102563455|NCT05988710|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102563456|NCT05988697|Trametinib|trametinib|mesh-list
102563457|NCT05988697|Dabrafenib|dabrafenib|mesh-list
102563458|NCT05988697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102563459|NCT05988697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102563460|NCT05988697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102563461|NCT05988697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563462|NCT05988684|Metformin|metformin|mesh-list
102563463|NCT05988684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102563464|NCT05988684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563465|NCT05988671|Dexamethasone|dexamethasone|mesh-list
102563466|NCT05988671|Dexamethasone acetate|dexamethasone acetate|mesh-list
102563467|NCT05988671|Dexmedetomidine|dexmedetomidine|mesh-list
102563468|NCT05988671|BB 1101|bb 1101|mesh-list
102563469|NCT05988671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102563470|NCT05988671|Antiemetics|antiemetics|mesh-ancestor
102563471|NCT05988671|Autonomic Agents|autonomic agents|mesh-ancestor
102563472|NCT05988671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102563473|NCT05988671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563474|NCT05988671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102563475|NCT05988671|Glucocorticoids|glucocorticoids|mesh-ancestor
102563476|NCT05988671|Hormones|hormones|mesh-ancestor
102563477|NCT05988671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102563478|NCT05988671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102563479|NCT05988671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102563480|NCT05988671|Protease Inhibitors|protease inhibitors|mesh-ancestor
102563481|NCT05988671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102563482|NCT05988671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563483|NCT05988671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102563484|NCT05988671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102563485|NCT05988671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102563486|NCT05988671|Analgesics|analgesics|mesh-ancestor
102563487|NCT05988671|Sensory System Agents|sensory system agents|mesh-ancestor
102563488|NCT05988671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102563489|NCT05988671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102563490|NCT05988671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102563491|NCT05988671|Adrenergic Agents|adrenergic agents|mesh-ancestor
102563492|NCT05988671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102563493|NCT05988632|Insulin|insulin|mesh-list
102563494|NCT05988632|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102563495|NCT05988632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102563496|NCT05988632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563497|NCT05988463|Artesunate|artesunate|mesh-list
102563498|NCT05988463|Antimalarials|antimalarials|mesh-ancestor
102563499|NCT05988463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102563500|NCT05988463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102563501|NCT05988463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102563502|NCT05988463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102563503|NCT05988463|Antiviral Agents|antiviral agents|mesh-ancestor
102563504|NCT05988463|Schistosomicides|schistosomicides|mesh-ancestor
102563505|NCT05988463|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102563506|NCT05988463|Anthelmintics|anthelmintics|mesh-ancestor
102563507|NCT05988177|Spiramycin|spiramycin|mesh-list
102563508|NCT05988177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102563509|NCT05988177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102563510|NCT05988177|Coccidiostats|coccidiostats|mesh-ancestor
102563511|NCT05988177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102563512|NCT05988177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102563513|NCT05988034|Moxifloxacin|moxifloxacin|mesh-list
102563514|NCT05988034|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102563515|NCT05988034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102563516|NCT05988034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102563517|NCT05988034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102563518|NCT05988034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102563519|NCT05988034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102563520|NCT05988034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563521|NCT05988034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102563522|NCT05988034|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102563523|NCT05988034|Contraceptive Agents|contraceptive agents|mesh-ancestor
102563524|NCT05988034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102563525|NCT05988034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563526|NCT05988034|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102563527|NCT05988034|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102563528|NCT05988034|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102563529|NCT05987722|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
102563530|NCT05987722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102563531|NCT05987696|Cytarabine|cytarabine|mesh-list
102563532|NCT05987696|Cyclophosphamide|cyclophosphamide|mesh-list
102563533|NCT05987696|Fludarabine|fludarabine|mesh-list
102563534|NCT05987696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102563535|NCT05987696|Immunologic Factors|immunologic factors|mesh-ancestor
102563536|NCT05987696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563537|NCT05987696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102563538|NCT05987696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102563539|NCT05987696|Alkylating Agents|alkylating agents|mesh-ancestor
102563540|NCT05987696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563541|NCT05987696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102563542|NCT05987696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102563543|NCT05987696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102563544|NCT05987696|Antimetabolites|antimetabolites|mesh-ancestor
102563545|NCT05987696|Antiviral Agents|antiviral agents|mesh-ancestor
102563546|NCT05987696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102563547|NCT05987657|Progesterone|progesterone|mesh-list
102563548|NCT05987657|Progestins|progestins|mesh-ancestor
102563550|NCT05987657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102563551|NCT05987657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563552|NCT05987397|Ubiquinone|ubiquinone|mesh-list
102563553|NCT05987397|Idebenone|idebenone|mesh-list
102563554|NCT05987397|Antioxidants|antioxidants|mesh-ancestor
102563555|NCT05987397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563556|NCT05987397|Protective Agents|protective agents|mesh-ancestor
102563557|NCT05987397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563558|NCT05987397|Micronutrients|micronutrients|mesh-ancestor
102563559|NCT05987371|Albuterol|albuterol|mesh-list
102563560|NCT05987371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102563561|NCT05987371|Autonomic Agents|autonomic agents|mesh-ancestor
102563562|NCT05987371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102563563|NCT05987371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563564|NCT05987371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102563565|NCT05987371|Respiratory System Agents|respiratory system agents|mesh-ancestor
102563566|NCT05987371|Tocolytic Agents|tocolytic agents|mesh-ancestor
102563567|NCT05987371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102563568|NCT05987371|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102563569|NCT05987371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102563570|NCT05987371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102563571|NCT05987371|Adrenergic Agents|adrenergic agents|mesh-ancestor
102563572|NCT05987371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102563573|NCT05987371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563574|NCT05987345|Antibodies|antibodies|mesh-list
102563575|NCT05987345|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102563576|NCT05987345|Immunologic Factors|immunologic factors|mesh-ancestor
102563577|NCT05987345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563578|NCT05987241|Nivolumab|nivolumab|mesh-list
102563579|NCT05987241|Relatlimab|relatlimab|mesh-list
102563580|NCT05987241|Immunoglobulins|immunoglobulins|mesh-list
102563581|NCT05987241|Immunoglobulin G|immunoglobulin g|mesh-list
102563582|NCT05987241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102563583|NCT05987241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102563584|NCT05987241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102563585|NCT05987241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563586|NCT05987241|Immunologic Factors|immunologic factors|mesh-ancestor
102563587|NCT05987241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563588|NCT05987176|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102563589|NCT05987176|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102563590|NCT05987176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563591|NCT05987124|Defibrotide|defibrotide|mesh-list
102563592|NCT05987124|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102563593|NCT05987124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102563594|NCT05987124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563595|NCT05987124|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102563596|NCT05986968|Aspirin|aspirin|mesh-list
102563597|NCT05986968|Ticagrelor|ticagrelor|mesh-list
102563598|NCT05986968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102563599|NCT05986968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102563600|NCT05986968|Analgesics|analgesics|mesh-ancestor
102563601|NCT05986968|Sensory System Agents|sensory system agents|mesh-ancestor
102563602|NCT05986968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102563603|NCT05986968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563604|NCT05986968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102563605|NCT05986968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102563606|NCT05986968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102563607|NCT05986968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102563608|NCT05986968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563609|NCT05986968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102563610|NCT05986968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102563611|NCT05986968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102563613|NCT05986968|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102563614|NCT05986968|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102563615|NCT05986968|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101583487|NCT04259008|Manganese|manganese|mesh-list
102563616|NCT05986968|Purinergic Agents|purinergic agents|mesh-ancestor
102563617|NCT05986968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102563618|NCT05986942|Fentanyl|fentanyl|mesh-list
102563619|NCT05986942|Dexmedetomidine|dexmedetomidine|mesh-list
102563620|NCT05986942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102563621|NCT05986942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102563622|NCT05986942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563623|NCT05986942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102563624|NCT05986942|Analgesics|analgesics|mesh-ancestor
102563625|NCT05986942|Sensory System Agents|sensory system agents|mesh-ancestor
102563626|NCT05986942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102563627|NCT05986942|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102563628|NCT05986942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102563629|NCT05986942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102563630|NCT05986942|Adrenergic Agents|adrenergic agents|mesh-ancestor
102563631|NCT05986942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102563632|NCT05986942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563633|NCT05986942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102563634|NCT05986942|Narcotics|narcotics|mesh-ancestor
102563635|NCT05986942|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102563636|NCT05986942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102563637|NCT05986942|Anesthetics, General|anesthetics, general|mesh-ancestor
102563638|NCT05986942|Anesthetics|anesthetics|mesh-ancestor
102563639|NCT05986838|Metformin|metformin|mesh-list
102563640|NCT05986838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102563641|NCT05986838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563642|NCT05986773|Metolazone|metolazone|mesh-list
102563643|NCT05986773|Furosemide|furosemide|mesh-list
102563644|NCT05986773|Acetazolamide|acetazolamide|mesh-list
102563645|NCT05986773|Diuretics|diuretics|mesh-ancestor
102563646|NCT05986773|Natriuretic Agents|natriuretic agents|mesh-ancestor
102563647|NCT05986773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563648|NCT05986773|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102563649|NCT05986773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102563650|NCT05986773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563651|NCT05986773|Anticonvulsants|anticonvulsants|mesh-ancestor
102563652|NCT05986773|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102563653|NCT05986773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102563654|NCT05986773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102563655|NCT05986773|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102563656|NCT05986734|Immunoglobulins|immunoglobulins|mesh-list
102563657|NCT05986734|Immunologic Factors|immunologic factors|mesh-ancestor
102563658|NCT05986734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563659|NCT05986591|Bromides|bromides|mesh-list
102563660|NCT05986591|Tiotropium Bromide|tiotropium bromide|mesh-list
102563661|NCT05986591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102563662|NCT05986591|Autonomic Agents|autonomic agents|mesh-ancestor
102563663|NCT05986591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102563664|NCT05986591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563665|NCT05986591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102563666|NCT05986591|Respiratory System Agents|respiratory system agents|mesh-ancestor
102563667|NCT05986591|Parasympatholytics|parasympatholytics|mesh-ancestor
102563668|NCT05986591|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102563669|NCT05986591|Cholinergic Agents|cholinergic agents|mesh-ancestor
102563670|NCT05986591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102563671|NCT05986591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563672|NCT05986591|Anticonvulsants|anticonvulsants|mesh-ancestor
102563673|NCT05986422|Methylprednisolone|methylprednisolone|mesh-list
102563674|NCT05986422|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102563675|NCT05986422|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102563676|NCT05986422|Prednisolone|prednisolone|mesh-list
102563677|NCT05986422|Prednisolone acetate|prednisolone acetate|mesh-list
102563678|NCT05986422|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102563679|NCT05986422|Prednisolone phosphate|prednisolone phosphate|mesh-list
102563680|NCT05986422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102563681|NCT05986422|Antiemetics|antiemetics|mesh-ancestor
102563682|NCT05986422|Autonomic Agents|autonomic agents|mesh-ancestor
102563683|NCT05986422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102563684|NCT05986422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563685|NCT05986422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102563686|NCT05986422|Glucocorticoids|glucocorticoids|mesh-ancestor
102563687|NCT05986422|Hormones|hormones|mesh-ancestor
102563688|NCT05986422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102563689|NCT05986422|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102563690|NCT05986422|Protective Agents|protective agents|mesh-ancestor
102563691|NCT05986422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102563692|NCT05986422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102563694|NCT05986344|Contraceptive Agents|contraceptive agents|mesh-list
102563695|NCT05986344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102563696|NCT05986344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563697|NCT05986344|Trace Elements|trace elements|mesh-ancestor
102563698|NCT05986344|Micronutrients|micronutrients|mesh-ancestor
102563699|NCT05986331|Pembrolizumab|pembrolizumab|mesh-list
102563700|NCT05986331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102563701|NCT05986331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102563702|NCT05986331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102563703|NCT05986331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563704|NCT05986266|Carbetocin|carbetocin|mesh-list
102563705|NCT05986266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563706|NCT05986266|Oxytocics|oxytocics|mesh-ancestor
102563707|NCT05986266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102563708|NCT05986240|Venetoclax|venetoclax|mesh-list
102563709|NCT05986240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102563710|NCT05986201|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102563711|NCT05986201|Hemostatics|hemostatics|mesh-list
102563712|NCT05986201|Coagulants|coagulants|mesh-ancestor
102563713|NCT05986136|Dapagliflozin|dapagliflozin|mesh-list
102563714|NCT05986136|Mesalamine|mesalamine|mesh-list
102563715|NCT05986136|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102563716|NCT05986136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563717|NCT05986136|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102563718|NCT05986136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563719|NCT05986136|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102563720|NCT05986136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102563721|NCT05986136|Analgesics|analgesics|mesh-ancestor
102563722|NCT05986136|Sensory System Agents|sensory system agents|mesh-ancestor
102563723|NCT05986136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102563724|NCT05986136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102563725|NCT05986136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102563726|NCT05986084|Cabotegravir|cabotegravir|mesh-list
102563727|NCT05986084|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102563728|NCT05986084|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102563729|NCT05986084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102563730|NCT05986084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563731|NCT05986084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102563732|NCT05986084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102563733|NCT05986084|Antiviral Agents|antiviral agents|mesh-ancestor
102563734|NCT05986084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102563735|NCT05986071|Fulvestrant|fulvestrant|mesh-list
102563736|NCT05986071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102563737|NCT05986071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102563738|NCT05986071|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102563739|NCT05986071|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102563740|NCT05986071|Hormone Antagonists|hormone antagonists|mesh-ancestor
102563741|NCT05986071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102563742|NCT05986071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563743|NCT05985798|Chlorotrianisene|chlorotrianisene|mesh-list
102563744|NCT05985798|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102563745|NCT05985798|Estrogens|estrogens|mesh-ancestor
102563746|NCT05985798|Hormones|hormones|mesh-ancestor
102563747|NCT05985798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102563748|NCT05985798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563749|NCT05985798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102563750|NCT05985798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102563751|NCT05985590|Drospirenone|drospirenone|mesh-list
102563752|NCT05985590|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102563753|NCT05985590|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
102563754|NCT05985590|Estradiol|estradiol|mesh-list
102110686|NCT05176509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102563755|NCT05985590|Estrogens|estrogens|mesh-ancestor
102563756|NCT05985590|Hormones|hormones|mesh-ancestor
102563757|NCT05985590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102563758|NCT05985590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563759|NCT05985590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102563760|NCT05985590|Contraceptive Agents|contraceptive agents|mesh-ancestor
102563761|NCT05985590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102563762|NCT05985590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102563763|NCT05985590|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102563764|NCT05985590|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102563765|NCT05985590|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102563766|NCT05985590|Hormone Antagonists|hormone antagonists|mesh-ancestor
102563767|NCT05985590|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102563768|NCT05985590|Diuretics|diuretics|mesh-ancestor
102563769|NCT05985590|Natriuretic Agents|natriuretic agents|mesh-ancestor
102563770|NCT05985343|Glycopyrrolate|glycopyrrolate|mesh-list
102563771|NCT05985343|Neostigmine|neostigmine|mesh-list
102563772|NCT05985343|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102563773|NCT05985343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102563774|NCT05985343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563775|NCT05985343|Cholinergic Agents|cholinergic agents|mesh-ancestor
102563776|NCT05985343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102563777|NCT05985343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563778|NCT05985343|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102563779|NCT05985343|Autonomic Agents|autonomic agents|mesh-ancestor
102563780|NCT05985343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102563781|NCT05985343|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102563782|NCT05985343|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102563783|NCT05985343|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102563784|NCT05985278|Catalase|catalase|mesh-list
102563785|NCT05985278|Antioxidants|antioxidants|mesh-ancestor
102563786|NCT05985278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563787|NCT05985278|Protective Agents|protective agents|mesh-ancestor
102563788|NCT05985278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563789|NCT05985187|Docetaxel|docetaxel|mesh-list
102563790|NCT05985187|Trastuzumab|trastuzumab|mesh-list
102563791|NCT05985187|Pertuzumab|pertuzumab|mesh-list
102563792|NCT05985187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102563793|NCT05985187|Tubulin Modulators|tubulin modulators|mesh-ancestor
102563794|NCT05985187|Antimitotic Agents|antimitotic agents|mesh-ancestor
102563795|NCT05985187|Mitosis Modulators|mitosis modulators|mesh-ancestor
102563796|NCT05985187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563797|NCT05985187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102563798|NCT05985070|Vitamin D|vitamin d|mesh-list
102563799|NCT05985070|Cholecalciferol|cholecalciferol|mesh-list
102563800|NCT05985070|Vitamins|vitamins|mesh-ancestor
102563801|NCT05985070|Micronutrients|micronutrients|mesh-ancestor
102563802|NCT05985070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563803|NCT05985070|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102563804|NCT05985070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102563805|NCT05984511|Bevacizumab|bevacizumab|mesh-list
102563806|NCT05984511|Atezolizumab|atezolizumab|mesh-list
102563807|NCT05984511|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102563808|NCT05984511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102563809|NCT05984511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102563810|NCT05984511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102563811|NCT05984511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102563812|NCT05984511|Growth Substances|growth substances|mesh-ancestor
102563813|NCT05984511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563814|NCT05984511|Growth Inhibitors|growth inhibitors|mesh-ancestor
102563815|NCT05984511|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102563816|NCT05984511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563817|NCT05984511|Immunologic Factors|immunologic factors|mesh-ancestor
102563818|NCT05984381|Dapsone|dapsone|mesh-list
102563819|NCT05984381|Prednisolone|prednisolone|mesh-list
102563820|NCT05984381|Methotrexate|methotrexate|mesh-list
102563821|NCT05984381|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102563822|NCT05984381|Abortifacient Agents|abortifacient agents|mesh-ancestor
102563823|NCT05984381|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102563824|NCT05984381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563825|NCT05984381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102563826|NCT05984381|Antimetabolites|antimetabolites|mesh-ancestor
102563827|NCT05984381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563828|NCT05984381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102563829|NCT05984381|Dermatologic Agents|dermatologic agents|mesh-ancestor
102563830|NCT05984381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102563831|NCT05984381|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102563832|NCT05984381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102563833|NCT05984381|Immunologic Factors|immunologic factors|mesh-ancestor
102563834|NCT05984381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102563835|NCT05984381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102563836|NCT05984381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102563837|NCT05984381|Glucocorticoids|glucocorticoids|mesh-ancestor
102563838|NCT05984381|Hormones|hormones|mesh-ancestor
102563839|NCT05984381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102563840|NCT05984381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102563841|NCT05984381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102563842|NCT05984381|Antimalarials|antimalarials|mesh-ancestor
102563843|NCT05984381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102563844|NCT05984381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102563845|NCT05984381|Leprostatic Agents|leprostatic agents|mesh-ancestor
102563846|NCT05984381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102563847|NCT05983965|Acalabrutinib|acalabrutinib|mesh-list
102563848|NCT05983965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102563849|NCT05983952|Antibodies|antibodies|mesh-list
102563850|NCT05983952|Immunologic Factors|immunologic factors|mesh-ancestor
102563851|NCT05983952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563852|NCT05983237|Temozolomide|temozolomide|mesh-list
102563853|NCT05983237|Fluzoparib|fluzoparib|mesh-list
102563854|NCT05983237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102563855|NCT05983237|Alkylating Agents|alkylating agents|mesh-ancestor
102563856|NCT05983237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563857|NCT05983237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102563858|NCT05983237|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102563859|NCT05983237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102563860|NCT05983055|Dexamethasone|dexamethasone|mesh-list
102563861|NCT05983055|Dexamethasone acetate|dexamethasone acetate|mesh-list
102563862|NCT05983055|BB 1101|bb 1101|mesh-list
102563863|NCT05983055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102563864|NCT05983055|Antiemetics|antiemetics|mesh-ancestor
102563865|NCT05983055|Autonomic Agents|autonomic agents|mesh-ancestor
102563866|NCT05983055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102563867|NCT05983055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563868|NCT05983055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102563869|NCT05983055|Glucocorticoids|glucocorticoids|mesh-ancestor
102563870|NCT05983055|Hormones|hormones|mesh-ancestor
102563871|NCT05983055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102563872|NCT05983055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102563873|NCT05983055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102563874|NCT05983055|Protease Inhibitors|protease inhibitors|mesh-ancestor
102563875|NCT05983055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102563876|NCT05983055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563877|NCT05977998|Diphenhydramine|diphenhydramine|mesh-list
102563878|NCT05977998|Promethazine|promethazine|mesh-list
102563879|NCT05977998|Dexamethasone|dexamethasone|mesh-list
102563880|NCT05977998|Paclitaxel|paclitaxel|mesh-list
102563881|NCT05977998|Famotidine|famotidine|mesh-list
102563882|NCT05977998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102563883|NCT05977998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102563884|NCT05977998|Tubulin Modulators|tubulin modulators|mesh-ancestor
102563885|NCT05977998|Antimitotic Agents|antimitotic agents|mesh-ancestor
102563886|NCT05977998|Mitosis Modulators|mitosis modulators|mesh-ancestor
102563887|NCT05977998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563888|NCT05977998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102563889|NCT05977998|Antiemetics|antiemetics|mesh-ancestor
102563890|NCT05977998|Autonomic Agents|autonomic agents|mesh-ancestor
102563891|NCT05977998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102563892|NCT05977998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563893|NCT05977998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102563894|NCT05977998|Glucocorticoids|glucocorticoids|mesh-ancestor
102563895|NCT05977998|Hormones|hormones|mesh-ancestor
102563896|NCT05977998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102563897|NCT05977998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102563898|NCT05977998|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102563899|NCT05977998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102563900|NCT05977998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102563901|NCT05977998|Anesthetics, Local|anesthetics, local|mesh-ancestor
102563902|NCT05977998|Anesthetics|anesthetics|mesh-ancestor
102563903|NCT05977998|Sensory System Agents|sensory system agents|mesh-ancestor
102110841|NCT05037123|Anesthetics|anesthetics|mesh-ancestor
102563904|NCT05977998|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102563905|NCT05977998|Histamine Antagonists|histamine antagonists|mesh-ancestor
102563906|NCT05977998|Histamine Agents|histamine agents|mesh-ancestor
102563907|NCT05977998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102563908|NCT05977998|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102563909|NCT05977998|Antipruritics|antipruritics|mesh-ancestor
102563910|NCT05977998|Dermatologic Agents|dermatologic agents|mesh-ancestor
102563911|NCT05977998|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102563912|NCT05977998|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102563913|NCT05970380|Anesthetics|anesthetics|mesh-list
102563914|NCT05970380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102563915|NCT05970380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563916|NCT05969756|Fluorides|fluorides|mesh-list
102563917|NCT05969756|Fluorides, Topical|fluorides, topical|mesh-list
102563918|NCT05969756|Cariostatic Agents|cariostatic agents|mesh-ancestor
102563919|NCT05969756|Protective Agents|protective agents|mesh-ancestor
102563920|NCT05969756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563921|NCT05965219|Metformin|metformin|mesh-list
102563922|NCT05965219|Itraconazole|itraconazole|mesh-list
102563923|NCT05965219|Carbamazepine|carbamazepine|mesh-list
102563924|NCT05965219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102563925|NCT05965219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563926|NCT05965219|Antifungal Agents|antifungal agents|mesh-ancestor
102563927|NCT05965219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102563928|NCT05965219|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102563929|NCT05965219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102563930|NCT05965219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102563931|NCT05965219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563932|NCT05965219|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102563933|NCT05965219|Hormone Antagonists|hormone antagonists|mesh-ancestor
102563934|NCT05965219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102563935|NCT05965219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102563936|NCT05965219|Anticonvulsants|anticonvulsants|mesh-ancestor
102563937|NCT05965219|Antimanic Agents|antimanic agents|mesh-ancestor
102563938|NCT05965219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102563939|NCT05965219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102563940|NCT05965219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102563941|NCT05965219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102563942|NCT05965219|Analgesics|analgesics|mesh-ancestor
102563943|NCT05965219|Sensory System Agents|sensory system agents|mesh-ancestor
102563944|NCT05965219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102563945|NCT05965219|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102563946|NCT05965219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102563947|NCT05965219|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102563948|NCT05965219|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102563949|NCT05962424|Ketamine|ketamine|mesh-list
102563950|NCT05962424|Analgesics|analgesics|mesh-ancestor
102563951|NCT05962424|Sensory System Agents|sensory system agents|mesh-ancestor
102563952|NCT05962424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102563953|NCT05962424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563954|NCT05962424|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102563955|NCT05962424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102563956|NCT05962424|Anesthetics, General|anesthetics, general|mesh-ancestor
102563957|NCT05962424|Anesthetics|anesthetics|mesh-ancestor
102563958|NCT05962424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102563959|NCT05962424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102563960|NCT05962424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102563961|NCT05962424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102563962|NCT05962424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563963|NCT05959629|Sodium Hypochlorite|sodium hypochlorite|mesh-list
102563964|NCT05959629|Eusol|eusol|mesh-list
102563965|NCT05959629|Disinfectants|disinfectants|mesh-ancestor
102563966|NCT05959629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102563967|NCT05955222|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
102563968|NCT05955222|Vasodilator Agents|vasodilator agents|mesh-ancestor
102563969|NCT05955222|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
102563970|NCT05955222|Protective Agents|protective agents|mesh-ancestor
102563971|NCT05955222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563972|NCT05948462|Cisplatin|cisplatin|mesh-list
102563973|NCT05948462|Carboplatin|carboplatin|mesh-list
102563974|NCT05948462|Pemetrexed|pemetrexed|mesh-list
102563975|NCT05948462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102563976|NCT05948462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102563977|NCT05948462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563978|NCT05948462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102563979|NCT05948462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102563980|NCT05946603|Fluorophosphate|fluorophosphate|mesh-list
102563981|NCT05946603|Cariostatic Agents|cariostatic agents|mesh-ancestor
102563982|NCT05946603|Protective Agents|protective agents|mesh-ancestor
102563983|NCT05946603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563985|NCT05943535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102563986|NCT05938387|Vaccines|vaccines|mesh-list
102563987|NCT05938387|Immunologic Factors|immunologic factors|mesh-ancestor
102563988|NCT05938387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102563989|NCT05927649|Moxifloxacin|moxifloxacin|mesh-list
102563990|NCT05927649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102563991|NCT05927649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102563992|NCT05927649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102563993|NCT05927649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102563994|NCT05927649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102563995|NCT05927649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102563996|NCT05927649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102563997|NCT05920967|Dexamethasone|dexamethasone|mesh-list
102563998|NCT05920967|Dexamethasone acetate|dexamethasone acetate|mesh-list
102563999|NCT05920967|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102564000|NCT05920967|BB 1101|bb 1101|mesh-list
102564001|NCT05920967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102564002|NCT05920967|Antiemetics|antiemetics|mesh-ancestor
102564003|NCT05920967|Autonomic Agents|autonomic agents|mesh-ancestor
102564004|NCT05920967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102564005|NCT05920967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564006|NCT05920967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102564007|NCT05920967|Glucocorticoids|glucocorticoids|mesh-ancestor
102564008|NCT05920967|Hormones|hormones|mesh-ancestor
102564009|NCT05920967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102564010|NCT05920967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102564011|NCT05920967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564012|NCT05920967|Protease Inhibitors|protease inhibitors|mesh-ancestor
102564013|NCT05920967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102564014|NCT05920967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564015|NCT05920343|Rivaroxaban|rivaroxaban|mesh-list
102564016|NCT05920343|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102564017|NCT05920343|Antithrombins|antithrombins|mesh-ancestor
102564018|NCT05920343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102564019|NCT05920343|Protease Inhibitors|protease inhibitors|mesh-ancestor
102564020|NCT05920343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102564021|NCT05920343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564022|NCT05920343|Anticoagulants|anticoagulants|mesh-ancestor
102564023|NCT05919537|Paclitaxel|paclitaxel|mesh-list
102564024|NCT05919537|Docetaxel|docetaxel|mesh-list
102564025|NCT05919537|Gemcitabine|gemcitabine|mesh-list
102564026|NCT05919537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102564027|NCT05919537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564028|NCT05919537|Tubulin Modulators|tubulin modulators|mesh-ancestor
102564029|NCT05919537|Antimitotic Agents|antimitotic agents|mesh-ancestor
102564030|NCT05919537|Mitosis Modulators|mitosis modulators|mesh-ancestor
102564031|NCT05919537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564032|NCT05919537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102564033|NCT05919537|Antimetabolites|antimetabolites|mesh-ancestor
102564034|NCT05916287|Antihypertensive Agents|antihypertensive agents|mesh-list
102564035|NCT05913388|Pembrolizumab|pembrolizumab|mesh-list
102564036|NCT05913388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102564037|NCT05913388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564038|NCT05913388|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102564039|NCT05913388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564040|NCT05911594|Solifenacin Succinate|solifenacin succinate|mesh-list
102564041|NCT05911594|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102564042|NCT05911594|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102564043|NCT05911594|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102564044|NCT05911594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102564045|NCT05911594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564046|NCT05911594|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102564047|NCT05911594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102564048|NCT05911594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564049|NCT05911594|Cholinergic Agents|cholinergic agents|mesh-ancestor
102564050|NCT05911594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102564051|NCT05911594|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102564052|NCT05911594|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102564053|NCT05911594|Urological Agents|urological agents|mesh-ancestor
102564054|NCT05910970|Lenvatinib|lenvatinib|mesh-list
102564055|NCT05910970|Tislelizumab|tislelizumab|mesh-list
102564056|NCT05910970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564057|NCT05910970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102564058|NCT05910970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102564059|NCT05910970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564060|NCT05910970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102564061|NCT05910827|Docetaxel|docetaxel|mesh-list
102564062|NCT05910827|Cetuximab|cetuximab|mesh-list
102564063|NCT05910827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564064|NCT05910827|Tubulin Modulators|tubulin modulators|mesh-ancestor
102564065|NCT05910827|Antimitotic Agents|antimitotic agents|mesh-ancestor
102564066|NCT05910827|Mitosis Modulators|mitosis modulators|mesh-ancestor
102564067|NCT05910827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564068|NCT05910827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102564069|NCT05904886|Bevacizumab|bevacizumab|mesh-list
102564070|NCT05904886|Atezolizumab|atezolizumab|mesh-list
102564071|NCT05904886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102564072|NCT05904886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564073|NCT05904886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102564074|NCT05904886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102564075|NCT05904886|Growth Substances|growth substances|mesh-ancestor
102564076|NCT05904886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564077|NCT05904886|Growth Inhibitors|growth inhibitors|mesh-ancestor
102564078|NCT05904886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102564079|NCT05904886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564080|NCT05903092|Carboplatin|carboplatin|mesh-list
102564081|NCT05903092|Etoposide|etoposide|mesh-list
102564082|NCT05903092|Durvalumab|durvalumab|mesh-list
102564083|NCT05903092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564084|NCT05903092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102564085|NCT05903092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102564086|NCT05903092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102564087|NCT05903092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102564088|NCT05903092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564089|NCT05903092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102564090|NCT05900882|Dexamethasone|dexamethasone|mesh-list
102564091|NCT05900882|Lenalidomide|lenalidomide|mesh-list
102564092|NCT05900882|Bortezomib|bortezomib|mesh-list
102564093|NCT05900882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102564094|NCT05900882|Antiemetics|antiemetics|mesh-ancestor
102564095|NCT05900882|Autonomic Agents|autonomic agents|mesh-ancestor
102564096|NCT05900882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102564097|NCT05900882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564098|NCT05900882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102564099|NCT05900882|Glucocorticoids|glucocorticoids|mesh-ancestor
102564100|NCT05900882|Hormones|hormones|mesh-ancestor
102564101|NCT05900882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102564102|NCT05900882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102564103|NCT05900882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564104|NCT05900882|Immunologic Factors|immunologic factors|mesh-ancestor
102564105|NCT05900882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102564106|NCT05900882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102564107|NCT05900882|Growth Substances|growth substances|mesh-ancestor
102564108|NCT05900882|Growth Inhibitors|growth inhibitors|mesh-ancestor
102564109|NCT05891171|Leucovorin|leucovorin|mesh-list
102564110|NCT05891171|Carboplatin|carboplatin|mesh-list
102564111|NCT05891171|Fluorouracil|fluorouracil|mesh-list
102564112|NCT05891171|Oxaliplatin|oxaliplatin|mesh-list
102564113|NCT05891171|Pemetrexed|pemetrexed|mesh-list
102564114|NCT05891171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564115|NCT05891171|Antimetabolites|antimetabolites|mesh-ancestor
102564116|NCT05891171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564117|NCT05891171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102564118|NCT05891171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102564119|NCT05891171|Immunologic Factors|immunologic factors|mesh-ancestor
102564120|NCT05891171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564121|NCT05891171|Antidotes|antidotes|mesh-ancestor
102564122|NCT05891171|Protective Agents|protective agents|mesh-ancestor
102564123|NCT05891171|Vitamin B Complex|vitamin b complex|mesh-ancestor
102564124|NCT05891171|Vitamins|vitamins|mesh-ancestor
102564125|NCT05891171|Micronutrients|micronutrients|mesh-ancestor
102564126|NCT05891171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102564127|NCT05891171|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102564128|NCT05891171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102564129|NCT05887492|Pembrolizumab|pembrolizumab|mesh-list
102564130|NCT05887492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102564131|NCT05887492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564132|NCT05887492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102564133|NCT05887492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564134|NCT05886244|Eculizumab|eculizumab|mesh-list
101584006|NCT02862015|Folfirinox|folfirinox|mesh-list
102564135|NCT05886244|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102564136|NCT05886244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102564137|NCT05886244|Immunologic Factors|immunologic factors|mesh-ancestor
102564138|NCT05886244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564139|NCT05883540|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
102564140|NCT05883540|Hallucinogens|hallucinogens|mesh-ancestor
102564141|NCT05883540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564142|NCT05883540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102564143|NCT05883540|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102564144|NCT05883540|Serotonin Agents|serotonin agents|mesh-ancestor
102564145|NCT05883540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102564146|NCT05883540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564147|NCT05883540|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102564148|NCT05882877|KHK4083|khk4083|mesh-list
102564149|NCT05882877|Dermatologic Agents|dermatologic agents|mesh-ancestor
102564150|NCT05878769|Astegolimab|astegolimab|mesh-list
102564151|NCT05878769|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102564152|NCT05878769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102564153|NCT05878769|Antiviral Agents|antiviral agents|mesh-ancestor
102564154|NCT05878769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102564155|NCT05875857|Analgesics, Opioid|analgesics, opioid|mesh-list
102564156|NCT05875857|Narcotics|narcotics|mesh-ancestor
102564157|NCT05875857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102564158|NCT05875857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564159|NCT05875857|Analgesics|analgesics|mesh-ancestor
102564160|NCT05875857|Sensory System Agents|sensory system agents|mesh-ancestor
102564161|NCT05875857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102564162|NCT05875727|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102564163|NCT05875727|Immunologic Factors|immunologic factors|mesh-ancestor
102564164|NCT05875727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564165|NCT05871424|Buprenorphine|buprenorphine|mesh-list
102564166|NCT05871424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102564167|NCT05871424|Narcotics|narcotics|mesh-ancestor
102564168|NCT05871424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102564169|NCT05871424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564170|NCT05871424|Analgesics|analgesics|mesh-ancestor
102564171|NCT05871424|Sensory System Agents|sensory system agents|mesh-ancestor
102564172|NCT05871424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102564173|NCT05871424|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102564174|NCT05862233|Cyclosporine|cyclosporine|mesh-list
102564175|NCT05862233|Cyclosporins|cyclosporins|mesh-list
102564176|NCT05862233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102564177|NCT05862233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564178|NCT05862233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102564179|NCT05862233|Immunologic Factors|immunologic factors|mesh-ancestor
102564180|NCT05862233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564181|NCT05862233|Antifungal Agents|antifungal agents|mesh-ancestor
102564182|NCT05862233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102564183|NCT05862233|Dermatologic Agents|dermatologic agents|mesh-ancestor
102564184|NCT05862233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102564185|NCT05862233|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102564186|NCT05861050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102564187|NCT05861050|Obinutuzumab|obinutuzumab|mesh-list
102564188|NCT05861050|Lenalidomide|lenalidomide|mesh-list
102564189|NCT05861050|Venetoclax|venetoclax|mesh-list
102564190|NCT05861050|Antibodies|antibodies|mesh-list
102564191|NCT05861050|Immunoglobulins|immunoglobulins|mesh-list
102564192|NCT05861050|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102564193|NCT05861050|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102564194|NCT05861050|Immunologic Factors|immunologic factors|mesh-ancestor
102564195|NCT05861050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564196|NCT05861050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564197|NCT05861050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101584051|NCT03381261|Cholinergic Agents|cholinergic agents|mesh-ancestor
102564198|NCT05861050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102564199|NCT05861050|Growth Substances|growth substances|mesh-ancestor
102564200|NCT05861050|Growth Inhibitors|growth inhibitors|mesh-ancestor
102564201|NCT05856851|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102564202|NCT05856851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102564203|NCT05856851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102564204|NCT05856851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564205|NCT05856526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102564206|NCT05846880|Vitamin D|vitamin d|mesh-list
102564207|NCT05846880|Ergocalciferols|ergocalciferols|mesh-list
102564208|NCT05846880|Cholecalciferol|cholecalciferol|mesh-list
102564209|NCT05846880|Vitamins|vitamins|mesh-list
102564210|NCT05846880|Lenalidomide|lenalidomide|mesh-list
102564211|NCT05846880|Micronutrients|micronutrients|mesh-ancestor
102564212|NCT05846880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564213|NCT05846880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102564214|NCT05846880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102564215|NCT05846880|Immunologic Factors|immunologic factors|mesh-ancestor
102564216|NCT05846880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102564217|NCT05846880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102564218|NCT05846880|Growth Substances|growth substances|mesh-ancestor
102564219|NCT05846880|Growth Inhibitors|growth inhibitors|mesh-ancestor
102564220|NCT05846880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564222|NCT05846451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102564223|NCT05846451|Narcotics|narcotics|mesh-ancestor
102564224|NCT05846451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102564225|NCT05846451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564226|NCT05846451|Analgesics|analgesics|mesh-ancestor
102564227|NCT05846451|Sensory System Agents|sensory system agents|mesh-ancestor
102564228|NCT05846451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102564229|NCT05840861|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102564230|NCT05840861|Vortioxetine|vortioxetine|mesh-list
102564231|NCT05840861|Antidepressive Agents|antidepressive agents|mesh-ancestor
102564232|NCT05840861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102564233|NCT05840861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102564234|NCT05840861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102564235|NCT05840861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102564236|NCT05840861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564237|NCT05840861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102564238|NCT05840861|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102564239|NCT05840861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102564240|NCT05840861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102564241|NCT05840861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564242|NCT05840861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102564243|NCT05840861|Serotonin Agents|serotonin agents|mesh-ancestor
102564244|NCT05840861|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102564245|NCT05840861|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102564246|NCT05840861|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102564247|NCT05840861|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102564248|NCT05837897|Vedolizumab|vedolizumab|mesh-list
102564249|NCT05837897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102564250|NCT05837104|Vitamin B 6|vitamin b 6|mesh-list
102564251|NCT05837104|Pyridoxal|pyridoxal|mesh-list
102564252|NCT05837104|Pyridoxine|pyridoxine|mesh-list
102564253|NCT05837104|Vitamins|vitamins|mesh-ancestor
102564254|NCT05837104|Micronutrients|micronutrients|mesh-ancestor
102564255|NCT05837104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564256|NCT05837104|Vitamin B Complex|vitamin b complex|mesh-ancestor
102564257|NCT05829655|Suvorexant|suvorexant|mesh-list
102564258|NCT05829655|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102564259|NCT05829655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102564260|NCT05829655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102564261|NCT05829655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564262|NCT05829655|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102564263|NCT05829655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102564264|NCT05829655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564265|NCT05825625|Atezolizumab|atezolizumab|mesh-list
102564266|NCT05825625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102564267|NCT05825625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564268|NCT05825625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102564269|NCT05825625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564270|NCT05824559|Bevacizumab|bevacizumab|mesh-list
102564271|NCT05824559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102564272|NCT05824559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564273|NCT05824559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102564274|NCT05824559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102564275|NCT05824559|Growth Substances|growth substances|mesh-ancestor
102564276|NCT05824559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564277|NCT05824559|Growth Inhibitors|growth inhibitors|mesh-ancestor
102564278|NCT05815264|Vaccines|vaccines|mesh-list
102564279|NCT05815264|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102564280|NCT05815264|Immunologic Factors|immunologic factors|mesh-ancestor
102564281|NCT05815264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564282|NCT05815186|Sotorasib|sotorasib|mesh-list
102111203|NCT03609840|Antineoplastic Agents|antineoplastic agents|mesh-list
102564284|NCT05815186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564285|NCT05815186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102564286|NCT05815186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564287|NCT05814640|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102564288|NCT05814640|Olanzapine|olanzapine|mesh-list
102564289|NCT05814640|Aripiprazole|aripiprazole|mesh-list
102564290|NCT05814640|Lithium Carbonate|lithium carbonate|mesh-list
102564291|NCT05814640|Vortioxetine|vortioxetine|mesh-list
102564292|NCT05814640|Sertraline|sertraline|mesh-list
102564293|NCT05814640|Fluoxetine|fluoxetine|mesh-list
102564294|NCT05814640|Antiemetics|antiemetics|mesh-ancestor
102564295|NCT05814640|Autonomic Agents|autonomic agents|mesh-ancestor
102564296|NCT05814640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102564297|NCT05814640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564298|NCT05814640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102564299|NCT05814640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102564300|NCT05814640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102564301|NCT05814640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102564302|NCT05814640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102564303|NCT05814640|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102564304|NCT05814640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102564305|NCT05814640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102564306|NCT05814640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564307|NCT05814640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102564308|NCT05814640|Serotonin Agents|serotonin agents|mesh-ancestor
102564309|NCT05814640|Antidepressive Agents|antidepressive agents|mesh-ancestor
102564310|NCT05814640|Dopamine Agonists|dopamine agonists|mesh-ancestor
102564311|NCT05814640|Dopamine Agents|dopamine agents|mesh-ancestor
102564312|NCT05814640|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102564313|NCT05814640|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102564314|NCT05814640|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102564315|NCT05814640|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102564316|NCT05814640|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102564317|NCT05814640|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102564318|NCT05814640|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102564319|NCT05814640|Analgesics|analgesics|mesh-ancestor
102564320|NCT05814640|Sensory System Agents|sensory system agents|mesh-ancestor
102564321|NCT05814640|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102564322|NCT05814640|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102564323|NCT05814640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102564324|NCT05814640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102564325|NCT05814640|Antimanic Agents|antimanic agents|mesh-ancestor
102564326|NCT05814640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102564327|NCT05814640|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102564328|NCT05810597|Tirzepatide|tirzepatide|mesh-list
102564329|NCT05810597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102564330|NCT05810597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564331|NCT05810597|Incretins|incretins|mesh-ancestor
102564332|NCT05810597|Hormones|hormones|mesh-ancestor
102564333|NCT05810597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102564334|NCT05805501|Pembrolizumab|pembrolizumab|mesh-list
102564335|NCT05805501|Axitinib|axitinib|mesh-list
102564336|NCT05805501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102564337|NCT05805501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564338|NCT05805501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102564339|NCT05805501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564340|NCT05805501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102564341|NCT05805501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102564342|NCT05804162|Moxifloxacin|moxifloxacin|mesh-list
102564343|NCT05804162|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102564344|NCT05804162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102564345|NCT05804162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102564346|NCT05804162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102564347|NCT05804162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102564348|NCT05804162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102564349|NCT05804162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564350|NCT05804162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564351|NCT05804162|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102564352|NCT05804162|Contraceptive Agents|contraceptive agents|mesh-ancestor
102564353|NCT05804162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102564354|NCT05804162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564355|NCT05804162|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102564356|NCT05804162|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102564357|NCT05804162|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102564358|NCT05804084|Acetazolamide|acetazolamide|mesh-list
102564359|NCT05804084|Anticonvulsants|anticonvulsants|mesh-ancestor
102564360|NCT05804084|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102564361|NCT05804084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102564362|NCT05804084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564363|NCT05804084|Diuretics|diuretics|mesh-ancestor
102564364|NCT05804084|Natriuretic Agents|natriuretic agents|mesh-ancestor
102564365|NCT05804084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564366|NCT05803382|Capecitabine|capecitabine|mesh-list
101584228|NCT04252456|Antidotes|antidotes|mesh-ancestor
102564367|NCT05803382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102564368|NCT05803382|Antimetabolites|antimetabolites|mesh-ancestor
102564369|NCT05803382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564370|NCT05803382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564371|NCT05788081|Rituximab|rituximab|mesh-list
102564372|NCT05788081|Nivolumab|nivolumab|mesh-list
102564373|NCT05788081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102564374|NCT05788081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564375|NCT05788081|Immunologic Factors|immunologic factors|mesh-ancestor
102564376|NCT05788081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564377|NCT05788081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102564378|NCT05788081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102564379|NCT05788081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564380|NCT05786547|Varenicline|varenicline|mesh-list
102564381|NCT05786547|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102564382|NCT05786547|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102564383|NCT05786547|Cholinergic Agents|cholinergic agents|mesh-ancestor
102564384|NCT05786547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102564385|NCT05786547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564386|NCT05786547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564387|NCT05786066|Ketamine|ketamine|mesh-list
102564388|NCT05786066|Analgesics|analgesics|mesh-ancestor
102564389|NCT05786066|Sensory System Agents|sensory system agents|mesh-ancestor
102564390|NCT05786066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102564391|NCT05786066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564392|NCT05786066|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102564393|NCT05786066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102564394|NCT05786066|Anesthetics, General|anesthetics, general|mesh-ancestor
102564395|NCT05786066|Anesthetics|anesthetics|mesh-ancestor
102564396|NCT05786066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102564397|NCT05786066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102564398|NCT05786066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102564399|NCT05786066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102564400|NCT05786066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564401|NCT05771779|Vaccines|vaccines|mesh-list
102564402|NCT05771779|Immunologic Factors|immunologic factors|mesh-ancestor
102564403|NCT05771779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564404|NCT05770531|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
102564405|NCT05770531|Immunoconjugates|immunoconjugates|mesh-ancestor
102564406|NCT05770531|Immunologic Factors|immunologic factors|mesh-ancestor
102564407|NCT05770531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564408|NCT05765513|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102564409|NCT05761171|Cytarabine|cytarabine|mesh-list
102564410|NCT05761171|Prednisone|prednisone|mesh-list
102564411|NCT05761171|Prednisolone|prednisolone|mesh-list
102564412|NCT05761171|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102564413|NCT05761171|Methylprednisolone|methylprednisolone|mesh-list
102564414|NCT05761171|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102564415|NCT05761171|Prednisolone acetate|prednisolone acetate|mesh-list
102564416|NCT05761171|Hydrocortisone|hydrocortisone|mesh-list
102564417|NCT05761171|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102564418|NCT05761171|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102564419|NCT05761171|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102564420|NCT05761171|Cortisone|cortisone|mesh-list
102564421|NCT05761171|Methotrexate|methotrexate|mesh-list
102564422|NCT05761171|Fludarabine|fludarabine|mesh-list
102564423|NCT05761171|Fludarabine phosphate|fludarabine phosphate|mesh-list
102564424|NCT05761171|Vincristine|vincristine|mesh-list
102564425|NCT05761171|Asparaginase|asparaginase|mesh-list
102564426|NCT05761171|Pegaspargase|pegaspargase|mesh-list
102564427|NCT05761171|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102564428|NCT05761171|Prednisolone phosphate|prednisolone phosphate|mesh-list
102564429|NCT05761171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102564430|NCT05761171|Glucocorticoids|glucocorticoids|mesh-ancestor
102564431|NCT05761171|Hormones|hormones|mesh-ancestor
102564432|NCT05761171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102564433|NCT05761171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564434|NCT05761171|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102564435|NCT05761171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564436|NCT05761171|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102564437|NCT05761171|Abortifacient Agents|abortifacient agents|mesh-ancestor
102564438|NCT05761171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102564439|NCT05761171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102564440|NCT05761171|Antimetabolites|antimetabolites|mesh-ancestor
102564441|NCT05761171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564442|NCT05761171|Dermatologic Agents|dermatologic agents|mesh-ancestor
102564443|NCT05761171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102564444|NCT05761171|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102564445|NCT05761171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102564446|NCT05761171|Immunologic Factors|immunologic factors|mesh-ancestor
102564447|NCT05761171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102564448|NCT05761171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102564449|NCT05761171|Antiviral Agents|antiviral agents|mesh-ancestor
102564450|NCT05761171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102564451|NCT05761171|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102564452|NCT05761171|Tubulin Modulators|tubulin modulators|mesh-ancestor
102564453|NCT05761171|Antimitotic Agents|antimitotic agents|mesh-ancestor
102564454|NCT05761171|Mitosis Modulators|mitosis modulators|mesh-ancestor
102564456|NCT05761171|Autonomic Agents|autonomic agents|mesh-ancestor
102564457|NCT05761171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102564458|NCT05761171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102564459|NCT05761171|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102564460|NCT05761171|Protective Agents|protective agents|mesh-ancestor
102564461|NCT05759949|Fulvestrant|fulvestrant|mesh-list
102564462|NCT05759949|Palbociclib|palbociclib|mesh-list
102564463|NCT05759949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102564464|NCT05759949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564465|NCT05759949|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102564466|NCT05759949|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102564467|NCT05759949|Hormone Antagonists|hormone antagonists|mesh-ancestor
101584322|NCT05125146|Trazodone|trazodone|mesh-list
102564468|NCT05759949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102564469|NCT05759949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564470|NCT05759949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102564471|NCT05759949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102564472|NCT05759949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564473|NCT05758831|Rituximab|rituximab|mesh-list
102564474|NCT05758831|Ocrelizumab|ocrelizumab|mesh-list
102564475|NCT05758831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102564476|NCT05758831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564477|NCT05758831|Immunologic Factors|immunologic factors|mesh-ancestor
102564478|NCT05758831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564479|NCT05758831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102564480|NCT05752916|Clopidogrel|clopidogrel|mesh-list
102564481|NCT05752916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
102564482|NCT05752916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564483|NCT05752916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564484|NCT05752916|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102564485|NCT05752916|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102564486|NCT05752916|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102564487|NCT05752916|Purinergic Agents|purinergic agents|mesh-ancestor
102564488|NCT05752916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102564489|NCT05752409|Ketamine|ketamine|mesh-list
102564490|NCT05752409|Propofol|propofol|mesh-list
102564491|NCT05752409|Esketamine|esketamine|mesh-list
102564492|NCT05752409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102564493|NCT05752409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102564494|NCT05752409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564495|NCT05752409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102564496|NCT05752409|Anesthetics, General|anesthetics, general|mesh-ancestor
102564497|NCT05752409|Anesthetics|anesthetics|mesh-ancestor
102564498|NCT05752409|Analgesics|analgesics|mesh-ancestor
102564499|NCT05752409|Sensory System Agents|sensory system agents|mesh-ancestor
102564500|NCT05752409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102564501|NCT05752409|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102564502|NCT05752409|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102564503|NCT05752409|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102111429|NCT03525912|Anesthetics|anesthetics|mesh-ancestor
102564504|NCT05752409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102564505|NCT05752409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564506|NCT05752409|Antidepressive Agents|antidepressive agents|mesh-ancestor
102564507|NCT05752409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102564508|NCT05747794|Paclitaxel|paclitaxel|mesh-list
102564509|NCT05747794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102564510|NCT05747794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564511|NCT05747794|Tubulin Modulators|tubulin modulators|mesh-ancestor
102564512|NCT05747794|Antimitotic Agents|antimitotic agents|mesh-ancestor
102564513|NCT05747794|Mitosis Modulators|mitosis modulators|mesh-ancestor
102564514|NCT05747794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564515|NCT05746819|Antipyretics|antipyretics|mesh-list
102564516|NCT05746819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564517|NCT05746481|Carboplatin|carboplatin|mesh-list
102564518|NCT05746481|Pemetrexed|pemetrexed|mesh-list
102564519|NCT05746481|Atezolizumab|atezolizumab|mesh-list
102564520|NCT05746481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564521|NCT05746481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102564522|NCT05746481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564523|NCT05746481|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102564524|NCT05746481|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102564525|NCT05746481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102564526|NCT05746481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102564527|NCT05745038|Zaleplon|zaleplon|mesh-list
102564528|NCT05745038|Anticonvulsants|anticonvulsants|mesh-ancestor
102564529|NCT05745038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102564530|NCT05745038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102564531|NCT05745038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564532|NCT05745038|GABA Modulators|gaba modulators|mesh-ancestor
102564533|NCT05745038|GABA Agents|gaba agents|mesh-ancestor
102564534|NCT05745038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102564535|NCT05745038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564536|NCT05723562|Dostarlimab|dostarlimab|mesh-list
102564537|NCT05723562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564538|NCT05721937|Abrocitinib|abrocitinib|mesh-list
102564539|NCT05721937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102564540|NCT05721937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102564541|NCT05721937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564542|NCT05715411|Methamphetamine|methamphetamine|mesh-list
102564543|NCT05715411|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102564544|NCT05715411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564545|NCT05715411|Sympathomimetics|sympathomimetics|mesh-ancestor
102564546|NCT05715411|Autonomic Agents|autonomic agents|mesh-ancestor
102564547|NCT05715411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102564548|NCT05715411|Dopamine Agents|dopamine agents|mesh-ancestor
102564549|NCT05715411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102564550|NCT05715411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564551|NCT05715411|Adrenergic Agents|adrenergic agents|mesh-ancestor
102564552|NCT05715411|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102564553|NCT05715411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102564554|NCT05715411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102564555|NCT05715411|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102564556|NCT05714384|Calcium|calcium|mesh-list
102564557|NCT05714384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102564558|NCT05714384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564559|NCT05713838|Durvalumab|durvalumab|mesh-list
102564560|NCT05713838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102564561|NCT05713838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564562|NCT05705492|Olanzapine|olanzapine|mesh-list
102564563|NCT05705492|Antiemetics|antiemetics|mesh-ancestor
102564564|NCT05705492|Autonomic Agents|autonomic agents|mesh-ancestor
102564565|NCT05705492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102564566|NCT05705492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564567|NCT05705492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102564568|NCT05705492|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102564569|NCT05705492|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102564570|NCT05705492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102564571|NCT05705492|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102564572|NCT05705492|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102564573|NCT05705492|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102564574|NCT05705492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102564575|NCT05705492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564576|NCT05705492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102564577|NCT05705492|Serotonin Agents|serotonin agents|mesh-ancestor
102564578|NCT05705258|Aflibercept|aflibercept|mesh-list
102564579|NCT05705258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102564580|NCT05705258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102564581|NCT05705258|Growth Substances|growth substances|mesh-ancestor
102564582|NCT05705258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564583|NCT05705258|Growth Inhibitors|growth inhibitors|mesh-ancestor
102564584|NCT05705258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564585|NCT05696782|Durvalumab|durvalumab|mesh-list
102564586|NCT05696782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102564587|NCT05696782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564588|NCT05693766|Capecitabine|capecitabine|mesh-list
102564589|NCT05693766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102564590|NCT05693766|Antimetabolites|antimetabolites|mesh-ancestor
102564591|NCT05693766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564592|NCT05693766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564593|NCT05692960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
102564594|NCT05692960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102564595|NCT05692960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564596|NCT05689047|Artesunate|artesunate|mesh-list
102564597|NCT05689047|Pyronaridine|pyronaridine|mesh-list
102564598|NCT05689047|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
102564599|NCT05689047|Antimalarials|antimalarials|mesh-ancestor
102564600|NCT05689047|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102564601|NCT05689047|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102564602|NCT05689047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102564603|NCT05689047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564604|NCT05689047|Antiviral Agents|antiviral agents|mesh-ancestor
102564605|NCT05689047|Schistosomicides|schistosomicides|mesh-ancestor
102564606|NCT05689047|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102564607|NCT05689047|Anthelmintics|anthelmintics|mesh-ancestor
102564608|NCT05687344|Nifedipine|nifedipine|mesh-list
102564609|NCT05687344|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102564610|NCT05687344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102564611|NCT05687344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564612|NCT05687344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102564613|NCT05687344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564614|NCT05687344|Vasodilator Agents|vasodilator agents|mesh-ancestor
102564615|NCT05687344|Tocolytic Agents|tocolytic agents|mesh-ancestor
102564616|NCT05687344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102564617|NCT05685719|Itraconazole|itraconazole|mesh-list
102564618|NCT05685719|Rifampin|rifampin|mesh-list
102564619|NCT05685719|Antifungal Agents|antifungal agents|mesh-ancestor
102564620|NCT05685719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102564621|NCT05685719|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102564622|NCT05685719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102564623|NCT05685719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102564624|NCT05685719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564625|NCT05685719|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102564626|NCT05685719|Hormone Antagonists|hormone antagonists|mesh-ancestor
102564627|NCT05685719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102564628|NCT05685719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564629|NCT05685719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102564630|NCT05685719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102564631|NCT05685719|Antitubercular Agents|antitubercular agents|mesh-ancestor
102564632|NCT05685719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102564633|NCT05685719|Leprostatic Agents|leprostatic agents|mesh-ancestor
102564634|NCT05685719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102564635|NCT05685719|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102564636|NCT05685719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102564637|NCT05685719|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102564638|NCT05685719|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102564639|NCT05685719|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102564640|NCT05685719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102564641|NCT05676931|Docetaxel|docetaxel|mesh-list
102564642|NCT05676931|Quemliclustat|quemliclustat|mesh-list
102564643|NCT05676931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564644|NCT05676931|Tubulin Modulators|tubulin modulators|mesh-ancestor
102564645|NCT05676931|Antimitotic Agents|antimitotic agents|mesh-ancestor
102564646|NCT05676931|Mitosis Modulators|mitosis modulators|mesh-ancestor
102564647|NCT05676931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564648|NCT05676931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102564649|NCT05676931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102564650|NCT05661955|Tislelizumab|tislelizumab|mesh-list
102564651|NCT05661955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102564652|NCT05661955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564653|NCT05661669|Ketamine|ketamine|mesh-list
102564654|NCT05661669|Analgesics|analgesics|mesh-ancestor
102564655|NCT05661669|Sensory System Agents|sensory system agents|mesh-ancestor
102564656|NCT05661669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102564657|NCT05661669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564658|NCT05661669|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102564659|NCT05661669|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102564660|NCT05661669|Anesthetics, General|anesthetics, general|mesh-ancestor
102564661|NCT05661669|Anesthetics|anesthetics|mesh-ancestor
102564662|NCT05661669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102564663|NCT05661669|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102564664|NCT05661669|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102564665|NCT05661669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102564666|NCT05661669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564667|NCT05659381|Cisplatin|cisplatin|mesh-list
102564668|NCT05659381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564669|NCT05657873|Immunomodulating Agents|immunomodulating agents|mesh-list
102564670|NCT05657873|Immunologic Factors|immunologic factors|mesh-ancestor
102564671|NCT05657873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564672|NCT05653713|Lenograstim|lenograstim|mesh-list
102564673|NCT05653713|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102564674|NCT05653713|Immunologic Factors|immunologic factors|mesh-ancestor
102564675|NCT05653713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564676|NCT05650879|Trastuzumab|trastuzumab|mesh-list
102564677|NCT05650879|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102564678|NCT05650879|Maytansine|maytansine|mesh-list
102564679|NCT05650879|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
102564680|NCT05650879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102564681|NCT05650879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564682|NCT05650879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102564683|NCT05650879|Tubulin Modulators|tubulin modulators|mesh-ancestor
102564684|NCT05650879|Antimitotic Agents|antimitotic agents|mesh-ancestor
102564685|NCT05650879|Mitosis Modulators|mitosis modulators|mesh-ancestor
102564686|NCT05650879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564687|NCT05650879|Immunotoxins|immunotoxins|mesh-ancestor
102564688|NCT05650879|Immunoconjugates|immunoconjugates|mesh-ancestor
102564689|NCT05650879|Immunologic Factors|immunologic factors|mesh-ancestor
102564690|NCT05650879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564691|NCT05646082|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102564692|NCT05646082|Dostarlimab|dostarlimab|mesh-list
102564693|NCT05646082|Antiviral Agents|antiviral agents|mesh-ancestor
102564694|NCT05646082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102564695|NCT05646082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564696|NCT05645432|Pregnanolone|pregnanolone|mesh-list
102564697|NCT05645432|Brexanolone|brexanolone|mesh-list
102564698|NCT05645432|Anesthetics|anesthetics|mesh-ancestor
102564699|NCT05645432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102564700|NCT05645432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564701|NCT05645432|Neurosteroids|neurosteroids|mesh-ancestor
102564702|NCT05645432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102564703|NCT05645432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564704|NCT05645432|GABA Modulators|gaba modulators|mesh-ancestor
102564705|NCT05645432|GABA Agents|gaba agents|mesh-ancestor
102564706|NCT05644561|Ravulizumab|ravulizumab|mesh-list
102564707|NCT05644561|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102564708|NCT05644561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102564709|NCT05644561|Immunologic Factors|immunologic factors|mesh-ancestor
102564710|NCT05644561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564711|NCT05643560|Factor VIII|factor viii|mesh-list
102564712|NCT05643560|Coagulants|coagulants|mesh-ancestor
102564713|NCT05641324|Dexamethasone|dexamethasone|mesh-list
102564714|NCT05641324|Lenalidomide|lenalidomide|mesh-list
102564715|NCT05641324|Daratumumab|daratumumab|mesh-list
102564716|NCT05641324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102564717|NCT05641324|Antiemetics|antiemetics|mesh-ancestor
102564718|NCT05641324|Autonomic Agents|autonomic agents|mesh-ancestor
102564719|NCT05641324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102564720|NCT05641324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564721|NCT05641324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102564722|NCT05641324|Glucocorticoids|glucocorticoids|mesh-ancestor
102564723|NCT05641324|Hormones|hormones|mesh-ancestor
102564724|NCT05641324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102564725|NCT05641324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102564726|NCT05641324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564727|NCT05641324|Immunologic Factors|immunologic factors|mesh-ancestor
102564728|NCT05641324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102564729|NCT05641324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102564730|NCT05641324|Growth Substances|growth substances|mesh-ancestor
102564731|NCT05641324|Growth Inhibitors|growth inhibitors|mesh-ancestor
102564732|NCT05634707|Temozolomide|temozolomide|mesh-list
102564733|NCT05634707|Fluoxetine|fluoxetine|mesh-list
102564734|NCT05634707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102564735|NCT05634707|Alkylating Agents|alkylating agents|mesh-ancestor
102564736|NCT05634707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564737|NCT05634707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564738|NCT05634707|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102564739|NCT05634707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102564740|NCT05634707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102564741|NCT05634707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102564742|NCT05634707|Serotonin Agents|serotonin agents|mesh-ancestor
102564743|NCT05634707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564744|NCT05634707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102564745|NCT05634707|Antidepressive Agents|antidepressive agents|mesh-ancestor
102564746|NCT05634707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102564747|NCT05634707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102564748|NCT05634707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102564749|NCT05634707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102564750|NCT05632133|Ibuprofen|ibuprofen|mesh-list
102564751|NCT05632133|Lacosamide|lacosamide|mesh-list
102564752|NCT05632133|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102564753|NCT05632133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102564754|NCT05632133|Analgesics|analgesics|mesh-ancestor
102564755|NCT05632133|Sensory System Agents|sensory system agents|mesh-ancestor
102564756|NCT05632133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102564757|NCT05632133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564758|NCT05632133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102564759|NCT05632133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102564760|NCT05632133|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102564761|NCT05632133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102564762|NCT05632133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564763|NCT05632133|Anticonvulsants|anticonvulsants|mesh-ancestor
102564764|NCT05632133|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102564765|NCT05632133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102564766|NCT05632133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102564767|NCT05628883|Cyclophosphamide|cyclophosphamide|mesh-list
102564768|NCT05628883|Fludarabine|fludarabine|mesh-list
102564769|NCT05628883|Interleukin-2|interleukin-2|mesh-list
102564770|NCT05628883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102564771|NCT05628883|Immunologic Factors|immunologic factors|mesh-ancestor
102564772|NCT05628883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564773|NCT05628883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102564774|NCT05628883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102564775|NCT05628883|Alkylating Agents|alkylating agents|mesh-ancestor
102564776|NCT05628883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564777|NCT05628883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564778|NCT05628883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102564779|NCT05628883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102564780|NCT05628883|Analgesics|analgesics|mesh-ancestor
102564781|NCT05628883|Sensory System Agents|sensory system agents|mesh-ancestor
102564782|NCT05628883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102564783|NCT05621811|ATI 7505|ati 7505|mesh-list
102564784|NCT05621811|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
102564785|NCT05621811|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102564786|NCT05621811|Serotonin Agents|serotonin agents|mesh-ancestor
102564787|NCT05621811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102564788|NCT05621811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564789|NCT05621811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564790|NCT05621616|Mirabegron|mirabegron|mesh-list
102564791|NCT05621616|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102564792|NCT05621616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102564793|NCT05621616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102564794|NCT05621616|Adrenergic Agents|adrenergic agents|mesh-ancestor
102564795|NCT05621616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102564796|NCT05621616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564797|NCT05621616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564798|NCT05621616|Urological Agents|urological agents|mesh-ancestor
102111720|NCT02298582|Fentanyl|fentanyl|mesh-list
102564799|NCT05618587|Lithium Carbonate|lithium carbonate|mesh-list
102564800|NCT05618587|Antidepressive Agents|antidepressive agents|mesh-ancestor
102564801|NCT05618587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102564802|NCT05618587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102564803|NCT05618587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564804|NCT05618587|Antimanic Agents|antimanic agents|mesh-ancestor
102564805|NCT05618587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102564806|NCT05618587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102564807|NCT05618587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564808|NCT05609370|Bevacizumab|bevacizumab|mesh-list
102564809|NCT05609370|Tislelizumab|tislelizumab|mesh-list
102564810|NCT05609370|Capecitabine|capecitabine|mesh-list
102564811|NCT05609370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102564812|NCT05609370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564813|NCT05609370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102564814|NCT05609370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102564815|NCT05609370|Growth Substances|growth substances|mesh-ancestor
102564816|NCT05609370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564817|NCT05609370|Growth Inhibitors|growth inhibitors|mesh-ancestor
102564818|NCT05609370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102564819|NCT05609370|Antimetabolites|antimetabolites|mesh-ancestor
102564820|NCT05609370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564821|NCT05603429|Antioxidants|antioxidants|mesh-list
102564822|NCT05603429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564823|NCT05603429|Protective Agents|protective agents|mesh-ancestor
102564824|NCT05603429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564825|NCT05602194|Asparaginase|asparaginase|mesh-list
102564826|NCT05602194|Pegaspargase|pegaspargase|mesh-list
102564827|NCT05602194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564828|NCT05598905|Pregabalin|pregabalin|mesh-list
102564829|NCT05598905|Lacosamide|lacosamide|mesh-list
102564830|NCT05598905|Oxycodone|oxycodone|mesh-list
102564831|NCT05598905|Analgesics|analgesics|mesh-ancestor
102564832|NCT05598905|Sensory System Agents|sensory system agents|mesh-ancestor
102564833|NCT05598905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102564834|NCT05598905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564835|NCT05598905|Anticonvulsants|anticonvulsants|mesh-ancestor
102564836|NCT05598905|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102564837|NCT05598905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102564838|NCT05598905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564839|NCT05598905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102564840|NCT05598905|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102564841|NCT05598905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102564842|NCT05598905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102564843|NCT05598905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102564844|NCT05598905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102564845|NCT05598905|Narcotics|narcotics|mesh-ancestor
102564846|NCT05598905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102564847|NCT05598905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102564848|NCT05595369|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
102564849|NCT05595369|Antiviral Agents|antiviral agents|mesh-ancestor
102564850|NCT05595369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102564851|NCT05586776|Chlorhexidine|chlorhexidine|mesh-list
102564852|NCT05586776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102564853|NCT05586776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
102564854|NCT05586776|Mupirocin|mupirocin|mesh-list
102564855|NCT05586776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102564856|NCT05586776|Disinfectants|disinfectants|mesh-ancestor
102564857|NCT05586776|Dermatologic Agents|dermatologic agents|mesh-ancestor
102564858|NCT05586776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102564859|NCT05586776|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102564860|NCT05586776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102564861|NCT05586776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564862|NCT05584137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102564863|NCT05584137|Antibodies|antibodies|mesh-list
102564864|NCT05584137|Immunoglobulins|immunoglobulins|mesh-list
102564865|NCT05584137|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102564866|NCT05584137|Immunologic Factors|immunologic factors|mesh-ancestor
102564867|NCT05584137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564868|NCT05584137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564869|NCT05583552|Imetelstat|imetelstat|mesh-list
102564870|NCT05583552|Motesanib diphosphate|motesanib diphosphate|mesh-list
102564871|NCT05583552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102564872|NCT05583552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564873|NCT05583552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102564875|NCT05578872|Ipilimumab|ipilimumab|mesh-list
102564876|NCT05578872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102564877|NCT05578872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564878|NCT05578872|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102564879|NCT05578872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564880|NCT05576207|Micronutrients|micronutrients|mesh-list
102564881|NCT05576207|Trace Elements|trace elements|mesh-list
102564882|NCT05576207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564883|NCT05568095|Leucovorin|leucovorin|mesh-list
102564884|NCT05568095|Fluorouracil|fluorouracil|mesh-list
102564885|NCT05568095|Capecitabine|capecitabine|mesh-list
102564886|NCT05568095|Oxaliplatin|oxaliplatin|mesh-list
102564887|NCT05568095|Nivolumab|nivolumab|mesh-list
102564888|NCT05568095|Antimetabolites|antimetabolites|mesh-ancestor
102564889|NCT05568095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564890|NCT05568095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102564891|NCT05568095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564892|NCT05568095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102564893|NCT05568095|Immunologic Factors|immunologic factors|mesh-ancestor
102564894|NCT05568095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564895|NCT05568095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102564896|NCT05568095|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102564897|NCT05568095|Antidotes|antidotes|mesh-ancestor
102564898|NCT05568095|Protective Agents|protective agents|mesh-ancestor
102564899|NCT05568095|Vitamin B Complex|vitamin b complex|mesh-ancestor
102564900|NCT05568095|Vitamins|vitamins|mesh-ancestor
102564901|NCT05568095|Micronutrients|micronutrients|mesh-ancestor
102564902|NCT05557591|Cemiplimab|cemiplimab|mesh-list
102564903|NCT05557591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102564904|NCT05557591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564905|NCT05555888|Capecitabine|capecitabine|mesh-list
102564906|NCT05555888|Oxaliplatin|oxaliplatin|mesh-list
102564907|NCT05555888|Antibodies|antibodies|mesh-list
102564908|NCT05555888|Immunologic Factors|immunologic factors|mesh-ancestor
102564909|NCT05555888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564910|NCT05555888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102564911|NCT05555888|Antimetabolites|antimetabolites|mesh-ancestor
102564912|NCT05555888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564913|NCT05555888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564914|NCT05555732|Carboplatin|carboplatin|mesh-list
102564915|NCT05555732|Pembrolizumab|pembrolizumab|mesh-list
102564916|NCT05555732|Pemetrexed|pemetrexed|mesh-list
102564917|NCT05555732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564918|NCT05555732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102564919|NCT05555732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102564920|NCT05555732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564921|NCT05555732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102564922|NCT05555732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102564923|NCT05555732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102564924|NCT05552508|Benralizumab|benralizumab|mesh-list
102564925|NCT05552508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102564926|NCT05552508|Respiratory System Agents|respiratory system agents|mesh-ancestor
102564927|NCT05543850|Pancrelipase|pancrelipase|mesh-list
102564928|NCT05543850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102564929|NCT05539989|Vaccines|vaccines|mesh-list
102564930|NCT05539989|BCG Vaccine|bcg vaccine|mesh-list
102564931|NCT05539989|Immunologic Factors|immunologic factors|mesh-ancestor
102564932|NCT05539989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564933|NCT05539989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102564934|NCT05529147|Antihypertensive Agents|antihypertensive agents|mesh-list
102564935|NCT05526690|Metformin|metformin|mesh-list
102564936|NCT05526690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102564937|NCT05526690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564938|NCT05526430|Harmine|harmine|mesh-list
102564939|NCT05526430|Hallucinogens|hallucinogens|mesh-ancestor
102564940|NCT05526430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564941|NCT05526430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102564942|NCT05526430|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102564943|NCT05526430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102564944|NCT05526430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564945|NCT05522673|Rolipram|rolipram|mesh-list
102564946|NCT05522673|Antidepressive Agents|antidepressive agents|mesh-ancestor
102564947|NCT05522673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102564948|NCT05522673|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102564949|NCT05522673|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102564950|NCT05522673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102564951|NCT05522673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564953|NCT05521048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102564954|NCT05521048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102564955|NCT05521048|Antimalarials|antimalarials|mesh-ancestor
102564956|NCT05521048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102564957|NCT05521048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102564958|NCT05520567|Azacitidine|azacitidine|mesh-list
102564959|NCT05520567|Venetoclax|venetoclax|mesh-list
102564960|NCT05520567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102564961|NCT05520567|Antimetabolites|antimetabolites|mesh-ancestor
102564962|NCT05520567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564963|NCT05520567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564964|NCT05520567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102564965|NCT05520138|Abiraterone Acetate|abiraterone acetate|mesh-list
102564966|NCT05520138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564967|NCT05520138|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102564968|NCT05520138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102564969|NCT05520138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564970|NCT05520138|Hormone Antagonists|hormone antagonists|mesh-ancestor
102564971|NCT05520138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102564972|NCT05520138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564973|NCT05520138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102564974|NCT05516849|Oxandrolone|oxandrolone|mesh-list
102564975|NCT05516849|Androgens|androgens|mesh-ancestor
102564976|NCT05516849|Hormones|hormones|mesh-ancestor
102564977|NCT05516849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102564978|NCT05516849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564979|NCT05516849|Anabolic Agents|anabolic agents|mesh-ancestor
102564980|NCT05511025|Acetaminophen|acetaminophen|mesh-list
102564981|NCT05511025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102564982|NCT05511025|Analgesics|analgesics|mesh-ancestor
102564983|NCT05511025|Sensory System Agents|sensory system agents|mesh-ancestor
102564984|NCT05511025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102564985|NCT05511025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564986|NCT05511025|Antipyretics|antipyretics|mesh-ancestor
102564987|NCT05510427|Bevacizumab|bevacizumab|mesh-list
102564988|NCT05510427|Atezolizumab|atezolizumab|mesh-list
102564989|NCT05510427|Infigratinib|infigratinib|mesh-list
102564990|NCT05510427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102564991|NCT05510427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102564992|NCT05510427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102564993|NCT05510427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102564994|NCT05510427|Growth Substances|growth substances|mesh-ancestor
102564995|NCT05510427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102564996|NCT05510427|Growth Inhibitors|growth inhibitors|mesh-ancestor
102564997|NCT05510427|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102564998|NCT05510427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102564999|NCT05505292|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102565000|NCT05505292|Lifitegrast|lifitegrast|mesh-list
102565001|NCT05505292|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102565002|NCT05497726|Bevacizumab|bevacizumab|mesh-list
102565003|NCT05497726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102565004|NCT05497726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565005|NCT05497726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102565006|NCT05497726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102565007|NCT05497726|Growth Substances|growth substances|mesh-ancestor
102565008|NCT05497726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565009|NCT05497726|Growth Inhibitors|growth inhibitors|mesh-ancestor
102565010|NCT05493501|Paclitaxel|paclitaxel|mesh-list
102565011|NCT05493501|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102565012|NCT05493501|Carboplatin|carboplatin|mesh-list
102565013|NCT05493501|Gemcitabine|gemcitabine|mesh-list
102565014|NCT05493501|Pemetrexed|pemetrexed|mesh-list
102565015|NCT05493501|Osimertinib|osimertinib|mesh-list
102565016|NCT05493501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102565017|NCT05493501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565018|NCT05493501|Tubulin Modulators|tubulin modulators|mesh-ancestor
102565019|NCT05493501|Antimitotic Agents|antimitotic agents|mesh-ancestor
102565020|NCT05493501|Mitosis Modulators|mitosis modulators|mesh-ancestor
102565021|NCT05493501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565022|NCT05493501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102565023|NCT05493501|Antimetabolites|antimetabolites|mesh-ancestor
102565024|NCT05493501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102565025|NCT05493501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102565026|NCT05493501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102565027|NCT05493501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102565028|NCT05490381|Ethiodized Oil|ethiodized oil|mesh-list
102565029|NCT05490381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565030|NCT05486416|Propofol|propofol|mesh-list
102565031|NCT05486416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102565032|NCT05486416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102565033|NCT05486416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565034|NCT05486416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102565035|NCT05486416|Anesthetics, General|anesthetics, general|mesh-ancestor
102565036|NCT05486416|Anesthetics|anesthetics|mesh-ancestor
102565037|NCT05478499|Deucravacitinib|deucravacitinib|mesh-list
102565038|NCT05478499|Dermatologic Agents|dermatologic agents|mesh-ancestor
102565039|NCT05478499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102565040|NCT05478499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102565041|NCT05478499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565042|NCT05478278|Moxifloxacin|moxifloxacin|mesh-list
102565043|NCT05478278|Psilocybin|psilocybin|mesh-list
102565044|NCT05478278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102565045|NCT05478278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102565046|NCT05478278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102565047|NCT05478278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102565048|NCT05478278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102565049|NCT05478278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565050|NCT05478278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565051|NCT05478278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565052|NCT05478278|Hallucinogens|hallucinogens|mesh-ancestor
102565053|NCT05478278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102565054|NCT05478174|Propofol|propofol|mesh-list
102565055|NCT05478174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102565056|NCT05478174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102565057|NCT05478174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565058|NCT05478174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102565059|NCT05478174|Anesthetics, General|anesthetics, general|mesh-ancestor
102565060|NCT05478174|Anesthetics|anesthetics|mesh-ancestor
102565061|NCT05477953|Nifurtimox|nifurtimox|mesh-list
102565062|NCT05477953|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102565063|NCT05477953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102565064|NCT05477953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102565065|NCT05477953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102565066|NCT05476926|Ranibizumab|ranibizumab|mesh-list
102565067|NCT05476926|Faricimab|faricimab|mesh-list
102565068|NCT05476926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102565069|NCT05476926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102565070|NCT05476926|Growth Substances|growth substances|mesh-ancestor
102565071|NCT05476926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565072|NCT05476926|Growth Inhibitors|growth inhibitors|mesh-ancestor
102565073|NCT05476926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565074|NCT05476094|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
102565075|NCT05476094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102565076|NCT05476094|Antimetabolites|antimetabolites|mesh-ancestor
102565077|NCT05476094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565078|NCT05476094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102565079|NCT05475210|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102565080|NCT05475210|(177)Lu-DOTA-EB-TATE|(177)lu-dota-eb-tate|mesh-list
102565081|NCT05475210|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102565082|NCT05475210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565083|NCT05470283|Cyclophosphamide|cyclophosphamide|mesh-list
102565084|NCT05470283|Fludarabine|fludarabine|mesh-list
102565085|NCT05470283|Fludarabine phosphate|fludarabine phosphate|mesh-list
102565086|NCT05470283|Furosemide|furosemide|mesh-list
102565087|NCT05470283|Acetazolamide|acetazolamide|mesh-list
102565088|NCT05470283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102565089|NCT05470283|Immunologic Factors|immunologic factors|mesh-ancestor
102565090|NCT05470283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565091|NCT05470283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102565092|NCT05470283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102565093|NCT05470283|Alkylating Agents|alkylating agents|mesh-ancestor
102565094|NCT05470283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565095|NCT05470283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565096|NCT05470283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102565097|NCT05470283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102565098|NCT05470283|Antimetabolites|antimetabolites|mesh-ancestor
102565099|NCT05470283|Diuretics|diuretics|mesh-ancestor
102565100|NCT05470283|Natriuretic Agents|natriuretic agents|mesh-ancestor
102565101|NCT05470283|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102565102|NCT05470283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102565103|NCT05470283|Anticonvulsants|anticonvulsants|mesh-ancestor
102565104|NCT05470283|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102565105|NCT05470283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102565106|NCT05468203|Dapagliflozin|dapagliflozin|mesh-list
102565107|NCT05468203|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102565108|NCT05468203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565109|NCT05468203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102565110|NCT05468203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565111|NCT05461755|Tretinoin|tretinoin|mesh-list
102565112|NCT05461755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565113|NCT05461755|Keratolytic Agents|keratolytic agents|mesh-ancestor
102565114|NCT05461755|Dermatologic Agents|dermatologic agents|mesh-ancestor
102565115|NCT05459129|Paclitaxel|paclitaxel|mesh-list
102565116|NCT05459129|Carboplatin|carboplatin|mesh-list
102565117|NCT05459129|Atezolizumab|atezolizumab|mesh-list
102565118|NCT05459129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102565119|NCT05459129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565120|NCT05459129|Tubulin Modulators|tubulin modulators|mesh-ancestor
102565121|NCT05459129|Antimitotic Agents|antimitotic agents|mesh-ancestor
102565122|NCT05459129|Mitosis Modulators|mitosis modulators|mesh-ancestor
102565123|NCT05459129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565124|NCT05459129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102565125|NCT05459129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102565126|NCT05456256|Carboplatin|carboplatin|mesh-list
102565127|NCT05456256|Pemetrexed|pemetrexed|mesh-list
102565128|NCT05456256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565129|NCT05456256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102565130|NCT05456256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565131|NCT05456256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102565132|NCT05456256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102565133|NCT05453396|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
102565134|NCT05453396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102565135|NCT05453396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565136|NCT05451849|Cyclophosphamide|cyclophosphamide|mesh-list
102565137|NCT05451849|Fludarabine|fludarabine|mesh-list
102565138|NCT05451849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102565139|NCT05451849|Immunologic Factors|immunologic factors|mesh-ancestor
102565140|NCT05451849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565141|NCT05451849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102565142|NCT05451849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102565143|NCT05451849|Alkylating Agents|alkylating agents|mesh-ancestor
102565144|NCT05451849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565145|NCT05451849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565146|NCT05451849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102565147|NCT05450965|Onvansertib|onvansertib|mesh-list
102565148|NCT05450965|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102565149|NCT05450965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102565150|NCT05450965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565151|NCT05444582|Levonorgestrel|levonorgestrel|mesh-list
102565152|NCT05444582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102565153|NCT05444582|Contraceptive Agents|contraceptive agents|mesh-ancestor
102565154|NCT05444582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102565155|NCT05444582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565156|NCT05444582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102565157|NCT05444582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102565158|NCT05444582|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102565159|NCT05442034|Mitogens|mitogens|mesh-list
102565160|NCT05442034|Mitosis Modulators|mitosis modulators|mesh-ancestor
102565161|NCT05442034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565162|NCT05427981|Buprenorphine|buprenorphine|mesh-list
101585037|NCT00650065|Cetirizine|cetirizine|mesh-list
102565163|NCT05427981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102565164|NCT05427981|Narcotics|narcotics|mesh-ancestor
102565165|NCT05427981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102565166|NCT05427981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565167|NCT05427981|Analgesics|analgesics|mesh-ancestor
102565168|NCT05427981|Sensory System Agents|sensory system agents|mesh-ancestor
102565169|NCT05427981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102565170|NCT05427981|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102565171|NCT05425875|Dimercaprol|dimercaprol|mesh-list
102565172|NCT05425875|Chelating Agents|chelating agents|mesh-ancestor
102565173|NCT05425875|Sequestering Agents|sequestering agents|mesh-ancestor
102565174|NCT05425875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565175|NCT05419011|Vaccines|vaccines|mesh-list
102112098|NCT03513276|Racepinephrine|racepinephrine|mesh-list
102565176|NCT05419011|Immunologic Factors|immunologic factors|mesh-ancestor
102565177|NCT05419011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565178|NCT05415215|Trastuzumab|trastuzumab|mesh-list
102565179|NCT05415215|Pertuzumab|pertuzumab|mesh-list
102565180|NCT05415215|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102565181|NCT05415215|Maytansine|maytansine|mesh-list
102565182|NCT05415215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102565183|NCT05415215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565184|NCT05415215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102565185|NCT05415215|Tubulin Modulators|tubulin modulators|mesh-ancestor
102565186|NCT05415215|Antimitotic Agents|antimitotic agents|mesh-ancestor
102565187|NCT05415215|Mitosis Modulators|mitosis modulators|mesh-ancestor
102565188|NCT05415215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565189|NCT05415215|Immunotoxins|immunotoxins|mesh-ancestor
102565190|NCT05415215|Immunoconjugates|immunoconjugates|mesh-ancestor
102565191|NCT05415215|Immunologic Factors|immunologic factors|mesh-ancestor
102565192|NCT05415215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565193|NCT05414240|Ibudilast|ibudilast|mesh-list
102565194|NCT05414240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102565195|NCT05414240|Autonomic Agents|autonomic agents|mesh-ancestor
102565196|NCT05414240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102565197|NCT05414240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565198|NCT05414240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102565199|NCT05414240|Respiratory System Agents|respiratory system agents|mesh-ancestor
102565200|NCT05414240|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102565201|NCT05414240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102565202|NCT05414240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565203|NCT05414240|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102565204|NCT05414240|Vasodilator Agents|vasodilator agents|mesh-ancestor
102565205|NCT05411094|Durvalumab|durvalumab|mesh-list
102565206|NCT05411094|Olaparib|olaparib|mesh-list
102565207|NCT05411094|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102565208|NCT05411094|Immunoglobulins|immunoglobulins|mesh-list
102565209|NCT05411094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102565210|NCT05411094|Immunoglobulin G|immunoglobulin g|mesh-list
102565211|NCT05411094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102565212|NCT05411094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565213|NCT05411094|Immunologic Factors|immunologic factors|mesh-ancestor
102565214|NCT05411094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565215|NCT05411094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101585083|NCT02654743|Sulforaphane|sulforaphane|mesh-list
102565216|NCT05411094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565217|NCT05401227|Ketamine|ketamine|mesh-list
102565218|NCT05401227|Analgesics|analgesics|mesh-ancestor
102565219|NCT05401227|Sensory System Agents|sensory system agents|mesh-ancestor
102565220|NCT05401227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102565221|NCT05401227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565222|NCT05401227|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102565223|NCT05401227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102565224|NCT05401227|Anesthetics, General|anesthetics, general|mesh-ancestor
102565225|NCT05401227|Anesthetics|anesthetics|mesh-ancestor
102565226|NCT05401227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102565227|NCT05401227|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102565228|NCT05401227|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102565229|NCT05401227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102565230|NCT05401227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565231|NCT05398653|Cyclosporine|cyclosporine|mesh-list
102565232|NCT05398653|Cyclosporins|cyclosporins|mesh-list
102565233|NCT05398653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102565234|NCT05398653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565235|NCT05398653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102565236|NCT05398653|Immunologic Factors|immunologic factors|mesh-ancestor
102565237|NCT05398653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565238|NCT05398653|Antifungal Agents|antifungal agents|mesh-ancestor
102565239|NCT05398653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102565240|NCT05398653|Dermatologic Agents|dermatologic agents|mesh-ancestor
102565241|NCT05398653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102565242|NCT05398653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102565243|NCT05397639|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1h-indole dimesylate monohydrate|mesh-list
102565244|NCT05397639|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102565245|NCT05397639|Serotonin Agents|serotonin agents|mesh-ancestor
102565246|NCT05397639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102565247|NCT05397639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154353|NCT03365115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102565248|NCT05397639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565250|NCT05389423|Cyclophosphamide|cyclophosphamide|mesh-list
102565251|NCT05389423|Rituximab|rituximab|mesh-list
102565252|NCT05389423|Doxorubicin|doxorubicin|mesh-list
102565253|NCT05389423|Etoposide|etoposide|mesh-list
102565254|NCT05389423|Vincristine|vincristine|mesh-list
102565255|NCT05389423|Pomalidomide|pomalidomide|mesh-list
102565256|NCT05389423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102565257|NCT05389423|Immunologic Factors|immunologic factors|mesh-ancestor
102565258|NCT05389423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565259|NCT05389423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102565260|NCT05389423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102565261|NCT05389423|Alkylating Agents|alkylating agents|mesh-ancestor
102565262|NCT05389423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565263|NCT05389423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565264|NCT05389423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102565265|NCT05389423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102565266|NCT05389423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102565267|NCT05389423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102565268|NCT05389423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102565269|NCT05389423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102565270|NCT05389423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102565271|NCT05389423|Glucocorticoids|glucocorticoids|mesh-ancestor
102565272|NCT05389423|Hormones|hormones|mesh-ancestor
102565273|NCT05389423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102565274|NCT05389423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102565275|NCT05389423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102565276|NCT05389423|Tubulin Modulators|tubulin modulators|mesh-ancestor
102565277|NCT05389423|Antimitotic Agents|antimitotic agents|mesh-ancestor
102565278|NCT05389423|Mitosis Modulators|mitosis modulators|mesh-ancestor
102565279|NCT05389423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102565280|NCT05389423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102565281|NCT05389423|Growth Substances|growth substances|mesh-ancestor
102565282|NCT05389423|Growth Inhibitors|growth inhibitors|mesh-ancestor
102565283|NCT05382325|Pembrolizumab|pembrolizumab|mesh-list
102565284|NCT05382325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102565285|NCT05382325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565286|NCT05382325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102565287|NCT05382325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565288|NCT05378555|Ketamine|ketamine|mesh-list
102565289|NCT05378555|Analgesics|analgesics|mesh-ancestor
102565290|NCT05378555|Sensory System Agents|sensory system agents|mesh-ancestor
102565291|NCT05378555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102565292|NCT05378555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565293|NCT05378555|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102565294|NCT05378555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102565295|NCT05378555|Anesthetics, General|anesthetics, general|mesh-ancestor
102565296|NCT05378555|Anesthetics|anesthetics|mesh-ancestor
102565297|NCT05378555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102565298|NCT05378555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102565299|NCT05378555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102565300|NCT05378555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102565301|NCT05378555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565302|NCT05372614|Trastuzumab|trastuzumab|mesh-list
102565303|NCT05372614|Camptothecin|camptothecin|mesh-list
102565304|NCT05372614|Maleic acid|maleic acid|mesh-list
102565305|NCT05372614|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
102565306|NCT05372614|Immunoconjugates|immunoconjugates|mesh-list
102565307|NCT05372614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102565308|NCT05372614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565309|NCT05372614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102565310|NCT05372614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565311|NCT05372614|Immunologic Factors|immunologic factors|mesh-ancestor
102565312|NCT05372614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565313|NCT05372614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102565314|NCT05372614|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102565315|NCT05372614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102565316|NCT05361395|Carboplatin|carboplatin|mesh-list
102565317|NCT05361395|Etoposide|etoposide|mesh-list
102565318|NCT05361395|Atezolizumab|atezolizumab|mesh-list
102565319|NCT05361395|Durvalumab|durvalumab|mesh-list
102565320|NCT05361395|AMG 757|amg 757|mesh-list
102565321|NCT05361395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565322|NCT05361395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102565323|NCT05361395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102565324|NCT05361395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102565326|NCT05361395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565327|NCT05361395|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102565328|NCT05361395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102565329|NCT05344469|Interferons|interferons|mesh-list
102565330|NCT05344469|Interferon-beta|interferon-beta|mesh-list
102565331|NCT05344469|Ofatumumab|ofatumumab|mesh-list
102565332|NCT05344469|Glatiramer Acetate|glatiramer acetate|mesh-list
102565333|NCT05344469|(T,G)-A-L|(t,g)-a-l|mesh-list
102565334|NCT05344469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565335|NCT05344469|Antiviral Agents|antiviral agents|mesh-ancestor
102565336|NCT05344469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102565337|NCT05344469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102565338|NCT05344469|Immunologic Factors|immunologic factors|mesh-ancestor
102565339|NCT05344469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565340|NCT05344469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102565341|NCT05344469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102565342|NCT05337137|Bevacizumab|bevacizumab|mesh-list
102565343|NCT05337137|Nivolumab|nivolumab|mesh-list
102565344|NCT05337137|Relatlimab|relatlimab|mesh-list
102565345|NCT05337137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102565346|NCT05337137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565347|NCT05337137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102565348|NCT05337137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102565349|NCT05337137|Growth Substances|growth substances|mesh-ancestor
102565350|NCT05337137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565351|NCT05337137|Growth Inhibitors|growth inhibitors|mesh-ancestor
102565352|NCT05337137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102565353|NCT05337137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565354|NCT05329766|Leucovorin|leucovorin|mesh-list
102565355|NCT05329766|Fluorouracil|fluorouracil|mesh-list
102565356|NCT05329766|Oxaliplatin|oxaliplatin|mesh-list
102565357|NCT05329766|Quemliclustat|quemliclustat|mesh-list
102565358|NCT05329766|Antimetabolites|antimetabolites|mesh-ancestor
102565359|NCT05329766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565360|NCT05329766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102565361|NCT05329766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565362|NCT05329766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102565363|NCT05329766|Immunologic Factors|immunologic factors|mesh-ancestor
102565364|NCT05329766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565365|NCT05329766|Antidotes|antidotes|mesh-ancestor
102565366|NCT05329766|Protective Agents|protective agents|mesh-ancestor
102565367|NCT05329766|Vitamin B Complex|vitamin b complex|mesh-ancestor
102565368|NCT05329766|Vitamins|vitamins|mesh-ancestor
102565369|NCT05329766|Micronutrients|micronutrients|mesh-ancestor
102565370|NCT05329766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102565371|NCT05329766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102565372|NCT05324852|Midazolam|midazolam|mesh-list
102565373|NCT05324852|Loxapine|loxapine|mesh-list
102565374|NCT05324852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102565375|NCT05324852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102565376|NCT05324852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102565377|NCT05324852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565378|NCT05324852|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102565379|NCT05324852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102565380|NCT05324852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102565381|NCT05324852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102565382|NCT05324852|Anesthetics, General|anesthetics, general|mesh-ancestor
102565383|NCT05324852|Anesthetics|anesthetics|mesh-ancestor
102565384|NCT05324852|GABA Modulators|gaba modulators|mesh-ancestor
102565385|NCT05324852|GABA Agents|gaba agents|mesh-ancestor
102565386|NCT05324852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102565387|NCT05324852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565388|NCT05324852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102565389|NCT05324852|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102565390|NCT05324852|Dopamine Agents|dopamine agents|mesh-ancestor
102565391|NCT05321420|Pirfenidone|pirfenidone|mesh-list
102565392|NCT05321420|Analgesics|analgesics|mesh-ancestor
102565393|NCT05321420|Sensory System Agents|sensory system agents|mesh-ancestor
102565394|NCT05321420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102565395|NCT05321420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565396|NCT05321420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102565397|NCT05321420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102565398|NCT05321420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102565399|NCT05321420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102565400|NCT05321420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565401|NCT05319756|Oxycodone|oxycodone|mesh-list
102565402|NCT05319756|Gabapentin|gabapentin|mesh-list
102565403|NCT05319756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102565404|NCT05319756|Narcotics|narcotics|mesh-ancestor
102565405|NCT05319756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102565406|NCT05319756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565407|NCT05319756|Analgesics|analgesics|mesh-ancestor
102565408|NCT05319756|Sensory System Agents|sensory system agents|mesh-ancestor
102565409|NCT05319756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102565410|NCT05319756|Anticonvulsants|anticonvulsants|mesh-ancestor
102565411|NCT05319756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102565412|NCT05319756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102565413|NCT05319756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102565414|NCT05319756|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102565415|NCT05319756|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102565416|NCT05319756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102565417|NCT05319756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565418|NCT05319756|Antimanic Agents|antimanic agents|mesh-ancestor
102565419|NCT05315648|Anesthetics|anesthetics|mesh-list
102565420|NCT05315648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101585271|NCT02654041|Methimazole|methimazole|mesh-list
102565421|NCT05315648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565422|NCT05308901|Pembrolizumab|pembrolizumab|mesh-list
102565423|NCT05308901|Lenvatinib|lenvatinib|mesh-list
102565424|NCT05308901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102565425|NCT05308901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565426|NCT05308901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102565427|NCT05308901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565428|NCT05308901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102565429|NCT05308901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102565430|NCT05305105|Psilocybin|psilocybin|mesh-list
102565431|NCT05305105|Hallucinogens|hallucinogens|mesh-ancestor
102565432|NCT05305105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565433|NCT05305105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102565434|NCT05301608|Psilocybin|psilocybin|mesh-list
102565435|NCT05301608|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
102565436|NCT05301608|Hallucinogens|hallucinogens|mesh-ancestor
102565437|NCT05301608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565438|NCT05301608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102565439|NCT05301608|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102565440|NCT05301608|Serotonin Agents|serotonin agents|mesh-ancestor
102565441|NCT05301608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102565442|NCT05301608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565443|NCT05301608|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102565444|NCT05301361|Methylphenidate|methylphenidate|mesh-list
102565445|NCT05301361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102565446|NCT05301361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565447|NCT05301361|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102565448|NCT05301361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102565449|NCT05301361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102565450|NCT05301361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565451|NCT05301361|Dopamine Agents|dopamine agents|mesh-ancestor
102565452|NCT05301361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102565453|NCT05300035|Antibodies|antibodies|mesh-list
102565454|NCT05300035|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102565455|NCT05300035|Immunologic Factors|immunologic factors|mesh-ancestor
102565456|NCT05300035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565457|NCT05296798|Paclitaxel|paclitaxel|mesh-list
102565458|NCT05296798|Docetaxel|docetaxel|mesh-list
102565459|NCT05296798|Trastuzumab|trastuzumab|mesh-list
102565460|NCT05296798|Pertuzumab|pertuzumab|mesh-list
102565461|NCT05296798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102565462|NCT05296798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565463|NCT05296798|Tubulin Modulators|tubulin modulators|mesh-ancestor
102565464|NCT05296798|Antimitotic Agents|antimitotic agents|mesh-ancestor
102565465|NCT05296798|Mitosis Modulators|mitosis modulators|mesh-ancestor
102565466|NCT05296798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565467|NCT05296798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102565468|NCT05290090|Rituximab|rituximab|mesh-list
102565469|NCT05290090|Lenalidomide|lenalidomide|mesh-list
102565470|NCT05290090|Zanubrutinib|zanubrutinib|mesh-list
102565471|NCT05290090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102565472|NCT05290090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565473|NCT05290090|Immunologic Factors|immunologic factors|mesh-ancestor
102565474|NCT05290090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112395|NCT03446612|Hematinics|hematinics|mesh-ancestor
102565475|NCT05290090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102565476|NCT05290090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102565477|NCT05290090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102565478|NCT05290090|Growth Substances|growth substances|mesh-ancestor
102565479|NCT05290090|Growth Inhibitors|growth inhibitors|mesh-ancestor
102565480|NCT05290090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102565481|NCT05290090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102565482|NCT05290090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565483|NCT05287503|Ambroxol|ambroxol|mesh-list
102565484|NCT05287503|Expectorants|expectorants|mesh-ancestor
102565485|NCT05287503|Respiratory System Agents|respiratory system agents|mesh-ancestor
102565486|NCT05280340|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102565487|NCT05280340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102565488|NCT05279898|Dexmedetomidine|dexmedetomidine|mesh-list
102565489|NCT05279898|Ketamine|ketamine|mesh-list
102565490|NCT05279898|Remifentanil|remifentanil|mesh-list
102565491|NCT05279898|Propofol|propofol|mesh-list
102565492|NCT05279898|Ropivacaine|ropivacaine|mesh-list
102565493|NCT05279898|Rocuronium|rocuronium|mesh-list
102565494|NCT05279898|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102565495|NCT05279898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102565496|NCT05279898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565497|NCT05279898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102565498|NCT05279898|Analgesics|analgesics|mesh-ancestor
102565499|NCT05279898|Sensory System Agents|sensory system agents|mesh-ancestor
102565500|NCT05279898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102565501|NCT05279898|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102565502|NCT05279898|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102565503|NCT05279898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102565504|NCT05279898|Adrenergic Agents|adrenergic agents|mesh-ancestor
102565505|NCT05279898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102565506|NCT05279898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565507|NCT05279898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102565508|NCT05279898|Anesthetics, General|anesthetics, general|mesh-ancestor
102565509|NCT05279898|Anesthetics|anesthetics|mesh-ancestor
102565510|NCT05279898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102565511|NCT05279898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102565512|NCT05279898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102565513|NCT05279898|Anesthetics, Local|anesthetics, local|mesh-ancestor
102565514|NCT05279898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102565515|NCT05279898|Narcotics|narcotics|mesh-ancestor
102565516|NCT05279898|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102565517|NCT05279898|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102565518|NCT05279898|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102565519|NCT05277051|Dostarlimab|dostarlimab|mesh-list
102565520|NCT05277051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565521|NCT05273567|Guanfacine|guanfacine|mesh-list
102565522|NCT05273567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102565523|NCT05273567|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102565524|NCT05273567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102565525|NCT05273567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102565526|NCT05273567|Adrenergic Agents|adrenergic agents|mesh-ancestor
102565527|NCT05273567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102565528|NCT05273567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565529|NCT05273567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565530|NCT05266729|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
102565531|NCT05266729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102565532|NCT05266729|Antimetabolites|antimetabolites|mesh-ancestor
102565533|NCT05266729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565534|NCT05266729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102565535|NCT05262270|Naltrexone|naltrexone|mesh-list
102565536|NCT05262270|Buprenorphine|buprenorphine|mesh-list
102565537|NCT05262270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102565538|NCT05262270|Narcotics|narcotics|mesh-ancestor
102565539|NCT05262270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102565540|NCT05262270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565541|NCT05262270|Analgesics|analgesics|mesh-ancestor
102565542|NCT05262270|Sensory System Agents|sensory system agents|mesh-ancestor
102565543|NCT05262270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102565544|NCT05262270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102565545|NCT05262270|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102565546|NCT05257083|Dexamethasone|dexamethasone|mesh-list
102565547|NCT05257083|Cyclophosphamide|cyclophosphamide|mesh-list
102565548|NCT05257083|Fludarabine|fludarabine|mesh-list
102565549|NCT05257083|Lenalidomide|lenalidomide|mesh-list
102565550|NCT05257083|Bortezomib|bortezomib|mesh-list
102565551|NCT05257083|Daratumumab|daratumumab|mesh-list
102565552|NCT05257083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102565553|NCT05257083|Immunologic Factors|immunologic factors|mesh-ancestor
102565554|NCT05257083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565555|NCT05257083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102565556|NCT05257083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102565557|NCT05257083|Alkylating Agents|alkylating agents|mesh-ancestor
102565558|NCT05257083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565559|NCT05257083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565560|NCT05257083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102565561|NCT05257083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102565562|NCT05257083|Antiemetics|antiemetics|mesh-ancestor
102565563|NCT05257083|Autonomic Agents|autonomic agents|mesh-ancestor
102565564|NCT05257083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102565565|NCT05257083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102565566|NCT05257083|Glucocorticoids|glucocorticoids|mesh-ancestor
102565567|NCT05257083|Hormones|hormones|mesh-ancestor
102565568|NCT05257083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102565569|NCT05257083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102565570|NCT05257083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102565571|NCT05257083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102565572|NCT05257083|Growth Substances|growth substances|mesh-ancestor
102565573|NCT05257083|Growth Inhibitors|growth inhibitors|mesh-ancestor
102565574|NCT05257018|Doxorubicin|doxorubicin|mesh-list
102565575|NCT05257018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102565576|NCT05257018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565577|NCT05257018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102565578|NCT05257018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102565579|NCT05257018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102565580|NCT05257018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565581|NCT05255991|Treprostinil|treprostinil|mesh-list
102565582|NCT05255991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102565583|NCT05254171|Paclitaxel|paclitaxel|mesh-list
102565584|NCT05254171|Gemcitabine|gemcitabine|mesh-list
102565585|NCT05254171|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102565586|NCT05254171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565587|NCT05254171|Tubulin Modulators|tubulin modulators|mesh-ancestor
102565588|NCT05254171|Antimitotic Agents|antimitotic agents|mesh-ancestor
102565589|NCT05254171|Mitosis Modulators|mitosis modulators|mesh-ancestor
102565590|NCT05254171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565591|NCT05254171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102565592|NCT05254171|Antimetabolites|antimetabolites|mesh-ancestor
102565593|NCT05249426|Cetuximab|cetuximab|mesh-list
102565594|NCT05249426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102565595|NCT05249426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565596|NCT05243862|Atezolizumab|atezolizumab|mesh-list
102565597|NCT05243862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102565598|NCT05243862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565599|NCT05243862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102565600|NCT05243862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565601|NCT05233098|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
102565602|NCT05233098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102565603|NCT05233098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565604|NCT05224102|Faricimab|faricimab|mesh-list
102565605|NCT05224102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102565606|NCT05224102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102565607|NCT05224102|Growth Substances|growth substances|mesh-ancestor
102565608|NCT05224102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565609|NCT05224102|Growth Inhibitors|growth inhibitors|mesh-ancestor
102565610|NCT05224102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565611|NCT05223816|Nivolumab|nivolumab|mesh-list
102565612|NCT05223816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102565613|NCT05223816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565614|NCT05223816|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102565615|NCT05223816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565616|NCT05216250|Botulinum Toxins|botulinum toxins|mesh-list
102565617|NCT05216250|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102565618|NCT05216250|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102565619|NCT05216250|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102565620|NCT05216250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102565621|NCT05216250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565622|NCT05216250|Cholinergic Agents|cholinergic agents|mesh-ancestor
102565623|NCT05216250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102112545|NCT02152917|Hemostatics|hemostatics|mesh-ancestor
102565624|NCT05216250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565625|NCT05216250|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102565626|NCT05216250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102565627|NCT05215340|Pembrolizumab|pembrolizumab|mesh-list
102565628|NCT05215340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102565629|NCT05215340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565630|NCT05215340|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102565631|NCT05215340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565632|NCT05211336|Prednisone|prednisone|mesh-list
102565633|NCT05211336|Lenalidomide|lenalidomide|mesh-list
102565634|NCT05211336|Venetoclax|venetoclax|mesh-list
102565635|NCT05211336|Obinutuzumab|obinutuzumab|mesh-list
102565636|NCT05211336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102565637|NCT05211336|Glucocorticoids|glucocorticoids|mesh-ancestor
102565638|NCT05211336|Hormones|hormones|mesh-ancestor
102565639|NCT05211336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102565640|NCT05211336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565641|NCT05211336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102565642|NCT05211336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565643|NCT05211336|Immunologic Factors|immunologic factors|mesh-ancestor
102565644|NCT05211336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102565645|NCT05211336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102565646|NCT05211336|Growth Substances|growth substances|mesh-ancestor
102565647|NCT05211336|Growth Inhibitors|growth inhibitors|mesh-ancestor
102565648|NCT05211336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102565649|NCT05200143|Nivolumab|nivolumab|mesh-list
102565650|NCT05200143|Ipilimumab|ipilimumab|mesh-list
102565651|NCT05200143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102565652|NCT05200143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565653|NCT05200143|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102565654|NCT05200143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565655|NCT05197426|Azacitidine|azacitidine|mesh-list
102565656|NCT05197426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102565657|NCT05197426|Antimetabolites|antimetabolites|mesh-ancestor
102565658|NCT05197426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565659|NCT05197426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565660|NCT05197426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102565661|NCT05189223|Buprenorphine|buprenorphine|mesh-list
102565662|NCT05189223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102565663|NCT05189223|Narcotics|narcotics|mesh-ancestor
102565664|NCT05189223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102565665|NCT05189223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565666|NCT05189223|Analgesics|analgesics|mesh-ancestor
102565667|NCT05189223|Sensory System Agents|sensory system agents|mesh-ancestor
102565668|NCT05189223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102565669|NCT05189223|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102565670|NCT05186779|Progestins|progestins|mesh-list
102565671|NCT05186779|Hormones|hormones|mesh-ancestor
102565672|NCT05186779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102565673|NCT05186779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565674|NCT05185947|Paclitaxel|paclitaxel|mesh-list
102565675|NCT05185947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102565676|NCT05185947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565677|NCT05185947|Tubulin Modulators|tubulin modulators|mesh-ancestor
102565678|NCT05185947|Antimitotic Agents|antimitotic agents|mesh-ancestor
101585533|NCT04283487|Levan|levan|mesh-list
102565679|NCT05185947|Mitosis Modulators|mitosis modulators|mesh-ancestor
102565680|NCT05185947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565681|NCT05180825|Trametinib|trametinib|mesh-list
102565682|NCT05180825|Vinblastine|vinblastine|mesh-list
102565683|NCT05180825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565684|NCT05180825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102565685|NCT05180825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102565686|NCT05180825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565687|NCT05180825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102565688|NCT05180825|Tubulin Modulators|tubulin modulators|mesh-ancestor
102565689|NCT05180825|Antimitotic Agents|antimitotic agents|mesh-ancestor
102565690|NCT05180825|Mitosis Modulators|mitosis modulators|mesh-ancestor
102565691|NCT05179356|Dapagliflozin|dapagliflozin|mesh-list
102565692|NCT05179356|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102565693|NCT05179356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565694|NCT05179356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102565695|NCT05179356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565696|NCT05177146|Ketamine|ketamine|mesh-list
102565697|NCT05177146|Analgesics|analgesics|mesh-ancestor
102565698|NCT05177146|Sensory System Agents|sensory system agents|mesh-ancestor
102565699|NCT05177146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102565700|NCT05177146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565701|NCT05177146|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102565702|NCT05177146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102565703|NCT05177146|Anesthetics, General|anesthetics, general|mesh-ancestor
102565704|NCT05177146|Anesthetics|anesthetics|mesh-ancestor
102565705|NCT05177146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102565706|NCT05177146|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102565707|NCT05177146|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102565708|NCT05177146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102565709|NCT05177146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565710|NCT05166421|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
102565711|NCT05166421|Antiviral Agents|antiviral agents|mesh-ancestor
102565712|NCT05166421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102565713|NCT05161533|Cisplatin|cisplatin|mesh-list
102565714|NCT05161533|Carboplatin|carboplatin|mesh-list
102565715|NCT05161533|Etoposide|etoposide|mesh-list
102565716|NCT05161533|Etoposide phosphate|etoposide phosphate|mesh-list
102565717|NCT05161533|Durvalumab|durvalumab|mesh-list
102565718|NCT05161533|Podophyllotoxin|podophyllotoxin|mesh-list
102565719|NCT05161533|Immunoglobulins|immunoglobulins|mesh-list
102565720|NCT05161533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102565721|NCT05161533|Immunoglobulin G|immunoglobulin g|mesh-list
102565722|NCT05161533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565723|NCT05161533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102565724|NCT05161533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102565725|NCT05161533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102565726|NCT05161533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102565727|NCT05161533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565728|NCT05161533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102565729|NCT05161533|Immunologic Factors|immunologic factors|mesh-ancestor
102565730|NCT05161533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565731|NCT05161533|Keratolytic Agents|keratolytic agents|mesh-ancestor
102565732|NCT05161533|Dermatologic Agents|dermatologic agents|mesh-ancestor
102565733|NCT05161533|Tubulin Modulators|tubulin modulators|mesh-ancestor
102565734|NCT05161533|Antimitotic Agents|antimitotic agents|mesh-ancestor
102565735|NCT05161533|Mitosis Modulators|mitosis modulators|mesh-ancestor
102565736|NCT05156788|Lenvatinib|lenvatinib|mesh-list
102565737|NCT05156788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565738|NCT05156788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102565739|NCT05156788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102565740|NCT05156788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565741|NCT05156268|Pembrolizumab|pembrolizumab|mesh-list
102565742|NCT05156268|Olaparib|olaparib|mesh-list
102565743|NCT05156268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102565744|NCT05156268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565745|NCT05156268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102565746|NCT05156268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565747|NCT05156268|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102565748|NCT05156268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102565749|NCT05155709|Azacitidine|azacitidine|mesh-list
102565750|NCT05155709|Venetoclax|venetoclax|mesh-list
102565751|NCT05155709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102565752|NCT05155709|Antimetabolites|antimetabolites|mesh-ancestor
102565753|NCT05155709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565754|NCT05155709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565755|NCT05155709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102565756|NCT05155254|Pembrolizumab|pembrolizumab|mesh-list
102565757|NCT05155254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102565758|NCT05155254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565759|NCT05155254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102565760|NCT05155254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565761|NCT05154487|Fulvestrant|fulvestrant|mesh-list
102565762|NCT05154487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102565763|NCT05154487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565764|NCT05154487|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102565765|NCT05154487|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102565766|NCT05154487|Hormone Antagonists|hormone antagonists|mesh-ancestor
102565767|NCT05154487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102565768|NCT05154487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565769|NCT05154136|Itraconazole|itraconazole|mesh-list
102565770|NCT05154136|Antifungal Agents|antifungal agents|mesh-ancestor
102565771|NCT05154136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102565772|NCT05154136|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102565773|NCT05154136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102565774|NCT05154136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102565775|NCT05154136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565776|NCT05154136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102565777|NCT05154136|Hormone Antagonists|hormone antagonists|mesh-ancestor
102565778|NCT05154136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102565779|NCT05154136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565780|NCT05154136|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102565781|NCT05152576|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102565782|NCT05152576|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102565783|NCT05152576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102565784|NCT05152576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102565785|NCT05152576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565786|NCT05152576|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102565787|NCT05152576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102565788|NCT05152576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565789|NCT05152576|Cholinergic Agents|cholinergic agents|mesh-ancestor
102565790|NCT05152576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102565791|NCT05152147|Fluorouracil|fluorouracil|mesh-list
102565792|NCT05152147|Capecitabine|capecitabine|mesh-list
102565793|NCT05152147|Oxaliplatin|oxaliplatin|mesh-list
102565794|NCT05152147|Trastuzumab|trastuzumab|mesh-list
102565795|NCT05152147|Tislelizumab|tislelizumab|mesh-list
102565796|NCT05152147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565797|NCT05152147|Antimetabolites|antimetabolites|mesh-ancestor
102565798|NCT05152147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565799|NCT05152147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102565800|NCT05152147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102565801|NCT05152147|Immunologic Factors|immunologic factors|mesh-ancestor
102565802|NCT05152147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565803|NCT05152147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102565804|NCT05147805|Treprostinil|treprostinil|mesh-list
102565805|NCT05147805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102565806|NCT05142189|Docetaxel|docetaxel|mesh-list
102565807|NCT05142189|Cemiplimab|cemiplimab|mesh-list
102565808|NCT05142189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565809|NCT05142189|Tubulin Modulators|tubulin modulators|mesh-ancestor
102565810|NCT05142189|Antimitotic Agents|antimitotic agents|mesh-ancestor
102565811|NCT05142189|Mitosis Modulators|mitosis modulators|mesh-ancestor
102565812|NCT05142189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565813|NCT05142189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102565814|NCT05141721|Leucovorin|leucovorin|mesh-list
102565815|NCT05141721|Bevacizumab|bevacizumab|mesh-list
102565816|NCT05141721|Ipilimumab|ipilimumab|mesh-list
102565817|NCT05141721|Atezolizumab|atezolizumab|mesh-list
102565818|NCT05141721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102565819|NCT05141721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565820|NCT05141721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102565821|NCT05141721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102565822|NCT05141721|Growth Substances|growth substances|mesh-ancestor
102565823|NCT05141721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565824|NCT05141721|Growth Inhibitors|growth inhibitors|mesh-ancestor
102565825|NCT05141721|Antidotes|antidotes|mesh-ancestor
102565826|NCT05141721|Protective Agents|protective agents|mesh-ancestor
102565827|NCT05141721|Vitamin B Complex|vitamin b complex|mesh-ancestor
102565828|NCT05141721|Vitamins|vitamins|mesh-ancestor
102565829|NCT05141721|Micronutrients|micronutrients|mesh-ancestor
102565830|NCT05141721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102565831|NCT05141721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565832|NCT05137938|Ketamine|ketamine|mesh-list
102565833|NCT05137938|Analgesics|analgesics|mesh-ancestor
102565834|NCT05137938|Sensory System Agents|sensory system agents|mesh-ancestor
102565835|NCT05137938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102565836|NCT05137938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565837|NCT05137938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102565838|NCT05137938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102565839|NCT05137938|Anesthetics, General|anesthetics, general|mesh-ancestor
102565840|NCT05137938|Anesthetics|anesthetics|mesh-ancestor
102565841|NCT05137938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102565842|NCT05137938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102565843|NCT05137938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102565844|NCT05137938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102565845|NCT05137938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565846|NCT05130060|Trifluridine|trifluridine|mesh-list
102565847|NCT05130060|Vaccines|vaccines|mesh-list
102565848|NCT05130060|Immunologic Factors|immunologic factors|mesh-ancestor
102565849|NCT05130060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565850|NCT05130060|Antimetabolites|antimetabolites|mesh-ancestor
102565851|NCT05130060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565852|NCT05130060|Antiviral Agents|antiviral agents|mesh-ancestor
102565853|NCT05130060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102565855|NCT05129358|Diuretics|diuretics|mesh-ancestor
102565856|NCT05129358|Natriuretic Agents|natriuretic agents|mesh-ancestor
102565857|NCT05129358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565858|NCT05129358|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102565859|NCT05129358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102565860|NCT05129358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565861|NCT05120349|Osimertinib|osimertinib|mesh-list
102565862|NCT05120349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565863|NCT05120349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102565864|NCT05120349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102565865|NCT05120349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565866|NCT05119296|Pembrolizumab|pembrolizumab|mesh-list
102565867|NCT05119296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102565868|NCT05119296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565869|NCT05119296|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102565870|NCT05119296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565871|NCT05117554|Midazolam|midazolam|mesh-list
102565872|NCT05117554|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102565873|NCT05117554|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102565874|NCT05117554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102565875|NCT05117554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565876|NCT05117554|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102565877|NCT05117554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102565878|NCT05117554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102565879|NCT05117554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102565880|NCT05117554|Anesthetics, General|anesthetics, general|mesh-ancestor
102565881|NCT05117554|Anesthetics|anesthetics|mesh-ancestor
102565882|NCT05117554|GABA Modulators|gaba modulators|mesh-ancestor
102565883|NCT05117554|GABA Agents|gaba agents|mesh-ancestor
102565884|NCT05117554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102565885|NCT05117554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565886|NCT05117125|Heparin|heparin|mesh-list
102565887|NCT05117125|Anticoagulants|anticoagulants|mesh-ancestor
102565888|NCT05117125|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102565889|NCT05117125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102565890|NCT05117125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565891|NCT05116202|Nivolumab|nivolumab|mesh-list
102565892|NCT05116202|Ipilimumab|ipilimumab|mesh-list
102565893|NCT05116202|Atezolizumab|atezolizumab|mesh-list
102565894|NCT05116202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102565895|NCT05116202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565896|NCT05116202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102565897|NCT05116202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565898|NCT05114460|Naloxone|naloxone|mesh-list
102565899|NCT05114460|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102565900|NCT05114460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565901|NCT05114460|Sensory System Agents|sensory system agents|mesh-ancestor
102565902|NCT05114460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102565903|NCT05107453|Levobupivacaine|levobupivacaine|mesh-list
102565904|NCT05107453|Anesthetics, Local|anesthetics, local|mesh-ancestor
102565905|NCT05107453|Anesthetics|anesthetics|mesh-ancestor
102565906|NCT05107453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102565907|NCT05107453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565908|NCT05107453|Sensory System Agents|sensory system agents|mesh-ancestor
102565909|NCT05107453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102565910|NCT05105841|Venetoclax|venetoclax|mesh-list
102565911|NCT05105841|Obinutuzumab|obinutuzumab|mesh-list
102565912|NCT05105841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565913|NCT05105841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102565914|NCT05104723|Tofacitinib|tofacitinib|mesh-list
102565915|NCT05104723|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102565916|NCT05104723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102565917|NCT05104723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102565918|NCT05104723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565919|NCT05099848|Leucovorin|leucovorin|mesh-list
102565920|NCT05099848|Fluorouracil|fluorouracil|mesh-list
102565921|NCT05099848|Oxaliplatin|oxaliplatin|mesh-list
102565922|NCT05099848|Apatinib|apatinib|mesh-list
102565923|NCT05099848|Antimetabolites|antimetabolites|mesh-ancestor
102565924|NCT05099848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565925|NCT05099848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102565926|NCT05099848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565927|NCT05099848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102565928|NCT05099848|Immunologic Factors|immunologic factors|mesh-ancestor
102565929|NCT05099848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565930|NCT05099848|Antidotes|antidotes|mesh-ancestor
102565931|NCT05099848|Protective Agents|protective agents|mesh-ancestor
102565932|NCT05099848|Vitamin B Complex|vitamin b complex|mesh-ancestor
102565933|NCT05099848|Vitamins|vitamins|mesh-ancestor
102565934|NCT05099848|Micronutrients|micronutrients|mesh-ancestor
102565935|NCT05099848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102565936|NCT05099848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102565937|NCT05098327|Pioglitazone|pioglitazone|mesh-list
102565938|NCT05098327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102565939|NCT05098327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565940|NCT05092373|Paclitaxel|paclitaxel|mesh-list
102565941|NCT05092373|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102565942|NCT05092373|Atezolizumab|atezolizumab|mesh-list
102565943|NCT05092373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102565944|NCT05092373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102565945|NCT05092373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565946|NCT05092373|Tubulin Modulators|tubulin modulators|mesh-ancestor
102565947|NCT05092373|Antimitotic Agents|antimitotic agents|mesh-ancestor
102565948|NCT05092373|Mitosis Modulators|mitosis modulators|mesh-ancestor
101585812|NCT05253508|Lidocaine|lidocaine|mesh-list
102565949|NCT05092373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565950|NCT05092373|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102565951|NCT05092373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102565952|NCT05092373|Immunologic Factors|immunologic factors|mesh-ancestor
102565953|NCT05092373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565954|NCT05091567|Carboplatin|carboplatin|mesh-list
102565955|NCT05091567|Etoposide|etoposide|mesh-list
102565956|NCT05091567|Atezolizumab|atezolizumab|mesh-list
102565957|NCT05091567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565958|NCT05091567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102565959|NCT05091567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102565960|NCT05091567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102565961|NCT05091567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102565962|NCT05091567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565963|NCT05091567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102565964|NCT05091567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102565965|NCT05089630|Vaccines|vaccines|mesh-list
102565966|NCT05089630|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
102565967|NCT05089630|Immunologic Factors|immunologic factors|mesh-ancestor
102565968|NCT05089630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565969|NCT05089630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102565970|NCT05082610|Pembrolizumab|pembrolizumab|mesh-list
102565971|NCT05082610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102565972|NCT05082610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565973|NCT05082610|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102565974|NCT05082610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565975|NCT05076175|Ozanimod|ozanimod|mesh-list
102565976|NCT05076175|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102565977|NCT05076175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565978|NCT05076175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102565979|NCT05076175|Immunologic Factors|immunologic factors|mesh-ancestor
102565980|NCT05076175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565981|NCT05074589|Leucovorin|leucovorin|mesh-list
102565982|NCT05074589|Fluorouracil|fluorouracil|mesh-list
102565983|NCT05074589|Irinotecan|irinotecan|mesh-list
102565984|NCT05074589|Levoleucovorin|levoleucovorin|mesh-list
102565985|NCT05074589|Antimetabolites|antimetabolites|mesh-ancestor
102565986|NCT05074589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102565987|NCT05074589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102565988|NCT05074589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102565989|NCT05074589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102565990|NCT05074589|Immunologic Factors|immunologic factors|mesh-ancestor
102565991|NCT05074589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102565992|NCT05074589|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102565993|NCT05074589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102565994|NCT05074589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102565995|NCT05074589|Antidotes|antidotes|mesh-ancestor
102565996|NCT05074589|Protective Agents|protective agents|mesh-ancestor
102565997|NCT05074589|Vitamin B Complex|vitamin b complex|mesh-ancestor
102565998|NCT05074589|Vitamins|vitamins|mesh-ancestor
102565999|NCT05074589|Micronutrients|micronutrients|mesh-ancestor
102566000|NCT05064085|Capecitabine|capecitabine|mesh-list
102566001|NCT05064085|Cemiplimab|cemiplimab|mesh-list
102566002|NCT05064085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102566003|NCT05064085|Antimetabolites|antimetabolites|mesh-ancestor
102566004|NCT05064085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566005|NCT05064085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566006|NCT05064085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102566007|NCT05061654|Tazobactam|tazobactam|mesh-list
102566008|NCT05061654|Ceftolozane|ceftolozane|mesh-list
102566009|NCT05061654|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
102566010|NCT05061654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102566011|NCT05061654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102566012|NCT05061654|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102566013|NCT05061654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102566014|NCT05061654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566015|NCT05061654|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102566016|NCT05060965|Nicotine|nicotine|mesh-list
102566017|NCT05060965|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102566018|NCT05060965|Autonomic Agents|autonomic agents|mesh-ancestor
102566019|NCT05060965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102566020|NCT05060965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566021|NCT05060965|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102566022|NCT05060965|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102566023|NCT05060965|Cholinergic Agents|cholinergic agents|mesh-ancestor
102566024|NCT05060965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102566025|NCT05060965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566026|NCT05053126|Pregabalin|pregabalin|mesh-list
102566027|NCT05053126|Oxycodone|oxycodone|mesh-list
102566028|NCT05053126|Analgesics|analgesics|mesh-ancestor
102566029|NCT05053126|Sensory System Agents|sensory system agents|mesh-ancestor
102566030|NCT05053126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102566031|NCT05053126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566032|NCT05053126|Anticonvulsants|anticonvulsants|mesh-ancestor
102566033|NCT05053126|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102566034|NCT05053126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102566035|NCT05053126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566036|NCT05053126|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102566037|NCT05053126|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102566038|NCT05053126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102566039|NCT05053126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102566040|NCT05053126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102566041|NCT05053126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102566042|NCT05053126|Narcotics|narcotics|mesh-ancestor
102566043|NCT05051449|Ketamine|ketamine|mesh-list
102566044|NCT05051449|Analgesics|analgesics|mesh-ancestor
102566045|NCT05051449|Sensory System Agents|sensory system agents|mesh-ancestor
102566046|NCT05051449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102566047|NCT05051449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566048|NCT05051449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102566049|NCT05051449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102566050|NCT05051449|Anesthetics, General|anesthetics, general|mesh-ancestor
102566051|NCT05051449|Anesthetics|anesthetics|mesh-ancestor
102566052|NCT05051449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102566053|NCT05051449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102566054|NCT05051449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102566055|NCT05051449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102566056|NCT05051449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566057|NCT05049616|Nifedipine|nifedipine|mesh-list
102566058|NCT05049616|Diuretics|diuretics|mesh-list
102566059|NCT05049616|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102566060|NCT05049616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102566061|NCT05049616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102566062|NCT05049616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566063|NCT05049616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102566064|NCT05049616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566065|NCT05049616|Vasodilator Agents|vasodilator agents|mesh-ancestor
102566066|NCT05049616|Tocolytic Agents|tocolytic agents|mesh-ancestor
102566067|NCT05049616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102566068|NCT05049616|Natriuretic Agents|natriuretic agents|mesh-ancestor
102566069|NCT05049616|Protease Inhibitors|protease inhibitors|mesh-ancestor
102566070|NCT05049616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102566071|NCT05049213|Povidone-Iodine|povidone-iodine|mesh-list
102154354|NCT03365115|Anesthetics, General|anesthetics, general|mesh-ancestor
102566072|NCT05049213|Povidone|povidone|mesh-list
102566073|NCT05049213|Plasma Substitutes|plasma substitutes|mesh-ancestor
102566074|NCT05049213|Blood Substitutes|blood substitutes|mesh-ancestor
102566075|NCT05049213|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102566076|NCT05049213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102566077|NCT05047250|Atezolizumab|atezolizumab|mesh-list
102566078|NCT05047250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102566079|NCT05047250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566080|NCT05047250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102566081|NCT05047250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566082|NCT05047172|Aspirin|aspirin|mesh-list
102566083|NCT05047172|Rivaroxaban|rivaroxaban|mesh-list
102566084|NCT05047172|Clopidogrel|clopidogrel|mesh-list
102566085|NCT05047172|Ticagrelor|ticagrelor|mesh-list
102566086|NCT05047172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102566087|NCT05047172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102566088|NCT05047172|Analgesics|analgesics|mesh-ancestor
102566089|NCT05047172|Sensory System Agents|sensory system agents|mesh-ancestor
102566090|NCT05047172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102566091|NCT05047172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566092|NCT05047172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102566093|NCT05047172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102566094|NCT05047172|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102566095|NCT05047172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102566096|NCT05047172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566097|NCT05047172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102566098|NCT05047172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102566099|NCT05047172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102566100|NCT05047172|Antipyretics|antipyretics|mesh-ancestor
102566101|NCT05047172|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102566102|NCT05047172|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102566103|NCT05047172|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102566104|NCT05047172|Purinergic Agents|purinergic agents|mesh-ancestor
102566105|NCT05047172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102566106|NCT05047172|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102566107|NCT05047172|Antithrombins|antithrombins|mesh-ancestor
102566108|NCT05047172|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102566109|NCT05047172|Protease Inhibitors|protease inhibitors|mesh-ancestor
102566110|NCT05047172|Anticoagulants|anticoagulants|mesh-ancestor
102566111|NCT05043090|Durvalumab|durvalumab|mesh-list
102566112|NCT05043090|Sunitinib|sunitinib|mesh-list
102566113|NCT05043090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102566114|NCT05043090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566115|NCT05043090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102566116|NCT05043090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102566117|NCT05043090|Growth Substances|growth substances|mesh-ancestor
102566118|NCT05043090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566119|NCT05043090|Growth Inhibitors|growth inhibitors|mesh-ancestor
102566120|NCT05043090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102566121|NCT05043090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102566122|NCT05043090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566123|NCT05036278|Factor VIII|factor viii|mesh-list
102566124|NCT05036278|Coagulants|coagulants|mesh-ancestor
102566125|NCT05032820|Lenalidomide|lenalidomide|mesh-list
102566126|NCT05032820|Immunologic Factors|immunologic factors|mesh-ancestor
102566127|NCT05032820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566128|NCT05032820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102566129|NCT05032820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102566130|NCT05032820|Growth Substances|growth substances|mesh-ancestor
102566131|NCT05032820|Growth Inhibitors|growth inhibitors|mesh-ancestor
102566132|NCT05032820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566133|NCT05030298|Temozolomide|temozolomide|mesh-list
102566134|NCT05030298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102566135|NCT05030298|Alkylating Agents|alkylating agents|mesh-ancestor
102566136|NCT05030298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566137|NCT05030298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566138|NCT05025605|Dexmedetomidine|dexmedetomidine|mesh-list
102566139|NCT05025605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102566140|NCT05025605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102566141|NCT05025605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566142|NCT05025605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102566143|NCT05025605|Analgesics|analgesics|mesh-ancestor
102566144|NCT05025605|Sensory System Agents|sensory system agents|mesh-ancestor
102566145|NCT05025605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102566146|NCT05025605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102566147|NCT05025605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102566148|NCT05025605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102566149|NCT05025605|Adrenergic Agents|adrenergic agents|mesh-ancestor
102566150|NCT05025605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101586002|NCT02647489|Antacids|antacids|mesh-ancestor
102566151|NCT05025605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566152|NCT05020600|Pregabalin|pregabalin|mesh-list
102566153|NCT05020600|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102566154|NCT05020600|Amitriptyline|amitriptyline|mesh-list
102566155|NCT05020600|Analgesics|analgesics|mesh-ancestor
102566156|NCT05020600|Sensory System Agents|sensory system agents|mesh-ancestor
102566157|NCT05020600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102566158|NCT05020600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566159|NCT05020600|Anticonvulsants|anticonvulsants|mesh-ancestor
102566160|NCT05020600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102566161|NCT05020600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102566162|NCT05020600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566163|NCT05020600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102566164|NCT05020600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102566165|NCT05020600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102566166|NCT05020600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102566167|NCT05020600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102566168|NCT05020600|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102566169|NCT05020600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102566170|NCT05020600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102566171|NCT05020600|Antidepressive Agents|antidepressive agents|mesh-ancestor
102566172|NCT05020600|Dopamine Agents|dopamine agents|mesh-ancestor
102566173|NCT05020600|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102566174|NCT05020600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102566175|NCT05020600|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102566176|NCT05020600|Adrenergic Agents|adrenergic agents|mesh-ancestor
102566177|NCT05011266|Buprenorphine|buprenorphine|mesh-list
102566178|NCT05011266|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102566179|NCT05011266|Naloxone|naloxone|mesh-list
102566180|NCT05011266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102566181|NCT05011266|Narcotics|narcotics|mesh-ancestor
102566182|NCT05011266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102566183|NCT05011266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566184|NCT05011266|Analgesics|analgesics|mesh-ancestor
102566185|NCT05011266|Sensory System Agents|sensory system agents|mesh-ancestor
102566186|NCT05011266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102566187|NCT05011266|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102566188|NCT05010434|Bevacizumab|bevacizumab|mesh-list
102566189|NCT05010434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102566190|NCT05010434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566191|NCT05010434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102566192|NCT05010434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102566193|NCT05010434|Growth Substances|growth substances|mesh-ancestor
102566194|NCT05010434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566195|NCT05010434|Growth Inhibitors|growth inhibitors|mesh-ancestor
102566196|NCT05001880|Bevacizumab|bevacizumab|mesh-list
102566197|NCT05001880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102566198|NCT05001880|Atezolizumab|atezolizumab|mesh-list
102566199|NCT05001880|Carboplatin|carboplatin|mesh-list
102566200|NCT05001880|Pemetrexed|pemetrexed|mesh-list
102566201|NCT05001880|Endothelial Growth Factors|endothelial growth factors|mesh-list
102566202|NCT05001880|Antibodies|antibodies|mesh-list
102566203|NCT05001880|Immunoglobulins|immunoglobulins|mesh-list
102566204|NCT05001880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102566205|NCT05001880|Immunoglobulin G|immunoglobulin g|mesh-list
102566206|NCT05001880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566207|NCT05001880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102566208|NCT05001880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102566209|NCT05001880|Growth Substances|growth substances|mesh-ancestor
102566210|NCT05001880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566211|NCT05001880|Growth Inhibitors|growth inhibitors|mesh-ancestor
102566212|NCT05001880|Immunologic Factors|immunologic factors|mesh-ancestor
102566213|NCT05001880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102566214|NCT05001880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566215|NCT05001880|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102566216|NCT05001880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102566217|NCT05001880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102566218|NCT05000450|Cyclophosphamide|cyclophosphamide|mesh-list
102566219|NCT05000450|Fludarabine|fludarabine|mesh-list
102566220|NCT05000450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102566221|NCT05000450|Immunologic Factors|immunologic factors|mesh-ancestor
102566222|NCT05000450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566224|NCT05000450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102566225|NCT05000450|Alkylating Agents|alkylating agents|mesh-ancestor
102566226|NCT05000450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566227|NCT05000450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566228|NCT05000450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102566229|NCT04999202|Pembrolizumab|pembrolizumab|mesh-list
102566230|NCT04999202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102566231|NCT04999202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566232|NCT04999202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102566233|NCT04999202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566234|NCT04998279|Lenograstim|lenograstim|mesh-list
102566235|NCT04998279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102566236|NCT04998279|Immunologic Factors|immunologic factors|mesh-ancestor
102566237|NCT04998279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566238|NCT04994808|Fludarabine|fludarabine|mesh-list
102566239|NCT04994808|Clofarabine|clofarabine|mesh-list
102566240|NCT04994808|Treosulfan|treosulfan|mesh-list
102566241|NCT04994808|Busulfan|busulfan|mesh-list
102566242|NCT04994808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566243|NCT04994808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102566244|NCT04994808|Antimetabolites|antimetabolites|mesh-ancestor
102566245|NCT04994808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566246|NCT04994808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102566247|NCT04994808|Immunologic Factors|immunologic factors|mesh-ancestor
102566248|NCT04994808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566249|NCT04994808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102566250|NCT04994808|Alkylating Agents|alkylating agents|mesh-ancestor
102566251|NCT04994808|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102566252|NCT04994509|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102566253|NCT04994509|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
102566254|NCT04994509|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102566255|NCT04994509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102566256|NCT04994509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102566257|NCT04994509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566258|NCT04994509|Antiviral Agents|antiviral agents|mesh-ancestor
102566259|NCT04994509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102566260|NCT04994509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102566261|NCT04994509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102566262|NCT04981509|Listerine|listerine|mesh-list
102566263|NCT04981509|Bevacizumab|bevacizumab|mesh-list
102566264|NCT04981509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102566265|NCT04981509|Atezolizumab|atezolizumab|mesh-list
102566266|NCT04981509|Endothelial Growth Factors|endothelial growth factors|mesh-list
102566267|NCT04981509|Antibodies|antibodies|mesh-list
102566268|NCT04981509|Immunoglobulins|immunoglobulins|mesh-list
102566269|NCT04981509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102566270|NCT04981509|Immunoglobulin G|immunoglobulin g|mesh-list
102566271|NCT04981509|Fluorides|fluorides|mesh-list
102566272|NCT04981509|Sodium Fluoride|sodium fluoride|mesh-list
102566273|NCT04981509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566274|NCT04981509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102566275|NCT04981509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102566276|NCT04981509|Growth Substances|growth substances|mesh-ancestor
102566277|NCT04981509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566278|NCT04981509|Growth Inhibitors|growth inhibitors|mesh-ancestor
102566279|NCT04981509|Immunologic Factors|immunologic factors|mesh-ancestor
102566280|NCT04981509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566281|NCT04981509|Cariostatic Agents|cariostatic agents|mesh-ancestor
102566282|NCT04981509|Protective Agents|protective agents|mesh-ancestor
102566283|NCT04981509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102566284|NCT04981509|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102566285|NCT04981509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102566286|NCT04973930|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102566287|NCT04973930|Escitalopram|escitalopram|mesh-list
102566288|NCT04973930|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102566289|NCT04973930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102566290|NCT04973930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102566291|NCT04973930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566292|NCT04973930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102566293|NCT04973930|Serotonin Agents|serotonin agents|mesh-ancestor
102154355|NCT03365115|Anesthetics|anesthetics|mesh-ancestor
102566294|NCT04973930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566295|NCT04973930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102566297|NCT04973930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102566298|NCT04973930|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102566299|NCT04965077|Antibodies|antibodies|mesh-list
102566300|NCT04965077|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102566301|NCT04965077|Immunologic Factors|immunologic factors|mesh-ancestor
102566302|NCT04965077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566303|NCT04964960|Paclitaxel|paclitaxel|mesh-list
102566304|NCT04964960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102566305|NCT04964960|Carboplatin|carboplatin|mesh-list
102566306|NCT04964960|Pembrolizumab|pembrolizumab|mesh-list
102566307|NCT04964960|Pemetrexed|pemetrexed|mesh-list
102566308|NCT04964960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102566309|NCT04964960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566310|NCT04964960|Tubulin Modulators|tubulin modulators|mesh-ancestor
102566311|NCT04964960|Antimitotic Agents|antimitotic agents|mesh-ancestor
102566312|NCT04964960|Mitosis Modulators|mitosis modulators|mesh-ancestor
102566313|NCT04964960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566314|NCT04964960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102566315|NCT04964960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102566316|NCT04964960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102566317|NCT04964960|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102566318|NCT04964960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102566319|NCT04962126|Atezolizumab|atezolizumab|mesh-list
102566320|NCT04962126|Obinutuzumab|obinutuzumab|mesh-list
102566321|NCT04962126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102566322|NCT04962126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102566323|NCT04962126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566324|NCT04962126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102566325|NCT04962126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566326|NCT04956120|Dialysis Solutions|dialysis solutions|mesh-list
102566327|NCT04956120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102566328|NCT04953962|Nivolumab|nivolumab|mesh-list
102566329|NCT04953962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566330|NCT04953962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102566331|NCT04953962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102566332|NCT04953962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566333|NCT04952753|Leucovorin|leucovorin|mesh-list
102566334|NCT04952753|Bevacizumab|bevacizumab|mesh-list
102566335|NCT04952753|Tislelizumab|tislelizumab|mesh-list
102566336|NCT04952753|Oxaliplatin|oxaliplatin|mesh-list
102566337|NCT04952753|Irinotecan|irinotecan|mesh-list
102566338|NCT04952753|Levoleucovorin|levoleucovorin|mesh-list
102566339|NCT04952753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102566340|NCT04952753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566341|NCT04952753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102566342|NCT04952753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102566343|NCT04952753|Growth Substances|growth substances|mesh-ancestor
102566344|NCT04952753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566345|NCT04952753|Growth Inhibitors|growth inhibitors|mesh-ancestor
102566346|NCT04952753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102566347|NCT04952753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102566348|NCT04952753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102566349|NCT04952753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566350|NCT04952753|Antidotes|antidotes|mesh-ancestor
102566351|NCT04952753|Protective Agents|protective agents|mesh-ancestor
102566352|NCT04952753|Vitamin B Complex|vitamin b complex|mesh-ancestor
102566353|NCT04952753|Vitamins|vitamins|mesh-ancestor
102566354|NCT04952753|Micronutrients|micronutrients|mesh-ancestor
102566355|NCT04939480|Atezolizumab|atezolizumab|mesh-list
102566356|NCT04939480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102566357|NCT04939480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566358|NCT04939480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102566359|NCT04939480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566360|NCT04933617|Prednisone|prednisone|mesh-list
102566361|NCT04933617|Cyclophosphamide|cyclophosphamide|mesh-list
102566362|NCT04933617|Rituximab|rituximab|mesh-list
102566363|NCT04933617|Doxorubicin|doxorubicin|mesh-list
102566364|NCT04933617|Etoposide|etoposide|mesh-list
102566365|NCT04933617|Vincristine|vincristine|mesh-list
102566366|NCT04933617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102566367|NCT04933617|Immunologic Factors|immunologic factors|mesh-ancestor
102566368|NCT04933617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566369|NCT04933617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102566370|NCT04933617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102566371|NCT04933617|Alkylating Agents|alkylating agents|mesh-ancestor
102566372|NCT04933617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566373|NCT04933617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566374|NCT04933617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102566375|NCT04933617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102566376|NCT04933617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102566377|NCT04933617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102566378|NCT04933617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102566379|NCT04933617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102566380|NCT04933617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102566381|NCT04933617|Glucocorticoids|glucocorticoids|mesh-ancestor
102566382|NCT04933617|Hormones|hormones|mesh-ancestor
102566383|NCT04933617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102566384|NCT04933617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102566385|NCT04933617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102566386|NCT04933617|Tubulin Modulators|tubulin modulators|mesh-ancestor
102566387|NCT04933617|Antimitotic Agents|antimitotic agents|mesh-ancestor
102566388|NCT04933617|Mitosis Modulators|mitosis modulators|mesh-ancestor
102566389|NCT04932434|Psilocybin|psilocybin|mesh-list
102566390|NCT04932434|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
102566391|NCT04932434|Hallucinogens|hallucinogens|mesh-ancestor
102566392|NCT04932434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566393|NCT04932434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102566394|NCT04932434|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102566395|NCT04932434|Serotonin Agents|serotonin agents|mesh-ancestor
102566396|NCT04932434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102566397|NCT04932434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566398|NCT04932434|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102566399|NCT04931342|Maytansine|maytansine|mesh-list
102566400|NCT04931342|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102566401|NCT04931342|Cyclophosphamide|cyclophosphamide|mesh-list
102566402|NCT04931342|Bevacizumab|bevacizumab|mesh-list
102566403|NCT04931342|Trastuzumab|trastuzumab|mesh-list
102566404|NCT04931342|Atezolizumab|atezolizumab|mesh-list
102566405|NCT04931342|Letrozole|letrozole|mesh-list
102566406|NCT04931342|Olaparib|olaparib|mesh-list
102566407|NCT04931342|Palbociclib|palbociclib|mesh-list
102566408|NCT04931342|Ipatasertib|ipatasertib|mesh-list
102566409|NCT04931342|Hormones|hormones|mesh-list
102566410|NCT04931342|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
102566411|NCT04931342|Inavolisib|inavolisib|mesh-list
102566412|NCT04931342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102566413|NCT04931342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566414|NCT04931342|Tubulin Modulators|tubulin modulators|mesh-ancestor
102566415|NCT04931342|Antimitotic Agents|antimitotic agents|mesh-ancestor
102566416|NCT04931342|Mitosis Modulators|mitosis modulators|mesh-ancestor
102566417|NCT04931342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566418|NCT04931342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102566419|NCT04931342|Immunologic Factors|immunologic factors|mesh-ancestor
102566420|NCT04931342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566421|NCT04931342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102566422|NCT04931342|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102566423|NCT04931342|Alkylating Agents|alkylating agents|mesh-ancestor
102566424|NCT04931342|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102566425|NCT04931342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102566426|NCT04931342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102566427|NCT04931342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102566428|NCT04931342|Growth Substances|growth substances|mesh-ancestor
102566429|NCT04931342|Growth Inhibitors|growth inhibitors|mesh-ancestor
102566430|NCT04931342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102566431|NCT04931342|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102566432|NCT04931342|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102566433|NCT04931342|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102566434|NCT04931342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102566435|NCT04931342|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102566436|NCT04931342|Hormone Antagonists|hormone antagonists|mesh-ancestor
102566437|NCT04931342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102566438|NCT04931342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102566439|NCT04931342|Immunotoxins|immunotoxins|mesh-ancestor
102566440|NCT04931342|Immunoconjugates|immunoconjugates|mesh-ancestor
102566441|NCT04931342|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
102566442|NCT04927780|Leucovorin|leucovorin|mesh-list
102566443|NCT04927780|Fluorouracil|fluorouracil|mesh-list
102566444|NCT04927780|Oxaliplatin|oxaliplatin|mesh-list
102566445|NCT04927780|Irinotecan|irinotecan|mesh-list
102566446|NCT04927780|Calcium|calcium|mesh-list
102566447|NCT04927780|Levoleucovorin|levoleucovorin|mesh-list
102566448|NCT04927780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102566449|NCT04927780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566450|NCT04927780|Antimetabolites|antimetabolites|mesh-ancestor
102566451|NCT04927780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566452|NCT04927780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102566453|NCT04927780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566454|NCT04927780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102566455|NCT04927780|Immunologic Factors|immunologic factors|mesh-ancestor
102566456|NCT04927780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102566457|NCT04927780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102566458|NCT04927780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102566459|NCT04927780|Antidotes|antidotes|mesh-ancestor
102566460|NCT04927780|Protective Agents|protective agents|mesh-ancestor
102566461|NCT04927780|Vitamin B Complex|vitamin b complex|mesh-ancestor
102566462|NCT04927780|Vitamins|vitamins|mesh-ancestor
102566463|NCT04927780|Micronutrients|micronutrients|mesh-ancestor
102566464|NCT04925752|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102566465|NCT04925752|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102566466|NCT04925752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102566467|NCT04925752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102566468|NCT04925752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566469|NCT04925752|Antiviral Agents|antiviral agents|mesh-ancestor
102566470|NCT04925752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102566471|NCT04925752|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102566472|NCT04925752|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102566473|NCT04925557|Ocrelizumab|ocrelizumab|mesh-list
102566474|NCT04925557|Immunologic Factors|immunologic factors|mesh-ancestor
102566475|NCT04925557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566476|NCT04924660|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
102566477|NCT04924660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102566478|NCT04924660|Vasodilator Agents|vasodilator agents|mesh-ancestor
102566479|NCT04921358|Docetaxel|docetaxel|mesh-list
102566480|NCT04921358|Tislelizumab|tislelizumab|mesh-list
102566481|NCT04921358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566482|NCT04921358|Tubulin Modulators|tubulin modulators|mesh-ancestor
102566483|NCT04921358|Antimitotic Agents|antimitotic agents|mesh-ancestor
102566484|NCT04921358|Mitosis Modulators|mitosis modulators|mesh-ancestor
102566485|NCT04921358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566486|NCT04921358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102566487|NCT04919226|Leucovorin|leucovorin|mesh-list
102566488|NCT04919226|Folic Acid|folic acid|mesh-list
102566489|NCT04919226|Fluorouracil|fluorouracil|mesh-list
102566490|NCT04919226|Capecitabine|capecitabine|mesh-list
102566491|NCT04919226|Oxaliplatin|oxaliplatin|mesh-list
102566492|NCT04919226|Everolimus|everolimus|mesh-list
102566493|NCT04919226|Temozolomide|temozolomide|mesh-list
102566494|NCT04919226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102566495|NCT04919226|Levoleucovorin|levoleucovorin|mesh-list
102566496|NCT04919226|Edotreotide|edotreotide|mesh-list
102566497|NCT04919226|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
102566498|NCT04919226|Antimetabolites|antimetabolites|mesh-ancestor
102566499|NCT04919226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566500|NCT04919226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102566501|NCT04919226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566502|NCT04919226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102566503|NCT04919226|Immunologic Factors|immunologic factors|mesh-ancestor
102566504|NCT04919226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566505|NCT04919226|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102566506|NCT04919226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102566507|NCT04919226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102566508|NCT04919226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102566509|NCT04919226|Alkylating Agents|alkylating agents|mesh-ancestor
102566510|NCT04919226|Antidotes|antidotes|mesh-ancestor
102566511|NCT04919226|Protective Agents|protective agents|mesh-ancestor
102566512|NCT04919226|Vitamin B Complex|vitamin b complex|mesh-ancestor
102566513|NCT04919226|Vitamins|vitamins|mesh-ancestor
102566514|NCT04919226|Micronutrients|micronutrients|mesh-ancestor
102566515|NCT04919226|Hematinics|hematinics|mesh-ancestor
102566516|NCT04919226|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102566517|NCT04895761|Cyclophosphamide|cyclophosphamide|mesh-list
102566518|NCT04895761|Letrozole|letrozole|mesh-list
102566519|NCT04895761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102566520|NCT04895761|Immunologic Factors|immunologic factors|mesh-ancestor
102566521|NCT04895761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566522|NCT04895761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102566523|NCT04895761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102566524|NCT04895761|Alkylating Agents|alkylating agents|mesh-ancestor
102566525|NCT04895761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566526|NCT04895761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566527|NCT04895761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102566528|NCT04895761|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102566529|NCT04895761|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102566530|NCT04895761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102566531|NCT04895761|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102566532|NCT04895761|Hormone Antagonists|hormone antagonists|mesh-ancestor
102566533|NCT04895761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102566534|NCT04892264|Dexamethasone|dexamethasone|mesh-list
102566535|NCT04892264|Dexamethasone acetate|dexamethasone acetate|mesh-list
102566536|NCT04892264|Lenalidomide|lenalidomide|mesh-list
102566537|NCT04892264|Daratumumab|daratumumab|mesh-list
102566538|NCT04892264|Ichthammol|ichthammol|mesh-list
102566539|NCT04892264|BB 1101|bb 1101|mesh-list
102566540|NCT04892264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102566541|NCT04892264|Antiemetics|antiemetics|mesh-ancestor
102566542|NCT04892264|Autonomic Agents|autonomic agents|mesh-ancestor
102566543|NCT04892264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102566544|NCT04892264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566545|NCT04892264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102566546|NCT04892264|Glucocorticoids|glucocorticoids|mesh-ancestor
102566547|NCT04892264|Hormones|hormones|mesh-ancestor
102566548|NCT04892264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102566549|NCT04892264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102566550|NCT04892264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566551|NCT04892264|Protease Inhibitors|protease inhibitors|mesh-ancestor
102566552|NCT04892264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102566553|NCT04892264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566554|NCT04892264|Immunologic Factors|immunologic factors|mesh-ancestor
102566555|NCT04892264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102566556|NCT04892264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102566557|NCT04892264|Growth Substances|growth substances|mesh-ancestor
102566558|NCT04892264|Growth Inhibitors|growth inhibitors|mesh-ancestor
102566559|NCT04892264|Dermatologic Agents|dermatologic agents|mesh-ancestor
102566560|NCT04880863|Docetaxel|docetaxel|mesh-list
102566561|NCT04880863|Obinutuzumab|obinutuzumab|mesh-list
102566562|NCT04880863|Naptumomab estafenatox|naptumomab estafenatox|mesh-list
102566563|NCT04880863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566564|NCT04880863|Tubulin Modulators|tubulin modulators|mesh-ancestor
102566565|NCT04880863|Antimitotic Agents|antimitotic agents|mesh-ancestor
102566566|NCT04880863|Mitosis Modulators|mitosis modulators|mesh-ancestor
102566567|NCT04880863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566568|NCT04880863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102566569|NCT04880863|Immunoconjugates|immunoconjugates|mesh-ancestor
102566570|NCT04880863|Immunologic Factors|immunologic factors|mesh-ancestor
102566571|NCT04880863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566572|NCT04879329|Pembrolizumab|pembrolizumab|mesh-list
102566573|NCT04879329|Disitamab vedotin|disitamab vedotin|mesh-list
102566574|NCT04879329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102566575|NCT04879329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566576|NCT04879329|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102566577|NCT04879329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566578|NCT04879329|Immunoconjugates|immunoconjugates|mesh-ancestor
102566579|NCT04879329|Immunologic Factors|immunologic factors|mesh-ancestor
102566580|NCT04879329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566581|NCT04878029|Immunoconjugates|immunoconjugates|mesh-list
102566582|NCT04878029|Immunologic Factors|immunologic factors|mesh-ancestor
102566583|NCT04878029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566584|NCT04875975|Rozanolixizumab|rozanolixizumab|mesh-list
102566585|NCT04875975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102566586|NCT04875975|Immunologic Factors|immunologic factors|mesh-ancestor
101586435|NCT00910000|Antimetabolites|antimetabolites|mesh-ancestor
102566587|NCT04875975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102566588|NCT04871529|Carboplatin|carboplatin|mesh-list
102566589|NCT04871529|Gemcitabine|gemcitabine|mesh-list
102566590|NCT04871529|Avelumab|avelumab|mesh-list
102566591|NCT04871529|Immunoglobulins|immunoglobulins|mesh-list
102566592|NCT04871529|Immunoglobulin G|immunoglobulin g|mesh-list
102566593|NCT04871529|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102566594|NCT04871529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102566595|NCT04871529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102566596|NCT04871529|Antimetabolites|antimetabolites|mesh-ancestor
102566597|NCT04871529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102566598|NCT04871529|Immunologic Factors|immunologic factors|mesh-ancestor
102566599|NCT04871529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902699|NCT05177926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102614303|NCT00001259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614305|NCT00003143|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102614306|NCT00003143|Protective Agents|protective agents|mesh-ancestor
102614307|NCT00003143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614308|NCT00003431|Flt3 ligand protein|flt3 ligand protein|mesh-list
102614309|NCT00003431|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102614310|NCT00003431|Immunologic Factors|immunologic factors|mesh-ancestor
102614311|NCT00003431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614312|NCT00003431|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102614313|NCT00003431|Protective Agents|protective agents|mesh-ancestor
102614314|NCT00003149|Interleukin-12|interleukin-12|mesh-list
102614315|NCT00003149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102614316|NCT00003149|Immunologic Factors|immunologic factors|mesh-ancestor
102614317|NCT00003149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614318|NCT00003149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102614319|NCT00003149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102614320|NCT00003149|Growth Substances|growth substances|mesh-ancestor
102614321|NCT00003149|Growth Inhibitors|growth inhibitors|mesh-ancestor
102614322|NCT00003149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614323|NCT00003437|Cytarabine|cytarabine|mesh-list
102614324|NCT00003437|Dexamethasone|dexamethasone|mesh-list
102614325|NCT00003437|Prednisolone|prednisolone|mesh-list
102614326|NCT00003437|Cyclophosphamide|cyclophosphamide|mesh-list
102614327|NCT00003437|Doxorubicin|doxorubicin|mesh-list
102614328|NCT00003437|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102614329|NCT00003437|Methotrexate|methotrexate|mesh-list
102614330|NCT00003437|Vincristine|vincristine|mesh-list
102614331|NCT00003437|Daunorubicin|daunorubicin|mesh-list
102614332|NCT00003437|Asparaginase|asparaginase|mesh-list
102614333|NCT00003437|Mercaptopurine|mercaptopurine|mesh-list
102614334|NCT00003437|Pegaspargase|pegaspargase|mesh-list
102614335|NCT00003437|Thioguanine|thioguanine|mesh-list
102614336|NCT00003437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102614337|NCT00003437|Immunologic Factors|immunologic factors|mesh-ancestor
102614338|NCT00003437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614339|NCT00003437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102614340|NCT00003437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102614341|NCT00003437|Alkylating Agents|alkylating agents|mesh-ancestor
102614342|NCT00003437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614343|NCT00003437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614344|NCT00003437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102614345|NCT00003437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102614346|NCT00003437|Antiemetics|antiemetics|mesh-ancestor
102614347|NCT00003437|Autonomic Agents|autonomic agents|mesh-ancestor
102614348|NCT00003437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102614349|NCT00003437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102614350|NCT00003437|Glucocorticoids|glucocorticoids|mesh-ancestor
102614351|NCT00003437|Hormones|hormones|mesh-ancestor
101586511|NCT02639143|Clopidogrel|clopidogrel|mesh-list
102614352|NCT00003437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102614353|NCT00003437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102614354|NCT00003437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102614355|NCT00003437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102614356|NCT00003437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102614357|NCT00003437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102614358|NCT00003437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102614359|NCT00003437|Abortifacient Agents|abortifacient agents|mesh-ancestor
102614360|NCT00003437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102614361|NCT00003437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102614362|NCT00003437|Antimetabolites|antimetabolites|mesh-ancestor
102614363|NCT00003437|Dermatologic Agents|dermatologic agents|mesh-ancestor
102614364|NCT00003437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102614365|NCT00003437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102614366|NCT00003437|Antiviral Agents|antiviral agents|mesh-ancestor
102614367|NCT00003437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102614368|NCT00003437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102614369|NCT00003437|Tubulin Modulators|tubulin modulators|mesh-ancestor
102614370|NCT00003437|Antimitotic Agents|antimitotic agents|mesh-ancestor
102614371|NCT00003437|Mitosis Modulators|mitosis modulators|mesh-ancestor
102614372|NCT00003443|Bryostatin 1|bryostatin 1|mesh-list
102614373|NCT00003443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102614374|NCT00003443|Immunologic Factors|immunologic factors|mesh-ancestor
102614375|NCT00003443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614376|NCT00003443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614377|NCT00003449|Dexamethasone|dexamethasone|mesh-list
102614378|NCT00003449|Paclitaxel|paclitaxel|mesh-list
102614379|NCT00003449|Gemcitabine|gemcitabine|mesh-list
102274839|NCT01454934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102614380|NCT00003449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102614381|NCT00003449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614382|NCT00003449|Tubulin Modulators|tubulin modulators|mesh-ancestor
102614383|NCT00003449|Antimitotic Agents|antimitotic agents|mesh-ancestor
102614384|NCT00003449|Mitosis Modulators|mitosis modulators|mesh-ancestor
102614385|NCT00003449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614386|NCT00003449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102614387|NCT00003449|Antiemetics|antiemetics|mesh-ancestor
102614388|NCT00003449|Autonomic Agents|autonomic agents|mesh-ancestor
102614389|NCT00003449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102614390|NCT00003449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614391|NCT00003449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102614392|NCT00003449|Glucocorticoids|glucocorticoids|mesh-ancestor
102614393|NCT00003449|Hormones|hormones|mesh-ancestor
102614394|NCT00003449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102614395|NCT00003449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102614396|NCT00003449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102614397|NCT00003449|Antimetabolites|antimetabolites|mesh-ancestor
102614398|NCT00002801|Leucovorin|leucovorin|mesh-list
102614399|NCT00002801|Tegafur|tegafur|mesh-list
102614400|NCT00002801|Calcium|calcium|mesh-list
102614401|NCT00002801|Levoleucovorin|levoleucovorin|mesh-list
102614402|NCT00002801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102614403|NCT00002801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614404|NCT00002801|Antidotes|antidotes|mesh-ancestor
102614405|NCT00002801|Protective Agents|protective agents|mesh-ancestor
102614406|NCT00002801|Vitamin B Complex|vitamin b complex|mesh-ancestor
102614407|NCT00002801|Vitamins|vitamins|mesh-ancestor
102614408|NCT00002801|Micronutrients|micronutrients|mesh-ancestor
102614409|NCT00002801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102614410|NCT00002801|Antimetabolites|antimetabolites|mesh-ancestor
102614411|NCT00002801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614412|NCT00002801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614413|NCT00002813|Vinorelbine|vinorelbine|mesh-list
102614414|NCT00002813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614415|NCT00002813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102614416|NCT00002813|Tubulin Modulators|tubulin modulators|mesh-ancestor
102614417|NCT00002813|Antimitotic Agents|antimitotic agents|mesh-ancestor
102614418|NCT00002813|Mitosis Modulators|mitosis modulators|mesh-ancestor
102614419|NCT00002813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614420|NCT00002819|Paclitaxel|paclitaxel|mesh-list
102614421|NCT00002819|Cyclophosphamide|cyclophosphamide|mesh-list
102614422|NCT00002819|Carboplatin|carboplatin|mesh-list
102614423|NCT00002819|Mitoxantrone|mitoxantrone|mesh-list
102614424|NCT00002819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102614425|NCT00002819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614426|NCT00002819|Tubulin Modulators|tubulin modulators|mesh-ancestor
102614427|NCT00002819|Antimitotic Agents|antimitotic agents|mesh-ancestor
102614428|NCT00002819|Mitosis Modulators|mitosis modulators|mesh-ancestor
102614429|NCT00002819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614430|NCT00002819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102614431|NCT00002819|Immunologic Factors|immunologic factors|mesh-ancestor
102614432|NCT00002819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614433|NCT00002819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102614434|NCT00002819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102614435|NCT00002819|Alkylating Agents|alkylating agents|mesh-ancestor
102614436|NCT00002819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102614437|NCT00002819|Analgesics|analgesics|mesh-ancestor
102614438|NCT00002819|Sensory System Agents|sensory system agents|mesh-ancestor
102614439|NCT00002819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102614440|NCT00002819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102614441|NCT00002819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102614442|NCT00002819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102614443|NCT00002825|Docetaxel|docetaxel|mesh-list
102614444|NCT00002825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614445|NCT00002825|Tubulin Modulators|tubulin modulators|mesh-ancestor
102614446|NCT00002825|Antimitotic Agents|antimitotic agents|mesh-ancestor
102614447|NCT00002825|Mitosis Modulators|mitosis modulators|mesh-ancestor
102614448|NCT00002825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614449|NCT00002831|Cyclosporine|cyclosporine|mesh-list
102614450|NCT00002831|Methylprednisolone|methylprednisolone|mesh-list
102614451|NCT00002831|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102614452|NCT00002831|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102614453|NCT00002831|Prednisolone|prednisolone|mesh-list
102614454|NCT00002831|Prednisolone acetate|prednisolone acetate|mesh-list
102274840|NCT01442246|Leuprolide|leuprolide|mesh-list
102614455|NCT00002831|Cyclophosphamide|cyclophosphamide|mesh-list
102614456|NCT00002831|Busulfan|busulfan|mesh-list
102614457|NCT00002831|Methotrexate|methotrexate|mesh-list
102614458|NCT00002831|Decitabine|decitabine|mesh-list
102614459|NCT00002831|Tacrolimus|tacrolimus|mesh-list
102614460|NCT00002831|Cyclosporins|cyclosporins|mesh-list
102614461|NCT00002831|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102614462|NCT00002831|Prednisolone phosphate|prednisolone phosphate|mesh-list
102614463|NCT00002831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102614464|NCT00002831|Immunologic Factors|immunologic factors|mesh-ancestor
102614465|NCT00002831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614466|NCT00002831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102614467|NCT00002831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102614468|NCT00002831|Alkylating Agents|alkylating agents|mesh-ancestor
102614469|NCT00002831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614470|NCT00002831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614471|NCT00002831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102614472|NCT00002831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102614473|NCT00002831|Abortifacient Agents|abortifacient agents|mesh-ancestor
102614474|NCT00002831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102614475|NCT00002831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102614476|NCT00002831|Antimetabolites|antimetabolites|mesh-ancestor
102614477|NCT00002831|Dermatologic Agents|dermatologic agents|mesh-ancestor
102614478|NCT00002831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102614479|NCT00002831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102614480|NCT00002831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102614481|NCT00002831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102614482|NCT00002831|Antifungal Agents|antifungal agents|mesh-ancestor
102614483|NCT00002831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102614484|NCT00002831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102614485|NCT00002831|Antiemetics|antiemetics|mesh-ancestor
102614486|NCT00002831|Autonomic Agents|autonomic agents|mesh-ancestor
102614487|NCT00002831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102614488|NCT00002831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102614489|NCT00002831|Glucocorticoids|glucocorticoids|mesh-ancestor
102614490|NCT00002831|Hormones|hormones|mesh-ancestor
102614491|NCT00002831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102614492|NCT00002831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102614493|NCT00002831|Protective Agents|protective agents|mesh-ancestor
102614494|NCT00002831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102614495|NCT00002837|Paclitaxel|paclitaxel|mesh-list
102614496|NCT00002837|Cyclophosphamide|cyclophosphamide|mesh-list
102614497|NCT00002837|Doxorubicin|doxorubicin|mesh-list
102614498|NCT00002837|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102614499|NCT00002837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102614500|NCT00002837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614501|NCT00002837|Tubulin Modulators|tubulin modulators|mesh-ancestor
102614502|NCT00002837|Antimitotic Agents|antimitotic agents|mesh-ancestor
102614503|NCT00002837|Mitosis Modulators|mitosis modulators|mesh-ancestor
102614504|NCT00002837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614505|NCT00002837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102614506|NCT00002837|Immunologic Factors|immunologic factors|mesh-ancestor
102614507|NCT00002837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614508|NCT00002837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102614509|NCT00002837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102614510|NCT00002837|Alkylating Agents|alkylating agents|mesh-ancestor
102614511|NCT00002837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102614512|NCT00002837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102614513|NCT00002837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102614514|NCT00002837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102614515|NCT00002837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102614516|NCT00003461|Antibodies|antibodies|mesh-list
102614517|NCT00003461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102614518|NCT00003461|Immunologic Factors|immunologic factors|mesh-ancestor
102614519|NCT00003461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614520|NCT00003467|Carmustine|carmustine|mesh-list
102614521|NCT00003467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102614522|NCT00003467|Alkylating Agents|alkylating agents|mesh-ancestor
102614523|NCT00003467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614524|NCT00003467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614525|NCT00002849|Interferons|interferons|mesh-list
102614526|NCT00002849|Interferon-alpha|interferon-alpha|mesh-list
102614527|NCT00002849|Dexamethasone|dexamethasone|mesh-list
102274841|NCT01442246|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102614528|NCT00002849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102614529|NCT00002849|Antiemetics|antiemetics|mesh-ancestor
102614530|NCT00002849|Autonomic Agents|autonomic agents|mesh-ancestor
102614531|NCT00002849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102614532|NCT00002849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614533|NCT00002849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102614534|NCT00002849|Glucocorticoids|glucocorticoids|mesh-ancestor
102614535|NCT00002849|Hormones|hormones|mesh-ancestor
102614536|NCT00002849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102614537|NCT00002849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102614538|NCT00002849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614539|NCT00002849|Antiviral Agents|antiviral agents|mesh-ancestor
102614540|NCT00002849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102614541|NCT00002849|Immunologic Factors|immunologic factors|mesh-ancestor
102614542|NCT00002855|Ketoconazole|ketoconazole|mesh-list
102614543|NCT00002855|Hydrocortisone|hydrocortisone|mesh-list
102614544|NCT00002855|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102614545|NCT00002855|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102614546|NCT00002855|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102614547|NCT00002855|Doxorubicin|doxorubicin|mesh-list
102614548|NCT00002855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102614549|NCT00002855|Bicalutamide|bicalutamide|mesh-list
102614550|NCT00002855|Vinblastine|vinblastine|mesh-list
102614551|NCT00002855|Flutamide|flutamide|mesh-list
102614552|NCT00002855|Estramustine|estramustine|mesh-list
102614553|NCT00002855|Nilutamide|nilutamide|mesh-list
102614554|NCT00002855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102614555|NCT00002855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614556|NCT00002855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102614557|NCT00002855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102614558|NCT00002855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102614559|NCT00002855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614560|NCT00002855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102614561|NCT00002855|Antifungal Agents|antifungal agents|mesh-ancestor
102614562|NCT00002855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102614563|NCT00002855|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102614564|NCT00002855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102614565|NCT00002855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102614566|NCT00002855|Hormone Antagonists|hormone antagonists|mesh-ancestor
102614567|NCT00002855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102614568|NCT00002855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614569|NCT00002855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102614570|NCT00002855|Androgen Antagonists|androgen antagonists|mesh-ancestor
102614571|NCT00002855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102614572|NCT00002855|Tubulin Modulators|tubulin modulators|mesh-ancestor
102614573|NCT00002855|Antimitotic Agents|antimitotic agents|mesh-ancestor
102614574|NCT00002855|Mitosis Modulators|mitosis modulators|mesh-ancestor
102614575|NCT00002855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102614576|NCT00002855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102614577|NCT00002855|Alkylating Agents|alkylating agents|mesh-ancestor
102614578|NCT00003173|Thiotepa|thiotepa|mesh-list
102614579|NCT00003173|Immunologic Factors|immunologic factors|mesh-ancestor
102614580|NCT00003173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614581|NCT00003173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102614582|NCT00003173|Alkylating Agents|alkylating agents|mesh-ancestor
102614583|NCT00003173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614584|NCT00003173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614585|NCT00003173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102614586|NCT00003173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102614587|NCT00003179|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102614588|NCT00003179|Medroxyprogesterone|medroxyprogesterone|mesh-list
102614589|NCT00003179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102614590|NCT00003179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102614591|NCT00003179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102614592|NCT00003179|Contraceptive Agents|contraceptive agents|mesh-ancestor
102614593|NCT00003179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102614594|NCT00003179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614595|NCT00003179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102614596|NCT00003179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102614597|NCT00003179|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102614598|NCT00003179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102614599|NCT00003179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614600|NCT00002879|Cladribine|cladribine|mesh-list
102614601|NCT00002879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614602|NCT00002879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102614603|NCT00002879|Immunologic Factors|immunologic factors|mesh-ancestor
102614604|NCT00002879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614605|NCT00003185|Cyclophosphamide|cyclophosphamide|mesh-list
102614606|NCT00003185|Sargramostim|sargramostim|mesh-list
102614607|NCT00003185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102614608|NCT00003185|Immunologic Factors|immunologic factors|mesh-ancestor
102614609|NCT00003185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614610|NCT00003185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102614611|NCT00003185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102614612|NCT00003185|Alkylating Agents|alkylating agents|mesh-ancestor
102614613|NCT00003185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614614|NCT00003185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614615|NCT00003185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102614616|NCT00003557|Dolastatin 10|dolastatin 10|mesh-list
102614617|NCT00003557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614618|NCT00003557|Tubulin Modulators|tubulin modulators|mesh-ancestor
102614619|NCT00003557|Antimitotic Agents|antimitotic agents|mesh-ancestor
102614620|NCT00003557|Mitosis Modulators|mitosis modulators|mesh-ancestor
102614621|NCT00003557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614622|NCT00003935|Etoposide|etoposide|mesh-list
102614623|NCT00003935|Vincristine|vincristine|mesh-list
102614624|NCT00003935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102614625|NCT00003935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614626|NCT00003935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102614627|NCT00003935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102614628|NCT00003935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102614629|NCT00003935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614630|NCT00003935|Tubulin Modulators|tubulin modulators|mesh-ancestor
102614631|NCT00003935|Antimitotic Agents|antimitotic agents|mesh-ancestor
102614632|NCT00003935|Mitosis Modulators|mitosis modulators|mesh-ancestor
102614633|NCT00003191|Fenretinide|fenretinide|mesh-list
102614634|NCT00003191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614635|NCT00003191|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102614636|NCT00003191|Protective Agents|protective agents|mesh-ancestor
102614637|NCT00003191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614638|NCT00003941|Etoposide|etoposide|mesh-list
102614639|NCT00003941|Ifosfamide|ifosfamide|mesh-list
102614640|NCT00003941|Bleomycin|bleomycin|mesh-list
102614641|NCT00003941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614642|NCT00003941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102614643|NCT00003941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102614644|NCT00003941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102614645|NCT00003941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102614646|NCT00003941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614647|NCT00003941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102614648|NCT00003941|Alkylating Agents|alkylating agents|mesh-ancestor
102614649|NCT00003941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102614650|NCT00384527|Vancomycin|vancomycin|mesh-list
102614651|NCT00384527|Nitazoxanide|nitazoxanide|mesh-list
102614652|NCT00384527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102614653|NCT00384527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102614654|NCT00384527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102614655|NCT00003569|Paclitaxel|paclitaxel|mesh-list
102614656|NCT00003569|Cisplatin|cisplatin|mesh-list
102614657|NCT00003569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102614658|NCT00003569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614659|NCT00003569|Tubulin Modulators|tubulin modulators|mesh-ancestor
102614660|NCT00003569|Antimitotic Agents|antimitotic agents|mesh-ancestor
102614661|NCT00003569|Mitosis Modulators|mitosis modulators|mesh-ancestor
102614662|NCT00003569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614663|NCT00003953|Tamoxifen|tamoxifen|mesh-list
102614664|NCT00003953|Cyclophosphamide|cyclophosphamide|mesh-list
102614665|NCT00003953|Docetaxel|docetaxel|mesh-list
102614666|NCT00003953|Doxorubicin|doxorubicin|mesh-list
102614667|NCT00003953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102614668|NCT00003953|Fluorouracil|fluorouracil|mesh-list
102614669|NCT00003953|Methotrexate|methotrexate|mesh-list
102614670|NCT00003953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102614671|NCT00003953|Immunologic Factors|immunologic factors|mesh-ancestor
102614672|NCT00003953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614673|NCT00003953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102614674|NCT00003953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102614675|NCT00003953|Alkylating Agents|alkylating agents|mesh-ancestor
102614676|NCT00003953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614677|NCT00003953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614678|NCT00003953|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102614679|NCT00003953|Tubulin Modulators|tubulin modulators|mesh-ancestor
101903004|NCT00333359|Gabapentin|gabapentin|mesh-list
102614680|NCT00003953|Antimitotic Agents|antimitotic agents|mesh-ancestor
102614681|NCT00003953|Mitosis Modulators|mitosis modulators|mesh-ancestor
102614682|NCT00003953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102614683|NCT00003953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102614684|NCT00003953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102614685|NCT00003953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102614686|NCT00003953|Antimetabolites|antimetabolites|mesh-ancestor
102614687|NCT00003953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102614688|NCT00003953|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102614689|NCT00003953|Abortifacient Agents|abortifacient agents|mesh-ancestor
102614690|NCT00003953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102614691|NCT00003953|Dermatologic Agents|dermatologic agents|mesh-ancestor
102614692|NCT00003953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102614693|NCT00003953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102614694|NCT00003953|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102614695|NCT00003953|Hormone Antagonists|hormone antagonists|mesh-ancestor
102614696|NCT00003953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102614697|NCT00003953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102614698|NCT00003953|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102614699|NCT00003953|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101586842|NCT02857959|Penicillin G|penicillin g|mesh-list
102614700|NCT00003953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102614701|NCT00003959|Sargramostim|sargramostim|mesh-list
102614702|NCT00003959|Immunologic Factors|immunologic factors|mesh-ancestor
102614703|NCT00003959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614704|NCT02972723|Metformin|metformin|mesh-list
102614705|NCT02972723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102614706|NCT02972723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614707|NCT00003203|Cyclophosphamide|cyclophosphamide|mesh-list
102614708|NCT00003203|Cisplatin|cisplatin|mesh-list
102614709|NCT00003203|Carboplatin|carboplatin|mesh-list
102614710|NCT00003203|Vincristine|vincristine|mesh-list
102614711|NCT00003203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102614712|NCT00003203|Immunologic Factors|immunologic factors|mesh-ancestor
102614713|NCT00003203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614714|NCT00003203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102614715|NCT00003203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102614716|NCT00003203|Alkylating Agents|alkylating agents|mesh-ancestor
102614717|NCT00003203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614718|NCT00003203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614719|NCT00003203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102614720|NCT00003203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102614721|NCT00003203|Tubulin Modulators|tubulin modulators|mesh-ancestor
102614722|NCT00003203|Antimitotic Agents|antimitotic agents|mesh-ancestor
102614723|NCT00003203|Mitosis Modulators|mitosis modulators|mesh-ancestor
102614724|NCT00003575|Etoposide|etoposide|mesh-list
102614725|NCT00003575|Ifosfamide|ifosfamide|mesh-list
102614726|NCT00003575|Interleukin-12|interleukin-12|mesh-list
102614727|NCT00003575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102614728|NCT00003575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614729|NCT00003575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102614730|NCT00003575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102614731|NCT00003575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102614732|NCT00003575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614733|NCT00003575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102614734|NCT00003575|Immunologic Factors|immunologic factors|mesh-ancestor
102614735|NCT00003575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614736|NCT00003575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102614737|NCT00003575|Alkylating Agents|alkylating agents|mesh-ancestor
102614738|NCT00003575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102614739|NCT00003575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102614740|NCT00003575|Growth Substances|growth substances|mesh-ancestor
102614741|NCT00003575|Growth Inhibitors|growth inhibitors|mesh-ancestor
102614742|NCT00003539|Paclitaxel|paclitaxel|mesh-list
102614743|NCT00003539|Trastuzumab|trastuzumab|mesh-list
102614744|NCT00003539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102614745|NCT00003539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614746|NCT00003539|Tubulin Modulators|tubulin modulators|mesh-ancestor
102614747|NCT00003539|Antimitotic Agents|antimitotic agents|mesh-ancestor
102614748|NCT00003539|Mitosis Modulators|mitosis modulators|mesh-ancestor
102614749|NCT00003539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614750|NCT00003539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102614751|NCT00003209|Fluorouracil|fluorouracil|mesh-list
102614752|NCT00003209|Methotrexate|methotrexate|mesh-list
102274842|NCT01442246|Fertility Agents|fertility agents|mesh-ancestor
102274843|NCT01442246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102614754|NCT00003209|Mitomycins|mitomycins|mesh-list
102614755|NCT00003209|Mitomycin|mitomycin|mesh-list
102614756|NCT00003209|Bleomycin|bleomycin|mesh-list
102614757|NCT00003209|Vinblastine|vinblastine|mesh-list
102614758|NCT00003209|Vindesine|vindesine|mesh-list
102614759|NCT00003209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614760|NCT00003209|Antimetabolites|antimetabolites|mesh-ancestor
102614761|NCT00003209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586914|NCT00956943|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102614762|NCT00003209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102614763|NCT00003209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102614764|NCT00003209|Immunologic Factors|immunologic factors|mesh-ancestor
102614765|NCT00003209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614766|NCT00003209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102614767|NCT00003209|Abortifacient Agents|abortifacient agents|mesh-ancestor
102614768|NCT00003209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102614769|NCT00003209|Dermatologic Agents|dermatologic agents|mesh-ancestor
102614770|NCT00003209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102614771|NCT00003209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102614772|NCT00003209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102614773|NCT00003209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102614774|NCT00003209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102614775|NCT00003209|Alkylating Agents|alkylating agents|mesh-ancestor
102614776|NCT00003209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102614777|NCT00003209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102614778|NCT00003209|Tubulin Modulators|tubulin modulators|mesh-ancestor
102614779|NCT00003209|Antimitotic Agents|antimitotic agents|mesh-ancestor
102614780|NCT00003209|Mitosis Modulators|mitosis modulators|mesh-ancestor
102614781|NCT00003587|Paclitaxel|paclitaxel|mesh-list
102614782|NCT00003587|Vinorelbine|vinorelbine|mesh-list
102614783|NCT00003587|Docetaxel|docetaxel|mesh-list
102614784|NCT00003587|Carboplatin|carboplatin|mesh-list
102614785|NCT00003587|Gemcitabine|gemcitabine|mesh-list
102614786|NCT00003587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102614787|NCT00003587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614788|NCT00003587|Tubulin Modulators|tubulin modulators|mesh-ancestor
102614789|NCT00003587|Antimitotic Agents|antimitotic agents|mesh-ancestor
102614790|NCT00003587|Mitosis Modulators|mitosis modulators|mesh-ancestor
102614791|NCT00003587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614792|NCT00003587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102614793|NCT00003587|Antimetabolites|antimetabolites|mesh-ancestor
102614794|NCT00003215|Leucovorin|leucovorin|mesh-list
102614795|NCT00003215|Cytarabine|cytarabine|mesh-list
102614796|NCT00003215|Prednisone|prednisone|mesh-list
102614797|NCT00003215|Methylprednisolone|methylprednisolone|mesh-list
102614798|NCT00003215|Hydrocortisone|hydrocortisone|mesh-list
102614799|NCT00003215|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102614800|NCT00003215|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102614801|NCT00003215|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102614802|NCT00003215|Cyclophosphamide|cyclophosphamide|mesh-list
102614803|NCT00003215|Melphalan|melphalan|mesh-list
102614804|NCT00003215|Doxorubicin|doxorubicin|mesh-list
102614805|NCT00003215|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102614806|NCT00003215|Methotrexate|methotrexate|mesh-list
102614807|NCT00003215|Etoposide|etoposide|mesh-list
102614808|NCT00003215|Vincristine|vincristine|mesh-list
102614809|NCT00003215|Mitoxantrone|mitoxantrone|mesh-list
102614810|NCT00003215|Levoleucovorin|levoleucovorin|mesh-list
102614811|NCT00003215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102614812|NCT00003215|Immunologic Factors|immunologic factors|mesh-ancestor
102614813|NCT00003215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614814|NCT00003215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102614815|NCT00003215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102614816|NCT00003215|Alkylating Agents|alkylating agents|mesh-ancestor
102614817|NCT00003215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614818|NCT00003215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614819|NCT00003215|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102614820|NCT00003215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102614821|NCT00003215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102614822|NCT00003215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102614823|NCT00003215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102614824|NCT00003215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102274844|NCT01442246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903151|NCT01199432|Fluorouracil|fluorouracil|mesh-list
102614825|NCT00003215|Glucocorticoids|glucocorticoids|mesh-ancestor
102614826|NCT00003215|Hormones|hormones|mesh-ancestor
102614827|NCT00003215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102614828|NCT00003215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102274845|NCT01442246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101903229|NCT00308087|Rituximab|rituximab|mesh-list
102614829|NCT00003215|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102614830|NCT00003215|Abortifacient Agents|abortifacient agents|mesh-ancestor
102614831|NCT00003215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102614832|NCT00003215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102614833|NCT00003215|Antimetabolites|antimetabolites|mesh-ancestor
102614834|NCT00003215|Dermatologic Agents|dermatologic agents|mesh-ancestor
102614835|NCT00003215|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102614836|NCT00003215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102614837|NCT00003215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102614838|NCT00003215|Antiviral Agents|antiviral agents|mesh-ancestor
102614839|NCT00003215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102614840|NCT00003215|Antidotes|antidotes|mesh-ancestor
102614841|NCT00003215|Protective Agents|protective agents|mesh-ancestor
102614842|NCT00003215|Vitamin B Complex|vitamin b complex|mesh-ancestor
102614843|NCT00003215|Vitamins|vitamins|mesh-ancestor
102614844|NCT00003215|Micronutrients|micronutrients|mesh-ancestor
102614845|NCT00003215|Tubulin Modulators|tubulin modulators|mesh-ancestor
102614846|NCT00003215|Antimitotic Agents|antimitotic agents|mesh-ancestor
102614847|NCT00003215|Mitosis Modulators|mitosis modulators|mesh-ancestor
102614848|NCT00003215|Antiemetics|antiemetics|mesh-ancestor
102614849|NCT00003215|Autonomic Agents|autonomic agents|mesh-ancestor
102614850|NCT00003215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102614851|NCT00003215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102614852|NCT00003215|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102614853|NCT00003215|Analgesics|analgesics|mesh-ancestor
102614854|NCT00003215|Sensory System Agents|sensory system agents|mesh-ancestor
102614855|NCT00003995|Trastuzumab|trastuzumab|mesh-list
102614856|NCT00003995|Irinotecan|irinotecan|mesh-list
102614857|NCT00003995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102614858|NCT00003995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614859|NCT00003995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102614860|NCT00003995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102614861|NCT00003995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102614862|NCT00003995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614863|NCT00003593|Cytarabine|cytarabine|mesh-list
102614864|NCT00003593|Hydrocortisone|hydrocortisone|mesh-list
102614865|NCT00003593|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102614866|NCT00003593|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102614867|NCT00003593|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102614868|NCT00003593|Methotrexate|methotrexate|mesh-list
102614869|NCT00003593|Thioguanine|thioguanine|mesh-list
102614870|NCT00003593|Daunorubicin|daunorubicin|mesh-list
102614871|NCT00003593|Asparaginase|asparaginase|mesh-list
102614872|NCT00003593|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102614873|NCT00003593|Abortifacient Agents|abortifacient agents|mesh-ancestor
102614874|NCT00003593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102614875|NCT00003593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614876|NCT00003593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102614877|NCT00003593|Antimetabolites|antimetabolites|mesh-ancestor
102614878|NCT00003593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614879|NCT00003593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614880|NCT00003593|Dermatologic Agents|dermatologic agents|mesh-ancestor
102614881|NCT00003593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102614882|NCT00003593|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102614883|NCT00003593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102614884|NCT00003593|Immunologic Factors|immunologic factors|mesh-ancestor
102614885|NCT00003593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102614886|NCT00003593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102614887|NCT00003593|Antiviral Agents|antiviral agents|mesh-ancestor
102614888|NCT00003593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102614889|NCT00003593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102614890|NCT00003593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102614891|NCT00003593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102614892|NCT00003593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102614893|NCT00003599|Vitamin E|vitamin e|mesh-list
102614894|NCT00003599|Tocopherols|tocopherols|mesh-list
102614895|NCT00003599|alpha-Tocopherol|alpha-tocopherol|mesh-list
102614896|NCT00003599|Isotretinoin|isotretinoin|mesh-list
102614897|NCT00003599|Vitamins|vitamins|mesh-ancestor
102614898|NCT00003599|Micronutrients|micronutrients|mesh-ancestor
102614899|NCT00003599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614900|NCT00003599|Antioxidants|antioxidants|mesh-ancestor
102614901|NCT00003599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614902|NCT00003599|Protective Agents|protective agents|mesh-ancestor
102614903|NCT00003599|Dermatologic Agents|dermatologic agents|mesh-ancestor
102614904|NCT00003605|Cyclophosphamide|cyclophosphamide|mesh-list
102614905|NCT00003605|Rituximab|rituximab|mesh-list
102614906|NCT00003605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102614907|NCT00003605|Immunologic Factors|immunologic factors|mesh-ancestor
102614908|NCT00003605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614909|NCT00003605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102614910|NCT00003605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102614911|NCT00003605|Alkylating Agents|alkylating agents|mesh-ancestor
102614912|NCT00003605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614913|NCT00003605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614914|NCT00003605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102614915|NCT00003605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102614916|NCT00003611|Acitretin|acitretin|mesh-list
102614917|NCT00003611|Keratolytic Agents|keratolytic agents|mesh-ancestor
102614918|NCT00003611|Dermatologic Agents|dermatologic agents|mesh-ancestor
102614919|NCT00003617|Clarithromycin|clarithromycin|mesh-list
102614920|NCT00003617|Tinidazole|tinidazole|mesh-list
102614921|NCT00003617|Chlorambucil|chlorambucil|mesh-list
102614922|NCT00003617|Omeprazole|omeprazole|mesh-list
102614923|NCT00003617|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102614924|NCT00003617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102614925|NCT00003617|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102614926|NCT00003617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102614927|NCT00003617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614928|NCT00003617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102614929|NCT00003617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102614930|NCT00003617|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102614931|NCT00003617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102614932|NCT00003617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102614933|NCT00003617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102614934|NCT00003617|Alkylating Agents|alkylating agents|mesh-ancestor
102614935|NCT00003617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614936|NCT00003617|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
102614937|NCT00003617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102614938|NCT00003617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102614939|NCT00004001|Prednisone|prednisone|mesh-list
102614940|NCT00004001|Docetaxel|docetaxel|mesh-list
102614941|NCT00004001|Mitoxantrone|mitoxantrone|mesh-list
102614942|NCT00004001|Estramustine|estramustine|mesh-list
102614943|NCT00004001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614944|NCT00004001|Tubulin Modulators|tubulin modulators|mesh-ancestor
102614945|NCT00004001|Antimitotic Agents|antimitotic agents|mesh-ancestor
102614946|NCT00004001|Mitosis Modulators|mitosis modulators|mesh-ancestor
102614947|NCT00004001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614948|NCT00004001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102614949|NCT00004001|Glucocorticoids|glucocorticoids|mesh-ancestor
102614950|NCT00004001|Hormones|hormones|mesh-ancestor
102614951|NCT00004001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102614952|NCT00004001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614953|NCT00004001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102614954|NCT00004001|Analgesics|analgesics|mesh-ancestor
102614955|NCT00004001|Sensory System Agents|sensory system agents|mesh-ancestor
101587119|NCT00656695|Cyclosporins|cyclosporins|mesh-list
102614956|NCT00004001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102614957|NCT00004001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102614958|NCT00004001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102614959|NCT00004001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102614960|NCT00004001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102614961|NCT00004001|Alkylating Agents|alkylating agents|mesh-ancestor
102614962|NCT00004013|Paclitaxel|paclitaxel|mesh-list
102614963|NCT00004013|Trastuzumab|trastuzumab|mesh-list
102614964|NCT00004013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102614965|NCT00004013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614966|NCT00004013|Tubulin Modulators|tubulin modulators|mesh-ancestor
102614967|NCT00004013|Antimitotic Agents|antimitotic agents|mesh-ancestor
102614968|NCT00004013|Mitosis Modulators|mitosis modulators|mesh-ancestor
102614969|NCT00004013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614970|NCT00004013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102614971|NCT00004025|Aldesleukin|aldesleukin|mesh-list
102614972|NCT00004025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614973|NCT00004025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102614974|NCT00004025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102614975|NCT00004025|Antiviral Agents|antiviral agents|mesh-ancestor
102614976|NCT00004025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102614977|NCT00004037|Docetaxel|docetaxel|mesh-list
102274846|NCT01442246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274847|NCT01439282|Capecitabine|capecitabine|mesh-list
102614978|NCT00004037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614979|NCT00004037|Tubulin Modulators|tubulin modulators|mesh-ancestor
102614980|NCT00004037|Antimitotic Agents|antimitotic agents|mesh-ancestor
102614981|NCT00004037|Mitosis Modulators|mitosis modulators|mesh-ancestor
102614982|NCT00004037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614983|NCT00004043|Calcitriol|calcitriol|mesh-list
102614984|NCT00004043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102614985|NCT00004043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614986|NCT00004043|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102614987|NCT00004043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102614988|NCT00004043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614989|NCT00004043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102614990|NCT00004043|Vitamins|vitamins|mesh-ancestor
102614991|NCT00004043|Micronutrients|micronutrients|mesh-ancestor
102614992|NCT00004043|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102614993|NCT00004055|Paclitaxel|paclitaxel|mesh-list
102614994|NCT00004055|Topotecan|topotecan|mesh-list
102614995|NCT00004055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102614996|NCT00004055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614997|NCT00004055|Tubulin Modulators|tubulin modulators|mesh-ancestor
102614998|NCT00004055|Antimitotic Agents|antimitotic agents|mesh-ancestor
102614999|NCT00004055|Mitosis Modulators|mitosis modulators|mesh-ancestor
102615000|NCT00004055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615001|NCT00004055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102615002|NCT00004055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102615003|NCT00004055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615004|NCT00004061|Cyclophosphamide|cyclophosphamide|mesh-list
102615005|NCT00004061|Ifosfamide|ifosfamide|mesh-list
102615006|NCT00004061|Etoposide|etoposide|mesh-list
102615007|NCT00004061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102615008|NCT00004061|Immunologic Factors|immunologic factors|mesh-ancestor
102615009|NCT00004061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615010|NCT00004061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102615011|NCT00004061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102615012|NCT00004061|Alkylating Agents|alkylating agents|mesh-ancestor
102615013|NCT00004061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615014|NCT00004061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615015|NCT00004061|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102615016|NCT00004061|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102615017|NCT00004061|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102615018|NCT00004061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102615019|NCT00004061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615020|NCT00004067|Paclitaxel|paclitaxel|mesh-list
102615021|NCT00004067|Cyclophosphamide|cyclophosphamide|mesh-list
102615022|NCT00004067|Doxorubicin|doxorubicin|mesh-list
102615023|NCT00004067|Trastuzumab|trastuzumab|mesh-list
102615024|NCT00004067|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102615025|NCT00004067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102615026|NCT00004067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615027|NCT00004067|Tubulin Modulators|tubulin modulators|mesh-ancestor
102615028|NCT00004067|Antimitotic Agents|antimitotic agents|mesh-ancestor
102615029|NCT00004067|Mitosis Modulators|mitosis modulators|mesh-ancestor
102615030|NCT00004067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615031|NCT00004067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102615032|NCT00004067|Immunologic Factors|immunologic factors|mesh-ancestor
102615033|NCT00004067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615034|NCT00004067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102615035|NCT00004067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102615036|NCT00004067|Alkylating Agents|alkylating agents|mesh-ancestor
102615037|NCT00004067|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102615038|NCT00004067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102615039|NCT00004067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102615040|NCT00004067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102615041|NCT00004067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615042|NCT00004067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102615043|NCT00004073|Suramin|suramin|mesh-list
102615044|NCT00004073|Antinematodal Agents|antinematodal agents|mesh-ancestor
102615045|NCT00004073|Anthelmintics|anthelmintics|mesh-ancestor
102615046|NCT00004073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102615047|NCT00004073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102615048|NCT00004073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615049|NCT00004073|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102615050|NCT00004073|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102615051|NCT00004085|Antibodies|antibodies|mesh-list
102615052|NCT00004085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102615053|NCT00004085|Immunologic Factors|immunologic factors|mesh-ancestor
102615054|NCT00004085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615055|NCT00004091|Antibodies|antibodies|mesh-list
102615056|NCT00004091|Immunologic Factors|immunologic factors|mesh-ancestor
102615057|NCT00004091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615059|NCT00004097|Gemcitabine|gemcitabine|mesh-list
102615060|NCT00004097|Fluorouracil|fluorouracil|mesh-list
102615061|NCT00004097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102615062|NCT00004097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615063|NCT00004097|Tubulin Modulators|tubulin modulators|mesh-ancestor
102615064|NCT00004097|Antimitotic Agents|antimitotic agents|mesh-ancestor
102615065|NCT00004097|Mitosis Modulators|mitosis modulators|mesh-ancestor
102615066|NCT00004097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615067|NCT00004097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102615068|NCT00004097|Antimetabolites|antimetabolites|mesh-ancestor
102615069|NCT00004097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102615070|NCT00004097|Immunologic Factors|immunologic factors|mesh-ancestor
102615071|NCT00004097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615072|NCT00004103|Irinotecan|irinotecan|mesh-list
102615073|NCT00004103|Floxuridine|floxuridine|mesh-list
102615074|NCT00004103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615075|NCT00004103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102615076|NCT00004103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102615077|NCT00004103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615078|NCT00004103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615079|NCT00004103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102615080|NCT00004103|Antimetabolites|antimetabolites|mesh-ancestor
102615081|NCT00004109|Doxorubicin|doxorubicin|mesh-list
102615082|NCT00004109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102615083|NCT00004109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102615084|NCT00004109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615085|NCT00004109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102615086|NCT00004109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102615087|NCT00004109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615088|NCT00004109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615089|NCT00003239|Interferons|interferons|mesh-list
102615090|NCT00003239|Cytarabine|cytarabine|mesh-list
102615091|NCT00003239|Interferon-alpha|interferon-alpha|mesh-list
102615092|NCT00003239|Interferon alpha-2|interferon alpha-2|mesh-list
102615093|NCT00003239|Homoharringtonine|homoharringtonine|mesh-list
102615094|NCT00003239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615095|NCT00003239|Antiviral Agents|antiviral agents|mesh-ancestor
102615096|NCT00003239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102615097|NCT00003239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102615098|NCT00003239|Antimetabolites|antimetabolites|mesh-ancestor
102615099|NCT00003239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615100|NCT00003239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102615101|NCT00003239|Immunologic Factors|immunologic factors|mesh-ancestor
102615102|NCT00003239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615103|NCT00003239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102615104|NCT00003239|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102615105|NCT00003239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615106|NCT00004115|Antibodies|antibodies|mesh-list
102615107|NCT00004115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102615108|NCT00004115|Immunologic Factors|immunologic factors|mesh-ancestor
102615109|NCT00004115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615110|NCT00003245|Irinotecan|irinotecan|mesh-list
102615111|NCT00003245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102615112|NCT00003245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102615113|NCT00003245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615114|NCT00003245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615115|NCT00003245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615116|NCT00004127|Leucovorin|leucovorin|mesh-list
102615117|NCT00004127|Fluorouracil|fluorouracil|mesh-list
102615118|NCT00004127|Oxaliplatin|oxaliplatin|mesh-list
102615119|NCT00004127|Calcium|calcium|mesh-list
102615120|NCT00004127|Levoleucovorin|levoleucovorin|mesh-list
102615121|NCT00004127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102615122|NCT00004127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615123|NCT00004127|Antimetabolites|antimetabolites|mesh-ancestor
102615124|NCT00004127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615125|NCT00004127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102615126|NCT00004127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274848|NCT01439282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102615127|NCT00004127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102615128|NCT00004127|Immunologic Factors|immunologic factors|mesh-ancestor
101903446|NCT01200212|Bevacizumab|bevacizumab|mesh-list
102615129|NCT00004127|Antidotes|antidotes|mesh-ancestor
102274849|NCT01439282|Antimetabolites|antimetabolites|mesh-ancestor
102274850|NCT01439282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615130|NCT00004127|Protective Agents|protective agents|mesh-ancestor
102615131|NCT00004127|Vitamin B Complex|vitamin b complex|mesh-ancestor
102615132|NCT00004127|Vitamins|vitamins|mesh-ancestor
102615133|NCT00004127|Micronutrients|micronutrients|mesh-ancestor
102615134|NCT00003251|Paclitaxel|paclitaxel|mesh-list
102615135|NCT00003251|Amifostine|amifostine|mesh-list
102615136|NCT00003251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102615137|NCT00003251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615138|NCT00003251|Tubulin Modulators|tubulin modulators|mesh-ancestor
102615139|NCT00003251|Antimitotic Agents|antimitotic agents|mesh-ancestor
102615140|NCT00003251|Mitosis Modulators|mitosis modulators|mesh-ancestor
102615141|NCT00003251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615142|NCT00003251|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102615143|NCT00003251|Protective Agents|protective agents|mesh-ancestor
102615144|NCT00003251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615145|NCT00004139|Gemcitabine|gemcitabine|mesh-list
102615146|NCT00004139|Docetaxel|docetaxel|mesh-list
102615147|NCT00004139|Irinotecan|irinotecan|mesh-list
102615148|NCT00004139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102615149|NCT00004139|Antimetabolites|antimetabolites|mesh-ancestor
102615150|NCT00004139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615151|NCT00004139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615152|NCT00004139|Tubulin Modulators|tubulin modulators|mesh-ancestor
102615153|NCT00004139|Antimitotic Agents|antimitotic agents|mesh-ancestor
102615154|NCT00004139|Mitosis Modulators|mitosis modulators|mesh-ancestor
102615155|NCT00004139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102615156|NCT00004139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102615157|NCT00004139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615158|NCT00004145|Cyclophosphamide|cyclophosphamide|mesh-list
102615159|NCT00004145|Fludarabine|fludarabine|mesh-list
102615160|NCT00004145|Fludarabine phosphate|fludarabine phosphate|mesh-list
102615161|NCT00004145|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102615162|NCT00004145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102615163|NCT00004145|Immunologic Factors|immunologic factors|mesh-ancestor
102615164|NCT00004145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587316|NCT00948675|Paclitaxel|paclitaxel|mesh-list
102615165|NCT00004145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102615166|NCT00004145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102615167|NCT00004145|Alkylating Agents|alkylating agents|mesh-ancestor
102615168|NCT00004145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615169|NCT00004145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615170|NCT00004145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102615171|NCT00004145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102615172|NCT00004145|Antimetabolites|antimetabolites|mesh-ancestor
102615173|NCT00003263|Interferons|interferons|mesh-list
102615174|NCT00003263|Interferon-alpha|interferon-alpha|mesh-list
102615175|NCT00003263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615176|NCT00003263|Antiviral Agents|antiviral agents|mesh-ancestor
102615177|NCT00003263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102615178|NCT00003263|Immunologic Factors|immunologic factors|mesh-ancestor
102615179|NCT00003263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615180|NCT00004157|Oprelvekin|oprelvekin|mesh-list
102615181|NCT00004157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615182|NCT00003269|Cyclophosphamide|cyclophosphamide|mesh-list
102615183|NCT00003269|Etoposide|etoposide|mesh-list
102615184|NCT00003269|Sargramostim|sargramostim|mesh-list
102615185|NCT00003269|Amifostine|amifostine|mesh-list
102615186|NCT00003269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102615187|NCT00003269|Immunologic Factors|immunologic factors|mesh-ancestor
102615188|NCT00003269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615189|NCT00003269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102615190|NCT00003269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102615191|NCT00003269|Alkylating Agents|alkylating agents|mesh-ancestor
102615192|NCT00003269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615193|NCT00003269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615194|NCT00003269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102615195|NCT00003269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102615196|NCT00003269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102615197|NCT00003269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102615198|NCT00003269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615199|NCT00003269|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102615200|NCT00003269|Protective Agents|protective agents|mesh-ancestor
102615201|NCT00004163|Trastuzumab|trastuzumab|mesh-list
101903519|NCT03833570|Melatonin|melatonin|mesh-list
102615202|NCT00004163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102615203|NCT00004163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274851|NCT01439282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274852|NCT01352520|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102615205|NCT00003281|Topotecan|topotecan|mesh-list
102615206|NCT00003281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102615207|NCT00003281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615208|NCT00003281|Tubulin Modulators|tubulin modulators|mesh-ancestor
102615209|NCT00003281|Antimitotic Agents|antimitotic agents|mesh-ancestor
102615210|NCT00003281|Mitosis Modulators|mitosis modulators|mesh-ancestor
102615211|NCT00003281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615212|NCT00003281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102615213|NCT00003281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102615214|NCT00003281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615215|NCT00003287|Leucovorin|leucovorin|mesh-list
102615216|NCT00003287|Fluorouracil|fluorouracil|mesh-list
102615217|NCT00003287|Oxaliplatin|oxaliplatin|mesh-list
102615218|NCT00003287|Calcium|calcium|mesh-list
102615219|NCT00003287|Levoleucovorin|levoleucovorin|mesh-list
102615220|NCT00003287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102615221|NCT00003287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615222|NCT00003287|Antimetabolites|antimetabolites|mesh-ancestor
102615223|NCT00003287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615224|NCT00003287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102615225|NCT00003287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615226|NCT00003287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102615227|NCT00003287|Immunologic Factors|immunologic factors|mesh-ancestor
102615228|NCT00003287|Antidotes|antidotes|mesh-ancestor
102615229|NCT00003287|Protective Agents|protective agents|mesh-ancestor
102615230|NCT00003287|Vitamin B Complex|vitamin b complex|mesh-ancestor
102615231|NCT00003287|Vitamins|vitamins|mesh-ancestor
102615232|NCT00003287|Micronutrients|micronutrients|mesh-ancestor
102615233|NCT00004187|Capecitabine|capecitabine|mesh-list
102615234|NCT00004187|Oxaliplatin|oxaliplatin|mesh-list
102615235|NCT00004187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102615236|NCT00004187|Antimetabolites|antimetabolites|mesh-ancestor
102615237|NCT00004187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615238|NCT00004187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615239|NCT00384137|Tacrolimus|tacrolimus|mesh-list
102615240|NCT00384137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102615241|NCT00384137|Immunologic Factors|immunologic factors|mesh-ancestor
102615242|NCT00384137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615243|NCT00384137|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102615244|NCT00384137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615245|NCT00384137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615246|NCT00384215|Insulin Glargine|insulin glargine|mesh-list
102615247|NCT00384215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102615248|NCT00384215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615249|NCT00003293|Procarbazine|procarbazine|mesh-list
102615250|NCT00003293|Leflunomide|leflunomide|mesh-list
102615251|NCT00003293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615252|NCT00003293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615253|NCT00003293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102615254|NCT00003293|Immunologic Factors|immunologic factors|mesh-ancestor
102615255|NCT00003293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615256|NCT00003293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615257|NCT00004199|Gemcitabine|gemcitabine|mesh-list
102615258|NCT00004199|Prinomastat|prinomastat|mesh-list
102615259|NCT00004199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615260|NCT00004199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102615261|NCT00004199|Antimetabolites|antimetabolites|mesh-ancestor
102615262|NCT00004199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615263|NCT00004199|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
102615264|NCT00004199|Protease Inhibitors|protease inhibitors|mesh-ancestor
102615265|NCT00004199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615266|NCT00003299|Paclitaxel|paclitaxel|mesh-list
102615267|NCT00003299|Etoposide|etoposide|mesh-list
102615268|NCT00003299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102615269|NCT00003299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615270|NCT00003299|Tubulin Modulators|tubulin modulators|mesh-ancestor
102615271|NCT00003299|Antimitotic Agents|antimitotic agents|mesh-ancestor
102615272|NCT00003299|Mitosis Modulators|mitosis modulators|mesh-ancestor
102615273|NCT00003299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615274|NCT00003299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102615275|NCT00003299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102615276|NCT00003299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615277|NCT00004205|Tamoxifen|tamoxifen|mesh-list
102615278|NCT00004205|Letrozole|letrozole|mesh-list
102615279|NCT00004205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615281|NCT00004205|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102615282|NCT00004205|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102615283|NCT00004205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615284|NCT00004205|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102615285|NCT00004205|Hormone Antagonists|hormone antagonists|mesh-ancestor
102615286|NCT00004205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102615287|NCT00004205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615288|NCT00004205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102615289|NCT00004205|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102615290|NCT00004205|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102615291|NCT00004205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102615292|NCT00003305|Leucovorin|leucovorin|mesh-list
102615293|NCT00003305|Calcium|calcium|mesh-list
102615294|NCT00003305|Levoleucovorin|levoleucovorin|mesh-list
102615295|NCT00003305|Aminopterin|aminopterin|mesh-list
102615296|NCT00003305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102615297|NCT00003305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615298|NCT00003305|Antidotes|antidotes|mesh-ancestor
102615299|NCT00003305|Protective Agents|protective agents|mesh-ancestor
102615300|NCT00003305|Vitamin B Complex|vitamin b complex|mesh-ancestor
102615301|NCT00003305|Vitamins|vitamins|mesh-ancestor
102615302|NCT00003305|Micronutrients|micronutrients|mesh-ancestor
102615303|NCT00003305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102615304|NCT00003305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615305|NCT00003305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615306|NCT00003311|Cytarabine|cytarabine|mesh-list
102615307|NCT00003311|Dexamethasone|dexamethasone|mesh-list
102615308|NCT00003311|Cyclophosphamide|cyclophosphamide|mesh-list
102615309|NCT00003311|Doxorubicin|doxorubicin|mesh-list
102615310|NCT00003311|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102615311|NCT00003311|Methotrexate|methotrexate|mesh-list
102615312|NCT00003311|Vincristine|vincristine|mesh-list
102615313|NCT00003311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102615314|NCT00003311|Immunologic Factors|immunologic factors|mesh-ancestor
102615315|NCT00003311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615316|NCT00003311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102615317|NCT00003311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102615318|NCT00003311|Alkylating Agents|alkylating agents|mesh-ancestor
102615319|NCT00003311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615320|NCT00003311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615321|NCT00003311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102615322|NCT00003311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102615323|NCT00003311|Antiemetics|antiemetics|mesh-ancestor
102615324|NCT00003311|Autonomic Agents|autonomic agents|mesh-ancestor
102615325|NCT00003311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102615326|NCT00003311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102615327|NCT00003311|Glucocorticoids|glucocorticoids|mesh-ancestor
102615328|NCT00003311|Hormones|hormones|mesh-ancestor
102615329|NCT00003311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102615330|NCT00003311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102615331|NCT00003311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102615332|NCT00003311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102615333|NCT00003311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102615334|NCT00003311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615335|NCT00003311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102615336|NCT00003311|Abortifacient Agents|abortifacient agents|mesh-ancestor
102615337|NCT00003311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102615338|NCT00003311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102615339|NCT00003311|Antimetabolites|antimetabolites|mesh-ancestor
102615340|NCT00003311|Dermatologic Agents|dermatologic agents|mesh-ancestor
102615341|NCT00003311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102615342|NCT00003311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102615343|NCT00003311|Antiviral Agents|antiviral agents|mesh-ancestor
102615344|NCT00003311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102615345|NCT00003311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102615346|NCT00003311|Tubulin Modulators|tubulin modulators|mesh-ancestor
102615347|NCT00003311|Antimitotic Agents|antimitotic agents|mesh-ancestor
102615348|NCT00003311|Mitosis Modulators|mitosis modulators|mesh-ancestor
102615349|NCT00003317|Paclitaxel|paclitaxel|mesh-list
102615350|NCT00003317|Carboplatin|carboplatin|mesh-list
102274853|NCT01352520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102274854|NCT01352520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274855|NCT01352520|Immunotoxins|immunotoxins|mesh-ancestor
102615351|NCT00003317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102615352|NCT00003317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615353|NCT00003317|Tubulin Modulators|tubulin modulators|mesh-ancestor
102615354|NCT00003317|Antimitotic Agents|antimitotic agents|mesh-ancestor
102615355|NCT00003317|Mitosis Modulators|mitosis modulators|mesh-ancestor
102615356|NCT00003317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615357|NCT00004217|Cytarabine|cytarabine|mesh-list
102615358|NCT00004217|Daunorubicin|daunorubicin|mesh-list
102615359|NCT00004217|Sargramostim|sargramostim|mesh-list
102615360|NCT00004217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102615361|NCT00004217|Antimetabolites|antimetabolites|mesh-ancestor
102615362|NCT00004217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615363|NCT00004217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615364|NCT00004217|Antiviral Agents|antiviral agents|mesh-ancestor
102615365|NCT00004217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102615366|NCT00004217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102615367|NCT00004217|Immunologic Factors|immunologic factors|mesh-ancestor
102615368|NCT00004217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615369|NCT00004217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102615370|NCT00004217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102615371|NCT00004217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102615372|NCT00004217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615373|NCT00003323|Flutamide|flutamide|mesh-list
102615374|NCT00003323|Finasteride|finasteride|mesh-list
102615375|NCT00003323|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102615376|NCT00003323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102615377|NCT00003323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615378|NCT00003323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615379|NCT00003323|Hormone Antagonists|hormone antagonists|mesh-ancestor
102615380|NCT00003323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102615381|NCT00003323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615382|NCT00003323|Urological Agents|urological agents|mesh-ancestor
102615383|NCT00003323|Androgen Antagonists|androgen antagonists|mesh-ancestor
102615384|NCT00003323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102615385|NCT00003323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615386|NCT00004229|Endostatins|endostatins|mesh-list
102615387|NCT00004229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615388|NCT00004229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102615389|NCT00004229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102615390|NCT00004229|Growth Substances|growth substances|mesh-ancestor
102615391|NCT00004229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615392|NCT00004229|Growth Inhibitors|growth inhibitors|mesh-ancestor
102615393|NCT00004235|Docetaxel|docetaxel|mesh-list
102615394|NCT00004235|Irinotecan|irinotecan|mesh-list
102615395|NCT00004235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615396|NCT00004235|Tubulin Modulators|tubulin modulators|mesh-ancestor
102615397|NCT00004235|Antimitotic Agents|antimitotic agents|mesh-ancestor
102615398|NCT00004235|Mitosis Modulators|mitosis modulators|mesh-ancestor
102615399|NCT00004235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615400|NCT00004235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102615401|NCT00004235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102615402|NCT00004235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615403|NCT00003335|Cyclosporine|cyclosporine|mesh-list
102615404|NCT00003335|Methylprednisolone|methylprednisolone|mesh-list
102615405|NCT00003335|Melphalan|melphalan|mesh-list
102615406|NCT00003335|Busulfan|busulfan|mesh-list
102615407|NCT00003335|Cyclosporins|cyclosporins|mesh-list
102615408|NCT00003335|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102615409|NCT00003335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615410|NCT00003335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615411|NCT00003335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102615412|NCT00003335|Immunologic Factors|immunologic factors|mesh-ancestor
102615413|NCT00003335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615414|NCT00003335|Antifungal Agents|antifungal agents|mesh-ancestor
102615415|NCT00003335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102615416|NCT00003335|Dermatologic Agents|dermatologic agents|mesh-ancestor
102615417|NCT00003335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102615418|NCT00003335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102615419|NCT00003335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102615420|NCT00003335|Antiemetics|antiemetics|mesh-ancestor
102615421|NCT00003335|Autonomic Agents|autonomic agents|mesh-ancestor
102615422|NCT00003335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102615423|NCT00003335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102615424|NCT00003335|Glucocorticoids|glucocorticoids|mesh-ancestor
102615425|NCT00003335|Hormones|hormones|mesh-ancestor
102615426|NCT00003335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102274856|NCT01352520|Immunoconjugates|immunoconjugates|mesh-ancestor
101587577|NCT00902668|Lovastatin|lovastatin|mesh-list
102274857|NCT01352520|Immunologic Factors|immunologic factors|mesh-ancestor
102615427|NCT00003335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102615428|NCT00003335|Protective Agents|protective agents|mesh-ancestor
102615429|NCT00003335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615430|NCT00003335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102615431|NCT00003335|Alkylating Agents|alkylating agents|mesh-ancestor
102615432|NCT00003335|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102615433|NCT00003341|Epoetin Alfa|epoetin alfa|mesh-list
102615434|NCT00003341|Hematinics|hematinics|mesh-ancestor
102615436|NCT00004253|Carboplatin|carboplatin|mesh-list
102615437|NCT00004253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102615438|NCT00004253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615439|NCT00004253|Tubulin Modulators|tubulin modulators|mesh-ancestor
102615440|NCT00004253|Antimitotic Agents|antimitotic agents|mesh-ancestor
102615441|NCT00004253|Mitosis Modulators|mitosis modulators|mesh-ancestor
102615442|NCT00004253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615443|NCT00004265|Paclitaxel|paclitaxel|mesh-list
102615444|NCT00004265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102615445|NCT00004265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615446|NCT00004265|Tubulin Modulators|tubulin modulators|mesh-ancestor
102615447|NCT00004265|Antimitotic Agents|antimitotic agents|mesh-ancestor
102615448|NCT00004265|Mitosis Modulators|mitosis modulators|mesh-ancestor
102615449|NCT00004265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615450|NCT00003365|Curcumin|curcumin|mesh-list
102615451|NCT00003365|Sulindac|sulindac|mesh-list
102615452|NCT00003365|Quercetin|quercetin|mesh-list
102615453|NCT00003365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102615454|NCT00003365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102615455|NCT00003365|Analgesics|analgesics|mesh-ancestor
102615456|NCT00003365|Sensory System Agents|sensory system agents|mesh-ancestor
102615457|NCT00003365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102615458|NCT00003365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615459|NCT00003365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102615460|NCT00003365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102615461|NCT00003365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615462|NCT00003365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615463|NCT00003365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615464|NCT00003365|Antioxidants|antioxidants|mesh-ancestor
102615465|NCT00003365|Protective Agents|protective agents|mesh-ancestor
102615466|NCT00003365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102615467|NCT00004829|Tobramycin|tobramycin|mesh-list
102615468|NCT00004829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102615469|NCT00004829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102615470|NCT00004313|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
102615471|NCT00004313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102615472|NCT00004313|Immunologic Factors|immunologic factors|mesh-ancestor
102615473|NCT00004313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615474|NCT00004853|Lenograstim|lenograstim|mesh-list
102615475|NCT00004853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102615476|NCT00004853|Immunologic Factors|immunologic factors|mesh-ancestor
102615477|NCT00004853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615478|NCT00004865|Paclitaxel|paclitaxel|mesh-list
102615479|NCT00004865|Fluorouracil|fluorouracil|mesh-list
102615480|NCT00004865|Cetuximab|cetuximab|mesh-list
102615481|NCT00004865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102615482|NCT00004865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615483|NCT00004865|Tubulin Modulators|tubulin modulators|mesh-ancestor
102615484|NCT00004865|Antimitotic Agents|antimitotic agents|mesh-ancestor
102615485|NCT00004865|Mitosis Modulators|mitosis modulators|mesh-ancestor
102615486|NCT00004865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615487|NCT00004865|Antimetabolites|antimetabolites|mesh-ancestor
101587641|NCT02846428|Capecitabine|capecitabine|mesh-list
102615488|NCT00004865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102615489|NCT00004865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102615490|NCT00004865|Immunologic Factors|immunologic factors|mesh-ancestor
102615491|NCT00004865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615492|NCT00004865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102615493|NCT00004361|Citric Acid|citric acid|mesh-list
102615494|NCT00004361|Sodium Citrate|sodium citrate|mesh-list
101903804|NCT03817970|Dermatologic Agents|dermatologic agents|mesh-ancestor
102615495|NCT00004361|Calcium|calcium|mesh-list
102615496|NCT00004361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102615497|NCT00004361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615498|NCT00004361|Anticoagulants|anticoagulants|mesh-ancestor
102615499|NCT00004361|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102615500|NCT00004361|Chelating Agents|chelating agents|mesh-ancestor
102274858|NCT01352520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615501|NCT00004361|Sequestering Agents|sequestering agents|mesh-ancestor
102615502|NCT00004361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615503|NCT00004373|Alprazolam|alprazolam|mesh-list
102615504|NCT00004373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102615505|NCT00004373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102615506|NCT00004373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615507|NCT00004373|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102615508|NCT00004373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102615509|NCT00004373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102615510|NCT00004373|GABA Modulators|gaba modulators|mesh-ancestor
102615511|NCT00004373|GABA Agents|gaba agents|mesh-ancestor
102615512|NCT00004373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102615513|NCT00004373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615514|NCT00004871|Azacitidine|azacitidine|mesh-list
102615515|NCT00004871|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
102615516|NCT00004871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102615517|NCT00004871|Antimetabolites|antimetabolites|mesh-ancestor
102615518|NCT00004871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615519|NCT00004871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615520|NCT00004871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615521|NCT00004397|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
102615522|NCT00004397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615523|NCT00004397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615524|NCT00004883|Trastuzumab|trastuzumab|mesh-list
102615525|NCT00004883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102615526|NCT00004883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615527|NCT00004403|Albendazole|albendazole|mesh-list
102615528|NCT00004403|Dexamethasone|dexamethasone|mesh-list
102615529|NCT00004403|Phenytoin|phenytoin|mesh-list
102615530|NCT00004403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102615531|NCT00004403|Antiemetics|antiemetics|mesh-ancestor
102615532|NCT00004403|Autonomic Agents|autonomic agents|mesh-ancestor
102615533|NCT00004403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102615534|NCT00004403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615535|NCT00004403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102615536|NCT00004403|Glucocorticoids|glucocorticoids|mesh-ancestor
102615537|NCT00004403|Hormones|hormones|mesh-ancestor
101587702|NCT02844634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102615538|NCT00004403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102615539|NCT00004403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102615540|NCT00004403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615541|NCT00004403|Anthelmintics|anthelmintics|mesh-ancestor
102615542|NCT00004403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102615543|NCT00004403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102615544|NCT00004403|Anticestodal Agents|anticestodal agents|mesh-ancestor
102615545|NCT00004403|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102615546|NCT00004403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102615547|NCT00004403|Tubulin Modulators|tubulin modulators|mesh-ancestor
102615548|NCT00004403|Antimitotic Agents|antimitotic agents|mesh-ancestor
102615549|NCT00004403|Mitosis Modulators|mitosis modulators|mesh-ancestor
102615550|NCT00004403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615551|NCT00004403|Anticonvulsants|anticonvulsants|mesh-ancestor
102615552|NCT00004403|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102615553|NCT00004403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102615554|NCT00004403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102615555|NCT00004403|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102615556|NCT00004403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102615557|NCT00004889|Rituximab|rituximab|mesh-list
102615558|NCT00004889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102615559|NCT00004889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615560|NCT00004889|Immunologic Factors|immunologic factors|mesh-ancestor
102615561|NCT00004889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615562|NCT00004889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102615563|NCT00385307|Amibegron|amibegron|mesh-list
102615564|NCT00385307|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
102615565|NCT00385307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102615566|NCT00385307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102615567|NCT00385307|Adrenergic Agents|adrenergic agents|mesh-ancestor
102615568|NCT00385307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102615569|NCT00385307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615570|NCT00385307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615571|NCT00385307|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102615572|NCT00004901|Fluorouracil|fluorouracil|mesh-list
102274859|NCT01326312|Leuprolide|leuprolide|mesh-list
102615573|NCT00004901|Hydroxyurea|hydroxyurea|mesh-list
102274860|NCT01326312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102615574|NCT00004901|Eniluracil|eniluracil|mesh-list
102615575|NCT00004901|Antimetabolites|antimetabolites|mesh-ancestor
102615576|NCT00004901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615577|NCT00004901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102615578|NCT00004901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615579|NCT00004901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102615580|NCT00004901|Immunologic Factors|immunologic factors|mesh-ancestor
102615581|NCT00004901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615582|NCT00004901|Antisickling Agents|antisickling agents|mesh-ancestor
102615583|NCT00004901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615584|NCT00004901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102615585|NCT00004433|Pergolide|pergolide|mesh-list
102615586|NCT00004433|Dopamine Agonists|dopamine agonists|mesh-ancestor
102615587|NCT00004433|Dopamine Agents|dopamine agents|mesh-ancestor
102615588|NCT00004433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102615589|NCT00004433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615590|NCT00004433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615591|NCT00004913|Leucovorin|leucovorin|mesh-list
102615592|NCT00004913|Docetaxel|docetaxel|mesh-list
102615593|NCT00004913|Fluorouracil|fluorouracil|mesh-list
102615594|NCT00004913|Calcium|calcium|mesh-list
102615595|NCT00004913|Levoleucovorin|levoleucovorin|mesh-list
102615596|NCT00004913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615597|NCT00004913|Tubulin Modulators|tubulin modulators|mesh-ancestor
102615598|NCT00004913|Antimitotic Agents|antimitotic agents|mesh-ancestor
102615599|NCT00004913|Mitosis Modulators|mitosis modulators|mesh-ancestor
102615600|NCT00004913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615601|NCT00004913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102615602|NCT00004913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615603|NCT00004913|Antimetabolites|antimetabolites|mesh-ancestor
102615604|NCT00004913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102615605|NCT00004913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102615606|NCT00004913|Immunologic Factors|immunologic factors|mesh-ancestor
102615607|NCT00004913|Antidotes|antidotes|mesh-ancestor
102615608|NCT00004913|Protective Agents|protective agents|mesh-ancestor
102615609|NCT00004913|Vitamin B Complex|vitamin b complex|mesh-ancestor
102615610|NCT00004913|Vitamins|vitamins|mesh-ancestor
102615611|NCT00004913|Micronutrients|micronutrients|mesh-ancestor
102615612|NCT00004919|Irinotecan|irinotecan|mesh-list
102615613|NCT00004919|Amifostine|amifostine|mesh-list
102615614|NCT00004919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615615|NCT00004919|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102615616|NCT00004919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102615617|NCT00004919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615618|NCT00004919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615619|NCT00004919|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102615620|NCT00004919|Protective Agents|protective agents|mesh-ancestor
102615621|NCT00004919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615622|NCT00004925|Doxorubicin|doxorubicin|mesh-list
102615623|NCT00004925|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102615624|NCT00004925|Trastuzumab|trastuzumab|mesh-list
102615625|NCT00004925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102615626|NCT00004925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615627|NCT00004925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102615628|NCT00004925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102615629|NCT00004925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615630|NCT00004925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615631|NCT00004925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102615632|NCT00004931|Leucovorin|leucovorin|mesh-list
102615633|NCT00004931|Fluorouracil|fluorouracil|mesh-list
102615634|NCT00004931|Oxaliplatin|oxaliplatin|mesh-list
102615635|NCT00004931|Calcium|calcium|mesh-list
102615636|NCT00004931|Levoleucovorin|levoleucovorin|mesh-list
102615637|NCT00004931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102615638|NCT00004931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615639|NCT00004931|Antimetabolites|antimetabolites|mesh-ancestor
102615640|NCT00004931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615641|NCT00004931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102615642|NCT00004931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615643|NCT00004931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102615644|NCT00004931|Immunologic Factors|immunologic factors|mesh-ancestor
102615645|NCT00004931|Antidotes|antidotes|mesh-ancestor
102615646|NCT00004931|Protective Agents|protective agents|mesh-ancestor
102615647|NCT00004931|Vitamin B Complex|vitamin b complex|mesh-ancestor
102615648|NCT00004931|Vitamins|vitamins|mesh-ancestor
102274861|NCT01326312|Fertility Agents|fertility agents|mesh-ancestor
102615649|NCT00004931|Micronutrients|micronutrients|mesh-ancestor
102615650|NCT00004979|Paclitaxel|paclitaxel|mesh-list
102615651|NCT00004979|Topotecan|topotecan|mesh-list
102615652|NCT00004979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102615653|NCT00004979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615654|NCT00004979|Tubulin Modulators|tubulin modulators|mesh-ancestor
102615655|NCT00004979|Antimitotic Agents|antimitotic agents|mesh-ancestor
102615656|NCT00004979|Mitosis Modulators|mitosis modulators|mesh-ancestor
102615657|NCT00004979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615658|NCT00004979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102615659|NCT00004979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102615660|NCT00004979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615661|NCT00004985|Nelfinavir|nelfinavir|mesh-list
102615662|NCT00004985|Capravirine|capravirine|mesh-list
102615663|NCT00004985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102615664|NCT00004985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102615665|NCT00004985|Protease Inhibitors|protease inhibitors|mesh-ancestor
102615666|NCT00004985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615667|NCT00004985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615668|NCT00004985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102615669|NCT00004985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102615670|NCT00004985|Antiviral Agents|antiviral agents|mesh-ancestor
102615671|NCT00004985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102615672|NCT00004985|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102615673|NCT00004985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102615674|NCT00004997|Leucovorin|leucovorin|mesh-list
102615675|NCT00004997|Antidotes|antidotes|mesh-ancestor
102615676|NCT00004997|Protective Agents|protective agents|mesh-ancestor
102615677|NCT00004997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615678|NCT00004997|Vitamin B Complex|vitamin b complex|mesh-ancestor
102615679|NCT00004997|Vitamins|vitamins|mesh-ancestor
102615680|NCT00004997|Micronutrients|micronutrients|mesh-ancestor
102615681|NCT00005009|Vaccines|vaccines|mesh-list
102615682|NCT00005009|Immunologic Factors|immunologic factors|mesh-ancestor
102615683|NCT00005009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615684|NCT00004583|Ritonavir|ritonavir|mesh-list
102615685|NCT00004583|Lopinavir|lopinavir|mesh-list
102615686|NCT00004583|Nelfinavir|nelfinavir|mesh-list
102615687|NCT00004583|Lamivudine|lamivudine|mesh-list
102615688|NCT00004583|Stavudine|stavudine|mesh-list
102615689|NCT00004583|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102615690|NCT00004583|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102615691|NCT00004583|Protease Inhibitors|protease inhibitors|mesh-ancestor
102615692|NCT00004583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615693|NCT00004583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615694|NCT00004583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102615695|NCT00004583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102615696|NCT00004583|Antiviral Agents|antiviral agents|mesh-ancestor
102615697|NCT00004583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102615698|NCT00004583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102615699|NCT00004583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102615700|NCT00004583|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102615701|NCT00004583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102615702|NCT00004583|Antimetabolites|antimetabolites|mesh-ancestor
102615703|NCT00005015|Fluoxetine|fluoxetine|mesh-list
102615704|NCT00005015|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102615705|NCT00005015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102615706|NCT00005015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102615707|NCT00005015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615708|NCT00005015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102615709|NCT00005015|Serotonin Agents|serotonin agents|mesh-ancestor
102615710|NCT00005015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615711|NCT00005015|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102615712|NCT00005015|Antidepressive Agents|antidepressive agents|mesh-ancestor
102615713|NCT00005015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102615714|NCT00005015|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102615715|NCT00005015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102615716|NCT00005015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615717|NCT00004637|Vitamin E|vitamin e|mesh-list
102615718|NCT00004637|Vitamins|vitamins|mesh-ancestor
102615719|NCT00004637|Micronutrients|micronutrients|mesh-ancestor
102615720|NCT00004637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615721|NCT00004637|Antioxidants|antioxidants|mesh-ancestor
101903996|NCT03556904|Docetaxel|docetaxel|mesh-list
102615722|NCT00004637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615723|NCT00004637|Protective Agents|protective agents|mesh-ancestor
102615724|NCT00005021|Paclitaxel|paclitaxel|mesh-list
102615725|NCT00005021|Carboplatin|carboplatin|mesh-list
102274862|NCT01326312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102615726|NCT00005021|Topotecan|topotecan|mesh-list
102615727|NCT00005021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102615728|NCT00005021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615729|NCT00005021|Tubulin Modulators|tubulin modulators|mesh-ancestor
102615730|NCT00005021|Antimitotic Agents|antimitotic agents|mesh-ancestor
102615731|NCT00005021|Mitosis Modulators|mitosis modulators|mesh-ancestor
102615732|NCT00005021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615733|NCT00005021|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102615734|NCT00005021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102615735|NCT00005021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615736|NCT00004643|Cytarabine|cytarabine|mesh-list
102615737|NCT00004643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102615738|NCT00004643|Antimetabolites|antimetabolites|mesh-ancestor
102615739|NCT00004643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615740|NCT00004643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615741|NCT00004643|Antiviral Agents|antiviral agents|mesh-ancestor
102615742|NCT00004643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102615743|NCT00004643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102615744|NCT00004643|Immunologic Factors|immunologic factors|mesh-ancestor
101587897|NCT03763162|Dermatologic Agents|dermatologic agents|mesh-ancestor
102615745|NCT00004643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615746|NCT00005033|Trastuzumab|trastuzumab|mesh-list
102615747|NCT00005033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102615748|NCT00005033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615749|NCT00005039|Vaccines|vaccines|mesh-list
102615750|NCT00005039|Immunologic Factors|immunologic factors|mesh-ancestor
102615751|NCT00005039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615752|NCT00004685|Albuterol|albuterol|mesh-list
102615753|NCT00004685|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102615754|NCT00004685|Autonomic Agents|autonomic agents|mesh-ancestor
102615755|NCT00004685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102615756|NCT00004685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615757|NCT00004685|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102615758|NCT00004685|Respiratory System Agents|respiratory system agents|mesh-ancestor
102615759|NCT00004685|Tocolytic Agents|tocolytic agents|mesh-ancestor
102615760|NCT00004685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102615761|NCT00004685|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102615762|NCT00004685|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102615763|NCT00004685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102615764|NCT00004685|Adrenergic Agents|adrenergic agents|mesh-ancestor
102615765|NCT00004685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102615766|NCT00004685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615767|NCT00005045|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
102615768|NCT00005045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615769|NCT00005045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102615770|NCT00005045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102615771|NCT00005045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615772|NCT00005045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102615773|NCT00005045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615774|NCT00005051|Paclitaxel|paclitaxel|mesh-list
102615775|NCT00005051|Carboplatin|carboplatin|mesh-list
102615776|NCT00005051|Topotecan|topotecan|mesh-list
102615777|NCT00005051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102615778|NCT00005051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615779|NCT00005051|Tubulin Modulators|tubulin modulators|mesh-ancestor
102615780|NCT00005051|Antimitotic Agents|antimitotic agents|mesh-ancestor
102615781|NCT00005051|Mitosis Modulators|mitosis modulators|mesh-ancestor
102615782|NCT00005051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615783|NCT00005051|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102615784|NCT00005051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102615785|NCT00005051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615786|NCT00004697|Choline|choline|mesh-list
102615787|NCT00004697|Lipotropic Agents|lipotropic agents|mesh-ancestor
102615788|NCT00004697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102615789|NCT00004697|Antimetabolites|antimetabolites|mesh-ancestor
102615790|NCT00004697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615791|NCT00004697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102615792|NCT00004697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102615793|NCT00004697|Nootropic Agents|nootropic agents|mesh-ancestor
102615794|NCT00004727|Aspirin|aspirin|mesh-list
102615795|NCT00004727|Ticlopidine|ticlopidine|mesh-list
102615796|NCT00004727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102274863|NCT01326312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615797|NCT00004727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102615798|NCT00004727|Analgesics|analgesics|mesh-ancestor
102615799|NCT00004727|Sensory System Agents|sensory system agents|mesh-ancestor
102615800|NCT00004727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102615801|NCT00004727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615802|NCT00004727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102615803|NCT00004727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102615804|NCT00004727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102615805|NCT00004727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101587966|NCT02642419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102615806|NCT00004727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615807|NCT00004727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102615808|NCT00004727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102615809|NCT00004727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615810|NCT00004727|Antipyretics|antipyretics|mesh-ancestor
102615811|NCT00004727|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102615812|NCT00004727|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102615813|NCT00004727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102615814|NCT00004727|Purinergic Agents|purinergic agents|mesh-ancestor
102615815|NCT00004727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102615816|NCT00004727|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102615817|NCT00004727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102615818|NCT00004733|Levodopa|levodopa|mesh-list
102615819|NCT00004733|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102615820|NCT00004733|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102615821|NCT00004733|Dopamine Agents|dopamine agents|mesh-ancestor
102615822|NCT00004733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102615823|NCT00004733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615824|NCT00004733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615825|NCT00004739|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102615826|NCT00004739|Antiviral Agents|antiviral agents|mesh-ancestor
102615827|NCT00004739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102615828|NCT00005057|Ganciclovir|ganciclovir|mesh-list
102615829|NCT00005057|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102615830|NCT00005057|Antiviral Agents|antiviral agents|mesh-ancestor
102615831|NCT00005057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102615832|NCT00005057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102615833|NCT00005057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615834|NCT00005057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615835|NCT00004757|Acyclovir|acyclovir|mesh-list
102615836|NCT00004757|Antiviral Agents|antiviral agents|mesh-ancestor
102615837|NCT00004757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102615838|NCT00005069|Arsenic Trioxide|arsenic trioxide|mesh-list
102615839|NCT00005069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615840|NCT00004763|Leuprolide|leuprolide|mesh-list
102615841|NCT00004763|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102615842|NCT00004763|Norethindrone|norethindrone|mesh-list
102615843|NCT00004763|Norethindrone Acetate|norethindrone acetate|mesh-list
102615844|NCT00004763|Norinyl|norinyl|mesh-list
102615845|NCT00004763|Estradiol|estradiol|mesh-list
102615846|NCT00004763|Estrogens|estrogens|mesh-ancestor
102615847|NCT00004763|Hormones|hormones|mesh-ancestor
102615848|NCT00004763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102615849|NCT00004763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615850|NCT00004763|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102615851|NCT00004763|Contraceptive Agents|contraceptive agents|mesh-ancestor
102615852|NCT00004763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102615853|NCT00004763|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102615854|NCT00004763|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102615855|NCT00004763|Fertility Agents|fertility agents|mesh-ancestor
102615856|NCT00004763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102615857|NCT00004763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615858|NCT00004763|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102615859|NCT00004763|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102615860|NCT00004763|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102615861|NCT00004763|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102615862|NCT00004787|Lenograstim|lenograstim|mesh-list
102615863|NCT00004787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102615864|NCT00004787|Immunologic Factors|immunologic factors|mesh-ancestor
102615865|NCT00004787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615866|NCT00005081|Carmustine|carmustine|mesh-list
102615867|NCT00005081|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
102615868|NCT00005081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102615869|NCT00005081|Alkylating Agents|alkylating agents|mesh-ancestor
102615870|NCT00005081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274864|NCT01326312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102615871|NCT00005081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615872|NCT00005081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615873|NCT00005087|Paclitaxel|paclitaxel|mesh-list
102615874|NCT00005087|Cisplatin|cisplatin|mesh-list
102615875|NCT00005087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101588029|NCT02637193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615876|NCT00005087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615877|NCT00005087|Tubulin Modulators|tubulin modulators|mesh-ancestor
102615878|NCT00005087|Antimitotic Agents|antimitotic agents|mesh-ancestor
102615879|NCT00005087|Mitosis Modulators|mitosis modulators|mesh-ancestor
102615880|NCT00005087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615881|NCT00004799|Vaccines|vaccines|mesh-list
102615882|NCT00004799|Immunologic Factors|immunologic factors|mesh-ancestor
102615883|NCT00004799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615884|NCT00005093|Gemcitabine|gemcitabine|mesh-list
102615885|NCT00005093|Tacedinaline|tacedinaline|mesh-list
102615886|NCT00005093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102615887|NCT00005093|Antimetabolites|antimetabolites|mesh-ancestor
102615888|NCT00005093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615889|NCT00005093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615890|NCT00005093|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102615891|NCT00005093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615892|NCT00004811|Itraconazole|itraconazole|mesh-list
102615893|NCT00004811|Antifungal Agents|antifungal agents|mesh-ancestor
102615894|NCT00004811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102615895|NCT00004811|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102615896|NCT00004811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102615897|NCT00004811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615898|NCT00004811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615899|NCT00004811|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102615900|NCT00004811|Hormone Antagonists|hormone antagonists|mesh-ancestor
102615901|NCT00004811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102615902|NCT00004811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615903|NCT00004811|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102615904|NCT00004817|Phenytoin|phenytoin|mesh-list
102615905|NCT00004817|Valproic Acid|valproic acid|mesh-list
102615906|NCT00004817|Anticonvulsants|anticonvulsants|mesh-ancestor
102615907|NCT00004817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615908|NCT00004817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615909|NCT00004817|GABA Agents|gaba agents|mesh-ancestor
102615910|NCT00004817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102615911|NCT00004817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615912|NCT00004817|Antimanic Agents|antimanic agents|mesh-ancestor
102615913|NCT00004817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102615914|NCT00004817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102615915|NCT00004817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102615916|NCT00004817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102615917|NCT00004817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102615918|NCT00004817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102615919|NCT00004817|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102615920|NCT00004817|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102615921|NCT00005117|Pravastatin|pravastatin|mesh-list
102615922|NCT00005117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102615923|NCT00005117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102615924|NCT00005117|Antimetabolites|antimetabolites|mesh-ancestor
102615925|NCT00005117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615926|NCT00005117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102615927|NCT00005117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102615928|NCT00005117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102615929|NCT00385385|KRM 1648|krm 1648|mesh-list
102615930|NCT00385385|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102615931|NCT00385385|Antitubercular Agents|antitubercular agents|mesh-ancestor
102615932|NCT00385385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102615933|NCT00385385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102615934|NCT00385385|Leprostatic Agents|leprostatic agents|mesh-ancestor
101588107|NCT00653341|Insulin|insulin|mesh-list
102615935|NCT00385463|Montelukast|montelukast|mesh-list
102615936|NCT00385463|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102615937|NCT00385463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102615938|NCT00385463|Respiratory System Agents|respiratory system agents|mesh-ancestor
102615939|NCT00385463|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102615940|NCT00385463|Hormone Antagonists|hormone antagonists|mesh-ancestor
102615941|NCT00385463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102615942|NCT00385463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615943|NCT00385463|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102615944|NCT00385463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101904214|NCT01203488|Vitamin A|vitamin a|mesh-list
102615945|NCT00385463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615946|NCT00385463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102615947|NCT00385463|Autonomic Agents|autonomic agents|mesh-ancestor
102615948|NCT00385463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102615949|NCT00385463|Glucocorticoids|glucocorticoids|mesh-ancestor
102615950|NCT00385463|Hormones|hormones|mesh-ancestor
102615951|NCT00385463|Sympathomimetics|sympathomimetics|mesh-ancestor
102615952|NCT00423371|Hyaluronic Acid|hyaluronic acid|mesh-list
102615953|NCT00423371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102615954|NCT00423371|Immunologic Factors|immunologic factors|mesh-ancestor
102615955|NCT00423371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615956|NCT00423371|Viscosupplements|viscosupplements|mesh-ancestor
102615957|NCT00423371|Protective Agents|protective agents|mesh-ancestor
102615958|NCT00005579|Dolastatin 10|dolastatin 10|mesh-list
102615959|NCT00005579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615960|NCT00005579|Tubulin Modulators|tubulin modulators|mesh-ancestor
102615961|NCT00005579|Antimitotic Agents|antimitotic agents|mesh-ancestor
102615962|NCT00005579|Mitosis Modulators|mitosis modulators|mesh-ancestor
102615963|NCT00005579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615964|NCT00005585|Leucovorin|leucovorin|mesh-list
102615965|NCT00005585|Cytarabine|cytarabine|mesh-list
102615966|NCT00005585|Dexamethasone|dexamethasone|mesh-list
102615967|NCT00005585|Cyclophosphamide|cyclophosphamide|mesh-list
102615968|NCT00005585|Methotrexate|methotrexate|mesh-list
102615969|NCT00005585|Vincristine|vincristine|mesh-list
102615970|NCT00005585|Daunorubicin|daunorubicin|mesh-list
102615971|NCT00005585|Asparaginase|asparaginase|mesh-list
102615972|NCT00005585|Mercaptopurine|mercaptopurine|mesh-list
102615973|NCT00005585|Pegaspargase|pegaspargase|mesh-list
102615974|NCT00005585|Thioguanine|thioguanine|mesh-list
102615975|NCT00005585|Levoleucovorin|levoleucovorin|mesh-list
102615976|NCT00005585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102615977|NCT00005585|Immunologic Factors|immunologic factors|mesh-ancestor
102615978|NCT00005585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102615979|NCT00005585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102615980|NCT00005585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102615981|NCT00005585|Alkylating Agents|alkylating agents|mesh-ancestor
102615982|NCT00005585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102615983|NCT00005585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102615984|NCT00005585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102615985|NCT00005585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102615986|NCT00005585|Antiemetics|antiemetics|mesh-ancestor
102615987|NCT00005585|Autonomic Agents|autonomic agents|mesh-ancestor
102615988|NCT00005585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102615989|NCT00005585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102615990|NCT00005585|Glucocorticoids|glucocorticoids|mesh-ancestor
102615991|NCT00005585|Hormones|hormones|mesh-ancestor
102615992|NCT00005585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102615993|NCT00005585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102615994|NCT00005585|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102615995|NCT00005585|Abortifacient Agents|abortifacient agents|mesh-ancestor
102615996|NCT00005585|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102615997|NCT00005585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102615998|NCT00005585|Antimetabolites|antimetabolites|mesh-ancestor
102615999|NCT00005585|Dermatologic Agents|dermatologic agents|mesh-ancestor
102616000|NCT00005585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102616001|NCT00005585|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102616002|NCT00005585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102616003|NCT00005585|Antiviral Agents|antiviral agents|mesh-ancestor
102616004|NCT00005585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102616005|NCT00005585|Antidotes|antidotes|mesh-ancestor
102616006|NCT00005585|Protective Agents|protective agents|mesh-ancestor
102616007|NCT00005585|Vitamin B Complex|vitamin b complex|mesh-ancestor
102616008|NCT00005585|Vitamins|vitamins|mesh-ancestor
102616009|NCT00005585|Micronutrients|micronutrients|mesh-ancestor
102616010|NCT00005585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102616011|NCT00005585|Tubulin Modulators|tubulin modulators|mesh-ancestor
102616012|NCT00005585|Antimitotic Agents|antimitotic agents|mesh-ancestor
102616013|NCT00005585|Mitosis Modulators|mitosis modulators|mesh-ancestor
102616014|NCT00005585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102616015|NCT00005585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102616016|NCT00005585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102616017|NCT00005591|Gemcitabine|gemcitabine|mesh-list
102616018|NCT00005591|Cetuximab|cetuximab|mesh-list
102274865|NCT01326312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274866|NCT01321554|Lenvatinib|lenvatinib|mesh-list
102616019|NCT00005591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102616020|NCT00005591|Antimetabolites|antimetabolites|mesh-ancestor
102616021|NCT00005591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616022|NCT00005591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616023|NCT00005591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102616024|NCT01926444|Trimebutine|trimebutine|mesh-list
102616025|NCT01926444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102616026|NCT01926444|Parasympatholytics|parasympatholytics|mesh-ancestor
102616027|NCT01926444|Autonomic Agents|autonomic agents|mesh-ancestor
102616028|NCT01926444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102616029|NCT01926444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616030|NCT00005597|Temozolomide|temozolomide|mesh-list
102616031|NCT00005597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102616032|NCT00005597|Alkylating Agents|alkylating agents|mesh-ancestor
102616033|NCT00005597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616034|NCT00005597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616035|NCT04172844|Azacitidine|azacitidine|mesh-list
102616036|NCT04172844|Venetoclax|venetoclax|mesh-list
102616037|NCT04172844|Enzyme Inhibitors|enzyme inhibitors|mesh-list
102616038|NCT04172844|Pevonedistat|pevonedistat|mesh-list
102616039|NCT04172844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102616040|NCT04172844|Antimetabolites|antimetabolites|mesh-ancestor
102616041|NCT04172844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616042|NCT04172844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616043|NCT00005603|Cytarabine|cytarabine|mesh-list
102616044|NCT00005603|Dexamethasone|dexamethasone|mesh-list
102616045|NCT00005603|Prednisone|prednisone|mesh-list
102616046|NCT00005603|Cyclophosphamide|cyclophosphamide|mesh-list
102616047|NCT00005603|Doxorubicin|doxorubicin|mesh-list
102616048|NCT00005603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102616049|NCT00005603|Methotrexate|methotrexate|mesh-list
102616050|NCT00005603|Vincristine|vincristine|mesh-list
102616051|NCT00005603|Daunorubicin|daunorubicin|mesh-list
102616052|NCT00005603|Asparaginase|asparaginase|mesh-list
102616053|NCT00005603|Mercaptopurine|mercaptopurine|mesh-list
102616054|NCT00005603|Thioguanine|thioguanine|mesh-list
102616055|NCT00005603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102616056|NCT00005603|Immunologic Factors|immunologic factors|mesh-ancestor
102616057|NCT00005603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616058|NCT00005603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102616059|NCT00005603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102616060|NCT00005603|Alkylating Agents|alkylating agents|mesh-ancestor
102616061|NCT00005603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616062|NCT00005603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616063|NCT00005603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102616064|NCT00005603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102616065|NCT00005603|Antiemetics|antiemetics|mesh-ancestor
102616066|NCT00005603|Autonomic Agents|autonomic agents|mesh-ancestor
102616067|NCT00005603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102616068|NCT00005603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102616069|NCT00005603|Glucocorticoids|glucocorticoids|mesh-ancestor
102616070|NCT00005603|Hormones|hormones|mesh-ancestor
102616071|NCT00005603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102616072|NCT00005603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102616073|NCT00005603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102616074|NCT00005603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102616075|NCT00005603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102616076|NCT00005603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102616077|NCT00005603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102616078|NCT00005603|Abortifacient Agents|abortifacient agents|mesh-ancestor
102616079|NCT00005603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102616080|NCT00005603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102616081|NCT00005603|Antimetabolites|antimetabolites|mesh-ancestor
102616082|NCT00005603|Dermatologic Agents|dermatologic agents|mesh-ancestor
102616083|NCT00005603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102616084|NCT00005603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102616085|NCT00005603|Antiviral Agents|antiviral agents|mesh-ancestor
102616086|NCT00005603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102616087|NCT00005603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102616088|NCT00005603|Tubulin Modulators|tubulin modulators|mesh-ancestor
102616089|NCT00005603|Antimitotic Agents|antimitotic agents|mesh-ancestor
102616090|NCT00005603|Mitosis Modulators|mitosis modulators|mesh-ancestor
102616091|NCT00005609|Rituximab|rituximab|mesh-list
102616092|NCT00005609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102616093|NCT00005609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616094|NCT00005609|Immunologic Factors|immunologic factors|mesh-ancestor
102616095|NCT00005609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616096|NCT00005609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102274867|NCT01321554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616097|NCT00005615|Interferons|interferons|mesh-list
102616099|NCT00005615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616100|NCT00005615|Antiviral Agents|antiviral agents|mesh-ancestor
102616101|NCT00005615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102616102|NCT00005615|Immunologic Factors|immunologic factors|mesh-ancestor
102616103|NCT00005615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616104|NCT00005627|Carboplatin|carboplatin|mesh-list
102616105|NCT00005627|Docetaxel|docetaxel|mesh-list
102616106|NCT00005627|Estramustine|estramustine|mesh-list
102616107|NCT00005627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616108|NCT00005627|Tubulin Modulators|tubulin modulators|mesh-ancestor
102616109|NCT00005627|Antimitotic Agents|antimitotic agents|mesh-ancestor
102616110|NCT00005627|Mitosis Modulators|mitosis modulators|mesh-ancestor
102616111|NCT00005627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616112|NCT00005627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102616113|NCT00005627|Alkylating Agents|alkylating agents|mesh-ancestor
102616114|NCT00005627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102616115|NCT00005639|Azacitidine|azacitidine|mesh-list
102616116|NCT00005639|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
102616117|NCT00005639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102616118|NCT00005639|Antimetabolites|antimetabolites|mesh-ancestor
102616119|NCT00005639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616120|NCT00005639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616121|NCT00005639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102616122|NCT00005663|Valacyclovir|valacyclovir|mesh-list
102616123|NCT00005663|Antiviral Agents|antiviral agents|mesh-ancestor
102616124|NCT00005663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102616125|NCT00385853|Temozolomide|temozolomide|mesh-list
102616126|NCT00385853|Vatalanib|vatalanib|mesh-list
102616127|NCT00385853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102616128|NCT00385853|Alkylating Agents|alkylating agents|mesh-ancestor
102616129|NCT00385853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616130|NCT00385853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616131|NCT00385853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102616132|NCT00385853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102616133|NCT00005765|Nicotine|nicotine|mesh-list
102616134|NCT00005765|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102616135|NCT00005765|Autonomic Agents|autonomic agents|mesh-ancestor
102616136|NCT00005765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102616137|NCT00005765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616138|NCT00005765|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102616139|NCT00005765|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102616140|NCT00005765|Cholinergic Agents|cholinergic agents|mesh-ancestor
102616141|NCT00005765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101588304|NCT03612466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616142|NCT00005765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616143|NCT00005777|Dexamethasone|dexamethasone|mesh-list
102616144|NCT00005777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102616145|NCT00005777|Antiemetics|antiemetics|mesh-ancestor
102616146|NCT00005777|Autonomic Agents|autonomic agents|mesh-ancestor
102616147|NCT00005777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102616148|NCT00005777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616149|NCT00005777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102616150|NCT00005777|Glucocorticoids|glucocorticoids|mesh-ancestor
102616151|NCT00005777|Hormones|hormones|mesh-ancestor
102616152|NCT00005777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102616153|NCT00005777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102616154|NCT00005777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616155|NCT00385931|Valsartan|valsartan|mesh-list
102616156|NCT00385931|Simvastatin|simvastatin|mesh-list
102616157|NCT00385931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102616158|NCT00385931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102616159|NCT00385931|Antimetabolites|antimetabolites|mesh-ancestor
102616160|NCT00385931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616161|NCT00385931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102616162|NCT00385931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102616163|NCT00385931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102616164|NCT00385931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102616165|NCT00385931|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102616166|NCT00385931|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102616167|NCT00386399|Mitomycins|mitomycins|mesh-list
102616168|NCT00386399|Mitomycin|mitomycin|mesh-list
102616169|NCT00386399|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102616170|NCT00386399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616171|NCT00386399|Alkylating Agents|alkylating agents|mesh-ancestor
102616172|NCT00386399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274868|NCT01321554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102616173|NCT00386399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102616174|NCT00386399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102616175|NCT00005807|Epothilones|epothilones|mesh-list
102616176|NCT00005807|Tubulin Modulators|tubulin modulators|mesh-ancestor
102616177|NCT00005807|Antimitotic Agents|antimitotic agents|mesh-ancestor
102616178|NCT00005807|Mitosis Modulators|mitosis modulators|mesh-ancestor
102616179|NCT00005807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616180|NCT00005807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616181|NCT00005813|Antibodies|antibodies|mesh-list
102616182|NCT00005813|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102616183|NCT00005813|Immunologic Factors|immunologic factors|mesh-ancestor
102616184|NCT00005813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616185|NCT04567433|Hydrocortisone|hydrocortisone|mesh-list
102616186|NCT04567433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102616187|NCT00003647|Dacarbazine|dacarbazine|mesh-list
102616188|NCT00003647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102616189|NCT00003647|Alkylating Agents|alkylating agents|mesh-ancestor
102616190|NCT00003647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616191|NCT00003647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616192|NCT05895526|Fluorides|fluorides|mesh-list
102616193|NCT05895526|Fluorides, Topical|fluorides, topical|mesh-list
102616194|NCT05895526|Cariostatic Agents|cariostatic agents|mesh-ancestor
102616195|NCT05895526|Protective Agents|protective agents|mesh-ancestor
102616196|NCT05895526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616197|NCT05895513|Pimavanserin|pimavanserin|mesh-list
102616198|NCT05895513|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102616199|NCT05895513|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102616200|NCT05895513|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102616201|NCT05895513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102616202|NCT05895513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102616203|NCT05895513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616204|NCT05895513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102616205|NCT05895513|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102616206|NCT05895513|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102616207|NCT05895513|Serotonin Agents|serotonin agents|mesh-ancestor
102616208|NCT05895513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102616209|NCT05895513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616210|NCT05895448|Sofosbuvir|sofosbuvir|mesh-list
102616211|NCT05895448|Velpatasvir|velpatasvir|mesh-list
102616212|NCT05895448|Antiviral Agents|antiviral agents|mesh-ancestor
102616213|NCT05895448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102616214|NCT05895370|Interleukin-2|interleukin-2|mesh-list
102616215|NCT05895370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616216|NCT05895370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102616217|NCT05895370|Analgesics|analgesics|mesh-ancestor
102616218|NCT05895370|Sensory System Agents|sensory system agents|mesh-ancestor
102616219|NCT05895370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102616220|NCT05895370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616221|NCT05895305|Paclitaxel|paclitaxel|mesh-list
102616222|NCT05895305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102616223|NCT05895305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616224|NCT05895305|Tubulin Modulators|tubulin modulators|mesh-ancestor
102616225|NCT05895305|Antimitotic Agents|antimitotic agents|mesh-ancestor
102616226|NCT05895305|Mitosis Modulators|mitosis modulators|mesh-ancestor
102616227|NCT05895305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616228|NCT05895240|Urinastatin|urinastatin|mesh-list
102616229|NCT05895240|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102616230|NCT05895240|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102616231|NCT05895240|Protease Inhibitors|protease inhibitors|mesh-ancestor
102616232|NCT05895240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102616233|NCT05895240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616234|NCT05895136|Enoxaparin|enoxaparin|mesh-list
102616235|NCT05895136|Anticoagulants|anticoagulants|mesh-ancestor
102616236|NCT05895136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102616237|NCT05895136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102616238|NCT05895136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616239|NCT05895123|Atorvastatin|atorvastatin|mesh-list
102616240|NCT05895123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102616241|NCT05895123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102274869|NCT01321554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102616242|NCT05895123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102616243|NCT05895123|Antimetabolites|antimetabolites|mesh-ancestor
102616244|NCT05895123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616245|NCT05895123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101904513|NCT00033540|Antimetabolites|antimetabolites|mesh-ancestor
102616246|NCT05895123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102616247|NCT05895123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102616248|NCT05894954|Hormones|hormones|mesh-list
102616249|NCT05894954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102616250|NCT05894954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616251|NCT05894889|Paclitaxel|paclitaxel|mesh-list
102616252|NCT05894889|Carboplatin|carboplatin|mesh-list
102616253|NCT05894889|Pembrolizumab|pembrolizumab|mesh-list
102616254|NCT05894889|Pemetrexed|pemetrexed|mesh-list
102616255|NCT05894889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102616256|NCT05894889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616257|NCT05894889|Tubulin Modulators|tubulin modulators|mesh-ancestor
102616258|NCT05894889|Antimitotic Agents|antimitotic agents|mesh-ancestor
102616259|NCT05894889|Mitosis Modulators|mitosis modulators|mesh-ancestor
102616260|NCT05894889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616261|NCT05894889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102616262|NCT05894889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102616263|NCT05894889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102616264|NCT05894889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102616265|NCT05894889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102616266|NCT05894824|Ramucirumab|ramucirumab|mesh-list
102616267|NCT05894824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616268|NCT05894486|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102616269|NCT05894486|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102616270|NCT05894486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616271|NCT05894447|Pembrolizumab|pembrolizumab|mesh-list
102616272|NCT05894447|Obinutuzumab|obinutuzumab|mesh-list
102616273|NCT05894447|Naptumomab estafenatox|naptumomab estafenatox|mesh-list
102616274|NCT05894447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102616275|NCT05894447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616276|NCT05894447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102616277|NCT05894447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616278|NCT05894447|Immunoconjugates|immunoconjugates|mesh-ancestor
102616279|NCT05894447|Immunologic Factors|immunologic factors|mesh-ancestor
102616280|NCT05894447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616281|NCT05894200|Fluorides|fluorides|mesh-list
102616282|NCT05894200|Cariostatic Agents|cariostatic agents|mesh-ancestor
102616283|NCT05894200|Protective Agents|protective agents|mesh-ancestor
102616284|NCT05894200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616285|NCT05894057|Midazolam|midazolam|mesh-list
102616286|NCT05894057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102616287|NCT05894057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102616288|NCT05894057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102616289|NCT05894057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616290|NCT05894057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102616291|NCT05894057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102616292|NCT05894057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102616293|NCT05894057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102616294|NCT05894057|Anesthetics, General|anesthetics, general|mesh-ancestor
102616295|NCT05894057|Anesthetics|anesthetics|mesh-ancestor
102616296|NCT05894057|GABA Modulators|gaba modulators|mesh-ancestor
102616297|NCT05894057|GABA Agents|gaba agents|mesh-ancestor
102616298|NCT05894057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102616299|NCT05894057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616300|NCT05893888|Cisplatin|cisplatin|mesh-list
102616301|NCT05893888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616302|NCT05893810|Mupirocin|mupirocin|mesh-list
102616303|NCT05893810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102616304|NCT05893810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102616305|NCT05893810|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102616306|NCT05893810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102616307|NCT05893810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616308|NCT05893654|Melphalan|melphalan|mesh-list
102616309|NCT05893654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102616310|NCT05893654|Alkylating Agents|alkylating agents|mesh-ancestor
102616311|NCT05893654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616312|NCT05893654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616313|NCT05893654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102616314|NCT05893654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102616315|NCT05893654|Immunologic Factors|immunologic factors|mesh-ancestor
102616316|NCT05893654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616317|NCT05893511|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101904586|NCT03952572|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102616318|NCT05893511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102616319|NCT05893472|Venetoclax|venetoclax|mesh-list
102616320|NCT05893472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616322|NCT05892913|Ephedrine|ephedrine|mesh-list
102616323|NCT05892913|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102616324|NCT05892913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102616325|NCT05892913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102616326|NCT05892913|Autonomic Agents|autonomic agents|mesh-ancestor
102616327|NCT05892913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102616328|NCT05892913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616329|NCT05892913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102616330|NCT05892913|Respiratory System Agents|respiratory system agents|mesh-ancestor
102616331|NCT05892913|Mydriatics|mydriatics|mesh-ancestor
102616332|NCT05892913|Parasympatholytics|parasympatholytics|mesh-ancestor
102616333|NCT05892913|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102616334|NCT05892913|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102616335|NCT05892913|Cholinergic Agents|cholinergic agents|mesh-ancestor
102616336|NCT05892913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102616337|NCT05892913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616338|NCT05892913|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102616339|NCT05892913|Sympathomimetics|sympathomimetics|mesh-ancestor
102616340|NCT05892913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102616341|NCT05892913|Adrenergic Agents|adrenergic agents|mesh-ancestor
102616342|NCT05889741|Ropivacaine|ropivacaine|mesh-list
102616343|NCT05889741|Anesthetics, Local|anesthetics, local|mesh-ancestor
102616344|NCT05889741|Anesthetics|anesthetics|mesh-ancestor
102616345|NCT05889741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102616346|NCT05889741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616347|NCT05889741|Sensory System Agents|sensory system agents|mesh-ancestor
102616348|NCT05889741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102616349|NCT05887830|Nivolumab|nivolumab|mesh-list
102616350|NCT05887830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102616351|NCT05887830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616352|NCT05887830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102616353|NCT05887830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616354|NCT05885230|Lidocaine|lidocaine|mesh-list
102616355|NCT05885230|Bupivacaine|bupivacaine|mesh-list
102616356|NCT05885230|Anesthetics, Local|anesthetics, local|mesh-ancestor
102616357|NCT05885230|Anesthetics|anesthetics|mesh-ancestor
102616358|NCT05885230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102616359|NCT05885230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616360|NCT05885230|Sensory System Agents|sensory system agents|mesh-ancestor
102616361|NCT05885230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102616362|NCT05885230|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102616363|NCT05885230|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102616364|NCT05885230|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102616365|NCT05885230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102616366|NCT05885230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616367|NCT05877027|Diclofenac|diclofenac|mesh-list
102616368|NCT05877027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102616369|NCT05877027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102616370|NCT05877027|Analgesics|analgesics|mesh-ancestor
102616371|NCT05877027|Sensory System Agents|sensory system agents|mesh-ancestor
102616372|NCT05877027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102616373|NCT05877027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616374|NCT05877027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102616375|NCT05877027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102616376|NCT05877027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102616377|NCT05877027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102616378|NCT05877027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616379|NCT05861258|Minocycline|minocycline|mesh-list
102616380|NCT05861258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102616381|NCT05861258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102616382|NCT05807204|Acetylcysteine|acetylcysteine|mesh-list
102616383|NCT05807204|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102616384|NCT05807204|Antiviral Agents|antiviral agents|mesh-ancestor
102616385|NCT05807204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102616386|NCT05807204|Expectorants|expectorants|mesh-ancestor
102616387|NCT05807204|Respiratory System Agents|respiratory system agents|mesh-ancestor
102616388|NCT05807204|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102616389|NCT05807204|Antioxidants|antioxidants|mesh-ancestor
102616390|NCT05807204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616391|NCT05807204|Protective Agents|protective agents|mesh-ancestor
102274870|NCT01321554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274871|NCT01308437|Insulin|insulin|mesh-list
102274872|NCT01308437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102616392|NCT05807204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616393|NCT05807204|Antidotes|antidotes|mesh-ancestor
102616394|NCT05784571|Insulin|insulin|mesh-list
102616395|NCT05784571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102616396|NCT05784571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616397|NCT05779943|Furosemide|furosemide|mesh-list
102616398|NCT05779943|Fluorides|fluorides|mesh-list
102616399|NCT05779943|Diuretics|diuretics|mesh-ancestor
102616400|NCT05779943|Natriuretic Agents|natriuretic agents|mesh-ancestor
102616401|NCT05779943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616402|NCT05779943|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102616403|NCT05779943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102616404|NCT05779943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616405|NCT05779943|Cariostatic Agents|cariostatic agents|mesh-ancestor
102616406|NCT05779943|Protective Agents|protective agents|mesh-ancestor
102616407|NCT05779007|Pirfenidone|pirfenidone|mesh-list
102616408|NCT05779007|Nintedanib|nintedanib|mesh-list
102616409|NCT05779007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616410|NCT05779007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102616411|NCT05779007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102616412|NCT05779007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616413|NCT05779007|Analgesics|analgesics|mesh-ancestor
102616414|NCT05779007|Sensory System Agents|sensory system agents|mesh-ancestor
102616415|NCT05779007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102616416|NCT05779007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616417|NCT05779007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102616418|NCT05779007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102616419|NCT05779007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102616420|NCT05779007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102616421|NCT05775471|Pembrolizumab|pembrolizumab|mesh-list
102616422|NCT05775471|Immunoconjugates|immunoconjugates|mesh-list
102616423|NCT05775471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102616424|NCT05775471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616425|NCT05775471|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102616426|NCT05775471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616427|NCT05775471|Immunologic Factors|immunologic factors|mesh-ancestor
102616428|NCT05775471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616429|NCT05767047|Apremilast|apremilast|mesh-list
102616430|NCT05767047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102616431|NCT05767047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102616432|NCT05767047|Analgesics|analgesics|mesh-ancestor
102616433|NCT05767047|Sensory System Agents|sensory system agents|mesh-ancestor
102616434|NCT05767047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102616435|NCT05767047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616436|NCT05767047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102616437|NCT05767047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102616438|NCT05767047|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102616439|NCT05767047|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102616440|NCT05767047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102616441|NCT05767047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616442|NCT05727098|Ketamine|ketamine|mesh-list
102616443|NCT05727098|Bupivacaine|bupivacaine|mesh-list
102616444|NCT05727098|Anesthetics, Local|anesthetics, local|mesh-list
102616445|NCT05727098|Anesthetics|anesthetics|mesh-list
102616446|NCT05727098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102616447|NCT05727098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616448|NCT05727098|Sensory System Agents|sensory system agents|mesh-ancestor
102616449|NCT05727098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102616450|NCT05727098|Analgesics|analgesics|mesh-ancestor
102616451|NCT05727098|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102616452|NCT05727098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102616453|NCT05727098|Anesthetics, General|anesthetics, general|mesh-ancestor
102616454|NCT05727098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102616455|NCT05727098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102616456|NCT05727098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102616457|NCT05727098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616458|NCT05717062|Varespladib methyl|varespladib methyl|mesh-list
102616459|NCT05717062|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
102616460|NCT05717062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102616461|NCT05717062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616462|NCT05677451|Remibrutinib|remibrutinib|mesh-list
102616463|NCT05677451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101904735|NCT03216226|Glucagon|glucagon|mesh-list
102274873|NCT01308437|Isophane Insulin, Human|isophane insulin, human|mesh-list
102616464|NCT05677451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102616465|NCT05677451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616467|NCT05656352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102616468|NCT05656352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102616469|NCT05656352|Analgesics|analgesics|mesh-ancestor
102616470|NCT05656352|Sensory System Agents|sensory system agents|mesh-ancestor
102616471|NCT05656352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102616472|NCT05656352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616473|NCT05656352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102616474|NCT05656352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102616475|NCT05638620|Bupivacaine|bupivacaine|mesh-list
102616476|NCT05638620|Anesthetics, Local|anesthetics, local|mesh-ancestor
102616477|NCT05638620|Anesthetics|anesthetics|mesh-ancestor
102616478|NCT05638620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102616479|NCT05638620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616480|NCT05638620|Sensory System Agents|sensory system agents|mesh-ancestor
102616481|NCT05638620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102616482|NCT05632809|Durvalumab|durvalumab|mesh-list
102616483|NCT05632809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102616484|NCT05632809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616485|NCT05610527|Etonogestrel|etonogestrel|mesh-list
102616486|NCT05610527|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102616487|NCT05610527|Contraceptive Agents|contraceptive agents|mesh-ancestor
102616488|NCT05610527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102616489|NCT05610527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616490|NCT05610527|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102616491|NCT05608369|Vorinostat|vorinostat|mesh-list
102616492|NCT05608369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616493|NCT05608369|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102616494|NCT05608369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102616495|NCT05608369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616496|NCT05590468|Niacinamide|niacinamide|mesh-list
102616497|NCT05590468|Niacin|niacin|mesh-list
102616498|NCT05590468|Nicotinic Acids|nicotinic acids|mesh-list
102616499|NCT05590468|Vitamin B Complex|vitamin b complex|mesh-ancestor
102616500|NCT05590468|Vitamins|vitamins|mesh-ancestor
102616501|NCT05590468|Micronutrients|micronutrients|mesh-ancestor
102616502|NCT05590468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616503|NCT05590468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102616504|NCT05590468|Antimetabolites|antimetabolites|mesh-ancestor
102616505|NCT05590468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616506|NCT05590468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102616507|NCT05590468|Vasodilator Agents|vasodilator agents|mesh-ancestor
102616508|NCT05565560|Apremilast|apremilast|mesh-list
102616509|NCT05565560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102616510|NCT05565560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102616511|NCT05565560|Analgesics|analgesics|mesh-ancestor
102616512|NCT05565560|Sensory System Agents|sensory system agents|mesh-ancestor
102616513|NCT05565560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102616514|NCT05565560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616515|NCT05565560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102616516|NCT05565560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102616517|NCT05565560|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102616518|NCT05565560|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102616519|NCT05565560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102616520|NCT05565560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616521|NCT05564546|Nitric Oxide|nitric oxide|mesh-list
102616522|NCT05564546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102616523|NCT05564546|Autonomic Agents|autonomic agents|mesh-ancestor
102616524|NCT05564546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102616525|NCT05564546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616526|NCT05564546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102616527|NCT05564546|Respiratory System Agents|respiratory system agents|mesh-ancestor
102616528|NCT05564546|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102616529|NCT05564546|Antioxidants|antioxidants|mesh-ancestor
102616530|NCT05564546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616531|NCT05564546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102616532|NCT05564546|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102616533|NCT05564546|Vasodilator Agents|vasodilator agents|mesh-ancestor
102274874|NCT01308437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102274875|NCT01308437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616534|NCT05564546|Gasotransmitters|gasotransmitters|mesh-ancestor
102616535|NCT05564546|Protective Agents|protective agents|mesh-ancestor
102616536|NCT05527808|Carboplatin|carboplatin|mesh-list
102616537|NCT05527808|Pemetrexed|pemetrexed|mesh-list
102616538|NCT05527808|Tislelizumab|tislelizumab|mesh-list
102616539|NCT05527808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616540|NCT05527808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102616541|NCT05527808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616542|NCT05527808|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102616543|NCT05527808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102616544|NCT05527808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102616545|NCT05496335|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102616546|NCT05496335|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102616547|NCT05496335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102616548|NCT05496335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616549|NCT05496335|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102616550|NCT05496335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102616551|NCT05496335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616552|NCT05496335|Cholinergic Agents|cholinergic agents|mesh-ancestor
102616553|NCT05496335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102616554|NCT05480098|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102616555|NCT05480098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102616556|NCT05480098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102616557|NCT05480098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102616558|NCT05480098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102616559|NCT05480098|Adrenergic Agents|adrenergic agents|mesh-ancestor
102616560|NCT05480098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102616561|NCT05480098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616562|NCT05480098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616563|NCT05426031|Protamines|protamines|mesh-list
102616564|NCT05426031|Heparin Antagonists|heparin antagonists|mesh-ancestor
102616565|NCT05426031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616566|NCT05426031|Coagulants|coagulants|mesh-ancestor
102616567|NCT05423106|Tenofovir|tenofovir|mesh-list
102616568|NCT05423106|Entecavir|entecavir|mesh-list
102616569|NCT05423106|Antiviral Agents|antiviral agents|mesh-ancestor
102616570|NCT05423106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102616571|NCT05423106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102616572|NCT05423106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102616573|NCT05423106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102616574|NCT05423106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616575|NCT05423106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102616576|NCT05423106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102616577|NCT05399277|Rivaroxaban|rivaroxaban|mesh-list
102616578|NCT05399277|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102616579|NCT05399277|Antithrombins|antithrombins|mesh-ancestor
102616580|NCT05399277|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102616581|NCT05399277|Protease Inhibitors|protease inhibitors|mesh-ancestor
102616582|NCT05399277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102616583|NCT05399277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616584|NCT05399277|Anticoagulants|anticoagulants|mesh-ancestor
102616585|NCT05362409|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102616586|NCT05362409|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102616587|NCT05362409|Dermatologic Agents|dermatologic agents|mesh-ancestor
102616588|NCT05319873|Carboplatin|carboplatin|mesh-list
102616589|NCT05319873|Docetaxel|docetaxel|mesh-list
102616590|NCT05319873|Trastuzumab|trastuzumab|mesh-list
102616591|NCT05319873|Fulvestrant|fulvestrant|mesh-list
102616592|NCT05319873|Pertuzumab|pertuzumab|mesh-list
102616593|NCT05319873|Tucatinib|tucatinib|mesh-list
102616594|NCT05319873|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
102616595|NCT05319873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102616596|NCT05319873|Antibodies|antibodies|mesh-list
102616597|NCT05319873|Immunoglobulins|immunoglobulins|mesh-list
102616598|NCT05319873|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102616599|NCT05319873|Immunologic Factors|immunologic factors|mesh-ancestor
102616600|NCT05319873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616601|NCT05319873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616602|NCT05319873|Tubulin Modulators|tubulin modulators|mesh-ancestor
102616603|NCT05319873|Antimitotic Agents|antimitotic agents|mesh-ancestor
102616604|NCT05319873|Mitosis Modulators|mitosis modulators|mesh-ancestor
102616605|NCT05319873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616606|NCT05319873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102616607|NCT05319873|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102274876|NCT01268293|Lenvatinib|lenvatinib|mesh-list
102616608|NCT05319873|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102274877|NCT01268293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274878|NCT01268293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102616609|NCT05319873|Hormone Antagonists|hormone antagonists|mesh-ancestor
102616610|NCT05319873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102616611|NCT05319873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102616612|NCT05319873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102616613|NCT05249452|Hydroxyurea|hydroxyurea|mesh-list
102616614|NCT05249452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616615|NCT05249452|Antisickling Agents|antisickling agents|mesh-ancestor
102616616|NCT05249452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102616617|NCT05249452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616618|NCT05249452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102616619|NCT05239741|Leucovorin|leucovorin|mesh-list
102616620|NCT05239741|Bevacizumab|bevacizumab|mesh-list
102616621|NCT05239741|Pembrolizumab|pembrolizumab|mesh-list
102616622|NCT05239741|Cetuximab|cetuximab|mesh-list
102616623|NCT05239741|Fluorouracil|fluorouracil|mesh-list
102616624|NCT05239741|Oxaliplatin|oxaliplatin|mesh-list
102616625|NCT05239741|Irinotecan|irinotecan|mesh-list
102616626|NCT05239741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102616627|NCT05239741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616628|NCT05239741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102616629|NCT05239741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102616630|NCT05239741|Growth Substances|growth substances|mesh-ancestor
102616631|NCT05239741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616632|NCT05239741|Growth Inhibitors|growth inhibitors|mesh-ancestor
102616633|NCT05239741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102616634|NCT05239741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616635|NCT05239741|Antimetabolites|antimetabolites|mesh-ancestor
102616636|NCT05239741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102616637|NCT05239741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102616638|NCT05239741|Immunologic Factors|immunologic factors|mesh-ancestor
102616639|NCT05239741|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102616640|NCT05239741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102616641|NCT05239741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102616642|NCT05239741|Antidotes|antidotes|mesh-ancestor
102616643|NCT05239741|Protective Agents|protective agents|mesh-ancestor
102616644|NCT05239741|Vitamin B Complex|vitamin b complex|mesh-ancestor
102616645|NCT05239741|Vitamins|vitamins|mesh-ancestor
102616646|NCT05239741|Micronutrients|micronutrients|mesh-ancestor
102616647|NCT05188326|Azacitidine|azacitidine|mesh-list
102616648|NCT05188326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102616649|NCT05188326|Antimetabolites|antimetabolites|mesh-ancestor
102616650|NCT05188326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616651|NCT05188326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101588828|NCT02837614|Analgesics|analgesics|mesh-ancestor
102616652|NCT05188326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102616653|NCT05180942|Atorvastatin|atorvastatin|mesh-list
102616654|NCT05180942|Calcium|calcium|mesh-list
102616655|NCT05180942|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102616656|NCT05180942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616657|NCT05180942|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102616658|NCT05180942|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102616659|NCT05180942|Antimetabolites|antimetabolites|mesh-ancestor
102616660|NCT05180942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616661|NCT05180942|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102616662|NCT05180942|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102616663|NCT05180942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102616664|NCT05164653|Valsartan|valsartan|mesh-list
102616665|NCT05164653|Angiotensin II|angiotensin ii|mesh-list
102616666|NCT05164653|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102616667|NCT05164653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
102616668|NCT05164653|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102616669|NCT05164653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102616670|NCT05164653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102616671|NCT05164653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616672|NCT05164653|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102616673|NCT05164653|Protease Inhibitors|protease inhibitors|mesh-ancestor
102616674|NCT05164653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102616675|NCT05160896|Bevacizumab|bevacizumab|mesh-list
102616676|NCT05160896|Cetuximab|cetuximab|mesh-list
102616677|NCT05160896|Irinotecan|irinotecan|mesh-list
102616678|NCT05160896|Raltitrexed|raltitrexed|mesh-list
102616679|NCT05160896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102616680|NCT05160896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616681|NCT05160896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102274879|NCT01268293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102274880|NCT01268293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616682|NCT05160896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102616683|NCT05160896|Growth Substances|growth substances|mesh-ancestor
102616684|NCT05160896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616685|NCT05160896|Growth Inhibitors|growth inhibitors|mesh-ancestor
102616686|NCT05160896|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102616687|NCT05160896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102616688|NCT05160896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102616689|NCT05160896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616690|NCT05160896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102616691|NCT05160896|Antimetabolites|antimetabolites|mesh-ancestor
102616692|NCT05160896|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102616693|NCT05129670|Calcium Carbonate|calcium carbonate|mesh-list
102616694|NCT05129670|Antacids|antacids|mesh-ancestor
102616695|NCT05129670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616696|NCT05129670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102616697|NCT05128617|Paclitaxel|paclitaxel|mesh-list
102616698|NCT05128617|Cyclophosphamide|cyclophosphamide|mesh-list
102616699|NCT05128617|Epirubicin|epirubicin|mesh-list
102616700|NCT05128617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102616701|NCT05128617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616702|NCT05128617|Tubulin Modulators|tubulin modulators|mesh-ancestor
102616703|NCT05128617|Antimitotic Agents|antimitotic agents|mesh-ancestor
102616704|NCT05128617|Mitosis Modulators|mitosis modulators|mesh-ancestor
102616705|NCT05128617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616706|NCT05128617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102616707|NCT05128617|Immunologic Factors|immunologic factors|mesh-ancestor
102616708|NCT05128617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616709|NCT05128617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102616710|NCT05128617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102616711|NCT05128617|Alkylating Agents|alkylating agents|mesh-ancestor
102616712|NCT05128617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102616713|NCT05128617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102616714|NCT05128617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102616715|NCT05128617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102616716|NCT05128617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102616717|NCT05107375|Vaccines|vaccines|mesh-list
102616718|NCT05107375|Immunologic Factors|immunologic factors|mesh-ancestor
102616719|NCT05107375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616720|NCT05094128|Upadacitinib|upadacitinib|mesh-list
102616721|NCT05094128|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102616722|NCT05094128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102616723|NCT05094128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102616724|NCT05094128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616725|NCT05094128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102616726|NCT05065957|Capecitabine|capecitabine|mesh-list
102616727|NCT05065957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102616728|NCT05065957|Antimetabolites|antimetabolites|mesh-ancestor
102616729|NCT05065957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616730|NCT05065957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616731|NCT05031520|Metoprolol|metoprolol|mesh-list
102616732|NCT05031520|Nitroglycerin|nitroglycerin|mesh-list
102616733|NCT05031520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102616734|NCT05031520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102616735|NCT05031520|Sympatholytics|sympatholytics|mesh-ancestor
102616736|NCT05031520|Autonomic Agents|autonomic agents|mesh-ancestor
102616737|NCT05031520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102616738|NCT05031520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616739|NCT05031520|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102616740|NCT05031520|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102616741|NCT05031520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102616742|NCT05031520|Adrenergic Agents|adrenergic agents|mesh-ancestor
102616743|NCT05031520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102616744|NCT05031520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616745|NCT05031520|Vasodilator Agents|vasodilator agents|mesh-ancestor
102616746|NCT04989829|Omeprazole|omeprazole|mesh-list
102616747|NCT04989829|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102616748|NCT04989829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102616749|NCT04989829|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102616750|NCT04989829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102616751|NCT04989829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616752|NCT04988035|Remdesivir|remdesivir|mesh-list
102616753|NCT04988035|Antimetabolites|antimetabolites|mesh-ancestor
102616754|NCT04988035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616755|NCT04988035|Antiviral Agents|antiviral agents|mesh-ancestor
102616756|NCT04988035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102616757|NCT04939792|Vitamin D|vitamin d|mesh-list
102616758|NCT04939792|Ergocalciferols|ergocalciferols|mesh-list
102616759|NCT04939792|Cholecalciferol|cholecalciferol|mesh-list
102616760|NCT04939792|Vitamins|vitamins|mesh-list
102616761|NCT04939792|Micronutrients|micronutrients|mesh-ancestor
102616762|NCT04939792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616763|NCT04939792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102616764|NCT04939792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102616765|NCT04850495|Prednisone|prednisone|mesh-list
102616766|NCT04850495|Cortisone|cortisone|mesh-list
102616767|NCT04850495|Cyclophosphamide|cyclophosphamide|mesh-list
102616768|NCT04850495|Rituximab|rituximab|mesh-list
102616769|NCT04850495|Doxorubicin|doxorubicin|mesh-list
102616770|NCT04850495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102616771|NCT04850495|Vincristine|vincristine|mesh-list
102616772|NCT04850495|Zanubrutinib|zanubrutinib|mesh-list
102616773|NCT04850495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102616774|NCT04850495|Antibodies|antibodies|mesh-list
102616775|NCT04850495|Immunoglobulins|immunoglobulins|mesh-list
102616776|NCT04850495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102616777|NCT04850495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102616778|NCT04850495|Immunologic Factors|immunologic factors|mesh-ancestor
102616779|NCT04850495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616780|NCT04850495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102616781|NCT04850495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102616782|NCT04850495|Alkylating Agents|alkylating agents|mesh-ancestor
102616783|NCT04850495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616784|NCT04850495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616785|NCT04850495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102616786|NCT04850495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102616787|NCT04850495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102616788|NCT04850495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102616789|NCT04850495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102616790|NCT04850495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102616791|NCT04850495|Glucocorticoids|glucocorticoids|mesh-ancestor
102616792|NCT04850495|Hormones|hormones|mesh-ancestor
102616793|NCT04850495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102616794|NCT04850495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102616795|NCT04850495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102616796|NCT04850495|Tubulin Modulators|tubulin modulators|mesh-ancestor
102616797|NCT04850495|Antimitotic Agents|antimitotic agents|mesh-ancestor
102616798|NCT04850495|Mitosis Modulators|mitosis modulators|mesh-ancestor
102616799|NCT04850495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102616800|NCT04804735|Anesthetics|anesthetics|mesh-list
102616801|NCT04804735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102616802|NCT04804735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616803|NCT04763135|Mirtazapine|mirtazapine|mesh-list
102616804|NCT04763135|Escitalopram|escitalopram|mesh-list
102616805|NCT04763135|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102616806|NCT04763135|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102616807|NCT04763135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102616808|NCT04763135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616809|NCT04763135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102616810|NCT04763135|Serotonin Agents|serotonin agents|mesh-ancestor
102616811|NCT04763135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616812|NCT04763135|Antidepressive Agents|antidepressive agents|mesh-ancestor
102616813|NCT04763135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102616814|NCT04763135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102616815|NCT04763135|Histamine Antagonists|histamine antagonists|mesh-ancestor
102616816|NCT04763135|Histamine Agents|histamine agents|mesh-ancestor
102616817|NCT04763135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102616818|NCT04763135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102616819|NCT04763135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102616820|NCT04763135|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102616821|NCT04763135|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102616822|NCT04763135|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102616823|NCT04763135|Adrenergic Agents|adrenergic agents|mesh-ancestor
102616824|NCT04763135|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102616825|NCT04763135|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102616826|NCT04763135|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102616827|NCT04762979|Fulvestrant|fulvestrant|mesh-list
102274881|NCT01267175|Insulin|insulin|mesh-list
102274882|NCT01267175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102616828|NCT04762979|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102616829|NCT04762979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102616830|NCT04762979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616831|NCT04762979|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102616832|NCT04762979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102616833|NCT04762979|Hormone Antagonists|hormone antagonists|mesh-ancestor
102616834|NCT04762979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102616835|NCT04762979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616836|NCT04762979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102616837|NCT04762979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102616838|NCT04762979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616839|NCT04723134|Leucovorin|leucovorin|mesh-list
102616840|NCT04723134|Folic Acid|folic acid|mesh-list
102616841|NCT04723134|Calcium|calcium|mesh-list
102616842|NCT04723134|Levoleucovorin|levoleucovorin|mesh-list
102616843|NCT04723134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102616844|NCT04723134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616845|NCT04723134|Antidotes|antidotes|mesh-ancestor
102616846|NCT04723134|Protective Agents|protective agents|mesh-ancestor
102616847|NCT04723134|Vitamin B Complex|vitamin b complex|mesh-ancestor
102616848|NCT04723134|Vitamins|vitamins|mesh-ancestor
102616849|NCT04723134|Micronutrients|micronutrients|mesh-ancestor
102616850|NCT04723134|Hematinics|hematinics|mesh-ancestor
102616851|NCT04711135|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102616852|NCT04711135|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102616853|NCT04711135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616854|NCT04700072|Pembrolizumab|pembrolizumab|mesh-list
102616855|NCT04700072|Lenvatinib|lenvatinib|mesh-list
102616856|NCT04700072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102616857|NCT04700072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616858|NCT04700072|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102616859|NCT04700072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616860|NCT04700072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102616861|NCT04700072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102616862|NCT04666272|Trametinib|trametinib|mesh-list
102616863|NCT04666272|Dabrafenib|dabrafenib|mesh-list
102616864|NCT04666272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616865|NCT04666272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102616866|NCT04666272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102616867|NCT04666272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616868|NCT04649060|Dexamethasone|dexamethasone|mesh-list
102616869|NCT04649060|Melphalan|melphalan|mesh-list
102616870|NCT04649060|Daratumumab|daratumumab|mesh-list
102616871|NCT04649060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102616872|NCT04649060|Antiemetics|antiemetics|mesh-ancestor
102616873|NCT04649060|Autonomic Agents|autonomic agents|mesh-ancestor
102616874|NCT04649060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102616875|NCT04649060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616876|NCT04649060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102616877|NCT04649060|Glucocorticoids|glucocorticoids|mesh-ancestor
102616878|NCT04649060|Hormones|hormones|mesh-ancestor
102616879|NCT04649060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102616880|NCT04649060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102616881|NCT04649060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616882|NCT04649060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102616883|NCT04649060|Alkylating Agents|alkylating agents|mesh-ancestor
102616884|NCT04649060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616885|NCT04649060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102616886|NCT04649060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102616887|NCT04649060|Immunologic Factors|immunologic factors|mesh-ancestor
102616888|NCT04608487|Cyclophosphamide|cyclophosphamide|mesh-list
102616889|NCT04608487|Fludarabine|fludarabine|mesh-list
102616890|NCT04608487|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
102616891|NCT04608487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102616892|NCT04608487|Immunologic Factors|immunologic factors|mesh-ancestor
102616893|NCT04608487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616894|NCT04608487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102616895|NCT04608487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102616896|NCT04608487|Alkylating Agents|alkylating agents|mesh-ancestor
102616897|NCT04608487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616898|NCT04608487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616899|NCT04608487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102616900|NCT04608487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102616901|NCT04602767|Phenylephrine|phenylephrine|mesh-list
102616902|NCT04602767|Vasopressins|vasopressins|mesh-list
102616903|NCT04602767|Arginine Vasopressin|arginine vasopressin|mesh-list
102616904|NCT04602767|Oxymetazoline|oxymetazoline|mesh-list
102616905|NCT04602767|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102616906|NCT04602767|Mydriatics|mydriatics|mesh-ancestor
102616907|NCT04602767|Autonomic Agents|autonomic agents|mesh-ancestor
102616908|NCT04602767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102616909|NCT04602767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616910|NCT04602767|Sympathomimetics|sympathomimetics|mesh-ancestor
102616911|NCT04602767|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102616912|NCT04602767|Nasal Decongestants|nasal decongestants|mesh-ancestor
102616913|NCT04602767|Respiratory System Agents|respiratory system agents|mesh-ancestor
102616914|NCT04602767|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102616915|NCT04602767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102616916|NCT04602767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102616917|NCT04602767|Adrenergic Agents|adrenergic agents|mesh-ancestor
102616918|NCT04602767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102616919|NCT04602767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616920|NCT04602767|Protective Agents|protective agents|mesh-ancestor
102616921|NCT04602767|Hemostatics|hemostatics|mesh-ancestor
102616922|NCT04602767|Coagulants|coagulants|mesh-ancestor
102616923|NCT04602767|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102616924|NCT04602767|Natriuretic Agents|natriuretic agents|mesh-ancestor
102616925|NCT04581447|Metformin|metformin|mesh-list
102616926|NCT04581447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102616927|NCT04581447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616928|NCT04524689|Carboplatin|carboplatin|mesh-list
102616929|NCT04524689|Pembrolizumab|pembrolizumab|mesh-list
102616930|NCT04524689|Pemetrexed|pemetrexed|mesh-list
102616931|NCT04524689|Maytansine|maytansine|mesh-list
102616932|NCT04524689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616933|NCT04524689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102616934|NCT04524689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102616935|NCT04524689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616936|NCT04524689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102616937|NCT04524689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102616938|NCT04524689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102616939|NCT04524689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102616940|NCT04524689|Tubulin Modulators|tubulin modulators|mesh-ancestor
102616941|NCT04524689|Antimitotic Agents|antimitotic agents|mesh-ancestor
102616942|NCT04524689|Mitosis Modulators|mitosis modulators|mesh-ancestor
102616943|NCT04520685|Cannabidiol|cannabidiol|mesh-list
102616944|NCT04520685|Anticonvulsants|anticonvulsants|mesh-ancestor
102616945|NCT04519151|Pembrolizumab|pembrolizumab|mesh-list
102616946|NCT04519151|Lenvatinib|lenvatinib|mesh-list
102616947|NCT04519151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101589146|NCT00667927|Busulfan|busulfan|mesh-list
102616948|NCT04519151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102616949|NCT04519151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102616950|NCT04519151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616951|NCT04519151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102616952|NCT04519151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102616953|NCT04511650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102616954|NCT04506372|Enzyme Inhibitors|enzyme inhibitors|mesh-list
102616955|NCT04506372|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102616956|NCT04506372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616957|NCT04506372|Protease Inhibitors|protease inhibitors|mesh-ancestor
102616958|NCT04497012|Iron|iron|mesh-list
102616959|NCT04497012|Trace Elements|trace elements|mesh-ancestor
102616960|NCT04497012|Micronutrients|micronutrients|mesh-ancestor
102616961|NCT04497012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616962|NCT04484259|Aspirin|aspirin|mesh-list
102616963|NCT04484259|Clopidogrel|clopidogrel|mesh-list
102616964|NCT04484259|Ticagrelor|ticagrelor|mesh-list
102616965|NCT04484259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102616966|NCT04484259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102616967|NCT04484259|Analgesics|analgesics|mesh-ancestor
102616968|NCT04484259|Sensory System Agents|sensory system agents|mesh-ancestor
102616969|NCT04484259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102616970|NCT04484259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616971|NCT04484259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102616972|NCT04484259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102616973|NCT04484259|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102616974|NCT04484259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102616975|NCT04484259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102616976|NCT04484259|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102616977|NCT04484259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101905252|NCT01330810|Curcumin|curcumin|mesh-list
102616978|NCT04484259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102616979|NCT04484259|Antipyretics|antipyretics|mesh-ancestor
102274883|NCT01267175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616980|NCT04484259|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102616981|NCT04484259|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102616982|NCT04484259|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102616983|NCT04484259|Purinergic Agents|purinergic agents|mesh-ancestor
102616984|NCT04484259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102616985|NCT04463693|Etonogestrel|etonogestrel|mesh-list
102616986|NCT04463693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102616987|NCT04463693|Contraceptive Agents|contraceptive agents|mesh-ancestor
102616988|NCT04463693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102616989|NCT04463693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616990|NCT04463693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102616991|NCT04392011|Midazolam|midazolam|mesh-list
102616992|NCT04392011|Dextromethorphan|dextromethorphan|mesh-list
102616993|NCT04392011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102616994|NCT04392011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102616995|NCT04392011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102616996|NCT04392011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102616997|NCT04392011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102616998|NCT04392011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102616999|NCT04392011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102617000|NCT04392011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102617001|NCT04392011|Anesthetics, General|anesthetics, general|mesh-ancestor
102617002|NCT04392011|Anesthetics|anesthetics|mesh-ancestor
102617003|NCT04392011|GABA Modulators|gaba modulators|mesh-ancestor
102617004|NCT04392011|GABA Agents|gaba agents|mesh-ancestor
102617005|NCT04392011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102617006|NCT04392011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617007|NCT04392011|Antitussive Agents|antitussive agents|mesh-ancestor
102617008|NCT04392011|Respiratory System Agents|respiratory system agents|mesh-ancestor
102617009|NCT04392011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102617010|NCT04392011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102617011|NCT04370301|Mycophenolic Acid|mycophenolic acid|mesh-list
102617012|NCT04370301|Cyclophosphamide|cyclophosphamide|mesh-list
102617013|NCT04370301|Melphalan|melphalan|mesh-list
102617014|NCT04370301|Mechlorethamine|mechlorethamine|mesh-list
102617015|NCT04370301|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102617016|NCT04370301|Fludarabine|fludarabine|mesh-list
102617017|NCT04370301|Tacrolimus|tacrolimus|mesh-list
102617018|NCT04370301|Lenograstim|lenograstim|mesh-list
102617019|NCT04370301|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
102617020|NCT04370301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102617021|NCT04370301|Immunologic Factors|immunologic factors|mesh-ancestor
102617022|NCT04370301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617023|NCT04370301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102617024|NCT04370301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102617025|NCT04370301|Alkylating Agents|alkylating agents|mesh-ancestor
102617026|NCT04370301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617027|NCT04370301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617028|NCT04370301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102617029|NCT04370301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102617030|NCT04370301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102617031|NCT04370301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102617032|NCT04370301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102617033|NCT04370301|Antitubercular Agents|antitubercular agents|mesh-ancestor
102617034|NCT04370301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102617035|NCT04370301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102617036|NCT04370301|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102617037|NCT04370301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102617038|NCT04348916|Pembrolizumab|pembrolizumab|mesh-list
102617039|NCT04348916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102617040|NCT04348916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617041|NCT04348916|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102617042|NCT04348916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617043|NCT04299113|Vinorelbine|vinorelbine|mesh-list
102617044|NCT04299113|Mocetinostat|mocetinostat|mesh-list
102617045|NCT04299113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102617046|NCT04299113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617047|NCT04299113|Tubulin Modulators|tubulin modulators|mesh-ancestor
102617048|NCT04299113|Antimitotic Agents|antimitotic agents|mesh-ancestor
102617049|NCT04299113|Mitosis Modulators|mitosis modulators|mesh-ancestor
102617050|NCT04299113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617051|NCT04299113|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102617052|NCT04299113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102617053|NCT04291001|Ulipristal acetate|ulipristal acetate|mesh-list
102274884|NCT01231841|Cyclosporine|cyclosporine|mesh-list
102617054|NCT04291001|Etonogestrel|etonogestrel|mesh-list
102617055|NCT04291001|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102617056|NCT04291001|Contraceptive Agents|contraceptive agents|mesh-ancestor
102617057|NCT04291001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102617058|NCT04291001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617059|NCT04291001|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102617060|NCT04285580|Bimatoprost|bimatoprost|mesh-list
102617061|NCT04285580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102617062|NCT04272606|Tranexamic Acid|tranexamic acid|mesh-list
102617063|NCT04272606|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101589261|NCT04250116|Clopidogrel|clopidogrel|mesh-list
102617064|NCT04272606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102617065|NCT04272606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617066|NCT04272606|Hemostatics|hemostatics|mesh-ancestor
102617067|NCT04272606|Coagulants|coagulants|mesh-ancestor
102617068|NCT04245371|Lidocaine|lidocaine|mesh-list
102617069|NCT04245371|Anesthetics, Local|anesthetics, local|mesh-ancestor
102617070|NCT04245371|Anesthetics|anesthetics|mesh-ancestor
102617071|NCT04245371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102617072|NCT04245371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617073|NCT04245371|Sensory System Agents|sensory system agents|mesh-ancestor
102617074|NCT04245371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102617075|NCT04245371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102617076|NCT04245371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102617077|NCT04245371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102617078|NCT04245371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102617079|NCT04245371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617080|NCT04231539|Nicotine|nicotine|mesh-list
102617081|NCT04231539|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102617082|NCT04231539|Autonomic Agents|autonomic agents|mesh-ancestor
102617083|NCT04231539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102617084|NCT04231539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617085|NCT04231539|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102617086|NCT04231539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102617087|NCT04231539|Cholinergic Agents|cholinergic agents|mesh-ancestor
102617088|NCT04231539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102617089|NCT04231539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617090|NCT04200313|Pancrelipase|pancrelipase|mesh-list
102617091|NCT04200313|Pancreatin|pancreatin|mesh-list
102617092|NCT04200313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102617093|NCT04200248|Aflibercept|aflibercept|mesh-list
102617094|NCT04200248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102617095|NCT04200248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102617096|NCT04200248|Growth Substances|growth substances|mesh-ancestor
102617097|NCT04200248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617098|NCT04200248|Growth Inhibitors|growth inhibitors|mesh-ancestor
102617099|NCT04200248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617100|NCT04137887|Vaccines|vaccines|mesh-list
102617101|NCT04137887|Immunologic Factors|immunologic factors|mesh-ancestor
102617102|NCT04137887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617103|NCT04095273|Pembrolizumab|pembrolizumab|mesh-list
102617104|NCT04095273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102617105|NCT04095273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617106|NCT04095273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102617107|NCT04095273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617108|NCT03992131|Rucaparib|rucaparib|mesh-list
102617109|NCT03992131|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
102617110|NCT03992131|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102617111|NCT03992131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102617112|NCT03992131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617113|NCT03992131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617114|NCT03992131|Immunoconjugates|immunoconjugates|mesh-ancestor
102617115|NCT03992131|Immunologic Factors|immunologic factors|mesh-ancestor
102617116|NCT03992131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617117|NCT03954366|Rucaparib|rucaparib|mesh-list
102617118|NCT03954366|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102617119|NCT03954366|Contraceptive Agents|contraceptive agents|mesh-list
102617120|NCT03954366|Contraceptives, Oral|contraceptives, oral|mesh-list
102617121|NCT03954366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102617122|NCT03954366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102617123|NCT03954366|Antimetabolites|antimetabolites|mesh-ancestor
102617124|NCT03954366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617125|NCT03954366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102617126|NCT03954366|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101905388|NCT03445858|Decitabine|decitabine|mesh-list
102274885|NCT01231841|Cyclosporins|cyclosporins|mesh-list
102617127|NCT03954366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102617128|NCT03954366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102617129|NCT03954366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617130|NCT03954366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101589314|NCT00669487|Antimetabolites|antimetabolites|mesh-ancestor
102617131|NCT03954366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102617132|NCT03954366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617133|NCT03923270|Durvalumab|durvalumab|mesh-list
102617134|NCT03923270|Olaparib|olaparib|mesh-list
102617135|NCT03923270|Tremelimumab|tremelimumab|mesh-list
102617136|NCT03923270|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102617137|NCT03923270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102617138|NCT03923270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617139|NCT03923270|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102617140|NCT03923270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102617141|NCT03923270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617142|NCT03923270|Immunologic Factors|immunologic factors|mesh-ancestor
102617143|NCT03923270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617144|NCT03912220|Niacinamide|niacinamide|mesh-list
102617145|NCT03912220|Niacin|niacin|mesh-list
102617146|NCT03912220|Nicotinic Acids|nicotinic acids|mesh-list
102617147|NCT03912220|Vitamin B Complex|vitamin b complex|mesh-ancestor
102617148|NCT03912220|Vitamins|vitamins|mesh-ancestor
102617149|NCT03912220|Micronutrients|micronutrients|mesh-ancestor
102617150|NCT03912220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617151|NCT03912220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102617152|NCT03912220|Antimetabolites|antimetabolites|mesh-ancestor
102617153|NCT03912220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617154|NCT03912220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102617155|NCT03912220|Vasodilator Agents|vasodilator agents|mesh-ancestor
102617156|NCT03889912|Cemiplimab|cemiplimab|mesh-list
102617157|NCT03889912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102617158|NCT03889912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617159|NCT03872791|Paclitaxel|paclitaxel|mesh-list
102617160|NCT03872791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102617161|NCT03872791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617162|NCT03872791|Tubulin Modulators|tubulin modulators|mesh-ancestor
102617163|NCT03872791|Antimitotic Agents|antimitotic agents|mesh-ancestor
102617164|NCT03872791|Mitosis Modulators|mitosis modulators|mesh-ancestor
102617165|NCT03872791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617166|NCT03864042|Losartan|losartan|mesh-list
102617167|NCT03864042|Midazolam|midazolam|mesh-list
102617168|NCT03864042|Dextromethorphan|dextromethorphan|mesh-list
102617169|NCT03864042|Caffeine|caffeine|mesh-list
102617170|NCT03864042|Modafinil|modafinil|mesh-list
102617171|NCT03864042|Bupropion|bupropion|mesh-list
102617172|NCT03864042|Omeprazole|omeprazole|mesh-list
102617173|NCT03864042|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102617174|NCT03864042|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102617175|NCT03864042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102617176|NCT03864042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102617177|NCT03864042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617178|NCT03864042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102617179|NCT03864042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102617180|NCT03864042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102617181|NCT03864042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102617182|NCT03864042|Anesthetics, General|anesthetics, general|mesh-ancestor
102617183|NCT03864042|Anesthetics|anesthetics|mesh-ancestor
102617184|NCT03864042|GABA Modulators|gaba modulators|mesh-ancestor
102617185|NCT03864042|GABA Agents|gaba agents|mesh-ancestor
102617186|NCT03864042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102617187|NCT03864042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617188|NCT03864042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102617189|NCT03864042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102617190|NCT03864042|Antimetabolites|antimetabolites|mesh-ancestor
102617191|NCT03864042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102617192|NCT03864042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102617193|NCT03864042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102617194|NCT03864042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102617195|NCT03864042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102617196|NCT03864042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102617197|NCT03864042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102617198|NCT03864042|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102617199|NCT03864042|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102617200|NCT03864042|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102617201|NCT03864042|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102617202|NCT03864042|Purinergic Agents|purinergic agents|mesh-ancestor
102617203|NCT03864042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102617204|NCT03864042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102617205|NCT03864042|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102617206|NCT03864042|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102617207|NCT03864042|Antidepressive Agents|antidepressive agents|mesh-ancestor
102617208|NCT03864042|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102617209|NCT03864042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102617210|NCT03864042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102617211|NCT03864042|Dopamine Agents|dopamine agents|mesh-ancestor
102617212|NCT03864042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102617213|NCT03864042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102617214|NCT03864042|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102617215|NCT03864042|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102617216|NCT03864042|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102617217|NCT03864042|Antitussive Agents|antitussive agents|mesh-ancestor
102617218|NCT03864042|Respiratory System Agents|respiratory system agents|mesh-ancestor
102617219|NCT03864042|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102617220|NCT03864042|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102617221|NCT03737604|Bupivacaine|bupivacaine|mesh-list
102617222|NCT03737604|Ropivacaine|ropivacaine|mesh-list
102617223|NCT03737604|Anesthetics, Local|anesthetics, local|mesh-ancestor
102617224|NCT03737604|Anesthetics|anesthetics|mesh-ancestor
102617225|NCT03737604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102617226|NCT03737604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617227|NCT03737604|Sensory System Agents|sensory system agents|mesh-ancestor
102617228|NCT03737604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102617229|NCT03676504|Cyclophosphamide|cyclophosphamide|mesh-list
102617230|NCT03676504|Fludarabine|fludarabine|mesh-list
102617231|NCT03676504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102617232|NCT03676504|Immunologic Factors|immunologic factors|mesh-ancestor
102617233|NCT03676504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617234|NCT03676504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102617235|NCT03676504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102617236|NCT03676504|Alkylating Agents|alkylating agents|mesh-ancestor
102617237|NCT03676504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617238|NCT03676504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617239|NCT03676504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102617240|NCT03600155|Nivolumab|nivolumab|mesh-list
102617241|NCT03600155|Ipilimumab|ipilimumab|mesh-list
102617242|NCT03600155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102617243|NCT03600155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617244|NCT03600155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102617245|NCT03600155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617246|NCT03597594|Fludarabine|fludarabine|mesh-list
102617247|NCT03597594|Busulfan|busulfan|mesh-list
102617248|NCT03597594|Thiotepa|thiotepa|mesh-list
102617249|NCT03597594|Thymoglobulin|thymoglobulin|mesh-list
102617250|NCT03597594|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102617251|NCT03597594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617252|NCT03597594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617253|NCT03597594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102617254|NCT03597594|Immunologic Factors|immunologic factors|mesh-ancestor
102617255|NCT03597594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617256|NCT03597594|Alkylating Agents|alkylating agents|mesh-ancestor
102617257|NCT03597594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102617258|NCT03597594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102617259|NCT03563690|Celecoxib|celecoxib|mesh-list
102617260|NCT03563690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102617261|NCT03563690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102617262|NCT03563690|Analgesics|analgesics|mesh-ancestor
102617263|NCT03563690|Sensory System Agents|sensory system agents|mesh-ancestor
102617264|NCT03563690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102617265|NCT03563690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617266|NCT03563690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102617267|NCT03563690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101589460|NCT02887313|Protective Agents|protective agents|mesh-ancestor
102617268|NCT03563690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102617269|NCT03563690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102617270|NCT03563690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102617271|NCT03563690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617272|NCT03557008|Metronidazole|metronidazole|mesh-list
102617273|NCT03557008|Vancomycin|vancomycin|mesh-list
102617274|NCT03557008|Neomycin|neomycin|mesh-list
102617275|NCT03557008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102617276|NCT03557008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102617277|NCT03557008|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102617278|NCT03557008|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102617279|NCT03557008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102617280|NCT03557008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102617281|NCT03557008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617283|NCT03404193|Venetoclax|venetoclax|mesh-list
102617284|NCT03404193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102617285|NCT03404193|Antimetabolites|antimetabolites|mesh-ancestor
102617286|NCT03404193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617287|NCT03404193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617288|NCT03404193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102617289|NCT03395847|Pembrolizumab|pembrolizumab|mesh-list
102617290|NCT03395847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102617291|NCT03395847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617292|NCT03395847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102617293|NCT03395847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617294|NCT03347617|Pembrolizumab|pembrolizumab|mesh-list
102617295|NCT03347617|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102617296|NCT03347617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102617297|NCT03347617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617298|NCT03347617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102617299|NCT03347617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617300|NCT03347617|Hematinics|hematinics|mesh-ancestor
102617301|NCT03347617|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102617302|NCT03347617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102617303|NCT03328273|Acalabrutinib|acalabrutinib|mesh-list
102617304|NCT03328273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617305|NCT03178149|Tacrolimus|tacrolimus|mesh-list
102617306|NCT03178149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102617307|NCT03178149|Immunologic Factors|immunologic factors|mesh-ancestor
102617308|NCT03178149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617309|NCT03178149|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102617310|NCT03178149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102617311|NCT03178149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617312|NCT03136029|Antioxidants|antioxidants|mesh-list
102617313|NCT03136029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617314|NCT03136029|Protective Agents|protective agents|mesh-ancestor
102617315|NCT03136029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617316|NCT03040999|Cisplatin|cisplatin|mesh-list
102617317|NCT03040999|Pembrolizumab|pembrolizumab|mesh-list
102617318|NCT03040999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617319|NCT03040999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102617320|NCT03040999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102617321|NCT03040999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617322|NCT02990338|Dexamethasone|dexamethasone|mesh-list
102617323|NCT02990338|Pomalidomide|pomalidomide|mesh-list
102617324|NCT02990338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102617325|NCT02990338|Antiemetics|antiemetics|mesh-ancestor
102617326|NCT02990338|Autonomic Agents|autonomic agents|mesh-ancestor
102617327|NCT02990338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102617328|NCT02990338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617329|NCT02990338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102617330|NCT02990338|Glucocorticoids|glucocorticoids|mesh-ancestor
102617331|NCT02990338|Hormones|hormones|mesh-ancestor
102617332|NCT02990338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102617333|NCT02990338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102617334|NCT02990338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617335|NCT02990338|Immunologic Factors|immunologic factors|mesh-ancestor
102617336|NCT02990338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101589525|NCT01188551|Fentanyl|fentanyl|mesh-list
102617337|NCT02990338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102617338|NCT02990338|Growth Substances|growth substances|mesh-ancestor
102617339|NCT02990338|Growth Inhibitors|growth inhibitors|mesh-ancestor
102617340|NCT02971956|Pembrolizumab|pembrolizumab|mesh-list
102617341|NCT02971956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102617342|NCT02971956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617343|NCT02971956|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102617344|NCT02971956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617345|NCT02787369|Idelalisib|idelalisib|mesh-list
102617346|NCT02787369|Ricolinostat|ricolinostat|mesh-list
102274887|NCT01231841|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102274888|NCT01231841|Immunoglobulins|immunoglobulins|mesh-list
102274889|NCT01231841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102617348|NCT02787369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102617349|NCT02787369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617350|NCT02787369|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102617351|NCT02366728|Temozolomide|temozolomide|mesh-list
102617352|NCT02366728|Basiliximab|basiliximab|mesh-list
102617353|NCT02366728|Immunologic Factors|immunologic factors|mesh-ancestor
102617354|NCT02366728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617355|NCT02366728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102617356|NCT02366728|Alkylating Agents|alkylating agents|mesh-ancestor
102617357|NCT02366728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617358|NCT02366728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617359|NCT02366728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102617360|NCT02333370|Tamoxifen|tamoxifen|mesh-list
102617361|NCT02333370|Letrozole|letrozole|mesh-list
102617362|NCT02333370|Fulvestrant|fulvestrant|mesh-list
102617363|NCT02333370|Goserelin|goserelin|mesh-list
102617364|NCT02333370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617365|NCT02333370|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102617366|NCT02333370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102617367|NCT02333370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102617368|NCT02333370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617369|NCT02333370|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102617370|NCT02333370|Hormone Antagonists|hormone antagonists|mesh-ancestor
102617371|NCT02333370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102617372|NCT02333370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617373|NCT02333370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102617374|NCT02333370|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102617375|NCT02333370|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102617376|NCT02333370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102617377|NCT02333370|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102617378|NCT02303444|Sorafenib|sorafenib|mesh-list
102617379|NCT02303444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617380|NCT02303444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102617381|NCT02303444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102617382|NCT02303444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617383|NCT02246920|Fluticasone|fluticasone|mesh-list
102617384|NCT02246920|Xhance|xhance|mesh-list
102617385|NCT02246920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102617386|NCT02246920|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102617387|NCT02246920|Autonomic Agents|autonomic agents|mesh-ancestor
102617388|NCT02246920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102617389|NCT02246920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617390|NCT02246920|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102617391|NCT02246920|Respiratory System Agents|respiratory system agents|mesh-ancestor
102617392|NCT02246920|Dermatologic Agents|dermatologic agents|mesh-ancestor
102617393|NCT02246920|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102617394|NCT01972919|Gemcitabine|gemcitabine|mesh-list
102617395|NCT01972919|Capecitabine|capecitabine|mesh-list
102617396|NCT01972919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102617397|NCT01972919|Antimetabolites|antimetabolites|mesh-ancestor
102617398|NCT01972919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617399|NCT01972919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617400|NCT01832402|Fentanyl|fentanyl|mesh-list
102617401|NCT01832402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102617402|NCT01832402|Narcotics|narcotics|mesh-ancestor
102617403|NCT01832402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102617404|NCT01832402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617405|NCT01832402|Analgesics|analgesics|mesh-ancestor
102617406|NCT01832402|Sensory System Agents|sensory system agents|mesh-ancestor
102617407|NCT01832402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102617408|NCT01832402|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102617409|NCT01832402|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102617410|NCT01832402|Anesthetics, General|anesthetics, general|mesh-ancestor
102617411|NCT01832402|Anesthetics|anesthetics|mesh-ancestor
102617412|NCT01661881|Cytarabine|cytarabine|mesh-list
102617413|NCT01661881|Rituximab|rituximab|mesh-list
102617414|NCT01661881|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102617415|NCT01661881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102617416|NCT01661881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617417|NCT01661881|Immunologic Factors|immunologic factors|mesh-ancestor
102617418|NCT01661881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274890|NCT01231841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617419|NCT01661881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102617420|NCT01661881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102617422|NCT01661881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617423|NCT01661881|Antiviral Agents|antiviral agents|mesh-ancestor
102617424|NCT01661881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102617425|NCT01661881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102617426|NCT01661881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102617427|NCT01661881|Alkylating Agents|alkylating agents|mesh-ancestor
102617428|NCT01473628|Rituximab|rituximab|mesh-list
102617429|NCT01473628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102617430|NCT01473628|Antibodies|antibodies|mesh-list
102617431|NCT01473628|Immunoglobulins|immunoglobulins|mesh-list
102617432|NCT01473628|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102617433|NCT01473628|Immunologic Factors|immunologic factors|mesh-ancestor
102617434|NCT01473628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617435|NCT01473628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617436|NCT01473628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102617437|NCT01210625|Psyllium|psyllium|mesh-list
102617438|NCT01210625|Cathartics|cathartics|mesh-ancestor
102617439|NCT01210625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102617440|NCT01009190|Carboplatin|carboplatin|mesh-list
102617441|NCT01009190|Rucaparib|rucaparib|mesh-list
102617442|NCT01009190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617443|NCT01009190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102617444|NCT01009190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102617445|NCT01009190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617446|NCT00321555|Immunotoxins|immunotoxins|mesh-list
102617447|NCT00321555|Immunoconjugates|immunoconjugates|mesh-ancestor
102617448|NCT00321555|Immunologic Factors|immunologic factors|mesh-ancestor
102617449|NCT00321555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617450|NCT00003653|Leuprolide|leuprolide|mesh-list
102617451|NCT00003653|Goserelin|goserelin|mesh-list
102617452|NCT00003653|Flutamide|flutamide|mesh-list
102617453|NCT00003653|Bicalutamide|bicalutamide|mesh-list
102617454|NCT00003653|Cyproterone Acetate|cyproterone acetate|mesh-list
102617455|NCT00003653|Nilutamide|nilutamide|mesh-list
102617456|NCT00003653|Buserelin|buserelin|mesh-list
102617457|NCT00003653|Cyproterone|cyproterone|mesh-list
102617458|NCT00003653|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102617459|NCT00003653|Fertility Agents|fertility agents|mesh-ancestor
102617460|NCT00003653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102617461|NCT00003653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617462|NCT00003653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102617463|NCT00003653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617464|NCT00003653|Androgen Antagonists|androgen antagonists|mesh-ancestor
102617465|NCT00003653|Hormone Antagonists|hormone antagonists|mesh-ancestor
102617466|NCT00003653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102617467|NCT00003653|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102617468|NCT00003653|Contraceptive Agents|contraceptive agents|mesh-ancestor
102617469|NCT00003671|Leucovorin|leucovorin|mesh-list
102617470|NCT00003671|Cytarabine|cytarabine|mesh-list
102617471|NCT00003671|Dexamethasone|dexamethasone|mesh-list
102617472|NCT00003671|Cyclophosphamide|cyclophosphamide|mesh-list
102617473|NCT00003671|Methotrexate|methotrexate|mesh-list
102617474|NCT00003671|Vincristine|vincristine|mesh-list
102617475|NCT00003671|Daunorubicin|daunorubicin|mesh-list
102617476|NCT00003671|Asparaginase|asparaginase|mesh-list
102617477|NCT00003671|Mercaptopurine|mercaptopurine|mesh-list
102617478|NCT00003671|Thioguanine|thioguanine|mesh-list
102617479|NCT00003671|Levoleucovorin|levoleucovorin|mesh-list
102617480|NCT00003671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102617481|NCT00003671|Immunologic Factors|immunologic factors|mesh-ancestor
102617482|NCT00003671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617483|NCT00003671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102617484|NCT00003671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102617485|NCT00003671|Alkylating Agents|alkylating agents|mesh-ancestor
102617486|NCT00003671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617487|NCT00003671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617488|NCT00003671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102617489|NCT00003671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102617490|NCT00003671|Antiemetics|antiemetics|mesh-ancestor
102617491|NCT00003671|Autonomic Agents|autonomic agents|mesh-ancestor
102617492|NCT00003671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102617493|NCT00003671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102274891|NCT01231841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102274892|NCT01231841|Immunologic Factors|immunologic factors|mesh-ancestor
102617494|NCT00003671|Glucocorticoids|glucocorticoids|mesh-ancestor
102617495|NCT00003671|Hormones|hormones|mesh-ancestor
102617496|NCT00003671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102617497|NCT00003671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102617498|NCT00003671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102617499|NCT00003671|Abortifacient Agents|abortifacient agents|mesh-ancestor
102617500|NCT00003671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102617501|NCT00003671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102617502|NCT00003671|Antimetabolites|antimetabolites|mesh-ancestor
102617503|NCT00003671|Dermatologic Agents|dermatologic agents|mesh-ancestor
102617504|NCT00003671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102617505|NCT00003671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102617506|NCT00003671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102617507|NCT00003671|Antiviral Agents|antiviral agents|mesh-ancestor
102617508|NCT00003671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102617509|NCT00003671|Antidotes|antidotes|mesh-ancestor
102617510|NCT00003671|Protective Agents|protective agents|mesh-ancestor
102617511|NCT00003671|Vitamin B Complex|vitamin b complex|mesh-ancestor
102617512|NCT00003671|Vitamins|vitamins|mesh-ancestor
102617513|NCT00003671|Micronutrients|micronutrients|mesh-ancestor
102617514|NCT00003671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102617515|NCT00003671|Tubulin Modulators|tubulin modulators|mesh-ancestor
102617516|NCT00003671|Antimitotic Agents|antimitotic agents|mesh-ancestor
102617517|NCT00003671|Mitosis Modulators|mitosis modulators|mesh-ancestor
102617518|NCT00003671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102617519|NCT00003671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102617520|NCT00003671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102617521|NCT00003677|Dolastatin 10|dolastatin 10|mesh-list
102617522|NCT00003677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617523|NCT00003677|Tubulin Modulators|tubulin modulators|mesh-ancestor
102617524|NCT00003677|Antimitotic Agents|antimitotic agents|mesh-ancestor
102617525|NCT00003677|Mitosis Modulators|mitosis modulators|mesh-ancestor
102617526|NCT00003677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617527|NCT00384605|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
102617528|NCT00384605|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102617529|NCT00384605|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102617530|NCT00384605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102617531|NCT00384605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617532|NCT00384605|Hormones|hormones|mesh-ancestor
102617533|NCT00384605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102617534|NCT00384605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617535|NCT00003683|Doxorubicin|doxorubicin|mesh-list
102617536|NCT00003683|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102617537|NCT00003683|Ifosfamide|ifosfamide|mesh-list
102617538|NCT00003683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102617539|NCT00003683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617540|NCT00003683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102617541|NCT00003683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102617542|NCT00003683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102617543|NCT00003683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617544|NCT00003683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102617545|NCT00003683|Alkylating Agents|alkylating agents|mesh-ancestor
102617546|NCT00003707|Gemcitabine|gemcitabine|mesh-list
102617547|NCT00003707|Tipifarnib|tipifarnib|mesh-list
102617548|NCT00003707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102617549|NCT00003707|Antimetabolites|antimetabolites|mesh-ancestor
102617550|NCT00003707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617551|NCT00003707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617552|NCT00003719|Irinotecan|irinotecan|mesh-list
102617553|NCT00003719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102617554|NCT00003719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102617555|NCT00003719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102617556|NCT00003719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617557|NCT00003719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617558|NCT00003725|Valrubicin|valrubicin|mesh-list
102617559|NCT00003725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617560|NCT00003725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102617561|NCT00003725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102617562|NCT00003725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102617563|NCT00003725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617564|NCT00003731|Temozolomide|temozolomide|mesh-list
102617565|NCT00003731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102617566|NCT00003731|Alkylating Agents|alkylating agents|mesh-ancestor
102617567|NCT00003731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905834|NCT00546754|Losartan|losartan|mesh-list
102617568|NCT00003731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617569|NCT00003743|Aldesleukin|aldesleukin|mesh-list
102617570|NCT00003743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617571|NCT00003743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102617572|NCT00003743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102617573|NCT00003743|Antiviral Agents|antiviral agents|mesh-ancestor
102617574|NCT00003743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102617575|NCT00384917|Ketoconazole|ketoconazole|mesh-list
102617576|NCT00384917|Antifungal Agents|antifungal agents|mesh-ancestor
102617577|NCT00384917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102617578|NCT00384917|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102617579|NCT00384917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102617580|NCT00384917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102617581|NCT00384917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617582|NCT00384917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102617583|NCT00384917|Hormone Antagonists|hormone antagonists|mesh-ancestor
102617584|NCT00384917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102617585|NCT00384917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617586|NCT00384917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102617587|NCT05444153|Empagliflozin|empagliflozin|mesh-list
102617588|NCT05444153|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102617589|NCT05444153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617590|NCT05444153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102617591|NCT05444153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617592|NCT00003797|Gemcitabine|gemcitabine|mesh-list
102617593|NCT00003797|Trastuzumab|trastuzumab|mesh-list
102617594|NCT00003797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102617595|NCT00003797|Antimetabolites|antimetabolites|mesh-ancestor
102617596|NCT00003797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617597|NCT00003797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617598|NCT00003797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102617599|NCT00003803|Gemcitabine|gemcitabine|mesh-list
102617600|NCT00003803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617601|NCT00003803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102617602|NCT00003803|Antimetabolites|antimetabolites|mesh-ancestor
102617603|NCT00003803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617604|NCT00003815|Cytarabine|cytarabine|mesh-list
102617605|NCT00003815|Prednisolone|prednisolone|mesh-list
102617606|NCT00003815|Cyclophosphamide|cyclophosphamide|mesh-list
102617607|NCT00003815|Melphalan|melphalan|mesh-list
102617608|NCT00003815|Carmustine|carmustine|mesh-list
102617609|NCT00003815|Doxorubicin|doxorubicin|mesh-list
102617610|NCT00003815|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102617611|NCT00003815|Etoposide|etoposide|mesh-list
102617612|NCT00003815|Vincristine|vincristine|mesh-list
102617613|NCT00003815|Bleomycin|bleomycin|mesh-list
102617614|NCT00003815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102617615|NCT00003815|Immunologic Factors|immunologic factors|mesh-ancestor
102617616|NCT00003815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617617|NCT00003815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102617618|NCT00003815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102617619|NCT00003815|Alkylating Agents|alkylating agents|mesh-ancestor
102617620|NCT00003815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617621|NCT00003815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617622|NCT00003815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102617623|NCT00003815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102617624|NCT00003815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102617625|NCT00003815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102617626|NCT00003815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102617627|NCT00003815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102617628|NCT00003815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102617629|NCT00003815|Antimetabolites|antimetabolites|mesh-ancestor
102617630|NCT00003815|Antiviral Agents|antiviral agents|mesh-ancestor
102617631|NCT00003815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102617632|NCT00003815|Tubulin Modulators|tubulin modulators|mesh-ancestor
102617633|NCT00003815|Antimitotic Agents|antimitotic agents|mesh-ancestor
102617634|NCT00003815|Mitosis Modulators|mitosis modulators|mesh-ancestor
102617635|NCT00003815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102617636|NCT00003815|Glucocorticoids|glucocorticoids|mesh-ancestor
102617637|NCT00003815|Hormones|hormones|mesh-ancestor
102617638|NCT00003815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102617639|NCT00003815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102617640|NCT00003821|Aminopterin|aminopterin|mesh-list
102274893|NCT01231841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905911|NCT00282347|Anesthetics|anesthetics|mesh-ancestor
102617641|NCT00003821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102617642|NCT00003821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102617643|NCT00003821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617645|NCT00003827|Topotecan|topotecan|mesh-list
102617646|NCT00003827|Amifostine|amifostine|mesh-list
102617647|NCT00003827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102617648|NCT00003827|Antimetabolites|antimetabolites|mesh-ancestor
102617649|NCT00003827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617650|NCT00003827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617651|NCT00003827|Antiviral Agents|antiviral agents|mesh-ancestor
102617652|NCT00003827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102617653|NCT00003827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102617654|NCT00003827|Immunologic Factors|immunologic factors|mesh-ancestor
102617655|NCT00003827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617656|NCT00003827|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102617657|NCT00003827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102617658|NCT00003827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102617659|NCT00003827|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102617660|NCT00003827|Protective Agents|protective agents|mesh-ancestor
102617661|NCT00003851|Gemcitabine|gemcitabine|mesh-list
102617662|NCT00003851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102617663|NCT00003851|Antimetabolites|antimetabolites|mesh-ancestor
102617664|NCT00003851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617665|NCT00003851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617666|NCT00003881|Paclitaxel|paclitaxel|mesh-list
102617667|NCT00003881|Carboplatin|carboplatin|mesh-list
102617668|NCT00003881|Trastuzumab|trastuzumab|mesh-list
102617669|NCT00003881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102617670|NCT00003881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617671|NCT00003881|Tubulin Modulators|tubulin modulators|mesh-ancestor
102617672|NCT00003881|Antimitotic Agents|antimitotic agents|mesh-ancestor
102617673|NCT00003881|Mitosis Modulators|mitosis modulators|mesh-ancestor
102617674|NCT00003881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617675|NCT00003881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102617676|NCT00003893|Cyclophosphamide|cyclophosphamide|mesh-list
102617677|NCT00003893|Doxorubicin|doxorubicin|mesh-list
102617678|NCT00003893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102617679|NCT00003893|Fluorouracil|fluorouracil|mesh-list
102617680|NCT00003893|Methotrexate|methotrexate|mesh-list
102617681|NCT00003893|Epirubicin|epirubicin|mesh-list
102617682|NCT00003893|Mitoxantrone|mitoxantrone|mesh-list
102617683|NCT00003893|Mitomycins|mitomycins|mesh-list
102617684|NCT00003893|Mitomycin|mitomycin|mesh-list
102617685|NCT00003893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102617686|NCT00003893|Immunologic Factors|immunologic factors|mesh-ancestor
102617687|NCT00003893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617688|NCT00003893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102617689|NCT00003893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102617690|NCT00003893|Alkylating Agents|alkylating agents|mesh-ancestor
102617691|NCT00003893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617692|NCT00003893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617693|NCT00003893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102617694|NCT00003893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102617695|NCT00003893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102617696|NCT00003893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102617697|NCT00003893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102617698|NCT00003893|Antimetabolites|antimetabolites|mesh-ancestor
102617699|NCT00003893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102617700|NCT00003893|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102617701|NCT00003893|Abortifacient Agents|abortifacient agents|mesh-ancestor
102617702|NCT00003893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102617703|NCT00003893|Dermatologic Agents|dermatologic agents|mesh-ancestor
102617704|NCT00003893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102617705|NCT00003893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102617706|NCT00003893|Analgesics|analgesics|mesh-ancestor
102617707|NCT00003893|Sensory System Agents|sensory system agents|mesh-ancestor
102617708|NCT00003893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102617709|NCT00003899|Paclitaxel|paclitaxel|mesh-list
102617710|NCT00003899|Cyclophosphamide|cyclophosphamide|mesh-list
102617711|NCT00003899|Melphalan|melphalan|mesh-list
102617712|NCT00003899|Thiotepa|thiotepa|mesh-list
102617713|NCT00003899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102617714|NCT00003899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274894|NCT01231841|Antifungal Agents|antifungal agents|mesh-ancestor
102617715|NCT00003899|Tubulin Modulators|tubulin modulators|mesh-ancestor
102617716|NCT00003899|Antimitotic Agents|antimitotic agents|mesh-ancestor
102274895|NCT01231841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102617717|NCT00003899|Mitosis Modulators|mitosis modulators|mesh-ancestor
102617718|NCT00003899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617719|NCT00003899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102617720|NCT00003899|Immunologic Factors|immunologic factors|mesh-ancestor
102617721|NCT00003899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617722|NCT00003899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102617723|NCT00003899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102617724|NCT00003899|Alkylating Agents|alkylating agents|mesh-ancestor
102617725|NCT00003899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102617726|NCT00003917|Topotecan|topotecan|mesh-list
102617727|NCT00003917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102617728|NCT00003917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102617729|NCT00003917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102617730|NCT00003917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617731|NCT00003917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617732|NCT00003923|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
102617733|NCT00003923|Trioxsalen|trioxsalen|mesh-list
102617734|NCT00003923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617735|NCT00003923|Dermatologic Agents|dermatologic agents|mesh-ancestor
102617736|NCT00003923|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102617737|NCT00003929|Lomustine|lomustine|mesh-list
102617738|NCT00003929|Procarbazine|procarbazine|mesh-list
102617739|NCT00003929|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102617740|NCT00003929|Alkylating Agents|alkylating agents|mesh-ancestor
102617741|NCT00003929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617742|NCT00003929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617743|NCT02210663|Veliparib|veliparib|mesh-list
102617744|NCT02210663|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102617745|NCT02210663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102617746|NCT02210663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617747|NCT02210663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617748|NCT04568837|Dexamethasone|dexamethasone|mesh-list
102617749|NCT04568837|Dexamethasone acetate|dexamethasone acetate|mesh-list
102617750|NCT04568837|Prednisone|prednisone|mesh-list
102617751|NCT04568837|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102617752|NCT04568837|BB 1101|bb 1101|mesh-list
102617753|NCT04568837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102617754|NCT04568837|Antiemetics|antiemetics|mesh-ancestor
102617755|NCT04568837|Autonomic Agents|autonomic agents|mesh-ancestor
102617756|NCT04568837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102617757|NCT04568837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617758|NCT04568837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102617759|NCT04568837|Glucocorticoids|glucocorticoids|mesh-ancestor
102617760|NCT04568837|Hormones|hormones|mesh-ancestor
102617761|NCT04568837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102617762|NCT04568837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102617763|NCT04568837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617764|NCT04568837|Protease Inhibitors|protease inhibitors|mesh-ancestor
102617765|NCT04568837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102617766|NCT04568837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617767|NCT02210819|Rivaroxaban|rivaroxaban|mesh-list
102617768|NCT02210819|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102617769|NCT02210819|Antithrombins|antithrombins|mesh-ancestor
102617770|NCT02210819|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102617771|NCT02210819|Protease Inhibitors|protease inhibitors|mesh-ancestor
102617772|NCT02210819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102617773|NCT02210819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617774|NCT02210819|Anticoagulants|anticoagulants|mesh-ancestor
102617775|NCT04564469|Furosemide|furosemide|mesh-list
102617776|NCT04564469|Diuretics|diuretics|mesh-ancestor
102617777|NCT04564469|Natriuretic Agents|natriuretic agents|mesh-ancestor
102617778|NCT04564469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617779|NCT04564469|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102617780|NCT04564469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102617781|NCT04564469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617782|NCT04564001|Infliximab|infliximab|mesh-list
102617783|NCT04564001|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102617784|NCT04564001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102617785|NCT04564001|Dermatologic Agents|dermatologic agents|mesh-ancestor
102617786|NCT04564001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102617787|NCT04564001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102274896|NCT01231841|Dermatologic Agents|dermatologic agents|mesh-ancestor
102274897|NCT01231841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102617788|NCT04568603|Islatravir|islatravir|mesh-list
102617789|NCT04568603|Methadone|methadone|mesh-list
102617790|NCT04568603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102617791|NCT04568603|Narcotics|narcotics|mesh-ancestor
102617792|NCT04568603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102617793|NCT04568603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617794|NCT04568603|Analgesics|analgesics|mesh-ancestor
102617795|NCT04568603|Sensory System Agents|sensory system agents|mesh-ancestor
102617796|NCT04568603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102617797|NCT04568603|Antitussive Agents|antitussive agents|mesh-ancestor
102617798|NCT04568603|Respiratory System Agents|respiratory system agents|mesh-ancestor
102617799|NCT04568603|Antiviral Agents|antiviral agents|mesh-ancestor
102617800|NCT04568603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102617801|NCT04568603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102617802|NCT04568603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617803|NCT04568603|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102617804|NCT04568603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102617805|NCT04568603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102617806|NCT04563299|Prednisolone|prednisolone|mesh-list
102617807|NCT04563299|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102617808|NCT04563299|Methylprednisolone|methylprednisolone|mesh-list
102617809|NCT04563299|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102617810|NCT04563299|Prednisolone acetate|prednisolone acetate|mesh-list
102617811|NCT04563299|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102617812|NCT04563299|Prednisolone phosphate|prednisolone phosphate|mesh-list
102617813|NCT04563299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102617814|NCT04563299|Glucocorticoids|glucocorticoids|mesh-ancestor
102617815|NCT04563299|Hormones|hormones|mesh-ancestor
102617816|NCT04563299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102617817|NCT04563299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617818|NCT04563299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102617819|NCT04563299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617820|NCT04563299|Antiemetics|antiemetics|mesh-ancestor
102617821|NCT04563299|Autonomic Agents|autonomic agents|mesh-ancestor
102617822|NCT04563299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102617823|NCT04563299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102617824|NCT04563299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102617825|NCT04563299|Protective Agents|protective agents|mesh-ancestor
102617826|NCT04561817|Paclitaxel|paclitaxel|mesh-list
102617827|NCT04561817|Ipatasertib|ipatasertib|mesh-list
102617828|NCT04561817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102617829|NCT04561817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617830|NCT04561817|Tubulin Modulators|tubulin modulators|mesh-ancestor
102617831|NCT04561817|Antimitotic Agents|antimitotic agents|mesh-ancestor
102617832|NCT04561817|Mitosis Modulators|mitosis modulators|mesh-ancestor
102617833|NCT04561817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617834|NCT04561817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102617835|NCT04561817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102617836|NCT02211833|Pemetrexed|pemetrexed|mesh-list
102617837|NCT02211833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617838|NCT02211833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102617839|NCT02211833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617840|NCT02211833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102617841|NCT02211833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102617842|NCT02211443|Antibodies|antibodies|mesh-list
102617843|NCT02211443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102617844|NCT02211443|Immunologic Factors|immunologic factors|mesh-ancestor
102617845|NCT02211443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617846|NCT02211521|Hyaluronic Acid|hyaluronic acid|mesh-list
102617847|NCT02211521|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102617848|NCT02211521|Immunologic Factors|immunologic factors|mesh-ancestor
102617849|NCT02211521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617850|NCT02211521|Viscosupplements|viscosupplements|mesh-ancestor
102617851|NCT02211521|Protective Agents|protective agents|mesh-ancestor
102617852|NCT01597908|Trametinib|trametinib|mesh-list
102617853|NCT01597908|Vemurafenib|vemurafenib|mesh-list
102617854|NCT01597908|Dabrafenib|dabrafenib|mesh-list
102617855|NCT01597908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617856|NCT01597908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102617857|NCT01597908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102617858|NCT01597908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617859|NCT01948908|Midazolam|midazolam|mesh-list
102617860|NCT01948908|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102617861|NCT01948908|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102617862|NCT01948908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102617863|NCT01948908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617864|NCT01948908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102617865|NCT01948908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102617866|NCT01948908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102617867|NCT01948908|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102617868|NCT01948908|Anesthetics, General|anesthetics, general|mesh-ancestor
102617869|NCT01948908|Anesthetics|anesthetics|mesh-ancestor
102617870|NCT01948908|GABA Modulators|gaba modulators|mesh-ancestor
102617871|NCT01948908|GABA Agents|gaba agents|mesh-ancestor
102617872|NCT01948908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102617873|NCT01948908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617874|NCT01925274|Irinotecan|irinotecan|mesh-list
102617875|NCT01925274|Cetuximab|cetuximab|mesh-list
102617876|NCT01925274|Gedatolisib|gedatolisib|mesh-list
102617877|NCT01925274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102617878|NCT01925274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102617879|NCT01925274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102617880|NCT01925274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617881|NCT01925274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617882|NCT01925274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102617883|NCT01925274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102617884|NCT01948830|Ranibizumab|ranibizumab|mesh-list
102617885|NCT01948830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102617886|NCT01948830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102617887|NCT01948830|Growth Substances|growth substances|mesh-ancestor
102617888|NCT01948830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617889|NCT01948830|Growth Inhibitors|growth inhibitors|mesh-ancestor
102617890|NCT01948830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617891|NCT01972464|Progesterone|progesterone|mesh-list
102617892|NCT01972464|Progestins|progestins|mesh-ancestor
102617893|NCT01972464|Hormones|hormones|mesh-ancestor
102617894|NCT01972464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102617895|NCT01972464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617896|NCT01924182|Morphine|morphine|mesh-list
102617897|NCT01924182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102617898|NCT01924182|Narcotics|narcotics|mesh-ancestor
102617899|NCT01924182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102617900|NCT01924182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617901|NCT01924182|Analgesics|analgesics|mesh-ancestor
102617902|NCT01924182|Sensory System Agents|sensory system agents|mesh-ancestor
102617903|NCT01924182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102617904|NCT01946880|Mycophenolic Acid|mycophenolic acid|mesh-list
102617905|NCT01946880|Hydroxychloroquine|hydroxychloroquine|mesh-list
102617906|NCT01946880|Chloroquine|chloroquine|mesh-list
102617907|NCT01946880|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
102617908|NCT01946880|Prednisone|prednisone|mesh-list
102617909|NCT01946880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102617910|NCT01946880|Glucocorticoids|glucocorticoids|mesh-ancestor
102617911|NCT01946880|Hormones|hormones|mesh-ancestor
102617912|NCT01946880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102617913|NCT01946880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617914|NCT01946880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102617915|NCT01946880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617916|NCT01946880|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102617917|NCT01946880|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102617918|NCT01946880|Antitubercular Agents|antitubercular agents|mesh-ancestor
102617919|NCT01946880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102617920|NCT01946880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102617921|NCT01946880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102617922|NCT01946880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617923|NCT01946880|Antimalarials|antimalarials|mesh-ancestor
102617924|NCT01946880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102617925|NCT01946880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102617926|NCT01946880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102617927|NCT01946880|Amebicides|amebicides|mesh-ancestor
102617928|NCT01946880|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102617929|NCT01946880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102617930|NCT01946880|Analgesics|analgesics|mesh-ancestor
102617931|NCT01946880|Sensory System Agents|sensory system agents|mesh-ancestor
102617932|NCT01946880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102617933|NCT01946880|Filaricides|filaricides|mesh-ancestor
102617934|NCT01946880|Antinematodal Agents|antinematodal agents|mesh-ancestor
102617935|NCT01946880|Anthelmintics|anthelmintics|mesh-ancestor
102617936|NCT01972152|Glucagon|glucagon|mesh-list
102617937|NCT01972152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102617938|NCT01972152|Hormones|hormones|mesh-ancestor
102617939|NCT01972152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102274899|NCT01133756|Carboplatin|carboplatin|mesh-list
102274900|NCT01133756|Gemcitabine|gemcitabine|mesh-list
102617940|NCT01972152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617941|NCT01972074|Memantine|memantine|mesh-list
102617942|NCT01972074|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102617943|NCT01972074|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102617944|NCT01972074|Dopamine Agents|dopamine agents|mesh-ancestor
102617945|NCT01972074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102617946|NCT01972074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617947|NCT01972074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617948|NCT01972074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102617949|NCT01972074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102617950|NCT01618266|Dexamethasone|dexamethasone|mesh-list
102617951|NCT01618266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102617952|NCT01618266|Antiemetics|antiemetics|mesh-ancestor
102617953|NCT01618266|Autonomic Agents|autonomic agents|mesh-ancestor
102617954|NCT01618266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102617955|NCT01618266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617956|NCT01618266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102617957|NCT01618266|Glucocorticoids|glucocorticoids|mesh-ancestor
102617958|NCT01618266|Hormones|hormones|mesh-ancestor
102617959|NCT01618266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102617960|NCT01618266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102617961|NCT01618266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617962|NCT01918332|Valsartan|valsartan|mesh-list
102617963|NCT01918332|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102617964|NCT01918332|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102617965|NCT01918332|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102617966|NCT01918332|Antimetabolites|antimetabolites|mesh-ancestor
102617967|NCT01918332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617968|NCT01918332|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102617969|NCT01918332|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102617970|NCT01918332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102617971|NCT01918332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102617972|NCT01918332|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102617973|NCT01918332|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102617974|NCT01922934|Topiramate|topiramate|mesh-list
102617975|NCT01922934|Phentermine|phentermine|mesh-list
102617976|NCT01922934|Anticonvulsants|anticonvulsants|mesh-ancestor
102617977|NCT01922934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102617978|NCT01922934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102617979|NCT01922934|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102617980|NCT01922934|Appetite Depressants|appetite depressants|mesh-ancestor
102617981|NCT01922934|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102617982|NCT01922934|Sympathomimetics|sympathomimetics|mesh-ancestor
102617983|NCT01922934|Autonomic Agents|autonomic agents|mesh-ancestor
102617984|NCT01922934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102617985|NCT01922934|Adrenergic Agents|adrenergic agents|mesh-ancestor
102617986|NCT01922934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102617987|NCT01922934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617988|NCT01921140|Olaparib|olaparib|mesh-list
102617989|NCT01921140|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102617990|NCT01921140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102617991|NCT01921140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617992|NCT01921140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102617993|NCT01917006|Botulinum Toxins|botulinum toxins|mesh-list
102617994|NCT01917006|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102617995|NCT01917006|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102617996|NCT01917006|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102617997|NCT01917006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102617998|NCT01917006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102617999|NCT01917006|Cholinergic Agents|cholinergic agents|mesh-ancestor
102618000|NCT01917006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102618001|NCT01917006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618002|NCT01917006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102618003|NCT01917006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102618004|NCT01916226|Cetirizine|cetirizine|mesh-list
102618005|NCT01916226|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102618006|NCT01916226|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102618007|NCT01916226|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102618008|NCT01916226|Histamine Antagonists|histamine antagonists|mesh-ancestor
102618009|NCT01916226|Histamine Agents|histamine agents|mesh-ancestor
102618010|NCT01916226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102618011|NCT01916226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618012|NCT01916226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618013|NCT01915914|Fluticasone|fluticasone|mesh-list
102618014|NCT01915914|Xhance|xhance|mesh-list
102618015|NCT01915914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102618016|NCT01915914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102618017|NCT01915914|Autonomic Agents|autonomic agents|mesh-ancestor
102618018|NCT01915914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102618019|NCT01915914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618020|NCT01915914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102618021|NCT01915914|Respiratory System Agents|respiratory system agents|mesh-ancestor
102618022|NCT01915914|Dermatologic Agents|dermatologic agents|mesh-ancestor
102618023|NCT01915914|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102618024|NCT01968954|Bococizumab|bococizumab|mesh-list
102618025|NCT01968954|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102618026|NCT01968954|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102618027|NCT01968954|Antimetabolites|antimetabolites|mesh-ancestor
102618028|NCT01968954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618029|NCT01968954|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102618030|NCT01919190|Bupivacaine|bupivacaine|mesh-list
102618031|NCT01919190|Anesthetics, Local|anesthetics, local|mesh-ancestor
102618032|NCT01919190|Anesthetics|anesthetics|mesh-ancestor
102618033|NCT01919190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102618034|NCT01919190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618035|NCT01919190|Sensory System Agents|sensory system agents|mesh-ancestor
102618036|NCT01919190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102618037|NCT01620060|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102618038|NCT01620060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102618039|NCT01620060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102618040|NCT01620060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102618041|NCT01620060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618042|NCT01620060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102618043|NCT01620060|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102618044|NCT01620060|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102618045|NCT01620060|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102618046|NCT01620060|Adrenergic Agents|adrenergic agents|mesh-ancestor
102618047|NCT01620060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102618048|NCT01620060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618049|NCT01620060|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102618050|NCT01620060|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102618051|NCT01620060|Serotonin Agents|serotonin agents|mesh-ancestor
102618052|NCT01620060|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102618053|NCT01620060|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102618054|NCT01620060|Dopamine Agents|dopamine agents|mesh-ancestor
102618055|NCT01914666|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102618056|NCT01914666|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102618057|NCT01914666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102618058|NCT01914666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102618059|NCT01914666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618060|NCT01914666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102618061|NCT01914666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618062|NCT01914666|Analgesics|analgesics|mesh-ancestor
102618063|NCT01914666|Sensory System Agents|sensory system agents|mesh-ancestor
102618064|NCT01914666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102618065|NCT01914666|Antidepressive Agents|antidepressive agents|mesh-ancestor
102618066|NCT01914666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102618067|NCT01914666|Dopamine Agents|dopamine agents|mesh-ancestor
102618068|NCT01913340|Epoetin Alfa|epoetin alfa|mesh-list
102618069|NCT01913340|Hematinics|hematinics|mesh-ancestor
102618070|NCT01912872|Omalizumab|omalizumab|mesh-list
102618071|NCT01912872|Budesonide|budesonide|mesh-list
102618072|NCT01912872|Formoterol Fumarate|formoterol fumarate|mesh-list
102618073|NCT01912872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102618074|NCT01912872|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102618075|NCT01912872|Autonomic Agents|autonomic agents|mesh-ancestor
102618076|NCT01912872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102618077|NCT01912872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618078|NCT01912872|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102618079|NCT01912872|Respiratory System Agents|respiratory system agents|mesh-ancestor
102618080|NCT01912872|Glucocorticoids|glucocorticoids|mesh-ancestor
102618081|NCT01912872|Hormones|hormones|mesh-ancestor
102618082|NCT01912872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102618083|NCT01912872|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102274902|NCT01133756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274903|NCT01133756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102618084|NCT01912872|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102618085|NCT01912872|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102618086|NCT01912872|Adrenergic Agents|adrenergic agents|mesh-ancestor
102618087|NCT01912872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102618088|NCT01912872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618089|NCT01912872|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102618090|NCT01911780|Amlodipine|amlodipine|mesh-list
102618091|NCT01911780|Telmisartan|telmisartan|mesh-list
102618092|NCT01911780|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102618093|NCT01911780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102618094|NCT01911780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102618095|NCT01911780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102618096|NCT01911780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618097|NCT01911780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102618098|NCT01911780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618099|NCT01911780|Vasodilator Agents|vasodilator agents|mesh-ancestor
102618100|NCT01911780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102618101|NCT01911780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102618102|NCT01911780|Diuretics|diuretics|mesh-ancestor
102618103|NCT01911780|Natriuretic Agents|natriuretic agents|mesh-ancestor
102618104|NCT01911780|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102618105|NCT01911546|Everolimus|everolimus|mesh-list
102618106|NCT01911546|Tacrolimus|tacrolimus|mesh-list
102618107|NCT01911546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102618108|NCT01911546|Immunologic Factors|immunologic factors|mesh-ancestor
102618109|NCT01911546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618110|NCT01911546|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102618111|NCT01911546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102618112|NCT01911546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618113|NCT01911546|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102618114|NCT01911546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102618115|NCT01911546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102618116|NCT01908816|Ranibizumab|ranibizumab|mesh-list
102618117|NCT01908816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102618118|NCT01908816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102618119|NCT01908816|Growth Substances|growth substances|mesh-ancestor
102618120|NCT01908816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618121|NCT01908816|Growth Inhibitors|growth inhibitors|mesh-ancestor
102618122|NCT01908816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102618123|NCT01908582|Rifampin|rifampin|mesh-list
102618124|NCT01908582|Evacetrapib|evacetrapib|mesh-list
102618125|NCT01908582|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102618126|NCT01908582|Antitubercular Agents|antitubercular agents|mesh-ancestor
102618127|NCT01908582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102618128|NCT01908582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102618129|NCT01908582|Leprostatic Agents|leprostatic agents|mesh-ancestor
102618130|NCT01908582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102618131|NCT01908582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102618132|NCT01908582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618133|NCT01908582|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102618134|NCT01908582|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102618135|NCT01908582|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102618136|NCT01908582|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102618137|NCT01908582|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102618138|NCT01908582|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102618139|NCT01908582|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102618140|NCT01908582|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102618141|NCT01908582|Antimetabolites|antimetabolites|mesh-ancestor
102618142|NCT01908582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102618143|NCT01907100|Cisplatin|cisplatin|mesh-list
102618144|NCT01907100|Pemetrexed|pemetrexed|mesh-list
102618145|NCT01907100|Nintedanib|nintedanib|mesh-list
102618146|NCT01907100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102618147|NCT01907100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102618148|NCT01907100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618149|NCT01907100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102618150|NCT01907100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102618151|NCT01907100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102618152|NCT01889862|Dextrans|dextrans|mesh-list
102618153|NCT01889862|Anticoagulants|anticoagulants|mesh-ancestor
102618154|NCT01889862|Plasma Substitutes|plasma substitutes|mesh-ancestor
102618155|NCT01889862|Blood Substitutes|blood substitutes|mesh-ancestor
102618156|NCT01887288|Capecitabine|capecitabine|mesh-list
102618157|NCT01887288|Digoxin|digoxin|mesh-list
102618159|NCT01887288|Antimetabolites|antimetabolites|mesh-ancestor
102618160|NCT01887288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618161|NCT01887288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102618162|NCT01887288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102618163|NCT01887288|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102618164|NCT01887288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102618165|NCT01887288|Protective Agents|protective agents|mesh-ancestor
102618166|NCT01887288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618167|NCT03405714|Brivaracetam|brivaracetam|mesh-list
102618168|NCT03405714|Anticonvulsants|anticonvulsants|mesh-ancestor
102618169|NCT01885182|Oxycodone|oxycodone|mesh-list
102618170|NCT01885182|Naloxone|naloxone|mesh-list
102618171|NCT01885182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102618172|NCT01885182|Narcotics|narcotics|mesh-ancestor
102618173|NCT01885182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102618174|NCT01885182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618175|NCT01885182|Analgesics|analgesics|mesh-ancestor
102618176|NCT01885182|Sensory System Agents|sensory system agents|mesh-ancestor
102618177|NCT01885182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102618178|NCT01885182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102618179|NCT01885104|Bisacodyl|bisacodyl|mesh-list
102618180|NCT01885104|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
102618181|NCT01885104|Laxatives|laxatives|mesh-list
102618182|NCT01885104|Cathartics|cathartics|mesh-ancestor
102618183|NCT01885104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102618184|NCT01906008|Minocycline|minocycline|mesh-list
102618185|NCT01906008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102618186|NCT01906008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102618187|NCT01904760|Dexmedetomidine|dexmedetomidine|mesh-list
102618188|NCT01904760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102618189|NCT01904760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102618190|NCT01904760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618191|NCT01904760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102618192|NCT01904760|Analgesics|analgesics|mesh-ancestor
102618193|NCT01904760|Sensory System Agents|sensory system agents|mesh-ancestor
102618194|NCT01904760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102618195|NCT01904760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102618196|NCT01904760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102618197|NCT01904760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102618198|NCT01904760|Adrenergic Agents|adrenergic agents|mesh-ancestor
102618199|NCT01904760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102618200|NCT01904760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618201|NCT01904058|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102618202|NCT01904058|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102618203|NCT01904058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102618204|NCT01881126|Timolol|timolol|mesh-list
102618205|NCT01881126|Bimatoprost|bimatoprost|mesh-list
102618206|NCT01881126|Travoprost|travoprost|mesh-list
102618207|NCT01881126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618208|NCT01881126|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102618209|NCT01881126|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102618210|NCT01881126|Adrenergic Agents|adrenergic agents|mesh-ancestor
102618211|NCT01881126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102618212|NCT01881126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618213|NCT01881126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102618214|NCT01881126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102618215|NCT01880736|Insulin|insulin|mesh-list
102618216|NCT01880736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102618217|NCT01880736|Insulin, Long-Acting|insulin, long-acting|mesh-list
102618218|NCT01880736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102618219|NCT01880736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618220|NCT01880424|Linaclotide|linaclotide|mesh-list
102618221|NCT01880424|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102618222|NCT01880424|Enzyme Activators|enzyme activators|mesh-ancestor
102618223|NCT01880424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618224|NCT01880424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102618225|NCT01862874|Vaccines|vaccines|mesh-list
102618226|NCT01862874|Immunologic Factors|immunologic factors|mesh-ancestor
102618227|NCT01862874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618228|NCT01903434|Evacetrapib|evacetrapib|mesh-list
102618229|NCT01903434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102274904|NCT01133756|Antimetabolites|antimetabolites|mesh-ancestor
102274905|NCT01133756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618230|NCT01903434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102618231|NCT01903434|Antimetabolites|antimetabolites|mesh-ancestor
102618232|NCT01903434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618233|NCT01903434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102618234|NCT01903356|Linagliptin|linagliptin|mesh-list
102618235|NCT01903356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102618236|NCT01903356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618237|NCT01903356|Incretins|incretins|mesh-ancestor
102618238|NCT01903356|Hormones|hormones|mesh-ancestor
102618239|NCT01903356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102618240|NCT01903356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102618241|NCT01903356|Protease Inhibitors|protease inhibitors|mesh-ancestor
102618242|NCT01903356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102618243|NCT01903356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618244|NCT01862640|Brexpiprazole|brexpiprazole|mesh-list
102618245|NCT01862640|Serotonin Agents|serotonin agents|mesh-ancestor
102618246|NCT01862640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102618247|NCT01862640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618248|NCT01862640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618249|NCT01862640|Dopamine Agonists|dopamine agonists|mesh-ancestor
102618250|NCT01862640|Dopamine Agents|dopamine agents|mesh-ancestor
102618251|NCT01902966|Propranolol|propranolol|mesh-list
102618252|NCT01902966|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102618253|NCT01902966|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102618254|NCT01902966|Adrenergic Agents|adrenergic agents|mesh-ancestor
102618255|NCT01902966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102618256|NCT01902966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618257|NCT01902966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618258|NCT01902966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102618259|NCT01902966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102618260|NCT01902966|Vasodilator Agents|vasodilator agents|mesh-ancestor
102618261|NCT01862328|Paclitaxel|paclitaxel|mesh-list
102618262|NCT01862328|Docetaxel|docetaxel|mesh-list
102618263|NCT01862328|Carboplatin|carboplatin|mesh-list
102618264|NCT01862328|Gemcitabine|gemcitabine|mesh-list
102618265|NCT01862328|Pevonedistat|pevonedistat|mesh-list
102618266|NCT01862328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102618267|NCT01862328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102618268|NCT01862328|Tubulin Modulators|tubulin modulators|mesh-ancestor
102618269|NCT01862328|Antimitotic Agents|antimitotic agents|mesh-ancestor
102618270|NCT01862328|Mitosis Modulators|mitosis modulators|mesh-ancestor
102618271|NCT01862328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618272|NCT01862328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102618273|NCT01862328|Antimetabolites|antimetabolites|mesh-ancestor
102618274|NCT01862328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102618275|NCT01862250|Clonidine|clonidine|mesh-list
102618276|NCT01862250|Analgesics|analgesics|mesh-ancestor
102618277|NCT01862250|Sensory System Agents|sensory system agents|mesh-ancestor
102618278|NCT01862250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102618279|NCT01862250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618280|NCT01862250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102618281|NCT01862250|Sympatholytics|sympatholytics|mesh-ancestor
102618282|NCT01862250|Autonomic Agents|autonomic agents|mesh-ancestor
102618283|NCT01862250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102618284|NCT01862250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102618285|NCT01862250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102618286|NCT01862250|Adrenergic Agents|adrenergic agents|mesh-ancestor
102618287|NCT01862250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102618288|NCT01862250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618289|NCT01876446|Irinotecan|irinotecan|mesh-list
102618290|NCT01876446|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102618291|NCT01876446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102618292|NCT01876446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102618293|NCT01876446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618294|NCT01876446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102618295|NCT04414800|Fentanyl|fentanyl|mesh-list
102618296|NCT04414800|Ketamine|ketamine|mesh-list
102618297|NCT04414800|Analgesics|analgesics|mesh-ancestor
102618298|NCT04414800|Sensory System Agents|sensory system agents|mesh-ancestor
102618299|NCT04414800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102618300|NCT04414800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618301|NCT04414800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102618302|NCT04414800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101906573|NCT03789032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102618303|NCT04414800|Anesthetics, General|anesthetics, general|mesh-ancestor
102618304|NCT04414800|Anesthetics|anesthetics|mesh-ancestor
102618305|NCT04414800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102618306|NCT04414800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102618307|NCT04414800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102618308|NCT04414800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102618309|NCT04414800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618310|NCT04414800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102618311|NCT04414800|Narcotics|narcotics|mesh-ancestor
102618312|NCT04414800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102618313|NCT01898442|Ticagrelor|ticagrelor|mesh-list
102618314|NCT01898442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102618315|NCT01898442|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102618316|NCT01898442|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102618317|NCT01898442|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102618318|NCT01898442|Purinergic Agents|purinergic agents|mesh-ancestor
102618319|NCT01898442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102618320|NCT01898442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618321|NCT01898442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618322|NCT01898208|Anti-Infective Agents|anti-infective agents|mesh-list
102618323|NCT01898208|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102618324|NCT01898130|Bevacizumab|bevacizumab|mesh-list
102618325|NCT01898130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102618326|NCT01898130|Antibodies|antibodies|mesh-list
102618327|NCT01898130|Immunoglobulins|immunoglobulins|mesh-list
102618328|NCT01898130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102618329|NCT01898130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102618330|NCT01898130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102618331|NCT01898130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102618332|NCT01898130|Growth Substances|growth substances|mesh-ancestor
102618333|NCT01898130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618334|NCT01898130|Growth Inhibitors|growth inhibitors|mesh-ancestor
102618335|NCT01898130|Immunologic Factors|immunologic factors|mesh-ancestor
102618336|NCT01876368|Olmesartan|olmesartan|mesh-list
102618337|NCT01876368|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
102618338|NCT01876368|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102618339|NCT01876368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102618340|NCT01876368|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102618341|NCT01876368|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102618342|NCT01876368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618343|NCT01873950|Quinidine|quinidine|mesh-list
102618344|NCT01873950|Quinidine gluconate|quinidine gluconate|mesh-list
102618345|NCT01873950|Verapamil|verapamil|mesh-list
102618346|NCT01873950|Dofetilide|dofetilide|mesh-list
102618347|NCT01873950|Ranolazine|ranolazine|mesh-list
102618348|NCT01873950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102618349|NCT01873950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102618350|NCT01873950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102618351|NCT01873950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618352|NCT01873950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102618353|NCT01873950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618354|NCT01873950|Vasodilator Agents|vasodilator agents|mesh-ancestor
102618355|NCT01873950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102618356|NCT01873950|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102618357|NCT01873950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102618358|NCT01873950|Adrenergic Agents|adrenergic agents|mesh-ancestor
102618359|NCT01873950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102618360|NCT01873950|Antimalarials|antimalarials|mesh-ancestor
102618361|NCT01873950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102618362|NCT01873950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102618363|NCT01873950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102618364|NCT01873950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102618365|NCT01873950|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102618366|NCT01873950|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102618367|NCT01873950|Cholinergic Agents|cholinergic agents|mesh-ancestor
102618368|NCT01873950|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102618369|NCT01873950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102618370|NCT01873950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102618371|NCT01873950|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102618372|NCT01896726|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
102618373|NCT01896726|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
102618374|NCT01896726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102618375|NCT01896726|Contraceptive Agents|contraceptive agents|mesh-ancestor
102618376|NCT01896726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102274906|NCT01133756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101906649|NCT01306760|Anesthetics|anesthetics|mesh-ancestor
102274907|NCT01133756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102618377|NCT01896726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618378|NCT01896726|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102618379|NCT01896726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102618380|NCT01896726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102618381|NCT01896726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102618382|NCT01896726|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102618383|NCT01896726|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
102618384|NCT01896726|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102618385|NCT01896726|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102618386|NCT01856790|Liraglutide|liraglutide|mesh-list
102618387|NCT01856790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102618388|NCT01856790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618389|NCT01856790|Incretins|incretins|mesh-ancestor
102618390|NCT01856790|Hormones|hormones|mesh-ancestor
102618391|NCT01856790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102618392|NCT01856322|Sulindac|sulindac|mesh-list
102618393|NCT01856322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102618394|NCT01856322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102618395|NCT01856322|Analgesics|analgesics|mesh-ancestor
101590603|NCT05032794|Laxatives|laxatives|mesh-ancestor
102618396|NCT01856322|Sensory System Agents|sensory system agents|mesh-ancestor
102618397|NCT01856322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102618398|NCT01856322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618399|NCT01856322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102618400|NCT01856322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102618401|NCT01856322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102618402|NCT01856322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102618403|NCT01856322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102618404|NCT01856322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618405|NCT01871532|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102618406|NCT01871532|Hormones|hormones|mesh-ancestor
102618407|NCT01871532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102618408|NCT01871532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618409|NCT01855074|Risperidone|risperidone|mesh-list
102618410|NCT01855074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102618411|NCT01855074|Serotonin Agents|serotonin agents|mesh-ancestor
102618412|NCT01855074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102618413|NCT01855074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618414|NCT01855074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618415|NCT01855074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102618416|NCT01855074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102618417|NCT01855074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102618418|NCT01855074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102618419|NCT01855074|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102618420|NCT01855074|Dopamine Agents|dopamine agents|mesh-ancestor
102618421|NCT01895322|Tolvaptan|tolvaptan|mesh-list
102618422|NCT01895322|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102618423|NCT01895322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618424|NCT01895322|Natriuretic Agents|natriuretic agents|mesh-ancestor
102618425|NCT01895322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618426|NCT01894776|Maraviroc|maraviroc|mesh-list
102618427|NCT01894776|Rifabutin|rifabutin|mesh-list
102618428|NCT01894776|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102618429|NCT01894776|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102618430|NCT01894776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618431|NCT01894776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102618432|NCT01894776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102618433|NCT01894776|Antiviral Agents|antiviral agents|mesh-ancestor
102618434|NCT01894776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102618435|NCT01894776|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102618436|NCT01894776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102618437|NCT01894776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102618438|NCT01894776|Antitubercular Agents|antitubercular agents|mesh-ancestor
102618439|NCT01854918|Evolocumab|evolocumab|mesh-list
102618440|NCT01854918|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102618441|NCT01854918|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102618442|NCT01854918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102618443|NCT01854918|Antimetabolites|antimetabolites|mesh-ancestor
102618444|NCT01854918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618445|NCT01854918|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102618446|NCT01854918|Protease Inhibitors|protease inhibitors|mesh-ancestor
102618447|NCT01854918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102618448|NCT01854918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102274908|NCT01126736|Pemetrexed|pemetrexed|mesh-list
102618449|NCT01894152|Everolimus|everolimus|mesh-list
102618450|NCT01894152|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102618451|NCT01894152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102618452|NCT01894152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102618453|NCT01894152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618454|NCT01894152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102618455|NCT01894152|Immunologic Factors|immunologic factors|mesh-ancestor
102618456|NCT01894152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618457|NCT01894152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102618458|NCT01854528|Interferons|interferons|mesh-list
102618459|NCT01854528|Ribavirin|ribavirin|mesh-list
102618460|NCT01854528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102618461|NCT01854528|Antiviral Agents|antiviral agents|mesh-ancestor
102618462|NCT01854528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102618463|NCT01854528|Antimetabolites|antimetabolites|mesh-ancestor
102618464|NCT01854528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618465|NCT01853982|Tazobactam|tazobactam|mesh-list
102618466|NCT01853982|Piperacillin|piperacillin|mesh-list
102618467|NCT01853982|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102618468|NCT01853982|Ceftolozane|ceftolozane|mesh-list
102618469|NCT01853982|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
102618470|NCT01853982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102618471|NCT01853982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102618472|NCT01853982|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102618473|NCT01853982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102618474|NCT01853982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618475|NCT01853982|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102618476|NCT01853280|Methylphenidate|methylphenidate|mesh-list
102618477|NCT01853280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102618478|NCT01853280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618479|NCT01853280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102618480|NCT01853280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102618481|NCT01853280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102618482|NCT01853280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618483|NCT01853280|Dopamine Agents|dopamine agents|mesh-ancestor
102618484|NCT01853280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102618485|NCT01891890|Lamotrigine|lamotrigine|mesh-list
102618486|NCT01891890|Oxcarbazepine|oxcarbazepine|mesh-list
102618487|NCT01891890|Levetiracetam|levetiracetam|mesh-list
102618488|NCT01891890|Anticonvulsants|anticonvulsants|mesh-ancestor
102618489|NCT01891890|Nootropic Agents|nootropic agents|mesh-ancestor
102618490|NCT01891890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102618491|NCT01891890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102618492|NCT01891890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618493|NCT01891890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102618494|NCT01891890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618495|NCT01891890|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102618496|NCT01891890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102618497|NCT01891890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102618498|NCT01891890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102618499|NCT01891890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102618500|NCT01891890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102618501|NCT01891890|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102618502|NCT01891890|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102618503|NCT01852812|Montelukast|montelukast|mesh-list
102618504|NCT01852812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102618505|NCT01852812|Respiratory System Agents|respiratory system agents|mesh-ancestor
102618506|NCT01852812|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102618507|NCT01852812|Hormone Antagonists|hormone antagonists|mesh-ancestor
102618508|NCT01852812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102618509|NCT01852812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618510|NCT01852812|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102618511|NCT01852812|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102618512|NCT01852812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618513|NCT01869192|Cyclophosphamide|cyclophosphamide|mesh-list
102618514|NCT01869192|Docetaxel|docetaxel|mesh-list
102618515|NCT01869192|Capecitabine|capecitabine|mesh-list
102618516|NCT01869192|Epirubicin|epirubicin|mesh-list
102618517|NCT01869192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102618518|NCT01869192|Immunologic Factors|immunologic factors|mesh-ancestor
102618519|NCT01869192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274909|NCT01126736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274910|NCT01126736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102618520|NCT01869192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102618521|NCT01869192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102618522|NCT01869192|Alkylating Agents|alkylating agents|mesh-ancestor
102618523|NCT01869192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618524|NCT01869192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102618525|NCT01869192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102618526|NCT01869192|Tubulin Modulators|tubulin modulators|mesh-ancestor
102618527|NCT01869192|Antimitotic Agents|antimitotic agents|mesh-ancestor
102618528|NCT01869192|Mitosis Modulators|mitosis modulators|mesh-ancestor
102618529|NCT01869192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102618530|NCT01869192|Antimetabolites|antimetabolites|mesh-ancestor
102618531|NCT01869192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102618532|NCT01869192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102618533|NCT01869192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102618534|NCT01869192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102618535|NCT01851720|Fentanyl|fentanyl|mesh-list
102618536|NCT01851720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102618537|NCT01851720|Narcotics|narcotics|mesh-ancestor
102618538|NCT01851720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102618539|NCT01851720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618540|NCT01851720|Analgesics|analgesics|mesh-ancestor
102618541|NCT01851720|Sensory System Agents|sensory system agents|mesh-ancestor
102618542|NCT01851720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102618543|NCT01851720|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102618544|NCT01851720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102618545|NCT01851720|Anesthetics, General|anesthetics, general|mesh-ancestor
102618546|NCT01851720|Anesthetics|anesthetics|mesh-ancestor
102618547|NCT01851330|Sofosbuvir|sofosbuvir|mesh-list
102618548|NCT01851330|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102618549|NCT01851330|Ledipasvir|ledipasvir|mesh-list
102618550|NCT01851330|Antiviral Agents|antiviral agents|mesh-ancestor
102618551|NCT01851330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102618552|NCT01868022|Paclitaxel|paclitaxel|mesh-list
102618553|NCT01868022|Docetaxel|docetaxel|mesh-list
102618554|NCT01868022|Carboplatin|carboplatin|mesh-list
102618555|NCT01868022|Pemetrexed|pemetrexed|mesh-list
102618556|NCT01868022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102618557|NCT01868022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102618558|NCT01868022|Tubulin Modulators|tubulin modulators|mesh-ancestor
102618559|NCT01868022|Antimitotic Agents|antimitotic agents|mesh-ancestor
102618560|NCT01868022|Mitosis Modulators|mitosis modulators|mesh-ancestor
102618561|NCT01868022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618562|NCT01868022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102618563|NCT01868022|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101590809|NCT00677755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102618564|NCT01868022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102618565|NCT01850004|Dasatinib|dasatinib|mesh-list
102618566|NCT01850004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102618567|NCT01850004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102618568|NCT01850004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102618569|NCT01850004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618570|NCT01867710|Dexamethasone|dexamethasone|mesh-list
102618571|NCT01867710|Prednisone|prednisone|mesh-list
102618572|NCT01867710|Abiraterone Acetate|abiraterone acetate|mesh-list
102618573|NCT01867710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102618574|NCT01867710|Antiemetics|antiemetics|mesh-ancestor
102618575|NCT01867710|Autonomic Agents|autonomic agents|mesh-ancestor
102618576|NCT01867710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102618577|NCT01867710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618578|NCT01867710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102618579|NCT01867710|Glucocorticoids|glucocorticoids|mesh-ancestor
102618580|NCT01867710|Hormones|hormones|mesh-ancestor
102618581|NCT01867710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102618582|NCT01867710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102618583|NCT01867710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102618584|NCT01867710|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102618585|NCT01867710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102618586|NCT01867710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618587|NCT01867710|Hormone Antagonists|hormone antagonists|mesh-ancestor
102618588|NCT01867710|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102618589|NCT01832766|Dronabinol|dronabinol|mesh-list
102618590|NCT01832766|Hallucinogens|hallucinogens|mesh-ancestor
102618591|NCT01832766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274911|NCT01126736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618592|NCT01832766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102618593|NCT01832766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102618594|NCT01832766|Analgesics|analgesics|mesh-ancestor
102618595|NCT01832766|Sensory System Agents|sensory system agents|mesh-ancestor
102618596|NCT01832766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102618597|NCT01832766|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102618598|NCT01832766|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102618599|NCT01832766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102618600|NCT01832766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618601|NCT01832766|Hormones|hormones|mesh-ancestor
102618602|NCT01832766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102618603|NCT01832532|Liraglutide|liraglutide|mesh-list
102618604|NCT01832532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102618605|NCT01832532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618606|NCT01832532|Incretins|incretins|mesh-ancestor
102618607|NCT01832532|Hormones|hormones|mesh-ancestor
102618608|NCT01832532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102618609|NCT04414956|Vitamin K|vitamin k|mesh-list
102618610|NCT04414956|Agglutinins|agglutinins|mesh-list
102618611|NCT04414956|Vitamins|vitamins|mesh-ancestor
102618612|NCT04414956|Micronutrients|micronutrients|mesh-ancestor
102618613|NCT04414956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618614|NCT04414956|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102618615|NCT04414956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102618616|NCT04414956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618617|NCT04414956|Hemostatics|hemostatics|mesh-ancestor
102618618|NCT04414956|Coagulants|coagulants|mesh-ancestor
102618619|NCT04414956|Immunologic Factors|immunologic factors|mesh-ancestor
102618620|NCT01848990|Insulin|insulin|mesh-list
102618621|NCT01848990|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102618622|NCT01848990|Insulin Aspart|insulin aspart|mesh-list
102618623|NCT01848990|Insulin Lispro|insulin lispro|mesh-list
102618624|NCT01848990|Insulin glulisine|insulin glulisine|mesh-list
102618625|NCT01848990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102618626|NCT01848990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618627|NCT01867086|Carboplatin|carboplatin|mesh-list
102618628|NCT01867086|Vaccines|vaccines|mesh-list
102618629|NCT01867086|Immunologic Factors|immunologic factors|mesh-ancestor
102618630|NCT01867086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618631|NCT01867086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102618632|NCT01848834|Pembrolizumab|pembrolizumab|mesh-list
102618633|NCT01848834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102618634|NCT01848834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102618635|NCT01848834|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102618636|NCT01848834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618637|NCT04600362|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102618638|NCT04600362|Immunologic Factors|immunologic factors|mesh-ancestor
102618639|NCT04600362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618640|NCT01848210|Troxerutin|troxerutin|mesh-list
102618641|NCT01848210|Anticoagulants|anticoagulants|mesh-ancestor
102618642|NCT01830816|Ixazomib|ixazomib|mesh-list
102618643|NCT01830816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102618644|NCT01830816|Protease Inhibitors|protease inhibitors|mesh-ancestor
102618645|NCT01830816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102618646|NCT01830816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618647|NCT01846416|Atezolizumab|atezolizumab|mesh-list
102618648|NCT01846416|Antibodies|antibodies|mesh-list
102618649|NCT01846416|Immunologic Factors|immunologic factors|mesh-ancestor
102618650|NCT01846416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618651|NCT01846416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102618652|NCT01846416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618653|NCT01846416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102618654|NCT01846416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102618655|NCT04589754|Ifosfamide|ifosfamide|mesh-list
102618656|NCT04589754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102618657|NCT04589754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618658|NCT04589754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102618659|NCT04589754|Alkylating Agents|alkylating agents|mesh-ancestor
102618660|NCT01846104|Vaccines|vaccines|mesh-list
102618661|NCT01846104|Immunologic Factors|immunologic factors|mesh-ancestor
102618662|NCT01846104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618663|NCT01803282|Leucovorin|leucovorin|mesh-list
102618664|NCT01803282|Paclitaxel|paclitaxel|mesh-list
102618665|NCT01803282|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102274912|NCT01126736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102618666|NCT01803282|Bevacizumab|bevacizumab|mesh-list
102618667|NCT01803282|Carboplatin|carboplatin|mesh-list
102618668|NCT01803282|Gemcitabine|gemcitabine|mesh-list
101906943|NCT01309178|Natriuretic Agents|natriuretic agents|mesh-ancestor
102618669|NCT01803282|Oxaliplatin|oxaliplatin|mesh-list
101907018|NCT00243503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102618670|NCT01803282|Irinotecan|irinotecan|mesh-list
102618671|NCT01803282|Pemetrexed|pemetrexed|mesh-list
102618672|NCT01803282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102618673|NCT01803282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102618674|NCT01803282|Tubulin Modulators|tubulin modulators|mesh-ancestor
102618675|NCT01803282|Antimitotic Agents|antimitotic agents|mesh-ancestor
102618676|NCT01803282|Mitosis Modulators|mitosis modulators|mesh-ancestor
102618677|NCT01803282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618678|NCT01803282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102618679|NCT01803282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102618680|NCT01803282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102618681|NCT01803282|Growth Substances|growth substances|mesh-ancestor
102618682|NCT01803282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618683|NCT01803282|Growth Inhibitors|growth inhibitors|mesh-ancestor
102618684|NCT01803282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102618685|NCT01803282|Antimetabolites|antimetabolites|mesh-ancestor
102618686|NCT01803282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102618687|NCT01803282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102618688|NCT01803282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102618689|NCT01803282|Antidotes|antidotes|mesh-ancestor
102618690|NCT01803282|Protective Agents|protective agents|mesh-ancestor
102618691|NCT01803282|Vitamin B Complex|vitamin b complex|mesh-ancestor
102618692|NCT01803282|Vitamins|vitamins|mesh-ancestor
102618693|NCT01803282|Micronutrients|micronutrients|mesh-ancestor
102618694|NCT01803282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102618695|NCT01803282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102618696|NCT01844778|Tobramycin|tobramycin|mesh-list
102618697|NCT01844778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102618698|NCT01844778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102618699|NCT01802580|Fluocinonide|fluocinonide|mesh-list
102618700|NCT01802580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102618701|NCT01802580|Glucocorticoids|glucocorticoids|mesh-ancestor
102618702|NCT01802580|Hormones|hormones|mesh-ancestor
102618703|NCT01802580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102618704|NCT01802580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618705|NCT01802580|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102618706|NCT01611090|Rituximab|rituximab|mesh-list
102618707|NCT01611090|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102618708|NCT01611090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102618709|NCT01611090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102618710|NCT01611090|Immunologic Factors|immunologic factors|mesh-ancestor
102618711|NCT01611090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618712|NCT01611090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102618713|NCT01611090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102618714|NCT01611090|Alkylating Agents|alkylating agents|mesh-ancestor
102618715|NCT01611090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618716|NCT01844700|Risperidone|risperidone|mesh-list
102618717|NCT01844700|Aripiprazole|aripiprazole|mesh-list
102618718|NCT01844700|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102618719|NCT01844700|Ziprasidone|ziprasidone|mesh-list
102618720|NCT01844700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102618721|NCT01844700|Serotonin Agents|serotonin agents|mesh-ancestor
102618722|NCT01844700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102618723|NCT01844700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618724|NCT01844700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618725|NCT01844700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102618726|NCT01844700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102618727|NCT01844700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102618728|NCT01844700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102618729|NCT01844700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102618730|NCT01844700|Dopamine Agents|dopamine agents|mesh-ancestor
102618731|NCT01844700|Antidepressive Agents|antidepressive agents|mesh-ancestor
102618732|NCT01844700|Dopamine Agonists|dopamine agonists|mesh-ancestor
102618733|NCT01844700|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102618734|NCT01844700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102618735|NCT01844700|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102618736|NCT01844700|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102618737|NCT01827384|Carboplatin|carboplatin|mesh-list
102618738|NCT01827384|Everolimus|everolimus|mesh-list
102618739|NCT01827384|Temozolomide|temozolomide|mesh-list
102618740|NCT01827384|Trametinib|trametinib|mesh-list
102618741|NCT01827384|Veliparib|veliparib|mesh-list
102618742|NCT01827384|Adavosertib|adavosertib|mesh-list
102618743|NCT01827384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102618744|NCT01827384|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102618745|NCT01827384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102618746|NCT01827384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102618747|NCT01827384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618748|NCT01827384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102618749|NCT01827384|Immunologic Factors|immunologic factors|mesh-ancestor
102618750|NCT01827384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618751|NCT01827384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102618752|NCT01827384|Alkylating Agents|alkylating agents|mesh-ancestor
102618753|NCT01827384|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102618754|NCT01844076|Quinacrine|quinacrine|mesh-list
102618755|NCT01844076|Capecitabine|capecitabine|mesh-list
102618756|NCT01844076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102618757|NCT01844076|Antimetabolites|antimetabolites|mesh-ancestor
102618758|NCT01844076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618759|NCT01844076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102618760|NCT01844076|Anticestodal Agents|anticestodal agents|mesh-ancestor
102618761|NCT01844076|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102618762|NCT01844076|Anthelmintics|anthelmintics|mesh-ancestor
102618763|NCT01844076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102618764|NCT01844076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102618765|NCT01844076|Antimalarials|antimalarials|mesh-ancestor
102618766|NCT01844076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102618767|NCT01844076|Antinematodal Agents|antinematodal agents|mesh-ancestor
102618768|NCT01844076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102618769|NCT01826448|Vemurafenib|vemurafenib|mesh-list
102618770|NCT01826448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102618771|NCT01826448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102618772|NCT01826448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102618773|NCT01826448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618774|NCT01826370|Linagliptin|linagliptin|mesh-list
102618775|NCT01826370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102618776|NCT01826370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618777|NCT01826370|Incretins|incretins|mesh-ancestor
102618778|NCT01826370|Hormones|hormones|mesh-ancestor
102618779|NCT01826370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102618780|NCT01826370|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102618781|NCT01826370|Protease Inhibitors|protease inhibitors|mesh-ancestor
102618782|NCT01826370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102618783|NCT01826370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618784|NCT01799226|Triclosan|triclosan|mesh-list
102618785|NCT01799226|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102618786|NCT01799226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102618787|NCT01799226|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102618788|NCT01799226|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102618789|NCT01799226|Antimetabolites|antimetabolites|mesh-ancestor
102618790|NCT01799226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618791|NCT01799226|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102618792|NCT01798992|Metoprolol|metoprolol|mesh-list
102618793|NCT01798992|Carvedilol|carvedilol|mesh-list
102618794|NCT01798992|Doxazosin|doxazosin|mesh-list
102618795|NCT01798992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102618796|NCT01798992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102618797|NCT01798992|Sympatholytics|sympatholytics|mesh-ancestor
102618798|NCT01798992|Autonomic Agents|autonomic agents|mesh-ancestor
102618799|NCT01798992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102618800|NCT01798992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618801|NCT01798992|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102618802|NCT01798992|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102618803|NCT01798992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102618804|NCT01798992|Adrenergic Agents|adrenergic agents|mesh-ancestor
102618805|NCT01798992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102618806|NCT01798992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618807|NCT01798992|Antioxidants|antioxidants|mesh-ancestor
102618808|NCT01798992|Protective Agents|protective agents|mesh-ancestor
102618809|NCT01798992|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102618810|NCT01798992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102618811|NCT01798992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102618812|NCT01798992|Vasodilator Agents|vasodilator agents|mesh-ancestor
102618813|NCT01798992|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102618814|NCT01798992|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102618815|NCT01798056|Vaccines|vaccines|mesh-list
102618816|NCT01798056|Immunologic Factors|immunologic factors|mesh-ancestor
102274913|NCT01126736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102618817|NCT01798056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618818|NCT01824342|Denosumab|denosumab|mesh-list
102274914|NCT01111461|Lenvatinib|lenvatinib|mesh-list
102618819|NCT01824342|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102618820|NCT01824342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618821|NCT01823328|Ketamine|ketamine|mesh-list
102618822|NCT01823328|Etomidate|etomidate|mesh-list
102618823|NCT01823328|Analgesics|analgesics|mesh-ancestor
102618824|NCT01823328|Sensory System Agents|sensory system agents|mesh-ancestor
102618825|NCT01823328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102618826|NCT01823328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618827|NCT01823328|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102618828|NCT01823328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102618829|NCT01823328|Anesthetics, General|anesthetics, general|mesh-ancestor
102618830|NCT01823328|Anesthetics|anesthetics|mesh-ancestor
102618831|NCT01823328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102618832|NCT01823328|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102618833|NCT01823328|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102618834|NCT01823328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102618835|NCT01823328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618836|NCT01823328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102618837|NCT01840410|Ranibizumab|ranibizumab|mesh-list
102618838|NCT01840410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102618839|NCT01840410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102618840|NCT01840410|Growth Substances|growth substances|mesh-ancestor
102618841|NCT01840410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618842|NCT01840410|Growth Inhibitors|growth inhibitors|mesh-ancestor
102618843|NCT01840410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102618844|NCT01797432|Triamcinolone|triamcinolone|mesh-list
102618845|NCT01797432|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102618846|NCT01797432|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102618847|NCT01797432|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102618848|NCT01797432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102618849|NCT01797432|Glucocorticoids|glucocorticoids|mesh-ancestor
102618850|NCT01797432|Hormones|hormones|mesh-ancestor
102618851|NCT01797432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102618852|NCT01797432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618853|NCT01797432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102618854|NCT01797432|Immunologic Factors|immunologic factors|mesh-ancestor
102618855|NCT01797432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102618856|NCT01797432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618857|NCT01797120|Everolimus|everolimus|mesh-list
102618858|NCT01797120|MTOR Inhibitors|mtor inhibitors|mesh-list
102618859|NCT01797120|Fulvestrant|fulvestrant|mesh-list
102618860|NCT01797120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102618861|NCT01797120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102618862|NCT01797120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618863|NCT01797120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102618864|NCT01797120|Immunologic Factors|immunologic factors|mesh-ancestor
102618865|NCT01797120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618866|NCT01797120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102618867|NCT01797120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102618868|NCT01797120|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102618869|NCT01797120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102618870|NCT01797120|Hormone Antagonists|hormone antagonists|mesh-ancestor
102618871|NCT01797120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102618872|NCT01796964|Aflibercept|aflibercept|mesh-list
102618873|NCT01796964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102618874|NCT01796964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102618875|NCT01796964|Growth Substances|growth substances|mesh-ancestor
102618876|NCT01796964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618877|NCT01796964|Growth Inhibitors|growth inhibitors|mesh-ancestor
102618878|NCT01796964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102618879|NCT01794780|Fluticasone|fluticasone|mesh-list
102618880|NCT01794780|Budesonide|budesonide|mesh-list
102618881|NCT01794780|Theophylline|theophylline|mesh-list
102618882|NCT01794780|Formoterol Fumarate|formoterol fumarate|mesh-list
102618883|NCT01794780|Tiotropium Bromide|tiotropium bromide|mesh-list
102618884|NCT01794780|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102618885|NCT01794780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102618886|NCT01794780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102618887|NCT01794780|Autonomic Agents|autonomic agents|mesh-ancestor
102618888|NCT01794780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102618889|NCT01794780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618890|NCT01794780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101907168|NCT04883840|Antimetabolites|antimetabolites|mesh-ancestor
102618891|NCT01794780|Respiratory System Agents|respiratory system agents|mesh-ancestor
102618892|NCT01794780|Dermatologic Agents|dermatologic agents|mesh-ancestor
102618893|NCT01794780|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102618894|NCT01794780|Glucocorticoids|glucocorticoids|mesh-ancestor
102618895|NCT01794780|Hormones|hormones|mesh-ancestor
102618896|NCT01794780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102618897|NCT01794780|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102618898|NCT01794780|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102618899|NCT01794780|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102618900|NCT01794780|Adrenergic Agents|adrenergic agents|mesh-ancestor
102618901|NCT01794780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102618902|NCT01794780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618903|NCT01794780|Parasympatholytics|parasympatholytics|mesh-ancestor
102618904|NCT01794780|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102618905|NCT01794780|Cholinergic Agents|cholinergic agents|mesh-ancestor
102618906|NCT01794780|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102618907|NCT01794780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102618908|NCT01794780|Vasodilator Agents|vasodilator agents|mesh-ancestor
102618909|NCT01794780|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102618910|NCT01794780|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102618911|NCT01794780|Purinergic Agents|purinergic agents|mesh-ancestor
102618912|NCT01838616|Oxycodone|oxycodone|mesh-list
102618913|NCT01838616|Tapentadol|tapentadol|mesh-list
102618914|NCT01838616|Naloxone|naloxone|mesh-list
102618915|NCT01838616|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102618916|NCT01838616|Narcotics|narcotics|mesh-ancestor
102618917|NCT01838616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102618918|NCT01838616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618919|NCT01838616|Analgesics|analgesics|mesh-ancestor
102618920|NCT01838616|Sensory System Agents|sensory system agents|mesh-ancestor
102618921|NCT01838616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102618922|NCT01838616|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102618923|NCT01838616|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102618924|NCT01838616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102618925|NCT01838616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102618926|NCT01838616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618927|NCT01838616|Adrenergic Agents|adrenergic agents|mesh-ancestor
102618928|NCT01838616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102618929|NCT01794000|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102618930|NCT01794000|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102618931|NCT01609218|Charcoal|charcoal|mesh-list
102618932|NCT01609218|Antidotes|antidotes|mesh-ancestor
102618933|NCT01609218|Protective Agents|protective agents|mesh-ancestor
101591167|NCT02820922|Anesthetics|anesthetics|mesh-list
102618934|NCT01609218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618935|NCT04580472|Clindamycin|clindamycin|mesh-list
102618936|NCT04580472|Clindamycin palmitate|clindamycin palmitate|mesh-list
102618937|NCT04580472|Clindamycin phosphate|clindamycin phosphate|mesh-list
102618938|NCT04580472|Cephalexin|cephalexin|mesh-list
102618939|NCT04580472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102618940|NCT04580472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102618941|NCT04580472|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102618942|NCT04580472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102618943|NCT04580472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618944|NCT01611558|Ipilimumab|ipilimumab|mesh-list
102618945|NCT01611558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102618946|NCT01611558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102618947|NCT01611558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102618948|NCT01611558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618949|NCT01818726|Deferasirox|deferasirox|mesh-list
102618950|NCT01818726|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102618951|NCT01818726|Chelating Agents|chelating agents|mesh-ancestor
102618952|NCT01818726|Sequestering Agents|sequestering agents|mesh-ancestor
102618953|NCT01818726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618954|NCT01818336|Amoxicillin|amoxicillin|mesh-list
102618955|NCT01818336|Penicillins|penicillins|mesh-list
102618956|NCT01818336|Penicillin G|penicillin g|mesh-list
102618957|NCT01818336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102618958|NCT01818336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102618959|NCT01818258|Ritonavir|ritonavir|mesh-list
102618960|NCT01818258|Lopinavir|lopinavir|mesh-list
102618961|NCT01818258|Lamivudine|lamivudine|mesh-list
102618962|NCT01818258|Zidovudine|zidovudine|mesh-list
102618963|NCT01818258|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102618964|NCT01818258|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102618965|NCT01818258|Protease Inhibitors|protease inhibitors|mesh-ancestor
102618966|NCT01818258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102618967|NCT01818258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618969|NCT01818258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102618970|NCT01818258|Antiviral Agents|antiviral agents|mesh-ancestor
102618971|NCT01818258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102618972|NCT01818258|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102618973|NCT01818258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102618974|NCT01818258|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102618975|NCT01818258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102618976|NCT01818258|Antimetabolites|antimetabolites|mesh-ancestor
102618977|NCT01817790|Fluticasone|fluticasone|mesh-list
102618978|NCT01817790|Xhance|xhance|mesh-list
102618979|NCT01817790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102618980|NCT01817790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102618981|NCT01817790|Autonomic Agents|autonomic agents|mesh-ancestor
102618982|NCT01817790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102618983|NCT01817790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618984|NCT01817790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102618985|NCT01817790|Respiratory System Agents|respiratory system agents|mesh-ancestor
102618986|NCT01817790|Dermatologic Agents|dermatologic agents|mesh-ancestor
102618987|NCT01817790|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102618988|NCT01793688|Ampicillin|ampicillin|mesh-list
102618989|NCT01793688|Sulbactam|sulbactam|mesh-list
102618990|NCT01793688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102618991|NCT01793688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102618992|NCT01793688|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102618993|NCT01793688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102618994|NCT01793688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102618995|NCT01792830|Metformin|metformin|mesh-list
102618996|NCT01792830|Insulin Glargine|insulin glargine|mesh-list
102618997|NCT01792830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102618998|NCT01792830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102618999|NCT01792518|Linagliptin|linagliptin|mesh-list
102619000|NCT01792518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102619001|NCT01792518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619002|NCT01792518|Incretins|incretins|mesh-ancestor
102619003|NCT01792518|Hormones|hormones|mesh-ancestor
101591221|NCT04745728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102619004|NCT01792518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102619005|NCT01792518|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102619006|NCT01792518|Protease Inhibitors|protease inhibitors|mesh-ancestor
102619007|NCT01792518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102619008|NCT01792518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619009|NCT01792284|Insulin|insulin|mesh-list
102619010|NCT01792284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102619011|NCT01792284|Insulin Lispro|insulin lispro|mesh-list
102619012|NCT01792284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102619013|NCT01792284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619014|NCT04414566|Cisplatin|cisplatin|mesh-list
102619015|NCT04414566|Gemcitabine|gemcitabine|mesh-list
102619016|NCT04414566|Docetaxel|docetaxel|mesh-list
102619017|NCT04414566|Fluorouracil|fluorouracil|mesh-list
102619018|NCT04414566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102619019|NCT04414566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102619020|NCT04414566|Antimetabolites|antimetabolites|mesh-ancestor
102619021|NCT04414566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619022|NCT04414566|Tubulin Modulators|tubulin modulators|mesh-ancestor
102619023|NCT04414566|Antimitotic Agents|antimitotic agents|mesh-ancestor
102619024|NCT04414566|Mitosis Modulators|mitosis modulators|mesh-ancestor
102619025|NCT04414566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102619026|NCT04414566|Immunologic Factors|immunologic factors|mesh-ancestor
102619027|NCT04414566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619028|NCT01791894|Arsenic Trioxide|arsenic trioxide|mesh-list
102619029|NCT01791894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102619030|NCT04592016|Diclofenac|diclofenac|mesh-list
102619031|NCT04592016|Coal Tar|coal tar|mesh-list
102619032|NCT04592016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102619033|NCT04592016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102619034|NCT04592016|Analgesics|analgesics|mesh-ancestor
102619035|NCT04592016|Sensory System Agents|sensory system agents|mesh-ancestor
102619036|NCT04592016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101907316|NCT01321034|Vitamins|vitamins|mesh-ancestor
102619037|NCT04592016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619038|NCT04592016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102619039|NCT04592016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102619040|NCT04592016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102619041|NCT04592016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102619042|NCT04592016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619044|NCT04592016|Dermatologic Agents|dermatologic agents|mesh-ancestor
102619045|NCT01837680|Insulin|insulin|mesh-list
102619046|NCT01837680|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102619047|NCT01837680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102619048|NCT01837680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619049|NCT01836276|Varenicline|varenicline|mesh-list
102619050|NCT01836276|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102619051|NCT01836276|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102619052|NCT01836276|Cholinergic Agents|cholinergic agents|mesh-ancestor
102619053|NCT01836276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102619054|NCT01836276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619055|NCT01836276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619056|NCT01790568|Methotrexate|methotrexate|mesh-list
102619057|NCT01790568|Vorinostat|vorinostat|mesh-list
102619058|NCT01790568|Tacrolimus|tacrolimus|mesh-list
102619059|NCT01790568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102619060|NCT01790568|Abortifacient Agents|abortifacient agents|mesh-ancestor
102619061|NCT01790568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102619062|NCT01790568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619063|NCT01790568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102619064|NCT01790568|Antimetabolites|antimetabolites|mesh-ancestor
102619065|NCT01790568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619066|NCT01790568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102619067|NCT01790568|Dermatologic Agents|dermatologic agents|mesh-ancestor
102619068|NCT01790568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102619069|NCT01790568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102619070|NCT01790568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102619071|NCT01790568|Immunologic Factors|immunologic factors|mesh-ancestor
102619072|NCT01790568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102619073|NCT01790568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102619074|NCT01790568|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102619075|NCT01790568|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102619076|NCT01836198|Clarithromycin|clarithromycin|mesh-list
102619077|NCT01836198|Ketoconazole|ketoconazole|mesh-list
102619078|NCT01836198|Gemfibrozil|gemfibrozil|mesh-list
102619079|NCT01836198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102619080|NCT01836198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102619081|NCT01836198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102619082|NCT01836198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102619083|NCT01836198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619084|NCT01836198|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102619085|NCT01836198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102619086|NCT01836198|Antifungal Agents|antifungal agents|mesh-ancestor
102619087|NCT01836198|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102619088|NCT01836198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102619089|NCT01836198|Hormone Antagonists|hormone antagonists|mesh-ancestor
102619090|NCT01836198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102619091|NCT01836198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619092|NCT01836198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102619093|NCT01836198|Antimetabolites|antimetabolites|mesh-ancestor
102619094|NCT01836198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102619095|NCT01836198|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102619096|NCT01816074|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102619097|NCT01816074|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102619098|NCT01816074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619099|NCT01816074|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102619100|NCT01816074|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102619101|NCT01816074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102619102|NCT01816074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619103|NCT01816074|Dopamine Agents|dopamine agents|mesh-ancestor
102619104|NCT01816074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102619105|NCT01815918|Hydrocortisone|hydrocortisone|mesh-list
102619106|NCT01815918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102619107|NCT01789320|Triamcinolone|triamcinolone|mesh-list
102619108|NCT01789320|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102619109|NCT01789320|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102619110|NCT01789320|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102619111|NCT01789320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102619112|NCT01789320|Glucocorticoids|glucocorticoids|mesh-ancestor
102619113|NCT01789320|Hormones|hormones|mesh-ancestor
102274915|NCT01111461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102619114|NCT01789320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102619115|NCT01789320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619116|NCT01789320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102619117|NCT01789320|Immunologic Factors|immunologic factors|mesh-ancestor
102619118|NCT01789320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102619119|NCT01789320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619120|NCT01788228|Vaccines|vaccines|mesh-list
102619121|NCT01788228|Immunologic Factors|immunologic factors|mesh-ancestor
102619122|NCT01788228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619123|NCT01607346|Ezogabine|ezogabine|mesh-list
102619124|NCT01607346|Anticonvulsants|anticonvulsants|mesh-ancestor
102619125|NCT01607346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102619126|NCT01607346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619127|NCT01815138|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102619128|NCT01815138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102619129|NCT01815138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619130|NCT01606800|Ribavirin|ribavirin|mesh-list
102619131|NCT01606800|Interferon alpha-2|interferon alpha-2|mesh-list
102619132|NCT01606800|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102619133|NCT01606800|Antimetabolites|antimetabolites|mesh-ancestor
102619134|NCT01606800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619135|NCT01606800|Antiviral Agents|antiviral agents|mesh-ancestor
102619136|NCT01606800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102619137|NCT01606800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102619138|NCT01814748|Metformin|metformin|mesh-list
102619139|NCT01814748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102619140|NCT01814748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619141|NCT01814670|Botulinum Toxins|botulinum toxins|mesh-list
102619142|NCT01814670|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102619143|NCT01814670|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102619144|NCT01814670|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102619145|NCT01814670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102619146|NCT01814670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619147|NCT01814670|Cholinergic Agents|cholinergic agents|mesh-ancestor
102619148|NCT01814670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102619149|NCT01814670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619150|NCT01814670|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102619151|NCT01814670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102619152|NCT01814046|Aldesleukin|aldesleukin|mesh-list
102619153|NCT01814046|Cyclophosphamide|cyclophosphamide|mesh-list
102619154|NCT01814046|Fludarabine|fludarabine|mesh-list
102619155|NCT01814046|Interleukin-2|interleukin-2|mesh-list
102619156|NCT01814046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102619157|NCT01814046|Immunologic Factors|immunologic factors|mesh-ancestor
102619158|NCT01814046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619159|NCT01814046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102619160|NCT01814046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102619161|NCT01814046|Alkylating Agents|alkylating agents|mesh-ancestor
102619162|NCT01814046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619163|NCT01814046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102619164|NCT01814046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102619165|NCT01814046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102619166|NCT01814046|Analgesics|analgesics|mesh-ancestor
102619167|NCT01814046|Sensory System Agents|sensory system agents|mesh-ancestor
102619168|NCT01814046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102619169|NCT01814046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102619170|NCT01814046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102619171|NCT01814046|Antiviral Agents|antiviral agents|mesh-ancestor
102619172|NCT01814046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102619173|NCT01813890|Tapentadol|tapentadol|mesh-list
102619174|NCT01813890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102619175|NCT01813890|Narcotics|narcotics|mesh-ancestor
102619176|NCT01813890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102619177|NCT01813890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619178|NCT01813890|Analgesics|analgesics|mesh-ancestor
102619179|NCT01813890|Sensory System Agents|sensory system agents|mesh-ancestor
102619180|NCT01813890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102619181|NCT01813890|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102619182|NCT01813890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102619183|NCT01813890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102619184|NCT01813890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619185|NCT01813890|Adrenergic Agents|adrenergic agents|mesh-ancestor
102274916|NCT01111461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102274917|NCT01111461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102619186|NCT01813890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102619187|NCT01813422|Evolocumab|evolocumab|mesh-list
102619188|NCT01813422|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102619189|NCT01813422|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102619190|NCT01813422|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102619191|NCT01813422|Antimetabolites|antimetabolites|mesh-ancestor
102619192|NCT01813422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619193|NCT01813422|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102619194|NCT01813422|Protease Inhibitors|protease inhibitors|mesh-ancestor
102619195|NCT01813422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102619196|NCT01813422|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102619197|NCT01786668|Tofacitinib|tofacitinib|mesh-list
102619198|NCT01786668|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102619199|NCT01786668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102619200|NCT01786668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102619201|NCT01786668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619202|NCT04414254|Cefprozil|cefprozil|mesh-list
102619203|NCT04414254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102619204|NCT04414254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102619205|NCT01770912|Triamcinolone|triamcinolone|mesh-list
102619206|NCT01770912|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102619207|NCT01770912|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102619208|NCT01770912|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102619209|NCT01770912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102619210|NCT01770912|Glucocorticoids|glucocorticoids|mesh-ancestor
102619211|NCT01770912|Hormones|hormones|mesh-ancestor
102619212|NCT01770912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102619213|NCT01770912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619214|NCT01770912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102619215|NCT01770912|Immunologic Factors|immunologic factors|mesh-ancestor
102619216|NCT01770912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102619217|NCT01770912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619218|NCT01811706|4-Aminopyridine|4-aminopyridine|mesh-list
102619219|NCT01811706|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102619220|NCT01811706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102619221|NCT01811706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619222|NCT01811238|Oxycodone|oxycodone|mesh-list
102619223|NCT01811238|Naloxone|naloxone|mesh-list
102619224|NCT01811238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102619225|NCT01811238|Narcotics|narcotics|mesh-ancestor
102619226|NCT01811238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102619227|NCT01811238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619228|NCT01811238|Analgesics|analgesics|mesh-ancestor
102619229|NCT01811238|Sensory System Agents|sensory system agents|mesh-ancestor
102619230|NCT01811238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102619231|NCT01811238|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102619232|NCT01769508|Fluorouracil|fluorouracil|mesh-list
102619233|NCT01769508|Oxaliplatin|oxaliplatin|mesh-list
102619234|NCT01769508|Lapatinib|lapatinib|mesh-list
102619235|NCT01769508|Antimetabolites|antimetabolites|mesh-ancestor
102619236|NCT01769508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619237|NCT01769508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102619238|NCT01769508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102619239|NCT01769508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102619240|NCT01769508|Immunologic Factors|immunologic factors|mesh-ancestor
102619241|NCT01769508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619242|NCT01769508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102619243|NCT01769508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102619244|NCT01810380|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102619245|NCT01810380|Brexpiprazole|brexpiprazole|mesh-list
102619246|NCT01810380|Antidepressive Agents|antidepressive agents|mesh-ancestor
102619247|NCT01810380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102619248|NCT01810380|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102619249|NCT01810380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102619250|NCT01810380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102619251|NCT01810380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619252|NCT01810380|Serotonin Agents|serotonin agents|mesh-ancestor
102619253|NCT01810380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102619254|NCT01810380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619255|NCT01810380|Dopamine Agonists|dopamine agonists|mesh-ancestor
102619256|NCT01810380|Dopamine Agents|dopamine agents|mesh-ancestor
102619257|NCT01810302|Nicardipine|nicardipine|mesh-list
102619258|NCT01810302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101907540|NCT02118610|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102619259|NCT01810302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102619260|NCT01810302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102619261|NCT01810302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619262|NCT01810302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102619263|NCT01810302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619264|NCT01810302|Vasodilator Agents|vasodilator agents|mesh-ancestor
102619265|NCT01783938|Nivolumab|nivolumab|mesh-list
102619266|NCT01783938|Ipilimumab|ipilimumab|mesh-list
102619267|NCT01783938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102619268|NCT01783938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102619269|NCT01783938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102619270|NCT01783938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619271|NCT01768572|Hydroxychloroquine|hydroxychloroquine|mesh-list
102619272|NCT01768572|Sulfasalazine|sulfasalazine|mesh-list
102619273|NCT01768572|Methotrexate|methotrexate|mesh-list
102619274|NCT01768572|Leflunomide|leflunomide|mesh-list
102619275|NCT01768572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102619276|NCT01768572|Abortifacient Agents|abortifacient agents|mesh-ancestor
102619277|NCT01768572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102619278|NCT01768572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619279|NCT01768572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102619280|NCT01768572|Antimetabolites|antimetabolites|mesh-ancestor
102619281|NCT01768572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619282|NCT01768572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102619283|NCT01768572|Dermatologic Agents|dermatologic agents|mesh-ancestor
102619284|NCT01768572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102619285|NCT01768572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102619286|NCT01768572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102619287|NCT01768572|Immunologic Factors|immunologic factors|mesh-ancestor
102619288|NCT01768572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102619289|NCT01768572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102619290|NCT01768572|Antimalarials|antimalarials|mesh-ancestor
102619291|NCT01768572|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102619292|NCT01768572|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102619293|NCT01768572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102619294|NCT01768572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102619295|NCT01768572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102619296|NCT01768572|Analgesics|analgesics|mesh-ancestor
102619297|NCT01768572|Sensory System Agents|sensory system agents|mesh-ancestor
102619298|NCT01768572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102619299|NCT01768572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102619300|NCT01768572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102619301|NCT01783548|Beclomethasone|beclomethasone|mesh-list
102619302|NCT01783548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102619303|NCT01783548|Glucocorticoids|glucocorticoids|mesh-ancestor
102619304|NCT01783548|Hormones|hormones|mesh-ancestor
102619305|NCT01783548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102619306|NCT01783548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619307|NCT01783548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102619308|NCT01783548|Respiratory System Agents|respiratory system agents|mesh-ancestor
102619309|NCT01809210|Carboplatin|carboplatin|mesh-list
102619310|NCT01809210|Gemcitabine|gemcitabine|mesh-list
102619311|NCT01809210|Pemetrexed|pemetrexed|mesh-list
102619312|NCT01809210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102619313|NCT01809210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102619314|NCT01809210|Antimetabolites|antimetabolites|mesh-ancestor
102619315|NCT01809210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619316|NCT01809210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102619317|NCT01809210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102619318|NCT01809210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102619319|NCT01809132|Zinc|zinc|mesh-list
102619320|NCT01809132|Methylprednisolone|methylprednisolone|mesh-list
102619321|NCT01809132|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102619322|NCT01809132|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102619323|NCT01809132|Prednisolone|prednisolone|mesh-list
102619324|NCT01809132|Prednisolone acetate|prednisolone acetate|mesh-list
102619325|NCT01809132|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102619326|NCT01809132|Pentoxifylline|pentoxifylline|mesh-list
102619327|NCT01809132|Zinc Sulfate|zinc sulfate|mesh-list
102619328|NCT01809132|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102619329|NCT01809132|Prednisolone phosphate|prednisolone phosphate|mesh-list
102619330|NCT01809132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102619331|NCT01809132|Antiemetics|antiemetics|mesh-ancestor
102619332|NCT01809132|Autonomic Agents|autonomic agents|mesh-ancestor
102619333|NCT01809132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102274918|NCT01111461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619334|NCT01809132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619335|NCT01809132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102619336|NCT01809132|Glucocorticoids|glucocorticoids|mesh-ancestor
102619337|NCT01809132|Hormones|hormones|mesh-ancestor
102619338|NCT01809132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102619339|NCT01809132|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102619340|NCT01809132|Protective Agents|protective agents|mesh-ancestor
102619341|NCT01809132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102619342|NCT01809132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102619343|NCT01809132|Trace Elements|trace elements|mesh-ancestor
102619344|NCT01809132|Micronutrients|micronutrients|mesh-ancestor
102619345|NCT01809132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102619346|NCT01809132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102619347|NCT01809132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102619348|NCT01809132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619349|NCT01809132|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102619350|NCT01809132|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102619351|NCT01809132|Vasodilator Agents|vasodilator agents|mesh-ancestor
102619352|NCT01809132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102619353|NCT01809132|Antioxidants|antioxidants|mesh-ancestor
102619354|NCT01809132|Astringents|astringents|mesh-ancestor
102619355|NCT01809132|Dermatologic Agents|dermatologic agents|mesh-ancestor
102619356|NCT01766778|Metformin|metformin|mesh-list
102619357|NCT01766778|Vildagliptin|vildagliptin|mesh-list
102619358|NCT01766778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102619359|NCT01766778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619360|NCT01766778|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102619361|NCT01766778|Protease Inhibitors|protease inhibitors|mesh-ancestor
102619362|NCT01766778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101591602|NCT02627521|Ticagrelor|ticagrelor|mesh-list
102619363|NCT01766778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619364|NCT01808196|Losartan|losartan|mesh-list
102619365|NCT01808196|Angiotensin II|angiotensin ii|mesh-list
102619366|NCT01808196|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
102619367|NCT01808196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102619368|NCT01808196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102619369|NCT01808196|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102619370|NCT01808196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619371|NCT01808196|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102619372|NCT01808118|Adalimumab|adalimumab|mesh-list
102619373|NCT01808118|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102619374|NCT01808118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102619375|NCT01808118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102619376|NCT01782690|Gemcitabine|gemcitabine|mesh-list
102619377|NCT01782690|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102619378|NCT01782690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102619379|NCT01782690|Antimetabolites|antimetabolites|mesh-ancestor
102619380|NCT01782690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619381|NCT01782690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102619382|NCT01782690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102619383|NCT01782690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102619384|NCT01766310|Folic Acid|folic acid|mesh-list
102619385|NCT01766310|Hematinics|hematinics|mesh-ancestor
102619386|NCT01766310|Vitamin B Complex|vitamin b complex|mesh-ancestor
102619387|NCT01766310|Vitamins|vitamins|mesh-ancestor
102619388|NCT01766310|Micronutrients|micronutrients|mesh-ancestor
102619389|NCT01766310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619390|NCT01782222|Rotigotine|rotigotine|mesh-list
102619391|NCT01782222|Dopamine Agonists|dopamine agonists|mesh-ancestor
102619392|NCT01782222|Dopamine Agents|dopamine agents|mesh-ancestor
102619393|NCT01782222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102619394|NCT01782222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619395|NCT01782222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619396|NCT01807182|Aldesleukin|aldesleukin|mesh-list
102619397|NCT01807182|Cyclophosphamide|cyclophosphamide|mesh-list
102619398|NCT01807182|Fludarabine|fludarabine|mesh-list
102619399|NCT01807182|Fludarabine phosphate|fludarabine phosphate|mesh-list
102619400|NCT01807182|Interleukin-2|interleukin-2|mesh-list
102619401|NCT01807182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102619402|NCT01807182|Immunologic Factors|immunologic factors|mesh-ancestor
102619403|NCT01807182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619404|NCT01807182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102619405|NCT01807182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102619406|NCT01807182|Alkylating Agents|alkylating agents|mesh-ancestor
102619407|NCT01807182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619408|NCT01807182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102619409|NCT01807182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102619410|NCT01807182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102619411|NCT01807182|Antimetabolites|antimetabolites|mesh-ancestor
102619412|NCT01807182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102619413|NCT01807182|Analgesics|analgesics|mesh-ancestor
102619414|NCT01807182|Sensory System Agents|sensory system agents|mesh-ancestor
102619415|NCT01807182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102619416|NCT01807182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102619417|NCT01807182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102619418|NCT01807182|Antiviral Agents|antiviral agents|mesh-ancestor
102619419|NCT01807182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102619420|NCT01765764|Bimatoprost|bimatoprost|mesh-list
102619421|NCT01765764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102619422|NCT01765764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102619423|NCT01780974|Thioctic Acid|thioctic acid|mesh-list
102619424|NCT01780974|Antioxidants|antioxidants|mesh-ancestor
102619425|NCT01780974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619426|NCT01780974|Protective Agents|protective agents|mesh-ancestor
102619427|NCT01780974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619428|NCT01780974|Vitamin B Complex|vitamin b complex|mesh-ancestor
102619429|NCT01780974|Vitamins|vitamins|mesh-ancestor
102619430|NCT01780974|Micronutrients|micronutrients|mesh-ancestor
102619431|NCT01780662|Gemcitabine|gemcitabine|mesh-list
102619432|NCT01780662|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102619433|NCT01780662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102619434|NCT01780662|Antibodies|antibodies|mesh-list
102619435|NCT01780662|Immunoglobulins|immunoglobulins|mesh-list
101591655|NCT04329832|Azithromycin|azithromycin|mesh-list
102619436|NCT01780662|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102619437|NCT01780662|Immunoconjugates|immunoconjugates|mesh-list
102619438|NCT01780662|Immunologic Factors|immunologic factors|mesh-ancestor
102619439|NCT01780662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619440|NCT01780662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102619441|NCT01780662|Antimetabolites|antimetabolites|mesh-ancestor
102619442|NCT01780662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619443|NCT01780662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102619444|NCT01780662|Immunotoxins|immunotoxins|mesh-ancestor
102619445|NCT01780506|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102619446|NCT01780506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102619447|NCT01780506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102619448|NCT01780506|Antiviral Agents|antiviral agents|mesh-ancestor
102619449|NCT01780506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102619450|NCT01762800|Fluticasone|fluticasone|mesh-list
102619451|NCT01762800|Xhance|xhance|mesh-list
102619452|NCT01762800|Bromides|bromides|mesh-list
102619453|NCT01762800|Tiotropium Bromide|tiotropium bromide|mesh-list
102619454|NCT01762800|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102619455|NCT01762800|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102619456|NCT01762800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102619457|NCT01762800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102619458|NCT01762800|Autonomic Agents|autonomic agents|mesh-ancestor
102619459|NCT01762800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102619460|NCT01762800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619461|NCT01762800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102619462|NCT01762800|Respiratory System Agents|respiratory system agents|mesh-ancestor
102619463|NCT01762800|Dermatologic Agents|dermatologic agents|mesh-ancestor
102619464|NCT01762800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102619465|NCT01762800|Parasympatholytics|parasympatholytics|mesh-ancestor
102619466|NCT01762800|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102619467|NCT01762800|Cholinergic Agents|cholinergic agents|mesh-ancestor
102619468|NCT01762800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102619469|NCT01762800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619470|NCT01762800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102619471|NCT01762800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102619472|NCT01762800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102619473|NCT01762800|Adrenergic Agents|adrenergic agents|mesh-ancestor
102619474|NCT01762800|Anticonvulsants|anticonvulsants|mesh-ancestor
102619475|NCT01762800|Glucocorticoids|glucocorticoids|mesh-ancestor
102619476|NCT01762800|Hormones|hormones|mesh-ancestor
102619477|NCT01762800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102619478|NCT01762800|Sympathomimetics|sympathomimetics|mesh-ancestor
102619479|NCT04562532|Sirolimus|sirolimus|mesh-list
102619480|NCT04562532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102619481|NCT04562532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102274919|NCT01104155|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102619482|NCT04562532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102619483|NCT04562532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102619484|NCT04562532|Antifungal Agents|antifungal agents|mesh-ancestor
102619485|NCT04562532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102619486|NCT04562532|Immunologic Factors|immunologic factors|mesh-ancestor
102619487|NCT04562532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619488|NCT01778010|Cocaine|cocaine|mesh-list
102619489|NCT01778010|Modafinil|modafinil|mesh-list
102619490|NCT01778010|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102619491|NCT01778010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619492|NCT01778010|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102619493|NCT01778010|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102619494|NCT01778010|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102619495|NCT01778010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619496|NCT01778010|Anesthetics, Local|anesthetics, local|mesh-ancestor
102619497|NCT01778010|Anesthetics|anesthetics|mesh-ancestor
102619498|NCT01778010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102619499|NCT01778010|Sensory System Agents|sensory system agents|mesh-ancestor
102619500|NCT01778010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102619501|NCT01778010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102619502|NCT01778010|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102619503|NCT01778010|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102619504|NCT01778010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102619505|NCT01778010|Dopamine Agents|dopamine agents|mesh-ancestor
101591724|NCT00922597|Coagulants|coagulants|mesh-ancestor
102619506|NCT01778010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102619507|NCT01777854|Omeprazole|omeprazole|mesh-list
102619508|NCT01777854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102619509|NCT01777854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102619510|NCT01777854|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102619511|NCT01777854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102619512|NCT01777854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619513|NCT01777620|Botulinum Toxins|botulinum toxins|mesh-list
102619514|NCT01777620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102619515|NCT01777620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102619516|NCT01777620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102619517|NCT01777620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102619518|NCT01777620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619519|NCT01777620|Cholinergic Agents|cholinergic agents|mesh-ancestor
102619520|NCT01777620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102619521|NCT01777620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619522|NCT01777620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102619523|NCT01777620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102619524|NCT01777542|Insulin|insulin|mesh-list
102619525|NCT01777542|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102619526|NCT01777542|Mitogens|mitogens|mesh-list
102619527|NCT01777542|Mecasermin|mecasermin|mesh-list
102619528|NCT01777542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102619529|NCT01777542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619530|NCT01777542|Mitosis Modulators|mitosis modulators|mesh-ancestor
102619531|NCT01777542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619532|NCT01777542|Growth Substances|growth substances|mesh-ancestor
102619533|NCT01777152|Prednisone|prednisone|mesh-list
102619534|NCT01777152|Cyclophosphamide|cyclophosphamide|mesh-list
102619535|NCT01777152|Doxorubicin|doxorubicin|mesh-list
102619536|NCT01777152|Vincristine|vincristine|mesh-list
102619537|NCT01777152|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102619538|NCT01777152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102619539|NCT01777152|Immunologic Factors|immunologic factors|mesh-ancestor
102619540|NCT01777152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619541|NCT01777152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102619542|NCT01777152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102619543|NCT01777152|Alkylating Agents|alkylating agents|mesh-ancestor
102619544|NCT01777152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619545|NCT01777152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102619546|NCT01777152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102619547|NCT01777152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102619548|NCT01777152|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102619549|NCT01777152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102619550|NCT01777152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102619551|NCT01777152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102619552|NCT01777152|Glucocorticoids|glucocorticoids|mesh-ancestor
102619553|NCT01777152|Hormones|hormones|mesh-ancestor
102619554|NCT01777152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102619555|NCT01777152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102619556|NCT01777152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102619557|NCT01777152|Tubulin Modulators|tubulin modulators|mesh-ancestor
102619558|NCT01777152|Antimitotic Agents|antimitotic agents|mesh-ancestor
102274920|NCT01104155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101907841|NCT00496834|Diuretics|diuretics|mesh-ancestor
102274921|NCT01104155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102619559|NCT01777152|Mitosis Modulators|mitosis modulators|mesh-ancestor
102619560|NCT01777152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102619561|NCT01777152|Immunotoxins|immunotoxins|mesh-ancestor
102619562|NCT01777152|Immunoconjugates|immunoconjugates|mesh-ancestor
102619563|NCT01775124|Ranibizumab|ranibizumab|mesh-list
102619564|NCT01775124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102619565|NCT01775124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101591799|NCT02810782|Morphine|morphine|mesh-list
102619566|NCT01775124|Growth Substances|growth substances|mesh-ancestor
102619567|NCT01775124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619568|NCT01775124|Growth Inhibitors|growth inhibitors|mesh-ancestor
102619569|NCT01775124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102619570|NCT01733316|Cysteamine|cysteamine|mesh-list
102619571|NCT01733316|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
102619572|NCT01733316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619573|NCT01732926|Rituximab|rituximab|mesh-list
102619574|NCT01732926|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102619575|NCT01732926|Idelalisib|idelalisib|mesh-list
102619576|NCT01732926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102619577|NCT01732926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102619578|NCT01732926|Immunologic Factors|immunologic factors|mesh-ancestor
102619579|NCT01732926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619580|NCT01732926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102619581|NCT01732926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102619582|NCT01732926|Alkylating Agents|alkylating agents|mesh-ancestor
102619583|NCT01732926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619584|NCT01732926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102619585|NCT01732770|Zoledronic Acid|zoledronic acid|mesh-list
102619586|NCT01732770|Denosumab|denosumab|mesh-list
102619587|NCT01732770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102619588|NCT01732770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619589|NCT01774968|Insulin|insulin|mesh-list
102619590|NCT01774968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102619591|NCT01774968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619592|NCT01732536|Mometasone Furoate|mometasone furoate|mesh-list
102619593|NCT01732536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102619594|NCT01732536|Dermatologic Agents|dermatologic agents|mesh-ancestor
102619595|NCT01732536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102619596|NCT01755702|Acetaminophen|acetaminophen|mesh-list
102619597|NCT01755702|Ibuprofen|ibuprofen|mesh-list
102619598|NCT01755702|Caffeine|caffeine|mesh-list
102619599|NCT01755702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102619600|NCT01755702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102619601|NCT01755702|Analgesics|analgesics|mesh-ancestor
102619602|NCT01755702|Sensory System Agents|sensory system agents|mesh-ancestor
102619603|NCT01755702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102619604|NCT01755702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619605|NCT01755702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102619606|NCT01755702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102619607|NCT01755702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102619608|NCT01755702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102619609|NCT01755702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619610|NCT01755702|Antipyretics|antipyretics|mesh-ancestor
102619611|NCT01755702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102619612|NCT01755702|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102619613|NCT01755702|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102619614|NCT01755702|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102619615|NCT01755702|Purinergic Agents|purinergic agents|mesh-ancestor
102619616|NCT01755702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102619617|NCT01732458|Ondansetron|ondansetron|mesh-list
102619618|NCT01732458|Aprepitant|aprepitant|mesh-list
102619619|NCT01732458|Fosaprepitant|fosaprepitant|mesh-list
102619620|NCT01732458|Antiemetics|antiemetics|mesh-ancestor
102619621|NCT01732458|Autonomic Agents|autonomic agents|mesh-ancestor
102619622|NCT01732458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102619623|NCT01732458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619624|NCT01732458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102619625|NCT01732458|Antipruritics|antipruritics|mesh-ancestor
102619626|NCT01732458|Dermatologic Agents|dermatologic agents|mesh-ancestor
102619627|NCT01732458|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102619628|NCT01732458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102619629|NCT01732458|Serotonin Agents|serotonin agents|mesh-ancestor
102619630|NCT01732458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102619631|NCT01732458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619632|NCT01732458|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102619633|NCT01708902|Metformin|metformin|mesh-list
102619634|NCT01708902|Linagliptin|linagliptin|mesh-list
102619635|NCT01708902|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102619636|NCT01708902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619637|NCT01708902|Incretins|incretins|mesh-ancestor
102619638|NCT01708902|Hormones|hormones|mesh-ancestor
102619639|NCT01708902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102619640|NCT01708902|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102619641|NCT01708902|Protease Inhibitors|protease inhibitors|mesh-ancestor
102619642|NCT01708902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102619643|NCT01708902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619644|NCT01755546|Buprenorphine|buprenorphine|mesh-list
102619645|NCT01755546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102619646|NCT01755546|Narcotics|narcotics|mesh-ancestor
102619647|NCT01755546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102619648|NCT01755546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619649|NCT01755546|Analgesics|analgesics|mesh-ancestor
102619650|NCT01755546|Sensory System Agents|sensory system agents|mesh-ancestor
102619651|NCT01755546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102619652|NCT01755546|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102619653|NCT04413864|Dexmedetomidine|dexmedetomidine|mesh-list
102619654|NCT04413864|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102619655|NCT04413864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102619656|NCT04413864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619657|NCT04413864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102619658|NCT04413864|Analgesics|analgesics|mesh-ancestor
102619659|NCT04413864|Sensory System Agents|sensory system agents|mesh-ancestor
102619660|NCT04413864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102619661|NCT04413864|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102619662|NCT04413864|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102619663|NCT04413864|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102619664|NCT04413864|Adrenergic Agents|adrenergic agents|mesh-ancestor
102619665|NCT04413864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102619666|NCT04413864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619667|NCT01755234|Propofol|propofol|mesh-list
102619668|NCT01755234|Sevoflurane|sevoflurane|mesh-list
102619669|NCT01755234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102619670|NCT01755234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102619671|NCT01755234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619672|NCT01755234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102619673|NCT01755234|Anesthetics, General|anesthetics, general|mesh-ancestor
102619674|NCT01755234|Anesthetics|anesthetics|mesh-ancestor
102619675|NCT01755234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102619676|NCT01755234|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102619677|NCT01730586|Paclitaxel|paclitaxel|mesh-list
102619678|NCT01730586|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102619679|NCT01730586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102619680|NCT01730586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102619681|NCT01730586|Tubulin Modulators|tubulin modulators|mesh-ancestor
102619682|NCT01730586|Antimitotic Agents|antimitotic agents|mesh-ancestor
102619683|NCT01730586|Mitosis Modulators|mitosis modulators|mesh-ancestor
102619684|NCT01730586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619685|NCT01755156|Metformin|metformin|mesh-list
102619686|NCT01755156|Insulin Glargine|insulin glargine|mesh-list
102619687|NCT01755156|Glimepiride|glimepiride|mesh-list
102619688|NCT01755156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102619689|NCT01755156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619690|NCT01755156|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102619691|NCT01755156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102619692|NCT01755156|Immunologic Factors|immunologic factors|mesh-ancestor
102619693|NCT01754376|Aldesleukin|aldesleukin|mesh-list
102619694|NCT01754376|Interleukin-2|interleukin-2|mesh-list
102619695|NCT01754376|Vemurafenib|vemurafenib|mesh-list
102619696|NCT01754376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102619697|NCT01754376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102619698|NCT01754376|Analgesics|analgesics|mesh-ancestor
102619699|NCT01754376|Sensory System Agents|sensory system agents|mesh-ancestor
102619700|NCT01754376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102619701|NCT01754376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619702|NCT01754376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102619703|NCT01754376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102619704|NCT01754376|Antiviral Agents|antiviral agents|mesh-ancestor
102619705|NCT01754376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102619706|NCT01754376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102619707|NCT01754376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102619708|NCT01754376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619709|NCT01605396|Exemestane|exemestane|mesh-list
102619710|NCT01605396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102619711|NCT01605396|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102619712|NCT01605396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102619713|NCT01605396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102619714|NCT01605396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619715|NCT01605396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102619716|NCT01605396|Hormone Antagonists|hormone antagonists|mesh-ancestor
102619717|NCT01605396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102619718|NCT01605396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619719|NCT01730118|Mitogens|mitogens|mesh-list
102619720|NCT01730118|Mitosis Modulators|mitosis modulators|mesh-ancestor
102619721|NCT01730118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619722|NCT01730040|Atorvastatin|atorvastatin|mesh-list
102619723|NCT01730040|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102619724|NCT01730040|Ezetimibe|ezetimibe|mesh-list
102619725|NCT01730040|Alirocumab|alirocumab|mesh-list
102619726|NCT01730040|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102619727|NCT01730040|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102619728|NCT01730040|Antimetabolites|antimetabolites|mesh-ancestor
102619729|NCT01730040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619730|NCT01730040|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102619731|NCT01730040|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102619732|NCT01730040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102619733|NCT01730040|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102619734|NCT01730040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102619735|NCT01730040|Protease Inhibitors|protease inhibitors|mesh-ancestor
102619736|NCT01706328|Fluticasone|fluticasone|mesh-list
102619737|NCT01706328|Xhance|xhance|mesh-list
102619738|NCT01706328|Albuterol|albuterol|mesh-list
102619739|NCT01706328|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102619740|NCT01706328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102619741|NCT01706328|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102619742|NCT01706328|Autonomic Agents|autonomic agents|mesh-ancestor
102619743|NCT01706328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102619744|NCT01706328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619745|NCT01706328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102619746|NCT01706328|Respiratory System Agents|respiratory system agents|mesh-ancestor
102619747|NCT01706328|Dermatologic Agents|dermatologic agents|mesh-ancestor
102619748|NCT01706328|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102619749|NCT01706328|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102619750|NCT01706328|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102619751|NCT01706328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102619752|NCT01706328|Adrenergic Agents|adrenergic agents|mesh-ancestor
102619753|NCT01706328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101592001|NCT04236778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102619754|NCT01706328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619755|NCT01706328|Tocolytic Agents|tocolytic agents|mesh-ancestor
102619756|NCT01706328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102619757|NCT01706250|Salicylic Acid|salicylic acid|mesh-list
102619758|NCT01706250|Salicylates|salicylates|mesh-list
102619759|NCT01706250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102619760|NCT01706250|Antifungal Agents|antifungal agents|mesh-ancestor
102619761|NCT01706250|Keratolytic Agents|keratolytic agents|mesh-ancestor
102619762|NCT01706250|Dermatologic Agents|dermatologic agents|mesh-ancestor
102619763|NCT01706250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102619764|NCT01706250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102619765|NCT01706250|Analgesics|analgesics|mesh-ancestor
102619766|NCT01706250|Sensory System Agents|sensory system agents|mesh-ancestor
102619767|NCT01706250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102619768|NCT01706250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619769|NCT01706250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102619770|NCT01706250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102619771|NCT01706250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102619772|NCT01706250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102619773|NCT01706250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619774|NCT01729728|Tapentadol|tapentadol|mesh-list
102619775|NCT01729728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102619776|NCT01729728|Narcotics|narcotics|mesh-ancestor
102619777|NCT01729728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102619778|NCT01729728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619779|NCT01729728|Analgesics|analgesics|mesh-ancestor
102619780|NCT01729728|Sensory System Agents|sensory system agents|mesh-ancestor
102619781|NCT01729728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102619782|NCT01729728|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102619783|NCT01729728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102274922|NCT01104155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102274923|NCT01104155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274924|NCT01067287|Pidilizumab|pidilizumab|mesh-list
102619784|NCT01729728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102619785|NCT01729728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619786|NCT01729728|Adrenergic Agents|adrenergic agents|mesh-ancestor
102619787|NCT01729728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102619788|NCT01728324|Ribavirin|ribavirin|mesh-list
102619789|NCT01728324|Antimetabolites|antimetabolites|mesh-ancestor
102619790|NCT01728324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619791|NCT01728324|Antiviral Agents|antiviral agents|mesh-ancestor
102619792|NCT01728324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102619793|NCT01728246|Acetaminophen|acetaminophen|mesh-list
102619794|NCT01728246|Tramadol|tramadol|mesh-list
102619795|NCT01728246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102619796|NCT01728246|Analgesics|analgesics|mesh-ancestor
102619797|NCT01728246|Sensory System Agents|sensory system agents|mesh-ancestor
102619798|NCT01728246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102619799|NCT01728246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619800|NCT01728246|Antipyretics|antipyretics|mesh-ancestor
102619801|NCT01728246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102619802|NCT01728246|Narcotics|narcotics|mesh-ancestor
102619803|NCT01728246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102619804|NCT04414020|Progesterone|progesterone|mesh-list
102619805|NCT04414020|Progestins|progestins|mesh-ancestor
102619806|NCT04414020|Hormones|hormones|mesh-ancestor
102619807|NCT04414020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102619808|NCT04414020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619809|NCT01705236|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102619810|NCT01705236|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102619811|NCT01705236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619812|NCT01705236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102619813|NCT01705236|Immunologic Factors|immunologic factors|mesh-ancestor
102619814|NCT01705236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619815|NCT01751802|Ecopipam|ecopipam|mesh-list
102619816|NCT01751802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102619817|NCT01751802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102619818|NCT01751802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102619819|NCT01751802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619820|NCT01751802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102619821|NCT01751802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102619822|NCT01751802|Dopamine Agents|dopamine agents|mesh-ancestor
102619823|NCT01751802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102619824|NCT01751802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619825|NCT01703286|Glimepiride|glimepiride|mesh-list
102619826|NCT01703286|Linagliptin|linagliptin|mesh-list
102619827|NCT01703286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102619828|NCT01703286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102619829|NCT01703286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619830|NCT01703286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102619831|NCT01703286|Immunologic Factors|immunologic factors|mesh-ancestor
102619832|NCT01703286|Incretins|incretins|mesh-ancestor
102619833|NCT01703286|Hormones|hormones|mesh-ancestor
102619834|NCT01703286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102619835|NCT01703286|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102619836|NCT01703286|Protease Inhibitors|protease inhibitors|mesh-ancestor
102619837|NCT01703286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102619838|NCT01703286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619839|NCT01727700|Aripiprazole|aripiprazole|mesh-list
102619840|NCT01727700|Antidepressive Agents|antidepressive agents|mesh-ancestor
102619841|NCT01727700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102619842|NCT01727700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102619843|NCT01727700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102619844|NCT01727700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102619845|NCT01727700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619846|NCT01727700|Dopamine Agonists|dopamine agonists|mesh-ancestor
102619847|NCT01727700|Dopamine Agents|dopamine agents|mesh-ancestor
102619848|NCT01727700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102619849|NCT01727700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619850|NCT01727700|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102619851|NCT01727700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102619852|NCT01727700|Serotonin Agents|serotonin agents|mesh-ancestor
102619853|NCT01727700|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102619854|NCT01727700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102619855|NCT01727700|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102619856|NCT01727700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102619857|NCT01725282|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102619858|NCT01725282|Antidepressive Agents|antidepressive agents|mesh-ancestor
102619859|NCT01725282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102619860|NCT01725282|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102619861|NCT01725282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102619862|NCT01725282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102619863|NCT01725282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619864|NCT01725126|Metformin|metformin|mesh-list
102619865|NCT01725126|Liraglutide|liraglutide|mesh-list
102619866|NCT01725126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102619867|NCT01725126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619868|NCT01725126|Incretins|incretins|mesh-ancestor
102619869|NCT01725126|Hormones|hormones|mesh-ancestor
102619870|NCT01725126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102619871|NCT01751724|Caffeine|caffeine|mesh-list
102619872|NCT01751724|Caffeine citrate|caffeine citrate|mesh-list
102619873|NCT01751724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619874|NCT01751724|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102619875|NCT01751724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619876|NCT01751724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102619877|NCT01751724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102619878|NCT01751724|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102619879|NCT01751724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102619880|NCT01751724|Purinergic Agents|purinergic agents|mesh-ancestor
102619881|NCT01751724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102619882|NCT01751646|Vitamin D|vitamin d|mesh-list
102619883|NCT01751646|Ergocalciferols|ergocalciferols|mesh-list
102619884|NCT01751646|Cholecalciferol|cholecalciferol|mesh-list
102619885|NCT01751646|Vitamins|vitamins|mesh-list
102619886|NCT01751646|Micronutrients|micronutrients|mesh-ancestor
102619887|NCT01751646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619888|NCT01751646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102619889|NCT01751646|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102619890|NCT01751568|Raltegravir Potassium|raltegravir potassium|mesh-list
102619891|NCT01751568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102619892|NCT01751568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102619893|NCT01751568|Antiviral Agents|antiviral agents|mesh-ancestor
102619894|NCT01751568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102619895|NCT01751568|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102619896|NCT01751568|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102619897|NCT01751568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102619898|NCT01751568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619899|NCT01751178|Ethanol|ethanol|mesh-list
102619900|NCT01751178|Chlorhexidine|chlorhexidine|mesh-list
102619901|NCT01751178|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102619902|NCT01751178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102619903|NCT01751178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102619904|NCT01751178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102619905|NCT01751178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619906|NCT01751178|Disinfectants|disinfectants|mesh-ancestor
102619907|NCT01751178|Dermatologic Agents|dermatologic agents|mesh-ancestor
102619908|NCT01606254|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102619909|NCT01606254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102619910|NCT01606254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102619911|NCT01606254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102619912|NCT01606254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619913|NCT01606254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102619914|NCT01606254|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102619915|NCT01606254|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102619916|NCT01606254|Serotonin Agents|serotonin agents|mesh-ancestor
102619917|NCT01606254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102619918|NCT01606254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619919|NCT01606254|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102619920|NCT01606254|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102619921|NCT01606254|Dopamine Agents|dopamine agents|mesh-ancestor
102619922|NCT01723254|Immunoglobulin E|immunoglobulin e|mesh-list
102619923|NCT01723254|Immunologic Factors|immunologic factors|mesh-ancestor
102619924|NCT01723254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619925|NCT01722162|Bevacizumab|bevacizumab|mesh-list
102619926|NCT01722162|Capecitabine|capecitabine|mesh-list
102619927|NCT01722162|Levocetirizine|levocetirizine|mesh-list
102619928|NCT01722162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102274925|NCT01067287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102619929|NCT01722162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102619930|NCT01722162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102619931|NCT01722162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102619932|NCT01722162|Growth Substances|growth substances|mesh-ancestor
102619933|NCT01722162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619934|NCT01722162|Growth Inhibitors|growth inhibitors|mesh-ancestor
102619935|NCT01722162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102619936|NCT01722162|Antimetabolites|antimetabolites|mesh-ancestor
102619937|NCT01722162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619938|NCT01722162|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102619939|NCT01722162|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102619940|NCT01722162|Histamine Antagonists|histamine antagonists|mesh-ancestor
102619941|NCT01722162|Histamine Agents|histamine agents|mesh-ancestor
102619942|NCT01722162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102619943|NCT01721772|Nivolumab|nivolumab|mesh-list
102619944|NCT01721772|Dacarbazine|dacarbazine|mesh-list
102619945|NCT01721772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102619946|NCT01721772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102619947|NCT01721772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102619948|NCT01721772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619949|NCT01721772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102619950|NCT01721772|Alkylating Agents|alkylating agents|mesh-ancestor
102619951|NCT01702428|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102619952|NCT01702428|Immunologic Factors|immunologic factors|mesh-ancestor
102619953|NCT01702428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619954|NCT01701258|Amisulpride|amisulpride|mesh-list
102619955|NCT01701258|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102619956|NCT01701258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101592185|NCT01106586|Ritonavir|ritonavir|mesh-list
102619957|NCT01701258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102619958|NCT01701258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619959|NCT01701258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102619960|NCT01701258|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102619961|NCT01701258|Dopamine Agents|dopamine agents|mesh-ancestor
102619962|NCT01701258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102619963|NCT01701258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619964|NCT01701258|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102619965|NCT01701258|Antidepressive Agents|antidepressive agents|mesh-ancestor
102619966|NCT01700946|Cytarabine|cytarabine|mesh-list
102619967|NCT01700946|Aldesleukin|aldesleukin|mesh-list
102619968|NCT01700946|Dexamethasone|dexamethasone|mesh-list
102619969|NCT01700946|Hydrocortisone|hydrocortisone|mesh-list
102619970|NCT01700946|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102619971|NCT01700946|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102619972|NCT01700946|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102619973|NCT01700946|Cyclophosphamide|cyclophosphamide|mesh-list
102619974|NCT01700946|Rituximab|rituximab|mesh-list
102619975|NCT01700946|Methotrexate|methotrexate|mesh-list
102619976|NCT01700946|Etoposide|etoposide|mesh-list
102619977|NCT01700946|Vincristine|vincristine|mesh-list
102619978|NCT01700946|Interleukin-2|interleukin-2|mesh-list
102619979|NCT01700946|Asparaginase|asparaginase|mesh-list
102619980|NCT01700946|Mitoxantrone|mitoxantrone|mesh-list
102619981|NCT01700946|Mercaptopurine|mercaptopurine|mesh-list
102619982|NCT01700946|Clofarabine|clofarabine|mesh-list
102619983|NCT01700946|Vinblastine|vinblastine|mesh-list
102619984|NCT01700946|Pegaspargase|pegaspargase|mesh-list
102619985|NCT01700946|Teniposide|teniposide|mesh-list
102619986|NCT01700946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102619987|NCT01700946|Immunologic Factors|immunologic factors|mesh-ancestor
102619988|NCT01700946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102619989|NCT01700946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102619990|NCT01700946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102619991|NCT01700946|Alkylating Agents|alkylating agents|mesh-ancestor
102619992|NCT01700946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102619993|NCT01700946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102619994|NCT01700946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102619995|NCT01700946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102619996|NCT01700946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102619997|NCT01700946|Antiemetics|antiemetics|mesh-ancestor
102619998|NCT01700946|Autonomic Agents|autonomic agents|mesh-ancestor
102619999|NCT01700946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102620000|NCT01700946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102620001|NCT01700946|Glucocorticoids|glucocorticoids|mesh-ancestor
102620002|NCT01700946|Hormones|hormones|mesh-ancestor
102620003|NCT01700946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102620004|NCT01700946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102620005|NCT01700946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101908284|NCT04386616|Astegolimab|astegolimab|mesh-list
102620006|NCT01700946|Abortifacient Agents|abortifacient agents|mesh-ancestor
102620007|NCT01700946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102620008|NCT01700946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102620009|NCT01700946|Antimetabolites|antimetabolites|mesh-ancestor
102620010|NCT01700946|Dermatologic Agents|dermatologic agents|mesh-ancestor
102620011|NCT01700946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102620012|NCT01700946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102620013|NCT01700946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102620014|NCT01700946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102620015|NCT01700946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102620016|NCT01700946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102620017|NCT01700946|Antiviral Agents|antiviral agents|mesh-ancestor
102620018|NCT01700946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102620019|NCT01700946|Tubulin Modulators|tubulin modulators|mesh-ancestor
102620020|NCT01700946|Antimitotic Agents|antimitotic agents|mesh-ancestor
102620021|NCT01700946|Mitosis Modulators|mitosis modulators|mesh-ancestor
102620022|NCT01700946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102620023|NCT01700946|Analgesics|analgesics|mesh-ancestor
102620024|NCT01700946|Sensory System Agents|sensory system agents|mesh-ancestor
102620025|NCT01700946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102620026|NCT01700946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102620027|NCT01748994|Pioglitazone|pioglitazone|mesh-list
102620028|NCT01748994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102620029|NCT01748994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620030|NCT01721070|Ketoconazole|ketoconazole|mesh-list
102620031|NCT01721070|Sufentanil|sufentanil|mesh-list
102620032|NCT01721070|Dsuvia|dsuvia|mesh-list
102620033|NCT01721070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102620034|NCT01721070|Narcotics|narcotics|mesh-ancestor
102620035|NCT01721070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102620036|NCT01721070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620037|NCT01721070|Analgesics|analgesics|mesh-ancestor
102620038|NCT01721070|Sensory System Agents|sensory system agents|mesh-ancestor
102620039|NCT01721070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102620040|NCT01721070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102620041|NCT01721070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102620042|NCT01721070|Anesthetics, General|anesthetics, general|mesh-ancestor
102620043|NCT01721070|Anesthetics|anesthetics|mesh-ancestor
102620044|NCT01721070|Antifungal Agents|antifungal agents|mesh-ancestor
102620045|NCT01721070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102620046|NCT01721070|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102620047|NCT01721070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102620048|NCT01721070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102620049|NCT01721070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620050|NCT01721070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102620051|NCT01721070|Hormone Antagonists|hormone antagonists|mesh-ancestor
102620052|NCT01721070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102620053|NCT01721070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102620054|NCT01748292|Ranibizumab|ranibizumab|mesh-list
102620055|NCT01748292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102620056|NCT01748292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102620057|NCT01748292|Growth Substances|growth substances|mesh-ancestor
102620058|NCT01748292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620059|NCT01748292|Growth Inhibitors|growth inhibitors|mesh-ancestor
102620060|NCT01748292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102620061|NCT01720602|Letrozole|letrozole|mesh-list
102620062|NCT01720602|Anastrozole|anastrozole|mesh-list
102620063|NCT01720602|Vorinostat|vorinostat|mesh-list
102620064|NCT01720602|Exemestane|exemestane|mesh-list
102620065|NCT01720602|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102620066|NCT01720602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102620067|NCT01720602|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102620068|NCT01720602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102620069|NCT01720602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102620070|NCT01720602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620071|NCT01720602|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102620072|NCT01720602|Hormone Antagonists|hormone antagonists|mesh-ancestor
102620073|NCT01720602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102620074|NCT01720602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620075|NCT01720602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102620076|NCT01720602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102620077|NCT01720602|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102620078|NCT01746732|Moxifloxacin|moxifloxacin|mesh-list
102620079|NCT01746732|Evacetrapib|evacetrapib|mesh-list
102620080|NCT01746732|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102620081|NCT01746732|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102620082|NCT01746732|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102620083|NCT01746732|Antimetabolites|antimetabolites|mesh-ancestor
102620084|NCT01746732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620085|NCT01746732|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102620086|NCT01746732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102620087|NCT01746732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102620088|NCT01746732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102620089|NCT01746732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102620090|NCT01746732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102620091|NCT01746732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102620092|NCT01746732|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102620093|NCT01746732|Contraceptive Agents|contraceptive agents|mesh-ancestor
102620094|NCT01746732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102620095|NCT01746732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620096|NCT01746732|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102620097|NCT01746732|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102620098|NCT01746732|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102620099|NCT01720524|Sildenafil Citrate|sildenafil citrate|mesh-list
102620100|NCT01720524|Vasodilator Agents|vasodilator agents|mesh-ancestor
102620101|NCT01720524|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102620102|NCT01720524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102620103|NCT01720524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102620104|NCT01720524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620105|NCT01720524|Urological Agents|urological agents|mesh-ancestor
102620106|NCT01717638|Vaccines|vaccines|mesh-list
102620107|NCT01717638|Immunologic Factors|immunologic factors|mesh-ancestor
102620108|NCT01717638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620109|NCT01745094|Solifenacin Succinate|solifenacin succinate|mesh-list
102620110|NCT01745094|Mirabegron|mirabegron|mesh-list
102620111|NCT01745094|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102620112|NCT01745094|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102620113|NCT01745094|Cholinergic Agents|cholinergic agents|mesh-ancestor
102620114|NCT01745094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102620115|NCT01745094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620116|NCT01745094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620117|NCT01745094|Urological Agents|urological agents|mesh-ancestor
102620118|NCT01745094|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102620119|NCT01745094|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102620120|NCT01745094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102620121|NCT01745094|Adrenergic Agents|adrenergic agents|mesh-ancestor
102620122|NCT01717326|Ribavirin|ribavirin|mesh-list
102620123|NCT01717326|Grazoprevir|grazoprevir|mesh-list
102620124|NCT01717326|Antimetabolites|antimetabolites|mesh-ancestor
102620125|NCT01717326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620126|NCT01717326|Antiviral Agents|antiviral agents|mesh-ancestor
102620127|NCT01717326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102620128|NCT01744782|Cysteamine|cysteamine|mesh-list
102620129|NCT01744782|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
102620130|NCT01744782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620131|NCT01604850|Sofosbuvir|sofosbuvir|mesh-list
102620132|NCT01604850|Antiviral Agents|antiviral agents|mesh-ancestor
102620133|NCT01604850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102620134|NCT01742286|Ceritinib|ceritinib|mesh-list
102620135|NCT01742286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102620136|NCT01742286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102620137|NCT01742286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102620138|NCT01742286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620139|NCT01716234|Posaconazole|posaconazole|mesh-list
102620140|NCT01716234|Antifungal Agents|antifungal agents|mesh-ancestor
102620141|NCT01716234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102620142|NCT01716234|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102620143|NCT01716234|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102620144|NCT01716234|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102620145|NCT01716234|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102620146|NCT01716234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102620147|NCT01716234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102620148|NCT01716234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620149|NCT01716234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102620150|NCT01716234|Hormone Antagonists|hormone antagonists|mesh-ancestor
102620151|NCT01716234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102620152|NCT01716234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620153|NCT01716156|Ribavirin|ribavirin|mesh-list
102620154|NCT01716156|Grazoprevir|grazoprevir|mesh-list
102620155|NCT01716156|Antimetabolites|antimetabolites|mesh-ancestor
102620156|NCT01716156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620157|NCT01716156|Antiviral Agents|antiviral agents|mesh-ancestor
102620158|NCT01716156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102620159|NCT01739790|Acetylcysteine|acetylcysteine|mesh-list
102620160|NCT01739790|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102620161|NCT01739790|Antiviral Agents|antiviral agents|mesh-ancestor
102620162|NCT01739790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102620163|NCT01739790|Expectorants|expectorants|mesh-ancestor
102620164|NCT01739790|Respiratory System Agents|respiratory system agents|mesh-ancestor
102620165|NCT01739790|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102620166|NCT01739790|Antioxidants|antioxidants|mesh-ancestor
102620167|NCT01739790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620168|NCT01739790|Protective Agents|protective agents|mesh-ancestor
102620169|NCT01739790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620170|NCT01739790|Antidotes|antidotes|mesh-ancestor
102620171|NCT01696032|Paclitaxel|paclitaxel|mesh-list
102620172|NCT01696032|Carboplatin|carboplatin|mesh-list
102620173|NCT01696032|Gemcitabine|gemcitabine|mesh-list
102620174|NCT01696032|Doxorubicin|doxorubicin|mesh-list
102620175|NCT01696032|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102620176|NCT01696032|Topotecan|topotecan|mesh-list
102620177|NCT01696032|Guadecitabine|guadecitabine|mesh-list
102620178|NCT01696032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102620179|NCT01696032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102620180|NCT01696032|Tubulin Modulators|tubulin modulators|mesh-ancestor
102620181|NCT01696032|Antimitotic Agents|antimitotic agents|mesh-ancestor
102620182|NCT01696032|Mitosis Modulators|mitosis modulators|mesh-ancestor
102620183|NCT01696032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620184|NCT01696032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102620185|NCT01696032|Antimetabolites|antimetabolites|mesh-ancestor
102620186|NCT01696032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102620187|NCT01696032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102620188|NCT01696032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102620189|NCT01696032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102620190|NCT01696032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102620191|NCT01695954|Ritonavir|ritonavir|mesh-list
102620192|NCT01695954|Darunavir|darunavir|mesh-list
102620193|NCT01695954|Efavirenz|efavirenz|mesh-list
102620194|NCT01695954|Pitavastatin|pitavastatin|mesh-list
102620195|NCT01695954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102620196|NCT01695954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102620197|NCT01695954|Protease Inhibitors|protease inhibitors|mesh-ancestor
102620198|NCT01695954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102620199|NCT01695954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620200|NCT01695954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102620201|NCT01695954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102620202|NCT01695954|Antiviral Agents|antiviral agents|mesh-ancestor
102620203|NCT01695954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102620204|NCT01695954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102620205|NCT01695954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102620206|NCT01695954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102620207|NCT01695954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102620208|NCT01695954|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102620209|NCT01695954|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102620210|NCT01695954|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102620211|NCT01695954|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102620212|NCT01695954|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102620213|NCT01695954|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102620214|NCT01695954|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102620215|NCT01695954|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102620216|NCT01695954|Antimetabolites|antimetabolites|mesh-ancestor
102620217|NCT01695954|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102620218|NCT01694706|Omeprazole|omeprazole|mesh-list
102620219|NCT01694706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102620220|NCT01694706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102620221|NCT01694706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102620222|NCT01694706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102620223|NCT01694706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620224|NCT01715298|Glycopyrrolate|glycopyrrolate|mesh-list
102620225|NCT01715298|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102274927|NCT01005745|Aldesleukin|aldesleukin|mesh-list
102620226|NCT01715298|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102620227|NCT01715298|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101908503|NCT01354522|Docetaxel|docetaxel|mesh-list
102620228|NCT01715298|Cholinergic Agents|cholinergic agents|mesh-ancestor
102620229|NCT01715298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102620230|NCT01715298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620231|NCT01715298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620232|NCT01739400|Macitentan|macitentan|mesh-list
102620233|NCT01739400|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
102620234|NCT01739400|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102620235|NCT01739400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620236|NCT01739400|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
102620237|NCT01712178|Adalimumab|adalimumab|mesh-list
101592470|NCT05538052|Analgesics|analgesics|mesh-ancestor
102620238|NCT01712178|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102620239|NCT01712178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102620240|NCT01712178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102620241|NCT01693068|Dacarbazine|dacarbazine|mesh-list
102620242|NCT01693068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102620243|NCT01693068|Alkylating Agents|alkylating agents|mesh-ancestor
102620244|NCT01693068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620245|NCT01693068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102620246|NCT01691898|Rituximab|rituximab|mesh-list
102620247|NCT01691898|Obinutuzumab|obinutuzumab|mesh-list
102620248|NCT01691898|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
102620249|NCT01691898|Pinatuzumab vedotin|pinatuzumab vedotin|mesh-list
102620250|NCT01691898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102620251|NCT01691898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102620252|NCT01691898|Immunologic Factors|immunologic factors|mesh-ancestor
102620253|NCT01691898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620254|NCT01691898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102620255|NCT01691898|Immunoconjugates|immunoconjugates|mesh-ancestor
102620256|NCT01737840|Pantoprazole|pantoprazole|mesh-list
102620257|NCT01737840|Ranitidine|ranitidine|mesh-list
102620258|NCT01737840|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
102620259|NCT01737840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102620260|NCT01737840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102620261|NCT01737840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102620262|NCT01737840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102620263|NCT01737840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620264|NCT01737840|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102620265|NCT01737840|Histamine Antagonists|histamine antagonists|mesh-ancestor
102620266|NCT01737840|Histamine Agents|histamine agents|mesh-ancestor
102620267|NCT01737840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102620268|NCT01737840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620269|NCT01711866|Rotigotine|rotigotine|mesh-list
102620270|NCT01711866|Dopamine Agonists|dopamine agonists|mesh-ancestor
102620271|NCT01711866|Dopamine Agents|dopamine agents|mesh-ancestor
102620272|NCT01711866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102620273|NCT01711866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620274|NCT01711866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620275|NCT01691508|Prednisone|prednisone|mesh-list
102620276|NCT01691508|Prednisolone|prednisolone|mesh-list
102620277|NCT01691508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102620278|NCT01691508|Glucocorticoids|glucocorticoids|mesh-ancestor
102620279|NCT01691508|Hormones|hormones|mesh-ancestor
102620280|NCT01691508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102620281|NCT01691508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620282|NCT01691508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102620283|NCT01691508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102620284|NCT01682460|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102620285|NCT01682460|Lubricant Eye Drops|lubricant eye drops|mesh-list
102620286|NCT01682460|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102620287|NCT01709838|Deferasirox|deferasirox|mesh-list
102620288|NCT01709838|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102620289|NCT01709838|Chelating Agents|chelating agents|mesh-ancestor
102620290|NCT01709838|Sequestering Agents|sequestering agents|mesh-ancestor
102620291|NCT01709838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620292|NCT01688466|Pomalidomide|pomalidomide|mesh-list
102620293|NCT01688466|Immunologic Factors|immunologic factors|mesh-ancestor
102620294|NCT01688466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620295|NCT01688466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102620296|NCT01688466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102620297|NCT01688466|Growth Substances|growth substances|mesh-ancestor
102620298|NCT01688466|Growth Inhibitors|growth inhibitors|mesh-ancestor
102620299|NCT01688466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102620300|NCT01682148|Botulinum Toxins|botulinum toxins|mesh-list
102620301|NCT01682148|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102620302|NCT01682148|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102620303|NCT01682148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102620304|NCT01682148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102620305|NCT01682148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620306|NCT01682148|Cholinergic Agents|cholinergic agents|mesh-ancestor
102620307|NCT01682148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102620308|NCT01682148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620309|NCT01682148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102620310|NCT01682148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102620311|NCT01681992|Vaccines|vaccines|mesh-list
102620312|NCT01681992|Immunologic Factors|immunologic factors|mesh-ancestor
102620313|NCT01681992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620314|NCT01687998|Evacetrapib|evacetrapib|mesh-list
102620315|NCT01687998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102620316|NCT01687998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102620317|NCT01687998|Antimetabolites|antimetabolites|mesh-ancestor
102620318|NCT01687998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620319|NCT01687998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102620320|NCT01681212|Ipilimumab|ipilimumab|mesh-list
102620321|NCT01681212|Dacarbazine|dacarbazine|mesh-list
102620322|NCT01681212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102620323|NCT01681212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102620324|NCT01681212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102620325|NCT01681212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620326|NCT01681212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102620327|NCT01681212|Alkylating Agents|alkylating agents|mesh-ancestor
102620328|NCT01687296|Fluticasone|fluticasone|mesh-list
102620329|NCT01687296|Xhance|xhance|mesh-list
102620330|NCT01687296|Prednisone|prednisone|mesh-list
102620331|NCT01687296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102620332|NCT01687296|Albuterol|albuterol|mesh-list
102620333|NCT01687296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102620334|NCT01687296|Glucocorticoids|glucocorticoids|mesh-ancestor
102620335|NCT01687296|Hormones|hormones|mesh-ancestor
102620336|NCT01687296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102620337|NCT01687296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620338|NCT01687296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102620339|NCT01687296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102620340|NCT01687296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102620341|NCT01687296|Autonomic Agents|autonomic agents|mesh-ancestor
102620342|NCT01687296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102620343|NCT01687296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102620344|NCT01687296|Respiratory System Agents|respiratory system agents|mesh-ancestor
102620345|NCT01687296|Dermatologic Agents|dermatologic agents|mesh-ancestor
102620346|NCT01687296|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102620347|NCT01687296|Tocolytic Agents|tocolytic agents|mesh-ancestor
102620348|NCT01687296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102620349|NCT01687296|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102620350|NCT01687296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102620351|NCT01687296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102620352|NCT01687296|Adrenergic Agents|adrenergic agents|mesh-ancestor
102620353|NCT01687296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102620354|NCT01687296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620355|NCT01568892|Dolutegravir|dolutegravir|mesh-list
102620356|NCT01568892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102620357|NCT01568892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102620358|NCT01568892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102620359|NCT01568892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620360|NCT01568892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102620361|NCT01568892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102620362|NCT01568892|Antiviral Agents|antiviral agents|mesh-ancestor
102620363|NCT01568892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102620364|NCT01568112|Aspirin|aspirin|mesh-list
102620365|NCT01568112|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102620366|NCT01568112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102620367|NCT01568112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102620368|NCT01568112|Analgesics|analgesics|mesh-ancestor
102620369|NCT01568112|Sensory System Agents|sensory system agents|mesh-ancestor
102620370|NCT01568112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102620371|NCT01568112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620372|NCT01568112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102620373|NCT01568112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102620374|NCT01568112|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102620375|NCT01568112|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102620376|NCT01568112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274928|NCT01005745|Interleukin-2|interleukin-2|mesh-list
101908660|NCT01352338|Glucocorticoids|glucocorticoids|mesh-ancestor
102620377|NCT01568112|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102620378|NCT01568112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102620379|NCT01568112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102620380|NCT01568112|Antipyretics|antipyretics|mesh-ancestor
102620381|NCT01568112|Dermatologic Agents|dermatologic agents|mesh-ancestor
102620382|NCT01568112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102620383|NCT01568112|Immunologic Factors|immunologic factors|mesh-ancestor
102620384|NCT01568034|Levodopa|levodopa|mesh-list
102620385|NCT01568034|Carbidopa|carbidopa|mesh-list
102620386|NCT01568034|Opicapone|opicapone|mesh-list
102620387|NCT01568034|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102620388|NCT01568034|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102620389|NCT01568034|Dopamine Agents|dopamine agents|mesh-ancestor
102620390|NCT01568034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102620391|NCT01568034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620392|NCT01568034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620393|NCT01568034|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102620394|NCT01568034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102620395|NCT01568034|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102620396|NCT01687218|Tenofovir|tenofovir|mesh-list
102620397|NCT01687218|Emtricitabine|emtricitabine|mesh-list
102620398|NCT01687218|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102620399|NCT01687218|Glycerol|glycerol|mesh-list
102620400|NCT01687218|Antiviral Agents|antiviral agents|mesh-ancestor
102620401|NCT01687218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102620402|NCT01687218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102620403|NCT01687218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102620404|NCT01687218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102620405|NCT01687218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620406|NCT01687218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102620407|NCT01687218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102620408|NCT01687218|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102620409|NCT01687218|Protective Agents|protective agents|mesh-ancestor
102620410|NCT01687218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620411|NCT01686828|Letrozole|letrozole|mesh-list
102620412|NCT01686828|Methyltestosterone|methyltestosterone|mesh-list
102620413|NCT01686828|Acyline|acyline|mesh-list
102620414|NCT01686828|Testosterone|testosterone|mesh-list
102620415|NCT01686828|Testosterone undecanoate|testosterone undecanoate|mesh-list
102620416|NCT01686828|Testosterone enanthate|testosterone enanthate|mesh-list
102620417|NCT01686828|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102620418|NCT01686828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102620419|NCT01686828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102620420|NCT01686828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102620421|NCT01686828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102620422|NCT01686828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620423|NCT01686828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102620424|NCT01686828|Hormone Antagonists|hormone antagonists|mesh-ancestor
102620425|NCT01686828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102620426|NCT01686828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620427|NCT01686828|Androgens|androgens|mesh-ancestor
102620428|NCT01686828|Hormones|hormones|mesh-ancestor
102620429|NCT01686828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102620430|NCT01686828|Anabolic Agents|anabolic agents|mesh-ancestor
102620431|NCT01603602|Botulinum Toxins|botulinum toxins|mesh-list
102620432|NCT01603602|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102620433|NCT01603602|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102620434|NCT01603602|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102620435|NCT01603602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102620436|NCT01603602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620437|NCT01603602|Cholinergic Agents|cholinergic agents|mesh-ancestor
102620438|NCT01603602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102620439|NCT01603602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620440|NCT01603602|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102620441|NCT01603602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102620442|NCT01684878|Paclitaxel|paclitaxel|mesh-list
102620443|NCT01684878|Gemcitabine|gemcitabine|mesh-list
102620444|NCT01684878|Topotecan|topotecan|mesh-list
102620445|NCT01684878|Pertuzumab|pertuzumab|mesh-list
102620446|NCT01684878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102620447|NCT01684878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102620448|NCT01684878|Tubulin Modulators|tubulin modulators|mesh-ancestor
102274929|NCT01005745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102620449|NCT01684878|Antimitotic Agents|antimitotic agents|mesh-ancestor
102620450|NCT01684878|Mitosis Modulators|mitosis modulators|mesh-ancestor
102620451|NCT01684878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620452|NCT01684878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102620453|NCT01684878|Antimetabolites|antimetabolites|mesh-ancestor
102620454|NCT01684878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102620455|NCT01684878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102620456|NCT01684878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102620457|NCT01684878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102620458|NCT01684722|Vitamin D|vitamin d|mesh-list
102620459|NCT01684722|Ergocalciferols|ergocalciferols|mesh-list
102620460|NCT01684722|Cholecalciferol|cholecalciferol|mesh-list
102620461|NCT01684722|Vitamins|vitamins|mesh-list
102620462|NCT01684722|Micronutrients|micronutrients|mesh-ancestor
102620463|NCT01684722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620464|NCT01684722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102620465|NCT01684722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102620466|NCT01592292|Adalimumab|adalimumab|mesh-list
102620467|NCT01592292|Infliximab|infliximab|mesh-list
102620468|NCT01592292|Etanercept|etanercept|mesh-list
102620469|NCT01592292|Rituximab|rituximab|mesh-list
102620470|NCT01592292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102620471|NCT01592292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102620472|NCT01592292|Immunologic Factors|immunologic factors|mesh-ancestor
102620473|NCT01592292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620474|NCT01592292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102620475|NCT01592292|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102620476|NCT01592292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102620477|NCT01592292|Dermatologic Agents|dermatologic agents|mesh-ancestor
102620478|NCT01592292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102620479|NCT01592292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102620480|NCT01592292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102620481|NCT01592292|Analgesics|analgesics|mesh-ancestor
102620482|NCT01592292|Sensory System Agents|sensory system agents|mesh-ancestor
102620483|NCT01592292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102620484|NCT01592292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102620485|NCT01565850|Darunavir|darunavir|mesh-list
102620486|NCT01565850|Cobicistat|cobicistat|mesh-list
102620487|NCT01565850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102620488|NCT01565850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620489|NCT01565850|Antiviral Agents|antiviral agents|mesh-ancestor
102620490|NCT01565850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102620491|NCT01565850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102620492|NCT01565850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102620493|NCT01565850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102620494|NCT01565850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102620495|NCT01565850|Protease Inhibitors|protease inhibitors|mesh-ancestor
102620496|NCT01565850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102620497|NCT01565850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102620498|NCT01565694|Solifenacin Succinate|solifenacin succinate|mesh-list
102620499|NCT01565694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102620500|NCT01565694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102620501|NCT01565694|Cholinergic Agents|cholinergic agents|mesh-ancestor
102620502|NCT01565694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102620503|NCT01565694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620504|NCT01565694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620505|NCT01565694|Urological Agents|urological agents|mesh-ancestor
102620506|NCT01543152|Cyclophosphamide|cyclophosphamide|mesh-list
102620507|NCT01543152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102620508|NCT01543152|Immunologic Factors|immunologic factors|mesh-ancestor
102620509|NCT01543152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620510|NCT01543152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102620511|NCT01543152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102620512|NCT01543152|Alkylating Agents|alkylating agents|mesh-ancestor
102620513|NCT01543152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620514|NCT01543152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102620515|NCT01543152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102620516|NCT01565148|Ranibizumab|ranibizumab|mesh-list
102620517|NCT01565148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102620518|NCT01565148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102620519|NCT01565148|Growth Substances|growth substances|mesh-ancestor
102620520|NCT01565148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620521|NCT01565148|Growth Inhibitors|growth inhibitors|mesh-ancestor
102620522|NCT01565148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102620523|NCT04410354|Remdesivir|remdesivir|mesh-list
102620524|NCT04410354|Antimetabolites|antimetabolites|mesh-ancestor
102274930|NCT01005745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102620525|NCT04410354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620526|NCT04410354|Antiviral Agents|antiviral agents|mesh-ancestor
102620528|NCT01564758|Linezolid|linezolid|mesh-list
102620529|NCT01564758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102620530|NCT01564758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102620531|NCT01564758|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102620532|NCT01564758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102620533|NCT01564758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620534|NCT01589094|Gemcitabine|gemcitabine|mesh-list
102620535|NCT01589094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102620536|NCT01589094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102620537|NCT01589094|Antimetabolites|antimetabolites|mesh-ancestor
102620538|NCT01589094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620539|NCT01563354|Everolimus|everolimus|mesh-list
102620540|NCT01563354|Pasireotide|pasireotide|mesh-list
102620541|NCT01563354|Somatostatin|somatostatin|mesh-list
102620542|NCT01563354|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102620543|NCT01563354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102620544|NCT01563354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102620545|NCT01563354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620546|NCT01563354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102620547|NCT01563354|Immunologic Factors|immunologic factors|mesh-ancestor
102620548|NCT01563354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620549|NCT01563354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102620550|NCT01563354|Hormones|hormones|mesh-ancestor
102620551|NCT01563354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102620552|NCT03027960|Empagliflozin|empagliflozin|mesh-list
102620553|NCT03027960|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102620554|NCT03027960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620555|NCT03027960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102620556|NCT03027960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620557|NCT01539642|Sufentanil|sufentanil|mesh-list
102620558|NCT01539642|Dsuvia|dsuvia|mesh-list
102620559|NCT01539642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102620560|NCT01539642|Narcotics|narcotics|mesh-ancestor
102620561|NCT01539642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102620562|NCT01539642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620563|NCT01539642|Analgesics|analgesics|mesh-ancestor
102620564|NCT01539642|Sensory System Agents|sensory system agents|mesh-ancestor
102620565|NCT01539642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102620566|NCT01539642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102620567|NCT01539642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102620568|NCT01539642|Anesthetics, General|anesthetics, general|mesh-ancestor
102620569|NCT01539642|Anesthetics|anesthetics|mesh-ancestor
102620570|NCT01538472|Cytarabine|cytarabine|mesh-list
102620571|NCT01538472|Rituximab|rituximab|mesh-list
102620572|NCT01538472|Melphalan|melphalan|mesh-list
102620573|NCT01538472|Carmustine|carmustine|mesh-list
102620574|NCT01538472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102620575|NCT01538472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102620576|NCT01538472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102620577|NCT01538472|Immunologic Factors|immunologic factors|mesh-ancestor
102620578|NCT01538472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620579|NCT01538472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102620580|NCT01538472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102620581|NCT01538472|Antimetabolites|antimetabolites|mesh-ancestor
102620582|NCT01538472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620583|NCT01538472|Antiviral Agents|antiviral agents|mesh-ancestor
102620584|NCT01538472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102620585|NCT01538472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102620586|NCT01538472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102620587|NCT01538472|Alkylating Agents|alkylating agents|mesh-ancestor
102620588|NCT01538472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102620589|NCT01562028|Bevacizumab|bevacizumab|mesh-list
102620590|NCT01562028|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102620591|NCT01562028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102620592|NCT01562028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102620593|NCT01562028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102620594|NCT01562028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102620595|NCT01562028|Growth Substances|growth substances|mesh-ancestor
102620596|NCT01562028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620597|NCT01562028|Growth Inhibitors|growth inhibitors|mesh-ancestor
102620598|NCT01562028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102620599|NCT01562028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102274931|NCT01005745|Analgesics|analgesics|mesh-ancestor
102274932|NCT01005745|Sensory System Agents|sensory system agents|mesh-ancestor
102274933|NCT01005745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102620600|NCT01562028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620601|NCT04767828|Capecitabine|capecitabine|mesh-list
102620602|NCT04767828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102620603|NCT04767828|Antimetabolites|antimetabolites|mesh-ancestor
102620604|NCT04767828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620605|NCT04767828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102620606|NCT01585584|Protease Inhibitors|protease inhibitors|mesh-list
102620607|NCT01585584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102620608|NCT01585584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620609|NCT01537068|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
102620610|NCT01537068|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102620611|NCT01537068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102620612|NCT01537068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102620613|NCT01537068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620614|NCT01537068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102620615|NCT01537068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620616|NCT01537068|Antidepressive Agents|antidepressive agents|mesh-ancestor
102620617|NCT01537068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102620618|NCT01585428|Aldesleukin|aldesleukin|mesh-list
102620619|NCT01585428|Cyclophosphamide|cyclophosphamide|mesh-list
102620620|NCT01585428|Fludarabine|fludarabine|mesh-list
102620621|NCT01585428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102620622|NCT01585428|Immunologic Factors|immunologic factors|mesh-ancestor
102620623|NCT01585428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620624|NCT01585428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102620625|NCT01585428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102620626|NCT01585428|Alkylating Agents|alkylating agents|mesh-ancestor
102620627|NCT01585428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620628|NCT01585428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102620629|NCT01585428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102620630|NCT01585428|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102620631|NCT01585428|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102620632|NCT01585428|Antiviral Agents|antiviral agents|mesh-ancestor
102620633|NCT01585428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102620634|NCT01585272|Rivastigmine|rivastigmine|mesh-list
102620635|NCT01585272|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102620636|NCT01585272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102620637|NCT01585272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620638|NCT01585272|Cholinergic Agents|cholinergic agents|mesh-ancestor
102620639|NCT01585272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102620640|NCT01585272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620641|NCT01585272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101592886|NCT00696007|Antimetabolites|antimetabolites|mesh-ancestor
102620642|NCT01585272|Protective Agents|protective agents|mesh-ancestor
102620643|NCT01585194|Nivolumab|nivolumab|mesh-list
102620644|NCT01585194|Ipilimumab|ipilimumab|mesh-list
102620645|NCT01585194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102620646|NCT01585194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102620647|NCT01585194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102620648|NCT01585194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620649|NCT01560780|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102620650|NCT01560780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102620651|NCT01585038|Efavirenz|efavirenz|mesh-list
102620652|NCT01585038|Rilpivirine|rilpivirine|mesh-list
102620653|NCT01585038|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102620654|NCT01585038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102620655|NCT01585038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102620656|NCT01585038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620657|NCT01585038|Antiviral Agents|antiviral agents|mesh-ancestor
102620658|NCT01585038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102620659|NCT01585038|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102620660|NCT01585038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102620661|NCT01585038|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102620662|NCT01585038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102620663|NCT01585038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102620664|NCT01585038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102620665|NCT01585038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102620666|NCT01585038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102620667|NCT01559844|Ribavirin|ribavirin|mesh-list
102620668|NCT01559844|Sofosbuvir|sofosbuvir|mesh-list
102620669|NCT01559844|Antimetabolites|antimetabolites|mesh-ancestor
102274934|NCT01005745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620670|NCT01559844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620671|NCT01559844|Antiviral Agents|antiviral agents|mesh-ancestor
102620672|NCT01559844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102620673|NCT01584648|Trametinib|trametinib|mesh-list
102620674|NCT01584648|Dabrafenib|dabrafenib|mesh-list
102620675|NCT01584648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102620676|NCT01584648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102620677|NCT01584648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102620678|NCT01584648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620679|NCT01559454|Buprenorphine|buprenorphine|mesh-list
102620680|NCT01559454|Methadone|methadone|mesh-list
102620681|NCT01559454|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102620682|NCT01559454|Naloxone|naloxone|mesh-list
102620683|NCT01559454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102620684|NCT01559454|Narcotics|narcotics|mesh-ancestor
102620685|NCT01559454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102620686|NCT01559454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620687|NCT01559454|Analgesics|analgesics|mesh-ancestor
102620688|NCT01559454|Sensory System Agents|sensory system agents|mesh-ancestor
102620689|NCT01559454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102620690|NCT01559454|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102620691|NCT01559454|Antitussive Agents|antitussive agents|mesh-ancestor
102620692|NCT01559454|Respiratory System Agents|respiratory system agents|mesh-ancestor
102620693|NCT01583166|Epinephrine|epinephrine|mesh-list
102620694|NCT01583166|Bupivacaine|bupivacaine|mesh-list
102620695|NCT01583166|Anesthetics, Local|anesthetics, local|mesh-ancestor
102620696|NCT01583166|Anesthetics|anesthetics|mesh-ancestor
102620697|NCT01583166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102620698|NCT01583166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620699|NCT01583166|Sensory System Agents|sensory system agents|mesh-ancestor
102620700|NCT01583166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102620701|NCT01583166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102620702|NCT01583166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102620703|NCT01583166|Adrenergic Agents|adrenergic agents|mesh-ancestor
102620704|NCT01583166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102620705|NCT01583166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620706|NCT01583166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102620707|NCT01583166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102620708|NCT01583166|Autonomic Agents|autonomic agents|mesh-ancestor
102620709|NCT01583166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102620710|NCT01583166|Respiratory System Agents|respiratory system agents|mesh-ancestor
102620711|NCT01583166|Mydriatics|mydriatics|mesh-ancestor
102620712|NCT01583166|Sympathomimetics|sympathomimetics|mesh-ancestor
102620713|NCT01583166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102620714|NCT01582854|Actovegin|actovegin|mesh-list
102620715|NCT01582854|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102620716|NCT01582854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620717|NCT01582854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102620718|NCT01582854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102620719|NCT01582854|Antioxidants|antioxidants|mesh-ancestor
102620720|NCT01582854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620721|NCT01582854|Protective Agents|protective agents|mesh-ancestor
102620722|NCT01582854|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102620723|NCT01582308|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102620724|NCT01582308|Vildagliptin|vildagliptin|mesh-list
102620725|NCT01582308|Saxagliptin|saxagliptin|mesh-list
102620726|NCT01582308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102620727|NCT01582308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620728|NCT01582308|Incretins|incretins|mesh-ancestor
102620729|NCT01582308|Hormones|hormones|mesh-ancestor
102620730|NCT01582308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102620731|NCT01582308|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102620732|NCT01582308|Protease Inhibitors|protease inhibitors|mesh-ancestor
102620733|NCT01582308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102620734|NCT01582308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620735|NCT01558674|Torsemide|torsemide|mesh-list
102620736|NCT01558674|Furosemide|furosemide|mesh-list
102620737|NCT01558674|Diuretics|diuretics|mesh-ancestor
102620738|NCT01558674|Natriuretic Agents|natriuretic agents|mesh-ancestor
102620739|NCT01558674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620740|NCT01558674|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102620741|NCT01558674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102274935|NCT01005745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102620742|NCT01558674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620743|NCT01558674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101909027|NCT00027378|Fluoxetine|fluoxetine|mesh-list
101909101|NCT00025662|Interleukin-2|interleukin-2|mesh-list
102620744|NCT01535040|Memantine|memantine|mesh-list
102620745|NCT01535040|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102620746|NCT01535040|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102620747|NCT01535040|Dopamine Agents|dopamine agents|mesh-ancestor
102620748|NCT01535040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102620749|NCT01535040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620750|NCT01535040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620751|NCT01535040|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102620752|NCT01535040|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102620753|NCT01534962|Ranolazine|ranolazine|mesh-list
102620754|NCT01534962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102620755|NCT01534962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102620756|NCT01534962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620757|NCT01582152|Bevacizumab|bevacizumab|mesh-list
102620758|NCT01582152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102620759|NCT01582152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102620760|NCT01582152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102620761|NCT01582152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102620762|NCT01582152|Growth Substances|growth substances|mesh-ancestor
102620763|NCT01582152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620764|NCT01582152|Growth Inhibitors|growth inhibitors|mesh-ancestor
102620765|NCT01557504|Metformin|metformin|mesh-list
102620766|NCT01557504|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102620767|NCT01557504|Hormones|hormones|mesh-list
102620768|NCT01557504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102620769|NCT01557504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620770|NCT01557504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102620771|NCT01557504|Incretins|incretins|mesh-ancestor
102620772|NCT01557504|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102620773|NCT01557504|Protease Inhibitors|protease inhibitors|mesh-ancestor
102620774|NCT01557504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102620775|NCT01557504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620776|NCT01580670|Infliximab|infliximab|mesh-list
102620777|NCT01580670|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102620778|NCT01580670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102620779|NCT01580670|Dermatologic Agents|dermatologic agents|mesh-ancestor
102620780|NCT01580670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102620781|NCT01580670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102620782|NCT01534260|Bortezomib|bortezomib|mesh-list
102620783|NCT01534260|Sorafenib|sorafenib|mesh-list
102620784|NCT01534260|Vorinostat|vorinostat|mesh-list
102620785|NCT01534260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102620786|NCT01534260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102620787|NCT01534260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102620788|NCT01534260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620789|NCT01534260|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102620790|NCT01534182|Interferons|interferons|mesh-list
102620791|NCT01534182|Interferon-beta|interferon-beta|mesh-list
102620792|NCT01534182|Glatiramer Acetate|glatiramer acetate|mesh-list
102620793|NCT01534182|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102620794|NCT01534182|(T,G)-A-L|(t,g)-a-l|mesh-list
102620795|NCT01534182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102620796|NCT01534182|Antiviral Agents|antiviral agents|mesh-ancestor
102620797|NCT01534182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102620798|NCT01534182|Immunologic Factors|immunologic factors|mesh-ancestor
102620799|NCT01534182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620800|NCT01534182|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102620801|NCT01534182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620802|NCT01534182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102620803|NCT01534182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102620804|NCT01534182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102620805|NCT01579812|Metformin|metformin|mesh-list
102620806|NCT01579812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102620807|NCT01579812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620808|NCT01579578|Paclitaxel|paclitaxel|mesh-list
102620809|NCT01579578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102620810|NCT01579578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102620811|NCT01579578|Tubulin Modulators|tubulin modulators|mesh-ancestor
102620812|NCT01579578|Antimitotic Agents|antimitotic agents|mesh-ancestor
102620813|NCT01579578|Mitosis Modulators|mitosis modulators|mesh-ancestor
102620814|NCT01579578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620815|NCT01578486|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
102620816|NCT01578486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102620817|NCT01578486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102620818|NCT01578486|Analgesics|analgesics|mesh-ancestor
102620819|NCT01578486|Sensory System Agents|sensory system agents|mesh-ancestor
102620820|NCT01578486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102620821|NCT01578486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620822|NCT01578486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102620823|NCT01578486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102620824|NCT01555164|Metformin|metformin|mesh-list
102620825|NCT01555164|Ranolazine|ranolazine|mesh-list
102620826|NCT01555164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102620827|NCT01555164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620828|NCT01555164|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102620829|NCT01555164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102620830|NCT01555164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620831|NCT03028428|Hyaluronic Acid|hyaluronic acid|mesh-list
102620832|NCT03028428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102620833|NCT03028428|Immunologic Factors|immunologic factors|mesh-ancestor
102620834|NCT03028428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620835|NCT03028428|Viscosupplements|viscosupplements|mesh-ancestor
102620836|NCT03028428|Protective Agents|protective agents|mesh-ancestor
102620837|NCT01578330|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102620838|NCT01578330|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102620839|NCT01578330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620840|NCT01578330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102620841|NCT01578330|Immunologic Factors|immunologic factors|mesh-ancestor
102620842|NCT01578330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620843|NCT01577160|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102620844|NCT01577160|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102620845|NCT01577160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102620846|NCT01577160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102620847|NCT01577160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620848|NCT01577160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102620849|NCT01577160|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102620850|NCT01577160|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102620851|NCT01577160|Serotonin Agents|serotonin agents|mesh-ancestor
102620852|NCT01577160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102620853|NCT01577160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620854|NCT01577160|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102620855|NCT01577160|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102620856|NCT01577160|Dopamine Agents|dopamine agents|mesh-ancestor
102620857|NCT01554618|Exenatide|exenatide|mesh-list
102620858|NCT01554618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102620859|NCT01554618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620860|NCT01554618|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102620861|NCT01554618|Incretins|incretins|mesh-ancestor
102620862|NCT01554618|Hormones|hormones|mesh-ancestor
102620863|NCT01554618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102620864|NCT01531998|Dexamethasone|dexamethasone|mesh-list
102620865|NCT01531998|Lenalidomide|lenalidomide|mesh-list
102620866|NCT01531998|Bortezomib|bortezomib|mesh-list
102620867|NCT01531998|Siltuximab|siltuximab|mesh-list
102620868|NCT01531998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102620869|NCT01531998|Antiemetics|antiemetics|mesh-ancestor
102620870|NCT01531998|Autonomic Agents|autonomic agents|mesh-ancestor
102620871|NCT01531998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102620872|NCT01531998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620873|NCT01531998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102620874|NCT01531998|Glucocorticoids|glucocorticoids|mesh-ancestor
102620875|NCT01531998|Hormones|hormones|mesh-ancestor
102620876|NCT01531998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102620877|NCT01531998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102620878|NCT01531998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102620879|NCT01531998|Immunologic Factors|immunologic factors|mesh-ancestor
102620880|NCT01531998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102620881|NCT01531998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102620882|NCT01531998|Growth Substances|growth substances|mesh-ancestor
102620883|NCT01531998|Growth Inhibitors|growth inhibitors|mesh-ancestor
102620884|NCT01553916|Lithium Carbonate|lithium carbonate|mesh-list
102620885|NCT01553916|Antidepressive Agents|antidepressive agents|mesh-ancestor
102620886|NCT01553916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102620887|NCT01553916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102620888|NCT01553916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620889|NCT01553916|Antimanic Agents|antimanic agents|mesh-ancestor
102620890|NCT01553916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102620891|NCT01553916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102620892|NCT01553916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620893|NCT01553136|Varenicline|varenicline|mesh-list
102620894|NCT01553136|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102620895|NCT01553136|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102620896|NCT01553136|Cholinergic Agents|cholinergic agents|mesh-ancestor
102620897|NCT01553136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102620898|NCT01553136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620899|NCT01553136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620900|NCT01552902|Methylphenidate|methylphenidate|mesh-list
102620901|NCT01552902|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102620902|NCT01552902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102620903|NCT01552902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620904|NCT01552902|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102620905|NCT01552902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102620906|NCT01552902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102620907|NCT01552902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620908|NCT01552902|Dopamine Agents|dopamine agents|mesh-ancestor
102620909|NCT01552902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102620910|NCT02072928|Botulinum Toxins|botulinum toxins|mesh-list
102620911|NCT02072928|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102620912|NCT02072928|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101593166|NCT02689882|Niacin|niacin|mesh-list
102620913|NCT02072928|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102620914|NCT02072928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102620915|NCT02072928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620916|NCT02072928|Cholinergic Agents|cholinergic agents|mesh-ancestor
102620917|NCT02072928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102620918|NCT02072928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620919|NCT02072928|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102620920|NCT02072928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102620922|NCT01529346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102620923|NCT01529346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102620924|NCT01529346|Analgesics|analgesics|mesh-ancestor
102620925|NCT01529346|Sensory System Agents|sensory system agents|mesh-ancestor
102620926|NCT01529346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102620927|NCT01529346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620928|NCT01529346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102620929|NCT01529346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102620930|NCT01529346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102620931|NCT01529346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102620932|NCT01529346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620933|NCT01529268|Cysteamine|cysteamine|mesh-list
102620934|NCT01529268|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
102620935|NCT01529268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620936|NCT01529112|Lenvatinib|lenvatinib|mesh-list
102620937|NCT01529112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102620938|NCT01529112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102620939|NCT01529112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102620940|NCT01529112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620941|NCT01575054|Botulinum Toxins|botulinum toxins|mesh-list
102620942|NCT01575054|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102620943|NCT01575054|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102620944|NCT01575054|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102620945|NCT01575054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102620946|NCT01575054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620947|NCT01575054|Cholinergic Agents|cholinergic agents|mesh-ancestor
102620948|NCT01575054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102620949|NCT01575054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620950|NCT01575054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102620951|NCT01575054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102620952|NCT01528254|Metformin|metformin|mesh-list
102620953|NCT01528254|Vildagliptin|vildagliptin|mesh-list
102620954|NCT01528254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102620955|NCT01528254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620956|NCT01528254|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102620957|NCT01528254|Protease Inhibitors|protease inhibitors|mesh-ancestor
102620958|NCT01528254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102620959|NCT01528254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620960|NCT01526148|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102620961|NCT01526148|Lithium Carbonate|lithium carbonate|mesh-list
102620962|NCT01526148|Antidepressive Agents|antidepressive agents|mesh-ancestor
102274936|NCT01005745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102274937|NCT01005745|Antiviral Agents|antiviral agents|mesh-ancestor
102620963|NCT01526148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102620964|NCT01526148|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102620965|NCT01526148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102620966|NCT01526148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102620967|NCT01526148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620968|NCT01526148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102620969|NCT01526148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620970|NCT01526148|Antimanic Agents|antimanic agents|mesh-ancestor
102620971|NCT01525602|Paclitaxel|paclitaxel|mesh-list
102620972|NCT01525602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102620973|NCT01525602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102620974|NCT01525602|Tubulin Modulators|tubulin modulators|mesh-ancestor
102620975|NCT01525602|Antimitotic Agents|antimitotic agents|mesh-ancestor
102620976|NCT01525602|Mitosis Modulators|mitosis modulators|mesh-ancestor
102620977|NCT01525602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102620978|NCT01549002|Fentanyl|fentanyl|mesh-list
102620979|NCT01549002|Morphine|morphine|mesh-list
102620980|NCT01549002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102620981|NCT01549002|Narcotics|narcotics|mesh-ancestor
102620982|NCT01549002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102620983|NCT01549002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102620984|NCT01549002|Analgesics|analgesics|mesh-ancestor
102620985|NCT01549002|Sensory System Agents|sensory system agents|mesh-ancestor
102620986|NCT01549002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102620987|NCT01549002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102620988|NCT01549002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102620989|NCT01549002|Anesthetics, General|anesthetics, general|mesh-ancestor
102620990|NCT01549002|Anesthetics|anesthetics|mesh-ancestor
102620991|NCT01548768|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
102620992|NCT01548768|Antirheumatic Agents|antirheumatic agents|mesh-list
102620993|NCT01548768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102620994|NCT01572792|Bromides|bromides|mesh-list
102620995|NCT01572792|Formoterol Fumarate|formoterol fumarate|mesh-list
102620996|NCT01572792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102620997|NCT01572792|Autonomic Agents|autonomic agents|mesh-ancestor
102620998|NCT01572792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102620999|NCT01572792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621000|NCT01572792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102621001|NCT01572792|Respiratory System Agents|respiratory system agents|mesh-ancestor
102621002|NCT01572792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102621003|NCT01572792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102621004|NCT01572792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102621005|NCT01572792|Adrenergic Agents|adrenergic agents|mesh-ancestor
102621006|NCT01572792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102621007|NCT01572792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621008|NCT01572792|Anticonvulsants|anticonvulsants|mesh-ancestor
102621009|NCT01547598|Timolol|timolol|mesh-list
102621010|NCT01547598|Bimatoprost|bimatoprost|mesh-list
102621011|NCT01547598|Travoprost|travoprost|mesh-list
102621012|NCT01547598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102621013|NCT01547598|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102621014|NCT01547598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102621015|NCT01547598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102621016|NCT01547598|Adrenergic Agents|adrenergic agents|mesh-ancestor
102621017|NCT01547598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102621018|NCT01547598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621019|NCT01547598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621020|NCT01547598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102621021|NCT01547598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102621022|NCT01547286|Methacholine Chloride|methacholine chloride|mesh-list
102621023|NCT01547286|Miotics|miotics|mesh-ancestor
102621024|NCT01547286|Autonomic Agents|autonomic agents|mesh-ancestor
102621025|NCT01547286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102621026|NCT01547286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621027|NCT01547286|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102621028|NCT01547286|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
102621029|NCT01547286|Respiratory System Agents|respiratory system agents|mesh-ancestor
102621030|NCT01547286|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102621031|NCT01547286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102621032|NCT01547286|Cholinergic Agents|cholinergic agents|mesh-ancestor
102621033|NCT01547286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102621034|NCT01547286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274938|NCT01005745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102274939|NCT00978458|Temozolomide|temozolomide|mesh-list
102621035|NCT01524978|Cetuximab|cetuximab|mesh-list
102621036|NCT01524978|Vemurafenib|vemurafenib|mesh-list
102621037|NCT01524978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102621038|NCT01524978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102621039|NCT01524978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102621040|NCT01524978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102621041|NCT01524978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621043|NCT01524198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102621044|NCT01524198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102621045|NCT01524198|Autonomic Agents|autonomic agents|mesh-ancestor
102621046|NCT01524198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102621047|NCT01524198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621048|NCT01524198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102621049|NCT01524198|Respiratory System Agents|respiratory system agents|mesh-ancestor
102621050|NCT01524198|Glucocorticoids|glucocorticoids|mesh-ancestor
102621051|NCT01524198|Hormones|hormones|mesh-ancestor
102621052|NCT01524198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102621053|NCT01523886|Rocuronium|rocuronium|mesh-list
102621054|NCT01523886|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102621055|NCT01523886|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102621056|NCT01523886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102621057|NCT01523886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102621058|NCT01523886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621059|NCT01546038|Cytarabine|cytarabine|mesh-list
102621060|NCT01546038|Decitabine|decitabine|mesh-list
102621061|NCT01546038|Daunorubicin|daunorubicin|mesh-list
102621062|NCT01546038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102621063|NCT01546038|Antimetabolites|antimetabolites|mesh-ancestor
102621064|NCT01546038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621065|NCT01546038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102621066|NCT01546038|Antiviral Agents|antiviral agents|mesh-ancestor
102621067|NCT01546038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102621068|NCT01546038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102621069|NCT01546038|Immunologic Factors|immunologic factors|mesh-ancestor
102621070|NCT01546038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621071|NCT01546038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102621072|NCT01546038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102621073|NCT01546038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102621074|NCT01546038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102621075|NCT01571232|Dexamethasone|dexamethasone|mesh-list
102621076|NCT01571232|Bevacizumab|bevacizumab|mesh-list
102621077|NCT01571232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102621078|NCT01571232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102621079|NCT01571232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102621080|NCT01571232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102621081|NCT01571232|Growth Substances|growth substances|mesh-ancestor
102621082|NCT01571232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621083|NCT01571232|Growth Inhibitors|growth inhibitors|mesh-ancestor
102621084|NCT01571232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102621085|NCT01571232|Antiemetics|antiemetics|mesh-ancestor
102621086|NCT01571232|Autonomic Agents|autonomic agents|mesh-ancestor
102621087|NCT01571232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102621088|NCT01571232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102621089|NCT01571232|Glucocorticoids|glucocorticoids|mesh-ancestor
102621090|NCT01571232|Hormones|hormones|mesh-ancestor
102621091|NCT01571232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102621092|NCT01571232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102621093|NCT01522950|Atenolol|atenolol|mesh-list
102621094|NCT01522950|Nebivolol|nebivolol|mesh-list
102621095|NCT01522950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102621096|NCT01522950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102621097|NCT01522950|Sympatholytics|sympatholytics|mesh-ancestor
102621098|NCT01522950|Autonomic Agents|autonomic agents|mesh-ancestor
102621099|NCT01522950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102621100|NCT01522950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621101|NCT01522950|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102621102|NCT01522950|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102621103|NCT01522950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102621104|NCT01522950|Adrenergic Agents|adrenergic agents|mesh-ancestor
102621105|NCT01522950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102621106|NCT01522950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621107|NCT01522950|Vasodilator Agents|vasodilator agents|mesh-ancestor
102621108|NCT01522950|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102621109|NCT01522950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101909395|NCT01108926|Emtricitabine|emtricitabine|mesh-list
102621111|NCT01522404|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102621112|NCT01522404|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102621113|NCT01522404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102621114|NCT01522404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102621115|NCT01522404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621116|NCT01522404|Adrenergic Agents|adrenergic agents|mesh-ancestor
102621117|NCT01522404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102621118|NCT01522404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621119|NCT01543776|Abiraterone Acetate|abiraterone acetate|mesh-list
102621120|NCT01543776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102621121|NCT01543776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102621122|NCT01543776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102621123|NCT01543776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621124|NCT01543776|Hormone Antagonists|hormone antagonists|mesh-ancestor
102621125|NCT01543776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102621126|NCT01543776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621127|NCT01543776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102621128|NCT01518192|Doxycycline|doxycycline|mesh-list
102621129|NCT01518192|Cefuroxime|cefuroxime|mesh-list
102621130|NCT01518192|Cefuroxime axetil|cefuroxime axetil|mesh-list
102621131|NCT01518192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102621132|NCT01518192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102621133|NCT01518192|Antimalarials|antimalarials|mesh-ancestor
102621134|NCT01518192|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102621135|NCT01518192|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102621136|NCT01517802|Prednisone|prednisone|mesh-list
102621137|NCT01517802|Abiraterone Acetate|abiraterone acetate|mesh-list
102621138|NCT01517802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102621139|NCT01517802|Glucocorticoids|glucocorticoids|mesh-ancestor
102621140|NCT01517802|Hormones|hormones|mesh-ancestor
102621141|NCT01517802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102621142|NCT01517802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621143|NCT01517802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102621144|NCT01517802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102621145|NCT01517802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102621146|NCT01517802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102621147|NCT01517802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621148|NCT01517802|Hormone Antagonists|hormone antagonists|mesh-ancestor
102621149|NCT01517802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102621150|NCT04714710|Canrenoic Acid|canrenoic acid|mesh-list
102621151|NCT04714710|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102621152|NCT04714710|Hormone Antagonists|hormone antagonists|mesh-ancestor
102621153|NCT04714710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102621154|NCT04714710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621155|NCT04714710|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102621156|NCT04714710|Diuretics|diuretics|mesh-ancestor
102621157|NCT04714710|Natriuretic Agents|natriuretic agents|mesh-ancestor
102621158|NCT01520922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102621159|NCT01520922|Ofatumumab|ofatumumab|mesh-list
102621160|NCT01520922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102621161|NCT01520922|Alkylating Agents|alkylating agents|mesh-ancestor
102621162|NCT01520922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621163|NCT01520922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102621164|NCT01517412|Metformin|metformin|mesh-list
102621165|NCT01517412|Lixisenatide|lixisenatide|mesh-list
102621166|NCT01517412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102621167|NCT01517412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621168|NCT01489956|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
102621169|NCT01489956|Freund's Adjuvant|freund's adjuvant|mesh-list
102621170|NCT01489956|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
102621171|NCT01489956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102621172|NCT01489956|Immunologic Factors|immunologic factors|mesh-ancestor
102621173|NCT01489956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621174|NCT01516008|Tapentadol|tapentadol|mesh-list
102621175|NCT01516008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102621176|NCT01516008|Narcotics|narcotics|mesh-ancestor
102621177|NCT01516008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102621178|NCT01516008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621179|NCT01516008|Analgesics|analgesics|mesh-ancestor
102621180|NCT01516008|Sensory System Agents|sensory system agents|mesh-ancestor
102621181|NCT01516008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101909479|NCT01363336|Nifedipine|nifedipine|mesh-list
102274940|NCT00978458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102621182|NCT01516008|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102621183|NCT01516008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102621184|NCT01516008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102621185|NCT01516008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621186|NCT01516008|Adrenergic Agents|adrenergic agents|mesh-ancestor
102621187|NCT01516008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102621188|NCT01489254|Glatiramer Acetate|glatiramer acetate|mesh-list
102621189|NCT01489254|(T,G)-A-L|(t,g)-a-l|mesh-list
102621190|NCT01489254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102621191|NCT01489254|Immunologic Factors|immunologic factors|mesh-ancestor
102621192|NCT01489254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621193|NCT01489254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102621194|NCT01489254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102621195|NCT01489020|Immunomodulating Agents|immunomodulating agents|mesh-list
102621196|NCT01489020|Immunologic Factors|immunologic factors|mesh-ancestor
102621197|NCT01489020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621198|NCT01514682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102621199|NCT01514448|Everolimus|everolimus|mesh-list
102621200|NCT01514448|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102621201|NCT01514448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102621202|NCT01514448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102621203|NCT01514448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621204|NCT01514448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102621205|NCT01514448|Immunologic Factors|immunologic factors|mesh-ancestor
102621206|NCT01514448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621207|NCT01514448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102621208|NCT01514370|Interferons|interferons|mesh-list
102621209|NCT01514370|Interferon-beta|interferon-beta|mesh-list
102621210|NCT01514370|Interferon beta-1a|interferon beta-1a|mesh-list
102621211|NCT01514370|Curcumin|curcumin|mesh-list
102621212|NCT01514370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102621213|NCT01514370|Antiviral Agents|antiviral agents|mesh-ancestor
102621214|NCT01514370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102621215|NCT01514370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102621216|NCT01514370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102621217|NCT01514370|Analgesics|analgesics|mesh-ancestor
102621218|NCT01514370|Sensory System Agents|sensory system agents|mesh-ancestor
102621219|NCT01514370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102621220|NCT01514370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621221|NCT01514370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102621222|NCT01514370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102621223|NCT01514370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102621224|NCT01514370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621225|NCT01514370|Immunologic Factors|immunologic factors|mesh-ancestor
102621226|NCT01514370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102621227|NCT01519674|Insulin|insulin|mesh-list
102621228|NCT01519674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102621229|NCT01519674|Metformin|metformin|mesh-list
102621230|NCT01519674|Insulin Aspart|insulin aspart|mesh-list
102621231|NCT01519674|Insulin, Long-Acting|insulin, long-acting|mesh-list
102621232|NCT01519674|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102621233|NCT01519674|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102621234|NCT01519674|Biphasic Insulins|biphasic insulins|mesh-list
102621235|NCT01519674|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
102621236|NCT01519674|Insulin, Isophane|insulin, isophane|mesh-list
102621237|NCT01519674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102621238|NCT01519674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621239|NCT01519674|Incretins|incretins|mesh-ancestor
102621240|NCT01519674|Hormones|hormones|mesh-ancestor
102621241|NCT01519674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102621242|NCT01519674|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102621243|NCT01519674|Protease Inhibitors|protease inhibitors|mesh-ancestor
102621244|NCT01519674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102621245|NCT01519674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621246|NCT01519518|Heparin|heparin|mesh-list
102621247|NCT01519518|Calcium heparin|calcium heparin|mesh-list
102621248|NCT01519518|Bivalirudin|bivalirudin|mesh-list
102621249|NCT01519518|Anticoagulants|anticoagulants|mesh-ancestor
102621250|NCT01519518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102621251|NCT01519518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102621252|NCT01519518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621253|NCT01519518|Antithrombins|antithrombins|mesh-ancestor
101909565|NCT01363804|Tivozanib|tivozanib|mesh-list
102621254|NCT01519518|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102621255|NCT01519518|Protease Inhibitors|protease inhibitors|mesh-ancestor
102621256|NCT01519518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102621258|NCT01518972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102621259|NCT01518972|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102621260|NCT01518972|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102621261|NCT01518972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102621262|NCT01518972|Adrenergic Agents|adrenergic agents|mesh-ancestor
102621263|NCT01518972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102621264|NCT01518972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621265|NCT01518972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621266|NCT01513590|Insulin|insulin|mesh-list
102621267|NCT01513590|Insulin Aspart|insulin aspart|mesh-list
102621268|NCT01513590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102621269|NCT01513590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621270|NCT04672512|Prednisone|prednisone|mesh-list
102621271|NCT04672512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102621272|NCT04672512|Glucocorticoids|glucocorticoids|mesh-ancestor
102621273|NCT04672512|Hormones|hormones|mesh-ancestor
102621274|NCT04672512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102621275|NCT04672512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621276|NCT04672512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102621277|NCT04672512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102621278|NCT01512108|Liraglutide|liraglutide|mesh-list
102621279|NCT01512108|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102621280|NCT01512108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621281|NCT01512108|Incretins|incretins|mesh-ancestor
102621282|NCT01512108|Hormones|hormones|mesh-ancestor
102621283|NCT01512108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102621284|NCT01486758|Azithromycin|azithromycin|mesh-list
102621285|NCT01486758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102621286|NCT01486758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102621287|NCT01463982|Capecitabine|capecitabine|mesh-list
102621288|NCT01463982|Irinotecan|irinotecan|mesh-list
102621289|NCT01463982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102621290|NCT01463982|Antimetabolites|antimetabolites|mesh-ancestor
102621291|NCT01463982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621292|NCT01463982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102621293|NCT01463982|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102621294|NCT01463982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102621295|NCT01463982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102621296|NCT01510158|Allopurinol|allopurinol|mesh-list
102621297|NCT01510158|Lesinurad|lesinurad|mesh-list
102621298|NCT01510158|Antimetabolites|antimetabolites|mesh-ancestor
102621299|NCT01510158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621300|NCT01510158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102621301|NCT01510158|Gout Suppressants|gout suppressants|mesh-ancestor
102621302|NCT01510158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102621303|NCT01510158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102621304|NCT01510158|Antioxidants|antioxidants|mesh-ancestor
102621305|NCT01510158|Protective Agents|protective agents|mesh-ancestor
102621306|NCT01510158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621307|NCT01510158|Uricosuric Agents|uricosuric agents|mesh-ancestor
102621308|NCT04080882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102621309|NCT04080882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102621310|NCT04080882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102621311|NCT04080882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102621312|NCT04080882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621313|NCT04080882|Cholinergic Agents|cholinergic agents|mesh-ancestor
102621314|NCT04080882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102621315|NCT04080882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621316|NCT04080882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102621317|NCT04080882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102621318|NCT01484496|Belimumab|belimumab|mesh-list
102621319|NCT01484496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102621320|NCT01484496|Immunologic Factors|immunologic factors|mesh-ancestor
102621321|NCT01484496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621322|NCT01509846|Vaccines|vaccines|mesh-list
102621323|NCT01509846|Immunologic Factors|immunologic factors|mesh-ancestor
102621324|NCT01509846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621325|NCT01462344|Fluticasone|fluticasone|mesh-list
102621326|NCT01462344|Xhance|xhance|mesh-list
102621327|NCT01462344|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102621328|NCT01462344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102274941|NCT00978458|Alkylating Agents|alkylating agents|mesh-ancestor
102621329|NCT01462344|Autonomic Agents|autonomic agents|mesh-ancestor
102621330|NCT01462344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102621331|NCT01462344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621332|NCT01462344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102621333|NCT01462344|Respiratory System Agents|respiratory system agents|mesh-ancestor
102621334|NCT01462344|Glucocorticoids|glucocorticoids|mesh-ancestor
102621335|NCT01462344|Hormones|hormones|mesh-ancestor
102621336|NCT01462344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102621337|NCT01462344|Sympathomimetics|sympathomimetics|mesh-ancestor
102621338|NCT01462344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102621339|NCT01462344|Dermatologic Agents|dermatologic agents|mesh-ancestor
102621340|NCT01462344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102621341|NCT01462266|Metformin|metformin|mesh-list
102621342|NCT01462266|Insulin Glargine|insulin glargine|mesh-list
102621343|NCT01462266|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102621344|NCT01462266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102621345|NCT01462266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621346|NCT01462266|Incretins|incretins|mesh-ancestor
102621347|NCT01462266|Hormones|hormones|mesh-ancestor
102621348|NCT01462266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102621349|NCT01462266|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102621350|NCT01462266|Protease Inhibitors|protease inhibitors|mesh-ancestor
102621351|NCT01462266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102621352|NCT01462266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621353|NCT04087590|Glycopyrrolate|glycopyrrolate|mesh-list
102621354|NCT04087590|Formoterol Fumarate|formoterol fumarate|mesh-list
102621355|NCT04087590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102621356|NCT04087590|Autonomic Agents|autonomic agents|mesh-ancestor
102621357|NCT04087590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102621358|NCT04087590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621359|NCT04087590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102621360|NCT04087590|Respiratory System Agents|respiratory system agents|mesh-ancestor
102621361|NCT04087590|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102621362|NCT04087590|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102621363|NCT04087590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102621364|NCT04087590|Adrenergic Agents|adrenergic agents|mesh-ancestor
102621365|NCT04087590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102621366|NCT04087590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621367|NCT04087590|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102621368|NCT04087590|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102621369|NCT04087590|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102621370|NCT04087590|Cholinergic Agents|cholinergic agents|mesh-ancestor
102621371|NCT01508676|Diclofenac|diclofenac|mesh-list
102621372|NCT01508676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102621373|NCT01508676|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102621374|NCT01508676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102621375|NCT01508676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102621376|NCT01508676|Analgesics|analgesics|mesh-ancestor
102621377|NCT01508676|Sensory System Agents|sensory system agents|mesh-ancestor
102621378|NCT01508676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102621379|NCT01508676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593648|NCT02785666|Ribavirin|ribavirin|mesh-list
102621380|NCT01508676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102621381|NCT01508676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102621382|NCT01508676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102621383|NCT01508676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621384|NCT02985372|Cytarabine|cytarabine|mesh-list
102621385|NCT02985372|Decitabine|decitabine|mesh-list
102621386|NCT02985372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102621387|NCT02985372|Antimetabolites|antimetabolites|mesh-ancestor
102621388|NCT02985372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621389|NCT02985372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102621390|NCT02985372|Antiviral Agents|antiviral agents|mesh-ancestor
102621391|NCT02985372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102621392|NCT02985372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102621393|NCT02985372|Immunologic Factors|immunologic factors|mesh-ancestor
102621394|NCT02985372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621395|NCT02985372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102621396|NCT02985216|Pregabalin|pregabalin|mesh-list
102621397|NCT02985216|Analgesics|analgesics|mesh-ancestor
102621398|NCT02985216|Sensory System Agents|sensory system agents|mesh-ancestor
102621399|NCT02985216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102621400|NCT02985216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621401|NCT02985216|Anticonvulsants|anticonvulsants|mesh-ancestor
102621402|NCT02985216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102274942|NCT00978458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621403|NCT02985216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102621404|NCT02985216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621405|NCT02985216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102621406|NCT02985216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102621407|NCT02985216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102621408|NCT02985216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102621409|NCT02985216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102621410|NCT01461096|Vaccines|vaccines|mesh-list
102621411|NCT01461096|Immunologic Factors|immunologic factors|mesh-ancestor
102621412|NCT01461096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621413|NCT01480674|Trastuzumab|trastuzumab|mesh-list
102621414|NCT01480674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102621415|NCT01480674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102621416|NCT01506882|Levetiracetam|levetiracetam|mesh-list
102621417|NCT01506882|Anticonvulsants|anticonvulsants|mesh-ancestor
102621418|NCT01506882|Nootropic Agents|nootropic agents|mesh-ancestor
102621419|NCT01506726|Salicylic Acid|salicylic acid|mesh-list
102621420|NCT01506726|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
102621421|NCT01506726|Salicylates|salicylates|mesh-list
102621422|NCT01506726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102621423|NCT01506726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102621424|NCT01506726|Analgesics|analgesics|mesh-ancestor
102621425|NCT01506726|Sensory System Agents|sensory system agents|mesh-ancestor
102621426|NCT01506726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102621427|NCT01506726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621428|NCT01506726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102621429|NCT01506726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102621430|NCT01506726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102621431|NCT01506726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102621432|NCT01506726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621433|NCT01506726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102621434|NCT01506726|Antifungal Agents|antifungal agents|mesh-ancestor
102621435|NCT01506726|Keratolytic Agents|keratolytic agents|mesh-ancestor
102621436|NCT01506726|Dermatologic Agents|dermatologic agents|mesh-ancestor
102621437|NCT01505868|Carboplatin|carboplatin|mesh-list
102621438|NCT01505868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102621439|NCT01505634|Ciprofloxacin|ciprofloxacin|mesh-list
102621440|NCT01505634|Imipenem|imipenem|mesh-list
102621441|NCT01505634|Relebactam|relebactam|mesh-list
102621442|NCT01505634|Cilastatin|cilastatin|mesh-list
102621443|NCT01505634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102621444|NCT01505634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102621445|NCT01505634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102621446|NCT01505634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102621447|NCT01505634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102621448|NCT01505634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621449|NCT01505634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102621450|NCT01505634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101593711|NCT01106352|Docetaxel|docetaxel|mesh-list
102621451|NCT01505634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102621452|NCT01505634|Protease Inhibitors|protease inhibitors|mesh-ancestor
102621453|NCT01505634|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102621454|NCT01460628|Modafinil|modafinil|mesh-list
102621455|NCT01460628|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102621456|NCT01460628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621457|NCT01460628|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102621458|NCT01460628|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102621459|NCT01460628|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102621460|NCT01460628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621461|NCT01480596|Belimumab|belimumab|mesh-list
102621462|NCT01480596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102621463|NCT01480596|Immunologic Factors|immunologic factors|mesh-ancestor
102621464|NCT01480596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621465|NCT01459614|Gemcitabine|gemcitabine|mesh-list
102621466|NCT01459614|Docetaxel|docetaxel|mesh-list
102621467|NCT01459614|Capecitabine|capecitabine|mesh-list
102621468|NCT01459614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102621469|NCT01459614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102621470|NCT01459614|Antimetabolites|antimetabolites|mesh-ancestor
102621471|NCT01459614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621472|NCT01459614|Tubulin Modulators|tubulin modulators|mesh-ancestor
102621473|NCT01459614|Antimitotic Agents|antimitotic agents|mesh-ancestor
102621474|NCT01459614|Mitosis Modulators|mitosis modulators|mesh-ancestor
102621475|NCT01458522|Lacosamide|lacosamide|mesh-list
102621476|NCT01458522|Fosphenytoin|fosphenytoin|mesh-list
101909767|NCT00070018|Tubulin Modulators|tubulin modulators|mesh-ancestor
102621477|NCT01458522|Anticonvulsants|anticonvulsants|mesh-ancestor
102274943|NCT00978458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102621478|NCT01458522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102621479|NCT01458522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102621480|NCT01458522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102621481|NCT01458522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621482|NCT03026946|Cyclosporine|cyclosporine|mesh-list
102621483|NCT03026946|Alitretinoin|alitretinoin|mesh-list
102621484|NCT03026946|Cyclosporins|cyclosporins|mesh-list
102621485|NCT03026946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102621486|NCT03026946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621487|NCT03026946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102621488|NCT03026946|Immunologic Factors|immunologic factors|mesh-ancestor
102621489|NCT03026946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621490|NCT03026946|Antifungal Agents|antifungal agents|mesh-ancestor
102621491|NCT03026946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102621492|NCT03026946|Dermatologic Agents|dermatologic agents|mesh-ancestor
102621493|NCT03026946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102621494|NCT03026946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102621495|NCT03026946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102621496|NCT01458366|Carboplatin|carboplatin|mesh-list
102621497|NCT01458366|Etoposide|etoposide|mesh-list
102621498|NCT01458366|Etoposide phosphate|etoposide phosphate|mesh-list
102621499|NCT01458366|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102621500|NCT01458366|Ofatumumab|ofatumumab|mesh-list
102621501|NCT01458366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102621502|NCT01458366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102621503|NCT01458366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102621504|NCT01458366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102621505|NCT01458366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102621506|NCT01458366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621507|NCT01458366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102621508|NCT01458366|Alkylating Agents|alkylating agents|mesh-ancestor
102621509|NCT01458210|Dulaglutide|dulaglutide|mesh-list
102621510|NCT01458210|Moxifloxacin|moxifloxacin|mesh-list
102621511|NCT01458210|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102621512|NCT01458210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102621513|NCT01458210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621514|NCT01458210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102621515|NCT01458210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102621516|NCT01458210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102621517|NCT01458210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102621518|NCT01458210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102621519|NCT01458210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621520|NCT01458210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102621521|NCT01458210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102621522|NCT01458210|Contraceptive Agents|contraceptive agents|mesh-ancestor
102621523|NCT01458210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102621524|NCT01458210|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102621525|NCT01458210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102621526|NCT01458210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102621527|NCT01457118|Etirinotecan pegol|etirinotecan pegol|mesh-list
102621528|NCT01457118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102621529|NCT01457118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102621530|NCT01457118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102621531|NCT01457118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102621532|NCT01457118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621533|NCT01501110|Acetylcysteine|acetylcysteine|mesh-list
102621534|NCT01501110|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102621535|NCT01501110|Antiviral Agents|antiviral agents|mesh-ancestor
102621536|NCT01501110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102621537|NCT01501110|Expectorants|expectorants|mesh-ancestor
102621538|NCT01501110|Respiratory System Agents|respiratory system agents|mesh-ancestor
102621539|NCT01501110|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102621540|NCT01501110|Antioxidants|antioxidants|mesh-ancestor
102621541|NCT01501110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621542|NCT01501110|Protective Agents|protective agents|mesh-ancestor
102621543|NCT01501110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621544|NCT01501110|Antidotes|antidotes|mesh-ancestor
102621545|NCT01500720|Topotecan|topotecan|mesh-list
102621546|NCT01500720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102621547|NCT01500720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102621548|NCT01500720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102621549|NCT01500720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274944|NCT00956007|Cetuximab|cetuximab|mesh-list
101909853|NCT03752138|Decitabine|decitabine|mesh-list
102621550|NCT01500720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102621551|NCT01476696|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102621552|NCT01476696|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102621553|NCT01455012|Rotigotine|rotigotine|mesh-list
102621554|NCT01455012|Dopamine Agonists|dopamine agonists|mesh-ancestor
102621555|NCT01455012|Dopamine Agents|dopamine agents|mesh-ancestor
102621556|NCT01455012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102621557|NCT01455012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621558|NCT01455012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621559|NCT01454778|Paclitaxel|paclitaxel|mesh-list
102621560|NCT01454778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102621561|NCT01454778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102621562|NCT01454778|Tubulin Modulators|tubulin modulators|mesh-ancestor
102621563|NCT01454778|Antimitotic Agents|antimitotic agents|mesh-ancestor
102621564|NCT01454778|Mitosis Modulators|mitosis modulators|mesh-ancestor
102621565|NCT01454778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621566|NCT01454076|Clarithromycin|clarithromycin|mesh-list
102621567|NCT01454076|Rifampin|rifampin|mesh-list
102621568|NCT01454076|Ketoconazole|ketoconazole|mesh-list
102621569|NCT01454076|Ixazomib|ixazomib|mesh-list
102621570|NCT01454076|Glycine|glycine|mesh-list
102621571|NCT01454076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102621572|NCT01454076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102621573|NCT01454076|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102621574|NCT01454076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102621575|NCT01454076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621576|NCT01454076|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102621577|NCT01454076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102621578|NCT01454076|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102621579|NCT01454076|Antitubercular Agents|antitubercular agents|mesh-ancestor
102621580|NCT01454076|Leprostatic Agents|leprostatic agents|mesh-ancestor
102621581|NCT01454076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102621582|NCT01454076|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102621583|NCT01454076|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102621584|NCT01454076|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101593852|NCT02957032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102621585|NCT01454076|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102621586|NCT01454076|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102621587|NCT01454076|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102621588|NCT01454076|Antifungal Agents|antifungal agents|mesh-ancestor
102621589|NCT01454076|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102621590|NCT01454076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102621591|NCT01454076|Hormone Antagonists|hormone antagonists|mesh-ancestor
102621592|NCT01454076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102621593|NCT01454076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621594|NCT01454076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102621595|NCT01454076|Protease Inhibitors|protease inhibitors|mesh-ancestor
102621596|NCT01454076|Glycine Agents|glycine agents|mesh-ancestor
102621597|NCT01454076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102621598|NCT01453998|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102621599|NCT01453998|Immunologic Factors|immunologic factors|mesh-ancestor
102621600|NCT01453998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621601|NCT01453374|Naltrexone|naltrexone|mesh-list
102621602|NCT01453374|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102621603|NCT01453374|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102621604|NCT01453374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621605|NCT01453374|Sensory System Agents|sensory system agents|mesh-ancestor
102621606|NCT01453374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102621607|NCT01453140|Sirolimus|sirolimus|mesh-list
102621608|NCT01453140|Cyclophosphamide|cyclophosphamide|mesh-list
102621609|NCT01453140|Temsirolimus|temsirolimus|mesh-list
102621610|NCT01453140|Interleukin-2|interleukin-2|mesh-list
102621611|NCT01453140|Azacitidine|azacitidine|mesh-list
102621612|NCT01453140|MTOR Inhibitors|mtor inhibitors|mesh-list
102621613|NCT01453140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102621614|NCT01453140|Immunologic Factors|immunologic factors|mesh-ancestor
102621615|NCT01453140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621616|NCT01453140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102621617|NCT01453140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102621618|NCT01453140|Alkylating Agents|alkylating agents|mesh-ancestor
102621619|NCT01453140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621620|NCT01453140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102621621|NCT01453140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102621622|NCT01453140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102621623|NCT01453140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102621624|NCT01453140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102621625|NCT01453140|Antifungal Agents|antifungal agents|mesh-ancestor
102621626|NCT01453140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102621627|NCT01453140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102621628|NCT01453140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102621629|NCT01453140|Analgesics|analgesics|mesh-ancestor
102621630|NCT01453140|Sensory System Agents|sensory system agents|mesh-ancestor
102621631|NCT01453140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102621632|NCT01453140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102621633|NCT01453140|Antimetabolites|antimetabolites|mesh-ancestor
102621635|NCT01499940|Cholecalciferol|cholecalciferol|mesh-list
102621636|NCT01499940|Vitamins|vitamins|mesh-ancestor
102621637|NCT01499940|Micronutrients|micronutrients|mesh-ancestor
102621638|NCT01499940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621639|NCT01499940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102621640|NCT01499940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102621641|NCT01499160|Everolimus|everolimus|mesh-list
102621642|NCT01499160|Letrozole|letrozole|mesh-list
102621643|NCT01499160|Lapatinib|lapatinib|mesh-list
102621644|NCT01499160|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102621645|NCT01499160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102621646|NCT01499160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102621647|NCT01499160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621648|NCT01499160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102621649|NCT01499160|Immunologic Factors|immunologic factors|mesh-ancestor
102621650|NCT01499160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621651|NCT01499160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102621652|NCT01499160|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102621653|NCT01499160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102621654|NCT01499160|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102621655|NCT01499160|Hormone Antagonists|hormone antagonists|mesh-ancestor
102621656|NCT01499160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102621657|NCT01498068|Interferons|interferons|mesh-list
102621658|NCT01498068|Ribavirin|ribavirin|mesh-list
102621659|NCT01498068|Interferon-alpha|interferon-alpha|mesh-list
102621660|NCT01498068|Interferon alpha-2|interferon alpha-2|mesh-list
102621661|NCT01498068|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102621662|NCT01498068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102621663|NCT01498068|Antiviral Agents|antiviral agents|mesh-ancestor
102621664|NCT01498068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102621665|NCT01498068|Antimetabolites|antimetabolites|mesh-ancestor
102621666|NCT01498068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621667|NCT01498068|Immunologic Factors|immunologic factors|mesh-ancestor
102621668|NCT01498068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621669|NCT01497366|Sofosbuvir|sofosbuvir|mesh-list
102621670|NCT01497366|Antiviral Agents|antiviral agents|mesh-ancestor
102621671|NCT01497366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102621672|NCT01475838|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102621673|NCT01475838|Antiviral Agents|antiviral agents|mesh-ancestor
102621674|NCT01475838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102621675|NCT01475838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102621676|NCT01475838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102621677|NCT01451814|Nicotine|nicotine|mesh-list
102621678|NCT01451814|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102621679|NCT01451814|Autonomic Agents|autonomic agents|mesh-ancestor
102621680|NCT01451814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102621681|NCT01451814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621682|NCT01451814|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102621683|NCT01451814|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102621684|NCT01451814|Cholinergic Agents|cholinergic agents|mesh-ancestor
102621685|NCT01451814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102621686|NCT01451814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621687|NCT01496430|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
102621688|NCT01496430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102621689|NCT01496430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102621690|NCT01496430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621691|NCT04408326|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102621692|NCT04408326|Angiotensin II|angiotensin ii|mesh-list
102621693|NCT04408326|Giapreza|giapreza|mesh-list
102621694|NCT04408326|Angiotensinogen|angiotensinogen|mesh-list
101909991|NCT01366300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102621695|NCT04408326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102621696|NCT04408326|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102621697|NCT04408326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102621698|NCT04408326|Protease Inhibitors|protease inhibitors|mesh-ancestor
102621699|NCT04408326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102621700|NCT04408326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621701|NCT01474746|Sertraline|sertraline|mesh-list
102621702|NCT01474746|Antidepressive Agents|antidepressive agents|mesh-ancestor
102621703|NCT01474746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102621704|NCT01474746|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102621705|NCT01474746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102621706|NCT01474746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102621707|NCT01474746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621708|NCT01474746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102621709|NCT01474746|Serotonin Agents|serotonin agents|mesh-ancestor
102621710|NCT01474746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621711|NCT01450800|Nitrofurantoin|nitrofurantoin|mesh-list
102621712|NCT01450800|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102621713|NCT01450800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102621714|NCT01450800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102621715|NCT01474512|Ixekizumab|ixekizumab|mesh-list
102621716|NCT01474512|Dermatologic Agents|dermatologic agents|mesh-ancestor
102621717|NCT02985606|Caffeine|caffeine|mesh-list
102621718|NCT02985606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102621719|NCT02985606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621720|NCT02985606|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102621721|NCT02985606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102621722|NCT02985606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621723|NCT02985606|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102621724|NCT02985606|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102621725|NCT02985606|Purinergic Agents|purinergic agents|mesh-ancestor
102621726|NCT02985606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102621727|NCT01473732|Mycophenolic Acid|mycophenolic acid|mesh-list
102621728|NCT01473732|Everolimus|everolimus|mesh-list
102621729|NCT01473732|Tacrolimus|tacrolimus|mesh-list
102621730|NCT01473732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102621731|NCT01473732|Immunologic Factors|immunologic factors|mesh-ancestor
102621732|NCT01473732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621733|NCT01473732|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102621734|NCT01473732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102621735|NCT01473732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621736|NCT01473732|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102621737|NCT01473732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102621738|NCT01473732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102621739|NCT01473732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102621740|NCT01473732|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102621741|NCT01473732|Antitubercular Agents|antitubercular agents|mesh-ancestor
102621742|NCT01473732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102621743|NCT01473732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102621744|NCT01450098|Evacetrapib|evacetrapib|mesh-list
102621745|NCT01450098|Propyl Gallate|propyl gallate|mesh-list
102621746|NCT01450098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102621747|NCT01450098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102621748|NCT01450098|Antimetabolites|antimetabolites|mesh-ancestor
102621749|NCT01450098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621750|NCT01450098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102621751|NCT01450098|Antioxidants|antioxidants|mesh-ancestor
102621752|NCT01450098|Protective Agents|protective agents|mesh-ancestor
102621753|NCT01450098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621754|NCT01449630|Celecoxib|celecoxib|mesh-list
102621755|NCT01449630|LY3031207|ly3031207|mesh-list
102621756|NCT01449630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102621757|NCT01449630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102621758|NCT01449630|Analgesics|analgesics|mesh-ancestor
102621759|NCT01449630|Sensory System Agents|sensory system agents|mesh-ancestor
102621760|NCT01449630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102621761|NCT01449630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621762|NCT01449630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102621763|NCT01449630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101594039|NCT05342272|Lactoferrin|lactoferrin|mesh-list
102621764|NCT01449630|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102621765|NCT01449630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102621766|NCT01449630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102621767|NCT01449630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621768|NCT01449630|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
102621769|NCT01449630|Hormone Antagonists|hormone antagonists|mesh-ancestor
102621770|NCT01449630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101910068|NCT03747614|Hormones|hormones|mesh-ancestor
102621772|NCT01473420|Hematinics|hematinics|mesh-ancestor
102621773|NCT04674774|Lansoprazole|lansoprazole|mesh-list
102621774|NCT04674774|Dexlansoprazole|dexlansoprazole|mesh-list
102621775|NCT04674774|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102621776|NCT04674774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102621777|NCT04674774|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102621778|NCT04674774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102621779|NCT04674774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621780|NCT01492686|Edaravone|edaravone|mesh-list
102621781|NCT01492686|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102621782|NCT01492686|Antioxidants|antioxidants|mesh-ancestor
102621783|NCT01492686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621784|NCT01492686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102621785|NCT01492686|Protective Agents|protective agents|mesh-ancestor
102621786|NCT01492686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621787|NCT01449006|Maraviroc|maraviroc|mesh-list
102621788|NCT01449006|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102621789|NCT01449006|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102621790|NCT01449006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621791|NCT01449006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102621792|NCT01449006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102621793|NCT01449006|Antiviral Agents|antiviral agents|mesh-ancestor
102621794|NCT01449006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102621795|NCT01449006|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102621796|NCT01491672|Everolimus|everolimus|mesh-list
102621797|NCT01491672|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102621798|NCT01491672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102621799|NCT01491672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102621800|NCT01491672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621801|NCT01491672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102621802|NCT01491672|Immunologic Factors|immunologic factors|mesh-ancestor
102621803|NCT01491672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621804|NCT01491672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102621805|NCT01447446|Ribavirin|ribavirin|mesh-list
102621806|NCT01447446|Interferon-alpha|interferon-alpha|mesh-list
102621807|NCT01447446|Interferon alpha-2|interferon alpha-2|mesh-list
102621808|NCT01447446|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
102621809|NCT01447446|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102621810|NCT01447446|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102621811|NCT01447446|Antimetabolites|antimetabolites|mesh-ancestor
102621812|NCT01447446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621813|NCT01447446|Antiviral Agents|antiviral agents|mesh-ancestor
102621814|NCT01447446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102621815|NCT01447446|Immunologic Factors|immunologic factors|mesh-ancestor
102621816|NCT01447446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621817|NCT01447446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102621818|NCT01471782|Blinatumomab|blinatumomab|mesh-list
102621819|NCT01471782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102621820|NCT01490580|Atropine|atropine|mesh-list
102621821|NCT01490580|Sufentanil|sufentanil|mesh-list
102621822|NCT01490580|Propofol|propofol|mesh-list
102621823|NCT01490580|Atracurium|atracurium|mesh-list
102621824|NCT01490580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102621825|NCT01490580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102621826|NCT01490580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621827|NCT01490580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102621828|NCT01490580|Anesthetics, General|anesthetics, general|mesh-ancestor
102621829|NCT01490580|Anesthetics|anesthetics|mesh-ancestor
102621830|NCT01490580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102621831|NCT01490580|Narcotics|narcotics|mesh-ancestor
102621832|NCT01490580|Analgesics|analgesics|mesh-ancestor
102621833|NCT01490580|Sensory System Agents|sensory system agents|mesh-ancestor
102621834|NCT01490580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102621835|NCT01490580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102621836|NCT01490580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102621837|NCT01490580|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102621838|NCT01490580|Autonomic Agents|autonomic agents|mesh-ancestor
102621839|NCT01490580|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102621840|NCT01490580|Respiratory System Agents|respiratory system agents|mesh-ancestor
102621841|NCT01490580|Mydriatics|mydriatics|mesh-ancestor
102621842|NCT01490580|Parasympatholytics|parasympatholytics|mesh-ancestor
102274945|NCT00956007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101910160|NCT01371448|Paroxetine|paroxetine|mesh-list
102621843|NCT01490580|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102621844|NCT01490580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102621845|NCT01490580|Cholinergic Agents|cholinergic agents|mesh-ancestor
102621846|NCT01490580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101910211|NCT03127384|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102621847|NCT01490580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621848|NCT01490580|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102621849|NCT01490580|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102621850|NCT01490580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102621851|NCT01490580|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102621852|NCT01490190|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102621853|NCT01490190|Etonogestrel|etonogestrel|mesh-list
102621854|NCT01490190|NuvaRing|nuvaring|mesh-list
102621855|NCT01490190|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102621856|NCT01490190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102621857|NCT01490190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102621858|NCT01490190|Contraceptive Agents|contraceptive agents|mesh-ancestor
102621859|NCT01490190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102621860|NCT01490190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621861|NCT01490190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102621862|NCT01490190|Estrogens|estrogens|mesh-ancestor
102621863|NCT01490190|Hormones|hormones|mesh-ancestor
102621864|NCT01490190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102621865|NCT01446042|Methyltestosterone|methyltestosterone|mesh-list
102621866|NCT01446042|Testosterone|testosterone|mesh-list
102621867|NCT01446042|Testosterone undecanoate|testosterone undecanoate|mesh-list
102621868|NCT01446042|Testosterone enanthate|testosterone enanthate|mesh-list
102621869|NCT01446042|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102621870|NCT01446042|Androgens|androgens|mesh-ancestor
102621871|NCT01446042|Hormones|hormones|mesh-ancestor
102621872|NCT01446042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102621873|NCT01446042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621874|NCT01446042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102621875|NCT01446042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102621876|NCT01446042|Anabolic Agents|anabolic agents|mesh-ancestor
102621877|NCT01445886|Calcitriol|calcitriol|mesh-list
102621878|NCT01445886|Calcipotriene|calcipotriene|mesh-list
102621879|NCT01445886|Dermatologic Agents|dermatologic agents|mesh-ancestor
102621880|NCT01445886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102621881|NCT01445886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621882|NCT01445886|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102621883|NCT01445886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102621884|NCT01445886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621885|NCT01445886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102621886|NCT01445886|Vitamins|vitamins|mesh-ancestor
102621887|NCT01445886|Micronutrients|micronutrients|mesh-ancestor
102621888|NCT01445886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102621889|NCT01470612|Tofacitinib|tofacitinib|mesh-list
102621890|NCT01470612|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102621891|NCT01470612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102621892|NCT01470612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102621893|NCT01470612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621894|NCT04073316|Warfarin|warfarin|mesh-list
102621895|NCT04073316|Rivaroxaban|rivaroxaban|mesh-list
102621896|NCT04073316|Anticoagulants|anticoagulants|mesh-ancestor
102621897|NCT04073316|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102621898|NCT04073316|Antithrombins|antithrombins|mesh-ancestor
102621899|NCT04073316|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102621900|NCT04073316|Protease Inhibitors|protease inhibitors|mesh-ancestor
102621901|NCT04073316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102621902|NCT04073316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621903|NCT04089852|Nitrous Oxide|nitrous oxide|mesh-list
102621904|NCT04089852|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102621905|NCT04089852|Anesthetics, General|anesthetics, general|mesh-ancestor
102621906|NCT04089852|Anesthetics|anesthetics|mesh-ancestor
102621907|NCT04089852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102621908|NCT04089852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621909|NCT04089852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102621910|NCT04089852|Analgesics|analgesics|mesh-ancestor
102621911|NCT04089852|Sensory System Agents|sensory system agents|mesh-ancestor
102621912|NCT04089852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102621913|NCT03026244|Vitamin D|vitamin d|mesh-list
102621914|NCT03026244|Caseins|caseins|mesh-list
102621915|NCT03026244|Vitamins|vitamins|mesh-ancestor
102621916|NCT03026244|Micronutrients|micronutrients|mesh-ancestor
102621917|NCT03026244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621918|NCT03026244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102621919|NCT03026244|Chelating Agents|chelating agents|mesh-ancestor
102621920|NCT03026244|Sequestering Agents|sequestering agents|mesh-ancestor
102621921|NCT03026244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621922|NCT01470144|Epoprostenol|epoprostenol|mesh-list
102621923|NCT01470144|Tezosentan|tezosentan|mesh-list
102621924|NCT01470144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102621925|NCT01470144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102621926|NCT01470144|Vasodilator Agents|vasodilator agents|mesh-ancestor
102621927|NCT01443858|Meclizine|meclizine|mesh-list
102621928|NCT01443858|Nicotine|nicotine|mesh-list
102621929|NCT01443858|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102621930|NCT01443858|Autonomic Agents|autonomic agents|mesh-ancestor
102621931|NCT01443858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102621932|NCT01443858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621933|NCT01443858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102621934|NCT01443858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102621935|NCT01443858|Cholinergic Agents|cholinergic agents|mesh-ancestor
102621936|NCT01443858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102621937|NCT01443858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621938|NCT01443858|Antiemetics|antiemetics|mesh-ancestor
102621939|NCT01443858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102621940|NCT01443858|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102621941|NCT01443858|Histamine Antagonists|histamine antagonists|mesh-ancestor
102621942|NCT01443858|Histamine Agents|histamine agents|mesh-ancestor
102621943|NCT01443858|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102621944|NCT01443858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102621945|NCT01443078|Carboplatin|carboplatin|mesh-list
102621946|NCT01443078|Gemcitabine|gemcitabine|mesh-list
102621947|NCT01443078|Docetaxel|docetaxel|mesh-list
102621948|NCT01443078|Pemetrexed|pemetrexed|mesh-list
102621949|NCT01443078|Vinorelbine|vinorelbine|mesh-list
102621950|NCT01443078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102621951|NCT01443078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102621952|NCT01443078|Antimetabolites|antimetabolites|mesh-ancestor
102621953|NCT01443078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621954|NCT01443078|Tubulin Modulators|tubulin modulators|mesh-ancestor
102621955|NCT01443078|Antimitotic Agents|antimitotic agents|mesh-ancestor
102621956|NCT01443078|Mitosis Modulators|mitosis modulators|mesh-ancestor
102621957|NCT01443078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102621958|NCT01443078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102621959|NCT01443078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102621960|NCT01443078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102621961|NCT01439880|Evolocumab|evolocumab|mesh-list
102621962|NCT01439880|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102621963|NCT01439880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102621964|NCT01439880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102621965|NCT01439880|Antimetabolites|antimetabolites|mesh-ancestor
102621966|NCT01439880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621967|NCT01439880|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102621968|NCT01439880|Protease Inhibitors|protease inhibitors|mesh-ancestor
102621969|NCT01439880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102621970|NCT01439880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102621971|NCT01469364|Aztreonam|aztreonam|mesh-list
102621972|NCT01469364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102621973|NCT01469364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102621974|NCT01439568|Carboplatin|carboplatin|mesh-list
102621975|NCT01439568|Etoposide|etoposide|mesh-list
102621976|NCT01439568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102621977|NCT01439568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102621978|NCT01439568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102621979|NCT01439568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102621980|NCT01439568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102621981|NCT01439568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621982|NCT01469052|Axitinib|axitinib|mesh-list
102621983|NCT01469052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102621984|NCT01469052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102621985|NCT01469052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102621986|NCT01469052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621987|NCT01468818|Cyclophosphamide|cyclophosphamide|mesh-list
102621988|NCT01468818|Fludarabine|fludarabine|mesh-list
102621989|NCT01468818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102621990|NCT01468818|Immunologic Factors|immunologic factors|mesh-ancestor
102621991|NCT01468818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102621992|NCT01468818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102621993|NCT01468818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102621994|NCT01468818|Alkylating Agents|alkylating agents|mesh-ancestor
102274946|NCT00956007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102621995|NCT01468818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102621996|NCT01468818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102621997|NCT01468818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102621998|NCT01442376|Ondansetron|ondansetron|mesh-list
102621999|NCT01442376|Palonosetron|palonosetron|mesh-list
102622000|NCT01442376|Antiemetics|antiemetics|mesh-ancestor
102622001|NCT01442376|Autonomic Agents|autonomic agents|mesh-ancestor
102622002|NCT01442376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102622003|NCT01442376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622004|NCT01442376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102622005|NCT01442376|Antipruritics|antipruritics|mesh-ancestor
102622006|NCT01442376|Dermatologic Agents|dermatologic agents|mesh-ancestor
102622007|NCT01442376|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102622008|NCT01442376|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102622009|NCT01442376|Serotonin Agents|serotonin agents|mesh-ancestor
102622010|NCT01442376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102622011|NCT01442376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622012|NCT01442064|Ranibizumab|ranibizumab|mesh-list
102622013|NCT01442064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102622014|NCT01442064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102622015|NCT01442064|Growth Substances|growth substances|mesh-ancestor
102622016|NCT01442064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622017|NCT01442064|Growth Inhibitors|growth inhibitors|mesh-ancestor
102622018|NCT01442064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102622019|NCT01441596|Vinorelbine|vinorelbine|mesh-list
102622020|NCT01441596|Afatinib|afatinib|mesh-list
102622021|NCT01441596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102622022|NCT01441596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102622023|NCT01441596|Tubulin Modulators|tubulin modulators|mesh-ancestor
102622024|NCT01441596|Antimitotic Agents|antimitotic agents|mesh-ancestor
102622025|NCT01441596|Mitosis Modulators|mitosis modulators|mesh-ancestor
102622026|NCT01441596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622027|NCT01441596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102622028|NCT01441596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102622029|NCT01441440|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102622030|NCT01441440|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102622031|NCT01441440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102622032|NCT01441440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102622033|NCT01441440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622034|NCT01441440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102622035|NCT01441440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622036|NCT01441440|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102622037|NCT01441440|Antidepressive Agents|antidepressive agents|mesh-ancestor
102622038|NCT01441440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102622039|NCT03026478|Betamethasone|betamethasone|mesh-list
102622040|NCT03026478|Betamethasone Valerate|betamethasone valerate|mesh-list
102622041|NCT03026478|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102622042|NCT03026478|Betamethasone benzoate|betamethasone benzoate|mesh-list
102622043|NCT03026478|Clobetasol|clobetasol|mesh-list
102622044|NCT03026478|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102622045|NCT03026478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102622046|NCT03026478|Glucocorticoids|glucocorticoids|mesh-ancestor
102622047|NCT03026478|Hormones|hormones|mesh-ancestor
102622048|NCT03026478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102622049|NCT03026478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622050|NCT03026478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102622051|NCT03026478|Respiratory System Agents|respiratory system agents|mesh-ancestor
102622052|NCT04066764|Nadroparin|nadroparin|mesh-list
102622053|NCT04066764|Warfarin|warfarin|mesh-list
102622054|NCT04066764|Rivaroxaban|rivaroxaban|mesh-list
102622055|NCT04066764|Anticoagulants|anticoagulants|mesh-ancestor
102622056|NCT04066764|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102622057|NCT04066764|Antithrombins|antithrombins|mesh-ancestor
102622058|NCT04066764|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102622059|NCT04066764|Protease Inhibitors|protease inhibitors|mesh-ancestor
102622060|NCT04066764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102622061|NCT04066764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622062|NCT04066764|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102622063|NCT04066764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102622064|NCT01437540|Bromides|bromides|mesh-list
102622065|NCT01437540|Formoterol Fumarate|formoterol fumarate|mesh-list
102622066|NCT01437540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102622067|NCT01437540|Autonomic Agents|autonomic agents|mesh-ancestor
102622068|NCT01437540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102622069|NCT01437540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622070|NCT01437540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102622071|NCT01437540|Respiratory System Agents|respiratory system agents|mesh-ancestor
102622072|NCT01437540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102622073|NCT01437540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102622074|NCT01437540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102622075|NCT01437540|Adrenergic Agents|adrenergic agents|mesh-ancestor
102622076|NCT01437540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102622077|NCT01437540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622078|NCT01437540|Anticonvulsants|anticonvulsants|mesh-ancestor
102622079|NCT01420536|Salicylic Acid|salicylic acid|mesh-list
102622080|NCT01420536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102622081|NCT01420536|Antifungal Agents|antifungal agents|mesh-ancestor
102622082|NCT01420536|Keratolytic Agents|keratolytic agents|mesh-ancestor
102622083|NCT01420536|Dermatologic Agents|dermatologic agents|mesh-ancestor
102622084|NCT01467492|Interferons|interferons|mesh-list
102622085|NCT01467492|Ribavirin|ribavirin|mesh-list
102622086|NCT01467492|Interferon-alpha|interferon-alpha|mesh-list
102622087|NCT01467492|Interferon alpha-2|interferon alpha-2|mesh-list
102622088|NCT01467492|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102622089|NCT01467492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102622090|NCT01467492|Antiviral Agents|antiviral agents|mesh-ancestor
102622091|NCT01467492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102622092|NCT01467492|Antimetabolites|antimetabolites|mesh-ancestor
102622093|NCT01467492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622094|NCT01467492|Immunologic Factors|immunologic factors|mesh-ancestor
102622095|NCT01467492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622096|NCT01466790|Ribavirin|ribavirin|mesh-list
102622097|NCT01466790|Sofosbuvir|sofosbuvir|mesh-list
102622098|NCT01466790|Simeprevir|simeprevir|mesh-list
102622099|NCT01466790|Antimetabolites|antimetabolites|mesh-ancestor
102622100|NCT01466790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622101|NCT01466790|Antiviral Agents|antiviral agents|mesh-ancestor
102622102|NCT01466790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102622103|NCT01466790|Protease Inhibitors|protease inhibitors|mesh-ancestor
102622104|NCT01466790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102622105|NCT01418352|Aripiprazole|aripiprazole|mesh-list
102622106|NCT01418352|Antidepressive Agents|antidepressive agents|mesh-ancestor
102622107|NCT01418352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102622108|NCT01418352|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102622109|NCT01418352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102622110|NCT01418352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102622111|NCT01418352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622112|NCT01418352|Dopamine Agonists|dopamine agonists|mesh-ancestor
102622113|NCT01418352|Dopamine Agents|dopamine agents|mesh-ancestor
102622114|NCT01418352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102622115|NCT01418352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622116|NCT01418352|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102622117|NCT01418352|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102622118|NCT01418352|Serotonin Agents|serotonin agents|mesh-ancestor
102622119|NCT01418352|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102622120|NCT01418352|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102622121|NCT01418352|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102622122|NCT01418352|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102622123|NCT01436370|Vaccines|vaccines|mesh-list
102622124|NCT01436370|Immunologic Factors|immunologic factors|mesh-ancestor
102622125|NCT01436370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622126|NCT01465464|Orantinib|orantinib|mesh-list
102622127|NCT01465464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102622128|NCT01465464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102622129|NCT01465464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622130|NCT01465386|Bortezomib|bortezomib|mesh-list
102622131|NCT01465386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102622132|NCT04082364|Trastuzumab|trastuzumab|mesh-list
102622133|NCT04082364|Margetuximab|margetuximab|mesh-list
102622134|NCT04082364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102622135|NCT04082364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102622136|NCT01465230|Lenalidomide|lenalidomide|mesh-list
102622137|NCT01465230|Immunologic Factors|immunologic factors|mesh-ancestor
102622138|NCT01465230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622139|NCT01465230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102622140|NCT01465230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102622141|NCT01465230|Growth Substances|growth substances|mesh-ancestor
102622142|NCT01465230|Growth Inhibitors|growth inhibitors|mesh-ancestor
102622143|NCT01465230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102622144|NCT01435122|Axitinib|axitinib|mesh-list
102622145|NCT01435122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102622146|NCT01435122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102622147|NCT01435122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101910433|NCT00352534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102622148|NCT01435122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622149|NCT01393626|Tofacitinib|tofacitinib|mesh-list
102622150|NCT01393626|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102622151|NCT01393626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102622152|NCT01393626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102622153|NCT01393626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622154|NCT01393158|Apremilast|apremilast|mesh-list
102622155|NCT01393158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102622156|NCT01393158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102622157|NCT01393158|Analgesics|analgesics|mesh-ancestor
102622158|NCT01393158|Sensory System Agents|sensory system agents|mesh-ancestor
102622159|NCT01393158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102622160|NCT01393158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622161|NCT01393158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102622162|NCT01393158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102622163|NCT01393158|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102622164|NCT01393158|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102622165|NCT01393158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102622166|NCT01393158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622167|NCT01413360|Vitamins|vitamins|mesh-list
102622168|NCT01413360|Ascorbic Acid|ascorbic acid|mesh-list
102622169|NCT01413360|Micronutrients|micronutrients|mesh-ancestor
102622170|NCT01413360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622171|NCT01413360|Antioxidants|antioxidants|mesh-ancestor
102622172|NCT01413360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622173|NCT01413360|Protective Agents|protective agents|mesh-ancestor
102622174|NCT03815448|Methotrexate|methotrexate|mesh-list
102622175|NCT03815448|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102622176|NCT03815448|Abortifacient Agents|abortifacient agents|mesh-ancestor
102622177|NCT03815448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102622178|NCT03815448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622179|NCT03815448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102622180|NCT03815448|Antimetabolites|antimetabolites|mesh-ancestor
102622181|NCT03815448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622182|NCT03815448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102622183|NCT03815448|Dermatologic Agents|dermatologic agents|mesh-ancestor
102622184|NCT03815448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102622185|NCT03815448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102622186|NCT03815448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102622187|NCT03815448|Immunologic Factors|immunologic factors|mesh-ancestor
102622188|NCT03815448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102622189|NCT03815448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102622190|NCT01392378|Acetaminophen|acetaminophen|mesh-list
102622191|NCT01392378|Ibuprofen|ibuprofen|mesh-list
102622192|NCT01392378|Vaccines|vaccines|mesh-list
102622193|NCT01392378|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102622194|NCT01392378|Immunologic Factors|immunologic factors|mesh-ancestor
102622195|NCT01392378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622196|NCT01392378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102622197|NCT01392378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102622198|NCT01392378|Analgesics|analgesics|mesh-ancestor
102622199|NCT01392378|Sensory System Agents|sensory system agents|mesh-ancestor
102622200|NCT01392378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102622201|NCT01392378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102622202|NCT01392378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102622203|NCT01392378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102622204|NCT01392378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102622205|NCT01392378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622206|NCT01392378|Antipyretics|antipyretics|mesh-ancestor
102622207|NCT01412424|Octreotide|octreotide|mesh-list
102622208|NCT01412424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102622209|NCT01412424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102622210|NCT01412424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102622211|NCT01433250|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102622212|NCT01433250|Immunologic Factors|immunologic factors|mesh-ancestor
102622213|NCT01433250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622214|NCT01432938|Dulaglutide|dulaglutide|mesh-list
102622215|NCT01432938|Warfarin|warfarin|mesh-list
102622216|NCT01432938|Anticoagulants|anticoagulants|mesh-ancestor
102622217|NCT01432938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102622218|NCT01432938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622219|NCT01392300|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102622220|NCT01392300|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102274947|NCT00832429|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
102622221|NCT01392300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102274948|NCT00832429|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102274949|NCT00832429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622222|NCT01392300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622223|NCT01392300|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102622224|NCT01392300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102622225|NCT01392300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622226|NCT01392300|Cholinergic Agents|cholinergic agents|mesh-ancestor
102622227|NCT01392300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102622228|NCT01432626|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
102622229|NCT01432626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102622230|NCT01432626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102622231|NCT01432626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622232|NCT01432626|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102622233|NCT01391130|Sunitinib|sunitinib|mesh-list
102622234|NCT01391130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102622235|NCT01391130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102622236|NCT01391130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102622237|NCT01391130|Growth Substances|growth substances|mesh-ancestor
102622238|NCT01391130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622239|NCT01391130|Growth Inhibitors|growth inhibitors|mesh-ancestor
102622240|NCT01391130|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102622241|NCT01391130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102622242|NCT01391130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622243|NCT04046094|Ascorbic Acid|ascorbic acid|mesh-list
102622244|NCT04046094|Vitamins|vitamins|mesh-ancestor
102622245|NCT04046094|Micronutrients|micronutrients|mesh-ancestor
102622246|NCT04046094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622247|NCT04046094|Antioxidants|antioxidants|mesh-ancestor
102622248|NCT04046094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622249|NCT04046094|Protective Agents|protective agents|mesh-ancestor
102622250|NCT01410240|Hemostatics|hemostatics|mesh-list
102622251|NCT01410240|Coagulants|coagulants|mesh-ancestor
102622252|NCT01408914|Rifampin|rifampin|mesh-list
102622253|NCT01408914|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102622254|NCT01408914|Antitubercular Agents|antitubercular agents|mesh-ancestor
102622255|NCT01408914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101594558|NCT02200978|Arsenic Trioxide|arsenic trioxide|mesh-list
102622256|NCT01408914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102622257|NCT01408914|Leprostatic Agents|leprostatic agents|mesh-ancestor
102622258|NCT01408914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102622259|NCT01408914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102622260|NCT01408914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622261|NCT01408914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102622262|NCT01408914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102622263|NCT01408914|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102622264|NCT01408914|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102622265|NCT01408914|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102622266|NCT01408914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102622267|NCT04044222|Carboplatin|carboplatin|mesh-list
102622268|NCT04044222|Etoposide|etoposide|mesh-list
102622269|NCT04044222|Etoposide phosphate|etoposide phosphate|mesh-list
102622270|NCT04044222|Ifosfamide|ifosfamide|mesh-list
102622271|NCT04044222|Isophosphamide mustard|isophosphamide mustard|mesh-list
102622272|NCT04044222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102622273|NCT04044222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102622274|NCT04044222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102622275|NCT04044222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102622276|NCT04044222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102622277|NCT04044222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622278|NCT04044222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102622279|NCT04044222|Alkylating Agents|alkylating agents|mesh-ancestor
102622280|NCT01390428|Grazoprevir|grazoprevir|mesh-list
102622281|NCT01390428|Antiviral Agents|antiviral agents|mesh-ancestor
102622282|NCT01390428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102622283|NCT01429584|Bupivacaine|bupivacaine|mesh-list
102622284|NCT01429584|Anesthetics, Local|anesthetics, local|mesh-ancestor
102622285|NCT01429584|Anesthetics|anesthetics|mesh-ancestor
102622286|NCT01429584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102622287|NCT01429584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622288|NCT01429584|Sensory System Agents|sensory system agents|mesh-ancestor
102622289|NCT01429584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102622290|NCT01405950|Clonidine|clonidine|mesh-list
102622291|NCT01405950|Tizanidine|tizanidine|mesh-list
102622292|NCT01405950|Analgesics|analgesics|mesh-ancestor
102622293|NCT01405950|Sensory System Agents|sensory system agents|mesh-ancestor
102622294|NCT01405950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102622295|NCT01405950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622297|NCT01405950|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102622298|NCT01405950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102622299|NCT01405950|Parasympatholytics|parasympatholytics|mesh-ancestor
102622300|NCT01405950|Autonomic Agents|autonomic agents|mesh-ancestor
102622301|NCT01405950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102622302|NCT01405950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102622303|NCT01405950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102622304|NCT01405950|Adrenergic Agents|adrenergic agents|mesh-ancestor
102622305|NCT01405950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102622306|NCT01405950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622307|NCT01405950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102622308|NCT01405950|Sympatholytics|sympatholytics|mesh-ancestor
102622309|NCT01405560|Ribavirin|ribavirin|mesh-list
102622310|NCT01405560|Antimetabolites|antimetabolites|mesh-ancestor
102622311|NCT01405560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622312|NCT01405560|Antiviral Agents|antiviral agents|mesh-ancestor
102622313|NCT01405560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102622314|NCT01428882|Midazolam|midazolam|mesh-list
102622315|NCT01428882|Propofol|propofol|mesh-list
102622316|NCT01428882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102622317|NCT01428882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102622318|NCT01428882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622319|NCT01428882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102622320|NCT01428882|Anesthetics, General|anesthetics, general|mesh-ancestor
102622321|NCT01428882|Anesthetics|anesthetics|mesh-ancestor
102622322|NCT01428882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102622323|NCT01428882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102622324|NCT01428882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102622325|NCT01428882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102622326|NCT01428882|GABA Modulators|gaba modulators|mesh-ancestor
102622327|NCT01428882|GABA Agents|gaba agents|mesh-ancestor
102622328|NCT01428882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102622329|NCT01428882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622330|NCT01428258|Coal Tar|coal tar|mesh-list
102622331|NCT01428258|Keratolytic Agents|keratolytic agents|mesh-ancestor
102622332|NCT01428258|Dermatologic Agents|dermatologic agents|mesh-ancestor
102622333|NCT01442688|Amoxicillin|amoxicillin|mesh-list
102622334|NCT01442688|Mesalamine|mesalamine|mesh-list
102622335|NCT01442688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102622336|NCT01442688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102622337|NCT01442688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102622338|NCT01442688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102622339|NCT01442688|Analgesics|analgesics|mesh-ancestor
102622340|NCT01442688|Sensory System Agents|sensory system agents|mesh-ancestor
102622341|NCT01442688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102622342|NCT01442688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622343|NCT01442688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102622344|NCT01442688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102622345|NCT03814200|Rifampin|rifampin|mesh-list
102622346|NCT03814200|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102622347|NCT03814200|Antitubercular Agents|antitubercular agents|mesh-ancestor
102622348|NCT03814200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101594646|NCT02883023|Bleomycin|bleomycin|mesh-list
102622349|NCT03814200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102622350|NCT03814200|Leprostatic Agents|leprostatic agents|mesh-ancestor
102622351|NCT03814200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102622352|NCT03814200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102622353|NCT03814200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622354|NCT03814200|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102622355|NCT03814200|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102622356|NCT03814200|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102622357|NCT03814200|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102622358|NCT03814200|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102622359|NCT03814200|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102622360|NCT01426854|Nepafenac|nepafenac|mesh-list
102622361|NCT01426854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102274951|NCT00796263|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102622362|NCT01426854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102622363|NCT01426854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102622364|NCT01426854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102622365|NCT01426854|Analgesics|analgesics|mesh-ancestor
102622366|NCT01426854|Sensory System Agents|sensory system agents|mesh-ancestor
101910650|NCT01114542|Insulin Glargine|insulin glargine|mesh-list
102274952|NCT00796263|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102622367|NCT01426854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102622368|NCT01426854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622369|NCT01426854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102622370|NCT01426854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102622371|NCT01403610|Bevacizumab|bevacizumab|mesh-list
102622372|NCT01403610|Phosphoramide Mustards|phosphoramide mustards|mesh-list
102622373|NCT01403610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102622374|NCT01403610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102622375|NCT01403610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102622376|NCT01403610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102622377|NCT01403610|Growth Substances|growth substances|mesh-ancestor
102622378|NCT01403610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622379|NCT01403610|Growth Inhibitors|growth inhibitors|mesh-ancestor
102622380|NCT01403610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102622381|NCT01403610|Alkylating Agents|alkylating agents|mesh-ancestor
102622382|NCT01403610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622383|NCT01402986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102622384|NCT01402986|Immunologic Factors|immunologic factors|mesh-ancestor
102622385|NCT01402986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622386|NCT01389102|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102622387|NCT01389102|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102622388|NCT01389102|Estradiol|estradiol|mesh-list
102622389|NCT01389102|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102622390|NCT01389102|Estrogens|estrogens|mesh-ancestor
102622391|NCT01389102|Hormones|hormones|mesh-ancestor
102622392|NCT01389102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102622393|NCT01389102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622394|NCT01389102|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102622395|NCT01389102|Contraceptive Agents|contraceptive agents|mesh-ancestor
102622396|NCT01389102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102622397|NCT01389102|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102622398|NCT01402284|Dexamethasone|dexamethasone|mesh-list
101594724|NCT04317872|Hormones|hormones|mesh-ancestor
102622399|NCT01402284|Lenalidomide|lenalidomide|mesh-list
102622400|NCT01402284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102622401|NCT01402284|Antiemetics|antiemetics|mesh-ancestor
102622402|NCT01402284|Autonomic Agents|autonomic agents|mesh-ancestor
102622403|NCT01402284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102622404|NCT01402284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622405|NCT01402284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102622406|NCT01402284|Glucocorticoids|glucocorticoids|mesh-ancestor
102622407|NCT01402284|Hormones|hormones|mesh-ancestor
102622408|NCT01402284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102622409|NCT01402284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102622410|NCT01402284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102622411|NCT01402284|Immunologic Factors|immunologic factors|mesh-ancestor
102622412|NCT01402284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102622413|NCT01402284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102622414|NCT01402284|Growth Substances|growth substances|mesh-ancestor
102622415|NCT01402284|Growth Inhibitors|growth inhibitors|mesh-ancestor
102622416|NCT01388790|Cetuximab|cetuximab|mesh-list
102622417|NCT01388790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102622418|NCT01388790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102622419|NCT01388478|Pramipexole|pramipexole|mesh-list
102622420|NCT01388478|Antioxidants|antioxidants|mesh-ancestor
102622421|NCT01388478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622422|NCT01388478|Protective Agents|protective agents|mesh-ancestor
102622423|NCT01388478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622424|NCT01388478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102622425|NCT01388478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102622426|NCT01388478|Dopamine Agonists|dopamine agonists|mesh-ancestor
102622427|NCT01388478|Dopamine Agents|dopamine agents|mesh-ancestor
102622428|NCT01388478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102622429|NCT01400958|Modafinil|modafinil|mesh-list
102622430|NCT01400958|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102622431|NCT01400958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622432|NCT01400958|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102622433|NCT01400958|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102622434|NCT01400958|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102622435|NCT01400958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622436|NCT01400412|Ritonavir|ritonavir|mesh-list
102622437|NCT01400412|Darunavir|darunavir|mesh-list
102622438|NCT01400412|Tenofovir|tenofovir|mesh-list
102622439|NCT01400412|Emtricitabine|emtricitabine|mesh-list
102622440|NCT01400412|Maraviroc|maraviroc|mesh-list
101910750|NCT01368328|Niacin|niacin|mesh-list
101910796|NCT03792672|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102622442|NCT01400412|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102622443|NCT01400412|Protease Inhibitors|protease inhibitors|mesh-ancestor
102622444|NCT01400412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102622445|NCT01400412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622446|NCT01400412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102622447|NCT01400412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102622448|NCT01400412|Antiviral Agents|antiviral agents|mesh-ancestor
102622449|NCT01400412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102622450|NCT01400412|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102622451|NCT01400412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102622452|NCT01400412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102622453|NCT01400412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102622454|NCT01400412|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102622455|NCT01400412|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102622456|NCT01400412|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102622457|NCT01422876|Linagliptin|linagliptin|mesh-list
102622458|NCT01422876|Empagliflozin|empagliflozin|mesh-list
102622459|NCT01422876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102622460|NCT01422876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622461|NCT01422876|Incretins|incretins|mesh-ancestor
102622462|NCT01422876|Hormones|hormones|mesh-ancestor
102622463|NCT01422876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101594784|NCT04823052|Sulindac|sulindac|mesh-list
102622464|NCT01422876|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102622465|NCT01422876|Protease Inhibitors|protease inhibitors|mesh-ancestor
102622466|NCT01422876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102622467|NCT01422876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622468|NCT01422876|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102622469|NCT01422720|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102622470|NCT01422720|Anticonvulsants|anticonvulsants|mesh-ancestor
102622471|NCT01422720|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102622472|NCT01422720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102622473|NCT01422720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102622474|NCT01422720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622475|NCT01387932|Doxorubicin|doxorubicin|mesh-list
102622476|NCT01387932|Ethiodized Oil|ethiodized oil|mesh-list
102622477|NCT01387932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102622478|NCT01387932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102622479|NCT01387932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102622480|NCT01387932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102622481|NCT01387932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102622482|NCT01387932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622483|NCT04413786|Oxytocin|oxytocin|mesh-list
102622484|NCT04413786|Oxytocics|oxytocics|mesh-ancestor
102622485|NCT04413786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102622486|NCT04413786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622487|NCT01422408|Fluocinonide|fluocinonide|mesh-list
102622488|NCT01422408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102622489|NCT01422408|Glucocorticoids|glucocorticoids|mesh-ancestor
102622490|NCT01422408|Hormones|hormones|mesh-ancestor
102622491|NCT01422408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102622492|NCT01422408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622493|NCT01422408|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102622494|NCT01387542|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102622495|NCT01387542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102622496|NCT01387542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102622497|NCT01387542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102622498|NCT01387542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622499|NCT01387542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102622500|NCT01387542|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102622501|NCT01387542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102622502|NCT01387542|Serotonin Agents|serotonin agents|mesh-ancestor
102622503|NCT01387542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102622504|NCT01387542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622505|NCT01387542|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102622506|NCT01387542|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102622507|NCT01387542|Dopamine Agents|dopamine agents|mesh-ancestor
102622508|NCT01387074|Botulinum Toxins|botulinum toxins|mesh-list
102622509|NCT01387074|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102622510|NCT01387074|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102622511|NCT01387074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102622512|NCT01387074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102622513|NCT01387074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622514|NCT01387074|Cholinergic Agents|cholinergic agents|mesh-ancestor
102622515|NCT01387074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102622516|NCT01387074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622517|NCT01387074|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102622518|NCT01387074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102622519|NCT01386606|Methyltestosterone|methyltestosterone|mesh-list
102622520|NCT01386606|Enclomiphene|enclomiphene|mesh-list
102622521|NCT01386606|Clomiphene|clomiphene|mesh-list
102622522|NCT01386606|Zuclomiphene|zuclomiphene|mesh-list
102622523|NCT01386606|Testosterone|testosterone|mesh-list
102622524|NCT01386606|Testosterone undecanoate|testosterone undecanoate|mesh-list
102622525|NCT01386606|Testosterone enanthate|testosterone enanthate|mesh-list
102622526|NCT01386606|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102622527|NCT01386606|Androgens|androgens|mesh-ancestor
102622528|NCT01386606|Hormones|hormones|mesh-ancestor
102622529|NCT01386606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102622530|NCT01386606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622531|NCT01386606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102622532|NCT01386606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102622533|NCT01386606|Anabolic Agents|anabolic agents|mesh-ancestor
102622534|NCT01386606|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102622535|NCT01386606|Hormone Antagonists|hormone antagonists|mesh-ancestor
102622536|NCT01386606|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102622537|NCT01386606|Fertility Agents|fertility agents|mesh-ancestor
102622538|NCT01386606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102622539|NCT01386606|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102622540|NCT01386606|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102622541|NCT01385748|Clonidine|clonidine|mesh-list
102622542|NCT01385748|Analgesics|analgesics|mesh-ancestor
102622543|NCT01385748|Sensory System Agents|sensory system agents|mesh-ancestor
102622544|NCT01385748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102622545|NCT01385748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622546|NCT01385748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102622547|NCT01385748|Sympatholytics|sympatholytics|mesh-ancestor
102622548|NCT01385748|Autonomic Agents|autonomic agents|mesh-ancestor
102622549|NCT01385748|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102622550|NCT01385748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102622551|NCT01385748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102622552|NCT01385748|Adrenergic Agents|adrenergic agents|mesh-ancestor
102622553|NCT01385748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102622554|NCT01385748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594871|NCT00602901|Naproxen|naproxen|mesh-list
102622555|NCT01397448|Rabeprazole|rabeprazole|mesh-list
102622556|NCT01397448|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102622557|NCT01397448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102622558|NCT01397448|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102622559|NCT01397448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102622560|NCT01397448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622561|NCT01384734|Ritonavir|ritonavir|mesh-list
102622562|NCT01384734|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102622563|NCT01384734|Tenofovir|tenofovir|mesh-list
102622564|NCT01384734|Raltegravir Potassium|raltegravir potassium|mesh-list
102622565|NCT01384734|Fostemsavir|fostemsavir|mesh-list
102622566|NCT01384734|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102622567|NCT01384734|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102622568|NCT01384734|Protease Inhibitors|protease inhibitors|mesh-ancestor
102622569|NCT01384734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102622570|NCT01384734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622571|NCT01384734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102622572|NCT01384734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102622573|NCT01384734|Antiviral Agents|antiviral agents|mesh-ancestor
102622574|NCT01384734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102622575|NCT01384734|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102622576|NCT01384734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102622577|NCT01384734|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102622578|NCT01384734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102622579|NCT01384734|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102622580|NCT01384734|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102622581|NCT01384734|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101594899|NCT02777320|Analgesics|analgesics|mesh-ancestor
102622582|NCT01384734|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102622583|NCT01396512|Vaccines|vaccines|mesh-list
102622584|NCT01396512|Immunologic Factors|immunologic factors|mesh-ancestor
101983724|NCT01165255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102622585|NCT01396512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274953|NCT00796263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102622586|NCT01396434|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102622587|NCT01396434|Immunologic Factors|immunologic factors|mesh-ancestor
102622588|NCT01396434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622589|NCT01383954|Diclofenac|diclofenac|mesh-list
102622590|NCT01383954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102622591|NCT01383954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102622592|NCT01383954|Analgesics|analgesics|mesh-ancestor
102622593|NCT01383954|Sensory System Agents|sensory system agents|mesh-ancestor
102622594|NCT01383954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102622595|NCT01383954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622596|NCT01383954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102622597|NCT01383954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102622598|NCT01383954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102622599|NCT01383954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102622600|NCT01383954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622601|NCT05365464|Progesterone|progesterone|mesh-list
102622602|NCT05365464|Progestins|progestins|mesh-ancestor
102622603|NCT05365464|Hormones|hormones|mesh-ancestor
102622604|NCT05365464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102622605|NCT05365464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622606|NCT01383486|Naproxen|naproxen|mesh-list
102622607|NCT01383486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102622608|NCT01383486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102622609|NCT01383486|Analgesics|analgesics|mesh-ancestor
102622610|NCT01383486|Sensory System Agents|sensory system agents|mesh-ancestor
102622611|NCT01383486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102622612|NCT01383486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622613|NCT01383486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102622614|NCT01383486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102622615|NCT01383486|Gout Suppressants|gout suppressants|mesh-ancestor
102622616|NCT01383486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102622617|NCT01383486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102622618|NCT01383486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622619|NCT04766736|Antibodies|antibodies|mesh-list
102622620|NCT04766736|Immunologic Factors|immunologic factors|mesh-ancestor
102622621|NCT04766736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622622|NCT01396278|Fluticasone|fluticasone|mesh-list
102622623|NCT01396278|Xhance|xhance|mesh-list
102622624|NCT01396278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102622625|NCT01396278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102622626|NCT01396278|Autonomic Agents|autonomic agents|mesh-ancestor
102622627|NCT01396278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102622628|NCT01396278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622629|NCT01396278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102622630|NCT01396278|Respiratory System Agents|respiratory system agents|mesh-ancestor
102622631|NCT01396278|Dermatologic Agents|dermatologic agents|mesh-ancestor
102622632|NCT01396278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102622633|NCT05365074|Chloroprocaine|chloroprocaine|mesh-list
102622634|NCT05365074|Anesthetics, Local|anesthetics, local|mesh-ancestor
102622635|NCT05365074|Anesthetics|anesthetics|mesh-ancestor
102622636|NCT05365074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102622637|NCT05365074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622638|NCT05365074|Sensory System Agents|sensory system agents|mesh-ancestor
102622639|NCT05365074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102622640|NCT01383096|Artefenomel|artefenomel|mesh-list
102622641|NCT01383096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102622642|NCT01383096|Antimalarials|antimalarials|mesh-ancestor
102622643|NCT01383096|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102622644|NCT01383096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102622645|NCT01383096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102622646|NCT01382940|Acetaminophen|acetaminophen|mesh-list
102622647|NCT01382940|Methylprednisolone|methylprednisolone|mesh-list
102622648|NCT01382940|Rituximab|rituximab|mesh-list
102622649|NCT01382940|Methotrexate|methotrexate|mesh-list
102622650|NCT01382940|Histamine Antagonists|histamine antagonists|mesh-list
102622651|NCT01382940|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
102622652|NCT01382940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102622653|NCT01382940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102622654|NCT01382940|Immunologic Factors|immunologic factors|mesh-ancestor
102622655|NCT01382940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622656|NCT01382940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102622657|NCT01382940|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101910946|NCT01113372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102622658|NCT01382940|Abortifacient Agents|abortifacient agents|mesh-ancestor
102622659|NCT01382940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102274954|NCT00796263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622660|NCT01382940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102622661|NCT01382940|Antimetabolites|antimetabolites|mesh-ancestor
102622662|NCT01382940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622663|NCT01382940|Dermatologic Agents|dermatologic agents|mesh-ancestor
102622664|NCT01382940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102622665|NCT01382940|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102622666|NCT01382940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102622667|NCT01382940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102622668|NCT01382940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102622670|NCT01382940|Sensory System Agents|sensory system agents|mesh-ancestor
102622671|NCT01382940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102622672|NCT01382940|Antipyretics|antipyretics|mesh-ancestor
102622673|NCT01382940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102622674|NCT01382940|Antiemetics|antiemetics|mesh-ancestor
102622675|NCT01382940|Autonomic Agents|autonomic agents|mesh-ancestor
102622676|NCT01382940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102622677|NCT01382940|Glucocorticoids|glucocorticoids|mesh-ancestor
102622678|NCT01382940|Hormones|hormones|mesh-ancestor
102622679|NCT01382940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102622680|NCT01382940|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102622681|NCT01382940|Protective Agents|protective agents|mesh-ancestor
102622682|NCT01382940|Histamine Agents|histamine agents|mesh-ancestor
102622683|NCT01382940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102622684|NCT01381926|Exenatide|exenatide|mesh-list
102622685|NCT01381926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102622686|NCT01381926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622687|NCT01381926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102622688|NCT01381926|Incretins|incretins|mesh-ancestor
102622689|NCT01381926|Hormones|hormones|mesh-ancestor
102622690|NCT01381926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102622691|NCT01395888|Fluticasone|fluticasone|mesh-list
102622692|NCT01395888|Xhance|xhance|mesh-list
102622693|NCT01395888|Tiotropium Bromide|tiotropium bromide|mesh-list
102622694|NCT01395888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102622695|NCT01395888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102622696|NCT01395888|Autonomic Agents|autonomic agents|mesh-ancestor
102622697|NCT01395888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102622698|NCT01395888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622699|NCT01395888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102622700|NCT01395888|Respiratory System Agents|respiratory system agents|mesh-ancestor
102622701|NCT01395888|Dermatologic Agents|dermatologic agents|mesh-ancestor
102622702|NCT01395888|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102622703|NCT01395888|Parasympatholytics|parasympatholytics|mesh-ancestor
102622704|NCT01395888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102622705|NCT01395888|Cholinergic Agents|cholinergic agents|mesh-ancestor
102622706|NCT01395888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102622707|NCT01395888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622708|NCT01381692|Sirolimus|sirolimus|mesh-list
102622709|NCT01381692|Dexamethasone|dexamethasone|mesh-list
102622710|NCT01381692|Dexamethasone acetate|dexamethasone acetate|mesh-list
102622711|NCT01381692|Rituximab|rituximab|mesh-list
102622712|NCT01381692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102622713|NCT01381692|Bortezomib|bortezomib|mesh-list
102622714|NCT01381692|Temsirolimus|temsirolimus|mesh-list
102622715|NCT01381692|MTOR Inhibitors|mtor inhibitors|mesh-list
102622716|NCT01381692|Antibodies|antibodies|mesh-list
102622717|NCT01381692|Immunoglobulins|immunoglobulins|mesh-list
102622718|NCT01381692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102622719|NCT01381692|BB 1101|bb 1101|mesh-list
102622720|NCT01381692|Immunologic Factors|immunologic factors|mesh-ancestor
102622721|NCT01381692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622722|NCT01381692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102622723|NCT01381692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102622724|NCT01381692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102622725|NCT01381692|Antiemetics|antiemetics|mesh-ancestor
102622726|NCT01381692|Autonomic Agents|autonomic agents|mesh-ancestor
102622727|NCT01381692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102622728|NCT01381692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102622729|NCT01381692|Glucocorticoids|glucocorticoids|mesh-ancestor
102622730|NCT01381692|Hormones|hormones|mesh-ancestor
102622731|NCT01381692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102622732|NCT01381692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102622733|NCT01381692|Protease Inhibitors|protease inhibitors|mesh-ancestor
102622734|NCT01381692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102622735|NCT01381692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622736|NCT01381692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102274955|NCT00796263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102622737|NCT01381692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102622738|NCT01381692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102622739|NCT01381692|Antifungal Agents|antifungal agents|mesh-ancestor
102622740|NCT01381692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102622741|NCT01381692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102622742|NCT01395030|Choline|choline|mesh-list
102622743|NCT01395030|Lipotropic Agents|lipotropic agents|mesh-ancestor
102622744|NCT01395030|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102622745|NCT01395030|Antimetabolites|antimetabolites|mesh-ancestor
102622746|NCT01395030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622747|NCT01395030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102622748|NCT01395030|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102622749|NCT01395030|Nootropic Agents|nootropic agents|mesh-ancestor
102622750|NCT01394952|Dulaglutide|dulaglutide|mesh-list
102622751|NCT01394952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102622752|NCT01394952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622753|NCT01394718|Acetaminophen|acetaminophen|mesh-list
102622754|NCT01394718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102622755|NCT01394718|Analgesics|analgesics|mesh-ancestor
102622756|NCT01394718|Sensory System Agents|sensory system agents|mesh-ancestor
102622757|NCT01394718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102622758|NCT01394718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622759|NCT01394718|Antipyretics|antipyretics|mesh-ancestor
102622760|NCT01394250|Lidocaine|lidocaine|mesh-list
102622761|NCT01394250|Anesthetics, Local|anesthetics, local|mesh-ancestor
102622762|NCT01394250|Anesthetics|anesthetics|mesh-ancestor
102622763|NCT01394250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102622764|NCT01394250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622765|NCT01394250|Sensory System Agents|sensory system agents|mesh-ancestor
102622766|NCT01394250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102622767|NCT01394250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102622768|NCT01394250|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102622769|NCT01394250|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102622770|NCT01394250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102622771|NCT01394250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622772|NCT01380990|Busulfan|busulfan|mesh-list
102622773|NCT01380990|Alkylating Agents|alkylating agents|mesh-ancestor
102622774|NCT01380990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622775|NCT01380990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102622776|NCT01380990|Immunologic Factors|immunologic factors|mesh-ancestor
102622777|NCT01380990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622778|NCT01380990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102622779|NCT01380990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102622780|NCT01380990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102622781|NCT05361330|Fluoxetine|fluoxetine|mesh-list
102622782|NCT05361330|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102622783|NCT05361330|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102622784|NCT05361330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102622785|NCT05361330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622786|NCT05361330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102622787|NCT05361330|Serotonin Agents|serotonin agents|mesh-ancestor
101595087|NCT02775370|Apatinib|apatinib|mesh-list
102622788|NCT05361330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622789|NCT05361330|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102622790|NCT05361330|Antidepressive Agents|antidepressive agents|mesh-ancestor
102622791|NCT05361330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102622792|NCT05361330|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102622793|NCT05361330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102622794|NCT05361330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102622795|NCT00214968|Modafinil|modafinil|mesh-list
102622796|NCT00214968|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102622797|NCT00214968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622798|NCT00214968|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102622799|NCT00214968|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102622800|NCT00214968|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102622801|NCT00214968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622802|NCT03592212|Albuterol|albuterol|mesh-list
102622803|NCT03592212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102622804|NCT03592212|Autonomic Agents|autonomic agents|mesh-ancestor
102622805|NCT03592212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102622806|NCT03592212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274956|NCT00796263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102274957|NCT00796263|Antiviral Agents|antiviral agents|mesh-ancestor
102622807|NCT03592212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102622808|NCT03592212|Respiratory System Agents|respiratory system agents|mesh-ancestor
102622809|NCT03592212|Tocolytic Agents|tocolytic agents|mesh-ancestor
102622810|NCT03592212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102622811|NCT03592212|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102622812|NCT03592212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102622813|NCT03592212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102622814|NCT03592212|Adrenergic Agents|adrenergic agents|mesh-ancestor
102622815|NCT03592212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101595132|NCT02776540|Antipyretics|antipyretics|mesh-ancestor
102622816|NCT03592212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622817|NCT03024450|Trastuzumab|trastuzumab|mesh-list
102622818|NCT03024450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102622819|NCT03024450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102622820|NCT04263090|Nivolumab|nivolumab|mesh-list
102622821|NCT04263090|ON 01910|on 01910|mesh-list
102622822|NCT04263090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102622823|NCT04263090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102622824|NCT04263090|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102622825|NCT04263090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622826|NCT04263090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102622827|NCT04263090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102622828|NCT05630274|Moxifloxacin|moxifloxacin|mesh-list
102622829|NCT05630274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102622830|NCT05630274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102622831|NCT05630274|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102622832|NCT05630274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102622833|NCT05630274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102622834|NCT05630274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622835|NCT05630274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102622836|NCT05632692|Menthol|menthol|mesh-list
102622837|NCT05632692|Antipruritics|antipruritics|mesh-ancestor
102622838|NCT05632692|Dermatologic Agents|dermatologic agents|mesh-ancestor
102622839|NCT03594162|Cyclophosphamide|cyclophosphamide|mesh-list
102622840|NCT03594162|Fludarabine|fludarabine|mesh-list
102622841|NCT03594162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102622842|NCT03594162|Immunologic Factors|immunologic factors|mesh-ancestor
102622843|NCT03594162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622844|NCT03594162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102622845|NCT03594162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102622846|NCT03594162|Alkylating Agents|alkylating agents|mesh-ancestor
102622847|NCT03594162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622848|NCT03594162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102622849|NCT03594162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102622850|NCT04407312|Aspirin|aspirin|mesh-list
102622851|NCT04407312|Cilostazol|cilostazol|mesh-list
102622852|NCT04407312|Clopidogrel|clopidogrel|mesh-list
102622853|NCT04407312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102622854|NCT04407312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102622855|NCT04407312|Analgesics|analgesics|mesh-ancestor
102622856|NCT04407312|Sensory System Agents|sensory system agents|mesh-ancestor
102622857|NCT04407312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102622858|NCT04407312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622859|NCT04407312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102622860|NCT04407312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102622861|NCT04407312|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102622862|NCT04407312|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102622863|NCT04407312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595187|NCT02772640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102622864|NCT04407312|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102622865|NCT04407312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102622866|NCT04407312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102622867|NCT04407312|Antipyretics|antipyretics|mesh-ancestor
102622868|NCT04407312|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102622869|NCT04407312|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102622870|NCT04407312|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102622871|NCT04407312|Purinergic Agents|purinergic agents|mesh-ancestor
102622872|NCT04407312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102622873|NCT04407312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102622874|NCT04407312|Autonomic Agents|autonomic agents|mesh-ancestor
102622875|NCT04407312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102622876|NCT04407312|Respiratory System Agents|respiratory system agents|mesh-ancestor
102622877|NCT04407312|Vasodilator Agents|vasodilator agents|mesh-ancestor
102622878|NCT04407312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102622879|NCT04407312|Protective Agents|protective agents|mesh-ancestor
102622880|NCT04407312|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102622881|NCT04407312|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102622882|NCT04326738|Midazolam|midazolam|mesh-list
102622883|NCT04326738|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102622884|NCT04326738|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102622885|NCT04326738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102622886|NCT04326738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622887|NCT04326738|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102622888|NCT04326738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102622889|NCT04326738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102622890|NCT04326738|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102622891|NCT04326738|Anesthetics, General|anesthetics, general|mesh-ancestor
102622892|NCT04326738|Anesthetics|anesthetics|mesh-ancestor
102622893|NCT04326738|GABA Modulators|gaba modulators|mesh-ancestor
102622894|NCT04326738|GABA Agents|gaba agents|mesh-ancestor
102622895|NCT04326738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102622896|NCT04326738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622897|NCT04347486|Atropine|atropine|mesh-list
102622898|NCT04347486|Neostigmine|neostigmine|mesh-list
102622899|NCT04347486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102622900|NCT04347486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102622901|NCT04347486|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102622902|NCT04347486|Autonomic Agents|autonomic agents|mesh-ancestor
102622903|NCT04347486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102622904|NCT04347486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622905|NCT04347486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102622906|NCT04347486|Respiratory System Agents|respiratory system agents|mesh-ancestor
102622907|NCT04347486|Mydriatics|mydriatics|mesh-ancestor
102622908|NCT04347486|Parasympatholytics|parasympatholytics|mesh-ancestor
102622909|NCT04347486|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102622910|NCT04347486|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102622911|NCT04347486|Cholinergic Agents|cholinergic agents|mesh-ancestor
102622912|NCT04347486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102622913|NCT04347486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622914|NCT04347486|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102622915|NCT04347486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102622916|NCT04347486|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102622917|NCT04407234|Acetaminophen|acetaminophen|mesh-list
102622918|NCT04407234|Tirzepatide|tirzepatide|mesh-list
102622919|NCT04407234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102622920|NCT04407234|Analgesics|analgesics|mesh-ancestor
102622921|NCT04407234|Sensory System Agents|sensory system agents|mesh-ancestor
102622922|NCT04407234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102622923|NCT04407234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622924|NCT04407234|Antipyretics|antipyretics|mesh-ancestor
102622925|NCT04407234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102622926|NCT04407234|Incretins|incretins|mesh-ancestor
102622927|NCT04407234|Hormones|hormones|mesh-ancestor
102622928|NCT04407234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102622929|NCT05632224|Aprepitant|aprepitant|mesh-list
102622930|NCT05632224|Granisetron|granisetron|mesh-list
102622931|NCT05632224|Antiemetics|antiemetics|mesh-ancestor
102622932|NCT05632224|Autonomic Agents|autonomic agents|mesh-ancestor
102622933|NCT05632224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102622934|NCT05632224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622935|NCT05632224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102622936|NCT05632224|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102622937|NCT05632224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102622938|NCT05632224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622939|NCT05632224|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102622940|NCT05632224|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102622941|NCT05632224|Serotonin Agents|serotonin agents|mesh-ancestor
102622942|NCT03024840|Propofol|propofol|mesh-list
102622943|NCT03024840|Sevoflurane|sevoflurane|mesh-list
102622944|NCT03024840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102622945|NCT03024840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102622946|NCT03024840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622947|NCT03024840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102622948|NCT03024840|Anesthetics, General|anesthetics, general|mesh-ancestor
102622949|NCT03024840|Anesthetics|anesthetics|mesh-ancestor
102622950|NCT03024840|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102622951|NCT03024840|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101595274|NCT02770378|Ritonavir|ritonavir|mesh-list
102622952|NCT05631678|Itraconazole|itraconazole|mesh-list
102622953|NCT05631678|Rifampin|rifampin|mesh-list
102622954|NCT05631678|Antifungal Agents|antifungal agents|mesh-ancestor
102622955|NCT05631678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102622956|NCT05631678|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102622957|NCT05631678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102622958|NCT05631678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102622959|NCT05631678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622960|NCT05631678|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102622961|NCT05631678|Hormone Antagonists|hormone antagonists|mesh-ancestor
102622962|NCT05631678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102622963|NCT05631678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622964|NCT05631678|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102622965|NCT05631678|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102622966|NCT05631678|Antitubercular Agents|antitubercular agents|mesh-ancestor
102622967|NCT05631678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102622968|NCT05631678|Leprostatic Agents|leprostatic agents|mesh-ancestor
102622969|NCT05631678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102622970|NCT05631678|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102622971|NCT05631678|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102622972|NCT05631678|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102622973|NCT05631678|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101595300|NCT02770378|Analgesics|analgesics|mesh-ancestor
102622974|NCT05631678|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102622975|NCT05631678|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102622976|NCT03599778|Apatinib|apatinib|mesh-list
102622977|NCT03599778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102622978|NCT03599778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102622979|NCT03599778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102622980|NCT03599778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622981|NCT04008264|Scopolamine|scopolamine|mesh-list
102622982|NCT04008264|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102622983|NCT04008264|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102622984|NCT04008264|Antiemetics|antiemetics|mesh-ancestor
102622985|NCT04008264|Autonomic Agents|autonomic agents|mesh-ancestor
102622986|NCT04008264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102622987|NCT04008264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102622988|NCT04008264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102622989|NCT04008264|Mydriatics|mydriatics|mesh-ancestor
102622990|NCT04008264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102622991|NCT04008264|Cholinergic Agents|cholinergic agents|mesh-ancestor
102622992|NCT04008264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102622993|NCT04008264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102622994|NCT04008264|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102622995|NCT04008264|Parasympatholytics|parasympatholytics|mesh-ancestor
102622996|NCT03595254|Nicotine|nicotine|mesh-list
102622997|NCT03595254|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102622998|NCT03595254|Autonomic Agents|autonomic agents|mesh-ancestor
102622999|NCT03595254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102623000|NCT03595254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623001|NCT03595254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102623002|NCT03595254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102623003|NCT03595254|Cholinergic Agents|cholinergic agents|mesh-ancestor
102623004|NCT03595254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102623005|NCT03595254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623006|NCT03599466|Lisinopril|lisinopril|mesh-list
102623007|NCT03599466|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102623008|NCT03599466|Protease Inhibitors|protease inhibitors|mesh-ancestor
102623009|NCT03599466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102623010|NCT03599466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623011|NCT03599466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102623012|NCT03599466|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102623013|NCT03599466|Protective Agents|protective agents|mesh-ancestor
102623014|NCT03599466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623015|NCT03986970|Tenofovir|tenofovir|mesh-list
102623016|NCT03986970|Emtricitabine|emtricitabine|mesh-list
102623017|NCT03986970|Antiviral Agents|antiviral agents|mesh-ancestor
102623018|NCT03986970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102623019|NCT03986970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102623020|NCT03986970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102623021|NCT03986970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102623022|NCT03986970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623023|NCT03986970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102623024|NCT03986970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102623025|NCT03594396|Durvalumab|durvalumab|mesh-list
102623026|NCT03594396|Olaparib|olaparib|mesh-list
102623027|NCT03594396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102623028|NCT03594396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274959|NCT00715442|Sunitinib|sunitinib|mesh-list
101911394|NCT01373632|Sirolimus|sirolimus|mesh-list
102623029|NCT03594396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102623030|NCT03594396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102623031|NCT03594396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623032|NCT03594240|Folic Acid|folic acid|mesh-list
102623033|NCT03594240|Vitamin B Complex|vitamin b complex|mesh-list
102623034|NCT03594240|Vitamins|vitamins|mesh-ancestor
102623035|NCT03594240|Micronutrients|micronutrients|mesh-ancestor
102623036|NCT03594240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623037|NCT03594240|Hematinics|hematinics|mesh-ancestor
102623038|NCT03976362|Paclitaxel|paclitaxel|mesh-list
102623039|NCT03976362|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102623040|NCT03976362|Carboplatin|carboplatin|mesh-list
102623041|NCT03976362|Pembrolizumab|pembrolizumab|mesh-list
102623042|NCT03976362|Olaparib|olaparib|mesh-list
102623043|NCT03976362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102623044|NCT03976362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102623045|NCT03976362|Tubulin Modulators|tubulin modulators|mesh-ancestor
102623046|NCT03976362|Antimitotic Agents|antimitotic agents|mesh-ancestor
102623047|NCT03976362|Mitosis Modulators|mitosis modulators|mesh-ancestor
102623048|NCT03976362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623049|NCT03976362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102623050|NCT03976362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102623051|NCT03976362|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102623052|NCT03976362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102623053|NCT03598374|Folic Acid|folic acid|mesh-list
102623054|NCT03598374|Vitamin B Complex|vitamin b complex|mesh-list
102623055|NCT03598374|Inositol|inositol|mesh-list
102623056|NCT03598374|Hematinics|hematinics|mesh-ancestor
102623057|NCT03598374|Vitamins|vitamins|mesh-ancestor
102623058|NCT03598374|Micronutrients|micronutrients|mesh-ancestor
102623059|NCT03598374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623060|NCT04407078|Neostigmine|neostigmine|mesh-list
102623061|NCT04407078|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102623062|NCT04407078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102623063|NCT04407078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623064|NCT04407078|Cholinergic Agents|cholinergic agents|mesh-ancestor
102623065|NCT04407078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102623066|NCT04407078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623067|NCT04407078|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102623068|NCT04407078|Autonomic Agents|autonomic agents|mesh-ancestor
102623069|NCT04407078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102623070|NCT00217620|Sorafenib|sorafenib|mesh-list
102623071|NCT00217620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102623072|NCT00217620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102623073|NCT00217620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102623074|NCT00217620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623075|NCT00217464|Fulvestrant|fulvestrant|mesh-list
102623076|NCT00217464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102623077|NCT00217464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102623078|NCT00217464|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102623079|NCT00217464|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102623080|NCT00217464|Hormone Antagonists|hormone antagonists|mesh-ancestor
102623081|NCT00217464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102623082|NCT00217464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623083|NCT03597282|Nivolumab|nivolumab|mesh-list
102623084|NCT03597282|Ipilimumab|ipilimumab|mesh-list
102623085|NCT03597282|Poly ICLC|poly iclc|mesh-list
102623086|NCT03597282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102623087|NCT03597282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102623088|NCT03597282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102623089|NCT03597282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623090|NCT03597282|Interferon Inducers|interferon inducers|mesh-ancestor
102623091|NCT03597282|Immunologic Factors|immunologic factors|mesh-ancestor
102623092|NCT03597282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623093|NCT03593304|Vitamins|vitamins|mesh-list
102623094|NCT03593304|Vitamin B 12|vitamin b 12|mesh-list
102623095|NCT03593304|Pyridoxine|pyridoxine|mesh-list
102623096|NCT03593304|Pyridoxal|pyridoxal|mesh-list
102623097|NCT03593304|Vitamin B 6|vitamin b 6|mesh-list
102623098|NCT03593304|Vitamin B Complex|vitamin b complex|mesh-list
102623099|NCT03593304|Micronutrients|micronutrients|mesh-ancestor
102623100|NCT03593304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623101|NCT00211536|Insulin|insulin|mesh-list
102623102|NCT00211536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102623103|NCT00211536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102623104|NCT00211536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623105|NCT03596970|Everolimus|everolimus|mesh-list
102623106|NCT03596970|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102623107|NCT03596970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102623108|NCT03596970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102623109|NCT03596970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623110|NCT03596970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102623111|NCT03596970|Immunologic Factors|immunologic factors|mesh-ancestor
102623112|NCT03596970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623113|NCT03596970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102623114|NCT03596892|Cyclophosphamide|cyclophosphamide|mesh-list
102623115|NCT03596892|Busulfan|busulfan|mesh-list
102623116|NCT03596892|Decitabine|decitabine|mesh-list
102623117|NCT03596892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101595431|NCT00580047|Vitamin D|vitamin d|mesh-list
102623118|NCT03596892|Immunologic Factors|immunologic factors|mesh-ancestor
102623119|NCT03596892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623120|NCT03596892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102623121|NCT03596892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102623122|NCT03596892|Alkylating Agents|alkylating agents|mesh-ancestor
102623123|NCT03596892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623124|NCT03596892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102623125|NCT03596892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102623126|NCT03596892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102623127|NCT03596892|Antimetabolites|antimetabolites|mesh-ancestor
102623128|NCT03596892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102623129|NCT03592836|Furosemide|furosemide|mesh-list
102623130|NCT03592836|Diuretics|diuretics|mesh-list
102623131|NCT03592836|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
102623132|NCT03592836|Natriuretic Agents|natriuretic agents|mesh-ancestor
102623133|NCT03592836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623134|NCT03592836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102623135|NCT03592836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623136|NCT03596502|Warfarin|warfarin|mesh-list
102623137|NCT03596502|Anticoagulants|anticoagulants|mesh-list
102623138|NCT04197570|Analgesics, Opioid|analgesics, opioid|mesh-list
102623139|NCT04197570|Analgesics|analgesics|mesh-list
102623140|NCT04197570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
102623141|NCT04197570|Anesthetics|anesthetics|mesh-list
102623142|NCT04197570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102623143|NCT04197570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623144|NCT04197570|Narcotics|narcotics|mesh-ancestor
102623145|NCT04197570|Sensory System Agents|sensory system agents|mesh-ancestor
102623146|NCT04197570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102623147|NCT04197882|Molgramostim|molgramostim|mesh-list
102623148|NCT04197882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102623149|NCT03024060|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102623150|NCT03024060|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102623151|NCT03024060|Dermatologic Agents|dermatologic agents|mesh-ancestor
102623152|NCT03024216|Atezolizumab|atezolizumab|mesh-list
102623153|NCT03024216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102623154|NCT03024216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623155|NCT03024216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102623156|NCT03024216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102623157|NCT03981744|Ustekinumab|ustekinumab|mesh-list
102623158|NCT03981744|Dermatologic Agents|dermatologic agents|mesh-ancestor
102623159|NCT03591900|Insulin|insulin|mesh-list
102623160|NCT03591900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102623161|NCT03591900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623162|NCT03591744|Dexamethasone|dexamethasone|mesh-list
102623163|NCT03591744|Dexamethasone acetate|dexamethasone acetate|mesh-list
102623164|NCT03591744|Doxorubicin|doxorubicin|mesh-list
102623165|NCT03591744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102623166|NCT03591744|Lenalidomide|lenalidomide|mesh-list
102623167|NCT03591744|Bortezomib|bortezomib|mesh-list
102623168|NCT03591744|Daratumumab|daratumumab|mesh-list
102623169|NCT03591744|Ichthammol|ichthammol|mesh-list
102623170|NCT03591744|BB 1101|bb 1101|mesh-list
102623171|NCT03591744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102623172|NCT03591744|Antiemetics|antiemetics|mesh-ancestor
102623173|NCT03591744|Autonomic Agents|autonomic agents|mesh-ancestor
102623174|NCT03591744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102623175|NCT03591744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623176|NCT03591744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102623177|NCT03591744|Glucocorticoids|glucocorticoids|mesh-ancestor
102623178|NCT03591744|Hormones|hormones|mesh-ancestor
102623179|NCT03591744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102623180|NCT03591744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101911468|NCT01319734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102623181|NCT03591744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102623182|NCT03591744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102623183|NCT03591744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102623184|NCT03591744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102623185|NCT03591744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102623186|NCT03591744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623187|NCT03591744|Immunologic Factors|immunologic factors|mesh-ancestor
102623188|NCT03591744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102623189|NCT03591744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102623190|NCT03591744|Growth Substances|growth substances|mesh-ancestor
102623191|NCT03591744|Growth Inhibitors|growth inhibitors|mesh-ancestor
102623192|NCT03591744|Protease Inhibitors|protease inhibitors|mesh-ancestor
102623193|NCT03591744|Dermatologic Agents|dermatologic agents|mesh-ancestor
102623194|NCT04196946|Fentanyl|fentanyl|mesh-list
102623195|NCT04196946|Alfentanil|alfentanil|mesh-list
102623196|NCT04196946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102623197|NCT04196946|Narcotics|narcotics|mesh-ancestor
102623198|NCT04196946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102623199|NCT04196946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623200|NCT04196946|Analgesics|analgesics|mesh-ancestor
102623201|NCT04196946|Sensory System Agents|sensory system agents|mesh-ancestor
102623202|NCT04196946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102623203|NCT04196946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102623204|NCT04196946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102623205|NCT04196946|Anesthetics, General|anesthetics, general|mesh-ancestor
102623206|NCT04196946|Anesthetics|anesthetics|mesh-ancestor
102623207|NCT03023904|Nivolumab|nivolumab|mesh-list
102623208|NCT03023904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102623209|NCT03023904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102623210|NCT03023904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102623211|NCT03023904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623212|NCT04196010|Cytarabine|cytarabine|mesh-list
102623213|NCT04196010|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
102623214|NCT04196010|Mitoxantrone|mitoxantrone|mesh-list
102623215|NCT04196010|Cladribine|cladribine|mesh-list
102623216|NCT04196010|Lenograstim|lenograstim|mesh-list
102623217|NCT04196010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102623218|NCT04196010|Antimetabolites|antimetabolites|mesh-ancestor
102623219|NCT04196010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623220|NCT04196010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102623221|NCT04196010|Antiviral Agents|antiviral agents|mesh-ancestor
102623222|NCT04196010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102623223|NCT04196010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102623224|NCT04196010|Immunologic Factors|immunologic factors|mesh-ancestor
102623225|NCT04196010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623226|NCT04196010|Analgesics|analgesics|mesh-ancestor
102623227|NCT04196010|Sensory System Agents|sensory system agents|mesh-ancestor
102623228|NCT04196010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102623229|NCT04196010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102623230|NCT04196010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102623231|NCT04196010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102623232|NCT04196010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102623233|NCT04196400|Betamethasone|betamethasone|mesh-list
102623234|NCT04196400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102623235|NCT04196400|Glucocorticoids|glucocorticoids|mesh-ancestor
102623236|NCT04196400|Hormones|hormones|mesh-ancestor
102623237|NCT04196400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102623238|NCT04196400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623239|NCT04196400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102623240|NCT04196400|Respiratory System Agents|respiratory system agents|mesh-ancestor
102623241|NCT03023436|Fluorouracil|fluorouracil|mesh-list
102623242|NCT03023436|Capecitabine|capecitabine|mesh-list
102623243|NCT03023436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102623244|NCT03023436|Antimetabolites|antimetabolites|mesh-ancestor
102623245|NCT03023436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623246|NCT03023436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102623247|NCT03023436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102623248|NCT03023436|Immunologic Factors|immunologic factors|mesh-ancestor
102623249|NCT03023436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623250|NCT04195074|Tenofovir|tenofovir|mesh-list
102623251|NCT04195074|Entecavir|entecavir|mesh-list
102623252|NCT04195074|Antiviral Agents|antiviral agents|mesh-ancestor
102623253|NCT04195074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102623254|NCT04195074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102623255|NCT04195074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102623256|NCT04195074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102623257|NCT04195074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623258|NCT04195074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102274960|NCT00715442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102623259|NCT04195074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102623260|NCT03590262|Metformin|metformin|mesh-list
102623261|NCT03590262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102623262|NCT03590262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623263|NCT04029636|Xenon|xenon|mesh-list
102623264|NCT04029636|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102623265|NCT04029636|Anesthetics, General|anesthetics, general|mesh-ancestor
102623266|NCT04029636|Anesthetics|anesthetics|mesh-ancestor
102623267|NCT04029636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102623268|NCT04029636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623269|NCT04194684|Paclitaxel|paclitaxel|mesh-list
102623270|NCT04194684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102623271|NCT04194684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102623272|NCT04194684|Tubulin Modulators|tubulin modulators|mesh-ancestor
102623273|NCT04194684|Antimitotic Agents|antimitotic agents|mesh-ancestor
102623274|NCT04194684|Mitosis Modulators|mitosis modulators|mesh-ancestor
102623275|NCT04194684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623276|NCT04194294|Lidocaine|lidocaine|mesh-list
102623277|NCT04194294|Anesthetics, Local|anesthetics, local|mesh-ancestor
102623278|NCT04194294|Anesthetics|anesthetics|mesh-ancestor
102623279|NCT04194294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102623280|NCT04194294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623281|NCT04194294|Sensory System Agents|sensory system agents|mesh-ancestor
102623282|NCT04194294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102623283|NCT04194294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102623284|NCT04194294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102623285|NCT04194294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102623286|NCT04194294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102623287|NCT04194294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623288|NCT04029090|Edaravone|edaravone|mesh-list
102623289|NCT04029090|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102623290|NCT04029090|Antioxidants|antioxidants|mesh-ancestor
102623291|NCT04029090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623292|NCT04029090|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102623293|NCT04029090|Protective Agents|protective agents|mesh-ancestor
102623294|NCT04029090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623295|NCT04194216|Clindamycin|clindamycin|mesh-list
102623296|NCT04194216|Clindamycin palmitate|clindamycin palmitate|mesh-list
102623297|NCT04194216|Clindamycin phosphate|clindamycin phosphate|mesh-list
102623298|NCT04194216|Cephalexin|cephalexin|mesh-list
102623299|NCT04194216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102623300|NCT04194216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102623301|NCT04194216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102623302|NCT04194216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102623303|NCT04194216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623304|NCT04193982|Vitamin E|vitamin e|mesh-list
102623305|NCT04193982|Vitamins|vitamins|mesh-ancestor
102623306|NCT04193982|Micronutrients|micronutrients|mesh-ancestor
102623307|NCT04193982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623308|NCT04193982|Antioxidants|antioxidants|mesh-ancestor
102623309|NCT04193982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623310|NCT04193982|Protective Agents|protective agents|mesh-ancestor
102623311|NCT04028778|Gefitinib|gefitinib|mesh-list
102623312|NCT04028778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102623313|NCT04028778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102623314|NCT04028778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102623315|NCT04028778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623316|NCT04028856|Interferons|interferons|mesh-list
102623317|NCT04028856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102623318|NCT04028856|Antiviral Agents|antiviral agents|mesh-ancestor
102623319|NCT04028856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102623320|NCT03594474|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102623321|NCT03594474|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
102274961|NCT00715442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102274962|NCT00715442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102274963|NCT00715442|Growth Substances|growth substances|mesh-ancestor
102274964|NCT00715442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274965|NCT00715442|Growth Inhibitors|growth inhibitors|mesh-ancestor
102274966|NCT00715442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102274967|NCT00715442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102274968|NCT00715442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274969|NCT00697684|Clofarabine|clofarabine|mesh-list
102274970|NCT00697684|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102623322|NCT03594474|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102274971|NCT00697684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102623323|NCT03594474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102623324|NCT04193592|Pirfenidone|pirfenidone|mesh-list
102623325|NCT04193592|Analgesics|analgesics|mesh-ancestor
102623326|NCT04193592|Sensory System Agents|sensory system agents|mesh-ancestor
102623327|NCT04193592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102623328|NCT04193592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623329|NCT04193592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102623330|NCT04193592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102623331|NCT04193592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102623332|NCT04193592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102623333|NCT04193592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102623334|NCT03933384|Tenofovir|tenofovir|mesh-list
102623335|NCT03933384|Entecavir|entecavir|mesh-list
102623336|NCT03933384|Antiviral Agents|antiviral agents|mesh-ancestor
102623337|NCT03933384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102623338|NCT03933384|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102623339|NCT03933384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102623340|NCT03933384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102623341|NCT03933384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623342|NCT03933384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102623343|NCT03933384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102623344|NCT04028466|Omeprazole|omeprazole|mesh-list
102623345|NCT04028466|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102623346|NCT04028466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102623347|NCT04028466|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102623348|NCT04028466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102623349|NCT04028466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623350|NCT04027764|Paclitaxel|paclitaxel|mesh-list
102623351|NCT04027764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102623352|NCT04027764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102623353|NCT04027764|Tubulin Modulators|tubulin modulators|mesh-ancestor
102623354|NCT04027764|Antimitotic Agents|antimitotic agents|mesh-ancestor
102623355|NCT04027764|Mitosis Modulators|mitosis modulators|mesh-ancestor
102623356|NCT04027764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623357|NCT04027530|Ertugliflozin|ertugliflozin|mesh-list
102623358|NCT04027530|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102623359|NCT04027530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623360|NCT04027530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102623361|NCT04027530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623362|NCT03023358|Prednisone|prednisone|mesh-list
102623363|NCT03023358|Cyclophosphamide|cyclophosphamide|mesh-list
102623364|NCT03023358|Doxorubicin|doxorubicin|mesh-list
102623365|NCT03023358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102623366|NCT03023358|Vincristine|vincristine|mesh-list
102623367|NCT03023358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102623368|NCT03023358|Immunologic Factors|immunologic factors|mesh-ancestor
102623369|NCT03023358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623370|NCT03023358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102623371|NCT03023358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102623372|NCT03023358|Alkylating Agents|alkylating agents|mesh-ancestor
102623373|NCT03023358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623374|NCT03023358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102623375|NCT03023358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102623376|NCT03023358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102623377|NCT03023358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102623378|NCT03023358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102623379|NCT03023358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102623380|NCT03023358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102623381|NCT03023358|Glucocorticoids|glucocorticoids|mesh-ancestor
102623382|NCT03023358|Hormones|hormones|mesh-ancestor
102623383|NCT03023358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102623384|NCT03023358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102623385|NCT03023358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102623386|NCT03023358|Tubulin Modulators|tubulin modulators|mesh-ancestor
102623387|NCT03023358|Antimitotic Agents|antimitotic agents|mesh-ancestor
102623388|NCT03023358|Mitosis Modulators|mitosis modulators|mesh-ancestor
102623389|NCT04192812|Leuprolide|leuprolide|mesh-list
102623390|NCT04192812|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102623391|NCT04192812|Fertility Agents|fertility agents|mesh-ancestor
102623392|NCT04192812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102623393|NCT04192812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623394|NCT04192812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102623395|NCT04192812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274972|NCT00697684|Antimetabolites|antimetabolites|mesh-ancestor
101595723|NCT05655728|Metformin|metformin|mesh-list
102623396|NCT04407000|Favipiravir|favipiravir|mesh-list
102623397|NCT04407000|Antiviral Agents|antiviral agents|mesh-ancestor
102623398|NCT04407000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102623399|NCT04192656|Methylprednisolone|methylprednisolone|mesh-list
102623400|NCT04192656|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102623401|NCT04192656|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102623402|NCT04192656|Prednisolone|prednisolone|mesh-list
102623403|NCT04192656|Prednisolone acetate|prednisolone acetate|mesh-list
102623404|NCT04192656|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102623405|NCT04192656|Prednisolone phosphate|prednisolone phosphate|mesh-list
102623406|NCT04192656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102623407|NCT04192656|Antiemetics|antiemetics|mesh-ancestor
102623408|NCT04192656|Autonomic Agents|autonomic agents|mesh-ancestor
102623409|NCT04192656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102623410|NCT04192656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623411|NCT04192656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102623412|NCT04192656|Glucocorticoids|glucocorticoids|mesh-ancestor
102623413|NCT04192656|Hormones|hormones|mesh-ancestor
102623414|NCT04192656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102623415|NCT04192656|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102623416|NCT04192656|Protective Agents|protective agents|mesh-ancestor
102623417|NCT04192656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102623418|NCT04192656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102623419|NCT04191954|Fasudil|fasudil|mesh-list
102623420|NCT04191954|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102623421|NCT04191954|Lubricant Eye Drops|lubricant eye drops|mesh-list
102623422|NCT04191954|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102623423|NCT04191954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102623424|NCT04191954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102623425|NCT04191954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623426|NCT04191954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102623427|NCT04191954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623428|NCT04191954|Vasodilator Agents|vasodilator agents|mesh-ancestor
102623429|NCT04191954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102623430|NCT04191954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102623431|NCT04192032|Nicotine|nicotine|mesh-list
102623432|NCT04192032|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102623433|NCT04192032|Autonomic Agents|autonomic agents|mesh-ancestor
102623434|NCT04192032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102623435|NCT04192032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623436|NCT04192032|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102623437|NCT04192032|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102623438|NCT04192032|Cholinergic Agents|cholinergic agents|mesh-ancestor
102623439|NCT04192032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102623440|NCT04192032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623441|NCT03023982|Morphine|morphine|mesh-list
102623442|NCT03023982|Bupivacaine|bupivacaine|mesh-list
102623443|NCT03023982|Anesthetics, Local|anesthetics, local|mesh-ancestor
102623444|NCT03023982|Anesthetics|anesthetics|mesh-ancestor
102623445|NCT03023982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102623446|NCT03023982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623447|NCT03023982|Sensory System Agents|sensory system agents|mesh-ancestor
102623448|NCT03023982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102623449|NCT03023982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102623450|NCT03023982|Narcotics|narcotics|mesh-ancestor
102623451|NCT03023982|Analgesics|analgesics|mesh-ancestor
102623452|NCT04192110|Diuretics|diuretics|mesh-list
102623453|NCT04192110|Natriuretic Agents|natriuretic agents|mesh-ancestor
101595784|NCT04316936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102623454|NCT04192110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623455|NCT04025736|Tranexamic Acid|tranexamic acid|mesh-list
102623456|NCT04025736|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102623457|NCT04025736|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102623458|NCT04025736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623459|NCT04025736|Hemostatics|hemostatics|mesh-ancestor
102623460|NCT04025736|Coagulants|coagulants|mesh-ancestor
102623461|NCT04190160|Xultophy|xultophy|mesh-list
102623462|NCT04190160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102623463|NCT04190160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623464|NCT04190160|Incretins|incretins|mesh-ancestor
102623465|NCT04190160|Hormones|hormones|mesh-ancestor
102274973|NCT00697684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623466|NCT04190160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102623467|NCT04190004|Vasopressins|vasopressins|mesh-list
102623468|NCT04190004|Arginine Vasopressin|arginine vasopressin|mesh-list
102623469|NCT04190004|Hemostatics|hemostatics|mesh-ancestor
102623470|NCT04190004|Coagulants|coagulants|mesh-ancestor
102623471|NCT04190004|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102274974|NCT00697684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102623472|NCT04190004|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102623473|NCT04190004|Natriuretic Agents|natriuretic agents|mesh-ancestor
102623474|NCT04190004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623475|NCT04406376|Prednisone|prednisone|mesh-list
102623476|NCT04406376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102623477|NCT04406376|Glucocorticoids|glucocorticoids|mesh-ancestor
102623478|NCT04406376|Hormones|hormones|mesh-ancestor
102623479|NCT04406376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102623480|NCT04406376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623481|NCT04406376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102623482|NCT04406376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102623483|NCT04024800|Pembrolizumab|pembrolizumab|mesh-list
102623484|NCT04024800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102623485|NCT04024800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102623486|NCT04024800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102623487|NCT04024800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623488|NCT04198662|Epinephrine|epinephrine|mesh-list
102623489|NCT04198662|Ropivacaine|ropivacaine|mesh-list
102623490|NCT04198662|Anesthetics, Local|anesthetics, local|mesh-ancestor
102623491|NCT04198662|Anesthetics|anesthetics|mesh-ancestor
102623492|NCT04198662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102623493|NCT04198662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623494|NCT04198662|Sensory System Agents|sensory system agents|mesh-ancestor
102623495|NCT04198662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102623496|NCT04198662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102623497|NCT04198662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102623498|NCT04198662|Adrenergic Agents|adrenergic agents|mesh-ancestor
102623499|NCT04198662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102623500|NCT04198662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623501|NCT04198662|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102623502|NCT04198662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102623503|NCT04198662|Autonomic Agents|autonomic agents|mesh-ancestor
102623504|NCT04198662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102623505|NCT04198662|Respiratory System Agents|respiratory system agents|mesh-ancestor
102623506|NCT04198662|Mydriatics|mydriatics|mesh-ancestor
102623507|NCT04198662|Sympathomimetics|sympathomimetics|mesh-ancestor
102623508|NCT04198662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102623509|NCT04406610|Immunomodulating Agents|immunomodulating agents|mesh-list
102623510|NCT04406610|Immunologic Factors|immunologic factors|mesh-ancestor
102623511|NCT04406610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623512|NCT04023630|Rivaroxaban|rivaroxaban|mesh-list
102623513|NCT04023630|Clopidogrel|clopidogrel|mesh-list
102623514|NCT04023630|Ticagrelor|ticagrelor|mesh-list
102623515|NCT04023630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102623516|NCT04023630|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102623517|NCT04023630|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102623518|NCT04023630|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102623519|NCT04023630|Purinergic Agents|purinergic agents|mesh-ancestor
102623520|NCT04023630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102623521|NCT04023630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623522|NCT04023630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623523|NCT04023630|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102623524|NCT04023630|Antithrombins|antithrombins|mesh-ancestor
102623525|NCT04023630|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102623526|NCT04023630|Protease Inhibitors|protease inhibitors|mesh-ancestor
102623527|NCT04023630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102623528|NCT04023630|Anticoagulants|anticoagulants|mesh-ancestor
102623529|NCT04199754|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102623530|NCT04022304|Isophane Insulin, Human|isophane insulin, human|mesh-list
102623531|NCT04022304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102623532|NCT04022304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623533|NCT04020666|Kallikreins|kallikreins|mesh-list
102623534|NCT04020666|Coagulants|coagulants|mesh-ancestor
102623535|NCT04020666|Fertility Agents, Male|fertility agents, male|mesh-ancestor
102623536|NCT04020666|Fertility Agents|fertility agents|mesh-ancestor
102623537|NCT04020666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102623538|NCT04020666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623539|NCT03929640|Acetaminophen|acetaminophen|mesh-list
102623540|NCT03929640|Ibuprofen|ibuprofen|mesh-list
102623541|NCT03929640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102623542|NCT03929640|Analgesics|analgesics|mesh-ancestor
102623543|NCT03929640|Sensory System Agents|sensory system agents|mesh-ancestor
102623544|NCT03929640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102623545|NCT03929640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623546|NCT03929640|Antipyretics|antipyretics|mesh-ancestor
102623547|NCT03929640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102623548|NCT03929640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102623549|NCT03929640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102623550|NCT03929640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102623551|NCT03929640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102623552|NCT03929640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623553|NCT04021992|Rituximab|rituximab|mesh-list
102623554|NCT04021992|Gemcitabine|gemcitabine|mesh-list
102623555|NCT04021992|Doxorubicin|doxorubicin|mesh-list
102623556|NCT04021992|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102623557|NCT04021992|Vinorelbine|vinorelbine|mesh-list
102623558|NCT04021992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102623559|NCT04021992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102623560|NCT04021992|Immunologic Factors|immunologic factors|mesh-ancestor
102623561|NCT04021992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623562|NCT04021992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102623563|NCT04021992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102623564|NCT04021992|Antimetabolites|antimetabolites|mesh-ancestor
102623565|NCT04021992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623566|NCT04021992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102623567|NCT04021992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102623568|NCT04021992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102623569|NCT04021992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102623570|NCT04021992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102623571|NCT04021992|Tubulin Modulators|tubulin modulators|mesh-ancestor
102623572|NCT04021992|Antimitotic Agents|antimitotic agents|mesh-ancestor
102623573|NCT04021992|Mitosis Modulators|mitosis modulators|mesh-ancestor
102623574|NCT04020588|Minocycline|minocycline|mesh-list
102623575|NCT04020588|Celecoxib|celecoxib|mesh-list
102623576|NCT04020588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102623577|NCT04020588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102623578|NCT04020588|Analgesics|analgesics|mesh-ancestor
102623579|NCT04020588|Sensory System Agents|sensory system agents|mesh-ancestor
102623580|NCT04020588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102623581|NCT04020588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623582|NCT04020588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102623583|NCT04020588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102623584|NCT04020588|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102623585|NCT04020588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102623586|NCT04020588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101595921|NCT00698269|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102623587|NCT04020588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623588|NCT04020588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102623589|NCT04020588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102623590|NCT04145856|Simethicone|simethicone|mesh-list
102623591|NCT04145856|Alverine|alverine|mesh-list
102623592|NCT04145856|Antifoaming Agents|antifoaming agents|mesh-ancestor
102623593|NCT04145856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623594|NCT04145856|Emollients|emollients|mesh-ancestor
102623595|NCT04145856|Dermatologic Agents|dermatologic agents|mesh-ancestor
102623596|NCT04145856|Parasympatholytics|parasympatholytics|mesh-ancestor
102623597|NCT04145856|Autonomic Agents|autonomic agents|mesh-ancestor
102623598|NCT04145856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102623599|NCT04145856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623600|NCT04140786|Gentamicins|gentamicins|mesh-list
102623601|NCT04140786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102623602|NCT04140786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102623603|NCT04140786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102623604|NCT04140786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102623605|NCT04140786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623606|NCT04147650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102623607|NCT04147650|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102623608|NCT04022226|Ketamine|ketamine|mesh-list
102623609|NCT04022226|Methohexital|methohexital|mesh-list
102623610|NCT04022226|Analgesics|analgesics|mesh-ancestor
102623611|NCT04022226|Sensory System Agents|sensory system agents|mesh-ancestor
102623612|NCT04022226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102623613|NCT04022226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623614|NCT04022226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102623615|NCT04022226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102623616|NCT04022226|Anesthetics, General|anesthetics, general|mesh-ancestor
102623617|NCT04022226|Anesthetics|anesthetics|mesh-ancestor
102623618|NCT04022226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102623619|NCT04022226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102274975|NCT00697684|Immunologic Factors|immunologic factors|mesh-ancestor
102623620|NCT04022226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102274976|NCT00697684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623621|NCT04022226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102623622|NCT04022226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623623|NCT04029012|Methoxyflurane|methoxyflurane|mesh-list
102623624|NCT04029012|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102623625|NCT04029012|Anesthetics, General|anesthetics, general|mesh-ancestor
102623626|NCT04029012|Anesthetics|anesthetics|mesh-ancestor
102623627|NCT04029012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102623628|NCT04029012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623629|NCT04025658|Oxytocin|oxytocin|mesh-list
102623630|NCT04025658|Oxytocics|oxytocics|mesh-ancestor
102623631|NCT04025658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102623632|NCT04025658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623633|NCT05586438|Colistin|colistin|mesh-list
102623634|NCT05586438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102623635|NCT05586438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102623636|NCT04145232|Nivolumab|nivolumab|mesh-list
102623637|NCT04145232|Ipilimumab|ipilimumab|mesh-list
102623638|NCT04145232|Atezolizumab|atezolizumab|mesh-list
102623639|NCT04145232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102623640|NCT04145232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102623641|NCT04145232|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102623642|NCT04145232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623643|NCT04144920|Oxymetazoline|oxymetazoline|mesh-list
102623644|NCT04144920|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102623645|NCT04144920|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102623646|NCT04144920|Adrenergic Agents|adrenergic agents|mesh-ancestor
102623647|NCT04144920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102623648|NCT04144920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623649|NCT04144920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623650|NCT04144920|Sympathomimetics|sympathomimetics|mesh-ancestor
102623651|NCT04144920|Autonomic Agents|autonomic agents|mesh-ancestor
102623652|NCT04144920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102623653|NCT04144920|Nasal Decongestants|nasal decongestants|mesh-ancestor
102623654|NCT04144920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102623655|NCT04144920|Respiratory System Agents|respiratory system agents|mesh-ancestor
102623656|NCT04026282|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
102623657|NCT04026282|Hormones|hormones|mesh-ancestor
102623658|NCT04026282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102623659|NCT04026282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623660|NCT04144218|Lacosamide|lacosamide|mesh-list
102623661|NCT04144218|Anticonvulsants|anticonvulsants|mesh-ancestor
102623662|NCT04144218|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102623663|NCT04144218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102623664|NCT04144218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102623665|NCT04144218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623666|NCT05580822|Tenecteplase|tenecteplase|mesh-list
102623667|NCT05580822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102623668|NCT05580822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102623669|NCT05580822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623670|NCT05580354|Tislelizumab|tislelizumab|mesh-list
102623671|NCT05580354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102623672|NCT05580354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102623673|NCT04143906|Carboplatin|carboplatin|mesh-list
102623674|NCT04143906|Gemcitabine|gemcitabine|mesh-list
102623675|NCT04143906|Vinorelbine|vinorelbine|mesh-list
102623676|NCT04143906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102623677|NCT04143906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102623678|NCT04143906|Antimetabolites|antimetabolites|mesh-ancestor
102623679|NCT04143906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623680|NCT04143906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102623681|NCT04143906|Tubulin Modulators|tubulin modulators|mesh-ancestor
102623682|NCT04143906|Antimitotic Agents|antimitotic agents|mesh-ancestor
102623683|NCT04143906|Mitosis Modulators|mitosis modulators|mesh-ancestor
102623684|NCT02708706|Hyaluronic Acid|hyaluronic acid|mesh-list
102623685|NCT02708706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102623686|NCT02708706|Immunologic Factors|immunologic factors|mesh-ancestor
102623687|NCT02708706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623688|NCT02708706|Viscosupplements|viscosupplements|mesh-ancestor
102623689|NCT02708706|Protective Agents|protective agents|mesh-ancestor
102623690|NCT05587608|Anesthetics|anesthetics|mesh-list
102623691|NCT05587608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101911975|NCT01221402|Vasodilator Agents|vasodilator agents|mesh-ancestor
102623692|NCT05587608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623693|NCT02703714|Pembrolizumab|pembrolizumab|mesh-list
102623694|NCT02703714|Sargramostim|sargramostim|mesh-list
102623695|NCT02703714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102623696|NCT02703714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102623697|NCT02703714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102623698|NCT02703714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623699|NCT02703714|Immunologic Factors|immunologic factors|mesh-ancestor
102623700|NCT02703714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623701|NCT03945864|Anti-Infective Agents|anti-infective agents|mesh-list
102623702|NCT03945864|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102623703|NCT03904446|Methylergonovine|methylergonovine|mesh-list
102623704|NCT03904446|Oxytocics|oxytocics|mesh-ancestor
102623705|NCT03904446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102623706|NCT03904446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623707|NCT03916068|Vitamin E|vitamin e|mesh-list
102623708|NCT03916068|Pentoxifylline|pentoxifylline|mesh-list
102623709|NCT03916068|Vitamins|vitamins|mesh-ancestor
102623710|NCT03916068|Micronutrients|micronutrients|mesh-ancestor
102623711|NCT03916068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623712|NCT03916068|Antioxidants|antioxidants|mesh-ancestor
102623713|NCT03916068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623714|NCT03916068|Protective Agents|protective agents|mesh-ancestor
102623715|NCT03916068|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102623716|NCT03916068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102623717|NCT03916068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102623718|NCT03916068|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102623719|NCT03916068|Vasodilator Agents|vasodilator agents|mesh-ancestor
102623720|NCT03916068|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102623721|NCT04143282|Metformin|metformin|mesh-list
102623722|NCT04143282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102623723|NCT04143282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623724|NCT04149678|Cyclosporine|cyclosporine|mesh-list
102623725|NCT04149678|Cyclosporins|cyclosporins|mesh-list
102623726|NCT04149678|Ozanimod|ozanimod|mesh-list
102623727|NCT04149678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102623728|NCT04149678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623729|NCT04149678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102623730|NCT04149678|Immunologic Factors|immunologic factors|mesh-ancestor
102623731|NCT04149678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623732|NCT04149678|Antifungal Agents|antifungal agents|mesh-ancestor
102623733|NCT04149678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102623734|NCT04149678|Dermatologic Agents|dermatologic agents|mesh-ancestor
102623735|NCT04149678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102623736|NCT04149678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102623737|NCT04149678|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102623738|NCT05581992|Sotorasib|sotorasib|mesh-list
102623739|NCT05581992|Omeprazole|omeprazole|mesh-list
102623740|NCT05581992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102623741|NCT05581992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102623742|NCT05581992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102623743|NCT05581992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101596063|NCT00940017|Hormone Antagonists|hormone antagonists|mesh-ancestor
102623744|NCT05581992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623745|NCT05581992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102623746|NCT05581992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102623747|NCT05581992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102623748|NCT03020940|Cefuroxime|cefuroxime|mesh-list
102623749|NCT03020940|Cefuroxime axetil|cefuroxime axetil|mesh-list
102623750|NCT03020940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102623751|NCT03020940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102623752|NCT03645408|Exenatide|exenatide|mesh-list
102623753|NCT03645408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102623754|NCT03645408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623755|NCT03645408|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102623756|NCT03645408|Incretins|incretins|mesh-ancestor
102623757|NCT03645408|Hormones|hormones|mesh-ancestor
102623758|NCT03645408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102623759|NCT04141410|Simendan|simendan|mesh-list
102623760|NCT04141410|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102623761|NCT04141410|Vasodilator Agents|vasodilator agents|mesh-ancestor
102623762|NCT04141410|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102623763|NCT04141410|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102623764|NCT04141410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102623765|NCT04141410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274977|NCT00697684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102274978|NCT00675922|Silver Nitrate|silver nitrate|mesh-list
102274979|NCT00675922|Mafenide|mafenide|mesh-list
102623766|NCT04141410|Protective Agents|protective agents|mesh-ancestor
102623767|NCT04141410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623769|NCT05586204|Immunologic Factors|immunologic factors|mesh-ancestor
102623770|NCT05586204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623771|NCT04149444|Trifluridine|trifluridine|mesh-list
102623772|NCT04149444|Antimetabolites|antimetabolites|mesh-ancestor
102623773|NCT04149444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623774|NCT04149444|Antiviral Agents|antiviral agents|mesh-ancestor
102623775|NCT04149444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102623776|NCT03020706|Magnesium Sulfate|magnesium sulfate|mesh-list
102623777|NCT03020706|Analgesics|analgesics|mesh-ancestor
102623778|NCT03020706|Sensory System Agents|sensory system agents|mesh-ancestor
102623779|NCT03020706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102623780|NCT03020706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623781|NCT03020706|Anesthetics|anesthetics|mesh-ancestor
102623782|NCT03020706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102623783|NCT03020706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102623784|NCT03020706|Anticonvulsants|anticonvulsants|mesh-ancestor
102623785|NCT03020706|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102623786|NCT03020706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102623787|NCT03020706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623788|NCT03020706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102623789|NCT03020706|Tocolytic Agents|tocolytic agents|mesh-ancestor
102623790|NCT03020706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102623791|NCT03900624|Dexamethasone|dexamethasone|mesh-list
102623792|NCT03900624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102623793|NCT03900624|Antiemetics|antiemetics|mesh-ancestor
102623794|NCT03900624|Autonomic Agents|autonomic agents|mesh-ancestor
102623795|NCT03900624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102623796|NCT03900624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623797|NCT03900624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102623798|NCT03900624|Glucocorticoids|glucocorticoids|mesh-ancestor
102623799|NCT03900624|Hormones|hormones|mesh-ancestor
102623800|NCT03900624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102623801|NCT03900624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102623802|NCT03900624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102623803|NCT04149132|Nitric Oxide|nitric oxide|mesh-list
102623804|NCT04149132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102623805|NCT04149132|Autonomic Agents|autonomic agents|mesh-ancestor
102623806|NCT04149132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102623807|NCT04149132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623808|NCT04149132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102623809|NCT04149132|Respiratory System Agents|respiratory system agents|mesh-ancestor
102623810|NCT04149132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102623811|NCT04149132|Antioxidants|antioxidants|mesh-ancestor
102623812|NCT04149132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623813|NCT04149132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102623814|NCT04149132|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102623815|NCT04149132|Vasodilator Agents|vasodilator agents|mesh-ancestor
102623816|NCT04149132|Gasotransmitters|gasotransmitters|mesh-ancestor
102623817|NCT04149132|Protective Agents|protective agents|mesh-ancestor
102623818|NCT03908892|Tetracycline|tetracycline|mesh-list
102623819|NCT03908892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102623820|NCT03908892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102623821|NCT03908892|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102623822|NCT03908892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102623823|NCT03908892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623824|NCT04140318|Paclitaxel|paclitaxel|mesh-list
102623825|NCT04140318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102623826|NCT04140318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102623827|NCT04140318|Tubulin Modulators|tubulin modulators|mesh-ancestor
102623828|NCT04140318|Antimitotic Agents|antimitotic agents|mesh-ancestor
102623829|NCT04140318|Mitosis Modulators|mitosis modulators|mesh-ancestor
102623830|NCT04140318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623831|NCT03021330|Cytarabine|cytarabine|mesh-list
102623832|NCT03021330|Daunorubicin|daunorubicin|mesh-list
102623833|NCT03021330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102623834|NCT03021330|Antimetabolites|antimetabolites|mesh-ancestor
102623835|NCT03021330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623836|NCT03021330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102623837|NCT03021330|Antiviral Agents|antiviral agents|mesh-ancestor
102623838|NCT03021330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102623839|NCT03021330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102623840|NCT03021330|Immunologic Factors|immunologic factors|mesh-ancestor
102274980|NCT00675922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102623841|NCT03021330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623843|NCT03021330|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102623844|NCT03021330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102623845|NCT03021330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102623846|NCT04140006|Alendronate|alendronate|mesh-list
102623847|NCT04140006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102623848|NCT04140006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623849|NCT04146324|Nivolumab|nivolumab|mesh-list
102623850|NCT04146324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102623851|NCT04146324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101596151|NCT01185782|Hormones|hormones|mesh-list
102623852|NCT04146324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102623853|NCT04146324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623854|NCT03588936|Nivolumab|nivolumab|mesh-list
102623855|NCT03588936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102623856|NCT03588936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102623857|NCT03588936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102623858|NCT03588936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623859|NCT03022500|Durvalumab|durvalumab|mesh-list
102623860|NCT03022500|Tremelimumab|tremelimumab|mesh-list
102623861|NCT03022500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102623862|NCT03022500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102623863|NCT04148898|Bevacizumab|bevacizumab|mesh-list
102623864|NCT04148898|Osimertinib|osimertinib|mesh-list
102623865|NCT04148898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102623866|NCT04148898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102623867|NCT04148898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102623868|NCT04148898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102623869|NCT04148898|Growth Substances|growth substances|mesh-ancestor
102623870|NCT04148898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623871|NCT04148898|Growth Inhibitors|growth inhibitors|mesh-ancestor
102623872|NCT04148898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102623873|NCT04148898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102623874|NCT04148898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623875|NCT04148820|Aspirin|aspirin|mesh-list
102623876|NCT04148820|Perindopril|perindopril|mesh-list
102623877|NCT04148820|Atorvastatin|atorvastatin|mesh-list
102623878|NCT04148820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102623879|NCT04148820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102623880|NCT04148820|Analgesics|analgesics|mesh-ancestor
102623881|NCT04148820|Sensory System Agents|sensory system agents|mesh-ancestor
102623882|NCT04148820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102623883|NCT04148820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623884|NCT04148820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102623885|NCT04148820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102623886|NCT04148820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102623887|NCT04148820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102623888|NCT04148820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623889|NCT04148820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102623890|NCT04148820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102623891|NCT04148820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102623892|NCT04148820|Antipyretics|antipyretics|mesh-ancestor
102623893|NCT04148820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102623894|NCT04148820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102623895|NCT04148820|Antimetabolites|antimetabolites|mesh-ancestor
102623896|NCT04148820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102623897|NCT04148820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102623898|NCT04148820|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102623899|NCT04148820|Protease Inhibitors|protease inhibitors|mesh-ancestor
102623900|NCT04148820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102623901|NCT03941496|Azacitidine|azacitidine|mesh-list
102623902|NCT03941496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102623903|NCT03941496|Antimetabolites|antimetabolites|mesh-ancestor
102623904|NCT03941496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623905|NCT03941496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102623906|NCT03941496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102623907|NCT03580980|Acetaminophen|acetaminophen|mesh-list
102623908|NCT03580980|Ketamine|ketamine|mesh-list
102623909|NCT03580980|Morphine|morphine|mesh-list
102623910|NCT03580980|Levobupivacaine|levobupivacaine|mesh-list
102623911|NCT03580980|Analgesics|analgesics|mesh-ancestor
102623912|NCT03580980|Sensory System Agents|sensory system agents|mesh-ancestor
102274981|NCT00675922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102274982|NCT00675922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102623913|NCT03580980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102623914|NCT03580980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623915|NCT03580980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102623916|NCT03580980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102623917|NCT03580980|Anesthetics, General|anesthetics, general|mesh-ancestor
102623918|NCT03580980|Anesthetics|anesthetics|mesh-ancestor
102623919|NCT03580980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102623920|NCT03580980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102623921|NCT03580980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102623922|NCT03580980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102623923|NCT03580980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623924|NCT03580980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102623925|NCT03580980|Narcotics|narcotics|mesh-ancestor
102623926|NCT03580980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102623927|NCT03580980|Antipyretics|antipyretics|mesh-ancestor
102623928|NCT03580980|Anesthetics, Local|anesthetics, local|mesh-ancestor
102623929|NCT03587220|Lidocaine|lidocaine|mesh-list
102623930|NCT03587220|Capsaicin|capsaicin|mesh-list
102623931|NCT03587220|Histamine|histamine|mesh-list
102623932|NCT03587220|Anesthetics, Local|anesthetics, local|mesh-ancestor
102623933|NCT03587220|Anesthetics|anesthetics|mesh-ancestor
102623934|NCT03587220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102623935|NCT03587220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623936|NCT03587220|Sensory System Agents|sensory system agents|mesh-ancestor
102623937|NCT03587220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102623938|NCT03587220|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102623939|NCT03587220|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102623940|NCT03587220|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102623941|NCT03587220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102623942|NCT03587220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623943|NCT03587220|Antipruritics|antipruritics|mesh-ancestor
102623944|NCT03587220|Dermatologic Agents|dermatologic agents|mesh-ancestor
102623945|NCT03587220|Histamine Agonists|histamine agonists|mesh-ancestor
102623946|NCT03587220|Histamine Agents|histamine agents|mesh-ancestor
102623947|NCT03587220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102623948|NCT03586908|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102623949|NCT03586908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102623950|NCT04147572|Tiotropium Bromide|tiotropium bromide|mesh-list
102623951|NCT04147572|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102623952|NCT04147572|Autonomic Agents|autonomic agents|mesh-ancestor
101596280|NCT01185080|Adenosine|adenosine|mesh-list
102623953|NCT04147572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102623954|NCT04147572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623955|NCT04147572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102623956|NCT04147572|Respiratory System Agents|respiratory system agents|mesh-ancestor
102623957|NCT04147572|Parasympatholytics|parasympatholytics|mesh-ancestor
102623958|NCT04147572|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102623959|NCT04147572|Cholinergic Agents|cholinergic agents|mesh-ancestor
102623960|NCT04147572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102623961|NCT04147572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623962|NCT03580590|Diltiazem|diltiazem|mesh-list
102623963|NCT03580590|Tranexamic Acid|tranexamic acid|mesh-list
102623964|NCT03580590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102623965|NCT03580590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102623966|NCT03580590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623967|NCT03580590|Hemostatics|hemostatics|mesh-ancestor
102623968|NCT03580590|Coagulants|coagulants|mesh-ancestor
102623969|NCT03580590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102623970|NCT03580590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102623971|NCT03580590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102623972|NCT03580590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102623973|NCT03580590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623974|NCT03580590|Vasodilator Agents|vasodilator agents|mesh-ancestor
102623975|NCT03891576|Niraparib|niraparib|mesh-list
102623976|NCT03891576|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102623977|NCT03891576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102623978|NCT03891576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623979|NCT03891576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102623980|NCT03586674|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102623981|NCT03586674|Fenofibrate|fenofibrate|mesh-list
102623982|NCT03586674|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102623983|NCT03586674|Antimetabolites|antimetabolites|mesh-ancestor
102623984|NCT03586674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102623985|NCT03586674|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102623986|NCT03586674|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102623987|NCT03586674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102623989|NCT03346668|Analgesics|analgesics|mesh-ancestor
102623990|NCT03346668|Sensory System Agents|sensory system agents|mesh-ancestor
102623991|NCT03346668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102623992|NCT03346668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102623993|NCT03346668|Anticonvulsants|anticonvulsants|mesh-ancestor
102623994|NCT03346668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102623995|NCT03346668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102623996|NCT03346668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102623997|NCT03346668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102623998|NCT03346668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102623999|NCT03346668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102624000|NCT03346668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102624001|NCT03346668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624002|NCT03346668|Antimanic Agents|antimanic agents|mesh-ancestor
102624003|NCT03585738|Folic Acid|folic acid|mesh-list
102624004|NCT03585738|Vitamin B Complex|vitamin b complex|mesh-list
102624005|NCT03585738|Inositol|inositol|mesh-list
102624006|NCT03585738|Hematinics|hematinics|mesh-ancestor
102624007|NCT03585738|Vitamins|vitamins|mesh-ancestor
102624008|NCT03585738|Micronutrients|micronutrients|mesh-ancestor
102624009|NCT03585738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624010|NCT03583164|Olorofim|olorofim|mesh-list
102624011|NCT03583164|Antifungal Agents|antifungal agents|mesh-ancestor
102624012|NCT03583164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102624013|NCT03589326|Cytarabine|cytarabine|mesh-list
102624014|NCT03589326|Dexamethasone|dexamethasone|mesh-list
102624015|NCT03589326|Prednisone|prednisone|mesh-list
102624016|NCT03589326|Methotrexate|methotrexate|mesh-list
102624017|NCT03589326|Vincristine|vincristine|mesh-list
102624018|NCT03589326|Imatinib Mesylate|imatinib mesylate|mesh-list
102624019|NCT03589326|Ponatinib|ponatinib|mesh-list
102624020|NCT03589326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102624021|NCT03589326|Antiemetics|antiemetics|mesh-ancestor
102624022|NCT03589326|Autonomic Agents|autonomic agents|mesh-ancestor
102624023|NCT03589326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102624024|NCT03589326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624025|NCT03589326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102624026|NCT03589326|Glucocorticoids|glucocorticoids|mesh-ancestor
102624027|NCT03589326|Hormones|hormones|mesh-ancestor
102624028|NCT03589326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102624029|NCT03589326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102624030|NCT03589326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102624031|NCT03589326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102624032|NCT03589326|Abortifacient Agents|abortifacient agents|mesh-ancestor
102624033|NCT03589326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102624034|NCT03589326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102624035|NCT03589326|Antimetabolites|antimetabolites|mesh-ancestor
102624036|NCT03589326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624037|NCT03589326|Dermatologic Agents|dermatologic agents|mesh-ancestor
102624038|NCT03589326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102624039|NCT03589326|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102624040|NCT03589326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102624041|NCT03589326|Immunologic Factors|immunologic factors|mesh-ancestor
102624042|NCT03589326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102624043|NCT03589326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102624044|NCT03589326|Antiviral Agents|antiviral agents|mesh-ancestor
102624045|NCT03589326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101596368|NCT04568902|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
102624046|NCT03589326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102624047|NCT03589326|Tubulin Modulators|tubulin modulators|mesh-ancestor
102624048|NCT03589326|Antimitotic Agents|antimitotic agents|mesh-ancestor
102624049|NCT03589326|Mitosis Modulators|mitosis modulators|mesh-ancestor
102624050|NCT03589326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102624051|NCT03156036|Capecitabine|capecitabine|mesh-list
102624052|NCT03156036|Temozolomide|temozolomide|mesh-list
102624053|NCT03156036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102624054|NCT03156036|Antimetabolites|antimetabolites|mesh-ancestor
102624055|NCT03156036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624056|NCT03156036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102624057|NCT03156036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102624058|NCT03156036|Alkylating Agents|alkylating agents|mesh-ancestor
101912337|NCT03773796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102624059|NCT03583866|Candesartan|candesartan|mesh-list
102624060|NCT03583866|Candesartan cilexetil|candesartan cilexetil|mesh-list
102624061|NCT03583866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102624062|NCT03583866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102274983|NCT00675922|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102624063|NCT03583866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102624064|NCT03583866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624065|NCT03585426|Vancomycin|vancomycin|mesh-list
102624066|NCT03585426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102624067|NCT03585426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102624068|NCT03585036|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
102624069|NCT03585036|Tramadol|tramadol|mesh-list
102624070|NCT03585036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102624071|NCT03585036|Narcotics|narcotics|mesh-ancestor
102624072|NCT03585036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102624073|NCT03585036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596400|NCT02759926|Quinine|quinine|mesh-list
102624074|NCT03585036|Analgesics|analgesics|mesh-ancestor
102624075|NCT03585036|Sensory System Agents|sensory system agents|mesh-ancestor
102624076|NCT03585036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102624077|NCT03585036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102624078|NCT03585036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102624079|NCT03585036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102624080|NCT03585036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102624081|NCT03155568|Bupivacaine|bupivacaine|mesh-list
102624082|NCT03155568|Anesthetics, Local|anesthetics, local|mesh-ancestor
102624083|NCT03155568|Anesthetics|anesthetics|mesh-ancestor
102624084|NCT03155568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102624085|NCT03155568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624086|NCT03155568|Sensory System Agents|sensory system agents|mesh-ancestor
102624087|NCT03155568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102624088|NCT03155646|Clonidine|clonidine|mesh-list
102624089|NCT03155646|Dexmedetomidine|dexmedetomidine|mesh-list
102624090|NCT03155646|Levobupivacaine|levobupivacaine|mesh-list
102624091|NCT03155646|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102624092|NCT03155646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102624093|NCT03155646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624094|NCT03155646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102624095|NCT03155646|Analgesics|analgesics|mesh-ancestor
102624096|NCT03155646|Sensory System Agents|sensory system agents|mesh-ancestor
102624097|NCT03155646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102624098|NCT03155646|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102624099|NCT03155646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102624100|NCT03155646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102624101|NCT03155646|Adrenergic Agents|adrenergic agents|mesh-ancestor
102624102|NCT03155646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102624103|NCT03155646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624104|NCT03155646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102624105|NCT03155646|Sympatholytics|sympatholytics|mesh-ancestor
102624106|NCT03155646|Autonomic Agents|autonomic agents|mesh-ancestor
102624107|NCT03155646|Anesthetics, Local|anesthetics, local|mesh-ancestor
102624108|NCT03155646|Anesthetics|anesthetics|mesh-ancestor
102624109|NCT03584178|Budesonide|budesonide|mesh-list
102624110|NCT03584178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102624111|NCT03584178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102624112|NCT03584178|Autonomic Agents|autonomic agents|mesh-ancestor
102624113|NCT03584178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102624114|NCT03584178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624115|NCT03584178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102624116|NCT03584178|Respiratory System Agents|respiratory system agents|mesh-ancestor
102624117|NCT03584178|Glucocorticoids|glucocorticoids|mesh-ancestor
102624118|NCT03584178|Hormones|hormones|mesh-ancestor
102624119|NCT03584178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102624120|NCT04405206|Capecitabine|capecitabine|mesh-list
102624121|NCT04405206|Oxaliplatin|oxaliplatin|mesh-list
102624122|NCT04405206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102624123|NCT04405206|Antimetabolites|antimetabolites|mesh-ancestor
102624124|NCT04405206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624125|NCT04405206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102624126|NCT03101046|Docetaxel|docetaxel|mesh-list
102624127|NCT03101046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101596465|NCT02759224|Histamine Agents|histamine agents|mesh-ancestor
102624128|NCT03101046|Tubulin Modulators|tubulin modulators|mesh-ancestor
102624129|NCT03101046|Antimitotic Agents|antimitotic agents|mesh-ancestor
102624130|NCT03101046|Mitosis Modulators|mitosis modulators|mesh-ancestor
102624131|NCT03101046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624132|NCT03159936|Tofacitinib|tofacitinib|mesh-list
102624133|NCT03159936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624134|NCT03159936|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102274984|NCT00675922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101912481|NCT01131546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624135|NCT03159936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102624136|NCT03159936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102624137|NCT03156816|Colchicine|colchicine|mesh-list
102624138|NCT03156816|Gout Suppressants|gout suppressants|mesh-ancestor
101596482|NCT04586920|Midazolam|midazolam|mesh-list
102624139|NCT03156816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102624140|NCT03156816|Tubulin Modulators|tubulin modulators|mesh-ancestor
102624141|NCT03156816|Antimitotic Agents|antimitotic agents|mesh-ancestor
102624142|NCT03156816|Mitosis Modulators|mitosis modulators|mesh-ancestor
102624143|NCT03156816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624144|NCT03156816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102624145|NCT03583476|Amoxicillin|amoxicillin|mesh-list
102624146|NCT03583476|Metronidazole|metronidazole|mesh-list
102624147|NCT03583476|Clarithromycin|clarithromycin|mesh-list
102624148|NCT03583476|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
102624149|NCT03583476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102624150|NCT03583476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102624151|NCT03583476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102624152|NCT03583476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102624153|NCT03583476|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102624154|NCT03583476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102624155|NCT03583476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624156|NCT03583476|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102624157|NCT03583476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102624158|NCT03583242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
102624159|NCT03583242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102624160|NCT03583242|Growth Substances|growth substances|mesh-ancestor
102624161|NCT03583242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624162|NCT03583242|Growth Inhibitors|growth inhibitors|mesh-ancestor
102624163|NCT03583242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102624164|NCT05703126|N,N-dimethylarginine|n,n-dimethylarginine|mesh-list
102624165|NCT05703126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101596511|NCT02758990|Tocopherols|tocopherols|mesh-list
102624166|NCT05703126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624167|NCT03159390|Phenylacetic acid|phenylacetic acid|mesh-list
102624168|NCT03159390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102624169|NCT03159390|Antimetabolites|antimetabolites|mesh-ancestor
102624170|NCT03159390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624171|NCT03159390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102624172|NCT03582306|Chlorophyllin|chlorophyllin|mesh-list
102624173|NCT03582306|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
102624174|NCT03582306|Protective Agents|protective agents|mesh-ancestor
102624175|NCT03582306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624176|NCT03159234|Epinephrine|epinephrine|mesh-list
102624177|NCT03159234|Racepinephrine|racepinephrine|mesh-list
102624178|NCT03159234|Epinephryl borate|epinephryl borate|mesh-list
102624179|NCT03159234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102624180|NCT03159234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102624181|NCT03159234|Adrenergic Agents|adrenergic agents|mesh-ancestor
102624182|NCT03159234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102624183|NCT03159234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624184|NCT03159234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624185|NCT03159234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102624186|NCT03159234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102624187|NCT03159234|Autonomic Agents|autonomic agents|mesh-ancestor
102624188|NCT03159234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102624189|NCT03159234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102624190|NCT03159234|Respiratory System Agents|respiratory system agents|mesh-ancestor
102624191|NCT03159234|Mydriatics|mydriatics|mesh-ancestor
102624192|NCT03159234|Sympathomimetics|sympathomimetics|mesh-ancestor
102624193|NCT03159234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102624194|NCT05701332|Gemcitabine|gemcitabine|mesh-list
102624195|NCT05701332|BCG Vaccine|bcg vaccine|mesh-list
102624196|NCT05701332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102624197|NCT05701332|Antimetabolites|antimetabolites|mesh-ancestor
102624198|NCT05701332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624199|NCT05701332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102624200|NCT05701332|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102624201|NCT05701332|Immunologic Factors|immunologic factors|mesh-ancestor
102624202|NCT05701332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624203|NCT03581916|JNJ-64326067|jnj-64326067|mesh-list
102624204|NCT03581916|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102624205|NCT03581916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624206|NCT05703048|Dexmedetomidine|dexmedetomidine|mesh-list
102624207|NCT05703048|Esmolol|esmolol|mesh-list
102624208|NCT05703048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102624209|NCT05703048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102624210|NCT05703048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624211|NCT05703048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102624212|NCT05703048|Analgesics|analgesics|mesh-ancestor
102624213|NCT05703048|Sensory System Agents|sensory system agents|mesh-ancestor
102624214|NCT05703048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102624215|NCT05703048|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102624216|NCT05703048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102624217|NCT05703048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102624218|NCT05703048|Adrenergic Agents|adrenergic agents|mesh-ancestor
102624219|NCT05703048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102624220|NCT05703048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624221|NCT05703048|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102624222|NCT05703048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102624223|NCT05703048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102624224|NCT03158142|Atropine|atropine|mesh-list
102624225|NCT03158142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102624226|NCT03158142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102624227|NCT03158142|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102624228|NCT03158142|Autonomic Agents|autonomic agents|mesh-ancestor
102624229|NCT03158142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102624230|NCT03158142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624231|NCT03158142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102624232|NCT03158142|Respiratory System Agents|respiratory system agents|mesh-ancestor
102624233|NCT03158142|Mydriatics|mydriatics|mesh-ancestor
102624234|NCT03158142|Parasympatholytics|parasympatholytics|mesh-ancestor
102624235|NCT03158142|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102624236|NCT03158142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102624237|NCT03158142|Cholinergic Agents|cholinergic agents|mesh-ancestor
102624238|NCT03158142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102624239|NCT03158142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624240|NCT03028740|Cenicriviroc|cenicriviroc|mesh-list
102624241|NCT03028740|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102624242|NCT03028740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624243|NCT03028740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102624244|NCT03028740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102624245|NCT03028740|Antiviral Agents|antiviral agents|mesh-ancestor
102624246|NCT03028740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102624247|NCT03027648|Levonorgestrel|levonorgestrel|mesh-list
102624248|NCT03027648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102624249|NCT03027648|Contraceptive Agents|contraceptive agents|mesh-ancestor
102624250|NCT03027648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102624251|NCT03027648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624252|NCT03027648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102624253|NCT03027648|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102624254|NCT03027648|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102624255|NCT01671384|Valproic Acid|valproic acid|mesh-list
102624256|NCT01671384|Anticonvulsants|anticonvulsants|mesh-ancestor
102624257|NCT01671384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102624258|NCT01671384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624259|NCT01671384|GABA Agents|gaba agents|mesh-ancestor
102624260|NCT01671384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102624261|NCT01671384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624262|NCT01671384|Antimanic Agents|antimanic agents|mesh-ancestor
102624263|NCT01671384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102624264|NCT01671384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102624265|NCT01671384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102624266|NCT01671774|Zoledronic Acid|zoledronic acid|mesh-list
102624267|NCT01671774|Interleukin-2|interleukin-2|mesh-list
102624268|NCT01671774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102624269|NCT01671774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102624270|NCT01671774|Analgesics|analgesics|mesh-ancestor
102624271|NCT01671774|Sensory System Agents|sensory system agents|mesh-ancestor
102624272|NCT01671774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102624273|NCT01671774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624274|NCT01671774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102624275|NCT01671852|Mometasone Furoate|mometasone furoate|mesh-list
102624276|NCT01671852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102624277|NCT01671852|Dermatologic Agents|dermatologic agents|mesh-ancestor
102624278|NCT01671852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102624279|NCT01672086|Calcium Carbonate|calcium carbonate|mesh-list
102624280|NCT01672086|Antacids|antacids|mesh-ancestor
102624281|NCT01672086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912556|NCT03925740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102274985|NCT00675922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912649|NCT01131000|Ibuprofen|ibuprofen|mesh-list
102624282|NCT01672086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102624283|NCT05547750|Vitamin K|vitamin k|mesh-list
102624284|NCT05547750|Vitamin K 2|vitamin k 2|mesh-list
102624285|NCT05547750|Vitamins|vitamins|mesh-ancestor
102624286|NCT05547750|Micronutrients|micronutrients|mesh-ancestor
102624287|NCT05547750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624288|NCT05547750|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102624289|NCT05547750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102624290|NCT05547750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624291|NCT05547750|Hemostatics|hemostatics|mesh-ancestor
102624292|NCT05547750|Coagulants|coagulants|mesh-ancestor
102624293|NCT04296006|Amphetamine|amphetamine|mesh-list
102624294|NCT04296006|Dextroamphetamine|dextroamphetamine|mesh-list
102624295|NCT04296006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102624296|NCT04296006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624297|NCT04296006|Sympathomimetics|sympathomimetics|mesh-ancestor
102624298|NCT04296006|Autonomic Agents|autonomic agents|mesh-ancestor
102624299|NCT04296006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102624300|NCT04296006|Dopamine Agents|dopamine agents|mesh-ancestor
102624301|NCT04296006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102624302|NCT04296006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624303|NCT04296006|Adrenergic Agents|adrenergic agents|mesh-ancestor
102624304|NCT04296006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102624305|NCT04296006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102624306|NCT04296006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102624307|NCT04296006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102624308|NCT01672476|Valsartan|valsartan|mesh-list
102624309|NCT01672476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102624310|NCT01672476|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102624311|NCT01672476|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102624312|NCT01672476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624313|NCT01672554|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102624314|NCT01672554|Antidepressive Agents|antidepressive agents|mesh-ancestor
102624315|NCT01672554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102624316|NCT01672554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102624317|NCT01672554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102624318|NCT01672554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102624319|NCT01672554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624320|NCT05067582|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
102624321|NCT05067582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102624322|NCT05067582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624323|NCT05033808|Epirubicin|epirubicin|mesh-list
102624324|NCT05033808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102624325|NCT05033808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102624326|NCT05033808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102624327|NCT05033808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102624328|NCT05033808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102624329|NCT05033808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624330|NCT04026984|Rifamycins|rifamycins|mesh-list
102624331|NCT04026984|Rifamycin SV|rifamycin sv|mesh-list
102624332|NCT04026984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102624333|NCT04026984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102624334|NCT04026984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102624335|NCT04903314|Cenobamate|cenobamate|mesh-list
102624336|NCT04903314|Anticonvulsants|anticonvulsants|mesh-ancestor
102624337|NCT03153072|Amiodarone|amiodarone|mesh-list
102624338|NCT03153072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102624339|NCT03153072|Vasodilator Agents|vasodilator agents|mesh-ancestor
102624340|NCT03153072|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102624341|NCT03153072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102624342|NCT03153072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624343|NCT03153072|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102624344|NCT03153072|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102624345|NCT03153072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102624346|NCT03153072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102624347|NCT03153072|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102624348|NCT03153072|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102624349|NCT03153072|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102624350|NCT01673724|Pramipexole|pramipexole|mesh-list
102624351|NCT01673724|Bromocriptine|bromocriptine|mesh-list
102624352|NCT01673724|Antioxidants|antioxidants|mesh-ancestor
102624353|NCT01673724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624354|NCT01673724|Protective Agents|protective agents|mesh-ancestor
102624355|NCT01673724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624356|NCT01673724|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102624357|NCT01673724|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102624358|NCT01673724|Dopamine Agonists|dopamine agonists|mesh-ancestor
102624359|NCT01673724|Dopamine Agents|dopamine agents|mesh-ancestor
102624360|NCT01673724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102624361|NCT01673724|Hormone Antagonists|hormone antagonists|mesh-ancestor
102624362|NCT01673724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102624363|NCT04765098|Tamoxifen|tamoxifen|mesh-list
102624364|NCT04765098|Etoposide|etoposide|mesh-list
102624365|NCT04765098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102624366|NCT04765098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102624367|NCT04765098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102624368|NCT04765098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102624369|NCT04765098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102624370|NCT04765098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624371|NCT04765098|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102624372|NCT04765098|Hormone Antagonists|hormone antagonists|mesh-ancestor
102624373|NCT04765098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102624374|NCT04765098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624375|NCT04765098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102624376|NCT04765098|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102624377|NCT04765098|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102624378|NCT04765098|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102624379|NCT01674036|Venglustat|venglustat|mesh-list
102624380|NCT01674036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102624381|NCT01674036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624382|NCT03378102|Interferon-gamma|interferon-gamma|mesh-list
102624383|NCT03378102|Antiviral Agents|antiviral agents|mesh-ancestor
102624384|NCT03378102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102624385|NCT03032328|Vitamin D|vitamin d|mesh-list
102624386|NCT03032328|Vitamins|vitamins|mesh-ancestor
102624387|NCT03032328|Micronutrients|micronutrients|mesh-ancestor
102624388|NCT03032328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624389|NCT03032328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102624390|NCT04747392|Teriparatide|teriparatide|mesh-list
102624391|NCT04747392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102624392|NCT04747392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624393|NCT04747392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102624394|NCT01674192|Prucalopride|prucalopride|mesh-list
102624395|NCT01674192|Laxatives|laxatives|mesh-ancestor
102624396|NCT01674192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102624397|NCT01674192|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
102624398|NCT01674192|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102624399|NCT01674192|Serotonin Agents|serotonin agents|mesh-ancestor
102624400|NCT01674192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102624401|NCT01674192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624402|NCT01674192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624403|NCT01674270|Bicalutamide|bicalutamide|mesh-list
102624404|NCT01674270|Androgen Antagonists|androgen antagonists|mesh-ancestor
102624405|NCT01674270|Hormone Antagonists|hormone antagonists|mesh-ancestor
102624406|NCT01674270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102624407|NCT01674270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624408|NCT01674270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102624409|NCT01674504|Montelukast|montelukast|mesh-list
102624410|NCT01674504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102624411|NCT01674504|Respiratory System Agents|respiratory system agents|mesh-ancestor
102624412|NCT01674504|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102624413|NCT01674504|Hormone Antagonists|hormone antagonists|mesh-ancestor
102624414|NCT01674504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102624415|NCT01674504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624416|NCT01674504|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102624417|NCT01674504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102624418|NCT01674504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624419|NCT05353062|Epinephrine|epinephrine|mesh-list
102624420|NCT05353062|Hemostatics|hemostatics|mesh-list
102624421|NCT05353062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102624422|NCT05353062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102624423|NCT05353062|Adrenergic Agents|adrenergic agents|mesh-ancestor
102624424|NCT05353062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102274986|NCT00466531|Cyclophosphamide|cyclophosphamide|mesh-list
101912702|NCT01131936|Amlodipine|amlodipine|mesh-list
102274987|NCT00466531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102624425|NCT05353062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624426|NCT05353062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624427|NCT05353062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102624428|NCT05353062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102624429|NCT05353062|Autonomic Agents|autonomic agents|mesh-ancestor
102624430|NCT05353062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102624431|NCT05353062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102624432|NCT05353062|Respiratory System Agents|respiratory system agents|mesh-ancestor
102624433|NCT05353062|Mydriatics|mydriatics|mesh-ancestor
102624434|NCT05353062|Sympathomimetics|sympathomimetics|mesh-ancestor
102624435|NCT05353062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102624436|NCT05353062|Coagulants|coagulants|mesh-ancestor
102624437|NCT03152370|Leucovorin|leucovorin|mesh-list
102624438|NCT03152370|Folic Acid|folic acid|mesh-list
102624439|NCT03152370|Capecitabine|capecitabine|mesh-list
102624440|NCT03152370|Oxaliplatin|oxaliplatin|mesh-list
102624441|NCT03152370|Levoleucovorin|levoleucovorin|mesh-list
102624442|NCT03152370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102624443|NCT03152370|Antimetabolites|antimetabolites|mesh-ancestor
102624444|NCT03152370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624445|NCT03152370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102624446|NCT03152370|Antidotes|antidotes|mesh-ancestor
102624447|NCT03152370|Protective Agents|protective agents|mesh-ancestor
102624448|NCT03152370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624449|NCT03152370|Vitamin B Complex|vitamin b complex|mesh-ancestor
102624450|NCT03152370|Vitamins|vitamins|mesh-ancestor
102624451|NCT03152370|Micronutrients|micronutrients|mesh-ancestor
102624452|NCT03152370|Hematinics|hematinics|mesh-ancestor
102624453|NCT02187120|Tranexamic Acid|tranexamic acid|mesh-list
102624454|NCT02187120|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102624455|NCT02187120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102624456|NCT02187120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624457|NCT02187120|Hemostatics|hemostatics|mesh-ancestor
102624458|NCT02187120|Coagulants|coagulants|mesh-ancestor
102624459|NCT01674738|Bevacizumab|bevacizumab|mesh-list
102624460|NCT01674738|Pemetrexed|pemetrexed|mesh-list
102624461|NCT01674738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102624462|NCT01674738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102624463|NCT01674738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102624464|NCT01674738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102624465|NCT01674738|Growth Substances|growth substances|mesh-ancestor
102624466|NCT01674738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624467|NCT01674738|Growth Inhibitors|growth inhibitors|mesh-ancestor
102624468|NCT01674738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102624469|NCT01674738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624470|NCT01674738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102624471|NCT01674738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102624472|NCT01675206|Vitamin K|vitamin k|mesh-list
102624473|NCT01675206|Vitamin K 2|vitamin k 2|mesh-list
102624474|NCT01675206|Vitamins|vitamins|mesh-ancestor
102624475|NCT01675206|Micronutrients|micronutrients|mesh-ancestor
102624476|NCT01675206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624477|NCT01675206|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102624478|NCT01675206|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101596828|NCT04115644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102624479|NCT01675206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624480|NCT01675206|Hemostatics|hemostatics|mesh-ancestor
102624481|NCT01675206|Coagulants|coagulants|mesh-ancestor
102624482|NCT03150576|Paclitaxel|paclitaxel|mesh-list
102624483|NCT03150576|Carboplatin|carboplatin|mesh-list
102624484|NCT03150576|Olaparib|olaparib|mesh-list
102624485|NCT03150576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102624486|NCT03150576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102624487|NCT03150576|Tubulin Modulators|tubulin modulators|mesh-ancestor
102624488|NCT03150576|Antimitotic Agents|antimitotic agents|mesh-ancestor
102624489|NCT03150576|Mitosis Modulators|mitosis modulators|mesh-ancestor
102624490|NCT03150576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624491|NCT03150576|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102624492|NCT03150576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102624493|NCT04747080|Dexamethasone|dexamethasone|mesh-list
102624494|NCT04747080|Dexamethasone acetate|dexamethasone acetate|mesh-list
102624495|NCT04747080|BB 1101|bb 1101|mesh-list
102624496|NCT04747080|Tacrolimus|tacrolimus|mesh-list
102624497|NCT04747080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101912787|NCT05401812|Hormones|hormones|mesh-ancestor
102624498|NCT04747080|Antiemetics|antiemetics|mesh-ancestor
102624499|NCT04747080|Autonomic Agents|autonomic agents|mesh-ancestor
102624500|NCT04747080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102624501|NCT04747080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624502|NCT04747080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102624503|NCT04747080|Glucocorticoids|glucocorticoids|mesh-ancestor
102624505|NCT04747080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102624506|NCT04747080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102624507|NCT04747080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101596859|NCT00636064|Parecoxib|parecoxib|mesh-list
102624508|NCT04747080|Protease Inhibitors|protease inhibitors|mesh-ancestor
102624509|NCT04747080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102624510|NCT04747080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624511|NCT04747080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102624512|NCT04747080|Immunologic Factors|immunologic factors|mesh-ancestor
102624513|NCT04747080|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102624514|NCT01675362|Selenium|selenium|mesh-list
102624515|NCT01675362|Losartan|losartan|mesh-list
102624516|NCT01675362|Verapamil|verapamil|mesh-list
102624517|NCT01675362|Calcium Channel Blockers|calcium channel blockers|mesh-list
102624518|NCT01675362|Calcium|calcium|mesh-list
102624519|NCT01675362|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
102624520|NCT01675362|Antioxidants|antioxidants|mesh-list
102624521|NCT01675362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102624522|NCT01675362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624523|NCT01675362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102624524|NCT01675362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102624525|NCT01675362|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102624526|NCT01675362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624527|NCT01675362|Protective Agents|protective agents|mesh-ancestor
102624528|NCT01675362|Trace Elements|trace elements|mesh-ancestor
102624529|NCT01675362|Micronutrients|micronutrients|mesh-ancestor
102624530|NCT01675362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102624531|NCT01675362|Vasodilator Agents|vasodilator agents|mesh-ancestor
102624532|NCT01675518|ASP7991|asp7991|mesh-list
102624533|NCT01675518|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
102624534|NCT01675518|Hormone Antagonists|hormone antagonists|mesh-ancestor
102624535|NCT01675518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102624536|NCT01675518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624537|NCT03158532|Nitroglycerin|nitroglycerin|mesh-list
102624538|NCT03158532|Vasodilator Agents|vasodilator agents|mesh-ancestor
102624539|NCT01675986|Pregabalin|pregabalin|mesh-list
102624540|NCT01675986|Hydroxyzine|hydroxyzine|mesh-list
102624541|NCT01675986|Analgesics|analgesics|mesh-ancestor
102624542|NCT01675986|Sensory System Agents|sensory system agents|mesh-ancestor
102624543|NCT01675986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102624544|NCT01675986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624545|NCT01675986|Anticonvulsants|anticonvulsants|mesh-ancestor
102624546|NCT01675986|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102624547|NCT01675986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102624548|NCT01675986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624549|NCT01675986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102624550|NCT01675986|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102624551|NCT01675986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102624552|NCT01675986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102624553|NCT01675986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102624554|NCT01675986|Antipruritics|antipruritics|mesh-ancestor
102624555|NCT01675986|Dermatologic Agents|dermatologic agents|mesh-ancestor
101596889|NCT04217668|Diuretics|diuretics|mesh-ancestor
102624556|NCT01675986|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102624557|NCT01675986|Histamine Antagonists|histamine antagonists|mesh-ancestor
102624558|NCT01675986|Histamine Agents|histamine agents|mesh-ancestor
102624559|NCT01675986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102624560|NCT03875664|Bupivacaine|bupivacaine|mesh-list
102624561|NCT03875664|Anesthetics, Local|anesthetics, local|mesh-ancestor
102624562|NCT03875664|Anesthetics|anesthetics|mesh-ancestor
102624563|NCT03875664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102624564|NCT03875664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624565|NCT03875664|Sensory System Agents|sensory system agents|mesh-ancestor
102624566|NCT03875664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102624567|NCT01670136|Sildenafil Citrate|sildenafil citrate|mesh-list
102624568|NCT01670136|Vasodilator Agents|vasodilator agents|mesh-ancestor
102624569|NCT01670136|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102624570|NCT01670136|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102624571|NCT01670136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102624572|NCT01670136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624573|NCT01670136|Urological Agents|urological agents|mesh-ancestor
102274988|NCT00466531|Immunologic Factors|immunologic factors|mesh-ancestor
102624574|NCT03873480|Epinephrine|epinephrine|mesh-list
102624575|NCT03873480|Bupivacaine|bupivacaine|mesh-list
102624576|NCT03873480|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102624577|NCT03873480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102624578|NCT03873480|Adrenergic Agents|adrenergic agents|mesh-ancestor
102624579|NCT03873480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102624580|NCT03873480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624581|NCT03873480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624582|NCT03873480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102624583|NCT03873480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102624584|NCT03873480|Autonomic Agents|autonomic agents|mesh-ancestor
102624585|NCT03873480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102624586|NCT03873480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102624587|NCT03873480|Respiratory System Agents|respiratory system agents|mesh-ancestor
102624588|NCT03873480|Mydriatics|mydriatics|mesh-ancestor
102624589|NCT03873480|Sympathomimetics|sympathomimetics|mesh-ancestor
102624590|NCT03873480|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102624591|NCT03873480|Anesthetics, Local|anesthetics, local|mesh-ancestor
102624592|NCT03873480|Anesthetics|anesthetics|mesh-ancestor
102624593|NCT03873480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102624594|NCT03873480|Sensory System Agents|sensory system agents|mesh-ancestor
102624595|NCT04764084|Niraparib|niraparib|mesh-list
102624596|NCT04764084|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102624597|NCT04764084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102624598|NCT04764084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624599|NCT04764084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102624600|NCT03866772|Misoprostol|misoprostol|mesh-list
102624601|NCT03866772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102624602|NCT03866772|Abortifacient Agents|abortifacient agents|mesh-ancestor
102624603|NCT03866772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102624604|NCT03866772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624605|NCT03866772|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102624606|NCT03866772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102624607|NCT03866772|Oxytocics|oxytocics|mesh-ancestor
102624608|NCT03866538|Budesonide|budesonide|mesh-list
102624609|NCT03866538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102624610|NCT03866538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102624611|NCT03866538|Autonomic Agents|autonomic agents|mesh-ancestor
102624612|NCT03866538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102624613|NCT03866538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624614|NCT03866538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102624615|NCT03866538|Respiratory System Agents|respiratory system agents|mesh-ancestor
102624616|NCT03866538|Glucocorticoids|glucocorticoids|mesh-ancestor
102624617|NCT03866538|Hormones|hormones|mesh-ancestor
102624618|NCT03866538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102624619|NCT03865992|Curcumin|curcumin|mesh-list
102624620|NCT03865992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102624621|NCT03865992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102624622|NCT03865992|Analgesics|analgesics|mesh-ancestor
102624623|NCT03865992|Sensory System Agents|sensory system agents|mesh-ancestor
102624624|NCT03865992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102624625|NCT03865992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624626|NCT03865992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102624627|NCT03865992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102624628|NCT03865992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102624629|NCT03865992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102624630|NCT03865992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624631|NCT03865212|Interferons|interferons|mesh-list
102624632|NCT03865212|Interferon-beta|interferon-beta|mesh-list
102624633|NCT03865212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102624634|NCT03865212|Antiviral Agents|antiviral agents|mesh-ancestor
102624635|NCT03865212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102624636|NCT03865212|Immunologic Factors|immunologic factors|mesh-ancestor
102624637|NCT03865212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624638|NCT01677390|Everolimus|everolimus|mesh-list
102624639|NCT01677390|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102624640|NCT01677390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102624641|NCT01677390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102624642|NCT01677390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624643|NCT01677390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102624644|NCT01677390|Immunologic Factors|immunologic factors|mesh-ancestor
102624645|NCT01677390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624646|NCT01677390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102624647|NCT03749070|Silymarin|silymarin|mesh-list
102624648|NCT03749070|Antioxidants|antioxidants|mesh-ancestor
102624649|NCT03749070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912965|NCT01232244|Hormones|hormones|mesh-ancestor
102274989|NCT00466531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624650|NCT03749070|Protective Agents|protective agents|mesh-ancestor
102624651|NCT03749070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624653|NCT03748134|Fluorouracil|fluorouracil|mesh-list
102624654|NCT03748134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102624655|NCT03748134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102624656|NCT03748134|Tubulin Modulators|tubulin modulators|mesh-ancestor
102624657|NCT03748134|Antimitotic Agents|antimitotic agents|mesh-ancestor
102624658|NCT03748134|Mitosis Modulators|mitosis modulators|mesh-ancestor
102624659|NCT03748134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624660|NCT03748134|Antimetabolites|antimetabolites|mesh-ancestor
102624661|NCT03748134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102624662|NCT03748134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102624663|NCT03748134|Immunologic Factors|immunologic factors|mesh-ancestor
102624664|NCT03748134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624665|NCT01345656|Spironolactone|spironolactone|mesh-list
102624666|NCT01345656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102624667|NCT01345656|Hormone Antagonists|hormone antagonists|mesh-ancestor
102624668|NCT01345656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102624669|NCT01345656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624670|NCT01345656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102624671|NCT01345656|Diuretics|diuretics|mesh-ancestor
102624672|NCT01345656|Natriuretic Agents|natriuretic agents|mesh-ancestor
102624673|NCT03747120|Paclitaxel|paclitaxel|mesh-list
102624674|NCT03747120|Pembrolizumab|pembrolizumab|mesh-list
102624675|NCT03747120|Trastuzumab|trastuzumab|mesh-list
102624676|NCT03747120|Pertuzumab|pertuzumab|mesh-list
102624677|NCT03747120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102624678|NCT03747120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102624679|NCT03747120|Tubulin Modulators|tubulin modulators|mesh-ancestor
102624680|NCT03747120|Antimitotic Agents|antimitotic agents|mesh-ancestor
102624681|NCT03747120|Mitosis Modulators|mitosis modulators|mesh-ancestor
102624682|NCT03747120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624683|NCT03747120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102624684|NCT03747120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102624685|NCT04763616|Cemiplimab|cemiplimab|mesh-list
102624686|NCT04763616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102624687|NCT04763616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102624688|NCT03652974|Valproic Acid|valproic acid|mesh-list
102624689|NCT03652974|Clozapine|clozapine|mesh-list
102624690|NCT03652974|Amisulpride|amisulpride|mesh-list
102624691|NCT03652974|Anticonvulsants|anticonvulsants|mesh-ancestor
102624692|NCT03652974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102624693|NCT03652974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624694|NCT03652974|GABA Agents|gaba agents|mesh-ancestor
102624695|NCT03652974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102624696|NCT03652974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624697|NCT03652974|Antimanic Agents|antimanic agents|mesh-ancestor
102624698|NCT03652974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102624699|NCT03652974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102624700|NCT03652974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102624701|NCT03652974|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102624702|NCT03652974|Serotonin Agents|serotonin agents|mesh-ancestor
102624703|NCT03652974|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102624704|NCT03652974|GABA Antagonists|gaba antagonists|mesh-ancestor
102624705|NCT03652974|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102624706|NCT03652974|Dopamine Agents|dopamine agents|mesh-ancestor
102624707|NCT03652974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102624708|NCT03652974|Antidepressive Agents|antidepressive agents|mesh-ancestor
102624709|NCT03649152|Propagermanium|propagermanium|mesh-list
102624710|NCT03649152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102624711|NCT03649152|Interferon Inducers|interferon inducers|mesh-ancestor
102624712|NCT03649152|Immunologic Factors|immunologic factors|mesh-ancestor
102624713|NCT03649152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624714|NCT03646188|Doxorubicin|doxorubicin|mesh-list
102624715|NCT03646188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102624716|NCT03646188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102624717|NCT03646188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102624718|NCT03646188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102624719|NCT03646188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102624720|NCT03646188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102274990|NCT00466531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101912997|NCT02528760|Antiemetics|antiemetics|mesh-ancestor
102624721|NCT03646188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624722|NCT03642210|Levonorgestrel|levonorgestrel|mesh-list
102274991|NCT00466531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102624723|NCT03642210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102624724|NCT03642210|Contraceptive Agents|contraceptive agents|mesh-ancestor
102624725|NCT03642210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102624726|NCT03642210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624727|NCT03642210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102624728|NCT03642210|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102624729|NCT03642210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102624731|NCT02082678|Antiemetics|antiemetics|mesh-ancestor
102624732|NCT02082678|Autonomic Agents|autonomic agents|mesh-ancestor
102624733|NCT02082678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102624734|NCT02082678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624735|NCT02082678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102624736|NCT02082678|Antipruritics|antipruritics|mesh-ancestor
102624737|NCT02082678|Dermatologic Agents|dermatologic agents|mesh-ancestor
102624738|NCT02082678|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102624739|NCT02082678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102624740|NCT02082678|Serotonin Agents|serotonin agents|mesh-ancestor
102624741|NCT02082678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102624742|NCT02082678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624743|NCT03843294|Nivolumab|nivolumab|mesh-list
102624744|NCT03843294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102624745|NCT03843294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102624746|NCT03843294|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102624747|NCT03843294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624748|NCT01677468|Doxorubicin|doxorubicin|mesh-list
102624749|NCT01677468|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102624750|NCT01677468|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
102624751|NCT01677468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102624752|NCT01677468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102624753|NCT01677468|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102624754|NCT01677468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102624755|NCT01677468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102624756|NCT01677468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624757|NCT01677468|Hemostatics|hemostatics|mesh-ancestor
102624758|NCT01677468|Coagulants|coagulants|mesh-ancestor
102624759|NCT00003816|Cyclophosphamide|cyclophosphamide|mesh-list
102624760|NCT00003816|Melphalan|melphalan|mesh-list
102624761|NCT00003816|Busulfan|busulfan|mesh-list
102624762|NCT00003816|Thiotepa|thiotepa|mesh-list
102624763|NCT00003816|Carboplatin|carboplatin|mesh-list
102624764|NCT00003816|Fludarabine|fludarabine|mesh-list
102624765|NCT00003816|Fludarabine phosphate|fludarabine phosphate|mesh-list
102624766|NCT00003816|Etoposide|etoposide|mesh-list
102624767|NCT00003816|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102624768|NCT00003816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102624769|NCT00003816|Immunologic Factors|immunologic factors|mesh-ancestor
102624770|NCT00003816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624771|NCT00003816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102624772|NCT00003816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102624773|NCT00003816|Alkylating Agents|alkylating agents|mesh-ancestor
102624774|NCT00003816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624775|NCT00003816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102624776|NCT00003816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102624777|NCT00003816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102624778|NCT00003816|Antimetabolites|antimetabolites|mesh-ancestor
102624779|NCT00003816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102624780|NCT00003816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102624781|NCT00003816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102624782|NCT00003816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102624783|NCT03618654|Metformin|metformin|mesh-list
102624784|NCT03618654|Durvalumab|durvalumab|mesh-list
102624785|NCT03618654|Immunoglobulins|immunoglobulins|mesh-list
102624786|NCT03618654|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102624787|NCT03618654|Immunoglobulin G|immunoglobulin g|mesh-list
102624788|NCT03618654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102624789|NCT03618654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624790|NCT03618654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102624791|NCT03618654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102624792|NCT03618654|Immunologic Factors|immunologic factors|mesh-ancestor
102624793|NCT04763070|Ciprofloxacin|ciprofloxacin|mesh-list
102624794|NCT04763070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102274992|NCT00466531|Alkylating Agents|alkylating agents|mesh-ancestor
102624795|NCT04763070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102624796|NCT04763070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102624797|NCT04763070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102624798|NCT04763070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102624799|NCT04763070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624800|NCT04763070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102624801|NCT04763070|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102624802|NCT04763070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102624803|NCT03611556|Leucovorin|leucovorin|mesh-list
102624804|NCT03611556|Paclitaxel|paclitaxel|mesh-list
102624805|NCT03611556|Gemcitabine|gemcitabine|mesh-list
102624806|NCT03611556|Oxaliplatin|oxaliplatin|mesh-list
102624807|NCT03611556|Fluorouracil|fluorouracil|mesh-list
102624808|NCT03611556|Durvalumab|durvalumab|mesh-list
102624809|NCT03611556|Levoleucovorin|levoleucovorin|mesh-list
102624810|NCT03611556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102624811|NCT03611556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102624812|NCT03611556|Tubulin Modulators|tubulin modulators|mesh-ancestor
102624813|NCT03611556|Antimitotic Agents|antimitotic agents|mesh-ancestor
102624814|NCT03611556|Mitosis Modulators|mitosis modulators|mesh-ancestor
102624815|NCT03611556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624816|NCT03611556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102624817|NCT03611556|Antimetabolites|antimetabolites|mesh-ancestor
102624818|NCT03611556|Antidotes|antidotes|mesh-ancestor
102624819|NCT03611556|Protective Agents|protective agents|mesh-ancestor
102624820|NCT03611556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624821|NCT03611556|Vitamin B Complex|vitamin b complex|mesh-ancestor
102624822|NCT03611556|Vitamins|vitamins|mesh-ancestor
102624823|NCT03611556|Micronutrients|micronutrients|mesh-ancestor
102624824|NCT03611556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102624825|NCT03611556|Immunologic Factors|immunologic factors|mesh-ancestor
102624826|NCT03611556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102624827|NCT03609060|Dexamethasone|dexamethasone|mesh-list
102624828|NCT03609060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102624829|NCT03609060|Antiemetics|antiemetics|mesh-ancestor
102624830|NCT03609060|Autonomic Agents|autonomic agents|mesh-ancestor
101597133|NCT02749162|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102624831|NCT03609060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102624832|NCT03609060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624833|NCT03609060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102624834|NCT03609060|Glucocorticoids|glucocorticoids|mesh-ancestor
102624835|NCT03609060|Hormones|hormones|mesh-ancestor
102624836|NCT03609060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102624837|NCT03609060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102624838|NCT03609060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102624839|NCT03704766|alpha-Defensins|alpha-defensins|mesh-list
102624840|NCT03704766|Defensins|defensins|mesh-list
102624841|NCT03704766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102624842|NCT03826992|Cytarabine|cytarabine|mesh-list
102624843|NCT03826992|Daunorubicin|daunorubicin|mesh-list
102624844|NCT03826992|Venetoclax|venetoclax|mesh-list
102624845|NCT03826992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102624846|NCT03826992|Antimetabolites|antimetabolites|mesh-ancestor
102624847|NCT03826992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624848|NCT03826992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102624849|NCT03826992|Antiviral Agents|antiviral agents|mesh-ancestor
102624850|NCT03826992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102624851|NCT03826992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102624852|NCT03826992|Immunologic Factors|immunologic factors|mesh-ancestor
102624853|NCT03826992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624854|NCT03826992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102624855|NCT03826992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102624856|NCT03826992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102624857|NCT03826992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102624858|NCT00004092|Paclitaxel|paclitaxel|mesh-list
102624859|NCT00004092|Cyclophosphamide|cyclophosphamide|mesh-list
102624860|NCT00004092|Carboplatin|carboplatin|mesh-list
102624861|NCT00004092|Doxorubicin|doxorubicin|mesh-list
102624862|NCT00004092|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102624863|NCT00004092|Thiotepa|thiotepa|mesh-list
102624864|NCT00004092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102624865|NCT00004092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102624866|NCT00004092|Tubulin Modulators|tubulin modulators|mesh-ancestor
102624867|NCT00004092|Antimitotic Agents|antimitotic agents|mesh-ancestor
102624868|NCT00004092|Mitosis Modulators|mitosis modulators|mesh-ancestor
101913148|NCT01234272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102624869|NCT00004092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624870|NCT00004092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102624871|NCT00004092|Immunologic Factors|immunologic factors|mesh-ancestor
102624872|NCT00004092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624873|NCT00004092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102624874|NCT00004092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102624875|NCT00004092|Alkylating Agents|alkylating agents|mesh-ancestor
102624876|NCT00004092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102624877|NCT00004092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102624878|NCT00004092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102624879|NCT00004092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102624880|NCT00004092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102624881|NCT00004146|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
102624882|NCT00004146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102624883|NCT00004146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102624884|NCT00004146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102624885|NCT00004146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624886|NCT00004146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102624887|NCT00004146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624888|NCT00004500|Pulmonary Surfactants|pulmonary surfactants|mesh-list
102624889|NCT00004500|Respiratory System Agents|respiratory system agents|mesh-ancestor
102624890|NCT03825198|Dexamethasone|dexamethasone|mesh-list
102624892|NCT03825198|Sufentanil|sufentanil|mesh-list
102624893|NCT03825198|Morphine|morphine|mesh-list
102624894|NCT03825198|Bromides|bromides|mesh-list
102624895|NCT03825198|Propofol|propofol|mesh-list
102624896|NCT03825198|Sevoflurane|sevoflurane|mesh-list
102624897|NCT03825198|Levobupivacaine|levobupivacaine|mesh-list
102624898|NCT03825198|Rocuronium|rocuronium|mesh-list
102624899|NCT03825198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102624900|NCT03825198|Antiemetics|antiemetics|mesh-ancestor
102624901|NCT03825198|Autonomic Agents|autonomic agents|mesh-ancestor
102624902|NCT03825198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102624903|NCT03825198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624904|NCT03825198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102624905|NCT03825198|Glucocorticoids|glucocorticoids|mesh-ancestor
102624906|NCT03825198|Hormones|hormones|mesh-ancestor
102624907|NCT03825198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102624908|NCT03825198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102624909|NCT03825198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102624910|NCT03825198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102624911|NCT03825198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102624912|NCT03825198|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102624913|NCT03825198|Anesthetics, General|anesthetics, general|mesh-ancestor
102624914|NCT03825198|Anesthetics|anesthetics|mesh-ancestor
102624915|NCT03825198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102624916|NCT03825198|Narcotics|narcotics|mesh-ancestor
102624917|NCT03825198|Analgesics|analgesics|mesh-ancestor
102624918|NCT03825198|Sensory System Agents|sensory system agents|mesh-ancestor
102624919|NCT03825198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102624920|NCT03825198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102624921|NCT03825198|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102624922|NCT03825198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102624923|NCT03825198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102624924|NCT03825198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102624925|NCT03825198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102624926|NCT03825198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624927|NCT03825198|Anticonvulsants|anticonvulsants|mesh-ancestor
102624928|NCT03825198|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102624929|NCT03825198|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102624930|NCT03825198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102624931|NCT03825198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102624932|NCT03825198|Anesthetics, Local|anesthetics, local|mesh-ancestor
102624933|NCT03824106|Vitamin D|vitamin d|mesh-list
102624934|NCT03824106|Vitamins|vitamins|mesh-ancestor
102624935|NCT03824106|Micronutrients|micronutrients|mesh-ancestor
102624936|NCT03824106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624937|NCT03824106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102624938|NCT03817320|Leucovorin|leucovorin|mesh-list
102624939|NCT03817320|Cytarabine|cytarabine|mesh-list
102624940|NCT03817320|Dexamethasone|dexamethasone|mesh-list
102624941|NCT03817320|Hydrocortisone|hydrocortisone|mesh-list
102624942|NCT03817320|Doxorubicin|doxorubicin|mesh-list
102624943|NCT03817320|Methotrexate|methotrexate|mesh-list
102624944|NCT03817320|Vincristine|vincristine|mesh-list
102624945|NCT03817320|Asparaginase|asparaginase|mesh-list
102274993|NCT00466531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624946|NCT03817320|Ixazomib|ixazomib|mesh-list
102624947|NCT03817320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102624948|NCT03817320|Antiemetics|antiemetics|mesh-ancestor
102624949|NCT03817320|Autonomic Agents|autonomic agents|mesh-ancestor
102624950|NCT03817320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102624951|NCT03817320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624952|NCT03817320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102624953|NCT03817320|Glucocorticoids|glucocorticoids|mesh-ancestor
102624955|NCT03817320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102624956|NCT03817320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102624957|NCT03817320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102624958|NCT03817320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102624959|NCT03817320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102624960|NCT03817320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102624961|NCT03817320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102624962|NCT03817320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102624963|NCT03817320|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102624964|NCT03817320|Abortifacient Agents|abortifacient agents|mesh-ancestor
102624965|NCT03817320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102624966|NCT03817320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102624967|NCT03817320|Antimetabolites|antimetabolites|mesh-ancestor
102624968|NCT03817320|Dermatologic Agents|dermatologic agents|mesh-ancestor
102624969|NCT03817320|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102624970|NCT03817320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102624971|NCT03817320|Immunologic Factors|immunologic factors|mesh-ancestor
102624972|NCT03817320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102624973|NCT03817320|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102624974|NCT03817320|Antiviral Agents|antiviral agents|mesh-ancestor
102624975|NCT03817320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102624976|NCT03817320|Antidotes|antidotes|mesh-ancestor
102624977|NCT03817320|Protective Agents|protective agents|mesh-ancestor
102624978|NCT03817320|Vitamin B Complex|vitamin b complex|mesh-ancestor
102624979|NCT03817320|Vitamins|vitamins|mesh-ancestor
102624980|NCT03817320|Micronutrients|micronutrients|mesh-ancestor
102624981|NCT03817320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102624982|NCT03817320|Tubulin Modulators|tubulin modulators|mesh-ancestor
102624983|NCT03817320|Antimitotic Agents|antimitotic agents|mesh-ancestor
102624984|NCT03817320|Mitosis Modulators|mitosis modulators|mesh-ancestor
102624985|NCT03817320|Protease Inhibitors|protease inhibitors|mesh-ancestor
102624986|NCT03684018|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102624987|NCT03684018|Immunologic Factors|immunologic factors|mesh-ancestor
102624988|NCT03684018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102624989|NCT03580356|Omalizumab|omalizumab|mesh-list
102624990|NCT03580356|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102624991|NCT03580356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102624992|NCT03580356|Respiratory System Agents|respiratory system agents|mesh-ancestor
102624993|NCT03575052|Pimavanserin|pimavanserin|mesh-list
102624994|NCT03575052|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102624995|NCT03575052|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102624996|NCT03575052|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102624997|NCT03575052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102624998|NCT03575052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102624999|NCT03575052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625000|NCT03575052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102625001|NCT03575052|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102625002|NCT03575052|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102625003|NCT03575052|Serotonin Agents|serotonin agents|mesh-ancestor
102625004|NCT03575052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102625005|NCT03575052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625006|NCT03556020|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
102625007|NCT03556020|Vasodilator Agents|vasodilator agents|mesh-ancestor
102625008|NCT01677546|Insulin|insulin|mesh-list
102625009|NCT01677546|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102625010|NCT01677546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102625011|NCT01677546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625012|NCT04403724|Fentanyl|fentanyl|mesh-list
102625013|NCT04403724|Morphine|morphine|mesh-list
102625014|NCT04403724|Bupivacaine|bupivacaine|mesh-list
102625015|NCT04403724|Anesthetics, Local|anesthetics, local|mesh-ancestor
102625016|NCT04403724|Anesthetics|anesthetics|mesh-ancestor
102625017|NCT04403724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102625018|NCT04403724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625019|NCT04403724|Sensory System Agents|sensory system agents|mesh-ancestor
102625020|NCT04403724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102625021|NCT04403724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102625022|NCT04403724|Narcotics|narcotics|mesh-ancestor
102625023|NCT04403724|Analgesics|analgesics|mesh-ancestor
102625024|NCT04403724|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102625025|NCT04403724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101913298|NCT04624776|Antiemetics|antiemetics|mesh-ancestor
102625026|NCT04403724|Anesthetics, General|anesthetics, general|mesh-ancestor
102625027|NCT03567876|Venetoclax|venetoclax|mesh-list
102625028|NCT03567876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625029|NCT04403568|Ursolic acid|ursolic acid|mesh-list
102625030|NCT04403568|Curcumin|curcumin|mesh-list
102625031|NCT04403568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101597356|NCT02874768|Dexmedetomidine|dexmedetomidine|mesh-list
101597357|NCT02874768|Propofol|propofol|mesh-list
101597358|NCT02874768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101597359|NCT02874768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101597360|NCT02874768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597361|NCT02874768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101597362|NCT02874768|Analgesics|analgesics|mesh-ancestor
101597363|NCT02874768|Sensory System Agents|sensory system agents|mesh-ancestor
101264642|NCT01768780|Bupivacaine|bupivacaine|mesh-list
101597364|NCT02874768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101597365|NCT02874768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102625032|NCT04403568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102625033|NCT04403568|Analgesics|analgesics|mesh-ancestor
102625034|NCT04403568|Sensory System Agents|sensory system agents|mesh-ancestor
102625035|NCT04403568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102625036|NCT04403568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625037|NCT04403568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102625038|NCT04403568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102625039|NCT04403568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625040|NCT04403568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102625041|NCT04403568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625042|NCT04403568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102625043|NCT04403568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102625044|NCT04403568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102625045|NCT03564756|Ascorbic Acid|ascorbic acid|mesh-list
102625046|NCT03564756|Vitamins|vitamins|mesh-ancestor
102625047|NCT03564756|Micronutrients|micronutrients|mesh-ancestor
102625048|NCT03564756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625049|NCT03564756|Antioxidants|antioxidants|mesh-ancestor
102625050|NCT03564756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625051|NCT03564756|Protective Agents|protective agents|mesh-ancestor
102625052|NCT03462966|Rifaximin|rifaximin|mesh-list
102625053|NCT03462966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102625054|NCT03462966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102625055|NCT03462966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102625056|NCT03458598|Analgesics, Opioid|analgesics, opioid|mesh-list
102625057|NCT03458598|Narcotics|narcotics|mesh-ancestor
102625058|NCT03458598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101597367|NCT02874768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102625059|NCT03458598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625060|NCT03458598|Analgesics|analgesics|mesh-ancestor
102625061|NCT03458598|Sensory System Agents|sensory system agents|mesh-ancestor
102625062|NCT03458598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102625063|NCT03791736|Octreotide|octreotide|mesh-list
102625064|NCT03791736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102625065|NCT03791736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102625066|NCT03791736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625067|NCT01679964|Raltegravir Potassium|raltegravir potassium|mesh-list
102625068|NCT01679964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102625069|NCT01679964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102625070|NCT01679964|Antiviral Agents|antiviral agents|mesh-ancestor
102625071|NCT01679964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102625072|NCT01679964|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102625073|NCT01679964|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102625074|NCT01679964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102625075|NCT01679964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625076|NCT03524898|Paclitaxel|paclitaxel|mesh-list
102625077|NCT03524898|Gemcitabine|gemcitabine|mesh-list
102625078|NCT03524898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102625079|NCT03524898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625080|NCT03524898|Tubulin Modulators|tubulin modulators|mesh-ancestor
102625081|NCT03524898|Antimitotic Agents|antimitotic agents|mesh-ancestor
102625082|NCT03524898|Mitosis Modulators|mitosis modulators|mesh-ancestor
102625083|NCT03524898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625084|NCT03524898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102625085|NCT03524898|Antimetabolites|antimetabolites|mesh-ancestor
102625086|NCT03524820|Cetuximab|cetuximab|mesh-list
102625087|NCT03524820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102625088|NCT03524820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625089|NCT03524508|Fluorouracil|fluorouracil|mesh-list
102625090|NCT03524508|Irinotecan|irinotecan|mesh-list
102625091|NCT03524508|Antimetabolites|antimetabolites|mesh-ancestor
102625092|NCT03524508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625093|NCT03524508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102625094|NCT03524508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625095|NCT03524508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102625096|NCT03524508|Immunologic Factors|immunologic factors|mesh-ancestor
102625097|NCT03524508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625098|NCT03524508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102625099|NCT03524508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102625100|NCT03524508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101913372|NCT01140984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102625101|NCT03522168|Risperidone|risperidone|mesh-list
102274994|NCT00466531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625102|NCT03522168|Aripiprazole|aripiprazole|mesh-list
102625103|NCT03522168|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102625104|NCT03522168|Serotonin Agents|serotonin agents|mesh-ancestor
102625105|NCT03522168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102625106|NCT03522168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625107|NCT03522168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625108|NCT03522168|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102625109|NCT03522168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102625110|NCT03522168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102625111|NCT03522168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102625112|NCT03522168|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102625113|NCT03522168|Dopamine Agents|dopamine agents|mesh-ancestor
102625114|NCT03522168|Antidepressive Agents|antidepressive agents|mesh-ancestor
102625115|NCT03522168|Dopamine Agonists|dopamine agonists|mesh-ancestor
102625116|NCT03522168|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102625117|NCT03522168|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102625118|NCT03522168|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102625119|NCT03522168|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102625120|NCT03457818|Denosumab|denosumab|mesh-list
102625121|NCT03457818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102625122|NCT03457818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625123|NCT01676844|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102625124|NCT01676844|Potassium phosphate|potassium phosphate|mesh-list
102625125|NCT01676844|Cariostatic Agents|cariostatic agents|mesh-ancestor
102625126|NCT01676844|Protective Agents|protective agents|mesh-ancestor
102625127|NCT01676844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625128|NCT04403334|Moxifloxacin|moxifloxacin|mesh-list
102625129|NCT04403334|Levofloxacin|levofloxacin|mesh-list
102625130|NCT04403334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102625131|NCT04403334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102625132|NCT04403334|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102625133|NCT04403334|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102625134|NCT04403334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102625135|NCT04403334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625136|NCT04403334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625137|NCT04403334|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102625138|NCT04403334|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102625139|NCT04403334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102625140|NCT03779646|Bisoprolol|bisoprolol|mesh-list
102625141|NCT03779646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102625142|NCT03779646|Sympatholytics|sympatholytics|mesh-ancestor
102625143|NCT03779646|Autonomic Agents|autonomic agents|mesh-ancestor
102625144|NCT03779646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102625145|NCT03779646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625146|NCT03779646|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102625147|NCT03779646|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102625148|NCT03779646|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102625149|NCT03779646|Adrenergic Agents|adrenergic agents|mesh-ancestor
102625150|NCT03779646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102625151|NCT03779646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625152|NCT03774732|Paclitaxel|paclitaxel|mesh-list
102625153|NCT03774732|Cisplatin|cisplatin|mesh-list
102625154|NCT03774732|Carboplatin|carboplatin|mesh-list
102625155|NCT03774732|Pembrolizumab|pembrolizumab|mesh-list
102625156|NCT03774732|Pemetrexed|pemetrexed|mesh-list
102625157|NCT03774732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102625158|NCT03774732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625159|NCT03774732|Tubulin Modulators|tubulin modulators|mesh-ancestor
102625160|NCT03774732|Antimitotic Agents|antimitotic agents|mesh-ancestor
102625161|NCT03774732|Mitosis Modulators|mitosis modulators|mesh-ancestor
102625162|NCT03774732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625163|NCT03774732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102625164|NCT03774732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102625165|NCT03774732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102625166|NCT03774732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102625167|NCT03774732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102625168|NCT05347134|Gemcitabine|gemcitabine|mesh-list
102625169|NCT05347134|Capecitabine|capecitabine|mesh-list
102625170|NCT05347134|Vinorelbine|vinorelbine|mesh-list
102625171|NCT05347134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102625172|NCT05347134|Antimetabolites|antimetabolites|mesh-ancestor
102274995|NCT00466531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102274996|NCT00244933|Gemcitabine|gemcitabine|mesh-list
102274997|NCT00244933|Genistein|genistein|mesh-list
102625173|NCT05347134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625174|NCT05347134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625175|NCT05347134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102625176|NCT05347134|Tubulin Modulators|tubulin modulators|mesh-ancestor
102625177|NCT05347134|Antimitotic Agents|antimitotic agents|mesh-ancestor
102625178|NCT05347134|Mitosis Modulators|mitosis modulators|mesh-ancestor
102625179|NCT00089778|Aldesleukin|aldesleukin|mesh-list
102625180|NCT00089778|Interleukin-2|interleukin-2|mesh-list
102625181|NCT00089778|Mitogens|mitogens|mesh-list
102625182|NCT00089778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625183|NCT00089778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102625184|NCT00089778|Analgesics|analgesics|mesh-ancestor
102625185|NCT00089778|Sensory System Agents|sensory system agents|mesh-ancestor
102625186|NCT00089778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102625187|NCT00089778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625188|NCT00089778|Mitosis Modulators|mitosis modulators|mesh-ancestor
102625189|NCT00089778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625190|NCT00089778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102625191|NCT00089778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102625192|NCT00089778|Antiviral Agents|antiviral agents|mesh-ancestor
102625193|NCT00089778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102625194|NCT00089544|Thalidomide|thalidomide|mesh-list
102625195|NCT00089544|Doxorubicin|doxorubicin|mesh-list
102625196|NCT00089544|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102625197|NCT00089544|Ifosfamide|ifosfamide|mesh-list
102625198|NCT00089544|Isophosphamide mustard|isophosphamide mustard|mesh-list
102625199|NCT00089544|Dacarbazine|dacarbazine|mesh-list
102625200|NCT00089544|Imidazole|imidazole|mesh-list
102625201|NCT00089544|Lenograstim|lenograstim|mesh-list
102625202|NCT00089544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102625203|NCT00089544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625204|NCT00089544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102625205|NCT00089544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102625206|NCT00089544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102625207|NCT00089544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625208|NCT00089544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102625209|NCT00089544|Immunologic Factors|immunologic factors|mesh-ancestor
102625210|NCT00089544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625211|NCT00089544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102625212|NCT00089544|Alkylating Agents|alkylating agents|mesh-ancestor
102625213|NCT00089544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102625214|NCT00089544|Leprostatic Agents|leprostatic agents|mesh-ancestor
102625215|NCT00089544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102625216|NCT00089544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102625217|NCT00089544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102625218|NCT00089544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102625219|NCT00089544|Growth Substances|growth substances|mesh-ancestor
102625220|NCT00089544|Growth Inhibitors|growth inhibitors|mesh-ancestor
102625221|NCT00089076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102625222|NCT00089076|Ipilimumab|ipilimumab|mesh-list
102625223|NCT00089076|Antibodies|antibodies|mesh-list
102625224|NCT00089076|Immunoglobulins|immunoglobulins|mesh-list
102625225|NCT00089076|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102625226|NCT00089076|Immunologic Factors|immunologic factors|mesh-ancestor
102625227|NCT00089076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625228|NCT00089076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101597529|NCT02613013|Proxymetacaine|proxymetacaine|mesh-list
102625229|NCT00089076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102625230|NCT00089076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625231|NCT03773562|Erenumab|erenumab|mesh-list
101645299|NCT03439124|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
102625232|NCT03773562|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
102625233|NCT03773562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625234|NCT03773562|Analgesics|analgesics|mesh-ancestor
102625235|NCT03773562|Sensory System Agents|sensory system agents|mesh-ancestor
102625236|NCT03773562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102625237|NCT03773562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625238|NCT00088374|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102625239|NCT00088374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102625240|NCT00088374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625241|NCT00087594|Ribavirin|ribavirin|mesh-list
102625242|NCT00087594|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101913520|NCT05848531|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102625243|NCT00087594|Antimetabolites|antimetabolites|mesh-ancestor
101597560|NCT02611921|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102625244|NCT00087594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625245|NCT00087594|Antiviral Agents|antiviral agents|mesh-ancestor
102625246|NCT00087594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102625248|NCT03770286|Fluorides, Topical|fluorides, topical|mesh-list
102625249|NCT03770286|Cariostatic Agents|cariostatic agents|mesh-ancestor
102625250|NCT03770286|Protective Agents|protective agents|mesh-ancestor
102625251|NCT03770286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625252|NCT00087516|Metformin|metformin|mesh-list
102625253|NCT00087516|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102625254|NCT00087516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102625255|NCT00087516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625256|NCT00087516|Incretins|incretins|mesh-ancestor
102625257|NCT00087516|Hormones|hormones|mesh-ancestor
101597574|NCT01046136|Expectorants|expectorants|mesh-ancestor
102625258|NCT00087516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102625259|NCT00087516|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102625260|NCT00087516|Protease Inhibitors|protease inhibitors|mesh-ancestor
102625261|NCT00087516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102625262|NCT00087516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625263|NCT03768960|Daratumumab|daratumumab|mesh-list
102625264|NCT03768960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625265|NCT00087126|Topotecan|topotecan|mesh-list
102625266|NCT00087126|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102625267|NCT00087126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102625268|NCT00087126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102625269|NCT00087126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625270|NCT00087126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625271|NCT00086346|Cyclosporine|cyclosporine|mesh-list
102625272|NCT00086346|Sirolimus|sirolimus|mesh-list
102625273|NCT00086346|Tacrolimus|tacrolimus|mesh-list
102625274|NCT00086346|Cyclosporins|cyclosporins|mesh-list
102625275|NCT00086346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102625276|NCT00086346|Immunologic Factors|immunologic factors|mesh-ancestor
102625277|NCT00086346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625278|NCT00086346|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102625279|NCT00086346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101597595|NCT02736682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102625280|NCT00086346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625281|NCT00086346|Antifungal Agents|antifungal agents|mesh-ancestor
102625282|NCT00086346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102625283|NCT00086346|Dermatologic Agents|dermatologic agents|mesh-ancestor
102625284|NCT00086346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102625285|NCT00086346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102625286|NCT00086346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102625287|NCT00086346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625288|NCT00085566|Everolimus|everolimus|mesh-list
102625289|NCT00085566|Gefitinib|gefitinib|mesh-list
102625290|NCT00085566|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102625291|NCT00085566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102625292|NCT00085566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102625293|NCT00085566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625294|NCT00085566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102625295|NCT00085566|Immunologic Factors|immunologic factors|mesh-ancestor
102625296|NCT00085566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625297|NCT00085566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625298|NCT00085098|Cyclophosphamide|cyclophosphamide|mesh-list
102625299|NCT00085098|Cisplatin|cisplatin|mesh-list
102625300|NCT00085098|Carboplatin|carboplatin|mesh-list
102625301|NCT00085098|Etoposide|etoposide|mesh-list
102625302|NCT00085098|Lenograstim|lenograstim|mesh-list
102625303|NCT00085098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102625304|NCT00085098|Immunologic Factors|immunologic factors|mesh-ancestor
102625305|NCT00085098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625306|NCT00085098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102625307|NCT00085098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102625308|NCT00085098|Alkylating Agents|alkylating agents|mesh-ancestor
102625309|NCT00085098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625310|NCT00085098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625311|NCT00085098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102625312|NCT00085098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102625313|NCT00085098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102625314|NCT00085098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102625315|NCT00085098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102625316|NCT00085098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102625317|NCT00084864|Calcitriol|calcitriol|mesh-list
102625318|NCT00084864|Dexamethasone|dexamethasone|mesh-list
102274998|NCT00244933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102274999|NCT00244933|Antimetabolites|antimetabolites|mesh-ancestor
102625319|NCT00084864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102625320|NCT00084864|Antiemetics|antiemetics|mesh-ancestor
102625321|NCT00084864|Autonomic Agents|autonomic agents|mesh-ancestor
102275000|NCT00244933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625322|NCT00084864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102625323|NCT00084864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625324|NCT00084864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102625325|NCT00084864|Glucocorticoids|glucocorticoids|mesh-ancestor
102625326|NCT00084864|Hormones|hormones|mesh-ancestor
102625327|NCT00084864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102625328|NCT00084864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102625329|NCT00084864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625330|NCT00084864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102625331|NCT00084864|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102625332|NCT00084864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102625333|NCT00084864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625334|NCT00084864|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102625335|NCT00084864|Vitamins|vitamins|mesh-ancestor
102625336|NCT00084864|Micronutrients|micronutrients|mesh-ancestor
102625337|NCT00084864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102625338|NCT01677702|Lactoferrin|lactoferrin|mesh-list
102625339|NCT01677702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102625340|NCT01473108|Eplerenone|eplerenone|mesh-list
102625341|NCT01473108|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102625342|NCT01473108|Hormone Antagonists|hormone antagonists|mesh-ancestor
102625343|NCT01473108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102625344|NCT01473108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625345|NCT01473108|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102625346|NCT01473108|Diuretics|diuretics|mesh-ancestor
102625347|NCT01473108|Natriuretic Agents|natriuretic agents|mesh-ancestor
102625348|NCT01473108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102625349|NCT00084318|Docetaxel|docetaxel|mesh-list
102625350|NCT00084318|Cetuximab|cetuximab|mesh-list
102625351|NCT00084318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625352|NCT00084318|Tubulin Modulators|tubulin modulators|mesh-ancestor
102625353|NCT00084318|Antimitotic Agents|antimitotic agents|mesh-ancestor
102625354|NCT00084318|Mitosis Modulators|mitosis modulators|mesh-ancestor
102625355|NCT00084318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625356|NCT00084318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102625357|NCT00083616|Panitumumab|panitumumab|mesh-list
102625358|NCT00083616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102625359|NCT00083616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625360|NCT00083226|Doxorubicin|doxorubicin|mesh-list
102625361|NCT00083226|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102625362|NCT00083226|Bortezomib|bortezomib|mesh-list
102625363|NCT00083226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102625364|NCT00083226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625365|NCT00083226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101597680|NCT02737774|Carboplatin|carboplatin|mesh-list
102625366|NCT00083226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102625367|NCT00083226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102625368|NCT00083226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625369|NCT00082758|Interleukin-2|interleukin-2|mesh-list
102625370|NCT00082758|Denileukin diftitox|denileukin diftitox|mesh-list
102625371|NCT00082758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625372|NCT00082758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102625373|NCT00082758|Analgesics|analgesics|mesh-ancestor
102625374|NCT00082758|Sensory System Agents|sensory system agents|mesh-ancestor
102625375|NCT00082758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102625376|NCT00082758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625377|NCT03438318|Atezolizumab|atezolizumab|mesh-list
102625378|NCT03438318|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102625379|NCT03438318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625380|NCT03438318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102625381|NCT03438318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625382|NCT03087942|Indoleacetic Acids|indoleacetic acids|mesh-list
102625383|NCT03087942|Plant Growth Regulators|plant growth regulators|mesh-ancestor
102625384|NCT03087942|Growth Substances|growth substances|mesh-ancestor
102625385|NCT03087942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625386|NCT01678092|Omalizumab|omalizumab|mesh-list
102625387|NCT01678092|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102625388|NCT01678092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102625389|NCT01678092|Respiratory System Agents|respiratory system agents|mesh-ancestor
102625390|NCT04402320|Midazolam|midazolam|mesh-list
102625391|NCT04402320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102625392|NCT04402320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102625393|NCT04402320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102275001|NCT00244933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625394|NCT04402320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625395|NCT04402320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102625396|NCT04402320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102625397|NCT04402320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102625398|NCT04402320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102625399|NCT04402320|Anesthetics, General|anesthetics, general|mesh-ancestor
102625400|NCT04402320|Anesthetics|anesthetics|mesh-ancestor
102625401|NCT04402320|GABA Modulators|gaba modulators|mesh-ancestor
102625402|NCT04402320|GABA Agents|gaba agents|mesh-ancestor
102625403|NCT04402320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102625404|NCT04402320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625405|NCT03436056|Pembrolizumab|pembrolizumab|mesh-list
102625406|NCT03436056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102625407|NCT03436056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625408|NCT03436056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102625409|NCT03436056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625410|NCT03088176|Trametinib|trametinib|mesh-list
102625411|NCT03088176|Dabrafenib|dabrafenib|mesh-list
102625412|NCT03088176|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
102625413|NCT03088176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625414|NCT03088176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102625415|NCT03088176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101597699|NCT05626348|Hydroxychloroquine|hydroxychloroquine|mesh-list
102625416|NCT03088176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625417|NCT03088176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102625418|NCT01678404|Rituximab|rituximab|mesh-list
102625419|NCT01678404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102625420|NCT01678404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625421|NCT01678404|Immunologic Factors|immunologic factors|mesh-ancestor
102625422|NCT01678404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625423|NCT01678404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102625424|NCT03087864|Paclitaxel|paclitaxel|mesh-list
102625425|NCT03087864|Carboplatin|carboplatin|mesh-list
102625426|NCT03087864|Atezolizumab|atezolizumab|mesh-list
102625427|NCT03087864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102625428|NCT03087864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625429|NCT03087864|Tubulin Modulators|tubulin modulators|mesh-ancestor
102625430|NCT03087864|Antimitotic Agents|antimitotic agents|mesh-ancestor
102625431|NCT03087864|Mitosis Modulators|mitosis modulators|mesh-ancestor
102625432|NCT03087864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625433|NCT03087864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102625434|NCT03087864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102625435|NCT01678716|Micronutrients|micronutrients|mesh-list
102625436|NCT01678716|Trace Elements|trace elements|mesh-list
102625437|NCT01678716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625438|NCT00081510|Anastrozole|anastrozole|mesh-list
102625439|NCT00081510|Lonafarnib|lonafarnib|mesh-list
102625440|NCT00081510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102625441|NCT00081510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625442|NCT00081510|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102625443|NCT00081510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102625444|NCT00081510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102625445|NCT00081510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625446|NCT00081510|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102625447|NCT00081510|Hormone Antagonists|hormone antagonists|mesh-ancestor
102625448|NCT00081510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102625449|NCT00081510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625450|NCT00088452|Lamotrigine|lamotrigine|mesh-list
102625451|NCT00088452|Valproic Acid|valproic acid|mesh-list
102625452|NCT00088452|Ethosuximide|ethosuximide|mesh-list
102625453|NCT00088452|Anticonvulsants|anticonvulsants|mesh-ancestor
102625454|NCT00088452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102625455|NCT00088452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102625456|NCT00088452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625457|NCT00088452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102625458|NCT00088452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625459|NCT00088452|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102625460|NCT00088452|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102625461|NCT00088452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102625462|NCT00088452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102625463|NCT00088452|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102625464|NCT00088452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102625465|NCT00088452|GABA Agents|gaba agents|mesh-ancestor
102625466|NCT00088452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102275002|NCT00244933|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102275003|NCT00244933|Protective Agents|protective agents|mesh-ancestor
102625467|NCT00088452|Antimanic Agents|antimanic agents|mesh-ancestor
102625468|NCT01679106|Fentanyl|fentanyl|mesh-list
102625469|NCT01679106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102625470|NCT01679106|Narcotics|narcotics|mesh-ancestor
102625471|NCT01679106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102625472|NCT01679106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625473|NCT01679106|Analgesics|analgesics|mesh-ancestor
102625474|NCT01679106|Sensory System Agents|sensory system agents|mesh-ancestor
102625475|NCT01679106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102625476|NCT01679106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102625477|NCT01679106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102625478|NCT01679106|Anesthetics, General|anesthetics, general|mesh-ancestor
102625479|NCT01679106|Anesthetics|anesthetics|mesh-ancestor
102625480|NCT04403100|Ritonavir|ritonavir|mesh-list
102625481|NCT04403100|Lopinavir|lopinavir|mesh-list
102625482|NCT04403100|Hydroxychloroquine|hydroxychloroquine|mesh-list
102625483|NCT04403100|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102625484|NCT04403100|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102625485|NCT04403100|Protease Inhibitors|protease inhibitors|mesh-ancestor
102625486|NCT04403100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102625487|NCT04403100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625488|NCT04403100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102625489|NCT04403100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102625490|NCT04403100|Antiviral Agents|antiviral agents|mesh-ancestor
102625491|NCT04403100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102625492|NCT04403100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102625493|NCT04403100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102625494|NCT04403100|Antimalarials|antimalarials|mesh-ancestor
101597797|NCT01125917|Buprenorphine|buprenorphine|mesh-list
102625495|NCT04403100|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102625496|NCT04403100|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102625497|NCT04403100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102625498|NCT03086538|Pemetrexed|pemetrexed|mesh-list
102625499|NCT03086538|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102625500|NCT03086538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625501|NCT03086538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102625502|NCT03086538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625503|NCT03086538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102625504|NCT03086538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102625505|NCT03086538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102625506|NCT03473730|Daratumumab|daratumumab|mesh-list
102625507|NCT03473730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625508|NCT03081858|Paclitaxel|paclitaxel|mesh-list
101597806|NCT02732236|Rituximab|rituximab|mesh-list
102625509|NCT03081858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102625510|NCT03081858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625511|NCT03081858|Tubulin Modulators|tubulin modulators|mesh-ancestor
102625512|NCT03081858|Antimitotic Agents|antimitotic agents|mesh-ancestor
102625513|NCT03081858|Mitosis Modulators|mitosis modulators|mesh-ancestor
102625514|NCT03081858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625515|NCT01679340|Oxaliplatin|oxaliplatin|mesh-list
102625516|NCT01679340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625517|NCT01679574|Metformin|metformin|mesh-list
102625518|NCT01679574|Letrozole|letrozole|mesh-list
102625519|NCT01679574|Clomiphene|clomiphene|mesh-list
102625520|NCT01679574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102625521|NCT01679574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625522|NCT01679574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625523|NCT01679574|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102625524|NCT01679574|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102625525|NCT01679574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102625526|NCT01679574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625527|NCT01679574|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102625528|NCT01679574|Hormone Antagonists|hormone antagonists|mesh-ancestor
102625529|NCT01679574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102625530|NCT01679574|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102625531|NCT01679574|Fertility Agents|fertility agents|mesh-ancestor
102625532|NCT01679574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102625533|NCT01679574|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102625534|NCT01679574|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102625535|NCT01679652|Nebivolol|nebivolol|mesh-list
102625536|NCT01679652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102625537|NCT01679652|Vasodilator Agents|vasodilator agents|mesh-ancestor
102625538|NCT01679652|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101913810|NCT05843344|Dexmedetomidine|dexmedetomidine|mesh-list
102625539|NCT01679652|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102625540|NCT01679652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102625541|NCT01679652|Adrenergic Agents|adrenergic agents|mesh-ancestor
102625542|NCT01679652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102625543|NCT01679652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625544|NCT01679652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625545|NCT04761744|Nivolumab|nivolumab|mesh-list
101597834|NCT02731846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102625546|NCT04761744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102625547|NCT04761744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625548|NCT04761744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102625549|NCT04761744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625550|NCT03089658|Avelumab|avelumab|mesh-list
102625551|NCT03089658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102625552|NCT03089658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625553|NCT03417492|Sildenafil Citrate|sildenafil citrate|mesh-list
102625554|NCT03417492|Citric Acid|citric acid|mesh-list
102625555|NCT03417492|Sodium Citrate|sodium citrate|mesh-list
102625556|NCT03417492|Anticoagulants|anticoagulants|mesh-ancestor
102625557|NCT03417492|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102625558|NCT03417492|Chelating Agents|chelating agents|mesh-ancestor
102625559|NCT03417492|Sequestering Agents|sequestering agents|mesh-ancestor
102625560|NCT03417492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625561|NCT03417492|Vasodilator Agents|vasodilator agents|mesh-ancestor
102625562|NCT03417492|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102625563|NCT03417492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102625564|NCT03417492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102625565|NCT03417492|Urological Agents|urological agents|mesh-ancestor
102625566|NCT03395184|PF-06700841|pf-06700841|mesh-list
102625567|NCT03395184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102625568|NCT03395184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102625569|NCT03395184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625570|NCT03080766|Decitabine|decitabine|mesh-list
102625571|NCT03080766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102625572|NCT03080766|Antimetabolites|antimetabolites|mesh-ancestor
102625573|NCT03080766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625574|NCT03080766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625575|NCT03080766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102625576|NCT03088722|Contraceptive Agents|contraceptive agents|mesh-list
102625577|NCT03088722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102625578|NCT03088722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625579|NCT03088644|(18)F-JNJ-64413739|(18)f-jnj-64413739|mesh-list
102625580|NCT03088644|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102625581|NCT03088644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625582|NCT03088254|Amlodipine|amlodipine|mesh-list
102625583|NCT03088254|Telmisartan|telmisartan|mesh-list
102625584|NCT03088254|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102625585|NCT03088254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102625586|NCT03088254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102625587|NCT03088254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102625588|NCT03088254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625589|NCT03088254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102625590|NCT03088254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625591|NCT03088254|Vasodilator Agents|vasodilator agents|mesh-ancestor
102625592|NCT03088254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102625593|NCT03088254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102625594|NCT03088254|Antimetabolites|antimetabolites|mesh-ancestor
102625595|NCT03088254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102625596|NCT03088254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102625597|NCT03088254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102625598|NCT03088254|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102625599|NCT03088254|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102625600|NCT05684718|Itraconazole|itraconazole|mesh-list
102625601|NCT05684718|Rifabutin|rifabutin|mesh-list
102625602|NCT05684718|Antifungal Agents|antifungal agents|mesh-ancestor
102625603|NCT05684718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102625604|NCT05684718|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102625605|NCT05684718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102625606|NCT05684718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102625607|NCT05684718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625608|NCT05684718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102625609|NCT05684718|Hormone Antagonists|hormone antagonists|mesh-ancestor
102625610|NCT05684718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102625611|NCT05684718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625612|NCT05684718|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102625613|NCT05684718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101913886|NCT05842681|Hormones|hormones|mesh-ancestor
102625614|NCT05684718|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102625615|NCT05684718|Antitubercular Agents|antitubercular agents|mesh-ancestor
102625616|NCT05684484|Salicylic Acid|salicylic acid|mesh-list
102625617|NCT05684484|Salicylates|salicylates|mesh-list
102625618|NCT05684484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102625619|NCT05684484|Antifungal Agents|antifungal agents|mesh-ancestor
102625620|NCT05684484|Keratolytic Agents|keratolytic agents|mesh-ancestor
102625621|NCT05684484|Dermatologic Agents|dermatologic agents|mesh-ancestor
102625622|NCT05684484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102625623|NCT05684484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102625624|NCT05684484|Analgesics|analgesics|mesh-ancestor
102625625|NCT05684484|Sensory System Agents|sensory system agents|mesh-ancestor
102625626|NCT05684484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102625627|NCT05684484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625628|NCT05684484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102625629|NCT05684484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102625630|NCT05684484|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102625631|NCT05684484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102625632|NCT05684484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625633|NCT03086382|Lacosamide|lacosamide|mesh-list
102625634|NCT03086382|Anticonvulsants|anticonvulsants|mesh-ancestor
102625635|NCT03086382|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102625636|NCT03086382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102625637|NCT03086382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102625638|NCT03086382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625639|NCT03086226|Itraconazole|itraconazole|mesh-list
102625640|NCT03086226|Antifungal Agents|antifungal agents|mesh-ancestor
102625641|NCT03086226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102625642|NCT03086226|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102625643|NCT03086226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102625644|NCT03086226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102625645|NCT03086226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625646|NCT03086226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102625647|NCT03086226|Hormone Antagonists|hormone antagonists|mesh-ancestor
102625648|NCT03086226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102625649|NCT03086226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625650|NCT03086226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102625651|NCT03085992|Bevacizumab|bevacizumab|mesh-list
102625652|NCT03085992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102625653|NCT03085992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625654|NCT03085992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102625655|NCT03085992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102625656|NCT03085992|Growth Substances|growth substances|mesh-ancestor
102625657|NCT03085992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625658|NCT03085992|Growth Inhibitors|growth inhibitors|mesh-ancestor
102625659|NCT03086070|Omeprazole|omeprazole|mesh-list
102625660|NCT03086070|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102625661|NCT03086070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102625662|NCT03086070|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102625663|NCT03086070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102625664|NCT03086070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625665|NCT05688306|Oprelvekin|oprelvekin|mesh-list
102625666|NCT05688306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625667|NCT03086148|Ketamine|ketamine|mesh-list
102625668|NCT03086148|Analgesics|analgesics|mesh-ancestor
102625669|NCT03086148|Sensory System Agents|sensory system agents|mesh-ancestor
102625670|NCT03086148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102625671|NCT03086148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625672|NCT03086148|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102625673|NCT03086148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102625674|NCT03086148|Anesthetics, General|anesthetics, general|mesh-ancestor
102625675|NCT03086148|Anesthetics|anesthetics|mesh-ancestor
101597928|NCT00847015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102625676|NCT03086148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102625677|NCT03086148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102625678|NCT03086148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102625679|NCT03086148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102625680|NCT03086148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625681|NCT03359538|Sirolimus|sirolimus|mesh-list
102625682|NCT03359538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102625683|NCT03359538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102625684|NCT03359538|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102625685|NCT03359538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101913971|NCT05839314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102275004|NCT00244933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625686|NCT03359538|Antifungal Agents|antifungal agents|mesh-ancestor
102625687|NCT03359538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102625688|NCT03359538|Immunologic Factors|immunologic factors|mesh-ancestor
102625689|NCT03359538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625690|NCT05345808|Triamcinolone|triamcinolone|mesh-list
102625691|NCT05345808|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102625692|NCT05345808|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102625693|NCT05345808|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102625694|NCT05345808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102625695|NCT05345808|Glucocorticoids|glucocorticoids|mesh-ancestor
102625696|NCT05345808|Hormones|hormones|mesh-ancestor
102625697|NCT05345808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102625698|NCT05345808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625699|NCT05345808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102625700|NCT05345808|Immunologic Factors|immunologic factors|mesh-ancestor
102625701|NCT05345808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102625702|NCT05345808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625703|NCT02336958|Ropivacaine|ropivacaine|mesh-list
102625704|NCT02336958|Prilocaine|prilocaine|mesh-list
102625705|NCT02336958|Anesthetics, Local|anesthetics, local|mesh-ancestor
102625706|NCT02336958|Anesthetics|anesthetics|mesh-ancestor
102625707|NCT02336958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102625708|NCT02336958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625709|NCT02336958|Sensory System Agents|sensory system agents|mesh-ancestor
102625710|NCT02336958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102625711|NCT03085368|Trastuzumab|trastuzumab|mesh-list
102625712|NCT03085368|Lapatinib|lapatinib|mesh-list
102625713|NCT03085368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102625714|NCT03085368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625715|NCT03085368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102625716|NCT03085368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102625717|NCT03085368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625718|NCT05638932|Tofacitinib|tofacitinib|mesh-list
102625719|NCT05638932|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102625720|NCT05638932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102625721|NCT05638932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102625722|NCT05638932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625723|NCT03085290|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102625724|NCT03085290|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102625725|NCT05687760|Calcium|calcium|mesh-list
102625726|NCT05687760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102625727|NCT05687760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625728|NCT03084978|Anesthetics|anesthetics|mesh-list
102625729|NCT03084978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102625730|NCT03084978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625731|NCT03084588|Methadone|methadone|mesh-list
102625732|NCT03084588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102625733|NCT03084588|Narcotics|narcotics|mesh-ancestor
102625734|NCT03084588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102625735|NCT03084588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625736|NCT03084588|Analgesics|analgesics|mesh-ancestor
102625737|NCT03084588|Sensory System Agents|sensory system agents|mesh-ancestor
102625738|NCT03084588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102625739|NCT03084588|Antitussive Agents|antitussive agents|mesh-ancestor
102625740|NCT03084588|Respiratory System Agents|respiratory system agents|mesh-ancestor
102625741|NCT05345574|Dexmedetomidine|dexmedetomidine|mesh-list
102625742|NCT05345574|Remifentanil|remifentanil|mesh-list
102625743|NCT05345574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102625744|NCT05345574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102625745|NCT05345574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625746|NCT05345574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102625747|NCT05345574|Analgesics|analgesics|mesh-ancestor
102625748|NCT05345574|Sensory System Agents|sensory system agents|mesh-ancestor
102625749|NCT05345574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102625750|NCT05345574|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102625751|NCT05345574|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102625752|NCT05345574|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102625753|NCT05345574|Adrenergic Agents|adrenergic agents|mesh-ancestor
102625754|NCT05345574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102625755|NCT05345574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625756|NCT05345574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102625757|NCT05345574|Narcotics|narcotics|mesh-ancestor
102625758|NCT05598606|Zoledronic Acid|zoledronic acid|mesh-list
102625759|NCT05598606|Denosumab|denosumab|mesh-list
102625760|NCT05598606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102625761|NCT05598606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625762|NCT04400916|Tranexamic Acid|tranexamic acid|mesh-list
102625763|NCT04400916|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102625764|NCT04400916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102625765|NCT04400916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625766|NCT04400916|Hemostatics|hemostatics|mesh-ancestor
102625767|NCT04400916|Coagulants|coagulants|mesh-ancestor
102625768|NCT05582538|Paclitaxel|paclitaxel|mesh-list
102625769|NCT05582538|Durvalumab|durvalumab|mesh-list
102625770|NCT05582538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102625771|NCT05582538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625772|NCT05582538|Tubulin Modulators|tubulin modulators|mesh-ancestor
102625773|NCT05582538|Antimitotic Agents|antimitotic agents|mesh-ancestor
102625774|NCT05582538|Mitosis Modulators|mitosis modulators|mesh-ancestor
102625775|NCT05582538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625776|NCT05582538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102625777|NCT05571072|Analgesics, Opioid|analgesics, opioid|mesh-list
102625778|NCT05571072|Narcotics|narcotics|mesh-ancestor
102625779|NCT05571072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102625780|NCT05571072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625781|NCT05571072|Analgesics|analgesics|mesh-ancestor
102625782|NCT05571072|Sensory System Agents|sensory system agents|mesh-ancestor
102625783|NCT05571072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102625784|NCT03832452|Moxifloxacin|moxifloxacin|mesh-list
102625785|NCT03832452|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
102625786|NCT03832452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102625787|NCT03832452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102625788|NCT03832452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102625789|NCT03832452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102625790|NCT03832452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102625791|NCT03832452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625792|NCT03832452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625793|NCT03832452|Antiviral Agents|antiviral agents|mesh-ancestor
102625794|NCT04279938|Rituximab|rituximab|mesh-list
102625795|NCT04279938|Pembrolizumab|pembrolizumab|mesh-list
102625796|NCT04279938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102625797|NCT04279938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625798|NCT04279938|Immunologic Factors|immunologic factors|mesh-ancestor
102625799|NCT04279938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625800|NCT04279938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102625801|NCT04279938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102625802|NCT04279938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625803|NCT05686434|Osimertinib|osimertinib|mesh-list
102625804|NCT05686434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625805|NCT05686434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102625806|NCT05686434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102625807|NCT05686434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625808|NCT03083184|Ethanol|ethanol|mesh-list
102625809|NCT03083184|Enoxaparin|enoxaparin|mesh-list
102625810|NCT03083184|Anticoagulants|anticoagulants|mesh-ancestor
102625811|NCT03083184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102625812|NCT03083184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102625813|NCT03083184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625814|NCT03083184|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102625815|NCT03083184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102625816|NCT03083184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102625817|NCT03083184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625818|NCT03338244|Azithromycin|azithromycin|mesh-list
102625819|NCT03338244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102625820|NCT03338244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102625821|NCT05512962|Triamcinolone|triamcinolone|mesh-list
102625822|NCT05512962|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102625823|NCT05512962|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102625824|NCT05512962|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102625825|NCT05512962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102625826|NCT05512962|Glucocorticoids|glucocorticoids|mesh-ancestor
102625827|NCT05512962|Hormones|hormones|mesh-ancestor
102625828|NCT05512962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102625829|NCT05512962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625830|NCT05512962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102625831|NCT05512962|Immunologic Factors|immunologic factors|mesh-ancestor
102275005|NCT00244933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102275006|NCT00244933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102275007|NCT00244933|Phytoestrogens|phytoestrogens|mesh-ancestor
102625832|NCT05512962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102625833|NCT05512962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625834|NCT03082092|Methylprednisolone|methylprednisolone|mesh-list
102625835|NCT03082092|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102625836|NCT03082092|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102625837|NCT03082092|Prednisolone|prednisolone|mesh-list
102625838|NCT03082092|Prednisolone acetate|prednisolone acetate|mesh-list
102625839|NCT03082092|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102625840|NCT03082092|Prednisolone phosphate|prednisolone phosphate|mesh-list
102625841|NCT03082092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102625842|NCT03082092|Antiemetics|antiemetics|mesh-ancestor
102625843|NCT03082092|Autonomic Agents|autonomic agents|mesh-ancestor
102625844|NCT03082092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102625845|NCT03082092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625846|NCT03082092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102625847|NCT03082092|Glucocorticoids|glucocorticoids|mesh-ancestor
102625848|NCT03082092|Hormones|hormones|mesh-ancestor
102625849|NCT03082092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102625850|NCT03082092|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102625851|NCT03082092|Protective Agents|protective agents|mesh-ancestor
102625852|NCT03082092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102625853|NCT03082092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625854|NCT04401852|Magnesium Sulfate|magnesium sulfate|mesh-list
102625855|NCT04401852|Analgesics|analgesics|mesh-ancestor
102625856|NCT04401852|Sensory System Agents|sensory system agents|mesh-ancestor
102625857|NCT04401852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102625858|NCT04401852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625859|NCT04401852|Anesthetics|anesthetics|mesh-ancestor
102625860|NCT04401852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102625861|NCT04401852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102625862|NCT04401852|Anticonvulsants|anticonvulsants|mesh-ancestor
102625863|NCT04401852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102625864|NCT04401852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102625865|NCT04401852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625866|NCT04401852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102625867|NCT04401852|Tocolytic Agents|tocolytic agents|mesh-ancestor
102625868|NCT04401852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102625869|NCT03082482|Nicotine|nicotine|mesh-list
102625870|NCT03082482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102625871|NCT03082482|Autonomic Agents|autonomic agents|mesh-ancestor
102625872|NCT03082482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102625873|NCT03082482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625874|NCT03082482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102625875|NCT03082482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102625876|NCT03082482|Cholinergic Agents|cholinergic agents|mesh-ancestor
102625877|NCT03082482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102625878|NCT03082482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625879|NCT03308916|Liver Extracts|liver extracts|mesh-list
102625880|NCT03308916|Hematinics|hematinics|mesh-ancestor
102625881|NCT03081702|Hydroxychloroquine|hydroxychloroquine|mesh-list
102625882|NCT03081702|Itraconazole|itraconazole|mesh-list
102625883|NCT03081702|Antimalarials|antimalarials|mesh-ancestor
102625884|NCT03081702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102625885|NCT03081702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102625886|NCT03081702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102625887|NCT03081702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102625888|NCT03081702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625889|NCT03081702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102625890|NCT03081702|Antifungal Agents|antifungal agents|mesh-ancestor
102625891|NCT03081702|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102625892|NCT03081702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102625893|NCT03081702|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102625894|NCT03081702|Hormone Antagonists|hormone antagonists|mesh-ancestor
102625895|NCT03081702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102625896|NCT03081702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625897|NCT03081702|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102625898|NCT04399434|Insulin|insulin|mesh-list
102625899|NCT04399434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102625900|NCT04399434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625901|NCT04760574|Testosterone|testosterone|mesh-list
102275008|NCT00244933|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102275009|NCT00244933|Estrogens|estrogens|mesh-ancestor
102625902|NCT04760574|Androgens|androgens|mesh-ancestor
102625903|NCT04760574|Hormones|hormones|mesh-ancestor
102638133|NCT00716586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625904|NCT04760574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102625905|NCT04760574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625906|NCT03237390|Gemcitabine|gemcitabine|mesh-list
102625907|NCT03237390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102625908|NCT03237390|Antimetabolites|antimetabolites|mesh-ancestor
102625909|NCT03237390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625910|NCT03237390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625911|NCT04400136|Lansoprazole|lansoprazole|mesh-list
102625912|NCT04400136|Dexlansoprazole|dexlansoprazole|mesh-list
102625913|NCT04400136|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102625914|NCT04400136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102625915|NCT04400136|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102625916|NCT04400136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102625917|NCT04400136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625919|NCT05338086|Denosumab|denosumab|mesh-list
102625920|NCT05338086|Calcium|calcium|mesh-list
102625921|NCT05338086|Vitamins|vitamins|mesh-ancestor
102625922|NCT05338086|Micronutrients|micronutrients|mesh-ancestor
102625923|NCT05338086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625924|NCT05338086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102625925|NCT05338086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102625926|NCT04857840|Firibastat|firibastat|mesh-list
102625927|NCT04857840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102625928|NCT04582968|Capecitabine|capecitabine|mesh-list
102625929|NCT04582968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102625930|NCT04582968|Antimetabolites|antimetabolites|mesh-ancestor
102625931|NCT04582968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625932|NCT04582968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625933|NCT03261570|Digoxin|digoxin|mesh-list
102625934|NCT03261570|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
102625935|NCT03261570|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102625936|NCT03261570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102625937|NCT03261570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102625938|NCT03261570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625939|NCT03261570|Protective Agents|protective agents|mesh-ancestor
102625940|NCT03261570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625941|NCT03261570|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102625942|NCT03261570|Cholinergic Agents|cholinergic agents|mesh-ancestor
102625943|NCT03261570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102625944|NCT03227562|Risperidone|risperidone|mesh-list
102625945|NCT03227562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102625946|NCT03227562|Serotonin Agents|serotonin agents|mesh-ancestor
102625947|NCT03227562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102625948|NCT03227562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625949|NCT03227562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625950|NCT03227562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102625951|NCT03227562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102625952|NCT03227562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102625953|NCT03227562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102625954|NCT03227562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102625955|NCT03227562|Dopamine Agents|dopamine agents|mesh-ancestor
102625956|NCT04278378|Folic Acid|folic acid|mesh-list
102625957|NCT04278378|Riboflavin|riboflavin|mesh-list
102625958|NCT04278378|Hematinics|hematinics|mesh-ancestor
102625959|NCT04278378|Vitamin B Complex|vitamin b complex|mesh-ancestor
102625960|NCT04278378|Vitamins|vitamins|mesh-ancestor
102625961|NCT04278378|Micronutrients|micronutrients|mesh-ancestor
102625962|NCT04278378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625963|NCT04278378|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102625964|NCT04278378|Dermatologic Agents|dermatologic agents|mesh-ancestor
102625965|NCT04551144|Methyltestosterone|methyltestosterone|mesh-list
102625966|NCT04551144|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102625967|NCT04551144|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102625968|NCT04551144|Estradiol|estradiol|mesh-list
102625969|NCT04551144|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102625970|NCT04551144|Testosterone|testosterone|mesh-list
102625971|NCT04551144|Testosterone undecanoate|testosterone undecanoate|mesh-list
102625972|NCT04551144|Testosterone enanthate|testosterone enanthate|mesh-list
102625973|NCT04551144|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102625974|NCT04551144|Estrogens|estrogens|mesh-ancestor
102625975|NCT04551144|Hormones|hormones|mesh-ancestor
102625976|NCT04551144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102275010|NCT00244933|Hormones|hormones|mesh-ancestor
101914309|NCT05681780|Nivolumab|nivolumab|mesh-list
102625977|NCT04551144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102625978|NCT04551144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102625979|NCT04551144|Contraceptive Agents|contraceptive agents|mesh-ancestor
102625980|NCT04551144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102625981|NCT04551144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102625982|NCT04551144|Androgens|androgens|mesh-ancestor
102625983|NCT04551144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102625984|NCT04551144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102625985|NCT04551144|Anabolic Agents|anabolic agents|mesh-ancestor
102625987|NCT04785924|Relebactam|relebactam|mesh-list
102625988|NCT04785924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102625989|NCT04785924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102625990|NCT04785924|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102625991|NCT04785924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102625992|NCT04785924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625993|NCT04451772|Upadacitinib|upadacitinib|mesh-list
102625994|NCT04451772|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102625995|NCT04451772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102625996|NCT04451772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102625997|NCT04451772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102625998|NCT04451772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102625999|NCT03831984|Bromfenac|bromfenac|mesh-list
102626000|NCT03831984|Hyaluronic Acid|hyaluronic acid|mesh-list
102626001|NCT03831984|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102626002|NCT03831984|Immunologic Factors|immunologic factors|mesh-ancestor
102626003|NCT03831984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626004|NCT03831984|Viscosupplements|viscosupplements|mesh-ancestor
102626005|NCT03831984|Protective Agents|protective agents|mesh-ancestor
102626006|NCT03831984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102626007|NCT03831984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102626008|NCT03831984|Analgesics|analgesics|mesh-ancestor
102626009|NCT03831984|Sensory System Agents|sensory system agents|mesh-ancestor
102626010|NCT03831984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102626011|NCT03831984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102626012|NCT03831984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102626013|NCT02084706|Triamcinolone|triamcinolone|mesh-list
102626014|NCT02084706|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102626015|NCT02084706|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102626016|NCT02084706|Lidocaine|lidocaine|mesh-list
102626017|NCT02084706|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102626018|NCT02084706|Anesthetics, Local|anesthetics, local|mesh-ancestor
102626019|NCT02084706|Anesthetics|anesthetics|mesh-ancestor
102626020|NCT02084706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102626021|NCT02084706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626022|NCT02084706|Sensory System Agents|sensory system agents|mesh-ancestor
102626023|NCT02084706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102626024|NCT02084706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102626025|NCT02084706|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102626026|NCT02084706|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102626027|NCT02084706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102626028|NCT02084706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626029|NCT02084706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102626030|NCT02084706|Glucocorticoids|glucocorticoids|mesh-ancestor
102626031|NCT02084706|Hormones|hormones|mesh-ancestor
102626032|NCT02084706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102626033|NCT02084706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102626034|NCT02084706|Immunologic Factors|immunologic factors|mesh-ancestor
102626035|NCT02084706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102626036|NCT04704024|Tenofovir|tenofovir|mesh-list
102626037|NCT04704024|Lamivudine|lamivudine|mesh-list
102626038|NCT04704024|Antiviral Agents|antiviral agents|mesh-ancestor
102626039|NCT04704024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102626040|NCT04704024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102626041|NCT04704024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102626042|NCT04704024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102626043|NCT04704024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626044|NCT04704024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102626045|NCT04704024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102626046|NCT04433988|Pentoxifylline|pentoxifylline|mesh-list
102626047|NCT04433988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102626048|NCT04433988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102626049|NCT04433988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626050|NCT04433988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102626051|NCT04433988|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102275011|NCT00244933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102626052|NCT04433988|Protective Agents|protective agents|mesh-ancestor
102626053|NCT04433988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626054|NCT04433988|Vasodilator Agents|vasodilator agents|mesh-ancestor
102626055|NCT04433988|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102626056|NCT04433988|Antioxidants|antioxidants|mesh-ancestor
102626057|NCT04685538|Tetracaine|tetracaine|mesh-list
102626058|NCT04685538|Chloroprocaine|chloroprocaine|mesh-list
102626059|NCT04685538|Anesthetics, Local|anesthetics, local|mesh-ancestor
102626060|NCT04685538|Anesthetics|anesthetics|mesh-ancestor
102626061|NCT04685538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102626062|NCT04685538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626063|NCT04685538|Sensory System Agents|sensory system agents|mesh-ancestor
102626064|NCT04685538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102626065|NCT05121246|Palivizumab|palivizumab|mesh-list
102626066|NCT05121246|Antiviral Agents|antiviral agents|mesh-ancestor
102626067|NCT05121246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102626068|NCT04344678|Sildenafil Citrate|sildenafil citrate|mesh-list
102626069|NCT04344678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626070|NCT04344678|Vasodilator Agents|vasodilator agents|mesh-ancestor
102626071|NCT04344678|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102626072|NCT04344678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102626073|NCT04344678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102626074|NCT04344678|Urological Agents|urological agents|mesh-ancestor
102626075|NCT03249558|Morphine|morphine|mesh-list
102626076|NCT03249558|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102626077|NCT03249558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102626078|NCT03249558|Narcotics|narcotics|mesh-ancestor
102626079|NCT03249558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102626080|NCT03249558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626081|NCT03249558|Analgesics|analgesics|mesh-ancestor
102626082|NCT03249558|Sensory System Agents|sensory system agents|mesh-ancestor
102626083|NCT03249558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102626084|NCT03249558|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102626085|NCT03249558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102626086|NCT03249558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102626087|NCT03249558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626088|NCT03249558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102626089|NCT03249558|Antidepressive Agents|antidepressive agents|mesh-ancestor
102626090|NCT03249558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102626091|NCT03249558|Dopamine Agents|dopamine agents|mesh-ancestor
102626092|NCT03246828|Gliclazide|gliclazide|mesh-list
102626093|NCT03246828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102626094|NCT03246828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626095|NCT04316442|Immunoconjugates|immunoconjugates|mesh-list
102626096|NCT04316442|Immunologic Factors|immunologic factors|mesh-ancestor
102626097|NCT04316442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626098|NCT03204786|Vasopressins|vasopressins|mesh-list
102626099|NCT03204786|Arginine Vasopressin|arginine vasopressin|mesh-list
102626100|NCT03204786|Hemostatics|hemostatics|mesh-ancestor
102626101|NCT03204786|Coagulants|coagulants|mesh-ancestor
102626102|NCT03204786|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102626103|NCT03204786|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102626104|NCT03204786|Natriuretic Agents|natriuretic agents|mesh-ancestor
102626105|NCT03204786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626106|NCT03204396|Dulaglutide|dulaglutide|mesh-list
102626107|NCT03204396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102626108|NCT03204396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626109|NCT02008656|Leucovorin|leucovorin|mesh-list
102626110|NCT02008656|Fluorouracil|fluorouracil|mesh-list
102626111|NCT02008656|Capecitabine|capecitabine|mesh-list
102626112|NCT02008656|Oxaliplatin|oxaliplatin|mesh-list
102626113|NCT02008656|Antimetabolites|antimetabolites|mesh-ancestor
102626114|NCT02008656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626115|NCT02008656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102626116|NCT02008656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102626117|NCT02008656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102626118|NCT02008656|Immunologic Factors|immunologic factors|mesh-ancestor
102626119|NCT02008656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626120|NCT02008656|Antidotes|antidotes|mesh-ancestor
102626121|NCT02008656|Protective Agents|protective agents|mesh-ancestor
102626122|NCT02008656|Vitamin B Complex|vitamin b complex|mesh-ancestor
102626123|NCT02008656|Vitamins|vitamins|mesh-ancestor
102626124|NCT02008656|Micronutrients|micronutrients|mesh-ancestor
102626125|NCT04300140|Nivolumab|nivolumab|mesh-list
102626126|NCT04300140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102275012|NCT00121719|Lenvatinib|lenvatinib|mesh-list
102626127|NCT04300140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102626128|NCT04300140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102626129|NCT04300140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626130|NCT03174132|Lidocaine|lidocaine|mesh-list
102626131|NCT03174132|Hyaluronic Acid|hyaluronic acid|mesh-list
102626132|NCT03174132|Anesthetics, Local|anesthetics, local|mesh-ancestor
102626133|NCT03174132|Anesthetics|anesthetics|mesh-ancestor
102626134|NCT03174132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102626135|NCT03174132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626136|NCT03174132|Sensory System Agents|sensory system agents|mesh-ancestor
102626137|NCT03174132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102626138|NCT03174132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102626139|NCT03174132|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102626140|NCT03174132|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102626141|NCT03174132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102626142|NCT03174132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626143|NCT03174132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102626144|NCT03174132|Immunologic Factors|immunologic factors|mesh-ancestor
102626145|NCT03174132|Viscosupplements|viscosupplements|mesh-ancestor
102626146|NCT03174132|Protective Agents|protective agents|mesh-ancestor
102626147|NCT03173976|Zoledronic Acid|zoledronic acid|mesh-list
102626148|NCT03173976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102626149|NCT03173976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626150|NCT01812252|Azacitidine|azacitidine|mesh-list
102626151|NCT01812252|Decitabine|decitabine|mesh-list
102626152|NCT01812252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102626153|NCT01812252|Antimetabolites|antimetabolites|mesh-ancestor
102626154|NCT01812252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626155|NCT01812252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102626156|NCT01812252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102626157|NCT03818802|Niacinamide|niacinamide|mesh-list
102626158|NCT03818802|Niacin|niacin|mesh-list
102626159|NCT03818802|Nicotinic Acids|nicotinic acids|mesh-list
102626160|NCT03818802|Vitamin B Complex|vitamin b complex|mesh-ancestor
102626161|NCT03818802|Vitamins|vitamins|mesh-ancestor
102626162|NCT03818802|Micronutrients|micronutrients|mesh-ancestor
102626163|NCT03818802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626164|NCT03818802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102626165|NCT03818802|Antimetabolites|antimetabolites|mesh-ancestor
102626166|NCT03818802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626167|NCT03818802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102626168|NCT03818802|Vasodilator Agents|vasodilator agents|mesh-ancestor
102626169|NCT04398108|Margetuximab|margetuximab|mesh-list
102626170|NCT04398108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102626171|NCT01625286|Paclitaxel|paclitaxel|mesh-list
102626172|NCT01625286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102626173|NCT01625286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102626174|NCT01625286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102626175|NCT01625286|Tubulin Modulators|tubulin modulators|mesh-ancestor
102626176|NCT01625286|Antimitotic Agents|antimitotic agents|mesh-ancestor
102626177|NCT01625286|Mitosis Modulators|mitosis modulators|mesh-ancestor
102626178|NCT01625286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626179|NCT01583322|Nintedanib|nintedanib|mesh-list
102626180|NCT01583322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102626181|NCT01583322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102626182|NCT01583322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102626183|NCT01583322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626184|NCT05158062|Paclitaxel|paclitaxel|mesh-list
102626185|NCT05158062|Docetaxel|docetaxel|mesh-list
102626186|NCT05158062|Bevacizumab|bevacizumab|mesh-list
102626187|NCT05158062|Carboplatin|carboplatin|mesh-list
102626188|NCT05158062|Pembrolizumab|pembrolizumab|mesh-list
102626189|NCT05158062|Olaparib|olaparib|mesh-list
102626190|NCT05158062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102626191|NCT05158062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102626192|NCT05158062|Tubulin Modulators|tubulin modulators|mesh-ancestor
102275013|NCT00121719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102275014|NCT00121719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102275015|NCT00121719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102275016|NCT00121719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275017|NCT00053209|Gemcitabine|gemcitabine|mesh-list
102275018|NCT00053209|Pemetrexed|pemetrexed|mesh-list
102275019|NCT00053209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102275020|NCT00053209|Antimetabolites|antimetabolites|mesh-ancestor
102275021|NCT00053209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275022|NCT00053209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102275023|NCT00053209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102275024|NCT00053209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102626193|NCT05158062|Antimitotic Agents|antimitotic agents|mesh-ancestor
102626194|NCT05158062|Mitosis Modulators|mitosis modulators|mesh-ancestor
102626195|NCT05158062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626196|NCT05158062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102626197|NCT05158062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102626198|NCT05158062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102626199|NCT05158062|Growth Substances|growth substances|mesh-ancestor
102626200|NCT05158062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626201|NCT05158062|Growth Inhibitors|growth inhibitors|mesh-ancestor
102626202|NCT05158062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102626203|NCT05158062|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102626204|NCT05158062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102626206|NCT01076868|Antimalarials|antimalarials|mesh-ancestor
102626207|NCT01076868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102626208|NCT01076868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102626209|NCT01076868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102626210|NCT03193866|Interferons|interferons|mesh-list
102626211|NCT03193866|Interferon-beta|interferon-beta|mesh-list
102626212|NCT03193866|Rituximab|rituximab|mesh-list
102626213|NCT03193866|Alemtuzumab|alemtuzumab|mesh-list
102626214|NCT03193866|Glatiramer Acetate|glatiramer acetate|mesh-list
102626215|NCT03193866|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102626216|NCT03193866|Natalizumab|natalizumab|mesh-list
102626217|NCT03193866|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102626218|NCT03193866|(T,G)-A-L|(t,g)-a-l|mesh-list
102626219|NCT03193866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102626220|NCT03193866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102626221|NCT03193866|Immunologic Factors|immunologic factors|mesh-ancestor
102626222|NCT03193866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626223|NCT03193866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102626224|NCT03193866|Antiviral Agents|antiviral agents|mesh-ancestor
102626225|NCT03193866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102626226|NCT03193866|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102626227|NCT03193866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626228|NCT03193866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102626229|NCT03193866|Dermatologic Agents|dermatologic agents|mesh-ancestor
102626230|NCT03193866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102626231|NCT04195776|Tenofovir|tenofovir|mesh-list
102626232|NCT04195776|Antiviral Agents|antiviral agents|mesh-ancestor
102626233|NCT04195776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102626234|NCT04195776|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102626235|NCT04195776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102626236|NCT04195776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102626237|NCT04195776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626238|NCT04195776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102626239|NCT04195776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102626240|NCT03708588|Ticagrelor|ticagrelor|mesh-list
102626241|NCT03708588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102626242|NCT03708588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102626243|NCT03708588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102626244|NCT03708588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102626245|NCT03708588|Purinergic Agents|purinergic agents|mesh-ancestor
102626246|NCT03708588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102626247|NCT03708588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626248|NCT03708588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626249|NCT04130802|Dexamethasone|dexamethasone|mesh-list
102626250|NCT04130802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102626251|NCT04130802|Antiemetics|antiemetics|mesh-ancestor
102626252|NCT04130802|Autonomic Agents|autonomic agents|mesh-ancestor
102626253|NCT04130802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102626254|NCT04130802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626255|NCT04130802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102626256|NCT04130802|Glucocorticoids|glucocorticoids|mesh-ancestor
102626257|NCT04130802|Hormones|hormones|mesh-ancestor
102626258|NCT04130802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102626259|NCT04130802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102626260|NCT04130802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102626261|NCT03087162|Dexlansoprazole|dexlansoprazole|mesh-list
102626262|NCT03087162|Lansoprazole|lansoprazole|mesh-list
102626263|NCT03087162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102626264|NCT03087162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102275025|NCT00053209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102626265|NCT03087162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102275026|NCT00039429|Atrasentan|atrasentan|mesh-list
102626266|NCT03087162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102626267|NCT03087162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626268|NCT03165942|Ethanol|ethanol|mesh-list
102626269|NCT03165942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102626270|NCT03165942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102626271|NCT03165942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102626272|NCT03165942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626273|NCT03163992|Pembrolizumab|pembrolizumab|mesh-list
102626274|NCT03163992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102626275|NCT03163992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102626276|NCT03163992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102626277|NCT03163992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626278|NCT04397328|Hydroxychloroquine|hydroxychloroquine|mesh-list
102626279|NCT04397328|Antimalarials|antimalarials|mesh-ancestor
102626280|NCT04397328|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102626281|NCT04397328|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102626282|NCT04397328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102626283|NCT04397328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102626284|NCT04397328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626285|NCT04397328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102626286|NCT03162432|Vitamin D|vitamin d|mesh-list
102626287|NCT03162432|Cholecalciferol|cholecalciferol|mesh-list
102626288|NCT03162432|Vitamins|vitamins|mesh-ancestor
102626289|NCT03162432|Micronutrients|micronutrients|mesh-ancestor
102626290|NCT03162432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626291|NCT03162432|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102626292|NCT03162432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102626293|NCT03392376|Haloperidol|haloperidol|mesh-list
102626294|NCT03392376|Haloperidol decanoate|haloperidol decanoate|mesh-list
102626295|NCT03392376|Antiemetics|antiemetics|mesh-ancestor
102626296|NCT03392376|Autonomic Agents|autonomic agents|mesh-ancestor
102626297|NCT03392376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102626298|NCT03392376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626299|NCT03392376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102626300|NCT03392376|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102626301|NCT03392376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102626302|NCT03392376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102626303|NCT03392376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102626304|NCT03392376|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102626305|NCT03392376|Dopamine Agents|dopamine agents|mesh-ancestor
102626306|NCT03392376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102626307|NCT03392376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626308|NCT03392376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102626309|NCT05243628|Insulin|insulin|mesh-list
102626310|NCT05243628|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102626311|NCT05243628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102626312|NCT05243628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626313|NCT05249478|Fentanyl|fentanyl|mesh-list
102626314|NCT05249478|Bupivacaine|bupivacaine|mesh-list
102626315|NCT05249478|Anesthetics, Local|anesthetics, local|mesh-ancestor
102626316|NCT05249478|Anesthetics|anesthetics|mesh-ancestor
102626317|NCT05249478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102626318|NCT05249478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626319|NCT05249478|Sensory System Agents|sensory system agents|mesh-ancestor
102626320|NCT05249478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102626321|NCT05249478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102626322|NCT05249478|Narcotics|narcotics|mesh-ancestor
102626323|NCT05249478|Analgesics|analgesics|mesh-ancestor
102626324|NCT05249478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102626325|NCT05249478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102626326|NCT05249478|Anesthetics, General|anesthetics, general|mesh-ancestor
102626327|NCT05244252|Bupivacaine|bupivacaine|mesh-list
102626328|NCT05244252|Anesthetics, Local|anesthetics, local|mesh-ancestor
102626329|NCT05244252|Anesthetics|anesthetics|mesh-ancestor
102626330|NCT05244252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102626331|NCT05244252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626332|NCT05244252|Sensory System Agents|sensory system agents|mesh-ancestor
102626333|NCT05244252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102626334|NCT03286842|Olaparib|olaparib|mesh-list
102626335|NCT03286842|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102626336|NCT03286842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102626337|NCT03286842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626338|NCT03286842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102626339|NCT05240274|Metformin|metformin|mesh-list
102626340|NCT05240274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102626341|NCT05240274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275027|NCT00039429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102626342|NCT05244018|Vitamin D|vitamin d|mesh-list
102626343|NCT05244018|Ergocalciferols|ergocalciferols|mesh-list
102626344|NCT05244018|Cholecalciferol|cholecalciferol|mesh-list
102626345|NCT05244018|Vitamins|vitamins|mesh-list
102626346|NCT05244018|Micronutrients|micronutrients|mesh-ancestor
102626347|NCT05244018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626348|NCT05244018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102626349|NCT05244018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102626350|NCT02398500|Ranibizumab|ranibizumab|mesh-list
102626351|NCT02398500|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102626352|NCT02398500|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102626353|NCT02398500|Growth Substances|growth substances|mesh-ancestor
102626354|NCT02398500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626355|NCT02398500|Growth Inhibitors|growth inhibitors|mesh-ancestor
102626356|NCT02398500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102626357|NCT02984514|Deoxyglucose|deoxyglucose|mesh-list
102626358|NCT02984514|Antimetabolites|antimetabolites|mesh-ancestor
102626359|NCT02984514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626360|NCT02984514|Antiviral Agents|antiviral agents|mesh-ancestor
102626361|NCT02984514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102626362|NCT04276428|Insulin|insulin|mesh-list
102626363|NCT04276428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102626364|NCT04276428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626365|NCT05248932|Norepinephrine|norepinephrine|mesh-list
102626366|NCT05248932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102626367|NCT05248932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102626368|NCT05248932|Adrenergic Agents|adrenergic agents|mesh-ancestor
102626369|NCT05248932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102626370|NCT05248932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626371|NCT05248932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626372|NCT05248932|Sympathomimetics|sympathomimetics|mesh-ancestor
102626373|NCT05248932|Autonomic Agents|autonomic agents|mesh-ancestor
102626374|NCT05248932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102626375|NCT05248932|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102626376|NCT02395614|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102626377|NCT02395614|Gentamicins|gentamicins|mesh-list
102626378|NCT02395614|Cefazolin|cefazolin|mesh-list
102626379|NCT02395614|Bacitracin|bacitracin|mesh-list
102626380|NCT02395614|Chlorhexidine|chlorhexidine|mesh-list
102626381|NCT02395614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102626382|NCT02395614|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102626383|NCT02395614|Disinfectants|disinfectants|mesh-ancestor
102626384|NCT02395614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102626385|NCT02395614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102626386|NCT02395614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626387|NCT04396938|Lamotrigine|lamotrigine|mesh-list
102626388|NCT04396938|Anticonvulsants|anticonvulsants|mesh-ancestor
102626389|NCT04396938|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102626390|NCT04396938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102626391|NCT04396938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626392|NCT04396938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102626393|NCT04396938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626394|NCT04396938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102626395|NCT04396938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102626396|NCT04396938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102626397|NCT04396938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102626398|NCT04396938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102626399|NCT00639678|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102626400|NCT00639678|Immunologic Factors|immunologic factors|mesh-ancestor
102626401|NCT00639678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626402|NCT02914158|Tamoxifen|tamoxifen|mesh-list
102626403|NCT02914158|Leuprolide|leuprolide|mesh-list
102626404|NCT02914158|Goserelin|goserelin|mesh-list
102626405|NCT02914158|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102626406|NCT02914158|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102626407|NCT02914158|Hormone Antagonists|hormone antagonists|mesh-ancestor
102626408|NCT02914158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102626409|NCT02914158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626410|NCT02914158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102626411|NCT02914158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102626412|NCT02914158|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102626413|NCT02914158|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102626414|NCT02914158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102626415|NCT02914158|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102626416|NCT02914158|Fertility Agents|fertility agents|mesh-ancestor
102626417|NCT02914158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102626418|NCT02914158|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102626419|NCT02914158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102626420|NCT02914158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626421|NCT03136146|Dexamethasone|dexamethasone|mesh-list
102626422|NCT03136146|Dexamethasone acetate|dexamethasone acetate|mesh-list
102626423|NCT03136146|Cyclophosphamide|cyclophosphamide|mesh-list
102626424|NCT03136146|Rituximab|rituximab|mesh-list
102626425|NCT03136146|Etoposide|etoposide|mesh-list
102626426|NCT03136146|Vincristine|vincristine|mesh-list
102626427|NCT03136146|Etoposide phosphate|etoposide phosphate|mesh-list
102626428|NCT03136146|Bortezomib|bortezomib|mesh-list
102626429|NCT03136146|Clofarabine|clofarabine|mesh-list
102626430|NCT03136146|Ofatumumab|ofatumumab|mesh-list
102626431|NCT03136146|Podophyllotoxin|podophyllotoxin|mesh-list
102626432|NCT03136146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102626433|NCT03136146|Antibodies|antibodies|mesh-list
102626434|NCT03136146|Immunoglobulins|immunoglobulins|mesh-list
102626435|NCT03136146|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102626436|NCT03136146|Lenograstim|lenograstim|mesh-list
102626437|NCT03136146|BB 1101|bb 1101|mesh-list
102626438|NCT03136146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102626439|NCT03136146|Immunologic Factors|immunologic factors|mesh-ancestor
102626440|NCT03136146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626441|NCT03136146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102626442|NCT03136146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102626443|NCT03136146|Alkylating Agents|alkylating agents|mesh-ancestor
102626444|NCT03136146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626445|NCT03136146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102626446|NCT03136146|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102626447|NCT03136146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102626448|NCT03136146|Antiemetics|antiemetics|mesh-ancestor
102626449|NCT03136146|Autonomic Agents|autonomic agents|mesh-ancestor
102626450|NCT03136146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102626451|NCT03136146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102626452|NCT03136146|Glucocorticoids|glucocorticoids|mesh-ancestor
102626453|NCT03136146|Hormones|hormones|mesh-ancestor
102626454|NCT03136146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102626455|NCT03136146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102626456|NCT03136146|Protease Inhibitors|protease inhibitors|mesh-ancestor
102626457|NCT03136146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102626458|NCT03136146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102626459|NCT03136146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102626460|NCT03136146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102626461|NCT03136146|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102626462|NCT03136146|Tubulin Modulators|tubulin modulators|mesh-ancestor
102626463|NCT03136146|Antimitotic Agents|antimitotic agents|mesh-ancestor
102626464|NCT03136146|Mitosis Modulators|mitosis modulators|mesh-ancestor
102626465|NCT03136146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102626466|NCT03136146|Antimetabolites|antimetabolites|mesh-ancestor
102626467|NCT03136146|Keratolytic Agents|keratolytic agents|mesh-ancestor
102626468|NCT03136146|Dermatologic Agents|dermatologic agents|mesh-ancestor
102626469|NCT05241132|Paclitaxel|paclitaxel|mesh-list
102626470|NCT05241132|Cisplatin|cisplatin|mesh-list
102626471|NCT05241132|Tislelizumab|tislelizumab|mesh-list
102626472|NCT05241132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102626473|NCT05241132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102626474|NCT05241132|Tubulin Modulators|tubulin modulators|mesh-ancestor
102626475|NCT05241132|Antimitotic Agents|antimitotic agents|mesh-ancestor
102626476|NCT05241132|Mitosis Modulators|mitosis modulators|mesh-ancestor
102626477|NCT05241132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626478|NCT05241132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102626479|NCT05241054|Acetaminophen|acetaminophen|mesh-list
102626480|NCT05241054|Nitroglycerin|nitroglycerin|mesh-list
102626481|NCT05241054|Fentanyl|fentanyl|mesh-list
102626482|NCT05241054|Bupivacaine|bupivacaine|mesh-list
102626483|NCT05241054|Propofol|propofol|mesh-list
102626484|NCT05241054|Sevoflurane|sevoflurane|mesh-list
102626485|NCT05241054|Atracurium|atracurium|mesh-list
102626486|NCT05241054|Anesthetics, Local|anesthetics, local|mesh-ancestor
102626487|NCT05241054|Anesthetics|anesthetics|mesh-ancestor
102626488|NCT05241054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102275028|NCT00039429|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101914812|NCT05118672|Acetaminophen|acetaminophen|mesh-list
102626489|NCT05241054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626490|NCT05241054|Sensory System Agents|sensory system agents|mesh-ancestor
102626491|NCT05241054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102626492|NCT05241054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102626493|NCT05241054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102626494|NCT05241054|Anesthetics, General|anesthetics, general|mesh-ancestor
102626495|NCT05241054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102626496|NCT05241054|Narcotics|narcotics|mesh-ancestor
102626497|NCT05241054|Analgesics|analgesics|mesh-ancestor
102626498|NCT05241054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102626499|NCT05241054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102626500|NCT05241054|Antipyretics|antipyretics|mesh-ancestor
102626501|NCT05241054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102626502|NCT05241054|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102626503|NCT05241054|Vasodilator Agents|vasodilator agents|mesh-ancestor
102626504|NCT05241054|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102626505|NCT05241054|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102626506|NCT05241054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102626507|NCT05241054|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102626508|NCT05241054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102626509|NCT05241054|Cholinergic Agents|cholinergic agents|mesh-ancestor
102626510|NCT05241054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102626511|NCT05241054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626512|NCT00638508|Ketorolac|ketorolac|mesh-list
102626513|NCT00638508|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102626514|NCT00638508|Ropivacaine|ropivacaine|mesh-list
102626515|NCT00638508|Anesthetics, Local|anesthetics, local|mesh-ancestor
102626516|NCT00638508|Anesthetics|anesthetics|mesh-ancestor
102626517|NCT00638508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102626518|NCT00638508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626519|NCT00638508|Sensory System Agents|sensory system agents|mesh-ancestor
102626520|NCT00638508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102626521|NCT00638508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102626522|NCT00638508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102626523|NCT00638508|Analgesics|analgesics|mesh-ancestor
102626524|NCT00638508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102626525|NCT00638508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102626526|NCT00638508|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102626527|NCT00638508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102626528|NCT00638508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626529|NCT00637806|Megestrol|megestrol|mesh-list
102626530|NCT00637806|Megestrol Acetate|megestrol acetate|mesh-list
102626531|NCT00637806|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102626532|NCT00637806|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102626533|NCT00637806|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102626534|NCT00637806|Contraceptive Agents|contraceptive agents|mesh-ancestor
102626535|NCT00637806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102626536|NCT00637806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626537|NCT00637806|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102626538|NCT00637806|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102626539|NCT00637806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102626540|NCT00637806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102626541|NCT00637806|Appetite Stimulants|appetite stimulants|mesh-ancestor
102626542|NCT00637806|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102626543|NCT00637728|Megestrol|megestrol|mesh-list
102626544|NCT00637728|Megestrol Acetate|megestrol acetate|mesh-list
102626545|NCT00637728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102626546|NCT00637728|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102626547|NCT00637728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102626548|NCT00637728|Contraceptive Agents|contraceptive agents|mesh-ancestor
102626549|NCT00637728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102626550|NCT00637728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626551|NCT00637728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102626552|NCT00637728|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102626553|NCT00637728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102626554|NCT00637728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102626555|NCT00637728|Appetite Stimulants|appetite stimulants|mesh-ancestor
102626556|NCT00637728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102626557|NCT01922466|Loxoprofen|loxoprofen|mesh-list
102626558|NCT01922466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102626559|NCT01922466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102626560|NCT01922466|Analgesics|analgesics|mesh-ancestor
102626561|NCT01922466|Sensory System Agents|sensory system agents|mesh-ancestor
102626562|NCT01922466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102626563|NCT01922466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626564|NCT01922466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102626565|NCT01922466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102626566|NCT00637572|Megestrol|megestrol|mesh-list
102626567|NCT00637572|Megestrol Acetate|megestrol acetate|mesh-list
101914888|NCT05102591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102275029|NCT00039429|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102626568|NCT00637572|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102626569|NCT00637572|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102626570|NCT00637572|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102626571|NCT00637572|Contraceptive Agents|contraceptive agents|mesh-ancestor
102626572|NCT00637572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102626573|NCT00637572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626574|NCT00637572|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102626575|NCT00637572|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102626576|NCT00637572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102626577|NCT00637572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102626578|NCT00637572|Appetite Stimulants|appetite stimulants|mesh-ancestor
102626579|NCT00637572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102626580|NCT00637416|Lansoprazole|lansoprazole|mesh-list
102626581|NCT00637416|Dexlansoprazole|dexlansoprazole|mesh-list
102626582|NCT00637416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102626583|NCT00637416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102626584|NCT00637416|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102626585|NCT00637416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102626586|NCT00637416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626587|NCT00636792|Rituximab|rituximab|mesh-list
102626588|NCT00636792|Bortezomib|bortezomib|mesh-list
102626589|NCT00636792|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102626590|NCT00636792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102626591|NCT00636792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102626592|NCT00636792|Immunologic Factors|immunologic factors|mesh-ancestor
102626593|NCT00636792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626594|NCT00636792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102626595|NCT00636792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102626596|NCT00636792|Alkylating Agents|alkylating agents|mesh-ancestor
102626597|NCT00636792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626598|NCT03153462|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
102626599|NCT03153462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102626600|NCT03153462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102626601|NCT00636636|Gabapentin|gabapentin|mesh-list
102626602|NCT00636636|Analgesics|analgesics|mesh-ancestor
102626603|NCT00636636|Sensory System Agents|sensory system agents|mesh-ancestor
102626604|NCT00636636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102626605|NCT00636636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626606|NCT00636636|Anticonvulsants|anticonvulsants|mesh-ancestor
102626607|NCT00636636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102626608|NCT00636636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102626609|NCT00636636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102626610|NCT00636636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102626611|NCT00636636|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102626612|NCT00636636|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102626613|NCT00636636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102626614|NCT00636636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626615|NCT00636636|Antimanic Agents|antimanic agents|mesh-ancestor
102626616|NCT05244954|Chloroquine|chloroquine|mesh-list
102626617|NCT05244954|Piperaquine|piperaquine|mesh-list
102626618|NCT05244954|Artenimol|artenimol|mesh-list
102626619|NCT05244954|Amebicides|amebicides|mesh-ancestor
102626620|NCT05244954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102626621|NCT05244954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102626622|NCT05244954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102626623|NCT05244954|Antimalarials|antimalarials|mesh-ancestor
102626624|NCT05244954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102626625|NCT01929252|Dexmedetomidine|dexmedetomidine|mesh-list
102626626|NCT01929252|Levobupivacaine|levobupivacaine|mesh-list
102626627|NCT01929252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102626628|NCT01929252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102626629|NCT01929252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626630|NCT01929252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102626631|NCT01929252|Analgesics|analgesics|mesh-ancestor
102626632|NCT01929252|Sensory System Agents|sensory system agents|mesh-ancestor
102626633|NCT01929252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102626634|NCT01929252|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102626635|NCT01929252|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102626636|NCT01929252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102626637|NCT01929252|Adrenergic Agents|adrenergic agents|mesh-ancestor
102626638|NCT01929252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102626639|NCT01929252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275030|NCT00039429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626640|NCT01929252|Anesthetics, Local|anesthetics, local|mesh-ancestor
102626641|NCT01929252|Anesthetics|anesthetics|mesh-ancestor
102626642|NCT04275960|Selitrectinib|selitrectinib|mesh-list
102626643|NCT04275960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102626644|NCT04275960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626645|NCT00634920|Cyclosporine|cyclosporine|mesh-list
102626646|NCT00634920|Mycophenolic Acid|mycophenolic acid|mesh-list
102626647|NCT00634920|Prednisolone|prednisolone|mesh-list
102626648|NCT00634920|Everolimus|everolimus|mesh-list
102626649|NCT00634920|Cyclosporins|cyclosporins|mesh-list
102626650|NCT00634920|Basiliximab|basiliximab|mesh-list
102626651|NCT00634920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102626652|NCT00634920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626653|NCT00634920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102626654|NCT00634920|Immunologic Factors|immunologic factors|mesh-ancestor
102626655|NCT00634920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626656|NCT00634920|Antifungal Agents|antifungal agents|mesh-ancestor
102626657|NCT00634920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102626658|NCT00634920|Dermatologic Agents|dermatologic agents|mesh-ancestor
102626659|NCT00634920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102626660|NCT00634920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102626661|NCT00634920|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102626662|NCT00634920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102626663|NCT00634920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102626664|NCT00634920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102626665|NCT00634920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102626666|NCT00634920|Antitubercular Agents|antitubercular agents|mesh-ancestor
102626667|NCT00634920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102626668|NCT00634920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102626669|NCT00634920|Glucocorticoids|glucocorticoids|mesh-ancestor
102626670|NCT00634920|Hormones|hormones|mesh-ancestor
102626671|NCT00634920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102626672|NCT00634920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102626673|NCT01923012|Vitamin K|vitamin k|mesh-list
102626674|NCT01923012|Vitamin K 2|vitamin k 2|mesh-list
102626675|NCT01923012|Vitamins|vitamins|mesh-ancestor
102626676|NCT01923012|Micronutrients|micronutrients|mesh-ancestor
102626677|NCT01923012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626678|NCT01923012|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102626679|NCT01923012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102626680|NCT01923012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626681|NCT01923012|Hemostatics|hemostatics|mesh-ancestor
102626682|NCT01923012|Coagulants|coagulants|mesh-ancestor
102626683|NCT01923090|Finasteride|finasteride|mesh-list
102626684|NCT01923090|Dutasteride|dutasteride|mesh-list
102626685|NCT01923090|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102626686|NCT01923090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102626687|NCT01923090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102626688|NCT01923090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626689|NCT01923090|Hormone Antagonists|hormone antagonists|mesh-ancestor
102626690|NCT01923090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102626691|NCT01923090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626692|NCT01923090|Urological Agents|urological agents|mesh-ancestor
102626693|NCT01929330|Dutasteride|dutasteride|mesh-list
102626694|NCT01929330|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101598967|NCT00606411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102626695|NCT01929330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102626696|NCT01929330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102626697|NCT01929330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626698|NCT01929330|Hormone Antagonists|hormone antagonists|mesh-ancestor
102626699|NCT01929330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102626700|NCT01929330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626701|NCT00634842|Insulin|insulin|mesh-list
102626702|NCT00634842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102626703|NCT00634842|Insulin Detemir|insulin detemir|mesh-list
102626704|NCT00634842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102626705|NCT00634842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626706|NCT04396548|Midodrine|midodrine|mesh-list
102626707|NCT04396548|Anesthetics|anesthetics|mesh-list
102626708|NCT04396548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102626709|NCT04396548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626710|NCT04396548|Sympathomimetics|sympathomimetics|mesh-ancestor
102626711|NCT04396548|Autonomic Agents|autonomic agents|mesh-ancestor
102626712|NCT04396548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102626713|NCT04396548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102275032|NCT00014508|Cyclophosphamide|cyclophosphamide|mesh-list
102626714|NCT04396548|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102626715|NCT04396548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102626716|NCT04396548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102626717|NCT04396548|Adrenergic Agents|adrenergic agents|mesh-ancestor
102626718|NCT04396548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102626719|NCT04396548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626720|NCT01929798|Pancrelipase|pancrelipase|mesh-list
102626721|NCT01929798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102626722|NCT00633984|Cycloserine|cycloserine|mesh-list
102626723|NCT00633984|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102626724|NCT00633984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102626725|NCT00633984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102626726|NCT00633984|Antitubercular Agents|antitubercular agents|mesh-ancestor
102626727|NCT00633984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102626728|NCT00633984|Antimetabolites|antimetabolites|mesh-ancestor
102626729|NCT00633984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626730|NCT04395612|Niraparib|niraparib|mesh-list
102626731|NCT04395612|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102626732|NCT04395612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102626733|NCT04395612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626734|NCT04395612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102626735|NCT01923558|Donepezil|donepezil|mesh-list
102626736|NCT01923558|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102626737|NCT01923558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102626738|NCT01923558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626739|NCT01923558|Cholinergic Agents|cholinergic agents|mesh-ancestor
102626740|NCT01923558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102626741|NCT01923558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626742|NCT01923558|Nootropic Agents|nootropic agents|mesh-ancestor
102626743|NCT01921218|Cyclosporine|cyclosporine|mesh-list
102626744|NCT01921218|Mycophenolic Acid|mycophenolic acid|mesh-list
102626745|NCT01921218|Prednisone|prednisone|mesh-list
102626746|NCT01921218|Abatacept|abatacept|mesh-list
102626747|NCT01921218|Tacrolimus|tacrolimus|mesh-list
102626748|NCT01921218|Cyclosporins|cyclosporins|mesh-list
102626749|NCT01921218|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
102626750|NCT01921218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102626751|NCT01921218|Glucocorticoids|glucocorticoids|mesh-ancestor
102626752|NCT01921218|Hormones|hormones|mesh-ancestor
102626753|NCT01921218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102626754|NCT01921218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626755|NCT01921218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102626756|NCT01921218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102626757|NCT01921218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102626758|NCT01921218|Immunologic Factors|immunologic factors|mesh-ancestor
102626759|NCT01921218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102626760|NCT01921218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626761|NCT01921218|Antifungal Agents|antifungal agents|mesh-ancestor
102626762|NCT01921218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102626763|NCT01921218|Dermatologic Agents|dermatologic agents|mesh-ancestor
102626764|NCT01921218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102626765|NCT01921218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102626766|NCT01921218|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102626767|NCT01921218|Antitubercular Agents|antitubercular agents|mesh-ancestor
102626768|NCT01921218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102626769|NCT01921218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102626770|NCT01921218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102626771|NCT03129828|Bortezomib|bortezomib|mesh-list
102626772|NCT03129828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102626773|NCT01922076|Adavosertib|adavosertib|mesh-list
102626774|NCT01922076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102626775|NCT01922076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626776|NCT00633750|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102626777|NCT00633750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102626778|NCT00633750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102626779|NCT00633750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102626780|NCT00633750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626781|NCT00633360|Drospirenone|drospirenone|mesh-list
102626782|NCT00633360|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102626783|NCT00633360|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
102275033|NCT00014508|Melphalan|melphalan|mesh-list
102275034|NCT00014508|Fludarabine|fludarabine|mesh-list
102626784|NCT00633360|Estradiol|estradiol|mesh-list
102626785|NCT00633360|Estrogens|estrogens|mesh-ancestor
102626786|NCT00633360|Hormones|hormones|mesh-ancestor
101915106|NCT04925375|Abatacept|abatacept|mesh-list
102626787|NCT00633360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102626788|NCT00633360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626789|NCT00633360|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102626790|NCT00633360|Contraceptive Agents|contraceptive agents|mesh-ancestor
102626791|NCT00633360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102626792|NCT00633360|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102626793|NCT00633360|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102626794|NCT00633360|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102626795|NCT00633360|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102626796|NCT00633360|Hormone Antagonists|hormone antagonists|mesh-ancestor
102626797|NCT00633360|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102626798|NCT00633360|Diuretics|diuretics|mesh-ancestor
102626799|NCT00633360|Natriuretic Agents|natriuretic agents|mesh-ancestor
102626800|NCT00988260|Ganirelix|ganirelix|mesh-list
102626801|NCT00988260|Hormone Antagonists|hormone antagonists|mesh-ancestor
102626802|NCT00988260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102626803|NCT00988260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626804|NCT00633126|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
102626805|NCT00633126|Cephalosporins|cephalosporins|mesh-list
102626806|NCT00633126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102626807|NCT00633126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102626808|NCT00989664|Tositumomab I-131|tositumomab i-131|mesh-list
102626809|NCT00989664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102626810|NCT01923870|Enclomiphene|enclomiphene|mesh-list
102626811|NCT01923870|Clomiphene|clomiphene|mesh-list
102626812|NCT01923870|Zuclomiphene|zuclomiphene|mesh-list
102626813|NCT01923870|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102626814|NCT01923870|Hormone Antagonists|hormone antagonists|mesh-ancestor
102626815|NCT01923870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102626816|NCT01923870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626817|NCT01923870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102626818|NCT01923870|Fertility Agents|fertility agents|mesh-ancestor
102626819|NCT01923870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102626820|NCT01923870|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102626821|NCT01923870|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102626822|NCT00632736|Ropinirole|ropinirole|mesh-list
102626823|NCT00632736|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102626824|NCT00632736|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102626825|NCT00632736|Dopamine Agonists|dopamine agonists|mesh-ancestor
102626826|NCT00632736|Dopamine Agents|dopamine agents|mesh-ancestor
102626827|NCT00632736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102626828|NCT00632736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626829|NCT00632736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626830|NCT01923948|Pregabalin|pregabalin|mesh-list
102626831|NCT01923948|Analgesics|analgesics|mesh-ancestor
102626832|NCT01923948|Sensory System Agents|sensory system agents|mesh-ancestor
102626833|NCT01923948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102626834|NCT01923948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626835|NCT01923948|Anticonvulsants|anticonvulsants|mesh-ancestor
102626836|NCT01923948|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102626837|NCT01923948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102626838|NCT01923948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626839|NCT01923948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102626840|NCT01923948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102626841|NCT01923948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102626842|NCT01923948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102626843|NCT01923948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102626844|NCT00989196|Factor VIII|factor viii|mesh-list
102626845|NCT00989196|Coagulants|coagulants|mesh-ancestor
102626846|NCT00631488|Metformin|metformin|mesh-list
102626847|NCT00631488|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102626848|NCT00631488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102626849|NCT00631488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626850|NCT00631488|Incretins|incretins|mesh-ancestor
102626851|NCT00631488|Hormones|hormones|mesh-ancestor
102626852|NCT00631488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102626853|NCT00631488|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102626854|NCT00631488|Protease Inhibitors|protease inhibitors|mesh-ancestor
102626855|NCT00631488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102626856|NCT00631488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626857|NCT01924104|Aspirin|aspirin|mesh-list
102275035|NCT00014508|Fludarabine phosphate|fludarabine phosphate|mesh-list
102275036|NCT00014508|Cyclosporins|cyclosporins|mesh-list
102626858|NCT01924104|Heparin|heparin|mesh-list
102626859|NCT01924104|Calcium heparin|calcium heparin|mesh-list
102275037|NCT00014508|Sargramostim|sargramostim|mesh-list
102626860|NCT01924104|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102626861|NCT01924104|Tinzaparin|tinzaparin|mesh-list
102626862|NCT01924104|Dalteparin|dalteparin|mesh-list
102626863|NCT01924104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102626864|NCT01924104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102626865|NCT01924104|Analgesics|analgesics|mesh-ancestor
102626866|NCT01924104|Sensory System Agents|sensory system agents|mesh-ancestor
102626867|NCT01924104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102626868|NCT01924104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626869|NCT01924104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102626870|NCT01924104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102626871|NCT01924104|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102626872|NCT01924104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102626873|NCT01924104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626874|NCT01924104|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102626875|NCT01924104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102626876|NCT01924104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102626877|NCT01924104|Antipyretics|antipyretics|mesh-ancestor
102626878|NCT01924104|Anticoagulants|anticoagulants|mesh-ancestor
102626879|NCT00987402|Ethanol|ethanol|mesh-list
102626880|NCT00987402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102626881|NCT00987402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102626882|NCT00987402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102626883|NCT00987402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626884|NCT00630786|Panitumumab|panitumumab|mesh-list
102626885|NCT00630786|Conatumumab|conatumumab|mesh-list
102626886|NCT00630786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102626887|NCT00630786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102626888|NCT00630396|Minocycline|minocycline|mesh-list
102626889|NCT00630396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102626890|NCT00630396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102626891|NCT00636480|Chlorhexidine|chlorhexidine|mesh-list
102626892|NCT00636480|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102626893|NCT00636480|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102626894|NCT00636480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102626895|NCT00636480|Disinfectants|disinfectants|mesh-ancestor
102626896|NCT00636480|Dermatologic Agents|dermatologic agents|mesh-ancestor
102626897|NCT00630552|Conatumumab|conatumumab|mesh-list
102626898|NCT00630552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102626899|NCT00630552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102626900|NCT01925352|Mitogens|mitogens|mesh-list
101599187|NCT02723578|Pemetrexed|pemetrexed|mesh-list
102626901|NCT01925352|Mitosis Modulators|mitosis modulators|mesh-ancestor
102626902|NCT01925352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626903|NCT03095352|Carboplatin|carboplatin|mesh-list
102626904|NCT03095352|Pembrolizumab|pembrolizumab|mesh-list
102626905|NCT03095352|Trastuzumab|trastuzumab|mesh-list
102626906|NCT03095352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102626907|NCT03095352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102626908|NCT03095352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102626909|NCT03095352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626910|NCT01920204|Midostaurin|midostaurin|mesh-list
102626911|NCT01920204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102626912|NCT01920204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102626913|NCT01920204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102626914|NCT01920204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626915|NCT04275258|Analgesics, Opioid|analgesics, opioid|mesh-list
102626916|NCT04275258|Narcotics|narcotics|mesh-ancestor
102626917|NCT04275258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102626918|NCT04275258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626919|NCT04275258|Analgesics|analgesics|mesh-ancestor
102626920|NCT04275258|Sensory System Agents|sensory system agents|mesh-ancestor
102626921|NCT04275258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102626922|NCT01925820|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102626923|NCT01925820|Entecavir|entecavir|mesh-list
102626924|NCT01925820|Antiviral Agents|antiviral agents|mesh-ancestor
102626925|NCT01925820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102626926|NCT01925898|Midazolam|midazolam|mesh-list
102626927|NCT01925898|Ketamine|ketamine|mesh-list
102626928|NCT01925898|Analgesics|analgesics|mesh-ancestor
102626929|NCT01925898|Sensory System Agents|sensory system agents|mesh-ancestor
102626930|NCT01925898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102626931|NCT01925898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626932|NCT01925898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102275038|NCT00014508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102275039|NCT00014508|Immunologic Factors|immunologic factors|mesh-ancestor
102626933|NCT01925898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102275040|NCT00014508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626934|NCT01925898|Anesthetics, General|anesthetics, general|mesh-ancestor
102626935|NCT01925898|Anesthetics|anesthetics|mesh-ancestor
102626936|NCT01925898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102626937|NCT01925898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102626938|NCT01925898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102626939|NCT01925898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102626940|NCT01925898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626941|NCT01925898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102626942|NCT01925898|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102626943|NCT01925898|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102626944|NCT01925898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102626945|NCT01925898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102626946|NCT01925898|GABA Modulators|gaba modulators|mesh-ancestor
102626947|NCT01925898|GABA Agents|gaba agents|mesh-ancestor
102626948|NCT00983580|Aspirin|aspirin|mesh-list
102626949|NCT00983580|Eflornithine|eflornithine|mesh-list
102626950|NCT00983580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102626951|NCT00983580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102626952|NCT00983580|Analgesics|analgesics|mesh-ancestor
102626953|NCT00983580|Sensory System Agents|sensory system agents|mesh-ancestor
102626954|NCT00983580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102626955|NCT00983580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626956|NCT00983580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102626957|NCT00983580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102626958|NCT00983580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102626959|NCT00983580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102626960|NCT00983580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626961|NCT00983580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102626962|NCT00983580|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102626963|NCT00983580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102626964|NCT00983580|Antipyretics|antipyretics|mesh-ancestor
102626965|NCT00983580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102626966|NCT00983580|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102626967|NCT00983580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102626968|NCT00983580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101599251|NCT00625859|Bupropion|bupropion|mesh-list
102626969|NCT00983580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102626970|NCT00983580|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
102626971|NCT00982878|Maraviroc|maraviroc|mesh-list
102626972|NCT00982878|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102626973|NCT00982878|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102626974|NCT00982878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626975|NCT00982878|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102626976|NCT00982878|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102626977|NCT00982878|Antiviral Agents|antiviral agents|mesh-ancestor
102626978|NCT00982878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102626979|NCT00982878|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102626980|NCT00982488|Imatinib Mesylate|imatinib mesylate|mesh-list
102626981|NCT00982488|Dasatinib|dasatinib|mesh-list
102626982|NCT00982488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102626983|NCT00982488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102626984|NCT00982488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102626985|NCT00982488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102626986|NCT00982020|Olanzapine|olanzapine|mesh-list
102626987|NCT00982020|Antiemetics|antiemetics|mesh-ancestor
102626988|NCT00982020|Autonomic Agents|autonomic agents|mesh-ancestor
102626989|NCT00982020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102626990|NCT00982020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102626991|NCT00982020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102626992|NCT00982020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102626993|NCT00982020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102626994|NCT00982020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102626995|NCT00982020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102626996|NCT00982020|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102626997|NCT00982020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102626998|NCT00982020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102626999|NCT00982020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627000|NCT00982020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102627001|NCT00982020|Serotonin Agents|serotonin agents|mesh-ancestor
102627002|NCT01926132|Ascorbic Acid|ascorbic acid|mesh-list
102627003|NCT01926132|Antioxidants|antioxidants|mesh-ancestor
102627004|NCT01926132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627005|NCT01926132|Protective Agents|protective agents|mesh-ancestor
102627006|NCT01926132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275041|NCT00014508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102627007|NCT01926132|Vitamins|vitamins|mesh-ancestor
102627008|NCT01926132|Micronutrients|micronutrients|mesh-ancestor
102627009|NCT01926210|Letrozole|letrozole|mesh-list
102627010|NCT01926210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102627011|NCT01926210|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102627012|NCT01926210|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102627013|NCT01926210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102627014|NCT01926210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627015|NCT01926210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102627016|NCT01926210|Hormone Antagonists|hormone antagonists|mesh-ancestor
102627017|NCT01926210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102627018|NCT01926210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627019|NCT01926288|Entecavir|entecavir|mesh-list
102627020|NCT01926288|Maleic acid|maleic acid|mesh-list
102627021|NCT01926288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102627022|NCT01926288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627023|NCT01926288|Antiviral Agents|antiviral agents|mesh-ancestor
102627024|NCT01926288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102627025|NCT00981084|Modafinil|modafinil|mesh-list
102627026|NCT00981084|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102627027|NCT00981084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627028|NCT00981084|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102627029|NCT00981084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102627030|NCT00981084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102627031|NCT00981084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627032|NCT00980148|Azithromycin|azithromycin|mesh-list
102627033|NCT00980148|Doxycycline|doxycycline|mesh-list
102627034|NCT00980148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102627035|NCT00980148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101599317|NCT04931368|Rituximab|rituximab|mesh-list
102627036|NCT00980148|Antimalarials|antimalarials|mesh-ancestor
102627037|NCT00980148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102627038|NCT00980148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102627039|NCT03064854|Paclitaxel|paclitaxel|mesh-list
102627040|NCT03064854|Carboplatin|carboplatin|mesh-list
102627041|NCT03064854|Gemcitabine|gemcitabine|mesh-list
102627042|NCT03064854|Pemetrexed|pemetrexed|mesh-list
102627043|NCT03064854|Spartalizumab|spartalizumab|mesh-list
102627044|NCT03064854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102627045|NCT03064854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102627046|NCT03064854|Tubulin Modulators|tubulin modulators|mesh-ancestor
102627047|NCT03064854|Antimitotic Agents|antimitotic agents|mesh-ancestor
102627048|NCT03064854|Mitosis Modulators|mitosis modulators|mesh-ancestor
102627049|NCT03064854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627050|NCT03064854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102627051|NCT03064854|Antimetabolites|antimetabolites|mesh-ancestor
102627052|NCT03064854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102627053|NCT03064854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102627054|NCT03064854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102627055|NCT03064854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102627056|NCT03064854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102627057|NCT00983814|Carbidopa|carbidopa|mesh-list
102627058|NCT00983814|Droxidopa|droxidopa|mesh-list
102627059|NCT00983814|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102627060|NCT00983814|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102627061|NCT00983814|Dopamine Agents|dopamine agents|mesh-ancestor
102627062|NCT00983814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102627063|NCT00983814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627064|NCT00983814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627065|NCT00983814|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102627066|NCT00983814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102627067|NCT01921920|Omeprazole|omeprazole|mesh-list
102627068|NCT01921920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102627069|NCT01921920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102627070|NCT01921920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102627071|NCT01921920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102627072|NCT01921920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627073|NCT04275414|Bevacizumab|bevacizumab|mesh-list
102627074|NCT04275414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102627075|NCT04275414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102627076|NCT04275414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102627077|NCT04275414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102627078|NCT04275414|Growth Substances|growth substances|mesh-ancestor
102627079|NCT04275414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627080|NCT04275414|Growth Inhibitors|growth inhibitors|mesh-ancestor
102627081|NCT04395768|Vitamin D|vitamin d|mesh-list
102627082|NCT04395768|Cholecalciferol|cholecalciferol|mesh-list
102627083|NCT04395768|Vitamins|vitamins|mesh-list
102627084|NCT04395768|Ascorbic Acid|ascorbic acid|mesh-list
102627085|NCT04395768|Vitamin B 12|vitamin b 12|mesh-list
102627086|NCT04395768|Azithromycin|azithromycin|mesh-list
102627087|NCT04395768|Hydroxychloroquine|hydroxychloroquine|mesh-list
102627088|NCT04395768|Micronutrients|micronutrients|mesh-ancestor
102627089|NCT04395768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627090|NCT04395768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102627091|NCT04395768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627092|NCT04395768|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102627093|NCT04395768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102627094|NCT04395768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102627095|NCT04395768|Antimalarials|antimalarials|mesh-ancestor
102627096|NCT04395768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102627097|NCT04395768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102627098|NCT04395768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102627099|NCT04395768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102627100|NCT04395768|Antioxidants|antioxidants|mesh-ancestor
102627101|NCT04395768|Protective Agents|protective agents|mesh-ancestor
102627102|NCT04395768|Vitamin B Complex|vitamin b complex|mesh-ancestor
102627103|NCT01927224|Nifurtimox|nifurtimox|mesh-list
102627104|NCT01927224|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102627105|NCT01927224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102627106|NCT01927224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102627107|NCT01927224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102627108|NCT01922154|Ranibizumab|ranibizumab|mesh-list
102627109|NCT01922154|Mitomycin|mitomycin|mesh-list
102627110|NCT01922154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102627111|NCT01922154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102627112|NCT01922154|Growth Substances|growth substances|mesh-ancestor
102627113|NCT01922154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627114|NCT01922154|Growth Inhibitors|growth inhibitors|mesh-ancestor
102627115|NCT01922154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102627116|NCT01922154|Alkylating Agents|alkylating agents|mesh-ancestor
102627117|NCT01922154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627118|NCT01922154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102627119|NCT01922154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102627120|NCT01922154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102627121|NCT03423342|Niacinamide|niacinamide|mesh-list
102627122|NCT03423342|Niacin|niacin|mesh-list
102627123|NCT03423342|Nicotinic Acids|nicotinic acids|mesh-list
102627124|NCT03423342|Vitamin B Complex|vitamin b complex|mesh-ancestor
102627125|NCT03423342|Vitamins|vitamins|mesh-ancestor
102627126|NCT03423342|Micronutrients|micronutrients|mesh-ancestor
102627127|NCT03423342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627128|NCT03423342|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102627129|NCT03423342|Antimetabolites|antimetabolites|mesh-ancestor
102627130|NCT03423342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627131|NCT03423342|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102627132|NCT03423342|Vasodilator Agents|vasodilator agents|mesh-ancestor
102627133|NCT01928160|Carboplatin|carboplatin|mesh-list
102627134|NCT01928160|Pemetrexed|pemetrexed|mesh-list
102627135|NCT01928160|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102627136|NCT01928160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102627137|NCT01928160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102627138|NCT01928160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627139|NCT01928160|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102627140|NCT01928160|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102627141|NCT01928160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102627142|NCT01928316|Mizolastine|mizolastine|mesh-list
102627143|NCT01928316|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102627144|NCT01928316|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102627145|NCT01928316|Histamine Antagonists|histamine antagonists|mesh-ancestor
102627146|NCT01928316|Histamine Agents|histamine agents|mesh-ancestor
102627147|NCT01928316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102627148|NCT01928316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627149|NCT01928316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627150|NCT03050736|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
102627151|NCT03050736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102627152|NCT03050736|Alkylating Agents|alkylating agents|mesh-ancestor
102627153|NCT03050736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275042|NCT00014508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102275043|NCT00014508|Alkylating Agents|alkylating agents|mesh-ancestor
101915481|NCT04579523|Antibodies|antibodies|mesh-list
102627154|NCT03050736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102627155|NCT04559646|Hemostatics|hemostatics|mesh-list
102627156|NCT04559646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102627158|NCT04550520|Glucagon|glucagon|mesh-list
102627159|NCT04550520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102627160|NCT04550520|Hormones|hormones|mesh-ancestor
102627161|NCT04550520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102627162|NCT04550520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627163|NCT01928628|Valsartan|valsartan|mesh-list
102627164|NCT01928628|Lercanidipine|lercanidipine|mesh-list
102627165|NCT01928628|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102627166|NCT01928628|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102627167|NCT01928628|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102627168|NCT01928628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627169|NCT01928628|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102627170|NCT01928628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102627171|NCT01928628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102627172|NCT01928628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627173|NCT01929096|Edaravone|edaravone|mesh-list
102627174|NCT01929096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102627175|NCT01929096|Antioxidants|antioxidants|mesh-ancestor
102627176|NCT01929096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627177|NCT01929096|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102627178|NCT01929096|Protective Agents|protective agents|mesh-ancestor
102627179|NCT01929096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627180|NCT03059004|TEMPO|tempo|mesh-list
102627181|NCT03059004|Antioxidants|antioxidants|mesh-ancestor
102627182|NCT03059004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627183|NCT03059004|Protective Agents|protective agents|mesh-ancestor
102627184|NCT03059004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627185|NCT04554888|Doxepin|doxepin|mesh-list
102627186|NCT04554888|Histamine|histamine|mesh-list
102627187|NCT04554888|Histamine Agonists|histamine agonists|mesh-ancestor
102627188|NCT04554888|Histamine Agents|histamine agents|mesh-ancestor
102627189|NCT04554888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102627190|NCT04554888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627191|NCT04554888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627192|NCT04554888|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102627193|NCT04554888|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102627194|NCT04554888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102627195|NCT04554888|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102627196|NCT04554888|Antidepressive Agents|antidepressive agents|mesh-ancestor
102627197|NCT04554888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102627198|NCT04554888|Histamine Antagonists|histamine antagonists|mesh-ancestor
102627199|NCT05601960|Sunscreening Agents|sunscreening agents|mesh-list
102627200|NCT05601960|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102627201|NCT05601960|Protective Agents|protective agents|mesh-ancestor
102627202|NCT05601960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627203|NCT05601960|Dermatologic Agents|dermatologic agents|mesh-ancestor
102627204|NCT05605002|Serotonin|serotonin|mesh-list
102627205|NCT05605002|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102627206|NCT05605002|Serotonin Agents|serotonin agents|mesh-ancestor
102627207|NCT05605002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102627208|NCT05605002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627209|NCT05605002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627210|NCT03238248|Azacitidine|azacitidine|mesh-list
102627211|NCT03238248|Pevonedistat|pevonedistat|mesh-list
102627212|NCT03238248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102627213|NCT03238248|Antimetabolites|antimetabolites|mesh-ancestor
102627214|NCT03238248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627215|NCT03238248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102627216|NCT03238248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102627217|NCT04124016|Grape Seed Extract|grape seed extract|mesh-list
102627218|NCT04124016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102627219|NCT04124016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102627220|NCT04124016|Antioxidants|antioxidants|mesh-ancestor
102627221|NCT04124016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627222|NCT04124016|Protective Agents|protective agents|mesh-ancestor
102627223|NCT04124016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627224|NCT04124094|Fluticasone|fluticasone|mesh-list
102627225|NCT04124094|Xhance|xhance|mesh-list
101915548|NCT04499248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102627226|NCT04124094|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102627227|NCT04124094|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102627228|NCT04124094|Charcoal|charcoal|mesh-list
102627229|NCT04124094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102627230|NCT04124094|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102627231|NCT04124094|Autonomic Agents|autonomic agents|mesh-ancestor
102627232|NCT04124094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102627233|NCT04124094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627234|NCT04124094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102627235|NCT04124094|Respiratory System Agents|respiratory system agents|mesh-ancestor
102627236|NCT04124094|Dermatologic Agents|dermatologic agents|mesh-ancestor
102627237|NCT04124094|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102627238|NCT04124094|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102627239|NCT04124094|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102627240|NCT04124094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102627241|NCT04124094|Adrenergic Agents|adrenergic agents|mesh-ancestor
102627242|NCT04124094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102627243|NCT04124094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627244|NCT04124094|Glucocorticoids|glucocorticoids|mesh-ancestor
102627245|NCT04124094|Hormones|hormones|mesh-ancestor
102627246|NCT04124094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102627247|NCT04124094|Sympathomimetics|sympathomimetics|mesh-ancestor
102627248|NCT04124094|Antidotes|antidotes|mesh-ancestor
102627249|NCT04124094|Protective Agents|protective agents|mesh-ancestor
102627250|NCT03033576|Nivolumab|nivolumab|mesh-list
102627251|NCT03033576|Ipilimumab|ipilimumab|mesh-list
102627252|NCT03033576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102627253|NCT03033576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102627254|NCT03033576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102627255|NCT03033576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627256|NCT04123392|Cyclophosphamide|cyclophosphamide|mesh-list
102627257|NCT04123392|Busulfan|busulfan|mesh-list
102627258|NCT04123392|Decitabine|decitabine|mesh-list
102627259|NCT04123392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102627260|NCT04123392|Immunologic Factors|immunologic factors|mesh-ancestor
102627261|NCT04123392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627262|NCT04123392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102627263|NCT04123392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102627264|NCT04123392|Alkylating Agents|alkylating agents|mesh-ancestor
102627265|NCT04123392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627266|NCT04123392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102627267|NCT04123392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102627268|NCT04123392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102627269|NCT04123392|Antimetabolites|antimetabolites|mesh-ancestor
102627270|NCT04123392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102627271|NCT04760262|Remifentanil|remifentanil|mesh-list
102627272|NCT04760262|Propofol|propofol|mesh-list
102627273|NCT04760262|Sevoflurane|sevoflurane|mesh-list
102627274|NCT04760262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102627275|NCT04760262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102627276|NCT04760262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627277|NCT04760262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102627278|NCT04760262|Anesthetics, General|anesthetics, general|mesh-ancestor
102627279|NCT04760262|Anesthetics|anesthetics|mesh-ancestor
102627280|NCT04760262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102627281|NCT04760262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102627282|NCT04760262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102627283|NCT04760262|Narcotics|narcotics|mesh-ancestor
102627284|NCT04760262|Analgesics|analgesics|mesh-ancestor
102627285|NCT04760262|Sensory System Agents|sensory system agents|mesh-ancestor
102627286|NCT04760262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102627287|NCT03047928|Nivolumab|nivolumab|mesh-list
102627288|NCT03047928|Vaccines|vaccines|mesh-list
102627289|NCT03047928|Immunologic Factors|immunologic factors|mesh-ancestor
102627290|NCT03047928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627291|NCT03047928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102627292|NCT03047928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102627293|NCT03047928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102627294|NCT03047928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627295|NCT05607810|Aflibercept|aflibercept|mesh-list
102627296|NCT05607810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102627297|NCT05607810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102627298|NCT05607810|Growth Substances|growth substances|mesh-ancestor
102627299|NCT05607810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627300|NCT05607810|Growth Inhibitors|growth inhibitors|mesh-ancestor
101915626|NCT04415476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102627301|NCT05607810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102627302|NCT04126278|Dexamethasone|dexamethasone|mesh-list
102627303|NCT04126278|Cortisone|cortisone|mesh-list
102627304|NCT04126278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102627305|NCT04126278|Antiemetics|antiemetics|mesh-ancestor
102627306|NCT04126278|Autonomic Agents|autonomic agents|mesh-ancestor
102627307|NCT04126278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102627308|NCT04126278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627309|NCT04126278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102627310|NCT04126278|Glucocorticoids|glucocorticoids|mesh-ancestor
102627311|NCT04126278|Hormones|hormones|mesh-ancestor
102627312|NCT04126278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102627313|NCT04126278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102627314|NCT04126278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102627315|NCT04127682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102627316|NCT04127682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102627317|NCT04122066|Sofosbuvir|sofosbuvir|mesh-list
102627318|NCT04122066|Antiviral Agents|antiviral agents|mesh-ancestor
102627319|NCT04122066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102627320|NCT04121910|Itraconazole|itraconazole|mesh-list
102627321|NCT04121910|Antifungal Agents|antifungal agents|mesh-ancestor
102627322|NCT04121910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102627323|NCT04121910|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102627324|NCT04121910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102627325|NCT04121910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102627326|NCT04121910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627327|NCT04121910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102627328|NCT04121910|Hormone Antagonists|hormone antagonists|mesh-ancestor
102627329|NCT04121910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102627330|NCT04121910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627331|NCT04121910|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102627332|NCT04129788|Bisacodyl|bisacodyl|mesh-list
102627333|NCT04129788|Cathartics|cathartics|mesh-ancestor
102627334|NCT04129788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102627335|NCT04129788|Laxatives|laxatives|mesh-ancestor
102627336|NCT03831126|Betamethasone|betamethasone|mesh-list
102627337|NCT03831126|Betamethasone Valerate|betamethasone valerate|mesh-list
102627338|NCT03831126|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102627339|NCT03831126|Betamethasone benzoate|betamethasone benzoate|mesh-list
102627340|NCT03831126|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102627341|NCT03831126|Glucocorticoids|glucocorticoids|mesh-ancestor
102627342|NCT03831126|Hormones|hormones|mesh-ancestor
102627343|NCT03831126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102627344|NCT03831126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627345|NCT03831126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102627346|NCT03831126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102627347|NCT03831126|Respiratory System Agents|respiratory system agents|mesh-ancestor
102627348|NCT04073784|Gemcitabine|gemcitabine|mesh-list
102627349|NCT04073784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102627350|NCT04073784|Antimetabolites|antimetabolites|mesh-ancestor
102627351|NCT04073784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627352|NCT04073784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102627353|NCT05606796|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102627354|NCT05606796|Latanoprost|latanoprost|mesh-list
102627355|NCT05606796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102627356|NCT04129710|Rituximab|rituximab|mesh-list
102627357|NCT04129710|Methotrexate|methotrexate|mesh-list
102627358|NCT04129710|Etoposide|etoposide|mesh-list
102627359|NCT04129710|Lenalidomide|lenalidomide|mesh-list
102627360|NCT04129710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102627361|NCT04129710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102627362|NCT04129710|Immunologic Factors|immunologic factors|mesh-ancestor
102627363|NCT04129710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627364|NCT04129710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102627365|NCT04129710|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102627366|NCT04129710|Abortifacient Agents|abortifacient agents|mesh-ancestor
102627367|NCT04129710|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102627368|NCT04129710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102627369|NCT04129710|Antimetabolites|antimetabolites|mesh-ancestor
102627370|NCT04129710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627371|NCT04129710|Dermatologic Agents|dermatologic agents|mesh-ancestor
102627372|NCT04129710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102627373|NCT04129710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102627374|NCT04129710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102275044|NCT00014508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915771|NCT04292808|Methoxyflurane|methoxyflurane|mesh-list
102627375|NCT04129710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102638134|NCT00716742|Bimatoprost|bimatoprost|mesh-list
102627376|NCT04129710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102627377|NCT04129710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102627378|NCT04129710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102627379|NCT04129710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102627380|NCT04129710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102627381|NCT04129710|Growth Substances|growth substances|mesh-ancestor
102627382|NCT04129710|Growth Inhibitors|growth inhibitors|mesh-ancestor
102627383|NCT03200808|Methylene Blue|methylene blue|mesh-list
102627384|NCT03200808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102627385|NCT03200808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627386|NCT04129008|Aspirin|aspirin|mesh-list
102627387|NCT04129008|Indobufen|indobufen|mesh-list
102627388|NCT04129008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102627389|NCT04129008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102627390|NCT04129008|Analgesics|analgesics|mesh-ancestor
102627391|NCT04129008|Sensory System Agents|sensory system agents|mesh-ancestor
102627392|NCT04129008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102627393|NCT04129008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627394|NCT04129008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102627395|NCT04129008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102627396|NCT04129008|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102627397|NCT04129008|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102627398|NCT04129008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627399|NCT04129008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102627400|NCT04129008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102627401|NCT04129008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102627402|NCT04129008|Antipyretics|antipyretics|mesh-ancestor
102627403|NCT04128462|Phenylacetic acid|phenylacetic acid|mesh-list
102627404|NCT04128462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102627405|NCT04128462|Antimetabolites|antimetabolites|mesh-ancestor
102627406|NCT04128462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627407|NCT04128462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102627408|NCT04120350|Rituximab|rituximab|mesh-list
102627409|NCT04120350|Methotrexate|methotrexate|mesh-list
102627410|NCT04120350|Lenalidomide|lenalidomide|mesh-list
102627411|NCT04120350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102627412|NCT04120350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102627413|NCT04120350|Immunologic Factors|immunologic factors|mesh-ancestor
102627414|NCT04120350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627415|NCT04120350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102627416|NCT04120350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102627417|NCT04120350|Abortifacient Agents|abortifacient agents|mesh-ancestor
102627418|NCT04120350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102627419|NCT04120350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102627420|NCT04120350|Antimetabolites|antimetabolites|mesh-ancestor
102627421|NCT04120350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627422|NCT04120350|Dermatologic Agents|dermatologic agents|mesh-ancestor
102627423|NCT04120350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102627424|NCT04120350|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102627425|NCT04120350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101599718|NCT03792256|Hormones|hormones|mesh-ancestor
102627426|NCT04120350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102627427|NCT04120350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102627428|NCT04120350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102627429|NCT04120350|Growth Substances|growth substances|mesh-ancestor
102627430|NCT04120350|Growth Inhibitors|growth inhibitors|mesh-ancestor
102627431|NCT04394598|Capecitabine|capecitabine|mesh-list
102627432|NCT04394598|Irinotecan|irinotecan|mesh-list
102627433|NCT04394598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102627434|NCT04394598|Antimetabolites|antimetabolites|mesh-ancestor
102627435|NCT04394598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627436|NCT04394598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102627437|NCT04394598|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102627438|NCT04394598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102627439|NCT04394598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102627440|NCT04127916|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102627441|NCT04127916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102627442|NCT04127916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102627443|NCT04127916|Alkylating Agents|alkylating agents|mesh-ancestor
102627444|NCT04127916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627445|NCT05602428|Anesthetics|anesthetics|mesh-list
102627446|NCT05602428|Esketamine|esketamine|mesh-list
102638135|NCT00716742|Travoprost|travoprost|mesh-list
102275045|NCT00014508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102275046|NCT00014508|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101915848|NCT04071769|Xenon|xenon|mesh-list
102627447|NCT05602428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102627448|NCT05602428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627449|NCT05602428|Antidepressive Agents|antidepressive agents|mesh-ancestor
102627450|NCT05602428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102627451|NCT02983890|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102627452|NCT02983890|Dicloxacillin|dicloxacillin|mesh-list
102627453|NCT02983890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102627454|NCT04127058|Iloperidone|iloperidone|mesh-list
102627455|NCT04127058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102627456|NCT04127058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102627457|NCT04127058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102627458|NCT04127058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627459|NCT04127058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102627460|NCT03012360|Ciprofloxacin|ciprofloxacin|mesh-list
102627461|NCT03012360|Ceftriaxone|ceftriaxone|mesh-list
102627462|NCT03012360|Linezolid|linezolid|mesh-list
102627463|NCT03012360|Imipenem|imipenem|mesh-list
102627464|NCT03012360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102627465|NCT03012360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102627466|NCT03012360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102627467|NCT03012360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102627468|NCT03012360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102627469|NCT03012360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627470|NCT03012360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102627471|NCT03012360|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102627472|NCT03012360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102627473|NCT03012360|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102627474|NCT04120974|Insulin|insulin|mesh-list
102627475|NCT04120974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102627476|NCT04120974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627477|NCT04126668|Vorolanib|vorolanib|mesh-list
102627478|NCT04126668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102627479|NCT04126668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102627480|NCT04126668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627481|NCT04758936|Clonidine|clonidine|mesh-list
102627482|NCT04758936|Dexmedetomidine|dexmedetomidine|mesh-list
102627483|NCT04758936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102627484|NCT04758936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102627485|NCT04758936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627486|NCT04758936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102627487|NCT04758936|Analgesics|analgesics|mesh-ancestor
102627488|NCT04758936|Sensory System Agents|sensory system agents|mesh-ancestor
102627489|NCT04758936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102627490|NCT04758936|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102627491|NCT04758936|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102627492|NCT04758936|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102627493|NCT04758936|Adrenergic Agents|adrenergic agents|mesh-ancestor
102627494|NCT04758936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102627495|NCT04758936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627496|NCT04758936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102627497|NCT04758936|Sympatholytics|sympatholytics|mesh-ancestor
102627498|NCT04758936|Autonomic Agents|autonomic agents|mesh-ancestor
102627499|NCT04126044|Bevacizumab|bevacizumab|mesh-list
102627500|NCT04126044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102627501|NCT04126044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102627502|NCT04126044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102627503|NCT04126044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102627504|NCT04126044|Growth Substances|growth substances|mesh-ancestor
102627505|NCT04126044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627506|NCT04126044|Growth Inhibitors|growth inhibitors|mesh-ancestor
102627507|NCT04758858|Glucagon|glucagon|mesh-list
102627508|NCT04758858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627509|NCT04758858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102627510|NCT04758858|Hormones|hormones|mesh-ancestor
102627511|NCT04758858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102627512|NCT04125888|Immunomodulating Agents|immunomodulating agents|mesh-list
102627513|NCT04125888|Immunologic Factors|immunologic factors|mesh-ancestor
102627514|NCT04125888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627515|NCT02975310|Anesthetics|anesthetics|mesh-list
102627516|NCT02975310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102627517|NCT02975310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627518|NCT04394208|Silymarin|silymarin|mesh-list
102627519|NCT04394208|Antioxidants|antioxidants|mesh-ancestor
102627520|NCT04394208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915919|NCT03988530|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102275047|NCT00014508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102627521|NCT04394208|Protective Agents|protective agents|mesh-ancestor
102627522|NCT04394208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627523|NCT03829566|Methylprednisolone|methylprednisolone|mesh-list
102627524|NCT03829566|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102627525|NCT03829566|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102627526|NCT03829566|Prednisolone|prednisolone|mesh-list
102627527|NCT03829566|Prednisolone acetate|prednisolone acetate|mesh-list
102627528|NCT03829566|Cyclophosphamide|cyclophosphamide|mesh-list
102627529|NCT03829566|Rituximab|rituximab|mesh-list
102627530|NCT03829566|Thymoglobulin|thymoglobulin|mesh-list
102627531|NCT03829566|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102627532|NCT03829566|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102627533|NCT03829566|Prednisolone phosphate|prednisolone phosphate|mesh-list
102627534|NCT03829566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102627535|NCT03829566|Immunologic Factors|immunologic factors|mesh-ancestor
102627536|NCT03829566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627537|NCT03829566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102627538|NCT03829566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102627539|NCT03829566|Alkylating Agents|alkylating agents|mesh-ancestor
102627540|NCT03829566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627541|NCT03829566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102627542|NCT03829566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102627543|NCT03829566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102627544|NCT03829566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102627545|NCT03829566|Antiemetics|antiemetics|mesh-ancestor
102627546|NCT03829566|Autonomic Agents|autonomic agents|mesh-ancestor
102627547|NCT03829566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102627548|NCT03829566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102627549|NCT03829566|Glucocorticoids|glucocorticoids|mesh-ancestor
102627550|NCT03829566|Hormones|hormones|mesh-ancestor
102627551|NCT03829566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102627552|NCT03829566|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102627553|NCT03829566|Protective Agents|protective agents|mesh-ancestor
102627554|NCT03829566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102627555|NCT03933306|Dexmedetomidine|dexmedetomidine|mesh-list
102627556|NCT03933306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102627557|NCT03933306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102627558|NCT03933306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627559|NCT03933306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102627560|NCT03933306|Analgesics|analgesics|mesh-ancestor
102627561|NCT03933306|Sensory System Agents|sensory system agents|mesh-ancestor
102627562|NCT03933306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102627563|NCT03933306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102627564|NCT03933306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102627565|NCT03933306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102627566|NCT03933306|Adrenergic Agents|adrenergic agents|mesh-ancestor
102627567|NCT03933306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102627568|NCT03933306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627569|NCT04394442|Hydroxychloroquine|hydroxychloroquine|mesh-list
102627570|NCT04394442|Antimalarials|antimalarials|mesh-ancestor
102627571|NCT04394442|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102627572|NCT04394442|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102627573|NCT04394442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102627574|NCT04394442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102627575|NCT04394442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627576|NCT04394442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102627577|NCT02972424|Teriparatide|teriparatide|mesh-list
102627578|NCT02972424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102627579|NCT02972424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627580|NCT02972424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102627581|NCT05608590|Ethiodized Oil|ethiodized oil|mesh-list
102627582|NCT05608590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102627583|NCT04393584|Leucovorin|leucovorin|mesh-list
102627584|NCT04393584|Docetaxel|docetaxel|mesh-list
102627585|NCT04393584|Oxaliplatin|oxaliplatin|mesh-list
102627586|NCT04393584|Irinotecan|irinotecan|mesh-list
102627587|NCT04393584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102627588|NCT04393584|Tubulin Modulators|tubulin modulators|mesh-ancestor
102627589|NCT04393584|Antimitotic Agents|antimitotic agents|mesh-ancestor
102627590|NCT04393584|Mitosis Modulators|mitosis modulators|mesh-ancestor
102627591|NCT04393584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627592|NCT04393584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102627593|NCT04393584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102627594|NCT04393584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102627595|NCT04393584|Antidotes|antidotes|mesh-ancestor
102627596|NCT04393584|Protective Agents|protective agents|mesh-ancestor
102627597|NCT04393584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627598|NCT04393584|Vitamin B Complex|vitamin b complex|mesh-ancestor
102627599|NCT04393584|Vitamins|vitamins|mesh-ancestor
102627600|NCT04393584|Micronutrients|micronutrients|mesh-ancestor
102627601|NCT02965950|Cyclophosphamide|cyclophosphamide|mesh-list
102627602|NCT02965950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102627603|NCT02965950|Immunologic Factors|immunologic factors|mesh-ancestor
102627604|NCT02965950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627605|NCT02965950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102627606|NCT02965950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102627607|NCT02965950|Alkylating Agents|alkylating agents|mesh-ancestor
102627608|NCT02965950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627609|NCT02965950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102627610|NCT02965950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102627611|NCT03828474|Acetazolamide|acetazolamide|mesh-list
102627612|NCT03828474|Anticonvulsants|anticonvulsants|mesh-ancestor
102627613|NCT03828474|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102627614|NCT03828474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102627615|NCT03828474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627616|NCT03828474|Diuretics|diuretics|mesh-ancestor
102627617|NCT03828474|Natriuretic Agents|natriuretic agents|mesh-ancestor
102627618|NCT03828474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627619|NCT03828084|Decitabine|decitabine|mesh-list
102627620|NCT03828084|Tetrahydrouridine|tetrahydrouridine|mesh-list
102627621|NCT03828084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102627622|NCT03828084|Antimetabolites|antimetabolites|mesh-ancestor
102627623|NCT03828084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627624|NCT03828084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102627625|NCT03828084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102627626|NCT04274166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102627627|NCT04274166|Immunologic Factors|immunologic factors|mesh-ancestor
102627628|NCT04274166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627629|NCT02983734|Cycloserine|cycloserine|mesh-list
102627630|NCT02983734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102627631|NCT02983734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102627632|NCT02983734|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102627633|NCT02983734|Antitubercular Agents|antitubercular agents|mesh-ancestor
102627634|NCT02983734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102627635|NCT02983734|Antimetabolites|antimetabolites|mesh-ancestor
101599920|NCT03664882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102627636|NCT02983734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627637|NCT03821454|Capecitabine|capecitabine|mesh-list
102627638|NCT03821454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102627639|NCT03821454|Antimetabolites|antimetabolites|mesh-ancestor
102627640|NCT03821454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627641|NCT03821454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102627642|NCT03820518|Calcitriol|calcitriol|mesh-list
102627643|NCT03820518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102627644|NCT03820518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627645|NCT03820518|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102627646|NCT03820518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102627647|NCT03820518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627648|NCT03820518|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102627649|NCT03820518|Vitamins|vitamins|mesh-ancestor
102627650|NCT03820518|Micronutrients|micronutrients|mesh-ancestor
102627651|NCT03820518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102627652|NCT03820206|Tranexamic Acid|tranexamic acid|mesh-list
102627653|NCT03820206|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102627654|NCT03820206|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102627655|NCT03820206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627656|NCT03820206|Hemostatics|hemostatics|mesh-ancestor
102627657|NCT03820206|Coagulants|coagulants|mesh-ancestor
102627658|NCT02955654|Aripiprazole|aripiprazole|mesh-list
102627659|NCT02955654|Antidepressive Agents|antidepressive agents|mesh-ancestor
102627660|NCT02955654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102627661|NCT02955654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102627662|NCT02955654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102627663|NCT02955654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102627664|NCT02955654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627665|NCT02955654|Dopamine Agonists|dopamine agonists|mesh-ancestor
102627666|NCT02955654|Dopamine Agents|dopamine agents|mesh-ancestor
102627667|NCT02955654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102627668|NCT02955654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275049|NCT00014508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102627669|NCT02955654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102627670|NCT02955654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102627671|NCT02955654|Serotonin Agents|serotonin agents|mesh-ancestor
102627672|NCT02955654|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102627673|NCT02955654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102627674|NCT02955654|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102627675|NCT02955654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102627676|NCT04392648|Dexamethasone|dexamethasone|mesh-list
102627677|NCT04392648|Cyclophosphamide|cyclophosphamide|mesh-list
102627678|NCT04392648|Bortezomib|bortezomib|mesh-list
102627679|NCT04392648|Pomalidomide|pomalidomide|mesh-list
102627680|NCT04392648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102627681|NCT04392648|Immunologic Factors|immunologic factors|mesh-ancestor
102627682|NCT04392648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627683|NCT04392648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102627684|NCT04392648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102627685|NCT04392648|Alkylating Agents|alkylating agents|mesh-ancestor
102627686|NCT04392648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627687|NCT04392648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102627688|NCT04392648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102627689|NCT04392648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102627690|NCT04392648|Antiemetics|antiemetics|mesh-ancestor
102627691|NCT04392648|Autonomic Agents|autonomic agents|mesh-ancestor
102627692|NCT04392648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102627693|NCT04392648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102627694|NCT04392648|Glucocorticoids|glucocorticoids|mesh-ancestor
102627695|NCT04392648|Hormones|hormones|mesh-ancestor
102627696|NCT04392648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102627697|NCT04392648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102627698|NCT04392648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102627699|NCT04392648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102627700|NCT04392648|Growth Substances|growth substances|mesh-ancestor
102627701|NCT04392648|Growth Inhibitors|growth inhibitors|mesh-ancestor
102627702|NCT03826602|Metformin|metformin|mesh-list
102627703|NCT03826602|Tucatinib|tucatinib|mesh-list
102627704|NCT03826602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102627705|NCT03826602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627706|NCT03826602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102627707|NCT03826602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102627708|NCT03826602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102627709|NCT03826602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627710|NCT01453920|Ranibizumab|ranibizumab|mesh-list
102627711|NCT01453920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102627712|NCT01453920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102627713|NCT01453920|Growth Substances|growth substances|mesh-ancestor
102627714|NCT01453920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627715|NCT01453920|Growth Inhibitors|growth inhibitors|mesh-ancestor
102627716|NCT01453920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102627717|NCT03820908|Bisantrene|bisantrene|mesh-list
102627718|NCT03820908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102627719|NCT03820908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102627720|NCT02953548|Cannabidiol|cannabidiol|mesh-list
102627721|NCT02953548|Anticonvulsants|anticonvulsants|mesh-ancestor
102627722|NCT03112044|Sofosbuvir|sofosbuvir|mesh-list
102627723|NCT03112044|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102627724|NCT03112044|Velpatasvir|velpatasvir|mesh-list
102627725|NCT03112044|Antiviral Agents|antiviral agents|mesh-ancestor
102627726|NCT03112044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102627727|NCT02952222|Dexmedetomidine|dexmedetomidine|mesh-list
102627728|NCT02952222|Propofol|propofol|mesh-list
102627729|NCT02952222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102627730|NCT02952222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102627731|NCT02952222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627732|NCT02952222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102627733|NCT02952222|Analgesics|analgesics|mesh-ancestor
102627734|NCT02952222|Sensory System Agents|sensory system agents|mesh-ancestor
102627735|NCT02952222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102627736|NCT02952222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102627737|NCT02952222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102627738|NCT02952222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102627739|NCT02952222|Adrenergic Agents|adrenergic agents|mesh-ancestor
102627740|NCT02952222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102627741|NCT02952222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627742|NCT02952222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102627743|NCT02952222|Anesthetics, General|anesthetics, general|mesh-ancestor
102627744|NCT02952222|Anesthetics|anesthetics|mesh-ancestor
102627745|NCT03826368|Cannabidiol|cannabidiol|mesh-list
102627746|NCT03826368|Anticonvulsants|anticonvulsants|mesh-ancestor
102627747|NCT04391478|Milrinone|milrinone|mesh-list
102627748|NCT04391478|Sildenafil Citrate|sildenafil citrate|mesh-list
102627749|NCT04391478|Vasodilator Agents|vasodilator agents|mesh-ancestor
102627750|NCT04391478|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102627751|NCT04391478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102627752|NCT04391478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102627753|NCT04391478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627754|NCT04391478|Urological Agents|urological agents|mesh-ancestor
102627755|NCT04391478|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102627756|NCT04391478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102627757|NCT04391478|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102627758|NCT04391478|Protective Agents|protective agents|mesh-ancestor
102627759|NCT04391478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627760|NCT03828006|Red yeast rice|red yeast rice|mesh-list
102627761|NCT03828006|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102627762|NCT03828006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102627763|NCT03828006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102627764|NCT03828006|Antimetabolites|antimetabolites|mesh-ancestor
102627765|NCT03828006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627766|NCT03828006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102627767|NCT03828006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102627768|NCT04391868|Sildenafil Citrate|sildenafil citrate|mesh-list
102627769|NCT04391868|Citric Acid|citric acid|mesh-list
102627770|NCT04391868|Sodium Citrate|sodium citrate|mesh-list
102627771|NCT04391868|Anticoagulants|anticoagulants|mesh-ancestor
102627772|NCT04391868|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102627773|NCT04391868|Chelating Agents|chelating agents|mesh-ancestor
102627774|NCT04391868|Sequestering Agents|sequestering agents|mesh-ancestor
101600057|NCT03436498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102627775|NCT04391868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627776|NCT04391868|Vasodilator Agents|vasodilator agents|mesh-ancestor
102627777|NCT04391868|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102627778|NCT04391868|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102627779|NCT04391868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102627780|NCT04391868|Urological Agents|urological agents|mesh-ancestor
102627781|NCT03829332|Pembrolizumab|pembrolizumab|mesh-list
102627782|NCT03829332|Lenvatinib|lenvatinib|mesh-list
102627783|NCT03829332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102627784|NCT03829332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102627785|NCT03829332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102627786|NCT03829332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627787|NCT03829332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102627788|NCT03829332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102627789|NCT02983188|Antipsychotic Agents|antipsychotic agents|mesh-list
102627790|NCT02983188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102627791|NCT02983188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102627792|NCT02983188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627793|NCT02983188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102627794|NCT01450176|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
102627795|NCT01450176|Bepotastine besilate|bepotastine besilate|mesh-list
102627796|NCT01450176|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102627797|NCT01450176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102627798|NCT01450176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102627799|NCT01450176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102627800|NCT01450176|Analgesics|analgesics|mesh-ancestor
102627801|NCT01450176|Sensory System Agents|sensory system agents|mesh-ancestor
102627802|NCT01450176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102627803|NCT01450176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627804|NCT01450176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102627805|NCT01450176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102627806|NCT01450176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102627807|NCT01450176|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102627808|NCT01450176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102627809|NCT01450176|Histamine Antagonists|histamine antagonists|mesh-ancestor
102627810|NCT01450176|Histamine Agents|histamine agents|mesh-ancestor
102627811|NCT01450176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102627812|NCT01450176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627813|NCT01454622|Metformin|metformin|mesh-list
102627814|NCT01454622|Canagliflozin|canagliflozin|mesh-list
102275050|NCT00014508|Antifungal Agents|antifungal agents|mesh-ancestor
102275051|NCT00014508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102627815|NCT01454622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102627816|NCT01454622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275052|NCT00014508|Dermatologic Agents|dermatologic agents|mesh-ancestor
102627817|NCT01454622|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102627818|NCT01454622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627819|NCT01450410|Nicotinic Acids|nicotinic acids|mesh-list
102627820|NCT01450410|Niacin|niacin|mesh-list
102627821|NCT01450410|Niacinamide|niacinamide|mesh-list
102627822|NCT01450410|Vitamin B Complex|vitamin b complex|mesh-ancestor
102627823|NCT01450410|Vitamins|vitamins|mesh-ancestor
102627824|NCT01450410|Micronutrients|micronutrients|mesh-ancestor
102627825|NCT01450410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627826|NCT01450410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102627827|NCT01450410|Antimetabolites|antimetabolites|mesh-ancestor
102627828|NCT01450410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627829|NCT01450410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102627830|NCT01450410|Vasodilator Agents|vasodilator agents|mesh-ancestor
102627831|NCT01450566|Lidocaine|lidocaine|mesh-list
102627832|NCT01450566|Anesthetics, Local|anesthetics, local|mesh-ancestor
102627833|NCT01450566|Anesthetics|anesthetics|mesh-ancestor
102627834|NCT01450566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102627835|NCT01450566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627836|NCT01450566|Sensory System Agents|sensory system agents|mesh-ancestor
102627837|NCT01450566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102627838|NCT01450566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102627839|NCT01450566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102627840|NCT01450566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101600129|NCT01032018|Citalopram|citalopram|mesh-list
102627841|NCT01450566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102627842|NCT01450566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627843|NCT02947386|Nivolumab|nivolumab|mesh-list
102627844|NCT02947386|Nimotuzumab|nimotuzumab|mesh-list
102627845|NCT02947386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102627846|NCT02947386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102627847|NCT02947386|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102627848|NCT02947386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627849|NCT03043014|Misoprostol|misoprostol|mesh-list
102627850|NCT03043014|Mifepristone|mifepristone|mesh-list
102627851|NCT03043014|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102627852|NCT03043014|Abortifacient Agents|abortifacient agents|mesh-ancestor
102627853|NCT03043014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102627854|NCT03043014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627855|NCT03043014|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102627856|NCT03043014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102627857|NCT03043014|Oxytocics|oxytocics|mesh-ancestor
102627858|NCT03043014|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102627859|NCT03043014|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102627860|NCT03043014|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102627861|NCT03043014|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102627862|NCT03043014|Contraceptive Agents|contraceptive agents|mesh-ancestor
102627863|NCT03043014|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102627864|NCT03043014|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102627865|NCT03043014|Hormone Antagonists|hormone antagonists|mesh-ancestor
102627866|NCT03043014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102627867|NCT03043014|Luteolytic Agents|luteolytic agents|mesh-ancestor
102627868|NCT03043014|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102627869|NCT03043014|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102627870|NCT02983344|Fentanyl|fentanyl|mesh-list
102627871|NCT02983344|Ropivacaine|ropivacaine|mesh-list
102627872|NCT02983344|Anesthetics, Local|anesthetics, local|mesh-ancestor
102627873|NCT02983344|Anesthetics|anesthetics|mesh-ancestor
102627874|NCT02983344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102627875|NCT02983344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627876|NCT02983344|Sensory System Agents|sensory system agents|mesh-ancestor
102627877|NCT02983344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102275053|NCT00014508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102275054|NCT00006390|Cyclophosphamide|cyclophosphamide|mesh-list
102275055|NCT00006390|Alemtuzumab|alemtuzumab|mesh-list
102275056|NCT00006390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102275057|NCT00006390|Immunologic Factors|immunologic factors|mesh-ancestor
102275058|NCT00006390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275059|NCT00006390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102275060|NCT00006390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102275061|NCT00006390|Alkylating Agents|alkylating agents|mesh-ancestor
102275062|NCT00006390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275063|NCT00006390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102275064|NCT00006390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102627878|NCT02983344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102627879|NCT02983344|Narcotics|narcotics|mesh-ancestor
102627880|NCT02983344|Analgesics|analgesics|mesh-ancestor
102627881|NCT02983344|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102627882|NCT02983344|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102627883|NCT02983344|Anesthetics, General|anesthetics, general|mesh-ancestor
102627884|NCT03824340|Doxycycline|doxycycline|mesh-list
102627885|NCT03824340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102627886|NCT03824340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102627887|NCT03824340|Antimalarials|antimalarials|mesh-ancestor
102627888|NCT03824340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102627889|NCT03824340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102627890|NCT01455246|Meropenem|meropenem|mesh-list
102627891|NCT01455246|Daptomycin|daptomycin|mesh-list
102627892|NCT01455246|Ceftazidime|ceftazidime|mesh-list
102627893|NCT01455246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102627894|NCT01455246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102627895|NCT02934282|HBOC 201|hboc 201|mesh-list
102627896|NCT02934282|Blood Substitutes|blood substitutes|mesh-ancestor
102627897|NCT03823950|Lenograstim|lenograstim|mesh-list
102627898|NCT03823950|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102627899|NCT03823950|Immunologic Factors|immunologic factors|mesh-ancestor
102627900|NCT03823950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627901|NCT01451268|Panobinostat|panobinostat|mesh-list
102627902|NCT01451268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102627903|NCT01451268|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102627904|NCT01451268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102627905|NCT01451268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627906|NCT03823638|Mannitol|mannitol|mesh-list
102627907|NCT03823638|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102627908|NCT03823638|Diuretics|diuretics|mesh-ancestor
102627909|NCT03823638|Natriuretic Agents|natriuretic agents|mesh-ancestor
102627910|NCT03823638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627911|NCT02884908|Pregabalin|pregabalin|mesh-list
102627912|NCT02884908|Analgesics|analgesics|mesh-ancestor
102627913|NCT02884908|Sensory System Agents|sensory system agents|mesh-ancestor
102627914|NCT02884908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102627915|NCT02884908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627916|NCT02884908|Anticonvulsants|anticonvulsants|mesh-ancestor
102627917|NCT02884908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102627918|NCT02884908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102627919|NCT02884908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627920|NCT02884908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102627921|NCT02884908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102627922|NCT02884908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102627923|NCT02884908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102627924|NCT02884908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102627925|NCT01451580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102627926|NCT01451580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102627927|NCT01451580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102627928|NCT01451658|Propranolol|propranolol|mesh-list
102627929|NCT01451658|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102627930|NCT01451658|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102627931|NCT01451658|Adrenergic Agents|adrenergic agents|mesh-ancestor
102627932|NCT01451658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102627933|NCT01451658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627934|NCT01451658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627935|NCT01451658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102627936|NCT01451658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102627937|NCT01451658|Vasodilator Agents|vasodilator agents|mesh-ancestor
102627938|NCT02851056|Lenograstim|lenograstim|mesh-list
102627939|NCT02851056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102627940|NCT02851056|Immunologic Factors|immunologic factors|mesh-ancestor
102627941|NCT02851056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627942|NCT02935374|Amoxicillin|amoxicillin|mesh-list
102627943|NCT02935374|Clavulanic Acid|clavulanic acid|mesh-list
102627944|NCT02935374|Clavulanic Acids|clavulanic acids|mesh-list
102627945|NCT02935374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102627946|NCT02935374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102627947|NCT02935374|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102627948|NCT02935374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102627949|NCT02935374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627950|NCT01452750|Lansoprazole|lansoprazole|mesh-list
101916360|NCT03497169|Dopamine Agents|dopamine agents|mesh-ancestor
102627951|NCT01452750|Dexlansoprazole|dexlansoprazole|mesh-list
102627952|NCT01452750|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102627953|NCT01452750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102627954|NCT01452750|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102275065|NCT00006390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102627955|NCT01452750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102627956|NCT01452750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627957|NCT01452828|Tedizolid|tedizolid|mesh-list
102627958|NCT01452828|Tedizolid phosphate|tedizolid phosphate|mesh-list
102627959|NCT01452828|Oxazolidinones|oxazolidinones|mesh-list
102627960|NCT01452828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102627961|NCT01452828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102627962|NCT01452828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102627963|NCT01452828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102627964|NCT01452828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627965|NCT01452906|Omeprazole|omeprazole|mesh-list
102627966|NCT01452906|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102627967|NCT01452906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102627968|NCT01452906|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102627969|NCT01452906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102627970|NCT01452906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627971|NCT03823248|Folic Acid|folic acid|mesh-list
102627972|NCT03823248|Vitamin B Complex|vitamin b complex|mesh-list
102627973|NCT03823248|Hematinics|hematinics|mesh-ancestor
102627974|NCT03823248|Vitamins|vitamins|mesh-ancestor
102627975|NCT03823248|Micronutrients|micronutrients|mesh-ancestor
102627976|NCT03823248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627977|NCT03822936|Fluorouracil|fluorouracil|mesh-list
102627978|NCT03822936|Oxaliplatin|oxaliplatin|mesh-list
102627979|NCT03822936|Irinotecan|irinotecan|mesh-list
102627980|NCT03822936|Antimetabolites|antimetabolites|mesh-ancestor
102627981|NCT03822936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102627982|NCT03822936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102627983|NCT03822936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102627984|NCT03822936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102627985|NCT03822936|Immunologic Factors|immunologic factors|mesh-ancestor
102627986|NCT03822936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627987|NCT03822936|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102627988|NCT03822936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102627989|NCT03822936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102627990|NCT03822546|Nicotine|nicotine|mesh-list
102627991|NCT03822546|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102627992|NCT03822546|Autonomic Agents|autonomic agents|mesh-ancestor
102627993|NCT03822546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102627994|NCT03822546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102627995|NCT03822546|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102627996|NCT03822546|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102627997|NCT03822546|Cholinergic Agents|cholinergic agents|mesh-ancestor
102627998|NCT03822546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102627999|NCT03822546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628000|NCT01453686|Hydrocortisone|hydrocortisone|mesh-list
102628001|NCT01453686|Clobetasol|clobetasol|mesh-list
102628002|NCT01453686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102628003|NCT01453686|Glucocorticoids|glucocorticoids|mesh-ancestor
102628004|NCT01453686|Hormones|hormones|mesh-ancestor
102628005|NCT01453686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102628006|NCT01453686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628007|NCT01455870|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102628008|NCT01455870|Exenatide|exenatide|mesh-list
102628009|NCT01455870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102628010|NCT01455870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628011|NCT01455870|Incretins|incretins|mesh-ancestor
102628012|NCT01455870|Hormones|hormones|mesh-ancestor
102628013|NCT01455870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102628014|NCT01455870|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102628015|NCT01455870|Protease Inhibitors|protease inhibitors|mesh-ancestor
102628016|NCT01455870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102628017|NCT01455870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628018|NCT01455870|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102628019|NCT01456260|Lansoprazole|lansoprazole|mesh-list
102628020|NCT01456260|Dexlansoprazole|dexlansoprazole|mesh-list
102628021|NCT01456260|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102628022|NCT01456260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102628023|NCT01456260|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102628024|NCT01456260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102628025|NCT01456260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628026|NCT01890408|Ropivacaine|ropivacaine|mesh-list
102628027|NCT01890408|Anesthetics, Local|anesthetics, local|mesh-ancestor
102628028|NCT01890408|Anesthetics|anesthetics|mesh-ancestor
102628029|NCT01890408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102628030|NCT01890408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628031|NCT01890408|Sensory System Agents|sensory system agents|mesh-ancestor
102628032|NCT01890408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102628033|NCT04849650|Amisulpride|amisulpride|mesh-list
102628034|NCT04849650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102628035|NCT04849650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102628036|NCT04849650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102628037|NCT04849650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628038|NCT04849650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102628039|NCT04849650|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102628040|NCT04849650|Dopamine Agents|dopamine agents|mesh-ancestor
102628041|NCT04849650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102628042|NCT04849650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628043|NCT04849650|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102628044|NCT04849650|Antidepressive Agents|antidepressive agents|mesh-ancestor
102628046|NCT04272372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102628047|NCT04272372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102628048|NCT04272372|Analgesics|analgesics|mesh-ancestor
102628049|NCT04272372|Sensory System Agents|sensory system agents|mesh-ancestor
102628050|NCT04272372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102628051|NCT04272372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628052|NCT04272372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102628053|NCT04272372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102628054|NCT04272372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102628055|NCT04272372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102628056|NCT04272372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628057|NCT01891500|Nitric Oxide|nitric oxide|mesh-list
102628058|NCT01891500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102628059|NCT01891500|Autonomic Agents|autonomic agents|mesh-ancestor
102628060|NCT01891500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102628061|NCT01891500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628062|NCT01891500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102628063|NCT01891500|Respiratory System Agents|respiratory system agents|mesh-ancestor
102628064|NCT01891500|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102628065|NCT01891500|Antioxidants|antioxidants|mesh-ancestor
102628066|NCT01891500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628067|NCT01891500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102628068|NCT01891500|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102628069|NCT01891500|Vasodilator Agents|vasodilator agents|mesh-ancestor
102628070|NCT01891500|Gasotransmitters|gasotransmitters|mesh-ancestor
102628071|NCT01891500|Protective Agents|protective agents|mesh-ancestor
102628072|NCT02439450|Pembrolizumab|pembrolizumab|mesh-list
102628073|NCT02439450|Nivolumab|nivolumab|mesh-list
102628074|NCT02439450|Pemetrexed|pemetrexed|mesh-list
102628075|NCT02439450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102628076|NCT02439450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102628077|NCT02439450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102628078|NCT02439450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628079|NCT02439450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102628080|NCT02439450|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102628081|NCT02439450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102628082|NCT02862132|Vedolizumab|vedolizumab|mesh-list
102628083|NCT02862132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102628084|NCT02859402|Fludarabine|fludarabine|mesh-list
102628085|NCT02859402|Busulfan|busulfan|mesh-list
102628086|NCT02859402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102628087|NCT02859402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628088|NCT02859402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102628089|NCT02859402|Immunologic Factors|immunologic factors|mesh-ancestor
102628090|NCT02859402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628091|NCT02859402|Alkylating Agents|alkylating agents|mesh-ancestor
102628092|NCT02859402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102628093|NCT02859402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102628094|NCT04844268|Vaccines|vaccines|mesh-list
102628095|NCT04844268|Immunologic Factors|immunologic factors|mesh-ancestor
102628096|NCT04844268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628097|NCT04842552|Hydralazine|hydralazine|mesh-list
102628098|NCT04842552|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102628099|NCT04842552|Vasodilator Agents|vasodilator agents|mesh-ancestor
102628100|NCT02535312|Cisplatin|cisplatin|mesh-list
102628101|NCT02535312|Pemetrexed|pemetrexed|mesh-list
102628102|NCT02535312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102275066|NCT00005962|Cytarabine|cytarabine|mesh-list
102275067|NCT00005962|Cyclophosphamide|cyclophosphamide|mesh-list
102275068|NCT00005962|Daunorubicin|daunorubicin|mesh-list
102628103|NCT02535312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102628104|NCT02535312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628105|NCT02535312|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102628106|NCT02535312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102628107|NCT01891812|Nitrous Oxide|nitrous oxide|mesh-list
102628108|NCT01891812|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102628109|NCT01891812|Anesthetics, General|anesthetics, general|mesh-ancestor
102628110|NCT01891812|Anesthetics|anesthetics|mesh-ancestor
102628111|NCT01891812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102628112|NCT01891812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628113|NCT01891812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102628114|NCT01891812|Analgesics|analgesics|mesh-ancestor
102628115|NCT01891812|Sensory System Agents|sensory system agents|mesh-ancestor
102628116|NCT01891812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102628117|NCT04390464|Ravulizumab|ravulizumab|mesh-list
102628118|NCT04390464|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102628119|NCT04390464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102628120|NCT04390464|Immunologic Factors|immunologic factors|mesh-ancestor
102628121|NCT04390464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628122|NCT01892748|Vitamin D|vitamin d|mesh-list
102628123|NCT01892748|Cholecalciferol|cholecalciferol|mesh-list
102628124|NCT01892748|Vitamins|vitamins|mesh-ancestor
102628125|NCT01892748|Micronutrients|micronutrients|mesh-ancestor
102628126|NCT01892748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628127|NCT01892748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102628128|NCT01892748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102628129|NCT01893060|Chlorhexidine|chlorhexidine|mesh-list
102628130|NCT01893060|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102628131|NCT01893060|Povidone-Iodine|povidone-iodine|mesh-list
102628132|NCT01893060|Povidone|povidone|mesh-list
102628133|NCT01893060|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102628134|NCT01893060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102628135|NCT01893060|Disinfectants|disinfectants|mesh-ancestor
102628136|NCT01893060|Dermatologic Agents|dermatologic agents|mesh-ancestor
102628137|NCT01893060|Plasma Substitutes|plasma substitutes|mesh-ancestor
102628138|NCT01893060|Blood Substitutes|blood substitutes|mesh-ancestor
102628139|NCT02848560|Xenon|xenon|mesh-list
102628140|NCT02848560|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102628141|NCT02848560|Anesthetics, General|anesthetics, general|mesh-ancestor
102628142|NCT02848560|Anesthetics|anesthetics|mesh-ancestor
102628143|NCT02848560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102628144|NCT02848560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628145|NCT01457820|Allopurinol|allopurinol|mesh-list
102628146|NCT01457820|Antimetabolites|antimetabolites|mesh-ancestor
102628147|NCT01457820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628148|NCT01457820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102628149|NCT01457820|Gout Suppressants|gout suppressants|mesh-ancestor
102628150|NCT01457820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102628151|NCT01457820|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102628152|NCT01457820|Antioxidants|antioxidants|mesh-ancestor
102628153|NCT01457820|Protective Agents|protective agents|mesh-ancestor
102628154|NCT01457820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628155|NCT05020782|Belimumab|belimumab|mesh-list
102628156|NCT05020782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102628157|NCT05020782|Immunologic Factors|immunologic factors|mesh-ancestor
102628158|NCT05020782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628159|NCT01893294|Gemcitabine|gemcitabine|mesh-list
102628160|NCT01893294|Fluorouracil|fluorouracil|mesh-list
102628161|NCT01893294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102628162|NCT01893294|Antimetabolites|antimetabolites|mesh-ancestor
102628163|NCT01893294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628164|NCT01893294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102628165|NCT01893294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102628166|NCT01893294|Immunologic Factors|immunologic factors|mesh-ancestor
102628167|NCT01893294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628168|NCT01458054|Ritonavir|ritonavir|mesh-list
102628169|NCT01458054|Omeprazole|omeprazole|mesh-list
102628170|NCT01458054|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102628171|NCT01458054|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102628172|NCT01458054|Protease Inhibitors|protease inhibitors|mesh-ancestor
102628173|NCT01458054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102628174|NCT01458054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628175|NCT01458054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102628176|NCT01458054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102628177|NCT01458054|Antiviral Agents|antiviral agents|mesh-ancestor
102275069|NCT00005962|Topotecan|topotecan|mesh-list
102628178|NCT01458054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102628179|NCT01458054|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102628180|NCT01458054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102628181|NCT01458054|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102628182|NCT01458054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102628183|NCT01458054|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102628184|NCT01893450|Pentoxifylline|pentoxifylline|mesh-list
102628185|NCT01893450|Bromocriptine|bromocriptine|mesh-list
102628186|NCT01893450|Methimazole|methimazole|mesh-list
102628187|NCT01893450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102628188|NCT01893450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102628189|NCT01893450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628190|NCT01893450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102628191|NCT01893450|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102628192|NCT01893450|Protective Agents|protective agents|mesh-ancestor
102628193|NCT01893450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628194|NCT01893450|Vasodilator Agents|vasodilator agents|mesh-ancestor
102628195|NCT01893450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102628196|NCT01893450|Antioxidants|antioxidants|mesh-ancestor
102628197|NCT01893450|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102628198|NCT01893450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102628199|NCT01893450|Hormone Antagonists|hormone antagonists|mesh-ancestor
102628200|NCT01893450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102628201|NCT01893450|Dopamine Agonists|dopamine agonists|mesh-ancestor
102628202|NCT01893450|Dopamine Agents|dopamine agents|mesh-ancestor
102628203|NCT01893450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102628204|NCT01893450|Antithyroid Agents|antithyroid agents|mesh-ancestor
102628205|NCT05027100|Irinotecan|irinotecan|mesh-list
102628206|NCT05027100|Tislelizumab|tislelizumab|mesh-list
102628207|NCT05027100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102628208|NCT05027100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102628209|NCT05027100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102628210|NCT05027100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628211|NCT05027100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102628212|NCT05027100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102628213|NCT01458600|Diclofenac|diclofenac|mesh-list
102628214|NCT01458600|Propranolol|propranolol|mesh-list
102628215|NCT01458600|Metoprolol|metoprolol|mesh-list
102628216|NCT01458600|Methimazole|methimazole|mesh-list
102628217|NCT01458600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102628218|NCT01458600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102628219|NCT01458600|Analgesics|analgesics|mesh-ancestor
102628220|NCT01458600|Sensory System Agents|sensory system agents|mesh-ancestor
102628221|NCT01458600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102628222|NCT01458600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628223|NCT01458600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102628224|NCT01458600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102628225|NCT01458600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102628226|NCT01458600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102628227|NCT01458600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628228|NCT01458600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102628229|NCT01458600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102628230|NCT01458600|Adrenergic Agents|adrenergic agents|mesh-ancestor
102628231|NCT01458600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102628232|NCT01458600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102628233|NCT01458600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102628234|NCT01458600|Vasodilator Agents|vasodilator agents|mesh-ancestor
102628235|NCT01458600|Sympatholytics|sympatholytics|mesh-ancestor
102628236|NCT01458600|Autonomic Agents|autonomic agents|mesh-ancestor
102628237|NCT01458600|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102628238|NCT01458600|Antithyroid Agents|antithyroid agents|mesh-ancestor
102628239|NCT01458600|Hormone Antagonists|hormone antagonists|mesh-ancestor
102628240|NCT01458600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102628241|NCT02832570|Sildenafil Citrate|sildenafil citrate|mesh-list
102628242|NCT02832570|Vasodilator Agents|vasodilator agents|mesh-ancestor
102628243|NCT02832570|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102628244|NCT02832570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102628245|NCT02832570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102628246|NCT02832570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628247|NCT02832570|Urological Agents|urological agents|mesh-ancestor
102628248|NCT02742324|Interferon-alpha|interferon-alpha|mesh-list
102628249|NCT02742324|Interferon alpha-2|interferon alpha-2|mesh-list
102628250|NCT02742324|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
102628251|NCT02742324|Antiviral Agents|antiviral agents|mesh-ancestor
102628252|NCT02742324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102628253|NCT02742324|Immunologic Factors|immunologic factors|mesh-ancestor
102628254|NCT02742324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628255|NCT02742324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102628256|NCT01459146|Lumefantrine|lumefantrine|mesh-list
102628257|NCT01459146|Artemether|artemether|mesh-list
102628258|NCT01459146|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102628259|NCT01459146|Albendazole|albendazole|mesh-list
102628260|NCT01459146|Praziquantel|praziquantel|mesh-list
102628261|NCT01459146|Antimalarials|antimalarials|mesh-ancestor
102628262|NCT01459146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102628263|NCT01459146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102628264|NCT01459146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102628265|NCT01459146|Anthelmintics|anthelmintics|mesh-ancestor
102628266|NCT01459146|Anticestodal Agents|anticestodal agents|mesh-ancestor
102628267|NCT01459146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102628268|NCT01459146|Tubulin Modulators|tubulin modulators|mesh-ancestor
102628269|NCT01459146|Antimitotic Agents|antimitotic agents|mesh-ancestor
102628270|NCT01459146|Mitosis Modulators|mitosis modulators|mesh-ancestor
102628271|NCT01459146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628272|NCT01459146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102628273|NCT05026398|Fenfluramine|fenfluramine|mesh-list
102628274|NCT05026398|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102628275|NCT05026398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102628276|NCT05026398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102628277|NCT05026398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628278|NCT05026398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102628279|NCT05026398|Serotonin Agents|serotonin agents|mesh-ancestor
102628280|NCT05026398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628281|NCT05586750|Atorvastatin|atorvastatin|mesh-list
102628282|NCT05586750|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102628283|NCT05586750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102628284|NCT05586750|Antimetabolites|antimetabolites|mesh-ancestor
102628285|NCT05586750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628286|NCT05586750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102628287|NCT05586750|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102628288|NCT05586750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102628289|NCT02720094|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102628290|NCT02720094|Cabotegravir|cabotegravir|mesh-list
102628291|NCT02720094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102628292|NCT02720094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102628293|NCT02720094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102628294|NCT02720094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628295|NCT02720094|Antiviral Agents|antiviral agents|mesh-ancestor
102628296|NCT02720094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102628297|NCT02720094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102628298|NCT02720094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102628299|NCT02720094|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102628300|NCT02720094|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102628301|NCT02716974|Docetaxel|docetaxel|mesh-list
102628302|NCT02716974|Leuprolide|leuprolide|mesh-list
102628303|NCT02716974|Bicalutamide|bicalutamide|mesh-list
102628304|NCT02716974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102628305|NCT02716974|Tubulin Modulators|tubulin modulators|mesh-ancestor
102628306|NCT02716974|Antimitotic Agents|antimitotic agents|mesh-ancestor
102628307|NCT02716974|Mitosis Modulators|mitosis modulators|mesh-ancestor
102628308|NCT02716974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628309|NCT02716974|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102628310|NCT02716974|Fertility Agents|fertility agents|mesh-ancestor
102628311|NCT02716974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102628312|NCT02716974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628313|NCT02716974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102628314|NCT02716974|Androgen Antagonists|androgen antagonists|mesh-ancestor
102628315|NCT02716974|Hormone Antagonists|hormone antagonists|mesh-ancestor
102628316|NCT02716974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102628317|NCT01459380|Bevacizumab|bevacizumab|mesh-list
102628318|NCT01459380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102628319|NCT01459380|Carboplatin|carboplatin|mesh-list
102628320|NCT01459380|Doxorubicin|doxorubicin|mesh-list
102628321|NCT01459380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102628322|NCT01459380|Veliparib|veliparib|mesh-list
102628323|NCT01459380|Endothelial Growth Factors|endothelial growth factors|mesh-list
102628324|NCT01459380|Antibodies|antibodies|mesh-list
102275071|NCT00005962|Sargramostim|sargramostim|mesh-list
102275072|NCT00005962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102275073|NCT00005962|Immunologic Factors|immunologic factors|mesh-ancestor
102628325|NCT01459380|Immunoglobulins|immunoglobulins|mesh-list
102628326|NCT01459380|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102628327|NCT01459380|Immunoglobulin G|immunoglobulin g|mesh-list
102628328|NCT01459380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102628329|NCT01459380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102628330|NCT01459380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102628331|NCT01459380|Growth Substances|growth substances|mesh-ancestor
102628332|NCT01459380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628333|NCT01459380|Growth Inhibitors|growth inhibitors|mesh-ancestor
102628334|NCT01459380|Immunologic Factors|immunologic factors|mesh-ancestor
102628335|NCT01459380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102628336|NCT01459380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102628337|NCT01459380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102628338|NCT01459380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102628339|NCT01459380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628340|NCT01459380|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102628341|NCT04346004|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
102628342|NCT04346004|Hematinics|hematinics|mesh-ancestor
102628343|NCT02680314|Methotrexate|methotrexate|mesh-list
102628344|NCT02680314|Misoprostol|misoprostol|mesh-list
102628345|NCT02680314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102628346|NCT02680314|Abortifacient Agents|abortifacient agents|mesh-ancestor
102628347|NCT02680314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102628348|NCT02680314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628349|NCT02680314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102628350|NCT02680314|Antimetabolites|antimetabolites|mesh-ancestor
102628351|NCT02680314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628352|NCT02680314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102628353|NCT02680314|Dermatologic Agents|dermatologic agents|mesh-ancestor
102628354|NCT02680314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102628355|NCT02680314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102628356|NCT02680314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101600692|NCT00610623|Azithromycin|azithromycin|mesh-list
102628357|NCT02680314|Immunologic Factors|immunologic factors|mesh-ancestor
102628358|NCT02680314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102628359|NCT02680314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102628360|NCT02680314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102628361|NCT02680314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102628362|NCT02680314|Oxytocics|oxytocics|mesh-ancestor
102628363|NCT02707692|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102628364|NCT02707692|Immunologic Factors|immunologic factors|mesh-ancestor
102628365|NCT02707692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628366|NCT02706678|Tacrolimus|tacrolimus|mesh-list
102628367|NCT02706678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102628368|NCT02706678|Immunologic Factors|immunologic factors|mesh-ancestor
102628369|NCT02706678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628370|NCT02706678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102628371|NCT02706678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102628372|NCT02706678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628373|NCT02705196|Paclitaxel|paclitaxel|mesh-list
102628374|NCT02705196|Gemcitabine|gemcitabine|mesh-list
102628375|NCT02705196|Atezolizumab|atezolizumab|mesh-list
102628376|NCT02705196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102628377|NCT02705196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102628378|NCT02705196|Tubulin Modulators|tubulin modulators|mesh-ancestor
102628379|NCT02705196|Antimitotic Agents|antimitotic agents|mesh-ancestor
102628380|NCT02705196|Mitosis Modulators|mitosis modulators|mesh-ancestor
102628381|NCT02705196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628382|NCT02705196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102628383|NCT02705196|Antimetabolites|antimetabolites|mesh-ancestor
102628384|NCT02705196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102628385|NCT02705196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102628386|NCT02703948|Lidocaine|lidocaine|mesh-list
102628387|NCT02703948|Anesthetics, Local|anesthetics, local|mesh-ancestor
102628388|NCT02703948|Anesthetics|anesthetics|mesh-ancestor
102628389|NCT02703948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102628390|NCT02703948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628391|NCT02703948|Sensory System Agents|sensory system agents|mesh-ancestor
102628392|NCT02703948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102628393|NCT02703948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102275074|NCT00005962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275075|NCT00005962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102275076|NCT00005962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102628394|NCT02703948|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102628395|NCT02703948|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102628396|NCT02703948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102628397|NCT02703948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628398|NCT02666742|Aspirin|aspirin|mesh-list
102628399|NCT02666742|Rivaroxaban|rivaroxaban|mesh-list
102628400|NCT02666742|Edoxaban|edoxaban|mesh-list
102628401|NCT02666742|Dabigatran|dabigatran|mesh-list
102628402|NCT02666742|Anticoagulants|anticoagulants|mesh-list
102628403|NCT02666742|Coagulants|coagulants|mesh-list
102628404|NCT02666742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102628405|NCT02666742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102628406|NCT02666742|Analgesics|analgesics|mesh-ancestor
102628407|NCT02666742|Sensory System Agents|sensory system agents|mesh-ancestor
102628408|NCT02666742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102628409|NCT02666742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628410|NCT02666742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102628411|NCT02666742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102628412|NCT02666742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102628413|NCT02666742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102628414|NCT02666742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628415|NCT02666742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102628416|NCT02666742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102628417|NCT02666742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102628418|NCT02666742|Antipyretics|antipyretics|mesh-ancestor
102628419|NCT02666742|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102628420|NCT02666742|Antithrombins|antithrombins|mesh-ancestor
102628421|NCT02666742|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101600746|NCT02705872|Anesthetics|anesthetics|mesh-ancestor
102628422|NCT02666742|Protease Inhibitors|protease inhibitors|mesh-ancestor
102628423|NCT02684292|Pembrolizumab|pembrolizumab|mesh-list
102628424|NCT02684292|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102628425|NCT02684292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102628426|NCT02684292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102628427|NCT02684292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102628428|NCT02684292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628429|NCT02684292|Immunotoxins|immunotoxins|mesh-ancestor
102628430|NCT02684292|Immunoconjugates|immunoconjugates|mesh-ancestor
102628431|NCT02684292|Immunologic Factors|immunologic factors|mesh-ancestor
102628432|NCT02684292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628433|NCT05586516|Paclitaxel|paclitaxel|mesh-list
102628434|NCT05586516|Gemcitabine|gemcitabine|mesh-list
102628435|NCT05586516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102628436|NCT05586516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102628437|NCT05586516|Tubulin Modulators|tubulin modulators|mesh-ancestor
102628438|NCT05586516|Antimitotic Agents|antimitotic agents|mesh-ancestor
102628439|NCT05586516|Mitosis Modulators|mitosis modulators|mesh-ancestor
102628440|NCT05586516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628441|NCT05586516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102628442|NCT05586516|Antimetabolites|antimetabolites|mesh-ancestor
102628443|NCT04390854|Clotrimazole|clotrimazole|mesh-list
102628444|NCT04390854|Miconazole|miconazole|mesh-list
102628445|NCT04390854|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102628446|NCT04390854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102628447|NCT04390854|Antifungal Agents|antifungal agents|mesh-ancestor
102628448|NCT04390854|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102628449|NCT04390854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102628450|NCT04390854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102628451|NCT04390854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628452|NCT04390854|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102628453|NCT04390854|Hormone Antagonists|hormone antagonists|mesh-ancestor
102628454|NCT04390854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102628455|NCT04390854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628456|NCT04390854|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102628457|NCT04390854|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102628458|NCT02465736|Cisplatin|cisplatin|mesh-list
102628459|NCT02465736|Docetaxel|docetaxel|mesh-list
102628460|NCT02465736|Vinorelbine|vinorelbine|mesh-list
102628461|NCT02465736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102628462|NCT02465736|Tubulin Modulators|tubulin modulators|mesh-ancestor
102628463|NCT02465736|Antimitotic Agents|antimitotic agents|mesh-ancestor
102628464|NCT02465736|Mitosis Modulators|mitosis modulators|mesh-ancestor
102628465|NCT02465736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628466|NCT02465736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102628467|NCT02630316|Treprostinil|treprostinil|mesh-list
102638136|NCT00716742|Latanoprost|latanoprost|mesh-list
102275077|NCT00005962|Alkylating Agents|alkylating agents|mesh-ancestor
102275078|NCT00005962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275079|NCT00005962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102628468|NCT02630316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102628469|NCT02359968|Paclitaxel|paclitaxel|mesh-list
102628470|NCT02359968|Fluorouracil|fluorouracil|mesh-list
102628471|NCT02359968|Oxaliplatin|oxaliplatin|mesh-list
102628472|NCT02359968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102628473|NCT02359968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102628474|NCT02359968|Tubulin Modulators|tubulin modulators|mesh-ancestor
102628475|NCT02359968|Antimitotic Agents|antimitotic agents|mesh-ancestor
102628476|NCT02359968|Mitosis Modulators|mitosis modulators|mesh-ancestor
102628477|NCT02359968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628478|NCT02359968|Antimetabolites|antimetabolites|mesh-ancestor
102628479|NCT02359968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102628480|NCT02359968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102628481|NCT02359968|Immunologic Factors|immunologic factors|mesh-ancestor
102628482|NCT02359968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628483|NCT02624544|Desonide|desonide|mesh-list
102628484|NCT02624544|Esomeprazole|esomeprazole|mesh-list
102628485|NCT02624544|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102628486|NCT02624544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102628487|NCT02624544|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102628488|NCT02624544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102628489|NCT02624544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628490|NCT02624544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102628491|NCT02603328|Atorvastatin|atorvastatin|mesh-list
102628492|NCT02603328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102628493|NCT02603328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102628494|NCT02603328|Antimetabolites|antimetabolites|mesh-ancestor
102628495|NCT02603328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628496|NCT02603328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102628497|NCT02603328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102628498|NCT02603328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102628499|NCT02323698|Caffeine|caffeine|mesh-list
102628500|NCT02323698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102628501|NCT02323698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628502|NCT02323698|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102628503|NCT02323698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102628504|NCT02323698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628505|NCT02323698|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102628506|NCT02323698|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102628507|NCT02323698|Purinergic Agents|purinergic agents|mesh-ancestor
102628508|NCT02323698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102628509|NCT01451736|Risperidone|risperidone|mesh-list
102628510|NCT01451736|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102628511|NCT01451736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102628512|NCT01451736|Serotonin Agents|serotonin agents|mesh-ancestor
102628513|NCT01451736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102628514|NCT01451736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628515|NCT01451736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628516|NCT01451736|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102628517|NCT01451736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102628518|NCT01451736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102628519|NCT01451736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102628520|NCT01451736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102628521|NCT01451736|Dopamine Agents|dopamine agents|mesh-ancestor
102628522|NCT01451736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102628523|NCT01451736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102628524|NCT01450956|Sevoflurane|sevoflurane|mesh-list
102628525|NCT01450956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102628526|NCT01450956|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102628527|NCT01450956|Anesthetics, General|anesthetics, general|mesh-ancestor
102628528|NCT01450956|Anesthetics|anesthetics|mesh-ancestor
102628529|NCT01450956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102628530|NCT01450956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628531|NCT02300922|Antibodies|antibodies|mesh-list
102628532|NCT02300922|Immunologic Factors|immunologic factors|mesh-ancestor
102628533|NCT02300922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628534|NCT01453530|Glycopyrrolate|glycopyrrolate|mesh-list
102628535|NCT01453530|Neostigmine|neostigmine|mesh-list
102628536|NCT01453530|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102628537|NCT01453530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102628538|NCT01453530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628539|NCT01453530|Cholinergic Agents|cholinergic agents|mesh-ancestor
102275080|NCT00005962|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101916947|NCT02408770|Ulipristal acetate|ulipristal acetate|mesh-list
102628540|NCT01453530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102628541|NCT01453530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628542|NCT01453530|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102628543|NCT01453530|Autonomic Agents|autonomic agents|mesh-ancestor
102628544|NCT01453530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102628545|NCT01453530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102628546|NCT01453530|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102628547|NCT01453530|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102628549|NCT02983422|Furosemide|furosemide|mesh-list
102628550|NCT02983422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102628551|NCT02983422|Autonomic Agents|autonomic agents|mesh-ancestor
102628552|NCT02983422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102628553|NCT02983422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628554|NCT02983422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102628555|NCT02983422|Respiratory System Agents|respiratory system agents|mesh-ancestor
102628556|NCT02983422|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102628557|NCT02983422|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102628558|NCT02983422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102628559|NCT02983422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628560|NCT02983422|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102628561|NCT02983422|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102628562|NCT02983422|Purinergic Agents|purinergic agents|mesh-ancestor
102628563|NCT02983422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102628564|NCT02983422|Protective Agents|protective agents|mesh-ancestor
102628565|NCT02983422|Diuretics|diuretics|mesh-ancestor
102628566|NCT02983422|Natriuretic Agents|natriuretic agents|mesh-ancestor
102628567|NCT02983422|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102628568|NCT02983422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102628569|NCT05585814|Bevacizumab|bevacizumab|mesh-list
102628570|NCT05585814|Pembrolizumab|pembrolizumab|mesh-list
102628571|NCT05585814|Capecitabine|capecitabine|mesh-list
102628572|NCT05585814|Oxaliplatin|oxaliplatin|mesh-list
102628573|NCT05585814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102628574|NCT05585814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102628575|NCT05585814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102628576|NCT05585814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102628577|NCT05585814|Growth Substances|growth substances|mesh-ancestor
102628578|NCT05585814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628579|NCT05585814|Growth Inhibitors|growth inhibitors|mesh-ancestor
102628580|NCT05585814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102628581|NCT05585814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628582|NCT05585814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102628583|NCT05585814|Antimetabolites|antimetabolites|mesh-ancestor
102628584|NCT02013648|Cytarabine|cytarabine|mesh-list
102628585|NCT02013648|Daunorubicin|daunorubicin|mesh-list
102628586|NCT02013648|Dasatinib|dasatinib|mesh-list
102628587|NCT02013648|Idarubicin|idarubicin|mesh-list
102628588|NCT02013648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102628589|NCT02013648|Antimetabolites|antimetabolites|mesh-ancestor
102628590|NCT02013648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628591|NCT02013648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102628592|NCT02013648|Antiviral Agents|antiviral agents|mesh-ancestor
102628593|NCT02013648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102628594|NCT02013648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102628595|NCT02013648|Immunologic Factors|immunologic factors|mesh-ancestor
102628596|NCT02013648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628597|NCT02013648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102628598|NCT02013648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102628599|NCT02013648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102628600|NCT02013648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102628601|NCT02013648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102628602|NCT05585736|Mydriatics|mydriatics|mesh-list
102628603|NCT05585736|Autonomic Agents|autonomic agents|mesh-ancestor
102628604|NCT05585736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102628605|NCT05585736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628606|NCT01989780|Paclitaxel|paclitaxel|mesh-list
102628607|NCT01989780|Bevacizumab|bevacizumab|mesh-list
102628608|NCT01989780|Letrozole|letrozole|mesh-list
102628609|NCT01989780|Fulvestrant|fulvestrant|mesh-list
102628610|NCT01989780|Anastrozole|anastrozole|mesh-list
102628611|NCT01989780|Exemestane|exemestane|mesh-list
102275081|NCT00005962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102628612|NCT01989780|Goserelin|goserelin|mesh-list
102628613|NCT01989780|Leuprolide|leuprolide|mesh-list
102275082|NCT00005962|Antimetabolites|antimetabolites|mesh-ancestor
102628614|NCT01989780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102628615|NCT01989780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102628616|NCT01989780|Tubulin Modulators|tubulin modulators|mesh-ancestor
102628617|NCT01989780|Antimitotic Agents|antimitotic agents|mesh-ancestor
102628618|NCT01989780|Mitosis Modulators|mitosis modulators|mesh-ancestor
102628619|NCT01989780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628620|NCT01989780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102628621|NCT01989780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102628622|NCT01989780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102628623|NCT01989780|Growth Substances|growth substances|mesh-ancestor
102628624|NCT01989780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628625|NCT01989780|Growth Inhibitors|growth inhibitors|mesh-ancestor
102628626|NCT01989780|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102628627|NCT01989780|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102628628|NCT01989780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102628629|NCT01989780|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102628630|NCT01989780|Hormone Antagonists|hormone antagonists|mesh-ancestor
102628631|NCT01989780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102628632|NCT01989780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102628633|NCT01989780|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102628634|NCT01989780|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102628635|NCT01989780|Fertility Agents|fertility agents|mesh-ancestor
102628636|NCT01989780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102628638|NCT02549898|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102628639|NCT02549898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102628640|NCT02549898|Autonomic Agents|autonomic agents|mesh-ancestor
102628641|NCT02549898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102628642|NCT02549898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628643|NCT02549898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102628644|NCT02549898|Respiratory System Agents|respiratory system agents|mesh-ancestor
102628645|NCT02549898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102628646|NCT02549898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102628647|NCT02549898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628648|NCT02549898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102628649|NCT02549898|Vasodilator Agents|vasodilator agents|mesh-ancestor
102628650|NCT02549898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102628651|NCT02549898|Protective Agents|protective agents|mesh-ancestor
102628652|NCT02549898|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102628653|NCT02549898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102628654|NCT02549898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102628655|NCT02549898|Hematinics|hematinics|mesh-ancestor
102628656|NCT02549898|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102628657|NCT02549898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102628658|NCT05585580|Paclitaxel|paclitaxel|mesh-list
102628659|NCT05585580|Lenvatinib|lenvatinib|mesh-list
102628660|NCT05585580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102628661|NCT05585580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102628662|NCT05585580|Tubulin Modulators|tubulin modulators|mesh-ancestor
102628663|NCT05585580|Antimitotic Agents|antimitotic agents|mesh-ancestor
102628664|NCT05585580|Mitosis Modulators|mitosis modulators|mesh-ancestor
102628665|NCT05585580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628666|NCT05585580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102628667|NCT05585580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102628668|NCT02513784|Chlorhexidine|chlorhexidine|mesh-list
102628669|NCT02513784|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102628670|NCT02513784|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102628671|NCT02513784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102628672|NCT02513784|Disinfectants|disinfectants|mesh-ancestor
102628673|NCT02513784|Dermatologic Agents|dermatologic agents|mesh-ancestor
102628674|NCT02283996|Methylprednisolone|methylprednisolone|mesh-list
102628675|NCT02283996|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102628676|NCT02283996|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102628677|NCT02283996|Prednisolone|prednisolone|mesh-list
102628678|NCT02283996|Prednisolone acetate|prednisolone acetate|mesh-list
102628679|NCT02283996|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102628680|NCT02283996|Prednisolone phosphate|prednisolone phosphate|mesh-list
102628681|NCT02283996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102628682|NCT02283996|Antiemetics|antiemetics|mesh-ancestor
102628683|NCT02283996|Autonomic Agents|autonomic agents|mesh-ancestor
102628684|NCT02283996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102628685|NCT02283996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275083|NCT00005962|Antiviral Agents|antiviral agents|mesh-ancestor
102628686|NCT02283996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102628687|NCT02283996|Glucocorticoids|glucocorticoids|mesh-ancestor
102628688|NCT02283996|Hormones|hormones|mesh-ancestor
102275084|NCT00005962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102275085|NCT00005962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101917170|NCT01959139|Protective Agents|protective agents|mesh-ancestor
102628689|NCT02283996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102628690|NCT02283996|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102628691|NCT02283996|Protective Agents|protective agents|mesh-ancestor
102628692|NCT02283996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102628693|NCT02283996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102628694|NCT02369484|Afatinib|afatinib|mesh-list
102628695|NCT02369484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102628696|NCT02369484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102628697|NCT02369484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102628698|NCT02369484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628699|NCT04390152|Ritonavir|ritonavir|mesh-list
102628700|NCT04390152|Lopinavir|lopinavir|mesh-list
102628701|NCT04390152|Azithromycin|azithromycin|mesh-list
102628702|NCT04390152|Hydroxychloroquine|hydroxychloroquine|mesh-list
102628703|NCT04390152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102628704|NCT04390152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102628705|NCT04390152|Protease Inhibitors|protease inhibitors|mesh-ancestor
102628706|NCT04390152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102628707|NCT04390152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628708|NCT04390152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102628709|NCT04390152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102628710|NCT04390152|Antiviral Agents|antiviral agents|mesh-ancestor
102628711|NCT04390152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102628712|NCT04390152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102628713|NCT04390152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102628714|NCT04390152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102628715|NCT04390152|Antimalarials|antimalarials|mesh-ancestor
102628716|NCT04390152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102628717|NCT04390152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102628718|NCT04390152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102628719|NCT02227992|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102628720|NCT02227992|Hemostatics|hemostatics|mesh-ancestor
102628721|NCT02227992|Coagulants|coagulants|mesh-ancestor
102628722|NCT02496780|Insulin|insulin|mesh-list
102628723|NCT02496780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102628724|NCT02496780|Insulin Aspart|insulin aspart|mesh-list
102628725|NCT02496780|Insulin Detemir|insulin detemir|mesh-list
102628726|NCT02496780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102628727|NCT02496780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628728|NCT01953588|Fulvestrant|fulvestrant|mesh-list
102628729|NCT01953588|Anastrozole|anastrozole|mesh-list
102628730|NCT01953588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102628731|NCT01953588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102628732|NCT01953588|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102628733|NCT01953588|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102628734|NCT01953588|Hormone Antagonists|hormone antagonists|mesh-ancestor
102628735|NCT01953588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102628736|NCT01953588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628737|NCT01953588|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102628738|NCT01953588|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102628739|NCT01953588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102628740|NCT01953588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628741|NCT01953510|Vaccines|vaccines|mesh-list
102628742|NCT01953510|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102628743|NCT01953510|Immunologic Factors|immunologic factors|mesh-ancestor
102628744|NCT01953510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628745|NCT01943994|Psilocybin|psilocybin|mesh-list
102628746|NCT01943994|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
102628747|NCT01943994|Nicotine|nicotine|mesh-list
102628748|NCT01943994|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102628749|NCT01943994|Autonomic Agents|autonomic agents|mesh-ancestor
102628750|NCT01943994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102628751|NCT01943994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628752|NCT01943994|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102628753|NCT01943994|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102628754|NCT01943994|Cholinergic Agents|cholinergic agents|mesh-ancestor
102628755|NCT01943994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102628756|NCT01943994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628757|NCT01943994|Hallucinogens|hallucinogens|mesh-ancestor
102628758|NCT01943994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102628759|NCT01943994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102628760|NCT01943994|Serotonin Agents|serotonin agents|mesh-ancestor
102628761|NCT01943994|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102628762|NCT02456532|Zolpidem|zolpidem|mesh-list
102628763|NCT02456532|Eszopiclone|eszopiclone|mesh-list
102628764|NCT02456532|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102628765|NCT02456532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102628766|NCT02456532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102628767|NCT02456532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628768|NCT02456532|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102628769|NCT02456532|GABA Agonists|gaba agonists|mesh-ancestor
102628770|NCT02456532|GABA Agents|gaba agents|mesh-ancestor
102628771|NCT02456532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102628772|NCT02456532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628773|NCT05578950|Itraconazole|itraconazole|mesh-list
102628774|NCT05578950|Terbinafine|terbinafine|mesh-list
102628775|NCT05578950|Antifungal Agents|antifungal agents|mesh-ancestor
102628776|NCT05578950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102628777|NCT05578950|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102628778|NCT05578950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102628779|NCT05578950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102628780|NCT05578950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628781|NCT05578950|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102628782|NCT05578950|Hormone Antagonists|hormone antagonists|mesh-ancestor
102628783|NCT05578950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102628784|NCT05578950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628785|NCT05578950|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102628786|NCT05586126|Sevoflurane|sevoflurane|mesh-list
102628787|NCT05586126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102628788|NCT05586126|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102628789|NCT05586126|Anesthetics, General|anesthetics, general|mesh-ancestor
102628790|NCT05586126|Anesthetics|anesthetics|mesh-ancestor
102628791|NCT05586126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102628792|NCT05586126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628793|NCT01893996|Adalimumab|adalimumab|mesh-list
102628794|NCT01893996|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102628795|NCT01893996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102628796|NCT01893996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102628797|NCT02442180|Methylprednisolone|methylprednisolone|mesh-list
102628798|NCT02442180|Prednisolone|prednisolone|mesh-list
102628799|NCT02442180|Lenograstim|lenograstim|mesh-list
102628800|NCT02442180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102628801|NCT02442180|Immunologic Factors|immunologic factors|mesh-ancestor
102628802|NCT02442180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628803|NCT02442180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102628804|NCT02442180|Antiemetics|antiemetics|mesh-ancestor
102628805|NCT02442180|Autonomic Agents|autonomic agents|mesh-ancestor
102628806|NCT02442180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102628807|NCT02442180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102628808|NCT02442180|Glucocorticoids|glucocorticoids|mesh-ancestor
102628809|NCT02442180|Hormones|hormones|mesh-ancestor
102628810|NCT02442180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102628811|NCT02442180|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102628812|NCT02442180|Protective Agents|protective agents|mesh-ancestor
102628813|NCT02442180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102628814|NCT02442180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102628815|NCT01924260|Gemcitabine|gemcitabine|mesh-list
102628816|NCT01924260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102628817|NCT01924260|Antimetabolites|antimetabolites|mesh-ancestor
102628818|NCT01924260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628819|NCT01924260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102628820|NCT02432742|Hyaluronic Acid|hyaluronic acid|mesh-list
102628821|NCT02432742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102628822|NCT02432742|Immunologic Factors|immunologic factors|mesh-ancestor
102628823|NCT02432742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628824|NCT02432742|Viscosupplements|viscosupplements|mesh-ancestor
102628825|NCT02432742|Protective Agents|protective agents|mesh-ancestor
102628826|NCT02086500|Tranexamic Acid|tranexamic acid|mesh-list
102628827|NCT02086500|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102628828|NCT02086500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102628829|NCT02086500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628830|NCT02086500|Hemostatics|hemostatics|mesh-ancestor
102628831|NCT02086500|Coagulants|coagulants|mesh-ancestor
102628832|NCT02104986|Cisplatin|cisplatin|mesh-list
102628833|NCT02104986|Ifosfamide|ifosfamide|mesh-list
102628834|NCT02104986|Bleomycin|bleomycin|mesh-list
102628835|NCT02104986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102275086|NCT00005962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102628836|NCT02104986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102275087|NCT00005962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102628837|NCT02104986|Alkylating Agents|alkylating agents|mesh-ancestor
102628838|NCT02104986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628839|NCT02104986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102628840|NCT02425566|Trimethaphan|trimethaphan|mesh-list
102628841|NCT02425566|Nitroglycerin|nitroglycerin|mesh-list
102628842|NCT02425566|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
102628843|NCT02425566|Vasodilator Agents|vasodilator agents|mesh-ancestor
102628844|NCT02425566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102628845|NCT02425566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102628846|NCT02425566|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
102628847|NCT02425566|Autonomic Agents|autonomic agents|mesh-ancestor
102628848|NCT02425566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102628849|NCT02425566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628850|NCT02425566|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102628851|NCT02425566|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102628852|NCT02425566|Cholinergic Agents|cholinergic agents|mesh-ancestor
102628853|NCT02425566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102628854|NCT02425566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628855|NCT04757532|Methyltestosterone|methyltestosterone|mesh-list
102628856|NCT04757532|Anastrozole|anastrozole|mesh-list
102628857|NCT04757532|Chlorthalidone|chlorthalidone|mesh-list
102628858|NCT04757532|Bupropion|bupropion|mesh-list
102628859|NCT04757532|Testosterone|testosterone|mesh-list
102628860|NCT04757532|Testosterone undecanoate|testosterone undecanoate|mesh-list
102628861|NCT04757532|Testosterone enanthate|testosterone enanthate|mesh-list
102628862|NCT04757532|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102628863|NCT04757532|Danazol|danazol|mesh-list
102628864|NCT04757532|Androgens|androgens|mesh-ancestor
102628865|NCT04757532|Hormones|hormones|mesh-ancestor
102628866|NCT04757532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102628867|NCT04757532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628868|NCT04757532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102628869|NCT04757532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102628870|NCT04757532|Anabolic Agents|anabolic agents|mesh-ancestor
102628871|NCT04757532|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102628872|NCT04757532|Antidepressive Agents|antidepressive agents|mesh-ancestor
102628873|NCT04757532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102628874|NCT04757532|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102628875|NCT04757532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102628876|NCT04757532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102628877|NCT04757532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628878|NCT04757532|Dopamine Agents|dopamine agents|mesh-ancestor
102628879|NCT04757532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102628880|NCT04757532|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102628881|NCT04757532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102628882|NCT04757532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102628883|NCT04757532|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102628884|NCT04757532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102628885|NCT04757532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102628886|NCT04757532|Hormone Antagonists|hormone antagonists|mesh-ancestor
102628887|NCT04757532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102628888|NCT04757532|Diuretics|diuretics|mesh-ancestor
102628889|NCT04757532|Natriuretic Agents|natriuretic agents|mesh-ancestor
102628890|NCT04757532|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102628891|NCT02069730|Androgens|androgens|mesh-list
102628892|NCT02069730|Androgen Antagonists|androgen antagonists|mesh-list
102628893|NCT02069730|Hormones|hormones|mesh-ancestor
102628894|NCT02069730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102628895|NCT02069730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628896|NCT02069730|Hormone Antagonists|hormone antagonists|mesh-ancestor
102628897|NCT02068092|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
102628898|NCT02068092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102628899|NCT02068092|Antioxidants|antioxidants|mesh-ancestor
102628900|NCT02068092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628901|NCT02068092|Protective Agents|protective agents|mesh-ancestor
102628902|NCT02068092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628903|NCT02068092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102628904|NCT02063022|Dactinomycin|dactinomycin|mesh-list
102628905|NCT02063022|Cyclophosphamide|cyclophosphamide|mesh-list
102628906|NCT02063022|Melphalan|melphalan|mesh-list
102628907|NCT02063022|Busulfan|busulfan|mesh-list
102628908|NCT02063022|Ifosfamide|ifosfamide|mesh-list
102628909|NCT02063022|Isophosphamide mustard|isophosphamide mustard|mesh-list
102628910|NCT02063022|Doxorubicin|doxorubicin|mesh-list
102628911|NCT02063022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102628913|NCT02063022|Etoposide phosphate|etoposide phosphate|mesh-list
102628914|NCT02063022|Vincristine|vincristine|mesh-list
102628915|NCT02063022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102628916|NCT02063022|Immunologic Factors|immunologic factors|mesh-ancestor
102628917|NCT02063022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628918|NCT02063022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102628919|NCT02063022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102628920|NCT02063022|Alkylating Agents|alkylating agents|mesh-ancestor
102628921|NCT02063022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628922|NCT02063022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102628923|NCT02063022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102628924|NCT02063022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102628925|NCT02063022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102628926|NCT02063022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102628927|NCT02063022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102628928|NCT02063022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102628929|NCT02063022|Tubulin Modulators|tubulin modulators|mesh-ancestor
102628930|NCT02063022|Antimitotic Agents|antimitotic agents|mesh-ancestor
102628931|NCT02063022|Mitosis Modulators|mitosis modulators|mesh-ancestor
102628932|NCT02063022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102628933|NCT02063022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102628934|NCT02063022|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102628935|NCT02063022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102628936|NCT01895010|Tropisetron|tropisetron|mesh-list
102628937|NCT01895010|Antiemetics|antiemetics|mesh-ancestor
102628938|NCT01895010|Autonomic Agents|autonomic agents|mesh-ancestor
102628939|NCT01895010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102628940|NCT01895010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628941|NCT01895010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102628942|NCT01895010|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102628943|NCT01895010|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102628944|NCT01895010|Serotonin Agents|serotonin agents|mesh-ancestor
102628945|NCT01895010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102628946|NCT01895010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628947|NCT02030028|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102628948|NCT02030028|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
102628949|NCT02030028|beta-Endorphin|beta-endorphin|mesh-list
102628950|NCT02030028|Hormones|hormones|mesh-ancestor
102628951|NCT02030028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102628952|NCT02030028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628953|NCT02030028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102628954|NCT02030028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628955|NCT01896336|Zolpidem|zolpidem|mesh-list
102628956|NCT01896336|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102628957|NCT01896336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102628958|NCT01896336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102628959|NCT01896336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628960|NCT01896336|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102628961|NCT01896336|GABA Agonists|gaba agonists|mesh-ancestor
102628962|NCT01896336|GABA Agents|gaba agents|mesh-ancestor
102628963|NCT01896336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102628964|NCT01896336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628965|NCT00575718|Nicotine|nicotine|mesh-list
102628966|NCT00575718|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102628967|NCT00575718|Autonomic Agents|autonomic agents|mesh-ancestor
102628968|NCT00575718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102628969|NCT00575718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628970|NCT00575718|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102628971|NCT00575718|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102628972|NCT00575718|Cholinergic Agents|cholinergic agents|mesh-ancestor
102628973|NCT00575718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102628974|NCT00575718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628975|NCT02087748|Diclofenac|diclofenac|mesh-list
102628976|NCT02087748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102628977|NCT02087748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102628978|NCT02087748|Analgesics|analgesics|mesh-ancestor
102628979|NCT02087748|Sensory System Agents|sensory system agents|mesh-ancestor
102628980|NCT02087748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102628981|NCT02087748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628982|NCT02087748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102628983|NCT02087748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102275088|NCT00005962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102628984|NCT02087748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102628985|NCT02087748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102628986|NCT02087748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102628987|NCT01490502|Vitamin D|vitamin d|mesh-list
102628988|NCT01490502|Cholecalciferol|cholecalciferol|mesh-list
102628989|NCT01490502|Vitamins|vitamins|mesh-ancestor
102628990|NCT01490502|Micronutrients|micronutrients|mesh-ancestor
102628991|NCT01490502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628992|NCT01490502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102628993|NCT01490502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102628994|NCT01428024|Hyaluronic Acid|hyaluronic acid|mesh-list
102628995|NCT01428024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102628996|NCT01428024|Immunologic Factors|immunologic factors|mesh-ancestor
102628997|NCT01428024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102628998|NCT01428024|Viscosupplements|viscosupplements|mesh-ancestor
102628999|NCT01428024|Protective Agents|protective agents|mesh-ancestor
102629000|NCT01412190|Hyaluronic Acid|hyaluronic acid|mesh-list
102629001|NCT01412190|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102629002|NCT01412190|Immunologic Factors|immunologic factors|mesh-ancestor
102629003|NCT01412190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629004|NCT01412190|Viscosupplements|viscosupplements|mesh-ancestor
102629005|NCT01412190|Protective Agents|protective agents|mesh-ancestor
102629006|NCT01331148|Vitamin D|vitamin d|mesh-list
102629007|NCT01331148|Cholecalciferol|cholecalciferol|mesh-list
102629008|NCT01331148|Vitamins|vitamins|mesh-ancestor
102629009|NCT01331148|Micronutrients|micronutrients|mesh-ancestor
102629010|NCT01331148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629011|NCT01331148|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102629012|NCT01331148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102629013|NCT00273624|Olanzapine|olanzapine|mesh-list
102629014|NCT00273624|Antiemetics|antiemetics|mesh-ancestor
102629015|NCT00273624|Autonomic Agents|autonomic agents|mesh-ancestor
102629016|NCT00273624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102629017|NCT00273624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629018|NCT00273624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102629019|NCT00273624|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102629020|NCT00273624|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102629021|NCT00273624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102629022|NCT00273624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102629023|NCT00273624|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102629024|NCT00273624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102629025|NCT00273624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102629026|NCT00273624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629027|NCT00273624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102629028|NCT00273624|Serotonin Agents|serotonin agents|mesh-ancestor
102629029|NCT00262470|Indomethacin|indomethacin|mesh-list
102629030|NCT00262470|Octreotide|octreotide|mesh-list
102629031|NCT00262470|Propranolol|propranolol|mesh-list
102629032|NCT00262470|Clonidine|clonidine|mesh-list
102629033|NCT00262470|Mecamylamine|mecamylamine|mesh-list
102629034|NCT00262470|Acetazolamide|acetazolamide|mesh-list
102629035|NCT00262470|Isosorbide|isosorbide|mesh-list
102629036|NCT00262470|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
102629037|NCT00262470|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
102629038|NCT00262470|Midodrine|midodrine|mesh-list
102629039|NCT00262470|Memantine|memantine|mesh-list
102629040|NCT00262470|Entacapone|entacapone|mesh-list
102629041|NCT00262470|Melatonin|melatonin|mesh-list
102629042|NCT00262470|Modafinil|modafinil|mesh-list
102629043|NCT00262470|Sertraline|sertraline|mesh-list
102629044|NCT00262470|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102629045|NCT00262470|Antioxidants|antioxidants|mesh-ancestor
102629046|NCT00262470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629047|NCT00262470|Protective Agents|protective agents|mesh-ancestor
102629048|NCT00262470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629049|NCT00262470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102629050|NCT00262470|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102629051|NCT00262470|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102629052|NCT00262470|Adrenergic Agents|adrenergic agents|mesh-ancestor
102629053|NCT00262470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102629054|NCT00262470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102629055|NCT00262470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102629056|NCT00262470|Vasodilator Agents|vasodilator agents|mesh-ancestor
102629057|NCT00262470|Antidepressive Agents|antidepressive agents|mesh-ancestor
102629058|NCT00262470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102629059|NCT00262470|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102629060|NCT00262470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101917470|NCT05795283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102629061|NCT00262470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102629062|NCT00262470|Serotonin Agents|serotonin agents|mesh-ancestor
102629063|NCT00262470|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102629064|NCT00262470|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102629065|NCT00262470|Dopamine Agents|dopamine agents|mesh-ancestor
102629066|NCT00262470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102629067|NCT00262470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102629068|NCT00262470|Analgesics|analgesics|mesh-ancestor
102629069|NCT00262470|Sensory System Agents|sensory system agents|mesh-ancestor
102629070|NCT00262470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102629071|NCT00262470|Sympatholytics|sympatholytics|mesh-ancestor
102629072|NCT00262470|Autonomic Agents|autonomic agents|mesh-ancestor
102629073|NCT00262470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102629074|NCT00262470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102629075|NCT00262470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102629076|NCT00262470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102629077|NCT00262470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102629078|NCT00262470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102629079|NCT00262470|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102629080|NCT00262470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102629081|NCT00262470|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102629082|NCT00262470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102629083|NCT00262470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102629084|NCT00262470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102629085|NCT00262470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102629086|NCT00262470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102629087|NCT00262470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102629088|NCT00262470|Gout Suppressants|gout suppressants|mesh-ancestor
102629089|NCT00262470|Tocolytic Agents|tocolytic agents|mesh-ancestor
102629090|NCT00262470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102629091|NCT00262470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102629092|NCT00262470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102629093|NCT00262470|Anticonvulsants|anticonvulsants|mesh-ancestor
102629094|NCT00262470|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102629095|NCT00262470|Diuretics|diuretics|mesh-ancestor
102629096|NCT00262470|Natriuretic Agents|natriuretic agents|mesh-ancestor
102629097|NCT00262470|Sympathomimetics|sympathomimetics|mesh-ancestor
102629098|NCT00262470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102629099|NCT00262470|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102629100|NCT00262470|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102629101|NCT00262470|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102629102|NCT00262470|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102629103|NCT00262470|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
102629104|NCT00262470|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102629105|NCT00262470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102629106|NCT00262470|Cholinergic Agents|cholinergic agents|mesh-ancestor
102629107|NCT01253070|Cytarabine|cytarabine|mesh-list
102629108|NCT01253070|Sorafenib|sorafenib|mesh-list
102629109|NCT01253070|Daunorubicin|daunorubicin|mesh-list
102629110|NCT01253070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102629111|NCT01253070|Antimetabolites|antimetabolites|mesh-ancestor
102629112|NCT01253070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629113|NCT01253070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102629114|NCT01253070|Antiviral Agents|antiviral agents|mesh-ancestor
102629115|NCT01253070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102629116|NCT01253070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102629117|NCT01253070|Immunologic Factors|immunologic factors|mesh-ancestor
102629118|NCT01253070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629119|NCT01253070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102629120|NCT01253070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102629121|NCT01253070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102629122|NCT01253070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102629123|NCT01253070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102629124|NCT01212822|Leucovorin|leucovorin|mesh-list
102629125|NCT01212822|Bevacizumab|bevacizumab|mesh-list
102629126|NCT01212822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102629127|NCT01212822|Fluorouracil|fluorouracil|mesh-list
102629128|NCT01212822|Oxaliplatin|oxaliplatin|mesh-list
102629129|NCT01212822|Antibodies|antibodies|mesh-list
102629130|NCT01212822|Immunoglobulins|immunoglobulins|mesh-list
102629131|NCT01212822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102629132|NCT01212822|Levoleucovorin|levoleucovorin|mesh-list
102629133|NCT01212822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102629134|NCT01212822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102629135|NCT01212822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101917549|NCT05690503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102629136|NCT01212822|Growth Substances|growth substances|mesh-ancestor
102629137|NCT01212822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629138|NCT01212822|Growth Inhibitors|growth inhibitors|mesh-ancestor
102629139|NCT01212822|Immunologic Factors|immunologic factors|mesh-ancestor
102629140|NCT01212822|Antimetabolites|antimetabolites|mesh-ancestor
102629141|NCT01212822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629142|NCT01212822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102629143|NCT01212822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102629144|NCT01212822|Antidotes|antidotes|mesh-ancestor
102629145|NCT01212822|Protective Agents|protective agents|mesh-ancestor
102629146|NCT01212822|Vitamin B Complex|vitamin b complex|mesh-ancestor
102629148|NCT01212822|Micronutrients|micronutrients|mesh-ancestor
102629149|NCT00163566|Dihydrotestosterone|dihydrotestosterone|mesh-list
102629150|NCT00163566|Androgens|androgens|mesh-ancestor
102629151|NCT00163566|Hormones|hormones|mesh-ancestor
102629152|NCT00163566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102629153|NCT00163566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629154|NCT04705662|Lactulose|lactulose|mesh-list
102629155|NCT04705662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102629156|NCT04782960|Bupivacaine|bupivacaine|mesh-list
102629157|NCT04782960|Anesthetics|anesthetics|mesh-list
102629158|NCT04782960|Anesthetics, Local|anesthetics, local|mesh-ancestor
102629159|NCT04782960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102629160|NCT04782960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629161|NCT04782960|Sensory System Agents|sensory system agents|mesh-ancestor
102629162|NCT04782960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102629163|NCT01026012|Regadenoson|regadenoson|mesh-list
102629164|NCT01026012|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
101601500|NCT02872818|Estradiol|estradiol|mesh-list
102629165|NCT01026012|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102629166|NCT01026012|Purinergic Agonists|purinergic agonists|mesh-ancestor
102629167|NCT01026012|Purinergic Agents|purinergic agents|mesh-ancestor
102629168|NCT01026012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102629169|NCT01026012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629170|NCT01026012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629171|NCT02088216|Acetylcysteine|acetylcysteine|mesh-list
102629172|NCT02088216|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102629173|NCT02088216|Antiviral Agents|antiviral agents|mesh-ancestor
102629174|NCT02088216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102629175|NCT02088216|Expectorants|expectorants|mesh-ancestor
102629176|NCT02088216|Respiratory System Agents|respiratory system agents|mesh-ancestor
102629177|NCT02088216|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102629178|NCT02088216|Antioxidants|antioxidants|mesh-ancestor
102629179|NCT02088216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629180|NCT02088216|Protective Agents|protective agents|mesh-ancestor
102629181|NCT02088216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629182|NCT02088216|Antidotes|antidotes|mesh-ancestor
102629183|NCT01014936|Tepotinib|tepotinib|mesh-list
102629184|NCT01014936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102629185|NCT01896180|Latanoprost|latanoprost|mesh-list
102629186|NCT01896180|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102629187|NCT01896180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102629188|NCT00981162|Everolimus|everolimus|mesh-list
102629189|NCT00981162|Sorafenib|sorafenib|mesh-list
102629190|NCT00981162|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102629191|NCT00981162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102629192|NCT00981162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102629193|NCT00981162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629194|NCT00981162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102629195|NCT00981162|Immunologic Factors|immunologic factors|mesh-ancestor
102629196|NCT00981162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629197|NCT00981162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102629198|NCT00877500|Epothilones|epothilones|mesh-list
102629199|NCT00877500|Epothilone B|epothilone b|mesh-list
102629200|NCT00877500|Tubulin Modulators|tubulin modulators|mesh-ancestor
102629201|NCT00877500|Antimitotic Agents|antimitotic agents|mesh-ancestor
102629202|NCT00877500|Mitosis Modulators|mitosis modulators|mesh-ancestor
102629203|NCT00877500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629204|NCT00877500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102629205|NCT00875004|Epoetin Alfa|epoetin alfa|mesh-list
102629206|NCT00875004|Hematinics|hematinics|mesh-ancestor
102629207|NCT05320692|Apatinib|apatinib|mesh-list
102629208|NCT05320692|Chlorotrianisene|chlorotrianisene|mesh-list
102629209|NCT05320692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102629210|NCT05320692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102629211|NCT05320692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102629212|NCT05320692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917700|NCT05193318|Anesthetics, General|anesthetics, general|mesh-ancestor
102629213|NCT05320692|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102629214|NCT05320692|Estrogens|estrogens|mesh-ancestor
102629215|NCT05320692|Hormones|hormones|mesh-ancestor
102629216|NCT05320692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102629217|NCT05320692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629218|NCT05320692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102629219|NCT01763580|Prednisolone|prednisolone|mesh-list
102629220|NCT01763580|Tacrolimus|tacrolimus|mesh-list
102629221|NCT01763580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102629222|NCT01763580|Immunologic Factors|immunologic factors|mesh-ancestor
102629223|NCT01763580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629224|NCT01763580|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102629225|NCT01763580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102629226|NCT01763580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629227|NCT01763580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102629228|NCT01763580|Glucocorticoids|glucocorticoids|mesh-ancestor
102629229|NCT01763580|Hormones|hormones|mesh-ancestor
102629230|NCT01763580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102629231|NCT01763580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102629232|NCT01763580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102629233|NCT03969420|Cytarabine|cytarabine|mesh-list
102629234|NCT03969420|Alvocidib|alvocidib|mesh-list
102629235|NCT03969420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102629236|NCT03969420|Antimetabolites|antimetabolites|mesh-ancestor
102629237|NCT03969420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629238|NCT03969420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102629239|NCT03969420|Antiviral Agents|antiviral agents|mesh-ancestor
102629240|NCT03969420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102629241|NCT03969420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102629242|NCT03969420|Immunologic Factors|immunologic factors|mesh-ancestor
102629243|NCT03969420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629244|NCT03969420|Growth Inhibitors|growth inhibitors|mesh-ancestor
102629245|NCT03969420|Growth Substances|growth substances|mesh-ancestor
102629246|NCT03969420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102629247|NCT03969420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102629248|NCT01740492|Ketamine|ketamine|mesh-list
102629249|NCT01740492|Analgesics|analgesics|mesh-ancestor
102629250|NCT01740492|Sensory System Agents|sensory system agents|mesh-ancestor
102629251|NCT01740492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102629252|NCT01740492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629253|NCT01740492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102629254|NCT01740492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102629255|NCT01740492|Anesthetics, General|anesthetics, general|mesh-ancestor
102629256|NCT01740492|Anesthetics|anesthetics|mesh-ancestor
102629257|NCT01740492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102629258|NCT01740492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102629259|NCT01740492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102629260|NCT01740492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102629261|NCT01740492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629262|NCT04780854|Metformin|metformin|mesh-list
102629263|NCT04780854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102629264|NCT04780854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629265|NCT04780152|Fluoxetine|fluoxetine|mesh-list
102629266|NCT04780152|Antidepressive Agents|antidepressive agents|mesh-list
102629267|NCT04780152|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102629268|NCT04780152|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102629269|NCT04780152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102629270|NCT04780152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629271|NCT04780152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102629272|NCT04780152|Serotonin Agents|serotonin agents|mesh-ancestor
102629273|NCT04780152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629274|NCT04780152|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102629275|NCT04780152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102629276|NCT04780152|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102629277|NCT04780152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102629278|NCT04780152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102629279|NCT00644280|Ranibizumab|ranibizumab|mesh-list
102629280|NCT00644280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102629281|NCT00644280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102629282|NCT00644280|Growth Substances|growth substances|mesh-ancestor
102629283|NCT00644280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629284|NCT00644280|Growth Inhibitors|growth inhibitors|mesh-ancestor
102638137|NCT00716742|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102275089|NCT00005962|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102629285|NCT00644280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102629286|NCT04779762|Ustekinumab|ustekinumab|mesh-list
102629287|NCT04779762|Dermatologic Agents|dermatologic agents|mesh-ancestor
102629288|NCT04777968|Fluorides|fluorides|mesh-list
102629289|NCT04777968|Cariostatic Agents|cariostatic agents|mesh-ancestor
102629290|NCT04777968|Protective Agents|protective agents|mesh-ancestor
102629291|NCT04777968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629292|NCT01722708|Metronidazole|metronidazole|mesh-list
102629293|NCT01722708|Clindamycin|clindamycin|mesh-list
102629294|NCT01722708|Clindamycin palmitate|clindamycin palmitate|mesh-list
102629295|NCT01722708|Clindamycin phosphate|clindamycin phosphate|mesh-list
102629296|NCT01722708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102629297|NCT01722708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102629298|NCT01722708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102629299|NCT01722708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102629300|NCT01722708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102629301|NCT01722708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102629302|NCT01722708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629303|NCT01711632|Vemurafenib|vemurafenib|mesh-list
102629304|NCT01711632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102629305|NCT01711632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102629306|NCT01711632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102629307|NCT01711632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629308|NCT04756206|Dutasteride|dutasteride|mesh-list
102629309|NCT04756206|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102629310|NCT04756206|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102629311|NCT04756206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102629312|NCT04756206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629313|NCT04756206|Hormone Antagonists|hormone antagonists|mesh-ancestor
102629314|NCT04756206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102629315|NCT04756206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629316|NCT04779060|Dexamethasone|dexamethasone|mesh-list
102629317|NCT04779060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102629318|NCT04779060|Antiemetics|antiemetics|mesh-ancestor
102629319|NCT04779060|Autonomic Agents|autonomic agents|mesh-ancestor
102629320|NCT04779060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102629321|NCT04779060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629322|NCT04779060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102629323|NCT04779060|Glucocorticoids|glucocorticoids|mesh-ancestor
102629324|NCT04779060|Hormones|hormones|mesh-ancestor
102629325|NCT04779060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102629326|NCT04779060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102629327|NCT04779060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102629328|NCT04778514|Contraceptive Agents|contraceptive agents|mesh-list
102629329|NCT04778514|Contraceptives, Oral|contraceptives, oral|mesh-list
102629330|NCT04778514|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
102629331|NCT04778514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102629332|NCT04778514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629333|NCT04778514|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102629334|NCT04777110|Esketamine|esketamine|mesh-list
102629335|NCT04777110|Antidepressive Agents|antidepressive agents|mesh-ancestor
102629336|NCT04777110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102629337|NCT01895400|Cilostazol|cilostazol|mesh-list
102629338|NCT01895400|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102629339|NCT01895400|Autonomic Agents|autonomic agents|mesh-ancestor
102629340|NCT01895400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102629341|NCT01895400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629342|NCT01895400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102629343|NCT01895400|Respiratory System Agents|respiratory system agents|mesh-ancestor
102629344|NCT01895400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102629345|NCT01895400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102629346|NCT01895400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629347|NCT01895400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102629348|NCT01895400|Vasodilator Agents|vasodilator agents|mesh-ancestor
102629349|NCT01895400|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102629350|NCT01895400|Protective Agents|protective agents|mesh-ancestor
102629351|NCT01895400|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102629352|NCT01895400|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102629353|NCT01895400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102629354|NCT05171946|Vaccines|vaccines|mesh-list
102629355|NCT05171946|Immunologic Factors|immunologic factors|mesh-ancestor
102629356|NCT05171946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275090|NCT00005962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102275091|NCT00005962|Immunotoxins|immunotoxins|mesh-ancestor
102629357|NCT05605314|Cyclosporine|cyclosporine|mesh-list
102629358|NCT05605314|Cyclosporins|cyclosporins|mesh-list
102629359|NCT05605314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102629360|NCT05605314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629361|NCT05605314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102629362|NCT05605314|Immunologic Factors|immunologic factors|mesh-ancestor
101601701|NCT05252325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102629363|NCT05605314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629364|NCT05605314|Antifungal Agents|antifungal agents|mesh-ancestor
102629365|NCT05605314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102629366|NCT05605314|Dermatologic Agents|dermatologic agents|mesh-ancestor
102629367|NCT05605314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102629368|NCT05605314|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102629369|NCT05605158|Pioglitazone|pioglitazone|mesh-list
102629370|NCT05605158|Empagliflozin|empagliflozin|mesh-list
102629371|NCT05605158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102629372|NCT05605158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629373|NCT05605158|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102629374|NCT05605158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629375|NCT04775238|Copper|copper|mesh-list
102629376|NCT04775238|Trace Elements|trace elements|mesh-ancestor
102629377|NCT04775238|Micronutrients|micronutrients|mesh-ancestor
102629378|NCT04775238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629379|NCT05580042|Tofacitinib|tofacitinib|mesh-list
102629380|NCT05580042|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102629381|NCT05580042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102629382|NCT05580042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102629383|NCT05580042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629384|NCT04773756|Sofosbuvir|sofosbuvir|mesh-list
102629385|NCT04773756|Antiviral Agents|antiviral agents|mesh-ancestor
102629386|NCT04773756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102629387|NCT03012984|Dexmedetomidine|dexmedetomidine|mesh-list
102629388|NCT03012984|Morphine|morphine|mesh-list
102629389|NCT03012984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102629390|NCT03012984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102629391|NCT03012984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629392|NCT03012984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102629393|NCT03012984|Analgesics|analgesics|mesh-ancestor
102629394|NCT03012984|Sensory System Agents|sensory system agents|mesh-ancestor
102629395|NCT03012984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102629396|NCT03012984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102629397|NCT03012984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102629398|NCT03012984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102629399|NCT03012984|Adrenergic Agents|adrenergic agents|mesh-ancestor
102629400|NCT03012984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102629401|NCT03012984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629402|NCT03012984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102629403|NCT03012984|Narcotics|narcotics|mesh-ancestor
102629404|NCT02744430|Mirabegron|mirabegron|mesh-list
102629405|NCT02744430|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102629406|NCT02744430|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102629407|NCT02744430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102629408|NCT02744430|Adrenergic Agents|adrenergic agents|mesh-ancestor
102629409|NCT02744430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102629410|NCT02744430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629411|NCT02744430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629412|NCT02744430|Urological Agents|urological agents|mesh-ancestor
102629413|NCT00054756|Hormones|hormones|mesh-list
102629414|NCT00054756|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
102629415|NCT00054756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102629416|NCT00054756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629417|NCT01896960|Fentanyl|fentanyl|mesh-list
102629418|NCT01896960|Bupivacaine|bupivacaine|mesh-list
102629419|NCT01896960|Anesthetics, Local|anesthetics, local|mesh-ancestor
102629420|NCT01896960|Anesthetics|anesthetics|mesh-ancestor
102629421|NCT01896960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102629422|NCT01896960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629423|NCT01896960|Sensory System Agents|sensory system agents|mesh-ancestor
101601768|NCT04307693|Ritonavir|ritonavir|mesh-list
102629424|NCT01896960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102629425|NCT01896960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102629426|NCT01896960|Narcotics|narcotics|mesh-ancestor
102629427|NCT01896960|Analgesics|analgesics|mesh-ancestor
102629428|NCT01896960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102275092|NCT00005962|Immunoconjugates|immunoconjugates|mesh-ancestor
102629429|NCT01896960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102629430|NCT01896960|Anesthetics, General|anesthetics, general|mesh-ancestor
102629431|NCT00055692|Bevacizumab|bevacizumab|mesh-list
102275093|NCT00005847|Interferons|interferons|mesh-list
102275094|NCT00005847|Interferon-alpha|interferon-alpha|mesh-list
102275095|NCT00005847|Paclitaxel|paclitaxel|mesh-list
102275096|NCT00005847|Vinorelbine|vinorelbine|mesh-list
102275097|NCT00005847|Mitoxantrone|mitoxantrone|mesh-list
102275098|NCT00005847|Estramustine|estramustine|mesh-list
102275099|NCT00005847|Isotretinoin|isotretinoin|mesh-list
102629432|NCT00055692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102629433|NCT00055692|Antibodies|antibodies|mesh-list
102629434|NCT00055692|Immunoglobulins|immunoglobulins|mesh-list
102629435|NCT00055692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102629436|NCT00055692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102629437|NCT00055692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102629438|NCT00055692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102629439|NCT00055692|Growth Substances|growth substances|mesh-ancestor
102629440|NCT00055692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629441|NCT00055692|Growth Inhibitors|growth inhibitors|mesh-ancestor
102629442|NCT00055692|Immunologic Factors|immunologic factors|mesh-ancestor
102629443|NCT04772352|Febuxostat|febuxostat|mesh-list
102629444|NCT04772352|Gout Suppressants|gout suppressants|mesh-ancestor
102629445|NCT04772352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102629446|NCT00056472|Olanzapine|olanzapine|mesh-list
102629447|NCT00056472|Sertraline|sertraline|mesh-list
102629448|NCT00056472|Antiemetics|antiemetics|mesh-ancestor
102629449|NCT00056472|Autonomic Agents|autonomic agents|mesh-ancestor
102629450|NCT00056472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102629451|NCT00056472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629452|NCT00056472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102629453|NCT00056472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102629454|NCT00056472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102629455|NCT00056472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102629456|NCT00056472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102629457|NCT00056472|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102629458|NCT00056472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102629459|NCT00056472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102629460|NCT00056472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629461|NCT00056472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102629462|NCT00056472|Serotonin Agents|serotonin agents|mesh-ancestor
102629463|NCT00056472|Antidepressive Agents|antidepressive agents|mesh-ancestor
102629464|NCT00056550|Antithrombins|antithrombins|mesh-list
102629465|NCT00056550|Antithrombin III|antithrombin iii|mesh-list
102629466|NCT00056550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102629467|NCT00056550|Protease Inhibitors|protease inhibitors|mesh-ancestor
102629468|NCT00056550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102629469|NCT00056550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629470|NCT00056550|Anticoagulants|anticoagulants|mesh-ancestor
102629471|NCT04771884|Vancomycin|vancomycin|mesh-list
102629472|NCT04771884|Meropenem|meropenem|mesh-list
102629473|NCT04771884|Ceftriaxone|ceftriaxone|mesh-list
102629474|NCT04771884|Linezolid|linezolid|mesh-list
102629475|NCT04771884|Ceftazidime|ceftazidime|mesh-list
102629476|NCT04771884|Ceftizoxime|ceftizoxime|mesh-list
102629477|NCT04771884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102629478|NCT04771884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102629479|NCT04771884|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102629480|NCT04771884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102629481|NCT04771884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629482|NCT02538744|Doxazosin|doxazosin|mesh-list
102629483|NCT02538744|Cocaine|cocaine|mesh-list
102629484|NCT02538744|Modafinil|modafinil|mesh-list
102629485|NCT02538744|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102629486|NCT02538744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629487|NCT02538744|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102629488|NCT02538744|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102629489|NCT02538744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102629490|NCT02538744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629491|NCT02538744|Anesthetics, Local|anesthetics, local|mesh-ancestor
102629492|NCT02538744|Anesthetics|anesthetics|mesh-ancestor
102629493|NCT02538744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102629494|NCT02538744|Sensory System Agents|sensory system agents|mesh-ancestor
102629495|NCT02538744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102629496|NCT02538744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102629497|NCT02538744|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102629498|NCT02538744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102629499|NCT02538744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102275100|NCT00005847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101983877|NCT03388164|Dexetimide|dexetimide|mesh-list
101917935|NCT03930680|Dexrazoxane|dexrazoxane|mesh-list
102275101|NCT00005847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102629500|NCT02538744|Dopamine Agents|dopamine agents|mesh-ancestor
102629501|NCT02538744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102629502|NCT02538744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102629503|NCT02538744|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102629504|NCT02538744|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102629505|NCT02538744|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102629506|NCT02538744|Adrenergic Agents|adrenergic agents|mesh-ancestor
102629507|NCT00060528|Metronidazole|metronidazole|mesh-list
102629508|NCT00060528|Molgramostim|molgramostim|mesh-list
102629509|NCT00060528|Sargramostim|sargramostim|mesh-list
102629510|NCT00060528|Immunologic Factors|immunologic factors|mesh-ancestor
102629511|NCT00060528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629512|NCT00060528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102629513|NCT00060528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102629514|NCT00060528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102629515|NCT00060528|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102629516|NCT00060528|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102629517|NCT04696224|Tranexamic Acid|tranexamic acid|mesh-list
102629518|NCT04696224|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102629519|NCT04696224|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102629520|NCT04696224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629521|NCT04696224|Hemostatics|hemostatics|mesh-ancestor
102629522|NCT04696224|Coagulants|coagulants|mesh-ancestor
102629524|NCT04753008|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102629525|NCT04753008|Sympathomimetics|sympathomimetics|mesh-ancestor
102629526|NCT04753008|Autonomic Agents|autonomic agents|mesh-ancestor
102629527|NCT04753008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102629528|NCT04753008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629529|NCT04753008|Dopamine Agents|dopamine agents|mesh-ancestor
102629530|NCT04753008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102629531|NCT04753008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629532|NCT04753008|Protective Agents|protective agents|mesh-ancestor
102629533|NCT04771026|Dexamethasone|dexamethasone|mesh-list
102629534|NCT04771026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102629535|NCT04771026|Antiemetics|antiemetics|mesh-ancestor
102629536|NCT04771026|Autonomic Agents|autonomic agents|mesh-ancestor
102629537|NCT04771026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102629538|NCT04771026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629539|NCT04771026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102629540|NCT04771026|Glucocorticoids|glucocorticoids|mesh-ancestor
102629541|NCT04771026|Hormones|hormones|mesh-ancestor
102629542|NCT04771026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102629543|NCT04771026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102629544|NCT04771026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102629545|NCT00063570|Gemcitabine|gemcitabine|mesh-list
102629546|NCT00063570|Pemetrexed|pemetrexed|mesh-list
102629547|NCT00063570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102629548|NCT00063570|Antimetabolites|antimetabolites|mesh-ancestor
102629549|NCT00063570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629550|NCT00063570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102629551|NCT00063570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102629552|NCT00063570|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102629553|NCT00063570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102629554|NCT01897038|Sorafenib|sorafenib|mesh-list
102629555|NCT01897038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102629556|NCT01897038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102629557|NCT01897038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102629558|NCT01897038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629559|NCT04770792|Chlorhexidine|chlorhexidine|mesh-list
102629560|NCT04770792|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102629561|NCT04770792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102629562|NCT04770792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102629563|NCT04770792|Disinfectants|disinfectants|mesh-ancestor
102629564|NCT04770792|Dermatologic Agents|dermatologic agents|mesh-ancestor
102629565|NCT00064038|Dexamethasone|dexamethasone|mesh-list
102629566|NCT00064038|Lenalidomide|lenalidomide|mesh-list
102629567|NCT00064038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102629568|NCT00064038|Antiemetics|antiemetics|mesh-ancestor
102629569|NCT00064038|Autonomic Agents|autonomic agents|mesh-ancestor
102629570|NCT00064038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102629571|NCT00064038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275102|NCT00005847|Tubulin Modulators|tubulin modulators|mesh-ancestor
102629572|NCT00064038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102629573|NCT00064038|Glucocorticoids|glucocorticoids|mesh-ancestor
102629574|NCT00064038|Hormones|hormones|mesh-ancestor
102629575|NCT00064038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102629576|NCT00064038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102629577|NCT00064038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102629578|NCT00064038|Immunologic Factors|immunologic factors|mesh-ancestor
102629579|NCT00064038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102629580|NCT00064038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102629581|NCT00064038|Growth Substances|growth substances|mesh-ancestor
102629582|NCT00064038|Growth Inhibitors|growth inhibitors|mesh-ancestor
102629583|NCT01960530|Dexamethasone|dexamethasone|mesh-list
102629584|NCT01960530|Hydrocortisone|hydrocortisone|mesh-list
102629585|NCT01960530|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102629586|NCT01960530|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102629587|NCT01960530|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102629588|NCT01960530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102629589|NCT01960530|Antiemetics|antiemetics|mesh-ancestor
102629590|NCT01960530|Autonomic Agents|autonomic agents|mesh-ancestor
102629591|NCT01960530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102629592|NCT01960530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629593|NCT01960530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102629594|NCT01960530|Glucocorticoids|glucocorticoids|mesh-ancestor
102629595|NCT01960530|Hormones|hormones|mesh-ancestor
102629596|NCT01960530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102629597|NCT01960530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102629598|NCT01960530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102629599|NCT01897428|Bepotastine besilate|bepotastine besilate|mesh-list
102629600|NCT01897428|Salicylates|salicylates|mesh-list
102629601|NCT01897428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102629602|NCT01897428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102629603|NCT01897428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102629604|NCT01897428|Analgesics|analgesics|mesh-ancestor
102629605|NCT01897428|Sensory System Agents|sensory system agents|mesh-ancestor
102629606|NCT01897428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102629607|NCT01897428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629608|NCT01897428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102629609|NCT01897428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102629610|NCT01897428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102629611|NCT01897428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102629612|NCT01897428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629613|NCT00024102|Doxorubicin|doxorubicin|mesh-list
102629614|NCT00024102|Capecitabine|capecitabine|mesh-list
102629615|NCT00024102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102629616|NCT00024102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102629617|NCT00024102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102629618|NCT00024102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101601968|NCT04255251|Fluorides|fluorides|mesh-list
102629619|NCT00024102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102629620|NCT00024102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629621|NCT00024102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102629622|NCT00024102|Antimetabolites|antimetabolites|mesh-ancestor
102629623|NCT00074802|Paroxetine|paroxetine|mesh-list
102629624|NCT00074802|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102629625|NCT00074802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102629626|NCT00074802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102629627|NCT00074802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629628|NCT00074802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102629629|NCT00074802|Serotonin Agents|serotonin agents|mesh-ancestor
102629630|NCT00074802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629631|NCT00074802|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102629632|NCT00074802|Antidepressive Agents|antidepressive agents|mesh-ancestor
102629633|NCT00074802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102629634|NCT00074802|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102629635|NCT00074802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102629636|NCT00074802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102629637|NCT02505750|Capecitabine|capecitabine|mesh-list
102629638|NCT02505750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102629639|NCT02505750|Antimetabolites|antimetabolites|mesh-ancestor
102629640|NCT02505750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629641|NCT02505750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102629642|NCT00030264|Methotrexate|methotrexate|mesh-list
102629643|NCT00030264|Vinblastine|vinblastine|mesh-list
102629644|NCT00030264|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102629645|NCT00030264|Abortifacient Agents|abortifacient agents|mesh-ancestor
102629646|NCT00030264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102275103|NCT00005847|Antimitotic Agents|antimitotic agents|mesh-ancestor
102629647|NCT00030264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629648|NCT00030264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102629649|NCT00030264|Antimetabolites|antimetabolites|mesh-ancestor
102629650|NCT00030264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629651|NCT00030264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102629652|NCT00030264|Dermatologic Agents|dermatologic agents|mesh-ancestor
102629653|NCT00030264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102629654|NCT00030264|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102629655|NCT00030264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102629656|NCT00030264|Immunologic Factors|immunologic factors|mesh-ancestor
102629657|NCT00030264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102629658|NCT00030264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102629659|NCT00030264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102629660|NCT00030264|Tubulin Modulators|tubulin modulators|mesh-ancestor
102629661|NCT00030264|Antimitotic Agents|antimitotic agents|mesh-ancestor
102629662|NCT00030264|Mitosis Modulators|mitosis modulators|mesh-ancestor
102629663|NCT01897116|Hydroxychloroquine|hydroxychloroquine|mesh-list
102629664|NCT01897116|Vemurafenib|vemurafenib|mesh-list
102629665|NCT01897116|Antimalarials|antimalarials|mesh-ancestor
102629666|NCT01897116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102629667|NCT01897116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102629668|NCT01897116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102629669|NCT01897116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102629670|NCT01897116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629671|NCT01897116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102629672|NCT01897116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102629673|NCT01897116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102629674|NCT00036738|Cyclosporine|cyclosporine|mesh-list
102629675|NCT00036738|Mycophenolic Acid|mycophenolic acid|mesh-list
102629676|NCT00036738|Fludarabine|fludarabine|mesh-list
102629677|NCT00036738|Fludarabine phosphate|fludarabine phosphate|mesh-list
102629678|NCT00036738|Imatinib Mesylate|imatinib mesylate|mesh-list
102629679|NCT00036738|Dasatinib|dasatinib|mesh-list
102629680|NCT00036738|Cyclosporins|cyclosporins|mesh-list
102629681|NCT00036738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102629682|NCT00036738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102629683|NCT00036738|Antimetabolites|antimetabolites|mesh-ancestor
102629684|NCT00036738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629685|NCT00036738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102629686|NCT00036738|Immunologic Factors|immunologic factors|mesh-ancestor
102629687|NCT00036738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629688|NCT00036738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102629689|NCT00036738|Antifungal Agents|antifungal agents|mesh-ancestor
102629690|NCT00036738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102629691|NCT00036738|Dermatologic Agents|dermatologic agents|mesh-ancestor
102629692|NCT00036738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102629693|NCT00036738|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102629694|NCT00036738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102629695|NCT00036738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102629696|NCT00036738|Antitubercular Agents|antitubercular agents|mesh-ancestor
102629697|NCT00036738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102629698|NCT00036738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102629699|NCT00038610|Cytarabine|cytarabine|mesh-list
102629700|NCT00038610|Dexamethasone|dexamethasone|mesh-list
102629701|NCT00038610|Cyclophosphamide|cyclophosphamide|mesh-list
102629702|NCT00038610|Doxorubicin|doxorubicin|mesh-list
102629703|NCT00038610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102629704|NCT00038610|Methotrexate|methotrexate|mesh-list
102629705|NCT00038610|Vincristine|vincristine|mesh-list
102629706|NCT00038610|Imatinib Mesylate|imatinib mesylate|mesh-list
102629707|NCT00038610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102629708|NCT00038610|Immunologic Factors|immunologic factors|mesh-ancestor
102629709|NCT00038610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629710|NCT00038610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102629711|NCT00038610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102629712|NCT00038610|Alkylating Agents|alkylating agents|mesh-ancestor
102629713|NCT00038610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629714|NCT00038610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102629715|NCT00038610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102629716|NCT00038610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102629717|NCT00038610|Antiemetics|antiemetics|mesh-ancestor
102629718|NCT00038610|Autonomic Agents|autonomic agents|mesh-ancestor
102629719|NCT00038610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102629720|NCT00038610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102629721|NCT00038610|Glucocorticoids|glucocorticoids|mesh-ancestor
102629722|NCT00038610|Hormones|hormones|mesh-ancestor
102629723|NCT00038610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102629724|NCT00038610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102629725|NCT00038610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102629726|NCT00038610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102629727|NCT00038610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102629728|NCT00038610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102629729|NCT00038610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102629730|NCT00038610|Abortifacient Agents|abortifacient agents|mesh-ancestor
102629731|NCT00038610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102629732|NCT00038610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102629734|NCT00038610|Dermatologic Agents|dermatologic agents|mesh-ancestor
102629735|NCT00038610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102629736|NCT00038610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102629737|NCT00038610|Antiviral Agents|antiviral agents|mesh-ancestor
102629738|NCT00038610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102629739|NCT00038610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102629740|NCT00038610|Tubulin Modulators|tubulin modulators|mesh-ancestor
102629741|NCT00038610|Antimitotic Agents|antimitotic agents|mesh-ancestor
102629742|NCT00038610|Mitosis Modulators|mitosis modulators|mesh-ancestor
102629743|NCT00038610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102629744|NCT00156936|Naltrexone|naltrexone|mesh-list
102629745|NCT00156936|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102629746|NCT00156936|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102629747|NCT00156936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629748|NCT00156936|Sensory System Agents|sensory system agents|mesh-ancestor
102629749|NCT00156936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102629750|NCT00046566|Caseins|caseins|mesh-list
102629751|NCT00046566|Chelating Agents|chelating agents|mesh-ancestor
102629752|NCT00046566|Sequestering Agents|sequestering agents|mesh-ancestor
102629753|NCT00046566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629754|NCT00079326|Trastuzumab|trastuzumab|mesh-list
102629755|NCT00079326|Epothilone B|epothilone b|mesh-list
102629756|NCT00079326|Epothilones|epothilones|mesh-list
102629757|NCT00079326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102629758|NCT00079326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102629759|NCT00079326|Tubulin Modulators|tubulin modulators|mesh-ancestor
102629760|NCT00079326|Antimitotic Agents|antimitotic agents|mesh-ancestor
102629761|NCT00079326|Mitosis Modulators|mitosis modulators|mesh-ancestor
102629762|NCT00079326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629763|NCT02187354|Blinatumomab|blinatumomab|mesh-list
102629764|NCT02187354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102629765|NCT01898052|Anesthetics|anesthetics|mesh-list
102629766|NCT01898052|Levobupivacaine|levobupivacaine|mesh-list
102629767|NCT01898052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102629768|NCT01898052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629769|NCT01898052|Anesthetics, Local|anesthetics, local|mesh-ancestor
102629770|NCT01898052|Sensory System Agents|sensory system agents|mesh-ancestor
102629771|NCT01898052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102629772|NCT00051168|Travoprost|travoprost|mesh-list
102629773|NCT00051168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102629774|NCT00083382|Pamidronate|pamidronate|mesh-list
102629775|NCT00083382|Thalidomide|thalidomide|mesh-list
102629776|NCT00083382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102629777|NCT00083382|Immunologic Factors|immunologic factors|mesh-ancestor
102629778|NCT00083382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629779|NCT00083382|Leprostatic Agents|leprostatic agents|mesh-ancestor
102629780|NCT00083382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102629781|NCT00083382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102629782|NCT00083382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102629783|NCT00083382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102629784|NCT00083382|Growth Substances|growth substances|mesh-ancestor
102629785|NCT00083382|Growth Inhibitors|growth inhibitors|mesh-ancestor
102629786|NCT00083382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102629787|NCT00083382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102629788|NCT00167544|Hydrocortisone|hydrocortisone|mesh-list
102629789|NCT00167544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102629790|NCT00167934|Valproic Acid|valproic acid|mesh-list
102629791|NCT00167934|Anticonvulsants|anticonvulsants|mesh-ancestor
102629792|NCT00167934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102629793|NCT00167934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629794|NCT00167934|GABA Agents|gaba agents|mesh-ancestor
102629795|NCT00167934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102629796|NCT00167934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629797|NCT00167934|Antimanic Agents|antimanic agents|mesh-ancestor
102629798|NCT00167934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102275104|NCT00005847|Mitosis Modulators|mitosis modulators|mesh-ancestor
101918302|NCT03724890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102629799|NCT00167934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102629800|NCT00167934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102629801|NCT00168324|Dexamethasone|dexamethasone|mesh-list
102629802|NCT00168324|Dexamethasone acetate|dexamethasone acetate|mesh-list
102629803|NCT00168324|BB 1101|bb 1101|mesh-list
102629804|NCT00168324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102629805|NCT00168324|Antiemetics|antiemetics|mesh-ancestor
102629806|NCT00168324|Autonomic Agents|autonomic agents|mesh-ancestor
102629807|NCT00168324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102629808|NCT00168324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629809|NCT00168324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102629810|NCT00168324|Glucocorticoids|glucocorticoids|mesh-ancestor
102629811|NCT00168324|Hormones|hormones|mesh-ancestor
102629812|NCT00168324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102629813|NCT00168324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102629814|NCT00168324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102629815|NCT00168324|Protease Inhibitors|protease inhibitors|mesh-ancestor
102629816|NCT00168324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102629817|NCT00168324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629818|NCT02091882|Aripiprazole|aripiprazole|mesh-list
102629819|NCT02091882|Antidepressive Agents|antidepressive agents|mesh-ancestor
102629820|NCT02091882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102629821|NCT02091882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102629822|NCT02091882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102629823|NCT02091882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102629824|NCT02091882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629825|NCT02091882|Dopamine Agonists|dopamine agonists|mesh-ancestor
102629826|NCT02091882|Dopamine Agents|dopamine agents|mesh-ancestor
102629827|NCT02091882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102629828|NCT02091882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629829|NCT02091882|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102629830|NCT02091882|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102629831|NCT02091882|Serotonin Agents|serotonin agents|mesh-ancestor
102629832|NCT02091882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102629833|NCT02091882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102629834|NCT02091882|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102629835|NCT02091882|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102629836|NCT00085254|Temozolomide|temozolomide|mesh-list
102629837|NCT00085254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102629838|NCT00085254|Alkylating Agents|alkylating agents|mesh-ancestor
102629839|NCT00085254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629840|NCT00085254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102629841|NCT00253890|Trazodone|trazodone|mesh-list
102629842|NCT00253890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102629843|NCT00253890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102629844|NCT00253890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102629845|NCT00253890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629846|NCT00253890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102629847|NCT00253890|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102629848|NCT00253890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102629849|NCT00253890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102629850|NCT00253890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629851|NCT00253890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102629852|NCT00253890|Serotonin Agents|serotonin agents|mesh-ancestor
102629853|NCT00253890|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102629854|NCT00253890|Antidepressive Agents|antidepressive agents|mesh-ancestor
102629855|NCT00254592|Paclitaxel|paclitaxel|mesh-list
102629856|NCT00254592|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102629857|NCT00254592|Cyclophosphamide|cyclophosphamide|mesh-list
102629858|NCT00254592|Bevacizumab|bevacizumab|mesh-list
102629859|NCT00254592|Carboplatin|carboplatin|mesh-list
102629860|NCT00254592|Doxorubicin|doxorubicin|mesh-list
102629861|NCT00254592|Trastuzumab|trastuzumab|mesh-list
102629862|NCT00254592|Sargramostim|sargramostim|mesh-list
102629863|NCT00254592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102629864|NCT00254592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102629865|NCT00254592|Tubulin Modulators|tubulin modulators|mesh-ancestor
102629866|NCT00254592|Antimitotic Agents|antimitotic agents|mesh-ancestor
102629867|NCT00254592|Mitosis Modulators|mitosis modulators|mesh-ancestor
102629868|NCT00254592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629869|NCT00254592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102629870|NCT00254592|Immunologic Factors|immunologic factors|mesh-ancestor
102629871|NCT00254592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629872|NCT00254592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102629873|NCT00254592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102629874|NCT00254592|Alkylating Agents|alkylating agents|mesh-ancestor
102629875|NCT00254592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102629876|NCT00254592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102629877|NCT00254592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102629878|NCT00254592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102629879|NCT00254592|Growth Substances|growth substances|mesh-ancestor
102629880|NCT00254592|Growth Inhibitors|growth inhibitors|mesh-ancestor
102629881|NCT00254592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102629882|NCT00254592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102629883|NCT00254592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102629884|NCT00254592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102629885|NCT00255684|Cyclosporine|cyclosporine|mesh-list
102629886|NCT00255684|Mycophenolic Acid|mycophenolic acid|mesh-list
102629887|NCT00255684|Cyclophosphamide|cyclophosphamide|mesh-list
102629888|NCT00255684|Fludarabine|fludarabine|mesh-list
102629889|NCT00255684|Fludarabine phosphate|fludarabine phosphate|mesh-list
102629890|NCT00255684|Cyclosporins|cyclosporins|mesh-list
102629891|NCT00255684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102629892|NCT00255684|Immunologic Factors|immunologic factors|mesh-ancestor
102629893|NCT00255684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629894|NCT00255684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102629895|NCT00255684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102629896|NCT00255684|Alkylating Agents|alkylating agents|mesh-ancestor
102629897|NCT00255684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629898|NCT00255684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102629899|NCT00255684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102629900|NCT00255684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102629901|NCT00255684|Antimetabolites|antimetabolites|mesh-ancestor
102629902|NCT00255684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102629903|NCT00255684|Antifungal Agents|antifungal agents|mesh-ancestor
102629904|NCT00255684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102629905|NCT00255684|Dermatologic Agents|dermatologic agents|mesh-ancestor
102629906|NCT00255684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102629907|NCT00255684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102629908|NCT00255684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102629909|NCT00255684|Antitubercular Agents|antitubercular agents|mesh-ancestor
102629910|NCT00255684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102629911|NCT00256776|Thalidomide|thalidomide|mesh-list
102629912|NCT00256776|Dexamethasone|dexamethasone|mesh-list
102629913|NCT00256776|Bortezomib|bortezomib|mesh-list
102629914|NCT00256776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102629915|NCT00256776|Antiemetics|antiemetics|mesh-ancestor
102629916|NCT00256776|Autonomic Agents|autonomic agents|mesh-ancestor
102629917|NCT00256776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102629918|NCT00256776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629919|NCT00256776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102629920|NCT00256776|Glucocorticoids|glucocorticoids|mesh-ancestor
102629921|NCT00256776|Hormones|hormones|mesh-ancestor
102629922|NCT00256776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102629923|NCT00256776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102629924|NCT00256776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102629925|NCT00256776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102629926|NCT00256776|Immunologic Factors|immunologic factors|mesh-ancestor
102629927|NCT00256776|Leprostatic Agents|leprostatic agents|mesh-ancestor
102629928|NCT00256776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102629929|NCT00256776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102629930|NCT00256776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102629931|NCT00256776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102629932|NCT00256776|Growth Substances|growth substances|mesh-ancestor
102629933|NCT00256776|Growth Inhibitors|growth inhibitors|mesh-ancestor
102629934|NCT00258180|Cyclophosphamide|cyclophosphamide|mesh-list
102629935|NCT00258180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102629936|NCT00258180|Immunologic Factors|immunologic factors|mesh-ancestor
102629937|NCT00258180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629938|NCT00258180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102629939|NCT00258180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102629940|NCT00258180|Alkylating Agents|alkylating agents|mesh-ancestor
102629941|NCT00258180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629942|NCT00258180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102629943|NCT00258180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102629944|NCT00176202|Valproic Acid|valproic acid|mesh-list
102629945|NCT00176202|Anticonvulsants|anticonvulsants|mesh-list
102629946|NCT00176202|Risperidone|risperidone|mesh-list
101918375|NCT01238718|Sensory System Agents|sensory system agents|mesh-ancestor
101918451|NCT03790800|Urapidil|urapidil|mesh-list
102629947|NCT00176202|Antipsychotic Agents|antipsychotic agents|mesh-list
102629948|NCT00176202|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102629949|NCT00176202|Serotonin Agents|serotonin agents|mesh-ancestor
102629950|NCT00176202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102629951|NCT00176202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629952|NCT00176202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629953|NCT00176202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101602300|NCT04209166|Serotonin|serotonin|mesh-list
102629954|NCT00176202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102629955|NCT00176202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102629956|NCT00176202|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102629957|NCT00176202|Dopamine Agents|dopamine agents|mesh-ancestor
102629958|NCT00176202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102629959|NCT00176202|GABA Agents|gaba agents|mesh-ancestor
102629960|NCT00176202|Antimanic Agents|antimanic agents|mesh-ancestor
102629961|NCT00176592|Glatiramer Acetate|glatiramer acetate|mesh-list
102629962|NCT00176592|Interferon beta-1b|interferon beta-1b|mesh-list
102629963|NCT00176592|(T,G)-A-L|(t,g)-a-l|mesh-list
102629964|NCT00176592|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102629965|NCT00176592|Immunologic Factors|immunologic factors|mesh-ancestor
102629966|NCT00176592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629967|NCT00176592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102629968|NCT00176592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102629969|NCT00176826|Busulfan|busulfan|mesh-list
102629970|NCT00176826|Alkylating Agents|alkylating agents|mesh-ancestor
102629971|NCT00176826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629972|NCT00176826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102629973|NCT00176826|Immunologic Factors|immunologic factors|mesh-ancestor
102629974|NCT00176826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629975|NCT00176826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102629976|NCT00176826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102629977|NCT00176826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102629978|NCT00176904|Cyclophosphamide|cyclophosphamide|mesh-list
102629979|NCT00176904|Busulfan|busulfan|mesh-list
102629980|NCT00176904|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102629981|NCT00176904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102629982|NCT00176904|Immunologic Factors|immunologic factors|mesh-ancestor
102629983|NCT00176904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629984|NCT00176904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102629985|NCT00176904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102629986|NCT00176904|Alkylating Agents|alkylating agents|mesh-ancestor
102629987|NCT00176904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102629988|NCT00176904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102629989|NCT00176904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102629990|NCT00179478|Interferons|interferons|mesh-list
102629991|NCT00179478|Interferon-beta|interferon-beta|mesh-list
102629992|NCT00179478|Interferon beta-1a|interferon beta-1a|mesh-list
102629993|NCT00179478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102629994|NCT00179478|Antiviral Agents|antiviral agents|mesh-ancestor
102629995|NCT00179478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102629996|NCT00179478|Immunologic Factors|immunologic factors|mesh-ancestor
102629997|NCT00179478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102629998|NCT00179478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102629999|NCT00182754|Octreotide|octreotide|mesh-list
102630000|NCT00182754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102630001|NCT00182754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102630002|NCT00182754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630003|NCT00085410|Bortezomib|bortezomib|mesh-list
102630004|NCT00085410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630005|NCT00186498|Memantine|memantine|mesh-list
102630006|NCT00186498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102630007|NCT00186498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102630008|NCT00186498|Dopamine Agents|dopamine agents|mesh-ancestor
102630009|NCT00186498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102630010|NCT00186498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630011|NCT00186498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602399|NCT04213222|Bevacizumab|bevacizumab|mesh-list
102630012|NCT00186498|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102630013|NCT00186498|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102630014|NCT00265200|Zoledronic Acid|zoledronic acid|mesh-list
102630015|NCT00265200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102630016|NCT00265200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630017|NCT00087672|Lenalidomide|lenalidomide|mesh-list
101918463|NCT03971201|Sorafenib|sorafenib|mesh-list
102630018|NCT00087672|Immunologic Factors|immunologic factors|mesh-ancestor
102630019|NCT00087672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630020|NCT00087672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102630021|NCT00087672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102630022|NCT00087672|Growth Substances|growth substances|mesh-ancestor
101918526|NCT03970577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630023|NCT00087672|Growth Inhibitors|growth inhibitors|mesh-ancestor
102630024|NCT00087672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630025|NCT00088218|Cytarabine|cytarabine|mesh-list
102630026|NCT00088218|Clofarabine|clofarabine|mesh-list
102630027|NCT00088218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102630028|NCT00088218|Antimetabolites|antimetabolites|mesh-ancestor
102630029|NCT00088218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630030|NCT00088218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630031|NCT00088218|Antiviral Agents|antiviral agents|mesh-ancestor
102630032|NCT00088218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102630033|NCT00088218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102630034|NCT00088218|Immunologic Factors|immunologic factors|mesh-ancestor
102630035|NCT00088218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630036|NCT00189228|Omalizumab|omalizumab|mesh-list
102630037|NCT00189228|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102630038|NCT00189228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102630039|NCT00189228|Respiratory System Agents|respiratory system agents|mesh-ancestor
102630040|NCT00091260|Dexamethasone|dexamethasone|mesh-list
102630041|NCT00091260|Dexamethasone acetate|dexamethasone acetate|mesh-list
102630042|NCT00091260|Lenalidomide|lenalidomide|mesh-list
102630043|NCT00091260|BB 1101|bb 1101|mesh-list
102630044|NCT00091260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102630045|NCT00091260|Antiemetics|antiemetics|mesh-ancestor
102630046|NCT00091260|Autonomic Agents|autonomic agents|mesh-ancestor
102630047|NCT00091260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102630048|NCT00091260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630049|NCT00091260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102630050|NCT00091260|Glucocorticoids|glucocorticoids|mesh-ancestor
102630051|NCT00091260|Hormones|hormones|mesh-ancestor
102630052|NCT00091260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102630053|NCT00091260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102630054|NCT00091260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630055|NCT00091260|Protease Inhibitors|protease inhibitors|mesh-ancestor
102630056|NCT00091260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102630057|NCT00091260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630058|NCT00091260|Immunologic Factors|immunologic factors|mesh-ancestor
102630059|NCT00091260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102630060|NCT00091260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102630061|NCT00091260|Growth Substances|growth substances|mesh-ancestor
102630062|NCT00091260|Growth Inhibitors|growth inhibitors|mesh-ancestor
102630063|NCT00193128|Docetaxel|docetaxel|mesh-list
102630064|NCT00193128|Capecitabine|capecitabine|mesh-list
102630065|NCT00193128|Oxaliplatin|oxaliplatin|mesh-list
102630066|NCT00193128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630067|NCT00193128|Tubulin Modulators|tubulin modulators|mesh-ancestor
102630068|NCT00193128|Antimitotic Agents|antimitotic agents|mesh-ancestor
102630069|NCT00193128|Mitosis Modulators|mitosis modulators|mesh-ancestor
102630070|NCT00193128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630071|NCT00193128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102630072|NCT00193128|Antimetabolites|antimetabolites|mesh-ancestor
102630073|NCT00193596|Paclitaxel|paclitaxel|mesh-list
102630074|NCT00193596|Etoposide|etoposide|mesh-list
102630075|NCT00193596|Carboplatin|carboplatin|mesh-list
102630076|NCT00193596|Gemcitabine|gemcitabine|mesh-list
102630077|NCT00193596|Irinotecan|irinotecan|mesh-list
102630078|NCT00193596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102630079|NCT00193596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630080|NCT00193596|Tubulin Modulators|tubulin modulators|mesh-ancestor
102630081|NCT00193596|Antimitotic Agents|antimitotic agents|mesh-ancestor
102630082|NCT00193596|Mitosis Modulators|mitosis modulators|mesh-ancestor
102630083|NCT00193596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630084|NCT00193596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102630085|NCT00193596|Antimetabolites|antimetabolites|mesh-ancestor
102630086|NCT00193596|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102630087|NCT00193596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102630088|NCT00193596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102630089|NCT00193596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102630090|NCT00194532|Ciprofloxacin|ciprofloxacin|mesh-list
102630091|NCT00194532|Cefpodoxime|cefpodoxime|mesh-list
102630092|NCT00194532|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
102630093|NCT00194532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102630094|NCT00194532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102630095|NCT00194532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102630096|NCT00194532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102630097|NCT00194532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102638138|NCT00716742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102630098|NCT00194532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630099|NCT00194532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630100|NCT00194532|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102630101|NCT00194532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102630102|NCT00194610|Botulinum Toxins|botulinum toxins|mesh-list
102630103|NCT00194610|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102630104|NCT00194610|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102630105|NCT00194610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102630106|NCT00194610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630107|NCT00194610|Cholinergic Agents|cholinergic agents|mesh-ancestor
102630108|NCT00194610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102630109|NCT00194610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630110|NCT00194610|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102630111|NCT00194610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102630113|NCT00093756|Carboplatin|carboplatin|mesh-list
102630114|NCT00093756|Bortezomib|bortezomib|mesh-list
102630115|NCT00093756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102630116|NCT00093756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630117|NCT00093756|Tubulin Modulators|tubulin modulators|mesh-ancestor
102630118|NCT00093756|Antimitotic Agents|antimitotic agents|mesh-ancestor
102630119|NCT00093756|Mitosis Modulators|mitosis modulators|mesh-ancestor
102630120|NCT00093756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630121|NCT04118556|Sirolimus|sirolimus|mesh-list
102630122|NCT04118556|Infliximab|infliximab|mesh-list
102630123|NCT04118556|Etanercept|etanercept|mesh-list
102630124|NCT04118556|Everolimus|everolimus|mesh-list
102630125|NCT04118556|Vedolizumab|vedolizumab|mesh-list
102630126|NCT04118556|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102630127|NCT04118556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102630128|NCT04118556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102630129|NCT04118556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630130|NCT04118556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102630131|NCT04118556|Immunologic Factors|immunologic factors|mesh-ancestor
102630132|NCT04118556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630133|NCT04118556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630134|NCT04118556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102630135|NCT04118556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102630136|NCT04118556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102630137|NCT04118556|Antifungal Agents|antifungal agents|mesh-ancestor
102630138|NCT04118556|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102630139|NCT04118556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102630140|NCT04118556|Dermatologic Agents|dermatologic agents|mesh-ancestor
102630141|NCT04118556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102630142|NCT04118556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102630143|NCT04118556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102630144|NCT04118556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102630145|NCT04118556|Analgesics|analgesics|mesh-ancestor
102630146|NCT04118556|Sensory System Agents|sensory system agents|mesh-ancestor
102630147|NCT04118556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102630148|NCT00267696|Bevacizumab|bevacizumab|mesh-list
102630149|NCT00267696|Carboplatin|carboplatin|mesh-list
102630150|NCT00267696|Gemcitabine|gemcitabine|mesh-list
102630151|NCT00267696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102630152|NCT00267696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101602498|NCT02879513|Immunologic Factors|immunologic factors|mesh-ancestor
102630153|NCT00267696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102630154|NCT00267696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102630155|NCT00267696|Growth Substances|growth substances|mesh-ancestor
102630156|NCT00267696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630157|NCT00267696|Growth Inhibitors|growth inhibitors|mesh-ancestor
102630158|NCT00267696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102630159|NCT00267696|Antimetabolites|antimetabolites|mesh-ancestor
102630160|NCT00267696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630161|NCT00195624|Cyclosporine|cyclosporine|mesh-list
102630162|NCT00195624|Alemtuzumab|alemtuzumab|mesh-list
102630163|NCT00195624|Cyclosporins|cyclosporins|mesh-list
102630164|NCT00195624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102630165|NCT00195624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630166|NCT00195624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102630167|NCT00195624|Immunologic Factors|immunologic factors|mesh-ancestor
102630168|NCT00195624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630169|NCT00195624|Antifungal Agents|antifungal agents|mesh-ancestor
102630170|NCT00195624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102630171|NCT00195624|Dermatologic Agents|dermatologic agents|mesh-ancestor
101918615|NCT00203021|(T,G)-A-L|(t,g)-a-l|mesh-list
101918698|NCT05418166|Evolocumab|evolocumab|mesh-list
102630172|NCT00195624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102630173|NCT00195624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102630174|NCT00195624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102630175|NCT00195624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630176|NCT00195702|Adalimumab|adalimumab|mesh-list
102630177|NCT00195702|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102630178|NCT00195702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102630179|NCT00195702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102630180|NCT00197184|Vaccines|vaccines|mesh-list
102630181|NCT00197184|Immunologic Factors|immunologic factors|mesh-ancestor
102630182|NCT00197184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630183|NCT00098670|Rituximab|rituximab|mesh-list
102630184|NCT00098670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102630185|NCT00098670|Alemtuzumab|alemtuzumab|mesh-list
102630186|NCT00098670|Fludarabine|fludarabine|mesh-list
102630187|NCT00098670|Fludarabine phosphate|fludarabine phosphate|mesh-list
102630188|NCT00098670|Antibodies|antibodies|mesh-list
102630189|NCT00098670|Immunoglobulins|immunoglobulins|mesh-list
102630190|NCT00098670|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102630191|NCT00098670|Immunologic Factors|immunologic factors|mesh-ancestor
102630192|NCT00098670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630193|NCT00098670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630194|NCT00098670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102630195|NCT00098670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102630196|NCT00098670|Antimetabolites|antimetabolites|mesh-ancestor
102630197|NCT00098670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630198|NCT00098670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102630199|NCT00201864|Fulvestrant|fulvestrant|mesh-list
102630200|NCT00201864|Exemestane|exemestane|mesh-list
102630201|NCT00201864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102630202|NCT00201864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630203|NCT00201864|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102630204|NCT00201864|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102630205|NCT00201864|Hormone Antagonists|hormone antagonists|mesh-ancestor
102630206|NCT00201864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102630207|NCT00201864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630208|NCT00201864|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102630209|NCT00201864|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102630210|NCT00201864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102630211|NCT00201864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630212|NCT00202722|Remifentanil|remifentanil|mesh-list
102630213|NCT00202722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102630214|NCT00202722|Narcotics|narcotics|mesh-ancestor
102630215|NCT00202722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102630216|NCT00202722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630217|NCT00202722|Analgesics|analgesics|mesh-ancestor
102630218|NCT00202722|Sensory System Agents|sensory system agents|mesh-ancestor
102630219|NCT00202722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102630220|NCT00100698|Hormones|hormones|mesh-list
102630221|NCT00100698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102630222|NCT00100698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630223|NCT00103116|Vaccines|vaccines|mesh-list
102630224|NCT00103116|Immunologic Factors|immunologic factors|mesh-ancestor
102630225|NCT00103116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630226|NCT00205374|Cidofovir|cidofovir|mesh-list
102630227|NCT00205374|Antiviral Agents|antiviral agents|mesh-ancestor
102630228|NCT00205374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102630229|NCT00205374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102630230|NCT00205374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630231|NCT00103194|Lapatinib|lapatinib|mesh-list
102630232|NCT00103194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630233|NCT00103194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102630234|NCT00103194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102630235|NCT00103194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630236|NCT00208026|Pimecrolimus|pimecrolimus|mesh-list
102630237|NCT00208026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102630238|NCT00208026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102630239|NCT00208026|Analgesics|analgesics|mesh-ancestor
102630240|NCT00208026|Sensory System Agents|sensory system agents|mesh-ancestor
102630241|NCT00208026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102630242|NCT00208026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630243|NCT00208026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102630244|NCT00208026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102630245|NCT00208026|Dermatologic Agents|dermatologic agents|mesh-ancestor
102630246|NCT00208026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102630247|NCT00208026|Immunologic Factors|immunologic factors|mesh-ancestor
102630248|NCT00208026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102630249|NCT00208026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102630250|NCT00208026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630251|NCT00106392|Tacrolimus|tacrolimus|mesh-list
102630252|NCT00106392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102630253|NCT00106392|Immunologic Factors|immunologic factors|mesh-ancestor
102630254|NCT00106392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630255|NCT00106392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102630256|NCT00106392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102630257|NCT00106392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630258|NCT00211692|Interferons|interferons|mesh-list
102630259|NCT00211692|Ribavirin|ribavirin|mesh-list
102630260|NCT00211692|Interferon-alpha|interferon-alpha|mesh-list
102630261|NCT00211692|Interferon alfacon-1|interferon alfacon-1|mesh-list
102630262|NCT00211692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630263|NCT00211692|Antiviral Agents|antiviral agents|mesh-ancestor
102630264|NCT00211692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102630265|NCT00211692|Antimetabolites|antimetabolites|mesh-ancestor
102630266|NCT00211692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630267|NCT00211692|Immunologic Factors|immunologic factors|mesh-ancestor
102630268|NCT00211692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630269|NCT01899690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102630270|NCT01899690|Clindamycin|clindamycin|mesh-list
102630271|NCT01899690|Cephalexin|cephalexin|mesh-list
102630272|NCT01899690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102630273|NCT01899690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102630274|NCT01899690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102630275|NCT01899690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630276|NCT01899846|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
102630277|NCT01899846|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
102630278|NCT01899846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102630279|NCT01899846|Hormone Antagonists|hormone antagonists|mesh-ancestor
102630280|NCT01899846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102630281|NCT01899846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630282|NCT01899846|Progestins|progestins|mesh-ancestor
102630283|NCT01899846|Hormones|hormones|mesh-ancestor
102630284|NCT00214890|Tenofovir|tenofovir|mesh-list
102630285|NCT00214890|Abacavir|abacavir|mesh-list
102630286|NCT00214890|Antiviral Agents|antiviral agents|mesh-ancestor
102630287|NCT00214890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102630288|NCT00214890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102630289|NCT00214890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102630290|NCT00214890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102630291|NCT00214890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630292|NCT00214890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102630293|NCT00214890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102630294|NCT00216060|Risedronic Acid|risedronic acid|mesh-list
102630295|NCT00216060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102630296|NCT00216060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102630297|NCT00216060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630298|NCT00216060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102630299|NCT00216060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630300|NCT00216060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102630301|NCT00282282|Sirolimus|sirolimus|mesh-list
102630302|NCT00282282|Fludarabine|fludarabine|mesh-list
102630303|NCT00282282|Busulfan|busulfan|mesh-list
102630304|NCT00282282|Tacrolimus|tacrolimus|mesh-list
102630305|NCT00282282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630306|NCT00282282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630307|NCT00282282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102630308|NCT00282282|Immunologic Factors|immunologic factors|mesh-ancestor
102630309|NCT00282282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630310|NCT00282282|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102630311|NCT00282282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102630312|NCT00282282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102630313|NCT00282282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102630314|NCT00282282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102630315|NCT00282282|Antifungal Agents|antifungal agents|mesh-ancestor
102630316|NCT00282282|Alkylating Agents|alkylating agents|mesh-ancestor
102630317|NCT00282282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102630318|NCT00282282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102630319|NCT00282828|Clonazepam|clonazepam|mesh-list
102275105|NCT00005847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275106|NCT00005847|Antiviral Agents|antiviral agents|mesh-ancestor
102275107|NCT00005847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102630320|NCT00282828|Sertraline|sertraline|mesh-list
102630321|NCT00282828|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102630322|NCT00282828|Antidepressive Agents|antidepressive agents|mesh-ancestor
102630323|NCT00282828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102630324|NCT00282828|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102630325|NCT00282828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102630326|NCT00282828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102630327|NCT00282828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630328|NCT00282828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102630329|NCT00282828|Serotonin Agents|serotonin agents|mesh-ancestor
102630330|NCT00282828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630331|NCT00282828|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102630332|NCT00282828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102630333|NCT00282828|Anticonvulsants|anticonvulsants|mesh-ancestor
102630334|NCT00282828|GABA Modulators|gaba modulators|mesh-ancestor
102630335|NCT00282828|GABA Agents|gaba agents|mesh-ancestor
102630336|NCT00112242|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
102630337|NCT00112242|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102630338|NCT00112242|Immunologic Factors|immunologic factors|mesh-ancestor
102630339|NCT00112242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630340|NCT00223236|Choline|choline|mesh-list
102630341|NCT00223236|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
102630342|NCT00223236|Lipotropic Agents|lipotropic agents|mesh-ancestor
102630343|NCT00223236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102630344|NCT00223236|Antimetabolites|antimetabolites|mesh-ancestor
102630345|NCT00223236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630346|NCT00223236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102630347|NCT00223236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102630348|NCT00223236|Nootropic Agents|nootropic agents|mesh-ancestor
102630349|NCT00223704|Icatibant|icatibant|mesh-list
102630350|NCT00223704|Aminocaproic Acid|aminocaproic acid|mesh-list
102630351|NCT00223704|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102630352|NCT00223704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102630353|NCT00223704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630354|NCT00223704|Hemostatics|hemostatics|mesh-ancestor
102630355|NCT00223704|Coagulants|coagulants|mesh-ancestor
102630356|NCT00223704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102630357|NCT00223704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102630358|NCT00223704|Analgesics|analgesics|mesh-ancestor
102630359|NCT00223704|Sensory System Agents|sensory system agents|mesh-ancestor
102630360|NCT00223704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102630361|NCT00223704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630362|NCT00223704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102630363|NCT00223704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102630364|NCT00223704|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
102630365|NCT00223704|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
102630366|NCT00223704|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102630367|NCT00223704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102630368|NCT00223704|Immunologic Factors|immunologic factors|mesh-ancestor
102630369|NCT00224952|Carbamazepine|carbamazepine|mesh-list
102630370|NCT00224952|Valproic Acid|valproic acid|mesh-list
102630371|NCT00224952|Anticonvulsants|anticonvulsants|mesh-ancestor
102630372|NCT00224952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102630373|NCT00224952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630374|NCT00224952|GABA Agents|gaba agents|mesh-ancestor
102630375|NCT00224952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102630376|NCT00224952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630377|NCT00224952|Antimanic Agents|antimanic agents|mesh-ancestor
102630378|NCT00224952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102630379|NCT00224952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102630380|NCT00224952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102630381|NCT00224952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102630382|NCT00224952|Analgesics|analgesics|mesh-ancestor
102630383|NCT00224952|Sensory System Agents|sensory system agents|mesh-ancestor
102630384|NCT00224952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102630385|NCT00224952|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102630386|NCT00224952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102630387|NCT00224952|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102630388|NCT00224952|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102630389|NCT00225420|Docetaxel|docetaxel|mesh-list
102630390|NCT00225420|Leuprolide|leuprolide|mesh-list
102630391|NCT00225420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630392|NCT00225420|Tubulin Modulators|tubulin modulators|mesh-ancestor
102275108|NCT00005847|Immunologic Factors|immunologic factors|mesh-ancestor
102630393|NCT00225420|Antimitotic Agents|antimitotic agents|mesh-ancestor
102630394|NCT00225420|Mitosis Modulators|mitosis modulators|mesh-ancestor
102630395|NCT00225420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630396|NCT00225420|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102630397|NCT00225420|Fertility Agents|fertility agents|mesh-ancestor
102630398|NCT00225420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102630399|NCT00225420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630400|NCT00225420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102630401|NCT00225498|Olanzapine|olanzapine|mesh-list
102630402|NCT00225498|Risperidone|risperidone|mesh-list
102630403|NCT00225498|Ziprasidone|ziprasidone|mesh-list
102630404|NCT00225498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102630405|NCT00225498|Serotonin Agents|serotonin agents|mesh-ancestor
102630406|NCT00225498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101602766|NCT01190930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102630407|NCT00225498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630408|NCT00225498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630409|NCT00225498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102630410|NCT00225498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102630411|NCT00225498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102630412|NCT00225498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102630413|NCT00225498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102630414|NCT00225498|Dopamine Agents|dopamine agents|mesh-ancestor
102630415|NCT00225498|Antiemetics|antiemetics|mesh-ancestor
102630416|NCT00225498|Autonomic Agents|autonomic agents|mesh-ancestor
102630417|NCT00225498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102630418|NCT00225498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102630419|NCT00225498|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102630420|NCT00225498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102630421|NCT00225498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102630422|NCT00225732|Ibuprofen|ibuprofen|mesh-list
102630423|NCT00225732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102630424|NCT00225732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102630425|NCT00225732|Analgesics|analgesics|mesh-ancestor
102630426|NCT00225732|Sensory System Agents|sensory system agents|mesh-ancestor
102630427|NCT00225732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102630428|NCT00225732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630429|NCT00225732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102630430|NCT00225732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102630431|NCT00225732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102630432|NCT00225732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102630433|NCT00225732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630434|NCT02096718|Afatinib|afatinib|mesh-list
102630435|NCT02096718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630436|NCT02096718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102630437|NCT02096718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102630438|NCT02096718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630439|NCT02097732|Ipilimumab|ipilimumab|mesh-list
102630440|NCT02097732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102630441|NCT02097732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630442|NCT02097732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102630443|NCT02097732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630444|NCT00286182|Epoetin Alfa|epoetin alfa|mesh-list
102630445|NCT00286182|Hematinics|hematinics|mesh-ancestor
102630446|NCT00226590|Paclitaxel|paclitaxel|mesh-list
102630447|NCT00226590|Carboplatin|carboplatin|mesh-list
102630448|NCT00226590|Gemcitabine|gemcitabine|mesh-list
102630449|NCT00226590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102630450|NCT00226590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630451|NCT00226590|Tubulin Modulators|tubulin modulators|mesh-ancestor
102630452|NCT00226590|Antimitotic Agents|antimitotic agents|mesh-ancestor
102630453|NCT00226590|Mitosis Modulators|mitosis modulators|mesh-ancestor
102630454|NCT00226590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630455|NCT00226590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102630456|NCT00226590|Antimetabolites|antimetabolites|mesh-ancestor
102630457|NCT00114114|Goserelin|goserelin|mesh-list
102630458|NCT00114114|Testosterone|testosterone|mesh-list
102630459|NCT00114114|Androgens|androgens|mesh-ancestor
102630460|NCT00114114|Hormones|hormones|mesh-ancestor
102630461|NCT00114114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102630462|NCT00114114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630463|NCT00114114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102630464|NCT00114114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102275109|NCT00005847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630465|NCT00227760|Cediranib|cediranib|mesh-list
102275110|NCT00005847|Analgesics|analgesics|mesh-ancestor
102630466|NCT00227760|Maleic acid|maleic acid|mesh-list
102630467|NCT00227760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102630468|NCT00227760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630469|NCT00227760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630470|NCT00227760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102630471|NCT00227994|Donepezil|donepezil|mesh-list
102630472|NCT00227994|Galantamine|galantamine|mesh-list
102630473|NCT00227994|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102630474|NCT00227994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102630475|NCT00227994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630476|NCT00227994|Cholinergic Agents|cholinergic agents|mesh-ancestor
102630477|NCT00227994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102630478|NCT00227994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630479|NCT00227994|Nootropic Agents|nootropic agents|mesh-ancestor
102630480|NCT00227994|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102630481|NCT00227994|Autonomic Agents|autonomic agents|mesh-ancestor
102630482|NCT00227994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102630483|NCT00114504|Simvastatin|simvastatin|mesh-list
102630484|NCT00114504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102630485|NCT00114504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102630486|NCT00114504|Antimetabolites|antimetabolites|mesh-ancestor
102630487|NCT00114504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630488|NCT00114504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102630489|NCT00114504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102630490|NCT00114504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102630491|NCT01898676|Valproic Acid|valproic acid|mesh-list
102630492|NCT01898676|Anticonvulsants|anticonvulsants|mesh-ancestor
102630493|NCT01898676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102630494|NCT01898676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630495|NCT01898676|GABA Agents|gaba agents|mesh-ancestor
102630496|NCT01898676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102630497|NCT01898676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630498|NCT01898676|Antimanic Agents|antimanic agents|mesh-ancestor
102630499|NCT01898676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102630500|NCT01898676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102630501|NCT01898676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102630502|NCT00288366|Aripiprazole|aripiprazole|mesh-list
102630503|NCT00288366|Ziprasidone|ziprasidone|mesh-list
102630504|NCT00288366|Antidepressive Agents|antidepressive agents|mesh-ancestor
102630505|NCT00288366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102630506|NCT00288366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102630507|NCT00288366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102630508|NCT00288366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102630509|NCT00288366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630510|NCT00288366|Dopamine Agonists|dopamine agonists|mesh-ancestor
102630511|NCT00288366|Dopamine Agents|dopamine agents|mesh-ancestor
102630512|NCT00288366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102630513|NCT00288366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630514|NCT00288366|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102630515|NCT00288366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102630516|NCT00288366|Serotonin Agents|serotonin agents|mesh-ancestor
102630517|NCT00288366|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102630518|NCT00288366|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102630519|NCT00288366|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102630520|NCT00288366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102630521|NCT00288600|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102630522|NCT00288600|Immunoglobulins|immunoglobulins|mesh-list
102630523|NCT00288600|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102630524|NCT00288600|Antibodies|antibodies|mesh-list
102630525|NCT00288600|gamma-Globulins|gamma-globulins|mesh-list
102630526|NCT00288600|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102630527|NCT00288600|Immunologic Factors|immunologic factors|mesh-ancestor
102630528|NCT00288600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630529|NCT00290472|Sirolimus|sirolimus|mesh-list
102630530|NCT00290472|Temsirolimus|temsirolimus|mesh-list
102630531|NCT00290472|MTOR Inhibitors|mtor inhibitors|mesh-list
102630532|NCT00290472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102630533|NCT00290472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102630534|NCT00290472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630535|NCT00290472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102630536|NCT00290472|Immunologic Factors|immunologic factors|mesh-ancestor
102630537|NCT00290472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630538|NCT00290472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102275111|NCT00005847|Sensory System Agents|sensory system agents|mesh-ancestor
101918972|NCT01244880|Anesthetics, General|anesthetics, general|mesh-ancestor
102275112|NCT00005847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102630539|NCT00290472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102630540|NCT00290472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102630541|NCT00290472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102630542|NCT00290472|Antifungal Agents|antifungal agents|mesh-ancestor
102630543|NCT04752852|Dexamethasone|dexamethasone|mesh-list
102630544|NCT04752852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102630545|NCT04752852|Antiemetics|antiemetics|mesh-ancestor
102630546|NCT04752852|Autonomic Agents|autonomic agents|mesh-ancestor
102630547|NCT04752852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102630548|NCT04752852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630549|NCT04752852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102630550|NCT04752852|Glucocorticoids|glucocorticoids|mesh-ancestor
102630551|NCT04752852|Hormones|hormones|mesh-ancestor
102630552|NCT04752852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102630553|NCT04752852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102630554|NCT04752852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630555|NCT01899144|Albuterol|albuterol|mesh-list
102630556|NCT01899144|Procaterol|procaterol|mesh-list
102630557|NCT01899144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102630558|NCT01899144|Autonomic Agents|autonomic agents|mesh-ancestor
102630559|NCT01899144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102630560|NCT01899144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630561|NCT01899144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102630562|NCT01899144|Respiratory System Agents|respiratory system agents|mesh-ancestor
102630563|NCT01899144|Tocolytic Agents|tocolytic agents|mesh-ancestor
102630564|NCT01899144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102630565|NCT01899144|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102630566|NCT01899144|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102630567|NCT01899144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102630568|NCT01899144|Adrenergic Agents|adrenergic agents|mesh-ancestor
102630569|NCT01899144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102630570|NCT01899144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630571|NCT01899144|Sympathomimetics|sympathomimetics|mesh-ancestor
102630572|NCT00234078|Rebamipide|rebamipide|mesh-list
102630573|NCT00234078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102630574|NCT00234078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102630575|NCT00234078|Antioxidants|antioxidants|mesh-ancestor
102630576|NCT00234078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630577|NCT00234078|Protective Agents|protective agents|mesh-ancestor
102630578|NCT00234078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630579|NCT00234078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102630580|NCT00118404|Fluoxetine|fluoxetine|mesh-list
102630581|NCT00118404|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102630582|NCT00118404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101602954|NCT02697058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630583|NCT00118404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102630584|NCT00118404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630585|NCT00118404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102630586|NCT00118404|Serotonin Agents|serotonin agents|mesh-ancestor
102630587|NCT00118404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630588|NCT00118404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102630589|NCT00118404|Antidepressive Agents|antidepressive agents|mesh-ancestor
102630590|NCT00118404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102630591|NCT00118404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102630592|NCT00118404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102630593|NCT00118404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102630594|NCT00121836|Bevacizumab|bevacizumab|mesh-list
102630595|NCT00121836|Capecitabine|capecitabine|mesh-list
102630596|NCT00121836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102630597|NCT00121836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630598|NCT00121836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102630599|NCT00121836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102630600|NCT00121836|Growth Substances|growth substances|mesh-ancestor
102630601|NCT00121836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630602|NCT00121836|Growth Inhibitors|growth inhibitors|mesh-ancestor
102630603|NCT00121836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102630604|NCT00121836|Antimetabolites|antimetabolites|mesh-ancestor
102630605|NCT00121836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630606|NCT00237666|Ziprasidone|ziprasidone|mesh-list
102630607|NCT00237666|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102630608|NCT00237666|Serotonin Agents|serotonin agents|mesh-ancestor
102630609|NCT00237666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102275113|NCT00005847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102275114|NCT00005847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102630610|NCT00237666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630611|NCT00237666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630612|NCT00237666|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102630613|NCT00237666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102630614|NCT00237666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102630615|NCT00237666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102630616|NCT00237666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102630617|NCT00237666|Dopamine Agents|dopamine agents|mesh-ancestor
102630618|NCT00296322|Mitomycins|mitomycins|mesh-list
102630619|NCT00296322|Mitomycin|mitomycin|mesh-list
102630620|NCT00296322|Doxifluridine|doxifluridine|mesh-list
102630621|NCT00296322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630622|NCT00296322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102630623|NCT00296322|Alkylating Agents|alkylating agents|mesh-ancestor
102630624|NCT00296322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630625|NCT00296322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102630626|NCT00296322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102630627|NCT00296322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102630628|NCT00296322|Antimetabolites|antimetabolites|mesh-ancestor
102630629|NCT00296322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102630630|NCT00296322|Immunologic Factors|immunologic factors|mesh-ancestor
102630631|NCT00296322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630632|NCT00296322|Appetite Stimulants|appetite stimulants|mesh-ancestor
102630633|NCT00296322|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102630634|NCT00123162|Sildenafil Citrate|sildenafil citrate|mesh-list
102630635|NCT00123162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630636|NCT00123162|Vasodilator Agents|vasodilator agents|mesh-ancestor
102630637|NCT00123162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102630638|NCT00123162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102630639|NCT00123162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102630640|NCT00123162|Urological Agents|urological agents|mesh-ancestor
102630641|NCT00123630|Omalizumab|omalizumab|mesh-list
102630642|NCT00123630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102630643|NCT00123630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102630644|NCT00123630|Respiratory System Agents|respiratory system agents|mesh-ancestor
102630645|NCT00124176|Albuterol|albuterol|mesh-list
102630646|NCT00124176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102630647|NCT00124176|Autonomic Agents|autonomic agents|mesh-ancestor
102630648|NCT00124176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102630649|NCT00124176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630650|NCT00124176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102630651|NCT00124176|Respiratory System Agents|respiratory system agents|mesh-ancestor
102630652|NCT00124176|Tocolytic Agents|tocolytic agents|mesh-ancestor
102630653|NCT00124176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102630654|NCT00124176|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102630655|NCT00124176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102630656|NCT00124176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102630657|NCT00124176|Adrenergic Agents|adrenergic agents|mesh-ancestor
102630658|NCT00124176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102630659|NCT00124176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630660|NCT00240162|Vatalanib|vatalanib|mesh-list
102630661|NCT00240162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102630662|NCT00240162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102630663|NCT00240162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630664|NCT00299988|Immunoglobulins|immunoglobulins|mesh-list
102630665|NCT00299988|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102630666|NCT00299988|Antibodies|antibodies|mesh-list
102630667|NCT00299988|gamma-Globulins|gamma-globulins|mesh-list
102630668|NCT00299988|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102630669|NCT00299988|Immunologic Factors|immunologic factors|mesh-ancestor
102630670|NCT00299988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630671|NCT04226352|Dextromethorphan|dextromethorphan|mesh-list
102630672|NCT04226352|Antitussive Agents|antitussive agents|mesh-ancestor
102630673|NCT04226352|Respiratory System Agents|respiratory system agents|mesh-ancestor
102630674|NCT04226352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102630675|NCT04226352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102630676|NCT04226352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102630677|NCT04226352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630678|NCT04226352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630679|NCT00300456|Simvastatin|simvastatin|mesh-list
102630680|NCT00300456|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102630681|NCT00300456|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102630682|NCT00300456|Antimetabolites|antimetabolites|mesh-ancestor
102275116|NCT00005847|Dermatologic Agents|dermatologic agents|mesh-ancestor
102630683|NCT00300456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630684|NCT00300456|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102630685|NCT00300456|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102630686|NCT00300456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102630687|NCT00125034|Oxaliplatin|oxaliplatin|mesh-list
102630688|NCT00125034|Cetuximab|cetuximab|mesh-list
102630689|NCT00125034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630690|NCT00125034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102630691|NCT02100930|Molgramostim|molgramostim|mesh-list
102630692|NCT02100930|Isotretinoin|isotretinoin|mesh-list
102630693|NCT02100930|Antibodies|antibodies|mesh-list
102630694|NCT02100930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102630695|NCT02100930|Sargramostim|sargramostim|mesh-list
102630696|NCT02100930|Immunologic Factors|immunologic factors|mesh-ancestor
102630697|NCT02100930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630698|NCT02100930|Dermatologic Agents|dermatologic agents|mesh-ancestor
102630699|NCT02100930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630700|NCT02101008|Disulfiram|disulfiram|mesh-list
102630701|NCT02101008|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102630702|NCT02101008|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
102630703|NCT02101008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102630704|NCT02101008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630705|NCT00241176|Aripiprazole|aripiprazole|mesh-list
102630706|NCT00241176|Antidepressive Agents|antidepressive agents|mesh-ancestor
102630707|NCT00241176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102630708|NCT00241176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102630709|NCT00241176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102630710|NCT00241176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102630711|NCT00241176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630712|NCT00241176|Dopamine Agonists|dopamine agonists|mesh-ancestor
102630713|NCT00241176|Dopamine Agents|dopamine agents|mesh-ancestor
102630714|NCT00241176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102630715|NCT00241176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630716|NCT00241176|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102630717|NCT00241176|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102630718|NCT00241176|Serotonin Agents|serotonin agents|mesh-ancestor
102630719|NCT00241176|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102630720|NCT00241176|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102630721|NCT00241176|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102630722|NCT00241176|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102630723|NCT02102100|Menthol|menthol|mesh-list
102630724|NCT02102100|Nicotine|nicotine|mesh-list
102630725|NCT02102100|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102630726|NCT02102100|Autonomic Agents|autonomic agents|mesh-ancestor
102630727|NCT02102100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102630728|NCT02102100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630729|NCT02102100|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102630730|NCT02102100|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102630731|NCT02102100|Cholinergic Agents|cholinergic agents|mesh-ancestor
102630732|NCT02102100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102630733|NCT02102100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630734|NCT02102100|Antipruritics|antipruritics|mesh-ancestor
102630735|NCT02102100|Dermatologic Agents|dermatologic agents|mesh-ancestor
102630736|NCT02094534|Insulin|insulin|mesh-list
102630737|NCT02094534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102630738|NCT02094534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630739|NCT00242502|Bevacizumab|bevacizumab|mesh-list
102630740|NCT00242502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102630741|NCT00242502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102630742|NCT00242502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630743|NCT00242502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102630744|NCT00242502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102630745|NCT00242502|Growth Substances|growth substances|mesh-ancestor
102630746|NCT00242502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630747|NCT00242502|Growth Inhibitors|growth inhibitors|mesh-ancestor
102630748|NCT00242502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102630749|NCT00242502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102630750|NCT00242502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630751|NCT04389060|Grape Seed Extract|grape seed extract|mesh-list
102630752|NCT04389060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102630753|NCT04389060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630754|NCT04389060|Antioxidants|antioxidants|mesh-ancestor
102630755|NCT04389060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919193|NCT01148316|Antidepressive Agents|antidepressive agents|mesh-ancestor
102630756|NCT04389060|Protective Agents|protective agents|mesh-ancestor
102630757|NCT04389060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630758|NCT01899066|Carboplatin|carboplatin|mesh-list
102630759|NCT01899066|Etoposide|etoposide|mesh-list
102630760|NCT01899066|Vincristine|vincristine|mesh-list
102630761|NCT01899066|Ranibizumab|ranibizumab|mesh-list
102630762|NCT01899066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630763|NCT01899066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102630764|NCT01899066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102630765|NCT01899066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102630766|NCT01899066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102630767|NCT01899066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630768|NCT01899066|Tubulin Modulators|tubulin modulators|mesh-ancestor
102630769|NCT01899066|Antimitotic Agents|antimitotic agents|mesh-ancestor
102630770|NCT01899066|Mitosis Modulators|mitosis modulators|mesh-ancestor
102630771|NCT01899066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102630772|NCT01899066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102630773|NCT01899066|Growth Substances|growth substances|mesh-ancestor
102630774|NCT01899066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630775|NCT01899066|Growth Inhibitors|growth inhibitors|mesh-ancestor
102630776|NCT00127218|Niacin|niacin|mesh-list
102630777|NCT00127218|Atorvastatin|atorvastatin|mesh-list
102630778|NCT00127218|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102630779|NCT00127218|Simvastatin|simvastatin|mesh-list
102630780|NCT00127218|Pravastatin|pravastatin|mesh-list
102630781|NCT00127218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102630782|NCT00127218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102630783|NCT00127218|Antimetabolites|antimetabolites|mesh-ancestor
102630784|NCT00127218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630785|NCT00127218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102630786|NCT00127218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102630787|NCT00127218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102630788|NCT00127218|Vasodilator Agents|vasodilator agents|mesh-ancestor
102630789|NCT00127218|Vitamin B Complex|vitamin b complex|mesh-ancestor
102630790|NCT00127218|Vitamins|vitamins|mesh-ancestor
102630791|NCT00127218|Micronutrients|micronutrients|mesh-ancestor
102630792|NCT00127218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630793|NCT00127530|4-Aminopyridine|4-aminopyridine|mesh-list
102630794|NCT00127530|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102630795|NCT00127530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102630796|NCT00127530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630797|NCT00250926|Dexamethasone|dexamethasone|mesh-list
102630798|NCT00250926|Dexamethasone acetate|dexamethasone acetate|mesh-list
102630799|NCT00250926|Rituximab|rituximab|mesh-list
102630800|NCT00250926|Bortezomib|bortezomib|mesh-list
102630801|NCT00250926|BB 1101|bb 1101|mesh-list
102630802|NCT00250926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102630803|NCT00250926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630804|NCT00250926|Immunologic Factors|immunologic factors|mesh-ancestor
102630805|NCT00250926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630806|NCT00250926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102630807|NCT00250926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102630808|NCT00250926|Antiemetics|antiemetics|mesh-ancestor
102630809|NCT00250926|Autonomic Agents|autonomic agents|mesh-ancestor
102630810|NCT00250926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102630811|NCT00250926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102630812|NCT00250926|Glucocorticoids|glucocorticoids|mesh-ancestor
102630813|NCT00250926|Hormones|hormones|mesh-ancestor
102630814|NCT00250926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102630815|NCT00250926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102630816|NCT00250926|Protease Inhibitors|protease inhibitors|mesh-ancestor
102630817|NCT00250926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102630818|NCT00250926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630819|NCT00303966|Sorafenib|sorafenib|mesh-list
102630820|NCT00303966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630821|NCT00303966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102630822|NCT00303966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102630823|NCT00303966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630824|NCT00304746|Testosterone|testosterone|mesh-list
102630825|NCT00304746|Androgens|androgens|mesh-ancestor
102630826|NCT00304746|Hormones|hormones|mesh-ancestor
102630827|NCT00304746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101919267|NCT01252056|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102630828|NCT00304746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630829|NCT00134004|Mycophenolic Acid|mycophenolic acid|mesh-list
102630830|NCT00134004|Cyclophosphamide|cyclophosphamide|mesh-list
102630831|NCT00134004|Fludarabine|fludarabine|mesh-list
102630832|NCT00134004|Fludarabine phosphate|fludarabine phosphate|mesh-list
102630833|NCT00134004|Tacrolimus|tacrolimus|mesh-list
102630834|NCT00134004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102630835|NCT00134004|Immunologic Factors|immunologic factors|mesh-ancestor
102630836|NCT00134004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630837|NCT00134004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102630838|NCT00134004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102630839|NCT00134004|Alkylating Agents|alkylating agents|mesh-ancestor
102630840|NCT00134004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630841|NCT00134004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630842|NCT00134004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102630843|NCT00134004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102630844|NCT00134004|Antimetabolites|antimetabolites|mesh-ancestor
102630845|NCT00134004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102630846|NCT00134004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102630847|NCT00134004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102630848|NCT00134004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102630849|NCT00134004|Antitubercular Agents|antitubercular agents|mesh-ancestor
102630850|NCT00134004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102630851|NCT00134004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101603223|NCT01004406|Atorvastatin|atorvastatin|mesh-list
102630852|NCT00135798|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102630853|NCT00135798|Antiviral Agents|antiviral agents|mesh-ancestor
102630854|NCT00135798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102630855|NCT02103114|Antithrombin III|antithrombin iii|mesh-list
102630856|NCT02103114|Antithrombins|antithrombins|mesh-list
102630857|NCT02103114|Thrombin|thrombin|mesh-list
102630858|NCT02103114|Hemostatics|hemostatics|mesh-ancestor
102630859|NCT02103114|Coagulants|coagulants|mesh-ancestor
102630860|NCT02103114|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102630861|NCT02103114|Protease Inhibitors|protease inhibitors|mesh-ancestor
102630862|NCT02103114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102630863|NCT02103114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630864|NCT02103114|Anticoagulants|anticoagulants|mesh-ancestor
102630865|NCT01790022|Methylprednisolone|methylprednisolone|mesh-list
102630866|NCT01790022|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102630867|NCT01790022|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102630868|NCT01790022|Prednisolone|prednisolone|mesh-list
102630869|NCT01790022|Prednisolone acetate|prednisolone acetate|mesh-list
102630870|NCT01790022|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102630871|NCT01790022|Prednisolone phosphate|prednisolone phosphate|mesh-list
102630872|NCT01790022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102630873|NCT01790022|Antiemetics|antiemetics|mesh-ancestor
102630874|NCT01790022|Autonomic Agents|autonomic agents|mesh-ancestor
102630875|NCT01790022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102630876|NCT01790022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630877|NCT01790022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102630878|NCT01790022|Glucocorticoids|glucocorticoids|mesh-ancestor
102630879|NCT01790022|Hormones|hormones|mesh-ancestor
102630880|NCT01790022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102630881|NCT01790022|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102630882|NCT01790022|Protective Agents|protective agents|mesh-ancestor
102630883|NCT01790022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102630884|NCT01790022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630885|NCT00140556|Bevacizumab|bevacizumab|mesh-list
102630886|NCT00140556|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102630887|NCT00140556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102630888|NCT00140556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630889|NCT00140556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102630890|NCT00140556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102630891|NCT00140556|Growth Substances|growth substances|mesh-ancestor
102630892|NCT00140556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630893|NCT00140556|Growth Inhibitors|growth inhibitors|mesh-ancestor
102630894|NCT00140556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102630895|NCT00140556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102630896|NCT00140556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630897|NCT00142116|Thalidomide|thalidomide|mesh-list
102630898|NCT00142116|Rituximab|rituximab|mesh-list
102630899|NCT00142116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102630900|NCT00142116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630901|NCT00142116|Immunologic Factors|immunologic factors|mesh-ancestor
102630902|NCT00142116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630903|NCT00142116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102275117|NCT00005847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102630904|NCT00142116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102630905|NCT00142116|Leprostatic Agents|leprostatic agents|mesh-ancestor
102630906|NCT00142116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102275118|NCT00005847|Alkylating Agents|alkylating agents|mesh-ancestor
102275119|NCT00005847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102630907|NCT00142116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102630908|NCT00142116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102630909|NCT00142116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102630910|NCT00142116|Growth Substances|growth substances|mesh-ancestor
102630911|NCT00142116|Growth Inhibitors|growth inhibitors|mesh-ancestor
102630912|NCT05201430|Capecitabine|capecitabine|mesh-list
102630913|NCT05201430|Oxaliplatin|oxaliplatin|mesh-list
102630914|NCT05201430|Irinotecan|irinotecan|mesh-list
101603294|NCT04521946|Tacrolimus|tacrolimus|mesh-list
102630915|NCT05201430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102630916|NCT05201430|Antimetabolites|antimetabolites|mesh-ancestor
102630917|NCT05201430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630918|NCT05201430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630919|NCT05201430|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102630920|NCT05201430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102630921|NCT05201430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102630922|NCT00142506|Sildenafil Citrate|sildenafil citrate|mesh-list
102630923|NCT00142506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630924|NCT00142506|Vasodilator Agents|vasodilator agents|mesh-ancestor
102630925|NCT00142506|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102630926|NCT00142506|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102630927|NCT00142506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102630928|NCT00142506|Urological Agents|urological agents|mesh-ancestor
102630929|NCT05266794|Selenium|selenium|mesh-list
102630930|NCT05266794|Thioctic Acid|thioctic acid|mesh-list
102630931|NCT05266794|Antioxidants|antioxidants|mesh-ancestor
102630932|NCT05266794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630933|NCT05266794|Protective Agents|protective agents|mesh-ancestor
102630934|NCT05266794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630935|NCT05266794|Trace Elements|trace elements|mesh-ancestor
102630936|NCT05266794|Micronutrients|micronutrients|mesh-ancestor
102630937|NCT05266794|Vitamin B Complex|vitamin b complex|mesh-ancestor
102630938|NCT05266794|Vitamins|vitamins|mesh-ancestor
102630939|NCT00142818|Naltrexone|naltrexone|mesh-list
102630940|NCT00142818|Modafinil|modafinil|mesh-list
102630941|NCT00142818|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102630942|NCT00142818|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102630943|NCT00142818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630944|NCT00142818|Sensory System Agents|sensory system agents|mesh-ancestor
102630945|NCT00142818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102630946|NCT00142818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102630947|NCT00142818|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102630948|NCT00142818|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102630949|NCT00142818|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102630950|NCT00142818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630951|NCT05266716|Methamphetamine|methamphetamine|mesh-list
102630952|NCT05266716|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102630953|NCT05266716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630954|NCT05266716|Sympathomimetics|sympathomimetics|mesh-ancestor
102630955|NCT05266716|Autonomic Agents|autonomic agents|mesh-ancestor
102630956|NCT05266716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102630957|NCT05266716|Dopamine Agents|dopamine agents|mesh-ancestor
102630958|NCT05266716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102630959|NCT05266716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630960|NCT05266716|Adrenergic Agents|adrenergic agents|mesh-ancestor
102630961|NCT05266716|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102630962|NCT05266716|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102630963|NCT05266716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102630964|NCT05266716|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102630965|NCT05266560|Propofol|propofol|mesh-list
102630966|NCT05266560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102630967|NCT05266560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102630968|NCT05266560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630969|NCT05266560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102630970|NCT05266560|Anesthetics, General|anesthetics, general|mesh-ancestor
102630971|NCT05266560|Anesthetics|anesthetics|mesh-ancestor
102630972|NCT00147966|Rituximab|rituximab|mesh-list
102630973|NCT00147966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101603359|NCT04314674|Mannitol|mannitol|mesh-list
102630974|NCT00147966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630975|NCT00147966|Immunologic Factors|immunologic factors|mesh-ancestor
102630976|NCT00147966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630977|NCT00147966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102630978|NCT04528212|Glimepiride|glimepiride|mesh-list
102630979|NCT04528212|Curcumin|curcumin|mesh-list
102630980|NCT04528212|Fenofibrate|fenofibrate|mesh-list
102630981|NCT04528212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102630982|NCT04528212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102630983|NCT04528212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102630984|NCT04528212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102630985|NCT04528212|Immunologic Factors|immunologic factors|mesh-ancestor
102630986|NCT04528212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102630987|NCT04528212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102630988|NCT04528212|Analgesics|analgesics|mesh-ancestor
102630989|NCT04528212|Sensory System Agents|sensory system agents|mesh-ancestor
102630990|NCT04528212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102630991|NCT04528212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102630992|NCT04528212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102630993|NCT04528212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102630994|NCT04528212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102630995|NCT04528212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102630996|NCT04528212|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102630997|NCT04528212|Antimetabolites|antimetabolites|mesh-ancestor
102630998|NCT04528212|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102630999|NCT00148668|Carboplatin|carboplatin|mesh-list
102631000|NCT00148668|Docetaxel|docetaxel|mesh-list
102631001|NCT00148668|Trastuzumab|trastuzumab|mesh-list
102631002|NCT00148668|Vinorelbine|vinorelbine|mesh-list
102631003|NCT00148668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631004|NCT00148668|Tubulin Modulators|tubulin modulators|mesh-ancestor
102631005|NCT00148668|Antimitotic Agents|antimitotic agents|mesh-ancestor
102631006|NCT00148668|Mitosis Modulators|mitosis modulators|mesh-ancestor
102631007|NCT00148668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631008|NCT00148668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102631009|NCT00148668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102631010|NCT00149838|Antidepressive Agents|antidepressive agents|mesh-list
102631011|NCT00149838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102631012|NCT00324870|Bevacizumab|bevacizumab|mesh-list
102631013|NCT00324870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102631014|NCT00324870|Vorinostat|vorinostat|mesh-list
102631015|NCT00324870|Antibodies|antibodies|mesh-list
102631016|NCT00324870|Immunoglobulins|immunoglobulins|mesh-list
102631017|NCT00324870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102631018|NCT00324870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631019|NCT00324870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102631020|NCT00324870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102631021|NCT00324870|Growth Substances|growth substances|mesh-ancestor
102631022|NCT00324870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631023|NCT00324870|Growth Inhibitors|growth inhibitors|mesh-ancestor
102631024|NCT00324870|Immunologic Factors|immunologic factors|mesh-ancestor
102631025|NCT00324870|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102631026|NCT00324870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102631027|NCT00324870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631028|NCT00151320|Rituximab|rituximab|mesh-list
102631029|NCT00151320|Bortezomib|bortezomib|mesh-list
102631030|NCT00151320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102631031|NCT00151320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631032|NCT00151320|Immunologic Factors|immunologic factors|mesh-ancestor
102631033|NCT00151320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631034|NCT00151320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102631035|NCT00328614|Ascorbic Acid|ascorbic acid|mesh-list
102631036|NCT00328614|Goserelin|goserelin|mesh-list
102631037|NCT00328614|Methyltestosterone|methyltestosterone|mesh-list
102631038|NCT00328614|Bicalutamide|bicalutamide|mesh-list
102631039|NCT00328614|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
102631040|NCT00328614|Androgens|androgens|mesh-list
102631041|NCT00328614|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
102631042|NCT00328614|Ethylene|ethylene|mesh-list
102631043|NCT00328614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102631044|NCT00328614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631045|NCT00328614|Hormones|hormones|mesh-ancestor
102631046|NCT00328614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102631047|NCT00328614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631048|NCT00328614|Antioxidants|antioxidants|mesh-ancestor
101603422|NCT02689336|Temozolomide|temozolomide|mesh-list
102631049|NCT00328614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631050|NCT00328614|Protective Agents|protective agents|mesh-ancestor
102631051|NCT00328614|Vitamins|vitamins|mesh-ancestor
102631052|NCT00328614|Micronutrients|micronutrients|mesh-ancestor
102631053|NCT00328614|Estrogens|estrogens|mesh-ancestor
102275120|NCT00005644|Paclitaxel|paclitaxel|mesh-list
102631054|NCT00328614|Anabolic Agents|anabolic agents|mesh-ancestor
102631055|NCT00328614|Androgen Antagonists|androgen antagonists|mesh-ancestor
102631056|NCT00328614|Hormone Antagonists|hormone antagonists|mesh-ancestor
102631057|NCT00328614|Plant Growth Regulators|plant growth regulators|mesh-ancestor
102631058|NCT00328614|Growth Substances|growth substances|mesh-ancestor
102631059|NCT00328614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102631060|NCT00328614|Analgesics|analgesics|mesh-ancestor
102631061|NCT00328614|Sensory System Agents|sensory system agents|mesh-ancestor
102631062|NCT00328614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102631063|NCT00328770|Sirolimus|sirolimus|mesh-list
102631064|NCT00328770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102631065|NCT00328770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102631066|NCT00328770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102631067|NCT00328770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631068|NCT00328770|Antifungal Agents|antifungal agents|mesh-ancestor
102631069|NCT00328770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102631070|NCT00328770|Immunologic Factors|immunologic factors|mesh-ancestor
102631071|NCT00328770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631072|NCT04177680|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
102631073|NCT04177680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102631074|NCT04177680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102631075|NCT00330876|Pitavastatin|pitavastatin|mesh-list
102631076|NCT00330876|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102631077|NCT00330876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102631078|NCT00330876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102631079|NCT00330876|Antimetabolites|antimetabolites|mesh-ancestor
102631080|NCT00330876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631081|NCT00330876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102631082|NCT00330876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102631083|NCT00334074|Cytarabine|cytarabine|mesh-list
102631084|NCT00334074|Clofarabine|clofarabine|mesh-list
102631085|NCT00334074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102631086|NCT00334074|Antimetabolites|antimetabolites|mesh-ancestor
102631087|NCT00334074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631088|NCT00334074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631089|NCT00334074|Antiviral Agents|antiviral agents|mesh-ancestor
102631090|NCT00334074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102631091|NCT00334074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102631092|NCT00334074|Immunologic Factors|immunologic factors|mesh-ancestor
102631093|NCT00334074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631094|NCT00335478|Daptomycin|daptomycin|mesh-list
102631095|NCT00335478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102631096|NCT00335478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102631097|NCT04345926|Propofol|propofol|mesh-list
102631098|NCT04345926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102631099|NCT04345926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102631100|NCT04345926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631101|NCT04345926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102631102|NCT04345926|Anesthetics, General|anesthetics, general|mesh-ancestor
102631103|NCT04345926|Anesthetics|anesthetics|mesh-ancestor
102631104|NCT00337350|Rosiglitazone|rosiglitazone|mesh-list
102631105|NCT00337350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102631106|NCT00337350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631107|NCT00338598|Glycine|glycine|mesh-list
102631108|NCT00338598|Glycine Agents|glycine agents|mesh-ancestor
102631109|NCT00338598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102631110|NCT00338598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631111|NCT00338598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631112|NCT00338988|Capecitabine|capecitabine|mesh-list
102631113|NCT00338988|Oxaliplatin|oxaliplatin|mesh-list
102631114|NCT00338988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102631115|NCT00338988|Antimetabolites|antimetabolites|mesh-ancestor
102631116|NCT00338988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631117|NCT00338988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631118|NCT00343044|Bevacizumab|bevacizumab|mesh-list
102631119|NCT00343044|Topotecan|topotecan|mesh-list
102631120|NCT00343044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102631121|NCT00343044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631122|NCT00343044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102631123|NCT00343044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102631124|NCT00343044|Growth Substances|growth substances|mesh-ancestor
102631125|NCT00343044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631126|NCT00343044|Growth Inhibitors|growth inhibitors|mesh-ancestor
102631127|NCT00343044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102631128|NCT00343044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102631129|NCT00343044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102631130|NCT00343044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631131|NCT00344370|Atorvastatin|atorvastatin|mesh-list
102275121|NCT00005644|Gemcitabine|gemcitabine|mesh-list
102631132|NCT00344370|Pitavastatin|pitavastatin|mesh-list
102631133|NCT00344370|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102631134|NCT00344370|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102631135|NCT00344370|Antimetabolites|antimetabolites|mesh-ancestor
102631136|NCT00344370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631137|NCT00344370|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102631138|NCT00344370|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102631139|NCT00344370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102631140|NCT00344682|Memantine|memantine|mesh-list
102631141|NCT00344682|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102631142|NCT00344682|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102631143|NCT00344682|Dopamine Agents|dopamine agents|mesh-ancestor
102631144|NCT00344682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102631145|NCT00344682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631146|NCT00344682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631147|NCT00344682|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102631148|NCT00344682|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102631149|NCT00345384|Dexmedetomidine|dexmedetomidine|mesh-list
102631150|NCT00345384|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102631151|NCT00345384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102631152|NCT00345384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631153|NCT00345384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102631154|NCT00345384|Analgesics|analgesics|mesh-ancestor
102631155|NCT00345384|Sensory System Agents|sensory system agents|mesh-ancestor
102631156|NCT00345384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102631157|NCT00345384|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102631158|NCT00345384|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102631159|NCT00345384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102631160|NCT00345384|Adrenergic Agents|adrenergic agents|mesh-ancestor
102631161|NCT00345384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102631162|NCT00345384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631163|NCT01791114|Propranolol|propranolol|mesh-list
102631164|NCT01791114|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102631165|NCT01791114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102631166|NCT01791114|Adrenergic Agents|adrenergic agents|mesh-ancestor
102631167|NCT01791114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102631168|NCT01791114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631169|NCT01791114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631170|NCT01791114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102631171|NCT01791114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102631172|NCT01791114|Vasodilator Agents|vasodilator agents|mesh-ancestor
102631173|NCT01791192|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102631174|NCT01791192|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102631175|NCT01791192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631176|NCT01791192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102631177|NCT01791192|Immunologic Factors|immunologic factors|mesh-ancestor
102631178|NCT01791192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631179|NCT00350142|Gemcitabine|gemcitabine|mesh-list
102631180|NCT00350142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102631181|NCT00350142|Antimetabolites|antimetabolites|mesh-ancestor
102631182|NCT00350142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631183|NCT00350142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631184|NCT00350532|Clonidine|clonidine|mesh-list
102631185|NCT00350532|Analgesics|analgesics|mesh-ancestor
102631186|NCT00350532|Sensory System Agents|sensory system agents|mesh-ancestor
102631187|NCT00350532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102631188|NCT00350532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631189|NCT00350532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102631190|NCT00350532|Sympatholytics|sympatholytics|mesh-ancestor
102631191|NCT00350532|Autonomic Agents|autonomic agents|mesh-ancestor
102631192|NCT00350532|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102631193|NCT00350532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102631194|NCT00350532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102631195|NCT00350532|Adrenergic Agents|adrenergic agents|mesh-ancestor
102631196|NCT00350532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102631197|NCT00350532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631198|NCT00351000|Ziprasidone|ziprasidone|mesh-list
102631199|NCT00351000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102631200|NCT00351000|Serotonin Agents|serotonin agents|mesh-ancestor
102631201|NCT00351000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102631202|NCT00351000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631203|NCT00351000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919638|NCT04113538|Growth Substances|growth substances|mesh-ancestor
102275122|NCT00005644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102631204|NCT00351000|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102631205|NCT00351000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102631206|NCT00351000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102631207|NCT00351000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102631208|NCT00351000|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102631209|NCT00351000|Dopamine Agents|dopamine agents|mesh-ancestor
102631210|NCT00351936|Aripiprazole|aripiprazole|mesh-list
102631211|NCT00351936|Antidepressive Agents|antidepressive agents|mesh-ancestor
102631212|NCT00351936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102631213|NCT00351936|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102631214|NCT00351936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102631215|NCT00351936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102631216|NCT00351936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631217|NCT00351936|Dopamine Agonists|dopamine agonists|mesh-ancestor
102631218|NCT00351936|Dopamine Agents|dopamine agents|mesh-ancestor
102631219|NCT00351936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102631220|NCT00351936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631221|NCT00351936|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102631222|NCT00351936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102631223|NCT00351936|Serotonin Agents|serotonin agents|mesh-ancestor
102631224|NCT00351936|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102631225|NCT00351936|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102631226|NCT00351936|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102631227|NCT00351936|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102631229|NCT00352794|Lenalidomide|lenalidomide|mesh-list
102631230|NCT00352794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102631231|NCT00352794|Glucocorticoids|glucocorticoids|mesh-ancestor
102631232|NCT00352794|Hormones|hormones|mesh-ancestor
102631233|NCT00352794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102631234|NCT00352794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631235|NCT00352794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102631236|NCT00352794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631237|NCT00352794|Immunologic Factors|immunologic factors|mesh-ancestor
102631238|NCT00352794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102631239|NCT00352794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102631240|NCT00352794|Growth Substances|growth substances|mesh-ancestor
102631241|NCT00352794|Growth Inhibitors|growth inhibitors|mesh-ancestor
102631242|NCT00353418|Ribavirin|ribavirin|mesh-list
102631243|NCT00353418|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102631244|NCT00353418|Antimetabolites|antimetabolites|mesh-ancestor
102631245|NCT00353418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631246|NCT00353418|Antiviral Agents|antiviral agents|mesh-ancestor
101603632|NCT02682862|Olodaterol|olodaterol|mesh-list
102631247|NCT00353418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102631248|NCT00353652|Chlorthalidone|chlorthalidone|mesh-list
102631249|NCT00353652|Spironolactone|spironolactone|mesh-list
102631250|NCT00353652|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102631251|NCT00353652|Hormone Antagonists|hormone antagonists|mesh-ancestor
102631252|NCT00353652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102631253|NCT00353652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631254|NCT00353652|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102631255|NCT00353652|Diuretics|diuretics|mesh-ancestor
102631256|NCT00353652|Natriuretic Agents|natriuretic agents|mesh-ancestor
102631257|NCT00353652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102631258|NCT00353652|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102631259|NCT00353652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102631260|NCT00353652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631261|NCT02982798|Metformin|metformin|mesh-list
102631262|NCT02982798|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102631263|NCT02982798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102631264|NCT02982798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631265|NCT02982798|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102631266|NCT02982798|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102631267|NCT02982798|Antimetabolites|antimetabolites|mesh-ancestor
102631268|NCT02982798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631269|NCT02982798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102631270|NCT02982798|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102631271|NCT02982798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102631272|NCT03709914|Fosfomycin|fosfomycin|mesh-list
102631273|NCT03709914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102631274|NCT03709914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102631275|NCT01794078|Ambrisentan|ambrisentan|mesh-list
102631276|NCT01794078|Aminophylline|aminophylline|mesh-list
102631277|NCT01794078|Theophylline|theophylline|mesh-list
102631278|NCT01794078|Ethylene|ethylene|mesh-list
102631279|NCT01794078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102631280|NCT01794078|Autonomic Agents|autonomic agents|mesh-ancestor
102631281|NCT01794078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102631282|NCT01794078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631283|NCT01794078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102631284|NCT01794078|Respiratory System Agents|respiratory system agents|mesh-ancestor
102631285|NCT01794078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102631286|NCT01794078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102631287|NCT01794078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631288|NCT01794078|Vasodilator Agents|vasodilator agents|mesh-ancestor
102631289|NCT01794078|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102631290|NCT01794078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102631291|NCT01794078|Purinergic Agents|purinergic agents|mesh-ancestor
102631292|NCT01794078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102631293|NCT01794078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102631294|NCT01794078|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102631295|NCT01794078|Protective Agents|protective agents|mesh-ancestor
102631296|NCT01794078|Plant Growth Regulators|plant growth regulators|mesh-ancestor
102631297|NCT01794078|Growth Substances|growth substances|mesh-ancestor
102631298|NCT00354978|Leucovorin|leucovorin|mesh-list
102631299|NCT00354978|Bevacizumab|bevacizumab|mesh-list
102631300|NCT00354978|Fluorouracil|fluorouracil|mesh-list
102631301|NCT00354978|Irinotecan|irinotecan|mesh-list
102631302|NCT00354978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102631303|NCT00354978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631304|NCT00354978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102631305|NCT00354978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102631306|NCT00354978|Growth Substances|growth substances|mesh-ancestor
102631307|NCT00354978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631308|NCT00354978|Growth Inhibitors|growth inhibitors|mesh-ancestor
102631309|NCT00354978|Antimetabolites|antimetabolites|mesh-ancestor
102631310|NCT00354978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631311|NCT00354978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102631312|NCT00354978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102631313|NCT00354978|Immunologic Factors|immunologic factors|mesh-ancestor
102631314|NCT00354978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102631315|NCT00354978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102631316|NCT00354978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102631317|NCT00354978|Antidotes|antidotes|mesh-ancestor
102631318|NCT00354978|Protective Agents|protective agents|mesh-ancestor
102631319|NCT00354978|Vitamin B Complex|vitamin b complex|mesh-ancestor
102631320|NCT00354978|Vitamins|vitamins|mesh-ancestor
102631321|NCT00354978|Micronutrients|micronutrients|mesh-ancestor
102631322|NCT00357162|Belinostat|belinostat|mesh-list
102631323|NCT00357162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631324|NCT00357162|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102631325|NCT00357162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102631326|NCT00357162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631327|NCT03549000|Spartalizumab|spartalizumab|mesh-list
102631328|NCT03549000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102631329|NCT03549000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631330|NCT03549000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102631331|NCT03549000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631332|NCT03984240|Midazolam|midazolam|mesh-list
102631333|NCT03984240|Dexmedetomidine|dexmedetomidine|mesh-list
102631334|NCT03984240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102631335|NCT03984240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102631336|NCT03984240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631337|NCT03984240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102631338|NCT03984240|Analgesics|analgesics|mesh-ancestor
102631339|NCT03984240|Sensory System Agents|sensory system agents|mesh-ancestor
102631340|NCT03984240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102631341|NCT03984240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102631342|NCT03984240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102631343|NCT03984240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102631344|NCT03984240|Adrenergic Agents|adrenergic agents|mesh-ancestor
102631345|NCT03984240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102631346|NCT03984240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631347|NCT03984240|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102631348|NCT03984240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102631349|NCT03984240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102631350|NCT03984240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101919783|NCT01258296|Fentanyl|fentanyl|mesh-list
102631351|NCT03984240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102275123|NCT00005644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102275124|NCT00005644|Tubulin Modulators|tubulin modulators|mesh-ancestor
102631352|NCT03984240|Anesthetics, General|anesthetics, general|mesh-ancestor
102631353|NCT03984240|Anesthetics|anesthetics|mesh-ancestor
102631354|NCT03984240|GABA Modulators|gaba modulators|mesh-ancestor
102631355|NCT03984240|GABA Agents|gaba agents|mesh-ancestor
102631356|NCT00359736|Sildenafil Citrate|sildenafil citrate|mesh-list
102631357|NCT00359736|Vasodilator Agents|vasodilator agents|mesh-ancestor
102631358|NCT00359736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102631359|NCT00359736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102631360|NCT00359736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102631361|NCT00359736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631362|NCT00359736|Urological Agents|urological agents|mesh-ancestor
102631363|NCT00360126|Lamotrigine|lamotrigine|mesh-list
102631364|NCT00360126|Anticonvulsants|anticonvulsants|mesh-ancestor
102631365|NCT00360126|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102631366|NCT00360126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102631367|NCT00360126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631368|NCT00360126|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102631369|NCT00360126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631370|NCT00360126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102631371|NCT00360126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102631372|NCT00360126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102631373|NCT00360126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102631374|NCT00360126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102631375|NCT00360360|Paclitaxel|paclitaxel|mesh-list
102631376|NCT00360360|Bevacizumab|bevacizumab|mesh-list
102631377|NCT00360360|Carboplatin|carboplatin|mesh-list
102631378|NCT00360360|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102631379|NCT00360360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102631380|NCT00360360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631381|NCT00360360|Tubulin Modulators|tubulin modulators|mesh-ancestor
102631382|NCT00360360|Antimitotic Agents|antimitotic agents|mesh-ancestor
102631383|NCT00360360|Mitosis Modulators|mitosis modulators|mesh-ancestor
102631384|NCT00360360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631385|NCT00360360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102631386|NCT00360360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102631387|NCT00360360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102631388|NCT00360360|Growth Substances|growth substances|mesh-ancestor
102631389|NCT00360360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631390|NCT00360360|Growth Inhibitors|growth inhibitors|mesh-ancestor
102631391|NCT00360360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102631392|NCT00360360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102631393|NCT01552590|Tolvaptan|tolvaptan|mesh-list
102631394|NCT01552590|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102631395|NCT01552590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631396|NCT01552590|Natriuretic Agents|natriuretic agents|mesh-ancestor
102631397|NCT01552590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631398|NCT00549978|Cilostazol|cilostazol|mesh-list
102631399|NCT00549978|Probucol|probucol|mesh-list
102631400|NCT00549978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102631401|NCT00549978|Autonomic Agents|autonomic agents|mesh-ancestor
102631402|NCT00549978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102631403|NCT00549978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631404|NCT00549978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102631405|NCT00549978|Respiratory System Agents|respiratory system agents|mesh-ancestor
102631406|NCT00549978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102631407|NCT00549978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102631408|NCT00549978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631409|NCT00549978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102631410|NCT00549978|Vasodilator Agents|vasodilator agents|mesh-ancestor
102631411|NCT00549978|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102631412|NCT00549978|Protective Agents|protective agents|mesh-ancestor
102631413|NCT00549978|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102631414|NCT00549978|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102631415|NCT00549978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102631416|NCT00549978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102631417|NCT00549978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102631418|NCT00549978|Antimetabolites|antimetabolites|mesh-ancestor
102631419|NCT00549978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102631420|NCT00549978|Antioxidants|antioxidants|mesh-ancestor
102631421|NCT03983226|Carboplatin|carboplatin|mesh-list
102631422|NCT03983226|Gemcitabine|gemcitabine|mesh-list
102631423|NCT03983226|Doxorubicin|doxorubicin|mesh-list
102631424|NCT03983226|Niraparib|niraparib|mesh-list
102631425|NCT03983226|Taxane|taxane|mesh-list
102631426|NCT03983226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631427|NCT03983226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102631428|NCT03983226|Antimetabolites|antimetabolites|mesh-ancestor
102631429|NCT03983226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631430|NCT03983226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102631431|NCT03983226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102631432|NCT03983226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102631433|NCT03983226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102631434|NCT03983226|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102631435|NCT00360672|Lenalidomide|lenalidomide|mesh-list
102631436|NCT00360672|Immunologic Factors|immunologic factors|mesh-ancestor
102631437|NCT00360672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631438|NCT00360672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102631439|NCT00360672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102631440|NCT00360672|Growth Substances|growth substances|mesh-ancestor
102631441|NCT00360672|Growth Inhibitors|growth inhibitors|mesh-ancestor
102631442|NCT00360672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631443|NCT00360828|Irinotecan|irinotecan|mesh-list
102631444|NCT00360828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102631445|NCT00360828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102631446|NCT00360828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102631447|NCT00360828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631448|NCT00360828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631449|NCT00361140|Fludarabine|fludarabine|mesh-list
102631450|NCT00361140|Fludarabine phosphate|fludarabine phosphate|mesh-list
102631451|NCT00361140|Busulfan|busulfan|mesh-list
102631452|NCT00361140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631453|NCT00361140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102631454|NCT00361140|Antimetabolites|antimetabolites|mesh-ancestor
102631455|NCT00361140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631456|NCT00361140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102631457|NCT00361140|Immunologic Factors|immunologic factors|mesh-ancestor
102631458|NCT00361140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631459|NCT00361140|Alkylating Agents|alkylating agents|mesh-ancestor
102631460|NCT00361140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102631461|NCT00361140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102631462|NCT00362466|Imatinib Mesylate|imatinib mesylate|mesh-list
102631463|NCT00362466|Dasatinib|dasatinib|mesh-list
102631464|NCT00362466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631465|NCT00362466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102631466|NCT00362466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102631467|NCT00362466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631468|NCT00305682|Mycophenolic Acid|mycophenolic acid|mesh-list
102631469|NCT00305682|Sirolimus|sirolimus|mesh-list
102631470|NCT00305682|Cyclophosphamide|cyclophosphamide|mesh-list
102631471|NCT00305682|Fludarabine|fludarabine|mesh-list
102631472|NCT00305682|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102631473|NCT00305682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102631474|NCT00305682|Immunologic Factors|immunologic factors|mesh-ancestor
102631475|NCT00305682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631476|NCT00305682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102631477|NCT00305682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102631478|NCT00305682|Alkylating Agents|alkylating agents|mesh-ancestor
102631479|NCT00305682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631480|NCT00305682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631481|NCT00305682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102631482|NCT00305682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102631483|NCT00305682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102631484|NCT00305682|Antitubercular Agents|antitubercular agents|mesh-ancestor
102631485|NCT00305682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102631486|NCT00305682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102631487|NCT00305682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102631488|NCT00305682|Antifungal Agents|antifungal agents|mesh-ancestor
102631489|NCT00305760|Cyclophosphamide|cyclophosphamide|mesh-list
102631490|NCT00305760|Cetuximab|cetuximab|mesh-list
102631491|NCT00305760|Vaccines|vaccines|mesh-list
102631492|NCT00305760|Immunologic Factors|immunologic factors|mesh-ancestor
102631493|NCT00305760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631494|NCT00305760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102631495|NCT00305760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102631496|NCT00305760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102631497|NCT00305760|Alkylating Agents|alkylating agents|mesh-ancestor
102631498|NCT00305760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631499|NCT00305760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631500|NCT00305760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102631501|NCT00305760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102631502|NCT00309738|Simvastatin|simvastatin|mesh-list
102631503|NCT00309738|Pitavastatin|pitavastatin|mesh-list
102631504|NCT00309738|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102631505|NCT00309738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102631506|NCT00309738|Antimetabolites|antimetabolites|mesh-ancestor
102631507|NCT00309738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631508|NCT00309738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102631509|NCT00309738|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102631510|NCT00309738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102631511|NCT00310050|Pemetrexed|pemetrexed|mesh-list
102631512|NCT00310050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631513|NCT00310050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102631514|NCT00310050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631515|NCT00310050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102631516|NCT00310050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102631517|NCT00363168|Ranibizumab|ranibizumab|mesh-list
102631518|NCT00363168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102631519|NCT00363168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102631520|NCT00363168|Growth Substances|growth substances|mesh-ancestor
102631521|NCT00363168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631522|NCT00363168|Growth Inhibitors|growth inhibitors|mesh-ancestor
102631523|NCT00363168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631524|NCT00365274|Prednisone|prednisone|mesh-list
102631525|NCT00365274|Cyclophosphamide|cyclophosphamide|mesh-list
102631526|NCT00365274|Doxorubicin|doxorubicin|mesh-list
102631527|NCT00365274|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102631528|NCT00365274|Vincristine|vincristine|mesh-list
102631529|NCT00365274|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102631530|NCT00365274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102631531|NCT00365274|Immunologic Factors|immunologic factors|mesh-ancestor
102631532|NCT00365274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631533|NCT00365274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102631534|NCT00365274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102631535|NCT00365274|Alkylating Agents|alkylating agents|mesh-ancestor
102631536|NCT00365274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631537|NCT00365274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631538|NCT00365274|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102631539|NCT00365274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102631540|NCT00365274|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102631541|NCT00365274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102631542|NCT00365274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102631543|NCT00365274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102631544|NCT00365274|Glucocorticoids|glucocorticoids|mesh-ancestor
102631545|NCT00365274|Hormones|hormones|mesh-ancestor
102631546|NCT00365274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102631547|NCT00365274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102631548|NCT00365274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102631549|NCT00365274|Tubulin Modulators|tubulin modulators|mesh-ancestor
102631550|NCT00365274|Antimitotic Agents|antimitotic agents|mesh-ancestor
102631551|NCT00365274|Mitosis Modulators|mitosis modulators|mesh-ancestor
102631552|NCT00365274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102631553|NCT00365274|Immunotoxins|immunotoxins|mesh-ancestor
102631554|NCT00365274|Immunoconjugates|immunoconjugates|mesh-ancestor
102631555|NCT00311376|Botulinum Toxins|botulinum toxins|mesh-list
102631556|NCT00311376|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102631557|NCT00311376|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102631558|NCT00311376|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102631559|NCT00311376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102631560|NCT00311376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631561|NCT00311376|Cholinergic Agents|cholinergic agents|mesh-ancestor
102631562|NCT00311376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102631563|NCT00311376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631564|NCT00311376|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102631565|NCT00311376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102631566|NCT02104830|Lenograstim|lenograstim|mesh-list
102631567|NCT02104830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102631568|NCT02104830|Immunologic Factors|immunologic factors|mesh-ancestor
102631569|NCT02104830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631570|NCT00313560|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102631571|NCT00313560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631572|NCT00313560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102631573|NCT00313560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102631574|NCT00313560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631575|NCT00314106|Aldesleukin|aldesleukin|mesh-list
102631576|NCT00314106|Cyclophosphamide|cyclophosphamide|mesh-list
102631577|NCT00314106|Fludarabine|fludarabine|mesh-list
102631578|NCT00314106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102631579|NCT00314106|Immunologic Factors|immunologic factors|mesh-ancestor
102631580|NCT00314106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631581|NCT00314106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102631582|NCT00314106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102631583|NCT00314106|Alkylating Agents|alkylating agents|mesh-ancestor
102631584|NCT00314106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631585|NCT00314106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631586|NCT00314106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102631587|NCT00314106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102631588|NCT00314106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102631589|NCT00314106|Antiviral Agents|antiviral agents|mesh-ancestor
102631590|NCT00314106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102631591|NCT00316524|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
102631592|NCT00316524|Antiviral Agents|antiviral agents|mesh-ancestor
102631593|NCT00316524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102631594|NCT00318708|Fluticasone|fluticasone|mesh-list
102631595|NCT00318708|Xhance|xhance|mesh-list
102631596|NCT00318708|Clarithromycin|clarithromycin|mesh-list
102631597|NCT00318708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102631598|NCT00318708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102631599|NCT00318708|Autonomic Agents|autonomic agents|mesh-ancestor
102631600|NCT00318708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102631601|NCT00318708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631602|NCT00318708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102631603|NCT00318708|Respiratory System Agents|respiratory system agents|mesh-ancestor
102631604|NCT00318708|Dermatologic Agents|dermatologic agents|mesh-ancestor
102631605|NCT00318708|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102631606|NCT00318708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102631607|NCT00318708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102631608|NCT00318708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102631609|NCT00318708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102631610|NCT00318708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631611|NCT00318708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102631612|NCT00318708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102631613|NCT00319644|Dimercaprol|dimercaprol|mesh-list
102631614|NCT00319644|Chelating Agents|chelating agents|mesh-ancestor
102631615|NCT00319644|Sequestering Agents|sequestering agents|mesh-ancestor
102631616|NCT00319644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631617|NCT02448420|Trastuzumab|trastuzumab|mesh-list
102631618|NCT02448420|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102631619|NCT02448420|Palbociclib|palbociclib|mesh-list
102631620|NCT02448420|Antibodies|antibodies|mesh-list
102631621|NCT02448420|Immunoconjugates|immunoconjugates|mesh-list
102631622|NCT02448420|Immunologic Factors|immunologic factors|mesh-ancestor
102631623|NCT02448420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631624|NCT02448420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102631625|NCT02448420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631626|NCT02448420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102631627|NCT02448420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102631628|NCT02448420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631629|NCT02448420|Tubulin Modulators|tubulin modulators|mesh-ancestor
102631630|NCT02448420|Antimitotic Agents|antimitotic agents|mesh-ancestor
102631631|NCT02448420|Mitosis Modulators|mitosis modulators|mesh-ancestor
102631632|NCT02448420|Immunotoxins|immunotoxins|mesh-ancestor
102631633|NCT02422446|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
102631634|NCT02422446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102631635|NCT02422446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102631636|NCT02405676|Cytarabine|cytarabine|mesh-list
102631637|NCT02405676|Prednisone|prednisone|mesh-list
102631638|NCT02405676|Cyclophosphamide|cyclophosphamide|mesh-list
102631639|NCT02405676|Ifosfamide|ifosfamide|mesh-list
102631640|NCT02405676|Isophosphamide mustard|isophosphamide mustard|mesh-list
102631641|NCT02405676|Rituximab|rituximab|mesh-list
102631642|NCT02405676|Methotrexate|methotrexate|mesh-list
102631643|NCT02405676|Etoposide|etoposide|mesh-list
102631644|NCT02405676|Etoposide phosphate|etoposide phosphate|mesh-list
102631645|NCT02405676|Vincristine|vincristine|mesh-list
102631646|NCT02405676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102631647|NCT02405676|Immunologic Factors|immunologic factors|mesh-ancestor
102631648|NCT02405676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920096|NCT05941130|Hormones|hormones|mesh-ancestor
102631649|NCT02405676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102631650|NCT02405676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102275126|NCT00005644|Mitosis Modulators|mitosis modulators|mesh-ancestor
102275127|NCT00005644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631651|NCT02405676|Alkylating Agents|alkylating agents|mesh-ancestor
102631652|NCT02405676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631653|NCT02405676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631654|NCT02405676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102631655|NCT02405676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102631656|NCT02405676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102631658|NCT02405676|Hormones|hormones|mesh-ancestor
102631659|NCT02405676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102631660|NCT02405676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102631661|NCT02405676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102631662|NCT02405676|Abortifacient Agents|abortifacient agents|mesh-ancestor
102631663|NCT02405676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102631664|NCT02405676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102631665|NCT02405676|Antimetabolites|antimetabolites|mesh-ancestor
102631666|NCT02405676|Dermatologic Agents|dermatologic agents|mesh-ancestor
102631667|NCT02405676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102631668|NCT02405676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102631669|NCT02405676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102631670|NCT02405676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102631671|NCT02405676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102631672|NCT02405676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102631673|NCT02405676|Antiviral Agents|antiviral agents|mesh-ancestor
102631674|NCT02405676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102631675|NCT02405676|Tubulin Modulators|tubulin modulators|mesh-ancestor
102631676|NCT02405676|Antimitotic Agents|antimitotic agents|mesh-ancestor
102631677|NCT02405676|Mitosis Modulators|mitosis modulators|mesh-ancestor
102631678|NCT00321594|Belinostat|belinostat|mesh-list
102631679|NCT00321594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631680|NCT00321594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102631681|NCT00321594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102631682|NCT00321594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631683|NCT04751136|Cerebrolysin|cerebrolysin|mesh-list
102631684|NCT04751136|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102631685|NCT04751136|Protective Agents|protective agents|mesh-ancestor
102631686|NCT04751136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631687|NCT04751136|Nootropic Agents|nootropic agents|mesh-ancestor
102631688|NCT00390234|Aflibercept|aflibercept|mesh-list
102631689|NCT00390234|Endothelial Growth Factors|endothelial growth factors|mesh-list
102631690|NCT00390234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102631691|NCT00390234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102631692|NCT00390234|Growth Substances|growth substances|mesh-ancestor
102631693|NCT00390234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631694|NCT00390234|Growth Inhibitors|growth inhibitors|mesh-ancestor
102631695|NCT00390234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631696|NCT00391716|Gabapentin|gabapentin|mesh-list
102631697|NCT00391716|Analgesics|analgesics|mesh-ancestor
102631698|NCT00391716|Sensory System Agents|sensory system agents|mesh-ancestor
102631699|NCT00391716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102631700|NCT00391716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631701|NCT00391716|Anticonvulsants|anticonvulsants|mesh-ancestor
102631702|NCT00391716|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102631703|NCT00391716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102631704|NCT00391716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102631705|NCT00391716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102631706|NCT00391716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102631707|NCT00391716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102631708|NCT00391716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102631709|NCT00391716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631710|NCT00391716|Antimanic Agents|antimanic agents|mesh-ancestor
102631711|NCT00392496|Sunitinib|sunitinib|mesh-list
102631712|NCT00392496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631713|NCT00392496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102631714|NCT00392496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102631715|NCT00392496|Growth Substances|growth substances|mesh-ancestor
101604104|NCT02675374|Histamine Agents|histamine agents|mesh-ancestor
102631716|NCT00392496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631717|NCT00392496|Growth Inhibitors|growth inhibitors|mesh-ancestor
102631718|NCT00392496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102275128|NCT00005644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102275129|NCT00005644|Antimetabolites|antimetabolites|mesh-ancestor
102275130|NCT00003871|Vaccines|vaccines|mesh-list
102631719|NCT00392496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102631720|NCT00392496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631721|NCT01958190|Sirolimus|sirolimus|mesh-list
102631722|NCT01958190|Tacrolimus|tacrolimus|mesh-list
102631723|NCT01958190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102631724|NCT01958190|Immunologic Factors|immunologic factors|mesh-ancestor
102631725|NCT01958190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631726|NCT01958190|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102631727|NCT01958190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102631728|NCT01958190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631729|NCT01958190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102631730|NCT01958190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102631731|NCT01958190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102631732|NCT01958190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631733|NCT01958190|Antifungal Agents|antifungal agents|mesh-ancestor
102631734|NCT00638898|Melphalan|melphalan|mesh-list
102631735|NCT00638898|Busulfan|busulfan|mesh-list
102631736|NCT00638898|Topotecan|topotecan|mesh-list
102631737|NCT00638898|Lenograstim|lenograstim|mesh-list
102631738|NCT00638898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102631739|NCT00638898|Immunologic Factors|immunologic factors|mesh-ancestor
102631740|NCT00638898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631741|NCT00638898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102631742|NCT00638898|Alkylating Agents|alkylating agents|mesh-ancestor
102631743|NCT00638898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631744|NCT00638898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631745|NCT00638898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102631746|NCT00638898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102631747|NCT00638898|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102631748|NCT00638898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102631749|NCT00638898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102631750|NCT00393978|Topiramate|topiramate|mesh-list
102631751|NCT00393978|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102631752|NCT00393978|Antidepressive Agents|antidepressive agents|mesh-ancestor
102631753|NCT00393978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102631754|NCT00393978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102631755|NCT00393978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102631756|NCT00393978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102631757|NCT00393978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631758|NCT00393978|Anticonvulsants|anticonvulsants|mesh-ancestor
102631759|NCT00393978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102631760|NCT00396006|Protease Inhibitors|protease inhibitors|mesh-list
102631761|NCT00396006|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
102631762|NCT00396006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102631763|NCT00396006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631764|NCT00396006|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102631765|NCT00396006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102631766|NCT00397020|Valproic Acid|valproic acid|mesh-list
102631767|NCT00397020|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102631768|NCT00397020|Antidepressive Agents|antidepressive agents|mesh-ancestor
102631769|NCT00397020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102631770|NCT00397020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102631771|NCT00397020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102631772|NCT00397020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102631773|NCT00397020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631774|NCT00397020|Anticonvulsants|anticonvulsants|mesh-ancestor
102631775|NCT00397020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102631776|NCT00397020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631777|NCT00397020|GABA Agents|gaba agents|mesh-ancestor
102631778|NCT00397020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102631779|NCT00397020|Antimanic Agents|antimanic agents|mesh-ancestor
102631780|NCT00397878|Saracatinib|saracatinib|mesh-list
102631781|NCT00397878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631782|NCT00397878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102631783|NCT00397878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631784|NCT00400686|Epoetin Alfa|epoetin alfa|mesh-list
102631785|NCT00400686|Hematinics|hematinics|mesh-ancestor
102631786|NCT05220462|Midazolam|midazolam|mesh-list
102631787|NCT05220462|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102631788|NCT05220462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102631789|NCT05220462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102631790|NCT05220462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631791|NCT05220462|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102631792|NCT05220462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102631793|NCT05220462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102631794|NCT05220462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102631795|NCT05220462|Anesthetics, General|anesthetics, general|mesh-ancestor
102631796|NCT05220462|Anesthetics|anesthetics|mesh-ancestor
102631797|NCT05220462|GABA Modulators|gaba modulators|mesh-ancestor
102631798|NCT05220462|GABA Agents|gaba agents|mesh-ancestor
102631799|NCT05220462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102631800|NCT05220462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631801|NCT00373386|Hormones|hormones|mesh-list
102631802|NCT00373386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102631803|NCT00373386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631804|NCT00374088|Acetylcysteine|acetylcysteine|mesh-list
102631805|NCT00374088|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102631806|NCT00374088|Antiviral Agents|antiviral agents|mesh-ancestor
102631807|NCT00374088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102631808|NCT00374088|Expectorants|expectorants|mesh-ancestor
102631809|NCT00374088|Respiratory System Agents|respiratory system agents|mesh-ancestor
102631810|NCT00374088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102631811|NCT00374088|Antioxidants|antioxidants|mesh-ancestor
102631812|NCT00374088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631813|NCT00374088|Protective Agents|protective agents|mesh-ancestor
102631814|NCT00374088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631815|NCT00374088|Antidotes|antidotes|mesh-ancestor
102631816|NCT00374244|Pimozide|pimozide|mesh-list
102631817|NCT00374244|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102631818|NCT00374244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102631819|NCT00374244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102631820|NCT00374244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631821|NCT00374244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102631822|NCT00374244|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102631823|NCT00374244|Dopamine Agents|dopamine agents|mesh-ancestor
102631824|NCT00374244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102631825|NCT00374244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631826|NCT00374244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102631827|NCT00377832|Acetaminophen|acetaminophen|mesh-list
102631828|NCT00377832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102631829|NCT00377832|Analgesics|analgesics|mesh-ancestor
102631830|NCT00377832|Sensory System Agents|sensory system agents|mesh-ancestor
102631831|NCT00377832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102631832|NCT00377832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631833|NCT00377832|Antipyretics|antipyretics|mesh-ancestor
102631834|NCT00401778|Everolimus|everolimus|mesh-list
102631835|NCT00401778|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102631836|NCT00401778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102631837|NCT00401778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102631838|NCT00401778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631839|NCT00401778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102631840|NCT00401778|Immunologic Factors|immunologic factors|mesh-ancestor
102631841|NCT00401778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631842|NCT00401778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631843|NCT00402714|Pentostatin|pentostatin|mesh-list
102631844|NCT00402714|Methoxsalen|methoxsalen|mesh-list
102631845|NCT00402714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631846|NCT00402714|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
102631847|NCT00402714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102631848|NCT00402714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631849|NCT00402714|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102631850|NCT00402714|Dermatologic Agents|dermatologic agents|mesh-ancestor
102631851|NCT00405288|Hydrocortisone|hydrocortisone|mesh-list
102631852|NCT00405288|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102631853|NCT00405288|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102631854|NCT00405288|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102631855|NCT00405288|Pramoxine|pramoxine|mesh-list
102631856|NCT00405288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102631857|NCT00405288|Anesthetics, Local|anesthetics, local|mesh-ancestor
102631858|NCT00405288|Anesthetics|anesthetics|mesh-ancestor
102631859|NCT00405288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102631860|NCT00405288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631861|NCT00405288|Sensory System Agents|sensory system agents|mesh-ancestor
102631862|NCT00405288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102631863|NCT00381810|Acetaminophen|acetaminophen|mesh-list
102631864|NCT00381810|Diphenhydramine|diphenhydramine|mesh-list
102631865|NCT00381810|Promethazine|promethazine|mesh-list
102631866|NCT00381810|Methylprednisolone|methylprednisolone|mesh-list
102631867|NCT00381810|Rituximab|rituximab|mesh-list
102631868|NCT00381810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102631869|NCT00381810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920305|NCT05751187|Pemetrexed|pemetrexed|mesh-list
102631870|NCT00381810|Immunologic Factors|immunologic factors|mesh-ancestor
102631871|NCT00381810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631872|NCT00381810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102631873|NCT00381810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102631874|NCT00381810|Analgesics|analgesics|mesh-ancestor
102631875|NCT00381810|Sensory System Agents|sensory system agents|mesh-ancestor
102631876|NCT00381810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102631877|NCT00381810|Antipyretics|antipyretics|mesh-ancestor
102631878|NCT00381810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102631879|NCT00381810|Antiemetics|antiemetics|mesh-ancestor
102631880|NCT00381810|Autonomic Agents|autonomic agents|mesh-ancestor
102631881|NCT00381810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102631882|NCT00381810|Glucocorticoids|glucocorticoids|mesh-ancestor
102631883|NCT00381810|Hormones|hormones|mesh-ancestor
102631884|NCT00381810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102631885|NCT00381810|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102631886|NCT00381810|Protective Agents|protective agents|mesh-ancestor
102631887|NCT00381810|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102631888|NCT00381810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102631889|NCT00381810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102631890|NCT00381810|Anesthetics, Local|anesthetics, local|mesh-ancestor
102631891|NCT00381810|Anesthetics|anesthetics|mesh-ancestor
102631892|NCT00381810|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102631893|NCT00381810|Histamine Antagonists|histamine antagonists|mesh-ancestor
102631894|NCT00381810|Histamine Agents|histamine agents|mesh-ancestor
102631895|NCT00381810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102631896|NCT00381810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631897|NCT00381810|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102631898|NCT00381810|Antipruritics|antipruritics|mesh-ancestor
102631899|NCT00381810|Dermatologic Agents|dermatologic agents|mesh-ancestor
102631900|NCT00458952|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
102631901|NCT00458952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631902|NCT00458952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102631903|NCT00458952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631904|NCT00458952|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102631905|NCT00459732|Zinc|zinc|mesh-list
102631906|NCT00459732|Zinc Sulfate|zinc sulfate|mesh-list
102631907|NCT00459732|Trace Elements|trace elements|mesh-ancestor
102631908|NCT00459732|Micronutrients|micronutrients|mesh-ancestor
102631909|NCT00459732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631910|NCT00459732|Astringents|astringents|mesh-ancestor
102631911|NCT00459732|Dermatologic Agents|dermatologic agents|mesh-ancestor
102631912|NCT00459810|Paclitaxel|paclitaxel|mesh-list
102631913|NCT00459810|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
102631914|NCT00459810|Estradiol|estradiol|mesh-list
102631915|NCT00459810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102631916|NCT00459810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631917|NCT00459810|Tubulin Modulators|tubulin modulators|mesh-ancestor
102631918|NCT00459810|Antimitotic Agents|antimitotic agents|mesh-ancestor
102631919|NCT00459810|Mitosis Modulators|mitosis modulators|mesh-ancestor
102631920|NCT00459810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631921|NCT00459810|Estrogens|estrogens|mesh-ancestor
102631922|NCT00459810|Hormones|hormones|mesh-ancestor
102631923|NCT00459810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102631924|NCT00459810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631925|NCT00405522|Remifentanil|remifentanil|mesh-list
102631926|NCT00405522|Propofol|propofol|mesh-list
102631927|NCT00405522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102631928|NCT00405522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102631929|NCT00405522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631930|NCT00405522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102631931|NCT00405522|Anesthetics, General|anesthetics, general|mesh-ancestor
102631932|NCT00405522|Anesthetics|anesthetics|mesh-ancestor
102631933|NCT00405522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102631934|NCT00405522|Narcotics|narcotics|mesh-ancestor
102631935|NCT00405522|Analgesics|analgesics|mesh-ancestor
102631936|NCT00405522|Sensory System Agents|sensory system agents|mesh-ancestor
102631937|NCT00405522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102631938|NCT00461292|Botulinum Toxins|botulinum toxins|mesh-list
102631939|NCT00461292|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102631940|NCT00461292|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102631941|NCT00461292|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102631942|NCT00461292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102631943|NCT00461292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631944|NCT00461292|Cholinergic Agents|cholinergic agents|mesh-ancestor
102631945|NCT00461292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102631946|NCT00461292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631947|NCT00461292|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102275131|NCT00003871|Immunologic Factors|immunologic factors|mesh-ancestor
102631948|NCT00461292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102631949|NCT00382590|Cytarabine|cytarabine|mesh-list
102631950|NCT00382590|Azacitidine|azacitidine|mesh-list
102631951|NCT00382590|Valproic Acid|valproic acid|mesh-list
102631952|NCT00382590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102631953|NCT00382590|Antimetabolites|antimetabolites|mesh-ancestor
102631954|NCT00382590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631955|NCT00382590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631956|NCT00382590|Antiviral Agents|antiviral agents|mesh-ancestor
102631957|NCT00382590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102631958|NCT00382590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102631959|NCT00382590|Immunologic Factors|immunologic factors|mesh-ancestor
102631960|NCT00382590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631961|NCT00382590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102631962|NCT00382590|Anticonvulsants|anticonvulsants|mesh-ancestor
102631963|NCT00382590|GABA Agents|gaba agents|mesh-ancestor
102631964|NCT00382590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102631965|NCT00382590|Antimanic Agents|antimanic agents|mesh-ancestor
102631966|NCT00382590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102631967|NCT00382590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102631968|NCT00382590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102631969|NCT00382824|Ubiquinone|ubiquinone|mesh-list
102631970|NCT00382824|Coenzyme Q10|coenzyme q10|mesh-list
102631971|NCT00382824|Micronutrients|micronutrients|mesh-ancestor
102631972|NCT00382824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631973|NCT00382824|Vitamins|vitamins|mesh-ancestor
102631974|NCT00462072|Infliximab|infliximab|mesh-list
102631975|NCT00462072|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102631976|NCT00462072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102631977|NCT00462072|Dermatologic Agents|dermatologic agents|mesh-ancestor
102631978|NCT00462072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102631979|NCT00462072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102631980|NCT00462228|Memantine|memantine|mesh-list
102631981|NCT00462228|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102631982|NCT00462228|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102631983|NCT00462228|Dopamine Agents|dopamine agents|mesh-ancestor
102631984|NCT00462228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102631985|NCT00462228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631986|NCT00462228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102631987|NCT00462228|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102631988|NCT00462228|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102631989|NCT00408564|Gemcitabine|gemcitabine|mesh-list
102631990|NCT00408564|Capecitabine|capecitabine|mesh-list
102631991|NCT00408564|Oxaliplatin|oxaliplatin|mesh-list
102631992|NCT00408564|Cetuximab|cetuximab|mesh-list
102631993|NCT00408564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102631994|NCT00408564|Antimetabolites|antimetabolites|mesh-ancestor
102631995|NCT00408564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102631996|NCT00408564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102631997|NCT00408564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102631998|NCT00383448|Cyclosporine|cyclosporine|mesh-list
102631999|NCT00383448|Melphalan|melphalan|mesh-list
102632000|NCT00383448|Alemtuzumab|alemtuzumab|mesh-list
102632001|NCT00383448|Hydroxyurea|hydroxyurea|mesh-list
102632002|NCT00383448|Clofarabine|clofarabine|mesh-list
102632003|NCT00383448|Cyclosporins|cyclosporins|mesh-list
102632004|NCT00383448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102632005|NCT00383448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632006|NCT00383448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102632007|NCT00383448|Immunologic Factors|immunologic factors|mesh-ancestor
102632008|NCT00383448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632009|NCT00383448|Antifungal Agents|antifungal agents|mesh-ancestor
102632010|NCT00383448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102632011|NCT00383448|Dermatologic Agents|dermatologic agents|mesh-ancestor
102632012|NCT00383448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102632013|NCT00383448|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102632014|NCT00383448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102632015|NCT00383448|Alkylating Agents|alkylating agents|mesh-ancestor
102632016|NCT00383448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632017|NCT00383448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102632018|NCT00383448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102632019|NCT00383448|Antisickling Agents|antisickling agents|mesh-ancestor
102275132|NCT00003871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632020|NCT00383448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102632021|NCT00383448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102632022|NCT00383448|Antimetabolites|antimetabolites|mesh-ancestor
102632023|NCT00384774|Lasmiditan|lasmiditan|mesh-list
102632024|NCT00384774|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102632025|NCT00384774|Serotonin Agents|serotonin agents|mesh-ancestor
102632026|NCT00384774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102632027|NCT00384774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632028|NCT00384774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632029|NCT00410826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102632030|NCT00410826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632031|NCT00410826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102632032|NCT00410826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102632033|NCT00410826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632034|NCT00464646|Cyclophosphamide|cyclophosphamide|mesh-list
102632035|NCT00464646|Bevacizumab|bevacizumab|mesh-list
102632036|NCT00464646|Docetaxel|docetaxel|mesh-list
102632037|NCT00464646|Trastuzumab|trastuzumab|mesh-list
102632038|NCT00464646|Epirubicin|epirubicin|mesh-list
102632039|NCT00464646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102632040|NCT00464646|Immunologic Factors|immunologic factors|mesh-ancestor
102632041|NCT00464646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632042|NCT00464646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102632043|NCT00464646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102632044|NCT00464646|Alkylating Agents|alkylating agents|mesh-ancestor
102632045|NCT00464646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632046|NCT00464646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632047|NCT00464646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102632048|NCT00464646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102632049|NCT00464646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102632050|NCT00464646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102632051|NCT00464646|Growth Substances|growth substances|mesh-ancestor
102632052|NCT00464646|Growth Inhibitors|growth inhibitors|mesh-ancestor
102632053|NCT00464646|Tubulin Modulators|tubulin modulators|mesh-ancestor
102632054|NCT00464646|Antimitotic Agents|antimitotic agents|mesh-ancestor
102632055|NCT00464646|Mitosis Modulators|mitosis modulators|mesh-ancestor
102632056|NCT00464646|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102632057|NCT00464646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102632058|NCT00464646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102632059|NCT00464646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102632060|NCT00385008|Naproxen|naproxen|mesh-list
102632061|NCT00385008|Sumatriptan|sumatriptan|mesh-list
102632062|NCT00385008|Eletriptan|eletriptan|mesh-list
102632063|NCT00385008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102632064|NCT00385008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102632065|NCT00385008|Analgesics|analgesics|mesh-ancestor
102632066|NCT00385008|Sensory System Agents|sensory system agents|mesh-ancestor
102632067|NCT00385008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102632068|NCT00385008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632069|NCT00385008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102632070|NCT00385008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102632071|NCT00385008|Gout Suppressants|gout suppressants|mesh-ancestor
102632072|NCT00385008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102632073|NCT00385008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102632074|NCT00385008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632075|NCT00385008|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102632076|NCT00385008|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102632077|NCT00385008|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102632078|NCT00385008|Serotonin Agents|serotonin agents|mesh-ancestor
102632079|NCT00385008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102632080|NCT00410904|Pemetrexed|pemetrexed|mesh-list
102632081|NCT00410904|Cediranib|cediranib|mesh-list
102632082|NCT00410904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632083|NCT00410904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102632084|NCT00410904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632085|NCT00410904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102632086|NCT00410904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102632087|NCT00410904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102632088|NCT00385788|Gemcitabine|gemcitabine|mesh-list
102632089|NCT00385788|Methotrexate|methotrexate|mesh-list
102632090|NCT00385788|Fludarabine phosphate|fludarabine phosphate|mesh-list
102275133|NCT00003809|Cetuximab|cetuximab|mesh-list
102275134|NCT00003809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102275135|NCT00003809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102275136|NCT00003808|Theophylline|theophylline|mesh-list
102275137|NCT00003808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102275138|NCT00003808|Autonomic Agents|autonomic agents|mesh-ancestor
102275139|NCT00003808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101920552|NCT05303311|Anesthetics|anesthetics|mesh-ancestor
102632091|NCT00385788|Fludarabine|fludarabine|mesh-list
102275140|NCT00003808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632093|NCT00385788|Tacrolimus|tacrolimus|mesh-list
101604508|NCT02670616|Rituximab|rituximab|mesh-list
102632094|NCT00385788|Thymoglobulin|thymoglobulin|mesh-list
102632095|NCT00385788|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102632096|NCT00385788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102632097|NCT00385788|Antimetabolites|antimetabolites|mesh-ancestor
102632098|NCT00385788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632099|NCT00385788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632100|NCT00385788|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102632101|NCT00385788|Abortifacient Agents|abortifacient agents|mesh-ancestor
102632102|NCT00385788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102632103|NCT00385788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632104|NCT00385788|Dermatologic Agents|dermatologic agents|mesh-ancestor
102632105|NCT00385788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102632106|NCT00385788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102632107|NCT00385788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102632108|NCT00385788|Immunologic Factors|immunologic factors|mesh-ancestor
102632109|NCT00385788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102632110|NCT00385788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102632111|NCT00385788|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102632112|NCT00385788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102632113|NCT00385788|Alkylating Agents|alkylating agents|mesh-ancestor
102632114|NCT00385788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102632115|NCT00411684|Ulipristal acetate|ulipristal acetate|mesh-list
102632116|NCT00411684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102632117|NCT00411684|Contraceptive Agents|contraceptive agents|mesh-ancestor
102632118|NCT00411684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102632119|NCT00411684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632120|NCT00411684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102632121|NCT00412074|Vitamin D|vitamin d|mesh-list
102632122|NCT00412074|Ergocalciferols|ergocalciferols|mesh-list
102632123|NCT00412074|Cholecalciferol|cholecalciferol|mesh-list
102632124|NCT00412074|Vitamins|vitamins|mesh-list
102632125|NCT00412074|Micronutrients|micronutrients|mesh-ancestor
102632126|NCT00412074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632127|NCT00412074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102632128|NCT00412074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102632129|NCT00412464|PENTA|penta|mesh-list
102632130|NCT00412464|Fondaparinux|fondaparinux|mesh-list
102632131|NCT00412464|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102632132|NCT00412464|Antithrombins|antithrombins|mesh-ancestor
102632133|NCT00412464|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102632134|NCT00412464|Protease Inhibitors|protease inhibitors|mesh-ancestor
102632135|NCT00412464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102632136|NCT00412464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632137|NCT00412464|Anticoagulants|anticoagulants|mesh-ancestor
102632138|NCT00412464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102632139|NCT00412464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102632140|NCT00466752|Sorafenib|sorafenib|mesh-list
102632141|NCT00466752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632142|NCT00466752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102632143|NCT00466752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102632144|NCT00466752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632145|NCT02115750|Etanercept|etanercept|mesh-list
102632146|NCT02115750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102632147|NCT02115750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102632148|NCT02115750|Analgesics|analgesics|mesh-ancestor
102632149|NCT02115750|Sensory System Agents|sensory system agents|mesh-ancestor
102632150|NCT02115750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102632151|NCT02115750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632152|NCT02115750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102632153|NCT02115750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102632154|NCT02115750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102632155|NCT02115750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102632156|NCT02115750|Immunologic Factors|immunologic factors|mesh-ancestor
102632157|NCT00413166|Idarubicin|idarubicin|mesh-list
102632158|NCT00413166|Tretinoin|tretinoin|mesh-list
102632159|NCT00413166|Arsenic Trioxide|arsenic trioxide|mesh-list
102632160|NCT00413166|Gemtuzumab|gemtuzumab|mesh-list
102632161|NCT00413166|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102632162|NCT00413166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632163|NCT00413166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102632164|NCT00413166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102632165|NCT00413166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102632166|NCT00413166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632168|NCT00413166|Dermatologic Agents|dermatologic agents|mesh-ancestor
102632169|NCT00413166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102632170|NCT00413166|Immunotoxins|immunotoxins|mesh-ancestor
102632171|NCT00413166|Immunoconjugates|immunoconjugates|mesh-ancestor
102632172|NCT00413166|Immunologic Factors|immunologic factors|mesh-ancestor
102632173|NCT00413166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632174|NCT00413400|Etanercept|etanercept|mesh-list
102632175|NCT00413400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102632176|NCT00413400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102632177|NCT00413400|Analgesics|analgesics|mesh-ancestor
102632178|NCT00413400|Sensory System Agents|sensory system agents|mesh-ancestor
102632179|NCT00413400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102632180|NCT00413400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632181|NCT00413400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102632182|NCT00413400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102632183|NCT00413400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102632184|NCT00413400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102632185|NCT00413400|Immunologic Factors|immunologic factors|mesh-ancestor
102632186|NCT00413478|Azacitidine|azacitidine|mesh-list
102632187|NCT00413478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102632188|NCT00413478|Antimetabolites|antimetabolites|mesh-ancestor
102632189|NCT00413478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632190|NCT00413478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632191|NCT00413478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102632192|NCT00413634|Anagrelide|anagrelide|mesh-list
102632193|NCT00413634|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102632194|NCT00413634|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102632195|NCT00413634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632196|NCT00413634|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102632197|NCT00387036|Fluticasone|fluticasone|mesh-list
102632198|NCT00387036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102632199|NCT00387036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102632200|NCT00387036|Autonomic Agents|autonomic agents|mesh-ancestor
102632201|NCT00387036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102632202|NCT00387036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632203|NCT00387036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102632204|NCT00387036|Respiratory System Agents|respiratory system agents|mesh-ancestor
102632205|NCT00387036|Dermatologic Agents|dermatologic agents|mesh-ancestor
102632206|NCT00387036|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102632207|NCT04388904|Tenofovir|tenofovir|mesh-list
102632208|NCT04388904|Emtricitabine|emtricitabine|mesh-list
102632209|NCT04388904|Darunavir|darunavir|mesh-list
102632210|NCT04388904|Cobicistat|cobicistat|mesh-list
102632211|NCT04388904|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
102632212|NCT04388904|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
102632213|NCT04388904|Antiviral Agents|antiviral agents|mesh-ancestor
102632214|NCT04388904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102632215|NCT04388904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102632216|NCT04388904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102632217|NCT04388904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102632218|NCT04388904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632219|NCT04388904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102632220|NCT04388904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102632221|NCT04388904|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102632222|NCT04388904|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102632223|NCT04388904|Protease Inhibitors|protease inhibitors|mesh-ancestor
102632224|NCT04388904|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102632225|NCT04388904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102632226|NCT00387660|Carboplatin|carboplatin|mesh-list
102632227|NCT00387660|Irinotecan|irinotecan|mesh-list
102632228|NCT00387660|Camptothecin|camptothecin|mesh-list
102632229|NCT00387660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632230|NCT00387660|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102632231|NCT00387660|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102632232|NCT00387660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102632233|NCT00387660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632234|NCT00387660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102632235|NCT00472056|Cytarabine|cytarabine|mesh-list
102632236|NCT00472056|Rituximab|rituximab|mesh-list
102632237|NCT00472056|Etoposide|etoposide|mesh-list
102632238|NCT00472056|Melphalan|melphalan|mesh-list
102632239|NCT00472056|Carmustine|carmustine|mesh-list
102632240|NCT00472056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102632241|NCT00472056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632242|NCT00472056|Immunologic Factors|immunologic factors|mesh-ancestor
102275141|NCT00003808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102632243|NCT00472056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632244|NCT00472056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102632245|NCT00472056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102632246|NCT00472056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102632247|NCT00472056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102632248|NCT00472056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102632249|NCT00472056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632250|NCT00472056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102632251|NCT00472056|Antimetabolites|antimetabolites|mesh-ancestor
102632252|NCT00472056|Antiviral Agents|antiviral agents|mesh-ancestor
102632253|NCT00472056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102632254|NCT00472056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102632255|NCT00472056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102632256|NCT00472056|Alkylating Agents|alkylating agents|mesh-ancestor
102632257|NCT00472056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102632258|NCT00415506|Rituximab|rituximab|mesh-list
102632259|NCT00415506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102632260|NCT00415506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632261|NCT00415506|Immunologic Factors|immunologic factors|mesh-ancestor
102632262|NCT00415506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632263|NCT00415506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102632264|NCT00389532|Vaccines|vaccines|mesh-list
102632265|NCT00389532|Immunologic Factors|immunologic factors|mesh-ancestor
102632266|NCT00389532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632267|NCT01957956|Temozolomide|temozolomide|mesh-list
102632268|NCT01957956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102632269|NCT01957956|Alkylating Agents|alkylating agents|mesh-ancestor
102632270|NCT01957956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632271|NCT01957956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632272|NCT00475878|Escitalopram|escitalopram|mesh-list
102632273|NCT00475878|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102632274|NCT00475878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102632275|NCT00475878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102632276|NCT00475878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632277|NCT00475878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102632278|NCT00475878|Serotonin Agents|serotonin agents|mesh-ancestor
102632279|NCT00475878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632280|NCT01795170|Pyridoxine|pyridoxine|mesh-list
102632281|NCT01795170|Vitamin B Complex|vitamin b complex|mesh-ancestor
102632282|NCT01795170|Vitamins|vitamins|mesh-ancestor
102632283|NCT01795170|Micronutrients|micronutrients|mesh-ancestor
102632284|NCT01795170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632285|NCT00477204|Simvastatin|simvastatin|mesh-list
102632286|NCT00477204|Ezetimibe|ezetimibe|mesh-list
102632287|NCT00477204|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
102632288|NCT00477204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102632289|NCT00477204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102632290|NCT00477204|Antimetabolites|antimetabolites|mesh-ancestor
102632291|NCT00477204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632292|NCT00477204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102632293|NCT00477204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102632294|NCT00477204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102632295|NCT00528450|Idarubicin|idarubicin|mesh-list
102632296|NCT00528450|Arsenic Trioxide|arsenic trioxide|mesh-list
102632297|NCT00528450|Tretinoin|tretinoin|mesh-list
102632298|NCT00528450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102632299|NCT00528450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632300|NCT00528450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102632301|NCT00528450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102632302|NCT00528450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102632303|NCT00528450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632304|NCT00528450|Keratolytic Agents|keratolytic agents|mesh-ancestor
102632305|NCT00528450|Dermatologic Agents|dermatologic agents|mesh-ancestor
102632306|NCT00478218|Dexamethasone|dexamethasone|mesh-list
102632307|NCT00478218|Cyclophosphamide|cyclophosphamide|mesh-list
102632308|NCT00478218|Lenalidomide|lenalidomide|mesh-list
102632309|NCT00478218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102632310|NCT00478218|Immunologic Factors|immunologic factors|mesh-ancestor
102632311|NCT00478218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632312|NCT00478218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102632313|NCT00478218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102632314|NCT00478218|Alkylating Agents|alkylating agents|mesh-ancestor
102632315|NCT00478218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632316|NCT00478218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632317|NCT00478218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102632318|NCT00478218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102632320|NCT00478218|Autonomic Agents|autonomic agents|mesh-ancestor
102632321|NCT00478218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102632322|NCT00478218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102632323|NCT00478218|Glucocorticoids|glucocorticoids|mesh-ancestor
102632324|NCT00478218|Hormones|hormones|mesh-ancestor
102632325|NCT00478218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102632326|NCT00478218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102632327|NCT00478218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102632328|NCT00478218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102632329|NCT00478218|Growth Substances|growth substances|mesh-ancestor
102632330|NCT00478218|Growth Inhibitors|growth inhibitors|mesh-ancestor
102632331|NCT00479154|Botulinum Toxins|botulinum toxins|mesh-list
102632332|NCT00479154|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102632333|NCT00479154|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102632334|NCT00479154|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102632335|NCT00479154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102632336|NCT00479154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632337|NCT00479154|Cholinergic Agents|cholinergic agents|mesh-ancestor
102632338|NCT00479154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102632339|NCT00479154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632340|NCT00479154|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102632341|NCT00479154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102632342|NCT04270656|Insulin|insulin|mesh-list
102632343|NCT04270656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102632344|NCT04270656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632345|NCT00424554|Temozolomide|temozolomide|mesh-list
102632346|NCT00424554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102632347|NCT00424554|Alkylating Agents|alkylating agents|mesh-ancestor
102632348|NCT00424554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632349|NCT00424554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632350|NCT00425802|Cyclosporine|cyclosporine|mesh-list
102632351|NCT00425802|Mycophenolic Acid|mycophenolic acid|mesh-list
102632352|NCT00425802|Cyclophosphamide|cyclophosphamide|mesh-list
102632353|NCT00425802|Rituximab|rituximab|mesh-list
102632354|NCT00425802|Fludarabine|fludarabine|mesh-list
102632355|NCT00425802|Fludarabine phosphate|fludarabine phosphate|mesh-list
102632356|NCT00425802|Cyclosporins|cyclosporins|mesh-list
102632357|NCT00425802|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102632358|NCT00425802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102632359|NCT00425802|Immunologic Factors|immunologic factors|mesh-ancestor
102632360|NCT00425802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632361|NCT00425802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102632362|NCT00425802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102632363|NCT00425802|Alkylating Agents|alkylating agents|mesh-ancestor
102632364|NCT00425802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632365|NCT00425802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632366|NCT00425802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102632367|NCT00425802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102632368|NCT00425802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102632369|NCT00425802|Antimetabolites|antimetabolites|mesh-ancestor
102632370|NCT00425802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102632371|NCT00425802|Antifungal Agents|antifungal agents|mesh-ancestor
102632372|NCT00425802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102632373|NCT00425802|Dermatologic Agents|dermatologic agents|mesh-ancestor
102632374|NCT00425802|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102632375|NCT00425802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102632376|NCT00425802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102632377|NCT00425802|Antitubercular Agents|antitubercular agents|mesh-ancestor
102632378|NCT00425802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102632379|NCT00530634|Gemcitabine|gemcitabine|mesh-list
102632380|NCT00530634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632381|NCT00530634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102632382|NCT00530634|Antimetabolites|antimetabolites|mesh-ancestor
102632383|NCT00530634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632384|NCT00531882|Pioglitazone|pioglitazone|mesh-list
102632385|NCT00531882|Ibuprofen|ibuprofen|mesh-list
102632386|NCT00531882|Simvastatin|simvastatin|mesh-list
102632387|NCT00531882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102632388|NCT00531882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102632389|NCT00531882|Analgesics|analgesics|mesh-ancestor
102275142|NCT00003808|Respiratory System Agents|respiratory system agents|mesh-ancestor
102632390|NCT00531882|Sensory System Agents|sensory system agents|mesh-ancestor
102632391|NCT00531882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102632392|NCT00531882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632393|NCT00531882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102632394|NCT00531882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102632395|NCT00531882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102632396|NCT00531882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102632397|NCT00531882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632398|NCT00531882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102632399|NCT00531882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102632401|NCT00531882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102632402|NCT00531882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102632403|NCT00531882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102632404|NCT00428298|Valacyclovir|valacyclovir|mesh-list
102632405|NCT00428298|Antiviral Agents|antiviral agents|mesh-ancestor
102632406|NCT00428298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102632407|NCT00486018|Ranibizumab|ranibizumab|mesh-list
102632408|NCT00486018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102632409|NCT00486018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102632410|NCT00486018|Growth Substances|growth substances|mesh-ancestor
102632411|NCT00486018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632412|NCT00486018|Growth Inhibitors|growth inhibitors|mesh-ancestor
102632413|NCT00486018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632414|NCT00486642|Bicalutamide|bicalutamide|mesh-list
102632415|NCT00486642|Androgen Antagonists|androgen antagonists|mesh-ancestor
102632416|NCT00486642|Hormone Antagonists|hormone antagonists|mesh-ancestor
102632417|NCT00486642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102632418|NCT00486642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632419|NCT00486642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632420|NCT00428922|Bevacizumab|bevacizumab|mesh-list
102632421|NCT00428922|Trastuzumab|trastuzumab|mesh-list
102632422|NCT00428922|Docetaxel|docetaxel|mesh-list
102632423|NCT00428922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102632424|NCT00428922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632425|NCT00428922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102632426|NCT00428922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102632427|NCT00428922|Growth Substances|growth substances|mesh-ancestor
102632428|NCT00428922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632429|NCT00428922|Growth Inhibitors|growth inhibitors|mesh-ancestor
101604848|NCT02666716|Fluconazole|fluconazole|mesh-list
102632430|NCT00428922|Tubulin Modulators|tubulin modulators|mesh-ancestor
102632431|NCT00428922|Antimitotic Agents|antimitotic agents|mesh-ancestor
102632432|NCT00428922|Mitosis Modulators|mitosis modulators|mesh-ancestor
102632433|NCT00428922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632434|NCT00533442|Mycophenolic Acid|mycophenolic acid|mesh-list
102632435|NCT00533442|Sirolimus|sirolimus|mesh-list
102632436|NCT00533442|Tacrolimus|tacrolimus|mesh-list
102632437|NCT00533442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102632438|NCT00533442|Immunologic Factors|immunologic factors|mesh-ancestor
102632439|NCT00533442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632440|NCT00533442|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102632441|NCT00533442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102632442|NCT00533442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632443|NCT00533442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102632444|NCT00533442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632445|NCT00533442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102632446|NCT00533442|Antitubercular Agents|antitubercular agents|mesh-ancestor
102632447|NCT00533442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102632448|NCT00533442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102632449|NCT00533442|Antifungal Agents|antifungal agents|mesh-ancestor
102632450|NCT00533910|Rifaximin|rifaximin|mesh-list
102632451|NCT00533910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102632452|NCT00533910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102632453|NCT00533910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102632454|NCT01954524|Sildenafil Citrate|sildenafil citrate|mesh-list
102632455|NCT01954524|Vasodilator Agents|vasodilator agents|mesh-ancestor
102632456|NCT01954524|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102632457|NCT01954524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102632458|NCT01954524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102632459|NCT01954524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632460|NCT01954524|Urological Agents|urological agents|mesh-ancestor
102632461|NCT00535002|Yohimbine|yohimbine|mesh-list
102632462|NCT00535002|Mydriatics|mydriatics|mesh-ancestor
102275143|NCT00003808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102632463|NCT00535002|Autonomic Agents|autonomic agents|mesh-ancestor
102632464|NCT00535002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102275144|NCT00003808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102632465|NCT00535002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632466|NCT00535002|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102632467|NCT00535002|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102632468|NCT00535002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102632469|NCT00535002|Adrenergic Agents|adrenergic agents|mesh-ancestor
102632470|NCT00535002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102632471|NCT00535002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632472|NCT00535002|Urological Agents|urological agents|mesh-ancestor
102632473|NCT02117934|Vaccines|vaccines|mesh-list
102632474|NCT02117934|Immunologic Factors|immunologic factors|mesh-ancestor
102632475|NCT02117934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632476|NCT00429702|Diphenhydramine|diphenhydramine|mesh-list
102632477|NCT00429702|Promethazine|promethazine|mesh-list
102632478|NCT00429702|Dexamethasone|dexamethasone|mesh-list
102632479|NCT00429702|Lorazepam|lorazepam|mesh-list
102632480|NCT00429702|Ondansetron|ondansetron|mesh-list
102632481|NCT00429702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102632482|NCT00429702|Antiemetics|antiemetics|mesh-ancestor
102632483|NCT00429702|Autonomic Agents|autonomic agents|mesh-ancestor
102632484|NCT00429702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102632485|NCT00429702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632486|NCT00429702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102632487|NCT00429702|Glucocorticoids|glucocorticoids|mesh-ancestor
102632488|NCT00429702|Hormones|hormones|mesh-ancestor
102632489|NCT00429702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102632490|NCT00429702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102632491|NCT00429702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632492|NCT00429702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632493|NCT00429702|Antipruritics|antipruritics|mesh-ancestor
102632494|NCT00429702|Dermatologic Agents|dermatologic agents|mesh-ancestor
102632495|NCT00429702|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102632496|NCT00429702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102632497|NCT00429702|Serotonin Agents|serotonin agents|mesh-ancestor
102632498|NCT00429702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101604898|NCT00645268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102632499|NCT00429702|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102632500|NCT00429702|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102632501|NCT00429702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102632502|NCT00429702|Anesthetics, Local|anesthetics, local|mesh-ancestor
102632503|NCT00429702|Anesthetics|anesthetics|mesh-ancestor
102632504|NCT00429702|Sensory System Agents|sensory system agents|mesh-ancestor
102632505|NCT00429702|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102632506|NCT00429702|Histamine Antagonists|histamine antagonists|mesh-ancestor
102632507|NCT00429702|Histamine Agents|histamine agents|mesh-ancestor
102632508|NCT00429702|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102632509|NCT00429702|Anticonvulsants|anticonvulsants|mesh-ancestor
102632510|NCT00429702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102632511|NCT00429702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102632512|NCT00429702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102632513|NCT00429702|GABA Modulators|gaba modulators|mesh-ancestor
102632514|NCT00429702|GABA Agents|gaba agents|mesh-ancestor
102632515|NCT00535392|Levetiracetam|levetiracetam|mesh-list
102632516|NCT00535392|Anticonvulsants|anticonvulsants|mesh-ancestor
102632517|NCT00535392|Nootropic Agents|nootropic agents|mesh-ancestor
102632518|NCT00535782|Methotrexate|methotrexate|mesh-list
102632519|NCT00535782|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102632520|NCT00535782|Abortifacient Agents|abortifacient agents|mesh-ancestor
102632521|NCT00535782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102632522|NCT00535782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632523|NCT00535782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102632524|NCT00535782|Antimetabolites|antimetabolites|mesh-ancestor
102632525|NCT00535782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632526|NCT00535782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632527|NCT00535782|Dermatologic Agents|dermatologic agents|mesh-ancestor
102632528|NCT00535782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102632529|NCT00535782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102632530|NCT00535782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102632531|NCT00535782|Immunologic Factors|immunologic factors|mesh-ancestor
102632532|NCT00535782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102632533|NCT00535782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102632534|NCT00431184|Pentazocine|pentazocine|mesh-list
102632535|NCT00431184|Lorazepam|lorazepam|mesh-list
102632536|NCT00431184|Anticonvulsants|anticonvulsants|mesh-ancestor
102632537|NCT00431184|Antiemetics|antiemetics|mesh-ancestor
102632538|NCT00431184|Autonomic Agents|autonomic agents|mesh-ancestor
102632539|NCT00431184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102275145|NCT00003808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632540|NCT00431184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632541|NCT00431184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102632542|NCT00431184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102632543|NCT00431184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102632544|NCT00431184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102632545|NCT00431184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102632546|NCT00431184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102632547|NCT00431184|GABA Modulators|gaba modulators|mesh-ancestor
102632548|NCT00431184|GABA Agents|gaba agents|mesh-ancestor
102632549|NCT00431184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102632550|NCT00431184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632551|NCT00431184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102632552|NCT00431184|Narcotics|narcotics|mesh-ancestor
102632553|NCT00431184|Analgesics|analgesics|mesh-ancestor
102632554|NCT00431184|Sensory System Agents|sensory system agents|mesh-ancestor
102632555|NCT00431184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102632556|NCT00431184|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102632557|NCT00535938|Botulinum Toxins|botulinum toxins|mesh-list
102632558|NCT00535938|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102632559|NCT00535938|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102632560|NCT00535938|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102632561|NCT00535938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102632562|NCT00535938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632563|NCT00535938|Cholinergic Agents|cholinergic agents|mesh-ancestor
102632564|NCT00535938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102632565|NCT00535938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632566|NCT00535938|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102632567|NCT00535938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102632568|NCT01795794|Omeprazole|omeprazole|mesh-list
102632569|NCT01795794|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102632570|NCT01795794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102632571|NCT01795794|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102632572|NCT01795794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102632573|NCT01795794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632574|NCT01796028|Metformin|metformin|mesh-list
102632575|NCT01796028|Docetaxel|docetaxel|mesh-list
102632576|NCT01796028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102632577|NCT01796028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632578|NCT01796028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632579|NCT01796028|Tubulin Modulators|tubulin modulators|mesh-ancestor
102632580|NCT01796028|Antimitotic Agents|antimitotic agents|mesh-ancestor
102632581|NCT01796028|Mitosis Modulators|mitosis modulators|mesh-ancestor
102632582|NCT01796028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632583|NCT00491244|Interferons|interferons|mesh-list
102632584|NCT00491244|Ribavirin|ribavirin|mesh-list
102632585|NCT00491244|Interferon-alpha|interferon-alpha|mesh-list
102632586|NCT00491244|Interferon alpha-2|interferon alpha-2|mesh-list
102632587|NCT00491244|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102632588|NCT00491244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632589|NCT00491244|Antiviral Agents|antiviral agents|mesh-ancestor
102632590|NCT00491244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102632591|NCT00491244|Antimetabolites|antimetabolites|mesh-ancestor
102632592|NCT00491244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632593|NCT00491244|Immunologic Factors|immunologic factors|mesh-ancestor
102632594|NCT00491244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632595|NCT00492336|Rasagiline|rasagiline|mesh-list
102632596|NCT00492336|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102632597|NCT00492336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102632598|NCT00492336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632599|NCT00492336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102632600|NCT00492336|Protective Agents|protective agents|mesh-ancestor
102632601|NCT00492336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632602|NCT00538434|Reslizumab|reslizumab|mesh-list
102632603|NCT00538434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102632604|NCT00538434|Respiratory System Agents|respiratory system agents|mesh-ancestor
102632605|NCT00538824|Thalidomide|thalidomide|mesh-list
102632606|NCT00538824|Dexamethasone|dexamethasone|mesh-list
102632607|NCT00538824|Lenalidomide|lenalidomide|mesh-list
102632608|NCT00538824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102632609|NCT00538824|Antiemetics|antiemetics|mesh-ancestor
102632610|NCT00538824|Autonomic Agents|autonomic agents|mesh-ancestor
102632611|NCT00538824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102632612|NCT00538824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632613|NCT00538824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102632614|NCT00538824|Glucocorticoids|glucocorticoids|mesh-ancestor
102632615|NCT00538824|Hormones|hormones|mesh-ancestor
102275146|NCT00003808|Vasodilator Agents|vasodilator agents|mesh-ancestor
102632616|NCT00538824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102632617|NCT00538824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102632618|NCT00538824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632619|NCT00538824|Immunologic Factors|immunologic factors|mesh-ancestor
102632620|NCT00538824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102632621|NCT00538824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102632622|NCT00538824|Growth Substances|growth substances|mesh-ancestor
102632623|NCT00538824|Growth Inhibitors|growth inhibitors|mesh-ancestor
102632624|NCT00538824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102632625|NCT00538824|Leprostatic Agents|leprostatic agents|mesh-ancestor
102632626|NCT00538824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102632627|NCT00538824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102632628|NCT00539526|Bimatoprost|bimatoprost|mesh-list
102632630|NCT00539526|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102632631|NCT00539526|Latanoprost|latanoprost|mesh-list
102632632|NCT00539526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102632633|NCT00539526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102632634|NCT01796106|Fluorides|fluorides|mesh-list
102632635|NCT01796106|Fluorides, Topical|fluorides, topical|mesh-list
102632636|NCT01796106|Cariostatic Agents|cariostatic agents|mesh-ancestor
102632637|NCT01796106|Protective Agents|protective agents|mesh-ancestor
102632638|NCT01796106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632639|NCT00541242|Bimatoprost|bimatoprost|mesh-list
102632640|NCT00541242|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102632641|NCT00541242|Latanoprost|latanoprost|mesh-list
102632642|NCT00541242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102632643|NCT00541242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102632644|NCT00438204|Bevacizumab|bevacizumab|mesh-list
102632645|NCT00438204|Gemcitabine|gemcitabine|mesh-list
102632646|NCT00438204|Pemetrexed|pemetrexed|mesh-list
102632647|NCT00438204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102632648|NCT00438204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632649|NCT00438204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102632650|NCT00438204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102632651|NCT00438204|Growth Substances|growth substances|mesh-ancestor
102632652|NCT00438204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632653|NCT00438204|Growth Inhibitors|growth inhibitors|mesh-ancestor
102632654|NCT00438204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102632655|NCT00438204|Antimetabolites|antimetabolites|mesh-ancestor
102632656|NCT00438204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632657|NCT00438204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102632658|NCT00438204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102632659|NCT00438204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102632660|NCT00439296|Cytarabine|cytarabine|mesh-list
102632661|NCT00439296|Dexamethasone|dexamethasone|mesh-list
102632662|NCT00439296|Cyclophosphamide|cyclophosphamide|mesh-list
102632663|NCT00439296|Doxorubicin|doxorubicin|mesh-list
102632664|NCT00439296|Methotrexate|methotrexate|mesh-list
102632665|NCT00439296|Asparaginase|asparaginase|mesh-list
102632666|NCT00439296|Mercaptopurine|mercaptopurine|mesh-list
102632667|NCT00439296|Thioguanine|thioguanine|mesh-list
102632668|NCT00439296|Pegaspargase|pegaspargase|mesh-list
102632669|NCT00439296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102632670|NCT00439296|Immunologic Factors|immunologic factors|mesh-ancestor
102632671|NCT00439296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632672|NCT00439296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102632673|NCT00439296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102632674|NCT00439296|Alkylating Agents|alkylating agents|mesh-ancestor
102632675|NCT00439296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632676|NCT00439296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632677|NCT00439296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102632678|NCT00439296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102632679|NCT00439296|Antiemetics|antiemetics|mesh-ancestor
102632680|NCT00439296|Autonomic Agents|autonomic agents|mesh-ancestor
102632681|NCT00439296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102632682|NCT00439296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102632683|NCT00439296|Glucocorticoids|glucocorticoids|mesh-ancestor
102632684|NCT00439296|Hormones|hormones|mesh-ancestor
102632685|NCT00439296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102632686|NCT00439296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102632687|NCT00439296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102632688|NCT00439296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102632689|NCT00439296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102632690|NCT00439296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102632691|NCT00439296|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102632692|NCT00439296|Abortifacient Agents|abortifacient agents|mesh-ancestor
102632693|NCT00439296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102632694|NCT00439296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102632695|NCT00439296|Antimetabolites|antimetabolites|mesh-ancestor
102632696|NCT00439296|Dermatologic Agents|dermatologic agents|mesh-ancestor
102632697|NCT00439296|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102632698|NCT00439296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102632699|NCT00439296|Antiviral Agents|antiviral agents|mesh-ancestor
102632700|NCT00439296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102632701|NCT03117660|Vitamin A|vitamin a|mesh-list
102632702|NCT03117660|Vitamins|vitamins|mesh-ancestor
102632703|NCT03117660|Micronutrients|micronutrients|mesh-ancestor
102632704|NCT03117660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632705|NCT00439374|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
102632706|NCT00439374|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
102632707|NCT00439374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102632708|NCT00439374|Hormone Antagonists|hormone antagonists|mesh-ancestor
102632709|NCT00439374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102632710|NCT00439374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632711|NCT00439374|Progestins|progestins|mesh-ancestor
102632712|NCT00439374|Hormones|hormones|mesh-ancestor
102632713|NCT00439608|Paclitaxel|paclitaxel|mesh-list
102632714|NCT00439608|Carboplatin|carboplatin|mesh-list
102632715|NCT00439608|Cetuximab|cetuximab|mesh-list
102632716|NCT00439608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102632717|NCT00439608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632718|NCT00439608|Tubulin Modulators|tubulin modulators|mesh-ancestor
102632719|NCT00439608|Antimitotic Agents|antimitotic agents|mesh-ancestor
102632720|NCT00439608|Mitosis Modulators|mitosis modulators|mesh-ancestor
102632721|NCT00439608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632722|NCT00439608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102632723|NCT04750122|Carboplatin|carboplatin|mesh-list
102632724|NCT04750122|Docetaxel|docetaxel|mesh-list
102632725|NCT04750122|Trastuzumab|trastuzumab|mesh-list
102632726|NCT04750122|Pertuzumab|pertuzumab|mesh-list
102632727|NCT04750122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632728|NCT04750122|Tubulin Modulators|tubulin modulators|mesh-ancestor
102632729|NCT04750122|Antimitotic Agents|antimitotic agents|mesh-ancestor
102632730|NCT04750122|Mitosis Modulators|mitosis modulators|mesh-ancestor
102632731|NCT04750122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632732|NCT04750122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102632733|NCT00443352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102632734|NCT00443352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102632735|NCT00443352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102632736|NCT00443352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102632737|NCT00443352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632738|NCT00443352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102632739|NCT00443352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632740|NCT00443352|Analgesics|analgesics|mesh-ancestor
102632741|NCT00443352|Sensory System Agents|sensory system agents|mesh-ancestor
102632742|NCT00443352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102632743|NCT00443352|Antidepressive Agents|antidepressive agents|mesh-ancestor
102632744|NCT00443352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102632745|NCT00443352|Dopamine Agents|dopamine agents|mesh-ancestor
102632746|NCT00445302|Plerixafor|plerixafor|mesh-list
102632747|NCT00445302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102632748|NCT00445302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102632749|NCT00445302|Antiviral Agents|antiviral agents|mesh-ancestor
102632750|NCT00445302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102632751|NCT00504504|Rituximab|rituximab|mesh-list
102632752|NCT00504504|Doxorubicin|doxorubicin|mesh-list
102632753|NCT00504504|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102632754|NCT00504504|Dacarbazine|dacarbazine|mesh-list
102632755|NCT00504504|Bleomycin|bleomycin|mesh-list
102632756|NCT00504504|Vinblastine|vinblastine|mesh-list
102632757|NCT00504504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102632758|NCT00504504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632759|NCT00504504|Immunologic Factors|immunologic factors|mesh-ancestor
102632760|NCT00504504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275147|NCT00003808|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102632761|NCT00504504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102632762|NCT00504504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102632763|NCT00504504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102632764|NCT00504504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102632765|NCT00504504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102632766|NCT00504504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632767|NCT00504504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102632768|NCT00504504|Alkylating Agents|alkylating agents|mesh-ancestor
102632769|NCT00504504|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102632770|NCT00504504|Tubulin Modulators|tubulin modulators|mesh-ancestor
102632771|NCT00504504|Antimitotic Agents|antimitotic agents|mesh-ancestor
102632772|NCT00504504|Mitosis Modulators|mitosis modulators|mesh-ancestor
102632773|NCT00504660|Celecoxib|celecoxib|mesh-list
102632774|NCT00504660|Capecitabine|capecitabine|mesh-list
102632775|NCT00504660|Thioguanine|thioguanine|mesh-list
102632776|NCT00504660|Temozolomide|temozolomide|mesh-list
102632777|NCT00504660|Lomustine|lomustine|mesh-list
102632778|NCT00504660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102632779|NCT00504660|Antimetabolites|antimetabolites|mesh-ancestor
102632780|NCT00504660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632781|NCT00504660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632782|NCT00504660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102632783|NCT00504660|Alkylating Agents|alkylating agents|mesh-ancestor
102632784|NCT00504660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102632785|NCT00504660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101605182|NCT02663050|Diclofenac|diclofenac|mesh-list
102632786|NCT00504660|Analgesics|analgesics|mesh-ancestor
102632787|NCT00504660|Sensory System Agents|sensory system agents|mesh-ancestor
102632788|NCT00504660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102632789|NCT00504660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632790|NCT00504660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102632791|NCT00504660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102632792|NCT00504660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102632793|NCT00504660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102632794|NCT00504660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102632795|NCT00505518|Psychotropic Drugs|psychotropic drugs|mesh-list
102632796|NCT00544908|Dasatinib|dasatinib|mesh-list
102632797|NCT00544908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632798|NCT00544908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102632799|NCT00544908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102632800|NCT00544908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632801|NCT00447330|Bevacizumab|bevacizumab|mesh-list
102632802|NCT00447330|Capecitabine|capecitabine|mesh-list
102632803|NCT00447330|Oxaliplatin|oxaliplatin|mesh-list
102632804|NCT00447330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102632805|NCT00447330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632806|NCT00447330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102632807|NCT00447330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102632808|NCT00447330|Growth Substances|growth substances|mesh-ancestor
102632809|NCT00447330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632810|NCT00447330|Growth Inhibitors|growth inhibitors|mesh-ancestor
102632811|NCT00447330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102632812|NCT00447330|Antimetabolites|antimetabolites|mesh-ancestor
102632813|NCT00447330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632814|NCT02115048|Letrozole|letrozole|mesh-list
102632815|NCT02115048|Afatinib|afatinib|mesh-list
102632816|NCT02115048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632817|NCT02115048|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102632818|NCT02115048|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102632819|NCT02115048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102632820|NCT02115048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632821|NCT02115048|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102632822|NCT02115048|Hormone Antagonists|hormone antagonists|mesh-ancestor
102632823|NCT02115048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102632824|NCT02115048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632825|NCT02115048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102632826|NCT00546156|Paclitaxel|paclitaxel|mesh-list
102632827|NCT00546156|Cyclophosphamide|cyclophosphamide|mesh-list
102632828|NCT00546156|Bevacizumab|bevacizumab|mesh-list
102632829|NCT00546156|Doxorubicin|doxorubicin|mesh-list
102632830|NCT00546156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102632831|NCT00546156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632832|NCT00546156|Tubulin Modulators|tubulin modulators|mesh-ancestor
102632833|NCT00546156|Antimitotic Agents|antimitotic agents|mesh-ancestor
102632834|NCT00546156|Mitosis Modulators|mitosis modulators|mesh-ancestor
102632835|NCT00546156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632836|NCT00546156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102632837|NCT00546156|Immunologic Factors|immunologic factors|mesh-ancestor
102632838|NCT00546156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632839|NCT00546156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102632840|NCT00546156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101921326|NCT03175432|Atezolizumab|atezolizumab|mesh-list
102275148|NCT00003808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102632841|NCT00546156|Alkylating Agents|alkylating agents|mesh-ancestor
102632842|NCT00546156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102632843|NCT00546156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102632844|NCT00546156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102632845|NCT00546156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102632846|NCT00546156|Growth Substances|growth substances|mesh-ancestor
102632847|NCT00546156|Growth Inhibitors|growth inhibitors|mesh-ancestor
102632848|NCT00546156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102632849|NCT00546156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102632850|NCT00546156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102632851|NCT00546156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102632852|NCT00449046|Fluticasone|fluticasone|mesh-list
102632853|NCT00449046|Xhance|xhance|mesh-list
102632854|NCT00449046|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102632855|NCT00449046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102632856|NCT00449046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102632857|NCT00449046|Autonomic Agents|autonomic agents|mesh-ancestor
102632858|NCT00449046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102632859|NCT00449046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632860|NCT00449046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102632861|NCT00449046|Respiratory System Agents|respiratory system agents|mesh-ancestor
102632862|NCT00449046|Dermatologic Agents|dermatologic agents|mesh-ancestor
102632863|NCT00449046|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102632864|NCT00449046|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102632865|NCT00449046|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102632866|NCT00449046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102632867|NCT00449046|Adrenergic Agents|adrenergic agents|mesh-ancestor
102632868|NCT00449046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102632869|NCT00449046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632870|NCT00449748|Everolimus|everolimus|mesh-list
102632871|NCT00449748|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102632872|NCT00449748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102632873|NCT00449748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102632874|NCT00449748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632875|NCT00449748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102632876|NCT00449748|Immunologic Factors|immunologic factors|mesh-ancestor
102632877|NCT00449748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632878|NCT00449748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632879|NCT00509496|Aldesleukin|aldesleukin|mesh-list
102632880|NCT00509496|Cyclophosphamide|cyclophosphamide|mesh-list
102632881|NCT00509496|Fludarabine|fludarabine|mesh-list
102632882|NCT00509496|Fludarabine phosphate|fludarabine phosphate|mesh-list
102632883|NCT00509496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102632884|NCT00509496|Immunologic Factors|immunologic factors|mesh-ancestor
102632885|NCT00509496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632886|NCT00509496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102632887|NCT00509496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102632888|NCT00509496|Alkylating Agents|alkylating agents|mesh-ancestor
102632889|NCT00509496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632890|NCT00509496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632891|NCT00509496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102632892|NCT00509496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102632893|NCT00509496|Antimetabolites|antimetabolites|mesh-ancestor
102632894|NCT00509496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102632895|NCT00509496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102632896|NCT00509496|Antiviral Agents|antiviral agents|mesh-ancestor
102632897|NCT00509496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102632898|NCT00548418|Bevacizumab|bevacizumab|mesh-list
102632899|NCT00548418|Topotecan|topotecan|mesh-list
102632900|NCT00548418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102632901|NCT00548418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632902|NCT00548418|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102632903|NCT00548418|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102632904|NCT00548418|Growth Substances|growth substances|mesh-ancestor
102632905|NCT00548418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632906|NCT00548418|Growth Inhibitors|growth inhibitors|mesh-ancestor
102632907|NCT00548418|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102632908|NCT00548418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102632909|NCT00548418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102632910|NCT00548418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632911|NCT00511992|Paclitaxel|paclitaxel|mesh-list
102632912|NCT00511992|Bevacizumab|bevacizumab|mesh-list
102632913|NCT00511992|Cisplatin|cisplatin|mesh-list
102275149|NCT00003808|Purinergic Agents|purinergic agents|mesh-ancestor
101921401|NCT02584478|Paclitaxel|paclitaxel|mesh-list
102632914|NCT00511992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102632915|NCT00511992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632916|NCT00511992|Tubulin Modulators|tubulin modulators|mesh-ancestor
102632917|NCT00511992|Antimitotic Agents|antimitotic agents|mesh-ancestor
102632918|NCT00511992|Mitosis Modulators|mitosis modulators|mesh-ancestor
102632919|NCT00511992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632920|NCT00511992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102632921|NCT00511992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102632922|NCT00511992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102632923|NCT00511992|Growth Substances|growth substances|mesh-ancestor
102632924|NCT00511992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632925|NCT00511992|Growth Inhibitors|growth inhibitors|mesh-ancestor
102632926|NCT00451698|Epoetin Alfa|epoetin alfa|mesh-list
102632927|NCT00451698|Hematinics|hematinics|mesh-ancestor
102632928|NCT00549042|Hydromorphone|hydromorphone|mesh-list
102632929|NCT00549042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102632930|NCT00549042|Narcotics|narcotics|mesh-ancestor
102632931|NCT00549042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102632932|NCT00549042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632933|NCT00549042|Analgesics|analgesics|mesh-ancestor
102632934|NCT00549042|Sensory System Agents|sensory system agents|mesh-ancestor
102632935|NCT00549042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102632936|NCT00452868|Donepezil|donepezil|mesh-list
102632937|NCT00452868|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102632938|NCT00452868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102632939|NCT00452868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632940|NCT00452868|Cholinergic Agents|cholinergic agents|mesh-ancestor
102632941|NCT00452868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102632942|NCT00452868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632943|NCT00452868|Nootropic Agents|nootropic agents|mesh-ancestor
102632944|NCT00453336|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
102632945|NCT00453336|Trioxsalen|trioxsalen|mesh-list
102632946|NCT00453336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632947|NCT00453336|Dermatologic Agents|dermatologic agents|mesh-ancestor
102632948|NCT00453336|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102632949|NCT00549822|Letrozole|letrozole|mesh-list
102632950|NCT00549822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102632951|NCT00549822|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102632952|NCT00549822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102632953|NCT00549822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102632954|NCT00549822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632955|NCT00549822|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102632956|NCT00549822|Hormone Antagonists|hormone antagonists|mesh-ancestor
102632957|NCT00549822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102632958|NCT00549822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632959|NCT00550290|Cefazolin|cefazolin|mesh-list
102632960|NCT00550290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102632961|NCT00550290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102632962|NCT01797198|Repaglinide|repaglinide|mesh-list
102632963|NCT01797198|Gemfibrozil|gemfibrozil|mesh-list
102632964|NCT01797198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102632965|NCT01797198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632966|NCT01797198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102632967|NCT01797198|Antimetabolites|antimetabolites|mesh-ancestor
102632968|NCT01797198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632969|NCT01797198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102632970|NCT01797198|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102632971|NCT01797198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102632972|NCT01797198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102632973|NCT00552786|Acetylcysteine|acetylcysteine|mesh-list
102632974|NCT00552786|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102632975|NCT00552786|Antiviral Agents|antiviral agents|mesh-ancestor
102632976|NCT00552786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102632977|NCT00552786|Expectorants|expectorants|mesh-ancestor
102632978|NCT00552786|Respiratory System Agents|respiratory system agents|mesh-ancestor
102632979|NCT00552786|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102632980|NCT00552786|Antioxidants|antioxidants|mesh-ancestor
102632981|NCT00552786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632982|NCT00552786|Protective Agents|protective agents|mesh-ancestor
102632983|NCT00552786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632984|NCT00552786|Antidotes|antidotes|mesh-ancestor
102632985|NCT00517530|Obinutuzumab|obinutuzumab|mesh-list
102275150|NCT00003808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102275151|NCT00003592|Paclitaxel|paclitaxel|mesh-list
102632986|NCT00517530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102632987|NCT00517530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102275152|NCT00003592|Methotrexate|methotrexate|mesh-list
102632988|NCT00518154|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
102632989|NCT00518154|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102632990|NCT00518154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102632991|NCT00518154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102632992|NCT00518154|Cholinergic Agents|cholinergic agents|mesh-ancestor
102632993|NCT00518154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102632994|NCT00518154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102632995|NCT00553098|Cyclosporine|cyclosporine|mesh-list
102632996|NCT00553098|Mycophenolic Acid|mycophenolic acid|mesh-list
102632997|NCT00553098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102632998|NCT00553098|Alemtuzumab|alemtuzumab|mesh-list
102632999|NCT00553098|Fludarabine|fludarabine|mesh-list
102633000|NCT00553098|Fludarabine phosphate|fludarabine phosphate|mesh-list
102633001|NCT00553098|Antibodies|antibodies|mesh-list
102633002|NCT00553098|Immunoglobulins|immunoglobulins|mesh-list
102633003|NCT00553098|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102633004|NCT00553098|Cyclosporins|cyclosporins|mesh-list
102633005|NCT00553098|Immunologic Factors|immunologic factors|mesh-ancestor
102633006|NCT00553098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633007|NCT00553098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102633008|NCT00553098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102633009|NCT00553098|Antimetabolites|antimetabolites|mesh-ancestor
102633010|NCT00553098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633011|NCT00553098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102633012|NCT00553098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102633013|NCT00553098|Antifungal Agents|antifungal agents|mesh-ancestor
102633014|NCT00553098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102633015|NCT00553098|Dermatologic Agents|dermatologic agents|mesh-ancestor
102633016|NCT00553098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102633017|NCT00553098|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102633018|NCT00553098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102633019|NCT00553098|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102633020|NCT00553098|Antitubercular Agents|antitubercular agents|mesh-ancestor
102633021|NCT00553098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102633022|NCT00553410|Letrozole|letrozole|mesh-list
102633023|NCT00553410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102633024|NCT00553410|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102633025|NCT00553410|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102633026|NCT00553410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102633027|NCT00553410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633028|NCT00553410|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102633029|NCT00553410|Hormone Antagonists|hormone antagonists|mesh-ancestor
102633030|NCT00553410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102633031|NCT00553410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633032|NCT00554970|Budesonide|budesonide|mesh-list
102633033|NCT00554970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102633034|NCT00554970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102633035|NCT00554970|Autonomic Agents|autonomic agents|mesh-ancestor
102633036|NCT00554970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102633037|NCT00554970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633038|NCT00554970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102633039|NCT00554970|Respiratory System Agents|respiratory system agents|mesh-ancestor
102633040|NCT00554970|Glucocorticoids|glucocorticoids|mesh-ancestor
102633041|NCT00554970|Hormones|hormones|mesh-ancestor
101605458|NCT00648154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102633042|NCT00554970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102633043|NCT00524472|Insulin|insulin|mesh-list
102633044|NCT00524472|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102633045|NCT00524472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102633046|NCT00524472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633047|NCT00555048|Cyclophosphamide|cyclophosphamide|mesh-list
102633048|NCT00555048|Busulfan|busulfan|mesh-list
102633049|NCT00555048|Methotrexate|methotrexate|mesh-list
102633050|NCT00555048|Alemtuzumab|alemtuzumab|mesh-list
102633051|NCT00555048|Tacrolimus|tacrolimus|mesh-list
102633052|NCT00555048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102633053|NCT00555048|Immunologic Factors|immunologic factors|mesh-ancestor
102633054|NCT00555048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633055|NCT00555048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102633056|NCT00555048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102633057|NCT00555048|Alkylating Agents|alkylating agents|mesh-ancestor
102633058|NCT00555048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633059|NCT00555048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102633060|NCT00555048|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102275153|NCT00003592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102633061|NCT00555048|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102633062|NCT00555048|Abortifacient Agents|abortifacient agents|mesh-ancestor
102633063|NCT00555048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102633064|NCT00555048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102633065|NCT00555048|Antimetabolites|antimetabolites|mesh-ancestor
102633066|NCT00555048|Dermatologic Agents|dermatologic agents|mesh-ancestor
102633067|NCT00555048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102633068|NCT00555048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102633069|NCT00555048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102633070|NCT00555048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102633071|NCT00555048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102633072|NCT00525798|Calcitonin|calcitonin|mesh-list
102633073|NCT00525798|Salmon calcitonin|salmon calcitonin|mesh-list
102633074|NCT00525798|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
102633075|NCT00525798|Katacalcin|katacalcin|mesh-list
102633076|NCT00525798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102633077|NCT00525798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633078|NCT00525798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102633079|NCT00525798|Vasodilator Agents|vasodilator agents|mesh-ancestor
102633080|NCT00525876|Cyclophosphamide|cyclophosphamide|mesh-list
102633081|NCT00525876|Rituximab|rituximab|mesh-list
102633082|NCT00525876|Fludarabine|fludarabine|mesh-list
102633083|NCT00525876|Fludarabine phosphate|fludarabine phosphate|mesh-list
102633084|NCT00525876|Alemtuzumab|alemtuzumab|mesh-list
102633085|NCT00525876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102633086|NCT00525876|Immunologic Factors|immunologic factors|mesh-ancestor
102633087|NCT00525876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633088|NCT00525876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102633089|NCT00525876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102633090|NCT00525876|Alkylating Agents|alkylating agents|mesh-ancestor
102633091|NCT00525876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633092|NCT00525876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102633093|NCT00525876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102633094|NCT00525876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102633095|NCT00525876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102633096|NCT00525876|Antimetabolites|antimetabolites|mesh-ancestor
102633097|NCT00555750|Eszopiclone|eszopiclone|mesh-list
102633098|NCT00555750|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102633099|NCT00555750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102633100|NCT00555750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633101|NCT00556140|Aripiprazole|aripiprazole|mesh-list
102633102|NCT00556140|Antidepressive Agents|antidepressive agents|mesh-ancestor
102633103|NCT00556140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102633104|NCT00556140|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102633105|NCT00556140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102633106|NCT00556140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102633107|NCT00556140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633108|NCT00556140|Dopamine Agonists|dopamine agonists|mesh-ancestor
102633109|NCT00556140|Dopamine Agents|dopamine agents|mesh-ancestor
102633110|NCT00556140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102633111|NCT00556140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633112|NCT00556140|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102633113|NCT00556140|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102633114|NCT00556140|Serotonin Agents|serotonin agents|mesh-ancestor
102633115|NCT00556140|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102633116|NCT00556140|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102633117|NCT00556140|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102633118|NCT00556140|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102633119|NCT00527124|Prednisone|prednisone|mesh-list
102633120|NCT00527124|Docetaxel|docetaxel|mesh-list
102633121|NCT00527124|Cediranib|cediranib|mesh-list
102633122|NCT00527124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102633123|NCT00527124|Tubulin Modulators|tubulin modulators|mesh-ancestor
102633124|NCT00527124|Antimitotic Agents|antimitotic agents|mesh-ancestor
102633125|NCT00527124|Mitosis Modulators|mitosis modulators|mesh-ancestor
102633126|NCT00527124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633127|NCT00527124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102633128|NCT00527124|Glucocorticoids|glucocorticoids|mesh-ancestor
102633129|NCT00527124|Hormones|hormones|mesh-ancestor
102633130|NCT00527124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102633131|NCT00527124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633132|NCT00527124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102633133|NCT00527124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102633134|NCT00527124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102633135|NCT00527592|Travoprost|travoprost|mesh-list
102275154|NCT00003592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102633137|NCT00527592|Latanoprost|latanoprost|mesh-list
102633138|NCT00527592|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102633139|NCT00527592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102633140|NCT00556452|Busulfan|busulfan|mesh-list
102633141|NCT00556452|Clofarabine|clofarabine|mesh-list
102633142|NCT00556452|Alkylating Agents|alkylating agents|mesh-ancestor
102633143|NCT00556452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633144|NCT00556452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102633145|NCT00556452|Immunologic Factors|immunologic factors|mesh-ancestor
102633146|NCT00556452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633147|NCT00556452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102633148|NCT00556452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102633149|NCT00556452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102633150|NCT00556452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102633151|NCT00556452|Antimetabolites|antimetabolites|mesh-ancestor
102633152|NCT03158376|Gabapentin|gabapentin|mesh-list
102633153|NCT03158376|Analgesics|analgesics|mesh-ancestor
102633154|NCT03158376|Sensory System Agents|sensory system agents|mesh-ancestor
102633155|NCT03158376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102633156|NCT03158376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633157|NCT03158376|Anticonvulsants|anticonvulsants|mesh-ancestor
102633158|NCT03158376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102633159|NCT03158376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102633160|NCT03158376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102633161|NCT03158376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102633162|NCT03158376|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102633163|NCT03158376|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102633164|NCT03158376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102633165|NCT03158376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633166|NCT03158376|Antimanic Agents|antimanic agents|mesh-ancestor
102633167|NCT01797900|Paclitaxel|paclitaxel|mesh-list
102633168|NCT01797900|Cisplatin|cisplatin|mesh-list
102633169|NCT01797900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102633170|NCT01797900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102633171|NCT01797900|Tubulin Modulators|tubulin modulators|mesh-ancestor
102633172|NCT01797900|Antimitotic Agents|antimitotic agents|mesh-ancestor
102633173|NCT01797900|Mitosis Modulators|mitosis modulators|mesh-ancestor
102633174|NCT01797900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633175|NCT03572790|Prucalopride|prucalopride|mesh-list
102633176|NCT03572790|Laxatives|laxatives|mesh-ancestor
102633177|NCT03572790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102633178|NCT03572790|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
102633179|NCT03572790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102633180|NCT03572790|Serotonin Agents|serotonin agents|mesh-ancestor
102633181|NCT03572790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102633182|NCT03572790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633183|NCT03572790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633184|NCT03428802|Pembrolizumab|pembrolizumab|mesh-list
102633185|NCT03428802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102633186|NCT03428802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102633187|NCT03428802|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102633188|NCT03428802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633189|NCT03379194|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102633190|NCT03379194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102633191|NCT02319486|Carboplatin|carboplatin|mesh-list
102633192|NCT02319486|Etoposide|etoposide|mesh-list
102633193|NCT02319486|Vincristine|vincristine|mesh-list
102633194|NCT02319486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102633195|NCT02319486|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102633196|NCT02319486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102633197|NCT02319486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102633198|NCT02319486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102633199|NCT02319486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633200|NCT02319486|Tubulin Modulators|tubulin modulators|mesh-ancestor
102633201|NCT02319486|Antimitotic Agents|antimitotic agents|mesh-ancestor
102633202|NCT02319486|Mitosis Modulators|mitosis modulators|mesh-ancestor
102633203|NCT03117972|Leucovorin|leucovorin|mesh-list
102633204|NCT03117972|Bevacizumab|bevacizumab|mesh-list
102633205|NCT03117972|Fluorouracil|fluorouracil|mesh-list
102633206|NCT03117972|Capecitabine|capecitabine|mesh-list
102633207|NCT03117972|Oxaliplatin|oxaliplatin|mesh-list
102275155|NCT00003592|Tubulin Modulators|tubulin modulators|mesh-ancestor
102275156|NCT00003592|Antimitotic Agents|antimitotic agents|mesh-ancestor
102633208|NCT03117972|Irinotecan|irinotecan|mesh-list
102633209|NCT03117972|Levoleucovorin|levoleucovorin|mesh-list
102633210|NCT03117972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102633211|NCT03117972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102633212|NCT03117972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102633213|NCT03117972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102633214|NCT03117972|Growth Substances|growth substances|mesh-ancestor
102633215|NCT03117972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633216|NCT03117972|Growth Inhibitors|growth inhibitors|mesh-ancestor
102633217|NCT03117972|Antimetabolites|antimetabolites|mesh-ancestor
102633218|NCT03117972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633219|NCT03117972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102633220|NCT03117972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102633221|NCT03117972|Immunologic Factors|immunologic factors|mesh-ancestor
102633222|NCT03117972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102633223|NCT03117972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102633224|NCT03117972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102633225|NCT03117972|Antidotes|antidotes|mesh-ancestor
102633226|NCT03117972|Protective Agents|protective agents|mesh-ancestor
102633227|NCT03117972|Vitamin B Complex|vitamin b complex|mesh-ancestor
102633228|NCT03117972|Vitamins|vitamins|mesh-ancestor
102633229|NCT03117972|Micronutrients|micronutrients|mesh-ancestor
102633230|NCT05622162|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
102633231|NCT05622162|18F-JK-PSMA-7|18f-jk-psma-7|mesh-list
102633232|NCT05622162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633233|NCT00558012|Vitamin D|vitamin d|mesh-list
102633234|NCT00558012|Zoledronic Acid|zoledronic acid|mesh-list
102633235|NCT00558012|Calcium|calcium|mesh-list
102633236|NCT00558012|Vitamins|vitamins|mesh-ancestor
102633237|NCT00558012|Micronutrients|micronutrients|mesh-ancestor
102633238|NCT00558012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633239|NCT00558012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102633240|NCT00558012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102633241|NCT00561834|Ranibizumab|ranibizumab|mesh-list
102633242|NCT00561834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102633243|NCT00561834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102633244|NCT00561834|Growth Substances|growth substances|mesh-ancestor
102633245|NCT00561834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633246|NCT00561834|Growth Inhibitors|growth inhibitors|mesh-ancestor
102633247|NCT00561834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102633248|NCT04388202|Sertraline|sertraline|mesh-list
102633249|NCT04388202|Escitalopram|escitalopram|mesh-list
102633250|NCT04388202|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102633251|NCT04388202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102633252|NCT04388202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102633253|NCT04388202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633254|NCT04388202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102633255|NCT04388202|Serotonin Agents|serotonin agents|mesh-ancestor
102633256|NCT04388202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633257|NCT04388202|Antidepressive Agents|antidepressive agents|mesh-ancestor
102633258|NCT04388202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102633259|NCT02128230|Thalidomide|thalidomide|mesh-list
102633260|NCT02128230|Dexamethasone|dexamethasone|mesh-list
102633261|NCT02128230|Dexamethasone acetate|dexamethasone acetate|mesh-list
102633262|NCT02128230|Cyclophosphamide|cyclophosphamide|mesh-list
102633263|NCT02128230|Melphalan|melphalan|mesh-list
102633264|NCT02128230|Cisplatin|cisplatin|mesh-list
102633265|NCT02128230|Doxorubicin|doxorubicin|mesh-list
102633266|NCT02128230|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102633267|NCT02128230|Etoposide|etoposide|mesh-list
102633268|NCT02128230|Etoposide phosphate|etoposide phosphate|mesh-list
102633269|NCT02128230|Lenalidomide|lenalidomide|mesh-list
102633270|NCT02128230|Lenograstim|lenograstim|mesh-list
102633271|NCT02128230|BB 1101|bb 1101|mesh-list
102633272|NCT02128230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102633273|NCT02128230|Immunologic Factors|immunologic factors|mesh-ancestor
102633274|NCT02128230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633275|NCT02128230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102633276|NCT02128230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102633277|NCT02128230|Alkylating Agents|alkylating agents|mesh-ancestor
102633278|NCT02128230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633279|NCT02128230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102633280|NCT02128230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102633281|NCT02128230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102633282|NCT02128230|Antiemetics|antiemetics|mesh-ancestor
102633283|NCT02128230|Autonomic Agents|autonomic agents|mesh-ancestor
102633284|NCT02128230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102275157|NCT00003592|Mitosis Modulators|mitosis modulators|mesh-ancestor
102633285|NCT02128230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102633286|NCT02128230|Glucocorticoids|glucocorticoids|mesh-ancestor
102633287|NCT02128230|Hormones|hormones|mesh-ancestor
102633288|NCT02128230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102633289|NCT02128230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102633290|NCT02128230|Protease Inhibitors|protease inhibitors|mesh-ancestor
102633291|NCT02128230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102633292|NCT02128230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102633293|NCT02128230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102633294|NCT02128230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102633295|NCT02128230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102633296|NCT02128230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102633297|NCT02128230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102633298|NCT02128230|Growth Substances|growth substances|mesh-ancestor
102633299|NCT02128230|Growth Inhibitors|growth inhibitors|mesh-ancestor
102633300|NCT02128230|Leprostatic Agents|leprostatic agents|mesh-ancestor
102633301|NCT02128230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102633302|NCT02128230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102633303|NCT02128230|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102633304|NCT03416244|Nivolumab|nivolumab|mesh-list
102633305|NCT03416244|Ipilimumab|ipilimumab|mesh-list
101605706|NCT00706225|Hormones|hormones|mesh-ancestor
102633306|NCT03416244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102633307|NCT03416244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102633308|NCT03416244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102633309|NCT03416244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633310|NCT05560620|Caffeine|caffeine|mesh-list
102633311|NCT05560620|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102633312|NCT05560620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633313|NCT05560620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102633314|NCT05560620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102633315|NCT05560620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633316|NCT05560620|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102633317|NCT05560620|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102633318|NCT05560620|Purinergic Agents|purinergic agents|mesh-ancestor
102633319|NCT05560620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102633320|NCT04388124|Bosentan|bosentan|mesh-list
102633321|NCT04388124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102633322|NCT04388124|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102633323|NCT04388124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633324|NCT03172416|Oxaliplatin|oxaliplatin|mesh-list
102633325|NCT03172416|Nivolumab|nivolumab|mesh-list
102633326|NCT03172416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102633327|NCT03172416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102633328|NCT03172416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102633329|NCT03172416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633330|NCT05559996|Hyaluronic Acid|hyaluronic acid|mesh-list
102633331|NCT05559996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102633332|NCT05559996|Immunologic Factors|immunologic factors|mesh-ancestor
102633333|NCT05559996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633334|NCT05559996|Viscosupplements|viscosupplements|mesh-ancestor
102633335|NCT05559996|Protective Agents|protective agents|mesh-ancestor
102633336|NCT02812212|Diuretics|diuretics|mesh-list
102633337|NCT02812212|Natriuretic Agents|natriuretic agents|mesh-ancestor
102633338|NCT02812212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633339|NCT05559450|Blinatumomab|blinatumomab|mesh-list
102633340|NCT05559450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102633341|NCT00564954|Methylphenidate|methylphenidate|mesh-list
102633342|NCT00564954|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
102633343|NCT00564954|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102633344|NCT00564954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633345|NCT00564954|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102633346|NCT00564954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102633347|NCT00564954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102633348|NCT00564954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633349|NCT00564954|Dopamine Agents|dopamine agents|mesh-ancestor
102633350|NCT00564954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102633351|NCT00565266|Beclomethasone|beclomethasone|mesh-list
102633352|NCT00565266|Bromides|bromides|mesh-list
102633353|NCT00565266|Tiotropium Bromide|tiotropium bromide|mesh-list
102633354|NCT00565266|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102633355|NCT00565266|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102633356|NCT00565266|Autonomic Agents|autonomic agents|mesh-ancestor
102633357|NCT00565266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102633358|NCT00565266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633359|NCT00565266|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101921844|NCT03892668|Coagulants|coagulants|mesh-ancestor
101921917|NCT01255956|Antifungal Agents|antifungal agents|mesh-ancestor
102633360|NCT00565266|Respiratory System Agents|respiratory system agents|mesh-ancestor
102633361|NCT00565266|Parasympatholytics|parasympatholytics|mesh-ancestor
102633362|NCT00565266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101605778|NCT00839527|Hormones|hormones|mesh-ancestor
102633363|NCT00565266|Cholinergic Agents|cholinergic agents|mesh-ancestor
102633364|NCT00565266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102633365|NCT00565266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633366|NCT00565266|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102633367|NCT00565266|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102633368|NCT00565266|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102633369|NCT00565266|Adrenergic Agents|adrenergic agents|mesh-ancestor
102633370|NCT00565266|Anticonvulsants|anticonvulsants|mesh-ancestor
102633371|NCT00565266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102633372|NCT00565266|Glucocorticoids|glucocorticoids|mesh-ancestor
102633373|NCT00565266|Hormones|hormones|mesh-ancestor
102633374|NCT00565266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102633375|NCT00568386|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102633376|NCT00568386|Lubricant Eye Drops|lubricant eye drops|mesh-list
102633377|NCT00568386|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102633378|NCT01797978|Methylene Blue|methylene blue|mesh-list
102633379|NCT01797978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102633380|NCT01797978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633381|NCT05363202|Fluticasone|fluticasone|mesh-list
102633382|NCT05363202|Xhance|xhance|mesh-list
102633383|NCT05363202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102633384|NCT05363202|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102633385|NCT05363202|Autonomic Agents|autonomic agents|mesh-ancestor
102633386|NCT05363202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102633387|NCT05363202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633388|NCT05363202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102633389|NCT05363202|Respiratory System Agents|respiratory system agents|mesh-ancestor
102633390|NCT05363202|Dermatologic Agents|dermatologic agents|mesh-ancestor
102633391|NCT05363202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102633392|NCT05461092|Morphine|morphine|mesh-list
102633393|NCT05461092|Analgesics, Opioid|analgesics, opioid|mesh-list
102633394|NCT05461092|Bupivacaine|bupivacaine|mesh-list
102633395|NCT05461092|Anesthetics, Local|anesthetics, local|mesh-ancestor
102633396|NCT05461092|Anesthetics|anesthetics|mesh-ancestor
102633397|NCT05461092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102633398|NCT05461092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633399|NCT05461092|Sensory System Agents|sensory system agents|mesh-ancestor
102633400|NCT05461092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102633401|NCT05461092|Narcotics|narcotics|mesh-ancestor
102633402|NCT05461092|Analgesics|analgesics|mesh-ancestor
102633403|NCT02129478|Olanzapine|olanzapine|mesh-list
102633404|NCT02129478|Antiemetics|antiemetics|mesh-ancestor
102633405|NCT02129478|Autonomic Agents|autonomic agents|mesh-ancestor
102633406|NCT02129478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102633407|NCT02129478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633408|NCT02129478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102633409|NCT02129478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102633410|NCT02129478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102633411|NCT02129478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102633412|NCT02129478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102633413|NCT02129478|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102633414|NCT02129478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102633415|NCT02129478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102633416|NCT02129478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633417|NCT02129478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102633418|NCT02129478|Serotonin Agents|serotonin agents|mesh-ancestor
102633419|NCT02129556|Pembrolizumab|pembrolizumab|mesh-list
102633420|NCT02129556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102633421|NCT02129556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102633422|NCT02129556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102633423|NCT02129556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633424|NCT05362500|Tranylcypromine|tranylcypromine|mesh-list
102633425|NCT05362500|Glycolic acid|glycolic acid|mesh-list
102633426|NCT05362500|Tranexamic Acid|tranexamic acid|mesh-list
102633427|NCT05362500|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102633428|NCT05362500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102633429|NCT05362500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633430|NCT05362500|Hemostatics|hemostatics|mesh-ancestor
102633431|NCT05362500|Coagulants|coagulants|mesh-ancestor
102633432|NCT05362500|Keratolytic Agents|keratolytic agents|mesh-ancestor
102633433|NCT05362500|Dermatologic Agents|dermatologic agents|mesh-ancestor
102633434|NCT05362500|Antidepressive Agents|antidepressive agents|mesh-ancestor
101921992|NCT01259934|Interferon alpha-2|interferon alpha-2|mesh-list
102633435|NCT05362500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102633436|NCT05362500|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102633437|NCT05362500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102633438|NCT05362500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102633439|NCT05362500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102633440|NCT05362500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102633441|NCT05362500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633442|NCT05161806|Aflibercept|aflibercept|mesh-list
102633443|NCT05161806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102633444|NCT05161806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102633445|NCT05161806|Growth Substances|growth substances|mesh-ancestor
102633446|NCT05161806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633447|NCT05161806|Growth Inhibitors|growth inhibitors|mesh-ancestor
102633448|NCT05161806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102633449|NCT05362188|Niacinamide|niacinamide|mesh-list
102633450|NCT05362188|Niacin|niacin|mesh-list
102633451|NCT05362188|Nicotinic Acids|nicotinic acids|mesh-list
102633452|NCT05362188|Vitamin B Complex|vitamin b complex|mesh-ancestor
102633453|NCT05362188|Vitamins|vitamins|mesh-ancestor
102633454|NCT05362188|Micronutrients|micronutrients|mesh-ancestor
102633455|NCT05362188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633456|NCT05362188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102633457|NCT05362188|Antimetabolites|antimetabolites|mesh-ancestor
102633458|NCT05362188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633459|NCT05362188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102633460|NCT05362188|Vasodilator Agents|vasodilator agents|mesh-ancestor
102633461|NCT05353374|Fusidic Acid|fusidic acid|mesh-list
102633462|NCT05353374|Petrolatum|petrolatum|mesh-list
102633463|NCT05353374|Emollients|emollients|mesh-ancestor
102633464|NCT05353374|Dermatologic Agents|dermatologic agents|mesh-ancestor
102633465|NCT05353374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102633466|NCT05353374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102633467|NCT05353374|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102633468|NCT05353374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102633469|NCT05353374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633470|NCT05214222|Paclitaxel|paclitaxel|mesh-list
102633471|NCT05214222|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102633472|NCT05214222|Cisplatin|cisplatin|mesh-list
102633473|NCT05214222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102633474|NCT05214222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102633475|NCT05214222|Tubulin Modulators|tubulin modulators|mesh-ancestor
102633476|NCT05214222|Antimitotic Agents|antimitotic agents|mesh-ancestor
102633477|NCT05214222|Mitosis Modulators|mitosis modulators|mesh-ancestor
102633478|NCT05214222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633479|NCT05198232|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
102633480|NCT05198232|TEMPO|tempo|mesh-list
102633481|NCT05198232|Antioxidants|antioxidants|mesh-ancestor
102633482|NCT05198232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633483|NCT05198232|Protective Agents|protective agents|mesh-ancestor
102633484|NCT05198232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633485|NCT05198232|Antacids|antacids|mesh-ancestor
102633486|NCT05198232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102633487|NCT04747236|Gemcitabine|gemcitabine|mesh-list
102633488|NCT04747236|Azacitidine|azacitidine|mesh-list
102633489|NCT04747236|Romidepsin|romidepsin|mesh-list
102633490|NCT04747236|Belinostat|belinostat|mesh-list
102633491|NCT04747236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102633492|NCT04747236|Antimetabolites|antimetabolites|mesh-ancestor
102633493|NCT04747236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633494|NCT04747236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102633495|NCT04747236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102633496|NCT04747236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102633497|NCT04747236|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102633498|NCT01797666|Pioglitazone|pioglitazone|mesh-list
102633499|NCT01797666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102633500|NCT01797666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633501|NCT05017194|Emodepside|emodepside|mesh-list
102633502|NCT05017194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102633503|NCT05017194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102633504|NCT04501380|Rifamycins|rifamycins|mesh-list
102633505|NCT04501380|Rifamycin SV|rifamycin sv|mesh-list
102633506|NCT04501380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102633507|NCT04501380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102633508|NCT04501380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102633509|NCT04465734|Sorafenib|sorafenib|mesh-list
102633510|NCT04465734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102633511|NCT04465734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102275158|NCT00003592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633512|NCT04465734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102633513|NCT04465734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633515|NCT03856632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
102633516|NCT03856632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102633517|NCT03856632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633518|NCT03856632|Incretins|incretins|mesh-ancestor
102633519|NCT03856632|Hormones|hormones|mesh-ancestor
102633520|NCT03856632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102633521|NCT04286178|Coenzyme Q10|coenzyme q10|mesh-list
102633522|NCT04286178|Micronutrients|micronutrients|mesh-ancestor
102633523|NCT04286178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633524|NCT04286178|Vitamins|vitamins|mesh-ancestor
102633525|NCT04655976|Docetaxel|docetaxel|mesh-list
102633526|NCT04655976|Dostarlimab|dostarlimab|mesh-list
102633527|NCT04655976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102633528|NCT04655976|Tubulin Modulators|tubulin modulators|mesh-ancestor
102633529|NCT04655976|Antimitotic Agents|antimitotic agents|mesh-ancestor
102633530|NCT04655976|Mitosis Modulators|mitosis modulators|mesh-ancestor
102633531|NCT04655976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633532|NCT01798602|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102633533|NCT01798602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102633534|NCT01798602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102633535|NCT01798602|Antimetabolites|antimetabolites|mesh-ancestor
102633536|NCT01798602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633537|NCT01798602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102633538|NCT01798602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102633539|NCT01798602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102633540|NCT02783430|Ketamine|ketamine|mesh-list
102633541|NCT02783430|Milnacipran|milnacipran|mesh-list
102633542|NCT02783430|Levomilnacipran|levomilnacipran|mesh-list
102633543|NCT02783430|Analgesics|analgesics|mesh-ancestor
102633544|NCT02783430|Sensory System Agents|sensory system agents|mesh-ancestor
102633545|NCT02783430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102633546|NCT02783430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633547|NCT02783430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102633548|NCT02783430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102633549|NCT02783430|Anesthetics, General|anesthetics, general|mesh-ancestor
102633550|NCT02783430|Anesthetics|anesthetics|mesh-ancestor
102633551|NCT02783430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102633552|NCT02783430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102633553|NCT02783430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102633554|NCT02783430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102633555|NCT02783430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633556|NCT02783430|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102633557|NCT02783430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102633558|NCT02783430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102633559|NCT02783430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102633560|NCT02783430|Antidepressive Agents|antidepressive agents|mesh-ancestor
102633561|NCT02783430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102633562|NCT03642366|Tadalafil|tadalafil|mesh-list
102633563|NCT03642366|Vasodilator Agents|vasodilator agents|mesh-ancestor
102633564|NCT03642366|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102633565|NCT03642366|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102633566|NCT03642366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102633567|NCT03642366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633568|NCT03642366|Urological Agents|urological agents|mesh-ancestor
102633569|NCT00604968|Doxorubicin|doxorubicin|mesh-list
102633570|NCT00604968|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102633571|NCT00604968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102633572|NCT00604968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102633573|NCT00604968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102633574|NCT00604968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102633575|NCT00604968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102633576|NCT00604968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633577|NCT00605202|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102633578|NCT00605202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102633579|NCT00605202|Diuretics|diuretics|mesh-ancestor
102633580|NCT00605202|Natriuretic Agents|natriuretic agents|mesh-ancestor
102633581|NCT00605202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633582|NCT00605202|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102633583|NCT00605202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102633584|NCT00605202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633585|NCT03548454|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102633587|NCT03548454|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102633588|NCT03548454|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102633589|NCT03548454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102633590|NCT03548454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633591|NCT03548454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102633592|NCT03548454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633593|NCT03548454|Analgesics|analgesics|mesh-ancestor
102633594|NCT03548454|Sensory System Agents|sensory system agents|mesh-ancestor
102633595|NCT03548454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102633596|NCT03548454|Antidepressive Agents|antidepressive agents|mesh-ancestor
102633597|NCT03548454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102633598|NCT03548454|Dopamine Agents|dopamine agents|mesh-ancestor
102633599|NCT03548454|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102633600|NCT03548454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102633601|NCT03548454|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102633602|NCT03548454|Adrenergic Agents|adrenergic agents|mesh-ancestor
102633603|NCT00605904|Acamprosate|acamprosate|mesh-list
102633604|NCT00605904|Yohimbine|yohimbine|mesh-list
102633605|NCT00605904|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102633606|NCT00605904|Mydriatics|mydriatics|mesh-ancestor
102633607|NCT00605904|Autonomic Agents|autonomic agents|mesh-ancestor
102633608|NCT00605904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102633609|NCT00605904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633610|NCT00605904|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102633611|NCT00605904|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102633612|NCT00605904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102633613|NCT00605904|Adrenergic Agents|adrenergic agents|mesh-ancestor
102633614|NCT00605904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102633615|NCT00605904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633616|NCT00605904|Urological Agents|urological agents|mesh-ancestor
102633617|NCT01798914|Insulin|insulin|mesh-list
102633618|NCT01798914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102633619|NCT01798914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633620|NCT05194488|Botulinum Toxins|botulinum toxins|mesh-list
102633621|NCT05194488|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102633622|NCT05194488|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102633623|NCT05194488|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102633624|NCT05194488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102633625|NCT05194488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633626|NCT05194488|Cholinergic Agents|cholinergic agents|mesh-ancestor
102633627|NCT05194488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102633628|NCT05194488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633629|NCT05194488|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102633630|NCT05194488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102633631|NCT05175768|Niacinamide|niacinamide|mesh-list
102633632|NCT05175768|Niacin|niacin|mesh-list
102633633|NCT05175768|Nicotinic Acids|nicotinic acids|mesh-list
102633634|NCT05175768|Vitamin B Complex|vitamin b complex|mesh-ancestor
102633635|NCT05175768|Vitamins|vitamins|mesh-ancestor
102633636|NCT05175768|Micronutrients|micronutrients|mesh-ancestor
102633637|NCT05175768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633638|NCT05175768|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102633639|NCT05175768|Antimetabolites|antimetabolites|mesh-ancestor
102633640|NCT05175768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633641|NCT05175768|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102633642|NCT05175768|Vasodilator Agents|vasodilator agents|mesh-ancestor
102633643|NCT05097846|Amoxicillin|amoxicillin|mesh-list
102633644|NCT05097846|Doxycycline|doxycycline|mesh-list
102633645|NCT05097846|Furazolidone|furazolidone|mesh-list
102633646|NCT05097846|Esomeprazole|esomeprazole|mesh-list
102633647|NCT05097846|Bismuth|bismuth|mesh-list
102633648|NCT05097846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102633649|NCT05097846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101606068|NCT02658214|Antidotes|antidotes|mesh-ancestor
102633650|NCT05097846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102633651|NCT05097846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102633652|NCT05097846|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102633653|NCT05097846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102633654|NCT05097846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275159|NCT00003592|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102275160|NCT00003592|Abortifacient Agents|abortifacient agents|mesh-ancestor
102633655|NCT05097846|Antimalarials|antimalarials|mesh-ancestor
102633656|NCT05097846|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102633657|NCT05097846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102633658|NCT05097846|Antacids|antacids|mesh-ancestor
102633659|NCT05097846|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102633660|NCT05097846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102633661|NCT05097846|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
102633662|NCT05097846|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102633663|NCT00608634|Perillyl alcohol|perillyl alcohol|mesh-list
102633664|NCT00608634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102633665|NCT00608634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102633666|NCT00608634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633667|NCT02897700|Cyclophosphamide|cyclophosphamide|mesh-list
102633668|NCT02897700|Doxorubicin|doxorubicin|mesh-list
102633669|NCT02897700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102633670|NCT02897700|Fluorouracil|fluorouracil|mesh-list
102633671|NCT02897700|Methotrexate|methotrexate|mesh-list
102633672|NCT02897700|Epirubicin|epirubicin|mesh-list
102633673|NCT02897700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102633674|NCT02897700|Immunologic Factors|immunologic factors|mesh-ancestor
102633675|NCT02897700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633676|NCT02897700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102633677|NCT02897700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102633678|NCT02897700|Alkylating Agents|alkylating agents|mesh-ancestor
102633679|NCT02897700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633680|NCT02897700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102633681|NCT02897700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102633682|NCT02897700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102633683|NCT02897700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102633684|NCT02897700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102633685|NCT02897700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102633686|NCT02897700|Antimetabolites|antimetabolites|mesh-ancestor
102633687|NCT02897700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102633688|NCT02897700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102633689|NCT02897700|Abortifacient Agents|abortifacient agents|mesh-ancestor
102633690|NCT02897700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102633691|NCT02897700|Dermatologic Agents|dermatologic agents|mesh-ancestor
102633692|NCT02897700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102633693|NCT02897700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102633694|NCT02889666|Cisplatin|cisplatin|mesh-list
102633695|NCT02889666|Carboplatin|carboplatin|mesh-list
102633696|NCT02889666|Gemcitabine|gemcitabine|mesh-list
102633697|NCT02889666|Docetaxel|docetaxel|mesh-list
102633698|NCT02889666|Oxaliplatin|oxaliplatin|mesh-list
102633699|NCT02889666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102633700|NCT02889666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102633701|NCT02889666|Antimetabolites|antimetabolites|mesh-ancestor
102633702|NCT02889666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633703|NCT02889666|Tubulin Modulators|tubulin modulators|mesh-ancestor
102633704|NCT02889666|Antimitotic Agents|antimitotic agents|mesh-ancestor
102633705|NCT02889666|Mitosis Modulators|mitosis modulators|mesh-ancestor
102633706|NCT00609804|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102633707|NCT00609804|Sorafenib|sorafenib|mesh-list
102633708|NCT00609804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102633709|NCT00609804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102633710|NCT00609804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102633711|NCT00609804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633712|NCT00610428|Prochlorperazine|prochlorperazine|mesh-list
102633713|NCT00610428|Antiemetics|antiemetics|mesh-ancestor
102633714|NCT00610428|Autonomic Agents|autonomic agents|mesh-ancestor
102633715|NCT00610428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102633716|NCT00610428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633717|NCT00610428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102633718|NCT00610428|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102633719|NCT00610428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102633720|NCT00610428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102633721|NCT00610428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102633722|NCT00610428|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102633723|NCT00610428|Dopamine Agents|dopamine agents|mesh-ancestor
102633724|NCT00610428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102633725|NCT00610428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633726|NCT02446236|Rituximab|rituximab|mesh-list
101922222|NCT01157052|Calcium|calcium|mesh-list
102633727|NCT02446236|Lenalidomide|lenalidomide|mesh-list
102633728|NCT02446236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102633729|NCT02446236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102633730|NCT02446236|Immunologic Factors|immunologic factors|mesh-ancestor
102633731|NCT02446236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275162|NCT00003592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633732|NCT02446236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102633733|NCT02446236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102633734|NCT02446236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102633735|NCT02446236|Growth Substances|growth substances|mesh-ancestor
102633736|NCT02446236|Growth Inhibitors|growth inhibitors|mesh-ancestor
102633737|NCT00610740|Gemcitabine|gemcitabine|mesh-list
102633738|NCT00610740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102633739|NCT00610740|Antimetabolites|antimetabolites|mesh-ancestor
102633740|NCT00610740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633741|NCT00610740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102633742|NCT00611442|Lubiprostone|lubiprostone|mesh-list
102633743|NCT00611442|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102633744|NCT00611442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102633745|NCT00611442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633746|NCT02136420|Promethazine|promethazine|mesh-list
102633747|NCT02136420|Diphenhydramine|diphenhydramine|mesh-list
102633748|NCT02136420|Antipruritics|antipruritics|mesh-ancestor
102633749|NCT02136420|Dermatologic Agents|dermatologic agents|mesh-ancestor
102633750|NCT02136420|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102633751|NCT02136420|Histamine Antagonists|histamine antagonists|mesh-ancestor
102633752|NCT02136420|Histamine Agents|histamine agents|mesh-ancestor
102633753|NCT02136420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102633754|NCT02136420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633755|NCT02136420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633756|NCT02136420|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102633757|NCT02136420|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102633758|NCT02136420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102633759|NCT02136420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102633760|NCT02136420|Anesthetics, Local|anesthetics, local|mesh-ancestor
102633761|NCT02136420|Anesthetics|anesthetics|mesh-ancestor
102633762|NCT02136420|Sensory System Agents|sensory system agents|mesh-ancestor
102633763|NCT02136420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102633764|NCT02136420|Antiemetics|antiemetics|mesh-ancestor
102633765|NCT02136420|Autonomic Agents|autonomic agents|mesh-ancestor
102633766|NCT02136420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102633767|NCT02136498|Varenicline|varenicline|mesh-list
102633768|NCT02136498|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102633769|NCT02136498|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102633770|NCT02136498|Cholinergic Agents|cholinergic agents|mesh-ancestor
102633771|NCT02136498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102633772|NCT02136498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633773|NCT02136498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633774|NCT00612222|Aldesleukin|aldesleukin|mesh-list
102633775|NCT00612222|Cyclophosphamide|cyclophosphamide|mesh-list
102633776|NCT00612222|Fludarabine|fludarabine|mesh-list
102633777|NCT00612222|Fludarabine phosphate|fludarabine phosphate|mesh-list
102633778|NCT00612222|Interleukin-2|interleukin-2|mesh-list
102633779|NCT00612222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102633780|NCT00612222|Immunologic Factors|immunologic factors|mesh-ancestor
102633781|NCT00612222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633782|NCT00612222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102633783|NCT00612222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102633784|NCT00612222|Alkylating Agents|alkylating agents|mesh-ancestor
102633785|NCT00612222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633786|NCT00612222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102633787|NCT00612222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102633788|NCT00612222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102633789|NCT00612222|Antimetabolites|antimetabolites|mesh-ancestor
102633790|NCT00612222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102633791|NCT00612222|Analgesics|analgesics|mesh-ancestor
102633792|NCT00612222|Sensory System Agents|sensory system agents|mesh-ancestor
102633793|NCT00612222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102633794|NCT00612222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102633795|NCT00612222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102633796|NCT00612222|Antiviral Agents|antiviral agents|mesh-ancestor
102633797|NCT00612222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102633798|NCT01711242|Capecitabine|capecitabine|mesh-list
102633799|NCT01711242|Oxaliplatin|oxaliplatin|mesh-list
102633800|NCT01711242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102633801|NCT01711242|Antimetabolites|antimetabolites|mesh-ancestor
102633802|NCT01711242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633803|NCT01711242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102633804|NCT04405908|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102633805|NCT04405908|Aluminum sulfate|aluminum sulfate|mesh-list
101922366|NCT01156350|Busulfan|busulfan|mesh-list
102633806|NCT04405908|1018 oligonucleotide|1018 oligonucleotide|mesh-list
102633807|NCT04405908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102633808|NCT04405908|Immunologic Factors|immunologic factors|mesh-ancestor
102633809|NCT04405908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633810|NCT04405908|Antacids|antacids|mesh-ancestor
102633811|NCT04405908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633812|NCT04405908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102633813|NCT04331496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102633814|NCT04304274|Morphine|morphine|mesh-list
102633815|NCT04304274|Ropivacaine|ropivacaine|mesh-list
102633816|NCT04304274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102633817|NCT04304274|Narcotics|narcotics|mesh-ancestor
102633818|NCT04304274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102633819|NCT04304274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633820|NCT04304274|Analgesics|analgesics|mesh-ancestor
102633821|NCT04304274|Sensory System Agents|sensory system agents|mesh-ancestor
102633822|NCT04304274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102633823|NCT04304274|Anesthetics, Local|anesthetics, local|mesh-ancestor
102633824|NCT04304274|Anesthetics|anesthetics|mesh-ancestor
102633825|NCT02132832|Buspirone|buspirone|mesh-list
102633826|NCT02132832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102633827|NCT02132832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102633828|NCT02132832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102633829|NCT02132832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633830|NCT02132832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102633831|NCT02132832|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102633832|NCT02132832|Serotonin Agents|serotonin agents|mesh-ancestor
102633833|NCT02132832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102633834|NCT02132832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633835|NCT00614406|Celecoxib|celecoxib|mesh-list
102633836|NCT00614406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102633837|NCT00614406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102633838|NCT00614406|Analgesics|analgesics|mesh-ancestor
102633839|NCT00614406|Sensory System Agents|sensory system agents|mesh-ancestor
102633840|NCT00614406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102633841|NCT00614406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633842|NCT00614406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102633843|NCT00614406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102633844|NCT00614406|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102633845|NCT00614406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102633846|NCT00614406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102633847|NCT00614406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633848|NCT00614484|Paclitaxel|paclitaxel|mesh-list
102633849|NCT00614484|Carboplatin|carboplatin|mesh-list
102633850|NCT00614484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102633851|NCT00614484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102633852|NCT00614484|Tubulin Modulators|tubulin modulators|mesh-ancestor
102633853|NCT00614484|Antimitotic Agents|antimitotic agents|mesh-ancestor
102633854|NCT00614484|Mitosis Modulators|mitosis modulators|mesh-ancestor
102633855|NCT00614484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633856|NCT04159974|Durvalumab|durvalumab|mesh-list
102633857|NCT04159974|Tremelimumab|tremelimumab|mesh-list
102633858|NCT04159974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102633859|NCT04159974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102633860|NCT04142502|Dexmedetomidine|dexmedetomidine|mesh-list
102633861|NCT04142502|Propofol|propofol|mesh-list
102633862|NCT04142502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102633863|NCT04142502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102633864|NCT04142502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633865|NCT04142502|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102633866|NCT04142502|Anesthetics, General|anesthetics, general|mesh-ancestor
102633867|NCT04142502|Anesthetics|anesthetics|mesh-ancestor
102633868|NCT04142502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102633869|NCT04142502|Analgesics|analgesics|mesh-ancestor
102633870|NCT04142502|Sensory System Agents|sensory system agents|mesh-ancestor
102633871|NCT04142502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102633872|NCT04142502|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102633873|NCT04142502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102633874|NCT04142502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102633875|NCT04142502|Adrenergic Agents|adrenergic agents|mesh-ancestor
102633876|NCT04142502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102633877|NCT04142502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633878|NCT00569010|Cytarabine|cytarabine|mesh-list
102633879|NCT00569010|Azacitidine|azacitidine|mesh-list
102633880|NCT00569010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102275163|NCT00003592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101606295|NCT04167592|Benzydamine|benzydamine|mesh-list
102633881|NCT00569010|Antimetabolites|antimetabolites|mesh-ancestor
102633882|NCT00569010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633883|NCT00569010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102633884|NCT00569010|Antiviral Agents|antiviral agents|mesh-ancestor
102633885|NCT00569010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102633886|NCT00569010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102633887|NCT00569010|Immunologic Factors|immunologic factors|mesh-ancestor
102633888|NCT00569010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633889|NCT00569010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102633890|NCT00616122|Cyclophosphamide|cyclophosphamide|mesh-list
102633891|NCT00616122|Methotrexate|methotrexate|mesh-list
102633892|NCT00616122|Sunitinib|sunitinib|mesh-list
102633893|NCT00616122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102633894|NCT00616122|Immunologic Factors|immunologic factors|mesh-ancestor
102633895|NCT00616122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633896|NCT00616122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102633897|NCT00616122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102633898|NCT00616122|Alkylating Agents|alkylating agents|mesh-ancestor
102633899|NCT00616122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633900|NCT00616122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102633901|NCT00616122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102633902|NCT00616122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102633903|NCT00616122|Abortifacient Agents|abortifacient agents|mesh-ancestor
102633904|NCT00616122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102633905|NCT00616122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102633906|NCT00616122|Antimetabolites|antimetabolites|mesh-ancestor
102633907|NCT00616122|Dermatologic Agents|dermatologic agents|mesh-ancestor
102633908|NCT00616122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102633909|NCT00616122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102633910|NCT00616122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102633911|NCT00616122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102633912|NCT00616122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102633913|NCT00616122|Growth Substances|growth substances|mesh-ancestor
102633914|NCT00616122|Growth Inhibitors|growth inhibitors|mesh-ancestor
102633915|NCT00616122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102633916|NCT00617058|Metformin|metformin|mesh-list
102633917|NCT00617058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102633918|NCT00617058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633919|NCT00618540|Fludarabine|fludarabine|mesh-list
102633920|NCT00618540|Fludarabine phosphate|fludarabine phosphate|mesh-list
102633921|NCT00618540|Melphalan|melphalan|mesh-list
102633922|NCT00618540|Alemtuzumab|alemtuzumab|mesh-list
102633923|NCT00618540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102633924|NCT00618540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102633925|NCT00618540|Antimetabolites|antimetabolites|mesh-ancestor
102633926|NCT00618540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633927|NCT00618540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102633928|NCT00618540|Immunologic Factors|immunologic factors|mesh-ancestor
102633929|NCT00618540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633930|NCT00618540|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101606375|NCT02644720|Hormones|hormones|mesh-ancestor
102633931|NCT00618540|Alkylating Agents|alkylating agents|mesh-ancestor
102633932|NCT00618540|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102633933|NCT00618540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102633934|NCT00570960|Dextrans|dextrans|mesh-list
102633935|NCT00570960|Anticoagulants|anticoagulants|mesh-ancestor
102633936|NCT00570960|Plasma Substitutes|plasma substitutes|mesh-ancestor
102633937|NCT00570960|Blood Substitutes|blood substitutes|mesh-ancestor
102633938|NCT00571428|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102633939|NCT00571428|Formoterol Fumarate|formoterol fumarate|mesh-list
102633940|NCT00571428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102633941|NCT00571428|Autonomic Agents|autonomic agents|mesh-ancestor
102633942|NCT00571428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102633943|NCT00571428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633944|NCT00571428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102633945|NCT00571428|Respiratory System Agents|respiratory system agents|mesh-ancestor
102633946|NCT00571428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102633947|NCT00571428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102633948|NCT00571428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102633949|NCT00571428|Adrenergic Agents|adrenergic agents|mesh-ancestor
102633950|NCT00571428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102275164|NCT00003592|Antimetabolites|antimetabolites|mesh-ancestor
102633951|NCT00571428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633952|NCT00571974|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102275165|NCT00003592|Dermatologic Agents|dermatologic agents|mesh-ancestor
102275166|NCT00003592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102633953|NCT00571974|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102633954|NCT00571974|Dermatologic Agents|dermatologic agents|mesh-ancestor
102633955|NCT00574236|Doxorubicin|doxorubicin|mesh-list
102633956|NCT00574236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102633957|NCT00574236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102633958|NCT00574236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102633959|NCT00574236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102633960|NCT00574236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102633961|NCT00574236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633962|NCT00574548|Vaccines|vaccines|mesh-list
102633963|NCT00574548|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102633964|NCT00574548|Immunologic Factors|immunologic factors|mesh-ancestor
102633965|NCT00574548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633966|NCT01168219|Methotrexate|methotrexate|mesh-list
102633967|NCT01168219|Fludarabine phosphate|fludarabine phosphate|mesh-list
102633968|NCT01168219|Azacitidine|azacitidine|mesh-list
102633969|NCT01168219|Fludarabine|fludarabine|mesh-list
102633970|NCT01168219|Busulfan|busulfan|mesh-list
102633971|NCT01168219|Tacrolimus|tacrolimus|mesh-list
102633972|NCT01168219|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102633973|NCT01168219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102633974|NCT01168219|Abortifacient Agents|abortifacient agents|mesh-ancestor
102633975|NCT01168219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102633976|NCT01168219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102633977|NCT01168219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102633978|NCT01168219|Antimetabolites|antimetabolites|mesh-ancestor
102633979|NCT01168219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633980|NCT01168219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102633981|NCT01168219|Dermatologic Agents|dermatologic agents|mesh-ancestor
102633982|NCT01168219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102633983|NCT01168219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102633984|NCT01168219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102633985|NCT01168219|Immunologic Factors|immunologic factors|mesh-ancestor
102633986|NCT01168219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102633987|NCT01168219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102633988|NCT01168219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102633989|NCT01168219|Alkylating Agents|alkylating agents|mesh-ancestor
102633990|NCT01168219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102633991|NCT01168219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102633992|NCT01115803|Everolimus|everolimus|mesh-list
102633993|NCT01115803|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102633994|NCT01115803|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102633995|NCT01115803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102633996|NCT01115803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102633997|NCT01115803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102633998|NCT01115803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102633999|NCT01115803|Immunologic Factors|immunologic factors|mesh-ancestor
102634000|NCT01115803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634001|NCT01115803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634002|NCT01115569|Hydrocodone|hydrocodone|mesh-list
102634003|NCT01115569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102634004|NCT01115569|Narcotics|narcotics|mesh-ancestor
102634005|NCT01115569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102634006|NCT01115569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634007|NCT01115569|Analgesics|analgesics|mesh-ancestor
102634008|NCT01115569|Sensory System Agents|sensory system agents|mesh-ancestor
102634009|NCT01115569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102634010|NCT01115569|Antitussive Agents|antitussive agents|mesh-ancestor
102634011|NCT01115569|Respiratory System Agents|respiratory system agents|mesh-ancestor
102634012|NCT01107886|Saxagliptin|saxagliptin|mesh-list
102634013|NCT01107886|Incretins|incretins|mesh-ancestor
102634014|NCT01107886|Hormones|hormones|mesh-ancestor
102634015|NCT01107886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102634016|NCT01107886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634017|NCT01107886|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102634018|NCT01107886|Protease Inhibitors|protease inhibitors|mesh-ancestor
102634019|NCT01107886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102634020|NCT01107886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634021|NCT01107886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102634022|NCT01107457|Ixekizumab|ixekizumab|mesh-list
102634023|NCT01107457|Dermatologic Agents|dermatologic agents|mesh-ancestor
102634024|NCT05767008|Sunscreening Agents|sunscreening agents|mesh-list
102634025|NCT05767008|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101922516|NCT01266252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102634026|NCT05767008|Protective Agents|protective agents|mesh-ancestor
102634027|NCT05767008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634028|NCT05767008|Dermatologic Agents|dermatologic agents|mesh-ancestor
102634030|NCT05766605|Doxorubicin|doxorubicin|mesh-list
102634031|NCT05766605|Fluorouracil|fluorouracil|mesh-list
102634032|NCT05766605|Oxaliplatin|oxaliplatin|mesh-list
102634033|NCT05766605|Raltitrexed|raltitrexed|mesh-list
102634034|NCT05766605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634035|NCT05766605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102634036|NCT05766605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102634037|NCT05766605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102634038|NCT05766605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102634039|NCT05766605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634040|NCT05766605|Antimetabolites|antimetabolites|mesh-ancestor
102634041|NCT05766605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102634042|NCT05766605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102634043|NCT05766605|Immunologic Factors|immunologic factors|mesh-ancestor
102634044|NCT05766605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634045|NCT05766605|Antidotes|antidotes|mesh-ancestor
102634046|NCT05766605|Protective Agents|protective agents|mesh-ancestor
102634047|NCT05766605|Vitamin B Complex|vitamin b complex|mesh-ancestor
102634048|NCT05766605|Vitamins|vitamins|mesh-ancestor
102634049|NCT05766605|Micronutrients|micronutrients|mesh-ancestor
102634050|NCT05766605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102634051|NCT05766436|Dexmedetomidine|dexmedetomidine|mesh-list
102634052|NCT05766436|Melatonin|melatonin|mesh-list
102634053|NCT05766436|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102634054|NCT05766436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102634055|NCT05766436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634056|NCT05766436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102634057|NCT05766436|Analgesics|analgesics|mesh-ancestor
102634058|NCT05766436|Sensory System Agents|sensory system agents|mesh-ancestor
102634059|NCT05766436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102634060|NCT05766436|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102634061|NCT05766436|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102634062|NCT05766436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102634063|NCT05766436|Adrenergic Agents|adrenergic agents|mesh-ancestor
102634064|NCT05766436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102634065|NCT05766436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634066|NCT05766436|Antioxidants|antioxidants|mesh-ancestor
102634067|NCT05766436|Protective Agents|protective agents|mesh-ancestor
102634068|NCT05766397|Methoxyflurane|methoxyflurane|mesh-list
102634069|NCT05766397|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102634070|NCT05766397|Anesthetics, General|anesthetics, general|mesh-ancestor
102634071|NCT05766397|Anesthetics|anesthetics|mesh-ancestor
102634072|NCT05766397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102634073|NCT05766397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634074|NCT05766384|Xenon|xenon|mesh-list
102634075|NCT05766384|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102634076|NCT05766384|Anesthetics, General|anesthetics, general|mesh-ancestor
102634077|NCT05766384|Anesthetics|anesthetics|mesh-ancestor
102634078|NCT05766384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102634079|NCT05766384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634080|NCT05766267|Moxifloxacin|moxifloxacin|mesh-list
102634081|NCT05766267|Rifampin|rifampin|mesh-list
102634082|NCT05766267|Isoniazid|isoniazid|mesh-list
102634083|NCT05766267|Pyrazinamide|pyrazinamide|mesh-list
102634084|NCT05766267|Ethambutol|ethambutol|mesh-list
102634085|NCT05766267|Rifabutin|rifabutin|mesh-list
102634086|NCT05766267|Bedaquiline|bedaquiline|mesh-list
102634087|NCT05766267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102634088|NCT05766267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102634089|NCT05766267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102634090|NCT05766267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102634091|NCT05766267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102634092|NCT05766267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634093|NCT05766267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634094|NCT05766267|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102634095|NCT05766267|Antitubercular Agents|antitubercular agents|mesh-ancestor
102634096|NCT05766267|Leprostatic Agents|leprostatic agents|mesh-ancestor
102634097|NCT05766267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102634098|NCT05766267|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101922582|NCT03876444|Methylprednisolone|methylprednisolone|mesh-list
102634099|NCT05766267|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102634100|NCT05766267|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102634101|NCT05766267|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102634102|NCT05766267|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102634103|NCT05766267|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101606537|NCT02644252|Antioxidants|antioxidants|mesh-ancestor
102634104|NCT05766267|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102634105|NCT05766267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102634106|NCT05766267|Antimetabolites|antimetabolites|mesh-ancestor
102634107|NCT05766267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102634109|NCT05766176|Immunoglobulins|immunoglobulins|mesh-list
102634110|NCT05766176|Immunologic Factors|immunologic factors|mesh-ancestor
102634111|NCT05766176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634112|NCT05766124|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102634113|NCT05766124|Plasminogen|plasminogen|mesh-list
102634114|NCT05766124|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102634115|NCT05766124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102634116|NCT05766124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634117|NCT05766085|Dexamethasone|dexamethasone|mesh-list
102634118|NCT05766085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102634119|NCT05766085|Antiemetics|antiemetics|mesh-ancestor
102634120|NCT05766085|Autonomic Agents|autonomic agents|mesh-ancestor
102634121|NCT05766085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102634122|NCT05766085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634123|NCT05766085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102634124|NCT05766085|Glucocorticoids|glucocorticoids|mesh-ancestor
102634125|NCT05766085|Hormones|hormones|mesh-ancestor
102634126|NCT05766085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102634127|NCT05766085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102634128|NCT05766085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634129|NCT05765825|Carboplatin|carboplatin|mesh-list
102634130|NCT05765825|Etoposide|etoposide|mesh-list
102634131|NCT05765825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634132|NCT05765825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102634133|NCT05765825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102634134|NCT05765825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102634135|NCT05765825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102634136|NCT05765825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634137|NCT05765747|Celecoxib|celecoxib|mesh-list
102634138|NCT05765747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102634139|NCT05765747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102634140|NCT05765747|Analgesics|analgesics|mesh-ancestor
102634141|NCT05765747|Sensory System Agents|sensory system agents|mesh-ancestor
102634142|NCT05765747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102634143|NCT05765747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634144|NCT05765747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102634145|NCT05765747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102634146|NCT05765747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102634147|NCT05765747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102634148|NCT05765747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102634149|NCT05765747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634150|NCT05765617|Calcitriol|calcitriol|mesh-list
102634151|NCT05765617|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102634152|NCT05765617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634153|NCT05765617|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102634154|NCT05765617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102634155|NCT05765617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634156|NCT05765617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102634157|NCT05765617|Vitamins|vitamins|mesh-ancestor
102634158|NCT05765617|Micronutrients|micronutrients|mesh-ancestor
102634159|NCT05765617|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102634160|NCT05765578|Vaccines|vaccines|mesh-list
102634161|NCT05765578|Immunologic Factors|immunologic factors|mesh-ancestor
102634162|NCT05765578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634163|NCT05765500|Leuprolide|leuprolide|mesh-list
102634164|NCT05765500|Relugolix|relugolix|mesh-list
102634165|NCT05765500|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102634166|NCT05765500|Fertility Agents|fertility agents|mesh-ancestor
102634167|NCT05765500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102634168|NCT05765500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634169|NCT05765500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102634170|NCT05765500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634171|NCT05765500|Androgen Antagonists|androgen antagonists|mesh-ancestor
102634172|NCT05765500|Hormone Antagonists|hormone antagonists|mesh-ancestor
102634173|NCT05765500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102275167|NCT00003592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102634174|NCT05765357|Trastuzumab|trastuzumab|mesh-list
102634175|NCT05765357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102634176|NCT05765357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634177|NCT05765240|Hyaluronic Acid|hyaluronic acid|mesh-list
102634178|NCT05765240|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102634179|NCT05765240|Immunologic Factors|immunologic factors|mesh-ancestor
102634180|NCT05765240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634181|NCT05765240|Viscosupplements|viscosupplements|mesh-ancestor
102634182|NCT05765240|Protective Agents|protective agents|mesh-ancestor
102634183|NCT05765110|Dopamine|dopamine|mesh-list
102634184|NCT05765110|Dopamine Agonists|dopamine agonists|mesh-list
102634185|NCT05765110|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102634186|NCT05765110|Sympathomimetics|sympathomimetics|mesh-ancestor
102634187|NCT05765110|Autonomic Agents|autonomic agents|mesh-ancestor
102634188|NCT05765110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102634189|NCT05765110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634190|NCT05765110|Dopamine Agents|dopamine agents|mesh-ancestor
102634191|NCT05765110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102634192|NCT05765110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634193|NCT05765110|Protective Agents|protective agents|mesh-ancestor
102634194|NCT05765097|Pancrelipase|pancrelipase|mesh-list
102634195|NCT05765097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102634196|NCT05764811|Canagliflozin|canagliflozin|mesh-list
102634197|NCT05764811|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102634198|NCT05764811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634199|NCT05764811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102634200|NCT05764811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634201|NCT05764798|Zolpidem|zolpidem|mesh-list
102634202|NCT05764798|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102634203|NCT05764798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102634204|NCT05764798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102634205|NCT05764798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634206|NCT05764798|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102634207|NCT05764798|GABA Agonists|gaba agonists|mesh-ancestor
102634208|NCT05764798|GABA Agents|gaba agents|mesh-ancestor
102634209|NCT05764798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102634210|NCT05764798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634211|NCT05764746|Artesunate|artesunate|mesh-list
102634212|NCT05764746|Lumefantrine|lumefantrine|mesh-list
102634213|NCT05764746|Artemether|artemether|mesh-list
102634214|NCT05764746|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102634215|NCT05764746|Amodiaquine|amodiaquine|mesh-list
102634216|NCT05764746|Antimalarials|antimalarials|mesh-ancestor
102634217|NCT05764746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102634218|NCT05764746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102634219|NCT05764746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102634220|NCT05764746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634221|NCT05764746|Antiviral Agents|antiviral agents|mesh-ancestor
102634222|NCT05764746|Schistosomicides|schistosomicides|mesh-ancestor
102634223|NCT05764746|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102634224|NCT05764746|Anthelmintics|anthelmintics|mesh-ancestor
102634225|NCT05764707|Acetaminophen|acetaminophen|mesh-list
102634226|NCT05764707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102634227|NCT05764707|Analgesics|analgesics|mesh-ancestor
102634228|NCT05764707|Sensory System Agents|sensory system agents|mesh-ancestor
102634229|NCT05764707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102634230|NCT05764707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634231|NCT05764707|Antipyretics|antipyretics|mesh-ancestor
102634232|NCT05763602|Povidone-Iodine|povidone-iodine|mesh-list
102634233|NCT05763602|Povidone|povidone|mesh-list
102634234|NCT05763602|Plasma Substitutes|plasma substitutes|mesh-ancestor
102634235|NCT05763602|Blood Substitutes|blood substitutes|mesh-ancestor
102634236|NCT05763602|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102634237|NCT05763602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102634238|NCT05757622|Remifentanil|remifentanil|mesh-list
102634239|NCT05757622|Propofol|propofol|mesh-list
102634240|NCT05757622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102634241|NCT05757622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102634242|NCT05757622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634243|NCT05757622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102634244|NCT05757622|Anesthetics, General|anesthetics, general|mesh-ancestor
102634245|NCT05757622|Anesthetics|anesthetics|mesh-ancestor
102634246|NCT05757622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102634247|NCT05757622|Narcotics|narcotics|mesh-ancestor
102634248|NCT05757622|Analgesics|analgesics|mesh-ancestor
102275168|NCT00003592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102634249|NCT05757622|Sensory System Agents|sensory system agents|mesh-ancestor
102634250|NCT05757622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102634251|NCT05746650|Hormones|hormones|mesh-list
102634252|NCT05746650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102634253|NCT05746650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634254|NCT05743400|Thymoglobulin|thymoglobulin|mesh-list
102634255|NCT05743400|Immunologic Factors|immunologic factors|mesh-ancestor
102634256|NCT05743400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634257|NCT05743400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102634258|NCT05731726|Celecoxib|celecoxib|mesh-list
102634259|NCT05731726|Capecitabine|capecitabine|mesh-list
102634260|NCT05731726|Oxaliplatin|oxaliplatin|mesh-list
102634261|NCT05731726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102634262|NCT05731726|Antimetabolites|antimetabolites|mesh-ancestor
102634263|NCT05731726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634264|NCT05731726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634265|NCT05731726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102634266|NCT05731726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102634267|NCT05731726|Analgesics|analgesics|mesh-ancestor
102634268|NCT05731726|Sensory System Agents|sensory system agents|mesh-ancestor
102634269|NCT05731726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102634270|NCT05731726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634271|NCT05731726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102634272|NCT05731726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102634273|NCT05731726|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102634274|NCT05731726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102634275|NCT05731726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102634276|NCT05715931|Leucovorin|leucovorin|mesh-list
102634277|NCT05715931|Docetaxel|docetaxel|mesh-list
102634278|NCT05715931|Oxaliplatin|oxaliplatin|mesh-list
102634279|NCT05715931|Trastuzumab|trastuzumab|mesh-list
102634280|NCT05715931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634281|NCT05715931|Tubulin Modulators|tubulin modulators|mesh-ancestor
102634282|NCT05715931|Antimitotic Agents|antimitotic agents|mesh-ancestor
102634283|NCT05715931|Mitosis Modulators|mitosis modulators|mesh-ancestor
102634284|NCT05715931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634285|NCT05715931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102634286|NCT05715931|Antidotes|antidotes|mesh-ancestor
102634287|NCT05715931|Protective Agents|protective agents|mesh-ancestor
102634288|NCT05715931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634289|NCT05715931|Vitamin B Complex|vitamin b complex|mesh-ancestor
102634290|NCT05715931|Vitamins|vitamins|mesh-ancestor
102634291|NCT05715931|Micronutrients|micronutrients|mesh-ancestor
102634292|NCT05708183|Micronutrients|micronutrients|mesh-list
102634293|NCT05708183|Trace Elements|trace elements|mesh-list
102634294|NCT05708183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634295|NCT05594823|Furosemide|furosemide|mesh-list
102634296|NCT05594823|Diuretics|diuretics|mesh-list
102634297|NCT05594823|Natriuretic Agents|natriuretic agents|mesh-ancestor
102634298|NCT05594823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634299|NCT05594823|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102634300|NCT05594823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102634301|NCT05594823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634302|NCT05581797|Psilocybin|psilocybin|mesh-list
102634303|NCT05581797|Hallucinogens|hallucinogens|mesh-ancestor
102634304|NCT05581797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634305|NCT05581797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102634306|NCT05510544|Plerixafor|plerixafor|mesh-list
102634307|NCT05510544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102634308|NCT05510544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102634309|NCT05510544|Antiviral Agents|antiviral agents|mesh-ancestor
102634310|NCT05510544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102634311|NCT05509699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102634312|NCT05509699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634313|NCT05509699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102634314|NCT05509699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634315|NCT05441215|Ritonavir|ritonavir|mesh-list
102634316|NCT05441215|Nirmatrelvir|nirmatrelvir|mesh-list
102634317|NCT05441215|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102634318|NCT05441215|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102634319|NCT05441215|Protease Inhibitors|protease inhibitors|mesh-ancestor
102634320|NCT05441215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102634321|NCT05441215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634322|NCT05441215|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102634323|NCT05441215|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102275170|NCT00003592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102634324|NCT05441215|Antiviral Agents|antiviral agents|mesh-ancestor
102634325|NCT05441215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102634326|NCT05441215|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102634327|NCT05441215|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102634328|NCT05431777|Avelumab|avelumab|mesh-list
102634329|NCT05431777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102634330|NCT05431777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634331|NCT05327647|Bicalutamide|bicalutamide|mesh-list
102634332|NCT05327647|Androgen Antagonists|androgen antagonists|mesh-list
102634333|NCT05327647|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
102634334|NCT05327647|Hormone Antagonists|hormone antagonists|mesh-ancestor
102634335|NCT05327647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102634336|NCT05327647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634337|NCT05327647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634338|NCT05320380|Cytarabine|cytarabine|mesh-list
102634339|NCT05320380|Prednisolone|prednisolone|mesh-list
102634340|NCT05320380|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102634341|NCT05320380|Methylprednisolone|methylprednisolone|mesh-list
102634342|NCT05320380|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102634343|NCT05320380|Prednisolone acetate|prednisolone acetate|mesh-list
102634344|NCT05320380|Hydrocortisone|hydrocortisone|mesh-list
102634345|NCT05320380|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102634346|NCT05320380|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102634347|NCT05320380|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102634348|NCT05320380|Cortisone|cortisone|mesh-list
102634349|NCT05320380|Methotrexate|methotrexate|mesh-list
102634350|NCT05320380|Fludarabine phosphate|fludarabine phosphate|mesh-list
102634351|NCT05320380|Fludarabine|fludarabine|mesh-list
102634352|NCT05320380|Daunorubicin|daunorubicin|mesh-list
102634353|NCT05320380|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102634354|NCT05320380|Prednisolone phosphate|prednisolone phosphate|mesh-list
102634355|NCT05320380|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102634356|NCT05320380|Abortifacient Agents|abortifacient agents|mesh-ancestor
102634357|NCT05320380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102634358|NCT05320380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634359|NCT05320380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102634360|NCT05320380|Antimetabolites|antimetabolites|mesh-ancestor
102634361|NCT05320380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634362|NCT05320380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634363|NCT05320380|Dermatologic Agents|dermatologic agents|mesh-ancestor
102634364|NCT05320380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102634365|NCT05320380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102634366|NCT05320380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102634367|NCT05320380|Immunologic Factors|immunologic factors|mesh-ancestor
102634368|NCT05320380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102634369|NCT05320380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102634370|NCT05320380|Antiviral Agents|antiviral agents|mesh-ancestor
102634371|NCT05320380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102634372|NCT05320380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102634373|NCT05320380|Glucocorticoids|glucocorticoids|mesh-ancestor
102634374|NCT05320380|Hormones|hormones|mesh-ancestor
102634375|NCT05320380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102634376|NCT05320380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102634377|NCT05320380|Antiemetics|antiemetics|mesh-ancestor
102634378|NCT05320380|Autonomic Agents|autonomic agents|mesh-ancestor
102634379|NCT05320380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102634380|NCT05320380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102634381|NCT05320380|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102634382|NCT05320380|Protective Agents|protective agents|mesh-ancestor
102634383|NCT05320380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102634384|NCT05320380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102634385|NCT05320380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102634386|NCT05259527|Vitamin D|vitamin d|mesh-list
102634387|NCT05259527|Ergocalciferols|ergocalciferols|mesh-list
102634388|NCT05259527|Cholecalciferol|cholecalciferol|mesh-list
102634389|NCT05259527|Vitamins|vitamins|mesh-list
102634390|NCT05259527|Micronutrients|micronutrients|mesh-ancestor
102634391|NCT05259527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634392|NCT05259527|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102634393|NCT05259527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102634394|NCT05256641|Acalabrutinib|acalabrutinib|mesh-list
102634395|NCT05256641|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102634396|NCT05256641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634397|NCT05256641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102634398|NCT05256641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101922871|NCT01269294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102634399|NCT05256641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634400|NCT05187377|Hormones|hormones|mesh-list
102638139|NCT00716742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102275171|NCT00003592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102634401|NCT05187377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102634402|NCT05187377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634403|NCT05177588|Metformin|metformin|mesh-list
102634404|NCT05177588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102634405|NCT05177588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634406|NCT05171660|Bevacizumab|bevacizumab|mesh-list
102634407|NCT05171660|Capecitabine|capecitabine|mesh-list
102634408|NCT05171660|Oxaliplatin|oxaliplatin|mesh-list
102634409|NCT05171660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102634410|NCT05171660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634411|NCT05171660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102634412|NCT05171660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102634413|NCT05171660|Growth Substances|growth substances|mesh-ancestor
102634414|NCT05171660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634415|NCT05171660|Growth Inhibitors|growth inhibitors|mesh-ancestor
102634416|NCT05171660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102634417|NCT05171660|Antimetabolites|antimetabolites|mesh-ancestor
102634418|NCT05171660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634419|NCT05133258|Ciprofloxacin|ciprofloxacin|mesh-list
102634420|NCT05133258|Dexamethasone|dexamethasone|mesh-list
102634421|NCT05133258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102634422|NCT05133258|Antiemetics|antiemetics|mesh-ancestor
102634423|NCT05133258|Autonomic Agents|autonomic agents|mesh-ancestor
102634424|NCT05133258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102634425|NCT05133258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634426|NCT05133258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102634427|NCT05133258|Glucocorticoids|glucocorticoids|mesh-ancestor
102634428|NCT05133258|Hormones|hormones|mesh-ancestor
102634429|NCT05133258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102634430|NCT05133258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102634431|NCT05133258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634432|NCT05133258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102634433|NCT05133258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102634434|NCT05133258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102634435|NCT05133258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102634436|NCT05133258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102634437|NCT05133258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634438|NCT05133258|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102634439|NCT05133258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102634440|NCT05091346|Pembrolizumab|pembrolizumab|mesh-list
102634441|NCT05091346|Lenvatinib|lenvatinib|mesh-list
102634442|NCT05091346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102634443|NCT05091346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634444|NCT05091346|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102634445|NCT05091346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634446|NCT05091346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102634447|NCT05091346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102634448|NCT05059873|Prednisone|prednisone|mesh-list
102634449|NCT05059873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102634450|NCT05059873|Glucocorticoids|glucocorticoids|mesh-ancestor
102634451|NCT05059873|Hormones|hormones|mesh-ancestor
102634452|NCT05059873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102634453|NCT05059873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634454|NCT05059873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102634455|NCT05059873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634456|NCT05055024|Mazindol|mazindol|mesh-list
102634457|NCT05055024|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102634458|NCT05055024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634459|NCT05055024|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102634460|NCT05055024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102634461|NCT05055024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102634462|NCT05055024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634463|NCT05055024|Adrenergic Agents|adrenergic agents|mesh-ancestor
102634464|NCT05055024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102634465|NCT05055024|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102634466|NCT05055024|Dopamine Agents|dopamine agents|mesh-ancestor
102634467|NCT05053971|Entinostat|entinostat|mesh-list
102634468|NCT05053971|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
102634469|NCT05053971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634470|NCT05053971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102634471|NCT05053971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634472|NCT05047978|Caseins|caseins|mesh-list
102275172|NCT00003518|Paclitaxel|paclitaxel|mesh-list
102634473|NCT05047978|Chelating Agents|chelating agents|mesh-ancestor
102634474|NCT05047978|Sequestering Agents|sequestering agents|mesh-ancestor
102634475|NCT05047978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634476|NCT05045664|Obinutuzumab|obinutuzumab|mesh-list
102634477|NCT05045664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102634478|NCT05045664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634479|NCT05037552|Hemostatics|hemostatics|mesh-list
102634480|NCT05037552|Coagulants|coagulants|mesh-ancestor
102634481|NCT05028634|Vaccines|vaccines|mesh-list
102634482|NCT05028634|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102634483|NCT05028634|Immunologic Factors|immunologic factors|mesh-ancestor
102634484|NCT05028634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634485|NCT05028075|Cobalt|cobalt|mesh-list
102634486|NCT05028075|Trace Elements|trace elements|mesh-ancestor
102634487|NCT05028075|Micronutrients|micronutrients|mesh-ancestor
102634488|NCT05028075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634489|NCT05012631|Losartan|losartan|mesh-list
102634490|NCT05012631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102634491|NCT05012631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102634492|NCT05012631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102634493|NCT05012631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102634494|NCT05012631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634495|NCT04989218|Cisplatin|cisplatin|mesh-list
102634496|NCT04989218|Gemcitabine|gemcitabine|mesh-list
102634497|NCT04989218|Durvalumab|durvalumab|mesh-list
102634498|NCT04989218|Tremelimumab|tremelimumab|mesh-list
102634499|NCT04989218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634500|NCT04989218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102634501|NCT04989218|Antimetabolites|antimetabolites|mesh-ancestor
102634502|NCT04989218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634503|NCT04989218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102634504|NCT04964544|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102634505|NCT04964544|Calcium|calcium|mesh-list
102634506|NCT04964544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102634507|NCT04964544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634508|NCT04964544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102634509|NCT04964544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102634510|NCT04964544|Antimetabolites|antimetabolites|mesh-ancestor
102634511|NCT04964544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634512|NCT04964544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102634513|NCT04964544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102634514|NCT04964544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102634515|NCT04954196|Amlodipine|amlodipine|mesh-list
102634516|NCT04954196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102634517|NCT04954196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102634518|NCT04954196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102634519|NCT04954196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634520|NCT04954196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102634521|NCT04954196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634522|NCT04954196|Vasodilator Agents|vasodilator agents|mesh-ancestor
102634523|NCT04944290|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102634524|NCT04944290|Brinzolamide|brinzolamide|mesh-list
102634525|NCT04944290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102634526|NCT04944290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102634527|NCT04944290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102634528|NCT04944290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102634529|NCT04944290|Adrenergic Agents|adrenergic agents|mesh-ancestor
102634530|NCT04944290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102634531|NCT04944290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634532|NCT04944290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634533|NCT04944290|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102634534|NCT04944290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102634535|NCT04937166|Azacitidine|azacitidine|mesh-list
102634536|NCT04937166|Venetoclax|venetoclax|mesh-list
102634537|NCT04937166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102634538|NCT04937166|Antimetabolites|antimetabolites|mesh-ancestor
102634539|NCT04937166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634540|NCT04937166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634541|NCT04937166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102634542|NCT04920032|Irinotecan|irinotecan|mesh-list
102634543|NCT04920032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102634544|NCT04920032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102634545|NCT04920032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102275173|NCT00003518|Gemcitabine|gemcitabine|mesh-list
102275174|NCT00003518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102275175|NCT00003518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102275176|NCT00003518|Tubulin Modulators|tubulin modulators|mesh-ancestor
102275177|NCT00003518|Antimitotic Agents|antimitotic agents|mesh-ancestor
101983950|NCT03756883|Fluticasone|fluticasone|mesh-list
102275178|NCT00003518|Mitosis Modulators|mitosis modulators|mesh-ancestor
102275179|NCT00003518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275180|NCT00003518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102275181|NCT00003518|Antimetabolites|antimetabolites|mesh-ancestor
102275182|NCT00003444|Interferons|interferons|mesh-list
102275183|NCT00003444|Interferon-alpha|interferon-alpha|mesh-list
102275184|NCT00003444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102275185|NCT00003444|Antiviral Agents|antiviral agents|mesh-ancestor
102634546|NCT04920032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634547|NCT04920032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634548|NCT04908176|Midazolam|midazolam|mesh-list
102634549|NCT04908176|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102634550|NCT04908176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102634551|NCT04908176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102634552|NCT04908176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634553|NCT04908176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102634554|NCT04908176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102634555|NCT04908176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102634556|NCT04908176|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102634557|NCT04908176|Anesthetics, General|anesthetics, general|mesh-ancestor
102634558|NCT04908176|Anesthetics|anesthetics|mesh-ancestor
102634559|NCT04908176|GABA Modulators|gaba modulators|mesh-ancestor
102634560|NCT04908176|GABA Agents|gaba agents|mesh-ancestor
102634561|NCT04908176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102634562|NCT04908176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634563|NCT04893109|Paclitaxel|paclitaxel|mesh-list
102634564|NCT04893109|Maytansine|maytansine|mesh-list
102634565|NCT04893109|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102634566|NCT04893109|Trastuzumab|trastuzumab|mesh-list
102634567|NCT04893109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102634568|NCT04893109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634569|NCT04893109|Tubulin Modulators|tubulin modulators|mesh-ancestor
102634570|NCT04893109|Antimitotic Agents|antimitotic agents|mesh-ancestor
102634571|NCT04893109|Mitosis Modulators|mitosis modulators|mesh-ancestor
102634572|NCT04893109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634573|NCT04893109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102634574|NCT04893109|Immunotoxins|immunotoxins|mesh-ancestor
102634575|NCT04893109|Immunoconjugates|immunoconjugates|mesh-ancestor
102634576|NCT04893109|Immunologic Factors|immunologic factors|mesh-ancestor
102634577|NCT04893109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634578|NCT04882540|Brivaracetam|brivaracetam|mesh-list
102634579|NCT04882540|Anticonvulsants|anticonvulsants|mesh-ancestor
102634580|NCT04859829|Immunoglobulins|immunoglobulins|mesh-list
102634581|NCT04859829|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102634582|NCT04859829|Antibodies|antibodies|mesh-list
102634583|NCT04859829|gamma-Globulins|gamma-globulins|mesh-list
102634584|NCT04859829|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102634585|NCT04859829|Immunologic Factors|immunologic factors|mesh-ancestor
102634586|NCT04859829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634587|NCT04851158|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102634588|NCT04851158|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102634589|NCT04851158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102634590|NCT04851158|Antitubercular Agents|antitubercular agents|mesh-ancestor
102634591|NCT04788043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102634592|NCT04788043|Pembrolizumab|pembrolizumab|mesh-list
102634593|NCT04788043|Magrolimab|magrolimab|mesh-list
102634594|NCT04788043|Antibodies|antibodies|mesh-list
102634595|NCT04788043|Immunoglobulins|immunoglobulins|mesh-list
102634596|NCT04788043|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102634597|NCT04788043|Immunologic Factors|immunologic factors|mesh-ancestor
102634598|NCT04788043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634599|NCT04788043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634600|NCT04788043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102634601|NCT04788043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634602|NCT04778267|Dexamethasone|dexamethasone|mesh-list
102634603|NCT04778267|Bupivacaine|bupivacaine|mesh-list
102275186|NCT00003444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102275187|NCT00003444|Immunologic Factors|immunologic factors|mesh-ancestor
102275188|NCT00003444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275189|NCT00003388|Cytarabine|cytarabine|mesh-list
102634604|NCT04778267|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102634605|NCT04778267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102634606|NCT04778267|Antiemetics|antiemetics|mesh-ancestor
102634607|NCT04778267|Autonomic Agents|autonomic agents|mesh-ancestor
102634608|NCT04778267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101607045|NCT01153724|Fluconazole|fluconazole|mesh-list
102634609|NCT04778267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634610|NCT04778267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102634611|NCT04778267|Glucocorticoids|glucocorticoids|mesh-ancestor
102634612|NCT04778267|Hormones|hormones|mesh-ancestor
102634613|NCT04778267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102634614|NCT04778267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102634615|NCT04778267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634616|NCT04778267|Anesthetics, Local|anesthetics, local|mesh-ancestor
102634617|NCT04778267|Anesthetics|anesthetics|mesh-ancestor
102634618|NCT04778267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102634619|NCT04778267|Sensory System Agents|sensory system agents|mesh-ancestor
102634620|NCT04761627|Ustekinumab|ustekinumab|mesh-list
102634621|NCT04761627|Dermatologic Agents|dermatologic agents|mesh-ancestor
102634622|NCT04760691|Tenofovir|tenofovir|mesh-list
102634623|NCT04760691|Emtricitabine|emtricitabine|mesh-list
102634624|NCT04760691|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102634625|NCT04760691|Leuprolide|leuprolide|mesh-list
102634626|NCT04760691|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102634627|NCT04760691|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102634628|NCT04760691|Estradiol|estradiol|mesh-list
102634629|NCT04760691|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102634630|NCT04760691|Estrogens|estrogens|mesh-list
102634631|NCT04760691|Antiviral Agents|antiviral agents|mesh-ancestor
102634632|NCT04760691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102634633|NCT04760691|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102634634|NCT04760691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102634635|NCT04760691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102634636|NCT04760691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634637|NCT04760691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102634638|NCT04760691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102634639|NCT04760691|Hormones|hormones|mesh-ancestor
102634640|NCT04760691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102634641|NCT04760691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634642|NCT04760691|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102634643|NCT04760691|Contraceptive Agents|contraceptive agents|mesh-ancestor
102634644|NCT04760691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102634645|NCT04760691|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102634646|NCT04760691|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102634647|NCT04760691|Fertility Agents|fertility agents|mesh-ancestor
102634648|NCT04760691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102634649|NCT04760691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634650|NCT04735471|Cyclophosphamide|cyclophosphamide|mesh-list
102634651|NCT04735471|Fludarabine|fludarabine|mesh-list
102634652|NCT04735471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102634653|NCT04735471|Immunologic Factors|immunologic factors|mesh-ancestor
102634654|NCT04735471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634655|NCT04735471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102634656|NCT04735471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102634657|NCT04735471|Alkylating Agents|alkylating agents|mesh-ancestor
102634658|NCT04735471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634659|NCT04735471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634660|NCT04735471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102634661|NCT04718181|Omeprazole|omeprazole|mesh-list
102634662|NCT04718181|Risdiplam|risdiplam|mesh-list
102634663|NCT04718181|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102634664|NCT04718181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102634665|NCT04718181|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102634666|NCT04718181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102634667|NCT04718181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634668|NCT04718181|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102634669|NCT04718181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102634670|NCT04718181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634671|NCT04713735|Lactoferrin|lactoferrin|mesh-list
102634672|NCT04713735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102634673|NCT04682366|Tamsulosin|tamsulosin|mesh-list
102634674|NCT04682366|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102634675|NCT04682366|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102634676|NCT04682366|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102634677|NCT04682366|Adrenergic Agents|adrenergic agents|mesh-ancestor
102634678|NCT04682366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102634679|NCT04682366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275190|NCT00003388|Prednisone|prednisone|mesh-list
102275191|NCT00003388|Cyclophosphamide|cyclophosphamide|mesh-list
102275192|NCT00003388|Doxorubicin|doxorubicin|mesh-list
102634680|NCT04682366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634681|NCT04682366|Urological Agents|urological agents|mesh-ancestor
102634682|NCT04656301|Psilocybin|psilocybin|mesh-list
102634683|NCT04656301|Hallucinogens|hallucinogens|mesh-ancestor
102634684|NCT04656301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634685|NCT04656301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102634686|NCT04573504|Clindamycin|clindamycin|mesh-list
102634687|NCT04573504|Clindamycin palmitate|clindamycin palmitate|mesh-list
102634688|NCT04573504|Clindamycin phosphate|clindamycin phosphate|mesh-list
102634689|NCT04573504|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102634690|NCT04573504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102634691|NCT04573504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102634692|NCT04573504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102634693|NCT04573504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102634694|NCT04573504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634695|NCT04573504|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102634696|NCT04560972|Carboplatin|carboplatin|mesh-list
102634697|NCT04560972|Etoposide|etoposide|mesh-list
102634698|NCT04560972|Etoposide phosphate|etoposide phosphate|mesh-list
102634699|NCT04560972|Atezolizumab|atezolizumab|mesh-list
102634700|NCT04560972|Podophyllotoxin|podophyllotoxin|mesh-list
102634701|NCT04560972|LB100|lb100|mesh-list
102634702|NCT04560972|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102634703|NCT04560972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634704|NCT04560972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102634705|NCT04560972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102634706|NCT04560972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102634707|NCT04560972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102634708|NCT04560972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634709|NCT04560972|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102634710|NCT04560972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102634711|NCT04560972|Immunologic Factors|immunologic factors|mesh-ancestor
102634712|NCT04560972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634713|NCT04560972|Keratolytic Agents|keratolytic agents|mesh-ancestor
102634714|NCT04560972|Dermatologic Agents|dermatologic agents|mesh-ancestor
102634715|NCT04560972|Tubulin Modulators|tubulin modulators|mesh-ancestor
102634716|NCT04560972|Antimitotic Agents|antimitotic agents|mesh-ancestor
102634717|NCT04560972|Mitosis Modulators|mitosis modulators|mesh-ancestor
102634718|NCT04521335|Copper|copper|mesh-list
102634719|NCT04521335|Disulfiram|disulfiram|mesh-list
102634720|NCT04521335|Trace Elements|trace elements|mesh-ancestor
102634721|NCT04521335|Micronutrients|micronutrients|mesh-ancestor
102634722|NCT04521335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634723|NCT04521335|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102634724|NCT04521335|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
102634725|NCT04521335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102634726|NCT04521335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634727|NCT04515615|Oxaliplatin|oxaliplatin|mesh-list
102634728|NCT04515615|Tegafur|tegafur|mesh-list
102634729|NCT04515615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634730|NCT04515615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102634731|NCT04515615|Antimetabolites|antimetabolites|mesh-ancestor
101607167|NCT01121666|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102634732|NCT04515615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634733|NCT04505410|Infliximab|infliximab|mesh-list
102634734|NCT04505410|Ustekinumab|ustekinumab|mesh-list
102634735|NCT04505410|Tofacitinib|tofacitinib|mesh-list
102634736|NCT04505410|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102634737|NCT04505410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102634738|NCT04505410|Dermatologic Agents|dermatologic agents|mesh-ancestor
102634739|NCT04505410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102634740|NCT04505410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102634741|NCT04505410|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102634742|NCT04505410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102634743|NCT04505410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102634744|NCT04505410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634745|NCT04477304|Analgesics, Opioid|analgesics, opioid|mesh-list
102634746|NCT04477304|Narcotics|narcotics|mesh-ancestor
102634747|NCT04477304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102634748|NCT04477304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634749|NCT04477304|Analgesics|analgesics|mesh-ancestor
102634750|NCT04477304|Sensory System Agents|sensory system agents|mesh-ancestor
102634751|NCT04477304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102634752|NCT04280692|Lumefantrine|lumefantrine|mesh-list
102634753|NCT04280692|Artemether|artemether|mesh-list
102634754|NCT04280692|Pyrimethamine|pyrimethamine|mesh-list
102634755|NCT04280692|Piperaquine|piperaquine|mesh-list
102275193|NCT00003388|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102275194|NCT00003388|Methotrexate|methotrexate|mesh-list
102275195|NCT00003388|Vincristine|vincristine|mesh-list
102634756|NCT04280692|Primaquine|primaquine|mesh-list
102634757|NCT04280692|Sulfadoxine|sulfadoxine|mesh-list
102634758|NCT04280692|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102634759|NCT04280692|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
102634760|NCT04280692|Antimalarials|antimalarials|mesh-ancestor
102634761|NCT04280692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102634762|NCT04280692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102634763|NCT04280692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102634764|NCT04280692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102634765|NCT04280692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102634766|NCT04280692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634767|NCT04280692|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102634768|NCT04247126|Paclitaxel|paclitaxel|mesh-list
102634769|NCT04247126|Gemcitabine|gemcitabine|mesh-list
102634770|NCT04247126|Fulvestrant|fulvestrant|mesh-list
102634771|NCT04247126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102634772|NCT04247126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634773|NCT04247126|Tubulin Modulators|tubulin modulators|mesh-ancestor
102634774|NCT04247126|Antimitotic Agents|antimitotic agents|mesh-ancestor
102634775|NCT04247126|Mitosis Modulators|mitosis modulators|mesh-ancestor
101607251|NCT00824473|Azelastine|azelastine|mesh-list
102634776|NCT04247126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634777|NCT04247126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102634778|NCT04247126|Antimetabolites|antimetabolites|mesh-ancestor
102634779|NCT04247126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102634780|NCT04247126|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102634781|NCT04247126|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102634782|NCT04247126|Hormone Antagonists|hormone antagonists|mesh-ancestor
102634783|NCT04247126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102634784|NCT04247126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634785|NCT04191889|Apatinib|apatinib|mesh-list
102634786|NCT04191889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634787|NCT04191889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102634788|NCT04191889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102634789|NCT04191889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634790|NCT04179162|Gemcitabine|gemcitabine|mesh-list
102634791|NCT04179162|BCG Vaccine|bcg vaccine|mesh-list
102634792|NCT04179162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102634793|NCT04179162|Antimetabolites|antimetabolites|mesh-ancestor
102634794|NCT04179162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634795|NCT04179162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634796|NCT04179162|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102634797|NCT04179162|Immunologic Factors|immunologic factors|mesh-ancestor
102634798|NCT04179162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634799|NCT04163432|Carboplatin|carboplatin|mesh-list
102634800|NCT04163432|Pemetrexed|pemetrexed|mesh-list
102634801|NCT04163432|Durvalumab|durvalumab|mesh-list
102634802|NCT04163432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634803|NCT04163432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102634804|NCT04163432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634805|NCT04163432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102634806|NCT04163432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102634807|NCT04163432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102634808|NCT04151706|Cyclophosphamide|cyclophosphamide|mesh-list
102634809|NCT04151706|Busulfan|busulfan|mesh-list
102634810|NCT04151706|Thiotepa|thiotepa|mesh-list
102634811|NCT04151706|Fludarabine|fludarabine|mesh-list
102634812|NCT04151706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102634813|NCT04151706|Immunologic Factors|immunologic factors|mesh-ancestor
102634814|NCT04151706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634815|NCT04151706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102634816|NCT04151706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102634817|NCT04151706|Alkylating Agents|alkylating agents|mesh-ancestor
102634818|NCT04151706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634819|NCT04151706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634820|NCT04151706|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102634821|NCT04119453|Apatinib|apatinib|mesh-list
102634822|NCT04119453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634823|NCT04119453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102634824|NCT04119453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102634825|NCT04119453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634826|NCT04099251|Nivolumab|nivolumab|mesh-list
102634827|NCT04099251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102634828|NCT04099251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634829|NCT04099251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102634830|NCT04099251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634832|NCT04068610|Durvalumab|durvalumab|mesh-list
102634833|NCT04068610|Fluorouracil|fluorouracil|mesh-list
102634834|NCT04068610|Oxaliplatin|oxaliplatin|mesh-list
102634835|NCT04068610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102634836|NCT04068610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634837|NCT04068610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634838|NCT04068610|Antimetabolites|antimetabolites|mesh-ancestor
102634839|NCT04068610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634840|NCT04068610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102634841|NCT04068610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102634842|NCT04068610|Immunologic Factors|immunologic factors|mesh-ancestor
102634843|NCT04068610|Antidotes|antidotes|mesh-ancestor
102634844|NCT04068610|Protective Agents|protective agents|mesh-ancestor
102634845|NCT04068610|Vitamin B Complex|vitamin b complex|mesh-ancestor
102634846|NCT04068610|Vitamins|vitamins|mesh-ancestor
102634847|NCT04068610|Micronutrients|micronutrients|mesh-ancestor
102634848|NCT04006119|Cemiplimab|cemiplimab|mesh-list
102634849|NCT04006119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102634850|NCT04006119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634851|NCT04004793|Dapagliflozin|dapagliflozin|mesh-list
102634852|NCT04004793|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102634853|NCT04004793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634854|NCT04004793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102634855|NCT04004793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634856|NCT04002011|Warfarin|warfarin|mesh-list
102634857|NCT04002011|Rivaroxaban|rivaroxaban|mesh-list
102634858|NCT04002011|Dabigatran|dabigatran|mesh-list
102634859|NCT04002011|Apixaban|apixaban|mesh-list
102634860|NCT04002011|Edoxaban|edoxaban|mesh-list
102634861|NCT04002011|Anticoagulants|anticoagulants|mesh-ancestor
102634862|NCT04002011|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102634863|NCT04002011|Antithrombins|antithrombins|mesh-ancestor
102634864|NCT04002011|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102634865|NCT04002011|Protease Inhibitors|protease inhibitors|mesh-ancestor
102634866|NCT04002011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102634867|NCT04002011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634868|NCT03903692|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102634869|NCT03903692|Laxatives|laxatives|mesh-ancestor
102634870|NCT03903692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102634871|NCT03884998|Nivolumab|nivolumab|mesh-list
102634872|NCT03884998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102634873|NCT03884998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634874|NCT03884998|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102634875|NCT03884998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634876|NCT03831711|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
102634877|NCT03831711|Bombesin|bombesin|mesh-list
102634878|NCT03831711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634879|NCT03831711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102634880|NCT03831711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634881|NCT03831711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102634882|NCT03789591|Hydroxyurea|hydroxyurea|mesh-list
102634883|NCT03789591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634884|NCT03789591|Antisickling Agents|antisickling agents|mesh-ancestor
102634885|NCT03789591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102634886|NCT03789591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634887|NCT03789591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102634888|NCT03783026|Apremilast|apremilast|mesh-list
102634889|NCT03783026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102634890|NCT03783026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102634891|NCT03783026|Analgesics|analgesics|mesh-ancestor
102634892|NCT03783026|Sensory System Agents|sensory system agents|mesh-ancestor
102634893|NCT03783026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102634894|NCT03783026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634895|NCT03783026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102634896|NCT03783026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102634897|NCT03783026|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102634898|NCT03783026|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102634899|NCT03783026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102634900|NCT03783026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634901|NCT03775460|Prednisolone|prednisolone|mesh-list
102634902|NCT03775460|Methotrexate|methotrexate|mesh-list
102634903|NCT03775460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102634904|NCT03775460|Abortifacient Agents|abortifacient agents|mesh-ancestor
102275196|NCT00003388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102634905|NCT03775460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102634906|NCT03775460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634907|NCT03775460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102634908|NCT03775460|Antimetabolites|antimetabolites|mesh-ancestor
102634909|NCT03775460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634910|NCT03775460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634911|NCT03775460|Dermatologic Agents|dermatologic agents|mesh-ancestor
102634912|NCT03775460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102634913|NCT03775460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102634914|NCT03775460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102634915|NCT03775460|Immunologic Factors|immunologic factors|mesh-ancestor
102634916|NCT03775460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102634917|NCT03775460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102634918|NCT03775460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102634919|NCT03775460|Glucocorticoids|glucocorticoids|mesh-ancestor
102634920|NCT03775460|Hormones|hormones|mesh-ancestor
102634921|NCT03775460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102634922|NCT03775460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102634923|NCT03591731|Nivolumab|nivolumab|mesh-list
102634924|NCT03591731|Ipilimumab|ipilimumab|mesh-list
102634925|NCT03591731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102634926|NCT03591731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634927|NCT03591731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102634928|NCT03591731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634929|NCT03538691|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102634930|NCT03538691|Dexetimide|dexetimide|mesh-list
102634931|NCT03538691|Citalopram|citalopram|mesh-list
102634932|NCT03538691|Fluoxetine|fluoxetine|mesh-list
102634933|NCT03538691|Paroxetine|paroxetine|mesh-list
102634934|NCT03538691|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102634935|NCT03538691|Sertraline|sertraline|mesh-list
102634936|NCT03538691|Escitalopram|escitalopram|mesh-list
102634937|NCT03538691|Brexpiprazole|brexpiprazole|mesh-list
102634938|NCT03538691|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102634939|NCT03538691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102634940|NCT03538691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102634941|NCT03538691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634942|NCT03538691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102634943|NCT03538691|Serotonin Agents|serotonin agents|mesh-ancestor
102634944|NCT03538691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634945|NCT03538691|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102634946|NCT03538691|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102634947|NCT03538691|Parasympatholytics|parasympatholytics|mesh-ancestor
102634948|NCT03538691|Autonomic Agents|autonomic agents|mesh-ancestor
102634949|NCT03538691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102634950|NCT03538691|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102634951|NCT03538691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102634952|NCT03538691|Cholinergic Agents|cholinergic agents|mesh-ancestor
102634953|NCT03538691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102634954|NCT03538691|Antidepressive Agents|antidepressive agents|mesh-ancestor
102634955|NCT03538691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102634956|NCT03538691|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102634957|NCT03538691|Analgesics|analgesics|mesh-ancestor
102634958|NCT03538691|Sensory System Agents|sensory system agents|mesh-ancestor
102634959|NCT03538691|Dopamine Agents|dopamine agents|mesh-ancestor
102634960|NCT03538691|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102634961|NCT03538691|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102634962|NCT03538691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102634963|NCT03538691|Dopamine Agonists|dopamine agonists|mesh-ancestor
102634964|NCT03489018|Vaccines|vaccines|mesh-list
102634965|NCT03489018|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102634966|NCT03489018|Immunologic Factors|immunologic factors|mesh-ancestor
102634967|NCT03489018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634968|NCT03469960|Nivolumab|nivolumab|mesh-list
102634969|NCT03469960|Ipilimumab|ipilimumab|mesh-list
102634970|NCT03469960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102634971|NCT03469960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634972|NCT03469960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102634973|NCT03469960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634974|NCT03439033|Edetic Acid|edetic acid|mesh-list
102634975|NCT03439033|N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid|n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid|mesh-list
101923476|NCT05659810|Gabapentin|gabapentin|mesh-list
102634976|NCT03439033|Chelating Agents|chelating agents|mesh-ancestor
102634977|NCT03439033|Sequestering Agents|sequestering agents|mesh-ancestor
102634978|NCT03439033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634979|NCT03439033|Anticoagulants|anticoagulants|mesh-ancestor
102634980|NCT03439033|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102634981|NCT03330886|Atezolizumab|atezolizumab|mesh-list
102634982|NCT03330886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102634983|NCT03330886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102634984|NCT03330886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102634985|NCT03330886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634986|NCT03282799|Etonogestrel|etonogestrel|mesh-list
102634987|NCT03282799|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102634988|NCT03282799|Contraceptive Agents|contraceptive agents|mesh-ancestor
102634989|NCT03282799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102634990|NCT03282799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102634991|NCT03282799|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102634992|NCT03125928|Paclitaxel|paclitaxel|mesh-list
102634993|NCT03125928|Trastuzumab|trastuzumab|mesh-list
102634994|NCT03125928|Atezolizumab|atezolizumab|mesh-list
102634995|NCT03125928|Pertuzumab|pertuzumab|mesh-list
102634996|NCT03125928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102634997|NCT03125928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102634998|NCT03125928|Tubulin Modulators|tubulin modulators|mesh-ancestor
102634999|NCT03125928|Antimitotic Agents|antimitotic agents|mesh-ancestor
102635000|NCT03125928|Mitosis Modulators|mitosis modulators|mesh-ancestor
102635001|NCT03125928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635002|NCT03125928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102635003|NCT03125928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102635004|NCT02987543|Olaparib|olaparib|mesh-list
102635005|NCT02987543|Abiraterone Acetate|abiraterone acetate|mesh-list
102635006|NCT02987543|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102635007|NCT02987543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635008|NCT02987543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635009|NCT02987543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102635010|NCT02987543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102635011|NCT02987543|Hormone Antagonists|hormone antagonists|mesh-ancestor
102635012|NCT02987543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102635013|NCT02987543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635014|NCT02987543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102635015|NCT02983045|Paclitaxel|paclitaxel|mesh-list
102635016|NCT02983045|Cisplatin|cisplatin|mesh-list
102635017|NCT02983045|Carboplatin|carboplatin|mesh-list
102635018|NCT02983045|Nivolumab|nivolumab|mesh-list
102635019|NCT02983045|Pemetrexed|pemetrexed|mesh-list
102635020|NCT02983045|Ipilimumab|ipilimumab|mesh-list
102635021|NCT02983045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102635022|NCT02983045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102635023|NCT02983045|Tubulin Modulators|tubulin modulators|mesh-ancestor
102635024|NCT02983045|Antimitotic Agents|antimitotic agents|mesh-ancestor
102635025|NCT02983045|Mitosis Modulators|mitosis modulators|mesh-ancestor
102635026|NCT02983045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635027|NCT02983045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102635028|NCT02983045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102635029|NCT02983045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635030|NCT02983045|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102635031|NCT02983045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102635032|NCT02894398|Letrozole|letrozole|mesh-list
102635033|NCT02894398|Fulvestrant|fulvestrant|mesh-list
102635034|NCT02894398|Palbociclib|palbociclib|mesh-list
102635035|NCT02894398|Anastrozole|anastrozole|mesh-list
102635036|NCT02894398|Exemestane|exemestane|mesh-list
102635037|NCT02894398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102635038|NCT02894398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102635039|NCT02894398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102635040|NCT02894398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635041|NCT02894398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635042|NCT02894398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102635043|NCT02894398|Hormone Antagonists|hormone antagonists|mesh-ancestor
102635044|NCT02894398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102635045|NCT02894398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635046|NCT02894398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102635047|NCT02894398|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102638140|NCT00716820|Sunitinib|sunitinib|mesh-list
102275197|NCT00003388|Immunologic Factors|immunologic factors|mesh-ancestor
101923528|NCT05594680|Methotrexate|methotrexate|mesh-list
102275198|NCT00003388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923608|NCT05310734|Benzyl Alcohol|benzyl alcohol|mesh-list
102635048|NCT02894398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102635049|NCT02678052|Vedolizumab|vedolizumab|mesh-list
102635050|NCT02678052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102635051|NCT02576717|Ozanimod|ozanimod|mesh-list
102635052|NCT02576717|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102635053|NCT02576717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635054|NCT02576717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102635055|NCT02576717|Immunologic Factors|immunologic factors|mesh-ancestor
102635056|NCT02576717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635057|NCT02564263|Paclitaxel|paclitaxel|mesh-list
102635058|NCT02564263|Docetaxel|docetaxel|mesh-list
102635059|NCT02564263|Pembrolizumab|pembrolizumab|mesh-list
102635060|NCT02564263|Irinotecan|irinotecan|mesh-list
102635061|NCT02564263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102635062|NCT02564263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102635063|NCT02564263|Tubulin Modulators|tubulin modulators|mesh-ancestor
102635064|NCT02564263|Antimitotic Agents|antimitotic agents|mesh-ancestor
102635065|NCT02564263|Mitosis Modulators|mitosis modulators|mesh-ancestor
102635066|NCT02564263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635067|NCT02564263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102635068|NCT02564263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102635069|NCT02564263|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102635070|NCT02564263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102635071|NCT02564263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635072|NCT02540018|Paclitaxel|paclitaxel|mesh-list
102635073|NCT02540018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102635074|NCT02540018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102635075|NCT02540018|Tubulin Modulators|tubulin modulators|mesh-ancestor
102635076|NCT02540018|Antimitotic Agents|antimitotic agents|mesh-ancestor
102635077|NCT02540018|Mitosis Modulators|mitosis modulators|mesh-ancestor
102635078|NCT02540018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635079|NCT02423265|Ranolazine|ranolazine|mesh-list
102635080|NCT02423265|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102635081|NCT02423265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102635082|NCT02423265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635083|NCT02368886|Clobetasol|clobetasol|mesh-list
102635084|NCT02368886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102635085|NCT02368886|Glucocorticoids|glucocorticoids|mesh-ancestor
102635086|NCT02368886|Hormones|hormones|mesh-ancestor
102635087|NCT02368886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102635088|NCT02368886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635089|NCT02301286|Aspirin|aspirin|mesh-list
102635090|NCT02301286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102635091|NCT02301286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102635092|NCT02301286|Analgesics|analgesics|mesh-ancestor
102635093|NCT02301286|Sensory System Agents|sensory system agents|mesh-ancestor
102635094|NCT02301286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102635095|NCT02301286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635096|NCT02301286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102635097|NCT02301286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102635098|NCT02301286|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102635099|NCT02301286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102635100|NCT02301286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635101|NCT02301286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102635102|NCT02301286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102635103|NCT02301286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635104|NCT02301286|Antipyretics|antipyretics|mesh-ancestor
102635105|NCT02126969|Carboplatin|carboplatin|mesh-list
102635106|NCT02126969|Docetaxel|docetaxel|mesh-list
102635107|NCT02126969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102635108|NCT02126969|Tubulin Modulators|tubulin modulators|mesh-ancestor
102635109|NCT02126969|Antimitotic Agents|antimitotic agents|mesh-ancestor
102635110|NCT02126969|Mitosis Modulators|mitosis modulators|mesh-ancestor
102635111|NCT02126969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635112|NCT02099188|Leucovorin|leucovorin|mesh-list
102635113|NCT02099188|Docetaxel|docetaxel|mesh-list
102635114|NCT02099188|Doxorubicin|doxorubicin|mesh-list
102635115|NCT02099188|Fluorouracil|fluorouracil|mesh-list
102635116|NCT02099188|Etoposide|etoposide|mesh-list
102635117|NCT02099188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102635118|NCT02099188|Ifosfamide|ifosfamide|mesh-list
102635119|NCT02099188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102635120|NCT02099188|Tubulin Modulators|tubulin modulators|mesh-ancestor
102635121|NCT02099188|Antimitotic Agents|antimitotic agents|mesh-ancestor
102635122|NCT02099188|Mitosis Modulators|mitosis modulators|mesh-ancestor
102275199|NCT00003388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102635123|NCT02099188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635124|NCT02099188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102635125|NCT02099188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102635126|NCT02099188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102635127|NCT02099188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635128|NCT02099188|Antimetabolites|antimetabolites|mesh-ancestor
102635129|NCT02099188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102635130|NCT02099188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102635131|NCT02099188|Immunologic Factors|immunologic factors|mesh-ancestor
102635132|NCT02099188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635133|NCT02099188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102635134|NCT02099188|Antidotes|antidotes|mesh-ancestor
102635135|NCT02099188|Protective Agents|protective agents|mesh-ancestor
102635136|NCT02099188|Vitamin B Complex|vitamin b complex|mesh-ancestor
102635137|NCT02099188|Vitamins|vitamins|mesh-ancestor
102635138|NCT02099188|Micronutrients|micronutrients|mesh-ancestor
102635139|NCT02099188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102635140|NCT02099188|Alkylating Agents|alkylating agents|mesh-ancestor
102635141|NCT02099175|Leucovorin|leucovorin|mesh-list
102635142|NCT02099175|Docetaxel|docetaxel|mesh-list
102635143|NCT02099175|Doxorubicin|doxorubicin|mesh-list
102635144|NCT02099175|Fluorouracil|fluorouracil|mesh-list
102635145|NCT02099175|Etoposide|etoposide|mesh-list
102635146|NCT02099175|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102635147|NCT02099175|Ifosfamide|ifosfamide|mesh-list
102635148|NCT02099175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102635149|NCT02099175|Tubulin Modulators|tubulin modulators|mesh-ancestor
102635150|NCT02099175|Antimitotic Agents|antimitotic agents|mesh-ancestor
102635151|NCT02099175|Mitosis Modulators|mitosis modulators|mesh-ancestor
102635152|NCT02099175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635153|NCT02099175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102635154|NCT02099175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102635155|NCT02099175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102635156|NCT02099175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635157|NCT02099175|Antimetabolites|antimetabolites|mesh-ancestor
102635158|NCT02099175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102635159|NCT02099175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102635160|NCT02099175|Immunologic Factors|immunologic factors|mesh-ancestor
102635161|NCT02099175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635162|NCT02099175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102635163|NCT02099175|Antidotes|antidotes|mesh-ancestor
102635164|NCT02099175|Protective Agents|protective agents|mesh-ancestor
102635165|NCT02099175|Vitamin B Complex|vitamin b complex|mesh-ancestor
102635166|NCT02099175|Vitamins|vitamins|mesh-ancestor
102635167|NCT02099175|Micronutrients|micronutrients|mesh-ancestor
102635168|NCT02099175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102635169|NCT02099175|Alkylating Agents|alkylating agents|mesh-ancestor
102635170|NCT01946074|Paclitaxel|paclitaxel|mesh-list
102635171|NCT01946074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102635172|NCT01946074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102635173|NCT01946074|Tubulin Modulators|tubulin modulators|mesh-ancestor
102635174|NCT01946074|Antimitotic Agents|antimitotic agents|mesh-ancestor
102635175|NCT01946074|Mitosis Modulators|mitosis modulators|mesh-ancestor
102635176|NCT01946074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635177|NCT01715285|Prednisone|prednisone|mesh-list
102635178|NCT01715285|Abiraterone Acetate|abiraterone acetate|mesh-list
102635179|NCT01715285|Androgens|androgens|mesh-list
102635180|NCT01715285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102635181|NCT01715285|Glucocorticoids|glucocorticoids|mesh-ancestor
102635182|NCT01715285|Hormones|hormones|mesh-ancestor
102635183|NCT01715285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102635184|NCT01715285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635185|NCT01715285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102635186|NCT01715285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102635187|NCT01715285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102635188|NCT01715285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635189|NCT01715285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635190|NCT01715285|Hormone Antagonists|hormone antagonists|mesh-ancestor
102635191|NCT01715285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102635192|NCT01705184|Bevacizumab|bevacizumab|mesh-list
102635193|NCT01705184|Pemetrexed|pemetrexed|mesh-list
101923678|NCT04955938|Ivosidenib|ivosidenib|mesh-list
102635194|NCT01705184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102635195|NCT01705184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102635196|NCT01705184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102635197|NCT01705184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102275200|NCT00003388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102635198|NCT01705184|Growth Substances|growth substances|mesh-ancestor
102635199|NCT01705184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635200|NCT01705184|Growth Inhibitors|growth inhibitors|mesh-ancestor
102635201|NCT01705184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635202|NCT01705184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635203|NCT01705184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102635204|NCT01705184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102635206|NCT01285817|Cyclophosphamide|cyclophosphamide|mesh-list
102635207|NCT01285817|Methotrexate|methotrexate|mesh-list
102635208|NCT01285817|Vinblastine|vinblastine|mesh-list
102635209|NCT01285817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102635210|NCT01285817|Immunologic Factors|immunologic factors|mesh-ancestor
102635211|NCT01285817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635212|NCT01285817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102635213|NCT01285817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102635214|NCT01285817|Alkylating Agents|alkylating agents|mesh-ancestor
102635215|NCT01285817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635216|NCT01285817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102635217|NCT01285817|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102635218|NCT01285817|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102635219|NCT01285817|Abortifacient Agents|abortifacient agents|mesh-ancestor
102635220|NCT01285817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102635221|NCT01285817|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102635222|NCT01285817|Antimetabolites|antimetabolites|mesh-ancestor
102635223|NCT01285817|Dermatologic Agents|dermatologic agents|mesh-ancestor
102635224|NCT01285817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635225|NCT01285817|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102635226|NCT01285817|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102635227|NCT01285817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102635228|NCT01285817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102635229|NCT01285817|Analgesics|analgesics|mesh-ancestor
102635230|NCT01285817|Sensory System Agents|sensory system agents|mesh-ancestor
102635231|NCT01285817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102635232|NCT01285817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102635233|NCT01285817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102635234|NCT01285817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102635235|NCT01285817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102635236|NCT01285817|Tubulin Modulators|tubulin modulators|mesh-ancestor
102635237|NCT01285817|Antimitotic Agents|antimitotic agents|mesh-ancestor
102635238|NCT01285817|Mitosis Modulators|mitosis modulators|mesh-ancestor
102635239|NCT01285479|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102635240|NCT01285479|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102635241|NCT01285479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635242|NCT01285479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102635243|NCT01285479|Immunologic Factors|immunologic factors|mesh-ancestor
102635244|NCT01285479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635245|NCT01250496|Aminophylline|aminophylline|mesh-list
102635246|NCT01250496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102635247|NCT01250496|Autonomic Agents|autonomic agents|mesh-ancestor
102635248|NCT01250496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102635249|NCT01250496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635250|NCT01250496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102635251|NCT01250496|Respiratory System Agents|respiratory system agents|mesh-ancestor
102635252|NCT01250496|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102635253|NCT01250496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102635254|NCT01250496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635255|NCT01250496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635256|NCT01250496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102635257|NCT01250496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102635258|NCT01250496|Purinergic Agents|purinergic agents|mesh-ancestor
102635259|NCT01250496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102635260|NCT01250496|Protective Agents|protective agents|mesh-ancestor
102635261|NCT01105975|Atorvastatin|atorvastatin|mesh-list
102635262|NCT01105975|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102635263|NCT01105975|Simvastatin|simvastatin|mesh-list
102635264|NCT01105975|Evacetrapib|evacetrapib|mesh-list
102635265|NCT01105975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102635266|NCT01105975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102275201|NCT00003388|Alkylating Agents|alkylating agents|mesh-ancestor
102635267|NCT01105975|Antimetabolites|antimetabolites|mesh-ancestor
102635268|NCT01105975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635269|NCT01105975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102635270|NCT01105975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102635271|NCT01105975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635272|NCT00651456|Bevacizumab|bevacizumab|mesh-list
102635273|NCT00651456|Cisplatin|cisplatin|mesh-list
102635274|NCT00651456|Pemetrexed|pemetrexed|mesh-list
102635275|NCT00651456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102635276|NCT00651456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102635277|NCT00651456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102635278|NCT00651456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102635279|NCT00651456|Growth Substances|growth substances|mesh-ancestor
102635280|NCT00651456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635281|NCT00651456|Growth Inhibitors|growth inhibitors|mesh-ancestor
102635282|NCT00651456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635283|NCT00651456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635284|NCT00651456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102635285|NCT00651456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102635286|NCT00280202|Dimercaprol|dimercaprol|mesh-list
102635287|NCT00280202|Chelating Agents|chelating agents|mesh-ancestor
102635288|NCT00280202|Sequestering Agents|sequestering agents|mesh-ancestor
102635289|NCT00280202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635290|NCT00079417|Iodine|iodine|mesh-list
102635291|NCT00079417|Cadexomer iodine|cadexomer iodine|mesh-list
102635292|NCT00079417|Carboplatin|carboplatin|mesh-list
102635293|NCT00079417|Vincristine|vincristine|mesh-list
102635294|NCT00079417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102635295|NCT00079417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102635296|NCT00079417|Tubulin Modulators|tubulin modulators|mesh-ancestor
102635297|NCT00079417|Antimitotic Agents|antimitotic agents|mesh-ancestor
102635298|NCT00079417|Mitosis Modulators|mitosis modulators|mesh-ancestor
102635299|NCT00079417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635300|NCT00079417|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102635301|NCT00079417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102635302|NCT00079417|Trace Elements|trace elements|mesh-ancestor
102635303|NCT00079417|Micronutrients|micronutrients|mesh-ancestor
102635304|NCT00079417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635305|NCT04387500|Axitinib|axitinib|mesh-list
102635306|NCT04387500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102635307|NCT04387500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102635308|NCT04387500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635309|NCT04387500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635310|NCT04386876|Ritonavir|ritonavir|mesh-list
102635311|NCT04386876|Lopinavir|lopinavir|mesh-list
102635312|NCT04386876|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102635313|NCT04386876|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102635314|NCT04386876|Protease Inhibitors|protease inhibitors|mesh-ancestor
102635315|NCT04386876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635316|NCT04386876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635317|NCT04386876|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102635318|NCT04386876|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102635319|NCT04386876|Antiviral Agents|antiviral agents|mesh-ancestor
102635320|NCT04386876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102635321|NCT04386876|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102635322|NCT04386876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102635323|NCT04386642|Tranexamic Acid|tranexamic acid|mesh-list
102635324|NCT04386642|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102635325|NCT04386642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102635326|NCT04386642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635327|NCT04386642|Hemostatics|hemostatics|mesh-ancestor
102635328|NCT04386642|Coagulants|coagulants|mesh-ancestor
102635329|NCT04385550|Paclitaxel|paclitaxel|mesh-list
102635330|NCT04385550|Docetaxel|docetaxel|mesh-list
102635331|NCT04385550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102635332|NCT04385550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102635333|NCT04385550|Tubulin Modulators|tubulin modulators|mesh-ancestor
102635334|NCT04385550|Antimitotic Agents|antimitotic agents|mesh-ancestor
102635335|NCT04385550|Mitosis Modulators|mitosis modulators|mesh-ancestor
102635336|NCT04385550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635337|NCT04384380|Hydroxychloroquine|hydroxychloroquine|mesh-list
102635338|NCT04384380|Antimalarials|antimalarials|mesh-ancestor
102635339|NCT04384380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102635340|NCT04384380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102635341|NCT04384380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102635342|NCT04384380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635343|NCT04384380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923816|NCT04313972|Naltrexone|naltrexone|mesh-list
102635344|NCT04384380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102635345|NCT04384458|Hydroxychloroquine|hydroxychloroquine|mesh-list
102635346|NCT04384458|Ivermectin|ivermectin|mesh-list
102635347|NCT04384458|Antimalarials|antimalarials|mesh-ancestor
102635348|NCT04384458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102635349|NCT04384458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102635350|NCT04384458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102635351|NCT04384458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635352|NCT04384458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635353|NCT04384458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102635354|NCT04383990|Insulin|insulin|mesh-list
102635355|NCT04383990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102635356|NCT04383990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635357|NCT04381884|Ivermectin|ivermectin|mesh-list
102635358|NCT04381884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102635359|NCT04381884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102635360|NCT04381962|Azithromycin|azithromycin|mesh-list
102635361|NCT04381962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102635362|NCT04381962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102635363|NCT04381104|Acetaminophen|acetaminophen|mesh-list
102635364|NCT04381104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102635365|NCT04381104|Analgesics|analgesics|mesh-ancestor
102635366|NCT04381104|Sensory System Agents|sensory system agents|mesh-ancestor
102635367|NCT04381104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102635368|NCT04381104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635369|NCT04381104|Antipyretics|antipyretics|mesh-ancestor
102635370|NCT04380402|Atorvastatin|atorvastatin|mesh-list
102635371|NCT04380402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102635372|NCT04380402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102635373|NCT04380402|Antimetabolites|antimetabolites|mesh-ancestor
102635374|NCT04380402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635375|NCT04380402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102635376|NCT04380402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102635377|NCT04380402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635378|NCT04380012|Trastuzumab|trastuzumab|mesh-list
102635379|NCT04380012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102635380|NCT04380012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102635381|NCT04379310|Calcium Channel Blockers|calcium channel blockers|mesh-list
102635382|NCT04379310|Calcium|calcium|mesh-list
102635383|NCT04379310|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102635384|NCT04379310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102635385|NCT04379310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635386|NCT04379310|Protease Inhibitors|protease inhibitors|mesh-ancestor
102635387|NCT04379310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635388|NCT04379310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635389|NCT04379310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102635390|NCT04378608|Ribavirin|ribavirin|mesh-list
102635391|NCT04378608|Antimetabolites|antimetabolites|mesh-ancestor
102635392|NCT04378608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635393|NCT04378608|Antiviral Agents|antiviral agents|mesh-ancestor
102635394|NCT04378608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102635395|NCT04376970|Fluorometholone|fluorometholone|mesh-list
102635396|NCT04376970|Cyclosporine|cyclosporine|mesh-list
102635397|NCT04376970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102635398|NCT04376970|Cyclosporins|cyclosporins|mesh-list
102635399|NCT04376970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635400|NCT04376970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635401|NCT04376970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102635402|NCT04376970|Immunologic Factors|immunologic factors|mesh-ancestor
102635403|NCT04376970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635404|NCT04376970|Antifungal Agents|antifungal agents|mesh-ancestor
102635405|NCT04376970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102635406|NCT04376970|Dermatologic Agents|dermatologic agents|mesh-ancestor
102635407|NCT04376970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102635408|NCT04376970|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102635409|NCT04376970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102635410|NCT04376970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102635411|NCT04376970|Glucocorticoids|glucocorticoids|mesh-ancestor
102635412|NCT04376970|Hormones|hormones|mesh-ancestor
102635413|NCT04376970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102635414|NCT04376970|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102635415|NCT04377048|Gemcitabine|gemcitabine|mesh-list
102635416|NCT04377048|Tegafur|tegafur|mesh-list
102635417|NCT04377048|Nivolumab|nivolumab|mesh-list
102635418|NCT04377048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102635419|NCT04377048|Antimetabolites|antimetabolites|mesh-ancestor
102638141|NCT00716820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102635420|NCT04377048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635421|NCT04377048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102635422|NCT04377048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102635423|NCT04377048|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102635424|NCT04376814|Ritonavir|ritonavir|mesh-list
102635425|NCT04376814|Lopinavir|lopinavir|mesh-list
102635426|NCT04376814|Hydroxychloroquine|hydroxychloroquine|mesh-list
102635427|NCT04376814|Favipiravir|favipiravir|mesh-list
102635428|NCT04376814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102635429|NCT04376814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102635430|NCT04376814|Protease Inhibitors|protease inhibitors|mesh-ancestor
102635431|NCT04376814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635432|NCT04376814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635433|NCT04376814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102635434|NCT04376814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102635435|NCT04376814|Antiviral Agents|antiviral agents|mesh-ancestor
102635436|NCT04376814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102635437|NCT04376814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102635438|NCT04376814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102635439|NCT04376814|Antimalarials|antimalarials|mesh-ancestor
102635440|NCT04376814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102635441|NCT04376814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102635442|NCT04376814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102635443|NCT04374942|Hydroxychloroquine|hydroxychloroquine|mesh-list
102635444|NCT04374942|Antimalarials|antimalarials|mesh-ancestor
102635445|NCT04374942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102635446|NCT04374942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102635447|NCT04374942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102635448|NCT04374942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635449|NCT04374942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635450|NCT04374942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102635451|NCT04374318|Dexmedetomidine|dexmedetomidine|mesh-list
102635452|NCT04374318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102635453|NCT04374318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102635454|NCT04374318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635455|NCT04374318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102635456|NCT04374318|Analgesics|analgesics|mesh-ancestor
102635457|NCT04374318|Sensory System Agents|sensory system agents|mesh-ancestor
102635458|NCT04374318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102635459|NCT04374318|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102635460|NCT04374318|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102635461|NCT04374318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102635462|NCT04374318|Adrenergic Agents|adrenergic agents|mesh-ancestor
102635463|NCT04374318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102635464|NCT04374318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635465|NCT04374552|Azithromycin|azithromycin|mesh-list
102635466|NCT04374552|Hydroxychloroquine|hydroxychloroquine|mesh-list
102635467|NCT04374552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102635468|NCT04374552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102635469|NCT04374552|Antimalarials|antimalarials|mesh-ancestor
102635470|NCT04374552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102635471|NCT04374552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102635472|NCT04374552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635473|NCT04374552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635474|NCT04374552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102635475|NCT04374006|Propolis|propolis|mesh-list
102635476|NCT04374006|Dienogest|dienogest|mesh-list
102635477|NCT04374006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102635478|NCT04374006|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102635479|NCT04374006|Contraceptive Agents|contraceptive agents|mesh-ancestor
102635480|NCT04374006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102635481|NCT04374006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635482|NCT04374006|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102635483|NCT04374006|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102635484|NCT04374006|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102635485|NCT04374006|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102635486|NCT04374006|Hormone Antagonists|hormone antagonists|mesh-ancestor
102635487|NCT04374006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102635488|NCT04374006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102635489|NCT04374006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102635490|NCT04372836|Vasopressins|vasopressins|mesh-list
102635491|NCT04372836|Arginine Vasopressin|arginine vasopressin|mesh-list
102275202|NCT00003388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923965|NCT03500445|Dexamethasone|dexamethasone|mesh-list
102635492|NCT04372836|Hemostatics|hemostatics|mesh-ancestor
102635493|NCT04372836|Coagulants|coagulants|mesh-ancestor
102635494|NCT04372836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102635495|NCT04372836|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102635496|NCT04372836|Natriuretic Agents|natriuretic agents|mesh-ancestor
102635497|NCT04372836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635498|NCT04371978|Linagliptin|linagliptin|mesh-list
102635499|NCT04371978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102635500|NCT04371978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635501|NCT04371978|Incretins|incretins|mesh-ancestor
102635502|NCT04371978|Hormones|hormones|mesh-ancestor
102241616|NCT04433559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635503|NCT04371978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102635504|NCT04371978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102635505|NCT04371978|Protease Inhibitors|protease inhibitors|mesh-ancestor
102635506|NCT04371978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635507|NCT04371978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635508|NCT04371822|Protoporphyrin IX|protoporphyrin ix|mesh-list
102635509|NCT04371822|Tin protoporphyrin IX|tin protoporphyrin ix|mesh-list
102635510|NCT04371822|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102635511|NCT04371822|Dermatologic Agents|dermatologic agents|mesh-ancestor
102635512|NCT04371822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635513|NCT04371822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635514|NCT04370262|Famotidine|famotidine|mesh-list
102635515|NCT04370262|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102635516|NCT04370262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102635517|NCT04370262|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102635518|NCT04370262|Histamine Antagonists|histamine antagonists|mesh-ancestor
102635519|NCT04370262|Histamine Agents|histamine agents|mesh-ancestor
102635520|NCT04370262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102635521|NCT04370262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635522|NCT04370262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635523|NCT04368546|Sunitinib|sunitinib|mesh-list
102635524|NCT04368546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102635525|NCT04368546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102635526|NCT04368546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102635527|NCT04368546|Growth Substances|growth substances|mesh-ancestor
102635528|NCT04368546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635529|NCT04368546|Growth Inhibitors|growth inhibitors|mesh-ancestor
102635530|NCT04368546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102635531|NCT04368546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635532|NCT04368546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635533|NCT04366596|Paclitaxel|paclitaxel|mesh-list
102635534|NCT04366596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102635535|NCT04366596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102635536|NCT04366596|Tubulin Modulators|tubulin modulators|mesh-ancestor
102635537|NCT04366596|Antimitotic Agents|antimitotic agents|mesh-ancestor
102635538|NCT04366596|Mitosis Modulators|mitosis modulators|mesh-ancestor
102635539|NCT04366596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635540|NCT04366128|Immunomodulating Agents|immunomodulating agents|mesh-list
102635541|NCT04366128|Immunologic Factors|immunologic factors|mesh-ancestor
102635542|NCT04366128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635543|NCT04366050|Ramipril|ramipril|mesh-list
102635544|NCT04366050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102635545|NCT04366050|Protease Inhibitors|protease inhibitors|mesh-ancestor
102635546|NCT04366050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635547|NCT04366050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635548|NCT04366050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102635549|NCT04365582|Ritonavir|ritonavir|mesh-list
102635550|NCT04365582|Lopinavir|lopinavir|mesh-list
102635551|NCT04365582|Azithromycin|azithromycin|mesh-list
102635552|NCT04365582|Hydroxychloroquine|hydroxychloroquine|mesh-list
102635553|NCT04365582|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102635554|NCT04365582|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102635555|NCT04365582|Protease Inhibitors|protease inhibitors|mesh-ancestor
102635556|NCT04365582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635557|NCT04365582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635558|NCT04365582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102635559|NCT04365582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102635560|NCT04365582|Antiviral Agents|antiviral agents|mesh-ancestor
102635561|NCT04365582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102635562|NCT04365582|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102635563|NCT04365582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102635564|NCT04365582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102635565|NCT04365582|Antimalarials|antimalarials|mesh-ancestor
102635566|NCT04365582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101924043|NCT02969837|Dexamethasone|dexamethasone|mesh-list
102635567|NCT04365582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102635568|NCT04365582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102635569|NCT04365270|Chlorhexidine|chlorhexidine|mesh-list
102635570|NCT04365270|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102635571|NCT04365270|Titanium dioxide|titanium dioxide|mesh-list
102635572|NCT04365270|Chitosan|chitosan|mesh-list
102635573|NCT04365270|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102635574|NCT04365270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102635575|NCT04365270|Disinfectants|disinfectants|mesh-ancestor
102635576|NCT04365270|Dermatologic Agents|dermatologic agents|mesh-ancestor
102635577|NCT04365270|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102635578|NCT04365270|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102635579|NCT04365270|Antimetabolites|antimetabolites|mesh-ancestor
102635580|NCT04365270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635581|NCT04365270|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102635582|NCT04365270|Chelating Agents|chelating agents|mesh-ancestor
102635583|NCT04365270|Sequestering Agents|sequestering agents|mesh-ancestor
102635584|NCT04365270|Hemostatics|hemostatics|mesh-ancestor
102635585|NCT04365270|Coagulants|coagulants|mesh-ancestor
102635586|NCT04365270|Sunscreening Agents|sunscreening agents|mesh-ancestor
102635587|NCT04365270|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102635588|NCT04365270|Protective Agents|protective agents|mesh-ancestor
102635589|NCT04365270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635590|NCT04365270|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102635591|NCT04365426|Contraceptive Agents|contraceptive agents|mesh-list
102635592|NCT04365426|Contraceptives, Oral|contraceptives, oral|mesh-list
102635593|NCT04365426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102635594|NCT04365426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635595|NCT04365426|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102635596|NCT04365036|Gemcitabine|gemcitabine|mesh-list
102635597|NCT04365036|Oxaliplatin|oxaliplatin|mesh-list
102635598|NCT04365036|Pegaspargase|pegaspargase|mesh-list
102635599|NCT04365036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102635600|NCT04365036|Antimetabolites|antimetabolites|mesh-ancestor
102635601|NCT04365036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635602|NCT04365036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102635603|NCT04364022|Ritonavir|ritonavir|mesh-list
102635604|NCT04364022|Lopinavir|lopinavir|mesh-list
102635605|NCT04364022|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102635606|NCT04364022|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102635607|NCT04364022|Protease Inhibitors|protease inhibitors|mesh-ancestor
102635608|NCT04364022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635609|NCT04364022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635610|NCT04364022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102635611|NCT04364022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102635612|NCT04364022|Antiviral Agents|antiviral agents|mesh-ancestor
102635613|NCT04364022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102635614|NCT04364022|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102635615|NCT04364022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102635616|NCT04363866|Hydroxychloroquine|hydroxychloroquine|mesh-list
102635617|NCT04363866|Antimalarials|antimalarials|mesh-ancestor
102635618|NCT04363866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102635619|NCT04363866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102635620|NCT04363866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102635621|NCT04363866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635622|NCT04363866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635623|NCT04363866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102635624|NCT04362384|Vitamin E|vitamin e|mesh-list
102635625|NCT04362384|Prednisolone|prednisolone|mesh-list
102635626|NCT04362384|Vitamins|vitamins|mesh-ancestor
102635627|NCT04362384|Micronutrients|micronutrients|mesh-ancestor
102635628|NCT04362384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635629|NCT04362384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102635630|NCT04362384|Glucocorticoids|glucocorticoids|mesh-ancestor
102635631|NCT04362384|Hormones|hormones|mesh-ancestor
102635632|NCT04362384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102635633|NCT04362384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102635634|NCT04362384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102635635|NCT04362384|Protective Agents|protective agents|mesh-ancestor
102635636|NCT04362384|Antioxidants|antioxidants|mesh-ancestor
102635637|NCT04362384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635638|NCT04361214|Leflunomide|leflunomide|mesh-list
102635639|NCT04361214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635640|NCT04361214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635641|NCT04361214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102635642|NCT04361214|Immunologic Factors|immunologic factors|mesh-ancestor
102635643|NCT04361214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275203|NCT00003388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102635644|NCT04361370|Bevacizumab|bevacizumab|mesh-list
102635645|NCT04361370|Pembrolizumab|pembrolizumab|mesh-list
102635647|NCT04361370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102635648|NCT04361370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102635649|NCT04361370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102635650|NCT04361370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102635651|NCT04361370|Growth Substances|growth substances|mesh-ancestor
102635652|NCT04361370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635653|NCT04361370|Growth Inhibitors|growth inhibitors|mesh-ancestor
102635654|NCT04361370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102635655|NCT04361370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635656|NCT04361370|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102635657|NCT04361370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635658|NCT04361058|Nivolumab|nivolumab|mesh-list
102635659|NCT04361058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102635660|NCT04361058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102635661|NCT04361058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102635662|NCT04361058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635663|NCT04359966|Amoxicillin|amoxicillin|mesh-list
102635664|NCT04359966|Metronidazole|metronidazole|mesh-list
102635665|NCT04359966|Clarithromycin|clarithromycin|mesh-list
102635666|NCT04359966|Levofloxacin|levofloxacin|mesh-list
102635667|NCT04359966|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
102635668|NCT04359966|Esomeprazole|esomeprazole|mesh-list
102635669|NCT04359966|Bismuth|bismuth|mesh-list
102635670|NCT04359966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102635671|NCT04359966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102635672|NCT04359966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102635673|NCT04359966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102635674|NCT04359966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102635675|NCT04359966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102635676|NCT04359966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102635677|NCT04359966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635678|NCT04359966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635679|NCT04359966|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102635680|NCT04359966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102635681|NCT04359966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102635682|NCT04359966|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102635683|NCT04359966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102635684|NCT04359966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102635685|NCT04359966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102635686|NCT04359966|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102635687|NCT04359966|Antacids|antacids|mesh-ancestor
102635688|NCT04360122|Levamisole|levamisole|mesh-list
102635689|NCT04360122|Inosine Pranobex|inosine pranobex|mesh-list
102635690|NCT04360122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102635691|NCT04360122|Immunologic Factors|immunologic factors|mesh-ancestor
102635692|NCT04360122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635693|NCT04360122|Antinematodal Agents|antinematodal agents|mesh-ancestor
102635694|NCT04360122|Anthelmintics|anthelmintics|mesh-ancestor
102635695|NCT04360122|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102635696|NCT04360122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102635697|NCT04360122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102635698|NCT04360122|Antiviral Agents|antiviral agents|mesh-ancestor
102635699|NCT04360356|Ivermectin|ivermectin|mesh-list
102635700|NCT04360356|Nitazoxanide|nitazoxanide|mesh-list
102635701|NCT04360356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102635702|NCT04360356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102635703|NCT04359576|Hemostatics|hemostatics|mesh-list
101608188|NCT01076075|Gliclazide|gliclazide|mesh-list
102635704|NCT04359576|Coagulants|coagulants|mesh-ancestor
102635705|NCT04358796|Perflubron|perflubron|mesh-list
102635706|NCT04358796|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102635707|NCT04358718|Anesthetics|anesthetics|mesh-list
102635708|NCT04358718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102635709|NCT04358718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635710|NCT04358562|Gefitinib|gefitinib|mesh-list
102635711|NCT04358562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102635712|NCT04358562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102635713|NCT04358562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635714|NCT04358562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635715|NCT04357860|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102635716|NCT04358016|Terlipressin|terlipressin|mesh-list
102635717|NCT04358016|Somatostatin|somatostatin|mesh-list
102635718|NCT04358016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102275204|NCT00003388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102635719|NCT04358016|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102635720|NCT04358016|Hormones|hormones|mesh-ancestor
102635721|NCT04358016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102635722|NCT04358016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635723|NCT04357392|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102635724|NCT04357392|Prednisone|prednisone|mesh-list
102635725|NCT04357392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635726|NCT04357392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102635727|NCT04357392|Glucocorticoids|glucocorticoids|mesh-ancestor
102635728|NCT04357392|Hormones|hormones|mesh-ancestor
102635729|NCT04357392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102635730|NCT04357392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102635731|NCT04357392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102635732|NCT04357002|Tranexamic Acid|tranexamic acid|mesh-list
102635733|NCT04357002|Dinoprostone|dinoprostone|mesh-list
102635734|NCT04357002|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102635735|NCT04357002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102635736|NCT04357002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635737|NCT04357002|Hemostatics|hemostatics|mesh-ancestor
102635738|NCT04357002|Coagulants|coagulants|mesh-ancestor
102635739|NCT04357002|Oxytocics|oxytocics|mesh-ancestor
102635740|NCT04357002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102635741|NCT04357002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635742|NCT04356222|Methotrexate|methotrexate|mesh-list
102635743|NCT04356222|Durvalumab|durvalumab|mesh-list
102635744|NCT04356222|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102635745|NCT04356222|Abortifacient Agents|abortifacient agents|mesh-ancestor
102635746|NCT04356222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102635747|NCT04356222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635748|NCT04356222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102635749|NCT04356222|Antimetabolites|antimetabolites|mesh-ancestor
102635750|NCT04356222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635751|NCT04356222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102635752|NCT04356222|Dermatologic Agents|dermatologic agents|mesh-ancestor
102635753|NCT04356222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635754|NCT04356222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102635755|NCT04356222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102635756|NCT04356222|Immunologic Factors|immunologic factors|mesh-ancestor
102635757|NCT04356222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102635758|NCT04356222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102635759|NCT04356222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102635760|NCT04356144|Thrombin|thrombin|mesh-list
102635761|NCT04356144|Hemostatics|hemostatics|mesh-ancestor
102635762|NCT04356144|Coagulants|coagulants|mesh-ancestor
102635763|NCT04355598|Lidocaine|lidocaine|mesh-list
102635764|NCT04355598|Nitroglycerin|nitroglycerin|mesh-list
102635765|NCT04355598|Prilocaine|prilocaine|mesh-list
102635766|NCT04355598|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
102635767|NCT04355598|Anesthetics, Local|anesthetics, local|mesh-ancestor
102635768|NCT04355598|Anesthetics|anesthetics|mesh-ancestor
102635769|NCT04355598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102635770|NCT04355598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635771|NCT04355598|Sensory System Agents|sensory system agents|mesh-ancestor
102635772|NCT04355598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102635773|NCT04355598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102635774|NCT04355598|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102635775|NCT04355598|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102635776|NCT04355598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102635777|NCT04355598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635778|NCT04355598|Vasodilator Agents|vasodilator agents|mesh-ancestor
102635779|NCT04355598|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
102635780|NCT04355520|Fulvestrant|fulvestrant|mesh-list
102635781|NCT04355520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102635782|NCT04355520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102635783|NCT04355520|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102635784|NCT04355520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102635785|NCT04355520|Hormone Antagonists|hormone antagonists|mesh-ancestor
102635786|NCT04355520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102635787|NCT04355520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635788|NCT04355052|Azithromycin|azithromycin|mesh-list
102635789|NCT04355052|Hydroxychloroquine|hydroxychloroquine|mesh-list
102635790|NCT04355052|Camostat|camostat|mesh-list
102635791|NCT04355052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102275205|NCT00003388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102275206|NCT00003388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102635792|NCT04355052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102635793|NCT04355052|Antimalarials|antimalarials|mesh-ancestor
102635794|NCT04355052|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102635795|NCT04355052|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102635796|NCT04355052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635797|NCT04355052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635798|NCT04355052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102635799|NCT04355052|Protease Inhibitors|protease inhibitors|mesh-ancestor
102635800|NCT04355052|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102635801|NCT04355052|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102635802|NCT04354662|Leucovorin|leucovorin|mesh-list
102635803|NCT04354662|Docetaxel|docetaxel|mesh-list
102635804|NCT04354662|Fluorouracil|fluorouracil|mesh-list
102635805|NCT04354662|Oxaliplatin|oxaliplatin|mesh-list
102635806|NCT04354662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102635807|NCT04354662|Tubulin Modulators|tubulin modulators|mesh-ancestor
102635808|NCT04354662|Antimitotic Agents|antimitotic agents|mesh-ancestor
102635809|NCT04354662|Mitosis Modulators|mitosis modulators|mesh-ancestor
102635810|NCT04354662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635811|NCT04354662|Antimetabolites|antimetabolites|mesh-ancestor
102635812|NCT04354662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102635813|NCT04354662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102635814|NCT04354662|Immunologic Factors|immunologic factors|mesh-ancestor
102635815|NCT04354662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635816|NCT04354662|Antidotes|antidotes|mesh-ancestor
102635817|NCT04354662|Protective Agents|protective agents|mesh-ancestor
102635818|NCT04354662|Vitamin B Complex|vitamin b complex|mesh-ancestor
102635819|NCT04354662|Vitamins|vitamins|mesh-ancestor
102635820|NCT04354662|Micronutrients|micronutrients|mesh-ancestor
102635821|NCT04354350|Telmisartan|telmisartan|mesh-list
102635822|NCT04354350|Ramipril|ramipril|mesh-list
102635823|NCT04354350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102635824|NCT04354350|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102635825|NCT04354350|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102635826|NCT04354350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635827|NCT04354350|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102635828|NCT04354350|Protease Inhibitors|protease inhibitors|mesh-ancestor
102635829|NCT04354350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635830|NCT04353336|Hydroxychloroquine|hydroxychloroquine|mesh-list
102635831|NCT04353336|Chloroquine|chloroquine|mesh-list
102635832|NCT04353336|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
102635833|NCT04353336|Antimalarials|antimalarials|mesh-ancestor
102635834|NCT04353336|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102635835|NCT04353336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102635836|NCT04353336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102635837|NCT04353336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635838|NCT04353336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635839|NCT04353336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102635840|NCT04353336|Amebicides|amebicides|mesh-ancestor
102635841|NCT04353336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102635842|NCT04353336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102635843|NCT04353336|Analgesics|analgesics|mesh-ancestor
102635844|NCT04353336|Sensory System Agents|sensory system agents|mesh-ancestor
102635845|NCT04353336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102635846|NCT04353336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635847|NCT04353336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102635848|NCT04353336|Filaricides|filaricides|mesh-ancestor
102635849|NCT04353336|Antinematodal Agents|antinematodal agents|mesh-ancestor
102635850|NCT04353336|Anthelmintics|anthelmintics|mesh-ancestor
102635851|NCT04353180|Tretinoin|tretinoin|mesh-list
102635852|NCT04353180|Isotretinoin|isotretinoin|mesh-list
102635853|NCT04353180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102635854|NCT04353180|Keratolytic Agents|keratolytic agents|mesh-ancestor
102635855|NCT04353180|Dermatologic Agents|dermatologic agents|mesh-ancestor
102635856|NCT04352946|Hydroxychloroquine|hydroxychloroquine|mesh-list
102635857|NCT04352946|Antimalarials|antimalarials|mesh-ancestor
102635858|NCT04352946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102635859|NCT04352946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102635860|NCT04352946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102635861|NCT04352946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635862|NCT04352946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635863|NCT04352946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102635864|NCT04352400|Nafamostat|nafamostat|mesh-list
102635865|NCT04352400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102635866|NCT04352400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102635867|NCT04352400|Analgesics|analgesics|mesh-ancestor
102635868|NCT04352400|Sensory System Agents|sensory system agents|mesh-ancestor
102635869|NCT04352400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102635870|NCT04352400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635871|NCT04352400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102635872|NCT04352400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102635874|NCT04352400|Protease Inhibitors|protease inhibitors|mesh-ancestor
102635875|NCT04352400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635876|NCT04352400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635877|NCT04352400|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102635878|NCT04352400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102635879|NCT04352400|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102635880|NCT04352400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102635881|NCT04352400|Immunologic Factors|immunologic factors|mesh-ancestor
102635882|NCT04351308|Apatinib|apatinib|mesh-list
102635883|NCT04351308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102635884|NCT04351308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102635885|NCT04351308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635886|NCT04351308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635887|NCT04351152|Lenzilumab|lenzilumab|mesh-list
102635888|NCT04351152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102635889|NCT04350528|Pentobarbital|pentobarbital|mesh-list
102635890|NCT04350528|Chlorpromazine|chlorpromazine|mesh-list
102635891|NCT04350528|Antiemetics|antiemetics|mesh-ancestor
102635892|NCT04350528|Autonomic Agents|autonomic agents|mesh-ancestor
102635893|NCT04350528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102635894|NCT04350528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635895|NCT04350528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102635896|NCT04350528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102635897|NCT04350528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102635898|NCT04350528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102635899|NCT04350528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102635900|NCT04350528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102635901|NCT04350528|Dopamine Agents|dopamine agents|mesh-ancestor
102635902|NCT04350528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102635903|NCT04350528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635904|NCT04350528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102635905|NCT04350528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102635906|NCT04350528|GABA Modulators|gaba modulators|mesh-ancestor
102635907|NCT04350528|GABA Agents|gaba agents|mesh-ancestor
102635908|NCT04350684|Interferons|interferons|mesh-list
102635909|NCT04350684|Ritonavir|ritonavir|mesh-list
102635910|NCT04350684|Lopinavir|lopinavir|mesh-list
102635911|NCT04350684|Interferon-beta|interferon-beta|mesh-list
102635912|NCT04350684|Interferon beta-1a|interferon beta-1a|mesh-list
102635913|NCT04350684|Hydroxychloroquine|hydroxychloroquine|mesh-list
102635914|NCT04350684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102635915|NCT04350684|Antiviral Agents|antiviral agents|mesh-ancestor
102635916|NCT04350684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102635917|NCT04350684|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102635918|NCT04350684|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102635919|NCT04350684|Protease Inhibitors|protease inhibitors|mesh-ancestor
102635920|NCT04350684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635921|NCT04350684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635922|NCT04350684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102635923|NCT04350684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102635924|NCT04350684|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102635925|NCT04350684|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102635926|NCT04350684|Antimalarials|antimalarials|mesh-ancestor
102635927|NCT04350684|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102635928|NCT04350684|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102635929|NCT04350684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102635930|NCT04350684|Immunologic Factors|immunologic factors|mesh-ancestor
102635931|NCT04350684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635932|NCT04350684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102635933|NCT04350450|Hydroxychloroquine|hydroxychloroquine|mesh-list
102635934|NCT04350450|Antimalarials|antimalarials|mesh-ancestor
102635935|NCT04350450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102635936|NCT04350450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102635937|NCT04350450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102635938|NCT04350450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635939|NCT04350450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635940|NCT04350450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102635941|NCT04349592|Azithromycin|azithromycin|mesh-list
102635942|NCT04349592|Hydroxychloroquine|hydroxychloroquine|mesh-list
102635943|NCT04349592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102275207|NCT00003388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102635944|NCT04349592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102635945|NCT04349592|Antimalarials|antimalarials|mesh-ancestor
102635946|NCT04349592|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102635947|NCT04349592|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102635948|NCT04349592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635949|NCT04349592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635950|NCT04349592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102635951|NCT04347252|Glucagon|glucagon|mesh-list
102635952|NCT04347252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102635953|NCT04347252|Hormones|hormones|mesh-ancestor
102635954|NCT04347252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102635955|NCT04347252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635956|NCT04346862|Acetylcarnitine|acetylcarnitine|mesh-list
102635957|NCT04346862|Vitamin B Complex|vitamin b complex|mesh-ancestor
102635958|NCT04346862|Vitamins|vitamins|mesh-ancestor
102635959|NCT04346862|Micronutrients|micronutrients|mesh-ancestor
102635960|NCT04346862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635961|NCT04346862|Nootropic Agents|nootropic agents|mesh-ancestor
102635962|NCT04345848|Heparin|heparin|mesh-list
102635963|NCT04345848|Enoxaparin|enoxaparin|mesh-list
102635964|NCT04345848|Calcium heparin|calcium heparin|mesh-list
102635965|NCT04345848|Anticoagulants|anticoagulants|mesh-ancestor
102635966|NCT04345848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102635967|NCT04345848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102635968|NCT04345848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635969|NCT04345692|Hydroxychloroquine|hydroxychloroquine|mesh-list
102635970|NCT04345692|Antimalarials|antimalarials|mesh-ancestor
102635971|NCT04345692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102635972|NCT04345692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102635973|NCT04345692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102635974|NCT04345692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102635975|NCT04345692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635976|NCT04345692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102635977|NCT04345458|Etanercept|etanercept|mesh-list
102635978|NCT04345458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102635979|NCT04345458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102635980|NCT04345458|Analgesics|analgesics|mesh-ancestor
102635981|NCT04345458|Sensory System Agents|sensory system agents|mesh-ancestor
102635982|NCT04345458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102635983|NCT04345458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102635984|NCT04345458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102635985|NCT04345458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102635986|NCT04345458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102635987|NCT04345458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102635988|NCT04345458|Immunologic Factors|immunologic factors|mesh-ancestor
102635989|NCT04344756|Heparin|heparin|mesh-list
102635990|NCT04344756|Calcium heparin|calcium heparin|mesh-list
102635991|NCT04344756|Tinzaparin|tinzaparin|mesh-list
102635992|NCT04344756|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102635993|NCT04344756|Dalteparin|dalteparin|mesh-list
102635994|NCT04344756|Anticoagulants|anticoagulants|mesh-ancestor
102635995|NCT04344756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102635996|NCT04344756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102635997|NCT04344756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102635998|NCT04344288|Prednisone|prednisone|mesh-list
102635999|NCT04344288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102636000|NCT04344288|Glucocorticoids|glucocorticoids|mesh-ancestor
102636001|NCT04344288|Hormones|hormones|mesh-ancestor
102636002|NCT04344288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102636003|NCT04344288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636004|NCT04344288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102636005|NCT04344288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102636006|NCT04343742|Chlorine dioxide|chlorine dioxide|mesh-list
102636007|NCT04343742|Dental Disinfectants|dental disinfectants|mesh-ancestor
102636008|NCT04343742|Disinfectants|disinfectants|mesh-ancestor
102636009|NCT04343742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102636010|NCT04342728|Vitamins|vitamins|mesh-list
102636011|NCT04342728|Ascorbic Acid|ascorbic acid|mesh-list
102636012|NCT04342728|Zinc|zinc|mesh-list
102636013|NCT04342728|Micronutrients|micronutrients|mesh-ancestor
102636014|NCT04342728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636015|NCT04342728|Trace Elements|trace elements|mesh-ancestor
102636016|NCT04342728|Antioxidants|antioxidants|mesh-ancestor
102636017|NCT04342728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636018|NCT04342728|Protective Agents|protective agents|mesh-ancestor
102636019|NCT04342650|Chloroquine|chloroquine|mesh-list
102636020|NCT04342650|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
101924491|NCT01587222|Octreotide|octreotide|mesh-list
102636021|NCT04342650|Amebicides|amebicides|mesh-ancestor
102636022|NCT04342650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102636023|NCT04342650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102636024|NCT04342650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102636025|NCT04342650|Antimalarials|antimalarials|mesh-ancestor
102636026|NCT04342650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102636027|NCT04342650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102636028|NCT04342650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102636029|NCT04342650|Analgesics|analgesics|mesh-ancestor
102636030|NCT04342650|Sensory System Agents|sensory system agents|mesh-ancestor
102636031|NCT04342650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102636032|NCT04342650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636033|NCT04342650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102636034|NCT04342650|Filaricides|filaricides|mesh-ancestor
102636035|NCT04342650|Antinematodal Agents|antinematodal agents|mesh-ancestor
102636036|NCT04342650|Anthelmintics|anthelmintics|mesh-ancestor
102636037|NCT04341402|Antifungal Agents|antifungal agents|mesh-list
102636038|NCT04341402|Clotrimazole|clotrimazole|mesh-list
102636039|NCT04341402|Miconazole|miconazole|mesh-list
102636040|NCT04341402|Diclofenac|diclofenac|mesh-list
102636041|NCT04341402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102636042|NCT04341402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102636043|NCT04341402|Analgesics|analgesics|mesh-ancestor
102636044|NCT04341402|Sensory System Agents|sensory system agents|mesh-ancestor
102636045|NCT04341402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102636046|NCT04341402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636047|NCT04341402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102636048|NCT04341402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102636049|NCT04341402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102636050|NCT04341402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102636051|NCT04341402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636052|NCT04341402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102636053|NCT04341402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102636054|NCT04341402|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102636055|NCT04341402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102636056|NCT04341402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102636057|NCT04341402|Hormone Antagonists|hormone antagonists|mesh-ancestor
102636058|NCT04341402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102636059|NCT04341402|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102636060|NCT04341402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102636061|NCT04340544|Hydroxychloroquine|hydroxychloroquine|mesh-list
102636062|NCT04340544|Antimalarials|antimalarials|mesh-ancestor
102636063|NCT04340544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102636064|NCT04340544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102636065|NCT04340544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102636066|NCT04340544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102636067|NCT04340544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636068|NCT04340544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102636069|NCT04340778|Lidocaine|lidocaine|mesh-list
102636070|NCT04340778|Prilocaine|prilocaine|mesh-list
102636071|NCT04340778|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
102636072|NCT04340778|Dinoprostone|dinoprostone|mesh-list
102636073|NCT04340778|Anesthetics, Local|anesthetics, local|mesh-ancestor
102636074|NCT04340778|Anesthetics|anesthetics|mesh-ancestor
102636075|NCT04340778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102636076|NCT04340778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636077|NCT04340778|Sensory System Agents|sensory system agents|mesh-ancestor
102636078|NCT04340778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102636079|NCT04340778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102636080|NCT04340778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102636081|NCT04340778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102636082|NCT04340778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102636083|NCT04340778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636084|NCT04340778|Oxytocics|oxytocics|mesh-ancestor
102636085|NCT04340778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102636086|NCT04340778|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
102636087|NCT04340388|Tenofovir|tenofovir|mesh-list
102636088|NCT04340388|Lamivudine|lamivudine|mesh-list
102636089|NCT04340388|Zidovudine|zidovudine|mesh-list
102636090|NCT04340388|Dolutegravir|dolutegravir|mesh-list
102636091|NCT04340388|Darunavir|darunavir|mesh-list
102636092|NCT04340388|Abacavir|abacavir|mesh-list
102636093|NCT04340388|Cobicistat|cobicistat|mesh-list
102636094|NCT04340388|Rilpivirine|rilpivirine|mesh-list
102636095|NCT04340388|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102636096|NCT04340388|Antiviral Agents|antiviral agents|mesh-ancestor
102636097|NCT04340388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102636098|NCT04340388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102636099|NCT04340388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102275208|NCT00003388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102275209|NCT00003388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102636100|NCT04340388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102636101|NCT04340388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636103|NCT04340388|Antimetabolites|antimetabolites|mesh-ancestor
102636104|NCT04340388|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102636105|NCT04340388|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102636106|NCT04340388|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102636107|NCT04340388|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102636108|NCT04340388|Protease Inhibitors|protease inhibitors|mesh-ancestor
102636109|NCT04340388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102636110|NCT04340388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102636111|NCT04338906|Hydroxychloroquine|hydroxychloroquine|mesh-list
102636112|NCT04338906|Camostat|camostat|mesh-list
102636113|NCT04338906|Antimalarials|antimalarials|mesh-ancestor
102636114|NCT04338906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102636115|NCT04338906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102636116|NCT04338906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102636117|NCT04338906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102636118|NCT04338906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636119|NCT04338906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102636120|NCT04338906|Protease Inhibitors|protease inhibitors|mesh-ancestor
102636121|NCT04338906|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102636122|NCT04338906|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102636123|NCT04338438|Apatinib|apatinib|mesh-list
102636124|NCT04338438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102636125|NCT04338438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102636126|NCT04338438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102636127|NCT04338438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636128|NCT04338126|Tranexamic Acid|tranexamic acid|mesh-list
102636129|NCT04338126|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102636130|NCT04338126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102636131|NCT04338126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636132|NCT04338126|Hemostatics|hemostatics|mesh-ancestor
102636133|NCT04338126|Coagulants|coagulants|mesh-ancestor
102636134|NCT04337658|Capecitabine|capecitabine|mesh-list
102636135|NCT04337658|Trastuzumab|trastuzumab|mesh-list
102636136|NCT04337658|Fulvestrant|fulvestrant|mesh-list
102636137|NCT04337658|Pertuzumab|pertuzumab|mesh-list
102636138|NCT04337658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102636139|NCT04337658|Antimetabolites|antimetabolites|mesh-ancestor
102636140|NCT04337658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636141|NCT04337658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102636142|NCT04337658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102636143|NCT04337658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102636144|NCT04337658|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102636145|NCT04337658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102636146|NCT04337658|Hormone Antagonists|hormone antagonists|mesh-ancestor
102636147|NCT04337658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102636148|NCT04337658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636149|NCT04337268|Glucagon|glucagon|mesh-list
102636150|NCT04337268|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102636151|NCT04337268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102636152|NCT04337268|Hormones|hormones|mesh-ancestor
102636153|NCT04337268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102636154|NCT04337268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636155|NCT04337268|Incretins|incretins|mesh-ancestor
102636156|NCT04336566|Melatonin|melatonin|mesh-list
102636157|NCT04336566|Antioxidants|antioxidants|mesh-ancestor
102636158|NCT04336566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636159|NCT04336566|Protective Agents|protective agents|mesh-ancestor
102636160|NCT04336566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636161|NCT04336566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102636162|NCT04336488|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102636163|NCT04336488|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-list
102636164|NCT04336488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102636165|NCT04336488|Glucocorticoids|glucocorticoids|mesh-ancestor
102636166|NCT04336488|Hormones|hormones|mesh-ancestor
102636167|NCT04336488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102636168|NCT04336488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636169|NCT04336488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102636170|NCT04336488|Immunologic Factors|immunologic factors|mesh-ancestor
101924642|NCT01166100|Fluoxetine|fluoxetine|mesh-list
102275210|NCT00003388|Glucocorticoids|glucocorticoids|mesh-ancestor
102275211|NCT00003388|Hormones|hormones|mesh-ancestor
102636171|NCT04336488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102636172|NCT04336488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636173|NCT04336488|Protease Inhibitors|protease inhibitors|mesh-ancestor
102636174|NCT04335786|Valsartan|valsartan|mesh-list
102636175|NCT04335786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102636176|NCT04335786|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102636177|NCT04335786|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102636178|NCT04335786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636179|NCT04334928|Tenofovir|tenofovir|mesh-list
102636180|NCT04334928|Emtricitabine|emtricitabine|mesh-list
102636181|NCT04334928|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102636182|NCT04334928|Hydroxychloroquine|hydroxychloroquine|mesh-list
102636183|NCT04334928|Antiviral Agents|antiviral agents|mesh-ancestor
102636184|NCT04334928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102636185|NCT04334928|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102636186|NCT04334928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102636187|NCT04334928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102636188|NCT04334928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636189|NCT04334928|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102636190|NCT04334928|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102636191|NCT04334928|Antimalarials|antimalarials|mesh-ancestor
102636192|NCT04334928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102636193|NCT04334928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102636194|NCT04334928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102636195|NCT04334850|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102636196|NCT04334850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102636197|NCT04334382|Azithromycin|azithromycin|mesh-list
102636198|NCT04334382|Hydroxychloroquine|hydroxychloroquine|mesh-list
101608659|NCT00975000|Cinacalcet|cinacalcet|mesh-list
102636199|NCT04334382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102636200|NCT04334382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102636201|NCT04334382|Antimalarials|antimalarials|mesh-ancestor
102636202|NCT04334382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102636203|NCT04334382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102636204|NCT04334382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102636205|NCT04334382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636206|NCT04334382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102636207|NCT04333992|Remifentanil|remifentanil|mesh-list
102636208|NCT04333992|Propofol|propofol|mesh-list
102636209|NCT04333992|Sevoflurane|sevoflurane|mesh-list
102636210|NCT04333992|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102636211|NCT04333992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102636212|NCT04333992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636213|NCT04333992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102636214|NCT04333992|Anesthetics, General|anesthetics, general|mesh-ancestor
102636215|NCT04333992|Anesthetics|anesthetics|mesh-ancestor
102636216|NCT04333992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102636217|NCT04333992|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102636218|NCT04333992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102636219|NCT04333992|Narcotics|narcotics|mesh-ancestor
102636220|NCT04333992|Analgesics|analgesics|mesh-ancestor
102636221|NCT04333992|Sensory System Agents|sensory system agents|mesh-ancestor
102636222|NCT04333992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102636223|NCT04332978|Fluticasone|fluticasone|mesh-list
102636224|NCT04332978|Xhance|xhance|mesh-list
102636225|NCT04332978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102636226|NCT04332978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102636227|NCT04332978|Autonomic Agents|autonomic agents|mesh-ancestor
102636228|NCT04332978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102636229|NCT04332978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636230|NCT04332978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102636231|NCT04332978|Respiratory System Agents|respiratory system agents|mesh-ancestor
102636232|NCT04332978|Dermatologic Agents|dermatologic agents|mesh-ancestor
102636233|NCT04332978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102636234|NCT04332666|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
102636235|NCT04332666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102636236|NCT04332666|Vasodilator Agents|vasodilator agents|mesh-ancestor
102636237|NCT04332276|Dopamine|dopamine|mesh-list
102636238|NCT04332276|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102636239|NCT04332276|Sympathomimetics|sympathomimetics|mesh-ancestor
102636240|NCT04332276|Autonomic Agents|autonomic agents|mesh-ancestor
102636241|NCT04332276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102636242|NCT04332276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636243|NCT04332276|Dopamine Agents|dopamine agents|mesh-ancestor
102636244|NCT04332276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102636245|NCT04332276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636246|NCT04332276|Protective Agents|protective agents|mesh-ancestor
102636247|NCT04332042|Tofacitinib|tofacitinib|mesh-list
102636248|NCT04332042|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102636249|NCT04332042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102636250|NCT04332042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102636251|NCT04332042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636252|NCT04341870|Azithromycin|azithromycin|mesh-list
102636253|NCT04341870|Hydroxychloroquine|hydroxychloroquine|mesh-list
102636254|NCT04341870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102636255|NCT04341870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102636256|NCT04341870|Antimalarials|antimalarials|mesh-ancestor
102636257|NCT04341870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102636258|NCT04341870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102636259|NCT04341870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102636260|NCT04341870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636261|NCT04341870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102636262|NCT04331418|Dexmedetomidine|dexmedetomidine|mesh-list
102636263|NCT04331418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102636264|NCT04331418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102636265|NCT04331418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636266|NCT04331418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102636267|NCT04331418|Analgesics|analgesics|mesh-ancestor
102636268|NCT04331418|Sensory System Agents|sensory system agents|mesh-ancestor
102636269|NCT04331418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102636270|NCT04331418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102636271|NCT04331418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102636272|NCT04331418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102636273|NCT04331418|Adrenergic Agents|adrenergic agents|mesh-ancestor
102636274|NCT04331418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102636275|NCT04331418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636277|NCT04330872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102636278|NCT04330872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102636279|NCT04330872|Analgesics|analgesics|mesh-ancestor
102636280|NCT04330872|Sensory System Agents|sensory system agents|mesh-ancestor
102636281|NCT04330872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102636282|NCT04330872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636283|NCT04330872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102636284|NCT04330872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102636285|NCT04330872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102636286|NCT04330872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102636287|NCT04330872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636288|NCT04330872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102636289|NCT04330872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102636290|NCT04330872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102636291|NCT04330872|Antipyretics|antipyretics|mesh-ancestor
102636292|NCT04330326|Sorbitol|sorbitol|mesh-list
102636293|NCT04330326|Cathartics|cathartics|mesh-ancestor
102636294|NCT04330326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102636295|NCT04329858|Methamphetamine|methamphetamine|mesh-list
102636296|NCT04329858|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102636297|NCT04329858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636298|NCT04329858|Sympathomimetics|sympathomimetics|mesh-ancestor
102636299|NCT04329858|Autonomic Agents|autonomic agents|mesh-ancestor
102636300|NCT04329858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102636301|NCT04329858|Dopamine Agents|dopamine agents|mesh-ancestor
102636302|NCT04329858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102636303|NCT04329858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636304|NCT04329858|Adrenergic Agents|adrenergic agents|mesh-ancestor
102636305|NCT04329858|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102636306|NCT04329858|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102636307|NCT04329858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102636308|NCT04329858|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102636309|NCT00704106|Entecavir|entecavir|mesh-list
102636310|NCT00704106|Antiviral Agents|antiviral agents|mesh-ancestor
102636311|NCT00704106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102636312|NCT05614752|Fexuprazan|fexuprazan|mesh-list
102636313|NCT05614752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102636314|NCT05508594|Sufentanil|sufentanil|mesh-list
102636315|NCT05508594|Ketamine|ketamine|mesh-list
102636316|NCT05508594|Analgesics|analgesics|mesh-ancestor
102636317|NCT05508594|Sensory System Agents|sensory system agents|mesh-ancestor
102636318|NCT05508594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102636319|NCT05508594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636320|NCT05508594|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102636321|NCT05508594|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102636322|NCT05508594|Anesthetics, General|anesthetics, general|mesh-ancestor
102636323|NCT05508594|Anesthetics|anesthetics|mesh-ancestor
102636324|NCT05508594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102636325|NCT05508594|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102636326|NCT05508594|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102636327|NCT05508594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102636328|NCT05508594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636329|NCT05508594|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102636330|NCT05508594|Narcotics|narcotics|mesh-ancestor
102636331|NCT05508594|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102636332|NCT05417100|Methadone|methadone|mesh-list
102636333|NCT05417100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102636334|NCT05417100|Narcotics|narcotics|mesh-ancestor
102636335|NCT05417100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102636336|NCT05417100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636337|NCT05417100|Analgesics|analgesics|mesh-ancestor
102636338|NCT05417100|Sensory System Agents|sensory system agents|mesh-ancestor
102636339|NCT05417100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102636340|NCT05417100|Antitussive Agents|antitussive agents|mesh-ancestor
102636341|NCT05417100|Respiratory System Agents|respiratory system agents|mesh-ancestor
102636342|NCT05278884|Anesthetics|anesthetics|mesh-list
102636343|NCT05278884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102636344|NCT05278884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636345|NCT05136690|Nicotine|nicotine|mesh-list
102636346|NCT05136690|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102636347|NCT05136690|Autonomic Agents|autonomic agents|mesh-ancestor
102636348|NCT05136690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102636349|NCT05136690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636350|NCT05136690|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102636351|NCT05136690|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102636352|NCT05136690|Cholinergic Agents|cholinergic agents|mesh-ancestor
102636353|NCT05136690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102636354|NCT05136690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636355|NCT05035680|Vaccines|vaccines|mesh-list
102636356|NCT05035680|Immunologic Factors|immunologic factors|mesh-ancestor
102636357|NCT05035680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636358|NCT04831320|Paclitaxel|paclitaxel|mesh-list
102636359|NCT04831320|Nivolumab|nivolumab|mesh-list
102636360|NCT04831320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102636361|NCT04831320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102636362|NCT04831320|Tubulin Modulators|tubulin modulators|mesh-ancestor
102636363|NCT04831320|Antimitotic Agents|antimitotic agents|mesh-ancestor
102636364|NCT04831320|Mitosis Modulators|mitosis modulators|mesh-ancestor
102636365|NCT04831320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636366|NCT04831320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102636367|NCT04831320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102636368|NCT03063450|Nivolumab|nivolumab|mesh-list
102636369|NCT03063450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102636370|NCT03063450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102636371|NCT03063450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102636372|NCT03063450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636373|NCT01326000|Cetuximab|cetuximab|mesh-list
102636374|NCT01326000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102636375|NCT01326000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102636376|NCT03035214|Dexamethasone|dexamethasone|mesh-list
102636377|NCT03035214|Dexamethasone acetate|dexamethasone acetate|mesh-list
102636378|NCT03035214|BB 1101|bb 1101|mesh-list
102636379|NCT03035214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102636380|NCT03035214|Antiemetics|antiemetics|mesh-ancestor
102636381|NCT03035214|Autonomic Agents|autonomic agents|mesh-ancestor
102636382|NCT03035214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102636383|NCT03035214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636384|NCT03035214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102636385|NCT03035214|Glucocorticoids|glucocorticoids|mesh-ancestor
102636386|NCT03035214|Hormones|hormones|mesh-ancestor
102636387|NCT03035214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102636388|NCT03035214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102636389|NCT03035214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102636390|NCT03035214|Protease Inhibitors|protease inhibitors|mesh-ancestor
102636391|NCT03035214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102636392|NCT03035214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636393|NCT03035058|Vedolizumab|vedolizumab|mesh-list
101924862|NCT01173510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102636394|NCT03035058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102636395|NCT03033654|Sunscreening Agents|sunscreening agents|mesh-list
102636396|NCT03033654|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102636397|NCT03033654|Protective Agents|protective agents|mesh-ancestor
102636398|NCT03033654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636399|NCT03033654|Dermatologic Agents|dermatologic agents|mesh-ancestor
102636400|NCT03033732|Buprenorphine|buprenorphine|mesh-list
102636401|NCT03033732|Methadone|methadone|mesh-list
102636402|NCT03033732|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102636403|NCT03033732|Naloxone|naloxone|mesh-list
102636404|NCT03033732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102636405|NCT03033732|Narcotics|narcotics|mesh-ancestor
102636406|NCT03033732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102636407|NCT03033732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636408|NCT03033732|Analgesics|analgesics|mesh-ancestor
102636409|NCT03033732|Sensory System Agents|sensory system agents|mesh-ancestor
102636410|NCT03033732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102636411|NCT03033732|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102636412|NCT03033732|Antitussive Agents|antitussive agents|mesh-ancestor
102636413|NCT03033732|Respiratory System Agents|respiratory system agents|mesh-ancestor
102636414|NCT03033264|Dinoprostone|dinoprostone|mesh-list
101608878|NCT05769842|Propofol|propofol|mesh-list
102636415|NCT03033264|Oxytocics|oxytocics|mesh-ancestor
102636416|NCT03033264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102636417|NCT03033264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636418|NCT03033342|Omeprazole|omeprazole|mesh-list
102636419|NCT03033342|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102636420|NCT03033342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102636421|NCT03033342|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102636422|NCT03033342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102636423|NCT03033342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636424|NCT03030768|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102636425|NCT03030768|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102636426|NCT03030768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102636427|NCT03030768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102636428|NCT03030768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636429|NCT03030768|Antiviral Agents|antiviral agents|mesh-ancestor
102636430|NCT03030768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102636431|NCT03030768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102636432|NCT03030768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102636433|NCT03030690|Methamphetamine|methamphetamine|mesh-list
102636434|NCT03030690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102636435|NCT03030690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636436|NCT03030690|Sympathomimetics|sympathomimetics|mesh-ancestor
102636437|NCT03030690|Autonomic Agents|autonomic agents|mesh-ancestor
102636438|NCT03030690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102636439|NCT03030690|Dopamine Agents|dopamine agents|mesh-ancestor
102636440|NCT03030690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102636441|NCT03030690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636442|NCT03030690|Adrenergic Agents|adrenergic agents|mesh-ancestor
102636443|NCT03030690|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102636444|NCT03030690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102636445|NCT03030690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102636446|NCT03030690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102636447|NCT03030300|Metformin|metformin|mesh-list
102636448|NCT03030300|Pioglitazone|pioglitazone|mesh-list
102636449|NCT03030300|Insulin|insulin|mesh-list
102636450|NCT03030300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102636451|NCT03030300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636452|NCT03029442|Denosumab|denosumab|mesh-list
102636453|NCT03029442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102636454|NCT03029442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636455|NCT03023514|Thioctic Acid|thioctic acid|mesh-list
102636456|NCT03023514|Progesterone|progesterone|mesh-list
102636457|NCT03023514|Progestins|progestins|mesh-ancestor
102636458|NCT03023514|Hormones|hormones|mesh-ancestor
102636459|NCT03023514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102636460|NCT03023514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636461|NCT03023514|Antioxidants|antioxidants|mesh-ancestor
102636462|NCT03023514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636463|NCT03023514|Protective Agents|protective agents|mesh-ancestor
102636464|NCT03023514|Vitamin B Complex|vitamin b complex|mesh-ancestor
102636465|NCT03023514|Vitamins|vitamins|mesh-ancestor
102636466|NCT03023514|Micronutrients|micronutrients|mesh-ancestor
102636467|NCT03019926|Hydroxychloroquine|hydroxychloroquine|mesh-list
101924934|NCT01288404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102636468|NCT03019926|Antimalarials|antimalarials|mesh-ancestor
102636469|NCT03019926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102636470|NCT03019926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102636471|NCT03019926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102636472|NCT03019926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102636473|NCT03019926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636474|NCT03019926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102636475|NCT03019848|Curcumin|curcumin|mesh-list
102636476|NCT03019848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102636477|NCT03019848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102636478|NCT03019848|Analgesics|analgesics|mesh-ancestor
102636479|NCT03019848|Sensory System Agents|sensory system agents|mesh-ancestor
102636480|NCT03019848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101608943|NCT05616494|Docetaxel|docetaxel|mesh-list
102636481|NCT03019848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636482|NCT03019848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102636483|NCT03019848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102636484|NCT03019848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102636485|NCT03019848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102636486|NCT03019848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636487|NCT03019614|Hydrocortisone|hydrocortisone|mesh-list
102636488|NCT03019614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102636489|NCT03019536|Flutemetamol|flutemetamol|mesh-list
102636490|NCT03019536|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102636491|NCT03019536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636492|NCT03019224|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102636493|NCT03019224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102636494|NCT03019224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102636495|NCT03018990|Ethanol|ethanol|mesh-list
102636496|NCT03018990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102636497|NCT03018990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102636498|NCT03018990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102636499|NCT03018990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636500|NCT03018756|Fentanyl|fentanyl|mesh-list
102636501|NCT03018756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102636502|NCT03018756|Narcotics|narcotics|mesh-ancestor
102636503|NCT03018756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102636504|NCT03018756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636505|NCT03018756|Analgesics|analgesics|mesh-ancestor
102636506|NCT03018756|Sensory System Agents|sensory system agents|mesh-ancestor
102636507|NCT03018756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102636508|NCT03018756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102636509|NCT03018756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102636510|NCT03018756|Anesthetics, General|anesthetics, general|mesh-ancestor
102636511|NCT03018756|Anesthetics|anesthetics|mesh-ancestor
102636512|NCT03018444|Atorvastatin|atorvastatin|mesh-list
102636513|NCT03018444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102636514|NCT03018444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102636515|NCT03018444|Antimetabolites|antimetabolites|mesh-ancestor
102636516|NCT03018444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636517|NCT03018444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102636518|NCT03018444|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102636519|NCT03018444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102636520|NCT03017430|Ketorolac|ketorolac|mesh-list
102636521|NCT03017430|Phenazepam|phenazepam|mesh-list
102636522|NCT03017430|Clonidine|clonidine|mesh-list
102636523|NCT03017430|Pregabalin|pregabalin|mesh-list
102636524|NCT03017430|Metoclopramide|metoclopramide|mesh-list
102636525|NCT03017430|Loperamide|loperamide|mesh-list
102636526|NCT03017430|Antidiarrheals|antidiarrheals|mesh-list
102636527|NCT03017430|Analgesics|analgesics|mesh-ancestor
102636528|NCT03017430|Sensory System Agents|sensory system agents|mesh-ancestor
102636529|NCT03017430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102636530|NCT03017430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636531|NCT03017430|Anticonvulsants|anticonvulsants|mesh-ancestor
102636532|NCT03017430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102636533|NCT03017430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102636534|NCT03017430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636535|NCT03017430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102636536|NCT03017430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102636537|NCT03017430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102636538|NCT03017430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102636539|NCT03017430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102636540|NCT03017430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102636541|NCT03017430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102636542|NCT03017430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102636543|NCT03017430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102636544|NCT03017430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101925006|NCT01174056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102275212|NCT00003388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102636545|NCT03017430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102636546|NCT03017430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102636547|NCT03017430|Sympatholytics|sympatholytics|mesh-ancestor
102636548|NCT03017430|Autonomic Agents|autonomic agents|mesh-ancestor
102636549|NCT03017430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102636550|NCT03017430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102636551|NCT03017430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102636552|NCT03017430|Adrenergic Agents|adrenergic agents|mesh-ancestor
102636553|NCT03017430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102636554|NCT03017430|Antiemetics|antiemetics|mesh-ancestor
102636555|NCT03017430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102636556|NCT03017430|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102636557|NCT03017430|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102636558|NCT03017430|Dopamine Agents|dopamine agents|mesh-ancestor
102636559|NCT03017430|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102636560|NCT03017430|Immunologic Factors|immunologic factors|mesh-ancestor
102636561|NCT03017430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102636562|NCT03017430|GABA Agents|gaba agents|mesh-ancestor
102636563|NCT03017352|Exenatide|exenatide|mesh-list
102636564|NCT03017352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102636565|NCT03017352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636566|NCT03017352|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102636567|NCT03017352|Incretins|incretins|mesh-ancestor
102636568|NCT03017352|Hormones|hormones|mesh-ancestor
102636569|NCT03017352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102636570|NCT03016884|Vaccines|vaccines|mesh-list
102636571|NCT03016884|Immunologic Factors|immunologic factors|mesh-ancestor
102636572|NCT03016884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636573|NCT03016806|Cyclophosphamide|cyclophosphamide|mesh-list
102636574|NCT03016806|Melphalan|melphalan|mesh-list
102636575|NCT03016806|Busulfan|busulfan|mesh-list
102636576|NCT03016806|Fludarabine|fludarabine|mesh-list
102636578|NCT03016806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102636579|NCT03016806|Immunologic Factors|immunologic factors|mesh-ancestor
102636580|NCT03016806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636581|NCT03016806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102636582|NCT03016806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102636583|NCT03016806|Alkylating Agents|alkylating agents|mesh-ancestor
102636584|NCT03016806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636585|NCT03016806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102636586|NCT03016806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102636587|NCT03016806|Protective Agents|protective agents|mesh-ancestor
102636588|NCT03016650|Acetaminophen|acetaminophen|mesh-list
102636589|NCT03016650|Ibuprofen|ibuprofen|mesh-list
102636590|NCT03016650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102636591|NCT03016650|Analgesics|analgesics|mesh-ancestor
102636592|NCT03016650|Sensory System Agents|sensory system agents|mesh-ancestor
102636593|NCT03016650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102636594|NCT03016650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636595|NCT03016650|Antipyretics|antipyretics|mesh-ancestor
102636596|NCT03016650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102636597|NCT03016650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102636598|NCT03016650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102636599|NCT03016650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102636600|NCT03016650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102636601|NCT03016650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636602|NCT03016260|Adalimumab|adalimumab|mesh-list
102636603|NCT03016260|Infliximab|infliximab|mesh-list
102636604|NCT03016260|Golimumab|golimumab|mesh-list
102636605|NCT03016260|Certolizumab Pegol|certolizumab pegol|mesh-list
102636606|NCT03016260|Etanercept|etanercept|mesh-list
102636607|NCT03016260|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102636608|NCT03016260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102636609|NCT03016260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102636610|NCT03016260|Dermatologic Agents|dermatologic agents|mesh-ancestor
102636611|NCT03016260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102636612|NCT03016260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102636613|NCT03016260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102636614|NCT03016260|Analgesics|analgesics|mesh-ancestor
102636615|NCT03016260|Sensory System Agents|sensory system agents|mesh-ancestor
102636616|NCT03016260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102636617|NCT03016260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636618|NCT03016260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102636619|NCT03016260|Immunologic Factors|immunologic factors|mesh-ancestor
102636620|NCT03015246|Morphine|morphine|mesh-list
102636621|NCT03015246|Buprenorphine|buprenorphine|mesh-list
102275213|NCT00003388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102636622|NCT03015246|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102636623|NCT03015246|Naloxone|naloxone|mesh-list
102636624|NCT03015246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102636625|NCT03015246|Narcotics|narcotics|mesh-ancestor
102636626|NCT03015246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102636627|NCT03015246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636628|NCT03015246|Analgesics|analgesics|mesh-ancestor
102636629|NCT03015246|Sensory System Agents|sensory system agents|mesh-ancestor
102636630|NCT03015246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102636631|NCT03015246|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102636632|NCT03015168|Capecitabine|capecitabine|mesh-list
102636633|NCT03015168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102636634|NCT03015168|Antimetabolites|antimetabolites|mesh-ancestor
102636635|NCT03015168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636636|NCT03015168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102636637|NCT03014778|Chlorhexidine|chlorhexidine|mesh-list
102636638|NCT03014778|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102636639|NCT03014778|Povidone-Iodine|povidone-iodine|mesh-list
102636640|NCT03014778|Povidone|povidone|mesh-list
102636641|NCT03014778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102636642|NCT03014778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102636643|NCT03014778|Disinfectants|disinfectants|mesh-ancestor
102636644|NCT03014778|Dermatologic Agents|dermatologic agents|mesh-ancestor
102636645|NCT03014778|Plasma Substitutes|plasma substitutes|mesh-ancestor
102636646|NCT03014778|Blood Substitutes|blood substitutes|mesh-ancestor
102636647|NCT03014076|Trastuzumab|trastuzumab|mesh-list
102636648|NCT03014076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102636649|NCT03014076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102636650|NCT03013140|Anesthetics|anesthetics|mesh-list
102636651|NCT03013140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102636652|NCT03013140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636653|NCT03011970|Oxytocin|oxytocin|mesh-list
102636654|NCT03011970|Oxytocics|oxytocics|mesh-ancestor
102636655|NCT03011970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102636656|NCT03011970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636657|NCT03010098|Remifentanil|remifentanil|mesh-list
102636658|NCT03010098|Propofol|propofol|mesh-list
102636659|NCT03010098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102636660|NCT03010098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102636661|NCT03010098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636662|NCT03010098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102636663|NCT03010098|Anesthetics, General|anesthetics, general|mesh-ancestor
102636664|NCT03010098|Anesthetics|anesthetics|mesh-ancestor
102636665|NCT03010098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102636666|NCT03010098|Narcotics|narcotics|mesh-ancestor
102636667|NCT03010098|Analgesics|analgesics|mesh-ancestor
102636668|NCT03010098|Sensory System Agents|sensory system agents|mesh-ancestor
102636669|NCT03010098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102636670|NCT03009474|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
102636671|NCT03009474|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102636672|NCT03009474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102636673|NCT03009474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102636674|NCT03009474|Antimetabolites|antimetabolites|mesh-ancestor
102636675|NCT03009474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636676|NCT03009474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102636677|NCT03009474|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102636678|NCT03009474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102636679|NCT03009474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102636680|NCT03009006|Calcium, Dietary|calcium, dietary|mesh-list
102636681|NCT03009006|Chlorhexidine|chlorhexidine|mesh-list
102636682|NCT03009006|Calcium|calcium|mesh-list
102636683|NCT03009006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102636684|NCT03009006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636685|NCT03009006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102636686|NCT03009006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102636687|NCT03009006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102636688|NCT03009006|Disinfectants|disinfectants|mesh-ancestor
102636689|NCT03008148|Temozolomide|temozolomide|mesh-list
102636690|NCT03008148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102636691|NCT03008148|Alkylating Agents|alkylating agents|mesh-ancestor
102636692|NCT03008148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636693|NCT03008148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102636694|NCT03007992|Vinorelbine|vinorelbine|mesh-list
102636695|NCT03007992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102636696|NCT03007992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102275214|NCT00003388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102636697|NCT03007992|Tubulin Modulators|tubulin modulators|mesh-ancestor
102636698|NCT03007992|Antimitotic Agents|antimitotic agents|mesh-ancestor
102636699|NCT03007992|Mitosis Modulators|mitosis modulators|mesh-ancestor
102636700|NCT03007992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636701|NCT03007446|Oxaliplatin|oxaliplatin|mesh-list
102636702|NCT03007446|Apatinib|apatinib|mesh-list
102636703|NCT03007446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102636704|NCT03007446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102636705|NCT03007446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102636706|NCT03007446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636707|NCT03007524|Calcium, Dietary|calcium, dietary|mesh-list
102636708|NCT03007524|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102636709|NCT03007524|Calcium|calcium|mesh-list
102636710|NCT03007524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102636711|NCT03007524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636712|NCT03007524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102636713|NCT03007524|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102636714|NCT03007524|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102636715|NCT03007524|Antimetabolites|antimetabolites|mesh-ancestor
102636716|NCT03007524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636717|NCT03007524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102636718|NCT03007524|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102636719|NCT03007524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102636720|NCT03006042|Bupivacaine|bupivacaine|mesh-list
102636721|NCT03006042|Anesthetics, Local|anesthetics, local|mesh-ancestor
102636722|NCT03006042|Anesthetics|anesthetics|mesh-ancestor
102636723|NCT03006042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102636724|NCT03006042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636725|NCT03006042|Sensory System Agents|sensory system agents|mesh-ancestor
102636726|NCT03006042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102636727|NCT03005496|Vitamin D|vitamin d|mesh-list
102636728|NCT03005496|Cholecalciferol|cholecalciferol|mesh-list
102636729|NCT03005496|Beta Carotene|beta carotene|mesh-list
102636730|NCT03005496|Zinc|zinc|mesh-list
102636731|NCT03005496|Dexamethasone|dexamethasone|mesh-list
102636732|NCT03005496|Dexamethasone acetate|dexamethasone acetate|mesh-list
102636733|NCT03005496|Nifedipine|nifedipine|mesh-list
102636734|NCT03005496|BB 1101|bb 1101|mesh-list
102636735|NCT03005496|Carotenoids|carotenoids|mesh-list
102636736|NCT03005496|Picolinic acid|picolinic acid|mesh-list
102636737|NCT03005496|Vitamins|vitamins|mesh-ancestor
102636738|NCT03005496|Micronutrients|micronutrients|mesh-ancestor
102636739|NCT03005496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636740|NCT03005496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102636741|NCT03005496|Antiemetics|antiemetics|mesh-ancestor
102636742|NCT03005496|Autonomic Agents|autonomic agents|mesh-ancestor
102636743|NCT03005496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102636744|NCT03005496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102636745|NCT03005496|Glucocorticoids|glucocorticoids|mesh-ancestor
102636746|NCT03005496|Hormones|hormones|mesh-ancestor
102636747|NCT03005496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102636748|NCT03005496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102636749|NCT03005496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102636750|NCT03005496|Protease Inhibitors|protease inhibitors|mesh-ancestor
102636751|NCT03005496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102636752|NCT03005496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636753|NCT03005496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102636754|NCT03005496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102636755|NCT03005496|Trace Elements|trace elements|mesh-ancestor
102636756|NCT03005496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102636757|NCT03005496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102636758|NCT03005496|Vasodilator Agents|vasodilator agents|mesh-ancestor
102636759|NCT03005496|Tocolytic Agents|tocolytic agents|mesh-ancestor
102636760|NCT03005496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102636761|NCT03005496|Antioxidants|antioxidants|mesh-ancestor
102636762|NCT03005496|Protective Agents|protective agents|mesh-ancestor
102636763|NCT03005496|Provitamins|provitamins|mesh-ancestor
102636764|NCT03005496|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102636765|NCT03005496|Chelating Agents|chelating agents|mesh-ancestor
102636766|NCT03005496|Sequestering Agents|sequestering agents|mesh-ancestor
102636767|NCT03005808|Ropivacaine|ropivacaine|mesh-list
102636768|NCT03005808|Anesthetics, Local|anesthetics, local|mesh-ancestor
102636769|NCT03005808|Anesthetics|anesthetics|mesh-ancestor
102275215|NCT00003388|Abortifacient Agents|abortifacient agents|mesh-ancestor
102636770|NCT03005808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102636771|NCT03005808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275216|NCT00003388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102636772|NCT03005808|Sensory System Agents|sensory system agents|mesh-ancestor
102636773|NCT03005808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102636774|NCT03005340|Cholecalciferol|cholecalciferol|mesh-list
102636775|NCT03005340|Vitamin D|vitamin d|mesh-list
102636776|NCT03005340|Bazedoxifene|bazedoxifene|mesh-list
102636777|NCT03005340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102636778|NCT03005340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636779|NCT03005340|Vitamins|vitamins|mesh-ancestor
102636780|NCT03005340|Micronutrients|micronutrients|mesh-ancestor
102636781|NCT03005340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102636782|NCT03005340|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102636783|NCT03005340|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102636784|NCT03005340|Hormone Antagonists|hormone antagonists|mesh-ancestor
102636785|NCT03005340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102636786|NCT03005184|Icatibant|icatibant|mesh-list
102636787|NCT03005184|Valsartan|valsartan|mesh-list
102636788|NCT03005184|Enalapril|enalapril|mesh-list
102636789|NCT03005184|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102636790|NCT03005184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102636791|NCT03005184|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102636792|NCT03005184|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102636793|NCT03005184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636794|NCT03005184|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102636795|NCT03005184|Protease Inhibitors|protease inhibitors|mesh-ancestor
102636796|NCT03005184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102636797|NCT03005184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102636798|NCT03005184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102636799|NCT03005184|Analgesics|analgesics|mesh-ancestor
102636800|NCT03005184|Sensory System Agents|sensory system agents|mesh-ancestor
102636801|NCT03005184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102636802|NCT03005184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636803|NCT03005184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102636804|NCT03005184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102636805|NCT03005184|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
102636806|NCT03005184|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
102636807|NCT03005184|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102636808|NCT03005184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102636809|NCT03005184|Immunologic Factors|immunologic factors|mesh-ancestor
102636810|NCT03004014|Propofol|propofol|mesh-list
102636811|NCT03004014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102636812|NCT03004014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102636813|NCT03004014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636814|NCT03004014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102636815|NCT03004014|Anesthetics, General|anesthetics, general|mesh-ancestor
102636816|NCT03004014|Anesthetics|anesthetics|mesh-ancestor
102636817|NCT03002844|Carboplatin|carboplatin|mesh-list
102636818|NCT03002844|Gemcitabine|gemcitabine|mesh-list
102636819|NCT03002844|Pemetrexed|pemetrexed|mesh-list
102636820|NCT03002844|Gefitinib|gefitinib|mesh-list
102636821|NCT03002844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102636822|NCT03002844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102636823|NCT03002844|Antimetabolites|antimetabolites|mesh-ancestor
102636824|NCT03002844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636825|NCT03002844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102636826|NCT03002844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102636827|NCT03002844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102636828|NCT03002844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102636829|NCT03002376|Cemiplimab|cemiplimab|mesh-list
102636830|NCT03002376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102636831|NCT03002376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102636832|NCT03002064|Docetaxel|docetaxel|mesh-list
102636833|NCT03002064|Fluorouracil|fluorouracil|mesh-list
102636834|NCT03002064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102636835|NCT03002064|Tubulin Modulators|tubulin modulators|mesh-ancestor
102636836|NCT03002064|Antimitotic Agents|antimitotic agents|mesh-ancestor
102636837|NCT03002064|Mitosis Modulators|mitosis modulators|mesh-ancestor
102636838|NCT03002064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636839|NCT03002064|Antimetabolites|antimetabolites|mesh-ancestor
102636840|NCT03002064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102636841|NCT03002064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102275217|NCT00003388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102636842|NCT03002064|Immunologic Factors|immunologic factors|mesh-ancestor
102636843|NCT03002064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636844|NCT03001128|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102636845|NCT03001128|Antiviral Agents|antiviral agents|mesh-ancestor
102636846|NCT03001128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102636847|NCT03000660|Dexamethasone|dexamethasone|mesh-list
102636848|NCT03000660|Venetoclax|venetoclax|mesh-list
102636849|NCT03000660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102636850|NCT03000660|Antiemetics|antiemetics|mesh-ancestor
102636851|NCT03000660|Autonomic Agents|autonomic agents|mesh-ancestor
102636852|NCT03000660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102636853|NCT03000660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636854|NCT03000660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102636855|NCT03000660|Glucocorticoids|glucocorticoids|mesh-ancestor
102636856|NCT03000660|Hormones|hormones|mesh-ancestor
102636857|NCT03000660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102636858|NCT03000660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102636859|NCT03000660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102636860|NCT03000036|Doxorubicin|doxorubicin|mesh-list
102636861|NCT03000036|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
102636862|NCT03000036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102636863|NCT03000036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102636864|NCT03000036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102636865|NCT03000036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102636866|NCT03000036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102636867|NCT03000036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636868|NCT03000036|Chelating Agents|chelating agents|mesh-ancestor
102636869|NCT03000036|Sequestering Agents|sequestering agents|mesh-ancestor
102636870|NCT02995824|Raltegravir Potassium|raltegravir potassium|mesh-list
102636871|NCT02995824|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102636872|NCT02995824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102636873|NCT02995824|Antiviral Agents|antiviral agents|mesh-ancestor
102636874|NCT02995824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102636875|NCT02995824|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102636876|NCT02995824|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102636877|NCT02995824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102636878|NCT02995824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636879|NCT02989272|Magnesium Sulfate|magnesium sulfate|mesh-list
102636880|NCT02989272|Analgesics|analgesics|mesh-ancestor
102636881|NCT02989272|Sensory System Agents|sensory system agents|mesh-ancestor
102636882|NCT02989272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102636883|NCT02989272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636884|NCT02989272|Anesthetics|anesthetics|mesh-ancestor
102636885|NCT02989272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102636886|NCT02989272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102636887|NCT02989272|Anticonvulsants|anticonvulsants|mesh-ancestor
102636888|NCT02989272|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102636889|NCT02989272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102636890|NCT02989272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636891|NCT02989272|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102636892|NCT02989272|Tocolytic Agents|tocolytic agents|mesh-ancestor
102636893|NCT02989272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102636894|NCT02989038|Nicotine|nicotine|mesh-list
102636895|NCT02989038|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102636896|NCT02989038|Autonomic Agents|autonomic agents|mesh-ancestor
102636897|NCT02989038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102636898|NCT02989038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636899|NCT02989038|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102636900|NCT02989038|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102636901|NCT02989038|Cholinergic Agents|cholinergic agents|mesh-ancestor
102636902|NCT02989038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102636903|NCT02989038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636904|NCT02988024|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
102636905|NCT02988024|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102636906|NCT02988024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102636907|NCT02988024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102636908|NCT02988024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636909|NCT02988024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102636910|NCT02988024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636911|NCT02988024|Antidepressive Agents|antidepressive agents|mesh-ancestor
102636912|NCT02988024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102636913|NCT02987556|Insulin|insulin|mesh-list
102636914|NCT02987556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102275218|NCT00003388|Antimetabolites|antimetabolites|mesh-ancestor
102275219|NCT00003388|Dermatologic Agents|dermatologic agents|mesh-ancestor
101925380|NCT01177176|Bupropion|bupropion|mesh-list
102636915|NCT02987556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636916|NCT02987400|Venetoclax|venetoclax|mesh-list
102636917|NCT02987400|Obinutuzumab|obinutuzumab|mesh-list
102636918|NCT02987400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102636919|NCT02987400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102636920|NCT02987244|Prednisone|prednisone|mesh-list
102636921|NCT02987244|Cyclophosphamide|cyclophosphamide|mesh-list
102636922|NCT02987244|Etoposide|etoposide|mesh-list
102636923|NCT02987244|Epirubicin|epirubicin|mesh-list
102636924|NCT02987244|Vindesine|vindesine|mesh-list
102636925|NCT02987244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102636926|NCT02987244|Immunologic Factors|immunologic factors|mesh-ancestor
102636927|NCT02987244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636928|NCT02987244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102636929|NCT02987244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102636930|NCT02987244|Alkylating Agents|alkylating agents|mesh-ancestor
102636931|NCT02987244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636932|NCT02987244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102636933|NCT02987244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102636934|NCT02987244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102636935|NCT02987244|Glucocorticoids|glucocorticoids|mesh-ancestor
102636936|NCT02987244|Hormones|hormones|mesh-ancestor
102636937|NCT02987244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102636938|NCT02987244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102636939|NCT02987244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102636940|NCT02987244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102636941|NCT02987244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102636942|NCT02987244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102636943|NCT02987244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102636944|NCT02987244|Tubulin Modulators|tubulin modulators|mesh-ancestor
102636945|NCT02987244|Antimitotic Agents|antimitotic agents|mesh-ancestor
102636946|NCT02987244|Mitosis Modulators|mitosis modulators|mesh-ancestor
102636947|NCT02987166|Pembrolizumab|pembrolizumab|mesh-list
102636948|NCT02987166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102636949|NCT02987166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102636950|NCT02987166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102636951|NCT02987166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636952|NCT02982486|Nivolumab|nivolumab|mesh-list
102636953|NCT02982486|Ipilimumab|ipilimumab|mesh-list
102636954|NCT02982486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102636955|NCT02982486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102636956|NCT02982486|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102636957|NCT02982486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636958|NCT02981784|Ponatinib|ponatinib|mesh-list
102636959|NCT02981784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102636960|NCT02981784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102636961|NCT02981784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102636962|NCT02981784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636963|NCT02980926|Bupivacaine|bupivacaine|mesh-list
102636964|NCT02980926|Mepivacaine|mepivacaine|mesh-list
102636965|NCT02980926|Anesthetics, Local|anesthetics, local|mesh-ancestor
102636966|NCT02980926|Anesthetics|anesthetics|mesh-ancestor
102636967|NCT02980926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102636968|NCT02980926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636969|NCT02980926|Sensory System Agents|sensory system agents|mesh-ancestor
102636970|NCT02980926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102636971|NCT02980458|Deferiprone|deferiprone|mesh-list
102636972|NCT02980458|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102636973|NCT02980458|Chelating Agents|chelating agents|mesh-ancestor
102636974|NCT02980458|Sequestering Agents|sequestering agents|mesh-ancestor
102636975|NCT02980458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636976|NCT02978976|Betamethasone|betamethasone|mesh-list
102636977|NCT02978976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102636978|NCT02978976|Glucocorticoids|glucocorticoids|mesh-ancestor
102636979|NCT02978976|Hormones|hormones|mesh-ancestor
102636980|NCT02978976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102636981|NCT02978976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102636982|NCT02978976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102636983|NCT02978976|Respiratory System Agents|respiratory system agents|mesh-ancestor
102636984|NCT02979132|Iron|iron|mesh-list
102636985|NCT02979132|Trace Elements|trace elements|mesh-ancestor
102636986|NCT02979132|Micronutrients|micronutrients|mesh-ancestor
102275220|NCT00003388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102636987|NCT02979132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925448|NCT01177566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102636988|NCT02978040|Tirofiban|tirofiban|mesh-list
102636989|NCT02978040|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102636990|NCT02978040|Cangrelor|cangrelor|mesh-list
102636991|NCT02978040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102636992|NCT02978040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102636993|NCT02978040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102636994|NCT02978040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102636995|NCT02978040|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102636996|NCT02978040|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102636997|NCT02978040|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102636998|NCT02978040|Purinergic Agents|purinergic agents|mesh-ancestor
102636999|NCT02978040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102637000|NCT02978040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637001|NCT02976246|Vitamin K|vitamin k|mesh-list
102637002|NCT02976246|Vitamin K 2|vitamin k 2|mesh-list
102637003|NCT02976246|Vitamins|vitamins|mesh-ancestor
102637004|NCT02976246|Micronutrients|micronutrients|mesh-ancestor
102637005|NCT02976246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637006|NCT02976246|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102637007|NCT02976246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102637008|NCT02976246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637009|NCT02976246|Hemostatics|hemostatics|mesh-ancestor
102637010|NCT02976246|Coagulants|coagulants|mesh-ancestor
102637011|NCT02976012|Aflibercept|aflibercept|mesh-list
102637012|NCT02976012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102637013|NCT02976012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102637014|NCT02976012|Growth Substances|growth substances|mesh-ancestor
102637015|NCT02976012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637016|NCT02976012|Growth Inhibitors|growth inhibitors|mesh-ancestor
102637017|NCT02976012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102637018|NCT02975076|Aspirin|aspirin|mesh-list
102637019|NCT02975076|Clopidogrel|clopidogrel|mesh-list
102637020|NCT02975076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102637021|NCT02975076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102637022|NCT02975076|Analgesics|analgesics|mesh-ancestor
102637023|NCT02975076|Sensory System Agents|sensory system agents|mesh-ancestor
102637024|NCT02975076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102637025|NCT02975076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637026|NCT02975076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102637027|NCT02975076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102637028|NCT02975076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102637029|NCT02975076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102637030|NCT02975076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637031|NCT02975076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102637032|NCT02975076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102637033|NCT02975076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102637034|NCT02975076|Antipyretics|antipyretics|mesh-ancestor
102637035|NCT02975076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102637036|NCT02975076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102637037|NCT02975076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102637038|NCT02975076|Purinergic Agents|purinergic agents|mesh-ancestor
102637039|NCT02975076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102637040|NCT02974920|Aspirin|aspirin|mesh-list
102637041|NCT02974920|Rivaroxaban|rivaroxaban|mesh-list
102637042|NCT02974920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102637043|NCT02974920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102637044|NCT02974920|Analgesics|analgesics|mesh-ancestor
102637045|NCT02974920|Sensory System Agents|sensory system agents|mesh-ancestor
102637046|NCT02974920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102637047|NCT02974920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637048|NCT02974920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102637049|NCT02974920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102637050|NCT02974920|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102637051|NCT02974920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102637052|NCT02974920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637053|NCT02974920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102637054|NCT02974920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102637055|NCT02974920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102637056|NCT02974920|Antipyretics|antipyretics|mesh-ancestor
102637057|NCT02974920|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102637058|NCT02974920|Antithrombins|antithrombins|mesh-ancestor
102637059|NCT02974920|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102637060|NCT02974920|Protease Inhibitors|protease inhibitors|mesh-ancestor
102637061|NCT02974920|Anticoagulants|anticoagulants|mesh-ancestor
102637062|NCT02973204|Everolimus|everolimus|mesh-list
102275221|NCT00003388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102637063|NCT02973204|Sorafenib|sorafenib|mesh-list
102637064|NCT02973204|Octreotide|octreotide|mesh-list
102637065|NCT02973204|Lanreotide|lanreotide|mesh-list
102637066|NCT02973204|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102637067|NCT02973204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102637068|NCT02973204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102637069|NCT02973204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637070|NCT02973204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102637071|NCT02973204|Immunologic Factors|immunologic factors|mesh-ancestor
102637072|NCT02973204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637073|NCT02973204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102637074|NCT02973204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102637075|NCT02973204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102637076|NCT02959476|Ropivacaine|ropivacaine|mesh-list
102637077|NCT02959476|Anesthetics, Local|anesthetics, local|mesh-ancestor
102637078|NCT02959476|Anesthetics|anesthetics|mesh-ancestor
102637079|NCT02959476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102637080|NCT02959476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637081|NCT02959476|Sensory System Agents|sensory system agents|mesh-ancestor
102637082|NCT02959476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102637083|NCT02958852|Letrozole|letrozole|mesh-list
102637084|NCT02958852|Fulvestrant|fulvestrant|mesh-list
102637085|NCT02958852|Atorvastatin|atorvastatin|mesh-list
102637086|NCT02958852|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102637087|NCT02958852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102637088|NCT02958852|Antimetabolites|antimetabolites|mesh-ancestor
102637089|NCT02958852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637090|NCT02958852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102637091|NCT02958852|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102637092|NCT02958852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102637093|NCT02958852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102637094|NCT02958852|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102637095|NCT02958852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102637096|NCT02958852|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102637097|NCT02958852|Hormone Antagonists|hormone antagonists|mesh-ancestor
102637098|NCT02958852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102637099|NCT02958852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637100|NCT02958852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102637101|NCT02958852|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102637102|NCT02641782|Aldesleukin|aldesleukin|mesh-list
102637103|NCT02641782|Interleukin-2|interleukin-2|mesh-list
102637104|NCT02641782|Tretinoin|tretinoin|mesh-list
102637105|NCT02641782|Dinutuximab|dinutuximab|mesh-list
102637106|NCT02641782|Isotretinoin|isotretinoin|mesh-list
102637107|NCT02641782|Antibodies|antibodies|mesh-list
102637108|NCT02641782|Sargramostim|sargramostim|mesh-list
102637109|NCT02641782|Immunologic Factors|immunologic factors|mesh-ancestor
102637110|NCT02641782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637111|NCT02641782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102637112|NCT02641782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102637113|NCT02641782|Analgesics|analgesics|mesh-ancestor
102637114|NCT02641782|Sensory System Agents|sensory system agents|mesh-ancestor
102637115|NCT02641782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102637116|NCT02641782|Keratolytic Agents|keratolytic agents|mesh-ancestor
102637117|NCT02641782|Dermatologic Agents|dermatologic agents|mesh-ancestor
102637118|NCT02641782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102637119|NCT02641782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102637120|NCT02641782|Antiviral Agents|antiviral agents|mesh-ancestor
102637121|NCT02641782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102637122|NCT02641314|Celecoxib|celecoxib|mesh-list
102637123|NCT02641314|Propranolol|propranolol|mesh-list
102637124|NCT02641314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637125|NCT02641314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102637126|NCT02641314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637127|NCT02641314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102637128|NCT02641314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102637129|NCT02641314|Analgesics|analgesics|mesh-ancestor
102637130|NCT02641314|Sensory System Agents|sensory system agents|mesh-ancestor
102637131|NCT02641314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102637132|NCT02641314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102637133|NCT02641314|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102637134|NCT02641314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102637135|NCT02641314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102637136|NCT02641314|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102275222|NCT00003388|Antiviral Agents|antiviral agents|mesh-ancestor
102637137|NCT02641314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102637138|NCT02641314|Adrenergic Agents|adrenergic agents|mesh-ancestor
102637139|NCT02641314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102637140|NCT02641314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102637141|NCT02641314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102637142|NCT02641314|Vasodilator Agents|vasodilator agents|mesh-ancestor
102637143|NCT04769778|Valsartan|valsartan|mesh-list
102637144|NCT04769778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102637145|NCT04769778|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102637146|NCT04769778|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102637147|NCT04769778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637148|NCT04769076|Paclitaxel|paclitaxel|mesh-list
102637149|NCT04769076|Cisplatin|cisplatin|mesh-list
102637150|NCT04769076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102637151|NCT04769076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102637152|NCT04769076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102637153|NCT04769076|Tubulin Modulators|tubulin modulators|mesh-ancestor
102637154|NCT04769076|Antimitotic Agents|antimitotic agents|mesh-ancestor
102637155|NCT04769076|Mitosis Modulators|mitosis modulators|mesh-ancestor
102637156|NCT04769076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637157|NCT04769076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102637158|NCT04768764|Bupivacaine|bupivacaine|mesh-list
102637159|NCT04768764|Anesthetics|anesthetics|mesh-list
102637160|NCT04768764|Anesthetics, Local|anesthetics, local|mesh-ancestor
102637161|NCT04768764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102637162|NCT04768764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637163|NCT04768764|Sensory System Agents|sensory system agents|mesh-ancestor
102637164|NCT04768764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102637165|NCT04768530|Nitazoxanide|nitazoxanide|mesh-list
102637166|NCT04768530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102637167|NCT04768530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102637168|NCT04748562|Progesterone|progesterone|mesh-list
102637169|NCT04748562|Progestins|progestins|mesh-ancestor
102637170|NCT04748562|Hormones|hormones|mesh-ancestor
102637171|NCT04748562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102637172|NCT04748562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637173|NCT04745286|Ketamine|ketamine|mesh-list
102637174|NCT04745286|Esketamine|esketamine|mesh-list
102637175|NCT04745286|Analgesics|analgesics|mesh-ancestor
102637176|NCT04745286|Sensory System Agents|sensory system agents|mesh-ancestor
102637177|NCT04745286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102637178|NCT04745286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637179|NCT04745286|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102637180|NCT04745286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102637181|NCT04745286|Anesthetics, General|anesthetics, general|mesh-ancestor
102637182|NCT04745286|Anesthetics|anesthetics|mesh-ancestor
102637183|NCT04745286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102637184|NCT04745286|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102637185|NCT04745286|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102637186|NCT04745286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102637187|NCT04745286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637188|NCT04745286|Antidepressive Agents|antidepressive agents|mesh-ancestor
102637189|NCT04745286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102637190|NCT04745442|Antithrombins|antithrombins|mesh-list
102637191|NCT04745442|Antithrombin III|antithrombin iii|mesh-list
102637192|NCT04745442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102637193|NCT04745442|Protease Inhibitors|protease inhibitors|mesh-ancestor
102637194|NCT04745442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102637195|NCT04745442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637196|NCT04745442|Anticoagulants|anticoagulants|mesh-ancestor
102637197|NCT04743180|Paclitaxel|paclitaxel|mesh-list
102637198|NCT04743180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102637199|NCT04743180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102637200|NCT04743180|Tubulin Modulators|tubulin modulators|mesh-ancestor
102637201|NCT04743180|Antimitotic Agents|antimitotic agents|mesh-ancestor
102637202|NCT04743180|Mitosis Modulators|mitosis modulators|mesh-ancestor
102637203|NCT04743180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637204|NCT04740840|Amlodipine|amlodipine|mesh-list
102637205|NCT04740840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102637206|NCT04740840|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102637207|NCT04740840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102637208|NCT04740840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637209|NCT04740840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102637210|NCT04740840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637211|NCT04740840|Vasodilator Agents|vasodilator agents|mesh-ancestor
101925678|NCT01185678|Desogestrel|desogestrel|mesh-list
102637212|NCT04739826|Flumatinib|flumatinib|mesh-list
102637213|NCT04739826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102637214|NCT04739826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102637215|NCT04739826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637216|NCT04739202|Bevacizumab|bevacizumab|mesh-list
102637217|NCT04739202|Atezolizumab|atezolizumab|mesh-list
102637218|NCT04739202|Ipatasertib|ipatasertib|mesh-list
102637219|NCT04739202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102637220|NCT04739202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102637221|NCT04739202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102637222|NCT04739202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102637223|NCT04739202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102637224|NCT04739202|Growth Substances|growth substances|mesh-ancestor
102637225|NCT04739202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637226|NCT04739202|Growth Inhibitors|growth inhibitors|mesh-ancestor
102637227|NCT04739202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102637228|NCT04739202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637229|NCT04739202|Immunologic Factors|immunologic factors|mesh-ancestor
102637230|NCT04739202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102637231|NCT04739202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102637232|NCT04738188|Epirubicin|epirubicin|mesh-list
102637233|NCT04738188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102637234|NCT04738188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102637235|NCT04738188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102637236|NCT04738188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102637237|NCT04738188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102637238|NCT04738188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637239|NCT04737408|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102637240|NCT04737408|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102637241|NCT04737408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102637242|NCT04737408|Antimetabolites|antimetabolites|mesh-ancestor
102637243|NCT04737408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637244|NCT04737408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102637245|NCT04737408|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102637246|NCT04737408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102637247|NCT05314140|Calcium|calcium|mesh-list
102637248|NCT05314140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102637249|NCT05314140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637250|NCT05313906|Cisplatin|cisplatin|mesh-list
102637251|NCT05313906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102637252|NCT05313828|Fluorometholone|fluorometholone|mesh-list
102637253|NCT05313828|Tobramycin|tobramycin|mesh-list
102637254|NCT05313828|Acyclovir|acyclovir|mesh-list
102637255|NCT05313828|Hyaluronic Acid|hyaluronic acid|mesh-list
102637256|NCT05313828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102637257|NCT05313828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102637258|NCT05313828|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102637259|NCT05313828|Immunologic Factors|immunologic factors|mesh-ancestor
102637260|NCT05313828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637261|NCT05313828|Viscosupplements|viscosupplements|mesh-ancestor
102637262|NCT05313828|Protective Agents|protective agents|mesh-ancestor
102637263|NCT05313828|Antiviral Agents|antiviral agents|mesh-ancestor
102637264|NCT05313828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102637265|NCT05313828|Glucocorticoids|glucocorticoids|mesh-ancestor
102637266|NCT05313828|Hormones|hormones|mesh-ancestor
102637267|NCT05313828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102637268|NCT05313828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102637269|NCT05313750|Levofloxacin|levofloxacin|mesh-list
102637270|NCT05313750|Sitafloxacin|sitafloxacin|mesh-list
102637271|NCT05313750|Anti-Infective Agents|anti-infective agents|mesh-list
102637272|NCT05313750|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102637273|NCT05313750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102637274|NCT05313750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102637275|NCT05313750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102637276|NCT05313750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102637277|NCT05313750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637278|NCT05313750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102637279|NCT05313750|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102637280|NCT05313750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102637281|NCT04662684|Rivaroxaban|rivaroxaban|mesh-list
102637282|NCT04662684|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102275223|NCT00003388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101925749|NCT01182246|Estrogens|estrogens|mesh-ancestor
102637283|NCT04662684|Antithrombins|antithrombins|mesh-ancestor
102637284|NCT04662684|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102637285|NCT04662684|Protease Inhibitors|protease inhibitors|mesh-ancestor
102275224|NCT00003388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102637286|NCT04662684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102637287|NCT04662684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637289|NCT05139966|Fluorides|fluorides|mesh-list
102637290|NCT05139966|Cariostatic Agents|cariostatic agents|mesh-ancestor
102637291|NCT05139966|Protective Agents|protective agents|mesh-ancestor
102637292|NCT05139966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637293|NCT05138718|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102637294|NCT05138718|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102637295|NCT05138718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637296|NCT00575016|Botulinum Toxins|botulinum toxins|mesh-list
102637297|NCT00575016|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102637298|NCT00575016|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102637299|NCT00575016|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102637300|NCT00575016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102637301|NCT00575016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637302|NCT00575016|Cholinergic Agents|cholinergic agents|mesh-ancestor
102637303|NCT00575016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102637304|NCT00575016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637305|NCT00575016|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102637306|NCT00575016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102637307|NCT00577590|Metformin|metformin|mesh-list
102637308|NCT00577590|Rosiglitazone|rosiglitazone|mesh-list
102637309|NCT00577590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101609783|NCT01131182|Metformin|metformin|mesh-list
102637310|NCT00577590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637311|NCT00578214|Midazolam|midazolam|mesh-list
102637312|NCT00578214|Anesthetics|anesthetics|mesh-ancestor
102637313|NCT00578214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102637314|NCT00578214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637315|NCT00578214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102637316|NCT00578214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102637317|NCT00578214|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102637318|NCT00578214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102637319|NCT00578214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102637320|NCT00578214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102637321|NCT00578214|Anesthetics, General|anesthetics, general|mesh-ancestor
102637322|NCT00578214|GABA Modulators|gaba modulators|mesh-ancestor
102637323|NCT00578214|GABA Agents|gaba agents|mesh-ancestor
102637324|NCT00578214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102637325|NCT00578214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637326|NCT00580398|Varenicline|varenicline|mesh-list
102637327|NCT00580398|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102637328|NCT00580398|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102637329|NCT00580398|Cholinergic Agents|cholinergic agents|mesh-ancestor
102637330|NCT00580398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102637331|NCT00580398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637332|NCT00580398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637333|NCT00582660|Celecoxib|celecoxib|mesh-list
102637334|NCT00582660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102637335|NCT00582660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102637336|NCT00582660|Analgesics|analgesics|mesh-ancestor
102637337|NCT00582660|Sensory System Agents|sensory system agents|mesh-ancestor
102637338|NCT00582660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102637339|NCT00582660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637340|NCT00582660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102637341|NCT00582660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102637342|NCT00582660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102637343|NCT00582660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102637344|NCT00582660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102637345|NCT00582660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637346|NCT00582894|Fludarabine|fludarabine|mesh-list
102637347|NCT00582894|Alemtuzumab|alemtuzumab|mesh-list
102637348|NCT00582894|Busulfan|busulfan|mesh-list
102637349|NCT00582894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102637350|NCT00582894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637351|NCT00582894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102637352|NCT00582894|Immunologic Factors|immunologic factors|mesh-ancestor
102637353|NCT00582894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637354|NCT00582894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102637355|NCT00582894|Alkylating Agents|alkylating agents|mesh-ancestor
102637356|NCT00582894|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102637357|NCT00582894|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102637358|NCT00585780|Prazosin|prazosin|mesh-list
102637359|NCT00585780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102637360|NCT00585780|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102637361|NCT00585780|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102637362|NCT00585780|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102637363|NCT00585780|Adrenergic Agents|adrenergic agents|mesh-ancestor
102637364|NCT00585780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102637365|NCT00585780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637366|NCT00585780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637367|NCT00586482|Nicotine|nicotine|mesh-list
102637368|NCT00586482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102637369|NCT00586482|Autonomic Agents|autonomic agents|mesh-ancestor
102637370|NCT00586482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102637371|NCT00586482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637372|NCT00586482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102637373|NCT00586482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102637374|NCT00586482|Cholinergic Agents|cholinergic agents|mesh-ancestor
101609853|NCT03262116|Insulin|insulin|mesh-list
102637375|NCT00586482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102637376|NCT00586482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637377|NCT03708354|Tocotrienols|tocotrienols|mesh-list
102637378|NCT03708354|Vitamin E|vitamin e|mesh-list
102637379|NCT03708354|Tocopherols|tocopherols|mesh-list
102637380|NCT03708354|Antioxidants|antioxidants|mesh-ancestor
102637381|NCT03708354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637382|NCT03708354|Protective Agents|protective agents|mesh-ancestor
102637383|NCT03708354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637384|NCT03708354|Vitamins|vitamins|mesh-ancestor
102637385|NCT03708354|Micronutrients|micronutrients|mesh-ancestor
102637386|NCT03297684|Aflibercept|aflibercept|mesh-list
102637387|NCT03297684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102637388|NCT03297684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102637389|NCT03297684|Growth Substances|growth substances|mesh-ancestor
102637390|NCT03297684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637391|NCT03297684|Growth Inhibitors|growth inhibitors|mesh-ancestor
102637392|NCT03297684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102637393|NCT01740648|Fluorouracil|fluorouracil|mesh-list
102637394|NCT01740648|Trametinib|trametinib|mesh-list
102637395|NCT01740648|Antimetabolites|antimetabolites|mesh-ancestor
102637396|NCT01740648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637397|NCT01740648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102637398|NCT01740648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102637399|NCT01740648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102637400|NCT01740648|Immunologic Factors|immunologic factors|mesh-ancestor
102637401|NCT01740648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637402|NCT01740648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102637403|NCT01740648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102637404|NCT01685424|Etoricoxib|etoricoxib|mesh-list
102637405|NCT01685424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102637406|NCT01685424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102637407|NCT01685424|Analgesics|analgesics|mesh-ancestor
102637408|NCT01685424|Sensory System Agents|sensory system agents|mesh-ancestor
102637409|NCT01685424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102637410|NCT01685424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637411|NCT01685424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102637412|NCT01685424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102637413|NCT01685424|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102637414|NCT01685424|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102637415|NCT01685424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102637416|NCT01685424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637417|NCT01327638|Etoricoxib|etoricoxib|mesh-list
102637418|NCT01327638|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
102637419|NCT01327638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102637420|NCT01327638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102637421|NCT01327638|Analgesics|analgesics|mesh-ancestor
102637422|NCT01327638|Sensory System Agents|sensory system agents|mesh-ancestor
102637423|NCT01327638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102637424|NCT01327638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637425|NCT01327638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102637426|NCT01327638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102637427|NCT01327638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102637428|NCT01327638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102637429|NCT01327638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637430|NCT00393354|Etoricoxib|etoricoxib|mesh-list
102637431|NCT00393354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925894|NCT01291524|Pregabalin|pregabalin|mesh-list
102275225|NCT00003388|Tubulin Modulators|tubulin modulators|mesh-ancestor
102275226|NCT00003388|Antimitotic Agents|antimitotic agents|mesh-ancestor
102637432|NCT00393354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637433|NCT00393354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102637434|NCT00393354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102637435|NCT00393354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102637436|NCT00393354|Analgesics|analgesics|mesh-ancestor
102637437|NCT00393354|Sensory System Agents|sensory system agents|mesh-ancestor
102637438|NCT00393354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102637439|NCT00393354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102637440|NCT00393354|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102637441|NCT00393354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102637442|NCT00393354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102637443|NCT00166530|Atorvastatin|atorvastatin|mesh-list
102637444|NCT00166530|Simvastatin|simvastatin|mesh-list
102637445|NCT00166530|Ezetimibe|ezetimibe|mesh-list
102241617|NCT04433559|Urological Agents|urological agents|mesh-ancestor
102637446|NCT00166530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102637447|NCT00166530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102637448|NCT00166530|Antimetabolites|antimetabolites|mesh-ancestor
102637449|NCT00166530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637450|NCT00166530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102637451|NCT00166530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102637452|NCT00166530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102637453|NCT00588900|Irinotecan|irinotecan|mesh-list
102637454|NCT00588900|Cediranib|cediranib|mesh-list
102637455|NCT00588900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102637456|NCT00588900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102637457|NCT00588900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102637458|NCT00588900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637459|NCT00588900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102637460|NCT00588900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102637461|NCT00589056|Nelfinavir|nelfinavir|mesh-list
102637462|NCT00589056|Etoposide|etoposide|mesh-list
102637463|NCT00589056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102637464|NCT00589056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102637465|NCT00589056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102637466|NCT00589056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102637467|NCT00589056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102637468|NCT00589056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637469|NCT00589056|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102637470|NCT00589056|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102637471|NCT00589056|Protease Inhibitors|protease inhibitors|mesh-ancestor
102637472|NCT00589056|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102637473|NCT00589056|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102637474|NCT00589056|Antiviral Agents|antiviral agents|mesh-ancestor
102637475|NCT00589056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102637476|NCT00590226|Insulin|insulin|mesh-list
102637477|NCT00590226|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102637478|NCT00590226|Insulin Aspart|insulin aspart|mesh-list
102637479|NCT00590226|Insulin, Isophane|insulin, isophane|mesh-list
102637480|NCT00590226|Isophane Insulin, Human|isophane insulin, human|mesh-list
102637481|NCT00590226|Isophane insulin, beef|isophane insulin, beef|mesh-list
102637482|NCT00590226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102637483|NCT00590226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637484|NCT00590460|Fludarabine|fludarabine|mesh-list
102637485|NCT00590460|Alemtuzumab|alemtuzumab|mesh-list
102637486|NCT00590460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102637487|NCT00590460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102637488|NCT00590772|Montelukast|montelukast|mesh-list
102637489|NCT00590772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102637490|NCT00590772|Respiratory System Agents|respiratory system agents|mesh-ancestor
102637491|NCT00590772|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102637492|NCT00590772|Hormone Antagonists|hormone antagonists|mesh-ancestor
102637493|NCT00590772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102637494|NCT00590772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637495|NCT00590772|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102637496|NCT00590772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102637497|NCT00590772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637498|NCT00592176|Bevacizumab|bevacizumab|mesh-list
102637499|NCT00592176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102637500|NCT00592176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102637501|NCT00592176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102637502|NCT00592176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102637503|NCT00592176|Growth Substances|growth substances|mesh-ancestor
102275227|NCT00003388|Mitosis Modulators|mitosis modulators|mesh-ancestor
102637504|NCT00592176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637505|NCT00592176|Growth Inhibitors|growth inhibitors|mesh-ancestor
102637506|NCT00592488|Acetylcarnitine|acetylcarnitine|mesh-list
102637507|NCT00592488|Vitamin B Complex|vitamin b complex|mesh-ancestor
102637508|NCT00592488|Vitamins|vitamins|mesh-ancestor
102637509|NCT00592488|Micronutrients|micronutrients|mesh-ancestor
102637510|NCT00592488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637511|NCT00592488|Nootropic Agents|nootropic agents|mesh-ancestor
102637512|NCT00595530|Ketamine|ketamine|mesh-list
102637513|NCT00595530|Analgesics|analgesics|mesh-ancestor
102637514|NCT00595530|Sensory System Agents|sensory system agents|mesh-ancestor
102637515|NCT00595530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102637516|NCT00595530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637517|NCT00595530|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102637518|NCT00595530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102637519|NCT00595530|Anesthetics, General|anesthetics, general|mesh-ancestor
102637520|NCT00595530|Anesthetics|anesthetics|mesh-ancestor
102637521|NCT00595530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102637522|NCT00595530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102637523|NCT00595530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102637524|NCT00595530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102637525|NCT00595530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637526|NCT00596622|Lithium Carbonate|lithium carbonate|mesh-list
102637527|NCT00596622|Antidepressive Agents|antidepressive agents|mesh-ancestor
102637528|NCT00596622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102637529|NCT00596622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102637530|NCT00596622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637531|NCT00596622|Antimanic Agents|antimanic agents|mesh-ancestor
102637532|NCT00596622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102637533|NCT00596622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102637534|NCT00596622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637535|NCT00597402|Bevacizumab|bevacizumab|mesh-list
102637536|NCT00597402|Irinotecan|irinotecan|mesh-list
102637537|NCT00597402|Temozolomide|temozolomide|mesh-list
102637538|NCT00597402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102637539|NCT00597402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102637540|NCT00597402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102637541|NCT00597402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102637542|NCT00597402|Growth Substances|growth substances|mesh-ancestor
102637543|NCT00597402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637544|NCT00597402|Growth Inhibitors|growth inhibitors|mesh-ancestor
102637545|NCT00597402|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102637546|NCT00597402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102637547|NCT00597402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102637548|NCT00597402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637549|NCT00597402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102637550|NCT00597402|Alkylating Agents|alkylating agents|mesh-ancestor
102637551|NCT00598806|Apaziquone|apaziquone|mesh-list
102637552|NCT00598806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102637553|NCT00601926|Bevacizumab|bevacizumab|mesh-list
102637554|NCT00601926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102637555|NCT00601926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102637556|NCT00601926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102637557|NCT00601926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102637558|NCT00601926|Growth Substances|growth substances|mesh-ancestor
102637559|NCT00601926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637560|NCT00601926|Growth Inhibitors|growth inhibitors|mesh-ancestor
102637561|NCT00603018|Fluoxetine|fluoxetine|mesh-list
102637562|NCT00603018|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102637563|NCT00603018|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102637564|NCT00603018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102637565|NCT00603018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637566|NCT00603018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102637567|NCT00603018|Serotonin Agents|serotonin agents|mesh-ancestor
102637568|NCT00603018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637569|NCT00603018|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102637570|NCT00603018|Antidepressive Agents|antidepressive agents|mesh-ancestor
102637571|NCT00603018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101610052|NCT00915681|Silybin|silybin|mesh-list
102637572|NCT00603018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102637573|NCT00603018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102637574|NCT00603018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102637575|NCT00603408|Cisplatin|cisplatin|mesh-list
102637576|NCT00603408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102275228|NCT00003376|Paclitaxel|paclitaxel|mesh-list
102637577|NCT00603720|Phenylephrine|phenylephrine|mesh-list
102637578|NCT00603720|Oxymetazoline|oxymetazoline|mesh-list
102637579|NCT00603720|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
102637580|NCT00603720|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102637581|NCT00603720|Mydriatics|mydriatics|mesh-ancestor
102637582|NCT00603720|Autonomic Agents|autonomic agents|mesh-ancestor
102637583|NCT00603720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102637584|NCT00603720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637585|NCT00603720|Sympathomimetics|sympathomimetics|mesh-ancestor
102637586|NCT00603720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102637587|NCT00603720|Nasal Decongestants|nasal decongestants|mesh-ancestor
102637588|NCT00603720|Respiratory System Agents|respiratory system agents|mesh-ancestor
102637589|NCT00603720|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102637590|NCT00603720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102637591|NCT00603720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102637592|NCT00603720|Adrenergic Agents|adrenergic agents|mesh-ancestor
102637593|NCT00603720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102637594|NCT00603720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637595|NCT00603720|Protective Agents|protective agents|mesh-ancestor
102637596|NCT00603720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102637597|NCT00625404|Tenofovir|tenofovir|mesh-list
102637598|NCT00625404|Emtricitabine|emtricitabine|mesh-list
102637599|NCT00625404|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102637600|NCT00625404|Antiviral Agents|antiviral agents|mesh-ancestor
102637601|NCT00625404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102637602|NCT00625404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102637603|NCT00625404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102637604|NCT00625404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102637605|NCT00625404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637606|NCT00625404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102637607|NCT00625404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102637608|NCT00626340|Fluoxetine|fluoxetine|mesh-list
102637609|NCT00626340|Estrogens|estrogens|mesh-list
102637610|NCT00626340|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102637611|NCT00626340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102637612|NCT00626340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102637613|NCT00626340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637614|NCT00626340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102637615|NCT00626340|Serotonin Agents|serotonin agents|mesh-ancestor
102637616|NCT00626340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637617|NCT00626340|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102637618|NCT00626340|Antidepressive Agents|antidepressive agents|mesh-ancestor
102637619|NCT00626340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102637620|NCT00626340|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102637621|NCT00626340|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102637622|NCT00626340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102637623|NCT00626340|Hormones|hormones|mesh-ancestor
102637624|NCT00626340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102637625|NCT00626574|Epoetin Alfa|epoetin alfa|mesh-list
102637626|NCT00626574|Hematinics|hematinics|mesh-ancestor
102637627|NCT00626886|Bupivacaine|bupivacaine|mesh-list
102637628|NCT00626886|Anesthetics, Local|anesthetics, local|mesh-ancestor
102637629|NCT00626886|Anesthetics|anesthetics|mesh-ancestor
102637630|NCT00626886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102637631|NCT00626886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637632|NCT00626886|Sensory System Agents|sensory system agents|mesh-ancestor
102637633|NCT00626886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102637634|NCT00628134|Calfactant|calfactant|mesh-list
102637635|NCT00628134|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
102637636|NCT00628134|Respiratory System Agents|respiratory system agents|mesh-ancestor
102637637|NCT00632814|Factor VIII|factor viii|mesh-list
102637638|NCT00632814|Coagulants|coagulants|mesh-ancestor
102637639|NCT00632970|Ritonavir|ritonavir|mesh-list
102637640|NCT00632970|Lopinavir|lopinavir|mesh-list
102637641|NCT00632970|Tenofovir|tenofovir|mesh-list
102637642|NCT00632970|Emtricitabine|emtricitabine|mesh-list
102637643|NCT00632970|Raltegravir Potassium|raltegravir potassium|mesh-list
102637644|NCT00632970|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102637645|NCT00632970|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102637646|NCT00632970|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102637647|NCT00632970|Protease Inhibitors|protease inhibitors|mesh-ancestor
102637648|NCT00632970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102637649|NCT00632970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275229|NCT00003376|Vinblastine|vinblastine|mesh-list
102275230|NCT00003376|Carboplatin|carboplatin|mesh-list
102637650|NCT00632970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102637651|NCT00632970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102637652|NCT00632970|Antiviral Agents|antiviral agents|mesh-ancestor
102637653|NCT00632970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102637654|NCT00632970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102637655|NCT00632970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102637656|NCT00632970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102637657|NCT00632970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102637658|NCT00632970|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102637659|NCT00632970|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102637660|NCT00635232|Irbesartan|irbesartan|mesh-list
102637661|NCT00635232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102637662|NCT00635232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102637663|NCT00635232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102637664|NCT00635232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637665|NCT00637494|Mifepristone|mifepristone|mesh-list
102637666|NCT00637494|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102637667|NCT00637494|Abortifacient Agents|abortifacient agents|mesh-ancestor
102637668|NCT00637494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102637669|NCT00637494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637670|NCT00637494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102637671|NCT00637494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102637672|NCT00637494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102637673|NCT00637494|Contraceptive Agents|contraceptive agents|mesh-ancestor
102637674|NCT00637494|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102637675|NCT00637494|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102637676|NCT00637494|Hormone Antagonists|hormone antagonists|mesh-ancestor
102637677|NCT00637494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102637678|NCT00637494|Luteolytic Agents|luteolytic agents|mesh-ancestor
102637679|NCT00637494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102637680|NCT00637494|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102637681|NCT00638820|Busulfan|busulfan|mesh-list
102637682|NCT00638820|Alemtuzumab|alemtuzumab|mesh-list
102637683|NCT00638820|Clofarabine|clofarabine|mesh-list
102637684|NCT00638820|Alkylating Agents|alkylating agents|mesh-ancestor
102637685|NCT00638820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637686|NCT00638820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102637687|NCT00638820|Immunologic Factors|immunologic factors|mesh-ancestor
102637688|NCT00638820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637689|NCT00638820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102637690|NCT00638820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102637691|NCT00638820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102637692|NCT00638820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102637693|NCT00638820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102637694|NCT00638820|Antimetabolites|antimetabolites|mesh-ancestor
102637695|NCT00641862|Vitamin B 12|vitamin b 12|mesh-list
102637696|NCT00641862|Hydroxocobalamin|hydroxocobalamin|mesh-list
102637697|NCT00641862|Vitamins|vitamins|mesh-ancestor
102637698|NCT00641862|Micronutrients|micronutrients|mesh-ancestor
102637699|NCT00641862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637700|NCT00641862|Vitamin B Complex|vitamin b complex|mesh-ancestor
102637701|NCT00641862|Hematinics|hematinics|mesh-ancestor
102637702|NCT00643578|Formoterol Fumarate|formoterol fumarate|mesh-list
102637703|NCT00643578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102637704|NCT00643578|Autonomic Agents|autonomic agents|mesh-ancestor
102637705|NCT00643578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102637706|NCT00643578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637707|NCT00643578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102637708|NCT00643578|Respiratory System Agents|respiratory system agents|mesh-ancestor
102637709|NCT00643578|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102637710|NCT00643578|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102637711|NCT00643578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102637712|NCT00643578|Adrenergic Agents|adrenergic agents|mesh-ancestor
102637713|NCT00643578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102637714|NCT00643578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637715|NCT00644592|Fenofibrate|fenofibrate|mesh-list
102637716|NCT00644592|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102637717|NCT00644592|Antimetabolites|antimetabolites|mesh-ancestor
102637718|NCT00644592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637719|NCT00644592|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102637720|NCT00645450|Propranolol|propranolol|mesh-list
102275231|NCT00003376|Doxorubicin|doxorubicin|mesh-list
102275232|NCT00003376|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102637721|NCT00645450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102637722|NCT00645450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102637723|NCT00645450|Adrenergic Agents|adrenergic agents|mesh-ancestor
102637724|NCT00645450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102637725|NCT00645450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637726|NCT00645450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637727|NCT00645450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102637728|NCT00645450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102637729|NCT00645450|Vasodilator Agents|vasodilator agents|mesh-ancestor
102637731|NCT00647400|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102637732|NCT00647400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102637733|NCT00647400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102637734|NCT00648648|Carboplatin|carboplatin|mesh-list
102637735|NCT00648648|Gemcitabine|gemcitabine|mesh-list
102637736|NCT00648648|Adavosertib|adavosertib|mesh-list
102637737|NCT00648648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102637738|NCT00648648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102637739|NCT00648648|Antimetabolites|antimetabolites|mesh-ancestor
102637740|NCT00648648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637741|NCT00648648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102637742|NCT00652314|Thrombin|thrombin|mesh-list
102637743|NCT00652314|Hemostatics|hemostatics|mesh-ancestor
102637744|NCT00652314|Coagulants|coagulants|mesh-ancestor
102637745|NCT00654030|Vaccines|vaccines|mesh-list
102637746|NCT00654030|Immunologic Factors|immunologic factors|mesh-ancestor
102637747|NCT00654030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637748|NCT00656448|Epoetin Alfa|epoetin alfa|mesh-list
102637749|NCT00656448|Hematinics|hematinics|mesh-ancestor
102637750|NCT00660504|Etoposide|etoposide|mesh-list
102637751|NCT00660504|Amrubicin|amrubicin|mesh-list
102637752|NCT00660504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102637753|NCT00660504|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102637754|NCT00660504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102637755|NCT00660504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102637756|NCT00660504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102637757|NCT00660504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637758|NCT00661674|Palonosetron|palonosetron|mesh-list
102637759|NCT00661674|Hydroxyzine|hydroxyzine|mesh-list
102637760|NCT00661674|Antiemetics|antiemetics|mesh-ancestor
102637761|NCT00661674|Autonomic Agents|autonomic agents|mesh-ancestor
102637762|NCT00661674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102637763|NCT00661674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637764|NCT00661674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102637765|NCT00661674|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102637766|NCT00661674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102637767|NCT00661674|Serotonin Agents|serotonin agents|mesh-ancestor
102637768|NCT00661674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102637769|NCT00661674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637770|NCT00661674|Antipruritics|antipruritics|mesh-ancestor
102637771|NCT00661674|Dermatologic Agents|dermatologic agents|mesh-ancestor
102637772|NCT00661674|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102637773|NCT00661674|Histamine Antagonists|histamine antagonists|mesh-ancestor
102637774|NCT00661674|Histamine Agents|histamine agents|mesh-ancestor
102637775|NCT00662298|Prednisolone|prednisolone|mesh-list
102637776|NCT00662298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102637777|NCT00662298|Glucocorticoids|glucocorticoids|mesh-ancestor
102637778|NCT00662298|Hormones|hormones|mesh-ancestor
102637779|NCT00662298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102637780|NCT00662298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637781|NCT00662298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102637782|NCT00662298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102637783|NCT00666666|Acetic Acid|acetic acid|mesh-list
102637784|NCT00666666|Bicalutamide|bicalutamide|mesh-list
102637785|NCT00666666|Gossypol acetic acid|gossypol acetic acid|mesh-list
102637786|NCT00666666|Gossypol|gossypol|mesh-list
102637787|NCT00666666|Hormones|hormones|mesh-list
102637788|NCT00666666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102637789|NCT00666666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637790|NCT00666666|Androgen Antagonists|androgen antagonists|mesh-ancestor
102637791|NCT00666666|Hormone Antagonists|hormone antagonists|mesh-ancestor
102637792|NCT00666666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102637793|NCT00666666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102637794|NCT00666666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102275233|NCT00003376|Methotrexate|methotrexate|mesh-list
102637795|NCT00666666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102637796|NCT00666666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102637797|NCT00666666|Contraceptive Agents|contraceptive agents|mesh-ancestor
102637798|NCT00666666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102275234|NCT00003376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102637799|NCT00666666|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
102637800|NCT00666666|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
102637801|NCT00666666|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102637802|NCT00666978|Bupropion|bupropion|mesh-list
102637803|NCT00666978|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102637804|NCT00666978|Antidepressive Agents|antidepressive agents|mesh-ancestor
102637805|NCT00666978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102637806|NCT00666978|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102637807|NCT00666978|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102637808|NCT00666978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102637809|NCT00666978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637810|NCT00666978|Dopamine Agents|dopamine agents|mesh-ancestor
102637811|NCT00666978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102637812|NCT00666978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241618|NCT04911959|Lenvatinib|lenvatinib|mesh-list
102637813|NCT00666978|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102637814|NCT00666978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102637815|NCT00666978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102637816|NCT00670956|Betamethasone|betamethasone|mesh-list
102637817|NCT00670956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102637818|NCT00670956|Glucocorticoids|glucocorticoids|mesh-ancestor
102637819|NCT00670956|Hormones|hormones|mesh-ancestor
102637820|NCT00670956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102637821|NCT00670956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637822|NCT00670956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102637823|NCT00670956|Respiratory System Agents|respiratory system agents|mesh-ancestor
102637824|NCT00671502|Carisoprodol|carisoprodol|mesh-list
102637825|NCT00671502|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102637826|NCT00671502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637827|NCT00671502|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102637828|NCT00671502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102637829|NCT00671970|Bevacizumab|bevacizumab|mesh-list
102637830|NCT00671970|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102637831|NCT00671970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102637832|NCT00671970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102637833|NCT00671970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102637834|NCT00671970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102637835|NCT00671970|Growth Substances|growth substances|mesh-ancestor
102637836|NCT00671970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637837|NCT00671970|Growth Inhibitors|growth inhibitors|mesh-ancestor
102637838|NCT00671970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102637839|NCT00671970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102637840|NCT00671970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637841|NCT00672204|Sirolimus|sirolimus|mesh-list
102637842|NCT00672204|Thymoglobulin|thymoglobulin|mesh-list
102637843|NCT00672204|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102637844|NCT00672204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102637845|NCT00672204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102637846|NCT00672204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102637847|NCT00672204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102637848|NCT00672204|Antifungal Agents|antifungal agents|mesh-ancestor
102637849|NCT00672204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102637850|NCT00672204|Immunologic Factors|immunologic factors|mesh-ancestor
102637851|NCT00672204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637852|NCT00672438|Alfentanil|alfentanil|mesh-list
102637853|NCT00672438|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102637854|NCT00672438|Narcotics|narcotics|mesh-ancestor
102637855|NCT00672438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102637856|NCT00672438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637857|NCT00672438|Analgesics|analgesics|mesh-ancestor
102637858|NCT00672438|Sensory System Agents|sensory system agents|mesh-ancestor
102637859|NCT00672438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102637860|NCT00672438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102637861|NCT00672438|Anesthetics, General|anesthetics, general|mesh-ancestor
102637862|NCT00672438|Anesthetics|anesthetics|mesh-ancestor
102637863|NCT00672594|Sunitinib|sunitinib|mesh-list
102637864|NCT00672594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102637865|NCT00672594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102637866|NCT00672594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102637867|NCT00672594|Growth Substances|growth substances|mesh-ancestor
102637868|NCT00672594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637869|NCT00672594|Growth Inhibitors|growth inhibitors|mesh-ancestor
102637870|NCT00672594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102637871|NCT00672594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102637872|NCT00672594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637873|NCT00673764|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102637874|NCT00673764|Lubricant Eye Drops|lubricant eye drops|mesh-list
102637875|NCT00673764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102637876|NCT00675792|Bromides|bromides|mesh-list
102637877|NCT00675792|Rocuronium|rocuronium|mesh-list
102637878|NCT00675792|Neostigmine|neostigmine|mesh-list
102637879|NCT00675792|Anticonvulsants|anticonvulsants|mesh-ancestor
101610363|NCT00666796|Ethanol|ethanol|mesh-list
102637880|NCT00675792|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102637881|NCT00675792|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102637882|NCT00675792|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102637883|NCT00675792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102637884|NCT00675792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637885|NCT00675792|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102637886|NCT00675792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102637887|NCT00675792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637888|NCT00675792|Cholinergic Agents|cholinergic agents|mesh-ancestor
102637889|NCT00675792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102637890|NCT00675792|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102637891|NCT00675792|Autonomic Agents|autonomic agents|mesh-ancestor
102637892|NCT00676806|Cyclophosphamide|cyclophosphamide|mesh-list
102637893|NCT00676806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102637894|NCT00676806|Immunologic Factors|immunologic factors|mesh-ancestor
102637895|NCT00676806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637896|NCT00676806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102637897|NCT00676806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102637898|NCT00676806|Alkylating Agents|alkylating agents|mesh-ancestor
102637899|NCT00676806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637900|NCT00676806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102637901|NCT00676806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102637902|NCT00678834|Tocopherols|tocopherols|mesh-list
102637903|NCT00678834|Vitamin E|vitamin e|mesh-list
102637904|NCT00678834|Tocotrienols|tocotrienols|mesh-list
102637905|NCT00678834|alpha-Tocopherol|alpha-tocopherol|mesh-list
102637906|NCT00678834|Antioxidants|antioxidants|mesh-ancestor
102637907|NCT00678834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637908|NCT00678834|Protective Agents|protective agents|mesh-ancestor
102637909|NCT00678834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637910|NCT00678834|Vitamins|vitamins|mesh-ancestor
102637911|NCT00678834|Micronutrients|micronutrients|mesh-ancestor
102637912|NCT00679380|Budesonide|budesonide|mesh-list
102637913|NCT00679380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102637914|NCT00679380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102637915|NCT00679380|Autonomic Agents|autonomic agents|mesh-ancestor
102637916|NCT00679380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102637917|NCT00679380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637918|NCT00679380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102637919|NCT00679380|Respiratory System Agents|respiratory system agents|mesh-ancestor
102637920|NCT00679380|Glucocorticoids|glucocorticoids|mesh-ancestor
102637921|NCT00679380|Hormones|hormones|mesh-ancestor
102637922|NCT00679380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102637923|NCT00680706|Thiamine|thiamine|mesh-list
102637924|NCT00680706|Vitamins|vitamins|mesh-ancestor
102637925|NCT00680706|Micronutrients|micronutrients|mesh-ancestor
102637926|NCT00680706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637927|NCT00680706|Vitamin B Complex|vitamin b complex|mesh-ancestor
102637928|NCT00682734|Diphenhydramine|diphenhydramine|mesh-list
102637929|NCT00682734|Promethazine|promethazine|mesh-list
102637930|NCT00682734|Metoclopramide|metoclopramide|mesh-list
102637931|NCT00682734|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102637932|NCT00682734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102637933|NCT00682734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102637934|NCT00682734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637935|NCT00682734|Anesthetics, Local|anesthetics, local|mesh-ancestor
102637936|NCT00682734|Anesthetics|anesthetics|mesh-ancestor
102637937|NCT00682734|Sensory System Agents|sensory system agents|mesh-ancestor
102637938|NCT00682734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102637939|NCT00682734|Antiemetics|antiemetics|mesh-ancestor
102637940|NCT00682734|Autonomic Agents|autonomic agents|mesh-ancestor
102637941|NCT00682734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102637942|NCT00682734|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102637943|NCT00682734|Histamine Antagonists|histamine antagonists|mesh-ancestor
102637944|NCT00682734|Histamine Agents|histamine agents|mesh-ancestor
102637945|NCT00682734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102637946|NCT00682734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637947|NCT00682734|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102275235|NCT00003376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102275236|NCT00003376|Tubulin Modulators|tubulin modulators|mesh-ancestor
102637948|NCT00682734|Antipruritics|antipruritics|mesh-ancestor
102637949|NCT00682734|Dermatologic Agents|dermatologic agents|mesh-ancestor
102637950|NCT00682734|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102637951|NCT00682734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102637952|NCT00682734|Dopamine Agents|dopamine agents|mesh-ancestor
102637953|NCT00683046|Fludarabine|fludarabine|mesh-list
102637954|NCT00683046|Melphalan|melphalan|mesh-list
102637955|NCT00683046|Alemtuzumab|alemtuzumab|mesh-list
102637956|NCT00683046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102637957|NCT00683046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637958|NCT00683046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102637959|NCT00683046|Immunologic Factors|immunologic factors|mesh-ancestor
102637960|NCT00683046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637961|NCT00683046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102637962|NCT00683046|Alkylating Agents|alkylating agents|mesh-ancestor
102637963|NCT00683046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102637964|NCT00683046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102637965|NCT00687102|Tamoxifen|tamoxifen|mesh-list
102637966|NCT00687102|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
102637967|NCT00687102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102637968|NCT00687102|Hormone Antagonists|hormone antagonists|mesh-ancestor
102637969|NCT00687102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102637970|NCT00687102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637971|NCT00687102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102637972|NCT00687102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102637973|NCT00687102|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102637974|NCT00687102|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102637975|NCT00687102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102637976|NCT00690924|Calcitriol|calcitriol|mesh-list
102637977|NCT00690924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102637978|NCT00690924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637979|NCT00690924|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102637980|NCT00690924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102637981|NCT00690924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637982|NCT00690924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102637983|NCT00690924|Vitamins|vitamins|mesh-ancestor
102637984|NCT00690924|Micronutrients|micronutrients|mesh-ancestor
102637985|NCT00690924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102637986|NCT00691002|Calcitriol|calcitriol|mesh-list
102637987|NCT00691002|Hydrocortisone|hydrocortisone|mesh-list
102637988|NCT00691002|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101610501|NCT00663442|Dopamine Agents|dopamine agents|mesh-ancestor
102637989|NCT00691002|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102637990|NCT00691002|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102637991|NCT00691002|Calcipotriene|calcipotriene|mesh-list
102637992|NCT00691002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102637993|NCT00691002|Dermatologic Agents|dermatologic agents|mesh-ancestor
102637994|NCT00691002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102637995|NCT00691002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102637996|NCT00691002|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102637997|NCT00691002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102637998|NCT00691002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102637999|NCT00691002|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102638000|NCT00691002|Vitamins|vitamins|mesh-ancestor
102638001|NCT00691002|Micronutrients|micronutrients|mesh-ancestor
102638002|NCT00691002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102638003|NCT00695292|Carboplatin|carboplatin|mesh-list
102638004|NCT00695292|Irinotecan|irinotecan|mesh-list
102638005|NCT00695292|Sunitinib|sunitinib|mesh-list
102638006|NCT00695292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102638007|NCT00695292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102638008|NCT00695292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102638009|NCT00695292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102638010|NCT00695292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638011|NCT00695292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102638012|NCT00695292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102638013|NCT00695292|Growth Substances|growth substances|mesh-ancestor
102638014|NCT00695292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638015|NCT00695292|Growth Inhibitors|growth inhibitors|mesh-ancestor
102638016|NCT00695292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102638017|NCT00696618|Plasma-lyte 148|plasma-lyte 148|mesh-list
102638018|NCT00696618|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102638019|NCT00696618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102275237|NCT00003376|Antimitotic Agents|antimitotic agents|mesh-ancestor
102638020|NCT00700440|Cetuximab|cetuximab|mesh-list
102638021|NCT00700440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102638022|NCT00700440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102638023|NCT00701376|Liver Extracts|liver extracts|mesh-list
102638024|NCT00701376|Hematinics|hematinics|mesh-ancestor
102638025|NCT00702780|Escitalopram|escitalopram|mesh-list
102638026|NCT00702780|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102638027|NCT00702780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102638028|NCT00702780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102638029|NCT00702780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638030|NCT00702780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102638031|NCT00702780|Serotonin Agents|serotonin agents|mesh-ancestor
102638032|NCT00702780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638033|NCT00704028|Dextrans|dextrans|mesh-list
102638034|NCT00704028|Iron-Dextran Complex|iron-dextran complex|mesh-list
102638035|NCT00704028|Anticoagulants|anticoagulants|mesh-ancestor
102638036|NCT00704028|Plasma Substitutes|plasma substitutes|mesh-ancestor
102638037|NCT00704028|Blood Substitutes|blood substitutes|mesh-ancestor
102638038|NCT00704028|Hematinics|hematinics|mesh-ancestor
102638039|NCT00704262|Hydrocortisone|hydrocortisone|mesh-list
102638040|NCT00704262|Calcipotriene|calcipotriene|mesh-list
102638041|NCT00704262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102638042|NCT00704262|Dermatologic Agents|dermatologic agents|mesh-ancestor
102638043|NCT00706446|Fluticasone|fluticasone|mesh-list
102638044|NCT00706446|Xhance|xhance|mesh-list
102638045|NCT00706446|Budesonide|budesonide|mesh-list
102638046|NCT00706446|Bromides|bromides|mesh-list
102638047|NCT00706446|Formoterol Fumarate|formoterol fumarate|mesh-list
102638048|NCT00706446|Tiotropium Bromide|tiotropium bromide|mesh-list
102638049|NCT00706446|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102638050|NCT00706446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102638051|NCT00706446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102638052|NCT00706446|Autonomic Agents|autonomic agents|mesh-ancestor
102638053|NCT00706446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102638054|NCT00706446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638055|NCT00706446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102638056|NCT00706446|Respiratory System Agents|respiratory system agents|mesh-ancestor
102638057|NCT00706446|Dermatologic Agents|dermatologic agents|mesh-ancestor
102638058|NCT00706446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102638059|NCT00706446|Glucocorticoids|glucocorticoids|mesh-ancestor
102638060|NCT00706446|Hormones|hormones|mesh-ancestor
102638061|NCT00706446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102638062|NCT00706446|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102638063|NCT00706446|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102638064|NCT00706446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102638065|NCT00706446|Adrenergic Agents|adrenergic agents|mesh-ancestor
102638066|NCT00706446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102638067|NCT00706446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638068|NCT00706446|Parasympatholytics|parasympatholytics|mesh-ancestor
102638069|NCT00706446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102638070|NCT00706446|Cholinergic Agents|cholinergic agents|mesh-ancestor
102638071|NCT00706446|Anticonvulsants|anticonvulsants|mesh-ancestor
102638072|NCT00706836|Pregabalin|pregabalin|mesh-list
102638073|NCT00706836|Analgesics|analgesics|mesh-ancestor
102638074|NCT00706836|Sensory System Agents|sensory system agents|mesh-ancestor
102638075|NCT00706836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102638076|NCT00706836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638077|NCT00706836|Anticonvulsants|anticonvulsants|mesh-ancestor
102638078|NCT00706836|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102638079|NCT00706836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102638080|NCT00706836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638081|NCT00706836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102638082|NCT00706836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102638083|NCT00706836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102638084|NCT00706836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102638085|NCT00706836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102638086|NCT00708942|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102638087|NCT00708942|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102638088|NCT00708942|Dermatologic Agents|dermatologic agents|mesh-ancestor
102638089|NCT00711828|Dexamethasone|dexamethasone|mesh-list
102638090|NCT00711828|Cyclophosphamide|cyclophosphamide|mesh-list
102638091|NCT00711828|Rituximab|rituximab|mesh-list
102638092|NCT00711828|Bortezomib|bortezomib|mesh-list
101926572|NCT03846180|Somatostatin|somatostatin|mesh-list
102638093|NCT00711828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102638094|NCT00711828|Immunologic Factors|immunologic factors|mesh-ancestor
102638095|NCT00711828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275238|NCT00003376|Mitosis Modulators|mitosis modulators|mesh-ancestor
102638096|NCT00711828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102638097|NCT00711828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102638098|NCT00711828|Alkylating Agents|alkylating agents|mesh-ancestor
102638099|NCT00711828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638100|NCT00711828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102638101|NCT00711828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102638102|NCT00711828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102638103|NCT00711828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102638104|NCT00711828|Antiemetics|antiemetics|mesh-ancestor
102638105|NCT00711828|Autonomic Agents|autonomic agents|mesh-ancestor
102638106|NCT00711828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102638107|NCT00711828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102638108|NCT00711828|Glucocorticoids|glucocorticoids|mesh-ancestor
102638109|NCT00711828|Hormones|hormones|mesh-ancestor
102638110|NCT00711828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102638111|NCT00711828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102638112|NCT00712530|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102638113|NCT00712530|Antiviral Agents|antiviral agents|mesh-ancestor
102638114|NCT00712530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102638115|NCT00715884|Sirolimus|sirolimus|mesh-list
102638116|NCT00715884|Temsirolimus|temsirolimus|mesh-list
102638117|NCT00715884|MTOR Inhibitors|mtor inhibitors|mesh-list
102638118|NCT00715884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102638119|NCT00715884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102638120|NCT00715884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102638121|NCT00715884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102638122|NCT00715884|Antifungal Agents|antifungal agents|mesh-ancestor
102638123|NCT00715884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102638124|NCT00715884|Immunologic Factors|immunologic factors|mesh-ancestor
102638125|NCT00715884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638126|NCT00715884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102638127|NCT00715884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102638128|NCT00715884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638142|NCT00716820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102638143|NCT00716820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102638144|NCT00716820|Growth Substances|growth substances|mesh-ancestor
102638145|NCT00716820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638146|NCT00716820|Growth Inhibitors|growth inhibitors|mesh-ancestor
102638147|NCT00716820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102638148|NCT00716820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102638149|NCT00716820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638150|NCT00717054|Scopolamine|scopolamine|mesh-list
102638151|NCT00717054|Aprepitant|aprepitant|mesh-list
102638152|NCT00717054|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102638153|NCT00717054|Antiemetics|antiemetics|mesh-ancestor
102638154|NCT00717054|Autonomic Agents|autonomic agents|mesh-ancestor
102638155|NCT00717054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102638156|NCT00717054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638157|NCT00717054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102638158|NCT00717054|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102638159|NCT00717054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102638160|NCT00717054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638161|NCT00717054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102638162|NCT00717054|Mydriatics|mydriatics|mesh-ancestor
102638163|NCT00717054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102638164|NCT00717054|Cholinergic Agents|cholinergic agents|mesh-ancestor
102638165|NCT00717054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102638166|NCT00717054|Parasympatholytics|parasympatholytics|mesh-ancestor
102638167|NCT00717288|Insulin Detemir|insulin detemir|mesh-list
102638168|NCT00717288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102638169|NCT00717288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638170|NCT00719160|Esomeprazole|esomeprazole|mesh-list
102638171|NCT00719160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102638172|NCT00719160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102638173|NCT00719160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102638174|NCT00719160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102638175|NCT00719160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638176|NCT00720330|Lidocaine|lidocaine|mesh-list
102638177|NCT00720330|Ketamine|ketamine|mesh-list
102638178|NCT00720330|Ropivacaine|ropivacaine|mesh-list
102638179|NCT00720330|Anesthetics, Local|anesthetics, local|mesh-ancestor
102638180|NCT00720330|Anesthetics|anesthetics|mesh-ancestor
102638181|NCT00720330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102638182|NCT00720330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638183|NCT00720330|Sensory System Agents|sensory system agents|mesh-ancestor
102638184|NCT00720330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102638185|NCT00720330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102638186|NCT00720330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102638187|NCT00720330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102638188|NCT00720330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102638189|NCT00720330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638190|NCT00720330|Analgesics|analgesics|mesh-ancestor
102638191|NCT00720330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102638192|NCT00720330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102638193|NCT00720330|Anesthetics, General|anesthetics, general|mesh-ancestor
102638194|NCT00720330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102638195|NCT00720330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102638196|NCT00720330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102638197|NCT00721188|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102638198|NCT00721188|Hematinics|hematinics|mesh-ancestor
102638199|NCT00722436|Tranexamic Acid|tranexamic acid|mesh-list
102638200|NCT00722436|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102638201|NCT00722436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102638202|NCT00722436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638203|NCT00722436|Hemostatics|hemostatics|mesh-ancestor
102638204|NCT00722436|Coagulants|coagulants|mesh-ancestor
102638205|NCT00724464|Interferons|interferons|mesh-list
102638206|NCT00724464|Ribavirin|ribavirin|mesh-list
102638207|NCT00724464|Interferon-alpha|interferon-alpha|mesh-list
102638208|NCT00724464|Interferon alpha-2|interferon alpha-2|mesh-list
102638209|NCT00724464|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102638210|NCT00724464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102638211|NCT00724464|Antiviral Agents|antiviral agents|mesh-ancestor
102638212|NCT00724464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102638213|NCT00724464|Antimetabolites|antimetabolites|mesh-ancestor
102638214|NCT00724464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638215|NCT00724464|Immunologic Factors|immunologic factors|mesh-ancestor
102638216|NCT00724464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638217|NCT00726414|Quinine|quinine|mesh-list
102638218|NCT00726414|Antimalarials|antimalarials|mesh-ancestor
102638219|NCT00726414|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102638220|NCT00726414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102638221|NCT00726414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102638222|NCT00726414|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102638223|NCT00726414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638224|NCT00726414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102638225|NCT00726414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102638226|NCT00726414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102638227|NCT00726414|Analgesics|analgesics|mesh-ancestor
102638228|NCT00726414|Sensory System Agents|sensory system agents|mesh-ancestor
102638229|NCT00727740|Indomethacin|indomethacin|mesh-list
102638230|NCT00727740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102638231|NCT00727740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102638232|NCT00727740|Analgesics|analgesics|mesh-ancestor
102638233|NCT00727740|Sensory System Agents|sensory system agents|mesh-ancestor
102638234|NCT00727740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102638235|NCT00727740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638236|NCT00727740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102638237|NCT00727740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102638238|NCT00727740|Gout Suppressants|gout suppressants|mesh-ancestor
102638239|NCT00727740|Tocolytic Agents|tocolytic agents|mesh-ancestor
102638240|NCT00727740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102638241|NCT00727740|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102638242|NCT00727740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102638243|NCT00727740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638244|NCT00728910|Niacin|niacin|mesh-list
102638245|NCT00728910|Atorvastatin|atorvastatin|mesh-list
102638246|NCT00728910|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102638247|NCT00728910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102638248|NCT00728910|Antimetabolites|antimetabolites|mesh-ancestor
102638249|NCT00728910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638250|NCT00728910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102638251|NCT00728910|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102638252|NCT00728910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102638253|NCT00728910|Vasodilator Agents|vasodilator agents|mesh-ancestor
102638254|NCT00728910|Vitamin B Complex|vitamin b complex|mesh-ancestor
102638255|NCT00728910|Vitamins|vitamins|mesh-ancestor
101926719|NCT03841890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102638256|NCT00728910|Micronutrients|micronutrients|mesh-ancestor
102638257|NCT00728910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638258|NCT00729846|Bevacizumab|bevacizumab|mesh-list
102638259|NCT00729846|Verteporfin|verteporfin|mesh-list
102638260|NCT00729846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102638261|NCT00729846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102638262|NCT00729846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102638263|NCT00729846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102638264|NCT00729846|Growth Substances|growth substances|mesh-ancestor
102638265|NCT00729846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638266|NCT00729846|Growth Inhibitors|growth inhibitors|mesh-ancestor
102638267|NCT00729846|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102638268|NCT00729846|Dermatologic Agents|dermatologic agents|mesh-ancestor
102638269|NCT00729924|Raltegravir Potassium|raltegravir potassium|mesh-list
102638270|NCT00729924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102638271|NCT00729924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102638272|NCT00729924|Antiviral Agents|antiviral agents|mesh-ancestor
102638273|NCT00729924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102638274|NCT00729924|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102638275|NCT00729924|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102638276|NCT00729924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102638277|NCT00729924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638278|NCT00731874|Tacrolimus|tacrolimus|mesh-list
102638279|NCT00731874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102638280|NCT00731874|Immunologic Factors|immunologic factors|mesh-ancestor
102638281|NCT00731874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638282|NCT00731874|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102638283|NCT00731874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102638284|NCT00731874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638285|NCT00732654|Immunomodulating Agents|immunomodulating agents|mesh-list
102638286|NCT00732654|Immunologic Factors|immunologic factors|mesh-list
102638287|NCT00732654|Caseins|caseins|mesh-list
102638288|NCT00732654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638289|NCT00732654|Chelating Agents|chelating agents|mesh-ancestor
102638290|NCT00732654|Sequestering Agents|sequestering agents|mesh-ancestor
102638291|NCT00732654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638292|NCT00733278|Copper|copper|mesh-list
102638293|NCT00733278|Contraceptive Agents|contraceptive agents|mesh-list
102638294|NCT00733278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102638295|NCT00733278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638296|NCT00733278|Trace Elements|trace elements|mesh-ancestor
102638297|NCT00733278|Micronutrients|micronutrients|mesh-ancestor
102638298|NCT00733356|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102638299|NCT00733356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102638300|NCT00733356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638301|NCT00733356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102638302|NCT00733356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102638303|NCT00733356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102241619|NCT04911959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102638304|NCT00733356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638305|NCT00733356|Dopamine Agents|dopamine agents|mesh-ancestor
102638306|NCT00733356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102638307|NCT00735306|Bevacizumab|bevacizumab|mesh-list
102638308|NCT00735306|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102638309|NCT00735306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102638310|NCT00735306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102638311|NCT00735306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102638312|NCT00735306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102638313|NCT00735306|Growth Substances|growth substances|mesh-ancestor
102638314|NCT00735306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638315|NCT00735306|Growth Inhibitors|growth inhibitors|mesh-ancestor
102638316|NCT00735306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102638317|NCT00735306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102638318|NCT00735306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638319|NCT00735462|Imiquimod|imiquimod|mesh-list
102638320|NCT00735462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102638321|NCT00735462|Immunologic Factors|immunologic factors|mesh-ancestor
102638322|NCT00735462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638323|NCT00735462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102638324|NCT00735462|Interferon Inducers|interferon inducers|mesh-ancestor
102275239|NCT00003376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275240|NCT00003376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102275241|NCT00003376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102275242|NCT00003376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102275243|NCT00003376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102638325|NCT00736242|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102638326|NCT00736242|Interferon alpha-2|interferon alpha-2|mesh-list
102638327|NCT00736242|Antiviral Agents|antiviral agents|mesh-ancestor
102638328|NCT00736242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102638329|NCT00736242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102638330|NCT00736632|Vitamin D|vitamin d|mesh-list
102638331|NCT00736632|Ergocalciferols|ergocalciferols|mesh-list
102638332|NCT00736632|Cholecalciferol|cholecalciferol|mesh-list
102638333|NCT00736632|Vitamins|vitamins|mesh-list
102638334|NCT00736632|Micronutrients|micronutrients|mesh-ancestor
102638335|NCT00736632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638336|NCT00736632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102638337|NCT00736632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102638338|NCT00737178|Copper|copper|mesh-list
102638339|NCT00737178|Trace Elements|trace elements|mesh-ancestor
102638340|NCT00737178|Micronutrients|micronutrients|mesh-ancestor
102638341|NCT00737178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638342|NCT00741156|Enalaprilat|enalaprilat|mesh-list
102638343|NCT00741156|Enalapril|enalapril|mesh-list
102638344|NCT00741156|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102638345|NCT00741156|Protease Inhibitors|protease inhibitors|mesh-ancestor
102638346|NCT00741156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241620|NCT04911959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102638347|NCT00741156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638348|NCT00741156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102638349|NCT00741468|Tolbutamide|tolbutamide|mesh-list
102638350|NCT00741468|Midazolam|midazolam|mesh-list
102638351|NCT00741468|Dextromethorphan|dextromethorphan|mesh-list
102638352|NCT00741468|Caffeine|caffeine|mesh-list
102638353|NCT00741468|Omeprazole|omeprazole|mesh-list
102638354|NCT00741468|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102638355|NCT00741468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102638356|NCT00741468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102638357|NCT00741468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638358|NCT00741468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102638359|NCT00741468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102638360|NCT00741468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102638361|NCT00741468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102638362|NCT00741468|Anesthetics, General|anesthetics, general|mesh-ancestor
102638363|NCT00741468|Anesthetics|anesthetics|mesh-ancestor
102638364|NCT00741468|GABA Modulators|gaba modulators|mesh-ancestor
102638365|NCT00741468|GABA Agents|gaba agents|mesh-ancestor
102638366|NCT00741468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102638367|NCT00741468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638368|NCT00741468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102638369|NCT00741468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102638370|NCT00741468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102638371|NCT00741468|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102638372|NCT00741468|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102638373|NCT00741468|Purinergic Agents|purinergic agents|mesh-ancestor
102638374|NCT00741468|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102638375|NCT00741468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102638376|NCT00741468|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102638377|NCT00741468|Antitussive Agents|antitussive agents|mesh-ancestor
102638378|NCT00741468|Respiratory System Agents|respiratory system agents|mesh-ancestor
102638379|NCT00741468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102638380|NCT00741468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102638381|NCT00741468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102638382|NCT00741858|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102638383|NCT00741858|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102638384|NCT00741858|Estradiol|estradiol|mesh-list
102638385|NCT00741858|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102638386|NCT00741858|Estrogens|estrogens|mesh-ancestor
102638387|NCT00741858|Hormones|hormones|mesh-ancestor
102638388|NCT00741858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102638389|NCT00741858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638390|NCT00741858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102638391|NCT00741858|Contraceptive Agents|contraceptive agents|mesh-ancestor
102638392|NCT00741858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102638393|NCT00741858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102638394|NCT00742872|Mosapride|mosapride|mesh-list
102638395|NCT00742872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638396|NCT00742872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102275244|NCT00003376|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102275245|NCT00003376|Abortifacient Agents|abortifacient agents|mesh-ancestor
102275246|NCT00003376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102275247|NCT00003376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275248|NCT00003376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102638397|NCT00742872|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102275249|NCT00003376|Antimetabolites|antimetabolites|mesh-ancestor
102638398|NCT00742872|Serotonin Agents|serotonin agents|mesh-ancestor
102638399|NCT00742872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102638400|NCT00742872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638401|NCT00743574|Vitamin D|vitamin d|mesh-list
102638402|NCT00743574|Ergocalciferols|ergocalciferols|mesh-list
102638403|NCT00743574|Cholecalciferol|cholecalciferol|mesh-list
102638404|NCT00743574|Vitamins|vitamins|mesh-list
102638405|NCT00743574|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102638406|NCT00743574|Medroxyprogesterone|medroxyprogesterone|mesh-list
102638407|NCT00743574|Calcium|calcium|mesh-list
102638408|NCT00743574|Micronutrients|micronutrients|mesh-ancestor
102638409|NCT00743574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638410|NCT00743574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102638411|NCT00743574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102638412|NCT00743574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102638413|NCT00743574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102638414|NCT00743574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102638415|NCT00743574|Contraceptive Agents|contraceptive agents|mesh-ancestor
102638416|NCT00743574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102638417|NCT00743574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102638418|NCT00743574|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102638419|NCT00743574|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102638420|NCT00743574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102638421|NCT00743574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102638422|NCT00743730|Morphine|morphine|mesh-list
102638423|NCT00743730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102638424|NCT00743730|Narcotics|narcotics|mesh-ancestor
102638425|NCT00743730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102638426|NCT00743730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638427|NCT00743730|Analgesics|analgesics|mesh-ancestor
102638428|NCT00743730|Sensory System Agents|sensory system agents|mesh-ancestor
102638429|NCT00743730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102638430|NCT00745290|Bupivacaine|bupivacaine|mesh-list
102638431|NCT00745290|Anesthetics, Local|anesthetics, local|mesh-ancestor
102638432|NCT00745290|Anesthetics|anesthetics|mesh-ancestor
102638433|NCT00745290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102638434|NCT00745290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638435|NCT00745290|Sensory System Agents|sensory system agents|mesh-ancestor
102638436|NCT00745290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102638437|NCT00751530|Raltegravir Potassium|raltegravir potassium|mesh-list
102638438|NCT00751530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102638439|NCT00751530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102638440|NCT00751530|Antiviral Agents|antiviral agents|mesh-ancestor
102638441|NCT00751530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102638442|NCT00751530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102638443|NCT00751530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102638444|NCT00751530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102638445|NCT00751530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638446|NCT00753636|Isradipine|isradipine|mesh-list
102638447|NCT00753636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102638448|NCT00753636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102638449|NCT00753636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102638450|NCT00753636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638451|NCT00753636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102638452|NCT00753636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638453|NCT00753636|Vasodilator Agents|vasodilator agents|mesh-ancestor
102638454|NCT00754494|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102638455|NCT00754494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102638456|NCT00754494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102638457|NCT00754494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102638458|NCT00754494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638459|NCT00755040|Cyclosporine|cyclosporine|mesh-list
102638460|NCT00755040|Cyclosporins|cyclosporins|mesh-list
102638461|NCT00755040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102638462|NCT00755040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638463|NCT00755040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102638464|NCT00755040|Immunologic Factors|immunologic factors|mesh-ancestor
102638465|NCT00755040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638466|NCT00755040|Antifungal Agents|antifungal agents|mesh-ancestor
102638467|NCT00755040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102638468|NCT00755040|Dermatologic Agents|dermatologic agents|mesh-ancestor
102638469|NCT00755040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102275250|NCT00003376|Dermatologic Agents|dermatologic agents|mesh-ancestor
102275251|NCT00003376|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102638470|NCT00755040|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102638471|NCT00755274|Vaccines|vaccines|mesh-list
102638472|NCT00755274|Immunologic Factors|immunologic factors|mesh-ancestor
102638473|NCT00755274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638474|NCT00756600|Anesthetics|anesthetics|mesh-list
102638475|NCT00756600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102638476|NCT00756600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638477|NCT00756678|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102638478|NCT00756678|Lubricant Eye Drops|lubricant eye drops|mesh-list
102638479|NCT00756678|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102638480|NCT00758784|Bromfenac|bromfenac|mesh-list
102638481|NCT00758784|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102638482|NCT00758784|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102638483|NCT00758784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102638484|NCT00758784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102638485|NCT00758784|Analgesics|analgesics|mesh-ancestor
102638486|NCT00758784|Sensory System Agents|sensory system agents|mesh-ancestor
102638487|NCT00758784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102638488|NCT00758784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638489|NCT00758784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102638490|NCT00758784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102638491|NCT00759330|Flurbiprofen|flurbiprofen|mesh-list
102638492|NCT00759330|Analgesics|analgesics|mesh-ancestor
102638493|NCT00759330|Sensory System Agents|sensory system agents|mesh-ancestor
102638494|NCT00759330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102638495|NCT00759330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638496|NCT00759330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102638497|NCT00759330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102638498|NCT00759330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102638499|NCT00759330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102638500|NCT00759330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102638501|NCT00759330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102638502|NCT00759330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638503|NCT00759408|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
102638504|NCT00759408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102638505|NCT00759408|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102638506|NCT00759408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638507|NCT00759642|Lapatinib|lapatinib|mesh-list
102638508|NCT00759642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102638509|NCT00759642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102638510|NCT00759642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102638511|NCT00759642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638512|NCT00759798|Cyclophosphamide|cyclophosphamide|mesh-list
102638513|NCT00759798|Rituximab|rituximab|mesh-list
102638514|NCT00759798|Fludarabine|fludarabine|mesh-list
102638515|NCT00759798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102638516|NCT00759798|Immunologic Factors|immunologic factors|mesh-ancestor
102638517|NCT00759798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638518|NCT00759798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102638519|NCT00759798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102638520|NCT00759798|Alkylating Agents|alkylating agents|mesh-ancestor
102638521|NCT00759798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638522|NCT00759798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102638523|NCT00759798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102638524|NCT00759798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102638525|NCT00760578|Pioglitazone|pioglitazone|mesh-list
102638526|NCT00760578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102638527|NCT00760578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638528|NCT00761202|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102638529|NCT00761202|Hyaluronic Acid|hyaluronic acid|mesh-list
102638530|NCT00761202|Glycerol|glycerol|mesh-list
102638531|NCT00761202|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102638532|NCT00761202|Immunologic Factors|immunologic factors|mesh-ancestor
102638533|NCT00761202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638534|NCT00761202|Viscosupplements|viscosupplements|mesh-ancestor
102638535|NCT00761202|Protective Agents|protective agents|mesh-ancestor
102638536|NCT00761202|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102638537|NCT00761202|Laxatives|laxatives|mesh-ancestor
102638538|NCT00761202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102638539|NCT00761592|Botulinum Toxins|botulinum toxins|mesh-list
102638540|NCT00761592|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102275252|NCT00003376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102275253|NCT00003376|Immunologic Factors|immunologic factors|mesh-ancestor
102638541|NCT00761592|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102638542|NCT00761592|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102638543|NCT00761592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102275254|NCT00003376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102638544|NCT00761592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638545|NCT00761592|Cholinergic Agents|cholinergic agents|mesh-ancestor
102638546|NCT00761592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102638547|NCT00761592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638548|NCT00761592|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102638549|NCT00761592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102638551|NCT00762450|Fluorides|fluorides|mesh-list
102638552|NCT00762450|Cariostatic Agents|cariostatic agents|mesh-ancestor
102638553|NCT00762450|Protective Agents|protective agents|mesh-ancestor
102638554|NCT00762450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638555|NCT00762450|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102638556|NCT00762450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102638557|NCT00762450|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102638558|NCT00762450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102638559|NCT00762450|Antimetabolites|antimetabolites|mesh-ancestor
102638560|NCT00762450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638561|NCT00762450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102638562|NCT00762528|Triclosan|triclosan|mesh-list
102638563|NCT00762528|Fluorides|fluorides|mesh-list
102638564|NCT00762528|Fluorophosphate|fluorophosphate|mesh-list
102638565|NCT00762528|Cariostatic Agents|cariostatic agents|mesh-ancestor
102638566|NCT00762528|Protective Agents|protective agents|mesh-ancestor
102638567|NCT00762528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638568|NCT00762528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102638569|NCT00762528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102638570|NCT00762528|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102638571|NCT00762528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102638572|NCT00762528|Antimetabolites|antimetabolites|mesh-ancestor
102638573|NCT00762528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638574|NCT00762528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102638575|NCT00765648|Labetalol|labetalol|mesh-list
102638576|NCT00765648|Nicardipine|nicardipine|mesh-list
102638577|NCT00765648|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102638578|NCT00765648|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102638579|NCT00765648|Adrenergic Agents|adrenergic agents|mesh-ancestor
102638580|NCT00765648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102638581|NCT00765648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638582|NCT00765648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638583|NCT00765648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102638584|NCT00765648|Sympathomimetics|sympathomimetics|mesh-ancestor
102638585|NCT00765648|Autonomic Agents|autonomic agents|mesh-ancestor
102638586|NCT00765648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102638587|NCT00765648|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102638588|NCT00765648|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102241621|NCT04911959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102638589|NCT00765648|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102638590|NCT00765648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102638591|NCT00765648|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102638592|NCT00765648|Vasodilator Agents|vasodilator agents|mesh-ancestor
102638593|NCT00766116|Azacitidine|azacitidine|mesh-list
102638594|NCT00766116|Gemtuzumab|gemtuzumab|mesh-list
102638595|NCT00766116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102638596|NCT00766116|Antimetabolites|antimetabolites|mesh-ancestor
102638597|NCT00766116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638598|NCT00766116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102638599|NCT00766116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102638600|NCT00766116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102638601|NCT00766116|Immunotoxins|immunotoxins|mesh-ancestor
102638602|NCT00766116|Immunoconjugates|immunoconjugates|mesh-ancestor
102638603|NCT00766116|Immunologic Factors|immunologic factors|mesh-ancestor
102638604|NCT00766116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638605|NCT00767364|Vaccines|vaccines|mesh-list
102638606|NCT00767364|Immunologic Factors|immunologic factors|mesh-ancestor
102638607|NCT00767364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638608|NCT00769314|Acyclovir|acyclovir|mesh-list
102638609|NCT00769314|Antiviral Agents|antiviral agents|mesh-ancestor
102638610|NCT00769314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102638611|NCT00769392|Lidocaine|lidocaine|mesh-list
102638612|NCT00769392|Tetracaine|tetracaine|mesh-list
102638613|NCT00769392|Proxymetacaine|proxymetacaine|mesh-list
102638614|NCT00769392|Anesthetics, Local|anesthetics, local|mesh-ancestor
102638615|NCT00769392|Anesthetics|anesthetics|mesh-ancestor
102275255|NCT00003376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102275256|NCT00003353|Melphalan|melphalan|mesh-list
102638616|NCT00769392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102638617|NCT00769392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638618|NCT00769392|Sensory System Agents|sensory system agents|mesh-ancestor
102638619|NCT00769392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102638620|NCT00769392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102638621|NCT00769392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102638622|NCT00769392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102638623|NCT00769392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102638624|NCT00769392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638626|NCT00770874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102638627|NCT00772590|Raltegravir Potassium|raltegravir potassium|mesh-list
102638628|NCT00772590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102638629|NCT00772590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102638630|NCT00772590|Antiviral Agents|antiviral agents|mesh-ancestor
102638631|NCT00772590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102638632|NCT00772590|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102638633|NCT00772590|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102638634|NCT00772590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102638635|NCT00772590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638636|NCT00775944|Nicotine|nicotine|mesh-list
102638637|NCT00775944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102638638|NCT00775944|Autonomic Agents|autonomic agents|mesh-ancestor
102638639|NCT00775944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102638640|NCT00775944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638641|NCT00775944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102638642|NCT00775944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102638643|NCT00775944|Cholinergic Agents|cholinergic agents|mesh-ancestor
102638644|NCT00775944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102638645|NCT00775944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638646|NCT00780234|Pioglitazone|pioglitazone|mesh-list
102638647|NCT00780234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102638648|NCT00780234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638649|NCT00784524|Aldesleukin|aldesleukin|mesh-list
102638650|NCT00784524|Interleukin-2|interleukin-2|mesh-list
102638651|NCT00784524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102638652|NCT00784524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102638653|NCT00784524|Analgesics|analgesics|mesh-ancestor
102638654|NCT00784524|Sensory System Agents|sensory system agents|mesh-ancestor
102638655|NCT00784524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102638656|NCT00784524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638657|NCT00784524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102638658|NCT00784524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102638659|NCT00784524|Antiviral Agents|antiviral agents|mesh-ancestor
102638660|NCT00784524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102638661|NCT00785772|Gabapentin|gabapentin|mesh-list
102638662|NCT00785772|Analgesics|analgesics|mesh-ancestor
102638663|NCT00785772|Sensory System Agents|sensory system agents|mesh-ancestor
102638664|NCT00785772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102638665|NCT00785772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638666|NCT00785772|Anticonvulsants|anticonvulsants|mesh-ancestor
102638667|NCT00785772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102638668|NCT00785772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102638669|NCT00785772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102638670|NCT00785772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102638671|NCT00785772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102638672|NCT00785772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102638673|NCT00785772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102638674|NCT00785772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638675|NCT00785772|Antimanic Agents|antimanic agents|mesh-ancestor
102638676|NCT00787332|Desirudin|desirudin|mesh-list
102638677|NCT00787332|Argatroban|argatroban|mesh-list
102638678|NCT00787332|Antithrombins|antithrombins|mesh-ancestor
102638679|NCT00787332|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102638680|NCT00787332|Protease Inhibitors|protease inhibitors|mesh-ancestor
102638681|NCT00787332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102638682|NCT00787332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638683|NCT00787332|Anticoagulants|anticoagulants|mesh-ancestor
102638684|NCT00787332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102638685|NCT00787332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102638686|NCT00787332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102638687|NCT00787722|Methylprednisolone|methylprednisolone|mesh-list
102638688|NCT00787722|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102638689|NCT00787722|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102638690|NCT00787722|Prednisolone|prednisolone|mesh-list
102275257|NCT00003353|Immunologic Factors|immunologic factors|mesh-ancestor
102638691|NCT00787722|Prednisolone acetate|prednisolone acetate|mesh-list
102638692|NCT00787722|Cyclophosphamide|cyclophosphamide|mesh-list
102638693|NCT00787722|Rituximab|rituximab|mesh-list
102638694|NCT00787722|Thymoglobulin|thymoglobulin|mesh-list
102638695|NCT00787722|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102638696|NCT00787722|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102638697|NCT00787722|Prednisolone phosphate|prednisolone phosphate|mesh-list
102638698|NCT00787722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102638699|NCT00787722|Immunologic Factors|immunologic factors|mesh-ancestor
102638700|NCT00787722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638701|NCT00787722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102638702|NCT00787722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102638703|NCT00787722|Alkylating Agents|alkylating agents|mesh-ancestor
102638704|NCT00787722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638705|NCT00787722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102638706|NCT00787722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102638707|NCT00787722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102638708|NCT00787722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102638709|NCT00787722|Antiemetics|antiemetics|mesh-ancestor
102638710|NCT00787722|Autonomic Agents|autonomic agents|mesh-ancestor
102638711|NCT00787722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102638712|NCT00787722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102638713|NCT00787722|Glucocorticoids|glucocorticoids|mesh-ancestor
102638714|NCT00787722|Hormones|hormones|mesh-ancestor
102638715|NCT00787722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102638716|NCT00787722|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102638717|NCT00787722|Protective Agents|protective agents|mesh-ancestor
102638718|NCT00787722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102638719|NCT00788892|Cytarabine|cytarabine|mesh-list
102638720|NCT00788892|Daunorubicin|daunorubicin|mesh-list
102638721|NCT00788892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102638722|NCT00788892|Antimetabolites|antimetabolites|mesh-ancestor
102638723|NCT00788892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638724|NCT00788892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102638725|NCT00788892|Antiviral Agents|antiviral agents|mesh-ancestor
102638726|NCT00788892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102638727|NCT00788892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102638728|NCT00788892|Immunologic Factors|immunologic factors|mesh-ancestor
102638729|NCT00788892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638730|NCT00788892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102638731|NCT00788892|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102638732|NCT00788892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102638733|NCT00788892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102638734|NCT00789672|Levodopa|levodopa|mesh-list
102638735|NCT00789672|Carbidopa|carbidopa|mesh-list
102638736|NCT00789672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102638737|NCT00789672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102638738|NCT00789672|Dopamine Agents|dopamine agents|mesh-ancestor
102638739|NCT00789672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102638740|NCT00789672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638741|NCT00789672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638742|NCT00789672|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102638743|NCT00789672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102638744|NCT00789750|Pioglitazone|pioglitazone|mesh-list
102638745|NCT00789750|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
102638746|NCT00789750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102638747|NCT00789750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638748|NCT00789750|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102638749|NCT00789750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102638750|NCT00789750|Antimetabolites|antimetabolites|mesh-ancestor
102638751|NCT00789750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638752|NCT00789750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102638753|NCT00790062|Oxytocin|oxytocin|mesh-list
102638754|NCT00790062|Oxytocics|oxytocics|mesh-ancestor
102638755|NCT00790062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102638756|NCT00790062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638757|NCT00793572|Cyclosporine|cyclosporine|mesh-list
102638758|NCT00793572|Mycophenolic Acid|mycophenolic acid|mesh-list
102638759|NCT00793572|Fludarabine|fludarabine|mesh-list
102638760|NCT00793572|Fludarabine phosphate|fludarabine phosphate|mesh-list
102638761|NCT00793572|Bortezomib|bortezomib|mesh-list
102638762|NCT00793572|Melphalan|melphalan|mesh-list
102638763|NCT00793572|Mechlorethamine|mechlorethamine|mesh-list
102638764|NCT00793572|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102275258|NCT00003353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638765|NCT00793572|Cyclosporins|cyclosporins|mesh-list
102275259|NCT00003353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102638767|NCT00793572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102638768|NCT00793572|Antimetabolites|antimetabolites|mesh-ancestor
102638769|NCT00793572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638770|NCT00793572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102638771|NCT00793572|Immunologic Factors|immunologic factors|mesh-ancestor
102638772|NCT00793572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638773|NCT00793572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102638774|NCT00793572|Antifungal Agents|antifungal agents|mesh-ancestor
102638775|NCT00793572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102638776|NCT00793572|Dermatologic Agents|dermatologic agents|mesh-ancestor
102638777|NCT00793572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102638778|NCT00793572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102638779|NCT00793572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102638780|NCT00793572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102638781|NCT00793572|Antitubercular Agents|antitubercular agents|mesh-ancestor
102638782|NCT00793572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102638783|NCT00793572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102638784|NCT00793572|Alkylating Agents|alkylating agents|mesh-ancestor
102638785|NCT00793572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102638786|NCT00793650|Bortezomib|bortezomib|mesh-list
102638787|NCT00793650|Melphalan|melphalan|mesh-list
102638788|NCT00793650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102638789|NCT00793650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102638790|NCT00793650|Alkylating Agents|alkylating agents|mesh-ancestor
102638791|NCT00793650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638792|NCT00793650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102638793|NCT00793650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102638794|NCT00793650|Immunologic Factors|immunologic factors|mesh-ancestor
102638795|NCT00793650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638796|NCT00795210|Hormones|hormones|mesh-list
102638797|NCT00795210|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
102638798|NCT00795210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102638799|NCT00795210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638800|NCT00795288|Simvastatin|simvastatin|mesh-list
102638801|NCT00795288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102638802|NCT00795288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102638803|NCT00795288|Antimetabolites|antimetabolites|mesh-ancestor
102638804|NCT00795288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638805|NCT00795288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102638806|NCT00795288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102638807|NCT00795288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102638808|NCT00795366|Vasopressins|vasopressins|mesh-list
102638809|NCT00795366|Arginine Vasopressin|arginine vasopressin|mesh-list
102638810|NCT00795366|Hemostatics|hemostatics|mesh-ancestor
102638811|NCT00795366|Coagulants|coagulants|mesh-ancestor
102638812|NCT00795366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102638813|NCT00795366|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102638814|NCT00795366|Natriuretic Agents|natriuretic agents|mesh-ancestor
102638815|NCT00795366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638816|NCT00796302|Risperidone|risperidone|mesh-list
102638817|NCT00796302|Methylphenidate|methylphenidate|mesh-list
102638818|NCT00796302|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102638819|NCT00796302|Serotonin Agents|serotonin agents|mesh-ancestor
102638820|NCT00796302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102638821|NCT00796302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638822|NCT00796302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638823|NCT00796302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102638824|NCT00796302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102638825|NCT00796302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102638826|NCT00796302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102638827|NCT00796302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102638828|NCT00796302|Dopamine Agents|dopamine agents|mesh-ancestor
102638829|NCT00796302|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102638830|NCT00796302|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102638831|NCT00796302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102638832|NCT00796302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102638833|NCT00796926|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102638834|NCT00796926|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102638835|NCT00798018|Lidocaine|lidocaine|mesh-list
102638836|NCT00798018|Tetracaine|tetracaine|mesh-list
102638837|NCT00798018|Anesthetics, Local|anesthetics, local|mesh-ancestor
102638838|NCT00798018|Anesthetics|anesthetics|mesh-ancestor
101927382|NCT01205022|Antibodies|antibodies|mesh-list
102638839|NCT00798018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102638840|NCT00798018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638841|NCT00798018|Sensory System Agents|sensory system agents|mesh-ancestor
102638842|NCT00798018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102638843|NCT00798018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102638844|NCT00798018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102638845|NCT00798018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102638846|NCT00798018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102638847|NCT00798018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638848|NCT00798720|Bortezomib|bortezomib|mesh-list
102638849|NCT00798720|Vorinostat|vorinostat|mesh-list
102638850|NCT00798720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102638851|NCT00798720|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102638852|NCT00798720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102638853|NCT00798720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638854|NCT00799578|Cysteamine|cysteamine|mesh-list
102638855|NCT00799578|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
102638856|NCT00799578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638857|NCT00799812|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102638858|NCT00799812|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102638859|NCT00799812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102638860|NCT00799812|Dermatologic Agents|dermatologic agents|mesh-ancestor
102638861|NCT00801138|Dexamethasone|dexamethasone|mesh-list
102638862|NCT00801138|Bupivacaine|bupivacaine|mesh-list
102638863|NCT00801138|Ropivacaine|ropivacaine|mesh-list
102638864|NCT00801138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102638865|NCT00801138|Antiemetics|antiemetics|mesh-ancestor
102638866|NCT00801138|Autonomic Agents|autonomic agents|mesh-ancestor
102638867|NCT00801138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102638868|NCT00801138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638869|NCT00801138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102638870|NCT00801138|Glucocorticoids|glucocorticoids|mesh-ancestor
102638871|NCT00801138|Hormones|hormones|mesh-ancestor
102638872|NCT00801138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102638873|NCT00801138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102638874|NCT00801138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102638875|NCT00801138|Anesthetics, Local|anesthetics, local|mesh-ancestor
102638876|NCT00801138|Anesthetics|anesthetics|mesh-ancestor
102638877|NCT00801138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102638878|NCT00801138|Sensory System Agents|sensory system agents|mesh-ancestor
102638879|NCT00801684|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102638880|NCT00801684|Formoterol Fumarate|formoterol fumarate|mesh-list
102638881|NCT00801684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102638882|NCT00801684|Autonomic Agents|autonomic agents|mesh-ancestor
102638883|NCT00801684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102638884|NCT00801684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638885|NCT00801684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102638886|NCT00801684|Respiratory System Agents|respiratory system agents|mesh-ancestor
102638887|NCT00801684|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102638888|NCT00801684|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102638889|NCT00801684|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102638890|NCT00801684|Adrenergic Agents|adrenergic agents|mesh-ancestor
102638891|NCT00801684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102638892|NCT00801684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638893|NCT00801684|Luteolytic Agents|luteolytic agents|mesh-ancestor
102638894|NCT00801684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102638895|NCT00801684|Contraceptive Agents|contraceptive agents|mesh-ancestor
102638896|NCT00801684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102638897|NCT00801684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102638898|NCT00801684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102638899|NCT00801684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102638900|NCT00803010|Sirolimus|sirolimus|mesh-list
102638901|NCT00803010|Methotrexate|methotrexate|mesh-list
102638902|NCT00803010|Tacrolimus|tacrolimus|mesh-list
102638903|NCT00803010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102638904|NCT00803010|Abortifacient Agents|abortifacient agents|mesh-ancestor
102638905|NCT00803010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102638906|NCT00803010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638907|NCT00803010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102638908|NCT00803010|Antimetabolites|antimetabolites|mesh-ancestor
102638909|NCT00803010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638910|NCT00803010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102638911|NCT00803010|Dermatologic Agents|dermatologic agents|mesh-ancestor
102638912|NCT00803010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102638913|NCT00803010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102638914|NCT00803010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102638915|NCT00803010|Immunologic Factors|immunologic factors|mesh-ancestor
102638916|NCT00803010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102638917|NCT00803010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102638918|NCT00803010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102638919|NCT00803010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102638920|NCT00803010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102638921|NCT00803010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102638922|NCT00803010|Antifungal Agents|antifungal agents|mesh-ancestor
102638923|NCT00803400|Alprazolam|alprazolam|mesh-list
102638924|NCT00803400|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102638925|NCT00803400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102638926|NCT00803400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638927|NCT00803400|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102638928|NCT00803400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102638929|NCT00803400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102638930|NCT00803400|GABA Modulators|gaba modulators|mesh-ancestor
102638931|NCT00803400|GABA Agents|gaba agents|mesh-ancestor
102638932|NCT00803400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102638933|NCT00803400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638934|NCT00804648|Timolol|timolol|mesh-list
102638935|NCT00804648|Maleic acid|maleic acid|mesh-list
102638936|NCT00804648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102638937|NCT00804648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638938|NCT00804648|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102638939|NCT00804648|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102638940|NCT00804648|Adrenergic Agents|adrenergic agents|mesh-ancestor
102638941|NCT00804648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102638942|NCT00804648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638943|NCT00804648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102638944|NCT00804648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102638945|NCT00806598|Cyclosporine|cyclosporine|mesh-list
102638946|NCT00806598|Methylprednisolone|methylprednisolone|mesh-list
102638947|NCT00806598|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102638948|NCT00806598|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102638949|NCT00806598|Prednisolone|prednisolone|mesh-list
102638950|NCT00806598|Prednisolone acetate|prednisolone acetate|mesh-list
102638951|NCT00806598|Cyclosporins|cyclosporins|mesh-list
102638952|NCT00806598|Thymoglobulin|thymoglobulin|mesh-list
102638953|NCT00806598|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102638954|NCT00806598|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102638955|NCT00806598|Prednisolone phosphate|prednisolone phosphate|mesh-list
102638956|NCT00806598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102638957|NCT00806598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638958|NCT00806598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102638959|NCT00806598|Immunologic Factors|immunologic factors|mesh-ancestor
102638960|NCT00806598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638961|NCT00806598|Antifungal Agents|antifungal agents|mesh-ancestor
102638962|NCT00806598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102638963|NCT00806598|Dermatologic Agents|dermatologic agents|mesh-ancestor
102638964|NCT00806598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102638965|NCT00806598|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102638966|NCT00806598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102638967|NCT00806598|Antiemetics|antiemetics|mesh-ancestor
102638968|NCT00806598|Autonomic Agents|autonomic agents|mesh-ancestor
102638969|NCT00806598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102638970|NCT00806598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102638971|NCT00806598|Glucocorticoids|glucocorticoids|mesh-ancestor
102638972|NCT00806598|Hormones|hormones|mesh-ancestor
102638973|NCT00806598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102638974|NCT00806598|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102638975|NCT00806598|Protective Agents|protective agents|mesh-ancestor
102638976|NCT00806598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102638977|NCT00806598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102638978|NCT00807768|Paclitaxel|paclitaxel|mesh-list
102638979|NCT00807768|Carboplatin|carboplatin|mesh-list
102638980|NCT00807768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102638981|NCT00807768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102638982|NCT00807768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102638983|NCT00807768|Tubulin Modulators|tubulin modulators|mesh-ancestor
102638984|NCT00807768|Antimitotic Agents|antimitotic agents|mesh-ancestor
102638985|NCT00807768|Mitosis Modulators|mitosis modulators|mesh-ancestor
102638986|NCT00807768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638987|NCT00808470|Beta Carotene|beta carotene|mesh-list
102638988|NCT00808470|Carotenoids|carotenoids|mesh-list
102275260|NCT00003353|Alkylating Agents|alkylating agents|mesh-ancestor
102275261|NCT00003353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275262|NCT00003353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102275263|NCT00003353|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102275264|NCT00003353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102275265|NCT00003309|Cyclophosphamide|cyclophosphamide|mesh-list
102275266|NCT00003309|Etoposide|etoposide|mesh-list
102275267|NCT00003309|Vincristine|vincristine|mesh-list
102275268|NCT00003309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102275269|NCT00003309|Immunologic Factors|immunologic factors|mesh-ancestor
102275270|NCT00003309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275271|NCT00003309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102275272|NCT00003309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102275273|NCT00003309|Alkylating Agents|alkylating agents|mesh-ancestor
102638989|NCT00808470|Vitamins|vitamins|mesh-ancestor
102638990|NCT00808470|Micronutrients|micronutrients|mesh-ancestor
102638991|NCT00808470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102638992|NCT00808470|Antioxidants|antioxidants|mesh-ancestor
102638993|NCT00808470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102638994|NCT00808470|Protective Agents|protective agents|mesh-ancestor
102638995|NCT00808470|Provitamins|provitamins|mesh-ancestor
102638996|NCT00810576|Bortezomib|bortezomib|mesh-list
102638997|NCT00810576|Vorinostat|vorinostat|mesh-list
102638998|NCT00810576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102638999|NCT00810576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102639000|NCT00810576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102639001|NCT00810576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639002|NCT00811434|Lactulose|lactulose|mesh-list
102639003|NCT00811434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102275274|NCT00003309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275275|NCT00003309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102275276|NCT00003309|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102639004|NCT00812604|Analgesics|analgesics|mesh-list
102639005|NCT00812604|Petrolatum|petrolatum|mesh-list
102639006|NCT00812604|Sensory System Agents|sensory system agents|mesh-ancestor
102639007|NCT00812604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102639008|NCT00812604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639009|NCT00812604|Emollients|emollients|mesh-ancestor
102639010|NCT00812604|Dermatologic Agents|dermatologic agents|mesh-ancestor
102639011|NCT00812838|Botulinum Toxins|botulinum toxins|mesh-list
102639012|NCT00812838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102639013|NCT00812838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102639014|NCT00812838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102639015|NCT00812838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102639016|NCT00812838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639017|NCT00812838|Cholinergic Agents|cholinergic agents|mesh-ancestor
102639018|NCT00812838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102639019|NCT00812838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639020|NCT00812838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102639021|NCT00812838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102639022|NCT00814788|Everolimus|everolimus|mesh-list
102639023|NCT00814788|Bicalutamide|bicalutamide|mesh-list
102639024|NCT00814788|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102639025|NCT00814788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102639026|NCT00814788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102639027|NCT00814788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639028|NCT00814788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102639029|NCT00814788|Immunologic Factors|immunologic factors|mesh-ancestor
102639030|NCT00814788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639031|NCT00814788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102639032|NCT00814788|Androgen Antagonists|androgen antagonists|mesh-ancestor
102639033|NCT00814788|Hormone Antagonists|hormone antagonists|mesh-ancestor
102639034|NCT00814788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102639035|NCT00820872|Carboplatin|carboplatin|mesh-list
102639036|NCT00820872|Docetaxel|docetaxel|mesh-list
102639037|NCT00820872|Trastuzumab|trastuzumab|mesh-list
102639038|NCT00820872|Lapatinib|lapatinib|mesh-list
102639039|NCT00820872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102639040|NCT00820872|Tubulin Modulators|tubulin modulators|mesh-ancestor
102639041|NCT00820872|Antimitotic Agents|antimitotic agents|mesh-ancestor
102639042|NCT00820872|Mitosis Modulators|mitosis modulators|mesh-ancestor
102639043|NCT00820872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639044|NCT00820872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102275277|NCT00003309|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102639045|NCT00820872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102639046|NCT00820872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102639047|NCT00821184|Solifenacin Succinate|solifenacin succinate|mesh-list
102639048|NCT00821184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102639049|NCT00821184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102639050|NCT00821184|Cholinergic Agents|cholinergic agents|mesh-ancestor
102639051|NCT00821184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102639052|NCT00821184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639053|NCT00821184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639054|NCT00821184|Urological Agents|urological agents|mesh-ancestor
102275278|NCT00003309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102639056|NCT05206812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102639057|NCT05206812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102639058|NCT05131152|Cyclosporine|cyclosporine|mesh-list
102639059|NCT05131152|Cyclosporins|cyclosporins|mesh-list
102639060|NCT05131152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102639061|NCT05131152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639062|NCT05131152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102639063|NCT05131152|Immunologic Factors|immunologic factors|mesh-ancestor
102639064|NCT05131152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639065|NCT05131152|Antifungal Agents|antifungal agents|mesh-ancestor
102639066|NCT05131152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102639067|NCT05131152|Dermatologic Agents|dermatologic agents|mesh-ancestor
102639068|NCT05131152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102639069|NCT05131152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102639070|NCT04900116|Bupivacaine|bupivacaine|mesh-list
102639071|NCT04900116|Anesthetics, Local|anesthetics, local|mesh-ancestor
102639072|NCT04900116|Anesthetics|anesthetics|mesh-ancestor
102639073|NCT04900116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102639074|NCT04900116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639075|NCT04900116|Sensory System Agents|sensory system agents|mesh-ancestor
102639076|NCT04900116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102639077|NCT04603248|Nivolumab|nivolumab|mesh-list
102639078|NCT04603248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102639079|NCT04603248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102639080|NCT04603248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102639081|NCT04603248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639082|NCT03936270|Letrozole|letrozole|mesh-list
102639083|NCT03936270|Palbociclib|palbociclib|mesh-list
102639084|NCT03936270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102639085|NCT03936270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102639086|NCT03936270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102639087|NCT03936270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102639088|NCT03936270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639089|NCT03936270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102639090|NCT03936270|Hormone Antagonists|hormone antagonists|mesh-ancestor
102639091|NCT03936270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102639092|NCT03936270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639093|NCT03936270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102639094|NCT03763656|Hydroxyurea|hydroxyurea|mesh-list
102639095|NCT03763656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102639096|NCT03763656|Antisickling Agents|antisickling agents|mesh-ancestor
102639097|NCT03763656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102639098|NCT03763656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639099|NCT03763656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102639100|NCT02682888|Oxytocin|oxytocin|mesh-list
102639101|NCT02682888|Oxytocics|oxytocics|mesh-ancestor
102639102|NCT02682888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102639103|NCT02682888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639104|NCT02641236|Vancomycin|vancomycin|mesh-list
102639105|NCT02641236|Polymyxins|polymyxins|mesh-list
102639106|NCT02641236|Polymyxin B|polymyxin b|mesh-list
102639107|NCT02641236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102639108|NCT02641236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102639109|NCT00142272|Ciprofloxacin|ciprofloxacin|mesh-list
102639110|NCT00142272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102639111|NCT00142272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102639112|NCT00142272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101611613|NCT00877006|Prednisone|prednisone|mesh-list
102639113|NCT00142272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102639114|NCT00142272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102639115|NCT00142272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639116|NCT00142272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102639117|NCT00142272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102639118|NCT00142272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102639119|NCT00821886|Carboplatin|carboplatin|mesh-list
102639120|NCT00821886|Trastuzumab|trastuzumab|mesh-list
102639121|NCT00821886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102639122|NCT00821886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102639123|NCT00821964|Paclitaxel|paclitaxel|mesh-list
102639124|NCT00821964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102639125|NCT00821964|Imiquimod|imiquimod|mesh-list
102639126|NCT00821964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102639127|NCT00821964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102275279|NCT00003309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102275280|NCT00003309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102639128|NCT00821964|Tubulin Modulators|tubulin modulators|mesh-ancestor
102639129|NCT00821964|Antimitotic Agents|antimitotic agents|mesh-ancestor
102639130|NCT00821964|Mitosis Modulators|mitosis modulators|mesh-ancestor
102639131|NCT00821964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639132|NCT00821964|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102639133|NCT00821964|Immunologic Factors|immunologic factors|mesh-ancestor
102639134|NCT00821964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639135|NCT00821964|Interferon Inducers|interferon inducers|mesh-ancestor
102639136|NCT00822354|Tadalafil|tadalafil|mesh-list
102639137|NCT00822354|Vasodilator Agents|vasodilator agents|mesh-ancestor
102639138|NCT00822354|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102639139|NCT00822354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102639140|NCT00822354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102639141|NCT00822354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639142|NCT00822354|Urological Agents|urological agents|mesh-ancestor
102639143|NCT00824070|Moxifloxacin|moxifloxacin|mesh-list
102639144|NCT00824070|Gatifloxacin|gatifloxacin|mesh-list
102639145|NCT00824070|Besifloxacin|besifloxacin|mesh-list
102639146|NCT00824070|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102639147|NCT00824070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102639148|NCT00824070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102639149|NCT00824070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102639150|NCT00824070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102639151|NCT00824070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102639152|NCT00824070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639153|NCT00824070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102639154|NCT00824070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102639155|NCT00824070|Contraceptive Agents|contraceptive agents|mesh-ancestor
102639156|NCT00824070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102639157|NCT00824070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639158|NCT00824070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102639159|NCT00824070|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102639160|NCT00824070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102639161|NCT00824070|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102639162|NCT00824070|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102639164|NCT00824460|Sevelamer|sevelamer|mesh-list
102639165|NCT00824460|Trace Elements|trace elements|mesh-ancestor
102639166|NCT00824460|Micronutrients|micronutrients|mesh-ancestor
102639167|NCT00824460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639168|NCT00824460|Chelating Agents|chelating agents|mesh-ancestor
102639169|NCT00824460|Sequestering Agents|sequestering agents|mesh-ancestor
102639170|NCT00824460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639171|NCT00824538|Sunitinib|sunitinib|mesh-list
102639172|NCT00824538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102639173|NCT00824538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102639174|NCT00824538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102639175|NCT00824538|Growth Substances|growth substances|mesh-ancestor
102639176|NCT00824538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639177|NCT00824538|Growth Inhibitors|growth inhibitors|mesh-ancestor
102639178|NCT00824538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102639179|NCT00824538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102639180|NCT00824538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639181|NCT00825786|Ropivacaine|ropivacaine|mesh-list
102639182|NCT00825786|Mepivacaine|mepivacaine|mesh-list
102639183|NCT00825786|Anesthetics, Local|anesthetics, local|mesh-ancestor
102639184|NCT00825786|Anesthetics|anesthetics|mesh-ancestor
102639185|NCT00825786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102639186|NCT00825786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639187|NCT00825786|Sensory System Agents|sensory system agents|mesh-ancestor
102639188|NCT00825786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102639189|NCT00826800|Bevacizumab|bevacizumab|mesh-list
102639190|NCT00826800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102639191|NCT00826800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102639192|NCT00826800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102639193|NCT00826800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102639194|NCT00826800|Growth Substances|growth substances|mesh-ancestor
102639195|NCT00826800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639196|NCT00826800|Growth Inhibitors|growth inhibitors|mesh-ancestor
102639197|NCT00830076|Metformin|metformin|mesh-list
102639198|NCT00830076|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102639199|NCT00830076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102639200|NCT00830076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275281|NCT00003309|Tubulin Modulators|tubulin modulators|mesh-ancestor
102639201|NCT00830076|Incretins|incretins|mesh-ancestor
102275282|NCT00003309|Antimitotic Agents|antimitotic agents|mesh-ancestor
102639202|NCT00830076|Hormones|hormones|mesh-ancestor
102639203|NCT00830076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102639204|NCT00830076|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102639205|NCT00830076|Protease Inhibitors|protease inhibitors|mesh-ancestor
102639206|NCT00830076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102639207|NCT00830076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639208|NCT00830388|Ketoconazole|ketoconazole|mesh-list
102639209|NCT00830388|Antifungal Agents|antifungal agents|mesh-ancestor
102639210|NCT00830388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102639211|NCT00830388|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102639212|NCT00830388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102639213|NCT00830388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102639214|NCT00830388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639215|NCT00830388|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102639216|NCT00830388|Hormone Antagonists|hormone antagonists|mesh-ancestor
102639217|NCT00830388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102639218|NCT00830388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639219|NCT00830388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102639220|NCT00831480|Everolimus|everolimus|mesh-list
102639221|NCT00831480|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102639222|NCT00831480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102639223|NCT00831480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102639224|NCT00831480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639225|NCT00831480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102639226|NCT00831480|Immunologic Factors|immunologic factors|mesh-ancestor
102639227|NCT00831480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639228|NCT00831480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102639229|NCT00832338|Dexamethasone|dexamethasone|mesh-list
102639230|NCT00832338|Docetaxel|docetaxel|mesh-list
102639231|NCT00832338|Cyclophosphamide|cyclophosphamide|mesh-list
102639232|NCT00832338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102639233|NCT00832338|Antiemetics|antiemetics|mesh-ancestor
102639234|NCT00832338|Autonomic Agents|autonomic agents|mesh-ancestor
102639235|NCT00832338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102639236|NCT00832338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639237|NCT00832338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102639238|NCT00832338|Glucocorticoids|glucocorticoids|mesh-ancestor
102639239|NCT00832338|Hormones|hormones|mesh-ancestor
102639240|NCT00832338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102639241|NCT00832338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102639242|NCT00832338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102639243|NCT00832338|Tubulin Modulators|tubulin modulators|mesh-ancestor
102639244|NCT00832338|Antimitotic Agents|antimitotic agents|mesh-ancestor
102639245|NCT00832338|Mitosis Modulators|mitosis modulators|mesh-ancestor
102639246|NCT00832338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639247|NCT00832338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102639248|NCT00832338|Immunologic Factors|immunologic factors|mesh-ancestor
102639249|NCT00832338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102639250|NCT00832338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102639251|NCT00832338|Alkylating Agents|alkylating agents|mesh-ancestor
102639252|NCT00832338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102639253|NCT00834210|Nicotinic Acids|nicotinic acids|mesh-list
102639254|NCT00834210|Dapsone|dapsone|mesh-list
102639255|NCT00834210|Tazarotene|tazarotene|mesh-list
102639256|NCT00834210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102639257|NCT00834210|Antimalarials|antimalarials|mesh-ancestor
102639258|NCT00834210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102639259|NCT00834210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102639260|NCT00834210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102639261|NCT00834210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102639262|NCT00834210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639263|NCT00834210|Leprostatic Agents|leprostatic agents|mesh-ancestor
102639264|NCT00834210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102639265|NCT00834210|Dermatologic Agents|dermatologic agents|mesh-ancestor
102639266|NCT00834210|Keratolytic Agents|keratolytic agents|mesh-ancestor
102639267|NCT00834210|Vitamin B Complex|vitamin b complex|mesh-ancestor
102639268|NCT00834210|Vitamins|vitamins|mesh-ancestor
102639269|NCT00834210|Micronutrients|micronutrients|mesh-ancestor
102639270|NCT00834210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639271|NCT00834288|Tramadol|tramadol|mesh-list
102639272|NCT00834288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102639273|NCT00834288|Narcotics|narcotics|mesh-ancestor
102639274|NCT00834288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101927810|NCT01381354|Antioxidants|antioxidants|mesh-ancestor
102639275|NCT00834288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639276|NCT00834288|Analgesics|analgesics|mesh-ancestor
102639277|NCT00834288|Sensory System Agents|sensory system agents|mesh-ancestor
102639278|NCT00834288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102639279|NCT00834678|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102639280|NCT00834678|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102639281|NCT00834678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102639282|NCT00834678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102639283|NCT00834678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102639284|NCT00834678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639285|NCT00834678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102639286|NCT00834678|Alkylating Agents|alkylating agents|mesh-ancestor
102639287|NCT00835224|Midodrine|midodrine|mesh-list
102639288|NCT00835224|Sympathomimetics|sympathomimetics|mesh-ancestor
102639289|NCT00835224|Autonomic Agents|autonomic agents|mesh-ancestor
102639290|NCT00835224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102639291|NCT00835224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639292|NCT00835224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102639293|NCT00835224|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102639294|NCT00835224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102639295|NCT00835224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102639296|NCT00835224|Adrenergic Agents|adrenergic agents|mesh-ancestor
102639297|NCT00835224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102639298|NCT00835224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639299|NCT00835926|Vaccines|vaccines|mesh-list
102639300|NCT00835926|Immunologic Factors|immunologic factors|mesh-ancestor
102639301|NCT00835926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639302|NCT00837252|Finasteride|finasteride|mesh-list
102639303|NCT00837252|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102639304|NCT00837252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102639305|NCT00837252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102639306|NCT00837252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639307|NCT00837252|Hormone Antagonists|hormone antagonists|mesh-ancestor
102639308|NCT00837252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102639309|NCT00837252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639310|NCT00837252|Urological Agents|urological agents|mesh-ancestor
102639311|NCT00839982|Cytarabine|cytarabine|mesh-list
102639312|NCT00839982|Clofarabine|clofarabine|mesh-list
102639313|NCT00839982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102639314|NCT00839982|Antimetabolites|antimetabolites|mesh-ancestor
102639315|NCT00839982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639316|NCT00839982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102639317|NCT00839982|Antiviral Agents|antiviral agents|mesh-ancestor
102639318|NCT00839982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102639319|NCT00839982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102639320|NCT00839982|Immunologic Factors|immunologic factors|mesh-ancestor
102639321|NCT00839982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639322|NCT00845130|Vitamins|vitamins|mesh-list
102639323|NCT00845130|Ascorbic Acid|ascorbic acid|mesh-list
102639324|NCT00845130|Micronutrients|micronutrients|mesh-ancestor
102639325|NCT00845130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639326|NCT00845130|Antioxidants|antioxidants|mesh-ancestor
102639327|NCT00845130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639328|NCT00845130|Protective Agents|protective agents|mesh-ancestor
102639329|NCT00848016|Acetic Acid|acetic acid|mesh-list
102639330|NCT00848016|Retinol acetate|retinol acetate|mesh-list
102639331|NCT00848016|Gossypol acetic acid|gossypol acetic acid|mesh-list
102639332|NCT00848016|Gossypol|gossypol|mesh-list
102639333|NCT00848016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102639334|NCT00848016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102639335|NCT00848016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102639336|NCT00848016|Immunologic Factors|immunologic factors|mesh-ancestor
102639337|NCT00848016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639338|NCT00848016|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102639339|NCT00848016|Protective Agents|protective agents|mesh-ancestor
102639340|NCT00848016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102639341|NCT00848016|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102639342|NCT00848016|Contraceptive Agents|contraceptive agents|mesh-ancestor
102639343|NCT00848016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102639344|NCT00848016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102639345|NCT00848016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102639346|NCT00848016|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
102639347|NCT00848016|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
102275283|NCT00003309|Mitosis Modulators|mitosis modulators|mesh-ancestor
102639348|NCT00849810|Metoprolol|metoprolol|mesh-list
102275285|NCT00003237|Cisplatin|cisplatin|mesh-list
102275286|NCT00003237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102275287|NCT00003237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102639349|NCT00849810|Nebivolol|nebivolol|mesh-list
102639350|NCT00849810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102639351|NCT00849810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102639352|NCT00849810|Sympatholytics|sympatholytics|mesh-ancestor
102639353|NCT00849810|Autonomic Agents|autonomic agents|mesh-ancestor
102639354|NCT00849810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102639355|NCT00849810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639356|NCT00849810|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102639357|NCT00849810|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102639358|NCT00849810|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102639359|NCT00849810|Adrenergic Agents|adrenergic agents|mesh-ancestor
102639360|NCT00849810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102639361|NCT00849810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639362|NCT00849810|Vasodilator Agents|vasodilator agents|mesh-ancestor
102639363|NCT00849810|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102639364|NCT00849810|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102639365|NCT00849810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102639366|NCT00856050|Letrozole|letrozole|mesh-list
102639367|NCT00856050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102639368|NCT00856050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102639369|NCT00856050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102639370|NCT00856050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102639371|NCT00856050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639372|NCT00856050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102639373|NCT00856050|Hormone Antagonists|hormone antagonists|mesh-ancestor
102639374|NCT00856050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102639375|NCT00856050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639376|NCT00858468|Vaccines|vaccines|mesh-list
102639377|NCT00858468|Immunologic Factors|immunologic factors|mesh-ancestor
102639378|NCT00858468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639379|NCT00858858|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102639380|NCT00858858|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102639381|NCT00858858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102639382|NCT00866034|Cetrorelix|cetrorelix|mesh-list
102639383|NCT00866034|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102639384|NCT00866034|Fertility Agents|fertility agents|mesh-ancestor
102639385|NCT00866034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102639386|NCT00866034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639387|NCT00866034|Hormone Antagonists|hormone antagonists|mesh-ancestor
102639388|NCT00866034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102639389|NCT00868140|Pioglitazone|pioglitazone|mesh-list
102639390|NCT00868140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102639391|NCT00868140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639392|NCT00868374|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102639393|NCT00868374|Antidepressive Agents|antidepressive agents|mesh-ancestor
102639394|NCT00868374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102639395|NCT00868374|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102639396|NCT00868374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102639397|NCT00868374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102639398|NCT00868374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639399|NCT00868452|Valproic Acid|valproic acid|mesh-list
102639400|NCT00868452|Lithium Carbonate|lithium carbonate|mesh-list
102639401|NCT00868452|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102639402|NCT00868452|Antidepressive Agents|antidepressive agents|mesh-ancestor
102639403|NCT00868452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102639404|NCT00868452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102639405|NCT00868452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639406|NCT00868452|Antimanic Agents|antimanic agents|mesh-ancestor
102639407|NCT00868452|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102639408|NCT00868452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102639409|NCT00868452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639410|NCT00868452|Anticonvulsants|anticonvulsants|mesh-ancestor
102639411|NCT00868452|GABA Agents|gaba agents|mesh-ancestor
102639412|NCT00868452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102639413|NCT00868452|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102639414|NCT00868452|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102639415|NCT00868452|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102639416|NCT00868452|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102275288|NCT00003237|Tubulin Modulators|tubulin modulators|mesh-ancestor
102275289|NCT00003237|Antimitotic Agents|antimitotic agents|mesh-ancestor
102275290|NCT00003237|Mitosis Modulators|mitosis modulators|mesh-ancestor
102639417|NCT00868452|Adrenergic Agents|adrenergic agents|mesh-ancestor
102639418|NCT00868452|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102639419|NCT00868452|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102639420|NCT00868452|Serotonin Agents|serotonin agents|mesh-ancestor
102639421|NCT00868452|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102639422|NCT00868452|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102639423|NCT00868452|Dopamine Agents|dopamine agents|mesh-ancestor
102639424|NCT00869622|Vitamin D|vitamin d|mesh-list
102639425|NCT00869622|Risedronic Acid|risedronic acid|mesh-list
102639426|NCT00869622|Calcium|calcium|mesh-list
102639427|NCT00869622|Vitamins|vitamins|mesh-ancestor
102639428|NCT00869622|Micronutrients|micronutrients|mesh-ancestor
102639429|NCT00869622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639430|NCT00869622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102639431|NCT00869622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102639432|NCT00869622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102639433|NCT00869622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102639434|NCT00869622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639435|NCT00871260|Regadenoson|regadenoson|mesh-list
102639436|NCT00871260|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
102639437|NCT00871260|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102639438|NCT00871260|Purinergic Agonists|purinergic agonists|mesh-ancestor
102639439|NCT00871260|Purinergic Agents|purinergic agents|mesh-ancestor
102639440|NCT00871260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102639441|NCT00871260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639442|NCT00871260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639443|NCT00874614|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
102639444|NCT00874614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102639445|NCT00874614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102639446|NCT00874614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639447|NCT00874614|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102275291|NCT00003237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275292|NCT00003129|Valrubicin|valrubicin|mesh-list
102275293|NCT00003129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102275294|NCT00003129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102275295|NCT00003129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102275296|NCT00003129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102275297|NCT00003129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275298|NCT00003027|Interferons|interferons|mesh-list
102275299|NCT00003027|Interferon-alpha|interferon-alpha|mesh-list
102275300|NCT00003027|Aldesleukin|aldesleukin|mesh-list
102275301|NCT00003027|Dacarbazine|dacarbazine|mesh-list
102275302|NCT00003027|Vinblastine|vinblastine|mesh-list
102275303|NCT00003027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102275304|NCT00003027|Antiviral Agents|antiviral agents|mesh-ancestor
102275305|NCT00003027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102275306|NCT00003027|Immunologic Factors|immunologic factors|mesh-ancestor
102275307|NCT00003027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275308|NCT00003027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102275309|NCT00003027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102275310|NCT00003027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102275311|NCT00003027|Alkylating Agents|alkylating agents|mesh-ancestor
102275312|NCT00003027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275313|NCT00003027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102275314|NCT00003027|Tubulin Modulators|tubulin modulators|mesh-ancestor
102275315|NCT00003027|Antimitotic Agents|antimitotic agents|mesh-ancestor
102639448|NCT00875550|Fentanyl|fentanyl|mesh-list
102639449|NCT00875550|Midazolam|midazolam|mesh-list
102639450|NCT00875550|Dexmedetomidine|dexmedetomidine|mesh-list
102639451|NCT00875550|Morphine|morphine|mesh-list
102639452|NCT00875550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102639453|NCT00875550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102639454|NCT00875550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639455|NCT00875550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102639456|NCT00875550|Analgesics|analgesics|mesh-ancestor
102639457|NCT00875550|Sensory System Agents|sensory system agents|mesh-ancestor
102639458|NCT00875550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102639459|NCT00875550|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102275316|NCT00003027|Mitosis Modulators|mitosis modulators|mesh-ancestor
102275317|NCT00002914|Piritrexim|piritrexim|mesh-list
102275318|NCT00002914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102275319|NCT00002914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102275320|NCT00002914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102639460|NCT00875550|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102639461|NCT00875550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102639462|NCT00875550|Adrenergic Agents|adrenergic agents|mesh-ancestor
102639463|NCT00875550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102639464|NCT00875550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639465|NCT00875550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102639466|NCT00875550|Narcotics|narcotics|mesh-ancestor
102639467|NCT00875550|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102639468|NCT00875550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102639469|NCT00875550|Anesthetics, General|anesthetics, general|mesh-ancestor
102639470|NCT00875550|Anesthetics|anesthetics|mesh-ancestor
102639471|NCT00875550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102639472|NCT00875550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102639473|NCT00875550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102639474|NCT00875550|GABA Modulators|gaba modulators|mesh-ancestor
102639475|NCT00875550|GABA Agents|gaba agents|mesh-ancestor
102639476|NCT00878436|Bicalutamide|bicalutamide|mesh-list
102639477|NCT00878436|Panobinostat|panobinostat|mesh-list
102639478|NCT00878436|Androgen Antagonists|androgen antagonists|mesh-ancestor
102639479|NCT00878436|Hormone Antagonists|hormone antagonists|mesh-ancestor
102639480|NCT00878436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102639481|NCT00878436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639482|NCT00878436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102639483|NCT00878436|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102639484|NCT00878436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102639485|NCT00878436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639486|NCT00878826|Enoxaparin|enoxaparin|mesh-list
102639487|NCT00878826|Anticoagulants|anticoagulants|mesh-ancestor
102639488|NCT00878826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102639489|NCT00878826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102639490|NCT00878826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639491|NCT00879060|Spironolactone|spironolactone|mesh-list
102639492|NCT00879060|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102639493|NCT00879060|Hormone Antagonists|hormone antagonists|mesh-ancestor
102639494|NCT00879060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102639495|NCT00879060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639496|NCT00879060|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102639497|NCT00879060|Diuretics|diuretics|mesh-ancestor
102639498|NCT00879060|Natriuretic Agents|natriuretic agents|mesh-ancestor
102639499|NCT00882102|Decitabine|decitabine|mesh-list
102639500|NCT00882102|Gemtuzumab|gemtuzumab|mesh-list
102639501|NCT00882102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102639502|NCT00882102|Antimetabolites|antimetabolites|mesh-ancestor
102639503|NCT00882102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639504|NCT00882102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102639505|NCT00882102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102639506|NCT00882102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102639507|NCT00882102|Immunotoxins|immunotoxins|mesh-ancestor
102639508|NCT00882102|Immunoconjugates|immunoconjugates|mesh-ancestor
102639509|NCT00882102|Immunologic Factors|immunologic factors|mesh-ancestor
102639510|NCT00882102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639511|NCT00884052|Levetiracetam|levetiracetam|mesh-list
102639512|NCT00884052|Anticonvulsants|anticonvulsants|mesh-ancestor
102639513|NCT00884052|Nootropic Agents|nootropic agents|mesh-ancestor
102639514|NCT00886236|Gabapentin|gabapentin|mesh-list
102639515|NCT00886236|Analgesics|analgesics|mesh-ancestor
102639516|NCT00886236|Sensory System Agents|sensory system agents|mesh-ancestor
102639517|NCT00886236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102639518|NCT00886236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639519|NCT00886236|Anticonvulsants|anticonvulsants|mesh-ancestor
102639520|NCT00886236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102639521|NCT00886236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102639522|NCT00886236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102639523|NCT00886236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102639524|NCT00886236|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102639525|NCT00886236|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102639526|NCT00886236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102639527|NCT00886236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639528|NCT00886236|Antimanic Agents|antimanic agents|mesh-ancestor
102639529|NCT00886626|Exenatide|exenatide|mesh-list
102639530|NCT00886626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102639531|NCT00886626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639532|NCT00886626|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102639533|NCT00886626|Incretins|incretins|mesh-ancestor
102639534|NCT00886626|Hormones|hormones|mesh-ancestor
102275321|NCT00002914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639535|NCT00886626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102639536|NCT00887562|Ubiquinone|ubiquinone|mesh-list
102275322|NCT00002872|Doxycycline|doxycycline|mesh-list
102639538|NCT00887562|Antioxidants|antioxidants|mesh-ancestor
102639539|NCT00887562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639540|NCT00887562|Protective Agents|protective agents|mesh-ancestor
102639541|NCT00887562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639542|NCT00887562|Micronutrients|micronutrients|mesh-ancestor
102639543|NCT00887640|Diphenhydramine|diphenhydramine|mesh-list
102639544|NCT00887640|Promethazine|promethazine|mesh-list
102639545|NCT00887640|Sirolimus|sirolimus|mesh-list
102639546|NCT00887640|Temsirolimus|temsirolimus|mesh-list
102639547|NCT00887640|MTOR Inhibitors|mtor inhibitors|mesh-list
102639548|NCT00887640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102639549|NCT00887640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102639550|NCT00887640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639551|NCT00887640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102639552|NCT00887640|Immunologic Factors|immunologic factors|mesh-ancestor
102639553|NCT00887640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639554|NCT00887640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102639555|NCT00887640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102639556|NCT00887640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102639557|NCT00887640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102639558|NCT00887640|Antifungal Agents|antifungal agents|mesh-ancestor
102639559|NCT00887640|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102639560|NCT00887640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102639561|NCT00887640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102639562|NCT00887640|Anesthetics, Local|anesthetics, local|mesh-ancestor
102639563|NCT00887640|Anesthetics|anesthetics|mesh-ancestor
102639564|NCT00887640|Sensory System Agents|sensory system agents|mesh-ancestor
102639565|NCT00887640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102639566|NCT00887640|Antiemetics|antiemetics|mesh-ancestor
102639567|NCT00887640|Autonomic Agents|autonomic agents|mesh-ancestor
102639568|NCT00887640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102639569|NCT00887640|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102639570|NCT00887640|Histamine Antagonists|histamine antagonists|mesh-ancestor
102639571|NCT00887640|Histamine Agents|histamine agents|mesh-ancestor
102639572|NCT00887640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102639573|NCT00887640|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102639574|NCT00887640|Antipruritics|antipruritics|mesh-ancestor
102639575|NCT00887640|Dermatologic Agents|dermatologic agents|mesh-ancestor
102639576|NCT00889200|Eszopiclone|eszopiclone|mesh-list
102639577|NCT00889200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102639578|NCT00889200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102639579|NCT00889200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639580|NCT00892710|Bevacizumab|bevacizumab|mesh-list
102639581|NCT00892710|Carboplatin|carboplatin|mesh-list
102639582|NCT00892710|Pemetrexed|pemetrexed|mesh-list
102639583|NCT00892710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102639584|NCT00892710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102639585|NCT00892710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102639586|NCT00892710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102639587|NCT00892710|Growth Substances|growth substances|mesh-ancestor
102639588|NCT00892710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639589|NCT00892710|Growth Inhibitors|growth inhibitors|mesh-ancestor
102639590|NCT00892710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102639591|NCT00892710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639592|NCT00892710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102639593|NCT00892710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102639594|NCT00894504|Carboplatin|carboplatin|mesh-list
102639595|NCT00894504|Gemcitabine|gemcitabine|mesh-list
102639596|NCT00894504|Panitumumab|panitumumab|mesh-list
102639597|NCT00894504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102639598|NCT00894504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102639599|NCT00894504|Antimetabolites|antimetabolites|mesh-ancestor
102639600|NCT00894504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639601|NCT00894504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102639602|NCT00895752|Riluzole|riluzole|mesh-list
102639603|NCT00895752|Anticonvulsants|anticonvulsants|mesh-ancestor
102639604|NCT00895752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102639605|NCT00895752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102639606|NCT00895752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102639607|NCT00895752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639608|NCT00895752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639609|NCT00895752|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102639610|NCT00895752|Protective Agents|protective agents|mesh-ancestor
102639611|NCT00896064|Vaccines|vaccines|mesh-list
102275323|NCT00002872|Bleomycin|bleomycin|mesh-list
102639612|NCT00896064|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102639613|NCT00896064|Immunologic Factors|immunologic factors|mesh-ancestor
102639614|NCT00896064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639615|NCT00898560|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102639616|NCT00898560|Anticonvulsants|anticonvulsants|mesh-ancestor
102639617|NCT00898560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102639618|NCT00898560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102639619|NCT00898560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102639620|NCT00898560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639621|NCT00899574|Imiquimod|imiquimod|mesh-list
102639622|NCT00899574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102639623|NCT00899574|Immunologic Factors|immunologic factors|mesh-ancestor
102639624|NCT00899574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639625|NCT00899574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102639626|NCT00899574|Interferon Inducers|interferon inducers|mesh-ancestor
102639627|NCT00900666|Botulinum Toxins|botulinum toxins|mesh-list
102639628|NCT00900666|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102639629|NCT00900666|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102639630|NCT00900666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102639631|NCT00900666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102639632|NCT00900666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639633|NCT00900666|Cholinergic Agents|cholinergic agents|mesh-ancestor
102639634|NCT00900666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102639635|NCT00900666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639636|NCT00900666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102639637|NCT00900666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102639638|NCT00902226|Escitalopram|escitalopram|mesh-list
102639639|NCT00902226|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102639640|NCT00902226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102639641|NCT00902226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102639642|NCT00902226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639643|NCT00902226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102639644|NCT00902226|Serotonin Agents|serotonin agents|mesh-ancestor
102639645|NCT00902226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639646|NCT00903162|Zoledronic Acid|zoledronic acid|mesh-list
102639647|NCT00903162|Letrozole|letrozole|mesh-list
102639648|NCT00903162|Leuprolide|leuprolide|mesh-list
102639649|NCT00903162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102639650|NCT00903162|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102639651|NCT00903162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102639652|NCT00903162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102639653|NCT00903162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639654|NCT00903162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102639655|NCT00903162|Hormone Antagonists|hormone antagonists|mesh-ancestor
102639656|NCT00903162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102639657|NCT00903162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639658|NCT00903162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102639659|NCT00903162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102639660|NCT00903162|Fertility Agents|fertility agents|mesh-ancestor
102639661|NCT00903162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102639662|NCT00903162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102639663|NCT00904488|Metolazone|metolazone|mesh-list
102639664|NCT00904488|Furosemide|furosemide|mesh-list
102639665|NCT00904488|Diuretics|diuretics|mesh-ancestor
102639666|NCT00904488|Natriuretic Agents|natriuretic agents|mesh-ancestor
102639667|NCT00904488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639668|NCT00904488|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102639669|NCT00904488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102639670|NCT00904488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639671|NCT00904488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102639672|NCT00904488|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102639673|NCT00905580|Pregabalin|pregabalin|mesh-list
102639674|NCT00905580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639675|NCT00905580|Analgesics|analgesics|mesh-ancestor
102639676|NCT00905580|Sensory System Agents|sensory system agents|mesh-ancestor
102639677|NCT00905580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102639678|NCT00905580|Anticonvulsants|anticonvulsants|mesh-ancestor
102639679|NCT00905580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102639680|NCT00905580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102639681|NCT00905580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275324|NCT00002872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102275326|NCT00002872|Antimalarials|antimalarials|mesh-ancestor
102639682|NCT00905580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102639683|NCT00905580|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102639684|NCT00905580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102639685|NCT00905580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102639686|NCT00905580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102639687|NCT00908466|Sirolimus|sirolimus|mesh-list
102639688|NCT00908466|Temsirolimus|temsirolimus|mesh-list
102639689|NCT00908466|MTOR Inhibitors|mtor inhibitors|mesh-list
102639690|NCT00908466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102639691|NCT00908466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102639692|NCT00908466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102639693|NCT00908466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102639694|NCT00908466|Antifungal Agents|antifungal agents|mesh-ancestor
102639695|NCT00908466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102639696|NCT00908466|Immunologic Factors|immunologic factors|mesh-ancestor
102639697|NCT00908466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639698|NCT00908466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102639699|NCT00908466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102639700|NCT00908466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639701|NCT00911586|Methyltestosterone|methyltestosterone|mesh-list
102639702|NCT00911586|Testosterone|testosterone|mesh-list
102639703|NCT00911586|Testosterone undecanoate|testosterone undecanoate|mesh-list
102639704|NCT00911586|Testosterone enanthate|testosterone enanthate|mesh-list
102639705|NCT00911586|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102639706|NCT00911586|Androgens|androgens|mesh-ancestor
102639707|NCT00911586|Hormones|hormones|mesh-ancestor
102639708|NCT00911586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102639709|NCT00911586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639710|NCT00911586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102639711|NCT00911586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102639712|NCT00911586|Anabolic Agents|anabolic agents|mesh-ancestor
102639713|NCT00911742|Tramadol|tramadol|mesh-list
102639714|NCT00911742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102639715|NCT00911742|Narcotics|narcotics|mesh-ancestor
102639716|NCT00911742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102639717|NCT00911742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639718|NCT00911742|Analgesics|analgesics|mesh-ancestor
102639719|NCT00911742|Sensory System Agents|sensory system agents|mesh-ancestor
102639720|NCT00911742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102639721|NCT00912990|Cisatracurium|cisatracurium|mesh-list
102639722|NCT00912990|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102639723|NCT00912990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102639724|NCT00912990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102639725|NCT00912990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639726|NCT00913068|Lidocaine|lidocaine|mesh-list
102639727|NCT00913068|Ropivacaine|ropivacaine|mesh-list
102639728|NCT00913068|Anesthetics, Local|anesthetics, local|mesh-ancestor
102639729|NCT00913068|Anesthetics|anesthetics|mesh-ancestor
102639730|NCT00913068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102639731|NCT00913068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639732|NCT00913068|Sensory System Agents|sensory system agents|mesh-ancestor
102639733|NCT00913068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102639734|NCT00913068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102639735|NCT00913068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102639736|NCT00913068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102639737|NCT00913068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102639738|NCT00913068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639739|NCT00916032|Factor VIII|factor viii|mesh-list
102639740|NCT00916032|Coagulants|coagulants|mesh-ancestor
102639741|NCT00922194|Metformin|metformin|mesh-list
102639742|NCT00922194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102639743|NCT00922194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639744|NCT00923910|Acetaminophen|acetaminophen|mesh-list
102639745|NCT00923910|Diphenhydramine|diphenhydramine|mesh-list
102639746|NCT00923910|Promethazine|promethazine|mesh-list
102639747|NCT00923910|Interleukin-4|interleukin-4|mesh-list
102639748|NCT00923910|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
102639749|NCT00923910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102639750|NCT00923910|Analgesics|analgesics|mesh-ancestor
102639751|NCT00923910|Sensory System Agents|sensory system agents|mesh-ancestor
102639752|NCT00923910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102275327|NCT00002872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102639753|NCT00923910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639754|NCT00923910|Antipyretics|antipyretics|mesh-ancestor
102639755|NCT00923910|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102639756|NCT00923910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102639757|NCT00923910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102639758|NCT00923910|Anesthetics, Local|anesthetics, local|mesh-ancestor
102639759|NCT00923910|Anesthetics|anesthetics|mesh-ancestor
102639760|NCT00923910|Antiemetics|antiemetics|mesh-ancestor
102639761|NCT00923910|Autonomic Agents|autonomic agents|mesh-ancestor
102639762|NCT00923910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102639763|NCT00923910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102639764|NCT00923910|Histamine Antagonists|histamine antagonists|mesh-ancestor
102639765|NCT00923910|Histamine Agents|histamine agents|mesh-ancestor
102639766|NCT00923910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102639767|NCT00923910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639768|NCT00923910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102639769|NCT00923910|Antipruritics|antipruritics|mesh-ancestor
102639770|NCT00923910|Dermatologic Agents|dermatologic agents|mesh-ancestor
102639771|NCT00923910|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102639772|NCT00923910|Immunologic Factors|immunologic factors|mesh-ancestor
102639773|NCT00923910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102639774|NCT00923910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102639775|NCT00924066|Epothilones|epothilones|mesh-list
102639776|NCT00924066|Tubulin Modulators|tubulin modulators|mesh-ancestor
102639777|NCT00924066|Antimitotic Agents|antimitotic agents|mesh-ancestor
102639778|NCT00924066|Mitosis Modulators|mitosis modulators|mesh-ancestor
102639779|NCT00924066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639780|NCT00924066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102639781|NCT00924612|Methyltestosterone|methyltestosterone|mesh-list
102639782|NCT00924612|Testosterone|testosterone|mesh-list
102639783|NCT00924612|Testosterone undecanoate|testosterone undecanoate|mesh-list
102639784|NCT00924612|Testosterone enanthate|testosterone enanthate|mesh-list
102639785|NCT00924612|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102639786|NCT00924612|Androgens|androgens|mesh-ancestor
102639787|NCT00924612|Hormones|hormones|mesh-ancestor
102639788|NCT00924612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102639789|NCT00924612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639790|NCT00924612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102639791|NCT00924612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102639792|NCT00924612|Anabolic Agents|anabolic agents|mesh-ancestor
102639793|NCT00925782|Melphalan|melphalan|mesh-list
102639794|NCT00925782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102639795|NCT00925782|Alkylating Agents|alkylating agents|mesh-ancestor
102639796|NCT00925782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639797|NCT00925782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102639798|NCT00925782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102639799|NCT00925782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102639800|NCT00925782|Immunologic Factors|immunologic factors|mesh-ancestor
102639801|NCT00925782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639802|NCT00925938|Misoprostol|misoprostol|mesh-list
102639803|NCT00925938|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102639804|NCT00925938|Abortifacient Agents|abortifacient agents|mesh-ancestor
102639805|NCT00925938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102639806|NCT00925938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639807|NCT00925938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102639808|NCT00925938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102639809|NCT00925938|Oxytocics|oxytocics|mesh-ancestor
102639810|NCT00926952|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
102639811|NCT00926952|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102639812|NCT00926952|Dermatologic Agents|dermatologic agents|mesh-ancestor
102639813|NCT00927888|Bupivacaine|bupivacaine|mesh-list
102639814|NCT00927888|Anesthetics, Local|anesthetics, local|mesh-ancestor
102639815|NCT00927888|Anesthetics|anesthetics|mesh-ancestor
102639816|NCT00927888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102639817|NCT00927888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639818|NCT00927888|Sensory System Agents|sensory system agents|mesh-ancestor
102639819|NCT00927888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102639820|NCT00928200|Cytarabine|cytarabine|mesh-list
102639821|NCT00928200|Dexamethasone|dexamethasone|mesh-list
102639822|NCT00928200|Dexamethasone acetate|dexamethasone acetate|mesh-list
102639823|NCT00928200|Doxorubicin|doxorubicin|mesh-list
102639824|NCT00928200|Methotrexate|methotrexate|mesh-list
102639825|NCT00928200|Vincristine|vincristine|mesh-list
102275328|NCT00002872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102639826|NCT00928200|Asparaginase|asparaginase|mesh-list
102639827|NCT00928200|Dexrazoxane|dexrazoxane|mesh-list
102639828|NCT00928200|Razoxane|razoxane|mesh-list
102639829|NCT00928200|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102639830|NCT00928200|BB 1101|bb 1101|mesh-list
102639831|NCT00928200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102275329|NCT00002872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102639832|NCT00928200|Antiemetics|antiemetics|mesh-ancestor
102639833|NCT00928200|Autonomic Agents|autonomic agents|mesh-ancestor
102639834|NCT00928200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102639835|NCT00928200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639836|NCT00928200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102639837|NCT00928200|Glucocorticoids|glucocorticoids|mesh-ancestor
102639838|NCT00928200|Hormones|hormones|mesh-ancestor
102639839|NCT00928200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102639840|NCT00928200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102639841|NCT00928200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102639842|NCT00928200|Protease Inhibitors|protease inhibitors|mesh-ancestor
102639843|NCT00928200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102639844|NCT00928200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639845|NCT00928200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102639846|NCT00928200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102639847|NCT00928200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102639848|NCT00928200|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102639849|NCT00928200|Abortifacient Agents|abortifacient agents|mesh-ancestor
102639850|NCT00928200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102639851|NCT00928200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102639852|NCT00928200|Antimetabolites|antimetabolites|mesh-ancestor
102639853|NCT00928200|Dermatologic Agents|dermatologic agents|mesh-ancestor
102639854|NCT00928200|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102639855|NCT00928200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102639856|NCT00928200|Immunologic Factors|immunologic factors|mesh-ancestor
102639857|NCT00928200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102639858|NCT00928200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102639859|NCT00928200|Antiviral Agents|antiviral agents|mesh-ancestor
102639860|NCT00928200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102639861|NCT00928200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102639862|NCT00928200|Tubulin Modulators|tubulin modulators|mesh-ancestor
102639863|NCT00928200|Antimitotic Agents|antimitotic agents|mesh-ancestor
102639864|NCT00928200|Mitosis Modulators|mitosis modulators|mesh-ancestor
102639865|NCT00928200|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102639866|NCT00928200|Protective Agents|protective agents|mesh-ancestor
102639867|NCT00931164|Sodium Oxybate|sodium oxybate|mesh-list
102639868|NCT00931164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102639869|NCT00931164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102639870|NCT00931164|Anesthetics, General|anesthetics, general|mesh-ancestor
102639871|NCT00931164|Anesthetics|anesthetics|mesh-ancestor
102639872|NCT00931164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102639873|NCT00931164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639874|NCT00931242|Thalidomide|thalidomide|mesh-list
102639875|NCT00931242|Apremilast|apremilast|mesh-list
102639876|NCT00931242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102639877|NCT00931242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102639878|NCT00931242|Analgesics|analgesics|mesh-ancestor
102639879|NCT00931242|Sensory System Agents|sensory system agents|mesh-ancestor
102639880|NCT00931242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102639881|NCT00931242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639882|NCT00931242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102639883|NCT00931242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102639884|NCT00931242|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102639885|NCT00931242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102639886|NCT00931242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102639887|NCT00931242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639888|NCT00931242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102639889|NCT00931242|Immunologic Factors|immunologic factors|mesh-ancestor
102639890|NCT00931242|Leprostatic Agents|leprostatic agents|mesh-ancestor
102639891|NCT00931242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102639892|NCT00931242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102639893|NCT00931242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102639894|NCT00931242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102639895|NCT00931242|Growth Substances|growth substances|mesh-ancestor
102639896|NCT00931242|Growth Inhibitors|growth inhibitors|mesh-ancestor
102639897|NCT00931242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102639898|NCT00932022|Trospium chloride|trospium chloride|mesh-list
102639899|NCT00932022|Parasympatholytics|parasympatholytics|mesh-ancestor
102639900|NCT00932022|Autonomic Agents|autonomic agents|mesh-ancestor
102639901|NCT00932022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102639902|NCT00932022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639903|NCT00932022|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102639904|NCT00932022|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102639905|NCT00932022|Cholinergic Agents|cholinergic agents|mesh-ancestor
102275330|NCT00002872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102639906|NCT00932022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102639907|NCT00932022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639908|NCT00932022|Urological Agents|urological agents|mesh-ancestor
102639909|NCT00939120|Tolterodine Tartrate|tolterodine tartrate|mesh-list
102639910|NCT00939120|Dutasteride|dutasteride|mesh-list
102639911|NCT00939120|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102639912|NCT00939120|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102639913|NCT00939120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102639914|NCT00939120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639915|NCT00939120|Hormone Antagonists|hormone antagonists|mesh-ancestor
102639916|NCT00939120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102639917|NCT00939120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639918|NCT00939120|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102639919|NCT00939120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102639920|NCT00939120|Cholinergic Agents|cholinergic agents|mesh-ancestor
102639921|NCT00939120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102639922|NCT00939120|Urological Agents|urological agents|mesh-ancestor
102639923|NCT00939900|Zoledronic Acid|zoledronic acid|mesh-list
102639924|NCT00939900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102639925|NCT00939900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639926|NCT00943098|Diclofenac|diclofenac|mesh-list
102639927|NCT00943098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102639928|NCT00943098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102639929|NCT00943098|Analgesics|analgesics|mesh-ancestor
102639930|NCT00943098|Sensory System Agents|sensory system agents|mesh-ancestor
102639931|NCT00943098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102639932|NCT00943098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639933|NCT00943098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102639934|NCT00943098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102639935|NCT00943098|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102639936|NCT00943098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102639937|NCT00943098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639938|NCT00943800|Vidarabine|vidarabine|mesh-list
102639939|NCT00943800|Fludarabine|fludarabine|mesh-list
102639940|NCT00943800|Fludarabine phosphate|fludarabine phosphate|mesh-list
102639941|NCT00943800|Melphalan|melphalan|mesh-list
102639942|NCT00943800|Busulfan|busulfan|mesh-list
102639943|NCT00943800|Thiotepa|thiotepa|mesh-list
102639944|NCT00943800|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102639945|NCT00943800|Thymoglobulin|thymoglobulin|mesh-list
102639946|NCT00943800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102639947|NCT00943800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102639948|NCT00943800|Antimetabolites|antimetabolites|mesh-ancestor
102639949|NCT00943800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639950|NCT00943800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102639951|NCT00943800|Immunologic Factors|immunologic factors|mesh-ancestor
102639952|NCT00943800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639953|NCT00943800|Antiviral Agents|antiviral agents|mesh-ancestor
102639954|NCT00943800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102639955|NCT00943800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102639956|NCT00943800|Alkylating Agents|alkylating agents|mesh-ancestor
102639957|NCT00943800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102639958|NCT00943878|Vaccines|vaccines|mesh-list
102639959|NCT00943878|Immunologic Factors|immunologic factors|mesh-ancestor
102639960|NCT00943878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639961|NCT00945282|Ritonavir|ritonavir|mesh-list
102639962|NCT00945282|Lopinavir|lopinavir|mesh-list
102639963|NCT00945282|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102639964|NCT00945282|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102639965|NCT00945282|Protease Inhibitors|protease inhibitors|mesh-ancestor
102639966|NCT00945282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101612522|NCT02853864|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102639967|NCT00945282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639968|NCT00945282|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102639969|NCT00945282|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102639970|NCT00945282|Antiviral Agents|antiviral agents|mesh-ancestor
102639971|NCT00945282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102639972|NCT00945282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102639973|NCT00945282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102639974|NCT00945750|Famotidine|famotidine|mesh-list
102639975|NCT00945750|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102639976|NCT00945750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102639977|NCT00945750|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102639978|NCT00945750|Histamine Antagonists|histamine antagonists|mesh-ancestor
102639979|NCT00945750|Histamine Agents|histamine agents|mesh-ancestor
102639980|NCT00945750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102275331|NCT00002868|Interferons|interferons|mesh-list
102639981|NCT00945750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639982|NCT00945750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639983|NCT00948090|Cyclophosphamide|cyclophosphamide|mesh-list
102639984|NCT00948090|Busulfan|busulfan|mesh-list
102639985|NCT00948090|Etoposide|etoposide|mesh-list
102639986|NCT00948090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102639987|NCT00948090|Immunologic Factors|immunologic factors|mesh-ancestor
102639988|NCT00948090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102639989|NCT00948090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102639990|NCT00948090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102639991|NCT00948090|Alkylating Agents|alkylating agents|mesh-ancestor
102639992|NCT00948090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102639993|NCT00948090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102639994|NCT00948090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102639995|NCT00948090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102639996|NCT00948090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102639997|NCT00948090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102639998|NCT00948090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102639999|NCT00950352|Choline|choline|mesh-list
102640000|NCT00950352|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
102640001|NCT00950352|Lipotropic Agents|lipotropic agents|mesh-ancestor
102640002|NCT00950352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102640003|NCT00950352|Antimetabolites|antimetabolites|mesh-ancestor
102640004|NCT00950352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640005|NCT00950352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102640006|NCT00950352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102640007|NCT00950352|Nootropic Agents|nootropic agents|mesh-ancestor
102640008|NCT00953862|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102640009|NCT00953862|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102640010|NCT00953862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102640011|NCT00953862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102640012|NCT00953862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640013|NCT00953862|Adrenergic Agents|adrenergic agents|mesh-ancestor
102640014|NCT00953862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102640015|NCT00953862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640016|NCT00955266|Calcium|calcium|mesh-list
102640017|NCT00955266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102640018|NCT00955266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640019|NCT00957684|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102640020|NCT00957684|Anticonvulsants|anticonvulsants|mesh-ancestor
102640021|NCT00957684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102640022|NCT00957684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102640023|NCT00957684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102640024|NCT00957684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640025|NCT00961662|Tagatose|tagatose|mesh-list
102640026|NCT00961662|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102640027|NCT00961662|Chelating Agents|chelating agents|mesh-ancestor
102640028|NCT00961662|Sequestering Agents|sequestering agents|mesh-ancestor
102640029|NCT00961662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640030|NCT00964548|Dantrolene|dantrolene|mesh-list
102640031|NCT00964548|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102640032|NCT00964548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612588|NCT00679666|Vitamins|vitamins|mesh-ancestor
102640033|NCT00964548|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102640034|NCT00964548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102640035|NCT00905268|Idebenone|idebenone|mesh-list
102640036|NCT00905268|Antioxidants|antioxidants|mesh-ancestor
102640037|NCT00905268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640038|NCT00905268|Protective Agents|protective agents|mesh-ancestor
102640039|NCT00905268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640040|NCT00967044|Everolimus|everolimus|mesh-list
102640041|NCT00967044|Panobinostat|panobinostat|mesh-list
102640042|NCT00967044|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102640043|NCT00967044|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102640044|NCT00967044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102640045|NCT00967044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640046|NCT00967044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102640047|NCT00967044|Immunologic Factors|immunologic factors|mesh-ancestor
102640048|NCT00967044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640049|NCT00967044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640050|NCT00967044|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102640051|NCT00973752|Cytarabine|cytarabine|mesh-list
102640052|NCT00973752|Prednisone|prednisone|mesh-list
102640053|NCT00973752|Doxorubicin|doxorubicin|mesh-list
102275332|NCT00002868|Cytarabine|cytarabine|mesh-list
101928721|NCT01309620|Zinc|zinc|mesh-list
102640054|NCT00973752|Methotrexate|methotrexate|mesh-list
102640055|NCT00973752|Vincristine|vincristine|mesh-list
102640056|NCT00973752|Asparaginase|asparaginase|mesh-list
102640057|NCT00973752|Mercaptopurine|mercaptopurine|mesh-list
102640058|NCT00973752|Clofarabine|clofarabine|mesh-list
102640059|NCT00973752|Pegaspargase|pegaspargase|mesh-list
102640060|NCT00973752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102640061|NCT00973752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640062|NCT00973752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102640063|NCT00973752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102640064|NCT00973752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102640065|NCT00973752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640066|NCT00973752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102640067|NCT00973752|Glucocorticoids|glucocorticoids|mesh-ancestor
102640068|NCT00973752|Hormones|hormones|mesh-ancestor
102640069|NCT00973752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102640070|NCT00973752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640071|NCT00973752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102640072|NCT00973752|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102640073|NCT00973752|Abortifacient Agents|abortifacient agents|mesh-ancestor
102640074|NCT00973752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102640075|NCT00973752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102640076|NCT00973752|Antimetabolites|antimetabolites|mesh-ancestor
102640077|NCT00973752|Dermatologic Agents|dermatologic agents|mesh-ancestor
102640078|NCT00973752|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102640079|NCT00973752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102640080|NCT00973752|Immunologic Factors|immunologic factors|mesh-ancestor
102640081|NCT00973752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102640082|NCT00973752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102640083|NCT00973752|Antiviral Agents|antiviral agents|mesh-ancestor
102640084|NCT00973752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102640085|NCT00973752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102640086|NCT00973752|Tubulin Modulators|tubulin modulators|mesh-ancestor
102640087|NCT00973752|Antimitotic Agents|antimitotic agents|mesh-ancestor
102640088|NCT00973752|Mitosis Modulators|mitosis modulators|mesh-ancestor
102640089|NCT00974142|Cyclosporine|cyclosporine|mesh-list
102640090|NCT00974142|Cyclosporins|cyclosporins|mesh-list
102640091|NCT00974142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102640092|NCT00974142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640093|NCT00974142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102640094|NCT00974142|Immunologic Factors|immunologic factors|mesh-ancestor
102640095|NCT00974142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640096|NCT00974142|Antifungal Agents|antifungal agents|mesh-ancestor
102640097|NCT00974142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102640098|NCT00974142|Dermatologic Agents|dermatologic agents|mesh-ancestor
101612664|NCT00680212|Vitamins|vitamins|mesh-ancestor
102640099|NCT00974142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102640100|NCT00974142|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102640101|NCT00974376|Gabapentin|gabapentin|mesh-list
102640102|NCT00974376|Analgesics|analgesics|mesh-ancestor
102640103|NCT00974376|Sensory System Agents|sensory system agents|mesh-ancestor
102640104|NCT00974376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102640105|NCT00974376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640106|NCT00974376|Anticonvulsants|anticonvulsants|mesh-ancestor
102640107|NCT00974376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102640108|NCT00974376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102640109|NCT00974376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102640110|NCT00974376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102640111|NCT00974376|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102640112|NCT00974376|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102640113|NCT00974376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102640114|NCT00974376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640115|NCT00974376|Antimanic Agents|antimanic agents|mesh-ancestor
102640116|NCT00976248|Everolimus|everolimus|mesh-list
102640117|NCT00976248|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102640118|NCT00976248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102640119|NCT00976248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102640120|NCT00976248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640121|NCT00976248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102640122|NCT00976248|Immunologic Factors|immunologic factors|mesh-ancestor
102640123|NCT00976248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640124|NCT00976248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640125|NCT00976404|Raltegravir Potassium|raltegravir potassium|mesh-list
102640126|NCT00976404|Maraviroc|maraviroc|mesh-list
102640127|NCT00976404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102640128|NCT00976404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102640130|NCT00976404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102640131|NCT00976404|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102640132|NCT00976404|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102640133|NCT00976404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102640134|NCT00976404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640135|NCT00976404|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102640136|NCT00976404|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102640137|NCT00976404|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102640138|NCT00983346|Bortezomib|bortezomib|mesh-list
102640139|NCT00983346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640140|NCT00986856|Fusidic Acid|fusidic acid|mesh-list
102640141|NCT00986856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102640142|NCT00986856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102640143|NCT00986856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102640144|NCT00986856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102640145|NCT00986856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640146|NCT00987480|Cyclosporine|cyclosporine|mesh-list
102640147|NCT00987480|Cyclophosphamide|cyclophosphamide|mesh-list
102640148|NCT00987480|Busulfan|busulfan|mesh-list
102640149|NCT00987480|Fludarabine|fludarabine|mesh-list
102640150|NCT00987480|Cyclosporins|cyclosporins|mesh-list
102640151|NCT00987480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102640152|NCT00987480|Immunologic Factors|immunologic factors|mesh-ancestor
102640153|NCT00987480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640154|NCT00987480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102640155|NCT00987480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102640156|NCT00987480|Alkylating Agents|alkylating agents|mesh-ancestor
102640157|NCT00987480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640158|NCT00987480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640159|NCT00987480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102640160|NCT00987480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102640161|NCT00987480|Antifungal Agents|antifungal agents|mesh-ancestor
102640162|NCT00987480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102640163|NCT00987480|Dermatologic Agents|dermatologic agents|mesh-ancestor
102640164|NCT00987480|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102640165|NCT00987558|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102640166|NCT00987558|Simvastatin|simvastatin|mesh-list
102640167|NCT00987558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102640168|NCT00987558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102640169|NCT00987558|Antimetabolites|antimetabolites|mesh-ancestor
101612726|NCT02881346|Betamethasone|betamethasone|mesh-list
102640170|NCT00987558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640171|NCT00987558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102640172|NCT00987558|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102640173|NCT00987558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102640174|NCT00987558|Anticonvulsants|anticonvulsants|mesh-ancestor
102640175|NCT00987558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102640176|NCT00987558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102640177|NCT00987558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102640178|NCT00987948|Maraviroc|maraviroc|mesh-list
102640179|NCT00987948|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102640180|NCT00987948|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102640181|NCT00987948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640182|NCT00987948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102640183|NCT00987948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102640184|NCT00987948|Antiviral Agents|antiviral agents|mesh-ancestor
102640185|NCT00987948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102640186|NCT00987948|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102640187|NCT00989586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102640188|NCT00989586|Veltuzumab|veltuzumab|mesh-list
102640189|NCT00989586|Antibodies|antibodies|mesh-list
102640190|NCT00989586|Immunoglobulins|immunoglobulins|mesh-list
102640191|NCT00989586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102640192|NCT00989586|Immunologic Factors|immunologic factors|mesh-ancestor
102640193|NCT00989586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640194|NCT00989586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640195|NCT00990288|Thrombin|thrombin|mesh-list
102640196|NCT00990288|Hemostatics|hemostatics|mesh-list
102640197|NCT00990288|Coagulants|coagulants|mesh-ancestor
102640198|NCT00991458|Cyclosporine|cyclosporine|mesh-list
102640199|NCT00991458|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102640200|NCT00991458|Cyclosporins|cyclosporins|mesh-list
102640201|NCT00991458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102640202|NCT00991458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640203|NCT00991458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101928738|NCT03783312|Antipyretics|antipyretics|mesh-ancestor
102275333|NCT00002868|Interferon-alpha|interferon-alpha|mesh-list
102640204|NCT00991458|Immunologic Factors|immunologic factors|mesh-ancestor
102640205|NCT00991458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640206|NCT00991458|Antifungal Agents|antifungal agents|mesh-ancestor
102640207|NCT00991458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102640208|NCT00991458|Dermatologic Agents|dermatologic agents|mesh-ancestor
102640209|NCT00991458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102640210|NCT00991458|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102640211|NCT00991458|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102640212|NCT00993798|Bupivacaine|bupivacaine|mesh-list
102640213|NCT00993798|Anesthetics, Local|anesthetics, local|mesh-ancestor
102640214|NCT00993798|Anesthetics|anesthetics|mesh-ancestor
102640215|NCT00993798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102640216|NCT00993798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640217|NCT00993798|Sensory System Agents|sensory system agents|mesh-ancestor
102640218|NCT00993798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102640219|NCT00997620|Fluticasone|fluticasone|mesh-list
102640220|NCT00997620|Xhance|xhance|mesh-list
102640221|NCT00997620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102640222|NCT00997620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102640223|NCT00997620|Autonomic Agents|autonomic agents|mesh-ancestor
102640224|NCT00997620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102640225|NCT00997620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640226|NCT00997620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102640227|NCT00997620|Respiratory System Agents|respiratory system agents|mesh-ancestor
102640228|NCT00997620|Dermatologic Agents|dermatologic agents|mesh-ancestor
102640229|NCT00997620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102640230|NCT00997932|Contraceptive Agents|contraceptive agents|mesh-list
102640231|NCT00997932|Levonorgestrel|levonorgestrel|mesh-list
102640232|NCT00997932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102640233|NCT00997932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640234|NCT00997932|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102640235|NCT00997932|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102640236|NCT00997932|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102640237|NCT00997932|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102640238|NCT00998010|Temozolomide|temozolomide|mesh-list
102640239|NCT00998010|Bortezomib|bortezomib|mesh-list
102640240|NCT00998010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102640241|NCT00998010|Alkylating Agents|alkylating agents|mesh-ancestor
102640242|NCT00998010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640243|NCT00998010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640244|NCT00999102|Metoprolol|metoprolol|mesh-list
102640245|NCT00999102|Nebivolol|nebivolol|mesh-list
102640246|NCT00999102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102640247|NCT00999102|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102640248|NCT00999102|Sympatholytics|sympatholytics|mesh-ancestor
102640249|NCT00999102|Autonomic Agents|autonomic agents|mesh-ancestor
102640250|NCT00999102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102640251|NCT00999102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640252|NCT00999102|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102640253|NCT00999102|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102640254|NCT00999102|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102640255|NCT00999102|Adrenergic Agents|adrenergic agents|mesh-ancestor
102640256|NCT00999102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102640257|NCT00999102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640258|NCT00999102|Vasodilator Agents|vasodilator agents|mesh-ancestor
102640259|NCT00999102|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102640260|NCT00999102|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102640261|NCT00999102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102640262|NCT01000818|Raltegravir Potassium|raltegravir potassium|mesh-list
102640263|NCT01000818|Omeprazole|omeprazole|mesh-list
102640264|NCT01000818|Famotidine|famotidine|mesh-list
102640265|NCT01000818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102640266|NCT01000818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102640267|NCT01000818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102640268|NCT01000818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102640269|NCT01000818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640270|NCT01000818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102640271|NCT01000818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102640272|NCT01000818|Antiviral Agents|antiviral agents|mesh-ancestor
102640273|NCT01000818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102640274|NCT01000818|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102640275|NCT01000818|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102640276|NCT01000818|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102640277|NCT01000818|Histamine Antagonists|histamine antagonists|mesh-ancestor
102640278|NCT01000818|Histamine Agents|histamine agents|mesh-ancestor
102275334|NCT00002868|Etoposide|etoposide|mesh-list
102640279|NCT01000818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102640280|NCT01000818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640281|NCT01001052|Colchicine|colchicine|mesh-list
102640282|NCT01001052|Gout Suppressants|gout suppressants|mesh-ancestor
102640283|NCT01001052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102640284|NCT01001052|Tubulin Modulators|tubulin modulators|mesh-ancestor
102640285|NCT01001052|Antimitotic Agents|antimitotic agents|mesh-ancestor
102640286|NCT01001052|Mitosis Modulators|mitosis modulators|mesh-ancestor
102640287|NCT01001052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640288|NCT01001052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640289|NCT01001442|Indatuximab ravtansine|indatuximab ravtansine|mesh-list
102640290|NCT01001442|Immunoconjugates|immunoconjugates|mesh-ancestor
102640291|NCT01001442|Immunologic Factors|immunologic factors|mesh-ancestor
102640292|NCT01001442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640293|NCT01003080|Hemostatics|hemostatics|mesh-list
102640294|NCT01003080|Coagulants|coagulants|mesh-ancestor
102640295|NCT01003938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102640296|NCT01003938|Topotecan|topotecan|mesh-list
102640297|NCT01003938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640298|NCT01003938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102640299|NCT01003938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102640300|NCT01003938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640301|NCT01003938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102640302|NCT01003938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102640303|NCT01004718|Deoxyglucose|deoxyglucose|mesh-list
102640304|NCT01004718|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102640305|NCT01004718|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102640306|NCT01004718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640307|NCT01004718|Antimetabolites|antimetabolites|mesh-ancestor
102640308|NCT01004718|Antiviral Agents|antiviral agents|mesh-ancestor
102640309|NCT01004718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102640310|NCT01005576|Fludarabine|fludarabine|mesh-list
102640311|NCT01005576|Melphalan|melphalan|mesh-list
102640312|NCT01005576|Alemtuzumab|alemtuzumab|mesh-list
102640313|NCT01005576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640314|NCT01005576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640315|NCT01005576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102640316|NCT01005576|Immunologic Factors|immunologic factors|mesh-ancestor
102640317|NCT01005576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640318|NCT01005576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102640319|NCT01005576|Alkylating Agents|alkylating agents|mesh-ancestor
102640320|NCT01005576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102640321|NCT01005576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102640322|NCT01005810|Acetylcysteine|acetylcysteine|mesh-list
102640323|NCT01005810|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102640324|NCT01005810|Antiviral Agents|antiviral agents|mesh-ancestor
102640325|NCT01005810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102640326|NCT01005810|Expectorants|expectorants|mesh-ancestor
102640327|NCT01005810|Respiratory System Agents|respiratory system agents|mesh-ancestor
102640328|NCT01005810|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102640329|NCT01005810|Antioxidants|antioxidants|mesh-ancestor
102640330|NCT01005810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640331|NCT01005810|Protective Agents|protective agents|mesh-ancestor
102640332|NCT01005810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640333|NCT01005810|Antidotes|antidotes|mesh-ancestor
102640334|NCT01005888|Complement C1s|complement c1s|mesh-list
102640335|NCT01005888|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
102640336|NCT01005888|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
102640337|NCT01005888|Immunologic Factors|immunologic factors|mesh-ancestor
102640338|NCT01005888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640339|NCT01005888|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102640340|NCT01005888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102640341|NCT01007994|Propranolol|propranolol|mesh-list
102640342|NCT01007994|Enalapril|enalapril|mesh-list
102640343|NCT01007994|Isradipine|isradipine|mesh-list
102640344|NCT01007994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102640345|NCT01007994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102640346|NCT01007994|Adrenergic Agents|adrenergic agents|mesh-ancestor
102640347|NCT01007994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102640348|NCT01007994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640349|NCT01007994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640350|NCT01007994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102640351|NCT01007994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102640352|NCT01007994|Vasodilator Agents|vasodilator agents|mesh-ancestor
102275335|NCT00002868|Idarubicin|idarubicin|mesh-list
102275336|NCT00002868|Busulfan|busulfan|mesh-list
102275337|NCT00002868|Hydroxyurea|hydroxyurea|mesh-list
102275338|NCT00002868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102275339|NCT00002868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640353|NCT01007994|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102640354|NCT01007994|Protease Inhibitors|protease inhibitors|mesh-ancestor
102640355|NCT01007994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102640356|NCT01007994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102640357|NCT01007994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102640358|NCT01007994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102640359|NCT01008462|Cytarabine|cytarabine|mesh-list
102640360|NCT01008462|Mycophenolic Acid|mycophenolic acid|mesh-list
102640361|NCT01008462|Cyclophosphamide|cyclophosphamide|mesh-list
102640362|NCT01008462|Melphalan|melphalan|mesh-list
102640363|NCT01008462|Mechlorethamine|mechlorethamine|mesh-list
102640364|NCT01008462|Carmustine|carmustine|mesh-list
102640365|NCT01008462|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102640366|NCT01008462|Fludarabine|fludarabine|mesh-list
102640367|NCT01008462|Fludarabine phosphate|fludarabine phosphate|mesh-list
102640368|NCT01008462|Etoposide|etoposide|mesh-list
102640369|NCT01008462|Etoposide phosphate|etoposide phosphate|mesh-list
102640370|NCT01008462|Podophyllotoxin|podophyllotoxin|mesh-list
102640371|NCT01008462|Tacrolimus|tacrolimus|mesh-list
101612937|NCT00905307|Serotonin Agents|serotonin agents|mesh-ancestor
102640372|NCT01008462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102640373|NCT01008462|Immunologic Factors|immunologic factors|mesh-ancestor
102640374|NCT01008462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640375|NCT01008462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102640376|NCT01008462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102640377|NCT01008462|Alkylating Agents|alkylating agents|mesh-ancestor
102640378|NCT01008462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640379|NCT01008462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640380|NCT01008462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102640381|NCT01008462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102640382|NCT01008462|Antimetabolites|antimetabolites|mesh-ancestor
102640383|NCT01008462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102640384|NCT01008462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102640385|NCT01008462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102640386|NCT01008462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102640387|NCT01008462|Antiviral Agents|antiviral agents|mesh-ancestor
102640388|NCT01008462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102640389|NCT01008462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102640390|NCT01008462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102640391|NCT01008462|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102640392|NCT01008462|Antitubercular Agents|antitubercular agents|mesh-ancestor
102640393|NCT01008462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102640394|NCT01008462|Keratolytic Agents|keratolytic agents|mesh-ancestor
102640395|NCT01008462|Dermatologic Agents|dermatologic agents|mesh-ancestor
102640396|NCT01008462|Tubulin Modulators|tubulin modulators|mesh-ancestor
102640397|NCT01008462|Antimitotic Agents|antimitotic agents|mesh-ancestor
102640398|NCT01008462|Mitosis Modulators|mitosis modulators|mesh-ancestor
102640399|NCT01010568|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102640400|NCT01010568|Ofatumumab|ofatumumab|mesh-list
102640401|NCT01010568|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102640402|NCT01010568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102640403|NCT01010568|Alkylating Agents|alkylating agents|mesh-ancestor
102640404|NCT01010568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640405|NCT01010568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640406|NCT01010568|Immunologic Factors|immunologic factors|mesh-ancestor
102640407|NCT01010568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640408|NCT01011816|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102640409|NCT01011816|Hemostatics|hemostatics|mesh-ancestor
102640410|NCT01011816|Coagulants|coagulants|mesh-ancestor
102640411|NCT01011894|Lenalidomide|lenalidomide|mesh-list
102640412|NCT01011894|Immunologic Factors|immunologic factors|mesh-ancestor
102640413|NCT01011894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640414|NCT01011894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102640415|NCT01011894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102640416|NCT01011894|Growth Substances|growth substances|mesh-ancestor
102640417|NCT01011894|Growth Inhibitors|growth inhibitors|mesh-ancestor
102640418|NCT01011894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640419|NCT01012674|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
102640420|NCT01012674|Chelating Agents|chelating agents|mesh-ancestor
102640421|NCT01012674|Sequestering Agents|sequestering agents|mesh-ancestor
102640422|NCT01012674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640423|NCT01015170|Bupropion|bupropion|mesh-list
102640424|NCT01015170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102640425|NCT01015170|Antidepressive Agents|antidepressive agents|mesh-ancestor
102640426|NCT01015170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102640427|NCT01015170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102640428|NCT01015170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102640429|NCT01015170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102640430|NCT01015170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640431|NCT01015170|Dopamine Agents|dopamine agents|mesh-ancestor
102640432|NCT01015170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102640433|NCT01015170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640434|NCT01015170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102640435|NCT01015170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102640436|NCT01015170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102640438|NCT01017042|Gout Suppressants|gout suppressants|mesh-ancestor
102640439|NCT01017042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102640440|NCT01017042|Tubulin Modulators|tubulin modulators|mesh-ancestor
102640441|NCT01017042|Antimitotic Agents|antimitotic agents|mesh-ancestor
102640442|NCT01017042|Mitosis Modulators|mitosis modulators|mesh-ancestor
102640443|NCT01017042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640444|NCT01017042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640445|NCT01018056|Riluzole|riluzole|mesh-list
102640446|NCT01018056|Anticonvulsants|anticonvulsants|mesh-ancestor
102640447|NCT01018056|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102640448|NCT01018056|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102640449|NCT01018056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102640450|NCT01018056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640451|NCT01018056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640452|NCT01018056|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102640453|NCT01018056|Protective Agents|protective agents|mesh-ancestor
102640454|NCT01018134|Desoximetasone|desoximetasone|mesh-list
102640455|NCT01018134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102640456|NCT01018134|Glucocorticoids|glucocorticoids|mesh-ancestor
102640457|NCT01018134|Hormones|hormones|mesh-ancestor
102640458|NCT01018134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102640459|NCT01018134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640460|NCT01020006|Gemcitabine|gemcitabine|mesh-list
102640461|NCT01020006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102640462|NCT01020006|Antimetabolites|antimetabolites|mesh-ancestor
102640463|NCT01020006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640464|NCT01020006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640465|NCT05395962|Carboplatin|carboplatin|mesh-list
102640466|NCT05395962|Bleomycin|bleomycin|mesh-list
102640467|NCT05395962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640468|NCT05395962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102640469|NCT05394480|Hydrocortisone|hydrocortisone|mesh-list
102640470|NCT05394480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102640471|NCT05017584|Bupivacaine|bupivacaine|mesh-list
102640472|NCT05017584|Anesthetics, Local|anesthetics, local|mesh-ancestor
102640473|NCT05017584|Anesthetics|anesthetics|mesh-ancestor
102640474|NCT05017584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102640475|NCT05017584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640476|NCT05017584|Sensory System Agents|sensory system agents|mesh-ancestor
102640477|NCT05017584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102640478|NCT04999332|Leucovorin|leucovorin|mesh-list
102640479|NCT04999332|Docetaxel|docetaxel|mesh-list
102640480|NCT04999332|Oxaliplatin|oxaliplatin|mesh-list
102640481|NCT04999332|Levoleucovorin|levoleucovorin|mesh-list
102640482|NCT04999332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640483|NCT04999332|Tubulin Modulators|tubulin modulators|mesh-ancestor
102640484|NCT04999332|Antimitotic Agents|antimitotic agents|mesh-ancestor
102640485|NCT04999332|Mitosis Modulators|mitosis modulators|mesh-ancestor
102640486|NCT04999332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640487|NCT04999332|Antidotes|antidotes|mesh-ancestor
102640488|NCT04999332|Protective Agents|protective agents|mesh-ancestor
102640489|NCT04999332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640490|NCT04999332|Vitamin B Complex|vitamin b complex|mesh-ancestor
102640491|NCT04999332|Vitamins|vitamins|mesh-ancestor
102640492|NCT04999332|Micronutrients|micronutrients|mesh-ancestor
102640493|NCT04147416|Propofol|propofol|mesh-list
102640494|NCT04147416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102640495|NCT04147416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102640496|NCT04147416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640497|NCT04147416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102640498|NCT04147416|Anesthetics, General|anesthetics, general|mesh-ancestor
102640499|NCT04147416|Anesthetics|anesthetics|mesh-ancestor
102640500|NCT02662062|Pembrolizumab|pembrolizumab|mesh-list
101929049|NCT05191264|Analgesics|analgesics|mesh-list
102640501|NCT02662062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640502|NCT02662062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102640503|NCT02662062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102640504|NCT02662062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640505|NCT02406222|Dexamethasone|dexamethasone|mesh-list
102640506|NCT02406222|Cyclophosphamide|cyclophosphamide|mesh-list
102640507|NCT02406222|Pomalidomide|pomalidomide|mesh-list
102640508|NCT02406222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102640509|NCT02406222|Immunologic Factors|immunologic factors|mesh-ancestor
102640510|NCT02406222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640511|NCT02406222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102640512|NCT02406222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102640513|NCT02406222|Alkylating Agents|alkylating agents|mesh-ancestor
102640514|NCT02406222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640515|NCT02406222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640516|NCT02406222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102640517|NCT02406222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102640518|NCT02406222|Antiemetics|antiemetics|mesh-ancestor
102640519|NCT02406222|Autonomic Agents|autonomic agents|mesh-ancestor
102640520|NCT02406222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102640521|NCT02406222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102640522|NCT02406222|Glucocorticoids|glucocorticoids|mesh-ancestor
102640523|NCT02406222|Hormones|hormones|mesh-ancestor
102640524|NCT02406222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102640525|NCT02406222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102640526|NCT02406222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102640527|NCT02406222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102640528|NCT02406222|Growth Substances|growth substances|mesh-ancestor
102640529|NCT02406222|Growth Inhibitors|growth inhibitors|mesh-ancestor
102640530|NCT00458796|Zoledronic Acid|zoledronic acid|mesh-list
102640531|NCT00458796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102640532|NCT00458796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640533|NCT01022190|Etoricoxib|etoricoxib|mesh-list
102640534|NCT01022190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102640535|NCT01022190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102640536|NCT01022190|Analgesics|analgesics|mesh-ancestor
102640537|NCT01022190|Sensory System Agents|sensory system agents|mesh-ancestor
102640538|NCT01022190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102640539|NCT01022190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640540|NCT01022190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102640541|NCT01022190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102640542|NCT01022190|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102640543|NCT01022190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102640544|NCT01022190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102640545|NCT01022190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640546|NCT01024686|Vaccines|vaccines|mesh-list
102640547|NCT01024686|Immunologic Factors|immunologic factors|mesh-ancestor
102640548|NCT01024686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640549|NCT01027806|Montelukast|montelukast|mesh-list
102640550|NCT01027806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102640551|NCT01027806|Respiratory System Agents|respiratory system agents|mesh-ancestor
102640552|NCT01027806|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102640553|NCT01027806|Hormone Antagonists|hormone antagonists|mesh-ancestor
102640554|NCT01027806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102640555|NCT01027806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640556|NCT01027806|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102640557|NCT01027806|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102640558|NCT01027806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640559|NCT01029054|Dexamethasone|dexamethasone|mesh-list
102640560|NCT01029054|Dexamethasone acetate|dexamethasone acetate|mesh-list
102640561|NCT01029054|Lenalidomide|lenalidomide|mesh-list
102640562|NCT01029054|BB 1101|bb 1101|mesh-list
102640563|NCT01029054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102640564|NCT01029054|Antiemetics|antiemetics|mesh-ancestor
102640565|NCT01029054|Autonomic Agents|autonomic agents|mesh-ancestor
102640566|NCT01029054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102640567|NCT01029054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640568|NCT01029054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102640569|NCT01029054|Glucocorticoids|glucocorticoids|mesh-ancestor
102640570|NCT01029054|Hormones|hormones|mesh-ancestor
102640571|NCT01029054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102275340|NCT00002868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101929125|NCT03777696|Misoprostol|misoprostol|mesh-list
102275341|NCT00002868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102640572|NCT01029054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102640573|NCT01029054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640574|NCT01029054|Protease Inhibitors|protease inhibitors|mesh-ancestor
102640575|NCT01029054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102640576|NCT01029054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640577|NCT01029054|Immunologic Factors|immunologic factors|mesh-ancestor
102640578|NCT01029054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102640579|NCT01029054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102640580|NCT01029054|Growth Substances|growth substances|mesh-ancestor
102640581|NCT01029054|Growth Inhibitors|growth inhibitors|mesh-ancestor
102640582|NCT01032954|Botulinum Toxins|botulinum toxins|mesh-list
102640583|NCT01032954|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102640584|NCT01032954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102640585|NCT01032954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640586|NCT01032954|Cholinergic Agents|cholinergic agents|mesh-ancestor
102640587|NCT01032954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102640588|NCT01032954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640589|NCT05592678|Donepezil|donepezil|mesh-list
102640590|NCT05592678|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102640591|NCT05592678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102640592|NCT05592678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640593|NCT05592678|Cholinergic Agents|cholinergic agents|mesh-ancestor
102640594|NCT05592678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102640595|NCT05592678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640596|NCT05592678|Nootropic Agents|nootropic agents|mesh-ancestor
102640597|NCT05402826|Vitamin E|vitamin e|mesh-list
102640598|NCT05402826|Vitamins|vitamins|mesh-ancestor
102640599|NCT05402826|Micronutrients|micronutrients|mesh-ancestor
102640600|NCT05402826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640601|NCT05402826|Antioxidants|antioxidants|mesh-ancestor
102640602|NCT05402826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640603|NCT05402826|Protective Agents|protective agents|mesh-ancestor
102640604|NCT05385042|Vitamin B 12|vitamin b 12|mesh-list
102640605|NCT05385042|Thiamine|thiamine|mesh-list
102640606|NCT05385042|Vitamins|vitamins|mesh-ancestor
102640607|NCT05385042|Micronutrients|micronutrients|mesh-ancestor
102640608|NCT05385042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640609|NCT05385042|Vitamin B Complex|vitamin b complex|mesh-ancestor
102640610|NCT05306028|Metformin|metformin|mesh-list
102640611|NCT05306028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102640612|NCT05306028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640613|NCT05179668|Dapagliflozin|dapagliflozin|mesh-list
102640614|NCT05179668|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102640615|NCT05179668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640616|NCT05179668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102640617|NCT05179668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640618|NCT04780932|Macitentan|macitentan|mesh-list
102640619|NCT04780932|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
102640620|NCT04780932|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102640621|NCT04780932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640622|NCT04780932|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
102640623|NCT04316910|Anesthetics|anesthetics|mesh-list
102640624|NCT04316910|Anesthetics, General|anesthetics, general|mesh-list
102640625|NCT04316910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102640626|NCT04316910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640627|NCT04308330|Vorinostat|vorinostat|mesh-list
102640628|NCT04308330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640629|NCT04308330|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102640630|NCT04308330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102640631|NCT04308330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640632|NCT03680508|Dostarlimab|dostarlimab|mesh-list
102640633|NCT03680508|Antibodies|antibodies|mesh-list
102640634|NCT03680508|Immunoglobulins|immunoglobulins|mesh-list
102640635|NCT03680508|Immunologic Factors|immunologic factors|mesh-ancestor
102640636|NCT03680508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640637|NCT03680508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640638|NCT01842672|Mitoxantrone|mitoxantrone|mesh-list
102640639|NCT01842672|Clofarabine|clofarabine|mesh-list
102640640|NCT01842672|Analgesics|analgesics|mesh-ancestor
102640641|NCT01842672|Sensory System Agents|sensory system agents|mesh-ancestor
102640642|NCT01842672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102640643|NCT01842672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640644|NCT01842672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640645|NCT01842672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102640646|NCT01842672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102640647|NCT01842672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102640648|NCT01842672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640649|NCT01842672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102640650|NCT01842672|Antimetabolites|antimetabolites|mesh-ancestor
102640651|NCT01034592|Lenalidomide|lenalidomide|mesh-list
102640652|NCT01034592|Immunologic Factors|immunologic factors|mesh-ancestor
102640653|NCT01034592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640654|NCT01034592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102640655|NCT01034592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102640656|NCT01034592|Growth Substances|growth substances|mesh-ancestor
102640657|NCT01034592|Growth Inhibitors|growth inhibitors|mesh-ancestor
102640658|NCT01034592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640659|NCT01037790|Palbociclib|palbociclib|mesh-list
102640660|NCT01037790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640661|NCT01037790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102640662|NCT01037790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102640663|NCT01037790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640664|NCT01043094|Pitavastatin|pitavastatin|mesh-list
102640665|NCT01043094|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102640666|NCT01043094|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102640667|NCT01043094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102640668|NCT01043094|Antimetabolites|antimetabolites|mesh-ancestor
102640669|NCT01043094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640670|NCT01043094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102640671|NCT01043094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102640672|NCT01043640|Cyclosporine|cyclosporine|mesh-list
102640673|NCT01043640|Mycophenolic Acid|mycophenolic acid|mesh-list
102640674|NCT01043640|Cyclophosphamide|cyclophosphamide|mesh-list
102640676|NCT01043640|Alemtuzumab|alemtuzumab|mesh-list
102640677|NCT01043640|Cyclosporins|cyclosporins|mesh-list
102640678|NCT01043640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102640679|NCT01043640|Immunologic Factors|immunologic factors|mesh-ancestor
102640680|NCT01043640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640681|NCT01043640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102640682|NCT01043640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102640683|NCT01043640|Alkylating Agents|alkylating agents|mesh-ancestor
102640684|NCT01043640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640685|NCT01043640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640686|NCT01043640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102640687|NCT01043640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102640688|NCT01043640|Antifungal Agents|antifungal agents|mesh-ancestor
102640689|NCT01043640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102640690|NCT01043640|Dermatologic Agents|dermatologic agents|mesh-ancestor
102640691|NCT01043640|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102640692|NCT01043640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102640693|NCT01043640|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102640694|NCT01043640|Antitubercular Agents|antitubercular agents|mesh-ancestor
102640695|NCT01043640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102640696|NCT01043640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102640697|NCT01044966|Temozolomide|temozolomide|mesh-list
102640698|NCT01044966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102640699|NCT01044966|Alkylating Agents|alkylating agents|mesh-ancestor
102640700|NCT01044966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640701|NCT01044966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640702|NCT01045122|Dexmedetomidine|dexmedetomidine|mesh-list
102640703|NCT01045122|Propofol|propofol|mesh-list
102640704|NCT01045122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102640705|NCT01045122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102640706|NCT01045122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640707|NCT01045122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102640708|NCT01045122|Analgesics|analgesics|mesh-ancestor
102640709|NCT01045122|Sensory System Agents|sensory system agents|mesh-ancestor
102640710|NCT01045122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102640711|NCT01045122|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102640712|NCT01045122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102640713|NCT01045122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102640714|NCT01045122|Adrenergic Agents|adrenergic agents|mesh-ancestor
102640715|NCT01045122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102640716|NCT01045122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640717|NCT01045122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102275342|NCT00002868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101929260|NCT03768258|Androgens|androgens|mesh-ancestor
101929334|NCT01399918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640718|NCT01045122|Anesthetics, General|anesthetics, general|mesh-ancestor
102640719|NCT01045122|Anesthetics|anesthetics|mesh-ancestor
102640720|NCT01050582|Risperidone|risperidone|mesh-list
102640721|NCT01050582|Antipsychotic Agents|antipsychotic agents|mesh-list
102640722|NCT01050582|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102640723|NCT01050582|Serotonin Agents|serotonin agents|mesh-ancestor
102640724|NCT01050582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102640725|NCT01050582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640726|NCT01050582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640727|NCT01050582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102640728|NCT01050582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102640729|NCT01050582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102640730|NCT01050582|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102640731|NCT01050582|Dopamine Agents|dopamine agents|mesh-ancestor
102640732|NCT01050660|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102640733|NCT01050660|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
102640734|NCT01050660|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102640735|NCT01050660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102640736|NCT01051440|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102640737|NCT01051440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102640738|NCT01051440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640739|NCT01051440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102640740|NCT01051440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102640741|NCT01051440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102640742|NCT01051440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640743|NCT01051440|Dopamine Agents|dopamine agents|mesh-ancestor
102640744|NCT01051440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102640745|NCT01051596|Temozolomide|temozolomide|mesh-list
102640746|NCT01051596|Veliparib|veliparib|mesh-list
102640747|NCT01051596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102640748|NCT01051596|Alkylating Agents|alkylating agents|mesh-ancestor
102640749|NCT01051596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640750|NCT01051596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640751|NCT01051596|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102640752|NCT01051596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102640753|NCT01053000|Tazarotene|tazarotene|mesh-list
102640754|NCT01053000|Dermatologic Agents|dermatologic agents|mesh-ancestor
102640755|NCT01053000|Keratolytic Agents|keratolytic agents|mesh-ancestor
102640756|NCT05822453|Gemcitabine|gemcitabine|mesh-list
102640757|NCT05822453|Tislelizumab|tislelizumab|mesh-list
102640758|NCT05822453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102640759|NCT05822453|Antimetabolites|antimetabolites|mesh-ancestor
101613344|NCT02848443|Growth Substances|growth substances|mesh-ancestor
102640760|NCT05822453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640761|NCT05822453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640762|NCT05822453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102640763|NCT01028820|Aripiprazole|aripiprazole|mesh-list
102640764|NCT01028820|Antidepressive Agents|antidepressive agents|mesh-ancestor
102640765|NCT01028820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102640766|NCT01028820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102640767|NCT01028820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102640768|NCT01028820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102640769|NCT01028820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640770|NCT01028820|Dopamine Agonists|dopamine agonists|mesh-ancestor
102640771|NCT01028820|Dopamine Agents|dopamine agents|mesh-ancestor
102640772|NCT01028820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102640773|NCT01028820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640774|NCT01028820|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102640775|NCT01028820|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102640776|NCT01028820|Serotonin Agents|serotonin agents|mesh-ancestor
102640777|NCT01028820|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102640778|NCT01028820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102640779|NCT01028820|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102640780|NCT01028820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102640781|NCT05822362|Cannabidiol|cannabidiol|mesh-list
102640782|NCT05822362|Anticonvulsants|anticonvulsants|mesh-ancestor
102640783|NCT05822323|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102640784|NCT05822323|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102640785|NCT05822323|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102640786|NCT05822323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102640787|NCT05822323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640788|NCT05822323|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102640789|NCT05822323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102275343|NCT00002868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640790|NCT05822323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640792|NCT05822323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102640793|NCT05821933|Aflutinib|aflutinib|mesh-list
102640794|NCT05821933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102640795|NCT05821933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102640796|NCT05821933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640797|NCT05821751|Pembrolizumab|pembrolizumab|mesh-list
102640798|NCT05821751|Nivolumab|nivolumab|mesh-list
102640799|NCT05821751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102640800|NCT05821751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640801|NCT05821751|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102640802|NCT05821751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640803|NCT05821712|Listerine|listerine|mesh-list
102640804|NCT05821712|Fluorides|fluorides|mesh-list
102640805|NCT05821712|Sodium Fluoride|sodium fluoride|mesh-list
102640806|NCT05821712|Cariostatic Agents|cariostatic agents|mesh-ancestor
102640807|NCT05821712|Protective Agents|protective agents|mesh-ancestor
102640808|NCT05821712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640809|NCT05821712|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102640810|NCT05821712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102640811|NCT05821686|Aldesleukin|aldesleukin|mesh-list
102640812|NCT05821686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640813|NCT05821686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102640814|NCT05821686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102640815|NCT05821686|Antiviral Agents|antiviral agents|mesh-ancestor
102640816|NCT05821686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102640817|NCT05821517|Methoxyflurane|methoxyflurane|mesh-list
102640818|NCT05821517|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102640819|NCT05821517|Anesthetics, General|anesthetics, general|mesh-ancestor
102640820|NCT05821517|Anesthetics|anesthetics|mesh-ancestor
102640821|NCT05821517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102640822|NCT05821517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640823|NCT05821478|Metronidazole|metronidazole|mesh-list
102640824|NCT05821478|Rifampin|rifampin|mesh-list
102640825|NCT05821478|Ceftriaxone|ceftriaxone|mesh-list
102640826|NCT05821478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102640827|NCT05821478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102640828|NCT05821478|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102640829|NCT05821478|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102640830|NCT05821478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102640831|NCT05821478|Antitubercular Agents|antitubercular agents|mesh-ancestor
102640832|NCT05821478|Leprostatic Agents|leprostatic agents|mesh-ancestor
102640833|NCT05821478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102640834|NCT05821478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102640835|NCT05821478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640836|NCT05821478|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102640837|NCT05821478|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102640838|NCT05821478|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102640839|NCT05821478|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102640840|NCT05821478|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102640841|NCT05821478|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102640842|NCT05821452|Paclitaxel|paclitaxel|mesh-list
102640843|NCT05821452|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102640844|NCT05821452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102640845|NCT05821452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640846|NCT05821452|Tubulin Modulators|tubulin modulators|mesh-ancestor
102640847|NCT05821452|Antimitotic Agents|antimitotic agents|mesh-ancestor
102640848|NCT05821452|Mitosis Modulators|mitosis modulators|mesh-ancestor
102640849|NCT05821452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640850|NCT05821361|Bevacizumab|bevacizumab|mesh-list
102640851|NCT05821361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102640852|NCT05821361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640853|NCT05821361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102640854|NCT05821361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102640855|NCT05821361|Growth Substances|growth substances|mesh-ancestor
102640856|NCT05821361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640857|NCT05821361|Growth Inhibitors|growth inhibitors|mesh-ancestor
102640858|NCT05821192|Dexamethasone|dexamethasone|mesh-list
102640859|NCT05821192|Rituximab|rituximab|mesh-list
102640860|NCT05821192|Gemcitabine|gemcitabine|mesh-list
102640861|NCT05821192|Antibodies|antibodies|mesh-list
102640862|NCT05821192|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102640863|NCT05821192|Immunologic Factors|immunologic factors|mesh-ancestor
102640864|NCT05821192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640865|NCT05821192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102640866|NCT05821192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640867|NCT05821192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102640868|NCT05821192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102640869|NCT05821192|Antiemetics|antiemetics|mesh-ancestor
102640870|NCT05821192|Autonomic Agents|autonomic agents|mesh-ancestor
102640871|NCT05821192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102640872|NCT05821192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102640873|NCT05821192|Glucocorticoids|glucocorticoids|mesh-ancestor
102640874|NCT05821192|Hormones|hormones|mesh-ancestor
102640875|NCT05821192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102640876|NCT05821192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102640877|NCT05821192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102640878|NCT05821192|Antimetabolites|antimetabolites|mesh-ancestor
102640879|NCT05821192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640880|NCT05821153|Aldesleukin|aldesleukin|mesh-list
102640881|NCT05821153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640882|NCT05821153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102640883|NCT05821153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102640884|NCT05821153|Antiviral Agents|antiviral agents|mesh-ancestor
102640885|NCT05821153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102640886|NCT05821062|Aspirin|aspirin|mesh-list
102640887|NCT05821062|Clopidogrel|clopidogrel|mesh-list
102640888|NCT05821062|Ticagrelor|ticagrelor|mesh-list
102640889|NCT05821062|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102640890|NCT05821062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102640891|NCT05821062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102640892|NCT05821062|Analgesics|analgesics|mesh-ancestor
102640893|NCT05821062|Sensory System Agents|sensory system agents|mesh-ancestor
102640894|NCT05821062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102640895|NCT05821062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640896|NCT05821062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102640897|NCT05821062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102640898|NCT05821062|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102640899|NCT05821062|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102640900|NCT05821062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640901|NCT05821062|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102640902|NCT05821062|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102640903|NCT05821062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102640904|NCT05821062|Antipyretics|antipyretics|mesh-ancestor
102640905|NCT05821062|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102640906|NCT05821062|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102640907|NCT05821062|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102640908|NCT05821062|Purinergic Agents|purinergic agents|mesh-ancestor
102640909|NCT05821062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102640910|NCT05818553|Pramoxine|pramoxine|mesh-list
102640911|NCT05818553|Anesthetics, Local|anesthetics, local|mesh-ancestor
102640912|NCT05818553|Anesthetics|anesthetics|mesh-ancestor
102640913|NCT05818553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102640914|NCT05818553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640915|NCT05818553|Sensory System Agents|sensory system agents|mesh-ancestor
102640916|NCT05818553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102640917|NCT05817162|Ropivacaine|ropivacaine|mesh-list
102640918|NCT05817162|Anesthetics, Local|anesthetics, local|mesh-ancestor
102640919|NCT05817162|Anesthetics|anesthetics|mesh-ancestor
102640920|NCT05817162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102640921|NCT05817162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640922|NCT05817162|Sensory System Agents|sensory system agents|mesh-ancestor
102640923|NCT05817162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102640924|NCT05809180|Rituximab|rituximab|mesh-list
102640925|NCT05809180|Pomalidomide|pomalidomide|mesh-list
102640926|NCT05809180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102640927|NCT05809180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640928|NCT05809180|Immunologic Factors|immunologic factors|mesh-ancestor
102640929|NCT05809180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640930|NCT05809180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102640931|NCT05809180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102640932|NCT05809180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102640933|NCT05809180|Growth Substances|growth substances|mesh-ancestor
102640934|NCT05809180|Growth Inhibitors|growth inhibitors|mesh-ancestor
102275345|NCT00002868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101929483|NCT03769818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102640935|NCT05802238|Tranexamic Acid|tranexamic acid|mesh-list
102275346|NCT00002868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102640937|NCT05802238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102640938|NCT05802238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640939|NCT05802238|Hemostatics|hemostatics|mesh-ancestor
102640940|NCT05802238|Coagulants|coagulants|mesh-ancestor
102640941|NCT05796570|Decitabine|decitabine|mesh-list
102640942|NCT05796570|Lenograstim|lenograstim|mesh-list
102640943|NCT05796570|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102640944|NCT05796570|Immunologic Factors|immunologic factors|mesh-ancestor
102640945|NCT05796570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640946|NCT05796570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102640947|NCT05796570|Antimetabolites|antimetabolites|mesh-ancestor
102640948|NCT05796570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640949|NCT05796570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640950|NCT05796570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101613570|NCT02842125|Pembrolizumab|pembrolizumab|mesh-list
102640951|NCT05791617|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
102640952|NCT05791617|Natriuretic Agents|natriuretic agents|mesh-ancestor
102640953|NCT05791617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640954|NCT05738057|Cisplatin|cisplatin|mesh-list
102640955|NCT05738057|Gemcitabine|gemcitabine|mesh-list
102640956|NCT05738057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102640957|NCT05738057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102640958|NCT05738057|Antimetabolites|antimetabolites|mesh-ancestor
102640959|NCT05738057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640960|NCT05699408|Insulin Glargine|insulin glargine|mesh-list
102640961|NCT05699408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102640962|NCT05699408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640963|NCT05668286|Triamcinolone|triamcinolone|mesh-list
102640964|NCT05668286|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102640965|NCT05668286|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102640966|NCT05668286|Prilocaine|prilocaine|mesh-list
102640967|NCT05668286|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102640968|NCT05668286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102640969|NCT05668286|Glucocorticoids|glucocorticoids|mesh-ancestor
102640970|NCT05668286|Hormones|hormones|mesh-ancestor
102640971|NCT05668286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102640972|NCT05668286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640973|NCT05668286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102640974|NCT05668286|Immunologic Factors|immunologic factors|mesh-ancestor
102640975|NCT05668286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102640976|NCT05668286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102640977|NCT05668286|Anesthetics, Local|anesthetics, local|mesh-ancestor
102640978|NCT05668286|Anesthetics|anesthetics|mesh-ancestor
102640979|NCT05668286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102640980|NCT05668286|Sensory System Agents|sensory system agents|mesh-ancestor
102640981|NCT05668286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102640982|NCT05664958|Bupivacaine|bupivacaine|mesh-list
102640983|NCT05664958|Anesthetics, Local|anesthetics, local|mesh-ancestor
102640984|NCT05664958|Anesthetics|anesthetics|mesh-ancestor
102640985|NCT05664958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102640986|NCT05664958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640987|NCT05664958|Sensory System Agents|sensory system agents|mesh-ancestor
102640988|NCT05664958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102640989|NCT05581823|Carbamazepine|carbamazepine|mesh-list
102640990|NCT05581823|Anticonvulsants|anticonvulsants|mesh-ancestor
102640991|NCT05581823|Antimanic Agents|antimanic agents|mesh-ancestor
102640992|NCT05581823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102640993|NCT05581823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102640994|NCT05581823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102640995|NCT05581823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102640996|NCT05581823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102640997|NCT05581823|Analgesics|analgesics|mesh-ancestor
102640998|NCT05581823|Sensory System Agents|sensory system agents|mesh-ancestor
102640999|NCT05581823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102641000|NCT05581823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102641001|NCT05581823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102641002|NCT05581823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641003|NCT05581823|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102641004|NCT05581823|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102641005|NCT05500599|Fentanyl|fentanyl|mesh-list
102641006|NCT05500599|Midazolam|midazolam|mesh-list
102641007|NCT05500599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102641008|NCT05500599|Narcotics|narcotics|mesh-ancestor
102275347|NCT00002868|Antimetabolites|antimetabolites|mesh-ancestor
102641009|NCT05500599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102641010|NCT05500599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641011|NCT05500599|Analgesics|analgesics|mesh-ancestor
102641012|NCT05500599|Sensory System Agents|sensory system agents|mesh-ancestor
102641013|NCT05500599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102641014|NCT05500599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102641015|NCT05500599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102641016|NCT05500599|Anesthetics, General|anesthetics, general|mesh-ancestor
102641017|NCT05500599|Anesthetics|anesthetics|mesh-ancestor
102641018|NCT05500599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102641019|NCT05500599|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102641020|NCT05500599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102641021|NCT05500599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102641022|NCT05500599|GABA Modulators|gaba modulators|mesh-ancestor
102641023|NCT05500599|GABA Agents|gaba agents|mesh-ancestor
102641024|NCT05500599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102641025|NCT05500599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641026|NCT05498116|Montelukast|montelukast|mesh-list
102641027|NCT05498116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102641028|NCT05498116|Respiratory System Agents|respiratory system agents|mesh-ancestor
102641029|NCT05498116|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102641030|NCT05498116|Hormone Antagonists|hormone antagonists|mesh-ancestor
102641031|NCT05498116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102641032|NCT05498116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641033|NCT05498116|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102641034|NCT05498116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102641035|NCT05498116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641036|NCT05471076|Complement C4b|complement c4b|mesh-list
102641037|NCT05471076|Immunologic Factors|immunologic factors|mesh-ancestor
102641038|NCT05471076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641039|NCT05469178|Carboplatin|carboplatin|mesh-list
102641040|NCT05469178|Pembrolizumab|pembrolizumab|mesh-list
102641041|NCT05469178|Pemetrexed|pemetrexed|mesh-list
102641042|NCT05469178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102641043|NCT05469178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102641044|NCT05469178|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102641045|NCT05469178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641046|NCT05469178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102641047|NCT05469178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102641048|NCT05469178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102641049|NCT05450484|Durvalumab|durvalumab|mesh-list
102641050|NCT05450484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102641051|NCT05450484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102641052|NCT05398484|Niacin|niacin|mesh-list
102641053|NCT05398484|Psilocybin|psilocybin|mesh-list
102641054|NCT05398484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102641055|NCT05398484|Antimetabolites|antimetabolites|mesh-ancestor
102641056|NCT05398484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641057|NCT05398484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102641058|NCT05398484|Vasodilator Agents|vasodilator agents|mesh-ancestor
102641059|NCT05398484|Vitamin B Complex|vitamin b complex|mesh-ancestor
102641060|NCT05398484|Vitamins|vitamins|mesh-ancestor
102641061|NCT05398484|Micronutrients|micronutrients|mesh-ancestor
102641062|NCT05398484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641063|NCT05398484|Hallucinogens|hallucinogens|mesh-ancestor
102641064|NCT05398484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102641065|NCT05351502|Nitric Oxide|nitric oxide|mesh-list
102641066|NCT05351502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102641067|NCT05351502|Autonomic Agents|autonomic agents|mesh-ancestor
102641068|NCT05351502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102641069|NCT05351502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641070|NCT05351502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102641071|NCT05351502|Respiratory System Agents|respiratory system agents|mesh-ancestor
102641072|NCT05351502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102641073|NCT05351502|Antioxidants|antioxidants|mesh-ancestor
102641074|NCT05351502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641075|NCT05351502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102641076|NCT05351502|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102641077|NCT05351502|Vasodilator Agents|vasodilator agents|mesh-ancestor
102641078|NCT05351502|Gasotransmitters|gasotransmitters|mesh-ancestor
102641079|NCT05351502|Protective Agents|protective agents|mesh-ancestor
102641080|NCT05327296|Propofol|propofol|mesh-list
102641081|NCT05327296|Isoflurane|isoflurane|mesh-list
102275348|NCT00002868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102641082|NCT05327296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102275349|NCT00002868|Immunologic Factors|immunologic factors|mesh-ancestor
102641083|NCT05327296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102641084|NCT05327296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641086|NCT05327296|Anesthetics, General|anesthetics, general|mesh-ancestor
102641087|NCT05327296|Anesthetics|anesthetics|mesh-ancestor
102641088|NCT05327296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102641089|NCT05317000|Nivolumab|nivolumab|mesh-list
102641090|NCT05317000|Azacitidine|azacitidine|mesh-list
102641091|NCT05317000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102641092|NCT05317000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102641093|NCT05317000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102641094|NCT05317000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641095|NCT05317000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102641096|NCT05317000|Antimetabolites|antimetabolites|mesh-ancestor
102641097|NCT05317000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102641098|NCT05292755|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102641099|NCT05292755|Lubricant Eye Drops|lubricant eye drops|mesh-list
102641100|NCT05292755|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102641101|NCT05292755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102641102|NCT05292755|Laxatives|laxatives|mesh-ancestor
102641103|NCT05292755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102641104|NCT05283395|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102641105|NCT05283395|Latanoprost|latanoprost|mesh-list
102641106|NCT05283395|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102641107|NCT05275205|Aflibercept|aflibercept|mesh-list
102641108|NCT05275205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102641109|NCT05275205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102641110|NCT05275205|Growth Substances|growth substances|mesh-ancestor
102641111|NCT05275205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641112|NCT05275205|Growth Inhibitors|growth inhibitors|mesh-ancestor
102641113|NCT05275205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102641114|NCT05270863|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102641115|NCT05270863|Carbachol|carbachol|mesh-list
102641116|NCT05270863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102641117|NCT05270863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102641118|NCT05270863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102641119|NCT05270863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102641120|NCT05270863|Adrenergic Agents|adrenergic agents|mesh-ancestor
102641121|NCT05270863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102641122|NCT05270863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641123|NCT05270863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641124|NCT05270863|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102641125|NCT05270863|Miotics|miotics|mesh-ancestor
102641126|NCT05270863|Autonomic Agents|autonomic agents|mesh-ancestor
102641127|NCT05270863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102641128|NCT05270863|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102641129|NCT05270863|Cholinergic Agents|cholinergic agents|mesh-ancestor
102641130|NCT05270863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102641131|NCT05270863|Analgesics|analgesics|mesh-ancestor
102641132|NCT05270863|Sensory System Agents|sensory system agents|mesh-ancestor
102641133|NCT05270863|Protective Agents|protective agents|mesh-ancestor
102641134|NCT05237141|Etonogestrel|etonogestrel|mesh-list
102641135|NCT05237141|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102641136|NCT05237141|Contraceptive Agents|contraceptive agents|mesh-ancestor
102641137|NCT05237141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102641138|NCT05237141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641139|NCT05237141|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102641140|NCT05232409|Pembrolizumab|pembrolizumab|mesh-list
102641141|NCT05232409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102641142|NCT05232409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102641143|NCT05232409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102641144|NCT05232409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641145|NCT05137262|Cisplatin|cisplatin|mesh-list
102641146|NCT05137262|Doxorubicin|doxorubicin|mesh-list
102641147|NCT05137262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102641148|NCT05137262|Methotrexate|methotrexate|mesh-list
102641149|NCT05137262|Durvalumab|durvalumab|mesh-list
102641150|NCT05137262|Abiraterone Acetate|abiraterone acetate|mesh-list
102641151|NCT05137262|Vinblastine|vinblastine|mesh-list
102641152|NCT05137262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102641153|NCT05137262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102641154|NCT05137262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102275350|NCT00002868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275351|NCT00002868|Alkylating Agents|alkylating agents|mesh-ancestor
102641155|NCT05137262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102641156|NCT05137262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102275352|NCT00002868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102275353|NCT00002868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102641157|NCT05137262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641158|NCT05137262|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102641159|NCT05137262|Abortifacient Agents|abortifacient agents|mesh-ancestor
102641160|NCT05137262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102641161|NCT05137262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641162|NCT05137262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102641163|NCT05137262|Antimetabolites|antimetabolites|mesh-ancestor
102641164|NCT05137262|Dermatologic Agents|dermatologic agents|mesh-ancestor
102641165|NCT05137262|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102641166|NCT05137262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102641167|NCT05137262|Immunologic Factors|immunologic factors|mesh-ancestor
102641168|NCT05137262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102641169|NCT05137262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102641170|NCT05137262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102641171|NCT05137262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102641172|NCT05137262|Hormone Antagonists|hormone antagonists|mesh-ancestor
102641173|NCT05137262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102641174|NCT05137262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102641175|NCT05137262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102641176|NCT05137262|Tubulin Modulators|tubulin modulators|mesh-ancestor
102641177|NCT05137262|Antimitotic Agents|antimitotic agents|mesh-ancestor
102641178|NCT05137262|Mitosis Modulators|mitosis modulators|mesh-ancestor
102641179|NCT05124691|Ivermectin|ivermectin|mesh-list
102641180|NCT05124691|Albendazole|albendazole|mesh-list
102641181|NCT05124691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102641182|NCT05124691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102641183|NCT05124691|Anthelmintics|anthelmintics|mesh-ancestor
102641184|NCT05124691|Anticestodal Agents|anticestodal agents|mesh-ancestor
102641185|NCT05124691|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102641186|NCT05124691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102641187|NCT05124691|Tubulin Modulators|tubulin modulators|mesh-ancestor
102641188|NCT05124691|Antimitotic Agents|antimitotic agents|mesh-ancestor
102641189|NCT05124691|Mitosis Modulators|mitosis modulators|mesh-ancestor
102641190|NCT05124691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641191|NCT05124691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102641192|NCT05114837|Cyclophosphamide|cyclophosphamide|mesh-list
102641193|NCT05114837|Fludarabine|fludarabine|mesh-list
102641194|NCT05114837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102641195|NCT05114837|Immunologic Factors|immunologic factors|mesh-ancestor
102641196|NCT05114837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641197|NCT05114837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102641198|NCT05114837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102641199|NCT05114837|Alkylating Agents|alkylating agents|mesh-ancestor
102641200|NCT05114837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641201|NCT05114837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102641202|NCT05114837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102641203|NCT05014087|Digoxin|digoxin|mesh-list
102641204|NCT05014087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102641205|NCT05014087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102641206|NCT05014087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102641207|NCT05014087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641208|NCT05014087|Protective Agents|protective agents|mesh-ancestor
102641209|NCT05014087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641210|NCT04955678|Sorbitol|sorbitol|mesh-list
102641211|NCT04955678|Calcium|calcium|mesh-list
102641212|NCT04955678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102641213|NCT04955678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641214|NCT04955678|Cathartics|cathartics|mesh-ancestor
102641215|NCT04955678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102641216|NCT05175547|Clevidipine|clevidipine|mesh-list
102641217|NCT05175547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102641218|NCT05175547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102641219|NCT05175547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641220|NCT05175547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102641221|NCT05175547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641222|NCT04924166|Hydrocortisone|hydrocortisone|mesh-list
102641223|NCT04924166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102641224|NCT04908371|Lidocaine|lidocaine|mesh-list
102641225|NCT04908371|Epinephrine|epinephrine|mesh-list
102641226|NCT04908371|Racepinephrine|racepinephrine|mesh-list
102641227|NCT04908371|Levobupivacaine|levobupivacaine|mesh-list
102641228|NCT04908371|Epinephryl borate|epinephryl borate|mesh-list
102641229|NCT04908371|Anesthetics, Local|anesthetics, local|mesh-ancestor
102641230|NCT04908371|Anesthetics|anesthetics|mesh-ancestor
102641231|NCT04908371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102641232|NCT04908371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641233|NCT04908371|Sensory System Agents|sensory system agents|mesh-ancestor
102641234|NCT04908371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102641235|NCT04908371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102641236|NCT04908371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102641237|NCT04908371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102641238|NCT04908371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102641239|NCT04908371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641240|NCT04908371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102641241|NCT04908371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102641242|NCT04908371|Adrenergic Agents|adrenergic agents|mesh-ancestor
102641243|NCT04908371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102641244|NCT04908371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102641245|NCT04908371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102641246|NCT04908371|Autonomic Agents|autonomic agents|mesh-ancestor
102641247|NCT04908371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102641248|NCT04908371|Respiratory System Agents|respiratory system agents|mesh-ancestor
102641249|NCT04908371|Mydriatics|mydriatics|mesh-ancestor
102641250|NCT04908371|Sympathomimetics|sympathomimetics|mesh-ancestor
102641251|NCT04908371|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102641252|NCT04870645|Chelating Agents|chelating agents|mesh-list
102641253|NCT04870645|Sequestering Agents|sequestering agents|mesh-ancestor
102641254|NCT04870645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641255|NCT04838379|Dexamethasone|dexamethasone|mesh-list
102641256|NCT04838379|Dexmedetomidine|dexmedetomidine|mesh-list
102641257|NCT04838379|Bupivacaine|bupivacaine|mesh-list
102641258|NCT04838379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102641259|NCT04838379|Antiemetics|antiemetics|mesh-ancestor
102641260|NCT04838379|Autonomic Agents|autonomic agents|mesh-ancestor
102641261|NCT04838379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102641262|NCT04838379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641263|NCT04838379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102641264|NCT04838379|Glucocorticoids|glucocorticoids|mesh-ancestor
102641265|NCT04838379|Hormones|hormones|mesh-ancestor
102641266|NCT04838379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102641267|NCT04838379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102641268|NCT04838379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102641269|NCT04838379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641270|NCT04838379|Anesthetics, Local|anesthetics, local|mesh-ancestor
102641271|NCT04838379|Anesthetics|anesthetics|mesh-ancestor
102641272|NCT04838379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102641273|NCT04838379|Sensory System Agents|sensory system agents|mesh-ancestor
102641274|NCT04838379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102641275|NCT04838379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102641276|NCT04838379|Analgesics|analgesics|mesh-ancestor
102641277|NCT04838379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102641278|NCT04838379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102641279|NCT04838379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102641280|NCT04838379|Adrenergic Agents|adrenergic agents|mesh-ancestor
102641281|NCT04838379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102641282|NCT04830878|Methotrexate|methotrexate|mesh-list
102641283|NCT04830878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102641284|NCT04830878|Abortifacient Agents|abortifacient agents|mesh-ancestor
102641285|NCT04830878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102641286|NCT04830878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641287|NCT04830878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102641288|NCT04830878|Antimetabolites|antimetabolites|mesh-ancestor
102641289|NCT04830878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641290|NCT04830878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102641291|NCT04830878|Dermatologic Agents|dermatologic agents|mesh-ancestor
102641292|NCT04830878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102641293|NCT04830878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102641294|NCT04830878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102641295|NCT04830878|Immunologic Factors|immunologic factors|mesh-ancestor
102641296|NCT04830878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102641297|NCT04830878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102641298|NCT04812366|Prednisone|prednisone|mesh-list
102641299|NCT04812366|Docetaxel|docetaxel|mesh-list
102641300|NCT04812366|Atezolizumab|atezolizumab|mesh-list
102641301|NCT04812366|Abiraterone Acetate|abiraterone acetate|mesh-list
102641302|NCT04812366|Niraparib|niraparib|mesh-list
102275354|NCT00002868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102641303|NCT04812366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102641304|NCT04812366|Tubulin Modulators|tubulin modulators|mesh-ancestor
102641305|NCT04812366|Antimitotic Agents|antimitotic agents|mesh-ancestor
102641306|NCT04812366|Mitosis Modulators|mitosis modulators|mesh-ancestor
102641307|NCT04812366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641308|NCT04812366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102641309|NCT04812366|Glucocorticoids|glucocorticoids|mesh-ancestor
102641310|NCT04812366|Hormones|hormones|mesh-ancestor
102641311|NCT04812366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102641312|NCT04812366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641313|NCT04812366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102641314|NCT04812366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102641315|NCT04812366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102641316|NCT04812366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102641317|NCT04812366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102641318|NCT04812366|Hormone Antagonists|hormone antagonists|mesh-ancestor
102641319|NCT04812366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102641320|NCT04812366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102641321|NCT04800107|Curcumin|curcumin|mesh-list
102641322|NCT04800107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102641323|NCT04800107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102641324|NCT04800107|Analgesics|analgesics|mesh-ancestor
102641325|NCT04800107|Sensory System Agents|sensory system agents|mesh-ancestor
102641326|NCT04800107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102641327|NCT04800107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641328|NCT04800107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102641329|NCT04800107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102641330|NCT04800107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102641331|NCT04800107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102641332|NCT04800107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641333|NCT04786574|Tolvaptan|tolvaptan|mesh-list
102641334|NCT04786574|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102641335|NCT04786574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641336|NCT04786574|Natriuretic Agents|natriuretic agents|mesh-ancestor
102641337|NCT04786574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641338|NCT04783857|Progesterone|progesterone|mesh-list
102641339|NCT04783857|Progestins|progestins|mesh-ancestor
102641340|NCT04783857|Hormones|hormones|mesh-ancestor
102641341|NCT04783857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102641342|NCT04783857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641343|NCT04761159|Ketamine|ketamine|mesh-list
102641344|NCT04761159|Analgesics|analgesics|mesh-ancestor
102641345|NCT04761159|Sensory System Agents|sensory system agents|mesh-ancestor
102641346|NCT04761159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102641347|NCT04761159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641348|NCT04761159|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102641349|NCT04761159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102641350|NCT04761159|Anesthetics, General|anesthetics, general|mesh-ancestor
102641351|NCT04761159|Anesthetics|anesthetics|mesh-ancestor
102641352|NCT04761159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102641353|NCT04761159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102641354|NCT04761159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102641355|NCT04761159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102641356|NCT04761159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641357|NCT04716296|Ketamine|ketamine|mesh-list
102641358|NCT04716296|Analgesics|analgesics|mesh-ancestor
102641359|NCT04716296|Sensory System Agents|sensory system agents|mesh-ancestor
102641360|NCT04716296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102641361|NCT04716296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641362|NCT04716296|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102641363|NCT04716296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102641364|NCT04716296|Anesthetics, General|anesthetics, general|mesh-ancestor
102641365|NCT04716296|Anesthetics|anesthetics|mesh-ancestor
102641366|NCT04716296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102641367|NCT04716296|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102641368|NCT04716296|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102641369|NCT04716296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102641370|NCT04716296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641371|NCT04704141|Hormones|hormones|mesh-list
102275355|NCT00002868|Antisickling Agents|antisickling agents|mesh-ancestor
102275356|NCT00002868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102275357|NCT00002650|Folic Acid|folic acid|mesh-list
102641372|NCT04704141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102641373|NCT04704141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641374|NCT04682041|Immunoglobulins|immunoglobulins|mesh-list
102641375|NCT04682041|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102641376|NCT04682041|Antibodies|antibodies|mesh-list
102641377|NCT04682041|Immunologic Factors|immunologic factors|mesh-ancestor
102641378|NCT04682041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641379|NCT04675931|Artesunate|artesunate|mesh-list
102641380|NCT04675931|Lumefantrine|lumefantrine|mesh-list
102641381|NCT04675931|Artemether|artemether|mesh-list
102641382|NCT04675931|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102641383|NCT04675931|Antimalarials|antimalarials|mesh-ancestor
102641384|NCT04675931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102641385|NCT04675931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102641386|NCT04675931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102641387|NCT04675931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102641388|NCT04675931|Antiviral Agents|antiviral agents|mesh-ancestor
102641389|NCT04675931|Schistosomicides|schistosomicides|mesh-ancestor
102641390|NCT04675931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102641391|NCT04675931|Anthelmintics|anthelmintics|mesh-ancestor
102641392|NCT04669678|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102641393|NCT04669678|Medroxyprogesterone|medroxyprogesterone|mesh-list
102641394|NCT04669678|Etonogestrel|etonogestrel|mesh-list
102641395|NCT04669678|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102641396|NCT04669678|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102641397|NCT04669678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102641398|NCT04669678|Contraceptive Agents|contraceptive agents|mesh-ancestor
102641399|NCT04669678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102641400|NCT04669678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641401|NCT04669678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102641402|NCT04669678|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102641403|NCT04669678|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102641404|NCT04669678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102641405|NCT04669678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102641406|NCT04652661|Midazolam|midazolam|mesh-list
102641407|NCT04652661|Dexmedetomidine|dexmedetomidine|mesh-list
102641408|NCT04652661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102641409|NCT04652661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102641410|NCT04652661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641411|NCT04652661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102641412|NCT04652661|Analgesics|analgesics|mesh-ancestor
102641413|NCT04652661|Sensory System Agents|sensory system agents|mesh-ancestor
102641414|NCT04652661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102641415|NCT04652661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102641416|NCT04652661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102641417|NCT04652661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102641418|NCT04652661|Adrenergic Agents|adrenergic agents|mesh-ancestor
102641419|NCT04652661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102641420|NCT04652661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641421|NCT04652661|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102641422|NCT04652661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102641423|NCT04652661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102641424|NCT04652661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102641425|NCT04652661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102641426|NCT04652661|Anesthetics, General|anesthetics, general|mesh-ancestor
102641427|NCT04652661|Anesthetics|anesthetics|mesh-ancestor
102641428|NCT04652661|GABA Modulators|gaba modulators|mesh-ancestor
102641429|NCT04652661|GABA Agents|gaba agents|mesh-ancestor
102641430|NCT04623931|Temozolomide|temozolomide|mesh-list
102641431|NCT04623931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102641432|NCT04623931|Alkylating Agents|alkylating agents|mesh-ancestor
102641433|NCT04623931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641434|NCT04623931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102641435|NCT04590781|Pembrolizumab|pembrolizumab|mesh-list
102641436|NCT04590781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102641437|NCT04590781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102641438|NCT04590781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102641439|NCT04590781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641440|NCT04573751|Verapamil|verapamil|mesh-list
102641441|NCT04573751|Epinephrine|epinephrine|mesh-list
102641442|NCT04573751|Racepinephrine|racepinephrine|mesh-list
102641443|NCT04573751|Epinephryl borate|epinephryl borate|mesh-list
102641444|NCT04573751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102641445|NCT04573751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102641446|NCT04573751|Adrenergic Agents|adrenergic agents|mesh-ancestor
102275358|NCT00002650|Hematinics|hematinics|mesh-ancestor
101930077|NCT03755700|Antiviral Agents|antiviral agents|mesh-ancestor
102641447|NCT04573751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102641448|NCT04573751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641449|NCT04573751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641450|NCT04573751|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102641451|NCT04573751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102641452|NCT04573751|Autonomic Agents|autonomic agents|mesh-ancestor
102641453|NCT04573751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102641454|NCT04573751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102641455|NCT04573751|Respiratory System Agents|respiratory system agents|mesh-ancestor
102641456|NCT04573751|Mydriatics|mydriatics|mesh-ancestor
102641457|NCT04573751|Sympathomimetics|sympathomimetics|mesh-ancestor
102641458|NCT04573751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102641459|NCT04573751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102641460|NCT04573751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102641461|NCT04573751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101614073|NCT00684112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102641462|NCT04573751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102641463|NCT04573751|Vasodilator Agents|vasodilator agents|mesh-ancestor
102641464|NCT04522622|Teriparatide|teriparatide|mesh-list
102641465|NCT04522622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102641466|NCT04522622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641467|NCT04522622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102641468|NCT04483102|Liver Extracts|liver extracts|mesh-list
102641469|NCT04483102|Hematinics|hematinics|mesh-ancestor
102641470|NCT04474483|Melatonin|melatonin|mesh-list
102641471|NCT04474483|Antioxidants|antioxidants|mesh-ancestor
102641472|NCT04474483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641473|NCT04474483|Protective Agents|protective agents|mesh-ancestor
102641474|NCT04474483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641475|NCT04474483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102641476|NCT04432207|Atezolizumab|atezolizumab|mesh-list
102641477|NCT04432207|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102641478|NCT04432207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641479|NCT04432207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102641480|NCT04432207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102641481|NCT04425447|Anesthetics|anesthetics|mesh-list
102641482|NCT04425447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102641483|NCT04425447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641484|NCT04345718|Buprenorphine|buprenorphine|mesh-list
102641485|NCT04345718|Analgesics, Opioid|analgesics, opioid|mesh-list
102641486|NCT04345718|Narcotics|narcotics|mesh-ancestor
102641487|NCT04345718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102641488|NCT04345718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641489|NCT04345718|Analgesics|analgesics|mesh-ancestor
102641490|NCT04345718|Sensory System Agents|sensory system agents|mesh-ancestor
102641491|NCT04345718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102641492|NCT04345718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102641493|NCT04332068|Ivermectin|ivermectin|mesh-list
102641494|NCT04332068|Permethrin|permethrin|mesh-list
102641495|NCT04332068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102641496|NCT04332068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102641497|NCT04332068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102641498|NCT04332068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641499|NCT04298541|Edotreotide|edotreotide|mesh-list
102641500|NCT04298541|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102641501|NCT04298541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641502|NCT04249037|Tenofovir|tenofovir|mesh-list
102641503|NCT04249037|Emtricitabine|emtricitabine|mesh-list
102641504|NCT04249037|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
102641505|NCT04249037|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102641506|NCT04249037|Antiviral Agents|antiviral agents|mesh-ancestor
102641507|NCT04249037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102641508|NCT04249037|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102641509|NCT04249037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102641510|NCT04249037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102641511|NCT04249037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641512|NCT04249037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102641513|NCT04190550|Cytarabine|cytarabine|mesh-list
102641514|NCT04190550|Idarubicin|idarubicin|mesh-list
102641515|NCT04190550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102641516|NCT04190550|Antimetabolites|antimetabolites|mesh-ancestor
102641517|NCT04190550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641518|NCT04190550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102641519|NCT04190550|Antiviral Agents|antiviral agents|mesh-ancestor
102641520|NCT04190550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102275359|NCT00002650|Vitamin B Complex|vitamin b complex|mesh-ancestor
102641521|NCT04190550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102641522|NCT04190550|Immunologic Factors|immunologic factors|mesh-ancestor
102641523|NCT04190550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641524|NCT04190550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102641525|NCT04190550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102641526|NCT04190550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102641527|NCT04190550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102641528|NCT04158739|Cytarabine|cytarabine|mesh-list
102641529|NCT04158739|Antibodies|antibodies|mesh-list
102641530|NCT04158739|Immunoglobulins|immunoglobulins|mesh-list
102641531|NCT04158739|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102641532|NCT04158739|Immunologic Factors|immunologic factors|mesh-ancestor
102641533|NCT04158739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641534|NCT04158739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102641535|NCT04158739|Antimetabolites|antimetabolites|mesh-ancestor
102641536|NCT04158739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641537|NCT04158739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102641538|NCT04158739|Antiviral Agents|antiviral agents|mesh-ancestor
102641539|NCT04158739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102641540|NCT04158739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102641541|NCT04148105|Cilostazol|cilostazol|mesh-list
102641542|NCT04148105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102641543|NCT04148105|Autonomic Agents|autonomic agents|mesh-ancestor
102641544|NCT04148105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102641545|NCT04148105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641546|NCT04148105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102641547|NCT04148105|Respiratory System Agents|respiratory system agents|mesh-ancestor
102641548|NCT04148105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102641549|NCT04148105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102641550|NCT04148105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641551|NCT04148105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102641552|NCT04148105|Vasodilator Agents|vasodilator agents|mesh-ancestor
102641553|NCT04148105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102641554|NCT04148105|Protective Agents|protective agents|mesh-ancestor
102641555|NCT04148105|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102641556|NCT04148105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102641557|NCT04148105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102641558|NCT04067518|Pegaspargase|pegaspargase|mesh-list
102641559|NCT04067518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102641560|NCT04033419|Memantine|memantine|mesh-list
102641561|NCT04033419|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102641562|NCT04033419|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102641563|NCT04033419|Dopamine Agents|dopamine agents|mesh-ancestor
102641564|NCT04033419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102641565|NCT04033419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641566|NCT04033419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641567|NCT04033419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102641568|NCT04033419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102641569|NCT04014283|Selenium|selenium|mesh-list
102641570|NCT04014283|Antioxidants|antioxidants|mesh-ancestor
102641571|NCT04014283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641572|NCT04014283|Protective Agents|protective agents|mesh-ancestor
102641573|NCT04014283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641574|NCT04014283|Trace Elements|trace elements|mesh-ancestor
102641575|NCT04014283|Micronutrients|micronutrients|mesh-ancestor
102641576|NCT04000529|Spartalizumab|spartalizumab|mesh-list
102641577|NCT04000529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101265303|NCT01772836|Biapenem|biapenem|mesh-list
102641578|NCT04000529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641579|NCT04000529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102641580|NCT04000529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102641581|NCT04257578|Acalabrutinib|acalabrutinib|mesh-list
102641582|NCT04257578|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
102641583|NCT04257578|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102641584|NCT04257578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102641585|NCT04257578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102641586|NCT04257578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102641587|NCT04257578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641588|NCT04257578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102641589|NCT03970746|Pembrolizumab|pembrolizumab|mesh-list
102641590|NCT03970746|Pemetrexed|pemetrexed|mesh-list
102641591|NCT03970746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102641592|NCT03970746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102275360|NCT00002650|Vitamins|vitamins|mesh-ancestor
102275361|NCT00002650|Micronutrients|micronutrients|mesh-ancestor
101930224|NCT04176016|Chelating Agents|chelating agents|mesh-ancestor
102641593|NCT03970746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102641594|NCT03970746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641595|NCT03970746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102641596|NCT03970746|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102641597|NCT03970746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102641599|NCT03912233|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102641600|NCT03912233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102641601|NCT03912233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641602|NCT03842865|Immunomodulating Agents|immunomodulating agents|mesh-list
102641603|NCT03842865|Immunologic Factors|immunologic factors|mesh-ancestor
102641604|NCT03842865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641605|NCT03834519|Prednisone|prednisone|mesh-list
102641606|NCT03834519|Prednisolone|prednisolone|mesh-list
102641607|NCT03834519|Pembrolizumab|pembrolizumab|mesh-list
102641608|NCT03834519|Olaparib|olaparib|mesh-list
102641609|NCT03834519|Abiraterone Acetate|abiraterone acetate|mesh-list
102641610|NCT03834519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102641611|NCT03834519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102641612|NCT03834519|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102641613|NCT03834519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641614|NCT03834519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102641615|NCT03834519|Glucocorticoids|glucocorticoids|mesh-ancestor
102641616|NCT03834519|Hormones|hormones|mesh-ancestor
102641617|NCT03834519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102641618|NCT03834519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641619|NCT03834519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102641620|NCT03834519|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102641621|NCT03834519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102641622|NCT03834519|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102641623|NCT03834519|Hormone Antagonists|hormone antagonists|mesh-ancestor
102641624|NCT03834519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102641625|NCT03781817|Ketamine|ketamine|mesh-list
102641626|NCT03781817|Analgesics|analgesics|mesh-ancestor
102641627|NCT03781817|Sensory System Agents|sensory system agents|mesh-ancestor
102641628|NCT03781817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102641629|NCT03781817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641630|NCT03781817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102641631|NCT03781817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102641632|NCT03781817|Anesthetics, General|anesthetics, general|mesh-ancestor
102641633|NCT03781817|Anesthetics|anesthetics|mesh-ancestor
102641634|NCT03781817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102641635|NCT03781817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102641636|NCT03781817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102641637|NCT03781817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102641638|NCT03781817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641639|NCT03732352|Deoxyglucose|deoxyglucose|mesh-list
102641640|NCT03732352|Osimertinib|osimertinib|mesh-list
102641641|NCT03732352|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102641642|NCT03732352|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102641643|NCT03732352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641644|NCT03732352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102641645|NCT03732352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102641646|NCT03732352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102641647|NCT03732352|Antimetabolites|antimetabolites|mesh-ancestor
102641648|NCT03732352|Antiviral Agents|antiviral agents|mesh-ancestor
102641649|NCT03732352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102641650|NCT03636451|Lidocaine|lidocaine|mesh-list
102641651|NCT03636451|Vasopressins|vasopressins|mesh-list
102641652|NCT03636451|Arginine Vasopressin|arginine vasopressin|mesh-list
102641653|NCT03636451|Anesthetics, Local|anesthetics, local|mesh-ancestor
102641654|NCT03636451|Anesthetics|anesthetics|mesh-ancestor
102641655|NCT03636451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102641656|NCT03636451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641657|NCT03636451|Sensory System Agents|sensory system agents|mesh-ancestor
102641658|NCT03636451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102641659|NCT03636451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102641660|NCT03636451|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102641661|NCT03636451|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102641662|NCT03636451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102641663|NCT03636451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641664|NCT03636451|Hemostatics|hemostatics|mesh-ancestor
102641665|NCT03636451|Coagulants|coagulants|mesh-ancestor
102641666|NCT03636451|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102641667|NCT03636451|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102641668|NCT03636451|Natriuretic Agents|natriuretic agents|mesh-ancestor
102641669|NCT03576989|Mineral Oil|mineral oil|mesh-list
102641670|NCT03576989|Emollients|emollients|mesh-ancestor
102641671|NCT03576989|Dermatologic Agents|dermatologic agents|mesh-ancestor
102641672|NCT03539952|Penicillamine|penicillamine|mesh-list
102641673|NCT03539952|Trientine|trientine|mesh-list
102641674|NCT03539952|Chelating Agents|chelating agents|mesh-ancestor
102641675|NCT03539952|Sequestering Agents|sequestering agents|mesh-ancestor
102641676|NCT03539952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641677|NCT03539952|Antidotes|antidotes|mesh-ancestor
102641678|NCT03539952|Protective Agents|protective agents|mesh-ancestor
102641679|NCT03539952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641680|NCT03539952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102641681|NCT03504163|Pembrolizumab|pembrolizumab|mesh-list
102641682|NCT03504163|BCG Vaccine|bcg vaccine|mesh-list
102641683|NCT03504163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102641684|NCT03504163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102641685|NCT03504163|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102641686|NCT03504163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641687|NCT03504163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102641688|NCT03504163|Immunologic Factors|immunologic factors|mesh-ancestor
102641689|NCT03504163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641690|NCT03454035|Palbociclib|palbociclib|mesh-list
102641691|NCT03454035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102641692|NCT03454035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102641693|NCT03454035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102641694|NCT03454035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641695|NCT03295227|Pembrolizumab|pembrolizumab|mesh-list
102641696|NCT03295227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102641697|NCT03295227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102641698|NCT03295227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102641699|NCT03295227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641700|NCT03278691|Ketorolac|ketorolac|mesh-list
102641701|NCT03278691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102641702|NCT03278691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102641703|NCT03278691|Analgesics|analgesics|mesh-ancestor
102641704|NCT03278691|Sensory System Agents|sensory system agents|mesh-ancestor
102641705|NCT03278691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102641706|NCT03278691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641707|NCT03278691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102641708|NCT03278691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102641709|NCT03278691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102641710|NCT03278691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102641711|NCT03278691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641712|NCT03105336|Cyclophosphamide|cyclophosphamide|mesh-list
102641713|NCT03105336|Fludarabine|fludarabine|mesh-list
102641714|NCT03105336|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
102641715|NCT03105336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102641716|NCT03105336|Immunologic Factors|immunologic factors|mesh-ancestor
102641717|NCT03105336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641718|NCT03105336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102641719|NCT03105336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102641720|NCT03105336|Alkylating Agents|alkylating agents|mesh-ancestor
102641721|NCT03105336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641722|NCT03105336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102641723|NCT03105336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102641724|NCT03105336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102641725|NCT03093909|Gemcitabine|gemcitabine|mesh-list
102641726|NCT03093909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102641727|NCT03093909|Antimetabolites|antimetabolites|mesh-ancestor
102641728|NCT03093909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641729|NCT03093909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102641730|NCT02621489|Metformin|metformin|mesh-list
102641731|NCT02621489|Insulin Aspart|insulin aspart|mesh-list
102641732|NCT02621489|Exenatide|exenatide|mesh-list
102641733|NCT02621489|Biguanides|biguanides|mesh-list
102641734|NCT02621489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102641735|NCT02621489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641736|NCT02621489|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102641737|NCT02621489|Incretins|incretins|mesh-ancestor
102275362|NCT00002650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275363|NCT03078725|Metformin|metformin|mesh-list
102641738|NCT02621489|Hormones|hormones|mesh-ancestor
102275364|NCT03078725|Glyburide|glyburide|mesh-list
102641739|NCT02621489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102641740|NCT02596880|Ribavirin|ribavirin|mesh-list
102641741|NCT02596880|Sofosbuvir|sofosbuvir|mesh-list
102641742|NCT02596880|Antimetabolites|antimetabolites|mesh-ancestor
102641743|NCT02596880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641744|NCT02596880|Antiviral Agents|antiviral agents|mesh-ancestor
102641745|NCT02596880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102641746|NCT02527434|Durvalumab|durvalumab|mesh-list
102641747|NCT02527434|Tremelimumab|tremelimumab|mesh-list
102641748|NCT02527434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102641749|NCT02527434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102641750|NCT02527434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102641751|NCT02527434|Immunologic Factors|immunologic factors|mesh-ancestor
102641752|NCT02527434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641753|NCT02474368|Cisplatin|cisplatin|mesh-list
102641754|NCT02474368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102641755|NCT01995344|Cyclophosphamide|cyclophosphamide|mesh-list
102641756|NCT01995344|Fludarabine|fludarabine|mesh-list
102641757|NCT01995344|Interleukin-2|interleukin-2|mesh-list
102641758|NCT01995344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102641759|NCT01995344|Immunologic Factors|immunologic factors|mesh-ancestor
102641760|NCT01995344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641761|NCT01995344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102641762|NCT01995344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102641763|NCT01995344|Alkylating Agents|alkylating agents|mesh-ancestor
102641764|NCT01995344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641765|NCT01995344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102641766|NCT01995344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102641767|NCT01995344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102641768|NCT01995344|Analgesics|analgesics|mesh-ancestor
102641769|NCT01995344|Sensory System Agents|sensory system agents|mesh-ancestor
102641770|NCT01995344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102641771|NCT01845688|Losartan|losartan|mesh-list
102641772|NCT01845688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102641773|NCT01845688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102641774|NCT01845688|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102641775|NCT01845688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102641776|NCT01845688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641777|NCT01591291|Ondansetron|ondansetron|mesh-list
102641778|NCT01591291|Antiemetics|antiemetics|mesh-ancestor
102641779|NCT01591291|Autonomic Agents|autonomic agents|mesh-ancestor
102641780|NCT01591291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102641781|NCT01591291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641782|NCT01591291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102641783|NCT01591291|Antipruritics|antipruritics|mesh-ancestor
102641784|NCT01591291|Dermatologic Agents|dermatologic agents|mesh-ancestor
102641785|NCT01591291|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102641786|NCT01591291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102641787|NCT01591291|Serotonin Agents|serotonin agents|mesh-ancestor
102641788|NCT01591291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102641789|NCT01591291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641790|NCT01093300|Paclitaxel|paclitaxel|mesh-list
102641791|NCT01093300|Everolimus|everolimus|mesh-list
102641792|NCT01093300|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102641793|NCT01093300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102641794|NCT01093300|Tubulin Modulators|tubulin modulators|mesh-ancestor
102641795|NCT01093300|Antimitotic Agents|antimitotic agents|mesh-ancestor
102641796|NCT01093300|Mitosis Modulators|mitosis modulators|mesh-ancestor
102641797|NCT01093300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641798|NCT01093300|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102641799|NCT01093300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102641800|NCT01093300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102641801|NCT01093300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102641802|NCT01093300|Immunologic Factors|immunologic factors|mesh-ancestor
102641803|NCT01093300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641804|NCT01053078|Naltrexone|naltrexone|mesh-list
102641805|NCT01053078|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102641806|NCT01053078|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102641807|NCT01053078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641808|NCT01053078|Sensory System Agents|sensory system agents|mesh-ancestor
102641809|NCT01053078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102641810|NCT01053156|Minocycline|minocycline|mesh-list
102641811|NCT01053156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102641812|NCT01053156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102641813|NCT01053312|Flutemetamol|flutemetamol|mesh-list
102275365|NCT03078725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102275366|NCT03078725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641814|NCT01053312|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102641815|NCT01053312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641816|NCT01054404|Furosemide|furosemide|mesh-list
102641817|NCT01054404|Diuretics|diuretics|mesh-ancestor
102641818|NCT01054404|Natriuretic Agents|natriuretic agents|mesh-ancestor
102641819|NCT01054404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641820|NCT01054404|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102641821|NCT01054404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102641822|NCT01054404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641823|NCT01055184|Vaccines|vaccines|mesh-list
102641824|NCT01055184|Immunologic Factors|immunologic factors|mesh-ancestor
102641825|NCT01055184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641826|NCT01060020|Sildenafil Citrate|sildenafil citrate|mesh-list
102641827|NCT01060020|Vasodilator Agents|vasodilator agents|mesh-ancestor
102641828|NCT01060020|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102641829|NCT01060020|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102641830|NCT01060020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102641831|NCT01060020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641832|NCT01060020|Urological Agents|urological agents|mesh-ancestor
102641833|NCT01060098|Adalimumab|adalimumab|mesh-list
102641834|NCT01060098|Etanercept|etanercept|mesh-list
102641835|NCT01060098|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102641836|NCT01060098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102641837|NCT01060098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102641838|NCT01060098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101614468|NCT05382390|Cytarabine|cytarabine|mesh-list
102641839|NCT01060098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102641840|NCT01060098|Analgesics|analgesics|mesh-ancestor
102641841|NCT01060098|Sensory System Agents|sensory system agents|mesh-ancestor
102641842|NCT01060098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102641843|NCT01060098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641844|NCT01060098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102641845|NCT01060098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102641846|NCT01060098|Immunologic Factors|immunologic factors|mesh-ancestor
102641847|NCT01061034|Aspirin|aspirin|mesh-list
102641848|NCT01061034|Omeprazole|omeprazole|mesh-list
102641849|NCT01061034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102641850|NCT01061034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102641851|NCT01061034|Analgesics|analgesics|mesh-ancestor
102641852|NCT01061034|Sensory System Agents|sensory system agents|mesh-ancestor
102641853|NCT01061034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102641854|NCT01061034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641855|NCT01061034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102641856|NCT01061034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102641857|NCT01061034|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102641858|NCT01061034|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102641859|NCT01061034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641860|NCT01061034|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102641861|NCT01061034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102641862|NCT01061034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102641863|NCT01061034|Antipyretics|antipyretics|mesh-ancestor
102641864|NCT01061034|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102641865|NCT01061034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102641866|NCT01061034|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102641867|NCT01065558|Ecopipam|ecopipam|mesh-list
102641868|NCT01065558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102641869|NCT01065558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102641870|NCT01065558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102641871|NCT01065558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641872|NCT01065558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102641873|NCT01065558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102641874|NCT01065558|Dopamine Agents|dopamine agents|mesh-ancestor
102641875|NCT01065558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102641876|NCT01065558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641877|NCT01066026|Hyaluronic Acid|hyaluronic acid|mesh-list
102641878|NCT01066026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102641879|NCT01066026|Immunologic Factors|immunologic factors|mesh-ancestor
102641880|NCT01066026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641881|NCT01066026|Viscosupplements|viscosupplements|mesh-ancestor
102641882|NCT01066026|Protective Agents|protective agents|mesh-ancestor
102641883|NCT01072188|Calcium Carbonate|calcium carbonate|mesh-list
102641884|NCT01072188|Calcium|calcium|mesh-list
102641885|NCT01072188|Fluorides|fluorides|mesh-list
102641886|NCT01072188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102641887|NCT01072188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641888|NCT01072188|Cariostatic Agents|cariostatic agents|mesh-ancestor
102641889|NCT01072188|Protective Agents|protective agents|mesh-ancestor
102641890|NCT01072188|Antacids|antacids|mesh-ancestor
102641891|NCT01072188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641892|NCT01072188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102641893|NCT01083732|Dabigatran|dabigatran|mesh-list
102641894|NCT01083732|Antithrombins|antithrombins|mesh-ancestor
102641895|NCT01083732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102641896|NCT01083732|Protease Inhibitors|protease inhibitors|mesh-ancestor
102641897|NCT01083732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102641898|NCT01083732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614538|NCT00673270|Hydrocortisone|hydrocortisone|mesh-list
102641899|NCT01083732|Anticoagulants|anticoagulants|mesh-ancestor
102641900|NCT01084278|Colchicine|colchicine|mesh-list
102641901|NCT01084278|Gout Suppressants|gout suppressants|mesh-ancestor
102641902|NCT01084278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102641903|NCT01084278|Tubulin Modulators|tubulin modulators|mesh-ancestor
102641904|NCT01084278|Antimitotic Agents|antimitotic agents|mesh-ancestor
102641905|NCT01084278|Mitosis Modulators|mitosis modulators|mesh-ancestor
102641906|NCT01084278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641907|NCT01084278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102641908|NCT01085760|Metronidazole|metronidazole|mesh-list
102641909|NCT01085760|Vancomycin|vancomycin|mesh-list
102641910|NCT01085760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102641911|NCT01085760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102641912|NCT01085760|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102641913|NCT01085760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102641914|NCT01090752|Metformin|metformin|mesh-list
102641915|NCT01090752|Pioglitazone|pioglitazone|mesh-list
102641916|NCT01090752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102641917|NCT01090752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641918|NCT01093794|Metformin|metformin|mesh-list
102641919|NCT01093794|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102641920|NCT01093794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102641921|NCT01093794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641922|NCT01093794|Incretins|incretins|mesh-ancestor
102641923|NCT01093794|Hormones|hormones|mesh-ancestor
102641924|NCT01093794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102641925|NCT01093794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102641926|NCT01093794|Protease Inhibitors|protease inhibitors|mesh-ancestor
102641927|NCT01093794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102641928|NCT01093794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641929|NCT01094106|Ropivacaine|ropivacaine|mesh-list
102641930|NCT01094106|Anesthetics, Local|anesthetics, local|mesh-ancestor
102641931|NCT01094106|Anesthetics|anesthetics|mesh-ancestor
102641932|NCT01094106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102641933|NCT01094106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641934|NCT01094106|Sensory System Agents|sensory system agents|mesh-ancestor
102641935|NCT01094106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102641936|NCT01094574|Propranolol|propranolol|mesh-list
102641937|NCT01094574|Alfentanil|alfentanil|mesh-list
102641938|NCT01094574|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102641939|NCT01094574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102641940|NCT01094574|Adrenergic Agents|adrenergic agents|mesh-ancestor
102641941|NCT01094574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102641942|NCT01094574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641943|NCT01094574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641944|NCT01094574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102641945|NCT01094574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102641946|NCT01094574|Vasodilator Agents|vasodilator agents|mesh-ancestor
102641947|NCT01094574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102641948|NCT01094574|Narcotics|narcotics|mesh-ancestor
102641949|NCT01094574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102641950|NCT01094574|Analgesics|analgesics|mesh-ancestor
102641951|NCT01094574|Sensory System Agents|sensory system agents|mesh-ancestor
102641952|NCT01094574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102641953|NCT01094574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102641954|NCT01094574|Anesthetics, General|anesthetics, general|mesh-ancestor
102641955|NCT01094574|Anesthetics|anesthetics|mesh-ancestor
102641956|NCT01095510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
102641957|NCT01095510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102641958|NCT01095510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102641959|NCT01095510|Immunologic Factors|immunologic factors|mesh-ancestor
102275367|NCT02341963|Ketamine|ketamine|mesh-list
102641960|NCT01095510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930519|NCT04136444|Padsevonil|padsevonil|mesh-list
102641961|NCT01096290|Lubiprostone|lubiprostone|mesh-list
102275368|NCT02341963|Analgesics|analgesics|mesh-ancestor
102641962|NCT01096290|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102641963|NCT01096290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102641964|NCT01096290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641965|NCT01096680|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102641966|NCT01096680|Modafinil|modafinil|mesh-list
102641967|NCT01096680|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102641968|NCT01096680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641969|NCT01096680|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102641970|NCT01096680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102641971|NCT01096680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102641972|NCT01096680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641973|NCT01096680|Dopamine Agents|dopamine agents|mesh-ancestor
102641974|NCT01096680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102641975|NCT01096680|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102641976|NCT01096680|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102641977|NCT01096680|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102641978|NCT01096992|Rituximab|rituximab|mesh-list
102641979|NCT01096992|Fludarabine|fludarabine|mesh-list
102641980|NCT01096992|Fludarabine phosphate|fludarabine phosphate|mesh-list
102641981|NCT01096992|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102641982|NCT01096992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102641983|NCT01096992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102641984|NCT01096992|Immunologic Factors|immunologic factors|mesh-ancestor
102641985|NCT01096992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102641986|NCT01096992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102641987|NCT01096992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102641988|NCT01096992|Antimetabolites|antimetabolites|mesh-ancestor
102641989|NCT01096992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102641990|NCT01096992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102641991|NCT01096992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102641992|NCT01096992|Alkylating Agents|alkylating agents|mesh-ancestor
102641993|NCT01097304|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102641994|NCT01097304|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102641995|NCT01097304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102641996|NCT01097460|Trastuzumab|trastuzumab|mesh-list
102641997|NCT01097460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102641998|NCT01097460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102641999|NCT01098318|Sertraline|sertraline|mesh-list
102642000|NCT01098318|Antidepressive Agents|antidepressive agents|mesh-ancestor
102642001|NCT01098318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102642002|NCT01098318|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102642003|NCT01098318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102642004|NCT01098318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102642005|NCT01098318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642006|NCT01098318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102642007|NCT01098318|Serotonin Agents|serotonin agents|mesh-ancestor
102642008|NCT01098318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642009|NCT01100112|Budesonide|budesonide|mesh-list
102642010|NCT01100112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102642011|NCT01100112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102642012|NCT01100112|Autonomic Agents|autonomic agents|mesh-ancestor
102642013|NCT01100112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102642014|NCT01100112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642015|NCT01100112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102642016|NCT01100112|Respiratory System Agents|respiratory system agents|mesh-ancestor
102642017|NCT01100112|Glucocorticoids|glucocorticoids|mesh-ancestor
102642018|NCT01100112|Hormones|hormones|mesh-ancestor
102642019|NCT01100112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102642020|NCT01100268|Methylphenidate|methylphenidate|mesh-list
102642021|NCT01100268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102642022|NCT01100268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642023|NCT01100268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102642024|NCT01100268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102642025|NCT01100268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102642026|NCT01100268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642027|NCT01100268|Dopamine Agents|dopamine agents|mesh-ancestor
102642028|NCT01100268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102642029|NCT01101750|Vaccines|vaccines|mesh-list
102642030|NCT01101750|Immunologic Factors|immunologic factors|mesh-ancestor
102642031|NCT01101750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275369|NCT02341963|Sensory System Agents|sensory system agents|mesh-ancestor
102642033|NCT01102218|Epoetin Alfa|epoetin alfa|mesh-list
102642034|NCT01102218|Hematinics|hematinics|mesh-ancestor
102642035|NCT01102218|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102642036|NCT01102218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102642037|NCT01102218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642038|NCT01102218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102642039|NCT01102218|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102642040|NCT01102218|Protective Agents|protective agents|mesh-ancestor
102642041|NCT01102218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642042|NCT01102218|Vasodilator Agents|vasodilator agents|mesh-ancestor
102642043|NCT01102218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102642044|NCT01102218|Antioxidants|antioxidants|mesh-ancestor
102642045|NCT01103934|Vitamin D|vitamin d|mesh-list
102642046|NCT01103934|Cholecalciferol|cholecalciferol|mesh-list
102642047|NCT01103934|Fluticasone|fluticasone|mesh-list
102642048|NCT01103934|Xhance|xhance|mesh-list
102642049|NCT01103934|Vitamins|vitamins|mesh-ancestor
102642050|NCT01103934|Micronutrients|micronutrients|mesh-ancestor
102642051|NCT01103934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642052|NCT01103934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102642053|NCT01103934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102642054|NCT01103934|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102642055|NCT01103934|Autonomic Agents|autonomic agents|mesh-ancestor
102642056|NCT01103934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102642057|NCT01103934|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102642058|NCT01103934|Respiratory System Agents|respiratory system agents|mesh-ancestor
102642059|NCT01103934|Dermatologic Agents|dermatologic agents|mesh-ancestor
102642060|NCT01103934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102642061|NCT01103934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102642062|NCT01105650|Cyclosporine|cyclosporine|mesh-list
102642063|NCT01105650|Methylprednisolone|methylprednisolone|mesh-list
102642064|NCT01105650|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102642065|NCT01105650|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102642066|NCT01105650|Prednisolone|prednisolone|mesh-list
102642067|NCT01105650|Prednisolone acetate|prednisolone acetate|mesh-list
102642068|NCT01105650|Cyclophosphamide|cyclophosphamide|mesh-list
102642069|NCT01105650|Fludarabine|fludarabine|mesh-list
102642070|NCT01105650|Interleukin-2|interleukin-2|mesh-list
102642071|NCT01105650|Cyclosporins|cyclosporins|mesh-list
102642072|NCT01105650|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102642073|NCT01105650|Prednisolone phosphate|prednisolone phosphate|mesh-list
102642074|NCT01105650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102642075|NCT01105650|Immunologic Factors|immunologic factors|mesh-ancestor
102642076|NCT01105650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642077|NCT01105650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102642078|NCT01105650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102642079|NCT01105650|Alkylating Agents|alkylating agents|mesh-ancestor
102642080|NCT01105650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642081|NCT01105650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102642082|NCT01105650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102642083|NCT01105650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102642084|NCT01105650|Antifungal Agents|antifungal agents|mesh-ancestor
102642085|NCT01105650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102642086|NCT01105650|Dermatologic Agents|dermatologic agents|mesh-ancestor
102642087|NCT01105650|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102642088|NCT01105650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102642089|NCT01105650|Antiemetics|antiemetics|mesh-ancestor
102642090|NCT01105650|Autonomic Agents|autonomic agents|mesh-ancestor
102642091|NCT01105650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102642092|NCT01105650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102642093|NCT01105650|Glucocorticoids|glucocorticoids|mesh-ancestor
102642094|NCT01105650|Hormones|hormones|mesh-ancestor
102642095|NCT01105650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102642096|NCT01105650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102642097|NCT01105650|Protective Agents|protective agents|mesh-ancestor
102642098|NCT01105650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102642099|NCT01105650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102642100|NCT01105650|Analgesics|analgesics|mesh-ancestor
102642101|NCT01105650|Sensory System Agents|sensory system agents|mesh-ancestor
102642102|NCT01110876|Temozolomide|temozolomide|mesh-list
102642103|NCT01110876|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102642104|NCT01110876|Vorinostat|vorinostat|mesh-list
102642105|NCT01110876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102642106|NCT01110876|Alkylating Agents|alkylating agents|mesh-ancestor
102642107|NCT01110876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642108|NCT01110876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102275370|NCT02341963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102642109|NCT01110876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102642110|NCT01110876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102642111|NCT01110876|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102642112|NCT01112358|Cetrorelix|cetrorelix|mesh-list
102642113|NCT01112358|Progesterone|progesterone|mesh-list
102642114|NCT01112358|Progestins|progestins|mesh-ancestor
102642115|NCT01112358|Hormones|hormones|mesh-ancestor
102642116|NCT01112358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102642117|NCT01112358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642118|NCT01112358|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102642119|NCT01112358|Fertility Agents|fertility agents|mesh-ancestor
102642120|NCT01112358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102642121|NCT01112358|Hormone Antagonists|hormone antagonists|mesh-ancestor
102642122|NCT01112670|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102642123|NCT01112670|Atorvastatin|atorvastatin|mesh-list
102642124|NCT01112670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102642125|NCT01112670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102642126|NCT01112670|Antimetabolites|antimetabolites|mesh-ancestor
102642127|NCT01112670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642128|NCT01112670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102642129|NCT01112670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102642130|NCT01112670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102642131|NCT01112670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102642132|NCT01112670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642133|NCT01112670|Incretins|incretins|mesh-ancestor
102642134|NCT01112670|Hormones|hormones|mesh-ancestor
102642135|NCT01112670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102642136|NCT01112670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102642137|NCT01112670|Protease Inhibitors|protease inhibitors|mesh-ancestor
102642138|NCT01115556|Ranibizumab|ranibizumab|mesh-list
102642139|NCT01115556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102642140|NCT01115556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102642141|NCT01115556|Growth Substances|growth substances|mesh-ancestor
102642142|NCT01115556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642143|NCT01115556|Growth Inhibitors|growth inhibitors|mesh-ancestor
102642144|NCT01115556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102642145|NCT01116102|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102642146|NCT01119222|Diphenhydramine|diphenhydramine|mesh-list
102642147|NCT01119222|Promethazine|promethazine|mesh-list
102642148|NCT01119222|Morphine|morphine|mesh-list
102642149|NCT01119222|Gabapentin|gabapentin|mesh-list
102642150|NCT01119222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102642151|NCT01119222|Narcotics|narcotics|mesh-ancestor
102642152|NCT01119222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102642153|NCT01119222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642154|NCT01119222|Analgesics|analgesics|mesh-ancestor
102642155|NCT01119222|Sensory System Agents|sensory system agents|mesh-ancestor
102642156|NCT01119222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102642157|NCT01119222|Anticonvulsants|anticonvulsants|mesh-ancestor
102642158|NCT01119222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102642159|NCT01119222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102642160|NCT01119222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102642161|NCT01119222|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102642162|NCT01119222|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102642163|NCT01119222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102642164|NCT01119222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642165|NCT01119222|Antimanic Agents|antimanic agents|mesh-ancestor
102642166|NCT01119222|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102642167|NCT01119222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102642168|NCT01119222|Anesthetics, Local|anesthetics, local|mesh-ancestor
102642169|NCT01119222|Anesthetics|anesthetics|mesh-ancestor
102642170|NCT01119222|Antiemetics|antiemetics|mesh-ancestor
102642171|NCT01119222|Autonomic Agents|autonomic agents|mesh-ancestor
102642172|NCT01119222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102642173|NCT01119222|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102642174|NCT01119222|Histamine Antagonists|histamine antagonists|mesh-ancestor
102642175|NCT01119222|Histamine Agents|histamine agents|mesh-ancestor
102642176|NCT01119222|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102642177|NCT01119222|Antipruritics|antipruritics|mesh-ancestor
102642178|NCT01119222|Dermatologic Agents|dermatologic agents|mesh-ancestor
102642179|NCT01120236|Leuprolide|leuprolide|mesh-list
102642180|NCT01120236|Goserelin|goserelin|mesh-list
102642181|NCT01120236|Bicalutamide|bicalutamide|mesh-list
101930748|NCT03696342|Gatifloxacin|gatifloxacin|mesh-list
102642182|NCT01120236|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102642183|NCT01120236|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102642184|NCT01120236|Fertility Agents|fertility agents|mesh-ancestor
102642185|NCT01120236|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102642186|NCT01120236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642187|NCT01120236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102642188|NCT01120236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102642189|NCT01120236|Androgen Antagonists|androgen antagonists|mesh-ancestor
102642190|NCT01120236|Hormone Antagonists|hormone antagonists|mesh-ancestor
102642191|NCT01120236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102642192|NCT01120236|Immunologic Factors|immunologic factors|mesh-ancestor
102642193|NCT01120704|Nicotine|nicotine|mesh-list
102642194|NCT01120704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102642195|NCT01120704|Autonomic Agents|autonomic agents|mesh-ancestor
102642196|NCT01120704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102642197|NCT01120704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642198|NCT01120704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102642199|NCT01120704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102642200|NCT01120704|Cholinergic Agents|cholinergic agents|mesh-ancestor
102642201|NCT01120704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102642202|NCT01120704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642203|NCT01122108|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
102642204|NCT01122108|Cholestyramine Resin|cholestyramine resin|mesh-list
102642205|NCT01122108|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102642206|NCT01122108|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102642207|NCT01122108|Antimetabolites|antimetabolites|mesh-ancestor
102642208|NCT01122108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642209|NCT01122108|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102642210|NCT05307042|Vasopressins|vasopressins|mesh-list
102642211|NCT05307042|Arginine Vasopressin|arginine vasopressin|mesh-list
102642212|NCT05307042|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
102642213|NCT05307042|Hemostatics|hemostatics|mesh-ancestor
102642214|NCT05307042|Coagulants|coagulants|mesh-ancestor
102642215|NCT05307042|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102642216|NCT05307042|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102642217|NCT05307042|Natriuretic Agents|natriuretic agents|mesh-ancestor
102642218|NCT05307042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642219|NCT04974138|Folic Acid|folic acid|mesh-list
102642220|NCT04974138|Amlodipine|amlodipine|mesh-list
102642221|NCT04974138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102642222|NCT04974138|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102642223|NCT04974138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102642224|NCT04974138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642225|NCT04974138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102642226|NCT04974138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642227|NCT04974138|Vasodilator Agents|vasodilator agents|mesh-ancestor
102642228|NCT04974138|Hematinics|hematinics|mesh-ancestor
102642229|NCT04974138|Vitamin B Complex|vitamin b complex|mesh-ancestor
102642230|NCT04974138|Vitamins|vitamins|mesh-ancestor
102642231|NCT04974138|Micronutrients|micronutrients|mesh-ancestor
102642232|NCT04973982|Tacrolimus|tacrolimus|mesh-list
102642233|NCT04973982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102642234|NCT04973982|Immunologic Factors|immunologic factors|mesh-ancestor
102642235|NCT04973982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642236|NCT04973982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102642237|NCT04973982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102642238|NCT04973982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642239|NCT04187352|Cisplatin|cisplatin|mesh-list
102642240|NCT04187352|Fluorouracil|fluorouracil|mesh-list
102642241|NCT04187352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102642242|NCT04187352|Antimetabolites|antimetabolites|mesh-ancestor
102642243|NCT04187352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642244|NCT04187352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102642245|NCT04187352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102642246|NCT04187352|Immunologic Factors|immunologic factors|mesh-ancestor
102642247|NCT04187352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642248|NCT04142892|Onapristone|onapristone|mesh-list
102642249|NCT04142892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102642250|NCT04142892|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102642251|NCT04142892|Fertility Agents|fertility agents|mesh-ancestor
102642252|NCT04142892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102642253|NCT04142892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642254|NCT04142892|Hormone Antagonists|hormone antagonists|mesh-ancestor
102642255|NCT04142892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102642256|NCT03697356|Dexamethasone|dexamethasone|mesh-list
102275371|NCT02341963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275372|NCT02341963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102642257|NCT03697356|Rituximab|rituximab|mesh-list
102275373|NCT02341963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102642258|NCT03697356|Lenalidomide|lenalidomide|mesh-list
102642259|NCT03697356|Bortezomib|bortezomib|mesh-list
102642260|NCT03697356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102642261|NCT03697356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102642262|NCT03697356|Immunologic Factors|immunologic factors|mesh-ancestor
102642263|NCT03697356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642264|NCT03697356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102642265|NCT03697356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102642266|NCT03697356|Antiemetics|antiemetics|mesh-ancestor
102642267|NCT03697356|Autonomic Agents|autonomic agents|mesh-ancestor
102642268|NCT03697356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102642269|NCT03697356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102642270|NCT03697356|Glucocorticoids|glucocorticoids|mesh-ancestor
102642271|NCT03697356|Hormones|hormones|mesh-ancestor
102642272|NCT03697356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102642273|NCT03697356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102642274|NCT03697356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102642275|NCT03697356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102642276|NCT03697356|Growth Substances|growth substances|mesh-ancestor
102642277|NCT03697356|Growth Inhibitors|growth inhibitors|mesh-ancestor
102642278|NCT03616782|Ixazomib|ixazomib|mesh-list
102642279|NCT03616782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102642280|NCT03616782|Protease Inhibitors|protease inhibitors|mesh-ancestor
102642281|NCT03616782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614914|NCT00696748|Androgens|androgens|mesh-ancestor
102642282|NCT03616782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642283|NCT02410512|Atezolizumab|atezolizumab|mesh-list
102642284|NCT02410512|Antibodies|antibodies|mesh-list
102642285|NCT02410512|Immunoglobulins|immunoglobulins|mesh-list
102642286|NCT02410512|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102642287|NCT02410512|Immunologic Factors|immunologic factors|mesh-ancestor
102642288|NCT02410512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642289|NCT02410512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102642290|NCT02410512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642291|NCT02410512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102642292|NCT02410512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102642293|NCT00255138|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102642294|NCT00255138|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102642295|NCT00255138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102642296|NCT00255138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102642297|NCT00255138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642298|NCT00255138|Adrenergic Agents|adrenergic agents|mesh-ancestor
102642299|NCT00255138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102642300|NCT00255138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642301|NCT01128192|Pasireotide|pasireotide|mesh-list
102642302|NCT01128192|Hormones|hormones|mesh-ancestor
102642303|NCT01128192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102642304|NCT01128192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642305|NCT01128270|Chloral Hydrate|chloral hydrate|mesh-list
102642306|NCT01128270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102642307|NCT01128270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102642308|NCT01128270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642309|NCT01128972|Listerine|listerine|mesh-list
102642310|NCT01128972|Fluorides|fluorides|mesh-list
102642311|NCT01128972|Sodium Fluoride|sodium fluoride|mesh-list
102642312|NCT01128972|Cariostatic Agents|cariostatic agents|mesh-ancestor
102642313|NCT01128972|Protective Agents|protective agents|mesh-ancestor
102642314|NCT01128972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642315|NCT01128972|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102642316|NCT01128972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102642317|NCT01129206|Deoxyglucose|deoxyglucose|mesh-list
102642318|NCT01129206|Docetaxel|docetaxel|mesh-list
102642319|NCT01129206|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102642320|NCT01129206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102642321|NCT01129206|Tubulin Modulators|tubulin modulators|mesh-ancestor
102642322|NCT01129206|Antimitotic Agents|antimitotic agents|mesh-ancestor
102642323|NCT01129206|Mitosis Modulators|mitosis modulators|mesh-ancestor
102642324|NCT01129206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642325|NCT01129206|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102642326|NCT01129206|Antimetabolites|antimetabolites|mesh-ancestor
102642327|NCT01129206|Antiviral Agents|antiviral agents|mesh-ancestor
102642328|NCT01129206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102642329|NCT01129440|Fluorides|fluorides|mesh-list
102642330|NCT01129440|Fluorides, Topical|fluorides, topical|mesh-list
102275374|NCT02341963|Anesthetics, General|anesthetics, general|mesh-ancestor
102642331|NCT01129440|Cariostatic Agents|cariostatic agents|mesh-ancestor
102275375|NCT02341963|Anesthetics|anesthetics|mesh-ancestor
102642333|NCT01129440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642334|NCT01130844|Mesalamine|mesalamine|mesh-list
102642335|NCT01130844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102642336|NCT01130844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102642337|NCT01130844|Analgesics|analgesics|mesh-ancestor
102642338|NCT01130844|Sensory System Agents|sensory system agents|mesh-ancestor
102642339|NCT01130844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102642340|NCT01130844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642341|NCT01130844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102642342|NCT01130844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102642343|NCT01134198|Mifepristone|mifepristone|mesh-list
102642344|NCT01134198|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102642345|NCT01134198|Abortifacient Agents|abortifacient agents|mesh-ancestor
102642346|NCT01134198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102642347|NCT01134198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642348|NCT01134198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102642349|NCT01134198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102642350|NCT01134198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102642351|NCT01134198|Contraceptive Agents|contraceptive agents|mesh-ancestor
102642352|NCT01134198|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102642353|NCT01134198|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102642354|NCT01134198|Hormone Antagonists|hormone antagonists|mesh-ancestor
102642355|NCT01134198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102642356|NCT01134198|Luteolytic Agents|luteolytic agents|mesh-ancestor
102642357|NCT01134198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102642358|NCT01134198|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102642359|NCT01135368|Lansoprazole|lansoprazole|mesh-list
102642360|NCT01135368|Dexlansoprazole|dexlansoprazole|mesh-list
102642361|NCT01135368|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102642362|NCT01135368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102642363|NCT01135368|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102642364|NCT01135368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102642365|NCT01135368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642366|NCT01136226|Leuprolide|leuprolide|mesh-list
102642367|NCT01136226|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102642368|NCT01136226|Fertility Agents|fertility agents|mesh-ancestor
102642369|NCT01136226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102642370|NCT01136226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642371|NCT01136226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102642372|NCT01136226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102642373|NCT01137396|Modafinil|modafinil|mesh-list
102642374|NCT01137396|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102642375|NCT01137396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642376|NCT01137396|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102642377|NCT01137396|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102642378|NCT01137396|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102642379|NCT01137396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642380|NCT01139190|Naproxen|naproxen|mesh-list
102642381|NCT01139190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102642382|NCT01139190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102642383|NCT01139190|Analgesics|analgesics|mesh-ancestor
102642384|NCT01139190|Sensory System Agents|sensory system agents|mesh-ancestor
102642385|NCT01139190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102642386|NCT01139190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642387|NCT01139190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102642388|NCT01139190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102642389|NCT01139190|Gout Suppressants|gout suppressants|mesh-ancestor
102642390|NCT01139190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102642391|NCT01139190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102642392|NCT01139190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642393|NCT01140360|Imatinib Mesylate|imatinib mesylate|mesh-list
102642394|NCT01140360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102642395|NCT01140360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102642396|NCT01140360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102642397|NCT01140360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642398|NCT01142310|Lamotrigine|lamotrigine|mesh-list
102642399|NCT01142310|Anticonvulsants|anticonvulsants|mesh-ancestor
102642400|NCT01142310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102642401|NCT01142310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102275376|NCT02341963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102275377|NCT02341963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102642402|NCT01142310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642403|NCT01142310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102642404|NCT01142310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642405|NCT01142310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102642406|NCT01142310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102642407|NCT01142310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102642408|NCT01142310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102642409|NCT01142310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102642411|NCT01144338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102642412|NCT01144338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642413|NCT01144338|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102642414|NCT01144338|Incretins|incretins|mesh-ancestor
102642415|NCT01144338|Hormones|hormones|mesh-ancestor
102642416|NCT01144338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102642417|NCT01144494|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102642418|NCT01144494|Lubricant Eye Drops|lubricant eye drops|mesh-list
102642419|NCT01144494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102642420|NCT01144494|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102642421|NCT01144494|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102642422|NCT01144494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102642423|NCT01144494|Adrenergic Agents|adrenergic agents|mesh-ancestor
102642424|NCT01144494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102642425|NCT01144494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642426|NCT01144494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642427|NCT01144494|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102642428|NCT01144494|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102642429|NCT01146600|Clarithromycin|clarithromycin|mesh-list
102642430|NCT01146600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102642431|NCT01146600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102642432|NCT01146600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102642433|NCT01146600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102642434|NCT01146600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642435|NCT01146600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102642436|NCT01146600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102642437|NCT01146834|Plerixafor|plerixafor|mesh-list
102642438|NCT01146834|Cyclophosphamide|cyclophosphamide|mesh-list
102642439|NCT01146834|Bortezomib|bortezomib|mesh-list
102642440|NCT01146834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102642441|NCT01146834|Immunologic Factors|immunologic factors|mesh-ancestor
102642442|NCT01146834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642443|NCT01146834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102642444|NCT01146834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102642445|NCT01146834|Alkylating Agents|alkylating agents|mesh-ancestor
102642446|NCT01146834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642447|NCT01146834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102642448|NCT01146834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102642449|NCT01146834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102642450|NCT01146834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102642451|NCT01146834|Antiviral Agents|antiviral agents|mesh-ancestor
102642452|NCT01146834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102642453|NCT01147302|Complement C1s|complement c1s|mesh-list
102642454|NCT01147302|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
102642455|NCT01147302|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
102642456|NCT01147302|Immunologic Factors|immunologic factors|mesh-ancestor
102642457|NCT01147302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642458|NCT01147302|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102642459|NCT01147302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102642460|NCT01149876|Tretinoin|tretinoin|mesh-list
102642461|NCT01149876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102642462|NCT01149876|Keratolytic Agents|keratolytic agents|mesh-ancestor
102642463|NCT01149876|Dermatologic Agents|dermatologic agents|mesh-ancestor
102642464|NCT01150500|Sirolimus|sirolimus|mesh-list
102642465|NCT01150500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102642466|NCT01150500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102642467|NCT01150500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102642468|NCT01150500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102642469|NCT01150500|Antifungal Agents|antifungal agents|mesh-ancestor
102642470|NCT01150500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102642471|NCT01150500|Immunologic Factors|immunologic factors|mesh-ancestor
102275378|NCT02341963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102275379|NCT02341963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101931042|NCT04109222|Vaccines|vaccines|mesh-list
102275380|NCT02341963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642472|NCT01150500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642474|NCT01151046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102642475|NCT01151046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102642476|NCT01151046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102642477|NCT01151046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102642478|NCT01151046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642479|NCT01151046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102642480|NCT01151046|Hormone Antagonists|hormone antagonists|mesh-ancestor
102642481|NCT01151046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102642482|NCT01151046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642483|NCT01151436|Hyaluronic Acid|hyaluronic acid|mesh-list
102642484|NCT01151436|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102642485|NCT01151436|Immunologic Factors|immunologic factors|mesh-ancestor
102642486|NCT01151436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642487|NCT01151436|Viscosupplements|viscosupplements|mesh-ancestor
102642488|NCT01151436|Protective Agents|protective agents|mesh-ancestor
102642489|NCT01153620|Polihexanide|polihexanide|mesh-list
102642490|NCT01153620|Disinfectants|disinfectants|mesh-ancestor
102642491|NCT01153620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102642492|NCT01163214|Ropivacaine|ropivacaine|mesh-list
102642493|NCT01163214|Anesthetics, Local|anesthetics, local|mesh-ancestor
102642494|NCT01163214|Anesthetics|anesthetics|mesh-ancestor
102642495|NCT01163214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102642496|NCT01163214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642497|NCT01163214|Sensory System Agents|sensory system agents|mesh-ancestor
102642498|NCT01163214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102642499|NCT01163604|Argatroban|argatroban|mesh-list
102642500|NCT01163604|Clopidogrel|clopidogrel|mesh-list
102642501|NCT01163604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642502|NCT01163604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642503|NCT01163604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102642504|NCT01163604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102642505|NCT01163604|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102642506|NCT01163604|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102642507|NCT01163604|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102642508|NCT01163604|Purinergic Agents|purinergic agents|mesh-ancestor
102642509|NCT01163604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102642510|NCT01163604|Antithrombins|antithrombins|mesh-ancestor
102642511|NCT01163604|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102642512|NCT01163604|Protease Inhibitors|protease inhibitors|mesh-ancestor
102642513|NCT01163604|Anticoagulants|anticoagulants|mesh-ancestor
102642514|NCT01168674|Ziprasidone|ziprasidone|mesh-list
102642515|NCT01168674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102642516|NCT01168674|Serotonin Agents|serotonin agents|mesh-ancestor
102642517|NCT01168674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102642518|NCT01168674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642519|NCT01168674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642520|NCT01168674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102642521|NCT01168674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102642522|NCT01168674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102642523|NCT01168674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102642524|NCT01168674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102642525|NCT01168674|Dopamine Agents|dopamine agents|mesh-ancestor
102642526|NCT01168908|Sildenafil Citrate|sildenafil citrate|mesh-list
102642527|NCT01168908|Vasodilator Agents|vasodilator agents|mesh-ancestor
102642528|NCT01168908|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102642529|NCT01168908|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102642530|NCT01168908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102642531|NCT01168908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642532|NCT01168908|Urological Agents|urological agents|mesh-ancestor
102642533|NCT01170390|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102642534|NCT01170390|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102642535|NCT01170390|Levonorgestrel|levonorgestrel|mesh-list
102642536|NCT01170390|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102642537|NCT01170390|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
102642538|NCT01170390|Estradiol|estradiol|mesh-list
102642539|NCT01170390|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102642540|NCT01170390|Estrogens|estrogens|mesh-ancestor
102642541|NCT01170390|Hormones|hormones|mesh-ancestor
102642542|NCT01170390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102642543|NCT01170390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275381|NCT05014685|Amoxicillin|amoxicillin|mesh-list
102275382|NCT05014685|Metronidazole|metronidazole|mesh-list
102642544|NCT01170390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102642545|NCT01170390|Contraceptive Agents|contraceptive agents|mesh-ancestor
102642546|NCT01170390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102642547|NCT01170390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102642548|NCT01170390|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102642549|NCT01170390|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102642550|NCT01170390|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102642551|NCT01170390|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102642552|NCT01134510|Complement C1s|complement c1s|mesh-list
102642553|NCT01134510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
102642554|NCT01134510|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
102642555|NCT01134510|Immunologic Factors|immunologic factors|mesh-ancestor
102642556|NCT01134510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642557|NCT01134510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102642558|NCT01134510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102642559|NCT01171794|Ibuprofen|ibuprofen|mesh-list
102642560|NCT01171794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102642561|NCT01171794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102642562|NCT01171794|Analgesics|analgesics|mesh-ancestor
102642563|NCT01171794|Sensory System Agents|sensory system agents|mesh-ancestor
102642564|NCT01171794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102642565|NCT01171794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642566|NCT01171794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102642567|NCT01171794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102642568|NCT01171794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102642569|NCT01171794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102642570|NCT01171794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642571|NCT01172418|Alemtuzumab|alemtuzumab|mesh-list
102642572|NCT01172418|Thymoglobulin|thymoglobulin|mesh-list
102642573|NCT01172418|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102642574|NCT01172418|Daclizumab|daclizumab|mesh-list
102642575|NCT01172418|Immunologic Factors|immunologic factors|mesh-ancestor
102642576|NCT01172418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642577|NCT01172418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102642578|NCT01172418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102642579|NCT01172418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102642580|NCT01175148|Atorvastatin|atorvastatin|mesh-list
102642581|NCT01175148|Calcium|calcium|mesh-list
102642582|NCT01175148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102642583|NCT01175148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642584|NCT01175148|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102642585|NCT01175148|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102642586|NCT01175148|Antimetabolites|antimetabolites|mesh-ancestor
102642587|NCT01175148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642588|NCT01175148|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102642589|NCT01175148|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102642590|NCT01175148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102642591|NCT01177098|Timolol|timolol|mesh-list
102642592|NCT01177098|Bimatoprost|bimatoprost|mesh-list
102642593|NCT01177098|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102642594|NCT01177098|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102642595|NCT01177098|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102642596|NCT01177098|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102642597|NCT01177098|Adrenergic Agents|adrenergic agents|mesh-ancestor
102642598|NCT01177098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102642599|NCT01177098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642600|NCT01177098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642601|NCT01177098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102642602|NCT01177098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102642603|NCT01177956|Fluorouracil|fluorouracil|mesh-list
102642604|NCT01177956|Cetuximab|cetuximab|mesh-list
102642605|NCT01177956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102642606|NCT01177956|Antimetabolites|antimetabolites|mesh-ancestor
102642607|NCT01177956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642608|NCT01177956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102642609|NCT01177956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102642610|NCT01177956|Immunologic Factors|immunologic factors|mesh-ancestor
102642611|NCT01177956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642612|NCT01177956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102642613|NCT01183650|Tadalafil|tadalafil|mesh-list
102642614|NCT01183650|Vasodilator Agents|vasodilator agents|mesh-ancestor
102642615|NCT01183650|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102275383|NCT05014685|Potassium Citrate|potassium citrate|mesh-list
102275384|NCT05014685|Rabeprazole|rabeprazole|mesh-list
102642616|NCT01183650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102642617|NCT01183650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102642618|NCT01183650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642619|NCT01183650|Urological Agents|urological agents|mesh-ancestor
102642620|NCT01184898|Cytarabine|cytarabine|mesh-list
102642621|NCT01184898|Sirolimus|sirolimus|mesh-list
102642622|NCT01184898|Etoposide|etoposide|mesh-list
102642623|NCT01184898|Mitoxantrone|mitoxantrone|mesh-list
102642624|NCT01184898|Etoposide phosphate|etoposide phosphate|mesh-list
102642625|NCT01184898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102642626|NCT01184898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102642627|NCT01184898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102642628|NCT01184898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102642629|NCT01184898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102642630|NCT01184898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642631|NCT01184898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102642632|NCT01184898|Antimetabolites|antimetabolites|mesh-ancestor
102642633|NCT01184898|Antiviral Agents|antiviral agents|mesh-ancestor
102642634|NCT01184898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102642635|NCT01184898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102642636|NCT01184898|Immunologic Factors|immunologic factors|mesh-ancestor
102642637|NCT01184898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642638|NCT01184898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102642639|NCT01184898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102642640|NCT01184898|Antifungal Agents|antifungal agents|mesh-ancestor
102642641|NCT01184898|Analgesics|analgesics|mesh-ancestor
102642642|NCT01184898|Sensory System Agents|sensory system agents|mesh-ancestor
102642643|NCT01184898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102642644|NCT01188876|Folic Acid|folic acid|mesh-list
102642645|NCT01188876|Vitamin B 12|vitamin b 12|mesh-list
102642646|NCT01188876|Hydroxocobalamin|hydroxocobalamin|mesh-list
102642647|NCT01188876|Carboplatin|carboplatin|mesh-list
102642648|NCT01188876|Vitamins|vitamins|mesh-ancestor
102642649|NCT01188876|Micronutrients|micronutrients|mesh-ancestor
102642650|NCT01188876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642651|NCT01188876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102642652|NCT01188876|Hematinics|hematinics|mesh-ancestor
102642653|NCT01188876|Vitamin B Complex|vitamin b complex|mesh-ancestor
102642654|NCT01193868|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
102642655|NCT01193868|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
102642656|NCT01193868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102642657|NCT01193868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642658|NCT01195116|Dexmedetomidine|dexmedetomidine|mesh-list
102642659|NCT01195116|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102642660|NCT01195116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102642661|NCT01195116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642662|NCT01195116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102642663|NCT01195116|Analgesics|analgesics|mesh-ancestor
102642664|NCT01195116|Sensory System Agents|sensory system agents|mesh-ancestor
102642665|NCT01195116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102642666|NCT01195116|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102642667|NCT01195116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102642668|NCT01195116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102642669|NCT01195116|Adrenergic Agents|adrenergic agents|mesh-ancestor
102642670|NCT01195116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102642671|NCT01195116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642672|NCT01197612|Budesonide|budesonide|mesh-list
102642673|NCT01197612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102642674|NCT01197612|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102642675|NCT01197612|Autonomic Agents|autonomic agents|mesh-ancestor
102642676|NCT01197612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102642677|NCT01197612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642678|NCT01197612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102642679|NCT01197612|Respiratory System Agents|respiratory system agents|mesh-ancestor
102642680|NCT01197612|Glucocorticoids|glucocorticoids|mesh-ancestor
102642681|NCT01197612|Hormones|hormones|mesh-ancestor
102642682|NCT01197612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102642683|NCT01198158|Bevacizumab|bevacizumab|mesh-list
102642684|NCT01198158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102642685|NCT01198158|Everolimus|everolimus|mesh-list
102642686|NCT01198158|Endothelial Growth Factors|endothelial growth factors|mesh-list
102642687|NCT01198158|Antibodies|antibodies|mesh-list
102642688|NCT01198158|Immunoglobulins|immunoglobulins|mesh-list
102642689|NCT01198158|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102275385|NCT05014685|Bismuth|bismuth|mesh-list
101931333|NCT04307940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102642690|NCT01198158|Immunoglobulin G|immunoglobulin g|mesh-list
102642691|NCT01198158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102642692|NCT01198158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102642693|NCT01198158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102642694|NCT01198158|Growth Substances|growth substances|mesh-ancestor
102642695|NCT01198158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642696|NCT01198158|Growth Inhibitors|growth inhibitors|mesh-ancestor
102642697|NCT01198158|Immunologic Factors|immunologic factors|mesh-ancestor
102642698|NCT01198158|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102642699|NCT01198158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102642700|NCT01198158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102642701|NCT01198158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642702|NCT01198158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102642703|NCT01203774|Insulin Glargine|insulin glargine|mesh-list
102642704|NCT01203774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102642705|NCT01203774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642706|NCT01205646|Zoledronic Acid|zoledronic acid|mesh-list
102642707|NCT01205646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102642708|NCT01205646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642709|NCT01206660|Desoximetasone|desoximetasone|mesh-list
102642710|NCT01206660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102642711|NCT01206660|Glucocorticoids|glucocorticoids|mesh-ancestor
102642712|NCT01206660|Hormones|hormones|mesh-ancestor
102642713|NCT01206660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102642714|NCT01206660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642715|NCT01207752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102642716|NCT01207752|Lubricant Eye Drops|lubricant eye drops|mesh-list
102642717|NCT01207752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102642718|NCT01207908|Mecasermin|mecasermin|mesh-list
102642719|NCT01207908|Growth Substances|growth substances|mesh-ancestor
102642720|NCT01207908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642721|NCT01208922|Ciprofloxacin|ciprofloxacin|mesh-list
102642722|NCT01208922|Rifamycins|rifamycins|mesh-list
102642723|NCT01208922|Rifamycin SV|rifamycin sv|mesh-list
102642724|NCT01208922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102642725|NCT01208922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102642726|NCT01208922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102642727|NCT01208922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102642728|NCT01208922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102642729|NCT01208922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642730|NCT01208922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102642731|NCT01208922|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102642732|NCT01208922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102642733|NCT01208922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102642734|NCT01210170|Mometasone Furoate|mometasone furoate|mesh-list
102642735|NCT01210170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102642736|NCT01210170|Dermatologic Agents|dermatologic agents|mesh-ancestor
102642737|NCT01210170|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102642738|NCT01210560|Tolvaptan|tolvaptan|mesh-list
102642739|NCT01210560|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102642740|NCT01210560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642741|NCT01210560|Natriuretic Agents|natriuretic agents|mesh-ancestor
102642742|NCT01210560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642743|NCT01211730|Insulin|insulin|mesh-list
102642744|NCT01211730|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102642745|NCT01211730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102642746|NCT01211730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642747|NCT01212900|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
102642748|NCT01212900|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102642749|NCT01212900|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102642750|NCT01212900|Antimetabolites|antimetabolites|mesh-ancestor
102642751|NCT01212900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642752|NCT01212900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102642753|NCT01212900|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102642754|NCT01215318|Silicon|silicon|mesh-list
102642755|NCT01215318|Trace Elements|trace elements|mesh-ancestor
102642756|NCT01215318|Micronutrients|micronutrients|mesh-ancestor
102642757|NCT01215318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642758|NCT01215786|Timolol|timolol|mesh-list
102642759|NCT01215786|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102642760|NCT01215786|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102642761|NCT01215786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101615405|NCT01101308|Oxycodone|oxycodone|mesh-list
102642762|NCT01215786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102642763|NCT01215786|Adrenergic Agents|adrenergic agents|mesh-ancestor
102642764|NCT01215786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102642765|NCT01215786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642766|NCT01215786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642767|NCT01215786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102642768|NCT01215786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102642770|NCT01216410|Oxymetazoline|oxymetazoline|mesh-list
102642771|NCT01216410|Ondansetron|ondansetron|mesh-list
102642772|NCT01216410|Metoclopramide|metoclopramide|mesh-list
102642773|NCT01216410|Antiemetics|antiemetics|mesh-ancestor
102642774|NCT01216410|Autonomic Agents|autonomic agents|mesh-ancestor
102642775|NCT01216410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102642776|NCT01216410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642777|NCT01216410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102642778|NCT01216410|Antipruritics|antipruritics|mesh-ancestor
102642779|NCT01216410|Dermatologic Agents|dermatologic agents|mesh-ancestor
102642780|NCT01216410|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102642781|NCT01216410|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102642782|NCT01216410|Serotonin Agents|serotonin agents|mesh-ancestor
102642783|NCT01216410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102642784|NCT01216410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642785|NCT01216410|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102642786|NCT01216410|Mydriatics|mydriatics|mesh-ancestor
102642787|NCT01216410|Sympathomimetics|sympathomimetics|mesh-ancestor
102642788|NCT01216410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102642789|NCT01216410|Nasal Decongestants|nasal decongestants|mesh-ancestor
102642790|NCT01216410|Respiratory System Agents|respiratory system agents|mesh-ancestor
102642791|NCT01216410|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102642792|NCT01216410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102642793|NCT01216410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102642794|NCT01216410|Adrenergic Agents|adrenergic agents|mesh-ancestor
102642795|NCT01216410|Protective Agents|protective agents|mesh-ancestor
102642796|NCT01216410|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102642797|NCT01216410|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102642798|NCT01216410|Dopamine Agents|dopamine agents|mesh-ancestor
102642799|NCT01218048|Carboplatin|carboplatin|mesh-list
102642800|NCT01218048|Cetuximab|cetuximab|mesh-list
102642801|NCT01218048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102642802|NCT01218048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102642803|NCT01218984|Naltrexone|naltrexone|mesh-list
102642804|NCT01218984|Hydromorphone|hydromorphone|mesh-list
102642805|NCT01218984|Naloxone|naloxone|mesh-list
102642806|NCT01218984|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102642807|NCT01218984|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102642808|NCT01218984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642809|NCT01218984|Sensory System Agents|sensory system agents|mesh-ancestor
102642810|NCT01218984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102642811|NCT01218984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102642812|NCT01218984|Narcotics|narcotics|mesh-ancestor
102642813|NCT01218984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102642814|NCT01218984|Analgesics|analgesics|mesh-ancestor
102642815|NCT01222260|Dexamethasone|dexamethasone|mesh-list
102642816|NCT01222260|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102642817|NCT01222260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102642818|NCT01222260|Antiemetics|antiemetics|mesh-ancestor
102642819|NCT01222260|Autonomic Agents|autonomic agents|mesh-ancestor
102642820|NCT01222260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102642821|NCT01222260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642822|NCT01222260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102642823|NCT01222260|Glucocorticoids|glucocorticoids|mesh-ancestor
102642824|NCT01222260|Hormones|hormones|mesh-ancestor
102642825|NCT01222260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102642826|NCT01222260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102642827|NCT01222260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102642828|NCT01222260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102642829|NCT01222260|Alkylating Agents|alkylating agents|mesh-ancestor
102642830|NCT01222260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642831|NCT01222572|Etoposide|etoposide|mesh-list
102642832|NCT01222572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101615477|NCT00931710|Diuretics|diuretics|mesh-ancestor
102642833|NCT01222572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102642834|NCT01222572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101931406|NCT03854110|Gemcitabine|gemcitabine|mesh-list
102642835|NCT01222572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102642836|NCT01222572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102642837|NCT01222572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931411|NCT04292730|Remdesivir|remdesivir|mesh-list
102642838|NCT01222884|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102642839|NCT01222884|Hematinics|hematinics|mesh-ancestor
102642840|NCT01223352|Bosentan|bosentan|mesh-list
102642841|NCT01223352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102642842|NCT01223352|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102642843|NCT01223352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642844|NCT01224210|Ambrisentan|ambrisentan|mesh-list
102642845|NCT01224210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102642846|NCT01224678|Vitamin D|vitamin d|mesh-list
102642847|NCT01224678|Vitamins|vitamins|mesh-ancestor
102642848|NCT01224678|Micronutrients|micronutrients|mesh-ancestor
102642849|NCT01224678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642850|NCT01224678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102642851|NCT01225068|Milnacipran|milnacipran|mesh-list
102642852|NCT01225068|Levomilnacipran|levomilnacipran|mesh-list
102642853|NCT01225068|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102642854|NCT01225068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102642855|NCT01225068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102642856|NCT01225068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642857|NCT01225068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102642858|NCT01225068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642859|NCT01225068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102642860|NCT01225068|Analgesics|analgesics|mesh-ancestor
102642861|NCT01225068|Sensory System Agents|sensory system agents|mesh-ancestor
102642862|NCT01225068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102642863|NCT01225068|Antidepressive Agents|antidepressive agents|mesh-ancestor
102642864|NCT01225068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102642865|NCT01226706|Botulinum Toxins|botulinum toxins|mesh-list
102642866|NCT01226706|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102642867|NCT01226706|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102642868|NCT01226706|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102642869|NCT01226706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102642870|NCT01226706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642871|NCT01226706|Cholinergic Agents|cholinergic agents|mesh-ancestor
102642872|NCT01226706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102642873|NCT01226706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642874|NCT01226706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102642875|NCT01226706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102642876|NCT01231230|Fluticasone|fluticasone|mesh-list
102642877|NCT01231230|Xhance|xhance|mesh-list
102642878|NCT01231230|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102642879|NCT01231230|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102642880|NCT01231230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102642881|NCT01231230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102642882|NCT01231230|Autonomic Agents|autonomic agents|mesh-ancestor
102642883|NCT01231230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102642884|NCT01231230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642885|NCT01231230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102642886|NCT01231230|Respiratory System Agents|respiratory system agents|mesh-ancestor
102642887|NCT01231230|Dermatologic Agents|dermatologic agents|mesh-ancestor
102642888|NCT01231230|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102642889|NCT01231230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102642890|NCT01231230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102642891|NCT01231230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102642892|NCT01231230|Adrenergic Agents|adrenergic agents|mesh-ancestor
102642893|NCT01231230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102642894|NCT01231230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642895|NCT01231230|Glucocorticoids|glucocorticoids|mesh-ancestor
102642896|NCT01231230|Hormones|hormones|mesh-ancestor
102642897|NCT01231230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102642898|NCT01231230|Sympathomimetics|sympathomimetics|mesh-ancestor
102642899|NCT01232946|Insulin|insulin|mesh-list
102642900|NCT01232946|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102642901|NCT01232946|Liraglutide|liraglutide|mesh-list
102642902|NCT01232946|Insulin Detemir|insulin detemir|mesh-list
102642903|NCT01232946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102642904|NCT01232946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642905|NCT01232946|Incretins|incretins|mesh-ancestor
102642906|NCT01232946|Hormones|hormones|mesh-ancestor
102642907|NCT01232946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102642908|NCT01235910|Cyclosporine|cyclosporine|mesh-list
102642909|NCT01235910|Cyclosporins|cyclosporins|mesh-list
102642910|NCT01235910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102642911|NCT01235910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931484|NCT01348100|Iloperidone|iloperidone|mesh-list
101931559|NCT03771586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102642912|NCT01235910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102642913|NCT01235910|Immunologic Factors|immunologic factors|mesh-ancestor
102642914|NCT01235910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642915|NCT01235910|Antifungal Agents|antifungal agents|mesh-ancestor
102642916|NCT01235910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102642917|NCT01235910|Dermatologic Agents|dermatologic agents|mesh-ancestor
102642918|NCT01235910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102642919|NCT01235910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102642920|NCT01236378|Sirolimus|sirolimus|mesh-list
102642921|NCT01236378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102642922|NCT01236378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102642923|NCT01236378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102642924|NCT01236378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102642925|NCT01236378|Antifungal Agents|antifungal agents|mesh-ancestor
102642926|NCT01236378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102642927|NCT01236378|Immunologic Factors|immunologic factors|mesh-ancestor
102642928|NCT01236378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642929|NCT01236768|Contraceptive Agents|contraceptive agents|mesh-list
102642930|NCT01236768|Contraceptives, Oral|contraceptives, oral|mesh-list
102642931|NCT01236768|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-list
102642932|NCT01236768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102642933|NCT01236768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642934|NCT01236768|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102642935|NCT01236768|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102642936|NCT01238640|Nicotine|nicotine|mesh-list
102642937|NCT01238640|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102642938|NCT01238640|Autonomic Agents|autonomic agents|mesh-ancestor
102642939|NCT01238640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102642940|NCT01238640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642941|NCT01238640|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102642942|NCT01238640|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102642943|NCT01238640|Cholinergic Agents|cholinergic agents|mesh-ancestor
102642944|NCT01238640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102642945|NCT01238640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642946|NCT01247064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102642947|NCT01247220|Ranibizumab|ranibizumab|mesh-list
102642948|NCT01247220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102642949|NCT01247220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102642950|NCT01247220|Growth Substances|growth substances|mesh-ancestor
102642951|NCT01247220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642952|NCT01247220|Growth Inhibitors|growth inhibitors|mesh-ancestor
102642953|NCT01247220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102642954|NCT01249872|Morphine|morphine|mesh-list
102642955|NCT01249872|Levobupivacaine|levobupivacaine|mesh-list
102642956|NCT01249872|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102642957|NCT01249872|Narcotics|narcotics|mesh-ancestor
102642958|NCT01249872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102642959|NCT01249872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642960|NCT01249872|Analgesics|analgesics|mesh-ancestor
102642961|NCT01249872|Sensory System Agents|sensory system agents|mesh-ancestor
102642962|NCT01249872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102642963|NCT01249872|Anesthetics, Local|anesthetics, local|mesh-ancestor
102642964|NCT01249872|Anesthetics|anesthetics|mesh-ancestor
102642965|NCT01250184|Lidocaine|lidocaine|mesh-list
102642966|NCT01250184|Anesthetics, Local|anesthetics, local|mesh-ancestor
102642967|NCT01250184|Anesthetics|anesthetics|mesh-ancestor
102642968|NCT01250184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102642969|NCT01250184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642970|NCT01250184|Sensory System Agents|sensory system agents|mesh-ancestor
102642971|NCT01250184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102642972|NCT01250184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102642973|NCT01250184|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102642974|NCT01250184|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102642975|NCT01250184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102642976|NCT01250184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642977|NCT01250730|Crizotinib|crizotinib|mesh-list
102642978|NCT01250730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102642979|NCT01250730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102642980|NCT01250730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102642981|NCT01250730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642982|NCT01251978|Ranibizumab|ranibizumab|mesh-list
102642983|NCT01251978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102642984|NCT01251978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102642985|NCT01251978|Growth Substances|growth substances|mesh-ancestor
101931629|NCT05217160|Morphine|morphine|mesh-list
102642986|NCT01251978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642987|NCT01251978|Growth Inhibitors|growth inhibitors|mesh-ancestor
102642988|NCT01251978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102642989|NCT01253460|Cyclophosphamide|cyclophosphamide|mesh-list
102642990|NCT01253460|Rituximab|rituximab|mesh-list
102642991|NCT01253460|Sapacitabine|sapacitabine|mesh-list
102642992|NCT01253460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102642993|NCT01253460|Immunologic Factors|immunologic factors|mesh-ancestor
102642994|NCT01253460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102642995|NCT01253460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102642996|NCT01253460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102642997|NCT01253460|Alkylating Agents|alkylating agents|mesh-ancestor
102642998|NCT01253460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102642999|NCT01253460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102643000|NCT01253460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102643001|NCT01253460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102643002|NCT01254396|Sildenafil Citrate|sildenafil citrate|mesh-list
102643003|NCT01254396|Vasodilator Agents|vasodilator agents|mesh-ancestor
102643004|NCT01254396|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102643005|NCT01254396|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102643006|NCT01254396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102643007|NCT01254396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643008|NCT01254396|Urological Agents|urological agents|mesh-ancestor
102643009|NCT01254552|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
102643010|NCT01254552|Chelating Agents|chelating agents|mesh-ancestor
102643011|NCT01254552|Sequestering Agents|sequestering agents|mesh-ancestor
102643012|NCT01254552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643013|NCT01244724|Escitalopram|escitalopram|mesh-list
102643014|NCT01244724|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102643015|NCT01244724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102643016|NCT01244724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102643017|NCT01244724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643018|NCT01244724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102643019|NCT01244724|Serotonin Agents|serotonin agents|mesh-ancestor
102643020|NCT01244724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643021|NCT01258374|Raltegravir Potassium|raltegravir potassium|mesh-list
102643022|NCT01258374|Darunavir|darunavir|mesh-list
102643023|NCT01258374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102643024|NCT01258374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102643025|NCT01258374|Antiviral Agents|antiviral agents|mesh-ancestor
102643026|NCT01258374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102643027|NCT01258374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102643028|NCT01258374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102643029|NCT01258374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102643030|NCT01258374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643031|NCT01258374|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102643032|NCT01258374|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102643033|NCT01258374|Protease Inhibitors|protease inhibitors|mesh-ancestor
102643034|NCT01262118|Tofacitinib|tofacitinib|mesh-list
102643035|NCT01262118|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102643036|NCT01262118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102643037|NCT01262118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101615689|NCT00862654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102643038|NCT01262118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643039|NCT01263132|Thiamine|thiamine|mesh-list
102643040|NCT01263132|Vitamin B 12|vitamin b 12|mesh-list
102643041|NCT01263132|Gabapentin|gabapentin|mesh-list
102643042|NCT01263132|Analgesics|analgesics|mesh-ancestor
102643043|NCT01263132|Sensory System Agents|sensory system agents|mesh-ancestor
102643044|NCT01263132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102643045|NCT01263132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643046|NCT01263132|Anticonvulsants|anticonvulsants|mesh-ancestor
102643047|NCT01263132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102643048|NCT01263132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102643049|NCT01263132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102643050|NCT01263132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102643051|NCT01263132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102643052|NCT01263132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102643053|NCT01263132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102643054|NCT01263132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643055|NCT01263132|Antimanic Agents|antimanic agents|mesh-ancestor
102643056|NCT01263132|Vitamin B Complex|vitamin b complex|mesh-ancestor
102643057|NCT01263132|Vitamins|vitamins|mesh-ancestor
102643058|NCT01263132|Micronutrients|micronutrients|mesh-ancestor
102643059|NCT01267656|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102643060|NCT01267656|Lubricant Eye Drops|lubricant eye drops|mesh-list
102643061|NCT01267656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102643063|NCT01270542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102643064|NCT01270542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102643065|NCT01270542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102643066|NCT01270542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102643067|NCT01270542|Growth Substances|growth substances|mesh-ancestor
102643068|NCT01270542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643069|NCT01270542|Growth Inhibitors|growth inhibitors|mesh-ancestor
102643070|NCT01271244|Escitalopram|escitalopram|mesh-list
102643071|NCT01271244|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102643072|NCT01271244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102643073|NCT01271244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102643074|NCT01271244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643075|NCT01271244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102643076|NCT01271244|Serotonin Agents|serotonin agents|mesh-ancestor
102643077|NCT01271244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643078|NCT01272960|Levonorgestrel|levonorgestrel|mesh-list
102643079|NCT01272960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102643080|NCT01272960|Contraceptive Agents|contraceptive agents|mesh-ancestor
102643081|NCT01272960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102643082|NCT01272960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643083|NCT01272960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102643084|NCT01272960|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102643085|NCT01272960|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102643086|NCT01275300|Aspirin|aspirin|mesh-list
102643087|NCT01275300|Niacin|niacin|mesh-list
102643088|NCT01275300|Niacinamide|niacinamide|mesh-list
102643089|NCT01275300|Nicotinic Acids|nicotinic acids|mesh-list
102643090|NCT01275300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102643091|NCT01275300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102643092|NCT01275300|Analgesics|analgesics|mesh-ancestor
102643093|NCT01275300|Sensory System Agents|sensory system agents|mesh-ancestor
102643094|NCT01275300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102643095|NCT01275300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643096|NCT01275300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102643097|NCT01275300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102643098|NCT01275300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102643099|NCT01275300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102643100|NCT01275300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643101|NCT01275300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102643102|NCT01275300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102643103|NCT01275300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102643104|NCT01275300|Antipyretics|antipyretics|mesh-ancestor
102643105|NCT01275300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102643106|NCT01275300|Antimetabolites|antimetabolites|mesh-ancestor
102643107|NCT01275300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102643108|NCT01275300|Vasodilator Agents|vasodilator agents|mesh-ancestor
102643109|NCT01275300|Vitamin B Complex|vitamin b complex|mesh-ancestor
102643110|NCT01275300|Vitamins|vitamins|mesh-ancestor
102643111|NCT01275300|Micronutrients|micronutrients|mesh-ancestor
102643112|NCT01276314|Prednisolone|prednisolone|mesh-list
102643113|NCT01276314|Etanercept|etanercept|mesh-list
102643114|NCT01276314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102643115|NCT01276314|Glucocorticoids|glucocorticoids|mesh-ancestor
102643116|NCT01276314|Hormones|hormones|mesh-ancestor
102643117|NCT01276314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102643118|NCT01276314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643119|NCT01276314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102643120|NCT01276314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102643121|NCT01276314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102643122|NCT01276314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102643123|NCT01276314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102643124|NCT01276314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102643125|NCT01276314|Analgesics|analgesics|mesh-ancestor
102643126|NCT01276314|Sensory System Agents|sensory system agents|mesh-ancestor
102643127|NCT01276314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102643128|NCT01276314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102275386|NCT05014685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643129|NCT01276314|Immunologic Factors|immunologic factors|mesh-ancestor
102643130|NCT01280058|Paclitaxel|paclitaxel|mesh-list
102643131|NCT01280058|Carboplatin|carboplatin|mesh-list
102643132|NCT01280058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102643133|NCT01280058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102275387|NCT05014685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102275388|NCT05014685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102643134|NCT01280058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102643135|NCT01280058|Tubulin Modulators|tubulin modulators|mesh-ancestor
102643136|NCT01280058|Antimitotic Agents|antimitotic agents|mesh-ancestor
102643137|NCT01280058|Mitosis Modulators|mitosis modulators|mesh-ancestor
102643138|NCT01280058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643139|NCT01280604|Fenofibrate|fenofibrate|mesh-list
102643140|NCT01280604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102643141|NCT01280604|Antimetabolites|antimetabolites|mesh-ancestor
102643142|NCT01280604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643143|NCT01280604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102643144|NCT01282242|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102643145|NCT01282242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102643146|NCT01282242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102643147|NCT01282242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643148|NCT01285050|Tenofovir|tenofovir|mesh-list
102643149|NCT01285050|Emtricitabine|emtricitabine|mesh-list
102643150|NCT01285050|Raltegravir Potassium|raltegravir potassium|mesh-list
102643151|NCT01285050|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102643152|NCT01285050|Antiviral Agents|antiviral agents|mesh-ancestor
102643153|NCT01285050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102643154|NCT01285050|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102643155|NCT01285050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102643156|NCT01285050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101615829|NCT02619526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102643157|NCT01285050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643158|NCT01285050|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102643159|NCT01285050|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102643160|NCT01285050|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102643161|NCT01286454|Fesoterodine|fesoterodine|mesh-list
102643162|NCT01286454|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102643163|NCT01286454|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102643164|NCT01286454|Cholinergic Agents|cholinergic agents|mesh-ancestor
102643165|NCT01286454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102643166|NCT01286454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643167|NCT01286454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643168|NCT01286454|Urological Agents|urological agents|mesh-ancestor
102643169|NCT01287078|Cyclosporine|cyclosporine|mesh-list
102643170|NCT01287078|Cyclosporins|cyclosporins|mesh-list
102643171|NCT01287078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102643172|NCT01287078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643173|NCT01287078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102643174|NCT01287078|Immunologic Factors|immunologic factors|mesh-ancestor
102643175|NCT01287078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643176|NCT01287078|Antifungal Agents|antifungal agents|mesh-ancestor
102643177|NCT01287078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102643178|NCT01287078|Dermatologic Agents|dermatologic agents|mesh-ancestor
102643179|NCT01287078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102643180|NCT01287078|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102643181|NCT01291056|Clomiphene|clomiphene|mesh-list
102643182|NCT01291056|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102643183|NCT01291056|Hormone Antagonists|hormone antagonists|mesh-ancestor
102643184|NCT01291056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102643185|NCT01291056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643186|NCT01291056|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102643187|NCT01291056|Fertility Agents|fertility agents|mesh-ancestor
102643188|NCT01291056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102643189|NCT01291056|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102643190|NCT01291056|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102643191|NCT01292304|Tolvaptan|tolvaptan|mesh-list
102643192|NCT01292304|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102643193|NCT01292304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643194|NCT01292304|Natriuretic Agents|natriuretic agents|mesh-ancestor
102643195|NCT01292304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643196|NCT01293396|Insulin|insulin|mesh-list
102643197|NCT01293396|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102643198|NCT01293396|Insulin Aspart|insulin aspart|mesh-list
102643199|NCT01293396|Insulin, Long-Acting|insulin, long-acting|mesh-list
102643200|NCT01293396|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102643201|NCT01293396|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
102275389|NCT05014685|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102275390|NCT05014685|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102643202|NCT01293396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102275391|NCT05014685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102643203|NCT01293396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643204|NCT01294098|Bupivacaine|bupivacaine|mesh-list
102643205|NCT01294098|Anesthetics, Local|anesthetics, local|mesh-ancestor
102643206|NCT01294098|Anesthetics|anesthetics|mesh-ancestor
102643207|NCT01294098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102643208|NCT01294098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643209|NCT01294098|Sensory System Agents|sensory system agents|mesh-ancestor
102643210|NCT01294098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102643211|NCT01295112|Dexamethasone|dexamethasone|mesh-list
102643212|NCT01295112|Dexamethasone acetate|dexamethasone acetate|mesh-list
102643213|NCT01295112|Bevacizumab|bevacizumab|mesh-list
102643214|NCT01295112|BB 1101|bb 1101|mesh-list
102643215|NCT01295112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102643216|NCT01295112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102643217|NCT01295112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102643218|NCT01295112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102643219|NCT01295112|Growth Substances|growth substances|mesh-ancestor
102643220|NCT01295112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643221|NCT01295112|Growth Inhibitors|growth inhibitors|mesh-ancestor
102643222|NCT01295112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102643223|NCT01295112|Antiemetics|antiemetics|mesh-ancestor
102643224|NCT01295112|Autonomic Agents|autonomic agents|mesh-ancestor
102643225|NCT01295112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102643226|NCT01295112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102643227|NCT01295112|Glucocorticoids|glucocorticoids|mesh-ancestor
102643228|NCT01295112|Hormones|hormones|mesh-ancestor
102643229|NCT01295112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102643230|NCT01295112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102643231|NCT01295112|Protease Inhibitors|protease inhibitors|mesh-ancestor
102643232|NCT01295112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102643233|NCT01295112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643234|NCT01301742|Empagliflozin|empagliflozin|mesh-list
102643235|NCT01301742|Gemfibrozil|gemfibrozil|mesh-list
102643236|NCT01301742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102643237|NCT01301742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643238|NCT01301742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102643239|NCT01301742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643240|NCT01301742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102643241|NCT01301742|Antimetabolites|antimetabolites|mesh-ancestor
102643242|NCT01301742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102643243|NCT01301742|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102643244|NCT01301742|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102643245|NCT01301742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102643246|NCT01304082|Lidocaine|lidocaine|mesh-list
102643247|NCT01304082|Anesthetics, Local|anesthetics, local|mesh-ancestor
102643248|NCT01304082|Anesthetics|anesthetics|mesh-ancestor
102643249|NCT01304082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102643250|NCT01304082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643251|NCT01304082|Sensory System Agents|sensory system agents|mesh-ancestor
102643252|NCT01304082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102643253|NCT01304082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102643254|NCT01304082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102643255|NCT01304082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102643256|NCT01304082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102643257|NCT01304082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643258|NCT01304238|PENTA|penta|mesh-list
102643259|NCT01304238|Lepirudin|lepirudin|mesh-list
102643260|NCT01304238|Danaparoid|danaparoid|mesh-list
102643261|NCT01304238|Fondaparinux|fondaparinux|mesh-list
102643262|NCT01304238|Argatroban|argatroban|mesh-list
102643263|NCT01304238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102643264|NCT01304238|Antithrombins|antithrombins|mesh-ancestor
102643265|NCT01304238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102643266|NCT01304238|Protease Inhibitors|protease inhibitors|mesh-ancestor
102643267|NCT01304238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102643268|NCT01304238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643269|NCT01304238|Anticoagulants|anticoagulants|mesh-ancestor
102643270|NCT01304238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102643271|NCT01304238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102643272|NCT01304238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102643273|NCT01305252|Treprostinil|treprostinil|mesh-list
102643274|NCT01305252|Tadalafil|tadalafil|mesh-list
102643275|NCT01305252|Vasodilator Agents|vasodilator agents|mesh-ancestor
102275392|NCT05014685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102275393|NCT05014685|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102643276|NCT01305252|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102643277|NCT01305252|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102643278|NCT01305252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102643279|NCT01305252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643280|NCT01305252|Urological Agents|urological agents|mesh-ancestor
102643281|NCT01305252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102643282|NCT01308060|Botulinum Toxins|botulinum toxins|mesh-list
102643283|NCT01308060|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102643284|NCT01308060|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102643285|NCT01308060|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102643286|NCT01308060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102643287|NCT01308060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643288|NCT01308060|Cholinergic Agents|cholinergic agents|mesh-ancestor
102643289|NCT01308060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102643290|NCT01308060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643291|NCT01308060|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102643292|NCT01308060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102643294|NCT01308294|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
102643295|NCT01308294|Immunologic Factors|immunologic factors|mesh-ancestor
102643296|NCT01308294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643297|NCT01308294|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102643298|NCT01308840|Gemcitabine|gemcitabine|mesh-list
102643299|NCT01308840|Oxaliplatin|oxaliplatin|mesh-list
102643300|NCT01308840|Panitumumab|panitumumab|mesh-list
102643301|NCT01308840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102643302|NCT01308840|Antimetabolites|antimetabolites|mesh-ancestor
102643303|NCT01308840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643304|NCT01308840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102643305|NCT01308840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102643306|NCT01311102|Lidocaine|lidocaine|mesh-list
102643307|NCT01311102|Anesthetics, Local|anesthetics, local|mesh-ancestor
102643308|NCT01311102|Anesthetics|anesthetics|mesh-ancestor
102643309|NCT01311102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102643310|NCT01311102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643311|NCT01311102|Sensory System Agents|sensory system agents|mesh-ancestor
102643312|NCT01311102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102643313|NCT01311102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102643314|NCT01311102|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102643315|NCT01311102|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102643316|NCT01311102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102643317|NCT01311102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643318|NCT01312038|Simethicone|simethicone|mesh-list
102643319|NCT01312038|Antifoaming Agents|antifoaming agents|mesh-ancestor
102643320|NCT01312038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643321|NCT01312038|Emollients|emollients|mesh-ancestor
102643322|NCT01312038|Dermatologic Agents|dermatologic agents|mesh-ancestor
102643323|NCT01312272|Oxytocin|oxytocin|mesh-list
102643324|NCT01312272|Oxytocics|oxytocics|mesh-ancestor
102643325|NCT01312272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102643326|NCT01312272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643327|NCT01312818|Dexamethasone|dexamethasone|mesh-list
102643328|NCT01312818|Methotrexate|methotrexate|mesh-list
102643329|NCT01312818|Bortezomib|bortezomib|mesh-list
102643330|NCT01312818|Imatinib Mesylate|imatinib mesylate|mesh-list
102643331|NCT01312818|Vorinostat|vorinostat|mesh-list
102643332|NCT01312818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102643333|NCT01312818|Antiemetics|antiemetics|mesh-ancestor
102643334|NCT01312818|Autonomic Agents|autonomic agents|mesh-ancestor
102643335|NCT01312818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102643336|NCT01312818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643337|NCT01312818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102643338|NCT01312818|Glucocorticoids|glucocorticoids|mesh-ancestor
102643339|NCT01312818|Hormones|hormones|mesh-ancestor
102643340|NCT01312818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102643341|NCT01312818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102643342|NCT01312818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102643343|NCT01312818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102643344|NCT01312818|Abortifacient Agents|abortifacient agents|mesh-ancestor
102643345|NCT01312818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102643346|NCT01312818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102643347|NCT01312818|Antimetabolites|antimetabolites|mesh-ancestor
102643348|NCT01312818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275394|NCT05014685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102275395|NCT05014685|Antacids|antacids|mesh-ancestor
102275396|NCT05014685|Diuretics|diuretics|mesh-ancestor
102643349|NCT01312818|Dermatologic Agents|dermatologic agents|mesh-ancestor
102643350|NCT01312818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102643351|NCT01312818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102643352|NCT01312818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102643353|NCT01312818|Immunologic Factors|immunologic factors|mesh-ancestor
102643354|NCT01312818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102643355|NCT01312818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102643356|NCT01312818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101616021|NCT02876432|Diclofenac|diclofenac|mesh-list
102643357|NCT01312818|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102643358|NCT01313520|Infliximab|infliximab|mesh-list
102643359|NCT01313520|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102643360|NCT01313520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102643361|NCT01313520|Dermatologic Agents|dermatologic agents|mesh-ancestor
102643362|NCT01313520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102643363|NCT01313520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102643364|NCT01315002|Nicotine|nicotine|mesh-list
102643365|NCT01315002|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102643366|NCT01315002|Autonomic Agents|autonomic agents|mesh-ancestor
102643367|NCT01315002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102643368|NCT01315002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643369|NCT01315002|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102643370|NCT01315002|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102643371|NCT01315002|Cholinergic Agents|cholinergic agents|mesh-ancestor
102643372|NCT01315002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102643373|NCT01315002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643374|NCT01315158|Fentanyl|fentanyl|mesh-list
102643375|NCT01315158|Midazolam|midazolam|mesh-list
102643376|NCT01315158|Analgesics, Opioid|analgesics, opioid|mesh-list
102643377|NCT01315158|Propofol|propofol|mesh-list
102643378|NCT01315158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102643379|NCT01315158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102643380|NCT01315158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643381|NCT01315158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102643382|NCT01315158|Anesthetics, General|anesthetics, general|mesh-ancestor
102643383|NCT01315158|Anesthetics|anesthetics|mesh-ancestor
102643384|NCT01315158|Narcotics|narcotics|mesh-ancestor
102643385|NCT01315158|Analgesics|analgesics|mesh-ancestor
102643386|NCT01315158|Sensory System Agents|sensory system agents|mesh-ancestor
102643387|NCT01315158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102643388|NCT01315158|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102643389|NCT01315158|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102643390|NCT01315158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102643391|NCT01315158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102643392|NCT01315158|GABA Modulators|gaba modulators|mesh-ancestor
102643393|NCT01315158|GABA Agents|gaba agents|mesh-ancestor
102643394|NCT01315158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102643395|NCT01315158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643396|NCT01318278|Dopamine|dopamine|mesh-list
102643397|NCT01318278|Vasopressins|vasopressins|mesh-list
102643398|NCT01318278|Arginine Vasopressin|arginine vasopressin|mesh-list
102643399|NCT01318278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643400|NCT01318278|Hemostatics|hemostatics|mesh-ancestor
102643401|NCT01318278|Coagulants|coagulants|mesh-ancestor
102643402|NCT01318278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102643403|NCT01318278|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102643404|NCT01318278|Natriuretic Agents|natriuretic agents|mesh-ancestor
102643405|NCT01318278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102643406|NCT01318278|Sympathomimetics|sympathomimetics|mesh-ancestor
102643407|NCT01318278|Autonomic Agents|autonomic agents|mesh-ancestor
102643408|NCT01318278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102643409|NCT01318278|Dopamine Agents|dopamine agents|mesh-ancestor
102643410|NCT01318278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102643411|NCT01318278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643412|NCT01318278|Protective Agents|protective agents|mesh-ancestor
102643413|NCT01318356|Doxycycline|doxycycline|mesh-list
102643414|NCT01318356|Tetracycline|tetracycline|mesh-list
102643415|NCT01318356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102643416|NCT01318356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102643417|NCT01318356|Antimalarials|antimalarials|mesh-ancestor
102275397|NCT05014685|Natriuretic Agents|natriuretic agents|mesh-ancestor
102643418|NCT01318356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102643419|NCT01318356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101931999|NCT05501860|Carticaine|carticaine|mesh-list
102643420|NCT01318356|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102643421|NCT01318356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102643422|NCT01318356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643423|NCT01324128|Iron|iron|mesh-list
102643424|NCT01324128|Sevelamer|sevelamer|mesh-list
102643425|NCT01324128|Trace Elements|trace elements|mesh-ancestor
102643426|NCT01324128|Micronutrients|micronutrients|mesh-ancestor
102643427|NCT01324128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643428|NCT01324128|Chelating Agents|chelating agents|mesh-ancestor
102643429|NCT01324128|Sequestering Agents|sequestering agents|mesh-ancestor
102643430|NCT01324128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643431|NCT01328184|Empagliflozin|empagliflozin|mesh-list
102643432|NCT01328184|Levonorgestrel|levonorgestrel|mesh-list
102643433|NCT01328184|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102643434|NCT01328184|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
102643435|NCT01328184|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
102643436|NCT01328184|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102643437|NCT01328184|Contraceptive Agents|contraceptive agents|mesh-ancestor
102643438|NCT01328184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102643439|NCT01328184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643440|NCT01328184|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102643441|NCT01328184|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102643442|NCT01328184|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102643443|NCT01328184|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102643444|NCT01328184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643445|NCT01328184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102643446|NCT01328184|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102643447|NCT01328184|Estrogens|estrogens|mesh-ancestor
102643448|NCT01328184|Hormones|hormones|mesh-ancestor
102643449|NCT01328184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102643450|NCT01328184|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102643451|NCT01328184|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
102643452|NCT01328184|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102643453|NCT01328184|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102643454|NCT01328964|Fluticasone|fluticasone|mesh-list
102643455|NCT01328964|Xhance|xhance|mesh-list
102643456|NCT01328964|Budesonide|budesonide|mesh-list
102643457|NCT01328964|Montelukast|montelukast|mesh-list
102643458|NCT01328964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102643459|NCT01328964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102643460|NCT01328964|Autonomic Agents|autonomic agents|mesh-ancestor
102643461|NCT01328964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102643462|NCT01328964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643463|NCT01328964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102643464|NCT01328964|Respiratory System Agents|respiratory system agents|mesh-ancestor
102643465|NCT01328964|Dermatologic Agents|dermatologic agents|mesh-ancestor
102643466|NCT01328964|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102643467|NCT01328964|Glucocorticoids|glucocorticoids|mesh-ancestor
102643468|NCT01328964|Hormones|hormones|mesh-ancestor
102643469|NCT01328964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102643470|NCT01328964|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102643471|NCT01328964|Hormone Antagonists|hormone antagonists|mesh-ancestor
102643472|NCT01328964|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102643473|NCT01328964|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102643474|NCT01328964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643475|NCT01330134|Lidocaine|lidocaine|mesh-list
102643476|NCT01330134|Anesthetics, Local|anesthetics, local|mesh-ancestor
102643477|NCT01330134|Anesthetics|anesthetics|mesh-ancestor
102643478|NCT01330134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102643479|NCT01330134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643480|NCT01330134|Sensory System Agents|sensory system agents|mesh-ancestor
102643481|NCT01330134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102643482|NCT01330134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102643483|NCT01330134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102643484|NCT01330134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102643485|NCT01330134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102643486|NCT01330134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643487|NCT01330290|Rotigotine|rotigotine|mesh-list
102643488|NCT01330290|Dopamine Agonists|dopamine agonists|mesh-ancestor
102643489|NCT01330290|Dopamine Agents|dopamine agents|mesh-ancestor
102643490|NCT01330290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102643491|NCT01330290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643492|NCT01330290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643493|NCT01331304|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102643494|NCT01331304|Antidepressive Agents|antidepressive agents|mesh-ancestor
102275398|NCT05014685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275400|NCT05014685|Respiratory System Agents|respiratory system agents|mesh-ancestor
102275401|NCT03111901|Pembrolizumab|pembrolizumab|mesh-list
102275402|NCT03111901|Interleukin-2|interleukin-2|mesh-list
102275403|NCT03111901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102275404|NCT03111901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102643495|NCT01331304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102643496|NCT01331304|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102643497|NCT01331304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102643498|NCT01331304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102643499|NCT01331304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643500|NCT01331694|Fluticasone|fluticasone|mesh-list
102643501|NCT01331694|Bromides|bromides|mesh-list
102643502|NCT01331694|Albuterol|albuterol|mesh-list
102643503|NCT01331694|Tiotropium Bromide|tiotropium bromide|mesh-list
102643504|NCT01331694|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102643505|NCT01331694|Ipratropium|ipratropium|mesh-list
102643506|NCT01331694|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102643507|NCT01331694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102643508|NCT01331694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102643509|NCT01331694|Autonomic Agents|autonomic agents|mesh-ancestor
102643510|NCT01331694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102643511|NCT01331694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643512|NCT01331694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102643513|NCT01331694|Respiratory System Agents|respiratory system agents|mesh-ancestor
102643514|NCT01331694|Dermatologic Agents|dermatologic agents|mesh-ancestor
102643515|NCT01331694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102643516|NCT01331694|Parasympatholytics|parasympatholytics|mesh-ancestor
102643517|NCT01331694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102643518|NCT01331694|Cholinergic Agents|cholinergic agents|mesh-ancestor
102643519|NCT01331694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102643520|NCT01331694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643521|NCT01331694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102643522|NCT01331694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102643523|NCT01331694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102643524|NCT01331694|Adrenergic Agents|adrenergic agents|mesh-ancestor
102643525|NCT01331694|Anticonvulsants|anticonvulsants|mesh-ancestor
102643526|NCT01331694|Tocolytic Agents|tocolytic agents|mesh-ancestor
102643527|NCT01331694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102643528|NCT01331694|Glucocorticoids|glucocorticoids|mesh-ancestor
102643529|NCT01331694|Hormones|hormones|mesh-ancestor
102643530|NCT01331694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102643531|NCT01331694|Sympathomimetics|sympathomimetics|mesh-ancestor
102643532|NCT01333098|Mifepristone|mifepristone|mesh-list
102643533|NCT01333098|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102643534|NCT01333098|Abortifacient Agents|abortifacient agents|mesh-ancestor
102643535|NCT01333098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102643536|NCT01333098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643537|NCT01333098|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102643538|NCT01333098|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102643539|NCT01333098|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102643540|NCT01333098|Contraceptive Agents|contraceptive agents|mesh-ancestor
102643541|NCT01333098|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102643542|NCT01333098|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102643543|NCT01333098|Hormone Antagonists|hormone antagonists|mesh-ancestor
102643544|NCT01333098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102643545|NCT01333098|Luteolytic Agents|luteolytic agents|mesh-ancestor
102643546|NCT01333098|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102643547|NCT01333098|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102643548|NCT01333488|Magnesium Sulfate|magnesium sulfate|mesh-list
102643549|NCT01333488|Analgesics|analgesics|mesh-ancestor
102643550|NCT01333488|Sensory System Agents|sensory system agents|mesh-ancestor
102643551|NCT01333488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102643552|NCT01333488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643553|NCT01333488|Anesthetics|anesthetics|mesh-ancestor
102643554|NCT01333488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102643555|NCT01333488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102643556|NCT01333488|Anticonvulsants|anticonvulsants|mesh-ancestor
102643557|NCT01333488|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102643558|NCT01333488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102643559|NCT01333488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643560|NCT01333488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102643561|NCT01333488|Tocolytic Agents|tocolytic agents|mesh-ancestor
102275405|NCT03111901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102275406|NCT03111901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643562|NCT01333488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102643563|NCT01335204|Bavituximab|bavituximab|mesh-list
102643564|NCT01335204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102643565|NCT01335204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102643566|NCT01335750|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102643567|NCT01336296|Mycophenolic Acid|mycophenolic acid|mesh-list
102643568|NCT01336296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102643569|NCT01336296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102643570|NCT01336296|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102643571|NCT01336296|Antitubercular Agents|antitubercular agents|mesh-ancestor
102643572|NCT01336296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102643573|NCT01336296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102643574|NCT01336296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102643575|NCT01336296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643576|NCT01337700|Milnacipran|milnacipran|mesh-list
102643577|NCT01337700|Levomilnacipran|levomilnacipran|mesh-list
102643578|NCT01337700|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102643579|NCT01337700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102643580|NCT01337700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102643581|NCT01337700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643582|NCT01337700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102643583|NCT01337700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643584|NCT01337700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102643585|NCT01337700|Analgesics|analgesics|mesh-ancestor
102643586|NCT01337700|Sensory System Agents|sensory system agents|mesh-ancestor
102643587|NCT01337700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102643588|NCT01337700|Antidepressive Agents|antidepressive agents|mesh-ancestor
102643589|NCT01337700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102643590|NCT01339260|Dexamethasone|dexamethasone|mesh-list
102643591|NCT01339260|Palonosetron|palonosetron|mesh-list
102643592|NCT01339260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102643593|NCT01339260|Antiemetics|antiemetics|mesh-ancestor
102643594|NCT01339260|Autonomic Agents|autonomic agents|mesh-ancestor
102643595|NCT01339260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102643596|NCT01339260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643597|NCT01339260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102643598|NCT01339260|Glucocorticoids|glucocorticoids|mesh-ancestor
102643599|NCT01339260|Hormones|hormones|mesh-ancestor
102643600|NCT01339260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102643601|NCT01339260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102643602|NCT01339260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102643603|NCT01339260|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102643604|NCT01339260|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102643605|NCT01339260|Serotonin Agents|serotonin agents|mesh-ancestor
102643606|NCT01339260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102643607|NCT01339260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643608|NCT01340586|Apixaban|apixaban|mesh-list
102643609|NCT01340586|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102643610|NCT01340586|Antithrombins|antithrombins|mesh-ancestor
102643611|NCT01340586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102643612|NCT01340586|Protease Inhibitors|protease inhibitors|mesh-ancestor
102643613|NCT01340586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102643614|NCT01340586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643615|NCT01340586|Anticoagulants|anticoagulants|mesh-ancestor
102643616|NCT01342770|Pioglitazone|pioglitazone|mesh-list
102643617|NCT01342770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102643618|NCT01342770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643619|NCT01343004|Teriparatide|teriparatide|mesh-list
102643620|NCT01343004|Abaloparatide|abaloparatide|mesh-list
102643621|NCT01343004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102643622|NCT01343004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643623|NCT01343004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102643624|NCT01347060|Fluticasone|fluticasone|mesh-list
102643626|NCT01347060|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102643627|NCT01347060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102643628|NCT01347060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102643629|NCT01347060|Autonomic Agents|autonomic agents|mesh-ancestor
102643630|NCT01347060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102643631|NCT01347060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643632|NCT01347060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102275407|NCT03111901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101932216|NCT03629054|Hormones|hormones|mesh-ancestor
102643633|NCT01347060|Respiratory System Agents|respiratory system agents|mesh-ancestor
102643634|NCT01347060|Dermatologic Agents|dermatologic agents|mesh-ancestor
102643635|NCT01347060|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102643636|NCT01347060|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102643637|NCT01347060|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102643638|NCT01347060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102643639|NCT01347060|Adrenergic Agents|adrenergic agents|mesh-ancestor
102643640|NCT01347060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102643641|NCT01347060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643642|NCT01351740|Ritonavir|ritonavir|mesh-list
102643643|NCT01351740|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102643644|NCT01351740|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102643645|NCT01351740|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102643646|NCT01351740|Protease Inhibitors|protease inhibitors|mesh-ancestor
102643647|NCT01351740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102643648|NCT01351740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643649|NCT01351740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102643650|NCT01351740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102643651|NCT01351740|Antiviral Agents|antiviral agents|mesh-ancestor
102643652|NCT01351740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102643653|NCT01351740|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102643654|NCT01351740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102643655|NCT01353144|Aspirin|aspirin|mesh-list
102643656|NCT01353144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102643657|NCT01353144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102643658|NCT01353144|Analgesics|analgesics|mesh-ancestor
102643659|NCT01353144|Sensory System Agents|sensory system agents|mesh-ancestor
102643660|NCT01353144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102643661|NCT01353144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643662|NCT01353144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102643663|NCT01353144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102643664|NCT01353144|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102643665|NCT01353144|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102643666|NCT01353144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643667|NCT01353144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102643668|NCT01353144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102643669|NCT01353144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102643670|NCT01353144|Antipyretics|antipyretics|mesh-ancestor
102643671|NCT01362192|Chlorhexidine|chlorhexidine|mesh-list
102643672|NCT01362192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102643673|NCT01362192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102643674|NCT01362192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102643675|NCT01362192|Disinfectants|disinfectants|mesh-ancestor
102643676|NCT01362192|Dermatologic Agents|dermatologic agents|mesh-ancestor
102643677|NCT01363050|Ketorolac|ketorolac|mesh-list
102643678|NCT01363050|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102643679|NCT01363050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102643680|NCT01363050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102643681|NCT01363050|Analgesics|analgesics|mesh-ancestor
102643682|NCT01363050|Sensory System Agents|sensory system agents|mesh-ancestor
102643683|NCT01363050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102643684|NCT01363050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643685|NCT01363050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102643686|NCT01363050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102643687|NCT01363050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102643688|NCT01363050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102643689|NCT01363050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643690|NCT01363128|Cytarabine|cytarabine|mesh-list
102643691|NCT01363128|Dexamethasone|dexamethasone|mesh-list
102643692|NCT01363128|Dexamethasone acetate|dexamethasone acetate|mesh-list
102643693|NCT01363128|Cyclophosphamide|cyclophosphamide|mesh-list
102643694|NCT01363128|Doxorubicin|doxorubicin|mesh-list
102643695|NCT01363128|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102643696|NCT01363128|Methotrexate|methotrexate|mesh-list
102643697|NCT01363128|Vincristine|vincristine|mesh-list
102643698|NCT01363128|Ofatumumab|ofatumumab|mesh-list
102643699|NCT01363128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102643700|NCT01363128|BB 1101|bb 1101|mesh-list
102643701|NCT01363128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102643702|NCT01363128|Immunologic Factors|immunologic factors|mesh-ancestor
102643703|NCT01363128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643704|NCT01363128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102643705|NCT01363128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102643706|NCT01363128|Alkylating Agents|alkylating agents|mesh-ancestor
101932284|NCT01048138|Parasympatholytics|parasympatholytics|mesh-ancestor
102643707|NCT01363128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643708|NCT01363128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102643709|NCT01363128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102643710|NCT01363128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102643712|NCT01363128|Autonomic Agents|autonomic agents|mesh-ancestor
102643713|NCT01363128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102643714|NCT01363128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102643715|NCT01363128|Glucocorticoids|glucocorticoids|mesh-ancestor
102643716|NCT01363128|Hormones|hormones|mesh-ancestor
102643717|NCT01363128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102643718|NCT01363128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102643719|NCT01363128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102643720|NCT01363128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102643721|NCT01363128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102643722|NCT01363128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102643723|NCT01363128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102643724|NCT01363128|Abortifacient Agents|abortifacient agents|mesh-ancestor
102643725|NCT01363128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102643726|NCT01363128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102643727|NCT01363128|Antimetabolites|antimetabolites|mesh-ancestor
102643728|NCT01363128|Dermatologic Agents|dermatologic agents|mesh-ancestor
102643729|NCT01363128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102643730|NCT01363128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102643731|NCT01363128|Antiviral Agents|antiviral agents|mesh-ancestor
102643732|NCT01363128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102643733|NCT01363128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102643734|NCT01363128|Tubulin Modulators|tubulin modulators|mesh-ancestor
102643735|NCT01363128|Antimitotic Agents|antimitotic agents|mesh-ancestor
102643736|NCT01363128|Mitosis Modulators|mitosis modulators|mesh-ancestor
102643737|NCT01363128|Protease Inhibitors|protease inhibitors|mesh-ancestor
102643738|NCT01365624|Ketorolac|ketorolac|mesh-list
102643739|NCT01365624|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102643740|NCT01365624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102643741|NCT01365624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102643742|NCT01365624|Analgesics|analgesics|mesh-ancestor
102643743|NCT01365624|Sensory System Agents|sensory system agents|mesh-ancestor
102643744|NCT01365624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102643745|NCT01365624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643746|NCT01365624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102643747|NCT01365624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102643748|NCT01365624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102643749|NCT01365624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102643750|NCT01365624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643751|NCT01371786|Mometasone Furoate|mometasone furoate|mesh-list
102643752|NCT01371786|Ciclesonide|ciclesonide|mesh-list
102643753|NCT01371786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102643754|NCT01371786|Dermatologic Agents|dermatologic agents|mesh-ancestor
102643755|NCT01371786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102643756|NCT01371786|Glucocorticoids|glucocorticoids|mesh-ancestor
102643757|NCT01371786|Hormones|hormones|mesh-ancestor
102643758|NCT01371786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102643759|NCT01371786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643760|NCT01377636|Isoproterenol|isoproterenol|mesh-list
102643761|NCT01377636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102643762|NCT01377636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102643763|NCT01377636|Adrenergic Agents|adrenergic agents|mesh-ancestor
102643764|NCT01377636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102643765|NCT01377636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643766|NCT01377636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643767|NCT01377636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102643768|NCT01377636|Autonomic Agents|autonomic agents|mesh-ancestor
102643769|NCT01377636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102643770|NCT01377636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102643771|NCT01377636|Respiratory System Agents|respiratory system agents|mesh-ancestor
102643772|NCT01377636|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102643773|NCT01377636|Sympathomimetics|sympathomimetics|mesh-ancestor
102643774|NCT01377636|Protective Agents|protective agents|mesh-ancestor
102643775|NCT01378416|Decitabine|decitabine|mesh-list
102643776|NCT01378416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102643777|NCT01378416|Antimetabolites|antimetabolites|mesh-ancestor
102643778|NCT01378416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275409|NCT03111901|Sensory System Agents|sensory system agents|mesh-ancestor
101932362|NCT01089855|Carbamazepine|carbamazepine|mesh-list
102643779|NCT01378416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102643780|NCT01378416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102643781|NCT01379664|Sevoflurane|sevoflurane|mesh-list
102643782|NCT01379664|Isoflurane|isoflurane|mesh-list
102643783|NCT01379664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102643784|NCT01379664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102643785|NCT01379664|Anesthetics, General|anesthetics, general|mesh-ancestor
102643786|NCT01379664|Anesthetics|anesthetics|mesh-ancestor
102643787|NCT01379664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102643788|NCT01379664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643789|NCT01380366|Hormones|hormones|mesh-list
102643790|NCT01380366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102643791|NCT01380366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643792|NCT01387464|Bromfenac|bromfenac|mesh-list
102643793|NCT01387464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102643794|NCT01387464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102643795|NCT01387464|Analgesics|analgesics|mesh-ancestor
102643796|NCT01387464|Sensory System Agents|sensory system agents|mesh-ancestor
102643797|NCT01387464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102643798|NCT01387464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643799|NCT01387464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102643800|NCT01387464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102643801|NCT01388946|Ropivacaine|ropivacaine|mesh-list
102643802|NCT01388946|Anesthetics, Local|anesthetics, local|mesh-ancestor
102643803|NCT01388946|Anesthetics|anesthetics|mesh-ancestor
102643804|NCT01388946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102643805|NCT01388946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643806|NCT01388946|Sensory System Agents|sensory system agents|mesh-ancestor
102643807|NCT01388946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102643808|NCT01390818|Niacinamide|niacinamide|mesh-list
102643809|NCT01390818|Sirolimus|sirolimus|mesh-list
102643810|NCT01390818|MTOR Inhibitors|mtor inhibitors|mesh-list
102643811|NCT01390818|Temsirolimus|temsirolimus|mesh-list
102643812|NCT01390818|Elafin|elafin|mesh-list
102643813|NCT01390818|Protease Inhibitors|protease inhibitors|mesh-ancestor
102643814|NCT01390818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102643815|NCT01390818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643816|NCT01390818|Vitamin B Complex|vitamin b complex|mesh-ancestor
102643817|NCT01390818|Vitamins|vitamins|mesh-ancestor
102643818|NCT01390818|Micronutrients|micronutrients|mesh-ancestor
102643819|NCT01390818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643820|NCT01390818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102643821|NCT01390818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102643822|NCT01390818|Immunologic Factors|immunologic factors|mesh-ancestor
102643823|NCT01390818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102643824|NCT01390818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102643825|NCT01390818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102643826|NCT01390818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102643827|NCT01390818|Antifungal Agents|antifungal agents|mesh-ancestor
102643828|NCT01391286|Bimatoprost|bimatoprost|mesh-list
102643829|NCT01391286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102643830|NCT01391286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102643831|NCT01391364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102643832|NCT01393392|Methadone|methadone|mesh-list
102643833|NCT01393392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102643834|NCT01393392|Narcotics|narcotics|mesh-ancestor
102643835|NCT01393392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102643836|NCT01393392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643837|NCT01393392|Analgesics|analgesics|mesh-ancestor
102643838|NCT01393392|Sensory System Agents|sensory system agents|mesh-ancestor
102643839|NCT01393392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102643840|NCT01393392|Antitussive Agents|antitussive agents|mesh-ancestor
102643841|NCT01393392|Respiratory System Agents|respiratory system agents|mesh-ancestor
102643842|NCT01393704|Vasopressins|vasopressins|mesh-list
102643843|NCT01393704|Arginine Vasopressin|arginine vasopressin|mesh-list
102643844|NCT01393704|Hemostatics|hemostatics|mesh-ancestor
102643845|NCT01393704|Coagulants|coagulants|mesh-ancestor
102643846|NCT01393704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102643847|NCT01393704|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102643848|NCT01393704|Natriuretic Agents|natriuretic agents|mesh-ancestor
102643849|NCT01393704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643850|NCT01399008|Colchicine|colchicine|mesh-list
102643851|NCT01399008|Allopurinol|allopurinol|mesh-list
102643852|NCT01399008|Gout Suppressants|gout suppressants|mesh-ancestor
102643853|NCT01399008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102643854|NCT01399008|Tubulin Modulators|tubulin modulators|mesh-ancestor
101932438|NCT02962102|Vitamins|vitamins|mesh-ancestor
102643855|NCT01399008|Antimitotic Agents|antimitotic agents|mesh-ancestor
102643856|NCT01399008|Mitosis Modulators|mitosis modulators|mesh-ancestor
102643857|NCT01399008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643858|NCT01399008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102643859|NCT01399008|Antimetabolites|antimetabolites|mesh-ancestor
102643860|NCT01399008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102643861|NCT01399008|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102643862|NCT01399008|Antioxidants|antioxidants|mesh-ancestor
102643863|NCT01399008|Protective Agents|protective agents|mesh-ancestor
102643864|NCT01399008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643865|NCT01399866|Cycloserine|cycloserine|mesh-list
102643866|NCT01399866|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102643867|NCT01399866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102643868|NCT01399866|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102643869|NCT01399866|Antitubercular Agents|antitubercular agents|mesh-ancestor
102643870|NCT01399866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102643871|NCT01399866|Antimetabolites|antimetabolites|mesh-ancestor
102643872|NCT01399866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643873|NCT01402050|Dinoprostone|dinoprostone|mesh-list
102643874|NCT01402050|Oxytocics|oxytocics|mesh-ancestor
102643875|NCT01402050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102643876|NCT01402050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643877|NCT01403376|Interferons|interferons|mesh-list
102643878|NCT01403376|Interferon-beta|interferon-beta|mesh-list
102643879|NCT01403376|Teriflunomide|teriflunomide|mesh-list
102643880|NCT01403376|Interferon beta-1b|interferon beta-1b|mesh-list
102643881|NCT01403376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102643882|NCT01403376|Antiviral Agents|antiviral agents|mesh-ancestor
102643883|NCT01403376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102643884|NCT01403376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102643885|NCT01403376|Immunologic Factors|immunologic factors|mesh-ancestor
102643886|NCT01403376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643887|NCT01403376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102643888|NCT01403376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102643889|NCT01403376|Analgesics|analgesics|mesh-ancestor
102643890|NCT01403376|Sensory System Agents|sensory system agents|mesh-ancestor
102643891|NCT01403376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102643892|NCT01403376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102643893|NCT01403376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102643894|NCT01403376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102643895|NCT01404936|Interferons|interferons|mesh-list
102643896|NCT01404936|Interferon-alpha|interferon-alpha|mesh-list
102643897|NCT01404936|Interferon alpha-2|interferon alpha-2|mesh-list
102643898|NCT01404936|Doxorubicin|doxorubicin|mesh-list
102643899|NCT01404936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102643900|NCT01404936|Bleomycin|bleomycin|mesh-list
102643901|NCT01404936|Dacarbazine|dacarbazine|mesh-list
102643902|NCT01404936|Vinblastine|vinblastine|mesh-list
102643903|NCT01404936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102643904|NCT01404936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102643905|NCT01404936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102643906|NCT01404936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102643907|NCT01404936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102643908|NCT01404936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643909|NCT01404936|Antiviral Agents|antiviral agents|mesh-ancestor
102643910|NCT01404936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102643911|NCT01404936|Immunologic Factors|immunologic factors|mesh-ancestor
102643912|NCT01404936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643913|NCT01404936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102643914|NCT01404936|Alkylating Agents|alkylating agents|mesh-ancestor
102643915|NCT01404936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102643916|NCT01404936|Tubulin Modulators|tubulin modulators|mesh-ancestor
102643917|NCT01404936|Antimitotic Agents|antimitotic agents|mesh-ancestor
102643918|NCT01404936|Mitosis Modulators|mitosis modulators|mesh-ancestor
102643919|NCT01410084|Vitamin D|vitamin d|mesh-list
102643920|NCT01410084|Cholecalciferol|cholecalciferol|mesh-list
102643921|NCT01410084|Vitamins|vitamins|mesh-list
102643922|NCT01410084|Vitamin E|vitamin e|mesh-list
102643923|NCT01410084|Micronutrients|micronutrients|mesh-ancestor
102643924|NCT01410084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643925|NCT01410084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102643926|NCT01410084|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102643927|NCT01410084|Antioxidants|antioxidants|mesh-ancestor
102643928|NCT01410084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643929|NCT01410084|Protective Agents|protective agents|mesh-ancestor
101932510|NCT03040024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102643930|NCT01413516|Varenicline|varenicline|mesh-list
102643931|NCT01413516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102643932|NCT01413516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102643933|NCT01413516|Cholinergic Agents|cholinergic agents|mesh-ancestor
102275410|NCT03111901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102643934|NCT01413516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102643935|NCT01413516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643936|NCT01413516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643937|NCT01413750|Paclitaxel|paclitaxel|mesh-list
102643938|NCT01413750|Carboplatin|carboplatin|mesh-list
102643939|NCT01413750|Vorinostat|vorinostat|mesh-list
102643940|NCT01413750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102643941|NCT01413750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102643942|NCT01413750|Tubulin Modulators|tubulin modulators|mesh-ancestor
102643943|NCT01413750|Antimitotic Agents|antimitotic agents|mesh-ancestor
102643944|NCT01413750|Mitosis Modulators|mitosis modulators|mesh-ancestor
102643945|NCT01413750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643946|NCT01413750|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102643947|NCT01413750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102643948|NCT01417026|Oxytocin|oxytocin|mesh-list
102643949|NCT01417026|Oxytocics|oxytocics|mesh-ancestor
102643950|NCT01417026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102643951|NCT01417026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643952|NCT01420146|Trastuzumab|trastuzumab|mesh-list
102643953|NCT01420146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102643954|NCT01420146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102643955|NCT01421472|Paclitaxel|paclitaxel|mesh-list
102643956|NCT01421472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102643957|NCT01421472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102643958|NCT01421472|Tubulin Modulators|tubulin modulators|mesh-ancestor
102643959|NCT01421472|Antimitotic Agents|antimitotic agents|mesh-ancestor
102643960|NCT01421472|Mitosis Modulators|mitosis modulators|mesh-ancestor
102643961|NCT01421472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643962|NCT01428336|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102643963|NCT01428336|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
102643964|NCT01428336|Cosyntropin|cosyntropin|mesh-list
102643965|NCT01428336|beta-Endorphin|beta-endorphin|mesh-list
102643966|NCT01428336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643967|NCT01428336|Hormones|hormones|mesh-ancestor
102643968|NCT01428336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102643969|NCT01428336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102643970|NCT01428336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643971|NCT01429272|Aspirin|aspirin|mesh-list
102643972|NCT01429272|Minocycline|minocycline|mesh-list
102643973|NCT01429272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102643974|NCT01429272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102643975|NCT01429272|Analgesics|analgesics|mesh-ancestor
102643976|NCT01429272|Sensory System Agents|sensory system agents|mesh-ancestor
102643977|NCT01429272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102643978|NCT01429272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102643979|NCT01429272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102643980|NCT01429272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102643981|NCT01429272|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102643982|NCT01429272|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102643983|NCT01429272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643984|NCT01429272|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102643985|NCT01429272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102643986|NCT01429272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102643987|NCT01429272|Antipyretics|antipyretics|mesh-ancestor
102643988|NCT01429272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102643989|NCT01429272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102643990|NCT01429350|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102643991|NCT01429350|Plasminogen|plasminogen|mesh-list
102643992|NCT01429350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102643993|NCT01429350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102643994|NCT01429350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102643995|NCT01432236|Pregabalin|pregabalin|mesh-list
102643996|NCT01432236|Analgesics|analgesics|mesh-ancestor
102643997|NCT01432236|Sensory System Agents|sensory system agents|mesh-ancestor
102643998|NCT01432236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102643999|NCT01432236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644000|NCT01432236|Anticonvulsants|anticonvulsants|mesh-ancestor
102644001|NCT01432236|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102644002|NCT01432236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102644003|NCT01432236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644004|NCT01432236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102644005|NCT01432236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101932582|NCT00725374|Hormones|hormones|mesh-ancestor
102644006|NCT01432236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102275411|NCT03111901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644007|NCT01432236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102644008|NCT01432236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102644010|NCT01434186|Saxagliptin|saxagliptin|mesh-list
102644011|NCT01434186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102644012|NCT01434186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644013|NCT01434186|Incretins|incretins|mesh-ancestor
102644014|NCT01434186|Hormones|hormones|mesh-ancestor
102644015|NCT01434186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102644016|NCT01434186|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102644017|NCT01434186|Protease Inhibitors|protease inhibitors|mesh-ancestor
102644018|NCT01434186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102644019|NCT01434186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644020|NCT01434342|Nicotine|nicotine|mesh-list
102644021|NCT01434342|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102644022|NCT01434342|Autonomic Agents|autonomic agents|mesh-ancestor
102644023|NCT01434342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102644024|NCT01434342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644025|NCT01434342|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102644026|NCT01434342|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102644027|NCT01434342|Cholinergic Agents|cholinergic agents|mesh-ancestor
102644028|NCT01434342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102644029|NCT01434342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644030|NCT01435824|Amoxicillin|amoxicillin|mesh-list
102644031|NCT01435824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102644032|NCT01435824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102644033|NCT01436526|Rivaroxaban|rivaroxaban|mesh-list
102644034|NCT01436526|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102644035|NCT01436526|Antithrombins|antithrombins|mesh-ancestor
102644036|NCT01436526|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102644037|NCT01436526|Protease Inhibitors|protease inhibitors|mesh-ancestor
102644038|NCT01436526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102644039|NCT01436526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644040|NCT01436526|Anticoagulants|anticoagulants|mesh-ancestor
102644041|NCT01438710|Tacrolimus|tacrolimus|mesh-list
102644042|NCT01438710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102644043|NCT01438710|Immunologic Factors|immunologic factors|mesh-ancestor
102644044|NCT01438710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644045|NCT01438710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102644046|NCT01438710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102644047|NCT01438710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644048|NCT01443546|Leuprolide|leuprolide|mesh-list
102644049|NCT01443546|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102644050|NCT01443546|Fertility Agents|fertility agents|mesh-ancestor
102644051|NCT01443546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102644052|NCT01443546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644053|NCT01443546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102644054|NCT01443546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102644055|NCT01444716|Ofatumumab|ofatumumab|mesh-list
102644056|NCT01444716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102644057|NCT01444716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102644058|NCT01444716|Immunologic Factors|immunologic factors|mesh-ancestor
102644059|NCT01444716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644060|NCT01445028|Isotretinoin|isotretinoin|mesh-list
102644061|NCT01445028|Dermatologic Agents|dermatologic agents|mesh-ancestor
102644062|NCT01452126|Ropivacaine|ropivacaine|mesh-list
102644063|NCT01452126|Anesthetics, Local|anesthetics, local|mesh-ancestor
102644064|NCT01452126|Anesthetics|anesthetics|mesh-ancestor
102644065|NCT01452126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102644066|NCT01452126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644067|NCT01452126|Sensory System Agents|sensory system agents|mesh-ancestor
102644068|NCT01452126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102644069|NCT01457430|Icatibant|icatibant|mesh-list
102644070|NCT01457430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102644071|NCT01457430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102644072|NCT01457430|Analgesics|analgesics|mesh-ancestor
102644073|NCT01457430|Sensory System Agents|sensory system agents|mesh-ancestor
102644074|NCT01457430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102644075|NCT01457430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644076|NCT01457430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102644077|NCT01457430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102644078|NCT01457430|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
102644079|NCT01457430|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
102644080|NCT01457430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644081|NCT01457430|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102644082|NCT01457430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102644083|NCT01457430|Immunologic Factors|immunologic factors|mesh-ancestor
102644084|NCT01458990|Omeprazole|omeprazole|mesh-list
102644085|NCT01458990|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102644086|NCT01458990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102644087|NCT01458990|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102644088|NCT01458990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102644089|NCT01458990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644090|NCT01460940|Lenalidomide|lenalidomide|mesh-list
102644091|NCT01460940|Panobinostat|panobinostat|mesh-list
102644092|NCT01460940|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
102644093|NCT01460940|Immunologic Factors|immunologic factors|mesh-ancestor
102644094|NCT01460940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644095|NCT01460940|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102644096|NCT01460940|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102644097|NCT01460940|Growth Substances|growth substances|mesh-ancestor
102644098|NCT01460940|Growth Inhibitors|growth inhibitors|mesh-ancestor
102644099|NCT01460940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102644100|NCT01460940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102644101|NCT01460940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644102|NCT01462812|Sumatriptan|sumatriptan|mesh-list
102644103|NCT01462812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102644104|NCT01462812|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102644105|NCT01462812|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102644106|NCT01462812|Serotonin Agents|serotonin agents|mesh-ancestor
102644107|NCT01462812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102644108|NCT01462812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644109|NCT01462812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644110|NCT01463202|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102644111|NCT01463202|Medroxyprogesterone|medroxyprogesterone|mesh-list
102644112|NCT01463202|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102644113|NCT01463202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102644114|NCT01463202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102644115|NCT01463202|Contraceptive Agents|contraceptive agents|mesh-ancestor
102644116|NCT01463202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102644117|NCT01463202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644118|NCT01463202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102644119|NCT01463202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102644120|NCT01463202|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102644121|NCT01463202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102644122|NCT01463202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102644123|NCT01467882|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102644124|NCT01467882|Luteolytic Agents|luteolytic agents|mesh-ancestor
102644125|NCT01467882|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102644126|NCT01467882|Contraceptive Agents|contraceptive agents|mesh-ancestor
102644127|NCT01467882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102644128|NCT01467882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644129|NCT01467882|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102644130|NCT01467882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102644131|NCT01467882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102644132|NCT01468350|4-Aminopyridine|4-aminopyridine|mesh-list
102644133|NCT01468350|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102644134|NCT01468350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102644135|NCT01468350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644136|NCT01468584|Ribavirin|ribavirin|mesh-list
102644137|NCT01468584|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102644138|NCT01468584|Antimetabolites|antimetabolites|mesh-ancestor
102644139|NCT01468584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644140|NCT01468584|Antiviral Agents|antiviral agents|mesh-ancestor
102644141|NCT01468584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102644142|NCT01472874|Trientine|trientine|mesh-list
102644143|NCT01472874|Chelating Agents|chelating agents|mesh-ancestor
102644144|NCT01472874|Sequestering Agents|sequestering agents|mesh-ancestor
102644145|NCT01472874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644146|NCT01474122|Macitentan|macitentan|mesh-list
102644147|NCT01474122|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
102644148|NCT01474122|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102644149|NCT01474122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644150|NCT01474122|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
102275412|NCT05014607|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101932807|NCT03731780|Chlorhexidine|chlorhexidine|mesh-list
102644151|NCT01474590|Doxycycline|doxycycline|mesh-list
102644152|NCT01474590|Isotretinoin|isotretinoin|mesh-list
102644153|NCT01474590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102644154|NCT01474590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102644155|NCT01474590|Antimalarials|antimalarials|mesh-ancestor
102644156|NCT01474590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102644157|NCT01474590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102644158|NCT01474590|Dermatologic Agents|dermatologic agents|mesh-ancestor
102644159|NCT01477320|Pantoprazole|pantoprazole|mesh-list
102644160|NCT01477320|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102644161|NCT01477320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102644162|NCT01477320|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102644163|NCT01477320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102644164|NCT01477320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644165|NCT01478256|Erythromycin|erythromycin|mesh-list
102644166|NCT01478256|Erythromycin Estolate|erythromycin estolate|mesh-list
102644167|NCT01478256|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
102644168|NCT01478256|Erythromycin stearate|erythromycin stearate|mesh-list
102644169|NCT01478256|Besifloxacin|besifloxacin|mesh-list
102644170|NCT01478256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102644171|NCT01478256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102644172|NCT01478256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102644173|NCT01478256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102644174|NCT01478256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102644175|NCT01478256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644176|NCT01478256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102644177|NCT01478256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102644178|NCT01478256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102644179|NCT01479270|Epinephrine|epinephrine|mesh-list
102644180|NCT01479270|Ropivacaine|ropivacaine|mesh-list
102644181|NCT01479270|Anesthetics, Local|anesthetics, local|mesh-ancestor
102644182|NCT01479270|Anesthetics|anesthetics|mesh-ancestor
102644183|NCT01479270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102644184|NCT01479270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644185|NCT01479270|Sensory System Agents|sensory system agents|mesh-ancestor
102644186|NCT01479270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102644187|NCT01479270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102644188|NCT01479270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102644189|NCT01479270|Adrenergic Agents|adrenergic agents|mesh-ancestor
102644190|NCT01479270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102644191|NCT01479270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644192|NCT01479270|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102644193|NCT01479270|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102644194|NCT01479270|Autonomic Agents|autonomic agents|mesh-ancestor
102644195|NCT01479270|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102644196|NCT01479270|Respiratory System Agents|respiratory system agents|mesh-ancestor
102644197|NCT01479270|Mydriatics|mydriatics|mesh-ancestor
102644198|NCT01479270|Sympathomimetics|sympathomimetics|mesh-ancestor
102644199|NCT01479270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102644200|NCT01479348|Tetrahydrouridine|tetrahydrouridine|mesh-list
102644201|NCT01479348|Antimetabolites|antimetabolites|mesh-ancestor
102644202|NCT01479348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644203|NCT01483560|Metformin|metformin|mesh-list
102644204|NCT01483560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102644205|NCT01483560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644206|NCT01484340|Nicotine|nicotine|mesh-list
102644207|NCT01484340|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102644208|NCT01484340|Autonomic Agents|autonomic agents|mesh-ancestor
102644209|NCT01484340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102644210|NCT01484340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644211|NCT01484340|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102644212|NCT01484340|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102644213|NCT01484340|Cholinergic Agents|cholinergic agents|mesh-ancestor
102644214|NCT01484340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102644215|NCT01484340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644216|NCT01485588|hI-con1|hi-con1|mesh-list
102644217|NCT01485588|Immunoconjugates|immunoconjugates|mesh-ancestor
102644218|NCT01485588|Immunologic Factors|immunologic factors|mesh-ancestor
102644219|NCT01485588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644220|NCT01488318|Cetuximab|cetuximab|mesh-list
102644221|NCT01488318|Dasatinib|dasatinib|mesh-list
102644222|NCT01488318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102644223|NCT01488318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102644224|NCT01488318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102644225|NCT01488318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102644226|NCT01488318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275413|NCT05014607|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102644227|NCT01495572|Aldesleukin|aldesleukin|mesh-list
102644228|NCT01495572|Cyclophosphamide|cyclophosphamide|mesh-list
102644229|NCT01495572|Fludarabine|fludarabine|mesh-list
102644230|NCT01495572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102644231|NCT01495572|Immunologic Factors|immunologic factors|mesh-ancestor
102644232|NCT01495572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644233|NCT01495572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102644234|NCT01495572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102644235|NCT01495572|Alkylating Agents|alkylating agents|mesh-ancestor
102644236|NCT01495572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644237|NCT01495572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102644238|NCT01495572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102644239|NCT01495572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102644240|NCT01495572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102644241|NCT01495572|Antiviral Agents|antiviral agents|mesh-ancestor
102644242|NCT01495572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102644243|NCT01504854|Resveratrol|resveratrol|mesh-list
102644244|NCT01504854|Antioxidants|antioxidants|mesh-ancestor
102644245|NCT01504854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644246|NCT01504854|Protective Agents|protective agents|mesh-ancestor
102644247|NCT01504854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644248|NCT01504854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102644249|NCT01504854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102644250|NCT01508832|Lidocaine|lidocaine|mesh-list
102644251|NCT01508832|Bupivacaine|bupivacaine|mesh-list
102644252|NCT01508832|Anesthetics, Local|anesthetics, local|mesh-ancestor
102644253|NCT01508832|Anesthetics|anesthetics|mesh-ancestor
102644254|NCT01508832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102644255|NCT01508832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644256|NCT01508832|Sensory System Agents|sensory system agents|mesh-ancestor
102644257|NCT01508832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102644258|NCT01508832|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102644259|NCT01508832|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102644260|NCT01508832|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102644261|NCT01508832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102644262|NCT01508832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644263|NCT01511640|Pregabalin|pregabalin|mesh-list
102644264|NCT01511640|Analgesics|analgesics|mesh-ancestor
102644265|NCT01511640|Sensory System Agents|sensory system agents|mesh-ancestor
102644266|NCT01511640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102644267|NCT01511640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644268|NCT01511640|Anticonvulsants|anticonvulsants|mesh-ancestor
102644269|NCT01511640|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102644270|NCT01511640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102644271|NCT01511640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644272|NCT01511640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102644273|NCT01511640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102644274|NCT01511640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102644275|NCT01511640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102644276|NCT01511640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102644277|NCT01513122|Ritonavir|ritonavir|mesh-list
102644278|NCT01513122|Lopinavir|lopinavir|mesh-list
102644279|NCT01513122|Raltegravir Potassium|raltegravir potassium|mesh-list
102644280|NCT01513122|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102644281|NCT01513122|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102644282|NCT01513122|Protease Inhibitors|protease inhibitors|mesh-ancestor
102644283|NCT01513122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102644284|NCT01513122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644285|NCT01513122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102644286|NCT01513122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102644287|NCT01513122|Antiviral Agents|antiviral agents|mesh-ancestor
102644288|NCT01513122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102644289|NCT01513122|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102644290|NCT01513122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102644291|NCT01513122|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102644292|NCT01513122|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102644293|NCT01513902|Tofacitinib|tofacitinib|mesh-list
102644294|NCT01513902|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102644295|NCT01513902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102644296|NCT01513902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102644297|NCT01513902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644298|NCT01515540|Lidocaine|lidocaine|mesh-list
102644299|NCT01515540|Anesthetics, Local|anesthetics, local|mesh-ancestor
102644300|NCT01515540|Anesthetics|anesthetics|mesh-ancestor
102644301|NCT01515540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102644302|NCT01515540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644303|NCT01515540|Sensory System Agents|sensory system agents|mesh-ancestor
102644304|NCT01515540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102644305|NCT01515540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102644306|NCT01515540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102644307|NCT01515540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102644308|NCT01515540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102644309|NCT01515540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644310|NCT01519284|Levodopa|levodopa|mesh-list
102644311|NCT01519284|Carbidopa|carbidopa|mesh-list
102644312|NCT01519284|Opicapone|opicapone|mesh-list
102644313|NCT01519284|Entacapone|entacapone|mesh-list
102644314|NCT01519284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102644315|NCT01519284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102644316|NCT01519284|Dopamine Agents|dopamine agents|mesh-ancestor
102644317|NCT01519284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102644318|NCT01519284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644319|NCT01519284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644320|NCT01519284|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102644321|NCT01519284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102644322|NCT01519284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102644323|NCT01520454|Heparin|heparin|mesh-list
102644324|NCT01520454|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102644325|NCT01520454|Anticoagulants|anticoagulants|mesh-ancestor
102644326|NCT01520454|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102644327|NCT01520454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102644328|NCT01520454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644329|NCT01520454|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102644330|NCT01520454|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102644331|NCT01520454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102644332|NCT01520688|Fluticasone|fluticasone|mesh-list
102644333|NCT01520688|Xhance|xhance|mesh-list
102644334|NCT01520688|Budesonide|budesonide|mesh-list
102644335|NCT01520688|Beclomethasone|beclomethasone|mesh-list
102644336|NCT01520688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102644337|NCT01520688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102644338|NCT01520688|Autonomic Agents|autonomic agents|mesh-ancestor
102644339|NCT01520688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102644340|NCT01520688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644341|NCT01520688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102644342|NCT01520688|Respiratory System Agents|respiratory system agents|mesh-ancestor
102644343|NCT01520688|Dermatologic Agents|dermatologic agents|mesh-ancestor
102644344|NCT01520688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102644345|NCT01520688|Glucocorticoids|glucocorticoids|mesh-ancestor
102644346|NCT01520688|Hormones|hormones|mesh-ancestor
102644347|NCT01520688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102644348|NCT01521546|Eplerenone|eplerenone|mesh-list
102644349|NCT01521546|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102644350|NCT01521546|Hormone Antagonists|hormone antagonists|mesh-ancestor
102644351|NCT01521546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102644352|NCT01521546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644353|NCT01521546|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102644354|NCT01521546|Diuretics|diuretics|mesh-ancestor
102644355|NCT01521546|Natriuretic Agents|natriuretic agents|mesh-ancestor
102644356|NCT01521546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102644357|NCT01523496|Vitamin D|vitamin d|mesh-list
102644358|NCT01523496|Ergocalciferols|ergocalciferols|mesh-list
102644359|NCT01523496|Cholecalciferol|cholecalciferol|mesh-list
102644360|NCT01523496|Calcifediol|calcifediol|mesh-list
102644361|NCT01523496|Vitamins|vitamins|mesh-list
102644362|NCT01523496|Micronutrients|micronutrients|mesh-ancestor
102644363|NCT01523496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644364|NCT01523496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102644365|NCT01523496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102644366|NCT01526538|Cycloserine|cycloserine|mesh-list
102644367|NCT01526538|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102644368|NCT01526538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102644369|NCT01526538|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102644370|NCT01526538|Antitubercular Agents|antitubercular agents|mesh-ancestor
102644371|NCT01526538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102275414|NCT05014607|Immunologic Factors|immunologic factors|mesh-ancestor
102275415|NCT05014607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644372|NCT01526538|Antimetabolites|antimetabolites|mesh-ancestor
102644373|NCT01526538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644375|NCT01529502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102644376|NCT01529502|Autonomic Agents|autonomic agents|mesh-ancestor
102644377|NCT01529502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102644378|NCT01529502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644379|NCT01529502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102644380|NCT01529502|Respiratory System Agents|respiratory system agents|mesh-ancestor
102644381|NCT01529502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102644382|NCT01529502|Antioxidants|antioxidants|mesh-ancestor
102644383|NCT01529502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644384|NCT01529502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102644385|NCT01529502|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102644386|NCT01529502|Vasodilator Agents|vasodilator agents|mesh-ancestor
102644387|NCT01529502|Gasotransmitters|gasotransmitters|mesh-ancestor
102644388|NCT01529502|Protective Agents|protective agents|mesh-ancestor
102644389|NCT01532700|Ofatumumab|ofatumumab|mesh-list
102644390|NCT01532700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102644391|NCT01533948|Axitinib|axitinib|mesh-list
102644392|NCT01533948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102644393|NCT01533948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102644394|NCT01533948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102644395|NCT01533948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644396|NCT01534416|Bupivacaine|bupivacaine|mesh-list
102644397|NCT01534416|Anesthetics, Local|anesthetics, local|mesh-ancestor
102644398|NCT01534416|Anesthetics|anesthetics|mesh-ancestor
102644399|NCT01534416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102644400|NCT01534416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644401|NCT01534416|Sensory System Agents|sensory system agents|mesh-ancestor
102644402|NCT01534416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102644403|NCT01535664|4-Aminopyridine|4-aminopyridine|mesh-list
102644404|NCT01535664|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102644405|NCT01535664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102644406|NCT01535664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644407|NCT01535976|Ketamine|ketamine|mesh-list
102644408|NCT01535976|Analgesics|analgesics|mesh-ancestor
102644409|NCT01535976|Sensory System Agents|sensory system agents|mesh-ancestor
102644410|NCT01535976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102644411|NCT01535976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644412|NCT01535976|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102644413|NCT01535976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102644414|NCT01535976|Anesthetics, General|anesthetics, general|mesh-ancestor
102644415|NCT01535976|Anesthetics|anesthetics|mesh-ancestor
102644416|NCT01535976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102644417|NCT01535976|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102644418|NCT01535976|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102644419|NCT01535976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102644420|NCT01535976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644421|NCT01536366|Repaglinide|repaglinide|mesh-list
102644422|NCT01536366|Opicapone|opicapone|mesh-list
102644423|NCT01536366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102644424|NCT01536366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644425|NCT01536366|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102644426|NCT01536366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102644427|NCT01536366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644428|NCT01536366|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102644429|NCT01536366|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102644430|NCT01537926|Acetylcysteine|acetylcysteine|mesh-list
102644431|NCT01537926|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102644432|NCT01537926|Antiviral Agents|antiviral agents|mesh-ancestor
102644433|NCT01537926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102644434|NCT01537926|Expectorants|expectorants|mesh-ancestor
102644435|NCT01537926|Respiratory System Agents|respiratory system agents|mesh-ancestor
102644436|NCT01537926|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102644437|NCT01537926|Antioxidants|antioxidants|mesh-ancestor
102644438|NCT01537926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644439|NCT01537926|Protective Agents|protective agents|mesh-ancestor
102644440|NCT01537926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644441|NCT01537926|Antidotes|antidotes|mesh-ancestor
102644442|NCT01538862|Lenograstim|lenograstim|mesh-list
102644443|NCT01538862|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102644444|NCT01538862|Immunologic Factors|immunologic factors|mesh-ancestor
102275416|NCT02341729|Ticagrelor|ticagrelor|mesh-list
102275417|NCT02341729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102644445|NCT01538862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644446|NCT01541358|Listerine|listerine|mesh-list
102644447|NCT01541358|Fluorides|fluorides|mesh-list
102644448|NCT01541358|Sodium Fluoride|sodium fluoride|mesh-list
102644449|NCT01541358|Cariostatic Agents|cariostatic agents|mesh-ancestor
102644450|NCT01541358|Protective Agents|protective agents|mesh-ancestor
102644451|NCT01541358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644452|NCT01541358|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102644453|NCT01541358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102644454|NCT01542372|Prazosin|prazosin|mesh-list
102644455|NCT01542372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102644456|NCT01542372|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102644457|NCT01542372|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102644458|NCT01542372|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102644459|NCT01542372|Adrenergic Agents|adrenergic agents|mesh-ancestor
102644460|NCT01542372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102644461|NCT01542372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644462|NCT01542372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644463|NCT01542684|Azacitidine|azacitidine|mesh-list
102644464|NCT01542684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102644465|NCT01542684|Antimetabolites|antimetabolites|mesh-ancestor
102644466|NCT01542684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644467|NCT01542684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102644468|NCT01542684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102644469|NCT01543074|Allyl sulfide|allyl sulfide|mesh-list
102644470|NCT01543074|Antioxidants|antioxidants|mesh-ancestor
102644471|NCT01543074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644472|NCT01543074|Protective Agents|protective agents|mesh-ancestor
102644473|NCT01543074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644474|NCT01543074|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102644475|NCT01543074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102644476|NCT01543074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102644477|NCT01543074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102644478|NCT01545336|Anastrozole|anastrozole|mesh-list
102644479|NCT01545336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102644480|NCT01545336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102644481|NCT01545336|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102644482|NCT01545336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102644483|NCT01545336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102644484|NCT01545336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644485|NCT01545336|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102644486|NCT01545336|Hormone Antagonists|hormone antagonists|mesh-ancestor
102644487|NCT01545336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102644488|NCT01545336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644489|NCT01548690|Phenylacetic acid|phenylacetic acid|mesh-list
102644490|NCT01548690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102644491|NCT01548690|Antimetabolites|antimetabolites|mesh-ancestor
102644492|NCT01548690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644493|NCT01548690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102644494|NCT01551888|Formoterol Fumarate|formoterol fumarate|mesh-list
102644495|NCT01551888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102644496|NCT01551888|Autonomic Agents|autonomic agents|mesh-ancestor
102644497|NCT01551888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102644498|NCT01551888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644499|NCT01551888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102644500|NCT01551888|Respiratory System Agents|respiratory system agents|mesh-ancestor
102644501|NCT01551888|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102644502|NCT01551888|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102644503|NCT01551888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102644504|NCT01551888|Adrenergic Agents|adrenergic agents|mesh-ancestor
102644505|NCT01551888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102644506|NCT01551888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644507|NCT01553058|Adalimumab|adalimumab|mesh-list
102644508|NCT01553058|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102644509|NCT01553058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102644510|NCT01553058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102644511|NCT01553292|Pulmonary Surfactants|pulmonary surfactants|mesh-list
102644512|NCT01553292|Respiratory System Agents|respiratory system agents|mesh-ancestor
102644513|NCT01556724|Ropivacaine|ropivacaine|mesh-list
102644514|NCT01556724|Anesthetics, Local|anesthetics, local|mesh-ancestor
102644515|NCT01556724|Anesthetics|anesthetics|mesh-ancestor
102275418|NCT02341729|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102275419|NCT02341729|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102644516|NCT01556724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102644517|NCT01556724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644518|NCT01556724|Sensory System Agents|sensory system agents|mesh-ancestor
102644519|NCT01556724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102644520|NCT01558128|Amiodarone|amiodarone|mesh-list
102644521|NCT01558128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102644522|NCT01558128|Vasodilator Agents|vasodilator agents|mesh-ancestor
102644523|NCT01558128|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102644524|NCT01558128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102644525|NCT01558128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644526|NCT01558128|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102644527|NCT01558128|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102644528|NCT01558128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102644529|NCT01558128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102644530|NCT01558128|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102644531|NCT01558128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102644532|NCT01558128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102644533|NCT01559064|Lidocaine|lidocaine|mesh-list
102644534|NCT01559064|Hyaluronic Acid|hyaluronic acid|mesh-list
102644535|NCT01559064|Anesthetics, Local|anesthetics, local|mesh-ancestor
102644536|NCT01559064|Anesthetics|anesthetics|mesh-ancestor
102644537|NCT01559064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102644538|NCT01559064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644539|NCT01559064|Sensory System Agents|sensory system agents|mesh-ancestor
102644540|NCT01559064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102644541|NCT01559064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102644542|NCT01559064|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102644543|NCT01559064|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102644544|NCT01559064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102644545|NCT01559064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644546|NCT01559064|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102644547|NCT01559064|Immunologic Factors|immunologic factors|mesh-ancestor
102644548|NCT01559064|Viscosupplements|viscosupplements|mesh-ancestor
102644549|NCT01559064|Protective Agents|protective agents|mesh-ancestor
102644550|NCT01559922|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
102644551|NCT01559922|Vasodilator Agents|vasodilator agents|mesh-ancestor
102644552|NCT01559922|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
102644553|NCT01559922|Protective Agents|protective agents|mesh-ancestor
102644554|NCT01559922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644555|NCT01560624|Treprostinil|treprostinil|mesh-list
102644556|NCT01560624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102644557|NCT01562886|Rilpivirine|rilpivirine|mesh-list
102644558|NCT01562886|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102644559|NCT01562886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102644560|NCT01562886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102644561|NCT01562886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644562|NCT01562886|Antiviral Agents|antiviral agents|mesh-ancestor
102644563|NCT01562886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102644564|NCT01562886|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102644565|NCT01562886|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102644566|NCT01563198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
102644567|NCT01563198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102644568|NCT01563198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644569|NCT01564914|Bevacizumab|bevacizumab|mesh-list
102644570|NCT01564914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102644571|NCT01564914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102644572|NCT01564914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102644573|NCT01564914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102644574|NCT01564914|Growth Substances|growth substances|mesh-ancestor
102644575|NCT01564914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644576|NCT01564914|Growth Inhibitors|growth inhibitors|mesh-ancestor
102644577|NCT01565538|Pemetrexed|pemetrexed|mesh-list
102644578|NCT01565538|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102644579|NCT01565538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102644580|NCT01565538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102644581|NCT01565538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644582|NCT01565538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102644583|NCT01565538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102644584|NCT01565538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102644585|NCT01565616|Fludarabine|fludarabine|mesh-list
102644586|NCT01565616|Busulfan|busulfan|mesh-list
102644587|NCT01565616|Thymoglobulin|thymoglobulin|mesh-list
101933187|NCT04009824|Antacids|antacids|mesh-ancestor
102644588|NCT01565616|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102644589|NCT01565616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102644590|NCT01565616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644591|NCT01565616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102644592|NCT01565616|Immunologic Factors|immunologic factors|mesh-ancestor
102644593|NCT01565616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644594|NCT01565616|Alkylating Agents|alkylating agents|mesh-ancestor
102644595|NCT01565616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102644596|NCT01565616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102644597|NCT01566162|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102644598|NCT01566162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102644599|NCT01566162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102644600|NCT01566162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102644601|NCT01566162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644602|NCT01566162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102644603|NCT01566162|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102644604|NCT01566162|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102644605|NCT01566162|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102644606|NCT01566162|Adrenergic Agents|adrenergic agents|mesh-ancestor
102644607|NCT01566162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102644608|NCT01566162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644609|NCT01566162|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102644610|NCT01566162|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102644611|NCT01566162|Serotonin Agents|serotonin agents|mesh-ancestor
102644612|NCT01566162|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102644613|NCT01566162|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102644614|NCT01566162|Dopamine Agents|dopamine agents|mesh-ancestor
102644615|NCT01569126|Fluoxetine|fluoxetine|mesh-list
102644616|NCT01569126|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102644617|NCT01569126|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102644618|NCT01569126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102644619|NCT01569126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644620|NCT01569126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102644621|NCT01569126|Serotonin Agents|serotonin agents|mesh-ancestor
102644622|NCT01569126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644623|NCT01569126|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102644624|NCT01569126|Antidepressive Agents|antidepressive agents|mesh-ancestor
102644625|NCT01569126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102644626|NCT01569126|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102644627|NCT01569126|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102644628|NCT01569126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102644629|NCT01569828|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102644630|NCT01569828|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102644631|NCT01569828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644632|NCT01577706|Alprazolam|alprazolam|mesh-list
102644633|NCT01577706|Dextroamphetamine|dextroamphetamine|mesh-list
102644634|NCT01577706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102644635|NCT01577706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102644636|NCT01577706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644637|NCT01577706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102644638|NCT01577706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102644639|NCT01577706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102644640|NCT01577706|GABA Modulators|gaba modulators|mesh-ancestor
102644641|NCT01577706|GABA Agents|gaba agents|mesh-ancestor
102644642|NCT01577706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102644643|NCT01577706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644644|NCT01577706|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102644645|NCT01577706|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102644646|NCT01577706|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102644647|NCT01577706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102644648|NCT01577706|Dopamine Agents|dopamine agents|mesh-ancestor
102644649|NCT01580592|Omalizumab|omalizumab|mesh-list
102644650|NCT01580592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102644651|NCT01580592|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102644652|NCT01580592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102644653|NCT01580592|Respiratory System Agents|respiratory system agents|mesh-ancestor
102644654|NCT01580592|Immunologic Factors|immunologic factors|mesh-ancestor
102644655|NCT01580592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644656|NCT01588158|Acetaminophen|acetaminophen|mesh-list
102644657|NCT01588158|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
102275420|NCT02341729|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102275421|NCT02341729|Purinergic Agents|purinergic agents|mesh-ancestor
102644658|NCT01588158|Hydrocodone|hydrocodone|mesh-list
102644659|NCT01588158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102644660|NCT01588158|Analgesics|analgesics|mesh-ancestor
102644661|NCT01588158|Sensory System Agents|sensory system agents|mesh-ancestor
102644662|NCT01588158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102644663|NCT01588158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644664|NCT01588158|Antipyretics|antipyretics|mesh-ancestor
102644665|NCT01588158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102644666|NCT01588158|Narcotics|narcotics|mesh-ancestor
102644667|NCT01588158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102644668|NCT01588158|Antitussive Agents|antitussive agents|mesh-ancestor
102644669|NCT01588158|Respiratory System Agents|respiratory system agents|mesh-ancestor
102644670|NCT01588158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102644671|NCT01588158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102644672|NCT01588158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102644673|NCT01588470|Pioglitazone|pioglitazone|mesh-list
102644674|NCT01588470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102644675|NCT01588470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644676|NCT01591746|Botulinum Toxins|botulinum toxins|mesh-list
102644677|NCT01591746|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102644678|NCT01591746|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102644679|NCT01591746|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102644680|NCT01591746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102644681|NCT01591746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644682|NCT01591746|Cholinergic Agents|cholinergic agents|mesh-ancestor
102644683|NCT01591746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102644684|NCT01591746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644685|NCT01591746|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102644686|NCT01591746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102644687|NCT05565924|Biguanides|biguanides|mesh-list
102644688|NCT05565924|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102644689|NCT05565924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644690|NCT05564832|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102644691|NCT05564832|Pilocarpine|pilocarpine|mesh-list
102644692|NCT05564832|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102644693|NCT05564832|Miotics|miotics|mesh-ancestor
102644694|NCT05564832|Autonomic Agents|autonomic agents|mesh-ancestor
102644695|NCT05564832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102644696|NCT05564832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644697|NCT05564832|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102644698|NCT05564832|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102644699|NCT05564832|Cholinergic Agents|cholinergic agents|mesh-ancestor
102644700|NCT05564832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102644701|NCT05564832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644702|NCT05564442|Benzocaine|benzocaine|mesh-list
102644703|NCT05564442|Anesthetics, Local|anesthetics, local|mesh-ancestor
102644704|NCT05564442|Anesthetics|anesthetics|mesh-ancestor
102644705|NCT05564442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102644706|NCT05564442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644707|NCT05564442|Sensory System Agents|sensory system agents|mesh-ancestor
102644708|NCT05564442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102644709|NCT05493540|Ibuprofen|ibuprofen|mesh-list
102644710|NCT05493540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102644711|NCT05493540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102644712|NCT05493540|Analgesics|analgesics|mesh-ancestor
102644713|NCT05493540|Sensory System Agents|sensory system agents|mesh-ancestor
102644714|NCT05493540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102644715|NCT05493540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644716|NCT05493540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102644717|NCT05493540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102644718|NCT05493540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102644719|NCT05493540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102644720|NCT05493540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644721|NCT05672472|Sivelestat|sivelestat|mesh-list
102644722|NCT05672472|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102644723|NCT05672472|Protease Inhibitors|protease inhibitors|mesh-ancestor
102644724|NCT05672472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102644725|NCT05672472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644726|NCT05672394|Lidocaine|lidocaine|mesh-list
102644727|NCT05672394|Epinephrine|epinephrine|mesh-list
102644728|NCT05672394|Bupivacaine|bupivacaine|mesh-list
102644729|NCT05672394|Anesthetics, Local|anesthetics, local|mesh-ancestor
102644730|NCT05672394|Anesthetics|anesthetics|mesh-ancestor
102644731|NCT05672394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102644732|NCT05672394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933392|NCT03408340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102644733|NCT05672394|Sensory System Agents|sensory system agents|mesh-ancestor
102644734|NCT05672394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102644735|NCT05672394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102644736|NCT05672394|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102644737|NCT05672394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102644738|NCT05672394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102644739|NCT05672394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644740|NCT05672394|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102644741|NCT05672394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102644742|NCT05672394|Adrenergic Agents|adrenergic agents|mesh-ancestor
102644743|NCT05672394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102644744|NCT05672394|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102644745|NCT05672394|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102644746|NCT05672394|Autonomic Agents|autonomic agents|mesh-ancestor
102644747|NCT05672394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102644748|NCT05672394|Respiratory System Agents|respiratory system agents|mesh-ancestor
102644749|NCT05672394|Mydriatics|mydriatics|mesh-ancestor
102644750|NCT05672394|Sympathomimetics|sympathomimetics|mesh-ancestor
102644751|NCT05672394|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102644752|NCT05607342|SR 142801|sr 142801|mesh-list
102644753|NCT05607342|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102644754|NCT05607342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102644755|NCT05607342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102644756|NCT05607342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644757|NCT05607342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102644758|NCT05326464|Tofacitinib|tofacitinib|mesh-list
102644759|NCT05326464|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102644760|NCT05326464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102644761|NCT05326464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102644762|NCT05326464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644763|NCT04887792|Acetazolamide|acetazolamide|mesh-list
102644764|NCT04887792|Anticonvulsants|anticonvulsants|mesh-ancestor
102644765|NCT04887792|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102644766|NCT04887792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102644767|NCT04887792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644768|NCT04887792|Diuretics|diuretics|mesh-ancestor
102644769|NCT04887792|Natriuretic Agents|natriuretic agents|mesh-ancestor
102644770|NCT04887792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644771|NCT04518228|Ritonavir|ritonavir|mesh-list
102644772|NCT04518228|Lopinavir|lopinavir|mesh-list
102644773|NCT04518228|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102644774|NCT04518228|Darunavir|darunavir|mesh-list
102644775|NCT04518228|Tenofovir|tenofovir|mesh-list
102644776|NCT04518228|Dolutegravir|dolutegravir|mesh-list
102644777|NCT04518228|Cobicistat|cobicistat|mesh-list
102644778|NCT04518228|Cabotegravir|cabotegravir|mesh-list
102644779|NCT04518228|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102644780|NCT04518228|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102644781|NCT04518228|Protease Inhibitors|protease inhibitors|mesh-ancestor
102644782|NCT04518228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102644783|NCT04518228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644784|NCT04518228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102644785|NCT04518228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102644786|NCT04518228|Antiviral Agents|antiviral agents|mesh-ancestor
102644787|NCT04518228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102644788|NCT04518228|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101365998|NCT00153634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102644789|NCT04518228|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102644790|NCT04518228|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102644791|NCT04518228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102644792|NCT04518228|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102644793|NCT04518228|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102644794|NCT03729258|Amantadine|amantadine|mesh-list
102644795|NCT03729258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102644796|NCT03729258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102644797|NCT03729258|Antiviral Agents|antiviral agents|mesh-ancestor
102644798|NCT03729258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102644799|NCT03729258|Dopamine Agents|dopamine agents|mesh-ancestor
102644800|NCT03729258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102644801|NCT03729258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644802|NCT03729258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644803|NCT03729258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102644804|NCT03729258|Analgesics|analgesics|mesh-ancestor
102644805|NCT03729258|Sensory System Agents|sensory system agents|mesh-ancestor
102644806|NCT03729258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102644807|NCT03355170|Domperidone|domperidone|mesh-list
102644808|NCT03355170|Lansoprazole|lansoprazole|mesh-list
102644809|NCT03355170|Dexlansoprazole|dexlansoprazole|mesh-list
102644810|NCT03355170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102644811|NCT03355170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102644812|NCT03355170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102644813|NCT03355170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102644814|NCT03355170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644815|NCT03355170|Antiemetics|antiemetics|mesh-ancestor
102644816|NCT03355170|Autonomic Agents|autonomic agents|mesh-ancestor
102644817|NCT03355170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102644818|NCT03355170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644819|NCT03355170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102644820|NCT03355170|Dopamine Agents|dopamine agents|mesh-ancestor
102644821|NCT03355170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102644822|NCT02760498|Cemiplimab|cemiplimab|mesh-list
102644823|NCT02760498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102644824|NCT02760498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102644825|NCT02538666|Nivolumab|nivolumab|mesh-list
102644826|NCT02538666|Ipilimumab|ipilimumab|mesh-list
102644827|NCT02538666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102644828|NCT02538666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102644829|NCT02538666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102644830|NCT02538666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644831|NCT02407236|Ustekinumab|ustekinumab|mesh-list
102644832|NCT02407236|Dermatologic Agents|dermatologic agents|mesh-ancestor
102644833|NCT00221598|Dialysis Solutions|dialysis solutions|mesh-list
102644834|NCT00221598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102644835|NCT05120076|Dexamethasone|dexamethasone|mesh-list
102644836|NCT05120076|Dexamethasone acetate|dexamethasone acetate|mesh-list
102644837|NCT05120076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102644838|NCT05120076|Antiemetics|antiemetics|mesh-ancestor
102644839|NCT05120076|Autonomic Agents|autonomic agents|mesh-ancestor
102644840|NCT05120076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102644841|NCT05120076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644842|NCT05120076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102644843|NCT05120076|Glucocorticoids|glucocorticoids|mesh-ancestor
102644844|NCT05120076|Hormones|hormones|mesh-ancestor
102644845|NCT05120076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102644846|NCT05120076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102644847|NCT05120076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102644848|NCT05094804|Docetaxel|docetaxel|mesh-list
102644849|NCT05094804|Cemiplimab|cemiplimab|mesh-list
102644850|NCT05094804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102644851|NCT05094804|Tubulin Modulators|tubulin modulators|mesh-ancestor
102644852|NCT05094804|Antimitotic Agents|antimitotic agents|mesh-ancestor
102644853|NCT05094804|Mitosis Modulators|mitosis modulators|mesh-ancestor
102644854|NCT05094804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644855|NCT05094804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102644856|NCT04873596|Midazolam|midazolam|mesh-list
102644857|NCT04873596|Dexmedetomidine|dexmedetomidine|mesh-list
102644858|NCT04873596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102644859|NCT04873596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102644860|NCT04873596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644861|NCT04873596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102644862|NCT04873596|Analgesics|analgesics|mesh-ancestor
102644863|NCT04873596|Sensory System Agents|sensory system agents|mesh-ancestor
102644864|NCT04873596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102644865|NCT04873596|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102644866|NCT04873596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102644867|NCT04873596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102644868|NCT04873596|Adrenergic Agents|adrenergic agents|mesh-ancestor
102644869|NCT04873596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102644870|NCT04873596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644871|NCT04873596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102644872|NCT04873596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102644873|NCT04873596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102644874|NCT04873596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102644875|NCT04873596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102644876|NCT04873596|Anesthetics, General|anesthetics, general|mesh-ancestor
102644877|NCT04873596|Anesthetics|anesthetics|mesh-ancestor
102644878|NCT04873596|GABA Modulators|gaba modulators|mesh-ancestor
102644879|NCT04873596|GABA Agents|gaba agents|mesh-ancestor
102644880|NCT04868760|Ipilimumab|ipilimumab|mesh-list
102644881|NCT04868760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102644882|NCT04868760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102644883|NCT04868760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102644884|NCT04868760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644885|NCT04508166|Sodium Oxybate|sodium oxybate|mesh-list
102644886|NCT04508166|Dexmedetomidine|dexmedetomidine|mesh-list
102644887|NCT04508166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102644888|NCT04508166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102644889|NCT04508166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644890|NCT04508166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102644891|NCT04508166|Analgesics|analgesics|mesh-ancestor
102644892|NCT04508166|Sensory System Agents|sensory system agents|mesh-ancestor
102644893|NCT04508166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102644894|NCT04508166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102644895|NCT04508166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102644896|NCT04508166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102644897|NCT04508166|Adrenergic Agents|adrenergic agents|mesh-ancestor
102644898|NCT04508166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102644899|NCT04508166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644900|NCT04508166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102644901|NCT04508166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102644902|NCT04508166|Anesthetics, General|anesthetics, general|mesh-ancestor
102644903|NCT04508166|Anesthetics|anesthetics|mesh-ancestor
102644904|NCT04444440|Ciprofloxacin|ciprofloxacin|mesh-list
102644905|NCT04444440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102644906|NCT04444440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102644907|NCT04444440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102644908|NCT04444440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102644909|NCT04444440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102644910|NCT04444440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644911|NCT04444440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102644912|NCT04444440|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102644913|NCT04444440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102644914|NCT04175964|Metformin|metformin|mesh-list
102644915|NCT04175964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102644916|NCT04175964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644917|NCT03624270|Ascorbic Acid|ascorbic acid|mesh-list
102644918|NCT03624270|Arsenic Trioxide|arsenic trioxide|mesh-list
102644919|NCT03624270|Antioxidants|antioxidants|mesh-ancestor
102644920|NCT03624270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644921|NCT03624270|Protective Agents|protective agents|mesh-ancestor
102644922|NCT03624270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644923|NCT03624270|Vitamins|vitamins|mesh-ancestor
102644924|NCT03624270|Micronutrients|micronutrients|mesh-ancestor
102644925|NCT03624270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102644926|NCT03498066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102644927|NCT03498066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102644928|NCT03498066|Adrenergic Agents|adrenergic agents|mesh-ancestor
102644929|NCT03498066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102644930|NCT03498066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644931|NCT03498066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644932|NCT03455088|Fluoxetine|fluoxetine|mesh-list
102644933|NCT03455088|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102644934|NCT03455088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102644935|NCT03455088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102644936|NCT03455088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644937|NCT03455088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102644938|NCT03455088|Serotonin Agents|serotonin agents|mesh-ancestor
102644939|NCT03455088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644940|NCT03455088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102644941|NCT03455088|Antidepressive Agents|antidepressive agents|mesh-ancestor
102644942|NCT03455088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102644943|NCT03455088|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102644944|NCT03455088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102644945|NCT03455088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102644946|NCT03355560|Nivolumab|nivolumab|mesh-list
102644947|NCT03355560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102644948|NCT03355560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102644949|NCT03355560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102644950|NCT03355560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644951|NCT01600170|Atorvastatin|atorvastatin|mesh-list
102644952|NCT01600170|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102644953|NCT01600170|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102644954|NCT01600170|Antimetabolites|antimetabolites|mesh-ancestor
101933542|NCT00086385|Nicotine|nicotine|mesh-list
102644955|NCT01600170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644956|NCT01600170|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102644957|NCT01600170|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102644958|NCT01600170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102644959|NCT01600950|Insulin Glargine|insulin glargine|mesh-list
102644960|NCT01600950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102644961|NCT01600950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644962|NCT01605942|Dexamethasone|dexamethasone|mesh-list
102644963|NCT01605942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102644964|NCT01605942|Antiemetics|antiemetics|mesh-ancestor
102644965|NCT01605942|Autonomic Agents|autonomic agents|mesh-ancestor
102644966|NCT01605942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102644967|NCT01605942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644968|NCT01605942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102644969|NCT01605942|Glucocorticoids|glucocorticoids|mesh-ancestor
102644970|NCT01605942|Hormones|hormones|mesh-ancestor
102644971|NCT01605942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101366215|NCT00406432|Antidepressive Agents|antidepressive agents|mesh-ancestor
102644972|NCT01605942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102644973|NCT01605942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102644974|NCT01608672|Botulinum Toxins|botulinum toxins|mesh-list
102644975|NCT01608672|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102644976|NCT01608672|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102644977|NCT01608672|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102644978|NCT01608672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102644979|NCT01608672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644980|NCT01608672|Cholinergic Agents|cholinergic agents|mesh-ancestor
102644981|NCT01608672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102644982|NCT01608672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644983|NCT01608672|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102644984|NCT01608672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102644985|NCT01610154|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102644986|NCT01610154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102644987|NCT01610154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102644988|NCT01610154|Incretins|incretins|mesh-ancestor
102644989|NCT01610154|Hormones|hormones|mesh-ancestor
102644990|NCT01610154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102644991|NCT01610154|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102644992|NCT01610154|Protease Inhibitors|protease inhibitors|mesh-ancestor
102644993|NCT01610154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102644994|NCT01610154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102644995|NCT01611948|Aprepitant|aprepitant|mesh-list
102644996|NCT01611948|Antiemetics|antiemetics|mesh-ancestor
102644997|NCT01611948|Autonomic Agents|autonomic agents|mesh-ancestor
102644998|NCT01611948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102644999|NCT01611948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645000|NCT01611948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102645001|NCT01611948|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102645002|NCT01611948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102645003|NCT01611948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645004|NCT01612884|Clopidogrel|clopidogrel|mesh-list
102645005|NCT01612884|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102645006|NCT01612884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102645007|NCT01612884|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102645008|NCT01612884|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102645009|NCT01612884|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102645010|NCT01612884|Purinergic Agents|purinergic agents|mesh-ancestor
102645011|NCT01612884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102645012|NCT01612884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645013|NCT01612884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645014|NCT01614210|Tamoxifen|tamoxifen|mesh-list
102645015|NCT01614210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102645016|NCT01614210|Hormone Antagonists|hormone antagonists|mesh-ancestor
102645017|NCT01614210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102645018|NCT01614210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645019|NCT01614210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102645020|NCT01614210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102645021|NCT01614210|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102645022|NCT01614210|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102645023|NCT01614210|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102275422|NCT02341729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101933615|NCT03743922|Vitamins|vitamins|mesh-ancestor
102275423|NCT02341729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645024|NCT01616082|Phentermine|phentermine|mesh-list
102645025|NCT01616082|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102645026|NCT01616082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645027|NCT01616082|Appetite Depressants|appetite depressants|mesh-ancestor
102645028|NCT01616082|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102645029|NCT01616082|Sympathomimetics|sympathomimetics|mesh-ancestor
102645030|NCT01616082|Autonomic Agents|autonomic agents|mesh-ancestor
102645031|NCT01616082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102645032|NCT01616082|Adrenergic Agents|adrenergic agents|mesh-ancestor
102645033|NCT01616082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102645034|NCT01616082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645035|NCT01616160|Mometasone Furoate|mometasone furoate|mesh-list
102645036|NCT01616160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102645037|NCT01616160|Dermatologic Agents|dermatologic agents|mesh-ancestor
102645038|NCT01616160|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102645039|NCT01619982|Vancomycin|vancomycin|mesh-list
102645040|NCT01619982|Cefazolin|cefazolin|mesh-list
102645041|NCT01619982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102645042|NCT01619982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102645043|NCT01620216|Sorafenib|sorafenib|mesh-list
102645044|NCT01620216|Sunitinib|sunitinib|mesh-list
102645045|NCT01620216|Dasatinib|dasatinib|mesh-list
102645046|NCT01620216|Ponatinib|ponatinib|mesh-list
102645047|NCT01620216|Idelalisib|idelalisib|mesh-list
102645048|NCT01620216|Antineoplastic Agents|antineoplastic agents|mesh-list
102645049|NCT01620216|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
102645050|NCT01620216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102645051|NCT01620216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102645052|NCT01620216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645053|NCT01620216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102645054|NCT01620216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102645055|NCT01620216|Growth Substances|growth substances|mesh-ancestor
102645056|NCT01620216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645057|NCT01620216|Growth Inhibitors|growth inhibitors|mesh-ancestor
102645058|NCT01621230|Fentanyl|fentanyl|mesh-list
102645059|NCT01621230|Bupivacaine|bupivacaine|mesh-list
102645060|NCT01621230|Anesthetics, Local|anesthetics, local|mesh-ancestor
102645061|NCT01621230|Anesthetics|anesthetics|mesh-ancestor
102645062|NCT01621230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102645063|NCT01621230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645064|NCT01621230|Sensory System Agents|sensory system agents|mesh-ancestor
102645065|NCT01621230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102645066|NCT01621230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102645067|NCT01621230|Narcotics|narcotics|mesh-ancestor
102645068|NCT01621230|Analgesics|analgesics|mesh-ancestor
102645069|NCT01621230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102645070|NCT01621230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102645071|NCT01621230|Anesthetics, General|anesthetics, general|mesh-ancestor
102645072|NCT01621776|Insulin|insulin|mesh-list
102645073|NCT01621776|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102645074|NCT01621776|Insulin Aspart|insulin aspart|mesh-list
102645075|NCT01621776|Insulin Lispro|insulin lispro|mesh-list
102645076|NCT01621776|Insulin glulisine|insulin glulisine|mesh-list
102645077|NCT01621776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102645078|NCT01621776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645079|NCT01631682|Propranolol|propranolol|mesh-list
102645080|NCT01631682|Oxytocin|oxytocin|mesh-list
102645081|NCT01631682|Mifepristone|mifepristone|mesh-list
102645082|NCT01631682|Oxytocics|oxytocics|mesh-ancestor
102645083|NCT01631682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102645084|NCT01631682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645085|NCT01631682|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102645086|NCT01631682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102645087|NCT01631682|Adrenergic Agents|adrenergic agents|mesh-ancestor
102645088|NCT01631682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102645089|NCT01631682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645090|NCT01631682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102645091|NCT01631682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102645092|NCT01631682|Vasodilator Agents|vasodilator agents|mesh-ancestor
102645093|NCT01631682|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102645094|NCT01631682|Abortifacient Agents|abortifacient agents|mesh-ancestor
102645095|NCT01631682|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102645096|NCT01631682|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102645097|NCT01631682|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102645098|NCT01631682|Contraceptive Agents|contraceptive agents|mesh-ancestor
102645099|NCT01631682|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102645100|NCT01631682|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102645101|NCT01631682|Hormone Antagonists|hormone antagonists|mesh-ancestor
101366329|NCT00051077|Antiviral Agents|antiviral agents|mesh-ancestor
102645102|NCT01631682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102645103|NCT01631682|Luteolytic Agents|luteolytic agents|mesh-ancestor
102645104|NCT01631682|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102645105|NCT01631682|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102645106|NCT01635504|Botulinum Toxins|botulinum toxins|mesh-list
102645107|NCT01635504|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102645108|NCT01635504|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102645109|NCT01635504|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102645110|NCT01635504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102645111|NCT01635504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645112|NCT01635504|Cholinergic Agents|cholinergic agents|mesh-ancestor
102645113|NCT01635504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102645114|NCT01635504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645115|NCT01635504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102645116|NCT01635504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102645117|NCT01636206|Lifitegrast|lifitegrast|mesh-list
102645118|NCT01636206|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102645119|NCT01636206|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102645120|NCT01639872|Risperidone|risperidone|mesh-list
102645121|NCT01639872|Clozapine|clozapine|mesh-list
102645122|NCT01639872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102645123|NCT01639872|Serotonin Agents|serotonin agents|mesh-ancestor
102645124|NCT01639872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102645125|NCT01639872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645126|NCT01639872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645127|NCT01639872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102645128|NCT01639872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102645129|NCT01639872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102645130|NCT01639872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102645131|NCT01639872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102645132|NCT01639872|Dopamine Agents|dopamine agents|mesh-ancestor
102645133|NCT01639872|GABA Antagonists|gaba antagonists|mesh-ancestor
102645134|NCT01639872|GABA Agents|gaba agents|mesh-ancestor
102645135|NCT01640340|Dexamethasone|dexamethasone|mesh-list
102645136|NCT01640340|Ondansetron|ondansetron|mesh-list
102645137|NCT01640340|Aprepitant|aprepitant|mesh-list
102645138|NCT01640340|Palonosetron|palonosetron|mesh-list
102645139|NCT01640340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102645140|NCT01640340|Antiemetics|antiemetics|mesh-ancestor
102645141|NCT01640340|Autonomic Agents|autonomic agents|mesh-ancestor
102645142|NCT01640340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102645143|NCT01640340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645144|NCT01640340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102645145|NCT01640340|Glucocorticoids|glucocorticoids|mesh-ancestor
102645146|NCT01640340|Hormones|hormones|mesh-ancestor
102645147|NCT01640340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102645148|NCT01640340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102645149|NCT01640340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102645150|NCT01640340|Antipruritics|antipruritics|mesh-ancestor
102645151|NCT01640340|Dermatologic Agents|dermatologic agents|mesh-ancestor
102645152|NCT01640340|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102645153|NCT01640340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102645154|NCT01640340|Serotonin Agents|serotonin agents|mesh-ancestor
102645155|NCT01640340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102645156|NCT01640340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645157|NCT01640340|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102645158|NCT01641120|Interferons|interferons|mesh-list
102645159|NCT01641120|Interferon-beta|interferon-beta|mesh-list
102645160|NCT01641120|Interferon beta-1a|interferon beta-1a|mesh-list
102645161|NCT01641120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102645162|NCT01641120|Antiviral Agents|antiviral agents|mesh-ancestor
102645163|NCT01641120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102645164|NCT01641120|Immunologic Factors|immunologic factors|mesh-ancestor
102645165|NCT01641120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645166|NCT01641120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102645167|NCT01643382|Insulin|insulin|mesh-list
102645168|NCT01643382|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102645169|NCT01643382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101366400|NCT00083538|Glucocorticoids|glucocorticoids|mesh-ancestor
102645170|NCT01643382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645171|NCT01643616|Midazolam|midazolam|mesh-list
102645172|NCT01643616|Ropivacaine|ropivacaine|mesh-list
102645173|NCT01643616|Prilocaine|prilocaine|mesh-list
102645174|NCT01643616|Anesthetics, Local|anesthetics, local|mesh-ancestor
102645175|NCT01643616|Anesthetics|anesthetics|mesh-ancestor
101933763|NCT03652818|Antipyretics|antipyretics|mesh-ancestor
102645176|NCT01643616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102645177|NCT01643616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645178|NCT01643616|Sensory System Agents|sensory system agents|mesh-ancestor
102645179|NCT01643616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102645180|NCT01643616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102645181|NCT01643616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102645182|NCT01643616|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102645183|NCT01643616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102645184|NCT01643616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102645185|NCT01643616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102645186|NCT01643616|Anesthetics, General|anesthetics, general|mesh-ancestor
102645187|NCT01643616|GABA Modulators|gaba modulators|mesh-ancestor
102645188|NCT01643616|GABA Agents|gaba agents|mesh-ancestor
102645189|NCT01643616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102645190|NCT01643616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645191|NCT01644396|Adalimumab|adalimumab|mesh-list
102645192|NCT01644396|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102645193|NCT01644396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102645194|NCT01644396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102645195|NCT01645098|Dexmedetomidine|dexmedetomidine|mesh-list
102645196|NCT01645098|Ketamine|ketamine|mesh-list
102645197|NCT01645098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102645198|NCT01645098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102645199|NCT01645098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645200|NCT01645098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102645201|NCT01645098|Analgesics|analgesics|mesh-ancestor
102645202|NCT01645098|Sensory System Agents|sensory system agents|mesh-ancestor
102645203|NCT01645098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102645204|NCT01645098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102645205|NCT01645098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102645206|NCT01645098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102645207|NCT01645098|Adrenergic Agents|adrenergic agents|mesh-ancestor
102645208|NCT01645098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102645209|NCT01645098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645210|NCT01645098|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102645211|NCT01645098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102645212|NCT01645098|Anesthetics, General|anesthetics, general|mesh-ancestor
102645213|NCT01645098|Anesthetics|anesthetics|mesh-ancestor
102645214|NCT01645098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102645215|NCT01645098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102645216|NCT01650402|Antihypertensive Agents|antihypertensive agents|mesh-list
102645217|NCT01651806|Tranexamic Acid|tranexamic acid|mesh-list
102645218|NCT01651806|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102645219|NCT01651806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102645220|NCT01651806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645221|NCT01651806|Hemostatics|hemostatics|mesh-ancestor
102645222|NCT01651806|Coagulants|coagulants|mesh-ancestor
102645223|NCT01652040|Methyltestosterone|methyltestosterone|mesh-list
102645224|NCT01652040|Testosterone|testosterone|mesh-list
102645225|NCT01652040|Testosterone undecanoate|testosterone undecanoate|mesh-list
102645226|NCT01652040|Testosterone enanthate|testosterone enanthate|mesh-list
102645227|NCT01652040|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102645228|NCT01652040|Androgens|androgens|mesh-ancestor
102645229|NCT01652040|Hormones|hormones|mesh-ancestor
102645230|NCT01652040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102645231|NCT01652040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645232|NCT01652040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102645233|NCT01652040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102645234|NCT01652040|Anabolic Agents|anabolic agents|mesh-ancestor
102645235|NCT01652976|Leucovorin|leucovorin|mesh-list
102645236|NCT01652976|Fluorouracil|fluorouracil|mesh-list
102645237|NCT01652976|Oxaliplatin|oxaliplatin|mesh-list
102645238|NCT01652976|Dasatinib|dasatinib|mesh-list
102645239|NCT01652976|Antimetabolites|antimetabolites|mesh-ancestor
102645240|NCT01652976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645241|NCT01652976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102645242|NCT01652976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102645243|NCT01652976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102645244|NCT01652976|Immunologic Factors|immunologic factors|mesh-ancestor
102645245|NCT01652976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645246|NCT01652976|Antidotes|antidotes|mesh-ancestor
102645247|NCT01652976|Protective Agents|protective agents|mesh-ancestor
102645248|NCT01652976|Vitamin B Complex|vitamin b complex|mesh-ancestor
102645249|NCT01652976|Vitamins|vitamins|mesh-ancestor
102275424|NCT02341729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645250|NCT01652976|Micronutrients|micronutrients|mesh-ancestor
102645251|NCT01652976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102275425|NCT05014373|Favipiravir|favipiravir|mesh-list
102645252|NCT01652976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102645253|NCT01656252|Cytarabine|cytarabine|mesh-list
102645254|NCT01656252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102645255|NCT01656252|Antimetabolites|antimetabolites|mesh-ancestor
102645256|NCT01656252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645257|NCT01656252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102645258|NCT01656252|Antiviral Agents|antiviral agents|mesh-ancestor
102645259|NCT01656252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102645260|NCT01656252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102645261|NCT01656252|Immunologic Factors|immunologic factors|mesh-ancestor
102645262|NCT01656252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645263|NCT01661088|Folfirinox|folfirinox|mesh-list
102645264|NCT01661088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102645265|NCT01661946|Bevacizumab|bevacizumab|mesh-list
102645266|NCT01661946|Ranibizumab|ranibizumab|mesh-list
102645267|NCT01661946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102645268|NCT01661946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102645269|NCT01661946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102645270|NCT01661946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102645271|NCT01661946|Growth Substances|growth substances|mesh-ancestor
102645272|NCT01661946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645273|NCT01661946|Growth Inhibitors|growth inhibitors|mesh-ancestor
102645274|NCT01663272|Gemcitabine|gemcitabine|mesh-list
102645275|NCT01663272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102645276|NCT01663272|Antimetabolites|antimetabolites|mesh-ancestor
102645277|NCT01663272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645278|NCT01663272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102645279|NCT01667796|Vitamin D|vitamin d|mesh-list
102645280|NCT01667796|Cholecalciferol|cholecalciferol|mesh-list
102645281|NCT01667796|Vitamins|vitamins|mesh-ancestor
102645282|NCT01667796|Micronutrients|micronutrients|mesh-ancestor
102645283|NCT01667796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645284|NCT01667796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102645285|NCT01667796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102645286|NCT01668030|Bacitracin|bacitracin|mesh-list
102645287|NCT01668030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102645288|NCT01668030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102645289|NCT01668030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102645290|NCT01669434|Ramipril|ramipril|mesh-list
102645291|NCT01669434|Enalapril|enalapril|mesh-list
102645292|NCT01669434|Enalaprilat|enalaprilat|mesh-list
102645293|NCT01669434|Lisinopril|lisinopril|mesh-list
102645294|NCT01669434|Perindopril|perindopril|mesh-list
102645295|NCT01669434|Benazepril|benazepril|mesh-list
102645296|NCT01669434|Captopril|captopril|mesh-list
102645297|NCT01669434|Quinapril|quinapril|mesh-list
102645298|NCT01669434|Trandolapril|trandolapril|mesh-list
102645299|NCT01669434|Fosinopril|fosinopril|mesh-list
102645300|NCT01669434|Moexipril|moexipril|mesh-list
102645301|NCT01669434|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102645302|NCT01669434|Protease Inhibitors|protease inhibitors|mesh-ancestor
102645303|NCT01669434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102645304|NCT01669434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645305|NCT01669434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102645306|NCT01669434|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102645307|NCT01669434|Protective Agents|protective agents|mesh-ancestor
102645308|NCT01669434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645309|NCT01678794|Candesartan|candesartan|mesh-list
102645310|NCT01678794|Candesartan cilexetil|candesartan cilexetil|mesh-list
102645311|NCT01678794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102645312|NCT01678794|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102645313|NCT01678794|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102645314|NCT01678794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645315|NCT01680900|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
102645316|NCT01680900|Antidepressive Agents|antidepressive agents|mesh-ancestor
102645317|NCT01680900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102645318|NCT01680900|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102645319|NCT01680900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102645320|NCT01680900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102645321|NCT01680900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645322|NCT01680900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102275426|NCT05014373|Antiviral Agents|antiviral agents|mesh-ancestor
102645323|NCT01680900|Serotonin Agents|serotonin agents|mesh-ancestor
102645324|NCT01680900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645325|NCT01680900|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102645326|NCT01680900|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102275427|NCT05014373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102645328|NCT01682538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102645329|NCT01682538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645330|NCT01684020|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102645331|NCT01684020|Hemostatics|hemostatics|mesh-ancestor
102645332|NCT01684020|Coagulants|coagulants|mesh-ancestor
102645333|NCT01684410|Protease Inhibitors|protease inhibitors|mesh-list
102645334|NCT01684410|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
102645335|NCT01684410|Protein C Inhibitor|protein c inhibitor|mesh-list
102645336|NCT01684410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102645337|NCT01684410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645338|NCT01684410|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102645339|NCT01684410|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102645340|NCT01689324|Vaccines|vaccines|mesh-list
102645341|NCT01689324|Immunologic Factors|immunologic factors|mesh-ancestor
102645342|NCT01689324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645343|NCT01692756|Triamcinolone|triamcinolone|mesh-list
102645344|NCT01692756|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102645345|NCT01692756|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102645346|NCT01692756|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102645347|NCT01692756|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102645348|NCT01692756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102645349|NCT01692756|Glucocorticoids|glucocorticoids|mesh-ancestor
102645350|NCT01692756|Hormones|hormones|mesh-ancestor
102645351|NCT01692756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102645352|NCT01692756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645353|NCT01692756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102645354|NCT01692756|Immunologic Factors|immunologic factors|mesh-ancestor
102645355|NCT01692756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102645356|NCT01692756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645357|NCT01695330|Bortezomib|bortezomib|mesh-list
102645358|NCT01695330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102645359|NCT01701102|Fentanyl|fentanyl|mesh-list
102645360|NCT01701102|Mepivacaine|mepivacaine|mesh-list
102645361|NCT01701102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102645362|NCT01701102|Narcotics|narcotics|mesh-ancestor
102645363|NCT01701102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102645364|NCT01701102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645365|NCT01701102|Analgesics|analgesics|mesh-ancestor
102645366|NCT01701102|Sensory System Agents|sensory system agents|mesh-ancestor
102645367|NCT01701102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102645368|NCT01701102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102645369|NCT01701102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102645370|NCT01701102|Anesthetics, General|anesthetics, general|mesh-ancestor
102645371|NCT01701102|Anesthetics|anesthetics|mesh-ancestor
102645372|NCT01701102|Anesthetics, Local|anesthetics, local|mesh-ancestor
102645373|NCT01701414|Bupivacaine|bupivacaine|mesh-list
102645374|NCT01701414|Anesthetics, Local|anesthetics, local|mesh-ancestor
102645375|NCT01701414|Anesthetics|anesthetics|mesh-ancestor
102645376|NCT01701414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102645377|NCT01701414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645378|NCT01701414|Sensory System Agents|sensory system agents|mesh-ancestor
102645379|NCT01701414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102645380|NCT01706952|Epinephrine|epinephrine|mesh-list
102645381|NCT01706952|Racepinephrine|racepinephrine|mesh-list
102645382|NCT01706952|Cocaine|cocaine|mesh-list
102645383|NCT01706952|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102645384|NCT01706952|Epinephryl borate|epinephryl borate|mesh-list
102645385|NCT01706952|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102645386|NCT01706952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102645387|NCT01706952|Adrenergic Agents|adrenergic agents|mesh-ancestor
102645388|NCT01706952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102645389|NCT01706952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645390|NCT01706952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645391|NCT01706952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102645392|NCT01706952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102645393|NCT01706952|Autonomic Agents|autonomic agents|mesh-ancestor
102645394|NCT01706952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102645395|NCT01706952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102645396|NCT01706952|Respiratory System Agents|respiratory system agents|mesh-ancestor
102645397|NCT01706952|Mydriatics|mydriatics|mesh-ancestor
102645398|NCT01706952|Sympathomimetics|sympathomimetics|mesh-ancestor
102645399|NCT01706952|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102645400|NCT01706952|Anesthetics, Local|anesthetics, local|mesh-ancestor
102645401|NCT01706952|Anesthetics|anesthetics|mesh-ancestor
102645402|NCT01706952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102645403|NCT01706952|Sensory System Agents|sensory system agents|mesh-ancestor
102645404|NCT01706952|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102645405|NCT01706952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102645406|NCT01706952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102645407|NCT01706952|Dopamine Agents|dopamine agents|mesh-ancestor
102645408|NCT01707420|Gabapentin|gabapentin|mesh-list
102645409|NCT01707420|Analgesics|analgesics|mesh-ancestor
102645410|NCT01707420|Sensory System Agents|sensory system agents|mesh-ancestor
102645411|NCT01707420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102645412|NCT01707420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645413|NCT01707420|Anticonvulsants|anticonvulsants|mesh-ancestor
102645414|NCT01707420|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102645415|NCT01707420|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102645416|NCT01707420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102645417|NCT01707420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102645418|NCT01707420|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102645419|NCT01707420|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102645420|NCT01707420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102645421|NCT01707420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645422|NCT01707420|Antimanic Agents|antimanic agents|mesh-ancestor
102645423|NCT01708122|Fentanyl|fentanyl|mesh-list
102645424|NCT01708122|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102645425|NCT01708122|Narcotics|narcotics|mesh-ancestor
102645426|NCT01708122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102645427|NCT01708122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645428|NCT01708122|Analgesics|analgesics|mesh-ancestor
102645429|NCT01708122|Sensory System Agents|sensory system agents|mesh-ancestor
102645430|NCT01708122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102645431|NCT01708122|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102645432|NCT01708122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102645433|NCT01708122|Anesthetics, General|anesthetics, general|mesh-ancestor
102645434|NCT01708122|Anesthetics|anesthetics|mesh-ancestor
102645435|NCT01708278|Folic Acid|folic acid|mesh-list
102645436|NCT01708278|Quercetin|quercetin|mesh-list
102645437|NCT01708278|Hematinics|hematinics|mesh-ancestor
102645438|NCT01708278|Vitamin B Complex|vitamin b complex|mesh-ancestor
102645439|NCT01708278|Vitamins|vitamins|mesh-ancestor
102645440|NCT01708278|Micronutrients|micronutrients|mesh-ancestor
102645441|NCT01708278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645442|NCT01708278|Antioxidants|antioxidants|mesh-ancestor
102645443|NCT01708278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645444|NCT01708278|Protective Agents|protective agents|mesh-ancestor
102645445|NCT01708590|Brodalumab|brodalumab|mesh-list
102645446|NCT01708590|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102645447|NCT01708590|Dermatologic Agents|dermatologic agents|mesh-ancestor
102645448|NCT01708590|Immunologic Factors|immunologic factors|mesh-ancestor
102645449|NCT01708590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645450|NCT05710146|Tranexamic Acid|tranexamic acid|mesh-list
102645451|NCT05710146|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102645452|NCT05710146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102645453|NCT05710146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645454|NCT05710146|Hemostatics|hemostatics|mesh-ancestor
102645455|NCT05710146|Coagulants|coagulants|mesh-ancestor
102645456|NCT05683548|Interferons|interferons|mesh-list
102645457|NCT05683548|Tenofovir|tenofovir|mesh-list
102645458|NCT05683548|Interferon-alpha|interferon-alpha|mesh-list
102645459|NCT05683548|Interferon alpha-2|interferon alpha-2|mesh-list
102645460|NCT05683548|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102645461|NCT05683548|REP 2139|rep 2139|mesh-list
102645462|NCT05683548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102645463|NCT05683548|Antiviral Agents|antiviral agents|mesh-ancestor
102645464|NCT05683548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102645465|NCT05683548|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102645466|NCT05683548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102645467|NCT05683548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102645468|NCT05683548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645469|NCT05683548|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102645470|NCT05683548|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102645471|NCT05683548|Immunologic Factors|immunologic factors|mesh-ancestor
102645472|NCT05683548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645473|NCT05661942|Calcium|calcium|mesh-list
102645474|NCT05661942|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102275428|NCT04762459|Pemetrexed|pemetrexed|mesh-list
101934057|NCT03726398|Macitentan|macitentan|mesh-list
102645475|NCT05661942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645476|NCT05636436|Vaccines|vaccines|mesh-list
102645477|NCT05636436|Immunologic Factors|immunologic factors|mesh-ancestor
102645478|NCT05636436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645480|NCT05463354|Immunologic Factors|immunologic factors|mesh-ancestor
102645481|NCT05463354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645482|NCT05293548|Vaccines|vaccines|mesh-list
102645483|NCT05293548|Immunologic Factors|immunologic factors|mesh-ancestor
102645484|NCT05293548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645485|NCT05157360|Vitamins|vitamins|mesh-list
102645486|NCT05157360|Hydrocortisone|hydrocortisone|mesh-list
102645487|NCT05157360|Micronutrients|micronutrients|mesh-ancestor
102645488|NCT05157360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645489|NCT05157360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102645490|NCT05136066|Peppermint oil|peppermint oil|mesh-list
102645491|NCT05136066|Antiemetics|antiemetics|mesh-ancestor
102645492|NCT05136066|Autonomic Agents|autonomic agents|mesh-ancestor
102645493|NCT05136066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102645494|NCT05136066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645495|NCT05136066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102645496|NCT05136066|Parasympatholytics|parasympatholytics|mesh-ancestor
102645497|NCT04676802|Analgesics, Opioid|analgesics, opioid|mesh-list
102645498|NCT04676802|Narcotics|narcotics|mesh-ancestor
102645499|NCT04676802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102645500|NCT04676802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645501|NCT04676802|Analgesics|analgesics|mesh-ancestor
102645502|NCT04676802|Sensory System Agents|sensory system agents|mesh-ancestor
102645503|NCT04676802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102645504|NCT04278768|Azacitidine|azacitidine|mesh-list
102645505|NCT04278768|Venetoclax|venetoclax|mesh-list
102645506|NCT04278768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102645507|NCT04278768|Antimetabolites|antimetabolites|mesh-ancestor
102645508|NCT04278768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645509|NCT04278768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102645510|NCT04278768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102645511|NCT04068948|Midazolam|midazolam|mesh-list
102645512|NCT04068948|Meperidine|meperidine|mesh-list
102645513|NCT04068948|Hydroxyzine|hydroxyzine|mesh-list
102645514|NCT04068948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102645515|NCT04068948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102645516|NCT04068948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102645517|NCT04068948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645518|NCT04068948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102645519|NCT04068948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102645520|NCT04068948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102645521|NCT04068948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102645522|NCT04068948|Anesthetics, General|anesthetics, general|mesh-ancestor
102645523|NCT04068948|Anesthetics|anesthetics|mesh-ancestor
102645524|NCT04068948|GABA Modulators|gaba modulators|mesh-ancestor
102645525|NCT04068948|GABA Agents|gaba agents|mesh-ancestor
102645526|NCT04068948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102645527|NCT04068948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645528|NCT04068948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102645529|NCT04068948|Narcotics|narcotics|mesh-ancestor
102645530|NCT04068948|Analgesics|analgesics|mesh-ancestor
102645531|NCT04068948|Sensory System Agents|sensory system agents|mesh-ancestor
102645532|NCT04068948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102645533|NCT04068948|Antipruritics|antipruritics|mesh-ancestor
102645534|NCT04068948|Dermatologic Agents|dermatologic agents|mesh-ancestor
102645535|NCT04068948|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102645536|NCT04068948|Histamine Antagonists|histamine antagonists|mesh-ancestor
102645537|NCT04068948|Histamine Agents|histamine agents|mesh-ancestor
102645538|NCT03517722|Ustekinumab|ustekinumab|mesh-list
102645539|NCT03517722|Dermatologic Agents|dermatologic agents|mesh-ancestor
102645540|NCT02130492|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102645541|NCT02130492|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102645542|NCT02130492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645543|NCT01309074|Pregabalin|pregabalin|mesh-list
102645544|NCT01309074|Sertraline|sertraline|mesh-list
102645545|NCT01309074|Analgesics|analgesics|mesh-ancestor
102645546|NCT01309074|Sensory System Agents|sensory system agents|mesh-ancestor
102645547|NCT01309074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102645548|NCT01309074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645549|NCT01309074|Anticonvulsants|anticonvulsants|mesh-ancestor
102275429|NCT04762459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102645550|NCT01309074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102275430|NCT04762459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102645551|NCT01309074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102645552|NCT01309074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645553|NCT01309074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102645554|NCT01309074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102645555|NCT01309074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102645556|NCT01309074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102645557|NCT01309074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102645558|NCT01309074|Antidepressive Agents|antidepressive agents|mesh-ancestor
102645559|NCT01309074|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102645560|NCT01309074|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102645561|NCT01309074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102645562|NCT01309074|Serotonin Agents|serotonin agents|mesh-ancestor
102645563|NCT01074294|Brexpiprazole|brexpiprazole|mesh-list
102645564|NCT01074294|Serotonin Agents|serotonin agents|mesh-ancestor
102645565|NCT01074294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102645566|NCT01074294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645567|NCT01074294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645568|NCT01074294|Dopamine Agonists|dopamine agonists|mesh-ancestor
102645569|NCT01074294|Dopamine Agents|dopamine agents|mesh-ancestor
102645570|NCT01074138|Tirbanibulin|tirbanibulin|mesh-list
102645571|NCT01074138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102645572|NCT01074138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645573|NCT00951132|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102645574|NCT00951132|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102645575|NCT00951132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102645576|NCT00951132|Antimetabolites|antimetabolites|mesh-ancestor
102645577|NCT00951132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645578|NCT00951132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102645579|NCT00951132|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102645580|NCT00951132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102645581|NCT01717872|Pyrithione zinc|pyrithione zinc|mesh-list
102645582|NCT01717872|Keratolytic Agents|keratolytic agents|mesh-ancestor
102645583|NCT01717872|Dermatologic Agents|dermatologic agents|mesh-ancestor
102645584|NCT01721226|Opiate Alkaloids|opiate alkaloids|mesh-list
102645585|NCT01721226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102645586|NCT01721226|Narcotics|narcotics|mesh-ancestor
102645587|NCT01721226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102645588|NCT01721226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645589|NCT01721226|Analgesics|analgesics|mesh-ancestor
102645590|NCT01721226|Sensory System Agents|sensory system agents|mesh-ancestor
101366868|NCT00159484|Celecoxib|celecoxib|mesh-list
102645591|NCT01721226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102645592|NCT01721460|Dexmedetomidine|dexmedetomidine|mesh-list
102645593|NCT01721460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102645594|NCT01721460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102645595|NCT01721460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645596|NCT01721460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102645597|NCT01721460|Analgesics|analgesics|mesh-ancestor
102645598|NCT01721460|Sensory System Agents|sensory system agents|mesh-ancestor
102645599|NCT01721460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102645600|NCT01721460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102645601|NCT01721460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102645602|NCT01721460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102645603|NCT01721460|Adrenergic Agents|adrenergic agents|mesh-ancestor
102645604|NCT01721460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102645605|NCT01721460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645606|NCT01722318|Plecanatide|plecanatide|mesh-list
102645607|NCT01722318|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102645608|NCT01722318|Enzyme Activators|enzyme activators|mesh-ancestor
102645609|NCT01722318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645610|NCT01722318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102645611|NCT01723722|Methadone|methadone|mesh-list
102645612|NCT01723722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102645613|NCT01723722|Narcotics|narcotics|mesh-ancestor
102645614|NCT01723722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102645615|NCT01723722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645616|NCT01723722|Analgesics|analgesics|mesh-ancestor
102645617|NCT01723722|Sensory System Agents|sensory system agents|mesh-ancestor
102645618|NCT01723722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102645619|NCT01723722|Antitussive Agents|antitussive agents|mesh-ancestor
102645620|NCT01723722|Respiratory System Agents|respiratory system agents|mesh-ancestor
102645621|NCT01728636|Tranexamic Acid|tranexamic acid|mesh-list
102645622|NCT01728636|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102645623|NCT01728636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102645624|NCT01728636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645625|NCT01728636|Hemostatics|hemostatics|mesh-ancestor
102645626|NCT01728636|Coagulants|coagulants|mesh-ancestor
102645627|NCT01729338|Cyclophosphamide|cyclophosphamide|mesh-list
102275431|NCT04762459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934275|NCT03479216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102645628|NCT01729338|Lenalidomide|lenalidomide|mesh-list
102645629|NCT01729338|Bortezomib|bortezomib|mesh-list
102645630|NCT01729338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102645631|NCT01729338|Immunologic Factors|immunologic factors|mesh-ancestor
102645632|NCT01729338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645633|NCT01729338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102645634|NCT01729338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102645635|NCT01729338|Alkylating Agents|alkylating agents|mesh-ancestor
102645636|NCT01729338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645637|NCT01729338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102645638|NCT01729338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102645639|NCT01729338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102645640|NCT01729338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102645641|NCT01729338|Growth Substances|growth substances|mesh-ancestor
102645642|NCT01729338|Growth Inhibitors|growth inhibitors|mesh-ancestor
102645643|NCT01729494|Mycophenolic Acid|mycophenolic acid|mesh-list
102645644|NCT01729494|Prednisone|prednisone|mesh-list
102645645|NCT01729494|Alemtuzumab|alemtuzumab|mesh-list
102645646|NCT01729494|Abatacept|abatacept|mesh-list
102645647|NCT01729494|Tacrolimus|tacrolimus|mesh-list
102645648|NCT01729494|Thymoglobulin|thymoglobulin|mesh-list
102645649|NCT01729494|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102645650|NCT01729494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102645651|NCT01729494|Glucocorticoids|glucocorticoids|mesh-ancestor
102645652|NCT01729494|Hormones|hormones|mesh-ancestor
102645653|NCT01729494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102645654|NCT01729494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645655|NCT01729494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102645656|NCT01729494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102645657|NCT01729494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102645658|NCT01729494|Immunologic Factors|immunologic factors|mesh-ancestor
102645659|NCT01729494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102645660|NCT01729494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102645661|NCT01729494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645662|NCT01729494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102645663|NCT01729494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102645664|NCT01729494|Antitubercular Agents|antitubercular agents|mesh-ancestor
102645665|NCT01729494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102645666|NCT01729494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102645667|NCT01729494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102645668|NCT01729494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102645669|NCT01729494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102645670|NCT05317260|Antiviral Agents|antiviral agents|mesh-list
102645671|NCT05317260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102645672|NCT05316480|Nimotuzumab|nimotuzumab|mesh-list
102645673|NCT05316480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102645674|NCT05316480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102645675|NCT05316246|Tislelizumab|tislelizumab|mesh-list
102645676|NCT05316246|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102645677|NCT05316246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102645678|NCT05316246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102645679|NCT05316246|Immunotoxins|immunotoxins|mesh-ancestor
102645680|NCT05316246|Immunoconjugates|immunoconjugates|mesh-ancestor
102645681|NCT05316246|Immunologic Factors|immunologic factors|mesh-ancestor
102645682|NCT05316246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645683|NCT05316168|Dexamethasone|dexamethasone|mesh-list
102645684|NCT05316168|Bupivacaine|bupivacaine|mesh-list
102645685|NCT05316168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102645686|NCT05316168|Antiemetics|antiemetics|mesh-ancestor
102645687|NCT05316168|Autonomic Agents|autonomic agents|mesh-ancestor
102645688|NCT05316168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102645689|NCT05316168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645690|NCT05316168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102645691|NCT05316168|Glucocorticoids|glucocorticoids|mesh-ancestor
102645692|NCT05316168|Hormones|hormones|mesh-ancestor
102645693|NCT05316168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102645694|NCT05316168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102645695|NCT05316168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102645696|NCT05316168|Anesthetics, Local|anesthetics, local|mesh-ancestor
102645697|NCT05316168|Anesthetics|anesthetics|mesh-ancestor
102645698|NCT05316168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102645699|NCT05316168|Sensory System Agents|sensory system agents|mesh-ancestor
102645700|NCT05315388|Vitamins|vitamins|mesh-list
102645701|NCT05315388|Micronutrients|micronutrients|mesh-ancestor
102645702|NCT05315388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645703|NCT04894188|Goserelin|goserelin|mesh-list
102275432|NCT04762459|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102645704|NCT04894188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102645705|NCT04894188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102645706|NCT04724772|Tranexamic Acid|tranexamic acid|mesh-list
102645707|NCT04724772|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102645708|NCT04724772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102645709|NCT04724772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645710|NCT04724772|Hemostatics|hemostatics|mesh-ancestor
102645711|NCT04724772|Coagulants|coagulants|mesh-ancestor
102645712|NCT04196868|Metformin|metformin|mesh-list
102645713|NCT04196868|Methotrexate|methotrexate|mesh-list
102645714|NCT04196868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102645715|NCT04196868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645716|NCT04196868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102645717|NCT04196868|Abortifacient Agents|abortifacient agents|mesh-ancestor
102645718|NCT04196868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102645719|NCT04196868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102645720|NCT04196868|Antimetabolites|antimetabolites|mesh-ancestor
102645721|NCT04196868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645722|NCT04196868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102645723|NCT04196868|Dermatologic Agents|dermatologic agents|mesh-ancestor
102645724|NCT04196868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102645725|NCT04196868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102645726|NCT04196868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102645727|NCT04196868|Immunologic Factors|immunologic factors|mesh-ancestor
102645728|NCT04196868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102645729|NCT04196868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102645730|NCT04007874|Vitamin E|vitamin e|mesh-list
102645731|NCT04007874|Levonorgestrel|levonorgestrel|mesh-list
102645732|NCT04007874|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102645733|NCT04007874|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
102645734|NCT04007874|Vitamins|vitamins|mesh-ancestor
102645735|NCT04007874|Micronutrients|micronutrients|mesh-ancestor
102645736|NCT04007874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645737|NCT04007874|Antioxidants|antioxidants|mesh-ancestor
102645738|NCT04007874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645739|NCT04007874|Protective Agents|protective agents|mesh-ancestor
102645740|NCT04007874|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102645741|NCT04007874|Contraceptive Agents|contraceptive agents|mesh-ancestor
102645742|NCT04007874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102645743|NCT04007874|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102645744|NCT04007874|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102645745|NCT04007874|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102645746|NCT04007874|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102645747|NCT04007874|Estrogens|estrogens|mesh-ancestor
102645748|NCT04007874|Hormones|hormones|mesh-ancestor
102645749|NCT04007874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102645750|NCT04007874|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102645751|NCT03878472|Oxaliplatin|oxaliplatin|mesh-list
102645752|NCT03878472|Apatinib|apatinib|mesh-list
102645753|NCT03878472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102645754|NCT03878472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102645755|NCT03878472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102645756|NCT03878472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645757|NCT03162510|Paclitaxel|paclitaxel|mesh-list
102645758|NCT03162510|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102645759|NCT03162510|Oxaliplatin|oxaliplatin|mesh-list
102645760|NCT03162510|Tegafur|tegafur|mesh-list
102645761|NCT03162510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102645762|NCT03162510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102645763|NCT03162510|Tubulin Modulators|tubulin modulators|mesh-ancestor
102645764|NCT03162510|Antimitotic Agents|antimitotic agents|mesh-ancestor
102645765|NCT03162510|Mitosis Modulators|mitosis modulators|mesh-ancestor
102645766|NCT03162510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645767|NCT03162510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102645768|NCT03162510|Antimetabolites|antimetabolites|mesh-ancestor
102645769|NCT02996760|Mitogens|mitogens|mesh-list
102645770|NCT02996760|Mitosis Modulators|mitosis modulators|mesh-ancestor
102645771|NCT02996760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645772|NCT02987946|Nadroparin|nadroparin|mesh-list
102645773|NCT02987946|Anticoagulants|anticoagulants|mesh-ancestor
102645774|NCT02987946|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102275433|NCT04762459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102645775|NCT02987946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102645776|NCT02987946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275434|NCT03078569|Testosterone|testosterone|mesh-list
102645777|NCT02394132|Imiquimod|imiquimod|mesh-list
102645778|NCT02394132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102645779|NCT02394132|Immunologic Factors|immunologic factors|mesh-ancestor
102645780|NCT02394132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645781|NCT02394132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102645782|NCT02394132|Interferon Inducers|interferon inducers|mesh-ancestor
102645783|NCT00700596|Salvinorin A|salvinorin a|mesh-list
102645784|NCT00700596|Hallucinogens|hallucinogens|mesh-ancestor
102645785|NCT00700596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645786|NCT00700596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102645787|NCT01733472|Remifentanil|remifentanil|mesh-list
102645788|NCT01733472|Propofol|propofol|mesh-list
102645789|NCT01733472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102645790|NCT01733472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102645791|NCT01733472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645792|NCT01733472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102645793|NCT01733472|Anesthetics, General|anesthetics, general|mesh-ancestor
102645794|NCT01733472|Anesthetics|anesthetics|mesh-ancestor
102645795|NCT01733472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102645796|NCT01733472|Narcotics|narcotics|mesh-ancestor
102645797|NCT01733472|Analgesics|analgesics|mesh-ancestor
102645798|NCT01733472|Sensory System Agents|sensory system agents|mesh-ancestor
102645799|NCT01733472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102645800|NCT01736358|Ketorolac|ketorolac|mesh-list
102645801|NCT01736358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102645802|NCT01736358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102645803|NCT01736358|Analgesics|analgesics|mesh-ancestor
102645804|NCT01736358|Sensory System Agents|sensory system agents|mesh-ancestor
102645805|NCT01736358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102645806|NCT01736358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645807|NCT01736358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102645808|NCT01736358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102645809|NCT01736358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102645810|NCT01736358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102645811|NCT01736358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645812|NCT01740258|Bevacizumab|bevacizumab|mesh-list
102645813|NCT01740258|Temozolomide|temozolomide|mesh-list
102645814|NCT01740258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102645815|NCT01740258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102645816|NCT01740258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102645817|NCT01740258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102645818|NCT01740258|Growth Substances|growth substances|mesh-ancestor
102645819|NCT01740258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645820|NCT01740258|Growth Inhibitors|growth inhibitors|mesh-ancestor
102645821|NCT01740258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102645822|NCT01740258|Alkylating Agents|alkylating agents|mesh-ancestor
102645823|NCT01740258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645824|NCT01740414|Ibudilast|ibudilast|mesh-list
102645825|NCT01740414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102645826|NCT01740414|Autonomic Agents|autonomic agents|mesh-ancestor
102645827|NCT01740414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102645828|NCT01740414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645829|NCT01740414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102645830|NCT01740414|Respiratory System Agents|respiratory system agents|mesh-ancestor
102645831|NCT01740414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102645832|NCT01740414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102645833|NCT01740414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645834|NCT01740414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102645835|NCT01740414|Vasodilator Agents|vasodilator agents|mesh-ancestor
102645836|NCT01740726|Fluoxetine|fluoxetine|mesh-list
102645837|NCT01740726|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102645838|NCT01740726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102645839|NCT01740726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102645840|NCT01740726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645841|NCT01740726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102645842|NCT01740726|Serotonin Agents|serotonin agents|mesh-ancestor
102645843|NCT01740726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645844|NCT01740726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102645845|NCT01740726|Antidepressive Agents|antidepressive agents|mesh-ancestor
102645846|NCT01740726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102275435|NCT03078569|Androgens|androgens|mesh-ancestor
102275436|NCT03078569|Hormones|hormones|mesh-ancestor
101367190|NCT00161239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102645847|NCT01740726|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102645848|NCT01740726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102645849|NCT01740726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102645850|NCT01742208|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
102645851|NCT01742208|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102645852|NCT01742208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645853|NCT01742208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102645854|NCT01742208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645855|NCT01744704|Mitogens|mitogens|mesh-list
102645856|NCT01744704|Mitosis Modulators|mitosis modulators|mesh-ancestor
102645857|NCT01744704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645858|NCT01746264|Vitamin D|vitamin d|mesh-list
102645859|NCT01746264|Cholecalciferol|cholecalciferol|mesh-list
102645860|NCT01746264|Vitamins|vitamins|mesh-ancestor
102645861|NCT01746264|Micronutrients|micronutrients|mesh-ancestor
102645862|NCT01746264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645863|NCT01746264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102645864|NCT01746264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102645865|NCT01746420|Becaplermin|becaplermin|mesh-list
102645866|NCT01746420|Anticoagulants|anticoagulants|mesh-ancestor
102645867|NCT01746420|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
102645868|NCT01746420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102645869|NCT01746420|Growth Substances|growth substances|mesh-ancestor
102645870|NCT01746420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645871|NCT01749930|Timolol|timolol|mesh-list
102645872|NCT01749930|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102645873|NCT01749930|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102645874|NCT01749930|Adrenergic Agents|adrenergic agents|mesh-ancestor
102645875|NCT01749930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102645876|NCT01749930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645877|NCT01749930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645878|NCT01749930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102645879|NCT01749930|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102645880|NCT01750086|Denosumab|denosumab|mesh-list
102645881|NCT01750086|Alendronate|alendronate|mesh-list
102645882|NCT01750086|Teriparatide|teriparatide|mesh-list
102645883|NCT01750086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102645884|NCT01750086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645885|NCT01750086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102645886|NCT01750398|Methyltestosterone|methyltestosterone|mesh-list
102645887|NCT01750398|Leuprolide|leuprolide|mesh-list
102645888|NCT01750398|Goserelin|goserelin|mesh-list
102645889|NCT01750398|Testosterone|testosterone|mesh-list
102645890|NCT01750398|Testosterone undecanoate|testosterone undecanoate|mesh-list
102645891|NCT01750398|Testosterone enanthate|testosterone enanthate|mesh-list
102645892|NCT01750398|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102645893|NCT01750398|Androgens|androgens|mesh-ancestor
102645894|NCT01750398|Hormones|hormones|mesh-ancestor
102645895|NCT01750398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102645896|NCT01750398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645897|NCT01750398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102645898|NCT01750398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102645899|NCT01750398|Anabolic Agents|anabolic agents|mesh-ancestor
102645900|NCT01750398|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102645901|NCT01750398|Fertility Agents|fertility agents|mesh-ancestor
102645902|NCT01750398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102645903|NCT01752426|Deuterium Oxide|deuterium oxide|mesh-list
102645904|NCT01752426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102645905|NCT01752426|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102645906|NCT01752426|Protective Agents|protective agents|mesh-ancestor
102645907|NCT01752426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645908|NCT01753362|Liraglutide|liraglutide|mesh-list
102645909|NCT01753362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102645910|NCT01753362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645911|NCT01753362|Incretins|incretins|mesh-ancestor
102645912|NCT01753362|Hormones|hormones|mesh-ancestor
102645913|NCT01753362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102645914|NCT01758588|Interferons|interferons|mesh-list
102645915|NCT01758588|Interferon-alpha|interferon-alpha|mesh-list
102645916|NCT01758588|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102645917|NCT01758588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102645918|NCT01758588|Antiviral Agents|antiviral agents|mesh-ancestor
102645919|NCT01758588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102645920|NCT01758588|Immunologic Factors|immunologic factors|mesh-ancestor
101934495|NCT04484350|Sympathomimetics|sympathomimetics|mesh-ancestor
102645921|NCT01758588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645922|NCT01759602|Complement C1s|complement c1s|mesh-list
102645923|NCT01759602|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
102645924|NCT01759602|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
102645925|NCT01759602|Immunologic Factors|immunologic factors|mesh-ancestor
102645926|NCT01759602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645927|NCT01759602|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102645928|NCT01759602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102645929|NCT01760304|Budesonide|budesonide|mesh-list
102645930|NCT01760304|Formoterol Fumarate|formoterol fumarate|mesh-list
102645931|NCT01760304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102645932|NCT01760304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102645933|NCT01760304|Autonomic Agents|autonomic agents|mesh-ancestor
102645934|NCT01760304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102645935|NCT01760304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645936|NCT01760304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102645937|NCT01760304|Respiratory System Agents|respiratory system agents|mesh-ancestor
102645938|NCT01760304|Glucocorticoids|glucocorticoids|mesh-ancestor
102645939|NCT01760304|Hormones|hormones|mesh-ancestor
102645940|NCT01760304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102645941|NCT01760304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102645942|NCT01760304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102645943|NCT01760304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102645944|NCT01760304|Adrenergic Agents|adrenergic agents|mesh-ancestor
102645945|NCT01760304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102645946|NCT01760304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645947|NCT01763346|Metformin|metformin|mesh-list
102645948|NCT01763346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102645949|NCT01763346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645950|NCT01766466|Ticagrelor|ticagrelor|mesh-list
102645951|NCT01766466|Cangrelor|cangrelor|mesh-list
102645952|NCT01766466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102645953|NCT01766466|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102645954|NCT01766466|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102645955|NCT01766466|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102645956|NCT01766466|Purinergic Agents|purinergic agents|mesh-ancestor
102645957|NCT01766466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102645958|NCT01766466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645959|NCT01766466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645960|NCT01769352|Prednisolone acetate|prednisolone acetate|mesh-list
102645961|NCT01769352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102645962|NCT01769586|Diphenhydramine|diphenhydramine|mesh-list
102645963|NCT01769586|Promethazine|promethazine|mesh-list
102645964|NCT01769586|Midazolam|midazolam|mesh-list
102645965|NCT01769586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102645966|NCT01769586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102645967|NCT01769586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102645968|NCT01769586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645969|NCT01769586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102645970|NCT01769586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102645971|NCT01769586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102645972|NCT01769586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102645973|NCT01769586|Anesthetics, General|anesthetics, general|mesh-ancestor
102645974|NCT01769586|Anesthetics|anesthetics|mesh-ancestor
102645975|NCT01769586|GABA Modulators|gaba modulators|mesh-ancestor
102645976|NCT01769586|GABA Agents|gaba agents|mesh-ancestor
102645977|NCT01769586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102645978|NCT01769586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102645979|NCT01769586|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102645980|NCT01769586|Anesthetics, Local|anesthetics, local|mesh-ancestor
102645981|NCT01769586|Sensory System Agents|sensory system agents|mesh-ancestor
102645982|NCT01769586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102645983|NCT01769586|Antiemetics|antiemetics|mesh-ancestor
102645984|NCT01769586|Autonomic Agents|autonomic agents|mesh-ancestor
102645985|NCT01769586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102645986|NCT01769586|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102645987|NCT01769586|Histamine Antagonists|histamine antagonists|mesh-ancestor
102645988|NCT01769586|Histamine Agents|histamine agents|mesh-ancestor
102645989|NCT01769586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102645990|NCT01769586|Antipruritics|antipruritics|mesh-ancestor
102645991|NCT01769586|Dermatologic Agents|dermatologic agents|mesh-ancestor
102275437|NCT03078569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102645992|NCT01773954|Aflibercept|aflibercept|mesh-list
102645993|NCT01773954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102645994|NCT01773954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102275438|NCT03078569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645995|NCT01773954|Growth Substances|growth substances|mesh-ancestor
102645996|NCT01773954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102645997|NCT01773954|Growth Inhibitors|growth inhibitors|mesh-ancestor
102645998|NCT01773954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102645999|NCT01778634|Azithromycin|azithromycin|mesh-list
102646000|NCT01778634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102646001|NCT01778634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102646002|NCT01783236|Acetaminophen|acetaminophen|mesh-list
102646003|NCT01783236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102646004|NCT01783236|Analgesics|analgesics|mesh-ancestor
102646005|NCT01783236|Sensory System Agents|sensory system agents|mesh-ancestor
102646006|NCT01783236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102646007|NCT01783236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646008|NCT01783236|Antipyretics|antipyretics|mesh-ancestor
102646010|NCT01783470|Adrenergic Agents|adrenergic agents|mesh-list
102646011|NCT01783470|Adrenergic Agonists|adrenergic agonists|mesh-list
102646012|NCT01783470|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102646013|NCT01783470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102646014|NCT01783470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102646015|NCT01783470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646016|NCT01783470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646017|NCT01783470|Urological Agents|urological agents|mesh-ancestor
102646018|NCT01783860|Azithromycin|azithromycin|mesh-list
102646019|NCT01783860|Doxycycline|doxycycline|mesh-list
102646020|NCT01783860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102646021|NCT01783860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102646022|NCT01783860|Antimalarials|antimalarials|mesh-ancestor
102646023|NCT01783860|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102646024|NCT01783860|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102646025|NCT01785186|Pyridoxine|pyridoxine|mesh-list
102646026|NCT01785186|Moxifloxacin|moxifloxacin|mesh-list
102646027|NCT01785186|Rifampin|rifampin|mesh-list
102646028|NCT01785186|Isoniazid|isoniazid|mesh-list
102646029|NCT01785186|Pyrazinamide|pyrazinamide|mesh-list
102646030|NCT01785186|Ethambutol|ethambutol|mesh-list
102646031|NCT01785186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102646032|NCT01785186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102646033|NCT01785186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102646034|NCT01785186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102646035|NCT01785186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102646036|NCT01785186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646037|NCT01785186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646038|NCT01785186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646039|NCT01785186|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102646040|NCT01785186|Antitubercular Agents|antitubercular agents|mesh-ancestor
102646041|NCT01785186|Leprostatic Agents|leprostatic agents|mesh-ancestor
102646042|NCT01785186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102646043|NCT01785186|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102646044|NCT01785186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102646045|NCT01785186|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102646046|NCT01785186|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102646047|NCT01785186|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102646048|NCT01785186|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102646049|NCT01785186|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102646050|NCT01785186|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102646051|NCT01785186|Antimetabolites|antimetabolites|mesh-ancestor
102646052|NCT01785186|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102646053|NCT01785186|Vitamin B Complex|vitamin b complex|mesh-ancestor
102646054|NCT01785186|Vitamins|vitamins|mesh-ancestor
102646055|NCT01785186|Micronutrients|micronutrients|mesh-ancestor
102646056|NCT01785810|Maraviroc|maraviroc|mesh-list
102646057|NCT01785810|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102646058|NCT01785810|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101367435|NCT00162643|Antimetabolites|antimetabolites|mesh-ancestor
102646059|NCT01785810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646060|NCT01785810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102646061|NCT01785810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102646062|NCT01785810|Antiviral Agents|antiviral agents|mesh-ancestor
102646063|NCT01785810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102646064|NCT01785810|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102646065|NCT01786902|Hormones|hormones|mesh-list
102646066|NCT01786902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102646067|NCT01786902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646068|NCT01787916|Liraglutide|liraglutide|mesh-list
102275439|NCT02345863|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102646069|NCT01787916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102646070|NCT01787916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646071|NCT01787916|Incretins|incretins|mesh-ancestor
102646072|NCT01787916|Hormones|hormones|mesh-ancestor
102646073|NCT01787916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102646074|NCT01790490|Ketamine|ketamine|mesh-list
102646075|NCT01790490|Lorazepam|lorazepam|mesh-list
102646076|NCT01790490|Analgesics|analgesics|mesh-ancestor
102646077|NCT01790490|Sensory System Agents|sensory system agents|mesh-ancestor
102646078|NCT01790490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102646079|NCT01790490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646080|NCT01790490|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102646081|NCT01790490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102646082|NCT01790490|Anesthetics, General|anesthetics, general|mesh-ancestor
102646083|NCT01790490|Anesthetics|anesthetics|mesh-ancestor
102646084|NCT01790490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102646085|NCT01790490|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102646086|NCT01790490|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102646087|NCT01790490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102646088|NCT01790490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646089|NCT01790490|Anticonvulsants|anticonvulsants|mesh-ancestor
102646090|NCT01790490|Antiemetics|antiemetics|mesh-ancestor
102646091|NCT01790490|Autonomic Agents|autonomic agents|mesh-ancestor
102646092|NCT01790490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102646093|NCT01790490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102646094|NCT01790490|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102646095|NCT01790490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102646096|NCT01790490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102646097|NCT01790490|GABA Modulators|gaba modulators|mesh-ancestor
102646098|NCT01790490|GABA Agents|gaba agents|mesh-ancestor
102646099|NCT01791972|Albuterol|albuterol|mesh-list
102646100|NCT01791972|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102646101|NCT01791972|Autonomic Agents|autonomic agents|mesh-ancestor
102646102|NCT01791972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102646103|NCT01791972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646104|NCT01791972|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102646105|NCT01791972|Respiratory System Agents|respiratory system agents|mesh-ancestor
102646106|NCT01791972|Tocolytic Agents|tocolytic agents|mesh-ancestor
102646107|NCT01791972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102646108|NCT01791972|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102646109|NCT01791972|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102646110|NCT01791972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102646111|NCT01791972|Adrenergic Agents|adrenergic agents|mesh-ancestor
102646112|NCT01791972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102646113|NCT01791972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646114|NCT01794702|Cytarabine|cytarabine|mesh-list
102646115|NCT01794702|Decitabine|decitabine|mesh-list
102646116|NCT01794702|Clofarabine|clofarabine|mesh-list
102646117|NCT01794702|Idarubicin|idarubicin|mesh-list
102646118|NCT01794702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102646119|NCT01794702|Antimetabolites|antimetabolites|mesh-ancestor
102646120|NCT01794702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646121|NCT01794702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646122|NCT01794702|Antiviral Agents|antiviral agents|mesh-ancestor
102646123|NCT01794702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102646124|NCT01794702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102646125|NCT01794702|Immunologic Factors|immunologic factors|mesh-ancestor
102646126|NCT01794702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646127|NCT01794702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102646128|NCT01794702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101367496|NCT00162916|Citalopram|citalopram|mesh-list
102646129|NCT01794702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102646130|NCT01794702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102646131|NCT01795716|Imatinib Mesylate|imatinib mesylate|mesh-list
102646132|NCT01795716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646133|NCT01795716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102646134|NCT01795716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102646135|NCT01795716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646136|NCT01810692|Tiotropium Bromide|tiotropium bromide|mesh-list
102646137|NCT01810692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102646138|NCT01810692|Autonomic Agents|autonomic agents|mesh-ancestor
102646139|NCT01810692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102275440|NCT02345863|Obinutuzumab|obinutuzumab|mesh-list
102646140|NCT01810692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646141|NCT01810692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101934718|NCT03425396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102646142|NCT01810692|Respiratory System Agents|respiratory system agents|mesh-ancestor
102275441|NCT02345863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102646143|NCT01810692|Parasympatholytics|parasympatholytics|mesh-ancestor
102646144|NCT01810692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102646145|NCT01810692|Cholinergic Agents|cholinergic agents|mesh-ancestor
102646146|NCT01810692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102646147|NCT01810692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646148|NCT01811940|Topiramate|topiramate|mesh-list
102646149|NCT01811940|Adderall|adderall|mesh-list
102646150|NCT01811940|Anticonvulsants|anticonvulsants|mesh-ancestor
102646151|NCT01811940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102646152|NCT01811940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646153|NCT01811940|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102646154|NCT01813734|Ponatinib|ponatinib|mesh-list
102646155|NCT01813734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646156|NCT01813734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102646157|NCT01813734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102646158|NCT01813734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646159|NCT01818414|Vitamins|vitamins|mesh-list
102646160|NCT01818414|Folic Acid|folic acid|mesh-list
102646161|NCT01818414|Misoprostol|misoprostol|mesh-list
102646162|NCT01818414|Micronutrients|micronutrients|mesh-ancestor
102646163|NCT01818414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646164|NCT01818414|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102646165|NCT01818414|Abortifacient Agents|abortifacient agents|mesh-ancestor
102646166|NCT01818414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102646167|NCT01818414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102646168|NCT01818414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102646169|NCT01818414|Oxytocics|oxytocics|mesh-ancestor
102646170|NCT01818414|Hematinics|hematinics|mesh-ancestor
102646171|NCT01818414|Vitamin B Complex|vitamin b complex|mesh-ancestor
102646172|NCT06020560|Dalteparin|dalteparin|mesh-list
102646173|NCT06020560|Tinzaparin|tinzaparin|mesh-list
102646174|NCT06020560|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102646175|NCT06020560|Anticoagulants|anticoagulants|mesh-ancestor
102646176|NCT06020560|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102646177|NCT06020560|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102646178|NCT06020560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646179|NCT06020456|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
102646180|NCT06020456|Hemostatics|hemostatics|mesh-ancestor
102646181|NCT06020456|Coagulants|coagulants|mesh-ancestor
102646182|NCT06020456|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102646183|NCT06020456|Natriuretic Agents|natriuretic agents|mesh-ancestor
102646184|NCT06020456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646185|NCT06020378|Hydroxychloroquine|hydroxychloroquine|mesh-list
102646186|NCT06020378|Antimalarials|antimalarials|mesh-ancestor
102646187|NCT06020378|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102646188|NCT06020378|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102646189|NCT06020378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102646190|NCT06020378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102646191|NCT06020378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646192|NCT06020378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102646193|NCT06020352|Axitinib|axitinib|mesh-list
102646194|NCT06020352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646195|NCT06020352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102646196|NCT06020352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102646197|NCT06020352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646198|NCT06020313|Resveratrol|resveratrol|mesh-list
102646199|NCT06020313|Antioxidants|antioxidants|mesh-ancestor
102646200|NCT06020313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646201|NCT06020313|Protective Agents|protective agents|mesh-ancestor
102646202|NCT06020313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646203|NCT06020313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102646204|NCT06020313|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102646205|NCT06020300|Pyridoxine|pyridoxine|mesh-list
102646206|NCT06020300|Pyridoxal|pyridoxal|mesh-list
102646207|NCT06020300|Vitamin B 6|vitamin b 6|mesh-list
102646208|NCT06020300|Colchicine|colchicine|mesh-list
102646209|NCT06020300|Gout Suppressants|gout suppressants|mesh-ancestor
102646210|NCT06020300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102646211|NCT06020300|Tubulin Modulators|tubulin modulators|mesh-ancestor
102646212|NCT06020300|Antimitotic Agents|antimitotic agents|mesh-ancestor
102646213|NCT06020300|Mitosis Modulators|mitosis modulators|mesh-ancestor
102646214|NCT06020300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646215|NCT06020300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646216|NCT06020300|Vitamin B Complex|vitamin b complex|mesh-ancestor
102646217|NCT06020300|Vitamins|vitamins|mesh-ancestor
102646218|NCT06020300|Micronutrients|micronutrients|mesh-ancestor
102646219|NCT06020300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646220|NCT06020196|Anesthetics|anesthetics|mesh-list
102646221|NCT06020196|Anesthetics, Local|anesthetics, local|mesh-list
102646222|NCT06020196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102646223|NCT06020196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646224|NCT06020196|Sensory System Agents|sensory system agents|mesh-ancestor
102646225|NCT06020196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102646226|NCT06020144|Tofacitinib|tofacitinib|mesh-list
102646227|NCT06020144|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102646228|NCT06020144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102646229|NCT06020144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102646230|NCT06020144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646231|NCT06020118|Vaccines|vaccines|mesh-list
102646232|NCT06020118|Immunologic Factors|immunologic factors|mesh-ancestor
102646233|NCT06020118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646234|NCT06019858|Vitamins|vitamins|mesh-list
102646235|NCT06019858|Micronutrients|micronutrients|mesh-ancestor
102646236|NCT06019858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646237|NCT06019754|Anesthetics|anesthetics|mesh-list
102646238|NCT06019754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102646239|NCT06019754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646240|NCT06019741|Aspirin|aspirin|mesh-list
102646241|NCT06019741|Rivaroxaban|rivaroxaban|mesh-list
102646242|NCT06019741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102646243|NCT06019741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102646244|NCT06019741|Analgesics|analgesics|mesh-ancestor
102646245|NCT06019741|Sensory System Agents|sensory system agents|mesh-ancestor
102646246|NCT06019741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102646247|NCT06019741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646248|NCT06019741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102646249|NCT06019741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102646250|NCT06019741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102646251|NCT06019741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102646252|NCT06019741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646253|NCT06019741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102646254|NCT06019741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102646255|NCT06019741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102646256|NCT06019741|Antipyretics|antipyretics|mesh-ancestor
102646257|NCT06019741|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102646258|NCT06019741|Antithrombins|antithrombins|mesh-ancestor
102646259|NCT06019741|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102646260|NCT06019741|Protease Inhibitors|protease inhibitors|mesh-ancestor
102646261|NCT06019741|Anticoagulants|anticoagulants|mesh-ancestor
102646262|NCT06019728|Acetaminophen|acetaminophen|mesh-list
102646263|NCT06019728|Diphenhydramine|diphenhydramine|mesh-list
102646264|NCT06019728|Promethazine|promethazine|mesh-list
102646265|NCT06019728|Dexamethasone|dexamethasone|mesh-list
102646266|NCT06019728|Montelukast|montelukast|mesh-list
102646267|NCT06019728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102646268|NCT06019728|Antiemetics|antiemetics|mesh-ancestor
102646269|NCT06019728|Autonomic Agents|autonomic agents|mesh-ancestor
102646270|NCT06019728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102646271|NCT06019728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646272|NCT06019728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102646273|NCT06019728|Glucocorticoids|glucocorticoids|mesh-ancestor
102646274|NCT06019728|Hormones|hormones|mesh-ancestor
102646275|NCT06019728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102646276|NCT06019728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102646277|NCT06019728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646278|NCT06019728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102646279|NCT06019728|Analgesics|analgesics|mesh-ancestor
102646280|NCT06019728|Sensory System Agents|sensory system agents|mesh-ancestor
102646281|NCT06019728|Antipyretics|antipyretics|mesh-ancestor
102646282|NCT06019728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102646283|NCT06019728|Respiratory System Agents|respiratory system agents|mesh-ancestor
102646284|NCT06019728|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102646285|NCT06019728|Hormone Antagonists|hormone antagonists|mesh-ancestor
102646286|NCT06019728|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102646287|NCT06019728|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102646288|NCT06019728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646289|NCT06019728|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102646290|NCT06019728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102646291|NCT06019728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102646292|NCT06019728|Anesthetics, Local|anesthetics, local|mesh-ancestor
102275442|NCT02345863|Alkylating Agents|alkylating agents|mesh-ancestor
102646293|NCT06019728|Anesthetics|anesthetics|mesh-ancestor
102646294|NCT06019728|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102275443|NCT02345863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646295|NCT06019728|Histamine Antagonists|histamine antagonists|mesh-ancestor
102646296|NCT06019728|Histamine Agents|histamine agents|mesh-ancestor
102646297|NCT06019728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102646298|NCT06019728|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102646299|NCT06019728|Antipruritics|antipruritics|mesh-ancestor
102646300|NCT06019728|Dermatologic Agents|dermatologic agents|mesh-ancestor
102646301|NCT06019520|Acetylcysteine|acetylcysteine|mesh-list
102646302|NCT06019520|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102646303|NCT06019520|Antiviral Agents|antiviral agents|mesh-ancestor
102646304|NCT06019520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102646305|NCT06019520|Expectorants|expectorants|mesh-ancestor
102646306|NCT06019520|Respiratory System Agents|respiratory system agents|mesh-ancestor
102646307|NCT06019520|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102646308|NCT06019520|Antioxidants|antioxidants|mesh-ancestor
102646309|NCT06019520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646310|NCT06019520|Protective Agents|protective agents|mesh-ancestor
102646311|NCT06019520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646312|NCT06019520|Antidotes|antidotes|mesh-ancestor
102646313|NCT06019507|Mycophenolic Acid|mycophenolic acid|mesh-list
102646314|NCT06019507|Cyclophosphamide|cyclophosphamide|mesh-list
102646315|NCT06019507|Tacrolimus|tacrolimus|mesh-list
102646316|NCT06019507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102646317|NCT06019507|Immunologic Factors|immunologic factors|mesh-ancestor
102646318|NCT06019507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646319|NCT06019507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102646320|NCT06019507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102646321|NCT06019507|Alkylating Agents|alkylating agents|mesh-ancestor
102646322|NCT06019507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646323|NCT06019507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646324|NCT06019507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102646325|NCT06019507|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102646326|NCT06019507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102646327|NCT06019507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102646328|NCT06019507|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102646329|NCT06019507|Antitubercular Agents|antitubercular agents|mesh-ancestor
102646330|NCT06019507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102646331|NCT06019507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102646332|NCT06019286|Hormones|hormones|mesh-list
102646333|NCT06019286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102646334|NCT06019286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646335|NCT06019130|Interferons|interferons|mesh-list
102646336|NCT06019130|Interferon-beta|interferon-beta|mesh-list
102646337|NCT06019130|Interferon beta-1a|interferon beta-1a|mesh-list
102646338|NCT06019130|Cisplatin|cisplatin|mesh-list
102646339|NCT06019130|Gemcitabine|gemcitabine|mesh-list
102646340|NCT06019130|Fluorouracil|fluorouracil|mesh-list
102646341|NCT06019130|Nivolumab|nivolumab|mesh-list
102646342|NCT06019130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646343|NCT06019130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102646344|NCT06019130|Antimetabolites|antimetabolites|mesh-ancestor
102646345|NCT06019130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646346|NCT06019130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102646347|NCT06019130|Immunologic Factors|immunologic factors|mesh-ancestor
102646348|NCT06019130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646349|NCT06019130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102646350|NCT06019130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102646351|NCT06019130|Antiviral Agents|antiviral agents|mesh-ancestor
102646352|NCT06019130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102646353|NCT06019130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102646354|NCT06018948|Dexmedetomidine|dexmedetomidine|mesh-list
102646355|NCT06018948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102646356|NCT06018948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102646357|NCT06018948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646358|NCT06018948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102646359|NCT06018948|Analgesics|analgesics|mesh-ancestor
102646360|NCT06018948|Sensory System Agents|sensory system agents|mesh-ancestor
102646361|NCT06018948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102646362|NCT06018948|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102646363|NCT06018948|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102646364|NCT06018948|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102275444|NCT02345863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646365|NCT06018948|Adrenergic Agents|adrenergic agents|mesh-ancestor
102646366|NCT06018948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102646367|NCT06018948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646368|NCT06018883|Paclitaxel|paclitaxel|mesh-list
102646369|NCT06018883|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102646370|NCT06018883|Gemcitabine|gemcitabine|mesh-list
102646371|NCT06018883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102646372|NCT06018883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646373|NCT06018883|Tubulin Modulators|tubulin modulators|mesh-ancestor
102646374|NCT06018883|Antimitotic Agents|antimitotic agents|mesh-ancestor
102646375|NCT06018883|Mitosis Modulators|mitosis modulators|mesh-ancestor
102646376|NCT06018883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646377|NCT06018883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102646378|NCT06018883|Antimetabolites|antimetabolites|mesh-ancestor
102646379|NCT06018805|Anesthetics|anesthetics|mesh-list
102646380|NCT06018805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102646381|NCT06018805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646382|NCT06018766|Sirolimus|sirolimus|mesh-list
102646383|NCT06018766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102646384|NCT06018766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102646385|NCT06018766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102646386|NCT06018766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646387|NCT06018766|Antifungal Agents|antifungal agents|mesh-ancestor
102646388|NCT06018766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102646389|NCT06018766|Immunologic Factors|immunologic factors|mesh-ancestor
102646390|NCT06018766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646391|NCT06018727|Hydrocortisone|hydrocortisone|mesh-list
102646392|NCT06018727|Yohimbine|yohimbine|mesh-list
102646393|NCT06018727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102646394|NCT06018727|Mydriatics|mydriatics|mesh-ancestor
102646395|NCT06018727|Autonomic Agents|autonomic agents|mesh-ancestor
102646396|NCT06018727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102646397|NCT06018727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646398|NCT06018727|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102646399|NCT06018727|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102646400|NCT06018727|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102646401|NCT06018727|Adrenergic Agents|adrenergic agents|mesh-ancestor
102646402|NCT06018727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102646403|NCT06018727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646404|NCT06018727|Urological Agents|urological agents|mesh-ancestor
102646405|NCT06018688|Aspirin|aspirin|mesh-list
102646406|NCT06018688|Osimertinib|osimertinib|mesh-list
102646407|NCT06018688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102646408|NCT06018688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102646409|NCT06018688|Analgesics|analgesics|mesh-ancestor
102646410|NCT06018688|Sensory System Agents|sensory system agents|mesh-ancestor
102646411|NCT06018688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102646412|NCT06018688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646413|NCT06018688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102646414|NCT06018688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102646415|NCT06018688|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102646416|NCT06018688|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102646417|NCT06018688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646418|NCT06018688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102646419|NCT06018688|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102646420|NCT06018688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102646421|NCT06018688|Antipyretics|antipyretics|mesh-ancestor
102646422|NCT06018688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646423|NCT06018688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102646424|NCT06018675|Lidocaine|lidocaine|mesh-list
102646425|NCT06018675|Anesthetics, Local|anesthetics, local|mesh-ancestor
102646426|NCT06018675|Anesthetics|anesthetics|mesh-ancestor
102646427|NCT06018675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102646428|NCT06018675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646429|NCT06018675|Sensory System Agents|sensory system agents|mesh-ancestor
102646430|NCT06018675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102646431|NCT06018675|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102646432|NCT06018675|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102646433|NCT06018675|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102646434|NCT06018675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102646435|NCT06018675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646436|NCT06014944|Antibodies|antibodies|mesh-list
102646437|NCT06014944|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102646438|NCT06014944|Immunologic Factors|immunologic factors|mesh-ancestor
102646439|NCT06014944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646440|NCT06014359|Dexmedetomidine|dexmedetomidine|mesh-list
102275445|NCT02345863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102275446|NCT03078257|Aspirin|aspirin|mesh-list
102275447|NCT03078257|Tirofiban|tirofiban|mesh-list
102646441|NCT06014359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102646442|NCT06014359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102646443|NCT06014359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646444|NCT06014359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102646445|NCT06014359|Analgesics|analgesics|mesh-ancestor
102646446|NCT06014359|Sensory System Agents|sensory system agents|mesh-ancestor
102646447|NCT06014359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102646448|NCT06014359|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102646449|NCT06014359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102646450|NCT06014359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102646451|NCT06014359|Adrenergic Agents|adrenergic agents|mesh-ancestor
102646452|NCT06014359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102646453|NCT06014359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646454|NCT06011772|Leucovorin|leucovorin|mesh-list
102646455|NCT06011772|Bevacizumab|bevacizumab|mesh-list
102646456|NCT06011772|Cetuximab|cetuximab|mesh-list
102646457|NCT06011772|Fluorouracil|fluorouracil|mesh-list
102646458|NCT06011772|Oxaliplatin|oxaliplatin|mesh-list
102646459|NCT06011772|Irinotecan|irinotecan|mesh-list
102646460|NCT06011772|Vaccines|vaccines|mesh-list
102646461|NCT06011772|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
102646462|NCT06011772|Immunologic Factors|immunologic factors|mesh-ancestor
102646463|NCT06011772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646464|NCT06011772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102646465|NCT06011772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646466|NCT06011772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102646467|NCT06011772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102646468|NCT06011772|Growth Substances|growth substances|mesh-ancestor
102646469|NCT06011772|Growth Inhibitors|growth inhibitors|mesh-ancestor
102646470|NCT06011772|Antimetabolites|antimetabolites|mesh-ancestor
102646471|NCT06011772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646472|NCT06011772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102646473|NCT06011772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102646474|NCT06011772|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102646475|NCT06011772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102646476|NCT06011772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102646477|NCT06011772|Antidotes|antidotes|mesh-ancestor
102646478|NCT06011772|Protective Agents|protective agents|mesh-ancestor
102646479|NCT06011772|Vitamin B Complex|vitamin b complex|mesh-ancestor
102646480|NCT06011772|Vitamins|vitamins|mesh-ancestor
102646481|NCT06011772|Micronutrients|micronutrients|mesh-ancestor
102646482|NCT06011772|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102646483|NCT06011746|Ketamine|ketamine|mesh-list
102646484|NCT06011746|Levobupivacaine|levobupivacaine|mesh-list
102646485|NCT06011746|Analgesics|analgesics|mesh-ancestor
102646486|NCT06011746|Sensory System Agents|sensory system agents|mesh-ancestor
102646487|NCT06011746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102646488|NCT06011746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646489|NCT06011746|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102646490|NCT06011746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102646491|NCT06011746|Anesthetics, General|anesthetics, general|mesh-ancestor
102646492|NCT06011746|Anesthetics|anesthetics|mesh-ancestor
102646493|NCT06011746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102646494|NCT06011746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102646495|NCT06011746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102646496|NCT06011746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102646497|NCT06011746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646498|NCT06011746|Anesthetics, Local|anesthetics, local|mesh-ancestor
102646499|NCT06002607|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102646500|NCT06002607|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102646501|NCT06002607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102646502|NCT06002607|Antitubercular Agents|antitubercular agents|mesh-ancestor
102646503|NCT05997134|Ketamine|ketamine|mesh-list
102646504|NCT05997134|Analgesics|analgesics|mesh-ancestor
102646505|NCT05997134|Sensory System Agents|sensory system agents|mesh-ancestor
102646506|NCT05997134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102646507|NCT05997134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646508|NCT05997134|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102646509|NCT05997134|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102646510|NCT05997134|Anesthetics, General|anesthetics, general|mesh-ancestor
102646511|NCT05997134|Anesthetics|anesthetics|mesh-ancestor
102646512|NCT05997134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102646513|NCT05997134|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102646514|NCT05997134|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102646515|NCT05997134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102646516|NCT05997134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646518|NCT05996523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102646519|NCT05996523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646520|NCT05996523|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102646521|NCT05996523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646522|NCT05982990|Fluticasone|fluticasone|mesh-list
102646523|NCT05982990|Xhance|xhance|mesh-list
102646524|NCT05982990|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102646525|NCT05982990|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102646526|NCT05982990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102646527|NCT05982990|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102646528|NCT05982990|Autonomic Agents|autonomic agents|mesh-ancestor
102646529|NCT05982990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102646530|NCT05982990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646531|NCT05982990|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102646532|NCT05982990|Respiratory System Agents|respiratory system agents|mesh-ancestor
102646533|NCT05982990|Dermatologic Agents|dermatologic agents|mesh-ancestor
102646534|NCT05982990|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102646535|NCT05982990|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102646536|NCT05982990|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102646537|NCT05982990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102646538|NCT05982990|Adrenergic Agents|adrenergic agents|mesh-ancestor
102646539|NCT05982990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102646540|NCT05982990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646541|NCT05982990|Glucocorticoids|glucocorticoids|mesh-ancestor
102646542|NCT05982990|Hormones|hormones|mesh-ancestor
102646543|NCT05982990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102646544|NCT05982990|Sympathomimetics|sympathomimetics|mesh-ancestor
102646545|NCT05979740|Disitamab vedotin|disitamab vedotin|mesh-list
102646546|NCT05979740|Immunoconjugates|immunoconjugates|mesh-ancestor
102646547|NCT05979740|Immunologic Factors|immunologic factors|mesh-ancestor
102646548|NCT05979740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646549|NCT05976763|Rituximab|rituximab|mesh-list
102646550|NCT05976763|Zanubrutinib|zanubrutinib|mesh-list
102646551|NCT05976763|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102646552|NCT05976763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102646553|NCT05976763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646554|NCT05976763|Immunologic Factors|immunologic factors|mesh-ancestor
102646555|NCT05976763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646556|NCT05976763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102646557|NCT05976763|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102646558|NCT05976763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646559|NCT05976763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102646560|NCT05976763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102646561|NCT05976347|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102646562|NCT05976347|Fluoxetine|fluoxetine|mesh-list
102646563|NCT05976347|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102646564|NCT05976347|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102646565|NCT05976347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102646566|NCT05976347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646567|NCT05976347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102646568|NCT05976347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646569|NCT05976347|Analgesics|analgesics|mesh-ancestor
102646570|NCT05976347|Sensory System Agents|sensory system agents|mesh-ancestor
102646571|NCT05976347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102646572|NCT05976347|Antidepressive Agents|antidepressive agents|mesh-ancestor
102646573|NCT05976347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102646574|NCT05976347|Dopamine Agents|dopamine agents|mesh-ancestor
102646575|NCT05976347|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102646576|NCT05976347|Serotonin Agents|serotonin agents|mesh-ancestor
102646577|NCT05976347|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102646578|NCT05976347|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102646579|NCT05976347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102646580|NCT05976347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102646581|NCT05976243|Remibrutinib|remibrutinib|mesh-list
102646582|NCT05976243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102646583|NCT05976243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102646584|NCT05976243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646585|NCT05972655|Capecitabine|capecitabine|mesh-list
102646586|NCT05972655|Oxaliplatin|oxaliplatin|mesh-list
102646587|NCT05972655|Antibodies|antibodies|mesh-list
102275448|NCT03078257|Fibrinolysin|fibrinolysin|mesh-list
102275449|NCT03078257|Clopidogrel|clopidogrel|mesh-list
101935228|NCT03690778|Metformin|metformin|mesh-list
102646588|NCT05972655|Immunologic Factors|immunologic factors|mesh-ancestor
102646589|NCT05972655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646590|NCT05972655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102646591|NCT05972655|Antimetabolites|antimetabolites|mesh-ancestor
102646592|NCT05972655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646593|NCT05972655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646594|NCT05971719|Glycerol|glycerol|mesh-list
102646595|NCT05971719|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102646596|NCT05971719|Protective Agents|protective agents|mesh-ancestor
102646597|NCT05971719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646598|NCT05968690|Propranolol|propranolol|mesh-list
102646599|NCT05968690|Naltrexone|naltrexone|mesh-list
102646600|NCT05968690|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102646601|NCT05968690|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102646602|NCT05968690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646603|NCT05968690|Sensory System Agents|sensory system agents|mesh-ancestor
102646604|NCT05968690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102646605|NCT05968690|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102646606|NCT05968690|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102646607|NCT05968690|Adrenergic Agents|adrenergic agents|mesh-ancestor
102646608|NCT05968690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102646609|NCT05968690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646610|NCT05968690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102646611|NCT05968690|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102646612|NCT05968690|Vasodilator Agents|vasodilator agents|mesh-ancestor
102646613|NCT05962502|Irinotecan|irinotecan|mesh-list
102646614|NCT05962502|Cetuximab|cetuximab|mesh-list
102646615|NCT05962502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102646616|NCT05962502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102646617|NCT05962502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102646618|NCT05962502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646619|NCT05962502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646620|NCT05962502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102646621|NCT05960773|Decitabine|decitabine|mesh-list
102646622|NCT05960773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102646623|NCT05960773|Antimetabolites|antimetabolites|mesh-ancestor
102646624|NCT05960773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646625|NCT05960773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646626|NCT05960773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102646627|NCT05957757|Tislelizumab|tislelizumab|mesh-list
102646628|NCT05957757|Disitamab vedotin|disitamab vedotin|mesh-list
102646629|NCT05957757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102646630|NCT05957757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646631|NCT05957757|Immunoconjugates|immunoconjugates|mesh-ancestor
102646632|NCT05957757|Immunologic Factors|immunologic factors|mesh-ancestor
102646633|NCT05957757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646634|NCT05947851|Rituximab|rituximab|mesh-list
102646635|NCT05947851|Venetoclax|venetoclax|mesh-list
102646636|NCT05947851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102646637|NCT05947851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646638|NCT05947851|Immunologic Factors|immunologic factors|mesh-ancestor
102646639|NCT05947851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646640|NCT05947851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102646641|NCT05937776|Deoxyglucose|deoxyglucose|mesh-list
102646642|NCT05937776|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102646643|NCT05937776|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
102646644|NCT05937776|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102646645|NCT05937776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646646|NCT05937776|Antimetabolites|antimetabolites|mesh-ancestor
102646647|NCT05937776|Antiviral Agents|antiviral agents|mesh-ancestor
102646648|NCT05937776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102646649|NCT05937776|Chelating Agents|chelating agents|mesh-ancestor
102646650|NCT05937776|Sequestering Agents|sequestering agents|mesh-ancestor
102646651|NCT05935098|Tislelizumab|tislelizumab|mesh-list
102646652|NCT05935098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102646653|NCT05935098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646654|NCT05934227|Amoxicillin|amoxicillin|mesh-list
102646655|NCT05934227|Metronidazole|metronidazole|mesh-list
102646656|NCT05934227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102646657|NCT05934227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102646658|NCT05934227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102646659|NCT05934227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102646660|NCT05933577|Pembrolizumab|pembrolizumab|mesh-list
102646661|NCT05933577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102646662|NCT05933577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646663|NCT05933577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102646664|NCT05933577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646665|NCT05930782|Piperaquine|piperaquine|mesh-list
102646666|NCT05930782|Antimalarials|antimalarials|mesh-ancestor
102646667|NCT05930782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102646668|NCT05930782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102646669|NCT05930782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102646670|NCT05930561|Aflibercept|aflibercept|mesh-list
102646671|NCT05930561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102646672|NCT05930561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102646673|NCT05930561|Growth Substances|growth substances|mesh-ancestor
102646674|NCT05930561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646675|NCT05930561|Growth Inhibitors|growth inhibitors|mesh-ancestor
102646676|NCT05930561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646677|NCT05930197|Bismuth|bismuth|mesh-list
102646678|NCT05930197|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
102646679|NCT05930197|Antacids|antacids|mesh-ancestor
102646680|NCT05930197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646681|NCT05930197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102646682|NCT05930197|Antidiarrheals|antidiarrheals|mesh-ancestor
102646683|NCT05929768|Paclitaxel|paclitaxel|mesh-list
102646684|NCT05929768|Docetaxel|docetaxel|mesh-list
102646685|NCT05929768|Cyclophosphamide|cyclophosphamide|mesh-list
102646686|NCT05929768|Carboplatin|carboplatin|mesh-list
102646687|NCT05929768|Doxorubicin|doxorubicin|mesh-list
102646688|NCT05929768|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102646689|NCT05929768|Pembrolizumab|pembrolizumab|mesh-list
102646690|NCT05929768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102646691|NCT05929768|Daunorubicin|daunorubicin|mesh-list
102646692|NCT05929768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102646693|NCT05929768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646694|NCT05929768|Tubulin Modulators|tubulin modulators|mesh-ancestor
102646695|NCT05929768|Antimitotic Agents|antimitotic agents|mesh-ancestor
102646696|NCT05929768|Mitosis Modulators|mitosis modulators|mesh-ancestor
102646697|NCT05929768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646698|NCT05929768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102646699|NCT05929768|Immunologic Factors|immunologic factors|mesh-ancestor
102646700|NCT05929768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646701|NCT05929768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102646702|NCT05929768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102646703|NCT05929768|Alkylating Agents|alkylating agents|mesh-ancestor
102646704|NCT05929768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102646705|NCT05929768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102646706|NCT05929768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102646707|NCT05929768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102646708|NCT05929768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102646709|NCT05929768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102646710|NCT05929768|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102646711|NCT05918055|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
102646712|NCT05918055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102646713|NCT05918055|Antimetabolites|antimetabolites|mesh-ancestor
102646714|NCT05918055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646715|NCT05918055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646716|NCT05915182|Budesonide|budesonide|mesh-list
102646717|NCT05915182|Glycopyrrolate|glycopyrrolate|mesh-list
102646718|NCT05915182|Bromides|bromides|mesh-list
102646719|NCT05915182|Formoterol Fumarate|formoterol fumarate|mesh-list
102646720|NCT05915182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102646721|NCT05915182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102646722|NCT05915182|Autonomic Agents|autonomic agents|mesh-ancestor
102646723|NCT05915182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102646724|NCT05915182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646725|NCT05915182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102646726|NCT05915182|Respiratory System Agents|respiratory system agents|mesh-ancestor
102646727|NCT05915182|Glucocorticoids|glucocorticoids|mesh-ancestor
102646728|NCT05915182|Hormones|hormones|mesh-ancestor
102646729|NCT05915182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102646730|NCT05915182|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102646731|NCT05915182|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102646732|NCT05915182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102646733|NCT05915182|Adrenergic Agents|adrenergic agents|mesh-ancestor
101935300|NCT03690622|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102646734|NCT05915182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102646735|NCT05915182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646736|NCT05915182|Anticonvulsants|anticonvulsants|mesh-ancestor
102275450|NCT03078257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102646737|NCT05915182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102646738|NCT05915182|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102646739|NCT05915182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102646740|NCT05915182|Cholinergic Agents|cholinergic agents|mesh-ancestor
102646742|NCT05907759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646743|NCT05907746|Mycophenolic Acid|mycophenolic acid|mesh-list
102646744|NCT05907746|Cyclophosphamide|cyclophosphamide|mesh-list
102646745|NCT05907746|Fludarabine|fludarabine|mesh-list
102646746|NCT05907746|Tacrolimus|tacrolimus|mesh-list
102646747|NCT05907746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102646748|NCT05907746|Immunologic Factors|immunologic factors|mesh-ancestor
102646749|NCT05907746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646750|NCT05907746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102646751|NCT05907746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102646752|NCT05907746|Alkylating Agents|alkylating agents|mesh-ancestor
102646753|NCT05907746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646754|NCT05907746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646755|NCT05907746|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102646756|NCT05907746|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102646757|NCT05907746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102646758|NCT05907746|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102646759|NCT05907746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102646760|NCT05907746|Antitubercular Agents|antitubercular agents|mesh-ancestor
102646761|NCT05907746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102646762|NCT05907746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102646763|NCT05907213|Ketamine|ketamine|mesh-list
102646764|NCT05907213|Analgesics|analgesics|mesh-ancestor
102646765|NCT05907213|Sensory System Agents|sensory system agents|mesh-ancestor
102646766|NCT05907213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102646767|NCT05907213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646768|NCT05907213|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102646769|NCT05907213|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102646770|NCT05907213|Anesthetics, General|anesthetics, general|mesh-ancestor
102646771|NCT05907213|Anesthetics|anesthetics|mesh-ancestor
102646772|NCT05907213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102646773|NCT05907213|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102646774|NCT05907213|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102646775|NCT05907213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102646776|NCT05907213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646777|NCT05907057|Azacitidine|azacitidine|mesh-list
102646778|NCT05907057|Ivosidenib|ivosidenib|mesh-list
102646779|NCT05907057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102646780|NCT05907057|Antimetabolites|antimetabolites|mesh-ancestor
102646781|NCT05907057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646782|NCT05907057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646783|NCT05907057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102646784|NCT05899816|KHK4083|khk4083|mesh-list
102646785|NCT05899816|Dermatologic Agents|dermatologic agents|mesh-ancestor
102646786|NCT05898828|Nivolumab|nivolumab|mesh-list
102646787|NCT05898828|Entinostat|entinostat|mesh-list
102646788|NCT05898828|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
102646789|NCT05898828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102646790|NCT05898828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646791|NCT05898828|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102646792|NCT05898828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646793|NCT05898828|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102646794|NCT05898828|Immunologic Factors|immunologic factors|mesh-ancestor
102646795|NCT05898828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646796|NCT05898828|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102646797|NCT05898828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102646798|NCT05898022|Furosemide|furosemide|mesh-list
102646799|NCT05898022|Diuretics|diuretics|mesh-ancestor
102646800|NCT05898022|Natriuretic Agents|natriuretic agents|mesh-ancestor
102646801|NCT05898022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646802|NCT05898022|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102646803|NCT05898022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102646804|NCT05898022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646805|NCT05890963|Ibalizumab|ibalizumab|mesh-list
102646806|NCT05890963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102646807|NCT05890963|Antiviral Agents|antiviral agents|mesh-ancestor
102646808|NCT05890963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102646809|NCT05890963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102646810|NCT05889624|Amitriptyline|amitriptyline|mesh-list
102275451|NCT03078257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102646811|NCT05889624|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102646812|NCT05889624|Antidepressive Agents|antidepressive agents|mesh-ancestor
102646813|NCT05889624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102646814|NCT05889624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102646815|NCT05889624|Analgesics|analgesics|mesh-ancestor
102646816|NCT05889624|Sensory System Agents|sensory system agents|mesh-ancestor
102646817|NCT05889624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102646818|NCT05889624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646819|NCT05889624|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102646820|NCT05889624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102646821|NCT05889624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102646822|NCT05889624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646823|NCT05889624|Adrenergic Agents|adrenergic agents|mesh-ancestor
102646824|NCT05889624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102646825|NCT05884320|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
102646826|NCT05884320|Immunoconjugates|immunoconjugates|mesh-ancestor
102646827|NCT05884320|Immunologic Factors|immunologic factors|mesh-ancestor
102646828|NCT05884320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646829|NCT05880706|Osimertinib|osimertinib|mesh-list
102646830|NCT05880706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646831|NCT05880706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102646832|NCT05880706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102646833|NCT05880706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646834|NCT05879484|Pembrolizumab|pembrolizumab|mesh-list
102646835|NCT05879484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102646836|NCT05879484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646837|NCT05879484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102646838|NCT05879484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646839|NCT05878184|Cyclophosphamide|cyclophosphamide|mesh-list
102646840|NCT05878184|Fludarabine|fludarabine|mesh-list
102646841|NCT05878184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102646842|NCT05878184|Immunologic Factors|immunologic factors|mesh-ancestor
102646843|NCT05878184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646844|NCT05878184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102646845|NCT05878184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102646846|NCT05878184|Alkylating Agents|alkylating agents|mesh-ancestor
102646847|NCT05878184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646848|NCT05878184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646849|NCT05878184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102646850|NCT05877820|Lenvatinib|lenvatinib|mesh-list
102646851|NCT05877820|Tislelizumab|tislelizumab|mesh-list
102646852|NCT05877820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646853|NCT05877820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102646854|NCT05877820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102646855|NCT05877820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646856|NCT05877820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102646857|NCT05876754|Ivosidenib|ivosidenib|mesh-list
102646858|NCT05876754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646859|NCT05876754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102646860|NCT05876754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646861|NCT05875077|Dexmedetomidine|dexmedetomidine|mesh-list
102646862|NCT05875077|Propofol|propofol|mesh-list
102646863|NCT05875077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102646864|NCT05875077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102646865|NCT05875077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646866|NCT05875077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102646867|NCT05875077|Analgesics|analgesics|mesh-ancestor
102646868|NCT05875077|Sensory System Agents|sensory system agents|mesh-ancestor
102646869|NCT05875077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102646870|NCT05875077|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102646871|NCT05875077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102646872|NCT05875077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102646873|NCT05875077|Adrenergic Agents|adrenergic agents|mesh-ancestor
102646874|NCT05875077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102646875|NCT05875077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646876|NCT05875077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102646877|NCT05875077|Anesthetics, General|anesthetics, general|mesh-ancestor
102646878|NCT05875077|Anesthetics|anesthetics|mesh-ancestor
102646879|NCT05864846|Cannabidiol|cannabidiol|mesh-list
102646880|NCT05864846|Anticonvulsants|anticonvulsants|mesh-ancestor
102646881|NCT05852158|Cefazolin|cefazolin|mesh-list
102646882|NCT05852158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102646883|NCT05852158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102646884|NCT05850546|Prednisone|prednisone|mesh-list
102646885|NCT05850546|Prednisolone|prednisolone|mesh-list
102646886|NCT05850546|Rituximab|rituximab|mesh-list
102646887|NCT05850546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102646888|NCT05850546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646889|NCT05850546|Immunologic Factors|immunologic factors|mesh-ancestor
102646890|NCT05850546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646891|NCT05850546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102646892|NCT05850546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102646893|NCT05850546|Glucocorticoids|glucocorticoids|mesh-ancestor
102646894|NCT05850546|Hormones|hormones|mesh-ancestor
102646895|NCT05850546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102646896|NCT05850546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102646897|NCT05849480|Capecitabine|capecitabine|mesh-list
102646898|NCT05849480|Oxaliplatin|oxaliplatin|mesh-list
102646899|NCT05849480|Pembrolizumab|pembrolizumab|mesh-list
102646900|NCT05849480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102646901|NCT05849480|Antimetabolites|antimetabolites|mesh-ancestor
102646902|NCT05849480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646903|NCT05849480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646904|NCT05849480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102646905|NCT05849480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102646906|NCT05843643|Upadacitinib|upadacitinib|mesh-list
102646907|NCT05843643|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102646908|NCT05843643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102646909|NCT05843643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102646910|NCT05843643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646911|NCT05843643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102646912|NCT05839951|Trifluridine|trifluridine|mesh-list
102646913|NCT05839951|Bevacizumab|bevacizumab|mesh-list
102646914|NCT05839951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102646915|NCT05839951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646916|NCT05839951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102646917|NCT05839951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102646918|NCT05839951|Growth Substances|growth substances|mesh-ancestor
102646919|NCT05839951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646920|NCT05839951|Growth Inhibitors|growth inhibitors|mesh-ancestor
102646921|NCT05839951|Antimetabolites|antimetabolites|mesh-ancestor
102646922|NCT05839951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646923|NCT05839951|Antiviral Agents|antiviral agents|mesh-ancestor
102646924|NCT05839951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102646925|NCT05833529|Cocaine|cocaine|mesh-list
102646926|NCT05833529|Anesthetics, Local|anesthetics, local|mesh-ancestor
102646927|NCT05833529|Anesthetics|anesthetics|mesh-ancestor
102646928|NCT05833529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102646929|NCT05833529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646930|NCT05833529|Sensory System Agents|sensory system agents|mesh-ancestor
102646931|NCT05833529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102646932|NCT05833529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102646933|NCT05833529|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102646934|NCT05833529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102646935|NCT05833529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102646936|NCT05833529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646937|NCT05833529|Dopamine Agents|dopamine agents|mesh-ancestor
102646938|NCT05833529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102646939|NCT05799612|Interferons|interferons|mesh-list
102646940|NCT05799612|Interferon-alpha|interferon-alpha|mesh-list
102646941|NCT05799612|Interferon alpha-2|interferon alpha-2|mesh-list
102646942|NCT05799612|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102646943|NCT05799612|Paclitaxel|paclitaxel|mesh-list
101368418|NCT00168532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102646944|NCT05799612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102646945|NCT05799612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646946|NCT05799612|Tubulin Modulators|tubulin modulators|mesh-ancestor
102646947|NCT05799612|Antimitotic Agents|antimitotic agents|mesh-ancestor
102646948|NCT05799612|Mitosis Modulators|mitosis modulators|mesh-ancestor
102646949|NCT05799612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646950|NCT05799612|Antiviral Agents|antiviral agents|mesh-ancestor
102646951|NCT05799612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102646952|NCT05799612|Immunologic Factors|immunologic factors|mesh-ancestor
102646953|NCT05799612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646954|NCT05797233|Cyclophosphamide|cyclophosphamide|mesh-list
102646955|NCT05797233|Fludarabine|fludarabine|mesh-list
102275452|NCT03078257|Analgesics|analgesics|mesh-ancestor
102275453|NCT03078257|Sensory System Agents|sensory system agents|mesh-ancestor
102646956|NCT05797233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102646957|NCT05797233|Immunologic Factors|immunologic factors|mesh-ancestor
102646958|NCT05797233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646959|NCT05797233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102646960|NCT05797233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102646961|NCT05797233|Alkylating Agents|alkylating agents|mesh-ancestor
102646962|NCT05797233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646963|NCT05797233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646964|NCT05797233|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102646965|NCT05795153|Remibrutinib|remibrutinib|mesh-list
102646966|NCT05795153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102646967|NCT05795153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102646968|NCT05795153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646969|NCT05781152|Adalimumab|adalimumab|mesh-list
102646970|NCT05781152|Infliximab|infliximab|mesh-list
102646971|NCT05781152|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102646972|NCT05781152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102646973|NCT05781152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102646974|NCT05781152|Dermatologic Agents|dermatologic agents|mesh-ancestor
102646975|NCT05781152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102646976|NCT05781035|Dexmedetomidine|dexmedetomidine|mesh-list
102646977|NCT05781035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102646978|NCT05781035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102646979|NCT05781035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102646980|NCT05781035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102646981|NCT05781035|Analgesics|analgesics|mesh-ancestor
102646982|NCT05781035|Sensory System Agents|sensory system agents|mesh-ancestor
102646983|NCT05781035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102646984|NCT05781035|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102646985|NCT05781035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102646986|NCT05781035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102646987|NCT05781035|Adrenergic Agents|adrenergic agents|mesh-ancestor
102646988|NCT05781035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102646989|NCT05781035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646990|NCT05777603|Vancomycin|vancomycin|mesh-list
102646991|NCT05777603|Aztreonam|aztreonam|mesh-list
102646992|NCT05777603|Pembrolizumab|pembrolizumab|mesh-list
102646993|NCT05777603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102646994|NCT05777603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102646995|NCT05777603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102646996|NCT05777603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102646997|NCT05777603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102646998|NCT05777603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102646999|NCT05776979|Lenalidomide|lenalidomide|mesh-list
102647000|NCT05776979|Immunologic Factors|immunologic factors|mesh-ancestor
102647001|NCT05776979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368488|NCT00054938|Analgesics|analgesics|mesh-ancestor
102647002|NCT05776979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102647003|NCT05776979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102647004|NCT05776979|Growth Substances|growth substances|mesh-ancestor
102647005|NCT05776979|Growth Inhibitors|growth inhibitors|mesh-ancestor
102647006|NCT05776979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647007|NCT05763875|Ezetimibe|ezetimibe|mesh-list
102647008|NCT05763875|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102647009|NCT05763875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102647010|NCT05763875|Antimetabolites|antimetabolites|mesh-ancestor
102647011|NCT05763875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647012|NCT05763875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102647013|NCT05748171|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
102647014|NCT05748171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102647015|NCT05748171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647016|NCT05748171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102647017|NCT05748171|Immunotoxins|immunotoxins|mesh-ancestor
102647018|NCT05748171|Immunoconjugates|immunoconjugates|mesh-ancestor
102647019|NCT05748171|Immunologic Factors|immunologic factors|mesh-ancestor
102647020|NCT05748171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647021|NCT05746559|Ravulizumab|ravulizumab|mesh-list
102647022|NCT05746559|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102647023|NCT05746559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102647024|NCT05746559|Immunologic Factors|immunologic factors|mesh-ancestor
102647025|NCT05746559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647026|NCT05740566|Topotecan|topotecan|mesh-list
102647027|NCT05740566|Amrubicin|amrubicin|mesh-list
102647028|NCT05740566|AMG 757|amg 757|mesh-list
102647029|NCT05740566|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102647030|NCT05740566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102647031|NCT05740566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102647032|NCT05740566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647033|NCT05740566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647034|NCT05727397|Aflibercept|aflibercept|mesh-list
102647035|NCT05727397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102647036|NCT05727397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102647037|NCT05727397|Growth Substances|growth substances|mesh-ancestor
102647038|NCT05727397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647039|NCT05727397|Growth Inhibitors|growth inhibitors|mesh-ancestor
102647040|NCT05727397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647041|NCT05717153|Eflornithine|eflornithine|mesh-list
102647042|NCT05717153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647043|NCT05717153|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102647044|NCT05717153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102647045|NCT05717153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102647046|NCT05717153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102647047|NCT05717153|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
102647048|NCT05717153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102647049|NCT05717153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647050|NCT05714059|Insulin|insulin|mesh-list
102647051|NCT05714059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102647052|NCT05714059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647053|NCT05713799|Thioctic Acid|thioctic acid|mesh-list
102647054|NCT05713799|Mirabegron|mirabegron|mesh-list
102647055|NCT05713799|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102647056|NCT05713799|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102647057|NCT05713799|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102647058|NCT05713799|Adrenergic Agents|adrenergic agents|mesh-ancestor
102647059|NCT05713799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102647060|NCT05713799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647061|NCT05713799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647062|NCT05713799|Urological Agents|urological agents|mesh-ancestor
102647063|NCT05713799|Antioxidants|antioxidants|mesh-ancestor
102647064|NCT05713799|Protective Agents|protective agents|mesh-ancestor
102647065|NCT05713799|Vitamin B Complex|vitamin b complex|mesh-ancestor
102647066|NCT05713799|Vitamins|vitamins|mesh-ancestor
102647067|NCT05713799|Micronutrients|micronutrients|mesh-ancestor
102647068|NCT05711628|Carboplatin|carboplatin|mesh-list
102647069|NCT05711628|Gemcitabine|gemcitabine|mesh-list
102647070|NCT05711628|Doxorubicin|doxorubicin|mesh-list
102647071|NCT05711628|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102647072|NCT05711628|Pembrolizumab|pembrolizumab|mesh-list
102647073|NCT05711628|Etoposide|etoposide|mesh-list
102647074|NCT05711628|Etoposide phosphate|etoposide phosphate|mesh-list
102647075|NCT05711628|Vinorelbine|vinorelbine|mesh-list
102647076|NCT05711628|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102647077|NCT05711628|Ifosfamide|ifosfamide|mesh-list
102647078|NCT05711628|Isophosphamide mustard|isophosphamide mustard|mesh-list
102647079|NCT05711628|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102647080|NCT05711628|Podophyllotoxin|podophyllotoxin|mesh-list
102647081|NCT05711628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102647082|NCT05711628|Antibodies|antibodies|mesh-list
102647083|NCT05711628|Immunoglobulins|immunoglobulins|mesh-list
102647084|NCT05711628|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102647085|NCT05711628|Immunoconjugates|immunoconjugates|mesh-list
102647086|NCT05711628|Immunologic Factors|immunologic factors|mesh-ancestor
102647087|NCT05711628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647088|NCT05711628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647089|NCT05711628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102647090|NCT05711628|Antimetabolites|antimetabolites|mesh-ancestor
102647091|NCT05711628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647092|NCT05711628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102647093|NCT05711628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102647094|NCT05711628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102647095|NCT05711628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102647096|NCT05711628|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102647097|NCT05711628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102647098|NCT05711628|Tubulin Modulators|tubulin modulators|mesh-ancestor
102647099|NCT05711628|Antimitotic Agents|antimitotic agents|mesh-ancestor
102647100|NCT05711628|Mitosis Modulators|mitosis modulators|mesh-ancestor
102647101|NCT05711628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102647102|NCT05711628|Alkylating Agents|alkylating agents|mesh-ancestor
102647103|NCT05711628|Immunotoxins|immunotoxins|mesh-ancestor
102647104|NCT05711628|Keratolytic Agents|keratolytic agents|mesh-ancestor
102647105|NCT05711628|Dermatologic Agents|dermatologic agents|mesh-ancestor
102647106|NCT05704634|Cemiplimab|cemiplimab|mesh-list
102647107|NCT05704634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102647108|NCT05704634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647109|NCT05688475|Dexamethasone|dexamethasone|mesh-list
102647110|NCT05688475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102647111|NCT05688475|Antiemetics|antiemetics|mesh-ancestor
102275454|NCT03078257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102647112|NCT05688475|Autonomic Agents|autonomic agents|mesh-ancestor
102647113|NCT05688475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102647114|NCT05688475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647115|NCT05688475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102647116|NCT05688475|Glucocorticoids|glucocorticoids|mesh-ancestor
102647117|NCT05688475|Hormones|hormones|mesh-ancestor
102647118|NCT05688475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102647119|NCT05688475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102647120|NCT05688475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647121|NCT05681039|Carboplatin|carboplatin|mesh-list
102647122|NCT05681039|Atezolizumab|atezolizumab|mesh-list
102647123|NCT05681039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647124|NCT05681039|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102647125|NCT05681039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647126|NCT05681039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102647127|NCT05678959|Antibodies, Anti-Idiotypic|antibodies, anti-idiotypic|mesh-list
102647128|NCT05678959|Immunologic Factors|immunologic factors|mesh-ancestor
102647129|NCT05678959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647130|NCT05677490|Calcium, Dietary|calcium, dietary|mesh-list
102647131|NCT05677490|Leucovorin|leucovorin|mesh-list
102647132|NCT05677490|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
102647133|NCT05677490|Tetrahydrofolates|tetrahydrofolates|mesh-list
102647134|NCT05677490|Fluorouracil|fluorouracil|mesh-list
102647135|NCT05677490|Oxaliplatin|oxaliplatin|mesh-list
102647136|NCT05677490|Nivolumab|nivolumab|mesh-list
102647137|NCT05677490|Irinotecan|irinotecan|mesh-list
102647138|NCT05677490|Calcium|calcium|mesh-list
102647139|NCT05677490|Levoleucovorin|levoleucovorin|mesh-list
102647140|NCT05677490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102647141|NCT05677490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647142|NCT05677490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102647143|NCT05677490|Antimetabolites|antimetabolites|mesh-ancestor
102647144|NCT05677490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647145|NCT05677490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102647146|NCT05677490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647147|NCT05677490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102647148|NCT05677490|Immunologic Factors|immunologic factors|mesh-ancestor
102647149|NCT05677490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102647150|NCT05677490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102647151|NCT05677490|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102647152|NCT05677490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102647153|NCT05677490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102647154|NCT05677490|Antidotes|antidotes|mesh-ancestor
102647155|NCT05677490|Protective Agents|protective agents|mesh-ancestor
102647156|NCT05677490|Vitamin B Complex|vitamin b complex|mesh-ancestor
102647157|NCT05677490|Vitamins|vitamins|mesh-ancestor
102647158|NCT05677490|Micronutrients|micronutrients|mesh-ancestor
102647159|NCT05669482|Paclitaxel|paclitaxel|mesh-list
102647160|NCT05669482|Gemcitabine|gemcitabine|mesh-list
102647161|NCT05669482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102647162|NCT05669482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647163|NCT05669482|Tubulin Modulators|tubulin modulators|mesh-ancestor
102647164|NCT05669482|Antimitotic Agents|antimitotic agents|mesh-ancestor
102647165|NCT05669482|Mitosis Modulators|mitosis modulators|mesh-ancestor
102647166|NCT05669482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647167|NCT05669482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102647168|NCT05669482|Antimetabolites|antimetabolites|mesh-ancestor
102647169|NCT05658562|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
102647170|NCT05658562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102647171|NCT05658562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647172|NCT05656664|Folic Acid|folic acid|mesh-list
102647173|NCT05656664|Hematinics|hematinics|mesh-ancestor
102647174|NCT05656664|Vitamin B Complex|vitamin b complex|mesh-ancestor
102647175|NCT05656664|Vitamins|vitamins|mesh-ancestor
102647176|NCT05656664|Micronutrients|micronutrients|mesh-ancestor
102647177|NCT05656664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647178|NCT05652478|Tenofovir|tenofovir|mesh-list
102647179|NCT05652478|Dolutegravir|dolutegravir|mesh-list
102647180|NCT05652478|Antiviral Agents|antiviral agents|mesh-ancestor
102647181|NCT05652478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102647182|NCT05652478|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102647183|NCT05652478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102647184|NCT05652478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102647185|NCT05652478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647186|NCT05652478|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102647187|NCT05652478|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102647188|NCT05652478|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102647189|NCT05652478|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102647190|NCT05652205|Linaclotide|linaclotide|mesh-list
102647191|NCT05652205|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102647192|NCT05652205|Enzyme Activators|enzyme activators|mesh-ancestor
102647193|NCT05652205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647194|NCT05652205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102647195|NCT05651711|KHK4083|khk4083|mesh-list
102647196|NCT05651711|Dermatologic Agents|dermatologic agents|mesh-ancestor
102647197|NCT05644223|Edaravone|edaravone|mesh-list
102647198|NCT05644223|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102647199|NCT05644223|Antioxidants|antioxidants|mesh-ancestor
102647200|NCT05644223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647201|NCT05644223|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102647202|NCT05644223|Protective Agents|protective agents|mesh-ancestor
102647203|NCT05644223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647204|NCT05642195|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101368709|NCT02964091|Ledipasvir|ledipasvir|mesh-list
102647205|NCT05642195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102647206|NCT05642195|Immunologic Factors|immunologic factors|mesh-ancestor
102647207|NCT05642195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647208|NCT05633979|Trastuzumab|trastuzumab|mesh-list
102647209|NCT05633979|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
102647210|NCT05633979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102647211|NCT05633979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647212|NCT05633979|Immunoconjugates|immunoconjugates|mesh-ancestor
102647213|NCT05633979|Immunologic Factors|immunologic factors|mesh-ancestor
102647214|NCT05633979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647215|NCT05633147|Clarithromycin|clarithromycin|mesh-list
102647216|NCT05633147|Midazolam|midazolam|mesh-list
102647217|NCT05633147|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102647218|NCT05633147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102647219|NCT05633147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102647220|NCT05633147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647221|NCT05633147|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102647222|NCT05633147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102647223|NCT05633147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102647224|NCT05633147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102647225|NCT05633147|Anesthetics, General|anesthetics, general|mesh-ancestor
102647226|NCT05633147|Anesthetics|anesthetics|mesh-ancestor
102647227|NCT05633147|GABA Modulators|gaba modulators|mesh-ancestor
102647228|NCT05633147|GABA Agents|gaba agents|mesh-ancestor
102647229|NCT05633147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102647230|NCT05633147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647231|NCT05633147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102647232|NCT05633147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102647233|NCT05633147|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102647234|NCT05633147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102647235|NCT05633147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102647236|NCT05633147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102647237|NCT05629585|Pembrolizumab|pembrolizumab|mesh-list
102647238|NCT05629585|Durvalumab|durvalumab|mesh-list
102647239|NCT05629585|Capecitabine|capecitabine|mesh-list
102647240|NCT05629585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102647241|NCT05629585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647242|NCT05629585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102647243|NCT05629585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647244|NCT05629585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102647245|NCT05629585|Antimetabolites|antimetabolites|mesh-ancestor
102647246|NCT05627232|Diphenhydramine|diphenhydramine|mesh-list
102647247|NCT05627232|Promethazine|promethazine|mesh-list
102647248|NCT05627232|Cytarabine|cytarabine|mesh-list
102647249|NCT05627232|Daunorubicin|daunorubicin|mesh-list
102647250|NCT05627232|Palbociclib|palbociclib|mesh-list
102647251|NCT05627232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102647252|NCT05627232|Antimetabolites|antimetabolites|mesh-ancestor
102647253|NCT05627232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647254|NCT05627232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647255|NCT05627232|Antiviral Agents|antiviral agents|mesh-ancestor
102647256|NCT05627232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102647257|NCT05627232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102647258|NCT05627232|Immunologic Factors|immunologic factors|mesh-ancestor
102647259|NCT05627232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647260|NCT05627232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102275455|NCT03078257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275456|NCT03078257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102647261|NCT05627232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102275457|NCT03078257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102647262|NCT05627232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102647263|NCT05627232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102647264|NCT05627232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102647265|NCT05627232|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102647266|NCT05627232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102647267|NCT05627232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102647268|NCT05627232|Anesthetics, Local|anesthetics, local|mesh-ancestor
102647269|NCT05627232|Anesthetics|anesthetics|mesh-ancestor
102647270|NCT05627232|Sensory System Agents|sensory system agents|mesh-ancestor
102647271|NCT05627232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102647272|NCT05627232|Antiemetics|antiemetics|mesh-ancestor
101368796|NCT00171067|Valsartan|valsartan|mesh-list
102647273|NCT05627232|Autonomic Agents|autonomic agents|mesh-ancestor
102647274|NCT05627232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102647275|NCT05627232|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102647276|NCT05627232|Histamine Antagonists|histamine antagonists|mesh-ancestor
102647277|NCT05627232|Histamine Agents|histamine agents|mesh-ancestor
102647278|NCT05627232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102647279|NCT05627232|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102647280|NCT05627232|Antipruritics|antipruritics|mesh-ancestor
102647281|NCT05627232|Dermatologic Agents|dermatologic agents|mesh-ancestor
102647282|NCT05625412|Docetaxel|docetaxel|mesh-list
102647283|NCT05625412|Capecitabine|capecitabine|mesh-list
102647284|NCT05625412|Nivolumab|nivolumab|mesh-list
102647285|NCT05625412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647286|NCT05625412|Tubulin Modulators|tubulin modulators|mesh-ancestor
102647287|NCT05625412|Antimitotic Agents|antimitotic agents|mesh-ancestor
102647288|NCT05625412|Mitosis Modulators|mitosis modulators|mesh-ancestor
102647289|NCT05625412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647290|NCT05625412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102647291|NCT05625412|Antimetabolites|antimetabolites|mesh-ancestor
102647292|NCT05625412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102647293|NCT05625412|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102647294|NCT05625399|Nivolumab|nivolumab|mesh-list
102647295|NCT05625399|Relatlimab|relatlimab|mesh-list
102647296|NCT05625399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102647297|NCT05625399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647298|NCT05625399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102647299|NCT05625399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647300|NCT05624554|Cyclophosphamide|cyclophosphamide|mesh-list
102647301|NCT05624554|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102647302|NCT05624554|Rituximab|rituximab|mesh-list
102647303|NCT05624554|Fludarabine|fludarabine|mesh-list
102647304|NCT05624554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102647305|NCT05624554|Immunologic Factors|immunologic factors|mesh-ancestor
102647306|NCT05624554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647307|NCT05624554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102647308|NCT05624554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102647309|NCT05624554|Alkylating Agents|alkylating agents|mesh-ancestor
102647310|NCT05624554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647311|NCT05624554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647312|NCT05624554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102647313|NCT05624554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102647314|NCT05623020|Dexamethasone|dexamethasone|mesh-list
102647315|NCT05623020|Lenalidomide|lenalidomide|mesh-list
102647316|NCT05623020|Daratumumab|daratumumab|mesh-list
102647317|NCT05623020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102647318|NCT05623020|Antiemetics|antiemetics|mesh-ancestor
102647319|NCT05623020|Autonomic Agents|autonomic agents|mesh-ancestor
102647320|NCT05623020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102647321|NCT05623020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647322|NCT05623020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102647323|NCT05623020|Glucocorticoids|glucocorticoids|mesh-ancestor
102647324|NCT05623020|Hormones|hormones|mesh-ancestor
102647325|NCT05623020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102647326|NCT05623020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102647327|NCT05623020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647328|NCT05623020|Immunologic Factors|immunologic factors|mesh-ancestor
102647329|NCT05623020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102647330|NCT05623020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102647331|NCT05623020|Growth Substances|growth substances|mesh-ancestor
102647332|NCT05623020|Growth Inhibitors|growth inhibitors|mesh-ancestor
102647333|NCT05622708|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102647334|NCT05622708|Immunologic Factors|immunologic factors|mesh-ancestor
102275458|NCT03078257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102647335|NCT05622708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647336|NCT05622318|Mycophenolic Acid|mycophenolic acid|mesh-list
102647337|NCT05622318|Cyclophosphamide|cyclophosphamide|mesh-list
102647338|NCT05622318|Tacrolimus|tacrolimus|mesh-list
102647339|NCT05622318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102647340|NCT05622318|Immunologic Factors|immunologic factors|mesh-ancestor
102647341|NCT05622318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647342|NCT05622318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101549056|NCT01317615|Mitosis Modulators|mitosis modulators|mesh-ancestor
102647343|NCT05622318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102647344|NCT05622318|Alkylating Agents|alkylating agents|mesh-ancestor
102647345|NCT05622318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647346|NCT05622318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647347|NCT05622318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102647348|NCT05622318|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102647349|NCT05622318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102647350|NCT05622318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102647351|NCT05622318|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102647352|NCT05622318|Antitubercular Agents|antitubercular agents|mesh-ancestor
102647353|NCT05622318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102647354|NCT05622318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102647355|NCT05622071|Tislelizumab|tislelizumab|mesh-list
102647356|NCT05622071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102647357|NCT05622071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647358|NCT05620407|Deucravacitinib|deucravacitinib|mesh-list
102647359|NCT05620407|Dermatologic Agents|dermatologic agents|mesh-ancestor
102647360|NCT05620407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102647361|NCT05620407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102647362|NCT05620407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647363|NCT05618808|Enoxaparin|enoxaparin|mesh-list
102647364|NCT05618808|Anticoagulants|anticoagulants|mesh-ancestor
102647365|NCT05618808|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102647366|NCT05618808|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102647367|NCT05618808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647368|NCT05617677|Deucravacitinib|deucravacitinib|mesh-list
102647369|NCT05617677|Dermatologic Agents|dermatologic agents|mesh-ancestor
102647370|NCT05617677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102647371|NCT05617677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102647372|NCT05617677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647373|NCT05611710|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102647374|NCT05611710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102647375|NCT05610163|Leucovorin|leucovorin|mesh-list
102647376|NCT05610163|Fluorouracil|fluorouracil|mesh-list
102647377|NCT05610163|Capecitabine|capecitabine|mesh-list
102647378|NCT05610163|Oxaliplatin|oxaliplatin|mesh-list
102647379|NCT05610163|Irinotecan|irinotecan|mesh-list
102647380|NCT05610163|Calcium|calcium|mesh-list
102647381|NCT05610163|Levoleucovorin|levoleucovorin|mesh-list
102647382|NCT05610163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102647383|NCT05610163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647384|NCT05610163|Antimetabolites|antimetabolites|mesh-ancestor
102647385|NCT05610163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647386|NCT05610163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102647387|NCT05610163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647388|NCT05610163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102647389|NCT05610163|Immunologic Factors|immunologic factors|mesh-ancestor
102647390|NCT05610163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102647391|NCT05610163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102647392|NCT05610163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102647393|NCT05610163|Antidotes|antidotes|mesh-ancestor
102647394|NCT05610163|Protective Agents|protective agents|mesh-ancestor
102647395|NCT05610163|Vitamin B Complex|vitamin b complex|mesh-ancestor
102647396|NCT05610163|Vitamins|vitamins|mesh-ancestor
102647397|NCT05610163|Micronutrients|micronutrients|mesh-ancestor
102647398|NCT05604170|Ganaxolone|ganaxolone|mesh-list
102647399|NCT05604170|Neurosteroids|neurosteroids|mesh-ancestor
102647400|NCT05604170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102647401|NCT05604170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647402|NCT05604170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647403|NCT05604170|GABA Modulators|gaba modulators|mesh-ancestor
102647404|NCT05604170|GABA Agents|gaba agents|mesh-ancestor
102647405|NCT05569044|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102647406|NCT05563220|Everolimus|everolimus|mesh-list
102647407|NCT05563220|Palbociclib|palbociclib|mesh-list
102275459|NCT03078257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101935972|NCT03448406|Empagliflozin|empagliflozin|mesh-list
102647408|NCT05563220|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102647409|NCT05563220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102647410|NCT05563220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101368950|NCT00171691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102647411|NCT05563220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275460|NCT03078257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647412|NCT05563220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102647413|NCT05563220|Immunologic Factors|immunologic factors|mesh-ancestor
102647414|NCT05563220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647415|NCT05563220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647416|NCT05548296|Gemcitabine|gemcitabine|mesh-list
102647417|NCT05548296|Prexasertib|prexasertib|mesh-list
102647418|NCT05548296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102647419|NCT05548296|Antimetabolites|antimetabolites|mesh-ancestor
102647420|NCT05548296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647421|NCT05548296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647422|NCT05548296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102647423|NCT05548296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102647424|NCT05534984|Tecovirimat|tecovirimat|mesh-list
102647425|NCT05534984|Antiviral Agents|antiviral agents|mesh-ancestor
102647426|NCT05534984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102647427|NCT05528848|Fentanyl|fentanyl|mesh-list
102647428|NCT05528848|Carfentanil|carfentanil|mesh-list
102647429|NCT05528848|Naloxone|naloxone|mesh-list
102647430|NCT05528848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102647431|NCT05528848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647432|NCT05528848|Sensory System Agents|sensory system agents|mesh-ancestor
102647433|NCT05528848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102647434|NCT05528848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102647435|NCT05528848|Narcotics|narcotics|mesh-ancestor
102647436|NCT05528848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102647437|NCT05528848|Analgesics|analgesics|mesh-ancestor
102647438|NCT05528848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102647439|NCT05528848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102647440|NCT05528848|Anesthetics, General|anesthetics, general|mesh-ancestor
102647441|NCT05528848|Anesthetics|anesthetics|mesh-ancestor
102647442|NCT05525065|Glucocorticoids|glucocorticoids|mesh-list
102647443|NCT05525065|Hormones|hormones|mesh-ancestor
102647444|NCT05525065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102647445|NCT05525065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647446|NCT05506943|Paclitaxel|paclitaxel|mesh-list
102647447|NCT05506943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102647448|NCT05506943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647449|NCT05506943|Tubulin Modulators|tubulin modulators|mesh-ancestor
102647450|NCT05506943|Antimitotic Agents|antimitotic agents|mesh-ancestor
102647451|NCT05506943|Mitosis Modulators|mitosis modulators|mesh-ancestor
102647452|NCT05506943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647453|NCT05497778|Paclitaxel|paclitaxel|mesh-list
102647454|NCT05497778|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102647455|NCT05497778|Gemcitabine|gemcitabine|mesh-list
102647456|NCT05497778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102647457|NCT05497778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647458|NCT05497778|Tubulin Modulators|tubulin modulators|mesh-ancestor
102647459|NCT05497778|Antimitotic Agents|antimitotic agents|mesh-ancestor
102647460|NCT05497778|Mitosis Modulators|mitosis modulators|mesh-ancestor
102647461|NCT05497778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647462|NCT05497778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102647463|NCT05497778|Antimetabolites|antimetabolites|mesh-ancestor
102647464|NCT05469737|Azacitidine|azacitidine|mesh-list
102647465|NCT05469737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102647466|NCT05469737|Antimetabolites|antimetabolites|mesh-ancestor
102647467|NCT05469737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647468|NCT05469737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647469|NCT05469737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102647470|NCT05468489|Carboplatin|carboplatin|mesh-list
102647471|NCT05468489|Etoposide|etoposide|mesh-list
102647472|NCT05468489|Etoposide phosphate|etoposide phosphate|mesh-list
102647473|NCT05468489|Atezolizumab|atezolizumab|mesh-list
102647474|NCT05468489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647475|NCT05468489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102647476|NCT05468489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102647477|NCT05468489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102647478|NCT05468489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102647479|NCT05468489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647480|NCT05468489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102647481|NCT05468489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102647482|NCT05464719|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
102647483|NCT05464719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102647484|NCT05464719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647485|NCT05459571|Dexamethasone|dexamethasone|mesh-list
101936048|NCT03673384|Fluticasone|fluticasone|mesh-list
102647486|NCT05459571|Cyclophosphamide|cyclophosphamide|mesh-list
102647487|NCT05459571|Fludarabine|fludarabine|mesh-list
102647488|NCT05459571|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
102647489|NCT05459571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102647490|NCT05459571|Immunologic Factors|immunologic factors|mesh-ancestor
102647491|NCT05459571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647492|NCT05459571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102647493|NCT05459571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102647494|NCT05459571|Alkylating Agents|alkylating agents|mesh-ancestor
102647495|NCT05459571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647496|NCT05459571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647497|NCT05459571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102647498|NCT05459571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102647499|NCT05459571|Antiemetics|antiemetics|mesh-ancestor
102647500|NCT05459571|Autonomic Agents|autonomic agents|mesh-ancestor
102647501|NCT05459571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102647502|NCT05459571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102647503|NCT05459571|Glucocorticoids|glucocorticoids|mesh-ancestor
102647504|NCT05459571|Hormones|hormones|mesh-ancestor
102647505|NCT05459571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102647506|NCT05459571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102647507|NCT05459571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102647508|NCT05420948|Paclitaxel|paclitaxel|mesh-list
102647509|NCT05420948|Carboplatin|carboplatin|mesh-list
102647510|NCT05420948|Pembrolizumab|pembrolizumab|mesh-list
102647511|NCT05420948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102647512|NCT05420948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647513|NCT05420948|Tubulin Modulators|tubulin modulators|mesh-ancestor
102647514|NCT05420948|Antimitotic Agents|antimitotic agents|mesh-ancestor
102647515|NCT05420948|Mitosis Modulators|mitosis modulators|mesh-ancestor
102647516|NCT05420948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647517|NCT05420948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102647518|NCT05420948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102647519|NCT05418348|Nimodipine|nimodipine|mesh-list
102647520|NCT05418348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102647521|NCT05418348|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102647522|NCT05418348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102647523|NCT05418348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647524|NCT05418348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102647525|NCT05418348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647526|NCT05418348|Vasodilator Agents|vasodilator agents|mesh-ancestor
102647527|NCT05416320|Calcipotriene|calcipotriene|mesh-list
102647528|NCT05416320|Dermatologic Agents|dermatologic agents|mesh-ancestor
102647529|NCT05407675|Nivolumab|nivolumab|mesh-list
102647530|NCT05407675|Ipilimumab|ipilimumab|mesh-list
102647531|NCT05407675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102647532|NCT05407675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647533|NCT05407675|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102647534|NCT05407675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647535|NCT05377606|Temazepam|temazepam|mesh-list
102647536|NCT05377606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102647537|NCT05377606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102647538|NCT05377606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647539|NCT05377606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102647540|NCT05377606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102647541|NCT05377606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102647542|NCT05377606|GABA Modulators|gaba modulators|mesh-ancestor
102647543|NCT05377606|GABA Agents|gaba agents|mesh-ancestor
102647544|NCT05377606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102647545|NCT05377606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647546|NCT05376319|Rituximab|rituximab|mesh-list
102647547|NCT05376319|Obinutuzumab|obinutuzumab|mesh-list
102647548|NCT05376319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102647549|NCT05376319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647550|NCT05376319|Immunologic Factors|immunologic factors|mesh-ancestor
102647551|NCT05376319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647552|NCT05376319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102647553|NCT05375825|LMB-100|lmb-100|mesh-list
102647554|NCT05375825|Immunoconjugates|immunoconjugates|mesh-ancestor
102647555|NCT05375825|Immunologic Factors|immunologic factors|mesh-ancestor
102647556|NCT05375825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647557|NCT05372367|Itraconazole|itraconazole|mesh-list
102647558|NCT05372367|Rifampin|rifampin|mesh-list
102275461|NCT03078257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101936131|NCT03669484|Fentanyl|fentanyl|mesh-list
102647559|NCT05372367|Antifungal Agents|antifungal agents|mesh-ancestor
102275462|NCT03078257|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102647560|NCT05372367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102647561|NCT05372367|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102647562|NCT05372367|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102647563|NCT05372367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102647564|NCT05372367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647565|NCT05372367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102647566|NCT05372367|Hormone Antagonists|hormone antagonists|mesh-ancestor
102647567|NCT05372367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102647568|NCT05372367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647569|NCT05372367|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102647570|NCT05372367|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102647571|NCT05372367|Antitubercular Agents|antitubercular agents|mesh-ancestor
102647572|NCT05372367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102647573|NCT05372367|Leprostatic Agents|leprostatic agents|mesh-ancestor
102647574|NCT05372367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102647575|NCT05372367|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102647576|NCT05372367|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102647577|NCT05372367|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102647578|NCT05372367|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102647579|NCT05372367|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102647580|NCT05372367|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102647581|NCT05360784|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102647582|NCT05360784|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102647583|NCT05360784|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102647584|NCT05360784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102647585|NCT05360784|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102647586|NCT05360784|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102647587|NCT05360784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102647588|NCT05360784|Adrenergic Agents|adrenergic agents|mesh-ancestor
102647589|NCT05360784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102647590|NCT05360784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647591|NCT05360784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647593|NCT05355701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102647594|NCT05355701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647595|NCT05350371|Pirfenidone|pirfenidone|mesh-list
102647596|NCT05350371|Analgesics|analgesics|mesh-ancestor
102647597|NCT05350371|Sensory System Agents|sensory system agents|mesh-ancestor
102647598|NCT05350371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102647599|NCT05350371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647600|NCT05350371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102647601|NCT05350371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102647602|NCT05350371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102647603|NCT05350371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102647604|NCT05350371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647605|NCT05348200|Clobetasol|clobetasol|mesh-list
102647606|NCT05348200|Lidocaine|lidocaine|mesh-list
102647607|NCT05348200|Halobetasol|halobetasol|mesh-list
102647608|NCT05348200|Anesthetics, Local|anesthetics, local|mesh-ancestor
102647609|NCT05348200|Anesthetics|anesthetics|mesh-ancestor
102647610|NCT05348200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102647611|NCT05348200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647612|NCT05348200|Sensory System Agents|sensory system agents|mesh-ancestor
102647613|NCT05348200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102647614|NCT05348200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102647615|NCT05348200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102647616|NCT05348200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102647617|NCT05348200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102647618|NCT05348200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647619|NCT05348200|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102647620|NCT05348200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102647621|NCT05348200|Glucocorticoids|glucocorticoids|mesh-ancestor
102647622|NCT05348200|Hormones|hormones|mesh-ancestor
102647623|NCT05348200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102647624|NCT05344625|Ketamine|ketamine|mesh-list
102647625|NCT05344625|Analgesics|analgesics|mesh-ancestor
102647626|NCT05344625|Sensory System Agents|sensory system agents|mesh-ancestor
102647627|NCT05344625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102647628|NCT05344625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275463|NCT03078257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102275464|NCT03078257|Antipyretics|antipyretics|mesh-ancestor
102647629|NCT05344625|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102647630|NCT05344625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102647631|NCT05344625|Anesthetics, General|anesthetics, general|mesh-ancestor
102647632|NCT05344625|Anesthetics|anesthetics|mesh-ancestor
102647633|NCT05344625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102647634|NCT05344625|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102647635|NCT05344625|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102647636|NCT05344625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102647637|NCT05344625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647638|NCT05325866|Bemarituzumab|bemarituzumab|mesh-list
102647639|NCT05325866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102647640|NCT05325866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647641|NCT05325502|Mannitol|mannitol|mesh-list
102647642|NCT05325502|Caffeine|caffeine|mesh-list
102647643|NCT05325502|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102647644|NCT05325502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647645|NCT05325502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102647646|NCT05325502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102647647|NCT05325502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647648|NCT05325502|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102647649|NCT05325502|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102647650|NCT05325502|Purinergic Agents|purinergic agents|mesh-ancestor
102647651|NCT05325502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102647652|NCT05325502|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102647653|NCT05325502|Diuretics|diuretics|mesh-ancestor
102647654|NCT05325502|Natriuretic Agents|natriuretic agents|mesh-ancestor
102647655|NCT05323656|Pembrolizumab|pembrolizumab|mesh-list
102647656|NCT05323656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102647657|NCT05323656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647658|NCT05323656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102647659|NCT05323656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647660|NCT05317416|Lenalidomide|lenalidomide|mesh-list
102647661|NCT05317416|Immunologic Factors|immunologic factors|mesh-ancestor
102647662|NCT05317416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647663|NCT05317416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102647664|NCT05317416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102647665|NCT05317416|Growth Substances|growth substances|mesh-ancestor
102647666|NCT05317416|Growth Inhibitors|growth inhibitors|mesh-ancestor
102647667|NCT05317416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647668|NCT05295173|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102647669|NCT05295173|Plasminogen|plasminogen|mesh-list
102647670|NCT05295173|Reteplase|reteplase|mesh-list
102647671|NCT05295173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102647672|NCT05295173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102647673|NCT05295173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647674|NCT05289349|Propofol|propofol|mesh-list
102647675|NCT05289349|Sevoflurane|sevoflurane|mesh-list
102647676|NCT05289349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102647677|NCT05289349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102647678|NCT05289349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647679|NCT05289349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102647680|NCT05289349|Anesthetics, General|anesthetics, general|mesh-ancestor
102647681|NCT05289349|Anesthetics|anesthetics|mesh-ancestor
102647682|NCT05289349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102647683|NCT05289349|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102647684|NCT05286827|Olaparib|olaparib|mesh-list
102647685|NCT05286827|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102647686|NCT05286827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102647687|NCT05286827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647688|NCT05286827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647689|NCT05285813|Acetaminophen|acetaminophen|mesh-list
102647690|NCT05285813|Diphenhydramine|diphenhydramine|mesh-list
102647691|NCT05285813|Promethazine|promethazine|mesh-list
102647692|NCT05285813|Dexamethasone|dexamethasone|mesh-list
102647693|NCT05285813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102647694|NCT05285813|Antiemetics|antiemetics|mesh-ancestor
102647695|NCT05285813|Autonomic Agents|autonomic agents|mesh-ancestor
102647696|NCT05285813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102647697|NCT05285813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647698|NCT05285813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102275465|NCT03078257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102275466|NCT03078257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102647699|NCT05285813|Glucocorticoids|glucocorticoids|mesh-ancestor
102647700|NCT05285813|Hormones|hormones|mesh-ancestor
102647701|NCT05285813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102647702|NCT05285813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102647703|NCT05285813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647704|NCT05285813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102647705|NCT05285813|Analgesics|analgesics|mesh-ancestor
102647706|NCT05285813|Sensory System Agents|sensory system agents|mesh-ancestor
102647707|NCT05285813|Antipyretics|antipyretics|mesh-ancestor
102647708|NCT05285813|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102647709|NCT05285813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102647710|NCT05285813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102647711|NCT05285813|Anesthetics, Local|anesthetics, local|mesh-ancestor
102647712|NCT05285813|Anesthetics|anesthetics|mesh-ancestor
102647713|NCT05285813|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102647714|NCT05285813|Histamine Antagonists|histamine antagonists|mesh-ancestor
102647715|NCT05285813|Histamine Agents|histamine agents|mesh-ancestor
102647716|NCT05285813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102647717|NCT05285813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647718|NCT05285813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102647719|NCT05285813|Antipruritics|antipruritics|mesh-ancestor
102647720|NCT05285813|Dermatologic Agents|dermatologic agents|mesh-ancestor
102647721|NCT05285384|Myeloma Proteins|myeloma proteins|mesh-list
102647722|NCT05285384|Paraproteins|paraproteins|mesh-list
102647723|NCT05285384|Immunologic Factors|immunologic factors|mesh-ancestor
102647724|NCT05285384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647725|NCT05284747|Evolocumab|evolocumab|mesh-list
102647726|NCT05284747|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102647727|NCT05284747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102647728|NCT05284747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102647729|NCT05284747|Antimetabolites|antimetabolites|mesh-ancestor
102647730|NCT05284747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647731|NCT05284747|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102647732|NCT05284747|Protease Inhibitors|protease inhibitors|mesh-ancestor
102647733|NCT05284747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102647734|NCT05284747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102647735|NCT05279417|Methotrexate|methotrexate|mesh-list
102647736|NCT05279417|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102647737|NCT05279417|Abortifacient Agents|abortifacient agents|mesh-ancestor
102647738|NCT05279417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102647739|NCT05279417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369281|NCT00046137|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102647740|NCT05279417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102647741|NCT05279417|Antimetabolites|antimetabolites|mesh-ancestor
102647742|NCT05279417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647743|NCT05279417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647744|NCT05279417|Dermatologic Agents|dermatologic agents|mesh-ancestor
102647745|NCT05279417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102647746|NCT05279417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102647747|NCT05279417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102647748|NCT05279417|Immunologic Factors|immunologic factors|mesh-ancestor
102647749|NCT05279417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102647750|NCT05279417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102647751|NCT05267470|Paclitaxel|paclitaxel|mesh-list
102647752|NCT05267470|Docetaxel|docetaxel|mesh-list
102647753|NCT05267470|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102647754|NCT05267470|Carboplatin|carboplatin|mesh-list
102647755|NCT05267470|Pembrolizumab|pembrolizumab|mesh-list
102647756|NCT05267470|Bemarituzumab|bemarituzumab|mesh-list
102647757|NCT05267470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102647758|NCT05267470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647759|NCT05267470|Tubulin Modulators|tubulin modulators|mesh-ancestor
102647760|NCT05267470|Antimitotic Agents|antimitotic agents|mesh-ancestor
102647761|NCT05267470|Mitosis Modulators|mitosis modulators|mesh-ancestor
102647762|NCT05267470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647763|NCT05267470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102647764|NCT05267470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102647765|NCT05247905|Capecitabine|capecitabine|mesh-list
102647766|NCT05247905|Temozolomide|temozolomide|mesh-list
102647767|NCT05247905|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102647768|NCT05247905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102647769|NCT05247905|Antimetabolites|antimetabolites|mesh-ancestor
102647770|NCT05247905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647771|NCT05247905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647772|NCT05247905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102647773|NCT05247905|Alkylating Agents|alkylating agents|mesh-ancestor
102647774|NCT05247905|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101936346|NCT03955341|Chlorhexidine|chlorhexidine|mesh-list
102647775|NCT05235737|Pembrolizumab|pembrolizumab|mesh-list
102647776|NCT05235737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102275467|NCT03078257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102647777|NCT05235737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647778|NCT05235737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102647779|NCT05235737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647781|NCT05185999|Dialysis Solutions|dialysis solutions|mesh-ancestor
102647782|NCT05185999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102647783|NCT05175430|Paroxetine|paroxetine|mesh-list
102647784|NCT05175430|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
102647785|NCT05175430|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102647786|NCT05175430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102647787|NCT05175430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102647788|NCT05175430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647789|NCT05175430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102647790|NCT05175430|Serotonin Agents|serotonin agents|mesh-ancestor
102647791|NCT05175430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647792|NCT05175430|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102647793|NCT05175430|Antidepressive Agents|antidepressive agents|mesh-ancestor
102647794|NCT05175430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102647795|NCT05175430|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102647796|NCT05175430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102647797|NCT05175430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102647798|NCT05175430|Hallucinogens|hallucinogens|mesh-ancestor
102647799|NCT05175430|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102647800|NCT05175430|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102647801|NCT05133791|Annexin A5|annexin a5|mesh-list
102647802|NCT05133791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102647803|NCT05133791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647804|NCT05115513|Dronabinol|dronabinol|mesh-list
102647805|NCT05115513|Hallucinogens|hallucinogens|mesh-ancestor
102647806|NCT05115513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647807|NCT05115513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102647808|NCT05115513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102647809|NCT05115513|Analgesics|analgesics|mesh-ancestor
102647810|NCT05115513|Sensory System Agents|sensory system agents|mesh-ancestor
102647811|NCT05115513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102647812|NCT05115513|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102647813|NCT05115513|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102647814|NCT05115513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102647815|NCT05115513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647816|NCT05115513|Hormones|hormones|mesh-ancestor
102647817|NCT05115513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102647818|NCT05112601|Nivolumab|nivolumab|mesh-list
102647819|NCT05112601|Ipilimumab|ipilimumab|mesh-list
102647820|NCT05112601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102647821|NCT05112601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647822|NCT05112601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102647823|NCT05112601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647824|NCT05105542|Cholinergic Agents|cholinergic agents|mesh-list
102647825|NCT05105542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102647826|NCT05105542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647827|NCT05105542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647828|NCT05101070|Pembrolizumab|pembrolizumab|mesh-list
102647829|NCT05101070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102647830|NCT05101070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647831|NCT05101070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102647832|NCT05101070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647833|NCT05092451|Cyclophosphamide|cyclophosphamide|mesh-list
102647834|NCT05092451|Fludarabine|fludarabine|mesh-list
102647835|NCT05092451|Fludarabine phosphate|fludarabine phosphate|mesh-list
102647836|NCT05092451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102647837|NCT05092451|Immunologic Factors|immunologic factors|mesh-ancestor
102647838|NCT05092451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647839|NCT05092451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102647840|NCT05092451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102647841|NCT05092451|Alkylating Agents|alkylating agents|mesh-ancestor
102647842|NCT05092451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647843|NCT05092451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647844|NCT05092451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102275468|NCT03078257|Purinergic Agents|purinergic agents|mesh-ancestor
102275469|NCT03078257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102275470|NCT02341573|Leukotriene Antagonists|leukotriene antagonists|mesh-list
102275471|NCT02341573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102275472|NCT02341573|Respiratory System Agents|respiratory system agents|mesh-ancestor
102647845|NCT05092451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102647846|NCT05092451|Antimetabolites|antimetabolites|mesh-ancestor
102647847|NCT05090566|Dexamethasone|dexamethasone|mesh-list
102647848|NCT05090566|Lenalidomide|lenalidomide|mesh-list
102647849|NCT05090566|Nirogacestat|nirogacestat|mesh-list
102647850|NCT05090566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102647851|NCT05090566|Antiemetics|antiemetics|mesh-ancestor
102647852|NCT05090566|Autonomic Agents|autonomic agents|mesh-ancestor
102647853|NCT05090566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102647854|NCT05090566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647855|NCT05090566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102647856|NCT05090566|Glucocorticoids|glucocorticoids|mesh-ancestor
102647857|NCT05090566|Hormones|hormones|mesh-ancestor
102647858|NCT05090566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102647859|NCT05090566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102647860|NCT05090566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647861|NCT05090566|Immunologic Factors|immunologic factors|mesh-ancestor
102647862|NCT05090566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102647863|NCT05090566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102647864|NCT05090566|Growth Substances|growth substances|mesh-ancestor
102647865|NCT05090566|Growth Inhibitors|growth inhibitors|mesh-ancestor
102647866|NCT05090566|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101369424|NCT00175396|Antioxidants|antioxidants|mesh-ancestor
102647867|NCT05090566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102647868|NCT05090566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647869|NCT05084053|Immunoglobulins|immunoglobulins|mesh-list
102647870|NCT05084053|Immunologic Factors|immunologic factors|mesh-ancestor
102647871|NCT05084053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647872|NCT05079230|Azacitidine|azacitidine|mesh-list
102647873|NCT05079230|Venetoclax|venetoclax|mesh-list
102647874|NCT05079230|Magrolimab|magrolimab|mesh-list
102647875|NCT05079230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102647876|NCT05079230|Antimetabolites|antimetabolites|mesh-ancestor
102647877|NCT05079230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647878|NCT05079230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647879|NCT05079230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102647880|NCT05079230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102647881|NCT05067283|Leucovorin|leucovorin|mesh-list
102647882|NCT05067283|Carboplatin|carboplatin|mesh-list
102647883|NCT05067283|Pembrolizumab|pembrolizumab|mesh-list
102647884|NCT05067283|Fluorouracil|fluorouracil|mesh-list
102647885|NCT05067283|Oxaliplatin|oxaliplatin|mesh-list
102647886|NCT05067283|Pemetrexed|pemetrexed|mesh-list
102647887|NCT05067283|Cetuximab|cetuximab|mesh-list
102647888|NCT05067283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647889|NCT05067283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102647890|NCT05067283|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102647891|NCT05067283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647892|NCT05067283|Antimetabolites|antimetabolites|mesh-ancestor
102647893|NCT05067283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102647894|NCT05067283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102647895|NCT05067283|Immunologic Factors|immunologic factors|mesh-ancestor
102647896|NCT05067283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647897|NCT05067283|Antidotes|antidotes|mesh-ancestor
102647898|NCT05067283|Protective Agents|protective agents|mesh-ancestor
102647899|NCT05067283|Vitamin B Complex|vitamin b complex|mesh-ancestor
102647900|NCT05067283|Vitamins|vitamins|mesh-ancestor
102647901|NCT05067283|Micronutrients|micronutrients|mesh-ancestor
102647902|NCT05067283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102647903|NCT05067283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102647904|NCT05067283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102647905|NCT05063552|Bevacizumab|bevacizumab|mesh-list
102647906|NCT05063552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102647907|NCT05063552|Cetuximab|cetuximab|mesh-list
102275473|NCT02341573|Hormone Antagonists|hormone antagonists|mesh-ancestor
102275474|NCT02341573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102275475|NCT02341573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275476|NCT05005715|Dexmedetomidine|dexmedetomidine|mesh-list
102275477|NCT05005715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102275478|NCT05005715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102275479|NCT05005715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647908|NCT05063552|Atezolizumab|atezolizumab|mesh-list
102647909|NCT05063552|Cisplatin|cisplatin|mesh-list
102647910|NCT05063552|Carboplatin|carboplatin|mesh-list
102275480|NCT05005715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102647911|NCT05063552|Docetaxel|docetaxel|mesh-list
102647912|NCT05063552|Endothelial Growth Factors|endothelial growth factors|mesh-list
102647913|NCT05063552|Antibodies|antibodies|mesh-list
102647914|NCT05063552|Immunoglobulins|immunoglobulins|mesh-list
102647915|NCT05063552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102647916|NCT05063552|Immunoglobulin G|immunoglobulin g|mesh-list
102647917|NCT05063552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647918|NCT05063552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102647919|NCT05063552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102647920|NCT05063552|Growth Substances|growth substances|mesh-ancestor
102647921|NCT05063552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647922|NCT05063552|Growth Inhibitors|growth inhibitors|mesh-ancestor
102647923|NCT05063552|Immunologic Factors|immunologic factors|mesh-ancestor
102647924|NCT05063552|Tubulin Modulators|tubulin modulators|mesh-ancestor
102647925|NCT05063552|Antimitotic Agents|antimitotic agents|mesh-ancestor
102647926|NCT05063552|Mitosis Modulators|mitosis modulators|mesh-ancestor
102647927|NCT05063552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647928|NCT05063552|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102647929|NCT05059522|Pemetrexed|pemetrexed|mesh-list
102647930|NCT05059522|Avelumab|avelumab|mesh-list
102647931|NCT05059522|Axitinib|axitinib|mesh-list
102647932|NCT05059522|Talazoparib|talazoparib|mesh-list
102647933|NCT05059522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647934|NCT05059522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102647935|NCT05059522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647936|NCT05059522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102647937|NCT05059522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102647938|NCT05059522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102647939|NCT05059522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102647940|NCT05059522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102647941|NCT05057806|Empagliflozin|empagliflozin|mesh-list
102647942|NCT05057806|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102647943|NCT05057806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647944|NCT05057806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102647945|NCT05057806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647946|NCT05041036|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
102647947|NCT05041036|Nirogacestat|nirogacestat|mesh-list
102647948|NCT05041036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102647949|NCT05041036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647950|NCT05039801|Paclitaxel|paclitaxel|mesh-list
102647951|NCT05039801|Bevacizumab|bevacizumab|mesh-list
102647952|NCT05039801|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102647953|NCT05039801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102647954|NCT05039801|Endothelial Growth Factors|endothelial growth factors|mesh-list
102647955|NCT05039801|Antibodies|antibodies|mesh-list
102647956|NCT05039801|Immunoglobulins|immunoglobulins|mesh-list
102647957|NCT05039801|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102647958|NCT05039801|Immunoglobulin G|immunoglobulin g|mesh-list
102647959|NCT05039801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102647960|NCT05039801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647961|NCT05039801|Tubulin Modulators|tubulin modulators|mesh-ancestor
102647962|NCT05039801|Antimitotic Agents|antimitotic agents|mesh-ancestor
102647963|NCT05039801|Mitosis Modulators|mitosis modulators|mesh-ancestor
102647964|NCT05039801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647965|NCT05039801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102647966|NCT05039801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102647967|NCT05039801|Growth Substances|growth substances|mesh-ancestor
102647968|NCT05039801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647969|NCT05039801|Growth Inhibitors|growth inhibitors|mesh-ancestor
102647970|NCT05039801|Immunologic Factors|immunologic factors|mesh-ancestor
102647971|NCT05027945|Mycophenolic Acid|mycophenolic acid|mesh-list
102275481|NCT05005715|Analgesics|analgesics|mesh-ancestor
102275482|NCT05005715|Sensory System Agents|sensory system agents|mesh-ancestor
102275483|NCT05005715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102275484|NCT05005715|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102275485|NCT05005715|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102275486|NCT05005715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102275487|NCT05005715|Adrenergic Agents|adrenergic agents|mesh-ancestor
102275488|NCT05005715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102275489|NCT05005715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275490|NCT02345707|Cabotegravir|cabotegravir|mesh-list
102275491|NCT02345707|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102275492|NCT02345707|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102275493|NCT02345707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102647972|NCT05027945|Sirolimus|sirolimus|mesh-list
102647973|NCT05027945|Cyclophosphamide|cyclophosphamide|mesh-list
102647974|NCT05027945|Busulfan|busulfan|mesh-list
102647975|NCT05027945|Fludarabine|fludarabine|mesh-list
102647976|NCT05027945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102647977|NCT05027945|Immunologic Factors|immunologic factors|mesh-ancestor
102647978|NCT05027945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102647979|NCT05027945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102647980|NCT05027945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102647981|NCT05027945|Alkylating Agents|alkylating agents|mesh-ancestor
102647982|NCT05027945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102647983|NCT05027945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647984|NCT05027945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101369608|NCT00176449|Bupropion|bupropion|mesh-list
102647985|NCT05027945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102647986|NCT05027945|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102647987|NCT05027945|Antitubercular Agents|antitubercular agents|mesh-ancestor
102647988|NCT05027945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102647989|NCT05027945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102647990|NCT05027945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102647991|NCT05027945|Antifungal Agents|antifungal agents|mesh-ancestor
102647992|NCT05024773|Paclitaxel|paclitaxel|mesh-list
102647993|NCT05024773|Hyaluronic Acid|hyaluronic acid|mesh-list
102647994|NCT05024773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102647995|NCT05024773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102647996|NCT05024773|Tubulin Modulators|tubulin modulators|mesh-ancestor
102647997|NCT05024773|Antimitotic Agents|antimitotic agents|mesh-ancestor
102647998|NCT05024773|Mitosis Modulators|mitosis modulators|mesh-ancestor
102647999|NCT05024773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648000|NCT05024773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102648001|NCT05024773|Immunologic Factors|immunologic factors|mesh-ancestor
102648002|NCT05024773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648003|NCT05024773|Viscosupplements|viscosupplements|mesh-ancestor
102648004|NCT05024773|Protective Agents|protective agents|mesh-ancestor
102648005|NCT05011058|Valganciclovir|valganciclovir|mesh-list
102648006|NCT05011058|Antiviral Agents|antiviral agents|mesh-ancestor
102648007|NCT05011058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102648008|NCT05006794|Docetaxel|docetaxel|mesh-list
102648009|NCT05006794|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
102648010|NCT05006794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648011|NCT05006794|Tubulin Modulators|tubulin modulators|mesh-ancestor
102648012|NCT05006794|Antimitotic Agents|antimitotic agents|mesh-ancestor
102648013|NCT05006794|Mitosis Modulators|mitosis modulators|mesh-ancestor
102648014|NCT05006794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648015|NCT05006794|Immunoconjugates|immunoconjugates|mesh-ancestor
102648016|NCT05006794|Immunologic Factors|immunologic factors|mesh-ancestor
102648017|NCT05006794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648018|NCT04978298|Phenelzine|phenelzine|mesh-list
102648019|NCT04978298|Ozanimod|ozanimod|mesh-list
102648020|NCT04978298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102648021|NCT04978298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648022|NCT04978298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102648023|NCT04978298|Immunologic Factors|immunologic factors|mesh-ancestor
102648024|NCT04978298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648025|NCT04978298|Antidepressive Agents|antidepressive agents|mesh-ancestor
102648026|NCT04978298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102648027|NCT04978298|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102648028|NCT04978298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648029|NCT04975919|Decitabine|decitabine|mesh-list
102648030|NCT04975919|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
102648031|NCT04975919|Venetoclax|venetoclax|mesh-list
102648032|NCT04975919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102648033|NCT04975919|Antimetabolites|antimetabolites|mesh-ancestor
102648034|NCT04975919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648035|NCT04975919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648036|NCT04975919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648037|NCT04949256|Calcium, Dietary|calcium, dietary|mesh-list
102648038|NCT04949256|Leucovorin|leucovorin|mesh-list
102648039|NCT04949256|Paclitaxel|paclitaxel|mesh-list
102275494|NCT02345707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275495|NCT02345707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102275496|NCT02345707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102275497|NCT02345707|Antiviral Agents|antiviral agents|mesh-ancestor
102275498|NCT02345707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102275499|NCT05005637|Antitubercular Agents|antitubercular agents|mesh-list
102275500|NCT05005637|Prednisone|prednisone|mesh-list
102648040|NCT04949256|Pembrolizumab|pembrolizumab|mesh-list
102648041|NCT04949256|Oxaliplatin|oxaliplatin|mesh-list
102648042|NCT04949256|Lenvatinib|lenvatinib|mesh-list
102275501|NCT05005637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102275502|NCT05005637|Glucocorticoids|glucocorticoids|mesh-ancestor
102648043|NCT04949256|Calcium|calcium|mesh-list
102648044|NCT04949256|Levoleucovorin|levoleucovorin|mesh-list
102648045|NCT04949256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102648046|NCT04949256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648047|NCT04949256|Tubulin Modulators|tubulin modulators|mesh-ancestor
102648048|NCT04949256|Antimitotic Agents|antimitotic agents|mesh-ancestor
102648049|NCT04949256|Mitosis Modulators|mitosis modulators|mesh-ancestor
102648050|NCT04949256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648051|NCT04949256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102648052|NCT04949256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102648053|NCT04949256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102648054|NCT04949256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648055|NCT04949256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102648056|NCT04949256|Antidotes|antidotes|mesh-ancestor
102648057|NCT04949256|Protective Agents|protective agents|mesh-ancestor
102648058|NCT04949256|Vitamin B Complex|vitamin b complex|mesh-ancestor
102648059|NCT04949256|Vitamins|vitamins|mesh-ancestor
102648060|NCT04949256|Micronutrients|micronutrients|mesh-ancestor
102648061|NCT04949256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102648062|NCT04949256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648063|NCT04938830|Palivizumab|palivizumab|mesh-list
102648064|NCT04938830|Antiviral Agents|antiviral agents|mesh-ancestor
102648065|NCT04938830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102648066|NCT04930094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102648067|NCT04930094|Immunologic Factors|immunologic factors|mesh-ancestor
102648068|NCT04930094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648069|NCT04921527|Paclitaxel|paclitaxel|mesh-list
102648070|NCT04921527|Chiauranib|chiauranib|mesh-list
102648071|NCT04921527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102648072|NCT04921527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648073|NCT04921527|Tubulin Modulators|tubulin modulators|mesh-ancestor
102648074|NCT04921527|Antimitotic Agents|antimitotic agents|mesh-ancestor
102648075|NCT04921527|Mitosis Modulators|mitosis modulators|mesh-ancestor
102648076|NCT04921527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648077|NCT04921527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102648078|NCT04921527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648079|NCT04915183|Atorvastatin|atorvastatin|mesh-list
102648080|NCT04915183|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102648081|NCT04915183|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102648082|NCT04915183|Antimetabolites|antimetabolites|mesh-ancestor
102648083|NCT04915183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648084|NCT04915183|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102648085|NCT04915183|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102648086|NCT04915183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648087|NCT04913220|Cemiplimab|cemiplimab|mesh-list
102648088|NCT04913220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102648089|NCT04913220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648090|NCT04902378|Insulin|insulin|mesh-list
102648091|NCT04902378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102648092|NCT04902378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648093|NCT04898504|Floxuridine|floxuridine|mesh-list
102648094|NCT04898504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102648095|NCT04898504|Antimetabolites|antimetabolites|mesh-ancestor
102648096|NCT04898504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648097|NCT04898504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648098|NCT04895722|Pembrolizumab|pembrolizumab|mesh-list
102648099|NCT04895722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102648100|NCT04895722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648101|NCT04895722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102648102|NCT04895722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648103|NCT04895709|Docetaxel|docetaxel|mesh-list
102648104|NCT04895709|Nivolumab|nivolumab|mesh-list
102648105|NCT04895709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648106|NCT04895709|Tubulin Modulators|tubulin modulators|mesh-ancestor
102648107|NCT04895709|Antimitotic Agents|antimitotic agents|mesh-ancestor
102648108|NCT04895709|Mitosis Modulators|mitosis modulators|mesh-ancestor
102648109|NCT04895709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648110|NCT04895709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102648111|NCT04895709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101369754|NCT00177853|Celecoxib|celecoxib|mesh-list
102648112|NCT04890093|Vincristine|vincristine|mesh-list
102275503|NCT05005637|Hormones|hormones|mesh-ancestor
101936692|NCT03006562|Heparin|heparin|mesh-list
102648113|NCT04890093|Temozolomide|temozolomide|mesh-list
102648114|NCT04890093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102648115|NCT04890093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648116|NCT04890093|Tubulin Modulators|tubulin modulators|mesh-ancestor
102648117|NCT04890093|Antimitotic Agents|antimitotic agents|mesh-ancestor
102648118|NCT04890093|Mitosis Modulators|mitosis modulators|mesh-ancestor
102648119|NCT04890093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648120|NCT04890093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102648121|NCT04890093|Alkylating Agents|alkylating agents|mesh-ancestor
102648122|NCT04882085|Ceftazidime|ceftazidime|mesh-list
102648123|NCT04882085|Avibactam|avibactam|mesh-list
102648124|NCT04882085|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
102648125|NCT04882085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102648126|NCT04882085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102648127|NCT04882085|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102648128|NCT04882085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648129|NCT04882085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648130|NCT04876079|Insulin|insulin|mesh-list
102648131|NCT04876079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102648132|NCT04876079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648133|NCT04857034|Deucravacitinib|deucravacitinib|mesh-list
102648134|NCT04857034|Dermatologic Agents|dermatologic agents|mesh-ancestor
102648135|NCT04857034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102648136|NCT04857034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648137|NCT04857034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648138|NCT04845035|Cytarabine|cytarabine|mesh-list
102648139|NCT04845035|Methotrexate|methotrexate|mesh-list
102648140|NCT04845035|Dasatinib|dasatinib|mesh-list
102648141|NCT04845035|Ponatinib|ponatinib|mesh-list
102648142|NCT04845035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102648143|NCT04845035|Abortifacient Agents|abortifacient agents|mesh-ancestor
102648144|NCT04845035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102648145|NCT04845035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648146|NCT04845035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102648147|NCT04845035|Antimetabolites|antimetabolites|mesh-ancestor
102648148|NCT04845035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648149|NCT04845035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648150|NCT04845035|Dermatologic Agents|dermatologic agents|mesh-ancestor
102648151|NCT04845035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648152|NCT04845035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102648153|NCT04845035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102648154|NCT04845035|Immunologic Factors|immunologic factors|mesh-ancestor
102648155|NCT04845035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102648156|NCT04845035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102648157|NCT04845035|Antiviral Agents|antiviral agents|mesh-ancestor
102648158|NCT04845035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102648159|NCT04845035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102648160|NCT04821622|Talazoparib|talazoparib|mesh-list
102648161|NCT04821622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102648162|NCT04821622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648163|NCT04821622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648164|NCT04821622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648165|NCT04811573|Thalidomide|thalidomide|mesh-list
102648166|NCT04811573|Apremilast|apremilast|mesh-list
102648167|NCT04811573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102648168|NCT04811573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102648169|NCT04811573|Analgesics|analgesics|mesh-ancestor
102648170|NCT04811573|Sensory System Agents|sensory system agents|mesh-ancestor
102648171|NCT04811573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102648172|NCT04811573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648173|NCT04811573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102648174|NCT04811573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102648175|NCT04811573|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102648176|NCT04811573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102648177|NCT04811573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648178|NCT04811573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648179|NCT04811573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102648180|NCT04811573|Immunologic Factors|immunologic factors|mesh-ancestor
102648181|NCT04811573|Leprostatic Agents|leprostatic agents|mesh-ancestor
102648182|NCT04811573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102648183|NCT04811573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102648184|NCT04811573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102648185|NCT04811573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102648186|NCT04811573|Growth Substances|growth substances|mesh-ancestor
102275504|NCT05005637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101936758|NCT03540030|Lidocaine|lidocaine|mesh-list
101936834|NCT02912650|Acetaminophen|acetaminophen|mesh-list
102648187|NCT04811573|Growth Inhibitors|growth inhibitors|mesh-ancestor
102648188|NCT04811573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648190|NCT04803201|Cyclophosphamide|cyclophosphamide|mesh-list
102648191|NCT04803201|Doxorubicin|doxorubicin|mesh-list
102648192|NCT04803201|Etoposide|etoposide|mesh-list
102648193|NCT04803201|Vincristine|vincristine|mesh-list
102648194|NCT04803201|Azacitidine|azacitidine|mesh-list
102648195|NCT04803201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102648196|NCT04803201|Immunologic Factors|immunologic factors|mesh-ancestor
102648197|NCT04803201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648198|NCT04803201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102648199|NCT04803201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102648200|NCT04803201|Alkylating Agents|alkylating agents|mesh-ancestor
102648201|NCT04803201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648202|NCT04803201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648203|NCT04803201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102648204|NCT04803201|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102648205|NCT04803201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102648206|NCT04803201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102648207|NCT04803201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648208|NCT04803201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102648209|NCT04803201|Glucocorticoids|glucocorticoids|mesh-ancestor
102648210|NCT04803201|Hormones|hormones|mesh-ancestor
102648211|NCT04803201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102648212|NCT04803201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102648213|NCT04803201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102648214|NCT04803201|Tubulin Modulators|tubulin modulators|mesh-ancestor
102648215|NCT04803201|Antimitotic Agents|antimitotic agents|mesh-ancestor
102648216|NCT04803201|Mitosis Modulators|mitosis modulators|mesh-ancestor
102648217|NCT04803201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102648218|NCT04803201|Antimetabolites|antimetabolites|mesh-ancestor
102648219|NCT04778397|Cytarabine|cytarabine|mesh-list
102648220|NCT04778397|Azacitidine|azacitidine|mesh-list
102648221|NCT04778397|Daunorubicin|daunorubicin|mesh-list
102648222|NCT04778397|Venetoclax|venetoclax|mesh-list
102648223|NCT04778397|Idarubicin|idarubicin|mesh-list
102648224|NCT04778397|Magrolimab|magrolimab|mesh-list
102648225|NCT04778397|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102648226|NCT04778397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102648227|NCT04778397|Antimetabolites|antimetabolites|mesh-ancestor
102648228|NCT04778397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648229|NCT04778397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648230|NCT04778397|Antiviral Agents|antiviral agents|mesh-ancestor
102648231|NCT04778397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102648232|NCT04778397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102648233|NCT04778397|Immunologic Factors|immunologic factors|mesh-ancestor
102648234|NCT04778397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648235|NCT04778397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648236|NCT04778397|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101369872|NCT00179023|Nasal Decongestants|nasal decongestants|mesh-ancestor
102648237|NCT04778397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102648238|NCT04778397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102648239|NCT04778397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102648240|NCT04778397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102648241|NCT04774094|Ceftazidime|ceftazidime|mesh-list
102648242|NCT04774094|Avibactam|avibactam|mesh-list
102648243|NCT04774094|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
102648244|NCT04774094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102648245|NCT04774094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102648246|NCT04774094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102648247|NCT04774094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648248|NCT04774094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648249|NCT04772079|Deucravacitinib|deucravacitinib|mesh-list
102648250|NCT04772079|Dermatologic Agents|dermatologic agents|mesh-ancestor
102648251|NCT04772079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102648252|NCT04772079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648253|NCT04772079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648254|NCT04753437|Amoxicillin|amoxicillin|mesh-list
102648255|NCT04753437|Clarithromycin|clarithromycin|mesh-list
102648256|NCT04753437|Potassium Citrate|potassium citrate|mesh-list
102648257|NCT04753437|Esomeprazole|esomeprazole|mesh-list
102648258|NCT04753437|Bismuth|bismuth|mesh-list
102648259|NCT04753437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648260|NCT04753437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102648261|NCT04753437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102648262|NCT04753437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102648263|NCT04753437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102648264|NCT04753437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102648265|NCT04753437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648266|NCT04753437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102648267|NCT04753437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102648268|NCT04753437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102648269|NCT04753437|Antacids|antacids|mesh-ancestor
102648270|NCT04753437|Diuretics|diuretics|mesh-ancestor
102648271|NCT04753437|Natriuretic Agents|natriuretic agents|mesh-ancestor
102648272|NCT04753437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648273|NCT04753437|Expectorants|expectorants|mesh-ancestor
102648274|NCT04753437|Respiratory System Agents|respiratory system agents|mesh-ancestor
102648275|NCT04745949|Prednisone|prednisone|mesh-list
102648276|NCT04745949|Cortisone|cortisone|mesh-list
102648277|NCT04745949|Cyclophosphamide|cyclophosphamide|mesh-list
102648278|NCT04745949|Rituximab|rituximab|mesh-list
102648279|NCT04745949|Doxorubicin|doxorubicin|mesh-list
102648280|NCT04745949|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102648281|NCT04745949|Nivolumab|nivolumab|mesh-list
102648282|NCT04745949|Daunorubicin|daunorubicin|mesh-list
102648283|NCT04745949|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102648284|NCT04745949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102648285|NCT04745949|Antibodies|antibodies|mesh-list
102648286|NCT04745949|Immunoglobulins|immunoglobulins|mesh-list
102648287|NCT04745949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102648288|NCT04745949|Immunoconjugates|immunoconjugates|mesh-list
102648289|NCT04745949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102648290|NCT04745949|Immunologic Factors|immunologic factors|mesh-ancestor
102648291|NCT04745949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648292|NCT04745949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102648293|NCT04745949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102648294|NCT04745949|Alkylating Agents|alkylating agents|mesh-ancestor
102648295|NCT04745949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648296|NCT04745949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648297|NCT04745949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102648298|NCT04745949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102648299|NCT04745949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102648300|NCT04745949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102648301|NCT04745949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101369938|NCT00408382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648302|NCT04745949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102648303|NCT04745949|Glucocorticoids|glucocorticoids|mesh-ancestor
102648304|NCT04745949|Hormones|hormones|mesh-ancestor
102648305|NCT04745949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102648306|NCT04745949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102648307|NCT04745949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102648308|NCT04745949|Immunotoxins|immunotoxins|mesh-ancestor
102648309|NCT04744116|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
102648310|NCT04744116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102648311|NCT04744116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648312|NCT04744116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648313|NCT04740671|Ranibizumab|ranibizumab|mesh-list
102648314|NCT04740671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102648315|NCT04740671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102648316|NCT04740671|Growth Substances|growth substances|mesh-ancestor
102648317|NCT04740671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648318|NCT04740671|Growth Inhibitors|growth inhibitors|mesh-ancestor
102648319|NCT04740671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648320|NCT04734990|Azacitidine|azacitidine|mesh-list
102648321|NCT04734990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102648322|NCT04734990|Antimetabolites|antimetabolites|mesh-ancestor
102648323|NCT04734990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648324|NCT04734990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648325|NCT04734990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648326|NCT04713514|Pembrolizumab|pembrolizumab|mesh-list
102648327|NCT04713514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102648328|NCT04713514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648329|NCT04713514|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102648330|NCT04713514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648331|NCT04711109|Denosumab|denosumab|mesh-list
102648332|NCT04711109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102648333|NCT04711109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648334|NCT04703920|Talazoparib|talazoparib|mesh-list
102648335|NCT04703920|Belinostat|belinostat|mesh-list
102648336|NCT04703920|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102648337|NCT04703920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102275505|NCT05005637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275506|NCT05005637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102648338|NCT04703920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648339|NCT04703920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648340|NCT04703920|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102648342|NCT04667234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102648343|NCT04667234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648344|NCT04667234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102648345|NCT04667234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648346|NCT04637594|Pembrolizumab|pembrolizumab|mesh-list
102648347|NCT04637594|Nivolumab|nivolumab|mesh-list
102648348|NCT04637594|Atezolizumab|atezolizumab|mesh-list
102648349|NCT04637594|Durvalumab|durvalumab|mesh-list
102648350|NCT04637594|Avelumab|avelumab|mesh-list
102648351|NCT04637594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102648352|NCT04637594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648353|NCT04637594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102648354|NCT04637594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648355|NCT04613557|Cyclophosphamide|cyclophosphamide|mesh-list
102648356|NCT04613557|Fludarabine|fludarabine|mesh-list
102648357|NCT04613557|Fludarabine phosphate|fludarabine phosphate|mesh-list
102648358|NCT04613557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102648359|NCT04613557|Immunologic Factors|immunologic factors|mesh-ancestor
102648360|NCT04613557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648361|NCT04613557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102648362|NCT04613557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102648363|NCT04613557|Alkylating Agents|alkylating agents|mesh-ancestor
102648364|NCT04613557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648365|NCT04613557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648366|NCT04613557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101304548|NCT02013856|Protective Agents|protective agents|mesh-ancestor
102648367|NCT04613557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102648368|NCT04613557|Antimetabolites|antimetabolites|mesh-ancestor
102648369|NCT04605094|Benralizumab|benralizumab|mesh-list
102648370|NCT04605094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102648371|NCT04605094|Respiratory System Agents|respiratory system agents|mesh-ancestor
102648372|NCT04605081|Naltrexone|naltrexone|mesh-list
102648373|NCT04605081|Bupropion|bupropion|mesh-list
102648374|NCT04605081|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102648375|NCT04605081|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102648376|NCT04605081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648377|NCT04605081|Sensory System Agents|sensory system agents|mesh-ancestor
102648378|NCT04605081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102648379|NCT04605081|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102648380|NCT04605081|Antidepressive Agents|antidepressive agents|mesh-ancestor
102648381|NCT04605081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102648382|NCT04605081|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102648383|NCT04605081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102648384|NCT04605081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102648385|NCT04605081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648386|NCT04605081|Dopamine Agents|dopamine agents|mesh-ancestor
102648387|NCT04605081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102648388|NCT04605081|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102648389|NCT04605081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102648390|NCT04605081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648391|NCT04600336|Oxybutynin|oxybutynin|mesh-list
102648392|NCT04600336|Parasympatholytics|parasympatholytics|mesh-ancestor
102648393|NCT04600336|Autonomic Agents|autonomic agents|mesh-ancestor
102648394|NCT04600336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102648395|NCT04600336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648396|NCT04600336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102648397|NCT04600336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102648398|NCT04600336|Cholinergic Agents|cholinergic agents|mesh-ancestor
102648399|NCT04600336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102648400|NCT04600336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648401|NCT04600336|Urological Agents|urological agents|mesh-ancestor
102648402|NCT04599504|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102648403|NCT04599504|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102648404|NCT04599504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648405|NCT04599504|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102648406|NCT04599504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102648407|NCT04599504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101936995|NCT00006489|Naltrexone|naltrexone|mesh-list
102275507|NCT05005637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648408|NCT04599504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648409|NCT04599504|Dopamine Agents|dopamine agents|mesh-ancestor
102648410|NCT04599504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102648412|NCT04599478|Bupropion|bupropion|mesh-list
102648413|NCT04599478|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102648414|NCT04599478|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102648415|NCT04599478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648416|NCT04599478|Sensory System Agents|sensory system agents|mesh-ancestor
102648417|NCT04599478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102648418|NCT04599478|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102648419|NCT04599478|Antidepressive Agents|antidepressive agents|mesh-ancestor
102648420|NCT04599478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102648421|NCT04599478|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102648422|NCT04599478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102648423|NCT04599478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102648424|NCT04599478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648425|NCT04599478|Dopamine Agents|dopamine agents|mesh-ancestor
102648426|NCT04599478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102648427|NCT04599478|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102648428|NCT04599478|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102648429|NCT04599478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648430|NCT04599140|Nivolumab|nivolumab|mesh-list
102648431|NCT04599140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102648432|NCT04599140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648433|NCT04599140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102648434|NCT04599140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648435|NCT04586660|Denosumab|denosumab|mesh-list
102648436|NCT04586660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102648437|NCT04586660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648438|NCT04578639|Rituximab|rituximab|mesh-list
102648439|NCT04578639|Ocrelizumab|ocrelizumab|mesh-list
102648440|NCT04578639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102648441|NCT04578639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648442|NCT04578639|Immunologic Factors|immunologic factors|mesh-ancestor
102648443|NCT04578639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648444|NCT04578639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102648445|NCT04555577|Temozolomide|temozolomide|mesh-list
102648446|NCT04555577|Peposertib|peposertib|mesh-list
102648447|NCT04555577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102648448|NCT04555577|Alkylating Agents|alkylating agents|mesh-ancestor
102648449|NCT04555577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648450|NCT04555577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648451|NCT04555577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102648452|NCT04555577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648453|NCT04530006|Amantadine|amantadine|mesh-list
102648454|NCT04530006|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102648455|NCT04530006|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102648456|NCT04530006|Antiviral Agents|antiviral agents|mesh-ancestor
102648457|NCT04530006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102648458|NCT04530006|Dopamine Agents|dopamine agents|mesh-ancestor
102648459|NCT04530006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102648460|NCT04530006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648461|NCT04530006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648462|NCT04530006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102648463|NCT04530006|Analgesics|analgesics|mesh-ancestor
102648464|NCT04530006|Sensory System Agents|sensory system agents|mesh-ancestor
102648465|NCT04530006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102648466|NCT04526210|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
102648467|NCT04526210|Choline|choline|mesh-list
102648468|NCT04526210|Bupropion|bupropion|mesh-list
102648469|NCT04526210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102648470|NCT04526210|Antidepressive Agents|antidepressive agents|mesh-ancestor
102648471|NCT04526210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102648472|NCT04526210|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102648473|NCT04526210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102648474|NCT04526210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102648475|NCT04526210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648476|NCT04526210|Dopamine Agents|dopamine agents|mesh-ancestor
102648477|NCT04526210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102648478|NCT04526210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648479|NCT04526210|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102648480|NCT04526210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102275508|NCT05005637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102648481|NCT04526210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648482|NCT04526210|Lipotropic Agents|lipotropic agents|mesh-ancestor
102648483|NCT04526210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102648484|NCT04526210|Antimetabolites|antimetabolites|mesh-ancestor
102648485|NCT04526210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102648486|NCT04526210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102648487|NCT04526210|Nootropic Agents|nootropic agents|mesh-ancestor
102648488|NCT04526210|Chelating Agents|chelating agents|mesh-ancestor
102648489|NCT04526210|Sequestering Agents|sequestering agents|mesh-ancestor
102648490|NCT04526210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102648491|NCT04526210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102648492|NCT04526210|Growth Substances|growth substances|mesh-ancestor
102648493|NCT04526210|Growth Inhibitors|growth inhibitors|mesh-ancestor
102648494|NCT04526210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648495|NCT04522323|Lenvatinib|lenvatinib|mesh-list
102648496|NCT04522323|Axitinib|axitinib|mesh-list
102648497|NCT04522323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648498|NCT04522323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102648499|NCT04522323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101370150|NCT00181558|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102648500|NCT04522323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648501|NCT04510311|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
102648502|NCT04510311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648503|NCT04510311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648504|NCT04510311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648505|NCT04510311|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102648506|NCT04493164|Cytarabine|cytarabine|mesh-list
102648507|NCT04493164|Daunorubicin|daunorubicin|mesh-list
102648508|NCT04493164|Ivosidenib|ivosidenib|mesh-list
102648509|NCT04493164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102648510|NCT04493164|Antimetabolites|antimetabolites|mesh-ancestor
102648511|NCT04493164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648512|NCT04493164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648513|NCT04493164|Antiviral Agents|antiviral agents|mesh-ancestor
102648514|NCT04493164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102648515|NCT04493164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102648516|NCT04493164|Immunologic Factors|immunologic factors|mesh-ancestor
102648517|NCT04493164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648518|NCT04493164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102648519|NCT04493164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102648520|NCT04493164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102648521|NCT04493164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648522|NCT04457596|Trastuzumab|trastuzumab|mesh-list
102648523|NCT04457596|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102648524|NCT04457596|Maytansine|maytansine|mesh-list
102648525|NCT04457596|Tucatinib|tucatinib|mesh-list
102648526|NCT04457596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102648527|NCT04457596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648528|NCT04457596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102648529|NCT04457596|Tubulin Modulators|tubulin modulators|mesh-ancestor
102648530|NCT04457596|Antimitotic Agents|antimitotic agents|mesh-ancestor
102648531|NCT04457596|Mitosis Modulators|mitosis modulators|mesh-ancestor
102648532|NCT04457596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648533|NCT04457596|Immunotoxins|immunotoxins|mesh-ancestor
102648534|NCT04457596|Immunoconjugates|immunoconjugates|mesh-ancestor
102648535|NCT04457596|Immunologic Factors|immunologic factors|mesh-ancestor
102648536|NCT04457596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648537|NCT04457596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102648538|NCT04457596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648539|NCT04455750|Leuprolide|leuprolide|mesh-list
102648540|NCT04455750|Goserelin|goserelin|mesh-list
102648541|NCT04455750|Rucaparib|rucaparib|mesh-list
102648542|NCT04455750|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102648543|NCT04455750|Fertility Agents|fertility agents|mesh-ancestor
102648544|NCT04455750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102648545|NCT04455750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648546|NCT04455750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102648547|NCT04455750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648548|NCT04455750|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102648549|NCT04455750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648550|NCT04455750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648551|NCT04435691|Azacitidine|azacitidine|mesh-list
102648552|NCT04435691|Venetoclax|venetoclax|mesh-list
101937136|NCT04056754|Prednisone|prednisone|mesh-list
102648553|NCT04435691|Magrolimab|magrolimab|mesh-list
102648554|NCT04435691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102648555|NCT04435691|Antimetabolites|antimetabolites|mesh-ancestor
101937197|NCT02992132|Serotonin Agents|serotonin agents|mesh-ancestor
102648556|NCT04435691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648557|NCT04435691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648558|NCT04435691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648559|NCT04435691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102648560|NCT04432506|Cyclophosphamide|cyclophosphamide|mesh-list
102648561|NCT04432506|Fludarabine|fludarabine|mesh-list
102648562|NCT04432506|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
102648563|NCT04432506|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102648564|NCT04432506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102648565|NCT04432506|Immunologic Factors|immunologic factors|mesh-ancestor
102648566|NCT04432506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648567|NCT04432506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102648568|NCT04432506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102648569|NCT04432506|Alkylating Agents|alkylating agents|mesh-ancestor
102648570|NCT04432506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648571|NCT04432506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648572|NCT04432506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102648573|NCT04432506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102648574|NCT04424303|Tofacitinib|tofacitinib|mesh-list
102648575|NCT04424303|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102648576|NCT04424303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102648577|NCT04424303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648578|NCT04424303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648579|NCT04422652|Bupropion|bupropion|mesh-list
102648580|NCT04422652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102648581|NCT04422652|Antidepressive Agents|antidepressive agents|mesh-ancestor
102648582|NCT04422652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102648583|NCT04422652|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102648584|NCT04422652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102648585|NCT04422652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102648586|NCT04422652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648587|NCT04422652|Dopamine Agents|dopamine agents|mesh-ancestor
102648588|NCT04422652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102648589|NCT04422652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648590|NCT04422652|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102648591|NCT04422652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102648592|NCT04422652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648593|NCT04394858|Temozolomide|temozolomide|mesh-list
102648594|NCT04394858|Olaparib|olaparib|mesh-list
102648595|NCT04394858|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102648596|NCT04394858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102648597|NCT04394858|Alkylating Agents|alkylating agents|mesh-ancestor
102648598|NCT04394858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648599|NCT04394858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648600|NCT04394858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648601|NCT04389632|Pembrolizumab|pembrolizumab|mesh-list
102648602|NCT04389632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102648603|NCT04389632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648604|NCT04389632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102648605|NCT04389632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648606|NCT04384692|Mycophenolic Acid|mycophenolic acid|mesh-list
102648607|NCT04384692|Cyclophosphamide|cyclophosphamide|mesh-list
102648608|NCT04384692|Melphalan|melphalan|mesh-list
102648609|NCT04384692|Busulfan|busulfan|mesh-list
102648610|NCT04384692|Mechlorethamine|mechlorethamine|mesh-list
102648611|NCT04384692|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102648612|NCT04384692|Methotrexate|methotrexate|mesh-list
102648613|NCT04384692|Fludarabine|fludarabine|mesh-list
102648614|NCT04384692|Tacrolimus|tacrolimus|mesh-list
102648615|NCT04384692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102648616|NCT04384692|Immunologic Factors|immunologic factors|mesh-ancestor
102648617|NCT04384692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648618|NCT04384692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102648619|NCT04384692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102648620|NCT04384692|Alkylating Agents|alkylating agents|mesh-ancestor
102648621|NCT04384692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648622|NCT04384692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648623|NCT04384692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102648624|NCT04384692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102648625|NCT04384692|Abortifacient Agents|abortifacient agents|mesh-ancestor
102648626|NCT04384692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102648627|NCT04384692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102648628|NCT04384692|Antimetabolites|antimetabolites|mesh-ancestor
102648629|NCT04384692|Dermatologic Agents|dermatologic agents|mesh-ancestor
102648630|NCT04384692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648631|NCT04384692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102648632|NCT04384692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102648633|NCT04384692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102648634|NCT04384692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102648635|NCT04384692|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102648636|NCT04384692|Antitubercular Agents|antitubercular agents|mesh-ancestor
102648637|NCT04384692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102648638|NCT04384692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102648639|NCT04381832|Docetaxel|docetaxel|mesh-list
102648640|NCT04381832|Quemliclustat|quemliclustat|mesh-list
102648641|NCT04381832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648642|NCT04381832|Tubulin Modulators|tubulin modulators|mesh-ancestor
102648643|NCT04381832|Antimitotic Agents|antimitotic agents|mesh-ancestor
102648644|NCT04381832|Mitosis Modulators|mitosis modulators|mesh-ancestor
102648645|NCT04381832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648646|NCT04381832|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102648647|NCT04381832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102648648|NCT04380636|Paclitaxel|paclitaxel|mesh-list
102648649|NCT04380636|Etoposide|etoposide|mesh-list
102648650|NCT04380636|Carboplatin|carboplatin|mesh-list
102648651|NCT04380636|Pembrolizumab|pembrolizumab|mesh-list
102648652|NCT04380636|Pemetrexed|pemetrexed|mesh-list
102648653|NCT04380636|Durvalumab|durvalumab|mesh-list
102648654|NCT04380636|Olaparib|olaparib|mesh-list
102648655|NCT04380636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102648656|NCT04380636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648657|NCT04380636|Tubulin Modulators|tubulin modulators|mesh-ancestor
102648658|NCT04380636|Antimitotic Agents|antimitotic agents|mesh-ancestor
102648659|NCT04380636|Mitosis Modulators|mitosis modulators|mesh-ancestor
102648660|NCT04380636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648661|NCT04380636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102648662|NCT04380636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102648663|NCT04380636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102648664|NCT04380636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102648665|NCT04380636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648666|NCT04380636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102648667|NCT04380636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102648668|NCT04380636|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102648669|NCT04377451|Metformin|metformin|mesh-list
102648670|NCT04377451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102648671|NCT04377451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648672|NCT04370795|Sirolimus|sirolimus|mesh-list
102648673|NCT04370795|Busulfan|busulfan|mesh-list
102648674|NCT04370795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102648675|NCT04370795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102648676|NCT04370795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102648677|NCT04370795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648678|NCT04370795|Antifungal Agents|antifungal agents|mesh-ancestor
102648679|NCT04370795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102648680|NCT04370795|Immunologic Factors|immunologic factors|mesh-ancestor
102648681|NCT04370795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648682|NCT04370795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648683|NCT04370795|Alkylating Agents|alkylating agents|mesh-ancestor
102648684|NCT04370795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102648685|NCT04370795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102648686|NCT04367311|Docetaxel|docetaxel|mesh-list
102648687|NCT04367311|Pemetrexed|pemetrexed|mesh-list
102648688|NCT04367311|Atezolizumab|atezolizumab|mesh-list
102648689|NCT04367311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648690|NCT04367311|Tubulin Modulators|tubulin modulators|mesh-ancestor
102648691|NCT04367311|Antimitotic Agents|antimitotic agents|mesh-ancestor
102648692|NCT04367311|Mitosis Modulators|mitosis modulators|mesh-ancestor
102648693|NCT04367311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648694|NCT04367311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648695|NCT04367311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102648696|NCT04367311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102275509|NCT05005637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102275510|NCT02336659|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102275511|NCT02336659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102275512|NCT02336659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275513|NCT02336659|Incretins|incretins|mesh-ancestor
102275514|NCT02336659|Hormones|hormones|mesh-ancestor
101937270|NCT05975411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102648697|NCT04367311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102648698|NCT04367311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102648699|NCT04340141|Leucovorin|leucovorin|mesh-list
102648700|NCT04340141|Fluorouracil|fluorouracil|mesh-list
102648701|NCT04340141|Oxaliplatin|oxaliplatin|mesh-list
102648702|NCT04340141|Irinotecan|irinotecan|mesh-list
102648703|NCT04340141|Calcium|calcium|mesh-list
102648704|NCT04340141|Levoleucovorin|levoleucovorin|mesh-list
102648705|NCT04340141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102648706|NCT04340141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648707|NCT04340141|Antimetabolites|antimetabolites|mesh-ancestor
102648708|NCT04340141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648709|NCT04340141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102648710|NCT04340141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648711|NCT04340141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102648712|NCT04340141|Immunologic Factors|immunologic factors|mesh-ancestor
102648713|NCT04340141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102648714|NCT04340141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102648715|NCT04340141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648716|NCT04340141|Antidotes|antidotes|mesh-ancestor
102648717|NCT04340141|Protective Agents|protective agents|mesh-ancestor
102648718|NCT04340141|Vitamin B Complex|vitamin b complex|mesh-ancestor
102648719|NCT04340141|Vitamins|vitamins|mesh-ancestor
102648720|NCT04340141|Micronutrients|micronutrients|mesh-ancestor
102648721|NCT04339751|Vorinostat|vorinostat|mesh-list
102648722|NCT04339751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648723|NCT04339751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102648724|NCT04339751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648725|NCT04339751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648726|NCT04338763|Gemcitabine|gemcitabine|mesh-list
102648727|NCT04338763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102648728|NCT04338763|Antimetabolites|antimetabolites|mesh-ancestor
102648729|NCT04338763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648730|NCT04338763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648731|NCT04329325|Dexamethasone|dexamethasone|mesh-list
102648732|NCT04329325|Methotrexate|methotrexate|mesh-list
102648733|NCT04329325|Dasatinib|dasatinib|mesh-list
102648734|NCT04329325|Blinatumomab|blinatumomab|mesh-list
102648735|NCT04329325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102648736|NCT04329325|Antiemetics|antiemetics|mesh-ancestor
102648737|NCT04329325|Autonomic Agents|autonomic agents|mesh-ancestor
102648738|NCT04329325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102648739|NCT04329325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648740|NCT04329325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102648741|NCT04329325|Glucocorticoids|glucocorticoids|mesh-ancestor
102648742|NCT04329325|Hormones|hormones|mesh-ancestor
102648743|NCT04329325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102648744|NCT04329325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102648745|NCT04329325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648746|NCT04329325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102648747|NCT04329325|Abortifacient Agents|abortifacient agents|mesh-ancestor
102648748|NCT04329325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102648749|NCT04329325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102648750|NCT04329325|Antimetabolites|antimetabolites|mesh-ancestor
102648751|NCT04329325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648752|NCT04329325|Dermatologic Agents|dermatologic agents|mesh-ancestor
102648753|NCT04329325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648754|NCT04329325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102648755|NCT04329325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102648756|NCT04329325|Immunologic Factors|immunologic factors|mesh-ancestor
102648757|NCT04329325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102648758|NCT04329325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102648759|NCT04329325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102648760|NCT04238819|Irinotecan|irinotecan|mesh-list
102648761|NCT04238819|Temozolomide|temozolomide|mesh-list
102648762|NCT04238819|Dinutuximab|dinutuximab|mesh-list
102648763|NCT04238819|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102648764|NCT04238819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102648765|NCT04238819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648766|NCT04238819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648767|NCT04238819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648768|NCT04238819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102648769|NCT04238819|Alkylating Agents|alkylating agents|mesh-ancestor
102648770|NCT04221542|Docetaxel|docetaxel|mesh-list
102648771|NCT04221542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648772|NCT04221542|Tubulin Modulators|tubulin modulators|mesh-ancestor
102648773|NCT04221542|Antimitotic Agents|antimitotic agents|mesh-ancestor
102648774|NCT04221542|Mitosis Modulators|mitosis modulators|mesh-ancestor
101937418|NCT05974501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648775|NCT04221542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648776|NCT04216329|Temozolomide|temozolomide|mesh-list
102648777|NCT04216329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102648778|NCT04216329|Alkylating Agents|alkylating agents|mesh-ancestor
102648779|NCT04216329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648780|NCT04216329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648781|NCT04209946|Pulmonary Surfactants|pulmonary surfactants|mesh-list
102648782|NCT04209946|Respiratory System Agents|respiratory system agents|mesh-ancestor
102648784|NCT04206319|Fluorides|fluorides|mesh-list
102648785|NCT04206319|Sodium Fluoride|sodium fluoride|mesh-list
102648786|NCT04206319|Cariostatic Agents|cariostatic agents|mesh-ancestor
102648787|NCT04206319|Protective Agents|protective agents|mesh-ancestor
102648788|NCT04206319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648789|NCT04206319|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102648790|NCT04206319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102648791|NCT04190056|Tamoxifen|tamoxifen|mesh-list
102648792|NCT04190056|Pembrolizumab|pembrolizumab|mesh-list
102648793|NCT04190056|Vorinostat|vorinostat|mesh-list
102648794|NCT04190056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102648795|NCT04190056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648796|NCT04190056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102648797|NCT04190056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648798|NCT04190056|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102648799|NCT04190056|Hormone Antagonists|hormone antagonists|mesh-ancestor
102648800|NCT04190056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102648801|NCT04190056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648802|NCT04190056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102648803|NCT04190056|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102648804|NCT04190056|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102648805|NCT04190056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102648806|NCT04190056|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102648807|NCT04190056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648808|NCT04189757|Acalabrutinib|acalabrutinib|mesh-list
102648809|NCT04189757|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102648810|NCT04189757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648811|NCT04189757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102648812|NCT04189757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648813|NCT04189757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648814|NCT04149964|Acetaminophen|acetaminophen|mesh-list
102648815|NCT04149964|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
102648816|NCT04149964|Oxycodone|oxycodone|mesh-list
102648817|NCT04149964|Hydrocodone|hydrocodone|mesh-list
102648818|NCT04149964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102648819|NCT04149964|Analgesics|analgesics|mesh-ancestor
102648820|NCT04149964|Sensory System Agents|sensory system agents|mesh-ancestor
102648821|NCT04149964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102648822|NCT04149964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648823|NCT04149964|Antipyretics|antipyretics|mesh-ancestor
102648824|NCT04149964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102648825|NCT04149964|Narcotics|narcotics|mesh-ancestor
102648826|NCT04149964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102648827|NCT04149964|Antitussive Agents|antitussive agents|mesh-ancestor
102648828|NCT04149964|Respiratory System Agents|respiratory system agents|mesh-ancestor
102648829|NCT04149964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102648830|NCT04149964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102648831|NCT04149964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102648832|NCT04137107|Oxaliplatin|oxaliplatin|mesh-list
102648833|NCT04137107|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102648834|NCT04137107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648835|NCT04137107|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102648836|NCT04137107|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102648837|NCT04137107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102648838|NCT04137107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648839|NCT04137107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102648840|NCT04137107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648841|NCT04137107|Analgesics|analgesics|mesh-ancestor
102648842|NCT04137107|Sensory System Agents|sensory system agents|mesh-ancestor
102648843|NCT04137107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102648844|NCT04137107|Antidepressive Agents|antidepressive agents|mesh-ancestor
102648845|NCT04137107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101937495|NCT05974267|Antimetabolites|antimetabolites|mesh-ancestor
102648846|NCT04137107|Dopamine Agents|dopamine agents|mesh-ancestor
102648848|NCT04131504|Infliximab|infliximab|mesh-list
102648849|NCT04131504|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102648850|NCT04131504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102648851|NCT04131504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102648852|NCT04131504|Dermatologic Agents|dermatologic agents|mesh-ancestor
102648853|NCT04131504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102648854|NCT04109066|Paclitaxel|paclitaxel|mesh-list
102648855|NCT04109066|Cyclophosphamide|cyclophosphamide|mesh-list
102648856|NCT04109066|Nivolumab|nivolumab|mesh-list
102648857|NCT04109066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102648858|NCT04109066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648859|NCT04109066|Tubulin Modulators|tubulin modulators|mesh-ancestor
102648860|NCT04109066|Antimitotic Agents|antimitotic agents|mesh-ancestor
102648861|NCT04109066|Mitosis Modulators|mitosis modulators|mesh-ancestor
102648862|NCT04109066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648863|NCT04109066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102648864|NCT04109066|Immunologic Factors|immunologic factors|mesh-ancestor
102648865|NCT04109066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648866|NCT04109066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102648867|NCT04109066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102648868|NCT04109066|Alkylating Agents|alkylating agents|mesh-ancestor
102648869|NCT04109066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102648870|NCT04109066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102648871|NCT04109066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102648872|NCT04102436|Aldesleukin|aldesleukin|mesh-list
102648873|NCT04102436|Cyclophosphamide|cyclophosphamide|mesh-list
102648874|NCT04102436|Fludarabine|fludarabine|mesh-list
102648875|NCT04102436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102648876|NCT04102436|Immunologic Factors|immunologic factors|mesh-ancestor
102648877|NCT04102436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648878|NCT04102436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102648879|NCT04102436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102648880|NCT04102436|Alkylating Agents|alkylating agents|mesh-ancestor
102648881|NCT04102436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648882|NCT04102436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648883|NCT04102436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102648884|NCT04102436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102648885|NCT04102436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102648886|NCT04102436|Antiviral Agents|antiviral agents|mesh-ancestor
102648887|NCT04102436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102648888|NCT04094688|Vitamin D|vitamin d|mesh-list
102648889|NCT04094688|Cholecalciferol|cholecalciferol|mesh-list
102648890|NCT04094688|Leucovorin|leucovorin|mesh-list
102648891|NCT04094688|Bevacizumab|bevacizumab|mesh-list
102648892|NCT04094688|Fluorouracil|fluorouracil|mesh-list
102648893|NCT04094688|Oxaliplatin|oxaliplatin|mesh-list
102648894|NCT04094688|Irinotecan|irinotecan|mesh-list
102648895|NCT04094688|Levoleucovorin|levoleucovorin|mesh-list
102648896|NCT04094688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102648897|NCT04094688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648898|NCT04094688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102648899|NCT04094688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102648900|NCT04094688|Growth Substances|growth substances|mesh-ancestor
102648901|NCT04094688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648902|NCT04094688|Growth Inhibitors|growth inhibitors|mesh-ancestor
102648903|NCT04094688|Vitamins|vitamins|mesh-ancestor
102648904|NCT04094688|Micronutrients|micronutrients|mesh-ancestor
102648905|NCT04094688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102648906|NCT04094688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102648907|NCT04094688|Antimetabolites|antimetabolites|mesh-ancestor
102648908|NCT04094688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648909|NCT04094688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102648910|NCT04094688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102648911|NCT04094688|Immunologic Factors|immunologic factors|mesh-ancestor
102648912|NCT04094688|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102648913|NCT04094688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102648914|NCT04094688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648915|NCT04094688|Antidotes|antidotes|mesh-ancestor
102648916|NCT04094688|Protective Agents|protective agents|mesh-ancestor
102648917|NCT04094688|Vitamin B Complex|vitamin b complex|mesh-ancestor
102648918|NCT04092283|Paclitaxel|paclitaxel|mesh-list
102648919|NCT04092283|Etoposide|etoposide|mesh-list
102648920|NCT04092283|Podophyllotoxin|podophyllotoxin|mesh-list
102648921|NCT04092283|Cisplatin|cisplatin|mesh-list
102648922|NCT04092283|Carboplatin|carboplatin|mesh-list
102648923|NCT04092283|Pemetrexed|pemetrexed|mesh-list
102648924|NCT04092283|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102648925|NCT04092283|Etoposide phosphate|etoposide phosphate|mesh-list
102648926|NCT04092283|Durvalumab|durvalumab|mesh-list
102648927|NCT04092283|Immunoglobulins|immunoglobulins|mesh-list
102648928|NCT04092283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102648929|NCT04092283|Immunoglobulin G|immunoglobulin g|mesh-list
102648930|NCT04092283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102648931|NCT04092283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648932|NCT04092283|Tubulin Modulators|tubulin modulators|mesh-ancestor
102648933|NCT04092283|Antimitotic Agents|antimitotic agents|mesh-ancestor
102648934|NCT04092283|Mitosis Modulators|mitosis modulators|mesh-ancestor
102648935|NCT04092283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648936|NCT04092283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102648937|NCT04092283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102648938|NCT04092283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648939|NCT04092283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102648940|NCT04092283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102648941|NCT04092283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102648942|NCT04092283|Immunologic Factors|immunologic factors|mesh-ancestor
102648943|NCT04092283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648944|NCT04092283|Keratolytic Agents|keratolytic agents|mesh-ancestor
102648945|NCT04092283|Dermatologic Agents|dermatologic agents|mesh-ancestor
102648946|NCT04082572|Pembrolizumab|pembrolizumab|mesh-list
102648947|NCT04082572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102648948|NCT04082572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648949|NCT04082572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102648950|NCT04082572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648951|NCT04076579|Olaparib|olaparib|mesh-list
102648952|NCT04076579|Trabectedin|trabectedin|mesh-list
102648953|NCT04076579|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102648954|NCT04076579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648955|NCT04076579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648956|NCT04076579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648957|NCT04076579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102648958|NCT04076579|Alkylating Agents|alkylating agents|mesh-ancestor
102648959|NCT04071366|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
102648960|NCT04071366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102648961|NCT04071366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648962|NCT04053322|Durvalumab|durvalumab|mesh-list
102648963|NCT04053322|Fulvestrant|fulvestrant|mesh-list
102648964|NCT04053322|Olaparib|olaparib|mesh-list
102648965|NCT04053322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102648966|NCT04053322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648967|NCT04053322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102648968|NCT04053322|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102648969|NCT04053322|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102648970|NCT04053322|Hormone Antagonists|hormone antagonists|mesh-ancestor
102648971|NCT04053322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102648972|NCT04053322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648973|NCT04053322|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102648974|NCT04053322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102648975|NCT04053322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648976|NCT04049110|Dapagliflozin|dapagliflozin|mesh-list
102648977|NCT04049110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102648978|NCT04049110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648979|NCT04049110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102648980|NCT04049110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102648981|NCT04034251|Paclitaxel|paclitaxel|mesh-list
102648982|NCT04034251|Capecitabine|capecitabine|mesh-list
102648983|NCT04034251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102648984|NCT04034251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648985|NCT04034251|Tubulin Modulators|tubulin modulators|mesh-ancestor
102648986|NCT04034251|Antimitotic Agents|antimitotic agents|mesh-ancestor
102648987|NCT04034251|Mitosis Modulators|mitosis modulators|mesh-ancestor
102648988|NCT04034251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102648989|NCT04034251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102648990|NCT04034251|Antimetabolites|antimetabolites|mesh-ancestor
102648991|NCT04025879|Paclitaxel|paclitaxel|mesh-list
102648992|NCT04025879|Docetaxel|docetaxel|mesh-list
102648993|NCT04025879|Carboplatin|carboplatin|mesh-list
102648994|NCT04025879|Nivolumab|nivolumab|mesh-list
102648995|NCT04025879|Pemetrexed|pemetrexed|mesh-list
101937569|NCT05953766|Anesthetics, Local|anesthetics, local|mesh-ancestor
102648996|NCT04025879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102648997|NCT04025879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102648998|NCT04025879|Tubulin Modulators|tubulin modulators|mesh-ancestor
102648999|NCT04025879|Antimitotic Agents|antimitotic agents|mesh-ancestor
102649000|NCT04025879|Mitosis Modulators|mitosis modulators|mesh-ancestor
102649001|NCT04025879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649002|NCT04025879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102649003|NCT04025879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102649004|NCT04025879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102649005|NCT04025879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102649006|NCT04025879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102649007|NCT04022239|Mycophenolic Acid|mycophenolic acid|mesh-list
102649008|NCT04022239|Cyclophosphamide|cyclophosphamide|mesh-list
102649009|NCT04022239|Melphalan|melphalan|mesh-list
102649010|NCT04022239|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102649011|NCT04022239|Mechlorethamine|mechlorethamine|mesh-list
102649012|NCT04022239|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102649013|NCT04022239|Rituximab|rituximab|mesh-list
102649014|NCT04022239|Fludarabine|fludarabine|mesh-list
102649015|NCT04022239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102649016|NCT04022239|Tacrolimus|tacrolimus|mesh-list
102649017|NCT04022239|Antibodies|antibodies|mesh-list
102649018|NCT04022239|Immunoglobulins|immunoglobulins|mesh-list
102649019|NCT04022239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102649020|NCT04022239|Lenograstim|lenograstim|mesh-list
102649021|NCT04022239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102649022|NCT04022239|Immunologic Factors|immunologic factors|mesh-ancestor
102649023|NCT04022239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649024|NCT04022239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102649025|NCT04022239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102649026|NCT04022239|Alkylating Agents|alkylating agents|mesh-ancestor
102649027|NCT04022239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649028|NCT04022239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649029|NCT04022239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102649030|NCT04022239|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102649031|NCT04022239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102649032|NCT04022239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102649033|NCT04022239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102649034|NCT04022239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102649035|NCT04022239|Antitubercular Agents|antitubercular agents|mesh-ancestor
102649036|NCT04022239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102649037|NCT04022239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102649038|NCT04015180|Aflibercept|aflibercept|mesh-list
102649039|NCT04015180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102649040|NCT04015180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102649041|NCT04015180|Growth Substances|growth substances|mesh-ancestor
102649042|NCT04015180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649043|NCT04015180|Growth Inhibitors|growth inhibitors|mesh-ancestor
102649044|NCT04015180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649045|NCT03994796|Adagrasib|adagrasib|mesh-list
102649046|NCT03994796|Entrectinib|entrectinib|mesh-list
102649047|NCT03994796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102649048|NCT03994796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102649049|NCT03994796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649050|NCT03994796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649051|NCT03989466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102649052|NCT03989466|Alemtuzumab|alemtuzumab|mesh-list
102649053|NCT03989466|Antibodies|antibodies|mesh-list
102649054|NCT03989466|Immunoglobulins|immunoglobulins|mesh-list
102649055|NCT03989466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102649056|NCT03989466|Immunologic Factors|immunologic factors|mesh-ancestor
102649057|NCT03989466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649058|NCT03989466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649059|NCT03974932|Acetaminophen|acetaminophen|mesh-list
102649060|NCT03974932|Ibuprofen|ibuprofen|mesh-list
102649061|NCT03974932|Celecoxib|celecoxib|mesh-list
102649062|NCT03974932|Bupivacaine|bupivacaine|mesh-list
102649063|NCT03974932|Anesthetics, Local|anesthetics, local|mesh-ancestor
102649064|NCT03974932|Anesthetics|anesthetics|mesh-ancestor
102649065|NCT03974932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102649066|NCT03974932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649067|NCT03974932|Sensory System Agents|sensory system agents|mesh-ancestor
102649068|NCT03974932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102275515|NCT02336659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102649069|NCT03974932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102649070|NCT03974932|Analgesics|analgesics|mesh-ancestor
102649071|NCT03974932|Antipyretics|antipyretics|mesh-ancestor
102649072|NCT03974932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102275516|NCT02336659|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102649073|NCT03974932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102649074|NCT03974932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102649075|NCT03974932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102649076|NCT03974932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102649077|NCT03974932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649078|NCT03974932|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102649079|NCT03944941|Cetuximab|cetuximab|mesh-list
102649080|NCT03944941|Avelumab|avelumab|mesh-list
102649081|NCT03944941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102649082|NCT03944941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649083|NCT03910244|Pomalidomide|pomalidomide|mesh-list
102649084|NCT03910244|Immunologic Factors|immunologic factors|mesh-ancestor
102649085|NCT03910244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649086|NCT03910244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102649087|NCT03910244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102649088|NCT03910244|Growth Substances|growth substances|mesh-ancestor
102649089|NCT03910244|Growth Inhibitors|growth inhibitors|mesh-ancestor
102649090|NCT03910244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649091|NCT03899155|Nivolumab|nivolumab|mesh-list
102649092|NCT03899155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102649093|NCT03899155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649094|NCT03899155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102649095|NCT03899155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649096|NCT03856515|Nicotine|nicotine|mesh-list
102649097|NCT03856515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102649098|NCT03856515|Autonomic Agents|autonomic agents|mesh-ancestor
102649099|NCT03856515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102649100|NCT03856515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649101|NCT03856515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102649102|NCT03856515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102649103|NCT03856515|Cholinergic Agents|cholinergic agents|mesh-ancestor
102649104|NCT03856515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102649105|NCT03856515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649106|NCT03789240|Rituximab|rituximab|mesh-list
102649107|NCT03789240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102649108|NCT03789240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649109|NCT03789240|Immunologic Factors|immunologic factors|mesh-ancestor
102649110|NCT03789240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649111|NCT03789240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102649112|NCT03784326|Fluorouracil|fluorouracil|mesh-list
102649113|NCT03784326|Oxaliplatin|oxaliplatin|mesh-list
102649114|NCT03784326|Atezolizumab|atezolizumab|mesh-list
102649115|NCT03784326|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102649116|NCT03784326|Antimetabolites|antimetabolites|mesh-ancestor
102649117|NCT03784326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649118|NCT03784326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101304591|NCT02013089|Sorafenib|sorafenib|mesh-list
102649119|NCT03784326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649120|NCT03784326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102649121|NCT03784326|Immunologic Factors|immunologic factors|mesh-ancestor
102649122|NCT03784326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649123|NCT03784326|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102649124|NCT03784326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102649125|NCT03777813|Leucovorin|leucovorin|mesh-list
102649126|NCT03777813|Oxaliplatin|oxaliplatin|mesh-list
102649127|NCT03777813|Durvalumab|durvalumab|mesh-list
102649128|NCT03777813|Levoleucovorin|levoleucovorin|mesh-list
102649129|NCT03777813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649130|NCT03777813|Antidotes|antidotes|mesh-ancestor
102649131|NCT03777813|Protective Agents|protective agents|mesh-ancestor
102649132|NCT03777813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649133|NCT03777813|Vitamin B Complex|vitamin b complex|mesh-ancestor
102649134|NCT03777813|Vitamins|vitamins|mesh-ancestor
102649135|NCT03777813|Micronutrients|micronutrients|mesh-ancestor
102649136|NCT03777813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102649137|NCT03761095|Dacarbazine|dacarbazine|mesh-list
102649138|NCT03761095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102649139|NCT03761095|Alkylating Agents|alkylating agents|mesh-ancestor
102649140|NCT03761095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649141|NCT03761095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649142|NCT03754933|Fludarabine|fludarabine|mesh-list
102649143|NCT03754933|Fludarabine phosphate|fludarabine phosphate|mesh-list
102649144|NCT03754933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649145|NCT03754933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102649146|NCT03754933|Antimetabolites|antimetabolites|mesh-ancestor
102649147|NCT03754933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649148|NCT03754933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102649149|NCT03754933|Immunologic Factors|immunologic factors|mesh-ancestor
102649150|NCT03754933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649151|NCT03733067|Abatacept|abatacept|mesh-list
102649152|NCT03733067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102649153|NCT03733067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649154|NCT03733067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102649155|NCT03733067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649156|NCT03733067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102649157|NCT03733067|Immunologic Factors|immunologic factors|mesh-ancestor
102649158|NCT03733067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649159|NCT03733067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102649160|NCT03725878|Folic Acid|folic acid|mesh-list
102649161|NCT03725878|Hematinics|hematinics|mesh-ancestor
102649162|NCT03725878|Vitamin B Complex|vitamin b complex|mesh-ancestor
102649163|NCT03725878|Vitamins|vitamins|mesh-ancestor
102649164|NCT03725878|Micronutrients|micronutrients|mesh-ancestor
102649165|NCT03725878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649166|NCT03718767|Nivolumab|nivolumab|mesh-list
102649167|NCT03718767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102649168|NCT03718767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649169|NCT03718767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102649170|NCT03718767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649171|NCT03717896|Thiamine|thiamine|mesh-list
102649172|NCT03717896|Vitamins|vitamins|mesh-ancestor
102649173|NCT03717896|Micronutrients|micronutrients|mesh-ancestor
102649174|NCT03717896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649175|NCT03717896|Vitamin B Complex|vitamin b complex|mesh-ancestor
102649176|NCT03694262|Bevacizumab|bevacizumab|mesh-list
102649177|NCT03694262|Atezolizumab|atezolizumab|mesh-list
102649178|NCT03694262|Rucaparib|rucaparib|mesh-list
102649179|NCT03694262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102649180|NCT03694262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649181|NCT03694262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102649182|NCT03694262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102649183|NCT03694262|Growth Substances|growth substances|mesh-ancestor
102649184|NCT03694262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649185|NCT03694262|Growth Inhibitors|growth inhibitors|mesh-ancestor
102649186|NCT03694262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102649187|NCT03694262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649188|NCT03694262|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102649189|NCT03694262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102649190|NCT03639935|Nivolumab|nivolumab|mesh-list
102649191|NCT03639935|Rucaparib|rucaparib|mesh-list
102649192|NCT03639935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102649193|NCT03639935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649194|NCT03639935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102649195|NCT03639935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649196|NCT03639935|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102649197|NCT03639935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102649198|NCT03634241|Pembrolizumab|pembrolizumab|mesh-list
102649199|NCT03634241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102649200|NCT03634241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649201|NCT03634241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102649202|NCT03634241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649203|NCT03624231|Durvalumab|durvalumab|mesh-list
102649204|NCT03624231|Tremelimumab|tremelimumab|mesh-list
102649205|NCT03624231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102649206|NCT03624231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649207|NCT03609216|Gemcitabine|gemcitabine|mesh-list
102649208|NCT03609216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649209|NCT03609216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102649210|NCT03609216|Antimetabolites|antimetabolites|mesh-ancestor
102649211|NCT03609216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649212|NCT03604315|Deoxyglucose|deoxyglucose|mesh-list
102649213|NCT03604315|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102649214|NCT03604315|Fluorides|fluorides|mesh-list
102275517|NCT02336659|Protease Inhibitors|protease inhibitors|mesh-ancestor
102275518|NCT02336659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102275519|NCT02336659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275520|NCT03081923|Durvalumab|durvalumab|mesh-list
102275521|NCT03081923|Tremelimumab|tremelimumab|mesh-list
102275522|NCT03081923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102275523|NCT03081923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102275524|NCT02341105|Amiodarone|amiodarone|mesh-list
102649215|NCT03604315|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102649216|NCT03604315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649217|NCT03604315|Cariostatic Agents|cariostatic agents|mesh-ancestor
102649218|NCT03604315|Protective Agents|protective agents|mesh-ancestor
102649219|NCT03604315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649220|NCT03604315|Antimetabolites|antimetabolites|mesh-ancestor
102649221|NCT03604315|Antiviral Agents|antiviral agents|mesh-ancestor
102649222|NCT03604315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102649223|NCT03587961|Ivacaftor|ivacaftor|mesh-list
102649224|NCT03587961|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102649225|NCT03587961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102649226|NCT03587961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649227|NCT03565783|Cemiplimab|cemiplimab|mesh-list
102649228|NCT03565783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102649229|NCT03565783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649230|NCT03564509|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102649231|NCT03564509|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102649232|NCT03564509|Hormones|hormones|mesh-ancestor
102649233|NCT03564509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102649234|NCT03564509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649235|NCT03564509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102649236|NCT03556384|Temozolomide|temozolomide|mesh-list
102649237|NCT03556384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102649238|NCT03556384|Alkylating Agents|alkylating agents|mesh-ancestor
102649239|NCT03556384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649240|NCT03556384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649241|NCT03528694|Durvalumab|durvalumab|mesh-list
102649242|NCT03528694|BCG Vaccine|bcg vaccine|mesh-list
102649243|NCT03528694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102649244|NCT03528694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649245|NCT03528694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102649246|NCT03528694|Immunologic Factors|immunologic factors|mesh-ancestor
101371088|NCT00188227|Anesthetics|anesthetics|mesh-ancestor
102649247|NCT03528694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649248|NCT03523858|Ocrelizumab|ocrelizumab|mesh-list
102649249|NCT03523858|Immunologic Factors|immunologic factors|mesh-ancestor
102649250|NCT03523858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649251|NCT03520660|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102649252|NCT03520660|Antiviral Agents|antiviral agents|mesh-ancestor
102649253|NCT03520660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102649254|NCT03486197|Pembrolizumab|pembrolizumab|mesh-list
102649255|NCT03486197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102649256|NCT03486197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649257|NCT03486197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102649258|NCT03486197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649259|NCT03477500|Cyclophosphamide|cyclophosphamide|mesh-list
102649260|NCT03477500|Alemtuzumab|alemtuzumab|mesh-list
102649261|NCT03477500|Cladribine|cladribine|mesh-list
102275525|NCT02341105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
102275526|NCT02341105|Vasodilator Agents|vasodilator agents|mesh-ancestor
102275527|NCT02341105|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102275528|NCT02341105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102275529|NCT02341105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275530|NCT02341105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102275531|NCT02341105|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102275532|NCT02341105|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102275533|NCT02341105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102275534|NCT02341105|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102275535|NCT02341105|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102275536|NCT02341105|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102275537|NCT03078101|Empagliflozin|empagliflozin|mesh-list
102275538|NCT03078101|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102275539|NCT03078101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275540|NCT03078101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102275541|NCT03078101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275542|NCT02345239|Pantoprazole|pantoprazole|mesh-list
102275543|NCT02345239|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102275544|NCT02345239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102275545|NCT02345239|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102275546|NCT02345239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102275547|NCT02345239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275548|NCT04688203|Magnesium Sulfate|magnesium sulfate|mesh-list
102275549|NCT04688203|Labetalol|labetalol|mesh-list
102649263|NCT03477500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102649264|NCT03477500|Immunologic Factors|immunologic factors|mesh-ancestor
102649265|NCT03477500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649266|NCT03477500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102649267|NCT03477500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102649268|NCT03477500|Alkylating Agents|alkylating agents|mesh-ancestor
102649269|NCT03477500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649270|NCT03477500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649271|NCT03477500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102649272|NCT03477500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102649273|NCT03467958|Ozanimod|ozanimod|mesh-list
102649274|NCT03467958|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102649275|NCT03467958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649276|NCT03467958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102649277|NCT03467958|Immunologic Factors|immunologic factors|mesh-ancestor
102649278|NCT03467958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649279|NCT03464097|Ozanimod|ozanimod|mesh-list
102649280|NCT03464097|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102649281|NCT03464097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649282|NCT03464097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102649283|NCT03464097|Immunologic Factors|immunologic factors|mesh-ancestor
102649284|NCT03464097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649285|NCT03440372|Ozanimod|ozanimod|mesh-list
101371153|NCT00409318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102649286|NCT03440372|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102649287|NCT03440372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649288|NCT03440372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102649289|NCT03440372|Immunologic Factors|immunologic factors|mesh-ancestor
102649290|NCT03440372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649291|NCT03422822|Abrocitinib|abrocitinib|mesh-list
102649292|NCT03422822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102649293|NCT03422822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102649294|NCT03422822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649295|NCT03348670|Prednisone|prednisone|mesh-list
102649296|NCT03348670|Abiraterone Acetate|abiraterone acetate|mesh-list
102649297|NCT03348670|Relugolix|relugolix|mesh-list
102649298|NCT03348670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102649299|NCT03348670|Glucocorticoids|glucocorticoids|mesh-ancestor
102649300|NCT03348670|Hormones|hormones|mesh-ancestor
102649301|NCT03348670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102649302|NCT03348670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649303|NCT03348670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102649304|NCT03348670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649305|NCT03348670|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102649306|NCT03348670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102649307|NCT03348670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649308|NCT03348670|Hormone Antagonists|hormone antagonists|mesh-ancestor
102649309|NCT03348670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102649310|NCT03348670|Androgen Antagonists|androgen antagonists|mesh-ancestor
102649311|NCT03259503|Rituximab|rituximab|mesh-list
102649312|NCT03259503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102649313|NCT03259503|Gemcitabine|gemcitabine|mesh-list
102649314|NCT03259503|Melphalan|melphalan|mesh-list
102649315|NCT03259503|Busulfan|busulfan|mesh-list
102649316|NCT03259503|Olaparib|olaparib|mesh-list
102649317|NCT03259503|Mechlorethamine|mechlorethamine|mesh-list
102649318|NCT03259503|Vorinostat|vorinostat|mesh-list
102649319|NCT03259503|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102649320|NCT03259503|Antibodies|antibodies|mesh-list
102649321|NCT03259503|Immunoglobulins|immunoglobulins|mesh-list
102649322|NCT03259503|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102649323|NCT03259503|Immunologic Factors|immunologic factors|mesh-ancestor
102649324|NCT03259503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649325|NCT03259503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649326|NCT03259503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102649327|NCT03259503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102649328|NCT03259503|Antimetabolites|antimetabolites|mesh-ancestor
102649329|NCT03259503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649330|NCT03259503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102649331|NCT03259503|Alkylating Agents|alkylating agents|mesh-ancestor
102649332|NCT03259503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102649333|NCT03259503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102275550|NCT04688203|Analgesics|analgesics|mesh-ancestor
101937909|NCT04968951|Vancomycin|vancomycin|mesh-list
102275551|NCT04688203|Sensory System Agents|sensory system agents|mesh-ancestor
102275552|NCT04688203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102275553|NCT04688203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275554|NCT04688203|Anesthetics|anesthetics|mesh-ancestor
102275555|NCT04688203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102275556|NCT04688203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102275557|NCT04688203|Anticonvulsants|anticonvulsants|mesh-ancestor
102275558|NCT04688203|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102275559|NCT04688203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102649334|NCT03259503|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102649335|NCT03259503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102649336|NCT03259503|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102649337|NCT03242915|Carboplatin|carboplatin|mesh-list
102649338|NCT03242915|Pembrolizumab|pembrolizumab|mesh-list
102649339|NCT03242915|Pemetrexed|pemetrexed|mesh-list
102649340|NCT03242915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649341|NCT03242915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102649342|NCT03242915|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102649343|NCT03242915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649344|NCT03242915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101304614|NCT02014337|Mifepristone|mifepristone|mesh-list
102649345|NCT03242915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102649346|NCT03242915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102649347|NCT03240016|Pembrolizumab|pembrolizumab|mesh-list
102649348|NCT03240016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102649349|NCT03240016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102649350|NCT03240016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649351|NCT03240016|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102649352|NCT03240016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649353|NCT03229499|Anastrozole|anastrozole|mesh-list
102649354|NCT03229499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102649355|NCT03229499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649356|NCT03229499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102649357|NCT03229499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102649358|NCT03229499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102649359|NCT03229499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649360|NCT03229499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102649361|NCT03229499|Hormone Antagonists|hormone antagonists|mesh-ancestor
102649362|NCT03229499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102649363|NCT03229499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649364|NCT03224767|Vemurafenib|vemurafenib|mesh-list
102649365|NCT03224767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649366|NCT03224767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102649367|NCT03224767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102649368|NCT03224767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649369|NCT03223025|Hormones|hormones|mesh-list
102649370|NCT03223025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102649371|NCT03223025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649372|NCT03158129|Cisplatin|cisplatin|mesh-list
102649373|NCT03158129|Carboplatin|carboplatin|mesh-list
102649374|NCT03158129|Docetaxel|docetaxel|mesh-list
102649375|NCT03158129|Nivolumab|nivolumab|mesh-list
102649376|NCT03158129|Pemetrexed|pemetrexed|mesh-list
102649377|NCT03158129|Ipilimumab|ipilimumab|mesh-list
102649378|NCT03158129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649379|NCT03158129|Tubulin Modulators|tubulin modulators|mesh-ancestor
102649380|NCT03158129|Antimitotic Agents|antimitotic agents|mesh-ancestor
102649381|NCT03158129|Mitosis Modulators|mitosis modulators|mesh-ancestor
102649382|NCT03158129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649383|NCT03158129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102649384|NCT03158129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102649385|NCT03158129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102649386|NCT03158129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102649387|NCT03158129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102649388|NCT03150693|Cytarabine|cytarabine|mesh-list
102649389|NCT03150693|Dexamethasone|dexamethasone|mesh-list
102649390|NCT03150693|Cyclophosphamide|cyclophosphamide|mesh-list
102649391|NCT03150693|Rituximab|rituximab|mesh-list
102649392|NCT03150693|Doxorubicin|doxorubicin|mesh-list
102649393|NCT03150693|Methotrexate|methotrexate|mesh-list
102649394|NCT03150693|Vincristine|vincristine|mesh-list
102649395|NCT03150693|Daunorubicin|daunorubicin|mesh-list
102649396|NCT03150693|Asparaginase|asparaginase|mesh-list
102649397|NCT03150693|Mercaptopurine|mercaptopurine|mesh-list
102649398|NCT03150693|Thioguanine|thioguanine|mesh-list
102649399|NCT03150693|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
102649400|NCT03150693|Pegaspargase|pegaspargase|mesh-list
102649401|NCT03150693|Allopurinol|allopurinol|mesh-list
102649402|NCT03150693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102649403|NCT03150693|Immunologic Factors|immunologic factors|mesh-ancestor
102649404|NCT03150693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649405|NCT03150693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102275560|NCT04688203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275561|NCT04688203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102649406|NCT03150693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102649407|NCT03150693|Alkylating Agents|alkylating agents|mesh-ancestor
102649408|NCT03150693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649409|NCT03150693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649410|NCT03150693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102649411|NCT03150693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102649412|NCT03150693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102649413|NCT03150693|Antiemetics|antiemetics|mesh-ancestor
102649414|NCT03150693|Autonomic Agents|autonomic agents|mesh-ancestor
102649415|NCT03150693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102649416|NCT03150693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102649417|NCT03150693|Glucocorticoids|glucocorticoids|mesh-ancestor
102649418|NCT03150693|Hormones|hormones|mesh-ancestor
102649419|NCT03150693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102649420|NCT03150693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102649421|NCT03150693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102649422|NCT03150693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102649423|NCT03150693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102649424|NCT03150693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102649425|NCT03150693|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102649426|NCT03150693|Abortifacient Agents|abortifacient agents|mesh-ancestor
102649427|NCT03150693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102649428|NCT03150693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102649429|NCT03150693|Antimetabolites|antimetabolites|mesh-ancestor
102649430|NCT03150693|Dermatologic Agents|dermatologic agents|mesh-ancestor
102649431|NCT03150693|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102649432|NCT03150693|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102649433|NCT03150693|Antiviral Agents|antiviral agents|mesh-ancestor
102649434|NCT03150693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102649435|NCT03150693|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102649436|NCT03150693|Tubulin Modulators|tubulin modulators|mesh-ancestor
102649437|NCT03150693|Antimitotic Agents|antimitotic agents|mesh-ancestor
102649438|NCT03150693|Mitosis Modulators|mitosis modulators|mesh-ancestor
102649439|NCT03150693|Gout Suppressants|gout suppressants|mesh-ancestor
102649440|NCT03150693|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102649441|NCT03150693|Antioxidants|antioxidants|mesh-ancestor
102649442|NCT03150693|Protective Agents|protective agents|mesh-ancestor
102649443|NCT03150693|Immunotoxins|immunotoxins|mesh-ancestor
102649444|NCT03150693|Immunoconjugates|immunoconjugates|mesh-ancestor
102649445|NCT03132454|Dexamethasone|dexamethasone|mesh-list
102649446|NCT03132454|Dexamethasone acetate|dexamethasone acetate|mesh-list
102649447|NCT03132454|Sorafenib|sorafenib|mesh-list
102649448|NCT03132454|Decitabine|decitabine|mesh-list
102649449|NCT03132454|Palbociclib|palbociclib|mesh-list
102649450|NCT03132454|Ichthammol|ichthammol|mesh-list
102649451|NCT03132454|BB 1101|bb 1101|mesh-list
102649452|NCT03132454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102649453|NCT03132454|Antiemetics|antiemetics|mesh-ancestor
102649454|NCT03132454|Autonomic Agents|autonomic agents|mesh-ancestor
102649455|NCT03132454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102649456|NCT03132454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649457|NCT03132454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102649458|NCT03132454|Glucocorticoids|glucocorticoids|mesh-ancestor
102649459|NCT03132454|Hormones|hormones|mesh-ancestor
102649460|NCT03132454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102649461|NCT03132454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102649462|NCT03132454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649463|NCT03132454|Protease Inhibitors|protease inhibitors|mesh-ancestor
102649464|NCT03132454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102649465|NCT03132454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649466|NCT03132454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102649467|NCT03132454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102649468|NCT03132454|Antimetabolites|antimetabolites|mesh-ancestor
102649469|NCT03132454|Dermatologic Agents|dermatologic agents|mesh-ancestor
102649470|NCT03120624|Iodine|iodine|mesh-list
102649471|NCT03120624|Interferons|interferons|mesh-list
102649472|NCT03120624|Interferon-beta|interferon-beta|mesh-list
102649473|NCT03120624|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
102649474|NCT03120624|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
102649475|NCT03120624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649476|NCT03120624|Antiviral Agents|antiviral agents|mesh-ancestor
102649477|NCT03120624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102649478|NCT03120624|Immunologic Factors|immunologic factors|mesh-ancestor
102649479|NCT03120624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649480|NCT03120624|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102649481|NCT03120624|Trace Elements|trace elements|mesh-ancestor
102649482|NCT03120624|Micronutrients|micronutrients|mesh-ancestor
102649483|NCT03120624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102649484|NCT03120624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102649485|NCT03120624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649486|NCT03120624|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102649487|NCT03118037|Zaleplon|zaleplon|mesh-list
102649488|NCT03118037|Anticonvulsants|anticonvulsants|mesh-ancestor
102649489|NCT03118037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102649490|NCT03118037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102649491|NCT03118037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649492|NCT03118037|GABA Modulators|gaba modulators|mesh-ancestor
102649493|NCT03118037|GABA Agents|gaba agents|mesh-ancestor
102649494|NCT03118037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102649495|NCT03118037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649496|NCT03099356|Sirolimus|sirolimus|mesh-list
102649497|NCT03099356|Cyclophosphamide|cyclophosphamide|mesh-list
102649498|NCT03099356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102649499|NCT03099356|Immunologic Factors|immunologic factors|mesh-ancestor
102649500|NCT03099356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649501|NCT03099356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102649502|NCT03099356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102649503|NCT03099356|Alkylating Agents|alkylating agents|mesh-ancestor
102649504|NCT03099356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649505|NCT03099356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649506|NCT03099356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102649507|NCT03099356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102649508|NCT03099356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102649509|NCT03099356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102649510|NCT03099356|Antifungal Agents|antifungal agents|mesh-ancestor
102649511|NCT03092518|Sodium thiosulfate|sodium thiosulfate|mesh-list
102649512|NCT03092518|Mitomycins|mitomycins|mesh-list
102649513|NCT03092518|Mitomycin|mitomycin|mesh-list
102649514|NCT03092518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649515|NCT03092518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102649516|NCT03092518|Alkylating Agents|alkylating agents|mesh-ancestor
102649517|NCT03092518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649518|NCT03092518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102649519|NCT03092518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102649520|NCT03092518|Antidotes|antidotes|mesh-ancestor
102649521|NCT03092518|Protective Agents|protective agents|mesh-ancestor
102649522|NCT03092518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649523|NCT03092518|Antioxidants|antioxidants|mesh-ancestor
102649524|NCT03092518|Antitubercular Agents|antitubercular agents|mesh-ancestor
102649525|NCT03092518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102649526|NCT03092518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102649527|NCT03092518|Chelating Agents|chelating agents|mesh-ancestor
102649528|NCT03092518|Sequestering Agents|sequestering agents|mesh-ancestor
102649529|NCT03007030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102649530|NCT03007030|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102649531|NCT03007030|Antibodies|antibodies|mesh-list
102649532|NCT03007030|Immunoglobulins|immunoglobulins|mesh-list
102649533|NCT03007030|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102649534|NCT03007030|Immunoconjugates|immunoconjugates|mesh-list
102649535|NCT03007030|Immunologic Factors|immunologic factors|mesh-ancestor
102649536|NCT03007030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649537|NCT03007030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649538|NCT03007030|Immunotoxins|immunotoxins|mesh-ancestor
102649539|NCT02979873|Sirolimus|sirolimus|mesh-list
102649540|NCT02979873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102649541|NCT02979873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102649542|NCT02979873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102649543|NCT02979873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649544|NCT02979873|Antifungal Agents|antifungal agents|mesh-ancestor
102649545|NCT02979873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102649546|NCT02979873|Immunologic Factors|immunologic factors|mesh-ancestor
102275562|NCT04688203|Tocolytic Agents|tocolytic agents|mesh-ancestor
102275563|NCT04688203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102275564|NCT04688203|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102275565|NCT04688203|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102649547|NCT02979873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649549|NCT02960022|Abiraterone Acetate|abiraterone acetate|mesh-list
102649550|NCT02960022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102649551|NCT02960022|Glucocorticoids|glucocorticoids|mesh-ancestor
102649552|NCT02960022|Hormones|hormones|mesh-ancestor
102649553|NCT02960022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102649554|NCT02960022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649555|NCT02960022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102649556|NCT02960022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649557|NCT02960022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102649558|NCT02960022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102649559|NCT02960022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649560|NCT02960022|Hormone Antagonists|hormone antagonists|mesh-ancestor
102649561|NCT02960022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102649562|NCT02938520|Rilpivirine|rilpivirine|mesh-list
102649563|NCT02938520|Cabotegravir|cabotegravir|mesh-list
102649564|NCT02938520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102649565|NCT02938520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102649566|NCT02938520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102649567|NCT02938520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649568|NCT02938520|Antiviral Agents|antiviral agents|mesh-ancestor
102649569|NCT02938520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102649570|NCT02938520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102649571|NCT02938520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102649572|NCT02938520|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102649573|NCT02938520|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102649574|NCT02871219|Lenalidomide|lenalidomide|mesh-list
102649575|NCT02871219|Obinutuzumab|obinutuzumab|mesh-list
102649576|NCT02871219|Immunologic Factors|immunologic factors|mesh-ancestor
102649577|NCT02871219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649578|NCT02871219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102649579|NCT02871219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102649580|NCT02871219|Growth Substances|growth substances|mesh-ancestor
102649581|NCT02871219|Growth Inhibitors|growth inhibitors|mesh-ancestor
102649582|NCT02871219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649583|NCT02871219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102649584|NCT02830360|Amiodarone|amiodarone|mesh-list
102649585|NCT02830360|Sotalol|sotalol|mesh-list
102649586|NCT02830360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102649587|NCT02830360|Vasodilator Agents|vasodilator agents|mesh-ancestor
102649588|NCT02830360|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102649589|NCT02830360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102649590|NCT02830360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649591|NCT02830360|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102649592|NCT02830360|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102649593|NCT02830360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102649594|NCT02830360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102649595|NCT02830360|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102649596|NCT02830360|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102649597|NCT02830360|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102649598|NCT02830360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102649599|NCT02830360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102649600|NCT02830360|Adrenergic Agents|adrenergic agents|mesh-ancestor
102649601|NCT02830360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102649602|NCT02830360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649603|NCT02830360|Sympatholytics|sympatholytics|mesh-ancestor
102649604|NCT02830360|Autonomic Agents|autonomic agents|mesh-ancestor
102649605|NCT02830360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102649606|NCT02784210|Prednisone|prednisone|mesh-list
102649607|NCT02784210|Methylprednisolone|methylprednisolone|mesh-list
102649608|NCT02784210|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102649609|NCT02784210|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102649610|NCT02784210|Prednisolone|prednisolone|mesh-list
102649611|NCT02784210|Prednisolone acetate|prednisolone acetate|mesh-list
102649612|NCT02784210|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102649613|NCT02784210|Prednisolone phosphate|prednisolone phosphate|mesh-list
102275566|NCT04688203|Adrenergic Agents|adrenergic agents|mesh-ancestor
102275567|NCT04688203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102275568|NCT04688203|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102275569|NCT04688203|Sympathomimetics|sympathomimetics|mesh-ancestor
102275570|NCT04688203|Autonomic Agents|autonomic agents|mesh-ancestor
102275571|NCT04688203|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102275572|NCT04688203|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102275573|NCT05254561|Immunomodulating Agents|immunomodulating agents|mesh-list
102275574|NCT05254561|Immunologic Factors|immunologic factors|mesh-ancestor
102275575|NCT05254561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649614|NCT02784210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102649616|NCT02784210|Hormones|hormones|mesh-ancestor
102649617|NCT02784210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102649618|NCT02784210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649619|NCT02784210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102649620|NCT02784210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649621|NCT02784210|Antiemetics|antiemetics|mesh-ancestor
102649622|NCT02784210|Autonomic Agents|autonomic agents|mesh-ancestor
102649623|NCT02784210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102649624|NCT02784210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102649625|NCT02784210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102649626|NCT02784210|Protective Agents|protective agents|mesh-ancestor
102649627|NCT02766465|Sirolimus|sirolimus|mesh-list
102649628|NCT02766465|Methotrexate|methotrexate|mesh-list
102649629|NCT02766465|Fludarabine|fludarabine|mesh-list
102649630|NCT02766465|Melphalan|melphalan|mesh-list
102649631|NCT02766465|Busulfan|busulfan|mesh-list
102649632|NCT02766465|Alemtuzumab|alemtuzumab|mesh-list
102649633|NCT02766465|Tacrolimus|tacrolimus|mesh-list
102649634|NCT02766465|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102649635|NCT02766465|Thymoglobulin|thymoglobulin|mesh-list
102649636|NCT02766465|Lenograstim|lenograstim|mesh-list
102649637|NCT02766465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102649638|NCT02766465|Abortifacient Agents|abortifacient agents|mesh-ancestor
102649639|NCT02766465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102649640|NCT02766465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649641|NCT02766465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102649642|NCT02766465|Antimetabolites|antimetabolites|mesh-ancestor
102649643|NCT02766465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649644|NCT02766465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649645|NCT02766465|Dermatologic Agents|dermatologic agents|mesh-ancestor
102649646|NCT02766465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102649647|NCT02766465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102649648|NCT02766465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102649649|NCT02766465|Immunologic Factors|immunologic factors|mesh-ancestor
102649650|NCT02766465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102649651|NCT02766465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102649652|NCT02766465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102649653|NCT02766465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102649654|NCT02766465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102649655|NCT02766465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102649656|NCT02766465|Antifungal Agents|antifungal agents|mesh-ancestor
102649657|NCT02766465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102649658|NCT02766465|Alkylating Agents|alkylating agents|mesh-ancestor
102649659|NCT02766465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102649660|NCT02766465|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102649661|NCT02766465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102649662|NCT02764541|Tamoxifen|tamoxifen|mesh-list
102649663|NCT02764541|Letrozole|letrozole|mesh-list
102649664|NCT02764541|Palbociclib|palbociclib|mesh-list
102649665|NCT02764541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649666|NCT02764541|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102649667|NCT02764541|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102649668|NCT02764541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102649669|NCT02764541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649670|NCT02764541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102649671|NCT02764541|Hormone Antagonists|hormone antagonists|mesh-ancestor
102649672|NCT02764541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102649673|NCT02764541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649674|NCT02764541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102649675|NCT02764541|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102649676|NCT02764541|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102649677|NCT02764541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102649678|NCT02764541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102649679|NCT02720068|Leucovorin|leucovorin|mesh-list
102649680|NCT02720068|Pembrolizumab|pembrolizumab|mesh-list
102649681|NCT02720068|Fluorouracil|fluorouracil|mesh-list
102649682|NCT02720068|Oxaliplatin|oxaliplatin|mesh-list
102649683|NCT02720068|Irinotecan|irinotecan|mesh-list
102275576|NCT04509973|Dexamethasone|dexamethasone|mesh-list
102649684|NCT02720068|Lenvatinib|lenvatinib|mesh-list
102649685|NCT02720068|Calcium|calcium|mesh-list
102649686|NCT02720068|Levoleucovorin|levoleucovorin|mesh-list
102649687|NCT02720068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102649688|NCT02720068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649689|NCT02720068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102649690|NCT02720068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649691|NCT02720068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102649692|NCT02720068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649693|NCT02720068|Antimetabolites|antimetabolites|mesh-ancestor
102649694|NCT02720068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102649695|NCT02720068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102649696|NCT02720068|Immunologic Factors|immunologic factors|mesh-ancestor
102649697|NCT02720068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102649698|NCT02720068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102649699|NCT02720068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102649700|NCT02720068|Antidotes|antidotes|mesh-ancestor
102649701|NCT02720068|Protective Agents|protective agents|mesh-ancestor
102649702|NCT02720068|Vitamin B Complex|vitamin b complex|mesh-ancestor
102649703|NCT02720068|Vitamins|vitamins|mesh-ancestor
102649704|NCT02720068|Micronutrients|micronutrients|mesh-ancestor
102649705|NCT02720068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102649706|NCT02667587|Nivolumab|nivolumab|mesh-list
102649707|NCT02667587|Temozolomide|temozolomide|mesh-list
102649708|NCT02667587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102649709|NCT02667587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649710|NCT02667587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102649711|NCT02667587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649712|NCT02667587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102649713|NCT02667587|Alkylating Agents|alkylating agents|mesh-ancestor
102649714|NCT02649790|Dexamethasone|dexamethasone|mesh-list
102649715|NCT02649790|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
102649716|NCT02649790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102649717|NCT02649790|Antiemetics|antiemetics|mesh-ancestor
102649718|NCT02649790|Autonomic Agents|autonomic agents|mesh-ancestor
102649719|NCT02649790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102649720|NCT02649790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649721|NCT02649790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102649722|NCT02649790|Glucocorticoids|glucocorticoids|mesh-ancestor
102649723|NCT02649790|Hormones|hormones|mesh-ancestor
102649724|NCT02649790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102649725|NCT02649790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102649726|NCT02649790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649727|NCT02649790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102649728|NCT02649790|Antimetabolites|antimetabolites|mesh-ancestor
102649729|NCT02649790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649730|NCT02626455|Prednisone|prednisone|mesh-list
102649731|NCT02626455|Cyclophosphamide|cyclophosphamide|mesh-list
102649732|NCT02626455|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102649733|NCT02626455|Rituximab|rituximab|mesh-list
102649734|NCT02626455|Doxorubicin|doxorubicin|mesh-list
102649735|NCT02626455|Vincristine|vincristine|mesh-list
102649736|NCT02626455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102649737|NCT02626455|Immunologic Factors|immunologic factors|mesh-ancestor
102649738|NCT02626455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649739|NCT02626455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102649740|NCT02626455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102649741|NCT02626455|Alkylating Agents|alkylating agents|mesh-ancestor
102649742|NCT02626455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649743|NCT02626455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649744|NCT02626455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102649745|NCT02626455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102649746|NCT02626455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102649747|NCT02626455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102649748|NCT02626455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102649749|NCT02626455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102649750|NCT02626455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102649751|NCT02626455|Glucocorticoids|glucocorticoids|mesh-ancestor
102649752|NCT02626455|Hormones|hormones|mesh-ancestor
102649753|NCT02626455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102649754|NCT02626455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102649755|NCT02626455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102649756|NCT02626455|Tubulin Modulators|tubulin modulators|mesh-ancestor
102649757|NCT02626455|Antimitotic Agents|antimitotic agents|mesh-ancestor
102649758|NCT02626455|Mitosis Modulators|mitosis modulators|mesh-ancestor
102649759|NCT02595060|Molgramostim|molgramostim|mesh-list
102275577|NCT04509973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102275578|NCT04509973|Antiemetics|antiemetics|mesh-ancestor
102275579|NCT04509973|Autonomic Agents|autonomic agents|mesh-ancestor
102275580|NCT04509973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102649760|NCT02595060|Sargramostim|sargramostim|mesh-list
102649761|NCT02595060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649762|NCT02595060|Immunologic Factors|immunologic factors|mesh-ancestor
102649763|NCT02595060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649764|NCT02587065|Interferons|interferons|mesh-list
102649765|NCT02587065|Interferon-beta|interferon-beta|mesh-list
102649766|NCT02587065|Interferon beta-1a|interferon beta-1a|mesh-list
102649767|NCT02587065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649768|NCT02587065|Antiviral Agents|antiviral agents|mesh-ancestor
102649769|NCT02587065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102649770|NCT02587065|Immunologic Factors|immunologic factors|mesh-ancestor
102649771|NCT02587065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649772|NCT02587065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102649773|NCT02531126|Ozanimod|ozanimod|mesh-list
102649774|NCT02531126|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102649775|NCT02531126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649776|NCT02531126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102649777|NCT02531126|Immunologic Factors|immunologic factors|mesh-ancestor
102649778|NCT02531126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649779|NCT02492867|Paclitaxel|paclitaxel|mesh-list
102649780|NCT02492867|Carboplatin|carboplatin|mesh-list
102649781|NCT02492867|Durvalumab|durvalumab|mesh-list
102649782|NCT02492867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102649783|NCT02492867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649784|NCT02492867|Tubulin Modulators|tubulin modulators|mesh-ancestor
102649785|NCT02492867|Antimitotic Agents|antimitotic agents|mesh-ancestor
102649786|NCT02492867|Mitosis Modulators|mitosis modulators|mesh-ancestor
102649787|NCT02492867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649788|NCT02492867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102649789|NCT02426658|Pemetrexed|pemetrexed|mesh-list
102649790|NCT02426658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649791|NCT02426658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102649792|NCT02426658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649793|NCT02426658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102649794|NCT02426658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102649795|NCT02375204|Paclitaxel|paclitaxel|mesh-list
102649796|NCT02375204|Etoposide|etoposide|mesh-list
102649797|NCT02375204|Carboplatin|carboplatin|mesh-list
102649798|NCT02375204|Ifosfamide|ifosfamide|mesh-list
102649799|NCT02375204|Etoposide phosphate|etoposide phosphate|mesh-list
102649800|NCT02375204|Lenograstim|lenograstim|mesh-list
102649801|NCT02375204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102649802|NCT02375204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649803|NCT02375204|Tubulin Modulators|tubulin modulators|mesh-ancestor
102649804|NCT02375204|Antimitotic Agents|antimitotic agents|mesh-ancestor
102649805|NCT02375204|Mitosis Modulators|mitosis modulators|mesh-ancestor
102649806|NCT02375204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649807|NCT02375204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102649808|NCT02375204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102649809|NCT02375204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102649810|NCT02375204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102649811|NCT02375204|Immunologic Factors|immunologic factors|mesh-ancestor
102649812|NCT02375204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649813|NCT02375204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102649814|NCT02375204|Alkylating Agents|alkylating agents|mesh-ancestor
102649815|NCT02343042|Clarithromycin|clarithromycin|mesh-list
102649816|NCT02343042|Dexamethasone|dexamethasone|mesh-list
102649817|NCT02343042|Lenalidomide|lenalidomide|mesh-list
102649818|NCT02343042|Bortezomib|bortezomib|mesh-list
102649819|NCT02343042|Daratumumab|daratumumab|mesh-list
102649820|NCT02343042|Pomalidomide|pomalidomide|mesh-list
102649821|NCT02343042|Ixazomib|ixazomib|mesh-list
102649822|NCT02343042|Elotuzumab|elotuzumab|mesh-list
102649823|NCT02343042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102649824|NCT02343042|Antiemetics|antiemetics|mesh-ancestor
102649825|NCT02343042|Autonomic Agents|autonomic agents|mesh-ancestor
102649826|NCT02343042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102649827|NCT02343042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649828|NCT02343042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102649829|NCT02343042|Glucocorticoids|glucocorticoids|mesh-ancestor
102649830|NCT02343042|Hormones|hormones|mesh-ancestor
102649831|NCT02343042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102649832|NCT02343042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102649833|NCT02343042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102275581|NCT04509973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938405|NCT03278925|Antioxidants|antioxidants|mesh-ancestor
102275582|NCT04509973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102649834|NCT02343042|Immunologic Factors|immunologic factors|mesh-ancestor
102649835|NCT02343042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102649836|NCT02343042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102649837|NCT02343042|Growth Substances|growth substances|mesh-ancestor
102649838|NCT02343042|Growth Inhibitors|growth inhibitors|mesh-ancestor
102649839|NCT02343042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102649840|NCT02343042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102649841|NCT02343042|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102649842|NCT02343042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102649843|NCT02343042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649844|NCT02343042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102649845|NCT02343042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102649846|NCT02343042|Protease Inhibitors|protease inhibitors|mesh-ancestor
102649847|NCT02339168|Metformin|metformin|mesh-list
102649848|NCT02339168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102649849|NCT02339168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649850|NCT02276495|Ketorolac|ketorolac|mesh-list
102649851|NCT02276495|Clonidine|clonidine|mesh-list
102649852|NCT02276495|Epinephrine|epinephrine|mesh-list
102649853|NCT02276495|Ropivacaine|ropivacaine|mesh-list
102649854|NCT02276495|Anesthetics, Local|anesthetics, local|mesh-ancestor
102649855|NCT02276495|Anesthetics|anesthetics|mesh-ancestor
102649856|NCT02276495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102649857|NCT02276495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649858|NCT02276495|Sensory System Agents|sensory system agents|mesh-ancestor
102649859|NCT02276495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102649860|NCT02276495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102649861|NCT02276495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102649862|NCT02276495|Adrenergic Agents|adrenergic agents|mesh-ancestor
102649863|NCT02276495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102649864|NCT02276495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649865|NCT02276495|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102649866|NCT02276495|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102649867|NCT02276495|Autonomic Agents|autonomic agents|mesh-ancestor
102649868|NCT02276495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102649869|NCT02276495|Respiratory System Agents|respiratory system agents|mesh-ancestor
102649870|NCT02276495|Mydriatics|mydriatics|mesh-ancestor
102649871|NCT02276495|Sympathomimetics|sympathomimetics|mesh-ancestor
102649872|NCT02276495|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102649873|NCT02276495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102649874|NCT02276495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102649875|NCT02276495|Analgesics|analgesics|mesh-ancestor
102649876|NCT02276495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102649877|NCT02276495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102649878|NCT02276495|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102649879|NCT02276495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102649880|NCT02276495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102649881|NCT02276495|Sympatholytics|sympatholytics|mesh-ancestor
102649882|NCT02276495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102649883|NCT02269319|Linezolid|linezolid|mesh-list
102649884|NCT02269319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102649885|NCT02269319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102649886|NCT02269319|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102649887|NCT02269319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102649888|NCT02269319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649889|NCT02208375|Olaparib|olaparib|mesh-list
102649890|NCT02208375|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102649891|NCT02208375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102649892|NCT02208375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649893|NCT02208375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649894|NCT02194738|Paclitaxel|paclitaxel|mesh-list
102649895|NCT02194738|Cisplatin|cisplatin|mesh-list
102649896|NCT02194738|Carboplatin|carboplatin|mesh-list
102649897|NCT02194738|Gemcitabine|gemcitabine|mesh-list
102649898|NCT02194738|Pembrolizumab|pembrolizumab|mesh-list
102649899|NCT02194738|Nivolumab|nivolumab|mesh-list
102649900|NCT02194738|Pemetrexed|pemetrexed|mesh-list
102649901|NCT02194738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102649902|NCT02194738|Crizotinib|crizotinib|mesh-list
102649903|NCT02194738|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102649904|NCT02194738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102275583|NCT04509973|Glucocorticoids|glucocorticoids|mesh-ancestor
102275584|NCT04509973|Hormones|hormones|mesh-ancestor
101938477|NCT03003325|Analgesics|analgesics|mesh-ancestor
102649905|NCT02194738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649906|NCT02194738|Tubulin Modulators|tubulin modulators|mesh-ancestor
102649907|NCT02194738|Antimitotic Agents|antimitotic agents|mesh-ancestor
102649908|NCT02194738|Mitosis Modulators|mitosis modulators|mesh-ancestor
102649909|NCT02194738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649910|NCT02194738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102649911|NCT02194738|Antimetabolites|antimetabolites|mesh-ancestor
102649912|NCT02194738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102649913|NCT02194738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102649914|NCT02194738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102649915|NCT02194738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102649916|NCT02194738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102649917|NCT02194738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102649918|NCT02176967|Cyclophosphamide|cyclophosphamide|mesh-list
102649919|NCT02176967|Carboplatin|carboplatin|mesh-list
102649920|NCT02176967|Doxorubicin|doxorubicin|mesh-list
102649921|NCT02176967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102649922|NCT02176967|Etoposide|etoposide|mesh-list
102649923|NCT02176967|Etoposide phosphate|etoposide phosphate|mesh-list
102649924|NCT02176967|Podophyllotoxin|podophyllotoxin|mesh-list
102649925|NCT02176967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102649926|NCT02176967|Immunologic Factors|immunologic factors|mesh-ancestor
102649927|NCT02176967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649928|NCT02176967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102649929|NCT02176967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102649930|NCT02176967|Alkylating Agents|alkylating agents|mesh-ancestor
102649931|NCT02176967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649932|NCT02176967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649933|NCT02176967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102649934|NCT02176967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102649935|NCT02176967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102649936|NCT02176967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102649937|NCT02176967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102649938|NCT02176967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102649939|NCT02176967|Keratolytic Agents|keratolytic agents|mesh-ancestor
102649940|NCT02176967|Dermatologic Agents|dermatologic agents|mesh-ancestor
102649941|NCT02176967|Tubulin Modulators|tubulin modulators|mesh-ancestor
102649942|NCT02176967|Antimitotic Agents|antimitotic agents|mesh-ancestor
102649943|NCT02176967|Mitosis Modulators|mitosis modulators|mesh-ancestor
102649944|NCT02139397|Eflornithine|eflornithine|mesh-list
102649945|NCT02139397|Bortezomib|bortezomib|mesh-list
102649946|NCT02139397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649947|NCT02139397|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102649948|NCT02139397|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102649949|NCT02139397|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102649950|NCT02139397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102649951|NCT02139397|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
102649952|NCT02139397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102649953|NCT02139397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649954|NCT02120404|Esmolol|esmolol|mesh-list
102649955|NCT02120404|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102649956|NCT02120404|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102649957|NCT02120404|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102649958|NCT02120404|Adrenergic Agents|adrenergic agents|mesh-ancestor
102649959|NCT02120404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102649960|NCT02120404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102649961|NCT02120404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649962|NCT02055456|Nandrolone Decanoate|nandrolone decanoate|mesh-list
102649963|NCT02055456|Nandrolone|nandrolone|mesh-list
102649964|NCT02055456|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
102649965|NCT02055456|Androgens|androgens|mesh-ancestor
102649966|NCT02055456|Hormones|hormones|mesh-ancestor
102649967|NCT02055456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102649968|NCT02055456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649969|NCT02055456|Anabolic Agents|anabolic agents|mesh-ancestor
102649970|NCT02055456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102649971|NCT02031250|Carboplatin|carboplatin|mesh-list
102649972|NCT02031250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649973|NCT01996865|Rituximab|rituximab|mesh-list
102649974|NCT01996865|Lenalidomide|lenalidomide|mesh-list
102649975|NCT01996865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102649976|NCT01996865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649977|NCT01996865|Immunologic Factors|immunologic factors|mesh-ancestor
102649978|NCT01996865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649979|NCT01996865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102649980|NCT01996865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102275585|NCT04509973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102649981|NCT01996865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102649982|NCT01996865|Growth Substances|growth substances|mesh-ancestor
102649983|NCT01996865|Growth Inhibitors|growth inhibitors|mesh-ancestor
102649984|NCT01995669|Lenalidomide|lenalidomide|mesh-list
102649985|NCT01995669|Obinutuzumab|obinutuzumab|mesh-list
102649986|NCT01995669|Immunologic Factors|immunologic factors|mesh-ancestor
102649987|NCT01995669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102649988|NCT01995669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102649989|NCT01995669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102649990|NCT01995669|Growth Substances|growth substances|mesh-ancestor
102649991|NCT01995669|Growth Inhibitors|growth inhibitors|mesh-ancestor
102649992|NCT01995669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102649993|NCT01995669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102649994|NCT01880567|Rituximab|rituximab|mesh-list
102649995|NCT01880567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102649996|NCT01880567|Antibodies|antibodies|mesh-list
102649997|NCT01880567|Immunoglobulins|immunoglobulins|mesh-list
102649998|NCT01880567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102649999|NCT01880567|Immunologic Factors|immunologic factors|mesh-ancestor
102650000|NCT01880567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102650001|NCT01880567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102650002|NCT01880567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102650003|NCT01750567|Metformin|metformin|mesh-list
102650004|NCT01750567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102650005|NCT01750567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102650006|NCT01740557|Aldesleukin|aldesleukin|mesh-list
102650007|NCT01740557|Cyclophosphamide|cyclophosphamide|mesh-list
102650008|NCT01740557|Fludarabine|fludarabine|mesh-list
102650009|NCT01740557|Fludarabine phosphate|fludarabine phosphate|mesh-list
102650010|NCT01740557|Interleukin-2|interleukin-2|mesh-list
102650011|NCT01740557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102650012|NCT01740557|Immunologic Factors|immunologic factors|mesh-ancestor
102650013|NCT01740557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102650014|NCT01740557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102650015|NCT01740557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102650016|NCT01740557|Alkylating Agents|alkylating agents|mesh-ancestor
102650017|NCT01740557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102650018|NCT01740557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102650019|NCT01740557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102650020|NCT01740557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102650021|NCT01740557|Antimetabolites|antimetabolites|mesh-ancestor
102650022|NCT01740557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102650023|NCT01740557|Analgesics|analgesics|mesh-ancestor
102650024|NCT01740557|Sensory System Agents|sensory system agents|mesh-ancestor
102650025|NCT01740557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102650026|NCT01740557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102650027|NCT01740557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102650028|NCT01740557|Antiviral Agents|antiviral agents|mesh-ancestor
102650029|NCT01740557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102650030|NCT01705977|Belimumab|belimumab|mesh-list
102650031|NCT01705977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102650032|NCT01705977|Immunologic Factors|immunologic factors|mesh-ancestor
102650033|NCT01705977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102650034|NCT01686711|Pioglitazone|pioglitazone|mesh-list
102650035|NCT01686711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102650036|NCT01686711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102650037|NCT01572506|Biotin|biotin|mesh-list
102650038|NCT01572506|Vitamin B Complex|vitamin b complex|mesh-ancestor
102650039|NCT01572506|Vitamins|vitamins|mesh-ancestor
102650040|NCT01572506|Micronutrients|micronutrients|mesh-ancestor
102650041|NCT01572506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102650042|NCT01568177|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
102650043|NCT01568177|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102650044|NCT01568177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102650045|NCT01503632|Mercaptopurine|mercaptopurine|mesh-list
102650046|NCT01503632|Antimetabolites|antimetabolites|mesh-ancestor
102650047|NCT01503632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102650048|NCT01503632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102650049|NCT01503632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102650050|NCT01503632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102650051|NCT01503632|Immunologic Factors|immunologic factors|mesh-ancestor
102650052|NCT01503632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102650053|NCT01503632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101938646|NCT01936532|Dexamethasone|dexamethasone|mesh-list
102650054|NCT01503632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102650055|NCT01306019|Busulfan|busulfan|mesh-list
102650056|NCT01306019|Alkylating Agents|alkylating agents|mesh-ancestor
102275586|NCT04509973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102650057|NCT01306019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102650058|NCT01306019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102650059|NCT01306019|Immunologic Factors|immunologic factors|mesh-ancestor
102650060|NCT01306019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102650061|NCT01306019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102650062|NCT01306019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102650063|NCT01306019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102650065|NCT01236560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102650066|NCT01236560|Temozolomide|temozolomide|mesh-list
102650067|NCT01236560|Vorinostat|vorinostat|mesh-list
102650068|NCT01236560|Endothelial Growth Factors|endothelial growth factors|mesh-list
102650069|NCT01236560|Antibodies|antibodies|mesh-list
102650070|NCT01236560|Immunoglobulins|immunoglobulins|mesh-list
102650071|NCT01236560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102650072|NCT01236560|Immunoglobulin G|immunoglobulin g|mesh-list
102650073|NCT01236560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102650074|NCT01236560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102650075|NCT01236560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102650076|NCT01236560|Growth Substances|growth substances|mesh-ancestor
102650077|NCT01236560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102650078|NCT01236560|Growth Inhibitors|growth inhibitors|mesh-ancestor
102650079|NCT01236560|Immunologic Factors|immunologic factors|mesh-ancestor
102650080|NCT01236560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102650081|NCT01236560|Alkylating Agents|alkylating agents|mesh-ancestor
102650082|NCT01236560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102650083|NCT01236560|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102650084|NCT01236560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102650085|NCT01231906|Cyclophosphamide|cyclophosphamide|mesh-list
102650086|NCT01231906|Ifosfamide|ifosfamide|mesh-list
102650087|NCT01231906|Isophosphamide mustard|isophosphamide mustard|mesh-list
102650088|NCT01231906|Doxorubicin|doxorubicin|mesh-list
102650089|NCT01231906|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102650090|NCT01231906|Etoposide|etoposide|mesh-list
102650091|NCT01231906|Vincristine|vincristine|mesh-list
102650092|NCT01231906|Etoposide phosphate|etoposide phosphate|mesh-list
102650093|NCT01231906|Topotecan|topotecan|mesh-list
102650094|NCT01231906|Podophyllotoxin|podophyllotoxin|mesh-list
102650095|NCT01231906|Dexrazoxane|dexrazoxane|mesh-list
102650096|NCT01231906|Razoxane|razoxane|mesh-list
102650097|NCT01231906|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
102650098|NCT01231906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102650099|NCT01231906|Immunologic Factors|immunologic factors|mesh-ancestor
102650100|NCT01231906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102650101|NCT01231906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102650102|NCT01231906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102650103|NCT01231906|Alkylating Agents|alkylating agents|mesh-ancestor
102650104|NCT01231906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102650105|NCT01231906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102650106|NCT01231906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102650107|NCT01231906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102650108|NCT01231906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102650109|NCT01231906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102650110|NCT01231906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102650111|NCT01231906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102650112|NCT01231906|Tubulin Modulators|tubulin modulators|mesh-ancestor
102650113|NCT01231906|Antimitotic Agents|antimitotic agents|mesh-ancestor
102650114|NCT01231906|Mitosis Modulators|mitosis modulators|mesh-ancestor
102650115|NCT01231906|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102650116|NCT01231906|Keratolytic Agents|keratolytic agents|mesh-ancestor
102650117|NCT01231906|Dermatologic Agents|dermatologic agents|mesh-ancestor
102650118|NCT01231906|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102650119|NCT01231906|Protective Agents|protective agents|mesh-ancestor
102650120|NCT01174121|Aldesleukin|aldesleukin|mesh-list
102650121|NCT01174121|Cyclophosphamide|cyclophosphamide|mesh-list
102650122|NCT01174121|Pembrolizumab|pembrolizumab|mesh-list
102650123|NCT01174121|Fludarabine|fludarabine|mesh-list
102275587|NCT04509973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102275588|NCT02336347|Quinidine|quinidine|mesh-list
102275589|NCT02336347|Dextromethorphan|dextromethorphan|mesh-list
102275590|NCT02336347|Antitussive Agents|antitussive agents|mesh-ancestor
102275591|NCT02336347|Respiratory System Agents|respiratory system agents|mesh-ancestor
102275592|NCT02336347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102275593|NCT02336347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102275594|NCT02336347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101938721|NCT00707655|Zalutumumab|zalutumumab|mesh-list
102650124|NCT01174121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102275595|NCT02336347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102650125|NCT01174121|Immunologic Factors|immunologic factors|mesh-ancestor
102650126|NCT01174121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102650127|NCT01174121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102650128|NCT01174121|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102650129|NCT01174121|Alkylating Agents|alkylating agents|mesh-ancestor
102650130|NCT01174121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102650131|NCT01174121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102650132|NCT01174121|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102650133|NCT01174121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102650134|NCT01174121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102650135|NCT01174121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102650136|NCT01174121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102650137|NCT01174121|Antiviral Agents|antiviral agents|mesh-ancestor
102650138|NCT01174121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102650139|NCT01125228|Interferons|interferons|mesh-list
102650140|NCT01125228|Interferon-alpha|interferon-alpha|mesh-list
102650141|NCT01125228|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
102650142|NCT01125228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102650143|NCT01125228|Antiviral Agents|antiviral agents|mesh-ancestor
102650144|NCT01125228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102650145|NCT01125228|Immunologic Factors|immunologic factors|mesh-ancestor
102650146|NCT01125228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102650147|NCT01081262|Paclitaxel|paclitaxel|mesh-list
102650148|NCT01081262|Bevacizumab|bevacizumab|mesh-list
102650149|NCT01081262|Carboplatin|carboplatin|mesh-list
102650150|NCT01081262|Capecitabine|capecitabine|mesh-list
102650151|NCT01081262|Oxaliplatin|oxaliplatin|mesh-list
102650152|NCT01081262|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102650153|NCT01081262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102650154|NCT01081262|Endothelial Growth Factors|endothelial growth factors|mesh-list
102650155|NCT01081262|Antibodies|antibodies|mesh-list
102650156|NCT01081262|Immunoglobulins|immunoglobulins|mesh-list
102650157|NCT01081262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102650158|NCT01081262|Immunoglobulin G|immunoglobulin g|mesh-list
102650159|NCT01081262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102650160|NCT01081262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102650161|NCT01081262|Tubulin Modulators|tubulin modulators|mesh-ancestor
102650162|NCT01081262|Antimitotic Agents|antimitotic agents|mesh-ancestor
102650163|NCT01081262|Mitosis Modulators|mitosis modulators|mesh-ancestor
102650164|NCT01081262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102650165|NCT01081262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102650166|NCT01081262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102650167|NCT01081262|Growth Substances|growth substances|mesh-ancestor
102650168|NCT01081262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102650169|NCT01081262|Growth Inhibitors|growth inhibitors|mesh-ancestor
102650170|NCT01081262|Immunologic Factors|immunologic factors|mesh-ancestor
102650171|NCT01081262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102650172|NCT01081262|Antimetabolites|antimetabolites|mesh-ancestor
102650173|NCT00923013|Rituximab|rituximab|mesh-list
102650174|NCT00923013|Cladribine|cladribine|mesh-list
102650175|NCT00923013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102650176|NCT00923013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102650177|NCT00923013|Immunologic Factors|immunologic factors|mesh-ancestor
102650178|NCT00923013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102650179|NCT00923013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102650180|NCT00923013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102650181|NCT00887146|Vincristine|vincristine|mesh-list
102650182|NCT00887146|Temozolomide|temozolomide|mesh-list
102650183|NCT00887146|Procarbazine|procarbazine|mesh-list
102650184|NCT00887146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102650185|NCT00887146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102650186|NCT00887146|Tubulin Modulators|tubulin modulators|mesh-ancestor
102650187|NCT00887146|Antimitotic Agents|antimitotic agents|mesh-ancestor
102650188|NCT00887146|Mitosis Modulators|mitosis modulators|mesh-ancestor
102650189|NCT00887146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102650190|NCT00887146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102650191|NCT00887146|Alkylating Agents|alkylating agents|mesh-ancestor
102650192|NCT00862433|Vitamins|vitamins|mesh-list
102650193|NCT00862433|Vitamin E|vitamin e|mesh-list
102275596|NCT02336347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102650194|NCT00862433|Tocopherols|tocopherols|mesh-list
102650195|NCT00862433|Tocotrienols|tocotrienols|mesh-list
102650196|NCT00862433|alpha-Tocopherol|alpha-tocopherol|mesh-list
102650197|NCT00862433|Micronutrients|micronutrients|mesh-ancestor
102650198|NCT00862433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102650199|NCT00862433|Antioxidants|antioxidants|mesh-ancestor
102275597|NCT02336347|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102650200|NCT00862433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102650201|NCT00862433|Protective Agents|protective agents|mesh-ancestor
102650202|NCT00788164|Imiquimod|imiquimod|mesh-list
102650203|NCT00788164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102650204|NCT00788164|Immunologic Factors|immunologic factors|mesh-ancestor
102650205|NCT00788164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102650206|NCT00788164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102650207|NCT00788164|Interferon Inducers|interferon inducers|mesh-ancestor
102650208|NCT00468234|Nicotine|nicotine|mesh-list
102650209|NCT00468234|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102650210|NCT00468234|Autonomic Agents|autonomic agents|mesh-ancestor
102650211|NCT00468234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102650212|NCT00468234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102650213|NCT00468234|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102650214|NCT00468234|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102650215|NCT00468234|Cholinergic Agents|cholinergic agents|mesh-ancestor
102650216|NCT00468234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102650217|NCT00468234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102650218|NCT00359684|Cysteamine|cysteamine|mesh-list
102650219|NCT00359684|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
102650220|NCT00359684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102650221|NCT00354393|Methotrexate|methotrexate|mesh-list
102650222|NCT00354393|Vinorelbine|vinorelbine|mesh-list
102650223|NCT00354393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102650224|NCT00354393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102650225|NCT00354393|Abortifacient Agents|abortifacient agents|mesh-ancestor
102650226|NCT00354393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102650227|NCT00354393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102650228|NCT00354393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102650229|NCT00354393|Antimetabolites|antimetabolites|mesh-ancestor
102650230|NCT00354393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102650231|NCT00354393|Dermatologic Agents|dermatologic agents|mesh-ancestor
102650232|NCT00354393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102650233|NCT00354393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102650234|NCT00354393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102650235|NCT00354393|Immunologic Factors|immunologic factors|mesh-ancestor
102650236|NCT00354393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102650237|NCT00354393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102650238|NCT00354393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102650239|NCT00354393|Tubulin Modulators|tubulin modulators|mesh-ancestor
102650240|NCT00354393|Antimitotic Agents|antimitotic agents|mesh-ancestor
102650241|NCT00354393|Mitosis Modulators|mitosis modulators|mesh-ancestor
102650242|NCT00304070|Cisplatin|cisplatin|mesh-list
102650243|NCT00304070|Doxorubicin|doxorubicin|mesh-list
102650244|NCT00304070|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102650245|NCT00304070|Etoposide|etoposide|mesh-list
102650246|NCT00304070|Etoposide phosphate|etoposide phosphate|mesh-list
102650247|NCT00304070|Podophyllotoxin|podophyllotoxin|mesh-list
102650248|NCT00304070|Mitotane|mitotane|mesh-list
102650249|NCT00304070|Lenograstim|lenograstim|mesh-list
102650250|NCT00304070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102650251|NCT00304070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102650252|NCT00304070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102650253|NCT00304070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102650254|NCT00304070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102650255|NCT00304070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102650256|NCT00304070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102650257|NCT00304070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102650258|NCT00304070|Immunologic Factors|immunologic factors|mesh-ancestor
102650259|NCT00304070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102650260|NCT00304070|Keratolytic Agents|keratolytic agents|mesh-ancestor
102650261|NCT00304070|Dermatologic Agents|dermatologic agents|mesh-ancestor
102650262|NCT00304070|Tubulin Modulators|tubulin modulators|mesh-ancestor
102650263|NCT00304070|Antimitotic Agents|antimitotic agents|mesh-ancestor
102650264|NCT00304070|Mitosis Modulators|mitosis modulators|mesh-ancestor
102650265|NCT00304070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102650266|NCT00160680|Levocetirizine|levocetirizine|mesh-list
102650267|NCT00160680|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102650268|NCT00160680|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102650269|NCT00160680|Histamine Antagonists|histamine antagonists|mesh-ancestor
102650270|NCT00160680|Histamine Agents|histamine agents|mesh-ancestor
102650271|NCT00160680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102275598|NCT02336347|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102275599|NCT02336347|Adrenergic Agents|adrenergic agents|mesh-ancestor
102650272|NCT00160680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102650273|NCT00160680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102650274|NCT00065676|Quercetin|quercetin|mesh-list
102650275|NCT00065676|Antioxidants|antioxidants|mesh-ancestor
102650276|NCT00065676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102650277|NCT00065676|Protective Agents|protective agents|mesh-ancestor
102650278|NCT00065676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102650279|NCT00044304|Imatinib Mesylate|imatinib mesylate|mesh-list
102650280|NCT00044304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102650281|NCT00044304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102650282|NCT00044304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102650283|NCT00044304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102650284|NCT00024622|Levodopa|levodopa|mesh-list
102650285|NCT00024622|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102650286|NCT00024622|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102650287|NCT00024622|Dopamine Agents|dopamine agents|mesh-ancestor
102650288|NCT00024622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102650289|NCT00024622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102650290|NCT00024622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102650291|NCT00018057|Fluoxetine|fluoxetine|mesh-list
102650292|NCT00018057|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102650293|NCT00018057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102650294|NCT00018057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102650295|NCT00018057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102650296|NCT00018057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102650297|NCT00018057|Serotonin Agents|serotonin agents|mesh-ancestor
102650298|NCT00018057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102650299|NCT00018057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102650300|NCT00018057|Antidepressive Agents|antidepressive agents|mesh-ancestor
102650301|NCT00018057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102650302|NCT00018057|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102650303|NCT00018057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102650304|NCT00018057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102650305|NCT00006421|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102650306|NCT00006421|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102650307|NCT00006421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102650308|NCT00001481|Estradiol|estradiol|mesh-list
102650309|NCT00001481|Progesterone|progesterone|mesh-list
102650310|NCT00001481|Estrogens|estrogens|mesh-ancestor
102650311|NCT00001481|Hormones|hormones|mesh-ancestor
102650312|NCT00001481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102650313|NCT00001481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102650314|NCT00001481|Progestins|progestins|mesh-ancestor
102650315|NCT00001230|Diethylcarbamazine|diethylcarbamazine|mesh-list
102650316|NCT00001230|Filaricides|filaricides|mesh-ancestor
102650317|NCT00001230|Antinematodal Agents|antinematodal agents|mesh-ancestor
102650318|NCT00001230|Anthelmintics|anthelmintics|mesh-ancestor
102650319|NCT00001230|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102650320|NCT00001230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102650321|NCT00001230|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
102650322|NCT00001230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102650323|NCT00001230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275600|NCT02336347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102275601|NCT02336347|Antimalarials|antimalarials|mesh-ancestor
102275602|NCT02336347|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102275603|NCT02336347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102275604|NCT02336347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102275605|NCT02336347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102275606|NCT02336347|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102275607|NCT02336347|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102275608|NCT02336347|Cholinergic Agents|cholinergic agents|mesh-ancestor
101939066|NCT03713372|Antibodies|antibodies|mesh-list
102275609|NCT02336347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102275610|NCT02336347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102275611|NCT02336347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102275612|NCT02336347|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102275613|NCT02336347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102275614|NCT02341027|Contraceptive Agents|contraceptive agents|mesh-list
102275616|NCT02341027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101939450|NCT02918266|Donepezil|donepezil|mesh-list
102275617|NCT02341027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275618|NCT02341027|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102275619|NCT02341027|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102275620|NCT02341027|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101939713|NCT01104519|Niacin|niacin|mesh-list
102275621|NCT02341027|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102275622|NCT02039479|Lithium Carbonate|lithium carbonate|mesh-list
102275623|NCT02039479|Antidepressive Agents|antidepressive agents|mesh-ancestor
101939882|NCT01109043|Adrenergic Agents|adrenergic agents|mesh-ancestor
101939883|NCT01109043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101939884|NCT01109043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939885|NCT01109121|Allopurinol|allopurinol|mesh-list
101939886|NCT01109121|Antimetabolites|antimetabolites|mesh-ancestor
101939887|NCT01109121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939888|NCT01109121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101939889|NCT01109121|Gout Suppressants|gout suppressants|mesh-ancestor
101939957|NCT04537923|Insulin Lispro|insulin lispro|mesh-list
102275624|NCT02039479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102275625|NCT02039479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101940104|NCT03942861|Prednisolone phosphate|prednisolone phosphate|mesh-list
101940180|NCT01111227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102275626|NCT02039479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275627|NCT02039479|Antimanic Agents|antimanic agents|mesh-ancestor
102275628|NCT02039479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101940408|NCT01115985|Antimetabolites|antimetabolites|mesh-ancestor
102275629|NCT02039479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101940478|NCT01116531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102275630|NCT02039479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275631|NCT02340481|Simethicone|simethicone|mesh-list
102275633|NCT02340481|Antidiarrheals|antidiarrheals|mesh-list
102275634|NCT02340481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102275635|NCT02340481|Antifoaming Agents|antifoaming agents|mesh-ancestor
101940706|NCT01122615|Sirolimus|sirolimus|mesh-list
102275636|NCT02340481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275638|NCT02340481|Dermatologic Agents|dermatologic agents|mesh-ancestor
102275639|NCT03077633|Progesterone|progesterone|mesh-list
102275640|NCT03077633|Progestins|progestins|mesh-ancestor
102275641|NCT03077633|Hormones|hormones|mesh-ancestor
102275642|NCT03077633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102275643|NCT03077633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275644|NCT05253781|Aspirin|aspirin|mesh-list
102275645|NCT05253781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102275646|NCT05253781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102275648|NCT05253781|Sensory System Agents|sensory system agents|mesh-ancestor
102275649|NCT05253781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101941214|NCT03648658|Acetaminophen|acetaminophen|mesh-list
102275650|NCT05253781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941321|NCT03925155|Iodine|iodine|mesh-list
102275651|NCT05253781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102275652|NCT05253781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102275653|NCT05253781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102275654|NCT05253781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102275655|NCT05253781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275656|NCT05253781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102275657|NCT05253781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102275658|NCT05253781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102275659|NCT05253781|Antipyretics|antipyretics|mesh-ancestor
102275660|NCT02340325|Kynurenic Acid|kynurenic acid|mesh-list
102275661|NCT02340325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102275662|NCT02340325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102275663|NCT02340325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102275664|NCT02340325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275665|NCT02340325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275666|NCT02340247|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102275667|NCT02340247|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
102275668|NCT02340247|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102275669|NCT02340247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102275670|NCT02340247|Cathartics|cathartics|mesh-ancestor
102275671|NCT02340013|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102275672|NCT02340013|Medroxyprogesterone|medroxyprogesterone|mesh-list
102275673|NCT02340013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102275674|NCT02340013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102275675|NCT02340013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102275676|NCT02340013|Contraceptive Agents|contraceptive agents|mesh-ancestor
102275677|NCT02340013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102275678|NCT02340013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275679|NCT02340013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102275680|NCT02340013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102275681|NCT02340013|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102275682|NCT02340013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102275683|NCT02340013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102275684|NCT05178823|Chlorhexidine|chlorhexidine|mesh-list
102275685|NCT05178823|Chlorine dioxide|chlorine dioxide|mesh-list
102275686|NCT05178823|Fluorides|fluorides|mesh-list
102275687|NCT05178823|Sodium Fluoride|sodium fluoride|mesh-list
102275688|NCT05178823|Cariostatic Agents|cariostatic agents|mesh-ancestor
102275689|NCT05178823|Protective Agents|protective agents|mesh-ancestor
102275690|NCT05178823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275691|NCT05178823|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102275692|NCT05178823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102275693|NCT05178823|Disinfectants|disinfectants|mesh-ancestor
102275694|NCT05178823|Dental Disinfectants|dental disinfectants|mesh-ancestor
102275695|NCT03105583|Vitamins|vitamins|mesh-list
102275696|NCT03105583|Micronutrients|micronutrients|mesh-ancestor
102275697|NCT03105583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275698|NCT03105115|Fentanyl|fentanyl|mesh-list
102275699|NCT03105115|Bupivacaine|bupivacaine|mesh-list
102275700|NCT03105115|Anesthetics, Local|anesthetics, local|mesh-ancestor
102275701|NCT03105115|Anesthetics|anesthetics|mesh-ancestor
101984477|NCT03751657|Protease Inhibitors|protease inhibitors|mesh-ancestor
102275702|NCT03105115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102275703|NCT03105115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275704|NCT03105115|Sensory System Agents|sensory system agents|mesh-ancestor
102275705|NCT03105115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102275706|NCT03105115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102275707|NCT03105115|Narcotics|narcotics|mesh-ancestor
102275708|NCT03105115|Analgesics|analgesics|mesh-ancestor
102275709|NCT03105115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102275710|NCT03105115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102275711|NCT03105115|Anesthetics, General|anesthetics, general|mesh-ancestor
102275712|NCT03105349|Ribavirin|ribavirin|mesh-list
102275713|NCT03105349|Sofosbuvir|sofosbuvir|mesh-list
102275714|NCT03105349|Grazoprevir|grazoprevir|mesh-list
102275715|NCT03105349|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
102275716|NCT03105349|Antimetabolites|antimetabolites|mesh-ancestor
102275717|NCT03105349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275718|NCT03105349|Antiviral Agents|antiviral agents|mesh-ancestor
102275719|NCT03105349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102275720|NCT03077555|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102275721|NCT03077555|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102275722|NCT03077555|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102275723|NCT03077555|Estradiol|estradiol|mesh-list
102275724|NCT03077555|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102275725|NCT03077555|Estrogens|estrogens|mesh-ancestor
102275726|NCT03077555|Hormones|hormones|mesh-ancestor
102275727|NCT03077555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102275728|NCT03077555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275729|NCT03077555|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102275730|NCT03077555|Contraceptive Agents|contraceptive agents|mesh-ancestor
102275731|NCT03077555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102275732|NCT03077555|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102275733|NCT03077555|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102275734|NCT03077555|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102275736|NCT02335255|Antifungal Agents|antifungal agents|mesh-ancestor
102275737|NCT02335255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102275738|NCT05012033|Prednisolone|prednisolone|mesh-list
102275739|NCT05012033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102275740|NCT05012033|Glucocorticoids|glucocorticoids|mesh-ancestor
102275741|NCT05012033|Hormones|hormones|mesh-ancestor
102275742|NCT05012033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102275743|NCT05012033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275744|NCT05012033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102275745|NCT05012033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102275746|NCT02344303|Moxifloxacin|moxifloxacin|mesh-list
102275747|NCT02344303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102275748|NCT02344303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102275749|NCT02344303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102275750|NCT02344303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102275751|NCT02344303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102275752|NCT02344303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275753|NCT02344303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102275754|NCT02334475|Methylprednisolone|methylprednisolone|mesh-list
102275755|NCT02334475|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102275756|NCT02334475|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102275757|NCT02334475|Prednisolone|prednisolone|mesh-list
102275758|NCT02334475|Prednisolone acetate|prednisolone acetate|mesh-list
102275759|NCT02334475|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102275760|NCT02334475|Prednisolone phosphate|prednisolone phosphate|mesh-list
102275761|NCT02334475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102275762|NCT02334475|Antiemetics|antiemetics|mesh-ancestor
102275763|NCT02334475|Autonomic Agents|autonomic agents|mesh-ancestor
102275764|NCT02334475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102275765|NCT02334475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275766|NCT02334475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102275767|NCT02334475|Glucocorticoids|glucocorticoids|mesh-ancestor
102275768|NCT02334475|Hormones|hormones|mesh-ancestor
102275769|NCT02334475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102275770|NCT02334475|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102275771|NCT02334475|Protective Agents|protective agents|mesh-ancestor
101372660|NCT00198094|Sertraline|sertraline|mesh-list
102275772|NCT02334475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102275773|NCT02334475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102275774|NCT02334631|Simethicone|simethicone|mesh-list
102275775|NCT02334631|Antifoaming Agents|antifoaming agents|mesh-ancestor
102275776|NCT02334631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275777|NCT02334631|Emollients|emollients|mesh-ancestor
102275778|NCT02334631|Dermatologic Agents|dermatologic agents|mesh-ancestor
102275780|NCT02338687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102275781|NCT02338687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275782|NCT02338531|Nirogacestat|nirogacestat|mesh-list
102275783|NCT02338531|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
102275784|NCT02338531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102275785|NCT02338531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275786|NCT02332135|Vitamin D|vitamin d|mesh-list
102275787|NCT02332135|Vitamins|vitamins|mesh-ancestor
102275788|NCT02332135|Micronutrients|micronutrients|mesh-ancestor
102275789|NCT02332135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275790|NCT02332135|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102275791|NCT02334163|Metronidazole|metronidazole|mesh-list
102275792|NCT02334163|Nitazoxanide|nitazoxanide|mesh-list
102275793|NCT02334163|Lactulose|lactulose|mesh-list
102275794|NCT02334163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102275795|NCT02334163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102275796|NCT02334163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102275797|NCT02334163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102275798|NCT02334163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102275799|NCT02332057|Diclofenac|diclofenac|mesh-list
102275800|NCT02332057|Lidocaine|lidocaine|mesh-list
102275801|NCT02332057|Anesthetics, Local|anesthetics, local|mesh-ancestor
102275802|NCT02332057|Anesthetics|anesthetics|mesh-ancestor
102275803|NCT02332057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102275804|NCT02332057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617484|NCT02836509|Ibuprofen|ibuprofen|mesh-list
102275805|NCT02332057|Sensory System Agents|sensory system agents|mesh-ancestor
102275806|NCT02332057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102275807|NCT02332057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102275808|NCT02332057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102275809|NCT02332057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102275810|NCT02332057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102275811|NCT02332057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275812|NCT02332057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102275813|NCT02332057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102275815|NCT02332057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102275816|NCT02332057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102275817|NCT02332057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102275818|NCT02332057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102275819|NCT02331745|Lenograstim|lenograstim|mesh-list
102275820|NCT02331745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102275821|NCT02331745|Immunologic Factors|immunologic factors|mesh-ancestor
102275822|NCT02331745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275823|NCT02638259|GP2015|gp2015|mesh-list
102275824|NCT02638259|Dermatologic Agents|dermatologic agents|mesh-ancestor
102275825|NCT02333929|Rivaroxaban|rivaroxaban|mesh-list
102275826|NCT02333929|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102275827|NCT02333929|Antithrombins|antithrombins|mesh-ancestor
102275828|NCT02333929|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102275829|NCT02333929|Protease Inhibitors|protease inhibitors|mesh-ancestor
102275830|NCT02333929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102275831|NCT02333929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275832|NCT02333929|Anticoagulants|anticoagulants|mesh-ancestor
102275833|NCT02333851|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
102275834|NCT02333851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102275835|NCT02333851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275836|NCT02334007|Dalteparin|dalteparin|mesh-list
102275837|NCT02334007|Tinzaparin|tinzaparin|mesh-list
102275838|NCT02334007|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102275839|NCT02334007|Anticoagulants|anticoagulants|mesh-ancestor
102275840|NCT02334007|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102275841|NCT02334007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102275842|NCT02334007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275843|NCT02637323|Triamcinolone|triamcinolone|mesh-list
102275844|NCT02637323|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102275845|NCT02637323|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102275846|NCT02637323|FX006|fx006|mesh-list
102275847|NCT02637323|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102275848|NCT02637323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102275849|NCT02637323|Glucocorticoids|glucocorticoids|mesh-ancestor
102275850|NCT02637323|Hormones|hormones|mesh-ancestor
102275851|NCT02637323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102275852|NCT02637323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984631|NCT01171885|Ropivacaine|ropivacaine|mesh-list
102275853|NCT02637323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102275854|NCT02637323|Immunologic Factors|immunologic factors|mesh-ancestor
102275855|NCT02637323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102275856|NCT02637323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275857|NCT02331823|Moxifloxacin|moxifloxacin|mesh-list
102275859|NCT02331823|Pyrazinamide|pyrazinamide|mesh-list
102275860|NCT02331823|Ethambutol|ethambutol|mesh-list
102275861|NCT02331823|Rifabutin|rifabutin|mesh-list
102275862|NCT02331823|Streptomycin|streptomycin|mesh-list
102275863|NCT02331823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102275864|NCT02331823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102275865|NCT02331823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102275866|NCT02331823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102275867|NCT02331823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102275868|NCT02331823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275869|NCT02331823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102275870|NCT02331823|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102275871|NCT02331823|Antitubercular Agents|antitubercular agents|mesh-ancestor
102275872|NCT02331823|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102275873|NCT02331823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102275874|NCT02331823|Antimetabolites|antimetabolites|mesh-ancestor
102275875|NCT02331823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102275876|NCT02331823|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102275877|NCT02890459|Denatonium|denatonium|mesh-list
102275878|NCT02890459|Aversive Agents|aversive agents|mesh-ancestor
102275879|NCT02890459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275880|NCT02890459|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
102275881|NCT02890459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275882|NCT02890459|Sensory System Agents|sensory system agents|mesh-ancestor
102275883|NCT02890459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102275884|NCT03077009|Hyaluronic Acid|hyaluronic acid|mesh-list
102275885|NCT03077009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102275886|NCT03077009|Immunologic Factors|immunologic factors|mesh-ancestor
102275887|NCT03077009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275888|NCT03077009|Viscosupplements|viscosupplements|mesh-ancestor
102275889|NCT03077009|Protective Agents|protective agents|mesh-ancestor
102275890|NCT04477525|Bupivacaine|bupivacaine|mesh-list
102275891|NCT04477525|Anesthetics, Local|anesthetics, local|mesh-ancestor
102275892|NCT04477525|Anesthetics|anesthetics|mesh-ancestor
102275893|NCT04477525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102275894|NCT04477525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275895|NCT04477525|Sensory System Agents|sensory system agents|mesh-ancestor
102275896|NCT04477525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102275897|NCT03079973|Calcipotriene|calcipotriene|mesh-list
102275898|NCT03079973|Dermatologic Agents|dermatologic agents|mesh-ancestor
102275899|NCT03861871|Fenfluramine|fenfluramine|mesh-list
102275900|NCT03861871|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102275901|NCT03861871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102275902|NCT03861871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102275903|NCT03861871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275904|NCT03861871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102275905|NCT03861871|Serotonin Agents|serotonin agents|mesh-ancestor
102275906|NCT03861871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275907|NCT05004545|Propofol|propofol|mesh-list
102275908|NCT05004545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102275909|NCT05004545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102275910|NCT05004545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275911|NCT05004545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102275912|NCT05004545|Anesthetics, General|anesthetics, general|mesh-ancestor
102275913|NCT05004545|Anesthetics|anesthetics|mesh-ancestor
102275914|NCT03079895|Nicotine|nicotine|mesh-list
102275915|NCT03079895|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102275916|NCT03079895|Autonomic Agents|autonomic agents|mesh-ancestor
102275917|NCT03079895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102275918|NCT03079895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275919|NCT03079895|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102275920|NCT03079895|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102275921|NCT03079895|Cholinergic Agents|cholinergic agents|mesh-ancestor
102275922|NCT03079895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102275923|NCT03079895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275924|NCT04463615|Leflunomide|leflunomide|mesh-list
102275925|NCT04463615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102275926|NCT04463615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275927|NCT04463615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102275928|NCT04463615|Immunologic Factors|immunologic factors|mesh-ancestor
102275929|NCT04463615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275930|NCT05003765|Magnesium Sulfate|magnesium sulfate|mesh-list
102275931|NCT05003765|Buprenorphine|buprenorphine|mesh-list
102275932|NCT05003765|Bupivacaine|bupivacaine|mesh-list
102275933|NCT05003765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102275934|NCT05003765|Anesthetics, Local|anesthetics, local|mesh-ancestor
102275935|NCT05003765|Anesthetics|anesthetics|mesh-ancestor
102275936|NCT05003765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102275937|NCT05003765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275938|NCT05003765|Sensory System Agents|sensory system agents|mesh-ancestor
102275939|NCT05003765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102275940|NCT05003765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102275941|NCT05003765|Narcotics|narcotics|mesh-ancestor
102275942|NCT05003765|Analgesics|analgesics|mesh-ancestor
102275943|NCT05003765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102275944|NCT05003765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102275945|NCT05003765|Anticonvulsants|anticonvulsants|mesh-ancestor
102275946|NCT05003765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102275947|NCT05003765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102275948|NCT05003765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275949|NCT05003765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102275950|NCT05003765|Tocolytic Agents|tocolytic agents|mesh-ancestor
102275951|NCT05003765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102275952|NCT02337283|BI 425809|bi 425809|mesh-list
102275953|NCT02337283|Nootropic Agents|nootropic agents|mesh-ancestor
102275954|NCT02333305|Coenzyme Q10|coenzyme q10|mesh-list
102275955|NCT02333305|Vitamins|vitamins|mesh-ancestor
102275956|NCT02333305|Micronutrients|micronutrients|mesh-ancestor
102275957|NCT02333305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275958|NCT02326987|Pregabalin|pregabalin|mesh-list
102275959|NCT02326987|Analgesics|analgesics|mesh-ancestor
102275960|NCT02326987|Sensory System Agents|sensory system agents|mesh-ancestor
102275961|NCT02326987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102275962|NCT02326987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275963|NCT02326987|Anticonvulsants|anticonvulsants|mesh-ancestor
102275964|NCT02326987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102275965|NCT02326987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102275966|NCT02326987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275967|NCT02326987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102275968|NCT02326987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102275969|NCT02326987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102275970|NCT02326987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102275971|NCT02326987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102275972|NCT02331511|Aspirin|aspirin|mesh-list
102275973|NCT02331511|Clopidogrel|clopidogrel|mesh-list
102275974|NCT02331511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102275975|NCT02331511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102275976|NCT02331511|Analgesics|analgesics|mesh-ancestor
102275977|NCT02331511|Sensory System Agents|sensory system agents|mesh-ancestor
102275978|NCT02331511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102275979|NCT02331511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102275980|NCT02331511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102275981|NCT02331511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102275982|NCT02331511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102275983|NCT02331511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102275984|NCT02331511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372870|NCT00199186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102275985|NCT02331511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102275986|NCT02331511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102275987|NCT02331511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102275988|NCT02331511|Antipyretics|antipyretics|mesh-ancestor
102275989|NCT02331511|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102275990|NCT02331511|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102275991|NCT02331511|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102275992|NCT02331511|Purinergic Agents|purinergic agents|mesh-ancestor
102275993|NCT02331511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102275994|NCT02326441|KX2-361|kx2-361|mesh-list
102275995|NCT02326441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102275996|NCT02326441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102275997|NCT02326441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102275998|NCT02326441|Tubulin Modulators|tubulin modulators|mesh-ancestor
102275999|NCT02326441|Antimitotic Agents|antimitotic agents|mesh-ancestor
102276000|NCT02326441|Mitosis Modulators|mitosis modulators|mesh-ancestor
102276001|NCT02326441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102276002|NCT02039791|Paclitaxel|paclitaxel|mesh-list
102276003|NCT02039791|Carboplatin|carboplatin|mesh-list
102276004|NCT02039791|Nimotuzumab|nimotuzumab|mesh-list
102276005|NCT02039791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102276006|NCT02039791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102276007|NCT02039791|Tubulin Modulators|tubulin modulators|mesh-ancestor
102276008|NCT02039791|Antimitotic Agents|antimitotic agents|mesh-ancestor
102276009|NCT02039791|Mitosis Modulators|mitosis modulators|mesh-ancestor
102276010|NCT02039791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276011|NCT02039791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102276012|NCT03573817|Formoterol Fumarate|formoterol fumarate|mesh-list
102276013|NCT03573817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102276014|NCT03573817|Autonomic Agents|autonomic agents|mesh-ancestor
102276015|NCT03573817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102276016|NCT03573817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276017|NCT03573817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102276018|NCT03573817|Respiratory System Agents|respiratory system agents|mesh-ancestor
102276019|NCT03573817|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102276020|NCT03573817|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102276021|NCT03573817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102276022|NCT03573817|Adrenergic Agents|adrenergic agents|mesh-ancestor
102276023|NCT03573817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102276024|NCT03573817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276025|NCT03111511|JNJ-56136379|jnj-56136379|mesh-list
102276026|NCT03111511|Drospirenone|drospirenone|mesh-list
102276027|NCT03111511|Midazolam|midazolam|mesh-list
102276028|NCT03111511|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102276029|NCT03111511|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
102276030|NCT03111511|Betadex|betadex|mesh-list
102276031|NCT03111511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102276032|NCT03111511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102276033|NCT03111511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102276034|NCT03111511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276035|NCT03111511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102276036|NCT03111511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102276037|NCT03111511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102276038|NCT03111511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102276039|NCT03111511|Anesthetics, General|anesthetics, general|mesh-ancestor
102276040|NCT03111511|Anesthetics|anesthetics|mesh-ancestor
102276041|NCT03111511|GABA Modulators|gaba modulators|mesh-ancestor
102276042|NCT03111511|GABA Agents|gaba agents|mesh-ancestor
102276043|NCT03111511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102276044|NCT03111511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276045|NCT03111511|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102276046|NCT03111511|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102276047|NCT03111511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102276048|NCT03111511|Contraceptive Agents|contraceptive agents|mesh-ancestor
102276049|NCT03111511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102276050|NCT03111511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102276051|NCT03111511|Estrogens|estrogens|mesh-ancestor
102276052|NCT03111511|Hormones|hormones|mesh-ancestor
102276053|NCT03111511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102276054|NCT03111511|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102276055|NCT03111511|Hormone Antagonists|hormone antagonists|mesh-ancestor
102276056|NCT03111511|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102276057|NCT03111511|Diuretics|diuretics|mesh-ancestor
102276058|NCT03111511|Natriuretic Agents|natriuretic agents|mesh-ancestor
102276059|NCT03111511|Antiviral Agents|antiviral agents|mesh-ancestor
102276060|NCT03111511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102276061|NCT03111511|Sequestering Agents|sequestering agents|mesh-ancestor
102276062|NCT03144115|Oxytocin|oxytocin|mesh-list
102276063|NCT03144115|Oxytocics|oxytocics|mesh-ancestor
102276064|NCT03144115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102276065|NCT03144115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276066|NCT02326285|Docetaxel|docetaxel|mesh-list
102276067|NCT02326285|Gefitinib|gefitinib|mesh-list
102276068|NCT02326285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102276069|NCT02326285|Tubulin Modulators|tubulin modulators|mesh-ancestor
102276070|NCT02326285|Antimitotic Agents|antimitotic agents|mesh-ancestor
102276071|NCT02326285|Mitosis Modulators|mitosis modulators|mesh-ancestor
102276072|NCT02326285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276073|NCT02326285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102276074|NCT02326285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102276075|NCT02332603|Methylprednisolone|methylprednisolone|mesh-list
102276076|NCT02332603|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102276077|NCT02332603|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102276078|NCT02332603|Prednisolone|prednisolone|mesh-list
102276079|NCT02332603|Prednisolone acetate|prednisolone acetate|mesh-list
102276080|NCT02332603|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102276081|NCT02332603|Prednisolone phosphate|prednisolone phosphate|mesh-list
102276082|NCT02332603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102276083|NCT02332603|Antiemetics|antiemetics|mesh-ancestor
102276084|NCT02332603|Autonomic Agents|autonomic agents|mesh-ancestor
102276085|NCT02332603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102276086|NCT02332603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276087|NCT02332603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102276088|NCT02332603|Glucocorticoids|glucocorticoids|mesh-ancestor
102276089|NCT02332603|Hormones|hormones|mesh-ancestor
102276090|NCT02332603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102276091|NCT02332603|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102276092|NCT02332603|Protective Agents|protective agents|mesh-ancestor
102276093|NCT02332603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102276094|NCT02332603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102276095|NCT02332447|Naloxone|naloxone|mesh-list
102276096|NCT02332447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102276097|NCT02332447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276098|NCT02332447|Sensory System Agents|sensory system agents|mesh-ancestor
102276099|NCT02332447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102276100|NCT05077813|Vitamin D|vitamin d|mesh-list
102276101|NCT05077813|Ergocalciferols|ergocalciferols|mesh-list
102276102|NCT05077813|Cholecalciferol|cholecalciferol|mesh-list
102276103|NCT05077813|Vitamins|vitamins|mesh-list
102276104|NCT05077813|Minocycline|minocycline|mesh-list
102276105|NCT05077813|Tretinoin|tretinoin|mesh-list
102276106|NCT05077813|Alitretinoin|alitretinoin|mesh-list
102276107|NCT05077813|Isotretinoin|isotretinoin|mesh-list
102276108|NCT05077813|Micronutrients|micronutrients|mesh-ancestor
102276109|NCT05077813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276110|NCT05077813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102276111|NCT05077813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102276112|NCT05077813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102276113|NCT05077813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102276114|NCT05077813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102276115|NCT05077813|Keratolytic Agents|keratolytic agents|mesh-ancestor
102276116|NCT05077813|Dermatologic Agents|dermatologic agents|mesh-ancestor
102276118|NCT02326051|Enoxaparin sodium|enoxaparin sodium|mesh-list
102276119|NCT02326051|Anticoagulants|anticoagulants|mesh-ancestor
102276120|NCT02326051|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102276121|NCT02326051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102276122|NCT02326051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276123|NCT05076955|Vancomycin|vancomycin|mesh-list
102276124|NCT05076955|Tobramycin|tobramycin|mesh-list
102276125|NCT05076955|Itraconazole|itraconazole|mesh-list
102276126|NCT05076955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102276127|NCT05076955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102276128|NCT05076955|Antifungal Agents|antifungal agents|mesh-ancestor
102276129|NCT05076955|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102276130|NCT05076955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102276131|NCT05076955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102276132|NCT05076955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276133|NCT05076955|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102276134|NCT05076955|Hormone Antagonists|hormone antagonists|mesh-ancestor
102276135|NCT05076955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102276136|NCT05076955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276137|NCT05076955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102276138|NCT05077111|Anesthetics|anesthetics|mesh-list
102276139|NCT05077111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102276140|NCT05077111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276141|NCT05075863|Letrozole|letrozole|mesh-list
102276142|NCT05075863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102276143|NCT05075863|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102276144|NCT05075863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102276145|NCT05075863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102276146|NCT05075863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276147|NCT05075863|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102276148|NCT05075863|Hormone Antagonists|hormone antagonists|mesh-ancestor
102276149|NCT05075863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102276150|NCT05075863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276151|NCT02330419|Naltrexone|naltrexone|mesh-list
102276152|NCT02330419|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102276153|NCT02330419|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102276154|NCT02330419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276155|NCT02330419|Sensory System Agents|sensory system agents|mesh-ancestor
102276156|NCT02330419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102276157|NCT05068141|Paclitaxel|paclitaxel|mesh-list
102276158|NCT05068141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102276159|NCT05068141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102276160|NCT05068141|Tubulin Modulators|tubulin modulators|mesh-ancestor
102276161|NCT05068141|Antimitotic Agents|antimitotic agents|mesh-ancestor
102276162|NCT05068141|Mitosis Modulators|mitosis modulators|mesh-ancestor
102276163|NCT05068141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276164|NCT03142165|Diphenhydramine|diphenhydramine|mesh-list
102276165|NCT03142165|Promethazine|promethazine|mesh-list
102276166|NCT03142165|Famotidine|famotidine|mesh-list
102276167|NCT03142165|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102276168|NCT03142165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102276169|NCT03142165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102276170|NCT03142165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276171|NCT03142165|Anesthetics, Local|anesthetics, local|mesh-ancestor
102276172|NCT03142165|Anesthetics|anesthetics|mesh-ancestor
102276173|NCT03142165|Sensory System Agents|sensory system agents|mesh-ancestor
102276174|NCT03142165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102276175|NCT03142165|Antiemetics|antiemetics|mesh-ancestor
102276176|NCT03142165|Autonomic Agents|autonomic agents|mesh-ancestor
102276177|NCT03142165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102276178|NCT03142165|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102276179|NCT03142165|Histamine Antagonists|histamine antagonists|mesh-ancestor
102276180|NCT03142165|Histamine Agents|histamine agents|mesh-ancestor
102276181|NCT03142165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102276182|NCT03142165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276183|NCT03142165|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102276184|NCT03142165|Antipruritics|antipruritics|mesh-ancestor
102276185|NCT03142165|Dermatologic Agents|dermatologic agents|mesh-ancestor
102276186|NCT03142165|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102276187|NCT03142165|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102276188|NCT02330029|Pinaverium|pinaverium|mesh-list
102276189|NCT02330029|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102276190|NCT02330029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102276191|NCT02330029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276192|NCT02330029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102276193|NCT02330029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276194|NCT02330029|Parasympatholytics|parasympatholytics|mesh-ancestor
102276195|NCT02330029|Autonomic Agents|autonomic agents|mesh-ancestor
102276196|NCT02330029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102276197|NCT04988971|Corticosterone|corticosterone|mesh-list
101373115|NCT00200629|Purinergic Agonists|purinergic agonists|mesh-ancestor
102276198|NCT04988971|Fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether|fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether|mesh-list
102276199|NCT04988971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102276200|NCT04988971|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102276201|NCT04988971|Anesthetics, General|anesthetics, general|mesh-ancestor
102276202|NCT04988971|Anesthetics|anesthetics|mesh-ancestor
102276203|NCT04988971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102276204|NCT04988971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276205|NCT02329795|Temozolomide|temozolomide|mesh-list
102276206|NCT02329795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102276207|NCT02329795|Alkylating Agents|alkylating agents|mesh-ancestor
102276208|NCT02329795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276209|NCT02329795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102276210|NCT02329561|Tramadol|tramadol|mesh-list
102276211|NCT02329561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102276212|NCT02329561|Narcotics|narcotics|mesh-ancestor
102276213|NCT02329561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102276214|NCT02329561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276215|NCT02329561|Analgesics|analgesics|mesh-ancestor
102276216|NCT02329561|Sensory System Agents|sensory system agents|mesh-ancestor
102276217|NCT02329561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102276218|NCT03143491|Paclitaxel|paclitaxel|mesh-list
102276219|NCT03143491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102276220|NCT03143491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102276221|NCT03143491|Tubulin Modulators|tubulin modulators|mesh-ancestor
102276222|NCT03143491|Antimitotic Agents|antimitotic agents|mesh-ancestor
102276223|NCT03143491|Mitosis Modulators|mitosis modulators|mesh-ancestor
102276224|NCT03143491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276225|NCT05002673|Anesthetics|anesthetics|mesh-list
102276226|NCT05002673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102276227|NCT05002673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276228|NCT03076151|Tacrolimus|tacrolimus|mesh-list
102276229|NCT03076151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102276230|NCT03076151|Immunologic Factors|immunologic factors|mesh-ancestor
102276231|NCT03076151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276232|NCT03076151|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102276233|NCT03076151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102276234|NCT03076151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276236|NCT05002517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102276237|NCT05002517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102276238|NCT05002517|Prednisolone|prednisolone|mesh-list
102276239|NCT05002517|Prednisolone acetate|prednisolone acetate|mesh-list
102276240|NCT05002517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102276241|NCT05002517|Prednisolone phosphate|prednisolone phosphate|mesh-list
102276242|NCT05002517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102276243|NCT05002517|Antiemetics|antiemetics|mesh-ancestor
102276244|NCT05002517|Autonomic Agents|autonomic agents|mesh-ancestor
102276245|NCT05002517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102276246|NCT05002517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276247|NCT05002517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102276248|NCT05002517|Glucocorticoids|glucocorticoids|mesh-ancestor
102276249|NCT05002517|Hormones|hormones|mesh-ancestor
102276250|NCT05002517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102276251|NCT05002517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102276252|NCT05002517|Protective Agents|protective agents|mesh-ancestor
102276253|NCT05002517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102276254|NCT05002517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102276255|NCT05002361|Dexamethasone|dexamethasone|mesh-list
102276256|NCT05002361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102276257|NCT05002361|Antiemetics|antiemetics|mesh-ancestor
102276258|NCT05002361|Autonomic Agents|autonomic agents|mesh-ancestor
102276259|NCT05002361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102276260|NCT05002361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276261|NCT05002361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102276262|NCT05002361|Glucocorticoids|glucocorticoids|mesh-ancestor
102276263|NCT05002361|Hormones|hormones|mesh-ancestor
102276264|NCT05002361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102276265|NCT05002361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102276266|NCT05002361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102276267|NCT02329405|Rifampin|rifampin|mesh-list
102276268|NCT02329405|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102276269|NCT02329405|Antitubercular Agents|antitubercular agents|mesh-ancestor
102276270|NCT02329405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102276271|NCT02329405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102276272|NCT02329405|Leprostatic Agents|leprostatic agents|mesh-ancestor
102276273|NCT02329405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102276274|NCT02329405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102276275|NCT02329405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276276|NCT02329405|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102276277|NCT02329405|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102276278|NCT02329405|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102276279|NCT02329405|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102276280|NCT02329405|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102276281|NCT02329405|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102276282|NCT02329171|Imiquimod|imiquimod|mesh-list
102276283|NCT02329171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102276284|NCT02329171|Immunologic Factors|immunologic factors|mesh-ancestor
102276285|NCT02329171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276286|NCT02329171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102276287|NCT02329171|Interferon Inducers|interferon inducers|mesh-ancestor
102276288|NCT04498741|Midazolam|midazolam|mesh-list
102276289|NCT04498741|Dabigatran|dabigatran|mesh-list
102276290|NCT04498741|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102276291|NCT04498741|Tacrolimus|tacrolimus|mesh-list
102276292|NCT04498741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102276293|NCT04498741|Immunologic Factors|immunologic factors|mesh-ancestor
102276294|NCT04498741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276295|NCT04498741|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102276296|NCT04498741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102276297|NCT04498741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276298|NCT04498741|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102276299|NCT04498741|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102276300|NCT04498741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102276301|NCT04498741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102276302|NCT04498741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102276303|NCT04498741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102276304|NCT04498741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102276305|NCT04498741|Anesthetics, General|anesthetics, general|mesh-ancestor
102276307|NCT04498741|GABA Modulators|gaba modulators|mesh-ancestor
102276308|NCT04498741|GABA Agents|gaba agents|mesh-ancestor
102276309|NCT04498741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102276310|NCT04498741|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102276311|NCT04498741|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102276312|NCT04498741|Antimetabolites|antimetabolites|mesh-ancestor
102276313|NCT04498741|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102276314|NCT04498741|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102276315|NCT04498741|Antithrombins|antithrombins|mesh-ancestor
102276316|NCT04498741|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102276317|NCT04498741|Protease Inhibitors|protease inhibitors|mesh-ancestor
102276318|NCT04498741|Anticoagulants|anticoagulants|mesh-ancestor
102276319|NCT03551743|Edoxaban|edoxaban|mesh-list
102276320|NCT03551743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102276321|NCT03551743|Antithrombins|antithrombins|mesh-ancestor
102276322|NCT03551743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102276323|NCT03551743|Protease Inhibitors|protease inhibitors|mesh-ancestor
102276324|NCT03551743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102276325|NCT03551743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276326|NCT03551743|Anticoagulants|anticoagulants|mesh-ancestor
102276327|NCT04654429|Ondansetron|ondansetron|mesh-list
102276328|NCT04654429|Antiemetics|antiemetics|mesh-ancestor
102276329|NCT04654429|Autonomic Agents|autonomic agents|mesh-ancestor
102276330|NCT04654429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102276331|NCT04654429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276332|NCT04654429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102276333|NCT04654429|Antipruritics|antipruritics|mesh-ancestor
102276334|NCT04654429|Dermatologic Agents|dermatologic agents|mesh-ancestor
102276335|NCT04654429|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102276336|NCT04654429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102276337|NCT04654429|Serotonin Agents|serotonin agents|mesh-ancestor
102276338|NCT04654429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102276339|NCT04654429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276340|NCT03111121|Glycopyrrolate|glycopyrrolate|mesh-list
102276341|NCT03111121|Neostigmine|neostigmine|mesh-list
102276342|NCT03111121|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102276343|NCT03111121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101373276|NCT00412789|Mitosis Modulators|mitosis modulators|mesh-ancestor
102276344|NCT03111121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276345|NCT03111121|Cholinergic Agents|cholinergic agents|mesh-ancestor
102276346|NCT03111121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102276347|NCT03111121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276348|NCT03111121|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102276349|NCT03111121|Autonomic Agents|autonomic agents|mesh-ancestor
102276350|NCT03111121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102276351|NCT03111121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102276352|NCT03111121|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102276353|NCT03111121|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102276354|NCT02328469|Doxycycline|doxycycline|mesh-list
102276355|NCT02328469|Ceftriaxone|ceftriaxone|mesh-list
102276356|NCT02328469|Acyclovir|acyclovir|mesh-list
102276357|NCT02328469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102276358|NCT02328469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102276359|NCT02328469|Antimalarials|antimalarials|mesh-ancestor
102276360|NCT02328469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102276361|NCT02328469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102276362|NCT02328469|Antiviral Agents|antiviral agents|mesh-ancestor
102276363|NCT04998071|Bupivacaine|bupivacaine|mesh-list
102276364|NCT04998071|Anesthetics, Local|anesthetics, local|mesh-ancestor
102276365|NCT04998071|Anesthetics|anesthetics|mesh-ancestor
102276366|NCT04998071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102276367|NCT04998071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276368|NCT04998071|Sensory System Agents|sensory system agents|mesh-ancestor
102276369|NCT04998071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102276370|NCT03734263|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
102276371|NCT03734263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102276372|NCT03073343|Betaine|betaine|mesh-list
102276373|NCT03073343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102276374|NCT03073343|Lipotropic Agents|lipotropic agents|mesh-ancestor
102276375|NCT03073343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102276376|NCT03073343|Antimetabolites|antimetabolites|mesh-ancestor
102276377|NCT03073343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276378|NCT03073343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102276379|NCT03073265|Apixaban|apixaban|mesh-list
102276380|NCT03073265|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102276381|NCT03073265|Antithrombins|antithrombins|mesh-ancestor
101985155|NCT03510663|Moxifloxacin|moxifloxacin|mesh-list
102276383|NCT03073265|Protease Inhibitors|protease inhibitors|mesh-ancestor
102276384|NCT03073265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102276385|NCT03073265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276386|NCT03073265|Anticoagulants|anticoagulants|mesh-ancestor
102276387|NCT04997837|Capecitabine|capecitabine|mesh-list
102276388|NCT04997837|Tegafur|tegafur|mesh-list
102276389|NCT04997837|Oxaliplatin|oxaliplatin|mesh-list
102276390|NCT04997837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102276391|NCT04997837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102276392|NCT04997837|Antimetabolites|antimetabolites|mesh-ancestor
102276393|NCT04997837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276394|NCT04997837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102276395|NCT04997837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102276396|NCT04202263|Minocycline|minocycline|mesh-list
102276397|NCT04202263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102276398|NCT04202263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102276399|NCT04996979|Ropivacaine|ropivacaine|mesh-list
102276400|NCT04996979|Anesthetics, Local|anesthetics, local|mesh-ancestor
102276401|NCT04996979|Anesthetics|anesthetics|mesh-ancestor
102276402|NCT04996979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102276403|NCT04996979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276404|NCT04996979|Sensory System Agents|sensory system agents|mesh-ancestor
102276405|NCT04996979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102276406|NCT03145285|Abiraterone Acetate|abiraterone acetate|mesh-list
102276407|NCT03145285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102276408|NCT03145285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102276409|NCT03145285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102276410|NCT03145285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276411|NCT03145285|Hormone Antagonists|hormone antagonists|mesh-ancestor
102276412|NCT03145285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102276413|NCT03145285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276414|NCT03145285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102276415|NCT04997291|Dexrazoxane|dexrazoxane|mesh-list
102276417|NCT04997291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102276418|NCT04997291|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102276419|NCT04997291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102276420|NCT04997291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102276421|NCT04997291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102276422|NCT04997291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276423|NCT04997291|Protective Agents|protective agents|mesh-ancestor
102276424|NCT04997291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276425|NCT04997291|Antimitotic Agents|antimitotic agents|mesh-ancestor
102276426|NCT04997291|Mitosis Modulators|mitosis modulators|mesh-ancestor
102276427|NCT02328079|Acyclovir|acyclovir|mesh-list
102276428|NCT02328079|Antiviral Agents|antiviral agents|mesh-list
102276429|NCT02328079|Prednisolone|prednisolone|mesh-list
102276430|NCT02328079|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102276431|NCT02328079|Methylprednisolone|methylprednisolone|mesh-list
102276432|NCT02328079|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102276433|NCT02328079|Prednisolone acetate|prednisolone acetate|mesh-list
102276434|NCT02328079|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102276435|NCT02328079|Prednisolone phosphate|prednisolone phosphate|mesh-list
102276436|NCT02328079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102276437|NCT02328079|Glucocorticoids|glucocorticoids|mesh-ancestor
102276438|NCT02328079|Hormones|hormones|mesh-ancestor
102276439|NCT02328079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102276440|NCT02328079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276441|NCT02328079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102276442|NCT02328079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102276443|NCT02328079|Antiemetics|antiemetics|mesh-ancestor
102276444|NCT02328079|Autonomic Agents|autonomic agents|mesh-ancestor
102276445|NCT02328079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102276446|NCT02328079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102276447|NCT02328079|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102276448|NCT02328079|Protective Agents|protective agents|mesh-ancestor
102276449|NCT02328079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102276450|NCT04992533|Oxymetazoline|oxymetazoline|mesh-list
102276451|NCT04992533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102276452|NCT04992533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102276453|NCT04992533|Adrenergic Agents|adrenergic agents|mesh-ancestor
102276454|NCT04992533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102276455|NCT04992533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276456|NCT04992533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276458|NCT04992533|Autonomic Agents|autonomic agents|mesh-ancestor
102276459|NCT04992533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102276460|NCT04992533|Nasal Decongestants|nasal decongestants|mesh-ancestor
102276461|NCT04992533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102276462|NCT04992533|Respiratory System Agents|respiratory system agents|mesh-ancestor
102276463|NCT02578069|Sirolimus|sirolimus|mesh-list
102276464|NCT02578069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102276465|NCT02578069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102276466|NCT02578069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102276467|NCT02578069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102276468|NCT02578069|Antifungal Agents|antifungal agents|mesh-ancestor
102276469|NCT02578069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102276470|NCT02578069|Immunologic Factors|immunologic factors|mesh-ancestor
102276471|NCT02578069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276472|NCT03074825|Chiauranib|chiauranib|mesh-list
102276473|NCT03074825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102276474|NCT03074825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102276475|NCT03074825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102276476|NCT03074825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276477|NCT03072485|Metformin|metformin|mesh-list
102276478|NCT03072485|Sirolimus|sirolimus|mesh-list
102276479|NCT03072485|Diclofenac|diclofenac|mesh-list
102276480|NCT03072485|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102276481|NCT03072485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276482|NCT03072485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102276483|NCT03072485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102276484|NCT03072485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101373426|NCT00085332|Docetaxel|docetaxel|mesh-list
102276485|NCT03072485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102276486|NCT03072485|Antifungal Agents|antifungal agents|mesh-ancestor
102276487|NCT03072485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102276488|NCT03072485|Immunologic Factors|immunologic factors|mesh-ancestor
102276489|NCT03072485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102276490|NCT03072485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276491|NCT03072485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102276492|NCT03072485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102276493|NCT03072485|Analgesics|analgesics|mesh-ancestor
102276494|NCT03072485|Sensory System Agents|sensory system agents|mesh-ancestor
102276495|NCT03072485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102276496|NCT03072485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102276497|NCT03072485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102276498|NCT03072485|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102276499|NCT05080543|Terlipressin|terlipressin|mesh-list
102276500|NCT05080543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102276501|NCT05080543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102276502|NCT03074591|Ferric Compounds|ferric compounds|mesh-list
102276503|NCT03074591|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102276504|NCT03074591|Hematinics|hematinics|mesh-ancestor
102276505|NCT04996433|Antidepressive Agents|antidepressive agents|mesh-list
102276506|NCT04996433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102276507|NCT03111433|Ubiquinone|ubiquinone|mesh-list
102276508|NCT03111433|Coenzyme Q10|coenzyme q10|mesh-list
102276509|NCT03111433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276510|NCT03111433|Micronutrients|micronutrients|mesh-ancestor
102276511|NCT03111433|Vitamins|vitamins|mesh-ancestor
102276512|NCT03143023|Fluorides|fluorides|mesh-list
102276513|NCT03143023|Cariostatic Agents|cariostatic agents|mesh-ancestor
102276514|NCT03143023|Protective Agents|protective agents|mesh-ancestor
102276515|NCT03143023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276516|NCT03074435|Ivermectin|ivermectin|mesh-list
102276517|NCT03074435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102276518|NCT03074435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102276519|NCT03142789|Cerivastatin|cerivastatin|mesh-list
102276520|NCT03142789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102276521|NCT03142789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102276522|NCT03142789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102276523|NCT03142789|Antimetabolites|antimetabolites|mesh-ancestor
102276524|NCT03142789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276525|NCT03142789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102276526|NCT03142789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102276527|NCT03072329|Bupivacaine|bupivacaine|mesh-list
102276528|NCT03072329|Anesthetics, Local|anesthetics, local|mesh-ancestor
102276529|NCT03072329|Anesthetics|anesthetics|mesh-ancestor
102276530|NCT03072329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102276531|NCT03072329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276532|NCT03072329|Sensory System Agents|sensory system agents|mesh-ancestor
102276533|NCT03072329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102276534|NCT02327689|Emtricitabine|emtricitabine|mesh-list
102276536|NCT02327689|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
102276537|NCT02327689|Antiviral Agents|antiviral agents|mesh-ancestor
102276538|NCT02327689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102276539|NCT02327689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102276540|NCT02327689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102276541|NCT02327689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102276542|NCT02327689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276543|NCT02327689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102276544|NCT02327689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102276545|NCT02327923|Ketorolac|ketorolac|mesh-list
102276546|NCT02327923|Lidocaine|lidocaine|mesh-list
102276547|NCT02327923|Atropine|atropine|mesh-list
102276548|NCT02327923|Ephedrine|ephedrine|mesh-list
102276549|NCT02327923|Fentanyl|fentanyl|mesh-list
102276550|NCT02327923|Glycopyrrolate|glycopyrrolate|mesh-list
102276551|NCT02327923|Morphine|morphine|mesh-list
102276552|NCT02327923|Tramadol|tramadol|mesh-list
102276553|NCT02327923|Ondansetron|ondansetron|mesh-list
102276554|NCT02327923|Bupivacaine|bupivacaine|mesh-list
102276555|NCT02327923|Propofol|propofol|mesh-list
102276556|NCT02327923|Neostigmine|neostigmine|mesh-list
102276557|NCT02327923|Vecuronium Bromide|vecuronium bromide|mesh-list
102276558|NCT02327923|Esmolol|esmolol|mesh-list
102276559|NCT02327923|Anesthetics, Local|anesthetics, local|mesh-ancestor
102276560|NCT02327923|Anesthetics|anesthetics|mesh-ancestor
102276561|NCT02327923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102276562|NCT02327923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276563|NCT02327923|Sensory System Agents|sensory system agents|mesh-ancestor
102276564|NCT02327923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102276565|NCT02327923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102276566|NCT02327923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102276567|NCT02327923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102276568|NCT02327923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102276569|NCT02327923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276570|NCT02327923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102276571|NCT02327923|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102276572|NCT02327923|Anesthetics, General|anesthetics, general|mesh-ancestor
102276573|NCT02327923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102276575|NCT02327923|Analgesics|analgesics|mesh-ancestor
102276576|NCT02327923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102276577|NCT02327923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102276578|NCT02327923|Antiemetics|antiemetics|mesh-ancestor
102276579|NCT02327923|Autonomic Agents|autonomic agents|mesh-ancestor
102276580|NCT02327923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102276581|NCT02327923|Antipruritics|antipruritics|mesh-ancestor
102276582|NCT02327923|Dermatologic Agents|dermatologic agents|mesh-ancestor
102276583|NCT02327923|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102276584|NCT02327923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102276585|NCT02327923|Serotonin Agents|serotonin agents|mesh-ancestor
102276586|NCT02327923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102276587|NCT02327923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102276588|NCT02327923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102276589|NCT02327923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102276590|NCT02327923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102276591|NCT02327923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102276592|NCT02327923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102276593|NCT02327923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102276594|NCT02327923|Respiratory System Agents|respiratory system agents|mesh-ancestor
102276595|NCT02327923|Mydriatics|mydriatics|mesh-ancestor
102276596|NCT02327923|Parasympatholytics|parasympatholytics|mesh-ancestor
102276597|NCT02327923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102276598|NCT02327923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102276599|NCT02327923|Cholinergic Agents|cholinergic agents|mesh-ancestor
102276600|NCT02327923|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102276601|NCT02327923|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102276602|NCT02327923|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102276603|NCT02327923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102276604|NCT02327923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102276605|NCT02327923|Adrenergic Agents|adrenergic agents|mesh-ancestor
102276606|NCT02327923|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102276607|NCT02327923|Sympathomimetics|sympathomimetics|mesh-ancestor
102276608|NCT02327923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102276609|NCT02327923|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102276610|NCT02327923|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102276611|NCT02327923|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102276612|NCT02327923|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102276613|NCT04991207|Bosentan|bosentan|mesh-list
102276614|NCT04991207|Zamicastat|zamicastat|mesh-list
102276615|NCT04991207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102276616|NCT04991207|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102276617|NCT04991207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276618|NCT04991207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102276619|NCT03072173|Xylometazoline|xylometazoline|mesh-list
102276620|NCT03072173|Nasal Decongestants|nasal decongestants|mesh-ancestor
102276621|NCT03072173|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102276622|NCT03072173|Respiratory System Agents|respiratory system agents|mesh-ancestor
102276623|NCT03074123|Cosyntropin|cosyntropin|mesh-list
102276624|NCT03074123|Hormones|hormones|mesh-ancestor
102276625|NCT03074123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102276626|NCT03074123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276627|NCT02327299|Fesoterodine|fesoterodine|mesh-list
102276628|NCT02327299|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102276629|NCT02327299|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102276630|NCT02327299|Cholinergic Agents|cholinergic agents|mesh-ancestor
102276631|NCT02327299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101373598|NCT00223717|Diuretics|diuretics|mesh-ancestor
102276632|NCT02327299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276633|NCT02327299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276634|NCT02327299|Urological Agents|urological agents|mesh-ancestor
102276635|NCT03494569|Fludarabine|fludarabine|mesh-list
102276636|NCT03494569|Melphalan|melphalan|mesh-list
102276637|NCT03494569|Mechlorethamine|mechlorethamine|mesh-list
102276638|NCT03494569|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102276639|NCT03494569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102276640|NCT03494569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276641|NCT03494569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102276642|NCT03494569|Immunologic Factors|immunologic factors|mesh-ancestor
102276643|NCT03494569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276644|NCT03494569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102276645|NCT03494569|Alkylating Agents|alkylating agents|mesh-ancestor
102276646|NCT03494569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102276647|NCT03071549|Salicylic Acid|salicylic acid|mesh-list
102276648|NCT03071549|Salicylates|salicylates|mesh-list
102276649|NCT03071549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102276650|NCT03071549|Antifungal Agents|antifungal agents|mesh-ancestor
102276651|NCT03071549|Keratolytic Agents|keratolytic agents|mesh-ancestor
102276652|NCT03071549|Dermatologic Agents|dermatologic agents|mesh-ancestor
102276653|NCT03071549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102276654|NCT03071549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102276655|NCT03071549|Analgesics|analgesics|mesh-ancestor
102276656|NCT03071549|Sensory System Agents|sensory system agents|mesh-ancestor
102276657|NCT03071549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102276658|NCT03071549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276659|NCT03071549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102276660|NCT03071549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102276661|NCT03071549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102276662|NCT03071549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102276663|NCT03071549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276664|NCT03144817|Dialysis Solutions|dialysis solutions|mesh-list
102276665|NCT03144817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102276666|NCT04994951|Triamcinolone|triamcinolone|mesh-list
102276667|NCT04994951|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102276668|NCT04994951|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102276669|NCT04994951|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102276670|NCT04994951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102276671|NCT04994951|Glucocorticoids|glucocorticoids|mesh-ancestor
102276673|NCT04994951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102276674|NCT04994951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276675|NCT04994951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102276676|NCT04994951|Immunologic Factors|immunologic factors|mesh-ancestor
102276677|NCT04994951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102276678|NCT04994951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276679|NCT03073889|Ropivacaine|ropivacaine|mesh-list
102276680|NCT03073889|Anesthetics, Local|anesthetics, local|mesh-ancestor
102276681|NCT03073889|Anesthetics|anesthetics|mesh-ancestor
102276682|NCT03073889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102276683|NCT03073889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276684|NCT03073889|Sensory System Agents|sensory system agents|mesh-ancestor
102276685|NCT03073889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102276687|NCT03071705|Gefitinib|gefitinib|mesh-list
102276688|NCT03071705|Afatinib|afatinib|mesh-list
102276689|NCT03071705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102276690|NCT03071705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276691|NCT03071705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102276692|NCT03071705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102276693|NCT03071705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102276694|NCT03071705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276695|NCT03351439|Celecoxib|celecoxib|mesh-list
102276696|NCT03351439|Naproxen|naproxen|mesh-list
102276697|NCT03351439|Gabapentin|gabapentin|mesh-list
102276698|NCT03351439|Zopiclone|zopiclone|mesh-list
102276699|NCT03351439|Analgesics|analgesics|mesh-ancestor
102276700|NCT03351439|Sensory System Agents|sensory system agents|mesh-ancestor
102276701|NCT03351439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102276702|NCT03351439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276703|NCT03351439|Anticonvulsants|anticonvulsants|mesh-ancestor
102276704|NCT03351439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102276705|NCT03351439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102276706|NCT03351439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102276707|NCT03351439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102276708|NCT03351439|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102276709|NCT03351439|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102276710|NCT03351439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102276711|NCT03351439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276712|NCT03351439|Antimanic Agents|antimanic agents|mesh-ancestor
102276713|NCT03351439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102276714|NCT03351439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102276716|NCT03351439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102276717|NCT03351439|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102276718|NCT03351439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102276719|NCT03351439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102276720|NCT03351439|Gout Suppressants|gout suppressants|mesh-ancestor
102276721|NCT03351439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102276722|NCT03139747|Everolimus|everolimus|mesh-list
102276723|NCT03139747|Lenvatinib|lenvatinib|mesh-list
102276724|NCT03139747|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102276725|NCT03139747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102276726|NCT03139747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102276727|NCT03139747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276728|NCT03139747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102276729|NCT03139747|Immunologic Factors|immunologic factors|mesh-ancestor
102276730|NCT03139747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276731|NCT03139747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102276732|NCT02037919|Etonogestrel|etonogestrel|mesh-list
102276733|NCT02037919|Desogestrel|desogestrel|mesh-list
102276734|NCT02037919|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102276735|NCT02037919|Contraceptive Agents|contraceptive agents|mesh-ancestor
102276736|NCT02037919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102276737|NCT02037919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276738|NCT02037919|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102276739|NCT02037919|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102276740|NCT02037919|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102276741|NCT02037919|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102276742|NCT02037919|Progestins|progestins|mesh-ancestor
102276743|NCT02037919|Hormones|hormones|mesh-ancestor
102276744|NCT02037919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102276745|NCT03139591|Dexamethasone|dexamethasone|mesh-list
102276746|NCT03139591|Lidocaine|lidocaine|mesh-list
102276747|NCT03139591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102276748|NCT03139591|Antiemetics|antiemetics|mesh-ancestor
102276749|NCT03139591|Autonomic Agents|autonomic agents|mesh-ancestor
102276750|NCT03139591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102276751|NCT03139591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276752|NCT03139591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102276753|NCT03139591|Glucocorticoids|glucocorticoids|mesh-ancestor
102276754|NCT03139591|Hormones|hormones|mesh-ancestor
102276755|NCT03139591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102276756|NCT03139591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102276757|NCT03139591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102276758|NCT03139591|Anesthetics, Local|anesthetics, local|mesh-ancestor
102276759|NCT03139591|Anesthetics|anesthetics|mesh-ancestor
102276760|NCT03139591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102276761|NCT03139591|Sensory System Agents|sensory system agents|mesh-ancestor
102276762|NCT03139591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102276763|NCT03139591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102276764|NCT03139591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102276765|NCT03139591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102276766|NCT03139591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276767|NCT04412291|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102276768|NCT04412291|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102276769|NCT04412291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102276770|NCT04412291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102276771|NCT03139513|Vemurafenib|vemurafenib|mesh-list
102276772|NCT03139513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102276773|NCT03139513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102276774|NCT03139513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102276775|NCT03139513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276777|NCT04986995|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102276778|NCT04986995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102276779|NCT04986995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276780|NCT04986995|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102276781|NCT04986995|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102276782|NCT03971929|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102276783|NCT03971929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102276784|NCT03971929|Diuretics|diuretics|mesh-ancestor
102276785|NCT03971929|Natriuretic Agents|natriuretic agents|mesh-ancestor
102276786|NCT03971929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276787|NCT03971929|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102276788|NCT03971929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102276789|NCT03971929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276790|NCT03070925|Anti-Infective Agents|anti-infective agents|mesh-list
102276791|NCT03070925|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102276792|NCT04986371|Niraparib|niraparib|mesh-list
102276793|NCT04986371|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102276794|NCT04986371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102276795|NCT04986371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276796|NCT04986371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102276797|NCT04988945|Durvalumab|durvalumab|mesh-list
102276798|NCT04988945|Tremelimumab|tremelimumab|mesh-list
102276799|NCT04988945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102276800|NCT04988945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102276801|NCT03070847|Tranexamic Acid|tranexamic acid|mesh-list
102276802|NCT03070847|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102276803|NCT03070847|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102276804|NCT03070847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276805|NCT03070847|Hemostatics|hemostatics|mesh-ancestor
102276806|NCT03070847|Coagulants|coagulants|mesh-ancestor
102276807|NCT03069911|Botulinum Toxins|botulinum toxins|mesh-list
102276808|NCT03069911|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102276809|NCT03069911|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102276810|NCT03069911|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102276811|NCT03069911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102276812|NCT03069911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276813|NCT03069911|Cholinergic Agents|cholinergic agents|mesh-ancestor
102276814|NCT03069911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102276815|NCT03069911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276816|NCT03069911|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102276817|NCT03069911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102276818|NCT04989257|Clopidogrel|clopidogrel|mesh-list
102276819|NCT04989257|Ticagrelor|ticagrelor|mesh-list
102276820|NCT04989257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102276821|NCT04989257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102276822|NCT04989257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102276823|NCT04989257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102276824|NCT04989257|Purinergic Agents|purinergic agents|mesh-ancestor
102276825|NCT04989257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102276826|NCT04989257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276827|NCT04989257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276828|NCT04892069|Insulin|insulin|mesh-list
102276829|NCT04892069|Insulin Aspart|insulin aspart|mesh-list
102276830|NCT04892069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102276831|NCT04892069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276832|NCT03140449|Calcitriol|calcitriol|mesh-list
102276833|NCT03140449|Sirolimus|sirolimus|mesh-list
101985619|NCT00004259|Carmustine|carmustine|mesh-list
102276834|NCT03140449|Temsirolimus|temsirolimus|mesh-list
102276835|NCT03140449|MTOR Inhibitors|mtor inhibitors|mesh-list
102276836|NCT03140449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102276837|NCT03140449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102276838|NCT03140449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102276839|NCT03140449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102276840|NCT03140449|Antifungal Agents|antifungal agents|mesh-ancestor
102276841|NCT03140449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102276842|NCT03140449|Immunologic Factors|immunologic factors|mesh-ancestor
102276843|NCT03140449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276844|NCT03140449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102276845|NCT03140449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102276846|NCT03140449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276847|NCT03140449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102276848|NCT03140449|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102276849|NCT03140449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102276850|NCT03140449|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102276852|NCT03140449|Micronutrients|micronutrients|mesh-ancestor
102276853|NCT03140449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102276854|NCT02659813|Copper|copper|mesh-list
102276855|NCT02659813|Nickel|nickel|mesh-list
102276856|NCT02659813|Trace Elements|trace elements|mesh-ancestor
102276857|NCT02659813|Micronutrients|micronutrients|mesh-ancestor
102276858|NCT02659813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276859|NCT04985435|Adalimumab|adalimumab|mesh-list
102276860|NCT04985435|Etanercept|etanercept|mesh-list
102276861|NCT04985435|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102276862|NCT04985435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102276863|NCT04985435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102276864|NCT04985435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102276865|NCT04985435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102276866|NCT04985435|Analgesics|analgesics|mesh-ancestor
102276867|NCT04985435|Sensory System Agents|sensory system agents|mesh-ancestor
102276868|NCT04985435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102276869|NCT04985435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276870|NCT04985435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102276871|NCT04985435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102276872|NCT04985435|Immunologic Factors|immunologic factors|mesh-ancestor
102276873|NCT03070613|Lectins|lectins|mesh-list
102276874|NCT03070613|Agglutinins|agglutinins|mesh-ancestor
102276875|NCT03070613|Immunologic Factors|immunologic factors|mesh-ancestor
102276876|NCT03070613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276877|NCT03070613|Coagulants|coagulants|mesh-ancestor
102276878|NCT03441139|Analgesics|analgesics|mesh-list
102276879|NCT03441139|Sensory System Agents|sensory system agents|mesh-ancestor
102276880|NCT03441139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102276881|NCT03441139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276882|NCT04988789|Paclitaxel|paclitaxel|mesh-list
102276883|NCT04988789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102276884|NCT04988789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102276885|NCT04988789|Tubulin Modulators|tubulin modulators|mesh-ancestor
102276886|NCT04988789|Antimitotic Agents|antimitotic agents|mesh-ancestor
102276887|NCT04988789|Mitosis Modulators|mitosis modulators|mesh-ancestor
102276888|NCT04988789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276889|NCT04985669|Prucalopride|prucalopride|mesh-list
102276890|NCT04985669|Laxatives|laxatives|mesh-ancestor
102276891|NCT04985669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102276892|NCT04985669|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
102276893|NCT04985669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102276894|NCT04985669|Serotonin Agents|serotonin agents|mesh-ancestor
102276895|NCT04985669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102276896|NCT04985669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276897|NCT04985669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276898|NCT04753957|Progesterone|progesterone|mesh-list
102276899|NCT04753957|Progestins|progestins|mesh-ancestor
102276900|NCT04753957|Hormones|hormones|mesh-ancestor
102276901|NCT04753957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102276902|NCT04753957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276903|NCT03070379|Lidocaine|lidocaine|mesh-list
102276904|NCT03070379|Anesthetics, Local|anesthetics, local|mesh-ancestor
102276905|NCT03070379|Anesthetics|anesthetics|mesh-ancestor
102276906|NCT03070379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102276907|NCT03070379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276908|NCT03070379|Sensory System Agents|sensory system agents|mesh-ancestor
102276909|NCT03070379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102276910|NCT03070379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102276911|NCT03070379|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101373929|NCT00095355|GABA Agents|gaba agents|mesh-ancestor
102276912|NCT03070379|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102276913|NCT03070379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102276914|NCT03070379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276915|NCT03227263|Bevacizumab|bevacizumab|mesh-list
102276916|NCT03227263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102276917|NCT03227263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102276918|NCT03227263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102276919|NCT03227263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102276920|NCT03227263|Growth Substances|growth substances|mesh-ancestor
102276921|NCT03227263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276922|NCT03227263|Growth Inhibitors|growth inhibitors|mesh-ancestor
102276923|NCT04985201|Irinotecan|irinotecan|mesh-list
102276924|NCT04985201|Simvastatin|simvastatin|mesh-list
102276925|NCT04985201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102276926|NCT04985201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102276927|NCT04985201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102276928|NCT04985201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276929|NCT04985201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102276930|NCT04985201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102276931|NCT04985201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102276932|NCT04985201|Antimetabolites|antimetabolites|mesh-ancestor
102276933|NCT04985201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102276934|NCT04985201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102276935|NCT02031601|Carboplatin|carboplatin|mesh-list
102276936|NCT02031601|Docetaxel|docetaxel|mesh-list
102276937|NCT02031601|Pemetrexed|pemetrexed|mesh-list
102276938|NCT02031601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102276939|NCT02031601|Gefitinib|gefitinib|mesh-list
102276940|NCT02031601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102276941|NCT02031601|Tubulin Modulators|tubulin modulators|mesh-ancestor
102276942|NCT02031601|Antimitotic Agents|antimitotic agents|mesh-ancestor
102276943|NCT02031601|Mitosis Modulators|mitosis modulators|mesh-ancestor
102276944|NCT02031601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276945|NCT02031601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102276946|NCT02031601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102276947|NCT02031601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102276948|NCT02031601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102276949|NCT04984577|Edaravone|edaravone|mesh-list
102276950|NCT04984577|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102276951|NCT04984577|Antioxidants|antioxidants|mesh-ancestor
102276952|NCT04984577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276953|NCT04984577|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102276954|NCT04984577|Protective Agents|protective agents|mesh-ancestor
102276955|NCT04984577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276956|NCT05088343|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102276957|NCT05088343|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102276958|NCT05088343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102276959|NCT05088343|Antimetabolites|antimetabolites|mesh-ancestor
102276960|NCT05088343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276961|NCT05088343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102276962|NCT05088343|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102276963|NCT05088343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102276964|NCT03068429|Sertraline|sertraline|mesh-list
102276965|NCT03068429|Antidepressive Agents|antidepressive agents|mesh-ancestor
102276966|NCT03068429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102276967|NCT03068429|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102276968|NCT03068429|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102276969|NCT03068429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102276970|NCT03068429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276971|NCT03068429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102276972|NCT03068429|Serotonin Agents|serotonin agents|mesh-ancestor
102276973|NCT03068429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276974|NCT03068351|Daratumumab|daratumumab|mesh-list
102276975|NCT03068351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102276976|NCT03140293|Lidocaine|lidocaine|mesh-list
102276977|NCT03140293|Ethyl Chloride|ethyl chloride|mesh-list
102276978|NCT03140293|Anesthetics, Local|anesthetics, local|mesh-ancestor
102276979|NCT03140293|Anesthetics|anesthetics|mesh-ancestor
102276980|NCT03140293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101373995|NCT02962258|Vasodilator Agents|vasodilator agents|mesh-ancestor
102276981|NCT03140293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276982|NCT03140293|Sensory System Agents|sensory system agents|mesh-ancestor
102276983|NCT03140293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102276984|NCT03140293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102276985|NCT03140293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102276986|NCT03140293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102276987|NCT03140293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102276988|NCT03140293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102276990|NCT04982861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102276991|NCT04982861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102276992|NCT04572217|Topiramate|topiramate|mesh-list
102276993|NCT04572217|Phentermine|phentermine|mesh-list
102276994|NCT04572217|Anticonvulsants|anticonvulsants|mesh-ancestor
102276995|NCT04572217|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102276996|NCT04572217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102276997|NCT04572217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102276998|NCT04572217|Appetite Depressants|appetite depressants|mesh-ancestor
102276999|NCT04572217|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102277000|NCT04572217|Sympathomimetics|sympathomimetics|mesh-ancestor
102277001|NCT04572217|Autonomic Agents|autonomic agents|mesh-ancestor
102277002|NCT04572217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102277003|NCT04572217|Adrenergic Agents|adrenergic agents|mesh-ancestor
102277004|NCT04572217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102277005|NCT04572217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277006|NCT05635955|Propofol|propofol|mesh-list
102277007|NCT05635955|Esketamine|esketamine|mesh-list
102277008|NCT05635955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102277009|NCT05635955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102277010|NCT05635955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277011|NCT05635955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102277012|NCT05635955|Anesthetics, General|anesthetics, general|mesh-ancestor
101618713|NCT00778921|Amlodipine|amlodipine|mesh-list
102277014|NCT05635955|Antidepressive Agents|antidepressive agents|mesh-ancestor
102277015|NCT05635955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102277016|NCT04452461|Leucovorin|leucovorin|mesh-list
102277017|NCT04452461|Paclitaxel|paclitaxel|mesh-list
102277018|NCT04452461|Gemcitabine|gemcitabine|mesh-list
102277019|NCT04452461|Oxaliplatin|oxaliplatin|mesh-list
102277020|NCT04452461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102277021|NCT04452461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102277022|NCT04452461|Tubulin Modulators|tubulin modulators|mesh-ancestor
102277023|NCT04452461|Antimitotic Agents|antimitotic agents|mesh-ancestor
102277024|NCT04452461|Mitosis Modulators|mitosis modulators|mesh-ancestor
102277025|NCT04452461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277026|NCT04452461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102277027|NCT04452461|Antimetabolites|antimetabolites|mesh-ancestor
102277028|NCT04452461|Antidotes|antidotes|mesh-ancestor
102277029|NCT04452461|Protective Agents|protective agents|mesh-ancestor
102277030|NCT04452461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277031|NCT04452461|Vitamin B Complex|vitamin b complex|mesh-ancestor
102277032|NCT04452461|Vitamins|vitamins|mesh-ancestor
102277033|NCT04452461|Micronutrients|micronutrients|mesh-ancestor
102277034|NCT03137017|Acetaminophen|acetaminophen|mesh-list
102277035|NCT03137017|Hydrocodone|hydrocodone|mesh-list
102277036|NCT03137017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102277037|NCT03137017|Analgesics|analgesics|mesh-ancestor
102277038|NCT03137017|Sensory System Agents|sensory system agents|mesh-ancestor
102277039|NCT03137017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102277040|NCT03137017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277041|NCT03137017|Antipyretics|antipyretics|mesh-ancestor
102277042|NCT03137017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102277043|NCT03137017|Narcotics|narcotics|mesh-ancestor
101374060|NCT00225706|Analgesics|analgesics|mesh-ancestor
102277044|NCT03137017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102277045|NCT03137017|Antitussive Agents|antitussive agents|mesh-ancestor
102277046|NCT03137017|Respiratory System Agents|respiratory system agents|mesh-ancestor
102277047|NCT03019003|Durvalumab|durvalumab|mesh-list
102277048|NCT03019003|Decitabine|decitabine|mesh-list
102277049|NCT03019003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102277050|NCT03019003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102277051|NCT03019003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102277052|NCT03019003|Antimetabolites|antimetabolites|mesh-ancestor
102277053|NCT03019003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277054|NCT03019003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102277055|NCT03013933|Cyclosporine|cyclosporine|mesh-list
102277056|NCT03013933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102277057|NCT03013933|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102277058|NCT03013933|Verapamil|verapamil|mesh-list
102277059|NCT03013933|Antibodies|antibodies|mesh-list
102277060|NCT03013933|Immunoglobulins|immunoglobulins|mesh-list
102277061|NCT03013933|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102277062|NCT03013933|Cyclosporins|cyclosporins|mesh-list
102277063|NCT03013933|Immunoconjugates|immunoconjugates|mesh-list
102277064|NCT03013933|Immunologic Factors|immunologic factors|mesh-ancestor
102277065|NCT03013933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277066|NCT03013933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102277067|NCT03013933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102277068|NCT03013933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277069|NCT03013933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102277070|NCT03013933|Antifungal Agents|antifungal agents|mesh-ancestor
102277071|NCT03013933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102277072|NCT03013933|Dermatologic Agents|dermatologic agents|mesh-ancestor
102277073|NCT03013933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102277074|NCT03013933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102277075|NCT03013933|Immunotoxins|immunotoxins|mesh-ancestor
102277076|NCT03013933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102277077|NCT03013933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102277078|NCT03013933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102277079|NCT03013933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102277080|NCT03013933|Vasodilator Agents|vasodilator agents|mesh-ancestor
102277081|NCT05635253|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102277082|NCT05635253|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102277083|NCT05635253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102277084|NCT04262479|Vitamin D|vitamin d|mesh-list
102277085|NCT04262479|Vitamins|vitamins|mesh-ancestor
102277086|NCT04262479|Micronutrients|micronutrients|mesh-ancestor
102277087|NCT04262479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277088|NCT04262479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102277089|NCT04133311|Latanoprost|latanoprost|mesh-list
102277090|NCT04133311|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101618807|NCT00833794|Tramadol|tramadol|mesh-list
102277091|NCT04133311|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102277092|NCT03217825|Losartan|losartan|mesh-list
102277093|NCT03217825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102277094|NCT03217825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102277095|NCT03217825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102277096|NCT03217825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102277097|NCT03217825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277098|NCT04035187|Itraconazole|itraconazole|mesh-list
102277099|NCT04035187|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
102277100|NCT04035187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102277101|NCT04035187|Antifungal Agents|antifungal agents|mesh-ancestor
102277102|NCT04035187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102277103|NCT04035187|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102277104|NCT04035187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102277105|NCT04035187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102277106|NCT04035187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277107|NCT04035187|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102277108|NCT04035187|Hormone Antagonists|hormone antagonists|mesh-ancestor
102277109|NCT04035187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102277110|NCT04035187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277111|NCT04035187|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102277112|NCT00157963|Losartan|losartan|mesh-list
102277113|NCT00157963|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102277114|NCT00157963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102277115|NCT00157963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102277116|NCT00157963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102277117|NCT00157963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102277118|NCT00157963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277119|NCT00157963|Diuretics|diuretics|mesh-ancestor
102277120|NCT00157963|Natriuretic Agents|natriuretic agents|mesh-ancestor
102277121|NCT00157963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277122|NCT00157963|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102277123|NCT00157963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102277124|NCT05087797|Nicorandil|nicorandil|mesh-list
102277125|NCT05087797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102277126|NCT05087797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102277127|NCT05087797|Vasodilator Agents|vasodilator agents|mesh-ancestor
102277128|NCT05087797|Vitamin B Complex|vitamin b complex|mesh-ancestor
102277129|NCT05087797|Vitamins|vitamins|mesh-ancestor
102277130|NCT05087797|Micronutrients|micronutrients|mesh-ancestor
102277131|NCT05087797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277132|NCT03906877|Hyaluronic Acid|hyaluronic acid|mesh-list
102277133|NCT03906877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102277134|NCT03906877|Immunologic Factors|immunologic factors|mesh-ancestor
102277135|NCT03906877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277136|NCT03906877|Viscosupplements|viscosupplements|mesh-ancestor
102277137|NCT03906877|Protective Agents|protective agents|mesh-ancestor
102277138|NCT03867799|Nivolumab|nivolumab|mesh-list
102277139|NCT03867799|Relatlimab|relatlimab|mesh-list
102277140|NCT03867799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102277141|NCT03867799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102277142|NCT03867799|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102277143|NCT03867799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277144|NCT04873297|Metoclopramide|metoclopramide|mesh-list
102277145|NCT04873297|Antiemetics|antiemetics|mesh-ancestor
102277146|NCT04873297|Autonomic Agents|autonomic agents|mesh-ancestor
102277147|NCT04873297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102277148|NCT04873297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277149|NCT04873297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102277150|NCT04873297|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102277151|NCT04873297|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102277152|NCT04873297|Dopamine Agents|dopamine agents|mesh-ancestor
102277153|NCT04873297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102277154|NCT04873297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277155|NCT05634473|Methacholine Chloride|methacholine chloride|mesh-list
102277156|NCT05634473|Miotics|miotics|mesh-ancestor
102277157|NCT05634473|Autonomic Agents|autonomic agents|mesh-ancestor
102277158|NCT05634473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102277159|NCT05634473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277160|NCT05634473|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102277161|NCT05634473|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
102277162|NCT05634473|Respiratory System Agents|respiratory system agents|mesh-ancestor
102277163|NCT05634473|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102277164|NCT05634473|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102277165|NCT05634473|Cholinergic Agents|cholinergic agents|mesh-ancestor
102277166|NCT05634473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102277167|NCT05634473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277168|NCT03138499|Nivolumab|nivolumab|mesh-list
102277169|NCT03138499|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102277170|NCT03138499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102277171|NCT03138499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102277172|NCT03138499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102277173|NCT03138499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277174|NCT03138499|Immunotoxins|immunotoxins|mesh-ancestor
102277175|NCT03138499|Immunoconjugates|immunoconjugates|mesh-ancestor
102277176|NCT03138499|Immunologic Factors|immunologic factors|mesh-ancestor
102277177|NCT03138499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277178|NCT04858711|Lidocaine|lidocaine|mesh-list
102277179|NCT04858711|Fentanyl|fentanyl|mesh-list
102277180|NCT04858711|Dexmedetomidine|dexmedetomidine|mesh-list
102277181|NCT04858711|Ketamine|ketamine|mesh-list
102277182|NCT04858711|Anesthetics, Local|anesthetics, local|mesh-ancestor
102277183|NCT04858711|Anesthetics|anesthetics|mesh-ancestor
102277184|NCT04858711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102277185|NCT04858711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277186|NCT04858711|Sensory System Agents|sensory system agents|mesh-ancestor
102277187|NCT04858711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102277188|NCT04858711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102277189|NCT04858711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102277190|NCT04858711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102277191|NCT04858711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102277192|NCT04858711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277193|NCT04858711|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102277194|NCT04858711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102277195|NCT04858711|Analgesics|analgesics|mesh-ancestor
102277196|NCT04858711|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102277197|NCT04858711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102277198|NCT04858711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102277199|NCT04858711|Adrenergic Agents|adrenergic agents|mesh-ancestor
102277200|NCT04858711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102277201|NCT04858711|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102277202|NCT04858711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102277203|NCT04858711|Anesthetics, General|anesthetics, general|mesh-ancestor
102277204|NCT04858711|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102277205|NCT04858711|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102277206|NCT04858711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102277207|NCT04858711|Narcotics|narcotics|mesh-ancestor
102277208|NCT04858711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102277209|NCT03068975|Alvimopan|alvimopan|mesh-list
102277210|NCT03068975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102277211|NCT02034331|Acetylcholine|acetylcholine|mesh-list
102277212|NCT02034331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277213|NCT02034331|Vasodilator Agents|vasodilator agents|mesh-ancestor
102277214|NCT02034331|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102277215|NCT02034331|Cholinergic Agents|cholinergic agents|mesh-ancestor
102277216|NCT02034331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102277217|NCT02034331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277218|NCT03067883|Ritonavir|ritonavir|mesh-list
102277219|NCT03067883|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102277220|NCT03067883|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102277221|NCT03067883|Protease Inhibitors|protease inhibitors|mesh-ancestor
102277222|NCT03067883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102277223|NCT03067883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277224|NCT03067883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102277225|NCT03067883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102277226|NCT03067883|Antiviral Agents|antiviral agents|mesh-ancestor
102277227|NCT03067883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102277228|NCT03067883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102277229|NCT03067883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102277230|NCT03285763|Atezolizumab|atezolizumab|mesh-list
102277231|NCT03285763|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102277232|NCT03285763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277233|NCT03285763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102277234|NCT03285763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102277235|NCT05393011|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102277236|NCT05393011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102277237|NCT05393011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277238|NCT03085771|Deferoxamine|deferoxamine|mesh-list
102277239|NCT03085771|Siderophores|siderophores|mesh-ancestor
102277240|NCT03085771|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102277241|NCT03085771|Chelating Agents|chelating agents|mesh-ancestor
102277242|NCT03085771|Sequestering Agents|sequestering agents|mesh-ancestor
102277243|NCT03085771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277244|NCT05619965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
102277245|NCT05619965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102277246|NCT05619965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277247|NCT04659629|Pembrolizumab|pembrolizumab|mesh-list
102277248|NCT04659629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102277249|NCT04659629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102277250|NCT04659629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102277251|NCT04659629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277252|NCT02998567|Pembrolizumab|pembrolizumab|mesh-list
102277253|NCT02998567|Guadecitabine|guadecitabine|mesh-list
102277254|NCT02998567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102277255|NCT02998567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102277256|NCT02998567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102277257|NCT02998567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277258|NCT02985619|Triamcinolone|triamcinolone|mesh-list
102277259|NCT02985619|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102277260|NCT02985619|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102277261|NCT02985619|Bevacizumab|bevacizumab|mesh-list
102277262|NCT02985619|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102277263|NCT02985619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102277264|NCT02985619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102277265|NCT02985619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102277266|NCT02985619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102277267|NCT02985619|Growth Substances|growth substances|mesh-ancestor
102277268|NCT02985619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277269|NCT02985619|Growth Inhibitors|growth inhibitors|mesh-ancestor
102277270|NCT02985619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102277271|NCT02985619|Glucocorticoids|glucocorticoids|mesh-ancestor
102277273|NCT02985619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102277274|NCT02985619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102277275|NCT02985619|Immunologic Factors|immunologic factors|mesh-ancestor
102277276|NCT02985619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102277277|NCT02985619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277278|NCT03110653|Remifentanil|remifentanil|mesh-list
102277279|NCT03110653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102277280|NCT03110653|Narcotics|narcotics|mesh-ancestor
102277281|NCT03110653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102277282|NCT03110653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277283|NCT03110653|Analgesics|analgesics|mesh-ancestor
102277284|NCT03110653|Sensory System Agents|sensory system agents|mesh-ancestor
102277285|NCT03110653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102277286|NCT05392387|Antiviral Agents|antiviral agents|mesh-list
102277287|NCT05392387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102277288|NCT02037529|Paclitaxel|paclitaxel|mesh-list
102277289|NCT02037529|Halichondrin B|halichondrin b|mesh-list
102277290|NCT02037529|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102277291|NCT02037529|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102277292|NCT02037529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102277293|NCT02037529|Tubulin Modulators|tubulin modulators|mesh-ancestor
102277294|NCT02037529|Antimitotic Agents|antimitotic agents|mesh-ancestor
102277295|NCT02037529|Mitosis Modulators|mitosis modulators|mesh-ancestor
102277296|NCT02037529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277297|NCT04450199|Vitamin D|vitamin d|mesh-list
102277298|NCT04450199|Ergocalciferols|ergocalciferols|mesh-list
102277299|NCT04450199|Cholecalciferol|cholecalciferol|mesh-list
102277300|NCT04450199|Vitamins|vitamins|mesh-list
102277301|NCT04450199|Micronutrients|micronutrients|mesh-ancestor
101374371|NCT04721899|Vitamin D|vitamin d|mesh-list
102277302|NCT04450199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277303|NCT04450199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102277304|NCT04450199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102277305|NCT01884259|Docetaxel|docetaxel|mesh-list
102277306|NCT01884259|Fluorouracil|fluorouracil|mesh-list
102277307|NCT01884259|Cetuximab|cetuximab|mesh-list
102277308|NCT01884259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102277309|NCT01884259|Tubulin Modulators|tubulin modulators|mesh-ancestor
102277310|NCT01884259|Antimitotic Agents|antimitotic agents|mesh-ancestor
102277311|NCT01884259|Mitosis Modulators|mitosis modulators|mesh-ancestor
102277312|NCT01884259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277313|NCT01884259|Antimetabolites|antimetabolites|mesh-ancestor
102277314|NCT01884259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102277315|NCT01884259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102277316|NCT01884259|Immunologic Factors|immunologic factors|mesh-ancestor
102277317|NCT01884259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277318|NCT01884259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102277319|NCT04930549|Dapagliflozin|dapagliflozin|mesh-list
102277320|NCT04930549|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102277321|NCT04930549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277322|NCT04930549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102277323|NCT04930549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277324|NCT04508621|Cyclobenzaprine|cyclobenzaprine|mesh-list
102277325|NCT04508621|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102277326|NCT04508621|Antidepressive Agents|antidepressive agents|mesh-ancestor
102277327|NCT04508621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102277328|NCT04508621|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102277329|NCT04508621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277330|NCT04508621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102277331|NCT04508621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102277332|NCT04508621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102277333|NCT04508621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102277334|NCT03067727|Dinoprostone|dinoprostone|mesh-list
102277335|NCT03067727|Oxytocics|oxytocics|mesh-ancestor
102277336|NCT03067727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102277337|NCT03067727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277338|NCT01794793|Cabergoline|cabergoline|mesh-list
102277339|NCT01794793|Pasireotide|pasireotide|mesh-list
102277340|NCT01794793|Somatostatin|somatostatin|mesh-list
102277341|NCT01794793|Hormones|hormones|mesh-ancestor
102277342|NCT01794793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102277343|NCT01794793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277344|NCT01794793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102277345|NCT01794793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102277346|NCT01794793|Dopamine Agonists|dopamine agonists|mesh-ancestor
102277347|NCT01794793|Dopamine Agents|dopamine agents|mesh-ancestor
102277348|NCT01794793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102277349|NCT01794793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277350|NCT03067103|Ketamine|ketamine|mesh-list
102277351|NCT03067103|Tramadol|tramadol|mesh-list
102277352|NCT03067103|Analgesics|analgesics|mesh-ancestor
102277353|NCT03067103|Sensory System Agents|sensory system agents|mesh-ancestor
102277354|NCT03067103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101374444|NCT00096291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102277355|NCT03067103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277356|NCT03067103|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102277357|NCT03067103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102277358|NCT03067103|Anesthetics, General|anesthetics, general|mesh-ancestor
102277359|NCT03067103|Anesthetics|anesthetics|mesh-ancestor
102277360|NCT03067103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102277361|NCT03067103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102277362|NCT03067103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102277363|NCT03067103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102277364|NCT03067103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277365|NCT03067103|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102277366|NCT03067103|Narcotics|narcotics|mesh-ancestor
102277367|NCT05492123|Cisplatin|cisplatin|mesh-list
102277368|NCT05492123|Nivolumab|nivolumab|mesh-list
102277369|NCT05492123|Ipilimumab|ipilimumab|mesh-list
102277370|NCT05492123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102277371|NCT05492123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102277372|NCT05492123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102277373|NCT05492123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277374|NCT01398319|Ethanol|ethanol|mesh-list
102277375|NCT01398319|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102277376|NCT01398319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102277377|NCT01398319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102277378|NCT01398319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277379|NCT01305889|Sertraline|sertraline|mesh-list
102277380|NCT01305889|Antidepressive Agents|antidepressive agents|mesh-ancestor
102277381|NCT01305889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102277382|NCT01305889|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102277383|NCT01305889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102277384|NCT01305889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102277385|NCT01305889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277386|NCT01305889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102277387|NCT01305889|Serotonin Agents|serotonin agents|mesh-ancestor
102277388|NCT01305889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277389|NCT05392075|Vaccines|vaccines|mesh-list
102277390|NCT05392075|Immunologic Factors|immunologic factors|mesh-ancestor
102277391|NCT05392075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277392|NCT00223171|Androgens|androgens|mesh-list
102277393|NCT00223171|Hormones|hormones|mesh-ancestor
102277394|NCT00223171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102277395|NCT00223171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277396|NCT03138031|Ethanol|ethanol|mesh-list
102277397|NCT03138031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102277398|NCT03138031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102277399|NCT03138031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102277400|NCT03138031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277401|NCT02735057|Paclitaxel|paclitaxel|mesh-list
102277402|NCT02735057|Carboplatin|carboplatin|mesh-list
102277403|NCT02735057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102277404|NCT02735057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102277405|NCT02735057|Tubulin Modulators|tubulin modulators|mesh-ancestor
102277406|NCT02735057|Antimitotic Agents|antimitotic agents|mesh-ancestor
102277407|NCT02735057|Mitosis Modulators|mitosis modulators|mesh-ancestor
102277408|NCT02735057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277409|NCT05431283|Tofacitinib|tofacitinib|mesh-list
102277410|NCT05431283|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102277411|NCT05431283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102277412|NCT05431283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102277413|NCT05431283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277414|NCT03208985|Ulipristal acetate|ulipristal acetate|mesh-list
102277415|NCT03208985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102277416|NCT03208985|Contraceptive Agents|contraceptive agents|mesh-ancestor
102277417|NCT03208985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102277418|NCT03208985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277419|NCT03208985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102277420|NCT03644953|Hydroxyurea|hydroxyurea|mesh-list
102277421|NCT03644953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102277422|NCT03644953|Antisickling Agents|antisickling agents|mesh-ancestor
102277423|NCT03644953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102277424|NCT03644953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277425|NCT03644953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102277426|NCT03630835|Annexin A5|annexin a5|mesh-list
102277427|NCT03630835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102277428|NCT03630835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277429|NCT04764097|Dapagliflozin|dapagliflozin|mesh-list
102277430|NCT04764097|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102277431|NCT04764097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277432|NCT04764097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102277433|NCT04764097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277434|NCT02902757|Deoxyglucose|deoxyglucose|mesh-list
102277435|NCT02902757|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102277436|NCT02902757|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102277437|NCT02902757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277438|NCT02902757|Antimetabolites|antimetabolites|mesh-ancestor
102277439|NCT02902757|Antiviral Agents|antiviral agents|mesh-ancestor
102277440|NCT02902757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102277441|NCT05391451|Anesthetics|anesthetics|mesh-list
102277442|NCT05391451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102277443|NCT05391451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277444|NCT03110341|Epoetin Alfa|epoetin alfa|mesh-list
102277445|NCT03110341|Hematinics|hematinics|mesh-ancestor
102277446|NCT04648189|Cetuximab|cetuximab|mesh-list
102277447|NCT04648189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102277448|NCT04648189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102277449|NCT04537897|Midazolam|midazolam|mesh-list
102277450|NCT04537897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102277451|NCT04537897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102277452|NCT04537897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102277453|NCT04537897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277454|NCT04537897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102277455|NCT04537897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102277456|NCT04537897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102277457|NCT04537897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102277458|NCT04537897|Anesthetics, General|anesthetics, general|mesh-ancestor
102277459|NCT04537897|Anesthetics|anesthetics|mesh-ancestor
102277460|NCT04537897|GABA Modulators|gaba modulators|mesh-ancestor
102277461|NCT04537897|GABA Agents|gaba agents|mesh-ancestor
102277462|NCT04537897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102277463|NCT04537897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277464|NCT04405063|Paclitaxel|paclitaxel|mesh-list
102277465|NCT04405063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102277466|NCT04405063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102277467|NCT04405063|Tubulin Modulators|tubulin modulators|mesh-ancestor
102277468|NCT04405063|Antimitotic Agents|antimitotic agents|mesh-ancestor
102277469|NCT04405063|Mitosis Modulators|mitosis modulators|mesh-ancestor
102277470|NCT04405063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277471|NCT05090449|Losartan|losartan|mesh-list
102277472|NCT05090449|Chlorthalidone|chlorthalidone|mesh-list
102277473|NCT05090449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102277474|NCT05090449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102277475|NCT05090449|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102277476|NCT05090449|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102277477|NCT05090449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277478|NCT05090449|Diuretics|diuretics|mesh-ancestor
102277479|NCT05090449|Natriuretic Agents|natriuretic agents|mesh-ancestor
102277480|NCT05090449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277481|NCT05090449|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102277482|NCT05090449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102277483|NCT05090137|Diuretics|diuretics|mesh-list
102277484|NCT05090137|Natriuretic Agents|natriuretic agents|mesh-ancestor
102277485|NCT05090137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277486|NCT03067415|Latanoprost|latanoprost|mesh-list
102277487|NCT03067415|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102277488|NCT03067415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102277489|NCT05089981|Acetylcysteine|acetylcysteine|mesh-list
102277490|NCT05089981|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102277491|NCT05089981|Antiviral Agents|antiviral agents|mesh-ancestor
102277492|NCT05089981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102277493|NCT05089981|Expectorants|expectorants|mesh-ancestor
102277494|NCT05089981|Respiratory System Agents|respiratory system agents|mesh-ancestor
102277495|NCT05089981|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102277496|NCT05089981|Antioxidants|antioxidants|mesh-ancestor
102277497|NCT05089981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277498|NCT05089981|Protective Agents|protective agents|mesh-ancestor
102277499|NCT05089981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277500|NCT05089981|Antidotes|antidotes|mesh-ancestor
102277501|NCT04206059|Dexmedetomidine|dexmedetomidine|mesh-list
102277502|NCT04206059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102277503|NCT04206059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102277504|NCT04206059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277505|NCT04206059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102277506|NCT04206059|Analgesics|analgesics|mesh-ancestor
102277507|NCT04206059|Sensory System Agents|sensory system agents|mesh-ancestor
102277508|NCT04206059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102277509|NCT04206059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102277510|NCT04206059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102277511|NCT04206059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102277512|NCT04206059|Adrenergic Agents|adrenergic agents|mesh-ancestor
102277513|NCT04206059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102277514|NCT04206059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277515|NCT05431049|Anesthetics|anesthetics|mesh-list
102277516|NCT05431049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102277517|NCT05431049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277518|NCT04132817|Paclitaxel|paclitaxel|mesh-list
102277519|NCT04132817|Nivolumab|nivolumab|mesh-list
102277520|NCT04132817|Ipilimumab|ipilimumab|mesh-list
102277521|NCT04132817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102277522|NCT04132817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102277523|NCT04132817|Tubulin Modulators|tubulin modulators|mesh-ancestor
102277524|NCT04132817|Antimitotic Agents|antimitotic agents|mesh-ancestor
102277525|NCT04132817|Mitosis Modulators|mitosis modulators|mesh-ancestor
101374695|NCT02967653|Antimetabolites|antimetabolites|mesh-ancestor
102277526|NCT04132817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277527|NCT04132817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102277528|NCT04132817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102277529|NCT03066635|Botulinum Toxins|botulinum toxins|mesh-list
102277530|NCT03066635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102277531|NCT03066635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102277532|NCT03066635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102277533|NCT03066635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102277534|NCT03066635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277535|NCT03066635|Cholinergic Agents|cholinergic agents|mesh-ancestor
102277536|NCT03066635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102277537|NCT03066635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277538|NCT03066635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102277539|NCT03066635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102277540|NCT03136237|Cyclosporine|cyclosporine|mesh-list
102277541|NCT03136237|Digoxin|digoxin|mesh-list
102277542|NCT03136237|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102277543|NCT03136237|Cyclosporins|cyclosporins|mesh-list
102277544|NCT03136237|Berotralstat|berotralstat|mesh-list
102277545|NCT03136237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102277546|NCT03136237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277547|NCT03136237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102277548|NCT03136237|Immunologic Factors|immunologic factors|mesh-ancestor
102277549|NCT03136237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277550|NCT03136237|Antifungal Agents|antifungal agents|mesh-ancestor
102277551|NCT03136237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102277552|NCT03136237|Dermatologic Agents|dermatologic agents|mesh-ancestor
102277553|NCT03136237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102277554|NCT03136237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102277555|NCT03136237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102277556|NCT03136237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102277557|NCT03136237|Antimetabolites|antimetabolites|mesh-ancestor
102277558|NCT03136237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102277559|NCT03136237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102277560|NCT03136237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102277561|NCT03136237|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102277562|NCT03136237|Protective Agents|protective agents|mesh-ancestor
102277563|NCT03136237|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102277564|NCT03136237|Protease Inhibitors|protease inhibitors|mesh-ancestor
102277565|NCT04001309|Anti-Infective Agents|anti-infective agents|mesh-list
102277566|NCT04001309|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102277567|NCT04021381|Magnesium citrate|magnesium citrate|mesh-list
102277568|NCT04021381|Cathartics|cathartics|mesh-ancestor
102277569|NCT04021381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102277570|NCT03066791|Curcumin|curcumin|mesh-list
102277571|NCT03066791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102277572|NCT03066791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102277573|NCT03066791|Analgesics|analgesics|mesh-ancestor
102277574|NCT03066791|Sensory System Agents|sensory system agents|mesh-ancestor
102277575|NCT03066791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102277576|NCT03066791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277577|NCT03066791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102277578|NCT03066791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102277579|NCT03066791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102277580|NCT03066791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102277581|NCT03066791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277582|NCT05729555|Diphenhydramine|diphenhydramine|mesh-list
102277583|NCT05729555|Promethazine|promethazine|mesh-list
102277584|NCT05729555|Ibuprofen|ibuprofen|mesh-list
101986353|NCT03851731|Naltrexone|naltrexone|mesh-list
102277585|NCT05729555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102277586|NCT05729555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102277587|NCT05729555|Analgesics|analgesics|mesh-ancestor
102277588|NCT05729555|Sensory System Agents|sensory system agents|mesh-ancestor
102277589|NCT05729555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102277590|NCT05729555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277591|NCT05729555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102277592|NCT05729555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102277593|NCT05729555|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102277594|NCT05729555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102277595|NCT05729555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277596|NCT05729555|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102277597|NCT05729555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102277598|NCT05729555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102277599|NCT05729555|Anesthetics, Local|anesthetics, local|mesh-ancestor
102277600|NCT05729555|Anesthetics|anesthetics|mesh-ancestor
102277601|NCT05729555|Antiemetics|antiemetics|mesh-ancestor
102277602|NCT05729555|Autonomic Agents|autonomic agents|mesh-ancestor
102277603|NCT05729555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102277604|NCT05729555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102277605|NCT05729555|Histamine Antagonists|histamine antagonists|mesh-ancestor
102277606|NCT05729555|Histamine Agents|histamine agents|mesh-ancestor
102277607|NCT05729555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102277608|NCT05729555|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102277609|NCT05729555|Antipruritics|antipruritics|mesh-ancestor
102277610|NCT05729555|Dermatologic Agents|dermatologic agents|mesh-ancestor
102277611|NCT01603459|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102277612|NCT01603459|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102277613|NCT01603459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102277614|NCT01603459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277615|NCT01603459|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102277616|NCT01603459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102277617|NCT01603459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277619|NCT01603459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102277620|NCT02926027|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
102277621|NCT02926027|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102277622|NCT02926027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102277623|NCT03136003|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
102277624|NCT03136003|Hemostatics|hemostatics|mesh-ancestor
102277625|NCT03136003|Coagulants|coagulants|mesh-ancestor
102277626|NCT03136003|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102277627|NCT03136003|Natriuretic Agents|natriuretic agents|mesh-ancestor
102277628|NCT03136003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277629|NCT05410847|Paclitaxel|paclitaxel|mesh-list
102277630|NCT05410847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102277631|NCT05410847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102277632|NCT05410847|Tubulin Modulators|tubulin modulators|mesh-ancestor
102277633|NCT05410847|Antimitotic Agents|antimitotic agents|mesh-ancestor
102277634|NCT05410847|Mitosis Modulators|mitosis modulators|mesh-ancestor
102277635|NCT05410847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277636|NCT04750291|Botulinum Toxins|botulinum toxins|mesh-list
102277637|NCT04750291|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102277638|NCT04750291|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102277639|NCT04750291|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102277640|NCT04750291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102277641|NCT04750291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277642|NCT04750291|Cholinergic Agents|cholinergic agents|mesh-ancestor
102277643|NCT04750291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102277644|NCT04750291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277645|NCT04750291|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102277646|NCT04750291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102277647|NCT03726749|Prednisone|prednisone|mesh-list
102277648|NCT03726749|Glucocorticoids|glucocorticoids|mesh-list
102277649|NCT03726749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102277650|NCT03726749|Hormones|hormones|mesh-ancestor
102277651|NCT03726749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102277652|NCT03726749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277653|NCT03726749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102277654|NCT03726749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102277655|NCT03821077|Immunomodulating Agents|immunomodulating agents|mesh-list
102277656|NCT03821077|Immunologic Factors|immunologic factors|mesh-ancestor
102277657|NCT03821077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986428|NCT01186549|Sympathomimetics|sympathomimetics|mesh-ancestor
102277658|NCT03136705|Niacinamide|niacinamide|mesh-list
102277659|NCT03136705|Niacin|niacin|mesh-list
102277660|NCT03136705|Nicotinic Acids|nicotinic acids|mesh-list
102277661|NCT03136705|Vitamin B Complex|vitamin b complex|mesh-ancestor
102277662|NCT03136705|Vitamins|vitamins|mesh-ancestor
102277663|NCT03136705|Micronutrients|micronutrients|mesh-ancestor
102277664|NCT03136705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277665|NCT03136705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102277666|NCT03136705|Antimetabolites|antimetabolites|mesh-ancestor
102277667|NCT03136705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277668|NCT03136705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102277669|NCT03136705|Vasodilator Agents|vasodilator agents|mesh-ancestor
102277670|NCT04540861|Siponimod|siponimod|mesh-list
102277671|NCT04540861|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102277672|NCT04540861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277673|NCT04540861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102277674|NCT04540861|Immunologic Factors|immunologic factors|mesh-ancestor
102277675|NCT04540861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277676|NCT03066557|Apatinib|apatinib|mesh-list
102277677|NCT03066557|Chlorotrianisene|chlorotrianisene|mesh-list
102277678|NCT03066557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102277679|NCT03066557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102277680|NCT03066557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102277681|NCT03066557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277682|NCT03066557|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102277683|NCT03066557|Estrogens|estrogens|mesh-ancestor
102277684|NCT03066557|Hormones|hormones|mesh-ancestor
101619393|NCT05659407|Rituximab|rituximab|mesh-list
102277685|NCT03066557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102277686|NCT03066557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277687|NCT03066557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102277688|NCT05728619|Temozolomide|temozolomide|mesh-list
102277689|NCT05728619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102277690|NCT05728619|Alkylating Agents|alkylating agents|mesh-ancestor
102277691|NCT05728619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277692|NCT05728619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102277693|NCT05737303|Paclitaxel|paclitaxel|mesh-list
102277694|NCT05737303|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102277695|NCT05737303|Carboplatin|carboplatin|mesh-list
102277696|NCT05737303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102277697|NCT05737303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102277698|NCT05737303|Tubulin Modulators|tubulin modulators|mesh-ancestor
102277699|NCT05737303|Antimitotic Agents|antimitotic agents|mesh-ancestor
102277700|NCT05737303|Mitosis Modulators|mitosis modulators|mesh-ancestor
102277701|NCT05737303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277702|NCT03066089|Fenugreek seed meal|fenugreek seed meal|mesh-list
102277703|NCT03066089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102277704|NCT03066089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277705|NCT05188313|Paclitaxel|paclitaxel|mesh-list
102277706|NCT05188313|Carboplatin|carboplatin|mesh-list
102277707|NCT05188313|Trastuzumab|trastuzumab|mesh-list
102277708|NCT05188313|Pertuzumab|pertuzumab|mesh-list
102277709|NCT05188313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102277710|NCT05188313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102277711|NCT05188313|Tubulin Modulators|tubulin modulators|mesh-ancestor
102277712|NCT05188313|Antimitotic Agents|antimitotic agents|mesh-ancestor
102277713|NCT05188313|Mitosis Modulators|mitosis modulators|mesh-ancestor
102277714|NCT05188313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277715|NCT05188313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102277716|NCT02514655|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102277717|NCT02514655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102277718|NCT03066011|Voriconazole|voriconazole|mesh-list
102277719|NCT03066011|Posaconazole|posaconazole|mesh-list
102277720|NCT03066011|Isavuconazole|isavuconazole|mesh-list
102277721|NCT03066011|Antifungal Agents|antifungal agents|mesh-ancestor
102277722|NCT03066011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102277723|NCT03066011|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102277724|NCT03066011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102277725|NCT03066011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102277726|NCT03066011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277727|NCT03066011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102277728|NCT03066011|Hormone Antagonists|hormone antagonists|mesh-ancestor
102277729|NCT03066011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102277730|NCT03066011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277731|NCT03066011|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101986499|NCT01328015|Oxybutynin|oxybutynin|mesh-list
102277732|NCT03066011|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102277733|NCT03066011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102277734|NCT03066011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102277735|NCT03135769|Avelumab|avelumab|mesh-list
102277736|NCT03135769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102277737|NCT03135769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102277738|NCT03123211|Veliparib|veliparib|mesh-list
102277739|NCT03123211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102277740|NCT03123211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102277741|NCT03123211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277742|NCT03123211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102277743|NCT05520749|Luspatercept|luspatercept|mesh-list
102277744|NCT05520749|Hematinics|hematinics|mesh-ancestor
102277745|NCT03073525|Atezolizumab|atezolizumab|mesh-list
102277746|NCT03073525|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102277747|NCT03073525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277748|NCT03073525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102277749|NCT03073525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102277750|NCT02563015|Vitamin D|vitamin d|mesh-list
102277751|NCT02563015|Cholecalciferol|cholecalciferol|mesh-list
102277752|NCT02563015|Vitamins|vitamins|mesh-ancestor
102277753|NCT02563015|Micronutrients|micronutrients|mesh-ancestor
102277754|NCT02563015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277755|NCT02563015|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102277756|NCT02563015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102277757|NCT02382445|Anesthetics|anesthetics|mesh-list
102277758|NCT02382445|Propofol|propofol|mesh-list
102277759|NCT02382445|Sevoflurane|sevoflurane|mesh-list
102277760|NCT02382445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102277761|NCT02382445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277762|NCT02382445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102277763|NCT02382445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102277764|NCT02382445|Anesthetics, General|anesthetics, general|mesh-ancestor
102277765|NCT02382445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102277766|NCT02382445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102277767|NCT05736757|Plasminogen|plasminogen|mesh-list
102277768|NCT05736757|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102277769|NCT05736757|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102277770|NCT05736757|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102277771|NCT05736757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277772|NCT04483739|Dexamethasone|dexamethasone|mesh-list
102277773|NCT04483739|Dexamethasone acetate|dexamethasone acetate|mesh-list
102277774|NCT04483739|Lenalidomide|lenalidomide|mesh-list
102277775|NCT04483739|BB 1101|bb 1101|mesh-list
102277776|NCT04483739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102277777|NCT04483739|Antiemetics|antiemetics|mesh-ancestor
102277778|NCT04483739|Autonomic Agents|autonomic agents|mesh-ancestor
102277779|NCT04483739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102277780|NCT04483739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277781|NCT04483739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102277782|NCT04483739|Glucocorticoids|glucocorticoids|mesh-ancestor
102277783|NCT04483739|Hormones|hormones|mesh-ancestor
102277784|NCT04483739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102277785|NCT04483739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102277786|NCT04483739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102277787|NCT04483739|Protease Inhibitors|protease inhibitors|mesh-ancestor
102277788|NCT04483739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102277789|NCT04483739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277790|NCT04483739|Immunologic Factors|immunologic factors|mesh-ancestor
102277791|NCT04483739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102277792|NCT04483739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102277793|NCT04483739|Growth Substances|growth substances|mesh-ancestor
102277794|NCT04483739|Growth Inhibitors|growth inhibitors|mesh-ancestor
102277795|NCT05727475|Fluorides|fluorides|mesh-list
102277796|NCT05727475|Cariostatic Agents|cariostatic agents|mesh-ancestor
102277797|NCT05727475|Protective Agents|protective agents|mesh-ancestor
102277798|NCT05727475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277799|NCT05091775|Mesalamine|mesalamine|mesh-list
102277800|NCT05091775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102277801|NCT05091775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102277802|NCT05091775|Analgesics|analgesics|mesh-ancestor
102277803|NCT05091775|Sensory System Agents|sensory system agents|mesh-ancestor
102277804|NCT05091775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102277805|NCT05091775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277806|NCT05091775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102277807|NCT05091775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102277808|NCT04821869|Albuterol|albuterol|mesh-list
102277809|NCT04821869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102277810|NCT04821869|Autonomic Agents|autonomic agents|mesh-ancestor
102277811|NCT04821869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102277812|NCT04821869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277813|NCT04821869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102277814|NCT04821869|Respiratory System Agents|respiratory system agents|mesh-ancestor
102277815|NCT04821869|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102277816|NCT04821869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102277817|NCT04821869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102277818|NCT04821869|Adrenergic Agents|adrenergic agents|mesh-ancestor
102277819|NCT04821869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102277820|NCT04821869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277821|NCT04821869|Tocolytic Agents|tocolytic agents|mesh-ancestor
102277822|NCT04821869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102277823|NCT05091463|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
102277824|NCT05091463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102277825|NCT05091463|Immunologic Factors|immunologic factors|mesh-ancestor
102277826|NCT05091463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277827|NCT02631551|Mometasone Furoate|mometasone furoate|mesh-list
102277828|NCT02631551|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
102277829|NCT02631551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102277830|NCT02631551|Dermatologic Agents|dermatologic agents|mesh-ancestor
102277831|NCT02631551|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102277832|NCT02631551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102277833|NCT02631551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102277834|NCT02631551|Analgesics|analgesics|mesh-ancestor
102277835|NCT02631551|Sensory System Agents|sensory system agents|mesh-ancestor
102277836|NCT02631551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102277837|NCT02631551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277838|NCT02631551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102277839|NCT02631551|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102277840|NCT02631551|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102277841|NCT02631551|Histamine Antagonists|histamine antagonists|mesh-ancestor
102277842|NCT02631551|Histamine Agents|histamine agents|mesh-ancestor
102277843|NCT02631551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102277844|NCT02631551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277845|NCT05091151|Dexmedetomidine|dexmedetomidine|mesh-list
102277846|NCT05091151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102277847|NCT05091151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102277848|NCT05091151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277849|NCT05091151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102277850|NCT05091151|Analgesics|analgesics|mesh-ancestor
102277851|NCT05091151|Sensory System Agents|sensory system agents|mesh-ancestor
102277852|NCT05091151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102277853|NCT05091151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102277854|NCT05091151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102277855|NCT05091151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102277856|NCT05091151|Adrenergic Agents|adrenergic agents|mesh-ancestor
102277857|NCT05091151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102277858|NCT05091151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277859|NCT05466539|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102277860|NCT05466539|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102277861|NCT05466539|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102277862|NCT05466539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102277863|NCT05466539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277864|NCT05466539|Cholinergic Agents|cholinergic agents|mesh-ancestor
102277865|NCT05466539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102277866|NCT05466539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277867|NCT05466539|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102277868|NCT05466539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102277869|NCT04447469|Mavrilimumab|mavrilimumab|mesh-list
102277870|NCT04447469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102277871|NCT04447235|Ivermectin|ivermectin|mesh-list
102277872|NCT04447235|Losartan|losartan|mesh-list
102277873|NCT04447235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102277874|NCT04447235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102277875|NCT04447235|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102277876|NCT04447235|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102277877|NCT04447235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277878|NCT04447235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102277879|NCT04447235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102277880|NCT01680991|Obinutuzumab|obinutuzumab|mesh-list
102277881|NCT01680991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102277882|NCT01680991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102277883|NCT01700569|Leucovorin|leucovorin|mesh-list
102277884|NCT01700569|Folic Acid|folic acid|mesh-list
102277885|NCT01700569|Temozolomide|temozolomide|mesh-list
102277886|NCT01700569|Levoleucovorin|levoleucovorin|mesh-list
102277887|NCT01700569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277888|NCT01700569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102277889|NCT01700569|Alkylating Agents|alkylating agents|mesh-ancestor
102277890|NCT01700569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277891|NCT01700569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102277892|NCT01700569|Antidotes|antidotes|mesh-ancestor
102277893|NCT01700569|Protective Agents|protective agents|mesh-ancestor
102277894|NCT01700569|Vitamin B Complex|vitamin b complex|mesh-ancestor
102277895|NCT01700569|Vitamins|vitamins|mesh-ancestor
102277896|NCT01700569|Micronutrients|micronutrients|mesh-ancestor
102277897|NCT01700569|Hematinics|hematinics|mesh-ancestor
102277898|NCT05090761|Magnesium Sulfate|magnesium sulfate|mesh-list
102277899|NCT05090761|Buprenorphine|buprenorphine|mesh-list
102277900|NCT05090761|Bupivacaine|bupivacaine|mesh-list
102277901|NCT05090761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102277902|NCT05090761|Anesthetics, Local|anesthetics, local|mesh-ancestor
102277903|NCT05090761|Anesthetics|anesthetics|mesh-ancestor
102277904|NCT05090761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102277905|NCT05090761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277906|NCT05090761|Sensory System Agents|sensory system agents|mesh-ancestor
102277907|NCT05090761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102277908|NCT05090761|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102277909|NCT05090761|Narcotics|narcotics|mesh-ancestor
102277910|NCT05090761|Analgesics|analgesics|mesh-ancestor
102277911|NCT05090761|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102277912|NCT05090761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102277913|NCT05090761|Anticonvulsants|anticonvulsants|mesh-ancestor
102277914|NCT05090761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102277915|NCT05090761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102277916|NCT05090761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277917|NCT05090761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102277918|NCT05090761|Tocolytic Agents|tocolytic agents|mesh-ancestor
102277919|NCT05090761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102277920|NCT03065309|Remifentanil|remifentanil|mesh-list
102277921|NCT03065309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102277922|NCT03065309|Narcotics|narcotics|mesh-ancestor
102277923|NCT03065309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102277924|NCT03065309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277925|NCT03065309|Analgesics|analgesics|mesh-ancestor
102277926|NCT03065309|Sensory System Agents|sensory system agents|mesh-ancestor
102277927|NCT03065309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102277928|NCT02819479|Bevacizumab|bevacizumab|mesh-list
102277930|NCT02819479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102277931|NCT02819479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102277932|NCT02819479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102277933|NCT02819479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102277934|NCT02819479|Growth Substances|growth substances|mesh-ancestor
102277935|NCT02819479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277936|NCT02819479|Growth Inhibitors|growth inhibitors|mesh-ancestor
102277937|NCT02819479|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102277938|NCT02819479|Diuretics|diuretics|mesh-ancestor
102277939|NCT02819479|Natriuretic Agents|natriuretic agents|mesh-ancestor
102277940|NCT05376943|Antiviral Agents|antiviral agents|mesh-list
102277941|NCT05376943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102277942|NCT04074785|Bevacizumab|bevacizumab|mesh-list
102277943|NCT04074785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102277944|NCT04074785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102277945|NCT04074785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102277946|NCT04074785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102277947|NCT04074785|Growth Substances|growth substances|mesh-ancestor
102277948|NCT04074785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277949|NCT04074785|Growth Inhibitors|growth inhibitors|mesh-ancestor
102277950|NCT04533841|Propranolol|propranolol|mesh-list
102277951|NCT04533841|Misoprostol|misoprostol|mesh-list
102277952|NCT04533841|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102277953|NCT04533841|Abortifacient Agents|abortifacient agents|mesh-ancestor
102277954|NCT04533841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102277955|NCT04533841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277956|NCT04533841|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102277957|NCT04533841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102277958|NCT04533841|Oxytocics|oxytocics|mesh-ancestor
102277959|NCT04533841|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102277960|NCT04533841|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102277961|NCT04533841|Adrenergic Agents|adrenergic agents|mesh-ancestor
102277962|NCT04533841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102277963|NCT04533841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277964|NCT04533841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102277965|NCT04533841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102277966|NCT04533841|Vasodilator Agents|vasodilator agents|mesh-ancestor
102277967|NCT04536805|Metformin|metformin|mesh-list
102277968|NCT04536805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102277969|NCT04536805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277970|NCT05376865|Vitamin D|vitamin d|mesh-list
102277971|NCT05376865|Vitamins|vitamins|mesh-ancestor
102277972|NCT05376865|Micronutrients|micronutrients|mesh-ancestor
102277973|NCT05376865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277974|NCT05376865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102277975|NCT04064411|Abaloparatide|abaloparatide|mesh-list
102277976|NCT04064411|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
102277977|NCT04064411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102277978|NCT04064411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277979|NCT04064411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102277980|NCT04012931|Rilpivirine|rilpivirine|mesh-list
101619695|NCT02817321|Morphine|morphine|mesh-list
102277981|NCT04012931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102277982|NCT04012931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102277983|NCT04012931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102277984|NCT04012931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102277985|NCT04012931|Antiviral Agents|antiviral agents|mesh-ancestor
102277986|NCT04012931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102277987|NCT04012931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102277988|NCT04012931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102277989|NCT03063359|Fentanyl|fentanyl|mesh-list
102277990|NCT03063359|Morphine|morphine|mesh-list
102277991|NCT03063359|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102277992|NCT03063359|Narcotics|narcotics|mesh-ancestor
102277993|NCT03063359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102277994|NCT03063359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102277995|NCT03063359|Analgesics|analgesics|mesh-ancestor
102277996|NCT03063359|Sensory System Agents|sensory system agents|mesh-ancestor
102277997|NCT03063359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102277998|NCT03063359|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102277999|NCT03063359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102278000|NCT03063359|Anesthetics, General|anesthetics, general|mesh-ancestor
102278001|NCT03063359|Anesthetics|anesthetics|mesh-ancestor
102278002|NCT02660359|Hemagglutinins|hemagglutinins|mesh-list
102278003|NCT02660359|Botulinum Toxins|botulinum toxins|mesh-list
102278004|NCT02660359|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102278005|NCT02660359|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102278006|NCT02660359|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102278007|NCT02660359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102278008|NCT02660359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278009|NCT02660359|Cholinergic Agents|cholinergic agents|mesh-ancestor
102278010|NCT02660359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102278011|NCT02660359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278012|NCT02660359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102278013|NCT02660359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102278014|NCT02660359|Agglutinins|agglutinins|mesh-ancestor
102278015|NCT02660359|Immunologic Factors|immunologic factors|mesh-ancestor
102278016|NCT02660359|Coagulants|coagulants|mesh-ancestor
102278017|NCT05067985|Anesthetics|anesthetics|mesh-list
102278018|NCT05067985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102278019|NCT05067985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278020|NCT04262869|Paclitaxel|paclitaxel|mesh-list
102278021|NCT04262869|Carboplatin|carboplatin|mesh-list
102278022|NCT04262869|Pemetrexed|pemetrexed|mesh-list
102278023|NCT04262869|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102278024|NCT04262869|Durvalumab|durvalumab|mesh-list
102278025|NCT04262869|Immunoglobulins|immunoglobulins|mesh-list
102278026|NCT04262869|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102278027|NCT04262869|Immunoglobulin G|immunoglobulin g|mesh-list
102278028|NCT04262869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102278029|NCT04262869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102278030|NCT04262869|Tubulin Modulators|tubulin modulators|mesh-ancestor
102278031|NCT04262869|Antimitotic Agents|antimitotic agents|mesh-ancestor
102278032|NCT04262869|Mitosis Modulators|mitosis modulators|mesh-ancestor
102278033|NCT04262869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278034|NCT04262869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102278035|NCT04262869|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102278036|NCT04262869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102278037|NCT04262869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102278038|NCT04262869|Immunologic Factors|immunologic factors|mesh-ancestor
102278039|NCT04262869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278040|NCT05092165|Methylene Blue|methylene blue|mesh-list
102278041|NCT05092165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102278042|NCT05092165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278043|NCT03062813|Entecavir|entecavir|mesh-list
102278044|NCT03062813|Tacrolimus|tacrolimus|mesh-list
102278045|NCT03062813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102278046|NCT03062813|Immunologic Factors|immunologic factors|mesh-ancestor
102278047|NCT03062813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278048|NCT03062813|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102278049|NCT03062813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102278050|NCT03062813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278051|NCT03062813|Antiviral Agents|antiviral agents|mesh-ancestor
102278052|NCT03062813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102278053|NCT04893161|Belimumab|belimumab|mesh-list
102278054|NCT04893161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102278055|NCT04893161|Immunologic Factors|immunologic factors|mesh-ancestor
102278056|NCT04893161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278057|NCT04884035|Prednisone|prednisone|mesh-list
102278058|NCT04884035|Prednisolone|prednisolone|mesh-list
102278059|NCT04884035|Cyclophosphamide|cyclophosphamide|mesh-list
102278060|NCT04884035|Rituximab|rituximab|mesh-list
102278061|NCT04884035|Doxorubicin|doxorubicin|mesh-list
102278062|NCT04884035|Vincristine|vincristine|mesh-list
102278063|NCT04884035|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
102278064|NCT04884035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102278065|NCT04884035|Immunologic Factors|immunologic factors|mesh-ancestor
102278066|NCT04884035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278067|NCT04884035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102278068|NCT04884035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102278069|NCT04884035|Alkylating Agents|alkylating agents|mesh-ancestor
102278070|NCT04884035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278071|NCT04884035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102278072|NCT04884035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102278073|NCT04884035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102278074|NCT04884035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102278075|NCT04884035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102278076|NCT04884035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102278077|NCT04884035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102278078|NCT04884035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102278079|NCT04884035|Glucocorticoids|glucocorticoids|mesh-ancestor
102278080|NCT04884035|Hormones|hormones|mesh-ancestor
102278081|NCT04884035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102278082|NCT04884035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102278083|NCT04884035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102278084|NCT04884035|Tubulin Modulators|tubulin modulators|mesh-ancestor
102278085|NCT04884035|Antimitotic Agents|antimitotic agents|mesh-ancestor
102278086|NCT04884035|Mitosis Modulators|mitosis modulators|mesh-ancestor
102278087|NCT04884035|Immunoconjugates|immunoconjugates|mesh-ancestor
102278088|NCT04582981|Raltitrexed|raltitrexed|mesh-list
102278089|NCT04582981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102278090|NCT04582981|Antimetabolites|antimetabolites|mesh-ancestor
102278091|NCT04582981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278092|NCT04582981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102278093|NCT04582981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102278094|NCT04582981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102278095|NCT04469179|Immunoglobulins|immunoglobulins|mesh-list
102278096|NCT04469179|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102278097|NCT04469179|Immunologic Factors|immunologic factors|mesh-ancestor
102278098|NCT04469179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278099|NCT04531579|Valproic Acid|valproic acid|mesh-list
102278100|NCT04531579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102278101|NCT04531579|Anticonvulsants|anticonvulsants|mesh-ancestor
102278102|NCT04531579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102278103|NCT04531579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278104|NCT04531579|GABA Agents|gaba agents|mesh-ancestor
102278105|NCT04531579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102278106|NCT04531579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278107|NCT04531579|Antimanic Agents|antimanic agents|mesh-ancestor
102278108|NCT04531579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102278109|NCT04531579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102278110|NCT04531579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102278111|NCT03839459|Denosumab|denosumab|mesh-list
102278112|NCT03839459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102278113|NCT03839459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278114|NCT05097781|Antibodies|antibodies|mesh-list
102278115|NCT05097781|Antibodies, Blocking|antibodies, blocking|mesh-list
102278116|NCT05097781|Immunologic Factors|immunologic factors|mesh-ancestor
102278117|NCT05097781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278118|NCT01117441|Cytarabine|cytarabine|mesh-list
102278119|NCT01117441|Dexamethasone|dexamethasone|mesh-list
102278120|NCT01117441|Prednisone|prednisone|mesh-list
102278121|NCT01117441|Cyclophosphamide|cyclophosphamide|mesh-list
102278122|NCT01117441|Ifosfamide|ifosfamide|mesh-list
102278123|NCT01117441|Doxorubicin|doxorubicin|mesh-list
102278124|NCT01117441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102278125|NCT01117441|Methotrexate|methotrexate|mesh-list
102278126|NCT01117441|Fludarabine|fludarabine|mesh-list
102278127|NCT01117441|Etoposide|etoposide|mesh-list
102278128|NCT01117441|Vincristine|vincristine|mesh-list
102278129|NCT01117441|Daunorubicin|daunorubicin|mesh-list
102278130|NCT01117441|Asparaginase|asparaginase|mesh-list
102278131|NCT01117441|Mercaptopurine|mercaptopurine|mesh-list
102278132|NCT01117441|Thioguanine|thioguanine|mesh-list
102278133|NCT01117441|Pegaspargase|pegaspargase|mesh-list
102278134|NCT01117441|Vindesine|vindesine|mesh-list
102278135|NCT01117441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102278136|NCT01117441|Immunologic Factors|immunologic factors|mesh-ancestor
102278137|NCT01117441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278138|NCT01117441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102278139|NCT01117441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102278140|NCT01117441|Alkylating Agents|alkylating agents|mesh-ancestor
102278141|NCT01117441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278142|NCT01117441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102278143|NCT01117441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102278144|NCT01117441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102278145|NCT01117441|Antiemetics|antiemetics|mesh-ancestor
102278146|NCT01117441|Autonomic Agents|autonomic agents|mesh-ancestor
102278147|NCT01117441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102278148|NCT01117441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102278149|NCT01117441|Glucocorticoids|glucocorticoids|mesh-ancestor
102278150|NCT01117441|Hormones|hormones|mesh-ancestor
102278151|NCT01117441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102278152|NCT01117441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102278153|NCT01117441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102278154|NCT01117441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102278155|NCT01117441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102278156|NCT01117441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102278157|NCT01117441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102278158|NCT01117441|Abortifacient Agents|abortifacient agents|mesh-ancestor
102278159|NCT01117441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102278160|NCT01117441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102278161|NCT01117441|Antimetabolites|antimetabolites|mesh-ancestor
102278162|NCT01117441|Dermatologic Agents|dermatologic agents|mesh-ancestor
102278163|NCT01117441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102278164|NCT01117441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102278165|NCT01117441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102278166|NCT01117441|Antiviral Agents|antiviral agents|mesh-ancestor
102278167|NCT01117441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102278168|NCT01117441|Tubulin Modulators|tubulin modulators|mesh-ancestor
102278169|NCT01117441|Antimitotic Agents|antimitotic agents|mesh-ancestor
102278170|NCT01117441|Mitosis Modulators|mitosis modulators|mesh-ancestor
102278171|NCT01101451|Cisplatin|cisplatin|mesh-list
102278172|NCT01101451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102278173|NCT03656627|Nivolumab|nivolumab|mesh-list
102278174|NCT03656627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102278175|NCT03656627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102278176|NCT03656627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102278177|NCT03656627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278178|NCT04759703|Pramipexole|pramipexole|mesh-list
102278179|NCT04759703|Antioxidants|antioxidants|mesh-ancestor
102278180|NCT04759703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278181|NCT04759703|Protective Agents|protective agents|mesh-ancestor
102278182|NCT04759703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278183|NCT04759703|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102278184|NCT04759703|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102278185|NCT04759703|Dopamine Agonists|dopamine agonists|mesh-ancestor
102278186|NCT04759703|Dopamine Agents|dopamine agents|mesh-ancestor
102278187|NCT04759703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102278188|NCT05026801|Azithromycin|azithromycin|mesh-list
102278189|NCT05026801|Hydroxychloroquine|hydroxychloroquine|mesh-list
102278190|NCT05026801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102278191|NCT05026801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102278192|NCT05026801|Antimalarials|antimalarials|mesh-ancestor
102278193|NCT05026801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102278194|NCT05026801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102278195|NCT05026801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102278196|NCT05026801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278197|NCT05026801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102278198|NCT03511625|Methylprednisolone|methylprednisolone|mesh-list
102278199|NCT03511625|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102278200|NCT03511625|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102278201|NCT03511625|Prednisolone|prednisolone|mesh-list
102278202|NCT03511625|Prednisolone acetate|prednisolone acetate|mesh-list
102278203|NCT03511625|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102278204|NCT03511625|Prednisolone phosphate|prednisolone phosphate|mesh-list
102278205|NCT03511625|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102278206|NCT03511625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102278207|NCT03511625|Antiemetics|antiemetics|mesh-ancestor
102278208|NCT03511625|Autonomic Agents|autonomic agents|mesh-ancestor
102278209|NCT03511625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102278210|NCT03511625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278211|NCT03511625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102278212|NCT03511625|Glucocorticoids|glucocorticoids|mesh-ancestor
102278213|NCT03511625|Hormones|hormones|mesh-ancestor
102278214|NCT03511625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102278215|NCT03511625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102278216|NCT03511625|Protective Agents|protective agents|mesh-ancestor
102278217|NCT03511625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102278218|NCT03511625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102278219|NCT03493061|Oxaliplatin|oxaliplatin|mesh-list
102278220|NCT03493061|Irinotecan|irinotecan|mesh-list
102278221|NCT03493061|Floxuridine|floxuridine|mesh-list
102278222|NCT03493061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102278223|NCT03493061|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102278224|NCT03493061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102278225|NCT03493061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102278226|NCT03493061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278227|NCT03493061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102278228|NCT03493061|Antimetabolites|antimetabolites|mesh-ancestor
102278229|NCT04523935|Topiramate|topiramate|mesh-list
102278230|NCT04523935|Lamotrigine|lamotrigine|mesh-list
102278231|NCT04523935|Diazepam|diazepam|mesh-list
102278232|NCT04523935|Gabapentin|gabapentin|mesh-list
102278233|NCT04523935|Amitriptyline|amitriptyline|mesh-list
102278234|NCT04523935|Anticonvulsants|anticonvulsants|mesh-list
102278235|NCT04523935|Clonazepam|clonazepam|mesh-list
102278236|NCT04523935|Trihexyphenidyl|trihexyphenidyl|mesh-list
102278237|NCT04523935|Baclofen|baclofen|mesh-list
102278238|NCT04523935|Tetrabenazine|tetrabenazine|mesh-list
102278239|NCT04523935|Analgesics|analgesics|mesh-ancestor
102278240|NCT04523935|Sensory System Agents|sensory system agents|mesh-ancestor
102278241|NCT04523935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102278242|NCT04523935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278243|NCT04523935|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102278244|NCT04523935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102278245|NCT04523935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102278246|NCT04523935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102278247|NCT04523935|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102278248|NCT04523935|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102278249|NCT04523935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102278250|NCT04523935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278251|NCT04523935|Antimanic Agents|antimanic agents|mesh-ancestor
102278252|NCT04523935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102278253|NCT04523935|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102278254|NCT04523935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102278255|NCT04523935|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102278256|NCT04523935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102278257|NCT04523935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102278258|NCT04523935|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102278259|NCT04523935|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102278260|NCT04523935|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102278261|NCT04523935|GABA Agonists|gaba agonists|mesh-ancestor
102278262|NCT04523935|GABA Agents|gaba agents|mesh-ancestor
102278263|NCT04523935|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102278264|NCT04523935|Antidepressive Agents|antidepressive agents|mesh-ancestor
102278265|NCT04523935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102278266|NCT04523935|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102278267|NCT04523935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102278268|NCT04523935|Adrenergic Agents|adrenergic agents|mesh-ancestor
102278269|NCT04523935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102278271|NCT04523935|Autonomic Agents|autonomic agents|mesh-ancestor
102278272|NCT04523935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102278273|NCT04523935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102278274|NCT04523935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102278275|NCT04523935|Anesthetics, General|anesthetics, general|mesh-ancestor
102278276|NCT04523935|Anesthetics|anesthetics|mesh-ancestor
102278277|NCT04523935|GABA Modulators|gaba modulators|mesh-ancestor
102278278|NCT04523935|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102278279|NCT04523935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102278280|NCT04523935|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102278281|NCT04523935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102278282|NCT04523935|Cholinergic Agents|cholinergic agents|mesh-ancestor
102278283|NCT02630693|Tamoxifen|tamoxifen|mesh-list
102278284|NCT02630693|Fulvestrant|fulvestrant|mesh-list
102278285|NCT02630693|Palbociclib|palbociclib|mesh-list
102278286|NCT02630693|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102278287|NCT02630693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102278288|NCT02630693|Hormone Antagonists|hormone antagonists|mesh-ancestor
102278289|NCT02630693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102278290|NCT02630693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278291|NCT02630693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102278293|NCT02630693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102278294|NCT02630693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102278295|NCT02630693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102278296|NCT02630693|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102278297|NCT02630693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102278298|NCT02630693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102278299|NCT02630693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278300|NCT02630693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102278301|NCT01938430|Sofosbuvir|sofosbuvir|mesh-list
102278302|NCT01938430|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102278303|NCT01938430|Ledipasvir|ledipasvir|mesh-list
102278304|NCT01938430|Antiviral Agents|antiviral agents|mesh-ancestor
102278305|NCT01938430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102278306|NCT04625530|Tranexamic Acid|tranexamic acid|mesh-list
102278307|NCT04625530|Ferric Compounds|ferric compounds|mesh-list
102278308|NCT04625530|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102278309|NCT04625530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102278310|NCT04625530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278311|NCT04625530|Hemostatics|hemostatics|mesh-ancestor
102278312|NCT04625530|Coagulants|coagulants|mesh-ancestor
102278313|NCT04625530|Hematinics|hematinics|mesh-ancestor
102278314|NCT01916824|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102278315|NCT01916824|Mirtazapine|mirtazapine|mesh-list
102278316|NCT01916824|Citalopram|citalopram|mesh-list
102278317|NCT01916824|Bupropion|bupropion|mesh-list
102278318|NCT01916824|Fluoxetine|fluoxetine|mesh-list
102278319|NCT01916824|Paroxetine|paroxetine|mesh-list
102278320|NCT01916824|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102278321|NCT01916824|Sertraline|sertraline|mesh-list
102278322|NCT01916824|Antidepressive Agents|antidepressive agents|mesh-list
102278323|NCT01916824|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
102278324|NCT01916824|Escitalopram|escitalopram|mesh-list
102278325|NCT01916824|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102278326|NCT01916824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102278327|NCT01916824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102278328|NCT01916824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278329|NCT01916824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102278330|NCT01916824|Serotonin Agents|serotonin agents|mesh-ancestor
102278331|NCT01916824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278332|NCT01916824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102278333|NCT01916824|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102278334|NCT01916824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102278335|NCT01916824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102278336|NCT01916824|Dopamine Agents|dopamine agents|mesh-ancestor
102278337|NCT01916824|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102278338|NCT01916824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101987095|NCT01109615|Pemetrexed|pemetrexed|mesh-list
102278339|NCT01916824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102278340|NCT01916824|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102278341|NCT01916824|Analgesics|analgesics|mesh-ancestor
102278342|NCT01916824|Sensory System Agents|sensory system agents|mesh-ancestor
102278343|NCT01916824|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102278344|NCT01916824|Histamine Antagonists|histamine antagonists|mesh-ancestor
102278345|NCT01916824|Histamine Agents|histamine agents|mesh-ancestor
102278346|NCT01916824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102278347|NCT01916824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102278348|NCT01916824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102278349|NCT01916824|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102278350|NCT01916824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102278351|NCT01916824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102278352|NCT01916824|Adrenergic Agents|adrenergic agents|mesh-ancestor
102278353|NCT01916824|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102278354|NCT01916824|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102278355|NCT01916824|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102278356|NCT01915732|Clindamycin|clindamycin|mesh-list
102278357|NCT01915732|Clindamycin palmitate|clindamycin palmitate|mesh-list
102278358|NCT01915732|Clindamycin phosphate|clindamycin phosphate|mesh-list
102278359|NCT01915732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102278360|NCT01915732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102278361|NCT01915732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102278362|NCT01915732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102278363|NCT01915732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278365|NCT01936870|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102278366|NCT01936870|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102278367|NCT01936870|Cholinergic Agents|cholinergic agents|mesh-ancestor
102278368|NCT01936870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102278369|NCT01936870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278370|NCT01936870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278371|NCT01936870|Urological Agents|urological agents|mesh-ancestor
102278372|NCT01618708|Hylan|hylan|mesh-list
102278373|NCT01618708|Viscosupplements|viscosupplements|mesh-ancestor
102278374|NCT01618708|Protective Agents|protective agents|mesh-ancestor
102278375|NCT01618708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278376|NCT02229149|Paclitaxel|paclitaxel|mesh-list
102278377|NCT02229149|Vinorelbine|vinorelbine|mesh-list
102278378|NCT02229149|Docetaxel|docetaxel|mesh-list
102278379|NCT02229149|Capecitabine|capecitabine|mesh-list
102278380|NCT02229149|Trastuzumab|trastuzumab|mesh-list
102278381|NCT02229149|Pertuzumab|pertuzumab|mesh-list
102278382|NCT02229149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102278383|NCT02229149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102278384|NCT02229149|Tubulin Modulators|tubulin modulators|mesh-ancestor
102278385|NCT02229149|Antimitotic Agents|antimitotic agents|mesh-ancestor
102278386|NCT02229149|Mitosis Modulators|mitosis modulators|mesh-ancestor
102278387|NCT02229149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278388|NCT02229149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102278389|NCT02229149|Antimetabolites|antimetabolites|mesh-ancestor
102278390|NCT02229149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102278391|NCT04642469|Durvalumab|durvalumab|mesh-list
102278392|NCT04642469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102278393|NCT04642469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102278394|NCT04440371|Betamethasone|betamethasone|mesh-list
102278395|NCT04440371|Calcipotriene|calcipotriene|mesh-list
102278396|NCT04440371|Tacrolimus|tacrolimus|mesh-list
102278397|NCT04440371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102278398|NCT04440371|Immunologic Factors|immunologic factors|mesh-ancestor
102278399|NCT04440371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278400|NCT04440371|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102278401|NCT04440371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102278402|NCT04440371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278403|NCT04440371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102278404|NCT04440371|Glucocorticoids|glucocorticoids|mesh-ancestor
102278405|NCT04440371|Hormones|hormones|mesh-ancestor
102278406|NCT04440371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102278407|NCT04440371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102278408|NCT04440371|Respiratory System Agents|respiratory system agents|mesh-ancestor
102278409|NCT04440371|Dermatologic Agents|dermatologic agents|mesh-ancestor
102278420|NCT00694655|Immunologic Factors|immunologic factors|mesh-ancestor
102278421|NCT00694655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278422|NCT04982939|Oxaliplatin|oxaliplatin|mesh-list
102278423|NCT04982939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102278424|NCT04982549|Paclitaxel|paclitaxel|mesh-list
102278425|NCT04982549|Carboplatin|carboplatin|mesh-list
102278426|NCT04982549|Pemetrexed|pemetrexed|mesh-list
102278427|NCT04982549|Durvalumab|durvalumab|mesh-list
102278428|NCT04982549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102278429|NCT04982549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102278430|NCT04982549|Tubulin Modulators|tubulin modulators|mesh-ancestor
102278431|NCT04982549|Antimitotic Agents|antimitotic agents|mesh-ancestor
102278432|NCT04982549|Mitosis Modulators|mitosis modulators|mesh-ancestor
102278433|NCT04982549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278434|NCT04982549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102278435|NCT04982549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102278436|NCT04982549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102278437|NCT04982549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102278438|NCT02592317|Pioglitazone|pioglitazone|mesh-list
102278439|NCT02592317|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102278440|NCT02592317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102278441|NCT02592317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102278442|NCT02592317|Antimetabolites|antimetabolites|mesh-ancestor
102278443|NCT02592317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278444|NCT02592317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102278445|NCT02592317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102278446|NCT02592317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102278447|NCT02592317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102278448|NCT02592317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278450|NCT03062423|Antiviral Agents|antiviral agents|mesh-ancestor
102278451|NCT03062423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102278452|NCT00790933|Vedolizumab|vedolizumab|mesh-list
102278453|NCT00790933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102278454|NCT04981457|Misoprostol|misoprostol|mesh-list
102278455|NCT04981457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102278456|NCT04981457|Abortifacient Agents|abortifacient agents|mesh-ancestor
102278457|NCT04981457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102278458|NCT04981457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278459|NCT04981457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102278460|NCT04981457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102278461|NCT04981457|Oxytocics|oxytocics|mesh-ancestor
102278462|NCT01676701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102278463|NCT01676701|Immunologic Factors|immunologic factors|mesh-ancestor
102278464|NCT01676701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278465|NCT04981379|Hydroxychloroquine|hydroxychloroquine|mesh-list
102278466|NCT04981379|Favipiravir|favipiravir|mesh-list
102278467|NCT04981379|Antimalarials|antimalarials|mesh-ancestor
102278468|NCT04981379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102278469|NCT04981379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102278470|NCT04981379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102278471|NCT04981379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102278472|NCT04981379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278473|NCT04981379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102278474|NCT04981379|Antiviral Agents|antiviral agents|mesh-ancestor
102278475|NCT04389775|Glucagon|glucagon|mesh-list
102278476|NCT04389775|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102278477|NCT04389775|Incretins|incretins|mesh-ancestor
102278478|NCT04389775|Hormones|hormones|mesh-ancestor
102278479|NCT04389775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102278480|NCT04389775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278481|NCT04389775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102278482|NCT03062501|Hydroxyurea|hydroxyurea|mesh-list
102278483|NCT03062501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102278484|NCT03062501|Antisickling Agents|antisickling agents|mesh-ancestor
102278485|NCT03062501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102278486|NCT03062501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278487|NCT03062501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102278488|NCT02102789|Leucovorin|leucovorin|mesh-list
102278489|NCT02102789|Dexamethasone|dexamethasone|mesh-list
102278490|NCT02102789|Fluorouracil|fluorouracil|mesh-list
102278491|NCT02102789|Oxaliplatin|oxaliplatin|mesh-list
102278492|NCT02102789|Floxuridine|floxuridine|mesh-list
102278493|NCT02102789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101987245|NCT01209533|Iloprost|iloprost|mesh-list
102278494|NCT02102789|Antiemetics|antiemetics|mesh-ancestor
102278495|NCT02102789|Autonomic Agents|autonomic agents|mesh-ancestor
102278496|NCT02102789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102278497|NCT02102789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278499|NCT02102789|Glucocorticoids|glucocorticoids|mesh-ancestor
102278500|NCT02102789|Hormones|hormones|mesh-ancestor
102278501|NCT02102789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102278502|NCT02102789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102278503|NCT02102789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102278504|NCT02102789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278505|NCT02102789|Antimetabolites|antimetabolites|mesh-ancestor
102278506|NCT02102789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102278507|NCT02102789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102278508|NCT02102789|Immunologic Factors|immunologic factors|mesh-ancestor
102278509|NCT02102789|Antidotes|antidotes|mesh-ancestor
102278510|NCT02102789|Protective Agents|protective agents|mesh-ancestor
102278511|NCT02102789|Vitamin B Complex|vitamin b complex|mesh-ancestor
102278512|NCT02102789|Vitamins|vitamins|mesh-ancestor
102278513|NCT02102789|Micronutrients|micronutrients|mesh-ancestor
102278514|NCT02926651|Tranexamic Acid|tranexamic acid|mesh-list
102278515|NCT02926651|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102278516|NCT02926651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102278517|NCT02926651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278518|NCT02926651|Hemostatics|hemostatics|mesh-ancestor
102278519|NCT02926651|Coagulants|coagulants|mesh-ancestor
102278520|NCT04305145|Prednisone|prednisone|mesh-list
102278521|NCT04305145|Methylprednisolone|methylprednisolone|mesh-list
102278522|NCT04305145|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102278523|NCT04305145|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102278524|NCT04305145|Prednisolone|prednisolone|mesh-list
102278525|NCT04305145|Prednisolone acetate|prednisolone acetate|mesh-list
102278526|NCT04305145|Infliximab|infliximab|mesh-list
102278527|NCT04305145|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102278528|NCT04305145|Prednisolone phosphate|prednisolone phosphate|mesh-list
102278529|NCT04305145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102278530|NCT04305145|Glucocorticoids|glucocorticoids|mesh-ancestor
102278531|NCT04305145|Hormones|hormones|mesh-ancestor
101378376|NCT00251680|Fenofibrate|fenofibrate|mesh-list
102278532|NCT04305145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102278533|NCT04305145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278534|NCT04305145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102278535|NCT04305145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102278536|NCT04305145|Antiemetics|antiemetics|mesh-ancestor
102278537|NCT04305145|Autonomic Agents|autonomic agents|mesh-ancestor
102278538|NCT04305145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102278539|NCT04305145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102278540|NCT04305145|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102278541|NCT04305145|Protective Agents|protective agents|mesh-ancestor
102278542|NCT04305145|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102278543|NCT04305145|Dermatologic Agents|dermatologic agents|mesh-ancestor
102278544|NCT04305145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102278545|NCT01670279|Brexpiprazole|brexpiprazole|mesh-list
102278546|NCT01670279|Serotonin Agents|serotonin agents|mesh-ancestor
102278547|NCT01670279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102278548|NCT01670279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278549|NCT01670279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278550|NCT01670279|Dopamine Agonists|dopamine agonists|mesh-ancestor
102278551|NCT01670279|Dopamine Agents|dopamine agents|mesh-ancestor
102278552|NCT04188145|Bevacizumab|bevacizumab|mesh-list
102278553|NCT04188145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102278554|NCT04188145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102278555|NCT04188145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102278556|NCT04188145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102278557|NCT04188145|Growth Substances|growth substances|mesh-ancestor
102278558|NCT04188145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278559|NCT04188145|Growth Inhibitors|growth inhibitors|mesh-ancestor
102278560|NCT03063983|Cyclophosphamide|cyclophosphamide|mesh-list
102278561|NCT03063983|Methotrexate|methotrexate|mesh-list
102278562|NCT03063983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102278563|NCT03063983|Immunologic Factors|immunologic factors|mesh-ancestor
102278564|NCT03063983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278565|NCT03063983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102278566|NCT03063983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102278567|NCT03063983|Alkylating Agents|alkylating agents|mesh-ancestor
102278568|NCT03063983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278569|NCT03063983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102278570|NCT03063983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102278571|NCT03063983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102278572|NCT03063983|Abortifacient Agents|abortifacient agents|mesh-ancestor
102278573|NCT03063983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102278574|NCT03063983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102278575|NCT03063983|Antimetabolites|antimetabolites|mesh-ancestor
102278576|NCT03063983|Dermatologic Agents|dermatologic agents|mesh-ancestor
102278577|NCT03063983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102278578|NCT03063983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102278579|NCT03063983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102278580|NCT03945721|Niraparib|niraparib|mesh-list
102278581|NCT03945721|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102278582|NCT03945721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102278583|NCT03945721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278584|NCT03945721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102278586|NCT01876355|Analgesics|analgesics|mesh-ancestor
102278587|NCT01876355|Sensory System Agents|sensory system agents|mesh-ancestor
102278588|NCT01876355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102278589|NCT01876355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278590|NCT01876355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102278591|NCT01876355|Sympatholytics|sympatholytics|mesh-ancestor
102278592|NCT01876355|Autonomic Agents|autonomic agents|mesh-ancestor
102278593|NCT01876355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102278594|NCT01876355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102278595|NCT01876355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102278596|NCT01876355|Adrenergic Agents|adrenergic agents|mesh-ancestor
102278597|NCT01876355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102278598|NCT01876355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278599|NCT02747407|Vaccines|vaccines|mesh-list
102278600|NCT02747407|Immunologic Factors|immunologic factors|mesh-ancestor
102278601|NCT02747407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278602|NCT01870193|Acetylcysteine|acetylcysteine|mesh-list
102278603|NCT01870193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102278604|NCT01870193|Glycine|glycine|mesh-list
102278605|NCT01870193|Antiviral Agents|antiviral agents|mesh-ancestor
102278606|NCT01870193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102278607|NCT01870193|Expectorants|expectorants|mesh-ancestor
102278608|NCT01870193|Respiratory System Agents|respiratory system agents|mesh-ancestor
102278609|NCT01870193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102278610|NCT01870193|Antioxidants|antioxidants|mesh-ancestor
102278611|NCT01870193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278612|NCT01870193|Protective Agents|protective agents|mesh-ancestor
102278613|NCT01870193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278614|NCT01870193|Antidotes|antidotes|mesh-ancestor
102278615|NCT01870193|Glycine Agents|glycine agents|mesh-ancestor
102278616|NCT01870193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102278617|NCT03063905|Buprenorphine|buprenorphine|mesh-list
102278618|NCT03063905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102278619|NCT03063905|Narcotics|narcotics|mesh-ancestor
102278620|NCT03063905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102278621|NCT03063905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278622|NCT03063905|Analgesics|analgesics|mesh-ancestor
102278623|NCT03063905|Sensory System Agents|sensory system agents|mesh-ancestor
102278624|NCT03063905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102278625|NCT03063905|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102278626|NCT04432415|Fluorides|fluorides|mesh-list
102278627|NCT04432415|Fluorides, Topical|fluorides, topical|mesh-list
102278628|NCT04432415|Cariostatic Agents|cariostatic agents|mesh-ancestor
102278629|NCT04432415|Protective Agents|protective agents|mesh-ancestor
102278630|NCT04432415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278631|NCT01402271|Paclitaxel|paclitaxel|mesh-list
102278632|NCT01402271|Carboplatin|carboplatin|mesh-list
102278633|NCT01402271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102278634|NCT01402271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102278635|NCT01402271|Tubulin Modulators|tubulin modulators|mesh-ancestor
102278636|NCT01402271|Antimitotic Agents|antimitotic agents|mesh-ancestor
102278637|NCT01402271|Mitosis Modulators|mitosis modulators|mesh-ancestor
102278638|NCT01402271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278639|NCT03063671|Dexmedetomidine|dexmedetomidine|mesh-list
102278640|NCT03063671|Ketamine|ketamine|mesh-list
102278641|NCT03063671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102278642|NCT03063671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102278643|NCT03063671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278644|NCT03063671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102278645|NCT03063671|Analgesics|analgesics|mesh-ancestor
102278646|NCT03063671|Sensory System Agents|sensory system agents|mesh-ancestor
102278647|NCT03063671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102278648|NCT03063671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102278649|NCT03063671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102278650|NCT03063671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102278651|NCT03063671|Adrenergic Agents|adrenergic agents|mesh-ancestor
102278652|NCT03063671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102278653|NCT03063671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278654|NCT03063671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102278655|NCT03063671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102278656|NCT03063671|Anesthetics, General|anesthetics, general|mesh-ancestor
102278657|NCT03063671|Anesthetics|anesthetics|mesh-ancestor
102278658|NCT03063671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102278659|NCT03063671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102278660|NCT03063827|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102278661|NCT03063827|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102278662|NCT03063827|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102278663|NCT03063827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102278664|NCT03063827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278665|NCT03063827|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102278666|NCT03063827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102278667|NCT03063827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278668|NCT03063827|Cholinergic Agents|cholinergic agents|mesh-ancestor
102278669|NCT03063827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102278670|NCT01669421|Protease Inhibitors|protease inhibitors|mesh-list
102278671|NCT01669421|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
102278672|NCT01669421|Protein C Inhibitor|protein c inhibitor|mesh-list
102278673|NCT01669421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102278674|NCT01669421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278675|NCT01669421|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102278676|NCT01669421|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102278677|NCT04973969|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102278678|NCT04973969|Luteolytic Agents|luteolytic agents|mesh-ancestor
102278679|NCT04973969|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102278680|NCT04973969|Contraceptive Agents|contraceptive agents|mesh-ancestor
102278681|NCT04973969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102278682|NCT04973969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278683|NCT04973969|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102278684|NCT04973969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102278685|NCT04973969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102278687|NCT02958709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102278688|NCT02958709|Antitubercular Agents|antitubercular agents|mesh-ancestor
102278689|NCT02958709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102278690|NCT02958709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102278691|NCT02958709|Leprostatic Agents|leprostatic agents|mesh-ancestor
102278692|NCT02958709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102278693|NCT02958709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102278694|NCT02958709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278695|NCT02958709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102278696|NCT02958709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102278697|NCT02958709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102278698|NCT02958709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102278699|NCT02958709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102278700|NCT02958709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102278701|NCT04979663|Gemcitabine|gemcitabine|mesh-list
102278702|NCT04979663|Oxaliplatin|oxaliplatin|mesh-list
102278703|NCT04979663|Tislelizumab|tislelizumab|mesh-list
102278704|NCT04979663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102278705|NCT04979663|Antimetabolites|antimetabolites|mesh-ancestor
102278706|NCT04979663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278707|NCT04979663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102278708|NCT04979663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102278709|NCT04979585|Paclitaxel|paclitaxel|mesh-list
102278710|NCT04979585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102278711|NCT04979585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102278712|NCT04979585|Tubulin Modulators|tubulin modulators|mesh-ancestor
102278713|NCT04979585|Antimitotic Agents|antimitotic agents|mesh-ancestor
102278714|NCT04979585|Mitosis Modulators|mitosis modulators|mesh-ancestor
102278715|NCT04979585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278716|NCT05103397|Prednisolone|prednisolone|mesh-list
102278717|NCT05103397|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102278718|NCT05103397|Methylprednisolone|methylprednisolone|mesh-list
101987467|NCT03716115|Budesonide|budesonide|mesh-list
102278720|NCT05103397|Prednisolone acetate|prednisolone acetate|mesh-list
102278721|NCT05103397|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102278722|NCT05103397|Prednisolone phosphate|prednisolone phosphate|mesh-list
102278723|NCT05103397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102278724|NCT05103397|Glucocorticoids|glucocorticoids|mesh-ancestor
102278725|NCT05103397|Hormones|hormones|mesh-ancestor
102278726|NCT05103397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102278727|NCT05103397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278728|NCT05103397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102278729|NCT05103397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102278730|NCT05103397|Antiemetics|antiemetics|mesh-ancestor
102278731|NCT05103397|Autonomic Agents|autonomic agents|mesh-ancestor
102278732|NCT05103397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102278733|NCT05103397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102278734|NCT05103397|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102278735|NCT05103397|Protective Agents|protective agents|mesh-ancestor
101378656|NCT04719481|Pravastatin|pravastatin|mesh-list
102278736|NCT05101447|Mycophenolic Acid|mycophenolic acid|mesh-list
102278737|NCT05101447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102278738|NCT05101447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102278739|NCT05101447|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102278740|NCT05101447|Antitubercular Agents|antitubercular agents|mesh-ancestor
102278741|NCT05101447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102278742|NCT05101447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102278743|NCT05101447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102278744|NCT05101447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278745|NCT05101291|Bupivacaine|bupivacaine|mesh-list
102278746|NCT05101291|Anesthetics, Local|anesthetics, local|mesh-ancestor
102278747|NCT05101291|Anesthetics|anesthetics|mesh-ancestor
102278748|NCT05101291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102278749|NCT05101291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278750|NCT05101291|Sensory System Agents|sensory system agents|mesh-ancestor
102278751|NCT05101291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102278752|NCT04342169|Hydroxychloroquine|hydroxychloroquine|mesh-list
102278753|NCT04342169|Antimalarials|antimalarials|mesh-ancestor
102278754|NCT04342169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102278755|NCT04342169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102278756|NCT04342169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102278757|NCT04342169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102278758|NCT04342169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278759|NCT04342169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102278760|NCT04979273|Epinephrine|epinephrine|mesh-list
102278761|NCT04979273|Racepinephrine|racepinephrine|mesh-list
102278762|NCT04979273|Epinephryl borate|epinephryl borate|mesh-list
102278763|NCT04979273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102278764|NCT04979273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102278765|NCT04979273|Adrenergic Agents|adrenergic agents|mesh-ancestor
102278766|NCT04979273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102278767|NCT04979273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278768|NCT04979273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278769|NCT04979273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102278770|NCT04979273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102278771|NCT04979273|Autonomic Agents|autonomic agents|mesh-ancestor
102278772|NCT04979273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102278773|NCT04979273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102278774|NCT04979273|Respiratory System Agents|respiratory system agents|mesh-ancestor
102278775|NCT04979273|Mydriatics|mydriatics|mesh-ancestor
102278776|NCT04979273|Sympathomimetics|sympathomimetics|mesh-ancestor
102278777|NCT04979273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102278778|NCT05103007|Chlorotrianisene|chlorotrianisene|mesh-list
102278779|NCT05103007|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102278780|NCT05103007|Estrogens|estrogens|mesh-ancestor
102278782|NCT05103007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102278783|NCT05103007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278784|NCT05103007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102278785|NCT05103007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102278786|NCT05092555|Fibrin fragment D|fibrin fragment d|mesh-list
102278787|NCT05092555|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102278788|NCT05092555|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102278789|NCT05092555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278790|NCT05092555|Hemostatics|hemostatics|mesh-ancestor
102278791|NCT05092555|Coagulants|coagulants|mesh-ancestor
102278792|NCT05036473|Levodopa|levodopa|mesh-list
102278793|NCT05036473|Carbidopa|carbidopa|mesh-list
102278794|NCT05036473|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102278795|NCT05036473|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102278796|NCT05036473|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102278797|NCT05036473|Dopamine Agents|dopamine agents|mesh-ancestor
102278798|NCT05036473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102278799|NCT05036473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278800|NCT05036473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278801|NCT05036473|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102278802|NCT05036473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102278803|NCT05036473|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102278804|NCT05036473|Immunologic Factors|immunologic factors|mesh-ancestor
102278805|NCT05036473|Dopamine Agonists|dopamine agonists|mesh-ancestor
102278806|NCT04985851|Durvalumab|durvalumab|mesh-list
102278807|NCT04985851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102278808|NCT04985851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102278809|NCT04985851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102278810|NCT04985851|Immunologic Factors|immunologic factors|mesh-ancestor
102278811|NCT04985851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278812|NCT05099575|Oxytocin|oxytocin|mesh-list
102278813|NCT05099575|Oxytocics|oxytocics|mesh-ancestor
102278814|NCT05099575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102278815|NCT05099575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278816|NCT03063515|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
102278817|NCT03063515|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102278818|NCT03063515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102278819|NCT03063515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278820|NCT03063515|Cholinergic Agents|cholinergic agents|mesh-ancestor
102278821|NCT03063515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102278822|NCT03063515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278823|NCT04973579|Anesthetics|anesthetics|mesh-list
102278824|NCT04973579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102278825|NCT04973579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278826|NCT04834063|Selenium|selenium|mesh-list
102278827|NCT04834063|Antioxidants|antioxidants|mesh-ancestor
102278828|NCT04834063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278829|NCT04834063|Protective Agents|protective agents|mesh-ancestor
102278830|NCT04834063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278831|NCT04834063|Trace Elements|trace elements|mesh-ancestor
102278832|NCT04834063|Micronutrients|micronutrients|mesh-ancestor
102278833|NCT04794205|Caryophyllene|caryophyllene|mesh-list
102278834|NCT04794205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102278835|NCT04794205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102278836|NCT04794205|Analgesics|analgesics|mesh-ancestor
102278837|NCT04794205|Sensory System Agents|sensory system agents|mesh-ancestor
102278838|NCT04794205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102278839|NCT04794205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278840|NCT04794205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102278841|NCT04794205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102278842|NCT04973033|Tofacitinib|tofacitinib|mesh-list
102278843|NCT04973033|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102278844|NCT04973033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102278845|NCT04973033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102278846|NCT04973033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278847|NCT03061565|Epoetin Alfa|epoetin alfa|mesh-list
102278848|NCT03061565|Hematinics|hematinics|mesh-ancestor
102278849|NCT02660281|Cyclophosphamide|cyclophosphamide|mesh-list
102278850|NCT02660281|Melphalan|melphalan|mesh-list
102278851|NCT02660281|Busulfan|busulfan|mesh-list
102278852|NCT02660281|Thiotepa|thiotepa|mesh-list
102278853|NCT02660281|Fludarabine|fludarabine|mesh-list
102278855|NCT02660281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102278856|NCT02660281|Immunologic Factors|immunologic factors|mesh-ancestor
102278857|NCT02660281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278858|NCT02660281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102278859|NCT02660281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102278860|NCT02660281|Alkylating Agents|alkylating agents|mesh-ancestor
102278861|NCT02660281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278862|NCT02660281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102278863|NCT02660281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102278864|NCT02660281|Protective Agents|protective agents|mesh-ancestor
101987617|NCT01110317|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102278865|NCT02438995|Cetuximab|cetuximab|mesh-list
102278866|NCT02438995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102278867|NCT02438995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102278868|NCT05107921|Bromfenac|bromfenac|mesh-list
102278869|NCT05107921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102278870|NCT05107921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102278871|NCT05107921|Analgesics|analgesics|mesh-ancestor
102278872|NCT05107921|Sensory System Agents|sensory system agents|mesh-ancestor
102278873|NCT05107921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102278874|NCT05107921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278875|NCT05107921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102278876|NCT05107921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102278877|NCT01669811|Esomeprazole|esomeprazole|mesh-list
102278878|NCT01669811|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102278879|NCT01669811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102278880|NCT01669811|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102278881|NCT01669811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102278882|NCT01669811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278883|NCT04978181|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102278884|NCT04978181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102278885|NCT04978181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102278886|NCT04978181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278887|NCT04437017|Dexamethasone|dexamethasone|mesh-list
102278888|NCT04437017|Fluprednisolone|fluprednisolone|mesh-list
102278889|NCT04437017|Olanzapine|olanzapine|mesh-list
102278890|NCT04437017|Serotonin|serotonin|mesh-list
102278891|NCT04437017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102278892|NCT04437017|Antiemetics|antiemetics|mesh-ancestor
102278893|NCT04437017|Autonomic Agents|autonomic agents|mesh-ancestor
102278894|NCT04437017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102278895|NCT04437017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278896|NCT04437017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102278897|NCT04437017|Glucocorticoids|glucocorticoids|mesh-ancestor
102278898|NCT04437017|Hormones|hormones|mesh-ancestor
102278899|NCT04437017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102278900|NCT04437017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102278901|NCT04437017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102278902|NCT04437017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102278903|NCT04437017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102278904|NCT04437017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102278905|NCT04437017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102278906|NCT04437017|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102278907|NCT04437017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102278908|NCT04437017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102278909|NCT04437017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278910|NCT04437017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102278911|NCT04437017|Serotonin Agents|serotonin agents|mesh-ancestor
102278912|NCT04437017|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102278913|NCT03061253|Nicotine|nicotine|mesh-list
102278914|NCT03061253|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102278915|NCT03061253|Autonomic Agents|autonomic agents|mesh-ancestor
102278916|NCT03061253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102278917|NCT03061253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278918|NCT03061253|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102278919|NCT03061253|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102278920|NCT03061253|Cholinergic Agents|cholinergic agents|mesh-ancestor
102278921|NCT03061253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102278922|NCT03061253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278923|NCT05107063|Pravastatin|pravastatin|mesh-list
102278924|NCT05107063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102278925|NCT05107063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102278926|NCT05107063|Antimetabolites|antimetabolites|mesh-ancestor
102278927|NCT05107063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278928|NCT05107063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102278929|NCT05107063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102278930|NCT05107063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102278931|NCT04977401|Glycerol|glycerol|mesh-list
102278932|NCT04977401|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102278933|NCT04977401|Protective Agents|protective agents|mesh-ancestor
102278934|NCT04977401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278935|NCT05106751|Hyaluronic Acid|hyaluronic acid|mesh-list
102278936|NCT05106751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102278937|NCT05106751|Immunologic Factors|immunologic factors|mesh-ancestor
102278938|NCT05106751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278939|NCT05106751|Viscosupplements|viscosupplements|mesh-ancestor
102278940|NCT05106751|Protective Agents|protective agents|mesh-ancestor
102278941|NCT04977557|Thiamine|thiamine|mesh-list
102278942|NCT04977557|Vitamin B Complex|vitamin b complex|mesh-ancestor
102278943|NCT04977557|Vitamins|vitamins|mesh-ancestor
102278944|NCT04977557|Micronutrients|micronutrients|mesh-ancestor
102278945|NCT04977557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278946|NCT04316143|Zamicastat|zamicastat|mesh-list
102278947|NCT04316143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102278948|NCT04316143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278949|NCT05104801|Tislelizumab|tislelizumab|mesh-list
102278950|NCT05104801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102278951|NCT05104801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102278952|NCT04530877|Infliximab|infliximab|mesh-list
102278953|NCT04530877|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102278954|NCT04530877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102278955|NCT04530877|Dermatologic Agents|dermatologic agents|mesh-ancestor
102278956|NCT04530877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102278957|NCT04530877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102278958|NCT04274023|Dostarlimab|dostarlimab|mesh-list
102278959|NCT04274023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102278960|NCT04971239|Methotrexate|methotrexate|mesh-list
102278961|NCT04971239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102278962|NCT04971239|Abortifacient Agents|abortifacient agents|mesh-ancestor
102278963|NCT04971239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102278964|NCT04971239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278965|NCT04971239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102278966|NCT04971239|Antimetabolites|antimetabolites|mesh-ancestor
102278967|NCT04971239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278968|NCT04971239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102278969|NCT04971239|Dermatologic Agents|dermatologic agents|mesh-ancestor
102278970|NCT04971239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102278971|NCT04971239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102278972|NCT04971239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102278973|NCT04971239|Immunologic Factors|immunologic factors|mesh-ancestor
102278974|NCT04971239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102278975|NCT04971239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102278976|NCT04903093|Famotidine|famotidine|mesh-list
102278977|NCT04903093|Abrocitinib|abrocitinib|mesh-list
102278978|NCT04903093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102278979|NCT04903093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102278980|NCT04903093|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102278981|NCT04903093|Histamine Antagonists|histamine antagonists|mesh-ancestor
102278982|NCT04903093|Histamine Agents|histamine agents|mesh-ancestor
102278983|NCT04903093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102278984|NCT04903093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102278985|NCT04903093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278986|NCT04903093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102278987|NCT04903093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102278988|NCT04529785|Ethanol|ethanol|mesh-list
102278989|NCT04529785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102278990|NCT04529785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102278991|NCT04529785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102278992|NCT04529785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102278993|NCT04271293|Edoxaban|edoxaban|mesh-list
102278994|NCT04271293|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102278995|NCT04271293|Antithrombins|antithrombins|mesh-ancestor
102278996|NCT04271293|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102278997|NCT04271293|Protease Inhibitors|protease inhibitors|mesh-ancestor
102278998|NCT04271293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102278999|NCT04271293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279000|NCT04271293|Anticoagulants|anticoagulants|mesh-ancestor
102279001|NCT03059849|Adalimumab|adalimumab|mesh-list
102279002|NCT03059849|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102279003|NCT03059849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102279004|NCT03059849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102279005|NCT04970693|Aflutinib|aflutinib|mesh-list
102279006|NCT04970693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102279007|NCT04970693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102279008|NCT04970693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279009|NCT04970069|Analgesics|analgesics|mesh-list
102279010|NCT04970069|Sensory System Agents|sensory system agents|mesh-ancestor
102279011|NCT04970069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102279012|NCT04970069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279013|NCT04970303|Methylphenidate|methylphenidate|mesh-list
102279014|NCT04970303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102279015|NCT04970303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279016|NCT04970303|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101378963|NCT00070187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102279017|NCT04970303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102279018|NCT04970303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102279019|NCT04970303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279020|NCT04970303|Dopamine Agents|dopamine agents|mesh-ancestor
102279021|NCT04970303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102279022|NCT04432259|Dexamethasone|dexamethasone|mesh-list
102279023|NCT04432259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102279024|NCT04432259|Antiemetics|antiemetics|mesh-ancestor
102279025|NCT04432259|Autonomic Agents|autonomic agents|mesh-ancestor
102279026|NCT04432259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102279027|NCT04432259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279028|NCT04432259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102279029|NCT04432259|Glucocorticoids|glucocorticoids|mesh-ancestor
102279030|NCT04432259|Hormones|hormones|mesh-ancestor
102279031|NCT04432259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102279032|NCT04432259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102279033|NCT04432259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102279035|NCT04964219|Esketamine|esketamine|mesh-list
102279036|NCT04964219|Analgesics|analgesics|mesh-ancestor
102279037|NCT04964219|Sensory System Agents|sensory system agents|mesh-ancestor
102279038|NCT04964219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102279039|NCT04964219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279040|NCT04964219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102279041|NCT04964219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102279042|NCT04964219|Anesthetics, General|anesthetics, general|mesh-ancestor
102279043|NCT04964219|Anesthetics|anesthetics|mesh-ancestor
102279044|NCT04964219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102279045|NCT04964219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102279046|NCT04964219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102279047|NCT04964219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102279048|NCT04964219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279049|NCT04964219|Antidepressive Agents|antidepressive agents|mesh-ancestor
102279050|NCT04964219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102279051|NCT04975373|Hyaluronic Acid|hyaluronic acid|mesh-list
102279052|NCT04975373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102279053|NCT04975373|Immunologic Factors|immunologic factors|mesh-ancestor
102279054|NCT04975373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279055|NCT04975373|Viscosupplements|viscosupplements|mesh-ancestor
102279056|NCT04975373|Protective Agents|protective agents|mesh-ancestor
102279057|NCT04974827|Carboplatin|carboplatin|mesh-list
102279058|NCT04974827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102279059|NCT04963595|Vinorelbine|vinorelbine|mesh-list
102279060|NCT04963595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102279061|NCT04963595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102279062|NCT04963595|Tubulin Modulators|tubulin modulators|mesh-ancestor
102279063|NCT04963595|Antimitotic Agents|antimitotic agents|mesh-ancestor
102279064|NCT04963595|Mitosis Modulators|mitosis modulators|mesh-ancestor
102279065|NCT04963595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279066|NCT04968509|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
102279067|NCT04968509|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
102279068|NCT04968509|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102279069|NCT04968509|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102279070|NCT04968509|Antimetabolites|antimetabolites|mesh-ancestor
102279071|NCT04968509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279072|NCT04968509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102279073|NCT04968509|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102279074|NCT04968509|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102279075|NCT04968509|Protease Inhibitors|protease inhibitors|mesh-ancestor
102279076|NCT04962425|Trastuzumab|trastuzumab|mesh-list
102279077|NCT04962425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102279078|NCT04962425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102279079|NCT03060707|Bromides|bromides|mesh-list
102279080|NCT03060707|Rocuronium|rocuronium|mesh-list
102279081|NCT03060707|Anticonvulsants|anticonvulsants|mesh-ancestor
102279082|NCT03060707|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102279083|NCT03060707|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102279084|NCT03060707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102279085|NCT03060707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102279086|NCT03060707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279087|NCT04967417|Paclitaxel|paclitaxel|mesh-list
102279088|NCT04967417|Carboplatin|carboplatin|mesh-list
102279089|NCT04967417|Pembrolizumab|pembrolizumab|mesh-list
102279090|NCT04967417|Pemetrexed|pemetrexed|mesh-list
102279091|NCT04967417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102279092|NCT04967417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102279093|NCT04967417|Tubulin Modulators|tubulin modulators|mesh-ancestor
102279094|NCT04967417|Antimitotic Agents|antimitotic agents|mesh-ancestor
102279096|NCT04967417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279097|NCT04967417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102279098|NCT04967417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102279099|NCT04967417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102279100|NCT04967417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102279101|NCT04967417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102279102|NCT03060005|Dextrans|dextrans|mesh-list
102279103|NCT03060005|Anticoagulants|anticoagulants|mesh-ancestor
102279104|NCT03060005|Plasma Substitutes|plasma substitutes|mesh-ancestor
102279105|NCT03060005|Blood Substitutes|blood substitutes|mesh-ancestor
102279106|NCT04210141|Antivenins|antivenins|mesh-list
102279107|NCT04210141|Immunologic Factors|immunologic factors|mesh-ancestor
102279108|NCT04210141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279109|NCT04418531|Antibodies|antibodies|mesh-list
102279111|NCT04418531|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102279112|NCT04418531|Immunologic Factors|immunologic factors|mesh-ancestor
102279113|NCT04418531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279114|NCT02615119|Isoproterenol|isoproterenol|mesh-list
102279115|NCT02615119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102279116|NCT02615119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102279117|NCT02615119|Adrenergic Agents|adrenergic agents|mesh-ancestor
102279118|NCT02615119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102279119|NCT02615119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279120|NCT02615119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279121|NCT02615119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102279122|NCT02615119|Autonomic Agents|autonomic agents|mesh-ancestor
102279123|NCT02615119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102279124|NCT02615119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102279125|NCT02615119|Respiratory System Agents|respiratory system agents|mesh-ancestor
102279126|NCT02615119|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102279127|NCT02615119|Sympathomimetics|sympathomimetics|mesh-ancestor
102279128|NCT02615119|Protective Agents|protective agents|mesh-ancestor
102279129|NCT02555293|Rifaximin|rifaximin|mesh-list
102279130|NCT02555293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102279131|NCT02555293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102279132|NCT02555293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102279133|NCT05104255|Anesthetics|anesthetics|mesh-list
102279134|NCT05104255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102279135|NCT05104255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279136|NCT03293017|Diazepam|diazepam|mesh-list
102279137|NCT03293017|Baclofen|baclofen|mesh-list
102279138|NCT03293017|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102279139|NCT03293017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279140|NCT03293017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102279141|NCT03293017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102279142|NCT03293017|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102279143|NCT03293017|GABA Agonists|gaba agonists|mesh-ancestor
102279144|NCT03293017|GABA Agents|gaba agents|mesh-ancestor
102279145|NCT03293017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102279146|NCT03293017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279147|NCT03293017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102279148|NCT03293017|Anticonvulsants|anticonvulsants|mesh-ancestor
102279149|NCT03293017|Antiemetics|antiemetics|mesh-ancestor
101379111|NCT00256828|Didanosine|didanosine|mesh-list
102279150|NCT03293017|Autonomic Agents|autonomic agents|mesh-ancestor
102279151|NCT03293017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102279152|NCT03293017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102279153|NCT03293017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102279154|NCT03293017|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102279155|NCT03293017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102279156|NCT03293017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102279157|NCT03293017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102279158|NCT03293017|Anesthetics, General|anesthetics, general|mesh-ancestor
102279159|NCT03293017|Anesthetics|anesthetics|mesh-ancestor
102279160|NCT03293017|GABA Modulators|gaba modulators|mesh-ancestor
102279161|NCT03198559|Vorinostat|vorinostat|mesh-list
102279162|NCT03198559|Disulfiram|disulfiram|mesh-list
102279163|NCT03198559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102279164|NCT03198559|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102279165|NCT03198559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102279166|NCT03198559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279167|NCT03198559|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102279168|NCT03198559|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
102279169|NCT02625623|Paclitaxel|paclitaxel|mesh-list
102279170|NCT02625623|Irinotecan|irinotecan|mesh-list
102279171|NCT02625623|Avelumab|avelumab|mesh-list
102279172|NCT02625623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102279173|NCT02625623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102279174|NCT02625623|Tubulin Modulators|tubulin modulators|mesh-ancestor
102279175|NCT02625623|Antimitotic Agents|antimitotic agents|mesh-ancestor
102279176|NCT02625623|Mitosis Modulators|mitosis modulators|mesh-ancestor
102279177|NCT02625623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279178|NCT02625623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102279179|NCT02625623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102279180|NCT02625623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102279181|NCT02625623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102279182|NCT02749513|Itraconazole|itraconazole|mesh-list
102279183|NCT02749513|Antifungal Agents|antifungal agents|mesh-ancestor
102279184|NCT02749513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102279185|NCT02749513|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102279186|NCT02749513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102279187|NCT02749513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102279188|NCT02749513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279189|NCT02749513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102279190|NCT02749513|Hormone Antagonists|hormone antagonists|mesh-ancestor
102279191|NCT02749513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102279192|NCT02749513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279193|NCT02749513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102279194|NCT05110339|Dexmedetomidine|dexmedetomidine|mesh-list
102279195|NCT05110339|Ropivacaine|ropivacaine|mesh-list
102279196|NCT05110339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102279197|NCT05110339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102279198|NCT05110339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279199|NCT05110339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102279200|NCT05110339|Analgesics|analgesics|mesh-ancestor
102279201|NCT05110339|Sensory System Agents|sensory system agents|mesh-ancestor
102279202|NCT05110339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102279203|NCT05110339|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101379173|NCT00257062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102279204|NCT05110339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102279205|NCT05110339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102279206|NCT05110339|Adrenergic Agents|adrenergic agents|mesh-ancestor
102279207|NCT05110339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102279208|NCT05110339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279209|NCT05110339|Anesthetics, Local|anesthetics, local|mesh-ancestor
102279210|NCT05110339|Anesthetics|anesthetics|mesh-ancestor
102279212|NCT04965545|Trace Elements|trace elements|mesh-ancestor
102279213|NCT04965545|Micronutrients|micronutrients|mesh-ancestor
102279214|NCT04965545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279215|NCT04425629|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
102279216|NCT04425629|Antiviral Agents|antiviral agents|mesh-ancestor
102279217|NCT04425629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102279218|NCT05105347|Prednisone|prednisone|mesh-list
102279219|NCT05105347|Adalimumab|adalimumab|mesh-list
102279220|NCT05105347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102279221|NCT05105347|Glucocorticoids|glucocorticoids|mesh-ancestor
102279222|NCT05105347|Hormones|hormones|mesh-ancestor
102279223|NCT05105347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102279224|NCT05105347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279225|NCT05105347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102279226|NCT05105347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102279227|NCT05105347|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102279228|NCT05105347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102279229|NCT05110651|Hydroxychloroquine|hydroxychloroquine|mesh-list
102279230|NCT05110651|Antimalarials|antimalarials|mesh-ancestor
102279231|NCT05110651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102279232|NCT05110651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102279233|NCT05110651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102279234|NCT05110651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102279235|NCT05110651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279236|NCT05110651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102279237|NCT03060785|Tenofovir|tenofovir|mesh-list
102279238|NCT03060785|Emtricitabine|emtricitabine|mesh-list
102279239|NCT03060785|Antiviral Agents|antiviral agents|mesh-ancestor
102279240|NCT03060785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102279241|NCT03060785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102279242|NCT03060785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102279243|NCT03060785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102279244|NCT03060785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279245|NCT03060785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102279246|NCT03060785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102279248|NCT04952207|Antiviral Agents|antiviral agents|mesh-list
102279249|NCT04952207|Grazoprevir|grazoprevir|mesh-list
102279250|NCT04952207|Ledipasvir|ledipasvir|mesh-list
102279251|NCT04952207|Velpatasvir|velpatasvir|mesh-list
102279252|NCT04952207|Asunaprevir|asunaprevir|mesh-list
102279253|NCT04952207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102279254|NCT04952207|Protease Inhibitors|protease inhibitors|mesh-ancestor
102279255|NCT04952207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102279256|NCT04952207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279257|NCT04632589|Losartan|losartan|mesh-list
102279258|NCT04632589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102279259|NCT04632589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102279260|NCT04632589|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102279261|NCT04632589|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102279262|NCT04632589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279263|NCT05108545|Amphotericin B|amphotericin b|mesh-list
102279264|NCT05108545|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102279265|NCT05108545|Amebicides|amebicides|mesh-ancestor
102279266|NCT05108545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102279267|NCT05108545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102279268|NCT05108545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102279269|NCT05108545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102279270|NCT05108545|Antifungal Agents|antifungal agents|mesh-ancestor
102279271|NCT05102695|Fibrin fragment D|fibrin fragment d|mesh-list
102279272|NCT05102695|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102279273|NCT05102695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102279274|NCT05102695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279275|NCT05102695|Hemostatics|hemostatics|mesh-ancestor
102279276|NCT05102695|Coagulants|coagulants|mesh-ancestor
102279277|NCT04952129|Selenium|selenium|mesh-list
102279278|NCT04952129|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
102279279|NCT04952129|Antioxidants|antioxidants|mesh-ancestor
102279280|NCT04952129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279281|NCT04952129|Protective Agents|protective agents|mesh-ancestor
102279282|NCT04952129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279283|NCT04952129|Trace Elements|trace elements|mesh-ancestor
102279284|NCT04952129|Micronutrients|micronutrients|mesh-ancestor
102279285|NCT04952129|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102279286|NCT04952129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102279287|NCT05007769|Atezolizumab|atezolizumab|mesh-list
102279288|NCT05007769|Ramucirumab|ramucirumab|mesh-list
102279289|NCT05007769|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102279290|NCT05007769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279291|NCT05007769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102279292|NCT05007769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102279293|NCT04952051|Folic Acid|folic acid|mesh-list
102279294|NCT04952051|Vitamin B Complex|vitamin b complex|mesh-list
102279295|NCT04952051|Amlodipine|amlodipine|mesh-list
102279296|NCT04952051|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102279297|NCT04952051|Enalapril|enalapril|mesh-list
102279298|NCT04952051|Enalaprilat|enalaprilat|mesh-list
102279299|NCT04952051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102279300|NCT04952051|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102279301|NCT04952051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102279302|NCT04952051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279303|NCT04952051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102279304|NCT04952051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279305|NCT04952051|Vasodilator Agents|vasodilator agents|mesh-ancestor
102279306|NCT04952051|Hematinics|hematinics|mesh-ancestor
102279307|NCT04952051|Vitamins|vitamins|mesh-ancestor
102279308|NCT04952051|Micronutrients|micronutrients|mesh-ancestor
102279309|NCT04952051|Diuretics|diuretics|mesh-ancestor
102279310|NCT04952051|Natriuretic Agents|natriuretic agents|mesh-ancestor
102279311|NCT04952051|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102279312|NCT04952051|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102279313|NCT04952051|Protease Inhibitors|protease inhibitors|mesh-ancestor
102279314|NCT04952051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102279315|NCT04960943|Trastuzumab|trastuzumab|mesh-list
102279316|NCT04960943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102279317|NCT04960943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102279318|NCT04431713|Exenatide|exenatide|mesh-list
102279319|NCT04431713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102279320|NCT04431713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279321|NCT04431713|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102279323|NCT04431713|Hormones|hormones|mesh-ancestor
102279324|NCT04431713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102279325|NCT05104333|Vaccines|vaccines|mesh-list
102279326|NCT05104333|Immunologic Factors|immunologic factors|mesh-ancestor
102279327|NCT05104333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279328|NCT03059615|Doxorubicin|doxorubicin|mesh-list
102279329|NCT03059615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102279330|NCT03059615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102279331|NCT03059615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102279332|NCT03059615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102279333|NCT03059615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102279334|NCT03059615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279335|NCT04951505|Cefepime|cefepime|mesh-list
102279336|NCT04951505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102279337|NCT04951505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102279338|NCT04951349|Petrolatum|petrolatum|mesh-list
102279339|NCT04951349|Emollients|emollients|mesh-ancestor
102279340|NCT04951349|Dermatologic Agents|dermatologic agents|mesh-ancestor
102279341|NCT02658019|Pembrolizumab|pembrolizumab|mesh-list
102279342|NCT02658019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102279343|NCT02658019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102279344|NCT02658019|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102279345|NCT02658019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279346|NCT03059303|Simeprevir|simeprevir|mesh-list
102279347|NCT03059303|Odalasvir|odalasvir|mesh-list
102279348|NCT03059303|Omeprazole|omeprazole|mesh-list
102279349|NCT03059303|Lansoprazole|lansoprazole|mesh-list
102279350|NCT03059303|Dexlansoprazole|dexlansoprazole|mesh-list
102279351|NCT03059303|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102279352|NCT03059303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102279353|NCT03059303|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102279354|NCT03059303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102279355|NCT03059303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279356|NCT03059303|Antiviral Agents|antiviral agents|mesh-ancestor
102279357|NCT03059303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102279358|NCT03059303|Protease Inhibitors|protease inhibitors|mesh-ancestor
102279359|NCT03059537|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
102279360|NCT03059537|Cathartics|cathartics|mesh-ancestor
102279361|NCT03059537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102279362|NCT04428775|Cromolyn Sodium|cromolyn sodium|mesh-list
102279363|NCT04428775|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
102279364|NCT04428775|Immunologic Factors|immunologic factors|mesh-ancestor
102279365|NCT04428775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279366|NCT04428775|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102279367|NCT04428775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102279368|NCT04428775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102279369|NCT04428775|Respiratory System Agents|respiratory system agents|mesh-ancestor
102279370|NCT04950569|Simendan|simendan|mesh-list
102279371|NCT04950569|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102279372|NCT04950569|Vasodilator Agents|vasodilator agents|mesh-ancestor
102279373|NCT04950569|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102279374|NCT04950569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102279375|NCT04950569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102279376|NCT04950569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279377|NCT04950569|Protective Agents|protective agents|mesh-ancestor
102279378|NCT04950569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279379|NCT04944641|Anticonvulsants|anticonvulsants|mesh-list
102279380|NCT04436419|Thioctic Acid|thioctic acid|mesh-list
102279381|NCT04436419|Antioxidants|antioxidants|mesh-ancestor
102279382|NCT04436419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279383|NCT04436419|Protective Agents|protective agents|mesh-ancestor
102279384|NCT04436419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279385|NCT04436419|Vitamin B Complex|vitamin b complex|mesh-ancestor
102279386|NCT04436419|Vitamins|vitamins|mesh-ancestor
102279387|NCT04436419|Micronutrients|micronutrients|mesh-ancestor
102279388|NCT04944173|Durvalumab|durvalumab|mesh-list
102279389|NCT04944173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102279390|NCT04944173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102279391|NCT04950647|Nitrofurazone|nitrofurazone|mesh-list
102279392|NCT04950647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102279393|NCT01675765|Cyclophosphamide|cyclophosphamide|mesh-list
102279394|NCT01675765|Cisplatin|cisplatin|mesh-list
102279395|NCT01675765|Pemetrexed|pemetrexed|mesh-list
102279396|NCT01675765|Immunologic Factors|immunologic factors|mesh-list
102279397|NCT01675765|Immunomodulating Agents|immunomodulating agents|mesh-list
102279398|NCT01675765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102279399|NCT01675765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279400|NCT01675765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102279401|NCT01675765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102279402|NCT01675765|Alkylating Agents|alkylating agents|mesh-ancestor
102279403|NCT01675765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279404|NCT01675765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102279405|NCT01675765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102279406|NCT01675765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102279407|NCT01675765|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102279408|NCT01675765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102279409|NCT04943237|Sulfasalazine|sulfasalazine|mesh-list
102279410|NCT04943237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102279411|NCT04943237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102279412|NCT04943237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102279413|NCT04943237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102279414|NCT04943237|Analgesics|analgesics|mesh-ancestor
102279415|NCT04943237|Sensory System Agents|sensory system agents|mesh-ancestor
102279416|NCT04943237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102279417|NCT04943237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279418|NCT04943237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102279419|NCT04943237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102279420|NCT04285255|Lidocaine|lidocaine|mesh-list
102279421|NCT04285255|Fentanyl|fentanyl|mesh-list
102279422|NCT04285255|Dexmedetomidine|dexmedetomidine|mesh-list
102279423|NCT04285255|Ketamine|ketamine|mesh-list
102279424|NCT04285255|Anesthetics, Local|anesthetics, local|mesh-ancestor
102279425|NCT04285255|Anesthetics|anesthetics|mesh-ancestor
102279426|NCT04285255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102279427|NCT04285255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279428|NCT04285255|Sensory System Agents|sensory system agents|mesh-ancestor
102279429|NCT04285255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102279430|NCT04285255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102279431|NCT04285255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102279432|NCT04285255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102279433|NCT04285255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102279434|NCT04285255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279435|NCT04285255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102279436|NCT04285255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102279437|NCT04285255|Analgesics|analgesics|mesh-ancestor
102279438|NCT04285255|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102279439|NCT04285255|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102279440|NCT04285255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102279441|NCT04285255|Adrenergic Agents|adrenergic agents|mesh-ancestor
102279442|NCT04285255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102279443|NCT04285255|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102279444|NCT04285255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102279445|NCT04285255|Anesthetics, General|anesthetics, general|mesh-ancestor
102279446|NCT04285255|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102279447|NCT04285255|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102279448|NCT04285255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102279449|NCT04285255|Narcotics|narcotics|mesh-ancestor
102279450|NCT04285255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102279451|NCT04121299|Amlodipine|amlodipine|mesh-list
102279452|NCT04121299|Carvedilol|carvedilol|mesh-list
102279453|NCT04121299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102279454|NCT04121299|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102279455|NCT04121299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102279456|NCT04121299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279457|NCT04121299|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102279458|NCT04121299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279459|NCT04121299|Vasodilator Agents|vasodilator agents|mesh-ancestor
102279460|NCT04121299|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102279461|NCT04121299|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102279462|NCT04121299|Adrenergic Agents|adrenergic agents|mesh-ancestor
102279463|NCT04121299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102279464|NCT04121299|Antioxidants|antioxidants|mesh-ancestor
102279465|NCT04121299|Protective Agents|protective agents|mesh-ancestor
102279466|NCT04121299|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102279467|NCT04121299|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102279468|NCT04942769|Selenium|selenium|mesh-list
102279469|NCT04942769|Antioxidants|antioxidants|mesh-ancestor
101621236|NCT04952389|Hormones|hormones|mesh-ancestor
102279470|NCT04942769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279471|NCT04942769|Protective Agents|protective agents|mesh-ancestor
102279472|NCT04942769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279474|NCT04942769|Micronutrients|micronutrients|mesh-ancestor
102279475|NCT04942301|Endostar protein|endostar protein|mesh-list
101988222|NCT01116791|Cisplatin|cisplatin|mesh-list
102279476|NCT04942301|Endostatins|endostatins|mesh-list
102279477|NCT04942301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102279478|NCT04942301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102279479|NCT04942301|Growth Substances|growth substances|mesh-ancestor
102279480|NCT04942301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279481|NCT04942301|Growth Inhibitors|growth inhibitors|mesh-ancestor
102279482|NCT04942301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102279483|NCT03057899|Fenugreek seed meal|fenugreek seed meal|mesh-list
102279484|NCT03057899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102279485|NCT03057899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279486|NCT04434001|Thrombin|thrombin|mesh-list
102279487|NCT04434001|Hemostatics|hemostatics|mesh-ancestor
102279488|NCT04434001|Coagulants|coagulants|mesh-ancestor
102279489|NCT03540901|Acetazolamide|acetazolamide|mesh-list
102279490|NCT03540901|Anticonvulsants|anticonvulsants|mesh-ancestor
102279491|NCT03540901|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102279492|NCT03540901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102279493|NCT03540901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279494|NCT03540901|Diuretics|diuretics|mesh-ancestor
102279495|NCT03540901|Natriuretic Agents|natriuretic agents|mesh-ancestor
102279496|NCT03540901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279497|NCT03517735|Remifentanil|remifentanil|mesh-list
102279498|NCT03517735|Propofol|propofol|mesh-list
102279499|NCT03517735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102279500|NCT03517735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102279501|NCT03517735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279502|NCT03517735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102279503|NCT03517735|Anesthetics, General|anesthetics, general|mesh-ancestor
102279504|NCT03517735|Anesthetics|anesthetics|mesh-ancestor
102279505|NCT03517735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102279506|NCT03517735|Narcotics|narcotics|mesh-ancestor
102279507|NCT03517735|Analgesics|analgesics|mesh-ancestor
102279508|NCT03517735|Sensory System Agents|sensory system agents|mesh-ancestor
102279509|NCT03517735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102279510|NCT04941131|Chlorhexidine|chlorhexidine|mesh-list
102279511|NCT04941131|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102279512|NCT04941131|Povidone-Iodine|povidone-iodine|mesh-list
102279513|NCT04941131|Povidone|povidone|mesh-list
102279514|NCT04941131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102279515|NCT04941131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102279516|NCT04941131|Disinfectants|disinfectants|mesh-ancestor
102279517|NCT04941131|Dermatologic Agents|dermatologic agents|mesh-ancestor
102279518|NCT04941131|Plasma Substitutes|plasma substitutes|mesh-ancestor
102279519|NCT04941131|Blood Substitutes|blood substitutes|mesh-ancestor
102279520|NCT03400501|Insulin|insulin|mesh-list
102279521|NCT03400501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102279522|NCT03400501|Insulin Glargine|insulin glargine|mesh-list
102279523|NCT03400501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102279524|NCT03400501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279526|NCT04426591|Vitamin B Complex|vitamin b complex|mesh-ancestor
102279527|NCT04426591|Vitamins|vitamins|mesh-ancestor
102279528|NCT04426591|Micronutrients|micronutrients|mesh-ancestor
102279529|NCT04426591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279530|NCT04940273|Remifentanil|remifentanil|mesh-list
102279531|NCT04940273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102279532|NCT04940273|Narcotics|narcotics|mesh-ancestor
102279533|NCT04940273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102279534|NCT04940273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279535|NCT04940273|Analgesics|analgesics|mesh-ancestor
102279536|NCT04940273|Sensory System Agents|sensory system agents|mesh-ancestor
102279537|NCT04940273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102279538|NCT04948385|Propofol|propofol|mesh-list
102279539|NCT04948385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102279540|NCT04948385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102279541|NCT04948385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279542|NCT04948385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102279543|NCT04948385|Anesthetics, General|anesthetics, general|mesh-ancestor
102279544|NCT04948385|Anesthetics|anesthetics|mesh-ancestor
102279545|NCT03057821|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102279546|NCT03057821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102279547|NCT03057821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102279548|NCT04948151|Sildenafil Citrate|sildenafil citrate|mesh-list
102279550|NCT04948151|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102279551|NCT04948151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102279552|NCT04948151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102279553|NCT04948151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279554|NCT04948151|Urological Agents|urological agents|mesh-ancestor
102279555|NCT02633293|Treprostinil|treprostinil|mesh-list
102279556|NCT02633293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102279557|NCT04938713|Ketamine|ketamine|mesh-list
102279558|NCT04938713|Esketamine|esketamine|mesh-list
102279559|NCT04938713|Analgesics|analgesics|mesh-ancestor
102279560|NCT04938713|Sensory System Agents|sensory system agents|mesh-ancestor
102279561|NCT04938713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102279562|NCT04938713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279563|NCT04938713|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102279564|NCT04938713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102279565|NCT04938713|Anesthetics, General|anesthetics, general|mesh-ancestor
102279566|NCT04938713|Anesthetics|anesthetics|mesh-ancestor
102279567|NCT04938713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102279568|NCT04938713|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102279569|NCT04938713|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102279570|NCT04938713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102279571|NCT04938713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279572|NCT04938713|Antidepressive Agents|antidepressive agents|mesh-ancestor
101304897|NCT02015949|Dopamine Agents|dopamine agents|mesh-ancestor
102279573|NCT04938713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102279574|NCT04938011|Progesterone|progesterone|mesh-list
102279575|NCT04938011|Progestins|progestins|mesh-ancestor
102279576|NCT04938011|Hormones|hormones|mesh-ancestor
102279577|NCT04938011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102279578|NCT04938011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279579|NCT03057509|Octreotide|octreotide|mesh-list
102279580|NCT03057509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102279581|NCT03057509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102279582|NCT03057509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102279583|NCT03572413|Bromides|bromides|mesh-list
102279584|NCT03572413|Rocuronium|rocuronium|mesh-list
102279585|NCT03572413|Anticonvulsants|anticonvulsants|mesh-ancestor
102279586|NCT03572413|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102279587|NCT03572413|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102279588|NCT03572413|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102279589|NCT03572413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102279590|NCT03572413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279591|NCT04956419|Fluconazole|fluconazole|mesh-list
102279592|NCT04956419|Antifungal Agents|antifungal agents|mesh-ancestor
102279593|NCT04956419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102279594|NCT04956419|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102279595|NCT04956419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102279596|NCT04956419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102279597|NCT04956419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279598|NCT04956419|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102279599|NCT04956419|Hormone Antagonists|hormone antagonists|mesh-ancestor
102279600|NCT04956419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102279601|NCT04956419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279602|NCT04956419|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102279603|NCT04956419|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102279604|NCT04946669|Abatacept|abatacept|mesh-list
102279605|NCT04946669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102279606|NCT04946669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279607|NCT04946669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102279608|NCT04946669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102279609|NCT04946669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102279610|NCT04946669|Immunologic Factors|immunologic factors|mesh-ancestor
102279611|NCT04946669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279612|NCT04946669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102279613|NCT03219775|Nivolumab|nivolumab|mesh-list
102279614|NCT03219775|Ipilimumab|ipilimumab|mesh-list
102279615|NCT03219775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102279616|NCT03219775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102279617|NCT03219775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102279618|NCT03219775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279619|NCT03100045|Artesunate|artesunate|mesh-list
102279620|NCT03100045|Artemisinins|artemisinins|mesh-list
102279621|NCT03100045|Artemisinin|artemisinin|mesh-list
102279622|NCT03100045|Antimalarials|antimalarials|mesh-ancestor
102279623|NCT03100045|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102279624|NCT03100045|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102279625|NCT03100045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102279626|NCT03100045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101988364|NCT01212887|Cyclophosphamide|cyclophosphamide|mesh-list
102279627|NCT03100045|Antiviral Agents|antiviral agents|mesh-ancestor
102279628|NCT03100045|Schistosomicides|schistosomicides|mesh-ancestor
102279629|NCT03100045|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102279630|NCT03100045|Anthelmintics|anthelmintics|mesh-ancestor
102279631|NCT04946123|Selenium|selenium|mesh-list
102279632|NCT04946123|Antioxidants|antioxidants|mesh-ancestor
101379516|NCT00071201|Antiviral Agents|antiviral agents|mesh-ancestor
102279633|NCT04946123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279634|NCT04946123|Protective Agents|protective agents|mesh-ancestor
102279635|NCT04946123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279636|NCT04946123|Trace Elements|trace elements|mesh-ancestor
102279637|NCT04946123|Micronutrients|micronutrients|mesh-ancestor
102279638|NCT04945577|Vitamin D|vitamin d|mesh-list
102279639|NCT04945577|Vitamins|vitamins|mesh-ancestor
102279640|NCT04945577|Micronutrients|micronutrients|mesh-ancestor
102279641|NCT04945577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279642|NCT04945577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102279643|NCT02623829|Botulinum Toxins|botulinum toxins|mesh-list
102279644|NCT02623829|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102279645|NCT02623829|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102279646|NCT02623829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102279647|NCT02623829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279648|NCT02623829|Cholinergic Agents|cholinergic agents|mesh-ancestor
102279649|NCT02623829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102279650|NCT02623829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279651|NCT02623829|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102279652|NCT02623829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102279653|NCT02655679|Ether|ether|mesh-list
102279654|NCT02655679|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102279655|NCT02655679|Anesthetics, General|anesthetics, general|mesh-ancestor
102279656|NCT02655679|Anesthetics|anesthetics|mesh-ancestor
102279657|NCT02655679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102279658|NCT02655679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279659|NCT04936295|Fulvestrant|fulvestrant|mesh-list
102279660|NCT04936295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102279661|NCT04936295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102279662|NCT04936295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102279663|NCT04936295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102279664|NCT04936295|Hormone Antagonists|hormone antagonists|mesh-ancestor
102279665|NCT04936295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102279666|NCT04936295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279667|NCT05114239|Timolol|timolol|mesh-list
102279668|NCT05114239|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102279669|NCT05114239|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102279670|NCT05114239|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102279671|NCT05114239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102279672|NCT05114239|Adrenergic Agents|adrenergic agents|mesh-ancestor
102279673|NCT05114239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102279674|NCT05114239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279675|NCT05114239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279676|NCT05114239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102279677|NCT05114239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102279678|NCT04418999|Loteprednol Etabonate|loteprednol etabonate|mesh-list
102279679|NCT04418999|Dexamethasone|dexamethasone|mesh-list
102279680|NCT04418999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102279681|NCT04418999|Antiemetics|antiemetics|mesh-ancestor
102279682|NCT04418999|Autonomic Agents|autonomic agents|mesh-ancestor
102279683|NCT04418999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102279684|NCT04418999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279685|NCT04418999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102279686|NCT04418999|Glucocorticoids|glucocorticoids|mesh-ancestor
102279687|NCT04418999|Hormones|hormones|mesh-ancestor
102279688|NCT04418999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102279689|NCT04418999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102279690|NCT04418999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102279691|NCT04418999|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102279692|NCT05113459|Disitamab vedotin|disitamab vedotin|mesh-list
102279693|NCT05113459|Immunoconjugates|immunoconjugates|mesh-ancestor
102279694|NCT05113459|Immunologic Factors|immunologic factors|mesh-ancestor
102279695|NCT05113459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279696|NCT04933019|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102279697|NCT04933019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102279698|NCT04935515|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102279699|NCT04935515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102279700|NCT04935515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102279701|NCT04935515|Anticoagulants|anticoagulants|mesh-list
102279702|NCT04935515|Coagulants|coagulants|mesh-list
102279703|NCT04935515|Histamine Antagonists|histamine antagonists|mesh-list
102279704|NCT04935515|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
102279705|NCT04935515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102279706|NCT04935515|Antitubercular Agents|antitubercular agents|mesh-ancestor
102279707|NCT04935515|Histamine Agents|histamine agents|mesh-ancestor
102279708|NCT04935515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102279709|NCT04935515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279710|NCT04935515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279711|NCT04376281|Norepinephrine|norepinephrine|mesh-list
102279712|NCT04376281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102279713|NCT04376281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102279714|NCT04376281|Adrenergic Agents|adrenergic agents|mesh-ancestor
102279715|NCT04376281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102279716|NCT04376281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279717|NCT04376281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279718|NCT04376281|Sympathomimetics|sympathomimetics|mesh-ancestor
102279719|NCT04376281|Autonomic Agents|autonomic agents|mesh-ancestor
102279720|NCT04376281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102279721|NCT04376281|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102279722|NCT04332445|Hyaluronic Acid|hyaluronic acid|mesh-list
102279723|NCT04332445|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102279724|NCT04332445|Immunologic Factors|immunologic factors|mesh-ancestor
102279725|NCT04332445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279726|NCT04332445|Viscosupplements|viscosupplements|mesh-ancestor
102279727|NCT04332445|Protective Agents|protective agents|mesh-ancestor
102279728|NCT03890887|Itraconazole|itraconazole|mesh-list
102279729|NCT03890887|Antifungal Agents|antifungal agents|mesh-ancestor
102279730|NCT03890887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102279731|NCT03890887|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102279732|NCT03890887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102279733|NCT03890887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102279734|NCT03890887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279735|NCT03890887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102279736|NCT03890887|Hormone Antagonists|hormone antagonists|mesh-ancestor
102279737|NCT03890887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102279738|NCT03890887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279739|NCT03890887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102279740|NCT04516993|Aspirin|aspirin|mesh-list
102279741|NCT04516993|Plasminogen|plasminogen|mesh-list
102279742|NCT04516993|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102279743|NCT04516993|Tenecteplase|tenecteplase|mesh-list
102279744|NCT04516993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102279745|NCT04516993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102279746|NCT04516993|Analgesics|analgesics|mesh-ancestor
102279747|NCT04516993|Sensory System Agents|sensory system agents|mesh-ancestor
102279748|NCT04516993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102279749|NCT04516993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279750|NCT04516993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102279751|NCT04516993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102279752|NCT04516993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102279753|NCT04516993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102279754|NCT04516993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279755|NCT04516993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102279756|NCT04516993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102279757|NCT04516993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102279758|NCT04516993|Antipyretics|antipyretics|mesh-ancestor
102279759|NCT05015335|Adalimumab|adalimumab|mesh-list
102279760|NCT05015335|Methotrexate|methotrexate|mesh-list
102279761|NCT05015335|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102279762|NCT05015335|Abortifacient Agents|abortifacient agents|mesh-ancestor
102279763|NCT05015335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102279764|NCT05015335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279765|NCT05015335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102279766|NCT05015335|Antimetabolites|antimetabolites|mesh-ancestor
102279767|NCT05015335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279768|NCT05015335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102279769|NCT05015335|Dermatologic Agents|dermatologic agents|mesh-ancestor
102279770|NCT05015335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102279771|NCT05015335|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102279772|NCT05015335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102279773|NCT05015335|Immunologic Factors|immunologic factors|mesh-ancestor
102279774|NCT05015335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102279775|NCT05015335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102279776|NCT05015335|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102279777|NCT05015335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102279778|NCT03056261|Anesthetics|anesthetics|mesh-list
102279779|NCT03056261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102279780|NCT03056261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279781|NCT03533257|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
102279782|NCT03533257|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
102279783|NCT03533257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102279784|NCT03533257|Antiviral Agents|antiviral agents|mesh-ancestor
102279785|NCT03533257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102279786|NCT03533257|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102279787|NCT03533257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102279789|NCT04574479|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102279790|NCT04574479|Narcotics|narcotics|mesh-ancestor
102279791|NCT04574479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102279792|NCT04574479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279793|NCT04574479|Analgesics|analgesics|mesh-ancestor
102279794|NCT04574479|Sensory System Agents|sensory system agents|mesh-ancestor
102279795|NCT04574479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102279796|NCT04931225|Landiolol|landiolol|mesh-list
102279797|NCT04931225|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102279798|NCT04931225|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102279799|NCT04931225|Adrenergic Agents|adrenergic agents|mesh-ancestor
102279800|NCT04931225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102279801|NCT04931225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279802|NCT04931225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279803|NCT04931225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102279804|NCT02195947|Hormones|hormones|mesh-list
102279805|NCT02195947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102279806|NCT02195947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279807|NCT01698307|Adalimumab|adalimumab|mesh-list
102279808|NCT01698307|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102279809|NCT01698307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102279810|NCT01698307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102279811|NCT04954339|Bevacizumab|bevacizumab|mesh-list
102279812|NCT04954339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102279813|NCT04954339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102279814|NCT04954339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102279815|NCT04954339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102279816|NCT04954339|Growth Substances|growth substances|mesh-ancestor
102279817|NCT04954339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279818|NCT04954339|Growth Inhibitors|growth inhibitors|mesh-ancestor
102279819|NCT01966263|Epinephrine|epinephrine|mesh-list
102279820|NCT01966263|Racepinephrine|racepinephrine|mesh-list
102279821|NCT01966263|Ropivacaine|ropivacaine|mesh-list
102279822|NCT01966263|Epinephryl borate|epinephryl borate|mesh-list
102279823|NCT01966263|Anesthetics, Local|anesthetics, local|mesh-ancestor
102279824|NCT01966263|Anesthetics|anesthetics|mesh-ancestor
102279825|NCT01966263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102279826|NCT01966263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279827|NCT01966263|Sensory System Agents|sensory system agents|mesh-ancestor
102279828|NCT01966263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102279829|NCT01966263|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102279830|NCT01966263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102279831|NCT01966263|Adrenergic Agents|adrenergic agents|mesh-ancestor
102279832|NCT01966263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102279833|NCT01966263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279834|NCT01966263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102279835|NCT01966263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102279836|NCT01966263|Autonomic Agents|autonomic agents|mesh-ancestor
102279837|NCT01966263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102279838|NCT01966263|Respiratory System Agents|respiratory system agents|mesh-ancestor
102279839|NCT01966263|Mydriatics|mydriatics|mesh-ancestor
102279840|NCT01966263|Sympathomimetics|sympathomimetics|mesh-ancestor
102279841|NCT01966263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102279842|NCT04400201|Propofol|propofol|mesh-list
102279843|NCT04400201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102279844|NCT04400201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102279845|NCT04400201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279846|NCT04400201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102279847|NCT04400201|Anesthetics, General|anesthetics, general|mesh-ancestor
102279848|NCT04400201|Anesthetics|anesthetics|mesh-ancestor
102279849|NCT04423107|Acetaminophen|acetaminophen|mesh-list
102279850|NCT04423107|Ibuprofen|ibuprofen|mesh-list
102279851|NCT04423107|Oxycodone|oxycodone|mesh-list
102279852|NCT04423107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102279853|NCT04423107|Analgesics|analgesics|mesh-ancestor
101988615|NCT03715023|PC-786|pc-786|mesh-list
102279854|NCT04423107|Sensory System Agents|sensory system agents|mesh-ancestor
102279855|NCT04423107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102279856|NCT04423107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279857|NCT04423107|Antipyretics|antipyretics|mesh-ancestor
102279858|NCT04423107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102279859|NCT04423107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102279860|NCT04423107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102279861|NCT04423107|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102279862|NCT04423107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102279863|NCT04423107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279864|NCT04423107|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102279865|NCT04423107|Narcotics|narcotics|mesh-ancestor
102279866|NCT04423107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102279867|NCT01675531|Oxycodone|oxycodone|mesh-list
102279868|NCT01675531|Naloxone|naloxone|mesh-list
102279869|NCT01675531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102279870|NCT01675531|Narcotics|narcotics|mesh-ancestor
102279871|NCT01675531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102279872|NCT01675531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279873|NCT01675531|Analgesics|analgesics|mesh-ancestor
102279874|NCT01675531|Sensory System Agents|sensory system agents|mesh-ancestor
102279875|NCT01675531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102279876|NCT01675531|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102279877|NCT05406999|Prednisolone|prednisolone|mesh-list
102279878|NCT05406999|Abiraterone Acetate|abiraterone acetate|mesh-list
102279879|NCT05406999|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102279880|NCT05406999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102279881|NCT05406999|Glucocorticoids|glucocorticoids|mesh-ancestor
102279882|NCT05406999|Hormones|hormones|mesh-ancestor
102279883|NCT05406999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102279884|NCT05406999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279885|NCT05406999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102279886|NCT05406999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102279887|NCT05406999|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102279888|NCT05406999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102279889|NCT05406999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279890|NCT05406999|Hormone Antagonists|hormone antagonists|mesh-ancestor
102279891|NCT05406999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102279892|NCT04930211|Dexamethasone|dexamethasone|mesh-list
102279893|NCT04930211|Lidocaine|lidocaine|mesh-list
102279894|NCT04930211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102279895|NCT04930211|Antiemetics|antiemetics|mesh-ancestor
102279896|NCT04930211|Autonomic Agents|autonomic agents|mesh-ancestor
102279897|NCT04930211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102279898|NCT04930211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279899|NCT04930211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102279900|NCT04930211|Glucocorticoids|glucocorticoids|mesh-ancestor
102279901|NCT04930211|Hormones|hormones|mesh-ancestor
102279902|NCT04930211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102279903|NCT04930211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102279904|NCT04930211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102279905|NCT04930211|Anesthetics, Local|anesthetics, local|mesh-ancestor
102279906|NCT04930211|Anesthetics|anesthetics|mesh-ancestor
102279907|NCT04930211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102279908|NCT04930211|Sensory System Agents|sensory system agents|mesh-ancestor
102279909|NCT04930211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102279910|NCT04930211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102279911|NCT04930211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102279912|NCT04930211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102279913|NCT04930211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279914|NCT04912271|Dexamethasone|dexamethasone|mesh-list
102279915|NCT04912271|Aprepitant|aprepitant|mesh-list
102279916|NCT04912271|Fosaprepitant|fosaprepitant|mesh-list
102279917|NCT04912271|Palonosetron|palonosetron|mesh-list
102279918|NCT04912271|Granisetron|granisetron|mesh-list
102279919|NCT04912271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102279920|NCT04912271|Antiemetics|antiemetics|mesh-ancestor
102279921|NCT04912271|Autonomic Agents|autonomic agents|mesh-ancestor
102279922|NCT04912271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102279923|NCT04912271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279924|NCT04912271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102279925|NCT04912271|Glucocorticoids|glucocorticoids|mesh-ancestor
102279926|NCT04912271|Hormones|hormones|mesh-ancestor
102279927|NCT04912271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102279928|NCT04912271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102279929|NCT04912271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102279930|NCT04912271|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102279931|NCT04912271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102279932|NCT04912271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279933|NCT04912271|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102279934|NCT04912271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102279935|NCT04912271|Serotonin Agents|serotonin agents|mesh-ancestor
102279936|NCT02807779|Dexamethasone|dexamethasone|mesh-list
102279937|NCT02807779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102279938|NCT02807779|Antiemetics|antiemetics|mesh-ancestor
102279939|NCT02807779|Autonomic Agents|autonomic agents|mesh-ancestor
102279940|NCT02807779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102279941|NCT02807779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279942|NCT02807779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102279943|NCT02807779|Glucocorticoids|glucocorticoids|mesh-ancestor
102279944|NCT02807779|Hormones|hormones|mesh-ancestor
102279945|NCT02807779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102279946|NCT02807779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102279947|NCT02807779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102279948|NCT04912193|Antithrombins|antithrombins|mesh-list
102279949|NCT04912193|Antithrombin III|antithrombin iii|mesh-list
102279950|NCT04912193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102279951|NCT04912193|Protease Inhibitors|protease inhibitors|mesh-ancestor
102279952|NCT04912193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102279953|NCT04912193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279954|NCT04912193|Anticoagulants|anticoagulants|mesh-ancestor
102279955|NCT02680561|Fluticasone|fluticasone|mesh-list
102279956|NCT02680561|Xhance|xhance|mesh-list
102279957|NCT02680561|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102279958|NCT02680561|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102279959|NCT02680561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102279960|NCT02680561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102279961|NCT02680561|Autonomic Agents|autonomic agents|mesh-ancestor
102279962|NCT02680561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102279963|NCT02680561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279964|NCT02680561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102279965|NCT02680561|Respiratory System Agents|respiratory system agents|mesh-ancestor
102279966|NCT02680561|Dermatologic Agents|dermatologic agents|mesh-ancestor
102279967|NCT02680561|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102279968|NCT02680561|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102279969|NCT02680561|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102279970|NCT02680561|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102279971|NCT02680561|Adrenergic Agents|adrenergic agents|mesh-ancestor
102279972|NCT02680561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102279973|NCT02680561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279974|NCT02680561|Glucocorticoids|glucocorticoids|mesh-ancestor
102279975|NCT02680561|Hormones|hormones|mesh-ancestor
102279976|NCT02680561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102279977|NCT02680561|Sympathomimetics|sympathomimetics|mesh-ancestor
102279978|NCT05025163|Fluorides|fluorides|mesh-list
102279979|NCT05025163|Fluorides, Topical|fluorides, topical|mesh-list
102279980|NCT05025163|Cariostatic Agents|cariostatic agents|mesh-ancestor
102279981|NCT05025163|Protective Agents|protective agents|mesh-ancestor
102279982|NCT05025163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279983|NCT02592031|Goserelin|goserelin|mesh-list
102279984|NCT02592031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102279985|NCT02592031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102279986|NCT04784299|Lidocaine|lidocaine|mesh-list
102279987|NCT04784299|Anesthetics, Local|anesthetics, local|mesh-ancestor
102279988|NCT04784299|Anesthetics|anesthetics|mesh-ancestor
102279989|NCT04784299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102279990|NCT04784299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102279991|NCT04784299|Sensory System Agents|sensory system agents|mesh-ancestor
102279992|NCT04784299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102279993|NCT04784299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102279994|NCT04784299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102279995|NCT04784299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102279996|NCT04784299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102279997|NCT04784299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102279999|NCT02333149|Antioxidants|antioxidants|mesh-ancestor
102280000|NCT02333149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280001|NCT02333149|Protective Agents|protective agents|mesh-ancestor
102280002|NCT02333149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280003|NCT02333149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102280004|NCT05117983|Antidepressive Agents|antidepressive agents|mesh-list
102280005|NCT05117983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102280006|NCT03807817|Ethanol|ethanol|mesh-list
102280007|NCT03807817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102280008|NCT03807817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102280009|NCT03807817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102280010|NCT03807817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280011|NCT05122117|Methylene Blue|methylene blue|mesh-list
102280012|NCT05122117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102280013|NCT05122117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280014|NCT05116345|Dexamethasone|dexamethasone|mesh-list
102280015|NCT05116345|Dexamethasone acetate|dexamethasone acetate|mesh-list
102280016|NCT05116345|BB 1101|bb 1101|mesh-list
102280017|NCT05116345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102280018|NCT05116345|Antiemetics|antiemetics|mesh-ancestor
102280019|NCT05116345|Autonomic Agents|autonomic agents|mesh-ancestor
102280020|NCT05116345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102280021|NCT05116345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280022|NCT05116345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102280023|NCT05116345|Glucocorticoids|glucocorticoids|mesh-ancestor
102280024|NCT05116345|Hormones|hormones|mesh-ancestor
102280025|NCT05116345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102280026|NCT05116345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102280027|NCT05116345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102280028|NCT05116345|Protease Inhibitors|protease inhibitors|mesh-ancestor
102280029|NCT05116345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102280030|NCT05116345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280031|NCT05076097|Rituximab|rituximab|mesh-list
102280032|NCT05076097|Lenalidomide|lenalidomide|mesh-list
102280033|NCT05076097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102280034|NCT05076097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102280035|NCT05076097|Immunologic Factors|immunologic factors|mesh-ancestor
102280036|NCT05076097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280037|NCT05076097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102280038|NCT05076097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102280039|NCT05076097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102280040|NCT05076097|Growth Substances|growth substances|mesh-ancestor
102280041|NCT05076097|Growth Inhibitors|growth inhibitors|mesh-ancestor
102280042|NCT04513639|Dexamethasone|dexamethasone|mesh-list
102280043|NCT04513639|Dexamethasone acetate|dexamethasone acetate|mesh-list
102280044|NCT04513639|Daratumumab|daratumumab|mesh-list
102280045|NCT04513639|BB 1101|bb 1101|mesh-list
102280046|NCT04513639|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102280047|NCT04513639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102280048|NCT04513639|Antiemetics|antiemetics|mesh-ancestor
102280049|NCT04513639|Autonomic Agents|autonomic agents|mesh-ancestor
102280050|NCT04513639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102280051|NCT04513639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280052|NCT04513639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102280053|NCT04513639|Glucocorticoids|glucocorticoids|mesh-ancestor
102280054|NCT04513639|Hormones|hormones|mesh-ancestor
102280055|NCT04513639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102280056|NCT04513639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102280057|NCT04513639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102280058|NCT04513639|Protease Inhibitors|protease inhibitors|mesh-ancestor
102280059|NCT04513639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102280060|NCT04513639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280061|NCT04513639|Immunologic Factors|immunologic factors|mesh-ancestor
102280062|NCT05229913|Esketamine|esketamine|mesh-list
102280063|NCT05229913|Antidepressive Agents|antidepressive agents|mesh-ancestor
102280064|NCT05229913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102280065|NCT05108155|Tacrine|tacrine|mesh-list
102280066|NCT05108155|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102280067|NCT05108155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102280068|NCT05108155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280069|NCT05108155|Cholinergic Agents|cholinergic agents|mesh-ancestor
102280070|NCT05108155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101621803|NCT01712490|Antimitotic Agents|antimitotic agents|mesh-ancestor
102280071|NCT05108155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280072|NCT05108155|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102280073|NCT05108155|Autonomic Agents|autonomic agents|mesh-ancestor
102280074|NCT05108155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102280075|NCT05108155|Nootropic Agents|nootropic agents|mesh-ancestor
102280076|NCT04375735|Pulmonary Surfactants|pulmonary surfactants|mesh-list
102280077|NCT04375735|Respiratory System Agents|respiratory system agents|mesh-ancestor
102280078|NCT01362439|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102280079|NCT01362439|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102280080|NCT01362439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102280081|NCT01362439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102280082|NCT01362439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280083|NCT01362439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102280084|NCT01362439|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102280085|NCT01362439|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102280086|NCT01362439|Serotonin Agents|serotonin agents|mesh-ancestor
102280087|NCT01362439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102280088|NCT01362439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280089|NCT01362439|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102280090|NCT01362439|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102280091|NCT01362439|Dopamine Agents|dopamine agents|mesh-ancestor
102280092|NCT05228743|Paclitaxel|paclitaxel|mesh-list
102280093|NCT05228743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102280094|NCT05228743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102280095|NCT05228743|Tubulin Modulators|tubulin modulators|mesh-ancestor
102280096|NCT05228743|Antimitotic Agents|antimitotic agents|mesh-ancestor
102280097|NCT05228743|Mitosis Modulators|mitosis modulators|mesh-ancestor
102280098|NCT05228743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280099|NCT03321019|Capsaicin|capsaicin|mesh-list
102280100|NCT03321019|Antipruritics|antipruritics|mesh-ancestor
102280101|NCT03321019|Dermatologic Agents|dermatologic agents|mesh-ancestor
102280102|NCT03321019|Sensory System Agents|sensory system agents|mesh-ancestor
102280103|NCT03321019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102280104|NCT03321019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280105|NCT04990921|Pembrolizumab|pembrolizumab|mesh-list
102280106|NCT04990921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102280107|NCT04990921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102280108|NCT04990921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102280109|NCT04990921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280110|NCT04507477|Rituximab|rituximab|mesh-list
102280111|NCT04507477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102280112|NCT04507477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102280113|NCT04507477|Immunologic Factors|immunologic factors|mesh-ancestor
102280114|NCT04507477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280115|NCT04507477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102280116|NCT01675141|Lenalidomide|lenalidomide|mesh-list
102280117|NCT01675141|Immunologic Factors|immunologic factors|mesh-ancestor
102280118|NCT01675141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280119|NCT01675141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102280120|NCT01675141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102280121|NCT01675141|Growth Substances|growth substances|mesh-ancestor
102280122|NCT01675141|Growth Inhibitors|growth inhibitors|mesh-ancestor
102280123|NCT01675141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102280124|NCT05102149|Vildagliptin|vildagliptin|mesh-list
102280125|NCT05102149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102280126|NCT05102149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280127|NCT05102149|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102280128|NCT05102149|Protease Inhibitors|protease inhibitors|mesh-ancestor
102280129|NCT05102149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102280130|NCT05102149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280131|NCT04412395|Lactoferrin|lactoferrin|mesh-list
102280132|NCT04412395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102280133|NCT04987099|Choline|choline|mesh-list
102280134|NCT04987099|Lipotropic Agents|lipotropic agents|mesh-ancestor
102280135|NCT04987099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102280136|NCT04987099|Antimetabolites|antimetabolites|mesh-ancestor
102280137|NCT04987099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280138|NCT04987099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102280139|NCT04987099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102280140|NCT04987099|Nootropic Agents|nootropic agents|mesh-ancestor
102280141|NCT03906721|Oxycodone|oxycodone|mesh-list
102280142|NCT03906721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102280143|NCT03906721|Narcotics|narcotics|mesh-ancestor
102280144|NCT03906721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102280145|NCT03906721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280146|NCT03906721|Analgesics|analgesics|mesh-ancestor
102280147|NCT03906721|Sensory System Agents|sensory system agents|mesh-ancestor
102280148|NCT03906721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102280149|NCT04663711|Anesthetics|anesthetics|mesh-list
102280150|NCT04663711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102280151|NCT04663711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280152|NCT04529863|Abatacept|abatacept|mesh-list
101988890|NCT03933605|Anesthetics|anesthetics|mesh-ancestor
102280153|NCT04529863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102280154|NCT04529863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280155|NCT04529863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102280156|NCT04529863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102280157|NCT04529863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102280158|NCT04529863|Immunologic Factors|immunologic factors|mesh-ancestor
102280159|NCT04529863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280160|NCT04529863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102280161|NCT04582591|Cannabidiol|cannabidiol|mesh-list
102280162|NCT04582591|Anticonvulsants|anticonvulsants|mesh-ancestor
102280163|NCT04497883|Maribavir|maribavir|mesh-list
102280164|NCT04497883|Antiviral Agents|antiviral agents|mesh-ancestor
102280165|NCT04497883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102280166|NCT03688633|Candesartan|candesartan|mesh-list
102280167|NCT03688633|Candesartan cilexetil|candesartan cilexetil|mesh-list
102280168|NCT03688633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102280169|NCT03688633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102280170|NCT03688633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102280171|NCT03688633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280172|NCT03963895|Thrombin|thrombin|mesh-list
102280173|NCT03963895|Hemostatics|hemostatics|mesh-ancestor
102280174|NCT03963895|Coagulants|coagulants|mesh-ancestor
102280175|NCT03662815|Molgramostim|molgramostim|mesh-list
102280176|NCT03662815|Sargramostim|sargramostim|mesh-list
102280177|NCT03662815|Immunologic Factors|immunologic factors|mesh-ancestor
102280178|NCT03662815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280179|NCT03662815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102280180|NCT03490903|Fentanyl|fentanyl|mesh-list
102280181|NCT03490903|Midazolam|midazolam|mesh-list
102280182|NCT03490903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102280183|NCT03490903|Narcotics|narcotics|mesh-ancestor
102280184|NCT03490903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102280185|NCT03490903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280186|NCT03490903|Analgesics|analgesics|mesh-ancestor
102280187|NCT03490903|Sensory System Agents|sensory system agents|mesh-ancestor
102280188|NCT03490903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102280189|NCT03490903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102280190|NCT03490903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102280191|NCT03490903|Anesthetics, General|anesthetics, general|mesh-ancestor
102280192|NCT03490903|Anesthetics|anesthetics|mesh-ancestor
102280193|NCT03490903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102280194|NCT03490903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102280195|NCT03490903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102280196|NCT03490903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102280197|NCT03490903|GABA Modulators|gaba modulators|mesh-ancestor
102280198|NCT03490903|GABA Agents|gaba agents|mesh-ancestor
102280199|NCT03490903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102280200|NCT03490903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280201|NCT04169191|Sildenafil Citrate|sildenafil citrate|mesh-list
102280202|NCT04169191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280203|NCT04169191|Vasodilator Agents|vasodilator agents|mesh-ancestor
102280204|NCT04169191|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102280205|NCT04169191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102280206|NCT04169191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102280207|NCT04169191|Urological Agents|urological agents|mesh-ancestor
102280208|NCT03954613|Memantine|memantine|mesh-list
102280209|NCT03954613|Donepezil|donepezil|mesh-list
102280210|NCT03954613|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102280211|NCT03954613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102280212|NCT03954613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280213|NCT03954613|Cholinergic Agents|cholinergic agents|mesh-ancestor
102280214|NCT03954613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102280215|NCT03954613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280216|NCT03954613|Nootropic Agents|nootropic agents|mesh-ancestor
102280217|NCT03954613|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102280218|NCT03954613|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102280219|NCT03954613|Dopamine Agents|dopamine agents|mesh-ancestor
102280220|NCT03954613|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102280221|NCT03954613|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102280222|NCT03367819|Cemiplimab|cemiplimab|mesh-list
102280223|NCT03367819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102280224|NCT03367819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102280225|NCT04023253|Solifenacin Succinate|solifenacin succinate|mesh-list
102280226|NCT04023253|Mirabegron|mirabegron|mesh-list
102280227|NCT04023253|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102280228|NCT04023253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102280229|NCT04023253|Cholinergic Agents|cholinergic agents|mesh-ancestor
102280231|NCT04023253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280232|NCT04023253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280233|NCT04023253|Urological Agents|urological agents|mesh-ancestor
102280234|NCT04023253|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102280235|NCT04023253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102280236|NCT04023253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102280237|NCT04023253|Adrenergic Agents|adrenergic agents|mesh-ancestor
102280238|NCT04875871|Copper|copper|mesh-list
102280239|NCT04875871|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102280240|NCT04875871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102280241|NCT04875871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280242|NCT04875871|Trace Elements|trace elements|mesh-ancestor
102280243|NCT04875871|Micronutrients|micronutrients|mesh-ancestor
102280244|NCT04875871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280245|NCT04781725|Cisplatin|cisplatin|mesh-list
102280246|NCT04781725|Vinblastine|vinblastine|mesh-list
102280247|NCT04781725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102280248|NCT04781725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102280249|NCT04781725|Tubulin Modulators|tubulin modulators|mesh-ancestor
102280250|NCT04781725|Antimitotic Agents|antimitotic agents|mesh-ancestor
102280251|NCT04781725|Mitosis Modulators|mitosis modulators|mesh-ancestor
102280252|NCT04781725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280253|NCT03580525|Nicotine|nicotine|mesh-list
102280254|NCT03580525|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102280255|NCT03580525|Autonomic Agents|autonomic agents|mesh-ancestor
102280256|NCT03580525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102280257|NCT03580525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280258|NCT03580525|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102280259|NCT03580525|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102280260|NCT03580525|Cholinergic Agents|cholinergic agents|mesh-ancestor
102280261|NCT03580525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102280262|NCT03580525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280263|NCT03554707|Bevacizumab|bevacizumab|mesh-list
102280264|NCT03554707|Irinotecan|irinotecan|mesh-list
102280265|NCT03554707|Temozolomide|temozolomide|mesh-list
102280266|NCT03554707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102280267|NCT03554707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102280268|NCT03554707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102280269|NCT03554707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102280270|NCT03554707|Growth Substances|growth substances|mesh-ancestor
102280271|NCT03554707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280272|NCT03554707|Growth Inhibitors|growth inhibitors|mesh-ancestor
102280273|NCT03554707|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102280274|NCT03554707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102280275|NCT03554707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102280276|NCT03554707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280277|NCT03554707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102280278|NCT03554707|Alkylating Agents|alkylating agents|mesh-ancestor
102280279|NCT04264663|Furazolidone|furazolidone|mesh-list
102280280|NCT04264663|Tinidazole|tinidazole|mesh-list
102280281|NCT04264663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102280282|NCT04264663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102280283|NCT04264663|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102280284|NCT04264663|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
102280285|NCT04264663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102280286|NCT04264663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102280287|NCT04264663|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102280288|NCT04264663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102280289|NCT04264663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280290|NCT04264663|Alkylating Agents|alkylating agents|mesh-ancestor
102280291|NCT04264663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102280292|NCT05403307|Vaccines|vaccines|mesh-list
102280293|NCT05403307|Immunologic Factors|immunologic factors|mesh-ancestor
102280294|NCT05403307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280295|NCT04563559|Prednisolone|prednisolone|mesh-list
102280296|NCT04563559|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102280297|NCT04563559|Methylprednisolone|methylprednisolone|mesh-list
102280298|NCT04563559|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102280300|NCT04563559|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102280301|NCT04563559|Prednisolone phosphate|prednisolone phosphate|mesh-list
102280302|NCT04563559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102280303|NCT04563559|Glucocorticoids|glucocorticoids|mesh-ancestor
102280304|NCT04563559|Hormones|hormones|mesh-ancestor
102280305|NCT04563559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102280306|NCT04563559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280307|NCT04563559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102280308|NCT04563559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102280309|NCT04563559|Antiemetics|antiemetics|mesh-ancestor
102280310|NCT04563559|Autonomic Agents|autonomic agents|mesh-ancestor
102280311|NCT04563559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102280312|NCT04563559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102280313|NCT04563559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102280314|NCT04563559|Protective Agents|protective agents|mesh-ancestor
102280315|NCT02124187|Nicotine|nicotine|mesh-list
102280316|NCT02124187|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102280317|NCT02124187|Autonomic Agents|autonomic agents|mesh-ancestor
102280318|NCT02124187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102280319|NCT02124187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280320|NCT02124187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102280321|NCT02124187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102280322|NCT02124187|Cholinergic Agents|cholinergic agents|mesh-ancestor
102280323|NCT02124187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102280324|NCT02124187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280325|NCT02002819|Levetiracetam|levetiracetam|mesh-list
102280326|NCT02002819|Anticonvulsants|anticonvulsants|mesh-ancestor
102280327|NCT02002819|Nootropic Agents|nootropic agents|mesh-ancestor
102280328|NCT01597193|Fulvestrant|fulvestrant|mesh-list
102280329|NCT01597193|Anastrozole|anastrozole|mesh-list
102280330|NCT01597193|Exemestane|exemestane|mesh-list
102280331|NCT01597193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102280332|NCT01597193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102280333|NCT01597193|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102280334|NCT01597193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102280335|NCT01597193|Hormone Antagonists|hormone antagonists|mesh-ancestor
102280336|NCT01597193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102280337|NCT01597193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280338|NCT01597193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102280339|NCT01597193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102280340|NCT01597193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102280341|NCT01597193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280342|NCT04930133|Afatinib|afatinib|mesh-list
102280343|NCT04930133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102280344|NCT04930133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102280345|NCT04930133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102280346|NCT04930133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280347|NCT03057041|Fentanyl|fentanyl|mesh-list
102280348|NCT03057041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102280349|NCT03057041|Narcotics|narcotics|mesh-ancestor
102280350|NCT03057041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102280351|NCT03057041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280352|NCT03057041|Analgesics|analgesics|mesh-ancestor
102280353|NCT03057041|Sensory System Agents|sensory system agents|mesh-ancestor
102280354|NCT03057041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102280355|NCT03057041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102280356|NCT03057041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102280357|NCT03057041|Anesthetics, General|anesthetics, general|mesh-ancestor
102280358|NCT03057041|Anesthetics|anesthetics|mesh-ancestor
102280359|NCT05123287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102280360|NCT05123287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280361|NCT05123287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102280362|NCT05123287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102280363|NCT04165993|Docetaxel|docetaxel|mesh-list
102280364|NCT04165993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102280365|NCT04165993|Tubulin Modulators|tubulin modulators|mesh-ancestor
102280366|NCT04165993|Antimitotic Agents|antimitotic agents|mesh-ancestor
102280367|NCT04165993|Mitosis Modulators|mitosis modulators|mesh-ancestor
102280368|NCT04165993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280369|NCT04911413|Tranexamic Acid|tranexamic acid|mesh-list
102280370|NCT04911413|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102280371|NCT04911413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102280372|NCT04911413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280373|NCT04911413|Hemostatics|hemostatics|mesh-ancestor
102280374|NCT04911413|Coagulants|coagulants|mesh-ancestor
102280375|NCT03889795|Metformin|metformin|mesh-list
102280376|NCT03889795|Digoxin|digoxin|mesh-list
102280377|NCT03889795|Simvastatin|simvastatin|mesh-list
102280378|NCT03889795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102280379|NCT03889795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280380|NCT03889795|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102280381|NCT03889795|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102280382|NCT03889795|Antimetabolites|antimetabolites|mesh-ancestor
102280383|NCT03889795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280384|NCT03889795|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102280385|NCT03889795|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102280386|NCT03889795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102280387|NCT03889795|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102280388|NCT03889795|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102280389|NCT03889795|Protective Agents|protective agents|mesh-ancestor
102280390|NCT02622113|Canagliflozin|canagliflozin|mesh-list
102280391|NCT02622113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102280392|NCT02622113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280393|NCT02622113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102280394|NCT02622113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280395|NCT04430777|Tranexamic Acid|tranexamic acid|mesh-list
102280396|NCT04430777|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102280397|NCT04430777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102280398|NCT04430777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280399|NCT04430777|Hemostatics|hemostatics|mesh-ancestor
102280400|NCT04430777|Coagulants|coagulants|mesh-ancestor
102280402|NCT04910477|Dexmedetomidine|dexmedetomidine|mesh-list
102280403|NCT04910477|Neostigmine|neostigmine|mesh-list
102280404|NCT04910477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102280405|NCT04910477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102280406|NCT04910477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280407|NCT04910477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102280408|NCT04910477|Analgesics|analgesics|mesh-ancestor
102280409|NCT04910477|Sensory System Agents|sensory system agents|mesh-ancestor
102280410|NCT04910477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102280411|NCT04910477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102280412|NCT04910477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102280413|NCT04910477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102280414|NCT04910477|Adrenergic Agents|adrenergic agents|mesh-ancestor
102280415|NCT04910477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102280416|NCT04910477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280417|NCT04910477|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102280418|NCT04910477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102280419|NCT04910477|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102280420|NCT04910477|Autonomic Agents|autonomic agents|mesh-ancestor
102280421|NCT04910477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102280422|NCT04910477|Respiratory System Agents|respiratory system agents|mesh-ancestor
102280423|NCT04910477|Mydriatics|mydriatics|mesh-ancestor
102280424|NCT04910477|Parasympatholytics|parasympatholytics|mesh-ancestor
102280425|NCT04910477|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102280426|NCT04910477|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102280427|NCT04910477|Cholinergic Agents|cholinergic agents|mesh-ancestor
102280428|NCT04910477|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102280429|NCT04910477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102280430|NCT04910477|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102280431|NCT03843151|Itraconazole|itraconazole|mesh-list
102280432|NCT03843151|Antifungal Agents|antifungal agents|mesh-ancestor
102280433|NCT03843151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102280434|NCT03843151|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102280435|NCT03843151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102280436|NCT03843151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102280437|NCT03843151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280438|NCT03843151|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102280439|NCT03843151|Hormone Antagonists|hormone antagonists|mesh-ancestor
102280440|NCT03843151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102280441|NCT03843151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280442|NCT03843151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102280443|NCT04929509|Listerine|listerine|mesh-list
102280444|NCT04929509|Fluorides|fluorides|mesh-list
102280445|NCT04929509|Sodium Fluoride|sodium fluoride|mesh-list
102280446|NCT04929509|Fluorides, Topical|fluorides, topical|mesh-list
102280447|NCT04929509|Cariostatic Agents|cariostatic agents|mesh-ancestor
102280448|NCT04929509|Protective Agents|protective agents|mesh-ancestor
102280449|NCT04929509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280450|NCT04929509|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102280451|NCT04929509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102280453|NCT03054467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102280454|NCT03054467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102280455|NCT03054467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102280456|NCT03054467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280457|NCT03054467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102280458|NCT03054467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280459|NCT03054467|Vasodilator Agents|vasodilator agents|mesh-ancestor
102280460|NCT04910165|Ropivacaine|ropivacaine|mesh-list
102280461|NCT04910165|Anesthetics, Local|anesthetics, local|mesh-ancestor
102280462|NCT04910165|Anesthetics|anesthetics|mesh-ancestor
102280463|NCT04910165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102280464|NCT04910165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280465|NCT04910165|Sensory System Agents|sensory system agents|mesh-ancestor
102280466|NCT04910165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102280467|NCT02730325|Immunoglobulins|immunoglobulins|mesh-list
102280468|NCT02730325|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102280469|NCT02730325|Antibodies|antibodies|mesh-list
102280470|NCT02730325|Immunologic Factors|immunologic factors|mesh-ancestor
102280471|NCT02730325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280472|NCT04928495|Acetylcysteine|acetylcysteine|mesh-list
102280473|NCT04928495|Bromhexine|bromhexine|mesh-list
102280474|NCT04928495|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102280475|NCT04928495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280476|NCT04928495|Antioxidants|antioxidants|mesh-ancestor
102280477|NCT04928495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280478|NCT04928495|Protective Agents|protective agents|mesh-ancestor
102280479|NCT04928495|Antiviral Agents|antiviral agents|mesh-ancestor
102280480|NCT04928495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102280481|NCT04928495|Expectorants|expectorants|mesh-ancestor
102280482|NCT04928495|Respiratory System Agents|respiratory system agents|mesh-ancestor
102280483|NCT04928495|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102280484|NCT04928495|Antidotes|antidotes|mesh-ancestor
102280485|NCT01573429|Bisphenol A|bisphenol a|mesh-list
102280486|NCT01573429|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102280487|NCT01573429|Estrogens|estrogens|mesh-ancestor
102280488|NCT01573429|Hormones|hormones|mesh-ancestor
102280489|NCT01573429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102280490|NCT01573429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280491|NCT01573429|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102280492|NCT01573429|Antioxidants|antioxidants|mesh-ancestor
102280493|NCT01573429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280494|NCT01573429|Protective Agents|protective agents|mesh-ancestor
102280495|NCT04909931|Vitamin D|vitamin d|mesh-list
102280496|NCT04909931|Ergocalciferols|ergocalciferols|mesh-list
102280497|NCT04909931|Vitamins|vitamins|mesh-ancestor
102280498|NCT04909931|Micronutrients|micronutrients|mesh-ancestor
102280499|NCT04909931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280500|NCT04909931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102280501|NCT04909931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102280502|NCT04918589|Tranexamic Acid|tranexamic acid|mesh-list
102280503|NCT04918589|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102280504|NCT04918589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102280505|NCT04918589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280506|NCT04918589|Hemostatics|hemostatics|mesh-ancestor
102280507|NCT04918589|Coagulants|coagulants|mesh-ancestor
102280508|NCT04101643|Evolocumab|evolocumab|mesh-list
102280509|NCT04101643|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102280510|NCT04101643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102280511|NCT04101643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102280512|NCT04101643|Antimetabolites|antimetabolites|mesh-ancestor
102280513|NCT04101643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280514|NCT04101643|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102280515|NCT04101643|Protease Inhibitors|protease inhibitors|mesh-ancestor
102280516|NCT04101643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102280517|NCT04101643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102280518|NCT02620787|Tedizolid|tedizolid|mesh-list
102280519|NCT02620787|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102280520|NCT02620787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102280521|NCT04909619|Anesthetics|anesthetics|mesh-list
102280522|NCT04909619|Anesthetics, Local|anesthetics, local|mesh-list
102280523|NCT04909619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102280524|NCT04909619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280525|NCT04909619|Sensory System Agents|sensory system agents|mesh-ancestor
102280526|NCT04909619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102280527|NCT03520231|Vitamin D|vitamin d|mesh-list
102280528|NCT03520231|Denosumab|denosumab|mesh-list
102280529|NCT03520231|Carboplatin|carboplatin|mesh-list
102280530|NCT03520231|Gemcitabine|gemcitabine|mesh-list
102280532|NCT03520231|Vitamins|vitamins|mesh-ancestor
102280533|NCT03520231|Micronutrients|micronutrients|mesh-ancestor
102280534|NCT03520231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280535|NCT03520231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102280536|NCT03520231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102280537|NCT03520231|Antimetabolites|antimetabolites|mesh-ancestor
102280538|NCT03520231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280539|NCT03520231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102280540|NCT03520231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102280541|NCT04927481|Mitoxantrone|mitoxantrone|mesh-list
102280542|NCT04927481|Analgesics|analgesics|mesh-ancestor
102280543|NCT04927481|Sensory System Agents|sensory system agents|mesh-ancestor
102280544|NCT04927481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102280545|NCT04927481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280546|NCT04927481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102280547|NCT04927481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102280548|NCT04927481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102280549|NCT04927481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102280550|NCT04927481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280551|NCT03056495|Vorinostat|vorinostat|mesh-list
102280552|NCT03056495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102280553|NCT03056495|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102280554|NCT03056495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102280555|NCT03056495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280556|NCT03171805|Propranolol|propranolol|mesh-list
102280557|NCT03171805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102280558|NCT03171805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102280559|NCT03171805|Adrenergic Agents|adrenergic agents|mesh-ancestor
102280560|NCT03171805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102280561|NCT03171805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280562|NCT03171805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280563|NCT03171805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102280564|NCT03171805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102280565|NCT03171805|Vasodilator Agents|vasodilator agents|mesh-ancestor
102280566|NCT04918433|Anesthetics|anesthetics|mesh-list
102280567|NCT04918433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102280568|NCT04918433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280569|NCT04926467|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102280570|NCT04926467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102280571|NCT03053219|Abivertinib|abivertinib|mesh-list
102280572|NCT03053219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102280573|NCT03053219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102280574|NCT03053219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280575|NCT03055793|Budesonide|budesonide|mesh-list
102280576|NCT03055793|Formoterol Fumarate|formoterol fumarate|mesh-list
102280577|NCT03055793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102280578|NCT03055793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102280579|NCT03055793|Autonomic Agents|autonomic agents|mesh-ancestor
102280580|NCT03055793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102280581|NCT03055793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280582|NCT03055793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102280583|NCT03055793|Respiratory System Agents|respiratory system agents|mesh-ancestor
102280584|NCT03055793|Glucocorticoids|glucocorticoids|mesh-ancestor
102280585|NCT03055793|Hormones|hormones|mesh-ancestor
102280586|NCT03055793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102280587|NCT03055793|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102280588|NCT03055793|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102280589|NCT03055793|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102280590|NCT03055793|Adrenergic Agents|adrenergic agents|mesh-ancestor
102280591|NCT03055793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102280592|NCT03055793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280593|NCT04926155|Metformin|metformin|mesh-list
102280594|NCT04926155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102280595|NCT04926155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280596|NCT04909775|Gemcitabine|gemcitabine|mesh-list
102280597|NCT04909775|Tislelizumab|tislelizumab|mesh-list
102280598|NCT04909775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102280599|NCT04909775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102280600|NCT04909775|Antimetabolites|antimetabolites|mesh-ancestor
102280601|NCT04909775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280602|NCT04909775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102280603|NCT04925141|Dasatinib|dasatinib|mesh-list
102280604|NCT04925141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102280605|NCT04925141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102280606|NCT04925141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102280607|NCT04925141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280608|NCT02651155|Lubiprostone|lubiprostone|mesh-list
102280609|NCT02651155|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102280610|NCT02651155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102280611|NCT02651155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280612|NCT04925063|Metformin|metformin|mesh-list
102280613|NCT04925063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102280614|NCT04925063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280615|NCT04909151|Methamphetamine|methamphetamine|mesh-list
102280616|NCT04909151|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102280617|NCT04909151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280618|NCT04909151|Sympathomimetics|sympathomimetics|mesh-ancestor
102280619|NCT04909151|Autonomic Agents|autonomic agents|mesh-ancestor
102280620|NCT04909151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102280621|NCT04909151|Dopamine Agents|dopamine agents|mesh-ancestor
102280622|NCT04909151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102280623|NCT04909151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280624|NCT04909151|Adrenergic Agents|adrenergic agents|mesh-ancestor
102280625|NCT04909151|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102280626|NCT04909151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102280627|NCT04909151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102280628|NCT04909151|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102280629|NCT05132413|Bevacizumab|bevacizumab|mesh-list
102280630|NCT05132413|Cisplatin|cisplatin|mesh-list
102280631|NCT05132413|Carboplatin|carboplatin|mesh-list
102280632|NCT05132413|Pemetrexed|pemetrexed|mesh-list
102280633|NCT05132413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102280634|NCT05132413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102280635|NCT05132413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102280636|NCT05132413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102280637|NCT05132413|Growth Substances|growth substances|mesh-ancestor
102280638|NCT05132413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280639|NCT05132413|Growth Inhibitors|growth inhibitors|mesh-ancestor
102280640|NCT05132413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102280641|NCT05132413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280642|NCT05132413|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102280643|NCT05132413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101380542|NCT00102414|Gemcitabine|gemcitabine|mesh-list
102280644|NCT04435717|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102280645|NCT04075981|Botulinum Toxins|botulinum toxins|mesh-list
102280646|NCT04075981|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102280647|NCT04075981|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102280648|NCT04075981|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102280649|NCT04075981|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102280650|NCT04075981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102280651|NCT04075981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280652|NCT04075981|Cholinergic Agents|cholinergic agents|mesh-ancestor
102280653|NCT04075981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102280654|NCT04075981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280655|NCT04075981|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102280656|NCT04075981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102280657|NCT04917497|Simendan|simendan|mesh-list
102280658|NCT04917497|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102280659|NCT04917497|Vasodilator Agents|vasodilator agents|mesh-ancestor
102280660|NCT04917497|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102280661|NCT04917497|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102280662|NCT04917497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102280663|NCT04917497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280664|NCT04917497|Protective Agents|protective agents|mesh-ancestor
102280665|NCT04917497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280666|NCT03933007|Fexofenadine|fexofenadine|mesh-list
102280667|NCT03933007|Colchicine|colchicine|mesh-list
102280668|NCT03933007|Midazolam|midazolam|mesh-list
102280669|NCT03933007|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102280670|NCT03933007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102280671|NCT03933007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102280672|NCT03933007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280673|NCT03933007|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102280674|NCT03933007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102280675|NCT03933007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102280676|NCT03933007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102280677|NCT03933007|Anesthetics, General|anesthetics, general|mesh-ancestor
102280678|NCT03933007|Anesthetics|anesthetics|mesh-ancestor
102280679|NCT03933007|GABA Modulators|gaba modulators|mesh-ancestor
102280680|NCT03933007|GABA Agents|gaba agents|mesh-ancestor
102280681|NCT03933007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102280682|NCT03933007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280683|NCT03933007|Gout Suppressants|gout suppressants|mesh-ancestor
102280684|NCT03933007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102280685|NCT03933007|Tubulin Modulators|tubulin modulators|mesh-ancestor
102280686|NCT03933007|Antimitotic Agents|antimitotic agents|mesh-ancestor
102280687|NCT03933007|Mitosis Modulators|mitosis modulators|mesh-ancestor
102280688|NCT03933007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102280689|NCT03933007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102280690|NCT03933007|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102280691|NCT03933007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102280692|NCT03933007|Histamine Antagonists|histamine antagonists|mesh-ancestor
102280693|NCT03933007|Histamine Agents|histamine agents|mesh-ancestor
102280694|NCT04907747|Amoxicillin|amoxicillin|mesh-list
102280695|NCT04907747|Furazolidone|furazolidone|mesh-list
102280696|NCT04907747|Esomeprazole|esomeprazole|mesh-list
102280697|NCT04907747|Bismuth|bismuth|mesh-list
102280698|NCT04907747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102280699|NCT04907747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102280700|NCT04907747|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102280701|NCT04907747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102280702|NCT04907747|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102280703|NCT04907747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102280704|NCT04907747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280705|NCT04907747|Antacids|antacids|mesh-ancestor
102280706|NCT04907747|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102280707|NCT04907747|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102280708|NCT04907747|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
102280709|NCT04907747|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102280710|NCT04907747|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102280711|NCT04907747|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102280712|NCT03052673|Fentanyl|fentanyl|mesh-list
102280713|NCT03052673|Ketamine|ketamine|mesh-list
102280714|NCT03052673|Analgesics|analgesics|mesh-ancestor
102280715|NCT03052673|Sensory System Agents|sensory system agents|mesh-ancestor
102280716|NCT03052673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102280717|NCT03052673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280718|NCT03052673|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102280719|NCT03052673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102280720|NCT03052673|Anesthetics, General|anesthetics, general|mesh-ancestor
102280721|NCT03052673|Anesthetics|anesthetics|mesh-ancestor
102280722|NCT03052673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102280723|NCT03052673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102280724|NCT03052673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102280725|NCT03052673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102280726|NCT03052673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280727|NCT03052673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102280728|NCT03052673|Narcotics|narcotics|mesh-ancestor
102280729|NCT03052673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102280730|NCT04907123|Diuretics|diuretics|mesh-list
102280731|NCT04907123|Natriuretic Agents|natriuretic agents|mesh-ancestor
102280732|NCT04907123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280733|NCT05030857|Midazolam|midazolam|mesh-list
102280734|NCT05030857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102280735|NCT05030857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102280736|NCT05030857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102280737|NCT05030857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280738|NCT05030857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102280739|NCT05030857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102280740|NCT05030857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102280741|NCT05030857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102280742|NCT05030857|Anesthetics, General|anesthetics, general|mesh-ancestor
102280743|NCT05030857|Anesthetics|anesthetics|mesh-ancestor
102280744|NCT05030857|GABA Modulators|gaba modulators|mesh-ancestor
102280745|NCT05030857|GABA Agents|gaba agents|mesh-ancestor
102280746|NCT05030857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102280747|NCT05030857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280748|NCT03319459|Trastuzumab|trastuzumab|mesh-list
102280749|NCT03319459|Cetuximab|cetuximab|mesh-list
102280750|NCT03319459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102280751|NCT03319459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102280752|NCT04916951|Amoxicillin|amoxicillin|mesh-list
102280753|NCT04916951|Cephalexin|cephalexin|mesh-list
102280754|NCT04916951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102280755|NCT04916951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102280756|NCT04430933|Paclitaxel|paclitaxel|mesh-list
102280757|NCT04430933|Docetaxel|docetaxel|mesh-list
102280758|NCT04430933|Carboplatin|carboplatin|mesh-list
102280759|NCT04430933|Pemetrexed|pemetrexed|mesh-list
102280760|NCT04430933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102280761|NCT04430933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102280762|NCT04430933|Tubulin Modulators|tubulin modulators|mesh-ancestor
102280763|NCT04430933|Antimitotic Agents|antimitotic agents|mesh-ancestor
102280764|NCT04430933|Mitosis Modulators|mitosis modulators|mesh-ancestor
102280765|NCT04430933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280766|NCT04430933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102280767|NCT04430933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102280768|NCT04430933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102280769|NCT04906655|Glycopyrrolate|glycopyrrolate|mesh-list
102280770|NCT04906655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102280771|NCT04906655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102280772|NCT04906655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102280773|NCT04906655|Cholinergic Agents|cholinergic agents|mesh-ancestor
102280774|NCT04906655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102280775|NCT04906655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280776|NCT04906655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280777|NCT03055091|Sorbitol|sorbitol|mesh-list
102280778|NCT03055091|Cathartics|cathartics|mesh-ancestor
102280779|NCT03055091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102280780|NCT02648581|Ustekinumab|ustekinumab|mesh-list
102280781|NCT02648581|Dermatologic Agents|dermatologic agents|mesh-ancestor
102280782|NCT02609815|Metformin|metformin|mesh-list
102280783|NCT02609815|Glimepiride|glimepiride|mesh-list
102280784|NCT02609815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102280785|NCT02609815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280786|NCT02609815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102280787|NCT02609815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102280788|NCT02609815|Immunologic Factors|immunologic factors|mesh-ancestor
102280789|NCT05132023|Metformin|metformin|mesh-list
102280790|NCT05132023|Empagliflozin|empagliflozin|mesh-list
102280791|NCT05132023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102280792|NCT05132023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280793|NCT05132023|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102280794|NCT05132023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280795|NCT05131711|Immunomodulating Agents|immunomodulating agents|mesh-list
102280796|NCT05131711|Immunologic Factors|immunologic factors|mesh-ancestor
102280797|NCT05131711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280798|NCT02619617|Pasireotide|pasireotide|mesh-list
102280799|NCT02619617|Hormones|hormones|mesh-ancestor
102280800|NCT02619617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102280801|NCT02619617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280802|NCT04012957|Darbepoetin alfa|darbepoetin alfa|mesh-list
102280803|NCT04012957|Hematinics|hematinics|mesh-ancestor
102280804|NCT04906031|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
102280805|NCT04906031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102280806|NCT04906031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102280807|NCT04906031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102280808|NCT04906031|Schistosomicides|schistosomicides|mesh-ancestor
102280809|NCT04906031|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102280810|NCT04906031|Anthelmintics|anthelmintics|mesh-ancestor
102280811|NCT05125627|Progesterone|progesterone|mesh-list
102280812|NCT05125627|Progestins|progestins|mesh-ancestor
102280813|NCT05125627|Hormones|hormones|mesh-ancestor
102280814|NCT05125627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102280815|NCT05125627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280816|NCT05125549|Clopidogrel|clopidogrel|mesh-list
102280817|NCT05125549|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102280818|NCT05125549|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102280819|NCT05125549|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102280820|NCT05125549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102280821|NCT05125549|Purinergic Agents|purinergic agents|mesh-ancestor
102280822|NCT05125549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102280823|NCT05125549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280824|NCT05125549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280825|NCT04903847|Tenofovir|tenofovir|mesh-list
102280826|NCT04903847|Lamivudine|lamivudine|mesh-list
102280827|NCT04903847|Dolutegravir|dolutegravir|mesh-list
102280828|NCT04903847|Antiviral Agents|antiviral agents|mesh-ancestor
102280829|NCT04903847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102280830|NCT04903847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102280831|NCT04903847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102280832|NCT04903847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102280833|NCT04903847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280835|NCT04903847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102280836|NCT04903847|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102280837|NCT04903847|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102280838|NCT04905953|Neostigmine|neostigmine|mesh-list
102280839|NCT04905953|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102280840|NCT04905953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102280841|NCT04905953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280842|NCT04905953|Cholinergic Agents|cholinergic agents|mesh-ancestor
102280843|NCT04905953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102280844|NCT04905953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280845|NCT04905953|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102280846|NCT04905953|Autonomic Agents|autonomic agents|mesh-ancestor
102280847|NCT04905953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102280848|NCT04916093|Metformin|metformin|mesh-list
102280849|NCT04916093|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102280850|NCT04916093|Vildagliptin|vildagliptin|mesh-list
102280851|NCT04916093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102280852|NCT04916093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280853|NCT04916093|Incretins|incretins|mesh-ancestor
102280854|NCT04916093|Hormones|hormones|mesh-ancestor
102280855|NCT04916093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102280856|NCT04916093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102280857|NCT04916093|Protease Inhibitors|protease inhibitors|mesh-ancestor
102280858|NCT04916093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101380750|NCT00268918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102280859|NCT04916093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280860|NCT05130619|Ethanol|ethanol|mesh-list
102280861|NCT05130619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102280862|NCT05130619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102280863|NCT05130619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102280864|NCT05130619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280865|NCT03512119|Ivacaftor|ivacaftor|mesh-list
102280866|NCT03512119|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102280867|NCT03512119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102280868|NCT03512119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280869|NCT02642809|Pembrolizumab|pembrolizumab|mesh-list
102280870|NCT02642809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102280871|NCT02642809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102280872|NCT02642809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102280873|NCT02642809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280874|NCT03052361|Ondansetron|ondansetron|mesh-list
102280875|NCT03052361|Antiemetics|antiemetics|mesh-ancestor
102280876|NCT03052361|Autonomic Agents|autonomic agents|mesh-ancestor
102280877|NCT03052361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102280878|NCT03052361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280879|NCT03052361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102280880|NCT03052361|Antipruritics|antipruritics|mesh-ancestor
102280881|NCT03052361|Dermatologic Agents|dermatologic agents|mesh-ancestor
102280882|NCT03052361|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102280883|NCT03052361|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102280884|NCT03052361|Serotonin Agents|serotonin agents|mesh-ancestor
102280885|NCT03052361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102280886|NCT03052361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280887|NCT02370589|Vaccines|vaccines|mesh-list
102280888|NCT02370589|Immunologic Factors|immunologic factors|mesh-ancestor
102280889|NCT02370589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280890|NCT01752049|Timolol|timolol|mesh-list
102280891|NCT01752049|Maleic acid|maleic acid|mesh-list
102280892|NCT01752049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102280893|NCT01752049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280894|NCT01752049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102280895|NCT01752049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102280896|NCT01752049|Adrenergic Agents|adrenergic agents|mesh-ancestor
102280897|NCT01752049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102280898|NCT01752049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280899|NCT01752049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102280900|NCT01752049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102280902|NCT04966507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
102280903|NCT04966507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102280904|NCT04949113|Nivolumab|nivolumab|mesh-list
102280905|NCT04949113|Ipilimumab|ipilimumab|mesh-list
102280906|NCT04949113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102280907|NCT04949113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102280908|NCT04949113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102280909|NCT04949113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280910|NCT05057845|Lenvatinib|lenvatinib|mesh-list
102280911|NCT05057845|Tislelizumab|tislelizumab|mesh-list
102280912|NCT05057845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102280913|NCT05057845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102280914|NCT05057845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102280915|NCT05057845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280916|NCT05057845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102280917|NCT05109949|Dapagliflozin|dapagliflozin|mesh-list
102280918|NCT05109949|Empagliflozin|empagliflozin|mesh-list
102280919|NCT05109949|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102280920|NCT05109949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280921|NCT05109949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102280922|NCT05109949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280923|NCT04901663|Amoxicillin|amoxicillin|mesh-list
102280924|NCT04901663|Clarithromycin|clarithromycin|mesh-list
102280925|NCT04901663|Omeprazole|omeprazole|mesh-list
102280926|NCT04901663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102280927|NCT04901663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102280928|NCT04901663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102280929|NCT04901663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102280930|NCT04901663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102280931|NCT04901663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102280932|NCT04901663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280933|NCT04901663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102280934|NCT04901663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102280935|NCT04901663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102280936|NCT05134519|Trastuzumab|trastuzumab|mesh-list
102280937|NCT05134519|Antibodies|antibodies|mesh-list
102280938|NCT05134519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102280939|NCT05134519|Immunologic Factors|immunologic factors|mesh-ancestor
102280940|NCT05134519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280941|NCT05134519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102280942|NCT05134519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102280943|NCT04394663|Omeprazole|omeprazole|mesh-list
102280944|NCT04394663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102280945|NCT04394663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102280946|NCT04394663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102280947|NCT04394663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102280948|NCT04394663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280949|NCT05133193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102280950|NCT05133193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102280951|NCT05133193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102280952|NCT05133193|Antitubercular Agents|antitubercular agents|mesh-ancestor
102280953|NCT04901117|Amoxicillin|amoxicillin|mesh-list
102280954|NCT04901117|Metronidazole|metronidazole|mesh-list
102280955|NCT04901117|Clarithromycin|clarithromycin|mesh-list
102280956|NCT04901117|Tetracycline|tetracycline|mesh-list
102280957|NCT04901117|Potassium Citrate|potassium citrate|mesh-list
102280958|NCT04901117|Bismuth|bismuth|mesh-list
102280959|NCT04901117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280960|NCT04901117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102280961|NCT04901117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102280962|NCT04901117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102280963|NCT04901117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102280964|NCT04901117|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102280965|NCT04901117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102280966|NCT04901117|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102280967|NCT04901117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102280968|NCT04901117|Antacids|antacids|mesh-ancestor
102280969|NCT04901117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102280970|NCT04901117|Diuretics|diuretics|mesh-ancestor
102280971|NCT04901117|Natriuretic Agents|natriuretic agents|mesh-ancestor
102280972|NCT04901117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280973|NCT04901117|Expectorants|expectorants|mesh-ancestor
102280974|NCT04901117|Respiratory System Agents|respiratory system agents|mesh-ancestor
102280975|NCT05121571|Sorafenib|sorafenib|mesh-list
102280976|NCT05121571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102280977|NCT05121571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102280978|NCT05121571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102280979|NCT05121571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102280980|NCT03051269|Calcium, Dietary|calcium, dietary|mesh-list
102280981|NCT03051269|Calcium|calcium|mesh-list
101989740|NCT01301053|Insulin|insulin|mesh-list
102280982|NCT03051269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102280983|NCT03051269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280984|NCT03051269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102280985|NCT04576663|Phenylephrine|phenylephrine|mesh-list
102280986|NCT04576663|Oxymetazoline|oxymetazoline|mesh-list
102280987|NCT04576663|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102280988|NCT04576663|Mydriatics|mydriatics|mesh-ancestor
102280989|NCT04576663|Autonomic Agents|autonomic agents|mesh-ancestor
102280990|NCT04576663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102280991|NCT04576663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102280992|NCT04576663|Sympathomimetics|sympathomimetics|mesh-ancestor
102280993|NCT04576663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102280994|NCT04576663|Nasal Decongestants|nasal decongestants|mesh-ancestor
102280995|NCT04576663|Respiratory System Agents|respiratory system agents|mesh-ancestor
102280996|NCT04576663|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102280997|NCT04576663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102280998|NCT04576663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102280999|NCT04576663|Adrenergic Agents|adrenergic agents|mesh-ancestor
102281000|NCT04576663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102281001|NCT04576663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281002|NCT04576663|Protective Agents|protective agents|mesh-ancestor
102281003|NCT05281549|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102281004|NCT05281549|Tenecteplase|tenecteplase|mesh-list
102281005|NCT05281549|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102281006|NCT05281549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102281007|NCT05281549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281008|NCT04400695|Paclitaxel|paclitaxel|mesh-list
102281009|NCT04400695|Vinorelbine|vinorelbine|mesh-list
102281010|NCT04400695|Docetaxel|docetaxel|mesh-list
102281011|NCT04400695|Capecitabine|capecitabine|mesh-list
102281012|NCT04400695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102281013|NCT04400695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281014|NCT04400695|Tubulin Modulators|tubulin modulators|mesh-ancestor
102281015|NCT04400695|Antimitotic Agents|antimitotic agents|mesh-ancestor
102281016|NCT04400695|Mitosis Modulators|mitosis modulators|mesh-ancestor
102281017|NCT04400695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281018|NCT04400695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102281019|NCT04400695|Antimetabolites|antimetabolites|mesh-ancestor
102281020|NCT05205499|Sirolimus|sirolimus|mesh-list
102281021|NCT05205499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102281022|NCT05205499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102281023|NCT05205499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102281024|NCT05205499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281025|NCT05205499|Antifungal Agents|antifungal agents|mesh-ancestor
102281026|NCT05205499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102281027|NCT05205499|Immunologic Factors|immunologic factors|mesh-ancestor
102281028|NCT05205499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281029|NCT05191225|Rituximab|rituximab|mesh-list
102281030|NCT05191225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102281031|NCT05191225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281032|NCT05191225|Immunologic Factors|immunologic factors|mesh-ancestor
102281033|NCT05191225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281034|NCT05191225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102281035|NCT03909217|Dexetimide|dexetimide|mesh-list
102281036|NCT03909217|Citalopram|citalopram|mesh-list
102281037|NCT03909217|Escitalopram|escitalopram|mesh-list
102281038|NCT03909217|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102281039|NCT03909217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102281040|NCT03909217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102281041|NCT03909217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281042|NCT03909217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102281043|NCT03909217|Serotonin Agents|serotonin agents|mesh-ancestor
102281044|NCT03909217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281045|NCT03909217|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102281046|NCT03909217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102281047|NCT03909217|Parasympatholytics|parasympatholytics|mesh-ancestor
102281048|NCT03909217|Autonomic Agents|autonomic agents|mesh-ancestor
102281049|NCT03909217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102281050|NCT03909217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102281051|NCT03909217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102281052|NCT03909217|Cholinergic Agents|cholinergic agents|mesh-ancestor
102281053|NCT03909217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102281054|NCT03909217|Antidepressive Agents|antidepressive agents|mesh-ancestor
102281055|NCT03909217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102281056|NCT02650921|Lidocaine|lidocaine|mesh-list
102281057|NCT02650921|Anesthetics, Local|anesthetics, local|mesh-ancestor
102281059|NCT02650921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102281060|NCT02650921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281061|NCT02650921|Sensory System Agents|sensory system agents|mesh-ancestor
102281062|NCT02650921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102281063|NCT02650921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102281064|NCT02650921|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102281065|NCT02650921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102281066|NCT02650921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101305024|NCT02016495|Vitamins|vitamins|mesh-ancestor
102281067|NCT02650921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281068|NCT04913987|Cimetidine|cimetidine|mesh-list
102281069|NCT04913987|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102281070|NCT04913987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102281071|NCT04913987|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102281072|NCT04913987|Histamine Antagonists|histamine antagonists|mesh-ancestor
102281073|NCT04913987|Histamine Agents|histamine agents|mesh-ancestor
102281074|NCT04913987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102281075|NCT04913987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281076|NCT04913987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281077|NCT04913987|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102281078|NCT04913987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102281079|NCT04913987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102281080|NCT01596335|Immunoglobulins|immunoglobulins|mesh-list
102281081|NCT01596335|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102281082|NCT01596335|Antibodies|antibodies|mesh-list
102281083|NCT01596335|Immunologic Factors|immunologic factors|mesh-ancestor
102281084|NCT01596335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281085|NCT04891679|Misoprostol|misoprostol|mesh-list
102281086|NCT04891679|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102281087|NCT04891679|Abortifacient Agents|abortifacient agents|mesh-ancestor
102281088|NCT04891679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102281089|NCT04891679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281090|NCT04891679|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102281091|NCT04891679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102281092|NCT04891679|Oxytocics|oxytocics|mesh-ancestor
102281093|NCT04913831|Cerebrolysin|cerebrolysin|mesh-list
102281094|NCT04913831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102281095|NCT04913831|Protective Agents|protective agents|mesh-ancestor
102281096|NCT04913831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281097|NCT04913831|Nootropic Agents|nootropic agents|mesh-ancestor
102281098|NCT04900415|Vitamin A|vitamin a|mesh-list
102281099|NCT04900415|Vitamins|vitamins|mesh-ancestor
102281100|NCT04900415|Micronutrients|micronutrients|mesh-ancestor
102281101|NCT04900415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281102|NCT04900571|Nitrofurantoin|nitrofurantoin|mesh-list
102281103|NCT04900571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102281104|NCT04900571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102281105|NCT04900571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102281106|NCT04891211|Vitamin D|vitamin d|mesh-list
102281107|NCT04891211|Vitamins|vitamins|mesh-ancestor
102281108|NCT04891211|Micronutrients|micronutrients|mesh-ancestor
102281109|NCT04891211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281110|NCT04891211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102281111|NCT04817189|Dexamethasone|dexamethasone|mesh-list
102281112|NCT04817189|Ondansetron|ondansetron|mesh-list
102281113|NCT04817189|Palonosetron|palonosetron|mesh-list
102281114|NCT04817189|Granisetron|granisetron|mesh-list
102281115|NCT04817189|Tropisetron|tropisetron|mesh-list
102281116|NCT04817189|Dolasetron|dolasetron|mesh-list
102281117|NCT04817189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102281118|NCT04817189|Antiemetics|antiemetics|mesh-ancestor
102281119|NCT04817189|Autonomic Agents|autonomic agents|mesh-ancestor
102281120|NCT04817189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102281121|NCT04817189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281122|NCT04817189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102281123|NCT04817189|Glucocorticoids|glucocorticoids|mesh-ancestor
102281124|NCT04817189|Hormones|hormones|mesh-ancestor
102281125|NCT04817189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102281126|NCT04817189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102281127|NCT04817189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281128|NCT04817189|Antipruritics|antipruritics|mesh-ancestor
102281129|NCT04817189|Dermatologic Agents|dermatologic agents|mesh-ancestor
102281130|NCT04817189|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102281131|NCT04817189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102281132|NCT04817189|Serotonin Agents|serotonin agents|mesh-ancestor
102281133|NCT04817189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102281134|NCT04817189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281135|NCT03050957|Menthol|menthol|mesh-list
102281136|NCT03050957|Antipruritics|antipruritics|mesh-ancestor
102281137|NCT03050957|Dermatologic Agents|dermatologic agents|mesh-ancestor
102281138|NCT04885049|Racecadotril|racecadotril|mesh-list
102281139|NCT04885049|Antidiarrheals|antidiarrheals|mesh-ancestor
102281140|NCT04885049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101381074|NCT04730375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102281141|NCT04885049|Protease Inhibitors|protease inhibitors|mesh-ancestor
102281142|NCT04885049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102281143|NCT04885049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281144|NCT04890353|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102281145|NCT04890353|Dermatologic Agents|dermatologic agents|mesh-ancestor
102281146|NCT04890353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102281147|NCT04890353|Immunologic Factors|immunologic factors|mesh-ancestor
102281148|NCT04890353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281149|NCT04430621|Hormones|hormones|mesh-list
102281150|NCT04430621|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102281151|NCT04430621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102281152|NCT04430621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281153|NCT04884503|Clonazepam|clonazepam|mesh-list
102281154|NCT04884503|Anticonvulsants|anticonvulsants|mesh-ancestor
102281155|NCT04884503|GABA Modulators|gaba modulators|mesh-ancestor
102281156|NCT04884503|GABA Agents|gaba agents|mesh-ancestor
102281157|NCT04884503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102281158|NCT04884503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281159|NCT04884503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281160|NCT04889651|Abiraterone Acetate|abiraterone acetate|mesh-list
102281161|NCT04889651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281162|NCT04889651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102281163|NCT04889651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102281164|NCT04889651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281165|NCT04889651|Hormone Antagonists|hormone antagonists|mesh-ancestor
102281166|NCT04889651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102281167|NCT04889651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281168|NCT04889651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102281169|NCT04898699|Tenofovir|tenofovir|mesh-list
102281170|NCT04898699|Emtricitabine|emtricitabine|mesh-list
102281171|NCT04898699|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102281172|NCT04898699|Antiviral Agents|antiviral agents|mesh-ancestor
102281173|NCT04898699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102281174|NCT04898699|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102281175|NCT04898699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102281176|NCT04898699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102281177|NCT04898699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281178|NCT04898699|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102281179|NCT04898699|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102281180|NCT04888715|Pirfenidone|pirfenidone|mesh-list
102281181|NCT04888715|Nintedanib|nintedanib|mesh-list
102281182|NCT04888715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281183|NCT04888715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102281184|NCT04888715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102281185|NCT04888715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281186|NCT04888715|Analgesics|analgesics|mesh-ancestor
102281187|NCT04888715|Sensory System Agents|sensory system agents|mesh-ancestor
102281188|NCT04888715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102281189|NCT04888715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281190|NCT04888715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102281191|NCT04888715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102281192|NCT04888715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102281193|NCT04888715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102281194|NCT04888403|Paclitaxel|paclitaxel|mesh-list
102281195|NCT04888403|Nedaplatin|nedaplatin|mesh-list
102281196|NCT04888403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102281197|NCT04888403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281198|NCT04888403|Tubulin Modulators|tubulin modulators|mesh-ancestor
102281199|NCT04888403|Antimitotic Agents|antimitotic agents|mesh-ancestor
102281200|NCT04888403|Mitosis Modulators|mitosis modulators|mesh-ancestor
102281201|NCT04888403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281202|NCT03050177|Gefitinib|gefitinib|mesh-list
102281204|NCT03050177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102281205|NCT03050177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102281206|NCT03050177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281207|NCT03051581|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102281208|NCT03051581|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102281209|NCT03051581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281210|NCT03050411|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102281212|NCT03050411|Gefitinib|gefitinib|mesh-list
102281213|NCT03050411|Osimertinib|osimertinib|mesh-list
102281214|NCT03050411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281215|NCT03050411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102281216|NCT03050411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102281217|NCT03050411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281218|NCT04887311|Tempol|tempol|mesh-list
102281219|NCT04887311|Antioxidants|antioxidants|mesh-ancestor
102281220|NCT04887311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281221|NCT04887311|Protective Agents|protective agents|mesh-ancestor
102281222|NCT04887311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281223|NCT04887311|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102281224|NCT04887311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102281225|NCT04887311|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102281226|NCT04887311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102281227|NCT03051503|Fentanyl|fentanyl|mesh-list
102281228|NCT03051503|Morphine|morphine|mesh-list
102281229|NCT03051503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102281230|NCT03051503|Narcotics|narcotics|mesh-ancestor
102281231|NCT03051503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102281232|NCT03051503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281233|NCT03051503|Analgesics|analgesics|mesh-ancestor
102281234|NCT03051503|Sensory System Agents|sensory system agents|mesh-ancestor
102281235|NCT03051503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102281236|NCT03051503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102281237|NCT03051503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102281238|NCT03051503|Anesthetics, General|anesthetics, general|mesh-ancestor
102281239|NCT03051503|Anesthetics|anesthetics|mesh-ancestor
102281240|NCT04896125|Bimatoprost|bimatoprost|mesh-list
102281241|NCT04896125|Latanoprost|latanoprost|mesh-list
102281242|NCT04896125|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102281243|NCT04896125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102281244|NCT04896125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102281245|NCT04895657|Tazobactam|tazobactam|mesh-list
102281246|NCT04895657|Piperacillin|piperacillin|mesh-list
102281247|NCT04895657|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102281248|NCT04895657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102281249|NCT04895657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102281250|NCT04895657|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102281251|NCT04895657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102281252|NCT04895657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281253|NCT04895423|Cyclosporine|cyclosporine|mesh-list
102281254|NCT04895423|Mycophenolic Acid|mycophenolic acid|mesh-list
102281255|NCT04895423|Methotrexate|methotrexate|mesh-list
102281256|NCT04895423|Cyclosporins|cyclosporins|mesh-list
102281257|NCT04895423|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102281258|NCT04895423|Abortifacient Agents|abortifacient agents|mesh-ancestor
102281259|NCT04895423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102281260|NCT04895423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281261|NCT04895423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102281262|NCT04895423|Antimetabolites|antimetabolites|mesh-ancestor
102281263|NCT04895423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281264|NCT04895423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281265|NCT04895423|Dermatologic Agents|dermatologic agents|mesh-ancestor
102281266|NCT04895423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102281267|NCT04895423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102281268|NCT04895423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102281269|NCT04895423|Immunologic Factors|immunologic factors|mesh-ancestor
102281270|NCT04895423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102281271|NCT04895423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102281272|NCT04895423|Antifungal Agents|antifungal agents|mesh-ancestor
102281273|NCT04895423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102281274|NCT04895423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102281275|NCT04895423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102281276|NCT04895423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102281277|NCT04895423|Antitubercular Agents|antitubercular agents|mesh-ancestor
102281278|NCT04895423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102281280|NCT04882163|Rituximab|rituximab|mesh-list
102281281|NCT04882163|Gemcitabine|gemcitabine|mesh-list
102281282|NCT04882163|Lenalidomide|lenalidomide|mesh-list
102281283|NCT04882163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102281284|NCT04882163|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
102281285|NCT04882163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101305034|NCT02016664|Analgesics|analgesics|mesh-ancestor
101381295|NCT00273013|Montelukast|montelukast|mesh-list
102281286|NCT04882163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281287|NCT04882163|Immunologic Factors|immunologic factors|mesh-ancestor
102281288|NCT04882163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281289|NCT04882163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102281290|NCT04882163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102281291|NCT04882163|Antiemetics|antiemetics|mesh-ancestor
102281292|NCT04882163|Autonomic Agents|autonomic agents|mesh-ancestor
102281293|NCT04882163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102281294|NCT04882163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102281295|NCT04882163|Glucocorticoids|glucocorticoids|mesh-ancestor
102281296|NCT04882163|Hormones|hormones|mesh-ancestor
102281297|NCT04882163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102281298|NCT04882163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102281299|NCT04882163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102281300|NCT04882163|Antimetabolites|antimetabolites|mesh-ancestor
102281301|NCT04882163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281302|NCT04882163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102281303|NCT04882163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102281304|NCT04882163|Growth Substances|growth substances|mesh-ancestor
102281305|NCT04882163|Growth Inhibitors|growth inhibitors|mesh-ancestor
102281306|NCT04882163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102281307|NCT04882163|Alkylating Agents|alkylating agents|mesh-ancestor
102281308|NCT04882163|Immunoconjugates|immunoconjugates|mesh-ancestor
102281309|NCT04885751|Rebamipide|rebamipide|mesh-list
102281310|NCT04885751|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102281311|NCT04885751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102281312|NCT04885751|Antioxidants|antioxidants|mesh-ancestor
102281313|NCT04885751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281314|NCT04885751|Protective Agents|protective agents|mesh-ancestor
102281315|NCT04885751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281316|NCT04885751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102281317|NCT03049163|Proxymetacaine|proxymetacaine|mesh-list
102281318|NCT03049163|Propoxycaine|propoxycaine|mesh-list
102281319|NCT03049163|Anesthetics|anesthetics|mesh-ancestor
102281320|NCT03049163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102281321|NCT03049163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281322|NCT03049163|Anesthetics, Local|anesthetics, local|mesh-ancestor
102281323|NCT03049163|Sensory System Agents|sensory system agents|mesh-ancestor
102281324|NCT03049163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102281325|NCT04881851|Folic Acid|folic acid|mesh-list
102281326|NCT04881851|Thioctic Acid|thioctic acid|mesh-list
102281327|NCT04881851|Inositol|inositol|mesh-list
102281328|NCT04881851|Hematinics|hematinics|mesh-ancestor
102281329|NCT04881851|Vitamin B Complex|vitamin b complex|mesh-ancestor
102281330|NCT04881851|Vitamins|vitamins|mesh-ancestor
102281331|NCT04881851|Micronutrients|micronutrients|mesh-ancestor
102281332|NCT04881851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281333|NCT04881851|Antioxidants|antioxidants|mesh-ancestor
102281334|NCT04881851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281335|NCT04881851|Protective Agents|protective agents|mesh-ancestor
102281336|NCT04871633|Azithromycin|azithromycin|mesh-list
102281337|NCT04871633|Remdesivir|remdesivir|mesh-list
102281338|NCT04871633|Dexamethasone|dexamethasone|mesh-list
102281339|NCT04871633|Prednisolone|prednisolone|mesh-list
102281340|NCT04871633|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102281341|NCT04871633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102281342|NCT04871633|Antiemetics|antiemetics|mesh-ancestor
102281343|NCT04871633|Autonomic Agents|autonomic agents|mesh-ancestor
102281344|NCT04871633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102281345|NCT04871633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281346|NCT04871633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102281347|NCT04871633|Glucocorticoids|glucocorticoids|mesh-ancestor
102281348|NCT04871633|Hormones|hormones|mesh-ancestor
102281349|NCT04871633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102281350|NCT04871633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102281351|NCT04871633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281352|NCT04871633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281353|NCT04871633|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102281354|NCT04871633|Protective Agents|protective agents|mesh-ancestor
102281355|NCT04871633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102281356|NCT04871633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102281357|NCT04871633|Antimetabolites|antimetabolites|mesh-ancestor
102281358|NCT04871633|Antiviral Agents|antiviral agents|mesh-ancestor
102281359|NCT04880993|Dapagliflozin|dapagliflozin|mesh-list
102281360|NCT04880993|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102281361|NCT04880993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281362|NCT04880993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102281363|NCT04880993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281364|NCT03046979|Apatinib|apatinib|mesh-list
102281365|NCT03046979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281366|NCT03046979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102281367|NCT03046979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102281368|NCT03046979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281369|NCT04676399|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102281370|NCT04676399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102281371|NCT04676399|Diuretics|diuretics|mesh-ancestor
102281372|NCT04676399|Natriuretic Agents|natriuretic agents|mesh-ancestor
102281373|NCT04676399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281374|NCT04676399|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102281375|NCT04676399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102281376|NCT04676399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281377|NCT03047057|Lidocaine|lidocaine|mesh-list
102281378|NCT03047057|Anesthetics, Local|anesthetics, local|mesh-ancestor
102281379|NCT03047057|Anesthetics|anesthetics|mesh-ancestor
102281380|NCT03047057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102281381|NCT03047057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281382|NCT03047057|Sensory System Agents|sensory system agents|mesh-ancestor
102281383|NCT03047057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102281384|NCT03047057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102281385|NCT03047057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102281386|NCT03047057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102281387|NCT03047057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102281388|NCT03047057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281389|NCT04550195|Famotidine|famotidine|mesh-list
102281390|NCT04550195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102281391|NCT04550195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102281392|NCT04550195|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102281393|NCT04550195|Histamine Antagonists|histamine antagonists|mesh-ancestor
102281394|NCT04550195|Histamine Agents|histamine agents|mesh-ancestor
102281395|NCT04550195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102281396|NCT04550195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281397|NCT04550195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281398|NCT04525391|Durvalumab|durvalumab|mesh-list
102281399|NCT04525391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102281400|NCT04525391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281401|NCT04879511|Metformin|metformin|mesh-list
102281402|NCT04879511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102281403|NCT04879511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281404|NCT04361825|Durvalumab|durvalumab|mesh-list
102281405|NCT04361825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102281406|NCT04361825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281407|NCT03046901|Vancomycin|vancomycin|mesh-list
102281408|NCT03046901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102281409|NCT03046901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102281410|NCT03871049|Dexamethasone|dexamethasone|mesh-list
102281411|NCT03871049|Bupivacaine|bupivacaine|mesh-list
102281412|NCT03871049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102281413|NCT03871049|Antiemetics|antiemetics|mesh-ancestor
102281414|NCT03871049|Autonomic Agents|autonomic agents|mesh-ancestor
102281415|NCT03871049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102281416|NCT03871049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281417|NCT03871049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102281418|NCT03871049|Glucocorticoids|glucocorticoids|mesh-ancestor
102281419|NCT03871049|Hormones|hormones|mesh-ancestor
102281420|NCT03871049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102281421|NCT03871049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102281422|NCT03871049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281423|NCT03871049|Anesthetics, Local|anesthetics, local|mesh-ancestor
102281424|NCT03871049|Anesthetics|anesthetics|mesh-ancestor
102281425|NCT03871049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102281426|NCT03871049|Sensory System Agents|sensory system agents|mesh-ancestor
102281427|NCT04870541|Nefopam|nefopam|mesh-list
102281428|NCT04870541|Ondansetron|ondansetron|mesh-list
102281429|NCT04870541|Antiemetics|antiemetics|mesh-ancestor
102281430|NCT04870541|Autonomic Agents|autonomic agents|mesh-ancestor
102281431|NCT04870541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102281432|NCT04870541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281433|NCT04870541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102281434|NCT04870541|Antipruritics|antipruritics|mesh-ancestor
102281435|NCT04870541|Dermatologic Agents|dermatologic agents|mesh-ancestor
102281436|NCT04870541|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102281437|NCT04870541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102281438|NCT04870541|Serotonin Agents|serotonin agents|mesh-ancestor
102281439|NCT04870541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102281440|NCT04870541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281441|NCT04870541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102281442|NCT04870541|Analgesics|analgesics|mesh-ancestor
102281443|NCT04870541|Sensory System Agents|sensory system agents|mesh-ancestor
102281444|NCT04870073|Mannitol|mannitol|mesh-list
102281445|NCT04870073|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102281446|NCT04870073|Diuretics|diuretics|mesh-ancestor
102281447|NCT04870073|Natriuretic Agents|natriuretic agents|mesh-ancestor
102281448|NCT04870073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281449|NCT02616029|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102281450|NCT02616029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102281451|NCT02616029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102281452|NCT02616029|Antiviral Agents|antiviral agents|mesh-ancestor
102281453|NCT02616029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102281454|NCT04878497|Warfarin|warfarin|mesh-list
102281455|NCT04878497|Rivaroxaban|rivaroxaban|mesh-list
102281456|NCT04878497|Dabigatran|dabigatran|mesh-list
102281457|NCT04878497|Apixaban|apixaban|mesh-list
102281458|NCT04878497|Edoxaban|edoxaban|mesh-list
102281459|NCT04878497|Anticoagulants|anticoagulants|mesh-ancestor
102281460|NCT04878497|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102281461|NCT04878497|Antithrombins|antithrombins|mesh-ancestor
102281462|NCT04878497|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102281463|NCT04878497|Protease Inhibitors|protease inhibitors|mesh-ancestor
102281464|NCT04878497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102281465|NCT04878497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281466|NCT03257033|Paclitaxel|paclitaxel|mesh-list
102281467|NCT03257033|Gemcitabine|gemcitabine|mesh-list
102281468|NCT03257033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102281469|NCT03257033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281470|NCT03257033|Tubulin Modulators|tubulin modulators|mesh-ancestor
102281471|NCT03257033|Antimitotic Agents|antimitotic agents|mesh-ancestor
102281472|NCT03257033|Mitosis Modulators|mitosis modulators|mesh-ancestor
102281473|NCT03257033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281474|NCT03257033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102281475|NCT03257033|Antimetabolites|antimetabolites|mesh-ancestor
102281476|NCT03250169|Alemtuzumab|alemtuzumab|mesh-list
102281477|NCT03250169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102281478|NCT03250169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281479|NCT02614859|Metformin|metformin|mesh-list
102281480|NCT02614859|Bicalutamide|bicalutamide|mesh-list
102281481|NCT02614859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102281482|NCT02614859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281483|NCT02614859|Androgen Antagonists|androgen antagonists|mesh-ancestor
102281484|NCT02614859|Hormone Antagonists|hormone antagonists|mesh-ancestor
102281485|NCT02614859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102281486|NCT02614859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281487|NCT01495637|Sargramostim|sargramostim|mesh-list
102281488|NCT01495637|Immunologic Factors|immunologic factors|mesh-ancestor
102281489|NCT01495637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281490|NCT04876859|Anesthetics|anesthetics|mesh-list
102281491|NCT04876859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102281492|NCT04876859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281493|NCT04876313|Paclitaxel|paclitaxel|mesh-list
102281494|NCT04876313|Nivolumab|nivolumab|mesh-list
102281495|NCT04876313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102281496|NCT04876313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281497|NCT04876313|Tubulin Modulators|tubulin modulators|mesh-ancestor
102281498|NCT04876313|Antimitotic Agents|antimitotic agents|mesh-ancestor
102281499|NCT04876313|Mitosis Modulators|mitosis modulators|mesh-ancestor
102281500|NCT04876313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281501|NCT04876313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102281502|NCT04876313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102281503|NCT03049085|Aspirin|aspirin|mesh-list
102281504|NCT03049085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281505|NCT03049085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102281506|NCT03049085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102281507|NCT03049085|Analgesics|analgesics|mesh-ancestor
102281508|NCT03049085|Sensory System Agents|sensory system agents|mesh-ancestor
101990229|NCT03901144|Glycerol|glycerol|mesh-list
102281509|NCT03049085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102281510|NCT03049085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102281511|NCT03049085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102281512|NCT03049085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102281513|NCT03049085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102281514|NCT03049085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281515|NCT03049085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102281516|NCT03049085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102281517|NCT03049085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102281518|NCT03049085|Antipyretics|antipyretics|mesh-ancestor
102281519|NCT04875611|Nivolumab|nivolumab|mesh-list
102281520|NCT04875611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102281521|NCT04875611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281522|NCT04875611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102281523|NCT04875611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281524|NCT04386317|Terazosin|terazosin|mesh-list
102281525|NCT04386317|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102281526|NCT04386317|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102281527|NCT04386317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102281528|NCT04386317|Adrenergic Agents|adrenergic agents|mesh-ancestor
102281529|NCT04386317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102281530|NCT04386317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281531|NCT04386317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281532|NCT04386317|Urological Agents|urological agents|mesh-ancestor
102281533|NCT05256953|Anesthetics|anesthetics|mesh-list
102281534|NCT05256953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102281535|NCT05256953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281536|NCT04874675|Acetaminophen|acetaminophen|mesh-list
102281537|NCT04874675|Ibuprofen|ibuprofen|mesh-list
102281538|NCT04874675|Diclofenac|diclofenac|mesh-list
102281539|NCT04874675|Codeine|codeine|mesh-list
102281540|NCT04874675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102281541|NCT04874675|Analgesics|analgesics|mesh-ancestor
102281542|NCT04874675|Sensory System Agents|sensory system agents|mesh-ancestor
102281543|NCT04874675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102281544|NCT04874675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281545|NCT04874675|Antipyretics|antipyretics|mesh-ancestor
102281546|NCT04874675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102281547|NCT04874675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102281548|NCT04874675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101381497|NCT00274417|Dutasteride|dutasteride|mesh-list
102281549|NCT04874675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102281550|NCT04874675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102281551|NCT04874675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281552|NCT04874675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102281553|NCT04874675|Narcotics|narcotics|mesh-ancestor
102281554|NCT04874675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102281555|NCT04874675|Antitussive Agents|antitussive agents|mesh-ancestor
102281556|NCT04874675|Respiratory System Agents|respiratory system agents|mesh-ancestor
102281557|NCT04868513|Chlorhexidine|chlorhexidine|mesh-list
102281558|NCT04868513|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102281559|NCT04868513|Fluorides|fluorides|mesh-list
102281560|NCT04868513|Cariostatic Agents|cariostatic agents|mesh-ancestor
102281561|NCT04868513|Protective Agents|protective agents|mesh-ancestor
102281562|NCT04868513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281563|NCT04868513|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102281564|NCT04868513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102281565|NCT04868513|Disinfectants|disinfectants|mesh-ancestor
102281566|NCT04868513|Dermatologic Agents|dermatologic agents|mesh-ancestor
102281567|NCT03047837|Aspirin|aspirin|mesh-list
102281568|NCT03047837|Metformin|metformin|mesh-list
102281569|NCT03047837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102281570|NCT03047837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281571|NCT03047837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102281572|NCT03047837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102281573|NCT03047837|Analgesics|analgesics|mesh-ancestor
102281574|NCT03047837|Sensory System Agents|sensory system agents|mesh-ancestor
102281575|NCT03047837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102281576|NCT03047837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102281577|NCT03047837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102281578|NCT03047837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102281579|NCT03047837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102281580|NCT03047837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281581|NCT03047837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102281582|NCT03047837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102281583|NCT03047837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102281584|NCT03047837|Antipyretics|antipyretics|mesh-ancestor
102281585|NCT05256173|Melatonin|melatonin|mesh-list
102281586|NCT05256173|Antioxidants|antioxidants|mesh-ancestor
102281587|NCT05256173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281588|NCT05256173|Protective Agents|protective agents|mesh-ancestor
102281589|NCT05256173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281590|NCT05256173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102281591|NCT02648347|Darbepoetin alfa|darbepoetin alfa|mesh-list
102281592|NCT02648347|Hematinics|hematinics|mesh-ancestor
102281593|NCT02614703|Acetic Acid|acetic acid|mesh-list
102281594|NCT02614703|Retinol acetate|retinol acetate|mesh-list
102281595|NCT02614703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102281596|NCT02614703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102281597|NCT02614703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102281598|NCT02614703|Immunologic Factors|immunologic factors|mesh-ancestor
102281599|NCT02614703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281600|NCT02614703|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102281601|NCT02614703|Protective Agents|protective agents|mesh-ancestor
102281602|NCT02614703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281603|NCT01669343|Letrozole|letrozole|mesh-list
102281604|NCT01669343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281605|NCT01669343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102281606|NCT01669343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102281607|NCT01669343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102281608|NCT01669343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281609|NCT01669343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102281610|NCT01669343|Hormone Antagonists|hormone antagonists|mesh-ancestor
102281611|NCT01669343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102281612|NCT01669343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281613|NCT04383743|Cisplatin|cisplatin|mesh-list
102281614|NCT04383743|Doxorubicin|doxorubicin|mesh-list
102281615|NCT04383743|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102281616|NCT04383743|Pembrolizumab|pembrolizumab|mesh-list
102281617|NCT04383743|Methotrexate|methotrexate|mesh-list
102281618|NCT04383743|Daunorubicin|daunorubicin|mesh-list
102281619|NCT04383743|Vinblastine|vinblastine|mesh-list
102281620|NCT04383743|Lenograstim|lenograstim|mesh-list
102281621|NCT04383743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281622|NCT04383743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102281623|NCT04383743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102281624|NCT04383743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102281625|NCT04383743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102281626|NCT04383743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281627|NCT04383743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102281628|NCT04383743|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102281629|NCT04383743|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102281630|NCT04383743|Abortifacient Agents|abortifacient agents|mesh-ancestor
102281631|NCT04383743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102281632|NCT04383743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281633|NCT04383743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102281634|NCT04383743|Antimetabolites|antimetabolites|mesh-ancestor
102281635|NCT04383743|Dermatologic Agents|dermatologic agents|mesh-ancestor
102281636|NCT04383743|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102281637|NCT04383743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102281638|NCT04383743|Immunologic Factors|immunologic factors|mesh-ancestor
102281639|NCT04383743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102281640|NCT04383743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102281641|NCT04383743|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102281642|NCT04383743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102281643|NCT04383743|Tubulin Modulators|tubulin modulators|mesh-ancestor
102281644|NCT04383743|Antimitotic Agents|antimitotic agents|mesh-ancestor
102281645|NCT04383743|Mitosis Modulators|mitosis modulators|mesh-ancestor
102281646|NCT03126643|Nivolumab|nivolumab|mesh-list
102281647|NCT03126643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102281648|NCT03126643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281649|NCT03126643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102281650|NCT03126643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281651|NCT04617067|Paclitaxel|paclitaxel|mesh-list
102281652|NCT04617067|Gemcitabine|gemcitabine|mesh-list
102281653|NCT04617067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102281654|NCT04617067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281655|NCT04617067|Tubulin Modulators|tubulin modulators|mesh-ancestor
102281656|NCT04617067|Antimitotic Agents|antimitotic agents|mesh-ancestor
102281657|NCT04617067|Mitosis Modulators|mitosis modulators|mesh-ancestor
102281658|NCT04617067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281659|NCT04617067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102281660|NCT04617067|Antimetabolites|antimetabolites|mesh-ancestor
102281661|NCT01594931|Artesunate|artesunate|mesh-list
102281662|NCT01594931|Pyronaridine|pyronaridine|mesh-list
102281663|NCT01594931|Antimalarials|antimalarials|mesh-ancestor
102281664|NCT01594931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102281665|NCT01594931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102281666|NCT01594931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102281667|NCT01594931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281668|NCT01594931|Antiviral Agents|antiviral agents|mesh-ancestor
102281669|NCT01594931|Schistosomicides|schistosomicides|mesh-ancestor
102281670|NCT01594931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102281671|NCT01594931|Anthelmintics|anthelmintics|mesh-ancestor
102281672|NCT03045185|Metronidazole|metronidazole|mesh-list
102281673|NCT03045185|Ciprofloxacin|ciprofloxacin|mesh-list
102281674|NCT03045185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102281675|NCT03045185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102281676|NCT03045185|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102281677|NCT03045185|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102281678|NCT03045185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102281679|NCT03045185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102281680|NCT03045185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102281681|NCT03045185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281682|NCT03045185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281683|NCT03045185|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102281684|NCT03045185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102281686|NCT04969237|Vitamins|vitamins|mesh-ancestor
102281687|NCT04969237|Micronutrients|micronutrients|mesh-ancestor
102281688|NCT04969237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281689|NCT04969237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102281690|NCT04341467|Olanzapine|olanzapine|mesh-list
102281691|NCT04341467|Amisulpride|amisulpride|mesh-list
102281692|NCT04341467|Antiemetics|antiemetics|mesh-ancestor
102281693|NCT04341467|Autonomic Agents|autonomic agents|mesh-ancestor
101381642|NCT00108498|Histamine Agents|histamine agents|mesh-ancestor
102281694|NCT04341467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102281695|NCT04341467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281696|NCT04341467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102281697|NCT04341467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102281698|NCT04341467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102281699|NCT04341467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102281700|NCT04341467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102281701|NCT04341467|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102281702|NCT04341467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102281703|NCT04341467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102281704|NCT04341467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281705|NCT04341467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102281706|NCT04341467|Serotonin Agents|serotonin agents|mesh-ancestor
102281707|NCT04341467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102281708|NCT04341467|Dopamine Agents|dopamine agents|mesh-ancestor
102281709|NCT04341467|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102281710|NCT04341467|Antidepressive Agents|antidepressive agents|mesh-ancestor
102281711|NCT04872881|Fentanyl|fentanyl|mesh-list
102281712|NCT04872881|Propofol|propofol|mesh-list
102281713|NCT04872881|Rocuronium|rocuronium|mesh-list
102281714|NCT04872881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102281715|NCT04872881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102281716|NCT04872881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281717|NCT04872881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102281718|NCT04872881|Anesthetics, General|anesthetics, general|mesh-ancestor
102281719|NCT04872881|Anesthetics|anesthetics|mesh-ancestor
102281720|NCT04872881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102281721|NCT04872881|Narcotics|narcotics|mesh-ancestor
102281722|NCT04872881|Analgesics|analgesics|mesh-ancestor
102281723|NCT04872881|Sensory System Agents|sensory system agents|mesh-ancestor
102281724|NCT04872881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102281725|NCT04872881|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102281726|NCT04872881|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102281727|NCT04872881|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102281728|NCT04872881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102281729|NCT03044873|Deucravacitinib|deucravacitinib|mesh-list
102281730|NCT03044873|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102281731|NCT03044873|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102281732|NCT03044873|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102281733|NCT03044873|Antimetabolites|antimetabolites|mesh-ancestor
102281734|NCT03044873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281735|NCT03044873|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102281736|NCT03044873|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102281737|NCT03044873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102281738|NCT03044873|Dermatologic Agents|dermatologic agents|mesh-ancestor
102281739|NCT03044873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102281740|NCT03044795|Veliparib|veliparib|mesh-list
102281741|NCT03044795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102281742|NCT03044795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102281743|NCT03044795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281744|NCT03044795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281745|NCT04341155|Dexamethasone|dexamethasone|mesh-list
102281746|NCT04341155|Dexamethasone acetate|dexamethasone acetate|mesh-list
102281747|NCT04341155|BB 1101|bb 1101|mesh-list
102281748|NCT04341155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102281749|NCT04341155|Antiemetics|antiemetics|mesh-ancestor
102281750|NCT04341155|Autonomic Agents|autonomic agents|mesh-ancestor
102281751|NCT04341155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102281752|NCT04341155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281753|NCT04341155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102281754|NCT04341155|Glucocorticoids|glucocorticoids|mesh-ancestor
102281755|NCT04341155|Hormones|hormones|mesh-ancestor
102281756|NCT04341155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102281757|NCT04341155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102281758|NCT04341155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281759|NCT04341155|Protease Inhibitors|protease inhibitors|mesh-ancestor
102281760|NCT04341155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102281761|NCT04341155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281762|NCT04865705|Paclitaxel|paclitaxel|mesh-list
102281763|NCT04865705|Cisplatin|cisplatin|mesh-list
102281764|NCT04865705|Carboplatin|carboplatin|mesh-list
102281765|NCT04865705|Tislelizumab|tislelizumab|mesh-list
102281766|NCT04865705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102281767|NCT04865705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281768|NCT04865705|Tubulin Modulators|tubulin modulators|mesh-ancestor
102281769|NCT04865705|Antimitotic Agents|antimitotic agents|mesh-ancestor
102281770|NCT04865705|Mitosis Modulators|mitosis modulators|mesh-ancestor
102281771|NCT04865705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281772|NCT04865705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102281773|NCT04858997|Palbociclib|palbociclib|mesh-list
102281774|NCT04858997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281775|NCT04858997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102281776|NCT04858997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102281777|NCT04858997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281778|NCT05135143|Antioxidants|antioxidants|mesh-list
102281779|NCT05135143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281780|NCT05135143|Protective Agents|protective agents|mesh-ancestor
102281781|NCT05135143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281782|NCT04865653|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
102281783|NCT04865653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102281784|NCT04865653|Hallucinogens|hallucinogens|mesh-ancestor
102281785|NCT04865653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281786|NCT04865653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102281787|NCT04865653|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102281788|NCT04865653|Serotonin Agents|serotonin agents|mesh-ancestor
102281789|NCT04865653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102281790|NCT04865653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281791|NCT04865653|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102281792|NCT05305183|Alendronate|alendronate|mesh-list
102281793|NCT05305183|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102281794|NCT05305183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281795|NCT01668797|Brexpiprazole|brexpiprazole|mesh-list
102281796|NCT01668797|Serotonin Agents|serotonin agents|mesh-ancestor
102281797|NCT01668797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102281798|NCT01668797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281799|NCT01668797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281800|NCT01668797|Dopamine Agonists|dopamine agonists|mesh-ancestor
102281801|NCT01668797|Dopamine Agents|dopamine agents|mesh-ancestor
102281802|NCT05304559|Ketamine|ketamine|mesh-list
102281803|NCT05304559|Esketamine|esketamine|mesh-list
102281804|NCT05304559|Analgesics|analgesics|mesh-ancestor
102281805|NCT05304559|Sensory System Agents|sensory system agents|mesh-ancestor
102281806|NCT05304559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102281807|NCT05304559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281808|NCT05304559|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102281809|NCT05304559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102281810|NCT05304559|Anesthetics, General|anesthetics, general|mesh-ancestor
102281811|NCT05304559|Anesthetics|anesthetics|mesh-ancestor
102281812|NCT05304559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102281813|NCT05304559|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102281814|NCT05304559|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102281815|NCT05304559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102281816|NCT05304559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281817|NCT05304559|Antidepressive Agents|antidepressive agents|mesh-ancestor
102281818|NCT05304559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102281819|NCT02613221|Panitumumab|panitumumab|mesh-list
102281820|NCT02613221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102281821|NCT02613221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281823|NCT05304169|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102281824|NCT05304169|Fertility Agents|fertility agents|mesh-ancestor
102281825|NCT05304169|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102281826|NCT05304169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281827|NCT05304169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102281828|NCT05304169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281829|NCT04858841|Levetiracetam|levetiracetam|mesh-list
102281830|NCT04858841|Anticonvulsants|anticonvulsants|mesh-ancestor
102281831|NCT04858841|Nootropic Agents|nootropic agents|mesh-ancestor
102281832|NCT04858529|Carboplatin|carboplatin|mesh-list
102281833|NCT04858529|Docetaxel|docetaxel|mesh-list
102281834|NCT04858529|Trastuzumab|trastuzumab|mesh-list
102281835|NCT04858529|Pertuzumab|pertuzumab|mesh-list
102281836|NCT04858529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281837|NCT04858529|Tubulin Modulators|tubulin modulators|mesh-ancestor
102281838|NCT04858529|Antimitotic Agents|antimitotic agents|mesh-ancestor
102281839|NCT04858529|Mitosis Modulators|mitosis modulators|mesh-ancestor
102281840|NCT04858529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281841|NCT04858529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102281842|NCT05302921|Nivolumab|nivolumab|mesh-list
102281843|NCT05302921|Ipilimumab|ipilimumab|mesh-list
102281844|NCT05302921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102281845|NCT05302921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281846|NCT05302921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102281847|NCT05302921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281848|NCT04682743|Acetaminophen|acetaminophen|mesh-list
102281849|NCT04682743|Ondansetron|ondansetron|mesh-list
102281850|NCT04682743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102281851|NCT04682743|Analgesics|analgesics|mesh-ancestor
102281852|NCT04682743|Sensory System Agents|sensory system agents|mesh-ancestor
102281853|NCT04682743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102281854|NCT04682743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281855|NCT04682743|Antipyretics|antipyretics|mesh-ancestor
102281856|NCT04682743|Antiemetics|antiemetics|mesh-ancestor
102281857|NCT04682743|Autonomic Agents|autonomic agents|mesh-ancestor
102281858|NCT04682743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102281859|NCT04682743|Antipruritics|antipruritics|mesh-ancestor
102281860|NCT04682743|Dermatologic Agents|dermatologic agents|mesh-ancestor
102281861|NCT04682743|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102281862|NCT04682743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102281863|NCT04682743|Serotonin Agents|serotonin agents|mesh-ancestor
102281864|NCT04682743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102281865|NCT04682743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281866|NCT03472573|Dexamethasone|dexamethasone|mesh-list
102281867|NCT03472573|Palbociclib|palbociclib|mesh-list
102281868|NCT03472573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102281869|NCT03472573|Antiemetics|antiemetics|mesh-ancestor
102281870|NCT03472573|Autonomic Agents|autonomic agents|mesh-ancestor
102281871|NCT03472573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102281872|NCT03472573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281873|NCT03472573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102281874|NCT03472573|Glucocorticoids|glucocorticoids|mesh-ancestor
102281875|NCT03472573|Hormones|hormones|mesh-ancestor
102281876|NCT03472573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102281877|NCT03472573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102281878|NCT03472573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281879|NCT03472573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102281880|NCT03472573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101623618|NCT00751218|Desloratadine|desloratadine|mesh-list
102281881|NCT03472573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281882|NCT04636333|Vaccines|vaccines|mesh-list
102281883|NCT04636333|Immunologic Factors|immunologic factors|mesh-ancestor
102281884|NCT04636333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281885|NCT03103009|Pasireotide|pasireotide|mesh-list
102281886|NCT03103009|Hormones|hormones|mesh-ancestor
102281887|NCT03103009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102281888|NCT03103009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281889|NCT03694249|Ifetroban|ifetroban|mesh-list
102281890|NCT03694249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102281891|NCT03020875|Acetaminophen|acetaminophen|mesh-list
102281892|NCT03020875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102281893|NCT03020875|Analgesics|analgesics|mesh-ancestor
102281894|NCT03020875|Sensory System Agents|sensory system agents|mesh-ancestor
102281895|NCT03020875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102281896|NCT03020875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281897|NCT03020875|Antipyretics|antipyretics|mesh-ancestor
102281898|NCT02996305|Gaboxadol|gaboxadol|mesh-list
102281899|NCT02996305|Analgesics|analgesics|mesh-ancestor
102281900|NCT02996305|Sensory System Agents|sensory system agents|mesh-ancestor
102281901|NCT02996305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102281902|NCT02996305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281903|NCT02996305|Anticonvulsants|anticonvulsants|mesh-ancestor
102281904|NCT02996305|GABA Agonists|gaba agonists|mesh-ancestor
102281905|NCT02996305|GABA Agents|gaba agents|mesh-ancestor
102281906|NCT02996305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102281907|NCT02996305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281908|NCT04866485|Pembrolizumab|pembrolizumab|mesh-list
102281909|NCT04866485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102281910|NCT04866485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281911|NCT04866485|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102281912|NCT04866485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281913|NCT02888041|Dinoprostone|dinoprostone|mesh-list
102281914|NCT02888041|Oxytocics|oxytocics|mesh-ancestor
102281915|NCT02888041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102281916|NCT02888041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281917|NCT02838745|Pemetrexed|pemetrexed|mesh-list
102281918|NCT02838745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281919|NCT02838745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102281920|NCT02838745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281921|NCT02838745|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102281922|NCT02838745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102281923|NCT00136435|Leucovorin|leucovorin|mesh-list
102281924|NCT00136435|Cytarabine|cytarabine|mesh-list
102281925|NCT00136435|Dexamethasone|dexamethasone|mesh-list
102281926|NCT00136435|Prednisone|prednisone|mesh-list
102281927|NCT00136435|Hydrocortisone|hydrocortisone|mesh-list
102281928|NCT00136435|Doxorubicin|doxorubicin|mesh-list
102281929|NCT00136435|Methotrexate|methotrexate|mesh-list
102281930|NCT00136435|Vincristine|vincristine|mesh-list
102281931|NCT00136435|Asparaginase|asparaginase|mesh-list
102281932|NCT00136435|Mercaptopurine|mercaptopurine|mesh-list
102281933|NCT00136435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102281934|NCT00136435|Antiemetics|antiemetics|mesh-ancestor
102281935|NCT00136435|Autonomic Agents|autonomic agents|mesh-ancestor
102281936|NCT00136435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102281937|NCT00136435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281938|NCT00136435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102281939|NCT00136435|Glucocorticoids|glucocorticoids|mesh-ancestor
102281940|NCT00136435|Hormones|hormones|mesh-ancestor
102281941|NCT00136435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102281942|NCT00136435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102281943|NCT00136435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281944|NCT00136435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102281945|NCT00136435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102281946|NCT00136435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102281947|NCT00136435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102281948|NCT00136435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281949|NCT00136435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102281950|NCT00136435|Abortifacient Agents|abortifacient agents|mesh-ancestor
102281951|NCT00136435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102281952|NCT00136435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102281953|NCT00136435|Antimetabolites|antimetabolites|mesh-ancestor
102281954|NCT00136435|Dermatologic Agents|dermatologic agents|mesh-ancestor
102281955|NCT00136435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102281956|NCT00136435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102281957|NCT00136435|Immunologic Factors|immunologic factors|mesh-ancestor
102281958|NCT00136435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102281959|NCT00136435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102281960|NCT00136435|Antiviral Agents|antiviral agents|mesh-ancestor
102281961|NCT00136435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102281962|NCT00136435|Antidotes|antidotes|mesh-ancestor
102281963|NCT00136435|Protective Agents|protective agents|mesh-ancestor
102281964|NCT00136435|Vitamin B Complex|vitamin b complex|mesh-ancestor
102281965|NCT00136435|Vitamins|vitamins|mesh-ancestor
102281966|NCT00136435|Micronutrients|micronutrients|mesh-ancestor
102281967|NCT00136435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102281968|NCT00136435|Tubulin Modulators|tubulin modulators|mesh-ancestor
102281969|NCT00136435|Antimitotic Agents|antimitotic agents|mesh-ancestor
102281970|NCT00136435|Mitosis Modulators|mitosis modulators|mesh-ancestor
102281971|NCT04864379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102281972|NCT04864379|Molgramostim|molgramostim|mesh-list
102281973|NCT04864379|Sargramostim|sargramostim|mesh-list
102281974|NCT04864379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281975|NCT04864379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102281976|NCT04864379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281977|NCT04864379|Immunologic Factors|immunologic factors|mesh-ancestor
102281978|NCT04864379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281979|NCT03044561|Sildenafil Citrate|sildenafil citrate|mesh-list
102281980|NCT03044561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281981|NCT03044561|Vasodilator Agents|vasodilator agents|mesh-ancestor
102281982|NCT03044561|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102281983|NCT03044561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102281984|NCT03044561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102281985|NCT03044561|Urological Agents|urological agents|mesh-ancestor
102281986|NCT02455141|Cyclophosphamide|cyclophosphamide|mesh-list
102281987|NCT02455141|Carboplatin|carboplatin|mesh-list
102281988|NCT02455141|Epirubicin|epirubicin|mesh-list
102281989|NCT02455141|Taxane|taxane|mesh-list
102281990|NCT02455141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102281991|NCT02455141|Immunologic Factors|immunologic factors|mesh-ancestor
102281992|NCT02455141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102281993|NCT02455141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102281994|NCT02455141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102281995|NCT02455141|Alkylating Agents|alkylating agents|mesh-ancestor
102281996|NCT02455141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102281997|NCT02455141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102281998|NCT02455141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102281999|NCT02455141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102282000|NCT02455141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102282001|NCT02455141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102282002|NCT02455141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102282003|NCT03044639|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
102282004|NCT03044639|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102282005|NCT03044639|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102282006|NCT02439385|Curcumin|curcumin|mesh-list
102282007|NCT02439385|Bevacizumab|bevacizumab|mesh-list
102282008|NCT02439385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102282009|NCT02439385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102282010|NCT02439385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102282011|NCT02439385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102282012|NCT02439385|Growth Substances|growth substances|mesh-ancestor
102282013|NCT02439385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282014|NCT02439385|Growth Inhibitors|growth inhibitors|mesh-ancestor
102282015|NCT02439385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102282016|NCT02439385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102282017|NCT02439385|Analgesics|analgesics|mesh-ancestor
102282018|NCT02439385|Sensory System Agents|sensory system agents|mesh-ancestor
102282019|NCT02439385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102282020|NCT02439385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102282021|NCT02439385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102282022|NCT02439385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102282023|NCT02439385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282024|NCT03104959|Acetylcysteine|acetylcysteine|mesh-list
102282025|NCT03104959|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102282026|NCT03104959|Antiviral Agents|antiviral agents|mesh-ancestor
102282027|NCT03104959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102282028|NCT03104959|Expectorants|expectorants|mesh-ancestor
102282029|NCT03104959|Respiratory System Agents|respiratory system agents|mesh-ancestor
102282030|NCT03104959|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102282031|NCT03104959|Antioxidants|antioxidants|mesh-ancestor
102282032|NCT03104959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282033|NCT03104959|Protective Agents|protective agents|mesh-ancestor
102282034|NCT03104959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282035|NCT03104959|Antidotes|antidotes|mesh-ancestor
102282036|NCT03044171|Listerine|listerine|mesh-list
102282037|NCT03044171|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102282038|NCT03044171|Fluorides|fluorides|mesh-list
102282039|NCT03044171|Sodium Fluoride|sodium fluoride|mesh-list
102282040|NCT03044171|Cariostatic Agents|cariostatic agents|mesh-ancestor
102282041|NCT03044171|Protective Agents|protective agents|mesh-ancestor
102282042|NCT03044171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282044|NCT03044171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102282045|NCT04856969|Dapagliflozin|dapagliflozin|mesh-list
102282046|NCT04856969|Olmesartan|olmesartan|mesh-list
102282047|NCT04856969|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102282048|NCT04856969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282049|NCT04856969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102282050|NCT04856969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282051|NCT04856969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102282052|NCT04856969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102282053|NCT04856969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102282054|NCT03981211|Sofosbuvir|sofosbuvir|mesh-list
102282055|NCT03981211|Antiviral Agents|antiviral agents|mesh-ancestor
102282056|NCT03981211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102282057|NCT04856111|Pirfenidone|pirfenidone|mesh-list
102282058|NCT04856111|Nintedanib|nintedanib|mesh-list
102282059|NCT04856111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102282060|NCT04856111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102282061|NCT04856111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102282062|NCT04856111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282063|NCT04856111|Analgesics|analgesics|mesh-ancestor
102282064|NCT04856111|Sensory System Agents|sensory system agents|mesh-ancestor
102282065|NCT04856111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102282066|NCT04856111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282067|NCT04856111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102282068|NCT04856111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102282069|NCT04856111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102282070|NCT04856111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102282071|NCT02053051|Insulin Aspart|insulin aspart|mesh-list
102282072|NCT02053051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102282073|NCT02053051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282074|NCT01371981|Cytarabine|cytarabine|mesh-list
102282075|NCT01371981|Etoposide|etoposide|mesh-list
102282076|NCT01371981|Podophyllotoxin|podophyllotoxin|mesh-list
102282077|NCT01371981|Daunorubicin|daunorubicin|mesh-list
102282078|NCT01371981|Mitoxantrone|mitoxantrone|mesh-list
102282079|NCT01371981|Etoposide phosphate|etoposide phosphate|mesh-list
102282080|NCT01371981|Bortezomib|bortezomib|mesh-list
102282081|NCT01371981|Sorafenib|sorafenib|mesh-list
102282082|NCT01371981|Asparaginase|asparaginase|mesh-list
102282083|NCT01371981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102282084|NCT01371981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102282085|NCT01371981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102282086|NCT01371981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102282087|NCT01371981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102282088|NCT01371981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282089|NCT01371981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102282090|NCT01371981|Antimetabolites|antimetabolites|mesh-ancestor
102282091|NCT01371981|Antiviral Agents|antiviral agents|mesh-ancestor
102282092|NCT01371981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102282093|NCT01371981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102282094|NCT01371981|Immunologic Factors|immunologic factors|mesh-ancestor
102282095|NCT01371981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282096|NCT01371981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102282097|NCT01371981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102282098|NCT01371981|Analgesics|analgesics|mesh-ancestor
102282099|NCT01371981|Sensory System Agents|sensory system agents|mesh-ancestor
102282100|NCT01371981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102282101|NCT01371981|Keratolytic Agents|keratolytic agents|mesh-ancestor
102282102|NCT01371981|Dermatologic Agents|dermatologic agents|mesh-ancestor
102282103|NCT01371981|Tubulin Modulators|tubulin modulators|mesh-ancestor
102282104|NCT01371981|Antimitotic Agents|antimitotic agents|mesh-ancestor
102282105|NCT01371981|Mitosis Modulators|mitosis modulators|mesh-ancestor
102282106|NCT02845453|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102282107|NCT02845453|Antidepressive Agents|antidepressive agents|mesh-ancestor
102282108|NCT02845453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102282109|NCT02845453|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102282110|NCT02845453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102282111|NCT02845453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102282112|NCT02845453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282114|NCT01799629|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102282115|NCT01799629|Protective Agents|protective agents|mesh-ancestor
102282116|NCT01799629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282117|NCT01597375|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101990830|NCT05397262|Immunologic Factors|immunologic factors|mesh-ancestor
102282118|NCT01597375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102282119|NCT03044093|Misoprostol|misoprostol|mesh-list
102282120|NCT03044093|Mifepristone|mifepristone|mesh-list
102282121|NCT03044093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102282122|NCT03044093|Abortifacient Agents|abortifacient agents|mesh-ancestor
102282123|NCT03044093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102282124|NCT03044093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282125|NCT03044093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102282126|NCT03044093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102282127|NCT03044093|Oxytocics|oxytocics|mesh-ancestor
102282128|NCT03044093|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102282129|NCT03044093|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102282130|NCT03044093|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102282131|NCT03044093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102282132|NCT03044093|Contraceptive Agents|contraceptive agents|mesh-ancestor
102282133|NCT03044093|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102282134|NCT03044093|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102282135|NCT03044093|Hormone Antagonists|hormone antagonists|mesh-ancestor
102282136|NCT03044093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102282137|NCT03044093|Luteolytic Agents|luteolytic agents|mesh-ancestor
102282138|NCT03044093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102282139|NCT03044093|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102282140|NCT01553071|Fenretinide|fenretinide|mesh-list
102282141|NCT01553071|Safingol|safingol|mesh-list
102282142|NCT01553071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102282143|NCT01553071|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102282144|NCT01553071|Protective Agents|protective agents|mesh-ancestor
102282145|NCT01553071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282146|NCT01553071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102282147|NCT01553071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282148|NCT01506973|Hydroxychloroquine|hydroxychloroquine|mesh-list
102282149|NCT01506973|Gemcitabine|gemcitabine|mesh-list
102282150|NCT01506973|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102282151|NCT01506973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102282152|NCT01506973|Antimetabolites|antimetabolites|mesh-ancestor
102282153|NCT01506973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282154|NCT01506973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102282155|NCT01506973|Antimalarials|antimalarials|mesh-ancestor
102282156|NCT01506973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102282157|NCT01506973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102282158|NCT01506973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102282159|NCT01506973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102282160|NCT01506973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102282161|NCT03041207|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102282162|NCT03041207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102282163|NCT03101995|Gemcitabine|gemcitabine|mesh-list
102282164|NCT03101995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102282165|NCT03101995|Antimetabolites|antimetabolites|mesh-ancestor
102282166|NCT03101995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282167|NCT03101995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102282168|NCT04848467|Vaccines|vaccines|mesh-list
102282169|NCT04848467|Immunologic Factors|immunologic factors|mesh-ancestor
102282170|NCT04848467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282171|NCT03104335|Apatinib|apatinib|mesh-list
102282172|NCT03104335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102282173|NCT03104335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102282174|NCT03104335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102282175|NCT03104335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282176|NCT04863365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102282177|NCT04863365|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102282178|NCT00484471|Valproic Acid|valproic acid|mesh-list
102282179|NCT00484471|Aripiprazole|aripiprazole|mesh-list
102282180|NCT00484471|Antidepressive Agents|antidepressive agents|mesh-ancestor
102282181|NCT00484471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102282182|NCT00484471|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102282183|NCT00484471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101623920|NCT02776137|Docetaxel|docetaxel|mesh-list
102282184|NCT00484471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102282185|NCT00484471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282186|NCT00484471|Dopamine Agonists|dopamine agonists|mesh-ancestor
102282187|NCT00484471|Dopamine Agents|dopamine agents|mesh-ancestor
102282188|NCT00484471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102282189|NCT00484471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282190|NCT00484471|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102282191|NCT00484471|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101990911|NCT03795805|Lidocaine|lidocaine|mesh-list
102282192|NCT00484471|Serotonin Agents|serotonin agents|mesh-ancestor
102282193|NCT00484471|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102282194|NCT00484471|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102282195|NCT00484471|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102282196|NCT00484471|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102282197|NCT00484471|Anticonvulsants|anticonvulsants|mesh-ancestor
102282198|NCT00484471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102282199|NCT00484471|GABA Agents|gaba agents|mesh-ancestor
102282200|NCT00484471|Antimanic Agents|antimanic agents|mesh-ancestor
102282201|NCT05430841|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102282202|NCT05430841|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102282203|NCT05430841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282204|NCT01746849|Cyclophosphamide|cyclophosphamide|mesh-list
102282205|NCT01746849|Thiotepa|thiotepa|mesh-list
102282206|NCT01746849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102282207|NCT01746849|Immunologic Factors|immunologic factors|mesh-ancestor
102282208|NCT01746849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282209|NCT01746849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102282210|NCT01746849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102282211|NCT01746849|Alkylating Agents|alkylating agents|mesh-ancestor
102282212|NCT01746849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282213|NCT01746849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102282214|NCT01746849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102282215|NCT04847921|Dalbavancin|dalbavancin|mesh-list
102282216|NCT04847921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102282217|NCT04847921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102282218|NCT04847687|Methylprednisolone|methylprednisolone|mesh-list
102282219|NCT04847687|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102282220|NCT04847687|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102282221|NCT04847687|Prednisolone|prednisolone|mesh-list
102282222|NCT04847687|Prednisolone acetate|prednisolone acetate|mesh-list
102282223|NCT04847687|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102282224|NCT04847687|Prednisolone phosphate|prednisolone phosphate|mesh-list
102282225|NCT04847687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102282226|NCT04847687|Antiemetics|antiemetics|mesh-ancestor
102282227|NCT04847687|Autonomic Agents|autonomic agents|mesh-ancestor
102282228|NCT04847687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102282229|NCT04847687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282230|NCT04847687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102282231|NCT04847687|Glucocorticoids|glucocorticoids|mesh-ancestor
102282232|NCT04847687|Hormones|hormones|mesh-ancestor
102282233|NCT04847687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102282234|NCT04847687|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102282235|NCT04847687|Protective Agents|protective agents|mesh-ancestor
102282236|NCT04847687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102282237|NCT04847687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102282238|NCT01729455|Belimumab|belimumab|mesh-list
102282239|NCT01729455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102282240|NCT01729455|Immunologic Factors|immunologic factors|mesh-ancestor
102282241|NCT01729455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282242|NCT03103867|Insulin|insulin|mesh-list
102282243|NCT03103867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102282244|NCT03103867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282245|NCT04847375|Pulmonary Surfactants|pulmonary surfactants|mesh-list
102282246|NCT04847375|Respiratory System Agents|respiratory system agents|mesh-ancestor
102282247|NCT04737343|Azathioprine|azathioprine|mesh-list
102282248|NCT04737343|Leflunomide|leflunomide|mesh-list
102282249|NCT04737343|Antimetabolites|antimetabolites|mesh-ancestor
102282250|NCT04737343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282251|NCT04737343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102282252|NCT04737343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102282253|NCT04737343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102282254|NCT04737343|Immunologic Factors|immunologic factors|mesh-ancestor
102282255|NCT04737343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282256|NCT04737343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102282257|NCT04737343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102282258|NCT05579769|Cyclosporine|cyclosporine|mesh-list
102282260|NCT05579769|Busulfan|busulfan|mesh-list
102282261|NCT05579769|Thiotepa|thiotepa|mesh-list
102282262|NCT05579769|Methotrexate|methotrexate|mesh-list
102282263|NCT05579769|Fludarabine|fludarabine|mesh-list
102282264|NCT05579769|Cyclosporins|cyclosporins|mesh-list
102282265|NCT05579769|Thymoglobulin|thymoglobulin|mesh-list
102282266|NCT05579769|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102282267|NCT05579769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101990983|NCT01131767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102282268|NCT05579769|Immunologic Factors|immunologic factors|mesh-ancestor
102282269|NCT05579769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282270|NCT05579769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102282271|NCT05579769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102282272|NCT05579769|Alkylating Agents|alkylating agents|mesh-ancestor
102282273|NCT05579769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282274|NCT05579769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102282275|NCT05579769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102282276|NCT05579769|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102282277|NCT05579769|Abortifacient Agents|abortifacient agents|mesh-ancestor
102282278|NCT05579769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102282279|NCT05579769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102282280|NCT05579769|Antimetabolites|antimetabolites|mesh-ancestor
102282281|NCT05579769|Dermatologic Agents|dermatologic agents|mesh-ancestor
102282282|NCT05579769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102282283|NCT05579769|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102282284|NCT05579769|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102282285|NCT05579769|Antifungal Agents|antifungal agents|mesh-ancestor
102282286|NCT05579769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102282287|NCT05579769|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102282288|NCT02609399|Oseltamivir|oseltamivir|mesh-list
102282289|NCT02609399|Peramivir|peramivir|mesh-list
102282290|NCT02609399|Antiviral Agents|antiviral agents|mesh-ancestor
102282291|NCT02609399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102282292|NCT02609399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102282293|NCT02609399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282294|NCT05430217|Buspirone|buspirone|mesh-list
102282295|NCT05430217|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102282296|NCT05430217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102282297|NCT05430217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102282298|NCT05430217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282299|NCT05430217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102282300|NCT05430217|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102282301|NCT05430217|Serotonin Agents|serotonin agents|mesh-ancestor
102282302|NCT05430217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102282303|NCT05430217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282304|NCT03103555|Cyclophosphamide|cyclophosphamide|mesh-list
102282305|NCT03103555|Bortezomib|bortezomib|mesh-list
102282306|NCT03103555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102282307|NCT03103555|Immunologic Factors|immunologic factors|mesh-ancestor
102282308|NCT03103555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282309|NCT03103555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102282310|NCT03103555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102282311|NCT03103555|Alkylating Agents|alkylating agents|mesh-ancestor
102282312|NCT03103555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282313|NCT03103555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102282314|NCT03103555|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102282315|NCT02720185|Dasatinib|dasatinib|mesh-list
102282316|NCT02720185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102282317|NCT02720185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102282318|NCT02720185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102282319|NCT02720185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282320|NCT04846673|Thioctic Acid|thioctic acid|mesh-list
102282321|NCT04846673|Pregabalin|pregabalin|mesh-list
102282322|NCT04846673|Analgesics|analgesics|mesh-ancestor
102282323|NCT04846673|Sensory System Agents|sensory system agents|mesh-ancestor
102282324|NCT04846673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102282325|NCT04846673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282326|NCT04846673|Anticonvulsants|anticonvulsants|mesh-ancestor
102282327|NCT04846673|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102282328|NCT04846673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102282329|NCT04846673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282330|NCT04846673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102282331|NCT04846673|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102282332|NCT04846673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102282333|NCT04846673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102282334|NCT04846673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102282335|NCT04846673|Antioxidants|antioxidants|mesh-ancestor
102282336|NCT04846673|Protective Agents|protective agents|mesh-ancestor
102282337|NCT04846673|Vitamin B Complex|vitamin b complex|mesh-ancestor
102282339|NCT04846673|Micronutrients|micronutrients|mesh-ancestor
102282340|NCT04498273|Aspirin|aspirin|mesh-list
102282341|NCT04498273|Apixaban|apixaban|mesh-list
102282342|NCT04498273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102282343|NCT04498273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102282344|NCT04498273|Analgesics|analgesics|mesh-ancestor
102282345|NCT04498273|Sensory System Agents|sensory system agents|mesh-ancestor
102282346|NCT04498273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102282347|NCT04498273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282348|NCT04498273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102282349|NCT04498273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102282350|NCT04498273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102282351|NCT04498273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102282352|NCT04498273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282353|NCT04498273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102282354|NCT04498273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102282355|NCT04498273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102282356|NCT04498273|Antipyretics|antipyretics|mesh-ancestor
102282357|NCT04498273|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102282358|NCT04498273|Antithrombins|antithrombins|mesh-ancestor
102282359|NCT04498273|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102282360|NCT04498273|Protease Inhibitors|protease inhibitors|mesh-ancestor
102282361|NCT04498273|Anticoagulants|anticoagulants|mesh-ancestor
102282362|NCT04853615|Empagliflozin|empagliflozin|mesh-list
102282363|NCT04853615|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102282364|NCT04853615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282365|NCT04853615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102282366|NCT04853615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282367|NCT05573607|Chromium|chromium|mesh-list
102282368|NCT05573607|Trace Elements|trace elements|mesh-ancestor
102282369|NCT05573607|Micronutrients|micronutrients|mesh-ancestor
102282370|NCT05573607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282371|NCT04435483|Acalabrutinib|acalabrutinib|mesh-list
102282372|NCT04435483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102282373|NCT04862117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102282374|NCT04862117|Cholinergic Agents|cholinergic agents|mesh-list
102282375|NCT04862117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102282376|NCT04862117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282377|NCT04862117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282378|NCT03040817|Esomeprazole|esomeprazole|mesh-list
102282379|NCT03040817|Mosapride|mosapride|mesh-list
102282380|NCT03040817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282381|NCT03040817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102282382|NCT03040817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102282383|NCT03040817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102282384|NCT03040817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102282385|NCT03040817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102282386|NCT03040817|Serotonin Agents|serotonin agents|mesh-ancestor
102282387|NCT03040817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102282388|NCT03040817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282389|NCT04853069|Estradiol|estradiol|mesh-list
102282390|NCT04853069|Estrogens|estrogens|mesh-ancestor
102282391|NCT04853069|Hormones|hormones|mesh-ancestor
102282392|NCT04853069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102282393|NCT04853069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282394|NCT05244811|Contraceptive Agents|contraceptive agents|mesh-list
102282395|NCT05244811|Contraceptives, Oral|contraceptives, oral|mesh-list
102282396|NCT05244811|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
102282397|NCT05244811|Progestins|progestins|mesh-list
102282398|NCT05244811|Estradiol|estradiol|mesh-list
102282399|NCT05244811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102282400|NCT05244811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282401|NCT05244811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102282402|NCT05244811|Hormones|hormones|mesh-ancestor
102282403|NCT05244811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102282404|NCT05244811|Estrogens|estrogens|mesh-ancestor
102282405|NCT05395065|Listerine|listerine|mesh-list
102282406|NCT05395065|Fluorides|fluorides|mesh-list
102282407|NCT05395065|Sodium Fluoride|sodium fluoride|mesh-list
102282408|NCT05395065|Fluorides, Topical|fluorides, topical|mesh-list
102282409|NCT05395065|Cariostatic Agents|cariostatic agents|mesh-ancestor
102282410|NCT05395065|Protective Agents|protective agents|mesh-ancestor
102282411|NCT05395065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282412|NCT05395065|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102282413|NCT05395065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102282414|NCT02710669|Propafenone|propafenone|mesh-list
102282415|NCT02710669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102282416|NCT02710669|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102282417|NCT02710669|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102282418|NCT02710669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102282419|NCT02710669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282420|NCT05392959|Dapagliflozin|dapagliflozin|mesh-list
102282421|NCT05392959|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102282422|NCT05392959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282423|NCT05392959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102282424|NCT05392959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282425|NCT04851977|Vaccines|vaccines|mesh-list
102282426|NCT04851977|Immunologic Factors|immunologic factors|mesh-ancestor
102282427|NCT04851977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282428|NCT05370495|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102282429|NCT05370495|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102282430|NCT05370417|Fluorides|fluorides|mesh-list
102282431|NCT05370417|Cariostatic Agents|cariostatic agents|mesh-ancestor
102282432|NCT05370417|Protective Agents|protective agents|mesh-ancestor
102282433|NCT05370417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282434|NCT05369793|Thioctic Acid|thioctic acid|mesh-list
102282435|NCT05369793|Antioxidants|antioxidants|mesh-ancestor
102282436|NCT05369793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282437|NCT05369793|Protective Agents|protective agents|mesh-ancestor
102282438|NCT05369793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282439|NCT05369793|Vitamin B Complex|vitamin b complex|mesh-ancestor
102282440|NCT05369793|Vitamins|vitamins|mesh-ancestor
102282441|NCT05369793|Micronutrients|micronutrients|mesh-ancestor
102282442|NCT04844333|Anesthetics|anesthetics|mesh-list
102282443|NCT04844333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102282444|NCT04844333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282445|NCT04423185|Atezolizumab|atezolizumab|mesh-list
102282446|NCT04423185|Imatinib Mesylate|imatinib mesylate|mesh-list
102282447|NCT04423185|Palbociclib|palbociclib|mesh-list
102282448|NCT04423185|Niraparib|niraparib|mesh-list
102282449|NCT04423185|Vemurafenib|vemurafenib|mesh-list
102282450|NCT04423185|Crizotinib|crizotinib|mesh-list
102282451|NCT04423185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102282452|NCT04423185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282453|NCT04423185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102282454|NCT04423185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102282455|NCT04423185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102282456|NCT04423185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102282457|NCT04423185|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102282458|NCT04850885|Dexamethasone|dexamethasone|mesh-list
102282459|NCT04850885|Lidocaine|lidocaine|mesh-list
102282460|NCT04850885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102282461|NCT04850885|Antiemetics|antiemetics|mesh-ancestor
102282462|NCT04850885|Autonomic Agents|autonomic agents|mesh-ancestor
102282463|NCT04850885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102282464|NCT04850885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282465|NCT04850885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102282466|NCT04850885|Glucocorticoids|glucocorticoids|mesh-ancestor
102282467|NCT04850885|Hormones|hormones|mesh-ancestor
102282468|NCT04850885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102282469|NCT04850885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102282470|NCT04850885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102282471|NCT04850885|Anesthetics, Local|anesthetics, local|mesh-ancestor
102282472|NCT04850885|Anesthetics|anesthetics|mesh-ancestor
102282473|NCT04850885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102282474|NCT04850885|Sensory System Agents|sensory system agents|mesh-ancestor
102282475|NCT04850885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102282476|NCT04850885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102282477|NCT04850885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102282478|NCT04850885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102282479|NCT04850885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282480|NCT04850417|Aspirin|aspirin|mesh-list
102282481|NCT04850417|Clopidogrel|clopidogrel|mesh-list
102282482|NCT04850417|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102282483|NCT04850417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102282484|NCT04850417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102282486|NCT04850417|Sensory System Agents|sensory system agents|mesh-ancestor
102282487|NCT04850417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102282488|NCT04850417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282489|NCT04850417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102282490|NCT04850417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102282491|NCT04850417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102282492|NCT04850417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102282493|NCT04850417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282494|NCT04850417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102282495|NCT04850417|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102282496|NCT04850417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102282497|NCT04850417|Antipyretics|antipyretics|mesh-ancestor
102282498|NCT04850417|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102282499|NCT04850417|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102282500|NCT04850417|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102282501|NCT04850417|Purinergic Agents|purinergic agents|mesh-ancestor
102282502|NCT04850417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102282503|NCT04850417|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102282504|NCT04850417|Adrenergic Agents|adrenergic agents|mesh-ancestor
102282505|NCT04843943|Bevacizumab|bevacizumab|mesh-list
102282506|NCT04843943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102282507|NCT04843943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102282508|NCT04843943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102282509|NCT04843943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102282510|NCT04843943|Growth Substances|growth substances|mesh-ancestor
102282511|NCT04843943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282512|NCT04843943|Growth Inhibitors|growth inhibitors|mesh-ancestor
102282514|NCT04850261|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102282515|NCT04850261|Fertility Agents|fertility agents|mesh-ancestor
102282516|NCT04850261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102282517|NCT04850261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282518|NCT04843553|Niacinamide|niacinamide|mesh-list
102282519|NCT04843553|Niacin|niacin|mesh-list
102282520|NCT04843553|Nicotinic Acids|nicotinic acids|mesh-list
102282521|NCT04843553|Vitamins|vitamins|mesh-ancestor
102282522|NCT04843553|Micronutrients|micronutrients|mesh-ancestor
102282523|NCT04843553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282524|NCT04843553|Vitamin B Complex|vitamin b complex|mesh-ancestor
102282525|NCT04843553|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102282526|NCT04843553|Antimetabolites|antimetabolites|mesh-ancestor
102282527|NCT04843553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282528|NCT04843553|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102282529|NCT04843553|Vasodilator Agents|vasodilator agents|mesh-ancestor
102282530|NCT02684461|Paclitaxel|paclitaxel|mesh-list
102282531|NCT02684461|Pembrolizumab|pembrolizumab|mesh-list
102282532|NCT02684461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102282533|NCT02684461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102282534|NCT02684461|Tubulin Modulators|tubulin modulators|mesh-ancestor
102282535|NCT02684461|Antimitotic Agents|antimitotic agents|mesh-ancestor
102282536|NCT02684461|Mitosis Modulators|mitosis modulators|mesh-ancestor
102282537|NCT02684461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282538|NCT02684461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102282539|NCT02684461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102282540|NCT03040193|Lidocaine|lidocaine|mesh-list
102282541|NCT03040193|Anesthetics, Local|anesthetics, local|mesh-ancestor
102282542|NCT03040193|Anesthetics|anesthetics|mesh-ancestor
102282543|NCT03040193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102282544|NCT03040193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282545|NCT03040193|Sensory System Agents|sensory system agents|mesh-ancestor
102282546|NCT03040193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102282547|NCT03040193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102282548|NCT03040193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102282549|NCT03040193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102282550|NCT03040193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102282551|NCT03040193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282552|NCT05373199|Insulin Lispro|insulin lispro|mesh-list
102282553|NCT05373199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102282554|NCT05373199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282555|NCT03039101|Montelukast|montelukast|mesh-list
102282556|NCT03039101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102282557|NCT03039101|Respiratory System Agents|respiratory system agents|mesh-ancestor
102282558|NCT03039101|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102282559|NCT03039101|Hormone Antagonists|hormone antagonists|mesh-ancestor
102282560|NCT03039101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102282561|NCT03039101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282562|NCT03039101|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102282563|NCT03039101|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102282564|NCT03039101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282566|NCT03103399|Carbidopa|carbidopa|mesh-list
102282567|NCT03103399|Entacapone|entacapone|mesh-list
102282568|NCT03103399|Benserazide|benserazide|mesh-list
102282569|NCT03103399|Dopa Decarboxylase|dopa decarboxylase|mesh-list
102282570|NCT03103399|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-list
102282571|NCT03103399|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102282572|NCT03103399|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102282573|NCT03103399|Dopamine Agents|dopamine agents|mesh-ancestor
102282574|NCT03103399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102282575|NCT03103399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282576|NCT03103399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282577|NCT03103399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102282578|NCT03103399|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102282579|NCT05357833|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102282580|NCT05357833|Hematinics|hematinics|mesh-ancestor
102282581|NCT05357833|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102282582|NCT05357833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102282583|NCT03043157|Rocuronium|rocuronium|mesh-list
102282584|NCT03043157|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102282585|NCT03043157|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102282586|NCT03043157|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102282587|NCT03043157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102282588|NCT03043157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282589|NCT05339113|FAPI-46|fapi-46|mesh-list
102282590|NCT05339113|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102282591|NCT05339113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282592|NCT05332795|Metformin|metformin|mesh-list
102282593|NCT05332795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102282594|NCT05332795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282595|NCT03042923|Mannitol|mannitol|mesh-list
102282596|NCT03042923|Lactulose|lactulose|mesh-list
102282597|NCT03042923|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102282598|NCT03042923|Diuretics|diuretics|mesh-ancestor
102282599|NCT03042923|Natriuretic Agents|natriuretic agents|mesh-ancestor
102282600|NCT03042923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282601|NCT03042923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102282602|NCT04429295|Vaccines|vaccines|mesh-list
102282603|NCT04429295|Immunologic Factors|immunologic factors|mesh-ancestor
102282604|NCT04429295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282605|NCT05258851|Ceftazidime|ceftazidime|mesh-list
102282606|NCT05258851|Colistin|colistin|mesh-list
102282607|NCT05258851|Avibactam|avibactam|mesh-list
102282608|NCT05258851|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
102282609|NCT05258851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102282610|NCT05258851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102282611|NCT05258851|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102282612|NCT05258851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102282613|NCT05258851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282614|NCT03043001|Memantine|memantine|mesh-list
102282615|NCT03043001|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102282616|NCT03043001|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102282617|NCT03043001|Dopamine Agents|dopamine agents|mesh-ancestor
102282618|NCT03043001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102282619|NCT03043001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282620|NCT03043001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282621|NCT03043001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102282622|NCT03043001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102282623|NCT04843007|Pemetrexed|pemetrexed|mesh-list
102282624|NCT04843007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102282625|NCT04843007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102282626|NCT04843007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282627|NCT04843007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102282628|NCT04843007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102282629|NCT04840745|Leuprolide|leuprolide|mesh-list
102282630|NCT04840745|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102282631|NCT04840745|Fertility Agents|fertility agents|mesh-ancestor
102282632|NCT04840745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102282633|NCT04840745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282634|NCT04840745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102282635|NCT04840745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102282636|NCT05072899|Hyaluronic Acid|hyaluronic acid|mesh-list
102282637|NCT05072899|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102282638|NCT05072899|Immunologic Factors|immunologic factors|mesh-ancestor
102282639|NCT05072899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282640|NCT05072899|Viscosupplements|viscosupplements|mesh-ancestor
102282641|NCT05072899|Protective Agents|protective agents|mesh-ancestor
101991372|NCT01649947|Paclitaxel|paclitaxel|mesh-list
102282643|NCT04839653|Gentamicins|gentamicins|mesh-list
102282644|NCT04839653|Ceftriaxone|ceftriaxone|mesh-list
102282645|NCT04839653|Polymyxins|polymyxins|mesh-list
102282646|NCT04839653|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102282647|NCT04839653|Cefotaxime|cefotaxime|mesh-list
102282648|NCT04839653|Cefoxitin|cefoxitin|mesh-list
102282649|NCT04839653|Polymyxin B|polymyxin b|mesh-list
102282650|NCT04839653|Amphotericin B|amphotericin b|mesh-list
102282651|NCT04839653|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102282652|NCT04839653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102282653|NCT04839653|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102282654|NCT04839653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102282655|NCT04839653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282656|NCT04839653|Amebicides|amebicides|mesh-ancestor
102282657|NCT04839653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102282658|NCT04839653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102282659|NCT04839653|Antifungal Agents|antifungal agents|mesh-ancestor
102282660|NCT04842383|Peppermint oil|peppermint oil|mesh-list
102282661|NCT04842383|Antiemetics|antiemetics|mesh-ancestor
102282662|NCT04842383|Autonomic Agents|autonomic agents|mesh-ancestor
102282663|NCT04842383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102282664|NCT04842383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282665|NCT04842383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102282666|NCT04842383|Parasympatholytics|parasympatholytics|mesh-ancestor
102282667|NCT04884139|Tenofovir|tenofovir|mesh-list
102282668|NCT04884139|Lamivudine|lamivudine|mesh-list
102282669|NCT04884139|Emtricitabine|emtricitabine|mesh-list
102282670|NCT04884139|Dolutegravir|dolutegravir|mesh-list
102282671|NCT04884139|Antiviral Agents|antiviral agents|mesh-ancestor
102282672|NCT04884139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102282673|NCT04884139|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102282674|NCT04884139|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102282675|NCT04884139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102282676|NCT04884139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282677|NCT04884139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102282678|NCT04884139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102282679|NCT04884139|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102282680|NCT04884139|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102282681|NCT04860167|Diclofenac|diclofenac|mesh-list
102282682|NCT04860167|Lidocaine|lidocaine|mesh-list
102282683|NCT04860167|Propofol|propofol|mesh-list
102282684|NCT04860167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102282685|NCT04860167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102282686|NCT04860167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282687|NCT04860167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102282688|NCT04860167|Anesthetics, General|anesthetics, general|mesh-ancestor
102282689|NCT04860167|Anesthetics|anesthetics|mesh-ancestor
102282690|NCT04860167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102282691|NCT04860167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102282692|NCT04860167|Analgesics|analgesics|mesh-ancestor
102282693|NCT04860167|Sensory System Agents|sensory system agents|mesh-ancestor
102282694|NCT04860167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102282695|NCT04860167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102282696|NCT04860167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102282697|NCT04860167|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102282698|NCT04860167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102282699|NCT04860167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282700|NCT04860167|Anesthetics, Local|anesthetics, local|mesh-ancestor
102282701|NCT04860167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102282702|NCT04860167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102282703|NCT04860167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102282704|NCT04860167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102282705|NCT02514031|Beta-lapachone|beta-lapachone|mesh-list
102282706|NCT02514031|Paclitaxel|paclitaxel|mesh-list
102282707|NCT02514031|Gemcitabine|gemcitabine|mesh-list
102282708|NCT02514031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102282709|NCT02514031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102282710|NCT02514031|Tubulin Modulators|tubulin modulators|mesh-ancestor
102282711|NCT02514031|Antimitotic Agents|antimitotic agents|mesh-ancestor
102282713|NCT02514031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282714|NCT02514031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102282715|NCT02514031|Antimetabolites|antimetabolites|mesh-ancestor
102282716|NCT02514031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102282717|NCT02514031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102282718|NCT02514031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102282719|NCT02514031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102282720|NCT02514031|Antiviral Agents|antiviral agents|mesh-ancestor
102282721|NCT04622917|Methylprednisolone|methylprednisolone|mesh-list
102282722|NCT04622917|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102282723|NCT04622917|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102282724|NCT04622917|Prednisolone|prednisolone|mesh-list
102282725|NCT04622917|Prednisolone acetate|prednisolone acetate|mesh-list
102282726|NCT04622917|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102282727|NCT04622917|Prednisolone phosphate|prednisolone phosphate|mesh-list
102282728|NCT04622917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102282729|NCT04622917|Antiemetics|antiemetics|mesh-ancestor
102282730|NCT04622917|Autonomic Agents|autonomic agents|mesh-ancestor
102282731|NCT04622917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102282732|NCT04622917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282733|NCT04622917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102282734|NCT04622917|Glucocorticoids|glucocorticoids|mesh-ancestor
102282735|NCT04622917|Hormones|hormones|mesh-ancestor
102282736|NCT04622917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102282737|NCT04622917|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102282738|NCT04622917|Protective Agents|protective agents|mesh-ancestor
102282739|NCT04622917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102282740|NCT04622917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102282741|NCT03038477|Durvalumab|durvalumab|mesh-list
102282742|NCT03038477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102282743|NCT03038477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102282744|NCT03038243|Vaccines|vaccines|mesh-list
102282745|NCT03038243|Immunologic Factors|immunologic factors|mesh-ancestor
102282746|NCT03038243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282747|NCT03038321|Levofloxacin|levofloxacin|mesh-list
102282748|NCT03038321|Lornoxicam|lornoxicam|mesh-list
102282749|NCT03038321|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102282750|NCT03038321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102282751|NCT03038321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101382770|NCT00110721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102282752|NCT03038321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102282753|NCT03038321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102282754|NCT03038321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102282755|NCT03038321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282756|NCT03038321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102282757|NCT03038321|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102282758|NCT03038321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102282759|NCT03038321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102282760|NCT03038321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102282761|NCT03038321|Analgesics|analgesics|mesh-ancestor
102282762|NCT03038321|Sensory System Agents|sensory system agents|mesh-ancestor
102282763|NCT03038321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102282764|NCT03038321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282765|NCT03038321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102282766|NCT03038321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102282767|NCT02531373|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102282768|NCT02531373|Immunologic Factors|immunologic factors|mesh-ancestor
102282769|NCT02531373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282770|NCT03042377|Calcium, Dietary|calcium, dietary|mesh-list
102282771|NCT03042377|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102282772|NCT03042377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102282773|NCT03042377|Calcium|calcium|mesh-list
102282774|NCT03042377|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102282775|NCT03042377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282776|NCT03042377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102282777|NCT03042377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102282778|NCT03042377|Antitubercular Agents|antitubercular agents|mesh-ancestor
102282779|NCT04859777|Pembrolizumab|pembrolizumab|mesh-list
102282780|NCT04859777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102282781|NCT04859777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102282782|NCT04859777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102282783|NCT04859777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282784|NCT05562609|Tranexamic Acid|tranexamic acid|mesh-list
102282785|NCT05562609|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102282786|NCT05562609|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102282787|NCT05562609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282788|NCT05562609|Hemostatics|hemostatics|mesh-ancestor
102282789|NCT05562609|Coagulants|coagulants|mesh-ancestor
102282790|NCT05071339|Ganirelix|ganirelix|mesh-list
102282791|NCT05071339|Hormone Antagonists|hormone antagonists|mesh-ancestor
102282792|NCT05071339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102282793|NCT05071339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282794|NCT02606279|Valsartan|valsartan|mesh-list
102282795|NCT02606279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102282796|NCT02606279|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102282797|NCT02606279|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102282798|NCT02606279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282799|NCT04859621|Vitamin D|vitamin d|mesh-list
102282800|NCT04859621|Ergocalciferols|ergocalciferols|mesh-list
102282801|NCT04859621|Cholecalciferol|cholecalciferol|mesh-list
102282802|NCT04859621|Vitamins|vitamins|mesh-list
102282803|NCT04859621|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102282804|NCT04859621|Micronutrients|micronutrients|mesh-ancestor
102282805|NCT04859621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282806|NCT04859621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102282807|NCT04859621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102282808|NCT04859621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102282809|NCT03039491|Vaccines|vaccines|mesh-list
102282810|NCT03039491|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102282811|NCT03039491|Immunologic Factors|immunologic factors|mesh-ancestor
102282812|NCT03039491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282813|NCT03037775|Nicotine|nicotine|mesh-list
102282814|NCT03037775|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102282815|NCT03037775|Autonomic Agents|autonomic agents|mesh-ancestor
102282816|NCT03037775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102282817|NCT03037775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282818|NCT03037775|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102282819|NCT03037775|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101382851|NCT00077402|Fenretinide|fenretinide|mesh-list
102282820|NCT03037775|Cholinergic Agents|cholinergic agents|mesh-ancestor
102282821|NCT03037775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102282822|NCT03037775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282823|NCT03039257|Vitamin A|vitamin a|mesh-list
102282824|NCT03039257|Vitamins|vitamins|mesh-ancestor
102282825|NCT03039257|Micronutrients|micronutrients|mesh-ancestor
102282826|NCT03039257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282827|NCT03038009|Pantoprazole|pantoprazole|mesh-list
102282828|NCT03038009|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102282829|NCT03038009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102282830|NCT03038009|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102282831|NCT03038009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102282832|NCT03038009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282833|NCT03466801|Prednisone|prednisone|mesh-list
102282834|NCT03466801|Glucocorticoids|glucocorticoids|mesh-list
102282835|NCT03466801|Immunosuppressive Agents|immunosuppressive agents|mesh-list
102282836|NCT03466801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102282837|NCT03466801|Hormones|hormones|mesh-ancestor
102282838|NCT03466801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102282839|NCT03466801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282840|NCT03466801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102282841|NCT03466801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102282842|NCT03466801|Immunologic Factors|immunologic factors|mesh-ancestor
102282843|NCT05069779|Diazepam|diazepam|mesh-list
102282844|NCT05069779|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102282845|NCT05069779|Anticonvulsants|anticonvulsants|mesh-ancestor
102282846|NCT05069779|Antiemetics|antiemetics|mesh-ancestor
102282847|NCT05069779|Autonomic Agents|autonomic agents|mesh-ancestor
102282848|NCT05069779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102282849|NCT05069779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282850|NCT05069779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102282851|NCT05069779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102282852|NCT05069779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102282853|NCT05069779|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102282854|NCT05069779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102282855|NCT05069779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102282856|NCT05069779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102282857|NCT05069779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102282858|NCT05069779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102282859|NCT05069779|Anesthetics, General|anesthetics, general|mesh-ancestor
102282860|NCT05069779|Anesthetics|anesthetics|mesh-ancestor
102282862|NCT05069779|GABA Agents|gaba agents|mesh-ancestor
102282863|NCT05069779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102282864|NCT05069779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282865|NCT03251911|Ivacaftor|ivacaftor|mesh-list
102282866|NCT03251911|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102282867|NCT03251911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102282868|NCT03251911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282869|NCT02643355|Clonidine|clonidine|mesh-list
102282870|NCT02643355|Olanzapine|olanzapine|mesh-list
101991588|NCT01231529|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102282871|NCT02643355|Antiemetics|antiemetics|mesh-ancestor
102282872|NCT02643355|Autonomic Agents|autonomic agents|mesh-ancestor
102282873|NCT02643355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102282874|NCT02643355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282875|NCT02643355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102282876|NCT02643355|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102282877|NCT02643355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102282878|NCT02643355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102282879|NCT02643355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102282880|NCT02643355|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102282881|NCT02643355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102282882|NCT02643355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102282883|NCT02643355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282884|NCT02643355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102282885|NCT02643355|Serotonin Agents|serotonin agents|mesh-ancestor
102282886|NCT02643355|Analgesics|analgesics|mesh-ancestor
102282887|NCT02643355|Sensory System Agents|sensory system agents|mesh-ancestor
102282888|NCT02643355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102282889|NCT02643355|Sympatholytics|sympatholytics|mesh-ancestor
102282890|NCT02643355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102282891|NCT02643355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102282892|NCT02643355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102282893|NCT02643355|Adrenergic Agents|adrenergic agents|mesh-ancestor
102282894|NCT03036605|Dexamethasone|dexamethasone|mesh-list
102282895|NCT03036605|Dexamethasone acetate|dexamethasone acetate|mesh-list
102282896|NCT03036605|Bupivacaine|bupivacaine|mesh-list
102282897|NCT03036605|BB 1101|bb 1101|mesh-list
102282898|NCT03036605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102282899|NCT03036605|Antiemetics|antiemetics|mesh-ancestor
102282900|NCT03036605|Autonomic Agents|autonomic agents|mesh-ancestor
102282901|NCT03036605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102282902|NCT03036605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282903|NCT03036605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102282904|NCT03036605|Glucocorticoids|glucocorticoids|mesh-ancestor
102282905|NCT03036605|Hormones|hormones|mesh-ancestor
102282906|NCT03036605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102282907|NCT03036605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102282908|NCT03036605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102282909|NCT03036605|Protease Inhibitors|protease inhibitors|mesh-ancestor
102282910|NCT03036605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102282911|NCT03036605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282912|NCT03036605|Anesthetics, Local|anesthetics, local|mesh-ancestor
102282913|NCT03036605|Anesthetics|anesthetics|mesh-ancestor
102282914|NCT03036605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102282915|NCT03036605|Sensory System Agents|sensory system agents|mesh-ancestor
102282916|NCT03098875|Remifentanil|remifentanil|mesh-list
102282917|NCT03098875|Propofol|propofol|mesh-list
102282918|NCT03098875|Sevoflurane|sevoflurane|mesh-list
102282919|NCT03098875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102282920|NCT03098875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102282921|NCT03098875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282922|NCT03098875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102282923|NCT03098875|Anesthetics, General|anesthetics, general|mesh-ancestor
102282924|NCT03098875|Anesthetics|anesthetics|mesh-ancestor
102282925|NCT03098875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102282926|NCT03098875|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102282927|NCT03098875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102282928|NCT03098875|Narcotics|narcotics|mesh-ancestor
102282929|NCT03098875|Analgesics|analgesics|mesh-ancestor
102282930|NCT03098875|Sensory System Agents|sensory system agents|mesh-ancestor
102282931|NCT03098875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102282932|NCT03099031|Tinzaparin|tinzaparin|mesh-list
102282933|NCT03099031|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102282934|NCT03099031|Dalteparin|dalteparin|mesh-list
102282935|NCT03099031|Anticoagulants|anticoagulants|mesh-ancestor
102282936|NCT03099031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102282937|NCT03099031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102282938|NCT03099031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282939|NCT04785287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102282940|NCT04785287|Nivolumab|nivolumab|mesh-list
102282941|NCT04785287|Antibodies|antibodies|mesh-list
102282942|NCT04785287|Immunoglobulins|immunoglobulins|mesh-list
102282943|NCT04785287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102282944|NCT04785287|Immunologic Factors|immunologic factors|mesh-ancestor
102282945|NCT04785287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282946|NCT04785287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102282947|NCT04785287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102282948|NCT04785287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282949|NCT03101137|Dexamethasone|dexamethasone|mesh-list
102282950|NCT03101137|Bupivacaine|bupivacaine|mesh-list
102282951|NCT03101137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102282952|NCT03101137|Antiemetics|antiemetics|mesh-ancestor
102282953|NCT03101137|Autonomic Agents|autonomic agents|mesh-ancestor
102282954|NCT03101137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102282955|NCT03101137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282956|NCT03101137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102282957|NCT03101137|Glucocorticoids|glucocorticoids|mesh-ancestor
102282958|NCT03101137|Hormones|hormones|mesh-ancestor
102282959|NCT03101137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102282960|NCT03101137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102282961|NCT03101137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102282962|NCT03101137|Anesthetics, Local|anesthetics, local|mesh-ancestor
102282963|NCT03101137|Anesthetics|anesthetics|mesh-ancestor
102282964|NCT03101137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102282965|NCT03101137|Sensory System Agents|sensory system agents|mesh-ancestor
102282966|NCT04833257|Tislelizumab|tislelizumab|mesh-list
102282967|NCT04833257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102282968|NCT04833257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102282969|NCT03098953|Loteprednol Etabonate|loteprednol etabonate|mesh-list
102282970|NCT03098953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102282971|NCT04833101|Vaccines|vaccines|mesh-list
102282972|NCT04833101|Immunologic Factors|immunologic factors|mesh-ancestor
102282973|NCT04833101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282974|NCT00794599|Cetirizine|cetirizine|mesh-list
102282975|NCT00794599|Desloratadine|desloratadine|mesh-list
102282976|NCT00794599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102282977|NCT00794599|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102282978|NCT00794599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102282979|NCT00794599|Histamine Antagonists|histamine antagonists|mesh-ancestor
102282980|NCT00794599|Histamine Agents|histamine agents|mesh-ancestor
102282981|NCT00794599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102282982|NCT00794599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282983|NCT00794599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282984|NCT00794599|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102282985|NCT00794599|Cholinergic Agents|cholinergic agents|mesh-ancestor
102282986|NCT00783133|Fexofenadine|fexofenadine|mesh-list
102282987|NCT00783133|Desloratadine|desloratadine|mesh-list
102282988|NCT00783133|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102282989|NCT00783133|Cholinergic Agents|cholinergic agents|mesh-ancestor
102282990|NCT00783133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102282991|NCT00783133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102282992|NCT00783133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102282993|NCT00783133|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102282994|NCT00783133|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102282995|NCT00783133|Histamine Antagonists|histamine antagonists|mesh-ancestor
102282996|NCT00783133|Histamine Agents|histamine agents|mesh-ancestor
102282997|NCT00783133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102282998|NCT03098407|Buprenorphine|buprenorphine|mesh-list
102282999|NCT03098407|Methadone|methadone|mesh-list
102283000|NCT03098407|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102283001|NCT03098407|Narcotics|narcotics|mesh-ancestor
102283002|NCT03098407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102283003|NCT03098407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283004|NCT03098407|Analgesics|analgesics|mesh-ancestor
102283005|NCT03098407|Sensory System Agents|sensory system agents|mesh-ancestor
102283006|NCT03098407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102283007|NCT03098407|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102283008|NCT03098407|Antitussive Agents|antitussive agents|mesh-ancestor
102283009|NCT03098407|Respiratory System Agents|respiratory system agents|mesh-ancestor
102283010|NCT04836143|Mitogens|mitogens|mesh-list
102283011|NCT04836143|Endothelial Growth Factors|endothelial growth factors|mesh-list
102283012|NCT04836143|Mitosis Modulators|mitosis modulators|mesh-ancestor
102283013|NCT04836143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283014|NCT04836143|Growth Substances|growth substances|mesh-ancestor
102283015|NCT04836143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283017|NCT05068453|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102283018|NCT05068453|Immunologic Factors|immunologic factors|mesh-ancestor
102283019|NCT05068453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283020|NCT00751075|Mometasone Furoate|mometasone furoate|mesh-list
102283021|NCT00751075|Amoxicillin|amoxicillin|mesh-list
102283022|NCT00751075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102283023|NCT00751075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102283024|NCT00751075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102283025|NCT00751075|Dermatologic Agents|dermatologic agents|mesh-ancestor
102283026|NCT00751075|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102283027|NCT00731185|Mometasone Furoate|mometasone furoate|mesh-list
102283028|NCT00731185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102283029|NCT00731185|Dermatologic Agents|dermatologic agents|mesh-ancestor
102283030|NCT00731185|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102283031|NCT04836299|Ivermectin|ivermectin|mesh-list
102283032|NCT04836299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102283033|NCT04836299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102283034|NCT00651391|Simvastatin|simvastatin|mesh-list
102283035|NCT00651391|Ezetimibe|ezetimibe|mesh-list
102283036|NCT00651391|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102283037|NCT00651391|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102283038|NCT00651391|Antimetabolites|antimetabolites|mesh-ancestor
102283039|NCT00651391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283040|NCT00651391|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102283041|NCT00651391|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102283042|NCT00651391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102283043|NCT00650689|Atorvastatin|atorvastatin|mesh-list
102283044|NCT00650689|Ezetimibe|ezetimibe|mesh-list
102283045|NCT00650689|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102283046|NCT00650689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102283047|NCT00650689|Antimetabolites|antimetabolites|mesh-ancestor
102283048|NCT00650689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283049|NCT00650689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102283050|NCT00650689|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102283051|NCT00650689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102283052|NCT05067517|Nintedanib|nintedanib|mesh-list
102283053|NCT05067517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102283054|NCT05067517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102283055|NCT05067517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102283056|NCT05067517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283057|NCT03100513|Lactulose|lactulose|mesh-list
102283058|NCT03100513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102283059|NCT00552097|Simvastatin|simvastatin|mesh-list
102283060|NCT00552097|Ezetimibe|ezetimibe|mesh-list
102283061|NCT00552097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102283062|NCT00552097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102283063|NCT00552097|Antimetabolites|antimetabolites|mesh-ancestor
102283064|NCT00552097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283065|NCT00552097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102283066|NCT00552097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102283067|NCT00552097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102283068|NCT00396175|Finasteride|finasteride|mesh-list
102283069|NCT00396175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283070|NCT00396175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283071|NCT00396175|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102283072|NCT00396175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102283073|NCT00396175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102283074|NCT00396175|Hormone Antagonists|hormone antagonists|mesh-ancestor
102283075|NCT00396175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102283076|NCT00396175|Urological Agents|urological agents|mesh-ancestor
102283077|NCT02603393|Fluticasone|fluticasone|mesh-list
102283078|NCT02603393|Tiotropium Bromide|tiotropium bromide|mesh-list
102283079|NCT02603393|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102283080|NCT02603393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102283081|NCT02603393|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102283082|NCT02603393|Autonomic Agents|autonomic agents|mesh-ancestor
102283083|NCT02603393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102283084|NCT02603393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283085|NCT02603393|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102283086|NCT02603393|Respiratory System Agents|respiratory system agents|mesh-ancestor
102283087|NCT02603393|Dermatologic Agents|dermatologic agents|mesh-ancestor
102283088|NCT02603393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102283089|NCT02603393|Parasympatholytics|parasympatholytics|mesh-ancestor
102283090|NCT02603393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102283091|NCT02603393|Cholinergic Agents|cholinergic agents|mesh-ancestor
102283092|NCT02603393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102283093|NCT02603393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283094|NCT02603393|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102283095|NCT02603393|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101991814|NCT03791905|Paclitaxel|paclitaxel|mesh-list
102283096|NCT02603393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102283097|NCT02603393|Adrenergic Agents|adrenergic agents|mesh-ancestor
102283098|NCT04832945|Ivermectin|ivermectin|mesh-list
102283099|NCT04832945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102283100|NCT04832945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102283101|NCT02642653|Lovastatin|lovastatin|mesh-list
102283102|NCT02642653|L 647318|l 647318|mesh-list
102283103|NCT02642653|Dihydromevinolin|dihydromevinolin|mesh-list
102283104|NCT02642653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102283105|NCT02642653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102283106|NCT02642653|Antimetabolites|antimetabolites|mesh-ancestor
102283107|NCT02642653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283108|NCT02642653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102283109|NCT02642653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102283110|NCT02642653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102283111|NCT01659567|Interferons|interferons|mesh-list
102283112|NCT01659567|Ribavirin|ribavirin|mesh-list
102283113|NCT01659567|Interferon-alpha|interferon-alpha|mesh-list
102283114|NCT01659567|Interferon alpha-2|interferon alpha-2|mesh-list
102283115|NCT01659567|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102283116|NCT01659567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102283117|NCT01659567|Antiviral Agents|antiviral agents|mesh-ancestor
102283118|NCT01659567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102283119|NCT01659567|Antimetabolites|antimetabolites|mesh-ancestor
102283120|NCT01659567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283121|NCT01659567|Immunologic Factors|immunologic factors|mesh-ancestor
102283122|NCT01659567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283123|NCT05363631|Selenium|selenium|mesh-list
102283124|NCT05363631|Pembrolizumab|pembrolizumab|mesh-list
102283125|NCT05363631|Axitinib|axitinib|mesh-list
102283126|NCT05363631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102283127|NCT05363631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102283128|NCT05363631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102283129|NCT05363631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283130|NCT05363631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102283131|NCT05363631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102283132|NCT05363631|Antioxidants|antioxidants|mesh-ancestor
102283133|NCT05363631|Protective Agents|protective agents|mesh-ancestor
102283134|NCT05363631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283135|NCT05363631|Trace Elements|trace elements|mesh-ancestor
102283136|NCT05363631|Micronutrients|micronutrients|mesh-ancestor
102283137|NCT03100435|Carbon Fiber|carbon fiber|mesh-list
102283138|NCT03100435|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102283139|NCT03100435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102283140|NCT03036995|Apremilast|apremilast|mesh-list
102283141|NCT03036995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102283142|NCT03036995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102283143|NCT03036995|Analgesics|analgesics|mesh-ancestor
102283144|NCT03036995|Sensory System Agents|sensory system agents|mesh-ancestor
102283145|NCT03036995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102283146|NCT03036995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283147|NCT03036995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102283148|NCT03036995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102283149|NCT03036995|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102283150|NCT03036995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102283151|NCT03036995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102283152|NCT03036995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283153|NCT05066035|Neostigmine|neostigmine|mesh-list
102283154|NCT05066035|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102283155|NCT05066035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101383200|NCT00077987|Sunitinib|sunitinib|mesh-list
102283156|NCT05066035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283157|NCT05066035|Cholinergic Agents|cholinergic agents|mesh-ancestor
102283158|NCT05066035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102283159|NCT05066035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283160|NCT05066035|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102283161|NCT05066035|Autonomic Agents|autonomic agents|mesh-ancestor
102283162|NCT05066035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102283163|NCT04822649|Adenosine|adenosine|mesh-list
102283164|NCT04822649|Analgesics|analgesics|mesh-ancestor
102283165|NCT04822649|Sensory System Agents|sensory system agents|mesh-ancestor
102283166|NCT04822649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102283167|NCT04822649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283168|NCT04822649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102283169|NCT04822649|Vasodilator Agents|vasodilator agents|mesh-ancestor
102283170|NCT04822649|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102283171|NCT04822649|Purinergic Agonists|purinergic agonists|mesh-ancestor
102283172|NCT04822649|Purinergic Agents|purinergic agents|mesh-ancestor
102283173|NCT04822649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102283174|NCT04822649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283175|NCT04822415|Mepivacaine|mepivacaine|mesh-list
102283176|NCT04822415|Carticaine|carticaine|mesh-list
102283177|NCT04822415|Anesthetics, Local|anesthetics, local|mesh-ancestor
102283178|NCT04822415|Anesthetics|anesthetics|mesh-ancestor
102283179|NCT04822415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102283180|NCT04822415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283181|NCT04822415|Sensory System Agents|sensory system agents|mesh-ancestor
102283182|NCT04822415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102283183|NCT05065177|Vaccines|vaccines|mesh-list
102283184|NCT05065177|Immunologic Factors|immunologic factors|mesh-ancestor
102283185|NCT05065177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283186|NCT04821947|Bupivacaine|bupivacaine|mesh-list
102283187|NCT04821947|Anesthetics, Local|anesthetics, local|mesh-list
102283188|NCT04821947|Anesthetics|anesthetics|mesh-list
102283189|NCT04821947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102283190|NCT04821947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283191|NCT04821947|Sensory System Agents|sensory system agents|mesh-ancestor
102283192|NCT04821947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102283193|NCT03037073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102283194|NCT03037073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102283195|NCT03037073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102283196|NCT03037073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102283197|NCT03037073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283198|NCT03037073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102283199|NCT03037073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283200|NCT03037073|Analgesics|analgesics|mesh-ancestor
102283201|NCT03037073|Sensory System Agents|sensory system agents|mesh-ancestor
102283202|NCT03037073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102283203|NCT03037073|Antidepressive Agents|antidepressive agents|mesh-ancestor
102283204|NCT03037073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102283205|NCT03037073|Dopamine Agents|dopamine agents|mesh-ancestor
102283206|NCT04831541|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102283207|NCT04831541|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102283208|NCT04831541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283209|NCT04470973|Amikacin|amikacin|mesh-list
102283210|NCT04470973|Cefuroxime|cefuroxime|mesh-list
102283211|NCT04470973|Cefuroxime axetil|cefuroxime axetil|mesh-list
102283212|NCT04470973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102283213|NCT04470973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102283214|NCT05046457|Beta-Cryptoxanthin|beta-cryptoxanthin|mesh-list
102283215|NCT05046457|Provitamins|provitamins|mesh-ancestor
102283216|NCT05046457|Vitamins|vitamins|mesh-ancestor
102283217|NCT05046457|Micronutrients|micronutrients|mesh-ancestor
102283218|NCT05046457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283219|NCT05063071|Tenofovir|tenofovir|mesh-list
102283220|NCT05063071|Antiviral Agents|antiviral agents|mesh-ancestor
102283221|NCT05063071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102283222|NCT05063071|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102283223|NCT05063071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102283224|NCT05063071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102283225|NCT05063071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283226|NCT05063071|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102283227|NCT05063071|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102283228|NCT05062681|Dexamethasone|dexamethasone|mesh-list
102283229|NCT05062681|Methylprednisolone|methylprednisolone|mesh-list
102283230|NCT05062681|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102283231|NCT05062681|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102283232|NCT05062681|Prednisolone|prednisolone|mesh-list
102283233|NCT05062681|Prednisolone acetate|prednisolone acetate|mesh-list
102283234|NCT05062681|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102283235|NCT05062681|Prednisolone phosphate|prednisolone phosphate|mesh-list
102283236|NCT05062681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102283237|NCT05062681|Antiemetics|antiemetics|mesh-ancestor
102283238|NCT05062681|Autonomic Agents|autonomic agents|mesh-ancestor
102283239|NCT05062681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102283240|NCT05062681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283241|NCT05062681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102283242|NCT05062681|Glucocorticoids|glucocorticoids|mesh-ancestor
102283243|NCT05062681|Hormones|hormones|mesh-ancestor
102283244|NCT05062681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102283245|NCT05062681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102283246|NCT05062681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102283247|NCT05062681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102283248|NCT05062681|Protective Agents|protective agents|mesh-ancestor
102283249|NCT05056519|Vaccines|vaccines|mesh-list
102283250|NCT05056519|Immunologic Factors|immunologic factors|mesh-ancestor
102283251|NCT05056519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283252|NCT05045443|Curcumin|curcumin|mesh-list
102283253|NCT05045443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102283254|NCT05045443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102283255|NCT05045443|Analgesics|analgesics|mesh-ancestor
102283256|NCT05045443|Sensory System Agents|sensory system agents|mesh-ancestor
102283257|NCT05045443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102283258|NCT05045443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283259|NCT05045443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102283260|NCT05045443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102283261|NCT05045443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102283262|NCT05045443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102283263|NCT05045443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283264|NCT05045053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102283265|NCT05045053|Lifitegrast|lifitegrast|mesh-list
102283266|NCT05045053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102283267|NCT05055895|Cholinergic Antagonists|cholinergic antagonists|mesh-list
102283268|NCT05055895|Cholinergic Agents|cholinergic agents|mesh-ancestor
102283269|NCT05055895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102283270|NCT05055895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283271|NCT05055895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283272|NCT05060809|Vitamin K|vitamin k|mesh-list
102283273|NCT05060809|Vitamin K 1|vitamin k 1|mesh-list
102283274|NCT05060809|Vitamins|vitamins|mesh-ancestor
102283275|NCT05060809|Micronutrients|micronutrients|mesh-ancestor
102283276|NCT05060809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283277|NCT05060809|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102283278|NCT05060809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102283279|NCT05060809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283280|NCT05060809|Hemostatics|hemostatics|mesh-ancestor
102283281|NCT05060809|Coagulants|coagulants|mesh-ancestor
102283282|NCT05060419|Meropenem|meropenem|mesh-list
102283283|NCT05060419|Tazobactam|tazobactam|mesh-list
102283284|NCT05060419|Piperacillin|piperacillin|mesh-list
102283285|NCT05060419|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102283286|NCT05060419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102283287|NCT05060419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102283288|NCT05060419|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102283289|NCT05060419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102283290|NCT05060419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283291|NCT03097003|Apremilast|apremilast|mesh-list
102283292|NCT03097003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102283293|NCT03097003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102283294|NCT03097003|Analgesics|analgesics|mesh-ancestor
102283295|NCT03097003|Sensory System Agents|sensory system agents|mesh-ancestor
102283296|NCT03097003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102283297|NCT03097003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283298|NCT03097003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102283299|NCT03097003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102283300|NCT03097003|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102283301|NCT03097003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102283302|NCT03097003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102283303|NCT03097003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283304|NCT02605967|Spartalizumab|spartalizumab|mesh-list
102283305|NCT02605967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102283306|NCT02605967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283307|NCT02605967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102283308|NCT02605967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102283309|NCT03036059|Ivermectin|ivermectin|mesh-list
102283310|NCT03036059|Albendazole|albendazole|mesh-list
102283311|NCT03036059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102283312|NCT03036059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102283313|NCT03036059|Anthelmintics|anthelmintics|mesh-ancestor
102283314|NCT03036059|Anticestodal Agents|anticestodal agents|mesh-ancestor
102283315|NCT03036059|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102283316|NCT03036059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102283317|NCT03036059|Tubulin Modulators|tubulin modulators|mesh-ancestor
102283318|NCT03036059|Antimitotic Agents|antimitotic agents|mesh-ancestor
102283319|NCT03036059|Mitosis Modulators|mitosis modulators|mesh-ancestor
102283320|NCT03036059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283321|NCT03036059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102283322|NCT04834427|Ketamine|ketamine|mesh-list
102283323|NCT04834427|Esketamine|esketamine|mesh-list
102283324|NCT04834427|Analgesics|analgesics|mesh-ancestor
102283325|NCT04834427|Sensory System Agents|sensory system agents|mesh-ancestor
102283326|NCT04834427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102283327|NCT04834427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283328|NCT04834427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102283329|NCT04834427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102283330|NCT04834427|Anesthetics, General|anesthetics, general|mesh-ancestor
102283331|NCT04834427|Anesthetics|anesthetics|mesh-ancestor
102283332|NCT04834427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102283333|NCT04834427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102283334|NCT04834427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102283335|NCT04834427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102283336|NCT04834427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283337|NCT04834427|Antidepressive Agents|antidepressive agents|mesh-ancestor
102283338|NCT04834427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102283339|NCT05035849|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102283340|NCT05035849|Acarbose|acarbose|mesh-list
102283341|NCT05035849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102283342|NCT05035849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283343|NCT05035849|Incretins|incretins|mesh-ancestor
102283344|NCT05035849|Hormones|hormones|mesh-ancestor
102283345|NCT05035849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102283346|NCT05035849|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102283347|NCT05035849|Protease Inhibitors|protease inhibitors|mesh-ancestor
102283348|NCT05035849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102283349|NCT05035849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283350|NCT05035849|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102283351|NCT04428437|Lenvatinib|lenvatinib|mesh-list
102283352|NCT04428437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102283353|NCT04428437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102283354|NCT04428437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102283355|NCT04428437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283356|NCT05035381|Leucovorin|leucovorin|mesh-list
102283357|NCT05035381|Bevacizumab|bevacizumab|mesh-list
102283358|NCT05035381|Pembrolizumab|pembrolizumab|mesh-list
102283359|NCT05035381|Fluorouracil|fluorouracil|mesh-list
102283360|NCT05035381|Irinotecan|irinotecan|mesh-list
102283361|NCT05035381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102283362|NCT05035381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102283363|NCT05035381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102283364|NCT05035381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102283365|NCT05035381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102283366|NCT05035381|Growth Substances|growth substances|mesh-ancestor
102283367|NCT05035381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283368|NCT05035381|Growth Inhibitors|growth inhibitors|mesh-ancestor
102283369|NCT05035381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283370|NCT05035381|Antimetabolites|antimetabolites|mesh-ancestor
102283371|NCT05035381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102283372|NCT05035381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102283373|NCT05035381|Immunologic Factors|immunologic factors|mesh-ancestor
102283374|NCT05035381|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102283375|NCT05035381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102283376|NCT05035381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102283377|NCT05035381|Antidotes|antidotes|mesh-ancestor
102283378|NCT05035381|Protective Agents|protective agents|mesh-ancestor
102283379|NCT05035381|Vitamin B Complex|vitamin b complex|mesh-ancestor
102283380|NCT05035381|Vitamins|vitamins|mesh-ancestor
102283381|NCT05035381|Micronutrients|micronutrients|mesh-ancestor
102283382|NCT04821323|Indomethacin|indomethacin|mesh-list
102283383|NCT04821323|Mannitol|mannitol|mesh-list
102283384|NCT04821323|Lactulose|lactulose|mesh-list
102283385|NCT04821323|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102283386|NCT04821323|Diuretics|diuretics|mesh-ancestor
102283387|NCT04821323|Natriuretic Agents|natriuretic agents|mesh-ancestor
102283388|NCT04821323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283389|NCT04821323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102283390|NCT04821323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102283391|NCT04821323|Analgesics|analgesics|mesh-ancestor
102283392|NCT04821323|Sensory System Agents|sensory system agents|mesh-ancestor
102283393|NCT04821323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102283394|NCT04821323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102283395|NCT04821323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102283396|NCT04821323|Gout Suppressants|gout suppressants|mesh-ancestor
102283397|NCT04821323|Tocolytic Agents|tocolytic agents|mesh-ancestor
102283398|NCT04821323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101992115|NCT01233791|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102283399|NCT04821323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102283400|NCT04821323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102283401|NCT04821323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283402|NCT04821323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102283404|NCT05035069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102283405|NCT05035069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102283406|NCT05035069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383473|NCT00290173|Autonomic Agents|autonomic agents|mesh-ancestor
102283407|NCT05035069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102283408|NCT05035069|Anesthetics, General|anesthetics, general|mesh-ancestor
102283409|NCT05035069|Anesthetics|anesthetics|mesh-ancestor
102283410|NCT05035147|Paclitaxel|paclitaxel|mesh-list
102283411|NCT05035147|Gemcitabine|gemcitabine|mesh-list
102283412|NCT05035147|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102283413|NCT05035147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102283414|NCT05035147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102283415|NCT05035147|Tubulin Modulators|tubulin modulators|mesh-ancestor
102283416|NCT05035147|Antimitotic Agents|antimitotic agents|mesh-ancestor
102283417|NCT05035147|Mitosis Modulators|mitosis modulators|mesh-ancestor
102283418|NCT05035147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283419|NCT05035147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102283420|NCT05035147|Antimetabolites|antimetabolites|mesh-ancestor
102283421|NCT04834115|Ivermectin|ivermectin|mesh-list
102283422|NCT04834115|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102283423|NCT04834115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102283424|NCT01505465|Melatonin|melatonin|mesh-list
102283425|NCT01505465|Antioxidants|antioxidants|mesh-ancestor
102283426|NCT01505465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283427|NCT01505465|Protective Agents|protective agents|mesh-ancestor
102283428|NCT01505465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283429|NCT01505465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102283430|NCT04831229|Menthol|menthol|mesh-list
102283431|NCT04831229|Antipruritics|antipruritics|mesh-ancestor
102283432|NCT04831229|Dermatologic Agents|dermatologic agents|mesh-ancestor
102283433|NCT04816253|Methylprednisolone|methylprednisolone|mesh-list
102283434|NCT04816253|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102283435|NCT04816253|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102283436|NCT04816253|Prednisolone|prednisolone|mesh-list
102283437|NCT04816253|Prednisolone acetate|prednisolone acetate|mesh-list
102283438|NCT04816253|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102283439|NCT04816253|Prednisolone phosphate|prednisolone phosphate|mesh-list
102283440|NCT04816253|Hyaluronic Acid|hyaluronic acid|mesh-list
102283441|NCT04816253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102283442|NCT04816253|Antiemetics|antiemetics|mesh-ancestor
102283443|NCT04816253|Autonomic Agents|autonomic agents|mesh-ancestor
102283444|NCT04816253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102283445|NCT04816253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283446|NCT04816253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102283447|NCT04816253|Glucocorticoids|glucocorticoids|mesh-ancestor
102283448|NCT04816253|Hormones|hormones|mesh-ancestor
102283449|NCT04816253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102283450|NCT04816253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102283451|NCT04816253|Protective Agents|protective agents|mesh-ancestor
102283452|NCT04816253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102283453|NCT04816253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102283454|NCT04816253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102283455|NCT04816253|Immunologic Factors|immunologic factors|mesh-ancestor
102283456|NCT04816253|Viscosupplements|viscosupplements|mesh-ancestor
102283457|NCT04816097|Dexamethasone|dexamethasone|mesh-list
102283458|NCT04816097|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102283459|NCT04816097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102283460|NCT04816097|Antiemetics|antiemetics|mesh-ancestor
102283461|NCT04816097|Autonomic Agents|autonomic agents|mesh-ancestor
102283462|NCT04816097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102283463|NCT04816097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283464|NCT04816097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102283466|NCT04816097|Hormones|hormones|mesh-ancestor
102283467|NCT04816097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102283468|NCT04816097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102283469|NCT04816097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102283470|NCT02600351|Sofosbuvir|sofosbuvir|mesh-list
102283471|NCT02600351|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102283472|NCT02600351|Ledipasvir|ledipasvir|mesh-list
102283473|NCT02600351|Antiviral Agents|antiviral agents|mesh-ancestor
102283474|NCT02600351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102283475|NCT04829435|Rasburicase|rasburicase|mesh-list
102283476|NCT04829435|Gout Suppressants|gout suppressants|mesh-ancestor
101992191|NCT03361956|JNJ-56136379|jnj-56136379|mesh-list
102283477|NCT04829435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102283478|NCT05042635|Ixekizumab|ixekizumab|mesh-list
102283479|NCT05042635|Dermatologic Agents|dermatologic agents|mesh-ancestor
102283480|NCT04815395|Oxytocin|oxytocin|mesh-list
102283481|NCT04815395|Oxytocics|oxytocics|mesh-ancestor
102283482|NCT04815395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102283483|NCT04815395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283484|NCT03096301|Salicylic Acid|salicylic acid|mesh-list
102283485|NCT03096301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102283486|NCT03096301|Antifungal Agents|antifungal agents|mesh-ancestor
102283487|NCT03096301|Keratolytic Agents|keratolytic agents|mesh-ancestor
102283488|NCT03096301|Dermatologic Agents|dermatologic agents|mesh-ancestor
102283489|NCT05034055|Atezolizumab|atezolizumab|mesh-list
102283490|NCT05034055|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102283491|NCT05034055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283492|NCT05034055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102283493|NCT05034055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102283494|NCT05042245|Silymarin|silymarin|mesh-list
102283495|NCT05042245|N-Methylaspartate|n-methylaspartate|mesh-list
102283496|NCT05042245|Antioxidants|antioxidants|mesh-ancestor
102283497|NCT05042245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283498|NCT05042245|Protective Agents|protective agents|mesh-ancestor
102283499|NCT05042245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283500|NCT05042245|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
102283501|NCT05042245|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102283502|NCT05042245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102283503|NCT03095209|Paclitaxel|paclitaxel|mesh-list
102283504|NCT03095209|Carboplatin|carboplatin|mesh-list
102283505|NCT03095209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102283506|NCT03095209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102283507|NCT03095209|Tubulin Modulators|tubulin modulators|mesh-ancestor
102283508|NCT03095209|Antimitotic Agents|antimitotic agents|mesh-ancestor
102283509|NCT03095209|Mitosis Modulators|mitosis modulators|mesh-ancestor
102283510|NCT03095209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283511|NCT05034133|Cisplatin|cisplatin|mesh-list
102283512|NCT05034133|Etoposide|etoposide|mesh-list
102283513|NCT05034133|Durvalumab|durvalumab|mesh-list
102283514|NCT05034133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102283515|NCT05034133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102283516|NCT05034133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102283517|NCT05034133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102283518|NCT05034133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102283519|NCT05034133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283520|NCT05034133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102283521|NCT03096457|Paromomycin|paromomycin|mesh-list
102283522|NCT03096457|Pentamidine|pentamidine|mesh-list
102283523|NCT03096457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102283524|NCT03096457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102283525|NCT03096457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102283526|NCT03096457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102283527|NCT03096457|Antifungal Agents|antifungal agents|mesh-ancestor
102283528|NCT03096457|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102283529|NCT03096223|KHK4083|khk4083|mesh-list
102283530|NCT03096223|Dermatologic Agents|dermatologic agents|mesh-ancestor
102283531|NCT04814303|Morphine|morphine|mesh-list
102283532|NCT04814303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102283533|NCT04814303|Narcotics|narcotics|mesh-ancestor
102283534|NCT04814303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102283535|NCT04814303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283536|NCT04814303|Analgesics|analgesics|mesh-ancestor
102283537|NCT04814303|Sensory System Agents|sensory system agents|mesh-ancestor
102283538|NCT04814303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102283539|NCT05053009|Ibuprofen|ibuprofen|mesh-list
102283540|NCT05053009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102283541|NCT05053009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102283542|NCT05053009|Analgesics|analgesics|mesh-ancestor
102283543|NCT05053009|Sensory System Agents|sensory system agents|mesh-ancestor
102283544|NCT05053009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102283545|NCT05053009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283546|NCT05053009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102283547|NCT05053009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102283548|NCT05053009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102283549|NCT05053009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102283550|NCT05053009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283551|NCT04813913|Bevacizumab|bevacizumab|mesh-list
102283552|NCT04813913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102283553|NCT04813913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102283554|NCT04813913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102283555|NCT04813913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102283556|NCT04813913|Growth Substances|growth substances|mesh-ancestor
102283557|NCT04813913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283558|NCT04813913|Growth Inhibitors|growth inhibitors|mesh-ancestor
102283559|NCT03094663|Cefazolin|cefazolin|mesh-list
102283560|NCT03094663|Dexamethasone|dexamethasone|mesh-list
102283561|NCT03094663|Dexamethasone acetate|dexamethasone acetate|mesh-list
102283562|NCT03094663|Methylprednisolone|methylprednisolone|mesh-list
102283563|NCT03094663|Epinephrine|epinephrine|mesh-list
102283564|NCT03094663|Bupivacaine|bupivacaine|mesh-list
102283565|NCT03094663|BB 1101|bb 1101|mesh-list
102283566|NCT03094663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102283567|NCT03094663|Antiemetics|antiemetics|mesh-ancestor
102283568|NCT03094663|Autonomic Agents|autonomic agents|mesh-ancestor
102283569|NCT03094663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102283570|NCT03094663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283571|NCT03094663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102283572|NCT03094663|Glucocorticoids|glucocorticoids|mesh-ancestor
102283573|NCT03094663|Hormones|hormones|mesh-ancestor
102283574|NCT03094663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102283575|NCT03094663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102283576|NCT03094663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102283577|NCT03094663|Protease Inhibitors|protease inhibitors|mesh-ancestor
102283578|NCT03094663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102283579|NCT03094663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283580|NCT03094663|Anesthetics, Local|anesthetics, local|mesh-ancestor
102283581|NCT03094663|Anesthetics|anesthetics|mesh-ancestor
102283582|NCT03094663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102283583|NCT03094663|Sensory System Agents|sensory system agents|mesh-ancestor
102283584|NCT03094663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102283585|NCT03094663|Protective Agents|protective agents|mesh-ancestor
102283586|NCT03094663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102283587|NCT03094663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102283588|NCT03094663|Adrenergic Agents|adrenergic agents|mesh-ancestor
102283589|NCT03094663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102283590|NCT03094663|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102283591|NCT03094663|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102283592|NCT03094663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102283593|NCT03094663|Respiratory System Agents|respiratory system agents|mesh-ancestor
102283594|NCT03094663|Mydriatics|mydriatics|mesh-ancestor
102283595|NCT03094663|Sympathomimetics|sympathomimetics|mesh-ancestor
102283596|NCT03094663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102283597|NCT03094663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102283598|NCT03094663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102283599|NCT04814381|Magnesium Sulfate|magnesium sulfate|mesh-list
102283600|NCT04814381|Ketamine|ketamine|mesh-list
102283601|NCT04814381|Analgesics|analgesics|mesh-ancestor
102283602|NCT04814381|Sensory System Agents|sensory system agents|mesh-ancestor
102283603|NCT04814381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102283604|NCT04814381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283605|NCT04814381|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102283606|NCT04814381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102283607|NCT04814381|Anesthetics, General|anesthetics, general|mesh-ancestor
102283608|NCT04814381|Anesthetics|anesthetics|mesh-ancestor
102283609|NCT04814381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102283610|NCT04814381|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102283611|NCT04814381|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102283612|NCT04814381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102283613|NCT04814381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283614|NCT04814381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102283615|NCT04814381|Anticonvulsants|anticonvulsants|mesh-ancestor
102283616|NCT04814381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102283617|NCT04814381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102283618|NCT04814381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102283619|NCT04814381|Tocolytic Agents|tocolytic agents|mesh-ancestor
102283620|NCT04814381|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102283621|NCT04819217|Charcoal|charcoal|mesh-list
102283622|NCT04819217|Antidotes|antidotes|mesh-ancestor
102283623|NCT04819217|Protective Agents|protective agents|mesh-ancestor
102283624|NCT04819217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283625|NCT05052619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102283626|NCT05052619|Cefmetazole|cefmetazole|mesh-list
102283627|NCT05052619|Sulperazone|sulperazone|mesh-list
102283628|NCT05052619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101992339|NCT05679765|Antiemetics|antiemetics|mesh-ancestor
102283629|NCT05052619|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102283630|NCT05052775|Chlorhexidine|chlorhexidine|mesh-list
102283631|NCT05052775|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102283632|NCT05052775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102283633|NCT05052775|Disinfectants|disinfectants|mesh-ancestor
102283634|NCT04813523|Cisplatin|cisplatin|mesh-list
102283635|NCT04813523|Pembrolizumab|pembrolizumab|mesh-list
102283636|NCT04813523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102283637|NCT04813523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102283638|NCT04813523|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102283639|NCT04813523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283640|NCT05032261|Norepinephrine|norepinephrine|mesh-list
102283641|NCT05032261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102283642|NCT05032261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102283643|NCT05032261|Adrenergic Agents|adrenergic agents|mesh-ancestor
102283644|NCT05032261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102283645|NCT05032261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283646|NCT05032261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283647|NCT05032261|Sympathomimetics|sympathomimetics|mesh-ancestor
102283648|NCT05032261|Autonomic Agents|autonomic agents|mesh-ancestor
102283649|NCT05032261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102283650|NCT05032261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102283651|NCT05619341|Psyllium|psyllium|mesh-list
102283652|NCT05619341|Cathartics|cathartics|mesh-ancestor
102283653|NCT05619341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102283654|NCT04814069|Tislelizumab|tislelizumab|mesh-list
102283655|NCT04814069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102283656|NCT04814069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102283657|NCT05051137|Hydroxychloroquine|hydroxychloroquine|mesh-list
102283658|NCT05051137|Sulfasalazine|sulfasalazine|mesh-list
102283659|NCT05051137|Infliximab|infliximab|mesh-list
102283660|NCT05051137|Antimalarials|antimalarials|mesh-ancestor
102283661|NCT05051137|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102283662|NCT05051137|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102283663|NCT05051137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102283664|NCT05051137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102283665|NCT05051137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283666|NCT05051137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102283667|NCT05051137|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102283668|NCT05051137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102283669|NCT05051137|Dermatologic Agents|dermatologic agents|mesh-ancestor
102283670|NCT05051137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102283671|NCT05051137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102283672|NCT05051137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102283673|NCT05051137|Analgesics|analgesics|mesh-ancestor
102283674|NCT05051137|Sensory System Agents|sensory system agents|mesh-ancestor
102283675|NCT05051137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102283676|NCT05051137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283677|NCT05038969|Esomeprazole|esomeprazole|mesh-list
102283678|NCT05038969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102283679|NCT05038969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102283680|NCT05038969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102283681|NCT05038969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102283682|NCT05038969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283683|NCT05038657|Atezolizumab|atezolizumab|mesh-list
102283684|NCT05038657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102283685|NCT05038657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283686|NCT05038657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102283687|NCT05038657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102283688|NCT05038111|Dexmedetomidine|dexmedetomidine|mesh-list
102283689|NCT05038111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102283690|NCT05038111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102283691|NCT05038111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283692|NCT05038111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102283693|NCT05038111|Analgesics|analgesics|mesh-ancestor
102283694|NCT05038111|Sensory System Agents|sensory system agents|mesh-ancestor
102283695|NCT05038111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102283696|NCT05038111|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102283697|NCT05038111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102283698|NCT05038111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102283699|NCT05038111|Adrenergic Agents|adrenergic agents|mesh-ancestor
102283700|NCT05038111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102283701|NCT05038111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283702|NCT05030077|Carboplatin|carboplatin|mesh-list
102283703|NCT05030077|Gemcitabine|gemcitabine|mesh-list
102283704|NCT05030077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102283705|NCT05030077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102283706|NCT05030077|Antimetabolites|antimetabolites|mesh-ancestor
102283707|NCT05030077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283708|NCT05029531|Immunomodulating Agents|immunomodulating agents|mesh-list
102283709|NCT05029531|Immunologic Factors|immunologic factors|mesh-ancestor
102283710|NCT05029531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283711|NCT05029453|Apatinib|apatinib|mesh-list
102283712|NCT05029453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102283713|NCT05029453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102283714|NCT05029453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102283715|NCT05029453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283716|NCT02640157|Sofosbuvir|sofosbuvir|mesh-list
102283717|NCT02640157|Antiviral Agents|antiviral agents|mesh-ancestor
102283718|NCT02640157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102283719|NCT05037253|Vitamin D|vitamin d|mesh-list
102283720|NCT05037253|Vitamins|vitamins|mesh-ancestor
102283721|NCT05037253|Micronutrients|micronutrients|mesh-ancestor
101383799|NCT00275119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102283722|NCT05037253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283723|NCT05037253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102283724|NCT05029297|Capsaicin|capsaicin|mesh-list
102283725|NCT05029297|Antipruritics|antipruritics|mesh-ancestor
102283726|NCT05029297|Dermatologic Agents|dermatologic agents|mesh-ancestor
102283727|NCT05029297|Sensory System Agents|sensory system agents|mesh-ancestor
102283728|NCT05029297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102283729|NCT05029297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283730|NCT05028907|Tocopherols|tocopherols|mesh-list
102283731|NCT05028907|Vitamin E|vitamin e|mesh-list
102283732|NCT05028907|alpha-Tocopherol|alpha-tocopherol|mesh-list
102283733|NCT05028907|Chloramphenicol|chloramphenicol|mesh-list
102283734|NCT05028907|Dexamethasone|dexamethasone|mesh-list
102283735|NCT05028907|Dexamethasone acetate|dexamethasone acetate|mesh-list
102283736|NCT05028907|Tetrahydrozoline|tetrahydrozoline|mesh-list
102283737|NCT05028907|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102283738|NCT05028907|Hyaluronic Acid|hyaluronic acid|mesh-list
102283739|NCT05028907|BB 1101|bb 1101|mesh-list
102283740|NCT05028907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102283741|NCT05028907|Antiemetics|antiemetics|mesh-ancestor
102283742|NCT05028907|Autonomic Agents|autonomic agents|mesh-ancestor
102283743|NCT05028907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102283744|NCT05028907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283745|NCT05028907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102283746|NCT05028907|Glucocorticoids|glucocorticoids|mesh-ancestor
102283747|NCT05028907|Hormones|hormones|mesh-ancestor
102283748|NCT05028907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102283749|NCT05028907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102283750|NCT05028907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102283751|NCT05028907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102283752|NCT05028907|Immunologic Factors|immunologic factors|mesh-ancestor
102283753|NCT05028907|Viscosupplements|viscosupplements|mesh-ancestor
102283754|NCT05028907|Protective Agents|protective agents|mesh-ancestor
102283755|NCT05028907|Antioxidants|antioxidants|mesh-ancestor
102283756|NCT05028907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283757|NCT05028907|Vitamins|vitamins|mesh-ancestor
102283758|NCT05028907|Micronutrients|micronutrients|mesh-ancestor
102283759|NCT05028907|Protease Inhibitors|protease inhibitors|mesh-ancestor
102283760|NCT05028907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102283761|NCT05028907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102283762|NCT05028907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102283763|NCT05028907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102283764|NCT05028907|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102283765|NCT05028907|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102283766|NCT05028907|Sympathomimetics|sympathomimetics|mesh-ancestor
102283767|NCT05028907|Nasal Decongestants|nasal decongestants|mesh-ancestor
102283768|NCT05028907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102283769|NCT05028907|Respiratory System Agents|respiratory system agents|mesh-ancestor
102283770|NCT05028049|Sufentanil|sufentanil|mesh-list
102283771|NCT05028049|Remifentanil|remifentanil|mesh-list
102283772|NCT05028049|Dsuvia|dsuvia|mesh-list
102283773|NCT05028049|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102283774|NCT05028049|Narcotics|narcotics|mesh-ancestor
102283775|NCT05028049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102283776|NCT05028049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283777|NCT05028049|Analgesics|analgesics|mesh-ancestor
102283778|NCT05028049|Sensory System Agents|sensory system agents|mesh-ancestor
102283779|NCT05028049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102283780|NCT05028049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102283781|NCT05028049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102283782|NCT05028049|Anesthetics, General|anesthetics, general|mesh-ancestor
102283783|NCT05028049|Anesthetics|anesthetics|mesh-ancestor
101383918|NCT00130195|Prednisolone|prednisolone|mesh-list
102283784|NCT05023915|Dexamethasone|dexamethasone|mesh-list
102283785|NCT05023915|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
102283786|NCT05023915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102283787|NCT05023915|Antiemetics|antiemetics|mesh-ancestor
102283788|NCT05023915|Autonomic Agents|autonomic agents|mesh-ancestor
102283789|NCT05023915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102283790|NCT05023915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283791|NCT05023915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102283792|NCT05023915|Glucocorticoids|glucocorticoids|mesh-ancestor
102283793|NCT05023915|Hormones|hormones|mesh-ancestor
102283794|NCT05023915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102283795|NCT05023915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102283796|NCT05023915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102283797|NCT05027581|Hyaluronic Acid|hyaluronic acid|mesh-list
102283798|NCT05027581|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102283799|NCT05027581|Immunologic Factors|immunologic factors|mesh-ancestor
102283800|NCT05027581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283801|NCT05027581|Viscosupplements|viscosupplements|mesh-ancestor
102283802|NCT05027581|Protective Agents|protective agents|mesh-ancestor
102283803|NCT05027191|Sevoflurane|sevoflurane|mesh-list
102283804|NCT05027191|Desflurane|desflurane|mesh-list
102283805|NCT05027191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102283806|NCT05027191|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102283807|NCT05027191|Anesthetics, General|anesthetics, general|mesh-ancestor
102283808|NCT05027191|Anesthetics|anesthetics|mesh-ancestor
102283809|NCT05027191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102283810|NCT05027191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283811|NCT03094507|Dolutegravir|dolutegravir|mesh-list
102283812|NCT03094507|Darunavir|darunavir|mesh-list
102283813|NCT03094507|Cobicistat|cobicistat|mesh-list
102283814|NCT03094507|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
102283815|NCT03094507|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102283816|NCT03094507|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102283817|NCT03094507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102283818|NCT03094507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283819|NCT03094507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102283820|NCT03094507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102283821|NCT03094507|Antiviral Agents|antiviral agents|mesh-ancestor
102283822|NCT03094507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102283823|NCT03094507|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102283824|NCT03094507|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102283825|NCT03094507|Protease Inhibitors|protease inhibitors|mesh-ancestor
102283826|NCT03094507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102283827|NCT03094507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102283828|NCT02528253|Tramadol|tramadol|mesh-list
102283829|NCT02528253|Tanezumab|tanezumab|mesh-list
102283830|NCT02528253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102283831|NCT02528253|Narcotics|narcotics|mesh-ancestor
102283832|NCT02528253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102283833|NCT02528253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283834|NCT02528253|Analgesics|analgesics|mesh-ancestor
102283835|NCT02528253|Sensory System Agents|sensory system agents|mesh-ancestor
102283836|NCT02528253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102283837|NCT03093103|Empagliflozin|empagliflozin|mesh-list
102283838|NCT03093103|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102283839|NCT03093103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283840|NCT03093103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102283841|NCT03093103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283842|NCT03093805|Calcipotriene|calcipotriene|mesh-list
102283843|NCT03093805|Dermatologic Agents|dermatologic agents|mesh-ancestor
102283844|NCT03093883|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102283845|NCT03093883|Hematinics|hematinics|mesh-ancestor
102283846|NCT05023759|Cannabidiol|cannabidiol|mesh-list
102283847|NCT05023759|Anticonvulsants|anticonvulsants|mesh-ancestor
102283848|NCT01672957|Mycophenolic Acid|mycophenolic acid|mesh-list
102283849|NCT01672957|Immunosuppressive Agents|immunosuppressive agents|mesh-list
102283850|NCT01672957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102283851|NCT01672957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102283852|NCT01672957|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102283853|NCT01672957|Antitubercular Agents|antitubercular agents|mesh-ancestor
102283854|NCT01672957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102283855|NCT01672957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102283856|NCT01672957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102283857|NCT01672957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283858|NCT01672957|Immunologic Factors|immunologic factors|mesh-ancestor
102283859|NCT01672957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283860|NCT05047393|Vitamin D|vitamin d|mesh-list
102283861|NCT05047393|Vitamins|vitamins|mesh-ancestor
102283862|NCT05047393|Micronutrients|micronutrients|mesh-ancestor
102283863|NCT05047393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283864|NCT05047393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102283865|NCT05017987|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
102283866|NCT05017987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283867|NCT05017987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102283868|NCT05017987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102283869|NCT05017987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102283870|NCT05021887|Fluticasone|fluticasone|mesh-list
102283871|NCT05021887|Xhance|xhance|mesh-list
102283872|NCT05021887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102283873|NCT05021887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102283874|NCT05021887|Autonomic Agents|autonomic agents|mesh-ancestor
102283875|NCT05021887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102283876|NCT05021887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283877|NCT05021887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102283878|NCT05021887|Respiratory System Agents|respiratory system agents|mesh-ancestor
102283879|NCT05021887|Dermatologic Agents|dermatologic agents|mesh-ancestor
102283880|NCT05021887|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102283881|NCT05021731|Rifampin|rifampin|mesh-list
102283882|NCT05021731|Rifapentine|rifapentine|mesh-list
102283883|NCT05021731|Isoniazid|isoniazid|mesh-list
102283884|NCT05021731|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102283885|NCT05021731|Antitubercular Agents|antitubercular agents|mesh-ancestor
102283886|NCT05021731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102283887|NCT05021731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102283888|NCT05021731|Leprostatic Agents|leprostatic agents|mesh-ancestor
102283889|NCT05021731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102283890|NCT05021731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102283891|NCT05021731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283892|NCT05021731|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102283893|NCT05021731|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102283894|NCT05021731|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102283895|NCT05021731|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102283896|NCT05021731|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102283897|NCT05021731|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102283898|NCT05021731|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102283899|NCT05021731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102283900|NCT05021731|Antimetabolites|antimetabolites|mesh-ancestor
102283901|NCT05021731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102283902|NCT05009953|Leucovorin|leucovorin|mesh-list
102283903|NCT05009953|Fluorouracil|fluorouracil|mesh-list
102283904|NCT05009953|Irinotecan|irinotecan|mesh-list
102283905|NCT05009953|Antimetabolites|antimetabolites|mesh-ancestor
102283906|NCT05009953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283907|NCT05009953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102283908|NCT05009953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102283909|NCT05009953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102283910|NCT05009953|Immunologic Factors|immunologic factors|mesh-ancestor
102283911|NCT05009953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283912|NCT05009953|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102283913|NCT05009953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102283914|NCT05009953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102283915|NCT05009953|Antidotes|antidotes|mesh-ancestor
102283916|NCT05009953|Protective Agents|protective agents|mesh-ancestor
102283917|NCT05009953|Vitamin B Complex|vitamin b complex|mesh-ancestor
102283918|NCT05009953|Vitamins|vitamins|mesh-ancestor
102283919|NCT05009953|Micronutrients|micronutrients|mesh-ancestor
102283920|NCT03079453|Dexamethasone|dexamethasone|mesh-list
102283921|NCT03079453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102283922|NCT03079453|Antiemetics|antiemetics|mesh-ancestor
102283923|NCT03079453|Autonomic Agents|autonomic agents|mesh-ancestor
102283924|NCT03079453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102283925|NCT03079453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283926|NCT03079453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102283927|NCT03079453|Glucocorticoids|glucocorticoids|mesh-ancestor
102283928|NCT03079453|Hormones|hormones|mesh-ancestor
102283929|NCT03079453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102283930|NCT03079453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102283931|NCT03079453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102283932|NCT05009017|Bevacizumab|bevacizumab|mesh-list
102283933|NCT05009017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102283934|NCT05009017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102283935|NCT05009017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101992641|NCT05681403|Carmustine|carmustine|mesh-list
102283936|NCT05009017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102283937|NCT05009017|Growth Substances|growth substances|mesh-ancestor
102283938|NCT05009017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283939|NCT05009017|Growth Inhibitors|growth inhibitors|mesh-ancestor
102283940|NCT05008939|Sevoflurane|sevoflurane|mesh-list
102283941|NCT05008939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102283942|NCT05008939|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102283943|NCT05008939|Anesthetics, General|anesthetics, general|mesh-ancestor
102283944|NCT05008939|Anesthetics|anesthetics|mesh-ancestor
102283945|NCT05008939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102283946|NCT05008939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283947|NCT05008861|Pembrolizumab|pembrolizumab|mesh-list
102283948|NCT05008861|Nivolumab|nivolumab|mesh-list
102283949|NCT05008861|Durvalumab|durvalumab|mesh-list
102283950|NCT05008861|Tislelizumab|tislelizumab|mesh-list
102283951|NCT05008861|Antibodies|antibodies|mesh-list
102283952|NCT05008861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102283953|NCT05008861|Immunologic Factors|immunologic factors|mesh-ancestor
102283954|NCT05008861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283955|NCT05008861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102283956|NCT05008861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102283957|NCT05008861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102283958|NCT05008861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283959|NCT05360277|Capecitabine|capecitabine|mesh-list
102283960|NCT05360277|Tislelizumab|tislelizumab|mesh-list
102283961|NCT05360277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102283962|NCT05360277|Antimetabolites|antimetabolites|mesh-ancestor
102283963|NCT05360277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283964|NCT05360277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102283965|NCT05360277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102283966|NCT05016973|Disitamab vedotin|disitamab vedotin|mesh-list
102283967|NCT05016973|Immunoconjugates|immunoconjugates|mesh-ancestor
102283968|NCT05016973|Immunologic Factors|immunologic factors|mesh-ancestor
102283969|NCT05016973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283970|NCT03091699|Nicotine|nicotine|mesh-list
102283971|NCT03091699|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102283972|NCT03091699|Autonomic Agents|autonomic agents|mesh-ancestor
102283973|NCT03091699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102283974|NCT03091699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283975|NCT03091699|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102283976|NCT03091699|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102283977|NCT03091699|Cholinergic Agents|cholinergic agents|mesh-ancestor
102283978|NCT03091699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102283979|NCT03091699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283980|NCT05344209|Sargramostim|sargramostim|mesh-list
102283981|NCT05344209|Immunologic Factors|immunologic factors|mesh-ancestor
102283982|NCT05344209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283983|NCT03091543|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
102283984|NCT03091543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102283985|NCT03091543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102283986|NCT03091543|Dopamine Agents|dopamine agents|mesh-ancestor
102283987|NCT03091543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102283988|NCT03091543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283989|NCT04253457|Triamcinolone|triamcinolone|mesh-list
102283990|NCT04253457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102283991|NCT04253457|Glucocorticoids|glucocorticoids|mesh-ancestor
102283992|NCT04253457|Hormones|hormones|mesh-ancestor
101941511|NCT01585623|Autonomic Agents|autonomic agents|mesh-ancestor
102283993|NCT04253457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102283994|NCT04253457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102283995|NCT05380947|Rabeprazole|rabeprazole|mesh-list
102283996|NCT05380947|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102283997|NCT05380947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102283998|NCT05380947|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102283999|NCT05380947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102284000|NCT05380947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284001|NCT02525133|Bupivacaine|bupivacaine|mesh-list
102284002|NCT02525133|Anesthetics, Local|anesthetics, local|mesh-ancestor
102284003|NCT02525133|Anesthetics|anesthetics|mesh-ancestor
102284004|NCT02525133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102284005|NCT02525133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284006|NCT02525133|Sensory System Agents|sensory system agents|mesh-ancestor
102284007|NCT02525133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102284008|NCT05602311|Anesthetics|anesthetics|mesh-list
102284009|NCT05602311|Anesthetics, General|anesthetics, general|mesh-list
102284010|NCT05602311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102284011|NCT05602311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284013|NCT05016349|Tocopherols|tocopherols|mesh-list
102284014|NCT05016349|Tretinoin|tretinoin|mesh-list
102284015|NCT05016349|Alitretinoin|alitretinoin|mesh-list
102284016|NCT05016349|Cannabidiol|cannabidiol|mesh-list
102284017|NCT05016349|Isotretinoin|isotretinoin|mesh-list
102284018|NCT05016349|Mifepristone|mifepristone|mesh-list
102284019|NCT05016349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102284020|NCT05016349|Hormone Antagonists|hormone antagonists|mesh-ancestor
102284021|NCT05016349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102284022|NCT05016349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284023|NCT05016349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102284024|NCT05016349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102284025|NCT05016349|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102284026|NCT05016349|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102284027|NCT05016349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102284028|NCT05016349|Anticonvulsants|anticonvulsants|mesh-ancestor
102284029|NCT05016349|Keratolytic Agents|keratolytic agents|mesh-ancestor
102284030|NCT05016349|Dermatologic Agents|dermatologic agents|mesh-ancestor
102284031|NCT05016349|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102284032|NCT05016349|Abortifacient Agents|abortifacient agents|mesh-ancestor
102284033|NCT05016349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102284034|NCT05016349|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102284035|NCT05016349|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102284036|NCT05016349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102284037|NCT05016349|Contraceptive Agents|contraceptive agents|mesh-ancestor
102284038|NCT05016349|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102284039|NCT05016349|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102284040|NCT05016349|Luteolytic Agents|luteolytic agents|mesh-ancestor
102284041|NCT05016349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102284042|NCT05016349|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102284043|NCT05016349|Antioxidants|antioxidants|mesh-ancestor
102284044|NCT05016349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284045|NCT05016349|Protective Agents|protective agents|mesh-ancestor
102284046|NCT05016349|Vitamins|vitamins|mesh-ancestor
102284047|NCT05016349|Micronutrients|micronutrients|mesh-ancestor
102284048|NCT05380635|Hypericin|hypericin|mesh-list
102284049|NCT05380635|Antidepressive Agents|antidepressive agents|mesh-ancestor
102284050|NCT05380635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102284051|NCT05380635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102284052|NCT05380635|Antiviral Agents|antiviral agents|mesh-ancestor
102284053|NCT05380635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102284054|NCT05380635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102284055|NCT05380635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284056|NCT05380635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102284057|NCT05380635|Immunologic Factors|immunologic factors|mesh-ancestor
102284058|NCT05380635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284059|NCT05538819|Glimepiride|glimepiride|mesh-list
102284060|NCT05538819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102284061|NCT05538819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102284062|NCT05538819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284063|NCT05538819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102284064|NCT05538819|Immunologic Factors|immunologic factors|mesh-ancestor
102284065|NCT03079219|Dexamethasone|dexamethasone|mesh-list
102284066|NCT03079219|Dexamethasone acetate|dexamethasone acetate|mesh-list
102284068|NCT03079219|Olanzapine|olanzapine|mesh-list
102284069|NCT03079219|Aprepitant|aprepitant|mesh-list
102284070|NCT03079219|Fosaprepitant|fosaprepitant|mesh-list
102284071|NCT03079219|BB 1101|bb 1101|mesh-list
102284072|NCT03079219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102284073|NCT03079219|Antiemetics|antiemetics|mesh-ancestor
102284074|NCT03079219|Autonomic Agents|autonomic agents|mesh-ancestor
102284075|NCT03079219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102284076|NCT03079219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284077|NCT03079219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102284078|NCT03079219|Glucocorticoids|glucocorticoids|mesh-ancestor
102284079|NCT03079219|Hormones|hormones|mesh-ancestor
102284080|NCT03079219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102284081|NCT03079219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102284082|NCT03079219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102284083|NCT03079219|Protease Inhibitors|protease inhibitors|mesh-ancestor
102284084|NCT03079219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102284085|NCT03079219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284086|NCT03079219|Antipruritics|antipruritics|mesh-ancestor
102284087|NCT03079219|Dermatologic Agents|dermatologic agents|mesh-ancestor
102284088|NCT03079219|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102284089|NCT03079219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102284090|NCT03079219|Serotonin Agents|serotonin agents|mesh-ancestor
102284091|NCT03079219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102284092|NCT03079219|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102284093|NCT03079219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102284094|NCT03079219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102284095|NCT03079219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102284096|NCT03079219|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102284097|NCT03079219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102284098|NCT03079219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102284099|NCT03079219|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102284100|NCT03078829|Leuprolide|leuprolide|mesh-list
102284101|NCT03078829|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102284102|NCT03078829|Fertility Agents|fertility agents|mesh-ancestor
102284103|NCT03078829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102284104|NCT03078829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284105|NCT03078829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102284106|NCT03078829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102284107|NCT05008237|Docetaxel|docetaxel|mesh-list
102284108|NCT05008237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102284109|NCT05008237|Tubulin Modulators|tubulin modulators|mesh-ancestor
102284110|NCT05008237|Antimitotic Agents|antimitotic agents|mesh-ancestor
102284111|NCT05008237|Mitosis Modulators|mitosis modulators|mesh-ancestor
102284112|NCT05008237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284113|NCT05014711|Fentanyl|fentanyl|mesh-list
102284114|NCT05014711|Remifentanil|remifentanil|mesh-list
102284115|NCT05014711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102284116|NCT05014711|Narcotics|narcotics|mesh-ancestor
102284117|NCT05014711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102284118|NCT05014711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284119|NCT05014711|Analgesics|analgesics|mesh-ancestor
102284120|NCT05014711|Sensory System Agents|sensory system agents|mesh-ancestor
102284121|NCT05014711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102284122|NCT05014711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102284123|NCT05014711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102284124|NCT05014711|Anesthetics, General|anesthetics, general|mesh-ancestor
102284125|NCT05014711|Anesthetics|anesthetics|mesh-ancestor
102284126|NCT05018923|Metronidazole|metronidazole|mesh-list
102284127|NCT05018923|Doxycycline|doxycycline|mesh-list
102284128|NCT05018923|Tetracycline|tetracycline|mesh-list
102284129|NCT05018923|Potassium Citrate|potassium citrate|mesh-list
102284130|NCT05018923|Rabeprazole|rabeprazole|mesh-list
102284131|NCT05018923|Bismuth|bismuth|mesh-list
102284132|NCT05018923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284133|NCT05018923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102284134|NCT05018923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102284135|NCT05018923|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102284136|NCT05018923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102284137|NCT05018923|Antimalarials|antimalarials|mesh-ancestor
102284138|NCT05018923|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102284139|NCT05018923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102284140|NCT05018923|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102284141|NCT05018923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102284142|NCT05018923|Antacids|antacids|mesh-ancestor
102284143|NCT05018923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102284144|NCT05018923|Diuretics|diuretics|mesh-ancestor
102284145|NCT05018923|Natriuretic Agents|natriuretic agents|mesh-ancestor
102284146|NCT05018923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284147|NCT05018923|Expectorants|expectorants|mesh-ancestor
102284148|NCT05018923|Respiratory System Agents|respiratory system agents|mesh-ancestor
102284149|NCT03086473|Caffeine|caffeine|mesh-list
102284150|NCT03086473|Caffeine citrate|caffeine citrate|mesh-list
102284151|NCT03086473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284152|NCT03086473|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102284153|NCT03086473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284154|NCT03086473|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102284155|NCT03086473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102284156|NCT03086473|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102284157|NCT03086473|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102284158|NCT03086473|Purinergic Agents|purinergic agents|mesh-ancestor
102284159|NCT03086473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102284160|NCT03086005|Metformin|metformin|mesh-list
102284161|NCT03086005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102284162|NCT03086005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284163|NCT03079141|Eplerenone|eplerenone|mesh-list
102284164|NCT03079141|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102284165|NCT03079141|Hormone Antagonists|hormone antagonists|mesh-ancestor
102284166|NCT03079141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102284167|NCT03079141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284168|NCT03079141|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102284169|NCT03079141|Diuretics|diuretics|mesh-ancestor
102284170|NCT03079141|Natriuretic Agents|natriuretic agents|mesh-ancestor
102284171|NCT03079141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102284172|NCT03085849|Durvalumab|durvalumab|mesh-list
102284173|NCT03085849|Tremelimumab|tremelimumab|mesh-list
102284174|NCT03085849|Guadecitabine|guadecitabine|mesh-list
102284175|NCT03085849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102284176|NCT03085849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102284177|NCT05001529|Antibodies|antibodies|mesh-list
102284178|NCT05001529|Immunologic Factors|immunologic factors|mesh-ancestor
102284179|NCT05001529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284180|NCT05001061|Misoprostol|misoprostol|mesh-list
102284181|NCT05001061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102284182|NCT05001061|Abortifacient Agents|abortifacient agents|mesh-ancestor
102284183|NCT05001061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102284184|NCT05001061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284185|NCT05001061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102284186|NCT05001061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102284187|NCT05001061|Oxytocics|oxytocics|mesh-ancestor
102284188|NCT05531955|Pirfenidone|pirfenidone|mesh-list
102284189|NCT05531955|Analgesics|analgesics|mesh-ancestor
102284190|NCT05531955|Sensory System Agents|sensory system agents|mesh-ancestor
102284191|NCT05531955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102284192|NCT05531955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284193|NCT05531955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102284194|NCT05531955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102284195|NCT05531955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102284196|NCT05531955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102284197|NCT05531955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102284198|NCT05339529|Glycine|glycine|mesh-list
102284199|NCT05339529|Thymalfasin|thymalfasin|mesh-list
102284200|NCT05339529|Glycine Agents|glycine agents|mesh-ancestor
102284201|NCT05339529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102284202|NCT05339529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284203|NCT05339529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284204|NCT05339529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102284205|NCT05339529|Immunologic Factors|immunologic factors|mesh-ancestor
102284206|NCT05006911|Bromfenac|bromfenac|mesh-list
102284207|NCT05006911|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102284208|NCT05006911|Phenylephrine|phenylephrine|mesh-list
102284209|NCT05006911|Oxymetazoline|oxymetazoline|mesh-list
102284210|NCT05006911|Hyaluronic Acid|hyaluronic acid|mesh-list
102284211|NCT05006911|Pilocarpine|pilocarpine|mesh-list
102284212|NCT05006911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102284213|NCT05006911|Immunologic Factors|immunologic factors|mesh-ancestor
102284214|NCT05006911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284215|NCT05006911|Viscosupplements|viscosupplements|mesh-ancestor
102284216|NCT05006911|Protective Agents|protective agents|mesh-ancestor
102284217|NCT05006911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102284218|NCT05006911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102284219|NCT05006911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102284220|NCT05006911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102284221|NCT05006911|Adrenergic Agents|adrenergic agents|mesh-ancestor
102284222|NCT05006911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102284223|NCT05006911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284224|NCT05006911|Sympathomimetics|sympathomimetics|mesh-ancestor
102284225|NCT05006911|Autonomic Agents|autonomic agents|mesh-ancestor
102284226|NCT05006911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102284227|NCT05006911|Nasal Decongestants|nasal decongestants|mesh-ancestor
102284228|NCT05006911|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102284229|NCT05006911|Respiratory System Agents|respiratory system agents|mesh-ancestor
102284230|NCT05006911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102284231|NCT05006911|Mydriatics|mydriatics|mesh-ancestor
102284232|NCT05006911|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102284233|NCT05006911|Miotics|miotics|mesh-ancestor
102284234|NCT05006911|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102284235|NCT05006911|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102284236|NCT05006911|Cholinergic Agents|cholinergic agents|mesh-ancestor
102284237|NCT05006911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102284238|NCT05006911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102284239|NCT05006911|Analgesics|analgesics|mesh-ancestor
102284240|NCT05006911|Sensory System Agents|sensory system agents|mesh-ancestor
102284241|NCT05006911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102284242|NCT05006911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102284244|NCT05339295|Ofloxacin|ofloxacin|mesh-list
102284245|NCT05339295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102284246|NCT05339295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102284247|NCT05339295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102284248|NCT05339295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102284249|NCT05339295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102284250|NCT05339295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102284251|NCT05339295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284252|NCT05339295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102284253|NCT05339295|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102284254|NCT05339295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102284255|NCT02637037|Metformin|metformin|mesh-list
102284256|NCT02637037|Dapagliflozin|dapagliflozin|mesh-list
102284257|NCT02637037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102284258|NCT02637037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284259|NCT02637037|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102284260|NCT02637037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284261|NCT05307081|Lubricant Eye Drops|lubricant eye drops|mesh-list
102284262|NCT05307081|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102284263|NCT05307081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102284264|NCT05306535|Salicylic Acid|salicylic acid|mesh-list
102284265|NCT05306535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102284266|NCT05306535|Antifungal Agents|antifungal agents|mesh-ancestor
102284267|NCT05306535|Keratolytic Agents|keratolytic agents|mesh-ancestor
102284268|NCT05306535|Dermatologic Agents|dermatologic agents|mesh-ancestor
102284269|NCT02637895|Vortioxetine|vortioxetine|mesh-list
102284270|NCT02637895|Antidepressive Agents|antidepressive agents|mesh-ancestor
102284271|NCT02637895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102284272|NCT02637895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102284273|NCT02637895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102284274|NCT02637895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102284275|NCT02637895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284276|NCT02637895|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102284277|NCT02637895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102284278|NCT02637895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102284279|NCT02637895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284280|NCT02637895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102284281|NCT02637895|Serotonin Agents|serotonin agents|mesh-ancestor
102284282|NCT02637895|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102284283|NCT02637895|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102284284|NCT02637895|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102284285|NCT02637895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102284286|NCT05013697|Paclitaxel|paclitaxel|mesh-list
102284287|NCT05013697|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102284288|NCT05013697|Cisplatin|cisplatin|mesh-list
102284289|NCT05013697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102284290|NCT05013697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102284291|NCT05013697|Tubulin Modulators|tubulin modulators|mesh-ancestor
102284292|NCT05013697|Antimitotic Agents|antimitotic agents|mesh-ancestor
102284293|NCT05013697|Mitosis Modulators|mitosis modulators|mesh-ancestor
102284294|NCT05013697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284295|NCT05509647|Heparin|heparin|mesh-list
102284296|NCT05509647|Calcium heparin|calcium heparin|mesh-list
102284297|NCT05509647|Anticoagulants|anticoagulants|mesh-ancestor
102284298|NCT05509647|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102284299|NCT05509647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102284300|NCT05509647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284301|NCT05305911|Dapagliflozin|dapagliflozin|mesh-list
102284302|NCT05305911|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102284303|NCT05305911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284304|NCT05305911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102284305|NCT05305911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284306|NCT05349435|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
102284307|NCT05349435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102284308|NCT05007223|Doxycycline|doxycycline|mesh-list
102284309|NCT05007223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102284310|NCT05007223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102284311|NCT05007223|Antimalarials|antimalarials|mesh-ancestor
102284312|NCT05007223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102284313|NCT05007223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102284314|NCT05000281|Ibuprofen|ibuprofen|mesh-list
101993019|NCT03089216|Calcium Carbonate|calcium carbonate|mesh-list
102284315|NCT05000281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102284316|NCT05000281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102284317|NCT05000281|Analgesics|analgesics|mesh-ancestor
102284318|NCT05000281|Sensory System Agents|sensory system agents|mesh-ancestor
102284319|NCT05000281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102284320|NCT05000281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284321|NCT05000281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102284322|NCT05000281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102284323|NCT05000281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102284324|NCT05000281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102284325|NCT05000281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284326|NCT03081949|Selenium|selenium|mesh-list
102284327|NCT03081949|Selenious Acid|selenious acid|mesh-list
102284328|NCT03081949|Sodium Selenite|sodium selenite|mesh-list
102284329|NCT03081949|Antioxidants|antioxidants|mesh-ancestor
102284330|NCT03081949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284331|NCT03081949|Protective Agents|protective agents|mesh-ancestor
102284332|NCT03081949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284333|NCT03081949|Trace Elements|trace elements|mesh-ancestor
102284334|NCT03081949|Micronutrients|micronutrients|mesh-ancestor
102284335|NCT05347173|Dexmedetomidine|dexmedetomidine|mesh-list
102284336|NCT05347173|Nalbuphine|nalbuphine|mesh-list
102284337|NCT05347173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102284338|NCT05347173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102284339|NCT05347173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284340|NCT05347173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102284341|NCT05347173|Analgesics|analgesics|mesh-ancestor
102284342|NCT05347173|Sensory System Agents|sensory system agents|mesh-ancestor
102284343|NCT05347173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102284344|NCT05347173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102284345|NCT05347173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102284346|NCT05347173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102284347|NCT05347173|Adrenergic Agents|adrenergic agents|mesh-ancestor
102284348|NCT05347173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102284349|NCT05347173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284350|NCT05347173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102284351|NCT05347173|Narcotics|narcotics|mesh-ancestor
102284352|NCT05006287|Warfarin|warfarin|mesh-list
102284353|NCT05006287|Rivaroxaban|rivaroxaban|mesh-list
102284354|NCT05006287|Dabigatran|dabigatran|mesh-list
102284355|NCT05006287|Apixaban|apixaban|mesh-list
102284356|NCT05006287|Anticoagulants|anticoagulants|mesh-list
102284357|NCT05006287|Edoxaban|edoxaban|mesh-list
102284358|NCT05006287|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102284359|NCT05006287|Antithrombins|antithrombins|mesh-ancestor
102284360|NCT05006287|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102284361|NCT05006287|Protease Inhibitors|protease inhibitors|mesh-ancestor
102284362|NCT05006287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102284363|NCT05006287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284364|NCT05013151|Castor Oil|castor oil|mesh-list
102284365|NCT05013151|Cathartics|cathartics|mesh-ancestor
102284366|NCT05013151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102284367|NCT05006209|Calcium|calcium|mesh-list
102284368|NCT05006209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102284369|NCT05006209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284370|NCT05335629|Dapagliflozin|dapagliflozin|mesh-list
102284371|NCT05335629|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102284372|NCT05335629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284374|NCT05335629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284375|NCT03076099|Dexmedetomidine|dexmedetomidine|mesh-list
102284376|NCT03076099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102284377|NCT03076099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102284378|NCT03076099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284379|NCT03076099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102284380|NCT03076099|Analgesics|analgesics|mesh-ancestor
102284381|NCT03076099|Sensory System Agents|sensory system agents|mesh-ancestor
102284382|NCT03076099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102284383|NCT03076099|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102284384|NCT03076099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102284385|NCT03076099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102284386|NCT03076099|Adrenergic Agents|adrenergic agents|mesh-ancestor
102284387|NCT03076099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102284388|NCT03076099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284389|NCT05554965|Propofol|propofol|mesh-list
102284390|NCT05554965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101384529|NCT00086541|Interferons|interferons|mesh-list
102284391|NCT05554965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102284392|NCT05554965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284393|NCT05554965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102284394|NCT05554965|Anesthetics, General|anesthetics, general|mesh-ancestor
102284395|NCT05554965|Anesthetics|anesthetics|mesh-ancestor
102284396|NCT05554419|Cytarabine|cytarabine|mesh-list
102284397|NCT05554419|Azacitidine|azacitidine|mesh-list
102284398|NCT05554419|Daunorubicin|daunorubicin|mesh-list
102284399|NCT05554419|Venetoclax|venetoclax|mesh-list
102284400|NCT05554419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102284401|NCT05554419|Antimetabolites|antimetabolites|mesh-ancestor
102284402|NCT05554419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284403|NCT05554419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102284404|NCT05554419|Antiviral Agents|antiviral agents|mesh-ancestor
102284405|NCT05554419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102284406|NCT05554419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102284407|NCT05554419|Immunologic Factors|immunologic factors|mesh-ancestor
102284408|NCT05554419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284409|NCT05554419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102284410|NCT05554419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102284411|NCT05554419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102284412|NCT05554419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102284413|NCT05331573|Apomorphine|apomorphine|mesh-list
102284414|NCT05331573|Emetics|emetics|mesh-ancestor
102284415|NCT05331573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284416|NCT05331573|Autonomic Agents|autonomic agents|mesh-ancestor
102284417|NCT05331573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102284418|NCT05331573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102284419|NCT05331573|Dopamine Agonists|dopamine agonists|mesh-ancestor
102284420|NCT05331573|Dopamine Agents|dopamine agents|mesh-ancestor
102284421|NCT05331573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102284422|NCT05331573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284423|NCT05260359|Ethanol|ethanol|mesh-list
102284424|NCT05260359|Sunscreening Agents|sunscreening agents|mesh-list
102284425|NCT05260359|Petrolatum|petrolatum|mesh-list
102284426|NCT05260359|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102284427|NCT05260359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102284428|NCT05260359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102284429|NCT05260359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284430|NCT05260359|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102284431|NCT05260359|Protective Agents|protective agents|mesh-ancestor
102284432|NCT05260359|Dermatologic Agents|dermatologic agents|mesh-ancestor
102284433|NCT05260359|Emollients|emollients|mesh-ancestor
102284434|NCT05329155|Heparin|heparin|mesh-list
102284435|NCT05329155|Calcium heparin|calcium heparin|mesh-list
102284436|NCT05329155|Anticoagulants|anticoagulants|mesh-ancestor
102284437|NCT05329155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102284438|NCT05329155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102284439|NCT05329155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284440|NCT05294835|Ketamine|ketamine|mesh-list
102284441|NCT05294835|Analgesics|analgesics|mesh-ancestor
102284442|NCT05294835|Sensory System Agents|sensory system agents|mesh-ancestor
102284443|NCT05294835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102284444|NCT05294835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284445|NCT05294835|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102284446|NCT05294835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102284447|NCT05294835|Anesthetics, General|anesthetics, general|mesh-ancestor
102284449|NCT05294835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102284450|NCT05294835|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102284451|NCT05294835|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102284452|NCT05294835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102284453|NCT05294835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284454|NCT02522325|Cocaine|cocaine|mesh-list
102284455|NCT02522325|Phendimetrazine|phendimetrazine|mesh-list
102284456|NCT02522325|Anesthetics, Local|anesthetics, local|mesh-ancestor
102284457|NCT02522325|Anesthetics|anesthetics|mesh-ancestor
102284458|NCT02522325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102284459|NCT02522325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284460|NCT02522325|Sensory System Agents|sensory system agents|mesh-ancestor
102284461|NCT02522325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102284462|NCT02522325|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102284463|NCT02522325|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102284464|NCT02522325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102284465|NCT02522325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101993175|NCT04370847|Narcotics|narcotics|mesh-ancestor
102284466|NCT02522325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284467|NCT02522325|Dopamine Agents|dopamine agents|mesh-ancestor
102284468|NCT02522325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102284469|NCT02522325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102284470|NCT05326347|Brexpiprazole|brexpiprazole|mesh-list
102284471|NCT05326347|Serotonin Agents|serotonin agents|mesh-ancestor
102284472|NCT05326347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102284473|NCT05326347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284474|NCT05326347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284475|NCT05326347|Dopamine Agonists|dopamine agonists|mesh-ancestor
102284476|NCT05326347|Dopamine Agents|dopamine agents|mesh-ancestor
102284477|NCT01659021|Ofatumumab|ofatumumab|mesh-list
102284478|NCT01659021|Idelalisib|idelalisib|mesh-list
102284479|NCT01659021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102284480|NCT01659021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102284481|NCT01659021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284482|NCT05012137|Ropivacaine|ropivacaine|mesh-list
102284483|NCT05012137|Anesthetics, Local|anesthetics, local|mesh-ancestor
102284484|NCT05012137|Anesthetics|anesthetics|mesh-ancestor
102284485|NCT05012137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102284486|NCT05012137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284487|NCT05012137|Sensory System Agents|sensory system agents|mesh-ancestor
102284488|NCT05012137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102284489|NCT05325645|Brexpiprazole|brexpiprazole|mesh-list
102284490|NCT05325645|Serotonin Agents|serotonin agents|mesh-ancestor
102284491|NCT05325645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102284492|NCT05325645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284493|NCT05325645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284494|NCT05325645|Dopamine Agonists|dopamine agonists|mesh-ancestor
102284495|NCT05325645|Dopamine Agents|dopamine agents|mesh-ancestor
102284496|NCT04925167|Heparin|heparin|mesh-list
102284497|NCT04925167|Calcium heparin|calcium heparin|mesh-list
102284498|NCT04925167|Argatroban|argatroban|mesh-list
102284499|NCT04925167|Anticoagulants|anticoagulants|mesh-ancestor
102284500|NCT04925167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102284501|NCT04925167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102284502|NCT04925167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284503|NCT04925167|Antithrombins|antithrombins|mesh-ancestor
102284504|NCT04925167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102284505|NCT04925167|Protease Inhibitors|protease inhibitors|mesh-ancestor
102284506|NCT04925167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102284507|NCT04925167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102284508|NCT05011669|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102284509|NCT05011669|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102284510|NCT05011669|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102284511|NCT05011669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102284512|NCT05011669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284513|NCT05011669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102284514|NCT05011669|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102284515|NCT05011669|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102284516|NCT05011669|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102284517|NCT05011669|Adrenergic Agents|adrenergic agents|mesh-ancestor
102284518|NCT05011669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102284519|NCT05011669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284520|NCT05011669|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102284521|NCT05011669|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102284522|NCT05011669|Serotonin Agents|serotonin agents|mesh-ancestor
102284523|NCT05011669|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102284524|NCT05011669|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102284525|NCT05011669|Dopamine Agents|dopamine agents|mesh-ancestor
102284527|NCT02524665|Salicylates|salicylates|mesh-list
102284528|NCT02524665|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102284529|NCT02524665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102284530|NCT02524665|Antifungal Agents|antifungal agents|mesh-ancestor
102284531|NCT02524665|Keratolytic Agents|keratolytic agents|mesh-ancestor
102284532|NCT02524665|Dermatologic Agents|dermatologic agents|mesh-ancestor
102284533|NCT02524665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102284534|NCT02524665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102284535|NCT02524665|Analgesics|analgesics|mesh-ancestor
102284536|NCT02524665|Sensory System Agents|sensory system agents|mesh-ancestor
102284537|NCT02524665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102284538|NCT02524665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284539|NCT02524665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102284540|NCT02524665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102284542|NCT02524665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102284543|NCT02524665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284544|NCT04998253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102284545|NCT04998253|Propofol|propofol|mesh-list
102284546|NCT04998253|Sevoflurane|sevoflurane|mesh-list
102284547|NCT04998253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102284548|NCT04998253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102284549|NCT04998253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284550|NCT04998253|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102284551|NCT04998253|Anesthetics, General|anesthetics, general|mesh-ancestor
102284552|NCT04998253|Anesthetics|anesthetics|mesh-ancestor
102284553|NCT04998253|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102284554|NCT04998253|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102284555|NCT02638129|Naltrexone|naltrexone|mesh-list
102284556|NCT02638129|Bupropion|bupropion|mesh-list
102284557|NCT02638129|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102284558|NCT02638129|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102284559|NCT02638129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284560|NCT02638129|Sensory System Agents|sensory system agents|mesh-ancestor
102284561|NCT02638129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102284562|NCT02638129|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102284563|NCT02638129|Antidepressive Agents|antidepressive agents|mesh-ancestor
102284564|NCT02638129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102284565|NCT02638129|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102284566|NCT02638129|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102284567|NCT02638129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102284568|NCT02638129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284569|NCT02638129|Dopamine Agents|dopamine agents|mesh-ancestor
102284570|NCT02638129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102284571|NCT02638129|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102284572|NCT02638129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102284573|NCT02638129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102284574|NCT02524275|Docetaxel|docetaxel|mesh-list
102284575|NCT02524275|Capecitabine|capecitabine|mesh-list
102284576|NCT02524275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102284577|NCT02524275|Tubulin Modulators|tubulin modulators|mesh-ancestor
102284578|NCT02524275|Antimitotic Agents|antimitotic agents|mesh-ancestor
102284579|NCT02524275|Mitosis Modulators|mitosis modulators|mesh-ancestor
102284580|NCT02524275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284581|NCT02524275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102284582|NCT02524275|Antimetabolites|antimetabolites|mesh-ancestor
102284583|NCT03079687|Olaparib|olaparib|mesh-list
102284584|NCT03079687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102284585|NCT03079687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102284586|NCT03079687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284587|NCT03079687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102284588|NCT04997707|Propofol|propofol|mesh-list
102284589|NCT04997707|Sevoflurane|sevoflurane|mesh-list
102284590|NCT04997707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102284591|NCT04997707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102284592|NCT04997707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284593|NCT04997707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102284594|NCT04997707|Anesthetics, General|anesthetics, general|mesh-ancestor
102284595|NCT04997707|Anesthetics|anesthetics|mesh-ancestor
102284596|NCT04997707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102284597|NCT04997707|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102284598|NCT05010499|Bupivacaine|bupivacaine|mesh-list
102284599|NCT05010499|Levobupivacaine|levobupivacaine|mesh-list
102284600|NCT05010499|Anesthetics, Local|anesthetics, local|mesh-ancestor
102284601|NCT05010499|Anesthetics|anesthetics|mesh-ancestor
102284602|NCT05010499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102284603|NCT05010499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284604|NCT05010499|Sensory System Agents|sensory system agents|mesh-ancestor
102284605|NCT05010499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102284606|NCT03075241|Zolpidem|zolpidem|mesh-list
102284607|NCT03075241|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102284608|NCT03075241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102284609|NCT03075241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102284610|NCT03075241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284611|NCT03075241|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102284612|NCT03075241|GABA Agonists|gaba agonists|mesh-ancestor
102284613|NCT03075241|GABA Agents|gaba agents|mesh-ancestor
102284614|NCT03075241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102284615|NCT03075241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284616|NCT04994119|Warfarin|warfarin|mesh-list
102284617|NCT04994119|Zamicastat|zamicastat|mesh-list
102284618|NCT04994119|Anticoagulants|anticoagulants|mesh-ancestor
102284619|NCT04994119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102284620|NCT04994119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284621|NCT01658943|Fluorouracil|fluorouracil|mesh-list
102284622|NCT01658943|Oxaliplatin|oxaliplatin|mesh-list
102284623|NCT01658943|Antimetabolites|antimetabolites|mesh-ancestor
102284624|NCT01658943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284625|NCT01658943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102284626|NCT01658943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102284627|NCT01658943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102284628|NCT01658943|Immunologic Factors|immunologic factors|mesh-ancestor
102284629|NCT01658943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284630|NCT02600819|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102284631|NCT02600819|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102284632|NCT02600819|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102284633|NCT02600819|Antiviral Agents|antiviral agents|mesh-ancestor
102284634|NCT02600819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102284635|NCT04433533|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102284636|NCT04433533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102284637|NCT04433533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102284638|NCT04433533|Antimetabolites|antimetabolites|mesh-ancestor
102284639|NCT04433533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284640|NCT04433533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102284641|NCT04433533|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102284642|NCT04433533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102284643|NCT04996459|Tislelizumab|tislelizumab|mesh-list
102284644|NCT04996459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102284645|NCT04996459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102284646|NCT03074773|Dexamethasone|dexamethasone|mesh-list
102284647|NCT03074773|Bupivacaine|bupivacaine|mesh-list
102284648|NCT03074773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102284649|NCT03074773|Antiemetics|antiemetics|mesh-ancestor
102284650|NCT03074773|Autonomic Agents|autonomic agents|mesh-ancestor
102284651|NCT03074773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102284652|NCT03074773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284653|NCT03074773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102284654|NCT03074773|Glucocorticoids|glucocorticoids|mesh-ancestor
102284655|NCT03074773|Hormones|hormones|mesh-ancestor
102284656|NCT03074773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102284657|NCT03074773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102284658|NCT03074773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102284659|NCT03074773|Anesthetics, Local|anesthetics, local|mesh-ancestor
102284660|NCT03074773|Anesthetics|anesthetics|mesh-ancestor
102284661|NCT03074773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102284662|NCT03074773|Sensory System Agents|sensory system agents|mesh-ancestor
102284663|NCT03077581|Anesthetics|anesthetics|mesh-list
102284664|NCT03077581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102284665|NCT03077581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284666|NCT03077503|Fentanyl|fentanyl|mesh-list
102284668|NCT03077503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102284669|NCT03077503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102284670|NCT03077503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284671|NCT03077503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102284672|NCT03077503|Analgesics|analgesics|mesh-ancestor
102284673|NCT03077503|Sensory System Agents|sensory system agents|mesh-ancestor
102284674|NCT03077503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102284675|NCT03077503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102284676|NCT03077503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102284677|NCT03077503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102284678|NCT03077503|Adrenergic Agents|adrenergic agents|mesh-ancestor
102284679|NCT03077503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102284680|NCT03077503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284681|NCT03077503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102284682|NCT03077503|Narcotics|narcotics|mesh-ancestor
102284683|NCT03077503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102284684|NCT03077503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102284685|NCT03077503|Anesthetics, General|anesthetics, general|mesh-ancestor
102284686|NCT03077503|Anesthetics|anesthetics|mesh-ancestor
102284687|NCT05518695|Antibodies, Blocking|antibodies, blocking|mesh-list
101993391|NCT05181124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102284688|NCT05518695|Immunologic Factors|immunologic factors|mesh-ancestor
102284689|NCT05518695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284690|NCT04136067|Insulin Glargine|insulin glargine|mesh-list
102284691|NCT04136067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102284692|NCT04136067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284694|NCT03073057|Formoterol Fumarate|formoterol fumarate|mesh-list
102284695|NCT03073057|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
102284696|NCT03073057|Charcoal|charcoal|mesh-list
102284697|NCT03073057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102284698|NCT03073057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102284699|NCT03073057|Autonomic Agents|autonomic agents|mesh-ancestor
102284700|NCT03073057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102284701|NCT03073057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284702|NCT03073057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102284703|NCT03073057|Respiratory System Agents|respiratory system agents|mesh-ancestor
102284704|NCT03073057|Glucocorticoids|glucocorticoids|mesh-ancestor
102284705|NCT03073057|Hormones|hormones|mesh-ancestor
102284706|NCT03073057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102284707|NCT03073057|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102284708|NCT03073057|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102284709|NCT03073057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102284710|NCT03073057|Adrenergic Agents|adrenergic agents|mesh-ancestor
102284711|NCT03073057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102284712|NCT03073057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284713|NCT03073057|Antidotes|antidotes|mesh-ancestor
102284714|NCT03073057|Protective Agents|protective agents|mesh-ancestor
102284715|NCT03073369|Ergocalciferols|ergocalciferols|mesh-list
102284716|NCT03073369|Vitamin D|vitamin d|mesh-list
102284717|NCT03073369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102284718|NCT03073369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284719|NCT03073369|Vitamins|vitamins|mesh-ancestor
102284720|NCT03073369|Micronutrients|micronutrients|mesh-ancestor
102284721|NCT03073369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102284722|NCT04433611|Lidocaine|lidocaine|mesh-list
102284723|NCT04433611|Anesthetics, Local|anesthetics, local|mesh-ancestor
102284724|NCT04433611|Anesthetics|anesthetics|mesh-ancestor
102284725|NCT04433611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102284726|NCT04433611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284727|NCT04433611|Sensory System Agents|sensory system agents|mesh-ancestor
102284728|NCT04433611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102284729|NCT04433611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102284730|NCT04433611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102284731|NCT04433611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101305209|NCT02018094|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102284732|NCT04433611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102284733|NCT04433611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284734|NCT04992481|Fluorides|fluorides|mesh-list
102284735|NCT04992481|Fluorides, Topical|fluorides, topical|mesh-list
102284736|NCT04992481|Cariostatic Agents|cariostatic agents|mesh-ancestor
102284737|NCT04992481|Protective Agents|protective agents|mesh-ancestor
102284738|NCT04992481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284739|NCT02597933|Nintedanib|nintedanib|mesh-list
102284740|NCT02597933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102284765|NCT03072589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284767|NCT04994743|Cortisone|cortisone|mesh-list
102284768|NCT04994743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102284769|NCT04994353|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102284770|NCT04807829|Nabilone|nabilone|mesh-list
102284771|NCT04807829|Antiemetics|antiemetics|mesh-ancestor
102284772|NCT04807829|Autonomic Agents|autonomic agents|mesh-ancestor
102284773|NCT04807829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102284774|NCT04807829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284775|NCT04807829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102284776|NCT04807829|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102284777|NCT04807829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102284778|NCT04807829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102284779|NCT04807829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102284804|NCT03072511|Nicotine|nicotine|mesh-list
102284805|NCT03072511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102284806|NCT03072511|Autonomic Agents|autonomic agents|mesh-ancestor
102284807|NCT03072511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102284808|NCT03072511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284809|NCT03072511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102284810|NCT03072511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102284811|NCT03072511|Cholinergic Agents|cholinergic agents|mesh-ancestor
102284812|NCT03072511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102284813|NCT03072511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284814|NCT03072121|Aspirin|aspirin|mesh-list
102284815|NCT03072121|Metoprolol|metoprolol|mesh-list
102284816|NCT03072121|Isosorbide|isosorbide|mesh-list
102284817|NCT03072121|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
102284818|NCT03072121|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
102284820|NCT03072121|Clopidogrel|clopidogrel|mesh-list
102284821|NCT03072121|Atorvastatin|atorvastatin|mesh-list
102284822|NCT03072121|Calcium|calcium|mesh-list
102284823|NCT03072121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102284824|NCT03072121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284825|NCT03072121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102284826|NCT03072121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102284827|NCT03072121|Analgesics|analgesics|mesh-ancestor
102284828|NCT03072121|Sensory System Agents|sensory system agents|mesh-ancestor
102284829|NCT03072121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102284830|NCT03072121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102284831|NCT03072121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102284832|NCT03072121|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102284833|NCT03072121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102284834|NCT03072121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284835|NCT03072121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102284836|NCT03072121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102284837|NCT03072121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102284838|NCT03072121|Antipyretics|antipyretics|mesh-ancestor
102284839|NCT03072121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102284840|NCT03072121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102284841|NCT03072121|Antimetabolites|antimetabolites|mesh-ancestor
102284842|NCT03072121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102284843|NCT03072121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102284844|NCT03072121|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102284845|NCT03072121|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102284846|NCT03072121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102284847|NCT03072121|Purinergic Agents|purinergic agents|mesh-ancestor
102284848|NCT03072121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102284849|NCT03072121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102284850|NCT03072121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102284851|NCT03072121|Sympatholytics|sympatholytics|mesh-ancestor
102284852|NCT03072121|Autonomic Agents|autonomic agents|mesh-ancestor
102284853|NCT03072121|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102284854|NCT03072121|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102284855|NCT03072121|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102284856|NCT03072121|Adrenergic Agents|adrenergic agents|mesh-ancestor
102284857|NCT03072121|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102284858|NCT03072121|Diuretics|diuretics|mesh-ancestor
102284859|NCT03072121|Natriuretic Agents|natriuretic agents|mesh-ancestor
102284860|NCT03072121|Vasodilator Agents|vasodilator agents|mesh-ancestor
102284861|NCT03072121|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102284862|NCT02597855|Aflibercept|aflibercept|mesh-list
102284863|NCT02597855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102284864|NCT02597855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102284865|NCT02597855|Growth Substances|growth substances|mesh-ancestor
102284866|NCT02597855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284867|NCT02597855|Growth Inhibitors|growth inhibitors|mesh-ancestor
102284868|NCT02597855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102284869|NCT04987567|Antioxidants|antioxidants|mesh-list
102284870|NCT04987567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284871|NCT04987567|Protective Agents|protective agents|mesh-ancestor
102284872|NCT04987567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284873|NCT03072199|Rituximab|rituximab|mesh-list
102284874|NCT03072199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102284875|NCT03072199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102284876|NCT03072199|Immunologic Factors|immunologic factors|mesh-ancestor
102284877|NCT03072199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284878|NCT03072199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102284879|NCT04806737|Teriflunomide|teriflunomide|mesh-list
102284880|NCT04806737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102284881|NCT04806737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102284882|NCT04806737|Analgesics|analgesics|mesh-ancestor
102284883|NCT04806737|Sensory System Agents|sensory system agents|mesh-ancestor
102284884|NCT04806737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102284885|NCT04806737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284886|NCT04806737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102284887|NCT04806737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102284888|NCT04806737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102284889|NCT04806737|Immunologic Factors|immunologic factors|mesh-ancestor
102284890|NCT04991155|Zamicastat|zamicastat|mesh-list
102284891|NCT04991155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101626600|NCT00811252|Dopamine Agents|dopamine agents|mesh-ancestor
102284892|NCT04991155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284893|NCT04462315|Cobalt|cobalt|mesh-list
102284894|NCT04462315|Chromium|chromium|mesh-list
102284895|NCT04462315|Everolimus|everolimus|mesh-list
102284896|NCT04462315|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102284897|NCT04462315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102284898|NCT04462315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102284899|NCT04462315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284900|NCT04462315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102284901|NCT04462315|Immunologic Factors|immunologic factors|mesh-ancestor
102284902|NCT04462315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284903|NCT04462315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102284904|NCT04462315|Trace Elements|trace elements|mesh-ancestor
102284905|NCT04462315|Micronutrients|micronutrients|mesh-ancestor
102284906|NCT04806425|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102284907|NCT04806425|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102284908|NCT04806425|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102284909|NCT04806425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102284910|NCT03071731|Bromides|bromides|mesh-list
102284911|NCT03071731|Ipratropium|ipratropium|mesh-list
102284912|NCT03071731|Bronchodilator Agents|bronchodilator agents|mesh-list
102284913|NCT03071731|Anticonvulsants|anticonvulsants|mesh-ancestor
102284914|NCT03071731|Autonomic Agents|autonomic agents|mesh-ancestor
102284915|NCT03071731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102284916|NCT03071731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284917|NCT03071731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102284918|NCT03071731|Respiratory System Agents|respiratory system agents|mesh-ancestor
102284919|NCT03071731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102284920|NCT03071731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284921|NCT03071731|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102284922|NCT03071731|Cholinergic Agents|cholinergic agents|mesh-ancestor
102284923|NCT04809935|Ethanol|ethanol|mesh-list
102284924|NCT04809935|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102284925|NCT04809935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102284926|NCT04809935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102284927|NCT04809935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284928|NCT04255927|Triclosan|triclosan|mesh-list
102284929|NCT04255927|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102284930|NCT04255927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102284931|NCT04255927|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102284932|NCT04255927|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102284933|NCT04255927|Antimetabolites|antimetabolites|mesh-ancestor
102284934|NCT04255927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284935|NCT04255927|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102284936|NCT03069781|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102284937|NCT03069781|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102284938|NCT03069781|Estradiol|estradiol|mesh-list
102284939|NCT03069781|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102284940|NCT03069781|Estrogens|estrogens|mesh-ancestor
102284941|NCT03069781|Hormones|hormones|mesh-ancestor
102284942|NCT03069781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102284943|NCT03069781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284944|NCT03069781|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102284945|NCT03069781|Contraceptive Agents|contraceptive agents|mesh-ancestor
102284946|NCT03069781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102284947|NCT03069781|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102284948|NCT03071575|Vaccines|vaccines|mesh-list
102284949|NCT03071575|Immunologic Factors|immunologic factors|mesh-ancestor
102284950|NCT03071575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284951|NCT04798391|Dexamethasone|dexamethasone|mesh-list
102284952|NCT04798391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102284953|NCT04798391|Antiemetics|antiemetics|mesh-ancestor
102284954|NCT04798391|Autonomic Agents|autonomic agents|mesh-ancestor
102284955|NCT04798391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102284956|NCT04798391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284957|NCT04798391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102284958|NCT04798391|Glucocorticoids|glucocorticoids|mesh-ancestor
102284959|NCT04798391|Hormones|hormones|mesh-ancestor
102284960|NCT04798391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102284961|NCT04798391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102284962|NCT04798391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102284963|NCT03071497|Protoporphyrin IX|protoporphyrin ix|mesh-list
102284964|NCT03071497|Zinc protoporphyrin|zinc protoporphyrin|mesh-list
101626681|NCT02717871|Mydriatics|mydriatics|mesh-list
102284965|NCT03071497|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102284966|NCT03071497|Dermatologic Agents|dermatologic agents|mesh-ancestor
102284967|NCT03071497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102284968|NCT03071497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284969|NCT05616455|Nitroglycerin|nitroglycerin|mesh-list
102284970|NCT05616455|Vasodilator Agents|vasodilator agents|mesh-ancestor
102284971|NCT04986319|Vitamin D|vitamin d|mesh-list
102284972|NCT04986319|Vitamins|vitamins|mesh-ancestor
102284973|NCT04986319|Micronutrients|micronutrients|mesh-ancestor
102284974|NCT04986319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284975|NCT04986319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102284976|NCT02593097|Metformin|metformin|mesh-list
102284977|NCT02593097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102284978|NCT02593097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284979|NCT04805801|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102284980|NCT04805801|Immunologic Factors|immunologic factors|mesh-ancestor
102284981|NCT04805801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284982|NCT01657461|Plasminogen|plasminogen|mesh-list
102284983|NCT01657461|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102284984|NCT01657461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102284985|NCT01657461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102284986|NCT01657461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284987|NCT05001919|Mitogens|mitogens|mesh-list
101385118|NCT00302341|Pafuramidine|pafuramidine|mesh-list
102284988|NCT05001919|Mitosis Modulators|mitosis modulators|mesh-ancestor
102284989|NCT05001919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993694|NCT04252287|Canagliflozin|canagliflozin|mesh-list
102284990|NCT05001763|Prucalopride|prucalopride|mesh-list
102284991|NCT05001763|Laxatives|laxatives|mesh-ancestor
102284992|NCT05001763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102284993|NCT05001763|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
102284994|NCT05001763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102284995|NCT05001763|Serotonin Agents|serotonin agents|mesh-ancestor
102284996|NCT05001763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102284997|NCT05001763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102284998|NCT05001763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102284999|NCT04989985|Oxaliplatin|oxaliplatin|mesh-list
102285000|NCT04989985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102285001|NCT02592551|Durvalumab|durvalumab|mesh-list
102285002|NCT02592551|Tremelimumab|tremelimumab|mesh-list
102285003|NCT02592551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102285004|NCT02592551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102285005|NCT04989127|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102285006|NCT04989127|Penicillins|penicillins|mesh-list
102285007|NCT04989127|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102285008|NCT04989127|Analgesics|analgesics|mesh-list
102285009|NCT04989127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102285010|NCT04989127|Antitubercular Agents|antitubercular agents|mesh-ancestor
102285011|NCT04989127|Sensory System Agents|sensory system agents|mesh-ancestor
102285012|NCT04989127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102285013|NCT04989127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285014|NCT04982809|Dexamethasone|dexamethasone|mesh-list
102285015|NCT04982809|Prednisolone|prednisolone|mesh-list
102285016|NCT04982809|Betamethasone|betamethasone|mesh-list
102285017|NCT04982809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102285018|NCT04982809|Antiemetics|antiemetics|mesh-ancestor
102285019|NCT04982809|Autonomic Agents|autonomic agents|mesh-ancestor
102285020|NCT04982809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102285021|NCT04982809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285022|NCT04982809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102285023|NCT04982809|Glucocorticoids|glucocorticoids|mesh-ancestor
102285024|NCT04982809|Hormones|hormones|mesh-ancestor
102285025|NCT04982809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102285026|NCT04982809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102285027|NCT04982809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102285028|NCT04982809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102285029|NCT04982809|Respiratory System Agents|respiratory system agents|mesh-ancestor
102285030|NCT03068533|Calcium Carbonate|calcium carbonate|mesh-list
102285031|NCT03068533|Calcium|calcium|mesh-list
102285032|NCT03068533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102285033|NCT03068533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285034|NCT03068533|Antacids|antacids|mesh-ancestor
102285035|NCT03068533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285036|NCT03068533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102285037|NCT05281341|Hormones|hormones|mesh-list
102285038|NCT05281341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102285039|NCT05281341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285040|NCT04808687|Paclitaxel|paclitaxel|mesh-list
102285041|NCT04808687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102285042|NCT04808687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102285043|NCT04808687|Tubulin Modulators|tubulin modulators|mesh-ancestor
102285044|NCT04808687|Antimitotic Agents|antimitotic agents|mesh-ancestor
102285045|NCT04808687|Mitosis Modulators|mitosis modulators|mesh-ancestor
102285046|NCT04808687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285047|NCT05279703|Epinephrine|epinephrine|mesh-list
102285048|NCT05279703|Racepinephrine|racepinephrine|mesh-list
102285049|NCT05279703|Epinephryl borate|epinephryl borate|mesh-list
102285050|NCT05279703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102285051|NCT05279703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102285052|NCT05279703|Adrenergic Agents|adrenergic agents|mesh-ancestor
102285053|NCT05279703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102285054|NCT05279703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285055|NCT05279703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285056|NCT05279703|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102285057|NCT05279703|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102285058|NCT05279703|Autonomic Agents|autonomic agents|mesh-ancestor
102285059|NCT05279703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102285060|NCT05279703|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102285061|NCT05279703|Respiratory System Agents|respiratory system agents|mesh-ancestor
102285062|NCT05279703|Mydriatics|mydriatics|mesh-ancestor
102285063|NCT05279703|Sympathomimetics|sympathomimetics|mesh-ancestor
102285064|NCT05279703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101993776|NCT01312350|Docetaxel|docetaxel|mesh-list
102285066|NCT05392933|Anesthetics, Local|anesthetics, local|mesh-ancestor
102285067|NCT05392933|Anesthetics|anesthetics|mesh-ancestor
102285068|NCT05392933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102285069|NCT05392933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285070|NCT05392933|Sensory System Agents|sensory system agents|mesh-ancestor
102285071|NCT05392933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102285072|NCT05392933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102285073|NCT05392933|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102285074|NCT05392933|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102285075|NCT05392933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102285076|NCT05392933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285077|NCT04796675|Cyclophosphamide|cyclophosphamide|mesh-list
102285078|NCT04796675|Fludarabine|fludarabine|mesh-list
102285079|NCT04796675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102285080|NCT04796675|Immunologic Factors|immunologic factors|mesh-ancestor
102285081|NCT04796675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285082|NCT04796675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102285083|NCT04796675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102285084|NCT04796675|Alkylating Agents|alkylating agents|mesh-ancestor
102285085|NCT04796675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285086|NCT04796675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102285087|NCT04796675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102285088|NCT05275725|Sildenafil Citrate|sildenafil citrate|mesh-list
102285089|NCT05275725|Vasodilator Agents|vasodilator agents|mesh-ancestor
102285090|NCT05275725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102285091|NCT05275725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102285092|NCT05275725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102285093|NCT05275725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285094|NCT05275725|Urological Agents|urological agents|mesh-ancestor
102285095|NCT05315817|Dialysis Solutions|dialysis solutions|mesh-list
102285096|NCT05315817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102285097|NCT04785755|Etilefrine|etilefrine|mesh-list
102285098|NCT04785755|Furosemide|furosemide|mesh-list
102285099|NCT04785755|Spironolactone|spironolactone|mesh-list
102285100|NCT04785755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102285101|NCT04785755|Diuretics|diuretics|mesh-list
102285102|NCT04785755|Natriuretic Agents|natriuretic agents|mesh-ancestor
102285103|NCT04785755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285104|NCT04785755|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102285105|NCT04785755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102285106|NCT04785755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285107|NCT04785755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102285108|NCT04785755|Hormone Antagonists|hormone antagonists|mesh-ancestor
102285109|NCT04785755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102285110|NCT04785755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102285111|NCT04785755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102285112|NCT04785755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102285113|NCT04785755|Adrenergic Agents|adrenergic agents|mesh-ancestor
102285114|NCT04785755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102285115|NCT04785755|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102285116|NCT04785755|Sympathomimetics|sympathomimetics|mesh-ancestor
102285117|NCT04785755|Autonomic Agents|autonomic agents|mesh-ancestor
102285118|NCT04785755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102285119|NCT04785755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102285120|NCT04785755|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102285121|NCT04785755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102285122|NCT04785755|Protective Agents|protective agents|mesh-ancestor
102285124|NCT04785911|Histamine|histamine|mesh-list
102285125|NCT04785911|Histamine Agonists|histamine agonists|mesh-ancestor
102285126|NCT04785911|Histamine Agents|histamine agents|mesh-ancestor
102285127|NCT04785911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102285128|NCT04785911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385297|NCT00081575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102285129|NCT04785911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285130|NCT04785911|Autonomic Agents|autonomic agents|mesh-ancestor
102285131|NCT04785911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102285132|NCT04785911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102285133|NCT04243941|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102285134|NCT04243941|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102285135|NCT04243941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285136|NCT05314101|Bevacizumab|bevacizumab|mesh-list
102285137|NCT05314101|Tislelizumab|tislelizumab|mesh-list
102285138|NCT05314101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102285139|NCT05314101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102285140|NCT05314101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102285141|NCT05314101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102285142|NCT05314101|Growth Substances|growth substances|mesh-ancestor
102285143|NCT05314101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285144|NCT05314101|Growth Inhibitors|growth inhibitors|mesh-ancestor
102285146|NCT02595749|Oxytocics|oxytocics|mesh-ancestor
102285147|NCT02595749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102285148|NCT02595749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285149|NCT04426721|Hyaluronic Acid|hyaluronic acid|mesh-list
102285150|NCT04426721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102285151|NCT04426721|Immunologic Factors|immunologic factors|mesh-ancestor
102285152|NCT04426721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285153|NCT04426721|Viscosupplements|viscosupplements|mesh-ancestor
102285154|NCT04426721|Protective Agents|protective agents|mesh-ancestor
102285155|NCT05221359|Insulin Aspart|insulin aspart|mesh-list
102285156|NCT05221359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102285157|NCT05221359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285158|NCT04794413|Pimavanserin|pimavanserin|mesh-list
102285159|NCT04794413|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102285160|NCT04794413|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102285161|NCT04794413|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102285162|NCT04794413|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102285163|NCT04794413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102285164|NCT04794413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285165|NCT04794413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102285166|NCT04794413|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102285167|NCT04794413|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102285168|NCT04794413|Serotonin Agents|serotonin agents|mesh-ancestor
102285169|NCT04794413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102285170|NCT04794413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285171|NCT05214573|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
102285172|NCT05214573|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102285173|NCT05214573|Glucagon|glucagon|mesh-list
102285174|NCT05214573|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102285175|NCT05214573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102285176|NCT05214573|Hormones|hormones|mesh-ancestor
102285177|NCT05214573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102285178|NCT05214573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285179|NCT05214573|Incretins|incretins|mesh-ancestor
102285180|NCT05214573|Protease Inhibitors|protease inhibitors|mesh-ancestor
102285181|NCT05214573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102285182|NCT05214573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285183|NCT05214573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102285184|NCT04988191|Bevacizumab|bevacizumab|mesh-list
102285185|NCT04988191|Irinotecan|irinotecan|mesh-list
102285186|NCT04988191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102285187|NCT04988191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102285188|NCT04988191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102285189|NCT04988191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102285190|NCT04988191|Growth Substances|growth substances|mesh-ancestor
102285191|NCT04988191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285192|NCT04988191|Growth Inhibitors|growth inhibitors|mesh-ancestor
102285193|NCT04988191|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102285194|NCT04988191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102285195|NCT04988191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102285196|NCT04988191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285197|NCT03069001|Ribavirin|ribavirin|mesh-list
102285198|NCT03069001|Sofosbuvir|sofosbuvir|mesh-list
102285199|NCT03069001|Simeprevir|simeprevir|mesh-list
102285200|NCT03069001|Antimetabolites|antimetabolites|mesh-ancestor
102285201|NCT03069001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285202|NCT03069001|Antiviral Agents|antiviral agents|mesh-ancestor
102285203|NCT03069001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102285204|NCT03069001|Protease Inhibitors|protease inhibitors|mesh-ancestor
102285205|NCT03069001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102285206|NCT03070405|Tenofovir|tenofovir|mesh-list
102285207|NCT03070405|Aminosalicylic Acid|aminosalicylic acid|mesh-list
102285208|NCT03070405|Antiviral Agents|antiviral agents|mesh-ancestor
102285209|NCT03070405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102285210|NCT03070405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102285211|NCT03070405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102285212|NCT03070405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102285213|NCT03070405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285214|NCT03070405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102285215|NCT03070405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102285216|NCT03070405|Antitubercular Agents|antitubercular agents|mesh-ancestor
102285217|NCT03070405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102285218|NCT03068065|Metformin|metformin|mesh-list
102285219|NCT03068065|Liraglutide|liraglutide|mesh-list
102285220|NCT03068065|Gliclazide|gliclazide|mesh-list
102285221|NCT03068065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102285222|NCT03068065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285223|NCT03068065|Incretins|incretins|mesh-ancestor
102285224|NCT03068065|Hormones|hormones|mesh-ancestor
102285225|NCT03068065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102285226|NCT05161611|Zinc Sulfate|zinc sulfate|mesh-list
102285227|NCT05161611|Astringents|astringents|mesh-ancestor
102285228|NCT05161611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285229|NCT05161611|Dermatologic Agents|dermatologic agents|mesh-ancestor
102285230|NCT03660475|Naltrexone|naltrexone|mesh-list
102285231|NCT03660475|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102285232|NCT03660475|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102285233|NCT03660475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285234|NCT03660475|Sensory System Agents|sensory system agents|mesh-ancestor
102285235|NCT03660475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102285236|NCT05211609|Methyldopa|methyldopa|mesh-list
102285237|NCT05211609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102285238|NCT05211609|Sympatholytics|sympatholytics|mesh-ancestor
102285239|NCT05211609|Autonomic Agents|autonomic agents|mesh-ancestor
102285240|NCT05211609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102285241|NCT05211609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285242|NCT05211609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102285243|NCT05211609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102285244|NCT05211609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102285245|NCT05211609|Adrenergic Agents|adrenergic agents|mesh-ancestor
102285246|NCT05211609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102285247|NCT05211609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285248|NCT05615987|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102285249|NCT05615987|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102285250|NCT05615987|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102285251|NCT05615987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102285252|NCT05615987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285253|NCT05615987|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102285254|NCT05615987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102285255|NCT05615987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285256|NCT05615987|Cholinergic Agents|cholinergic agents|mesh-ancestor
102285257|NCT05615987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102285258|NCT02594735|Abatacept|abatacept|mesh-list
102285259|NCT02594735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101941515|NCT01585623|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102285260|NCT02594735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285261|NCT02594735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102285262|NCT02594735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102285263|NCT02594735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102285264|NCT02594735|Immunologic Factors|immunologic factors|mesh-ancestor
102285265|NCT02594735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285266|NCT02594735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102285268|NCT05209425|Cholecalciferol|cholecalciferol|mesh-list
102285269|NCT05209425|Vitamins|vitamins|mesh-ancestor
102285270|NCT05209425|Micronutrients|micronutrients|mesh-ancestor
102285271|NCT05209425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285272|NCT05209425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102285273|NCT05209425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102285274|NCT04793243|Vitamin D|vitamin d|mesh-list
102285275|NCT04793243|Cholecalciferol|cholecalciferol|mesh-list
102285276|NCT04793243|Vitamins|vitamins|mesh-ancestor
102285277|NCT04793243|Micronutrients|micronutrients|mesh-ancestor
102285278|NCT04793243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285279|NCT04793243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102285280|NCT04793243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102285281|NCT04793399|Atezolizumab|atezolizumab|mesh-list
102285282|NCT04793399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102285283|NCT04793399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285284|NCT04793399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102285285|NCT04793399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102285286|NCT05157711|Bismuth subgallate|bismuth subgallate|mesh-list
102285287|NCT05157711|Phenylephrine|phenylephrine|mesh-list
102285288|NCT05157711|Oxymetazoline|oxymetazoline|mesh-list
102285289|NCT05157711|Zinc Oxide|zinc oxide|mesh-list
102285290|NCT05157711|Bismuth|bismuth|mesh-list
102285291|NCT05157711|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102285292|NCT05157711|Mydriatics|mydriatics|mesh-ancestor
102285293|NCT05157711|Autonomic Agents|autonomic agents|mesh-ancestor
102285294|NCT05157711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102285295|NCT05157711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285296|NCT05157711|Sympathomimetics|sympathomimetics|mesh-ancestor
102285297|NCT05157711|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102285298|NCT05157711|Nasal Decongestants|nasal decongestants|mesh-ancestor
102285299|NCT05157711|Respiratory System Agents|respiratory system agents|mesh-ancestor
102285300|NCT05157711|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102285301|NCT05157711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102285302|NCT05157711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102285303|NCT05157711|Adrenergic Agents|adrenergic agents|mesh-ancestor
102285304|NCT05157711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102285305|NCT05157711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285306|NCT05157711|Protective Agents|protective agents|mesh-ancestor
102285307|NCT05157711|Antacids|antacids|mesh-ancestor
102285308|NCT05157711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102285309|NCT05157711|Dermatologic Agents|dermatologic agents|mesh-ancestor
102285310|NCT05157711|Sunscreening Agents|sunscreening agents|mesh-ancestor
102285311|NCT05157711|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102285312|NCT05157711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102285313|NCT05157711|Hemostatics|hemostatics|mesh-ancestor
102285314|NCT05157711|Coagulants|coagulants|mesh-ancestor
102285315|NCT05105997|Dexamethasone|dexamethasone|mesh-list
102285316|NCT05105997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102285317|NCT05105997|Antiemetics|antiemetics|mesh-ancestor
102285318|NCT05105997|Autonomic Agents|autonomic agents|mesh-ancestor
102285319|NCT05105997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102285320|NCT05105997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285321|NCT05105997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102285322|NCT05105997|Glucocorticoids|glucocorticoids|mesh-ancestor
102285323|NCT05105997|Hormones|hormones|mesh-ancestor
102285324|NCT05105997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102285325|NCT05105997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102285326|NCT05105997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102285327|NCT03424525|Trimethoprim|trimethoprim|mesh-list
102285328|NCT03424525|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102285329|NCT03424525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102285330|NCT03424525|Antimalarials|antimalarials|mesh-ancestor
102285331|NCT03424525|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102285332|NCT03424525|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102285333|NCT03424525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102285334|NCT03424525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102285335|NCT03424525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285336|NCT03424525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102285337|NCT03424525|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102285338|NCT03424525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102285339|NCT04801511|Ascorbic Acid|ascorbic acid|mesh-list
102285340|NCT04801511|Vitamins|vitamins|mesh-ancestor
102285341|NCT04801511|Micronutrients|micronutrients|mesh-ancestor
102285342|NCT04801511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285343|NCT04801511|Antioxidants|antioxidants|mesh-ancestor
102285344|NCT04801511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285345|NCT04801511|Protective Agents|protective agents|mesh-ancestor
102285346|NCT04230759|Fluorouracil|fluorouracil|mesh-list
102285347|NCT04230759|Durvalumab|durvalumab|mesh-list
102285348|NCT04230759|Mitomycins|mitomycins|mesh-list
102285349|NCT04230759|Mitomycin|mitomycin|mesh-list
102285350|NCT04230759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102285351|NCT04230759|Antimetabolites|antimetabolites|mesh-ancestor
102285352|NCT04230759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285353|NCT04230759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102285354|NCT04230759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102285355|NCT04230759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102285356|NCT04230759|Immunologic Factors|immunologic factors|mesh-ancestor
102285357|NCT04230759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285358|NCT04230759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102285359|NCT04230759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102285360|NCT04230759|Alkylating Agents|alkylating agents|mesh-ancestor
102285361|NCT04230759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102285362|NCT04230759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102285363|NCT05471687|Adenosine|adenosine|mesh-list
102285364|NCT05471687|Analgesics|analgesics|mesh-ancestor
102285365|NCT05471687|Sensory System Agents|sensory system agents|mesh-ancestor
102285366|NCT05471687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102285367|NCT05471687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285368|NCT05471687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102285369|NCT05471687|Vasodilator Agents|vasodilator agents|mesh-ancestor
102285370|NCT05471687|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102285371|NCT05471687|Purinergic Agonists|purinergic agonists|mesh-ancestor
102285372|NCT05471687|Purinergic Agents|purinergic agents|mesh-ancestor
102285373|NCT05471687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102285374|NCT05471687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285375|NCT05370729|Acetylcysteine|acetylcysteine|mesh-list
102285376|NCT05370729|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102285377|NCT05370729|Antiviral Agents|antiviral agents|mesh-ancestor
102285378|NCT05370729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102285379|NCT05370729|Expectorants|expectorants|mesh-ancestor
102285380|NCT05370729|Respiratory System Agents|respiratory system agents|mesh-ancestor
102285381|NCT05370729|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102285382|NCT05370729|Antioxidants|antioxidants|mesh-ancestor
102285383|NCT05370729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285384|NCT05370729|Protective Agents|protective agents|mesh-ancestor
102285385|NCT05370729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285386|NCT05370729|Antidotes|antidotes|mesh-ancestor
102285387|NCT05471531|Vaccines|vaccines|mesh-list
102285388|NCT05471531|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102285389|NCT05471531|Immunologic Factors|immunologic factors|mesh-ancestor
102285390|NCT05471531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285391|NCT05204667|Acetaminophen|acetaminophen|mesh-list
102285392|NCT05204667|Aspirin|aspirin|mesh-list
102285393|NCT05204667|Methocarbamol|methocarbamol|mesh-list
102285394|NCT05204667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102285395|NCT05204667|Analgesics|analgesics|mesh-ancestor
102285396|NCT05204667|Sensory System Agents|sensory system agents|mesh-ancestor
102285397|NCT05204667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102285398|NCT05204667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285399|NCT05204667|Antipyretics|antipyretics|mesh-ancestor
102285400|NCT05204667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102285401|NCT05204667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102285402|NCT05204667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102285403|NCT05204667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102285404|NCT05204667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102285405|NCT05204667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285406|NCT05204667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102285407|NCT05204667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102285408|NCT05204667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102285409|NCT05204667|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102285410|NCT05204667|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102285411|NCT04801199|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102285452|NCT04799873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285454|NCT05201313|Mepivacaine|mepivacaine|mesh-list
102285455|NCT05201313|Anesthetics, Local|anesthetics, local|mesh-ancestor
102285456|NCT05201313|Anesthetics|anesthetics|mesh-ancestor
102285457|NCT05201313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102285458|NCT05201313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285459|NCT05201313|Sensory System Agents|sensory system agents|mesh-ancestor
102285460|NCT05201313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102285461|NCT05201313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102285462|NCT05201313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102285463|NCT05201313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102285464|NCT05201313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102285465|NCT05201313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285466|NCT05201001|Carboplatin|carboplatin|mesh-list
102285467|NCT05201001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102285468|NCT04799639|Paclitaxel|paclitaxel|mesh-list
102285469|NCT04799639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102285470|NCT04799639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102285471|NCT04799639|Tubulin Modulators|tubulin modulators|mesh-ancestor
102285472|NCT04799639|Antimitotic Agents|antimitotic agents|mesh-ancestor
102285473|NCT04799639|Mitosis Modulators|mitosis modulators|mesh-ancestor
102285474|NCT04799639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285475|NCT04798703|Paclitaxel|paclitaxel|mesh-list
102285476|NCT04798703|Hyaluronic Acid|hyaluronic acid|mesh-list
102285477|NCT04798703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102285478|NCT04798703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102285479|NCT04798703|Tubulin Modulators|tubulin modulators|mesh-ancestor
102285480|NCT04798703|Antimitotic Agents|antimitotic agents|mesh-ancestor
102285481|NCT04798703|Mitosis Modulators|mitosis modulators|mesh-ancestor
102285482|NCT04798703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285483|NCT04798703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102285484|NCT04798703|Immunologic Factors|immunologic factors|mesh-ancestor
102285485|NCT04798703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285486|NCT04798703|Viscosupplements|viscosupplements|mesh-ancestor
102285487|NCT04798703|Protective Agents|protective agents|mesh-ancestor
102285489|NCT04798313|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102285490|NCT04798313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285491|NCT01655823|Tetrodotoxin|tetrodotoxin|mesh-list
102285492|NCT01655823|Anesthetics, Local|anesthetics, local|mesh-ancestor
102285493|NCT01655823|Anesthetics|anesthetics|mesh-ancestor
102285494|NCT01655823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102285495|NCT01655823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285496|NCT01655823|Sensory System Agents|sensory system agents|mesh-ancestor
102285497|NCT01655823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102285498|NCT01655823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102285499|NCT01655823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102285500|NCT01655823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285501|NCT05197257|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102285502|NCT05197257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102285503|NCT05197257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285504|NCT05092581|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
102285505|NCT05092581|Antiviral Agents|antiviral agents|mesh-ancestor
102285506|NCT05092581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102285507|NCT04848857|Colchicine|colchicine|mesh-list
102285508|NCT04848857|Gout Suppressants|gout suppressants|mesh-ancestor
102285509|NCT04848857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102285510|NCT04848857|Tubulin Modulators|tubulin modulators|mesh-ancestor
102285511|NCT04848857|Antimitotic Agents|antimitotic agents|mesh-ancestor
102285512|NCT04848857|Mitosis Modulators|mitosis modulators|mesh-ancestor
102285513|NCT04848857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285514|NCT04848857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102285515|NCT04338659|Antibodies|antibodies|mesh-list
102285516|NCT04338659|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102285517|NCT04338659|Immunologic Factors|immunologic factors|mesh-ancestor
102285518|NCT04338659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285519|NCT05189535|Paclitaxel|paclitaxel|mesh-list
102285520|NCT05189535|Pentoxifylline|pentoxifylline|mesh-list
102285521|NCT05189535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102285522|NCT05189535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102285523|NCT05189535|Tubulin Modulators|tubulin modulators|mesh-ancestor
102285524|NCT05189535|Antimitotic Agents|antimitotic agents|mesh-ancestor
102285525|NCT05189535|Mitosis Modulators|mitosis modulators|mesh-ancestor
102285526|NCT05189535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285527|NCT05189535|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102285528|NCT05189535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102285529|NCT05189535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102285530|NCT05189535|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102285531|NCT05189535|Protective Agents|protective agents|mesh-ancestor
102285532|NCT05189535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285533|NCT05189535|Vasodilator Agents|vasodilator agents|mesh-ancestor
102285534|NCT05189535|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102285535|NCT05189535|Antioxidants|antioxidants|mesh-ancestor
102285536|NCT05089461|Mitoxantrone|mitoxantrone|mesh-list
102285537|NCT05089461|Analgesics|analgesics|mesh-ancestor
102285538|NCT05089461|Sensory System Agents|sensory system agents|mesh-ancestor
102285539|NCT05089461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102285540|NCT05089461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285541|NCT05089461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102285542|NCT05089461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102285543|NCT05089461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102285544|NCT05089461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102285545|NCT05089461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285546|NCT05730439|Lobeline|lobeline|mesh-list
102285547|NCT05730439|Nicotine|nicotine|mesh-list
102285548|NCT05730439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102285549|NCT05730439|Autonomic Agents|autonomic agents|mesh-ancestor
102285550|NCT05730439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102285551|NCT05730439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285552|NCT05730439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102285553|NCT05730439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102285554|NCT05730439|Cholinergic Agents|cholinergic agents|mesh-ancestor
102285555|NCT05730439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102285556|NCT05730439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285557|NCT05730439|Respiratory System Agents|respiratory system agents|mesh-ancestor
102285558|NCT04224987|Azithromycin|azithromycin|mesh-list
102285559|NCT04224987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102285560|NCT04224987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102285561|NCT04805515|Nicotine|nicotine|mesh-list
102285563|NCT04805515|Autonomic Agents|autonomic agents|mesh-ancestor
102285564|NCT04805515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102285565|NCT04805515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285566|NCT04805515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102285567|NCT04805515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102285568|NCT04805515|Cholinergic Agents|cholinergic agents|mesh-ancestor
102285569|NCT04805515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102285570|NCT04805515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285571|NCT05170919|Olanzapine|olanzapine|mesh-list
102285572|NCT05170919|Mirtazapine|mirtazapine|mesh-list
102285573|NCT05170919|Antiemetics|antiemetics|mesh-ancestor
102285574|NCT05170919|Autonomic Agents|autonomic agents|mesh-ancestor
102285575|NCT05170919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102285576|NCT05170919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285577|NCT05170919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102285578|NCT05170919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102285579|NCT05170919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102285580|NCT05170919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102285581|NCT05170919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102285582|NCT05170919|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102285583|NCT05170919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102285584|NCT05170919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102285585|NCT05170919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285586|NCT05170919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102285587|NCT05170919|Serotonin Agents|serotonin agents|mesh-ancestor
102285588|NCT05170919|Antidepressive Agents|antidepressive agents|mesh-ancestor
102285589|NCT05170919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102285590|NCT05170919|Histamine Antagonists|histamine antagonists|mesh-ancestor
102285591|NCT05170919|Histamine Agents|histamine agents|mesh-ancestor
102285592|NCT05170919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102285593|NCT05170919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102285594|NCT05170919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102285595|NCT05170919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102285596|NCT05170919|Adrenergic Agents|adrenergic agents|mesh-ancestor
102285597|NCT05170919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102285598|NCT05170919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102285599|NCT05170919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102285600|NCT05613491|Insulin|insulin|mesh-list
102285601|NCT05613491|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102285602|NCT05613491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102285603|NCT05613491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285604|NCT05151263|Salicylates|salicylates|mesh-list
102285605|NCT05151263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102285606|NCT05151263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102285607|NCT05151263|Analgesics|analgesics|mesh-ancestor
102285608|NCT05151263|Sensory System Agents|sensory system agents|mesh-ancestor
102285609|NCT05151263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102285610|NCT05151263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285611|NCT05151263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102285612|NCT05151263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102285613|NCT05151263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285614|NCT05151263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102285615|NCT05151263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102285616|NCT04788407|Nitazoxanide|nitazoxanide|mesh-list
102285617|NCT04788407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102285618|NCT04788407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102285619|NCT03066427|Sunitinib|sunitinib|mesh-list
102285620|NCT03066427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102285621|NCT03066427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102285622|NCT03066427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102285623|NCT03066427|Growth Substances|growth substances|mesh-ancestor
102285624|NCT03066427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285625|NCT03066427|Growth Inhibitors|growth inhibitors|mesh-ancestor
102285626|NCT03066427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102285627|NCT03066427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102285628|NCT03066427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285629|NCT05177133|Capecitabine|capecitabine|mesh-list
102285630|NCT05177133|Oxaliplatin|oxaliplatin|mesh-list
102285631|NCT05177133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102285632|NCT05177133|Antimetabolites|antimetabolites|mesh-ancestor
102285633|NCT05177133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285634|NCT05177133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102285636|NCT02866643|Etonogestrel|etonogestrel|mesh-list
102285637|NCT02866643|Desogestrel|desogestrel|mesh-list
102285638|NCT02866643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102285639|NCT02866643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285640|NCT02866643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102285641|NCT02866643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102285642|NCT02866643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102285643|NCT02866643|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102285644|NCT02866643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102285645|NCT02866643|Progestins|progestins|mesh-ancestor
102285646|NCT02866643|Hormones|hormones|mesh-ancestor
102285647|NCT02866643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102285648|NCT05176821|Amoxicillin|amoxicillin|mesh-list
102285649|NCT05176821|Furazolidone|furazolidone|mesh-list
102285650|NCT05176821|Potassium Citrate|potassium citrate|mesh-list
102285651|NCT05176821|Esomeprazole|esomeprazole|mesh-list
102285652|NCT05176821|Bismuth|bismuth|mesh-list
102285653|NCT05176821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285654|NCT05176821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102285655|NCT05176821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102285656|NCT05176821|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102285657|NCT05176821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102285658|NCT05176821|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102285659|NCT05176821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102285660|NCT05176821|Antacids|antacids|mesh-ancestor
102285661|NCT05176821|Diuretics|diuretics|mesh-ancestor
102285662|NCT05176821|Natriuretic Agents|natriuretic agents|mesh-ancestor
102285663|NCT05176821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285664|NCT05176821|Expectorants|expectorants|mesh-ancestor
102285665|NCT05176821|Respiratory System Agents|respiratory system agents|mesh-ancestor
102285666|NCT05176821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102285667|NCT05176821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102285669|NCT05176821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102285670|NCT05176821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102285671|NCT05176821|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102285672|NCT05555641|Nafamostat|nafamostat|mesh-list
102285673|NCT05555641|Heparin|heparin|mesh-list
102285674|NCT05555641|Calcium heparin|calcium heparin|mesh-list
102285675|NCT05555641|Anticoagulants|anticoagulants|mesh-ancestor
102285676|NCT05555641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102285677|NCT05555641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102285678|NCT05555641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285679|NCT05555641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102285680|NCT05555641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102285681|NCT05555641|Analgesics|analgesics|mesh-ancestor
102285682|NCT05555641|Sensory System Agents|sensory system agents|mesh-ancestor
102285683|NCT05555641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102285684|NCT05555641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285685|NCT05555641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102285686|NCT05555641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102285687|NCT05555641|Protease Inhibitors|protease inhibitors|mesh-ancestor
102285688|NCT05555641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102285689|NCT05555641|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102285690|NCT05555641|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102285691|NCT05555641|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102285692|NCT05555641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102285693|NCT05555641|Immunologic Factors|immunologic factors|mesh-ancestor
102285708|NCT01672801|Nimodipine|nimodipine|mesh-list
102285709|NCT01672801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102285710|NCT01672801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102285711|NCT01672801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102285712|NCT01672801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285713|NCT01672801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102285714|NCT01672801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285715|NCT01672801|Vasodilator Agents|vasodilator agents|mesh-ancestor
102285716|NCT05613335|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102285718|NCT05613335|Coagulants|coagulants|mesh-ancestor
102285719|NCT05078463|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
102285720|NCT05078463|Terephthalic acid|terephthalic acid|mesh-list
102285721|NCT05078463|Anesthetics, Local|anesthetics, local|mesh-ancestor
102285722|NCT05078463|Anesthetics|anesthetics|mesh-ancestor
102285723|NCT05078463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102285724|NCT05078463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285725|NCT05078463|Sensory System Agents|sensory system agents|mesh-ancestor
102285726|NCT05078463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102285727|NCT05078463|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
102285728|NCT05078463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102285729|NCT05078463|Antioxidants|antioxidants|mesh-ancestor
102285730|NCT05078463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285731|NCT05078463|Protective Agents|protective agents|mesh-ancestor
102285732|NCT05170113|Caffeine|caffeine|mesh-list
102285733|NCT05170113|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102285734|NCT05170113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285735|NCT05170113|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102285736|NCT05170113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102285737|NCT05170113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994446|NCT03433378|Dermatologic Agents|dermatologic agents|mesh-ancestor
102285738|NCT05170113|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102285740|NCT05170113|Purinergic Agents|purinergic agents|mesh-ancestor
102285741|NCT05170113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102285742|NCT05169957|Nivolumab|nivolumab|mesh-list
102285743|NCT05169957|Ipilimumab|ipilimumab|mesh-list
102285744|NCT05169957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102285745|NCT05169957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102285746|NCT05169957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102285747|NCT05169957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285748|NCT05611463|Docetaxel|docetaxel|mesh-list
102285749|NCT05611463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102285750|NCT05611463|Tubulin Modulators|tubulin modulators|mesh-ancestor
102285751|NCT05611463|Antimitotic Agents|antimitotic agents|mesh-ancestor
102285752|NCT05611463|Mitosis Modulators|mitosis modulators|mesh-ancestor
102285753|NCT05611463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285754|NCT05611385|Amphetamine|amphetamine|mesh-list
102285755|NCT05611385|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102285756|NCT05611385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285757|NCT05611385|Sympathomimetics|sympathomimetics|mesh-ancestor
102285758|NCT05611385|Autonomic Agents|autonomic agents|mesh-ancestor
102285759|NCT05611385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102285760|NCT05611385|Dopamine Agents|dopamine agents|mesh-ancestor
102285761|NCT05611385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102285762|NCT05611385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285763|NCT05611385|Adrenergic Agents|adrenergic agents|mesh-ancestor
102285764|NCT05611385|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102285765|NCT05611385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102285766|NCT05611385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102285767|NCT05611385|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102285768|NCT05475041|Liver Extracts|liver extracts|mesh-list
102285769|NCT05475041|Hematinics|hematinics|mesh-ancestor
102285770|NCT05611307|Hormones|hormones|mesh-list
102285771|NCT05611307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102285772|NCT05611307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285773|NCT02631577|Lenalidomide|lenalidomide|mesh-list
102285774|NCT02631577|Atezolizumab|atezolizumab|mesh-list
102285775|NCT02631577|Obinutuzumab|obinutuzumab|mesh-list
102285776|NCT02631577|Immunologic Factors|immunologic factors|mesh-ancestor
102285777|NCT02631577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285778|NCT02631577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102285779|NCT02631577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102285780|NCT02631577|Growth Substances|growth substances|mesh-ancestor
102285781|NCT02631577|Growth Inhibitors|growth inhibitors|mesh-ancestor
102285782|NCT02631577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102285783|NCT02631577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102285784|NCT02631577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285785|NCT02631577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102285786|NCT01667081|Grazoprevir|grazoprevir|mesh-list
102285787|NCT01667081|Antiviral Agents|antiviral agents|mesh-ancestor
102285788|NCT01667081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102285789|NCT03067753|Methylprednisolone|methylprednisolone|mesh-list
102285790|NCT03067753|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102285791|NCT03067753|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102285792|NCT03067753|Prednisolone|prednisolone|mesh-list
102285793|NCT03067753|Prednisolone acetate|prednisolone acetate|mesh-list
102285794|NCT03067753|Hormones|hormones|mesh-list
102285795|NCT03067753|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102285796|NCT03067753|Prednisolone phosphate|prednisolone phosphate|mesh-list
102285797|NCT03067753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102285798|NCT03067753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285799|NCT03067753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102285800|NCT03067753|Antiemetics|antiemetics|mesh-ancestor
102285801|NCT03067753|Autonomic Agents|autonomic agents|mesh-ancestor
102285802|NCT03067753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102285803|NCT03067753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102285804|NCT03067753|Glucocorticoids|glucocorticoids|mesh-ancestor
102285805|NCT03067753|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102285806|NCT03067753|Protective Agents|protective agents|mesh-ancestor
102285807|NCT03067753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102285808|NCT03067753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102285809|NCT04331639|Vitamin D|vitamin d|mesh-list
102285810|NCT04331639|Cholecalciferol|cholecalciferol|mesh-list
102285811|NCT04331639|Vitamins|vitamins|mesh-ancestor
102285812|NCT04331639|Micronutrients|micronutrients|mesh-ancestor
102285814|NCT04331639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102285815|NCT04331639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102285816|NCT03067597|Dinoprostone|dinoprostone|mesh-list
102285817|NCT03067597|Oxytocics|oxytocics|mesh-ancestor
102285818|NCT03067597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102285819|NCT03067597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285820|NCT02518971|Tamsulosin|tamsulosin|mesh-list
102285821|NCT02518971|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102285822|NCT02518971|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102285823|NCT02518971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102285824|NCT02518971|Adrenergic Agents|adrenergic agents|mesh-ancestor
102285825|NCT02518971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102285826|NCT02518971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285827|NCT02518971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285828|NCT02518971|Urological Agents|urological agents|mesh-ancestor
102285829|NCT04733963|Bevacizumab|bevacizumab|mesh-list
102285830|NCT04733963|Capecitabine|capecitabine|mesh-list
102285831|NCT04733963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102285832|NCT04733963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102285833|NCT04733963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102285834|NCT04733963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102285835|NCT04733963|Growth Substances|growth substances|mesh-ancestor
102285836|NCT04733963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285837|NCT04733963|Growth Inhibitors|growth inhibitors|mesh-ancestor
102285838|NCT04733963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102285839|NCT04733963|Antimetabolites|antimetabolites|mesh-ancestor
102285840|NCT04733963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285841|NCT03066115|Ascorbic Acid|ascorbic acid|mesh-list
102285842|NCT03066115|Ketorolac|ketorolac|mesh-list
102285843|NCT03066115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102285844|NCT03066115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102285845|NCT03066115|Analgesics|analgesics|mesh-ancestor
102285846|NCT03066115|Sensory System Agents|sensory system agents|mesh-ancestor
102285847|NCT03066115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102285848|NCT03066115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285849|NCT03066115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102285850|NCT03066115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102285851|NCT03066115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102285852|NCT03066115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102285853|NCT03066115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285854|NCT03066115|Antioxidants|antioxidants|mesh-ancestor
102285855|NCT03066115|Protective Agents|protective agents|mesh-ancestor
102285856|NCT03066115|Vitamins|vitamins|mesh-ancestor
102285857|NCT03066115|Micronutrients|micronutrients|mesh-ancestor
102285858|NCT04212039|Bupivacaine|bupivacaine|mesh-list
102285859|NCT04212039|Anesthetics, Local|anesthetics, local|mesh-ancestor
102285860|NCT04212039|Anesthetics|anesthetics|mesh-ancestor
102285861|NCT04212039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102285862|NCT04212039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285863|NCT04212039|Sensory System Agents|sensory system agents|mesh-ancestor
102285864|NCT04212039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102285866|NCT05048589|Immunologic Factors|immunologic factors|mesh-ancestor
102285867|NCT05048589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285868|NCT05728333|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102285869|NCT05728333|Tirofiban|tirofiban|mesh-list
102285870|NCT05728333|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102285871|NCT05728333|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102285872|NCT05728333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285873|NCT05728333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102285874|NCT04447651|Immunomodulating Agents|immunomodulating agents|mesh-list
102285875|NCT04447651|Immunologic Factors|immunologic factors|mesh-ancestor
102285876|NCT04447651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285877|NCT01364727|Amrubicin|amrubicin|mesh-list
102285878|NCT01364727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102285879|NCT04990869|Niacinamide|niacinamide|mesh-list
102285880|NCT04990869|Niacin|niacin|mesh-list
102285881|NCT04990869|Nicotinic Acids|nicotinic acids|mesh-list
102285882|NCT04990869|Vitamin B Complex|vitamin b complex|mesh-ancestor
102285883|NCT04990869|Vitamins|vitamins|mesh-ancestor
102285884|NCT04990869|Micronutrients|micronutrients|mesh-ancestor
102285885|NCT04990869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285886|NCT04990869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102285887|NCT04990869|Antimetabolites|antimetabolites|mesh-ancestor
101386004|NCT00418678|Nabilone|nabilone|mesh-list
102285888|NCT04990869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285889|NCT04990869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102285890|NCT04990869|Vasodilator Agents|vasodilator agents|mesh-ancestor
102285891|NCT04401553|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102285892|NCT04401553|Vancomycin|vancomycin|mesh-list
102285893|NCT04401553|Cephalosporins|cephalosporins|mesh-list
102285894|NCT04401553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102285895|NCT01364649|Vortioxetine|vortioxetine|mesh-list
102285896|NCT01364649|Escitalopram|escitalopram|mesh-list
102285897|NCT01364649|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102285898|NCT01364649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102285899|NCT01364649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102285900|NCT01364649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285901|NCT01364649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102285902|NCT01364649|Serotonin Agents|serotonin agents|mesh-ancestor
102285903|NCT01364649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285904|NCT01364649|Antidepressive Agents|antidepressive agents|mesh-ancestor
102285905|NCT01364649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102285906|NCT01364649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102285907|NCT01364649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102285908|NCT01364649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102285909|NCT01364649|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102285910|NCT01364649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102285911|NCT01364649|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102285912|NCT01364649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102285913|NCT03065569|Bupivacaine|bupivacaine|mesh-list
102285914|NCT03065569|Anesthetics, Local|anesthetics, local|mesh-ancestor
102285915|NCT03065569|Anesthetics|anesthetics|mesh-ancestor
102285916|NCT03065569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102285917|NCT03065569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285918|NCT03065569|Sensory System Agents|sensory system agents|mesh-ancestor
102285919|NCT03065569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102285920|NCT05723419|Anesthetics|anesthetics|mesh-list
102285921|NCT05723419|Anesthetics, Local|anesthetics, local|mesh-list
102285922|NCT05723419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102285923|NCT05723419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285924|NCT05723419|Sensory System Agents|sensory system agents|mesh-ancestor
102285925|NCT05723419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102285926|NCT02588261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102285927|NCT02588261|Gefitinib|gefitinib|mesh-list
102285928|NCT02588261|Naquotinib|naquotinib|mesh-list
102285929|NCT02588261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102285930|NCT02588261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102285931|NCT02588261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102285932|NCT02588261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285933|NCT04989699|Aflibercept|aflibercept|mesh-list
102285934|NCT04989699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101941518|NCT03926559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102285935|NCT04989699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102285936|NCT04989699|Growth Substances|growth substances|mesh-ancestor
102285937|NCT04989699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285938|NCT04989699|Growth Inhibitors|growth inhibitors|mesh-ancestor
102285939|NCT04989699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102285941|NCT05279131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102285942|NCT05279131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285943|NCT04426487|Progesterone|progesterone|mesh-list
102285944|NCT04426487|Progestins|progestins|mesh-ancestor
102285945|NCT04426487|Hormones|hormones|mesh-ancestor
102285946|NCT04426487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102285947|NCT04426487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285948|NCT04988217|Interferons|interferons|mesh-list
102285949|NCT04988217|Interferon-alpha|interferon-alpha|mesh-list
102285950|NCT04988217|Interferon alpha-2|interferon alpha-2|mesh-list
102285951|NCT04988217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102285952|NCT04988217|Antiviral Agents|antiviral agents|mesh-ancestor
102285953|NCT04988217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102285954|NCT04988217|Immunologic Factors|immunologic factors|mesh-ancestor
102285955|NCT04988217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285956|NCT05038839|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102285957|NCT05038839|Pamiparib|pamiparib|mesh-list
102285958|NCT05038839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102285959|NCT05038839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285960|NCT05038839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102285961|NCT01672723|Naltrexone|naltrexone|mesh-list
102285962|NCT01672723|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102285964|NCT01672723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285965|NCT01672723|Sensory System Agents|sensory system agents|mesh-ancestor
102285966|NCT01672723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102285967|NCT04443673|Glycine|glycine|mesh-list
102285968|NCT04443673|Glycine Agents|glycine agents|mesh-ancestor
102285969|NCT04443673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102285970|NCT04443673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285971|NCT04443673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285972|NCT05036577|Dexamethasone|dexamethasone|mesh-list
102285973|NCT05036577|Rituximab|rituximab|mesh-list
102285974|NCT05036577|Methotrexate|methotrexate|mesh-list
102285975|NCT05036577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102285976|NCT05036577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102285977|NCT05036577|Immunologic Factors|immunologic factors|mesh-ancestor
102285978|NCT05036577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102285979|NCT05036577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102285980|NCT05036577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102285981|NCT05036577|Antiemetics|antiemetics|mesh-ancestor
102285982|NCT05036577|Autonomic Agents|autonomic agents|mesh-ancestor
102285983|NCT05036577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102285984|NCT05036577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102285985|NCT05036577|Glucocorticoids|glucocorticoids|mesh-ancestor
102285986|NCT05036577|Hormones|hormones|mesh-ancestor
102285987|NCT05036577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102285988|NCT05036577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102285989|NCT05036577|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102285990|NCT05036577|Abortifacient Agents|abortifacient agents|mesh-ancestor
102285991|NCT05036577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102285992|NCT05036577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102285993|NCT05036577|Antimetabolites|antimetabolites|mesh-ancestor
102285994|NCT05036577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102285995|NCT05036577|Dermatologic Agents|dermatologic agents|mesh-ancestor
102285996|NCT05036577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102285997|NCT05036577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102285998|NCT05036577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102285999|NCT05036577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102286000|NCT04982367|Sirolimus|sirolimus|mesh-list
102286001|NCT04982367|Paclitaxel|paclitaxel|mesh-list
102286002|NCT04982367|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102286003|NCT04982367|Temsirolimus|temsirolimus|mesh-list
102286004|NCT04982367|MTOR Inhibitors|mtor inhibitors|mesh-list
102286005|NCT04982367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102286006|NCT04982367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102286007|NCT04982367|Tubulin Modulators|tubulin modulators|mesh-ancestor
102286008|NCT04982367|Antimitotic Agents|antimitotic agents|mesh-ancestor
102286009|NCT04982367|Mitosis Modulators|mitosis modulators|mesh-ancestor
102286010|NCT04982367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286011|NCT04982367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102286012|NCT04982367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102286013|NCT04982367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102286015|NCT04982367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102286016|NCT04982367|Immunologic Factors|immunologic factors|mesh-ancestor
102286017|NCT04982367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286018|NCT04982367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102286019|NCT04982367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102286020|NCT05034627|Asparaginase|asparaginase|mesh-list
102286021|NCT05034627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102286022|NCT05031975|Irinotecan|irinotecan|mesh-list
102286023|NCT05031975|Temozolomide|temozolomide|mesh-list
102286024|NCT05031975|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102286025|NCT05031975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102286026|NCT05031975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102286027|NCT05031975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286028|NCT05031975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102286029|NCT05031975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102286030|NCT05031975|Alkylating Agents|alkylating agents|mesh-ancestor
102286031|NCT02632747|Empagliflozin|empagliflozin|mesh-list
102286032|NCT02632747|Ramipril|ramipril|mesh-list
102286033|NCT02632747|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102286034|NCT02632747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286035|NCT02632747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102286036|NCT02632747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286037|NCT02632747|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102286038|NCT02632747|Protease Inhibitors|protease inhibitors|mesh-ancestor
102286039|NCT02632747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102286040|NCT02632747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102286041|NCT04218825|Mechlorethamine|mechlorethamine|mesh-list
102286042|NCT04218825|Alkylating Agents|alkylating agents|mesh-ancestor
102286043|NCT04218825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286044|NCT04218825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102286045|NCT04218825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102286046|NCT04216797|Diazepam|diazepam|mesh-list
102286047|NCT04216797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102286048|NCT04216797|Anticonvulsants|anticonvulsants|mesh-ancestor
102286049|NCT04216797|Antiemetics|antiemetics|mesh-ancestor
102286050|NCT04216797|Autonomic Agents|autonomic agents|mesh-ancestor
102286051|NCT04216797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102286052|NCT04216797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286053|NCT04216797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102286054|NCT04216797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102286055|NCT04216797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102286056|NCT04216797|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102286057|NCT04216797|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102286058|NCT04216797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102286059|NCT04216797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102286060|NCT04216797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102286061|NCT04216797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102286062|NCT04216797|Anesthetics, General|anesthetics, general|mesh-ancestor
102286063|NCT04216797|Anesthetics|anesthetics|mesh-ancestor
102286064|NCT04216797|GABA Modulators|gaba modulators|mesh-ancestor
102286065|NCT04216797|GABA Agents|gaba agents|mesh-ancestor
102286066|NCT04216797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102286067|NCT04216797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286068|NCT05029401|Ibogaine|ibogaine|mesh-list
102286069|NCT05029401|Hallucinogens|hallucinogens|mesh-ancestor
102286070|NCT05029401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286071|NCT05029401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102286072|NCT05029401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102286073|NCT05029401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102286074|NCT05029401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102286075|NCT05029401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286076|NCT05025813|Pembrolizumab|pembrolizumab|mesh-list
102286077|NCT05025813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102286078|NCT05025813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102286079|NCT05025813|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102286080|NCT05025813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286081|NCT04033237|Nicotine|nicotine|mesh-list
102286082|NCT04033237|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102286083|NCT04033237|Autonomic Agents|autonomic agents|mesh-ancestor
102286084|NCT04033237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102286085|NCT04033237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286086|NCT04033237|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102286087|NCT04033237|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102286088|NCT04033237|Cholinergic Agents|cholinergic agents|mesh-ancestor
102286089|NCT04033237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102286090|NCT04033237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286091|NCT04421547|Letrozole|letrozole|mesh-list
102286092|NCT04421547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102286093|NCT04421547|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102286094|NCT04421547|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102286095|NCT04421547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102286096|NCT04421547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286097|NCT04421547|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102286098|NCT04421547|Hormone Antagonists|hormone antagonists|mesh-ancestor
102286099|NCT04421547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102286100|NCT04421547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286101|NCT03066817|Ergocalciferols|ergocalciferols|mesh-list
102286102|NCT03066817|Vitamin D|vitamin d|mesh-list
102286103|NCT03066817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102286104|NCT03066817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286105|NCT03066817|Vitamins|vitamins|mesh-ancestor
102286106|NCT03066817|Micronutrients|micronutrients|mesh-ancestor
102286107|NCT03066817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102286108|NCT05060913|Lidocaine|lidocaine|mesh-list
102286109|NCT05060913|Prilocaine|prilocaine|mesh-list
102286110|NCT05060913|Benzocaine|benzocaine|mesh-list
101994826|NCT01321021|Antipruritics|antipruritics|mesh-ancestor
102286111|NCT05060913|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
102286112|NCT05060913|Anesthetics, Local|anesthetics, local|mesh-ancestor
102286113|NCT05060913|Anesthetics|anesthetics|mesh-ancestor
102286114|NCT05060913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102286115|NCT05060913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286116|NCT05060913|Sensory System Agents|sensory system agents|mesh-ancestor
102286117|NCT05060913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102286118|NCT05060913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102286119|NCT05060913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102286120|NCT05060913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102286121|NCT05060913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102286122|NCT05060913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286123|NCT05060913|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
102286124|NCT05165251|Amlodipine|amlodipine|mesh-list
102286125|NCT05165251|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
102286126|NCT05165251|Atorvastatin|atorvastatin|mesh-list
102286127|NCT05165251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102286128|NCT05165251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102286129|NCT05165251|Antimetabolites|antimetabolites|mesh-ancestor
102286130|NCT05165251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286131|NCT05165251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102286132|NCT05165251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102286133|NCT05165251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102286134|NCT05165251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102286135|NCT05165251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102286136|NCT05165251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102286137|NCT05165251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102286138|NCT05165251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286139|NCT05165251|Vasodilator Agents|vasodilator agents|mesh-ancestor
102286140|NCT04209075|Metformin|metformin|mesh-list
102286141|NCT04209075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102286142|NCT04209075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286143|NCT05023473|Morphine|morphine|mesh-list
102286144|NCT05023473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102286145|NCT05023473|Narcotics|narcotics|mesh-ancestor
102286146|NCT05023473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102286147|NCT05023473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286148|NCT05023473|Analgesics|analgesics|mesh-ancestor
102286149|NCT05023473|Sensory System Agents|sensory system agents|mesh-ancestor
102286150|NCT05023473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102286151|NCT03066661|Entrectinib|entrectinib|mesh-list
102286152|NCT03066661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102286153|NCT03066661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102286154|NCT03066661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286155|NCT03775629|Tramadol|tramadol|mesh-list
102286156|NCT03775629|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102286157|NCT03775629|Narcotics|narcotics|mesh-ancestor
102286158|NCT03775629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102286159|NCT03775629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286160|NCT03775629|Analgesics|analgesics|mesh-ancestor
102286161|NCT03775629|Sensory System Agents|sensory system agents|mesh-ancestor
102286162|NCT03775629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102286163|NCT01671319|Cyclophosphamide|cyclophosphamide|mesh-list
102286164|NCT01671319|Docetaxel|docetaxel|mesh-list
102286165|NCT01671319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102286166|NCT01671319|Immunologic Factors|immunologic factors|mesh-ancestor
102286167|NCT01671319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286168|NCT01671319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102286169|NCT01671319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102286170|NCT01671319|Alkylating Agents|alkylating agents|mesh-ancestor
102286171|NCT01671319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286172|NCT01671319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102286173|NCT01671319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102286174|NCT01671319|Tubulin Modulators|tubulin modulators|mesh-ancestor
102286175|NCT01671319|Antimitotic Agents|antimitotic agents|mesh-ancestor
102286176|NCT01671319|Mitosis Modulators|mitosis modulators|mesh-ancestor
102286177|NCT05019885|Ketamine|ketamine|mesh-list
102286178|NCT05019885|Analgesics|analgesics|mesh-ancestor
102286179|NCT05019885|Sensory System Agents|sensory system agents|mesh-ancestor
102286180|NCT05019885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102286181|NCT05019885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286182|NCT05019885|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102286183|NCT05019885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101994905|NCT05449015|Mydriatics|mydriatics|mesh-ancestor
102286184|NCT05019885|Anesthetics, General|anesthetics, general|mesh-ancestor
102286185|NCT05019885|Anesthetics|anesthetics|mesh-ancestor
102286186|NCT05019885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102286187|NCT05019885|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102286188|NCT05019885|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102286189|NCT05019885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102286190|NCT05019885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286191|NCT05016609|Sofosbuvir|sofosbuvir|mesh-list
102286192|NCT05016609|Velpatasvir|velpatasvir|mesh-list
102286193|NCT05016609|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102286194|NCT05016609|Antibodies|antibodies|mesh-list
102286195|NCT05016609|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
102286196|NCT05016609|Immunologic Factors|immunologic factors|mesh-ancestor
102286197|NCT05016609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286198|NCT05016609|Antiviral Agents|antiviral agents|mesh-ancestor
102286199|NCT05016609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102286200|NCT03763305|Fentanyl|fentanyl|mesh-list
102286201|NCT03763305|Remifentanil|remifentanil|mesh-list
102286202|NCT03763305|Propofol|propofol|mesh-list
102286203|NCT03763305|Sevoflurane|sevoflurane|mesh-list
102286204|NCT03763305|Desflurane|desflurane|mesh-list
102286205|NCT03763305|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102286206|NCT03763305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102286207|NCT03763305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102286208|NCT03763305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286209|NCT03763305|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102286210|NCT03763305|Anesthetics, General|anesthetics, general|mesh-ancestor
102286211|NCT03763305|Anesthetics|anesthetics|mesh-ancestor
102286212|NCT03763305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102286213|NCT03763305|Narcotics|narcotics|mesh-ancestor
102286214|NCT03763305|Analgesics|analgesics|mesh-ancestor
102286215|NCT03763305|Sensory System Agents|sensory system agents|mesh-ancestor
102286216|NCT03763305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102286217|NCT03763305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102286218|NCT03763305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102286219|NCT03763305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102286220|NCT05054361|Mannitol|mannitol|mesh-list
102286221|NCT05054361|Lactulose|lactulose|mesh-list
102286222|NCT05054361|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102286223|NCT05054361|Diuretics|diuretics|mesh-ancestor
102286224|NCT05054361|Natriuretic Agents|natriuretic agents|mesh-ancestor
102286225|NCT05054361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286226|NCT05054361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102286227|NCT04906213|Empagliflozin|empagliflozin|mesh-list
102286228|NCT04906213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102286229|NCT04906213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286230|NCT04906213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102286231|NCT04906213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286232|NCT01670539|Triamcinolone|triamcinolone|mesh-list
102286233|NCT01670539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102286234|NCT01670539|Glucocorticoids|glucocorticoids|mesh-ancestor
102286235|NCT01670539|Hormones|hormones|mesh-ancestor
102286236|NCT01670539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102286237|NCT01670539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286238|NCT02252887|Gemcitabine|gemcitabine|mesh-list
102286239|NCT02252887|Trastuzumab|trastuzumab|mesh-list
102286240|NCT02252887|Pertuzumab|pertuzumab|mesh-list
102286241|NCT02252887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102286242|NCT02252887|Antimetabolites|antimetabolites|mesh-ancestor
102286243|NCT02252887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286244|NCT02252887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102286245|NCT02252887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102286246|NCT04431895|Tofacitinib|tofacitinib|mesh-list
102286247|NCT04431895|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102286248|NCT04431895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102286249|NCT04431895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102286250|NCT04431895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286251|NCT03064633|Dexamethasone|dexamethasone|mesh-list
102286252|NCT03064633|Dexamethasone acetate|dexamethasone acetate|mesh-list
102286253|NCT03064633|Dexmedetomidine|dexmedetomidine|mesh-list
102286254|NCT03064633|Bupivacaine|bupivacaine|mesh-list
102286255|NCT03064633|BB 1101|bb 1101|mesh-list
102286256|NCT03064633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102286257|NCT03064633|Antiemetics|antiemetics|mesh-ancestor
102286258|NCT03064633|Autonomic Agents|autonomic agents|mesh-ancestor
102286259|NCT03064633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102286260|NCT03064633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286261|NCT03064633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102286262|NCT03064633|Glucocorticoids|glucocorticoids|mesh-ancestor
102286263|NCT03064633|Hormones|hormones|mesh-ancestor
102286264|NCT03064633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102286265|NCT03064633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102286266|NCT03064633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102286267|NCT03064633|Protease Inhibitors|protease inhibitors|mesh-ancestor
102286268|NCT03064633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102286269|NCT03064633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286270|NCT03064633|Anesthetics, Local|anesthetics, local|mesh-ancestor
102286271|NCT03064633|Anesthetics|anesthetics|mesh-ancestor
102286272|NCT03064633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102286273|NCT03064633|Sensory System Agents|sensory system agents|mesh-ancestor
102286274|NCT03064633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102286275|NCT03064633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102286276|NCT03064633|Analgesics|analgesics|mesh-ancestor
102286277|NCT03064633|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102286278|NCT03064633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102286279|NCT03064633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102286280|NCT03064633|Adrenergic Agents|adrenergic agents|mesh-ancestor
102286281|NCT03064633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102286282|NCT04950465|Fluorides|fluorides|mesh-list
102286283|NCT04950465|Cariostatic Agents|cariostatic agents|mesh-ancestor
102286284|NCT04950465|Protective Agents|protective agents|mesh-ancestor
102286285|NCT04950465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286286|NCT02589665|Mirikizumab|mirikizumab|mesh-list
102286287|NCT02589665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102286288|NCT02589665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102286289|NCT02589665|Analgesics|analgesics|mesh-ancestor
102286290|NCT02589665|Sensory System Agents|sensory system agents|mesh-ancestor
102286291|NCT02589665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102286292|NCT02589665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286293|NCT02589665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102286294|NCT02589665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102286295|NCT02589665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102286296|NCT02589665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102286297|NCT01697527|Aldesleukin|aldesleukin|mesh-list
102286298|NCT01697527|Cyclophosphamide|cyclophosphamide|mesh-list
102286299|NCT01697527|Fludarabine|fludarabine|mesh-list
102286300|NCT01697527|Fludarabine phosphate|fludarabine phosphate|mesh-list
102286301|NCT01697527|Interleukin-2|interleukin-2|mesh-list
102286302|NCT01697527|Vaccines|vaccines|mesh-list
102286303|NCT01697527|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101386432|NCT00309673|Anesthetics|anesthetics|mesh-ancestor
102286304|NCT01697527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102286305|NCT01697527|Immunologic Factors|immunologic factors|mesh-ancestor
102286306|NCT01697527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286307|NCT01697527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102286308|NCT01697527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102286309|NCT01697527|Alkylating Agents|alkylating agents|mesh-ancestor
102286310|NCT01697527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286311|NCT01697527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102286312|NCT01697527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102286313|NCT01697527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102286314|NCT01697527|Antimetabolites|antimetabolites|mesh-ancestor
102286315|NCT01697527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102286316|NCT01697527|Analgesics|analgesics|mesh-ancestor
102286317|NCT01697527|Sensory System Agents|sensory system agents|mesh-ancestor
102286318|NCT01697527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102286319|NCT01697527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102286320|NCT01697527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102286321|NCT01697527|Antiviral Agents|antiviral agents|mesh-ancestor
102286322|NCT01697527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102286323|NCT01697527|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102286324|NCT04426409|Ofloxacin|ofloxacin|mesh-list
102286325|NCT04426409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102286326|NCT04426409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102286327|NCT04426409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102286328|NCT04426409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102286329|NCT04426409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102286330|NCT04426409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102286331|NCT04426409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286332|NCT04426409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102286333|NCT04426409|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102286334|NCT04426409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102286335|NCT04426097|Iodine|iodine|mesh-list
102286336|NCT04426097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102286337|NCT04426097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102286338|NCT04426097|Trace Elements|trace elements|mesh-ancestor
102286339|NCT04426097|Micronutrients|micronutrients|mesh-ancestor
102286340|NCT04426097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286341|NCT05556083|Sildenafil Citrate|sildenafil citrate|mesh-list
102286342|NCT05556083|Vasodilator Agents|vasodilator agents|mesh-ancestor
102286343|NCT05556083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102286344|NCT05556083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102286345|NCT05556083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102286346|NCT05556083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286347|NCT05556083|Urological Agents|urological agents|mesh-ancestor
102286348|NCT05556005|Trimetazidine|trimetazidine|mesh-list
102286349|NCT05556005|Vasodilator Agents|vasodilator agents|mesh-ancestor
102286350|NCT04373603|Tranexamic Acid|tranexamic acid|mesh-list
102286351|NCT04373603|Hyaluronic Acid|hyaluronic acid|mesh-list
102286352|NCT04373603|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102286353|NCT04373603|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102286354|NCT04373603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286355|NCT04373603|Hemostatics|hemostatics|mesh-ancestor
102286356|NCT04373603|Coagulants|coagulants|mesh-ancestor
102286357|NCT04373603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102286358|NCT04373603|Immunologic Factors|immunologic factors|mesh-ancestor
102286359|NCT04373603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286360|NCT04373603|Viscosupplements|viscosupplements|mesh-ancestor
102286361|NCT04373603|Protective Agents|protective agents|mesh-ancestor
102286362|NCT02519595|Ketamine|ketamine|mesh-list
102286363|NCT02519595|Analgesics|analgesics|mesh-ancestor
102286364|NCT02519595|Sensory System Agents|sensory system agents|mesh-ancestor
102286365|NCT02519595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102286366|NCT02519595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286367|NCT02519595|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102286368|NCT02519595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102286369|NCT02519595|Anesthetics, General|anesthetics, general|mesh-ancestor
102286370|NCT02519595|Anesthetics|anesthetics|mesh-ancestor
102286371|NCT02519595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102286372|NCT02519595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102286373|NCT02519595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102286374|NCT02519595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102286375|NCT02519595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286376|NCT04278755|Drospirenone|drospirenone|mesh-list
102286377|NCT04278755|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102286378|NCT04278755|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
102286379|NCT04278755|Estradiol|estradiol|mesh-list
102286380|NCT04278755|Estrogens|estrogens|mesh-ancestor
102286381|NCT04278755|Hormones|hormones|mesh-ancestor
102286382|NCT04278755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102286383|NCT04278755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286384|NCT04278755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102286385|NCT04278755|Contraceptive Agents|contraceptive agents|mesh-ancestor
102286386|NCT04278755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102286387|NCT04278755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102286388|NCT04278755|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102286389|NCT04278755|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102286390|NCT04278755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102286391|NCT04278755|Hormone Antagonists|hormone antagonists|mesh-ancestor
102286392|NCT04278755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102286393|NCT04278755|Diuretics|diuretics|mesh-ancestor
102286394|NCT04278755|Natriuretic Agents|natriuretic agents|mesh-ancestor
102286395|NCT04277975|Analgesics, Opioid|analgesics, opioid|mesh-list
102286396|NCT04277975|Narcotics|narcotics|mesh-ancestor
102286397|NCT04277975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102286398|NCT04277975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286399|NCT04277975|Analgesics|analgesics|mesh-ancestor
102286400|NCT04277975|Sensory System Agents|sensory system agents|mesh-ancestor
102286401|NCT04277975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102286402|NCT04062695|Tofacitinib|tofacitinib|mesh-list
102286403|NCT04062695|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102286404|NCT04062695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102286405|NCT04062695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102286406|NCT04062695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286407|NCT04330079|Dapagliflozin|dapagliflozin|mesh-list
102286408|NCT04330079|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102286409|NCT04330079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286410|NCT04330079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102286411|NCT04330079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286412|NCT00660673|Levodopa|levodopa|mesh-list
102286414|NCT00660673|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102286415|NCT00660673|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102286416|NCT00660673|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102286417|NCT00660673|Dopamine Agents|dopamine agents|mesh-ancestor
102286418|NCT00660673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102286419|NCT00660673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286420|NCT00660673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286421|NCT00660673|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102286422|NCT00660673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102286423|NCT00660673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102286424|NCT00660673|Immunologic Factors|immunologic factors|mesh-ancestor
102286425|NCT00660673|Dopamine Agonists|dopamine agonists|mesh-ancestor
102286426|NCT03644381|Immunomodulating Agents|immunomodulating agents|mesh-list
102286427|NCT03644381|Immunologic Factors|immunologic factors|mesh-ancestor
102286428|NCT03644381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286429|NCT05612711|Dronabinol|dronabinol|mesh-list
102286430|NCT05612711|Hallucinogens|hallucinogens|mesh-ancestor
102286431|NCT05612711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286432|NCT05612711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102286433|NCT05612711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102286434|NCT05612711|Analgesics|analgesics|mesh-ancestor
102286435|NCT05612711|Sensory System Agents|sensory system agents|mesh-ancestor
102286436|NCT05612711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102286437|NCT05612711|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102286438|NCT05612711|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102286439|NCT05612711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102286440|NCT05612711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286441|NCT05612711|Hormones|hormones|mesh-ancestor
102286442|NCT05612711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102286443|NCT04807309|Danazol|danazol|mesh-list
102286444|NCT04807309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102286445|NCT04807309|Hormone Antagonists|hormone antagonists|mesh-ancestor
102286446|NCT04807309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102286447|NCT04807309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286448|NCT04744649|Fluorouracil|fluorouracil|mesh-list
102286449|NCT04744649|Antimetabolites|antimetabolites|mesh-ancestor
102286450|NCT04744649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286451|NCT04744649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102286452|NCT04744649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102286453|NCT04744649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102286454|NCT04744649|Immunologic Factors|immunologic factors|mesh-ancestor
102286455|NCT04744649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286457|NCT04426955|Cisplatin|cisplatin|mesh-list
102286458|NCT04426955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102286459|NCT04426955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102286460|NCT04426955|Tubulin Modulators|tubulin modulators|mesh-ancestor
102286461|NCT04426955|Antimitotic Agents|antimitotic agents|mesh-ancestor
102286462|NCT04426955|Mitosis Modulators|mitosis modulators|mesh-ancestor
102286463|NCT04426955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286464|NCT02630563|Cyclosporine|cyclosporine|mesh-list
102286465|NCT02630563|Mycophenolic Acid|mycophenolic acid|mesh-list
102286466|NCT02630563|Cyclosporins|cyclosporins|mesh-list
102286467|NCT02630563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102286468|NCT02630563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286469|NCT02630563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102286470|NCT02630563|Immunologic Factors|immunologic factors|mesh-ancestor
102286471|NCT02630563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286472|NCT02630563|Antifungal Agents|antifungal agents|mesh-ancestor
102286473|NCT02630563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102286474|NCT02630563|Dermatologic Agents|dermatologic agents|mesh-ancestor
102286475|NCT02630563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102286476|NCT02630563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102286477|NCT02630563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102286478|NCT02630563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102286479|NCT02630563|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102286480|NCT02630563|Antitubercular Agents|antitubercular agents|mesh-ancestor
102286481|NCT02630563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102286482|NCT05700695|Lactulose|lactulose|mesh-list
102286483|NCT05700695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102286484|NCT05555147|Ropivacaine|ropivacaine|mesh-list
102286485|NCT05555147|Anesthetics, Local|anesthetics, local|mesh-ancestor
102286486|NCT05555147|Anesthetics|anesthetics|mesh-ancestor
102286487|NCT05555147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102286488|NCT05555147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286490|NCT05555147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102286491|NCT02587247|Antibodies|antibodies|mesh-list
102286492|NCT02587247|Immunologic Factors|immunologic factors|mesh-ancestor
102286493|NCT02587247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286494|NCT02555111|Rivaroxaban|rivaroxaban|mesh-list
102286495|NCT02555111|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102286496|NCT02555111|Antithrombins|antithrombins|mesh-ancestor
102286497|NCT02555111|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102286498|NCT02555111|Protease Inhibitors|protease inhibitors|mesh-ancestor
102286499|NCT02555111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102286500|NCT02555111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286501|NCT02555111|Anticoagulants|anticoagulants|mesh-ancestor
102286502|NCT02521415|Acetaminophen|acetaminophen|mesh-list
102286503|NCT02521415|Ibuprofen|ibuprofen|mesh-list
102286504|NCT02521415|Fentanyl|fentanyl|mesh-list
102286505|NCT02521415|Ketamine|ketamine|mesh-list
102286506|NCT02521415|Analgesics|analgesics|mesh-list
102286507|NCT02521415|Sensory System Agents|sensory system agents|mesh-ancestor
102286508|NCT02521415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102286509|NCT02521415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386639|NCT00311974|Dihydralazine|dihydralazine|mesh-list
102286510|NCT02521415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102286511|NCT02521415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102286512|NCT02521415|Anesthetics, General|anesthetics, general|mesh-ancestor
102286513|NCT02521415|Anesthetics|anesthetics|mesh-ancestor
102286514|NCT02521415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102286515|NCT02521415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102286516|NCT02521415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102286517|NCT02521415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102286518|NCT02521415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286519|NCT02521415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102286520|NCT02521415|Narcotics|narcotics|mesh-ancestor
102286521|NCT02521415|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102286522|NCT02521415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102286523|NCT02521415|Antipyretics|antipyretics|mesh-ancestor
102286524|NCT02521415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102286525|NCT02521415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102286526|NCT02521415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102286527|NCT02521415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102286528|NCT02521415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102286529|NCT02078141|Deoxyglucose|deoxyglucose|mesh-list
102286530|NCT02078141|Antimetabolites|antimetabolites|mesh-ancestor
101941522|NCT03926559|Analgesics|analgesics|mesh-ancestor
102286531|NCT02078141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286532|NCT02078141|Antiviral Agents|antiviral agents|mesh-ancestor
102286533|NCT02078141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102286535|NCT02588339|Panobinostat|panobinostat|mesh-list
102286536|NCT02588339|Tacrolimus|tacrolimus|mesh-list
102286537|NCT02588339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102286538|NCT02588339|Immunologic Factors|immunologic factors|mesh-ancestor
102286539|NCT02588339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286540|NCT02588339|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102286541|NCT02588339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102286542|NCT02588339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286543|NCT02588339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102286544|NCT02588339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102286545|NCT02588339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102286546|NCT02588339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102286547|NCT02588339|Antifungal Agents|antifungal agents|mesh-ancestor
102286548|NCT02588339|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102286549|NCT01752491|Ascorbic Acid|ascorbic acid|mesh-list
102286550|NCT01752491|Temozolomide|temozolomide|mesh-list
102286551|NCT01752491|Vitamins|vitamins|mesh-ancestor
102286552|NCT01752491|Micronutrients|micronutrients|mesh-ancestor
102286553|NCT01752491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286554|NCT01752491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102286555|NCT01752491|Alkylating Agents|alkylating agents|mesh-ancestor
102286556|NCT01752491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286557|NCT01752491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102286558|NCT01752491|Antioxidants|antioxidants|mesh-ancestor
102286559|NCT01752491|Protective Agents|protective agents|mesh-ancestor
102286560|NCT05554211|Tranexamic Acid|tranexamic acid|mesh-list
102286561|NCT05554211|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102286562|NCT05554211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102286563|NCT05554211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286564|NCT05554211|Hemostatics|hemostatics|mesh-ancestor
102286565|NCT05554211|Coagulants|coagulants|mesh-ancestor
102286566|NCT05554055|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102286567|NCT05554055|Dalteparin|dalteparin|mesh-list
102286568|NCT05554055|Anticoagulants|anticoagulants|mesh-ancestor
102286569|NCT05554055|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102286570|NCT05554055|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102286571|NCT05554055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286572|NCT05700617|Dobutamine|dobutamine|mesh-list
102286573|NCT05700617|Milrinone|milrinone|mesh-list
102286574|NCT05700617|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102286575|NCT05700617|Sympathomimetics|sympathomimetics|mesh-ancestor
102286576|NCT05700617|Autonomic Agents|autonomic agents|mesh-ancestor
102286577|NCT05700617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102286578|NCT05700617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286579|NCT05700617|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102286580|NCT05700617|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102286581|NCT05700617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102286582|NCT05700617|Adrenergic Agents|adrenergic agents|mesh-ancestor
102286583|NCT05700617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102286584|NCT05700617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286585|NCT05700617|Protective Agents|protective agents|mesh-ancestor
102286586|NCT05700617|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102286587|NCT05700617|Vasodilator Agents|vasodilator agents|mesh-ancestor
102286588|NCT05700617|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102286589|NCT05700617|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102286590|NCT05700617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102286591|NCT05553743|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102286592|NCT05553743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102286593|NCT05553665|Lidocaine|lidocaine|mesh-list
102286594|NCT05553665|Fentanyl|fentanyl|mesh-list
102286595|NCT05553665|Midazolam|midazolam|mesh-list
102286596|NCT05553665|Complement System Proteins|complement system proteins|mesh-list
102286597|NCT05553665|Complement C4|complement c4|mesh-list
102286598|NCT05553665|Anesthetics, Local|anesthetics, local|mesh-ancestor
102286599|NCT05553665|Anesthetics|anesthetics|mesh-ancestor
102286600|NCT05553665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102286601|NCT05553665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286602|NCT05553665|Sensory System Agents|sensory system agents|mesh-ancestor
102286603|NCT05553665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102286604|NCT05553665|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102286605|NCT05553665|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102286606|NCT05553665|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102286607|NCT05553665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102286608|NCT05553665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286609|NCT05553665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102286610|NCT05553665|Narcotics|narcotics|mesh-ancestor
102286611|NCT05553665|Analgesics|analgesics|mesh-ancestor
102286612|NCT05553665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102286613|NCT05553665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102286614|NCT05553665|Anesthetics, General|anesthetics, general|mesh-ancestor
102286615|NCT05553665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102286616|NCT05553665|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102286617|NCT05553665|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102286618|NCT05553665|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102286619|NCT05553665|GABA Modulators|gaba modulators|mesh-ancestor
102286620|NCT05553665|GABA Agents|gaba agents|mesh-ancestor
102286621|NCT05553665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102286622|NCT05553665|Immunologic Factors|immunologic factors|mesh-ancestor
102286623|NCT02629159|Adalimumab|adalimumab|mesh-list
102286624|NCT02629159|Upadacitinib|upadacitinib|mesh-list
102286625|NCT02629159|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102286626|NCT02629159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102286627|NCT02629159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102286628|NCT02629159|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102286629|NCT02629159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102286630|NCT02629159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102286631|NCT02629159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286632|NCT05548985|Midodrine|midodrine|mesh-list
102286633|NCT05548985|Metoclopramide|metoclopramide|mesh-list
102286634|NCT05548985|Antiemetics|antiemetics|mesh-ancestor
102286635|NCT05548985|Autonomic Agents|autonomic agents|mesh-ancestor
101995348|NCT03763123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102286636|NCT05548985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102286637|NCT05548985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286638|NCT05548985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102286639|NCT05548985|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102286640|NCT05548985|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102286641|NCT05548985|Dopamine Agents|dopamine agents|mesh-ancestor
102286642|NCT05548985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102286643|NCT05548985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286644|NCT05548985|Sympathomimetics|sympathomimetics|mesh-ancestor
102286645|NCT05548985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102286646|NCT05548985|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102286647|NCT05548985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102286648|NCT05548985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102286649|NCT05548985|Adrenergic Agents|adrenergic agents|mesh-ancestor
102286650|NCT05548361|Chlorhexidine|chlorhexidine|mesh-list
102286651|NCT05548361|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102286652|NCT05548361|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102286653|NCT05548361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102286654|NCT05548361|Disinfectants|disinfectants|mesh-ancestor
102286655|NCT05548361|Dermatologic Agents|dermatologic agents|mesh-ancestor
102286656|NCT02628769|Solithromycin|solithromycin|mesh-list
102286657|NCT02628769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102286658|NCT02628769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102286659|NCT05552807|Paclitaxel|paclitaxel|mesh-list
102286660|NCT05552807|Docetaxel|docetaxel|mesh-list
102286661|NCT05552807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102286662|NCT05552807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102286663|NCT05552807|Tubulin Modulators|tubulin modulators|mesh-ancestor
102286664|NCT05552807|Antimitotic Agents|antimitotic agents|mesh-ancestor
102286665|NCT05552807|Mitosis Modulators|mitosis modulators|mesh-ancestor
102286666|NCT05552807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286667|NCT05552729|Vitamin D|vitamin d|mesh-list
102286668|NCT05552729|Ergocalciferols|ergocalciferols|mesh-list
102286669|NCT05552729|Cholecalciferol|cholecalciferol|mesh-list
102286670|NCT05552729|Vitamins|vitamins|mesh-list
102286671|NCT05552729|Micronutrients|micronutrients|mesh-ancestor
102286672|NCT05552729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286673|NCT05552729|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102286674|NCT05552729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102286675|NCT05699993|Itraconazole|itraconazole|mesh-list
102286676|NCT05699993|Dextromethorphan|dextromethorphan|mesh-list
102286677|NCT05699993|Antifungal Agents|antifungal agents|mesh-ancestor
102286678|NCT05699993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102286679|NCT05699993|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102286680|NCT05699993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102286681|NCT05699993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628389|NCT00720109|Vitamins|vitamins|mesh-ancestor
102286682|NCT05699993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286683|NCT05699993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102286684|NCT05699993|Hormone Antagonists|hormone antagonists|mesh-ancestor
102286685|NCT05699993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102286686|NCT05699993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286687|NCT05699993|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102286688|NCT05699993|Antitussive Agents|antitussive agents|mesh-ancestor
102286689|NCT05699993|Respiratory System Agents|respiratory system agents|mesh-ancestor
102286690|NCT05699993|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102286691|NCT05699993|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102286692|NCT05699993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102286693|NCT05552651|Paclitaxel|paclitaxel|mesh-list
102286694|NCT05552651|Carboplatin|carboplatin|mesh-list
102286695|NCT05552651|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102286696|NCT05552651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102286697|NCT05552651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102286698|NCT05552651|Tubulin Modulators|tubulin modulators|mesh-ancestor
102286699|NCT05552651|Antimitotic Agents|antimitotic agents|mesh-ancestor
102286700|NCT05552651|Mitosis Modulators|mitosis modulators|mesh-ancestor
102286701|NCT05552651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286702|NCT04981327|Apixaban|apixaban|mesh-list
102286703|NCT04981327|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102286704|NCT04981327|Antithrombins|antithrombins|mesh-ancestor
102286705|NCT04981327|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102286706|NCT04981327|Protease Inhibitors|protease inhibitors|mesh-ancestor
102286707|NCT04981327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102286708|NCT04981327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286709|NCT04981327|Anticoagulants|anticoagulants|mesh-ancestor
102286710|NCT05547659|Acetaminophen|acetaminophen|mesh-list
102286711|NCT05547659|Celecoxib|celecoxib|mesh-list
102286712|NCT05547659|Pregabalin|pregabalin|mesh-list
102286713|NCT05547659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102286714|NCT05547659|Analgesics|analgesics|mesh-ancestor
102286715|NCT05547659|Sensory System Agents|sensory system agents|mesh-ancestor
102286716|NCT05547659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102286717|NCT05547659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286718|NCT05547659|Antipyretics|antipyretics|mesh-ancestor
102286719|NCT05547659|Anticonvulsants|anticonvulsants|mesh-ancestor
102286720|NCT05547659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102286721|NCT05547659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102286722|NCT05547659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286723|NCT05547659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102286724|NCT05547659|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102286725|NCT05547659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102286726|NCT05547659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102286727|NCT05547659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102286728|NCT05547659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102286729|NCT05547659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102286730|NCT05547659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102286731|NCT05547659|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102286732|NCT05547659|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102286733|NCT05547659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102286734|NCT05541419|Budesonide|budesonide|mesh-list
102286735|NCT05541419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102286736|NCT05541419|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102286737|NCT05541419|Autonomic Agents|autonomic agents|mesh-ancestor
102286738|NCT05541419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102286739|NCT05541419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286740|NCT05541419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102286741|NCT05541419|Respiratory System Agents|respiratory system agents|mesh-ancestor
102286742|NCT05541419|Glucocorticoids|glucocorticoids|mesh-ancestor
102286743|NCT05541419|Hormones|hormones|mesh-ancestor
102286744|NCT05541419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102286745|NCT05546879|Bevacizumab|bevacizumab|mesh-list
102286746|NCT05546879|Atezolizumab|atezolizumab|mesh-list
102286747|NCT05546879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102286748|NCT05546879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102286749|NCT05546879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102286750|NCT05546879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102286751|NCT05546879|Growth Substances|growth substances|mesh-ancestor
102286752|NCT05546879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286753|NCT05546879|Growth Inhibitors|growth inhibitors|mesh-ancestor
102286754|NCT05546879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102286755|NCT05546879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286757|NCT05541185|Lidocaine|lidocaine|mesh-list
102286758|NCT05541185|Anesthetics, Local|anesthetics, local|mesh-ancestor
102286759|NCT05541185|Anesthetics|anesthetics|mesh-ancestor
102286760|NCT05541185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102286761|NCT05541185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286762|NCT05541185|Sensory System Agents|sensory system agents|mesh-ancestor
102286763|NCT05541185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102286764|NCT05541185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102286765|NCT05541185|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102286766|NCT05541185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102286767|NCT05541185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102286768|NCT05541185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286769|NCT05541185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102286770|NCT05541185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102286771|NCT05541185|Analgesics|analgesics|mesh-ancestor
102286772|NCT05541185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102286773|NCT05541185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102286774|NCT05541185|Gout Suppressants|gout suppressants|mesh-ancestor
102286775|NCT05541185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102286776|NCT05541185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102286777|NCT02518113|Dexamethasone|dexamethasone|mesh-list
102286778|NCT02518113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102286779|NCT02518113|Antiemetics|antiemetics|mesh-ancestor
102286780|NCT02518113|Autonomic Agents|autonomic agents|mesh-ancestor
102286781|NCT02518113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102286782|NCT02518113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286783|NCT02518113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102286784|NCT02518113|Glucocorticoids|glucocorticoids|mesh-ancestor
102286785|NCT02518113|Hormones|hormones|mesh-ancestor
102286786|NCT02518113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102286787|NCT02518113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101386935|NCT05567081|Hormones|hormones|mesh-ancestor
102286788|NCT02518113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102286790|NCT05541107|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102286791|NCT05541107|Amebicides|amebicides|mesh-ancestor
102286792|NCT05541107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102286793|NCT05541107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102286794|NCT05541107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102286795|NCT05541107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102286796|NCT05541107|Antifungal Agents|antifungal agents|mesh-ancestor
102286797|NCT03062839|Melatonin|melatonin|mesh-list
102286798|NCT03062839|Antioxidants|antioxidants|mesh-ancestor
102286799|NCT03062839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286800|NCT03062839|Protective Agents|protective agents|mesh-ancestor
102286801|NCT03062839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286802|NCT03062839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102286803|NCT05540951|Bevacizumab|bevacizumab|mesh-list
102286804|NCT05540951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102286805|NCT05540951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102286806|NCT05540951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102286807|NCT05540951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102286808|NCT05540951|Growth Substances|growth substances|mesh-ancestor
102286809|NCT05540951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286810|NCT05540951|Growth Inhibitors|growth inhibitors|mesh-ancestor
102286811|NCT04964505|Azacitidine|azacitidine|mesh-list
102286812|NCT04964505|Venetoclax|venetoclax|mesh-list
102286813|NCT04964505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102286814|NCT04964505|Antimetabolites|antimetabolites|mesh-ancestor
102286815|NCT04964505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286816|NCT04964505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102286817|NCT04964505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102286818|NCT04981093|Dexamethasone|dexamethasone|mesh-list
102286819|NCT04981093|Dexamethasone acetate|dexamethasone acetate|mesh-list
102286820|NCT04981093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102286821|NCT04981093|Antiemetics|antiemetics|mesh-ancestor
102286822|NCT04981093|Autonomic Agents|autonomic agents|mesh-ancestor
102286823|NCT04981093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102286824|NCT04981093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286825|NCT04981093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102286826|NCT04981093|Glucocorticoids|glucocorticoids|mesh-ancestor
102286827|NCT04981093|Hormones|hormones|mesh-ancestor
102286828|NCT04981093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102286829|NCT04981093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102286830|NCT04981093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102286831|NCT05551247|Endostatins|endostatins|mesh-list
102286832|NCT05551247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102286833|NCT05551247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102286834|NCT05551247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102286835|NCT05551247|Growth Substances|growth substances|mesh-ancestor
102286836|NCT05551247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286837|NCT05551247|Growth Inhibitors|growth inhibitors|mesh-ancestor
102286838|NCT05540483|Disitamab vedotin|disitamab vedotin|mesh-list
102286839|NCT05540483|Immunoconjugates|immunoconjugates|mesh-ancestor
102286840|NCT05540483|Immunologic Factors|immunologic factors|mesh-ancestor
102286841|NCT05540483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286842|NCT02629861|Calcitonin|calcitonin|mesh-list
102286843|NCT02629861|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
102286844|NCT02629861|Katacalcin|katacalcin|mesh-list
102286845|NCT02629861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102286846|NCT02629861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286847|NCT02629861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102286848|NCT02629861|Vasodilator Agents|vasodilator agents|mesh-ancestor
102286849|NCT02513823|Vitamin D|vitamin d|mesh-list
102286850|NCT02513823|Cholecalciferol|cholecalciferol|mesh-list
102286851|NCT02513823|Vitamins|vitamins|mesh-ancestor
102286852|NCT02513823|Micronutrients|micronutrients|mesh-ancestor
102286853|NCT02513823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286854|NCT02513823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102286855|NCT02513823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102286856|NCT05545475|Heparin|heparin|mesh-list
102286857|NCT05545475|Enoxaparin|enoxaparin|mesh-list
102286858|NCT05545475|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102286859|NCT05545475|Tinzaparin|tinzaparin|mesh-list
102286860|NCT05545475|Dalteparin|dalteparin|mesh-list
102286861|NCT05545475|Nadroparin|nadroparin|mesh-list
102286862|NCT05545475|Warfarin|warfarin|mesh-list
102286863|NCT05545475|Anticoagulants|anticoagulants|mesh-ancestor
102286864|NCT05545475|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101995578|NCT02561273|Hormones|hormones|mesh-ancestor
102286865|NCT05545475|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102286866|NCT05545475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286867|NCT05545397|Propofol|propofol|mesh-list
102286868|NCT05545397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102286869|NCT05545397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102286870|NCT05545397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286871|NCT05545397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102286872|NCT05545397|Anesthetics, General|anesthetics, general|mesh-ancestor
102286873|NCT05545397|Anesthetics|anesthetics|mesh-ancestor
102286874|NCT04952727|Vaccines|vaccines|mesh-list
102286875|NCT04952727|Immunologic Factors|immunologic factors|mesh-ancestor
102286876|NCT04952727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286877|NCT04433143|Minocycline|minocycline|mesh-list
102286878|NCT04433143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102286879|NCT04433143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102286880|NCT01665911|Listerine|listerine|mesh-list
102286881|NCT01665911|Fluorides|fluorides|mesh-list
102286882|NCT01665911|Sodium Fluoride|sodium fluoride|mesh-list
102286883|NCT01665911|Cariostatic Agents|cariostatic agents|mesh-ancestor
102286884|NCT01665911|Protective Agents|protective agents|mesh-ancestor
102286885|NCT01665911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286886|NCT01665911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102286887|NCT01665911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102286888|NCT03063073|Dexmedetomidine|dexmedetomidine|mesh-list
102286889|NCT03063073|Bupivacaine|bupivacaine|mesh-list
102286890|NCT03063073|Anesthetics, Local|anesthetics, local|mesh-ancestor
102286891|NCT03063073|Anesthetics|anesthetics|mesh-ancestor
102286892|NCT03063073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102286893|NCT03063073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286894|NCT03063073|Sensory System Agents|sensory system agents|mesh-ancestor
102286895|NCT03063073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102286896|NCT03063073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102286897|NCT03063073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102286898|NCT03063073|Analgesics|analgesics|mesh-ancestor
102286899|NCT03063073|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102286900|NCT03063073|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102286901|NCT03063073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102286902|NCT03063073|Adrenergic Agents|adrenergic agents|mesh-ancestor
102286903|NCT03063073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102286904|NCT03063073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286905|NCT04620733|Seladelpar|seladelpar|mesh-list
102286906|NCT04620733|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102286907|NCT04620733|Antimetabolites|antimetabolites|mesh-ancestor
102286908|NCT04620733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286909|NCT04620733|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102286911|NCT02476617|Ribavirin|ribavirin|mesh-list
102286912|NCT02476617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102286913|NCT02476617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102286914|NCT02476617|Protease Inhibitors|protease inhibitors|mesh-ancestor
102286915|NCT02476617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102286916|NCT02476617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286917|NCT02476617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102286918|NCT02476617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102286919|NCT02476617|Antiviral Agents|antiviral agents|mesh-ancestor
102286920|NCT02476617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102286921|NCT02476617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102286922|NCT02476617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102286923|NCT02476617|Antimetabolites|antimetabolites|mesh-ancestor
102286924|NCT04428307|Artemisinins|artemisinins|mesh-list
102286925|NCT04428307|Artemisinin|artemisinin|mesh-list
102286926|NCT04428307|Antimalarials|antimalarials|mesh-ancestor
102286927|NCT04428307|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102286928|NCT04428307|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102286929|NCT04428307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102286930|NCT05535725|Vancomycin|vancomycin|mesh-list
102286931|NCT05535725|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102286932|NCT05535725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102286933|NCT05535569|Paclitaxel|paclitaxel|mesh-list
102286934|NCT05535569|Nivolumab|nivolumab|mesh-list
102286935|NCT05535569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102286936|NCT05535569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102286937|NCT05535569|Tubulin Modulators|tubulin modulators|mesh-ancestor
102286938|NCT05535569|Antimitotic Agents|antimitotic agents|mesh-ancestor
102286939|NCT05535569|Mitosis Modulators|mitosis modulators|mesh-ancestor
102286940|NCT05535569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286941|NCT05535569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102286942|NCT05535569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102286943|NCT03822871|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102286944|NCT03822871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102286945|NCT03822871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286946|NCT03064165|Epinephrine|epinephrine|mesh-list
102286947|NCT03064165|Bupivacaine|bupivacaine|mesh-list
102286948|NCT03064165|Anesthetics, Local|anesthetics, local|mesh-ancestor
102286949|NCT03064165|Anesthetics|anesthetics|mesh-ancestor
102286950|NCT03064165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102286951|NCT03064165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286952|NCT03064165|Sensory System Agents|sensory system agents|mesh-ancestor
102286953|NCT03064165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102286954|NCT03064165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102286955|NCT03064165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102286956|NCT03064165|Adrenergic Agents|adrenergic agents|mesh-ancestor
102286957|NCT03064165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102286958|NCT03064165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286959|NCT03064165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102286960|NCT03064165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102286961|NCT03064165|Autonomic Agents|autonomic agents|mesh-ancestor
102286962|NCT03064165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102286963|NCT03064165|Respiratory System Agents|respiratory system agents|mesh-ancestor
102286964|NCT03064165|Mydriatics|mydriatics|mesh-ancestor
102286965|NCT03064165|Sympathomimetics|sympathomimetics|mesh-ancestor
102286966|NCT03064165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102286967|NCT05535413|Capecitabine|capecitabine|mesh-list
102286968|NCT05535413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102286969|NCT05535413|Antimetabolites|antimetabolites|mesh-ancestor
102286970|NCT05535413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286971|NCT05535413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102286972|NCT03813199|Methotrexate|methotrexate|mesh-list
102286973|NCT03813199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102286974|NCT03813199|Abortifacient Agents|abortifacient agents|mesh-ancestor
102286975|NCT03813199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102286976|NCT03813199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102286977|NCT03813199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102286978|NCT03813199|Antimetabolites|antimetabolites|mesh-ancestor
102286979|NCT03813199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286980|NCT03813199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102286981|NCT03813199|Dermatologic Agents|dermatologic agents|mesh-ancestor
102286982|NCT03813199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102286983|NCT03813199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102286984|NCT03813199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102286985|NCT03813199|Immunologic Factors|immunologic factors|mesh-ancestor
102286986|NCT03813199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102286987|NCT03813199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102286988|NCT05699135|Avelumab|avelumab|mesh-list
102286989|NCT05699135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102286990|NCT05699135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102286991|NCT03791593|Evolocumab|evolocumab|mesh-list
102286992|NCT03791593|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102286993|NCT03791593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102286994|NCT03791593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102286995|NCT03791593|Antimetabolites|antimetabolites|mesh-ancestor
102286996|NCT03791593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102286997|NCT03791593|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102286998|NCT03791593|Protease Inhibitors|protease inhibitors|mesh-ancestor
102286999|NCT03791593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102287000|NCT03791593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102287001|NCT03064243|Apatinib|apatinib|mesh-list
102287002|NCT03064243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102287003|NCT03064243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102287004|NCT03064243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387137|NCT00089622|Levodopa|levodopa|mesh-list
102287005|NCT03064243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287006|NCT03765619|Aspirin|aspirin|mesh-list
102287007|NCT03765619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102287008|NCT03765619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102287009|NCT03765619|Analgesics|analgesics|mesh-ancestor
102287010|NCT03765619|Sensory System Agents|sensory system agents|mesh-ancestor
102287011|NCT03765619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102287012|NCT03765619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287013|NCT03765619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102287014|NCT03765619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102287015|NCT03765619|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101995732|NCT03008616|Digoxin|digoxin|mesh-list
102287016|NCT03765619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102287017|NCT03765619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287018|NCT03765619|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102287019|NCT03765619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102287020|NCT03765619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102287021|NCT03765619|Antipyretics|antipyretics|mesh-ancestor
102287022|NCT05543603|Chlorhexidine|chlorhexidine|mesh-list
102287023|NCT05543603|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102287024|NCT05543603|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102287025|NCT05543603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102287026|NCT05543603|Disinfectants|disinfectants|mesh-ancestor
102287027|NCT05543603|Dermatologic Agents|dermatologic agents|mesh-ancestor
102287029|NCT04979923|Anesthetics, Local|anesthetics, local|mesh-ancestor
102287030|NCT04979923|Anesthetics|anesthetics|mesh-ancestor
102287031|NCT04979923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102287032|NCT04979923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287033|NCT04979923|Sensory System Agents|sensory system agents|mesh-ancestor
102287034|NCT04979923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102287035|NCT04979923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102287036|NCT04979923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102287037|NCT04979923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102287038|NCT04979923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102287039|NCT04979923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287040|NCT03706885|Efavirenz|efavirenz|mesh-list
102287041|NCT03706885|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102287042|NCT03706885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102287043|NCT03706885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102287044|NCT03706885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287045|NCT03706885|Antiviral Agents|antiviral agents|mesh-ancestor
102287046|NCT03706885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102287047|NCT03706885|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102287048|NCT03706885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102287049|NCT03706885|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102287050|NCT03706885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102287051|NCT03706885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102287052|NCT03706885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102287053|NCT01665599|Testosterone|testosterone|mesh-list
102287054|NCT01665599|Androgens|androgens|mesh-ancestor
102287055|NCT01665599|Hormones|hormones|mesh-ancestor
101387223|NCT00295984|Nicotine|nicotine|mesh-list
102287056|NCT01665599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102287057|NCT01665599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287059|NCT04979221|Antipruritics|antipruritics|mesh-ancestor
102287060|NCT04979221|Dermatologic Agents|dermatologic agents|mesh-ancestor
102287061|NCT04979221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102287062|NCT04979221|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102287063|NCT04979221|Histamine Antagonists|histamine antagonists|mesh-ancestor
102287064|NCT04979221|Histamine Agents|histamine agents|mesh-ancestor
102287065|NCT04979221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102287066|NCT04979221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287067|NCT04979221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287068|NCT04979221|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102287069|NCT04979221|Serotonin Agents|serotonin agents|mesh-ancestor
102287070|NCT04979221|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102287071|NCT05697809|Dexamethasone|dexamethasone|mesh-list
102287072|NCT05697809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102287073|NCT05697809|Antiemetics|antiemetics|mesh-ancestor
102287074|NCT05697809|Autonomic Agents|autonomic agents|mesh-ancestor
102287075|NCT05697809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102287076|NCT05697809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287077|NCT05697809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102287078|NCT05697809|Glucocorticoids|glucocorticoids|mesh-ancestor
102287079|NCT05697809|Hormones|hormones|mesh-ancestor
102287080|NCT05697809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102287081|NCT05697809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102287082|NCT05697809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102287083|NCT03980483|Methotrexate|methotrexate|mesh-list
102287084|NCT03980483|Tofacitinib|tofacitinib|mesh-list
102287085|NCT03980483|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102287086|NCT03980483|Abortifacient Agents|abortifacient agents|mesh-ancestor
102287087|NCT03980483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102287088|NCT03980483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287089|NCT03980483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102287090|NCT03980483|Antimetabolites|antimetabolites|mesh-ancestor
102287091|NCT03980483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287092|NCT03980483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102287093|NCT03980483|Dermatologic Agents|dermatologic agents|mesh-ancestor
102287094|NCT03980483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102287095|NCT03980483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102287096|NCT03980483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102287097|NCT03980483|Immunologic Factors|immunologic factors|mesh-ancestor
102287098|NCT03980483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102287099|NCT03980483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102287100|NCT03980483|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102287101|NCT03980483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102287102|NCT03063775|Fibrin Foam|fibrin foam|mesh-list
102287103|NCT03063775|Hemostatics|hemostatics|mesh-ancestor
102287104|NCT03063775|Coagulants|coagulants|mesh-ancestor
102287105|NCT03063541|Aspirin|aspirin|mesh-list
102287106|NCT03063541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102287107|NCT03063541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102287108|NCT03063541|Analgesics|analgesics|mesh-ancestor
102287109|NCT03063541|Sensory System Agents|sensory system agents|mesh-ancestor
102287110|NCT03063541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102287111|NCT03063541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287112|NCT03063541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102287113|NCT03063541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102287114|NCT03063541|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102287115|NCT03063541|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102287116|NCT03063541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287117|NCT03063541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102287118|NCT03063541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102287119|NCT03063541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102287120|NCT03063541|Antipyretics|antipyretics|mesh-ancestor
102287121|NCT04978597|Opicapone|opicapone|mesh-list
102287122|NCT04978597|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102287123|NCT04978597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102287124|NCT04978597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287125|NCT04978597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102287126|NCT04978597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102287127|NCT03490513|Anastrozole|anastrozole|mesh-list
102287128|NCT03490513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102287129|NCT03490513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102287130|NCT03490513|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102287131|NCT03490513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102287132|NCT03490513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102287133|NCT03490513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287134|NCT03490513|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102287135|NCT03490513|Hormone Antagonists|hormone antagonists|mesh-ancestor
102287136|NCT03490513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102287137|NCT03490513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287138|NCT03439345|Fenofibrate|fenofibrate|mesh-list
102287139|NCT03439345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102287140|NCT03439345|Antimetabolites|antimetabolites|mesh-ancestor
102287141|NCT03439345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287142|NCT03439345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102287143|NCT04977661|Vitamin E|vitamin e|mesh-list
102287144|NCT04977661|Tocopherols|tocopherols|mesh-list
102287145|NCT04977661|alpha-Tocopherol|alpha-tocopherol|mesh-list
102287146|NCT04977661|Pentoxifylline|pentoxifylline|mesh-list
102287147|NCT04977661|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102287148|NCT04977661|Vitamins|vitamins|mesh-ancestor
102287149|NCT04977661|Micronutrients|micronutrients|mesh-ancestor
102287150|NCT04977661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287151|NCT04977661|Antioxidants|antioxidants|mesh-ancestor
102287152|NCT04977661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287153|NCT04977661|Protective Agents|protective agents|mesh-ancestor
102287154|NCT04977661|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102287155|NCT04977661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102287156|NCT04977661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102287157|NCT04977661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102287158|NCT04977661|Vasodilator Agents|vasodilator agents|mesh-ancestor
102287159|NCT04977661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102287160|NCT04977661|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102287161|NCT04977661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101995882|NCT03916679|Fludarabine|fludarabine|mesh-list
102287162|NCT04977427|Prednisolone|prednisolone|mesh-list
102287163|NCT04977427|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102287164|NCT04977427|Methylprednisolone|methylprednisolone|mesh-list
102287165|NCT04977427|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102287166|NCT04977427|Prednisolone acetate|prednisolone acetate|mesh-list
102287167|NCT04977427|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102287168|NCT04977427|Prednisolone phosphate|prednisolone phosphate|mesh-list
102287169|NCT04977427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102287170|NCT04977427|Glucocorticoids|glucocorticoids|mesh-ancestor
102287171|NCT04977427|Hormones|hormones|mesh-ancestor
102287172|NCT04977427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102287173|NCT04977427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287174|NCT04977427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102287175|NCT04977427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102287176|NCT04977427|Antiemetics|antiemetics|mesh-ancestor
102287177|NCT04977427|Autonomic Agents|autonomic agents|mesh-ancestor
102287178|NCT04977427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102287179|NCT04977427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102287180|NCT04977427|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102287181|NCT04977427|Protective Agents|protective agents|mesh-ancestor
102287182|NCT04261855|Avelumab|avelumab|mesh-list
102287183|NCT04261855|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102287184|NCT04261855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102287185|NCT04261855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102287186|NCT04261855|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102287187|NCT04261855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287188|NCT04224415|Irinotecan|irinotecan|mesh-list
102287189|NCT04224415|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102287190|NCT04224415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102287191|NCT04224415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102287192|NCT04224415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287193|NCT04224415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102287194|NCT03239899|Pembrolizumab|pembrolizumab|mesh-list
102287195|NCT03239899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102287196|NCT03239899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102287197|NCT03239899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102287198|NCT03239899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287199|NCT03061981|Metformin|metformin|mesh-list
102287200|NCT03061981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102287201|NCT03061981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287202|NCT02510001|Crizotinib|crizotinib|mesh-list
102287203|NCT02510001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102287204|NCT02510001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102287205|NCT02510001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102287206|NCT02510001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287207|NCT02452047|Imipenem|imipenem|mesh-list
102287208|NCT02452047|Relebactam|relebactam|mesh-list
102287209|NCT02452047|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
102287210|NCT02452047|Cilastatin|cilastatin|mesh-list
102287211|NCT02452047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102287212|NCT02452047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102287213|NCT02452047|Protease Inhibitors|protease inhibitors|mesh-ancestor
102287214|NCT02452047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102287215|NCT02452047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287216|NCT02452047|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102287217|NCT04925505|Anesthetics|anesthetics|mesh-list
102287218|NCT04925505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102287219|NCT04925505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287220|NCT02475369|Pancrelipase|pancrelipase|mesh-list
102287221|NCT02475369|Pancreatin|pancreatin|mesh-list
102287222|NCT02475369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102287223|NCT02474589|Tecovirimat|tecovirimat|mesh-list
102287224|NCT02474589|Antiviral Agents|antiviral agents|mesh-ancestor
102287225|NCT02474589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102287226|NCT03862157|Azacitidine|azacitidine|mesh-list
102287227|NCT03862157|Venetoclax|venetoclax|mesh-list
102287228|NCT03862157|Enzyme Inhibitors|enzyme inhibitors|mesh-list
102287229|NCT03862157|Pevonedistat|pevonedistat|mesh-list
102287230|NCT03862157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102287231|NCT03862157|Antimetabolites|antimetabolites|mesh-ancestor
102287232|NCT03862157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287233|NCT03862157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102287234|NCT02474355|Osimertinib|osimertinib|mesh-list
102287235|NCT02474355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102287236|NCT02474355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102287237|NCT02474355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102287238|NCT02474355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287239|NCT02474199|Acetaminophen|acetaminophen|mesh-list
102287240|NCT02474199|Diphenhydramine|diphenhydramine|mesh-list
102287241|NCT02474199|Promethazine|promethazine|mesh-list
102287242|NCT02474199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102287243|NCT02474199|Analgesics|analgesics|mesh-ancestor
102287244|NCT02474199|Sensory System Agents|sensory system agents|mesh-ancestor
102287245|NCT02474199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102287246|NCT02474199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287247|NCT02474199|Antipyretics|antipyretics|mesh-ancestor
102287248|NCT02474199|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102287249|NCT02474199|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102287250|NCT02474199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102287251|NCT02474199|Anesthetics, Local|anesthetics, local|mesh-ancestor
102287252|NCT02474199|Anesthetics|anesthetics|mesh-ancestor
102287253|NCT02474199|Antiemetics|antiemetics|mesh-ancestor
102287254|NCT02474199|Autonomic Agents|autonomic agents|mesh-ancestor
102287255|NCT02474199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102287256|NCT02474199|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102287257|NCT02474199|Histamine Antagonists|histamine antagonists|mesh-ancestor
102287258|NCT02474199|Histamine Agents|histamine agents|mesh-ancestor
102287259|NCT02474199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102287260|NCT02474199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287261|NCT02474199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102287262|NCT02474199|Antipruritics|antipruritics|mesh-ancestor
102287263|NCT02474199|Dermatologic Agents|dermatologic agents|mesh-ancestor
102287265|NCT02450487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101387413|NCT00297076|Aplaviroc|aplaviroc|mesh-list
102287266|NCT02450487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102287267|NCT02450487|Analgesics|analgesics|mesh-ancestor
102287268|NCT02450487|Sensory System Agents|sensory system agents|mesh-ancestor
102287269|NCT02450487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102287270|NCT02450487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287271|NCT02450487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102287272|NCT02450487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102287273|NCT02450487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102287274|NCT02450487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102287275|NCT02450487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287276|NCT02506881|Darbepoetin alfa|darbepoetin alfa|mesh-list
102287277|NCT02506881|Hematinics|hematinics|mesh-ancestor
102287278|NCT02506257|Biguanides|biguanides|mesh-list
102287279|NCT02506257|Polihexanide|polihexanide|mesh-list
102287280|NCT02506257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102287281|NCT02506257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287282|NCT02506257|Disinfectants|disinfectants|mesh-ancestor
102287283|NCT02506257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102287284|NCT02505945|Omeprazole|omeprazole|mesh-list
102287285|NCT02505945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102287286|NCT02505945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102287287|NCT02505945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102287288|NCT02505945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102287289|NCT02505945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287290|NCT04213885|Riboflavin|riboflavin|mesh-list
102287291|NCT04213885|Vitamin B Complex|vitamin b complex|mesh-ancestor
102287292|NCT04213885|Vitamins|vitamins|mesh-ancestor
102287293|NCT04213885|Micronutrients|micronutrients|mesh-ancestor
102287294|NCT04213885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287295|NCT04213885|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102287296|NCT04213885|Dermatologic Agents|dermatologic agents|mesh-ancestor
102287297|NCT02448771|Bazedoxifene|bazedoxifene|mesh-list
102287298|NCT02448771|Palbociclib|palbociclib|mesh-list
102287299|NCT02448771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102287300|NCT02448771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102287301|NCT02448771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102287302|NCT02448771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287303|NCT02448771|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102287304|NCT02448771|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102287305|NCT02448771|Hormone Antagonists|hormone antagonists|mesh-ancestor
102287306|NCT02448771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102287307|NCT02448771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287308|NCT02448771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102287309|NCT02504541|Methyltestosterone|methyltestosterone|mesh-list
102287310|NCT02504541|Testosterone|testosterone|mesh-list
102287311|NCT02504541|Testosterone undecanoate|testosterone undecanoate|mesh-list
102287312|NCT02504541|Testosterone enanthate|testosterone enanthate|mesh-list
102287313|NCT02504541|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102287314|NCT02504541|Androgens|androgens|mesh-ancestor
102287315|NCT02504541|Hormones|hormones|mesh-ancestor
102287316|NCT02504541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102287317|NCT02504541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287318|NCT02504541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102287319|NCT02504541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102287321|NCT04924257|Esketamine|esketamine|mesh-list
102287322|NCT04924257|Antidepressive Agents|antidepressive agents|mesh-ancestor
102287323|NCT04924257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102287324|NCT04924179|Tislelizumab|tislelizumab|mesh-list
102287325|NCT04924179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102287326|NCT04924179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102287327|NCT04975945|Ceftriaxone|ceftriaxone|mesh-list
102287328|NCT04975945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102287329|NCT04975945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102287330|NCT03063307|Fluorides|fluorides|mesh-list
102287331|NCT03063307|Cariostatic Agents|cariostatic agents|mesh-ancestor
102287332|NCT03063307|Protective Agents|protective agents|mesh-ancestor
102287333|NCT03063307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287334|NCT04874935|Lansoprazole|lansoprazole|mesh-list
102287335|NCT04874935|Dexlansoprazole|dexlansoprazole|mesh-list
102287336|NCT04874935|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102287337|NCT04874935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102287338|NCT04874935|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102287339|NCT04874935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102287340|NCT04874935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287341|NCT02961361|Dexmedetomidine|dexmedetomidine|mesh-list
102287342|NCT02961361|Ropivacaine|ropivacaine|mesh-list
102287343|NCT02961361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102287344|NCT02961361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102287345|NCT02961361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287346|NCT02961361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102287347|NCT02961361|Analgesics|analgesics|mesh-ancestor
102287348|NCT02961361|Sensory System Agents|sensory system agents|mesh-ancestor
102287349|NCT02961361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102287350|NCT02961361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102287351|NCT02961361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102287352|NCT02961361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102287353|NCT02961361|Adrenergic Agents|adrenergic agents|mesh-ancestor
102287354|NCT02961361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102287355|NCT02961361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287356|NCT02961361|Anesthetics, Local|anesthetics, local|mesh-ancestor
102287357|NCT02961361|Anesthetics|anesthetics|mesh-ancestor
102287358|NCT04974853|Complement System Proteins|complement system proteins|mesh-list
102287359|NCT04974853|Immunologic Factors|immunologic factors|mesh-ancestor
102287360|NCT04974853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287361|NCT02725177|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102287362|NCT02725177|Hormones|hormones|mesh-ancestor
102287363|NCT02725177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102287364|NCT02725177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287365|NCT02426281|Paclitaxel|paclitaxel|mesh-list
102287366|NCT02426281|Gemcitabine|gemcitabine|mesh-list
102287367|NCT02426281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102287368|NCT02426281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102287369|NCT02426281|Tubulin Modulators|tubulin modulators|mesh-ancestor
102287370|NCT02426281|Antimitotic Agents|antimitotic agents|mesh-ancestor
102287371|NCT02426281|Mitosis Modulators|mitosis modulators|mesh-ancestor
102287372|NCT02426281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287373|NCT02426281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102287374|NCT02426281|Antimetabolites|antimetabolites|mesh-ancestor
102287375|NCT02448537|Gemcitabine|gemcitabine|mesh-list
102287376|NCT02448537|Doxorubicin|doxorubicin|mesh-list
102287377|NCT02448537|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102287378|NCT02448537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102287379|NCT02448537|Antimetabolites|antimetabolites|mesh-ancestor
102287380|NCT02448537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287381|NCT02448537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102287382|NCT02448537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102287383|NCT02448537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102287384|NCT02448537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102287385|NCT02448537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102287386|NCT04838743|Xultophy|xultophy|mesh-list
102287387|NCT04838743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102287388|NCT04838743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287389|NCT04838743|Incretins|incretins|mesh-ancestor
102287390|NCT04838743|Hormones|hormones|mesh-ancestor
102287391|NCT04838743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102287393|NCT03060265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102287394|NCT03060265|Analgesics|analgesics|mesh-ancestor
102287395|NCT03060265|Sensory System Agents|sensory system agents|mesh-ancestor
102287396|NCT03060265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102287397|NCT03060265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287398|NCT03060265|Antipyretics|antipyretics|mesh-ancestor
102287399|NCT02504151|Cannabidiol|cannabidiol|mesh-list
102287400|NCT02504151|Anticonvulsants|anticonvulsants|mesh-ancestor
102287401|NCT02448381|Hypericin|hypericin|mesh-list
102287402|NCT02448381|Antidepressive Agents|antidepressive agents|mesh-ancestor
102287403|NCT02448381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102287404|NCT02448381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102287405|NCT02448381|Antiviral Agents|antiviral agents|mesh-ancestor
102287406|NCT02448381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102287407|NCT02448381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102287408|NCT02448381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287409|NCT02448381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101387556|NCT05200559|Pembrolizumab|pembrolizumab|mesh-list
102287410|NCT02448381|Immunologic Factors|immunologic factors|mesh-ancestor
102287411|NCT02448381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287412|NCT02448225|Deoxyglucose|deoxyglucose|mesh-list
102287413|NCT02448225|Fluorides|fluorides|mesh-list
102287414|NCT02448225|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102287415|NCT02448225|Cariostatic Agents|cariostatic agents|mesh-ancestor
102287416|NCT02448225|Protective Agents|protective agents|mesh-ancestor
102287417|NCT02448225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287418|NCT02448225|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102287419|NCT02448225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287420|NCT02448225|Antimetabolites|antimetabolites|mesh-ancestor
102287421|NCT02448225|Antiviral Agents|antiviral agents|mesh-ancestor
102287422|NCT02448225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102287423|NCT02447991|Rizatriptan|rizatriptan|mesh-list
102287424|NCT02447991|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102287425|NCT02447991|Serotonin Agents|serotonin agents|mesh-ancestor
102287426|NCT02447991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102287427|NCT02447991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287428|NCT02447991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287429|NCT02586155|Atorvastatin|atorvastatin|mesh-list
102287430|NCT02586155|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102287431|NCT02586155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102287432|NCT02586155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102287433|NCT02586155|Antimetabolites|antimetabolites|mesh-ancestor
102287434|NCT02586155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287435|NCT02586155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102287436|NCT02586155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102287437|NCT02586155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102287438|NCT05536661|Lubricant Eye Drops|lubricant eye drops|mesh-list
102287439|NCT05536661|Hyaluronic Acid|hyaluronic acid|mesh-list
102287440|NCT05536661|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102287441|NCT05536661|Immunologic Factors|immunologic factors|mesh-ancestor
102287442|NCT05536661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287443|NCT05536661|Viscosupplements|viscosupplements|mesh-ancestor
102287444|NCT05536661|Protective Agents|protective agents|mesh-ancestor
102287445|NCT05536661|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102287446|NCT05536661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102287448|NCT05536271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102287449|NCT05536271|Sympatholytics|sympatholytics|mesh-ancestor
102287450|NCT05536271|Autonomic Agents|autonomic agents|mesh-ancestor
102287451|NCT05536271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102287452|NCT05536271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287453|NCT05536271|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102287454|NCT05536271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102287455|NCT05536271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102287456|NCT05536271|Adrenergic Agents|adrenergic agents|mesh-ancestor
102287457|NCT05536271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102287458|NCT05536271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287459|NCT05536193|Metformin|metformin|mesh-list
102287460|NCT05536193|Salicylic Acid|salicylic acid|mesh-list
102287461|NCT05536193|Salicylates|salicylates|mesh-list
102287462|NCT05536193|Mitogens|mitogens|mesh-list
102287463|NCT05536193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102287464|NCT05536193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996182|NCT01242605|Gemcitabine|gemcitabine|mesh-list
102287465|NCT05536193|Mitosis Modulators|mitosis modulators|mesh-ancestor
102287466|NCT05536193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287467|NCT05536193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102287468|NCT05536193|Antifungal Agents|antifungal agents|mesh-ancestor
102287469|NCT05536193|Keratolytic Agents|keratolytic agents|mesh-ancestor
102287470|NCT05536193|Dermatologic Agents|dermatologic agents|mesh-ancestor
102287471|NCT05536193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102287472|NCT05536193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102287473|NCT05536193|Analgesics|analgesics|mesh-ancestor
102287474|NCT05536193|Sensory System Agents|sensory system agents|mesh-ancestor
102287475|NCT05536193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102287476|NCT05536193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102287477|NCT05536193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102287478|NCT05536193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102287479|NCT05536193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102287480|NCT04425707|Hydroxychloroquine|hydroxychloroquine|mesh-list
102287481|NCT04425707|Ivermectin|ivermectin|mesh-list
102287482|NCT04425707|Antimalarials|antimalarials|mesh-ancestor
102287483|NCT04425707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102287484|NCT04425707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102287485|NCT04425707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102287486|NCT04425707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102287487|NCT04425707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287488|NCT04425707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102287489|NCT05697185|Evolocumab|evolocumab|mesh-list
102287490|NCT05697185|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102287491|NCT05697185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102287492|NCT05697185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102287493|NCT05697185|Antimetabolites|antimetabolites|mesh-ancestor
102287494|NCT05697185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287495|NCT05697185|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102287496|NCT05697185|Protease Inhibitors|protease inhibitors|mesh-ancestor
102287497|NCT05697185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102287498|NCT05697185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102287499|NCT05695781|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102287500|NCT05695781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102287501|NCT02581163|Ritonavir|ritonavir|mesh-list
102287502|NCT02581163|Ribavirin|ribavirin|mesh-list
102287503|NCT02581163|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102287504|NCT02581163|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102287505|NCT02581163|Protease Inhibitors|protease inhibitors|mesh-ancestor
102287506|NCT02581163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102287507|NCT02581163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287508|NCT02581163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102287509|NCT02581163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102287510|NCT02581163|Antiviral Agents|antiviral agents|mesh-ancestor
102287511|NCT02581163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102287512|NCT02581163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102287513|NCT02581163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102287514|NCT02581163|Antimetabolites|antimetabolites|mesh-ancestor
102287515|NCT05591417|Dexamethasone|dexamethasone|mesh-list
102287516|NCT05591417|Dexamethasone acetate|dexamethasone acetate|mesh-list
102287517|NCT05591417|Dexmedetomidine|dexmedetomidine|mesh-list
102287518|NCT05591417|Morphine|morphine|mesh-list
102287519|NCT05591417|BB 1101|bb 1101|mesh-list
102287520|NCT05591417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102287521|NCT05591417|Antiemetics|antiemetics|mesh-ancestor
102287522|NCT05591417|Autonomic Agents|autonomic agents|mesh-ancestor
102287523|NCT05591417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102287524|NCT05591417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287525|NCT05591417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102287526|NCT05591417|Glucocorticoids|glucocorticoids|mesh-ancestor
102287527|NCT05591417|Hormones|hormones|mesh-ancestor
102287528|NCT05591417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102287529|NCT05591417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102287530|NCT05591417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102287531|NCT05591417|Protease Inhibitors|protease inhibitors|mesh-ancestor
102287532|NCT05591417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102287533|NCT05591417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287534|NCT05591417|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102287535|NCT05591417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102287536|NCT05591417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102287537|NCT05591417|Analgesics|analgesics|mesh-ancestor
102287538|NCT05591417|Sensory System Agents|sensory system agents|mesh-ancestor
102287539|NCT05591417|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102287540|NCT05591417|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102287541|NCT05591417|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102287542|NCT05591417|Adrenergic Agents|adrenergic agents|mesh-ancestor
102287543|NCT05591417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102287544|NCT05591417|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102287545|NCT05591417|Narcotics|narcotics|mesh-ancestor
102287546|NCT01938547|Clevidipine|clevidipine|mesh-list
102287547|NCT01938547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102287548|NCT01938547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102287549|NCT01938547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287550|NCT01938547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102287551|NCT01938547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287552|NCT05695625|Anesthetics|anesthetics|mesh-list
102287553|NCT05695625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102287554|NCT05695625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287555|NCT05586737|Rituximab|rituximab|mesh-list
102287556|NCT05586737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102287557|NCT05586737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102287558|NCT05586737|Immunologic Factors|immunologic factors|mesh-ancestor
102287559|NCT05586737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287560|NCT05586737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102287561|NCT05678933|Prednisone|prednisone|mesh-list
102287562|NCT05678933|Cyclophosphamide|cyclophosphamide|mesh-list
102287563|NCT05678933|Vincristine|vincristine|mesh-list
102287564|NCT05678933|Azacitidine|azacitidine|mesh-list
102287565|NCT05678933|Epirubicin|epirubicin|mesh-list
102287566|NCT05678933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102287567|NCT05678933|Immunologic Factors|immunologic factors|mesh-ancestor
102287568|NCT05678933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287569|NCT05678933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102287570|NCT05678933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102287571|NCT05678933|Alkylating Agents|alkylating agents|mesh-ancestor
102287572|NCT05678933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287573|NCT05678933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102287574|NCT05678933|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102287575|NCT05678933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102287576|NCT05678933|Glucocorticoids|glucocorticoids|mesh-ancestor
102287577|NCT05678933|Hormones|hormones|mesh-ancestor
102287578|NCT05678933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102287579|NCT05678933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102287580|NCT05678933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102287581|NCT05678933|Tubulin Modulators|tubulin modulators|mesh-ancestor
102287582|NCT05678933|Antimitotic Agents|antimitotic agents|mesh-ancestor
102287583|NCT05678933|Mitosis Modulators|mitosis modulators|mesh-ancestor
102287584|NCT05678933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102287585|NCT05678933|Antimetabolites|antimetabolites|mesh-ancestor
102287586|NCT05678933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102287587|NCT05678933|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102287588|NCT05678933|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102287589|NCT05678933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102287590|NCT05678621|Amoxicillin|amoxicillin|mesh-list
102287591|NCT05678621|Ciprofloxacin|ciprofloxacin|mesh-list
102287592|NCT05678621|Clavulanic Acids|clavulanic acids|mesh-list
102287593|NCT05678621|Clavulanic Acid|clavulanic acid|mesh-list
102287594|NCT05678621|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102287595|NCT05678621|Trimethoprim|trimethoprim|mesh-list
102287596|NCT05678621|Sulfamethoxazole|sulfamethoxazole|mesh-list
102287597|NCT05678621|Immunoglobulins|immunoglobulins|mesh-list
102287598|NCT05678621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102287599|NCT05678621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102287600|NCT05678621|Immunologic Factors|immunologic factors|mesh-ancestor
102287601|NCT05678621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287602|NCT05678621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102287603|NCT05678621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102287604|NCT05678621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102287605|NCT05678621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287606|NCT05678621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102287607|NCT05678621|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102287608|NCT05678621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102287609|NCT05678621|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102287610|NCT05678621|Antimalarials|antimalarials|mesh-ancestor
102287611|NCT05678621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102287612|NCT05678621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102287613|NCT05678621|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102287614|NCT05678621|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102287615|NCT05678621|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102287616|NCT05678621|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102287617|NCT05697029|Tetrandrine|tetrandrine|mesh-list
102287618|NCT05697029|Antimalarials|antimalarials|mesh-ancestor
102287619|NCT05697029|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102287620|NCT05697029|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102287621|NCT05697029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102287622|NCT05697029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102287623|NCT05697029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102287624|NCT05697029|Antiviral Agents|antiviral agents|mesh-ancestor
102287625|NCT05697029|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102287626|NCT05697029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102287627|NCT05697029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287628|NCT05697029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102287629|NCT05697029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287630|NCT05697029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102287631|NCT05697029|Immunologic Factors|immunologic factors|mesh-ancestor
102287632|NCT02627677|Ponatinib|ponatinib|mesh-list
102287633|NCT02627677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102287634|NCT02627677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102287635|NCT02627677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102287636|NCT02627677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287637|NCT04964479|Pembrolizumab|pembrolizumab|mesh-list
102287638|NCT04964479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102287639|NCT04964479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102287640|NCT04964479|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102287641|NCT04964479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287642|NCT02501811|Plasma-lyte 148|plasma-lyte 148|mesh-list
102287643|NCT02501811|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102287644|NCT02501811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102287645|NCT02585999|Contraceptive Agents|contraceptive agents|mesh-list
102287646|NCT02585999|Ortho Evra|ortho evra|mesh-list
102287647|NCT02585999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102287648|NCT02585999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287649|NCT02585999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102287650|NCT05696951|Tranylcypromine|tranylcypromine|mesh-list
102287651|NCT05696951|Antidepressive Agents|antidepressive agents|mesh-ancestor
102287652|NCT05696951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102287653|NCT05696951|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102287654|NCT05696951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102287655|NCT05696951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287656|NCT05696951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102287657|NCT05696951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102287658|NCT05696951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102287659|NCT05696951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287661|NCT05041907|Ivermectin|ivermectin|mesh-list
102287662|NCT05041907|Nitazoxanide|nitazoxanide|mesh-list
102287663|NCT05041907|Remdesivir|remdesivir|mesh-list
102287664|NCT05041907|Favipiravir|favipiravir|mesh-list
102287665|NCT05041907|Nirmatrelvir|nirmatrelvir|mesh-list
102287666|NCT05041907|Sotrovimab|sotrovimab|mesh-list
102287667|NCT05041907|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
102287668|NCT05041907|Molnupiravir|molnupiravir|mesh-list
102287669|NCT05041907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102287670|NCT05041907|Fluoxetine|fluoxetine|mesh-list
102287671|NCT05041907|Antibodies|antibodies|mesh-list
102287672|NCT05041907|Immunoglobulins|immunoglobulins|mesh-list
102287673|NCT05041907|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102287674|NCT05041907|Immunologic Factors|immunologic factors|mesh-ancestor
102287675|NCT05041907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287676|NCT05041907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102287677|NCT05041907|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102287678|NCT05041907|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102287679|NCT05041907|Protease Inhibitors|protease inhibitors|mesh-ancestor
102287680|NCT05041907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102287681|NCT05041907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287682|NCT05041907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102287683|NCT05041907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102287684|NCT05041907|Antiviral Agents|antiviral agents|mesh-ancestor
102287685|NCT05041907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102287686|NCT05041907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102287687|NCT05041907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102287688|NCT05041907|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102287689|NCT05041907|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102287690|NCT05041907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102287691|NCT05041907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102287692|NCT05041907|Serotonin Agents|serotonin agents|mesh-ancestor
102287693|NCT05041907|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102287694|NCT05041907|Antidepressive Agents|antidepressive agents|mesh-ancestor
102287695|NCT05041907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102287696|NCT05041907|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102287697|NCT05041907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102287698|NCT05041907|Antimetabolites|antimetabolites|mesh-ancestor
102287699|NCT05674253|Hydrocortisone|hydrocortisone|mesh-list
102287700|NCT05674253|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102287701|NCT05674253|Dexmedetomidine|dexmedetomidine|mesh-list
102287702|NCT05674253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102287703|NCT05674253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102287704|NCT05674253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287705|NCT05674253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102287706|NCT05674253|Analgesics|analgesics|mesh-ancestor
102287707|NCT05674253|Sensory System Agents|sensory system agents|mesh-ancestor
102287708|NCT05674253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102287709|NCT05674253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102287710|NCT05674253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102287711|NCT05674253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102287712|NCT05674253|Adrenergic Agents|adrenergic agents|mesh-ancestor
102287713|NCT05674253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102287714|NCT05674253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287715|NCT05674253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102287716|NCT02500641|Naproxen|naproxen|mesh-list
102287717|NCT02500641|Colchicine|colchicine|mesh-list
102287718|NCT02500641|Allopurinol|allopurinol|mesh-list
102287719|NCT02500641|Febuxostat|febuxostat|mesh-list
102287720|NCT02500641|Omeprazole|omeprazole|mesh-list
102287721|NCT02500641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102287722|NCT02500641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102287723|NCT02500641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102287724|NCT02500641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102287725|NCT02500641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287726|NCT02500641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102287727|NCT02500641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102287728|NCT02500641|Analgesics|analgesics|mesh-ancestor
102287729|NCT02500641|Sensory System Agents|sensory system agents|mesh-ancestor
102287730|NCT02500641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102287731|NCT02500641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287732|NCT02500641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102287733|NCT02500641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102287734|NCT02500641|Gout Suppressants|gout suppressants|mesh-ancestor
102287735|NCT02500641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102287736|NCT02500641|Tubulin Modulators|tubulin modulators|mesh-ancestor
102287737|NCT02500641|Antimitotic Agents|antimitotic agents|mesh-ancestor
102287738|NCT02500641|Mitosis Modulators|mitosis modulators|mesh-ancestor
102287739|NCT02500641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102287741|NCT02500641|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102287742|NCT02500641|Antioxidants|antioxidants|mesh-ancestor
102287743|NCT02500641|Protective Agents|protective agents|mesh-ancestor
102287744|NCT04973293|Bevacizumab|bevacizumab|mesh-list
102287745|NCT04973293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102287746|NCT04973293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102287747|NCT04973293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102287748|NCT04973293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102287749|NCT04973293|Growth Substances|growth substances|mesh-ancestor
102287750|NCT04973293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287751|NCT04973293|Growth Inhibitors|growth inhibitors|mesh-ancestor
102287752|NCT04962451|Ticagrelor|ticagrelor|mesh-list
102287753|NCT04962451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102287754|NCT04962451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102287755|NCT04962451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102287756|NCT04962451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102287757|NCT04962451|Purinergic Agents|purinergic agents|mesh-ancestor
102287758|NCT04962451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102287759|NCT04962451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287760|NCT04962451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287761|NCT04953871|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
102287762|NCT04953871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102287763|NCT03059719|Exenatide|exenatide|mesh-list
102287764|NCT03059719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102287765|NCT03059719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287766|NCT03059719|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102287768|NCT03059719|Hormones|hormones|mesh-ancestor
102287769|NCT03059719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102287770|NCT03060031|Oxytocin|oxytocin|mesh-list
102287771|NCT03060031|Oxytocics|oxytocics|mesh-ancestor
102287772|NCT03060031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102287773|NCT03060031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287774|NCT02499783|Adalimumab|adalimumab|mesh-list
102287775|NCT02499783|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102287776|NCT02499783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102287777|NCT02499783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102287778|NCT04972045|Curcumin|curcumin|mesh-list
102287779|NCT04972045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102287780|NCT04972045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102287781|NCT04972045|Analgesics|analgesics|mesh-ancestor
102287782|NCT04972045|Sensory System Agents|sensory system agents|mesh-ancestor
102287783|NCT04972045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102287784|NCT04972045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287785|NCT04972045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102287786|NCT04972045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102287787|NCT04972045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102287788|NCT04972045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102287789|NCT04972045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287790|NCT03059017|Albuterol|albuterol|mesh-list
102287791|NCT03059017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102287792|NCT03059017|Autonomic Agents|autonomic agents|mesh-ancestor
102287793|NCT03059017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102287794|NCT03059017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287795|NCT03059017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102287796|NCT03059017|Respiratory System Agents|respiratory system agents|mesh-ancestor
102287797|NCT03059017|Tocolytic Agents|tocolytic agents|mesh-ancestor
102287798|NCT03059017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102287799|NCT03059017|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102287800|NCT03059017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102287801|NCT03059017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102287802|NCT03059017|Adrenergic Agents|adrenergic agents|mesh-ancestor
102287803|NCT03059017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102287804|NCT03059017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287805|NCT04971577|Simvastatin|simvastatin|mesh-list
102287806|NCT04971577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102287807|NCT04971577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102287808|NCT04971577|Antimetabolites|antimetabolites|mesh-ancestor
102287809|NCT04971577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287811|NCT04971577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102287812|NCT04971577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102287813|NCT04425655|Fludarabine|fludarabine|mesh-list
102287814|NCT04425655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102287815|NCT04970719|Remdesivir|remdesivir|mesh-list
102287816|NCT04970719|Dexamethasone|dexamethasone|mesh-list
102287817|NCT04970719|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
102287818|NCT04970719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102287819|NCT04970719|Antiemetics|antiemetics|mesh-ancestor
102287820|NCT04970719|Autonomic Agents|autonomic agents|mesh-ancestor
102287821|NCT04970719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102287822|NCT04970719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287823|NCT04970719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102287824|NCT04970719|Glucocorticoids|glucocorticoids|mesh-ancestor
102287825|NCT04970719|Hormones|hormones|mesh-ancestor
102287826|NCT04970719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102287827|NCT04970719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102287828|NCT04970719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102287829|NCT04970719|Antimetabolites|antimetabolites|mesh-ancestor
102287830|NCT04970719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287831|NCT04970719|Antiviral Agents|antiviral agents|mesh-ancestor
102287832|NCT04970719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102287833|NCT04970719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102287834|NCT04970719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102287835|NCT02466399|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102287836|NCT02466399|Latanoprost|latanoprost|mesh-list
102287837|NCT02466399|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102287838|NCT03059251|Obinutuzumab|obinutuzumab|mesh-list
102287839|NCT03059251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102287840|NCT03059251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102287841|NCT04970251|Aflibercept|aflibercept|mesh-list
102287842|NCT04970251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102287843|NCT04970251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102287844|NCT04970251|Growth Substances|growth substances|mesh-ancestor
102287845|NCT04970251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287846|NCT04970251|Growth Inhibitors|growth inhibitors|mesh-ancestor
102287847|NCT04970251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102287848|NCT04970329|Dextrans|dextrans|mesh-list
102287849|NCT04970329|Anticoagulants|anticoagulants|mesh-ancestor
102287850|NCT04970329|Plasma Substitutes|plasma substitutes|mesh-ancestor
102287851|NCT04970329|Blood Substitutes|blood substitutes|mesh-ancestor
102287852|NCT04960657|Glyburide|glyburide|mesh-list
102287853|NCT04960657|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
102287854|NCT04960657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102287855|NCT04960657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287856|NCT04960657|Growth Substances|growth substances|mesh-ancestor
102287857|NCT04960657|Vasodilator Agents|vasodilator agents|mesh-ancestor
102287858|NCT04960657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102287859|NCT04960657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287860|NCT02464059|Vitamin D|vitamin d|mesh-list
102287861|NCT02464059|Cholecalciferol|cholecalciferol|mesh-list
102287862|NCT02464059|Vitamins|vitamins|mesh-ancestor
102287863|NCT02464059|Micronutrients|micronutrients|mesh-ancestor
102287864|NCT02464059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287865|NCT02464059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102287866|NCT02464059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102287867|NCT02463357|Metformin|metformin|mesh-list
102287868|NCT02463357|Nifedipine|nifedipine|mesh-list
102287869|NCT02463357|Methazolamide|methazolamide|mesh-list
102287870|NCT02463357|Quercetin|quercetin|mesh-list
102287871|NCT02463357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102287872|NCT02463357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287873|NCT02463357|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102287874|NCT02463357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102287875|NCT02463357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287876|NCT02463357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102287877|NCT02463357|Vasodilator Agents|vasodilator agents|mesh-ancestor
102287878|NCT02463357|Tocolytic Agents|tocolytic agents|mesh-ancestor
102287879|NCT02463357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102287880|NCT02463357|Antioxidants|antioxidants|mesh-ancestor
102287881|NCT02463357|Protective Agents|protective agents|mesh-ancestor
102287882|NCT02463357|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102287883|NCT02463357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102287884|NCT02463357|Diuretics|diuretics|mesh-ancestor
102287885|NCT02463357|Natriuretic Agents|natriuretic agents|mesh-ancestor
102287886|NCT04959721|Triamcinolone|triamcinolone|mesh-list
102287887|NCT04959721|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102287888|NCT04959721|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102287889|NCT04959721|Bupivacaine|bupivacaine|mesh-list
102287890|NCT04959721|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102287891|NCT04959721|Anesthetics, Local|anesthetics, local|mesh-ancestor
102287892|NCT04959721|Anesthetics|anesthetics|mesh-ancestor
102287893|NCT04959721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102287894|NCT04959721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287895|NCT04959721|Sensory System Agents|sensory system agents|mesh-ancestor
102287896|NCT04959721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102287897|NCT04959721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102287898|NCT04959721|Glucocorticoids|glucocorticoids|mesh-ancestor
102287900|NCT04959721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102287901|NCT04959721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102287902|NCT04959721|Immunologic Factors|immunologic factors|mesh-ancestor
102287903|NCT04959721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102287904|NCT04959721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287905|NCT04968613|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
102287906|NCT04968613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102287907|NCT04968613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287908|NCT04968613|Dopamine Agents|dopamine agents|mesh-ancestor
102287909|NCT04968613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102287910|NCT04968613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287911|NCT04676555|Ofatumumab|ofatumumab|mesh-list
102287912|NCT04676555|Ocrelizumab|ocrelizumab|mesh-list
102287913|NCT04676555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102287914|NCT04676555|Immunologic Factors|immunologic factors|mesh-ancestor
102287915|NCT04676555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287916|NCT04314167|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
102287917|NCT04314167|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102287918|NCT04314167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102287919|NCT04314167|Antimetabolites|antimetabolites|mesh-ancestor
102287920|NCT04314167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287921|NCT04314167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102287922|NCT04314167|Protease Inhibitors|protease inhibitors|mesh-ancestor
102287923|NCT04314167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102287924|NCT04314167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102287925|NCT05575427|Levofloxacin|levofloxacin|mesh-list
102287926|NCT05575427|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102287927|NCT05575427|Minocycline|minocycline|mesh-list
102287928|NCT05575427|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102287929|NCT05575427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102287930|NCT05575427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102287931|NCT05575427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102287932|NCT05575427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102287933|NCT05575427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102287934|NCT05575427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287935|NCT05575427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102287936|NCT05575427|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102287937|NCT05575427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102287938|NCT05575427|Antimalarials|antimalarials|mesh-ancestor
102287939|NCT05575427|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102287940|NCT05575427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102287941|NCT04959253|Psilocybin|psilocybin|mesh-list
102287942|NCT04959253|Hallucinogens|hallucinogens|mesh-ancestor
102287943|NCT04959253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287944|NCT04959253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102287945|NCT02499159|Bupivacaine|bupivacaine|mesh-list
102287946|NCT02499159|Anesthetics, Local|anesthetics, local|mesh-ancestor
102287947|NCT02499159|Anesthetics|anesthetics|mesh-ancestor
102287948|NCT02499159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102287949|NCT02499159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287950|NCT02499159|Sensory System Agents|sensory system agents|mesh-ancestor
102287951|NCT02499159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102287952|NCT01664039|Bimatoprost|bimatoprost|mesh-list
102287953|NCT01664039|Travoprost|travoprost|mesh-list
102287954|NCT01664039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102287955|NCT01664039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102287956|NCT01664039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102287957|NCT05645705|Listerine|listerine|mesh-list
102287958|NCT05645705|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
102287959|NCT05645705|Sodium Fluoride|sodium fluoride|mesh-list
102287961|NCT05645705|Protective Agents|protective agents|mesh-ancestor
102287962|NCT05645705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287963|NCT05645705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102287964|NCT02445339|Naltrexone|naltrexone|mesh-list
102287965|NCT02445339|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102287966|NCT02445339|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102287967|NCT02445339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287968|NCT02445339|Sensory System Agents|sensory system agents|mesh-ancestor
102287969|NCT02445339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102287970|NCT04959409|Tetracaine|tetracaine|mesh-list
102287971|NCT04959409|Anesthetics, Local|anesthetics, local|mesh-ancestor
102287972|NCT04959409|Anesthetics|anesthetics|mesh-ancestor
102287973|NCT04959409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102287974|NCT04959409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287975|NCT04959409|Sensory System Agents|sensory system agents|mesh-ancestor
102287976|NCT04959409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102287977|NCT03058939|Tamoxifen|tamoxifen|mesh-list
102287978|NCT03058939|Paclitaxel|paclitaxel|mesh-list
102287979|NCT03058939|Carboplatin|carboplatin|mesh-list
102287980|NCT03058939|Trastuzumab|trastuzumab|mesh-list
102287981|NCT03058939|Letrozole|letrozole|mesh-list
102287982|NCT03058939|Pertuzumab|pertuzumab|mesh-list
102287983|NCT03058939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102287984|NCT03058939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102287985|NCT03058939|Tubulin Modulators|tubulin modulators|mesh-ancestor
102287986|NCT03058939|Antimitotic Agents|antimitotic agents|mesh-ancestor
102287987|NCT03058939|Mitosis Modulators|mitosis modulators|mesh-ancestor
102287988|NCT03058939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102287989|NCT03058939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102287990|NCT03058939|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102287991|NCT03058939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102287992|NCT03058939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102287993|NCT03058939|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102287994|NCT03058939|Hormone Antagonists|hormone antagonists|mesh-ancestor
102287995|NCT03058939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102287996|NCT03058939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102287997|NCT03058939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102287998|NCT03058939|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102287999|NCT03058939|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102288000|NCT03058939|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102288001|NCT03058471|Methotrexate|methotrexate|mesh-list
102288002|NCT03058471|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102288003|NCT03058471|Abortifacient Agents|abortifacient agents|mesh-ancestor
102288004|NCT03058471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102288005|NCT03058471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288006|NCT03058471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102288007|NCT03058471|Antimetabolites|antimetabolites|mesh-ancestor
102288008|NCT03058471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288009|NCT03058471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102288010|NCT03058471|Dermatologic Agents|dermatologic agents|mesh-ancestor
102288011|NCT03058471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102288012|NCT03058471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102288013|NCT03058471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102288014|NCT03058471|Immunologic Factors|immunologic factors|mesh-ancestor
102288015|NCT03058471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102288016|NCT03058471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102288017|NCT02579603|Pirfenidone|pirfenidone|mesh-list
102288018|NCT02579603|Nintedanib|nintedanib|mesh-list
102288019|NCT02579603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102288020|NCT02579603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102288021|NCT02579603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102288022|NCT02579603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288023|NCT02579603|Analgesics|analgesics|mesh-ancestor
102288024|NCT02579603|Sensory System Agents|sensory system agents|mesh-ancestor
102288025|NCT02579603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102288026|NCT02579603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288027|NCT02579603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102288028|NCT02579603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102288029|NCT02579603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102288030|NCT02579603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102288031|NCT04291079|Antibodies|antibodies|mesh-list
102288032|NCT04291079|Immunologic Factors|immunologic factors|mesh-ancestor
101629734|NCT02702817|Gout Suppressants|gout suppressants|mesh-ancestor
102288033|NCT04291079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288034|NCT03060889|Tranexamic Acid|tranexamic acid|mesh-list
102288035|NCT03060889|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102288036|NCT03060889|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102288037|NCT03060889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288038|NCT03060889|Hemostatics|hemostatics|mesh-ancestor
102288039|NCT03060889|Coagulants|coagulants|mesh-ancestor
102288040|NCT05546957|Aspirin|aspirin|mesh-list
102288041|NCT05546957|Rivaroxaban|rivaroxaban|mesh-list
102288042|NCT05546957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102288043|NCT05546957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102288044|NCT05546957|Analgesics|analgesics|mesh-ancestor
102288045|NCT05546957|Sensory System Agents|sensory system agents|mesh-ancestor
101388200|NCT06000501|Dopamine Agents|dopamine agents|mesh-ancestor
102288046|NCT05546957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102288047|NCT05546957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288048|NCT05546957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102288049|NCT05546957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102288050|NCT05546957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102288051|NCT05546957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102288052|NCT05546957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288053|NCT05546957|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102288054|NCT05546957|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102288055|NCT05546957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102288056|NCT05546957|Antipyretics|antipyretics|mesh-ancestor
102288057|NCT05546957|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102288058|NCT05546957|Antithrombins|antithrombins|mesh-ancestor
102288059|NCT05546957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102288060|NCT05546957|Protease Inhibitors|protease inhibitors|mesh-ancestor
102288061|NCT05546957|Anticoagulants|anticoagulants|mesh-ancestor
102288062|NCT04950205|Sevoflurane|sevoflurane|mesh-list
102288063|NCT04950205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102288064|NCT04950205|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102288065|NCT04950205|Anesthetics, General|anesthetics, general|mesh-ancestor
102288066|NCT04950205|Anesthetics|anesthetics|mesh-ancestor
102288067|NCT04950205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102288068|NCT04950205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288069|NCT02625259|Lansoprazole|lansoprazole|mesh-list
102288070|NCT02625259|Dexlansoprazole|dexlansoprazole|mesh-list
102288071|NCT02625259|Serabelisib|serabelisib|mesh-list
102288072|NCT02625259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102288073|NCT02625259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102288074|NCT02625259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102288075|NCT02625259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102288076|NCT02625259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288077|NCT02577107|Ranibizumab|ranibizumab|mesh-list
102288078|NCT02577107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102288079|NCT02577107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102288080|NCT02577107|Growth Substances|growth substances|mesh-ancestor
102288081|NCT02577107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288082|NCT02577107|Growth Inhibitors|growth inhibitors|mesh-ancestor
102288083|NCT02577107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102288085|NCT04958473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102288086|NCT04958473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102288087|NCT04958473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102288088|NCT04958473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288089|NCT04957927|Fluticasone|fluticasone|mesh-list
102288091|NCT04957927|Montelukast|montelukast|mesh-list
102288092|NCT04957927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102288093|NCT04957927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102288094|NCT04957927|Autonomic Agents|autonomic agents|mesh-ancestor
102288095|NCT04957927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102288096|NCT04957927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288097|NCT04957927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102288098|NCT04957927|Respiratory System Agents|respiratory system agents|mesh-ancestor
102288099|NCT04957927|Dermatologic Agents|dermatologic agents|mesh-ancestor
102288100|NCT04957927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102288101|NCT04957927|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102288102|NCT04957927|Hormone Antagonists|hormone antagonists|mesh-ancestor
102288103|NCT04957927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102288104|NCT04957927|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102288105|NCT04957927|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102288106|NCT04957927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288107|NCT04688801|Antineoplastic Agents|antineoplastic agents|mesh-list
102288108|NCT04950049|Dexamethasone|dexamethasone|mesh-list
102288109|NCT04950049|Dexamethasone acetate|dexamethasone acetate|mesh-list
102288110|NCT04950049|BB 1101|bb 1101|mesh-list
102288111|NCT04950049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102288112|NCT04950049|Antiemetics|antiemetics|mesh-ancestor
102288113|NCT04950049|Autonomic Agents|autonomic agents|mesh-ancestor
102288114|NCT04950049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102288115|NCT04950049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288116|NCT04950049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102288117|NCT04950049|Glucocorticoids|glucocorticoids|mesh-ancestor
102288118|NCT04950049|Hormones|hormones|mesh-ancestor
102288119|NCT04950049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102288120|NCT04950049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102288121|NCT04950049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102288122|NCT04950049|Protease Inhibitors|protease inhibitors|mesh-ancestor
102288123|NCT04950049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102288124|NCT04950049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288125|NCT05587673|Methylprednisolone|methylprednisolone|mesh-list
102288126|NCT05587673|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102288127|NCT05587673|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102288128|NCT05587673|Prednisolone|prednisolone|mesh-list
102288129|NCT05587673|Prednisolone acetate|prednisolone acetate|mesh-list
102288130|NCT05587673|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102288131|NCT05587673|Prednisolone phosphate|prednisolone phosphate|mesh-list
102288132|NCT05587673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102288133|NCT05587673|Antiemetics|antiemetics|mesh-ancestor
102288134|NCT05587673|Autonomic Agents|autonomic agents|mesh-ancestor
102288135|NCT05587673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102288136|NCT05587673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288137|NCT05587673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102288138|NCT05587673|Glucocorticoids|glucocorticoids|mesh-ancestor
102288139|NCT05587673|Hormones|hormones|mesh-ancestor
102288140|NCT05587673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102288141|NCT05587673|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102288142|NCT05587673|Protective Agents|protective agents|mesh-ancestor
102288143|NCT05587673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102288145|NCT02444793|Mogamulizumab|mogamulizumab|mesh-list
102288146|NCT02444793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102288147|NCT04966429|Maraviroc|maraviroc|mesh-list
102288148|NCT04966429|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102288149|NCT04966429|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102288150|NCT04966429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288151|NCT04966429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102288152|NCT04966429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102288153|NCT04966429|Antiviral Agents|antiviral agents|mesh-ancestor
102288154|NCT04966429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102288155|NCT04966429|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102288156|NCT04949347|Glycerol|glycerol|mesh-list
102288157|NCT04949347|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102288158|NCT04949347|Protective Agents|protective agents|mesh-ancestor
102288159|NCT04949347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288160|NCT04948957|Nitroglycerin|nitroglycerin|mesh-list
102288161|NCT04948957|Esmolol|esmolol|mesh-list
102288162|NCT04948957|Vasodilator Agents|vasodilator agents|mesh-ancestor
102288163|NCT04948957|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102288164|NCT04948957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102288165|NCT04948957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102288166|NCT04948957|Adrenergic Agents|adrenergic agents|mesh-ancestor
102288167|NCT04948957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102288168|NCT04948957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288169|NCT04948957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288170|NCT04948801|Sofosbuvir|sofosbuvir|mesh-list
102288171|NCT04948801|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102288172|NCT04948801|Velpatasvir|velpatasvir|mesh-list
102288173|NCT04948801|Antiviral Agents|antiviral agents|mesh-ancestor
102288174|NCT04948801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102288175|NCT04948567|Magnesium Sulfate|magnesium sulfate|mesh-list
102288176|NCT04948567|Analgesics|analgesics|mesh-ancestor
102288177|NCT04948567|Sensory System Agents|sensory system agents|mesh-ancestor
102288178|NCT04948567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102288179|NCT04948567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288180|NCT04948567|Anesthetics|anesthetics|mesh-ancestor
102288181|NCT04948567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102288182|NCT04948567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102288183|NCT04948567|Anticonvulsants|anticonvulsants|mesh-ancestor
102288184|NCT04948567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102288185|NCT04948567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102288186|NCT04948567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288187|NCT04948567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102288188|NCT04948567|Tocolytic Agents|tocolytic agents|mesh-ancestor
102288189|NCT04948567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102288190|NCT04419181|Carboplatin|carboplatin|mesh-list
102288191|NCT04419181|Docetaxel|docetaxel|mesh-list
102288192|NCT04419181|Trastuzumab|trastuzumab|mesh-list
102288193|NCT04419181|Pertuzumab|pertuzumab|mesh-list
102288194|NCT04419181|Maytansine|maytansine|mesh-list
102288195|NCT04419181|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102288196|NCT04419181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102288197|NCT04419181|Tubulin Modulators|tubulin modulators|mesh-ancestor
102288198|NCT04419181|Antimitotic Agents|antimitotic agents|mesh-ancestor
102288199|NCT04419181|Mitosis Modulators|mitosis modulators|mesh-ancestor
102288200|NCT04419181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288201|NCT04419181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102288202|NCT04419181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102288203|NCT04419181|Immunotoxins|immunotoxins|mesh-ancestor
102288204|NCT04419181|Immunoconjugates|immunoconjugates|mesh-ancestor
102288205|NCT04419181|Immunologic Factors|immunologic factors|mesh-ancestor
102288206|NCT04419181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288207|NCT04430179|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102288208|NCT04430179|Immunologic Factors|immunologic factors|mesh-ancestor
102288209|NCT04430179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288210|NCT04946929|Heparin|heparin|mesh-list
102288211|NCT04946929|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102288212|NCT04946929|Tinzaparin|tinzaparin|mesh-list
102288213|NCT04946929|Dalteparin|dalteparin|mesh-list
102288214|NCT04946929|Ticagrelor|ticagrelor|mesh-list
102288215|NCT04946929|Anticoagulants|anticoagulants|mesh-ancestor
102288216|NCT04946929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102288217|NCT04946929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102288218|NCT04946929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288219|NCT04946929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102288220|NCT04946929|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102288221|NCT04946929|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102288222|NCT04946929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102288223|NCT04946929|Purinergic Agents|purinergic agents|mesh-ancestor
102288224|NCT04946929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102288225|NCT04946929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288226|NCT03058237|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
102288227|NCT03058237|Baclofen|baclofen|mesh-list
102288228|NCT03058237|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102288229|NCT03058237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288230|NCT03058237|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102288231|NCT03058237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102288232|NCT03058237|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102288233|NCT03058237|GABA Agonists|gaba agonists|mesh-ancestor
102288234|NCT03058237|GABA Agents|gaba agents|mesh-ancestor
102288235|NCT03058237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102288236|NCT03058237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288237|NCT04947241|Gemcitabine|gemcitabine|mesh-list
102288238|NCT04947241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102288239|NCT04947241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102288240|NCT04947241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102288241|NCT04947241|Antimetabolites|antimetabolites|mesh-ancestor
102288242|NCT04947241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288243|NCT04947241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102288244|NCT04933279|Iodine|iodine|mesh-list
102288245|NCT04933279|Cadexomer iodine|cadexomer iodine|mesh-list
102288246|NCT04933279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102288247|NCT04933279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102288248|NCT04933279|Trace Elements|trace elements|mesh-ancestor
102288249|NCT04933279|Micronutrients|micronutrients|mesh-ancestor
102288250|NCT04933279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288251|NCT02577029|Interferons|interferons|mesh-list
102288252|NCT02577029|Tenofovir|tenofovir|mesh-list
102288253|NCT02577029|Interferon-alpha|interferon-alpha|mesh-list
102288254|NCT02577029|Interferon alpha-2|interferon alpha-2|mesh-list
102288255|NCT02577029|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102288256|NCT02577029|Entecavir|entecavir|mesh-list
102288257|NCT02577029|Histamine Antagonists|histamine antagonists|mesh-list
102288258|NCT02577029|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
102288259|NCT02577029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102288260|NCT02577029|Antiviral Agents|antiviral agents|mesh-ancestor
102288261|NCT02577029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102288262|NCT02577029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102288263|NCT02577029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102288264|NCT02577029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102288265|NCT02577029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288266|NCT02577029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102288267|NCT02577029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102288268|NCT02577029|Immunologic Factors|immunologic factors|mesh-ancestor
102288269|NCT02577029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288270|NCT02577029|Histamine Agents|histamine agents|mesh-ancestor
102288271|NCT02577029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102288272|NCT04946383|Dasatinib|dasatinib|mesh-list
102288273|NCT04946383|Quercetin|quercetin|mesh-list
102288274|NCT04946383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102288275|NCT04946383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102288276|NCT04946383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102288277|NCT04946383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288278|NCT04946383|Antioxidants|antioxidants|mesh-ancestor
102288279|NCT04946383|Protective Agents|protective agents|mesh-ancestor
102288280|NCT04946383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288281|NCT04943653|Paclitaxel|paclitaxel|mesh-list
102288282|NCT04943653|Capecitabine|capecitabine|mesh-list
102288283|NCT04943653|Oxaliplatin|oxaliplatin|mesh-list
102288284|NCT04943653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102288285|NCT04943653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102288286|NCT04943653|Tubulin Modulators|tubulin modulators|mesh-ancestor
102288287|NCT04943653|Antimitotic Agents|antimitotic agents|mesh-ancestor
102288288|NCT04943653|Mitosis Modulators|mitosis modulators|mesh-ancestor
102288289|NCT04943653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288290|NCT04943653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102288291|NCT04943653|Antimetabolites|antimetabolites|mesh-ancestor
102288292|NCT04943029|Paclitaxel|paclitaxel|mesh-list
101997015|NCT05166538|Ticagrelor|ticagrelor|mesh-list
102288293|NCT04943029|Carboplatin|carboplatin|mesh-list
102288294|NCT04943029|Pemetrexed|pemetrexed|mesh-list
102288295|NCT04943029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102288297|NCT04943029|Tubulin Modulators|tubulin modulators|mesh-ancestor
102288298|NCT04943029|Antimitotic Agents|antimitotic agents|mesh-ancestor
102288299|NCT04943029|Mitosis Modulators|mitosis modulators|mesh-ancestor
102288300|NCT04943029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288301|NCT04943029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102288302|NCT04943029|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102288303|NCT04943029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102288304|NCT03660059|Antirheumatic Agents|antirheumatic agents|mesh-list
102288305|NCT03660059|Peficitinib|peficitinib|mesh-list
102288306|NCT03660059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102288307|NCT03660059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288308|NCT03660059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102288309|NCT03660059|Immunologic Factors|immunologic factors|mesh-ancestor
102288310|NCT03660059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288311|NCT04946227|Paclitaxel|paclitaxel|mesh-list
102288312|NCT04946227|Pembrolizumab|pembrolizumab|mesh-list
102288313|NCT04946227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102288314|NCT04946227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102288315|NCT04946227|Tubulin Modulators|tubulin modulators|mesh-ancestor
102288316|NCT04946227|Antimitotic Agents|antimitotic agents|mesh-ancestor
102288317|NCT04946227|Mitosis Modulators|mitosis modulators|mesh-ancestor
102288318|NCT04946227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288319|NCT04946227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102288320|NCT04946227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102288321|NCT04932187|Capecitabine|capecitabine|mesh-list
102288322|NCT04932187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102288323|NCT04932187|Antimetabolites|antimetabolites|mesh-ancestor
102288324|NCT04932187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288325|NCT04932187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102288326|NCT04945681|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102288327|NCT04945681|Immunologic Factors|immunologic factors|mesh-ancestor
102288328|NCT04945681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288329|NCT03597347|Molgramostim|molgramostim|mesh-list
102288330|NCT03597347|Sargramostim|sargramostim|mesh-list
102288331|NCT03597347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102288332|NCT03597347|Immunologic Factors|immunologic factors|mesh-ancestor
102288333|NCT03597347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288334|NCT04930627|Empagliflozin|empagliflozin|mesh-list
102288335|NCT04930627|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102288336|NCT04930627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288337|NCT04930627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102288338|NCT04930627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288339|NCT03057769|Indomethacin|indomethacin|mesh-list
102288340|NCT03057769|Epinephrine|epinephrine|mesh-list
102288341|NCT03057769|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102288342|NCT03057769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102288343|NCT03057769|Adrenergic Agents|adrenergic agents|mesh-ancestor
102288344|NCT03057769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102288345|NCT03057769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288346|NCT03057769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288347|NCT03057769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102288348|NCT03057769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102288349|NCT03057769|Autonomic Agents|autonomic agents|mesh-ancestor
102288350|NCT03057769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102288351|NCT03057769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102288352|NCT03057769|Respiratory System Agents|respiratory system agents|mesh-ancestor
102288353|NCT03057769|Mydriatics|mydriatics|mesh-ancestor
102288354|NCT03057769|Sympathomimetics|sympathomimetics|mesh-ancestor
102288355|NCT03057769|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102288356|NCT03057769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102288357|NCT03057769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102288358|NCT03057769|Analgesics|analgesics|mesh-ancestor
102288359|NCT03057769|Sensory System Agents|sensory system agents|mesh-ancestor
102288360|NCT03057769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102288361|NCT03057769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102288362|NCT03057769|Gout Suppressants|gout suppressants|mesh-ancestor
102288363|NCT03057769|Tocolytic Agents|tocolytic agents|mesh-ancestor
102288364|NCT03057769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102288365|NCT03057769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102288366|NCT03057769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102288367|NCT04633577|Lidocaine|lidocaine|mesh-list
102288368|NCT04633577|Anesthetics, Local|anesthetics, local|mesh-ancestor
102288369|NCT04633577|Anesthetics|anesthetics|mesh-ancestor
102288370|NCT04633577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102288371|NCT04633577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288372|NCT04633577|Sensory System Agents|sensory system agents|mesh-ancestor
102288373|NCT04633577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102288374|NCT04633577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102288375|NCT04633577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102288376|NCT04633577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102288377|NCT04633577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102288378|NCT04633577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288379|NCT04941625|Cystatins|cystatins|mesh-list
102288380|NCT04941625|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
102288381|NCT04941625|Protease Inhibitors|protease inhibitors|mesh-ancestor
102288382|NCT04941625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102288383|NCT04941625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288384|NCT04922047|Tislelizumab|tislelizumab|mesh-list
102288385|NCT04922047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102288386|NCT04922047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102288387|NCT04406389|Heparin|heparin|mesh-list
102288388|NCT04406389|Calcium heparin|calcium heparin|mesh-list
102288389|NCT04406389|Enoxaparin|enoxaparin|mesh-list
102288390|NCT04406389|Enoxaparin sodium|enoxaparin sodium|mesh-list
102288391|NCT04406389|Argatroban|argatroban|mesh-list
102288392|NCT04406389|Anticoagulants|anticoagulants|mesh-ancestor
102288393|NCT04406389|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102288394|NCT04406389|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102288395|NCT04406389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288396|NCT04406389|Antithrombins|antithrombins|mesh-ancestor
102288397|NCT04406389|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102288398|NCT04406389|Protease Inhibitors|protease inhibitors|mesh-ancestor
102288399|NCT04406389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102288400|NCT04406389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102288401|NCT04921657|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102288402|NCT04921657|Simvastatin|simvastatin|mesh-list
102288403|NCT04921657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102288404|NCT04921657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102288405|NCT04921657|Antimetabolites|antimetabolites|mesh-ancestor
102288406|NCT04921657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288407|NCT04921657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102288408|NCT04921657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102288409|NCT04921657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102288411|NCT04930471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102288412|NCT04930471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288413|NCT04940689|Lidocaine|lidocaine|mesh-list
102288414|NCT04940689|Dexmedetomidine|dexmedetomidine|mesh-list
102288415|NCT04940689|Remifentanil|remifentanil|mesh-list
102288416|NCT04940689|Anesthetics, Local|anesthetics, local|mesh-ancestor
102288417|NCT04940689|Anesthetics|anesthetics|mesh-ancestor
102288418|NCT04940689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102288419|NCT04940689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288420|NCT04940689|Sensory System Agents|sensory system agents|mesh-ancestor
102288421|NCT04940689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102288422|NCT04940689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102288423|NCT04940689|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102288424|NCT04940689|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102288425|NCT04940689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102288426|NCT04940689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288427|NCT04940689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102288428|NCT04940689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102288429|NCT04940689|Analgesics|analgesics|mesh-ancestor
102288430|NCT04940689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102288431|NCT04940689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102288432|NCT04940689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102288433|NCT04940689|Adrenergic Agents|adrenergic agents|mesh-ancestor
102288434|NCT04940689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102288435|NCT04940689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102288436|NCT04940689|Narcotics|narcotics|mesh-ancestor
102288437|NCT05530811|Dexamethasone|dexamethasone|mesh-list
102288438|NCT05530811|Bupivacaine|bupivacaine|mesh-list
102288439|NCT05530811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102288440|NCT05530811|Antiemetics|antiemetics|mesh-ancestor
102288441|NCT05530811|Autonomic Agents|autonomic agents|mesh-ancestor
102288442|NCT05530811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102288443|NCT05530811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288444|NCT05530811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102288445|NCT05530811|Glucocorticoids|glucocorticoids|mesh-ancestor
102288446|NCT05530811|Hormones|hormones|mesh-ancestor
102288447|NCT05530811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102288448|NCT05530811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102288449|NCT05530811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102288450|NCT05530811|Anesthetics, Local|anesthetics, local|mesh-ancestor
102288451|NCT05530811|Anesthetics|anesthetics|mesh-ancestor
102288452|NCT05530811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102288453|NCT05530811|Sensory System Agents|sensory system agents|mesh-ancestor
102288454|NCT04940845|Denosumab|denosumab|mesh-list
102288455|NCT04940845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102288456|NCT04940845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288457|NCT04921111|Aluminum phosphate|aluminum phosphate|mesh-list
102288458|NCT04921111|Vaccines|vaccines|mesh-list
102288459|NCT04921111|Immunologic Factors|immunologic factors|mesh-ancestor
102288460|NCT04921111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288461|NCT04921111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102288462|NCT04921111|Antacids|antacids|mesh-ancestor
102288463|NCT04921111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288464|NCT04921111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102288465|NCT03387917|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102288466|NCT03387917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102288467|NCT03387917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102288468|NCT03057145|Olaparib|olaparib|mesh-list
102288469|NCT03057145|Prexasertib|prexasertib|mesh-list
102288470|NCT03057145|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102288471|NCT03057145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102288472|NCT03057145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288473|NCT03057145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102288474|NCT03057145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102288475|NCT04940143|Botulinum Toxins|botulinum toxins|mesh-list
102288476|NCT04940143|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102288477|NCT04940143|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102288478|NCT04940143|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102288479|NCT04940143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102288480|NCT04940143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288481|NCT04940143|Cholinergic Agents|cholinergic agents|mesh-ancestor
102288482|NCT04940143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102288483|NCT04940143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630184|NCT04215237|Atorvastatin|atorvastatin|mesh-list
102288484|NCT04940143|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102288485|NCT04940143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102288486|NCT04939675|Lamotrigine|lamotrigine|mesh-list
102288487|NCT04939675|Zonisamide|zonisamide|mesh-list
102288488|NCT04939675|Levetiracetam|levetiracetam|mesh-list
102288489|NCT04939675|Anticonvulsants|anticonvulsants|mesh-ancestor
102288490|NCT04939675|Nootropic Agents|nootropic agents|mesh-ancestor
102288491|NCT04939675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102288492|NCT04939675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102288493|NCT04939675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288494|NCT04939675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102288495|NCT04939675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288496|NCT04939675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102288497|NCT04939675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102288498|NCT04939675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102288499|NCT04939675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102288500|NCT04939675|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102288501|NCT04938583|Paclitaxel|paclitaxel|mesh-list
102288502|NCT04938583|Bevacizumab|bevacizumab|mesh-list
102288503|NCT04938583|Carboplatin|carboplatin|mesh-list
102288504|NCT04938583|Oregovomab|oregovomab|mesh-list
102288505|NCT04938583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102288506|NCT04938583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102288507|NCT04938583|Tubulin Modulators|tubulin modulators|mesh-ancestor
102288508|NCT04938583|Antimitotic Agents|antimitotic agents|mesh-ancestor
102288509|NCT04938583|Mitosis Modulators|mitosis modulators|mesh-ancestor
102288510|NCT04938583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288511|NCT04938583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102288512|NCT04938583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102288513|NCT04938583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102288514|NCT04938583|Growth Substances|growth substances|mesh-ancestor
102288515|NCT04938583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288516|NCT04938583|Growth Inhibitors|growth inhibitors|mesh-ancestor
102288517|NCT03055663|Midazolam|midazolam|mesh-list
102288518|NCT03055663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
102288519|NCT03055663|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102288520|NCT03055663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102288521|NCT03055663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288523|NCT03055663|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102288524|NCT03055663|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102288525|NCT03055663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102288526|NCT03055663|Anesthetics, General|anesthetics, general|mesh-ancestor
102288527|NCT03055663|Anesthetics|anesthetics|mesh-ancestor
102288528|NCT03055663|GABA Modulators|gaba modulators|mesh-ancestor
102288529|NCT03055663|GABA Agents|gaba agents|mesh-ancestor
102288530|NCT03055663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102288531|NCT03055663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288532|NCT03057691|Antidepressive Agents|antidepressive agents|mesh-list
102288533|NCT03057691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102288534|NCT04928365|Antibodies|antibodies|mesh-list
102288535|NCT04928365|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102288536|NCT04928365|Immunologic Factors|immunologic factors|mesh-ancestor
102288537|NCT04928365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288538|NCT04938037|Methylprednisolone|methylprednisolone|mesh-list
102288539|NCT04938037|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102288540|NCT04938037|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102288541|NCT04938037|Prednisolone|prednisolone|mesh-list
102288542|NCT04938037|Prednisolone acetate|prednisolone acetate|mesh-list
102288543|NCT04938037|Bupivacaine|bupivacaine|mesh-list
102288544|NCT04938037|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102288545|NCT04938037|Prednisolone phosphate|prednisolone phosphate|mesh-list
102288546|NCT04938037|Anesthetics, Local|anesthetics, local|mesh-ancestor
102288547|NCT04938037|Anesthetics|anesthetics|mesh-ancestor
102288548|NCT04938037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102288549|NCT04938037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288550|NCT04938037|Sensory System Agents|sensory system agents|mesh-ancestor
102288551|NCT04938037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102288552|NCT04938037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102288553|NCT04938037|Antiemetics|antiemetics|mesh-ancestor
102288554|NCT04938037|Autonomic Agents|autonomic agents|mesh-ancestor
102288555|NCT04938037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102288556|NCT04938037|Glucocorticoids|glucocorticoids|mesh-ancestor
102288557|NCT04938037|Hormones|hormones|mesh-ancestor
102288558|NCT04938037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102288559|NCT04938037|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102288560|NCT04938037|Protective Agents|protective agents|mesh-ancestor
102288561|NCT04938037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102288562|NCT04938037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102288563|NCT04937569|Ivermectin|ivermectin|mesh-list
102288564|NCT04937569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102288565|NCT04937569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102288566|NCT04937101|Chlorpheniramine|chlorpheniramine|mesh-list
102288567|NCT04937101|Codeine|codeine|mesh-list
102288568|NCT04937101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102288569|NCT04937101|Narcotics|narcotics|mesh-ancestor
102288570|NCT04937101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102288571|NCT04937101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288572|NCT04937101|Analgesics|analgesics|mesh-ancestor
102288573|NCT04937101|Sensory System Agents|sensory system agents|mesh-ancestor
102288574|NCT04937101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102288575|NCT04937101|Antitussive Agents|antitussive agents|mesh-ancestor
102288576|NCT04937101|Respiratory System Agents|respiratory system agents|mesh-ancestor
102288577|NCT04937101|Antipruritics|antipruritics|mesh-ancestor
102288578|NCT04937101|Dermatologic Agents|dermatologic agents|mesh-ancestor
102288579|NCT04937101|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102288580|NCT04937101|Histamine Antagonists|histamine antagonists|mesh-ancestor
102288581|NCT04937101|Histamine Agents|histamine agents|mesh-ancestor
102288582|NCT04937101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102288583|NCT04937101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288584|NCT04937101|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102288585|NCT04937023|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102288586|NCT04937023|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102288587|NCT04937023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102288588|NCT04936711|Bupivacaine|bupivacaine|mesh-list
102288589|NCT04936711|Anesthetics, Local|anesthetics, local|mesh-ancestor
102288590|NCT04936711|Anesthetics|anesthetics|mesh-ancestor
102288591|NCT04936711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102288592|NCT04936711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288593|NCT04936711|Sensory System Agents|sensory system agents|mesh-ancestor
102288594|NCT04936711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102288595|NCT04431349|Clopidogrel|clopidogrel|mesh-list
102288596|NCT04431349|Ticagrelor|ticagrelor|mesh-list
102288597|NCT04431349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102288598|NCT04431349|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102288599|NCT04431349|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102288600|NCT04431349|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102288601|NCT04431349|Purinergic Agents|purinergic agents|mesh-ancestor
102288602|NCT04431349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102288603|NCT04431349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288604|NCT04431349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288606|NCT03055741|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102288607|NCT03055741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102288608|NCT03055741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288609|NCT03055741|Cholinergic Agents|cholinergic agents|mesh-ancestor
102288610|NCT03055741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102288611|NCT03055741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288612|NCT03055741|Nootropic Agents|nootropic agents|mesh-ancestor
102288613|NCT04927039|Iloprost|iloprost|mesh-list
102288614|NCT04927039|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102288615|NCT04927039|Vasodilator Agents|vasodilator agents|mesh-ancestor
102288616|NCT04917679|Diacerein|diacerein|mesh-list
102288617|NCT04917679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102288618|NCT02443155|Liraglutide|liraglutide|mesh-list
102288619|NCT02443155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102288620|NCT02443155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288621|NCT02443155|Incretins|incretins|mesh-ancestor
102288622|NCT02443155|Hormones|hormones|mesh-ancestor
102288623|NCT02443155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102288624|NCT04935541|Dexmedetomidine|dexmedetomidine|mesh-list
102288625|NCT04935541|Remifentanil|remifentanil|mesh-list
102288626|NCT04935541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102288627|NCT04935541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102288628|NCT04935541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288629|NCT04935541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102288630|NCT04935541|Analgesics|analgesics|mesh-ancestor
102288631|NCT04935541|Sensory System Agents|sensory system agents|mesh-ancestor
102288632|NCT04935541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102288633|NCT04935541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102288634|NCT04935541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102288635|NCT04935541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102288636|NCT04935541|Adrenergic Agents|adrenergic agents|mesh-ancestor
102288637|NCT04935541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102288638|NCT04935541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288639|NCT04935541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102288641|NCT04935073|Cetrorelix|cetrorelix|mesh-list
102288642|NCT04935073|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102288643|NCT04935073|Hormones|hormones|mesh-ancestor
102288644|NCT04935073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102288645|NCT04935073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288646|NCT04935073|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102288647|NCT04935073|Fertility Agents|fertility agents|mesh-ancestor
102288648|NCT04935073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102288649|NCT04935073|Hormone Antagonists|hormone antagonists|mesh-ancestor
102288650|NCT04917757|Dexamethasone|dexamethasone|mesh-list
102288651|NCT04917757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102288652|NCT04917757|Antiemetics|antiemetics|mesh-ancestor
102288653|NCT04917757|Autonomic Agents|autonomic agents|mesh-ancestor
102288654|NCT04917757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102288655|NCT04917757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288656|NCT04917757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102288657|NCT04917757|Glucocorticoids|glucocorticoids|mesh-ancestor
102288658|NCT04917757|Hormones|hormones|mesh-ancestor
102288659|NCT04917757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102288660|NCT04917757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102288661|NCT04917757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102288662|NCT04916899|Rifampin|rifampin|mesh-list
102288663|NCT04916899|Isoniazid|isoniazid|mesh-list
102288664|NCT04916899|Pyrazinamide|pyrazinamide|mesh-list
102288665|NCT04916899|Ethambutol|ethambutol|mesh-list
102288666|NCT04916899|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102288667|NCT04916899|Antitubercular Agents|antitubercular agents|mesh-ancestor
102288668|NCT04916899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101997375|NCT01328002|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102288669|NCT04916899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102288670|NCT04916899|Leprostatic Agents|leprostatic agents|mesh-ancestor
102288671|NCT04916899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102288672|NCT04916899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102288673|NCT04916899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288674|NCT04916899|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102288675|NCT04916899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102288676|NCT04916899|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102288677|NCT04916899|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102288678|NCT04916899|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102288679|NCT04916899|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102288680|NCT04916899|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102288681|NCT04916899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102288682|NCT04916899|Antimetabolites|antimetabolites|mesh-ancestor
102288683|NCT04916899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102288684|NCT04916821|Propolis|propolis|mesh-list
102288685|NCT04916821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102288686|NCT04916665|Teduglutide|teduglutide|mesh-list
102288687|NCT04916665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102288688|NCT04916665|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102288689|NCT04916665|Protective Agents|protective agents|mesh-ancestor
102288690|NCT04916665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288691|NCT04916353|Triamcinolone|triamcinolone|mesh-list
102288692|NCT04916353|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102288693|NCT04916353|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102288694|NCT04916353|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102288695|NCT04916353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102288696|NCT04916353|Glucocorticoids|glucocorticoids|mesh-ancestor
102288697|NCT04916353|Hormones|hormones|mesh-ancestor
102288698|NCT04916353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102288699|NCT04916353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288700|NCT04916353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102288701|NCT04916353|Immunologic Factors|immunologic factors|mesh-ancestor
102288702|NCT04916353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102288703|NCT04916353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288704|NCT03056599|Interferons|interferons|mesh-list
102288705|NCT03056599|Interferon-alpha|interferon-alpha|mesh-list
102288706|NCT03056599|Interferon alpha-2|interferon alpha-2|mesh-list
102288707|NCT03056599|Aldesleukin|aldesleukin|mesh-list
102288708|NCT03056599|Interferon-gamma|interferon-gamma|mesh-list
102288709|NCT03056599|Gemcitabine|gemcitabine|mesh-list
102288710|NCT03056599|Docetaxel|docetaxel|mesh-list
102288711|NCT03056599|Doxorubicin|doxorubicin|mesh-list
102288712|NCT03056599|Pembrolizumab|pembrolizumab|mesh-list
102288714|NCT03056599|Bortezomib|bortezomib|mesh-list
102288715|NCT03056599|Ipilimumab|ipilimumab|mesh-list
102288716|NCT03056599|Atezolizumab|atezolizumab|mesh-list
102288717|NCT03056599|Durvalumab|durvalumab|mesh-list
102288718|NCT03056599|Avelumab|avelumab|mesh-list
102288719|NCT03056599|Trabectedin|trabectedin|mesh-list
102288720|NCT03056599|Olaratumab|olaratumab|mesh-list
102288721|NCT03056599|Entrectinib|entrectinib|mesh-list
102288722|NCT03056599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102288723|NCT03056599|Antimetabolites|antimetabolites|mesh-ancestor
102288724|NCT03056599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288725|NCT03056599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102288726|NCT03056599|Tubulin Modulators|tubulin modulators|mesh-ancestor
102288727|NCT03056599|Antimitotic Agents|antimitotic agents|mesh-ancestor
102288728|NCT03056599|Mitosis Modulators|mitosis modulators|mesh-ancestor
102288729|NCT03056599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102288730|NCT03056599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102288731|NCT03056599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102288732|NCT03056599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102288733|NCT03056599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102288734|NCT03056599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102288735|NCT03056599|Antiviral Agents|antiviral agents|mesh-ancestor
102288736|NCT03056599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102288737|NCT03056599|Immunologic Factors|immunologic factors|mesh-ancestor
102288738|NCT03056599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288739|NCT03056599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102288740|NCT03056599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102288741|NCT03056599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102288742|NCT03056599|Alkylating Agents|alkylating agents|mesh-ancestor
102288743|NCT03056599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101997483|NCT03390790|Lidocaine|lidocaine|mesh-list
102288744|NCT04915885|Contraceptive Agents|contraceptive agents|mesh-list
102288745|NCT04915885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102288746|NCT04915885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288747|NCT04915963|Vitamin D|vitamin d|mesh-list
102288748|NCT04915963|Vitamins|vitamins|mesh-ancestor
102288749|NCT04915963|Micronutrients|micronutrients|mesh-ancestor
102288750|NCT04915963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288751|NCT04915963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102288752|NCT04915807|Paclitaxel|paclitaxel|mesh-list
102288753|NCT04915807|Irinotecan|irinotecan|mesh-list
102288754|NCT04915807|Ramucirumab|ramucirumab|mesh-list
102288756|NCT04915807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102288757|NCT04915807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102288758|NCT04915807|Tubulin Modulators|tubulin modulators|mesh-ancestor
102288759|NCT04915807|Antimitotic Agents|antimitotic agents|mesh-ancestor
102288760|NCT04915807|Mitosis Modulators|mitosis modulators|mesh-ancestor
102288761|NCT04915807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288762|NCT04915807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102288763|NCT04915807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102288764|NCT04915807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102288765|NCT01360021|Budesonide|budesonide|mesh-list
102288766|NCT01360021|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
102288767|NCT01360021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102288768|NCT01360021|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102288769|NCT01360021|Autonomic Agents|autonomic agents|mesh-ancestor
102288770|NCT01360021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102288771|NCT01360021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288772|NCT01360021|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102288773|NCT01360021|Respiratory System Agents|respiratory system agents|mesh-ancestor
102288774|NCT01360021|Glucocorticoids|glucocorticoids|mesh-ancestor
102288775|NCT01360021|Hormones|hormones|mesh-ancestor
102288776|NCT01360021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102288777|NCT04912297|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102288778|NCT04912297|Immunologic Factors|immunologic factors|mesh-ancestor
102288779|NCT04912297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288780|NCT02497287|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102288781|NCT02497287|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102288782|NCT02497287|Sertraline|sertraline|mesh-list
102288783|NCT02497287|Antidepressive Agents|antidepressive agents|mesh-list
102288784|NCT02497287|Esketamine|esketamine|mesh-list
102288785|NCT02497287|Escitalopram|escitalopram|mesh-list
102288786|NCT02497287|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102288787|NCT02497287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102288788|NCT02497287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101287605|NCT05411757|Lenvatinib|lenvatinib|mesh-list
102288789|NCT02497287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288790|NCT02497287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102288792|NCT02497287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288793|NCT02497287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102288794|NCT02497287|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102288795|NCT02497287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102288796|NCT02497287|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102288797|NCT02497287|Analgesics|analgesics|mesh-ancestor
102288798|NCT02497287|Sensory System Agents|sensory system agents|mesh-ancestor
102288799|NCT02497287|Dopamine Agents|dopamine agents|mesh-ancestor
102288800|NCT04912141|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
102288801|NCT04912141|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102288802|NCT04912141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102288803|NCT04912141|Immunologic Factors|immunologic factors|mesh-ancestor
102288804|NCT04912141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288805|NCT02458287|Bococizumab|bococizumab|mesh-list
102288806|NCT02458287|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102288807|NCT02458287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102288808|NCT02458287|Antimetabolites|antimetabolites|mesh-ancestor
102288809|NCT02458287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288810|NCT02458287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102288811|NCT03056053|Zolpidem|zolpidem|mesh-list
102288812|NCT03056053|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102288813|NCT03056053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102288814|NCT03056053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102288815|NCT03056053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288816|NCT03056053|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102288817|NCT03056053|GABA Agonists|gaba agonists|mesh-ancestor
102288818|NCT03056053|GABA Agents|gaba agents|mesh-ancestor
102288819|NCT03056053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102288820|NCT03056053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288821|NCT02496039|Quinidine|quinidine|mesh-list
102288822|NCT02496039|Dextromethorphan|dextromethorphan|mesh-list
102288823|NCT02496039|Antitussive Agents|antitussive agents|mesh-ancestor
102288824|NCT02496039|Respiratory System Agents|respiratory system agents|mesh-ancestor
102288825|NCT02496039|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102288826|NCT02496039|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102288827|NCT02496039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102288828|NCT02496039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288829|NCT02496039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288830|NCT02496039|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101389045|NCT05971602|Ethambutol|ethambutol|mesh-list
102288831|NCT02496039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102288832|NCT02496039|Adrenergic Agents|adrenergic agents|mesh-ancestor
102288833|NCT02496039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102288834|NCT02496039|Antimalarials|antimalarials|mesh-ancestor
102288835|NCT02496039|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102288836|NCT02496039|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102288837|NCT02496039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102288838|NCT02496039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102288839|NCT02496039|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102288840|NCT02496039|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102288841|NCT02496039|Cholinergic Agents|cholinergic agents|mesh-ancestor
102288842|NCT02496039|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102288843|NCT02496039|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102288844|NCT02496039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102288845|NCT02496039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102288846|NCT02496039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102288847|NCT04922359|Lidocaine|lidocaine|mesh-list
102288848|NCT04922359|Anesthetics, Local|anesthetics, local|mesh-ancestor
102288849|NCT04922359|Anesthetics|anesthetics|mesh-ancestor
102288850|NCT04922359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102288851|NCT04922359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288852|NCT04922359|Sensory System Agents|sensory system agents|mesh-ancestor
102288853|NCT04922359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102288854|NCT04922359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102288855|NCT04922359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102288856|NCT04922359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102288857|NCT04922359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102288858|NCT04922359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288859|NCT02495883|Ethanol|ethanol|mesh-list
102288860|NCT02495883|Propranolol|propranolol|mesh-list
102288861|NCT02495883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102288862|NCT02495883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102288863|NCT02495883|Adrenergic Agents|adrenergic agents|mesh-ancestor
102288864|NCT02495883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102288865|NCT02495883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288866|NCT02495883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288867|NCT02495883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102288868|NCT02495883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102288869|NCT02495883|Vasodilator Agents|vasodilator agents|mesh-ancestor
102288870|NCT02495883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102288871|NCT02495883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102288872|NCT02495883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102288873|NCT04910347|Nivolumab|nivolumab|mesh-list
102288874|NCT04910347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102288875|NCT04910347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102288876|NCT04910347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102288877|NCT04910347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288878|NCT02439957|Valganciclovir|valganciclovir|mesh-list
102288879|NCT02439957|Brincidofovir|brincidofovir|mesh-list
102288880|NCT02439957|Antiviral Agents|antiviral agents|mesh-ancestor
102288881|NCT02439957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102288882|NCT02457195|Granisetron|granisetron|mesh-list
102288883|NCT02457195|Antiemetics|antiemetics|mesh-ancestor
102288884|NCT02457195|Autonomic Agents|autonomic agents|mesh-ancestor
102288885|NCT02457195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102288886|NCT02457195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288887|NCT02457195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102288888|NCT02457195|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102288889|NCT02457195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102288890|NCT02457195|Serotonin Agents|serotonin agents|mesh-ancestor
102288891|NCT02457195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102288892|NCT02457195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288893|NCT04913779|Immunomodulating Agents|immunomodulating agents|mesh-list
102288894|NCT04913779|Immunologic Factors|immunologic factors|mesh-ancestor
102288895|NCT04913779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288896|NCT03054259|Methylprednisolone|methylprednisolone|mesh-list
102288897|NCT03054259|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102288898|NCT03054259|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102288899|NCT03054259|Prednisolone|prednisolone|mesh-list
102288900|NCT03054259|Prednisolone acetate|prednisolone acetate|mesh-list
102288901|NCT03054259|Rituximab|rituximab|mesh-list
102288902|NCT03054259|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102288903|NCT03054259|Prednisolone phosphate|prednisolone phosphate|mesh-list
102288904|NCT03054259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102288905|NCT03054259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102288906|NCT03054259|Immunologic Factors|immunologic factors|mesh-ancestor
102288907|NCT03054259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288908|NCT03054259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102288909|NCT03054259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102288910|NCT03054259|Antiemetics|antiemetics|mesh-ancestor
102288911|NCT03054259|Autonomic Agents|autonomic agents|mesh-ancestor
102288912|NCT03054259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102288913|NCT03054259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102288914|NCT03054259|Glucocorticoids|glucocorticoids|mesh-ancestor
102288915|NCT03054259|Hormones|hormones|mesh-ancestor
102288916|NCT03054259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102288917|NCT03054259|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102288918|NCT03054259|Protective Agents|protective agents|mesh-ancestor
102288919|NCT03054259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102288920|NCT01653327|Ketamine|ketamine|mesh-list
102288921|NCT01653327|Analgesics|analgesics|mesh-ancestor
102288922|NCT01653327|Sensory System Agents|sensory system agents|mesh-ancestor
102288923|NCT01653327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102288924|NCT01653327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288925|NCT01653327|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102288926|NCT01653327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102288927|NCT01653327|Anesthetics, General|anesthetics, general|mesh-ancestor
102288928|NCT01653327|Anesthetics|anesthetics|mesh-ancestor
102288929|NCT01653327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102288930|NCT01653327|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102288931|NCT01653327|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102288932|NCT01653327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102288933|NCT01653327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288934|NCT03053869|Diazepam|diazepam|mesh-list
102288935|NCT03053869|Lorazepam|lorazepam|mesh-list
102288937|NCT03053869|Anticonvulsants|anticonvulsants|mesh-ancestor
102288938|NCT03053869|Antiemetics|antiemetics|mesh-ancestor
102288939|NCT03053869|Autonomic Agents|autonomic agents|mesh-ancestor
102288940|NCT03053869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102288941|NCT03053869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288942|NCT03053869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102288943|NCT03053869|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102288944|NCT03053869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102288945|NCT03053869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102288946|NCT03053869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102288947|NCT03053869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102288948|NCT03053869|GABA Modulators|gaba modulators|mesh-ancestor
102288949|NCT03053869|GABA Agents|gaba agents|mesh-ancestor
102288950|NCT03053869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102288951|NCT03053869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288952|NCT03053869|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102288953|NCT03053869|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102288954|NCT03053869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102288955|NCT03053869|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102288956|NCT03053869|Anesthetics, General|anesthetics, general|mesh-ancestor
102288957|NCT03053869|Anesthetics|anesthetics|mesh-ancestor
102288958|NCT03053947|Ketamine|ketamine|mesh-list
102288959|NCT03053947|Analgesics|analgesics|mesh-ancestor
102288960|NCT03053947|Sensory System Agents|sensory system agents|mesh-ancestor
102288961|NCT03053947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102288962|NCT03053947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288963|NCT03053947|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102288964|NCT03053947|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102288965|NCT03053947|Anesthetics, General|anesthetics, general|mesh-ancestor
102288966|NCT03053947|Anesthetics|anesthetics|mesh-ancestor
102288967|NCT03053947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102288968|NCT03053947|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102288969|NCT03053947|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102288970|NCT03053947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102288971|NCT03053947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389206|NCT05925023|Antifungal Agents|antifungal agents|mesh-ancestor
102288973|NCT04893733|Vitamin B Complex|vitamin b complex|mesh-list
102288974|NCT04893733|Vitamins|vitamins|mesh-ancestor
102288975|NCT04893733|Micronutrients|micronutrients|mesh-ancestor
102288976|NCT04893733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288977|NCT04893733|Hematinics|hematinics|mesh-ancestor
102288978|NCT02493855|Ritonavir|ritonavir|mesh-list
102288979|NCT02493855|Ribavirin|ribavirin|mesh-list
102288980|NCT02493855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102288981|NCT02493855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102288982|NCT02493855|Protease Inhibitors|protease inhibitors|mesh-ancestor
102288983|NCT02493855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102288984|NCT02493855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102288985|NCT02493855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102288986|NCT02493855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102288987|NCT02493855|Antiviral Agents|antiviral agents|mesh-ancestor
102288988|NCT02493855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102288989|NCT02493855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102288990|NCT02493855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102288991|NCT02493855|Antimetabolites|antimetabolites|mesh-ancestor
102288992|NCT04892563|Morphine|morphine|mesh-list
102288993|NCT04892563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102288994|NCT04892563|Narcotics|narcotics|mesh-ancestor
102288995|NCT04892563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102288996|NCT04892563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102288997|NCT04892563|Analgesics|analgesics|mesh-ancestor
102288998|NCT04892563|Sensory System Agents|sensory system agents|mesh-ancestor
102288999|NCT04892563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102289000|NCT04909255|Solifenacin Succinate|solifenacin succinate|mesh-list
102289001|NCT04909255|Mirabegron|mirabegron|mesh-list
102289002|NCT04909255|Tolterodine Tartrate|tolterodine tartrate|mesh-list
102289003|NCT04909255|Oxybutynin|oxybutynin|mesh-list
102289004|NCT04909255|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102289005|NCT04909255|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102289006|NCT04909255|Cholinergic Agents|cholinergic agents|mesh-ancestor
102289007|NCT04909255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102289008|NCT04909255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289009|NCT04909255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289010|NCT04909255|Urological Agents|urological agents|mesh-ancestor
102289011|NCT04909255|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102289012|NCT04909255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102289013|NCT04909255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102289014|NCT04909255|Adrenergic Agents|adrenergic agents|mesh-ancestor
102289015|NCT04909255|Parasympatholytics|parasympatholytics|mesh-ancestor
102289016|NCT04909255|Autonomic Agents|autonomic agents|mesh-ancestor
102289017|NCT04909255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102289018|NCT04891861|Rivaroxaban|rivaroxaban|mesh-list
102289019|NCT04891861|Apixaban|apixaban|mesh-list
102289020|NCT04891861|Edoxaban|edoxaban|mesh-list
102289021|NCT04891861|Dabigatran|dabigatran|mesh-list
102289022|NCT04891861|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102289023|NCT04891861|Antithrombins|antithrombins|mesh-ancestor
102289024|NCT04891861|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102289025|NCT04891861|Protease Inhibitors|protease inhibitors|mesh-ancestor
102289026|NCT04891861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102289027|NCT04891861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289028|NCT04891861|Anticoagulants|anticoagulants|mesh-ancestor
102289029|NCT03053167|Irinotecan|irinotecan|mesh-list
102289030|NCT03053167|Raltitrexed|raltitrexed|mesh-list
102289031|NCT03053167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102289032|NCT03053167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102289033|NCT03053167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102289034|NCT03053167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289035|NCT03053167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102289036|NCT03053167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102289037|NCT03053167|Antimetabolites|antimetabolites|mesh-ancestor
102289038|NCT03053167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102289039|NCT04901923|Itraconazole|itraconazole|mesh-list
102289040|NCT04901923|Acalabrutinib|acalabrutinib|mesh-list
102289041|NCT04901923|Antifungal Agents|antifungal agents|mesh-ancestor
102289042|NCT04901923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102289043|NCT04901923|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102289044|NCT04901923|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102289045|NCT04901923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102289046|NCT04901923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289047|NCT04901923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102289048|NCT04901923|Hormone Antagonists|hormone antagonists|mesh-ancestor
102289049|NCT04901923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102289050|NCT04901923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289051|NCT04901923|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102289052|NCT04901923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102289053|NCT03050905|Ritonavir|ritonavir|mesh-list
102289054|NCT03050905|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102289055|NCT03050905|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102289056|NCT03050905|Protease Inhibitors|protease inhibitors|mesh-ancestor
102289057|NCT03050905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102289058|NCT03050905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289059|NCT03050905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102289060|NCT03050905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102289061|NCT03050905|Antiviral Agents|antiviral agents|mesh-ancestor
102289062|NCT03050905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102289063|NCT03050905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102289064|NCT03050905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102289065|NCT03050827|Oxybutynin|oxybutynin|mesh-list
102289066|NCT03050827|Parasympatholytics|parasympatholytics|mesh-ancestor
102289067|NCT03050827|Autonomic Agents|autonomic agents|mesh-ancestor
102289068|NCT03050827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102289069|NCT03050827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289070|NCT03050827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102289071|NCT03050827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102289072|NCT03050827|Cholinergic Agents|cholinergic agents|mesh-ancestor
102289073|NCT03050827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102289074|NCT03050827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289075|NCT03050827|Urological Agents|urological agents|mesh-ancestor
102289076|NCT02438787|Golimumab|golimumab|mesh-list
102289077|NCT02438787|Ustekinumab|ustekinumab|mesh-list
102289078|NCT02438787|Dermatologic Agents|dermatologic agents|mesh-ancestor
102289079|NCT02438787|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102289080|NCT02438787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102289081|NCT02438787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102289082|NCT02438787|Immunologic Factors|immunologic factors|mesh-ancestor
102289083|NCT02438787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289084|NCT04901065|Lidocaine|lidocaine|mesh-list
102289085|NCT04901065|Anesthetics, Local|anesthetics, local|mesh-ancestor
102289086|NCT04901065|Anesthetics|anesthetics|mesh-ancestor
102289087|NCT04901065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102289088|NCT04901065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289089|NCT04901065|Sensory System Agents|sensory system agents|mesh-ancestor
102289090|NCT04901065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102289091|NCT04901065|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102289092|NCT04901065|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102289093|NCT04901065|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102289094|NCT04901065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102289095|NCT04901065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289096|NCT02493777|Methylphenidate|methylphenidate|mesh-list
102289097|NCT02493777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102289098|NCT02493777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289099|NCT02493777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102289100|NCT02493777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102289101|NCT02493777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102289102|NCT02493777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289103|NCT02493777|Dopamine Agents|dopamine agents|mesh-ancestor
102289104|NCT02493777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102289105|NCT04907149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102289106|NCT04906915|Ketamine|ketamine|mesh-list
102289107|NCT04906915|Analgesics|analgesics|mesh-ancestor
102289108|NCT04906915|Sensory System Agents|sensory system agents|mesh-ancestor
102289109|NCT04906915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102289110|NCT04906915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289111|NCT04906915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102289112|NCT04906915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102289113|NCT04906915|Anesthetics, General|anesthetics, general|mesh-ancestor
102289114|NCT04906915|Anesthetics|anesthetics|mesh-ancestor
102289115|NCT04906915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102289116|NCT04906915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102289117|NCT04906915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102289118|NCT04906915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102289119|NCT04906915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289120|NCT04890379|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102289121|NCT04890379|Dermatologic Agents|dermatologic agents|mesh-ancestor
102289122|NCT04890379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102289123|NCT04890379|Immunologic Factors|immunologic factors|mesh-ancestor
102289124|NCT04890379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289125|NCT04900129|Acetylcysteine|acetylcysteine|mesh-list
102289126|NCT04900129|Diclofenac|diclofenac|mesh-list
102289127|NCT04900129|Salicylates|salicylates|mesh-list
102289128|NCT04900129|Methyl salicylate|methyl salicylate|mesh-list
102289129|NCT04900129|Menthol|menthol|mesh-list
102289130|NCT04900129|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102289131|NCT04900129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102289132|NCT04900129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102289133|NCT04900129|Analgesics|analgesics|mesh-ancestor
102289134|NCT04900129|Sensory System Agents|sensory system agents|mesh-ancestor
102289135|NCT04900129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102289136|NCT04900129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289137|NCT04900129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102289138|NCT04900129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102289139|NCT04900129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102289140|NCT04900129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102289141|NCT04900129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289142|NCT04900129|Antipruritics|antipruritics|mesh-ancestor
102289143|NCT04900129|Dermatologic Agents|dermatologic agents|mesh-ancestor
102289144|NCT04900129|Antiviral Agents|antiviral agents|mesh-ancestor
102289145|NCT04900129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102289146|NCT04900129|Expectorants|expectorants|mesh-ancestor
102289147|NCT04900129|Respiratory System Agents|respiratory system agents|mesh-ancestor
102289148|NCT04900129|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102289149|NCT04900129|Antioxidants|antioxidants|mesh-ancestor
102289150|NCT04900129|Protective Agents|protective agents|mesh-ancestor
102289151|NCT04900129|Antidotes|antidotes|mesh-ancestor
102289152|NCT02616601|Fluorouracil|fluorouracil|mesh-list
102289153|NCT02616601|Antimetabolites|antimetabolites|mesh-ancestor
102289154|NCT02616601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289155|NCT02616601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102289156|NCT02616601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102289157|NCT02616601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102289158|NCT02616601|Immunologic Factors|immunologic factors|mesh-ancestor
102289159|NCT02616601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289160|NCT02492997|Glycerol|glycerol|mesh-list
102289161|NCT02492997|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102289162|NCT02492997|Protective Agents|protective agents|mesh-ancestor
102289163|NCT02492997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289164|NCT04393207|Dexamethasone|dexamethasone|mesh-list
102289165|NCT04393207|Dexamethasone acetate|dexamethasone acetate|mesh-list
102289166|NCT04393207|Methylprednisolone|methylprednisolone|mesh-list
102289167|NCT04393207|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102289168|NCT04393207|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102289169|NCT04393207|Prednisolone|prednisolone|mesh-list
102289170|NCT04393207|Prednisolone acetate|prednisolone acetate|mesh-list
102289171|NCT04393207|Bupivacaine|bupivacaine|mesh-list
102289172|NCT04393207|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102289173|NCT04393207|Prednisolone phosphate|prednisolone phosphate|mesh-list
102289174|NCT04393207|BB 1101|bb 1101|mesh-list
102289175|NCT04393207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102289176|NCT04393207|Antiemetics|antiemetics|mesh-ancestor
102289177|NCT04393207|Autonomic Agents|autonomic agents|mesh-ancestor
102289178|NCT04393207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102289179|NCT04393207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289180|NCT04393207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102289181|NCT04393207|Glucocorticoids|glucocorticoids|mesh-ancestor
102289182|NCT04393207|Hormones|hormones|mesh-ancestor
102289183|NCT04393207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102289184|NCT04393207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102289185|NCT04393207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102289186|NCT04393207|Protease Inhibitors|protease inhibitors|mesh-ancestor
102289187|NCT04393207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102289188|NCT04393207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289189|NCT04393207|Anesthetics, Local|anesthetics, local|mesh-ancestor
102289190|NCT04393207|Anesthetics|anesthetics|mesh-ancestor
102289191|NCT04393207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102289192|NCT04393207|Sensory System Agents|sensory system agents|mesh-ancestor
102289193|NCT04393207|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102289194|NCT04393207|Protective Agents|protective agents|mesh-ancestor
102289195|NCT02492841|Calcium, Dietary|calcium, dietary|mesh-list
102289196|NCT02492841|Calcium|calcium|mesh-list
102289197|NCT02492841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102289198|NCT02492841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289199|NCT02492841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102289200|NCT04814875|Carboplatin|carboplatin|mesh-list
102289201|NCT04814875|Doxorubicin|doxorubicin|mesh-list
102289202|NCT04814875|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102289203|NCT04814875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102289204|NCT04814875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102289205|NCT04814875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102289206|NCT04814875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102289207|NCT04814875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102289208|NCT04814875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289209|NCT04812535|Pembrolizumab|pembrolizumab|mesh-list
102289210|NCT04812535|Vilobelimab|vilobelimab|mesh-list
102289211|NCT04812535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102289212|NCT04812535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102289213|NCT04812535|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102289214|NCT04812535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289215|NCT04812535|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102289216|NCT04812535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102289217|NCT04812535|Immunologic Factors|immunologic factors|mesh-ancestor
102289218|NCT04812535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289219|NCT02492763|Metformin|metformin|mesh-list
102289220|NCT02492763|Liraglutide|liraglutide|mesh-list
102289221|NCT02492763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102289222|NCT02492763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289223|NCT02492763|Incretins|incretins|mesh-ancestor
102289224|NCT02492763|Hormones|hormones|mesh-ancestor
102289225|NCT02492763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102289226|NCT04899817|Granisetron|granisetron|mesh-list
102289227|NCT04899817|Antiemetics|antiemetics|mesh-ancestor
102289228|NCT04899817|Autonomic Agents|autonomic agents|mesh-ancestor
102289229|NCT04899817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102289230|NCT04899817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289231|NCT04899817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102289232|NCT04899817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102289233|NCT04899817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102289234|NCT04899817|Serotonin Agents|serotonin agents|mesh-ancestor
102289235|NCT04899817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102289236|NCT04899817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289237|NCT04905667|Trastuzumab|trastuzumab|mesh-list
102289238|NCT04905667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102289239|NCT04905667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102289240|NCT04397107|Aldesleukin|aldesleukin|mesh-list
102289241|NCT04397107|Interleukin-2|interleukin-2|mesh-list
102289242|NCT04397107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102289243|NCT04397107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102289244|NCT04397107|Analgesics|analgesics|mesh-ancestor
102289245|NCT04397107|Sensory System Agents|sensory system agents|mesh-ancestor
102289246|NCT04397107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101389512|NCT05836584|Levoleucovorin|levoleucovorin|mesh-list
102289247|NCT04397107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289248|NCT04397107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102289249|NCT04397107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102289250|NCT04397107|Antiviral Agents|antiviral agents|mesh-ancestor
102289251|NCT04397107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102289252|NCT02453841|Phenylephrine|phenylephrine|mesh-list
102289253|NCT02453841|Oxymetazoline|oxymetazoline|mesh-list
102289254|NCT02453841|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102289255|NCT02453841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102289256|NCT02453841|Adrenergic Agents|adrenergic agents|mesh-ancestor
102289257|NCT02453841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102289258|NCT02453841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289259|NCT02453841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289260|NCT02453841|Sympathomimetics|sympathomimetics|mesh-ancestor
102289261|NCT02453841|Autonomic Agents|autonomic agents|mesh-ancestor
102289262|NCT02453841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102289263|NCT02453841|Nasal Decongestants|nasal decongestants|mesh-ancestor
102289264|NCT02453841|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102289265|NCT02453841|Respiratory System Agents|respiratory system agents|mesh-ancestor
102289266|NCT02453841|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102289267|NCT02453841|Mydriatics|mydriatics|mesh-ancestor
102289268|NCT02453841|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102289269|NCT02453841|Protective Agents|protective agents|mesh-ancestor
102289270|NCT03081689|Paclitaxel|paclitaxel|mesh-list
102289271|NCT03081689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102289272|NCT03081689|Carboplatin|carboplatin|mesh-list
101997992|NCT03077438|Vaccines|vaccines|mesh-list
102289273|NCT03081689|Nivolumab|nivolumab|mesh-list
102289274|NCT03081689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102289275|NCT03081689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102289276|NCT03081689|Tubulin Modulators|tubulin modulators|mesh-ancestor
102289277|NCT03081689|Antimitotic Agents|antimitotic agents|mesh-ancestor
102289278|NCT03081689|Mitosis Modulators|mitosis modulators|mesh-ancestor
102289279|NCT03081689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289280|NCT03081689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102289281|NCT03081689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102289282|NCT04888663|Paclitaxel|paclitaxel|mesh-list
102289283|NCT04888663|Trastuzumab|trastuzumab|mesh-list
102289284|NCT04888663|Ramucirumab|ramucirumab|mesh-list
102289285|NCT04888663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102289286|NCT04888663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102289287|NCT04888663|Tubulin Modulators|tubulin modulators|mesh-ancestor
102289288|NCT04888663|Antimitotic Agents|antimitotic agents|mesh-ancestor
102289289|NCT04888663|Mitosis Modulators|mitosis modulators|mesh-ancestor
102289290|NCT04888663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289291|NCT04888663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102289292|NCT04899427|Tislelizumab|tislelizumab|mesh-list
102289293|NCT04899427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102289294|NCT04899427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102289295|NCT02453685|Insulin|insulin|mesh-list
102289296|NCT02453685|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102289297|NCT02453685|Insulin Glargine|insulin glargine|mesh-list
102289298|NCT02453685|Insulin Aspart|insulin aspart|mesh-list
102289299|NCT02453685|Insulin, Long-Acting|insulin, long-acting|mesh-list
102289300|NCT02453685|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102289301|NCT02453685|Biphasic Insulins|biphasic insulins|mesh-list
102289302|NCT02453685|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
102289303|NCT02453685|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102289304|NCT02453685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289305|NCT03051841|Dexamethasone|dexamethasone|mesh-list
102289306|NCT03051841|Bortezomib|bortezomib|mesh-list
102289307|NCT03051841|CKD-581|ckd-581|mesh-list
102289308|NCT03051841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102289309|NCT03051841|Antiemetics|antiemetics|mesh-ancestor
102289310|NCT03051841|Autonomic Agents|autonomic agents|mesh-ancestor
102289311|NCT03051841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102289312|NCT03051841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289313|NCT03051841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102289314|NCT03051841|Glucocorticoids|glucocorticoids|mesh-ancestor
102289315|NCT03051841|Hormones|hormones|mesh-ancestor
101389592|NCT05826964|Antimetabolites|antimetabolites|mesh-ancestor
102289316|NCT03051841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102289317|NCT03051841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102289318|NCT03051841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102289319|NCT03051841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102289320|NCT03051841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289321|NCT03051841|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102289322|NCT04905043|Acalabrutinib|acalabrutinib|mesh-list
102289323|NCT04905043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102289324|NCT02436759|Phenylephrine|phenylephrine|mesh-list
102289325|NCT02436759|Oxymetazoline|oxymetazoline|mesh-list
102289326|NCT02436759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102289327|NCT02436759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102289328|NCT02436759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102289329|NCT02436759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102289330|NCT02436759|Adrenergic Agents|adrenergic agents|mesh-ancestor
102289331|NCT02436759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102289332|NCT02436759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289333|NCT02436759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289334|NCT02436759|Sympathomimetics|sympathomimetics|mesh-ancestor
102289335|NCT02436759|Autonomic Agents|autonomic agents|mesh-ancestor
102289336|NCT02436759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102289337|NCT02436759|Nasal Decongestants|nasal decongestants|mesh-ancestor
102289338|NCT02436759|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102289339|NCT02436759|Respiratory System Agents|respiratory system agents|mesh-ancestor
102289340|NCT02436759|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102289341|NCT02436759|Mydriatics|mydriatics|mesh-ancestor
102289342|NCT02436759|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102289343|NCT02436759|Protective Agents|protective agents|mesh-ancestor
102289344|NCT04888741|Cyclosporine|cyclosporine|mesh-list
102289345|NCT04888741|Sirolimus|sirolimus|mesh-list
102289346|NCT04888741|Mycophenolic Acid|mycophenolic acid|mesh-list
102289347|NCT04888741|Cyclophosphamide|cyclophosphamide|mesh-list
102289348|NCT04888741|Cyclosporins|cyclosporins|mesh-list
102289349|NCT04888741|Thymoglobulin|thymoglobulin|mesh-list
102289350|NCT04888741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102289351|NCT04888741|Immunologic Factors|immunologic factors|mesh-ancestor
102289352|NCT04888741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289353|NCT04888741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102289354|NCT04888741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102289355|NCT04888741|Alkylating Agents|alkylating agents|mesh-ancestor
102289356|NCT04888741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289357|NCT04888741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102289358|NCT04888741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102289359|NCT04888741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102289360|NCT04888741|Antifungal Agents|antifungal agents|mesh-ancestor
102289361|NCT04888741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102289362|NCT04888741|Dermatologic Agents|dermatologic agents|mesh-ancestor
102289363|NCT04888741|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102289364|NCT04888741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102289365|NCT04888741|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102289366|NCT04888741|Antitubercular Agents|antitubercular agents|mesh-ancestor
102289367|NCT04888741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102289368|NCT04888819|Fexuprazan|fexuprazan|mesh-list
102289369|NCT04888819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102289370|NCT04904185|Cyclophosphamide|cyclophosphamide|mesh-list
102289371|NCT04904185|Pembrolizumab|pembrolizumab|mesh-list
102289372|NCT04904185|Fludarabine|fludarabine|mesh-list
102289373|NCT04904185|Fludarabine phosphate|fludarabine phosphate|mesh-list
102289374|NCT04904185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102289375|NCT04904185|Immunologic Factors|immunologic factors|mesh-ancestor
102289376|NCT04904185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289377|NCT04904185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102289378|NCT04904185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102289379|NCT04904185|Alkylating Agents|alkylating agents|mesh-ancestor
102289380|NCT04904185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289381|NCT04904185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102289382|NCT04904185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102289383|NCT04904185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101389668|NCT05797246|Growth Substances|growth substances|mesh-ancestor
102289384|NCT04904185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102289385|NCT04904185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102289386|NCT04904185|Antimetabolites|antimetabolites|mesh-ancestor
102289387|NCT04887961|Trabectedin|trabectedin|mesh-list
102289388|NCT04887961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102289389|NCT04887961|Alkylating Agents|alkylating agents|mesh-ancestor
102289390|NCT04887961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289391|NCT04887961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102289393|NCT04887649|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102289394|NCT04887649|Narcotics|narcotics|mesh-ancestor
102289395|NCT04887649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102289396|NCT04887649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289397|NCT04887649|Analgesics|analgesics|mesh-ancestor
102289398|NCT04887649|Sensory System Agents|sensory system agents|mesh-ancestor
102289399|NCT04887649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102289400|NCT03050437|Pemetrexed|pemetrexed|mesh-list
102289401|NCT03050437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102289402|NCT03050437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102289403|NCT03050437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289404|NCT03050437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102289405|NCT03050437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102289406|NCT02436135|Idelalisib|idelalisib|mesh-list
102289407|NCT02436135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102289408|NCT02436135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102289409|NCT02436135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289410|NCT04917861|Vaccines|vaccines|mesh-list
102289411|NCT04917861|Immunologic Factors|immunologic factors|mesh-ancestor
102289412|NCT04917861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289413|NCT02435277|Metformin|metformin|mesh-list
102289414|NCT02435277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102289415|NCT02435277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289416|NCT02420223|Propranolol|propranolol|mesh-list
102289417|NCT02420223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102289418|NCT02420223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102289419|NCT02420223|Adrenergic Agents|adrenergic agents|mesh-ancestor
102289420|NCT02420223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102289421|NCT02420223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289422|NCT02420223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289423|NCT02420223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102289425|NCT02420223|Vasodilator Agents|vasodilator agents|mesh-ancestor
102289426|NCT02433483|Cytarabine|cytarabine|mesh-list
102289427|NCT02433483|Hydrocortisone|hydrocortisone|mesh-list
102289428|NCT02433483|Methotrexate|methotrexate|mesh-list
102289429|NCT02433483|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102289430|NCT02433483|Abortifacient Agents|abortifacient agents|mesh-ancestor
102289431|NCT02433483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102289432|NCT02433483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289433|NCT02433483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102289434|NCT02433483|Antimetabolites|antimetabolites|mesh-ancestor
102289435|NCT02433483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289436|NCT02433483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102289437|NCT02433483|Dermatologic Agents|dermatologic agents|mesh-ancestor
102289438|NCT02433483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102289439|NCT02433483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102289440|NCT02433483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102289441|NCT02433483|Immunologic Factors|immunologic factors|mesh-ancestor
102289442|NCT02433483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102289443|NCT02433483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102289444|NCT02433483|Antiviral Agents|antiviral agents|mesh-ancestor
102289445|NCT02433483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102289446|NCT02433483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102289447|NCT02419755|Cytarabine|cytarabine|mesh-list
102289448|NCT02419755|Dexamethasone|dexamethasone|mesh-list
102289449|NCT02419755|Hydrocortisone|hydrocortisone|mesh-list
102289450|NCT02419755|Doxorubicin|doxorubicin|mesh-list
102289451|NCT02419755|Methotrexate|methotrexate|mesh-list
102289452|NCT02419755|Bortezomib|bortezomib|mesh-list
102289453|NCT02419755|Asparaginase|asparaginase|mesh-list
102289454|NCT02419755|Mitoxantrone|mitoxantrone|mesh-list
102289455|NCT02419755|Mercaptopurine|mercaptopurine|mesh-list
102289456|NCT02419755|Vorinostat|vorinostat|mesh-list
102289457|NCT02419755|Pegaspargase|pegaspargase|mesh-list
102289458|NCT02419755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102289459|NCT02419755|Antiemetics|antiemetics|mesh-ancestor
102289460|NCT02419755|Autonomic Agents|autonomic agents|mesh-ancestor
102289461|NCT02419755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102289462|NCT02419755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289463|NCT02419755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102289464|NCT02419755|Glucocorticoids|glucocorticoids|mesh-ancestor
102289465|NCT02419755|Hormones|hormones|mesh-ancestor
102289466|NCT02419755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102289467|NCT02419755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102289468|NCT02419755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102289469|NCT02419755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102289470|NCT02419755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102289471|NCT02419755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102289472|NCT02419755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102289473|NCT02419755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289474|NCT02419755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102289475|NCT02419755|Abortifacient Agents|abortifacient agents|mesh-ancestor
102289476|NCT02419755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102289477|NCT02419755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102289478|NCT02419755|Antimetabolites|antimetabolites|mesh-ancestor
102289479|NCT02419755|Dermatologic Agents|dermatologic agents|mesh-ancestor
102289480|NCT02419755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102289481|NCT02419755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102289482|NCT02419755|Immunologic Factors|immunologic factors|mesh-ancestor
102289483|NCT02419755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102289484|NCT02419755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102289485|NCT02419755|Antiviral Agents|antiviral agents|mesh-ancestor
102289486|NCT02419755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102289487|NCT02419755|Analgesics|analgesics|mesh-ancestor
102289488|NCT02419755|Sensory System Agents|sensory system agents|mesh-ancestor
102289489|NCT02419755|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102289490|NCT04913025|Pembrolizumab|pembrolizumab|mesh-list
102289491|NCT04913025|Nivolumab|nivolumab|mesh-list
102289492|NCT04913025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102289493|NCT04913025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102289494|NCT04913025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102289495|NCT04913025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289496|NCT04898101|Acalabrutinib|acalabrutinib|mesh-list
102289497|NCT04898101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102289498|NCT02432703|JNJ-42165279|jnj-42165279|mesh-list
102289499|NCT02432703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101998198|NCT05764304|Hormones|hormones|mesh-ancestor
102289500|NCT02432703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289501|NCT04887493|Alprostadil|alprostadil|mesh-list
102289502|NCT04887493|Misoprostol|misoprostol|mesh-list
102289503|NCT04887493|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102289504|NCT04887493|Abortifacient Agents|abortifacient agents|mesh-ancestor
102289505|NCT04887493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102289506|NCT04887493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289507|NCT04887493|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102289508|NCT04887493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102289509|NCT04887493|Oxytocics|oxytocics|mesh-ancestor
102289510|NCT04887493|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102289511|NCT04887493|Vasodilator Agents|vasodilator agents|mesh-ancestor
102289512|NCT04887493|Urological Agents|urological agents|mesh-ancestor
102289513|NCT02486757|Estradiol|estradiol|mesh-list
102289514|NCT02486757|Progesterone|progesterone|mesh-list
102289515|NCT02486757|Estrogens|estrogens|mesh-ancestor
102289516|NCT02486757|Hormones|hormones|mesh-ancestor
102289517|NCT02486757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102289518|NCT02486757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289519|NCT02486757|Progestins|progestins|mesh-ancestor
102289520|NCT04883203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102289521|NCT04883203|Plasma-lyte 148|plasma-lyte 148|mesh-list
102289522|NCT04883203|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102289523|NCT03051529|Anesthetics|anesthetics|mesh-list
102289524|NCT03051529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102289525|NCT03051529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289526|NCT04886869|Caffeine|caffeine|mesh-list
102289527|NCT04886869|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102289528|NCT04886869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289529|NCT04886869|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102289530|NCT04886869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102289531|NCT04886869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289532|NCT04886869|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102289533|NCT04886869|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102289534|NCT04886869|Purinergic Agents|purinergic agents|mesh-ancestor
102289535|NCT04886869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102289536|NCT04897477|Azacitidine|azacitidine|mesh-list
102289537|NCT04897477|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102289538|NCT04897477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102289539|NCT04897477|Antimetabolites|antimetabolites|mesh-ancestor
102289540|NCT04897477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289541|NCT04897477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102289542|NCT04897477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102289543|NCT04897477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102289544|NCT04897477|Alkylating Agents|alkylating agents|mesh-ancestor
102289545|NCT02576639|Umibecestat|umibecestat|mesh-list
102289546|NCT02576639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102289547|NCT02576639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289548|NCT02418585|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102289549|NCT02418585|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102289550|NCT02418585|Sertraline|sertraline|mesh-list
102289551|NCT02418585|Antidepressive Agents|antidepressive agents|mesh-list
102289552|NCT02418585|Esketamine|esketamine|mesh-list
102289553|NCT02418585|Escitalopram|escitalopram|mesh-list
102289554|NCT02418585|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102289555|NCT02418585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102289556|NCT02418585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102289557|NCT02418585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289558|NCT02418585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102289559|NCT02418585|Serotonin Agents|serotonin agents|mesh-ancestor
102289560|NCT02418585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289561|NCT02418585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102289562|NCT02418585|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102289563|NCT02418585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102289564|NCT02418585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102289565|NCT02418585|Analgesics|analgesics|mesh-ancestor
102289566|NCT02418585|Sensory System Agents|sensory system agents|mesh-ancestor
102289567|NCT02418585|Dopamine Agents|dopamine agents|mesh-ancestor
102289568|NCT05529875|Propofol|propofol|mesh-list
102289569|NCT05529875|Sevoflurane|sevoflurane|mesh-list
102289570|NCT05529875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102289571|NCT05529875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102289572|NCT05529875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289573|NCT05529875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102289574|NCT05529875|Anesthetics, General|anesthetics, general|mesh-ancestor
102289575|NCT05529875|Anesthetics|anesthetics|mesh-ancestor
102289576|NCT05529875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102289577|NCT05529875|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102289578|NCT03051451|Metformin|metformin|mesh-list
102289579|NCT03051451|Fluoxetine|fluoxetine|mesh-list
102289580|NCT03051451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102289581|NCT03051451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289582|NCT03051451|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102289583|NCT03051451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102289584|NCT03051451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102289585|NCT03051451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289586|NCT03051451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102289587|NCT03051451|Serotonin Agents|serotonin agents|mesh-ancestor
102289588|NCT03051451|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102289589|NCT03051451|Antidepressive Agents|antidepressive agents|mesh-ancestor
102289590|NCT03051451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102289591|NCT03051451|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102289592|NCT03051451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102289593|NCT03051451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102289594|NCT02417961|Benralizumab|benralizumab|mesh-list
102289595|NCT02417961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102289596|NCT02417961|Respiratory System Agents|respiratory system agents|mesh-ancestor
102289597|NCT02869217|Cyclophosphamide|cyclophosphamide|mesh-list
102289598|NCT02869217|Fludarabine|fludarabine|mesh-list
102289599|NCT02869217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102289600|NCT02869217|Immunologic Factors|immunologic factors|mesh-ancestor
102289601|NCT02869217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289602|NCT02869217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102289603|NCT02869217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102289604|NCT02869217|Alkylating Agents|alkylating agents|mesh-ancestor
102289605|NCT02869217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289606|NCT02869217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102289607|NCT02869217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102289608|NCT04883125|Pioglitazone|pioglitazone|mesh-list
102289609|NCT04883125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102289610|NCT04883125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289611|NCT05474183|Dexmedetomidine|dexmedetomidine|mesh-list
102289612|NCT05474183|Ketamine|ketamine|mesh-list
102289613|NCT05474183|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102289614|NCT05474183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102289615|NCT05474183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289616|NCT05474183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102289617|NCT05474183|Analgesics|analgesics|mesh-ancestor
102289618|NCT05474183|Sensory System Agents|sensory system agents|mesh-ancestor
102289619|NCT05474183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102289620|NCT05474183|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102289621|NCT05474183|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102289622|NCT05474183|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102289623|NCT05474183|Adrenergic Agents|adrenergic agents|mesh-ancestor
102289624|NCT05474183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102289625|NCT05474183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289626|NCT05474183|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102289627|NCT05474183|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102289628|NCT05474183|Anesthetics, General|anesthetics, general|mesh-ancestor
102289629|NCT05474183|Anesthetics|anesthetics|mesh-ancestor
102289630|NCT05474183|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102289631|NCT05474183|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102289632|NCT04885777|Lidocaine|lidocaine|mesh-list
102289633|NCT04885777|Anesthetics, Local|anesthetics, local|mesh-ancestor
102289634|NCT04885777|Anesthetics|anesthetics|mesh-ancestor
102289635|NCT04885777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102289636|NCT04885777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289637|NCT04885777|Sensory System Agents|sensory system agents|mesh-ancestor
102289638|NCT04885777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102289639|NCT04885777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102289640|NCT04885777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102289641|NCT04885777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102289642|NCT04885777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102289643|NCT04885777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289644|NCT04885855|Sofosbuvir|sofosbuvir|mesh-list
102289645|NCT04885855|Antiviral Agents|antiviral agents|mesh-ancestor
102289646|NCT04885855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101998371|NCT04065074|FX006|fx006|mesh-list
102289647|NCT02632721|Decitabine|decitabine|mesh-list
102289648|NCT02632721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102289649|NCT02632721|Antimetabolites|antimetabolites|mesh-ancestor
102289650|NCT02632721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289651|NCT02632721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102289652|NCT02632721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102289653|NCT05529095|Apomorphine|apomorphine|mesh-list
102289654|NCT05529095|Emetics|emetics|mesh-ancestor
101389978|NCT05686863|Propofol|propofol|mesh-list
102289655|NCT05529095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289656|NCT05529095|Autonomic Agents|autonomic agents|mesh-ancestor
102289657|NCT05529095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102289658|NCT05529095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102289659|NCT05529095|Dopamine Agonists|dopamine agonists|mesh-ancestor
102289660|NCT05529095|Dopamine Agents|dopamine agents|mesh-ancestor
102289661|NCT05529095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102289662|NCT05529095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289663|NCT01596127|Rituximab|rituximab|mesh-list
102289664|NCT01596127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102289665|NCT01596127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102289666|NCT01596127|Immunologic Factors|immunologic factors|mesh-ancestor
102289667|NCT01596127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289668|NCT01596127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102289669|NCT03051373|Paclitaxel|paclitaxel|mesh-list
102289670|NCT03051373|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102289671|NCT03051373|Gemcitabine|gemcitabine|mesh-list
102289672|NCT03051373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102289673|NCT03051373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102289674|NCT03051373|Tubulin Modulators|tubulin modulators|mesh-ancestor
102289675|NCT03051373|Antimitotic Agents|antimitotic agents|mesh-ancestor
102289676|NCT03051373|Mitosis Modulators|mitosis modulators|mesh-ancestor
102289677|NCT03051373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289678|NCT03051373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102289679|NCT03051373|Antimetabolites|antimetabolites|mesh-ancestor
102289680|NCT04895059|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102289681|NCT04895059|Ezetimibe|ezetimibe|mesh-list
102289682|NCT04895059|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102289683|NCT04895059|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102289684|NCT04895059|Antimetabolites|antimetabolites|mesh-ancestor
102289685|NCT04895059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289686|NCT04895059|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102289687|NCT04895059|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102289688|NCT04895059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102289689|NCT05467475|Esomeprazole|esomeprazole|mesh-list
102289690|NCT05467475|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102289691|NCT05467475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102289692|NCT05467475|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102289693|NCT05467475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102289694|NCT05467475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289695|NCT05534165|Tecovirimat|tecovirimat|mesh-list
102289696|NCT05534165|Antiviral Agents|antiviral agents|mesh-ancestor
102289697|NCT05534165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102289698|NCT01595581|Methyltestosterone|methyltestosterone|mesh-list
102289699|NCT01595581|Testosterone|testosterone|mesh-list
102289700|NCT01595581|Testosterone undecanoate|testosterone undecanoate|mesh-list
102289701|NCT01595581|Testosterone enanthate|testosterone enanthate|mesh-list
102289702|NCT01595581|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102289703|NCT01595581|Androgens|androgens|mesh-ancestor
102289704|NCT01595581|Hormones|hormones|mesh-ancestor
102289705|NCT01595581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102289706|NCT01595581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289707|NCT01595581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102289708|NCT01595581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102289709|NCT01595581|Anabolic Agents|anabolic agents|mesh-ancestor
102289710|NCT04885153|Fenofibrate|fenofibrate|mesh-list
102289711|NCT04885153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102289712|NCT04885153|Antimetabolites|antimetabolites|mesh-ancestor
102289713|NCT04885153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289714|NCT04885153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102289715|NCT03048643|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102289716|NCT03048643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102289717|NCT04884997|Temozolomide|temozolomide|mesh-list
102289718|NCT04884997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102289719|NCT04884997|Alkylating Agents|alkylating agents|mesh-ancestor
102289720|NCT04884997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289721|NCT04884997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102289722|NCT04885075|Midazolam|midazolam|mesh-list
102289724|NCT04885075|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102289725|NCT04885075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102289726|NCT04885075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102289727|NCT04885075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289728|NCT04885075|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102289729|NCT04885075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102289730|NCT04885075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102289731|NCT04885075|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102289732|NCT04885075|Anesthetics, General|anesthetics, general|mesh-ancestor
102289733|NCT04885075|Anesthetics|anesthetics|mesh-ancestor
102289734|NCT04885075|GABA Modulators|gaba modulators|mesh-ancestor
102289735|NCT04885075|GABA Agents|gaba agents|mesh-ancestor
102289736|NCT04885075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102289737|NCT04885075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289738|NCT04885075|Anticonvulsants|anticonvulsants|mesh-ancestor
102289739|NCT04885075|Antiemetics|antiemetics|mesh-ancestor
102289740|NCT04885075|Autonomic Agents|autonomic agents|mesh-ancestor
102289741|NCT04885075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102289742|NCT04885075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102289743|NCT04885075|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102289744|NCT04885075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102289745|NCT01610687|Nabiximols|nabiximols|mesh-list
102289746|NCT01610687|Analgesics|analgesics|mesh-ancestor
102289747|NCT01610687|Sensory System Agents|sensory system agents|mesh-ancestor
102289748|NCT01610687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102289749|NCT01610687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289750|NCT04884919|Chitosan|chitosan|mesh-list
102289751|NCT04884919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102289752|NCT04884919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102289753|NCT04884919|Antimetabolites|antimetabolites|mesh-ancestor
102289754|NCT04884919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289755|NCT04884919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102289756|NCT04884919|Chelating Agents|chelating agents|mesh-ancestor
102289757|NCT04884919|Sequestering Agents|sequestering agents|mesh-ancestor
102289758|NCT04884919|Hemostatics|hemostatics|mesh-ancestor
102289759|NCT04884919|Coagulants|coagulants|mesh-ancestor
102289760|NCT04878835|Ranibizumab|ranibizumab|mesh-list
102289761|NCT04878835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102289762|NCT04878835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102289763|NCT04878835|Growth Substances|growth substances|mesh-ancestor
102289764|NCT04878835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289765|NCT04878835|Growth Inhibitors|growth inhibitors|mesh-ancestor
102289766|NCT04878835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102289767|NCT04872283|Aspirin|aspirin|mesh-list
102289768|NCT04872283|Acetaminophen|acetaminophen|mesh-list
102289769|NCT04872283|Ketorolac|ketorolac|mesh-list
102289770|NCT04872283|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102289771|NCT04872283|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
102289772|NCT04872283|Oxycodone|oxycodone|mesh-list
102289773|NCT04872283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102289774|NCT04872283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102289775|NCT04872283|Analgesics|analgesics|mesh-ancestor
102289776|NCT04872283|Sensory System Agents|sensory system agents|mesh-ancestor
102289777|NCT04872283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102289778|NCT04872283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289779|NCT04872283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102289780|NCT04872283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102289781|NCT04872283|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102289782|NCT04872283|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102289783|NCT04872283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289784|NCT04872283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102289785|NCT04872283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102289786|NCT04872283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102289787|NCT04872283|Antipyretics|antipyretics|mesh-ancestor
102289788|NCT04872283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102289789|NCT04872283|Narcotics|narcotics|mesh-ancestor
102289790|NCT04872283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102289791|NCT05182385|Venetoclax|venetoclax|mesh-list
102289792|NCT05182385|Blinatumomab|blinatumomab|mesh-list
102289793|NCT05182385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102289794|NCT05533619|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
102289795|NCT05533619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102289796|NCT05533619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289797|NCT04389073|Cyclophosphamide|cyclophosphamide|mesh-list
102289798|NCT04389073|Bevacizumab|bevacizumab|mesh-list
102289799|NCT04389073|Capecitabine|capecitabine|mesh-list
102289800|NCT04389073|Vinorelbine|vinorelbine|mesh-list
102289801|NCT04389073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102289802|NCT04389073|Immunologic Factors|immunologic factors|mesh-ancestor
102289803|NCT04389073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289804|NCT04389073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102289805|NCT04389073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102289806|NCT04389073|Alkylating Agents|alkylating agents|mesh-ancestor
102289807|NCT04389073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289808|NCT04389073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102289809|NCT04389073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102289810|NCT04389073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102289811|NCT04389073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102289812|NCT04389073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102289813|NCT04389073|Growth Substances|growth substances|mesh-ancestor
102289814|NCT04389073|Growth Inhibitors|growth inhibitors|mesh-ancestor
102289815|NCT04389073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102289816|NCT04389073|Antimetabolites|antimetabolites|mesh-ancestor
102289817|NCT04389073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102289818|NCT04389073|Tubulin Modulators|tubulin modulators|mesh-ancestor
102289819|NCT04389073|Antimitotic Agents|antimitotic agents|mesh-ancestor
102289820|NCT04389073|Mitosis Modulators|mitosis modulators|mesh-ancestor
102289821|NCT04371445|Dexamethasone|dexamethasone|mesh-list
102289822|NCT04371445|Prednisolone|prednisolone|mesh-list
102289823|NCT04371445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102289824|NCT04371445|Methylprednisolone|methylprednisolone|mesh-list
102289825|NCT04371445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102289826|NCT04371445|Prednisolone acetate|prednisolone acetate|mesh-list
102289827|NCT04371445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102289828|NCT04371445|Prednisolone phosphate|prednisolone phosphate|mesh-list
102289829|NCT04371445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102289830|NCT04371445|Antiemetics|antiemetics|mesh-ancestor
102289831|NCT04371445|Autonomic Agents|autonomic agents|mesh-ancestor
102289832|NCT04371445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102289833|NCT04371445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289834|NCT04371445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102289835|NCT04371445|Glucocorticoids|glucocorticoids|mesh-ancestor
102289836|NCT04371445|Hormones|hormones|mesh-ancestor
102289837|NCT04371445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102289838|NCT04371445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102289839|NCT04371445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102289840|NCT04371445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102289841|NCT04371445|Protective Agents|protective agents|mesh-ancestor
102289842|NCT03049267|Apremilast|apremilast|mesh-list
102289843|NCT03049267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102289844|NCT03049267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102289845|NCT03049267|Analgesics|analgesics|mesh-ancestor
102289846|NCT03049267|Sensory System Agents|sensory system agents|mesh-ancestor
102289847|NCT03049267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102289848|NCT03049267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289849|NCT03049267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102289850|NCT03049267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102289851|NCT03049267|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102289852|NCT03049267|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102289853|NCT03049267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102289854|NCT03049267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289855|NCT05524259|Folic Acid|folic acid|mesh-list
102289856|NCT05524259|Vitamin B Complex|vitamin b complex|mesh-list
102289857|NCT05524259|Inositol|inositol|mesh-list
102289858|NCT05524259|Hematinics|hematinics|mesh-ancestor
102289859|NCT05524259|Vitamins|vitamins|mesh-ancestor
102289860|NCT05524259|Micronutrients|micronutrients|mesh-ancestor
101390179|NCT05605899|Alkylating Agents|alkylating agents|mesh-ancestor
102289861|NCT05524259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289862|NCT04112095|Norgestrel|norgestrel|mesh-list
102289863|NCT04112095|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102289864|NCT04112095|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102289865|NCT04112095|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102289866|NCT04112095|Contraceptive Agents|contraceptive agents|mesh-ancestor
102289867|NCT04112095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102289868|NCT04112095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289869|NCT04112095|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102289870|NCT04112095|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102289871|NCT05257993|Paclitaxel|paclitaxel|mesh-list
102289872|NCT05257993|Gemcitabine|gemcitabine|mesh-list
102289873|NCT05257993|Folfirinox|folfirinox|mesh-list
102289874|NCT05257993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102289875|NCT05257993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102289876|NCT05257993|Tubulin Modulators|tubulin modulators|mesh-ancestor
102289877|NCT05257993|Antimitotic Agents|antimitotic agents|mesh-ancestor
102289878|NCT05257993|Mitosis Modulators|mitosis modulators|mesh-ancestor
102289879|NCT05257993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289880|NCT05257993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102289881|NCT05257993|Antimetabolites|antimetabolites|mesh-ancestor
102289883|NCT05533073|Tramadol|tramadol|mesh-list
102289884|NCT05533073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102289885|NCT05533073|Narcotics|narcotics|mesh-ancestor
102289886|NCT05533073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102289887|NCT05533073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289888|NCT05533073|Analgesics|analgesics|mesh-ancestor
102289889|NCT05533073|Sensory System Agents|sensory system agents|mesh-ancestor
102289890|NCT05533073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102289891|NCT05533073|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102289892|NCT05533073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102289893|NCT05533073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102289894|NCT05533073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102289895|NCT05533073|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102289896|NCT05533073|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102289897|NCT05533073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102289898|NCT05533073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289899|NCT04050553|Tirzepatide|tirzepatide|mesh-list
102289900|NCT04050553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102289901|NCT04050553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289902|NCT04050553|Incretins|incretins|mesh-ancestor
102289903|NCT04050553|Hormones|hormones|mesh-ancestor
102289904|NCT04050553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102289905|NCT03946891|Furosemide|furosemide|mesh-list
102289906|NCT03946891|Diuretics|diuretics|mesh-ancestor
102289907|NCT03946891|Natriuretic Agents|natriuretic agents|mesh-ancestor
102289908|NCT03946891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289909|NCT03946891|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102289910|NCT03946891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102289911|NCT03946891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289912|NCT04300049|Glucagon|glucagon|mesh-list
102289913|NCT04300049|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102289914|NCT04300049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102289915|NCT04300049|Hormones|hormones|mesh-ancestor
102289916|NCT04300049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102289917|NCT04300049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289918|NCT04300049|Incretins|incretins|mesh-ancestor
102289919|NCT03849625|Aspirin|aspirin|mesh-list
102289920|NCT03849625|Acetaminophen|acetaminophen|mesh-list
102289921|NCT03849625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102289922|NCT03849625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102289923|NCT03849625|Analgesics|analgesics|mesh-ancestor
102289924|NCT03849625|Sensory System Agents|sensory system agents|mesh-ancestor
102289925|NCT03849625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102289926|NCT03849625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289927|NCT03849625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102289928|NCT03849625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102289929|NCT03849625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102289930|NCT03849625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102289931|NCT03849625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390242|NCT05590624|Adrenergic Agents|adrenergic agents|mesh-ancestor
102289932|NCT03849625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102289933|NCT03849625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102289934|NCT03849625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102289935|NCT03849625|Antipyretics|antipyretics|mesh-ancestor
102289936|NCT03046693|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
102289937|NCT03046693|Nootropic Agents|nootropic agents|mesh-ancestor
102289938|NCT03049345|Methylene Blue|methylene blue|mesh-list
102289939|NCT03049345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102289940|NCT03049345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289941|NCT05526911|Tenofovir|tenofovir|mesh-list
102289942|NCT05526911|Lamivudine|lamivudine|mesh-list
102289943|NCT05526911|Dolutegravir|dolutegravir|mesh-list
102289944|NCT05526911|Digoxin|digoxin|mesh-list
102289945|NCT05526911|Midazolam|midazolam|mesh-list
102289946|NCT05526911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102289947|NCT05526911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102289948|NCT05526911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102289949|NCT05526911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289950|NCT05526911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102289951|NCT05526911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102289952|NCT05526911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102289953|NCT05526911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102289954|NCT05526911|Anesthetics, General|anesthetics, general|mesh-ancestor
102289956|NCT05526911|GABA Modulators|gaba modulators|mesh-ancestor
102289957|NCT05526911|GABA Agents|gaba agents|mesh-ancestor
102289958|NCT05526911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102289959|NCT05526911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289960|NCT05526911|Antiviral Agents|antiviral agents|mesh-ancestor
102289961|NCT05526911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102289962|NCT05526911|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102289963|NCT05526911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102289964|NCT05526911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102289965|NCT05526911|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102289966|NCT05526911|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102289967|NCT05526911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102289968|NCT05526911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102289969|NCT05526911|Protective Agents|protective agents|mesh-ancestor
102289970|NCT05526911|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102289971|NCT05526911|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102289972|NCT04870489|Isotretinoin|isotretinoin|mesh-list
102289973|NCT04870489|Dermatologic Agents|dermatologic agents|mesh-ancestor
102289974|NCT02574845|Metformin|metformin|mesh-list
102289975|NCT02574845|Furosemide|furosemide|mesh-list
102289976|NCT02574845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102289977|NCT02574845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102289978|NCT02574845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102289979|NCT02574845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102289980|NCT02574845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102289981|NCT02574845|Antimetabolites|antimetabolites|mesh-ancestor
102289982|NCT02574845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289983|NCT02574845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102289984|NCT02574845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102289985|NCT02574845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102289986|NCT02574845|Diuretics|diuretics|mesh-ancestor
102289987|NCT02574845|Natriuretic Agents|natriuretic agents|mesh-ancestor
102289988|NCT02574845|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102289989|NCT02574845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102289990|NCT05334485|Bromides|bromides|mesh-list
102289991|NCT05334485|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
102289992|NCT05334485|Anticonvulsants|anticonvulsants|mesh-ancestor
102289993|NCT05334485|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102289994|NCT05334485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102289995|NCT05334485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102289996|NCT05334485|Cholinergic Agents|cholinergic agents|mesh-ancestor
102289997|NCT05334485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102289998|NCT05334485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290000|NCT05231941|Ropivacaine|ropivacaine|mesh-list
102290001|NCT05231941|Anesthetics, Local|anesthetics, local|mesh-ancestor
102290002|NCT05231941|Anesthetics|anesthetics|mesh-ancestor
102290003|NCT05231941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102290004|NCT05231941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290005|NCT05231941|Sensory System Agents|sensory system agents|mesh-ancestor
102290006|NCT05231941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102290007|NCT05231941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102290008|NCT05231941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102290009|NCT05231941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102290010|NCT05231941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102290011|NCT05231941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290012|NCT05216575|Almitrine|almitrine|mesh-list
102290013|NCT05216575|Respiratory System Agents|respiratory system agents|mesh-ancestor
102290014|NCT04877509|Vitamin D|vitamin d|mesh-list
102290015|NCT04877509|Vitamin A|vitamin a|mesh-list
102290016|NCT04877509|Selenium|selenium|mesh-list
102290017|NCT04877509|Copper|copper|mesh-list
102290018|NCT04877509|Vitamins|vitamins|mesh-ancestor
102290019|NCT04877509|Micronutrients|micronutrients|mesh-ancestor
102290020|NCT04877509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290021|NCT04877509|Antioxidants|antioxidants|mesh-ancestor
102290022|NCT04877509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290023|NCT04877509|Protective Agents|protective agents|mesh-ancestor
102290024|NCT04877509|Trace Elements|trace elements|mesh-ancestor
102290025|NCT04877509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102290026|NCT03044743|Cyclophosphamide|cyclophosphamide|mesh-list
102290027|NCT03044743|Fludarabine|fludarabine|mesh-list
102290028|NCT03044743|Interleukin-2|interleukin-2|mesh-list
102290029|NCT03044743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102290030|NCT03044743|Immunologic Factors|immunologic factors|mesh-ancestor
102290031|NCT03044743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290032|NCT03044743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102290033|NCT03044743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102290034|NCT03044743|Alkylating Agents|alkylating agents|mesh-ancestor
102290035|NCT03044743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290036|NCT03044743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102290037|NCT03044743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102290038|NCT03044743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102290039|NCT03044743|Analgesics|analgesics|mesh-ancestor
102290040|NCT03044743|Sensory System Agents|sensory system agents|mesh-ancestor
102290041|NCT03044743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102290042|NCT03044665|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102290043|NCT03044665|Ezetimibe|ezetimibe|mesh-list
102290044|NCT03044665|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102290045|NCT03044665|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102290046|NCT03044665|Antimetabolites|antimetabolites|mesh-ancestor
102290047|NCT03044665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290048|NCT03044665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102290049|NCT03044665|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102290050|NCT03044665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102290051|NCT05525351|Dexmedetomidine|dexmedetomidine|mesh-list
102290052|NCT05525351|Alfentanil|alfentanil|mesh-list
102290053|NCT05525351|Propofol|propofol|mesh-list
102290054|NCT05525351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102290055|NCT05525351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102290056|NCT05525351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290057|NCT05525351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102290058|NCT05525351|Analgesics|analgesics|mesh-ancestor
102290059|NCT05525351|Sensory System Agents|sensory system agents|mesh-ancestor
102290060|NCT05525351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102290061|NCT05525351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102290062|NCT05525351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102290063|NCT05525351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102290064|NCT05525351|Adrenergic Agents|adrenergic agents|mesh-ancestor
102290065|NCT05525351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102290066|NCT05525351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290067|NCT05525351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102290068|NCT05525351|Anesthetics, General|anesthetics, general|mesh-ancestor
102290069|NCT05525351|Anesthetics|anesthetics|mesh-ancestor
102290070|NCT05525351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102290071|NCT05525351|Narcotics|narcotics|mesh-ancestor
102290072|NCT04869475|Arsenic Trioxide|arsenic trioxide|mesh-list
102290073|NCT04869475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102290074|NCT05521763|Vaccines|vaccines|mesh-list
102290075|NCT05521763|Immunologic Factors|immunologic factors|mesh-ancestor
102290076|NCT05521763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290077|NCT05100017|Methocarbamol|methocarbamol|mesh-list
102290078|NCT05100017|Oxybutynin|oxybutynin|mesh-list
102290079|NCT05100017|Parasympatholytics|parasympatholytics|mesh-ancestor
102290080|NCT05100017|Autonomic Agents|autonomic agents|mesh-ancestor
102290081|NCT05100017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102290082|NCT05100017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290083|NCT05100017|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102290084|NCT05100017|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102290085|NCT05100017|Cholinergic Agents|cholinergic agents|mesh-ancestor
102290086|NCT05100017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102290087|NCT05100017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290088|NCT05100017|Urological Agents|urological agents|mesh-ancestor
102290089|NCT05100017|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102290090|NCT05100017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102290091|NCT04865185|Ethanol|ethanol|mesh-list
102290092|NCT04865185|Lidocaine|lidocaine|mesh-list
102290093|NCT04865185|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102290094|NCT04865185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102290095|NCT04865185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102290096|NCT04865185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290097|NCT04865185|Anesthetics, Local|anesthetics, local|mesh-ancestor
102290098|NCT04865185|Anesthetics|anesthetics|mesh-ancestor
102290099|NCT04865185|Sensory System Agents|sensory system agents|mesh-ancestor
102290100|NCT04865185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102290101|NCT04865185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102290102|NCT04865185|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101998805|NCT03912857|Apatinib|apatinib|mesh-list
101998810|NCT04892420|Dexamethasone|dexamethasone|mesh-list
102290103|NCT04865185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102290104|NCT04865185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102290105|NCT04865185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290106|NCT04876807|Acalabrutinib|acalabrutinib|mesh-list
102290107|NCT04876807|Omeprazole|omeprazole|mesh-list
102290108|NCT04876807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102290109|NCT04876807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102290110|NCT04876807|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102290111|NCT04876807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102290112|NCT04876807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290113|NCT04876807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102290114|NCT05518409|Donepezil|donepezil|mesh-list
102290115|NCT05518409|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102290116|NCT05518409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102290117|NCT05518409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290118|NCT05518409|Cholinergic Agents|cholinergic agents|mesh-ancestor
102290119|NCT05518409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102290120|NCT05518409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290121|NCT05518409|Nootropic Agents|nootropic agents|mesh-ancestor
102290122|NCT04876573|Cyproheptadine|cyproheptadine|mesh-list
102290123|NCT04876573|Antipruritics|antipruritics|mesh-ancestor
102290124|NCT04876573|Dermatologic Agents|dermatologic agents|mesh-ancestor
102290125|NCT04876573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102290126|NCT04876573|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102290127|NCT04876573|Histamine Antagonists|histamine antagonists|mesh-ancestor
102290128|NCT04876573|Histamine Agents|histamine agents|mesh-ancestor
102290129|NCT04876573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102290130|NCT04876573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290131|NCT04876573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290132|NCT04876573|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102290133|NCT04876573|Serotonin Agents|serotonin agents|mesh-ancestor
102290134|NCT04876573|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102290135|NCT04864717|Doxycycline|doxycycline|mesh-list
102290136|NCT04864717|Isotretinoin|isotretinoin|mesh-list
102290137|NCT04864717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102290138|NCT04864717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102290139|NCT04864717|Antimalarials|antimalarials|mesh-ancestor
102290140|NCT04864717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102290141|NCT04864717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102290142|NCT04864717|Dermatologic Agents|dermatologic agents|mesh-ancestor
102290143|NCT04876261|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
102290144|NCT04876261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102290145|NCT04876261|Antioxidants|antioxidants|mesh-ancestor
102290146|NCT04876261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290147|NCT04876261|Protective Agents|protective agents|mesh-ancestor
102290148|NCT04876261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290149|NCT04876261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102290150|NCT02613871|Sofosbuvir|sofosbuvir|mesh-list
102290151|NCT02613871|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102290152|NCT02613871|Ledipasvir|ledipasvir|mesh-list
102290153|NCT02613871|Antiviral Agents|antiviral agents|mesh-ancestor
102290154|NCT02613871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102290155|NCT04869709|Betamethasone|betamethasone|mesh-list
102290156|NCT04869709|Betamethasone Valerate|betamethasone valerate|mesh-list
102290157|NCT04869709|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102290158|NCT04869709|Betamethasone benzoate|betamethasone benzoate|mesh-list
102290159|NCT04869709|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102290160|NCT04869709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102290161|NCT04869709|Glucocorticoids|glucocorticoids|mesh-ancestor
102290162|NCT04869709|Hormones|hormones|mesh-ancestor
102290163|NCT04869709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102290164|NCT04869709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290165|NCT04869709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102290166|NCT04869709|Respiratory System Agents|respiratory system agents|mesh-ancestor
102290167|NCT02612077|Bevacizumab|bevacizumab|mesh-list
102290168|NCT02612077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102290169|NCT02612077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102290170|NCT02612077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102290171|NCT02612077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102290172|NCT02612077|Growth Substances|growth substances|mesh-ancestor
102290173|NCT02612077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290174|NCT02612077|Growth Inhibitors|growth inhibitors|mesh-ancestor
102290175|NCT04622735|Acetaminophen|acetaminophen|mesh-list
102290176|NCT04622735|Nefopam|nefopam|mesh-list
102290177|NCT04622735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102290178|NCT04622735|Analgesics|analgesics|mesh-ancestor
102290179|NCT04622735|Sensory System Agents|sensory system agents|mesh-ancestor
102290180|NCT04622735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102290181|NCT04622735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290182|NCT04622735|Antipyretics|antipyretics|mesh-ancestor
102290183|NCT05531591|Aripiprazole|aripiprazole|mesh-list
102290184|NCT05531591|Lithium Carbonate|lithium carbonate|mesh-list
102290185|NCT05531591|Bupropion|bupropion|mesh-list
102290186|NCT05531591|Nortriptyline|nortriptyline|mesh-list
102290187|NCT05531591|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102290188|NCT05531591|Antidepressive Agents|antidepressive agents|mesh-ancestor
102290189|NCT05531591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102290190|NCT05531591|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102290191|NCT05531591|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102290192|NCT05531591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102290193|NCT05531591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290194|NCT05531591|Dopamine Agents|dopamine agents|mesh-ancestor
102290195|NCT05531591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102290196|NCT05531591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290197|NCT05531591|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102290198|NCT05531591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102290199|NCT05531591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102290200|NCT05531591|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102290201|NCT05531591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102290202|NCT05531591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102290203|NCT05531591|Dopamine Agonists|dopamine agonists|mesh-ancestor
102290204|NCT05531591|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102290205|NCT05531591|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102290206|NCT05531591|Serotonin Agents|serotonin agents|mesh-ancestor
102290207|NCT05531591|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102290208|NCT05531591|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102290209|NCT05531591|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102290210|NCT05531591|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102290211|NCT05531591|Antimanic Agents|antimanic agents|mesh-ancestor
102290212|NCT05531591|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102290213|NCT05531591|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102290214|NCT05531591|Adrenergic Agents|adrenergic agents|mesh-ancestor
102290215|NCT05048615|Itraconazole|itraconazole|mesh-list
102290216|NCT05048615|Azacitidine|azacitidine|mesh-list
102290217|NCT05048615|Venetoclax|venetoclax|mesh-list
102290218|NCT05048615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102290219|NCT05048615|Antimetabolites|antimetabolites|mesh-ancestor
102290220|NCT05048615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290221|NCT05048615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102290223|NCT05048615|Antifungal Agents|antifungal agents|mesh-ancestor
102290224|NCT05048615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102290225|NCT05048615|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102290226|NCT05048615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102290227|NCT05048615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102290228|NCT05048615|Hormone Antagonists|hormone antagonists|mesh-ancestor
102290229|NCT05048615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102290230|NCT05048615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290231|NCT05048615|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102290232|NCT05531435|Anesthetics|anesthetics|mesh-list
102290233|NCT05531435|Anesthetics, Local|anesthetics, local|mesh-list
102290234|NCT05531435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102290235|NCT05531435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290236|NCT05531435|Sensory System Agents|sensory system agents|mesh-ancestor
102290237|NCT05531435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102290238|NCT05517239|Gemcitabine|gemcitabine|mesh-list
102290239|NCT05517239|Oxaliplatin|oxaliplatin|mesh-list
102290240|NCT05517239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102290241|NCT05517239|Antimetabolites|antimetabolites|mesh-ancestor
102290242|NCT05517239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290243|NCT05517239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102290244|NCT05519813|Metformin|metformin|mesh-list
102290245|NCT05519813|Pioglitazone|pioglitazone|mesh-list
102290246|NCT05519813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102290247|NCT05519813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290248|NCT02613403|Ribavirin|ribavirin|mesh-list
102290249|NCT02613403|Uprifosbuvir|uprifosbuvir|mesh-list
102290250|NCT02613403|Antimetabolites|antimetabolites|mesh-ancestor
102290251|NCT02613403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290252|NCT02613403|Antiviral Agents|antiviral agents|mesh-ancestor
102290253|NCT02613403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102290254|NCT05002127|Paclitaxel|paclitaxel|mesh-list
102290255|NCT05002127|Trastuzumab|trastuzumab|mesh-list
102290256|NCT05002127|Ramucirumab|ramucirumab|mesh-list
102290257|NCT05002127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102290258|NCT05002127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102290259|NCT05002127|Tubulin Modulators|tubulin modulators|mesh-ancestor
102290260|NCT05002127|Antimitotic Agents|antimitotic agents|mesh-ancestor
102290261|NCT05002127|Mitosis Modulators|mitosis modulators|mesh-ancestor
102290262|NCT05002127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290263|NCT05002127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102290264|NCT04429867|Hydroxychloroquine|hydroxychloroquine|mesh-list
102290265|NCT04429867|Antimalarials|antimalarials|mesh-ancestor
102290266|NCT04429867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102290267|NCT04429867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102290268|NCT04429867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102290269|NCT04429867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102290270|NCT04429867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290271|NCT04429867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102290272|NCT03044041|Tranexamic Acid|tranexamic acid|mesh-list
102290273|NCT03044041|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102290274|NCT03044041|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102290275|NCT03044041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290276|NCT03044041|Hemostatics|hemostatics|mesh-ancestor
102290277|NCT03044041|Coagulants|coagulants|mesh-ancestor
102290278|NCT03048097|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102290279|NCT03048097|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102290280|NCT03048097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290281|NCT05516303|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102290282|NCT05516303|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102290283|NCT05516303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290284|NCT05516303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102290285|NCT05516303|Immunologic Factors|immunologic factors|mesh-ancestor
102290286|NCT05516303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290287|NCT04863079|Pembrolizumab|pembrolizumab|mesh-list
102290288|NCT04863079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102290289|NCT04863079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102290290|NCT04863079|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102290291|NCT04863079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290292|NCT05512325|Bevacizumab|bevacizumab|mesh-list
102290293|NCT05512325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101632002|NCT02575729|Betamethasone|betamethasone|mesh-list
102290294|NCT05512325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102290295|NCT05512325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102290296|NCT05512325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102290297|NCT05512325|Growth Substances|growth substances|mesh-ancestor
102290298|NCT05512325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290299|NCT05512325|Growth Inhibitors|growth inhibitors|mesh-ancestor
102290301|NCT04868227|Cholecalciferol|cholecalciferol|mesh-list
102290302|NCT04868227|Vitamins|vitamins|mesh-ancestor
102290303|NCT04868227|Micronutrients|micronutrients|mesh-ancestor
102290304|NCT04868227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290305|NCT04868227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102290306|NCT04868227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102290307|NCT04863001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
102290308|NCT04873531|Neostigmine|neostigmine|mesh-list
102290309|NCT04873531|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102290310|NCT04873531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102290311|NCT04873531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290312|NCT04873531|Cholinergic Agents|cholinergic agents|mesh-ancestor
102290313|NCT04873531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102290314|NCT04873531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290315|NCT04873531|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102290316|NCT04873531|Autonomic Agents|autonomic agents|mesh-ancestor
102290317|NCT04873531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102290318|NCT04862845|Pregabalin|pregabalin|mesh-list
102290319|NCT04862845|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102290320|NCT04862845|Analgesics|analgesics|mesh-ancestor
102290321|NCT04862845|Sensory System Agents|sensory system agents|mesh-ancestor
102290322|NCT04862845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102290323|NCT04862845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290324|NCT04862845|Anticonvulsants|anticonvulsants|mesh-ancestor
102290325|NCT04862845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102290326|NCT04862845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102290327|NCT04862845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290328|NCT04862845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102290329|NCT04862845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102290330|NCT04862845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102290331|NCT04862845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102290332|NCT04862845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102290333|NCT04862845|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102290334|NCT04862845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102290335|NCT04862845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102290336|NCT04862845|Antidepressive Agents|antidepressive agents|mesh-ancestor
102290337|NCT04862845|Dopamine Agents|dopamine agents|mesh-ancestor
102290338|NCT04862377|Budesonide|budesonide|mesh-list
102290339|NCT04862377|Poractant alfa|poractant alfa|mesh-list
102290340|NCT04862377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102290341|NCT04862377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102290342|NCT04862377|Autonomic Agents|autonomic agents|mesh-ancestor
102290343|NCT04862377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102290344|NCT04862377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290345|NCT04862377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102290346|NCT04862377|Respiratory System Agents|respiratory system agents|mesh-ancestor
102290347|NCT04862377|Glucocorticoids|glucocorticoids|mesh-ancestor
102290348|NCT04862377|Hormones|hormones|mesh-ancestor
102290349|NCT04862377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102290350|NCT04862377|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
102290351|NCT04867993|Amikacin|amikacin|mesh-list
102290352|NCT04867993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102290353|NCT04867993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102290354|NCT04872985|Paclitaxel|paclitaxel|mesh-list
102290355|NCT04872985|Docetaxel|docetaxel|mesh-list
102290356|NCT04872985|Cyclophosphamide|cyclophosphamide|mesh-list
102290357|NCT04872985|Doxorubicin|doxorubicin|mesh-list
102290358|NCT04872985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102290359|NCT04872985|Epirubicin|epirubicin|mesh-list
102290360|NCT04872985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102290361|NCT04872985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102290362|NCT04872985|Tubulin Modulators|tubulin modulators|mesh-ancestor
102290363|NCT04872985|Antimitotic Agents|antimitotic agents|mesh-ancestor
102290364|NCT04872985|Mitosis Modulators|mitosis modulators|mesh-ancestor
102290365|NCT04872985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290366|NCT04872985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102290367|NCT04872985|Immunologic Factors|immunologic factors|mesh-ancestor
102290368|NCT04872985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290370|NCT04872985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102290371|NCT04872985|Alkylating Agents|alkylating agents|mesh-ancestor
102290372|NCT04872985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102290373|NCT04872985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102290374|NCT04872985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102290375|NCT04872985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102290376|NCT04872985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102290377|NCT04872907|Fluorides|fluorides|mesh-list
102290378|NCT04872907|Fluorides, Topical|fluorides, topical|mesh-list
102290379|NCT04872907|Cariostatic Agents|cariostatic agents|mesh-ancestor
102290380|NCT04872907|Protective Agents|protective agents|mesh-ancestor
102290381|NCT04872907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290382|NCT02566031|Glycopyrrolate|glycopyrrolate|mesh-list
102290383|NCT02566031|Tiotropium Bromide|tiotropium bromide|mesh-list
102290384|NCT02566031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102290385|NCT02566031|Autonomic Agents|autonomic agents|mesh-ancestor
102290386|NCT02566031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102290387|NCT02566031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290388|NCT02566031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102290389|NCT02566031|Respiratory System Agents|respiratory system agents|mesh-ancestor
102290390|NCT02566031|Parasympatholytics|parasympatholytics|mesh-ancestor
102290391|NCT02566031|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102290392|NCT02566031|Cholinergic Agents|cholinergic agents|mesh-ancestor
102290393|NCT02566031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102290394|NCT02566031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290395|NCT02566031|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102290396|NCT02566031|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102290397|NCT05507411|Immunomodulating Agents|immunomodulating agents|mesh-list
102290398|NCT05507411|Immunologic Factors|immunologic factors|mesh-ancestor
102290399|NCT05507411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290400|NCT05512013|Ibuprofen|ibuprofen|mesh-list
102290401|NCT05512013|Celecoxib|celecoxib|mesh-list
102290402|NCT05512013|Flurbiprofen|flurbiprofen|mesh-list
102290403|NCT05512013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102290404|NCT05512013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102290405|NCT05512013|Analgesics|analgesics|mesh-ancestor
102290406|NCT05512013|Sensory System Agents|sensory system agents|mesh-ancestor
102290407|NCT05512013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102290408|NCT05512013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290409|NCT05512013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102290410|NCT05512013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102290411|NCT05512013|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102290412|NCT05512013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102290413|NCT05512013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290414|NCT05512013|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102290415|NCT04894643|Paclitaxel|paclitaxel|mesh-list
102290416|NCT04894643|Gemcitabine|gemcitabine|mesh-list
102290417|NCT04894643|Capecitabine|capecitabine|mesh-list
102290418|NCT04894643|Pancrelipase|pancrelipase|mesh-list
102290419|NCT04894643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102290420|NCT04894643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102290421|NCT04894643|Tubulin Modulators|tubulin modulators|mesh-ancestor
102290422|NCT04894643|Antimitotic Agents|antimitotic agents|mesh-ancestor
102290423|NCT04894643|Mitosis Modulators|mitosis modulators|mesh-ancestor
101390798|NCT05383495|Analgesics|analgesics|mesh-ancestor
102290424|NCT04894643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290425|NCT04894643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102290426|NCT04894643|Antimetabolites|antimetabolites|mesh-ancestor
102290427|NCT04894643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102290428|NCT05511623|Tislelizumab|tislelizumab|mesh-list
102290429|NCT05511623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102290430|NCT05511623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102290431|NCT05506865|Tiotropium Bromide|tiotropium bromide|mesh-list
102290432|NCT05506865|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102290433|NCT05506865|Autonomic Agents|autonomic agents|mesh-ancestor
102290434|NCT05506865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102290435|NCT05506865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290436|NCT05506865|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102290437|NCT05506865|Respiratory System Agents|respiratory system agents|mesh-ancestor
102290438|NCT05506865|Parasympatholytics|parasympatholytics|mesh-ancestor
102290439|NCT05506865|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102290440|NCT05506865|Cholinergic Agents|cholinergic agents|mesh-ancestor
102290441|NCT05506865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102290442|NCT05506865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290443|NCT03048019|Tirofiban|tirofiban|mesh-list
102290444|NCT03048019|Cangrelor|cangrelor|mesh-list
102290445|NCT03048019|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102290446|NCT03048019|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102290447|NCT03048019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290448|NCT03048019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102290449|NCT03048019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102290450|NCT03048019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102290451|NCT03048019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102290452|NCT03048019|Purinergic Agents|purinergic agents|mesh-ancestor
102290453|NCT03048019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102290454|NCT03048019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290455|NCT05506319|Vasopressins|vasopressins|mesh-list
102290456|NCT05506319|Arginine Vasopressin|arginine vasopressin|mesh-list
102290457|NCT05506319|Norepinephrine|norepinephrine|mesh-list
102290458|NCT05506319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102290459|NCT05506319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102290460|NCT05506319|Adrenergic Agents|adrenergic agents|mesh-ancestor
102290461|NCT05506319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102290462|NCT05506319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290463|NCT05506319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290464|NCT05506319|Sympathomimetics|sympathomimetics|mesh-ancestor
102290465|NCT05506319|Autonomic Agents|autonomic agents|mesh-ancestor
102290466|NCT05506319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102290467|NCT05506319|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102290468|NCT05506319|Hemostatics|hemostatics|mesh-ancestor
102290469|NCT05506319|Coagulants|coagulants|mesh-ancestor
102290470|NCT05506319|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102290471|NCT05506319|Natriuretic Agents|natriuretic agents|mesh-ancestor
102290472|NCT05505539|Fluorouracil|fluorouracil|mesh-list
102290473|NCT05505539|Antimetabolites|antimetabolites|mesh-ancestor
102290474|NCT05505539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290475|NCT05505539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102290476|NCT05505539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102290477|NCT05505539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102290478|NCT05505539|Immunologic Factors|immunologic factors|mesh-ancestor
102290479|NCT05505539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290481|NCT05505461|Immunologic Factors|immunologic factors|mesh-ancestor
102290482|NCT05505461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290483|NCT05514275|Capecitabine|capecitabine|mesh-list
102290484|NCT05514275|Endostatins|endostatins|mesh-list
102290485|NCT05514275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102290486|NCT05514275|Antimetabolites|antimetabolites|mesh-ancestor
102290487|NCT05514275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290488|NCT05514275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102290489|NCT05514275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102290490|NCT05514275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102290491|NCT05514275|Growth Substances|growth substances|mesh-ancestor
102290492|NCT05514275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290493|NCT05514275|Growth Inhibitors|growth inhibitors|mesh-ancestor
102290494|NCT05514041|Varenicline|varenicline|mesh-list
102290495|NCT05514041|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102290496|NCT05514041|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102290497|NCT05514041|Cholinergic Agents|cholinergic agents|mesh-ancestor
102290498|NCT05514041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102290499|NCT05514041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290500|NCT05514041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290501|NCT04667663|Dexamethasone|dexamethasone|mesh-list
102290502|NCT04667663|Cyclophosphamide|cyclophosphamide|mesh-list
102290503|NCT04667663|Daratumumab|daratumumab|mesh-list
102290504|NCT04667663|Pomalidomide|pomalidomide|mesh-list
102290505|NCT04667663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102290506|NCT04667663|Immunologic Factors|immunologic factors|mesh-ancestor
102290507|NCT04667663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290508|NCT04667663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102290509|NCT04667663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102290510|NCT04667663|Alkylating Agents|alkylating agents|mesh-ancestor
102290511|NCT04667663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290512|NCT04667663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102290513|NCT04667663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102290514|NCT04667663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102290515|NCT04667663|Antiemetics|antiemetics|mesh-ancestor
102290516|NCT04667663|Autonomic Agents|autonomic agents|mesh-ancestor
102290517|NCT04667663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102290518|NCT04667663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102290519|NCT04667663|Glucocorticoids|glucocorticoids|mesh-ancestor
102290521|NCT04667663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102290522|NCT04667663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102290523|NCT04667663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102290524|NCT04667663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102290525|NCT04667663|Growth Substances|growth substances|mesh-ancestor
102290526|NCT04667663|Growth Inhibitors|growth inhibitors|mesh-ancestor
102290527|NCT02570711|Paclitaxel|paclitaxel|mesh-list
102290528|NCT02570711|Gemcitabine|gemcitabine|mesh-list
102290529|NCT02570711|Acalabrutinib|acalabrutinib|mesh-list
102290530|NCT02570711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102290531|NCT02570711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102290532|NCT02570711|Tubulin Modulators|tubulin modulators|mesh-ancestor
102290533|NCT02570711|Antimitotic Agents|antimitotic agents|mesh-ancestor
102290534|NCT02570711|Mitosis Modulators|mitosis modulators|mesh-ancestor
102290535|NCT02570711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439566|NCT05180097|Hormones|hormones|mesh-ancestor
101390988|NCT05331664|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101390989|NCT05331664|Cholinergic Agents|cholinergic agents|mesh-ancestor
101390990|NCT05331664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102290536|NCT02570711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102290537|NCT02570711|Antimetabolites|antimetabolites|mesh-ancestor
102290538|NCT05513729|Pioglitazone|pioglitazone|mesh-list
102290539|NCT05513729|Canagliflozin|canagliflozin|mesh-list
102290540|NCT05513729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102290541|NCT05513729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290542|NCT05513729|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102290543|NCT05513729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290544|NCT05504603|Rituximab|rituximab|mesh-list
102290545|NCT05504603|Zanubrutinib|zanubrutinib|mesh-list
102290546|NCT05504603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102290547|NCT05504603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102290548|NCT05504603|Immunologic Factors|immunologic factors|mesh-ancestor
102290549|NCT05504603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290550|NCT05504603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102290551|NCT05504603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102290552|NCT05504603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102290553|NCT05504603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290555|NCT05504213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102290556|NCT05504213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102290557|NCT05504213|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102290558|NCT05504213|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102290559|NCT05504213|Hormone Antagonists|hormone antagonists|mesh-ancestor
102290560|NCT05504213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102290561|NCT05504213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290562|NCT05510219|Obinutuzumab|obinutuzumab|mesh-list
102290563|NCT05510219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102290564|NCT05510219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102290565|NCT02564471|Doxycycline|doxycycline|mesh-list
102290566|NCT02564471|Chloroquine|chloroquine|mesh-list
102290567|NCT02564471|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
102290568|NCT02564471|Atovaquone|atovaquone|mesh-list
102290569|NCT02564471|Proguanil|proguanil|mesh-list
102290570|NCT02564471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102290571|NCT02564471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102290572|NCT02564471|Antimalarials|antimalarials|mesh-ancestor
102290573|NCT02564471|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102290574|NCT02564471|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102290575|NCT02564471|Amebicides|amebicides|mesh-ancestor
102290576|NCT02564471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102290577|NCT02564471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102290578|NCT02564471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102290579|NCT02564471|Analgesics|analgesics|mesh-ancestor
102290580|NCT02564471|Sensory System Agents|sensory system agents|mesh-ancestor
102290581|NCT02564471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102290582|NCT02564471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290583|NCT02564471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102290584|NCT02564471|Filaricides|filaricides|mesh-ancestor
102290585|NCT02564471|Antinematodal Agents|antinematodal agents|mesh-ancestor
102290586|NCT02564471|Anthelmintics|anthelmintics|mesh-ancestor
102290587|NCT02564471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102290588|NCT02564471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290589|NCT02564471|Antimetabolites|antimetabolites|mesh-ancestor
102290590|NCT05503667|Bevacizumab|bevacizumab|mesh-list
102290591|NCT05503667|Aflutinib|aflutinib|mesh-list
102290592|NCT05503667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102290593|NCT05503667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102290594|NCT05503667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101632296|NCT01056107|Incretins|incretins|mesh-ancestor
102290595|NCT05503667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102290596|NCT05503667|Growth Substances|growth substances|mesh-ancestor
102290597|NCT05503667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290598|NCT05503667|Growth Inhibitors|growth inhibitors|mesh-ancestor
102290599|NCT05503667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102290600|NCT05503667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102290601|NCT05503667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290602|NCT02563067|Indoleacetic Acids|indoleacetic acids|mesh-list
102290603|NCT02563067|Plant Growth Regulators|plant growth regulators|mesh-ancestor
102290604|NCT02563067|Growth Substances|growth substances|mesh-ancestor
102290605|NCT02563067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290606|NCT02568683|Vincristine|vincristine|mesh-list
102290607|NCT02568683|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102290608|NCT02568683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102290609|NCT02568683|Tubulin Modulators|tubulin modulators|mesh-ancestor
102290610|NCT02568683|Antimitotic Agents|antimitotic agents|mesh-ancestor
101391087|NCT05281471|Taxane|taxane|mesh-list
102290611|NCT02568683|Mitosis Modulators|mitosis modulators|mesh-ancestor
102290612|NCT02568683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290614|NCT05502731|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102290615|NCT05502731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102290616|NCT05502731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102290617|NCT05503043|Lidocaine|lidocaine|mesh-list
102290618|NCT05503043|Anesthetics, Local|anesthetics, local|mesh-ancestor
102290619|NCT05503043|Anesthetics|anesthetics|mesh-ancestor
102290620|NCT05503043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102290621|NCT05503043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290622|NCT05503043|Sensory System Agents|sensory system agents|mesh-ancestor
102290623|NCT05503043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102290624|NCT05503043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102290625|NCT05503043|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101999325|NCT03899285|Citalopram|citalopram|mesh-list
102290626|NCT05503043|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102290627|NCT05503043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102290628|NCT05503043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290629|NCT02563925|Durvalumab|durvalumab|mesh-list
102290630|NCT02563925|Tremelimumab|tremelimumab|mesh-list
102290631|NCT02563925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102290632|NCT02563925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102290633|NCT01663727|Paclitaxel|paclitaxel|mesh-list
102290634|NCT01663727|Bevacizumab|bevacizumab|mesh-list
102290635|NCT01663727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102290636|NCT01663727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102290637|NCT01663727|Tubulin Modulators|tubulin modulators|mesh-ancestor
102290638|NCT01663727|Antimitotic Agents|antimitotic agents|mesh-ancestor
102290639|NCT01663727|Mitosis Modulators|mitosis modulators|mesh-ancestor
102290640|NCT01663727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290641|NCT01663727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102290642|NCT01663727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102290643|NCT01663727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102290644|NCT01663727|Growth Substances|growth substances|mesh-ancestor
102290645|NCT01663727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290646|NCT01663727|Growth Inhibitors|growth inhibitors|mesh-ancestor
102290647|NCT03042325|Alogliptin|alogliptin|mesh-list
101391119|NCT05275023|Tenofovir|tenofovir|mesh-list
102290648|NCT03042325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102290649|NCT03042325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290650|NCT03042325|Incretins|incretins|mesh-ancestor
102290651|NCT03042325|Hormones|hormones|mesh-ancestor
102290652|NCT03042325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102290653|NCT03042325|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102290654|NCT03042325|Protease Inhibitors|protease inhibitors|mesh-ancestor
102290655|NCT03042325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102290656|NCT03042325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290657|NCT01594333|Methotrexate|methotrexate|mesh-list
102290658|NCT01594333|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102290659|NCT01594333|Abortifacient Agents|abortifacient agents|mesh-ancestor
102290660|NCT01594333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102290661|NCT01594333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290662|NCT01594333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102290663|NCT01594333|Antimetabolites|antimetabolites|mesh-ancestor
102290664|NCT01594333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290665|NCT01594333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102290666|NCT01594333|Dermatologic Agents|dermatologic agents|mesh-ancestor
102290667|NCT01594333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102290668|NCT01594333|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102290669|NCT01594333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102290670|NCT01594333|Immunologic Factors|immunologic factors|mesh-ancestor
102290671|NCT01594333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102290672|NCT01594333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102290673|NCT04338529|Cholecalciferol|cholecalciferol|mesh-list
102290674|NCT04338529|Calcium Carbonate|calcium carbonate|mesh-list
102290675|NCT04338529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102290676|NCT04338529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290677|NCT04338529|Vitamins|vitamins|mesh-ancestor
102290678|NCT04338529|Micronutrients|micronutrients|mesh-ancestor
102290679|NCT04338529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102290680|NCT04338529|Antacids|antacids|mesh-ancestor
102290681|NCT04338529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290682|NCT04338529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102290683|NCT04858633|Hydroxychloroquine|hydroxychloroquine|mesh-list
102290684|NCT04858633|Antimalarials|antimalarials|mesh-ancestor
102290685|NCT04858633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102290686|NCT04858633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102290687|NCT04858633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102290688|NCT04858633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102290689|NCT04858633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290690|NCT04858633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102290691|NCT03043495|Dexamethasone|dexamethasone|mesh-list
102290692|NCT03043495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102290693|NCT03043495|Antiemetics|antiemetics|mesh-ancestor
102290694|NCT03043495|Autonomic Agents|autonomic agents|mesh-ancestor
102290695|NCT03043495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102290696|NCT03043495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290697|NCT03043495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102290698|NCT03043495|Glucocorticoids|glucocorticoids|mesh-ancestor
102290699|NCT03043495|Hormones|hormones|mesh-ancestor
102290700|NCT03043495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102290701|NCT03043495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102290702|NCT03043495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102290703|NCT03043027|Bupivacaine|bupivacaine|mesh-list
102290704|NCT03043027|Anesthetics, Local|anesthetics, local|mesh-ancestor
102290705|NCT03043027|Anesthetics|anesthetics|mesh-ancestor
102290706|NCT03043027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102290707|NCT03043027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290708|NCT03043027|Sensory System Agents|sensory system agents|mesh-ancestor
102290709|NCT03043027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102290710|NCT04861207|Cladribine|cladribine|mesh-list
102290711|NCT04861207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102290712|NCT04861207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102290713|NCT04861207|Immunologic Factors|immunologic factors|mesh-ancestor
102290714|NCT04861207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290715|NCT04858087|Lumefantrine|lumefantrine|mesh-list
102290716|NCT04858087|Artemether|artemether|mesh-list
102290717|NCT04858087|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102290718|NCT04858087|Antimalarials|antimalarials|mesh-ancestor
102290719|NCT04858087|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102290720|NCT04858087|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102290721|NCT04858087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102290722|NCT03041935|Acetaminophen|acetaminophen|mesh-list
102290723|NCT03041935|Dexamethasone|dexamethasone|mesh-list
102290724|NCT03041935|Ketorolac|ketorolac|mesh-list
102290725|NCT03041935|Morphine|morphine|mesh-list
102290726|NCT03041935|Remifentanil|remifentanil|mesh-list
102290727|NCT03041935|Ondansetron|ondansetron|mesh-list
102290728|NCT03041935|Propofol|propofol|mesh-list
102290729|NCT03041935|Ropivacaine|ropivacaine|mesh-list
102290730|NCT03041935|Sevoflurane|sevoflurane|mesh-list
102290731|NCT03041935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102290732|NCT03041935|Antiemetics|antiemetics|mesh-ancestor
102290733|NCT03041935|Autonomic Agents|autonomic agents|mesh-ancestor
102290734|NCT03041935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102290735|NCT03041935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290736|NCT03041935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102290737|NCT03041935|Glucocorticoids|glucocorticoids|mesh-ancestor
102290738|NCT03041935|Hormones|hormones|mesh-ancestor
102290739|NCT03041935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102290740|NCT03041935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102290741|NCT03041935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102290742|NCT03041935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102290743|NCT03041935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102290744|NCT03041935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102290745|NCT03041935|Anesthetics, General|anesthetics, general|mesh-ancestor
102290746|NCT03041935|Anesthetics|anesthetics|mesh-ancestor
102290747|NCT03041935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102290748|NCT03041935|Narcotics|narcotics|mesh-ancestor
102290749|NCT03041935|Analgesics|analgesics|mesh-ancestor
102290750|NCT03041935|Sensory System Agents|sensory system agents|mesh-ancestor
102290751|NCT03041935|Anesthetics, Local|anesthetics, local|mesh-ancestor
102290752|NCT03041935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102290753|NCT03041935|Antipyretics|antipyretics|mesh-ancestor
102290754|NCT03041935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102290755|NCT03041935|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102290756|NCT03041935|Antipruritics|antipruritics|mesh-ancestor
102290757|NCT03041935|Dermatologic Agents|dermatologic agents|mesh-ancestor
102290758|NCT03041935|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102290759|NCT03041935|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102290760|NCT03041935|Serotonin Agents|serotonin agents|mesh-ancestor
102290761|NCT03041935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101391281|NCT05186974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102290762|NCT03041935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290763|NCT03041935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102290764|NCT03041935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102290765|NCT03041935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102290766|NCT03041935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102290768|NCT03042013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102290769|NCT03042013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102290770|NCT03042013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102290771|NCT03042013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290772|NCT03042871|Ranibizumab|ranibizumab|mesh-list
102290773|NCT03042871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102290774|NCT03042871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101999472|NCT03904745|Atosiban|atosiban|mesh-list
102290775|NCT03042871|Growth Substances|growth substances|mesh-ancestor
102290776|NCT03042871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290777|NCT03042871|Growth Inhibitors|growth inhibitors|mesh-ancestor
102290778|NCT03042871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102290779|NCT03042637|Tacrolimus|tacrolimus|mesh-list
102290780|NCT03042637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102290781|NCT03042637|Immunologic Factors|immunologic factors|mesh-ancestor
102290782|NCT03042637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290783|NCT03042637|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102290784|NCT03042637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102290785|NCT03042637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290786|NCT03045133|Morphine|morphine|mesh-list
102290787|NCT03045133|Methadone|methadone|mesh-list
102290788|NCT03045133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102290789|NCT03045133|Narcotics|narcotics|mesh-ancestor
102290790|NCT03045133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102290791|NCT03045133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290792|NCT03045133|Analgesics|analgesics|mesh-ancestor
102290793|NCT03045133|Sensory System Agents|sensory system agents|mesh-ancestor
101391361|NCT05146739|Immunologic Factors|immunologic factors|mesh-ancestor
101391362|NCT05146739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391363|NCT05146739|Antiviral Agents|antiviral agents|mesh-ancestor
101391364|NCT05146739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102290794|NCT03045133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102290795|NCT03045133|Antitussive Agents|antitussive agents|mesh-ancestor
102290796|NCT03045133|Respiratory System Agents|respiratory system agents|mesh-ancestor
102290797|NCT02609659|Ritonavir|ritonavir|mesh-list
102290798|NCT02609659|Ribavirin|ribavirin|mesh-list
102290799|NCT02609659|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102290800|NCT02609659|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102290801|NCT02609659|Protease Inhibitors|protease inhibitors|mesh-ancestor
102290802|NCT02609659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102290803|NCT02609659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290804|NCT02609659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102290805|NCT02609659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102290806|NCT02609659|Antiviral Agents|antiviral agents|mesh-ancestor
102290807|NCT02609659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102290808|NCT02609659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102290809|NCT02609659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102290810|NCT02609659|Antimetabolites|antimetabolites|mesh-ancestor
102290811|NCT04429711|Ivermectin|ivermectin|mesh-list
102290812|NCT04429711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102290813|NCT04429711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102290814|NCT04429633|Candesartan|candesartan|mesh-list
102290815|NCT04429633|Candesartan cilexetil|candesartan cilexetil|mesh-list
102290816|NCT04429633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102290817|NCT04429633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102290818|NCT04429633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102290819|NCT04429633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290821|NCT03042091|Ethanol|ethanol|mesh-list
102290822|NCT03042091|Neomycin|neomycin|mesh-list
102290823|NCT03042091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101391365|NCT05146739|Antidotes|antidotes|mesh-ancestor
101391366|NCT05146739|Protective Agents|protective agents|mesh-ancestor
101391367|NCT05146739|Vitamin B Complex|vitamin b complex|mesh-ancestor
101391368|NCT05146739|Vitamins|vitamins|mesh-ancestor
101391369|NCT05146739|Micronutrients|micronutrients|mesh-ancestor
101391375|NCT05139121|Contraceptive Agents|contraceptive agents|mesh-list
101391376|NCT05139121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101391377|NCT05139121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391378|NCT05137067|Cisplatin|cisplatin|mesh-list
101391379|NCT05137067|Docetaxel|docetaxel|mesh-list
101391380|NCT05137067|Antineoplastic Agents|antineoplastic agents|mesh-list
101391381|NCT05137067|Tubulin Modulators|tubulin modulators|mesh-ancestor
102290824|NCT03042091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102290825|NCT03042091|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102290826|NCT03042091|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102290827|NCT03042091|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102290828|NCT03042091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102290829|NCT03042091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290830|NCT03042091|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102290831|NCT03042091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102290832|NCT03042091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290833|NCT04859569|Denosumab|denosumab|mesh-list
102290834|NCT04859569|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102290835|NCT04859569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290836|NCT04856371|Letrozole|letrozole|mesh-list
102290837|NCT04856371|Fulvestrant|fulvestrant|mesh-list
102290838|NCT04856371|Palbociclib|palbociclib|mesh-list
102290839|NCT04856371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102290840|NCT04856371|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102290841|NCT04856371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102290842|NCT04856371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102290843|NCT04856371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290844|NCT04856371|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102290845|NCT04856371|Hormone Antagonists|hormone antagonists|mesh-ancestor
102290846|NCT04856371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102290847|NCT04856371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290848|NCT04856371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102290849|NCT04856371|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102290850|NCT04856371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102290851|NCT03041779|Acetaminophen|acetaminophen|mesh-list
102290852|NCT03041779|Diclofenac|diclofenac|mesh-list
102290853|NCT03041779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102290854|NCT03041779|Analgesics|analgesics|mesh-ancestor
102290855|NCT03041779|Sensory System Agents|sensory system agents|mesh-ancestor
102290856|NCT03041779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102290857|NCT03041779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391409|NCT05111626|Bemarituzumab|bemarituzumab|mesh-list
101305517|NCT02020005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305518|NCT02020122|Pregabalin|pregabalin|mesh-list
101391410|NCT05111626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101391411|NCT05111626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391439|NCT05077904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101391440|NCT05077904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101391441|NCT05077904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101391443|NCT05077904|GABA Agents|gaba agents|mesh-ancestor
101391444|NCT05077904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101391445|NCT05077904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391450|NCT05068791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101391451|NCT05068791|Antitussive Agents|antitussive agents|mesh-ancestor
101391452|NCT05068791|Respiratory System Agents|respiratory system agents|mesh-ancestor
101391453|NCT05068791|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101391454|NCT05068791|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101391455|NCT05068791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101391456|NCT05068791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391481|NCT05065918|Ethanol|ethanol|mesh-list
102290858|NCT03041779|Antipyretics|antipyretics|mesh-ancestor
102290859|NCT03041779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102290860|NCT03041779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102290861|NCT03041779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102290862|NCT03041779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102290863|NCT03041779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102290864|NCT03041779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290865|NCT02612779|Dexamethasone|dexamethasone|mesh-list
102290866|NCT02612779|Nivolumab|nivolumab|mesh-list
102290867|NCT02612779|Pomalidomide|pomalidomide|mesh-list
102290868|NCT02612779|Elotuzumab|elotuzumab|mesh-list
102290869|NCT02612779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102290870|NCT02612779|Antiemetics|antiemetics|mesh-ancestor
102290871|NCT02612779|Autonomic Agents|autonomic agents|mesh-ancestor
102290872|NCT02612779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102290873|NCT02612779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290874|NCT02612779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102290875|NCT02612779|Glucocorticoids|glucocorticoids|mesh-ancestor
102290876|NCT02612779|Hormones|hormones|mesh-ancestor
102290877|NCT02612779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102290878|NCT02612779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102290879|NCT02612779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102290880|NCT02612779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102290881|NCT02612779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102290882|NCT02612779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290883|NCT02612779|Immunologic Factors|immunologic factors|mesh-ancestor
102290884|NCT02612779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102290885|NCT02612779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102290886|NCT02612779|Growth Substances|growth substances|mesh-ancestor
102290887|NCT02612779|Growth Inhibitors|growth inhibitors|mesh-ancestor
102290888|NCT04866355|Ibuprofen|ibuprofen|mesh-list
102290889|NCT04866355|Scopolamine|scopolamine|mesh-list
102290890|NCT04866355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102290891|NCT04866355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102290892|NCT04866355|Analgesics|analgesics|mesh-ancestor
102290893|NCT04866355|Sensory System Agents|sensory system agents|mesh-ancestor
101632602|NCT00998738|Calcium|calcium|mesh-list
102290894|NCT04866355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102290895|NCT04866355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290896|NCT04866355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102290897|NCT04866355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102290898|NCT04866355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102290899|NCT04866355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102290900|NCT04866355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290901|NCT04866355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102290902|NCT04866355|Antiemetics|antiemetics|mesh-ancestor
102290903|NCT04866355|Autonomic Agents|autonomic agents|mesh-ancestor
102290904|NCT04866355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102290905|NCT04866355|Mydriatics|mydriatics|mesh-ancestor
102290906|NCT04866355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102290907|NCT04866355|Cholinergic Agents|cholinergic agents|mesh-ancestor
102290908|NCT04866355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102290909|NCT04866355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102290910|NCT02607865|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102290911|NCT02607865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102290912|NCT02607865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290913|NCT02607865|Incretins|incretins|mesh-ancestor
102290914|NCT02607865|Hormones|hormones|mesh-ancestor
102290915|NCT02607865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102290916|NCT02607865|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102290917|NCT02607865|Protease Inhibitors|protease inhibitors|mesh-ancestor
102290918|NCT02607865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102290919|NCT02607865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290920|NCT04856137|Paclitaxel|paclitaxel|mesh-list
102290921|NCT04856137|Rituximab|rituximab|mesh-list
102290922|NCT04856137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102290923|NCT04856137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102290924|NCT04856137|Tubulin Modulators|tubulin modulators|mesh-ancestor
102290925|NCT04856137|Antimitotic Agents|antimitotic agents|mesh-ancestor
102290926|NCT04856137|Mitosis Modulators|mitosis modulators|mesh-ancestor
101391482|NCT05065918|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102290927|NCT04856137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290928|NCT04856137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102290930|NCT04856137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290931|NCT04856137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102290932|NCT04855279|Listerine|listerine|mesh-list
102290933|NCT04855279|Fluorides|fluorides|mesh-list
102290934|NCT04855279|Sodium Fluoride|sodium fluoride|mesh-list
102290935|NCT04855279|Glycerol|glycerol|mesh-list
102290936|NCT04855279|Cariostatic Agents|cariostatic agents|mesh-ancestor
102290937|NCT04855279|Protective Agents|protective agents|mesh-ancestor
102290938|NCT04855279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290939|NCT04855279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102290940|NCT04855279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102290941|NCT04855279|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102290942|NCT04848259|Dexamethasone|dexamethasone|mesh-list
102290943|NCT04848259|Dexamethasone acetate|dexamethasone acetate|mesh-list
102290944|NCT04848259|BB 1101|bb 1101|mesh-list
102290945|NCT04848259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102290946|NCT04848259|Antiemetics|antiemetics|mesh-ancestor
102290947|NCT04848259|Autonomic Agents|autonomic agents|mesh-ancestor
102290948|NCT04848259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102290949|NCT04848259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290950|NCT04848259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102290951|NCT04848259|Glucocorticoids|glucocorticoids|mesh-ancestor
102290952|NCT04848259|Hormones|hormones|mesh-ancestor
102290953|NCT04848259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102290954|NCT04848259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102290955|NCT04848259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102290956|NCT04848259|Protease Inhibitors|protease inhibitors|mesh-ancestor
102290957|NCT04848259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102290958|NCT04848259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290959|NCT03039049|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102290960|NCT03039049|Luteolytic Agents|luteolytic agents|mesh-ancestor
102290961|NCT03039049|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102290962|NCT03039049|Contraceptive Agents|contraceptive agents|mesh-ancestor
102290963|NCT03039049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102290964|NCT03039049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290965|NCT03039049|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102290966|NCT03039049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102290967|NCT03039049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102290968|NCT04848181|Cyproterone Acetate|cyproterone acetate|mesh-list
102290969|NCT04848181|Finasteride|finasteride|mesh-list
102290970|NCT04848181|Cyproterone|cyproterone|mesh-list
102290971|NCT04848181|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102290972|NCT04848181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102290973|NCT04848181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102290974|NCT04848181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102290975|NCT04848181|Hormone Antagonists|hormone antagonists|mesh-ancestor
102290976|NCT04848181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102290977|NCT04848181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290978|NCT04848181|Urological Agents|urological agents|mesh-ancestor
102290979|NCT04848181|Androgen Antagonists|androgen antagonists|mesh-ancestor
102290980|NCT04848181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102290981|NCT04848181|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102290982|NCT04848181|Contraceptive Agents|contraceptive agents|mesh-ancestor
102290983|NCT04848181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102290984|NCT04847791|Lactoferrin|lactoferrin|mesh-list
102290985|NCT04847791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102290986|NCT04375813|Sirolimus|sirolimus|mesh-list
102290987|NCT04375813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102290988|NCT04375813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102290989|NCT04375813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102290990|NCT04375813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102290991|NCT04375813|Antifungal Agents|antifungal agents|mesh-ancestor
102290992|NCT04375813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102290993|NCT04375813|Immunologic Factors|immunologic factors|mesh-ancestor
102290994|NCT04375813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102290995|NCT04847245|Pregabalin|pregabalin|mesh-list
102290996|NCT04847245|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102290997|NCT04847245|Esketamine|esketamine|mesh-list
102290998|NCT04847245|Analgesics|analgesics|mesh-ancestor
102290999|NCT04847245|Sensory System Agents|sensory system agents|mesh-ancestor
102291000|NCT04847245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101999718|NCT01560572|Tacrolimus|tacrolimus|mesh-list
102291001|NCT04847245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291002|NCT04847245|Anticonvulsants|anticonvulsants|mesh-ancestor
102291003|NCT04847245|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102291004|NCT04847245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102291005|NCT04847245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291006|NCT04847245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102291007|NCT04847245|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102291008|NCT04847245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102291009|NCT04847245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102291010|NCT04847245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102291011|NCT04847245|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102291012|NCT04847245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102291013|NCT04847245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102291014|NCT04847245|Antidepressive Agents|antidepressive agents|mesh-ancestor
102291015|NCT04847245|Dopamine Agents|dopamine agents|mesh-ancestor
102291017|NCT04839913|Immunologic Factors|immunologic factors|mesh-ancestor
102291018|NCT04839913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291019|NCT04846621|Calcium Channel Blockers|calcium channel blockers|mesh-list
102291020|NCT04846621|Calcium|calcium|mesh-list
102291021|NCT04846621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102291022|NCT04846621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291023|NCT04846621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102291024|NCT04846621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291025|NCT04854577|Anesthetics|anesthetics|mesh-list
102291026|NCT04854577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102291027|NCT04854577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291028|NCT04839445|Anesthetics|anesthetics|mesh-list
102291029|NCT04839445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102291030|NCT04839445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291031|NCT04845607|Amiodarone|amiodarone|mesh-list
102291032|NCT04845607|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102291033|NCT04845607|Vasodilator Agents|vasodilator agents|mesh-ancestor
102291034|NCT04845607|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102291035|NCT04845607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102291036|NCT04845607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291037|NCT04845607|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102291038|NCT04845607|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102291039|NCT04845607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102291040|NCT04845607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102291041|NCT04845607|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102291042|NCT04845607|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102291043|NCT04845607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102291045|NCT04853797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102291046|NCT04853797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291047|NCT03040531|Vitamin D|vitamin d|mesh-list
102291048|NCT03040531|Cholecalciferol|cholecalciferol|mesh-list
102291049|NCT03040531|Alendronate|alendronate|mesh-list
102291050|NCT03040531|Genistein|genistein|mesh-list
102291051|NCT03040531|Calcium|calcium|mesh-list
102291052|NCT03040531|Vitamins|vitamins|mesh-ancestor
102291053|NCT03040531|Micronutrients|micronutrients|mesh-ancestor
102291054|NCT03040531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291055|NCT03040531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102291056|NCT03040531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102291057|NCT03040531|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102291058|NCT03040531|Protective Agents|protective agents|mesh-ancestor
102291059|NCT03040531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102291060|NCT03040531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102291061|NCT03040531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102291062|NCT03040531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291063|NCT03040531|Phytoestrogens|phytoestrogens|mesh-ancestor
102291064|NCT03040531|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102291065|NCT03040531|Estrogens|estrogens|mesh-ancestor
102291066|NCT03040531|Hormones|hormones|mesh-ancestor
102291067|NCT03040531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102291068|NCT04838665|Phenylephrine|phenylephrine|mesh-list
102291069|NCT04838665|Oxymetazoline|oxymetazoline|mesh-list
102291070|NCT04838665|Tropicamide|tropicamide|mesh-list
102291071|NCT04838665|Cyclopentolate|cyclopentolate|mesh-list
102291072|NCT04838665|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102291073|NCT04838665|Mydriatics|mydriatics|mesh-ancestor
102291074|NCT04838665|Autonomic Agents|autonomic agents|mesh-ancestor
102291075|NCT04838665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102291076|NCT04838665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291077|NCT04838665|Sympathomimetics|sympathomimetics|mesh-ancestor
102291078|NCT04838665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102291079|NCT04838665|Nasal Decongestants|nasal decongestants|mesh-ancestor
102291080|NCT04838665|Respiratory System Agents|respiratory system agents|mesh-ancestor
102291081|NCT04838665|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102291082|NCT04838665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102291083|NCT04838665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102291084|NCT04838665|Adrenergic Agents|adrenergic agents|mesh-ancestor
102291085|NCT04838665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102291086|NCT04838665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291087|NCT04838665|Protective Agents|protective agents|mesh-ancestor
102291088|NCT04838665|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102291089|NCT04838665|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102291090|NCT04838665|Cholinergic Agents|cholinergic agents|mesh-ancestor
102291091|NCT04838665|Parasympatholytics|parasympatholytics|mesh-ancestor
102291093|NCT04845061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102291094|NCT04845061|Vasodilator Agents|vasodilator agents|mesh-ancestor
102291095|NCT04845061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102291096|NCT04845061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102291097|NCT04845061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102291098|NCT04845061|Adrenergic Agents|adrenergic agents|mesh-ancestor
102291099|NCT04845061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102291100|NCT04845061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291101|NCT04845061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291102|NCT03040765|Zoledronic Acid|zoledronic acid|mesh-list
102291103|NCT03040765|Denosumab|denosumab|mesh-list
102291104|NCT03040765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102291105|NCT03040765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291106|NCT01668667|Gabapentin|gabapentin|mesh-list
102291107|NCT01668667|Analgesics|analgesics|mesh-ancestor
102291108|NCT01668667|Sensory System Agents|sensory system agents|mesh-ancestor
102291109|NCT01668667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102291110|NCT01668667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291111|NCT01668667|Anticonvulsants|anticonvulsants|mesh-ancestor
102291112|NCT01668667|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102291113|NCT01668667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102291114|NCT01668667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102291115|NCT01668667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102291116|NCT01668667|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102291117|NCT01668667|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102291118|NCT01668667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101632818|NCT00996476|Simeprevir|simeprevir|mesh-list
102291119|NCT01668667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291120|NCT01668667|Antimanic Agents|antimanic agents|mesh-ancestor
102291122|NCT03040219|Hematinics|hematinics|mesh-ancestor
102291123|NCT03040219|Vitamin B Complex|vitamin b complex|mesh-ancestor
102291124|NCT03040219|Vitamins|vitamins|mesh-ancestor
102291125|NCT03040219|Micronutrients|micronutrients|mesh-ancestor
102291126|NCT03040219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291127|NCT03038503|Terlipressin|terlipressin|mesh-list
102291128|NCT03038503|Methylene Blue|methylene blue|mesh-list
102291129|NCT03038503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102291130|NCT03038503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291131|NCT03038503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102291132|NCT03038503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102291133|NCT02608879|Chlorhexidine|chlorhexidine|mesh-list
102291134|NCT02608879|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102291135|NCT02608879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102291136|NCT02608879|Disinfectants|disinfectants|mesh-ancestor
102291137|NCT04142125|Rivaroxaban|rivaroxaban|mesh-list
102291138|NCT04142125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291139|NCT04142125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102291140|NCT04142125|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102291141|NCT04142125|Antithrombins|antithrombins|mesh-ancestor
102291142|NCT04142125|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102291143|NCT04142125|Protease Inhibitors|protease inhibitors|mesh-ancestor
102291144|NCT04142125|Anticoagulants|anticoagulants|mesh-ancestor
102291145|NCT04852315|Caffeine|caffeine|mesh-list
102291146|NCT04852315|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102291147|NCT04852315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291148|NCT04852315|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102291149|NCT04852315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101391690|NCT04989491|Immunologic Factors|immunologic factors|mesh-ancestor
102291150|NCT04852315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291151|NCT04852315|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102291152|NCT04852315|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102291153|NCT04852315|Purinergic Agents|purinergic agents|mesh-ancestor
102291154|NCT04852315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102291156|NCT03038425|Anesthetics, Local|anesthetics, local|mesh-ancestor
102291157|NCT03038425|Anesthetics|anesthetics|mesh-ancestor
102291158|NCT03038425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102291159|NCT03038425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291160|NCT03038425|Sensory System Agents|sensory system agents|mesh-ancestor
102291161|NCT03038425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102291162|NCT04851769|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
102291163|NCT04851769|Alirocumab|alirocumab|mesh-list
102291164|NCT04851769|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
102291165|NCT04851769|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102291166|NCT04851769|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102291167|NCT04851769|Antimetabolites|antimetabolites|mesh-ancestor
102291168|NCT04851769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291169|NCT04851769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102291170|NCT04851769|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102291171|NCT04851769|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102291172|NCT04851769|Protease Inhibitors|protease inhibitors|mesh-ancestor
102291173|NCT04843267|Tislelizumab|tislelizumab|mesh-list
102291174|NCT04843267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102291175|NCT04843267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102291176|NCT04852081|Tamoxifen|tamoxifen|mesh-list
102291177|NCT04852081|Letrozole|letrozole|mesh-list
102291178|NCT04852081|Fulvestrant|fulvestrant|mesh-list
102291179|NCT04852081|Palbociclib|palbociclib|mesh-list
102291180|NCT04852081|Anastrozole|anastrozole|mesh-list
102291181|NCT04852081|Exemestane|exemestane|mesh-list
102291182|NCT04852081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102291183|NCT04852081|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102291184|NCT04852081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102291185|NCT04852081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102291186|NCT04852081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291187|NCT04852081|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102291188|NCT04852081|Hormone Antagonists|hormone antagonists|mesh-ancestor
102291189|NCT04852081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102291190|NCT04852081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291191|NCT04852081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102291192|NCT04852081|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102291193|NCT04852081|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102291194|NCT04852081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102291195|NCT04852081|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102291196|NCT04852081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102291198|NCT04851457|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102291199|NCT04851457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102291200|NCT04851457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291201|NCT04851457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102291202|NCT02608099|Apixaban|apixaban|mesh-list
102291203|NCT02608099|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102291204|NCT02608099|Antithrombins|antithrombins|mesh-ancestor
102291205|NCT02608099|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102291206|NCT02608099|Protease Inhibitors|protease inhibitors|mesh-ancestor
102291207|NCT02608099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101391759|NCT04963296|Analgesics|analgesics|mesh-ancestor
101188805|NCT00003150|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101391785|NCT04963296|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101391786|NCT04963296|Antipruritics|antipruritics|mesh-ancestor
101391787|NCT04963296|Dermatologic Agents|dermatologic agents|mesh-ancestor
101391827|NCT04938765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101391828|NCT04938765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391829|NCT04938765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101391830|NCT04938765|Tocolytic Agents|tocolytic agents|mesh-ancestor
101391831|NCT04938765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101391833|NCT04935931|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101439866|NCT04859946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101439867|NCT04859946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101439868|NCT04843904|Rituximab|rituximab|mesh-list
101439869|NCT04843904|Obinutuzumab|obinutuzumab|mesh-list
101439870|NCT04843904|Venetoclax|venetoclax|mesh-list
101439871|NCT04843904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101439872|NCT04843904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439873|NCT04843904|Immunologic Factors|immunologic factors|mesh-ancestor
101439874|NCT04843904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439875|NCT04843904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102291208|NCT02608099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291209|NCT02608099|Anticoagulants|anticoagulants|mesh-ancestor
102291210|NCT04850755|Nivolumab|nivolumab|mesh-list
102291211|NCT04850755|Ipilimumab|ipilimumab|mesh-list
102291212|NCT04850755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102291213|NCT04850755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102291214|NCT04850755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102291215|NCT04850755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291216|NCT04842487|Prednisone|prednisone|mesh-list
102291217|NCT04842487|Cyclophosphamide|cyclophosphamide|mesh-list
102291218|NCT04842487|Rituximab|rituximab|mesh-list
102291219|NCT04842487|Vincristine|vincristine|mesh-list
102291220|NCT04842487|Lenalidomide|lenalidomide|mesh-list
102291221|NCT04842487|Doxorubicin|doxorubicin|mesh-list
102291222|NCT04842487|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101999921|NCT01152749|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102291223|NCT04842487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102291224|NCT04842487|Immunologic Factors|immunologic factors|mesh-ancestor
102291225|NCT04842487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291226|NCT04842487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102291227|NCT04842487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102291228|NCT04842487|Alkylating Agents|alkylating agents|mesh-ancestor
102291229|NCT04842487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291230|NCT04842487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102291231|NCT04842487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102291232|NCT04842487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102291233|NCT04842487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102291234|NCT04842487|Glucocorticoids|glucocorticoids|mesh-ancestor
102291236|NCT04842487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102291237|NCT04842487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102291238|NCT04842487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102291239|NCT04842487|Tubulin Modulators|tubulin modulators|mesh-ancestor
102291240|NCT04842487|Antimitotic Agents|antimitotic agents|mesh-ancestor
102291241|NCT04842487|Mitosis Modulators|mitosis modulators|mesh-ancestor
102291242|NCT04842487|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102291243|NCT04842487|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102291244|NCT04842487|Growth Substances|growth substances|mesh-ancestor
102291245|NCT04842487|Growth Inhibitors|growth inhibitors|mesh-ancestor
102291246|NCT04842487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102291247|NCT04842487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102291248|NCT04842487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102291249|NCT04842487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102291250|NCT04842331|Nitric Oxide|nitric oxide|mesh-list
102291251|NCT04842331|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102291252|NCT04842331|Autonomic Agents|autonomic agents|mesh-ancestor
102291253|NCT04842331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102291254|NCT04842331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291255|NCT04842331|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102291256|NCT04842331|Respiratory System Agents|respiratory system agents|mesh-ancestor
102291257|NCT04842331|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102291258|NCT04842331|Antioxidants|antioxidants|mesh-ancestor
102291259|NCT04842331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291260|NCT04842331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102291261|NCT04842331|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102291262|NCT04842331|Vasodilator Agents|vasodilator agents|mesh-ancestor
102291263|NCT04842331|Gasotransmitters|gasotransmitters|mesh-ancestor
102291264|NCT04842331|Protective Agents|protective agents|mesh-ancestor
102291265|NCT04837885|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102291266|NCT04837885|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102291267|NCT04837885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291268|NCT04833205|Nimotuzumab|nimotuzumab|mesh-list
102291269|NCT04833205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102291270|NCT04833205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102291271|NCT04312243|Nitric Oxide|nitric oxide|mesh-list
102291272|NCT04312243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102291273|NCT04312243|Autonomic Agents|autonomic agents|mesh-ancestor
102291274|NCT04312243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102291275|NCT04312243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291276|NCT04312243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102291277|NCT04312243|Respiratory System Agents|respiratory system agents|mesh-ancestor
102291278|NCT04312243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102291279|NCT04312243|Antioxidants|antioxidants|mesh-ancestor
102291280|NCT04312243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291281|NCT04312243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102291282|NCT04312243|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102291283|NCT04312243|Vasodilator Agents|vasodilator agents|mesh-ancestor
102291284|NCT04312243|Gasotransmitters|gasotransmitters|mesh-ancestor
102291285|NCT04312243|Protective Agents|protective agents|mesh-ancestor
102291286|NCT04841551|Deoxycholic Acid|deoxycholic acid|mesh-list
102291287|NCT04841551|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102291288|NCT04841551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102291289|NCT04837651|Antibodies|antibodies|mesh-list
102291290|NCT04837651|Immunologic Factors|immunologic factors|mesh-ancestor
102291291|NCT04837651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291292|NCT03039205|Clopidogrel|clopidogrel|mesh-list
102291293|NCT03039205|Ticagrelor|ticagrelor|mesh-list
102291294|NCT03039205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102291295|NCT03039205|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102291296|NCT03039205|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102291297|NCT03039205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102291298|NCT03039205|Purinergic Agents|purinergic agents|mesh-ancestor
101999992|NCT03888677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102291299|NCT03039205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102291300|NCT03039205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291301|NCT03039205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291302|NCT04837261|Propranolol|propranolol|mesh-list
102291303|NCT04837261|Amiodarone|amiodarone|mesh-list
102291304|NCT04837261|Flecainide|flecainide|mesh-list
102291305|NCT04837261|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102291306|NCT04837261|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102291307|NCT04837261|Adrenergic Agents|adrenergic agents|mesh-ancestor
102291308|NCT04837261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102291309|NCT04837261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291310|NCT04837261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291311|NCT04837261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102291312|NCT04837261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102291313|NCT04837261|Vasodilator Agents|vasodilator agents|mesh-ancestor
102291314|NCT04837261|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102291315|NCT04837261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102291316|NCT04837261|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102291317|NCT04837261|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102291318|NCT04837261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102291319|NCT04837261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102291320|NCT04837261|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102291321|NCT04837261|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102291322|NCT04837261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102291323|NCT04837261|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102291324|NCT04832035|Psychotropic Drugs|psychotropic drugs|mesh-list
102291325|NCT04824937|Talazoparib|talazoparib|mesh-list
102291326|NCT04824937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102291327|NCT04824937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102291328|NCT04824937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291329|NCT04824937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102291330|NCT03036085|Epinephrine|epinephrine|mesh-list
102291331|NCT03036085|Bupivacaine|bupivacaine|mesh-list
102291332|NCT03036085|Anesthetics, Local|anesthetics, local|mesh-ancestor
102291333|NCT03036085|Anesthetics|anesthetics|mesh-ancestor
102291334|NCT03036085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102291335|NCT03036085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291336|NCT03036085|Sensory System Agents|sensory system agents|mesh-ancestor
102291337|NCT03036085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102291338|NCT03036085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102291339|NCT03036085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102291340|NCT03036085|Adrenergic Agents|adrenergic agents|mesh-ancestor
102291341|NCT03036085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102291342|NCT03036085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291343|NCT03036085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102291344|NCT03036085|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102291345|NCT03036085|Autonomic Agents|autonomic agents|mesh-ancestor
101391932|NCT04898894|Cytarabine|cytarabine|mesh-list
101391955|NCT04898894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101391985|NCT04887935|Dapagliflozin|dapagliflozin|mesh-list
101391986|NCT04887935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101391987|NCT04887935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391988|NCT04887935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101391989|NCT04887935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391990|NCT04885998|AMG 757|amg 757|mesh-list
101391991|NCT04885998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391992|NCT04885530|Metformin|metformin|mesh-list
102291346|NCT03036085|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102291347|NCT03036085|Respiratory System Agents|respiratory system agents|mesh-ancestor
102291348|NCT03036085|Mydriatics|mydriatics|mesh-ancestor
102291349|NCT03036085|Sympathomimetics|sympathomimetics|mesh-ancestor
102291350|NCT03036085|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102291351|NCT04831255|Triamcinolone|triamcinolone|mesh-list
102291352|NCT04831255|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102291353|NCT04831255|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102291354|NCT04831255|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102291355|NCT04831255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102291356|NCT04831255|Glucocorticoids|glucocorticoids|mesh-ancestor
102291358|NCT04831255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102291359|NCT04831255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291360|NCT04831255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102291361|NCT04831255|Immunologic Factors|immunologic factors|mesh-ancestor
102291362|NCT04831255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102291363|NCT04831255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291364|NCT02431533|Calcium|calcium|mesh-list
102291365|NCT02431533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102291366|NCT02431533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291367|NCT02413593|Sofosbuvir|sofosbuvir|mesh-list
102291368|NCT02413593|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102291369|NCT02413593|Ledipasvir|ledipasvir|mesh-list
102291370|NCT02413593|Antiviral Agents|antiviral agents|mesh-ancestor
102291371|NCT02413593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102291372|NCT01652703|Evolocumab|evolocumab|mesh-list
102291373|NCT01652703|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102291374|NCT01652703|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102291375|NCT01652703|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102291376|NCT01652703|Antimetabolites|antimetabolites|mesh-ancestor
102291377|NCT01652703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291378|NCT01652703|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102291379|NCT01652703|Protease Inhibitors|protease inhibitors|mesh-ancestor
102291380|NCT01652703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102291381|NCT01652703|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102291382|NCT01652469|Docetaxel|docetaxel|mesh-list
102291383|NCT01652469|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102291384|NCT01652469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102291385|NCT01652469|Tubulin Modulators|tubulin modulators|mesh-ancestor
102291386|NCT01652469|Antimitotic Agents|antimitotic agents|mesh-ancestor
102291387|NCT01652469|Mitosis Modulators|mitosis modulators|mesh-ancestor
102291388|NCT01652469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291389|NCT01652469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102291390|NCT01652469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102291391|NCT02429427|Celecoxib|celecoxib|mesh-list
102291392|NCT02429427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102291393|NCT02429427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102291394|NCT02429427|Analgesics|analgesics|mesh-ancestor
102291395|NCT02429427|Sensory System Agents|sensory system agents|mesh-ancestor
102291396|NCT02429427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102291397|NCT02429427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291398|NCT02429427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102291399|NCT02429427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102291400|NCT02429427|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102291401|NCT02429427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102291402|NCT02429427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102291403|NCT02429427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291404|NCT02412657|Dexamethasone|dexamethasone|mesh-list
102291405|NCT02412657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102291406|NCT02412657|Antiemetics|antiemetics|mesh-ancestor
102291407|NCT02412657|Autonomic Agents|autonomic agents|mesh-ancestor
102291408|NCT02412657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102291409|NCT02412657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291410|NCT02412657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102291411|NCT02412657|Glucocorticoids|glucocorticoids|mesh-ancestor
102291412|NCT02412657|Hormones|hormones|mesh-ancestor
102291413|NCT02412657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102291414|NCT02412657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102291415|NCT02412657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102291417|NCT02412111|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102291418|NCT02412111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102291419|NCT02412111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291420|NCT02426541|Dapagliflozin|dapagliflozin|mesh-list
102291421|NCT02426541|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102291422|NCT02426541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291423|NCT02426541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102291424|NCT02426541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291425|NCT02484651|Rocuronium|rocuronium|mesh-list
102291426|NCT02484651|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102291427|NCT02484651|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102291428|NCT02484651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102291429|NCT02484651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102291430|NCT02484651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291431|NCT02410551|Fludarabine|fludarabine|mesh-list
102291432|NCT02410551|Fludarabine phosphate|fludarabine phosphate|mesh-list
102291433|NCT02410551|Busulfan|busulfan|mesh-list
102291434|NCT02410551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102291435|NCT02410551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102291436|NCT02410551|Antimetabolites|antimetabolites|mesh-ancestor
102291437|NCT02410551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291438|NCT02410551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102291439|NCT02410551|Immunologic Factors|immunologic factors|mesh-ancestor
102291440|NCT02410551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291441|NCT02410551|Alkylating Agents|alkylating agents|mesh-ancestor
102291442|NCT02410551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102291443|NCT02410551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102291444|NCT02424591|Ketamine|ketamine|mesh-list
102291445|NCT02424591|Analgesics|analgesics|mesh-ancestor
102291446|NCT02424591|Sensory System Agents|sensory system agents|mesh-ancestor
102291447|NCT02424591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102291448|NCT02424591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291449|NCT02424591|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102291450|NCT02424591|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102291451|NCT02424591|Anesthetics, General|anesthetics, general|mesh-ancestor
102291452|NCT02424591|Anesthetics|anesthetics|mesh-ancestor
102291453|NCT02424591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102291454|NCT02424591|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102291455|NCT02424591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102291456|NCT02424591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102291457|NCT02424591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291458|NCT02408523|Lacosamide|lacosamide|mesh-list
102291459|NCT02408523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102291460|NCT02408523|Anticonvulsants|anticonvulsants|mesh-ancestor
102291461|NCT02408523|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102291462|NCT02408523|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102291463|NCT02408523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102291464|NCT02408523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291465|NCT04822909|Thalidomide|thalidomide|mesh-list
102291466|NCT04822909|Apremilast|apremilast|mesh-list
102291467|NCT04822909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102291468|NCT04822909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102291469|NCT04822909|Analgesics|analgesics|mesh-ancestor
102291470|NCT04822909|Sensory System Agents|sensory system agents|mesh-ancestor
102291471|NCT04822909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102291472|NCT04822909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291473|NCT04822909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102291474|NCT04822909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102291475|NCT04822909|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102291476|NCT04822909|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102291477|NCT04822909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102291478|NCT04822909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291479|NCT04822909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102291480|NCT04822909|Immunologic Factors|immunologic factors|mesh-ancestor
102291481|NCT04822909|Leprostatic Agents|leprostatic agents|mesh-ancestor
102291482|NCT04822909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102291483|NCT04822909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102291484|NCT04822909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102291485|NCT04822909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102291486|NCT04822909|Growth Substances|growth substances|mesh-ancestor
102291487|NCT04822909|Growth Inhibitors|growth inhibitors|mesh-ancestor
102291488|NCT04822909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102291489|NCT04831099|Testosterone|testosterone|mesh-list
102291490|NCT04831099|Androgens|androgens|mesh-ancestor
102291491|NCT04831099|Hormones|hormones|mesh-ancestor
102291492|NCT04831099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102291493|NCT04831099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291494|NCT04830241|Antidepressive Agents|antidepressive agents|mesh-list
102291495|NCT04830241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102291496|NCT02603419|Avelumab|avelumab|mesh-list
102291497|NCT02603419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102291498|NCT02603419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102291499|NCT02603419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102291500|NCT02603419|Immunologic Factors|immunologic factors|mesh-ancestor
102291501|NCT02603419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291502|NCT04367935|Pentoxifylline|pentoxifylline|mesh-list
102291503|NCT04367935|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102291504|NCT04367935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102291505|NCT04367935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291506|NCT04367935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102291507|NCT04367935|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102291508|NCT04367935|Protective Agents|protective agents|mesh-ancestor
102291509|NCT04367935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291510|NCT04367935|Vasodilator Agents|vasodilator agents|mesh-ancestor
102291511|NCT04367935|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102291512|NCT04367935|Antioxidants|antioxidants|mesh-ancestor
102291513|NCT04829773|Midazolam|midazolam|mesh-list
102291514|NCT04829773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102291515|NCT04829773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102291516|NCT04829773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102291517|NCT04829773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291518|NCT04829773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102291519|NCT04829773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102291520|NCT04829773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102291521|NCT04829773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102291522|NCT04829773|Anesthetics, General|anesthetics, general|mesh-ancestor
102291523|NCT04829773|Anesthetics|anesthetics|mesh-ancestor
102291524|NCT04829773|GABA Modulators|gaba modulators|mesh-ancestor
102291525|NCT04829773|GABA Agents|gaba agents|mesh-ancestor
102291526|NCT04829773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102291527|NCT04829773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291528|NCT04829695|Artesunate|artesunate|mesh-list
102291529|NCT04829695|Lumefantrine|lumefantrine|mesh-list
102291530|NCT04829695|Artemether|artemether|mesh-list
102291531|NCT04829695|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102291532|NCT04829695|Amodiaquine|amodiaquine|mesh-list
102291533|NCT04829695|Antimalarials|antimalarials|mesh-ancestor
102291534|NCT04829695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102291535|NCT04829695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102291536|NCT04829695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102291537|NCT04829695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102291538|NCT04829695|Antiviral Agents|antiviral agents|mesh-ancestor
102291539|NCT04829695|Schistosomicides|schistosomicides|mesh-ancestor
102291540|NCT04829695|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102291541|NCT04829695|Anthelmintics|anthelmintics|mesh-ancestor
102291542|NCT04835233|Methyldopa|methyldopa|mesh-list
102291543|NCT04835233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102291544|NCT04835233|Sympatholytics|sympatholytics|mesh-ancestor
102291545|NCT04835233|Autonomic Agents|autonomic agents|mesh-ancestor
102291546|NCT04835233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102291547|NCT04835233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291548|NCT04835233|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102291549|NCT04835233|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102291550|NCT04835233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102291551|NCT04835233|Adrenergic Agents|adrenergic agents|mesh-ancestor
102291552|NCT04835233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102291553|NCT04835233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291554|NCT03035695|Hemostatics|hemostatics|mesh-list
102291555|NCT03035695|Coagulants|coagulants|mesh-ancestor
102291556|NCT04821583|Hydrocortisone|hydrocortisone|mesh-list
102291557|NCT04821583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102291558|NCT01667731|Sofosbuvir|sofosbuvir|mesh-list
102291559|NCT01667731|Antiviral Agents|antiviral agents|mesh-ancestor
102291560|NCT01667731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102291561|NCT04828525|Dexamethasone|dexamethasone|mesh-list
101941531|NCT01228617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102291562|NCT04828525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102291563|NCT04828525|Antiemetics|antiemetics|mesh-ancestor
102291564|NCT04828525|Autonomic Agents|autonomic agents|mesh-ancestor
102291565|NCT04828525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102291566|NCT04828525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291567|NCT04828525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102291568|NCT04828525|Glucocorticoids|glucocorticoids|mesh-ancestor
102291569|NCT04828525|Hormones|hormones|mesh-ancestor
102291570|NCT04828525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102291571|NCT04828525|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102291572|NCT04828525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102291573|NCT04821193|Chlorhexidine|chlorhexidine|mesh-list
102291574|NCT04821193|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102291575|NCT04821193|Disinfectants|disinfectants|mesh-list
102291576|NCT04821193|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102291577|NCT04821193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102291578|NCT04821193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101392189|NCT04796012|Alkylating Agents|alkylating agents|mesh-ancestor
101392190|NCT04796012|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101392191|NCT04796012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101392192|NCT04790370|Heparin|heparin|mesh-list
101392193|NCT04790370|Calcium heparin|calcium heparin|mesh-list
101392194|NCT04790370|Anticoagulants|anticoagulants|mesh-ancestor
101392195|NCT04790370|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101392196|NCT04790370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101392197|NCT04790370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305574|NCT02020213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101392228|NCT04765202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101392229|NCT04765202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101392230|NCT04757883|Antibodies|antibodies|mesh-list
101392231|NCT04757883|Immunologic Factors|immunologic factors|mesh-ancestor
101392233|NCT04740918|Trastuzumab|trastuzumab|mesh-list
102291579|NCT04821193|Dermatologic Agents|dermatologic agents|mesh-ancestor
102291580|NCT04820803|Cetylpyridinium|cetylpyridinium|mesh-list
102291581|NCT04820803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102291582|NCT04820803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102291583|NCT04827667|Dimercaprol|dimercaprol|mesh-list
102291584|NCT04827667|Chelating Agents|chelating agents|mesh-ancestor
102291585|NCT04827667|Sequestering Agents|sequestering agents|mesh-ancestor
102291586|NCT04827667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291587|NCT04360135|Acetaminophen|acetaminophen|mesh-list
102291588|NCT04360135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102291589|NCT04360135|Analgesics|analgesics|mesh-ancestor
102291590|NCT04360135|Sensory System Agents|sensory system agents|mesh-ancestor
102291591|NCT04360135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102291592|NCT04360135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291593|NCT04360135|Antipyretics|antipyretics|mesh-ancestor
102291594|NCT02605837|Budesonide|budesonide|mesh-list
102000289|NCT02527577|Anesthetics, Local|anesthetics, local|mesh-ancestor
102291595|NCT02605837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102291596|NCT02605837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102291597|NCT02605837|Autonomic Agents|autonomic agents|mesh-ancestor
102291598|NCT02605837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102291599|NCT02605837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291600|NCT02605837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102291601|NCT02605837|Respiratory System Agents|respiratory system agents|mesh-ancestor
102291602|NCT02605837|Glucocorticoids|glucocorticoids|mesh-ancestor
102291603|NCT02605837|Hormones|hormones|mesh-ancestor
102291604|NCT02605837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102291605|NCT04820101|Dexmedetomidine|dexmedetomidine|mesh-list
102291606|NCT04820101|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102291607|NCT04820101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102291608|NCT04820101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291609|NCT04820101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102291610|NCT04820101|Analgesics|analgesics|mesh-ancestor
102291611|NCT04820101|Sensory System Agents|sensory system agents|mesh-ancestor
102291612|NCT04820101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102291613|NCT04820101|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102291614|NCT04820101|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102291615|NCT04820101|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102291616|NCT04820101|Adrenergic Agents|adrenergic agents|mesh-ancestor
102291617|NCT04820101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102291618|NCT04820101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291619|NCT04819867|Propolis|propolis|mesh-list
102291620|NCT04819867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102291621|NCT02423343|Nivolumab|nivolumab|mesh-list
101392247|NCT04740918|Immunologic Factors|immunologic factors|mesh-ancestor
101392248|NCT04740918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392249|NCT04739761|Trastuzumab|trastuzumab|mesh-list
101392250|NCT04739761|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
101392251|NCT04739761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101392252|NCT04739761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102291622|NCT02423343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102291623|NCT02423343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102291624|NCT02423343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102291625|NCT02423343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291626|NCT04909515|Isotretinoin|isotretinoin|mesh-list
102291627|NCT04909515|Dermatologic Agents|dermatologic agents|mesh-ancestor
102291628|NCT05617729|Povidone-Iodine|povidone-iodine|mesh-list
102291629|NCT05617729|Povidone|povidone|mesh-list
102291630|NCT05617729|Plasma Substitutes|plasma substitutes|mesh-ancestor
102291631|NCT05617729|Blood Substitutes|blood substitutes|mesh-ancestor
102291632|NCT05617729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102291633|NCT05617729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102291634|NCT04818931|Cefazolin|cefazolin|mesh-list
102291635|NCT04818931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102291636|NCT04818931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102291637|NCT02406261|Midazolam|midazolam|mesh-list
102291638|NCT02406261|Donepezil|donepezil|mesh-list
102291639|NCT02406261|Simvastatin|simvastatin|mesh-list
102291640|NCT02406261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102291641|NCT02406261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102291642|NCT02406261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102291643|NCT02406261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291644|NCT02406261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102291645|NCT02406261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102291646|NCT02406261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102291647|NCT02406261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102291648|NCT02406261|Anesthetics, General|anesthetics, general|mesh-ancestor
102291649|NCT02406261|Anesthetics|anesthetics|mesh-ancestor
102291650|NCT02406261|GABA Modulators|gaba modulators|mesh-ancestor
102291651|NCT02406261|GABA Agents|gaba agents|mesh-ancestor
102291652|NCT02406261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102291653|NCT02406261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291654|NCT02406261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102291655|NCT02406261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102291656|NCT02406261|Antimetabolites|antimetabolites|mesh-ancestor
102291657|NCT02406261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102291658|NCT02406261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102291659|NCT02406261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102291660|NCT02406261|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102291661|NCT02406261|Cholinergic Agents|cholinergic agents|mesh-ancestor
102291662|NCT02406261|Nootropic Agents|nootropic agents|mesh-ancestor
102291663|NCT02485353|Cytarabine|cytarabine|mesh-list
102291664|NCT02485353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102291665|NCT02485353|Antimetabolites|antimetabolites|mesh-ancestor
102291666|NCT02485353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291667|NCT02485353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102291668|NCT02485353|Antiviral Agents|antiviral agents|mesh-ancestor
102291669|NCT02485353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102291670|NCT02485353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102291671|NCT02485353|Immunologic Factors|immunologic factors|mesh-ancestor
102291672|NCT02485353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291673|NCT02603107|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
102291674|NCT02603107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102291675|NCT02603107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291676|NCT02603107|Antiviral Agents|antiviral agents|mesh-ancestor
102291677|NCT02603107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102291678|NCT02603107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102291679|NCT02603107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102291680|NCT02603107|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102291681|NCT02603107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102291682|NCT02603107|Protease Inhibitors|protease inhibitors|mesh-ancestor
102291683|NCT02601625|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102291684|NCT02601625|Immunologic Factors|immunologic factors|mesh-ancestor
102291685|NCT02601625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291686|NCT04826497|Nicorandil|nicorandil|mesh-list
102291687|NCT04826497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102291688|NCT04826497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102291689|NCT04826497|Vasodilator Agents|vasodilator agents|mesh-ancestor
102291690|NCT04826497|Vitamin B Complex|vitamin b complex|mesh-ancestor
102291691|NCT04826497|Vitamins|vitamins|mesh-ancestor
102291692|NCT04826497|Micronutrients|micronutrients|mesh-ancestor
102291693|NCT04826497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291694|NCT04819243|Atezolizumab|atezolizumab|mesh-list
102291695|NCT04819243|Talazoparib|talazoparib|mesh-list
102291696|NCT04819243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102291697|NCT04819243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291698|NCT04819243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102291699|NCT04819243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102291700|NCT04819243|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102291701|NCT04819243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102291702|NCT02604589|Hydromorphone|hydromorphone|mesh-list
102291703|NCT02604589|Bupivacaine|bupivacaine|mesh-list
102291704|NCT02604589|Anesthetics, Local|anesthetics, local|mesh-ancestor
102291705|NCT02604589|Anesthetics|anesthetics|mesh-ancestor
102291706|NCT02604589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102291707|NCT02604589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291708|NCT02604589|Sensory System Agents|sensory system agents|mesh-ancestor
102291709|NCT02604589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102291710|NCT02604589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102291711|NCT02604589|Narcotics|narcotics|mesh-ancestor
102291712|NCT02604589|Analgesics|analgesics|mesh-ancestor
102291713|NCT04818151|Warfarin|warfarin|mesh-list
102291714|NCT04818151|Apixaban|apixaban|mesh-list
102291715|NCT04818151|Anticoagulants|anticoagulants|mesh-ancestor
102291716|NCT04818151|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102291717|NCT04818151|Antithrombins|antithrombins|mesh-ancestor
102291718|NCT04818151|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102291719|NCT04818151|Protease Inhibitors|protease inhibitors|mesh-ancestor
102291720|NCT04818151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101392334|NCT04694846|Autonomic Agents|autonomic agents|mesh-ancestor
102291721|NCT04818151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291722|NCT04817527|Edaravone|edaravone|mesh-list
102291723|NCT04817527|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102291724|NCT04817527|Antioxidants|antioxidants|mesh-ancestor
102291725|NCT04817527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291726|NCT04817527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102291727|NCT04817527|Protective Agents|protective agents|mesh-ancestor
102291728|NCT04817527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291729|NCT04357795|Cyclosporine|cyclosporine|mesh-list
102291730|NCT04357795|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102291731|NCT04357795|Cyclosporins|cyclosporins|mesh-list
102291732|NCT04357795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102291733|NCT04357795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291734|NCT04357795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102291735|NCT04357795|Immunologic Factors|immunologic factors|mesh-ancestor
102291736|NCT04357795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291737|NCT04357795|Antifungal Agents|antifungal agents|mesh-ancestor
102291738|NCT04357795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102291739|NCT04357795|Dermatologic Agents|dermatologic agents|mesh-ancestor
102291740|NCT04357795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102291741|NCT04357795|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102291742|NCT04357795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102291743|NCT02604199|Tenofovir|tenofovir|mesh-list
102291744|NCT02604199|Entecavir|entecavir|mesh-list
102291745|NCT02604199|Histamine Antagonists|histamine antagonists|mesh-list
102291746|NCT02604199|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
102291747|NCT02604199|Antiviral Agents|antiviral agents|mesh-ancestor
102291748|NCT02604199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102291749|NCT02604199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102291750|NCT02604199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102291751|NCT02604199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101392369|NCT04685135|Docetaxel|docetaxel|mesh-list
102291752|NCT02604199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291754|NCT02604199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102291755|NCT02604199|Histamine Agents|histamine agents|mesh-ancestor
102291756|NCT02604199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102291757|NCT02604199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291758|NCT04807543|Castor Oil|castor oil|mesh-list
102291759|NCT04807543|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
102291760|NCT04807543|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
102291761|NCT04807543|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102291762|NCT04807543|Hormone Antagonists|hormone antagonists|mesh-ancestor
102291763|NCT04807543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102291764|NCT04807543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291765|NCT04807543|Progestins|progestins|mesh-ancestor
102291766|NCT04807543|Hormones|hormones|mesh-ancestor
102291767|NCT04807543|Cathartics|cathartics|mesh-ancestor
102291768|NCT04807543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102291769|NCT04797949|Aspirin|aspirin|mesh-list
102291770|NCT04797949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102291771|NCT04797949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102291772|NCT04797949|Analgesics|analgesics|mesh-ancestor
102291773|NCT04797949|Sensory System Agents|sensory system agents|mesh-ancestor
102291774|NCT04797949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102291775|NCT04797949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291776|NCT04797949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102291777|NCT04797949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102291778|NCT04797949|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102291779|NCT04797949|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102291780|NCT04797949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291781|NCT04797949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102291782|NCT04797949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102291783|NCT04797949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102291784|NCT04797949|Antipyretics|antipyretics|mesh-ancestor
102291785|NCT04797793|Adapalene|adapalene|mesh-list
102291786|NCT04797793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102291787|NCT04797793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102291788|NCT04797793|Analgesics|analgesics|mesh-ancestor
102291789|NCT04797793|Sensory System Agents|sensory system agents|mesh-ancestor
102291790|NCT04797793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102291791|NCT04797793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291792|NCT04797793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102291793|NCT04797793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102291794|NCT04797793|Dermatologic Agents|dermatologic agents|mesh-ancestor
102291795|NCT04796857|Lenalidomide|lenalidomide|mesh-list
102291796|NCT04796857|Tislelizumab|tislelizumab|mesh-list
102291797|NCT04796857|Antibodies|antibodies|mesh-list
102291798|NCT04796857|Immunologic Factors|immunologic factors|mesh-ancestor
102291799|NCT04796857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291800|NCT04796857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102291801|NCT04796857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102291802|NCT04796857|Growth Substances|growth substances|mesh-ancestor
102291803|NCT04796857|Growth Inhibitors|growth inhibitors|mesh-ancestor
102291804|NCT04796857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102291805|NCT04796857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102291806|NCT04796623|Fulvestrant|fulvestrant|mesh-list
102291807|NCT04796623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102291808|NCT04796623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102291809|NCT04796623|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102291810|NCT04796623|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102291811|NCT04796623|Hormone Antagonists|hormone antagonists|mesh-ancestor
102291812|NCT04796623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102291813|NCT04796623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291814|NCT04815265|Dexmedetomidine|dexmedetomidine|mesh-list
102291815|NCT04815265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102291816|NCT04815265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102291817|NCT04815265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291818|NCT04815265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102291819|NCT04815265|Analgesics|analgesics|mesh-ancestor
101392436|NCT04652700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102291820|NCT04815265|Sensory System Agents|sensory system agents|mesh-ancestor
102291821|NCT04815265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102291822|NCT04815265|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102291823|NCT04815265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102291824|NCT04815265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102291825|NCT04815265|Adrenergic Agents|adrenergic agents|mesh-ancestor
102291827|NCT04815265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291828|NCT04815187|Montelukast|montelukast|mesh-list
102291829|NCT04815187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102291830|NCT04815187|Respiratory System Agents|respiratory system agents|mesh-ancestor
102291831|NCT04815187|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102291832|NCT04815187|Hormone Antagonists|hormone antagonists|mesh-ancestor
102291833|NCT04815187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102291834|NCT04815187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291835|NCT04815187|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102291836|NCT04815187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102291837|NCT04815187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291838|NCT04814719|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
102291839|NCT04814719|Anticoagulants|anticoagulants|mesh-ancestor
102291840|NCT04805827|Gabapentin|gabapentin|mesh-list
102291841|NCT04805827|Analgesics|analgesics|mesh-ancestor
102291842|NCT04805827|Sensory System Agents|sensory system agents|mesh-ancestor
102291843|NCT04805827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102291844|NCT04805827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291845|NCT04805827|Anticonvulsants|anticonvulsants|mesh-ancestor
102291846|NCT04805827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102291847|NCT04805827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102291848|NCT04805827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102291849|NCT04805827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102291850|NCT04805827|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102291851|NCT04805827|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102291852|NCT04805827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102291853|NCT04805827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291854|NCT04805827|Antimanic Agents|antimanic agents|mesh-ancestor
102291855|NCT02596711|Nicotine|nicotine|mesh-list
102291856|NCT02596711|Carbon Monoxide|carbon monoxide|mesh-list
102291857|NCT02596711|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102291858|NCT02596711|Autonomic Agents|autonomic agents|mesh-ancestor
102291859|NCT02596711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102291860|NCT02596711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291861|NCT02596711|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102291862|NCT02596711|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102291863|NCT02596711|Cholinergic Agents|cholinergic agents|mesh-ancestor
102291864|NCT02596711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102291865|NCT02596711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291866|NCT02596711|Antimetabolites|antimetabolites|mesh-ancestor
102291867|NCT02596711|Gasotransmitters|gasotransmitters|mesh-ancestor
102291868|NCT04805281|Lithium Carbonate|lithium carbonate|mesh-list
102291869|NCT04805281|Antidepressive Agents|antidepressive agents|mesh-ancestor
102291870|NCT04805281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102291871|NCT04805281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102291872|NCT04805281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392509|NCT04629248|Hormones|hormones|mesh-ancestor
102291873|NCT04805281|Antimanic Agents|antimanic agents|mesh-ancestor
102291874|NCT04805281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102291875|NCT04805281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102291876|NCT04805281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291877|NCT04814485|Paclitaxel|paclitaxel|mesh-list
102291878|NCT04814485|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102291879|NCT04814485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102291880|NCT04814485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102291881|NCT04814485|Tubulin Modulators|tubulin modulators|mesh-ancestor
102291882|NCT04814485|Antimitotic Agents|antimitotic agents|mesh-ancestor
102291883|NCT04814485|Mitosis Modulators|mitosis modulators|mesh-ancestor
102291884|NCT04814485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291885|NCT04804423|Listerine|listerine|mesh-list
102291886|NCT04804423|Fluorides|fluorides|mesh-list
102291887|NCT04804423|Sodium Fluoride|sodium fluoride|mesh-list
102291888|NCT04804423|Fluorides, Topical|fluorides, topical|mesh-list
102291889|NCT04804423|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
102291890|NCT04804423|Cariostatic Agents|cariostatic agents|mesh-ancestor
102291891|NCT04804423|Protective Agents|protective agents|mesh-ancestor
102291892|NCT04804423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291893|NCT04804423|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102291894|NCT04804423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102291895|NCT04794049|Lactulose|lactulose|mesh-list
102291896|NCT04794049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102291897|NCT04794127|Pioglitazone|pioglitazone|mesh-list
102291898|NCT04794127|Trabectedin|trabectedin|mesh-list
102291899|NCT04794127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102291900|NCT04794127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291901|NCT04794127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102291902|NCT04794127|Alkylating Agents|alkylating agents|mesh-ancestor
102291903|NCT04794127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291904|NCT04794127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102291905|NCT04804267|Linaclotide|linaclotide|mesh-list
102291906|NCT04804267|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102291907|NCT04804267|Enzyme Activators|enzyme activators|mesh-ancestor
102291908|NCT04804267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291909|NCT04804267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102291910|NCT04813471|Folic Acid|folic acid|mesh-list
102291911|NCT04813471|Nicorandil|nicorandil|mesh-list
102291912|NCT04813471|Vitamin B Complex|vitamin b complex|mesh-list
102291913|NCT04813471|Atorvastatin|atorvastatin|mesh-list
102291914|NCT04813471|Vitamins|vitamins|mesh-ancestor
102291915|NCT04813471|Micronutrients|micronutrients|mesh-ancestor
102291916|NCT04813471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291917|NCT04813471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102291918|NCT04813471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102291919|NCT04813471|Antimetabolites|antimetabolites|mesh-ancestor
102291920|NCT04813471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291921|NCT04813471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102291922|NCT04813471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102291923|NCT04813471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102291924|NCT04813471|Hematinics|hematinics|mesh-ancestor
102291925|NCT04813471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102291926|NCT04813471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102291927|NCT04813471|Vasodilator Agents|vasodilator agents|mesh-ancestor
102291928|NCT04803175|Valsartan|valsartan|mesh-list
101392546|NCT04619797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102291929|NCT04803175|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102291930|NCT04803175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102291931|NCT04803175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102291932|NCT04803175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102291933|NCT04803175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291934|NCT04792723|Aspirin|aspirin|mesh-list
102291935|NCT04792723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102291936|NCT04792723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102291937|NCT04792723|Analgesics|analgesics|mesh-ancestor
102291938|NCT04792723|Sensory System Agents|sensory system agents|mesh-ancestor
102291939|NCT04792723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102291940|NCT04792723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291941|NCT04792723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102291942|NCT04792723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102291943|NCT04792723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102291944|NCT04792723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102291945|NCT04792723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291946|NCT04792723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102291947|NCT04792723|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102291948|NCT04792723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102291950|NCT04792333|Firibastat|firibastat|mesh-list
102291951|NCT04792333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102291952|NCT04802785|Aspirin|aspirin|mesh-list
102291953|NCT04802785|Domperidone|domperidone|mesh-list
102291954|NCT04802785|Melatonin|melatonin|mesh-list
102291955|NCT04802785|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
102291956|NCT04802785|Simethicone|simethicone|mesh-list
102291957|NCT04802785|Magnesium Hydroxide|magnesium hydroxide|mesh-list
102291958|NCT04802785|Citric Acid|citric acid|mesh-list
102291959|NCT04802785|Sodium Citrate|sodium citrate|mesh-list
102291960|NCT04802785|Anticoagulants|anticoagulants|mesh-ancestor
102291961|NCT04802785|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102291962|NCT04802785|Chelating Agents|chelating agents|mesh-ancestor
102291963|NCT04802785|Sequestering Agents|sequestering agents|mesh-ancestor
102291964|NCT04802785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291965|NCT04802785|Antioxidants|antioxidants|mesh-ancestor
102291966|NCT04802785|Protective Agents|protective agents|mesh-ancestor
102291967|NCT04802785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102291968|NCT04802785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102291969|NCT04802785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102291970|NCT04802785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102291971|NCT04802785|Analgesics|analgesics|mesh-ancestor
102291972|NCT04802785|Sensory System Agents|sensory system agents|mesh-ancestor
102291973|NCT04802785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102291974|NCT04802785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102291975|NCT04802785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102291976|NCT04802785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102291977|NCT04802785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102291978|NCT04802785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102291979|NCT04802785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102291980|NCT04802785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102291981|NCT04802785|Antipyretics|antipyretics|mesh-ancestor
102291982|NCT04802785|Antiemetics|antiemetics|mesh-ancestor
102291983|NCT04802785|Autonomic Agents|autonomic agents|mesh-ancestor
102291984|NCT04802785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102291985|NCT04802785|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102291986|NCT04802785|Dopamine Agents|dopamine agents|mesh-ancestor
102291987|NCT04802785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102291988|NCT04802785|Antifoaming Agents|antifoaming agents|mesh-ancestor
102291989|NCT04802785|Emollients|emollients|mesh-ancestor
102291990|NCT04802785|Dermatologic Agents|dermatologic agents|mesh-ancestor
102291991|NCT04802785|Nootropic Agents|nootropic agents|mesh-ancestor
102291992|NCT04802785|Antacids|antacids|mesh-ancestor
102291993|NCT02598193|Pirfenidone|pirfenidone|mesh-list
102291994|NCT02598193|Nintedanib|nintedanib|mesh-list
102291995|NCT02598193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102291996|NCT02598193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102291997|NCT02598193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102291998|NCT02598193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102291999|NCT02598193|Analgesics|analgesics|mesh-ancestor
102292000|NCT02598193|Sensory System Agents|sensory system agents|mesh-ancestor
102292001|NCT02598193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102292002|NCT02598193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292003|NCT02598193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102292004|NCT02598193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102292005|NCT02598193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102292006|NCT02598193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102292007|NCT04802083|Eculizumab|eculizumab|mesh-list
102292008|NCT04802083|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102292009|NCT04802083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102292010|NCT04802083|Immunologic Factors|immunologic factors|mesh-ancestor
102292011|NCT04802083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292012|NCT04801303|Calcitriol|calcitriol|mesh-list
102292013|NCT04801303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102292014|NCT04801303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292015|NCT04801303|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101392604|NCT04580121|Hormones|hormones|mesh-ancestor
102292016|NCT04801303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102292017|NCT04801303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292018|NCT04801303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102292019|NCT04801303|Vitamins|vitamins|mesh-ancestor
102292020|NCT04801303|Micronutrients|micronutrients|mesh-ancestor
102292021|NCT04801303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102292022|NCT04790383|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
102292023|NCT04790383|Vasodilator Agents|vasodilator agents|mesh-ancestor
102292024|NCT04790383|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
102292025|NCT04790383|Protective Agents|protective agents|mesh-ancestor
102292026|NCT04790383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292027|NCT02388165|Vaccines|vaccines|mesh-list
102292028|NCT02388165|Immunologic Factors|immunologic factors|mesh-ancestor
102292029|NCT02388165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292030|NCT04811911|Methotrexate|methotrexate|mesh-list
102292031|NCT04811911|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102292032|NCT04811911|Abortifacient Agents|abortifacient agents|mesh-ancestor
102292033|NCT04811911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102292034|NCT04811911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292035|NCT04811911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102292036|NCT04811911|Antimetabolites|antimetabolites|mesh-ancestor
102292037|NCT04811911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292038|NCT04811911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102292039|NCT04811911|Dermatologic Agents|dermatologic agents|mesh-ancestor
102292040|NCT04811911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102292041|NCT04811911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102292042|NCT04811911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102292043|NCT04811911|Immunologic Factors|immunologic factors|mesh-ancestor
102292044|NCT04811911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102292045|NCT04811911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102292046|NCT04788979|Melatonin|melatonin|mesh-list
102292047|NCT04788979|Antioxidants|antioxidants|mesh-ancestor
102292048|NCT04788979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292049|NCT04788979|Protective Agents|protective agents|mesh-ancestor
102292050|NCT04788979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292051|NCT04788979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102292052|NCT04811209|Analgesics|analgesics|mesh-list
102292053|NCT04811209|Anesthetics|anesthetics|mesh-list
102292054|NCT04811209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102292055|NCT04811209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292056|NCT04811209|Sensory System Agents|sensory system agents|mesh-ancestor
102292057|NCT04811209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102292058|NCT04788355|Hydroxychloroquine|hydroxychloroquine|mesh-list
102292059|NCT04788355|Apixaban|apixaban|mesh-list
102292060|NCT04788355|Antimalarials|antimalarials|mesh-ancestor
102292061|NCT04788355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102292062|NCT04788355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102292063|NCT04788355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102292064|NCT04788355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102292065|NCT04788355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292066|NCT04788355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102292067|NCT04788355|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102292068|NCT04788355|Antithrombins|antithrombins|mesh-ancestor
102292069|NCT04788355|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102292070|NCT04788355|Protease Inhibitors|protease inhibitors|mesh-ancestor
102292071|NCT04788355|Anticoagulants|anticoagulants|mesh-ancestor
102292072|NCT04799743|Resveratrol|resveratrol|mesh-list
102292073|NCT04799743|Antioxidants|antioxidants|mesh-ancestor
102292074|NCT04799743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292075|NCT04799743|Protective Agents|protective agents|mesh-ancestor
102292076|NCT04799743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292077|NCT04799743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102292078|NCT04799743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102292079|NCT04788121|Tranexamic Acid|tranexamic acid|mesh-list
102292080|NCT04788121|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102292081|NCT04788121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102292082|NCT04788121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292083|NCT04788121|Hemostatics|hemostatics|mesh-ancestor
102292084|NCT04788121|Coagulants|coagulants|mesh-ancestor
102292085|NCT04810819|Methylprednisolone|methylprednisolone|mesh-list
102292086|NCT04810819|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102292087|NCT04810819|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102292088|NCT04810819|Prednisolone|prednisolone|mesh-list
102292089|NCT04810819|Prednisolone acetate|prednisolone acetate|mesh-list
102292090|NCT04810819|Dyphylline|dyphylline|mesh-list
102292091|NCT04810819|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102292092|NCT04810819|Prednisolone phosphate|prednisolone phosphate|mesh-list
102292093|NCT04810819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102292094|NCT04810819|Antiemetics|antiemetics|mesh-ancestor
102292095|NCT04810819|Autonomic Agents|autonomic agents|mesh-ancestor
102292096|NCT04810819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102292097|NCT04810819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292098|NCT04810819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102292099|NCT04810819|Glucocorticoids|glucocorticoids|mesh-ancestor
102292100|NCT04810819|Hormones|hormones|mesh-ancestor
102292101|NCT04810819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102292102|NCT04810819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102292103|NCT04810819|Protective Agents|protective agents|mesh-ancestor
102292104|NCT04810819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102292105|NCT04810819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102292106|NCT04810819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102292107|NCT04810819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102292108|NCT04810819|Respiratory System Agents|respiratory system agents|mesh-ancestor
102292109|NCT04810819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102292110|NCT04810819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102292111|NCT04810819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292112|NCT04810819|Vasodilator Agents|vasodilator agents|mesh-ancestor
102292113|NCT04810507|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102292114|NCT04810507|Anagliptin|anagliptin|mesh-list
102292115|NCT04810507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102292116|NCT04810507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292117|NCT04810507|Incretins|incretins|mesh-ancestor
102292118|NCT04810507|Hormones|hormones|mesh-ancestor
102292119|NCT04810507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102292120|NCT04810507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102292121|NCT04810507|Protease Inhibitors|protease inhibitors|mesh-ancestor
102292122|NCT04810507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102292123|NCT04810507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292124|NCT04810585|Aflibercept|aflibercept|mesh-list
102292125|NCT04810585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102292126|NCT04810585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102292127|NCT04810585|Growth Substances|growth substances|mesh-ancestor
102292128|NCT04810585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292129|NCT04810585|Growth Inhibitors|growth inhibitors|mesh-ancestor
102292130|NCT04810585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102292131|NCT04798729|Salicylic Acid|salicylic acid|mesh-list
102292132|NCT04798729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102292133|NCT04798729|Antifungal Agents|antifungal agents|mesh-ancestor
102292134|NCT04798729|Keratolytic Agents|keratolytic agents|mesh-ancestor
102292135|NCT04798729|Dermatologic Agents|dermatologic agents|mesh-ancestor
102292136|NCT04809649|Itraconazole|itraconazole|mesh-list
102292137|NCT04809649|Antifungal Agents|antifungal agents|mesh-ancestor
102292138|NCT04809649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102292139|NCT04809649|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102292140|NCT04809649|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102292141|NCT04809649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102292142|NCT04809649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292143|NCT04809649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102292144|NCT04809649|Hormone Antagonists|hormone antagonists|mesh-ancestor
102292145|NCT04809649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102292146|NCT04809649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292147|NCT04809649|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102292148|NCT04786795|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102292149|NCT04786795|Pancreatin|pancreatin|mesh-list
102292150|NCT04786795|Pancrelipase|pancrelipase|mesh-list
102292151|NCT04786795|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102292152|NCT04786795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102292153|NCT02596945|Epoetin Alfa|epoetin alfa|mesh-list
102292154|NCT02596945|Hematinics|hematinics|mesh-ancestor
102292155|NCT04786327|Edetic Acid|edetic acid|mesh-list
102292156|NCT04786327|Mitogens|mitogens|mesh-list
102292157|NCT04786327|Pentetic Acid|pentetic acid|mesh-list
102292158|NCT04786327|Mitosis Modulators|mitosis modulators|mesh-ancestor
102292159|NCT04786327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292160|NCT04786327|Anticoagulants|anticoagulants|mesh-ancestor
102292161|NCT04786327|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102292162|NCT04786327|Chelating Agents|chelating agents|mesh-ancestor
102292163|NCT04786327|Sequestering Agents|sequestering agents|mesh-ancestor
102292164|NCT04786327|Antidotes|antidotes|mesh-ancestor
102292165|NCT04786327|Protective Agents|protective agents|mesh-ancestor
102292166|NCT04786327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292167|NCT04786327|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102292168|NCT04153435|Calcium|calcium|mesh-list
102292169|NCT04153435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102292170|NCT04153435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292171|NCT01667419|Vemurafenib|vemurafenib|mesh-list
102292172|NCT01667419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102292173|NCT01667419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102292174|NCT01667419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102292175|NCT01667419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292176|NCT04808791|Trifluridine|trifluridine|mesh-list
102292177|NCT04808791|Oxaliplatin|oxaliplatin|mesh-list
102292178|NCT04808791|Irinotecan|irinotecan|mesh-list
102292179|NCT04808791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102292180|NCT04808791|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102292181|NCT04808791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102292182|NCT04808791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102292183|NCT04808791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292184|NCT04808791|Antimetabolites|antimetabolites|mesh-ancestor
102292185|NCT04808791|Antiviral Agents|antiviral agents|mesh-ancestor
102292186|NCT04808791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102292187|NCT04785547|Blinatumomab|blinatumomab|mesh-list
102292188|NCT04785547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102292189|NCT03843853|Bevacizumab|bevacizumab|mesh-list
102292190|NCT03843853|Pemetrexed|pemetrexed|mesh-list
102292191|NCT03843853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102292192|NCT03843853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102292193|NCT03843853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102292194|NCT03843853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102292195|NCT03843853|Growth Substances|growth substances|mesh-ancestor
102292196|NCT03843853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292197|NCT03843853|Growth Inhibitors|growth inhibitors|mesh-ancestor
102292198|NCT03843853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102292199|NCT03843853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292200|NCT03843853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102292201|NCT03843853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102292202|NCT04784767|Saponin QA-21V1|saponin qa-21v1|mesh-list
102292203|NCT04784767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102292204|NCT04784767|Immunologic Factors|immunologic factors|mesh-ancestor
102292205|NCT04784767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292206|NCT05054179|Ropivacaine|ropivacaine|mesh-list
102292207|NCT05054179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102292208|NCT05054179|Anesthetics, Local|anesthetics, local|mesh-ancestor
102292209|NCT05054179|Anesthetics|anesthetics|mesh-ancestor
102292210|NCT05054179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102292211|NCT05054179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292212|NCT05054179|Sensory System Agents|sensory system agents|mesh-ancestor
102292213|NCT05054179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102292214|NCT05611879|Paclitaxel|paclitaxel|mesh-list
102292215|NCT05611879|Carboplatin|carboplatin|mesh-list
102292216|NCT05611879|Pemetrexed|pemetrexed|mesh-list
102292217|NCT05611879|Tislelizumab|tislelizumab|mesh-list
102292218|NCT05611879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102292219|NCT05611879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102292220|NCT05611879|Tubulin Modulators|tubulin modulators|mesh-ancestor
102292221|NCT05611879|Antimitotic Agents|antimitotic agents|mesh-ancestor
102292222|NCT05611879|Mitosis Modulators|mitosis modulators|mesh-ancestor
102292223|NCT05611879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292224|NCT05611879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102292225|NCT05611879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102292226|NCT05611879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102292227|NCT05611879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102292228|NCT04789057|Atorvastatin|atorvastatin|mesh-list
102292229|NCT04789057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102292230|NCT04789057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102292231|NCT04789057|Antimetabolites|antimetabolites|mesh-ancestor
102292232|NCT04789057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292233|NCT04789057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102292234|NCT04789057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102292235|NCT04789057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102292236|NCT05613361|Colistin|colistin|mesh-list
102292237|NCT05613361|Curcumin|curcumin|mesh-list
102292238|NCT05613361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101633981|NCT02685657|Docetaxel|docetaxel|mesh-list
102292239|NCT05613361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102292240|NCT05613361|Analgesics|analgesics|mesh-ancestor
102292241|NCT05613361|Sensory System Agents|sensory system agents|mesh-ancestor
102292242|NCT05613361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102292243|NCT05613361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292244|NCT05613361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102292245|NCT05613361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102292246|NCT05613361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102292247|NCT05613361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102292248|NCT05613361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292249|NCT05613361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102292250|NCT05613361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102292251|NCT05611645|Bevacizumab|bevacizumab|mesh-list
102292252|NCT05611645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102292253|NCT05611645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102292254|NCT05611645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102292255|NCT05611645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102292256|NCT05611645|Growth Substances|growth substances|mesh-ancestor
102292257|NCT05611645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292258|NCT05611645|Growth Inhibitors|growth inhibitors|mesh-ancestor
102292260|NCT03267121|Tegafur|tegafur|mesh-list
102292261|NCT03267121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102292262|NCT03267121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102292263|NCT03267121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102292264|NCT03267121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292265|NCT03267121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102292266|NCT03267121|Antimetabolites|antimetabolites|mesh-ancestor
102292267|NCT02835079|Tamoxifen|tamoxifen|mesh-list
102292268|NCT02835079|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102292269|NCT02835079|Hormone Antagonists|hormone antagonists|mesh-ancestor
102292270|NCT02835079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102292271|NCT02835079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292272|NCT02835079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102292273|NCT02835079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102292274|NCT02835079|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102292275|NCT02835079|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102292276|NCT02835079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102292277|NCT01667107|Posaconazole|posaconazole|mesh-list
102292278|NCT01667107|Antifungal Agents|antifungal agents|mesh-ancestor
102292279|NCT01667107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102292280|NCT01667107|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102292281|NCT01667107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102292282|NCT01667107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102292283|NCT01667107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102292284|NCT01667107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102292285|NCT01667107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102292286|NCT01667107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292287|NCT01667107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102292288|NCT01667107|Hormone Antagonists|hormone antagonists|mesh-ancestor
102292289|NCT01667107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102292290|NCT01667107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292291|NCT04589611|Amobarbital|amobarbital|mesh-list
102292292|NCT04589611|Hyaluronic Acid|hyaluronic acid|mesh-list
101392939|NCT04294628|Trastuzumab|trastuzumab|mesh-list
102292293|NCT04589611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102292294|NCT04589611|Immunologic Factors|immunologic factors|mesh-ancestor
102292295|NCT04589611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292296|NCT04589611|Viscosupplements|viscosupplements|mesh-ancestor
102292297|NCT04589611|Protective Agents|protective agents|mesh-ancestor
102292298|NCT04589611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102292299|NCT04589611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102292300|NCT04589611|GABA Modulators|gaba modulators|mesh-ancestor
102292301|NCT04589611|GABA Agents|gaba agents|mesh-ancestor
102292302|NCT04589611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102292303|NCT04589611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292304|NCT05240131|Atezolizumab|atezolizumab|mesh-list
102292305|NCT05240131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102292306|NCT05240131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292307|NCT05240131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102292308|NCT05240131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102292309|NCT05188339|Heparin|heparin|mesh-list
102292310|NCT05188339|Citric Acid|citric acid|mesh-list
101634019|NCT02869100|Listerine|listerine|mesh-list
102292311|NCT05188339|Sodium Citrate|sodium citrate|mesh-list
102292312|NCT05188339|Anticoagulants|anticoagulants|mesh-ancestor
102292313|NCT05188339|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102292314|NCT05188339|Chelating Agents|chelating agents|mesh-ancestor
102292315|NCT05188339|Sequestering Agents|sequestering agents|mesh-ancestor
102292316|NCT05188339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292317|NCT05188339|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102292318|NCT05188339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102292320|NCT05614765|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102292321|NCT05614765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102292322|NCT05614765|Antimetabolites|antimetabolites|mesh-ancestor
102292323|NCT05614765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292324|NCT05614765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102292325|NCT02590003|Paclitaxel|paclitaxel|mesh-list
102292326|NCT02590003|Carboplatin|carboplatin|mesh-list
102292327|NCT02590003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102292328|NCT02590003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102292329|NCT02590003|Tubulin Modulators|tubulin modulators|mesh-ancestor
102292330|NCT02590003|Antimitotic Agents|antimitotic agents|mesh-ancestor
102292331|NCT02590003|Mitosis Modulators|mitosis modulators|mesh-ancestor
102292332|NCT02590003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292333|NCT04134325|Pembrolizumab|pembrolizumab|mesh-list
102292334|NCT04134325|Nivolumab|nivolumab|mesh-list
102292335|NCT04134325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102292336|NCT04134325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102292337|NCT04134325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102292338|NCT04134325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292339|NCT05474053|Ticagrelor|ticagrelor|mesh-list
102292340|NCT05474053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102292341|NCT05474053|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102292342|NCT05474053|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102292343|NCT05474053|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102292344|NCT05474053|Purinergic Agents|purinergic agents|mesh-ancestor
102292345|NCT05474053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102292346|NCT05474053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292347|NCT05474053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292348|NCT05473819|Anesthetics|anesthetics|mesh-list
102001041|NCT03385096|Immunologic Factors|immunologic factors|mesh-ancestor
102292349|NCT05473819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102292350|NCT05473819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292351|NCT04330729|Aspirin|aspirin|mesh-list
102292352|NCT04330729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102292353|NCT04330729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102292354|NCT04330729|Analgesics|analgesics|mesh-ancestor
102292355|NCT04330729|Sensory System Agents|sensory system agents|mesh-ancestor
102292356|NCT04330729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102292357|NCT04330729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292358|NCT04330729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102292359|NCT04330729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102292360|NCT04330729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102292361|NCT04330729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102292362|NCT04330729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292363|NCT04330729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102292364|NCT04330729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102292365|NCT04330729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102292366|NCT04330729|Antipyretics|antipyretics|mesh-ancestor
102292367|NCT05473741|Risperidone|risperidone|mesh-list
102292368|NCT05473741|Aripiprazole|aripiprazole|mesh-list
102292369|NCT05473741|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102292370|NCT05473741|Antipsychotic Agents|antipsychotic agents|mesh-list
102292371|NCT05473741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102292372|NCT05473741|Serotonin Agents|serotonin agents|mesh-ancestor
102292373|NCT05473741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102292374|NCT05473741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292375|NCT05473741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292376|NCT05473741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102292377|NCT05473741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102292378|NCT05473741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102292379|NCT05473741|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102292380|NCT05473741|Dopamine Agents|dopamine agents|mesh-ancestor
102292381|NCT05473741|Antidepressive Agents|antidepressive agents|mesh-ancestor
102292382|NCT05473741|Dopamine Agonists|dopamine agonists|mesh-ancestor
102292383|NCT05473741|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102292384|NCT05473741|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102292385|NCT05473741|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102292386|NCT05473741|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102292388|NCT03882307|Antiviral Agents|antiviral agents|mesh-ancestor
102292389|NCT03882307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102292390|NCT04762771|Colchicine|colchicine|mesh-list
102292391|NCT04762771|Gout Suppressants|gout suppressants|mesh-ancestor
102292392|NCT04762771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102292393|NCT04762771|Tubulin Modulators|tubulin modulators|mesh-ancestor
102292394|NCT04762771|Antimitotic Agents|antimitotic agents|mesh-ancestor
102292395|NCT04762771|Mitosis Modulators|mitosis modulators|mesh-ancestor
102292396|NCT04762771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292397|NCT04762771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102292398|NCT04754737|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102292399|NCT04754737|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102292400|NCT04754737|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102292401|NCT04754737|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102292402|NCT04754737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102292403|NCT04754737|Antitubercular Agents|antitubercular agents|mesh-ancestor
102292404|NCT04754737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102292405|NCT04754737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102292406|NCT04754737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292407|NCT04754737|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102292408|NCT04754737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102292409|NCT04754737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292410|NCT04754737|Cholinergic Agents|cholinergic agents|mesh-ancestor
102292411|NCT04754737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102292412|NCT04481035|Acetylcysteine|acetylcysteine|mesh-list
102292413|NCT04481035|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102292414|NCT04481035|Antiviral Agents|antiviral agents|mesh-ancestor
102292415|NCT04481035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102292416|NCT04481035|Expectorants|expectorants|mesh-ancestor
102292417|NCT04481035|Respiratory System Agents|respiratory system agents|mesh-ancestor
102292418|NCT04481035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102292419|NCT04481035|Antioxidants|antioxidants|mesh-ancestor
102292420|NCT04481035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393089|NCT04224493|Rituximab|rituximab|mesh-list
102292421|NCT04481035|Protective Agents|protective agents|mesh-ancestor
102292422|NCT04481035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001117|NCT03877679|Analgesics|analgesics|mesh-ancestor
102292423|NCT04481035|Antidotes|antidotes|mesh-ancestor
102292425|NCT02404311|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102292426|NCT02404311|Immunologic Factors|immunologic factors|mesh-ancestor
102292427|NCT02404311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292428|NCT03032107|Pembrolizumab|pembrolizumab|mesh-list
102292429|NCT03032107|Trastuzumab|trastuzumab|mesh-list
102292430|NCT03032107|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102292431|NCT03032107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102292432|NCT03032107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102292433|NCT03032107|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102292434|NCT03032107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292435|NCT03032107|Tubulin Modulators|tubulin modulators|mesh-ancestor
102292436|NCT03032107|Antimitotic Agents|antimitotic agents|mesh-ancestor
102292437|NCT03032107|Mitosis Modulators|mitosis modulators|mesh-ancestor
102292438|NCT03032107|Immunotoxins|immunotoxins|mesh-ancestor
102292439|NCT03032107|Immunoconjugates|immunoconjugates|mesh-ancestor
102292440|NCT03032107|Immunologic Factors|immunologic factors|mesh-ancestor
102292441|NCT03032107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292442|NCT05388175|Pulmonary Surfactants|pulmonary surfactants|mesh-list
102292443|NCT05388175|Respiratory System Agents|respiratory system agents|mesh-ancestor
102292444|NCT05700955|Pembrolizumab|pembrolizumab|mesh-list
102292445|NCT05700955|Temozolomide|temozolomide|mesh-list
102292446|NCT05700955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102292447|NCT05700955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102292448|NCT05700955|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102292449|NCT05700955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292450|NCT05700955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102292451|NCT05700955|Alkylating Agents|alkylating agents|mesh-ancestor
102292452|NCT01650519|Ibuprofen|ibuprofen|mesh-list
102292453|NCT01650519|Ketorolac|ketorolac|mesh-list
102292454|NCT01650519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102292455|NCT01650519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102292456|NCT01650519|Analgesics|analgesics|mesh-ancestor
102292457|NCT01650519|Sensory System Agents|sensory system agents|mesh-ancestor
102292458|NCT01650519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102292459|NCT01650519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292460|NCT01650519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102292461|NCT01650519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101393132|NCT04198649|Azithromycin|azithromycin|mesh-list
102292462|NCT01650519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102292463|NCT01650519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102292464|NCT01650519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292465|NCT02197039|Esomeprazole|esomeprazole|mesh-list
102292466|NCT02197039|Pantoprazole|pantoprazole|mesh-list
102292467|NCT02197039|Hemostatics|hemostatics|mesh-list
102292468|NCT02197039|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102292469|NCT02197039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102292470|NCT02197039|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102292471|NCT02197039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102292472|NCT02197039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292473|NCT02197039|Coagulants|coagulants|mesh-ancestor
102292474|NCT05557903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102292475|NCT05557903|Alemtuzumab|alemtuzumab|mesh-list
102292476|NCT05557903|Antibodies|antibodies|mesh-list
102292477|NCT05557903|Immunoglobulins|immunoglobulins|mesh-list
102292478|NCT05557903|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102292479|NCT05557903|Immunologic Factors|immunologic factors|mesh-ancestor
102292480|NCT05557903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292481|NCT05557903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102292482|NCT02386839|Mecasermin|mecasermin|mesh-list
102292483|NCT02386839|Growth Substances|growth substances|mesh-ancestor
102292484|NCT02386839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292485|NCT05347459|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102292486|NCT05347459|Dapagliflozin|dapagliflozin|mesh-list
102292487|NCT05347459|Empagliflozin|empagliflozin|mesh-list
102292488|NCT05347459|Linagliptin|linagliptin|mesh-list
102292489|NCT05347459|Canagliflozin|canagliflozin|mesh-list
102292490|NCT05347459|Vildagliptin|vildagliptin|mesh-list
102292491|NCT05347459|Saxagliptin|saxagliptin|mesh-list
102292492|NCT05347459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102292493|NCT05347459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292494|NCT05347459|Incretins|incretins|mesh-ancestor
102292495|NCT05347459|Hormones|hormones|mesh-ancestor
102292496|NCT05347459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102292497|NCT05347459|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102292498|NCT05347459|Protease Inhibitors|protease inhibitors|mesh-ancestor
102001189|NCT03384862|Folic Acid|folic acid|mesh-list
102292499|NCT05347459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102292500|NCT05347459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292501|NCT05347459|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102292502|NCT05346445|Fluoxetine|fluoxetine|mesh-list
102292503|NCT05346445|Citalopram|citalopram|mesh-list
102292504|NCT05346445|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101393173|NCT04177004|Sirolimus|sirolimus|mesh-list
102292505|NCT05346445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102292506|NCT05346445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102292507|NCT05346445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292508|NCT05346445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102292509|NCT05346445|Serotonin Agents|serotonin agents|mesh-ancestor
102292510|NCT05346445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292511|NCT05346445|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102292512|NCT05346445|Antidepressive Agents|antidepressive agents|mesh-ancestor
102292513|NCT05346445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102292514|NCT05346445|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102292515|NCT05346445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102292516|NCT05346445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102292517|NCT01649271|Trastuzumab|trastuzumab|mesh-list
102292518|NCT01649271|Afatinib|afatinib|mesh-list
102292519|NCT01649271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102292520|NCT01649271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102292521|NCT01649271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102292522|NCT01649271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102292523|NCT01649271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292524|NCT02385669|Ipilimumab|ipilimumab|mesh-list
102292525|NCT02385669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102292526|NCT02385669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102292527|NCT02385669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102292528|NCT02385669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292529|NCT02402907|Chlorhexidine|chlorhexidine|mesh-list
102292530|NCT02402907|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102292531|NCT02402907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102292533|NCT02402907|Disinfectants|disinfectants|mesh-ancestor
102292534|NCT02402907|Dermatologic Agents|dermatologic agents|mesh-ancestor
102292535|NCT02400333|Ticagrelor|ticagrelor|mesh-list
102292536|NCT02400333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102292537|NCT02400333|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102292538|NCT02400333|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102292539|NCT02400333|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102292540|NCT02400333|Purinergic Agents|purinergic agents|mesh-ancestor
102292541|NCT02400333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102292542|NCT02400333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292543|NCT02400333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292544|NCT02399475|Hormones|hormones|mesh-list
102292545|NCT02399475|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
102292546|NCT02399475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102292547|NCT02399475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292548|NCT02399163|Fluorides|fluorides|mesh-list
102292549|NCT02399163|Cariostatic Agents|cariostatic agents|mesh-ancestor
101393223|NCT04164069|Leucovorin|leucovorin|mesh-list
102292550|NCT02399163|Protective Agents|protective agents|mesh-ancestor
102292551|NCT02399163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292552|NCT02397837|Pramipexole|pramipexole|mesh-list
102292553|NCT02397837|Antioxidants|antioxidants|mesh-ancestor
102292554|NCT02397837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292555|NCT02397837|Protective Agents|protective agents|mesh-ancestor
102292556|NCT02397837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292557|NCT02397837|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102292558|NCT02397837|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102292559|NCT02397837|Dopamine Agonists|dopamine agonists|mesh-ancestor
102292560|NCT02397837|Dopamine Agents|dopamine agents|mesh-ancestor
102292561|NCT02397837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102292562|NCT05549167|Sirolimus|sirolimus|mesh-list
102292563|NCT05549167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102292564|NCT05549167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102292565|NCT05549167|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102292566|NCT05549167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102292567|NCT05549167|Antifungal Agents|antifungal agents|mesh-ancestor
102292568|NCT05549167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102292569|NCT05549167|Immunologic Factors|immunologic factors|mesh-ancestor
102292570|NCT05549167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292571|NCT05700721|Niraparib|niraparib|mesh-list
102292572|NCT05700721|Dostarlimab|dostarlimab|mesh-list
102292573|NCT05700721|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102292574|NCT05700721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102292575|NCT05700721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292576|NCT05700721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102292577|NCT04134559|Pembrolizumab|pembrolizumab|mesh-list
102292578|NCT04134559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102292579|NCT04134559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102292580|NCT04134559|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102292581|NCT04134559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292582|NCT05542147|Fenofibrate|fenofibrate|mesh-list
102292583|NCT05542147|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102292584|NCT05542147|Antimetabolites|antimetabolites|mesh-ancestor
102292585|NCT05542147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292586|NCT05542147|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102292588|NCT05548465|Remifentanil|remifentanil|mesh-list
102292589|NCT05548465|Dsuvia|dsuvia|mesh-list
102292590|NCT05548465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102292591|NCT05548465|Narcotics|narcotics|mesh-ancestor
102292592|NCT05548465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102292593|NCT05548465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292594|NCT05548465|Analgesics|analgesics|mesh-ancestor
102292595|NCT05548465|Sensory System Agents|sensory system agents|mesh-ancestor
102292596|NCT05548465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102292597|NCT05548465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102292598|NCT05548465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102292599|NCT05548465|Anesthetics, General|anesthetics, general|mesh-ancestor
102292600|NCT05548465|Anesthetics|anesthetics|mesh-ancestor
102292601|NCT05548075|Psilocybin|psilocybin|mesh-list
102292602|NCT05548075|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
102292603|NCT05548075|Hallucinogens|hallucinogens|mesh-ancestor
102292604|NCT05548075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292605|NCT05548075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102292606|NCT05548075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102292607|NCT05548075|Serotonin Agents|serotonin agents|mesh-ancestor
102292608|NCT05548075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102292609|NCT05548075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292610|NCT05548075|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102292611|NCT05554003|Temozolomide|temozolomide|mesh-list
102292612|NCT05554003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102292613|NCT05554003|Alkylating Agents|alkylating agents|mesh-ancestor
102292614|NCT05554003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292615|NCT05554003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102292617|NCT05541757|Anticoagulants|anticoagulants|mesh-ancestor
102292618|NCT05541757|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102292619|NCT05541757|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102292620|NCT05541757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292621|NCT05700565|Immunosuppressive Agents|immunosuppressive agents|mesh-list
102292622|NCT05700565|Immunomodulating Agents|immunomodulating agents|mesh-list
102292623|NCT05700565|Immunologic Factors|immunologic factors|mesh-ancestor
102292624|NCT05700565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292625|NCT05541445|Pembrolizumab|pembrolizumab|mesh-list
102292626|NCT05541445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102292627|NCT05541445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102292628|NCT05541445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101393354|NCT04092101|Nicotine|nicotine|mesh-list
101393355|NCT04092101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101393356|NCT04092101|Autonomic Agents|autonomic agents|mesh-ancestor
101393357|NCT04092101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101393358|NCT04092101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393359|NCT04092101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101393360|NCT04092101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101393361|NCT04092101|Cholinergic Agents|cholinergic agents|mesh-ancestor
101393362|NCT04092101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101456559|NCT00216827|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101305623|NCT02020629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101305624|NCT02020629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305625|NCT02020681|Fluorides|fluorides|mesh-list
101393364|NCT04090879|Nicotine|nicotine|mesh-list
102292629|NCT05541445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292630|NCT04325503|Levodopa|levodopa|mesh-list
102292631|NCT04325503|Carbidopa|carbidopa|mesh-list
102292632|NCT04325503|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102292633|NCT04325503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102292634|NCT04325503|Dopamine Agents|dopamine agents|mesh-ancestor
102292635|NCT04325503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102292636|NCT04325503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292637|NCT04325503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292638|NCT04325503|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102292639|NCT04325503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102292640|NCT05540977|Donepezil|donepezil|mesh-list
102292641|NCT05540977|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102292642|NCT05540977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102292643|NCT05540977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292644|NCT05540977|Cholinergic Agents|cholinergic agents|mesh-ancestor
102292645|NCT05540977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102001340|NCT03297216|Progestins|progestins|mesh-ancestor
102292646|NCT05540977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292647|NCT05540977|Nootropic Agents|nootropic agents|mesh-ancestor
102292648|NCT05547685|Methylene Blue|methylene blue|mesh-list
102292649|NCT05547685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102292650|NCT05547685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292651|NCT05540587|Warfarin|warfarin|mesh-list
102292652|NCT05540587|Edoxaban|edoxaban|mesh-list
102292653|NCT05540587|Anticoagulants|anticoagulants|mesh-ancestor
102292654|NCT05540587|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102292655|NCT05540587|Antithrombins|antithrombins|mesh-ancestor
102292656|NCT05540587|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102292657|NCT05540587|Protease Inhibitors|protease inhibitors|mesh-ancestor
102292658|NCT05540587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102292659|NCT05540587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292660|NCT05540431|Charcoal|charcoal|mesh-list
102292661|NCT05540431|Antidotes|antidotes|mesh-ancestor
102292662|NCT05540431|Protective Agents|protective agents|mesh-ancestor
102292663|NCT05540431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292664|NCT05553067|Antibodies|antibodies|mesh-list
102292665|NCT05553067|Immunologic Factors|immunologic factors|mesh-ancestor
102292666|NCT05553067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292667|NCT05540275|Bevacizumab|bevacizumab|mesh-list
102292668|NCT05540275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102292669|NCT05540275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102292670|NCT05540275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102292671|NCT05540275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102292672|NCT05540275|Growth Substances|growth substances|mesh-ancestor
101393392|NCT04047797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102292673|NCT05540275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292674|NCT05540275|Growth Inhibitors|growth inhibitors|mesh-ancestor
102292675|NCT04426123|Botulinum Toxins|botulinum toxins|mesh-list
102292676|NCT04426123|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102292677|NCT04426123|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102292678|NCT04426123|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102292679|NCT04426123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102292680|NCT04426123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292681|NCT04426123|Cholinergic Agents|cholinergic agents|mesh-ancestor
102292682|NCT04426123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102292683|NCT04426123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292684|NCT04426123|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102292685|NCT04426123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102292687|NCT01666951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102292688|NCT01666951|Immunologic Factors|immunologic factors|mesh-ancestor
102292689|NCT01666951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292690|NCT01666951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102292691|NCT01666951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102292692|NCT01666951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292693|NCT02586805|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102292694|NCT02586805|Immunologic Factors|immunologic factors|mesh-ancestor
102292695|NCT02586805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292696|NCT05550415|Simvastatin|simvastatin|mesh-list
102292697|NCT05550415|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102292698|NCT05550415|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102292699|NCT05550415|Antimetabolites|antimetabolites|mesh-ancestor
102292700|NCT05550415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292701|NCT05550415|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102292702|NCT05550415|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102292703|NCT05550415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102292704|NCT02586727|Aflibercept|aflibercept|mesh-list
102292705|NCT02586727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102292706|NCT02586727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102292707|NCT02586727|Growth Substances|growth substances|mesh-ancestor
102292708|NCT02586727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292709|NCT02586727|Growth Inhibitors|growth inhibitors|mesh-ancestor
102292710|NCT02586727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102292711|NCT05550025|Apatinib|apatinib|mesh-list
102292712|NCT05550025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102292713|NCT05550025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102292714|NCT05550025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102292715|NCT05550025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292716|NCT05700253|Hyaluronic Acid|hyaluronic acid|mesh-list
102292717|NCT05700253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102292718|NCT05700253|Immunologic Factors|immunologic factors|mesh-ancestor
102292719|NCT05700253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001415|NCT02526953|Tubulin Modulators|tubulin modulators|mesh-ancestor
102292720|NCT05700253|Viscosupplements|viscosupplements|mesh-ancestor
102292721|NCT05700253|Protective Agents|protective agents|mesh-ancestor
102292722|NCT05544253|Mitomycins|mitomycins|mesh-list
102292723|NCT05544253|Mitomycin|mitomycin|mesh-list
102292724|NCT05544253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102292725|NCT05544253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102292726|NCT05544253|Alkylating Agents|alkylating agents|mesh-ancestor
102292727|NCT05544253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292728|NCT05544253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102292729|NCT05544253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102292730|NCT05535517|Emollients|emollients|mesh-list
102292731|NCT05535517|Dermatologic Agents|dermatologic agents|mesh-ancestor
102292732|NCT05543941|Povidone-Iodine|povidone-iodine|mesh-list
102292733|NCT05543941|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102292734|NCT05543941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102292735|NCT02580877|Insulin|insulin|mesh-list
102292736|NCT02580877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102292737|NCT02580877|Insulin, Isophane|insulin, isophane|mesh-list
102292738|NCT02580877|Methamphetamine|methamphetamine|mesh-list
102292739|NCT02580877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102292740|NCT02580877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292741|NCT02580877|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102292742|NCT02580877|Sympathomimetics|sympathomimetics|mesh-ancestor
102292743|NCT02580877|Autonomic Agents|autonomic agents|mesh-ancestor
102292744|NCT02580877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102292745|NCT02580877|Dopamine Agents|dopamine agents|mesh-ancestor
102292746|NCT02580877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102292747|NCT02580877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292748|NCT02580877|Adrenergic Agents|adrenergic agents|mesh-ancestor
102292749|NCT02580877|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102292750|NCT02580877|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102292751|NCT02580877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102292752|NCT02580877|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102292753|NCT01905631|Diphenhydramine|diphenhydramine|mesh-list
102292754|NCT01905631|Promethazine|promethazine|mesh-list
102292755|NCT01905631|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102292756|NCT01905631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102292757|NCT01905631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102292758|NCT01905631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292759|NCT01905631|Anesthetics, Local|anesthetics, local|mesh-ancestor
102292760|NCT01905631|Anesthetics|anesthetics|mesh-ancestor
102292761|NCT01905631|Sensory System Agents|sensory system agents|mesh-ancestor
102292762|NCT01905631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102292763|NCT01905631|Antiemetics|antiemetics|mesh-ancestor
102292764|NCT01905631|Autonomic Agents|autonomic agents|mesh-ancestor
102292765|NCT01905631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102292766|NCT01905631|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102292767|NCT01905631|Histamine Antagonists|histamine antagonists|mesh-ancestor
102292768|NCT01905631|Histamine Agents|histamine agents|mesh-ancestor
102292769|NCT01905631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102292770|NCT01905631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292771|NCT01905631|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102292772|NCT01905631|Antipruritics|antipruritics|mesh-ancestor
102292773|NCT01905631|Dermatologic Agents|dermatologic agents|mesh-ancestor
102292774|NCT05679037|Thioctic Acid|thioctic acid|mesh-list
102292775|NCT05679037|Antioxidants|antioxidants|mesh-ancestor
102292776|NCT05679037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292777|NCT05679037|Protective Agents|protective agents|mesh-ancestor
102292778|NCT05679037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292779|NCT05679037|Vitamin B Complex|vitamin b complex|mesh-ancestor
102292780|NCT05679037|Vitamins|vitamins|mesh-ancestor
102292781|NCT05679037|Micronutrients|micronutrients|mesh-ancestor
102292782|NCT05197621|Vaccines|vaccines|mesh-list
102292783|NCT05197621|Immunologic Factors|immunologic factors|mesh-ancestor
102292784|NCT05197621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292785|NCT05672407|Tranexamic Acid|tranexamic acid|mesh-list
102292786|NCT05672407|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102292787|NCT05672407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102292788|NCT05672407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292789|NCT05672407|Hemostatics|hemostatics|mesh-ancestor
102292790|NCT05672407|Coagulants|coagulants|mesh-ancestor
102292791|NCT02582983|Enfuvirtide|enfuvirtide|mesh-list
102292792|NCT02582983|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102292793|NCT02582983|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102292794|NCT02582983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292795|NCT02582983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102292796|NCT02582983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102292797|NCT02582983|Antiviral Agents|antiviral agents|mesh-ancestor
102292798|NCT02582983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102292799|NCT02582749|Bicalutamide|bicalutamide|mesh-list
102292800|NCT02582749|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
102292801|NCT02582749|Androgen Antagonists|androgen antagonists|mesh-ancestor
102292802|NCT02582749|Hormone Antagonists|hormone antagonists|mesh-ancestor
102292803|NCT02582749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102292804|NCT02582749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292805|NCT02582749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102292806|NCT05695495|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
102292807|NCT05695495|Hallucinogens|hallucinogens|mesh-ancestor
102292808|NCT05695495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292809|NCT05695495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102292810|NCT05695495|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102292811|NCT05695495|Serotonin Agents|serotonin agents|mesh-ancestor
102292812|NCT05695495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102292813|NCT05695495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292814|NCT05695495|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102292815|NCT05461261|Prednisolone|prednisolone|mesh-list
102292816|NCT05461261|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102292817|NCT05461261|Methylprednisolone|methylprednisolone|mesh-list
102292818|NCT05461261|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102292819|NCT05461261|Prednisolone acetate|prednisolone acetate|mesh-list
102292820|NCT05461261|Docetaxel|docetaxel|mesh-list
102292821|NCT05461261|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102292822|NCT05461261|Prednisolone phosphate|prednisolone phosphate|mesh-list
102292823|NCT05461261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102292824|NCT05461261|Tubulin Modulators|tubulin modulators|mesh-ancestor
102292825|NCT05461261|Antimitotic Agents|antimitotic agents|mesh-ancestor
102292826|NCT05461261|Mitosis Modulators|mitosis modulators|mesh-ancestor
102292827|NCT05461261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292828|NCT05461261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102292829|NCT05461261|Glucocorticoids|glucocorticoids|mesh-ancestor
102292830|NCT05461261|Hormones|hormones|mesh-ancestor
102292831|NCT05461261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102292832|NCT05461261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292833|NCT05461261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102292834|NCT05461261|Antiemetics|antiemetics|mesh-ancestor
102292835|NCT05461261|Autonomic Agents|autonomic agents|mesh-ancestor
102292836|NCT05461261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102292837|NCT05461261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102292838|NCT05461261|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102292839|NCT05461261|Protective Agents|protective agents|mesh-ancestor
102292840|NCT05678413|Paclitaxel|paclitaxel|mesh-list
102292841|NCT05678413|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102292842|NCT05678413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102292843|NCT05678413|Tubulin Modulators|tubulin modulators|mesh-ancestor
102292844|NCT05678413|Antimitotic Agents|antimitotic agents|mesh-ancestor
102292845|NCT05678413|Mitosis Modulators|mitosis modulators|mesh-ancestor
102292846|NCT05678413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292847|NCT05123365|Acetylcysteine|acetylcysteine|mesh-list
102292848|NCT05123365|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102292849|NCT05123365|Antiviral Agents|antiviral agents|mesh-ancestor
102292850|NCT05123365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102292851|NCT05123365|Expectorants|expectorants|mesh-ancestor
102292852|NCT05123365|Respiratory System Agents|respiratory system agents|mesh-ancestor
102292853|NCT05123365|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102292854|NCT05123365|Antioxidants|antioxidants|mesh-ancestor
102292855|NCT05123365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292856|NCT05123365|Protective Agents|protective agents|mesh-ancestor
102292857|NCT05123365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292858|NCT05123365|Antidotes|antidotes|mesh-ancestor
102292859|NCT05678335|Hydroxychloroquine|hydroxychloroquine|mesh-list
102292860|NCT05678335|Tacrolimus|tacrolimus|mesh-list
102292861|NCT05678335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102292862|NCT05678335|Immunologic Factors|immunologic factors|mesh-ancestor
102292863|NCT05678335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292864|NCT05678335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102292865|NCT05678335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102292866|NCT05678335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292867|NCT05678335|Antimalarials|antimalarials|mesh-ancestor
102292868|NCT05678335|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102292869|NCT05678335|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102292870|NCT05678335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102001569|NCT03871517|Analgesics|analgesics|mesh-ancestor
102292871|NCT05678335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102292873|NCT02582671|Ribavirin|ribavirin|mesh-list
102292874|NCT02582671|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102292875|NCT02582671|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102292876|NCT02582671|Protease Inhibitors|protease inhibitors|mesh-ancestor
102292877|NCT02582671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102292878|NCT02582671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292879|NCT02582671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102292880|NCT02582671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102292881|NCT02582671|Antiviral Agents|antiviral agents|mesh-ancestor
102292882|NCT02582671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102292883|NCT02582671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102292884|NCT02582671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102292885|NCT02582671|Antimetabolites|antimetabolites|mesh-ancestor
102292886|NCT05696977|Cyclosporine|cyclosporine|mesh-list
102292887|NCT05696977|Cyclosporins|cyclosporins|mesh-list
102292888|NCT05696977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102292889|NCT05696977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292890|NCT05696977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102292891|NCT05696977|Immunologic Factors|immunologic factors|mesh-ancestor
102292892|NCT05696977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292893|NCT05696977|Antifungal Agents|antifungal agents|mesh-ancestor
102292894|NCT05696977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102292895|NCT05696977|Dermatologic Agents|dermatologic agents|mesh-ancestor
102292896|NCT05696977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102292897|NCT05696977|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102292898|NCT02585713|Dalteparin|dalteparin|mesh-list
102292899|NCT02585713|Tinzaparin|tinzaparin|mesh-list
102292900|NCT02585713|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102292901|NCT02585713|Apixaban|apixaban|mesh-list
102292902|NCT02585713|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102292903|NCT02585713|Antithrombins|antithrombins|mesh-ancestor
102292904|NCT02585713|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102292905|NCT02585713|Protease Inhibitors|protease inhibitors|mesh-ancestor
102292906|NCT02585713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102292907|NCT02585713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292908|NCT02585713|Anticoagulants|anticoagulants|mesh-ancestor
102292909|NCT02585713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102292910|NCT02585713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102292911|NCT05078671|Cobicistat|cobicistat|mesh-list
102292912|NCT05078671|Olaparib|olaparib|mesh-list
102292913|NCT05078671|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102292914|NCT05078671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102292915|NCT05078671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292916|NCT05078671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102292917|NCT05078671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102292918|NCT05078671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102292919|NCT05078671|Antiviral Agents|antiviral agents|mesh-ancestor
102292920|NCT05078671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102292921|NCT05078671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102292922|NCT05078671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102292923|NCT02579863|Dexamethasone|dexamethasone|mesh-list
102292924|NCT02579863|Pembrolizumab|pembrolizumab|mesh-list
102292925|NCT02579863|Lenalidomide|lenalidomide|mesh-list
102292926|NCT02579863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102292927|NCT02579863|Antiemetics|antiemetics|mesh-ancestor
102292928|NCT02579863|Autonomic Agents|autonomic agents|mesh-ancestor
102292929|NCT02579863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101393635|NCT03748641|Prednisone|prednisone|mesh-list
102292930|NCT02579863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292931|NCT02579863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102292932|NCT02579863|Glucocorticoids|glucocorticoids|mesh-ancestor
102292933|NCT02579863|Hormones|hormones|mesh-ancestor
102292934|NCT02579863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102292935|NCT02579863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102292936|NCT02579863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102292937|NCT02579863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102292938|NCT02579863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102292939|NCT02579863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292940|NCT02579863|Immunologic Factors|immunologic factors|mesh-ancestor
102292941|NCT02579863|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102292942|NCT02579863|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102292943|NCT02579863|Growth Substances|growth substances|mesh-ancestor
102292944|NCT02579863|Growth Inhibitors|growth inhibitors|mesh-ancestor
102292945|NCT05677945|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102292946|NCT05677945|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102292947|NCT05677945|Simvastatin|simvastatin|mesh-list
102292948|NCT05677945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102292949|NCT05677945|Antitubercular Agents|antitubercular agents|mesh-ancestor
102292950|NCT05677945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102292952|NCT05677945|Antimetabolites|antimetabolites|mesh-ancestor
102292953|NCT05677945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292954|NCT05677945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102292955|NCT05677945|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102292956|NCT05677945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102292957|NCT04964947|Tobramycin|tobramycin|mesh-list
102292958|NCT04964947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102292959|NCT04964947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102292960|NCT02582515|Cycloserine|cycloserine|mesh-list
102292961|NCT02582515|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102292962|NCT02582515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102292963|NCT02582515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102292964|NCT02582515|Antitubercular Agents|antitubercular agents|mesh-ancestor
102292965|NCT02582515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102292966|NCT02582515|Antimetabolites|antimetabolites|mesh-ancestor
102292967|NCT02582515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292968|NCT02579629|Ropivacaine|ropivacaine|mesh-list
101393692|NCT03719924|Paclitaxel|paclitaxel|mesh-list
102292969|NCT02579629|Anesthetics, Local|anesthetics, local|mesh-ancestor
102292970|NCT02579629|Anesthetics|anesthetics|mesh-ancestor
102292971|NCT02579629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102292972|NCT02579629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292973|NCT02579629|Sensory System Agents|sensory system agents|mesh-ancestor
102292974|NCT02579629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102292975|NCT05677555|Colchicine|colchicine|mesh-list
102292976|NCT05677555|Gout Suppressants|gout suppressants|mesh-ancestor
102292977|NCT05677555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102292978|NCT05677555|Tubulin Modulators|tubulin modulators|mesh-ancestor
102292979|NCT05677555|Antimitotic Agents|antimitotic agents|mesh-ancestor
102292980|NCT05677555|Mitosis Modulators|mitosis modulators|mesh-ancestor
101634696|NCT00577993|Glucocorticoids|glucocorticoids|mesh-ancestor
102292981|NCT05677555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292982|NCT05677555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102292984|NCT02343939|Azacitidine|azacitidine|mesh-list
102292985|NCT02343939|Decitabine|decitabine|mesh-list
102292986|NCT02343939|Daunorubicin|daunorubicin|mesh-list
102292987|NCT02343939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102292988|NCT02343939|Antimetabolites|antimetabolites|mesh-ancestor
102292989|NCT02343939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102292990|NCT02343939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102292991|NCT02343939|Antiviral Agents|antiviral agents|mesh-ancestor
102292992|NCT02343939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102292993|NCT02343939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102292994|NCT02343939|Immunologic Factors|immunologic factors|mesh-ancestor
102292995|NCT02343939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102292996|NCT02343939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102292997|NCT02343939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102292998|NCT02343939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102292999|NCT02343939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102293000|NCT02343549|Bevacizumab|bevacizumab|mesh-list
102293001|NCT02343549|Temozolomide|temozolomide|mesh-list
102293002|NCT02343549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102293003|NCT02343549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293004|NCT02343549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102293005|NCT02343549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102293006|NCT02343549|Growth Substances|growth substances|mesh-ancestor
102293007|NCT02343549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293008|NCT02343549|Growth Inhibitors|growth inhibitors|mesh-ancestor
102293009|NCT02343549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102293010|NCT02343549|Alkylating Agents|alkylating agents|mesh-ancestor
102293011|NCT02343549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293012|NCT02343159|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102293013|NCT02343159|Dermatologic Agents|dermatologic agents|mesh-ancestor
102293014|NCT02343159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102293015|NCT02343159|Immunologic Factors|immunologic factors|mesh-ancestor
102293016|NCT02343159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293017|NCT02395653|Fentanyl|fentanyl|mesh-list
102293018|NCT02395653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102293019|NCT02395653|Narcotics|narcotics|mesh-ancestor
102293020|NCT02395653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102293021|NCT02395653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293022|NCT02395653|Analgesics|analgesics|mesh-ancestor
102293023|NCT02395653|Sensory System Agents|sensory system agents|mesh-ancestor
102293024|NCT02395653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102293025|NCT02395653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102293026|NCT02395653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102293027|NCT02395653|Anesthetics, General|anesthetics, general|mesh-ancestor
102293028|NCT02395653|Anesthetics|anesthetics|mesh-ancestor
102293029|NCT01664923|Bicalutamide|bicalutamide|mesh-list
102293030|NCT01664923|Androgen Antagonists|androgen antagonists|mesh-ancestor
102293031|NCT01664923|Hormone Antagonists|hormone antagonists|mesh-ancestor
102293032|NCT01664923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102293033|NCT01664923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293034|NCT01664923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293035|NCT04778527|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102293036|NCT04778527|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102293037|NCT04778527|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102293038|NCT04778527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102293039|NCT04778527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293040|NCT04778527|Antiviral Agents|antiviral agents|mesh-ancestor
102293041|NCT04778527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102293042|NCT04778527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102293043|NCT04778527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102293044|NCT04403347|Losartan|losartan|mesh-list
102293045|NCT04403347|Antihypertensive Agents|antihypertensive agents|mesh-list
102293046|NCT04403347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102293047|NCT04403347|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102293048|NCT04403347|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102293049|NCT04403347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293050|NCT01664533|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102293051|NCT01664533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293052|NCT01664533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101634772|NCT00978068|Antiviral Agents|antiviral agents|mesh-ancestor
102293053|NCT01664533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102293054|NCT01664533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293055|NCT05673655|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102293056|NCT05673655|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102293057|NCT05673655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102293058|NCT05673655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102293059|NCT05673655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293060|NCT05673655|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102293061|NCT05673655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102293062|NCT05673655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293063|NCT05673655|Cholinergic Agents|cholinergic agents|mesh-ancestor
102293064|NCT05673655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102293065|NCT05692297|Denosumab|denosumab|mesh-list
102293066|NCT05692297|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102293067|NCT05692297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293068|NCT05696509|Anesthetics|anesthetics|mesh-list
102293069|NCT05696509|Propofol|propofol|mesh-list
102293070|NCT05696509|Sevoflurane|sevoflurane|mesh-list
102293071|NCT05696509|Isoflurane|isoflurane|mesh-list
102293072|NCT05696509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102293073|NCT05696509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293074|NCT05696509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102293075|NCT05696509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102293076|NCT05696509|Anesthetics, General|anesthetics, general|mesh-ancestor
102293077|NCT05696509|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102293078|NCT05696509|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102293079|NCT02584855|Ixekizumab|ixekizumab|mesh-list
102293080|NCT02584855|Dermatologic Agents|dermatologic agents|mesh-ancestor
102293081|NCT02581891|Aflibercept|aflibercept|mesh-list
102293082|NCT02581891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102293083|NCT02581891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102293084|NCT02581891|Growth Substances|growth substances|mesh-ancestor
102293085|NCT02581891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293086|NCT02581891|Growth Inhibitors|growth inhibitors|mesh-ancestor
102293087|NCT02581891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293088|NCT04523857|Hydroxychloroquine|hydroxychloroquine|mesh-list
102293089|NCT04523857|Antimalarials|antimalarials|mesh-ancestor
102293090|NCT04523857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102293091|NCT04523857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102293092|NCT04523857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102293093|NCT04523857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102293094|NCT04523857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293095|NCT04523857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102293096|NCT02581345|Adalimumab|adalimumab|mesh-list
102293097|NCT02581345|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102293098|NCT02581345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102293099|NCT02581345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102293101|NCT05579509|Midazolam|midazolam|mesh-list
102293102|NCT05579509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102293103|NCT05579509|Narcotics|narcotics|mesh-ancestor
102293104|NCT05579509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102293105|NCT05579509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293106|NCT05579509|Analgesics|analgesics|mesh-ancestor
102293107|NCT05579509|Sensory System Agents|sensory system agents|mesh-ancestor
101393815|NCT03568656|Olaparib|olaparib|mesh-list
102293108|NCT05579509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102293109|NCT05579509|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102293110|NCT05579509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102293111|NCT05579509|Anesthetics, General|anesthetics, general|mesh-ancestor
102293112|NCT05579509|Anesthetics|anesthetics|mesh-ancestor
102293113|NCT05579509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102293114|NCT05579509|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102293115|NCT05579509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102293116|NCT05579509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102293117|NCT05579509|GABA Modulators|gaba modulators|mesh-ancestor
102293118|NCT05579509|GABA Agents|gaba agents|mesh-ancestor
102293119|NCT05579509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102293120|NCT05579509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293121|NCT05696431|Fluorides|fluorides|mesh-list
102293122|NCT05696431|Cariostatic Agents|cariostatic agents|mesh-ancestor
102293123|NCT05696431|Protective Agents|protective agents|mesh-ancestor
102293124|NCT05696431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293125|NCT05575219|Clonidine|clonidine|mesh-list
102293126|NCT05575219|Analgesics|analgesics|mesh-ancestor
102293127|NCT05575219|Sensory System Agents|sensory system agents|mesh-ancestor
102293128|NCT05575219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102293129|NCT05575219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293130|NCT05575219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102293132|NCT05575219|Autonomic Agents|autonomic agents|mesh-ancestor
102293133|NCT05575219|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102293134|NCT05575219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102293135|NCT05575219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102293136|NCT05575219|Adrenergic Agents|adrenergic agents|mesh-ancestor
102293137|NCT05575219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102293138|NCT05575219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293139|NCT05568745|Misoprostol|misoprostol|mesh-list
102293140|NCT05568745|Oxytocin|oxytocin|mesh-list
102293141|NCT05568745|Oxytocics|oxytocics|mesh-ancestor
102293142|NCT05568745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102293143|NCT05568745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293144|NCT05568745|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102293145|NCT05568745|Abortifacient Agents|abortifacient agents|mesh-ancestor
102293146|NCT05568745|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102293147|NCT05568745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102293148|NCT04314895|Paclitaxel|paclitaxel|mesh-list
102293149|NCT04314895|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102293150|NCT04314895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102293151|NCT04314895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293152|NCT04314895|Tubulin Modulators|tubulin modulators|mesh-ancestor
102293153|NCT04314895|Antimitotic Agents|antimitotic agents|mesh-ancestor
102293154|NCT04314895|Mitosis Modulators|mitosis modulators|mesh-ancestor
102293155|NCT04314895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293156|NCT02581189|Ritonavir|ritonavir|mesh-list
102293157|NCT02581189|Ribavirin|ribavirin|mesh-list
102293158|NCT02581189|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102293159|NCT02581189|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102293160|NCT02581189|Protease Inhibitors|protease inhibitors|mesh-ancestor
102293161|NCT02581189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102293162|NCT02581189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293163|NCT02581189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102293164|NCT02581189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102293165|NCT02581189|Antiviral Agents|antiviral agents|mesh-ancestor
102293166|NCT02581189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102293167|NCT02581189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102293168|NCT02581189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102293169|NCT02581189|Antimetabolites|antimetabolites|mesh-ancestor
102293170|NCT05569681|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102293171|NCT05569681|Bemiparin|bemiparin|mesh-list
102293172|NCT05569681|Anticoagulants|anticoagulants|mesh-ancestor
102293173|NCT05569681|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102293174|NCT05569681|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102293175|NCT05569681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293176|NCT00352027|Prednisone|prednisone|mesh-list
102293177|NCT00352027|Hydrocortisone|hydrocortisone|mesh-list
102293178|NCT00352027|Cyclophosphamide|cyclophosphamide|mesh-list
102293179|NCT00352027|Mechlorethamine|mechlorethamine|mesh-list
102293180|NCT00352027|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102293181|NCT00352027|Doxorubicin|doxorubicin|mesh-list
102293182|NCT00352027|Etoposide|etoposide|mesh-list
102293183|NCT00352027|Vincristine|vincristine|mesh-list
102293184|NCT00352027|Bleomycin|bleomycin|mesh-list
102293185|NCT00352027|Vinblastine|vinblastine|mesh-list
102293186|NCT00352027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102293187|NCT00352027|Immunologic Factors|immunologic factors|mesh-ancestor
102293188|NCT00352027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293189|NCT00352027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102293190|NCT00352027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102293191|NCT00352027|Alkylating Agents|alkylating agents|mesh-ancestor
102293192|NCT00352027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293193|NCT00352027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293194|NCT00352027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102293195|NCT00352027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102293196|NCT00352027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102293197|NCT00352027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102293198|NCT00352027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102293199|NCT00352027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102293200|NCT00352027|Glucocorticoids|glucocorticoids|mesh-ancestor
102293201|NCT00352027|Hormones|hormones|mesh-ancestor
102293202|NCT00352027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102293203|NCT00352027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102293204|NCT00352027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102293205|NCT00352027|Tubulin Modulators|tubulin modulators|mesh-ancestor
102293206|NCT00352027|Antimitotic Agents|antimitotic agents|mesh-ancestor
102293207|NCT00352027|Mitosis Modulators|mitosis modulators|mesh-ancestor
102293208|NCT02576977|Dexamethasone|dexamethasone|mesh-list
102293209|NCT02576977|Pembrolizumab|pembrolizumab|mesh-list
102293210|NCT02576977|Pomalidomide|pomalidomide|mesh-list
102293211|NCT02576977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102293212|NCT02576977|Antiemetics|antiemetics|mesh-ancestor
102293213|NCT02576977|Autonomic Agents|autonomic agents|mesh-ancestor
102293214|NCT02576977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102293215|NCT02576977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293216|NCT02576977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102293217|NCT02576977|Glucocorticoids|glucocorticoids|mesh-ancestor
102293218|NCT02576977|Hormones|hormones|mesh-ancestor
102293219|NCT02576977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102293220|NCT02576977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102293221|NCT02576977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293222|NCT02576977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102293223|NCT02576977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102293224|NCT02576977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293225|NCT02576977|Immunologic Factors|immunologic factors|mesh-ancestor
102293226|NCT02576977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102293227|NCT02576977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102293228|NCT02576977|Growth Substances|growth substances|mesh-ancestor
102293229|NCT02576977|Growth Inhibitors|growth inhibitors|mesh-ancestor
102293230|NCT05867251|Carboplatin|carboplatin|mesh-list
102293231|NCT05867251|Letrozole|letrozole|mesh-list
102293232|NCT05867251|Fulvestrant|fulvestrant|mesh-list
102293233|NCT05867251|Palbociclib|palbociclib|mesh-list
102293234|NCT05867251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293235|NCT05867251|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102293236|NCT05867251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102293237|NCT05867251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102293238|NCT05867251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293239|NCT05867251|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102293240|NCT05867251|Hormone Antagonists|hormone antagonists|mesh-ancestor
102293241|NCT05867251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102293242|NCT05867251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293243|NCT05867251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102293244|NCT05867251|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102293245|NCT05867251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102293246|NCT05867212|Cabotegravir|cabotegravir|mesh-list
102293247|NCT05867212|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102293248|NCT05867212|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102001951|NCT01275911|Adrenergic Agents|adrenergic agents|mesh-ancestor
102293249|NCT05867212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102293250|NCT05867212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293251|NCT05867212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102293252|NCT05867212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102293253|NCT05867212|Antiviral Agents|antiviral agents|mesh-ancestor
102293254|NCT05867212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102293255|NCT05867056|Cysteamine|cysteamine|mesh-list
102293256|NCT05867056|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
102293257|NCT05867056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293258|NCT05867030|Rituximab|rituximab|mesh-list
102293259|NCT05867030|Lenalidomide|lenalidomide|mesh-list
102293260|NCT05867030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102293261|NCT05867030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293262|NCT05867030|Immunologic Factors|immunologic factors|mesh-ancestor
102293263|NCT05867030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293264|NCT05867030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102293265|NCT05867030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102293266|NCT05867030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102293267|NCT05867030|Growth Substances|growth substances|mesh-ancestor
102293268|NCT05867030|Growth Inhibitors|growth inhibitors|mesh-ancestor
102293269|NCT05866848|Caffeine|caffeine|mesh-list
102293270|NCT05866848|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102293271|NCT05866848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293272|NCT05866848|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102293273|NCT05866848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102293274|NCT05866848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293275|NCT05866848|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102293276|NCT05866848|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102293277|NCT05866848|Purinergic Agents|purinergic agents|mesh-ancestor
102293278|NCT05866848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102293279|NCT05866614|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102293280|NCT05866614|Immunologic Factors|immunologic factors|mesh-ancestor
102293281|NCT05866614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293282|NCT05866588|Coal Tar|coal tar|mesh-list
102293283|NCT05866588|Keratolytic Agents|keratolytic agents|mesh-ancestor
102293284|NCT05866588|Dermatologic Agents|dermatologic agents|mesh-ancestor
102293285|NCT05866575|Vortioxetine|vortioxetine|mesh-list
102293286|NCT05866575|Escitalopram|escitalopram|mesh-list
102293287|NCT05866575|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102293288|NCT05866575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102293289|NCT05866575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102293290|NCT05866575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293291|NCT05866575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102293292|NCT05866575|Serotonin Agents|serotonin agents|mesh-ancestor
102293293|NCT05866575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293294|NCT05866575|Antidepressive Agents|antidepressive agents|mesh-ancestor
102293295|NCT05866575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102293296|NCT05866575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102293297|NCT05866575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102293298|NCT05866575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102293299|NCT05866575|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102293300|NCT05866575|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102293301|NCT05866575|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102293302|NCT05866575|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102293303|NCT05866172|Zoledronic Acid|zoledronic acid|mesh-list
102293304|NCT05866172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102293305|NCT05866172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293306|NCT05866068|Clomiphene|clomiphene|mesh-list
101394014|NCT03407144|Prednisone|prednisone|mesh-list
102293307|NCT05866068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102293308|NCT05866068|Hormone Antagonists|hormone antagonists|mesh-ancestor
102293309|NCT05866068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102293310|NCT05866068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293311|NCT05866068|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102293312|NCT05866068|Fertility Agents|fertility agents|mesh-ancestor
102293313|NCT05866068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102293314|NCT05866068|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102293315|NCT05866068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102293316|NCT05866055|Midazolam|midazolam|mesh-list
102293317|NCT05866055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102293318|NCT05866055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102293319|NCT05866055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102293320|NCT05866055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002027|NCT04016779|Adrenergic Agents|adrenergic agents|mesh-ancestor
102293321|NCT05866055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102293322|NCT05866055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102293323|NCT05866055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102293324|NCT05866055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102293325|NCT05866055|Anesthetics, General|anesthetics, general|mesh-ancestor
102293326|NCT05866055|Anesthetics|anesthetics|mesh-ancestor
102293327|NCT05866055|GABA Modulators|gaba modulators|mesh-ancestor
102293328|NCT05866055|GABA Agents|gaba agents|mesh-ancestor
102293329|NCT05866055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102293330|NCT05866055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293331|NCT05865990|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
102293332|NCT05865990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102293333|NCT05865990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293334|NCT05865925|Irinotecan|irinotecan|mesh-list
102293335|NCT05865925|Floxuridine|floxuridine|mesh-list
102293336|NCT05865925|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102293337|NCT05865925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102293338|NCT05865925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102293339|NCT05865925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293340|NCT05865925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293341|NCT05865925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102293342|NCT05865925|Antimetabolites|antimetabolites|mesh-ancestor
102293343|NCT05865548|Aspirin|aspirin|mesh-list
102293344|NCT05865548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102293345|NCT05865548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102293346|NCT05865548|Analgesics|analgesics|mesh-ancestor
102293347|NCT05865548|Sensory System Agents|sensory system agents|mesh-ancestor
102293348|NCT05865548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102293349|NCT05865548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293350|NCT05865548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102293351|NCT05865548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102293352|NCT05865548|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102293353|NCT05865548|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102293354|NCT05865548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293355|NCT05865548|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102293356|NCT05865548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102293357|NCT05865548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102293358|NCT05865548|Antipyretics|antipyretics|mesh-ancestor
102293359|NCT05861440|Antitubercular Agents|antitubercular agents|mesh-list
102293360|NCT05861440|Prednisolone|prednisolone|mesh-list
102293361|NCT05861440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102293362|NCT05861440|Glucocorticoids|glucocorticoids|mesh-ancestor
102293363|NCT05861440|Hormones|hormones|mesh-ancestor
102293364|NCT05861440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102293365|NCT05861440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293366|NCT05861440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102293367|NCT05861440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293368|NCT05861440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102293369|NCT05861440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102293370|NCT05859074|Pembrolizumab|pembrolizumab|mesh-list
102293371|NCT05859074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102293372|NCT05859074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293373|NCT05859074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101394052|NCT03382834|Tamoxifen|tamoxifen|mesh-list
102293374|NCT05859074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293375|NCT05827068|Vaccines|vaccines|mesh-list
102293376|NCT05827068|Immunologic Factors|immunologic factors|mesh-ancestor
102293377|NCT05827068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293378|NCT05819710|Zopiclone|zopiclone|mesh-list
102293379|NCT05819710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102293380|NCT05819710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102293381|NCT05819710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293382|NCT05816356|Decitabine|decitabine|mesh-list
102293383|NCT05816356|Tetrahydrouridine|tetrahydrouridine|mesh-list
102293384|NCT05816356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102293385|NCT05816356|Antimetabolites|antimetabolites|mesh-ancestor
102293386|NCT05816356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293387|NCT05816356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293388|NCT05816356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102293389|NCT05815680|Metformin|metformin|mesh-list
102293390|NCT05815680|Digoxin|digoxin|mesh-list
102293391|NCT05815680|Warfarin|warfarin|mesh-list
102293392|NCT05815680|Atorvastatin|atorvastatin|mesh-list
102293393|NCT05815680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102293394|NCT05815680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293395|NCT05815680|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102293396|NCT05815680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102293397|NCT05815680|Antimetabolites|antimetabolites|mesh-ancestor
102293398|NCT05815680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293399|NCT05815680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102293400|NCT05815680|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102293401|NCT05815680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102293402|NCT05815680|Anticoagulants|anticoagulants|mesh-ancestor
102293403|NCT05815680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102293404|NCT05815680|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102293405|NCT05815680|Protective Agents|protective agents|mesh-ancestor
102293406|NCT05801419|Nicotine|nicotine|mesh-list
102293407|NCT05801419|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102293408|NCT05801419|Autonomic Agents|autonomic agents|mesh-ancestor
102293409|NCT05801419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102293410|NCT05801419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293411|NCT05801419|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102293412|NCT05801419|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102293413|NCT05801419|Cholinergic Agents|cholinergic agents|mesh-ancestor
102293414|NCT05801419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102293415|NCT05801419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293416|NCT05786417|Calcium Channel Blockers|calcium channel blockers|mesh-list
102293417|NCT05786417|Calcium|calcium|mesh-list
102293418|NCT05786417|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102293419|NCT05786417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102293420|NCT05786417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293421|NCT05786417|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102293422|NCT05786417|Adrenergic Agents|adrenergic agents|mesh-ancestor
102293423|NCT05786417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102293424|NCT05786417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293425|NCT05786417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102293426|NCT05781217|Goserelin|goserelin|mesh-list
102293427|NCT05781217|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102293428|NCT05781217|Leuprolide|leuprolide|mesh-list
102293429|NCT05781217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102293430|NCT05781217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293431|NCT05781217|Luteolytic Agents|luteolytic agents|mesh-ancestor
102293432|NCT05781217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102293433|NCT05781217|Contraceptive Agents|contraceptive agents|mesh-ancestor
102293434|NCT05781217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102293435|NCT05781217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293436|NCT05781217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102293437|NCT05781217|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102293438|NCT05781217|Fertility Agents|fertility agents|mesh-ancestor
102293439|NCT05776823|Naloxone|naloxone|mesh-list
102293440|NCT05776823|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102293441|NCT05776823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293442|NCT05776823|Sensory System Agents|sensory system agents|mesh-ancestor
102293443|NCT05776823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102293444|NCT05866029|Denosumab|denosumab|mesh-list
102293445|NCT05866029|Teriparatide|teriparatide|mesh-list
102293446|NCT05866029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102293447|NCT05866029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293448|NCT05866029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102293449|NCT05769530|Dexmedetomidine|dexmedetomidine|mesh-list
102293450|NCT05769530|Nalbuphine|nalbuphine|mesh-list
102293451|NCT05769530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102293452|NCT05769530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102293453|NCT05769530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293454|NCT05769530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102293455|NCT05769530|Analgesics|analgesics|mesh-ancestor
102293456|NCT05769530|Sensory System Agents|sensory system agents|mesh-ancestor
102293457|NCT05769530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102293458|NCT05769530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102293459|NCT05769530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102293460|NCT05769530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102293461|NCT05769530|Adrenergic Agents|adrenergic agents|mesh-ancestor
102293462|NCT05769530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102293463|NCT05769530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293464|NCT05769530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102293465|NCT05769530|Narcotics|narcotics|mesh-ancestor
102293466|NCT05740618|Mannitol|mannitol|mesh-list
102293467|NCT05740618|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102293468|NCT05740618|Diuretics|diuretics|mesh-ancestor
102293469|NCT05740618|Natriuretic Agents|natriuretic agents|mesh-ancestor
102293470|NCT05740618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293471|NCT05705505|Letrozole|letrozole|mesh-list
102293472|NCT05705505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293473|NCT05705505|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102293474|NCT05705505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102293475|NCT05705505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102293476|NCT05705505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293477|NCT05705505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102293478|NCT05705505|Hormone Antagonists|hormone antagonists|mesh-ancestor
102293479|NCT05705505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102293480|NCT05705505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293481|NCT05677295|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102293482|NCT05677295|Imipramine|imipramine|mesh-list
102293483|NCT05677295|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102293484|NCT05677295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102293485|NCT05677295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102293486|NCT05677295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293487|NCT05677295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102293488|NCT05677295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293489|NCT05677295|Analgesics|analgesics|mesh-ancestor
102293490|NCT05677295|Sensory System Agents|sensory system agents|mesh-ancestor
102293491|NCT05677295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102293492|NCT05677295|Antidepressive Agents|antidepressive agents|mesh-ancestor
102293493|NCT05677295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102293494|NCT05677295|Dopamine Agents|dopamine agents|mesh-ancestor
102293495|NCT05677295|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102293496|NCT05677295|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102293497|NCT05677295|Adrenergic Agents|adrenergic agents|mesh-ancestor
102293498|NCT05664750|Immunoglobulins|immunoglobulins|mesh-list
102293499|NCT05664750|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102293500|NCT05664750|Antibodies|antibodies|mesh-list
102293501|NCT05664750|Immunologic Factors|immunologic factors|mesh-ancestor
102293502|NCT05664750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293504|NCT05580523|Metformin|metformin|mesh-list
102293505|NCT05580523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102293506|NCT05580523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293507|NCT05580523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102293508|NCT05580523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102293509|NCT05580523|Analgesics|analgesics|mesh-ancestor
102293510|NCT05580523|Sensory System Agents|sensory system agents|mesh-ancestor
102293511|NCT05580523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102293512|NCT05580523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102293513|NCT05580523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102293514|NCT05580523|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102293515|NCT05580523|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101394191|NCT03260504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293516|NCT05580523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293517|NCT05580523|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102293518|NCT05580523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102293519|NCT05580523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102293520|NCT05580523|Antipyretics|antipyretics|mesh-ancestor
102293521|NCT05557877|Aspirin|aspirin|mesh-list
102293522|NCT05557877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102293523|NCT05557877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102293524|NCT05557877|Analgesics|analgesics|mesh-ancestor
102293525|NCT05557877|Sensory System Agents|sensory system agents|mesh-ancestor
102293526|NCT05557877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102293527|NCT05557877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293528|NCT05557877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102293529|NCT05557877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102293530|NCT05557877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102293531|NCT05557877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102293532|NCT05557877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293533|NCT05557877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102293534|NCT05557877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102293535|NCT05557877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102293536|NCT05557877|Antipyretics|antipyretics|mesh-ancestor
102293537|NCT05476991|Aspirin|aspirin|mesh-list
102293538|NCT05476991|Colchicine|colchicine|mesh-list
102293539|NCT05476991|Ticagrelor|ticagrelor|mesh-list
102293540|NCT05476991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102293541|NCT05476991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102293542|NCT05476991|Analgesics|analgesics|mesh-ancestor
102293543|NCT05476991|Sensory System Agents|sensory system agents|mesh-ancestor
102293544|NCT05476991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102293545|NCT05476991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293546|NCT05476991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102293547|NCT05476991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102293548|NCT05476991|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102293549|NCT05476991|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102293550|NCT05476991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293551|NCT05476991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102293552|NCT05476991|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102293553|NCT05476991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102293554|NCT05476991|Antipyretics|antipyretics|mesh-ancestor
102293555|NCT05476991|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102293556|NCT05476991|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102293557|NCT05476991|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102293558|NCT05476991|Purinergic Agents|purinergic agents|mesh-ancestor
102293559|NCT05476991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102293560|NCT05476991|Gout Suppressants|gout suppressants|mesh-ancestor
102293561|NCT05476991|Tubulin Modulators|tubulin modulators|mesh-ancestor
102293562|NCT05476991|Antimitotic Agents|antimitotic agents|mesh-ancestor
102293563|NCT05476991|Mitosis Modulators|mitosis modulators|mesh-ancestor
102293564|NCT05476991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293565|NCT05465226|Analgesics, Opioid|analgesics, opioid|mesh-list
102293566|NCT05465226|Narcotics|narcotics|mesh-ancestor
102293567|NCT05465226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102293568|NCT05465226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293569|NCT05465226|Analgesics|analgesics|mesh-ancestor
102293570|NCT05465226|Sensory System Agents|sensory system agents|mesh-ancestor
102293571|NCT05465226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102293572|NCT05463393|Xanthohumol|xanthohumol|mesh-list
102293573|NCT05463393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293574|NCT05463393|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102293575|NCT05463393|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102293576|NCT05463393|Growth Substances|growth substances|mesh-ancestor
102293577|NCT05463393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293578|NCT05463393|Growth Inhibitors|growth inhibitors|mesh-ancestor
102293579|NCT05419050|Denosumab|denosumab|mesh-list
102293580|NCT05419050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102293581|NCT05419050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293582|NCT05382806|Flumazenil|flumazenil|mesh-list
102293583|NCT05382806|Antidotes|antidotes|mesh-ancestor
102293584|NCT05382806|Protective Agents|protective agents|mesh-ancestor
101394302|NCT03201965|Glucocorticoids|glucocorticoids|mesh-ancestor
102293585|NCT05382806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293586|NCT05382806|GABA Modulators|gaba modulators|mesh-ancestor
102293587|NCT05382806|GABA Agents|gaba agents|mesh-ancestor
102293588|NCT05382806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102293589|NCT05382806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293590|NCT05379972|Pembrolizumab|pembrolizumab|mesh-list
102293591|NCT05379972|Olaparib|olaparib|mesh-list
102293592|NCT05379972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102293593|NCT05379972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293594|NCT05379972|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102293595|NCT05379972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293596|NCT05379972|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102293597|NCT05379972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102293598|NCT05367245|Butyric Acid|butyric acid|mesh-list
102293599|NCT05367245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293600|NCT05367245|Histamine Antagonists|histamine antagonists|mesh-ancestor
102293601|NCT05367245|Histamine Agents|histamine agents|mesh-ancestor
102293602|NCT05367245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102293603|NCT05367245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293604|NCT05312008|Oxytocin|oxytocin|mesh-list
102293605|NCT05312008|Oxytocics|oxytocics|mesh-ancestor
102293606|NCT05312008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102293607|NCT05312008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293608|NCT05265546|Psilocybin|psilocybin|mesh-list
102293609|NCT05265546|Hallucinogens|hallucinogens|mesh-ancestor
102293610|NCT05265546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293611|NCT05265546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102293612|NCT05238883|Tislelizumab|tislelizumab|mesh-list
102293613|NCT05238883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102293614|NCT05238883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293615|NCT05163496|Psilocybin|psilocybin|mesh-list
102293616|NCT05163496|Hallucinogens|hallucinogens|mesh-ancestor
102293617|NCT05163496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293618|NCT05163496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102002325|NCT01171859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102293619|NCT05162443|Adagrasib|adagrasib|mesh-list
102293620|NCT05162443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293621|NCT05107960|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
102293622|NCT05107960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102293623|NCT05107960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102293624|NCT05107960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293626|NCT05097599|Trastuzumab|trastuzumab|mesh-list
102293627|NCT05097599|Axitinib|axitinib|mesh-list
102293628|NCT05097599|Talazoparib|talazoparib|mesh-list
102293629|NCT05097599|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
102293630|NCT05097599|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
102293631|NCT05097599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102293632|NCT05097599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293633|NCT05097599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102293634|NCT05097599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293635|NCT05097599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102293636|NCT05097599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102293637|NCT05097599|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102293638|NCT05097599|Immunoconjugates|immunoconjugates|mesh-ancestor
102293639|NCT05097599|Immunologic Factors|immunologic factors|mesh-ancestor
102293640|NCT05097599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293641|NCT05002465|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102293642|NCT05002465|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102293643|NCT05002465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293644|NCT04996004|Doxorubicin|doxorubicin|mesh-list
102293645|NCT04996004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102293646|NCT04996004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293647|NCT04996004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102293648|NCT04996004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102293649|NCT04996004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102293650|NCT04996004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293651|NCT04952402|Vaccines|vaccines|mesh-list
102293652|NCT04952402|Immunologic Factors|immunologic factors|mesh-ancestor
102293653|NCT04952402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293654|NCT04941144|Vaccines|vaccines|mesh-list
102293655|NCT04941144|Immunologic Factors|immunologic factors|mesh-ancestor
102293656|NCT04941144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293657|NCT04892277|Cyclophosphamide|cyclophosphamide|mesh-list
102293658|NCT04892277|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102293659|NCT04892277|Fludarabine|fludarabine|mesh-list
102293660|NCT04892277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102293661|NCT04892277|Immunologic Factors|immunologic factors|mesh-ancestor
102293662|NCT04892277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293663|NCT04892277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102293664|NCT04892277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102293665|NCT04892277|Alkylating Agents|alkylating agents|mesh-ancestor
102293666|NCT04892277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293667|NCT04892277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293668|NCT04892277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102293669|NCT04842045|Midazolam|midazolam|mesh-list
102293670|NCT04842045|Psilocybin|psilocybin|mesh-list
102293671|NCT04842045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102293672|NCT04842045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102293673|NCT04842045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102293674|NCT04842045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293675|NCT04842045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102293676|NCT04842045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102293677|NCT04842045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102293678|NCT04842045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102293679|NCT04842045|Anesthetics, General|anesthetics, general|mesh-ancestor
102293680|NCT04842045|Anesthetics|anesthetics|mesh-ancestor
102293681|NCT04842045|GABA Modulators|gaba modulators|mesh-ancestor
102293682|NCT04842045|GABA Agents|gaba agents|mesh-ancestor
102293683|NCT04842045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102293684|NCT04842045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293685|NCT04842045|Hallucinogens|hallucinogens|mesh-ancestor
102293686|NCT04754945|Dexamethasone|dexamethasone|mesh-list
102293687|NCT04754945|Dexamethasone acetate|dexamethasone acetate|mesh-list
102293688|NCT04754945|Cyclophosphamide|cyclophosphamide|mesh-list
102293689|NCT04754945|Bortezomib|bortezomib|mesh-list
102293690|NCT04754945|Ichthammol|ichthammol|mesh-list
102293691|NCT04754945|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102293692|NCT04754945|BB 1101|bb 1101|mesh-list
102293693|NCT04754945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102293694|NCT04754945|Immunologic Factors|immunologic factors|mesh-ancestor
102293695|NCT04754945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293696|NCT04754945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102293697|NCT04754945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102293698|NCT04754945|Alkylating Agents|alkylating agents|mesh-ancestor
102293699|NCT04754945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293700|NCT04754945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293701|NCT04754945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102293702|NCT04754945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102293703|NCT04754945|Antiemetics|antiemetics|mesh-ancestor
102293704|NCT04754945|Autonomic Agents|autonomic agents|mesh-ancestor
102293705|NCT04754945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102293706|NCT04754945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102293707|NCT04754945|Glucocorticoids|glucocorticoids|mesh-ancestor
102293708|NCT04754945|Hormones|hormones|mesh-ancestor
102293709|NCT04754945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102293710|NCT04754945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102293711|NCT04754945|Protease Inhibitors|protease inhibitors|mesh-ancestor
102293712|NCT04754945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102293713|NCT04754945|Dermatologic Agents|dermatologic agents|mesh-ancestor
102293714|NCT04640779|Salicylates|salicylates|mesh-list
102293715|NCT04640779|Choline|choline|mesh-list
102293716|NCT04640779|Lipotropic Agents|lipotropic agents|mesh-ancestor
102293717|NCT04640779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102293718|NCT04640779|Antimetabolites|antimetabolites|mesh-ancestor
102293719|NCT04640779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293720|NCT04640779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102293721|NCT04640779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102293722|NCT04640779|Nootropic Agents|nootropic agents|mesh-ancestor
102293723|NCT04640779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102293724|NCT04640779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102293725|NCT04640779|Analgesics|analgesics|mesh-ancestor
102293726|NCT04640779|Sensory System Agents|sensory system agents|mesh-ancestor
102293727|NCT04640779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102293728|NCT04640779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293729|NCT04640779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102293730|NCT04640779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102293731|NCT04640779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102293732|NCT04640779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102293733|NCT04582669|Triamcinolone|triamcinolone|mesh-list
102293734|NCT04582669|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102293735|NCT04582669|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102293736|NCT04582669|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102293737|NCT04582669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102293738|NCT04582669|Glucocorticoids|glucocorticoids|mesh-ancestor
102293739|NCT04582669|Hormones|hormones|mesh-ancestor
102293740|NCT04582669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102293741|NCT04582669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293742|NCT04582669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102293743|NCT04582669|Immunologic Factors|immunologic factors|mesh-ancestor
102293744|NCT04582669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102293745|NCT04582669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293746|NCT04580498|Paclitaxel|paclitaxel|mesh-list
102293747|NCT04580498|Carboplatin|carboplatin|mesh-list
102293748|NCT04580498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102293749|NCT04580498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293750|NCT04580498|Tubulin Modulators|tubulin modulators|mesh-ancestor
102293751|NCT04580498|Antimitotic Agents|antimitotic agents|mesh-ancestor
102293752|NCT04580498|Mitosis Modulators|mitosis modulators|mesh-ancestor
102293753|NCT04580498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293754|NCT04483414|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102293755|NCT04483414|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102293756|NCT04483414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293757|NCT04428385|Artemisinins|artemisinins|mesh-list
102293758|NCT04428385|Artemisinin|artemisinin|mesh-list
102293759|NCT04428385|Antimalarials|antimalarials|mesh-ancestor
102293760|NCT04428385|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102293761|NCT04428385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102293762|NCT04428385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102293763|NCT04074161|Liraglutide|liraglutide|mesh-list
102293764|NCT04074161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102293765|NCT04074161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293766|NCT04074161|Incretins|incretins|mesh-ancestor
102293767|NCT04074161|Hormones|hormones|mesh-ancestor
102293768|NCT04074161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102293769|NCT04046575|Paclitaxel|paclitaxel|mesh-list
102293770|NCT04046575|Carboplatin|carboplatin|mesh-list
102293771|NCT04046575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102293772|NCT04046575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293773|NCT04046575|Tubulin Modulators|tubulin modulators|mesh-ancestor
102293774|NCT04046575|Antimitotic Agents|antimitotic agents|mesh-ancestor
102293775|NCT04046575|Mitosis Modulators|mitosis modulators|mesh-ancestor
102293776|NCT04046575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293777|NCT03997903|Imatinib Mesylate|imatinib mesylate|mesh-list
102293778|NCT03997903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293779|NCT03997903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102293780|NCT03997903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102293781|NCT03997903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293782|NCT03982212|Glatiramer Acetate|glatiramer acetate|mesh-list
102293783|NCT03982212|(T,G)-A-L|(t,g)-a-l|mesh-list
102293784|NCT03982212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102293785|NCT03982212|Immunologic Factors|immunologic factors|mesh-ancestor
102293786|NCT03982212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293787|NCT03982212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102293788|NCT03982212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102293789|NCT03913559|Acetaminophen|acetaminophen|mesh-list
102293790|NCT03913559|Diphenhydramine|diphenhydramine|mesh-list
102293791|NCT03913559|Promethazine|promethazine|mesh-list
102293792|NCT03913559|Cytarabine|cytarabine|mesh-list
102293793|NCT03913559|Methylprednisolone|methylprednisolone|mesh-list
102293794|NCT03913559|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102293795|NCT03913559|Hydrocortisone|hydrocortisone|mesh-list
102293796|NCT03913559|Methotrexate|methotrexate|mesh-list
102293797|NCT03913559|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
102293798|NCT03913559|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102293799|NCT03913559|Abortifacient Agents|abortifacient agents|mesh-ancestor
102293800|NCT03913559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102293801|NCT03913559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293802|NCT03913559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102293803|NCT03913559|Antimetabolites|antimetabolites|mesh-ancestor
102293804|NCT03913559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293805|NCT03913559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293806|NCT03913559|Dermatologic Agents|dermatologic agents|mesh-ancestor
102293807|NCT03913559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102293808|NCT03913559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102293809|NCT03913559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102293810|NCT03913559|Immunologic Factors|immunologic factors|mesh-ancestor
102293811|NCT03913559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102293812|NCT03913559|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102293813|NCT03913559|Antiviral Agents|antiviral agents|mesh-ancestor
102293814|NCT03913559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102293815|NCT03913559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102293817|NCT03913559|Sensory System Agents|sensory system agents|mesh-ancestor
102293818|NCT03913559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102293819|NCT03913559|Antipyretics|antipyretics|mesh-ancestor
102293820|NCT03913559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102293821|NCT03913559|Antiemetics|antiemetics|mesh-ancestor
102293822|NCT03913559|Autonomic Agents|autonomic agents|mesh-ancestor
102293823|NCT03913559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102293824|NCT03913559|Glucocorticoids|glucocorticoids|mesh-ancestor
102293825|NCT03913559|Hormones|hormones|mesh-ancestor
102293826|NCT03913559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102293827|NCT03913559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102293828|NCT03913559|Protective Agents|protective agents|mesh-ancestor
102293829|NCT03913559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102293830|NCT03913559|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102293831|NCT03913559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102293832|NCT03913559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102293833|NCT03913559|Anesthetics, Local|anesthetics, local|mesh-ancestor
102293834|NCT03913559|Anesthetics|anesthetics|mesh-ancestor
102293835|NCT03913559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102293836|NCT03913559|Histamine Antagonists|histamine antagonists|mesh-ancestor
102293837|NCT03913559|Histamine Agents|histamine agents|mesh-ancestor
102293838|NCT03913559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102293839|NCT03913559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102293840|NCT03913559|Antipruritics|antipruritics|mesh-ancestor
102293841|NCT03913559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102293842|NCT03913559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102293843|NCT03913559|Immunotoxins|immunotoxins|mesh-ancestor
102293844|NCT03913559|Immunoconjugates|immunoconjugates|mesh-ancestor
102293845|NCT03843528|Azacitidine|azacitidine|mesh-list
102293846|NCT03843528|Vorinostat|vorinostat|mesh-list
102293847|NCT03843528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102293848|NCT03843528|Antimetabolites|antimetabolites|mesh-ancestor
102293849|NCT03843528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293850|NCT03843528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293851|NCT03843528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102293852|NCT03843528|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102293853|NCT03779789|Vortioxetine|vortioxetine|mesh-list
102293854|NCT03779789|Fluvoxamine|fluvoxamine|mesh-list
102293855|NCT03779789|Citalopram|citalopram|mesh-list
102293856|NCT03779789|Fluoxetine|fluoxetine|mesh-list
102293857|NCT03779789|Paroxetine|paroxetine|mesh-list
102293858|NCT03779789|Sertraline|sertraline|mesh-list
102293859|NCT03779789|Escitalopram|escitalopram|mesh-list
101394629|NCT02615184|Dexlansoprazole|dexlansoprazole|mesh-list
102293860|NCT03779789|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102293861|NCT03779789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102293862|NCT03779789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102293863|NCT03779789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293864|NCT03779789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102293865|NCT03779789|Serotonin Agents|serotonin agents|mesh-ancestor
102293866|NCT03779789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293867|NCT03779789|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102293868|NCT03779789|Antidepressive Agents|antidepressive agents|mesh-ancestor
102293869|NCT03779789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102293870|NCT03779789|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102293871|NCT03779789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102293872|NCT03779789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102293873|NCT03779789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102293874|NCT03779789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102293875|NCT03779789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102293876|NCT03779789|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102293877|NCT03779789|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102293878|NCT03779789|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102293879|NCT03779789|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102293880|NCT03779789|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102293881|NCT03779789|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102293882|NCT03733210|Panitumumab|panitumumab|mesh-list
102293883|NCT03733210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102293884|NCT03733210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293885|NCT03733132|Metformin|metformin|mesh-list
102293886|NCT03733132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102293887|NCT03733132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293888|NCT03667820|Osimertinib|osimertinib|mesh-list
102293889|NCT03667820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293890|NCT03667820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102293891|NCT03667820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102293892|NCT03667820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293893|NCT03654053|Simvastatin|simvastatin|mesh-list
102293894|NCT03654053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102293895|NCT03654053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102293896|NCT03654053|Antimetabolites|antimetabolites|mesh-ancestor
102293897|NCT03654053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293898|NCT03654053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102293899|NCT03654053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102293900|NCT03654053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102293901|NCT03627468|Bromides|bromides|mesh-list
102293902|NCT03627468|Anticonvulsants|anticonvulsants|mesh-ancestor
102293903|NCT03620019|Denosumab|denosumab|mesh-list
102293904|NCT03620019|Pembrolizumab|pembrolizumab|mesh-list
102293905|NCT03620019|Nivolumab|nivolumab|mesh-list
102293906|NCT03620019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102293907|NCT03620019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293908|NCT03620019|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102293909|NCT03620019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293910|NCT03620019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102293911|NCT03620019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293912|NCT03614949|Atezolizumab|atezolizumab|mesh-list
102293913|NCT03614949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102293914|NCT03614949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293915|NCT03614949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102293916|NCT03614949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293917|NCT03613116|Vitamin D|vitamin d|mesh-list
102293918|NCT03613116|Cholecalciferol|cholecalciferol|mesh-list
102293919|NCT03613116|Vitamins|vitamins|mesh-ancestor
102293920|NCT03613116|Micronutrients|micronutrients|mesh-ancestor
102293921|NCT03613116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293922|NCT03613116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102293923|NCT03613116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102293924|NCT03588039|Paclitaxel|paclitaxel|mesh-list
102293925|NCT03588039|Pembrolizumab|pembrolizumab|mesh-list
101394721|NCT02426125|Docetaxel|docetaxel|mesh-list
102293926|NCT03588039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102293927|NCT03588039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293928|NCT03588039|Tubulin Modulators|tubulin modulators|mesh-ancestor
102293929|NCT03588039|Antimitotic Agents|antimitotic agents|mesh-ancestor
102293930|NCT03588039|Mitosis Modulators|mitosis modulators|mesh-ancestor
102293931|NCT03588039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293932|NCT03588039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102293933|NCT03588039|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102293934|NCT03553004|Niraparib|niraparib|mesh-list
102293935|NCT03553004|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102293936|NCT03553004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102293937|NCT03553004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293938|NCT03553004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293939|NCT03516617|Obinutuzumab|obinutuzumab|mesh-list
102293940|NCT03516617|Acalabrutinib|acalabrutinib|mesh-list
102293941|NCT03516617|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102293942|NCT03516617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102293943|NCT03516617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293944|NCT03516617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102293945|NCT03516617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102293946|NCT03516617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293947|NCT03488667|Pembrolizumab|pembrolizumab|mesh-list
102293948|NCT03488667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102293949|NCT03488667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293950|NCT03488667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102293951|NCT03488667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293953|NCT03406247|Ipilimumab|ipilimumab|mesh-list
102293954|NCT03406247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102293955|NCT03406247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293956|NCT03406247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102293957|NCT03406247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293958|NCT03399175|Immunosuppressive Agents|immunosuppressive agents|mesh-list
102293959|NCT03399175|Immunologic Factors|immunologic factors|mesh-ancestor
102293960|NCT03399175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293961|NCT03317535|Anesthetics|anesthetics|mesh-list
102293962|NCT03317535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102293963|NCT03317535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293964|NCT03313206|Pembrolizumab|pembrolizumab|mesh-list
102293965|NCT03313206|Lenvatinib|lenvatinib|mesh-list
102293966|NCT03313206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102293967|NCT03313206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293968|NCT03313206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102293969|NCT03313206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293970|NCT03313206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102293971|NCT03313206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102293972|NCT03250377|Brivaracetam|brivaracetam|mesh-list
102293973|NCT03250377|Anticonvulsants|anticonvulsants|mesh-ancestor
102293974|NCT03066648|Azacitidine|azacitidine|mesh-list
102293975|NCT03066648|Decitabine|decitabine|mesh-list
102293976|NCT03066648|Spartalizumab|spartalizumab|mesh-list
102293977|NCT03066648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102293978|NCT03066648|Antimetabolites|antimetabolites|mesh-ancestor
102293979|NCT03066648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102293980|NCT03066648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102293981|NCT03066648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102293982|NCT03066648|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102293983|NCT03066648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102293984|NCT03052816|Hydromorphone|hydromorphone|mesh-list
102293985|NCT03052816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102293986|NCT03052816|Narcotics|narcotics|mesh-ancestor
102293987|NCT03052816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102293988|NCT03052816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102293989|NCT03052816|Analgesics|analgesics|mesh-ancestor
102293990|NCT03052816|Sensory System Agents|sensory system agents|mesh-ancestor
102293991|NCT03052816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102293992|NCT03005145|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102293993|NCT03005145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102293994|NCT03005145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102293995|NCT03005145|Antitubercular Agents|antitubercular agents|mesh-ancestor
102293996|NCT02955940|Capecitabine|capecitabine|mesh-list
102293997|NCT02955940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102293998|NCT02955940|Antimetabolites|antimetabolites|mesh-ancestor
102293999|NCT02955940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294000|NCT02955940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294001|NCT02883062|Paclitaxel|paclitaxel|mesh-list
102294002|NCT02883062|Carboplatin|carboplatin|mesh-list
102294003|NCT02883062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102294004|NCT02883062|Atezolizumab|atezolizumab|mesh-list
102294005|NCT02883062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102294006|NCT02883062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102294007|NCT02883062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294008|NCT02883062|Tubulin Modulators|tubulin modulators|mesh-ancestor
102294009|NCT02883062|Antimitotic Agents|antimitotic agents|mesh-ancestor
102294010|NCT02883062|Mitosis Modulators|mitosis modulators|mesh-ancestor
102294011|NCT02883062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294012|NCT02883062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102294013|NCT02883062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102294014|NCT02883062|Immunologic Factors|immunologic factors|mesh-ancestor
102294015|NCT02883062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294016|NCT02721732|Pembrolizumab|pembrolizumab|mesh-list
102294017|NCT02721732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102294018|NCT02721732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294019|NCT02721732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102294020|NCT02721732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294021|NCT02684058|Carboplatin|carboplatin|mesh-list
102294022|NCT02684058|Vincristine|vincristine|mesh-list
102294023|NCT02684058|Trametinib|trametinib|mesh-list
102294024|NCT02684058|Dabrafenib|dabrafenib|mesh-list
102294025|NCT02684058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294026|NCT02684058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102294027|NCT02684058|Tubulin Modulators|tubulin modulators|mesh-ancestor
102294028|NCT02684058|Antimitotic Agents|antimitotic agents|mesh-ancestor
102294029|NCT02684058|Mitosis Modulators|mitosis modulators|mesh-ancestor
102294030|NCT02684058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294031|NCT02684058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102294032|NCT02684058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102294034|NCT02393625|Ceritinib|ceritinib|mesh-list
102294035|NCT02393625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102294036|NCT02393625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294037|NCT02393625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102294038|NCT02393625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294039|NCT02393625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102294040|NCT02393625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102294041|NCT02294032|Immunosuppressive Agents|immunosuppressive agents|mesh-list
102294042|NCT02294032|Immunologic Factors|immunologic factors|mesh-ancestor
102294043|NCT02294032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294044|NCT02168829|Aspirin|aspirin|mesh-list
102294045|NCT02168829|Rivaroxaban|rivaroxaban|mesh-list
102294046|NCT02168829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102294047|NCT02168829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102294048|NCT02168829|Analgesics|analgesics|mesh-ancestor
102294049|NCT02168829|Sensory System Agents|sensory system agents|mesh-ancestor
102294050|NCT02168829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102294051|NCT02168829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294052|NCT02168829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102294053|NCT02168829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102294054|NCT02168829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102294055|NCT02168829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102294056|NCT02168829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294057|NCT02168829|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102294058|NCT02168829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102294059|NCT02168829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102294060|NCT02168829|Antipyretics|antipyretics|mesh-ancestor
102294061|NCT02168829|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102294062|NCT02168829|Antithrombins|antithrombins|mesh-ancestor
102294063|NCT02168829|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102294064|NCT02168829|Protease Inhibitors|protease inhibitors|mesh-ancestor
102294065|NCT02168829|Anticoagulants|anticoagulants|mesh-ancestor
102294066|NCT01433289|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
102294067|NCT01433289|Antioxidants|antioxidants|mesh-ancestor
102294068|NCT01433289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294069|NCT01433289|Protective Agents|protective agents|mesh-ancestor
102294070|NCT01433289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294071|NCT01433289|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
102002781|NCT01178021|Primaquine|primaquine|mesh-list
102294072|NCT01433289|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102294073|NCT01433289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294074|NCT01433289|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102294075|NCT00995475|Fluticasone|fluticasone|mesh-list
102294077|NCT00995475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102294078|NCT00995475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102294079|NCT00995475|Autonomic Agents|autonomic agents|mesh-ancestor
102294080|NCT00995475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102294081|NCT00995475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294082|NCT00995475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102294083|NCT00995475|Respiratory System Agents|respiratory system agents|mesh-ancestor
102294084|NCT00995475|Dermatologic Agents|dermatologic agents|mesh-ancestor
102294085|NCT00995475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102294086|NCT00945529|Nitric Oxide|nitric oxide|mesh-list
102294087|NCT00945529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102294088|NCT00945529|Autonomic Agents|autonomic agents|mesh-ancestor
102294089|NCT00945529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102294090|NCT00945529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294091|NCT00945529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102294092|NCT00945529|Respiratory System Agents|respiratory system agents|mesh-ancestor
102294093|NCT00945529|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102294094|NCT00945529|Antioxidants|antioxidants|mesh-ancestor
102294095|NCT00945529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294096|NCT00945529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102294097|NCT00945529|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102294098|NCT00945529|Vasodilator Agents|vasodilator agents|mesh-ancestor
102294099|NCT00945529|Gasotransmitters|gasotransmitters|mesh-ancestor
102294100|NCT00945529|Protective Agents|protective agents|mesh-ancestor
101635831|NCT02674737|Tramadol|tramadol|mesh-list
102294101|NCT00921115|Fulvestrant|fulvestrant|mesh-list
102294102|NCT00921115|Anastrozole|anastrozole|mesh-list
102294103|NCT00921115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102294104|NCT00921115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294105|NCT00921115|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102294106|NCT00921115|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102294107|NCT00921115|Hormone Antagonists|hormone antagonists|mesh-ancestor
102294108|NCT00921115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102294109|NCT00921115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294110|NCT00921115|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102294111|NCT00921115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102294112|NCT00921115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102294113|NCT00921115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294114|NCT00130351|Formoterol Fumarate|formoterol fumarate|mesh-list
102294115|NCT00130351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102294116|NCT00130351|Autonomic Agents|autonomic agents|mesh-ancestor
102294117|NCT00130351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102294118|NCT00130351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294119|NCT00130351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102294120|NCT00130351|Respiratory System Agents|respiratory system agents|mesh-ancestor
102294121|NCT00130351|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102294122|NCT00130351|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102294123|NCT00130351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102294124|NCT00130351|Adrenergic Agents|adrenergic agents|mesh-ancestor
102294125|NCT00130351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102294126|NCT00130351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294127|NCT04028401|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102294128|NCT04028401|Dermatologic Agents|dermatologic agents|mesh-ancestor
102294129|NCT04425187|Bevacizumab|bevacizumab|mesh-list
102294130|NCT04425187|Gefitinib|gefitinib|mesh-list
102294131|NCT04425187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102294132|NCT04425187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294133|NCT04425187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102294134|NCT04425187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102294135|NCT04425187|Growth Substances|growth substances|mesh-ancestor
102294136|NCT04425187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294137|NCT04425187|Growth Inhibitors|growth inhibitors|mesh-ancestor
102294138|NCT04425187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102294139|NCT04425187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102294140|NCT04425187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294141|NCT05519839|Vaccines|vaccines|mesh-list
102294142|NCT05519839|Immunologic Factors|immunologic factors|mesh-ancestor
102294143|NCT05519839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294144|NCT05529667|Paclitaxel|paclitaxel|mesh-list
102294145|NCT05529667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102294146|NCT05529667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294147|NCT05529667|Tubulin Modulators|tubulin modulators|mesh-ancestor
102294148|NCT05529667|Antimitotic Agents|antimitotic agents|mesh-ancestor
102294149|NCT05529667|Mitosis Modulators|mitosis modulators|mesh-ancestor
102294150|NCT05529667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294152|NCT03571633|Trastuzumab|trastuzumab|mesh-list
102294153|NCT03571633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102294154|NCT03571633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294155|NCT03571633|Tubulin Modulators|tubulin modulators|mesh-ancestor
102294156|NCT03571633|Antimitotic Agents|antimitotic agents|mesh-ancestor
102294157|NCT03571633|Mitosis Modulators|mitosis modulators|mesh-ancestor
102294158|NCT03571633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294159|NCT03571633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102294160|NCT03519685|Contraceptive Agents|contraceptive agents|mesh-list
102294161|NCT03519685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102294162|NCT03519685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294163|NCT05533255|Z 350|z 350|mesh-list
102294164|NCT05533255|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102294165|NCT05533255|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102294166|NCT05533255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102294167|NCT05533255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294168|NCT05533255|Hormone Antagonists|hormone antagonists|mesh-ancestor
102294169|NCT05533255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102294170|NCT05533255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294171|NCT05529355|Tegafur|tegafur|mesh-list
102294172|NCT05529355|Endostar protein|endostar protein|mesh-list
102294173|NCT05529355|Endostatins|endostatins|mesh-list
102294174|NCT05529355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102294175|NCT05529355|Antimetabolites|antimetabolites|mesh-ancestor
102294176|NCT05529355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294177|NCT05529355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294178|NCT05529355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102294179|NCT05529355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102294180|NCT05529355|Growth Substances|growth substances|mesh-ancestor
102294181|NCT05529355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294182|NCT05529355|Growth Inhibitors|growth inhibitors|mesh-ancestor
102294183|NCT05528887|Cyclophosphamide|cyclophosphamide|mesh-list
102294184|NCT05528887|Fludarabine|fludarabine|mesh-list
102294185|NCT05528887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102294186|NCT05528887|Immunologic Factors|immunologic factors|mesh-ancestor
102294187|NCT05528887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294188|NCT05528887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102294189|NCT05528887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102294190|NCT05528887|Alkylating Agents|alkylating agents|mesh-ancestor
102294191|NCT05528887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294192|NCT05528887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294193|NCT05528887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102294194|NCT05501821|Pembrolizumab|pembrolizumab|mesh-list
102294195|NCT05501821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102294196|NCT05501821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294197|NCT05501821|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102294198|NCT05501821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294199|NCT05528653|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
102294200|NCT05528653|Antiviral Agents|antiviral agents|mesh-ancestor
102294201|NCT05528653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102294202|NCT05528653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102294203|NCT05528653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102294204|NCT05528653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102294205|NCT05528653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294206|NCT05528653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102294207|NCT05528653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102294209|NCT03009019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102294210|NCT03009019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102294211|NCT03009019|Analgesics|analgesics|mesh-ancestor
102294212|NCT03009019|Sensory System Agents|sensory system agents|mesh-ancestor
102294213|NCT03009019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102294214|NCT03009019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294215|NCT03009019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102294216|NCT03009019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102294217|NCT03009019|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102294218|NCT03009019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102294219|NCT03009019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102294220|NCT03009019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294221|NCT02575807|Pembrolizumab|pembrolizumab|mesh-list
102294222|NCT02575807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102294223|NCT02575807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294224|NCT02575807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102294225|NCT02575807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294226|NCT02813785|Docetaxel|docetaxel|mesh-list
102294227|NCT02813785|Atezolizumab|atezolizumab|mesh-list
102294228|NCT02813785|Antibodies|antibodies|mesh-list
102294229|NCT02813785|Immunologic Factors|immunologic factors|mesh-ancestor
102294230|NCT02813785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294231|NCT02813785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294232|NCT02813785|Tubulin Modulators|tubulin modulators|mesh-ancestor
102294233|NCT02813785|Antimitotic Agents|antimitotic agents|mesh-ancestor
102294234|NCT02813785|Mitosis Modulators|mitosis modulators|mesh-ancestor
102294235|NCT02813785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294236|NCT02813785|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102294237|NCT02813785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102294238|NCT04302181|Ropivacaine|ropivacaine|mesh-list
102294239|NCT04302181|Anesthetics, Local|anesthetics, local|mesh-ancestor
102294240|NCT04302181|Anesthetics|anesthetics|mesh-ancestor
102294241|NCT04302181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102294242|NCT04302181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294243|NCT04302181|Sensory System Agents|sensory system agents|mesh-ancestor
102294244|NCT04302181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102294249|NCT02644369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294250|NCT05527795|Oxymetazoline|oxymetazoline|mesh-list
102294251|NCT05527795|Immunomodulating Agents|immunomodulating agents|mesh-list
102294252|NCT05527795|Immunologic Factors|immunologic factors|mesh-ancestor
102294253|NCT05527795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294254|NCT05527795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102294255|NCT05527795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102294256|NCT05527795|Adrenergic Agents|adrenergic agents|mesh-ancestor
102294257|NCT05527795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102294258|NCT05527795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294259|NCT05527795|Sympathomimetics|sympathomimetics|mesh-ancestor
102294260|NCT05527795|Autonomic Agents|autonomic agents|mesh-ancestor
102294261|NCT05527795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102294262|NCT05527795|Nasal Decongestants|nasal decongestants|mesh-ancestor
102294263|NCT05527795|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102294264|NCT05527795|Respiratory System Agents|respiratory system agents|mesh-ancestor
102294265|NCT05532241|Chlorhexidine|chlorhexidine|mesh-list
102294266|NCT05532241|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102294267|NCT05532241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102294268|NCT05532241|Disinfectants|disinfectants|mesh-ancestor
102294269|NCT02431897|Estrogens|estrogens|mesh-list
102294270|NCT02431897|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
102294271|NCT02431897|Hormones|hormones|mesh-ancestor
102294272|NCT02431897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102294273|NCT02431897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294274|NCT05532085|Analgesics|analgesics|mesh-list
102294275|NCT05532085|Anesthetics|anesthetics|mesh-list
102294276|NCT05532085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102294277|NCT05532085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294278|NCT05532085|Sensory System Agents|sensory system agents|mesh-ancestor
102294279|NCT05532085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102294280|NCT02303119|Rituximab|rituximab|mesh-list
102294281|NCT02303119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102294282|NCT02303119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294283|NCT02303119|Immunologic Factors|immunologic factors|mesh-ancestor
102294284|NCT02303119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294285|NCT02303119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102294286|NCT02575339|Sorafenib|sorafenib|mesh-list
102294287|NCT02575339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294288|NCT02575339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102294289|NCT02575339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102003004|NCT03207243|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102294290|NCT02575339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294291|NCT01640587|Artesunate|artesunate|mesh-list
102294292|NCT01640587|Piperaquine|piperaquine|mesh-list
102294293|NCT01640587|Artenimol|artenimol|mesh-list
102294294|NCT01640587|Mefloquine|mefloquine|mesh-list
102294295|NCT01640587|Antimalarials|antimalarials|mesh-ancestor
102294296|NCT01640587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102294297|NCT01640587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102294298|NCT01640587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102294299|NCT01640587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294300|NCT01640587|Antiviral Agents|antiviral agents|mesh-ancestor
102294301|NCT01640587|Schistosomicides|schistosomicides|mesh-ancestor
102294302|NCT01640587|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102294303|NCT01640587|Anthelmintics|anthelmintics|mesh-ancestor
102294304|NCT01610713|Nabiximols|nabiximols|mesh-list
102294305|NCT01610713|Analgesics|analgesics|mesh-ancestor
102294306|NCT01610713|Sensory System Agents|sensory system agents|mesh-ancestor
102294307|NCT01610713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102294308|NCT01610713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294309|NCT01606189|Nabiximols|nabiximols|mesh-list
102294310|NCT01606189|Analgesics|analgesics|mesh-ancestor
102294311|NCT01606189|Sensory System Agents|sensory system agents|mesh-ancestor
102294312|NCT01606189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102294313|NCT01606189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294318|NCT01663987|Bromides|bromides|mesh-list
102294319|NCT01663987|Tiotropium Bromide|tiotropium bromide|mesh-list
102294320|NCT01663987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102294321|NCT01663987|Autonomic Agents|autonomic agents|mesh-ancestor
102294322|NCT01663987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102294323|NCT01663987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294324|NCT01663987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102294325|NCT01663987|Respiratory System Agents|respiratory system agents|mesh-ancestor
102294326|NCT01663987|Parasympatholytics|parasympatholytics|mesh-ancestor
102294327|NCT01663987|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102294328|NCT01663987|Cholinergic Agents|cholinergic agents|mesh-ancestor
102294329|NCT01663987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102294330|NCT01663987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294331|NCT01663987|Anticonvulsants|anticonvulsants|mesh-ancestor
102294332|NCT05305651|Sotrovimab|sotrovimab|mesh-list
102294333|NCT05305651|Antiviral Agents|antiviral agents|mesh-ancestor
102294334|NCT05305651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102294335|NCT05526469|Bupivacaine|bupivacaine|mesh-list
102294336|NCT05526469|Anesthetics, Local|anesthetics, local|mesh-ancestor
102294337|NCT05526469|Anesthetics|anesthetics|mesh-ancestor
102294338|NCT05526469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102294339|NCT05526469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294340|NCT05526469|Sensory System Agents|sensory system agents|mesh-ancestor
102294341|NCT05526469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102294342|NCT05155033|Aldesleukin|aldesleukin|mesh-list
102294343|NCT05155033|Pembrolizumab|pembrolizumab|mesh-list
102294344|NCT05155033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102294345|NCT05155033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294346|NCT05155033|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102294347|NCT05155033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294348|NCT05155033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102294349|NCT05155033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102294350|NCT05155033|Antiviral Agents|antiviral agents|mesh-ancestor
102294351|NCT05155033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102294352|NCT02380287|Antibodies|antibodies|mesh-list
102294353|NCT02380287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101395180|NCT00871013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102294354|NCT02380287|Immunologic Factors|immunologic factors|mesh-ancestor
102294355|NCT02380287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294356|NCT02342223|Hyaluronic Acid|hyaluronic acid|mesh-list
102294357|NCT02342223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102294358|NCT02342223|Immunologic Factors|immunologic factors|mesh-ancestor
102294359|NCT02342223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294360|NCT02342223|Viscosupplements|viscosupplements|mesh-ancestor
102294361|NCT02342223|Protective Agents|protective agents|mesh-ancestor
102294362|NCT02393547|Varenicline|varenicline|mesh-list
102294363|NCT02393547|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102294364|NCT02393547|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102294365|NCT02393547|Cholinergic Agents|cholinergic agents|mesh-ancestor
102294366|NCT02393547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102294367|NCT02393547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294368|NCT02393547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294369|NCT02574637|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102294370|NCT02574637|Immunologic Factors|immunologic factors|mesh-ancestor
102294371|NCT02574637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294372|NCT05531383|Memantine|memantine|mesh-list
102294373|NCT05531383|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102294374|NCT05531383|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102294375|NCT05531383|Dopamine Agents|dopamine agents|mesh-ancestor
102294376|NCT05531383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102294377|NCT05531383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294378|NCT05531383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294379|NCT05531383|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102294380|NCT05531383|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102294381|NCT02392611|Fulvestrant|fulvestrant|mesh-list
102294382|NCT02392611|Exemestane|exemestane|mesh-list
102294383|NCT02392611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102294384|NCT02392611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294385|NCT02392611|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102294386|NCT02392611|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102294387|NCT02392611|Hormone Antagonists|hormone antagonists|mesh-ancestor
102294388|NCT02392611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102294389|NCT02392611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294390|NCT02392611|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102294391|NCT02392611|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102294392|NCT02392611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102294393|NCT02392611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294394|NCT02378961|Sofosbuvir|sofosbuvir|mesh-list
102294395|NCT02378961|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102294397|NCT02378961|Antiviral Agents|antiviral agents|mesh-ancestor
102294398|NCT02378961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102294399|NCT05140525|Macitentan|macitentan|mesh-list
102294400|NCT05140525|Riociguat|riociguat|mesh-list
102294401|NCT05140525|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
102294402|NCT05140525|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102294403|NCT05140525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294404|NCT05140525|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
102294405|NCT05140525|Enzyme Activators|enzyme activators|mesh-ancestor
102294406|NCT05518513|Bupivacaine|bupivacaine|mesh-list
102294407|NCT05518513|Anesthetics, Local|anesthetics, local|mesh-ancestor
102294408|NCT05518513|Anesthetics|anesthetics|mesh-ancestor
102294409|NCT05518513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102294410|NCT05518513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294411|NCT05518513|Sensory System Agents|sensory system agents|mesh-ancestor
102294412|NCT05518513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102294413|NCT05518279|Tranexamic Acid|tranexamic acid|mesh-list
102294414|NCT05518279|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102294415|NCT05518279|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102294416|NCT05518279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294417|NCT05518279|Hemostatics|hemostatics|mesh-ancestor
102294418|NCT05518279|Coagulants|coagulants|mesh-ancestor
102294419|NCT05523661|Dasatinib|dasatinib|mesh-list
102294420|NCT05523661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294421|NCT05523661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102294422|NCT05523661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102294423|NCT05523661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294424|NCT05523037|Sevoflurane|sevoflurane|mesh-list
102294425|NCT05523037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102294426|NCT05523037|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102294427|NCT05523037|Anesthetics, General|anesthetics, general|mesh-ancestor
102294428|NCT05523037|Anesthetics|anesthetics|mesh-ancestor
102294429|NCT05523037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102294430|NCT05523037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294431|NCT04625647|Sotorasib|sotorasib|mesh-list
102294432|NCT04625647|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102294433|NCT04625647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294434|NCT04625647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102294435|NCT04625647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294436|NCT05122741|Aspirin|aspirin|mesh-list
102294437|NCT05122741|Clopidogrel|clopidogrel|mesh-list
102294438|NCT05122741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102294439|NCT05122741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102294440|NCT05122741|Analgesics|analgesics|mesh-ancestor
102294441|NCT05122741|Sensory System Agents|sensory system agents|mesh-ancestor
102294442|NCT05122741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102294443|NCT05122741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294444|NCT05122741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102294445|NCT05122741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102294446|NCT05122741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102294447|NCT05122741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102294448|NCT05122741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294449|NCT05122741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102294450|NCT05122741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102294451|NCT05122741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102294452|NCT05122741|Antipyretics|antipyretics|mesh-ancestor
102294453|NCT05122741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102294454|NCT05122741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102294455|NCT05122741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102294456|NCT05122741|Purinergic Agents|purinergic agents|mesh-ancestor
102294457|NCT05122741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102294458|NCT05525767|Bevacizumab|bevacizumab|mesh-list
102294459|NCT05525767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102294460|NCT05525767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294461|NCT05525767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102294462|NCT05525767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102294463|NCT05525767|Growth Substances|growth substances|mesh-ancestor
102294464|NCT05525767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294465|NCT05525767|Growth Inhibitors|growth inhibitors|mesh-ancestor
102294466|NCT05025085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102294467|NCT05025085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294468|NCT05025085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102294469|NCT05025085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294471|NCT05522491|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102294472|NCT05522491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102294473|NCT05522491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294474|NCT05522491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294475|NCT02340975|Durvalumab|durvalumab|mesh-list
102294476|NCT02340975|Tremelimumab|tremelimumab|mesh-list
102294477|NCT02340975|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102294478|NCT02340975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102294479|NCT02340975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294480|NCT02340975|Immunologic Factors|immunologic factors|mesh-ancestor
102294481|NCT02340975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294482|NCT02392377|Leucovorin|leucovorin|mesh-list
102294483|NCT02392377|Paclitaxel|paclitaxel|mesh-list
102294484|NCT02392377|Carboplatin|carboplatin|mesh-list
102294485|NCT02392377|Fluorouracil|fluorouracil|mesh-list
102294486|NCT02392377|Oxaliplatin|oxaliplatin|mesh-list
102294487|NCT02392377|Calcium|calcium|mesh-list
102294488|NCT02392377|Levoleucovorin|levoleucovorin|mesh-list
102294489|NCT02392377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102294490|NCT02392377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294491|NCT02392377|Tubulin Modulators|tubulin modulators|mesh-ancestor
102294492|NCT02392377|Antimitotic Agents|antimitotic agents|mesh-ancestor
102294493|NCT02392377|Mitosis Modulators|mitosis modulators|mesh-ancestor
102294494|NCT02392377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294495|NCT02392377|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102294496|NCT02392377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294497|NCT02392377|Antimetabolites|antimetabolites|mesh-ancestor
102294498|NCT02392377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102294499|NCT02392377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102294500|NCT02392377|Immunologic Factors|immunologic factors|mesh-ancestor
102294501|NCT02392377|Antidotes|antidotes|mesh-ancestor
102294502|NCT02392377|Protective Agents|protective agents|mesh-ancestor
102294503|NCT02392377|Vitamin B Complex|vitamin b complex|mesh-ancestor
102294504|NCT02392377|Vitamins|vitamins|mesh-ancestor
102294505|NCT02392377|Micronutrients|micronutrients|mesh-ancestor
102294506|NCT02340819|Teduglutide|teduglutide|mesh-list
102294507|NCT02340819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102294508|NCT02340819|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102294509|NCT02340819|Protective Agents|protective agents|mesh-ancestor
102294510|NCT02340819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294511|NCT04903899|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102294512|NCT04903899|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102294513|NCT04903899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294514|NCT04903509|Acetaminophen|acetaminophen|mesh-list
102294515|NCT04903509|Liraglutide|liraglutide|mesh-list
102294516|NCT04903509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102294517|NCT04903509|Analgesics|analgesics|mesh-ancestor
102294518|NCT04903509|Sensory System Agents|sensory system agents|mesh-ancestor
102294520|NCT04903509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294521|NCT04903509|Antipyretics|antipyretics|mesh-ancestor
102294522|NCT04903509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102294523|NCT04903509|Incretins|incretins|mesh-ancestor
102294524|NCT04903509|Hormones|hormones|mesh-ancestor
102294525|NCT04903509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102294526|NCT05517499|Dexamethasone|dexamethasone|mesh-list
102294527|NCT05517499|Dexamethasone acetate|dexamethasone acetate|mesh-list
102294528|NCT05517499|BB 1101|bb 1101|mesh-list
102294529|NCT05517499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102294530|NCT05517499|Antiemetics|antiemetics|mesh-ancestor
102294531|NCT05517499|Autonomic Agents|autonomic agents|mesh-ancestor
102294532|NCT05517499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102294533|NCT05517499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294534|NCT05517499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102294535|NCT05517499|Glucocorticoids|glucocorticoids|mesh-ancestor
102294536|NCT05517499|Hormones|hormones|mesh-ancestor
102294537|NCT05517499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102294538|NCT05517499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102294539|NCT05517499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294540|NCT05517499|Protease Inhibitors|protease inhibitors|mesh-ancestor
102294541|NCT05517499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102294542|NCT05517499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294543|NCT05512351|Bevacizumab|bevacizumab|mesh-list
102294544|NCT05512351|Tislelizumab|tislelizumab|mesh-list
102294545|NCT05512351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102294546|NCT05512351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294547|NCT05512351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102294548|NCT05512351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102294549|NCT05512351|Growth Substances|growth substances|mesh-ancestor
102294550|NCT05512351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294551|NCT05512351|Growth Inhibitors|growth inhibitors|mesh-ancestor
102294552|NCT02569957|Acetylcysteine|acetylcysteine|mesh-list
102294553|NCT02569957|Topotecan|topotecan|mesh-list
102294554|NCT02569957|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102294555|NCT02569957|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102294556|NCT02569957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102294557|NCT02569957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101395326|NCT00002889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294558|NCT02569957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294559|NCT02569957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294560|NCT02569957|Antiviral Agents|antiviral agents|mesh-ancestor
102294561|NCT02569957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102294562|NCT02569957|Expectorants|expectorants|mesh-ancestor
102294563|NCT02569957|Respiratory System Agents|respiratory system agents|mesh-ancestor
102294564|NCT02569957|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102294565|NCT02569957|Antioxidants|antioxidants|mesh-ancestor
102294566|NCT02569957|Protective Agents|protective agents|mesh-ancestor
102294567|NCT02569957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294568|NCT02569957|Antidotes|antidotes|mesh-ancestor
102294569|NCT01649427|Tacrolimus|tacrolimus|mesh-list
102294570|NCT01649427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102294571|NCT01649427|Immunologic Factors|immunologic factors|mesh-ancestor
102294572|NCT01649427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294573|NCT01649427|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102294574|NCT01649427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102294575|NCT01649427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294576|NCT05521633|Metformin|metformin|mesh-list
102294577|NCT05521633|Pioglitazone|pioglitazone|mesh-list
102294578|NCT05521633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102294579|NCT05521633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294580|NCT02336607|Metoprolol|metoprolol|mesh-list
102294581|NCT02336607|Felodipine|felodipine|mesh-list
102294582|NCT02336607|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102294583|NCT02336607|Lisinopril|lisinopril|mesh-list
102294584|NCT02336607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102294585|NCT02336607|Diuretics|diuretics|mesh-ancestor
102294586|NCT02336607|Natriuretic Agents|natriuretic agents|mesh-ancestor
102294587|NCT02336607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294588|NCT02336607|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102294589|NCT02336607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102294590|NCT02336607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294591|NCT02336607|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102294592|NCT02336607|Sympatholytics|sympatholytics|mesh-ancestor
102294593|NCT02336607|Autonomic Agents|autonomic agents|mesh-ancestor
102294594|NCT02336607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102294595|NCT02336607|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102294596|NCT02336607|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102294597|NCT02336607|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102294598|NCT02336607|Adrenergic Agents|adrenergic agents|mesh-ancestor
102294599|NCT02336607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102294600|NCT02336607|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102294601|NCT02336607|Protease Inhibitors|protease inhibitors|mesh-ancestor
102294602|NCT02336607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102294603|NCT02336607|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102294604|NCT02336607|Protective Agents|protective agents|mesh-ancestor
102294605|NCT02336607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102294606|NCT02336607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102294607|NCT02336607|Vasodilator Agents|vasodilator agents|mesh-ancestor
102294609|NCT02569801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102294610|NCT02569801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294611|NCT02569801|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102294612|NCT02569801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102294613|NCT02569801|Hormone Antagonists|hormone antagonists|mesh-ancestor
102294614|NCT02569801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102294615|NCT02569801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294616|NCT02573311|Tamsulosin|tamsulosin|mesh-list
102294617|NCT02573311|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102294618|NCT02573311|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102294619|NCT02573311|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102294620|NCT02573311|Adrenergic Agents|adrenergic agents|mesh-ancestor
102294621|NCT02573311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102294622|NCT02573311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294623|NCT02573311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294624|NCT02573311|Urological Agents|urological agents|mesh-ancestor
102294625|NCT05520853|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101395399|NCT00425152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294626|NCT05520853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294627|NCT05520853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102294628|NCT05520853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294629|NCT05516251|Topiramate|topiramate|mesh-list
102294630|NCT05516251|Anticonvulsants|anticonvulsants|mesh-ancestor
102294631|NCT05516251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102294632|NCT05516251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294633|NCT05086393|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102294634|NCT05086393|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102294635|NCT05086393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102294636|NCT05086393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102294637|NCT05086393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294638|NCT05086393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102294639|NCT05086393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294640|NCT05086393|Analgesics|analgesics|mesh-ancestor
102294641|NCT05086393|Sensory System Agents|sensory system agents|mesh-ancestor
102294642|NCT05086393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102294643|NCT05086393|Antidepressive Agents|antidepressive agents|mesh-ancestor
102294644|NCT05086393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102294645|NCT05086393|Dopamine Agents|dopamine agents|mesh-ancestor
102294646|NCT02571049|Sumatriptan|sumatriptan|mesh-list
102294647|NCT02571049|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102294648|NCT02571049|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102294649|NCT02571049|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102294650|NCT02571049|Serotonin Agents|serotonin agents|mesh-ancestor
102294651|NCT02571049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102294652|NCT02571049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294653|NCT02571049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294654|NCT05515939|Insulin|insulin|mesh-list
102294655|NCT05515939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102294656|NCT05515939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294657|NCT04295941|Trazodone|trazodone|mesh-list
102294658|NCT04295941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102294659|NCT04295941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102294660|NCT04295941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102294661|NCT04295941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294662|NCT04295941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102294663|NCT04295941|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102294664|NCT04295941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102003384|NCT03362788|Vitamin K|vitamin k|mesh-list
102294665|NCT04295941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102294666|NCT04295941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294667|NCT04295941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102294668|NCT04295941|Serotonin Agents|serotonin agents|mesh-ancestor
102294669|NCT04295941|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102294670|NCT04295941|Antidepressive Agents|antidepressive agents|mesh-ancestor
102294671|NCT04294771|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102294672|NCT04294771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294673|NCT04294771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102294674|NCT04294771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294675|NCT02573155|Tiotropium Bromide|tiotropium bromide|mesh-list
102294676|NCT02573155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102294677|NCT02573155|Autonomic Agents|autonomic agents|mesh-ancestor
102294678|NCT02573155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102294679|NCT02573155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294680|NCT02573155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102294681|NCT02573155|Respiratory System Agents|respiratory system agents|mesh-ancestor
102294682|NCT02573155|Parasympatholytics|parasympatholytics|mesh-ancestor
102294683|NCT02573155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102294684|NCT02573155|Cholinergic Agents|cholinergic agents|mesh-ancestor
102294685|NCT02573155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102294686|NCT02573155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294687|NCT05515471|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102294688|NCT05515471|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102294689|NCT05515315|Paclitaxel|paclitaxel|mesh-list
101395469|NCT00314626|Lamivudine|lamivudine|mesh-list
102294690|NCT05515315|Tislelizumab|tislelizumab|mesh-list
102294691|NCT05515315|Nedaplatin|nedaplatin|mesh-list
102294692|NCT05515315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102294693|NCT05515315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294694|NCT05515315|Tubulin Modulators|tubulin modulators|mesh-ancestor
102294695|NCT05515315|Antimitotic Agents|antimitotic agents|mesh-ancestor
102294696|NCT05515315|Mitosis Modulators|mitosis modulators|mesh-ancestor
102294697|NCT05515315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294698|NCT05515315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102294699|NCT05519371|Propofol|propofol|mesh-list
102294700|NCT05519371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102294701|NCT05519371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102294702|NCT05519371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294703|NCT05519371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102294704|NCT05519371|Anesthetics, General|anesthetics, general|mesh-ancestor
102294705|NCT05519371|Anesthetics|anesthetics|mesh-ancestor
102294706|NCT04847947|Vitamin D|vitamin d|mesh-list
102294707|NCT04847947|Cholecalciferol|cholecalciferol|mesh-list
102294708|NCT04847947|Vitamins|vitamins|mesh-ancestor
102294709|NCT04847947|Micronutrients|micronutrients|mesh-ancestor
102294710|NCT04847947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294711|NCT04847947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102294712|NCT04847947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102294713|NCT05514925|Bevacizumab|bevacizumab|mesh-list
102294714|NCT05514925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102294715|NCT05514925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294716|NCT05514925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102294717|NCT05514925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102294718|NCT05514925|Growth Substances|growth substances|mesh-ancestor
102294719|NCT05514925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294720|NCT05514925|Growth Inhibitors|growth inhibitors|mesh-ancestor
102294721|NCT05514847|Aspirin|aspirin|mesh-list
102294722|NCT05514847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102294723|NCT05514847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102294724|NCT05514847|Analgesics|analgesics|mesh-ancestor
102294725|NCT05514847|Sensory System Agents|sensory system agents|mesh-ancestor
102294726|NCT05514847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102294727|NCT05514847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294728|NCT05514847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102294729|NCT05514847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102294730|NCT05514847|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102294731|NCT05514847|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102294732|NCT05514847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294733|NCT05514847|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102294734|NCT05514847|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102294735|NCT05514847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102294736|NCT05514847|Antipyretics|antipyretics|mesh-ancestor
102294737|NCT05510323|Prednisolone|prednisolone|mesh-list
102294738|NCT05510323|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102294740|NCT05510323|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102294741|NCT05510323|Prednisolone acetate|prednisolone acetate|mesh-list
102294742|NCT05510323|Cyclophosphamide|cyclophosphamide|mesh-list
102294743|NCT05510323|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102294744|NCT05510323|Prednisolone phosphate|prednisolone phosphate|mesh-list
102294745|NCT05510323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102294746|NCT05510323|Immunologic Factors|immunologic factors|mesh-ancestor
102294747|NCT05510323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294748|NCT05510323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102294749|NCT05510323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102294750|NCT05510323|Alkylating Agents|alkylating agents|mesh-ancestor
102294751|NCT05510323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294752|NCT05510323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294753|NCT05510323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102294754|NCT05510323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102294755|NCT05510323|Glucocorticoids|glucocorticoids|mesh-ancestor
102294756|NCT05510323|Hormones|hormones|mesh-ancestor
102294757|NCT05510323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102294758|NCT05510323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102294759|NCT05510323|Antiemetics|antiemetics|mesh-ancestor
102294760|NCT05510323|Autonomic Agents|autonomic agents|mesh-ancestor
102294761|NCT05510323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102294762|NCT05510323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102294763|NCT05510323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102294764|NCT05510323|Protective Agents|protective agents|mesh-ancestor
102294765|NCT04843579|Clarithromycin|clarithromycin|mesh-list
102294767|NCT04843579|Pomalidomide|pomalidomide|mesh-list
102294768|NCT04843579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102294769|NCT04843579|Antiemetics|antiemetics|mesh-ancestor
102294770|NCT04843579|Autonomic Agents|autonomic agents|mesh-ancestor
102294771|NCT04843579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102294772|NCT04843579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294773|NCT04843579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102294774|NCT04843579|Glucocorticoids|glucocorticoids|mesh-ancestor
102294775|NCT04843579|Hormones|hormones|mesh-ancestor
102294776|NCT04843579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102294777|NCT04843579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102294778|NCT04843579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294779|NCT04843579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102294780|NCT04843579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102294781|NCT04843579|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102294782|NCT04843579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102294783|NCT04843579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294784|NCT04843579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102294785|NCT04843579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102294786|NCT04843579|Immunologic Factors|immunologic factors|mesh-ancestor
102294787|NCT04843579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102294788|NCT04843579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102294789|NCT04843579|Growth Substances|growth substances|mesh-ancestor
102294790|NCT04843579|Growth Inhibitors|growth inhibitors|mesh-ancestor
102294791|NCT05507671|BCG Vaccine|bcg vaccine|mesh-list
102294792|NCT05507671|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102294793|NCT05507671|Immunologic Factors|immunologic factors|mesh-ancestor
102294794|NCT05507671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294795|NCT02568397|Dabigatran|dabigatran|mesh-list
102294796|NCT02568397|Antithrombins|antithrombins|mesh-ancestor
102294797|NCT02568397|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102294798|NCT02568397|Protease Inhibitors|protease inhibitors|mesh-ancestor
102294799|NCT02568397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102294800|NCT02568397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294801|NCT02568397|Anticoagulants|anticoagulants|mesh-ancestor
102294802|NCT04812379|Aripiprazole|aripiprazole|mesh-list
102294803|NCT04812379|Antidepressive Agents|antidepressive agents|mesh-ancestor
102294804|NCT04812379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102294805|NCT04812379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102294806|NCT04812379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102294807|NCT04812379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102294808|NCT04812379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294809|NCT04812379|Dopamine Agonists|dopamine agonists|mesh-ancestor
102294810|NCT04812379|Dopamine Agents|dopamine agents|mesh-ancestor
102294811|NCT04812379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102294812|NCT04812379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294813|NCT04812379|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102294814|NCT04812379|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102294815|NCT04812379|Serotonin Agents|serotonin agents|mesh-ancestor
102294816|NCT04812379|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102294817|NCT04812379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102294818|NCT04812379|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102294819|NCT04812379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102294820|NCT04757857|Rivaroxaban|rivaroxaban|mesh-list
102294821|NCT04757857|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102294822|NCT04757857|Antithrombins|antithrombins|mesh-ancestor
102294823|NCT04757857|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102294824|NCT04757857|Protease Inhibitors|protease inhibitors|mesh-ancestor
102294825|NCT04757857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102294826|NCT04757857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294827|NCT04757857|Anticoagulants|anticoagulants|mesh-ancestor
102294828|NCT04755283|Rivaroxaban|rivaroxaban|mesh-list
102294829|NCT04755283|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102294830|NCT04755283|Antithrombins|antithrombins|mesh-ancestor
102294831|NCT04755283|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102294832|NCT04755283|Protease Inhibitors|protease inhibitors|mesh-ancestor
102294833|NCT04755283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102294834|NCT04755283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294835|NCT04755283|Anticoagulants|anticoagulants|mesh-ancestor
102294836|NCT05506969|Vaccines|vaccines|mesh-list
102294837|NCT05506969|1018 oligonucleotide|1018 oligonucleotide|mesh-list
102294838|NCT05506969|Immunologic Factors|immunologic factors|mesh-ancestor
102294839|NCT05506969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636570|NCT02662647|Cytarabine|cytarabine|mesh-list
102294840|NCT05506969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102294842|NCT04291885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102294843|NCT04291885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294844|NCT05513209|Anesthetics|anesthetics|mesh-list
102294845|NCT05513209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102294846|NCT05513209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294847|NCT05513131|Azacitidine|azacitidine|mesh-list
102294848|NCT05513131|Venetoclax|venetoclax|mesh-list
102294849|NCT05513131|Homoharringtonine|homoharringtonine|mesh-list
102294850|NCT05513131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102294851|NCT05513131|Antimetabolites|antimetabolites|mesh-ancestor
102294852|NCT05513131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294853|NCT05513131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294854|NCT05513131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102294855|NCT05513131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102294856|NCT05513131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102294857|NCT05506501|Anesthetics|anesthetics|mesh-list
102294858|NCT05506501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102294859|NCT05506501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294860|NCT05502913|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102294861|NCT05502913|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102294862|NCT05502913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102294863|NCT05502913|Antitubercular Agents|antitubercular agents|mesh-ancestor
102294864|NCT05509153|Acetylcysteine|acetylcysteine|mesh-list
102294865|NCT05509153|Antiviral Agents|antiviral agents|mesh-ancestor
102294866|NCT05509153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102294867|NCT05509153|Expectorants|expectorants|mesh-ancestor
102294868|NCT05509153|Respiratory System Agents|respiratory system agents|mesh-ancestor
102294869|NCT05509153|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102294870|NCT05509153|Antioxidants|antioxidants|mesh-ancestor
102294871|NCT05509153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294872|NCT05509153|Protective Agents|protective agents|mesh-ancestor
102294873|NCT05509153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294874|NCT04735393|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102294875|NCT04735393|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102294876|NCT04584853|Tamoxifen|tamoxifen|mesh-list
102294877|NCT04584853|Letrozole|letrozole|mesh-list
102294878|NCT04584853|Anastrozole|anastrozole|mesh-list
102294879|NCT04584853|Exemestane|exemestane|mesh-list
102294880|NCT04584853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294881|NCT04584853|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102294882|NCT04584853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102294883|NCT04584853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102294884|NCT04584853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294885|NCT04584853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102003606|NCT03179787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102294886|NCT04584853|Hormone Antagonists|hormone antagonists|mesh-ancestor
102294887|NCT04584853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102294888|NCT04584853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294889|NCT04584853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102294890|NCT04584853|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102294891|NCT04584853|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102294892|NCT04584853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102294893|NCT05505877|Tislelizumab|tislelizumab|mesh-list
102294894|NCT05505877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102294895|NCT05505877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294896|NCT04712851|Pembrolizumab|pembrolizumab|mesh-list
102294897|NCT04712851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102294898|NCT04712851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294899|NCT04712851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102294900|NCT04712851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294901|NCT02336451|Ceritinib|ceritinib|mesh-list
102294902|NCT02336451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294903|NCT02336451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102294904|NCT02336451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102294905|NCT02336451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294906|NCT01648101|Ezogabine|ezogabine|mesh-list
102294907|NCT01648101|Anticonvulsants|anticonvulsants|mesh-ancestor
102294908|NCT01648101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102294909|NCT01648101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294910|NCT02336373|Hydroxyurea|hydroxyurea|mesh-list
102294911|NCT02336373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101636647|NCT00649077|Meloxicam|meloxicam|mesh-list
102294912|NCT02336373|Antisickling Agents|antisickling agents|mesh-ancestor
102294913|NCT02336373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102294914|NCT02336373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294915|NCT02336373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102294916|NCT02372799|Fluoxetine|fluoxetine|mesh-list
102294917|NCT02372799|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
102294918|NCT02372799|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102294919|NCT02372799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102294920|NCT02372799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102294921|NCT02372799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294922|NCT02372799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102294923|NCT02372799|Serotonin Agents|serotonin agents|mesh-ancestor
102294924|NCT02372799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294925|NCT02372799|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102294926|NCT02372799|Antidepressive Agents|antidepressive agents|mesh-ancestor
102294927|NCT02372799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102294928|NCT02372799|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102294929|NCT02372799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102294930|NCT02372799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102294931|NCT02372799|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102294932|NCT02372799|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102294933|NCT02566993|Cyclophosphamide|cyclophosphamide|mesh-list
102294934|NCT02566993|Doxorubicin|doxorubicin|mesh-list
102294935|NCT02566993|Vincristine|vincristine|mesh-list
102294936|NCT02566993|Topotecan|topotecan|mesh-list
102294937|NCT02566993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102294938|NCT02566993|Immunologic Factors|immunologic factors|mesh-ancestor
102294939|NCT02566993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294940|NCT02566993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102294941|NCT02566993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102294942|NCT02566993|Alkylating Agents|alkylating agents|mesh-ancestor
102294943|NCT02566993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294944|NCT02566993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102294945|NCT02566993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102294946|NCT02566993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102294947|NCT02566993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102294948|NCT02566993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102294949|NCT02566993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102294950|NCT02566993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102294951|NCT02566993|Tubulin Modulators|tubulin modulators|mesh-ancestor
102294952|NCT02566993|Antimitotic Agents|antimitotic agents|mesh-ancestor
102294953|NCT02566993|Mitosis Modulators|mitosis modulators|mesh-ancestor
102294954|NCT02566993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102294955|NCT02311881|Acetaminophen|acetaminophen|mesh-list
102294956|NCT02311881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102294957|NCT02311881|Analgesics|analgesics|mesh-ancestor
102294958|NCT02311881|Sensory System Agents|sensory system agents|mesh-ancestor
102294959|NCT02311881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102294960|NCT02311881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294961|NCT02311881|Antipyretics|antipyretics|mesh-ancestor
102294962|NCT02565511|Umibecestat|umibecestat|mesh-list
102294963|NCT02565511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102294964|NCT02565511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294965|NCT04549051|Anesthetics|anesthetics|mesh-list
102294966|NCT04549051|Anesthetics, Local|anesthetics, local|mesh-list
102294967|NCT04549051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102294968|NCT04549051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294969|NCT04549051|Sensory System Agents|sensory system agents|mesh-ancestor
102294970|NCT04549051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102294971|NCT05505253|Alfacalcidol|alfacalcidol|mesh-list
102294972|NCT05505253|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
102294973|NCT05505253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102294974|NCT05505253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294975|NCT05505253|Vitamins|vitamins|mesh-ancestor
102294976|NCT05505253|Micronutrients|micronutrients|mesh-ancestor
102294977|NCT04697719|Aspirin|aspirin|mesh-list
102294978|NCT04697719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102294979|NCT04697719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102294980|NCT04697719|Analgesics|analgesics|mesh-ancestor
102294981|NCT04697719|Sensory System Agents|sensory system agents|mesh-ancestor
102294982|NCT04697719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102294983|NCT04697719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102294984|NCT04697719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102294985|NCT04697719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102294986|NCT04697719|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102294987|NCT04697719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102294988|NCT04697719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102294989|NCT04697719|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102294990|NCT04697719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102294991|NCT04697719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102294992|NCT04697719|Antipyretics|antipyretics|mesh-ancestor
102294993|NCT05504863|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
102294994|NCT05504863|Ferric Compounds|ferric compounds|mesh-list
102294995|NCT05504863|Hematinics|hematinics|mesh-ancestor
102294996|NCT05507983|Tranexamic Acid|tranexamic acid|mesh-list
102294997|NCT05507983|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102294998|NCT05507983|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102294999|NCT05507983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295000|NCT05507983|Hemostatics|hemostatics|mesh-ancestor
102295001|NCT05507983|Coagulants|coagulants|mesh-ancestor
102295002|NCT02335983|Dexamethasone|dexamethasone|mesh-list
102295003|NCT02335983|Lenalidomide|lenalidomide|mesh-list
102295004|NCT02335983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102295005|NCT02335983|Antiemetics|antiemetics|mesh-ancestor
102295006|NCT02335983|Autonomic Agents|autonomic agents|mesh-ancestor
102295007|NCT02335983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102295008|NCT02335983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295009|NCT02335983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102295010|NCT02335983|Glucocorticoids|glucocorticoids|mesh-ancestor
102295011|NCT02335983|Hormones|hormones|mesh-ancestor
102295012|NCT02335983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102295013|NCT02335983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102295014|NCT02335983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102295015|NCT02335983|Immunologic Factors|immunologic factors|mesh-ancestor
102295016|NCT02335983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102295017|NCT02335983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102295018|NCT02335983|Growth Substances|growth substances|mesh-ancestor
102295019|NCT02335983|Growth Inhibitors|growth inhibitors|mesh-ancestor
102295020|NCT04578691|Titanium dioxide|titanium dioxide|mesh-list
102295021|NCT04578691|Sunscreening Agents|sunscreening agents|mesh-ancestor
102295022|NCT04578691|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102295023|NCT04578691|Protective Agents|protective agents|mesh-ancestor
102295024|NCT04578691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295025|NCT04578691|Dermatologic Agents|dermatologic agents|mesh-ancestor
102295026|NCT04578691|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102295027|NCT02334423|Botulinum Toxins|botulinum toxins|mesh-list
102295028|NCT02334423|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102295029|NCT02334423|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102295030|NCT02334423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102295031|NCT02334423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102295032|NCT02334423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295033|NCT02334423|Cholinergic Agents|cholinergic agents|mesh-ancestor
102295034|NCT02334423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102295035|NCT02334423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295036|NCT02334423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102295037|NCT02334423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102295039|NCT02310789|Pilocarpine|pilocarpine|mesh-list
102295040|NCT02310789|Adrenergic Agents|adrenergic agents|mesh-list
102295041|NCT02310789|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102295042|NCT02310789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102295043|NCT02310789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295044|NCT02310789|Miotics|miotics|mesh-ancestor
102295045|NCT02310789|Autonomic Agents|autonomic agents|mesh-ancestor
102295046|NCT02310789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102295047|NCT02310789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295048|NCT02310789|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102295049|NCT02310789|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102295050|NCT02310789|Cholinergic Agents|cholinergic agents|mesh-ancestor
102295051|NCT02310789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102295052|NCT02372253|Verapamil|verapamil|mesh-list
102295053|NCT02372253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102295054|NCT02372253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102295055|NCT02372253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102295056|NCT02372253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295057|NCT02372253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102295058|NCT02372253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295059|NCT02372253|Vasodilator Agents|vasodilator agents|mesh-ancestor
102295060|NCT02371629|Glycopyrrolate|glycopyrrolate|mesh-list
102295061|NCT02371629|Bromides|bromides|mesh-list
102295062|NCT02371629|Albuterol|albuterol|mesh-list
102295063|NCT02371629|Anticonvulsants|anticonvulsants|mesh-ancestor
102295064|NCT02371629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102295065|NCT02371629|Autonomic Agents|autonomic agents|mesh-ancestor
102295066|NCT02371629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102295067|NCT02371629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295068|NCT02371629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102295069|NCT02371629|Respiratory System Agents|respiratory system agents|mesh-ancestor
102295070|NCT02371629|Tocolytic Agents|tocolytic agents|mesh-ancestor
102295071|NCT02371629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102295072|NCT02371629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102295073|NCT02371629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102295074|NCT02371629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102295075|NCT02371629|Adrenergic Agents|adrenergic agents|mesh-ancestor
102295076|NCT02371629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102295077|NCT02371629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295078|NCT02371629|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102295079|NCT02371629|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102295080|NCT02371629|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102295081|NCT02371629|Cholinergic Agents|cholinergic agents|mesh-ancestor
102295082|NCT02559817|Linaclotide|linaclotide|mesh-list
102295083|NCT02559817|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102295084|NCT02559817|Enzyme Activators|enzyme activators|mesh-ancestor
102295085|NCT02559817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295086|NCT02559817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102295087|NCT04577443|Adenosine|adenosine|mesh-list
102295088|NCT04577443|Analgesics|analgesics|mesh-ancestor
102295089|NCT04577443|Sensory System Agents|sensory system agents|mesh-ancestor
102295090|NCT04577443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102295091|NCT04577443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295092|NCT04577443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102295093|NCT04577443|Vasodilator Agents|vasodilator agents|mesh-ancestor
102295094|NCT04577443|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102295095|NCT04577443|Purinergic Agonists|purinergic agonists|mesh-ancestor
102295096|NCT04577443|Purinergic Agents|purinergic agents|mesh-ancestor
102295097|NCT04577443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102295098|NCT04577443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295099|NCT04411537|Capecitabine|capecitabine|mesh-list
102295100|NCT04411537|Irinotecan|irinotecan|mesh-list
102295101|NCT04411537|Antibodies|antibodies|mesh-list
102295102|NCT04411537|Immunologic Factors|immunologic factors|mesh-ancestor
102295103|NCT04411537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295104|NCT04411537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102295105|NCT04411537|Antimetabolites|antimetabolites|mesh-ancestor
102295106|NCT04411537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295107|NCT04411537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102295108|NCT04411537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102295109|NCT04411537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102003867|NCT05156814|Hormones|hormones|mesh-ancestor
102295110|NCT04411537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102295111|NCT04630171|Anesthetics|anesthetics|mesh-list
102295112|NCT04630171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102295113|NCT04630171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295114|NCT05503147|Nabiximols|nabiximols|mesh-list
102295115|NCT05503147|Analgesics|analgesics|mesh-ancestor
102295116|NCT05503147|Sensory System Agents|sensory system agents|mesh-ancestor
102295117|NCT05503147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102295118|NCT05503147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295119|NCT04619095|Psyllium|psyllium|mesh-list
102295120|NCT04619095|Cathartics|cathartics|mesh-ancestor
102295121|NCT04619095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102295122|NCT04631185|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102295123|NCT04631185|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102295124|NCT04631185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102295125|NCT04631185|Antitubercular Agents|antitubercular agents|mesh-ancestor
102295126|NCT05502991|Bevacizumab|bevacizumab|mesh-list
102295127|NCT05502991|Tislelizumab|tislelizumab|mesh-list
102295128|NCT05502991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102295129|NCT05502991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102295130|NCT05502991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102295131|NCT05502991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102295132|NCT05502991|Growth Substances|growth substances|mesh-ancestor
102295133|NCT05502991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295134|NCT05502991|Growth Inhibitors|growth inhibitors|mesh-ancestor
102295135|NCT02563561|Apaziquone|apaziquone|mesh-list
102295136|NCT02563561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102295137|NCT05499481|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102295138|NCT05499481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102295139|NCT05497843|Chiauranib|chiauranib|mesh-list
102295140|NCT05497843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102295141|NCT05497843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102295142|NCT05497843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102295143|NCT05497843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295144|NCT05497765|Silybin|silybin|mesh-list
102295145|NCT05497765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102295146|NCT05497765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102295147|NCT05497765|Protective Agents|protective agents|mesh-ancestor
102295148|NCT05497765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295149|NCT04424875|Melatonin|melatonin|mesh-list
102295150|NCT04424875|Antioxidants|antioxidants|mesh-ancestor
102295151|NCT04424875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295152|NCT04424875|Protective Agents|protective agents|mesh-ancestor
102295153|NCT04424875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295154|NCT04424875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102295155|NCT04277845|Dexamethasone|dexamethasone|mesh-list
102295156|NCT04277845|Dexamethasone acetate|dexamethasone acetate|mesh-list
102295157|NCT04277845|Lenalidomide|lenalidomide|mesh-list
102295158|NCT04277845|Bortezomib|bortezomib|mesh-list
102295159|NCT04277845|BB 1101|bb 1101|mesh-list
102295160|NCT04277845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102295161|NCT04277845|Antiemetics|antiemetics|mesh-ancestor
102295162|NCT04277845|Autonomic Agents|autonomic agents|mesh-ancestor
102295163|NCT04277845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102295164|NCT04277845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295165|NCT04277845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102295166|NCT04277845|Glucocorticoids|glucocorticoids|mesh-ancestor
102295167|NCT04277845|Hormones|hormones|mesh-ancestor
102295168|NCT04277845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102295169|NCT04277845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102295170|NCT04277845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102295171|NCT04277845|Protease Inhibitors|protease inhibitors|mesh-ancestor
102295172|NCT04277845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102295173|NCT04277845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295174|NCT04277845|Immunologic Factors|immunologic factors|mesh-ancestor
102295175|NCT04277845|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102295176|NCT04277845|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102295177|NCT04277845|Growth Substances|growth substances|mesh-ancestor
102295178|NCT04277845|Growth Inhibitors|growth inhibitors|mesh-ancestor
102295179|NCT02559505|Vaccines|vaccines|mesh-list
102295180|NCT02559505|Immunologic Factors|immunologic factors|mesh-ancestor
102295181|NCT02559505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295182|NCT05497063|Pyrimethamine|pyrimethamine|mesh-list
102295183|NCT05497063|Sulfadoxine|sulfadoxine|mesh-list
102295184|NCT05497063|Antimalarials|antimalarials|mesh-ancestor
102295185|NCT05497063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102295186|NCT05497063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102295187|NCT05497063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102295188|NCT05497063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102295189|NCT05497063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102295190|NCT05497063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295191|NCT05497063|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102295192|NCT05560945|Listerine|listerine|mesh-list
102295193|NCT05560945|Fluorides|fluorides|mesh-list
102295194|NCT05560945|Sodium Fluoride|sodium fluoride|mesh-list
102295195|NCT05560945|Cariostatic Agents|cariostatic agents|mesh-ancestor
102295196|NCT05560945|Protective Agents|protective agents|mesh-ancestor
102295197|NCT05560945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295198|NCT05560945|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102295199|NCT05560945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102295200|NCT04424563|Aminocaproic Acid|aminocaproic acid|mesh-list
102295201|NCT04424563|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102295202|NCT04424563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102295203|NCT04424563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295204|NCT04424563|Hemostatics|hemostatics|mesh-ancestor
102295205|NCT04424563|Coagulants|coagulants|mesh-ancestor
102295206|NCT05495893|Mycophenolic Acid|mycophenolic acid|mesh-list
102295207|NCT05495893|Cyclophosphamide|cyclophosphamide|mesh-list
102295208|NCT05495893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102295209|NCT05495893|Immunologic Factors|immunologic factors|mesh-ancestor
102295210|NCT05495893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295211|NCT05495893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102295212|NCT05495893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102295213|NCT05495893|Alkylating Agents|alkylating agents|mesh-ancestor
102295214|NCT05495893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295215|NCT05495893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102295216|NCT05495893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102295217|NCT05495893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102295218|NCT05495893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102295219|NCT05495893|Antitubercular Agents|antitubercular agents|mesh-ancestor
102295220|NCT05495893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102295221|NCT05495893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102295222|NCT05495893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102295223|NCT03542461|Nivolumab|nivolumab|mesh-list
102295224|NCT03542461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102295225|NCT03542461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102295226|NCT03542461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102295227|NCT03542461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295228|NCT02556307|Ribavirin|ribavirin|mesh-list
102295229|NCT02556307|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102295230|NCT02556307|Antimetabolites|antimetabolites|mesh-ancestor
102295231|NCT02556307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295232|NCT02556307|Antiviral Agents|antiviral agents|mesh-ancestor
102295233|NCT02556307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102295234|NCT04352101|Bupropion|bupropion|mesh-list
102295235|NCT04352101|Escitalopram|escitalopram|mesh-list
102295236|NCT04352101|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102295237|NCT04352101|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102295238|NCT04352101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102295239|NCT04352101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295240|NCT04352101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102295241|NCT04352101|Serotonin Agents|serotonin agents|mesh-ancestor
102295242|NCT04352101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295243|NCT04352101|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102295244|NCT04352101|Antidepressive Agents|antidepressive agents|mesh-ancestor
102295245|NCT04352101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102295246|NCT04352101|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102295247|NCT04352101|Dopamine Agents|dopamine agents|mesh-ancestor
102295248|NCT04352101|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102295249|NCT04352101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102295250|NCT04352101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102295251|NCT04424485|Parathyroid Hormone|parathyroid hormone|mesh-list
102295252|NCT04424485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102295253|NCT04424485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295254|NCT05494645|Bupivacaine|bupivacaine|mesh-list
102295255|NCT05494645|Anesthetics, Local|anesthetics, local|mesh-ancestor
102295256|NCT05494645|Anesthetics|anesthetics|mesh-ancestor
102295257|NCT05494645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102295258|NCT05494645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003998|NCT03855527|Fluorides|fluorides|mesh-list
102295259|NCT05494645|Sensory System Agents|sensory system agents|mesh-ancestor
102295260|NCT05494645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102295261|NCT05494567|Tadalafil|tadalafil|mesh-list
102295262|NCT05494567|Tamsulosin|tamsulosin|mesh-list
102295263|NCT05494567|Solifenacin Succinate|solifenacin succinate|mesh-list
102295264|NCT05494567|Vasodilator Agents|vasodilator agents|mesh-ancestor
102295265|NCT05494567|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102295266|NCT05494567|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102295267|NCT05494567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102295268|NCT05494567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295269|NCT05494567|Urological Agents|urological agents|mesh-ancestor
102295270|NCT05494567|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102295271|NCT05494567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102295272|NCT05494567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102295273|NCT05494567|Adrenergic Agents|adrenergic agents|mesh-ancestor
102295274|NCT05494567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102295275|NCT05494567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295276|NCT05494567|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102295277|NCT05494567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102295278|NCT05494567|Cholinergic Agents|cholinergic agents|mesh-ancestor
102295279|NCT00609115|Methylamphotericin B|methylamphotericin b|mesh-list
102295280|NCT00609115|Antifungal Agents|antifungal agents|mesh-ancestor
102295281|NCT00609115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102295282|NCT05494411|Mitomycins|mitomycins|mesh-list
102295283|NCT05494411|Mitomycin|mitomycin|mesh-list
102295284|NCT05494411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102295285|NCT05494411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102295286|NCT05494411|Alkylating Agents|alkylating agents|mesh-ancestor
102295287|NCT05494411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295288|NCT05494411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102295289|NCT05494411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102295290|NCT04085887|Panitumumab|panitumumab|mesh-list
102295291|NCT04085887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102295292|NCT04085887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102295293|NCT04080895|Lumefantrine|lumefantrine|mesh-list
102295294|NCT04080895|Artemether|artemether|mesh-list
102295295|NCT04080895|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102295296|NCT04080895|Amodiaquine|amodiaquine|mesh-list
102295297|NCT04080895|Antimalarials|antimalarials|mesh-ancestor
102295298|NCT04080895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102295299|NCT04080895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102295300|NCT04080895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102295301|NCT04251169|Paclitaxel|paclitaxel|mesh-list
102295302|NCT04251169|Pembrolizumab|pembrolizumab|mesh-list
102295303|NCT04251169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102295304|NCT04251169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396133|NCT00092079|Vitamin D|vitamin d|mesh-list
102295305|NCT04251169|Tubulin Modulators|tubulin modulators|mesh-ancestor
102295306|NCT04251169|Antimitotic Agents|antimitotic agents|mesh-ancestor
102295307|NCT04251169|Mitosis Modulators|mitosis modulators|mesh-ancestor
102295308|NCT04251169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295309|NCT04251169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102295310|NCT04251169|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102295311|NCT04279561|Edetic Acid|edetic acid|mesh-list
102295312|NCT04279561|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102295313|NCT04279561|Chelating Agents|chelating agents|mesh-ancestor
102295314|NCT04279561|Sequestering Agents|sequestering agents|mesh-ancestor
102295315|NCT04279561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295316|NCT04279561|Anticoagulants|anticoagulants|mesh-ancestor
102295317|NCT04279561|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102295318|NCT04279561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102295319|NCT01662895|Deferoxamine|deferoxamine|mesh-list
102295320|NCT01662895|Siderophores|siderophores|mesh-ancestor
102295321|NCT01662895|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102295322|NCT01662895|Chelating Agents|chelating agents|mesh-ancestor
102295323|NCT01662895|Sequestering Agents|sequestering agents|mesh-ancestor
102295324|NCT01662895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295325|NCT05498857|Ephedrine|ephedrine|mesh-list
102295326|NCT05498857|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102295327|NCT05498857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295328|NCT05498857|Sympathomimetics|sympathomimetics|mesh-ancestor
102295329|NCT05498857|Autonomic Agents|autonomic agents|mesh-ancestor
102295330|NCT05498857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102295331|NCT05498857|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102295332|NCT05498857|Adrenergic Agents|adrenergic agents|mesh-ancestor
102295333|NCT05498857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102295334|NCT05498857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295335|NCT05498467|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102295336|NCT05498467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102295337|NCT04139395|Citric Acid|citric acid|mesh-list
102295338|NCT04139395|Sodium Citrate|sodium citrate|mesh-list
102295339|NCT04139395|Gallium citrate|gallium citrate|mesh-list
102295340|NCT04139395|Anticoagulants|anticoagulants|mesh-ancestor
102295341|NCT04139395|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102295342|NCT04139395|Chelating Agents|chelating agents|mesh-ancestor
102295343|NCT04139395|Sequestering Agents|sequestering agents|mesh-ancestor
102295344|NCT04139395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295345|NCT04139395|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102295346|NCT02555215|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102295347|NCT02555215|Dermatologic Agents|dermatologic agents|mesh-ancestor
102295348|NCT02555215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102295349|NCT02555215|Immunologic Factors|immunologic factors|mesh-ancestor
102295350|NCT02555215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295351|NCT02555683|Indoleacetic Acids|indoleacetic acids|mesh-list
102295352|NCT02555683|Plant Growth Regulators|plant growth regulators|mesh-ancestor
102295353|NCT02555683|Growth Substances|growth substances|mesh-ancestor
102295354|NCT02555683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295355|NCT02554981|Cyclosporine|cyclosporine|mesh-list
102295356|NCT02554981|Cyclosporins|cyclosporins|mesh-list
102295357|NCT02554981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102295358|NCT02554981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295359|NCT02554981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102295360|NCT02554981|Immunologic Factors|immunologic factors|mesh-ancestor
102295361|NCT02554981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295362|NCT02554981|Antifungal Agents|antifungal agents|mesh-ancestor
102295363|NCT02554981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102295364|NCT02554981|Dermatologic Agents|dermatologic agents|mesh-ancestor
102295365|NCT02554981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102295366|NCT02554981|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102295367|NCT02556775|Immunoglobulins|immunoglobulins|mesh-list
102295368|NCT02556775|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102295369|NCT02556775|Antibodies|antibodies|mesh-list
102295370|NCT02556775|gamma-Globulins|gamma-globulins|mesh-list
102295371|NCT02556775|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102295372|NCT02556775|Immunologic Factors|immunologic factors|mesh-ancestor
102295373|NCT02556775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295374|NCT04080739|Ropivacaine|ropivacaine|mesh-list
102295375|NCT04080739|Anesthetics, Local|anesthetics, local|mesh-ancestor
102295376|NCT04080739|Anesthetics|anesthetics|mesh-ancestor
102295377|NCT04080739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102295378|NCT04080739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295379|NCT04080739|Sensory System Agents|sensory system agents|mesh-ancestor
102295380|NCT04080739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102295381|NCT05485207|Botulinum Toxins|botulinum toxins|mesh-list
102295382|NCT05485207|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102295383|NCT05485207|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102295384|NCT05485207|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102295385|NCT05485207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102295386|NCT05485207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295387|NCT05485207|Cholinergic Agents|cholinergic agents|mesh-ancestor
102295388|NCT05485207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102295389|NCT05485207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295390|NCT05485207|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102295391|NCT05485207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102295392|NCT03879109|Folfirinox|folfirinox|mesh-list
102295393|NCT03879109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102295394|NCT05488327|Lenalidomide|lenalidomide|mesh-list
102295395|NCT05488327|Immunologic Factors|immunologic factors|mesh-ancestor
102295396|NCT05488327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295397|NCT05488327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102295398|NCT05488327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102295399|NCT05488327|Growth Substances|growth substances|mesh-ancestor
102295400|NCT05488327|Growth Inhibitors|growth inhibitors|mesh-ancestor
102295401|NCT05488327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102295402|NCT05488171|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
102295403|NCT05488171|Hallucinogens|hallucinogens|mesh-ancestor
102295404|NCT05488171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295405|NCT05488171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102295406|NCT05488171|Serotonin Agents|serotonin agents|mesh-ancestor
102295407|NCT05488171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102295408|NCT05488171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295409|NCT05488171|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102295410|NCT05488171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102295411|NCT05488171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102295412|NCT05488171|Adrenergic Agents|adrenergic agents|mesh-ancestor
102295414|NCT05485051|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102295415|NCT05485051|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102295416|NCT05485051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102295417|NCT05485051|Disinfectants|disinfectants|mesh-ancestor
102295418|NCT05485051|Dermatologic Agents|dermatologic agents|mesh-ancestor
102295419|NCT05484817|Hormones|hormones|mesh-list
102295420|NCT05484817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102295421|NCT05484817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295422|NCT05484583|Carboplatin|carboplatin|mesh-list
102295423|NCT05484583|Etoposide|etoposide|mesh-list
102295424|NCT05484583|Durvalumab|durvalumab|mesh-list
102295425|NCT05484583|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102295426|NCT05484583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102295427|NCT05484583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102295428|NCT05484583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102295429|NCT05484583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102295430|NCT05484583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102295431|NCT05484583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295432|NCT05484583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102295433|NCT05484583|Immunologic Factors|immunologic factors|mesh-ancestor
102295434|NCT05484583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295435|NCT05479747|Analgesics|analgesics|mesh-list
102295436|NCT05479747|Sensory System Agents|sensory system agents|mesh-ancestor
102295437|NCT05479747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102295438|NCT05479747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295439|NCT05487469|Thymalfasin|thymalfasin|mesh-list
102295440|NCT05487469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102295441|NCT05487469|Immunologic Factors|immunologic factors|mesh-ancestor
102295442|NCT05487469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295443|NCT05479357|Oxytocin|oxytocin|mesh-list
102295444|NCT05479357|Carbetocin|carbetocin|mesh-list
102295445|NCT05479357|Oxytocics|oxytocics|mesh-ancestor
102295446|NCT05479357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102295447|NCT05479357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295448|NCT05487391|Paclitaxel|paclitaxel|mesh-list
102295449|NCT05487391|Vinorelbine|vinorelbine|mesh-list
102295450|NCT05487391|Carboplatin|carboplatin|mesh-list
102295451|NCT05487391|Pemetrexed|pemetrexed|mesh-list
102295452|NCT05487391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102295453|NCT05487391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102295454|NCT05487391|Tubulin Modulators|tubulin modulators|mesh-ancestor
102295455|NCT05487391|Antimitotic Agents|antimitotic agents|mesh-ancestor
102295456|NCT05487391|Mitosis Modulators|mitosis modulators|mesh-ancestor
102295457|NCT05487391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295458|NCT05487391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102295459|NCT05487391|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102295460|NCT05487391|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102295461|NCT05484193|Progesterone|progesterone|mesh-list
102295462|NCT05484193|Progestins|progestins|mesh-ancestor
102295463|NCT05484193|Hormones|hormones|mesh-ancestor
102295464|NCT05484193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102295465|NCT05484193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295466|NCT03796195|Bupivacaine|bupivacaine|mesh-list
102295467|NCT03796195|Anesthetics, Local|anesthetics, local|mesh-ancestor
102295468|NCT03796195|Anesthetics|anesthetics|mesh-ancestor
102295469|NCT03796195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102295470|NCT03796195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295471|NCT03796195|Sensory System Agents|sensory system agents|mesh-ancestor
102295472|NCT03796195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102295473|NCT05479123|Timolol|timolol|mesh-list
102295474|NCT05479123|Propranolol|propranolol|mesh-list
102295475|NCT05479123|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102295476|NCT05479123|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102295477|NCT05479123|Adrenergic Agents|adrenergic agents|mesh-ancestor
102295478|NCT05479123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102295479|NCT05479123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295480|NCT05479123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295481|NCT05479123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102295482|NCT05479123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102295483|NCT05479123|Vasodilator Agents|vasodilator agents|mesh-ancestor
102295484|NCT04268407|Amoxicillin|amoxicillin|mesh-list
102295485|NCT04268407|Clavulanic Acid|clavulanic acid|mesh-list
102295486|NCT04268407|Clavulanic Acids|clavulanic acids|mesh-list
102295487|NCT04268407|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102295488|NCT04268407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102295489|NCT04268407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102295490|NCT04268407|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102295491|NCT04268407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102295492|NCT04268407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295493|NCT05487001|Dexamethasone|dexamethasone|mesh-list
102295494|NCT05487001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102295495|NCT05487001|Antiemetics|antiemetics|mesh-ancestor
102295496|NCT05487001|Autonomic Agents|autonomic agents|mesh-ancestor
102295497|NCT05487001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102295498|NCT05487001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295499|NCT05487001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102295500|NCT05487001|Glucocorticoids|glucocorticoids|mesh-ancestor
102295502|NCT05487001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102295503|NCT05487001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102295504|NCT05487001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102295505|NCT05483647|Anesthetics|anesthetics|mesh-list
102295506|NCT05483647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102295507|NCT05483647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295508|NCT05475379|Vaccines|vaccines|mesh-list
102295509|NCT05475379|Immunologic Factors|immunologic factors|mesh-ancestor
102295510|NCT05475379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295511|NCT05475223|Carbon Monoxide|carbon monoxide|mesh-list
102295512|NCT05475223|Antimetabolites|antimetabolites|mesh-ancestor
102295513|NCT05475223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295514|NCT05475223|Gasotransmitters|gasotransmitters|mesh-ancestor
102295516|NCT05475223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295517|NCT04542733|Everolimus|everolimus|mesh-list
102295518|NCT04542733|Tacrolimus|tacrolimus|mesh-list
102295519|NCT04542733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102295520|NCT04542733|Immunologic Factors|immunologic factors|mesh-ancestor
102295521|NCT04542733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295522|NCT04542733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102295523|NCT04542733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102295524|NCT04542733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295525|NCT04542733|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102295526|NCT04542733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102295527|NCT04542733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102295528|NCT04424017|Antibodies|antibodies|mesh-list
102295529|NCT04424017|Immunologic Factors|immunologic factors|mesh-ancestor
102295530|NCT04424017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295531|NCT05477797|Lenalidomide|lenalidomide|mesh-list
102295532|NCT05477797|Ixazomib|ixazomib|mesh-list
102295533|NCT05477797|Immunologic Factors|immunologic factors|mesh-ancestor
102295534|NCT05477797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295535|NCT05477797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102295536|NCT05477797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102295537|NCT05477797|Growth Substances|growth substances|mesh-ancestor
102295538|NCT05477797|Growth Inhibitors|growth inhibitors|mesh-ancestor
102295539|NCT05477797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102295540|NCT05477797|Protease Inhibitors|protease inhibitors|mesh-ancestor
102295541|NCT05477797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102295542|NCT05477797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295543|NCT03386929|Palbociclib|palbociclib|mesh-list
102295544|NCT03386929|Avelumab|avelumab|mesh-list
102295545|NCT03386929|Axitinib|axitinib|mesh-list
102295546|NCT03386929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102295547|NCT03386929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102295548|NCT03386929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102295549|NCT03386929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295550|NCT03386929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102295551|NCT05472337|Colchicine|colchicine|mesh-list
102295552|NCT05472337|Gout Suppressants|gout suppressants|mesh-ancestor
102295553|NCT05472337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102295554|NCT05472337|Tubulin Modulators|tubulin modulators|mesh-ancestor
102295555|NCT05472337|Antimitotic Agents|antimitotic agents|mesh-ancestor
102295556|NCT05472337|Mitosis Modulators|mitosis modulators|mesh-ancestor
102295557|NCT05472337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295558|NCT05472337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102295559|NCT05472259|Leucovorin|leucovorin|mesh-list
102004282|NCT03733171|Hemostatics|hemostatics|mesh-list
102004299|NCT03207750|Vaccines|vaccines|mesh-list
102295560|NCT05472259|Fluorouracil|fluorouracil|mesh-list
102295561|NCT05472259|Oxaliplatin|oxaliplatin|mesh-list
102295562|NCT05472259|Irinotecan|irinotecan|mesh-list
102295563|NCT05472259|Antimetabolites|antimetabolites|mesh-ancestor
102295564|NCT05472259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295566|NCT05472259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102295567|NCT05472259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102295568|NCT05472259|Immunologic Factors|immunologic factors|mesh-ancestor
102295569|NCT05472259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295570|NCT05472259|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102295571|NCT05472259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102295572|NCT05472259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102295573|NCT05472259|Antidotes|antidotes|mesh-ancestor
102295574|NCT05472259|Protective Agents|protective agents|mesh-ancestor
102295575|NCT05472259|Vitamin B Complex|vitamin b complex|mesh-ancestor
102295576|NCT05472259|Vitamins|vitamins|mesh-ancestor
102295577|NCT05472259|Micronutrients|micronutrients|mesh-ancestor
102295578|NCT04266145|Dexmedetomidine|dexmedetomidine|mesh-list
102295579|NCT04266145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102295580|NCT04266145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102295581|NCT04266145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295582|NCT04266145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102295583|NCT04266145|Analgesics|analgesics|mesh-ancestor
102295584|NCT04266145|Sensory System Agents|sensory system agents|mesh-ancestor
102295585|NCT04266145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102295586|NCT04266145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102295587|NCT04266145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102295588|NCT04266145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102295589|NCT04266145|Adrenergic Agents|adrenergic agents|mesh-ancestor
102295590|NCT04266145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102295591|NCT04266145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295592|NCT03383419|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102295594|NCT03383419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102295595|NCT05477017|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102295596|NCT05477017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295597|NCT05477017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102295598|NCT05477017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295599|NCT02554279|Menotropins|menotropins|mesh-list
102295600|NCT02554279|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102295601|NCT02554279|Fertility Agents|fertility agents|mesh-ancestor
102295602|NCT02554279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102295603|NCT02554279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295604|NCT02554903|Macitentan|macitentan|mesh-list
102295605|NCT02554903|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
102295606|NCT02554903|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102295607|NCT02554903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295608|NCT02554903|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
102295609|NCT02332707|Ribavirin|ribavirin|mesh-list
102295610|NCT02332707|Grazoprevir|grazoprevir|mesh-list
102295611|NCT02332707|Ruzasvir|ruzasvir|mesh-list
102295612|NCT02332707|Uprifosbuvir|uprifosbuvir|mesh-list
102295613|NCT02332707|Antimetabolites|antimetabolites|mesh-ancestor
102295614|NCT02332707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295615|NCT02332707|Antiviral Agents|antiviral agents|mesh-ancestor
102295616|NCT02332707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102295617|NCT02370615|Itraconazole|itraconazole|mesh-list
102295618|NCT02370615|Digoxin|digoxin|mesh-list
102295619|NCT02370615|Midazolam|midazolam|mesh-list
102295620|NCT02370615|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
102295621|NCT02370615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102295622|NCT02370615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102295623|NCT02370615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102295624|NCT02370615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295625|NCT02370615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102295626|NCT02370615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102295627|NCT02370615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102295628|NCT02370615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102295629|NCT02370615|Anesthetics, General|anesthetics, general|mesh-ancestor
102295630|NCT02370615|Anesthetics|anesthetics|mesh-ancestor
102295631|NCT02370615|GABA Modulators|gaba modulators|mesh-ancestor
102295632|NCT02370615|GABA Agents|gaba agents|mesh-ancestor
102295633|NCT02370615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102295634|NCT02370615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295635|NCT02370615|Antifungal Agents|antifungal agents|mesh-ancestor
102295636|NCT02370615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102295637|NCT02370615|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102295638|NCT02370615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102295639|NCT02370615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102295640|NCT02370615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102295641|NCT02370615|Hormone Antagonists|hormone antagonists|mesh-ancestor
102295642|NCT02370615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102295643|NCT02370615|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102295644|NCT02370615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102295645|NCT02370615|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102295646|NCT02370615|Protective Agents|protective agents|mesh-ancestor
102295648|NCT02307513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102295649|NCT02307513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102295650|NCT02307513|Analgesics|analgesics|mesh-ancestor
102295651|NCT02307513|Sensory System Agents|sensory system agents|mesh-ancestor
102295652|NCT02307513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102295653|NCT02307513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295654|NCT02307513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102295655|NCT02307513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102295656|NCT02307513|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102295657|NCT02307513|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102295658|NCT02307513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102295659|NCT02307513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295660|NCT02328105|Paclitaxel|paclitaxel|mesh-list
102295661|NCT02328105|Carboplatin|carboplatin|mesh-list
102295662|NCT02328105|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102295663|NCT02328105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102295664|NCT02328105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102295665|NCT02328105|Tubulin Modulators|tubulin modulators|mesh-ancestor
102295666|NCT02328105|Antimitotic Agents|antimitotic agents|mesh-ancestor
102295667|NCT02328105|Mitosis Modulators|mitosis modulators|mesh-ancestor
102295668|NCT02328105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295669|NCT02305797|Lorazepam|lorazepam|mesh-list
102295670|NCT02305797|Anticonvulsants|anticonvulsants|mesh-ancestor
102295671|NCT02305797|Antiemetics|antiemetics|mesh-ancestor
102295672|NCT02305797|Autonomic Agents|autonomic agents|mesh-ancestor
102295673|NCT02305797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102295674|NCT02305797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295675|NCT02305797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102295676|NCT02305797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102295677|NCT02305797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102295678|NCT02305797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102295679|NCT02305797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102295680|NCT02305797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102295681|NCT02305797|GABA Modulators|gaba modulators|mesh-ancestor
102295682|NCT02305797|GABA Agents|gaba agents|mesh-ancestor
102295683|NCT02305797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102295684|NCT02305797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295685|NCT01646073|Adalimumab|adalimumab|mesh-list
102295686|NCT01646073|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102295687|NCT01646073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102295688|NCT01646073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102295689|NCT02551159|Carboplatin|carboplatin|mesh-list
102295690|NCT02551159|Fluorouracil|fluorouracil|mesh-list
102295691|NCT02551159|Cetuximab|cetuximab|mesh-list
102295692|NCT02551159|Durvalumab|durvalumab|mesh-list
102295693|NCT02551159|Tremelimumab|tremelimumab|mesh-list
102295694|NCT02551159|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102295695|NCT02551159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102295696|NCT02551159|Antimetabolites|antimetabolites|mesh-ancestor
102295697|NCT02551159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295698|NCT02551159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102295699|NCT02551159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102295700|NCT02551159|Immunologic Factors|immunologic factors|mesh-ancestor
102295701|NCT02551159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295702|NCT02551159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102295703|NCT04539379|Magnesium Sulfate|magnesium sulfate|mesh-list
102295704|NCT04539379|Analgesics|analgesics|mesh-ancestor
102295705|NCT04539379|Sensory System Agents|sensory system agents|mesh-ancestor
102295706|NCT04539379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102295707|NCT04539379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295708|NCT04539379|Anesthetics|anesthetics|mesh-ancestor
102295709|NCT04539379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102295710|NCT04539379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102295711|NCT04539379|Anticonvulsants|anticonvulsants|mesh-ancestor
102295712|NCT04539379|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102295713|NCT04539379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102295714|NCT04539379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295715|NCT04539379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102295717|NCT04539379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102295718|NCT05470075|Tramadol|tramadol|mesh-list
102295719|NCT05470075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102295720|NCT05470075|Narcotics|narcotics|mesh-ancestor
102295721|NCT05470075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102295722|NCT05470075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295723|NCT05470075|Analgesics|analgesics|mesh-ancestor
102295724|NCT05470075|Sensory System Agents|sensory system agents|mesh-ancestor
102295725|NCT05470075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102295726|NCT05481619|Vedolizumab|vedolizumab|mesh-list
102295727|NCT05481619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102295728|NCT02305563|Cytarabine|cytarabine|mesh-list
102295729|NCT02305563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102295730|NCT02305563|Antimetabolites|antimetabolites|mesh-ancestor
102295731|NCT02305563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295732|NCT02305563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102295733|NCT02305563|Antiviral Agents|antiviral agents|mesh-ancestor
102295734|NCT02305563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102295735|NCT02305563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102295736|NCT02305563|Immunologic Factors|immunologic factors|mesh-ancestor
102295737|NCT02305563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295738|NCT02304705|Sildenafil Citrate|sildenafil citrate|mesh-list
102295739|NCT02304705|Vasodilator Agents|vasodilator agents|mesh-ancestor
102295740|NCT02304705|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102295741|NCT02304705|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102295742|NCT02304705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102295743|NCT02304705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295744|NCT02304705|Urological Agents|urological agents|mesh-ancestor
102295745|NCT02553499|Pembrolizumab|pembrolizumab|mesh-list
102295746|NCT02553499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102295747|NCT02553499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102295748|NCT02553499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102295749|NCT02553499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295750|NCT02553265|Carbidopa|carbidopa|mesh-list
102295751|NCT02553265|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102295752|NCT02553265|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102295753|NCT02553265|Dopamine Agents|dopamine agents|mesh-ancestor
102295754|NCT02553265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102295755|NCT02553265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295756|NCT02553265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295757|NCT02553265|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102295758|NCT02553265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102295759|NCT03215095|Durvalumab|durvalumab|mesh-list
102295760|NCT03215095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102295761|NCT03215095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102295762|NCT01663103|Rilonacept|rilonacept|mesh-list
102295763|NCT01663103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102295764|NCT05501639|Tiotropium Bromide|tiotropium bromide|mesh-list
102295765|NCT05501639|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102295766|NCT05501639|Autonomic Agents|autonomic agents|mesh-ancestor
102295767|NCT05501639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102295768|NCT05501639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295769|NCT05501639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102295770|NCT05501639|Respiratory System Agents|respiratory system agents|mesh-ancestor
102295771|NCT05501639|Parasympatholytics|parasympatholytics|mesh-ancestor
102295772|NCT05501639|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102295773|NCT05501639|Cholinergic Agents|cholinergic agents|mesh-ancestor
102295774|NCT05501639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102295775|NCT05501639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295776|NCT05284643|Bevacizumab|bevacizumab|mesh-list
102295777|NCT05284643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102295778|NCT05284643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102295779|NCT05284643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102295780|NCT05284643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102295781|NCT05284643|Growth Substances|growth substances|mesh-ancestor
102295782|NCT05284643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295783|NCT05284643|Growth Inhibitors|growth inhibitors|mesh-ancestor
102295784|NCT04577963|Tislelizumab|tislelizumab|mesh-list
102004502|NCT03643159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102295785|NCT04577963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102295786|NCT04577963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102295787|NCT04532645|Olaparib|olaparib|mesh-list
102295788|NCT04532645|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102295789|NCT04532645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102295790|NCT04532645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295791|NCT04532645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102295792|NCT02560025|Cytarabine|cytarabine|mesh-list
102295793|NCT02560025|Daunorubicin|daunorubicin|mesh-list
102295794|NCT02560025|Idarubicin|idarubicin|mesh-list
102295795|NCT02560025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102295796|NCT02560025|Antimetabolites|antimetabolites|mesh-ancestor
102295797|NCT02560025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295798|NCT02560025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102295799|NCT02560025|Antiviral Agents|antiviral agents|mesh-ancestor
102295800|NCT02560025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102295801|NCT02560025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102295802|NCT02560025|Immunologic Factors|immunologic factors|mesh-ancestor
102295803|NCT02560025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295804|NCT02560025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102295805|NCT02560025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102295806|NCT02560025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102295807|NCT02560025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102295808|NCT05500937|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102295809|NCT05500937|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102295810|NCT05500937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102295811|NCT04524455|Dexamethasone|dexamethasone|mesh-list
102295812|NCT04524455|Blinatumomab|blinatumomab|mesh-list
102295813|NCT04524455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102295814|NCT04524455|Antiemetics|antiemetics|mesh-ancestor
102295815|NCT04524455|Autonomic Agents|autonomic agents|mesh-ancestor
102295816|NCT04524455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102295817|NCT04524455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295818|NCT04524455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102295820|NCT04524455|Hormones|hormones|mesh-ancestor
102295821|NCT04524455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102295822|NCT04524455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102295823|NCT04524455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102295824|NCT04411901|Cholecalciferol|cholecalciferol|mesh-list
102295825|NCT04411901|Vitamin D|vitamin d|mesh-list
102295826|NCT04411901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102295827|NCT04411901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295828|NCT04411901|Vitamins|vitamins|mesh-ancestor
102295829|NCT04411901|Micronutrients|micronutrients|mesh-ancestor
102295830|NCT04411901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102295831|NCT05508737|Trifluridine|trifluridine|mesh-list
102295832|NCT05508737|Pembrolizumab|pembrolizumab|mesh-list
102295833|NCT05508737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102295834|NCT05508737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102295835|NCT05508737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102295836|NCT05508737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295837|NCT05508737|Antimetabolites|antimetabolites|mesh-ancestor
102295838|NCT05508737|Antiviral Agents|antiviral agents|mesh-ancestor
102295839|NCT05508737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102295840|NCT05508035|Valsartan|valsartan|mesh-list
102295841|NCT05508035|Ramipril|ramipril|mesh-list
102295842|NCT05508035|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102295843|NCT05508035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102295844|NCT05508035|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102295845|NCT05508035|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102295846|NCT05508035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295847|NCT05508035|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102295848|NCT05508035|Protease Inhibitors|protease inhibitors|mesh-ancestor
102295849|NCT05508035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102295850|NCT02566889|Infliximab|infliximab|mesh-list
102295851|NCT02566889|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102295852|NCT02566889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102295853|NCT02566889|Dermatologic Agents|dermatologic agents|mesh-ancestor
102295854|NCT02566889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102295855|NCT02566889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102295856|NCT05507957|Chlorhexidine|chlorhexidine|mesh-list
102295857|NCT05507957|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102295858|NCT05507957|Ethanol|ethanol|mesh-list
102295859|NCT05507957|Povidone-Iodine|povidone-iodine|mesh-list
102295860|NCT05507957|Disinfectants|disinfectants|mesh-list
102295861|NCT05507957|Povidone|povidone|mesh-list
102295862|NCT05507957|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102295863|NCT05507957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102295864|NCT05507957|Dermatologic Agents|dermatologic agents|mesh-ancestor
102295865|NCT05507957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102295866|NCT05507957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295867|NCT05507957|Plasma Substitutes|plasma substitutes|mesh-ancestor
102295868|NCT05507957|Blood Substitutes|blood substitutes|mesh-ancestor
102295869|NCT04282109|Paclitaxel|paclitaxel|mesh-list
102295870|NCT04282109|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102295871|NCT04282109|Nivolumab|nivolumab|mesh-list
102295872|NCT04282109|Cetuximab|cetuximab|mesh-list
102295873|NCT04282109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102295874|NCT04282109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102295875|NCT04282109|Tubulin Modulators|tubulin modulators|mesh-ancestor
102295876|NCT04282109|Antimitotic Agents|antimitotic agents|mesh-ancestor
102295877|NCT04282109|Mitosis Modulators|mitosis modulators|mesh-ancestor
102295878|NCT04282109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295879|NCT04282109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102295880|NCT04282109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102295881|NCT03150173|Buprenorphine|buprenorphine|mesh-list
102295882|NCT03150173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102295883|NCT03150173|Narcotics|narcotics|mesh-ancestor
102295884|NCT03150173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102295885|NCT03150173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295886|NCT03150173|Analgesics|analgesics|mesh-ancestor
102295887|NCT03150173|Sensory System Agents|sensory system agents|mesh-ancestor
102295888|NCT03150173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102295889|NCT03150173|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102295890|NCT05563571|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102295892|NCT05563571|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102295893|NCT05563571|Prednisolone|prednisolone|mesh-list
102295894|NCT05563571|Prednisolone acetate|prednisolone acetate|mesh-list
102295895|NCT05563571|Lidocaine|lidocaine|mesh-list
102295896|NCT05563571|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102295897|NCT05563571|Prednisolone phosphate|prednisolone phosphate|mesh-list
102295898|NCT05563571|Anesthetics, Local|anesthetics, local|mesh-ancestor
102295899|NCT05563571|Anesthetics|anesthetics|mesh-ancestor
102295900|NCT05563571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102295901|NCT05563571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295902|NCT05563571|Sensory System Agents|sensory system agents|mesh-ancestor
102295903|NCT05563571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102295904|NCT05563571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102295905|NCT05563571|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102295906|NCT05563571|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102295907|NCT05563571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102295908|NCT05563571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295909|NCT05563571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102295910|NCT05563571|Antiemetics|antiemetics|mesh-ancestor
102295911|NCT05563571|Autonomic Agents|autonomic agents|mesh-ancestor
102295912|NCT05563571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102295913|NCT05563571|Glucocorticoids|glucocorticoids|mesh-ancestor
102295914|NCT05563571|Hormones|hormones|mesh-ancestor
102295915|NCT05563571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102295916|NCT05563571|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102295917|NCT05563571|Protective Agents|protective agents|mesh-ancestor
102295918|NCT05563571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102295919|NCT05563571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102295920|NCT02717507|Carvedilol|carvedilol|mesh-list
102295921|NCT02717507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102295922|NCT02717507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102295923|NCT02717507|Adrenergic Agents|adrenergic agents|mesh-ancestor
102295924|NCT02717507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102295925|NCT02717507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295926|NCT02717507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295927|NCT02717507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102295928|NCT02717507|Antioxidants|antioxidants|mesh-ancestor
102295929|NCT02717507|Protective Agents|protective agents|mesh-ancestor
102295930|NCT02717507|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102295931|NCT02717507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102295932|NCT02717507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102295933|NCT02717507|Vasodilator Agents|vasodilator agents|mesh-ancestor
102295934|NCT02717507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102004655|NCT04508686|Capecitabine|capecitabine|mesh-list
102295935|NCT02717507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102295937|NCT02489903|Etoposide|etoposide|mesh-list
102295938|NCT02489903|Vinorelbine|vinorelbine|mesh-list
102295939|NCT02489903|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102295940|NCT02489903|Carboplatin|carboplatin|mesh-list
102295941|NCT02489903|Gemcitabine|gemcitabine|mesh-list
102295942|NCT02489903|Irinotecan|irinotecan|mesh-list
102295943|NCT02489903|Pemetrexed|pemetrexed|mesh-list
102295944|NCT02489903|Taxane|taxane|mesh-list
102295945|NCT02489903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102295946|NCT02489903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102295947|NCT02489903|Tubulin Modulators|tubulin modulators|mesh-ancestor
102295948|NCT02489903|Antimitotic Agents|antimitotic agents|mesh-ancestor
102295949|NCT02489903|Mitosis Modulators|mitosis modulators|mesh-ancestor
102295950|NCT02489903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295951|NCT02489903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102295952|NCT02489903|Antimetabolites|antimetabolites|mesh-ancestor
102295953|NCT02489903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102295954|NCT02489903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102295955|NCT02489903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102295956|NCT02489903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102295957|NCT02489903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102295958|NCT02489903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102295959|NCT01174199|Sirolimus|sirolimus|mesh-list
102295960|NCT01174199|Vorinostat|vorinostat|mesh-list
102295961|NCT01174199|Temsirolimus|temsirolimus|mesh-list
102295962|NCT01174199|MTOR Inhibitors|mtor inhibitors|mesh-list
102295963|NCT01174199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102295964|NCT01174199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102295965|NCT01174199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102295966|NCT01174199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102295967|NCT01174199|Antifungal Agents|antifungal agents|mesh-ancestor
102295968|NCT01174199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102295969|NCT01174199|Immunologic Factors|immunologic factors|mesh-ancestor
102295970|NCT01174199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295971|NCT01174199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102295972|NCT01174199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102295973|NCT01174199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295974|NCT01174199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102295975|NCT04356599|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102295976|NCT04356599|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102295977|NCT04356599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295978|NCT05562869|Abatacept|abatacept|mesh-list
102295979|NCT05562869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102295980|NCT05562869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102295981|NCT05562869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102295982|NCT05562869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102295983|NCT05562869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102295984|NCT05562869|Immunologic Factors|immunologic factors|mesh-ancestor
102295985|NCT05562869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295986|NCT05562869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102295987|NCT04085237|Ropivacaine|ropivacaine|mesh-list
102295988|NCT04085237|Anesthetics, Local|anesthetics, local|mesh-ancestor
102295989|NCT04085237|Anesthetics|anesthetics|mesh-ancestor
102295990|NCT04085237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102295991|NCT04085237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102295992|NCT04085237|Sensory System Agents|sensory system agents|mesh-ancestor
102295993|NCT04085237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102295994|NCT04080869|Vitamin A|vitamin a|mesh-list
102295995|NCT04080869|Tretinoin|tretinoin|mesh-list
102295996|NCT04080869|Retinol palmitate|retinol palmitate|mesh-list
102295997|NCT04080869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102295998|NCT04080869|Keratolytic Agents|keratolytic agents|mesh-ancestor
102295999|NCT04080869|Dermatologic Agents|dermatologic agents|mesh-ancestor
102296000|NCT04080869|Antioxidants|antioxidants|mesh-ancestor
102296001|NCT04080869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296002|NCT04080869|Protective Agents|protective agents|mesh-ancestor
102296003|NCT04080869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296004|NCT04080869|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102296005|NCT04080869|Vitamins|vitamins|mesh-ancestor
102296006|NCT04080869|Micronutrients|micronutrients|mesh-ancestor
102296007|NCT00560495|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
102296008|NCT00560495|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
102296009|NCT00560495|Chelating Agents|chelating agents|mesh-ancestor
102296010|NCT00560495|Sequestering Agents|sequestering agents|mesh-ancestor
102004733|NCT02954653|Antimetabolites|antimetabolites|mesh-ancestor
102296011|NCT00560495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296012|NCT00560495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102296013|NCT00560495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102296014|NCT00560495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102296015|NCT00560495|Growth Substances|growth substances|mesh-ancestor
102296016|NCT00560495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296017|NCT00560495|Growth Inhibitors|growth inhibitors|mesh-ancestor
102296018|NCT00560495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102296019|NCT00560495|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102296020|NCT02559713|Vedolizumab|vedolizumab|mesh-list
102296021|NCT02559713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102296022|NCT05499065|Cetuximab|cetuximab|mesh-list
102296023|NCT05499065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102296024|NCT05499065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102296025|NCT04230161|Milbemycin oxime|milbemycin oxime|mesh-list
102296026|NCT04230161|Anthelmintics|anthelmintics|mesh-ancestor
102296027|NCT04230161|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102296028|NCT04230161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102296029|NCT04038437|Venetoclax|venetoclax|mesh-list
102296030|NCT04038437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102296031|NCT05491343|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102296032|NCT05491343|Medroxyprogesterone|medroxyprogesterone|mesh-list
102296033|NCT05491343|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102296034|NCT05491343|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102296035|NCT05491343|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102296036|NCT05491343|Contraceptive Agents|contraceptive agents|mesh-ancestor
102296037|NCT05491343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102296038|NCT05491343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296039|NCT05491343|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102296040|NCT05491343|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102296041|NCT05491343|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102296042|NCT05491343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102296043|NCT05491343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102296044|NCT05498441|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102296045|NCT05498441|Antidepressive Agents|antidepressive agents|mesh-ancestor
102296046|NCT05498441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102296047|NCT05498441|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102296048|NCT05498441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102296049|NCT05498441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102296050|NCT05498441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296051|NCT05485883|Lenvatinib|lenvatinib|mesh-list
102296052|NCT05485883|Tislelizumab|tislelizumab|mesh-list
102296053|NCT05485883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102296054|NCT05485883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102296055|NCT05485883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102296056|NCT05485883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296057|NCT05485883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102296058|NCT04273607|Heparin|heparin|mesh-list
102296059|NCT04273607|Calcium heparin|calcium heparin|mesh-list
102296060|NCT04273607|Enoxaparin|enoxaparin|mesh-list
102296061|NCT04273607|Anticoagulants|anticoagulants|mesh-ancestor
102296062|NCT04273607|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102296063|NCT04273607|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102296064|NCT04273607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296065|NCT05476081|Aspirin|aspirin|mesh-list
102296066|NCT05476081|Clopidogrel|clopidogrel|mesh-list
102296067|NCT05476081|Ticagrelor|ticagrelor|mesh-list
102296068|NCT05476081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102296069|NCT05476081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102296070|NCT05476081|Analgesics|analgesics|mesh-ancestor
102296071|NCT05476081|Sensory System Agents|sensory system agents|mesh-ancestor
102296072|NCT05476081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102296073|NCT05476081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296074|NCT05476081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102296075|NCT05476081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102296076|NCT05476081|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102296077|NCT05476081|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102296078|NCT05476081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296079|NCT05476081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102296080|NCT05476081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102296081|NCT05476081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102296082|NCT05476081|Antipyretics|antipyretics|mesh-ancestor
102296083|NCT05476081|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102296084|NCT05476081|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102296085|NCT05476081|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102296086|NCT05476081|Purinergic Agents|purinergic agents|mesh-ancestor
102296087|NCT05476081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102296088|NCT05476003|Midazolam|midazolam|mesh-list
102296089|NCT05476003|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102296090|NCT05476003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102296091|NCT05476003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102296092|NCT05476003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296093|NCT05476003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102296094|NCT05476003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102296095|NCT05476003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102296096|NCT05476003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102296097|NCT05476003|Anesthetics, General|anesthetics, general|mesh-ancestor
102296098|NCT05476003|Anesthetics|anesthetics|mesh-ancestor
102296099|NCT05476003|GABA Modulators|gaba modulators|mesh-ancestor
102296100|NCT05476003|GABA Agents|gaba agents|mesh-ancestor
102296101|NCT05476003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102296102|NCT05476003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296103|NCT02547649|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102296104|NCT02547649|Immunologic Factors|immunologic factors|mesh-ancestor
102296105|NCT02547649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296106|NCT03209479|Glatiramer Acetate|glatiramer acetate|mesh-list
102296107|NCT03209479|(T,G)-A-L|(t,g)-a-l|mesh-list
102296108|NCT03209479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102296109|NCT03209479|Immunologic Factors|immunologic factors|mesh-ancestor
102296110|NCT03209479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296111|NCT03209479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102296112|NCT03209479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102296113|NCT02535715|Insulin|insulin|mesh-list
102296114|NCT02535715|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102296115|NCT02535715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102296116|NCT02535715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296117|NCT02336815|Dexamethasone|dexamethasone|mesh-list
102296118|NCT02336815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102296119|NCT02336815|Antiemetics|antiemetics|mesh-ancestor
102296120|NCT02336815|Autonomic Agents|autonomic agents|mesh-ancestor
102296121|NCT02336815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102296122|NCT02336815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296123|NCT02336815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102296124|NCT02336815|Glucocorticoids|glucocorticoids|mesh-ancestor
102296125|NCT02336815|Hormones|hormones|mesh-ancestor
102296126|NCT02336815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102296127|NCT02336815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102296128|NCT02336815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102296129|NCT05434039|Diclofenac|diclofenac|mesh-list
102296130|NCT05434039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102296131|NCT05434039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102296132|NCT05434039|Analgesics|analgesics|mesh-ancestor
102296133|NCT05434039|Sensory System Agents|sensory system agents|mesh-ancestor
102296134|NCT05434039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102296135|NCT05434039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296136|NCT05434039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102296137|NCT05434039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102296138|NCT05434039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102296139|NCT05434039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102296140|NCT05434039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296141|NCT05466175|Prednisone|prednisone|mesh-list
102296142|NCT05466175|Vincristine|vincristine|mesh-list
102296143|NCT05466175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102296144|NCT05466175|Glucocorticoids|glucocorticoids|mesh-ancestor
102296145|NCT05466175|Hormones|hormones|mesh-ancestor
102296146|NCT05466175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102296147|NCT05466175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296148|NCT05466175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102296149|NCT05466175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396950|NCT00317785|Methotrexate|methotrexate|mesh-list
102296150|NCT05466175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102296151|NCT05466175|Tubulin Modulators|tubulin modulators|mesh-ancestor
102296152|NCT05466175|Antimitotic Agents|antimitotic agents|mesh-ancestor
102296153|NCT05466175|Mitosis Modulators|mitosis modulators|mesh-ancestor
102296154|NCT05466175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296155|NCT02546323|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102296156|NCT02546323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102296157|NCT02546323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102296158|NCT02546323|Antimetabolites|antimetabolites|mesh-ancestor
102296159|NCT02546323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296160|NCT02546323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102296161|NCT02546323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102296162|NCT02546323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102296163|NCT02545933|Aspirin|aspirin|mesh-list
102296164|NCT02545933|Ticagrelor|ticagrelor|mesh-list
102296165|NCT02545933|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102296166|NCT02545933|Vorapaxar|vorapaxar|mesh-list
102296167|NCT02545933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102296168|NCT02545933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102296169|NCT02545933|Analgesics|analgesics|mesh-ancestor
102296170|NCT02545933|Sensory System Agents|sensory system agents|mesh-ancestor
102296171|NCT02545933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102296172|NCT02545933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296173|NCT02545933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102296174|NCT02545933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102296175|NCT02545933|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102296176|NCT02545933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102296177|NCT02545933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296178|NCT02545933|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102296179|NCT02545933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102296180|NCT02545933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102296181|NCT02545933|Antipyretics|antipyretics|mesh-ancestor
102296182|NCT02545933|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102296183|NCT02545933|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102296184|NCT02545933|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102296185|NCT02545933|Purinergic Agents|purinergic agents|mesh-ancestor
102296186|NCT02545933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102296187|NCT02545075|Ipilimumab|ipilimumab|mesh-list
102296188|NCT02545075|Dacarbazine|dacarbazine|mesh-list
102296189|NCT02545075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102296191|NCT02545075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102296192|NCT02545075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296193|NCT02545075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102296194|NCT02545075|Alkylating Agents|alkylating agents|mesh-ancestor
102296195|NCT03007537|Epoetin Alfa|epoetin alfa|mesh-list
102296196|NCT03007537|Hematinics|hematinics|mesh-ancestor
102296197|NCT03004183|Valacyclovir|valacyclovir|mesh-list
102296198|NCT03004183|Pembrolizumab|pembrolizumab|mesh-list
102296199|NCT03004183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102296200|NCT03004183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102296201|NCT03004183|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102296202|NCT03004183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296203|NCT03004183|Antiviral Agents|antiviral agents|mesh-ancestor
102296204|NCT03004183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102296205|NCT02544763|Cannabidiol|cannabidiol|mesh-list
102296206|NCT02544763|Anticonvulsants|anticonvulsants|mesh-ancestor
102296207|NCT02556203|Aspirin|aspirin|mesh-list
102296208|NCT02556203|Vitamin K|vitamin k|mesh-list
102296209|NCT02556203|Rivaroxaban|rivaroxaban|mesh-list
102296210|NCT02556203|Clopidogrel|clopidogrel|mesh-list
102296211|NCT02556203|Vitamins|vitamins|mesh-ancestor
102296212|NCT02556203|Micronutrients|micronutrients|mesh-ancestor
102296213|NCT02556203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296214|NCT02556203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102296215|NCT02556203|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102296216|NCT02556203|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102296217|NCT02556203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102296218|NCT02556203|Purinergic Agents|purinergic agents|mesh-ancestor
102296219|NCT02556203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102296220|NCT02556203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296221|NCT02556203|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102296222|NCT02556203|Antithrombins|antithrombins|mesh-ancestor
102296223|NCT02556203|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102296224|NCT02556203|Protease Inhibitors|protease inhibitors|mesh-ancestor
102296225|NCT02556203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102296226|NCT02556203|Anticoagulants|anticoagulants|mesh-ancestor
102296227|NCT02556203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102296228|NCT02556203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102296229|NCT02556203|Analgesics|analgesics|mesh-ancestor
102296230|NCT02556203|Sensory System Agents|sensory system agents|mesh-ancestor
102296231|NCT02556203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102296232|NCT02556203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102296233|NCT02556203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102296234|NCT02556203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102296235|NCT02556203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102296236|NCT02556203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102296237|NCT02556203|Antipyretics|antipyretics|mesh-ancestor
102296238|NCT02556203|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102296239|NCT02556203|Hemostatics|hemostatics|mesh-ancestor
102296240|NCT02556203|Coagulants|coagulants|mesh-ancestor
102296241|NCT05485571|Methotrexate|methotrexate|mesh-list
102296242|NCT05485571|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102296243|NCT05485571|Abortifacient Agents|abortifacient agents|mesh-ancestor
102296244|NCT05485571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102296245|NCT05485571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296246|NCT05485571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102296247|NCT05485571|Antimetabolites|antimetabolites|mesh-ancestor
102296248|NCT05485571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296249|NCT05485571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102296250|NCT05485571|Dermatologic Agents|dermatologic agents|mesh-ancestor
102296251|NCT05485571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102296252|NCT05485571|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102296253|NCT05485571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102296254|NCT05485571|Immunologic Factors|immunologic factors|mesh-ancestor
102296255|NCT05485571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102296256|NCT05485571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102296257|NCT05496725|Micafungin|micafungin|mesh-list
102296258|NCT05496725|Antifungal Agents|antifungal agents|mesh-ancestor
102296259|NCT05496725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102296260|NCT05490719|Cisplatin|cisplatin|mesh-list
102296261|NCT05490719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102296262|NCT04424459|Analgesics, Opioid|analgesics, opioid|mesh-list
102296263|NCT04424459|Narcotics|narcotics|mesh-ancestor
102296264|NCT04424459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102296265|NCT04424459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296266|NCT04424459|Analgesics|analgesics|mesh-ancestor
102296267|NCT04424459|Sensory System Agents|sensory system agents|mesh-ancestor
102296268|NCT04424459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102296269|NCT05485259|Thioctic Acid|thioctic acid|mesh-list
102296270|NCT05485259|Antioxidants|antioxidants|mesh-ancestor
102296271|NCT05485259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296272|NCT05485259|Protective Agents|protective agents|mesh-ancestor
102296273|NCT05485259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296274|NCT05485259|Vitamin B Complex|vitamin b complex|mesh-ancestor
102296276|NCT05485259|Micronutrients|micronutrients|mesh-ancestor
102296277|NCT05490485|Cisplatin|cisplatin|mesh-list
102296278|NCT05490485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102296279|NCT05485103|Glycerol|glycerol|mesh-list
102296280|NCT05485103|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102296281|NCT05485103|Protective Agents|protective agents|mesh-ancestor
102296282|NCT05485103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296283|NCT05490407|Carboplatin|carboplatin|mesh-list
102296284|NCT05490407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102296285|NCT05490095|Everolimus|everolimus|mesh-list
102296286|NCT05490095|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102296287|NCT05490095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102296288|NCT05490095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102296289|NCT05490095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296290|NCT05490095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102296291|NCT05490095|Immunologic Factors|immunologic factors|mesh-ancestor
102296292|NCT05490095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296293|NCT05490095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102296294|NCT04424381|Rivaroxaban|rivaroxaban|mesh-list
102296295|NCT04424381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102296296|NCT04424381|Antithrombins|antithrombins|mesh-ancestor
102296297|NCT04424381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102296298|NCT04424381|Protease Inhibitors|protease inhibitors|mesh-ancestor
102296299|NCT04424381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102296300|NCT04424381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296301|NCT04424381|Anticoagulants|anticoagulants|mesh-ancestor
102296302|NCT05496179|Metoclopramide|metoclopramide|mesh-list
102296303|NCT05496179|Prucalopride|prucalopride|mesh-list
102296304|NCT05496179|Antiemetics|antiemetics|mesh-ancestor
102296305|NCT05496179|Autonomic Agents|autonomic agents|mesh-ancestor
102296306|NCT05496179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102296307|NCT05496179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296308|NCT05496179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102005035|NCT01183247|Immunologic Factors|immunologic factors|mesh-ancestor
102296309|NCT05496179|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102296310|NCT05496179|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102296311|NCT05496179|Dopamine Agents|dopamine agents|mesh-ancestor
102296312|NCT05496179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102296313|NCT05496179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296314|NCT05496179|Laxatives|laxatives|mesh-ancestor
102296315|NCT05496179|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
102296316|NCT05496179|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102296317|NCT05496179|Serotonin Agents|serotonin agents|mesh-ancestor
102296318|NCT05489939|Salicylates|salicylates|mesh-list
102296319|NCT05489939|Methyl salicylate|methyl salicylate|mesh-list
102296320|NCT05489939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102296321|NCT05489939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102296322|NCT05489939|Analgesics|analgesics|mesh-ancestor
102296323|NCT05489939|Sensory System Agents|sensory system agents|mesh-ancestor
102296324|NCT05489939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102296325|NCT05489939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296326|NCT05489939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102296327|NCT05489939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102296328|NCT05489939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102296329|NCT05489939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102296330|NCT05489939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296331|NCT03999749|Nivolumab|nivolumab|mesh-list
102296332|NCT03999749|Ipilimumab|ipilimumab|mesh-list
102296333|NCT03999749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102296334|NCT03999749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102296335|NCT03999749|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102296336|NCT03999749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296337|NCT05483543|Pamiparib|pamiparib|mesh-list
102296338|NCT05483543|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102296339|NCT05483543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102296340|NCT05483543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296341|NCT05483543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102296343|NCT04139213|Buprenorphine|buprenorphine|mesh-list
102296344|NCT04139213|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102296345|NCT04139213|Naloxone|naloxone|mesh-list
102296346|NCT04139213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102296347|NCT04139213|Narcotics|narcotics|mesh-ancestor
102296348|NCT04139213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102296349|NCT04139213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296350|NCT04139213|Analgesics|analgesics|mesh-ancestor
102296351|NCT04139213|Sensory System Agents|sensory system agents|mesh-ancestor
102296352|NCT04139213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102296353|NCT04139213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102296354|NCT04139213|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102296355|NCT05494775|Mitogens|mitogens|mesh-list
102296356|NCT05494775|Endothelial Growth Factors|endothelial growth factors|mesh-list
102296357|NCT05494775|Mitosis Modulators|mitosis modulators|mesh-ancestor
102296358|NCT05494775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296359|NCT05494775|Growth Substances|growth substances|mesh-ancestor
102296360|NCT05494775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296361|NCT05488925|Vitamin E|vitamin e|mesh-list
102296362|NCT05488925|Diclofenac|diclofenac|mesh-list
102296363|NCT05488925|Piroxicam|piroxicam|mesh-list
102296364|NCT05488925|Tramadol|tramadol|mesh-list
102296365|NCT05488925|Vitamins|vitamins|mesh-ancestor
102296366|NCT05488925|Micronutrients|micronutrients|mesh-ancestor
102296367|NCT05488925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296368|NCT05488925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102296369|NCT05488925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102296370|NCT05488925|Analgesics|analgesics|mesh-ancestor
102296371|NCT05488925|Sensory System Agents|sensory system agents|mesh-ancestor
102296372|NCT05488925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102296373|NCT05488925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102296374|NCT05488925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102296375|NCT05488925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102296376|NCT05488925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102296377|NCT05488925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296378|NCT05488925|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102296379|NCT05488925|Narcotics|narcotics|mesh-ancestor
102296380|NCT05488925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102296381|NCT05488925|Antioxidants|antioxidants|mesh-ancestor
102296382|NCT05488925|Protective Agents|protective agents|mesh-ancestor
102296383|NCT05482763|Itraconazole|itraconazole|mesh-list
102296384|NCT05482763|Terbinafine|terbinafine|mesh-list
102296385|NCT05482763|Ciclopirox|ciclopirox|mesh-list
102296386|NCT05482763|Amorolfine|amorolfine|mesh-list
102296387|NCT05482763|Antifungal Agents|antifungal agents|mesh-ancestor
102296388|NCT05482763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102296389|NCT05482763|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102296390|NCT05482763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102296391|NCT05482763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102296392|NCT05482763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296393|NCT05482763|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102296394|NCT05482763|Hormone Antagonists|hormone antagonists|mesh-ancestor
102296395|NCT05482763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102296396|NCT05482763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296397|NCT05482763|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102296398|NCT05482373|Oleuropein|oleuropein|mesh-list
102296399|NCT05482373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102296400|NCT05482373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102296401|NCT05482373|Vasodilator Agents|vasodilator agents|mesh-ancestor
102296402|NCT05482295|Vaccines|vaccines|mesh-list
102296403|NCT05482295|Immunologic Factors|immunologic factors|mesh-ancestor
102296404|NCT05482295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296405|NCT04245839|Cyclophosphamide|cyclophosphamide|mesh-list
102296406|NCT04245839|Fludarabine|fludarabine|mesh-list
102296407|NCT04245839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102296408|NCT04245839|Immunologic Factors|immunologic factors|mesh-ancestor
102296409|NCT04245839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296410|NCT04245839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102296411|NCT04245839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102296412|NCT04245839|Alkylating Agents|alkylating agents|mesh-ancestor
102296413|NCT04245839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296414|NCT04245839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102296415|NCT04245839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102296416|NCT05494307|Terbutaline|terbutaline|mesh-list
102296417|NCT05494307|Danazol|danazol|mesh-list
102296418|NCT05494307|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102296419|NCT05494307|Autonomic Agents|autonomic agents|mesh-ancestor
102296420|NCT05494307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102296421|NCT05494307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296422|NCT05494307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102296423|NCT05494307|Respiratory System Agents|respiratory system agents|mesh-ancestor
102296424|NCT05494307|Sympathomimetics|sympathomimetics|mesh-ancestor
102296425|NCT05494307|Tocolytic Agents|tocolytic agents|mesh-ancestor
102296426|NCT05494307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102296427|NCT05494307|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102296428|NCT05494307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102296429|NCT05494307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102296430|NCT05494307|Adrenergic Agents|adrenergic agents|mesh-ancestor
102296431|NCT05494307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102296432|NCT05494307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296433|NCT05494307|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102296434|NCT05494307|Hormone Antagonists|hormone antagonists|mesh-ancestor
102296435|NCT05494307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102296436|NCT04051619|Oxytocin|oxytocin|mesh-list
102296437|NCT04051619|Oxytocics|oxytocics|mesh-ancestor
102296438|NCT04051619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102296439|NCT04051619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296440|NCT05481437|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102296441|NCT05481437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102296442|NCT05481437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102296443|NCT05481437|Immunotoxins|immunotoxins|mesh-ancestor
102296444|NCT05481437|Immunoconjugates|immunoconjugates|mesh-ancestor
102296445|NCT05481437|Immunologic Factors|immunologic factors|mesh-ancestor
102296446|NCT05481437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296447|NCT05487521|Methylprednisolone|methylprednisolone|mesh-list
102296448|NCT05487521|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102296449|NCT05487521|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102296450|NCT05487521|Prednisolone|prednisolone|mesh-list
102296451|NCT05487521|Prednisolone acetate|prednisolone acetate|mesh-list
102296452|NCT05487521|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102296453|NCT05487521|Prednisolone phosphate|prednisolone phosphate|mesh-list
102296454|NCT05487521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102296455|NCT05487521|Antiemetics|antiemetics|mesh-ancestor
102296456|NCT05487521|Autonomic Agents|autonomic agents|mesh-ancestor
102296457|NCT05487521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102296458|NCT05487521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296459|NCT05487521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102296460|NCT05487521|Glucocorticoids|glucocorticoids|mesh-ancestor
102296461|NCT05487521|Hormones|hormones|mesh-ancestor
102296462|NCT05487521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102296463|NCT05487521|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102296464|NCT05487521|Protective Agents|protective agents|mesh-ancestor
102005184|NCT03851393|Sodium Citrate|sodium citrate|mesh-list
102296465|NCT05487521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102296466|NCT05487521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102296467|NCT05481281|Dexmedetomidine|dexmedetomidine|mesh-list
102296469|NCT05481281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102296470|NCT05481281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102296471|NCT05481281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296472|NCT05481281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102296473|NCT05481281|Analgesics|analgesics|mesh-ancestor
102296474|NCT05481281|Sensory System Agents|sensory system agents|mesh-ancestor
102296475|NCT05481281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102296476|NCT05481281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102296477|NCT05481281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102296478|NCT05481281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102296479|NCT05481281|Adrenergic Agents|adrenergic agents|mesh-ancestor
102296480|NCT05481281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102296481|NCT05481281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296482|NCT05481281|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102296483|NCT05481281|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102296484|NCT05481281|Anesthetics, General|anesthetics, general|mesh-ancestor
102296485|NCT05481281|Anesthetics|anesthetics|mesh-ancestor
102296486|NCT05481281|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102296487|NCT05481281|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102296488|NCT05487443|Gemcitabine|gemcitabine|mesh-list
102296489|NCT05487443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102296490|NCT05487443|Antimetabolites|antimetabolites|mesh-ancestor
102296491|NCT05487443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296492|NCT05487443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102296493|NCT02558231|Selexipag|selexipag|mesh-list
102296494|NCT02558231|Tadalafil|tadalafil|mesh-list
102296495|NCT02558231|Macitentan|macitentan|mesh-list
102296496|NCT02558231|Vasodilator Agents|vasodilator agents|mesh-ancestor
102296497|NCT02558231|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102296498|NCT02558231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102296499|NCT02558231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102296500|NCT02558231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296501|NCT02558231|Urological Agents|urological agents|mesh-ancestor
102296502|NCT02558231|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
102296503|NCT02558231|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102296504|NCT02558231|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
102296505|NCT02558231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102296506|NCT05486819|Propofol|propofol|mesh-list
102296507|NCT05486819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102296508|NCT05486819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102296509|NCT05486819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296510|NCT05486819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102296511|NCT05486819|Anesthetics, General|anesthetics, general|mesh-ancestor
102296512|NCT05486819|Anesthetics|anesthetics|mesh-ancestor
102296513|NCT03860987|Prednisone|prednisone|mesh-list
102296514|NCT03860987|Goserelin|goserelin|mesh-list
102296515|NCT03860987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102296516|NCT03860987|Glucocorticoids|glucocorticoids|mesh-ancestor
102296517|NCT03860987|Hormones|hormones|mesh-ancestor
102296518|NCT03860987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102296519|NCT03860987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296520|NCT03860987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102296521|NCT03860987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102296522|NCT05480111|Anesthetics|anesthetics|mesh-list
102296523|NCT05480111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102296524|NCT05480111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296525|NCT05475431|Bismuth|bismuth|mesh-list
102296526|NCT05475431|Antacids|antacids|mesh-ancestor
102296527|NCT05475431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296528|NCT05475431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102296529|NCT05492669|Lidocaine|lidocaine|mesh-list
102296530|NCT05492669|Anesthetics, Local|anesthetics, local|mesh-ancestor
102296531|NCT05492669|Anesthetics|anesthetics|mesh-ancestor
102296532|NCT05492669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102296533|NCT05492669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296534|NCT05492669|Sensory System Agents|sensory system agents|mesh-ancestor
102296535|NCT05492669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102296536|NCT05492669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102296537|NCT05492669|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102296538|NCT05492669|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102296539|NCT05492669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102296540|NCT05492669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296541|NCT05492591|Valacyclovir|valacyclovir|mesh-list
102296542|NCT05492591|Antiviral Agents|antiviral agents|mesh-ancestor
102296543|NCT05492591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102296544|NCT02554721|Aspirin|aspirin|mesh-list
102296545|NCT02554721|Cilostazol|cilostazol|mesh-list
102296546|NCT02554721|Clopidogrel|clopidogrel|mesh-list
102296547|NCT02554721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101397257|NCT00318838|Azimilide|azimilide|mesh-list
102296548|NCT02554721|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102296549|NCT02554721|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102296550|NCT02554721|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102296551|NCT02554721|Purinergic Agents|purinergic agents|mesh-ancestor
102296552|NCT02554721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102296553|NCT02554721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296554|NCT02554721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296555|NCT02554721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102296556|NCT02554721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102296557|NCT02554721|Analgesics|analgesics|mesh-ancestor
102296558|NCT02554721|Sensory System Agents|sensory system agents|mesh-ancestor
102296559|NCT02554721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102296560|NCT02554721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102296561|NCT02554721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102296562|NCT02554721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102296563|NCT02554721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102296564|NCT02554721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102296565|NCT02554721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102296566|NCT02554721|Antipyretics|antipyretics|mesh-ancestor
102296567|NCT02554721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102296568|NCT02554721|Autonomic Agents|autonomic agents|mesh-ancestor
102296569|NCT02554721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102296570|NCT02554721|Respiratory System Agents|respiratory system agents|mesh-ancestor
102296571|NCT02554721|Vasodilator Agents|vasodilator agents|mesh-ancestor
102296572|NCT02554721|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102296573|NCT02554721|Protective Agents|protective agents|mesh-ancestor
102296574|NCT02554721|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102296575|NCT02554721|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102296576|NCT03810911|Darbepoetin alfa|darbepoetin alfa|mesh-list
102296577|NCT03810911|Hematinics|hematinics|mesh-ancestor
102296578|NCT02552225|Amitriptyline|amitriptyline|mesh-list
102296579|NCT02552225|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102296580|NCT02552225|Antidepressive Agents|antidepressive agents|mesh-ancestor
102296581|NCT02552225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102296582|NCT02552225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102296583|NCT02552225|Analgesics|analgesics|mesh-ancestor
102296584|NCT02552225|Sensory System Agents|sensory system agents|mesh-ancestor
102296585|NCT02552225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102296586|NCT02552225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296587|NCT02552225|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102296588|NCT02552225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102296589|NCT02552225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102296590|NCT02552225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296591|NCT02552225|Adrenergic Agents|adrenergic agents|mesh-ancestor
102296592|NCT02552225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102296593|NCT02552147|Nicotine|nicotine|mesh-list
102296594|NCT02552147|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102296595|NCT02552147|Autonomic Agents|autonomic agents|mesh-ancestor
102296596|NCT02552147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102296597|NCT02552147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296598|NCT02552147|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102296599|NCT02552147|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102296600|NCT02552147|Cholinergic Agents|cholinergic agents|mesh-ancestor
102296601|NCT02552147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102296602|NCT02552147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296603|NCT05479487|Apatinib|apatinib|mesh-list
102296604|NCT05479487|Fluzoparib|fluzoparib|mesh-list
102296605|NCT05479487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102296606|NCT05479487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102296607|NCT05479487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102296608|NCT05479487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296609|NCT05479487|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102296610|NCT05479175|Ibuprofen|ibuprofen|mesh-list
102296611|NCT05479175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102296612|NCT05479175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102296614|NCT05479175|Sensory System Agents|sensory system agents|mesh-ancestor
102296615|NCT05479175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102296616|NCT05479175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296617|NCT05479175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102296618|NCT05479175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102296619|NCT05479175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102296620|NCT05479175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102296621|NCT05479175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296622|NCT02534935|Vaccines|vaccines|mesh-list
102296623|NCT02534935|Immunologic Factors|immunologic factors|mesh-ancestor
102296624|NCT02534935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296625|NCT02544451|Ivacaftor|ivacaftor|mesh-list
102296626|NCT02544451|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102296627|NCT02544451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102296628|NCT02544451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296629|NCT02551991|Leucovorin|leucovorin|mesh-list
102296630|NCT02551991|Fluorouracil|fluorouracil|mesh-list
102296631|NCT02551991|Oxaliplatin|oxaliplatin|mesh-list
102296632|NCT02551991|Antimetabolites|antimetabolites|mesh-ancestor
102296633|NCT02551991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296634|NCT02551991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102296635|NCT02551991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102296636|NCT02551991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102296637|NCT02551991|Immunologic Factors|immunologic factors|mesh-ancestor
102296638|NCT02551991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296639|NCT02551991|Antidotes|antidotes|mesh-ancestor
102296640|NCT02551991|Protective Agents|protective agents|mesh-ancestor
102296641|NCT02551991|Vitamin B Complex|vitamin b complex|mesh-ancestor
102296642|NCT02551991|Vitamins|vitamins|mesh-ancestor
102296643|NCT02551991|Micronutrients|micronutrients|mesh-ancestor
102296644|NCT05491811|Bevacizumab|bevacizumab|mesh-list
102296645|NCT05491811|Ensartinib|ensartinib|mesh-list
102296646|NCT05491811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102296647|NCT05491811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102296648|NCT05491811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102296649|NCT05491811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102296650|NCT05491811|Growth Substances|growth substances|mesh-ancestor
102296651|NCT05491811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296652|NCT05491811|Growth Inhibitors|growth inhibitors|mesh-ancestor
102296653|NCT05491811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102296654|NCT05491811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102296655|NCT05491811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296656|NCT05478785|Cisplatin|cisplatin|mesh-list
102296657|NCT05478785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102296658|NCT02880293|Mycophenolic Acid|mycophenolic acid|mesh-list
102296659|NCT02880293|Cyclophosphamide|cyclophosphamide|mesh-list
102296660|NCT02880293|Melphalan|melphalan|mesh-list
102296661|NCT02880293|Thiotepa|thiotepa|mesh-list
102296662|NCT02880293|Fludarabine|fludarabine|mesh-list
102296663|NCT02880293|Tacrolimus|tacrolimus|mesh-list
102296664|NCT02880293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102296665|NCT02880293|Immunologic Factors|immunologic factors|mesh-ancestor
102296666|NCT02880293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296667|NCT02880293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102296668|NCT02880293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102296669|NCT02880293|Alkylating Agents|alkylating agents|mesh-ancestor
102296670|NCT02880293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296671|NCT02880293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102296672|NCT02880293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102296673|NCT02880293|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102296674|NCT02880293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102296675|NCT02880293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102296676|NCT02880293|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102296677|NCT02880293|Antitubercular Agents|antitubercular agents|mesh-ancestor
102296678|NCT02880293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102296679|NCT02880293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102296680|NCT02865551|Anesthetics|anesthetics|mesh-list
102296681|NCT02865551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102296682|NCT02865551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296683|NCT05478083|Leuprolide|leuprolide|mesh-list
102296684|NCT05478083|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102005411|NCT03167151|Pembrolizumab|pembrolizumab|mesh-list
102296685|NCT05478083|Fertility Agents|fertility agents|mesh-ancestor
102296686|NCT05478083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102296687|NCT05478083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296688|NCT05478083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102296689|NCT05478083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102296690|NCT02544217|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
102296691|NCT02544217|Antioxidants|antioxidants|mesh-ancestor
102296692|NCT02544217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296693|NCT02544217|Protective Agents|protective agents|mesh-ancestor
102296694|NCT02544217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296695|NCT05427565|Caffeine|caffeine|mesh-list
102296696|NCT05427565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102296697|NCT05427565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296698|NCT05427565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102296699|NCT05427565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102296700|NCT05427565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296701|NCT05427565|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102296702|NCT05427565|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102296703|NCT05427565|Purinergic Agents|purinergic agents|mesh-ancestor
102296704|NCT05427565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102296705|NCT02533453|Exenatide|exenatide|mesh-list
102296706|NCT02533453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102296707|NCT02533453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296708|NCT02533453|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102296709|NCT02533453|Incretins|incretins|mesh-ancestor
102296710|NCT02533453|Hormones|hormones|mesh-ancestor
102296711|NCT02533453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102296712|NCT05424835|Capecitabine|capecitabine|mesh-list
102296713|NCT05424835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102296714|NCT05424835|Antimetabolites|antimetabolites|mesh-ancestor
102296715|NCT05424835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296716|NCT05424835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102296717|NCT02533375|Adalimumab|adalimumab|mesh-list
102296718|NCT02533375|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102296719|NCT02533375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102296720|NCT02533375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102296721|NCT01553149|Lenalidomide|lenalidomide|mesh-list
102296722|NCT01553149|Immunologic Factors|immunologic factors|mesh-ancestor
102296723|NCT01553149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296724|NCT01553149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102296725|NCT01553149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102296726|NCT01553149|Growth Substances|growth substances|mesh-ancestor
102296727|NCT01553149|Growth Inhibitors|growth inhibitors|mesh-ancestor
102296728|NCT01553149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102296729|NCT02551055|Paclitaxel|paclitaxel|mesh-list
102296730|NCT02551055|Docetaxel|docetaxel|mesh-list
102296731|NCT02551055|Serabelisib|serabelisib|mesh-list
102296732|NCT02551055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102296733|NCT02551055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102296734|NCT02551055|Tubulin Modulators|tubulin modulators|mesh-ancestor
102296735|NCT02551055|Antimitotic Agents|antimitotic agents|mesh-ancestor
102296736|NCT02551055|Mitosis Modulators|mitosis modulators|mesh-ancestor
102296737|NCT02551055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296738|NCT02551055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102296739|NCT05470673|Metronidazole|metronidazole|mesh-list
102296740|NCT05470673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102296741|NCT05470673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102296742|NCT05470673|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102296743|NCT05470673|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102296744|NCT05459285|Dulaglutide|dulaglutide|mesh-list
102296745|NCT05459285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102296746|NCT05459285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296747|NCT02542943|Fluorides|fluorides|mesh-list
102296748|NCT02542943|Cariostatic Agents|cariostatic agents|mesh-ancestor
102296749|NCT02542943|Protective Agents|protective agents|mesh-ancestor
102296750|NCT02542943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296751|NCT03284957|Everolimus|everolimus|mesh-list
102296752|NCT03284957|Palbociclib|palbociclib|mesh-list
102296753|NCT03284957|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102296754|NCT03284957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102296755|NCT03284957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102296756|NCT03284957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296757|NCT03284957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102005484|NCT01193855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102296758|NCT03284957|Immunologic Factors|immunologic factors|mesh-ancestor
102296759|NCT03284957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296760|NCT03284957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102296761|NCT02542631|Insulin|insulin|mesh-list
102296762|NCT02542631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102296764|NCT02542631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296765|NCT02549573|Apomorphine|apomorphine|mesh-list
102296766|NCT02549573|Emetics|emetics|mesh-ancestor
102296767|NCT02549573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296768|NCT02549573|Autonomic Agents|autonomic agents|mesh-ancestor
102296769|NCT02549573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102296770|NCT02549573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102296771|NCT02549573|Dopamine Agonists|dopamine agonists|mesh-ancestor
102296772|NCT02549573|Dopamine Agents|dopamine agents|mesh-ancestor
102296773|NCT02549573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102296774|NCT02549573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296775|NCT05477615|Carboplatin|carboplatin|mesh-list
102296776|NCT05477615|Pemetrexed|pemetrexed|mesh-list
102296777|NCT05477615|Lazertinib|lazertinib|mesh-list
102296778|NCT05477615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102296779|NCT05477615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102296780|NCT05477615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296781|NCT05477615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102296782|NCT05477615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102296783|NCT05477615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102296784|NCT02710097|Ethanol|ethanol|mesh-list
102296785|NCT02710097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102296786|NCT02710097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102296787|NCT02710097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102296788|NCT02710097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296789|NCT02529553|LY3076226|ly3076226|mesh-list
102296790|NCT02529553|Immunoconjugates|immunoconjugates|mesh-ancestor
102296791|NCT02529553|Immunologic Factors|immunologic factors|mesh-ancestor
102296792|NCT02529553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296793|NCT02547935|Dapagliflozin|dapagliflozin|mesh-list
102296794|NCT02547935|Saxagliptin|saxagliptin|mesh-list
102296795|NCT02547935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102296796|NCT02547935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296797|NCT02547935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102296798|NCT02547935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296799|NCT02547935|Incretins|incretins|mesh-ancestor
102296800|NCT02547935|Hormones|hormones|mesh-ancestor
102296801|NCT02547935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102296802|NCT02547935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102296803|NCT02547935|Protease Inhibitors|protease inhibitors|mesh-ancestor
102296804|NCT02547935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102296805|NCT04258111|Antibodies|antibodies|mesh-list
102296806|NCT04258111|Immunoglobulins|immunoglobulins|mesh-list
102296807|NCT04258111|Immunologic Factors|immunologic factors|mesh-ancestor
102296808|NCT04258111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296809|NCT02327169|Paclitaxel|paclitaxel|mesh-list
102296810|NCT02327169|Irinotecan|irinotecan|mesh-list
102296811|NCT02327169|Cetuximab|cetuximab|mesh-list
102296812|NCT02327169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102296813|NCT02327169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102296814|NCT02327169|Tubulin Modulators|tubulin modulators|mesh-ancestor
102296815|NCT02327169|Antimitotic Agents|antimitotic agents|mesh-ancestor
102296816|NCT02327169|Mitosis Modulators|mitosis modulators|mesh-ancestor
102296817|NCT02327169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296818|NCT02327169|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102296819|NCT02327169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102296820|NCT02327169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102296821|NCT02327169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102296822|NCT02327013|Vortioxetine|vortioxetine|mesh-list
101397509|NCT00319345|Mannitol|mannitol|mesh-list
102296823|NCT02327013|Antidepressive Agents|antidepressive agents|mesh-ancestor
102296824|NCT02327013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102296825|NCT02327013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102296826|NCT02327013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102296827|NCT02327013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102296828|NCT02327013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296829|NCT02327013|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102296830|NCT02327013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102296831|NCT02327013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102296832|NCT02327013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296833|NCT02327013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102296834|NCT02327013|Serotonin Agents|serotonin agents|mesh-ancestor
102296835|NCT02327013|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102296836|NCT02327013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102296837|NCT02327013|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102296838|NCT02327013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102296839|NCT02301975|Fluticasone|fluticasone|mesh-list
102296841|NCT02301975|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102296842|NCT02301975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102296843|NCT02301975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102296844|NCT02301975|Autonomic Agents|autonomic agents|mesh-ancestor
102296845|NCT02301975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102296846|NCT02301975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296847|NCT02301975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102296848|NCT02301975|Respiratory System Agents|respiratory system agents|mesh-ancestor
102296849|NCT02301975|Dermatologic Agents|dermatologic agents|mesh-ancestor
102296850|NCT02301975|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102296851|NCT02301975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102296852|NCT02301975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102296853|NCT02301975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102296854|NCT02301975|Adrenergic Agents|adrenergic agents|mesh-ancestor
102296855|NCT02301975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102296856|NCT02301975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296857|NCT04882839|Psilocybin|psilocybin|mesh-list
102296858|NCT04882839|Hallucinogens|hallucinogens|mesh-ancestor
102296859|NCT04882839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296860|NCT04882839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102296861|NCT02300259|Itraconazole|itraconazole|mesh-list
102296862|NCT02300259|Diltiazem|diltiazem|mesh-list
102296863|NCT02300259|Tadalafil|tadalafil|mesh-list
102296864|NCT02300259|Simvastatin|simvastatin|mesh-list
102296865|NCT02300259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102296866|NCT02300259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102296867|NCT02300259|Antimetabolites|antimetabolites|mesh-ancestor
102296868|NCT02300259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296869|NCT02300259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102296870|NCT02300259|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102296871|NCT02300259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102296872|NCT02300259|Antifungal Agents|antifungal agents|mesh-ancestor
102296873|NCT02300259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102296874|NCT02300259|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102296875|NCT02300259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102296876|NCT02300259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102296877|NCT02300259|Hormone Antagonists|hormone antagonists|mesh-ancestor
102296878|NCT02300259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102296879|NCT02300259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296880|NCT02300259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102296881|NCT02300259|Vasodilator Agents|vasodilator agents|mesh-ancestor
102296882|NCT02300259|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102296883|NCT02300259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102296884|NCT02300259|Urological Agents|urological agents|mesh-ancestor
102296885|NCT02300259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102296886|NCT02300259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102296887|NCT02300259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102296888|NCT02300259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102296889|NCT02300103|Sofosbuvir|sofosbuvir|mesh-list
102296890|NCT02300103|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102296891|NCT02300103|Velpatasvir|velpatasvir|mesh-list
102296892|NCT02300103|Antiviral Agents|antiviral agents|mesh-ancestor
102296893|NCT02300103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102296894|NCT02326467|Chlorhexidine|chlorhexidine|mesh-list
102296895|NCT02326467|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102296896|NCT02326467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102296897|NCT02326467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102296898|NCT02326467|Disinfectants|disinfectants|mesh-ancestor
102296899|NCT02326467|Dermatologic Agents|dermatologic agents|mesh-ancestor
102296900|NCT02299635|Nirogacestat|nirogacestat|mesh-list
102296901|NCT02299635|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
102296902|NCT02299635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102296903|NCT02299635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296904|NCT02366091|Methotrexate|methotrexate|mesh-list
102296905|NCT02366091|Colchicine|colchicine|mesh-list
102296906|NCT02366091|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102296907|NCT02366091|Abortifacient Agents|abortifacient agents|mesh-ancestor
102296908|NCT02366091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102296909|NCT02366091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296910|NCT02366091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102296911|NCT02366091|Antimetabolites|antimetabolites|mesh-ancestor
102296912|NCT02366091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296913|NCT02366091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102296914|NCT02366091|Dermatologic Agents|dermatologic agents|mesh-ancestor
102296915|NCT02366091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102296916|NCT02366091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102296917|NCT02366091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102296918|NCT02366091|Immunologic Factors|immunologic factors|mesh-ancestor
102296919|NCT02366091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102296920|NCT02366091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102296921|NCT02366091|Gout Suppressants|gout suppressants|mesh-ancestor
102296922|NCT02366091|Tubulin Modulators|tubulin modulators|mesh-ancestor
102296923|NCT02366091|Antimitotic Agents|antimitotic agents|mesh-ancestor
102296924|NCT02366091|Mitosis Modulators|mitosis modulators|mesh-ancestor
102296925|NCT05476679|Celecoxib|celecoxib|mesh-list
102296926|NCT05476679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102296927|NCT05476679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102296928|NCT05476679|Analgesics|analgesics|mesh-ancestor
102296929|NCT05476679|Sensory System Agents|sensory system agents|mesh-ancestor
102296930|NCT05476679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102296931|NCT05476679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296932|NCT05476679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102296933|NCT05476679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102296934|NCT05476679|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102296935|NCT05476679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102296936|NCT05476679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102296937|NCT05476679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296938|NCT02546765|Acetaminophen|acetaminophen|mesh-list
102296939|NCT02546765|Dexmedetomidine|dexmedetomidine|mesh-list
102296940|NCT02546765|Propofol|propofol|mesh-list
102296941|NCT02546765|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102296942|NCT02546765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102296943|NCT02546765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296944|NCT02546765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102296945|NCT02546765|Analgesics|analgesics|mesh-ancestor
102296946|NCT02546765|Sensory System Agents|sensory system agents|mesh-ancestor
102296947|NCT02546765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102296948|NCT02546765|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102296949|NCT02546765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102296950|NCT02546765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102296951|NCT02546765|Adrenergic Agents|adrenergic agents|mesh-ancestor
102296952|NCT02546765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102296953|NCT02546765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296954|NCT02546765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102296955|NCT02546765|Anesthetics, General|anesthetics, general|mesh-ancestor
102296956|NCT02546765|Anesthetics|anesthetics|mesh-ancestor
102296957|NCT02546765|Antipyretics|antipyretics|mesh-ancestor
102296958|NCT02553629|Rocuronium|rocuronium|mesh-list
102296959|NCT02553629|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102296960|NCT02553629|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102296961|NCT02553629|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102296962|NCT02553629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102296963|NCT02553629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296964|NCT03555851|Cyclophosphamide|cyclophosphamide|mesh-list
102296965|NCT03555851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102296966|NCT03555851|Immunologic Factors|immunologic factors|mesh-ancestor
102296967|NCT03555851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296968|NCT03555851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102296969|NCT03555851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102296970|NCT03555851|Alkylating Agents|alkylating agents|mesh-ancestor
102296971|NCT03555851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296972|NCT03555851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102296973|NCT03555851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102296974|NCT03029351|Exenatide|exenatide|mesh-list
102296975|NCT03029351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102296976|NCT03029351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296977|NCT03029351|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102296978|NCT03029351|Incretins|incretins|mesh-ancestor
102296979|NCT03029351|Hormones|hormones|mesh-ancestor
102296980|NCT03029351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102296981|NCT02325219|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102296982|NCT02325219|Immunologic Factors|immunologic factors|mesh-ancestor
102296983|NCT02325219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296984|NCT02365233|Insulin|insulin|mesh-list
102005706|NCT01426529|Sympathomimetics|sympathomimetics|mesh-ancestor
102296985|NCT02365233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102296986|NCT02365233|Pioglitazone|pioglitazone|mesh-list
102296987|NCT02365233|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102296988|NCT02365233|Insulin Glargine|insulin glargine|mesh-list
102296989|NCT02365233|Saxagliptin|saxagliptin|mesh-list
102296990|NCT02365233|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
102296991|NCT02365233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102296992|NCT02365233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102296993|NCT02365233|Incretins|incretins|mesh-ancestor
102296994|NCT02365233|Hormones|hormones|mesh-ancestor
102296995|NCT02365233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102296996|NCT02365233|Protease Inhibitors|protease inhibitors|mesh-ancestor
102296997|NCT02365233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102296998|NCT02365233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102296999|NCT02364999|Paclitaxel|paclitaxel|mesh-list
102297000|NCT02364999|Bevacizumab|bevacizumab|mesh-list
102297001|NCT02364999|Carboplatin|carboplatin|mesh-list
102297002|NCT02364999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102297003|NCT02364999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102297004|NCT02364999|Tubulin Modulators|tubulin modulators|mesh-ancestor
102297005|NCT02364999|Antimitotic Agents|antimitotic agents|mesh-ancestor
102297006|NCT02364999|Mitosis Modulators|mitosis modulators|mesh-ancestor
102297007|NCT02364999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297008|NCT02364999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102297009|NCT02364999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102297010|NCT02364999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102297011|NCT02364999|Growth Substances|growth substances|mesh-ancestor
102297012|NCT02364999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297013|NCT02364999|Growth Inhibitors|growth inhibitors|mesh-ancestor
102297014|NCT02363283|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
102297015|NCT02363283|Immunoconjugates|immunoconjugates|mesh-list
102297016|NCT02363283|Immunotoxins|immunotoxins|mesh-list
102297017|NCT02363283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102297018|NCT02363283|Immunologic Factors|immunologic factors|mesh-ancestor
102297019|NCT02363283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297020|NCT02363283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102297021|NCT02363283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102297022|NCT02321319|Hydromorphone|hydromorphone|mesh-list
102297023|NCT02321319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102297024|NCT02321319|Narcotics|narcotics|mesh-ancestor
102297025|NCT02321319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102297026|NCT02321319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297027|NCT02321319|Analgesics|analgesics|mesh-ancestor
102297028|NCT02321319|Sensory System Agents|sensory system agents|mesh-ancestor
102297029|NCT02321319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102297030|NCT02088541|Cytarabine|cytarabine|mesh-list
102297031|NCT02088541|Hydroxyurea|hydroxyurea|mesh-list
102297032|NCT02088541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102297033|NCT02088541|Antimetabolites|antimetabolites|mesh-ancestor
102297034|NCT02088541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297035|NCT02088541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102297036|NCT02088541|Antiviral Agents|antiviral agents|mesh-ancestor
102297037|NCT02088541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102297038|NCT02088541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102297039|NCT02088541|Immunologic Factors|immunologic factors|mesh-ancestor
102297040|NCT02088541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297041|NCT02088541|Antisickling Agents|antisickling agents|mesh-ancestor
102297042|NCT02088541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102297043|NCT02088541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102297044|NCT02294019|Ibuprofen|ibuprofen|mesh-list
102297045|NCT02294019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102297046|NCT02294019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102297047|NCT02294019|Analgesics|analgesics|mesh-ancestor
102297048|NCT02294019|Sensory System Agents|sensory system agents|mesh-ancestor
102297049|NCT02294019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102297050|NCT02294019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297051|NCT02294019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102297052|NCT02294019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102297053|NCT02294019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102297054|NCT02294019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102297055|NCT02294019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297057|NCT02320149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102297058|NCT02320149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102297059|NCT02320149|Dermatologic Agents|dermatologic agents|mesh-ancestor
102297060|NCT05405725|Denosumab|denosumab|mesh-list
102297062|NCT05405725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297063|NCT02293863|Oseltamivir|oseltamivir|mesh-list
102297064|NCT02293863|Antiviral Agents|antiviral agents|mesh-ancestor
102297065|NCT02293863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102297066|NCT02293863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102297067|NCT02293863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297068|NCT02293395|Aspirin|aspirin|mesh-list
102297069|NCT02293395|Rivaroxaban|rivaroxaban|mesh-list
102297070|NCT02293395|Clopidogrel|clopidogrel|mesh-list
102297071|NCT02293395|Ticagrelor|ticagrelor|mesh-list
102297072|NCT02293395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102297073|NCT02293395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102297074|NCT02293395|Analgesics|analgesics|mesh-ancestor
102297075|NCT02293395|Sensory System Agents|sensory system agents|mesh-ancestor
102297076|NCT02293395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102297077|NCT02293395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297078|NCT02293395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102297079|NCT02293395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102297080|NCT02293395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102297081|NCT02293395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102297082|NCT02293395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297083|NCT02293395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102297084|NCT02293395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102297085|NCT02293395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102297086|NCT02293395|Antipyretics|antipyretics|mesh-ancestor
102297087|NCT02293395|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102297088|NCT02293395|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102297089|NCT02293395|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102297090|NCT02293395|Purinergic Agents|purinergic agents|mesh-ancestor
102297091|NCT02293395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102297092|NCT02293395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102297093|NCT02293395|Antithrombins|antithrombins|mesh-ancestor
102297094|NCT02293395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102297095|NCT02293395|Protease Inhibitors|protease inhibitors|mesh-ancestor
102297096|NCT02293395|Anticoagulants|anticoagulants|mesh-ancestor
102297097|NCT05447065|Vitamin D|vitamin d|mesh-list
102297098|NCT05447065|Vitamins|vitamins|mesh-ancestor
102297099|NCT05447065|Micronutrients|micronutrients|mesh-ancestor
102297100|NCT05447065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297101|NCT05447065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102297102|NCT01351909|Cyclophosphamide|cyclophosphamide|mesh-list
102297103|NCT01351909|Veliparib|veliparib|mesh-list
102297104|NCT01351909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102297105|NCT01351909|Immunologic Factors|immunologic factors|mesh-ancestor
102297106|NCT01351909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297107|NCT01351909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102297108|NCT01351909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102297109|NCT01351909|Alkylating Agents|alkylating agents|mesh-ancestor
102297110|NCT01351909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297111|NCT01351909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102297112|NCT01351909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102297113|NCT01351909|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102297114|NCT01351909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102297115|NCT05401357|Bimatoprost|bimatoprost|mesh-list
102297116|NCT05401357|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102297117|NCT05401357|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102297118|NCT05401357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102297119|NCT05401279|Gemcitabine|gemcitabine|mesh-list
102297120|NCT05401279|Tislelizumab|tislelizumab|mesh-list
102297121|NCT05401279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102297122|NCT05401279|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102297123|NCT05401279|Antimetabolites|antimetabolites|mesh-ancestor
102297124|NCT05401279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297125|NCT05401279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102297126|NCT05451095|Ketamine|ketamine|mesh-list
102297127|NCT05451095|Analgesics|analgesics|mesh-ancestor
102297129|NCT05451095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102297130|NCT05451095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297131|NCT05451095|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102297132|NCT05451095|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102297133|NCT05451095|Anesthetics, General|anesthetics, general|mesh-ancestor
102297134|NCT05451095|Anesthetics|anesthetics|mesh-ancestor
102297135|NCT05451095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102297136|NCT05451095|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102297137|NCT05451095|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102297138|NCT05451095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102297139|NCT05451095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297141|NCT02954081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102297142|NCT02954081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102297143|NCT02954081|Analgesics|analgesics|mesh-ancestor
102297144|NCT02954081|Sensory System Agents|sensory system agents|mesh-ancestor
102297145|NCT02954081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102297146|NCT02954081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297147|NCT02954081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102297148|NCT02954081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102297149|NCT02954081|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102297150|NCT02954081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102297151|NCT02954081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102297152|NCT02954081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297153|NCT02532283|Oseltamivir|oseltamivir|mesh-list
102297154|NCT02532283|Antiviral Agents|antiviral agents|mesh-ancestor
102297155|NCT02532283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102297156|NCT02532283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102297157|NCT02532283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297158|NCT01349959|Azacitidine|azacitidine|mesh-list
102297159|NCT01349959|Entinostat|entinostat|mesh-list
102297160|NCT01349959|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
102297161|NCT01349959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102297162|NCT01349959|Antimetabolites|antimetabolites|mesh-ancestor
102297163|NCT01349959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297164|NCT01349959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102297165|NCT01349959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102297166|NCT01349881|Eflornithine|eflornithine|mesh-list
102297167|NCT01349881|Sulindac|sulindac|mesh-list
102297168|NCT01349881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102297169|NCT01349881|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102297170|NCT01349881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102297171|NCT01349881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102297172|NCT01349881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102297173|NCT01349881|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
102297174|NCT01349881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102297175|NCT01349881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297176|NCT01349881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102297177|NCT01349881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102297178|NCT01349881|Analgesics|analgesics|mesh-ancestor
102297179|NCT01349881|Sensory System Agents|sensory system agents|mesh-ancestor
102297180|NCT01349881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102297181|NCT01349881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297182|NCT01349881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102297183|NCT01349881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102297184|NCT01349881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102297185|NCT05417971|Fludarabine|fludarabine|mesh-list
102297186|NCT05417971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102297187|NCT05398705|Cepharanthine|cepharanthine|mesh-list
102297188|NCT05398705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102297189|NCT05398705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102297190|NCT05398705|Analgesics|analgesics|mesh-ancestor
102297191|NCT05398705|Sensory System Agents|sensory system agents|mesh-ancestor
102297192|NCT05398705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102297193|NCT05398705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638973|NCT04528173|Ketorolac|ketorolac|mesh-list
102297194|NCT05398705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102297195|NCT05398705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102297196|NCT05398705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102297197|NCT05398705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102297198|NCT05398705|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102297199|NCT05398705|Protective Agents|protective agents|mesh-ancestor
102297200|NCT05415865|Lidocaine|lidocaine|mesh-list
102297201|NCT05415865|Anesthetics, Local|anesthetics, local|mesh-ancestor
102297202|NCT05415865|Anesthetics|anesthetics|mesh-ancestor
102297203|NCT05415865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102297204|NCT05415865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297205|NCT05415865|Sensory System Agents|sensory system agents|mesh-ancestor
102297206|NCT05415865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102297207|NCT05415865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102297208|NCT05415865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102297209|NCT05415865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102297210|NCT05415865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102297211|NCT05415865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297212|NCT05415709|Paclitaxel|paclitaxel|mesh-list
102297213|NCT05415709|Cisplatin|cisplatin|mesh-list
102297214|NCT05415709|Carboplatin|carboplatin|mesh-list
102297215|NCT05415709|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102297216|NCT05415709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102297217|NCT05415709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102297218|NCT05415709|Tubulin Modulators|tubulin modulators|mesh-ancestor
102297219|NCT05415709|Antimitotic Agents|antimitotic agents|mesh-ancestor
102297220|NCT05415709|Mitosis Modulators|mitosis modulators|mesh-ancestor
102297221|NCT05415709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297222|NCT04262843|Vidarabine|vidarabine|mesh-list
102297223|NCT04262843|Mycophenolic Acid|mycophenolic acid|mesh-list
102297224|NCT04262843|Cyclophosphamide|cyclophosphamide|mesh-list
102297225|NCT04262843|Fludarabine|fludarabine|mesh-list
102297226|NCT04262843|Fludarabine phosphate|fludarabine phosphate|mesh-list
102297227|NCT04262843|Tacrolimus|tacrolimus|mesh-list
102297228|NCT04262843|Lenograstim|lenograstim|mesh-list
102297229|NCT04262843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102297230|NCT04262843|Immunologic Factors|immunologic factors|mesh-ancestor
102297231|NCT04262843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297232|NCT04262843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102297233|NCT04262843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102297234|NCT04262843|Alkylating Agents|alkylating agents|mesh-ancestor
102297235|NCT04262843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297236|NCT04262843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102297237|NCT04262843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102297238|NCT04262843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102297239|NCT04262843|Antimetabolites|antimetabolites|mesh-ancestor
102297240|NCT04262843|Antiviral Agents|antiviral agents|mesh-ancestor
102297241|NCT04262843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102297242|NCT04262843|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102297243|NCT04262843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102297244|NCT04262843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102297245|NCT04262843|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102297246|NCT04262843|Antitubercular Agents|antitubercular agents|mesh-ancestor
102297247|NCT04262843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102297248|NCT04262843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102297249|NCT02552303|Modafinil|modafinil|mesh-list
102297250|NCT02552303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102297251|NCT02552303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297252|NCT02552303|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102297253|NCT02552303|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102297254|NCT02552303|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102297255|NCT02552303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297256|NCT01660711|Leucovorin|leucovorin|mesh-list
102297257|NCT01660711|Fluorouracil|fluorouracil|mesh-list
102297258|NCT01660711|Oxaliplatin|oxaliplatin|mesh-list
102297259|NCT01660711|Irinotecan|irinotecan|mesh-list
102297260|NCT01660711|Antimetabolites|antimetabolites|mesh-ancestor
102297261|NCT01660711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297262|NCT01660711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102297263|NCT01660711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102297264|NCT01660711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102297265|NCT01660711|Immunologic Factors|immunologic factors|mesh-ancestor
102297266|NCT01660711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297267|NCT01660711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102297268|NCT01660711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102297270|NCT01660711|Antidotes|antidotes|mesh-ancestor
102297271|NCT01660711|Protective Agents|protective agents|mesh-ancestor
102297272|NCT01660711|Vitamin B Complex|vitamin b complex|mesh-ancestor
102297273|NCT01660711|Vitamins|vitamins|mesh-ancestor
102297274|NCT01660711|Micronutrients|micronutrients|mesh-ancestor
102297275|NCT02544113|Thymoglobulin|thymoglobulin|mesh-list
102297276|NCT02544113|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102297277|NCT02544113|Immunologic Factors|immunologic factors|mesh-ancestor
102297278|NCT02544113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297279|NCT02544113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102297280|NCT02538965|Lenalidomide|lenalidomide|mesh-list
102297281|NCT02538965|Immunologic Factors|immunologic factors|mesh-ancestor
102297282|NCT02538965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297283|NCT02538965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102297284|NCT02538965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102297285|NCT02538965|Growth Substances|growth substances|mesh-ancestor
102297286|NCT02538965|Growth Inhibitors|growth inhibitors|mesh-ancestor
102297287|NCT02538965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102297288|NCT02543801|Ketorolac|ketorolac|mesh-list
102297289|NCT02543801|Clonidine|clonidine|mesh-list
102297290|NCT02543801|Epinephrine|epinephrine|mesh-list
102297291|NCT02543801|Bupivacaine|bupivacaine|mesh-list
102297292|NCT02543801|Ropivacaine|ropivacaine|mesh-list
102297293|NCT02543801|Anesthetics, Local|anesthetics, local|mesh-ancestor
102297294|NCT02543801|Anesthetics|anesthetics|mesh-ancestor
102297295|NCT02543801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102297296|NCT02543801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297297|NCT02543801|Sensory System Agents|sensory system agents|mesh-ancestor
102297298|NCT02543801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102297299|NCT02543801|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102297300|NCT02543801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102297301|NCT02543801|Adrenergic Agents|adrenergic agents|mesh-ancestor
102297302|NCT02543801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102297303|NCT02543801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297304|NCT02543801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102297305|NCT02543801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102297306|NCT02543801|Autonomic Agents|autonomic agents|mesh-ancestor
102297307|NCT02543801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102297308|NCT02543801|Respiratory System Agents|respiratory system agents|mesh-ancestor
102297309|NCT02543801|Mydriatics|mydriatics|mesh-ancestor
102297310|NCT02543801|Sympathomimetics|sympathomimetics|mesh-ancestor
102297311|NCT02543801|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102297312|NCT02543801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102297313|NCT02543801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102297314|NCT02543801|Analgesics|analgesics|mesh-ancestor
102297315|NCT02543801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102297316|NCT02543801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102297317|NCT02543801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102297318|NCT02543801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102297319|NCT02543801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102297320|NCT02543801|Sympatholytics|sympatholytics|mesh-ancestor
102297321|NCT02543801|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102297322|NCT02481635|Paclitaxel|paclitaxel|mesh-list
102297323|NCT02481635|Gemcitabine|gemcitabine|mesh-list
102297324|NCT02481635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102297325|NCT02481635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102297326|NCT02481635|Tubulin Modulators|tubulin modulators|mesh-ancestor
102297327|NCT02481635|Antimitotic Agents|antimitotic agents|mesh-ancestor
102297328|NCT02481635|Mitosis Modulators|mitosis modulators|mesh-ancestor
102297329|NCT02481635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297330|NCT02481635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102297331|NCT02481635|Antimetabolites|antimetabolites|mesh-ancestor
102297332|NCT02470091|Denosumab|denosumab|mesh-list
102297333|NCT02470091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102297334|NCT02470091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297335|NCT02362503|Fostemsavir|fostemsavir|mesh-list
102297336|NCT02362503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102297337|NCT02362503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102297338|NCT02362503|Antiviral Agents|antiviral agents|mesh-ancestor
102297339|NCT02362503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102297340|NCT02362503|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102297341|NCT02362503|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102297342|NCT02362503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297343|NCT05411159|Analgesics, Opioid|analgesics, opioid|mesh-list
102297344|NCT05411159|Anesthetics|anesthetics|mesh-list
102297345|NCT05411159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102297346|NCT05411159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297348|NCT05411159|Analgesics|analgesics|mesh-ancestor
102297349|NCT05411159|Sensory System Agents|sensory system agents|mesh-ancestor
102297350|NCT05411159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102297351|NCT02362425|Acetylcysteine|acetylcysteine|mesh-list
102297352|NCT02362425|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102297353|NCT02362425|Antiviral Agents|antiviral agents|mesh-ancestor
102297354|NCT02362425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102297355|NCT02362425|Expectorants|expectorants|mesh-ancestor
102297356|NCT02362425|Respiratory System Agents|respiratory system agents|mesh-ancestor
102297357|NCT02362425|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102297358|NCT02362425|Antioxidants|antioxidants|mesh-ancestor
102297359|NCT02362425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297360|NCT02362425|Protective Agents|protective agents|mesh-ancestor
102297361|NCT02362425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297362|NCT02362425|Antidotes|antidotes|mesh-ancestor
102297363|NCT02362269|Vitamin D|vitamin d|mesh-list
102297364|NCT02362269|Vitamins|vitamins|mesh-ancestor
102297365|NCT02362269|Micronutrients|micronutrients|mesh-ancestor
102297366|NCT02362269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297367|NCT02362269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102297368|NCT02529995|Osimertinib|osimertinib|mesh-list
102297369|NCT02529995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102297370|NCT02529995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102297371|NCT02529995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102297372|NCT02529995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297373|NCT02319759|Ustekinumab|ustekinumab|mesh-list
102297374|NCT02319759|Dermatologic Agents|dermatologic agents|mesh-ancestor
102297375|NCT02318667|Golimumab|golimumab|mesh-list
102297376|NCT02318667|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102297377|NCT02318667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102297378|NCT02318667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102297379|NCT02318667|Immunologic Factors|immunologic factors|mesh-ancestor
102297380|NCT02318667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297381|NCT02292771|Vasotocin|vasotocin|mesh-list
102297382|NCT02292771|Atosiban|atosiban|mesh-list
102297383|NCT02292771|Hormone Antagonists|hormone antagonists|mesh-ancestor
101306100|NCT02023710|Carboplatin|carboplatin|mesh-list
102297384|NCT02292771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102297385|NCT02292771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297386|NCT02292771|Tocolytic Agents|tocolytic agents|mesh-ancestor
102297387|NCT02292771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102297388|NCT02292771|Oxytocics|oxytocics|mesh-ancestor
102297389|NCT02292771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102297390|NCT02291913|Tamoxifen|tamoxifen|mesh-list
102297391|NCT02291913|Everolimus|everolimus|mesh-list
102297392|NCT02291913|Letrozole|letrozole|mesh-list
102297393|NCT02291913|Fulvestrant|fulvestrant|mesh-list
102297394|NCT02291913|Anastrozole|anastrozole|mesh-list
102297395|NCT02291913|Exemestane|exemestane|mesh-list
102297396|NCT02291913|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102297397|NCT02291913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102297398|NCT02291913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102297399|NCT02291913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297400|NCT02291913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102297401|NCT02291913|Immunologic Factors|immunologic factors|mesh-ancestor
102297402|NCT02291913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297403|NCT02291913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102297404|NCT02291913|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102297405|NCT02291913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102297406|NCT02291913|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102297407|NCT02291913|Hormone Antagonists|hormone antagonists|mesh-ancestor
102297408|NCT02291913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102297409|NCT02291913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102297410|NCT02291913|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102297411|NCT02291913|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102297412|NCT02291913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102297413|NCT02291913|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102297414|NCT02291679|Linaclotide|linaclotide|mesh-list
102297415|NCT02291679|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102297416|NCT02291679|Enzyme Activators|enzyme activators|mesh-ancestor
102297417|NCT02291679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297418|NCT02291679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102297419|NCT02291601|Chlorhexidine|chlorhexidine|mesh-list
102297420|NCT02291601|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102297421|NCT02291601|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102297422|NCT02291601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102297423|NCT02291601|Disinfectants|disinfectants|mesh-ancestor
102297424|NCT02291601|Dermatologic Agents|dermatologic agents|mesh-ancestor
102297425|NCT02360475|Vaccines|vaccines|mesh-list
102297426|NCT02360475|Immunologic Factors|immunologic factors|mesh-ancestor
102297427|NCT02360475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297428|NCT02360397|Ranolazine|ranolazine|mesh-list
102297429|NCT02360397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102297430|NCT02360397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102297431|NCT02360397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297432|NCT02317809|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102297433|NCT02317809|Hormones|hormones|mesh-ancestor
102297434|NCT02317809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102297435|NCT02317809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297436|NCT02359851|Pembrolizumab|pembrolizumab|mesh-list
102006171|NCT01195649|Sorafenib|sorafenib|mesh-list
102297437|NCT02359851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102297439|NCT02359851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102297440|NCT02359851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297441|NCT01607905|Acetaminophen|acetaminophen|mesh-list
102297442|NCT01607905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102297443|NCT01607905|Analgesics|analgesics|mesh-ancestor
102297444|NCT01607905|Sensory System Agents|sensory system agents|mesh-ancestor
102297445|NCT01607905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102297446|NCT01607905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297447|NCT01607905|Antipyretics|antipyretics|mesh-ancestor
102297448|NCT02389543|Dexamethasone|dexamethasone|mesh-list
102297449|NCT02389543|Lenalidomide|lenalidomide|mesh-list
102297450|NCT02389543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102297451|NCT02389543|Antiemetics|antiemetics|mesh-ancestor
102297452|NCT02389543|Autonomic Agents|autonomic agents|mesh-ancestor
102297453|NCT02389543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102297454|NCT02389543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398233|NCT00332293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102297455|NCT02389543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102297456|NCT02389543|Glucocorticoids|glucocorticoids|mesh-ancestor
102297457|NCT02389543|Hormones|hormones|mesh-ancestor
102297458|NCT02389543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102297459|NCT02389543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102297460|NCT02389543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102297461|NCT02389543|Immunologic Factors|immunologic factors|mesh-ancestor
102297462|NCT02389543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102297463|NCT02389543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102297464|NCT02389543|Growth Substances|growth substances|mesh-ancestor
102297465|NCT02389543|Growth Inhibitors|growth inhibitors|mesh-ancestor
102297466|NCT05441605|Chlorhexidine|chlorhexidine|mesh-list
102297467|NCT05441605|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102297468|NCT05441605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102297469|NCT05441605|Disinfectants|disinfectants|mesh-ancestor
102297470|NCT00843037|Sunitinib|sunitinib|mesh-list
102297471|NCT00843037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102297472|NCT00843037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102297473|NCT00843037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102297474|NCT00843037|Growth Substances|growth substances|mesh-ancestor
102297475|NCT00843037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297476|NCT00843037|Growth Inhibitors|growth inhibitors|mesh-ancestor
102297477|NCT00843037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102297478|NCT00843037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102297479|NCT00843037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297480|NCT05441527|Muramidase|muramidase|mesh-list
102297481|NCT05441527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102297482|NCT02531035|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
102297483|NCT02531035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102297484|NCT02531035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297485|NCT02531035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102297486|NCT02531035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297487|NCT05004805|Methylene Blue|methylene blue|mesh-list
102297488|NCT05004805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102297489|NCT05004805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297490|NCT04261387|LUT014|lut014|mesh-list
102297491|NCT04261387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102297492|NCT04261387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102297493|NCT04261387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297494|NCT05411965|Pioglitazone|pioglitazone|mesh-list
102297495|NCT05411965|Dapagliflozin|dapagliflozin|mesh-list
102297496|NCT05411965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102297497|NCT05411965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297498|NCT05411965|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102297499|NCT05411965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297501|NCT04261075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102297502|NCT04261075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102297503|NCT05436769|Clarithromycin|clarithromycin|mesh-list
102297504|NCT05436769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102297505|NCT05436769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102297506|NCT05436769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102297507|NCT05436769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102006229|NCT00198718|Protective Agents|protective agents|mesh-ancestor
102297508|NCT05436769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297509|NCT05436769|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102297510|NCT05436769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102297511|NCT05378737|Exatecan|exatecan|mesh-list
102297512|NCT05378737|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102297513|NCT05378737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102297514|NCT05378737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102297515|NCT05378737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297516|NCT05378737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102297517|NCT03929029|Nivolumab|nivolumab|mesh-list
102297518|NCT03929029|Ipilimumab|ipilimumab|mesh-list
102297519|NCT03929029|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
102297520|NCT03929029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102297521|NCT03929029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102297522|NCT03929029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102297523|NCT03929029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297524|NCT03929029|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102297525|NCT03929029|Immunologic Factors|immunologic factors|mesh-ancestor
102297526|NCT03929029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297527|NCT01659853|Azelaic acid|azelaic acid|mesh-list
102297528|NCT01659853|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102297529|NCT01659853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102297530|NCT01659853|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102297531|NCT01659853|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102297532|NCT01659853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102297533|NCT01659853|Adrenergic Agents|adrenergic agents|mesh-ancestor
102297534|NCT01659853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102297535|NCT01659853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297536|NCT01659853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297537|NCT01659853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102297538|NCT01659853|Dermatologic Agents|dermatologic agents|mesh-ancestor
102297539|NCT05376553|Docetaxel|docetaxel|mesh-list
102297540|NCT05376553|Cemiplimab|cemiplimab|mesh-list
102297541|NCT05376553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102297542|NCT05376553|Tubulin Modulators|tubulin modulators|mesh-ancestor
102297543|NCT05376553|Antimitotic Agents|antimitotic agents|mesh-ancestor
102297544|NCT05376553|Mitosis Modulators|mitosis modulators|mesh-ancestor
102297545|NCT05376553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297546|NCT05376553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102297547|NCT05385367|Anesthetics|anesthetics|mesh-list
102297548|NCT05385367|Anesthetics, General|anesthetics, general|mesh-list
102297549|NCT05385367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102297550|NCT05385367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297551|NCT05576389|Fluzoparib|fluzoparib|mesh-list
102297552|NCT05576389|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102297553|NCT05576389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102297554|NCT05576389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297555|NCT05576389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102297556|NCT05341609|Ritonavir|ritonavir|mesh-list
102297557|NCT05341609|Nirmatrelvir|nirmatrelvir|mesh-list
102297558|NCT05341609|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
102297559|NCT05341609|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102297560|NCT05341609|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102297561|NCT05341609|Protease Inhibitors|protease inhibitors|mesh-ancestor
102297562|NCT05341609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102297563|NCT05341609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297564|NCT05341609|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102297565|NCT05341609|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102297566|NCT05341609|Antiviral Agents|antiviral agents|mesh-ancestor
102297567|NCT05341609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102297568|NCT05341609|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102297569|NCT05341609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102297570|NCT05371015|Ropivacaine|ropivacaine|mesh-list
102297571|NCT05371015|Anesthetics, Local|anesthetics, local|mesh-ancestor
102297572|NCT05371015|Anesthetics|anesthetics|mesh-ancestor
102297573|NCT05371015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102297574|NCT05371015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297575|NCT05371015|Sensory System Agents|sensory system agents|mesh-ancestor
102297576|NCT05371015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102297577|NCT02531113|Ozanimod|ozanimod|mesh-list
102297578|NCT02531113|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102297579|NCT02531113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297580|NCT02531113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102006309|NCT01193387|Insulin|insulin|mesh-list
102297582|NCT02531113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297583|NCT05509933|Budesonide|budesonide|mesh-list
102297584|NCT05509933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102297585|NCT05509933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102297586|NCT05509933|Autonomic Agents|autonomic agents|mesh-ancestor
102297587|NCT05509933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102297588|NCT05509933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297589|NCT05509933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102297590|NCT05509933|Respiratory System Agents|respiratory system agents|mesh-ancestor
102297591|NCT05509933|Glucocorticoids|glucocorticoids|mesh-ancestor
102297592|NCT05509933|Hormones|hormones|mesh-ancestor
102297593|NCT05509933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102297594|NCT05369533|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102297595|NCT05369533|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102297596|NCT05369533|Immunologic Factors|immunologic factors|mesh-ancestor
102297597|NCT05369533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297598|NCT05369533|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102297599|NCT05369533|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102297600|NCT05369533|Dopamine Agonists|dopamine agonists|mesh-ancestor
102297601|NCT05369533|Dopamine Agents|dopamine agents|mesh-ancestor
102297602|NCT05369533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102297603|NCT05369533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297604|NCT04248595|Azacitidine|azacitidine|mesh-list
102297605|NCT04248595|Homoharringtonine|homoharringtonine|mesh-list
102297606|NCT04248595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102297607|NCT04248595|Antimetabolites|antimetabolites|mesh-ancestor
102297608|NCT04248595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297609|NCT04248595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102297610|NCT04248595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102297611|NCT04248595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102297612|NCT04248595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102297613|NCT05334277|Bevacizumab|bevacizumab|mesh-list
102297614|NCT05334277|Carboplatin|carboplatin|mesh-list
102297615|NCT05334277|Pemetrexed|pemetrexed|mesh-list
102297616|NCT05334277|Aflutinib|aflutinib|mesh-list
102297617|NCT05334277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102297618|NCT05334277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102297619|NCT05334277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102297620|NCT05334277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102297621|NCT05334277|Growth Substances|growth substances|mesh-ancestor
102297622|NCT05334277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297623|NCT05334277|Growth Inhibitors|growth inhibitors|mesh-ancestor
102297624|NCT05334277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102297625|NCT05334277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297626|NCT05334277|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102297627|NCT05334277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102297628|NCT05334277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102297629|NCT05332717|Melatonin|melatonin|mesh-list
102297630|NCT05332717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297631|NCT05332717|Antioxidants|antioxidants|mesh-ancestor
102297632|NCT05332717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297633|NCT05332717|Protective Agents|protective agents|mesh-ancestor
102297634|NCT05332717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102297635|NCT05300269|Capecitabine|capecitabine|mesh-list
102297636|NCT05300269|Oxaliplatin|oxaliplatin|mesh-list
102297637|NCT05300269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102297638|NCT05300269|Antimetabolites|antimetabolites|mesh-ancestor
102297639|NCT05300269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297640|NCT05300269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102297641|NCT05325853|Proxymetacaine|proxymetacaine|mesh-list
102297642|NCT05325853|Propoxycaine|propoxycaine|mesh-list
102297643|NCT05325853|Anesthetics, Local|anesthetics, local|mesh-ancestor
102297644|NCT05325853|Anesthetics|anesthetics|mesh-ancestor
102297645|NCT05325853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102297646|NCT05325853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297647|NCT05325853|Sensory System Agents|sensory system agents|mesh-ancestor
102297648|NCT05325853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102297649|NCT05353933|Pantoprazole|pantoprazole|mesh-list
102297650|NCT05353933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102297651|NCT05353933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102297652|NCT05353933|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102297653|NCT05353933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102006376|NCT02517424|Dronabinol|dronabinol|mesh-list
102297654|NCT05353933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297655|NCT05352685|Propofol|propofol|mesh-list
102297656|NCT05352685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102297657|NCT05352685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102297658|NCT05352685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297659|NCT05352685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102297660|NCT05352685|Anesthetics, General|anesthetics, general|mesh-ancestor
102297661|NCT05352685|Anesthetics|anesthetics|mesh-ancestor
102297662|NCT05351593|Lenalidomide|lenalidomide|mesh-list
102297663|NCT05351593|Immunologic Factors|immunologic factors|mesh-ancestor
102297664|NCT05351593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297665|NCT05351593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102297666|NCT05351593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102297667|NCT05351593|Growth Substances|growth substances|mesh-ancestor
102297668|NCT05351593|Growth Inhibitors|growth inhibitors|mesh-ancestor
102297669|NCT05351593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102297670|NCT05321875|Candesartan|candesartan|mesh-list
102297671|NCT05321875|Candesartan cilexetil|candesartan cilexetil|mesh-list
102297672|NCT05321875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102297673|NCT05321875|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102297674|NCT05321875|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102297675|NCT05321875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297676|NCT05347069|Aspirin|aspirin|mesh-list
102297677|NCT05347069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102297678|NCT05347069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102297679|NCT05347069|Analgesics|analgesics|mesh-ancestor
102297680|NCT05347069|Sensory System Agents|sensory system agents|mesh-ancestor
102297681|NCT05347069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102297682|NCT05347069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297683|NCT05347069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102297684|NCT05347069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102297685|NCT05347069|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102297686|NCT05347069|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102297687|NCT05347069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297688|NCT05347069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102297689|NCT05347069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102297690|NCT05347069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102297691|NCT05347069|Antipyretics|antipyretics|mesh-ancestor
102297692|NCT05516953|Baclofen|baclofen|mesh-list
102297693|NCT05516953|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102297694|NCT05516953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297695|NCT05516953|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102297696|NCT05516953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102297697|NCT05516953|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102297698|NCT05516953|GABA Agonists|gaba agonists|mesh-ancestor
102297699|NCT05516953|GABA Agents|gaba agents|mesh-ancestor
102297700|NCT05516953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102297701|NCT05516953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297702|NCT02522767|Mesalamine|mesalamine|mesh-list
102297703|NCT02522767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102297704|NCT02522767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102297705|NCT02522767|Analgesics|analgesics|mesh-ancestor
102297706|NCT02522767|Sensory System Agents|sensory system agents|mesh-ancestor
102297707|NCT02522767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102297708|NCT02522767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297709|NCT02522767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102297710|NCT02522767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102297711|NCT02522377|Midazolam|midazolam|mesh-list
102297712|NCT02522377|Ketamine|ketamine|mesh-list
102297713|NCT02522377|Analgesics|analgesics|mesh-ancestor
102297714|NCT02522377|Sensory System Agents|sensory system agents|mesh-ancestor
102297715|NCT02522377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102297716|NCT02522377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297717|NCT02522377|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102297718|NCT02522377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102297719|NCT02522377|Anesthetics, General|anesthetics, general|mesh-ancestor
102297720|NCT02522377|Anesthetics|anesthetics|mesh-ancestor
102297721|NCT02522377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102297722|NCT02522377|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102297723|NCT02522377|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102297724|NCT02522377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102297725|NCT02522377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297726|NCT02522377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102297727|NCT02522377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102297729|NCT02522377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102297730|NCT02522377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102297731|NCT02522377|GABA Modulators|gaba modulators|mesh-ancestor
102297732|NCT02522377|GABA Agents|gaba agents|mesh-ancestor
102297733|NCT05318755|Testosterone|testosterone|mesh-list
102297734|NCT05318755|Androgens|androgens|mesh-ancestor
102297735|NCT05318755|Hormones|hormones|mesh-ancestor
102297736|NCT05318755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102297737|NCT05318755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297738|NCT05267743|Lansoprazole|lansoprazole|mesh-list
102297739|NCT05267743|Dexlansoprazole|dexlansoprazole|mesh-list
102297740|NCT05267743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102297741|NCT05267743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102297742|NCT05267743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102297743|NCT05267743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102297744|NCT05267743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297745|NCT05291845|Vaccines|vaccines|mesh-list
102297746|NCT05291845|Immunologic Factors|immunologic factors|mesh-ancestor
102297747|NCT05291845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297748|NCT05314621|Fluticasone|fluticasone|mesh-list
102297749|NCT05314621|Xhance|xhance|mesh-list
102297750|NCT05314621|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
102297751|NCT05314621|Dextrans|dextrans|mesh-list
102297752|NCT05314621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102297753|NCT05314621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102297754|NCT05314621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102297755|NCT05314621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102297756|NCT05314621|Autonomic Agents|autonomic agents|mesh-ancestor
102297757|NCT05314621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102297758|NCT05314621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297759|NCT05314621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102297760|NCT05314621|Respiratory System Agents|respiratory system agents|mesh-ancestor
102297761|NCT05314621|Dermatologic Agents|dermatologic agents|mesh-ancestor
102297762|NCT05314621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102297763|NCT05314621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102297764|NCT05314621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102297765|NCT05314621|Analgesics|analgesics|mesh-ancestor
102297766|NCT05314621|Sensory System Agents|sensory system agents|mesh-ancestor
102297767|NCT05314621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102297768|NCT05314621|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102297769|NCT05314621|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102297770|NCT05314621|Histamine Antagonists|histamine antagonists|mesh-ancestor
102297771|NCT05314621|Histamine Agents|histamine agents|mesh-ancestor
102297772|NCT05314621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102297773|NCT05314621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297774|NCT05314621|Anticoagulants|anticoagulants|mesh-ancestor
102297775|NCT05314621|Plasma Substitutes|plasma substitutes|mesh-ancestor
102297776|NCT05314621|Blood Substitutes|blood substitutes|mesh-ancestor
102297777|NCT05263609|Pembrolizumab|pembrolizumab|mesh-list
102297778|NCT05263609|Axitinib|axitinib|mesh-list
102297779|NCT05263609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102297780|NCT05263609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102297781|NCT05263609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102297782|NCT05263609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297783|NCT05263609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102297784|NCT05263609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102297785|NCT05313997|Diclofenac|diclofenac|mesh-list
102297786|NCT05313997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102297787|NCT05313997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102297788|NCT05313997|Analgesics|analgesics|mesh-ancestor
102297789|NCT05313997|Sensory System Agents|sensory system agents|mesh-ancestor
102297790|NCT05313997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102297791|NCT05313997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297792|NCT05313997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102297793|NCT05313997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102297794|NCT05313997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102297795|NCT05313997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102297796|NCT05313997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297797|NCT05259241|Thrombin|thrombin|mesh-list
102297798|NCT05259241|Hemostatics|hemostatics|mesh-ancestor
102297799|NCT05259241|Coagulants|coagulants|mesh-ancestor
102297800|NCT01657903|Listerine|listerine|mesh-list
102297801|NCT01657903|Fluorides|fluorides|mesh-list
102297802|NCT01657903|Sodium Fluoride|sodium fluoride|mesh-list
102297803|NCT01657903|Cariostatic Agents|cariostatic agents|mesh-ancestor
102297804|NCT01657903|Protective Agents|protective agents|mesh-ancestor
102297805|NCT01657903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297806|NCT01657903|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102297807|NCT01657903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102297808|NCT05256823|Celecoxib|celecoxib|mesh-list
102297809|NCT05256823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102297810|NCT05256823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102297811|NCT05256823|Analgesics|analgesics|mesh-ancestor
102297812|NCT05256823|Sensory System Agents|sensory system agents|mesh-ancestor
102297813|NCT05256823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102297814|NCT05256823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297815|NCT05256823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102297816|NCT05256823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102297817|NCT05256823|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102297818|NCT05256823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102297819|NCT05256823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102297820|NCT05256823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297821|NCT04243837|Pirfenidone|pirfenidone|mesh-list
102297822|NCT04243837|Analgesics|analgesics|mesh-ancestor
102297823|NCT04243837|Sensory System Agents|sensory system agents|mesh-ancestor
102297824|NCT04243837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102297825|NCT04243837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297826|NCT04243837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102297827|NCT04243837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102297828|NCT04243837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102297829|NCT04243837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102297830|NCT04243837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102297831|NCT05253937|Epinephrine|epinephrine|mesh-list
102297832|NCT05253937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102297833|NCT05253937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102297834|NCT05253937|Adrenergic Agents|adrenergic agents|mesh-ancestor
102297835|NCT05253937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102297836|NCT05253937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297837|NCT05253937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297838|NCT05253937|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102297839|NCT05253937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102297840|NCT05253937|Autonomic Agents|autonomic agents|mesh-ancestor
102297841|NCT05253937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102297842|NCT05253937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102297843|NCT05253937|Respiratory System Agents|respiratory system agents|mesh-ancestor
102297844|NCT05253937|Mydriatics|mydriatics|mesh-ancestor
102297845|NCT05253937|Sympathomimetics|sympathomimetics|mesh-ancestor
102297846|NCT05253937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102297847|NCT05218603|Bortezomib|bortezomib|mesh-list
102297848|NCT05218603|Daratumumab|daratumumab|mesh-list
102297849|NCT05218603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102297850|NCT05214001|Almotriptan|almotriptan|mesh-list
102297851|NCT05214001|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102297852|NCT05214001|Serotonin Agents|serotonin agents|mesh-ancestor
102297853|NCT05214001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102297854|NCT05214001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297855|NCT05214001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297856|NCT05280223|Dexmedetomidine|dexmedetomidine|mesh-list
102297857|NCT05280223|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102297858|NCT05280223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102297859|NCT05280223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297860|NCT05280223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102297861|NCT05280223|Analgesics|analgesics|mesh-ancestor
102297862|NCT05280223|Sensory System Agents|sensory system agents|mesh-ancestor
102297863|NCT05280223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102297864|NCT05280223|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102297865|NCT05280223|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102297866|NCT05280223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102297867|NCT05280223|Adrenergic Agents|adrenergic agents|mesh-ancestor
102297868|NCT05280223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102297869|NCT05280223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297870|NCT05277337|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102297871|NCT05277337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102297872|NCT05277337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102297873|NCT05277337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297874|NCT05277337|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102297875|NCT05277337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102297876|NCT05277337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297877|NCT05277337|Cholinergic Agents|cholinergic agents|mesh-ancestor
102297878|NCT05277337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102297879|NCT05248945|Carbamazepine|carbamazepine|mesh-list
102297880|NCT05248945|Anticonvulsants|anticonvulsants|mesh-ancestor
102297881|NCT05248945|Antimanic Agents|antimanic agents|mesh-ancestor
102297882|NCT05248945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102297883|NCT05248945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102297884|NCT05248945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297885|NCT05248945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102297886|NCT05248945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102297887|NCT05248945|Analgesics|analgesics|mesh-ancestor
102297888|NCT05248945|Sensory System Agents|sensory system agents|mesh-ancestor
102297889|NCT05248945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102297890|NCT05248945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102297891|NCT05248945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102297892|NCT05248945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297893|NCT05248945|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102297894|NCT05248945|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102297895|NCT04239313|Vaccines|vaccines|mesh-list
102297896|NCT04239313|Immunologic Factors|immunologic factors|mesh-ancestor
102297897|NCT04239313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297898|NCT05209867|Cannabidiol|cannabidiol|mesh-list
102297899|NCT05209867|Anticonvulsants|anticonvulsants|mesh-ancestor
102297900|NCT05273827|Paclitaxel|paclitaxel|mesh-list
102297901|NCT05273827|Pemetrexed|pemetrexed|mesh-list
102297902|NCT05273827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102297903|NCT05273827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102297904|NCT05273827|Tubulin Modulators|tubulin modulators|mesh-ancestor
102297905|NCT05273827|Antimitotic Agents|antimitotic agents|mesh-ancestor
102297906|NCT05273827|Mitosis Modulators|mitosis modulators|mesh-ancestor
102297907|NCT05273827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297908|NCT05273827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102297909|NCT05273827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102297910|NCT05273827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102297911|NCT05209711|Lidocaine|lidocaine|mesh-list
102297912|NCT05209711|Anesthetics, Local|anesthetics, local|mesh-ancestor
102297913|NCT05209711|Anesthetics|anesthetics|mesh-ancestor
102297914|NCT05209711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102297915|NCT05209711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297916|NCT05209711|Sensory System Agents|sensory system agents|mesh-ancestor
102297917|NCT05209711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102297918|NCT05209711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102297919|NCT05209711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102297920|NCT05209711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102297921|NCT05209711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102297922|NCT05209711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297923|NCT05243563|Clobetasol|clobetasol|mesh-list
102297924|NCT05243563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102297925|NCT05243563|Glucocorticoids|glucocorticoids|mesh-ancestor
102297926|NCT05243563|Hormones|hormones|mesh-ancestor
102297927|NCT05243563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102297928|NCT05243563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297929|NCT05272969|Vitamin D|vitamin d|mesh-list
102297930|NCT05272969|Calcium|calcium|mesh-list
102297931|NCT05272969|Vitamins|vitamins|mesh-ancestor
102297932|NCT05272969|Micronutrients|micronutrients|mesh-ancestor
102297933|NCT05272969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297934|NCT05272969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102297935|NCT05272969|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102297937|NCT05208619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102297938|NCT05208619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297939|NCT05206747|Methamphetamine|methamphetamine|mesh-list
102297940|NCT05206747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102297941|NCT05206747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297942|NCT05206747|Sympathomimetics|sympathomimetics|mesh-ancestor
102297943|NCT05206747|Autonomic Agents|autonomic agents|mesh-ancestor
102297944|NCT05206747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102297945|NCT05206747|Dopamine Agents|dopamine agents|mesh-ancestor
102297946|NCT05206747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102297947|NCT05206747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297948|NCT05206747|Adrenergic Agents|adrenergic agents|mesh-ancestor
102297949|NCT05206747|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102297950|NCT05206747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102297951|NCT05206747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102297952|NCT05206747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102297953|NCT05206435|Nicotine|nicotine|mesh-list
102297954|NCT05206435|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102297955|NCT05206435|Autonomic Agents|autonomic agents|mesh-ancestor
102297956|NCT05206435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102297957|NCT05206435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297958|NCT05206435|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102297959|NCT05206435|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102297960|NCT05206435|Cholinergic Agents|cholinergic agents|mesh-ancestor
102297961|NCT05206435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102297962|NCT05206435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297963|NCT05205811|Zonisamide|zonisamide|mesh-list
102297964|NCT05205811|Bupropion|bupropion|mesh-list
102297965|NCT05205811|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102297966|NCT05205811|Antidepressive Agents|antidepressive agents|mesh-ancestor
102297967|NCT05205811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102297968|NCT05205811|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102297969|NCT05205811|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102297970|NCT05205811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102297971|NCT05205811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297972|NCT05205811|Dopamine Agents|dopamine agents|mesh-ancestor
102297973|NCT05205811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102297974|NCT05205811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297975|NCT05205811|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102297976|NCT05205811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102297977|NCT05205811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102297978|NCT05205811|Anticonvulsants|anticonvulsants|mesh-ancestor
102297979|NCT05205811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102297980|NCT05205811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102297981|NCT05166967|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102297982|NCT05166967|Immunologic Factors|immunologic factors|mesh-ancestor
102297983|NCT05166967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297984|NCT05166967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102297985|NCT05166343|Epinephrine|epinephrine|mesh-list
102297986|NCT05166343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102297987|NCT05166343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102297988|NCT05166343|Adrenergic Agents|adrenergic agents|mesh-ancestor
102297989|NCT05166343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102297990|NCT05166343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102297991|NCT05166343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102297992|NCT05166343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102297993|NCT05166343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102297994|NCT05166343|Autonomic Agents|autonomic agents|mesh-ancestor
102297995|NCT05166343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102297996|NCT05166343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102297997|NCT05166343|Respiratory System Agents|respiratory system agents|mesh-ancestor
102297998|NCT05166343|Mydriatics|mydriatics|mesh-ancestor
102297999|NCT05166343|Sympathomimetics|sympathomimetics|mesh-ancestor
102298000|NCT05166343|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102298001|NCT01656733|Nicotine|nicotine|mesh-list
102298002|NCT01656733|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102298003|NCT01656733|Autonomic Agents|autonomic agents|mesh-ancestor
102298004|NCT01656733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102298005|NCT01656733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298006|NCT01656733|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102298007|NCT01656733|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102298009|NCT01656733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102298010|NCT01656733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298011|NCT05236543|Itraconazole|itraconazole|mesh-list
102298012|NCT05236543|Antifungal Agents|antifungal agents|mesh-ancestor
102298013|NCT05236543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102298014|NCT05236543|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102298015|NCT05236543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102298016|NCT05236543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102298017|NCT05236543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298018|NCT05236543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102298019|NCT05236543|Hormone Antagonists|hormone antagonists|mesh-ancestor
102298020|NCT05236543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102298021|NCT05236543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298022|NCT05236543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102298023|NCT05159245|Trastuzumab|trastuzumab|mesh-list
102298024|NCT05159245|Atezolizumab|atezolizumab|mesh-list
102298025|NCT05159245|Pertuzumab|pertuzumab|mesh-list
102298026|NCT05159245|Trametinib|trametinib|mesh-list
102298027|NCT05159245|Vemurafenib|vemurafenib|mesh-list
102298028|NCT05159245|Dabrafenib|dabrafenib|mesh-list
102298029|NCT05159245|Pralsetinib|pralsetinib|mesh-list
102298030|NCT05159245|Entrectinib|entrectinib|mesh-list
102298031|NCT05159245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102298032|NCT05159245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102298033|NCT05159245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102298034|NCT05159245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298035|NCT05159245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102298036|NCT05159245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102298037|NCT05157841|Bupivacaine|bupivacaine|mesh-list
102298038|NCT05157841|Anesthetics, Local|anesthetics, local|mesh-ancestor
102298039|NCT05157841|Anesthetics|anesthetics|mesh-ancestor
102298040|NCT05157841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102298041|NCT05157841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298042|NCT05157841|Sensory System Agents|sensory system agents|mesh-ancestor
102298043|NCT05157841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102298044|NCT05225155|Enoxaparin|enoxaparin|mesh-list
102298045|NCT05225155|Anticoagulants|anticoagulants|mesh-ancestor
102298046|NCT05225155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102298047|NCT05225155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102298048|NCT05225155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298049|NCT05190445|Paclitaxel|paclitaxel|mesh-list
102298050|NCT05190445|Ramucirumab|ramucirumab|mesh-list
102298051|NCT05190445|Tucatinib|tucatinib|mesh-list
102298052|NCT05190445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102298053|NCT05190445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102298054|NCT05190445|Tubulin Modulators|tubulin modulators|mesh-ancestor
102298055|NCT05190445|Antimitotic Agents|antimitotic agents|mesh-ancestor
102298056|NCT05190445|Mitosis Modulators|mitosis modulators|mesh-ancestor
102298057|NCT05190445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298058|NCT05190445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102298059|NCT05190445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102298060|NCT05189977|Propranolol|propranolol|mesh-list
102298061|NCT05189977|Prazosin|prazosin|mesh-list
102298062|NCT05189977|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102298063|NCT05189977|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102298064|NCT05189977|Adrenergic Agents|adrenergic agents|mesh-ancestor
102298065|NCT05189977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102298066|NCT05189977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298067|NCT05189977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298068|NCT05189977|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102298069|NCT05189977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102298070|NCT05189977|Vasodilator Agents|vasodilator agents|mesh-ancestor
102298071|NCT05189977|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102298072|NCT05189977|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102298073|NCT05148949|Vaccines|vaccines|mesh-list
102298074|NCT05148949|Immunologic Factors|immunologic factors|mesh-ancestor
102298075|NCT05148949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298076|NCT05107999|Doxepin|doxepin|mesh-list
101398965|NCT05574400|Caffeine|caffeine|mesh-list
102298077|NCT05107999|Antidepressive Agents|antidepressive agents|mesh-list
102298078|NCT05107999|Neurotransmitter Agents|neurotransmitter agents|mesh-list
102298079|NCT05107999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102298080|NCT05107999|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102298081|NCT05107999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101639873|NCT00813423|Sunitinib|sunitinib|mesh-list
102298084|NCT05107999|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102298085|NCT05107999|Histamine Antagonists|histamine antagonists|mesh-ancestor
102298087|NCT05107999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298088|NCT05186545|Fulvestrant|fulvestrant|mesh-list
102298089|NCT05186545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102298090|NCT05186545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102298091|NCT05186545|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102298092|NCT05186545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102298093|NCT05186545|Hormone Antagonists|hormone antagonists|mesh-ancestor
102298094|NCT05186545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102298095|NCT05186545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298096|NCT05107765|Pioglitazone|pioglitazone|mesh-list
102298097|NCT05107765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102298098|NCT05107765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006845|NCT03841721|Linezolid|linezolid|mesh-list
102298102|NCT05183737|Propolis|propolis|mesh-list
102298103|NCT05183737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102298104|NCT05177419|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
102298105|NCT05177419|Hallucinogens|hallucinogens|mesh-ancestor
102298106|NCT05177419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298107|NCT05177419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102298108|NCT05177419|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102298109|NCT05177419|Serotonin Agents|serotonin agents|mesh-ancestor
102298110|NCT05177419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102298111|NCT05177419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298112|NCT05177419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102298113|NCT05094427|Anesthetics|anesthetics|mesh-list
102298114|NCT05094427|Anesthetics, Local|anesthetics, local|mesh-list
102298115|NCT05094427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102298116|NCT05094427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298117|NCT05094427|Sensory System Agents|sensory system agents|mesh-ancestor
102298118|NCT05094427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102298119|NCT05175781|Dexmedetomidine|dexmedetomidine|mesh-list
102298120|NCT05175781|Ketamine|ketamine|mesh-list
102298121|NCT05175781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102298122|NCT05175781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102298123|NCT05175781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298124|NCT05175781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102298125|NCT05175781|Analgesics|analgesics|mesh-ancestor
102298126|NCT05175781|Sensory System Agents|sensory system agents|mesh-ancestor
102298127|NCT05175781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102298128|NCT05175781|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102298129|NCT05175781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102298130|NCT05175781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102298131|NCT05175781|Adrenergic Agents|adrenergic agents|mesh-ancestor
102298132|NCT05175781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102298133|NCT05175781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298134|NCT05175781|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102298135|NCT05175781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102298136|NCT05175781|Anesthetics, General|anesthetics, general|mesh-ancestor
102298137|NCT05175781|Anesthetics|anesthetics|mesh-ancestor
102298138|NCT05175781|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102298139|NCT05175781|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102298140|NCT04421911|Diclofenac|diclofenac|mesh-list
102298141|NCT04421911|Ketoprofen|ketoprofen|mesh-list
102298142|NCT04421911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102298143|NCT04421911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102298144|NCT04421911|Analgesics|analgesics|mesh-ancestor
102298145|NCT04421911|Sensory System Agents|sensory system agents|mesh-ancestor
102298146|NCT04421911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102298147|NCT04421911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298148|NCT04421911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102298149|NCT04421911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102298150|NCT04421911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102298151|NCT04421911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102298152|NCT04421911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298153|NCT05174611|Vitamin D|vitamin d|mesh-list
101639966|NCT04019782|Hylan|hylan|mesh-list
102298155|NCT05174611|Vitamins|vitamins|mesh-ancestor
102298156|NCT05174611|Micronutrients|micronutrients|mesh-ancestor
102298157|NCT05174611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298158|NCT05174611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102298159|NCT05174611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102298160|NCT05133817|Norepinephrine|norepinephrine|mesh-list
102298161|NCT05133817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
102298162|NCT05133817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102298163|NCT05133817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102298164|NCT05133817|Adrenergic Agents|adrenergic agents|mesh-ancestor
102298165|NCT05133817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102298166|NCT05133817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298167|NCT05133817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298168|NCT05133817|Sympathomimetics|sympathomimetics|mesh-ancestor
102298169|NCT05133817|Autonomic Agents|autonomic agents|mesh-ancestor
102298170|NCT05133817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102298171|NCT05171335|Lenvatinib|lenvatinib|mesh-list
102298172|NCT05171335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102298173|NCT05171335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102298174|NCT05171335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102298175|NCT05171335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298176|NCT02522299|Nemiralisib|nemiralisib|mesh-list
102298177|NCT02522299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102298178|NCT02522299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102298179|NCT02522299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298180|NCT01365091|Metformin|metformin|mesh-list
102298181|NCT01365091|Saxagliptin|saxagliptin|mesh-list
102298182|NCT01365091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102298183|NCT01365091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298184|NCT01365091|Incretins|incretins|mesh-ancestor
102298185|NCT01365091|Hormones|hormones|mesh-ancestor
102298186|NCT01365091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102298187|NCT01365091|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102298188|NCT01365091|Protease Inhibitors|protease inhibitors|mesh-ancestor
102298189|NCT01365091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102298190|NCT01365091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298191|NCT05082025|Fulvestrant|fulvestrant|mesh-list
102298192|NCT05082025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102298193|NCT05082025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102298194|NCT05082025|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102298195|NCT05082025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102298196|NCT05082025|Hormone Antagonists|hormone antagonists|mesh-ancestor
102298197|NCT05082025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102298198|NCT05082025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298199|NCT05079763|Monolaurin|monolaurin|mesh-list
102298200|NCT05079763|Cariostatic Agents|cariostatic agents|mesh-ancestor
102298201|NCT05079763|Protective Agents|protective agents|mesh-ancestor
102298202|NCT05079763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298203|NCT05050981|Hormones|hormones|mesh-list
102298204|NCT05050981|Serotonin|serotonin|mesh-list
102298205|NCT05050981|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
102298206|NCT05050981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102298207|NCT05050981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298208|NCT05050981|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102298209|NCT05050981|Serotonin Agents|serotonin agents|mesh-ancestor
102298210|NCT05050981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102298211|NCT05050981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298212|NCT05050981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102298213|NCT05050981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102298214|NCT05065645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102298215|NCT01364467|Phenylpropanolamine|phenylpropanolamine|mesh-list
102298216|NCT01364467|Guaifenesin|guaifenesin|mesh-list
101399097|NCT05145309|Magnesium citrate|magnesium citrate|mesh-list
102298217|NCT01364467|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
102298218|NCT01364467|Expectorants|expectorants|mesh-ancestor
102298219|NCT01364467|Respiratory System Agents|respiratory system agents|mesh-ancestor
102298220|NCT01364467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102298221|NCT01364467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102298222|NCT01364467|Adrenergic Agents|adrenergic agents|mesh-ancestor
102298223|NCT01364467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102298224|NCT01364467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640020|NCT02599168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102298225|NCT01364467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298226|NCT01364467|Appetite Depressants|appetite depressants|mesh-ancestor
102298227|NCT01364467|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102298228|NCT01364467|Sympathomimetics|sympathomimetics|mesh-ancestor
102298229|NCT01364467|Autonomic Agents|autonomic agents|mesh-ancestor
102298230|NCT01364467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102298231|NCT01364467|Nasal Decongestants|nasal decongestants|mesh-ancestor
102298232|NCT01364467|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102298233|NCT04226365|Nortriptyline|nortriptyline|mesh-list
102298234|NCT04226365|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102298235|NCT04226365|Antidepressive Agents|antidepressive agents|mesh-ancestor
102298236|NCT04226365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102298237|NCT04226365|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102298238|NCT04226365|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102298239|NCT04226365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102298240|NCT04226365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298241|NCT04226365|Adrenergic Agents|adrenergic agents|mesh-ancestor
102298242|NCT04226365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102298243|NCT04226365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298244|NCT05062837|Apatinib|apatinib|mesh-list
102298245|NCT05062837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102298246|NCT05062837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102298247|NCT05062837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102298248|NCT05062837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298249|NCT05110417|Bromides|bromides|mesh-list
102298250|NCT05110417|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
102298251|NCT05110417|Anticonvulsants|anticonvulsants|mesh-ancestor
102298252|NCT05110417|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102298253|NCT05110417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102298254|NCT05110417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298255|NCT05110417|Cholinergic Agents|cholinergic agents|mesh-ancestor
102298256|NCT05110417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102298257|NCT05110417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298258|NCT05031481|Butoconazole|butoconazole|mesh-list
102298259|NCT05031481|Antifungal Agents|antifungal agents|mesh-ancestor
102298260|NCT05031481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102298261|NCT05058859|Dapagliflozin|dapagliflozin|mesh-list
102298262|NCT05058859|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102298263|NCT05058859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298264|NCT05058859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102298265|NCT05058859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298266|NCT05057767|Midazolam|midazolam|mesh-list
102298267|NCT05057767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102298268|NCT05057767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102298269|NCT05057767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102298270|NCT05057767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298271|NCT05057767|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102298272|NCT05057767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102298273|NCT05057767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102298274|NCT05057767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102298275|NCT05057767|Anesthetics, General|anesthetics, general|mesh-ancestor
102298276|NCT05057767|Anesthetics|anesthetics|mesh-ancestor
102298277|NCT05057767|GABA Modulators|gaba modulators|mesh-ancestor
102298278|NCT05057767|GABA Agents|gaba agents|mesh-ancestor
102298279|NCT05057767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102298280|NCT05057767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298281|NCT04997317|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
102298282|NCT04997317|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
102298283|NCT04997317|Chelating Agents|chelating agents|mesh-ancestor
102298284|NCT04997317|Sequestering Agents|sequestering agents|mesh-ancestor
102298285|NCT04997317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298286|NCT04997317|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102298287|NCT04997239|Vaccines|vaccines|mesh-list
102298288|NCT04997239|Immunologic Factors|immunologic factors|mesh-ancestor
102298289|NCT04997239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298290|NCT04216693|Digoxin|digoxin|mesh-list
102298291|NCT04216693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102298292|NCT04216693|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102298293|NCT04216693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102298294|NCT04216693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298295|NCT04216693|Protective Agents|protective agents|mesh-ancestor
102298296|NCT04216693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298297|NCT01364389|Prednisone|prednisone|mesh-list
102298298|NCT01364389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102298299|NCT01364389|Glucocorticoids|glucocorticoids|mesh-ancestor
102298301|NCT01364389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102298302|NCT01364389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298303|NCT01364389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102298304|NCT01364389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102298305|NCT05054881|Iodine|iodine|mesh-list
102298306|NCT05054881|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102298307|NCT05054881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102298308|NCT05054881|Trace Elements|trace elements|mesh-ancestor
102298309|NCT05054881|Micronutrients|micronutrients|mesh-ancestor
102298310|NCT05054881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298311|NCT04949425|Adavosertib|adavosertib|mesh-list
102298312|NCT04949425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102298313|NCT04949425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298314|NCT04203901|Nivolumab|nivolumab|mesh-list
102298315|NCT04203901|Ipilimumab|ipilimumab|mesh-list
102298316|NCT04203901|Everolimus|everolimus|mesh-list
102298317|NCT04203901|Lenvatinib|lenvatinib|mesh-list
102298318|NCT04203901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102298319|NCT04203901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102298320|NCT04203901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102298321|NCT04203901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298323|NCT04203901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102298324|NCT04203901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102298325|NCT04203901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102298326|NCT04203901|Immunologic Factors|immunologic factors|mesh-ancestor
102298327|NCT04203901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298328|NCT04421209|Propranolol|propranolol|mesh-list
102298329|NCT04421209|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102298330|NCT04421209|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102298331|NCT04421209|Adrenergic Agents|adrenergic agents|mesh-ancestor
102298332|NCT04421209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102298333|NCT04421209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298334|NCT04421209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298335|NCT04421209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102298336|NCT04421209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102298337|NCT04421209|Vasodilator Agents|vasodilator agents|mesh-ancestor
102298338|NCT04946305|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102298339|NCT04946305|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102298340|NCT04946305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298341|NCT04984993|Tadalafil|tadalafil|mesh-list
102298342|NCT04984993|Vasodilator Agents|vasodilator agents|mesh-ancestor
102298343|NCT04984993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102298344|NCT04984993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102298345|NCT04984993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102298346|NCT04984993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298347|NCT04984993|Urological Agents|urological agents|mesh-ancestor
102298348|NCT04984837|Gemcitabine|gemcitabine|mesh-list
102298349|NCT04984837|Oxaliplatin|oxaliplatin|mesh-list
102298350|NCT04984837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102298351|NCT04984837|Antimetabolites|antimetabolites|mesh-ancestor
102298352|NCT04984837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298353|NCT04984837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102298354|NCT04983121|Antibodies|antibodies|mesh-list
102298355|NCT04983121|Mitogens|mitogens|mesh-list
102298356|NCT04983121|Immunoconjugates|immunoconjugates|mesh-list
102298357|NCT04983121|Immunologic Factors|immunologic factors|mesh-ancestor
102298358|NCT04983121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298359|NCT04983121|Mitosis Modulators|mitosis modulators|mesh-ancestor
102298360|NCT04983121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298361|NCT02291289|Bevacizumab|bevacizumab|mesh-list
102298362|NCT02291289|Trastuzumab|trastuzumab|mesh-list
102298363|NCT02291289|Cetuximab|cetuximab|mesh-list
102298364|NCT02291289|Atezolizumab|atezolizumab|mesh-list
102298365|NCT02291289|Pertuzumab|pertuzumab|mesh-list
102298366|NCT02291289|Capecitabine|capecitabine|mesh-list
102298367|NCT02291289|Fluorouracil|fluorouracil|mesh-list
102298368|NCT02291289|Vemurafenib|vemurafenib|mesh-list
102298369|NCT02291289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102298370|NCT02291289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102298371|NCT02291289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102298372|NCT02291289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102298373|NCT02291289|Growth Substances|growth substances|mesh-ancestor
102298374|NCT02291289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298375|NCT02291289|Growth Inhibitors|growth inhibitors|mesh-ancestor
102298376|NCT02291289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102298377|NCT02291289|Antimetabolites|antimetabolites|mesh-ancestor
102298378|NCT02291289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298379|NCT02291289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102298380|NCT02291289|Immunologic Factors|immunologic factors|mesh-ancestor
102298381|NCT02291289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102298382|NCT02291289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102298383|NCT02291289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102298384|NCT02317575|Insulin Lispro|insulin lispro|mesh-list
102298385|NCT02317575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102298386|NCT02317575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298387|NCT02289963|Alirocumab|alirocumab|mesh-list
102298388|NCT02289963|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102298389|NCT02289963|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102298390|NCT02289963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102298391|NCT02289963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102007129|NCT01200641|Protective Agents|protective agents|mesh-ancestor
102298392|NCT02289963|Antimetabolites|antimetabolites|mesh-ancestor
102298393|NCT02289963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298394|NCT02289963|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102298395|NCT02289963|Protease Inhibitors|protease inhibitors|mesh-ancestor
102298396|NCT02289963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102298398|NCT02289963|Immunologic Factors|immunologic factors|mesh-ancestor
102298399|NCT02289963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298400|NCT02358369|Timolol|timolol|mesh-list
102298401|NCT02358369|Bimatoprost|bimatoprost|mesh-list
102298402|NCT02358369|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102298403|NCT02358369|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102298404|NCT02358369|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102298405|NCT02358369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102298406|NCT02358369|Adrenergic Agents|adrenergic agents|mesh-ancestor
102298407|NCT02358369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102298408|NCT02358369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298409|NCT02358369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298410|NCT02358369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102298411|NCT02358369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102298412|NCT02316171|Mitomycins|mitomycins|mesh-list
102298413|NCT02316171|Mitomycin|mitomycin|mesh-list
102298414|NCT02316171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102298415|NCT02316171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102298416|NCT02316171|Alkylating Agents|alkylating agents|mesh-ancestor
102298417|NCT02316171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298418|NCT02316171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102298419|NCT02316171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102298420|NCT02315625|Everolimus|everolimus|mesh-list
102298421|NCT02315625|Sunitinib|sunitinib|mesh-list
102298422|NCT02315625|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102298423|NCT02315625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102298424|NCT02315625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101399309|NCT04302870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102298425|NCT02315625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298426|NCT02315625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102298427|NCT02315625|Immunologic Factors|immunologic factors|mesh-ancestor
102298428|NCT02315625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298429|NCT02315625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102298430|NCT02315625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102298431|NCT02315625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102298432|NCT02315625|Growth Substances|growth substances|mesh-ancestor
102298433|NCT02315625|Growth Inhibitors|growth inhibitors|mesh-ancestor
102298434|NCT02357979|Fluorides|fluorides|mesh-list
102298435|NCT02357979|Cariostatic Agents|cariostatic agents|mesh-ancestor
102298436|NCT02357979|Protective Agents|protective agents|mesh-ancestor
102298437|NCT02357979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298438|NCT02357901|Buprenorphine|buprenorphine|mesh-list
102298439|NCT02357901|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102298440|NCT02357901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102298441|NCT02357901|Narcotics|narcotics|mesh-ancestor
102298442|NCT02357901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102298443|NCT02357901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298444|NCT02357901|Analgesics|analgesics|mesh-ancestor
102298445|NCT02357901|Sensory System Agents|sensory system agents|mesh-ancestor
102298446|NCT02357901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102298447|NCT02357901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102298448|NCT01601847|Vitamin D|vitamin d|mesh-list
102298449|NCT01601847|Cholecalciferol|cholecalciferol|mesh-list
102298450|NCT01601847|Vitamins|vitamins|mesh-ancestor
102298451|NCT01601847|Micronutrients|micronutrients|mesh-ancestor
102298452|NCT01601847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298453|NCT01601847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102298454|NCT01601847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102298455|NCT02515279|Ribavirin|ribavirin|mesh-list
102298456|NCT02515279|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102298457|NCT02515279|Antimetabolites|antimetabolites|mesh-ancestor
102298458|NCT02515279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298459|NCT02515279|Antiviral Agents|antiviral agents|mesh-ancestor
102298460|NCT02515279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102298461|NCT02515045|Moxifloxacin|moxifloxacin|mesh-list
102298462|NCT02515045|Prednisolone|prednisolone|mesh-list
102298463|NCT02515045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102298464|NCT02515045|Methylprednisolone|methylprednisolone|mesh-list
102298465|NCT02515045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102298466|NCT02515045|Prednisolone acetate|prednisolone acetate|mesh-list
102298467|NCT02515045|Nepafenac|nepafenac|mesh-list
102298468|NCT02515045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102298469|NCT02515045|Prednisolone phosphate|prednisolone phosphate|mesh-list
102298470|NCT02515045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102298471|NCT02515045|Glucocorticoids|glucocorticoids|mesh-ancestor
102007205|NCT03843281|Acetaminophen|acetaminophen|mesh-list
102298472|NCT02515045|Hormones|hormones|mesh-ancestor
102298473|NCT02515045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102298474|NCT02515045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298475|NCT02515045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102298476|NCT02515045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102298477|NCT02515045|Antiemetics|antiemetics|mesh-ancestor
102298478|NCT02515045|Autonomic Agents|autonomic agents|mesh-ancestor
102298479|NCT02515045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102298480|NCT02515045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102298481|NCT02515045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102298482|NCT02515045|Protective Agents|protective agents|mesh-ancestor
102298483|NCT02515045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102298484|NCT02515045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102298485|NCT02515045|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102298486|NCT02515045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102298487|NCT02515045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102298488|NCT02515045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298489|NCT02515045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102298490|NCT02515045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102298491|NCT02515045|Analgesics|analgesics|mesh-ancestor
102298492|NCT02515045|Sensory System Agents|sensory system agents|mesh-ancestor
102298493|NCT02515045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102298494|NCT02513485|Levodopa|levodopa|mesh-list
102298495|NCT02513485|Carbidopa|carbidopa|mesh-list
102298496|NCT02513485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102298497|NCT02513485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102298498|NCT02513485|Dopamine Agents|dopamine agents|mesh-ancestor
102298499|NCT02513485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102298500|NCT02513485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298501|NCT02513485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298502|NCT02513485|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102298503|NCT02513485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102298504|NCT02289417|Apremilast|apremilast|mesh-list
102298505|NCT02289417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102298506|NCT02289417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102298507|NCT02289417|Analgesics|analgesics|mesh-ancestor
102298508|NCT02289417|Sensory System Agents|sensory system agents|mesh-ancestor
102298509|NCT02289417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102298510|NCT02289417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298511|NCT02289417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102298512|NCT02289417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102298513|NCT02289417|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102298514|NCT02289417|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102298515|NCT02289417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102298516|NCT02289417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298517|NCT02512861|Bupivacaine|bupivacaine|mesh-list
102298518|NCT02512861|Anesthetics, Local|anesthetics, local|mesh-ancestor
102298519|NCT02512861|Anesthetics|anesthetics|mesh-ancestor
102298520|NCT02512861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102298521|NCT02512861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298522|NCT02512861|Sensory System Agents|sensory system agents|mesh-ancestor
102298523|NCT02512861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102298524|NCT04979611|Exenatide|exenatide|mesh-list
102298525|NCT04979611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102298526|NCT04979611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298527|NCT04979611|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102298528|NCT04979611|Incretins|incretins|mesh-ancestor
102298529|NCT04979611|Hormones|hormones|mesh-ancestor
102298530|NCT04979611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102298531|NCT04979065|Vitamin D|vitamin d|mesh-list
102298532|NCT04979065|Vitamins|vitamins|mesh-ancestor
102298533|NCT04979065|Micronutrients|micronutrients|mesh-ancestor
102298534|NCT04979065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298535|NCT04979065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102298536|NCT02288325|Milnacipran|milnacipran|mesh-list
102298537|NCT02288325|Levomilnacipran|levomilnacipran|mesh-list
102298538|NCT02288325|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102298539|NCT02288325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102298540|NCT02288325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102298541|NCT02288325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298542|NCT02288325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102298543|NCT02288325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298544|NCT02288325|Antidepressive Agents|antidepressive agents|mesh-ancestor
102298545|NCT02288325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102298546|NCT02288325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102298547|NCT02288325|Analgesics|analgesics|mesh-ancestor
102298548|NCT02288325|Sensory System Agents|sensory system agents|mesh-ancestor
102298549|NCT02288325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102298550|NCT04978051|Icatibant|icatibant|mesh-list
102298551|NCT04978051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102298552|NCT04978051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102298553|NCT04978051|Analgesics|analgesics|mesh-ancestor
102298554|NCT04978051|Sensory System Agents|sensory system agents|mesh-ancestor
102298555|NCT04978051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102298556|NCT04978051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298557|NCT04978051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102298558|NCT04978051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102298559|NCT04978051|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
102298560|NCT04978051|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
102298561|NCT04978051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298562|NCT04978051|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102298563|NCT04978051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102298564|NCT04978051|Immunologic Factors|immunologic factors|mesh-ancestor
102298565|NCT04214353|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102298566|NCT04214353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102298567|NCT04214353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298568|NCT05010421|Clobetasol|clobetasol|mesh-list
102298569|NCT05010421|Emollients|emollients|mesh-list
102298570|NCT05010421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102298571|NCT05010421|Glucocorticoids|glucocorticoids|mesh-ancestor
102298572|NCT05010421|Hormones|hormones|mesh-ancestor
102298573|NCT05010421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102298574|NCT05010421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298575|NCT05010421|Dermatologic Agents|dermatologic agents|mesh-ancestor
102298576|NCT02504827|Ceftazidime|ceftazidime|mesh-list
102298577|NCT02504827|Avibactam|avibactam|mesh-list
102298578|NCT02504827|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
102298579|NCT02504827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102298580|NCT02504827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102298581|NCT02504827|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102298582|NCT02504827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102298583|NCT02504827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298584|NCT02504671|Folic Acid|folic acid|mesh-list
102298585|NCT02504671|Hematinics|hematinics|mesh-ancestor
102298586|NCT02504671|Vitamin B Complex|vitamin b complex|mesh-ancestor
102298587|NCT02504671|Vitamins|vitamins|mesh-ancestor
102298588|NCT02504671|Micronutrients|micronutrients|mesh-ancestor
102298589|NCT02504671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298590|NCT02314143|Trametinib|trametinib|mesh-list
102298591|NCT02314143|Dabrafenib|dabrafenib|mesh-list
102298592|NCT02314143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102298593|NCT02314143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102298594|NCT02314143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102298595|NCT02314143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298596|NCT02503501|Insulin glulisine|insulin glulisine|mesh-list
102298597|NCT02503501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102298598|NCT02503501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298599|NCT05007613|Atezolizumab|atezolizumab|mesh-list
102298600|NCT05007613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102298601|NCT05007613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298602|NCT05007613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102298603|NCT05007613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102298604|NCT04970407|Botulinum Toxins|botulinum toxins|mesh-list
102298605|NCT04970407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102298606|NCT04970407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102298607|NCT04970407|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102298608|NCT04970407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102298609|NCT04970407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102298610|NCT04970407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298611|NCT04970407|Cholinergic Agents|cholinergic agents|mesh-ancestor
102298612|NCT04970407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102298613|NCT04970407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298614|NCT04970407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102298615|NCT04970407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102298616|NCT02501629|Reslizumab|reslizumab|mesh-list
102298617|NCT02501629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102298618|NCT02501629|Respiratory System Agents|respiratory system agents|mesh-ancestor
102298619|NCT02501473|Rituximab|rituximab|mesh-list
102007351|NCT05669417|Anesthetics|anesthetics|mesh-ancestor
102298620|NCT02501473|Pembrolizumab|pembrolizumab|mesh-list
102298621|NCT02501473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102298622|NCT02501473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102298623|NCT02501473|Immunologic Factors|immunologic factors|mesh-ancestor
102298624|NCT02501473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298625|NCT02501473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102298626|NCT02501473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102298627|NCT02501473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298628|NCT02501161|Insulin|insulin|mesh-list
102298629|NCT02501161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102298630|NCT02501161|Insulin Glargine|insulin glargine|mesh-list
102298631|NCT02501161|Liraglutide|liraglutide|mesh-list
102298632|NCT02501161|Xultophy|xultophy|mesh-list
102298633|NCT02501161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102298634|NCT02501161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298635|NCT02501161|Incretins|incretins|mesh-ancestor
102298636|NCT02501161|Hormones|hormones|mesh-ancestor
102298637|NCT02501161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102298638|NCT04966585|Posaconazole|posaconazole|mesh-list
102298639|NCT04966585|Antifungal Agents|antifungal agents|mesh-ancestor
102298640|NCT04966585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102298641|NCT04966585|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102298642|NCT04966585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102298643|NCT04966585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102298644|NCT04966585|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102298645|NCT04966585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102298646|NCT04966585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102298647|NCT04966585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298648|NCT04966585|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102298649|NCT04966585|Hormone Antagonists|hormone antagonists|mesh-ancestor
102298650|NCT04966585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102298651|NCT04966585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298652|NCT04205539|Dexmedetomidine|dexmedetomidine|mesh-list
102298653|NCT04205539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102298654|NCT04205539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102298655|NCT04205539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298656|NCT04205539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102298657|NCT04205539|Analgesics|analgesics|mesh-ancestor
102298658|NCT04205539|Sensory System Agents|sensory system agents|mesh-ancestor
102298659|NCT04205539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102298660|NCT04205539|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102298661|NCT04205539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102298662|NCT04205539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102298663|NCT04205539|Adrenergic Agents|adrenergic agents|mesh-ancestor
102298664|NCT04205539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102298665|NCT04205539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298666|NCT02313909|Aspirin|aspirin|mesh-list
102298667|NCT02313909|Rivaroxaban|rivaroxaban|mesh-list
102298668|NCT02313909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102298669|NCT02313909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102298670|NCT02313909|Analgesics|analgesics|mesh-ancestor
102298671|NCT02313909|Sensory System Agents|sensory system agents|mesh-ancestor
102298672|NCT02313909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102298673|NCT02313909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298674|NCT02313909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102298675|NCT02313909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102298676|NCT02313909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102298677|NCT02313909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102298678|NCT02313909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298679|NCT02313909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102298680|NCT02313909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102298681|NCT02313909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102298682|NCT02313909|Antipyretics|antipyretics|mesh-ancestor
102298683|NCT02313909|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102298684|NCT02313909|Antithrombins|antithrombins|mesh-ancestor
102298685|NCT02313909|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102298686|NCT02313909|Protease Inhibitors|protease inhibitors|mesh-ancestor
102298687|NCT02313909|Anticoagulants|anticoagulants|mesh-ancestor
102298688|NCT02287467|Immunoglobulins|immunoglobulins|mesh-list
102298689|NCT02287467|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102298690|NCT02287467|Antibodies|antibodies|mesh-list
102298691|NCT02287467|gamma-Globulins|gamma-globulins|mesh-list
102298692|NCT02287467|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102298693|NCT02287467|Immunologic Factors|immunologic factors|mesh-ancestor
102007423|NCT02504398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298694|NCT02287467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298696|NCT02287233|Venetoclax|venetoclax|mesh-list
102298697|NCT02287233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102298698|NCT02287233|Antimetabolites|antimetabolites|mesh-ancestor
102298699|NCT02287233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298700|NCT02287233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102298701|NCT02287233|Antiviral Agents|antiviral agents|mesh-ancestor
102298702|NCT02287233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102298703|NCT02287233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102298704|NCT02287233|Immunologic Factors|immunologic factors|mesh-ancestor
102298705|NCT02287233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298706|NCT01646385|Etanercept|etanercept|mesh-list
102298707|NCT01646385|Antirheumatic Agents|antirheumatic agents|mesh-list
102298708|NCT01646385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102298709|NCT01646385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102298710|NCT01646385|Analgesics|analgesics|mesh-ancestor
102298711|NCT01646385|Sensory System Agents|sensory system agents|mesh-ancestor
102298712|NCT01646385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102298713|NCT01646385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298714|NCT01646385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102298715|NCT01646385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102298716|NCT01646385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102298717|NCT01646385|Immunologic Factors|immunologic factors|mesh-ancestor
102298718|NCT02286843|Trastuzumab|trastuzumab|mesh-list
102298719|NCT02286843|Pertuzumab|pertuzumab|mesh-list
102298720|NCT02286843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102298721|NCT02286843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102298722|NCT02281773|BI 409306|bi 409306|mesh-list
102298723|NCT02281773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102298724|NCT02281773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102298725|NCT02281773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298726|NCT02354235|Canagliflozin|canagliflozin|mesh-list
102298727|NCT02354235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102298728|NCT02354235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298729|NCT02354235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102298730|NCT02354235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298731|NCT02284893|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102298732|NCT02284893|Dapagliflozin|dapagliflozin|mesh-list
102298733|NCT02284893|Saxagliptin|saxagliptin|mesh-list
102298734|NCT02284893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102298735|NCT02284893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298736|NCT02284893|Incretins|incretins|mesh-ancestor
102298737|NCT02284893|Hormones|hormones|mesh-ancestor
102298738|NCT02284893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102298739|NCT02284893|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102298740|NCT02284893|Protease Inhibitors|protease inhibitors|mesh-ancestor
102298741|NCT02284893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102298742|NCT02284893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298743|NCT02284893|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102298744|NCT04965181|Nicotine|nicotine|mesh-list
102298745|NCT04965181|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102298746|NCT04965181|Autonomic Agents|autonomic agents|mesh-ancestor
102298747|NCT04965181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102298748|NCT04965181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298749|NCT04965181|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102298750|NCT04965181|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102298751|NCT04965181|Cholinergic Agents|cholinergic agents|mesh-ancestor
102298752|NCT04965181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102298753|NCT04965181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298754|NCT02483611|Lidocaine|lidocaine|mesh-list
102298755|NCT02483611|Magnesium Sulfate|magnesium sulfate|mesh-list
102298756|NCT02483611|Cisatracurium|cisatracurium|mesh-list
102298757|NCT02483611|Anesthetics, Local|anesthetics, local|mesh-ancestor
102298758|NCT02483611|Anesthetics|anesthetics|mesh-ancestor
102298759|NCT02483611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102298760|NCT02483611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298761|NCT02483611|Sensory System Agents|sensory system agents|mesh-ancestor
102298762|NCT02483611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102298763|NCT02483611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102298764|NCT02483611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102298765|NCT02483611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102298766|NCT02483611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102007503|NCT01205321|Bombesin|bombesin|mesh-list
102298767|NCT02483611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298768|NCT02483611|Analgesics|analgesics|mesh-ancestor
102298769|NCT02483611|Anticonvulsants|anticonvulsants|mesh-ancestor
102298770|NCT02483611|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102298771|NCT02483611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102298772|NCT02483611|Tocolytic Agents|tocolytic agents|mesh-ancestor
102298773|NCT02483611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102298774|NCT02483611|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102298775|NCT02483611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102298776|NCT02482129|Dexamethasone|dexamethasone|mesh-list
102298777|NCT02482129|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102298778|NCT02482129|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102298779|NCT02482129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102298780|NCT02482129|Antiemetics|antiemetics|mesh-ancestor
102298781|NCT02482129|Autonomic Agents|autonomic agents|mesh-ancestor
102298782|NCT02482129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102298783|NCT02482129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298784|NCT02482129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102298785|NCT02482129|Glucocorticoids|glucocorticoids|mesh-ancestor
102298786|NCT02482129|Hormones|hormones|mesh-ancestor
102298787|NCT02482129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102298788|NCT02482129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102298789|NCT02482129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102298790|NCT02495857|Hyaluronic Acid|hyaluronic acid|mesh-list
102298791|NCT02495857|Viscosupplements|viscosupplements|mesh-list
102298792|NCT02495857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102298793|NCT02495857|Immunologic Factors|immunologic factors|mesh-ancestor
102298794|NCT02495857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298795|NCT02495857|Protective Agents|protective agents|mesh-ancestor
102298796|NCT02495389|Mirabegron|mirabegron|mesh-list
102298797|NCT02495389|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102298798|NCT02495389|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102298799|NCT02495389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102298800|NCT02495389|Adrenergic Agents|adrenergic agents|mesh-ancestor
102298801|NCT02495389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102298802|NCT02495389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298803|NCT02495389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298804|NCT02495389|Urological Agents|urological agents|mesh-ancestor
102298805|NCT02495233|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102298806|NCT02495233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102298807|NCT02495233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102298808|NCT02495233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102298809|NCT02495233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298810|NCT02495077|Acetaminophen|acetaminophen|mesh-list
102298811|NCT02495077|Diphenhydramine|diphenhydramine|mesh-list
102298812|NCT02495077|Promethazine|promethazine|mesh-list
102298813|NCT02495077|Loratadine|loratadine|mesh-list
102298814|NCT02495077|Mycophenolic Acid|mycophenolic acid|mesh-list
102298815|NCT02495077|Prednisone|prednisone|mesh-list
102298816|NCT02495077|Methylprednisolone|methylprednisolone|mesh-list
102298817|NCT02495077|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102298818|NCT02495077|Infliximab|infliximab|mesh-list
102298820|NCT02495077|Thymoglobulin|thymoglobulin|mesh-list
102298821|NCT02495077|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102298822|NCT02495077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102298823|NCT02495077|Glucocorticoids|glucocorticoids|mesh-ancestor
102298824|NCT02495077|Hormones|hormones|mesh-ancestor
102298825|NCT02495077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102298826|NCT02495077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298827|NCT02495077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102298828|NCT02495077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102298829|NCT02495077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102298830|NCT02495077|Immunologic Factors|immunologic factors|mesh-ancestor
102298831|NCT02495077|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102298832|NCT02495077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102298833|NCT02495077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298834|NCT02495077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102298835|NCT02495077|Analgesics|analgesics|mesh-ancestor
102298836|NCT02495077|Sensory System Agents|sensory system agents|mesh-ancestor
102298837|NCT02495077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102298838|NCT02495077|Antipyretics|antipyretics|mesh-ancestor
102298839|NCT02495077|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102298840|NCT02495077|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102298841|NCT02495077|Antitubercular Agents|antitubercular agents|mesh-ancestor
102007572|NCT01205711|Protective Agents|protective agents|mesh-ancestor
102298842|NCT02495077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102298843|NCT02495077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102298844|NCT02495077|Antiemetics|antiemetics|mesh-ancestor
102298845|NCT02495077|Autonomic Agents|autonomic agents|mesh-ancestor
102298846|NCT02495077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102298847|NCT02495077|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102298848|NCT02495077|Protective Agents|protective agents|mesh-ancestor
102298849|NCT02495077|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102298850|NCT02495077|Dermatologic Agents|dermatologic agents|mesh-ancestor
102298851|NCT02495077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102298852|NCT02495077|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102298853|NCT02495077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102298854|NCT02495077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102298855|NCT02495077|Anesthetics, Local|anesthetics, local|mesh-ancestor
102298856|NCT02495077|Anesthetics|anesthetics|mesh-ancestor
102298857|NCT02495077|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102298858|NCT02495077|Histamine Antagonists|histamine antagonists|mesh-ancestor
102298859|NCT02495077|Histamine Agents|histamine agents|mesh-ancestor
102298860|NCT02495077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102298861|NCT02495077|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102298862|NCT02495077|Antipruritics|antipruritics|mesh-ancestor
102298863|NCT02495077|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102298864|NCT02278341|Epoetin Alfa|epoetin alfa|mesh-list
102298865|NCT02278341|Darbepoetin alfa|darbepoetin alfa|mesh-list
102298866|NCT02278341|Hematinics|hematinics|mesh-ancestor
102298867|NCT02278263|Tranexamic Acid|tranexamic acid|mesh-list
102298868|NCT02278263|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102298869|NCT02278263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102298870|NCT02278263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298871|NCT02278263|Hemostatics|hemostatics|mesh-ancestor
102298872|NCT02278263|Coagulants|coagulants|mesh-ancestor
102298873|NCT02494921|Prednisone|prednisone|mesh-list
102298874|NCT02494921|Docetaxel|docetaxel|mesh-list
102298875|NCT02494921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102298876|NCT02494921|Tubulin Modulators|tubulin modulators|mesh-ancestor
102298877|NCT02494921|Antimitotic Agents|antimitotic agents|mesh-ancestor
102298878|NCT02494921|Mitosis Modulators|mitosis modulators|mesh-ancestor
102298879|NCT02494921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298880|NCT02494921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102298881|NCT02494921|Glucocorticoids|glucocorticoids|mesh-ancestor
102298882|NCT02494921|Hormones|hormones|mesh-ancestor
102298883|NCT02494921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102298884|NCT02494921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298885|NCT02494921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102298886|NCT01653847|Mycophenolic Acid|mycophenolic acid|mesh-list
102298887|NCT01653847|Everolimus|everolimus|mesh-list
102298888|NCT01653847|Tacrolimus|tacrolimus|mesh-list
102298889|NCT01653847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102298890|NCT01653847|Immunologic Factors|immunologic factors|mesh-ancestor
102298891|NCT01653847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298892|NCT01653847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102298893|NCT01653847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101941535|NCT01227759|Tyrothricin|tyrothricin|mesh-list
102298894|NCT01653847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298895|NCT01653847|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102298896|NCT01653847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102298897|NCT01653847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102298898|NCT01653847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102298899|NCT01653847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102298900|NCT01653847|Antitubercular Agents|antitubercular agents|mesh-ancestor
102298901|NCT01653847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102298902|NCT01653847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102298903|NCT02493751|Avelumab|avelumab|mesh-list
102298904|NCT02493751|Axitinib|axitinib|mesh-list
102298905|NCT02493751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102298906|NCT02493751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102298907|NCT02493751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102298908|NCT02493751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102298909|NCT02493751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298910|NCT02493517|Lanreotide|lanreotide|mesh-list
102298911|NCT02493517|Somatostatin|somatostatin|mesh-list
102298912|NCT02493517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102298913|NCT02493517|Hormones|hormones|mesh-ancestor
102298914|NCT02493517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102298915|NCT02493517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298916|NCT02493361|Pembrolizumab|pembrolizumab|mesh-list
102298917|NCT02493361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102298918|NCT02493361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399830|NCT02394834|Antimetabolites|antimetabolites|mesh-ancestor
102298919|NCT02493361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102298920|NCT02493361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298921|NCT04959799|Dalbavancin|dalbavancin|mesh-list
102298922|NCT04959799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102298923|NCT04959799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102298925|NCT04959331|Nitrofurantoin|nitrofurantoin|mesh-list
102298926|NCT04959331|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
102298927|NCT04959331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102298928|NCT04959331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102298929|NCT04959331|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102298930|NCT02478463|Cabotegravir|cabotegravir|mesh-list
102298931|NCT02478463|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102298932|NCT02478463|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102298933|NCT02478463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102298934|NCT02478463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298935|NCT02478463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102298936|NCT02478463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102298937|NCT02478463|Antiviral Agents|antiviral agents|mesh-ancestor
102298938|NCT02478463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102298939|NCT02491411|Dexamethasone|dexamethasone|mesh-list
102298940|NCT02491411|Dexamethasone acetate|dexamethasone acetate|mesh-list
102298941|NCT02491411|Ichthammol|ichthammol|mesh-list
102298942|NCT02491411|BB 1101|bb 1101|mesh-list
102298943|NCT02491411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102298944|NCT02491411|Antiemetics|antiemetics|mesh-ancestor
102298945|NCT02491411|Autonomic Agents|autonomic agents|mesh-ancestor
102298946|NCT02491411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102298947|NCT02491411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298948|NCT02491411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102298949|NCT02491411|Glucocorticoids|glucocorticoids|mesh-ancestor
102298950|NCT02491411|Hormones|hormones|mesh-ancestor
102298951|NCT02491411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102298952|NCT02491411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102298953|NCT02491411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102298954|NCT02491411|Protease Inhibitors|protease inhibitors|mesh-ancestor
102298955|NCT02491411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102298956|NCT02491411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298957|NCT02491411|Dermatologic Agents|dermatologic agents|mesh-ancestor
102298958|NCT02517463|Ulipristal acetate|ulipristal acetate|mesh-list
102298959|NCT02517463|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102298960|NCT02517463|Contraceptive Agents|contraceptive agents|mesh-ancestor
102298961|NCT02517463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102298962|NCT02517463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298963|NCT02517463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102298964|NCT02490475|Docetaxel|docetaxel|mesh-list
102298965|NCT02490475|Pertuzumab|pertuzumab|mesh-list
102298966|NCT02490475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102298967|NCT02490475|Tubulin Modulators|tubulin modulators|mesh-ancestor
102298968|NCT02490475|Antimitotic Agents|antimitotic agents|mesh-ancestor
102298969|NCT02490475|Mitosis Modulators|mitosis modulators|mesh-ancestor
102298970|NCT02490475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298971|NCT02490475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102298972|NCT02477839|Lacosamide|lacosamide|mesh-list
102298973|NCT02477839|Anticonvulsants|anticonvulsants|mesh-ancestor
102298974|NCT02477839|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102298975|NCT02477839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102298976|NCT02477839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102298977|NCT02477839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102298978|NCT04939987|Acetaminophen|acetaminophen|mesh-list
102298979|NCT04939987|Ketorolac|ketorolac|mesh-list
102298980|NCT04939987|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102298981|NCT04939987|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
102298982|NCT04939987|Ketamine|ketamine|mesh-list
102298983|NCT04939987|Oxycodone|oxycodone|mesh-list
102298984|NCT04939987|Gabapentin|gabapentin|mesh-list
102298985|NCT04939987|Tramadol|tramadol|mesh-list
102298986|NCT04939987|Hydrocodone|hydrocodone|mesh-list
102298987|NCT04939987|Analgesics, Opioid|analgesics, opioid|mesh-list
102298988|NCT04939987|Analgesics|analgesics|mesh-ancestor
102298989|NCT04939987|Sensory System Agents|sensory system agents|mesh-ancestor
102298990|NCT04939987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101399896|NCT02099825|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102298991|NCT04939987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102298992|NCT04939987|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102298993|NCT04939987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102007723|NCT03639493|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102298994|NCT04939987|Anesthetics, General|anesthetics, general|mesh-ancestor
102298996|NCT04939987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102298997|NCT04939987|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102298998|NCT04939987|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102298999|NCT04939987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102299000|NCT04939987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299001|NCT04939987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102299002|NCT04939987|Antipyretics|antipyretics|mesh-ancestor
102299003|NCT04939987|Narcotics|narcotics|mesh-ancestor
102299004|NCT04939987|Anticonvulsants|anticonvulsants|mesh-ancestor
102299005|NCT04939987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102299006|NCT04939987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102299007|NCT04939987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102299008|NCT04939987|Antimanic Agents|antimanic agents|mesh-ancestor
102299009|NCT04939987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102299010|NCT04939987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102299011|NCT04939987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102299012|NCT04939987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102299013|NCT04939987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102299014|NCT04939987|Antitussive Agents|antitussive agents|mesh-ancestor
102299015|NCT04939987|Respiratory System Agents|respiratory system agents|mesh-ancestor
102299016|NCT02477527|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102299017|NCT02477527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102299018|NCT02477527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102299019|NCT02477527|Antiviral Agents|antiviral agents|mesh-ancestor
102299020|NCT02477527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102299021|NCT02477215|Dexamethasone|dexamethasone|mesh-list
102299022|NCT02477215|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102299023|NCT02477215|Ixazomib|ixazomib|mesh-list
102299024|NCT02477215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102299025|NCT02477215|Antiemetics|antiemetics|mesh-ancestor
102299026|NCT02477215|Autonomic Agents|autonomic agents|mesh-ancestor
102299027|NCT02477215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102299028|NCT02477215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299029|NCT02477215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102299030|NCT02477215|Glucocorticoids|glucocorticoids|mesh-ancestor
102299031|NCT02477215|Hormones|hormones|mesh-ancestor
102299032|NCT02477215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102299033|NCT02477215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102299034|NCT02477215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299035|NCT02477215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102299036|NCT02477215|Alkylating Agents|alkylating agents|mesh-ancestor
102299037|NCT02477215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299038|NCT02477215|Protease Inhibitors|protease inhibitors|mesh-ancestor
102299039|NCT02477215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102299040|NCT02487199|Ritonavir|ritonavir|mesh-list
102299041|NCT02487199|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102299042|NCT02487199|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102299043|NCT02487199|Protease Inhibitors|protease inhibitors|mesh-ancestor
102299044|NCT02487199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102299045|NCT02487199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299046|NCT02487199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102299047|NCT02487199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102299048|NCT02487199|Antiviral Agents|antiviral agents|mesh-ancestor
102299049|NCT02487199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102299050|NCT02487199|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102299051|NCT02487199|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102299052|NCT02475733|Metronidazole|metronidazole|mesh-list
102299053|NCT02475733|Meropenem|meropenem|mesh-list
102299054|NCT02475733|Ceftazidime|ceftazidime|mesh-list
102299055|NCT02475733|Avibactam|avibactam|mesh-list
102299056|NCT02475733|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
102299057|NCT02475733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102299058|NCT02475733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102299059|NCT02475733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102299060|NCT02475733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102299061|NCT02475733|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102299062|NCT02475733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102299063|NCT02475733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299064|NCT02486653|Tamsulosin|tamsulosin|mesh-list
102299065|NCT02486653|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102299066|NCT02486653|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102299067|NCT02486653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102299068|NCT02486653|Adrenergic Agents|adrenergic agents|mesh-ancestor
102299070|NCT02486653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299071|NCT02486653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299072|NCT02486653|Urological Agents|urological agents|mesh-ancestor
102299073|NCT02475265|Levonorgestrel|levonorgestrel|mesh-list
102299074|NCT02475265|Estradiol|estradiol|mesh-list
102299075|NCT02475265|Estrogens|estrogens|mesh-ancestor
102299076|NCT02475265|Hormones|hormones|mesh-ancestor
102299077|NCT02475265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102299078|NCT02475265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299079|NCT02475265|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102299080|NCT02475265|Contraceptive Agents|contraceptive agents|mesh-ancestor
102299081|NCT02475265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102299082|NCT02475265|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102299083|NCT02475265|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102299084|NCT02475265|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102299085|NCT02450539|Docetaxel|docetaxel|mesh-list
102299086|NCT02450539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299087|NCT02450539|Tubulin Modulators|tubulin modulators|mesh-ancestor
102299088|NCT02450539|Antimitotic Agents|antimitotic agents|mesh-ancestor
102299089|NCT02450539|Mitosis Modulators|mitosis modulators|mesh-ancestor
102299090|NCT02450539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299091|NCT02449915|Bupivacaine|bupivacaine|mesh-list
102299092|NCT02449915|Anesthetics, Local|anesthetics, local|mesh-ancestor
102299093|NCT02449915|Anesthetics|anesthetics|mesh-ancestor
102299094|NCT02449915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102299095|NCT02449915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299096|NCT02449915|Sensory System Agents|sensory system agents|mesh-ancestor
102299097|NCT02449915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102299098|NCT02472847|Dronabinol|dronabinol|mesh-list
102299099|NCT02472847|Hallucinogens|hallucinogens|mesh-ancestor
102299100|NCT02472847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299101|NCT02472847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102299102|NCT02472847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102299103|NCT02472847|Analgesics|analgesics|mesh-ancestor
102299104|NCT02472847|Sensory System Agents|sensory system agents|mesh-ancestor
102299105|NCT02472847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102299106|NCT02472847|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102299107|NCT02472847|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102299108|NCT02472847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102299109|NCT02472847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299110|NCT02472847|Hormones|hormones|mesh-ancestor
102299111|NCT02472847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102299112|NCT02472145|Decitabine|decitabine|mesh-list
102299113|NCT02472145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102299114|NCT02472145|Antimetabolites|antimetabolites|mesh-ancestor
102299115|NCT02472145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299116|NCT02472145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299117|NCT02472145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102299118|NCT02418949|Cyproheptadine|cyproheptadine|mesh-list
102299119|NCT02418949|Antipruritics|antipruritics|mesh-ancestor
102299120|NCT02418949|Dermatologic Agents|dermatologic agents|mesh-ancestor
102299121|NCT02418949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102299122|NCT02418949|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102299123|NCT02418949|Histamine Antagonists|histamine antagonists|mesh-ancestor
102299124|NCT02418949|Histamine Agents|histamine agents|mesh-ancestor
102299125|NCT02418949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102299126|NCT02418949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299127|NCT02418949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299128|NCT02418949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102299129|NCT02418949|Serotonin Agents|serotonin agents|mesh-ancestor
102299130|NCT02418949|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102299131|NCT04912765|Nivolumab|nivolumab|mesh-list
102299132|NCT04912765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102299133|NCT04912765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299134|NCT04912765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102299135|NCT04912765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299136|NCT02448043|Bimatoprost|bimatoprost|mesh-list
102299137|NCT02448043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102299138|NCT02447887|Interferon alpha-2|interferon alpha-2|mesh-list
102299139|NCT02447887|Ixazomib|ixazomib|mesh-list
102299140|NCT02447887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299141|NCT02447887|Protease Inhibitors|protease inhibitors|mesh-ancestor
102299142|NCT02447887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102299143|NCT02447887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299145|NCT02447887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102299146|NCT02470429|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102299147|NCT02470429|Lubricant Eye Drops|lubricant eye drops|mesh-list
102299148|NCT02470429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102299149|NCT02417935|Pregabalin|pregabalin|mesh-list
102299150|NCT02417935|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102299151|NCT02417935|Analgesics|analgesics|mesh-ancestor
102299152|NCT02417935|Sensory System Agents|sensory system agents|mesh-ancestor
102299153|NCT02417935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102299154|NCT02417935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299155|NCT02417935|Anticonvulsants|anticonvulsants|mesh-ancestor
102299156|NCT02417935|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102299157|NCT02417935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102299158|NCT02417935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299159|NCT02417935|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102299160|NCT02417935|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102299161|NCT02417935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102299162|NCT02417935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102299163|NCT02417935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102299164|NCT02417935|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102299165|NCT02417935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102299166|NCT02417935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102299167|NCT02417935|Antidepressive Agents|antidepressive agents|mesh-ancestor
102299168|NCT02417935|Dopamine Agents|dopamine agents|mesh-ancestor
102299169|NCT02447029|Lidocaine|lidocaine|mesh-list
102299170|NCT02447029|Anesthetics, Local|anesthetics, local|mesh-ancestor
102299171|NCT02447029|Anesthetics|anesthetics|mesh-ancestor
102299172|NCT02447029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102299173|NCT02447029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299174|NCT02447029|Sensory System Agents|sensory system agents|mesh-ancestor
102299175|NCT02447029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102299176|NCT02447029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102299177|NCT02447029|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102299178|NCT02447029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102299179|NCT02447029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102299180|NCT02447029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299181|NCT02416453|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
102299182|NCT02416453|Antiviral Agents|antiviral agents|mesh-ancestor
102299183|NCT02416453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102299184|NCT02469961|Dexmedetomidine|dexmedetomidine|mesh-list
102299185|NCT02469961|Propofol|propofol|mesh-list
102299186|NCT02469961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102299187|NCT02469961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102299188|NCT02469961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299189|NCT02469961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102299190|NCT02469961|Analgesics|analgesics|mesh-ancestor
101400064|NCT05952089|GABA Modulators|gaba modulators|mesh-ancestor
102299191|NCT02469961|Sensory System Agents|sensory system agents|mesh-ancestor
102299192|NCT02469961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102299193|NCT02469961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102299194|NCT02469961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102299196|NCT02469961|Adrenergic Agents|adrenergic agents|mesh-ancestor
102299197|NCT02469961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102299198|NCT02469961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299199|NCT02469961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102299200|NCT02469961|Anesthetics, General|anesthetics, general|mesh-ancestor
102299201|NCT02469961|Anesthetics|anesthetics|mesh-ancestor
102299202|NCT02415595|BMS-955176|bms-955176|mesh-list
102299203|NCT02415595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102299204|NCT02415595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102299205|NCT02415595|Antiviral Agents|antiviral agents|mesh-ancestor
102299206|NCT02415595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102299207|NCT02446717|Ribavirin|ribavirin|mesh-list
102299208|NCT02446717|Antimetabolites|antimetabolites|mesh-ancestor
102299209|NCT02446717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299210|NCT02446717|Antiviral Agents|antiviral agents|mesh-ancestor
102299211|NCT02446717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102299212|NCT02469415|Azacitidine|azacitidine|mesh-list
102299213|NCT02469415|Decitabine|decitabine|mesh-list
102299214|NCT02469415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102299215|NCT02469415|Antimetabolites|antimetabolites|mesh-ancestor
102299216|NCT02469415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299218|NCT02469415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102299219|NCT02446171|Naloxegol|naloxegol|mesh-list
102299220|NCT02446171|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102299221|NCT02446171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299222|NCT02446171|Sensory System Agents|sensory system agents|mesh-ancestor
102299223|NCT02446171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102299224|NCT02446015|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102299225|NCT02446015|Lubricant Eye Drops|lubricant eye drops|mesh-list
102299226|NCT02446015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102299227|NCT02415127|Interferons|interferons|mesh-list
102299228|NCT02415127|Interferon-gamma|interferon-gamma|mesh-list
102299229|NCT02415127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299230|NCT02415127|Antiviral Agents|antiviral agents|mesh-ancestor
102299231|NCT02415127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102299232|NCT02468557|Paclitaxel|paclitaxel|mesh-list
102299233|NCT02468557|Idelalisib|idelalisib|mesh-list
102299234|NCT02468557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102299235|NCT02468557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299236|NCT02468557|Tubulin Modulators|tubulin modulators|mesh-ancestor
102299237|NCT02468557|Antimitotic Agents|antimitotic agents|mesh-ancestor
102299238|NCT02468557|Mitosis Modulators|mitosis modulators|mesh-ancestor
102299239|NCT02468557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299240|NCT02468557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102299241|NCT02413489|Daratumumab|daratumumab|mesh-list
102299242|NCT02413489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299243|NCT02413333|Contact Lens Solutions|contact lens solutions|mesh-list
102299244|NCT02413333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102299245|NCT02413333|Disinfectants|disinfectants|mesh-ancestor
102299246|NCT02413333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102299247|NCT02444533|Bupivacaine|bupivacaine|mesh-list
102299248|NCT02444533|Anesthetics, Local|anesthetics, local|mesh-ancestor
102299249|NCT02444533|Anesthetics|anesthetics|mesh-ancestor
102299250|NCT02444533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102299251|NCT02444533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299252|NCT02444533|Sensory System Agents|sensory system agents|mesh-ancestor
102299253|NCT02444533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102299254|NCT01651039|Dexamethasone|dexamethasone|mesh-list
102299255|NCT01651039|Lenalidomide|lenalidomide|mesh-list
102299256|NCT01651039|Panobinostat|panobinostat|mesh-list
102299257|NCT01651039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102299258|NCT01651039|Antiemetics|antiemetics|mesh-ancestor
102299259|NCT01651039|Autonomic Agents|autonomic agents|mesh-ancestor
102299260|NCT01651039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102299261|NCT01651039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299262|NCT01651039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102299263|NCT01651039|Glucocorticoids|glucocorticoids|mesh-ancestor
102299264|NCT01651039|Hormones|hormones|mesh-ancestor
102299265|NCT01651039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102299266|NCT01651039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102299267|NCT01651039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299268|NCT01651039|Immunologic Factors|immunologic factors|mesh-ancestor
102299269|NCT01651039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102299270|NCT01651039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102299271|NCT01651039|Growth Substances|growth substances|mesh-ancestor
102299272|NCT01651039|Growth Inhibitors|growth inhibitors|mesh-ancestor
102299273|NCT01651039|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102299274|NCT01651039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102299275|NCT01651039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299276|NCT02349633|Palbociclib|palbociclib|mesh-list
102299277|NCT02349633|Avelumab|avelumab|mesh-list
102299278|NCT02349633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299279|NCT02349633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102299280|NCT02349633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102299281|NCT02349633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299282|NCT02349633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102299283|NCT02275611|Oxytocin|oxytocin|mesh-list
102299284|NCT02275611|Oxytocics|oxytocics|mesh-ancestor
102299285|NCT02275611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102299286|NCT02275611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299287|NCT04875585|Pembrolizumab|pembrolizumab|mesh-list
102299288|NCT04875585|Lenvatinib|lenvatinib|mesh-list
102299289|NCT04875585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102299290|NCT04875585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299291|NCT04875585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102299292|NCT04875585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299293|NCT04875585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102299294|NCT04875585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102299295|NCT02273973|Letrozole|letrozole|mesh-list
102299296|NCT02273973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299297|NCT02273973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102299298|NCT02273973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102299299|NCT02273973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102299300|NCT02273973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299301|NCT02273973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102299302|NCT02273973|Hormone Antagonists|hormone antagonists|mesh-ancestor
102299303|NCT02273973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102299304|NCT02273973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299305|NCT05649111|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102299306|NCT05649111|Difluprednate|difluprednate|mesh-list
102299307|NCT05649111|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102299308|NCT05649111|Glucocorticoids|glucocorticoids|mesh-ancestor
102299309|NCT05649111|Hormones|hormones|mesh-ancestor
102299310|NCT05649111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102299311|NCT05649111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299312|NCT02465515|rGLP-1 protein|rglp-1 protein|mesh-list
102299313|NCT02465515|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102299314|NCT02465515|Incretins|incretins|mesh-ancestor
102299315|NCT02465515|Hormones|hormones|mesh-ancestor
102299316|NCT02465515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102299317|NCT02465515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299318|NCT05561361|Spironolactone|spironolactone|mesh-list
102299319|NCT05561361|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102299320|NCT05561361|Hormone Antagonists|hormone antagonists|mesh-ancestor
102299321|NCT05561361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102299322|NCT05561361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299323|NCT05561361|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102299324|NCT05561361|Diuretics|diuretics|mesh-ancestor
102299325|NCT05561361|Natriuretic Agents|natriuretic agents|mesh-ancestor
102299326|NCT02412631|Varenicline|varenicline|mesh-list
102299327|NCT02412631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102299328|NCT02412631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102299329|NCT02412631|Cholinergic Agents|cholinergic agents|mesh-ancestor
102299330|NCT02412631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102299331|NCT02412631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299332|NCT02412631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299333|NCT02272803|Dexamethasone|dexamethasone|mesh-list
102299334|NCT02272803|Lenalidomide|lenalidomide|mesh-list
102299335|NCT02272803|Elotuzumab|elotuzumab|mesh-list
102299336|NCT02272803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102299337|NCT02272803|Antiemetics|antiemetics|mesh-ancestor
102299338|NCT02272803|Autonomic Agents|autonomic agents|mesh-ancestor
102299339|NCT02272803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102299340|NCT02272803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299341|NCT02272803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102299342|NCT02272803|Glucocorticoids|glucocorticoids|mesh-ancestor
102299343|NCT02272803|Hormones|hormones|mesh-ancestor
102299344|NCT02272803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102299345|NCT02272803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102299346|NCT02272803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299347|NCT02272803|Immunologic Factors|immunologic factors|mesh-ancestor
102299348|NCT02272803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102299349|NCT02272803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102299350|NCT02272803|Growth Substances|growth substances|mesh-ancestor
102299351|NCT02272803|Growth Inhibitors|growth inhibitors|mesh-ancestor
102299352|NCT02272725|Ibuprofen|ibuprofen|mesh-list
102299353|NCT02272725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102299354|NCT02272725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102299355|NCT02272725|Analgesics|analgesics|mesh-ancestor
102299356|NCT02272725|Sensory System Agents|sensory system agents|mesh-ancestor
102299357|NCT02272725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102299358|NCT02272725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299359|NCT02272725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102299360|NCT02272725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102299361|NCT02272725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102299362|NCT02272725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102299363|NCT02272725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299364|NCT01650805|Imatinib Mesylate|imatinib mesylate|mesh-list
102299365|NCT01650805|Ponatinib|ponatinib|mesh-list
102299366|NCT01650805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299367|NCT01650805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102299368|NCT01650805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102299369|NCT01650805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299370|NCT02442349|Osimertinib|osimertinib|mesh-list
102299371|NCT02442349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299372|NCT02442349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102299373|NCT02442349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102299374|NCT02442349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299375|NCT02442271|Ritonavir|ritonavir|mesh-list
102299376|NCT02442271|Ribavirin|ribavirin|mesh-list
102299377|NCT02442271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102299378|NCT02442271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102299379|NCT02442271|Protease Inhibitors|protease inhibitors|mesh-ancestor
102299380|NCT02442271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102299381|NCT02442271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299382|NCT02442271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102299383|NCT02442271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102299384|NCT02442271|Antiviral Agents|antiviral agents|mesh-ancestor
102299385|NCT02442271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102299386|NCT02442271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102299387|NCT02442271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102299388|NCT02442271|Antimetabolites|antimetabolites|mesh-ancestor
102299389|NCT02463409|Theophylline|theophylline|mesh-list
102299390|NCT02463409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102299391|NCT02463409|Autonomic Agents|autonomic agents|mesh-ancestor
102299392|NCT02463409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102299393|NCT02463409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299394|NCT02463409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102299395|NCT02463409|Respiratory System Agents|respiratory system agents|mesh-ancestor
102299396|NCT02463409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102299397|NCT02463409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102299398|NCT02463409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299399|NCT02463409|Vasodilator Agents|vasodilator agents|mesh-ancestor
102299400|NCT02463409|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102299401|NCT02463409|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102299402|NCT02463409|Purinergic Agents|purinergic agents|mesh-ancestor
102299403|NCT02463409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102299404|NCT02528357|Pembrolizumab|pembrolizumab|mesh-list
102299405|NCT02528357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102299406|NCT02528357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299407|NCT02528357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102299408|NCT02528357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299409|NCT04910503|Dexamethasone|dexamethasone|mesh-list
102299410|NCT04910503|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
102299411|NCT04910503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102299412|NCT04910503|Antiemetics|antiemetics|mesh-ancestor
102299413|NCT04910503|Autonomic Agents|autonomic agents|mesh-ancestor
102299414|NCT04910503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102299415|NCT04910503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299416|NCT04910503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102299417|NCT04910503|Glucocorticoids|glucocorticoids|mesh-ancestor
102299419|NCT04910503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102299420|NCT04910503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102299421|NCT04910503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299422|NCT04910425|Fluorides|fluorides|mesh-list
102299423|NCT04910425|Cariostatic Agents|cariostatic agents|mesh-ancestor
102299424|NCT04910425|Protective Agents|protective agents|mesh-ancestor
102299425|NCT04910425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299426|NCT02463331|Chloroquine|chloroquine|mesh-list
102299427|NCT02463331|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
102299428|NCT02463331|Prednisone|prednisone|mesh-list
102299429|NCT02463331|Azathioprine|azathioprine|mesh-list
102299430|NCT02463331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102299431|NCT02463331|Glucocorticoids|glucocorticoids|mesh-ancestor
102299432|NCT02463331|Hormones|hormones|mesh-ancestor
102299433|NCT02463331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102299434|NCT02463331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299435|NCT02463331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102299436|NCT02463331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299437|NCT02463331|Amebicides|amebicides|mesh-ancestor
102299438|NCT02463331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102299439|NCT02463331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102299440|NCT02463331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102299441|NCT02463331|Antimalarials|antimalarials|mesh-ancestor
102299442|NCT02463331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102299443|NCT02463331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102299444|NCT02463331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102299445|NCT02463331|Analgesics|analgesics|mesh-ancestor
102299446|NCT02463331|Sensory System Agents|sensory system agents|mesh-ancestor
102299447|NCT02463331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102299448|NCT02463331|Filaricides|filaricides|mesh-ancestor
102299449|NCT02463331|Antinematodal Agents|antinematodal agents|mesh-ancestor
102299450|NCT02463331|Anthelmintics|anthelmintics|mesh-ancestor
102299451|NCT02463331|Antimetabolites|antimetabolites|mesh-ancestor
102299452|NCT02463331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299453|NCT02463331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102299454|NCT02463331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102299455|NCT02463331|Immunologic Factors|immunologic factors|mesh-ancestor
102299456|NCT02463097|Insulin|insulin|mesh-list
102299457|NCT02463097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102299458|NCT02463097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299459|NCT05427149|Magnesium Sulfate|magnesium sulfate|mesh-list
102299460|NCT05427149|Analgesics|analgesics|mesh-ancestor
102299461|NCT05427149|Sensory System Agents|sensory system agents|mesh-ancestor
102299462|NCT05427149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102299463|NCT05427149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299464|NCT05427149|Anesthetics|anesthetics|mesh-ancestor
102299465|NCT05427149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102299466|NCT05427149|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102299467|NCT05427149|Anticonvulsants|anticonvulsants|mesh-ancestor
102299468|NCT05427149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102299469|NCT05427149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102299470|NCT05427149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299471|NCT05427149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102299472|NCT05427149|Tocolytic Agents|tocolytic agents|mesh-ancestor
102299473|NCT05427149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102299474|NCT02462473|Olanzapine|olanzapine|mesh-list
102299475|NCT02462473|Risperidone|risperidone|mesh-list
102299476|NCT02462473|Aripiprazole|aripiprazole|mesh-list
102299477|NCT02462473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102299478|NCT02462473|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102299479|NCT02462473|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102299480|NCT02462473|Serotonin Agents|serotonin agents|mesh-ancestor
102299481|NCT02462473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102299482|NCT02462473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299483|NCT02462473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299484|NCT02462473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102299485|NCT02462473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102299486|NCT02462473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102299487|NCT02462473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102299488|NCT02462473|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101941539|NCT03923829|Zinc|zinc|mesh-list
102299489|NCT02462473|Dopamine Agents|dopamine agents|mesh-ancestor
102299490|NCT02462473|Antiemetics|antiemetics|mesh-ancestor
102299491|NCT02462473|Autonomic Agents|autonomic agents|mesh-ancestor
102299492|NCT02462473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102299493|NCT02462473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102299494|NCT02462473|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102299495|NCT02462473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102299496|NCT02462473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102299497|NCT02462473|Antidepressive Agents|antidepressive agents|mesh-ancestor
102299498|NCT02462473|Dopamine Agonists|dopamine agonists|mesh-ancestor
102299499|NCT02462473|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102299500|NCT02462473|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102299501|NCT02462473|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102299502|NCT02462473|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102299503|NCT02440789|Sirolimus|sirolimus|mesh-list
102299504|NCT02440789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102299505|NCT02440789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102299506|NCT02440789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102299507|NCT02440789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299508|NCT02440789|Antifungal Agents|antifungal agents|mesh-ancestor
102299509|NCT02440789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102299510|NCT02440789|Immunologic Factors|immunologic factors|mesh-ancestor
102299511|NCT02440789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299512|NCT02538107|Epoetin Alfa|epoetin alfa|mesh-list
102299513|NCT02538107|Hematinics|hematinics|mesh-ancestor
102299514|NCT02272413|Bevacizumab|bevacizumab|mesh-list
102299515|NCT02272413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102299516|NCT02272413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299517|NCT02272413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102299518|NCT02272413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102299519|NCT02272413|Growth Substances|growth substances|mesh-ancestor
102299520|NCT02272413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299521|NCT02272413|Growth Inhibitors|growth inhibitors|mesh-ancestor
102299522|NCT05648799|Molnupiravir|molnupiravir|mesh-list
102299523|NCT05648799|Antiviral Agents|antiviral agents|mesh-ancestor
102299524|NCT05648799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102299525|NCT05400863|Metformin|metformin|mesh-list
102299526|NCT05400863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102299527|NCT05400863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299528|NCT02120807|Certolizumab Pegol|certolizumab pegol|mesh-list
102299529|NCT02120807|Pemetrexed|pemetrexed|mesh-list
102299530|NCT02120807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299531|NCT02120807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102299532|NCT02120807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299533|NCT02120807|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102299534|NCT02120807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102299535|NCT02120807|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102299536|NCT02120807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102299537|NCT02120807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102299538|NCT02120807|Immunologic Factors|immunologic factors|mesh-ancestor
102299539|NCT02120807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299540|NCT02120807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102299541|NCT02532647|Midazolam|midazolam|mesh-list
102299542|NCT02532647|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102299543|NCT02532647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102299544|NCT02532647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102299545|NCT02532647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299546|NCT02532647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102299547|NCT02532647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102299548|NCT02532647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102299549|NCT02532647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102299550|NCT02532647|Anesthetics, General|anesthetics, general|mesh-ancestor
102299551|NCT02532647|Anesthetics|anesthetics|mesh-ancestor
102299552|NCT02532647|GABA Modulators|gaba modulators|mesh-ancestor
102299553|NCT02532647|GABA Agents|gaba agents|mesh-ancestor
102299554|NCT02532647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102299555|NCT02532647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299556|NCT05443061|Nitroglycerin|nitroglycerin|mesh-list
102299557|NCT05443061|Vasodilator Agents|vasodilator agents|mesh-ancestor
102299558|NCT02537015|Bimatoprost|bimatoprost|mesh-list
102299559|NCT02537015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102299560|NCT01660763|Sufentanil|sufentanil|mesh-list
102299561|NCT01660763|Dsuvia|dsuvia|mesh-list
102299562|NCT01660763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102299563|NCT01660763|Narcotics|narcotics|mesh-ancestor
102299564|NCT01660763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102299565|NCT01660763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299566|NCT01660763|Analgesics|analgesics|mesh-ancestor
102299567|NCT01660763|Sensory System Agents|sensory system agents|mesh-ancestor
102299568|NCT01660763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102299569|NCT01660763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102299570|NCT01660763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102299571|NCT01660763|Anesthetics, General|anesthetics, general|mesh-ancestor
102299572|NCT01660763|Anesthetics|anesthetics|mesh-ancestor
102299573|NCT01937117|Trastuzumab|trastuzumab|mesh-list
102299574|NCT01937117|Pertuzumab|pertuzumab|mesh-list
102299575|NCT01937117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102299576|NCT01937117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299577|NCT04256213|Nivolumab|nivolumab|mesh-list
102299578|NCT04256213|Ipilimumab|ipilimumab|mesh-list
102299579|NCT04256213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102299580|NCT04256213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299581|NCT04256213|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102299582|NCT04256213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299583|NCT02268045|Rituximab|rituximab|mesh-list
102299584|NCT02268045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102299585|NCT02268045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299586|NCT02268045|Immunologic Factors|immunologic factors|mesh-ancestor
102299587|NCT02268045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299588|NCT02268045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102299589|NCT02267187|Anesthetics|anesthetics|mesh-list
102008325|NCT03521791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102299590|NCT02267187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102299591|NCT02267187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299593|NCT01638533|Romidepsin|romidepsin|mesh-list
102299594|NCT01638533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102299595|NCT01638533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102299596|NCT01638533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299597|NCT01638533|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102299598|NCT01638533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102299599|NCT01638533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299600|NCT01641939|Trastuzumab|trastuzumab|mesh-list
102299601|NCT01641939|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102299602|NCT01641939|Maytansine|maytansine|mesh-list
102299603|NCT01641939|Taxane|taxane|mesh-list
102299604|NCT01641939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102299605|NCT01641939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299606|NCT01641939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102299607|NCT01641939|Tubulin Modulators|tubulin modulators|mesh-ancestor
102299608|NCT01641939|Antimitotic Agents|antimitotic agents|mesh-ancestor
102299609|NCT01641939|Mitosis Modulators|mitosis modulators|mesh-ancestor
102299610|NCT01641939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299611|NCT01641939|Immunotoxins|immunotoxins|mesh-ancestor
102299612|NCT01641939|Immunoconjugates|immunoconjugates|mesh-ancestor
102299613|NCT01641939|Immunologic Factors|immunologic factors|mesh-ancestor
102299614|NCT01641939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299615|NCT02409355|Carboplatin|carboplatin|mesh-list
102299616|NCT02409355|Gemcitabine|gemcitabine|mesh-list
102299617|NCT02409355|Atezolizumab|atezolizumab|mesh-list
102299618|NCT02409355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299619|NCT02409355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102299620|NCT02409355|Antimetabolites|antimetabolites|mesh-ancestor
102299621|NCT02409355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299622|NCT02409355|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102299623|NCT02409355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102299624|NCT02438371|Indomethacin|indomethacin|mesh-list
102299625|NCT02438371|Nifedipine|nifedipine|mesh-list
102299626|NCT02438371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102299627|NCT02438371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102299628|NCT02438371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299629|NCT02438371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102299630|NCT02438371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299631|NCT02438371|Vasodilator Agents|vasodilator agents|mesh-ancestor
102299632|NCT02438371|Tocolytic Agents|tocolytic agents|mesh-ancestor
102299633|NCT02438371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102299634|NCT02438371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102299635|NCT02438371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102299636|NCT02438371|Analgesics|analgesics|mesh-ancestor
102299637|NCT02438371|Sensory System Agents|sensory system agents|mesh-ancestor
102299638|NCT02438371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102299639|NCT02438371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102299640|NCT02438371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102299641|NCT02438371|Gout Suppressants|gout suppressants|mesh-ancestor
102299642|NCT02438371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102299643|NCT02438371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102299645|NCT02438137|Dermatologic Agents|dermatologic agents|mesh-ancestor
102299646|NCT02438137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102299647|NCT02438137|Immunologic Factors|immunologic factors|mesh-ancestor
102299648|NCT02438137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299649|NCT04920565|Polymyxins|polymyxins|mesh-list
102299650|NCT04920565|Polymyxin B|polymyxin b|mesh-list
102299651|NCT04920565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102299652|NCT04920565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102299653|NCT04909021|Vaccines|vaccines|mesh-list
102299654|NCT04909021|Immunologic Factors|immunologic factors|mesh-ancestor
101400530|NCT05645718|Antimetabolites|antimetabolites|mesh-ancestor
102299655|NCT04909021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299656|NCT02460991|Sorafenib|sorafenib|mesh-list
102299657|NCT02460991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299658|NCT02460991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102299659|NCT02460991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102299660|NCT02460991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299661|NCT02459899|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
102299662|NCT02459899|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102299663|NCT02459899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299664|NCT02459899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102299665|NCT02459899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299667|NCT02436889|Tolterodine Tartrate|tolterodine tartrate|mesh-list
102299668|NCT02436889|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102299669|NCT02436889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102299670|NCT02436889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102299671|NCT02436889|Adrenergic Agents|adrenergic agents|mesh-ancestor
102299672|NCT02436889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102299673|NCT02436889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299674|NCT02436889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299675|NCT02436889|Urological Agents|urological agents|mesh-ancestor
102299676|NCT02436889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102299677|NCT02436889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102299678|NCT02436889|Cholinergic Agents|cholinergic agents|mesh-ancestor
102299679|NCT02436577|Ticagrelor|ticagrelor|mesh-list
102299680|NCT02436577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102299681|NCT02436577|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102299682|NCT02436577|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102299683|NCT02436577|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102299684|NCT02436577|Purinergic Agents|purinergic agents|mesh-ancestor
102299685|NCT02436577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102299686|NCT02436577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299687|NCT02436577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299688|NCT02459665|Metronidazole|metronidazole|mesh-list
102299689|NCT02459665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102299690|NCT02459665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102299691|NCT02459665|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102299692|NCT02459665|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102299693|NCT02265237|Ritonavir|ritonavir|mesh-list
102299694|NCT02265237|Ribavirin|ribavirin|mesh-list
102299695|NCT02265237|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102299696|NCT02265237|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102299697|NCT02265237|Protease Inhibitors|protease inhibitors|mesh-ancestor
102299698|NCT02265237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102299699|NCT02265237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299700|NCT02265237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102299701|NCT02265237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102299702|NCT02265237|Antiviral Agents|antiviral agents|mesh-ancestor
102299703|NCT02265237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102299704|NCT02265237|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102299705|NCT02265237|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102299706|NCT02265237|Antimetabolites|antimetabolites|mesh-ancestor
102299707|NCT04874025|Palbociclib|palbociclib|mesh-list
102299708|NCT04874025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299709|NCT04874025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102299710|NCT04874025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102299711|NCT04874025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299712|NCT02263365|Loperamide|loperamide|mesh-list
102299713|NCT02263365|Antidiarrheals|antidiarrheals|mesh-list
102299714|NCT02263365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102299715|NCT04858269|Paclitaxel|paclitaxel|mesh-list
102299716|NCT04858269|Carboplatin|carboplatin|mesh-list
102299717|NCT04858269|Pembrolizumab|pembrolizumab|mesh-list
102299718|NCT04858269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102299719|NCT04858269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299720|NCT04858269|Tubulin Modulators|tubulin modulators|mesh-ancestor
102299721|NCT04858269|Antimitotic Agents|antimitotic agents|mesh-ancestor
102299722|NCT04858269|Mitosis Modulators|mitosis modulators|mesh-ancestor
102299723|NCT04858269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299724|NCT04858269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102299725|NCT04858269|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102299726|NCT02261493|Botulinum Toxins|botulinum toxins|mesh-list
102299727|NCT02261493|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102299728|NCT02261493|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102299729|NCT02261493|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102299730|NCT02261493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102299731|NCT02261493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299732|NCT02261493|Cholinergic Agents|cholinergic agents|mesh-ancestor
102299733|NCT02261493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102299734|NCT02261493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299735|NCT02261493|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102299736|NCT02261493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102299737|NCT02260791|Adalimumab|adalimumab|mesh-list
102299738|NCT02260791|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102299739|NCT02260791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102299740|NCT02260791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102299741|NCT02260635|Evacetrapib|evacetrapib|mesh-list
102299742|NCT02260635|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102299743|NCT02260635|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102299744|NCT02260635|Antimetabolites|antimetabolites|mesh-ancestor
102299745|NCT02260635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299746|NCT02260635|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102299747|NCT02259231|Nivolumab|nivolumab|mesh-list
102299748|NCT02259231|Ipilimumab|ipilimumab|mesh-list
102299749|NCT02259231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102299750|NCT02259231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299751|NCT02259231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102299752|NCT02259231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299753|NCT02258529|Rituximab|rituximab|mesh-list
102299754|NCT02258529|Idelalisib|idelalisib|mesh-list
102299755|NCT02258529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102299756|NCT02258529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299757|NCT02258529|Immunologic Factors|immunologic factors|mesh-ancestor
102299758|NCT02258529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299759|NCT02258529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102299760|NCT02258529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102299761|NCT02258529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299762|NCT02256969|Sulfacetamide|sulfacetamide|mesh-list
102299763|NCT02256969|Prednisolone|prednisolone|mesh-list
102299764|NCT02256969|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102299765|NCT02256969|Methylprednisolone|methylprednisolone|mesh-list
102299766|NCT02256969|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102299767|NCT02256969|Prednisolone acetate|prednisolone acetate|mesh-list
102299768|NCT02256969|Mineral Oil|mineral oil|mesh-list
102299769|NCT02256969|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102299770|NCT02256969|Prednisolone phosphate|prednisolone phosphate|mesh-list
102299771|NCT02256969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102299772|NCT02256969|Glucocorticoids|glucocorticoids|mesh-ancestor
102299773|NCT02256969|Hormones|hormones|mesh-ancestor
102299774|NCT02256969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102299775|NCT02256969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299776|NCT02256969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102299777|NCT02256969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299778|NCT02256969|Antiemetics|antiemetics|mesh-ancestor
102299779|NCT02256969|Autonomic Agents|autonomic agents|mesh-ancestor
102299780|NCT02256969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102299781|NCT02256969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102299782|NCT02256969|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102299783|NCT02256969|Protective Agents|protective agents|mesh-ancestor
102299784|NCT02256969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102299785|NCT02256969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102299786|NCT02256969|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102299787|NCT02256969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102299788|NCT02256969|Emollients|emollients|mesh-ancestor
102299789|NCT02256969|Dermatologic Agents|dermatologic agents|mesh-ancestor
102299790|NCT02256267|Rifampin|rifampin|mesh-list
102299791|NCT02256267|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102299792|NCT02256267|Antitubercular Agents|antitubercular agents|mesh-ancestor
102299793|NCT02256267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102299794|NCT02256267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102299795|NCT02256267|Leprostatic Agents|leprostatic agents|mesh-ancestor
102299796|NCT02256267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102299797|NCT02256267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102299798|NCT02256267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299799|NCT02256267|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102299800|NCT02256267|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102299801|NCT02256267|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102299802|NCT02256267|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102299803|NCT02256267|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102299804|NCT02256267|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102299805|NCT05429463|Paclitaxel|paclitaxel|mesh-list
102299806|NCT05429463|Carboplatin|carboplatin|mesh-list
102299807|NCT05429463|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102299808|NCT05429463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102299809|NCT05429463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299810|NCT05429463|Tubulin Modulators|tubulin modulators|mesh-ancestor
102299811|NCT05429463|Antimitotic Agents|antimitotic agents|mesh-ancestor
102299812|NCT05429463|Mitosis Modulators|mitosis modulators|mesh-ancestor
102299813|NCT05429463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299814|NCT02255565|Methylphenidate|methylphenidate|mesh-list
102299815|NCT02255565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102299816|NCT02255565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299817|NCT02255565|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102299818|NCT02255565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102299819|NCT02255565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102299820|NCT02255565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299821|NCT02255565|Dopamine Agents|dopamine agents|mesh-ancestor
102299822|NCT02255565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102299823|NCT01640301|Aldesleukin|aldesleukin|mesh-list
102299824|NCT01640301|Cyclophosphamide|cyclophosphamide|mesh-list
102299825|NCT01640301|Fludarabine|fludarabine|mesh-list
102299826|NCT01640301|Fludarabine phosphate|fludarabine phosphate|mesh-list
102299827|NCT01640301|Interleukin-2|interleukin-2|mesh-list
102299828|NCT01640301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102299829|NCT01640301|Immunologic Factors|immunologic factors|mesh-ancestor
102299830|NCT01640301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299831|NCT01640301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102299832|NCT01640301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102299833|NCT01640301|Alkylating Agents|alkylating agents|mesh-ancestor
102299834|NCT01640301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299835|NCT01640301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299836|NCT01640301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102299837|NCT01640301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102299838|NCT01640301|Antimetabolites|antimetabolites|mesh-ancestor
102299839|NCT01640301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102299840|NCT01640301|Analgesics|analgesics|mesh-ancestor
102299841|NCT01640301|Sensory System Agents|sensory system agents|mesh-ancestor
102299842|NCT01640301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102299843|NCT01640301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102299844|NCT01640301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102299845|NCT01640301|Antiviral Agents|antiviral agents|mesh-ancestor
102299846|NCT01640301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102299847|NCT01642407|Sildenafil Citrate|sildenafil citrate|mesh-list
102299848|NCT01642407|Vasodilator Agents|vasodilator agents|mesh-ancestor
102299849|NCT01642407|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102299850|NCT01642407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102299851|NCT01642407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102299852|NCT01642407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299853|NCT01642407|Urological Agents|urological agents|mesh-ancestor
102299854|NCT02255097|Pembrolizumab|pembrolizumab|mesh-list
102299855|NCT02255097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102299856|NCT02255097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299857|NCT02255097|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102299858|NCT02255097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299859|NCT02254551|Bortezomib|bortezomib|mesh-list
102299860|NCT02254551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299861|NCT05640375|Methylprednisolone|methylprednisolone|mesh-list
102299862|NCT05640375|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102299863|NCT05640375|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102299865|NCT05640375|Prednisolone acetate|prednisolone acetate|mesh-list
102299866|NCT05640375|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102299867|NCT05640375|Prednisolone phosphate|prednisolone phosphate|mesh-list
102299868|NCT05640375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102299869|NCT05640375|Antiemetics|antiemetics|mesh-ancestor
102299870|NCT05640375|Autonomic Agents|autonomic agents|mesh-ancestor
102299871|NCT05640375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102299872|NCT05640375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299873|NCT05640375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102299874|NCT05640375|Glucocorticoids|glucocorticoids|mesh-ancestor
102299875|NCT05640375|Hormones|hormones|mesh-ancestor
102299876|NCT05640375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102299877|NCT05640375|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102299878|NCT05640375|Protective Agents|protective agents|mesh-ancestor
102299879|NCT05640375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102299880|NCT05640375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299881|NCT01641237|Listerine|listerine|mesh-list
102299882|NCT01641237|Fluorides|fluorides|mesh-list
102299883|NCT01641237|Sodium Fluoride|sodium fluoride|mesh-list
102299884|NCT01641237|Cariostatic Agents|cariostatic agents|mesh-ancestor
102299885|NCT01641237|Protective Agents|protective agents|mesh-ancestor
102299886|NCT01641237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299887|NCT01641237|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102299888|NCT01641237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102299889|NCT05650437|Vitamin D|vitamin d|mesh-list
102299891|NCT05650437|Micronutrients|micronutrients|mesh-ancestor
102299892|NCT05650437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299893|NCT05650437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102299894|NCT05617209|Thrombin|thrombin|mesh-list
102299895|NCT05617209|Hemostatics|hemostatics|mesh-ancestor
102299896|NCT05617209|Coagulants|coagulants|mesh-ancestor
102299897|NCT01639833|Hemostatics|hemostatics|mesh-list
102299898|NCT01639833|Coagulants|coagulants|mesh-ancestor
102299899|NCT01639131|Gemcitabine|gemcitabine|mesh-list
102299900|NCT01639131|Docetaxel|docetaxel|mesh-list
102299901|NCT01639131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102299902|NCT01639131|Antimetabolites|antimetabolites|mesh-ancestor
102299903|NCT01639131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299904|NCT01639131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299905|NCT01639131|Tubulin Modulators|tubulin modulators|mesh-ancestor
102299906|NCT01639131|Antimitotic Agents|antimitotic agents|mesh-ancestor
102299907|NCT01639131|Mitosis Modulators|mitosis modulators|mesh-ancestor
102299908|NCT01641159|Buspirone|buspirone|mesh-list
102299909|NCT01641159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102299910|NCT01641159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102299911|NCT01641159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102299912|NCT01641159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299913|NCT01641159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102299914|NCT01641159|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102299915|NCT01641159|Serotonin Agents|serotonin agents|mesh-ancestor
102299916|NCT01641159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102299917|NCT01641159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299918|NCT01641081|Formoterol Fumarate|formoterol fumarate|mesh-list
102299919|NCT01641081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102299920|NCT01641081|Autonomic Agents|autonomic agents|mesh-ancestor
102299921|NCT01641081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102299922|NCT01641081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299923|NCT01641081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102299924|NCT01641081|Respiratory System Agents|respiratory system agents|mesh-ancestor
102299925|NCT01641081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102299926|NCT01641081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102299927|NCT01641081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102299928|NCT01641081|Adrenergic Agents|adrenergic agents|mesh-ancestor
102299929|NCT01641081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102299930|NCT01641081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299931|NCT01640925|Chlorhexidine|chlorhexidine|mesh-list
102299932|NCT01640925|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102299933|NCT01640925|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102299934|NCT01640925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102299935|NCT01640925|Disinfectants|disinfectants|mesh-ancestor
102299936|NCT01640925|Dermatologic Agents|dermatologic agents|mesh-ancestor
102299937|NCT05369481|Minoxidil|minoxidil|mesh-list
102299938|NCT05369481|Sildenafil Citrate|sildenafil citrate|mesh-list
102299939|NCT05369481|Vasodilator Agents|vasodilator agents|mesh-ancestor
102299940|NCT05369481|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102299941|NCT05369481|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102299942|NCT05369481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102299943|NCT05369481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299944|NCT05369481|Urological Agents|urological agents|mesh-ancestor
102299945|NCT05369481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102299946|NCT04853589|Hyaluronic Acid|hyaluronic acid|mesh-list
102299947|NCT04853589|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102299948|NCT04853589|Immunologic Factors|immunologic factors|mesh-ancestor
102299949|NCT04853589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299950|NCT04853589|Viscosupplements|viscosupplements|mesh-ancestor
102299951|NCT04853589|Protective Agents|protective agents|mesh-ancestor
102299952|NCT01638429|Rifaximin|rifaximin|mesh-list
102299953|NCT01638429|Neomycin|neomycin|mesh-list
102299954|NCT01638429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102299955|NCT01638429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102299956|NCT01638429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102299957|NCT01638429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102299958|NCT01638429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102299959|NCT01638429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299960|NCT04853511|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102299961|NCT04853511|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102299962|NCT04853511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299963|NCT04853355|Spironolactone|spironolactone|mesh-list
102299964|NCT04853355|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102299965|NCT04853355|Hormone Antagonists|hormone antagonists|mesh-ancestor
102299966|NCT04853355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102299967|NCT04853355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299968|NCT04853355|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102299969|NCT04853355|Diuretics|diuretics|mesh-ancestor
102299970|NCT04853355|Natriuretic Agents|natriuretic agents|mesh-ancestor
102299971|NCT05369091|Simvastatin|simvastatin|mesh-list
102299972|NCT05369091|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102299973|NCT05369091|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102299974|NCT05369091|Antimetabolites|antimetabolites|mesh-ancestor
102299975|NCT05369091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299976|NCT05369091|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102299977|NCT05369091|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102299978|NCT05369091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102299979|NCT01601535|Irinotecan|irinotecan|mesh-list
102299980|NCT01601535|Temozolomide|temozolomide|mesh-list
102299981|NCT01601535|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102299982|NCT01601535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102299983|NCT01601535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102299984|NCT01601535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102299985|NCT01601535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102299986|NCT01601535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102299987|NCT01601535|Alkylating Agents|alkylating agents|mesh-ancestor
102299988|NCT05422365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102299989|NCT05422365|Immunoglobulins|immunoglobulins|mesh-list
102299990|NCT05422365|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102299991|NCT05422365|Antibodies|antibodies|mesh-list
102299992|NCT05422365|gamma-Globulins|gamma-globulins|mesh-list
102299993|NCT05422365|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102299994|NCT05422365|Immunologic Factors|immunologic factors|mesh-ancestor
102299995|NCT05422365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102299996|NCT04641273|Pregabalin|pregabalin|mesh-list
102299997|NCT04641273|Analgesics|analgesics|mesh-ancestor
102299998|NCT04641273|Sensory System Agents|sensory system agents|mesh-ancestor
102299999|NCT04641273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102300000|NCT04641273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300001|NCT04641273|Anticonvulsants|anticonvulsants|mesh-ancestor
102300002|NCT04641273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102300003|NCT04641273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102300004|NCT04641273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300005|NCT04641273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101400921|NCT04784715|Pertuzumab|pertuzumab|mesh-list
102300006|NCT04641273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102300007|NCT04641273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102300008|NCT04641273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102300009|NCT04641273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102300010|NCT04843917|Immunoglobulins|immunoglobulins|mesh-list
102300011|NCT04843917|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102300012|NCT04843917|Antibodies|antibodies|mesh-list
102300013|NCT04843917|Immunoglobulin G|immunoglobulin g|mesh-list
102300014|NCT04843917|Immunologic Factors|immunologic factors|mesh-ancestor
102300015|NCT04843917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300016|NCT04586985|Midazolam|midazolam|mesh-list
102300017|NCT04586985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102300018|NCT04586985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102300019|NCT04586985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102300020|NCT04586985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300021|NCT04586985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102300022|NCT04586985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102300023|NCT04586985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102300024|NCT04586985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102300025|NCT04586985|Anesthetics, General|anesthetics, general|mesh-ancestor
102300026|NCT04586985|Anesthetics|anesthetics|mesh-ancestor
102300027|NCT04586985|GABA Modulators|gaba modulators|mesh-ancestor
102300028|NCT04586985|GABA Agents|gaba agents|mesh-ancestor
102300029|NCT04586985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102300030|NCT04586985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300031|NCT05244057|Interferons|interferons|mesh-list
102300032|NCT05244057|Tenofovir|tenofovir|mesh-list
102300033|NCT05244057|Interferon-alpha|interferon-alpha|mesh-list
102300034|NCT05244057|Interferon alpha-2|interferon alpha-2|mesh-list
102300035|NCT05244057|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102300036|NCT05244057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102300037|NCT05244057|Antiviral Agents|antiviral agents|mesh-ancestor
102300038|NCT05244057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102300039|NCT05244057|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102008780|NCT05856500|Analgesics|analgesics|mesh-ancestor
102300040|NCT05244057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102300041|NCT05244057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102300042|NCT05244057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300044|NCT05244057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102300045|NCT05244057|Immunologic Factors|immunologic factors|mesh-ancestor
102300046|NCT05244057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300047|NCT05408403|Anesthetics|anesthetics|mesh-list
102300048|NCT05408403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102300049|NCT05408403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300050|NCT04830735|Dasatinib|dasatinib|mesh-list
102300051|NCT04830735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102300052|NCT04830735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102300053|NCT04830735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102300054|NCT04830735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300055|NCT05335317|Hormones|hormones|mesh-list
102300056|NCT05335317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102300057|NCT05335317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300058|NCT04419441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102300059|NCT04419441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300060|NCT04419441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102300061|NCT04419441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102300062|NCT05329779|Pregnanolone|pregnanolone|mesh-list
102300063|NCT05329779|Brexanolone|brexanolone|mesh-list
102300064|NCT05329779|Anesthetics|anesthetics|mesh-ancestor
102300065|NCT05329779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102300066|NCT05329779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300067|NCT05329779|Neurosteroids|neurosteroids|mesh-ancestor
102300068|NCT05329779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102300069|NCT05329779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300070|NCT05329779|GABA Modulators|gaba modulators|mesh-ancestor
102300071|NCT05329779|GABA Agents|gaba agents|mesh-ancestor
102300072|NCT04464759|Hydroxychloroquine|hydroxychloroquine|mesh-list
102300073|NCT04464759|Nivolumab|nivolumab|mesh-list
102300074|NCT04464759|Ipilimumab|ipilimumab|mesh-list
102300075|NCT04464759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102300076|NCT04464759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102300077|NCT04464759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102300078|NCT04464759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300079|NCT04464759|Antimalarials|antimalarials|mesh-ancestor
102300080|NCT04464759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102300081|NCT04464759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102300082|NCT04464759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102300083|NCT04464759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102300084|NCT04464759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102300085|NCT04850937|Esketamine|esketamine|mesh-list
102300086|NCT04850937|Antidepressive Agents|antidepressive agents|mesh-ancestor
102300087|NCT04850937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102300088|NCT01363713|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102300089|NCT01363713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102300090|NCT04411329|Dexamethasone|dexamethasone|mesh-list
102300091|NCT04411329|Dexmedetomidine|dexmedetomidine|mesh-list
102300092|NCT04411329|Bupivacaine|bupivacaine|mesh-list
102300093|NCT04411329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102300094|NCT04411329|Antiemetics|antiemetics|mesh-ancestor
102300095|NCT04411329|Autonomic Agents|autonomic agents|mesh-ancestor
102300096|NCT04411329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102300097|NCT04411329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300098|NCT04411329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102300099|NCT04411329|Glucocorticoids|glucocorticoids|mesh-ancestor
102300100|NCT04411329|Hormones|hormones|mesh-ancestor
102300101|NCT04411329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102300102|NCT04411329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102300103|NCT04411329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102300104|NCT04411329|Anesthetics, Local|anesthetics, local|mesh-ancestor
102300105|NCT04411329|Anesthetics|anesthetics|mesh-ancestor
102300106|NCT04411329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102300107|NCT04411329|Sensory System Agents|sensory system agents|mesh-ancestor
102300108|NCT04411329|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102300109|NCT04411329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102300110|NCT04411329|Analgesics|analgesics|mesh-ancestor
102300111|NCT04411329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102300112|NCT04411329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102300113|NCT04411329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102300114|NCT04411329|Adrenergic Agents|adrenergic agents|mesh-ancestor
102008909|NCT05615779|Levan|levan|mesh-list
102300115|NCT04411329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102300116|NCT04411329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300117|NCT05171673|Diclofenac|diclofenac|mesh-list
102300118|NCT05171673|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
102300119|NCT05171673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102300120|NCT05171673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102300121|NCT05171673|Analgesics|analgesics|mesh-ancestor
102300122|NCT05171673|Sensory System Agents|sensory system agents|mesh-ancestor
102300123|NCT05171673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102300124|NCT05171673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300125|NCT05171673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102300126|NCT05171673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102300127|NCT05171673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102300128|NCT05171673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102300129|NCT05171673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300130|NCT05147415|Metoprolol|metoprolol|mesh-list
102300131|NCT05147415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102300132|NCT05147415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102300133|NCT05147415|Sympatholytics|sympatholytics|mesh-ancestor
102300134|NCT05147415|Autonomic Agents|autonomic agents|mesh-ancestor
102300135|NCT05147415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102300136|NCT05147415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300137|NCT05147415|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102300138|NCT05147415|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102300139|NCT05147415|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102300140|NCT05147415|Adrenergic Agents|adrenergic agents|mesh-ancestor
102300141|NCT05147415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102300142|NCT05147415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300143|NCT04390581|Lidocaine|lidocaine|mesh-list
102300144|NCT04390581|Anesthetics, Local|anesthetics, local|mesh-ancestor
102300145|NCT04390581|Anesthetics|anesthetics|mesh-ancestor
102300146|NCT04390581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102300147|NCT04390581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300148|NCT04390581|Sensory System Agents|sensory system agents|mesh-ancestor
102300149|NCT04390581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102300150|NCT04390581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102300151|NCT04390581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102300152|NCT04390581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102300153|NCT04390581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102300154|NCT04390581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300155|NCT04183335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
102300156|NCT04183335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102300157|NCT04183335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300158|NCT04254549|Rifaximin|rifaximin|mesh-list
102300159|NCT04254549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102300160|NCT04254549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102300161|NCT04254549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102300162|NCT04225767|Calcium|calcium|mesh-list
101641958|NCT00941330|Cyclophosphamide|cyclophosphamide|mesh-list
102300163|NCT04225767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102300164|NCT04225767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300165|NCT04820673|Sarecycline|sarecycline|mesh-list
102300166|NCT04820673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102300167|NCT04820673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102300168|NCT04820673|Dermatologic Agents|dermatologic agents|mesh-ancestor
102300169|NCT04114539|Ecopipam|ecopipam|mesh-list
102300170|NCT04114539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102300171|NCT04114539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102300172|NCT04114539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102300173|NCT04114539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300174|NCT04114539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102300175|NCT04114539|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102300176|NCT04114539|Dopamine Agents|dopamine agents|mesh-ancestor
102300177|NCT04114539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102300178|NCT04114539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300179|NCT03263559|Cyclophosphamide|cyclophosphamide|mesh-list
102300180|NCT03263559|Thiotepa|thiotepa|mesh-list
102300181|NCT03263559|Fludarabine|fludarabine|mesh-list
102300182|NCT03263559|Hydroxyurea|hydroxyurea|mesh-list
102300183|NCT03263559|Thymoglobulin|thymoglobulin|mesh-list
102300184|NCT03263559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102300185|NCT03263559|Immunologic Factors|immunologic factors|mesh-ancestor
102300186|NCT03263559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300187|NCT03263559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102300188|NCT03263559|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102300189|NCT03263559|Alkylating Agents|alkylating agents|mesh-ancestor
102300190|NCT03263559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300191|NCT03263559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102300192|NCT03263559|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102300193|NCT03263559|Antisickling Agents|antisickling agents|mesh-ancestor
102300194|NCT03263559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102300195|NCT03263559|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102300196|NCT03256149|Dexamethasone|dexamethasone|mesh-list
102300197|NCT03256149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102300198|NCT03256149|Antiemetics|antiemetics|mesh-ancestor
102300199|NCT03256149|Autonomic Agents|autonomic agents|mesh-ancestor
102300200|NCT03256149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102300201|NCT03256149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300202|NCT03256149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102300203|NCT03256149|Glucocorticoids|glucocorticoids|mesh-ancestor
102300204|NCT03256149|Hormones|hormones|mesh-ancestor
102300205|NCT03256149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102300206|NCT03256149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102300207|NCT03256149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102300208|NCT03253263|Mecasermin|mecasermin|mesh-list
102300209|NCT03253263|Growth Substances|growth substances|mesh-ancestor
102300210|NCT03253263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300211|NCT01636947|Dexamethasone|dexamethasone|mesh-list
102300212|NCT01636947|Dexamethasone acetate|dexamethasone acetate|mesh-list
102300213|NCT01636947|Ondansetron|ondansetron|mesh-list
102300214|NCT01636947|Aprepitant|aprepitant|mesh-list
102300215|NCT01636947|Fosaprepitant|fosaprepitant|mesh-list
102300216|NCT01636947|Metoclopramide|metoclopramide|mesh-list
102300217|NCT01636947|Granisetron|granisetron|mesh-list
102300218|NCT01636947|Tropisetron|tropisetron|mesh-list
102300219|NCT01636947|Dolasetron|dolasetron|mesh-list
102300220|NCT01636947|Alizapride|alizapride|mesh-list
102300221|NCT01636947|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102300222|NCT01636947|BB 1101|bb 1101|mesh-list
102300223|NCT01636947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102300224|NCT01636947|Antiemetics|antiemetics|mesh-ancestor
102300225|NCT01636947|Autonomic Agents|autonomic agents|mesh-ancestor
102300226|NCT01636947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102300227|NCT01636947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300228|NCT01636947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102300229|NCT01636947|Glucocorticoids|glucocorticoids|mesh-ancestor
102300230|NCT01636947|Hormones|hormones|mesh-ancestor
102300231|NCT01636947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102300232|NCT01636947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102300233|NCT01636947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102300234|NCT01636947|Protease Inhibitors|protease inhibitors|mesh-ancestor
102300235|NCT01636947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102300236|NCT01636947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300237|NCT01636947|Antipruritics|antipruritics|mesh-ancestor
102300238|NCT01636947|Dermatologic Agents|dermatologic agents|mesh-ancestor
102300239|NCT01636947|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102300240|NCT01636947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102300241|NCT01636947|Serotonin Agents|serotonin agents|mesh-ancestor
102300242|NCT01636947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102300243|NCT01636947|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102300244|NCT01636947|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102300245|NCT01636947|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102300246|NCT01636947|Dopamine Agents|dopamine agents|mesh-ancestor
102300247|NCT03052725|Reslizumab|reslizumab|mesh-list
102300248|NCT03052725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102300249|NCT03052725|Respiratory System Agents|respiratory system agents|mesh-ancestor
102300250|NCT02980341|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
102300251|NCT02980341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102300252|NCT02980341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102300253|NCT04793919|Tretinoin|tretinoin|mesh-list
102300254|NCT04793919|Arsenic Trioxide|arsenic trioxide|mesh-list
102300255|NCT04793919|Gemtuzumab|gemtuzumab|mesh-list
102300256|NCT04793919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102300257|NCT04793919|Keratolytic Agents|keratolytic agents|mesh-ancestor
102300258|NCT04793919|Dermatologic Agents|dermatologic agents|mesh-ancestor
102300259|NCT04793919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102300260|NCT04793919|Immunotoxins|immunotoxins|mesh-ancestor
102300261|NCT04793919|Immunoconjugates|immunoconjugates|mesh-ancestor
102300262|NCT04793919|Immunologic Factors|immunologic factors|mesh-ancestor
102300263|NCT04793919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300264|NCT02817633|Carboplatin|carboplatin|mesh-list
102300265|NCT02817633|Docetaxel|docetaxel|mesh-list
102300266|NCT02817633|Nivolumab|nivolumab|mesh-list
102300267|NCT02817633|Pemetrexed|pemetrexed|mesh-list
102300268|NCT02817633|Dostarlimab|dostarlimab|mesh-list
102300269|NCT02817633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102300270|NCT02817633|Tubulin Modulators|tubulin modulators|mesh-ancestor
102300271|NCT02817633|Antimitotic Agents|antimitotic agents|mesh-ancestor
102300272|NCT02817633|Mitosis Modulators|mitosis modulators|mesh-ancestor
102300273|NCT02817633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300274|NCT02817633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102300275|NCT02817633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102300276|NCT02817633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102300277|NCT02817633|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102300278|NCT02817633|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102300279|NCT02775435|Paclitaxel|paclitaxel|mesh-list
102300280|NCT02775435|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102300281|NCT02775435|Carboplatin|carboplatin|mesh-list
102300282|NCT02775435|Pembrolizumab|pembrolizumab|mesh-list
102300283|NCT02775435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102300284|NCT02775435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102300285|NCT02775435|Tubulin Modulators|tubulin modulators|mesh-ancestor
102300286|NCT02775435|Antimitotic Agents|antimitotic agents|mesh-ancestor
102300287|NCT02775435|Mitosis Modulators|mitosis modulators|mesh-ancestor
102300288|NCT02775435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300289|NCT02775435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102300290|NCT02775435|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102300291|NCT02774421|Trastuzumab|trastuzumab|mesh-list
102300292|NCT02774421|Molgramostim|molgramostim|mesh-list
102300293|NCT02774421|Sargramostim|sargramostim|mesh-list
102300294|NCT02774421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102300295|NCT02774421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102300296|NCT02774421|Immunologic Factors|immunologic factors|mesh-ancestor
102300297|NCT02774421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300298|NCT04791969|Naltrexone|naltrexone|mesh-list
102300299|NCT04791969|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102300300|NCT04791969|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102300301|NCT04791969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300302|NCT04791969|Sensory System Agents|sensory system agents|mesh-ancestor
102300303|NCT04791969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102300304|NCT05651373|Hydroxychloroquine|hydroxychloroquine|mesh-list
102300305|NCT05651373|Prednisone|prednisone|mesh-list
102300306|NCT05651373|Certolizumab Pegol|certolizumab pegol|mesh-list
102300307|NCT05651373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102300308|NCT05651373|Glucocorticoids|glucocorticoids|mesh-ancestor
102300309|NCT05651373|Hormones|hormones|mesh-ancestor
102300310|NCT05651373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102300311|NCT05651373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300312|NCT05651373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102300313|NCT05651373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102300314|NCT05651373|Antimalarials|antimalarials|mesh-ancestor
102300315|NCT05651373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102300316|NCT05651373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102300317|NCT05651373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102300319|NCT05651373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300320|NCT05651373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102300321|NCT05651373|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102300322|NCT05651373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102300323|NCT05651373|Immunologic Factors|immunologic factors|mesh-ancestor
102300324|NCT03905889|Sunitinib|sunitinib|mesh-list
102300325|NCT03905889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102300326|NCT03905889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102300327|NCT03905889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102300328|NCT03905889|Growth Substances|growth substances|mesh-ancestor
102300329|NCT03905889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300330|NCT03905889|Growth Inhibitors|growth inhibitors|mesh-ancestor
102300331|NCT03905889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102300332|NCT03905889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102300333|NCT03905889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300334|NCT04804059|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102300335|NCT03846765|Phenylephrine|phenylephrine|mesh-list
102300336|NCT03846765|Dobutamine|dobutamine|mesh-list
102300337|NCT03846765|Oxymetazoline|oxymetazoline|mesh-list
102300338|NCT03846765|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102300339|NCT03846765|Mydriatics|mydriatics|mesh-ancestor
102300340|NCT03846765|Autonomic Agents|autonomic agents|mesh-ancestor
102300341|NCT03846765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102009079|NCT05022901|Immunologic Factors|immunologic factors|mesh-ancestor
102300342|NCT03846765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300343|NCT03846765|Sympathomimetics|sympathomimetics|mesh-ancestor
102300344|NCT03846765|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102300345|NCT03846765|Nasal Decongestants|nasal decongestants|mesh-ancestor
102300346|NCT03846765|Respiratory System Agents|respiratory system agents|mesh-ancestor
102300347|NCT03846765|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102300348|NCT03846765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102300349|NCT03846765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102300350|NCT03846765|Adrenergic Agents|adrenergic agents|mesh-ancestor
102300351|NCT03846765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102300352|NCT03846765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300353|NCT03846765|Protective Agents|protective agents|mesh-ancestor
102300354|NCT03846765|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102300355|NCT03846765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102300356|NCT05163405|Bortezomib|bortezomib|mesh-list
102300357|NCT05163405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102300358|NCT02311179|Cimetidine|cimetidine|mesh-list
102300359|NCT02311179|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102300360|NCT02311179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102300361|NCT02311179|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102300362|NCT02311179|Histamine Antagonists|histamine antagonists|mesh-ancestor
102300363|NCT02311179|Histamine Agents|histamine agents|mesh-ancestor
102300364|NCT02311179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102300365|NCT02311179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300366|NCT02311179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300367|NCT02311179|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102300368|NCT02311179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102300369|NCT02311179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102300370|NCT04801953|Nimodipine|nimodipine|mesh-list
102300371|NCT04801953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102300372|NCT04801953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102300373|NCT04801953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102300374|NCT04801953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300375|NCT04801953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102300376|NCT04801953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300377|NCT04801953|Vasodilator Agents|vasodilator agents|mesh-ancestor
102300378|NCT01635153|Micronutrients|micronutrients|mesh-list
102300379|NCT01635153|Trace Elements|trace elements|mesh-list
102300380|NCT01635153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300381|NCT04446039|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102300382|NCT04446039|Vortioxetine|vortioxetine|mesh-list
102300383|NCT04446039|Mirtazapine|mirtazapine|mesh-list
102300384|NCT04446039|Bupropion|bupropion|mesh-list
102300385|NCT04446039|Fluoxetine|fluoxetine|mesh-list
102300386|NCT04446039|Paroxetine|paroxetine|mesh-list
102300387|NCT04446039|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102300388|NCT04446039|Sertraline|sertraline|mesh-list
102300389|NCT04446039|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
102300390|NCT04446039|Tianeptine|tianeptine|mesh-list
102300391|NCT04446039|Escitalopram|escitalopram|mesh-list
101642194|NCT02592772|Menthol|menthol|mesh-list
102300392|NCT04446039|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102300393|NCT04446039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102300394|NCT04446039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102300395|NCT04446039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300396|NCT04446039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102300397|NCT04446039|Serotonin Agents|serotonin agents|mesh-ancestor
102300398|NCT04446039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300399|NCT04446039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102300400|NCT04446039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102300401|NCT04446039|Antidepressive Agents|antidepressive agents|mesh-ancestor
102300402|NCT04446039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102300403|NCT04446039|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102300404|NCT04446039|Dopamine Agents|dopamine agents|mesh-ancestor
102300405|NCT04446039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102300406|NCT04446039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102300407|NCT04446039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102300408|NCT04446039|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102300409|NCT04446039|Analgesics|analgesics|mesh-ancestor
102300410|NCT04446039|Sensory System Agents|sensory system agents|mesh-ancestor
102300411|NCT04446039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102300412|NCT04446039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102300413|NCT04446039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102300414|NCT04446039|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102300415|NCT04446039|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102300416|NCT04446039|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102300417|NCT04446039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102300418|NCT04446039|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102300419|NCT04446039|Histamine Antagonists|histamine antagonists|mesh-ancestor
102300420|NCT04446039|Histamine Agents|histamine agents|mesh-ancestor
102300421|NCT04446039|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102300422|NCT04446039|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102300423|NCT04446039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102300424|NCT04446039|Adrenergic Agents|adrenergic agents|mesh-ancestor
102300425|NCT04446039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102300426|NCT04446039|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102300427|NCT04192773|Lidocaine|lidocaine|mesh-list
102300428|NCT04192773|Anesthetics, Local|anesthetics, local|mesh-ancestor
102300429|NCT04192773|Anesthetics|anesthetics|mesh-ancestor
102300430|NCT04192773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102300431|NCT04192773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300432|NCT04192773|Sensory System Agents|sensory system agents|mesh-ancestor
102300433|NCT04192773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102300434|NCT04192773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102300435|NCT04192773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102300436|NCT04192773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102300437|NCT04192773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102300438|NCT04192773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300439|NCT04784247|Pembrolizumab|pembrolizumab|mesh-list
102300440|NCT04784247|Lenvatinib|lenvatinib|mesh-list
102300441|NCT04784247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102300442|NCT04784247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102300443|NCT04784247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102300444|NCT04784247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300445|NCT04784247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102300446|NCT04784247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102300447|NCT05031897|Mycophenolic Acid|mycophenolic acid|mesh-list
102300448|NCT05031897|Cyclophosphamide|cyclophosphamide|mesh-list
102300449|NCT05031897|Melphalan|melphalan|mesh-list
102300450|NCT05031897|Fludarabine|fludarabine|mesh-list
102300451|NCT05031897|Tacrolimus|tacrolimus|mesh-list
102300452|NCT05031897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102300453|NCT05031897|Immunologic Factors|immunologic factors|mesh-ancestor
102300454|NCT05031897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300455|NCT05031897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102300456|NCT05031897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102300457|NCT05031897|Alkylating Agents|alkylating agents|mesh-ancestor
102300458|NCT05031897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300459|NCT05031897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102300460|NCT05031897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102300461|NCT05031897|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102300462|NCT05031897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102300463|NCT05031897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102300464|NCT05031897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102300465|NCT05031897|Antitubercular Agents|antitubercular agents|mesh-ancestor
102300466|NCT05031897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102300467|NCT05031897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102300468|NCT04800471|Insulin|insulin|mesh-list
102300469|NCT04800471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102300470|NCT04800471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300471|NCT03591861|Carmustine|carmustine|mesh-list
102300472|NCT03591861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102300473|NCT03591861|Alkylating Agents|alkylating agents|mesh-ancestor
102300474|NCT03591861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300475|NCT03591861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102300476|NCT01600053|Lenalidomide|lenalidomide|mesh-list
102300477|NCT01600053|Immunologic Factors|immunologic factors|mesh-ancestor
102300478|NCT01600053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300479|NCT01600053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102300480|NCT01600053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102300481|NCT01600053|Growth Substances|growth substances|mesh-ancestor
102300482|NCT01600053|Growth Inhibitors|growth inhibitors|mesh-ancestor
102300483|NCT01600053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102300484|NCT03573297|Cariprazine|cariprazine|mesh-list
102300485|NCT03573297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102300486|NCT03573297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102300487|NCT03573297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102300488|NCT03573297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300489|NCT03573297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102300490|NCT03569241|Androgens|androgens|mesh-list
102300491|NCT03569241|Hormones|hormones|mesh-ancestor
102300492|NCT03569241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102300493|NCT03569241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300494|NCT04716387|Milbemycin oxime|milbemycin oxime|mesh-list
102300495|NCT04716387|Anthelmintics|anthelmintics|mesh-ancestor
102300496|NCT04716387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102300497|NCT04716387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102300499|NCT01068249|Letrozole|letrozole|mesh-list
102300500|NCT01068249|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102300501|NCT01068249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102300502|NCT01068249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102300503|NCT01068249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300504|NCT01068249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102300505|NCT01068249|Immunologic Factors|immunologic factors|mesh-ancestor
102300506|NCT01068249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300507|NCT01068249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102300508|NCT01068249|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102300509|NCT01068249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102300510|NCT01068249|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102300511|NCT01068249|Hormone Antagonists|hormone antagonists|mesh-ancestor
102300512|NCT01068249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102300513|NCT01035099|Letrozole|letrozole|mesh-list
102300514|NCT01035099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102300515|NCT01035099|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102300516|NCT01035099|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102300517|NCT01035099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102300518|NCT01035099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300519|NCT01035099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102300520|NCT01035099|Hormone Antagonists|hormone antagonists|mesh-ancestor
102300521|NCT01035099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102300522|NCT01035099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300523|NCT03560349|Lidocaine|lidocaine|mesh-list
102300524|NCT03560349|Anesthetics, Local|anesthetics, local|mesh-ancestor
102300525|NCT03560349|Anesthetics|anesthetics|mesh-ancestor
102300526|NCT03560349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102300527|NCT03560349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300528|NCT03560349|Sensory System Agents|sensory system agents|mesh-ancestor
102300529|NCT03560349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102300530|NCT03560349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102300531|NCT03560349|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102300532|NCT03560349|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102300533|NCT03560349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102300534|NCT03560349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300535|NCT04435431|Mesdopetam|mesdopetam|mesh-list
102300536|NCT04435431|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102300537|NCT04435431|Dopamine Agents|dopamine agents|mesh-ancestor
102300538|NCT04435431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101401526|NCT02288247|Tubulin Modulators|tubulin modulators|mesh-ancestor
102300539|NCT04435431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300540|NCT04435431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300541|NCT02246673|Febuxostat|febuxostat|mesh-list
102300542|NCT02246673|Verinurad|verinurad|mesh-list
102300543|NCT02246673|Gout Suppressants|gout suppressants|mesh-ancestor
102300544|NCT02246673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102300545|NCT03532425|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102300546|NCT03532425|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102300547|NCT03532425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102300548|NCT03532425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102300549|NCT03532425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300550|NCT03532425|Antiviral Agents|antiviral agents|mesh-ancestor
102300551|NCT03532425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102300552|NCT03532425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102300553|NCT03532425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102300554|NCT04191447|Budesonide|budesonide|mesh-list
102300555|NCT04191447|Formoterol Fumarate|formoterol fumarate|mesh-list
102300556|NCT04191447|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
102300557|NCT04191447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102300558|NCT04191447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102300559|NCT04191447|Autonomic Agents|autonomic agents|mesh-ancestor
102300560|NCT04191447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102300561|NCT04191447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300562|NCT04191447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102009301|NCT04311489|Ularitide|ularitide|mesh-list
102300563|NCT04191447|Respiratory System Agents|respiratory system agents|mesh-ancestor
102300564|NCT04191447|Glucocorticoids|glucocorticoids|mesh-ancestor
102300565|NCT04191447|Hormones|hormones|mesh-ancestor
102300566|NCT04191447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102300567|NCT04191447|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102300568|NCT04191447|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102300569|NCT04191447|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102300570|NCT04191447|Adrenergic Agents|adrenergic agents|mesh-ancestor
102300571|NCT04191447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102300572|NCT04191447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300573|NCT04274361|Ketamine|ketamine|mesh-list
102300574|NCT04274361|Analgesics|analgesics|mesh-ancestor
102300575|NCT04274361|Sensory System Agents|sensory system agents|mesh-ancestor
102300576|NCT04274361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102300577|NCT04274361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300578|NCT04274361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102300579|NCT04274361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102300580|NCT04274361|Anesthetics, General|anesthetics, general|mesh-ancestor
102300581|NCT04274361|Anesthetics|anesthetics|mesh-ancestor
102300582|NCT04274361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102300583|NCT04274361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102300584|NCT04274361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102300585|NCT04274361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102300586|NCT04274361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300587|NCT04251819|Baclofen|baclofen|mesh-list
102300588|NCT04251819|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102300589|NCT04251819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300590|NCT04251819|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102300591|NCT04251819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102300592|NCT04251819|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102300593|NCT04251819|GABA Agonists|gaba agonists|mesh-ancestor
102300594|NCT04251819|GABA Agents|gaba agents|mesh-ancestor
102300595|NCT04251819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102300596|NCT04251819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300597|NCT02243631|Probenecid|probenecid|mesh-list
102300598|NCT02243631|Uricosuric Agents|uricosuric agents|mesh-ancestor
102300599|NCT02243631|Gout Suppressants|gout suppressants|mesh-ancestor
102300600|NCT02243631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102300601|NCT03401073|Immunoglobulins|immunoglobulins|mesh-list
102300602|NCT03401073|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102300603|NCT03401073|Antibodies|antibodies|mesh-list
102300604|NCT03401073|gamma-Globulins|gamma-globulins|mesh-list
102300605|NCT03401073|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102300606|NCT03401073|Immunologic Factors|immunologic factors|mesh-ancestor
102300607|NCT03401073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300608|NCT02242305|Scopolamine|scopolamine|mesh-list
102300609|NCT02242305|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102300610|NCT02242305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102300611|NCT02242305|Antiemetics|antiemetics|mesh-ancestor
102300612|NCT02242305|Autonomic Agents|autonomic agents|mesh-ancestor
102300613|NCT02242305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102300614|NCT02242305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300615|NCT02242305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102300616|NCT02242305|Mydriatics|mydriatics|mesh-ancestor
102300617|NCT02242305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102300618|NCT02242305|Cholinergic Agents|cholinergic agents|mesh-ancestor
102300619|NCT02242305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102300620|NCT02242305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300621|NCT02242305|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102300622|NCT02242305|Parasympatholytics|parasympatholytics|mesh-ancestor
102300623|NCT02240121|Rifaximin|rifaximin|mesh-list
102300624|NCT02240121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102300625|NCT02240121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102300626|NCT02240121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102300627|NCT04780269|Dinoprostone|dinoprostone|mesh-list
102300628|NCT04780269|Oxytocics|oxytocics|mesh-ancestor
102300629|NCT04780269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102300630|NCT04780269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300631|NCT02238483|AZD7624|azd7624|mesh-list
102300632|NCT02238483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102300633|NCT02238483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102300634|NCT02238483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300635|NCT01632891|Ritonavir|ritonavir|mesh-list
102300636|NCT01632891|Lopinavir|lopinavir|mesh-list
102300637|NCT01632891|Tenofovir|tenofovir|mesh-list
102300638|NCT01632891|Emtricitabine|emtricitabine|mesh-list
102300639|NCT01632891|Nevirapine|nevirapine|mesh-list
102300640|NCT01632891|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102300641|NCT01632891|Efavirenz|efavirenz|mesh-list
102300642|NCT01632891|Trimethoprim|trimethoprim|mesh-list
102300643|NCT01632891|Sulfamethoxazole|sulfamethoxazole|mesh-list
102300644|NCT01632891|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102300645|NCT01632891|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102300646|NCT01632891|Protease Inhibitors|protease inhibitors|mesh-ancestor
102300647|NCT01632891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102300648|NCT01632891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300649|NCT01632891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102300650|NCT01632891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102300651|NCT01632891|Antiviral Agents|antiviral agents|mesh-ancestor
102300652|NCT01632891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102300653|NCT01632891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102300654|NCT01632891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102300655|NCT01632891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102300656|NCT01632891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102300657|NCT01632891|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102300658|NCT01632891|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102300659|NCT01632891|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102300660|NCT01632891|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102300661|NCT01632891|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102300662|NCT01632891|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102300663|NCT01632891|Antimalarials|antimalarials|mesh-ancestor
102300664|NCT01632891|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102300665|NCT01632891|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102300666|NCT01632891|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102300667|NCT01632891|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102300668|NCT01632891|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102300669|NCT02208843|Afatinib|afatinib|mesh-list
102300670|NCT02208843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102300671|NCT02208843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102300672|NCT02208843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102300673|NCT02208843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300674|NCT02208063|Vancomycin|vancomycin|mesh-list
102300675|NCT02208063|Cefazolin|cefazolin|mesh-list
102300676|NCT02208063|Daptomycin|daptomycin|mesh-list
102300677|NCT02208063|Penicillins|penicillins|mesh-list
102300678|NCT02208063|Cloxacillin|cloxacillin|mesh-list
102300679|NCT02208063|Oxacillin|oxacillin|mesh-list
102300680|NCT02208063|Telavancin|telavancin|mesh-list
102300681|NCT02208063|Nafcillin|nafcillin|mesh-list
102300682|NCT02208063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102300683|NCT02208063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102300684|NCT03729609|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102300685|NCT03729609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102300686|NCT03729609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102300688|NCT03729609|Immunoconjugates|immunoconjugates|mesh-ancestor
102300689|NCT03729609|Immunologic Factors|immunologic factors|mesh-ancestor
102300690|NCT03729609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300691|NCT02207907|Listerine|listerine|mesh-list
102300692|NCT02207907|Fluorides|fluorides|mesh-list
102300693|NCT02207907|Sodium Fluoride|sodium fluoride|mesh-list
102300694|NCT02207907|Cariostatic Agents|cariostatic agents|mesh-ancestor
102300695|NCT02207907|Protective Agents|protective agents|mesh-ancestor
102300696|NCT02207907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300697|NCT02207907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102300698|NCT02207907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102300699|NCT02207829|Tiotropium Bromide|tiotropium bromide|mesh-list
102300700|NCT02207829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102300701|NCT02207829|Autonomic Agents|autonomic agents|mesh-ancestor
102300702|NCT02207829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102300703|NCT02207829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300704|NCT02207829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102300705|NCT02207829|Respiratory System Agents|respiratory system agents|mesh-ancestor
102300706|NCT02207829|Parasympatholytics|parasympatholytics|mesh-ancestor
102300707|NCT02207829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102300708|NCT02207829|Cholinergic Agents|cholinergic agents|mesh-ancestor
102300709|NCT02207829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102300710|NCT02207829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300711|NCT02237157|Gemcitabine|gemcitabine|mesh-list
102300712|NCT02237157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102300713|NCT02237157|Antimetabolites|antimetabolites|mesh-ancestor
102300714|NCT02237157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300715|NCT02237157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102300716|NCT02236611|Glycopyrrolate|glycopyrrolate|mesh-list
102300717|NCT02236611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102300718|NCT02236611|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102300719|NCT02236611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102300720|NCT02236611|Cholinergic Agents|cholinergic agents|mesh-ancestor
102300721|NCT02236611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102300722|NCT02236611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300723|NCT02236611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300724|NCT02233803|Budesonide|budesonide|mesh-list
102300725|NCT02233803|Albuterol|albuterol|mesh-list
102300726|NCT02233803|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
102300727|NCT02233803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102300728|NCT02233803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102300729|NCT02233803|Autonomic Agents|autonomic agents|mesh-ancestor
102300730|NCT02233803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102300731|NCT02233803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300732|NCT02233803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102300733|NCT02233803|Respiratory System Agents|respiratory system agents|mesh-ancestor
102300734|NCT02233803|Glucocorticoids|glucocorticoids|mesh-ancestor
102300735|NCT02233803|Hormones|hormones|mesh-ancestor
102300736|NCT02233803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102300737|NCT02233803|Tocolytic Agents|tocolytic agents|mesh-ancestor
102300738|NCT02233803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102300739|NCT02233803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102300740|NCT02233803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102300741|NCT02233803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102300742|NCT02233803|Adrenergic Agents|adrenergic agents|mesh-ancestor
102300743|NCT02233803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102300744|NCT02233803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300745|NCT02233647|Cocaine|cocaine|mesh-list
102300746|NCT02233647|Anesthetics, Local|anesthetics, local|mesh-ancestor
102300747|NCT02233647|Anesthetics|anesthetics|mesh-ancestor
102300748|NCT02233647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102300749|NCT02233647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300750|NCT02233647|Sensory System Agents|sensory system agents|mesh-ancestor
102300751|NCT02233647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102300752|NCT02233647|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102300753|NCT02233647|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102300754|NCT02233647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102300755|NCT02233647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102300756|NCT02233647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300757|NCT02233647|Dopamine Agents|dopamine agents|mesh-ancestor
102300758|NCT02233647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102300759|NCT01632579|Celecoxib|celecoxib|mesh-list
101642576|NCT00747487|Idebenone|idebenone|mesh-list
102300760|NCT01632579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102300761|NCT01632579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102300762|NCT01632579|Analgesics|analgesics|mesh-ancestor
102300763|NCT01632579|Sensory System Agents|sensory system agents|mesh-ancestor
102300764|NCT01632579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102300765|NCT01632579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300766|NCT01632579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102300767|NCT01632579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102300768|NCT01632579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102300769|NCT01632579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102300770|NCT01632579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102300771|NCT01632579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300772|NCT01632345|Efavirenz|efavirenz|mesh-list
102300773|NCT01632345|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102300774|NCT01632345|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102300775|NCT01632345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102300776|NCT01632345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102300777|NCT01632345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300778|NCT01632345|Antiviral Agents|antiviral agents|mesh-ancestor
102300779|NCT01632345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102300780|NCT01632345|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102300781|NCT01632345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102300782|NCT01632345|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102300783|NCT01632345|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102300784|NCT01632345|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102300785|NCT01632345|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102300786|NCT01632345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102300787|NCT01632345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102300788|NCT02232243|Hydroxychloroquine|hydroxychloroquine|mesh-list
102300789|NCT02232243|Antimalarials|antimalarials|mesh-ancestor
102300790|NCT02232243|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102300791|NCT02232243|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102300792|NCT02232243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102300793|NCT02232243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102300794|NCT02232243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300795|NCT02232243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102300796|NCT02205333|Rituximab|rituximab|mesh-list
102300797|NCT02205333|Durvalumab|durvalumab|mesh-list
102300798|NCT02205333|Tremelimumab|tremelimumab|mesh-list
102300799|NCT02205333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102300800|NCT02205333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102300801|NCT02205333|Immunologic Factors|immunologic factors|mesh-ancestor
102300802|NCT02205333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300803|NCT02205333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102300804|NCT04776369|Lidocaine|lidocaine|mesh-list
102300805|NCT04776369|Magnesium Sulfate|magnesium sulfate|mesh-list
102300806|NCT04776369|Anesthetics, Local|anesthetics, local|mesh-ancestor
102300807|NCT04776369|Anesthetics|anesthetics|mesh-ancestor
102300808|NCT04776369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102300809|NCT04776369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300810|NCT04776369|Sensory System Agents|sensory system agents|mesh-ancestor
102300811|NCT04776369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102300812|NCT04776369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102300813|NCT04776369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102300814|NCT04776369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102300815|NCT04776369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101401815|NCT00333151|Incretins|incretins|mesh-ancestor
102300816|NCT04776369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300817|NCT04776369|Analgesics|analgesics|mesh-ancestor
102300818|NCT04776369|Anticonvulsants|anticonvulsants|mesh-ancestor
102300819|NCT04776369|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102300820|NCT04776369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102300821|NCT04776369|Tocolytic Agents|tocolytic agents|mesh-ancestor
102300822|NCT04776369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102300823|NCT02230527|Clopidogrel|clopidogrel|mesh-list
102300824|NCT02230527|Ticagrelor|ticagrelor|mesh-list
102300825|NCT02230527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102300826|NCT02230527|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102300827|NCT02230527|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102300828|NCT02230527|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102300829|NCT02230527|Purinergic Agents|purinergic agents|mesh-ancestor
102300830|NCT02230527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102300831|NCT02230527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300832|NCT02230527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300833|NCT03155061|Nivolumab|nivolumab|mesh-list
102300834|NCT03155061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102300835|NCT03155061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102300836|NCT03155061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102300837|NCT03155061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300838|NCT02227875|Insulin Glargine|insulin glargine|mesh-list
102300839|NCT02227875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102300840|NCT02227875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300841|NCT02203149|Grazoprevir|grazoprevir|mesh-list
102300842|NCT02203149|Antiviral Agents|antiviral agents|mesh-ancestor
102300843|NCT02203149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102300844|NCT02202837|Etanercept|etanercept|mesh-list
102300845|NCT02202837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102300846|NCT02202837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102300847|NCT02202837|Analgesics|analgesics|mesh-ancestor
102300848|NCT02202837|Sensory System Agents|sensory system agents|mesh-ancestor
102300849|NCT02202837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102300850|NCT02202837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300851|NCT02202837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102300852|NCT02202837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102300853|NCT02202837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102300854|NCT02202837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102300855|NCT02202837|Immunologic Factors|immunologic factors|mesh-ancestor
102300856|NCT02226549|Sofosbuvir|sofosbuvir|mesh-list
102300857|NCT02226549|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102300858|NCT02226549|Ledipasvir|ledipasvir|mesh-list
102300859|NCT02226549|Antiviral Agents|antiviral agents|mesh-ancestor
102300860|NCT02226549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102300861|NCT02226003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102300862|NCT02226003|Glimepiride|glimepiride|mesh-list
102300863|NCT02226003|Ertugliflozin|ertugliflozin|mesh-list
102300864|NCT02226003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102300865|NCT02226003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300866|NCT02226003|Incretins|incretins|mesh-ancestor
102300867|NCT02226003|Hormones|hormones|mesh-ancestor
102300868|NCT02226003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102300869|NCT02226003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102300870|NCT02226003|Protease Inhibitors|protease inhibitors|mesh-ancestor
102300871|NCT02226003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102300872|NCT02226003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300873|NCT02226003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102300874|NCT02226003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102300875|NCT02226003|Immunologic Factors|immunologic factors|mesh-ancestor
102300876|NCT02226003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102300877|NCT02469519|Dexamethasone|dexamethasone|mesh-list
102300878|NCT02469519|Betamethasone|betamethasone|mesh-list
102300879|NCT02469519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102300880|NCT02469519|Antiemetics|antiemetics|mesh-ancestor
102300881|NCT02469519|Autonomic Agents|autonomic agents|mesh-ancestor
102300882|NCT02469519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102300883|NCT02469519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300884|NCT02469519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102300885|NCT02469519|Glucocorticoids|glucocorticoids|mesh-ancestor
102300886|NCT02469519|Hormones|hormones|mesh-ancestor
102300887|NCT02469519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102300888|NCT02469519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102300889|NCT02469519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102300890|NCT02469519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102300891|NCT02469519|Respiratory System Agents|respiratory system agents|mesh-ancestor
102300892|NCT01634139|Tiotropium Bromide|tiotropium bromide|mesh-list
102300893|NCT01634139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102300894|NCT01634139|Autonomic Agents|autonomic agents|mesh-ancestor
102300895|NCT01634139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102300896|NCT01634139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300897|NCT01634139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102300898|NCT01634139|Respiratory System Agents|respiratory system agents|mesh-ancestor
102300899|NCT01634139|Parasympatholytics|parasympatholytics|mesh-ancestor
102300900|NCT01634139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102300901|NCT01634139|Cholinergic Agents|cholinergic agents|mesh-ancestor
102300902|NCT01634139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102300903|NCT01634139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300904|NCT02404441|Spartalizumab|spartalizumab|mesh-list
102300905|NCT02404441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102300906|NCT02404441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300907|NCT02404441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102300908|NCT02404441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102300909|NCT02101281|Mitogens|mitogens|mesh-list
102300910|NCT02101281|Mitosis Modulators|mitosis modulators|mesh-ancestor
102300911|NCT02101281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300912|NCT02224599|Cyclophosphamide|cyclophosphamide|mesh-list
102300913|NCT02224599|Imiquimod|imiquimod|mesh-list
102300914|NCT02224599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102300915|NCT02224599|Immunologic Factors|immunologic factors|mesh-ancestor
102300916|NCT02224599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300917|NCT02224599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102300918|NCT02224599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102300919|NCT02224599|Alkylating Agents|alkylating agents|mesh-ancestor
102300920|NCT02224599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300921|NCT02224599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102300922|NCT02224599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102300923|NCT02224599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102300924|NCT02224599|Interferon Inducers|interferon inducers|mesh-ancestor
102300925|NCT04763577|Bradykinin|bradykinin|mesh-list
102300926|NCT04763577|Kininogens|kininogens|mesh-list
102300927|NCT04763577|Vasodilator Agents|vasodilator agents|mesh-ancestor
102300928|NCT04763577|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
102300929|NCT04763577|Protease Inhibitors|protease inhibitors|mesh-ancestor
102300930|NCT04763577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102300931|NCT04763577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300932|NCT02201901|Sofosbuvir|sofosbuvir|mesh-list
102300933|NCT02201901|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102300934|NCT02201901|Velpatasvir|velpatasvir|mesh-list
102300935|NCT02201901|Antiviral Agents|antiviral agents|mesh-ancestor
102300936|NCT02201901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102300937|NCT02224053|Osimertinib|osimertinib|mesh-list
102300938|NCT02224053|Omeprazole|omeprazole|mesh-list
102300939|NCT02224053|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102300940|NCT02224053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102300941|NCT02224053|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102300942|NCT02224053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102300943|NCT02224053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300944|NCT02224053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102300945|NCT02224053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102300946|NCT04762875|Plerixafor|plerixafor|mesh-list
102300947|NCT04762875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102300948|NCT04762875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102300949|NCT04762875|Antiviral Agents|antiviral agents|mesh-ancestor
102300950|NCT04762875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102300951|NCT04774107|Ribavirin|ribavirin|mesh-list
102300952|NCT04774107|Antimetabolites|antimetabolites|mesh-ancestor
102300953|NCT04774107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300954|NCT04774107|Antiviral Agents|antiviral agents|mesh-ancestor
102300955|NCT04774107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102300956|NCT02457793|Ravoxertinib|ravoxertinib|mesh-list
102300957|NCT02457793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102300958|NCT02457793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102300959|NCT02457793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102300960|NCT02457793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300961|NCT02434939|Ketamine|ketamine|mesh-list
102300962|NCT02434939|Morphine|morphine|mesh-list
102300963|NCT02434939|Analgesics|analgesics|mesh-ancestor
102300964|NCT02434939|Sensory System Agents|sensory system agents|mesh-ancestor
102300965|NCT02434939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102300966|NCT02434939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300967|NCT02434939|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102300968|NCT02434939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102300969|NCT02434939|Anesthetics, General|anesthetics, general|mesh-ancestor
102300970|NCT02434939|Anesthetics|anesthetics|mesh-ancestor
102300971|NCT02434939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102300972|NCT02434939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102300973|NCT02434939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102300974|NCT02434939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102300975|NCT02434939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300976|NCT02434939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102300977|NCT02434939|Narcotics|narcotics|mesh-ancestor
102300978|NCT02457325|Carticaine|carticaine|mesh-list
102300979|NCT02457325|Anesthetics, Local|anesthetics, local|mesh-ancestor
102300980|NCT02457325|Anesthetics|anesthetics|mesh-ancestor
102300981|NCT02457325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102300982|NCT02457325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102300983|NCT02457325|Sensory System Agents|sensory system agents|mesh-ancestor
102300984|NCT02457325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102300985|NCT02434081|Nivolumab|nivolumab|mesh-list
102300986|NCT02434081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102300987|NCT02434081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102300988|NCT02434081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102300989|NCT02434081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102300990|NCT02222493|Infliximab|infliximab|mesh-list
102300991|NCT02222493|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102300992|NCT02222493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102300993|NCT02222493|Dermatologic Agents|dermatologic agents|mesh-ancestor
102300994|NCT02222493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102300995|NCT02222493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102300996|NCT01439997|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
102300997|NCT01439997|Hemostatics|hemostatics|mesh-ancestor
102300998|NCT01439997|Coagulants|coagulants|mesh-ancestor
102300999|NCT01439997|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102301000|NCT01439997|Natriuretic Agents|natriuretic agents|mesh-ancestor
102301001|NCT01439997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301002|NCT02403271|Durvalumab|durvalumab|mesh-list
102301003|NCT02403271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102301004|NCT02403271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102301005|NCT02219685|Sofosbuvir|sofosbuvir|mesh-list
102301006|NCT02219685|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102301007|NCT02219685|Ledipasvir|ledipasvir|mesh-list
102301008|NCT02219685|Antiviral Agents|antiviral agents|mesh-ancestor
102301009|NCT02219685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102301010|NCT02457247|Calcium Carbonate|calcium carbonate|mesh-list
102301011|NCT02457247|Antacids|antacids|mesh-ancestor
102301012|NCT02457247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301013|NCT02457247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102301014|NCT04929535|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102301015|NCT04929535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102301016|NCT04929535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102301017|NCT02198235|Dexamethasone|dexamethasone|mesh-list
102301018|NCT02198235|Buprenorphine|buprenorphine|mesh-list
102301019|NCT02198235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102301020|NCT02198235|Antiemetics|antiemetics|mesh-ancestor
102301021|NCT02198235|Autonomic Agents|autonomic agents|mesh-ancestor
102301022|NCT02198235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102301023|NCT02198235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301024|NCT02198235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102301025|NCT02198235|Glucocorticoids|glucocorticoids|mesh-ancestor
102301027|NCT02198235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102301028|NCT02198235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102301029|NCT02198235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102301030|NCT02198235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102301031|NCT02198235|Narcotics|narcotics|mesh-ancestor
102301032|NCT02198235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102301033|NCT02198235|Analgesics|analgesics|mesh-ancestor
102301034|NCT02198235|Sensory System Agents|sensory system agents|mesh-ancestor
102301035|NCT02198235|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102301036|NCT00346125|Doxorubicin|doxorubicin|mesh-list
102301037|NCT00346125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102301038|NCT00346125|Ifosfamide|ifosfamide|mesh-list
102301039|NCT00346125|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102301040|NCT00346125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102301041|NCT00346125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102301042|NCT00346125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102301043|NCT00346125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102301044|NCT00346125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102301045|NCT00346125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301046|NCT00346125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102301047|NCT00346125|Alkylating Agents|alkylating agents|mesh-ancestor
102301048|NCT00346125|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102301049|NCT02217501|Aspirin|aspirin|mesh-list
102301050|NCT02217501|Clopidogrel|clopidogrel|mesh-list
102301051|NCT02217501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102301052|NCT02217501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102301053|NCT02217501|Analgesics|analgesics|mesh-ancestor
102301054|NCT02217501|Sensory System Agents|sensory system agents|mesh-ancestor
102301055|NCT02217501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102301056|NCT02217501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301057|NCT02217501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102301058|NCT02217501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102301059|NCT02217501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102301060|NCT02217501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102301061|NCT02217501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301062|NCT02217501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102301063|NCT02217501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102301064|NCT02217501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102301066|NCT02217501|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102301067|NCT02217501|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102301068|NCT02217501|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102301069|NCT02217501|Purinergic Agents|purinergic agents|mesh-ancestor
102301070|NCT02217501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102301071|NCT01649869|Valganciclovir|valganciclovir|mesh-list
102301072|NCT01649869|Antiviral Agents|antiviral agents|mesh-ancestor
102301073|NCT01649869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102301074|NCT02197377|Chlorhexidine|chlorhexidine|mesh-list
102301075|NCT02197377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102301076|NCT02197377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102301077|NCT02197377|Disinfectants|disinfectants|mesh-ancestor
102301078|NCT02399449|Ferric gluconate|ferric gluconate|mesh-list
102301079|NCT02399449|Ferric Compounds|ferric compounds|mesh-list
102301080|NCT02399449|Hematinics|hematinics|mesh-ancestor
102301081|NCT02217345|Hormones|hormones|mesh-list
102301082|NCT02217345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102301083|NCT02217345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301084|NCT02428855|Dasatinib|dasatinib|mesh-list
102301085|NCT02428855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102301086|NCT02428855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102301087|NCT02428855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102301088|NCT02428855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301089|NCT02428699|Cod Liver Oil|cod liver oil|mesh-list
102301090|NCT02428699|Liver Extracts|liver extracts|mesh-list
102301091|NCT02428699|Hematinics|hematinics|mesh-ancestor
102301092|NCT02428699|Vitamins|vitamins|mesh-ancestor
102301093|NCT02428699|Micronutrients|micronutrients|mesh-ancestor
102301094|NCT02428699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301095|NCT02428231|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102301096|NCT02428231|Dermatologic Agents|dermatologic agents|mesh-ancestor
102301097|NCT02428231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102301098|NCT02428231|Immunologic Factors|immunologic factors|mesh-ancestor
102301099|NCT02428231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301100|NCT02427841|Paclitaxel|paclitaxel|mesh-list
102301101|NCT02427841|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102301102|NCT02427841|Gemcitabine|gemcitabine|mesh-list
102301103|NCT02427841|Fluorouracil|fluorouracil|mesh-list
102301104|NCT02427841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102301105|NCT02427841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102301106|NCT02427841|Tubulin Modulators|tubulin modulators|mesh-ancestor
102301107|NCT02427841|Antimitotic Agents|antimitotic agents|mesh-ancestor
102301108|NCT02427841|Mitosis Modulators|mitosis modulators|mesh-ancestor
102301109|NCT02427841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301110|NCT02427841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102301111|NCT02427841|Antimetabolites|antimetabolites|mesh-ancestor
102301112|NCT02427841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102301113|NCT02427841|Immunologic Factors|immunologic factors|mesh-ancestor
102301114|NCT02427841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301115|NCT02397889|Midazolam|midazolam|mesh-list
102301116|NCT02397889|Ketamine|ketamine|mesh-list
102301117|NCT02397889|Analgesics|analgesics|mesh-ancestor
102301118|NCT02397889|Sensory System Agents|sensory system agents|mesh-ancestor
102301119|NCT02397889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102301120|NCT02397889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301121|NCT02397889|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102301122|NCT02397889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102301123|NCT02397889|Anesthetics, General|anesthetics, general|mesh-ancestor
102301124|NCT02397889|Anesthetics|anesthetics|mesh-ancestor
102301125|NCT02397889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102301126|NCT02397889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102301127|NCT02397889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102301128|NCT02397889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102301129|NCT02397889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301130|NCT02397889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102301131|NCT02397889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102301132|NCT02397889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102301133|NCT02397889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102301134|NCT02397889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102301135|NCT02397889|GABA Modulators|gaba modulators|mesh-ancestor
102301136|NCT02397889|GABA Agents|gaba agents|mesh-ancestor
102301137|NCT02396953|Lanreotide|lanreotide|mesh-list
102301138|NCT02396953|Somatostatin|somatostatin|mesh-list
102301139|NCT02396953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102301140|NCT02396953|Hormones|hormones|mesh-ancestor
102301141|NCT02396953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102301142|NCT02396953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301143|NCT02387983|Posaconazole|posaconazole|mesh-list
102301144|NCT02387983|Antifungal Agents|antifungal agents|mesh-ancestor
102301145|NCT02387983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102301146|NCT02387983|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102301147|NCT02387983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102301148|NCT02387983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102301149|NCT02387983|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102301150|NCT02387983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102301151|NCT02387983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102301152|NCT02387983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301153|NCT02387983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102301154|NCT02387983|Hormone Antagonists|hormone antagonists|mesh-ancestor
102301155|NCT02387983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102301156|NCT02387983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301157|NCT02395627|Tamoxifen|tamoxifen|mesh-list
102301158|NCT02395627|Pembrolizumab|pembrolizumab|mesh-list
102301159|NCT02395627|Vorinostat|vorinostat|mesh-list
102301160|NCT02395627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102301161|NCT02395627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102301162|NCT02395627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102301163|NCT02395627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301164|NCT02395627|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102301165|NCT02395627|Hormone Antagonists|hormone antagonists|mesh-ancestor
102301166|NCT02395627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102301167|NCT02395627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301168|NCT02395627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102301169|NCT02395627|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102301170|NCT02395627|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102301171|NCT02395627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102301172|NCT02395627|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102301173|NCT02395627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102301175|NCT02395081|Ergocalciferols|ergocalciferols|mesh-list
102301176|NCT02395081|Cholecalciferol|cholecalciferol|mesh-list
102301177|NCT02395081|Vitamins|vitamins|mesh-list
102301178|NCT02395081|Micronutrients|micronutrients|mesh-ancestor
102301179|NCT02395081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301180|NCT02395081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102301181|NCT02395081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102301182|NCT02425111|Vedolizumab|vedolizumab|mesh-list
102301183|NCT02425111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102301184|NCT02393755|Capecitabine|capecitabine|mesh-list
102301185|NCT02393755|Nintedanib|nintedanib|mesh-list
102301186|NCT02393755|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102301187|NCT02393755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102301188|NCT02393755|Antimetabolites|antimetabolites|mesh-ancestor
102301189|NCT02393755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301190|NCT02393755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102301191|NCT02393755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102301192|NCT02393755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102301193|NCT02393209|Docetaxel|docetaxel|mesh-list
102301194|NCT02393209|Serabelisib|serabelisib|mesh-list
102301195|NCT02393209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102301196|NCT02393209|Tubulin Modulators|tubulin modulators|mesh-ancestor
102301197|NCT02393209|Antimitotic Agents|antimitotic agents|mesh-ancestor
102301198|NCT02393209|Mitosis Modulators|mitosis modulators|mesh-ancestor
102301199|NCT02393209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301200|NCT02393209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102301201|NCT02424097|Listerine|listerine|mesh-list
102301202|NCT02424097|Fluorides|fluorides|mesh-list
102301203|NCT02424097|Sodium Fluoride|sodium fluoride|mesh-list
102301204|NCT02424097|Fluorides, Topical|fluorides, topical|mesh-list
102301205|NCT02424097|Cariostatic Agents|cariostatic agents|mesh-ancestor
102301206|NCT02424097|Protective Agents|protective agents|mesh-ancestor
102301207|NCT02424097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301208|NCT02424097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102301209|NCT02424097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102301210|NCT02392507|Paclitaxel|paclitaxel|mesh-list
102301211|NCT02392507|Carboplatin|carboplatin|mesh-list
102301212|NCT02392507|Necitumumab|necitumumab|mesh-list
102301213|NCT02392507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102301214|NCT02392507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102301215|NCT02392507|Tubulin Modulators|tubulin modulators|mesh-ancestor
102301216|NCT02392507|Antimitotic Agents|antimitotic agents|mesh-ancestor
102301217|NCT02392507|Mitosis Modulators|mitosis modulators|mesh-ancestor
102301218|NCT02392507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301219|NCT02392507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102301220|NCT04904341|Cerebrolysin|cerebrolysin|mesh-list
102301221|NCT04904341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102301222|NCT04904341|Protective Agents|protective agents|mesh-ancestor
102301223|NCT04904341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301224|NCT04904341|Nootropic Agents|nootropic agents|mesh-ancestor
102301225|NCT02385799|Sertraline|sertraline|mesh-list
102301226|NCT02385799|Antidepressive Agents|antidepressive agents|mesh-ancestor
102301227|NCT02385799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102301228|NCT02385799|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102301229|NCT02385799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102301230|NCT02385799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102301231|NCT02385799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301232|NCT02385799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102301233|NCT02385799|Serotonin Agents|serotonin agents|mesh-ancestor
102301234|NCT02385799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301235|NCT02422303|Ketamine|ketamine|mesh-list
102301236|NCT02422303|Analgesics|analgesics|mesh-ancestor
102301237|NCT02422303|Sensory System Agents|sensory system agents|mesh-ancestor
102301238|NCT02422303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102301239|NCT02422303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301240|NCT02422303|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102301241|NCT02422303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102301242|NCT02422303|Anesthetics, General|anesthetics, general|mesh-ancestor
102301243|NCT02422303|Anesthetics|anesthetics|mesh-ancestor
102301244|NCT02422303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102301245|NCT02422303|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102301246|NCT02422303|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102301247|NCT02422303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102301248|NCT02422303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301249|NCT02391961|4-Aminopyridine|4-aminopyridine|mesh-list
102301250|NCT02391961|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102301251|NCT02391961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102301252|NCT02391961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301253|NCT02384941|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
102301254|NCT02384941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102301255|NCT02384941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301256|NCT02384941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102301257|NCT02384941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301258|NCT02384395|Lamivudine|lamivudine|mesh-list
102301259|NCT02384395|Abacavir|abacavir|mesh-list
102301260|NCT02384395|Dolutegravir|dolutegravir|mesh-list
102301261|NCT02384395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102301262|NCT02384395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102301263|NCT02384395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102301264|NCT02384395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301265|NCT02384395|Antiviral Agents|antiviral agents|mesh-ancestor
102301266|NCT02384395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102301267|NCT02384395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102301268|NCT02384395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102301269|NCT02384395|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102301270|NCT02384395|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102301271|NCT02391337|Digoxin|digoxin|mesh-list
102301272|NCT02391337|Bisoprolol|bisoprolol|mesh-list
102301273|NCT02391337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102301274|NCT02391337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102301275|NCT02391337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102301276|NCT02391337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301277|NCT02391337|Protective Agents|protective agents|mesh-ancestor
102301278|NCT02391337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301279|NCT02391337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102301280|NCT02391337|Sympatholytics|sympatholytics|mesh-ancestor
102301281|NCT02391337|Autonomic Agents|autonomic agents|mesh-ancestor
102301282|NCT02391337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102301283|NCT02391337|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102301284|NCT02391337|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102301285|NCT02391337|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102301286|NCT02391337|Adrenergic Agents|adrenergic agents|mesh-ancestor
102301287|NCT02391337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102301288|NCT01649791|Lenalidomide|lenalidomide|mesh-list
102301289|NCT01649791|Immunologic Factors|immunologic factors|mesh-ancestor
102301290|NCT01649791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301291|NCT01649791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102301292|NCT01649791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102301293|NCT01649791|Growth Substances|growth substances|mesh-ancestor
102301294|NCT01649791|Growth Inhibitors|growth inhibitors|mesh-ancestor
102301295|NCT01649791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102301296|NCT02347657|Ivacaftor|ivacaftor|mesh-list
102301297|NCT02347657|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102301298|NCT02347657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102301299|NCT02347657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301300|NCT02346721|Sofosbuvir|sofosbuvir|mesh-list
102301301|NCT02346721|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102301302|NCT02346721|Velpatasvir|velpatasvir|mesh-list
102301303|NCT02346721|Antiviral Agents|antiviral agents|mesh-ancestor
102301304|NCT02346721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102301305|NCT02388997|Omalizumab|omalizumab|mesh-list
102301306|NCT02388997|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102301307|NCT02388997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102301308|NCT02388997|Respiratory System Agents|respiratory system agents|mesh-ancestor
102301309|NCT02345161|Budesonide|budesonide|mesh-list
102301310|NCT02345161|Albuterol|albuterol|mesh-list
102301311|NCT02345161|Formoterol Fumarate|formoterol fumarate|mesh-list
102301312|NCT02345161|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
102301313|NCT02345161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102301314|NCT02345161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102301315|NCT02345161|Autonomic Agents|autonomic agents|mesh-ancestor
102301316|NCT02345161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102301317|NCT02345161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301318|NCT02345161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102301319|NCT02345161|Respiratory System Agents|respiratory system agents|mesh-ancestor
102301320|NCT02345161|Glucocorticoids|glucocorticoids|mesh-ancestor
102301321|NCT02345161|Hormones|hormones|mesh-ancestor
102301322|NCT02345161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102301323|NCT02345161|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102301324|NCT02345161|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102301325|NCT02345161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102301326|NCT02345161|Adrenergic Agents|adrenergic agents|mesh-ancestor
102301327|NCT02345161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102301328|NCT02345161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301329|NCT02345161|Tocolytic Agents|tocolytic agents|mesh-ancestor
102301330|NCT02345161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102301331|NCT02251275|Tolvaptan|tolvaptan|mesh-list
102301332|NCT02251275|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102301333|NCT02251275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301334|NCT02251275|Natriuretic Agents|natriuretic agents|mesh-ancestor
102301335|NCT02251275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301336|NCT02379637|Acetylcysteine|acetylcysteine|mesh-list
102301337|NCT02379637|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102301338|NCT02379637|Antiviral Agents|antiviral agents|mesh-ancestor
102301339|NCT02379637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102301340|NCT02379637|Expectorants|expectorants|mesh-ancestor
102301341|NCT02379637|Respiratory System Agents|respiratory system agents|mesh-ancestor
102301342|NCT02379637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102301343|NCT02379637|Antioxidants|antioxidants|mesh-ancestor
102301344|NCT02379637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301345|NCT02379637|Protective Agents|protective agents|mesh-ancestor
102301346|NCT02379637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301347|NCT02379637|Antidotes|antidotes|mesh-ancestor
102301348|NCT02195583|Zinc|zinc|mesh-list
102301349|NCT02195583|Listerine|listerine|mesh-list
102301350|NCT02195583|Fluorides|fluorides|mesh-list
102301351|NCT02195583|Sodium Fluoride|sodium fluoride|mesh-list
102301352|NCT02195583|Cariostatic Agents|cariostatic agents|mesh-ancestor
102301353|NCT02195583|Protective Agents|protective agents|mesh-ancestor
102301354|NCT02195583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301355|NCT02195583|Trace Elements|trace elements|mesh-ancestor
102301356|NCT02195583|Micronutrients|micronutrients|mesh-ancestor
102301357|NCT02195583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102301358|NCT02195583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102301359|NCT02379091|Leucovorin|leucovorin|mesh-list
102301360|NCT02379091|Folic Acid|folic acid|mesh-list
102301361|NCT02379091|Methotrexate|methotrexate|mesh-list
102301362|NCT02379091|Levoleucovorin|levoleucovorin|mesh-list
102301363|NCT02379091|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102301364|NCT02379091|Abortifacient Agents|abortifacient agents|mesh-ancestor
102301365|NCT02379091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102301366|NCT02379091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301367|NCT02379091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102301368|NCT02379091|Antimetabolites|antimetabolites|mesh-ancestor
102301369|NCT02379091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301370|NCT02379091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102301371|NCT02379091|Dermatologic Agents|dermatologic agents|mesh-ancestor
102301372|NCT02379091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102301373|NCT02379091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102301374|NCT02379091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102301375|NCT02379091|Immunologic Factors|immunologic factors|mesh-ancestor
102301376|NCT02379091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102301377|NCT02379091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102301378|NCT02379091|Antidotes|antidotes|mesh-ancestor
102301379|NCT02379091|Protective Agents|protective agents|mesh-ancestor
102301380|NCT02379091|Vitamin B Complex|vitamin b complex|mesh-ancestor
102301381|NCT02379091|Vitamins|vitamins|mesh-ancestor
102301382|NCT02379091|Micronutrients|micronutrients|mesh-ancestor
102301383|NCT02379091|Hematinics|hematinics|mesh-ancestor
102301384|NCT02378935|Sofosbuvir|sofosbuvir|mesh-list
102301385|NCT02378935|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102301386|NCT02378935|Velpatasvir|velpatasvir|mesh-list
102301387|NCT02378935|Antiviral Agents|antiviral agents|mesh-ancestor
102301388|NCT02378935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102301389|NCT02250651|Timolol|timolol|mesh-list
102301390|NCT02250651|Bimatoprost|bimatoprost|mesh-list
102301391|NCT02250651|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102301392|NCT02250651|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102301393|NCT02250651|Adrenergic Agents|adrenergic agents|mesh-ancestor
102301394|NCT02250651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102301395|NCT02250651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301396|NCT02250651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301397|NCT02250651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102301398|NCT02250651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102301399|NCT02214225|Vaccines|vaccines|mesh-list
102301400|NCT02214225|Immunologic Factors|immunologic factors|mesh-ancestor
102301401|NCT02214225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301402|NCT02249949|Efatutazone|efatutazone|mesh-list
102301403|NCT02249949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102301404|NCT02249091|Cytarabine|cytarabine|mesh-list
102301405|NCT02249091|Idarubicin|idarubicin|mesh-list
102301406|NCT02249091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102301407|NCT02249091|Antimetabolites|antimetabolites|mesh-ancestor
102301408|NCT02249091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301409|NCT02249091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102301410|NCT02249091|Antiviral Agents|antiviral agents|mesh-ancestor
102301411|NCT02249091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102301412|NCT02249091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102301413|NCT02249091|Immunologic Factors|immunologic factors|mesh-ancestor
102301414|NCT02249091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301415|NCT02249091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102301416|NCT02249091|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102301417|NCT02249091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102301418|NCT02249091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102301419|NCT02213055|Permethrin|permethrin|mesh-list
102301420|NCT02213055|Malathion|malathion|mesh-list
102301421|NCT02213055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102301422|NCT02213055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301423|NCT02213055|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102301424|NCT02213055|Cholinergic Agents|cholinergic agents|mesh-ancestor
102301425|NCT02213055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102301426|NCT02213055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301427|NCT02309515|Lenalidomide|lenalidomide|mesh-list
102301428|NCT02309515|Vaccines|vaccines|mesh-list
102301429|NCT02309515|Immunologic Factors|immunologic factors|mesh-ancestor
102301430|NCT02309515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301431|NCT02309515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102301432|NCT02309515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102301433|NCT02309515|Growth Substances|growth substances|mesh-ancestor
102301434|NCT02309515|Growth Inhibitors|growth inhibitors|mesh-ancestor
102301435|NCT02309515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102301436|NCT02309359|Methotrexate|methotrexate|mesh-list
102301437|NCT02309359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102301438|NCT02309359|Abortifacient Agents|abortifacient agents|mesh-ancestor
102301439|NCT02309359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102301440|NCT02309359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301441|NCT02309359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102301442|NCT02309359|Antimetabolites|antimetabolites|mesh-ancestor
102301443|NCT02309359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301444|NCT02309359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102301445|NCT02309359|Dermatologic Agents|dermatologic agents|mesh-ancestor
102301446|NCT02309359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102301447|NCT02309359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102301448|NCT02309359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102301449|NCT02309359|Immunologic Factors|immunologic factors|mesh-ancestor
102301450|NCT02309359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102301451|NCT02309359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102301452|NCT02375971|Ranibizumab|ranibizumab|mesh-list
102301453|NCT02375971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102301454|NCT02375971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102301455|NCT02375971|Growth Substances|growth substances|mesh-ancestor
102301456|NCT02375971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301457|NCT02375971|Growth Inhibitors|growth inhibitors|mesh-ancestor
102301458|NCT02375971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102301459|NCT04886323|Itraconazole|itraconazole|mesh-list
102301460|NCT04886323|Antifungal Agents|antifungal agents|mesh-ancestor
102301461|NCT04886323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102301462|NCT04886323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102010232|NCT03051620|Alendronate|alendronate|mesh-list
102301463|NCT04886323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102301464|NCT04886323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102301465|NCT04886323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301466|NCT04886323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102301467|NCT04886323|Hormone Antagonists|hormone antagonists|mesh-ancestor
102301468|NCT04886323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102301469|NCT04886323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301470|NCT04886323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102301471|NCT02212197|Leuprolide|leuprolide|mesh-list
102301472|NCT02212197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102301473|NCT02212197|Fertility Agents|fertility agents|mesh-ancestor
102301474|NCT02212197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102301475|NCT02212197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301476|NCT02212197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102301477|NCT02212197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102301478|NCT02193165|Triclosan|triclosan|mesh-list
102301479|NCT02193165|Cetylpyridinium|cetylpyridinium|mesh-list
102301480|NCT02193165|Fluorides|fluorides|mesh-list
102301481|NCT02193165|Tin Fluorides|tin fluorides|mesh-list
102301482|NCT02193165|Cariostatic Agents|cariostatic agents|mesh-ancestor
102301483|NCT02193165|Protective Agents|protective agents|mesh-ancestor
102301484|NCT02193165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301485|NCT02193165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102301486|NCT02193165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102301487|NCT02193165|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102301488|NCT02193165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102301489|NCT02193165|Antimetabolites|antimetabolites|mesh-ancestor
102301490|NCT02193165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301491|NCT02193165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102301492|NCT01617460|Aripiprazole|aripiprazole|mesh-list
102301493|NCT01617460|Antidepressive Agents|antidepressive agents|mesh-ancestor
102301494|NCT01617460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102301495|NCT01617460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102301496|NCT01617460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102301497|NCT01617460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102301498|NCT01617460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301499|NCT01617460|Dopamine Agonists|dopamine agonists|mesh-ancestor
102301500|NCT01617460|Dopamine Agents|dopamine agents|mesh-ancestor
102301501|NCT01617460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102301502|NCT01617460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301503|NCT01617460|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102301504|NCT01617460|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102301505|NCT01617460|Serotonin Agents|serotonin agents|mesh-ancestor
102301506|NCT01617460|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102301508|NCT01617460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102301509|NCT01617460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102301510|NCT01889602|Topiramate|topiramate|mesh-list
102301511|NCT01889602|Lorazepam|lorazepam|mesh-list
102301512|NCT01889602|Anticonvulsants|anticonvulsants|mesh-ancestor
102301513|NCT01889602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102301514|NCT01889602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301515|NCT01889602|Antiemetics|antiemetics|mesh-ancestor
102301516|NCT01889602|Autonomic Agents|autonomic agents|mesh-ancestor
102301517|NCT01889602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102301518|NCT01889602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102301519|NCT01889602|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102301520|NCT01889602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102301521|NCT01889602|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102301522|NCT01889602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102301523|NCT01889602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102301524|NCT01889602|GABA Modulators|gaba modulators|mesh-ancestor
102301525|NCT01889602|GABA Agents|gaba agents|mesh-ancestor
102301526|NCT01889602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102301527|NCT01889602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301528|NCT01935700|Colchicine|colchicine|mesh-list
102301529|NCT01935700|Gout Suppressants|gout suppressants|mesh-ancestor
102301530|NCT01935700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102301531|NCT01935700|Tubulin Modulators|tubulin modulators|mesh-ancestor
102301532|NCT01935700|Antimitotic Agents|antimitotic agents|mesh-ancestor
102301533|NCT01935700|Mitosis Modulators|mitosis modulators|mesh-ancestor
102301534|NCT01935700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301535|NCT01935700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102301536|NCT01618162|Liraglutide|liraglutide|mesh-list
102301537|NCT01618162|Xultophy|xultophy|mesh-list
102301538|NCT01618162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102301539|NCT01618162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301540|NCT01618162|Incretins|incretins|mesh-ancestor
102010291|NCT03337282|Anesthetics|anesthetics|mesh-list
102301542|NCT01618162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102301543|NCT04771767|Ketamine|ketamine|mesh-list
102301544|NCT04771767|Analgesics|analgesics|mesh-ancestor
102301545|NCT04771767|Sensory System Agents|sensory system agents|mesh-ancestor
102301546|NCT04771767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102301547|NCT04771767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301548|NCT04771767|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102301549|NCT04771767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102301550|NCT04771767|Anesthetics, General|anesthetics, general|mesh-ancestor
102301551|NCT04771767|Anesthetics|anesthetics|mesh-ancestor
102301552|NCT04771767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102301553|NCT04771767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102301554|NCT04771767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102301555|NCT04771767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102301556|NCT04771767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301557|NCT02341417|Cinacalcet|cinacalcet|mesh-list
102301558|NCT02341417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102301559|NCT02341417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301560|NCT02341417|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
102301561|NCT02341417|Hormone Antagonists|hormone antagonists|mesh-ancestor
102301562|NCT02341417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102301563|NCT02340949|Leucovorin|leucovorin|mesh-list
102301564|NCT02340949|Oxaliplatin|oxaliplatin|mesh-list
102301565|NCT02340949|Aflibercept|aflibercept|mesh-list
102301566|NCT02340949|Fluorouracil|fluorouracil|mesh-list
102301567|NCT02340949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102301568|NCT02340949|Antidotes|antidotes|mesh-ancestor
102301569|NCT02340949|Protective Agents|protective agents|mesh-ancestor
102301570|NCT02340949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301571|NCT02340949|Vitamin B Complex|vitamin b complex|mesh-ancestor
102301572|NCT02340949|Vitamins|vitamins|mesh-ancestor
102301573|NCT02340949|Micronutrients|micronutrients|mesh-ancestor
102301574|NCT02340949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102301575|NCT02340949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102301576|NCT02340949|Growth Substances|growth substances|mesh-ancestor
102301577|NCT02340949|Growth Inhibitors|growth inhibitors|mesh-ancestor
102301578|NCT02340949|Antimetabolites|antimetabolites|mesh-ancestor
102301579|NCT02340949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301580|NCT02340949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102301581|NCT02340949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102301582|NCT02340949|Immunologic Factors|immunologic factors|mesh-ancestor
102301583|NCT02374957|Cilostazol|cilostazol|mesh-list
102301584|NCT02374957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102301585|NCT02374957|Autonomic Agents|autonomic agents|mesh-ancestor
102301586|NCT02374957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102301587|NCT02374957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301588|NCT02374957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102301589|NCT02374957|Respiratory System Agents|respiratory system agents|mesh-ancestor
102301590|NCT02374957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102301591|NCT02374957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102301592|NCT02374957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301593|NCT02374957|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102301594|NCT02374957|Vasodilator Agents|vasodilator agents|mesh-ancestor
102301595|NCT02374957|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102301596|NCT02374957|Protective Agents|protective agents|mesh-ancestor
102301597|NCT02374957|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102301598|NCT02374957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102301599|NCT02374957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102301600|NCT02308033|Metronidazole|metronidazole|mesh-list
102301601|NCT02308033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102301602|NCT02308033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102301603|NCT02308033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102301604|NCT02308033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102301605|NCT02339155|Diphenhydramine|diphenhydramine|mesh-list
102301606|NCT02339155|Promethazine|promethazine|mesh-list
102301607|NCT02339155|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102301608|NCT02339155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102301609|NCT02339155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102301610|NCT02339155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301611|NCT02339155|Anesthetics, Local|anesthetics, local|mesh-ancestor
102301612|NCT02339155|Anesthetics|anesthetics|mesh-ancestor
102301613|NCT02339155|Sensory System Agents|sensory system agents|mesh-ancestor
102301614|NCT02339155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102301615|NCT02339155|Antiemetics|antiemetics|mesh-ancestor
102301616|NCT02339155|Autonomic Agents|autonomic agents|mesh-ancestor
102301617|NCT02339155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102301618|NCT02339155|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102301619|NCT02339155|Histamine Antagonists|histamine antagonists|mesh-ancestor
102301620|NCT02339155|Histamine Agents|histamine agents|mesh-ancestor
102301621|NCT02339155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102301622|NCT02339155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301623|NCT02339155|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102301624|NCT02339155|Antipruritics|antipruritics|mesh-ancestor
102301625|NCT02339155|Dermatologic Agents|dermatologic agents|mesh-ancestor
102301626|NCT02170077|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102301627|NCT02170077|Anticonvulsants|anticonvulsants|mesh-ancestor
102301628|NCT02170077|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102301629|NCT02170077|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102301630|NCT02170077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102301631|NCT02170077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301632|NCT02210091|Factor VIII|factor viii|mesh-list
102301634|NCT02210091|Coagulants|coagulants|mesh-ancestor
102301635|NCT02338999|Pioglitazone|pioglitazone|mesh-list
102301636|NCT02338999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102301637|NCT02338999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301638|NCT02169219|Prednisone|prednisone|mesh-list
102301639|NCT02169219|Rituximab|rituximab|mesh-list
102301640|NCT02169219|Glucocorticoids|glucocorticoids|mesh-list
102301641|NCT02169219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102301642|NCT02169219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102301643|NCT02169219|Immunologic Factors|immunologic factors|mesh-ancestor
102301644|NCT02169219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301645|NCT02169219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102301646|NCT02169219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102301647|NCT02169219|Hormones|hormones|mesh-ancestor
102301648|NCT02169219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102301649|NCT02169219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102301650|NCT02191137|Riociguat|riociguat|mesh-list
102301651|NCT02191137|Enzyme Activators|enzyme activators|mesh-ancestor
102301652|NCT02191137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301653|NCT02168439|Midazolam|midazolam|mesh-list
102301654|NCT02168439|Dexmedetomidine|dexmedetomidine|mesh-list
102301655|NCT02168439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102301656|NCT02168439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102301657|NCT02168439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301658|NCT02168439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102301659|NCT02168439|Analgesics|analgesics|mesh-ancestor
102301660|NCT02168439|Sensory System Agents|sensory system agents|mesh-ancestor
102301661|NCT02168439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102301662|NCT02168439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102301663|NCT02168439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102301664|NCT02168439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102301665|NCT02168439|Adrenergic Agents|adrenergic agents|mesh-ancestor
102301666|NCT02168439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102301667|NCT02168439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301668|NCT02168439|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102301669|NCT02168439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102301670|NCT02168439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102301671|NCT02168439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102301672|NCT02168439|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102301673|NCT02168439|Anesthetics, General|anesthetics, general|mesh-ancestor
102301675|NCT02168439|GABA Modulators|gaba modulators|mesh-ancestor
102301676|NCT02168439|GABA Agents|gaba agents|mesh-ancestor
102301677|NCT02338843|Angiotensin II|angiotensin ii|mesh-list
102301678|NCT02338843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102301679|NCT02135445|Relugolix|relugolix|mesh-list
102301680|NCT02135445|Androgen Antagonists|androgen antagonists|mesh-ancestor
102301681|NCT02135445|Hormone Antagonists|hormone antagonists|mesh-ancestor
102301682|NCT02135445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102301683|NCT02135445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301684|NCT02374099|Azacitidine|azacitidine|mesh-list
102301685|NCT02374099|Fulvestrant|fulvestrant|mesh-list
102301686|NCT02374099|Cc-486|cc-486|mesh-list
102301687|NCT02374099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102301688|NCT02374099|Antimetabolites|antimetabolites|mesh-ancestor
102301689|NCT02374099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301690|NCT02374099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102301691|NCT02374099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102301692|NCT02374099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102301693|NCT02374099|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102301694|NCT02374099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102301695|NCT02374099|Hormone Antagonists|hormone antagonists|mesh-ancestor
102301696|NCT02374099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102301697|NCT02374099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301698|NCT02134977|Leuprolide|leuprolide|mesh-list
102301699|NCT02134977|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102301700|NCT02134977|Fertility Agents|fertility agents|mesh-ancestor
102301701|NCT02134977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102301702|NCT02134977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301703|NCT02134977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102301704|NCT02134977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102301705|NCT02374021|Hydroxychloroquine|hydroxychloroquine|mesh-list
102301706|NCT02374021|Sulfasalazine|sulfasalazine|mesh-list
102301707|NCT02374021|Adalimumab|adalimumab|mesh-list
102301708|NCT02374021|Etanercept|etanercept|mesh-list
102301709|NCT02374021|Methotrexate|methotrexate|mesh-list
102301710|NCT02374021|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102301711|NCT02374021|Abortifacient Agents|abortifacient agents|mesh-ancestor
102301712|NCT02374021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102301713|NCT02374021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301714|NCT02374021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102301715|NCT02374021|Antimetabolites|antimetabolites|mesh-ancestor
102301716|NCT02374021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301717|NCT02374021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102301718|NCT02374021|Dermatologic Agents|dermatologic agents|mesh-ancestor
102301719|NCT02374021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102301720|NCT02374021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102301721|NCT02374021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102301722|NCT02374021|Immunologic Factors|immunologic factors|mesh-ancestor
102301723|NCT02374021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102301724|NCT02374021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102301725|NCT02374021|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102301726|NCT02374021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102301727|NCT02374021|Antimalarials|antimalarials|mesh-ancestor
102301728|NCT02374021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102301729|NCT02374021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102301730|NCT02374021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102301731|NCT02374021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102301732|NCT02374021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102301733|NCT02374021|Analgesics|analgesics|mesh-ancestor
101402747|NCT00090272|Ertapenem|ertapenem|mesh-list
102301734|NCT02374021|Sensory System Agents|sensory system agents|mesh-ancestor
102301735|NCT02374021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102301737|NCT02372383|Azithromycin|azithromycin|mesh-list
102301738|NCT02372383|Rifampin|rifampin|mesh-list
102301739|NCT02372383|Ethambutol|ethambutol|mesh-list
102301740|NCT02372383|Pancrelipase|pancrelipase|mesh-list
102301741|NCT02372383|Pancreatin|pancreatin|mesh-list
102301742|NCT02372383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102301743|NCT02372383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102301744|NCT02372383|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102301745|NCT02372383|Antitubercular Agents|antitubercular agents|mesh-ancestor
102301746|NCT02372383|Leprostatic Agents|leprostatic agents|mesh-ancestor
102301747|NCT02372383|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102301748|NCT02372383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102301749|NCT02372383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301750|NCT02372383|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102301751|NCT02372383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102301752|NCT02372383|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102301753|NCT02372383|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102301754|NCT02372383|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102301755|NCT02372383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102301756|NCT02372383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102301757|NCT01648699|Hydromorphone|hydromorphone|mesh-list
102301758|NCT01648699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102301759|NCT01648699|Narcotics|narcotics|mesh-ancestor
102301760|NCT01648699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102301761|NCT01648699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301762|NCT01648699|Analgesics|analgesics|mesh-ancestor
102301763|NCT01648699|Sensory System Agents|sensory system agents|mesh-ancestor
102301764|NCT01648699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102301765|NCT02134353|Mannitol|mannitol|mesh-list
102301766|NCT02134353|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102301767|NCT02134353|Diuretics|diuretics|mesh-ancestor
102301768|NCT02134353|Natriuretic Agents|natriuretic agents|mesh-ancestor
102301769|NCT02134353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301770|NCT01646125|Docetaxel|docetaxel|mesh-list
102301771|NCT01646125|Pemetrexed|pemetrexed|mesh-list
102301772|NCT01646125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102301773|NCT01646125|Tubulin Modulators|tubulin modulators|mesh-ancestor
102301774|NCT01646125|Antimitotic Agents|antimitotic agents|mesh-ancestor
102301775|NCT01646125|Mitosis Modulators|mitosis modulators|mesh-ancestor
102301776|NCT01646125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301777|NCT01646125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102301778|NCT01646125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102301779|NCT01646125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102301780|NCT01362790|Cyclophosphamide|cyclophosphamide|mesh-list
102301781|NCT01362790|Pentostatin|pentostatin|mesh-list
102301782|NCT01362790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102301783|NCT01362790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102301784|NCT01362790|Immunologic Factors|immunologic factors|mesh-ancestor
102301785|NCT01362790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301786|NCT01362790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102301787|NCT01362790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102301788|NCT01362790|Alkylating Agents|alkylating agents|mesh-ancestor
102301789|NCT01362790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301790|NCT01362790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102301791|NCT01362790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102301792|NCT01362790|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
102301793|NCT01362790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102301794|NCT02167893|Leuprolide|leuprolide|mesh-list
102301795|NCT02167893|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102301796|NCT02167893|Fertility Agents|fertility agents|mesh-ancestor
102301797|NCT02167893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102301798|NCT02167893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301799|NCT02167893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102301800|NCT02167893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402825|NCT00346294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102301801|NCT02167035|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
102301802|NCT02167035|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102301803|NCT02167035|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102301804|NCT02167035|Adrenergic Agents|adrenergic agents|mesh-ancestor
102301805|NCT02167035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102301806|NCT02167035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301807|NCT02167035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941546|NCT01128075|Interferon beta-1a|interferon beta-1a|mesh-list
102301808|NCT02167035|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102301809|NCT02167035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102301810|NCT02167035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102301811|NCT01615198|Olmesartan|olmesartan|mesh-list
102301812|NCT01615198|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102301813|NCT01615198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102301814|NCT01615198|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102301815|NCT01615198|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102301816|NCT01615198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301817|NCT02337907|Donepezil|donepezil|mesh-list
102301818|NCT02337907|BI 409306|bi 409306|mesh-list
102301819|NCT02337907|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102301820|NCT02337907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102301821|NCT02337907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301822|NCT02337907|Cholinergic Agents|cholinergic agents|mesh-ancestor
102301823|NCT02337907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102301824|NCT02337907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301825|NCT02337907|Nootropic Agents|nootropic agents|mesh-ancestor
102301826|NCT02337907|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102301827|NCT01913470|Losartan|losartan|mesh-list
102301828|NCT01913470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102301829|NCT01913470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102301830|NCT01913470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102301831|NCT01913470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102301832|NCT01913470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301833|NCT02166333|Vitamin D|vitamin d|mesh-list
102301834|NCT02166333|Ergocalciferols|ergocalciferols|mesh-list
102301835|NCT02166333|Cholecalciferol|cholecalciferol|mesh-list
102301836|NCT02166333|Vitamins|vitamins|mesh-list
102301837|NCT02166333|Micronutrients|micronutrients|mesh-ancestor
102301838|NCT02166333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301839|NCT02166333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102301840|NCT02166333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102301842|NCT02132949|Docetaxel|docetaxel|mesh-list
102301843|NCT02132949|Cyclophosphamide|cyclophosphamide|mesh-list
102301844|NCT02132949|Doxorubicin|doxorubicin|mesh-list
102301845|NCT02132949|Fluorouracil|fluorouracil|mesh-list
102301846|NCT02132949|Trastuzumab|trastuzumab|mesh-list
102301847|NCT02132949|Epirubicin|epirubicin|mesh-list
102301848|NCT02132949|Pertuzumab|pertuzumab|mesh-list
102301849|NCT02132949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102301850|NCT02132949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102301851|NCT02132949|Tubulin Modulators|tubulin modulators|mesh-ancestor
102301852|NCT02132949|Antimitotic Agents|antimitotic agents|mesh-ancestor
102301853|NCT02132949|Mitosis Modulators|mitosis modulators|mesh-ancestor
102301854|NCT02132949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301855|NCT02132949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102301856|NCT02132949|Immunologic Factors|immunologic factors|mesh-ancestor
102301857|NCT02132949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301858|NCT02132949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102301859|NCT02132949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102301860|NCT02132949|Alkylating Agents|alkylating agents|mesh-ancestor
102301861|NCT02132949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102301862|NCT02132949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102301863|NCT02132949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102301864|NCT02132949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102301865|NCT02132949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102301866|NCT02132949|Antimetabolites|antimetabolites|mesh-ancestor
102301867|NCT02132949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102301868|NCT02132949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102301869|NCT02165397|Rituximab|rituximab|mesh-list
102301870|NCT02165397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102301871|NCT02165397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102301872|NCT02165397|Immunologic Factors|immunologic factors|mesh-ancestor
102301873|NCT02165397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301874|NCT02165397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102301875|NCT02132637|Insulin|insulin|mesh-list
102301876|NCT02132637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102301877|NCT02132637|Insulin Glargine|insulin glargine|mesh-list
102301878|NCT02132637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102301879|NCT02132637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301880|NCT02164929|Acetaminophen|acetaminophen|mesh-list
102301881|NCT02164929|Dexamethasone|dexamethasone|mesh-list
102301882|NCT02164929|Lidocaine|lidocaine|mesh-list
102301883|NCT02164929|Epinephrine|epinephrine|mesh-list
102301884|NCT02164929|Midazolam|midazolam|mesh-list
102301885|NCT02164929|Hydromorphone|hydromorphone|mesh-list
102301886|NCT02164929|Ropivacaine|ropivacaine|mesh-list
102301887|NCT02164929|Propofol|propofol|mesh-list
102301888|NCT02164929|Sevoflurane|sevoflurane|mesh-list
102301889|NCT02164929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102301890|NCT02164929|Antiemetics|antiemetics|mesh-ancestor
102301891|NCT02164929|Autonomic Agents|autonomic agents|mesh-ancestor
102301892|NCT02164929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102301893|NCT02164929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301894|NCT02164929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102301895|NCT02164929|Glucocorticoids|glucocorticoids|mesh-ancestor
102301896|NCT02164929|Hormones|hormones|mesh-ancestor
102301897|NCT02164929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102301898|NCT02164929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102301899|NCT02164929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102301900|NCT02164929|Anesthetics, Local|anesthetics, local|mesh-ancestor
102301901|NCT02164929|Anesthetics|anesthetics|mesh-ancestor
102301902|NCT02164929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102301903|NCT02164929|Sensory System Agents|sensory system agents|mesh-ancestor
102301904|NCT02164929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102301905|NCT02164929|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102301906|NCT02164929|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102301907|NCT02164929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102301908|NCT02164929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301909|NCT02164929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102301910|NCT02164929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102301911|NCT02164929|Anesthetics, General|anesthetics, general|mesh-ancestor
102301912|NCT02164929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102301913|NCT02164929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102301914|NCT02164929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102301915|NCT02164929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102301916|NCT02164929|GABA Modulators|gaba modulators|mesh-ancestor
102301917|NCT02164929|GABA Agents|gaba agents|mesh-ancestor
102301918|NCT02164929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102301919|NCT02164929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102301920|NCT02164929|Analgesics|analgesics|mesh-ancestor
102301921|NCT02164929|Antipyretics|antipyretics|mesh-ancestor
102301922|NCT02164929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102301923|NCT02164929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102301924|NCT02164929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102301925|NCT02164929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102301926|NCT02164929|Adrenergic Agents|adrenergic agents|mesh-ancestor
102301927|NCT02164929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102301928|NCT02164929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102301929|NCT02164929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102301930|NCT02164929|Respiratory System Agents|respiratory system agents|mesh-ancestor
102301931|NCT02164929|Mydriatics|mydriatics|mesh-ancestor
102301932|NCT02164929|Sympathomimetics|sympathomimetics|mesh-ancestor
102301933|NCT02164929|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102301934|NCT02164929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102301935|NCT02164929|Narcotics|narcotics|mesh-ancestor
102301936|NCT01888432|Everolimus|everolimus|mesh-list
102301937|NCT01888432|Tacrolimus|tacrolimus|mesh-list
102301938|NCT01888432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102301939|NCT01888432|Immunologic Factors|immunologic factors|mesh-ancestor
102301940|NCT01888432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301941|NCT01888432|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102301942|NCT01888432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102301943|NCT01888432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301944|NCT01888432|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102301945|NCT01888432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102301946|NCT01888432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102301947|NCT02188719|Acetaminophen|acetaminophen|mesh-list
102301948|NCT02188719|Diphenhydramine|diphenhydramine|mesh-list
102301949|NCT02188719|Promethazine|promethazine|mesh-list
102301950|NCT02188719|Mycophenolic Acid|mycophenolic acid|mesh-list
102301951|NCT02188719|Valganciclovir|valganciclovir|mesh-list
102301952|NCT02188719|Ganciclovir|ganciclovir|mesh-list
102301953|NCT02188719|Anti-Infective Agents|anti-infective agents|mesh-list
102301954|NCT02188719|Prednisone|prednisone|mesh-list
102301955|NCT02188719|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102301956|NCT02188719|Everolimus|everolimus|mesh-list
102301957|NCT02188719|Liver Extracts|liver extracts|mesh-list
102301958|NCT02188719|Tacrolimus|tacrolimus|mesh-list
102301959|NCT02188719|Thymoglobulin|thymoglobulin|mesh-list
102301960|NCT02188719|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102301961|NCT02188719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102301962|NCT02188719|Glucocorticoids|glucocorticoids|mesh-ancestor
102301963|NCT02188719|Hormones|hormones|mesh-ancestor
102301964|NCT02188719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102301965|NCT02188719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102301966|NCT02188719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102301967|NCT02188719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102301968|NCT02188719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102301969|NCT02188719|Immunologic Factors|immunologic factors|mesh-ancestor
102301970|NCT02188719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102301971|NCT02188719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102301972|NCT02188719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102301973|NCT02188719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102301974|NCT02188719|Analgesics|analgesics|mesh-ancestor
102301975|NCT02188719|Sensory System Agents|sensory system agents|mesh-ancestor
102301976|NCT02188719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102301977|NCT02188719|Antipyretics|antipyretics|mesh-ancestor
102301978|NCT02188719|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102301979|NCT02188719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102301980|NCT02188719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102301981|NCT02188719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102301982|NCT02188719|Antitubercular Agents|antitubercular agents|mesh-ancestor
102301983|NCT02188719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102301984|NCT02188719|Hematinics|hematinics|mesh-ancestor
102301985|NCT02188719|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102301986|NCT02188719|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102301987|NCT02188719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102301988|NCT02188719|Anesthetics, Local|anesthetics, local|mesh-ancestor
102301989|NCT02188719|Anesthetics|anesthetics|mesh-ancestor
102301990|NCT02188719|Antiemetics|antiemetics|mesh-ancestor
102301991|NCT02188719|Autonomic Agents|autonomic agents|mesh-ancestor
102301992|NCT02188719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102301993|NCT02188719|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102301994|NCT02188719|Histamine Antagonists|histamine antagonists|mesh-ancestor
102301995|NCT02188719|Histamine Agents|histamine agents|mesh-ancestor
102301996|NCT02188719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102301997|NCT02188719|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102301998|NCT02188719|Antipruritics|antipruritics|mesh-ancestor
102301999|NCT02188719|Dermatologic Agents|dermatologic agents|mesh-ancestor
102302000|NCT02188719|Antiviral Agents|antiviral agents|mesh-ancestor
102302001|NCT02188719|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102302002|NCT02188719|Protective Agents|protective agents|mesh-ancestor
102302003|NCT01933672|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102302004|NCT01933672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102302005|NCT01933672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302007|NCT01933672|Hormones|hormones|mesh-ancestor
102302008|NCT01933672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102302009|NCT01933672|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102302010|NCT01933672|Protease Inhibitors|protease inhibitors|mesh-ancestor
102302011|NCT01933672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102302012|NCT01933672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302013|NCT02132247|Diclofenac|diclofenac|mesh-list
102302014|NCT02132247|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
102302015|NCT02132247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102302016|NCT02132247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102302017|NCT02132247|Analgesics|analgesics|mesh-ancestor
102302018|NCT02132247|Sensory System Agents|sensory system agents|mesh-ancestor
102302019|NCT02132247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102302020|NCT02132247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302021|NCT02132247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102302022|NCT02132247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102302023|NCT02132247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102302024|NCT02132247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102302025|NCT02132247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302026|NCT01629381|Rivaroxaban|rivaroxaban|mesh-list
102302027|NCT01629381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102302028|NCT01629381|Antithrombins|antithrombins|mesh-ancestor
102302029|NCT01629381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102302030|NCT01629381|Protease Inhibitors|protease inhibitors|mesh-ancestor
102302031|NCT01629381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102302032|NCT01629381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302033|NCT01629381|Anticoagulants|anticoagulants|mesh-ancestor
102302034|NCT05269017|Vitamin D|vitamin d|mesh-list
102302035|NCT05269017|Cholecalciferol|cholecalciferol|mesh-list
102302036|NCT05269017|Budesonide|budesonide|mesh-list
102302037|NCT05269017|Vitamins|vitamins|mesh-ancestor
102302038|NCT05269017|Micronutrients|micronutrients|mesh-ancestor
102302039|NCT05269017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302040|NCT05269017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102302041|NCT05269017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102302042|NCT05269017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102302043|NCT05269017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102302044|NCT05269017|Autonomic Agents|autonomic agents|mesh-ancestor
102302045|NCT05269017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102302046|NCT05269017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102302047|NCT05269017|Respiratory System Agents|respiratory system agents|mesh-ancestor
102302048|NCT05269017|Glucocorticoids|glucocorticoids|mesh-ancestor
102302049|NCT05269017|Hormones|hormones|mesh-ancestor
102302050|NCT05269017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102302051|NCT01628913|Everolimus|everolimus|mesh-list
102302052|NCT01628913|Dactolisib|dactolisib|mesh-list
102302053|NCT01628913|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102302054|NCT01628913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102302055|NCT01628913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102302056|NCT01628913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302057|NCT01628913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102302058|NCT01628913|Immunologic Factors|immunologic factors|mesh-ancestor
102302059|NCT01628913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302060|NCT01628913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102302061|NCT02164383|Nicotine|nicotine|mesh-list
102302062|NCT02164383|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102302063|NCT02164383|Autonomic Agents|autonomic agents|mesh-ancestor
102302064|NCT02164383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102302065|NCT02164383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302066|NCT02164383|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102302067|NCT02164383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102302068|NCT02164383|Cholinergic Agents|cholinergic agents|mesh-ancestor
102302069|NCT02164383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102302070|NCT02164383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302071|NCT02131233|Raltegravir Potassium|raltegravir potassium|mesh-list
102302072|NCT02131233|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102302073|NCT02131233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102302074|NCT02131233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102302075|NCT02131233|Antiviral Agents|antiviral agents|mesh-ancestor
102302076|NCT02131233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102302077|NCT02131233|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102302078|NCT02131233|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102302079|NCT02131233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102302080|NCT02131233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302081|NCT02131233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102302082|NCT02131233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102302083|NCT02131155|Afatinib|afatinib|mesh-list
102302084|NCT02131155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102302085|NCT02131155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102302086|NCT02131155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102302087|NCT02131155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302088|NCT01933594|Romidepsin|romidepsin|mesh-list
102302089|NCT01933594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102302090|NCT01933594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102302091|NCT01933594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102302092|NCT01933594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102302093|NCT01933594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302094|NCT01912768|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102302095|NCT02305849|Methotrexate|methotrexate|mesh-list
102302096|NCT02305849|Peficitinib|peficitinib|mesh-list
102302097|NCT02305849|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102302098|NCT02305849|Abortifacient Agents|abortifacient agents|mesh-ancestor
102302099|NCT02305849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102302100|NCT02305849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302101|NCT02305849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102302102|NCT02305849|Antimetabolites|antimetabolites|mesh-ancestor
102302103|NCT02305849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302104|NCT02305849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102302105|NCT02305849|Dermatologic Agents|dermatologic agents|mesh-ancestor
102302106|NCT02305849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102302107|NCT02305849|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102302108|NCT02305849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102302109|NCT02305849|Immunologic Factors|immunologic factors|mesh-ancestor
102302110|NCT02305849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102302111|NCT02305849|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102302112|NCT02371759|Anesthetics|anesthetics|mesh-list
102302113|NCT02371759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102302114|NCT02371759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302116|NCT02531633|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102302117|NCT02531633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102302118|NCT02531633|Glucocorticoids|glucocorticoids|mesh-ancestor
102302119|NCT02531633|Hormones|hormones|mesh-ancestor
102302120|NCT02531633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102302121|NCT02531633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302122|NCT02531633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102302123|NCT02531633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102302124|NCT02531633|Immunologic Factors|immunologic factors|mesh-ancestor
102302125|NCT02536313|Sofosbuvir|sofosbuvir|mesh-list
102302126|NCT02536313|Velpatasvir|velpatasvir|mesh-list
102302127|NCT02536313|Antiviral Agents|antiviral agents|mesh-ancestor
102302128|NCT02536313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102302129|NCT05412875|Nicotine|nicotine|mesh-list
102302130|NCT05412875|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102302131|NCT05412875|Autonomic Agents|autonomic agents|mesh-ancestor
102302132|NCT05412875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102302133|NCT05412875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302134|NCT05412875|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102302135|NCT05412875|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102302136|NCT05412875|Cholinergic Agents|cholinergic agents|mesh-ancestor
102302137|NCT05412875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102302138|NCT05412875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302139|NCT02187861|Rituximab|rituximab|mesh-list
102302140|NCT02187861|Venetoclax|venetoclax|mesh-list
102302141|NCT02187861|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102302142|NCT02187861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102302143|NCT02187861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102302144|NCT02187861|Immunologic Factors|immunologic factors|mesh-ancestor
102302145|NCT02187861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302146|NCT02187861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102302147|NCT02187861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102302148|NCT02187861|Alkylating Agents|alkylating agents|mesh-ancestor
102302149|NCT02187861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302150|NCT05379179|Fentanyl|fentanyl|mesh-list
102302151|NCT05379179|Ketamine|ketamine|mesh-list
102302152|NCT05379179|Analgesics|analgesics|mesh-ancestor
102302153|NCT05379179|Sensory System Agents|sensory system agents|mesh-ancestor
102302154|NCT05379179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102302155|NCT05379179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302156|NCT05379179|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102302157|NCT05379179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102302158|NCT05379179|Anesthetics, General|anesthetics, general|mesh-ancestor
102302159|NCT05379179|Anesthetics|anesthetics|mesh-ancestor
102302160|NCT05379179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102302161|NCT05379179|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102302162|NCT05379179|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102302163|NCT05379179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102302164|NCT05379179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302165|NCT05379179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102302166|NCT05379179|Narcotics|narcotics|mesh-ancestor
102302167|NCT05379179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102302168|NCT05383001|Durvalumab|durvalumab|mesh-list
102302169|NCT05383001|Tremelimumab|tremelimumab|mesh-list
102302170|NCT05383001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102302171|NCT05383001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102302172|NCT02527421|Betamethasone|betamethasone|mesh-list
102302173|NCT02527421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102302174|NCT02527421|Glucocorticoids|glucocorticoids|mesh-ancestor
102302175|NCT02527421|Hormones|hormones|mesh-ancestor
102302176|NCT02527421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102302177|NCT02527421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302178|NCT02527421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102302179|NCT02527421|Respiratory System Agents|respiratory system agents|mesh-ancestor
102302180|NCT05610371|Lidocaine|lidocaine|mesh-list
102302181|NCT05610371|Anesthetics, Local|anesthetics, local|mesh-ancestor
102302182|NCT05610371|Anesthetics|anesthetics|mesh-ancestor
102302183|NCT05610371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102302184|NCT05610371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302185|NCT05610371|Sensory System Agents|sensory system agents|mesh-ancestor
102302186|NCT05610371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102302187|NCT05610371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102302188|NCT05610371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102302189|NCT05610371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102302190|NCT05610371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102302191|NCT05610371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302192|NCT02163759|Adalimumab|adalimumab|mesh-list
102302193|NCT02163759|Etrolizumab|etrolizumab|mesh-list
102302194|NCT02163759|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102302195|NCT02163759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102302196|NCT02163759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102302197|NCT02163759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102302198|NCT02163759|Immunologic Factors|immunologic factors|mesh-ancestor
102302199|NCT02163759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302200|NCT02336737|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
102302201|NCT02336737|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102302202|NCT02336737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302203|NCT02163447|Pyrimethamine|pyrimethamine|mesh-list
102302204|NCT02163447|Piperaquine|piperaquine|mesh-list
102302205|NCT02163447|Sulfadoxine|sulfadoxine|mesh-list
102302206|NCT02163447|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
102302207|NCT02163447|Artenimol|artenimol|mesh-list
102302208|NCT02163447|Artemisinins|artemisinins|mesh-list
102302209|NCT02163447|Antimalarials|antimalarials|mesh-ancestor
102302210|NCT02163447|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102302211|NCT02163447|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102302212|NCT02163447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102302213|NCT02163447|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102302214|NCT02163447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102302215|NCT02163447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302216|NCT02163447|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102302217|NCT01887418|Methyltestosterone|methyltestosterone|mesh-list
102302218|NCT01887418|Testosterone|testosterone|mesh-list
102302219|NCT01887418|Testosterone undecanoate|testosterone undecanoate|mesh-list
102302220|NCT01887418|Testosterone enanthate|testosterone enanthate|mesh-list
102302221|NCT01887418|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102302222|NCT01887418|Androgens|androgens|mesh-ancestor
102302223|NCT01887418|Hormones|hormones|mesh-ancestor
102302224|NCT01887418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102302225|NCT01887418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302226|NCT01887418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102302227|NCT01887418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102302228|NCT01887418|Anabolic Agents|anabolic agents|mesh-ancestor
102302229|NCT01912612|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102302230|NCT01912612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102302231|NCT01912612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102302232|NCT01912612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102302233|NCT01912612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302234|NCT01912612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102302235|NCT01912612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302236|NCT01912612|Analgesics|analgesics|mesh-ancestor
102302237|NCT01912612|Sensory System Agents|sensory system agents|mesh-ancestor
102302238|NCT01912612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102302239|NCT01912612|Antidepressive Agents|antidepressive agents|mesh-ancestor
102302240|NCT01912612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102302241|NCT01912612|Dopamine Agents|dopamine agents|mesh-ancestor
102302242|NCT02302807|Paclitaxel|paclitaxel|mesh-list
102302243|NCT02302807|Docetaxel|docetaxel|mesh-list
102302244|NCT02302807|Atezolizumab|atezolizumab|mesh-list
102302245|NCT02302807|Antibodies|antibodies|mesh-list
102302246|NCT02302807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102302247|NCT02302807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102302248|NCT02302807|Tubulin Modulators|tubulin modulators|mesh-ancestor
102302249|NCT02302807|Antimitotic Agents|antimitotic agents|mesh-ancestor
102302250|NCT02302807|Mitosis Modulators|mitosis modulators|mesh-ancestor
102302251|NCT02302807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302252|NCT02302807|Immunologic Factors|immunologic factors|mesh-ancestor
102302253|NCT02302807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302254|NCT02302807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102302255|NCT02302807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102302256|NCT01931566|Pioglitazone|pioglitazone|mesh-list
102302257|NCT01931566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102302258|NCT01931566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302259|NCT05372939|Adalimumab|adalimumab|mesh-list
102302260|NCT05372939|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102302261|NCT05372939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102302262|NCT05372939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102302263|NCT01912456|Complement C1s|complement c1s|mesh-list
102302264|NCT01912456|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
102302265|NCT01912456|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
102302266|NCT01912456|Immunologic Factors|immunologic factors|mesh-ancestor
102302267|NCT01912456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302268|NCT01912456|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102302269|NCT01912456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102302270|NCT04251065|Daratumumab|daratumumab|mesh-list
102302271|NCT04251065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102302272|NCT01885936|Albuterol|albuterol|mesh-list
102302273|NCT01885936|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102302274|NCT01885936|Autonomic Agents|autonomic agents|mesh-ancestor
102302275|NCT01885936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102302276|NCT01885936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302277|NCT01885936|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102302278|NCT01885936|Respiratory System Agents|respiratory system agents|mesh-ancestor
102302279|NCT01885936|Tocolytic Agents|tocolytic agents|mesh-ancestor
102302280|NCT01885936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102302281|NCT01885936|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102302282|NCT01885936|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102302283|NCT01885936|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102302284|NCT01885936|Adrenergic Agents|adrenergic agents|mesh-ancestor
102302285|NCT01885936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102302286|NCT01885936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302287|NCT05305859|Azacitidine|azacitidine|mesh-list
102302288|NCT05305859|Venetoclax|venetoclax|mesh-list
102302289|NCT05305859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102302290|NCT05305859|Antimetabolites|antimetabolites|mesh-ancestor
102302291|NCT05305859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302292|NCT05305859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102011043|NCT01304069|Etoricoxib|etoricoxib|mesh-list
102302293|NCT05305859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102302294|NCT05368415|Norepinephrine|norepinephrine|mesh-list
102302296|NCT05368415|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102302297|NCT05368415|Adrenergic Agents|adrenergic agents|mesh-ancestor
102302298|NCT05368415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102302299|NCT05368415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302300|NCT05368415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302301|NCT05368415|Sympathomimetics|sympathomimetics|mesh-ancestor
102302302|NCT05368415|Autonomic Agents|autonomic agents|mesh-ancestor
102302303|NCT05368415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102302304|NCT05368415|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102302305|NCT05529173|Povidone-Iodine|povidone-iodine|mesh-list
102302306|NCT05529173|Povidone|povidone|mesh-list
102302307|NCT05529173|Plasma Substitutes|plasma substitutes|mesh-ancestor
102302308|NCT05529173|Blood Substitutes|blood substitutes|mesh-ancestor
102302309|NCT05529173|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102302310|NCT05529173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102302311|NCT05335109|Xenon|xenon|mesh-list
102302312|NCT05335109|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102302313|NCT05335109|Anesthetics, General|anesthetics, general|mesh-ancestor
102302314|NCT05335109|Anesthetics|anesthetics|mesh-ancestor
102302315|NCT05335109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102302316|NCT05335109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302317|NCT05300087|Albuterol|albuterol|mesh-list
102302318|NCT05300087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102302319|NCT05300087|Autonomic Agents|autonomic agents|mesh-ancestor
102302320|NCT05300087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102302321|NCT05300087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302322|NCT05300087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102302323|NCT05300087|Respiratory System Agents|respiratory system agents|mesh-ancestor
102302324|NCT05300087|Tocolytic Agents|tocolytic agents|mesh-ancestor
102302325|NCT05300087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102302326|NCT05300087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102302327|NCT05300087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102302328|NCT05300087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102302329|NCT05300087|Adrenergic Agents|adrenergic agents|mesh-ancestor
102302330|NCT05300087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102302331|NCT05300087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302332|NCT05333237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102302333|NCT01912222|Ixazomib|ixazomib|mesh-list
102302334|NCT01912222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102302335|NCT01912222|Protease Inhibitors|protease inhibitors|mesh-ancestor
102302336|NCT01912222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102302337|NCT01912222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302338|NCT05366933|Folic Acid|folic acid|mesh-list
102302339|NCT05366933|Vitamin B Complex|vitamin b complex|mesh-list
102302340|NCT05366933|Vitamins|vitamins|mesh-ancestor
102302341|NCT05366933|Micronutrients|micronutrients|mesh-ancestor
102302342|NCT05366933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302343|NCT05366933|Hematinics|hematinics|mesh-ancestor
102302344|NCT04250207|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102302345|NCT05500703|Dexmedetomidine|dexmedetomidine|mesh-list
102302346|NCT05500703|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102302347|NCT05500703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102302348|NCT05500703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302349|NCT05500703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102302350|NCT05500703|Analgesics|analgesics|mesh-ancestor
102302351|NCT05500703|Sensory System Agents|sensory system agents|mesh-ancestor
102302352|NCT05500703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102302353|NCT05500703|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102302354|NCT05500703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102302355|NCT05500703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102302356|NCT05500703|Adrenergic Agents|adrenergic agents|mesh-ancestor
102302357|NCT05500703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102302358|NCT05500703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302359|NCT04246151|Vancomycin|vancomycin|mesh-list
102302360|NCT04246151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102302361|NCT04246151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102302362|NCT05331521|Vincristine|vincristine|mesh-list
102302363|NCT05331521|Temozolomide|temozolomide|mesh-list
102302364|NCT05331521|Lomustine|lomustine|mesh-list
102302365|NCT05331521|Procarbazine|procarbazine|mesh-list
102302366|NCT05331521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102302367|NCT05331521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102302368|NCT05331521|Tubulin Modulators|tubulin modulators|mesh-ancestor
102302369|NCT05331521|Antimitotic Agents|antimitotic agents|mesh-ancestor
102302370|NCT05331521|Mitosis Modulators|mitosis modulators|mesh-ancestor
102302371|NCT05331521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302372|NCT05331521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102302373|NCT05331521|Alkylating Agents|alkylating agents|mesh-ancestor
102302374|NCT02525861|Protease Inhibitors|protease inhibitors|mesh-list
102302375|NCT02525861|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
102302376|NCT02525861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102302377|NCT02525861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302378|NCT02525861|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102302379|NCT02525861|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102302380|NCT02524847|Methoxsalen|methoxsalen|mesh-list
102302381|NCT02524847|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102302382|NCT02524847|Dermatologic Agents|dermatologic agents|mesh-ancestor
102302383|NCT04422275|Budesonide|budesonide|mesh-list
102302384|NCT04422275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102302385|NCT04422275|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102302386|NCT04422275|Autonomic Agents|autonomic agents|mesh-ancestor
102302387|NCT04422275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102302388|NCT04422275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302389|NCT04422275|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102302390|NCT04422275|Respiratory System Agents|respiratory system agents|mesh-ancestor
102302391|NCT04422275|Glucocorticoids|glucocorticoids|mesh-ancestor
102302392|NCT04422275|Hormones|hormones|mesh-ancestor
102302393|NCT04422275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102302394|NCT05361941|Tobramycin|tobramycin|mesh-list
102302395|NCT05361941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102302396|NCT05361941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102302397|NCT05290025|Nicotine|nicotine|mesh-list
102302398|NCT05290025|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102302399|NCT05290025|Autonomic Agents|autonomic agents|mesh-ancestor
102302400|NCT05290025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102302401|NCT05290025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302402|NCT05290025|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102302403|NCT05290025|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102302404|NCT05290025|Cholinergic Agents|cholinergic agents|mesh-ancestor
102302405|NCT05290025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102302406|NCT05290025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302407|NCT05324735|Pentoxifylline|pentoxifylline|mesh-list
102302408|NCT05324735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102302409|NCT05324735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102302410|NCT05324735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302411|NCT05324735|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102302412|NCT05324735|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102302413|NCT05324735|Protective Agents|protective agents|mesh-ancestor
102302414|NCT05324735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302415|NCT05324735|Vasodilator Agents|vasodilator agents|mesh-ancestor
102302416|NCT05324735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102302417|NCT05324735|Antioxidants|antioxidants|mesh-ancestor
102302418|NCT05359055|Itraconazole|itraconazole|mesh-list
102302419|NCT05359055|Rifampin|rifampin|mesh-list
102302420|NCT05359055|Antifungal Agents|antifungal agents|mesh-ancestor
102302421|NCT05359055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102302422|NCT05359055|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102302423|NCT05359055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102302424|NCT05359055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102302425|NCT05359055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302426|NCT05359055|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102302427|NCT05359055|Hormone Antagonists|hormone antagonists|mesh-ancestor
102302428|NCT05359055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102302429|NCT05359055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302430|NCT05359055|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102302431|NCT05359055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102302432|NCT05359055|Antitubercular Agents|antitubercular agents|mesh-ancestor
102302433|NCT05359055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102302434|NCT05359055|Leprostatic Agents|leprostatic agents|mesh-ancestor
102302435|NCT05359055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102302436|NCT05359055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102302437|NCT05359055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102302438|NCT05359055|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102302439|NCT05359055|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102302440|NCT05359055|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102302441|NCT05359055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102302442|NCT02524379|Glyburide|glyburide|mesh-list
102011190|NCT03714815|Macitentan|macitentan|mesh-list
102302443|NCT02524379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102302444|NCT02524379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302445|NCT02524145|Isoproterenol|isoproterenol|mesh-list
102302446|NCT02524145|Glycopyrrolate|glycopyrrolate|mesh-list
102302447|NCT02524145|Dexmedetomidine|dexmedetomidine|mesh-list
102302448|NCT02524145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102302449|NCT02524145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102302450|NCT02524145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302451|NCT02524145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102302452|NCT02524145|Analgesics|analgesics|mesh-ancestor
102302453|NCT02524145|Sensory System Agents|sensory system agents|mesh-ancestor
102302454|NCT02524145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102302455|NCT02524145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102302456|NCT02524145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102302457|NCT02524145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102302458|NCT02524145|Adrenergic Agents|adrenergic agents|mesh-ancestor
102302459|NCT02524145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102302460|NCT02524145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302461|NCT02524145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102302462|NCT02524145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102302463|NCT02524145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102302464|NCT02524145|Cholinergic Agents|cholinergic agents|mesh-ancestor
102302465|NCT02524145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102302466|NCT02524145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102302467|NCT02524145|Autonomic Agents|autonomic agents|mesh-ancestor
102302468|NCT02524145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102302469|NCT02524145|Respiratory System Agents|respiratory system agents|mesh-ancestor
102302470|NCT02524145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102302471|NCT02524145|Sympathomimetics|sympathomimetics|mesh-ancestor
102302472|NCT02524145|Protective Agents|protective agents|mesh-ancestor
102302473|NCT05357417|Bevacizumab|bevacizumab|mesh-list
102302474|NCT05357417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102302475|NCT05357417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102302476|NCT05357417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102302477|NCT05357417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102302478|NCT05357417|Growth Substances|growth substances|mesh-ancestor
102302479|NCT05357417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302480|NCT05357417|Growth Inhibitors|growth inhibitors|mesh-ancestor
102302481|NCT01658813|Interferons|interferons|mesh-list
102302482|NCT01658813|Fluorouracil|fluorouracil|mesh-list
102302483|NCT01658813|Antimetabolites|antimetabolites|mesh-ancestor
102302484|NCT01658813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302485|NCT01658813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102302486|NCT01658813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101306538|NCT02026050|Protease Inhibitors|protease inhibitors|mesh-ancestor
102302487|NCT01658813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102302488|NCT01658813|Immunologic Factors|immunologic factors|mesh-ancestor
102302489|NCT01658813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302490|NCT01658813|Antiviral Agents|antiviral agents|mesh-ancestor
102302491|NCT01658813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102302492|NCT02187471|Pregabalin|pregabalin|mesh-list
102302493|NCT02187471|Analgesics|analgesics|mesh-ancestor
102302494|NCT02187471|Sensory System Agents|sensory system agents|mesh-ancestor
102302495|NCT02187471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102302496|NCT02187471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302497|NCT02187471|Anticonvulsants|anticonvulsants|mesh-ancestor
102302498|NCT02187471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102302499|NCT02187471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102302500|NCT02187471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302501|NCT02187471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102302502|NCT02187471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102302503|NCT02187471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102302504|NCT02187471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102302505|NCT02187471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102302507|NCT02525471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102302508|NCT02525471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102302509|NCT02525471|Analgesics|analgesics|mesh-ancestor
102302510|NCT02525471|Sensory System Agents|sensory system agents|mesh-ancestor
102302511|NCT02525471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102302512|NCT02525471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302513|NCT02525471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102302514|NCT02525471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102302515|NCT02525471|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102302516|NCT05284409|Acetaminophen|acetaminophen|mesh-list
102302517|NCT05284409|Dexamethasone|dexamethasone|mesh-list
102302518|NCT05284409|Meperidine|meperidine|mesh-list
102302519|NCT05284409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102302520|NCT05284409|Antiemetics|antiemetics|mesh-ancestor
102302521|NCT05284409|Autonomic Agents|autonomic agents|mesh-ancestor
102302522|NCT05284409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102302523|NCT05284409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302524|NCT05284409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102302525|NCT05284409|Glucocorticoids|glucocorticoids|mesh-ancestor
102302526|NCT05284409|Hormones|hormones|mesh-ancestor
102302527|NCT05284409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102302528|NCT05284409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102302529|NCT05284409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102302530|NCT05284409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102302531|NCT05284409|Analgesics|analgesics|mesh-ancestor
102302532|NCT05284409|Sensory System Agents|sensory system agents|mesh-ancestor
102302533|NCT05284409|Antipyretics|antipyretics|mesh-ancestor
102302534|NCT05284409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102302535|NCT05284409|Narcotics|narcotics|mesh-ancestor
102302536|NCT05284409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102302537|NCT05284409|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102302538|NCT02523599|Bupivacaine|bupivacaine|mesh-list
102302539|NCT02523599|Anesthetics, Local|anesthetics, local|mesh-ancestor
102302540|NCT02523599|Anesthetics|anesthetics|mesh-ancestor
102302541|NCT02523599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102302542|NCT02523599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302543|NCT02523599|Sensory System Agents|sensory system agents|mesh-ancestor
102302544|NCT02523599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102302545|NCT05296577|Vinorelbine|vinorelbine|mesh-list
102302546|NCT05296577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102302547|NCT05296577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102302548|NCT05296577|Tubulin Modulators|tubulin modulators|mesh-ancestor
102302549|NCT05296577|Antimitotic Agents|antimitotic agents|mesh-ancestor
102302550|NCT05296577|Mitosis Modulators|mitosis modulators|mesh-ancestor
102302551|NCT05296577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302552|NCT05354999|Caffeine|caffeine|mesh-list
102302553|NCT05354999|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102302554|NCT05354999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302555|NCT05354999|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102302556|NCT05354999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102302557|NCT05354999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302558|NCT05354999|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102302559|NCT05354999|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102302560|NCT05354999|Purinergic Agents|purinergic agents|mesh-ancestor
102302561|NCT05354999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102302562|NCT02187159|Pregabalin|pregabalin|mesh-list
102302563|NCT02187159|Analgesics|analgesics|mesh-ancestor
102302564|NCT02187159|Sensory System Agents|sensory system agents|mesh-ancestor
102302565|NCT02187159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102302566|NCT02187159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302567|NCT02187159|Anticonvulsants|anticonvulsants|mesh-ancestor
102302568|NCT02187159|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102302569|NCT02187159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102302570|NCT02187159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302571|NCT02187159|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102302572|NCT02187159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102302573|NCT02187159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102302574|NCT02187159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102302575|NCT02187159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102302576|NCT02335411|Pembrolizumab|pembrolizumab|mesh-list
102302577|NCT02335411|Capecitabine|capecitabine|mesh-list
102302578|NCT02335411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102302579|NCT02335411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102302580|NCT02335411|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102302581|NCT02335411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302582|NCT02335411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102302583|NCT02335411|Antimetabolites|antimetabolites|mesh-ancestor
102302584|NCT02186301|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102302585|NCT02186301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102302586|NCT02186301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102302587|NCT02186301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102302588|NCT02186301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302589|NCT02161731|Warfarin|warfarin|mesh-list
102302590|NCT02161731|Evacetrapib|evacetrapib|mesh-list
102011339|NCT04051970|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102302591|NCT02161731|Anticoagulants|anticoagulants|mesh-ancestor
102302592|NCT02161731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102302593|NCT02161731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102302594|NCT02161731|Antimetabolites|antimetabolites|mesh-ancestor
102302595|NCT02161731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302596|NCT02161731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102302597|NCT02124759|Sevelamer|sevelamer|mesh-list
102302598|NCT02124759|Chelating Agents|chelating agents|mesh-ancestor
102302599|NCT02124759|Sequestering Agents|sequestering agents|mesh-ancestor
102302600|NCT02124759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302601|NCT02302339|Pembrolizumab|pembrolizumab|mesh-list
102302602|NCT02302339|Nivolumab|nivolumab|mesh-list
102302603|NCT02302339|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
102302604|NCT02302339|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102302605|NCT02302339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102302606|NCT02302339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102302607|NCT02302339|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102302608|NCT02302339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302609|NCT02302339|Immunoconjugates|immunoconjugates|mesh-ancestor
102302610|NCT02302339|Immunologic Factors|immunologic factors|mesh-ancestor
102302611|NCT02302339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302612|NCT04895917|Daratumumab|daratumumab|mesh-list
102302613|NCT04895917|Pomalidomide|pomalidomide|mesh-list
102302614|NCT04895917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102302615|NCT04895917|Immunologic Factors|immunologic factors|mesh-ancestor
102302616|NCT04895917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302617|NCT04895917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102302618|NCT04895917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102302619|NCT04895917|Growth Substances|growth substances|mesh-ancestor
102302620|NCT04895917|Growth Inhibitors|growth inhibitors|mesh-ancestor
102302621|NCT02161575|Ranibizumab|ranibizumab|mesh-list
102302622|NCT02161575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102302623|NCT02161575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102302624|NCT02161575|Growth Substances|growth substances|mesh-ancestor
102302625|NCT02161575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302626|NCT02161575|Growth Inhibitors|growth inhibitors|mesh-ancestor
102302627|NCT02161575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102302628|NCT02161185|Midazolam|midazolam|mesh-list
102302629|NCT02161185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102302630|NCT02161185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102302631|NCT02161185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102302632|NCT02161185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302633|NCT02161185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102302634|NCT02161185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102302636|NCT02161185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102302637|NCT02161185|Anesthetics, General|anesthetics, general|mesh-ancestor
102302638|NCT02161185|Anesthetics|anesthetics|mesh-ancestor
102302639|NCT02161185|GABA Modulators|gaba modulators|mesh-ancestor
102302640|NCT02161185|GABA Agents|gaba agents|mesh-ancestor
102302641|NCT02161185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102302642|NCT02161185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302643|NCT02159469|Methyltestosterone|methyltestosterone|mesh-list
102302644|NCT02159469|Testosterone|testosterone|mesh-list
102302645|NCT02159469|Testosterone undecanoate|testosterone undecanoate|mesh-list
102302646|NCT02159469|Testosterone enanthate|testosterone enanthate|mesh-list
102302647|NCT02159469|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102302648|NCT02159469|Androgens|androgens|mesh-ancestor
102302649|NCT02159469|Hormones|hormones|mesh-ancestor
102302650|NCT02159469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102302651|NCT02159469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302652|NCT02159469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102302653|NCT02159469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102302654|NCT02159469|Anabolic Agents|anabolic agents|mesh-ancestor
102302655|NCT02123511|Acetylcysteine|acetylcysteine|mesh-list
102302656|NCT02123511|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102302657|NCT02123511|Antiviral Agents|antiviral agents|mesh-ancestor
102302658|NCT02123511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102302659|NCT02123511|Expectorants|expectorants|mesh-ancestor
102302660|NCT02123511|Respiratory System Agents|respiratory system agents|mesh-ancestor
102302661|NCT02123511|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102302662|NCT02123511|Antioxidants|antioxidants|mesh-ancestor
102302663|NCT02123511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302664|NCT02123511|Protective Agents|protective agents|mesh-ancestor
102302665|NCT02123511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302666|NCT02123511|Antidotes|antidotes|mesh-ancestor
102302667|NCT04746339|Apixaban|apixaban|mesh-list
102302668|NCT04746339|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102302669|NCT04746339|Antithrombins|antithrombins|mesh-ancestor
102302670|NCT04746339|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102302671|NCT04746339|Protease Inhibitors|protease inhibitors|mesh-ancestor
102302672|NCT04746339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102302673|NCT04746339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302674|NCT04746339|Anticoagulants|anticoagulants|mesh-ancestor
102302675|NCT02301403|Nicotine|nicotine|mesh-list
102302676|NCT02301403|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102302677|NCT02301403|Autonomic Agents|autonomic agents|mesh-ancestor
102302678|NCT02301403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102302679|NCT02301403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302680|NCT02301403|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102302681|NCT02301403|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102302682|NCT02301403|Cholinergic Agents|cholinergic agents|mesh-ancestor
102302683|NCT02301403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102302684|NCT02301403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302685|NCT02333383|Adalimumab|adalimumab|mesh-list
102302686|NCT02333383|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102302687|NCT02333383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102302688|NCT02333383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102302689|NCT02369341|Vaccines|vaccines|mesh-list
102302690|NCT02369341|Immunologic Factors|immunologic factors|mesh-ancestor
102302691|NCT02369341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302692|NCT02121795|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102302693|NCT02121795|Antiviral Agents|antiviral agents|mesh-ancestor
102302694|NCT02121795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102302695|NCT02158533|Naltrexone|naltrexone|mesh-list
102302696|NCT02158533|Buprenorphine|buprenorphine|mesh-list
102302697|NCT02158533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102302698|NCT02158533|Narcotics|narcotics|mesh-ancestor
102302699|NCT02158533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102302700|NCT02158533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302701|NCT02158533|Analgesics|analgesics|mesh-ancestor
102302702|NCT02158533|Sensory System Agents|sensory system agents|mesh-ancestor
102302703|NCT02158533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102302704|NCT02158533|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102302705|NCT02158533|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102302706|NCT02120469|Everolimus|everolimus|mesh-list
102302707|NCT02120469|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102302708|NCT02120469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102302709|NCT02120469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102302710|NCT02120469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302711|NCT02120469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102302712|NCT02120469|Immunologic Factors|immunologic factors|mesh-ancestor
102302713|NCT02120469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302714|NCT02120469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102302715|NCT02180061|Pembrolizumab|pembrolizumab|mesh-list
102302716|NCT02180061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102302717|NCT02180061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102302718|NCT02180061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102302719|NCT02180061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302720|NCT02120157|Mycophenolic Acid|mycophenolic acid|mesh-list
102302721|NCT02120157|Cyclophosphamide|cyclophosphamide|mesh-list
102302722|NCT02120157|Busulfan|busulfan|mesh-list
102302723|NCT02120157|Tacrolimus|tacrolimus|mesh-list
102302724|NCT02120157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102302725|NCT02120157|Immunologic Factors|immunologic factors|mesh-ancestor
102302726|NCT02120157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302727|NCT02120157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102302728|NCT02120157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102302729|NCT02120157|Alkylating Agents|alkylating agents|mesh-ancestor
102302730|NCT02120157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302731|NCT02120157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102302732|NCT02120157|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102302733|NCT02120157|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102302734|NCT02120157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102302735|NCT02120157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102302736|NCT02120157|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102302737|NCT02120157|Antitubercular Agents|antitubercular agents|mesh-ancestor
102302738|NCT02120157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102302739|NCT02120157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102302740|NCT01365455|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102302741|NCT01365455|Immunologic Factors|immunologic factors|mesh-ancestor
102302742|NCT01365455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302743|NCT02155881|Ciclesonide|ciclesonide|mesh-list
102011495|NCT02601014|Nivolumab|nivolumab|mesh-list
102302744|NCT02155881|Glucocorticoids|glucocorticoids|mesh-ancestor
102302745|NCT02155881|Hormones|hormones|mesh-ancestor
102302746|NCT02155881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102302747|NCT02155881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302748|NCT02155881|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102302749|NCT05279807|Amlodipine|amlodipine|mesh-list
102302750|NCT05279807|Zofenopril|zofenopril|mesh-list
102302751|NCT05279807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102302752|NCT05279807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102302753|NCT05279807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102302754|NCT05279807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302755|NCT05279807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102302756|NCT05279807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302757|NCT05279807|Vasodilator Agents|vasodilator agents|mesh-ancestor
102302758|NCT05279807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102302759|NCT05279807|Protease Inhibitors|protease inhibitors|mesh-ancestor
102302760|NCT05279807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102302761|NCT05319431|Lenvatinib|lenvatinib|mesh-list
102302762|NCT05319431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102302763|NCT05319431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102302764|NCT05319431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102302765|NCT05319431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302766|NCT05276531|Progesterone|progesterone|mesh-list
102302767|NCT05276531|Progestins|progestins|mesh-ancestor
102302768|NCT05276531|Hormones|hormones|mesh-ancestor
102302769|NCT05276531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102302770|NCT05276531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302771|NCT01658579|Insulin|insulin|mesh-list
102302772|NCT01658579|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102302773|NCT01658579|Insulin Glargine|insulin glargine|mesh-list
102302774|NCT01658579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102302775|NCT01658579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302776|NCT05561309|Ropivacaine|ropivacaine|mesh-list
102302777|NCT05561309|Anesthetics, Local|anesthetics, local|mesh-ancestor
102302778|NCT05561309|Anesthetics|anesthetics|mesh-ancestor
102302779|NCT05561309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102302780|NCT05561309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302781|NCT05561309|Sensory System Agents|sensory system agents|mesh-ancestor
102302782|NCT05561309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102302783|NCT05268497|Antidepressive Agents|antidepressive agents|mesh-list
102302784|NCT05268497|Esketamine|esketamine|mesh-list
102302785|NCT05268497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102302786|NCT05266859|Calcium|calcium|mesh-list
102302787|NCT05266859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102302788|NCT05266859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302790|NCT05346731|Ondansetron|ondansetron|mesh-list
102302791|NCT05346731|Olanzapine|olanzapine|mesh-list
102302792|NCT05346731|Aprepitant|aprepitant|mesh-list
102302793|NCT05346731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102302794|NCT05346731|Antiemetics|antiemetics|mesh-ancestor
102302795|NCT05346731|Autonomic Agents|autonomic agents|mesh-ancestor
102302796|NCT05346731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102302797|NCT05346731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302798|NCT05346731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102302799|NCT05346731|Glucocorticoids|glucocorticoids|mesh-ancestor
102302800|NCT05346731|Hormones|hormones|mesh-ancestor
102302801|NCT05346731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102302802|NCT05346731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101306558|NCT02026479|Dexamethasone|dexamethasone|mesh-list
102302803|NCT05346731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102302804|NCT05346731|Antipruritics|antipruritics|mesh-ancestor
102302805|NCT05346731|Dermatologic Agents|dermatologic agents|mesh-ancestor
102302806|NCT05346731|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102302807|NCT05346731|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102302808|NCT05346731|Serotonin Agents|serotonin agents|mesh-ancestor
102302809|NCT05346731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102302810|NCT05346731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302811|NCT05346731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102302812|NCT05346731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102302813|NCT05346731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102302814|NCT05346731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102302815|NCT05346731|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102302816|NCT05346731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102302817|NCT05346731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102011591|NCT01334502|Prednisone|prednisone|mesh-list
102302818|NCT05346731|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102302819|NCT02118597|Interferons|interferons|mesh-list
102302820|NCT02118597|Ribavirin|ribavirin|mesh-list
102302821|NCT02118597|Simeprevir|simeprevir|mesh-list
102302822|NCT02118597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102302823|NCT02118597|Antiviral Agents|antiviral agents|mesh-ancestor
102302824|NCT02118597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102302825|NCT02118597|Antimetabolites|antimetabolites|mesh-ancestor
102302826|NCT02118597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302827|NCT02118597|Protease Inhibitors|protease inhibitors|mesh-ancestor
102302828|NCT02118597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102302829|NCT05218889|Paclitaxel|paclitaxel|mesh-list
102302830|NCT05218889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102302831|NCT05218889|Gemcitabine|gemcitabine|mesh-list
102302832|NCT05218889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102302833|NCT05218889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102302834|NCT05218889|Tubulin Modulators|tubulin modulators|mesh-ancestor
102302835|NCT05218889|Antimitotic Agents|antimitotic agents|mesh-ancestor
102302836|NCT05218889|Mitosis Modulators|mitosis modulators|mesh-ancestor
102302837|NCT05218889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302838|NCT05218889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102302839|NCT05218889|Antimetabolites|antimetabolites|mesh-ancestor
102302840|NCT02117349|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102302841|NCT02117349|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
102302842|NCT02117349|Hemostatics|hemostatics|mesh-ancestor
102302843|NCT02117349|Coagulants|coagulants|mesh-ancestor
102302844|NCT02177175|Carvedilol|carvedilol|mesh-list
102302845|NCT02177175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102302846|NCT02177175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102302847|NCT02177175|Adrenergic Agents|adrenergic agents|mesh-ancestor
102302848|NCT02177175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102302849|NCT02177175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302850|NCT02177175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302851|NCT02177175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102302852|NCT02177175|Antioxidants|antioxidants|mesh-ancestor
102302853|NCT02177175|Protective Agents|protective agents|mesh-ancestor
102302854|NCT02177175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102302855|NCT02177175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102302856|NCT02177175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102302857|NCT02177175|Vasodilator Agents|vasodilator agents|mesh-ancestor
102302858|NCT02177175|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102302859|NCT02177175|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102302860|NCT01657877|Calcium|calcium|mesh-list
102302861|NCT01657877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102302863|NCT05254925|Sunscreening Agents|sunscreening agents|mesh-list
102302864|NCT05254925|Petrolatum|petrolatum|mesh-list
102302865|NCT05254925|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102302866|NCT05254925|Protective Agents|protective agents|mesh-ancestor
102302867|NCT05254925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302868|NCT05254925|Dermatologic Agents|dermatologic agents|mesh-ancestor
102302869|NCT05254925|Emollients|emollients|mesh-ancestor
102302870|NCT05205473|Lidocaine|lidocaine|mesh-list
102302871|NCT05205473|Anesthetics|anesthetics|mesh-list
102302872|NCT05205473|Anesthetics, Local|anesthetics, local|mesh-ancestor
102302873|NCT05205473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102302874|NCT05205473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417898|NCT00159120|Antipsychotic Agents|antipsychotic agents|mesh-list
102302875|NCT05205473|Sensory System Agents|sensory system agents|mesh-ancestor
102302876|NCT05205473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102302877|NCT05205473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102302878|NCT05205473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102302879|NCT05205473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102302880|NCT05205473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102302881|NCT05205473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302882|NCT05253053|Paclitaxel|paclitaxel|mesh-list
102302883|NCT05253053|Atezolizumab|atezolizumab|mesh-list
102302884|NCT05253053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102302885|NCT05253053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102302886|NCT05253053|Tubulin Modulators|tubulin modulators|mesh-ancestor
102302887|NCT05253053|Antimitotic Agents|antimitotic agents|mesh-ancestor
102302888|NCT05253053|Mitosis Modulators|mitosis modulators|mesh-ancestor
102302889|NCT05253053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302890|NCT05253053|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102302891|NCT05253053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102302892|NCT04422197|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102302893|NCT04422197|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102302894|NCT04422197|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102302895|NCT04422197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102302896|NCT04422197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302897|NCT04422197|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102302898|NCT04422197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102302899|NCT04422197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302900|NCT04422197|Cholinergic Agents|cholinergic agents|mesh-ancestor
102302901|NCT04422197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102302902|NCT05252429|Docetaxel|docetaxel|mesh-list
102302903|NCT05252429|Pembrolizumab|pembrolizumab|mesh-list
102302904|NCT05252429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102302905|NCT05252429|Tubulin Modulators|tubulin modulators|mesh-ancestor
102302906|NCT05252429|Antimitotic Agents|antimitotic agents|mesh-ancestor
102302907|NCT05252429|Mitosis Modulators|mitosis modulators|mesh-ancestor
102302908|NCT05252429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302909|NCT05252429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102302910|NCT05252429|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102302911|NCT02175771|Fluticasone|fluticasone|mesh-list
102302912|NCT02175771|Xhance|xhance|mesh-list
102302913|NCT02175771|Albuterol|albuterol|mesh-list
102302914|NCT02175771|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102302915|NCT02175771|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102302916|NCT02175771|Adrenergic Agonists|adrenergic agonists|mesh-list
102302917|NCT02175771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102302918|NCT02175771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102302919|NCT02175771|Autonomic Agents|autonomic agents|mesh-ancestor
102302920|NCT02175771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102302921|NCT02175771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302922|NCT02175771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102302923|NCT02175771|Respiratory System Agents|respiratory system agents|mesh-ancestor
102302924|NCT02175771|Dermatologic Agents|dermatologic agents|mesh-ancestor
102302925|NCT02175771|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102302926|NCT02175771|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102302927|NCT02175771|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102302928|NCT02175771|Adrenergic Agents|adrenergic agents|mesh-ancestor
102302929|NCT02175771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102302930|NCT02175771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302931|NCT02175771|Tocolytic Agents|tocolytic agents|mesh-ancestor
102302932|NCT02175771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102302933|NCT02175771|Glucocorticoids|glucocorticoids|mesh-ancestor
102302935|NCT02175771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102302936|NCT02175771|Sympathomimetics|sympathomimetics|mesh-ancestor
102302937|NCT01657799|Veliparib|veliparib|mesh-list
102302938|NCT01657799|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102302939|NCT01657799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102302940|NCT01657799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302941|NCT01657799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102302942|NCT02116803|Fulvestrant|fulvestrant|mesh-list
102302943|NCT02116803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102302944|NCT02116803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102302945|NCT02116803|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102302946|NCT02116803|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102302947|NCT02116803|Hormone Antagonists|hormone antagonists|mesh-ancestor
102302948|NCT02116803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102302949|NCT02116803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302950|NCT02115321|Grazoprevir|grazoprevir|mesh-list
102302951|NCT02115321|Antiviral Agents|antiviral agents|mesh-ancestor
102302952|NCT02115321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102302953|NCT05248841|Insulin Glargine|insulin glargine|mesh-list
102302954|NCT05248841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102302955|NCT05248841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302956|NCT05248139|Prednisolone|prednisolone|mesh-list
102302957|NCT05248139|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102302958|NCT05248139|Methylprednisolone|methylprednisolone|mesh-list
102302959|NCT05248139|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102302960|NCT05248139|Prednisolone acetate|prednisolone acetate|mesh-list
102302961|NCT05248139|Triamcinolone|triamcinolone|mesh-list
102302962|NCT05248139|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102302963|NCT05248139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102302964|NCT05248139|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102302965|NCT05248139|Prednisolone phosphate|prednisolone phosphate|mesh-list
102302966|NCT05248139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102302967|NCT05248139|Glucocorticoids|glucocorticoids|mesh-ancestor
102302969|NCT05248139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102302970|NCT05248139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302971|NCT05248139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102302972|NCT05248139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102302973|NCT05248139|Antiemetics|antiemetics|mesh-ancestor
102302974|NCT05248139|Autonomic Agents|autonomic agents|mesh-ancestor
102302975|NCT05248139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102302976|NCT05248139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102302977|NCT05248139|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102302978|NCT05248139|Protective Agents|protective agents|mesh-ancestor
102302979|NCT05248139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102302980|NCT05248139|Immunologic Factors|immunologic factors|mesh-ancestor
102302981|NCT05248139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102302982|NCT05247125|Melatonin|melatonin|mesh-list
102302983|NCT05247125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302984|NCT05247125|Antioxidants|antioxidants|mesh-ancestor
102302985|NCT05247125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102302986|NCT05247125|Protective Agents|protective agents|mesh-ancestor
102302987|NCT05247125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102302988|NCT05154383|Vaccines|vaccines|mesh-list
102302989|NCT05154383|Immunologic Factors|immunologic factors|mesh-ancestor
102302990|NCT05154383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302991|NCT05196815|Dobutamine|dobutamine|mesh-list
102302992|NCT05196815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102302993|NCT05196815|Sympathomimetics|sympathomimetics|mesh-ancestor
102302994|NCT05196815|Autonomic Agents|autonomic agents|mesh-ancestor
102302995|NCT05196815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102302996|NCT05196815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102302997|NCT05196815|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102302998|NCT05196815|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102302999|NCT05196815|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102303000|NCT05196815|Adrenergic Agents|adrenergic agents|mesh-ancestor
102303001|NCT05196815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102303002|NCT05196815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303003|NCT05196815|Protective Agents|protective agents|mesh-ancestor
102303004|NCT05245877|Enoxaparin|enoxaparin|mesh-list
102303005|NCT05245877|Dalteparin|dalteparin|mesh-list
102303006|NCT05245877|Tinzaparin|tinzaparin|mesh-list
102303007|NCT05245877|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102303008|NCT05245877|Anticoagulants|anticoagulants|mesh-ancestor
102303009|NCT05245877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102303010|NCT05245877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102303011|NCT05245877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303012|NCT05149781|Antihypertensive Agents|antihypertensive agents|mesh-list
102303013|NCT02367781|Paclitaxel|paclitaxel|mesh-list
102303014|NCT02367781|Carboplatin|carboplatin|mesh-list
102303015|NCT02367781|Pemetrexed|pemetrexed|mesh-list
102303016|NCT02367781|Atezolizumab|atezolizumab|mesh-list
102303017|NCT02367781|Antibodies|antibodies|mesh-list
102303018|NCT02367781|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102303019|NCT02367781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102303020|NCT02367781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102303021|NCT02367781|Tubulin Modulators|tubulin modulators|mesh-ancestor
102303022|NCT02367781|Antimitotic Agents|antimitotic agents|mesh-ancestor
102303023|NCT02367781|Mitosis Modulators|mitosis modulators|mesh-ancestor
102303024|NCT02367781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303025|NCT02367781|Immunologic Factors|immunologic factors|mesh-ancestor
102303026|NCT02367781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303027|NCT02367781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102303028|NCT02367781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102303029|NCT02367781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102303030|NCT02367781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102303031|NCT02367781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102303032|NCT05191277|Antidepressive Agents|antidepressive agents|mesh-list
102303033|NCT05191277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102303034|NCT04242173|Cemiplimab|cemiplimab|mesh-list
102303035|NCT04242173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102303036|NCT04242173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102303037|NCT05239091|Lidocaine|lidocaine|mesh-list
102303038|NCT05239091|Anesthetics, Local|anesthetics, local|mesh-list
102303039|NCT05239091|Anesthetics|anesthetics|mesh-list
102303040|NCT05239091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102303041|NCT05239091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303042|NCT05239091|Sensory System Agents|sensory system agents|mesh-ancestor
102303043|NCT05239091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102303044|NCT05239091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102303045|NCT05239091|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102303046|NCT05239091|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102303047|NCT05239091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102303048|NCT05239091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303049|NCT02152371|Metformin|metformin|mesh-list
102303050|NCT02152371|Insulin Glargine|insulin glargine|mesh-list
102303051|NCT02152371|Dulaglutide|dulaglutide|mesh-list
102303052|NCT02152371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102303053|NCT02152371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303054|NCT02332291|Bupropion|bupropion|mesh-list
102303055|NCT02332291|Escitalopram|escitalopram|mesh-list
102303056|NCT02332291|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102303057|NCT02332291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102303058|NCT02332291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102303059|NCT02332291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303060|NCT02332291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102303061|NCT02332291|Serotonin Agents|serotonin agents|mesh-ancestor
102303062|NCT02332291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303063|NCT02332291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102303064|NCT02332291|Antidepressive Agents|antidepressive agents|mesh-ancestor
102303065|NCT02332291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102303066|NCT02332291|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102303067|NCT02332291|Dopamine Agents|dopamine agents|mesh-ancestor
102303068|NCT02332291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102303069|NCT02332291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102303070|NCT02332291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102303071|NCT01656395|Montelukast|montelukast|mesh-list
102303072|NCT01656395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102303073|NCT01656395|Respiratory System Agents|respiratory system agents|mesh-ancestor
102303074|NCT01656395|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102303075|NCT01656395|Hormone Antagonists|hormone antagonists|mesh-ancestor
102303076|NCT01656395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102303077|NCT01656395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303078|NCT01656395|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102303079|NCT01656395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102303080|NCT01656395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303081|NCT02114931|Adalimumab|adalimumab|mesh-list
102303082|NCT02114931|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102303083|NCT02114931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102303084|NCT02114931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102303085|NCT05185739|Pembrolizumab|pembrolizumab|mesh-list
102303086|NCT05185739|Lenvatinib|lenvatinib|mesh-list
102303087|NCT05185739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102303088|NCT05185739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102303089|NCT05185739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102303090|NCT05185739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303091|NCT05185739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102303092|NCT05185739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102303093|NCT05237687|Sirolimus|sirolimus|mesh-list
102303094|NCT05237687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102303095|NCT05237687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102303096|NCT05237687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102303097|NCT05237687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102303098|NCT05237687|Antifungal Agents|antifungal agents|mesh-ancestor
102303099|NCT05237687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102303100|NCT05237687|Immunologic Factors|immunologic factors|mesh-ancestor
102303101|NCT05237687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303102|NCT01657019|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102303103|NCT01657019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102303104|NCT01657019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303105|NCT01657019|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102303106|NCT01657019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102303107|NCT01657019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102303108|NCT01657019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303109|NCT01657019|Dopamine Agents|dopamine agents|mesh-ancestor
102303110|NCT01657019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102303111|NCT05181605|Folfirinox|folfirinox|mesh-list
102303112|NCT05181605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102303113|NCT02300311|Nicotinic Acids|nicotinic acids|mesh-list
102303114|NCT02300311|Capsaicin|capsaicin|mesh-list
102303115|NCT02300311|Nonivamide|nonivamide|mesh-list
102303116|NCT02300311|Vitamin B Complex|vitamin b complex|mesh-ancestor
102303117|NCT02300311|Vitamins|vitamins|mesh-ancestor
102303118|NCT02300311|Micronutrients|micronutrients|mesh-ancestor
102303119|NCT02300311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303120|NCT02300311|Sensory System Agents|sensory system agents|mesh-ancestor
102303121|NCT02300311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102303122|NCT02300311|Antipruritics|antipruritics|mesh-ancestor
102303123|NCT02300311|Dermatologic Agents|dermatologic agents|mesh-ancestor
102303124|NCT05141903|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102303125|NCT05141903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102303126|NCT05140499|Bupivacaine|bupivacaine|mesh-list
102303127|NCT05140499|Anesthetics, Local|anesthetics, local|mesh-ancestor
102303128|NCT05140499|Anesthetics|anesthetics|mesh-ancestor
102303129|NCT05140499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102303130|NCT05140499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303131|NCT05140499|Sensory System Agents|sensory system agents|mesh-ancestor
102303132|NCT05140499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102303133|NCT04229381|Coal Tar|coal tar|mesh-list
102303134|NCT04229381|Keratolytic Agents|keratolytic agents|mesh-ancestor
102303135|NCT04229381|Dermatologic Agents|dermatologic agents|mesh-ancestor
102303136|NCT05178485|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102303137|NCT05178485|Bupivacaine|bupivacaine|mesh-list
102303138|NCT05178485|Anesthetics, Local|anesthetics, local|mesh-ancestor
102303139|NCT05178485|Anesthetics|anesthetics|mesh-ancestor
102303140|NCT05178485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102303141|NCT05178485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303142|NCT05178485|Sensory System Agents|sensory system agents|mesh-ancestor
102303143|NCT05178485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102303144|NCT05178485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102303145|NCT05178485|Glucocorticoids|glucocorticoids|mesh-ancestor
102303146|NCT05178485|Hormones|hormones|mesh-ancestor
102303147|NCT05178485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102303148|NCT05178485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102303149|NCT05178485|Immunologic Factors|immunologic factors|mesh-ancestor
102303150|NCT05228951|Trastuzumab|trastuzumab|mesh-list
102303151|NCT05228951|Letrozole|letrozole|mesh-list
102303152|NCT05228951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102303153|NCT05228951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102303154|NCT05228951|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102303155|NCT05228951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102303156|NCT05228951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102303157|NCT05228951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303158|NCT05228951|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102303159|NCT05228951|Hormone Antagonists|hormone antagonists|mesh-ancestor
102303160|NCT05228951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102303161|NCT05228951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303162|NCT05227937|Amikacin|amikacin|mesh-list
102303163|NCT05227937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102303164|NCT05227937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102303165|NCT05174039|Miglustat|miglustat|mesh-list
102303166|NCT05174039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102303167|NCT05174039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303168|NCT05174039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102303169|NCT05174039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102303170|NCT05174039|Antiviral Agents|antiviral agents|mesh-ancestor
102303171|NCT05174039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102303172|NCT05174039|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102303173|NCT05174039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102303174|NCT05174039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303175|NCT05138549|Beta Carotene|beta carotene|mesh-list
102303176|NCT05138549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303177|NCT05138549|Provitamins|provitamins|mesh-ancestor
102303178|NCT05138549|Vitamins|vitamins|mesh-ancestor
102303179|NCT05138549|Micronutrients|micronutrients|mesh-ancestor
102303180|NCT02175225|Deferoxamine|deferoxamine|mesh-list
102303181|NCT02175225|Siderophores|siderophores|mesh-ancestor
102303182|NCT02175225|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102303183|NCT02175225|Chelating Agents|chelating agents|mesh-ancestor
102303184|NCT02175225|Sequestering Agents|sequestering agents|mesh-ancestor
102303185|NCT02175225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303186|NCT05170841|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
102303187|NCT05170841|Tramadol|tramadol|mesh-list
102303188|NCT05170841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102303189|NCT05170841|Narcotics|narcotics|mesh-ancestor
102303190|NCT05170841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102303191|NCT05170841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303192|NCT05170841|Analgesics|analgesics|mesh-ancestor
102303193|NCT05170841|Sensory System Agents|sensory system agents|mesh-ancestor
102303194|NCT05170841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102303195|NCT05170841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102303196|NCT05170841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102303197|NCT05170841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102303198|NCT05170841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102303200|NCT05135273|Immunologic Factors|immunologic factors|mesh-ancestor
102303201|NCT05135273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303202|NCT02299375|Albuterol|albuterol|mesh-list
102303203|NCT02299375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102303204|NCT02299375|Autonomic Agents|autonomic agents|mesh-ancestor
102303205|NCT02299375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102303206|NCT02299375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303207|NCT02299375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102303208|NCT02299375|Respiratory System Agents|respiratory system agents|mesh-ancestor
102303209|NCT02299375|Tocolytic Agents|tocolytic agents|mesh-ancestor
102303210|NCT02299375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102303211|NCT02299375|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102303212|NCT02299375|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102303213|NCT02299375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102303214|NCT02299375|Adrenergic Agents|adrenergic agents|mesh-ancestor
102303215|NCT02299375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102303216|NCT02299375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303217|NCT02151591|Varenicline|varenicline|mesh-list
102303218|NCT02151591|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102303219|NCT02151591|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102303220|NCT02151591|Cholinergic Agents|cholinergic agents|mesh-ancestor
102303221|NCT02151591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102303222|NCT02151591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303223|NCT02151591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303224|NCT02174523|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102303225|NCT02174523|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102303226|NCT02174523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102303227|NCT02174523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102303228|NCT02174523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303229|NCT02174523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102303230|NCT02174523|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102303231|NCT02174523|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102303232|NCT02174523|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102303233|NCT02174523|Adrenergic Agents|adrenergic agents|mesh-ancestor
102303234|NCT02174523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102303235|NCT02174523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303236|NCT02174523|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102303237|NCT02174523|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102303238|NCT02174523|Serotonin Agents|serotonin agents|mesh-ancestor
102303239|NCT02174523|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102303240|NCT02174523|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102303241|NCT02174523|Dopamine Agents|dopamine agents|mesh-ancestor
102303242|NCT04881799|Topiramate|topiramate|mesh-list
102303243|NCT04881799|Phentermine|phentermine|mesh-list
102303244|NCT04881799|Anticonvulsants|anticonvulsants|mesh-ancestor
102303245|NCT04881799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102303246|NCT04881799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303247|NCT04881799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102303248|NCT04881799|Appetite Depressants|appetite depressants|mesh-ancestor
102303249|NCT04881799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102303250|NCT04881799|Sympathomimetics|sympathomimetics|mesh-ancestor
102303251|NCT04881799|Autonomic Agents|autonomic agents|mesh-ancestor
102303252|NCT04881799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102303253|NCT04881799|Adrenergic Agents|adrenergic agents|mesh-ancestor
102303254|NCT04881799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102303255|NCT04881799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303256|NCT02297815|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102303257|NCT02297815|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102303258|NCT02297815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102303259|NCT02297815|Antitubercular Agents|antitubercular agents|mesh-ancestor
102303260|NCT02114385|Vaccines|vaccines|mesh-list
102303261|NCT02114385|Immunologic Factors|immunologic factors|mesh-ancestor
102303262|NCT02114385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303263|NCT05098457|Lidocaine|lidocaine|mesh-list
102303264|NCT05098457|Anesthetics, Local|anesthetics, local|mesh-ancestor
102303265|NCT05098457|Anesthetics|anesthetics|mesh-ancestor
102303266|NCT05098457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102303267|NCT05098457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303268|NCT05098457|Sensory System Agents|sensory system agents|mesh-ancestor
102303269|NCT05098457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102303270|NCT05098457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102303271|NCT05098457|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102303272|NCT05098457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102303273|NCT05098457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102303274|NCT05098457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303276|NCT02114151|Simeprevir|simeprevir|mesh-list
102303277|NCT02114151|Antiviral Agents|antiviral agents|mesh-ancestor
102303278|NCT02114151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102303279|NCT02114151|Protease Inhibitors|protease inhibitors|mesh-ancestor
102303280|NCT02114151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102303281|NCT02114151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303282|NCT05220293|Betamethasone|betamethasone|mesh-list
102303283|NCT05220293|Betamethasone Valerate|betamethasone valerate|mesh-list
102303284|NCT05220293|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102303285|NCT05220293|Betamethasone benzoate|betamethasone benzoate|mesh-list
102303286|NCT05220293|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102303287|NCT05220293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102303288|NCT05220293|Glucocorticoids|glucocorticoids|mesh-ancestor
102303289|NCT05220293|Hormones|hormones|mesh-ancestor
102303290|NCT05220293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102303291|NCT05220293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303292|NCT05220293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102303293|NCT05220293|Respiratory System Agents|respiratory system agents|mesh-ancestor
102303294|NCT02297503|Botulinum Toxins|botulinum toxins|mesh-list
102303295|NCT02297503|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102303296|NCT02297503|Hyaluronic Acid|hyaluronic acid|mesh-list
102303297|NCT02297503|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102303298|NCT02297503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102303299|NCT02297503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303300|NCT02297503|Cholinergic Agents|cholinergic agents|mesh-ancestor
102303301|NCT02297503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102303302|NCT02297503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303303|NCT02297503|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102303304|NCT02297503|Immunologic Factors|immunologic factors|mesh-ancestor
102303305|NCT02297503|Viscosupplements|viscosupplements|mesh-ancestor
102303306|NCT02297503|Protective Agents|protective agents|mesh-ancestor
102303307|NCT02366767|Insulin|insulin|mesh-list
102303308|NCT02366767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102303309|NCT02366767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303310|NCT02149875|Cerebrolysin|cerebrolysin|mesh-list
102303311|NCT02149875|3-n-butylphthalide|3-n-butylphthalide|mesh-list
102303312|NCT02149875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102303313|NCT02149875|Protective Agents|protective agents|mesh-ancestor
102303314|NCT02149875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303315|NCT02149875|Nootropic Agents|nootropic agents|mesh-ancestor
102303316|NCT02149875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102303317|NCT05124899|Sunscreening Agents|sunscreening agents|mesh-list
102303318|NCT05124899|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102303319|NCT05124899|Protective Agents|protective agents|mesh-ancestor
102303320|NCT05124899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303321|NCT05124899|Dermatologic Agents|dermatologic agents|mesh-ancestor
102303322|NCT05093621|Torsemide|torsemide|mesh-list
102303323|NCT05093621|Furosemide|furosemide|mesh-list
102303324|NCT05093621|Diuretics|diuretics|mesh-ancestor
102303325|NCT05093621|Natriuretic Agents|natriuretic agents|mesh-ancestor
102303326|NCT05093621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303327|NCT05093621|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102303328|NCT05093621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102303329|NCT05093621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303330|NCT05093621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102303331|NCT02112045|Melphalan|melphalan|mesh-list
102303332|NCT02112045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102303333|NCT02112045|Alkylating Agents|alkylating agents|mesh-ancestor
102303334|NCT02112045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303335|NCT02112045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102303336|NCT02112045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102303337|NCT02112045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102303338|NCT02112045|Immunologic Factors|immunologic factors|mesh-ancestor
102303339|NCT02112045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303340|NCT02147691|Azelaic acid|azelaic acid|mesh-list
102012089|NCT01332552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102303341|NCT02147691|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102303342|NCT02147691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102303343|NCT02147691|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102303344|NCT02147691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102303345|NCT02147691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102303346|NCT02147691|Adrenergic Agents|adrenergic agents|mesh-ancestor
102303347|NCT02147691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102303348|NCT02147691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303349|NCT02147691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303350|NCT02147691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102303351|NCT02147691|Dermatologic Agents|dermatologic agents|mesh-ancestor
102303352|NCT01655693|Doxorubicin|doxorubicin|mesh-list
102303353|NCT01655693|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102303354|NCT01655693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102303355|NCT01655693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102303356|NCT01655693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102303357|NCT01655693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102303358|NCT01655693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102303359|NCT01655693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303360|NCT05090657|Chlorhexidine|chlorhexidine|mesh-list
102303361|NCT05090657|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102303362|NCT05090657|Methylene Blue|methylene blue|mesh-list
102303363|NCT05090657|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102303364|NCT05090657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102303365|NCT05090657|Disinfectants|disinfectants|mesh-ancestor
102303366|NCT05090657|Dermatologic Agents|dermatologic agents|mesh-ancestor
102303367|NCT05090657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102303368|NCT05090657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303369|NCT05048849|Somatomedin B|somatomedin b|mesh-list
102303370|NCT05048849|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102303371|NCT05048849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102303372|NCT05048849|Protease Inhibitors|protease inhibitors|mesh-ancestor
102303373|NCT05048849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102303374|NCT05048849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303375|NCT01656161|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102303376|NCT01656161|Luteolytic Agents|luteolytic agents|mesh-ancestor
102303377|NCT01656161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102303378|NCT01656161|Contraceptive Agents|contraceptive agents|mesh-ancestor
102303379|NCT01656161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102303380|NCT01656161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303381|NCT01656161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102303382|NCT01656161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102303383|NCT01656161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102303384|NCT05046431|Golimumab|golimumab|mesh-list
102303385|NCT05046431|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102303386|NCT05046431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102303387|NCT05046431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102303388|NCT05046431|Immunologic Factors|immunologic factors|mesh-ancestor
102303389|NCT05046431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303390|NCT04751877|Dexamethasone|dexamethasone|mesh-list
102303391|NCT04751877|Lenalidomide|lenalidomide|mesh-list
102303392|NCT04751877|Bortezomib|bortezomib|mesh-list
102303393|NCT04751877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102303394|NCT04751877|Antiemetics|antiemetics|mesh-ancestor
102303395|NCT04751877|Autonomic Agents|autonomic agents|mesh-ancestor
102303396|NCT04751877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102303397|NCT04751877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303398|NCT04751877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102303399|NCT04751877|Glucocorticoids|glucocorticoids|mesh-ancestor
102303400|NCT04751877|Hormones|hormones|mesh-ancestor
102303401|NCT04751877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102303402|NCT04751877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102303403|NCT04751877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102303404|NCT04751877|Immunologic Factors|immunologic factors|mesh-ancestor
102303405|NCT04751877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102303406|NCT04751877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102303407|NCT04751877|Growth Substances|growth substances|mesh-ancestor
102303408|NCT04751877|Growth Inhibitors|growth inhibitors|mesh-ancestor
102303409|NCT02147067|Ranolazine|ranolazine|mesh-list
102303410|NCT02147067|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102303411|NCT02147067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102303412|NCT02147067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303413|NCT02107131|Ranibizumab|ranibizumab|mesh-list
102303414|NCT02107131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102012165|NCT01338090|Everolimus|everolimus|mesh-list
102303415|NCT02107131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102303416|NCT02107131|Growth Substances|growth substances|mesh-ancestor
102303417|NCT02107131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303418|NCT02107131|Growth Inhibitors|growth inhibitors|mesh-ancestor
102303419|NCT02107131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102303420|NCT02106975|Ascorbic Acid|ascorbic acid|mesh-list
102303421|NCT02106975|Vitamins|vitamins|mesh-ancestor
102303422|NCT02106975|Micronutrients|micronutrients|mesh-ancestor
101418508|NCT00154167|Adrenergic Agents|adrenergic agents|mesh-ancestor
102303423|NCT02106975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303424|NCT02106975|Antioxidants|antioxidants|mesh-ancestor
102303425|NCT02106975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303426|NCT02106975|Protective Agents|protective agents|mesh-ancestor
102303427|NCT05133765|Insulin|insulin|mesh-list
102303428|NCT05133765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102303429|NCT05133765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303430|NCT02520011|Cytarabine|cytarabine|mesh-list
102303431|NCT02520011|Mitoxantrone|mitoxantrone|mesh-list
102303432|NCT02520011|Alvocidib|alvocidib|mesh-list
102303433|NCT02520011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102303434|NCT02520011|Antimetabolites|antimetabolites|mesh-ancestor
102303435|NCT02520011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303436|NCT02520011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102303437|NCT02520011|Antiviral Agents|antiviral agents|mesh-ancestor
102303438|NCT02520011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102303439|NCT02520011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102303440|NCT02520011|Immunologic Factors|immunologic factors|mesh-ancestor
102303441|NCT02520011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303442|NCT02520011|Analgesics|analgesics|mesh-ancestor
102303443|NCT02520011|Sensory System Agents|sensory system agents|mesh-ancestor
102303444|NCT02520011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102303445|NCT02520011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102303446|NCT02520011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102303447|NCT02520011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102303448|NCT02520011|Growth Inhibitors|growth inhibitors|mesh-ancestor
102303449|NCT02520011|Growth Substances|growth substances|mesh-ancestor
102303450|NCT02520011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102303451|NCT05037539|Fentanyl|fentanyl|mesh-list
102303452|NCT05037539|Morphine|morphine|mesh-list
102303453|NCT05037539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102303454|NCT05037539|Narcotics|narcotics|mesh-ancestor
102303455|NCT05037539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102303456|NCT05037539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303457|NCT05037539|Analgesics|analgesics|mesh-ancestor
102303458|NCT05037539|Sensory System Agents|sensory system agents|mesh-ancestor
102303459|NCT05037539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102303460|NCT05037539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102303461|NCT05037539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102303462|NCT05037539|Anesthetics, General|anesthetics, general|mesh-ancestor
102303464|NCT02519231|Naproxen|naproxen|mesh-list
102303465|NCT02519231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102303466|NCT02519231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102303467|NCT02519231|Analgesics|analgesics|mesh-ancestor
102303468|NCT02519231|Sensory System Agents|sensory system agents|mesh-ancestor
102303469|NCT02519231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102303470|NCT02519231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303471|NCT02519231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102303472|NCT02519231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102303473|NCT02519231|Gout Suppressants|gout suppressants|mesh-ancestor
102303474|NCT02519231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102303475|NCT02519231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102303476|NCT02519231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303477|NCT02106351|Botulinum Toxins|botulinum toxins|mesh-list
102303478|NCT02106351|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102303479|NCT02106351|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102303480|NCT02106351|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102303481|NCT02106351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102303482|NCT02106351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303483|NCT02106351|Cholinergic Agents|cholinergic agents|mesh-ancestor
102303484|NCT02106351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102303485|NCT02106351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303486|NCT02106351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102303487|NCT02106351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102303488|NCT02075073|Trastuzumab|trastuzumab|mesh-list
102303489|NCT02075073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102303490|NCT02075073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102303491|NCT01364597|Brivaracetam|brivaracetam|mesh-list
102303492|NCT01364597|Anticonvulsants|anticonvulsants|mesh-ancestor
102303493|NCT04738149|Bimatoprost|bimatoprost|mesh-list
102303494|NCT04738149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102303495|NCT04995497|Lidocaine|lidocaine|mesh-list
102303496|NCT04995497|Anesthetics, Local|anesthetics, local|mesh-ancestor
102303497|NCT04995497|Anesthetics|anesthetics|mesh-ancestor
102303498|NCT04995497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102303499|NCT04995497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303500|NCT04995497|Sensory System Agents|sensory system agents|mesh-ancestor
102303501|NCT04995497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102303502|NCT04995497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102303503|NCT04995497|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102303504|NCT04995497|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102303505|NCT04995497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102303506|NCT04995497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303507|NCT05060627|Dexamethasone|dexamethasone|mesh-list
102303508|NCT05060627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102303509|NCT05060627|Antiemetics|antiemetics|mesh-ancestor
102303510|NCT05060627|Autonomic Agents|autonomic agents|mesh-ancestor
102303511|NCT05060627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102303512|NCT05060627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303513|NCT05060627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102303514|NCT05060627|Glucocorticoids|glucocorticoids|mesh-ancestor
102303515|NCT05060627|Hormones|hormones|mesh-ancestor
102303516|NCT05060627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102303517|NCT05060627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102303518|NCT05060627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102303519|NCT04421105|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
102303520|NCT04421105|Hallucinogens|hallucinogens|mesh-ancestor
102303521|NCT04421105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303522|NCT04421105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102303523|NCT04421105|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102303524|NCT04421105|Serotonin Agents|serotonin agents|mesh-ancestor
102303525|NCT04421105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102303526|NCT04421105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303527|NCT04421105|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102303528|NCT05024747|Nicotine|nicotine|mesh-list
102303529|NCT05024747|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102303530|NCT05024747|Autonomic Agents|autonomic agents|mesh-ancestor
102303531|NCT05024747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101645338|NCT03232918|Oxytocin|oxytocin|mesh-list
102303532|NCT05024747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303533|NCT05024747|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102303534|NCT05024747|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102303535|NCT05024747|Cholinergic Agents|cholinergic agents|mesh-ancestor
102303536|NCT05024747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102303537|NCT05024747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303539|NCT05056883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102303540|NCT05056883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102303541|NCT04991597|Lidocaine|lidocaine|mesh-list
102303542|NCT04991597|Epinephrine|epinephrine|mesh-list
102303543|NCT04991597|Racepinephrine|racepinephrine|mesh-list
102303544|NCT04991597|Epinephryl borate|epinephryl borate|mesh-list
102303545|NCT04991597|Anesthetics, Local|anesthetics, local|mesh-ancestor
102303546|NCT04991597|Anesthetics|anesthetics|mesh-ancestor
102303547|NCT04991597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102303548|NCT04991597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303549|NCT04991597|Sensory System Agents|sensory system agents|mesh-ancestor
102303550|NCT04991597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102303551|NCT04991597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102303552|NCT04991597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102303553|NCT04991597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102303554|NCT04991597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102303555|NCT04991597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303556|NCT04991597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102303557|NCT04991597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102303558|NCT04991597|Adrenergic Agents|adrenergic agents|mesh-ancestor
102303559|NCT04991597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102303560|NCT04991597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102303561|NCT04991597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102303562|NCT04991597|Autonomic Agents|autonomic agents|mesh-ancestor
102303563|NCT04991597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102303564|NCT04991597|Respiratory System Agents|respiratory system agents|mesh-ancestor
102303565|NCT04991597|Mydriatics|mydriatics|mesh-ancestor
102303567|NCT04991597|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102303568|NCT04949867|Glucagon|glucagon|mesh-list
102303569|NCT04949867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102303570|NCT04949867|Hormones|hormones|mesh-ancestor
102303571|NCT04949867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102303572|NCT04949867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303573|NCT05018117|Nicotine|nicotine|mesh-list
102303574|NCT05018117|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102303575|NCT05018117|Autonomic Agents|autonomic agents|mesh-ancestor
102303576|NCT05018117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102303577|NCT05018117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303578|NCT05018117|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102303579|NCT05018117|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102303580|NCT05018117|Cholinergic Agents|cholinergic agents|mesh-ancestor
102303581|NCT05018117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102303582|NCT05018117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303583|NCT05016869|Capecitabine|capecitabine|mesh-list
102303584|NCT05016869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102303585|NCT05016869|Antimetabolites|antimetabolites|mesh-ancestor
102303586|NCT05016869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303587|NCT05016869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102303588|NCT02141997|Adalimumab|adalimumab|mesh-list
102303589|NCT02141997|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102303590|NCT02141997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102303591|NCT02141997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102303592|NCT04411433|Azithromycin|azithromycin|mesh-list
102303593|NCT04411433|Hydroxychloroquine|hydroxychloroquine|mesh-list
102303594|NCT04411433|Favipiravir|favipiravir|mesh-list
102303595|NCT04411433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102303596|NCT04411433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102303597|NCT04411433|Antimalarials|antimalarials|mesh-ancestor
102303598|NCT04411433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102303599|NCT04411433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102303600|NCT04411433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102303601|NCT04411433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303602|NCT04411433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102303603|NCT04411433|Antiviral Agents|antiviral agents|mesh-ancestor
102303604|NCT04987463|Sirolimus|sirolimus|mesh-list
102303605|NCT04987463|Vigabatrin|vigabatrin|mesh-list
102303606|NCT04987463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102303607|NCT04987463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102303608|NCT04987463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102303609|NCT04987463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102303610|NCT04987463|Antifungal Agents|antifungal agents|mesh-ancestor
102303611|NCT04987463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102303612|NCT04987463|Immunologic Factors|immunologic factors|mesh-ancestor
102303613|NCT04987463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303614|NCT04987463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102303615|NCT04987463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303616|NCT04987463|Anticonvulsants|anticonvulsants|mesh-ancestor
102303617|NCT04987463|GABA Agents|gaba agents|mesh-ancestor
102303618|NCT04987463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102303619|NCT05012735|Pantothenic Acid|pantothenic acid|mesh-list
102303620|NCT05012735|Provitamins|provitamins|mesh-list
102303621|NCT05012735|Vitamins|vitamins|mesh-ancestor
102303622|NCT05012735|Micronutrients|micronutrients|mesh-ancestor
102303623|NCT05012735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303624|NCT05012735|Vitamin B Complex|vitamin b complex|mesh-ancestor
102303625|NCT02519777|Dolutegravir|dolutegravir|mesh-list
102303626|NCT02519777|Maraviroc|maraviroc|mesh-list
102303627|NCT02519777|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102303628|NCT02519777|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102303629|NCT02519777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102303630|NCT02519777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303631|NCT02519777|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102303632|NCT02519777|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102303633|NCT02519777|Antiviral Agents|antiviral agents|mesh-ancestor
102303634|NCT02519777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102303635|NCT02519777|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102303636|NCT02519777|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102303637|NCT02519777|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102303638|NCT05008913|Adavosertib|adavosertib|mesh-list
102303639|NCT05008913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102303640|NCT05008913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303641|NCT04982705|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102303642|NCT04982705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102303643|NCT04982705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303644|NCT04982705|Incretins|incretins|mesh-ancestor
102303645|NCT04982705|Hormones|hormones|mesh-ancestor
102303646|NCT04982705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102303647|NCT04982705|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102303648|NCT04982705|Protease Inhibitors|protease inhibitors|mesh-ancestor
102303649|NCT04982705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102303650|NCT04982705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303651|NCT04944095|Antibodies|antibodies|mesh-list
102303652|NCT04944095|Immunologic Factors|immunologic factors|mesh-ancestor
102303653|NCT04944095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303654|NCT02141295|Leucovorin|leucovorin|mesh-list
102303655|NCT02141295|Folic Acid|folic acid|mesh-list
102303656|NCT02141295|Bevacizumab|bevacizumab|mesh-list
102303657|NCT02141295|Oxaliplatin|oxaliplatin|mesh-list
102303658|NCT02141295|Levoleucovorin|levoleucovorin|mesh-list
102303659|NCT02141295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102303660|NCT02141295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102303661|NCT02141295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102303662|NCT02141295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102303663|NCT02141295|Growth Substances|growth substances|mesh-ancestor
102303664|NCT02141295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303665|NCT02141295|Growth Inhibitors|growth inhibitors|mesh-ancestor
102303666|NCT02141295|Antidotes|antidotes|mesh-ancestor
102303667|NCT02141295|Protective Agents|protective agents|mesh-ancestor
102303668|NCT02141295|Vitamin B Complex|vitamin b complex|mesh-ancestor
102303669|NCT02141295|Vitamins|vitamins|mesh-ancestor
102303670|NCT02141295|Micronutrients|micronutrients|mesh-ancestor
102303671|NCT02141295|Hematinics|hematinics|mesh-ancestor
102303672|NCT02514551|Paclitaxel|paclitaxel|mesh-list
102303673|NCT02514551|Ramucirumab|ramucirumab|mesh-list
102303674|NCT02514551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102303675|NCT02514551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102303676|NCT02514551|Tubulin Modulators|tubulin modulators|mesh-ancestor
102303677|NCT02514551|Antimitotic Agents|antimitotic agents|mesh-ancestor
102303678|NCT02514551|Mitosis Modulators|mitosis modulators|mesh-ancestor
102303679|NCT02514551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303680|NCT02141217|Amoxicillin|amoxicillin|mesh-list
102303681|NCT02141217|Clindamycin|clindamycin|mesh-list
102303682|NCT02141217|Clindamycin palmitate|clindamycin palmitate|mesh-list
102303683|NCT02141217|Clindamycin phosphate|clindamycin phosphate|mesh-list
102303684|NCT02141217|Clavulanic Acid|clavulanic acid|mesh-list
102303685|NCT02141217|Clavulanic Acids|clavulanic acids|mesh-list
101941551|NCT01128075|Antiviral Agents|antiviral agents|mesh-ancestor
102303686|NCT02141217|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102303687|NCT02141217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102303688|NCT02141217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102303689|NCT02141217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102303690|NCT02141217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102303691|NCT02141217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303692|NCT02141217|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102303693|NCT02514473|Ivacaftor|ivacaftor|mesh-list
102303694|NCT02514473|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102303695|NCT02514473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102303696|NCT02514473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303697|NCT02513771|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102303698|NCT02513771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102303699|NCT02513771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303700|NCT02513771|Incretins|incretins|mesh-ancestor
102303701|NCT02513771|Hormones|hormones|mesh-ancestor
102303702|NCT02513771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102303703|NCT02513771|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102303704|NCT02513771|Protease Inhibitors|protease inhibitors|mesh-ancestor
102303705|NCT02513771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102303706|NCT02513771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303707|NCT02513459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102303708|NCT02513459|Immunologic Factors|immunologic factors|mesh-ancestor
102303709|NCT02513459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303710|NCT02069379|Metformin|metformin|mesh-list
102303711|NCT02069379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101418799|NCT00139646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102303712|NCT02069379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303713|NCT02511431|Ritonavir|ritonavir|mesh-list
102303714|NCT02511431|Lonafarnib|lonafarnib|mesh-list
102303715|NCT02511431|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102012459|NCT02485990|Olaparib|olaparib|mesh-list
102303716|NCT02511431|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102303717|NCT02511431|Protease Inhibitors|protease inhibitors|mesh-ancestor
102303718|NCT02511431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102303719|NCT02511431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303720|NCT02511431|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102303721|NCT02511431|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102303722|NCT02511431|Antiviral Agents|antiviral agents|mesh-ancestor
102303723|NCT02511431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102303724|NCT02511431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102303725|NCT02511431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102303726|NCT02137785|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102303727|NCT02137785|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102303728|NCT02137785|Dermatologic Agents|dermatologic agents|mesh-ancestor
102303729|NCT05003453|Palmidrol|palmidrol|mesh-list
102303730|NCT05003453|Analgesics|analgesics|mesh-ancestor
102303731|NCT05003453|Sensory System Agents|sensory system agents|mesh-ancestor
102303732|NCT05003453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102303733|NCT05003453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303734|NCT05003453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102303735|NCT05003453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102303736|NCT05003453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102303737|NCT05003453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102303738|NCT05003453|Antiviral Agents|antiviral agents|mesh-ancestor
102303739|NCT05003453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102303740|NCT05003453|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102303741|NCT05003453|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102303742|NCT05003453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102303743|NCT05003453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303744|NCT05003453|Hormones|hormones|mesh-ancestor
102303745|NCT05003453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102303746|NCT01655069|Solifenacin Succinate|solifenacin succinate|mesh-list
102303747|NCT01655069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102303748|NCT01655069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102303749|NCT01655069|Cholinergic Agents|cholinergic agents|mesh-ancestor
102303750|NCT01655069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102303751|NCT01655069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303752|NCT01655069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303753|NCT01655069|Urological Agents|urological agents|mesh-ancestor
102303754|NCT01654601|Clozapine|clozapine|mesh-list
102303755|NCT01654601|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102303756|NCT01654601|Serotonin Agents|serotonin agents|mesh-ancestor
102303757|NCT01654601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102303758|NCT01654601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303759|NCT01654601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303760|NCT01654601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102303761|NCT01654601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102303762|NCT01654601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102303763|NCT01654601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102303764|NCT01654601|GABA Antagonists|gaba antagonists|mesh-ancestor
102303765|NCT01654601|GABA Agents|gaba agents|mesh-ancestor
102303767|NCT02068443|Alogliptin|alogliptin|mesh-list
102303768|NCT02068443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102303769|NCT02068443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303770|NCT02068443|Incretins|incretins|mesh-ancestor
102303771|NCT02068443|Hormones|hormones|mesh-ancestor
102303772|NCT02068443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102303773|NCT02068443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102303774|NCT02068443|Protease Inhibitors|protease inhibitors|mesh-ancestor
102303775|NCT02068443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102303776|NCT02068443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303777|NCT04978649|Amlodipine|amlodipine|mesh-list
102303778|NCT04978649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102303779|NCT04978649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102303780|NCT04978649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102303781|NCT04978649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303782|NCT04978649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102303783|NCT04978649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303784|NCT04978649|Vasodilator Agents|vasodilator agents|mesh-ancestor
102303785|NCT02508935|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
102303786|NCT02508935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102303787|NCT02508935|Narcotics|narcotics|mesh-ancestor
102303788|NCT02508935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102303789|NCT02508935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303790|NCT02508935|Analgesics|analgesics|mesh-ancestor
102012534|NCT01444092|Budesonide|budesonide|mesh-list
102303791|NCT02508935|Sensory System Agents|sensory system agents|mesh-ancestor
102303792|NCT02508935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102303793|NCT02508935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102303794|NCT02508935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102303795|NCT02508935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102303796|NCT02508935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102303797|NCT02507375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102303798|NCT02507375|Pertuzumab|pertuzumab|mesh-list
102303799|NCT02507375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102303800|NCT02507375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102303801|NCT02507375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102303802|NCT02507375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303803|NCT02507375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102303804|NCT02507219|Ibuprofen|ibuprofen|mesh-list
102303805|NCT02507219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102303806|NCT02507219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102303807|NCT02507219|Analgesics|analgesics|mesh-ancestor
102303808|NCT02507219|Sensory System Agents|sensory system agents|mesh-ancestor
102303809|NCT02507219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102303810|NCT02507219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303811|NCT02507219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102303812|NCT02507219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102303813|NCT02507219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102303814|NCT02507219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102303815|NCT02507219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303816|NCT02483975|Albuterol|albuterol|mesh-list
102303817|NCT02483975|Montelukast|montelukast|mesh-list
102303818|NCT02483975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102303819|NCT02483975|Respiratory System Agents|respiratory system agents|mesh-ancestor
102303820|NCT02483975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102303821|NCT02483975|Hormone Antagonists|hormone antagonists|mesh-ancestor
102303822|NCT02483975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102303823|NCT02483975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303824|NCT02483975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102303825|NCT02483975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102303826|NCT02483975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645646|NCT00933608|Memantine|memantine|mesh-list
102303827|NCT02483975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102303828|NCT02483975|Autonomic Agents|autonomic agents|mesh-ancestor
102303829|NCT02483975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102303830|NCT02483975|Tocolytic Agents|tocolytic agents|mesh-ancestor
102303831|NCT02483975|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102303832|NCT02483975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102303833|NCT02483975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102303834|NCT02483975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102303835|NCT02483975|Adrenergic Agents|adrenergic agents|mesh-ancestor
102303836|NCT02483975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102303837|NCT02047227|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102303838|NCT02047227|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102303840|NCT02047227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102303841|NCT02047227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303842|NCT02047227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102303843|NCT02483585|Erenumab|erenumab|mesh-list
102303844|NCT02483585|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
102303845|NCT02483585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303846|NCT02483585|Analgesics|analgesics|mesh-ancestor
102303847|NCT02483585|Sensory System Agents|sensory system agents|mesh-ancestor
102303848|NCT02483585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102303849|NCT02483585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303850|NCT02101983|Cytarabine|cytarabine|mesh-list
102303851|NCT02101983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102303852|NCT02101983|Antimetabolites|antimetabolites|mesh-ancestor
102303853|NCT02101983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303854|NCT02101983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102303855|NCT02101983|Antiviral Agents|antiviral agents|mesh-ancestor
102303856|NCT02101983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102303857|NCT02101983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102303858|NCT02101983|Immunologic Factors|immunologic factors|mesh-ancestor
102303859|NCT02101983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303860|NCT04974281|Lenvatinib|lenvatinib|mesh-list
102303861|NCT04974281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102012608|NCT00116220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102303862|NCT04974281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102303863|NCT04974281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102303864|NCT04974281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303865|NCT02503865|Orlistat|orlistat|mesh-list
102303866|NCT02503865|Diltiazem|diltiazem|mesh-list
102303867|NCT02503865|Atorvastatin|atorvastatin|mesh-list
102303868|NCT02503865|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102303869|NCT02503865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102303870|NCT02503865|Antimetabolites|antimetabolites|mesh-ancestor
102303871|NCT02503865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303872|NCT02503865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102303873|NCT02503865|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102303874|NCT02503865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102303875|NCT02503865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102303876|NCT02503865|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102303877|NCT02503865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102303878|NCT02503865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102303879|NCT02503865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303880|NCT02503865|Vasodilator Agents|vasodilator agents|mesh-ancestor
102303881|NCT02503865|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102303882|NCT02481947|Laxatives|laxatives|mesh-list
102303883|NCT02481947|Lubiprostone|lubiprostone|mesh-list
102303884|NCT02481947|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102303885|NCT02481947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102303886|NCT02481947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303887|NCT02481947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102303888|NCT02503085|Ibuprofen|ibuprofen|mesh-list
102303889|NCT02503085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102303890|NCT02503085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102303891|NCT02503085|Analgesics|analgesics|mesh-ancestor
102303892|NCT02503085|Sensory System Agents|sensory system agents|mesh-ancestor
102303893|NCT02503085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102303894|NCT02503085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303895|NCT02503085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102303896|NCT02503085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102303897|NCT02503085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102303898|NCT02503085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102303899|NCT02503085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303900|NCT02502149|Factor VIII|factor viii|mesh-list
102303901|NCT02502149|Coagulants|coagulants|mesh-ancestor
102303902|NCT02480621|Bupivacaine|bupivacaine|mesh-list
102303903|NCT02480621|Anesthetics, Local|anesthetics, local|mesh-ancestor
102303904|NCT02480621|Anesthetics|anesthetics|mesh-ancestor
102303905|NCT02480621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102303906|NCT02480621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303907|NCT02480621|Sensory System Agents|sensory system agents|mesh-ancestor
102303908|NCT02480621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102303909|NCT02046603|Methotrexate|methotrexate|mesh-list
102303910|NCT02046603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102303911|NCT02046603|Abortifacient Agents|abortifacient agents|mesh-ancestor
102303912|NCT02046603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102303913|NCT02046603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303914|NCT02046603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102303915|NCT02046603|Antimetabolites|antimetabolites|mesh-ancestor
102303916|NCT02046603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303917|NCT02046603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102303918|NCT02046603|Dermatologic Agents|dermatologic agents|mesh-ancestor
102303919|NCT02046603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102303920|NCT02046603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102303921|NCT02046603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102303922|NCT02046603|Immunologic Factors|immunologic factors|mesh-ancestor
102303923|NCT02046603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102303924|NCT02046603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102303925|NCT02046369|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102303926|NCT02046369|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102303927|NCT02046369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102303928|NCT02046369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102303929|NCT02046369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303930|NCT02046369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102303931|NCT02046369|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102303932|NCT02046369|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102303933|NCT02046369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102303934|NCT02046369|Adrenergic Agents|adrenergic agents|mesh-ancestor
102012688|NCT03778619|Analgesics|analgesics|mesh-ancestor
102303935|NCT02046369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102303936|NCT02046369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303937|NCT02046369|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102303938|NCT02046369|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102303939|NCT02046369|Serotonin Agents|serotonin agents|mesh-ancestor
102303940|NCT02046369|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102303941|NCT02046369|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102303942|NCT02046369|Dopamine Agents|dopamine agents|mesh-ancestor
102303944|NCT02101359|Tropicamide|tropicamide|mesh-list
102303945|NCT02101359|Mydriatics|mydriatics|mesh-list
102303946|NCT02101359|Anesthetics, Local|anesthetics, local|mesh-ancestor
102303947|NCT02101359|Anesthetics|anesthetics|mesh-ancestor
102303948|NCT02101359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102303949|NCT02101359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303950|NCT02101359|Sensory System Agents|sensory system agents|mesh-ancestor
102303951|NCT02101359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102303952|NCT02101359|Autonomic Agents|autonomic agents|mesh-ancestor
102303953|NCT02101359|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102303954|NCT02101359|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102303955|NCT02101359|Cholinergic Agents|cholinergic agents|mesh-ancestor
102303956|NCT02101359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102303957|NCT02101359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303958|NCT02100969|Immunoglobulins|immunoglobulins|mesh-list
102303959|NCT02100969|gamma-Globulins|gamma-globulins|mesh-list
102303960|NCT02100969|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102303961|NCT02100969|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102303962|NCT02100969|Immunologic Factors|immunologic factors|mesh-ancestor
102303963|NCT02100969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303964|NCT01885000|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102303965|NCT01885000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102303966|NCT01885000|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102303967|NCT01885000|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102303968|NCT01885000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102303969|NCT01885000|Adrenergic Agents|adrenergic agents|mesh-ancestor
102303970|NCT01885000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101645806|NCT04077892|Budesonide|budesonide|mesh-list
102303971|NCT01885000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303972|NCT01885000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303973|NCT01883362|Midostaurin|midostaurin|mesh-list
102303974|NCT01883362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102303975|NCT01883362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102303976|NCT01883362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102303977|NCT01883362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303978|NCT04724967|Dimenhydrinate|dimenhydrinate|mesh-list
102303979|NCT04724967|Antiemetics|antiemetics|mesh-ancestor
102303980|NCT04724967|Autonomic Agents|autonomic agents|mesh-ancestor
102303981|NCT04724967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102303982|NCT04724967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102303983|NCT04724967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102303984|NCT04724967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102303985|NCT04724967|Histamine Antagonists|histamine antagonists|mesh-ancestor
102303986|NCT04724967|Histamine Agents|histamine agents|mesh-ancestor
102303987|NCT04724967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102303988|NCT04724967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102303989|NCT02045979|Adalimumab|adalimumab|mesh-list
102303990|NCT02045979|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102303991|NCT02045979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102303992|NCT02045979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102303993|NCT04703751|Nitroglycerin|nitroglycerin|mesh-list
102303994|NCT04703751|Vasodilator Agents|vasodilator agents|mesh-ancestor
102303995|NCT04734405|Fluconazole|fluconazole|mesh-list
102303996|NCT04734405|Antifungal Agents|antifungal agents|mesh-ancestor
102303997|NCT04734405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102303998|NCT04734405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102303999|NCT04734405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102304000|NCT04734405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102304001|NCT04734405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304002|NCT04734405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102304003|NCT04734405|Hormone Antagonists|hormone antagonists|mesh-ancestor
102304004|NCT04734405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102304005|NCT04734405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304006|NCT04734405|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102304007|NCT04734405|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102304008|NCT01911442|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102304009|NCT01911442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102304010|NCT01911442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102304011|NCT01911442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102304012|NCT01911442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304013|NCT01911442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102304014|NCT01911442|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102304015|NCT01911442|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102304016|NCT01911442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102304017|NCT01911442|Adrenergic Agents|adrenergic agents|mesh-ancestor
102304018|NCT01911442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102304019|NCT01911442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304020|NCT01911442|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102304021|NCT01911442|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102304022|NCT01911442|Serotonin Agents|serotonin agents|mesh-ancestor
102304023|NCT01911442|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102304024|NCT01911442|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102304025|NCT01911442|Dopamine Agents|dopamine agents|mesh-ancestor
102304026|NCT01928758|Nicotine|nicotine|mesh-list
102304027|NCT01928758|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102304028|NCT01928758|Autonomic Agents|autonomic agents|mesh-ancestor
102304029|NCT01928758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102304030|NCT01928758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304031|NCT01928758|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102304032|NCT01928758|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102304033|NCT01928758|Cholinergic Agents|cholinergic agents|mesh-ancestor
102304034|NCT01928758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102304035|NCT01928758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304036|NCT01614886|Rivastigmine|rivastigmine|mesh-list
102304037|NCT01614886|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102304038|NCT01614886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102304039|NCT01614886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304040|NCT01614886|Cholinergic Agents|cholinergic agents|mesh-ancestor
102304041|NCT01614886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102304042|NCT01614886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304043|NCT01614886|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102304044|NCT01614886|Protective Agents|protective agents|mesh-ancestor
101419198|NCT00141011|Ancrod|ancrod|mesh-list
102304045|NCT04622254|Botulinum Toxins|botulinum toxins|mesh-list
102304046|NCT04622254|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102304047|NCT04622254|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102304048|NCT04622254|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102304049|NCT04622254|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102304050|NCT04622254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102304051|NCT04622254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304052|NCT04622254|Cholinergic Agents|cholinergic agents|mesh-ancestor
102304053|NCT04622254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102304054|NCT04622254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304055|NCT04622254|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102304056|NCT04622254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102304057|NCT04171726|Edoxaban|edoxaban|mesh-list
102304058|NCT04171726|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102304059|NCT04171726|Antithrombins|antithrombins|mesh-ancestor
102304060|NCT04171726|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102304061|NCT04171726|Protease Inhibitors|protease inhibitors|mesh-ancestor
102304062|NCT04171726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102304063|NCT04171726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304064|NCT04171726|Anticoagulants|anticoagulants|mesh-ancestor
102304065|NCT02100657|Dexamethasone|dexamethasone|mesh-list
102304066|NCT02100657|Bortezomib|bortezomib|mesh-list
102304067|NCT02100657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102304068|NCT02100657|Antiemetics|antiemetics|mesh-ancestor
102304069|NCT02100657|Autonomic Agents|autonomic agents|mesh-ancestor
102304070|NCT02100657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102304071|NCT02100657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304072|NCT02100657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102304073|NCT02100657|Glucocorticoids|glucocorticoids|mesh-ancestor
102304074|NCT02100657|Hormones|hormones|mesh-ancestor
102304075|NCT02100657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102304076|NCT02100657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102304077|NCT02100657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102304078|NCT02067663|Levonorgestrel|levonorgestrel|mesh-list
102304079|NCT02067663|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102304080|NCT02067663|Contraceptive Agents|contraceptive agents|mesh-ancestor
102304081|NCT02067663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102304082|NCT02067663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304083|NCT02067663|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102304084|NCT02067663|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102304085|NCT02067663|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102304086|NCT01909804|Ribavirin|ribavirin|mesh-list
102304087|NCT01909804|Antiviral Agents|antiviral agents|mesh-ancestor
102304088|NCT01909804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102304089|NCT01909804|Antimetabolites|antimetabolites|mesh-ancestor
102304090|NCT01909804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304091|NCT01880086|Clomiphene|clomiphene|mesh-list
102304092|NCT01880086|Enclomiphene|enclomiphene|mesh-list
102304093|NCT01880086|Zuclomiphene|zuclomiphene|mesh-list
102304094|NCT01880086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102304095|NCT01880086|Hormone Antagonists|hormone antagonists|mesh-ancestor
102304096|NCT01880086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102304097|NCT01880086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304098|NCT01880086|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102304099|NCT01880086|Fertility Agents|fertility agents|mesh-ancestor
102304100|NCT01880086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102304101|NCT01880086|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102304102|NCT01880086|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102304103|NCT01879618|Dalteparin|dalteparin|mesh-list
102304104|NCT01879618|Anticoagulants|anticoagulants|mesh-ancestor
102304105|NCT01879618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102304106|NCT01879618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102304107|NCT01879618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304108|NCT01926886|Trastuzumab|trastuzumab|mesh-list
102304109|NCT01926886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102304110|NCT01926886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102304111|NCT01909336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102304112|NCT01925950|Beclomethasone|beclomethasone|mesh-list
102304113|NCT01925950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102304114|NCT01925950|Glucocorticoids|glucocorticoids|mesh-ancestor
102304115|NCT01925950|Hormones|hormones|mesh-ancestor
102304116|NCT01925950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102304117|NCT01925950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304118|NCT01925950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102304119|NCT01925950|Respiratory System Agents|respiratory system agents|mesh-ancestor
102304120|NCT04415320|Ensartinib|ensartinib|mesh-list
102304121|NCT04415320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102304122|NCT04415320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102304123|NCT04415320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102304124|NCT04415320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304125|NCT01878292|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
102304126|NCT01878292|Antidepressive Agents|antidepressive agents|mesh-ancestor
102304127|NCT01878292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102304128|NCT01878292|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102304129|NCT01878292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102304130|NCT01878292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102304131|NCT01878292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304132|NCT01878292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102304133|NCT01878292|Serotonin Agents|serotonin agents|mesh-ancestor
102304134|NCT01878292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304135|NCT01878292|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102304136|NCT01878292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102304137|NCT01907854|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102304138|NCT01907854|Liraglutide|liraglutide|mesh-list
102304139|NCT01907854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102304140|NCT01907854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304141|NCT01907854|Incretins|incretins|mesh-ancestor
102304142|NCT01907854|Hormones|hormones|mesh-ancestor
102304143|NCT01907854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102304144|NCT01907854|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102304145|NCT01907854|Protease Inhibitors|protease inhibitors|mesh-ancestor
102304146|NCT01907854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102304147|NCT01907854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304148|NCT02480153|Adalimumab|adalimumab|mesh-list
102304149|NCT02480153|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102304150|NCT02480153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102304151|NCT02480153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102304152|NCT04972253|Infigratinib|infigratinib|mesh-list
102304153|NCT04972253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102304154|NCT02500979|Insulin|insulin|mesh-list
102304155|NCT02500979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102304156|NCT02500979|Insulin Lispro|insulin lispro|mesh-list
102304157|NCT02500979|Pramlintide|pramlintide|mesh-list
102304158|NCT02500979|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
102304159|NCT02500979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102304160|NCT02500979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304161|NCT02500979|Appetite Depressants|appetite depressants|mesh-ancestor
102304162|NCT02500979|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102304163|NCT02500979|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
102304164|NCT02500979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304165|NCT02500901|Niraparib|niraparib|mesh-list
102304166|NCT02500901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102304167|NCT02500901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102304168|NCT02500901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304169|NCT02500901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102304170|NCT01877668|Adalimumab|adalimumab|mesh-list
102304171|NCT01877668|Tofacitinib|tofacitinib|mesh-list
102304172|NCT01877668|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102304173|NCT01877668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102304174|NCT01877668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102304175|NCT01877668|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102304176|NCT01877668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102304177|NCT01877668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102304178|NCT01877668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304179|NCT01906372|Hormones|hormones|mesh-list
102304180|NCT01906372|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102304181|NCT01906372|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
102304182|NCT01906372|beta-Endorphin|beta-endorphin|mesh-list
101419311|NCT00155259|Antimetabolites|antimetabolites|mesh-ancestor
102304183|NCT01906372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102304184|NCT01906372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304185|NCT01906372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102304186|NCT01906372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304187|NCT01925170|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
102304188|NCT01925170|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101646023|NCT02581462|Pertuzumab|pertuzumab|mesh-list
102304189|NCT01925170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304190|NCT01876810|Gemfibrozil|gemfibrozil|mesh-list
102304191|NCT01876810|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102304192|NCT01876810|Antimetabolites|antimetabolites|mesh-ancestor
102304193|NCT01876810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304194|NCT01876810|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102304195|NCT01876810|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102304196|NCT01876810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102304197|NCT01876810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102304198|NCT01876732|Vitamin B 12|vitamin b 12|mesh-list
102304199|NCT01876732|Hydroxocobalamin|hydroxocobalamin|mesh-list
102304200|NCT01876732|Vitamins|vitamins|mesh-ancestor
102304201|NCT01876732|Micronutrients|micronutrients|mesh-ancestor
102304202|NCT01876732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304203|NCT01876732|Vitamin B Complex|vitamin b complex|mesh-ancestor
102304204|NCT01876732|Hematinics|hematinics|mesh-ancestor
102304205|NCT01905592|Niraparib|niraparib|mesh-list
102304206|NCT01905592|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102304207|NCT01905592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102304208|NCT01905592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304209|NCT01905592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102304210|NCT02500121|Pembrolizumab|pembrolizumab|mesh-list
102304211|NCT02500121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102304212|NCT02500121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102304213|NCT02500121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102304214|NCT02500121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304215|NCT01875250|Metronidazole|metronidazole|mesh-list
102304216|NCT01875250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102304217|NCT01875250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102304218|NCT01875250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102304219|NCT01875250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102304220|NCT01904032|Vitamin D|vitamin d|mesh-list
102304221|NCT01904032|Ergocalciferols|ergocalciferols|mesh-list
102304222|NCT01904032|Cholecalciferol|cholecalciferol|mesh-list
102304223|NCT01904032|Vitamins|vitamins|mesh-list
102304224|NCT01904032|Micronutrients|micronutrients|mesh-ancestor
102304225|NCT01904032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304226|NCT01904032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102304227|NCT01904032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102304228|NCT01921270|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102304229|NCT01921270|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102304230|NCT01921270|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102304231|NCT01921270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102304232|NCT01921270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304233|NCT01921270|Cholinergic Agents|cholinergic agents|mesh-ancestor
102304234|NCT01921270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102304235|NCT01921270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304236|NCT01921270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102304237|NCT01921270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102304238|NCT02325739|Spartalizumab|spartalizumab|mesh-list
102304239|NCT02325739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102304240|NCT02325739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304241|NCT02325739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102304242|NCT02325739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102304243|NCT01903720|Dexamethasone|dexamethasone|mesh-list
102304244|NCT01903720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102304245|NCT01903720|Antiemetics|antiemetics|mesh-ancestor
102304246|NCT01903720|Autonomic Agents|autonomic agents|mesh-ancestor
102304247|NCT01903720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102304248|NCT01903720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304249|NCT01903720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102304250|NCT01903720|Glucocorticoids|glucocorticoids|mesh-ancestor
102304251|NCT01903720|Hormones|hormones|mesh-ancestor
102304252|NCT01903720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102304253|NCT01903720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102304254|NCT01903720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102304255|NCT02366689|Triclosan|triclosan|mesh-list
102304256|NCT02366689|Cetylpyridinium|cetylpyridinium|mesh-list
102304257|NCT02366689|Fluorides|fluorides|mesh-list
102304258|NCT02366689|Tin Fluorides|tin fluorides|mesh-list
102304259|NCT02366689|Cariostatic Agents|cariostatic agents|mesh-ancestor
102304260|NCT02366689|Protective Agents|protective agents|mesh-ancestor
102304261|NCT02366689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304262|NCT02366689|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102304263|NCT02366689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102304264|NCT02366689|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102304266|NCT02366689|Antimetabolites|antimetabolites|mesh-ancestor
102304267|NCT02366689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304268|NCT02366689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102304269|NCT01903252|Mesalamine|mesalamine|mesh-list
102304270|NCT01903252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102304271|NCT01903252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102304272|NCT01903252|Analgesics|analgesics|mesh-ancestor
102304273|NCT01903252|Sensory System Agents|sensory system agents|mesh-ancestor
102304274|NCT01903252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102304275|NCT01903252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304276|NCT01903252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102304277|NCT01903252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102304278|NCT01613716|Dexamethasone|dexamethasone|mesh-list
102304279|NCT01613716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102304280|NCT01613716|Antiemetics|antiemetics|mesh-ancestor
102304281|NCT01613716|Autonomic Agents|autonomic agents|mesh-ancestor
102304282|NCT01613716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102304283|NCT01613716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304284|NCT01613716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102304285|NCT01613716|Glucocorticoids|glucocorticoids|mesh-ancestor
102304286|NCT01613716|Hormones|hormones|mesh-ancestor
102304287|NCT01613716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102304288|NCT01613716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102304289|NCT01613716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102304290|NCT05112952|Lazertinib|lazertinib|mesh-list
102304291|NCT05112952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102304292|NCT05112952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102304293|NCT05112952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304294|NCT01872910|Celecoxib|celecoxib|mesh-list
102304295|NCT01872910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102304296|NCT01872910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102304297|NCT01872910|Analgesics|analgesics|mesh-ancestor
102304298|NCT01872910|Sensory System Agents|sensory system agents|mesh-ancestor
102304299|NCT01872910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102304300|NCT01872910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304301|NCT01872910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102304302|NCT01872910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102304303|NCT01872910|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102304304|NCT01872910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102304305|NCT01872910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102304306|NCT01872910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304307|NCT01920568|Vitamin D|vitamin d|mesh-list
102304308|NCT01920568|Zoledronic Acid|zoledronic acid|mesh-list
102304309|NCT01920568|Denosumab|denosumab|mesh-list
102304310|NCT01920568|Calcium|calcium|mesh-list
102304311|NCT01920568|Vitamins|vitamins|mesh-ancestor
102304312|NCT01920568|Micronutrients|micronutrients|mesh-ancestor
102304313|NCT01920568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419446|NCT00155376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102304314|NCT01920568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102304315|NCT01920568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102304316|NCT01901848|Bupropion|bupropion|mesh-list
102304317|NCT01901848|Nicotine|nicotine|mesh-list
102304318|NCT01901848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102304319|NCT01901848|Autonomic Agents|autonomic agents|mesh-ancestor
102304320|NCT01901848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102304321|NCT01901848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304322|NCT01901848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102304323|NCT01901848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102304324|NCT01901848|Cholinergic Agents|cholinergic agents|mesh-ancestor
102304325|NCT01901848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102304326|NCT01901848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304327|NCT01901848|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102304328|NCT01901848|Antidepressive Agents|antidepressive agents|mesh-ancestor
102304329|NCT01901848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102304330|NCT01901848|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102304331|NCT01901848|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102304332|NCT01901848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102304333|NCT01901848|Dopamine Agents|dopamine agents|mesh-ancestor
102304334|NCT01901848|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102304335|NCT01901848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102304336|NCT01901848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102304337|NCT01901614|Anesthetics|anesthetics|mesh-list
102304338|NCT01901614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102304339|NCT01901614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304340|NCT02499575|Bupivacaine|bupivacaine|mesh-list
102304341|NCT02499575|Ropivacaine|ropivacaine|mesh-list
102304342|NCT02499575|Anesthetics, Local|anesthetics, local|mesh-ancestor
102304343|NCT02499575|Anesthetics|anesthetics|mesh-ancestor
102304344|NCT02499575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102304345|NCT02499575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304346|NCT02499575|Sensory System Agents|sensory system agents|mesh-ancestor
102304347|NCT02499575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102304348|NCT02065791|Canagliflozin|canagliflozin|mesh-list
102304349|NCT02065791|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102304350|NCT02065791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304351|NCT02065791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102304352|NCT02065791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304353|NCT02499029|Acetylcysteine|acetylcysteine|mesh-list
102304354|NCT02499029|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102304355|NCT02499029|Antiviral Agents|antiviral agents|mesh-ancestor
102304356|NCT02499029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102304357|NCT02499029|Expectorants|expectorants|mesh-ancestor
102304358|NCT02499029|Respiratory System Agents|respiratory system agents|mesh-ancestor
102304359|NCT02499029|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102304360|NCT02499029|Antioxidants|antioxidants|mesh-ancestor
102304361|NCT02499029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304362|NCT02499029|Protective Agents|protective agents|mesh-ancestor
102304363|NCT02499029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304364|NCT02499029|Antidotes|antidotes|mesh-ancestor
102304365|NCT04939883|Carvedilol|carvedilol|mesh-list
102304366|NCT04939883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102304367|NCT04939883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102304368|NCT04939883|Adrenergic Agents|adrenergic agents|mesh-ancestor
102304369|NCT04939883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102304370|NCT04939883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304371|NCT04939883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304372|NCT04939883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102304373|NCT04939883|Antioxidants|antioxidants|mesh-ancestor
102304374|NCT04939883|Protective Agents|protective agents|mesh-ancestor
102304375|NCT04939883|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102304376|NCT04939883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102304377|NCT04939883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102304378|NCT04939883|Vasodilator Agents|vasodilator agents|mesh-ancestor
102304379|NCT04939883|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102304380|NCT04939883|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102304381|NCT02065713|Golimumab|golimumab|mesh-list
102304382|NCT02065713|Methotrexate|methotrexate|mesh-list
101419512|NCT04517890|Anesthetics|anesthetics|mesh-ancestor
102304383|NCT02065713|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102304384|NCT02065713|Abortifacient Agents|abortifacient agents|mesh-ancestor
102304385|NCT02065713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102304386|NCT02065713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304387|NCT02065713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102304388|NCT02065713|Antimetabolites|antimetabolites|mesh-ancestor
102304389|NCT02065713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304390|NCT02065713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102304391|NCT02065713|Dermatologic Agents|dermatologic agents|mesh-ancestor
102304392|NCT02065713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102304393|NCT02065713|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102304394|NCT02065713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102304395|NCT02065713|Immunologic Factors|immunologic factors|mesh-ancestor
102304396|NCT02065713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102304397|NCT02065713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102304398|NCT02065713|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102304399|NCT02065713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102304400|NCT02497781|Ceftazidime|ceftazidime|mesh-list
102304401|NCT02497781|Cefepime|cefepime|mesh-list
102304402|NCT02497781|Avibactam|avibactam|mesh-list
102304403|NCT02497781|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
102304404|NCT02497781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102304405|NCT02497781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102304406|NCT02497781|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102304407|NCT02497781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102304408|NCT02497781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304409|NCT02497469|Adalimumab|adalimumab|mesh-list
102304410|NCT02497469|Vedolizumab|vedolizumab|mesh-list
102304411|NCT02497469|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102304412|NCT02497469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102304413|NCT02497469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102304414|NCT02497469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102304415|NCT02497391|Evacetrapib|evacetrapib|mesh-list
102304416|NCT02497391|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102304417|NCT02497391|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102304418|NCT02497391|Antimetabolites|antimetabolites|mesh-ancestor
102304419|NCT02497391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304420|NCT02497391|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102304421|NCT02476175|Mirabegron|mirabegron|mesh-list
102304422|NCT02476175|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102304423|NCT02476175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102304424|NCT02476175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102304425|NCT02476175|Adrenergic Agents|adrenergic agents|mesh-ancestor
102304426|NCT02476175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102304427|NCT02476175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304428|NCT02476175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304429|NCT02476175|Urological Agents|urological agents|mesh-ancestor
102304430|NCT02065557|Adalimumab|adalimumab|mesh-list
102304431|NCT02065557|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102304432|NCT02065557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102304433|NCT02065557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102304434|NCT02065245|Penicillins|penicillins|mesh-list
102304435|NCT02065245|Streptomycin|streptomycin|mesh-list
102304436|NCT02065245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102304437|NCT02065245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102304438|NCT02065245|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102304439|NCT02065245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102304440|NCT02065245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304441|NCT02063217|Sodium Oxybate|sodium oxybate|mesh-list
102304442|NCT02063217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102304443|NCT02063217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102304444|NCT02063217|Anesthetics, General|anesthetics, general|mesh-ancestor
102304445|NCT02063217|Anesthetics|anesthetics|mesh-ancestor
102304446|NCT02063217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102304447|NCT02063217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304448|NCT02497001|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
102304449|NCT02497001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102304450|NCT02497001|Respiratory System Agents|respiratory system agents|mesh-ancestor
102304451|NCT04182555|Bilirubin|bilirubin|mesh-list
102304452|NCT04182555|Antioxidants|antioxidants|mesh-ancestor
102304453|NCT04182555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304454|NCT04182555|Protective Agents|protective agents|mesh-ancestor
102304455|NCT04182555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304456|NCT02366143|Paclitaxel|paclitaxel|mesh-list
102304457|NCT02366143|Bevacizumab|bevacizumab|mesh-list
102304458|NCT02366143|Carboplatin|carboplatin|mesh-list
102304459|NCT02366143|Atezolizumab|atezolizumab|mesh-list
102304460|NCT02366143|Antibodies|antibodies|mesh-list
102304461|NCT02366143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102304462|NCT02366143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102304463|NCT02366143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102304464|NCT02366143|Tubulin Modulators|tubulin modulators|mesh-ancestor
102304465|NCT02366143|Antimitotic Agents|antimitotic agents|mesh-ancestor
102304466|NCT02366143|Mitosis Modulators|mitosis modulators|mesh-ancestor
102304467|NCT02366143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304468|NCT02366143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102304469|NCT02366143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102304470|NCT02366143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102304471|NCT02366143|Growth Substances|growth substances|mesh-ancestor
102304472|NCT02366143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304473|NCT02366143|Growth Inhibitors|growth inhibitors|mesh-ancestor
102304474|NCT02366143|Immunologic Factors|immunologic factors|mesh-ancestor
102304475|NCT02366143|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102304476|NCT02098395|Liraglutide|liraglutide|mesh-list
102304477|NCT02098395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102304478|NCT02098395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304479|NCT02098395|Incretins|incretins|mesh-ancestor
102304480|NCT02098395|Hormones|hormones|mesh-ancestor
102304481|NCT02098395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102304482|NCT02365519|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102304483|NCT02365519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102304484|NCT02096835|Dexamethasone|dexamethasone|mesh-list
102304485|NCT02096835|Tropisetron|tropisetron|mesh-list
102304486|NCT02096835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102304487|NCT02096835|Antiemetics|antiemetics|mesh-ancestor
102304488|NCT02096835|Autonomic Agents|autonomic agents|mesh-ancestor
102304489|NCT02096835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102304490|NCT02096835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304491|NCT02096835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102304492|NCT02096835|Glucocorticoids|glucocorticoids|mesh-ancestor
102304493|NCT02096835|Hormones|hormones|mesh-ancestor
102304494|NCT02096835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102304495|NCT02096835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102304496|NCT02096835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102304497|NCT02096835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102304498|NCT02096835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102304499|NCT02096835|Serotonin Agents|serotonin agents|mesh-ancestor
102304500|NCT02096835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102304501|NCT02096835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304502|NCT02294773|Letrozole|letrozole|mesh-list
102304503|NCT02294773|Clomiphene|clomiphene|mesh-list
102304504|NCT02294773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102304505|NCT02294773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102304506|NCT02294773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102304507|NCT02294773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102304508|NCT02294773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304509|NCT02294773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102304510|NCT02294773|Hormone Antagonists|hormone antagonists|mesh-ancestor
102304511|NCT02294773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102304512|NCT02294773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304513|NCT02294773|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102304514|NCT02294773|Fertility Agents|fertility agents|mesh-ancestor
102304515|NCT02294773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102304516|NCT02294773|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102304517|NCT02294773|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102304518|NCT02365285|Heparin|heparin|mesh-list
102304519|NCT02365285|Galantamine|galantamine|mesh-list
102304520|NCT02365285|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102304521|NCT02365285|Anticoagulants|anticoagulants|mesh-ancestor
102304522|NCT02365285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102304523|NCT02365285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102304524|NCT02365285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304525|NCT02365285|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102304526|NCT02365285|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102304527|NCT02365285|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102013293|NCT01309685|Varenicline|varenicline|mesh-list
102304528|NCT02365285|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102304529|NCT02365285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102304530|NCT02365285|Cholinergic Agents|cholinergic agents|mesh-ancestor
102304531|NCT02365285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102304532|NCT02365285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304533|NCT02365285|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102304534|NCT02365285|Autonomic Agents|autonomic agents|mesh-ancestor
102304535|NCT02365285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102304536|NCT02365285|Nootropic Agents|nootropic agents|mesh-ancestor
102304537|NCT02041299|Deferiprone|deferiprone|mesh-list
102304538|NCT02041299|Deferoxamine|deferoxamine|mesh-list
102304539|NCT02041299|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102304540|NCT02041299|Chelating Agents|chelating agents|mesh-ancestor
102304541|NCT02041299|Sequestering Agents|sequestering agents|mesh-ancestor
102304542|NCT02041299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304543|NCT02041299|Siderophores|siderophores|mesh-ancestor
102304544|NCT01645735|Vancomycin|vancomycin|mesh-list
102304545|NCT01645735|Ceftriaxone|ceftriaxone|mesh-list
102304546|NCT01645735|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
102304547|NCT01645735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102304548|NCT01645735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102304549|NCT01645111|Clevidipine|clevidipine|mesh-list
102304550|NCT01645111|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102304551|NCT01645111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102304552|NCT01645111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304553|NCT01645111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102304554|NCT01645111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304555|NCT02364037|Contraceptive Agents|contraceptive agents|mesh-list
102304556|NCT02364037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102304557|NCT02364037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304558|NCT01919164|Mitogens|mitogens|mesh-list
102304559|NCT01919164|Mitosis Modulators|mitosis modulators|mesh-ancestor
102304560|NCT01919164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304561|NCT01901224|Metformin|metformin|mesh-list
102304562|NCT01901224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102304563|NCT01901224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304564|NCT01901146|Paclitaxel|paclitaxel|mesh-list
102304565|NCT01901146|Trastuzumab|trastuzumab|mesh-list
102304566|NCT01901146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102304567|NCT01901146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102304568|NCT01901146|Tubulin Modulators|tubulin modulators|mesh-ancestor
102304569|NCT01901146|Antimitotic Agents|antimitotic agents|mesh-ancestor
102304570|NCT01901146|Mitosis Modulators|mitosis modulators|mesh-ancestor
102304571|NCT01901146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304572|NCT01901146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102304573|NCT01644643|Metronidazole|metronidazole|mesh-list
102304574|NCT01644643|Ceftazidime|ceftazidime|mesh-list
102304575|NCT01644643|Avibactam|avibactam|mesh-list
102304576|NCT01644643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102304577|NCT01644643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102304578|NCT01644643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102304579|NCT01644643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102304580|NCT01644643|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102304581|NCT01644643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102304582|NCT01644643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304583|NCT01864174|Metformin|metformin|mesh-list
102304584|NCT01864174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102304585|NCT01864174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304586|NCT04420351|Aspirin|aspirin|mesh-list
102304587|NCT04420351|Clopidogrel|clopidogrel|mesh-list
102304588|NCT04420351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102304589|NCT04420351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102304590|NCT04420351|Analgesics|analgesics|mesh-ancestor
102304591|NCT04420351|Sensory System Agents|sensory system agents|mesh-ancestor
102304592|NCT04420351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102304593|NCT04420351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304594|NCT04420351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102304595|NCT04420351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102304596|NCT04420351|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102304597|NCT04420351|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102304598|NCT04420351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304599|NCT04420351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102304600|NCT04420351|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102304601|NCT04420351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102304602|NCT04420351|Antipyretics|antipyretics|mesh-ancestor
102304603|NCT04420351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102304604|NCT04420351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102304605|NCT04420351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102304606|NCT04420351|Purinergic Agents|purinergic agents|mesh-ancestor
102304607|NCT04420351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102304609|NCT01900444|Immunologic Factors|immunologic factors|mesh-ancestor
102304610|NCT01900444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304611|NCT02496221|rGLP-1 protein|rglp-1 protein|mesh-list
102304612|NCT02496221|Incretins|incretins|mesh-ancestor
102304613|NCT02496221|Hormones|hormones|mesh-ancestor
102304614|NCT02496221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102304615|NCT02496221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304616|NCT02475629|Ibalizumab|ibalizumab|mesh-list
102304617|NCT02475629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102304618|NCT02475629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102304619|NCT02475629|Antiviral Agents|antiviral agents|mesh-ancestor
102304620|NCT02475629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102304621|NCT01653743|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102304622|NCT01653743|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102304623|NCT01653743|Hormones|hormones|mesh-ancestor
102304624|NCT01653743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102304625|NCT01653743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304626|NCT01653743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102304627|NCT02293993|Guadecitabine|guadecitabine|mesh-list
102304628|NCT02293993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102304629|NCT02322775|Benralizumab|benralizumab|mesh-list
102304630|NCT02322775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102304631|NCT02322775|Respiratory System Agents|respiratory system agents|mesh-ancestor
102304632|NCT01646827|Aripiprazole|aripiprazole|mesh-list
102304633|NCT01646827|Antidepressive Agents|antidepressive agents|mesh-ancestor
102304634|NCT01646827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102304635|NCT01646827|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102304636|NCT01646827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102304637|NCT01646827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102304638|NCT01646827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304639|NCT01646827|Dopamine Agonists|dopamine agonists|mesh-ancestor
102304640|NCT01646827|Dopamine Agents|dopamine agents|mesh-ancestor
102304641|NCT01646827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102304642|NCT01646827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304643|NCT01646827|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102304644|NCT01646827|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102304645|NCT01646827|Serotonin Agents|serotonin agents|mesh-ancestor
102304646|NCT01646827|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102304647|NCT01646827|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102304648|NCT01646827|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102304649|NCT01646827|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102304650|NCT02360995|Triclosan|triclosan|mesh-list
102304651|NCT02360995|Cetylpyridinium|cetylpyridinium|mesh-list
102304652|NCT02360995|Fluorides|fluorides|mesh-list
102304653|NCT02360995|Tin Fluorides|tin fluorides|mesh-list
102304654|NCT02360995|Cariostatic Agents|cariostatic agents|mesh-ancestor
102304655|NCT02360995|Protective Agents|protective agents|mesh-ancestor
102304656|NCT02360995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304657|NCT02360995|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102304658|NCT02360995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102304659|NCT02360995|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102304660|NCT02360995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102304661|NCT02360995|Antimetabolites|antimetabolites|mesh-ancestor
102304662|NCT02360995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304663|NCT02360995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102304664|NCT02359903|Infliximab|infliximab|mesh-list
102304665|NCT02359903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102304666|NCT02359903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102304667|NCT02359903|Dermatologic Agents|dermatologic agents|mesh-ancestor
102304668|NCT02359903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102304669|NCT02359903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102304670|NCT02291419|Aspirin|aspirin|mesh-list
102304671|NCT02291419|Ticagrelor|ticagrelor|mesh-list
102304672|NCT02291419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102304673|NCT02291419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102304674|NCT02291419|Analgesics|analgesics|mesh-ancestor
102304675|NCT02291419|Sensory System Agents|sensory system agents|mesh-ancestor
102013425|NCT01321775|Trastuzumab|trastuzumab|mesh-list
102304676|NCT02291419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102304677|NCT02291419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304678|NCT02291419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102304679|NCT02291419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102304680|NCT02291419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102304681|NCT02291419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102304682|NCT02291419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304683|NCT02291419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102304684|NCT02291419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102304685|NCT02291419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102304686|NCT02291419|Antipyretics|antipyretics|mesh-ancestor
102304687|NCT02291419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102304688|NCT02291419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102304689|NCT02291419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102304690|NCT02291419|Purinergic Agents|purinergic agents|mesh-ancestor
102304691|NCT02291419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102304692|NCT02319031|Ribavirin|ribavirin|mesh-list
102304693|NCT02319031|Sofosbuvir|sofosbuvir|mesh-list
102304694|NCT02319031|Antimetabolites|antimetabolites|mesh-ancestor
102304695|NCT02319031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304696|NCT02319031|Antiviral Agents|antiviral agents|mesh-ancestor
102304697|NCT02319031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102304698|NCT02359435|Amoxicillin|amoxicillin|mesh-list
102304699|NCT02359435|Metronidazole|metronidazole|mesh-list
102304700|NCT02359435|Clarithromycin|clarithromycin|mesh-list
102304701|NCT02359435|Pantoprazole|pantoprazole|mesh-list
102304702|NCT02359435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102304703|NCT02359435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102304704|NCT02359435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102304705|NCT02359435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102304706|NCT02359435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102304707|NCT02359435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102304708|NCT02359435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304709|NCT02359435|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102304710|NCT02359435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102304711|NCT02359435|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102304712|NCT02359435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102304713|NCT02359435|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102304714|NCT04599868|Magnesium Sulfate|magnesium sulfate|mesh-list
102304715|NCT04599868|Analgesics|analgesics|mesh-ancestor
102304716|NCT04599868|Sensory System Agents|sensory system agents|mesh-ancestor
102304717|NCT04599868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102304718|NCT04599868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304719|NCT04599868|Anesthetics|anesthetics|mesh-ancestor
102304720|NCT04599868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102304721|NCT04599868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102304722|NCT04599868|Anticonvulsants|anticonvulsants|mesh-ancestor
102304723|NCT04599868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102304724|NCT04599868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102304725|NCT04599868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304726|NCT04599868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102304727|NCT04599868|Tocolytic Agents|tocolytic agents|mesh-ancestor
102304728|NCT04599868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102304729|NCT01900054|Bepotastine besilate|bepotastine besilate|mesh-list
102304730|NCT01900054|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102304731|NCT01612156|Lidocaine|lidocaine|mesh-list
102304732|NCT01612156|Anesthetics, Local|anesthetics, local|mesh-ancestor
102304733|NCT01612156|Anesthetics|anesthetics|mesh-ancestor
102304734|NCT01612156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102304735|NCT01612156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304736|NCT01612156|Sensory System Agents|sensory system agents|mesh-ancestor
102304737|NCT01612156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102304738|NCT01612156|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102304739|NCT01612156|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102304740|NCT01612156|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102304741|NCT01612156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102304742|NCT01612156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304743|NCT01899742|Tiotropium Bromide|tiotropium bromide|mesh-list
102304744|NCT01899742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102304745|NCT01899742|Autonomic Agents|autonomic agents|mesh-ancestor
102304746|NCT01899742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102304747|NCT01899742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304748|NCT01899742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102304749|NCT01899742|Respiratory System Agents|respiratory system agents|mesh-ancestor
102304750|NCT01899742|Parasympatholytics|parasympatholytics|mesh-ancestor
102304751|NCT01899742|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102013503|NCT03758729|Nivolumab|nivolumab|mesh-list
102304752|NCT01899742|Cholinergic Agents|cholinergic agents|mesh-ancestor
102304753|NCT01899742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102304754|NCT01899742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304755|NCT01615822|Artefenomel|artefenomel|mesh-list
102304756|NCT01615822|Antimalarials|antimalarials|mesh-ancestor
102304757|NCT01615822|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102304758|NCT01615822|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102304759|NCT01615822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102304760|NCT01613326|Glycopyrrolate|glycopyrrolate|mesh-list
102304761|NCT01613326|Albuterol|albuterol|mesh-list
102304762|NCT01613326|Tiotropium Bromide|tiotropium bromide|mesh-list
102304763|NCT01613326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102304764|NCT01613326|Autonomic Agents|autonomic agents|mesh-ancestor
102304765|NCT01613326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102304766|NCT01613326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304767|NCT01613326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102304768|NCT01613326|Respiratory System Agents|respiratory system agents|mesh-ancestor
102304769|NCT01613326|Parasympatholytics|parasympatholytics|mesh-ancestor
102304770|NCT01613326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102304771|NCT01613326|Cholinergic Agents|cholinergic agents|mesh-ancestor
102304772|NCT01613326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102304773|NCT01613326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304774|NCT01613326|Tocolytic Agents|tocolytic agents|mesh-ancestor
102304775|NCT01613326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102304776|NCT01613326|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102304777|NCT01613326|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102304778|NCT01613326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102304779|NCT01613326|Adrenergic Agents|adrenergic agents|mesh-ancestor
102304780|NCT01613326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102304781|NCT01613326|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102304782|NCT01898806|Triamcinolone|triamcinolone|mesh-list
102304783|NCT01898806|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102304784|NCT01898806|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102304785|NCT01898806|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102304786|NCT01898806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102304787|NCT01898806|Glucocorticoids|glucocorticoids|mesh-ancestor
102304788|NCT01898806|Hormones|hormones|mesh-ancestor
102304789|NCT01898806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102304790|NCT01898806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304791|NCT01898806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102304792|NCT01898806|Immunologic Factors|immunologic factors|mesh-ancestor
102304793|NCT01898806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102304794|NCT01898806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304795|NCT02291029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102304796|NCT02291029|Immunologic Factors|immunologic factors|mesh-ancestor
102304797|NCT02291029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304798|NCT02290873|Midazolam|midazolam|mesh-list
102304799|NCT02290873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102304800|NCT02290873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102304801|NCT02290873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101419969|NCT00506272|Insulin|insulin|mesh-list
102304802|NCT02290873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304803|NCT02290873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102304804|NCT02290873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102304805|NCT02290873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102304806|NCT02290873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102304807|NCT02290873|Anesthetics, General|anesthetics, general|mesh-ancestor
102304808|NCT02290873|Anesthetics|anesthetics|mesh-ancestor
102304809|NCT02290873|GABA Modulators|gaba modulators|mesh-ancestor
102304810|NCT02290873|GABA Agents|gaba agents|mesh-ancestor
102304811|NCT02290873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102304812|NCT02290873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304813|NCT02358343|Sertraline|sertraline|mesh-list
102304814|NCT02358343|Antidepressive Agents|antidepressive agents|mesh-list
102304815|NCT02358343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102304816|NCT02358343|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102304817|NCT02358343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102304818|NCT02358343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102304819|NCT02358343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304820|NCT02358343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102304821|NCT02358343|Serotonin Agents|serotonin agents|mesh-ancestor
102304822|NCT02358343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304823|NCT02318095|Paclitaxel|paclitaxel|mesh-list
102304824|NCT02318095|Gemcitabine|gemcitabine|mesh-list
102304825|NCT02318095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102304826|NCT02318095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102304827|NCT02318095|Tubulin Modulators|tubulin modulators|mesh-ancestor
102304828|NCT02318095|Antimitotic Agents|antimitotic agents|mesh-ancestor
102304829|NCT02318095|Mitosis Modulators|mitosis modulators|mesh-ancestor
102304830|NCT02318095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304831|NCT02318095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102304832|NCT02318095|Antimetabolites|antimetabolites|mesh-ancestor
102304833|NCT02317627|Belumosudil|belumosudil|mesh-list
102304834|NCT02317627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102304835|NCT02317627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102304836|NCT02317627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304837|NCT02517905|Bupivacaine|bupivacaine|mesh-list
102304838|NCT02517905|Anesthetics, Local|anesthetics, local|mesh-ancestor
102304839|NCT02517905|Anesthetics|anesthetics|mesh-ancestor
102304840|NCT02517905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102304841|NCT02517905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304842|NCT02517905|Sensory System Agents|sensory system agents|mesh-ancestor
102304843|NCT02517905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102304844|NCT02473913|Silymarin|silymarin|mesh-list
102304845|NCT02473913|Antioxidants|antioxidants|mesh-ancestor
102304846|NCT02473913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304847|NCT02473913|Protective Agents|protective agents|mesh-ancestor
102304848|NCT02473913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304849|NCT02316847|Diazepam|diazepam|mesh-list
102304850|NCT02316847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102304851|NCT02316847|Anticonvulsants|anticonvulsants|mesh-ancestor
102304852|NCT02316847|Antiemetics|antiemetics|mesh-ancestor
102304853|NCT02316847|Autonomic Agents|autonomic agents|mesh-ancestor
102304854|NCT02316847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102304855|NCT02316847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304856|NCT02316847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102304857|NCT02316847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102304858|NCT02316847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102304859|NCT02316847|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102304860|NCT02316847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102304861|NCT02316847|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102304862|NCT02316847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102304863|NCT02316847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102304864|NCT02316847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102304865|NCT02316847|Anesthetics, General|anesthetics, general|mesh-ancestor
102304866|NCT02316847|Anesthetics|anesthetics|mesh-ancestor
102304867|NCT02316847|GABA Modulators|gaba modulators|mesh-ancestor
102304868|NCT02316847|GABA Agents|gaba agents|mesh-ancestor
102304869|NCT02316847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102304870|NCT02316847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304871|NCT02473445|Cysteamine|cysteamine|mesh-list
102304872|NCT02473445|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
102304873|NCT02473445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304874|NCT02473367|Raltegravir Potassium|raltegravir potassium|mesh-list
102304875|NCT02473367|Antacids|antacids|mesh-list
102304876|NCT02473367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102304877|NCT02473367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102304878|NCT02473367|Antiviral Agents|antiviral agents|mesh-ancestor
102304879|NCT02473367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102304880|NCT02473367|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102304881|NCT02473367|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102304882|NCT02473367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102304883|NCT02473367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304884|NCT02473367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102304885|NCT04965701|Osimertinib|osimertinib|mesh-list
102304886|NCT04965701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102304887|NCT04965701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102304888|NCT04965701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102304889|NCT04965701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304890|NCT02316613|Rituximab|rituximab|mesh-list
102304891|NCT02316613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102304892|NCT02316613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102304893|NCT02316613|Immunologic Factors|immunologic factors|mesh-ancestor
102304894|NCT02316613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304895|NCT02316613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102304896|NCT02492165|Vaccines|vaccines|mesh-list
102304897|NCT02492165|Immunologic Factors|immunologic factors|mesh-ancestor
102304898|NCT02492165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304899|NCT02354599|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102304900|NCT02354599|Immunologic Factors|immunologic factors|mesh-ancestor
102304901|NCT02354599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304902|NCT02286895|Vaccines|vaccines|mesh-list
102304903|NCT02286895|Immunologic Factors|immunologic factors|mesh-ancestor
102304904|NCT02286895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304906|NCT02472977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102304907|NCT02472977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102304908|NCT02472977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102304909|NCT02472977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304910|NCT02060487|Sildenafil Citrate|sildenafil citrate|mesh-list
102304911|NCT02060487|Citric Acid|citric acid|mesh-list
102304912|NCT02060487|Sodium Citrate|sodium citrate|mesh-list
102304913|NCT02060487|Anticoagulants|anticoagulants|mesh-ancestor
102304914|NCT02060487|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102304915|NCT02060487|Chelating Agents|chelating agents|mesh-ancestor
102304916|NCT02060487|Sequestering Agents|sequestering agents|mesh-ancestor
102304917|NCT02060487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304918|NCT02060487|Vasodilator Agents|vasodilator agents|mesh-ancestor
102304919|NCT02060487|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102304920|NCT02060487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102304921|NCT02060487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102304922|NCT02060487|Urological Agents|urological agents|mesh-ancestor
102304923|NCT02059239|Cytarabine|cytarabine|mesh-list
102304924|NCT02059239|Rituximab|rituximab|mesh-list
102304925|NCT02059239|Alemtuzumab|alemtuzumab|mesh-list
102304926|NCT02059239|Etoposide|etoposide|mesh-list
102304927|NCT02059239|Melphalan|melphalan|mesh-list
102304928|NCT02059239|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102304929|NCT02059239|Carmustine|carmustine|mesh-list
102304930|NCT02059239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102304931|NCT02059239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102304932|NCT02059239|Immunologic Factors|immunologic factors|mesh-ancestor
102304933|NCT02059239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304934|NCT02059239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102304935|NCT02059239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102304936|NCT02059239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102304937|NCT02059239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102304938|NCT02059239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102304939|NCT02059239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304940|NCT02059239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102304941|NCT02059239|Antimetabolites|antimetabolites|mesh-ancestor
102304942|NCT02059239|Antiviral Agents|antiviral agents|mesh-ancestor
102304943|NCT02059239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102304944|NCT02059239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101420110|NCT00143156|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102304945|NCT02059239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102304946|NCT02059239|Alkylating Agents|alkylating agents|mesh-ancestor
102304947|NCT02059239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102304948|NCT02059161|Insulin|insulin|mesh-list
102304949|NCT02059161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102304950|NCT02059161|Insulin Glargine|insulin glargine|mesh-list
102304951|NCT02059161|MK-1293|mk-1293|mesh-list
102304952|NCT02059161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102304953|NCT02059161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304954|NCT02059161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102304955|NCT02059161|Antimetabolites|antimetabolites|mesh-ancestor
102304956|NCT02059161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304957|NCT02059161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102304958|NCT01897714|Dexamethasone|dexamethasone|mesh-list
102304959|NCT01897714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102304960|NCT01897714|Antiemetics|antiemetics|mesh-ancestor
102304961|NCT01897714|Autonomic Agents|autonomic agents|mesh-ancestor
102304962|NCT01897714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102304963|NCT01897714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304964|NCT01897714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102304965|NCT01897714|Glucocorticoids|glucocorticoids|mesh-ancestor
102304966|NCT01897714|Hormones|hormones|mesh-ancestor
102304967|NCT01897714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102304968|NCT01897714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102304969|NCT01897714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102304970|NCT01861522|Bepotastine besilate|bepotastine besilate|mesh-list
102304971|NCT01861522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102304972|NCT01860976|Abatacept|abatacept|mesh-list
102304973|NCT01860976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102304974|NCT01860976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304975|NCT01860976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102304976|NCT01860976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102304977|NCT01860976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102304978|NCT01860976|Immunologic Factors|immunologic factors|mesh-ancestor
102304979|NCT01860976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304980|NCT01860976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102304981|NCT01860040|Gemcitabine|gemcitabine|mesh-list
102304983|NCT01860040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102304984|NCT01860040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102304985|NCT01860040|Antimetabolites|antimetabolites|mesh-ancestor
102304986|NCT01860040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102304987|NCT01860040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102304988|NCT01860040|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102304989|NCT01860040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102304990|NCT04618744|Insulin|insulin|mesh-list
102304991|NCT04618744|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102304992|NCT04618744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102304993|NCT04618744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102304994|NCT01896934|Sertraline|sertraline|mesh-list
102304995|NCT01896934|Antidepressive Agents|antidepressive agents|mesh-ancestor
102304996|NCT01896934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102304997|NCT01896934|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102304998|NCT01896934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102304999|NCT01896934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102305000|NCT01896934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305001|NCT01896934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102305002|NCT01896934|Serotonin Agents|serotonin agents|mesh-ancestor
102305003|NCT01896934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305004|NCT02039505|Vedolizumab|vedolizumab|mesh-list
102305005|NCT02039505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102305006|NCT02095197|Triamcinolone|triamcinolone|mesh-list
102305007|NCT02095197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102305008|NCT02095197|Glucocorticoids|glucocorticoids|mesh-ancestor
102305009|NCT02095197|Hormones|hormones|mesh-ancestor
102305010|NCT02095197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102305011|NCT02095197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305012|NCT02039427|Dexamethasone|dexamethasone|mesh-list
102305013|NCT02039427|Ketorolac|ketorolac|mesh-list
102305014|NCT02039427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102305015|NCT02039427|Antiemetics|antiemetics|mesh-ancestor
102305016|NCT02039427|Autonomic Agents|autonomic agents|mesh-ancestor
102305017|NCT02039427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102305018|NCT02039427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305019|NCT02039427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102305020|NCT02039427|Glucocorticoids|glucocorticoids|mesh-ancestor
102305021|NCT02039427|Hormones|hormones|mesh-ancestor
102305022|NCT02039427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102305023|NCT02039427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102305024|NCT02039427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102305025|NCT02039427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102305026|NCT02039427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102305027|NCT02039427|Analgesics|analgesics|mesh-ancestor
102305028|NCT02039427|Sensory System Agents|sensory system agents|mesh-ancestor
102305029|NCT02039427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102305030|NCT02039427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102305031|NCT02039427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102305032|NCT02039427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305033|NCT02094885|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102305034|NCT02094885|Hemostatics|hemostatics|mesh-ancestor
102305035|NCT02094885|Coagulants|coagulants|mesh-ancestor
102305036|NCT01896856|Trifluridine|trifluridine|mesh-list
102305037|NCT01896856|Irinotecan|irinotecan|mesh-list
102305038|NCT01896856|Guadecitabine|guadecitabine|mesh-list
102305039|NCT01896856|Azacitidine|azacitidine|mesh-list
102305040|NCT01896856|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102305041|NCT01896856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102305042|NCT01896856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102305043|NCT01896856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305044|NCT01896856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102305045|NCT01896856|Antimetabolites|antimetabolites|mesh-ancestor
102305046|NCT01896856|Antiviral Agents|antiviral agents|mesh-ancestor
102305047|NCT01896856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102305048|NCT01896856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102305049|NCT01896700|Methylphenidate|methylphenidate|mesh-list
102305050|NCT01896700|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102305051|NCT01896700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305052|NCT01896700|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102305053|NCT01896700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102305054|NCT01896700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102305055|NCT01896700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305056|NCT01896700|Dopamine Agents|dopamine agents|mesh-ancestor
102305057|NCT01896700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102305059|NCT01896232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102305060|NCT01896232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305061|NCT01896232|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
102305062|NCT01896232|Hormone Antagonists|hormone antagonists|mesh-ancestor
102305063|NCT01896232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102305064|NCT02460224|Spartalizumab|spartalizumab|mesh-list
102305065|NCT02460224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102305066|NCT02460224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305067|NCT02460224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102305068|NCT02460224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102305069|NCT02058537|Bethanechol|bethanechol|mesh-list
102305070|NCT02058537|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102305071|NCT02058537|Autonomic Agents|autonomic agents|mesh-ancestor
102305072|NCT02058537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102305073|NCT02058537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305074|NCT02058537|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102305075|NCT02058537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102305076|NCT02058537|Cholinergic Agents|cholinergic agents|mesh-ancestor
102305077|NCT02058537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102305078|NCT02058537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305079|NCT01612000|Hemagglutinins|hemagglutinins|mesh-list
102305080|NCT01612000|Agglutinins|agglutinins|mesh-ancestor
102305081|NCT01612000|Immunologic Factors|immunologic factors|mesh-ancestor
102305082|NCT01612000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305083|NCT01612000|Coagulants|coagulants|mesh-ancestor
102305084|NCT02409680|Aspirin|aspirin|mesh-list
102305085|NCT02409680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102305086|NCT02409680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102305087|NCT02409680|Analgesics|analgesics|mesh-ancestor
102305088|NCT02409680|Sensory System Agents|sensory system agents|mesh-ancestor
102305089|NCT02409680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102305090|NCT02409680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305091|NCT02409680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102305092|NCT02409680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102305093|NCT02409680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102305094|NCT02409680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102305095|NCT02409680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305096|NCT02409680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102305097|NCT02409680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102305098|NCT02409680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102305099|NCT02409680|Antipyretics|antipyretics|mesh-ancestor
102305100|NCT01894984|Risperidone|risperidone|mesh-list
102305101|NCT01894984|Antipsychotic Agents|antipsychotic agents|mesh-list
102305102|NCT01894984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102305103|NCT01894984|Serotonin Agents|serotonin agents|mesh-ancestor
102305104|NCT01894984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102305105|NCT01894984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305106|NCT01894984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305107|NCT01894984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102305108|NCT01894984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102305109|NCT01894984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102305110|NCT01894984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102305111|NCT01894984|Dopamine Agents|dopamine agents|mesh-ancestor
102305112|NCT02375672|Pembrolizumab|pembrolizumab|mesh-list
102305113|NCT02375672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102305114|NCT02375672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102305115|NCT02375672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102305116|NCT02375672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305117|NCT02491463|Vaccines|vaccines|mesh-list
102305118|NCT02491463|Immunologic Factors|immunologic factors|mesh-ancestor
102305119|NCT02491463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305120|NCT02038881|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
102305121|NCT02038881|Antiviral Agents|antiviral agents|mesh-ancestor
102305122|NCT02038881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102305123|NCT01857622|Edoxaban|edoxaban|mesh-list
102305124|NCT01857622|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102305125|NCT01857622|Antithrombins|antithrombins|mesh-ancestor
102305126|NCT01857622|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102305127|NCT01857622|Protease Inhibitors|protease inhibitors|mesh-ancestor
102305128|NCT01857622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102305129|NCT01857622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305130|NCT01857622|Anticoagulants|anticoagulants|mesh-ancestor
102305131|NCT01857310|Folic Acid|folic acid|mesh-list
102305132|NCT01857310|Hematinics|hematinics|mesh-ancestor
102305133|NCT01857310|Vitamin B Complex|vitamin b complex|mesh-ancestor
102305134|NCT01857310|Vitamins|vitamins|mesh-ancestor
102305135|NCT01857310|Micronutrients|micronutrients|mesh-ancestor
102305136|NCT01857310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305137|NCT02472353|Metformin|metformin|mesh-list
102305138|NCT02472353|Doxorubicin|doxorubicin|mesh-list
102305139|NCT02472353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102305140|NCT02472353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305141|NCT02472353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102305142|NCT02472353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102305143|NCT02472353|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102305144|NCT02472353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102305145|NCT02472353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102305146|NCT02472353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305147|NCT02314117|Fluorouracil|fluorouracil|mesh-list
102305148|NCT02314117|Capecitabine|capecitabine|mesh-list
102305149|NCT02314117|Ramucirumab|ramucirumab|mesh-list
102305150|NCT02314117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102305151|NCT02314117|Antimetabolites|antimetabolites|mesh-ancestor
102305152|NCT02314117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305153|NCT02314117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102305154|NCT02314117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102305155|NCT02314117|Immunologic Factors|immunologic factors|mesh-ancestor
102305156|NCT02314117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305157|NCT02058147|Insulin|insulin|mesh-list
102305158|NCT02058147|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102305159|NCT02058147|Metformin|metformin|mesh-list
102305160|NCT02058147|Insulin Glargine|insulin glargine|mesh-list
102305161|NCT02058147|Lixisenatide|lixisenatide|mesh-list
102305162|NCT02058147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102305163|NCT02058147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305164|NCT02489981|Tiotropium Bromide|tiotropium bromide|mesh-list
102305165|NCT02489981|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102305166|NCT02489981|Autonomic Agents|autonomic agents|mesh-ancestor
102305167|NCT02489981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102305168|NCT02489981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305169|NCT02489981|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102305170|NCT02489981|Respiratory System Agents|respiratory system agents|mesh-ancestor
102305171|NCT02489981|Parasympatholytics|parasympatholytics|mesh-ancestor
102305172|NCT02489981|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102305173|NCT02489981|Cholinergic Agents|cholinergic agents|mesh-ancestor
102305174|NCT02489981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102305175|NCT02489981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305176|NCT02471183|Selexipag|selexipag|mesh-list
102305177|NCT02471183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102305178|NCT04964063|Listerine|listerine|mesh-list
102305179|NCT04964063|Fluorides|fluorides|mesh-list
102305180|NCT04964063|Sodium Fluoride|sodium fluoride|mesh-list
102305181|NCT04964063|Cariostatic Agents|cariostatic agents|mesh-ancestor
102305182|NCT04964063|Protective Agents|protective agents|mesh-ancestor
102305183|NCT04964063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305184|NCT04964063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102305185|NCT04964063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102305186|NCT04204967|Fentanyl|fentanyl|mesh-list
102305187|NCT04204967|Remifentanil|remifentanil|mesh-list
102305188|NCT04204967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102305189|NCT04204967|Narcotics|narcotics|mesh-ancestor
102305190|NCT04204967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102305191|NCT04204967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305192|NCT04204967|Analgesics|analgesics|mesh-ancestor
102305193|NCT04204967|Sensory System Agents|sensory system agents|mesh-ancestor
102305194|NCT04204967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102305195|NCT04204967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102305196|NCT04204967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102305197|NCT04204967|Anesthetics, General|anesthetics, general|mesh-ancestor
102305198|NCT04204967|Anesthetics|anesthetics|mesh-ancestor
102305199|NCT01855828|Paclitaxel|paclitaxel|mesh-list
102013956|NCT05180292|Antioxidants|antioxidants|mesh-ancestor
102305200|NCT01855828|Cyclophosphamide|cyclophosphamide|mesh-list
102305201|NCT01855828|Fluorouracil|fluorouracil|mesh-list
102305202|NCT01855828|Trastuzumab|trastuzumab|mesh-list
102305203|NCT01855828|Epirubicin|epirubicin|mesh-list
102305204|NCT01855828|Pertuzumab|pertuzumab|mesh-list
102305205|NCT01855828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102305206|NCT01855828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102305207|NCT01855828|Tubulin Modulators|tubulin modulators|mesh-ancestor
102305208|NCT01855828|Antimitotic Agents|antimitotic agents|mesh-ancestor
102305209|NCT01855828|Mitosis Modulators|mitosis modulators|mesh-ancestor
102305210|NCT01855828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305211|NCT01855828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102305212|NCT01855828|Immunologic Factors|immunologic factors|mesh-ancestor
102305213|NCT01855828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305214|NCT01855828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102305215|NCT01855828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102305216|NCT01855828|Alkylating Agents|alkylating agents|mesh-ancestor
102305217|NCT01855828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102305218|NCT01855828|Antimetabolites|antimetabolites|mesh-ancestor
102305219|NCT01855828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102305220|NCT01855828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102305221|NCT01855828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102305222|NCT01855828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102305223|NCT01855828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102305224|NCT01855828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102305225|NCT04417335|BCG Vaccine|bcg vaccine|mesh-list
102305226|NCT04417335|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102305227|NCT04417335|Immunologic Factors|immunologic factors|mesh-ancestor
102305228|NCT04417335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305229|NCT02351167|Nicotine|nicotine|mesh-list
102305230|NCT02351167|Varenicline|varenicline|mesh-list
102305231|NCT02351167|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102305232|NCT02351167|Autonomic Agents|autonomic agents|mesh-ancestor
102305233|NCT02351167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102305234|NCT02351167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305235|NCT02351167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102305236|NCT02351167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102305237|NCT02351167|Cholinergic Agents|cholinergic agents|mesh-ancestor
102305238|NCT02351167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102305239|NCT02351167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305241|NCT02350309|Flurazepam|flurazepam|mesh-list
102305242|NCT02350309|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102305243|NCT02350309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102305244|NCT02350309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305245|NCT02350309|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102305246|NCT02350309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102305247|NCT02350309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102305248|NCT02350309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305249|NCT02350309|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102305250|NCT02350309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102305251|NCT02350309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102305252|NCT02350309|GABA Modulators|gaba modulators|mesh-ancestor
102305253|NCT02350309|GABA Agents|gaba agents|mesh-ancestor
102305254|NCT02038647|Paclitaxel|paclitaxel|mesh-list
102305255|NCT02038647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102305256|NCT02038647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102305257|NCT02038647|Tubulin Modulators|tubulin modulators|mesh-ancestor
102305258|NCT02038647|Antimitotic Agents|antimitotic agents|mesh-ancestor
102305259|NCT02038647|Mitosis Modulators|mitosis modulators|mesh-ancestor
102305260|NCT02038647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305261|NCT02057757|Nitazoxanide|nitazoxanide|mesh-list
102305262|NCT02057757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102305263|NCT02057757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102305264|NCT02037477|Esomeprazole|esomeprazole|mesh-list
102305265|NCT02037477|Rabeprazole|rabeprazole|mesh-list
102305266|NCT02037477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102305267|NCT02037477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102305268|NCT02037477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102305269|NCT02037477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102305270|NCT02037477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305271|NCT02057523|Hormones|hormones|mesh-list
102305272|NCT02057523|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102305273|NCT02057523|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
102305274|NCT02057523|beta-Endorphin|beta-endorphin|mesh-list
102305275|NCT02057523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102305276|NCT02057523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305277|NCT02057523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102305278|NCT02057523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305279|NCT02037165|Celecoxib|celecoxib|mesh-list
102014024|NCT04409964|Anesthetics|anesthetics|mesh-ancestor
102305280|NCT02037165|Pregabalin|pregabalin|mesh-list
102305281|NCT02037165|Analgesics|analgesics|mesh-ancestor
102305282|NCT02037165|Sensory System Agents|sensory system agents|mesh-ancestor
102305283|NCT02037165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102305284|NCT02037165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305285|NCT02037165|Anticonvulsants|anticonvulsants|mesh-ancestor
102305286|NCT02037165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102305287|NCT02037165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102305288|NCT02037165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305289|NCT02037165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102305290|NCT02037165|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102305291|NCT02037165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102305292|NCT02037165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102305293|NCT02037165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101420456|NCT00507091|Leucovorin|leucovorin|mesh-list
102305294|NCT02037165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102305295|NCT02037165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102305296|NCT02037165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102305297|NCT02037165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102305298|NCT02037165|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102305299|NCT02037165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102305300|NCT02037165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102305301|NCT02470403|Licogliflozin|licogliflozin|mesh-list
102305302|NCT02470403|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102305303|NCT02470403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305304|NCT02470403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102305305|NCT02470403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305306|NCT01855750|Prednisone|prednisone|mesh-list
102305307|NCT01855750|Cyclophosphamide|cyclophosphamide|mesh-list
102305308|NCT01855750|Rituximab|rituximab|mesh-list
102305309|NCT01855750|Doxorubicin|doxorubicin|mesh-list
102305311|NCT01855750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102305312|NCT01855750|Immunologic Factors|immunologic factors|mesh-ancestor
102305313|NCT01855750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305314|NCT01855750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102305315|NCT01855750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102305316|NCT01855750|Alkylating Agents|alkylating agents|mesh-ancestor
102305317|NCT01855750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305318|NCT01855750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102305319|NCT01855750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102305320|NCT01855750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102305321|NCT01855750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102305322|NCT01855750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102305323|NCT01855750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102305324|NCT01855750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102305325|NCT01855750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102305326|NCT01855750|Glucocorticoids|glucocorticoids|mesh-ancestor
102305327|NCT01855750|Hormones|hormones|mesh-ancestor
102305328|NCT01855750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102305329|NCT01855750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102305330|NCT01855750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102305331|NCT01855750|Tubulin Modulators|tubulin modulators|mesh-ancestor
102305332|NCT01855750|Antimitotic Agents|antimitotic agents|mesh-ancestor
102305333|NCT01855750|Mitosis Modulators|mitosis modulators|mesh-ancestor
102305334|NCT04963439|Macitentan|macitentan|mesh-list
102305335|NCT04963439|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
102305336|NCT04963439|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102305337|NCT04963439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305338|NCT04963439|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
102305339|NCT01622673|Raltegravir Potassium|raltegravir potassium|mesh-list
102305340|NCT01622673|Calcium Carbonate|calcium carbonate|mesh-list
102305341|NCT01622673|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102305342|NCT01622673|Antacids|antacids|mesh-list
102305343|NCT01622673|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
102305344|NCT01622673|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
102305345|NCT01622673|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
102305346|NCT01622673|TEMPO|tempo|mesh-list
102305347|NCT01622673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305348|NCT01622673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102305349|NCT01622673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102305350|NCT01622673|Antiviral Agents|antiviral agents|mesh-ancestor
102305351|NCT01622673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102305352|NCT01622673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102305353|NCT01622673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102305354|NCT01622673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102305355|NCT01622673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305356|NCT01622673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102305357|NCT01622673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102305358|NCT01622673|Immunologic Factors|immunologic factors|mesh-ancestor
102305359|NCT01622673|Antioxidants|antioxidants|mesh-ancestor
102305360|NCT01622673|Protective Agents|protective agents|mesh-ancestor
102305361|NCT02469077|Morphine|morphine|mesh-list
102305362|NCT02469077|Naloxone|naloxone|mesh-list
102305363|NCT02469077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102305364|NCT02469077|Narcotics|narcotics|mesh-ancestor
102305365|NCT02469077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102305366|NCT02469077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305367|NCT02469077|Analgesics|analgesics|mesh-ancestor
102305368|NCT02469077|Sensory System Agents|sensory system agents|mesh-ancestor
102305369|NCT02469077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102305370|NCT02469077|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102305371|NCT02486627|Levofloxacin|levofloxacin|mesh-list
102305372|NCT02486627|Meropenem|meropenem|mesh-list
102305373|NCT02486627|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102305374|NCT02486627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102305375|NCT02486627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102305376|NCT02486627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102305377|NCT02486627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102305378|NCT02486627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102305379|NCT02486627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305380|NCT02486627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102305381|NCT02486627|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102305382|NCT02486627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102305384|NCT02282293|Trimethoprim|trimethoprim|mesh-list
102305385|NCT02282293|Artenimol|artenimol|mesh-list
102305386|NCT02282293|Sulfamethoxazole|sulfamethoxazole|mesh-list
102305387|NCT02282293|Antimalarials|antimalarials|mesh-ancestor
102305388|NCT02282293|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102305389|NCT02282293|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102305390|NCT02282293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102305391|NCT02282293|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102305392|NCT02282293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102305393|NCT02282293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102305394|NCT02282293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305395|NCT02282293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102305396|NCT02282293|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102305397|NCT02282293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102305398|NCT01854658|Glycopyrrolate|glycopyrrolate|mesh-list
102305399|NCT01854658|Formoterol Fumarate|formoterol fumarate|mesh-list
102305400|NCT01854658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102305401|NCT01854658|Autonomic Agents|autonomic agents|mesh-ancestor
102305402|NCT01854658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102305403|NCT01854658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305404|NCT01854658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102305405|NCT01854658|Respiratory System Agents|respiratory system agents|mesh-ancestor
102305406|NCT01854658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102305407|NCT01854658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102305408|NCT01854658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102305409|NCT01854658|Adrenergic Agents|adrenergic agents|mesh-ancestor
102305410|NCT01854658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102305411|NCT01854658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305412|NCT01854658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102305413|NCT01854658|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102305414|NCT01854658|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102305415|NCT01854658|Cholinergic Agents|cholinergic agents|mesh-ancestor
102305416|NCT01892020|Insulin|insulin|mesh-list
102305417|NCT01892020|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102305418|NCT01892020|Insulin Aspart|insulin aspart|mesh-list
102305419|NCT01892020|Biphasic Insulins|biphasic insulins|mesh-list
102305420|NCT01892020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102305421|NCT01892020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305422|NCT02485691|Prednisone|prednisone|mesh-list
102305423|NCT02485691|Abiraterone Acetate|abiraterone acetate|mesh-list
102305424|NCT02485691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102305425|NCT02485691|Glucocorticoids|glucocorticoids|mesh-ancestor
102305426|NCT02485691|Hormones|hormones|mesh-ancestor
102305427|NCT02485691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102305428|NCT02485691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305429|NCT02485691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102305430|NCT02485691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102305431|NCT02485691|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102305432|NCT02485691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102305433|NCT02485691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305434|NCT02485691|Hormone Antagonists|hormone antagonists|mesh-ancestor
101421440|NCT00157872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102305435|NCT02485691|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102305436|NCT02517515|Ritonavir|ritonavir|mesh-list
102305437|NCT02517515|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102305438|NCT02517515|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102305439|NCT02517515|Protease Inhibitors|protease inhibitors|mesh-ancestor
102305440|NCT02517515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102305441|NCT02517515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305442|NCT02517515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102305443|NCT02517515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102305444|NCT02517515|Antiviral Agents|antiviral agents|mesh-ancestor
102305445|NCT02517515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102305446|NCT02517515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102305447|NCT02517515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102305448|NCT01891864|Etanercept|etanercept|mesh-list
102305449|NCT01891864|GP2015|gp2015|mesh-list
102305450|NCT01891864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102305451|NCT01891864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102305452|NCT01891864|Analgesics|analgesics|mesh-ancestor
102305453|NCT01891864|Sensory System Agents|sensory system agents|mesh-ancestor
102305454|NCT01891864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102305455|NCT01891864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305456|NCT01891864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101941556|NCT03923361|Propofol|propofol|mesh-list
102305457|NCT01891864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102305458|NCT01891864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102305459|NCT01891864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102305460|NCT01891864|Immunologic Factors|immunologic factors|mesh-ancestor
102305461|NCT01891864|Dermatologic Agents|dermatologic agents|mesh-ancestor
102305462|NCT02484911|Dexamethasone|dexamethasone|mesh-list
102305463|NCT02484911|Olanzapine|olanzapine|mesh-list
102305464|NCT02484911|Aprepitant|aprepitant|mesh-list
102305465|NCT02484911|Palonosetron|palonosetron|mesh-list
102305466|NCT02484911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102305467|NCT02484911|Antiemetics|antiemetics|mesh-ancestor
102305468|NCT02484911|Autonomic Agents|autonomic agents|mesh-ancestor
102305469|NCT02484911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102305470|NCT02484911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305471|NCT02484911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102305472|NCT02484911|Glucocorticoids|glucocorticoids|mesh-ancestor
102305473|NCT02484911|Hormones|hormones|mesh-ancestor
102305474|NCT02484911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102305475|NCT02484911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102305476|NCT02484911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102305477|NCT02484911|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102305478|NCT02484911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102305479|NCT02484911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102305480|NCT02484911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102305481|NCT02484911|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102305482|NCT02484911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102305483|NCT02484911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102305484|NCT02484911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305485|NCT02484911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102305486|NCT02484911|Serotonin Agents|serotonin agents|mesh-ancestor
102305487|NCT02484911|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102305488|NCT02484911|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102305489|NCT02484911|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102305490|NCT04306367|Pembrolizumab|pembrolizumab|mesh-list
102305491|NCT04306367|Olaparib|olaparib|mesh-list
102305492|NCT04306367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102305493|NCT04306367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102305494|NCT04306367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102305495|NCT04306367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305496|NCT04306367|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102305497|NCT04306367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102305498|NCT04616014|Insulin|insulin|mesh-list
102305499|NCT04616014|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102305500|NCT04616014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102305501|NCT04616014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014251|NCT00703846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102305502|NCT02451917|Insulin|insulin|mesh-list
102305503|NCT02451917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102305504|NCT02451917|Insulin Glargine|insulin glargine|mesh-list
102305505|NCT02451917|Insulin, Isophane|insulin, isophane|mesh-list
102305506|NCT02451917|Isophane Insulin, Human|isophane insulin, human|mesh-list
102305507|NCT02451917|Isophane insulin, beef|isophane insulin, beef|mesh-list
102305508|NCT02451917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102305509|NCT02451917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305510|NCT02349451|Adalimumab|adalimumab|mesh-list
102305511|NCT02349451|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102305512|NCT02349451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102305513|NCT02349451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102305514|NCT04956263|Dapagliflozin|dapagliflozin|mesh-list
102305515|NCT04956263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102305516|NCT04956263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305517|NCT04956263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102305518|NCT04956263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305519|NCT02409368|Nivolumab|nivolumab|mesh-list
102305520|NCT02409368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102305521|NCT02409368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102305522|NCT02409368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102305523|NCT02409368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305524|NCT04891484|Ondansetron|ondansetron|mesh-list
102305525|NCT04891484|Antiemetics|antiemetics|mesh-ancestor
102305526|NCT04891484|Autonomic Agents|autonomic agents|mesh-ancestor
102305527|NCT04891484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102305528|NCT04891484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305529|NCT04891484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102305530|NCT04891484|Antipruritics|antipruritics|mesh-ancestor
102305531|NCT04891484|Dermatologic Agents|dermatologic agents|mesh-ancestor
102305532|NCT04891484|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102305533|NCT04891484|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102305534|NCT04891484|Serotonin Agents|serotonin agents|mesh-ancestor
102305535|NCT04891484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102305536|NCT04891484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305537|NCT02408120|Insulin|insulin|mesh-list
102305538|NCT02408120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102305539|NCT02408120|Insulin Glargine|insulin glargine|mesh-list
102305540|NCT02408120|Insulin Aspart|insulin aspart|mesh-list
102305541|NCT02408120|Insulin, Long-Acting|insulin, long-acting|mesh-list
102305542|NCT02408120|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102305543|NCT02408120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102305544|NCT02408120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305545|NCT01853644|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102305546|NCT01853644|Tivozanib|tivozanib|mesh-list
102305547|NCT01853644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102305548|NCT01853644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102305549|NCT01853644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305550|NCT01853254|Ribavirin|ribavirin|mesh-list
102305551|NCT01853254|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102305552|NCT01853254|Antimetabolites|antimetabolites|mesh-ancestor
102305553|NCT01853254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305554|NCT01853254|Antiviral Agents|antiviral agents|mesh-ancestor
102305555|NCT01853254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102305556|NCT02373098|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102305557|NCT02373098|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102305558|NCT02373098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305559|NCT02373098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102305560|NCT02373098|Immunologic Factors|immunologic factors|mesh-ancestor
102305561|NCT02373098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305562|NCT01853176|Bupivacaine|bupivacaine|mesh-list
102305563|NCT01853176|Anesthetics, Local|anesthetics, local|mesh-ancestor
102305564|NCT01853176|Anesthetics|anesthetics|mesh-ancestor
102305565|NCT01853176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102305566|NCT01853176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305567|NCT01853176|Sensory System Agents|sensory system agents|mesh-ancestor
102305568|NCT01853176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102305569|NCT01852942|Losartan|losartan|mesh-list
102305570|NCT01852942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102305571|NCT01852942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102305572|NCT01852942|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102305573|NCT01852942|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102305574|NCT01852942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014338|NCT05262322|Apixaban|apixaban|mesh-list
102305575|NCT01852162|Dabigatran|dabigatran|mesh-list
102305576|NCT01852162|Antithrombins|antithrombins|mesh-ancestor
102305577|NCT01852162|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102305578|NCT01852162|Protease Inhibitors|protease inhibitors|mesh-ancestor
102305579|NCT01852162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102305580|NCT01852162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305581|NCT01852162|Anticoagulants|anticoagulants|mesh-ancestor
102305582|NCT01835470|Abatacept|abatacept|mesh-list
102305583|NCT01835470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102305584|NCT01835470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305585|NCT01835470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102305586|NCT01835470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102305587|NCT01835470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102305588|NCT01835470|Immunologic Factors|immunologic factors|mesh-ancestor
102305589|NCT01835470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305590|NCT01835470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102305591|NCT02451137|Insulin|insulin|mesh-list
102305592|NCT02451137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102305593|NCT02451137|Insulin Glargine|insulin glargine|mesh-list
102305594|NCT02451137|Insulin Detemir|insulin detemir|mesh-list
102305595|NCT02451137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102305596|NCT02451137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305597|NCT02372006|Afatinib|afatinib|mesh-list
102305598|NCT02372006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102305599|NCT02372006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102305600|NCT02372006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102305601|NCT02372006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305602|NCT02406248|Ticagrelor|ticagrelor|mesh-list
102305603|NCT02406248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102305604|NCT02406248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102305605|NCT02406248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102305606|NCT02406248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102305607|NCT02406248|Purinergic Agents|purinergic agents|mesh-ancestor
102305608|NCT02406248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102305609|NCT02406248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305610|NCT02406248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305611|NCT02450903|Ceritinib|ceritinib|mesh-list
102305612|NCT02450903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102305613|NCT02450903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102305614|NCT02450903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102305615|NCT02450903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305616|NCT02371616|Listerine|listerine|mesh-list
102305617|NCT02371616|Calcium|calcium|mesh-list
102305618|NCT02371616|Fluorides|fluorides|mesh-list
102305619|NCT02371616|Sodium Fluoride|sodium fluoride|mesh-list
102305620|NCT02371616|Fluorophosphate|fluorophosphate|mesh-list
102305621|NCT02371616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102305622|NCT02371616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305623|NCT02371616|Cariostatic Agents|cariostatic agents|mesh-ancestor
102305624|NCT02371616|Protective Agents|protective agents|mesh-ancestor
102305625|NCT02371616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102305626|NCT02371616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102305627|NCT01835158|Sunitinib|sunitinib|mesh-list
102305628|NCT01835158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102305629|NCT01835158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102305630|NCT01835158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102305631|NCT01835158|Growth Substances|growth substances|mesh-ancestor
102305632|NCT01835158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305633|NCT01835158|Growth Inhibitors|growth inhibitors|mesh-ancestor
102305634|NCT01835158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102305635|NCT01835158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102305636|NCT01835158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305637|NCT01833832|Sodium thiosulfate|sodium thiosulfate|mesh-list
102305638|NCT01833832|Antidotes|antidotes|mesh-ancestor
102305639|NCT01833832|Protective Agents|protective agents|mesh-ancestor
102305640|NCT01833832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305641|NCT01833832|Antioxidants|antioxidants|mesh-ancestor
102305642|NCT01833832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305643|NCT01833832|Antitubercular Agents|antitubercular agents|mesh-ancestor
102305644|NCT01833832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102305645|NCT01833832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102305646|NCT01833832|Chelating Agents|chelating agents|mesh-ancestor
102305647|NCT01833832|Sequestering Agents|sequestering agents|mesh-ancestor
102014399|NCT03302650|Sympathomimetics|sympathomimetics|mesh-ancestor
102305648|NCT01850602|Sevelamer|sevelamer|mesh-list
102305649|NCT01850602|Chelating Agents|chelating agents|mesh-ancestor
102305650|NCT01850602|Sequestering Agents|sequestering agents|mesh-ancestor
102305651|NCT01850602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305653|NCT02405780|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102305654|NCT02405780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102305655|NCT02405780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102305656|NCT02369510|Epinephrine|epinephrine|mesh-list
102305657|NCT02369510|Racepinephrine|racepinephrine|mesh-list
102305658|NCT02369510|Epinephryl borate|epinephryl borate|mesh-list
102305659|NCT02369510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102305660|NCT02369510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102305661|NCT02369510|Adrenergic Agents|adrenergic agents|mesh-ancestor
102305662|NCT02369510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102305663|NCT02369510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305664|NCT02369510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305665|NCT02369510|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102305666|NCT02369510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102305667|NCT02369510|Autonomic Agents|autonomic agents|mesh-ancestor
102305668|NCT02369510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102305669|NCT02369510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102305670|NCT02369510|Respiratory System Agents|respiratory system agents|mesh-ancestor
102305671|NCT02369510|Mydriatics|mydriatics|mesh-ancestor
102305672|NCT02369510|Sympathomimetics|sympathomimetics|mesh-ancestor
102305673|NCT02369510|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102305674|NCT01650194|Prednisone|prednisone|mesh-list
102305675|NCT01650194|Abiraterone Acetate|abiraterone acetate|mesh-list
102305676|NCT01650194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102305677|NCT01650194|Glucocorticoids|glucocorticoids|mesh-ancestor
102305678|NCT01650194|Hormones|hormones|mesh-ancestor
102305679|NCT01650194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102305680|NCT01650194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305681|NCT01650194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102305682|NCT01650194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102305683|NCT01650194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102305684|NCT01650194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102305685|NCT01650194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305686|NCT01650194|Hormone Antagonists|hormone antagonists|mesh-ancestor
102305687|NCT01650194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102305688|NCT02404220|Dexamethasone|dexamethasone|mesh-list
102305689|NCT02404220|Vincristine|vincristine|mesh-list
102305690|NCT02404220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102305691|NCT02404220|Antiemetics|antiemetics|mesh-ancestor
102305692|NCT02404220|Autonomic Agents|autonomic agents|mesh-ancestor
102305693|NCT02404220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102305694|NCT02404220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305695|NCT02404220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102305696|NCT02404220|Glucocorticoids|glucocorticoids|mesh-ancestor
102305697|NCT02404220|Hormones|hormones|mesh-ancestor
102305698|NCT02404220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102305699|NCT02404220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102305700|NCT02404220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102305701|NCT02404220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102305702|NCT02404220|Tubulin Modulators|tubulin modulators|mesh-ancestor
102305703|NCT02404220|Antimitotic Agents|antimitotic agents|mesh-ancestor
102305704|NCT02404220|Mitosis Modulators|mitosis modulators|mesh-ancestor
102305705|NCT02404220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305706|NCT02366468|Ranibizumab|ranibizumab|mesh-list
102305707|NCT02366468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102305708|NCT02366468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102305709|NCT02366468|Growth Substances|growth substances|mesh-ancestor
102305710|NCT02366468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305711|NCT02366468|Growth Inhibitors|growth inhibitors|mesh-ancestor
102305712|NCT02366468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102305713|NCT02335346|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102305714|NCT02335346|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102305715|NCT02335346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102305716|NCT02335346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102305717|NCT02335346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305718|NCT02335346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102305719|NCT02335346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305720|NCT02335346|Analgesics|analgesics|mesh-ancestor
102305721|NCT02335346|Sensory System Agents|sensory system agents|mesh-ancestor
102305722|NCT02335346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102305724|NCT02335346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102305725|NCT02335346|Dopamine Agents|dopamine agents|mesh-ancestor
102305726|NCT02403674|Tenofovir|tenofovir|mesh-list
102305727|NCT02403674|Lamivudine|lamivudine|mesh-list
102305728|NCT02403674|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102305729|NCT02403674|Antiviral Agents|antiviral agents|mesh-ancestor
102305730|NCT02403674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102305731|NCT02403674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102305732|NCT02403674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102305733|NCT02403674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102305734|NCT02403674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305735|NCT02403674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102305736|NCT02403674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102305737|NCT02401256|Efavirenz|efavirenz|mesh-list
102305738|NCT02401256|Bupropion|bupropion|mesh-list
102305739|NCT02401256|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102305740|NCT02401256|Montelukast|montelukast|mesh-list
102305741|NCT02401256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102305742|NCT02401256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102305743|NCT02401256|Antimetabolites|antimetabolites|mesh-ancestor
102305744|NCT02401256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305745|NCT02401256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102305746|NCT02401256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102305747|NCT02401256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102305748|NCT02401256|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102305749|NCT02401256|Antidepressive Agents|antidepressive agents|mesh-ancestor
102305750|NCT02401256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102305751|NCT02401256|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102305752|NCT02401256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102305753|NCT02401256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102305754|NCT02401256|Dopamine Agents|dopamine agents|mesh-ancestor
102305755|NCT02401256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102305756|NCT02401256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305757|NCT02401256|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102305758|NCT02401256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102305759|NCT02401256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102305760|NCT02401256|Respiratory System Agents|respiratory system agents|mesh-ancestor
102305761|NCT02401256|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102305762|NCT02401256|Hormone Antagonists|hormone antagonists|mesh-ancestor
102305763|NCT02401256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102305764|NCT02401256|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102305765|NCT02401256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102305766|NCT02401256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102305767|NCT02401256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102305768|NCT02401256|Antiviral Agents|antiviral agents|mesh-ancestor
102305769|NCT02401256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102305770|NCT02401256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102305771|NCT02401256|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102305772|NCT02401256|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102305773|NCT02401256|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102305774|NCT02349295|Ixekizumab|ixekizumab|mesh-list
102305775|NCT02349295|Dermatologic Agents|dermatologic agents|mesh-ancestor
102305776|NCT04877587|Gemcitabine|gemcitabine|mesh-list
102305777|NCT04877587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102305778|NCT04877587|Antimetabolites|antimetabolites|mesh-ancestor
102305779|NCT04877587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305780|NCT04877587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102305781|NCT02284243|Dexmedetomidine|dexmedetomidine|mesh-list
102305782|NCT02284243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102305783|NCT02284243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102305784|NCT02284243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305785|NCT02284243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102305786|NCT02284243|Analgesics|analgesics|mesh-ancestor
102305787|NCT02284243|Sensory System Agents|sensory system agents|mesh-ancestor
102305788|NCT02284243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102305789|NCT02284243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102305790|NCT02284243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102305791|NCT02284243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102305792|NCT02284243|Adrenergic Agents|adrenergic agents|mesh-ancestor
102305793|NCT02284243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102305794|NCT02284243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305795|NCT02284009|rGLP-1 protein|rglp-1 protein|mesh-list
102305796|NCT02284009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305797|NCT02284009|Incretins|incretins|mesh-ancestor
102305798|NCT02284009|Hormones|hormones|mesh-ancestor
102305799|NCT02284009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102305800|NCT02400476|Budesonide|budesonide|mesh-list
102305801|NCT02400476|Loperamide|loperamide|mesh-list
102305802|NCT02400476|Antidiarrheals|antidiarrheals|mesh-list
102305803|NCT02400476|Colestipol|colestipol|mesh-list
102305804|NCT02400476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102305805|NCT02400476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102305806|NCT02400476|Autonomic Agents|autonomic agents|mesh-ancestor
102305807|NCT02400476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102305808|NCT02400476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305809|NCT02400476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102305810|NCT02400476|Respiratory System Agents|respiratory system agents|mesh-ancestor
102305811|NCT02400476|Glucocorticoids|glucocorticoids|mesh-ancestor
102305812|NCT02400476|Hormones|hormones|mesh-ancestor
102305813|NCT02400476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102305814|NCT02400476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102305815|NCT02400476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102305816|NCT02400476|Antimetabolites|antimetabolites|mesh-ancestor
102305817|NCT02400476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305818|NCT02400476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102305819|NCT02400476|Sequestering Agents|sequestering agents|mesh-ancestor
102305820|NCT02363738|Infliximab|infliximab|mesh-list
102305821|NCT02363738|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102305822|NCT02363738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102305823|NCT02363738|Dermatologic Agents|dermatologic agents|mesh-ancestor
102305824|NCT02363738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102305825|NCT02363738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102305826|NCT02331680|Tolvaptan|tolvaptan|mesh-list
102305827|NCT02331680|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102305828|NCT02331680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305829|NCT02331680|Natriuretic Agents|natriuretic agents|mesh-ancestor
102305830|NCT02331680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305831|NCT02349061|Ustekinumab|ustekinumab|mesh-list
102305832|NCT02349061|Dermatologic Agents|dermatologic agents|mesh-ancestor
102305833|NCT02331368|Pembrolizumab|pembrolizumab|mesh-list
102305834|NCT02331368|Lenalidomide|lenalidomide|mesh-list
102305835|NCT02331368|Melphalan|melphalan|mesh-list
102305836|NCT02331368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102305837|NCT02331368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102305838|NCT02331368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102305839|NCT02331368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305840|NCT02331368|Immunologic Factors|immunologic factors|mesh-ancestor
102305841|NCT02331368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305842|NCT02331368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102305843|NCT02331368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102305844|NCT02331368|Growth Substances|growth substances|mesh-ancestor
102305845|NCT02331368|Growth Inhibitors|growth inhibitors|mesh-ancestor
102305846|NCT02331368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102305847|NCT02331368|Alkylating Agents|alkylating agents|mesh-ancestor
102305848|NCT02331368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102305849|NCT02331368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102305850|NCT02280421|Cyclosporine|cyclosporine|mesh-list
102305851|NCT02280421|Cyclosporins|cyclosporins|mesh-list
102305852|NCT02280421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102305853|NCT02280421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305854|NCT02280421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102305855|NCT02280421|Immunologic Factors|immunologic factors|mesh-ancestor
102305856|NCT02280421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305857|NCT02280421|Antifungal Agents|antifungal agents|mesh-ancestor
102305858|NCT02280421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102305859|NCT02280421|Dermatologic Agents|dermatologic agents|mesh-ancestor
102305860|NCT02280421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102305861|NCT02280421|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102305862|NCT04906382|Paclitaxel|paclitaxel|mesh-list
102305863|NCT04906382|Carboplatin|carboplatin|mesh-list
102305864|NCT04906382|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102305865|NCT04906382|Tislelizumab|tislelizumab|mesh-list
102305866|NCT04906382|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102305867|NCT04906382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102305868|NCT04906382|Tubulin Modulators|tubulin modulators|mesh-ancestor
102305869|NCT04906382|Antimitotic Agents|antimitotic agents|mesh-ancestor
102305870|NCT04906382|Mitosis Modulators|mitosis modulators|mesh-ancestor
102305871|NCT04906382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305872|NCT04906382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102305873|NCT02362412|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102305874|NCT02362412|Antidepressive Agents|antidepressive agents|mesh-ancestor
102305875|NCT02362412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102305876|NCT02362412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102305877|NCT02362412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102305878|NCT02362412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102305879|NCT02362412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305880|NCT02347813|Pioglitazone|pioglitazone|mesh-list
102305881|NCT02347813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102305882|NCT02347813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305883|NCT02359994|Hemostatics|hemostatics|mesh-list
102305884|NCT02359994|Coagulants|coagulants|mesh-ancestor
102305885|NCT04905446|Niacinamide|niacinamide|mesh-list
102305886|NCT04905446|Niacin|niacin|mesh-list
102305887|NCT04905446|Nicotinic Acids|nicotinic acids|mesh-list
102305888|NCT04905446|Vitamin B Complex|vitamin b complex|mesh-ancestor
102305889|NCT04905446|Vitamins|vitamins|mesh-ancestor
102305890|NCT04905446|Micronutrients|micronutrients|mesh-ancestor
102305891|NCT04905446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305892|NCT04905446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102305893|NCT04905446|Antimetabolites|antimetabolites|mesh-ancestor
102305894|NCT04905446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305895|NCT04905446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102305896|NCT04905446|Vasodilator Agents|vasodilator agents|mesh-ancestor
102305897|NCT02326298|Certolizumab Pegol|certolizumab pegol|mesh-list
102305898|NCT02326298|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102305899|NCT02326298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102305900|NCT02326298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102305901|NCT02326298|Immunologic Factors|immunologic factors|mesh-ancestor
102305902|NCT02326298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305903|NCT02326298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102305904|NCT02279719|Sorafenib|sorafenib|mesh-list
102305905|NCT02279719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102305906|NCT02279719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102305907|NCT02279719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102305908|NCT02279719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305909|NCT02279407|Dapagliflozin|dapagliflozin|mesh-list
102305910|NCT02279407|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102305911|NCT02279407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305912|NCT02279407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102305913|NCT02279407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305914|NCT02326220|Alirocumab|alirocumab|mesh-list
102305915|NCT02326220|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102305916|NCT02326220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102305917|NCT02326220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102305918|NCT02326220|Antimetabolites|antimetabolites|mesh-ancestor
102305919|NCT02326220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305920|NCT02326220|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102305921|NCT02326220|Protease Inhibitors|protease inhibitors|mesh-ancestor
102305922|NCT02326220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102305923|NCT02326220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102305924|NCT02358668|PAZ320|paz320|mesh-list
102305925|NCT02358668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102305926|NCT02358668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305927|NCT02282605|Chlorhexidine|chlorhexidine|mesh-list
102305928|NCT02282605|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102305929|NCT02282605|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102305930|NCT02282605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102305931|NCT02282605|Disinfectants|disinfectants|mesh-ancestor
102305932|NCT02282605|Dermatologic Agents|dermatologic agents|mesh-ancestor
102305933|NCT02282527|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
102305934|NCT02282527|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102305935|NCT02282527|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102305936|NCT02282527|Protease Inhibitors|protease inhibitors|mesh-ancestor
102305937|NCT02282527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102305938|NCT02282527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305939|NCT05650099|Cimetidine|cimetidine|mesh-list
102305940|NCT05650099|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102305941|NCT05650099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102305942|NCT05650099|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102305943|NCT05650099|Histamine Antagonists|histamine antagonists|mesh-ancestor
102305944|NCT05650099|Histamine Agents|histamine agents|mesh-ancestor
102014707|NCT03299296|Enoxaparin|enoxaparin|mesh-list
102305945|NCT05650099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102305946|NCT05650099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305947|NCT05650099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305948|NCT05650099|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102305949|NCT05650099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102305950|NCT05650099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102305951|NCT02278471|Losartan|losartan|mesh-list
102305952|NCT02278471|Amlodipine|amlodipine|mesh-list
102305953|NCT02278471|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102305954|NCT02278471|Atorvastatin|atorvastatin|mesh-list
102305955|NCT02278471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102305956|NCT02278471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102305957|NCT02278471|Antimetabolites|antimetabolites|mesh-ancestor
102305958|NCT02278471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305959|NCT02278471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102305960|NCT02278471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102305961|NCT02278471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102305962|NCT02278471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102305963|NCT02278471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102305964|NCT02278471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102305965|NCT02278471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102305966|NCT02278471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305967|NCT02278471|Vasodilator Agents|vasodilator agents|mesh-ancestor
102305968|NCT02278471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102305969|NCT02278471|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102305970|NCT02278471|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102305971|NCT02278471|Diuretics|diuretics|mesh-ancestor
102305972|NCT02278471|Natriuretic Agents|natriuretic agents|mesh-ancestor
102305973|NCT02278471|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102305975|NCT05565235|Bupivacaine|bupivacaine|mesh-list
102305976|NCT05565235|Anesthetics, Local|anesthetics, local|mesh-ancestor
102305977|NCT05565235|Anesthetics|anesthetics|mesh-ancestor
101422158|NCT00339001|Epoetin Alfa|epoetin alfa|mesh-list
102305978|NCT05565235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102305979|NCT05565235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305980|NCT05565235|Sensory System Agents|sensory system agents|mesh-ancestor
102305981|NCT05565235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102305982|NCT05565235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102305983|NCT05565235|Narcotics|narcotics|mesh-ancestor
102305984|NCT05565235|Analgesics|analgesics|mesh-ancestor
102305985|NCT02278003|Propofol|propofol|mesh-list
102305986|NCT02278003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102305987|NCT02278003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102305988|NCT02278003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305989|NCT02278003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102305990|NCT02278003|Anesthetics, General|anesthetics, general|mesh-ancestor
102305991|NCT02278003|Anesthetics|anesthetics|mesh-ancestor
102305992|NCT02277769|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102305993|NCT02277769|Immunologic Factors|immunologic factors|mesh-ancestor
102305994|NCT02277769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102305995|NCT02277691|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
102305996|NCT02277691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102305997|NCT02277691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102305998|NCT02277691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102305999|NCT02395172|Docetaxel|docetaxel|mesh-list
102306000|NCT02395172|Avelumab|avelumab|mesh-list
102306001|NCT02395172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102306002|NCT02395172|Tubulin Modulators|tubulin modulators|mesh-ancestor
102306003|NCT02395172|Antimitotic Agents|antimitotic agents|mesh-ancestor
102306004|NCT02395172|Mitosis Modulators|mitosis modulators|mesh-ancestor
102306005|NCT02395172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306006|NCT02395172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102306007|NCT04876027|Dulaglutide|dulaglutide|mesh-list
102306008|NCT04876027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102306009|NCT04876027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306010|NCT02358044|Ribavirin|ribavirin|mesh-list
102306011|NCT02358044|Sofosbuvir|sofosbuvir|mesh-list
102306012|NCT02358044|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102306013|NCT02358044|Grazoprevir|grazoprevir|mesh-list
102306014|NCT02358044|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
102306015|NCT02358044|Antimetabolites|antimetabolites|mesh-ancestor
102306016|NCT02358044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306017|NCT02358044|Antiviral Agents|antiviral agents|mesh-ancestor
102306018|NCT02358044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102306019|NCT05536219|Antibodies|antibodies|mesh-list
102306020|NCT05536219|Immunologic Factors|immunologic factors|mesh-ancestor
102306021|NCT05536219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306023|NCT05649241|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102306024|NCT05649241|Autonomic Agents|autonomic agents|mesh-ancestor
102306025|NCT05649241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102306026|NCT05649241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306027|NCT05649241|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102306028|NCT05649241|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102306029|NCT05649241|Cholinergic Agents|cholinergic agents|mesh-ancestor
102306030|NCT05649241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102306031|NCT05649241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306032|NCT02272777|Imatinib Mesylate|imatinib mesylate|mesh-list
102306033|NCT02272777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102306034|NCT02272777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102306035|NCT02272777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102306036|NCT02272777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306037|NCT02357810|Topotecan|topotecan|mesh-list
102306038|NCT02357810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102306039|NCT02357810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102306040|NCT02357810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102306041|NCT02357810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306042|NCT02357810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102306043|NCT02357576|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102306044|NCT02357576|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102306045|NCT02357576|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102306046|NCT02357576|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102306047|NCT01850446|Oseltamivir|oseltamivir|mesh-list
102306048|NCT01850446|Antiviral Agents|antiviral agents|mesh-ancestor
102306049|NCT01850446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102306050|NCT01850446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102306051|NCT01850446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306052|NCT01644175|Alirocumab|alirocumab|mesh-list
102306053|NCT01644175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102306054|NCT01644175|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102306055|NCT01644175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102306056|NCT01644175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102306057|NCT01644175|Antimetabolites|antimetabolites|mesh-ancestor
102306058|NCT01644175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306059|NCT01644175|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102306060|NCT01644175|Protease Inhibitors|protease inhibitors|mesh-ancestor
102306061|NCT01644175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102306062|NCT01644175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102306063|NCT01644175|Immunologic Factors|immunologic factors|mesh-ancestor
102306064|NCT01644175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306065|NCT04856761|Capecitabine|capecitabine|mesh-list
102306066|NCT04856761|Tegafur|tegafur|mesh-list
102306067|NCT04856761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102306068|NCT04856761|Antimetabolites|antimetabolites|mesh-ancestor
102306069|NCT04856761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306070|NCT04856761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102306071|NCT01832038|Lacosamide|lacosamide|mesh-list
102306072|NCT01832038|Anticonvulsants|anticonvulsants|mesh-ancestor
102306073|NCT01832038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102306074|NCT01832038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102306075|NCT01832038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102306076|NCT01832038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306077|NCT01849588|Sorafenib|sorafenib|mesh-list
102306078|NCT01849588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102306079|NCT01849588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102306080|NCT01849588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102306081|NCT01849588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306082|NCT02357342|Sirolimus|sirolimus|mesh-list
102306083|NCT02357342|Aflibercept|aflibercept|mesh-list
102306084|NCT02357342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102306085|NCT02357342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102306086|NCT02357342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102306087|NCT02357342|Growth Substances|growth substances|mesh-ancestor
102306088|NCT02357342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306089|NCT02357342|Growth Inhibitors|growth inhibitors|mesh-ancestor
102306090|NCT02357342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102306091|NCT02357342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102306092|NCT02357342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102306093|NCT02357342|Antifungal Agents|antifungal agents|mesh-ancestor
102306094|NCT02357342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102306095|NCT02357342|Immunologic Factors|immunologic factors|mesh-ancestor
102306097|NCT02325518|Dorzolamide|dorzolamide|mesh-list
102306098|NCT02325518|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102306099|NCT02325518|Maleic acid|maleic acid|mesh-list
102306100|NCT02325518|Brinzolamide|brinzolamide|mesh-list
102306101|NCT02325518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102306102|NCT02325518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102306103|NCT02325518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306104|NCT02325518|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102306105|NCT02325518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102306106|NCT02325518|Adrenergic Agents|adrenergic agents|mesh-ancestor
102306107|NCT02325518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102306108|NCT02325518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306109|NCT02325518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102306110|NCT02325518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102306111|NCT02325518|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102306112|NCT02270983|Linaclotide|linaclotide|mesh-list
102306113|NCT02270983|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102306114|NCT02270983|Enzyme Activators|enzyme activators|mesh-ancestor
102306115|NCT02270983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306116|NCT02270983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102306117|NCT02449889|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102306118|NCT02449889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102306119|NCT02449889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306120|NCT02324270|Diclofenac|diclofenac|mesh-list
102306121|NCT02324270|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
102306122|NCT02324270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102306123|NCT02324270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102306124|NCT02324270|Analgesics|analgesics|mesh-ancestor
102306125|NCT02324270|Sensory System Agents|sensory system agents|mesh-ancestor
102306126|NCT02324270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102306127|NCT02324270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306128|NCT02324270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102306129|NCT02324270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102306130|NCT02324270|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102306131|NCT02324270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102306132|NCT02324270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306133|NCT05648071|Pemetrexed|pemetrexed|mesh-list
102306134|NCT05648071|Nedaplatin|nedaplatin|mesh-list
102306135|NCT05648071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102306136|NCT05648071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102306137|NCT05648071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306138|NCT05648071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102306139|NCT05648071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102306140|NCT03689699|Nivolumab|nivolumab|mesh-list
102306141|NCT03689699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102306142|NCT03689699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102306143|NCT03689699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102306144|NCT03689699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306145|NCT01849276|Metformin|metformin|mesh-list
102306146|NCT01849276|Cytarabine|cytarabine|mesh-list
102306147|NCT01849276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102306148|NCT01849276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306149|NCT01849276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102306150|NCT01849276|Antimetabolites|antimetabolites|mesh-ancestor
102306151|NCT01849276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306152|NCT01849276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102306153|NCT01849276|Antiviral Agents|antiviral agents|mesh-ancestor
102306154|NCT01849276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102306155|NCT01849276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102306156|NCT01849276|Immunologic Factors|immunologic factors|mesh-ancestor
102306157|NCT02465489|Deferiprone|deferiprone|mesh-list
102306158|NCT02465489|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102306159|NCT02465489|Chelating Agents|chelating agents|mesh-ancestor
102306160|NCT02465489|Sequestering Agents|sequestering agents|mesh-ancestor
102306161|NCT02465489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306162|NCT04953923|Moxifloxacin|moxifloxacin|mesh-list
102306163|NCT04953923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102306164|NCT04953923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102306165|NCT04953923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102306166|NCT04953923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102306167|NCT04953923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102306168|NCT04953923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306170|NCT01601821|Sirolimus|sirolimus|mesh-list
102306171|NCT01601821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102306172|NCT01601821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102306173|NCT01601821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102306174|NCT01601821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102306175|NCT01601821|Antifungal Agents|antifungal agents|mesh-ancestor
102306176|NCT01601821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102306177|NCT01601821|Immunologic Factors|immunologic factors|mesh-ancestor
102306178|NCT01601821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306179|NCT01846624|Decitabine|decitabine|mesh-list
102306180|NCT01846624|Azacitidine|azacitidine|mesh-list
102306181|NCT01846624|Midostaurin|midostaurin|mesh-list
102306182|NCT01846624|Staurosporine|staurosporine|mesh-list
102306183|NCT01846624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102306184|NCT01846624|Antimetabolites|antimetabolites|mesh-ancestor
102306185|NCT01846624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306186|NCT01846624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102306187|NCT01846624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102306188|NCT01846624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102306189|NCT01827670|Fluorides|fluorides|mesh-list
102306190|NCT01827670|Tin Fluorides|tin fluorides|mesh-list
102306191|NCT01827670|Fluorophosphate|fluorophosphate|mesh-list
102306192|NCT01827670|Cariostatic Agents|cariostatic agents|mesh-ancestor
102306193|NCT01827670|Protective Agents|protective agents|mesh-ancestor
102306194|NCT01827670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306195|NCT01844830|Phenylephrine|phenylephrine|mesh-list
102306196|NCT01844830|Oxymetazoline|oxymetazoline|mesh-list
102306197|NCT01844830|Tetracaine|tetracaine|mesh-list
102306198|NCT01844830|Anesthetics, Local|anesthetics, local|mesh-ancestor
102306199|NCT01844830|Anesthetics|anesthetics|mesh-ancestor
102306200|NCT01844830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102306201|NCT01844830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306202|NCT01844830|Sensory System Agents|sensory system agents|mesh-ancestor
102306203|NCT01844830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102306204|NCT01844830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102306205|NCT01844830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102306206|NCT01844830|Adrenergic Agents|adrenergic agents|mesh-ancestor
102306207|NCT01844830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102306208|NCT01844830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306209|NCT01844830|Sympathomimetics|sympathomimetics|mesh-ancestor
102306210|NCT01844830|Autonomic Agents|autonomic agents|mesh-ancestor
102306211|NCT01844830|Nasal Decongestants|nasal decongestants|mesh-ancestor
102306212|NCT01844830|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102306213|NCT01844830|Respiratory System Agents|respiratory system agents|mesh-ancestor
102306214|NCT01844830|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102306215|NCT01844830|Mydriatics|mydriatics|mesh-ancestor
102306216|NCT01844830|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102306217|NCT01844830|Protective Agents|protective agents|mesh-ancestor
102306218|NCT02323334|Itraconazole|itraconazole|mesh-list
102306219|NCT02323334|Antifungal Agents|antifungal agents|mesh-ancestor
102306220|NCT02323334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102306221|NCT02323334|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102306222|NCT02323334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102306223|NCT02323334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102306224|NCT02323334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306225|NCT02323334|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102306226|NCT02323334|Hormone Antagonists|hormone antagonists|mesh-ancestor
102306227|NCT02323334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102306228|NCT02323334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306229|NCT02323334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102306230|NCT02322866|Sarecycline|sarecycline|mesh-list
102306231|NCT02322866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102306232|NCT02322866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102306233|NCT02322866|Dermatologic Agents|dermatologic agents|mesh-ancestor
102306234|NCT01827046|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102306235|NCT01827046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102306236|NCT01827046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102306237|NCT01827046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306238|NCT02356562|Ritonavir|ritonavir|mesh-list
102306239|NCT02356562|Ribavirin|ribavirin|mesh-list
102306240|NCT02356562|Sofosbuvir|sofosbuvir|mesh-list
102306241|NCT02356562|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102306242|NCT02356562|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102306243|NCT02356562|Protease Inhibitors|protease inhibitors|mesh-ancestor
102306244|NCT02356562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102306245|NCT02356562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306246|NCT02356562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102306247|NCT02356562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102306248|NCT02356562|Antiviral Agents|antiviral agents|mesh-ancestor
102306249|NCT02356562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102306250|NCT02356562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102306251|NCT02356562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102306252|NCT02356562|Antimetabolites|antimetabolites|mesh-ancestor
102306253|NCT02354690|Cyclophosphamide|cyclophosphamide|mesh-list
102306254|NCT02354690|Fludarabine|fludarabine|mesh-list
102306255|NCT02354690|Interleukin-2|interleukin-2|mesh-list
102306256|NCT02354690|Vemurafenib|vemurafenib|mesh-list
102306257|NCT02354690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102306258|NCT02354690|Immunologic Factors|immunologic factors|mesh-ancestor
102306259|NCT02354690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306260|NCT02354690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102306261|NCT02354690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102306262|NCT02354690|Alkylating Agents|alkylating agents|mesh-ancestor
102306263|NCT02354690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306264|NCT02354690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102306265|NCT02354690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102306266|NCT02354690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102306267|NCT02354690|Analgesics|analgesics|mesh-ancestor
102306268|NCT02354690|Sensory System Agents|sensory system agents|mesh-ancestor
102306269|NCT02354690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102306270|NCT02354690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102306271|NCT02354690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102306272|NCT02354222|Canagliflozin|canagliflozin|mesh-list
102306273|NCT02354222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102306274|NCT02354222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306275|NCT02354222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102306276|NCT02354222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306277|NCT02351960|Dexlansoprazole|dexlansoprazole|mesh-list
102306278|NCT02351960|Lansoprazole|lansoprazole|mesh-list
102306279|NCT02351960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102306280|NCT02351960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102306281|NCT02351960|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102306282|NCT02351960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102306283|NCT02351960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306284|NCT02351180|Beclomethasone|beclomethasone|mesh-list
102306285|NCT02351180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102306286|NCT02351180|Glucocorticoids|glucocorticoids|mesh-ancestor
102306287|NCT02351180|Hormones|hormones|mesh-ancestor
101422466|NCT00165633|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102306288|NCT02351180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102306289|NCT02351180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306290|NCT02351180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102306291|NCT02351180|Respiratory System Agents|respiratory system agents|mesh-ancestor
102306292|NCT02350478|Linagliptin|linagliptin|mesh-list
102306293|NCT02350478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102306294|NCT02350478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306295|NCT02350478|Incretins|incretins|mesh-ancestor
102306296|NCT02350478|Hormones|hormones|mesh-ancestor
102306297|NCT02350478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102306298|NCT02350478|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102306299|NCT02350478|Protease Inhibitors|protease inhibitors|mesh-ancestor
102306300|NCT02350478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102306301|NCT02350478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306302|NCT02349542|Bupivacaine|bupivacaine|mesh-list
102306303|NCT02349542|Anesthetics, Local|anesthetics, local|mesh-ancestor
102306304|NCT02349542|Anesthetics|anesthetics|mesh-ancestor
102306305|NCT02349542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102306306|NCT02349542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306307|NCT02349542|Sensory System Agents|sensory system agents|mesh-ancestor
102306308|NCT02349542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102306309|NCT02321930|Tofacitinib|tofacitinib|mesh-list
102306310|NCT02321930|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102306311|NCT02321930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102306312|NCT02321930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102306313|NCT02321930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306314|NCT02264821|Morphine|morphine|mesh-list
102306315|NCT02264821|Ropivacaine|ropivacaine|mesh-list
102306316|NCT02264821|Anesthetics, Local|anesthetics, local|mesh-list
102306317|NCT02264821|Anesthetics|anesthetics|mesh-list
102306318|NCT02264821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102306319|NCT02264821|Narcotics|narcotics|mesh-ancestor
102306320|NCT02264821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102306321|NCT02264821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306322|NCT02264821|Analgesics|analgesics|mesh-ancestor
102306323|NCT02264821|Sensory System Agents|sensory system agents|mesh-ancestor
102306324|NCT02264821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102306325|NCT04854889|Decitabine|decitabine|mesh-list
102306326|NCT04854889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102306327|NCT04854889|Antimetabolites|antimetabolites|mesh-ancestor
102306328|NCT04854889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306329|NCT04854889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102306330|NCT04854889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102306331|NCT02261467|Botulinum Toxins|botulinum toxins|mesh-list
102306332|NCT02261467|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102306333|NCT02261467|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102306334|NCT02261467|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102306335|NCT02261467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102306336|NCT02261467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306337|NCT02261467|Cholinergic Agents|cholinergic agents|mesh-ancestor
102306338|NCT02261467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102306339|NCT02261467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306340|NCT02261467|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102306341|NCT02261467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102306342|NCT05341843|Sertraline|sertraline|mesh-list
102306343|NCT05341843|Antidepressive Agents|antidepressive agents|mesh-ancestor
102306344|NCT05341843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102306345|NCT05341843|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102306346|NCT05341843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102306347|NCT05341843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102306348|NCT05341843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306349|NCT05341843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102306350|NCT05341843|Serotonin Agents|serotonin agents|mesh-ancestor
102306351|NCT05341843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306352|NCT05646199|Metformin|metformin|mesh-list
102306353|NCT05646199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102306354|NCT05646199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306355|NCT02258659|Paclitaxel|paclitaxel|mesh-list
102306356|NCT02258659|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102306357|NCT02258659|Carboplatin|carboplatin|mesh-list
102306358|NCT02258659|Fluorouracil|fluorouracil|mesh-list
102306359|NCT02258659|Hydroxyurea|hydroxyurea|mesh-list
102306360|NCT02258659|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102306361|NCT02258659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102306362|NCT02258659|Tubulin Modulators|tubulin modulators|mesh-ancestor
102306363|NCT02258659|Antimitotic Agents|antimitotic agents|mesh-ancestor
102306364|NCT02258659|Mitosis Modulators|mitosis modulators|mesh-ancestor
102306365|NCT02258659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306366|NCT02258659|Antimetabolites|antimetabolites|mesh-ancestor
102306367|NCT02258659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102306368|NCT02258659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102306369|NCT02258659|Immunologic Factors|immunologic factors|mesh-ancestor
102306370|NCT02258659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306371|NCT02258659|Antisickling Agents|antisickling agents|mesh-ancestor
102306372|NCT02258659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102306373|NCT02258659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102306374|NCT02320058|Nivolumab|nivolumab|mesh-list
102306375|NCT02320058|Ipilimumab|ipilimumab|mesh-list
102306376|NCT02320058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102306377|NCT02320058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102306378|NCT02320058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102306379|NCT02320058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306380|NCT02319668|Chlorhexidine|chlorhexidine|mesh-list
102306381|NCT02319668|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102306382|NCT02319668|Listerine|listerine|mesh-list
102306383|NCT02319668|Fluorides|fluorides|mesh-list
102306384|NCT02319668|Sodium Fluoride|sodium fluoride|mesh-list
102306385|NCT02319668|Cariostatic Agents|cariostatic agents|mesh-ancestor
102306386|NCT02319668|Protective Agents|protective agents|mesh-ancestor
102306387|NCT02319668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306388|NCT02319668|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102306389|NCT02319668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102306390|NCT02319668|Disinfectants|disinfectants|mesh-ancestor
102306391|NCT02319668|Dermatologic Agents|dermatologic agents|mesh-ancestor
102306392|NCT02092467|Adalimumab|adalimumab|mesh-list
102015162|NCT00702052|Everolimus|everolimus|mesh-list
102306393|NCT02092467|Etanercept|etanercept|mesh-list
102306394|NCT02092467|Tofacitinib|tofacitinib|mesh-list
102306395|NCT02092467|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102306396|NCT02092467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102306397|NCT02092467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102306398|NCT02092467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102306399|NCT02092467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102306400|NCT02092467|Analgesics|analgesics|mesh-ancestor
102306401|NCT02092467|Sensory System Agents|sensory system agents|mesh-ancestor
102306402|NCT02092467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102306403|NCT02092467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306404|NCT02092467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102306405|NCT02092467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102306406|NCT02092467|Immunologic Factors|immunologic factors|mesh-ancestor
102306407|NCT02092467|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102306408|NCT02092467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102306409|NCT02092467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102306410|NCT02092467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306411|NCT04420871|Capecitabine|capecitabine|mesh-list
102306412|NCT04420871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102306413|NCT04420871|Antimetabolites|antimetabolites|mesh-ancestor
102306414|NCT04420871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306415|NCT04420871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102306416|NCT02349386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102306417|NCT02349386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102306418|NCT02349386|Estradiol|estradiol|mesh-list
102306419|NCT02349386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102306420|NCT02349386|Estrogens|estrogens|mesh-ancestor
102306421|NCT02349386|Hormones|hormones|mesh-ancestor
102306422|NCT02349386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102306423|NCT02349386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306424|NCT02349386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102306425|NCT02349386|Contraceptive Agents|contraceptive agents|mesh-ancestor
102306426|NCT02349386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102306427|NCT02349386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102306428|NCT04892888|Vaccines|vaccines|mesh-list
102306429|NCT04892888|Immunologic Factors|immunologic factors|mesh-ancestor
102306430|NCT04892888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306431|NCT02036775|Ambroxol|ambroxol|mesh-list
102306432|NCT02036775|Expectorants|expectorants|mesh-ancestor
102306433|NCT02036775|Respiratory System Agents|respiratory system agents|mesh-ancestor
102306434|NCT02034591|Apixaban|apixaban|mesh-list
102306435|NCT02034591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102306436|NCT02034591|Antithrombins|antithrombins|mesh-ancestor
102306437|NCT02034591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102306438|NCT02034591|Protease Inhibitors|protease inhibitors|mesh-ancestor
102306439|NCT02034591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102306440|NCT02034591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306441|NCT02034591|Anticoagulants|anticoagulants|mesh-ancestor
102306442|NCT02091921|Ticagrelor|ticagrelor|mesh-list
102306443|NCT02091921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102306444|NCT02091921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102306445|NCT02091921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102306446|NCT02091921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102306447|NCT02091921|Purinergic Agents|purinergic agents|mesh-ancestor
102306448|NCT02091921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102306449|NCT02091921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306450|NCT02091921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306451|NCT04716933|Carboplatin|carboplatin|mesh-list
102306452|NCT04716933|Pembrolizumab|pembrolizumab|mesh-list
102306453|NCT04716933|Pemetrexed|pemetrexed|mesh-list
102306454|NCT04716933|Lenvatinib|lenvatinib|mesh-list
102306455|NCT04716933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102306456|NCT04716933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102306457|NCT04716933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102306458|NCT04716933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306459|NCT04716933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102306460|NCT04716933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102306461|NCT04716933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102306462|NCT04716933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102306463|NCT02034513|Insulin|insulin|mesh-list
102306464|NCT02034513|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102306465|NCT02034513|Insulin Glargine|insulin glargine|mesh-list
102306466|NCT02034513|Insulin Aspart|insulin aspart|mesh-list
102306467|NCT02034513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102306468|NCT02034513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306469|NCT02461745|Ribavirin|ribavirin|mesh-list
102306470|NCT02461745|Ritonavir|ritonavir|mesh-list
102306471|NCT02461745|Antimetabolites|antimetabolites|mesh-ancestor
102306472|NCT02461745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306473|NCT02461745|Antiviral Agents|antiviral agents|mesh-ancestor
102306474|NCT02461745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102306475|NCT02461745|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102306476|NCT02461745|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102306477|NCT02461745|Protease Inhibitors|protease inhibitors|mesh-ancestor
102306478|NCT02461745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102306479|NCT02461745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102306480|NCT02461745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102306481|NCT02461745|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102306482|NCT02461745|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102306483|NCT02034435|Amlodipine|amlodipine|mesh-list
102306484|NCT02034435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102306485|NCT02034435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102306486|NCT02034435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102306487|NCT02034435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306488|NCT02034435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102306489|NCT02034435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306490|NCT02034435|Vasodilator Agents|vasodilator agents|mesh-ancestor
102306491|NCT02033889|Insulin|insulin|mesh-list
102306492|NCT02033889|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102306493|NCT02033889|Metformin|metformin|mesh-list
102306494|NCT02033889|Insulin Glargine|insulin glargine|mesh-list
102306495|NCT02033889|Glimepiride|glimepiride|mesh-list
102306496|NCT02033889|Insulin Detemir|insulin detemir|mesh-list
102306497|NCT02033889|Ertugliflozin|ertugliflozin|mesh-list
102306498|NCT02033889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102306499|NCT02033889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306500|NCT02033889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102306501|NCT02033889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102306502|NCT02033889|Immunologic Factors|immunologic factors|mesh-ancestor
102306503|NCT02033889|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101422704|NCT00403949|Azelaic acid|azelaic acid|mesh-list
102306504|NCT02033889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306506|NCT02447003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102306507|NCT02447003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102306508|NCT02447003|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102306509|NCT02447003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306510|NCT04594018|Minoxidil|minoxidil|mesh-list
102306511|NCT04594018|Finasteride|finasteride|mesh-list
102306512|NCT04594018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102306513|NCT04594018|Vasodilator Agents|vasodilator agents|mesh-ancestor
102306514|NCT04594018|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102306515|NCT04594018|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102306516|NCT04594018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102306517|NCT04594018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306518|NCT04594018|Hormone Antagonists|hormone antagonists|mesh-ancestor
102306519|NCT04594018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102306520|NCT04594018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306521|NCT04594018|Urological Agents|urological agents|mesh-ancestor
102306522|NCT02054481|Ustekinumab|ustekinumab|mesh-list
102306523|NCT02054481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102306524|NCT02054481|Dermatologic Agents|dermatologic agents|mesh-ancestor
102306525|NCT02054481|Immunologic Factors|immunologic factors|mesh-ancestor
102306526|NCT02054481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306527|NCT02054325|Polidocanol|polidocanol|mesh-list
102306528|NCT02054325|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102306529|NCT02054325|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102306530|NCT02091375|Cannabidiol|cannabidiol|mesh-list
102306531|NCT02091375|Anticonvulsants|anticonvulsants|mesh-ancestor
102306532|NCT02032875|Ribavirin|ribavirin|mesh-list
102306533|NCT02032875|Sofosbuvir|sofosbuvir|mesh-list
102306534|NCT02032875|Antimetabolites|antimetabolites|mesh-ancestor
102306535|NCT02032875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306536|NCT02032875|Antiviral Agents|antiviral agents|mesh-ancestor
102306537|NCT02032875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102306538|NCT02032407|Dapsone|dapsone|mesh-list
102306539|NCT02032407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102306540|NCT02032407|Antimalarials|antimalarials|mesh-ancestor
102306541|NCT02032407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102306542|NCT02032407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102306543|NCT02032407|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102306544|NCT02032407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102306545|NCT02032407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306546|NCT02032407|Leprostatic Agents|leprostatic agents|mesh-ancestor
102306547|NCT02032407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102306548|NCT01843660|Acetaminophen|acetaminophen|mesh-list
102306549|NCT01843660|Tramadol|tramadol|mesh-list
102306550|NCT01843660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102306551|NCT01843660|Analgesics|analgesics|mesh-ancestor
102306552|NCT01843660|Sensory System Agents|sensory system agents|mesh-ancestor
102306553|NCT01843660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102306554|NCT01843660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306555|NCT01843660|Antipyretics|antipyretics|mesh-ancestor
102306556|NCT01843660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102306557|NCT01843660|Narcotics|narcotics|mesh-ancestor
102306558|NCT01843660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102306559|NCT02032173|Ranibizumab|ranibizumab|mesh-list
102306560|NCT02032173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102306561|NCT02032173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102306562|NCT02032173|Growth Substances|growth substances|mesh-ancestor
102306563|NCT02032173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306564|NCT02032173|Growth Inhibitors|growth inhibitors|mesh-ancestor
102306565|NCT02032173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102306566|NCT02461589|Liraglutide|liraglutide|mesh-list
102306567|NCT02461589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102306568|NCT02461589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306569|NCT02461589|Incretins|incretins|mesh-ancestor
102306570|NCT02461589|Hormones|hormones|mesh-ancestor
102306571|NCT02461589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102306572|NCT02089737|Panitumumab|panitumumab|mesh-list
101648401|NCT00795223|Analgesics|analgesics|mesh-ancestor
102306573|NCT02089737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102306574|NCT02089737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102306576|NCT02089347|Immunologic Factors|immunologic factors|mesh-ancestor
102306577|NCT02089347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306578|NCT02419469|Cytarabine|cytarabine|mesh-list
102306579|NCT02419469|Dexamethasone|dexamethasone|mesh-list
102306580|NCT02419469|Prednisone|prednisone|mesh-list
102306581|NCT02419469|Dexamethasone acetate|dexamethasone acetate|mesh-list
102306582|NCT02419469|Cyclophosphamide|cyclophosphamide|mesh-list
102306583|NCT02419469|Rituximab|rituximab|mesh-list
102306584|NCT02419469|Doxorubicin|doxorubicin|mesh-list
102306585|NCT02419469|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102306586|NCT02419469|Methotrexate|methotrexate|mesh-list
102306587|NCT02419469|Vincristine|vincristine|mesh-list
102306588|NCT02419469|Daunorubicin|daunorubicin|mesh-list
102306589|NCT02419469|Asparaginase|asparaginase|mesh-list
102306590|NCT02419469|Mercaptopurine|mercaptopurine|mesh-list
102306591|NCT02419469|Ofatumumab|ofatumumab|mesh-list
102306592|NCT02419469|Pegaspargase|pegaspargase|mesh-list
102306593|NCT02419469|Thioguanine|thioguanine|mesh-list
102306594|NCT02419469|BB 1101|bb 1101|mesh-list
102306595|NCT02419469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102306596|NCT02419469|Immunologic Factors|immunologic factors|mesh-ancestor
102306597|NCT02419469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306598|NCT02419469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102306599|NCT02419469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102306600|NCT02419469|Alkylating Agents|alkylating agents|mesh-ancestor
102306601|NCT02419469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306602|NCT02419469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102306603|NCT02419469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102306604|NCT02419469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102306605|NCT02419469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102306606|NCT02419469|Antiemetics|antiemetics|mesh-ancestor
102306607|NCT02419469|Autonomic Agents|autonomic agents|mesh-ancestor
102306608|NCT02419469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102306609|NCT02419469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102306610|NCT02419469|Glucocorticoids|glucocorticoids|mesh-ancestor
102306611|NCT02419469|Hormones|hormones|mesh-ancestor
102306612|NCT02419469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102306613|NCT02419469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102306614|NCT02419469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102306615|NCT02419469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102306616|NCT02419469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102306617|NCT02419469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102306618|NCT02419469|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102306619|NCT02419469|Abortifacient Agents|abortifacient agents|mesh-ancestor
102015374|NCT01350882|Sequestering Agents|sequestering agents|mesh-ancestor
102306620|NCT02419469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102306621|NCT02419469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102306622|NCT02419469|Antimetabolites|antimetabolites|mesh-ancestor
102306623|NCT02419469|Dermatologic Agents|dermatologic agents|mesh-ancestor
102306624|NCT02419469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102306625|NCT02419469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102306626|NCT02419469|Antiviral Agents|antiviral agents|mesh-ancestor
102306627|NCT02419469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102306628|NCT02419469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102306629|NCT02419469|Tubulin Modulators|tubulin modulators|mesh-ancestor
102306630|NCT02419469|Antimitotic Agents|antimitotic agents|mesh-ancestor
102306631|NCT02419469|Mitosis Modulators|mitosis modulators|mesh-ancestor
102306632|NCT02419469|Protease Inhibitors|protease inhibitors|mesh-ancestor
102306633|NCT04687761|Cytarabine|cytarabine|mesh-list
102306634|NCT04687761|Azacitidine|azacitidine|mesh-list
102306635|NCT04687761|Venetoclax|venetoclax|mesh-list
102306636|NCT04687761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102306637|NCT04687761|Antimetabolites|antimetabolites|mesh-ancestor
102306638|NCT04687761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306639|NCT04687761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102306640|NCT04687761|Antiviral Agents|antiviral agents|mesh-ancestor
102306641|NCT04687761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102306642|NCT04687761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102306643|NCT04687761|Immunologic Factors|immunologic factors|mesh-ancestor
102306644|NCT04687761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306645|NCT04687761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102306646|NCT02419313|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102306647|NCT02419313|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102306648|NCT02419313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102306649|NCT02419313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306650|NCT02419313|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102306651|NCT02419313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102306652|NCT02419313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306653|NCT02419313|Cholinergic Agents|cholinergic agents|mesh-ancestor
102306654|NCT02419313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102306655|NCT04730583|Deoxycholic Acid|deoxycholic acid|mesh-list
102306656|NCT04730583|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102306657|NCT04730583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102306659|NCT04730193|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102306660|NCT04730193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306661|NCT04730193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102306662|NCT04730193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102306663|NCT04730193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306664|NCT04730193|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102306665|NCT04730193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102306666|NCT04730193|Purinergic Agents|purinergic agents|mesh-ancestor
102306667|NCT04730193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102306668|NCT02088957|Phenytoin|phenytoin|mesh-list
102306669|NCT02088957|Brivaracetam|brivaracetam|mesh-list
102306670|NCT02088957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102306671|NCT02088957|Anticonvulsants|anticonvulsants|mesh-ancestor
102306672|NCT02088957|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102306673|NCT02088957|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102306674|NCT02088957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102306675|NCT02088957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306676|NCT02088957|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102306677|NCT02088957|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102306678|NCT02088177|Naltrexone|naltrexone|mesh-list
102306679|NCT02088177|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102306680|NCT02088177|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102306681|NCT02088177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306682|NCT02088177|Sensory System Agents|sensory system agents|mesh-ancestor
102306683|NCT02088177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102306684|NCT02030535|Tiotropium Bromide|tiotropium bromide|mesh-list
102306685|NCT02030535|Olodaterol|olodaterol|mesh-list
102306686|NCT02030535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102306687|NCT02030535|Autonomic Agents|autonomic agents|mesh-ancestor
102306688|NCT02030535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102306689|NCT02030535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306690|NCT02030535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102306691|NCT02030535|Respiratory System Agents|respiratory system agents|mesh-ancestor
102306692|NCT02030535|Parasympatholytics|parasympatholytics|mesh-ancestor
102306693|NCT02030535|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102306694|NCT02030535|Cholinergic Agents|cholinergic agents|mesh-ancestor
102306695|NCT02030535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102306696|NCT02030535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306697|NCT02029989|Chrysarobin|chrysarobin|mesh-list
102306698|NCT02029989|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102306699|NCT02029989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102306700|NCT02029989|Analgesics|analgesics|mesh-ancestor
102306701|NCT02029989|Sensory System Agents|sensory system agents|mesh-ancestor
102306702|NCT02029989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102306703|NCT02029989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306704|NCT02029989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102306705|NCT02029989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102306706|NCT02048241|Guanfacine|guanfacine|mesh-list
102306707|NCT02048241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102306708|NCT02048241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102306709|NCT02048241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102306710|NCT02048241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102306711|NCT02048241|Adrenergic Agents|adrenergic agents|mesh-ancestor
102306712|NCT02048241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102306713|NCT02048241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306714|NCT02048241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306715|NCT02087943|Thalidomide|thalidomide|mesh-list
102306716|NCT02087943|Apremilast|apremilast|mesh-list
102306717|NCT02087943|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102306718|NCT02087943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102306719|NCT02087943|Analgesics|analgesics|mesh-ancestor
102306720|NCT02087943|Sensory System Agents|sensory system agents|mesh-ancestor
101648551|NCT05003102|Narcotics|narcotics|mesh-ancestor
102306721|NCT02087943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102306722|NCT02087943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306723|NCT02087943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102306724|NCT02087943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102306725|NCT02087943|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102306726|NCT02087943|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102306727|NCT02087943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102306728|NCT02087943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306729|NCT02087943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102306730|NCT02087943|Immunologic Factors|immunologic factors|mesh-ancestor
102306731|NCT02087943|Leprostatic Agents|leprostatic agents|mesh-ancestor
102306732|NCT02087943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102306733|NCT02087943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102306734|NCT02087943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102306735|NCT02087943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102306736|NCT02087943|Growth Substances|growth substances|mesh-ancestor
102306737|NCT02087943|Growth Inhibitors|growth inhibitors|mesh-ancestor
102306738|NCT02087943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102306740|NCT04685811|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102306741|NCT04685811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306742|NCT04709211|Bupivacaine|bupivacaine|mesh-list
102306743|NCT04709211|Anesthetics, Local|anesthetics, local|mesh-ancestor
102306744|NCT04709211|Anesthetics|anesthetics|mesh-ancestor
102306745|NCT04709211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102306746|NCT04709211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306747|NCT04709211|Sensory System Agents|sensory system agents|mesh-ancestor
102306748|NCT04709211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102306749|NCT02443883|Ramucirumab|ramucirumab|mesh-list
102306750|NCT02443883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102306751|NCT02087241|Carboplatin|carboplatin|mesh-list
102306752|NCT02087241|Pemetrexed|pemetrexed|mesh-list
102306753|NCT02087241|Adavosertib|adavosertib|mesh-list
102306754|NCT02087241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102306755|NCT02087241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102306756|NCT02087241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306757|NCT02087241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102306758|NCT02087241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102306759|NCT02087085|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102306760|NCT02087085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102306761|NCT02087085|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102306762|NCT02087085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102306763|NCT02087085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102306764|NCT02087085|Adrenergic Agents|adrenergic agents|mesh-ancestor
102306765|NCT02087085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102306766|NCT02087085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306767|NCT02087085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306768|NCT04685577|Nefopam|nefopam|mesh-list
102306769|NCT04685577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102306770|NCT04685577|Analgesics|analgesics|mesh-ancestor
102306771|NCT04685577|Sensory System Agents|sensory system agents|mesh-ancestor
102306772|NCT04685577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102306773|NCT04685577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306774|NCT02443337|Necitumumab|necitumumab|mesh-list
102306775|NCT02443337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102306776|NCT02443337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102306777|NCT02443103|Guanabenz|guanabenz|mesh-list
102306778|NCT02443103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102306779|NCT02443103|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102306780|NCT02443103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102306781|NCT02443103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102306782|NCT02443103|Adrenergic Agents|adrenergic agents|mesh-ancestor
102306783|NCT02443103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102306784|NCT02443103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306785|NCT02443103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306786|NCT02022657|Tenofovir|tenofovir|mesh-list
102306787|NCT02022657|Emtricitabine|emtricitabine|mesh-list
102306788|NCT02022657|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102306789|NCT02022657|Antiviral Agents|antiviral agents|mesh-ancestor
102306790|NCT02022657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102306791|NCT02022657|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102306792|NCT02022657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102306793|NCT02022657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102306794|NCT02022657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306795|NCT02022657|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102306796|NCT02022657|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102306797|NCT02021643|Sofosbuvir|sofosbuvir|mesh-list
102306798|NCT02021643|Ribavirin|ribavirin|mesh-list
102306799|NCT02021643|Antiviral Agents|antiviral agents|mesh-ancestor
102306800|NCT02021643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102306801|NCT02021643|Antimetabolites|antimetabolites|mesh-ancestor
102306802|NCT02021643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306803|NCT02415959|Pancrelipase|pancrelipase|mesh-list
102306804|NCT02415959|Pancreatin|pancreatin|mesh-list
102306805|NCT02415959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102306806|NCT02021331|Cimetidine|cimetidine|mesh-list
102306807|NCT02021331|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102306808|NCT02021331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102306809|NCT02021331|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102306810|NCT02021331|Histamine Antagonists|histamine antagonists|mesh-ancestor
102306811|NCT02021331|Histamine Agents|histamine agents|mesh-ancestor
102306812|NCT02021331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102306813|NCT02021331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306814|NCT02021331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306815|NCT02021331|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102306816|NCT02021331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102306817|NCT02021331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102306818|NCT04681833|Vaccines|vaccines|mesh-list
102306819|NCT04681833|Immunologic Factors|immunologic factors|mesh-ancestor
102306820|NCT04681833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306821|NCT02441309|Ifosfamide|ifosfamide|mesh-list
102306822|NCT02441309|Mifamurtide|mifamurtide|mesh-list
102306823|NCT02441309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102306824|NCT02441309|Alkylating Agents|alkylating agents|mesh-ancestor
102306825|NCT02441309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306826|NCT02441309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102306827|NCT02441309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102306828|NCT02441309|Immunologic Factors|immunologic factors|mesh-ancestor
102306829|NCT02441309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306830|NCT01652729|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102306831|NCT01652729|Exenatide|exenatide|mesh-list
102306832|NCT01652729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102306833|NCT01652729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306834|NCT01652729|Incretins|incretins|mesh-ancestor
102306835|NCT01652729|Hormones|hormones|mesh-ancestor
102306836|NCT01652729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102306837|NCT01652729|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102306838|NCT01652729|Protease Inhibitors|protease inhibitors|mesh-ancestor
102306839|NCT01652729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102306840|NCT01652729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306841|NCT01652729|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102306842|NCT02083965|Factor VIII|factor viii|mesh-list
102306843|NCT02083965|Coagulants|coagulants|mesh-ancestor
102306844|NCT04681287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102306845|NCT04681287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306846|NCT04681287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102306847|NCT04681287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102306848|NCT02438813|Deoxycholic Acid|deoxycholic acid|mesh-list
102306849|NCT02438813|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102306850|NCT02438813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102306852|NCT02458469|Trazodone|trazodone|mesh-list
102306853|NCT02458469|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102306854|NCT02458469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102306855|NCT02458469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102306856|NCT02458469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306857|NCT02458469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102306858|NCT02458469|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102306859|NCT02458469|Serotonin Agents|serotonin agents|mesh-ancestor
102306860|NCT02458469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102306861|NCT02458469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306862|NCT02458469|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102306863|NCT02458469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102306864|NCT02458469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102306865|NCT02458469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102306866|NCT02458469|Antidepressive Agents|antidepressive agents|mesh-ancestor
102306867|NCT01843348|Cyclosporine|cyclosporine|mesh-list
102306868|NCT01843348|Mycophenolic Acid|mycophenolic acid|mesh-list
102306869|NCT01843348|Everolimus|everolimus|mesh-list
102306870|NCT01843348|Tacrolimus|tacrolimus|mesh-list
102306871|NCT01843348|Cyclosporins|cyclosporins|mesh-list
102306872|NCT01843348|Basiliximab|basiliximab|mesh-list
102306873|NCT01843348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102306874|NCT01843348|Immunologic Factors|immunologic factors|mesh-ancestor
102306875|NCT01843348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306876|NCT01843348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102306877|NCT01843348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102306878|NCT01843348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306879|NCT01843348|Antifungal Agents|antifungal agents|mesh-ancestor
102306880|NCT01843348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102306881|NCT01843348|Dermatologic Agents|dermatologic agents|mesh-ancestor
102306882|NCT01843348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102306883|NCT01843348|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102306884|NCT01843348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102306885|NCT01843348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102306886|NCT01843348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102306887|NCT01843348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102306888|NCT01843348|Antitubercular Agents|antitubercular agents|mesh-ancestor
102306889|NCT01843348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102306890|NCT01825876|Warfarin|warfarin|mesh-list
102306891|NCT01825876|Evacetrapib|evacetrapib|mesh-list
102306892|NCT01825876|Anticoagulants|anticoagulants|mesh-ancestor
102306893|NCT01825876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102306894|NCT01825876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102306895|NCT01825876|Antimetabolites|antimetabolites|mesh-ancestor
102306896|NCT01825876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306897|NCT01825876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102306898|NCT01825798|Metformin|metformin|mesh-list
102306899|NCT01825798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102306900|NCT01825798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306901|NCT02412761|Amlodipine|amlodipine|mesh-list
102306902|NCT02412761|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102306903|NCT02412761|Lisinopril|lisinopril|mesh-list
102306904|NCT02412761|Calcium Channel Blockers|calcium channel blockers|mesh-list
102306905|NCT02412761|Diuretics|diuretics|mesh-list
102306906|NCT02412761|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
102306907|NCT02412761|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102306908|NCT02412761|Enzyme Inhibitors|enzyme inhibitors|mesh-list
102306909|NCT02412761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102306910|NCT02412761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306911|NCT02412761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102306912|NCT02412761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102306913|NCT02412761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306914|NCT02412761|Vasodilator Agents|vasodilator agents|mesh-ancestor
102306915|NCT02412761|Natriuretic Agents|natriuretic agents|mesh-ancestor
102306916|NCT02412761|Protease Inhibitors|protease inhibitors|mesh-ancestor
102306917|NCT02412761|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102306918|NCT02412761|Protective Agents|protective agents|mesh-ancestor
102306919|NCT01842334|Nicotine|nicotine|mesh-list
101423154|NCT05860699|Anticonvulsants|anticonvulsants|mesh-ancestor
102306920|NCT01842334|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102306921|NCT01842334|Autonomic Agents|autonomic agents|mesh-ancestor
102306922|NCT01842334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102306923|NCT01842334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306924|NCT01842334|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102306925|NCT01842334|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102306926|NCT01842334|Cholinergic Agents|cholinergic agents|mesh-ancestor
102306927|NCT01842334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102306928|NCT01842334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306930|NCT02457611|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102306931|NCT02457611|Ledipasvir|ledipasvir|mesh-list
102306932|NCT02457611|Antiviral Agents|antiviral agents|mesh-ancestor
102306933|NCT02457611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102306934|NCT02083653|Fluorouracil|fluorouracil|mesh-list
102306935|NCT02083653|Capecitabine|capecitabine|mesh-list
102306936|NCT02083653|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102306937|NCT02083653|Antimetabolites|antimetabolites|mesh-ancestor
102306938|NCT02083653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306939|NCT02083653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102306940|NCT02083653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102306941|NCT02083653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102306942|NCT02083653|Immunologic Factors|immunologic factors|mesh-ancestor
102306943|NCT02083653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306944|NCT02436239|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
102306945|NCT02436239|Antidepressive Agents|antidepressive agents|mesh-ancestor
102306946|NCT02436239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102306947|NCT02436239|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102306948|NCT02436239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102306949|NCT02436239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102306950|NCT02436239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306951|NCT02436239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102306952|NCT02436239|Serotonin Agents|serotonin agents|mesh-ancestor
102306953|NCT02436239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306954|NCT02436239|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102306955|NCT02436239|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102306956|NCT02026011|Naltrexone|naltrexone|mesh-list
102306957|NCT02026011|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102306958|NCT02026011|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102306959|NCT02026011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306960|NCT02026011|Sensory System Agents|sensory system agents|mesh-ancestor
102306961|NCT02026011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102306962|NCT02456909|Morphine|morphine|mesh-list
102306963|NCT02456909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102306964|NCT02456909|Narcotics|narcotics|mesh-ancestor
102306965|NCT02456909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102306966|NCT02456909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306967|NCT02456909|Analgesics|analgesics|mesh-ancestor
102306968|NCT02456909|Sensory System Agents|sensory system agents|mesh-ancestor
102306969|NCT02456909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102306970|NCT02025621|Simendan|simendan|mesh-list
102306971|NCT02025621|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102306972|NCT02025621|Vasodilator Agents|vasodilator agents|mesh-ancestor
102306973|NCT02025621|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102306974|NCT02025621|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102306975|NCT02025621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102306976|NCT02025621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306977|NCT02025621|Protective Agents|protective agents|mesh-ancestor
102306978|NCT02025621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306979|NCT04729023|Temazepam|temazepam|mesh-list
102306980|NCT04729023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102306981|NCT04729023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102306982|NCT04729023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306983|NCT04729023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102306984|NCT04729023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102306985|NCT04729023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102306986|NCT04729023|GABA Modulators|gaba modulators|mesh-ancestor
102306987|NCT04729023|GABA Agents|gaba agents|mesh-ancestor
102306988|NCT04729023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102306989|NCT04729023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102306990|NCT02020941|Dexamethasone|dexamethasone|mesh-list
102306991|NCT02020941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102306992|NCT02020941|Antiemetics|antiemetics|mesh-ancestor
102306993|NCT02020941|Autonomic Agents|autonomic agents|mesh-ancestor
102306994|NCT02020941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102306995|NCT02020941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102306996|NCT02020941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102306997|NCT02020941|Glucocorticoids|glucocorticoids|mesh-ancestor
102306998|NCT02020941|Hormones|hormones|mesh-ancestor
102306999|NCT02020941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102307000|NCT02020941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102307001|NCT02020941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102307002|NCT01823224|Acetaminophen|acetaminophen|mesh-list
102307003|NCT01823224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102307004|NCT01823224|Analgesics|analgesics|mesh-ancestor
102307005|NCT01823224|Sensory System Agents|sensory system agents|mesh-ancestor
102307006|NCT01823224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102307007|NCT01823224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307008|NCT01823224|Antipyretics|antipyretics|mesh-ancestor
102307009|NCT01840228|Progesterone|progesterone|mesh-list
102307010|NCT01840228|Progestins|progestins|mesh-ancestor
102307011|NCT01840228|Hormones|hormones|mesh-ancestor
102307012|NCT01840228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102307013|NCT01840228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307014|NCT01823146|Oxytocin|oxytocin|mesh-list
102307015|NCT01823146|Oxytocics|oxytocics|mesh-ancestor
102307016|NCT01823146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102307017|NCT01823146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307018|NCT02083185|Leuprolide|leuprolide|mesh-list
102307019|NCT02083185|Relugolix|relugolix|mesh-list
102307020|NCT02083185|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102307021|NCT02083185|Fertility Agents|fertility agents|mesh-ancestor
102307022|NCT02083185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102307023|NCT02083185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307024|NCT02083185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102307025|NCT02083185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102307026|NCT02083185|Androgen Antagonists|androgen antagonists|mesh-ancestor
102307027|NCT02083185|Hormone Antagonists|hormone antagonists|mesh-ancestor
102307028|NCT02083185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102307029|NCT02412371|Paclitaxel|paclitaxel|mesh-list
102307030|NCT02412371|Carboplatin|carboplatin|mesh-list
102307031|NCT02412371|Veliparib|veliparib|mesh-list
102307032|NCT02412371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102307033|NCT02412371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102307034|NCT02412371|Tubulin Modulators|tubulin modulators|mesh-ancestor
102307035|NCT02412371|Antimitotic Agents|antimitotic agents|mesh-ancestor
102307036|NCT02412371|Mitosis Modulators|mitosis modulators|mesh-ancestor
102307037|NCT02412371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307038|NCT02412371|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102307039|NCT02412371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102307040|NCT01822756|Paclitaxel|paclitaxel|mesh-list
102307041|NCT01822756|Gemcitabine|gemcitabine|mesh-list
102307042|NCT01822756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102307043|NCT01822756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102307044|NCT01822756|Tubulin Modulators|tubulin modulators|mesh-ancestor
102307045|NCT01822756|Antimitotic Agents|antimitotic agents|mesh-ancestor
102307046|NCT01822756|Mitosis Modulators|mitosis modulators|mesh-ancestor
102307047|NCT01822756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307048|NCT01822756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102307049|NCT01822756|Antimetabolites|antimetabolites|mesh-ancestor
102307050|NCT01822678|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102307051|NCT01822678|Anticonvulsants|anticonvulsants|mesh-ancestor
102307052|NCT01822678|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102307053|NCT01822678|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102307054|NCT01822678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102307055|NCT01822678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307056|NCT01838590|Sofosbuvir|sofosbuvir|mesh-list
102307057|NCT01838590|Antiviral Agents|antiviral agents|mesh-ancestor
102307058|NCT01838590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102307059|NCT01611298|Vaccines|vaccines|mesh-list
102307060|NCT01611298|Immunologic Factors|immunologic factors|mesh-ancestor
102307061|NCT01611298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307062|NCT01822132|Naltrexone|naltrexone|mesh-list
102307063|NCT01822132|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102307064|NCT01822132|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102307065|NCT01822132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307066|NCT01822132|Sensory System Agents|sensory system agents|mesh-ancestor
102307067|NCT01822132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102307068|NCT01821898|Budesonide|budesonide|mesh-list
102015831|NCT04216017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102307069|NCT01821898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102307070|NCT01821898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102307071|NCT01821898|Autonomic Agents|autonomic agents|mesh-ancestor
102307072|NCT01821898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102307073|NCT01821898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307074|NCT01821898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102307075|NCT01821898|Respiratory System Agents|respiratory system agents|mesh-ancestor
102307076|NCT01821898|Glucocorticoids|glucocorticoids|mesh-ancestor
102307077|NCT01821898|Hormones|hormones|mesh-ancestor
102307078|NCT01821898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102307079|NCT02411591|Necitumumab|necitumumab|mesh-list
102307080|NCT02411591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102307081|NCT02411591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102307082|NCT02411201|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
102307083|NCT02411201|Chelating Agents|chelating agents|mesh-ancestor
102307084|NCT02411201|Sequestering Agents|sequestering agents|mesh-ancestor
102307085|NCT02411201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307086|NCT01838044|Celecoxib|celecoxib|mesh-list
102307087|NCT01838044|Pregabalin|pregabalin|mesh-list
102307088|NCT01838044|Analgesics|analgesics|mesh-ancestor
102307089|NCT01838044|Sensory System Agents|sensory system agents|mesh-ancestor
102307090|NCT01838044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102307091|NCT01838044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307093|NCT01838044|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102307094|NCT01838044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102307095|NCT01838044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307096|NCT01838044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102307097|NCT01838044|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102307098|NCT01838044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102307099|NCT01838044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102307100|NCT01838044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102307101|NCT01838044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102307102|NCT01838044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102307103|NCT01838044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102307104|NCT01838044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102307105|NCT01838044|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102307106|NCT01838044|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102307107|NCT01838044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102307108|NCT02435147|Denosumab|denosumab|mesh-list
102307109|NCT02435147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102307110|NCT02435147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307111|NCT02435069|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102307112|NCT02435069|Glycerol|glycerol|mesh-list
102307113|NCT02435069|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102307114|NCT02435069|Protective Agents|protective agents|mesh-ancestor
102307115|NCT02435069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307116|NCT04917731|Botulinum Toxins|botulinum toxins|mesh-list
102307117|NCT04917731|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102307118|NCT04917731|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102307119|NCT04917731|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102307120|NCT04917731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102307121|NCT04917731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307122|NCT04917731|Cholinergic Agents|cholinergic agents|mesh-ancestor
102307123|NCT04917731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102307124|NCT04917731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307125|NCT04917731|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102307126|NCT04917731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102307127|NCT01820572|Cyclosporine|cyclosporine|mesh-list
102307128|NCT01820572|Abatacept|abatacept|mesh-list
102307129|NCT01820572|Tacrolimus|tacrolimus|mesh-list
102307130|NCT01820572|Cyclosporins|cyclosporins|mesh-list
102307131|NCT01820572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102307132|NCT01820572|Immunologic Factors|immunologic factors|mesh-ancestor
102307133|NCT01820572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307134|NCT01820572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102307135|NCT01820572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102307136|NCT01820572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307137|NCT01820572|Antifungal Agents|antifungal agents|mesh-ancestor
102307138|NCT01820572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102307139|NCT01820572|Dermatologic Agents|dermatologic agents|mesh-ancestor
102307140|NCT01820572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102307141|NCT01820572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102307142|NCT01820572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102307143|NCT01820572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102307144|NCT01610596|Halobetasol|halobetasol|mesh-list
102307146|NCT01818700|Buprenorphine|buprenorphine|mesh-list
102307147|NCT01818700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102307148|NCT01818700|Narcotics|narcotics|mesh-ancestor
102307149|NCT01818700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102307150|NCT01818700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307151|NCT01818700|Analgesics|analgesics|mesh-ancestor
102307152|NCT01818700|Sensory System Agents|sensory system agents|mesh-ancestor
102307153|NCT01818700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102307154|NCT01818700|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102307155|NCT01817764|Fluticasone|fluticasone|mesh-list
102307156|NCT01817764|Xhance|xhance|mesh-list
102307157|NCT01817764|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102307158|NCT01817764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102307159|NCT01817764|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102307160|NCT01817764|Autonomic Agents|autonomic agents|mesh-ancestor
102307161|NCT01817764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102307162|NCT01817764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307163|NCT01817764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102307164|NCT01817764|Respiratory System Agents|respiratory system agents|mesh-ancestor
102307165|NCT01817764|Dermatologic Agents|dermatologic agents|mesh-ancestor
102307166|NCT01817764|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101941561|NCT03923361|Anesthetics, General|anesthetics, general|mesh-ancestor
102307167|NCT01817764|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102307168|NCT01817764|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102307169|NCT01817764|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102307170|NCT01817764|Adrenergic Agents|adrenergic agents|mesh-ancestor
102307171|NCT01817764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102307172|NCT01817764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307173|NCT04726618|Xenon|xenon|mesh-list
102307174|NCT04726618|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102307175|NCT04726618|Anesthetics, General|anesthetics, general|mesh-ancestor
102307176|NCT04726618|Anesthetics|anesthetics|mesh-ancestor
102307177|NCT04726618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102307178|NCT04726618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307179|NCT01817530|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102307180|NCT01817530|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102307181|NCT01817530|Norethindrone|norethindrone|mesh-list
102307182|NCT01817530|Norethindrone Acetate|norethindrone acetate|mesh-list
102307183|NCT01817530|Estradiol|estradiol|mesh-list
102307184|NCT01817530|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102307185|NCT01817530|Estrogens|estrogens|mesh-ancestor
102307186|NCT01817530|Hormones|hormones|mesh-ancestor
102307187|NCT01817530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102307188|NCT01817530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307189|NCT01817530|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102307190|NCT01817530|Contraceptive Agents|contraceptive agents|mesh-ancestor
102307191|NCT01817530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102307192|NCT01817530|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102307193|NCT01817530|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102307194|NCT01817530|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102307195|NCT01817530|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102307196|NCT01816984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102307197|NCT01816984|Cetuximab|cetuximab|mesh-list
102307198|NCT01816984|Antibodies|antibodies|mesh-list
102307199|NCT01816984|Immunoglobulins|immunoglobulins|mesh-list
102307200|NCT01816984|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102307201|NCT01816984|Immunologic Factors|immunologic factors|mesh-ancestor
102307202|NCT01816984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307203|NCT01816984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102307204|NCT01816594|Paclitaxel|paclitaxel|mesh-list
102307205|NCT01816594|Trastuzumab|trastuzumab|mesh-list
102307206|NCT01816594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102307207|NCT01816594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102307208|NCT01816594|Tubulin Modulators|tubulin modulators|mesh-ancestor
102307209|NCT01816594|Antimitotic Agents|antimitotic agents|mesh-ancestor
102307210|NCT01816594|Mitosis Modulators|mitosis modulators|mesh-ancestor
102307211|NCT01816594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307212|NCT01816594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102307213|NCT02453711|Liraglutide|liraglutide|mesh-list
102307214|NCT02453711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102307215|NCT02453711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307216|NCT02453711|Incretins|incretins|mesh-ancestor
102307217|NCT02453711|Hormones|hormones|mesh-ancestor
102307218|NCT02453711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102307219|NCT02453555|Empagliflozin|empagliflozin|mesh-list
102307220|NCT02453555|Linagliptin|linagliptin|mesh-list
102307221|NCT02453555|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102307222|NCT02453555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307223|NCT02453555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102307224|NCT02453555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307225|NCT02453555|Incretins|incretins|mesh-ancestor
102307227|NCT02453555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102307228|NCT02453555|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102307229|NCT02453555|Protease Inhibitors|protease inhibitors|mesh-ancestor
102307230|NCT02453555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102307231|NCT02453321|Bupivacaine|bupivacaine|mesh-list
102307232|NCT02453321|Anesthetics, Local|anesthetics, local|mesh-ancestor
102307233|NCT02453321|Anesthetics|anesthetics|mesh-ancestor
102307234|NCT02453321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102307235|NCT02453321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307236|NCT02453321|Sensory System Agents|sensory system agents|mesh-ancestor
102307237|NCT02453321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102307238|NCT01610284|Fulvestrant|fulvestrant|mesh-list
102307239|NCT01610284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102307240|NCT01610284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102307241|NCT01610284|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102307242|NCT01610284|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102307243|NCT01610284|Hormone Antagonists|hormone antagonists|mesh-ancestor
102307244|NCT01610284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102307245|NCT01610284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307246|NCT02452463|Durvalumab|durvalumab|mesh-list
102307247|NCT02452463|Nintedanib|nintedanib|mesh-list
102307248|NCT02452463|Immunoglobulins|immunoglobulins|mesh-list
102307249|NCT02452463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102307250|NCT02452463|Immunoglobulin G|immunoglobulin g|mesh-list
102307251|NCT02452463|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102307252|NCT02452463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102307253|NCT02452463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102307254|NCT02452463|Immunologic Factors|immunologic factors|mesh-ancestor
102307255|NCT02452463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307256|NCT02452463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102307257|NCT02452463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102307258|NCT02452463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307259|NCT03628391|Haloperidol|haloperidol|mesh-list
102307260|NCT03628391|Haloperidol decanoate|haloperidol decanoate|mesh-list
102307261|NCT03628391|Antiemetics|antiemetics|mesh-ancestor
102307262|NCT03628391|Autonomic Agents|autonomic agents|mesh-ancestor
102307263|NCT03628391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102307264|NCT03628391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307265|NCT03628391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102307266|NCT03628391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102307267|NCT03628391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102307268|NCT03628391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102307269|NCT03628391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102307270|NCT03628391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102307271|NCT03628391|Dopamine Agents|dopamine agents|mesh-ancestor
102307272|NCT03628391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102307273|NCT03628391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307274|NCT03628391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102307275|NCT01610206|Gemcitabine|gemcitabine|mesh-list
102307276|NCT01610206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102307277|NCT01610206|Antimetabolites|antimetabolites|mesh-ancestor
102307278|NCT01610206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307279|NCT01610206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102307280|NCT01816048|Listerine|listerine|mesh-list
102307281|NCT01816048|Fluorides|fluorides|mesh-list
102307282|NCT01816048|Sodium Fluoride|sodium fluoride|mesh-list
102307283|NCT01816048|Cariostatic Agents|cariostatic agents|mesh-ancestor
102307284|NCT01816048|Protective Agents|protective agents|mesh-ancestor
102307285|NCT01816048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307286|NCT01816048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102307287|NCT01816048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102307288|NCT01612858|Metformin|metformin|mesh-list
102307289|NCT01612858|Pioglitazone|pioglitazone|mesh-list
102307290|NCT01612858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102307291|NCT01612858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307292|NCT01612702|Dexamethasone|dexamethasone|mesh-list
102307293|NCT01612702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102307294|NCT01612702|Antiemetics|antiemetics|mesh-ancestor
102307295|NCT01612702|Autonomic Agents|autonomic agents|mesh-ancestor
102307296|NCT01612702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102307297|NCT01612702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307298|NCT01612702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102307299|NCT01612702|Glucocorticoids|glucocorticoids|mesh-ancestor
102307300|NCT01612702|Hormones|hormones|mesh-ancestor
102307301|NCT01612702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102307302|NCT01612702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102307303|NCT01612702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102307304|NCT02431559|Doxorubicin|doxorubicin|mesh-list
102307305|NCT02431559|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102307306|NCT02431559|Durvalumab|durvalumab|mesh-list
102307307|NCT02431559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102307308|NCT02431559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102307309|NCT02431559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102307310|NCT02431559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102307311|NCT02431559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102307312|NCT02431559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307313|NCT02431559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102307314|NCT04926545|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
102307315|NCT04926545|Fluorouracil|fluorouracil|mesh-list
102307316|NCT04926545|Irinotecan|irinotecan|mesh-list
102307317|NCT04926545|Antimetabolites|antimetabolites|mesh-ancestor
102307318|NCT04926545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307319|NCT04926545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102307320|NCT04926545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102307321|NCT04926545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102307322|NCT04926545|Immunologic Factors|immunologic factors|mesh-ancestor
102307323|NCT04926545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307324|NCT04926545|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102307325|NCT04926545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102307326|NCT04926545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102307327|NCT04926545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102307328|NCT04926545|Hormone Antagonists|hormone antagonists|mesh-ancestor
102307329|NCT04926545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102307330|NCT04926545|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102307331|NCT04926545|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102307332|NCT04926545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102307333|NCT01652573|Calcitonin|calcitonin|mesh-list
102307334|NCT01652573|Salmon calcitonin|salmon calcitonin|mesh-list
102307335|NCT01652573|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
102307336|NCT01652573|Katacalcin|katacalcin|mesh-list
102307337|NCT01652573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102307338|NCT01652573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307339|NCT01652573|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102307340|NCT01652573|Vasodilator Agents|vasodilator agents|mesh-ancestor
102307341|NCT02388191|Naproxen|naproxen|mesh-list
102307342|NCT02388191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102307343|NCT02388191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102307344|NCT02388191|Analgesics|analgesics|mesh-ancestor
102307345|NCT02388191|Sensory System Agents|sensory system agents|mesh-ancestor
102307346|NCT02388191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102307347|NCT02388191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307348|NCT02388191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102307349|NCT02388191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102307350|NCT02388191|Gout Suppressants|gout suppressants|mesh-ancestor
102307351|NCT02388191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102307352|NCT02388191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102307353|NCT02388191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307354|NCT01815736|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102307355|NCT01815736|Antiviral Agents|antiviral agents|mesh-ancestor
102307356|NCT01815736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102307357|NCT01815736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102307358|NCT01815736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102307359|NCT02387957|Bevacizumab|bevacizumab|mesh-list
102307360|NCT02387957|Ranibizumab|ranibizumab|mesh-list
102307361|NCT02387957|Aflibercept|aflibercept|mesh-list
102307362|NCT02387957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102307363|NCT02387957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102307364|NCT02387957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102307365|NCT02387957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102307366|NCT02387957|Growth Substances|growth substances|mesh-ancestor
102307367|NCT02387957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307368|NCT02387957|Growth Inhibitors|growth inhibitors|mesh-ancestor
102307369|NCT01815580|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102307370|NCT01815580|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102307371|NCT01815580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102307372|NCT01815580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102307373|NCT01815580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102307374|NCT01815580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307376|NCT01815580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102307377|NCT01815580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102307378|NCT01815580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102307379|NCT01799590|Topiramate|topiramate|mesh-list
102307380|NCT01799590|Anticonvulsants|anticonvulsants|mesh-ancestor
102307381|NCT01799590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102307382|NCT01799590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307383|NCT04902131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102307384|NCT04902131|Menotropins|menotropins|mesh-list
102307385|NCT04902131|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102307386|NCT04902131|Fertility Agents|fertility agents|mesh-ancestor
102307387|NCT04902131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102307388|NCT04902131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307389|NCT01815424|Tofacitinib|tofacitinib|mesh-list
102307390|NCT01815424|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102307391|NCT01815424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102307392|NCT01815424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102307393|NCT01815424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307394|NCT02431247|Tenofovir|tenofovir|mesh-list
102307395|NCT02431247|Emtricitabine|emtricitabine|mesh-list
102307396|NCT02431247|Darunavir|darunavir|mesh-list
102307397|NCT02431247|Cobicistat|cobicistat|mesh-list
102307398|NCT02431247|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
102307399|NCT02431247|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
102307400|NCT02431247|Antiviral Agents|antiviral agents|mesh-ancestor
102307401|NCT02431247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102307402|NCT02431247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102307403|NCT02431247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102307404|NCT02431247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102307405|NCT02431247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307406|NCT02431247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102307407|NCT02431247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102307408|NCT02431247|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102307409|NCT02431247|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102307410|NCT02431247|Protease Inhibitors|protease inhibitors|mesh-ancestor
102307411|NCT02431247|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102307412|NCT02431247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102307413|NCT01814878|Acetaminophen|acetaminophen|mesh-list
102307414|NCT01814878|Tramadol|tramadol|mesh-list
102307415|NCT01814878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102307416|NCT01814878|Analgesics|analgesics|mesh-ancestor
102307417|NCT01814878|Sensory System Agents|sensory system agents|mesh-ancestor
102307418|NCT01814878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102307419|NCT01814878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307420|NCT01814878|Antipyretics|antipyretics|mesh-ancestor
102307421|NCT01814878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102307422|NCT01814878|Narcotics|narcotics|mesh-ancestor
102307423|NCT01814878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102307424|NCT01814800|Immunoglobulins|immunoglobulins|mesh-list
102307425|NCT01814800|Immunologic Factors|immunologic factors|mesh-ancestor
102307426|NCT01814800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307427|NCT02407223|Ustekinumab|ustekinumab|mesh-list
102307428|NCT02407223|Dermatologic Agents|dermatologic agents|mesh-ancestor
102307429|NCT04602754|Calcium, Dietary|calcium, dietary|mesh-list
102307430|NCT04602754|Empagliflozin|empagliflozin|mesh-list
102307431|NCT04602754|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102307432|NCT04602754|Calcium|calcium|mesh-list
102307433|NCT04602754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102307434|NCT04602754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307435|NCT04602754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102307436|NCT04602754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102307437|NCT04602754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102307438|NCT04602754|Antimetabolites|antimetabolites|mesh-ancestor
102307439|NCT04602754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307440|NCT04602754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102307441|NCT04602754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102307442|NCT04602754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102307443|NCT04602754|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102307444|NCT04602754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102307445|NCT01813474|Olaparib|olaparib|mesh-list
102307446|NCT01813474|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102307447|NCT01813474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102307448|NCT01813474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307449|NCT01813474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102307450|NCT01868542|Insulin Detemir|insulin detemir|mesh-list
102307451|NCT01868542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102307452|NCT01868542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307453|NCT01797094|Botulinum Toxins|botulinum toxins|mesh-list
102307454|NCT01797094|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102307455|NCT01797094|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102307456|NCT01797094|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102307457|NCT01797094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102307458|NCT01797094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307459|NCT01797094|Cholinergic Agents|cholinergic agents|mesh-ancestor
102307460|NCT01797094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102307461|NCT01797094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307462|NCT01797094|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102307463|NCT01797094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102307464|NCT02383589|Mycophenolic Acid|mycophenolic acid|mesh-list
102307465|NCT02383589|Rituximab|rituximab|mesh-list
102307466|NCT02383589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102307467|NCT02383589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102307468|NCT02383589|Immunologic Factors|immunologic factors|mesh-ancestor
102307469|NCT02383589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307470|NCT02383589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102307471|NCT02383589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102307472|NCT02383589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102307473|NCT02383589|Antitubercular Agents|antitubercular agents|mesh-ancestor
102307474|NCT02383589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102307475|NCT02383589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102307476|NCT02383589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102307477|NCT02383589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307478|NCT01810432|Evacetrapib|evacetrapib|mesh-list
102307479|NCT01810432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102307480|NCT01810432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102307481|NCT01810432|Antimetabolites|antimetabolites|mesh-ancestor
102307482|NCT01810432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307483|NCT01810432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102307484|NCT02404805|Dolutegravir|dolutegravir|mesh-list
102307485|NCT02404805|Simeprevir|simeprevir|mesh-list
102307486|NCT02404805|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102307487|NCT02404805|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102307488|NCT02404805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102307489|NCT02404805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307490|NCT02404805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102307491|NCT02404805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102307492|NCT02404805|Antiviral Agents|antiviral agents|mesh-ancestor
102307493|NCT02404805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102307494|NCT02404805|Protease Inhibitors|protease inhibitors|mesh-ancestor
102307495|NCT02430311|Paclitaxel|paclitaxel|mesh-list
102307496|NCT02430311|Olaparib|olaparib|mesh-list
102307497|NCT02430311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102307498|NCT02430311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102307499|NCT02430311|Tubulin Modulators|tubulin modulators|mesh-ancestor
102307500|NCT02430311|Antimitotic Agents|antimitotic agents|mesh-ancestor
102307501|NCT02430311|Mitosis Modulators|mitosis modulators|mesh-ancestor
102307502|NCT02430311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307503|NCT02430311|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102307504|NCT02430311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102307505|NCT02383433|Gemcitabine|gemcitabine|mesh-list
102307506|NCT02383433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102307507|NCT02383433|Antimetabolites|antimetabolites|mesh-ancestor
102307508|NCT02383433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307509|NCT02383433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102307510|NCT02383355|Raltegravir Potassium|raltegravir potassium|mesh-list
102307511|NCT02383355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102307512|NCT02383355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102307513|NCT02383355|Antiviral Agents|antiviral agents|mesh-ancestor
102307514|NCT02383355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102307515|NCT02383355|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102016281|NCT05235100|Apatinib|apatinib|mesh-list
102307516|NCT02383355|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102307517|NCT02383355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102307518|NCT02383355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307519|NCT02404493|Decanoic acid|decanoic acid|mesh-list
102307520|NCT02404493|Antifungal Agents|antifungal agents|mesh-ancestor
102307521|NCT02404493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102307522|NCT02379221|Lidocaine|lidocaine|mesh-list
102307523|NCT02379221|Epinephrine|epinephrine|mesh-list
102307524|NCT02379221|Benzocaine|benzocaine|mesh-list
102307525|NCT02379221|Anesthetics, Local|anesthetics, local|mesh-ancestor
102307526|NCT02379221|Anesthetics|anesthetics|mesh-ancestor
102307527|NCT02379221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102307528|NCT02379221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307529|NCT02379221|Sensory System Agents|sensory system agents|mesh-ancestor
102307530|NCT02379221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102307531|NCT02379221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102307532|NCT02379221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102307533|NCT02379221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102307534|NCT02379221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102307535|NCT02379221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307536|NCT02379221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102307537|NCT02379221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102307538|NCT02379221|Adrenergic Agents|adrenergic agents|mesh-ancestor
102307539|NCT02379221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102307540|NCT02379221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102307541|NCT02379221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102307542|NCT02379221|Autonomic Agents|autonomic agents|mesh-ancestor
102307543|NCT02379221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102307544|NCT02379221|Respiratory System Agents|respiratory system agents|mesh-ancestor
102307545|NCT02379221|Mydriatics|mydriatics|mesh-ancestor
102307546|NCT02379221|Sympathomimetics|sympathomimetics|mesh-ancestor
102307547|NCT02379221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102307548|NCT02404103|Flunisolide|flunisolide|mesh-list
102307549|NCT02404103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102307550|NCT02404103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102307551|NCT02404103|Respiratory System Agents|respiratory system agents|mesh-ancestor
102307552|NCT02404025|Thymoglobulin|thymoglobulin|mesh-list
102307553|NCT02404025|Immunologic Factors|immunologic factors|mesh-ancestor
102307554|NCT02404025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307555|NCT02404025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102307556|NCT02403635|Midazolam|midazolam|mesh-list
102307557|NCT02403635|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102307558|NCT02403635|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102307559|NCT02403635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102307560|NCT02403635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307561|NCT02403635|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102307562|NCT02403635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102307563|NCT02403635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102307564|NCT02403635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102307565|NCT02403635|Anesthetics, General|anesthetics, general|mesh-ancestor
102307566|NCT02403635|Anesthetics|anesthetics|mesh-ancestor
102307567|NCT02403635|GABA Modulators|gaba modulators|mesh-ancestor
102307568|NCT02403635|GABA Agents|gaba agents|mesh-ancestor
102307569|NCT02403635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102307570|NCT02403635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307571|NCT02402933|Glucagon|glucagon|mesh-list
102307572|NCT02402933|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102307573|NCT02402933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102307574|NCT02402933|Hormones|hormones|mesh-ancestor
102307575|NCT02402933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102307576|NCT02402933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307577|NCT02402933|Incretins|incretins|mesh-ancestor
102307578|NCT01796470|Idelalisib|idelalisib|mesh-list
102307579|NCT01796470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102307580|NCT01796470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102307581|NCT01796470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307582|NCT04414852|Apatinib|apatinib|mesh-list
102307583|NCT04414852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102307584|NCT04414852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102307585|NCT04414852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101423864|NCT04616196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102307586|NCT04414852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307587|NCT04415008|Cytarabine|cytarabine|mesh-list
102307588|NCT04415008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102307589|NCT04415008|Antimetabolites|antimetabolites|mesh-ancestor
102307590|NCT04415008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307591|NCT04415008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102307592|NCT04415008|Antiviral Agents|antiviral agents|mesh-ancestor
102307593|NCT04415008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102307594|NCT04415008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102307595|NCT04415008|Immunologic Factors|immunologic factors|mesh-ancestor
102307596|NCT04415008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307597|NCT01810042|Ranibizumab|ranibizumab|mesh-list
102307598|NCT01810042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102307599|NCT01810042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102307600|NCT01810042|Growth Substances|growth substances|mesh-ancestor
102307601|NCT01810042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307602|NCT01810042|Growth Inhibitors|growth inhibitors|mesh-ancestor
102307603|NCT01810042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102307604|NCT01808248|Sofosbuvir|sofosbuvir|mesh-list
102307605|NCT01808248|Antiviral Agents|antiviral agents|mesh-ancestor
102307606|NCT01808248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102307607|NCT01867294|Doxycycline|doxycycline|mesh-list
102307608|NCT01867294|Hydrocortisone|hydrocortisone|mesh-list
102307609|NCT01867294|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102307610|NCT01867294|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102307611|NCT01867294|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102307612|NCT01867294|Spironolactone|spironolactone|mesh-list
102307613|NCT01867294|Sunscreening Agents|sunscreening agents|mesh-list
102307614|NCT01867294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102307615|NCT01867294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102307616|NCT01867294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102307617|NCT01867294|Antimalarials|antimalarials|mesh-ancestor
102307618|NCT01867294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102307619|NCT01867294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102307620|NCT01867294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102307621|NCT01867294|Hormone Antagonists|hormone antagonists|mesh-ancestor
102307622|NCT01867294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102307623|NCT01867294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307624|NCT01867294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102307625|NCT01867294|Diuretics|diuretics|mesh-ancestor
102307626|NCT01867294|Natriuretic Agents|natriuretic agents|mesh-ancestor
102307627|NCT01867294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102307628|NCT01867294|Protective Agents|protective agents|mesh-ancestor
102307629|NCT01867294|Dermatologic Agents|dermatologic agents|mesh-ancestor
102307630|NCT02423291|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102307631|NCT02423291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102307632|NCT02423291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102307633|NCT02423291|Immunotoxins|immunotoxins|mesh-ancestor
102307634|NCT02423291|Immunoconjugates|immunoconjugates|mesh-ancestor
102307635|NCT02423291|Immunologic Factors|immunologic factors|mesh-ancestor
102307636|NCT02423291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307637|NCT02401529|Acetaminophen|acetaminophen|mesh-list
102307638|NCT02401529|Dexamethasone|dexamethasone|mesh-list
102307639|NCT02401529|Prednisolone|prednisolone|mesh-list
102307640|NCT02401529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102307641|NCT02401529|Antiemetics|antiemetics|mesh-ancestor
102307642|NCT02401529|Autonomic Agents|autonomic agents|mesh-ancestor
102307643|NCT02401529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102307644|NCT02401529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307645|NCT02401529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102307646|NCT02401529|Glucocorticoids|glucocorticoids|mesh-ancestor
102307647|NCT02401529|Hormones|hormones|mesh-ancestor
102307648|NCT02401529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102307649|NCT02401529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102307650|NCT02401529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102307651|NCT02401529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102307652|NCT02401529|Analgesics|analgesics|mesh-ancestor
102307653|NCT02401529|Sensory System Agents|sensory system agents|mesh-ancestor
102307654|NCT02401529|Antipyretics|antipyretics|mesh-ancestor
102307655|NCT01866826|Rifaximin|rifaximin|mesh-list
102307656|NCT01866826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101423943|NCT04395989|Antimetabolites|antimetabolites|mesh-ancestor
102307657|NCT01866826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102307658|NCT01866826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102307659|NCT01865812|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
102307660|NCT01865812|Cathartics|cathartics|mesh-ancestor
102307661|NCT01865812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102307662|NCT01808092|Meropenem|meropenem|mesh-list
102307663|NCT01808092|Ceftazidime|ceftazidime|mesh-list
102307664|NCT01808092|Avibactam|avibactam|mesh-list
102307665|NCT01808092|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
102307666|NCT01808092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102307667|NCT01808092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102307668|NCT01808092|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102307669|NCT01808092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102307670|NCT01808092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307672|NCT01807234|Sumatriptan|sumatriptan|mesh-list
102307673|NCT01807234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102307674|NCT01807234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102307675|NCT01807234|Analgesics|analgesics|mesh-ancestor
102307676|NCT01807234|Sensory System Agents|sensory system agents|mesh-ancestor
102307677|NCT01807234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102307678|NCT01807234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307679|NCT01807234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102307680|NCT01807234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102307681|NCT01807234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102307682|NCT01807234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102307683|NCT01807234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307684|NCT01807234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102307685|NCT01807234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102307686|NCT01807234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102307687|NCT01807234|Serotonin Agents|serotonin agents|mesh-ancestor
102307688|NCT01807234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102307689|NCT02421887|Antioxidants|antioxidants|mesh-list
102307690|NCT02421887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307691|NCT02421887|Protective Agents|protective agents|mesh-ancestor
102307692|NCT02421887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307693|NCT01789606|Ibuprofen|ibuprofen|mesh-list
102307694|NCT01789606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102307695|NCT01789606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102307696|NCT01789606|Analgesics|analgesics|mesh-ancestor
102307697|NCT01789606|Sensory System Agents|sensory system agents|mesh-ancestor
102307698|NCT01789606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102307699|NCT01789606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307700|NCT01789606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102307701|NCT01789606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102307702|NCT01789606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102307703|NCT01789606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102307704|NCT01789606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307705|NCT01788358|Candesartan|candesartan|mesh-list
102307706|NCT01788358|Candesartan cilexetil|candesartan cilexetil|mesh-list
102307707|NCT01788358|Nifedipine|nifedipine|mesh-list
102307708|NCT01788358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102307709|NCT01788358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102307710|NCT01788358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102307711|NCT01788358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307712|NCT01788358|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102307713|NCT01788358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102307714|NCT01788358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102307715|NCT01788358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307716|NCT01788358|Vasodilator Agents|vasodilator agents|mesh-ancestor
102307717|NCT01788358|Tocolytic Agents|tocolytic agents|mesh-ancestor
102307718|NCT01788358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102307719|NCT01773070|Ritonavir|ritonavir|mesh-list
102307720|NCT01773070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102307721|NCT01773070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102307722|NCT01773070|Protease Inhibitors|protease inhibitors|mesh-ancestor
102307723|NCT01773070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102307724|NCT01773070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307725|NCT01773070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102307726|NCT01773070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102307727|NCT01773070|Antiviral Agents|antiviral agents|mesh-ancestor
102307728|NCT01773070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102307729|NCT01773070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102307730|NCT01773070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102307731|NCT01772368|Fluticasone|fluticasone|mesh-list
102307732|NCT01772368|Xhance|xhance|mesh-list
102307733|NCT01772368|Albuterol|albuterol|mesh-list
102307734|NCT01772368|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102307735|NCT01772368|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102307736|NCT01772368|Adrenergic Agonists|adrenergic agonists|mesh-list
102307737|NCT01772368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102307738|NCT01772368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102307739|NCT01772368|Autonomic Agents|autonomic agents|mesh-ancestor
102307740|NCT01772368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102307741|NCT01772368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307742|NCT01772368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102307743|NCT01772368|Respiratory System Agents|respiratory system agents|mesh-ancestor
102307744|NCT01772368|Dermatologic Agents|dermatologic agents|mesh-ancestor
102307745|NCT01772368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102307746|NCT01772368|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102307747|NCT01772368|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102307748|NCT01772368|Adrenergic Agents|adrenergic agents|mesh-ancestor
102307749|NCT01772368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102307750|NCT01772368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307751|NCT01772368|Tocolytic Agents|tocolytic agents|mesh-ancestor
102307752|NCT01772368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102307753|NCT01772368|Glucocorticoids|glucocorticoids|mesh-ancestor
102307754|NCT01772368|Hormones|hormones|mesh-ancestor
102307755|NCT01772368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102307756|NCT01772368|Sympathomimetics|sympathomimetics|mesh-ancestor
102307757|NCT01806298|Hormones|hormones|mesh-list
102307758|NCT01806298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102307759|NCT01806298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307760|NCT01772134|Fluticasone|fluticasone|mesh-list
102307761|NCT01772134|Xhance|xhance|mesh-list
102307762|NCT01772134|Bromides|bromides|mesh-list
102307763|NCT01772134|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102307764|NCT01772134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102307765|NCT01772134|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102307766|NCT01772134|Autonomic Agents|autonomic agents|mesh-ancestor
102307767|NCT01772134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102307768|NCT01772134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307769|NCT01772134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102307770|NCT01772134|Respiratory System Agents|respiratory system agents|mesh-ancestor
102307771|NCT01772134|Dermatologic Agents|dermatologic agents|mesh-ancestor
102307772|NCT01772134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102307773|NCT01772134|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101424077|NCT03897881|Pembrolizumab|pembrolizumab|mesh-list
102307774|NCT01772134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102307775|NCT01772134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102307776|NCT01772134|Adrenergic Agents|adrenergic agents|mesh-ancestor
102307777|NCT01772134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102307778|NCT01772134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307779|NCT01772134|Anticonvulsants|anticonvulsants|mesh-ancestor
102307780|NCT02017899|Vaccines|vaccines|mesh-list
102307781|NCT02017899|Immunologic Factors|immunologic factors|mesh-ancestor
102307782|NCT02017899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307783|NCT01993329|Mitomycin|mitomycin|mesh-list
102307784|NCT01993329|Cisplatin|cisplatin|mesh-list
102307785|NCT01993329|Ifosfamide|ifosfamide|mesh-list
102307786|NCT01993329|Mesna|mesna|mesh-list
102307787|NCT01993329|Protective Agents|protective agents|mesh-ancestor
102307788|NCT01993329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307789|NCT01993329|Alkylating Agents|alkylating agents|mesh-ancestor
102307790|NCT01993329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307791|NCT01993329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102307792|NCT01993329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102307793|NCT01993329|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102307794|NCT01993329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102307795|NCT01993329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102307796|NCT02016183|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102307797|NCT02016183|Candesartan|candesartan|mesh-list
102307798|NCT02016183|Candesartan cilexetil|candesartan cilexetil|mesh-list
102307799|NCT02016183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102307800|NCT02016183|Diuretics|diuretics|mesh-ancestor
102307801|NCT02016183|Natriuretic Agents|natriuretic agents|mesh-ancestor
102307802|NCT02016183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307803|NCT02016183|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102307804|NCT02016183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102307805|NCT02016183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307806|NCT02016183|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102307807|NCT02016183|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102307808|NCT02421419|Dexamethasone|dexamethasone|mesh-list
102307809|NCT02421419|Dexamethasone acetate|dexamethasone acetate|mesh-list
102307810|NCT02421419|Lidocaine|lidocaine|mesh-list
102307811|NCT02421419|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102307812|NCT02421419|BB 1101|bb 1101|mesh-list
102307813|NCT02421419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102307814|NCT02421419|Antiemetics|antiemetics|mesh-ancestor
102307815|NCT02421419|Autonomic Agents|autonomic agents|mesh-ancestor
102307816|NCT02421419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102307817|NCT02421419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016579|NCT01332747|Atorvastatin|atorvastatin|mesh-list
102307818|NCT02421419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102307819|NCT02421419|Glucocorticoids|glucocorticoids|mesh-ancestor
102307821|NCT02421419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102307822|NCT02421419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102307823|NCT02421419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102307824|NCT02421419|Anesthetics, Local|anesthetics, local|mesh-ancestor
102307825|NCT02421419|Anesthetics|anesthetics|mesh-ancestor
102307826|NCT02421419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102307827|NCT02421419|Sensory System Agents|sensory system agents|mesh-ancestor
102307828|NCT02421419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102307829|NCT02421419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102307830|NCT02421419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102307831|NCT02421419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102307832|NCT02421419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307833|NCT02421419|Protease Inhibitors|protease inhibitors|mesh-ancestor
102307834|NCT02421419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102307835|NCT02420717|Leucovorin|leucovorin|mesh-list
102307836|NCT02420717|Cytarabine|cytarabine|mesh-list
102307837|NCT02420717|Dexamethasone|dexamethasone|mesh-list
102307838|NCT02420717|Dexamethasone acetate|dexamethasone acetate|mesh-list
102307839|NCT02420717|Prednisone|prednisone|mesh-list
102307840|NCT02420717|Cortisone|cortisone|mesh-list
102307841|NCT02420717|Cyclophosphamide|cyclophosphamide|mesh-list
102307842|NCT02420717|Rituximab|rituximab|mesh-list
102307843|NCT02420717|Doxorubicin|doxorubicin|mesh-list
102307844|NCT02420717|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102307845|NCT02420717|Methotrexate|methotrexate|mesh-list
102307846|NCT02420717|Vincristine|vincristine|mesh-list
102307847|NCT02420717|Daunorubicin|daunorubicin|mesh-list
102307848|NCT02420717|Dasatinib|dasatinib|mesh-list
102307849|NCT02420717|Mercaptopurine|mercaptopurine|mesh-list
102307850|NCT02420717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102307851|NCT02420717|Antibodies|antibodies|mesh-list
102307852|NCT02420717|Immunoglobulins|immunoglobulins|mesh-list
102307853|NCT02420717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102307854|NCT02420717|BB 1101|bb 1101|mesh-list
102307855|NCT02420717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102307856|NCT02420717|Immunologic Factors|immunologic factors|mesh-ancestor
102307857|NCT02420717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307858|NCT02420717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102307859|NCT02420717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102307860|NCT02420717|Alkylating Agents|alkylating agents|mesh-ancestor
102307861|NCT02420717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307862|NCT02420717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102307863|NCT02420717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102307864|NCT02420717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102307865|NCT02420717|Antiemetics|antiemetics|mesh-ancestor
102307866|NCT02420717|Autonomic Agents|autonomic agents|mesh-ancestor
102307867|NCT02420717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102307868|NCT02420717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102307869|NCT02420717|Glucocorticoids|glucocorticoids|mesh-ancestor
102307870|NCT02420717|Hormones|hormones|mesh-ancestor
102307871|NCT02420717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102307872|NCT02420717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102307873|NCT02420717|Protease Inhibitors|protease inhibitors|mesh-ancestor
102307874|NCT02420717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102307875|NCT02420717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102307876|NCT02420717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102307877|NCT02420717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102307878|NCT02420717|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102307879|NCT02420717|Abortifacient Agents|abortifacient agents|mesh-ancestor
102307880|NCT02420717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102307881|NCT02420717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102307882|NCT02420717|Antimetabolites|antimetabolites|mesh-ancestor
102307883|NCT02420717|Dermatologic Agents|dermatologic agents|mesh-ancestor
102307884|NCT02420717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102307885|NCT02420717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102307886|NCT02420717|Antiviral Agents|antiviral agents|mesh-ancestor
102307887|NCT02420717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102307888|NCT02420717|Antidotes|antidotes|mesh-ancestor
102307889|NCT02420717|Protective Agents|protective agents|mesh-ancestor
102307890|NCT02420717|Vitamin B Complex|vitamin b complex|mesh-ancestor
102307891|NCT02420717|Vitamins|vitamins|mesh-ancestor
102016651|NCT01335321|Hormones|hormones|mesh-ancestor
102307892|NCT02420717|Micronutrients|micronutrients|mesh-ancestor
102307893|NCT02420717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102307894|NCT02420717|Tubulin Modulators|tubulin modulators|mesh-ancestor
102307896|NCT02420717|Mitosis Modulators|mitosis modulators|mesh-ancestor
102307897|NCT02420717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102307898|NCT02016105|Adalimumab|adalimumab|mesh-list
102307899|NCT02016105|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102307900|NCT02016105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102307901|NCT02016105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102307902|NCT02400749|Apremilast|apremilast|mesh-list
102307903|NCT02400749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102307904|NCT02400749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102307905|NCT02400749|Analgesics|analgesics|mesh-ancestor
102307906|NCT02400749|Sensory System Agents|sensory system agents|mesh-ancestor
102307907|NCT02400749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102307908|NCT02400749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307909|NCT02400749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102307910|NCT02400749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102307911|NCT02400749|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102307912|NCT02400749|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102307913|NCT02400749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101424210|NCT03172754|Nivolumab|nivolumab|mesh-list
102307914|NCT02400749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307915|NCT02420327|Galantamine|galantamine|mesh-list
102307916|NCT02420327|Nicotine|nicotine|mesh-list
102307917|NCT02420327|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102307918|NCT02420327|Autonomic Agents|autonomic agents|mesh-ancestor
102307919|NCT02420327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102307920|NCT02420327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307921|NCT02420327|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102307922|NCT02420327|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102307923|NCT02420327|Cholinergic Agents|cholinergic agents|mesh-ancestor
102307924|NCT02420327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102307925|NCT02420327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307926|NCT02420327|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102307927|NCT02420327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102307928|NCT02420327|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102307929|NCT02420327|Nootropic Agents|nootropic agents|mesh-ancestor
102307930|NCT02374853|Vancomycin|vancomycin|mesh-list
102307931|NCT02374853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102307932|NCT02374853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102307933|NCT02015793|Adalimumab|adalimumab|mesh-list
102307934|NCT02015793|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102307935|NCT02015793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102307936|NCT02015793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102307937|NCT02347631|Dipivefrin|dipivefrin|mesh-list
102307938|NCT02347631|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102307939|NCT02347631|Adrenergic Agents|adrenergic agents|mesh-ancestor
102307940|NCT02347631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102307941|NCT02347631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307942|NCT02347631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307943|NCT02015637|Ceftriaxone|ceftriaxone|mesh-list
102307944|NCT02015637|Delafloxacin|delafloxacin|mesh-list
102307945|NCT02015637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102307946|NCT02015637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102307947|NCT02347085|Glycopyrrolate|glycopyrrolate|mesh-list
102307948|NCT02347085|Formoterol Fumarate|formoterol fumarate|mesh-list
102307949|NCT02347085|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102307950|NCT02347085|Autonomic Agents|autonomic agents|mesh-ancestor
102307951|NCT02347085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102307952|NCT02347085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307953|NCT02347085|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102307954|NCT02347085|Respiratory System Agents|respiratory system agents|mesh-ancestor
102307955|NCT02347085|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102307956|NCT02347085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102307957|NCT02347085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102307958|NCT02347085|Adrenergic Agents|adrenergic agents|mesh-ancestor
102307959|NCT02347085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102307960|NCT02347085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307961|NCT02347085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102307962|NCT02347085|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102307963|NCT02347085|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102307964|NCT02347085|Cholinergic Agents|cholinergic agents|mesh-ancestor
102307965|NCT01621191|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102307966|NCT01621191|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102307967|NCT01621191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102307968|NCT01621191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102307969|NCT01621191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102307970|NCT01621191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102307971|NCT01621191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307972|NCT01621191|Analgesics|analgesics|mesh-ancestor
102307973|NCT01621191|Sensory System Agents|sensory system agents|mesh-ancestor
102307974|NCT01621191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102307975|NCT01621191|Antidepressive Agents|antidepressive agents|mesh-ancestor
102307976|NCT01621191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102307977|NCT01621191|Dopamine Agents|dopamine agents|mesh-ancestor
102307978|NCT02343263|Bupivacaine|bupivacaine|mesh-list
102307979|NCT02343263|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102307980|NCT02343263|Anesthetics, Local|anesthetics, local|mesh-ancestor
102307981|NCT02343263|Anesthetics|anesthetics|mesh-ancestor
102307982|NCT02343263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102307983|NCT02343263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307984|NCT02343263|Sensory System Agents|sensory system agents|mesh-ancestor
102307985|NCT02343263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102307986|NCT02343263|Hemostatics|hemostatics|mesh-ancestor
102307987|NCT02343263|Coagulants|coagulants|mesh-ancestor
102307988|NCT02342639|Rifaximin|rifaximin|mesh-list
102307989|NCT02342639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102307990|NCT02342639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102307991|NCT02342639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102307993|NCT01625091|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102307994|NCT01625091|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102307995|NCT01625091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102307996|NCT01625091|Sensory System Agents|sensory system agents|mesh-ancestor
102307997|NCT01625091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102307998|NCT02396537|Lidocaine|lidocaine|mesh-list
102307999|NCT02396537|Midazolam|midazolam|mesh-list
102308000|NCT02396537|Anesthetics, Local|anesthetics, local|mesh-ancestor
102308001|NCT02396537|Anesthetics|anesthetics|mesh-ancestor
102308002|NCT02396537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102308003|NCT02396537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308004|NCT02396537|Sensory System Agents|sensory system agents|mesh-ancestor
102308005|NCT02396537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102308006|NCT02396537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102308007|NCT02396537|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102308008|NCT02396537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102308009|NCT02396537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102308010|NCT02396537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308011|NCT02396537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102308012|NCT02396537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102308013|NCT02396537|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102308014|NCT02396537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102308015|NCT02396537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102308016|NCT02396537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102308017|NCT02396537|Anesthetics, General|anesthetics, general|mesh-ancestor
102308018|NCT02396537|GABA Modulators|gaba modulators|mesh-ancestor
102308019|NCT02396537|GABA Agents|gaba agents|mesh-ancestor
102308020|NCT02396537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102308021|NCT01624467|Necitumumab|necitumumab|mesh-list
102308022|NCT01624467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102308023|NCT01624467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308024|NCT01624233|Ixekizumab|ixekizumab|mesh-list
102308025|NCT01624233|Dermatologic Agents|dermatologic agents|mesh-ancestor
102308026|NCT01993017|Bupropion|bupropion|mesh-list
102308027|NCT01993017|Sertraline|sertraline|mesh-list
102308028|NCT01993017|Antidepressive Agents|antidepressive agents|mesh-list
102308029|NCT01993017|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102308030|NCT01993017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102308031|NCT01993017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102308032|NCT01993017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102308033|NCT01993017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102308034|NCT01993017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308035|NCT01993017|Dopamine Agents|dopamine agents|mesh-ancestor
102308036|NCT01993017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102308037|NCT01993017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308038|NCT01993017|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102308039|NCT01993017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102308040|NCT01993017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102308041|NCT01993017|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102308042|NCT01993017|Serotonin Agents|serotonin agents|mesh-ancestor
102016801|NCT05185869|Paclitaxel|paclitaxel|mesh-list
102308043|NCT01988493|Sorafenib|sorafenib|mesh-list
102308044|NCT01988493|Tepotinib|tepotinib|mesh-list
102308045|NCT01988493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308046|NCT01988493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102308047|NCT01988493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102308048|NCT01988493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308049|NCT02081079|Sofosbuvir|sofosbuvir|mesh-list
102308050|NCT02081079|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102308051|NCT02081079|Ledipasvir|ledipasvir|mesh-list
102308052|NCT02081079|Antiviral Agents|antiviral agents|mesh-ancestor
102308053|NCT02081079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102308054|NCT02081001|Glucagon|glucagon|mesh-list
102308055|NCT02081001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102308056|NCT02081001|Hormones|hormones|mesh-ancestor
102308057|NCT02081001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102308058|NCT02081001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308059|NCT02080221|Leucovorin|leucovorin|mesh-list
102308060|NCT02080221|Oxaliplatin|oxaliplatin|mesh-list
102308061|NCT02080221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308062|NCT02080221|Antidotes|antidotes|mesh-ancestor
102308063|NCT02080221|Protective Agents|protective agents|mesh-ancestor
102308064|NCT02080221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308065|NCT02080221|Vitamin B Complex|vitamin b complex|mesh-ancestor
102308066|NCT02080221|Vitamins|vitamins|mesh-ancestor
102308067|NCT02080221|Micronutrients|micronutrients|mesh-ancestor
102308068|NCT02014467|Vitamin D|vitamin d|mesh-list
102308069|NCT02014467|Denosumab|denosumab|mesh-list
102308070|NCT02014467|Calcium|calcium|mesh-list
102308071|NCT02014467|Vitamins|vitamins|mesh-ancestor
102308072|NCT02014467|Micronutrients|micronutrients|mesh-ancestor
102308073|NCT02014467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308074|NCT02014467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102308075|NCT02014467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102308076|NCT02013765|Trastuzumab|trastuzumab|mesh-list
102308077|NCT02013765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102308078|NCT02013765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308079|NCT02013609|Brexpiprazole|brexpiprazole|mesh-list
102308080|NCT02013609|Serotonin Agents|serotonin agents|mesh-ancestor
102308081|NCT02013609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102308082|NCT02013609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308083|NCT02013609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308084|NCT02013609|Dopamine Agonists|dopamine agonists|mesh-ancestor
102308085|NCT02013609|Dopamine Agents|dopamine agents|mesh-ancestor
102308086|NCT02013531|Brexpiprazole|brexpiprazole|mesh-list
102308087|NCT02013531|Serotonin Agents|serotonin agents|mesh-ancestor
102308088|NCT02013531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102308089|NCT02013531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308090|NCT02013531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308091|NCT02013531|Dopamine Agonists|dopamine agonists|mesh-ancestor
102308092|NCT02013531|Dopamine Agents|dopamine agents|mesh-ancestor
102308093|NCT01988103|Thalidomide|thalidomide|mesh-list
102308094|NCT01988103|Apremilast|apremilast|mesh-list
102308095|NCT01988103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102308096|NCT01988103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102308097|NCT01988103|Analgesics|analgesics|mesh-ancestor
102308098|NCT01988103|Sensory System Agents|sensory system agents|mesh-ancestor
102308099|NCT01988103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102308100|NCT01988103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308101|NCT01988103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102308102|NCT01988103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102308103|NCT01988103|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102308104|NCT01988103|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102308105|NCT01988103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102308106|NCT01988103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308107|NCT01988103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102308108|NCT01988103|Immunologic Factors|immunologic factors|mesh-ancestor
102308109|NCT01988103|Leprostatic Agents|leprostatic agents|mesh-ancestor
102308110|NCT01988103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102308111|NCT01988103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102308112|NCT01988103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102308113|NCT01988103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102308114|NCT01988103|Growth Substances|growth substances|mesh-ancestor
102308115|NCT01988103|Growth Inhibitors|growth inhibitors|mesh-ancestor
102308116|NCT01988103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102016881|NCT01342731|Tigecycline|tigecycline|mesh-list
102308117|NCT02013375|Sirolimus|sirolimus|mesh-list
102308118|NCT02013375|Cyclophosphamide|cyclophosphamide|mesh-list
102308119|NCT02013375|Alemtuzumab|alemtuzumab|mesh-list
102308120|NCT02013375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102308121|NCT02013375|Immunologic Factors|immunologic factors|mesh-ancestor
102308122|NCT02013375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308123|NCT02013375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102308124|NCT02013375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102308125|NCT02013375|Alkylating Agents|alkylating agents|mesh-ancestor
102308126|NCT02013375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308127|NCT02013375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308128|NCT02013375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102308129|NCT02013375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102308130|NCT02013375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102308131|NCT02013375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102308132|NCT02013375|Antifungal Agents|antifungal agents|mesh-ancestor
102308133|NCT02013375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102308134|NCT02079519|Bevacizumab|bevacizumab|mesh-list
102308135|NCT02079519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102308136|NCT02079519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308137|NCT02079519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102308138|NCT02079519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102308139|NCT02079519|Growth Substances|growth substances|mesh-ancestor
102308140|NCT02079519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308141|NCT02079519|Growth Inhibitors|growth inhibitors|mesh-ancestor
102308143|NCT02078817|Analgesics|analgesics|mesh-ancestor
102308144|NCT02078817|Sensory System Agents|sensory system agents|mesh-ancestor
102308145|NCT02078817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102308146|NCT02078817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308147|NCT02078817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102308148|NCT02078817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102308149|NCT02078817|Anesthetics, General|anesthetics, general|mesh-ancestor
102308150|NCT02078817|Anesthetics|anesthetics|mesh-ancestor
102308151|NCT02078817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102308152|NCT02078817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102308153|NCT02078817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102308154|NCT02078817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102308155|NCT02078817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308156|NCT02011113|Dexamethasone|dexamethasone|mesh-list
102308157|NCT02011113|Pomalidomide|pomalidomide|mesh-list
102308158|NCT02011113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102308159|NCT02011113|Antiemetics|antiemetics|mesh-ancestor
102308160|NCT02011113|Autonomic Agents|autonomic agents|mesh-ancestor
101424453|NCT04694677|Oxytocics|oxytocics|mesh-ancestor
102308161|NCT02011113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102308162|NCT02011113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308163|NCT02011113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102308164|NCT02011113|Glucocorticoids|glucocorticoids|mesh-ancestor
102308165|NCT02011113|Hormones|hormones|mesh-ancestor
102308166|NCT02011113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102308167|NCT02011113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102308168|NCT02011113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308169|NCT02011113|Immunologic Factors|immunologic factors|mesh-ancestor
102308170|NCT02011113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102308171|NCT02011113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102308172|NCT02011113|Growth Substances|growth substances|mesh-ancestor
102308173|NCT02011113|Growth Inhibitors|growth inhibitors|mesh-ancestor
102308174|NCT01807156|Tivozanib|tivozanib|mesh-list
102308175|NCT01807156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102308176|NCT01807156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102308177|NCT01807156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308178|NCT01987479|Methotrexate|methotrexate|mesh-list
102308179|NCT01987479|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102308180|NCT01987479|Abortifacient Agents|abortifacient agents|mesh-ancestor
102308181|NCT01987479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102308182|NCT01987479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308183|NCT01987479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102308184|NCT01987479|Antimetabolites|antimetabolites|mesh-ancestor
102308185|NCT01987479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308186|NCT01987479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308187|NCT01987479|Dermatologic Agents|dermatologic agents|mesh-ancestor
102308188|NCT01987479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102308189|NCT01987479|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102308190|NCT01987479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102308191|NCT01987479|Immunologic Factors|immunologic factors|mesh-ancestor
102308192|NCT01987479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102308193|NCT01987479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102016948|NCT02457208|Rifampin|rifampin|mesh-list
102308194|NCT01620489|Liraglutide|liraglutide|mesh-list
102308195|NCT01620489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102308196|NCT01620489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308197|NCT01620489|Incretins|incretins|mesh-ancestor
102308198|NCT01620489|Hormones|hormones|mesh-ancestor
102308199|NCT01620489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102308200|NCT02010567|Capecitabine|capecitabine|mesh-list
102308201|NCT02010567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102308202|NCT02010567|Antimetabolites|antimetabolites|mesh-ancestor
102308203|NCT02010567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308204|NCT02010567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308205|NCT01806064|Axitinib|axitinib|mesh-list
102308206|NCT01806064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308207|NCT01806064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102308208|NCT01806064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102308209|NCT01806064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308210|NCT01787188|Meloxicam|meloxicam|mesh-list
102308211|NCT01787188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102308212|NCT01787188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102308213|NCT01787188|Analgesics|analgesics|mesh-ancestor
102308214|NCT01787188|Sensory System Agents|sensory system agents|mesh-ancestor
102308215|NCT01787188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102308216|NCT01787188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308217|NCT01787188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102308218|NCT01787188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102308219|NCT01787188|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102308220|NCT01787188|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102308221|NCT01787188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102308222|NCT01787188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308223|NCT01787032|Ketoconazole|ketoconazole|mesh-list
102308224|NCT01787032|Voriconazole|voriconazole|mesh-list
102308225|NCT01787032|Antifungal Agents|antifungal agents|mesh-ancestor
102308226|NCT01787032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102308227|NCT01787032|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102308228|NCT01787032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102308229|NCT01787032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102308230|NCT01787032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308231|NCT01787032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102308232|NCT01787032|Hormone Antagonists|hormone antagonists|mesh-ancestor
102308233|NCT01787032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102308234|NCT01787032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308235|NCT01787032|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102308236|NCT01737268|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102308237|NCT01737268|Antidepressive Agents|antidepressive agents|mesh-ancestor
102308238|NCT01737268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102308239|NCT01737268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102308240|NCT01737268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102308241|NCT01737268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102308242|NCT01737268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308243|NCT01769404|Insulin Glargine|insulin glargine|mesh-list
102308244|NCT01769404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102308245|NCT01769404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308246|NCT01786174|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102308247|NCT01786174|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102308248|NCT01786174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308249|NCT01786174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102308250|NCT01786174|Immunologic Factors|immunologic factors|mesh-ancestor
102308251|NCT01786174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308252|NCT01768858|Adalimumab|adalimumab|mesh-list
102308253|NCT01768858|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102308254|NCT01768858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102308255|NCT01768858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102308256|NCT01736254|Gemfibrozil|gemfibrozil|mesh-list
102308257|NCT01736254|Evacetrapib|evacetrapib|mesh-list
102308258|NCT01736254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102308259|NCT01736254|Antimetabolites|antimetabolites|mesh-ancestor
102308260|NCT01736254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308261|NCT01736254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102308262|NCT01736254|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102308263|NCT01736254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102308264|NCT01736254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102308265|NCT01736254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102308266|NCT01785472|Olmesartan|olmesartan|mesh-list
102308267|NCT01785472|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
102308268|NCT01785472|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102308269|NCT01785472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102308270|NCT01785472|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102308271|NCT01785472|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102308272|NCT01785472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308273|NCT01785160|Raltegravir Potassium|raltegravir potassium|mesh-list
102308274|NCT01785160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102308275|NCT01785160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102308276|NCT01785160|Antiviral Agents|antiviral agents|mesh-ancestor
102308277|NCT01785160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102308278|NCT01785160|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102308279|NCT01785160|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102308280|NCT01785160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102308281|NCT01785160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308283|NCT01736176|Carbidopa|carbidopa|mesh-list
102308284|NCT01736176|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102308285|NCT01736176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102308286|NCT01736176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102308287|NCT01736176|Dopamine Agents|dopamine agents|mesh-ancestor
102308288|NCT01736176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102308289|NCT01736176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308290|NCT01736176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308291|NCT01736176|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102308292|NCT01736176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102308293|NCT01736176|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102308294|NCT01736176|Immunologic Factors|immunologic factors|mesh-ancestor
102308295|NCT01736176|Dopamine Agonists|dopamine agonists|mesh-ancestor
102308297|NCT01735630|Vitamin B Complex|vitamin b complex|mesh-ancestor
102308298|NCT01735630|Vitamins|vitamins|mesh-ancestor
102308299|NCT01735630|Micronutrients|micronutrients|mesh-ancestor
102308300|NCT01735630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308301|NCT04575922|Nivolumab|nivolumab|mesh-list
102308302|NCT04575922|Ipilimumab|ipilimumab|mesh-list
102308303|NCT04575922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102308304|NCT04575922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308305|NCT04575922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102308306|NCT04575922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308307|NCT01735396|Abiraterone Acetate|abiraterone acetate|mesh-list
102308308|NCT01735396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308309|NCT01735396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102308310|NCT01735396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102308311|NCT01735396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308312|NCT01735396|Hormone Antagonists|hormone antagonists|mesh-ancestor
102308313|NCT01735396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102308314|NCT01735396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308315|NCT01735396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102308316|NCT01734850|Busulfan|busulfan|mesh-list
102308317|NCT01734850|Alkylating Agents|alkylating agents|mesh-ancestor
102308318|NCT01734850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308319|NCT01734850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102308320|NCT01734850|Immunologic Factors|immunologic factors|mesh-ancestor
102308321|NCT01734850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308322|NCT01734850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102308323|NCT01734850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308324|NCT01734850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102308325|NCT01766050|Abatacept|abatacept|mesh-list
102308326|NCT01766050|Losartan|losartan|mesh-list
102308327|NCT01766050|Midazolam|midazolam|mesh-list
102308328|NCT01766050|Dextromethorphan|dextromethorphan|mesh-list
102308329|NCT01766050|Caffeine|caffeine|mesh-list
102308330|NCT01766050|Omeprazole|omeprazole|mesh-list
102308331|NCT01766050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102308332|NCT01766050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102308333|NCT01766050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102308334|NCT01766050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308335|NCT01766050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102308336|NCT01766050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102308337|NCT01766050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102308338|NCT01766050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102308339|NCT01766050|Anesthetics, General|anesthetics, general|mesh-ancestor
102308340|NCT01766050|Anesthetics|anesthetics|mesh-ancestor
102308341|NCT01766050|GABA Modulators|gaba modulators|mesh-ancestor
102308342|NCT01766050|GABA Agents|gaba agents|mesh-ancestor
102308343|NCT01766050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102308344|NCT01766050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308345|NCT01766050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102308346|NCT01766050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102308347|NCT01766050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102308348|NCT01766050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102308349|NCT01766050|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102308350|NCT01766050|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102308351|NCT01766050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102308352|NCT01766050|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102308353|NCT01766050|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102308354|NCT01766050|Purinergic Agents|purinergic agents|mesh-ancestor
102308355|NCT01766050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102308356|NCT01766050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102308357|NCT01766050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102308358|NCT01766050|Antitussive Agents|antitussive agents|mesh-ancestor
102308359|NCT01766050|Respiratory System Agents|respiratory system agents|mesh-ancestor
102308360|NCT01766050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101650214|NCT05590260|Iron|iron|mesh-list
102308362|NCT01766050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102308363|NCT01766050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102308364|NCT01766050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308365|NCT01766050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102308366|NCT01766050|Immunologic Factors|immunologic factors|mesh-ancestor
102308367|NCT01766050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102308368|NCT02341625|Nivolumab|nivolumab|mesh-list
102308369|NCT02341625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102308370|NCT02341625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308371|NCT02341625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102308372|NCT02341625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308373|NCT02370095|Treprostinil|treprostinil|mesh-list
102308374|NCT02370095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102308375|NCT02370095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102308376|NCT01783678|Sofosbuvir|sofosbuvir|mesh-list
102308377|NCT01783678|Antiviral Agents|antiviral agents|mesh-ancestor
102308378|NCT01783678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102308379|NCT01734772|Dabigatran|dabigatran|mesh-list
102308380|NCT01734772|Ticagrelor|ticagrelor|mesh-list
102308381|NCT01734772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102308382|NCT01734772|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102308383|NCT01734772|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102308384|NCT01734772|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102308385|NCT01734772|Purinergic Agents|purinergic agents|mesh-ancestor
102308386|NCT01734772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102308387|NCT01734772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308388|NCT01734772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308389|NCT01734772|Antithrombins|antithrombins|mesh-ancestor
102308390|NCT01734772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102308391|NCT01734772|Protease Inhibitors|protease inhibitors|mesh-ancestor
102308392|NCT01734772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102308393|NCT01734772|Anticoagulants|anticoagulants|mesh-ancestor
102308394|NCT02340221|Fulvestrant|fulvestrant|mesh-list
102308395|NCT02340221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102308396|NCT02340221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308397|NCT02340221|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102308398|NCT02340221|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102308399|NCT02340221|Hormone Antagonists|hormone antagonists|mesh-ancestor
102308400|NCT02340221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102308401|NCT02340221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308402|NCT02395055|Adalimumab|adalimumab|mesh-list
102308403|NCT02395055|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102308404|NCT02395055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102308405|NCT02395055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102308406|NCT02369159|Oseltamivir|oseltamivir|mesh-list
102308407|NCT02369159|Peramivir|peramivir|mesh-list
102308408|NCT02369159|Antiviral Agents|antiviral agents|mesh-ancestor
102308409|NCT02369159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102308410|NCT02369159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102308411|NCT02369159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308412|NCT02394665|Temozolomide|temozolomide|mesh-list
102308413|NCT02394665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102308414|NCT02394665|Alkylating Agents|alkylating agents|mesh-ancestor
102308415|NCT02394665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308416|NCT02394665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308417|NCT02367833|Contraceptive Agents|contraceptive agents|mesh-list
102308419|NCT02367833|Contraceptives, Oral|contraceptives, oral|mesh-list
102308420|NCT02367833|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
102308421|NCT02367833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102308422|NCT02367833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308423|NCT02367833|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102308424|NCT02367833|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102308425|NCT02338193|Metformin|metformin|mesh-list
102308426|NCT02338193|Dapagliflozin|dapagliflozin|mesh-list
102308427|NCT02338193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102308428|NCT02338193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308429|NCT02338193|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102308430|NCT02338193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308431|NCT01783444|Capecitabine|capecitabine|mesh-list
102308432|NCT01783444|Everolimus|everolimus|mesh-list
102308433|NCT01783444|Exemestane|exemestane|mesh-list
102308434|NCT01783444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102308435|NCT01783444|Antimetabolites|antimetabolites|mesh-ancestor
102308436|NCT01783444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308437|NCT01783444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308438|NCT01783444|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102308439|NCT01783444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102308440|NCT01783444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102308441|NCT01783444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102308442|NCT01783444|Immunologic Factors|immunologic factors|mesh-ancestor
102308443|NCT01783444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308444|NCT01783444|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102308445|NCT01783444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102308446|NCT01783444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102308447|NCT01783444|Hormone Antagonists|hormone antagonists|mesh-ancestor
102308448|NCT01783444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102308449|NCT02367131|Empagliflozin|empagliflozin|mesh-list
102308450|NCT02367131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102308451|NCT02367131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308452|NCT02367131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102308453|NCT02367131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308454|NCT01608724|Saxagliptin|saxagliptin|mesh-list
102308455|NCT01608724|Incretins|incretins|mesh-ancestor
102308456|NCT01608724|Hormones|hormones|mesh-ancestor
102308457|NCT01608724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102308458|NCT01608724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308459|NCT01608724|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102308460|NCT01608724|Protease Inhibitors|protease inhibitors|mesh-ancestor
102308461|NCT01608724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102308462|NCT01608724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308463|NCT01608724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102308464|NCT02366195|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
102308465|NCT02366195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102308466|NCT02366195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308467|NCT04905251|Misoprostol|misoprostol|mesh-list
102308468|NCT04905251|Mifepristone|mifepristone|mesh-list
102308469|NCT04905251|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102308470|NCT04905251|Abortifacient Agents|abortifacient agents|mesh-ancestor
102308471|NCT04905251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102308472|NCT04905251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308473|NCT04905251|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102308474|NCT04905251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102308475|NCT04905251|Oxytocics|oxytocics|mesh-ancestor
102308476|NCT04905251|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102308477|NCT04905251|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102308478|NCT04905251|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102308479|NCT04905251|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102308480|NCT04905251|Contraceptive Agents|contraceptive agents|mesh-ancestor
102308481|NCT04905251|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102308482|NCT04905251|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102308483|NCT04905251|Hormone Antagonists|hormone antagonists|mesh-ancestor
102308484|NCT04905251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102308485|NCT04905251|Luteolytic Agents|luteolytic agents|mesh-ancestor
102308486|NCT04905251|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102308487|NCT04905251|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102308489|NCT02364947|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102308490|NCT02364947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308491|NCT02364947|Sensory System Agents|sensory system agents|mesh-ancestor
102308492|NCT02364947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102308493|NCT02337491|Bevacizumab|bevacizumab|mesh-list
102308494|NCT02337491|Pembrolizumab|pembrolizumab|mesh-list
102308495|NCT02337491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102308496|NCT02337491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308497|NCT02337491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102308498|NCT02337491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102308499|NCT02337491|Growth Substances|growth substances|mesh-ancestor
102308500|NCT02337491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308501|NCT02337491|Growth Inhibitors|growth inhibitors|mesh-ancestor
102308502|NCT02337491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102308503|NCT02337491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308504|NCT01765582|Leucovorin|leucovorin|mesh-list
102308505|NCT01765582|Folic Acid|folic acid|mesh-list
102308506|NCT01765582|Bevacizumab|bevacizumab|mesh-list
102308507|NCT01765582|Fluorouracil|fluorouracil|mesh-list
102308508|NCT01765582|Capecitabine|capecitabine|mesh-list
102308509|NCT01765582|Oxaliplatin|oxaliplatin|mesh-list
102308511|NCT01765582|Levoleucovorin|levoleucovorin|mesh-list
102308512|NCT01765582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102308513|NCT01765582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308514|NCT01765582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102308515|NCT01765582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102308516|NCT01765582|Growth Substances|growth substances|mesh-ancestor
102308517|NCT01765582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308518|NCT01765582|Growth Inhibitors|growth inhibitors|mesh-ancestor
102308519|NCT01765582|Antimetabolites|antimetabolites|mesh-ancestor
102308520|NCT01765582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308521|NCT01765582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102308522|NCT01765582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102308523|NCT01765582|Immunologic Factors|immunologic factors|mesh-ancestor
102308524|NCT01765582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102308525|NCT01765582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102308526|NCT01765582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102308527|NCT01765582|Antidotes|antidotes|mesh-ancestor
102308528|NCT01765582|Protective Agents|protective agents|mesh-ancestor
102308529|NCT01765582|Vitamin B Complex|vitamin b complex|mesh-ancestor
102308530|NCT01765582|Vitamins|vitamins|mesh-ancestor
102308531|NCT01765582|Micronutrients|micronutrients|mesh-ancestor
102308532|NCT01765582|Hematinics|hematinics|mesh-ancestor
102308533|NCT04413838|Nivolumab|nivolumab|mesh-list
102308534|NCT04413838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102308535|NCT04413838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308536|NCT04413838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102308537|NCT04413838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308538|NCT01649375|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102308539|NCT01649375|Immunologic Factors|immunologic factors|mesh-ancestor
102308540|NCT01649375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308541|NCT01648283|Methadone|methadone|mesh-list
102308542|NCT01648283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102308543|NCT01648283|Narcotics|narcotics|mesh-ancestor
102308544|NCT01648283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101424896|NCT00152022|Adderall|adderall|mesh-list
102308545|NCT01648283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308546|NCT01648283|Analgesics|analgesics|mesh-ancestor
102308547|NCT01648283|Sensory System Agents|sensory system agents|mesh-ancestor
102308548|NCT01648283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102308549|NCT01648283|Antitussive Agents|antitussive agents|mesh-ancestor
102308550|NCT01648283|Respiratory System Agents|respiratory system agents|mesh-ancestor
102308551|NCT01649297|Empagliflozin|empagliflozin|mesh-list
102308552|NCT01649297|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102308553|NCT01649297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308554|NCT01649297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102308555|NCT01649297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308556|NCT01648205|Ranolazine|ranolazine|mesh-list
102308557|NCT01648205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102308558|NCT01648205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102308559|NCT01648205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308560|NCT02391545|Rituximab|rituximab|mesh-list
102308561|NCT02391545|Obinutuzumab|obinutuzumab|mesh-list
102308562|NCT02391545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102308563|NCT02391545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308564|NCT02391545|Immunologic Factors|immunologic factors|mesh-ancestor
102308565|NCT02391545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308566|NCT02391545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102308567|NCT02362451|Vaccines|vaccines|mesh-list
102308568|NCT02362451|Immunologic Factors|immunologic factors|mesh-ancestor
102308569|NCT02362451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308570|NCT01765270|Saxagliptin|saxagliptin|mesh-list
102308571|NCT01765270|Incretins|incretins|mesh-ancestor
102308572|NCT01765270|Hormones|hormones|mesh-ancestor
102308573|NCT01765270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102308574|NCT01765270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308575|NCT01765270|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102308576|NCT01765270|Protease Inhibitors|protease inhibitors|mesh-ancestor
102308577|NCT01765270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102308578|NCT01765270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308579|NCT01765270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102308580|NCT01733758|Liraglutide|liraglutide|mesh-list
102308581|NCT01733758|rGLP-1 protein|rglp-1 protein|mesh-list
102308582|NCT01733758|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102308583|NCT01733758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101650423|NCT04628988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308584|NCT01733758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308586|NCT01733758|Hormones|hormones|mesh-ancestor
102308587|NCT01733758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102308588|NCT01607554|Irinotecan|irinotecan|mesh-list
102308589|NCT01607554|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102308590|NCT01607554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102308591|NCT01607554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102308592|NCT01607554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308593|NCT01607554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308594|NCT01607476|Corticosterone|corticosterone|mesh-list
102308595|NCT01607476|Flutemetamol|flutemetamol|mesh-list
102308596|NCT01607476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102308597|NCT01607476|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102308598|NCT01607476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308599|NCT01765192|Montelukast|montelukast|mesh-list
102308600|NCT01765192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102308601|NCT01765192|Respiratory System Agents|respiratory system agents|mesh-ancestor
102308602|NCT01765192|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102308603|NCT01765192|Hormone Antagonists|hormone antagonists|mesh-ancestor
102308604|NCT01765192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102308605|NCT01765192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308606|NCT01765192|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102308607|NCT01765192|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102308608|NCT01765192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308609|NCT01733680|Amiloride|amiloride|mesh-list
102308610|NCT01733680|Diuretics|diuretics|mesh-ancestor
102308611|NCT01733680|Natriuretic Agents|natriuretic agents|mesh-ancestor
102308612|NCT01733680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308613|NCT01733680|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
102308614|NCT01733680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102308615|NCT01733680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102308616|NCT01733680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308617|NCT01733680|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
102308618|NCT01733680|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102308619|NCT02348216|Cyclophosphamide|cyclophosphamide|mesh-list
102308620|NCT02348216|Fludarabine|fludarabine|mesh-list
102308621|NCT02348216|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
102308622|NCT02348216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102308623|NCT02348216|Immunologic Factors|immunologic factors|mesh-ancestor
102308624|NCT02348216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308625|NCT02348216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102308626|NCT02348216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102308627|NCT02348216|Alkylating Agents|alkylating agents|mesh-ancestor
102308628|NCT02348216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308629|NCT02348216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308630|NCT02348216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102308631|NCT02348216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102308632|NCT04892498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102308633|NCT04892498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017395|NCT02458924|Vitamin B Complex|vitamin b complex|mesh-ancestor
102308634|NCT04892498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102308635|NCT04892498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308636|NCT04887506|Prednisone|prednisone|mesh-list
102308637|NCT04887506|Abiraterone Acetate|abiraterone acetate|mesh-list
102308638|NCT04887506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102308639|NCT04887506|Glucocorticoids|glucocorticoids|mesh-ancestor
102308640|NCT04887506|Hormones|hormones|mesh-ancestor
102308641|NCT04887506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102308642|NCT04887506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308643|NCT04887506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102308644|NCT04887506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308645|NCT04887506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102308646|NCT04887506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102308647|NCT04887506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308648|NCT04887506|Hormone Antagonists|hormone antagonists|mesh-ancestor
102308649|NCT04887506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102308650|NCT02336165|Bevacizumab|bevacizumab|mesh-list
102308651|NCT02336165|Durvalumab|durvalumab|mesh-list
102308652|NCT02336165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102308654|NCT02336165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102308655|NCT02336165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102308656|NCT02336165|Growth Substances|growth substances|mesh-ancestor
102308657|NCT02336165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308658|NCT02336165|Growth Inhibitors|growth inhibitors|mesh-ancestor
102308659|NCT02360111|Cyclophosphamide|cyclophosphamide|mesh-list
102308660|NCT02360111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102308661|NCT02360111|Immunologic Factors|immunologic factors|mesh-ancestor
102308662|NCT02360111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308663|NCT02360111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102308664|NCT02360111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102308665|NCT02360111|Alkylating Agents|alkylating agents|mesh-ancestor
102308666|NCT02360111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308667|NCT02360111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308668|NCT02360111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102308669|NCT02319044|Durvalumab|durvalumab|mesh-list
102308670|NCT02319044|Tremelimumab|tremelimumab|mesh-list
102308671|NCT02319044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102308672|NCT02319044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102308673|NCT02319044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308674|NCT02319044|Immunologic Factors|immunologic factors|mesh-ancestor
102308675|NCT02319044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308676|NCT01649765|Belimumab|belimumab|mesh-list
102308677|NCT01649765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102308678|NCT01649765|Immunologic Factors|immunologic factors|mesh-ancestor
102308679|NCT01649765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308680|NCT02317016|Osimertinib|osimertinib|mesh-list
102308681|NCT02317016|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102308682|NCT02317016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102308683|NCT02317016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102308684|NCT02317016|Antimetabolites|antimetabolites|mesh-ancestor
102308685|NCT02317016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308686|NCT02317016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102308687|NCT02317016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102308688|NCT02317016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102308689|NCT02317016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308690|NCT02317016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102308691|NCT02311478|Copper|copper|mesh-list
102308692|NCT02311478|Contraceptive Agents|contraceptive agents|mesh-list
102308693|NCT02311478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102308694|NCT02311478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308695|NCT02311478|Trace Elements|trace elements|mesh-ancestor
102308696|NCT02311478|Micronutrients|micronutrients|mesh-ancestor
102308697|NCT02281760|Trametinib|trametinib|mesh-list
102308698|NCT02281760|Dabrafenib|dabrafenib|mesh-list
102308699|NCT02281760|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
102308700|NCT02281760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308701|NCT02281760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102308702|NCT02281760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102308703|NCT02281760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308704|NCT02281760|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102308705|NCT02281760|Protective Agents|protective agents|mesh-ancestor
102308706|NCT02281760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308707|NCT02281760|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102308708|NCT02281760|Antioxidants|antioxidants|mesh-ancestor
102308709|NCT02390531|Bevacizumab|bevacizumab|mesh-list
102308710|NCT02390531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102308711|NCT02390531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308712|NCT02390531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102308713|NCT02390531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102308714|NCT02390531|Growth Substances|growth substances|mesh-ancestor
102308715|NCT02390531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308716|NCT02390531|Growth Inhibitors|growth inhibitors|mesh-ancestor
102308717|NCT02390219|Ivacaftor|ivacaftor|mesh-list
102308718|NCT02390219|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102308719|NCT02390219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102308720|NCT02390219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308721|NCT02334215|Methadone|methadone|mesh-list
102308722|NCT02334215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102308723|NCT02334215|Narcotics|narcotics|mesh-ancestor
102308724|NCT02334215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102308725|NCT02334215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308726|NCT02334215|Analgesics|analgesics|mesh-ancestor
102308727|NCT02334215|Sensory System Agents|sensory system agents|mesh-ancestor
102308728|NCT02334215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102308729|NCT02334215|Antitussive Agents|antitussive agents|mesh-ancestor
102308730|NCT02334215|Respiratory System Agents|respiratory system agents|mesh-ancestor
102308732|NCT02359877|Interferon-beta|interferon-beta|mesh-list
102308733|NCT02359877|Interferon beta-1a|interferon beta-1a|mesh-list
102308734|NCT02359877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308735|NCT02359877|Antiviral Agents|antiviral agents|mesh-ancestor
102308736|NCT02359877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102308737|NCT02359877|Immunologic Factors|immunologic factors|mesh-ancestor
102308738|NCT02359877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308739|NCT02359877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102308740|NCT02389829|Diphenhydramine|diphenhydramine|mesh-list
102308741|NCT02389829|Promethazine|promethazine|mesh-list
102308742|NCT02389829|Hydromorphone|hydromorphone|mesh-list
102308743|NCT02389829|Prochlorperazine|prochlorperazine|mesh-list
102308744|NCT02389829|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102308745|NCT02389829|Narcotics|narcotics|mesh-ancestor
102308746|NCT02389829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102308747|NCT02389829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308748|NCT02389829|Analgesics|analgesics|mesh-ancestor
102308749|NCT02389829|Sensory System Agents|sensory system agents|mesh-ancestor
102308750|NCT02389829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102308751|NCT02389829|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102308752|NCT02389829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102308753|NCT02389829|Anesthetics, Local|anesthetics, local|mesh-ancestor
102308754|NCT02389829|Anesthetics|anesthetics|mesh-ancestor
102308755|NCT02389829|Antiemetics|antiemetics|mesh-ancestor
102308756|NCT02389829|Autonomic Agents|autonomic agents|mesh-ancestor
102308757|NCT02389829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102308758|NCT02389829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102308759|NCT02389829|Histamine Antagonists|histamine antagonists|mesh-ancestor
102308760|NCT02389829|Histamine Agents|histamine agents|mesh-ancestor
102308761|NCT02389829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102308762|NCT02389829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308763|NCT02389829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102308764|NCT02389829|Antipruritics|antipruritics|mesh-ancestor
102308765|NCT02389829|Dermatologic Agents|dermatologic agents|mesh-ancestor
102308766|NCT02389829|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102308767|NCT02389829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102308768|NCT02389829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102308769|NCT02389829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102308770|NCT02389829|Dopamine Agents|dopamine agents|mesh-ancestor
102308771|NCT02358863|Leucovorin|leucovorin|mesh-list
102308772|NCT02358863|Cisplatin|cisplatin|mesh-list
102308773|NCT02358863|Docetaxel|docetaxel|mesh-list
102308774|NCT02358863|Capecitabine|capecitabine|mesh-list
102308775|NCT02358863|Oxaliplatin|oxaliplatin|mesh-list
102308776|NCT02358863|Irinotecan|irinotecan|mesh-list
102308777|NCT02358863|Epirubicin|epirubicin|mesh-list
102308778|NCT02358863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308779|NCT02358863|Tubulin Modulators|tubulin modulators|mesh-ancestor
102308780|NCT02358863|Antimitotic Agents|antimitotic agents|mesh-ancestor
102308781|NCT02358863|Mitosis Modulators|mitosis modulators|mesh-ancestor
102308782|NCT02358863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308783|NCT02358863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102308784|NCT02358863|Antimetabolites|antimetabolites|mesh-ancestor
102308785|NCT02358863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102308786|NCT02358863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102308787|NCT02358863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102308788|NCT02358863|Antidotes|antidotes|mesh-ancestor
102308789|NCT02358863|Protective Agents|protective agents|mesh-ancestor
102308790|NCT02358863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308791|NCT02358863|Vitamin B Complex|vitamin b complex|mesh-ancestor
102308793|NCT02358863|Micronutrients|micronutrients|mesh-ancestor
102308794|NCT02358863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102308795|NCT02358863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102308796|NCT02358473|Docetaxel|docetaxel|mesh-list
102308797|NCT02358473|Mogamulizumab|mogamulizumab|mesh-list
102308798|NCT02358473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308799|NCT02358473|Tubulin Modulators|tubulin modulators|mesh-ancestor
102308800|NCT02358473|Antimitotic Agents|antimitotic agents|mesh-ancestor
102308801|NCT02358473|Mitosis Modulators|mitosis modulators|mesh-ancestor
102308802|NCT02358473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308803|NCT02357459|Triamcinolone|triamcinolone|mesh-list
102308804|NCT02357459|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102308805|NCT02357459|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102308806|NCT02357459|FX006|fx006|mesh-list
102308807|NCT02357459|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101650642|NCT03479502|Prednisolone|prednisolone|mesh-list
102308808|NCT02357459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102308809|NCT02357459|Glucocorticoids|glucocorticoids|mesh-ancestor
102308810|NCT02357459|Hormones|hormones|mesh-ancestor
102308811|NCT02357459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102308812|NCT02357459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308813|NCT02357459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102308814|NCT02357459|Immunologic Factors|immunologic factors|mesh-ancestor
102308815|NCT02357459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102308816|NCT02357459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308817|NCT02332889|Decitabine|decitabine|mesh-list
102308818|NCT02332889|Poly ICLC|poly iclc|mesh-list
102308819|NCT02332889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102308820|NCT02332889|Antimetabolites|antimetabolites|mesh-ancestor
102308821|NCT02332889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308822|NCT02332889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308823|NCT02332889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102308824|NCT02332889|Interferon Inducers|interferon inducers|mesh-ancestor
102308825|NCT02332889|Immunologic Factors|immunologic factors|mesh-ancestor
102308826|NCT02332889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308827|NCT02357147|Pemetrexed|pemetrexed|mesh-list
102308828|NCT02357147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308829|NCT02357147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102308830|NCT02357147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308831|NCT02357147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102308832|NCT02357147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102308833|NCT02332655|Cannabidiol|cannabidiol|mesh-list
102308834|NCT02332655|Anticonvulsants|anticonvulsants|mesh-ancestor
102308835|NCT02388737|Lansoprazole|lansoprazole|mesh-list
102308836|NCT02388737|Dexlansoprazole|dexlansoprazole|mesh-list
102308837|NCT02388737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102308838|NCT02388737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102308839|NCT02388737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102308840|NCT02388737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102308841|NCT02388737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308842|NCT02355665|Nicotine|nicotine|mesh-list
102308843|NCT02355665|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102308844|NCT02355665|Autonomic Agents|autonomic agents|mesh-ancestor
102308845|NCT02355665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102308846|NCT02355665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308847|NCT02355665|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102308848|NCT02355665|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102308849|NCT02355665|Cholinergic Agents|cholinergic agents|mesh-ancestor
102308850|NCT02355665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102308851|NCT02355665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308852|NCT02010255|Sofosbuvir|sofosbuvir|mesh-list
102308853|NCT02010255|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102308854|NCT02010255|Ledipasvir|ledipasvir|mesh-list
102308855|NCT02010255|Antiviral Agents|antiviral agents|mesh-ancestor
102308856|NCT02010255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102308857|NCT04666701|Ketorolac|ketorolac|mesh-list
102308858|NCT04666701|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102308859|NCT04666701|Scopolamine|scopolamine|mesh-list
102308860|NCT04666701|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102308861|NCT04666701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102308862|NCT04666701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102308863|NCT04666701|Analgesics|analgesics|mesh-ancestor
102017618|NCT02456428|Vildagliptin|vildagliptin|mesh-list
102308864|NCT04666701|Sensory System Agents|sensory system agents|mesh-ancestor
102308865|NCT04666701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102308866|NCT04666701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308867|NCT04666701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102308868|NCT04666701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102308869|NCT04666701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102308870|NCT04666701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102308871|NCT04666701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308872|NCT04666701|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102308873|NCT04666701|Antiemetics|antiemetics|mesh-ancestor
102308874|NCT04666701|Autonomic Agents|autonomic agents|mesh-ancestor
102308875|NCT04666701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102308876|NCT04666701|Mydriatics|mydriatics|mesh-ancestor
102308877|NCT04666701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102308878|NCT04666701|Cholinergic Agents|cholinergic agents|mesh-ancestor
102308879|NCT04666701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102308880|NCT04666701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102308881|NCT04666701|Parasympatholytics|parasympatholytics|mesh-ancestor
102308883|NCT02330549|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102308884|NCT02330549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308885|NCT02330549|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102308886|NCT02330549|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102308887|NCT02330549|Antiviral Agents|antiviral agents|mesh-ancestor
102308888|NCT02330549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102308889|NCT01620177|Ethanol|ethanol|mesh-list
102308890|NCT01620177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102308891|NCT01620177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102308892|NCT01620177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102308893|NCT01620177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308894|NCT01986855|Ertugliflozin|ertugliflozin|mesh-list
102308895|NCT01986855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102308896|NCT01986855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308897|NCT01986855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102308898|NCT01986855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308899|NCT02353871|Botulinum Toxins|botulinum toxins|mesh-list
102308900|NCT02353871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102308901|NCT02353871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102308902|NCT02353871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102308903|NCT02353871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102308904|NCT02353871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308905|NCT02353871|Cholinergic Agents|cholinergic agents|mesh-ancestor
102308906|NCT02353871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102308907|NCT02353871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308908|NCT02353871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102308909|NCT02353871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102308910|NCT02009397|Ipilimumab|ipilimumab|mesh-list
102308911|NCT02009397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102308912|NCT02009397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308913|NCT02009397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102308914|NCT02009397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308915|NCT02312219|Folic Acid|folic acid|mesh-list
102308916|NCT02312219|Methotrexate|methotrexate|mesh-list
102308917|NCT02312219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102308918|NCT02312219|Abortifacient Agents|abortifacient agents|mesh-ancestor
102308919|NCT02312219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102308920|NCT02312219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308921|NCT02312219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102308922|NCT02312219|Antimetabolites|antimetabolites|mesh-ancestor
102308923|NCT02312219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308924|NCT02312219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308925|NCT02312219|Dermatologic Agents|dermatologic agents|mesh-ancestor
102308926|NCT02312219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102308927|NCT02312219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102308928|NCT02312219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102308929|NCT02312219|Immunologic Factors|immunologic factors|mesh-ancestor
102308930|NCT02312219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102308931|NCT02312219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102308932|NCT02312219|Hematinics|hematinics|mesh-ancestor
102308933|NCT02312219|Vitamin B Complex|vitamin b complex|mesh-ancestor
102308934|NCT02312219|Vitamins|vitamins|mesh-ancestor
102308935|NCT02312219|Micronutrients|micronutrients|mesh-ancestor
102308936|NCT01986231|Glucagon|glucagon|mesh-list
102308937|NCT01986231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102308938|NCT01986231|Hormones|hormones|mesh-ancestor
102308939|NCT01986231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102308940|NCT01986231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308941|NCT02312063|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102308942|NCT02312063|Glimepiride|glimepiride|mesh-list
102308943|NCT02312063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102308944|NCT02312063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308945|NCT02312063|Incretins|incretins|mesh-ancestor
102308946|NCT02312063|Hormones|hormones|mesh-ancestor
102308947|NCT02312063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102308948|NCT02312063|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102308949|NCT02312063|Protease Inhibitors|protease inhibitors|mesh-ancestor
102308950|NCT02312063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102308951|NCT02312063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308952|NCT02312063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102308953|NCT02312063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102308954|NCT02312063|Immunologic Factors|immunologic factors|mesh-ancestor
102308955|NCT02353169|Dexmedetomidine|dexmedetomidine|mesh-list
102308956|NCT02353169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102308957|NCT02353169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102308958|NCT02353169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308959|NCT02353169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102308960|NCT02353169|Analgesics|analgesics|mesh-ancestor
102308961|NCT02353169|Sensory System Agents|sensory system agents|mesh-ancestor
102308962|NCT02353169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102308963|NCT02353169|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102308964|NCT02353169|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102308965|NCT02353169|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102308966|NCT02353169|Adrenergic Agents|adrenergic agents|mesh-ancestor
102308967|NCT02353169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102308968|NCT02353169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308969|NCT02009163|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102308970|NCT02009163|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102308971|NCT02009163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308972|NCT02009163|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102308973|NCT02009163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102308974|NCT02009163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102308975|NCT02009163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102308976|NCT02009163|Dopamine Agents|dopamine agents|mesh-ancestor
102308977|NCT02009163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102308978|NCT01983969|Pyridoxine|pyridoxine|mesh-list
102308979|NCT01983969|Dexamethasone|dexamethasone|mesh-list
102308980|NCT01983969|Rituximab|rituximab|mesh-list
102308981|NCT01983969|Gemcitabine|gemcitabine|mesh-list
102308982|NCT01983969|Azacitidine|azacitidine|mesh-list
102308983|NCT01983969|Melphalan|melphalan|mesh-list
102308984|NCT01983969|Busulfan|busulfan|mesh-list
102308985|NCT01983969|Vorinostat|vorinostat|mesh-list
102308986|NCT01983969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102308987|NCT01983969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102308988|NCT01983969|Immunologic Factors|immunologic factors|mesh-ancestor
102308989|NCT01983969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102308990|NCT01983969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102308991|NCT01983969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102308992|NCT01983969|Antiemetics|antiemetics|mesh-ancestor
102308993|NCT01983969|Autonomic Agents|autonomic agents|mesh-ancestor
102308994|NCT01983969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102308995|NCT01983969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102308996|NCT01983969|Glucocorticoids|glucocorticoids|mesh-ancestor
102308997|NCT01983969|Hormones|hormones|mesh-ancestor
102308998|NCT01983969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102308999|NCT01983969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102309000|NCT01983969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102309001|NCT01983969|Antimetabolites|antimetabolites|mesh-ancestor
102309002|NCT01983969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309003|NCT01983969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102309004|NCT01983969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102309005|NCT01983969|Alkylating Agents|alkylating agents|mesh-ancestor
102309006|NCT01983969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102309007|NCT01983969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102309008|NCT01983969|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102309009|NCT01983969|Vitamin B Complex|vitamin b complex|mesh-ancestor
102309010|NCT01983969|Vitamins|vitamins|mesh-ancestor
102309011|NCT01983969|Micronutrients|micronutrients|mesh-ancestor
102309012|NCT02008773|Valacyclovir|valacyclovir|mesh-list
102309013|NCT02008773|Antiviral Agents|antiviral agents|mesh-ancestor
102309014|NCT02008773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102309015|NCT02257567|Rituximab|rituximab|mesh-list
102309016|NCT02257567|Obinutuzumab|obinutuzumab|mesh-list
102309017|NCT02257567|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102309018|NCT02257567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102309019|NCT02257567|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
102309020|NCT02257567|Immunoconjugates|immunoconjugates|mesh-list
102309021|NCT02257567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102309022|NCT02257567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102309023|NCT02257567|Immunologic Factors|immunologic factors|mesh-ancestor
102309024|NCT02257567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309025|NCT02257567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102309026|NCT02257567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102309027|NCT02257567|Alkylating Agents|alkylating agents|mesh-ancestor
102309028|NCT02257567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309029|NCT01642615|Dexlansoprazole|dexlansoprazole|mesh-list
102309030|NCT01642615|Lansoprazole|lansoprazole|mesh-list
102309031|NCT01642615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102309032|NCT01642615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102309033|NCT01642615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102309034|NCT01642615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102309035|NCT01642615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309036|NCT03571945|Anesthetics|anesthetics|mesh-list
102309037|NCT03571945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102309038|NCT03571945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309039|NCT02311361|Durvalumab|durvalumab|mesh-list
102309040|NCT02311361|Tremelimumab|tremelimumab|mesh-list
102309041|NCT02311361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102309042|NCT02311361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102309043|NCT02329223|Omalizumab|omalizumab|mesh-list
102309044|NCT02329223|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102309045|NCT02329223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102309046|NCT02329223|Respiratory System Agents|respiratory system agents|mesh-ancestor
102309047|NCT05302297|Cemiplimab|cemiplimab|mesh-list
102309048|NCT05302297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102309049|NCT05302297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102309050|NCT02310581|Buprenorphine|buprenorphine|mesh-list
102309051|NCT02310581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102309052|NCT02310581|Narcotics|narcotics|mesh-ancestor
102309053|NCT02310581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102309054|NCT02310581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309055|NCT02310581|Analgesics|analgesics|mesh-ancestor
102309056|NCT02310581|Sensory System Agents|sensory system agents|mesh-ancestor
102309057|NCT02310581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102309058|NCT02310581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102309059|NCT04892693|Talazoparib|talazoparib|mesh-list
102309060|NCT04892693|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102309061|NCT04892693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102309062|NCT04892693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309063|NCT04892693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102309064|NCT02309411|Rivaroxaban|rivaroxaban|mesh-list
102309065|NCT02309411|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102309066|NCT02309411|Antithrombins|antithrombins|mesh-ancestor
102309067|NCT02309411|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102309068|NCT02309411|Protease Inhibitors|protease inhibitors|mesh-ancestor
102309069|NCT02309411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102309070|NCT02309411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309071|NCT02309411|Anticoagulants|anticoagulants|mesh-ancestor
102309072|NCT02008227|Docetaxel|docetaxel|mesh-list
102309073|NCT02008227|Atezolizumab|atezolizumab|mesh-list
102309074|NCT02008227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102309075|NCT02008227|Tubulin Modulators|tubulin modulators|mesh-ancestor
102309076|NCT02008227|Antimitotic Agents|antimitotic agents|mesh-ancestor
102309077|NCT02008227|Mitosis Modulators|mitosis modulators|mesh-ancestor
102309078|NCT02008227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309079|NCT02008227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102309080|NCT02008227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102309081|NCT02348723|Warfarin|warfarin|mesh-list
102309082|NCT02348723|Dabigatran|dabigatran|mesh-list
102309083|NCT02348723|Anticoagulants|anticoagulants|mesh-ancestor
102309084|NCT02348723|Antithrombins|antithrombins|mesh-ancestor
102309085|NCT02348723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102309086|NCT02348723|Protease Inhibitors|protease inhibitors|mesh-ancestor
102309087|NCT02348723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102309088|NCT02348723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309089|NCT02006667|Gemcitabine|gemcitabine|mesh-list
102309091|NCT02006667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102309092|NCT02006667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102309093|NCT02006667|Antimetabolites|antimetabolites|mesh-ancestor
102309094|NCT02006667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309095|NCT02006667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102309096|NCT01983111|Acetaminophen|acetaminophen|mesh-list
102309097|NCT01983111|Buprenorphine|buprenorphine|mesh-list
102309098|NCT01983111|Tramadol|tramadol|mesh-list
102309099|NCT01983111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102309100|NCT01983111|Analgesics|analgesics|mesh-ancestor
102309101|NCT01983111|Sensory System Agents|sensory system agents|mesh-ancestor
102309102|NCT01983111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102309103|NCT01983111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309104|NCT01983111|Antipyretics|antipyretics|mesh-ancestor
102309105|NCT01983111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102309106|NCT01983111|Narcotics|narcotics|mesh-ancestor
102309107|NCT01983111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102309108|NCT01983111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102309110|NCT04672941|Tiotropium Bromide|tiotropium bromide|mesh-list
102309111|NCT04672941|Olodaterol|olodaterol|mesh-list
102309112|NCT04672941|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102309113|NCT04672941|Autonomic Agents|autonomic agents|mesh-ancestor
102309114|NCT04672941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102309115|NCT04672941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309116|NCT04672941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102309117|NCT04672941|Respiratory System Agents|respiratory system agents|mesh-ancestor
102309118|NCT04672941|Parasympatholytics|parasympatholytics|mesh-ancestor
102309119|NCT04672941|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102309120|NCT04672941|Cholinergic Agents|cholinergic agents|mesh-ancestor
102309121|NCT04672941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102309122|NCT04672941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309123|NCT04672941|Anticonvulsants|anticonvulsants|mesh-ancestor
102309124|NCT02348489|Guadecitabine|guadecitabine|mesh-list
102309125|NCT02348489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102309126|NCT01966107|Bromides|bromides|mesh-list
102309127|NCT01966107|Anticonvulsants|anticonvulsants|mesh-ancestor
102309128|NCT01982331|Vaccines|vaccines|mesh-list
102309129|NCT01982331|Immunologic Factors|immunologic factors|mesh-ancestor
102309130|NCT01982331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309131|NCT02326025|Doxorubicin|doxorubicin|mesh-list
102309132|NCT02326025|Olaratumab|olaratumab|mesh-list
102309133|NCT02326025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102309134|NCT02326025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102309135|NCT02326025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102309136|NCT02326025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102309137|NCT02326025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102309138|NCT02326025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309139|NCT01619865|Edotreotide|edotreotide|mesh-list
102309140|NCT01619865|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102309141|NCT01619865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309142|NCT02006121|Apomorphine|apomorphine|mesh-list
102309143|NCT02006121|Emetics|emetics|mesh-ancestor
102309144|NCT02006121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309145|NCT02006121|Autonomic Agents|autonomic agents|mesh-ancestor
102309146|NCT02006121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102309147|NCT02006121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102309148|NCT02006121|Dopamine Agonists|dopamine agonists|mesh-ancestor
102309149|NCT02006121|Dopamine Agents|dopamine agents|mesh-ancestor
102309150|NCT02006121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102309151|NCT02006121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309152|NCT02005887|Letrozole|letrozole|mesh-list
102309153|NCT02005887|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102309154|NCT02005887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102309155|NCT02005887|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102309156|NCT02005887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102309157|NCT02005887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102309158|NCT02005887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309159|NCT02005887|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102309160|NCT02005887|Hormone Antagonists|hormone antagonists|mesh-ancestor
102309161|NCT02005887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102309162|NCT02005887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309163|NCT02005887|Luteolytic Agents|luteolytic agents|mesh-ancestor
102309164|NCT02005887|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102309165|NCT02005887|Contraceptive Agents|contraceptive agents|mesh-ancestor
102309166|NCT02005887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102309167|NCT02005887|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102309168|NCT02005887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102309169|NCT01981473|Infliximab|infliximab|mesh-list
102309170|NCT01981473|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102309171|NCT01981473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102309172|NCT01981473|Dermatologic Agents|dermatologic agents|mesh-ancestor
102309173|NCT01981473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102309174|NCT01981473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102309175|NCT02005029|Erythromycin|erythromycin|mesh-list
102309176|NCT02005029|Erythromycin Estolate|erythromycin estolate|mesh-list
102309177|NCT02005029|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
102309178|NCT02005029|Erythromycin stearate|erythromycin stearate|mesh-list
102309179|NCT02005029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102309180|NCT02005029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102309181|NCT02005029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102309182|NCT02005029|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102309184|NCT02005029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309185|NCT04672005|Leucovorin|leucovorin|mesh-list
102309186|NCT04672005|Paclitaxel|paclitaxel|mesh-list
102309187|NCT04672005|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102309188|NCT04672005|Gemcitabine|gemcitabine|mesh-list
102309189|NCT04672005|Oxaliplatin|oxaliplatin|mesh-list
102309190|NCT04672005|Irinotecan|irinotecan|mesh-list
102309191|NCT04672005|Folfirinox|folfirinox|mesh-list
102309192|NCT04672005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102309193|NCT04672005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102309194|NCT04672005|Tubulin Modulators|tubulin modulators|mesh-ancestor
102309195|NCT04672005|Antimitotic Agents|antimitotic agents|mesh-ancestor
102309196|NCT04672005|Mitosis Modulators|mitosis modulators|mesh-ancestor
102309197|NCT04672005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309198|NCT04672005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102309199|NCT04672005|Antimetabolites|antimetabolites|mesh-ancestor
102309200|NCT04672005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102309201|NCT04672005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102309202|NCT04672005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102309203|NCT04672005|Antidotes|antidotes|mesh-ancestor
102309204|NCT04672005|Protective Agents|protective agents|mesh-ancestor
102309205|NCT04672005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309206|NCT04672005|Vitamin B Complex|vitamin b complex|mesh-ancestor
102309207|NCT04672005|Vitamins|vitamins|mesh-ancestor
102309208|NCT04672005|Micronutrients|micronutrients|mesh-ancestor
102309209|NCT04416399|Budesonide|budesonide|mesh-list
102309210|NCT04416399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102309211|NCT04416399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102309212|NCT04416399|Autonomic Agents|autonomic agents|mesh-ancestor
102309213|NCT04416399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102309214|NCT04416399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309215|NCT04416399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102309216|NCT04416399|Respiratory System Agents|respiratory system agents|mesh-ancestor
102309217|NCT04416399|Glucocorticoids|glucocorticoids|mesh-ancestor
102309218|NCT04416399|Hormones|hormones|mesh-ancestor
102309219|NCT04416399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102309220|NCT02282345|Talazoparib|talazoparib|mesh-list
102309221|NCT02282345|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102309222|NCT02282345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102309223|NCT02282345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309224|NCT02282345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102309225|NCT01732822|Clopidogrel|clopidogrel|mesh-list
102309226|NCT01732822|Ticagrelor|ticagrelor|mesh-list
102309227|NCT01732822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102309228|NCT01732822|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102309229|NCT01732822|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102309230|NCT01732822|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102309231|NCT01732822|Purinergic Agents|purinergic agents|mesh-ancestor
102309232|NCT01732822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102309233|NCT01732822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309234|NCT01732822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309235|NCT02004093|Paclitaxel|paclitaxel|mesh-list
102309236|NCT02004093|Carboplatin|carboplatin|mesh-list
102309237|NCT02004093|Gemcitabine|gemcitabine|mesh-list
102309238|NCT02004093|Pertuzumab|pertuzumab|mesh-list
102018001|NCT01349205|Analgesics|analgesics|mesh-ancestor
102309239|NCT02004093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102309240|NCT02004093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102309241|NCT02004093|Tubulin Modulators|tubulin modulators|mesh-ancestor
102309242|NCT02004093|Antimitotic Agents|antimitotic agents|mesh-ancestor
102309243|NCT02004093|Mitosis Modulators|mitosis modulators|mesh-ancestor
102309244|NCT02004093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309245|NCT02004093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102309246|NCT02004093|Antimetabolites|antimetabolites|mesh-ancestor
102309247|NCT02004093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102309249|NCT01641367|Emtricitabine|emtricitabine|mesh-list
102309250|NCT01641367|Raltegravir Potassium|raltegravir potassium|mesh-list
102309251|NCT01641367|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102309252|NCT01641367|Darunavir|darunavir|mesh-list
102309253|NCT01641367|Etravirine|etravirine|mesh-list
102309254|NCT01641367|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
102309255|NCT01641367|Protease Inhibitors|protease inhibitors|mesh-list
102309256|NCT01641367|Antiviral Agents|antiviral agents|mesh-ancestor
102309257|NCT01641367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102309258|NCT01641367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102309259|NCT01641367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102309260|NCT01641367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102309261|NCT01641367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309262|NCT01641367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102309263|NCT01641367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102309264|NCT01641367|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102309265|NCT01641367|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102309266|NCT01641367|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102309268|NCT02325713|Anthelmintics|anthelmintics|mesh-ancestor
102309269|NCT02325713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102309270|NCT02325713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102309271|NCT04877639|Dexmedetomidine|dexmedetomidine|mesh-list
102309272|NCT04877639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102309273|NCT04877639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102309274|NCT04877639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309275|NCT04877639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102309276|NCT04877639|Analgesics|analgesics|mesh-ancestor
102309277|NCT04877639|Sensory System Agents|sensory system agents|mesh-ancestor
102309278|NCT04877639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102309279|NCT04877639|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102309280|NCT04877639|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102309281|NCT04877639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102309282|NCT04877639|Adrenergic Agents|adrenergic agents|mesh-ancestor
102309283|NCT04877639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102309284|NCT04877639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309285|NCT02325401|Metformin|metformin|mesh-list
102309286|NCT02325401|Cisplatin|cisplatin|mesh-list
102309287|NCT02325401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102309288|NCT02325401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102309289|NCT02325401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309290|NCT02324699|Prednisone|prednisone|mesh-list
102309291|NCT02324699|Vedolizumab|vedolizumab|mesh-list
102309292|NCT02324699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102309293|NCT02324699|Glucocorticoids|glucocorticoids|mesh-ancestor
102309294|NCT02324699|Hormones|hormones|mesh-ancestor
102309295|NCT02324699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102309296|NCT02324699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309297|NCT02324699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102309298|NCT02324699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102309299|NCT02324699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102309300|NCT01979523|Trametinib|trametinib|mesh-list
102309301|NCT01979523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102309302|NCT01979523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102309303|NCT01979523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102309304|NCT01979523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309305|NCT02255461|Palbociclib|palbociclib|mesh-list
102309306|NCT02255461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102309307|NCT02255461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102309308|NCT02255461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102309309|NCT02255461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309310|NCT01764022|Paclitaxel|paclitaxel|mesh-list
102309311|NCT01764022|Trastuzumab|trastuzumab|mesh-list
102309312|NCT01764022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102309313|NCT01764022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102309314|NCT01764022|Tubulin Modulators|tubulin modulators|mesh-ancestor
102309315|NCT01764022|Antimitotic Agents|antimitotic agents|mesh-ancestor
102309316|NCT01764022|Mitosis Modulators|mitosis modulators|mesh-ancestor
102309317|NCT01764022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309318|NCT01764022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102309320|NCT02003391|Travoprost|travoprost|mesh-list
102309321|NCT02003391|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102309322|NCT02003391|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102309323|NCT02003391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102309324|NCT02003391|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102309325|NCT02003391|Adrenergic Agents|adrenergic agents|mesh-ancestor
102309326|NCT02003391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102309327|NCT02003391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309328|NCT02003391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309329|NCT02003391|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102309330|NCT02003391|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102309331|NCT02254681|Gemcitabine|gemcitabine|mesh-list
102309332|NCT02254681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102309333|NCT02254681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102309334|NCT02254681|Antimetabolites|antimetabolites|mesh-ancestor
102309335|NCT02254681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309336|NCT01965327|Interferons|interferons|mesh-list
102309337|NCT01965327|Interferon-gamma|interferon-gamma|mesh-list
102309338|NCT01965327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102309339|NCT01965327|Antiviral Agents|antiviral agents|mesh-ancestor
102309340|NCT01965327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102309341|NCT04872595|Cyclophosphamide|cyclophosphamide|mesh-list
102309342|NCT04872595|Melphalan|melphalan|mesh-list
102309343|NCT04872595|Busulfan|busulfan|mesh-list
102309344|NCT04872595|Thiotepa|thiotepa|mesh-list
102309345|NCT04872595|Fludarabine|fludarabine|mesh-list
102309346|NCT04872595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102309347|NCT04872595|Immunologic Factors|immunologic factors|mesh-ancestor
102309348|NCT04872595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309349|NCT04872595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102309350|NCT04872595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102309351|NCT04872595|Alkylating Agents|alkylating agents|mesh-ancestor
102309352|NCT04872595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309353|NCT04872595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102309354|NCT04872595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102309355|NCT01639729|Sufentanil|sufentanil|mesh-list
102309356|NCT01639729|Dsuvia|dsuvia|mesh-list
102309357|NCT01639729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102309358|NCT01639729|Narcotics|narcotics|mesh-ancestor
102309359|NCT01639729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102309360|NCT01639729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309361|NCT01639729|Analgesics|analgesics|mesh-ancestor
102309362|NCT01639729|Sensory System Agents|sensory system agents|mesh-ancestor
102309363|NCT01639729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102309364|NCT01639729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102309365|NCT01639729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102309366|NCT01639729|Anesthetics, General|anesthetics, general|mesh-ancestor
102309367|NCT01639729|Anesthetics|anesthetics|mesh-ancestor
102309368|NCT02002221|Metformin|metformin|mesh-list
102309369|NCT02002221|Vildagliptin|vildagliptin|mesh-list
102309370|NCT02002221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102309371|NCT02002221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309372|NCT02002221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102309373|NCT02002221|Protease Inhibitors|protease inhibitors|mesh-ancestor
102309374|NCT02002221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102309375|NCT02002221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309376|NCT05650723|Venetoclax|venetoclax|mesh-list
102309377|NCT05650723|Obinutuzumab|obinutuzumab|mesh-list
102309378|NCT05650723|Zanubrutinib|zanubrutinib|mesh-list
102309379|NCT05650723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102309380|NCT05650723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102309381|NCT05650723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102309382|NCT05650723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102309383|NCT05650723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309384|NCT05247697|Mirtazapine|mirtazapine|mesh-list
102309385|NCT05247697|Antidepressive Agents|antidepressive agents|mesh-ancestor
102309386|NCT05247697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102309387|NCT05247697|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102309388|NCT05247697|Histamine Antagonists|histamine antagonists|mesh-ancestor
102309389|NCT05247697|Histamine Agents|histamine agents|mesh-ancestor
102309390|NCT05247697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102309391|NCT05247697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309392|NCT05247697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309393|NCT05247697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102309394|NCT05247697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102309395|NCT05247697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102309396|NCT05247697|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102309397|NCT05247697|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102309398|NCT05247697|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102309399|NCT05247697|Adrenergic Agents|adrenergic agents|mesh-ancestor
102309400|NCT05247697|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102309401|NCT05247697|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102309402|NCT05247697|Serotonin Agents|serotonin agents|mesh-ancestor
102309403|NCT05247697|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102309404|NCT05100199|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102309405|NCT05100199|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102309406|NCT05100199|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102309407|NCT05100199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101425820|NCT00525772|Ciclesonide|ciclesonide|mesh-list
102309408|NCT05100199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309409|NCT05100199|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102309410|NCT05100199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102309411|NCT05100199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309412|NCT05100199|Cholinergic Agents|cholinergic agents|mesh-ancestor
102309413|NCT05100199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102309414|NCT02001987|Methotrexate|methotrexate|mesh-list
102309415|NCT02001987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102309416|NCT02001987|Abortifacient Agents|abortifacient agents|mesh-ancestor
102309417|NCT02001987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102309418|NCT02001987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309419|NCT02001987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102309420|NCT02001987|Antimetabolites|antimetabolites|mesh-ancestor
102309421|NCT02001987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309422|NCT02001987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102309423|NCT02001987|Dermatologic Agents|dermatologic agents|mesh-ancestor
102309424|NCT02001987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102309425|NCT02001987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102309426|NCT02001987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102309427|NCT02001987|Immunologic Factors|immunologic factors|mesh-ancestor
102309428|NCT02001987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102309429|NCT02001987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102309430|NCT01763164|Dacarbazine|dacarbazine|mesh-list
102309431|NCT01763164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102309432|NCT01763164|Alkylating Agents|alkylating agents|mesh-ancestor
102309433|NCT01763164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309434|NCT01763164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102309435|NCT01782742|Bexarotene|bexarotene|mesh-list
102309436|NCT01782742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102309437|NCT01732588|Artefenomel|artefenomel|mesh-list
102309438|NCT01732588|Antimalarials|antimalarials|mesh-ancestor
102309439|NCT01732588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102309440|NCT01732588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102309441|NCT01732588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102309442|NCT01639339|Belimumab|belimumab|mesh-list
102309443|NCT01639339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102309444|NCT01639339|Immunologic Factors|immunologic factors|mesh-ancestor
102309445|NCT01639339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309446|NCT01641133|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102309447|NCT01641133|Immunologic Factors|immunologic factors|mesh-ancestor
102309448|NCT01641133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309449|NCT04836637|Calcium, Dietary|calcium, dietary|mesh-list
102309450|NCT04836637|Calcium Carbonate|calcium carbonate|mesh-list
102309451|NCT04836637|Calcium|calcium|mesh-list
102309452|NCT04836637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102309453|NCT04836637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309454|NCT04836637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102309455|NCT04836637|Antacids|antacids|mesh-ancestor
102309456|NCT04836637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309457|NCT04836637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102309458|NCT04419259|Erenumab|erenumab|mesh-list
102309459|NCT04419259|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
102309460|NCT04419259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309461|NCT04419259|Analgesics|analgesics|mesh-ancestor
102309462|NCT04419259|Sensory System Agents|sensory system agents|mesh-ancestor
102309463|NCT04419259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102309464|NCT04419259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309465|NCT02000427|Blinatumomab|blinatumomab|mesh-list
102309466|NCT02000427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102309467|NCT04845217|Peppermint oil|peppermint oil|mesh-list
102309468|NCT04845217|Antiemetics|antiemetics|mesh-ancestor
102309469|NCT04845217|Autonomic Agents|autonomic agents|mesh-ancestor
102309470|NCT04845217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102309471|NCT04845217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309472|NCT04845217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102309473|NCT04845217|Parasympatholytics|parasympatholytics|mesh-ancestor
102309474|NCT05359393|Tislelizumab|tislelizumab|mesh-list
102309475|NCT05359393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102309476|NCT05359393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102309477|NCT01600885|Guanfacine|guanfacine|mesh-list
102309478|NCT01600885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102309479|NCT01600885|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102309480|NCT01600885|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102309481|NCT01600885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102309482|NCT01600885|Adrenergic Agents|adrenergic agents|mesh-ancestor
102309483|NCT01600885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102309484|NCT01600885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309485|NCT01600885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309486|NCT04625257|Antibodies|antibodies|mesh-list
102309487|NCT04625257|Immunologic Factors|immunologic factors|mesh-ancestor
102309488|NCT04625257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309489|NCT05369377|Zanubrutinib|zanubrutinib|mesh-list
102309490|NCT05369377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102309491|NCT05369377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102309492|NCT05369377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102309493|NCT05369377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309494|NCT04832269|Methylprednisolone|methylprednisolone|mesh-list
102309495|NCT04832269|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102309496|NCT04832269|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102309497|NCT04832269|Prednisolone|prednisolone|mesh-list
102309498|NCT04832269|Prednisolone acetate|prednisolone acetate|mesh-list
102309499|NCT04832269|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102309500|NCT04832269|Prednisolone phosphate|prednisolone phosphate|mesh-list
102309501|NCT04832269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102309502|NCT04832269|Antiemetics|antiemetics|mesh-ancestor
102309503|NCT04832269|Autonomic Agents|autonomic agents|mesh-ancestor
102309504|NCT04832269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102309505|NCT04832269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309506|NCT04832269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102309507|NCT04832269|Glucocorticoids|glucocorticoids|mesh-ancestor
102309508|NCT04832269|Hormones|hormones|mesh-ancestor
102309509|NCT04832269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102309510|NCT04832269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102309511|NCT04832269|Protective Agents|protective agents|mesh-ancestor
102309512|NCT04832269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102309513|NCT04832269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102309514|NCT04608331|Dexmedetomidine|dexmedetomidine|mesh-list
102309515|NCT04608331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102309516|NCT04608331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102309517|NCT04608331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309518|NCT04608331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102309519|NCT04608331|Analgesics|analgesics|mesh-ancestor
102309520|NCT04608331|Sensory System Agents|sensory system agents|mesh-ancestor
102309521|NCT04608331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102309522|NCT04608331|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102309523|NCT04608331|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102309524|NCT04608331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102309525|NCT04608331|Adrenergic Agents|adrenergic agents|mesh-ancestor
102309526|NCT04608331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102309527|NCT04608331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309528|NCT01637077|Pregabalin|pregabalin|mesh-list
102309529|NCT01637077|Analgesics|analgesics|mesh-ancestor
102309530|NCT01637077|Sensory System Agents|sensory system agents|mesh-ancestor
102309531|NCT01637077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102309532|NCT01637077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309533|NCT01637077|Anticonvulsants|anticonvulsants|mesh-ancestor
102309534|NCT01637077|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102309535|NCT01637077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102309536|NCT01637077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309537|NCT01637077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102309538|NCT01637077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102309539|NCT01637077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102309540|NCT01637077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102309541|NCT01637077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102309542|NCT02308163|Etanercept|etanercept|mesh-list
102309543|NCT02308163|Peficitinib|peficitinib|mesh-list
102309544|NCT02308163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102309545|NCT02308163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102309546|NCT02308163|Analgesics|analgesics|mesh-ancestor
102309547|NCT02308163|Sensory System Agents|sensory system agents|mesh-ancestor
102309548|NCT02308163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102309549|NCT02308163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309550|NCT02308163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102309551|NCT02308163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102309552|NCT02308163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102309553|NCT02308163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102309554|NCT02308163|Immunologic Factors|immunologic factors|mesh-ancestor
102309555|NCT02308163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102309556|NCT02308163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309557|NCT04001647|Ascorbic Acid|ascorbic acid|mesh-list
102309558|NCT04001647|Nitroprusside|nitroprusside|mesh-list
102309559|NCT04001647|Acetylcholine|acetylcholine|mesh-list
102309560|NCT04001647|Vitamins|vitamins|mesh-ancestor
102309561|NCT04001647|Micronutrients|micronutrients|mesh-ancestor
102309562|NCT04001647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309563|NCT04001647|Antioxidants|antioxidants|mesh-ancestor
102309564|NCT04001647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309565|NCT04001647|Protective Agents|protective agents|mesh-ancestor
102309566|NCT04001647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102309567|NCT04001647|Vasodilator Agents|vasodilator agents|mesh-ancestor
102309568|NCT04001647|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102309569|NCT04001647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102309570|NCT04001647|Cholinergic Agents|cholinergic agents|mesh-ancestor
102309571|NCT04001647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102309572|NCT03939637|Immunoglobulins|immunoglobulins|mesh-list
102309573|NCT03939637|Antibodies|antibodies|mesh-list
102309574|NCT03939637|gamma-Globulins|gamma-globulins|mesh-list
102309575|NCT03939637|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102309576|NCT03939637|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102309577|NCT03939637|Immunologic Factors|immunologic factors|mesh-ancestor
102309578|NCT03939637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309579|NCT04479241|Pembrolizumab|pembrolizumab|mesh-list
102309580|NCT04479241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102309581|NCT04479241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102309582|NCT04479241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102309583|NCT04479241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309584|NCT04880707|Anesthetics|anesthetics|mesh-list
102309585|NCT04880707|Anesthetics, Local|anesthetics, local|mesh-list
102309586|NCT04880707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102309587|NCT04880707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309588|NCT04880707|Sensory System Agents|sensory system agents|mesh-ancestor
102309589|NCT04880707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102309590|NCT01999335|Dexamethasone|dexamethasone|mesh-list
102309591|NCT01999335|Pomalidomide|pomalidomide|mesh-list
102309592|NCT01999335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102309593|NCT01999335|Antiemetics|antiemetics|mesh-ancestor
102309594|NCT01999335|Autonomic Agents|autonomic agents|mesh-ancestor
102309595|NCT01999335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102309596|NCT01999335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309597|NCT01999335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102309598|NCT01999335|Glucocorticoids|glucocorticoids|mesh-ancestor
102309599|NCT01999335|Hormones|hormones|mesh-ancestor
102309600|NCT01999335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102309601|NCT01999335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102309602|NCT01999335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102309603|NCT01999335|Immunologic Factors|immunologic factors|mesh-ancestor
102309604|NCT01999335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102309605|NCT01999335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102309606|NCT01999335|Growth Substances|growth substances|mesh-ancestor
102309607|NCT01999335|Growth Inhibitors|growth inhibitors|mesh-ancestor
102309608|NCT01999179|Heparin|heparin|mesh-list
102309609|NCT01999179|Enoxaparin|enoxaparin|mesh-list
102309610|NCT01999179|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102309611|NCT01999179|Tinzaparin|tinzaparin|mesh-list
102309612|NCT01999179|Dalteparin|dalteparin|mesh-list
102309613|NCT01999179|Rivaroxaban|rivaroxaban|mesh-list
102309614|NCT01999179|Dabigatran|dabigatran|mesh-list
102309615|NCT01999179|Apixaban|apixaban|mesh-list
102309616|NCT01999179|Anticoagulants|anticoagulants|mesh-list
102309617|NCT01999179|Edoxaban|edoxaban|mesh-list
102309618|NCT01999179|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102309619|NCT01999179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102309620|NCT01999179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309621|NCT01999179|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102309622|NCT01999179|Antithrombins|antithrombins|mesh-ancestor
102309623|NCT01999179|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102309624|NCT01999179|Protease Inhibitors|protease inhibitors|mesh-ancestor
102309625|NCT01999179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102309626|NCT01977729|Sertraline|sertraline|mesh-list
102309627|NCT01977729|Antidepressive Agents|antidepressive agents|mesh-ancestor
102309628|NCT01977729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102309629|NCT01977729|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102309630|NCT01977729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102309631|NCT01977729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102309632|NCT01977729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309634|NCT01977729|Serotonin Agents|serotonin agents|mesh-ancestor
102309635|NCT01977729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309636|NCT01998399|Ticagrelor|ticagrelor|mesh-list
102309637|NCT01998399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102309638|NCT01998399|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102309639|NCT01998399|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102309640|NCT01998399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102309641|NCT01998399|Purinergic Agents|purinergic agents|mesh-ancestor
102309642|NCT01998399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102309643|NCT01998399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309644|NCT01998399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309645|NCT01761292|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
102309646|NCT01761292|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102309647|NCT01761292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102309648|NCT01761292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309649|NCT01731886|Dexamethasone|dexamethasone|mesh-list
102309650|NCT01731886|Cyclophosphamide|cyclophosphamide|mesh-list
102309651|NCT01731886|Melphalan|melphalan|mesh-list
102309652|NCT01731886|Lenalidomide|lenalidomide|mesh-list
102309653|NCT01731886|Lenograstim|lenograstim|mesh-list
102309654|NCT01731886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102309655|NCT01731886|Immunologic Factors|immunologic factors|mesh-ancestor
102309656|NCT01731886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309657|NCT01731886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102309658|NCT01731886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102309659|NCT01731886|Alkylating Agents|alkylating agents|mesh-ancestor
102309660|NCT01731886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309661|NCT01731886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102309662|NCT01731886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102309663|NCT01731886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102309664|NCT01731886|Antiemetics|antiemetics|mesh-ancestor
102309665|NCT01731886|Autonomic Agents|autonomic agents|mesh-ancestor
102309666|NCT01731886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102309667|NCT01731886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102309668|NCT01731886|Glucocorticoids|glucocorticoids|mesh-ancestor
102309669|NCT01731886|Hormones|hormones|mesh-ancestor
102309670|NCT01731886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102309671|NCT01731886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102309672|NCT01731886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102309673|NCT01731886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102309674|NCT01731886|Growth Substances|growth substances|mesh-ancestor
102309675|NCT01731886|Growth Inhibitors|growth inhibitors|mesh-ancestor
102309676|NCT01731886|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102309677|NCT01759420|Ondansetron|ondansetron|mesh-list
102309678|NCT01759420|Antiemetics|antiemetics|mesh-ancestor
102309679|NCT01759420|Autonomic Agents|autonomic agents|mesh-ancestor
102309680|NCT01759420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102309681|NCT01759420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309682|NCT01759420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102309683|NCT01759420|Antipruritics|antipruritics|mesh-ancestor
102309684|NCT01759420|Dermatologic Agents|dermatologic agents|mesh-ancestor
102309685|NCT01759420|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102309686|NCT01759420|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102309687|NCT01759420|Serotonin Agents|serotonin agents|mesh-ancestor
102309688|NCT01759420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102309689|NCT01759420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309690|NCT01781026|Vemurafenib|vemurafenib|mesh-list
102309691|NCT01781026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102309692|NCT01781026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102309693|NCT01781026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102309694|NCT01781026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309695|NCT01729156|Metformin|metformin|mesh-list
102309696|NCT01729156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102309697|NCT01729156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309698|NCT01779700|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102309699|NCT01779700|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102309700|NCT01779700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309701|NCT01779700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102309702|NCT01779700|Immunologic Factors|immunologic factors|mesh-ancestor
102309703|NCT01779700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309704|NCT04572256|Montelukast|montelukast|mesh-list
102309705|NCT04572256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102309706|NCT04572256|Respiratory System Agents|respiratory system agents|mesh-ancestor
102309707|NCT04572256|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102309708|NCT04572256|Hormone Antagonists|hormone antagonists|mesh-ancestor
102309709|NCT04572256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102309710|NCT04572256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309711|NCT04572256|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102309712|NCT04572256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102309713|NCT04572256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309714|NCT01963611|Glatiramer Acetate|glatiramer acetate|mesh-list
102309715|NCT01963611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102309716|NCT01963611|Immunologic Factors|immunologic factors|mesh-ancestor
102309717|NCT01963611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309718|NCT01963611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102309719|NCT01963611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102309720|NCT01975701|Infigratinib|infigratinib|mesh-list
102309721|NCT01975701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102309723|NCT01962987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102309724|NCT01962987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102309725|NCT01962987|Analgesics|analgesics|mesh-ancestor
102309726|NCT01962987|Sensory System Agents|sensory system agents|mesh-ancestor
102309727|NCT01962987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102309728|NCT01962987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309729|NCT01962987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102309730|NCT01962987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102309731|NCT01962987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102309732|NCT01962987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102309733|NCT01962987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309734|NCT01962441|Sofosbuvir|sofosbuvir|mesh-list
102309735|NCT01962441|Antiviral Agents|antiviral agents|mesh-ancestor
102309736|NCT01962441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102309737|NCT01638013|Peficitinib|peficitinib|mesh-list
102309738|NCT01638013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102309739|NCT01638013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309740|NCT01638013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102309741|NCT01638013|Immunologic Factors|immunologic factors|mesh-ancestor
102309742|NCT01638013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309743|NCT01637623|Allopurinol|allopurinol|mesh-list
102309744|NCT01637623|Losartan|losartan|mesh-list
102309745|NCT01637623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102309746|NCT01637623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102309747|NCT01637623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102309748|NCT01637623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102309749|NCT01637623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309750|NCT01637623|Antimetabolites|antimetabolites|mesh-ancestor
102309751|NCT01637623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102309752|NCT01637623|Gout Suppressants|gout suppressants|mesh-ancestor
102309753|NCT01637623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102309754|NCT01637623|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102309755|NCT01637623|Antioxidants|antioxidants|mesh-ancestor
102309756|NCT01637623|Protective Agents|protective agents|mesh-ancestor
102309757|NCT01637623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309758|NCT01995825|Lamotrigine|lamotrigine|mesh-list
102309759|NCT01995825|Anticonvulsants|anticonvulsants|mesh-list
102309760|NCT01995825|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102309761|NCT01995825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102309762|NCT01995825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309763|NCT01995825|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102309764|NCT01995825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309765|NCT01995825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102309766|NCT01995825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102309767|NCT01995825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102309768|NCT01995825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102309769|NCT01995825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102309770|NCT04267081|Venetoclax|venetoclax|mesh-list
102309771|NCT04267081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102309772|NCT04792567|Siponimod|siponimod|mesh-list
102309773|NCT04792567|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102309774|NCT04792567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309775|NCT04792567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102309776|NCT04792567|Immunologic Factors|immunologic factors|mesh-ancestor
102309777|NCT04792567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309778|NCT04419025|Acetylcysteine|acetylcysteine|mesh-list
102309779|NCT04419025|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102309780|NCT04419025|Antiviral Agents|antiviral agents|mesh-ancestor
102309781|NCT04419025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102309782|NCT04419025|Expectorants|expectorants|mesh-ancestor
102309783|NCT04419025|Respiratory System Agents|respiratory system agents|mesh-ancestor
102309784|NCT04419025|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102309785|NCT04419025|Antioxidants|antioxidants|mesh-ancestor
102309786|NCT04419025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309787|NCT04419025|Protective Agents|protective agents|mesh-ancestor
102309788|NCT04419025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309789|NCT04419025|Antidotes|antidotes|mesh-ancestor
102309790|NCT04781647|Interferons|interferons|mesh-list
102309791|NCT04781647|Interferon-alpha|interferon-alpha|mesh-list
102309792|NCT04781647|Entecavir|entecavir|mesh-list
102309793|NCT04781647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102309794|NCT04781647|Antiviral Agents|antiviral agents|mesh-ancestor
102309795|NCT04781647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102309796|NCT04781647|Immunologic Factors|immunologic factors|mesh-ancestor
102309797|NCT04781647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309798|NCT05259787|Propofol|propofol|mesh-list
102309799|NCT05259787|Etomidate|etomidate|mesh-list
102309800|NCT05259787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102309801|NCT05259787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102309802|NCT05259787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309803|NCT05259787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102309804|NCT05259787|Anesthetics, General|anesthetics, general|mesh-ancestor
102309805|NCT05259787|Anesthetics|anesthetics|mesh-ancestor
102309806|NCT03565159|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102309807|NCT03565159|Immunologic Factors|immunologic factors|mesh-ancestor
102309808|NCT03565159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309809|NCT01756456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102309810|NCT01756456|Mitogens|mitogens|mesh-list
102309811|NCT01756456|Mitosis Modulators|mitosis modulators|mesh-ancestor
102309812|NCT01756456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309813|NCT05226325|Dexmedetomidine|dexmedetomidine|mesh-list
102309814|NCT05226325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102309815|NCT05226325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102309816|NCT05226325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309817|NCT05226325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102309818|NCT05226325|Analgesics|analgesics|mesh-ancestor
102309819|NCT05226325|Sensory System Agents|sensory system agents|mesh-ancestor
102309820|NCT05226325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102309821|NCT05226325|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102309822|NCT05226325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102309823|NCT05226325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102309824|NCT05226325|Adrenergic Agents|adrenergic agents|mesh-ancestor
102309825|NCT05226325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102309826|NCT05226325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309827|NCT05221021|Mirabegron|mirabegron|mesh-list
102309828|NCT05221021|Estradiol|estradiol|mesh-list
102309829|NCT05221021|Estrogens|estrogens|mesh-list
102309830|NCT05221021|Hormones|hormones|mesh-ancestor
102309831|NCT05221021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102309832|NCT05221021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309833|NCT05221021|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102309834|NCT05221021|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102309835|NCT05221021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102309836|NCT05221021|Adrenergic Agents|adrenergic agents|mesh-ancestor
102309837|NCT05221021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102309838|NCT05221021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309839|NCT05221021|Urological Agents|urological agents|mesh-ancestor
102309840|NCT03167437|Vorinostat|vorinostat|mesh-list
102309841|NCT03167437|Ustekinumab|ustekinumab|mesh-list
102309843|NCT03167437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102309844|NCT03167437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102309845|NCT03167437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309846|NCT03167437|Dermatologic Agents|dermatologic agents|mesh-ancestor
102309847|NCT03164473|Rituximab|rituximab|mesh-list
102309848|NCT03164473|Azathioprine|azathioprine|mesh-list
102309849|NCT03164473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102309850|NCT03164473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102309851|NCT03164473|Immunologic Factors|immunologic factors|mesh-ancestor
102309852|NCT03164473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309853|NCT03164473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102309854|NCT03164473|Antimetabolites|antimetabolites|mesh-ancestor
102309855|NCT03164473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309857|NCT03164473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102309858|NCT05218915|Dulaglutide|dulaglutide|mesh-list
102309859|NCT05218915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102309860|NCT05218915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309861|NCT01995201|Methotrexate|methotrexate|mesh-list
102309862|NCT01995201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102309863|NCT01995201|Abortifacient Agents|abortifacient agents|mesh-ancestor
102309864|NCT01995201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102309865|NCT01995201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309866|NCT01995201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102309867|NCT01995201|Antimetabolites|antimetabolites|mesh-ancestor
102309868|NCT01995201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309869|NCT01995201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102309870|NCT01995201|Dermatologic Agents|dermatologic agents|mesh-ancestor
102309871|NCT01995201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102309872|NCT01995201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102309873|NCT01995201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102309874|NCT01995201|Immunologic Factors|immunologic factors|mesh-ancestor
102309875|NCT01995201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102309876|NCT01995201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102309877|NCT01636687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102309878|NCT01636687|Immunologic Factors|immunologic factors|mesh-ancestor
102309879|NCT01636687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309880|NCT05165641|Anesthetics|anesthetics|mesh-list
102309881|NCT05165641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102309882|NCT05165641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309883|NCT04796467|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102309884|NCT04796467|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102309885|NCT04796467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309886|NCT05814432|Amphotericin B|amphotericin b|mesh-list
102309887|NCT05814432|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102309888|NCT05814432|Amebicides|amebicides|mesh-ancestor
102309889|NCT05814432|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102309890|NCT05814432|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102309891|NCT05814432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102309892|NCT05814432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102309893|NCT05814432|Antifungal Agents|antifungal agents|mesh-ancestor
102309894|NCT05814302|Acetaminophen|acetaminophen|mesh-list
102309895|NCT05814302|Ibuprofen|ibuprofen|mesh-list
102309896|NCT05814302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102309897|NCT05814302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102309898|NCT05814302|Analgesics|analgesics|mesh-ancestor
102309899|NCT05814302|Sensory System Agents|sensory system agents|mesh-ancestor
102309900|NCT05814302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102309901|NCT05814302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309902|NCT05814302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102309903|NCT05814302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102309904|NCT05814302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102309905|NCT05814302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102309906|NCT05814302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309907|NCT05814302|Antipyretics|antipyretics|mesh-ancestor
102309908|NCT05814159|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102309909|NCT05814159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102309910|NCT05814068|Antihypertensive Agents|antihypertensive agents|mesh-list
102309911|NCT05813951|Linezolid|linezolid|mesh-list
102309912|NCT05813951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102309913|NCT05813951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102309914|NCT05813951|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102309915|NCT05813951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102309916|NCT05813951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309917|NCT05813821|Anti-Infective Agents|anti-infective agents|mesh-list
102309918|NCT05813821|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102309919|NCT05813691|Antibodies|antibodies|mesh-list
102309920|NCT05813691|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
102309921|NCT05813691|Immunologic Factors|immunologic factors|mesh-ancestor
102309922|NCT05813691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309923|NCT05813665|Denosumab|denosumab|mesh-list
102309924|NCT05813665|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102309925|NCT05813665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309926|NCT05813600|Ritonavir|ritonavir|mesh-list
102309927|NCT05813600|Nirmatrelvir|nirmatrelvir|mesh-list
102309928|NCT05813600|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
102309929|NCT05813600|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102309930|NCT05813600|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102309931|NCT05813600|Protease Inhibitors|protease inhibitors|mesh-ancestor
102309932|NCT05813600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102309933|NCT05813600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309934|NCT05813600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102309935|NCT05813600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102309936|NCT05813600|Antiviral Agents|antiviral agents|mesh-ancestor
102309937|NCT05813600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102309938|NCT05813600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102309939|NCT05813600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102309940|NCT05813561|Fexuprazan|fexuprazan|mesh-list
102309941|NCT05813561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102309942|NCT05813522|Aflutinib|aflutinib|mesh-list
102309943|NCT05813522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102309944|NCT05813522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102309945|NCT05813522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309946|NCT05813496|Thioctic Acid|thioctic acid|mesh-list
102309947|NCT05813496|Antioxidants|antioxidants|mesh-ancestor
102309948|NCT05813496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309949|NCT05813496|Protective Agents|protective agents|mesh-ancestor
102309950|NCT05813496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309951|NCT05813496|Vitamin B Complex|vitamin b complex|mesh-ancestor
102309952|NCT05813496|Vitamins|vitamins|mesh-ancestor
102309953|NCT05813496|Micronutrients|micronutrients|mesh-ancestor
102309954|NCT05813470|Omalizumab|omalizumab|mesh-list
102309955|NCT05813470|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102309956|NCT05813470|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102309957|NCT05813470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102309958|NCT05813470|Respiratory System Agents|respiratory system agents|mesh-ancestor
102309959|NCT05813470|Immunologic Factors|immunologic factors|mesh-ancestor
102309960|NCT05813470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309961|NCT05813405|Antihypertensive Agents|antihypertensive agents|mesh-list
102309962|NCT05813366|Vitamin B 6|vitamin b 6|mesh-list
102309963|NCT05813366|Pyridoxal|pyridoxal|mesh-list
102309964|NCT05813366|Pyridoxine|pyridoxine|mesh-list
102309965|NCT05813366|Tryptophan|tryptophan|mesh-list
102309966|NCT05813366|Vitamins|vitamins|mesh-ancestor
102309967|NCT05813366|Micronutrients|micronutrients|mesh-ancestor
102309968|NCT05813366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309969|NCT05813366|Vitamin B Complex|vitamin b complex|mesh-ancestor
102309970|NCT05813366|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102309971|NCT05813366|Antidepressive Agents|antidepressive agents|mesh-ancestor
102309972|NCT05813366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102309973|NCT05813314|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
102309974|NCT05813314|Natriuretic Agents|natriuretic agents|mesh-ancestor
102309975|NCT05813314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309976|NCT05813249|Tocopherols|tocopherols|mesh-list
102309977|NCT05813249|Vitamin E|vitamin e|mesh-list
102309978|NCT05813249|Tocotrienols|tocotrienols|mesh-list
102309979|NCT05813249|alpha-Tocopherol|alpha-tocopherol|mesh-list
102309980|NCT05813249|Antioxidants|antioxidants|mesh-ancestor
102309981|NCT05813249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309982|NCT05813249|Protective Agents|protective agents|mesh-ancestor
102309983|NCT05813249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102309984|NCT05813249|Vitamins|vitamins|mesh-ancestor
102309985|NCT05813249|Micronutrients|micronutrients|mesh-ancestor
102309986|NCT05813184|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102309987|NCT05813184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102309988|NCT05813145|Fenofibrate|fenofibrate|mesh-list
102309989|NCT05813145|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102309990|NCT05813145|Antimetabolites|antimetabolites|mesh-ancestor
102309991|NCT05813145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102309992|NCT05813145|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102309993|NCT05813132|Cytarabine|cytarabine|mesh-list
102309995|NCT05813132|Etoposide|etoposide|mesh-list
102309996|NCT05813132|Etoposide phosphate|etoposide phosphate|mesh-list
102309997|NCT05813132|Melphalan|melphalan|mesh-list
102309998|NCT05813132|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102309999|NCT05813132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310000|NCT05813132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102310001|NCT05813132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102310002|NCT05813132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102310003|NCT05813132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102310004|NCT05813132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310005|NCT05813132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102310006|NCT05813132|Antimetabolites|antimetabolites|mesh-ancestor
102310007|NCT05813132|Antiviral Agents|antiviral agents|mesh-ancestor
102310009|NCT05813132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102310010|NCT05813132|Immunologic Factors|immunologic factors|mesh-ancestor
102310011|NCT05813132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310012|NCT05813132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102310013|NCT05813132|Alkylating Agents|alkylating agents|mesh-ancestor
102310014|NCT05813132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102310015|NCT05813106|Dexmedetomidine|dexmedetomidine|mesh-list
102310016|NCT05813106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102310017|NCT05813106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102310018|NCT05813106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310019|NCT05813106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102310020|NCT05813106|Analgesics|analgesics|mesh-ancestor
102310021|NCT05813106|Sensory System Agents|sensory system agents|mesh-ancestor
102310022|NCT05813106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102310023|NCT05813106|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102310024|NCT05813106|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102310025|NCT05813106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102310026|NCT05813106|Adrenergic Agents|adrenergic agents|mesh-ancestor
102310027|NCT05813106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102310028|NCT05813106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310029|NCT05813015|Docetaxel|docetaxel|mesh-list
102310030|NCT05813015|Tegafur|tegafur|mesh-list
102310031|NCT05813015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310032|NCT05813015|Tubulin Modulators|tubulin modulators|mesh-ancestor
102310033|NCT05813015|Antimitotic Agents|antimitotic agents|mesh-ancestor
102310034|NCT05813015|Mitosis Modulators|mitosis modulators|mesh-ancestor
102310035|NCT05813015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310036|NCT05813015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102310037|NCT05813015|Antimetabolites|antimetabolites|mesh-ancestor
102310038|NCT05811403|Sodium Hypochlorite|sodium hypochlorite|mesh-list
102310039|NCT05811403|Eusol|eusol|mesh-list
102310040|NCT05811403|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
102310041|NCT05811403|Disinfectants|disinfectants|mesh-ancestor
102310042|NCT05811403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102310043|NCT05811403|Antioxidants|antioxidants|mesh-ancestor
102310044|NCT05811403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310045|NCT05811403|Protective Agents|protective agents|mesh-ancestor
102310046|NCT05811403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310047|NCT05811403|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
102310048|NCT05811403|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101426465|NCT02944396|Paclitaxel|paclitaxel|mesh-list
102310049|NCT05811403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310050|NCT05811403|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102310051|NCT05808582|Fulvestrant|fulvestrant|mesh-list
102310052|NCT05808582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102310053|NCT05808582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310054|NCT05808582|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102310055|NCT05808582|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102310056|NCT05808582|Hormone Antagonists|hormone antagonists|mesh-ancestor
102310057|NCT05808582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102310058|NCT05808582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310059|NCT05796804|Anesthetics|anesthetics|mesh-list
102310060|NCT05796804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102310061|NCT05796804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310062|NCT05788874|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102310063|NCT05788874|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102310064|NCT05788874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310065|NCT05788289|Lenalidomide|lenalidomide|mesh-list
102310066|NCT05788289|Immunologic Factors|immunologic factors|mesh-ancestor
102018822|NCT04425863|Analgesics|analgesics|mesh-ancestor
102310067|NCT05788289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310068|NCT05788289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102310069|NCT05788289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102310070|NCT05788289|Growth Substances|growth substances|mesh-ancestor
102310071|NCT05788289|Growth Inhibitors|growth inhibitors|mesh-ancestor
102310072|NCT05788289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310074|NCT05775887|Immunologic Factors|immunologic factors|mesh-ancestor
102310075|NCT05775887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310076|NCT05757388|Acetaminophen|acetaminophen|mesh-list
102310077|NCT05757388|Parecoxib|parecoxib|mesh-list
102310078|NCT05757388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102310079|NCT05757388|Analgesics|analgesics|mesh-ancestor
102310080|NCT05757388|Sensory System Agents|sensory system agents|mesh-ancestor
102310081|NCT05757388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102310082|NCT05757388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310083|NCT05757388|Antipyretics|antipyretics|mesh-ancestor
102310084|NCT05757388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102310085|NCT05757388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102310086|NCT05757388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102310087|NCT05757388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310088|NCT05757388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102310089|NCT05757388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102310090|NCT05757388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102310091|NCT05755334|Ropivacaine|ropivacaine|mesh-list
102310092|NCT05755334|Anesthetics, Local|anesthetics, local|mesh-ancestor
102310093|NCT05755334|Anesthetics|anesthetics|mesh-ancestor
102310094|NCT05755334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102310095|NCT05755334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310096|NCT05755334|Sensory System Agents|sensory system agents|mesh-ancestor
102310097|NCT05755334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102310098|NCT05749393|Heparin|heparin|mesh-list
102310099|NCT05749393|Calcium heparin|calcium heparin|mesh-list
102310100|NCT05749393|Anticoagulants|anticoagulants|mesh-ancestor
102310101|NCT05749393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102310102|NCT05749393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102310103|NCT05749393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310104|NCT05732883|Dexamethasone|dexamethasone|mesh-list
102310105|NCT05732883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102310106|NCT05732883|Antiemetics|antiemetics|mesh-ancestor
102310107|NCT05732883|Autonomic Agents|autonomic agents|mesh-ancestor
102310108|NCT05732883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102310109|NCT05732883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310110|NCT05732883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102310111|NCT05732883|Glucocorticoids|glucocorticoids|mesh-ancestor
102310112|NCT05732883|Hormones|hormones|mesh-ancestor
102310113|NCT05732883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102310114|NCT05732883|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102310115|NCT05732883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310116|NCT05715814|Empagliflozin|empagliflozin|mesh-list
102310117|NCT05715814|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102310118|NCT05715814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310119|NCT05715814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102310120|NCT05715814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310121|NCT05688735|Isosorbide|isosorbide|mesh-list
102310122|NCT05688735|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
102310123|NCT05688735|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
102310124|NCT05688735|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102310125|NCT05688735|Diuretics|diuretics|mesh-ancestor
102310126|NCT05688735|Natriuretic Agents|natriuretic agents|mesh-ancestor
102310127|NCT05688735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310128|NCT05688735|Vasodilator Agents|vasodilator agents|mesh-ancestor
102310129|NCT05688735|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102310130|NCT05688735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310131|NCT05674994|Prednisone|prednisone|mesh-list
102310132|NCT05674994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102310133|NCT05674994|Glucocorticoids|glucocorticoids|mesh-ancestor
102310134|NCT05674994|Hormones|hormones|mesh-ancestor
102310135|NCT05674994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102310136|NCT05674994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310137|NCT05674994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102310138|NCT05674994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310139|NCT05662397|Cemiplimab|cemiplimab|mesh-list
102310140|NCT05662397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102018903|NCT03236584|Tenofovir|tenofovir|mesh-list
102310141|NCT05662397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310142|NCT05627596|Nicotine|nicotine|mesh-list
102310143|NCT05627596|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102310144|NCT05627596|Autonomic Agents|autonomic agents|mesh-ancestor
102310145|NCT05627596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102310146|NCT05627596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310147|NCT05627596|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102310148|NCT05627596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102310149|NCT05627596|Cholinergic Agents|cholinergic agents|mesh-ancestor
102310150|NCT05627596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102310151|NCT05627596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310152|NCT05582798|Protease Inhibitors|protease inhibitors|mesh-list
102310153|NCT05582798|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
102310154|NCT05582798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102310155|NCT05582798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310156|NCT05582798|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102310157|NCT05582798|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102310158|NCT05552196|Carbamazepine|carbamazepine|mesh-list
102310159|NCT05552196|Ponesimod|ponesimod|mesh-list
102310160|NCT05552196|Anticonvulsants|anticonvulsants|mesh-ancestor
102310161|NCT05552196|Antimanic Agents|antimanic agents|mesh-ancestor
102310162|NCT05552196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102310163|NCT05552196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102310164|NCT05552196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310165|NCT05552196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102310166|NCT05552196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102310167|NCT05552196|Analgesics|analgesics|mesh-ancestor
102310168|NCT05552196|Sensory System Agents|sensory system agents|mesh-ancestor
102310169|NCT05552196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102310170|NCT05552196|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102310171|NCT05552196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102310172|NCT05552196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310173|NCT05552196|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102310174|NCT05552196|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102310175|NCT05552196|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102310176|NCT05552196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102310177|NCT05552196|Immunologic Factors|immunologic factors|mesh-ancestor
102310178|NCT05538247|Indomethacin|indomethacin|mesh-list
102310179|NCT05538247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102310180|NCT05538247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102310181|NCT05538247|Analgesics|analgesics|mesh-ancestor
102310182|NCT05538247|Sensory System Agents|sensory system agents|mesh-ancestor
102310183|NCT05538247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102310184|NCT05538247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310185|NCT05538247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102310186|NCT05538247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102310187|NCT05538247|Gout Suppressants|gout suppressants|mesh-ancestor
102310188|NCT05538247|Tocolytic Agents|tocolytic agents|mesh-ancestor
102310189|NCT05538247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102310190|NCT05538247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102310191|NCT05538247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102310192|NCT05538247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310193|NCT05536414|Escitalopram|escitalopram|mesh-list
102310194|NCT05536414|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102310195|NCT05536414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102310196|NCT05536414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102310197|NCT05536414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310198|NCT05536414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102310199|NCT05536414|Serotonin Agents|serotonin agents|mesh-ancestor
102310200|NCT05536414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310201|NCT05496192|Nivolumab|nivolumab|mesh-list
102310202|NCT05496192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102310203|NCT05496192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310204|NCT05496192|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102310205|NCT05496192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310206|NCT05472623|Nivolumab|nivolumab|mesh-list
102310207|NCT05472623|Adagrasib|adagrasib|mesh-list
102310208|NCT05472623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102310209|NCT05472623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310210|NCT05472623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102310211|NCT05472623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310212|NCT05438394|Melphalan|melphalan|mesh-list
102018977|NCT04234464|Budesonide|budesonide|mesh-list
102310213|NCT05438394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102310214|NCT05438394|Alkylating Agents|alkylating agents|mesh-ancestor
102310215|NCT05438394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310216|NCT05438394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310217|NCT05438394|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102310218|NCT05438394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102310219|NCT05438394|Immunologic Factors|immunologic factors|mesh-ancestor
102310220|NCT05438394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310221|NCT05386030|Lidocaine|lidocaine|mesh-list
102310222|NCT05386030|Anesthetics, Local|anesthetics, local|mesh-ancestor
102310223|NCT05386030|Anesthetics|anesthetics|mesh-ancestor
102310224|NCT05386030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102310225|NCT05386030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310226|NCT05386030|Sensory System Agents|sensory system agents|mesh-ancestor
102310227|NCT05386030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102310228|NCT05386030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102310229|NCT05386030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102310230|NCT05386030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102310231|NCT05386030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102310232|NCT05386030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310234|NCT05287568|Cc-486|cc-486|mesh-list
102310235|NCT05287568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310236|NCT05287191|Magnesium Sulfate|magnesium sulfate|mesh-list
102310237|NCT05287191|Digoxin|digoxin|mesh-list
102310238|NCT05287191|Amiodarone|amiodarone|mesh-list
102310239|NCT05287191|Analgesics|analgesics|mesh-ancestor
102310240|NCT05287191|Sensory System Agents|sensory system agents|mesh-ancestor
102310241|NCT05287191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102310242|NCT05287191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310243|NCT05287191|Anesthetics|anesthetics|mesh-ancestor
102310244|NCT05287191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102310245|NCT05287191|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102310246|NCT05287191|Anticonvulsants|anticonvulsants|mesh-ancestor
102310247|NCT05287191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102310248|NCT05287191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102310249|NCT05287191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310250|NCT05287191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102310251|NCT05287191|Tocolytic Agents|tocolytic agents|mesh-ancestor
102310252|NCT05287191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102310253|NCT05287191|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102310254|NCT05287191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102310255|NCT05287191|Protective Agents|protective agents|mesh-ancestor
102310256|NCT05287191|Vasodilator Agents|vasodilator agents|mesh-ancestor
102310257|NCT05287191|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102310258|NCT05287191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102310259|NCT05287191|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102310260|NCT05287191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102310261|NCT05287191|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102310262|NCT05287191|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102310263|NCT05287191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102310264|NCT05259046|Vitamin K 2|vitamin k 2|mesh-list
102310265|NCT05259046|Vitamin K|vitamin k|mesh-list
102310266|NCT05259046|Menaquinone 7|menaquinone 7|mesh-list
102310267|NCT05259046|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102310268|NCT05259046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102310269|NCT05259046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310270|NCT05259046|Hemostatics|hemostatics|mesh-ancestor
102310271|NCT05259046|Coagulants|coagulants|mesh-ancestor
102310272|NCT05259046|Vitamins|vitamins|mesh-ancestor
102310273|NCT05259046|Micronutrients|micronutrients|mesh-ancestor
102310274|NCT05259046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310275|NCT05206682|Leuprolide|leuprolide|mesh-list
102310276|NCT05206682|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102310277|NCT05206682|Fertility Agents|fertility agents|mesh-ancestor
102310278|NCT05206682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102310279|NCT05206682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310280|NCT05206682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102310281|NCT05206682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310282|NCT05197842|Prednisone|prednisone|mesh-list
102310283|NCT05197842|Cyclophosphamide|cyclophosphamide|mesh-list
102310284|NCT05197842|Glucocorticoids|glucocorticoids|mesh-list
102310285|NCT05197842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102310286|NCT05197842|Immunologic Factors|immunologic factors|mesh-ancestor
102310287|NCT05197842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310288|NCT05197842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102310289|NCT05197842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102310290|NCT05197842|Alkylating Agents|alkylating agents|mesh-ancestor
102310291|NCT05197842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310292|NCT05197842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310293|NCT05197842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102310294|NCT05197842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102310295|NCT05197842|Hormones|hormones|mesh-ancestor
102310296|NCT05197842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102310297|NCT05197842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102310298|NCT05189457|Docetaxel|docetaxel|mesh-list
102310299|NCT05189457|Tislelizumab|tislelizumab|mesh-list
102310300|NCT05189457|Leuprolide|leuprolide|mesh-list
102310301|NCT05189457|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102310302|NCT05189457|Hormones|hormones|mesh-list
102310303|NCT05189457|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
102310304|NCT05189457|Relugolix|relugolix|mesh-list
102310305|NCT05189457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310306|NCT05189457|Tubulin Modulators|tubulin modulators|mesh-ancestor
102310307|NCT05189457|Antimitotic Agents|antimitotic agents|mesh-ancestor
102310308|NCT05189457|Mitosis Modulators|mitosis modulators|mesh-ancestor
102310309|NCT05189457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310310|NCT05189457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102310311|NCT05189457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310312|NCT05189457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102310313|NCT05189457|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102310314|NCT05189457|Fertility Agents|fertility agents|mesh-ancestor
102310315|NCT05189457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102310316|NCT05189457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102310317|NCT05189457|Luteolytic Agents|luteolytic agents|mesh-ancestor
102310318|NCT05189457|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102310319|NCT05189457|Contraceptive Agents|contraceptive agents|mesh-ancestor
102310320|NCT05189457|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102310321|NCT05189457|Androgen Antagonists|androgen antagonists|mesh-ancestor
102310322|NCT05189457|Hormone Antagonists|hormone antagonists|mesh-ancestor
102310323|NCT05129748|Sodium thiosulfate|sodium thiosulfate|mesh-list
102310324|NCT05129748|Mannitol|mannitol|mesh-list
102310325|NCT05129748|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102310326|NCT05129748|Diuretics|diuretics|mesh-ancestor
102310327|NCT05129748|Natriuretic Agents|natriuretic agents|mesh-ancestor
102310328|NCT05129748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310329|NCT05129748|Antidotes|antidotes|mesh-ancestor
102310330|NCT05129748|Protective Agents|protective agents|mesh-ancestor
102310331|NCT05129748|Antioxidants|antioxidants|mesh-ancestor
102310332|NCT05129748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310333|NCT05129748|Antitubercular Agents|antitubercular agents|mesh-ancestor
102310334|NCT05129748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102310335|NCT05129748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102310336|NCT05129748|Chelating Agents|chelating agents|mesh-ancestor
102310337|NCT05129748|Sequestering Agents|sequestering agents|mesh-ancestor
102310338|NCT05127746|Donepezil|donepezil|mesh-list
102310339|NCT05127746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102310340|NCT05127746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102310341|NCT05127746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310342|NCT05127746|Cholinergic Agents|cholinergic agents|mesh-ancestor
102310343|NCT05127746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102310344|NCT05127746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310345|NCT05127746|Nootropic Agents|nootropic agents|mesh-ancestor
102310346|NCT05054998|Deoxyglucose|deoxyglucose|mesh-list
102310347|NCT05054998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102310348|NCT05054998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102310349|NCT05054998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310350|NCT05054998|Antimetabolites|antimetabolites|mesh-ancestor
102310351|NCT05054998|Antiviral Agents|antiviral agents|mesh-ancestor
102310352|NCT05054998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102310353|NCT05024552|Cytarabine|cytarabine|mesh-list
102310354|NCT05024552|Daunorubicin|daunorubicin|mesh-list
102310355|NCT05024552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102310356|NCT05024552|Antimetabolites|antimetabolites|mesh-ancestor
102310357|NCT05024552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310358|NCT05024552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310359|NCT05024552|Antiviral Agents|antiviral agents|mesh-ancestor
102310360|NCT05024552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102019125|NCT03228238|Antimetabolites|antimetabolites|mesh-ancestor
102310361|NCT05024552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102310362|NCT05024552|Immunologic Factors|immunologic factors|mesh-ancestor
102310363|NCT05024552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310364|NCT05024552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102310365|NCT05024552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102310366|NCT05024552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102310367|NCT05024552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102310369|NCT05004662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102310370|NCT05004662|Autonomic Agents|autonomic agents|mesh-ancestor
102310371|NCT05004662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102310372|NCT05004662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310373|NCT05004662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102310374|NCT05004662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102310375|NCT05004662|Cholinergic Agents|cholinergic agents|mesh-ancestor
102310376|NCT05004662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102310377|NCT05004662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310378|NCT04933084|Analgesics, Opioid|analgesics, opioid|mesh-list
102310379|NCT04933084|Narcotics|narcotics|mesh-ancestor
102310380|NCT04933084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102310381|NCT04933084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310382|NCT04933084|Analgesics|analgesics|mesh-ancestor
102310383|NCT04933084|Sensory System Agents|sensory system agents|mesh-ancestor
102310384|NCT04933084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102310385|NCT04930887|Bupivacaine|bupivacaine|mesh-list
102310386|NCT04930887|Anesthetics, Local|anesthetics, local|mesh-ancestor
102310387|NCT04930887|Anesthetics|anesthetics|mesh-ancestor
102310388|NCT04930887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102310389|NCT04930887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310390|NCT04930887|Sensory System Agents|sensory system agents|mesh-ancestor
102310391|NCT04930887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102310392|NCT04863248|Docetaxel|docetaxel|mesh-list
102310393|NCT04863248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310394|NCT04863248|Tubulin Modulators|tubulin modulators|mesh-ancestor
102310395|NCT04863248|Antimitotic Agents|antimitotic agents|mesh-ancestor
102310396|NCT04863248|Mitosis Modulators|mitosis modulators|mesh-ancestor
102310397|NCT04863248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310398|NCT04815902|Losartan|losartan|mesh-list
102310399|NCT04815902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102310400|NCT04815902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102310401|NCT04815902|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102310402|NCT04815902|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102310403|NCT04815902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310404|NCT04807140|Paclitaxel|paclitaxel|mesh-list
102310405|NCT04807140|Carboplatin|carboplatin|mesh-list
102310406|NCT04807140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102310407|NCT04807140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310408|NCT04807140|Tubulin Modulators|tubulin modulators|mesh-ancestor
102310409|NCT04807140|Antimitotic Agents|antimitotic agents|mesh-ancestor
102310410|NCT04807140|Mitosis Modulators|mitosis modulators|mesh-ancestor
102310411|NCT04807140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310412|NCT04759248|Trastuzumab|trastuzumab|mesh-list
102310413|NCT04759248|Atezolizumab|atezolizumab|mesh-list
102310414|NCT04759248|Vinorelbine|vinorelbine|mesh-list
102310415|NCT04759248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102310416|NCT04759248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310417|NCT04759248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102310418|NCT04759248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310419|NCT04759248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102310420|NCT04759248|Tubulin Modulators|tubulin modulators|mesh-ancestor
102310421|NCT04759248|Antimitotic Agents|antimitotic agents|mesh-ancestor
102310422|NCT04759248|Mitosis Modulators|mitosis modulators|mesh-ancestor
102310423|NCT04756726|Dexamethasone|dexamethasone|mesh-list
102310424|NCT04756726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102310425|NCT04756726|Antiemetics|antiemetics|mesh-ancestor
102310426|NCT04756726|Autonomic Agents|autonomic agents|mesh-ancestor
102310427|NCT04756726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102310428|NCT04756726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310429|NCT04756726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102310430|NCT04756726|Glucocorticoids|glucocorticoids|mesh-ancestor
102310431|NCT04756726|Hormones|hormones|mesh-ancestor
102310432|NCT04756726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102310433|NCT04756726|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102310434|NCT04756726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310435|NCT04704505|Androgens|androgens|mesh-list
102019199|NCT00238420|Paclitaxel|paclitaxel|mesh-list
102310436|NCT04704505|Hormones|hormones|mesh-ancestor
102310437|NCT04704505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102310438|NCT04704505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310439|NCT04558918|Eculizumab|eculizumab|mesh-list
102310440|NCT04558918|Ravulizumab|ravulizumab|mesh-list
102310441|NCT04558918|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102310442|NCT04558918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102310443|NCT04558918|Immunologic Factors|immunologic factors|mesh-ancestor
102310444|NCT04558918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310445|NCT04529278|Liraglutide|liraglutide|mesh-list
102310446|NCT04529278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102310447|NCT04529278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310448|NCT04529278|Incretins|incretins|mesh-ancestor
102310449|NCT04529278|Hormones|hormones|mesh-ancestor
101652293|NCT02551861|Sofosbuvir|sofosbuvir|mesh-list
102310450|NCT04529278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102310452|NCT04526730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102310453|NCT04526730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310454|NCT04526730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102310455|NCT04526730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310456|NCT04503148|Propofol|propofol|mesh-list
102310457|NCT04503148|Anesthetics|anesthetics|mesh-list
102310458|NCT04503148|Anesthetics, General|anesthetics, general|mesh-list
102310459|NCT04503148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
102310460|NCT04503148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102310461|NCT04503148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102310462|NCT04503148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310463|NCT04503148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102310464|NCT04498832|Vaccines|vaccines|mesh-list
102310465|NCT04498832|Immunologic Factors|immunologic factors|mesh-ancestor
102310466|NCT04498832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310467|NCT04493203|Nivolumab|nivolumab|mesh-list
102310468|NCT04493203|Axitinib|axitinib|mesh-list
102310469|NCT04493203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102310470|NCT04493203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310471|NCT04493203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102310472|NCT04493203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310473|NCT04493203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102310474|NCT04493203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102310475|NCT04429516|Morphine|morphine|mesh-list
102310476|NCT04429516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102310477|NCT04429516|Narcotics|narcotics|mesh-ancestor
102310478|NCT04429516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102310479|NCT04429516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310480|NCT04429516|Analgesics|analgesics|mesh-ancestor
102310481|NCT04429516|Sensory System Agents|sensory system agents|mesh-ancestor
102310482|NCT04429516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102310483|NCT04417452|Adrenergic Agents|adrenergic agents|mesh-list
102310484|NCT04417452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102310485|NCT04417452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310486|NCT04417452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310487|NCT04412096|Timolol|timolol|mesh-list
102310488|NCT04412096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102310489|NCT04412096|Latanoprost|latanoprost|mesh-list
102310490|NCT04412096|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102310491|NCT04412096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102310492|NCT04412096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102310493|NCT04412096|Adrenergic Agents|adrenergic agents|mesh-ancestor
102310494|NCT04412096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102310495|NCT04412096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310496|NCT04412096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310497|NCT04412096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102310498|NCT04412096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102310499|NCT04405167|Dexamethasone|dexamethasone|mesh-list
102310500|NCT04405167|Lenalidomide|lenalidomide|mesh-list
102310501|NCT04405167|Ixazomib|ixazomib|mesh-list
102310502|NCT04405167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102310503|NCT04405167|Antiemetics|antiemetics|mesh-ancestor
102310504|NCT04405167|Autonomic Agents|autonomic agents|mesh-ancestor
102310505|NCT04405167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102310506|NCT04405167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310507|NCT04405167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102310508|NCT04405167|Glucocorticoids|glucocorticoids|mesh-ancestor
102310509|NCT04405167|Hormones|hormones|mesh-ancestor
102310510|NCT04405167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102310511|NCT04405167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102310512|NCT04405167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310513|NCT04405167|Protease Inhibitors|protease inhibitors|mesh-ancestor
102310514|NCT04405167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102310515|NCT04405167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310516|NCT04405167|Immunologic Factors|immunologic factors|mesh-ancestor
102310517|NCT04405167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102310518|NCT04405167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102310519|NCT04405167|Growth Substances|growth substances|mesh-ancestor
102310520|NCT04405167|Growth Inhibitors|growth inhibitors|mesh-ancestor
102310522|NCT04388852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102310523|NCT04388852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101652374|NCT00652327|Atorvastatin|atorvastatin|mesh-list
102310524|NCT04388852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102310525|NCT04388852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310526|NCT04357951|Cycloserine|cycloserine|mesh-list
102310527|NCT04357951|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102310528|NCT04357951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102310529|NCT04357951|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102310530|NCT04357951|Antitubercular Agents|antitubercular agents|mesh-ancestor
102310531|NCT04357951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102310532|NCT04357951|Antimetabolites|antimetabolites|mesh-ancestor
102310533|NCT04357951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310534|NCT04285229|Ixekizumab|ixekizumab|mesh-list
102310535|NCT04285229|Dermatologic Agents|dermatologic agents|mesh-ancestor
102310536|NCT04282668|Tretinoin|tretinoin|mesh-list
102310537|NCT04282668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310538|NCT04282668|Keratolytic Agents|keratolytic agents|mesh-ancestor
102310539|NCT04282668|Dermatologic Agents|dermatologic agents|mesh-ancestor
102310540|NCT04259060|Hydroxocobalamin|hydroxocobalamin|mesh-list
102310541|NCT04259060|Vitamin B 12|vitamin b 12|mesh-list
102310542|NCT04259060|Hematinics|hematinics|mesh-ancestor
102310543|NCT04259060|Vitamin B Complex|vitamin b complex|mesh-ancestor
102310544|NCT04259060|Vitamins|vitamins|mesh-ancestor
102310545|NCT04259060|Micronutrients|micronutrients|mesh-ancestor
102310546|NCT04259060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310547|NCT04219904|Deoxyglucose|deoxyglucose|mesh-list
102310548|NCT04219904|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102310549|NCT04219904|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102310550|NCT04219904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310551|NCT04219904|Antimetabolites|antimetabolites|mesh-ancestor
102310552|NCT04219904|Antiviral Agents|antiviral agents|mesh-ancestor
102310553|NCT04219904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102310554|NCT04218240|Lofexidine|lofexidine|mesh-list
102310555|NCT04218240|Pregabalin|pregabalin|mesh-list
102310556|NCT04218240|Analgesics|analgesics|mesh-ancestor
102310557|NCT04218240|Sensory System Agents|sensory system agents|mesh-ancestor
102310558|NCT04218240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102310559|NCT04218240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310560|NCT04218240|Anticonvulsants|anticonvulsants|mesh-ancestor
102310561|NCT04218240|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102310562|NCT04218240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102310563|NCT04218240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310564|NCT04218240|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102310565|NCT04218240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102310566|NCT04218240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102310567|NCT04218240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102310568|NCT04218240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102310569|NCT04218240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102310570|NCT04218240|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102310571|NCT04218240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102310572|NCT04218240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102310573|NCT04218240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102310574|NCT04218240|Adrenergic Agents|adrenergic agents|mesh-ancestor
102310575|NCT04218240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102310576|NCT04212793|Bevacizumab|bevacizumab|mesh-list
102310577|NCT04212793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102310578|NCT04212793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310579|NCT04212793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102310580|NCT04212793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102310581|NCT04212793|Growth Substances|growth substances|mesh-ancestor
102310582|NCT04212793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310583|NCT04212793|Growth Inhibitors|growth inhibitors|mesh-ancestor
102310584|NCT04084951|Nivolumab|nivolumab|mesh-list
102310585|NCT04084951|Ipilimumab|ipilimumab|mesh-list
102310586|NCT04084951|Atezolizumab|atezolizumab|mesh-list
102310587|NCT04084951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102310588|NCT04084951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310589|NCT04084951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102310590|NCT04084951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310591|NCT04083898|Prednisone|prednisone|mesh-list
102310592|NCT04083898|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102310593|NCT04083898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102310594|NCT04083898|Glucocorticoids|glucocorticoids|mesh-ancestor
102310595|NCT04083898|Hormones|hormones|mesh-ancestor
102310596|NCT04083898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102310597|NCT04083898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310598|NCT04083898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102310599|NCT04083898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310600|NCT04083898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102310601|NCT04083898|Alkylating Agents|alkylating agents|mesh-ancestor
102310602|NCT04083898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310604|NCT04035837|Interferon-alpha|interferon-alpha|mesh-list
102310605|NCT04035837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310606|NCT04035837|Antiviral Agents|antiviral agents|mesh-ancestor
102310607|NCT04035837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102310608|NCT04035837|Immunologic Factors|immunologic factors|mesh-ancestor
102310609|NCT04035837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310610|NCT04023227|Valsartan|valsartan|mesh-list
102310611|NCT04023227|Enalapril|enalapril|mesh-list
102310612|NCT04023227|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102310613|NCT04023227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102310614|NCT04023227|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102310615|NCT04023227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102310616|NCT04023227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310617|NCT04023227|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102310618|NCT04023227|Protease Inhibitors|protease inhibitors|mesh-ancestor
102310619|NCT04023227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102310620|NCT04022135|Folic Acid|folic acid|mesh-list
102310621|NCT04022135|Hematinics|hematinics|mesh-ancestor
102310622|NCT04022135|Vitamin B Complex|vitamin b complex|mesh-ancestor
102310623|NCT04022135|Vitamins|vitamins|mesh-ancestor
102310624|NCT04022135|Micronutrients|micronutrients|mesh-ancestor
102310625|NCT04022135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310626|NCT04001777|Osimertinib|osimertinib|mesh-list
102310627|NCT04001777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310628|NCT04001777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102310629|NCT04001777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102310630|NCT04001777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310631|NCT03987802|Insulin Aspart|insulin aspart|mesh-list
102310632|NCT03987802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102310633|NCT03987802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310634|NCT03983668|Pembrolizumab|pembrolizumab|mesh-list
102310635|NCT03983668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102310636|NCT03983668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310637|NCT03983668|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102310638|NCT03983668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310639|NCT03977012|Buprenorphine|buprenorphine|mesh-list
102310640|NCT03977012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102310641|NCT03977012|Narcotics|narcotics|mesh-ancestor
102310642|NCT03977012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102310643|NCT03977012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310644|NCT03977012|Analgesics|analgesics|mesh-ancestor
102310645|NCT03977012|Sensory System Agents|sensory system agents|mesh-ancestor
102310646|NCT03977012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102310647|NCT03977012|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102310648|NCT03915964|Adalimumab|adalimumab|mesh-list
102310649|NCT03915964|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
102310650|NCT03915964|Etanercept|etanercept|mesh-list
102310651|NCT03915964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102310652|NCT03915964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102310653|NCT03915964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102310654|NCT03915964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102310655|NCT03915964|Analgesics|analgesics|mesh-ancestor
102310656|NCT03915964|Sensory System Agents|sensory system agents|mesh-ancestor
102310657|NCT03915964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102310658|NCT03915964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310659|NCT03915964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102310660|NCT03915964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102310661|NCT03915964|Immunologic Factors|immunologic factors|mesh-ancestor
102310663|NCT03907423|Glimepiride|glimepiride|mesh-list
102310664|NCT03907423|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102310665|NCT03907423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102310666|NCT03907423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310667|NCT03907423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102310668|NCT03907423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102310669|NCT03907423|Antimetabolites|antimetabolites|mesh-ancestor
102310670|NCT03907423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310671|NCT03907423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102310672|NCT03907423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102310673|NCT03907423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102310674|NCT03907423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102310675|NCT03907423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102310676|NCT03907423|Immunologic Factors|immunologic factors|mesh-ancestor
102310677|NCT03897621|Tranexamic Acid|tranexamic acid|mesh-list
102310678|NCT03897621|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102310679|NCT03897621|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102310680|NCT03897621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310681|NCT03897621|Hemostatics|hemostatics|mesh-ancestor
102310682|NCT03897621|Coagulants|coagulants|mesh-ancestor
102310683|NCT03809884|Potassium Citrate|potassium citrate|mesh-list
102310684|NCT03809884|Diuretics|diuretics|mesh-ancestor
102310685|NCT03809884|Natriuretic Agents|natriuretic agents|mesh-ancestor
102310686|NCT03809884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310687|NCT03809884|Expectorants|expectorants|mesh-ancestor
102310688|NCT03809884|Respiratory System Agents|respiratory system agents|mesh-ancestor
102310689|NCT03805594|Pembrolizumab|pembrolizumab|mesh-list
102310690|NCT03805594|177Lu-PSMA-617|177lu-psma-617|mesh-list
102310691|NCT03805594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102310692|NCT03805594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310693|NCT03805594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102310694|NCT03805594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310695|NCT03805594|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102310696|NCT03768427|Atorvastatin|atorvastatin|mesh-list
102310697|NCT03768427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102310698|NCT03768427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102310699|NCT03768427|Antimetabolites|antimetabolites|mesh-ancestor
102310700|NCT03768427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310701|NCT03768427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102310702|NCT03768427|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102310703|NCT03768427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102310704|NCT03758781|Nivolumab|nivolumab|mesh-list
102310705|NCT03758781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102310706|NCT03758781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310707|NCT03758781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102310708|NCT03758781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310709|NCT03746080|Plerixafor|plerixafor|mesh-list
102310710|NCT03746080|Temozolomide|temozolomide|mesh-list
102310711|NCT03746080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102310712|NCT03746080|Alkylating Agents|alkylating agents|mesh-ancestor
102310713|NCT03746080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310714|NCT03746080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310715|NCT03746080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102310716|NCT03746080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102310717|NCT03746080|Antiviral Agents|antiviral agents|mesh-ancestor
102310718|NCT03746080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102310719|NCT03737994|Cisplatin|cisplatin|mesh-list
102310720|NCT03737994|Carboplatin|carboplatin|mesh-list
102310721|NCT03737994|Pemetrexed|pemetrexed|mesh-list
102310722|NCT03737994|Crizotinib|crizotinib|mesh-list
102310723|NCT03737994|Ceritinib|ceritinib|mesh-list
102310724|NCT03737994|Ensartinib|ensartinib|mesh-list
102310725|NCT03737994|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102310726|NCT03737994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310727|NCT03737994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102310728|NCT03737994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310729|NCT03737994|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102310730|NCT03737994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102310731|NCT03737994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102310732|NCT03724149|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102310733|NCT03724149|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
102310734|NCT03724149|Antiviral Agents|antiviral agents|mesh-ancestor
102310735|NCT03724149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102310736|NCT03598309|Curcumin|curcumin|mesh-list
102310737|NCT03598309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102310738|NCT03598309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102310739|NCT03598309|Analgesics|analgesics|mesh-ancestor
102310740|NCT03598309|Sensory System Agents|sensory system agents|mesh-ancestor
102310741|NCT03598309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102310742|NCT03598309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310743|NCT03598309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102310744|NCT03598309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102310745|NCT03598309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310746|NCT03598309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101427182|NCT00169572|Ondansetron|ondansetron|mesh-list
102310747|NCT03598309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310748|NCT03572933|Pregnanolone|pregnanolone|mesh-list
102310749|NCT03572933|Ganaxolone|ganaxolone|mesh-list
102310751|NCT03572933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102310752|NCT03572933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310753|NCT03572933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310754|NCT03572933|GABA Modulators|gaba modulators|mesh-ancestor
102310755|NCT03572933|GABA Agents|gaba agents|mesh-ancestor
102310756|NCT03572933|Anesthetics|anesthetics|mesh-ancestor
102310757|NCT03572933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102310758|NCT03558152|Vedolizumab|vedolizumab|mesh-list
102310759|NCT03558152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102310760|NCT03511196|Prednisone|prednisone|mesh-list
102310761|NCT03511196|Glucocorticoids|glucocorticoids|mesh-list
102310762|NCT03511196|Androgens|androgens|mesh-list
102310763|NCT03511196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102310764|NCT03511196|Hormones|hormones|mesh-ancestor
102310765|NCT03511196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102310766|NCT03511196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310767|NCT03511196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102310768|NCT03511196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310769|NCT03502668|Decitabine|decitabine|mesh-list
102310770|NCT03502668|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
102310771|NCT03502668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102310772|NCT03502668|Antimetabolites|antimetabolites|mesh-ancestor
102310773|NCT03502668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310774|NCT03502668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310775|NCT03502668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102310776|NCT03501368|Trametinib|trametinib|mesh-list
102310777|NCT03501368|Ceritinib|ceritinib|mesh-list
102310778|NCT03501368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310779|NCT03501368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102310780|NCT03501368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102310781|NCT03501368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310782|NCT03477175|Sorafenib|sorafenib|mesh-list
102310783|NCT03477175|Lenvatinib|lenvatinib|mesh-list
102310784|NCT03477175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310785|NCT03477175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102310786|NCT03477175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102310787|NCT03477175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310788|NCT03461406|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102310789|NCT03461406|Hemostatics|hemostatics|mesh-ancestor
102310790|NCT03461406|Coagulants|coagulants|mesh-ancestor
102310791|NCT03431974|Aminopterin|aminopterin|mesh-list
102310792|NCT03431974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102310793|NCT03431974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102310794|NCT03431974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310795|NCT03416335|Pembrolizumab|pembrolizumab|mesh-list
102310796|NCT03416335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102310797|NCT03416335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310798|NCT03416335|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102310799|NCT03416335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310800|NCT03311308|Metformin|metformin|mesh-list
102310801|NCT03311308|Pembrolizumab|pembrolizumab|mesh-list
102310802|NCT03311308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102310803|NCT03311308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310804|NCT03311308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102310805|NCT03311308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310806|NCT03311308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102310807|NCT03311308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310808|NCT03279393|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102310809|NCT03279393|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102310810|NCT03279393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310822|NCT03179449|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102310824|NCT03179449|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102310825|NCT03179449|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102310826|NCT02964078|Aldesleukin|aldesleukin|mesh-list
102310827|NCT02964078|Pembrolizumab|pembrolizumab|mesh-list
102310828|NCT02964078|Interleukin-2|interleukin-2|mesh-list
102310829|NCT02964078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102310830|NCT02964078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310831|NCT02964078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102310832|NCT02964078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310833|NCT02964078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102310834|NCT02964078|Analgesics|analgesics|mesh-ancestor
102310835|NCT02964078|Sensory System Agents|sensory system agents|mesh-ancestor
102310836|NCT02964078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102310837|NCT02964078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310838|NCT02964078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102310839|NCT02964078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102310840|NCT02964078|Antiviral Agents|antiviral agents|mesh-ancestor
102310841|NCT02964078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102310843|NCT02915744|Vinorelbine|vinorelbine|mesh-list
102310844|NCT02915744|Docetaxel|docetaxel|mesh-list
102310845|NCT02915744|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102310846|NCT02915744|Gemcitabine|gemcitabine|mesh-list
102310847|NCT02915744|Etirinotecan pegol|etirinotecan pegol|mesh-list
102310848|NCT02915744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102310849|NCT02915744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310850|NCT02915744|Tubulin Modulators|tubulin modulators|mesh-ancestor
102310851|NCT02915744|Antimitotic Agents|antimitotic agents|mesh-ancestor
102310852|NCT02915744|Mitosis Modulators|mitosis modulators|mesh-ancestor
102310853|NCT02915744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310854|NCT02915744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102310855|NCT02915744|Antimetabolites|antimetabolites|mesh-ancestor
102310856|NCT02915744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102310857|NCT02915744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102310858|NCT02915744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102310859|NCT02782949|Curcumin|curcumin|mesh-list
102310860|NCT02782949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102310861|NCT02782949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102310862|NCT02782949|Analgesics|analgesics|mesh-ancestor
102310863|NCT02782949|Sensory System Agents|sensory system agents|mesh-ancestor
102310864|NCT02782949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102310865|NCT02782949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310866|NCT02782949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102310867|NCT02782949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102310868|NCT02782949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310869|NCT02782949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102310870|NCT02782949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310871|NCT02736656|Viloxazine|viloxazine|mesh-list
102310872|NCT02736656|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102310873|NCT02736656|Antidepressive Agents|antidepressive agents|mesh-ancestor
102310874|NCT02736656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102310875|NCT02736656|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102310876|NCT02736656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102310877|NCT02736656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102310878|NCT02736656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310879|NCT02736656|Adrenergic Agents|adrenergic agents|mesh-ancestor
102310880|NCT02736656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102310881|NCT02736656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310882|NCT02506933|Vaccines|vaccines|mesh-list
102310883|NCT02506933|Immunologic Factors|immunologic factors|mesh-ancestor
102310884|NCT02506933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310885|NCT02491632|Dexamethasone|dexamethasone|mesh-list
102310887|NCT02491632|Ichthammol|ichthammol|mesh-list
102310888|NCT02491632|BB 1101|bb 1101|mesh-list
102310889|NCT02491632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102310890|NCT02491632|Antiemetics|antiemetics|mesh-ancestor
102310891|NCT02491632|Autonomic Agents|autonomic agents|mesh-ancestor
102310892|NCT02491632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102310893|NCT02491632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310894|NCT02491632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102310895|NCT02491632|Glucocorticoids|glucocorticoids|mesh-ancestor
102310896|NCT02491632|Hormones|hormones|mesh-ancestor
102310897|NCT02491632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102310898|NCT02491632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102310899|NCT02491632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310900|NCT02491632|Protease Inhibitors|protease inhibitors|mesh-ancestor
102310901|NCT02491632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102310902|NCT02491632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310903|NCT02491632|Dermatologic Agents|dermatologic agents|mesh-ancestor
102310904|NCT02409810|Dexmedetomidine|dexmedetomidine|mesh-list
102310905|NCT02409810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102310906|NCT02409810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102310907|NCT02409810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310908|NCT02409810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102310909|NCT02409810|Analgesics|analgesics|mesh-ancestor
102310910|NCT02409810|Sensory System Agents|sensory system agents|mesh-ancestor
102310911|NCT02409810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102310912|NCT02409810|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102310913|NCT02409810|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102310914|NCT02409810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102310915|NCT02409810|Adrenergic Agents|adrenergic agents|mesh-ancestor
102310916|NCT02409810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102310917|NCT02409810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310918|NCT02324608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102310919|NCT02324608|Cetuximab|cetuximab|mesh-list
102310920|NCT02324608|Antibodies|antibodies|mesh-list
102310921|NCT02324608|Immunoglobulins|immunoglobulins|mesh-list
102310922|NCT02324608|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102310923|NCT02324608|Immunologic Factors|immunologic factors|mesh-ancestor
102310924|NCT02324608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310925|NCT02324608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310926|NCT02286726|Cytarabine|cytarabine|mesh-list
102310927|NCT02286726|Daunorubicin|daunorubicin|mesh-list
102310928|NCT02286726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102310929|NCT02286726|Antimetabolites|antimetabolites|mesh-ancestor
102310930|NCT02286726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310931|NCT02286726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102310932|NCT02286726|Antiviral Agents|antiviral agents|mesh-ancestor
102310933|NCT02286726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102310934|NCT02286726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102310935|NCT02286726|Immunologic Factors|immunologic factors|mesh-ancestor
102310936|NCT02286726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310937|NCT02286726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102310938|NCT02286726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102310939|NCT02286726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102310940|NCT02286726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102310941|NCT02206815|Aspirin|aspirin|mesh-list
102310942|NCT02206815|Warfarin|warfarin|mesh-list
102310943|NCT02206815|Clopidogrel|clopidogrel|mesh-list
102310944|NCT02206815|Ticagrelor|ticagrelor|mesh-list
102310945|NCT02206815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102310946|NCT02206815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102310947|NCT02206815|Analgesics|analgesics|mesh-ancestor
102310948|NCT02206815|Sensory System Agents|sensory system agents|mesh-ancestor
102310949|NCT02206815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102310950|NCT02206815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310951|NCT02206815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102310952|NCT02206815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102310953|NCT02206815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102310954|NCT02206815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102310955|NCT02206815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310956|NCT02206815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102310957|NCT02206815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102310958|NCT02206815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101427399|NCT00147524|Quinapril|quinapril|mesh-list
102310959|NCT02206815|Antipyretics|antipyretics|mesh-ancestor
102310960|NCT02206815|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102310961|NCT02206815|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102310962|NCT02206815|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102310963|NCT02206815|Purinergic Agents|purinergic agents|mesh-ancestor
102310964|NCT02206815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102310965|NCT02206815|Anticoagulants|anticoagulants|mesh-ancestor
102310966|NCT02175680|Leronlimab|leronlimab|mesh-list
102310967|NCT02175680|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102310968|NCT02175680|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102310969|NCT02175680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310970|NCT02175680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102310971|NCT02175680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102310972|NCT02175680|Antiviral Agents|antiviral agents|mesh-ancestor
102310973|NCT02175680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102310974|NCT01983462|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102310976|NCT01983462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102310977|NCT01983462|Diuretics|diuretics|mesh-ancestor
102310978|NCT01983462|Natriuretic Agents|natriuretic agents|mesh-ancestor
102310979|NCT01983462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102310980|NCT01983462|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102310981|NCT01983462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102310982|NCT01983462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102310983|NCT01983462|Analgesics|analgesics|mesh-ancestor
102310984|NCT01983462|Sensory System Agents|sensory system agents|mesh-ancestor
102310985|NCT01983462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102310986|NCT01983462|Sympatholytics|sympatholytics|mesh-ancestor
102310987|NCT01983462|Autonomic Agents|autonomic agents|mesh-ancestor
102310988|NCT01983462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102310989|NCT01983462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102310990|NCT01983462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102310991|NCT01983462|Adrenergic Agents|adrenergic agents|mesh-ancestor
102310992|NCT01983462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102310993|NCT01919086|Dexamethasone|dexamethasone|mesh-list
102310994|NCT01919086|Lenalidomide|lenalidomide|mesh-list
102310995|NCT01919086|Bortezomib|bortezomib|mesh-list
102310996|NCT01919086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102310997|NCT01919086|Antiemetics|antiemetics|mesh-ancestor
102310998|NCT01919086|Autonomic Agents|autonomic agents|mesh-ancestor
102310999|NCT01919086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102311000|NCT01919086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311001|NCT01919086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102311002|NCT01919086|Glucocorticoids|glucocorticoids|mesh-ancestor
102311003|NCT01919086|Hormones|hormones|mesh-ancestor
102311004|NCT01919086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102311005|NCT01919086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102311006|NCT01919086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102311007|NCT01919086|Immunologic Factors|immunologic factors|mesh-ancestor
102311008|NCT01919086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102311009|NCT01919086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102311010|NCT01919086|Growth Substances|growth substances|mesh-ancestor
102311011|NCT01919086|Growth Inhibitors|growth inhibitors|mesh-ancestor
102311012|NCT01779375|Metformin|metformin|mesh-list
102311013|NCT01779375|Insulin Glargine|insulin glargine|mesh-list
102311014|NCT01779375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102311015|NCT01779375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311016|NCT01559935|Clarithromycin|clarithromycin|mesh-list
102311017|NCT01559935|Dexamethasone|dexamethasone|mesh-list
102311018|NCT01559935|Dexamethasone acetate|dexamethasone acetate|mesh-list
102311019|NCT01559935|Lenalidomide|lenalidomide|mesh-list
102311020|NCT01559935|BB 1101|bb 1101|mesh-list
102311021|NCT01559935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102311022|NCT01559935|Antiemetics|antiemetics|mesh-ancestor
102311023|NCT01559935|Autonomic Agents|autonomic agents|mesh-ancestor
102311024|NCT01559935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102311025|NCT01559935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311026|NCT01559935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102311027|NCT01559935|Glucocorticoids|glucocorticoids|mesh-ancestor
102311028|NCT01559935|Hormones|hormones|mesh-ancestor
102311029|NCT01559935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101427473|NCT03458143|Anesthetics|anesthetics|mesh-ancestor
102311030|NCT01559935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102311031|NCT01559935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102311032|NCT01559935|Protease Inhibitors|protease inhibitors|mesh-ancestor
102311033|NCT01559935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102311034|NCT01559935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311035|NCT01559935|Immunologic Factors|immunologic factors|mesh-ancestor
102019800|NCT03195946|Midazolam|midazolam|mesh-list
102311036|NCT01559935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102311037|NCT01559935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102311039|NCT01559935|Growth Inhibitors|growth inhibitors|mesh-ancestor
102311040|NCT01559935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102311041|NCT01559935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102311042|NCT01559935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102311043|NCT01559935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102311044|NCT01559935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102311045|NCT00981058|Gemcitabine|gemcitabine|mesh-list
102311046|NCT00981058|Necitumumab|necitumumab|mesh-list
102311047|NCT00981058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102311048|NCT00981058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102311049|NCT00981058|Antimetabolites|antimetabolites|mesh-ancestor
102311050|NCT00981058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311051|NCT00981058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102311053|NCT00667069|Luteolytic Agents|luteolytic agents|mesh-ancestor
102311054|NCT00667069|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102311055|NCT00667069|Contraceptive Agents|contraceptive agents|mesh-ancestor
102311056|NCT00667069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102311057|NCT00667069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311058|NCT00667069|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102311059|NCT00667069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102311060|NCT00667069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102311061|NCT00565851|Paclitaxel|paclitaxel|mesh-list
102311062|NCT00565851|Docetaxel|docetaxel|mesh-list
102311063|NCT00565851|Bevacizumab|bevacizumab|mesh-list
102311064|NCT00565851|Carboplatin|carboplatin|mesh-list
102311065|NCT00565851|Gemcitabine|gemcitabine|mesh-list
102311066|NCT00565851|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102311067|NCT00565851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102311068|NCT00565851|Endothelial Growth Factors|endothelial growth factors|mesh-list
102311069|NCT00565851|Antibodies|antibodies|mesh-list
102311070|NCT00565851|Immunoglobulins|immunoglobulins|mesh-list
102311071|NCT00565851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102311072|NCT00565851|Immunoglobulin G|immunoglobulin g|mesh-list
102311073|NCT00565851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102311074|NCT00565851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102311075|NCT00565851|Tubulin Modulators|tubulin modulators|mesh-ancestor
102311076|NCT00565851|Antimitotic Agents|antimitotic agents|mesh-ancestor
102311077|NCT00565851|Mitosis Modulators|mitosis modulators|mesh-ancestor
102311078|NCT00565851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311079|NCT00565851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102311080|NCT00565851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102311081|NCT00565851|Growth Substances|growth substances|mesh-ancestor
102311082|NCT00565851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311083|NCT00565851|Growth Inhibitors|growth inhibitors|mesh-ancestor
102311084|NCT00565851|Immunologic Factors|immunologic factors|mesh-ancestor
102311085|NCT00565851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102311086|NCT00565851|Antimetabolites|antimetabolites|mesh-ancestor
102311087|NCT00238563|Triamcinolone|triamcinolone|mesh-list
102311088|NCT00238563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102311089|NCT00238563|Glucocorticoids|glucocorticoids|mesh-ancestor
102311090|NCT00238563|Hormones|hormones|mesh-ancestor
102311091|NCT00238563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102311092|NCT00238563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311093|NCT04499677|Ritonavir|ritonavir|mesh-list
102311094|NCT04499677|Lopinavir|lopinavir|mesh-list
102311095|NCT04499677|Favipiravir|favipiravir|mesh-list
102311096|NCT04499677|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102311097|NCT04499677|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102311098|NCT04499677|Protease Inhibitors|protease inhibitors|mesh-ancestor
102311099|NCT04499677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102311100|NCT04499677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311101|NCT04499677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102311102|NCT04499677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102311103|NCT04499677|Antiviral Agents|antiviral agents|mesh-ancestor
102311104|NCT04499677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102311105|NCT04499677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102311106|NCT04499677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102311107|NCT05652751|Mitogens|mitogens|mesh-list
102311108|NCT05652751|Mitosis Modulators|mitosis modulators|mesh-ancestor
102311109|NCT05652751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311110|NCT02915263|Immunoglobulins|immunoglobulins|mesh-list
102311111|NCT02915263|Immunologic Factors|immunologic factors|mesh-ancestor
102311112|NCT02915263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311113|NCT02909335|Mycophenolic Acid|mycophenolic acid|mesh-list
102311114|NCT02909335|Prednisone|prednisone|mesh-list
102311115|NCT02909335|Methylprednisolone|methylprednisolone|mesh-list
102311116|NCT02909335|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102311117|NCT02909335|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102311118|NCT02909335|Prednisolone|prednisolone|mesh-list
102311119|NCT02909335|Prednisolone acetate|prednisolone acetate|mesh-list
102311120|NCT02909335|Everolimus|everolimus|mesh-list
102311121|NCT02909335|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102311122|NCT02909335|Prednisolone phosphate|prednisolone phosphate|mesh-list
102311123|NCT02909335|Tacrolimus|tacrolimus|mesh-list
102311124|NCT02909335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102311125|NCT02909335|Glucocorticoids|glucocorticoids|mesh-ancestor
102311126|NCT02909335|Hormones|hormones|mesh-ancestor
101941567|NCT03740295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311127|NCT02909335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102311128|NCT02909335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311129|NCT02909335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102311131|NCT02909335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102311132|NCT02909335|Immunologic Factors|immunologic factors|mesh-ancestor
102311133|NCT02909335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102311134|NCT02909335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102311135|NCT02909335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311136|NCT02909335|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102311137|NCT02909335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102311138|NCT02909335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102311139|NCT02909335|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102311140|NCT02909335|Antitubercular Agents|antitubercular agents|mesh-ancestor
102311141|NCT02909335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102311142|NCT02909335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102311143|NCT02909335|Antiemetics|antiemetics|mesh-ancestor
102311144|NCT02909335|Autonomic Agents|autonomic agents|mesh-ancestor
102311145|NCT02909335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102311146|NCT02909335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102311147|NCT02909335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102311148|NCT02909335|Protective Agents|protective agents|mesh-ancestor
102311149|NCT04417699|Oxaliplatin|oxaliplatin|mesh-list
102311150|NCT04417699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102311151|NCT05652517|Ethanol|ethanol|mesh-list
102311152|NCT05652517|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102311153|NCT05652517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102311154|NCT05652517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102311155|NCT05652517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311156|NCT04806373|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102311157|NCT04806373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102311158|NCT04806373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102311159|NCT04806373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311160|NCT03998293|Somatostatin|somatostatin|mesh-list
102311161|NCT03998293|Hormones|hormones|mesh-ancestor
102311162|NCT03998293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102311163|NCT03998293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311164|NCT01606306|Fluticasone|fluticasone|mesh-list
102311165|NCT01606306|Xhance|xhance|mesh-list
102311166|NCT01606306|Montelukast|montelukast|mesh-list
102311167|NCT01606306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102311168|NCT01606306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102311169|NCT01606306|Autonomic Agents|autonomic agents|mesh-ancestor
102311170|NCT01606306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102311171|NCT01606306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311172|NCT01606306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102311173|NCT01606306|Respiratory System Agents|respiratory system agents|mesh-ancestor
102311174|NCT01606306|Dermatologic Agents|dermatologic agents|mesh-ancestor
102311175|NCT01606306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102311176|NCT01606306|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102311177|NCT01606306|Hormone Antagonists|hormone antagonists|mesh-ancestor
102311178|NCT01606306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102311179|NCT01606306|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102311180|NCT01606306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102311181|NCT01606306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311182|NCT04567108|Benzocaine|benzocaine|mesh-list
102311183|NCT04567108|Anesthetics, Local|anesthetics, local|mesh-ancestor
102311184|NCT04567108|Anesthetics|anesthetics|mesh-ancestor
102311185|NCT04567108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102311186|NCT04567108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311188|NCT04567108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102311189|NCT01753570|Interferon-beta|interferon-beta|mesh-list
102311190|NCT01753570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102311191|NCT01753570|Antiviral Agents|antiviral agents|mesh-ancestor
102311192|NCT01753570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102311193|NCT01753570|Immunologic Factors|immunologic factors|mesh-ancestor
102311194|NCT01753570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311195|NCT01753336|Botulinum Toxins|botulinum toxins|mesh-list
102311196|NCT01753336|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102311197|NCT01753336|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102311198|NCT01753336|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102311199|NCT01753336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101653051|NCT04203368|Adenosine|adenosine|mesh-list
102311200|NCT01753336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311201|NCT01753336|Cholinergic Agents|cholinergic agents|mesh-ancestor
102311202|NCT01753336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102311203|NCT01753336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311204|NCT01753336|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102311205|NCT01753336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102311206|NCT01777282|Biguanides|biguanides|mesh-list
102311207|NCT01777282|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
102311208|NCT01777282|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
102311209|NCT01777282|rGLP-1 protein|rglp-1 protein|mesh-list
102311210|NCT01777282|Incretins|incretins|mesh-ancestor
102311211|NCT01777282|Hormones|hormones|mesh-ancestor
102311212|NCT01777282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102311213|NCT01777282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311214|NCT01777282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102311215|NCT01777282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102311216|NCT01777282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311217|NCT04571632|Pembrolizumab|pembrolizumab|mesh-list
102311218|NCT04571632|Ipilimumab|ipilimumab|mesh-list
102311219|NCT04571632|Avelumab|avelumab|mesh-list
102311220|NCT04571632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102311221|NCT04571632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102311222|NCT04571632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102311223|NCT04571632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311224|NCT01975389|Bococizumab|bococizumab|mesh-list
102311225|NCT01975389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102311226|NCT01975389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102311227|NCT01975389|Antimetabolites|antimetabolites|mesh-ancestor
102311228|NCT01975389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311229|NCT01975389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102311230|NCT01974141|Dapsone|dapsone|mesh-list
102311231|NCT01974141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102311232|NCT01974141|Antimalarials|antimalarials|mesh-ancestor
102311233|NCT01974141|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102311234|NCT01974141|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102311235|NCT01974141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102311236|NCT01974141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102311237|NCT01974141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311238|NCT01974141|Leprostatic Agents|leprostatic agents|mesh-ancestor
102311239|NCT01974141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102311240|NCT01945593|Factor VIII|factor viii|mesh-list
102311241|NCT01945593|BAX 855|bax 855|mesh-list
102311242|NCT01945593|Coagulants|coagulants|mesh-ancestor
102311243|NCT01945281|Amphotericin B|amphotericin b|mesh-list
102311244|NCT01945281|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102311245|NCT01945281|Caspofungin|caspofungin|mesh-list
102311246|NCT01945281|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
102311247|NCT01945281|Deoxycholic Acid|deoxycholic acid|mesh-list
102311248|NCT01945281|Amebicides|amebicides|mesh-ancestor
102311249|NCT01945281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102311250|NCT01945281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102311251|NCT01945281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102311252|NCT01945281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102311253|NCT01945281|Antifungal Agents|antifungal agents|mesh-ancestor
102311254|NCT01945281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102311255|NCT01945281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311256|NCT01945281|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102311257|NCT01945281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102311258|NCT01961349|Propofol|propofol|mesh-list
102311259|NCT01961349|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102311260|NCT01961349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101836564|NCT00501540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311261|NCT01961349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102311262|NCT01961349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311263|NCT01961349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102311264|NCT01961349|Anesthetics, General|anesthetics, general|mesh-ancestor
102311266|NCT01961349|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102311267|NCT01961349|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102311268|NCT01961349|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102311269|NCT01944969|Brexpiprazole|brexpiprazole|mesh-list
102311270|NCT01944969|Serotonin Agents|serotonin agents|mesh-ancestor
102311271|NCT01944969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102311272|NCT01944969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311273|NCT01944969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311274|NCT01944969|Dopamine Agonists|dopamine agonists|mesh-ancestor
102311276|NCT04661397|Tenofovir|tenofovir|mesh-list
102311277|NCT04661397|Emtricitabine|emtricitabine|mesh-list
102311278|NCT04661397|Darunavir|darunavir|mesh-list
102311279|NCT04661397|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102311280|NCT04661397|Cobicistat|cobicistat|mesh-list
102311281|NCT04661397|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
102311282|NCT04661397|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
102311283|NCT04661397|Antiviral Agents|antiviral agents|mesh-ancestor
102311284|NCT04661397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102311285|NCT04661397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102311286|NCT04661397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102311287|NCT04661397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102311288|NCT04661397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311289|NCT04661397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102311290|NCT04661397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102311291|NCT04661397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102311292|NCT04661397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102311293|NCT04661397|Protease Inhibitors|protease inhibitors|mesh-ancestor
102311294|NCT04661397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102311295|NCT04661397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102311296|NCT01973439|Abacavir|abacavir|mesh-list
102311297|NCT01973439|Dideoxynucleosides|dideoxynucleosides|mesh-list
102311298|NCT01973439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102311299|NCT01973439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102311300|NCT01973439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102311301|NCT01973439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311302|NCT01973439|Antiviral Agents|antiviral agents|mesh-ancestor
102311303|NCT01973439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102311304|NCT01973439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102311305|NCT01973439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102311306|NCT01973439|Antimetabolites|antimetabolites|mesh-ancestor
102311307|NCT01973283|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102311308|NCT01973283|Antidepressive Agents|antidepressive agents|mesh-list
102311309|NCT01973283|Escitalopram|escitalopram|mesh-list
102311310|NCT01973283|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102311311|NCT01973283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102311312|NCT01973283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102311313|NCT01973283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311314|NCT01973283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102311315|NCT01973283|Serotonin Agents|serotonin agents|mesh-ancestor
102311316|NCT01973283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311317|NCT01973283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102311318|NCT01973283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102311319|NCT01973283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102311320|NCT01973283|Analgesics|analgesics|mesh-ancestor
102311321|NCT01973283|Sensory System Agents|sensory system agents|mesh-ancestor
102311322|NCT01973283|Dopamine Agents|dopamine agents|mesh-ancestor
102311323|NCT01972659|Magnesium Sulfate|magnesium sulfate|mesh-list
102311324|NCT01972659|Analgesics|analgesics|mesh-ancestor
102311325|NCT01972659|Sensory System Agents|sensory system agents|mesh-ancestor
102311326|NCT01972659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102311327|NCT01972659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311328|NCT01972659|Anesthetics|anesthetics|mesh-ancestor
102311329|NCT01972659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102311330|NCT01972659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102311331|NCT01972659|Anticonvulsants|anticonvulsants|mesh-ancestor
102311332|NCT01972659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102311333|NCT01972659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102311334|NCT01972659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311335|NCT01972659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102311336|NCT01972659|Tocolytic Agents|tocolytic agents|mesh-ancestor
102311337|NCT01972659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102311338|NCT01942785|Brexpiprazole|brexpiprazole|mesh-list
102311339|NCT01942785|Serotonin Agents|serotonin agents|mesh-ancestor
102311340|NCT01942785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102311341|NCT01942785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311342|NCT01942785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311343|NCT01942785|Dopamine Agonists|dopamine agonists|mesh-ancestor
102311344|NCT01942785|Dopamine Agents|dopamine agents|mesh-ancestor
102311345|NCT01774786|Fluorouracil|fluorouracil|mesh-list
102311346|NCT01774786|Capecitabine|capecitabine|mesh-list
102311347|NCT01774786|Trastuzumab|trastuzumab|mesh-list
102311348|NCT01774786|Pertuzumab|pertuzumab|mesh-list
102311349|NCT01774786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102311350|NCT01774786|Antimetabolites|antimetabolites|mesh-ancestor
102311351|NCT01774786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311352|NCT01774786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102311353|NCT01774786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102311354|NCT01774786|Immunologic Factors|immunologic factors|mesh-ancestor
102311355|NCT01774786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311356|NCT01774786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102311357|NCT01942161|Aripiprazole|aripiprazole|mesh-list
102311358|NCT01942161|Antidepressive Agents|antidepressive agents|mesh-ancestor
102311359|NCT01942161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102311360|NCT01942161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102311361|NCT01942161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102311362|NCT01942161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102311363|NCT01942161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311364|NCT01942161|Dopamine Agonists|dopamine agonists|mesh-ancestor
102311365|NCT01942161|Dopamine Agents|dopamine agents|mesh-ancestor
102311366|NCT01942161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102311367|NCT01942161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311368|NCT01942161|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102311369|NCT01942161|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102311370|NCT01942161|Serotonin Agents|serotonin agents|mesh-ancestor
102311371|NCT01942161|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102311372|NCT01942161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102311373|NCT01942161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102311374|NCT01942161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102311375|NCT01971645|Dexamethasone|dexamethasone|mesh-list
102311376|NCT01971645|Ropivacaine|ropivacaine|mesh-list
102311377|NCT01971645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102311378|NCT01971645|Antiemetics|antiemetics|mesh-ancestor
102311379|NCT01971645|Autonomic Agents|autonomic agents|mesh-ancestor
102311380|NCT01971645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102311381|NCT01971645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311382|NCT01971645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102311383|NCT01971645|Glucocorticoids|glucocorticoids|mesh-ancestor
102311384|NCT01971645|Hormones|hormones|mesh-ancestor
102311385|NCT01971645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102311386|NCT01971645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102311387|NCT01971645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102311388|NCT01971645|Anesthetics, Local|anesthetics, local|mesh-ancestor
102311389|NCT01971645|Anesthetics|anesthetics|mesh-ancestor
102311390|NCT01971645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102311391|NCT01971645|Sensory System Agents|sensory system agents|mesh-ancestor
102311392|NCT01941537|Fezakinumab|fezakinumab|mesh-list
102311393|NCT01941537|Dermatologic Agents|dermatologic agents|mesh-ancestor
102311394|NCT01960413|Hydroxyurea|hydroxyurea|mesh-list
102311395|NCT01960413|Montelukast|montelukast|mesh-list
102311396|NCT01960413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102311397|NCT01960413|Respiratory System Agents|respiratory system agents|mesh-ancestor
102311398|NCT01960413|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102311399|NCT01960413|Hormone Antagonists|hormone antagonists|mesh-ancestor
102311400|NCT01960413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102311401|NCT01960413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311402|NCT01960413|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102311403|NCT01960413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102311404|NCT01960413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311405|NCT01960413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102311406|NCT01960413|Antisickling Agents|antisickling agents|mesh-ancestor
102311407|NCT01960413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102311408|NCT01960413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102311410|NCT01970475|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102311411|NCT01970475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102311412|NCT01970475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102311413|NCT01939977|Calcifediol|calcifediol|mesh-list
102311414|NCT01939977|Vitamins|vitamins|mesh-ancestor
102311415|NCT01939977|Micronutrients|micronutrients|mesh-ancestor
102311416|NCT01939977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311417|NCT01939977|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102311418|NCT01939899|Ixazomib|ixazomib|mesh-list
102311419|NCT01939899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102311420|NCT01939899|Protease Inhibitors|protease inhibitors|mesh-ancestor
102311421|NCT01939899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102311422|NCT01939899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311424|NCT01970397|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102311425|NCT01970397|Immunologic Factors|immunologic factors|mesh-ancestor
102311426|NCT01970397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311427|NCT01970397|Viscosupplements|viscosupplements|mesh-ancestor
102311428|NCT01970397|Protective Agents|protective agents|mesh-ancestor
102311429|NCT01970241|Insulin|insulin|mesh-list
102311430|NCT01970241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102311431|NCT01970241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102311432|NCT01970241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311433|NCT01728376|Daptomycin|daptomycin|mesh-list
102311434|NCT01728376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102311435|NCT01728376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102311436|NCT02488759|Nivolumab|nivolumab|mesh-list
102311437|NCT02488759|Ipilimumab|ipilimumab|mesh-list
102311438|NCT02488759|Relatlimab|relatlimab|mesh-list
102311439|NCT02488759|Daratumumab|daratumumab|mesh-list
102311440|NCT02488759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102311441|NCT02488759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102311442|NCT02488759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102311443|NCT02488759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311444|NCT02217709|Phenelzine|phenelzine|mesh-list
102311445|NCT02217709|Antidepressive Agents|antidepressive agents|mesh-ancestor
102311446|NCT02217709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102311447|NCT02217709|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102311448|NCT02217709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102311449|NCT02217709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311450|NCT02161783|Cyclophosphamide|cyclophosphamide|mesh-list
102311451|NCT02161783|Fludarabine|fludarabine|mesh-list
102311452|NCT02161783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102311453|NCT02161783|Immunologic Factors|immunologic factors|mesh-ancestor
102311454|NCT02161783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311455|NCT02161783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102311456|NCT02161783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102311457|NCT02161783|Alkylating Agents|alkylating agents|mesh-ancestor
102311458|NCT02161783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311459|NCT02161783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102311460|NCT02161783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102311461|NCT02158507|Lapatinib|lapatinib|mesh-list
102311462|NCT02158507|Veliparib|veliparib|mesh-list
102311463|NCT02158507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102311464|NCT02158507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102311465|NCT02158507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102311466|NCT02158507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311467|NCT02158507|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102311468|NCT04791553|Cenobamate|cenobamate|mesh-list
102311469|NCT04791553|Anticonvulsants|anticonvulsants|mesh-ancestor
102311470|NCT05651347|Melatonin|melatonin|mesh-list
102311471|NCT05651347|Antioxidants|antioxidants|mesh-ancestor
102311472|NCT05651347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311473|NCT05651347|Protective Agents|protective agents|mesh-ancestor
102311474|NCT05651347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311475|NCT05651347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102311476|NCT05651269|Gemcitabine|gemcitabine|mesh-list
102311477|NCT05651269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102311478|NCT05651269|Antimetabolites|antimetabolites|mesh-ancestor
102311479|NCT05651269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311480|NCT05651269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102311481|NCT01707004|Vidarabine|vidarabine|mesh-list
102311482|NCT01707004|Mycophenolic Acid|mycophenolic acid|mesh-list
102311483|NCT01707004|Cyclophosphamide|cyclophosphamide|mesh-list
102311484|NCT01707004|Busulfan|busulfan|mesh-list
102311485|NCT01707004|Fludarabine|fludarabine|mesh-list
102311486|NCT01707004|Fludarabine phosphate|fludarabine phosphate|mesh-list
102311487|NCT01707004|Azacitidine|azacitidine|mesh-list
102311488|NCT01707004|Decitabine|decitabine|mesh-list
102311489|NCT01707004|Tacrolimus|tacrolimus|mesh-list
102311490|NCT01707004|Lenograstim|lenograstim|mesh-list
102311491|NCT01707004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102311492|NCT01707004|Immunologic Factors|immunologic factors|mesh-ancestor
102311493|NCT01707004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311494|NCT01707004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102311495|NCT01707004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102311496|NCT01707004|Alkylating Agents|alkylating agents|mesh-ancestor
102311497|NCT01707004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653348|NCT02977052|Nivolumab|nivolumab|mesh-list
102311498|NCT01707004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102311499|NCT01707004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102311500|NCT01707004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102311501|NCT01707004|Antimetabolites|antimetabolites|mesh-ancestor
102311502|NCT01707004|Antiviral Agents|antiviral agents|mesh-ancestor
102311503|NCT01707004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102311504|NCT01707004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102311505|NCT01707004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102311506|NCT01707004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102311507|NCT01707004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102311508|NCT01707004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102311509|NCT01707004|Antitubercular Agents|antitubercular agents|mesh-ancestor
102311510|NCT01707004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102311511|NCT01939197|Ritonavir|ritonavir|mesh-list
102311512|NCT01939197|Ribavirin|ribavirin|mesh-list
102311513|NCT01939197|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102311514|NCT01939197|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102311515|NCT01939197|Protease Inhibitors|protease inhibitors|mesh-ancestor
102311516|NCT01939197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102311517|NCT01939197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311518|NCT01939197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102311519|NCT01939197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102311520|NCT01939197|Antiviral Agents|antiviral agents|mesh-ancestor
102311521|NCT01939197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102311522|NCT01939197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102311523|NCT01939197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102311524|NCT01939197|Antimetabolites|antimetabolites|mesh-ancestor
102311525|NCT01969851|Lacosamide|lacosamide|mesh-list
102311526|NCT01969851|Anticonvulsants|anticonvulsants|mesh-ancestor
102311527|NCT01969851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102311528|NCT01969851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102311529|NCT01969851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102311530|NCT01969851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311531|NCT01938573|Sirolimus|sirolimus|mesh-list
102311532|NCT01938573|Cisplatin|cisplatin|mesh-list
102311533|NCT01938573|Gemcitabine|gemcitabine|mesh-list
102311534|NCT01938573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102311535|NCT01938573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102311536|NCT01938573|Antimetabolites|antimetabolites|mesh-ancestor
102311537|NCT01938573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311538|NCT01938573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102311539|NCT01938573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102311540|NCT01938573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102311541|NCT01938573|Antifungal Agents|antifungal agents|mesh-ancestor
102311542|NCT01938573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102311543|NCT01938573|Immunologic Factors|immunologic factors|mesh-ancestor
102311544|NCT01938573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311545|NCT05546515|Suvorexant|suvorexant|mesh-list
102311546|NCT05546515|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-list
102311547|NCT05546515|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102311548|NCT05546515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102311549|NCT05546515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102311550|NCT05546515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311551|NCT05546515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102311552|NCT05546515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311553|NCT04789837|Cilostazol|cilostazol|mesh-list
102311554|NCT04789837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102311555|NCT04789837|Autonomic Agents|autonomic agents|mesh-ancestor
102311556|NCT04789837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102311557|NCT04789837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311558|NCT04789837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102311559|NCT04789837|Respiratory System Agents|respiratory system agents|mesh-ancestor
102311560|NCT04789837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102311561|NCT04789837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102311562|NCT04789837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311563|NCT04789837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102311564|NCT04789837|Vasodilator Agents|vasodilator agents|mesh-ancestor
102311565|NCT04789837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102311566|NCT04789837|Protective Agents|protective agents|mesh-ancestor
102311567|NCT04789837|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102311568|NCT04789837|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102311569|NCT04789837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102311570|NCT03522259|Rivaroxaban|rivaroxaban|mesh-list
102311571|NCT03522259|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102311572|NCT03522259|Antithrombins|antithrombins|mesh-ancestor
102311573|NCT03522259|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102311574|NCT03522259|Protease Inhibitors|protease inhibitors|mesh-ancestor
102311575|NCT03522259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102311576|NCT03522259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311577|NCT03522259|Anticoagulants|anticoagulants|mesh-ancestor
102311578|NCT01937871|Tadalafil|tadalafil|mesh-list
102311579|NCT01937871|Tamsulosin|tamsulosin|mesh-list
102311580|NCT01937871|Vasodilator Agents|vasodilator agents|mesh-ancestor
102311581|NCT01937871|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102311582|NCT01937871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102311583|NCT01937871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102311584|NCT01937871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311585|NCT01937871|Urological Agents|urological agents|mesh-ancestor
102311586|NCT01937871|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102311587|NCT01937871|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102311588|NCT01937871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102311589|NCT01937871|Adrenergic Agents|adrenergic agents|mesh-ancestor
102311590|NCT01937871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102311591|NCT01937871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311592|NCT01747447|Vitamin D|vitamin d|mesh-list
102311593|NCT01747447|Ergocalciferols|ergocalciferols|mesh-list
102311594|NCT01747447|Cholecalciferol|cholecalciferol|mesh-list
102311595|NCT01747447|Vitamins|vitamins|mesh-list
102311596|NCT01747447|Micronutrients|micronutrients|mesh-ancestor
102311597|NCT01747447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311598|NCT01747447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102311599|NCT01747447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102311600|NCT02740699|Atorvastatin|atorvastatin|mesh-list
102311601|NCT02740699|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102311602|NCT02740699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102311603|NCT02740699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102311604|NCT02740699|Antimetabolites|antimetabolites|mesh-ancestor
102311605|NCT02740699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311606|NCT02740699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102311607|NCT02740699|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102311608|NCT02740699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102311609|NCT01287091|Rabeprazole|rabeprazole|mesh-list
102311610|NCT01287091|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102311611|NCT01287091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102311612|NCT01287091|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102311613|NCT01287091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102311614|NCT01287091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311615|NCT01269463|Methylphenidate|methylphenidate|mesh-list
102311616|NCT01269463|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102311617|NCT01269463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311618|NCT01269463|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102311619|NCT01269463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102311620|NCT01269463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102311621|NCT01269463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311622|NCT01269463|Dopamine Agents|dopamine agents|mesh-ancestor
102311623|NCT01269463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102311624|NCT02539459|Everolimus|everolimus|mesh-list
102311625|NCT02539459|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102311626|NCT02539459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102311627|NCT02539459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102311628|NCT02539459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311629|NCT02539459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102311630|NCT02539459|Immunologic Factors|immunologic factors|mesh-ancestor
102311631|NCT02539459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311632|NCT02539459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102311633|NCT01706926|Mavrilimumab|mavrilimumab|mesh-list
102311634|NCT01706926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102311635|NCT01706926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102311636|NCT01706926|Immunologic Factors|immunologic factors|mesh-ancestor
102311637|NCT01706926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311639|NCT01634113|Tiotropium Bromide|tiotropium bromide|mesh-list
102311640|NCT01634113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102311641|NCT01634113|Autonomic Agents|autonomic agents|mesh-ancestor
102311642|NCT01634113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102311643|NCT01634113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311644|NCT01634113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102311645|NCT01634113|Respiratory System Agents|respiratory system agents|mesh-ancestor
102311646|NCT01634113|Parasympatholytics|parasympatholytics|mesh-ancestor
102311647|NCT01634113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102311648|NCT01634113|Cholinergic Agents|cholinergic agents|mesh-ancestor
102311649|NCT01634113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102311650|NCT01634113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311651|NCT01634113|Anticonvulsants|anticonvulsants|mesh-ancestor
102311652|NCT01937715|Bevacizumab|bevacizumab|mesh-list
102311653|NCT01937715|Gedatolisib|gedatolisib|mesh-list
102311654|NCT01937715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102311655|NCT01937715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102311656|NCT01937715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102311657|NCT01937715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102311658|NCT01937715|Growth Substances|growth substances|mesh-ancestor
102311659|NCT01937715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311660|NCT01937715|Growth Inhibitors|growth inhibitors|mesh-ancestor
102311661|NCT01937715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102311662|NCT01937715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102311663|NCT01937715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311664|NCT01937559|Tranexamic Acid|tranexamic acid|mesh-list
102311665|NCT01937559|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102311666|NCT01937559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102311667|NCT01937559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311668|NCT01937559|Hemostatics|hemostatics|mesh-ancestor
102311669|NCT01937559|Coagulants|coagulants|mesh-ancestor
102311670|NCT01918371|Ranibizumab|ranibizumab|mesh-list
102311671|NCT01918371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102311672|NCT01918371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102311673|NCT01918371|Growth Substances|growth substances|mesh-ancestor
102311674|NCT01918371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311675|NCT01918371|Growth Inhibitors|growth inhibitors|mesh-ancestor
102311676|NCT01918371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102311677|NCT04633551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102311678|NCT01916967|Desloratadine|desloratadine|mesh-list
102311679|NCT01916967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102311680|NCT01916967|Cholinergic Agents|cholinergic agents|mesh-ancestor
102311681|NCT01916967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102311682|NCT01916967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311683|NCT01916967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311684|NCT01916967|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102311685|NCT01916967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102311686|NCT01916967|Histamine Antagonists|histamine antagonists|mesh-ancestor
102311687|NCT01916967|Histamine Agents|histamine agents|mesh-ancestor
102311688|NCT01959243|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102311689|NCT01959243|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102311690|NCT01959243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102311691|NCT01959243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102311692|NCT01959243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102311693|NCT01959243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102311694|NCT01959243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102311695|NCT01959243|Adrenergic Agents|adrenergic agents|mesh-ancestor
102311696|NCT01959243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102311697|NCT01959243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311698|NCT01959243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311699|NCT01916109|Carboplatin|carboplatin|mesh-list
102311700|NCT01916109|Gemcitabine|gemcitabine|mesh-list
102311701|NCT01916109|Panitumumab|panitumumab|mesh-list
102311702|NCT01916109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102311703|NCT01916109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102311704|NCT01916109|Antimetabolites|antimetabolites|mesh-ancestor
102311705|NCT01916109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311706|NCT01916109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102311707|NCT01958619|Artefenomel|artefenomel|mesh-list
102311708|NCT01958619|Antimalarials|antimalarials|mesh-ancestor
102311709|NCT01958619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102311710|NCT01958619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102311711|NCT01958619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102311712|NCT01726270|Tamsulosin|tamsulosin|mesh-list
102311713|NCT01726270|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102311714|NCT01726270|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102311715|NCT01726270|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102311716|NCT01726270|Adrenergic Agents|adrenergic agents|mesh-ancestor
101428181|NCT00149708|Hormones|hormones|mesh-list
102311717|NCT01726270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102311718|NCT01726270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311719|NCT01726270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311720|NCT01726270|Urological Agents|urological agents|mesh-ancestor
102311721|NCT00942331|Bevacizumab|bevacizumab|mesh-list
102311722|NCT00942331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102311723|NCT00942331|Cisplatin|cisplatin|mesh-list
102311724|NCT00942331|Gemcitabine|gemcitabine|mesh-list
102311725|NCT00942331|Endothelial Growth Factors|endothelial growth factors|mesh-list
102311726|NCT00942331|Antibodies|antibodies|mesh-list
102311727|NCT00942331|Immunoglobulins|immunoglobulins|mesh-list
102311728|NCT00942331|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102311729|NCT00942331|Immunoglobulin G|immunoglobulin g|mesh-list
102311730|NCT00942331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102311731|NCT00942331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102311732|NCT00942331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102311733|NCT00942331|Growth Substances|growth substances|mesh-ancestor
102311734|NCT00942331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311735|NCT00942331|Growth Inhibitors|growth inhibitors|mesh-ancestor
102311736|NCT00942331|Immunologic Factors|immunologic factors|mesh-ancestor
102311737|NCT00942331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102311738|NCT00942331|Antimetabolites|antimetabolites|mesh-ancestor
102311739|NCT00942331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311740|NCT00630565|Dexamethasone|dexamethasone|mesh-list
102311741|NCT00630565|Cyclophosphamide|cyclophosphamide|mesh-list
102311742|NCT00630565|Busulfan|busulfan|mesh-list
102311743|NCT00630565|Etoposide|etoposide|mesh-list
102311744|NCT00630565|Sargramostim|sargramostim|mesh-list
102311745|NCT00630565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102311746|NCT00630565|Immunologic Factors|immunologic factors|mesh-ancestor
102311747|NCT00630565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311748|NCT00630565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102311749|NCT00630565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102311750|NCT00630565|Alkylating Agents|alkylating agents|mesh-ancestor
102311751|NCT00630565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311752|NCT00630565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102311753|NCT00630565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102311754|NCT00630565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102311755|NCT00630565|Antiemetics|antiemetics|mesh-ancestor
102311756|NCT00630565|Autonomic Agents|autonomic agents|mesh-ancestor
102311757|NCT00630565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102311758|NCT00630565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102311759|NCT00630565|Glucocorticoids|glucocorticoids|mesh-ancestor
102311760|NCT00630565|Hormones|hormones|mesh-ancestor
102311761|NCT00630565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102311762|NCT00630565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102311763|NCT00630565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102311764|NCT00630565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102311765|NCT00630565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102311766|NCT00630565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102311767|NCT01914393|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102311768|NCT01914393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102311769|NCT01914393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102311770|NCT01914393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102311771|NCT01914393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311772|NCT01914393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102311773|NCT01914393|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102311774|NCT01914393|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102311775|NCT01914393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102311776|NCT01914393|Adrenergic Agents|adrenergic agents|mesh-ancestor
102311777|NCT01914393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102311778|NCT01914393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311779|NCT01914393|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102311780|NCT01914393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102311781|NCT01914393|Serotonin Agents|serotonin agents|mesh-ancestor
102311782|NCT01914393|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102020553|NCT03118336|Empagliflozin|empagliflozin|mesh-list
102311783|NCT01914393|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102311784|NCT01914393|Dopamine Agents|dopamine agents|mesh-ancestor
102311786|NCT01545271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102311787|NCT01545271|Anesthetics, General|anesthetics, general|mesh-ancestor
102311788|NCT01545271|Anesthetics|anesthetics|mesh-ancestor
102311789|NCT01545271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102311790|NCT01545271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311791|NCT01931865|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102311792|NCT01931865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102311793|NCT01931865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102311794|NCT01931865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311795|NCT01931865|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102311796|NCT01931865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102311797|NCT01931865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311798|NCT01931865|Cholinergic Agents|cholinergic agents|mesh-ancestor
102311799|NCT01931865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102311800|NCT01617447|Aripiprazole|aripiprazole|mesh-list
102311801|NCT01617447|Antidepressive Agents|antidepressive agents|mesh-ancestor
102311802|NCT01617447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102311803|NCT01617447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102311804|NCT01617447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102311805|NCT01617447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102311806|NCT01617447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311807|NCT01617447|Dopamine Agonists|dopamine agonists|mesh-ancestor
102311808|NCT01617447|Dopamine Agents|dopamine agents|mesh-ancestor
102311809|NCT01617447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102311810|NCT01617447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311811|NCT01617447|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102311812|NCT01617447|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102311813|NCT01617447|Serotonin Agents|serotonin agents|mesh-ancestor
102311814|NCT01617447|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102311815|NCT01617447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102311816|NCT01617447|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102311817|NCT01617447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102311818|NCT00432679|Rosiglitazone|rosiglitazone|mesh-list
102311819|NCT00432679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102311820|NCT00432679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311821|NCT04798027|Vaccines|vaccines|mesh-list
102311822|NCT04798027|Immunologic Factors|immunologic factors|mesh-ancestor
102311823|NCT04798027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311824|NCT04797325|Prednisolone|prednisolone|mesh-list
102311825|NCT04797325|Infliximab|infliximab|mesh-list
102311826|NCT04797325|Vedolizumab|vedolizumab|mesh-list
102311827|NCT04797325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102311828|NCT04797325|Glucocorticoids|glucocorticoids|mesh-ancestor
102311829|NCT04797325|Hormones|hormones|mesh-ancestor
102311830|NCT04797325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102311831|NCT04797325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311832|NCT04797325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102311833|NCT04797325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102311834|NCT04797325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102311835|NCT04797325|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102311836|NCT04797325|Dermatologic Agents|dermatologic agents|mesh-ancestor
102311837|NCT04797325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102311838|NCT02246647|Mannitol|mannitol|mesh-list
102311839|NCT02246647|Lactulose|lactulose|mesh-list
102311840|NCT02246647|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102311841|NCT02246647|Diuretics|diuretics|mesh-ancestor
102311842|NCT02246647|Natriuretic Agents|natriuretic agents|mesh-ancestor
102311843|NCT02246647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311844|NCT02246647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102311845|NCT02244619|Acetaminophen|acetaminophen|mesh-list
102311846|NCT02244619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102311847|NCT02244619|Analgesics|analgesics|mesh-ancestor
102311848|NCT02244619|Sensory System Agents|sensory system agents|mesh-ancestor
101428317|NCT05785429|Colchicine|colchicine|mesh-list
102311849|NCT02244619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102311850|NCT02244619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311851|NCT02244619|Antipyretics|antipyretics|mesh-ancestor
102311852|NCT02243371|Cyclophosphamide|cyclophosphamide|mesh-list
102311853|NCT02243371|Nivolumab|nivolumab|mesh-list
102311854|NCT02243371|Immunologic Factors|immunologic factors|mesh-ancestor
102311855|NCT02243371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311856|NCT02243371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102311857|NCT02243371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102311858|NCT02243371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102020627|NCT03117790|Morphine|morphine|mesh-list
102311859|NCT02243371|Alkylating Agents|alkylating agents|mesh-ancestor
102311860|NCT02243371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311861|NCT02243371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102311862|NCT02243371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102311863|NCT02243371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102311864|NCT02243371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102311865|NCT01931475|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102311866|NCT01931475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102311867|NCT01931475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102311868|NCT01931475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102311869|NCT01931475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311870|NCT01931475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102311871|NCT01931475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311872|NCT01931475|Analgesics|analgesics|mesh-ancestor
102311873|NCT01931475|Sensory System Agents|sensory system agents|mesh-ancestor
102311874|NCT01931475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102311875|NCT01931475|Antidepressive Agents|antidepressive agents|mesh-ancestor
102311876|NCT01931475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102311877|NCT01931475|Dopamine Agents|dopamine agents|mesh-ancestor
102311878|NCT04630821|Sodium Hypochlorite|sodium hypochlorite|mesh-list
102311880|NCT04630821|Disinfectants|disinfectants|mesh-ancestor
102311881|NCT04630821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102311882|NCT01646177|Etanercept|etanercept|mesh-list
102311883|NCT01646177|Ixekizumab|ixekizumab|mesh-list
102311884|NCT01646177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102311885|NCT01646177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102311886|NCT01646177|Analgesics|analgesics|mesh-ancestor
102311887|NCT01646177|Sensory System Agents|sensory system agents|mesh-ancestor
102311888|NCT01646177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102311889|NCT01646177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311890|NCT01646177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102311891|NCT01646177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102311892|NCT01646177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102311893|NCT01646177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102311894|NCT01646177|Immunologic Factors|immunologic factors|mesh-ancestor
102311895|NCT01646177|Dermatologic Agents|dermatologic agents|mesh-ancestor
102311896|NCT01929135|Atorvastatin|atorvastatin|mesh-list
102311897|NCT01929135|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102311898|NCT01929135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102311899|NCT01929135|Antimetabolites|antimetabolites|mesh-ancestor
102311900|NCT01929135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311901|NCT01929135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102311902|NCT01929135|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102311903|NCT01929135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102311904|NCT01911429|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102311905|NCT01911429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102311906|NCT01911429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102311907|NCT01911429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102311908|NCT01911429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311909|NCT01911429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102311910|NCT01911429|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102311911|NCT01911429|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102311912|NCT01911429|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102311913|NCT01911429|Adrenergic Agents|adrenergic agents|mesh-ancestor
102311914|NCT01911429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102311915|NCT01911429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311916|NCT01911429|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102311917|NCT01911429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102311918|NCT01911429|Serotonin Agents|serotonin agents|mesh-ancestor
102311919|NCT01911429|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102311920|NCT01911429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102311921|NCT01911429|Dopamine Agents|dopamine agents|mesh-ancestor
102311922|NCT02324153|Riboflavin|riboflavin|mesh-list
102311923|NCT02324153|Vitamin B Complex|vitamin b complex|mesh-ancestor
102311924|NCT02324153|Vitamins|vitamins|mesh-ancestor
102311925|NCT02324153|Micronutrients|micronutrients|mesh-ancestor
102311926|NCT02324153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311927|NCT02324153|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102311928|NCT02324153|Dermatologic Agents|dermatologic agents|mesh-ancestor
102311929|NCT02280473|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102311930|NCT02280473|Laxatives|laxatives|mesh-ancestor
102311931|NCT02280473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102311932|NCT02308007|Metronidazole|metronidazole|mesh-list
102311934|NCT02308007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102311935|NCT02308007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102311936|NCT02308007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102311937|NCT02308007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102311938|NCT02308007|Antifungal Agents|antifungal agents|mesh-ancestor
102311939|NCT01910181|Vemurafenib|vemurafenib|mesh-list
102311940|NCT01910181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102311941|NCT01910181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102311942|NCT01910181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102311943|NCT01910181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311944|NCT04885907|Vaccines|vaccines|mesh-list
102311945|NCT04885907|Immunologic Factors|immunologic factors|mesh-ancestor
102311946|NCT04885907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311948|NCT01957215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102311949|NCT01957215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102311950|NCT01957215|Analgesics|analgesics|mesh-ancestor
102311951|NCT01957215|Sensory System Agents|sensory system agents|mesh-ancestor
102311952|NCT01957215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102311953|NCT01957215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102311954|NCT01957215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102311955|NCT01957215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102311956|NCT01957215|Gout Suppressants|gout suppressants|mesh-ancestor
102311957|NCT01957215|Tocolytic Agents|tocolytic agents|mesh-ancestor
102311958|NCT01957215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102311959|NCT01957215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102311960|NCT01957215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102311961|NCT01957215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311962|NCT01928433|Ciprofloxacin|ciprofloxacin|mesh-list
102311963|NCT01928433|Finafloxacin|finafloxacin|mesh-list
102311964|NCT01928433|Fluoroquinolones|fluoroquinolones|mesh-list
102311965|NCT01928433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102311966|NCT01928433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102311967|NCT01928433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102311968|NCT01928433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102311969|NCT01928433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102311970|NCT01928433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311971|NCT01928433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102311972|NCT01928433|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102311973|NCT01928433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102311974|NCT01928433|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102311975|NCT01928433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102311976|NCT02322281|Paclitaxel|paclitaxel|mesh-list
102311977|NCT02322281|Docetaxel|docetaxel|mesh-list
102311978|NCT02322281|Gemcitabine|gemcitabine|mesh-list
102311979|NCT02322281|Pemetrexed|pemetrexed|mesh-list
102311980|NCT02322281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102311981|NCT02322281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102311982|NCT02322281|Tubulin Modulators|tubulin modulators|mesh-ancestor
101428457|NCT05780437|Remdesivir|remdesivir|mesh-list
102311983|NCT02322281|Antimitotic Agents|antimitotic agents|mesh-ancestor
102311984|NCT02322281|Mitosis Modulators|mitosis modulators|mesh-ancestor
102311985|NCT02322281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311986|NCT02322281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102311987|NCT02322281|Antimetabolites|antimetabolites|mesh-ancestor
102311988|NCT02322281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102311989|NCT02322281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102311990|NCT02322281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102311991|NCT02243293|Ribavirin|ribavirin|mesh-list
102311992|NCT02243293|Antimetabolites|antimetabolites|mesh-ancestor
102311993|NCT02243293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102311994|NCT02243293|Antiviral Agents|antiviral agents|mesh-ancestor
102311995|NCT02243293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102311996|NCT02322047|Prazosin|prazosin|mesh-list
102311997|NCT02322047|Naltrexone|naltrexone|mesh-list
102311998|NCT02322047|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102311999|NCT02322047|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102312000|NCT02322047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312001|NCT02322047|Sensory System Agents|sensory system agents|mesh-ancestor
102312002|NCT02322047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102312003|NCT02322047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102312004|NCT02322047|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102312005|NCT02322047|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102312006|NCT02322047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101836565|NCT00501540|Antimanic Agents|antimanic agents|mesh-ancestor
102312007|NCT02322047|Adrenergic Agents|adrenergic agents|mesh-ancestor
102312008|NCT02322047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102312009|NCT02322047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312010|NCT02254291|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102312011|NCT02254291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102312012|NCT02254291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312013|NCT02254291|Incretins|incretins|mesh-ancestor
102312014|NCT02254291|Hormones|hormones|mesh-ancestor
102312015|NCT02254291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102312016|NCT02254291|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102312017|NCT02254291|Protease Inhibitors|protease inhibitors|mesh-ancestor
102312018|NCT02254291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102312019|NCT02254291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312020|NCT02277743|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102312021|NCT02277743|Immunologic Factors|immunologic factors|mesh-ancestor
102312022|NCT02277743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312024|NCT02320721|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102312025|NCT02320721|Insulin Glargine|insulin glargine|mesh-list
102312026|NCT02320721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102312027|NCT02320721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312028|NCT02320487|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102312029|NCT02320487|Obinutuzumab|obinutuzumab|mesh-list
102312030|NCT02320487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102312031|NCT02320487|Alkylating Agents|alkylating agents|mesh-ancestor
102312032|NCT02320487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312033|NCT02320487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102312034|NCT02320487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102312035|NCT04197089|Vitamin D|vitamin d|mesh-list
102312036|NCT04197089|Cholecalciferol|cholecalciferol|mesh-list
102312037|NCT04197089|Vitamins|vitamins|mesh-ancestor
102312038|NCT04197089|Micronutrients|micronutrients|mesh-ancestor
102312039|NCT04197089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312040|NCT04197089|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101428520|NCT05723705|Liver Extracts|liver extracts|mesh-list
102312041|NCT04197089|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102312042|NCT02252965|Metformin|metformin|mesh-list
102312043|NCT02252965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102312044|NCT02252965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312045|NCT02251717|Sofosbuvir|sofosbuvir|mesh-list
102312046|NCT02251717|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102312047|NCT02251717|Ledipasvir|ledipasvir|mesh-list
102312048|NCT02251717|Antiviral Agents|antiviral agents|mesh-ancestor
102312049|NCT02251717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102312050|NCT02242201|Ketorolac|ketorolac|mesh-list
102312051|NCT02242201|Epinephrine|epinephrine|mesh-list
102312052|NCT02242201|Bupivacaine|bupivacaine|mesh-list
102312053|NCT02242201|Ropivacaine|ropivacaine|mesh-list
102312054|NCT02242201|Anesthetics, Local|anesthetics, local|mesh-ancestor
102312055|NCT02242201|Anesthetics|anesthetics|mesh-ancestor
102312056|NCT02242201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102312057|NCT02242201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312058|NCT02242201|Sensory System Agents|sensory system agents|mesh-ancestor
102312059|NCT02242201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102312060|NCT02242201|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102312061|NCT02242201|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102312062|NCT02242201|Adrenergic Agents|adrenergic agents|mesh-ancestor
102312063|NCT02242201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102312064|NCT02242201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312065|NCT02242201|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102312066|NCT02242201|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102312067|NCT02242201|Autonomic Agents|autonomic agents|mesh-ancestor
102312068|NCT02242201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102312069|NCT02242201|Respiratory System Agents|respiratory system agents|mesh-ancestor
102312070|NCT02242201|Mydriatics|mydriatics|mesh-ancestor
102312071|NCT02242201|Sympathomimetics|sympathomimetics|mesh-ancestor
102312072|NCT02242201|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102312073|NCT02242201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102312074|NCT02242201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102312075|NCT02242201|Analgesics|analgesics|mesh-ancestor
102312076|NCT02242201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102312077|NCT02242201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102312078|NCT02242201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102312079|NCT02242201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102312080|NCT02242045|Idelalisib|idelalisib|mesh-list
102312081|NCT02242045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101836566|NCT00501540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102312082|NCT02242045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102312083|NCT02242045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312084|NCT02241889|Pancrelipase|pancrelipase|mesh-list
102312085|NCT02241889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102312086|NCT02241187|Cetuximab|cetuximab|mesh-list
102312087|NCT02241187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102312088|NCT02241187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102312089|NCT02249767|Tretinoin|tretinoin|mesh-list
102312090|NCT02249767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102312091|NCT02249767|Keratolytic Agents|keratolytic agents|mesh-ancestor
102312092|NCT02249767|Dermatologic Agents|dermatologic agents|mesh-ancestor
102312093|NCT04892953|Paclitaxel|paclitaxel|mesh-list
102312094|NCT04892953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102312095|NCT04892953|Carboplatin|carboplatin|mesh-list
102312096|NCT04892953|Gemcitabine|gemcitabine|mesh-list
102312097|NCT04892953|Pemetrexed|pemetrexed|mesh-list
102312098|NCT04892953|Durvalumab|durvalumab|mesh-list
102312099|NCT04892953|Immunoglobulins|immunoglobulins|mesh-list
102312100|NCT04892953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102312101|NCT04892953|Immunoglobulin G|immunoglobulin g|mesh-list
102312102|NCT04892953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102312103|NCT04892953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102312104|NCT04892953|Tubulin Modulators|tubulin modulators|mesh-ancestor
102312105|NCT04892953|Antimitotic Agents|antimitotic agents|mesh-ancestor
102312106|NCT04892953|Mitosis Modulators|mitosis modulators|mesh-ancestor
102312107|NCT04892953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312108|NCT04892953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102312109|NCT04892953|Antimetabolites|antimetabolites|mesh-ancestor
102312110|NCT04892953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102312111|NCT04892953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101307041|NCT02029313|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102312112|NCT04892953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102312113|NCT04892953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102312114|NCT04892953|Immunologic Factors|immunologic factors|mesh-ancestor
102312115|NCT04892953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312116|NCT02238379|Oxytocin|oxytocin|mesh-list
102312117|NCT02238379|Oxytocics|oxytocics|mesh-ancestor
102312118|NCT02238379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102312119|NCT02238379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312120|NCT02207491|Timolol|timolol|mesh-list
102312121|NCT02207491|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102312122|NCT02207491|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102312123|NCT02207491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312124|NCT02207491|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102312125|NCT02207491|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102312126|NCT02207491|Adrenergic Agents|adrenergic agents|mesh-ancestor
102312127|NCT02207491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102312128|NCT02207491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312129|NCT02207491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102312130|NCT02207491|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102312131|NCT02315066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102312132|NCT02315066|Immunoglobulin G|immunoglobulin g|mesh-list
102312133|NCT02315066|Immunologic Factors|immunologic factors|mesh-ancestor
102312134|NCT02315066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312135|NCT02207413|Vaccines|vaccines|mesh-list
102312136|NCT02207413|Immunologic Factors|immunologic factors|mesh-ancestor
102312137|NCT02207413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312138|NCT02276027|Ceritinib|ceritinib|mesh-list
102312139|NCT02276027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102312140|NCT02276027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102312141|NCT02276027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102312142|NCT02276027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312143|NCT02233543|Glycopyrrolate|glycopyrrolate|mesh-list
102312144|NCT02233543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102312145|NCT02233543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102312146|NCT02233543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102312147|NCT02233543|Cholinergic Agents|cholinergic agents|mesh-ancestor
102312148|NCT02233543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102312149|NCT02233543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312150|NCT02233543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312151|NCT04761133|Povidone-Iodine|povidone-iodine|mesh-list
102312152|NCT04761133|Povidone|povidone|mesh-list
102312153|NCT04761133|Plasma Substitutes|plasma substitutes|mesh-ancestor
102312154|NCT04761133|Blood Substitutes|blood substitutes|mesh-ancestor
102312155|NCT04761133|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102312156|NCT04761133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102312157|NCT02233309|Anesthetics|anesthetics|mesh-list
102312158|NCT02233309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102312159|NCT02233309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312160|NCT02280044|Rifaximin|rifaximin|mesh-list
102312161|NCT02280044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102312162|NCT02280044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102312163|NCT02280044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102312164|NCT02308748|Moxifloxacin|moxifloxacin|mesh-list
102312165|NCT02308748|Lidocaine|lidocaine|mesh-list
102312166|NCT02308748|Mexiletine|mexiletine|mesh-list
102312167|NCT02308748|Dofetilide|dofetilide|mesh-list
102312168|NCT02308748|Diltiazem|diltiazem|mesh-list
102312169|NCT02308748|Anesthetics, Local|anesthetics, local|mesh-ancestor
102312170|NCT02308748|Anesthetics|anesthetics|mesh-ancestor
102312171|NCT02308748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102312172|NCT02308748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312173|NCT02308748|Sensory System Agents|sensory system agents|mesh-ancestor
102312174|NCT02308748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102312175|NCT02308748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102312176|NCT02308748|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102312177|NCT02308748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102312178|NCT02308748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102312179|NCT02308748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312180|NCT02308748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102312181|NCT02308748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102312182|NCT02308748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102312183|NCT02308748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102312185|NCT02308748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102312186|NCT02308748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102312187|NCT02308748|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102312188|NCT02308748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102312189|NCT02308748|Vasodilator Agents|vasodilator agents|mesh-ancestor
102312190|NCT02308748|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102312191|NCT04745689|Carboplatin|carboplatin|mesh-list
102312192|NCT04745689|Etoposide|etoposide|mesh-list
102312193|NCT04745689|Durvalumab|durvalumab|mesh-list
102312194|NCT04745689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102312195|NCT04745689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102312196|NCT04745689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102312197|NCT04745689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102312198|NCT04745689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102312199|NCT04745689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312200|NCT04745689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102312201|NCT02308124|Midodrine|midodrine|mesh-list
102312202|NCT02308124|Bromides|bromides|mesh-list
102312203|NCT02308124|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
102312204|NCT02308124|Anticonvulsants|anticonvulsants|mesh-ancestor
102312205|NCT02308124|Sympathomimetics|sympathomimetics|mesh-ancestor
102312206|NCT02308124|Autonomic Agents|autonomic agents|mesh-ancestor
102312207|NCT02308124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102312208|NCT02308124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312209|NCT02308124|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102312210|NCT02308124|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102312211|NCT02308124|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102312212|NCT02308124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102312213|NCT02308124|Adrenergic Agents|adrenergic agents|mesh-ancestor
102312214|NCT02308124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102312215|NCT02308124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312216|NCT02308124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102312217|NCT02308124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102312218|NCT02308124|Cholinergic Agents|cholinergic agents|mesh-ancestor
102312219|NCT02232061|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102312220|NCT02232061|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102312221|NCT02232061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312222|NCT02232061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102312223|NCT02232061|Immunologic Factors|immunologic factors|mesh-ancestor
102312224|NCT02232061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312225|NCT02275481|Tiotropium Bromide|tiotropium bromide|mesh-list
102312226|NCT02275481|Formoterol Fumarate|formoterol fumarate|mesh-list
102312227|NCT02275481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102312228|NCT02275481|Autonomic Agents|autonomic agents|mesh-ancestor
102312229|NCT02275481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102312230|NCT02275481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312231|NCT02275481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102312232|NCT02275481|Respiratory System Agents|respiratory system agents|mesh-ancestor
102312233|NCT02275481|Parasympatholytics|parasympatholytics|mesh-ancestor
102312234|NCT02275481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102312235|NCT02275481|Cholinergic Agents|cholinergic agents|mesh-ancestor
102312236|NCT02275481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102312237|NCT02275481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312238|NCT02275481|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102312239|NCT02275481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102312240|NCT02275481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102312241|NCT02275481|Adrenergic Agents|adrenergic agents|mesh-ancestor
102312243|NCT02308046|Antifungal Agents|antifungal agents|mesh-ancestor
102312244|NCT02308046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102312245|NCT02318693|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102312246|NCT02318693|Glyburide|glyburide|mesh-list
102312247|NCT02318693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102312248|NCT02318693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312249|NCT02318693|Incretins|incretins|mesh-ancestor
102312250|NCT02318693|Hormones|hormones|mesh-ancestor
102312251|NCT02318693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102312252|NCT02318693|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102312253|NCT02318693|Protease Inhibitors|protease inhibitors|mesh-ancestor
102312254|NCT02318693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102312255|NCT02318693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312256|NCT02230891|Carvedilol|carvedilol|mesh-list
102312257|NCT02230891|Spironolactone|spironolactone|mesh-list
102312258|NCT02230891|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102312259|NCT02230891|Hormone Antagonists|hormone antagonists|mesh-ancestor
102312260|NCT02230891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102312261|NCT02230891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312262|NCT02230891|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102312263|NCT02230891|Diuretics|diuretics|mesh-ancestor
102312264|NCT02230891|Natriuretic Agents|natriuretic agents|mesh-ancestor
102312265|NCT02230891|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102312266|NCT02230891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102312267|NCT02230891|Adrenergic Agents|adrenergic agents|mesh-ancestor
102312268|NCT02230891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102312269|NCT02230891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312270|NCT02230891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102312271|NCT02230891|Antioxidants|antioxidants|mesh-ancestor
102312272|NCT02230891|Protective Agents|protective agents|mesh-ancestor
102312273|NCT02230891|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102312274|NCT02230891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102312275|NCT02230891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102312276|NCT02230891|Vasodilator Agents|vasodilator agents|mesh-ancestor
102312277|NCT02230891|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102312278|NCT02230891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102312279|NCT02302859|Nicotine|nicotine|mesh-list
102312280|NCT02302859|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102312281|NCT02302859|Autonomic Agents|autonomic agents|mesh-ancestor
102312282|NCT02302859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102312283|NCT02302859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312284|NCT02302859|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102312285|NCT02302859|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102312286|NCT02302859|Cholinergic Agents|cholinergic agents|mesh-ancestor
102312287|NCT02302859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102312288|NCT02302859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312289|NCT02274311|Clomiphene|clomiphene|mesh-list
102312290|NCT02274311|Enclomiphene|enclomiphene|mesh-list
102312291|NCT02274311|Zuclomiphene|zuclomiphene|mesh-list
102312292|NCT02274311|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102312293|NCT02274311|Hormone Antagonists|hormone antagonists|mesh-ancestor
102312294|NCT02274311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102312295|NCT02274311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312296|NCT02274311|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102312297|NCT02274311|Fertility Agents|fertility agents|mesh-ancestor
102312298|NCT02274311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102312299|NCT02274311|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102312300|NCT02274311|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102312301|NCT02316353|Complement C1s|complement c1s|mesh-list
102312302|NCT02316353|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
102312303|NCT02316353|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
102312304|NCT02316353|Immunologic Factors|immunologic factors|mesh-ancestor
102312305|NCT02316353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021072|NCT02439034|Narcotics|narcotics|mesh-ancestor
102312306|NCT02316353|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102312307|NCT02316353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102312308|NCT02279732|Paclitaxel|paclitaxel|mesh-list
102312309|NCT02279732|Carboplatin|carboplatin|mesh-list
102312310|NCT02279732|Ipilimumab|ipilimumab|mesh-list
102312311|NCT02279732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102312312|NCT02279732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102312313|NCT02279732|Tubulin Modulators|tubulin modulators|mesh-ancestor
102312314|NCT02279732|Antimitotic Agents|antimitotic agents|mesh-ancestor
102312315|NCT02279732|Mitosis Modulators|mitosis modulators|mesh-ancestor
101428778|NCT04777422|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102312316|NCT02279732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312317|NCT02279732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102312318|NCT02279732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102312319|NCT05649956|Letrozole|letrozole|mesh-list
102312320|NCT05649956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102312321|NCT05649956|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102312322|NCT05649956|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102312323|NCT05649956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102312324|NCT05649956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312325|NCT05649956|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102312326|NCT05649956|Hormone Antagonists|hormone antagonists|mesh-ancestor
102312327|NCT05649956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102312328|NCT05649956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312329|NCT04876430|Meropenem|meropenem|mesh-list
102312330|NCT04876430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102312331|NCT04876430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102312332|NCT02305238|Aflibercept|aflibercept|mesh-list
102312333|NCT02305238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102312334|NCT02305238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102312335|NCT02305238|Growth Substances|growth substances|mesh-ancestor
102312336|NCT02305238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312337|NCT02305238|Growth Inhibitors|growth inhibitors|mesh-ancestor
102312338|NCT02305238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102312339|NCT02304926|Simvastatin|simvastatin|mesh-list
102312340|NCT02304926|Ezetimibe|ezetimibe|mesh-list
102312341|NCT02304926|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
102312342|NCT02304926|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102312343|NCT02304926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102312344|NCT02304926|Antimetabolites|antimetabolites|mesh-ancestor
102312345|NCT02304926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312346|NCT02304926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102312347|NCT02304926|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102312348|NCT02304926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102312349|NCT01646255|Levodopa|levodopa|mesh-list
102312350|NCT01646255|Rotigotine|rotigotine|mesh-list
102312351|NCT01646255|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102312352|NCT01646255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102312353|NCT01646255|Dopamine Agents|dopamine agents|mesh-ancestor
102312354|NCT01646255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102312355|NCT01646255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312356|NCT01646255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312357|NCT01646255|Dopamine Agonists|dopamine agonists|mesh-ancestor
102312358|NCT02203591|Ethanol|ethanol|mesh-list
102312359|NCT02203591|Chlorhexidine|chlorhexidine|mesh-list
102312360|NCT02203591|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102312361|NCT02203591|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102312362|NCT02203591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102312363|NCT02203591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102312364|NCT02203591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312365|NCT02203591|Disinfectants|disinfectants|mesh-ancestor
102312366|NCT02203591|Dermatologic Agents|dermatologic agents|mesh-ancestor
102312367|NCT01642277|Solifenacin Succinate|solifenacin succinate|mesh-list
102312368|NCT01642277|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102312369|NCT01642277|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102312370|NCT01642277|Cholinergic Agents|cholinergic agents|mesh-ancestor
102312371|NCT01642277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102312372|NCT01642277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312373|NCT01642277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312374|NCT01642277|Urological Agents|urological agents|mesh-ancestor
102312375|NCT02230189|Methacholine Chloride|methacholine chloride|mesh-list
102312376|NCT02230189|Miotics|miotics|mesh-ancestor
102312377|NCT02230189|Autonomic Agents|autonomic agents|mesh-ancestor
102312378|NCT02230189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102312379|NCT02230189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312380|NCT02230189|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102312381|NCT02230189|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
102312382|NCT02230189|Respiratory System Agents|respiratory system agents|mesh-ancestor
102312383|NCT02230189|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102312384|NCT02230189|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102312385|NCT02230189|Cholinergic Agents|cholinergic agents|mesh-ancestor
102312386|NCT02230189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102312387|NCT02230189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312389|NCT02304302|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102312390|NCT02304302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102312392|NCT02304302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102312393|NCT02304302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312394|NCT02304302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312395|NCT02304302|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102312396|NCT02304302|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102312397|NCT02276612|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102312398|NCT02276612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102312399|NCT02276612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102312400|NCT02276612|Antiviral Agents|antiviral agents|mesh-ancestor
102312401|NCT02276612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102312402|NCT02301143|Paclitaxel|paclitaxel|mesh-list
102312403|NCT02301143|Gemcitabine|gemcitabine|mesh-list
102312404|NCT02301143|Capecitabine|capecitabine|mesh-list
102312405|NCT02301143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102312406|NCT02301143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102312407|NCT02301143|Tubulin Modulators|tubulin modulators|mesh-ancestor
102312408|NCT02301143|Antimitotic Agents|antimitotic agents|mesh-ancestor
102312409|NCT02301143|Mitosis Modulators|mitosis modulators|mesh-ancestor
102312410|NCT02301143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312411|NCT02301143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102312412|NCT02301143|Antimetabolites|antimetabolites|mesh-ancestor
102312413|NCT02276222|Glycopyrrolate|glycopyrrolate|mesh-list
102312414|NCT02276222|Tiotropium Bromide|tiotropium bromide|mesh-list
102312415|NCT02276222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102312416|NCT02276222|Autonomic Agents|autonomic agents|mesh-ancestor
102312417|NCT02276222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102312418|NCT02276222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312419|NCT02276222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102312420|NCT02276222|Respiratory System Agents|respiratory system agents|mesh-ancestor
102312421|NCT02276222|Parasympatholytics|parasympatholytics|mesh-ancestor
102312422|NCT02276222|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102312423|NCT02276222|Cholinergic Agents|cholinergic agents|mesh-ancestor
102312424|NCT02276222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102312425|NCT02276222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312426|NCT02276222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102312427|NCT02276222|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102312428|NCT02275052|Albuterol|albuterol|mesh-list
102312429|NCT02275052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102312430|NCT02275052|Autonomic Agents|autonomic agents|mesh-ancestor
102312431|NCT02275052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102312432|NCT02275052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312433|NCT02275052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102312434|NCT02275052|Respiratory System Agents|respiratory system agents|mesh-ancestor
102312435|NCT02275052|Tocolytic Agents|tocolytic agents|mesh-ancestor
102312436|NCT02275052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102312437|NCT02275052|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102312438|NCT02275052|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102312439|NCT02275052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102312440|NCT02275052|Adrenergic Agents|adrenergic agents|mesh-ancestor
102312441|NCT02275052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102312442|NCT02275052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312443|NCT05649020|Prilocaine|prilocaine|mesh-list
102312444|NCT05649020|Anesthetics, Local|anesthetics, local|mesh-ancestor
102312445|NCT05649020|Anesthetics|anesthetics|mesh-ancestor
102312446|NCT05649020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102312447|NCT05649020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312448|NCT05649020|Sensory System Agents|sensory system agents|mesh-ancestor
102312449|NCT05649020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102312450|NCT04869488|Prednisone|prednisone|mesh-list
102312451|NCT04869488|Apatinib|apatinib|mesh-list
102312452|NCT04869488|Abiraterone Acetate|abiraterone acetate|mesh-list
102312453|NCT04869488|Fluzoparib|fluzoparib|mesh-list
102312454|NCT04869488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102312455|NCT04869488|Glucocorticoids|glucocorticoids|mesh-ancestor
102312456|NCT04869488|Hormones|hormones|mesh-ancestor
102312457|NCT04869488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102312458|NCT04869488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312459|NCT04869488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102312460|NCT04869488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102312461|NCT04869488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102312462|NCT04869488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102312463|NCT04869488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312464|NCT04869488|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102312465|NCT04869488|Hormone Antagonists|hormone antagonists|mesh-ancestor
102312466|NCT04869488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102312467|NCT04869488|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102312469|NCT02274038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102312470|NCT02274038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102312471|NCT02274038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312472|NCT02274038|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102312473|NCT02274038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102312474|NCT01646021|Sirolimus|sirolimus|mesh-list
102312475|NCT01646021|Temsirolimus|temsirolimus|mesh-list
102312476|NCT01646021|MTOR Inhibitors|mtor inhibitors|mesh-list
102312477|NCT01646021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102312478|NCT01646021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102312479|NCT01646021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312480|NCT01646021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102312481|NCT01646021|Immunologic Factors|immunologic factors|mesh-ancestor
102312482|NCT01646021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312483|NCT01646021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102312484|NCT01646021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102312485|NCT01646021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102312486|NCT01646021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102312487|NCT01646021|Antifungal Agents|antifungal agents|mesh-ancestor
102312488|NCT01750918|Fluorouracil|fluorouracil|mesh-list
102312489|NCT01750918|Panitumumab|panitumumab|mesh-list
102312490|NCT01750918|Trametinib|trametinib|mesh-list
102312491|NCT01750918|Dabrafenib|dabrafenib|mesh-list
102312492|NCT01750918|Antimetabolites|antimetabolites|mesh-ancestor
102312493|NCT01750918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312494|NCT01750918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102312495|NCT01750918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102312496|NCT01750918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102312497|NCT01750918|Immunologic Factors|immunologic factors|mesh-ancestor
102312498|NCT01750918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312499|NCT01750918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102312500|NCT01750918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102312501|NCT01750918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102312502|NCT01750840|Cimetidine|cimetidine|mesh-list
102312503|NCT01750840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102312504|NCT01750840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102312505|NCT01750840|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102312506|NCT01750840|Histamine Antagonists|histamine antagonists|mesh-ancestor
102312507|NCT01750840|Histamine Agents|histamine agents|mesh-ancestor
102312508|NCT01750840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102312509|NCT01750840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312510|NCT01750840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312511|NCT01750840|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102312512|NCT01750840|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102312513|NCT01750840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102312514|NCT01606228|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102312515|NCT01606228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102312516|NCT01606228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102312517|NCT01606228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102312518|NCT01606228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312519|NCT01606228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102312520|NCT01606228|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102312521|NCT01606228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102312522|NCT01606228|Serotonin Agents|serotonin agents|mesh-ancestor
102312523|NCT01606228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102312524|NCT01606228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312525|NCT01606228|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102312526|NCT01606228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102312527|NCT01606228|Dopamine Agents|dopamine agents|mesh-ancestor
102312529|NCT02269943|Cc-486|cc-486|mesh-list
102312530|NCT02269943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102312531|NCT02269943|Antimetabolites|antimetabolites|mesh-ancestor
102312532|NCT02269943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312533|NCT02269943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102312534|NCT02269943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102312535|NCT01605370|Metoprolol|metoprolol|mesh-list
102312536|NCT01605370|Nebivolol|nebivolol|mesh-list
102312537|NCT01605370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102312538|NCT01605370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102312539|NCT01605370|Sympatholytics|sympatholytics|mesh-ancestor
102312540|NCT01605370|Autonomic Agents|autonomic agents|mesh-ancestor
102312541|NCT01605370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102312542|NCT01605370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312543|NCT01605370|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102312544|NCT01605370|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102312545|NCT01605370|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102312546|NCT01605370|Adrenergic Agents|adrenergic agents|mesh-ancestor
102312547|NCT01605370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102312548|NCT01605370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312549|NCT01605370|Vasodilator Agents|vasodilator agents|mesh-ancestor
102312550|NCT01605370|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102312551|NCT01605370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102312552|NCT01605370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102312553|NCT01605136|Afamelanotide|afamelanotide|mesh-list
102312554|NCT01605136|Dermatologic Agents|dermatologic agents|mesh-ancestor
102312555|NCT01706146|Rivaroxaban|rivaroxaban|mesh-list
102312556|NCT01706146|Apixaban|apixaban|mesh-list
102312557|NCT01706146|Dabigatran|dabigatran|mesh-list
102312558|NCT01706146|Anticoagulants|anticoagulants|mesh-list
102312559|NCT01706146|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102312560|NCT01706146|Antithrombins|antithrombins|mesh-ancestor
102312561|NCT01706146|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102312562|NCT01706146|Protease Inhibitors|protease inhibitors|mesh-ancestor
102312563|NCT01706146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102312564|NCT01706146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312565|NCT02269241|Drospirenone|drospirenone|mesh-list
102312566|NCT02269241|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102312567|NCT02269241|Hormone Antagonists|hormone antagonists|mesh-ancestor
102312568|NCT02269241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102312569|NCT02269241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312570|NCT02269241|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102312571|NCT02269241|Diuretics|diuretics|mesh-ancestor
102312572|NCT02269241|Natriuretic Agents|natriuretic agents|mesh-ancestor
102312573|NCT01750294|Chlorthalidone|chlorthalidone|mesh-list
102312574|NCT01750294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102312575|NCT01750294|Diuretics|diuretics|mesh-ancestor
102312576|NCT01750294|Natriuretic Agents|natriuretic agents|mesh-ancestor
102312577|NCT01750294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312578|NCT01750294|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102312579|NCT01750294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102312580|NCT01750294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312581|NCT01749982|Choline|choline|mesh-list
102312582|NCT01749982|Betaine|betaine|mesh-list
102312583|NCT01749982|Lipotropic Agents|lipotropic agents|mesh-ancestor
102312584|NCT01749982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102312585|NCT01749982|Antimetabolites|antimetabolites|mesh-ancestor
102312586|NCT01749982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312587|NCT01749982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102312588|NCT01749982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102312589|NCT01749982|Nootropic Agents|nootropic agents|mesh-ancestor
102312590|NCT02269163|Immunoglobulins|immunoglobulins|mesh-list
102312591|NCT02269163|Antibodies|antibodies|mesh-list
102312592|NCT02269163|gamma-Globulins|gamma-globulins|mesh-list
102312593|NCT02269163|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102312594|NCT02269163|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102312595|NCT02269163|Immunoglobulin G|immunoglobulin g|mesh-list
102312596|NCT02269163|Immunologic Factors|immunologic factors|mesh-ancestor
102312597|NCT02269163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312598|NCT01749826|Morphine|morphine|mesh-list
102312599|NCT01749826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102021374|NCT03789318|Antipyretics|antipyretics|mesh-ancestor
102312600|NCT01749826|Narcotics|narcotics|mesh-ancestor
102312601|NCT01749826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102312602|NCT01749826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312603|NCT01749826|Analgesics|analgesics|mesh-ancestor
102312605|NCT01749826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102312606|NCT01724866|Cyclophosphamide|cyclophosphamide|mesh-list
102312607|NCT01724866|Docetaxel|docetaxel|mesh-list
102312608|NCT01724866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102312609|NCT01724866|Immunologic Factors|immunologic factors|mesh-ancestor
102312610|NCT01724866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312611|NCT01724866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102312612|NCT01724866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102312613|NCT01724866|Alkylating Agents|alkylating agents|mesh-ancestor
102312614|NCT01724866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312615|NCT01724866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102312616|NCT01724866|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102312617|NCT01724866|Tubulin Modulators|tubulin modulators|mesh-ancestor
102312618|NCT01724866|Antimitotic Agents|antimitotic agents|mesh-ancestor
102312619|NCT01724866|Mitosis Modulators|mitosis modulators|mesh-ancestor
102312620|NCT02266433|Dexamethasone|dexamethasone|mesh-list
102312621|NCT02266433|Ketorolac|ketorolac|mesh-list
102312622|NCT02266433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102312623|NCT02266433|Antiemetics|antiemetics|mesh-ancestor
102312624|NCT02266433|Autonomic Agents|autonomic agents|mesh-ancestor
102312625|NCT02266433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102312626|NCT02266433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312627|NCT02266433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102312628|NCT02266433|Glucocorticoids|glucocorticoids|mesh-ancestor
102312629|NCT02266433|Hormones|hormones|mesh-ancestor
102312630|NCT02266433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102312631|NCT02266433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102312632|NCT02266433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102312633|NCT02266433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102312634|NCT02266433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102312635|NCT02266433|Analgesics|analgesics|mesh-ancestor
102312636|NCT02266433|Sensory System Agents|sensory system agents|mesh-ancestor
102312637|NCT02266433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102312638|NCT02266433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102312639|NCT02266433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102312640|NCT02266433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312641|NCT02273726|Epoetin Alfa|epoetin alfa|mesh-list
102312642|NCT02273726|Hematinics|hematinics|mesh-ancestor
102312643|NCT01723228|Rasagiline|rasagiline|mesh-list
102312644|NCT01723228|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102312645|NCT01723228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102312646|NCT01723228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312647|NCT01723228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102312648|NCT01723228|Protective Agents|protective agents|mesh-ancestor
102312649|NCT01723228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312650|NCT02273180|Insulin|insulin|mesh-list
102312651|NCT02273180|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102312652|NCT02273180|Insulin Glargine|insulin glargine|mesh-list
102312653|NCT02273180|Insulin Lispro|insulin lispro|mesh-list
102312654|NCT02273180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102312655|NCT02273180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312656|NCT01745380|Phenylephrine|phenylephrine|mesh-list
102312657|NCT01745380|Oxymetazoline|oxymetazoline|mesh-list
102312658|NCT01745380|Tetracaine|tetracaine|mesh-list
102312659|NCT01745380|Anesthetics, Local|anesthetics, local|mesh-ancestor
102312660|NCT01745380|Anesthetics|anesthetics|mesh-ancestor
102312661|NCT01745380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102312662|NCT01745380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312663|NCT01745380|Sensory System Agents|sensory system agents|mesh-ancestor
102312664|NCT01745380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102312665|NCT01745380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102312666|NCT01745380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102312667|NCT01745380|Adrenergic Agents|adrenergic agents|mesh-ancestor
102312668|NCT01745380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102312669|NCT01745380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312670|NCT01745380|Sympathomimetics|sympathomimetics|mesh-ancestor
102312671|NCT01745380|Autonomic Agents|autonomic agents|mesh-ancestor
102312672|NCT01745380|Nasal Decongestants|nasal decongestants|mesh-ancestor
102312673|NCT01745380|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102312674|NCT01745380|Respiratory System Agents|respiratory system agents|mesh-ancestor
102312675|NCT01745380|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102312676|NCT01745380|Mydriatics|mydriatics|mesh-ancestor
102312677|NCT01745380|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102312678|NCT01745380|Protective Agents|protective agents|mesh-ancestor
102312679|NCT04550104|Olaparib|olaparib|mesh-list
102312680|NCT04550104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102312681|NCT04550104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102312682|NCT04550104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312683|NCT04550104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102312684|NCT05648318|Lactulose|lactulose|mesh-list
102312685|NCT05648318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102312686|NCT02203513|Prexasertib|prexasertib|mesh-list
102312687|NCT02203513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102312688|NCT02203513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102312689|NCT02203513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312690|NCT01703260|Pioglitazone|pioglitazone|mesh-list
102312691|NCT01703260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102312692|NCT01703260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312693|NCT02299388|Liraglutide|liraglutide|mesh-list
102312694|NCT02299388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102312695|NCT02299388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312696|NCT02299388|Incretins|incretins|mesh-ancestor
102312697|NCT02299388|Hormones|hormones|mesh-ancestor
102312698|NCT02299388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102312699|NCT02202577|Chlorhexidine|chlorhexidine|mesh-list
102312700|NCT02202577|Povidone-Iodine|povidone-iodine|mesh-list
102312701|NCT02202577|Povidone|povidone|mesh-list
102312702|NCT02202577|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102312703|NCT02202577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102312704|NCT02202577|Disinfectants|disinfectants|mesh-ancestor
102312705|NCT02202577|Plasma Substitutes|plasma substitutes|mesh-ancestor
102312706|NCT02202577|Blood Substitutes|blood substitutes|mesh-ancestor
102312707|NCT01723072|Omalizumab|omalizumab|mesh-list
102312708|NCT01723072|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102312709|NCT01723072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102312710|NCT01723072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102312711|NCT01723072|Respiratory System Agents|respiratory system agents|mesh-ancestor
102312712|NCT01723072|Immunologic Factors|immunologic factors|mesh-ancestor
102312713|NCT01723072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312714|NCT02169505|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102312715|NCT02169505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102312716|NCT02169505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102312717|NCT02169505|Immunotoxins|immunotoxins|mesh-ancestor
102312718|NCT02169505|Immunoconjugates|immunoconjugates|mesh-ancestor
102312719|NCT02169505|Immunologic Factors|immunologic factors|mesh-ancestor
102312720|NCT02169505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312721|NCT01909791|Aflibercept|aflibercept|mesh-list
102312722|NCT01909791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102312723|NCT01909791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102312724|NCT01909791|Growth Substances|growth substances|mesh-ancestor
102312725|NCT01909791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312726|NCT01909791|Growth Inhibitors|growth inhibitors|mesh-ancestor
102312727|NCT01909791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102312728|NCT02202499|Varenicline|varenicline|mesh-list
102312729|NCT02202499|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102312730|NCT02202499|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102312731|NCT02202499|Cholinergic Agents|cholinergic agents|mesh-ancestor
102312732|NCT02202499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102312733|NCT02202499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312734|NCT02202499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312735|NCT02227849|Canagliflozin|canagliflozin|mesh-list
102312736|NCT02227849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102312737|NCT02227849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312738|NCT02227849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102312739|NCT02227849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312740|NCT02169271|Aspirin|aspirin|mesh-list
102312741|NCT02169271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102312742|NCT02169271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102312743|NCT02169271|Analgesics|analgesics|mesh-ancestor
102312744|NCT02169271|Sensory System Agents|sensory system agents|mesh-ancestor
102312745|NCT02169271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102312746|NCT02169271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312747|NCT02169271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102312748|NCT02169271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102312749|NCT02169271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102312750|NCT02169271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102312751|NCT02169271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312752|NCT02169271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102312753|NCT02169271|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102312754|NCT02169271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102312756|NCT01644188|Ezetimibe|ezetimibe|mesh-list
102312757|NCT01644188|Alirocumab|alirocumab|mesh-list
102312758|NCT01644188|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102312759|NCT01644188|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102312760|NCT01644188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102312761|NCT01644188|Antimetabolites|antimetabolites|mesh-ancestor
102312762|NCT01644188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312763|NCT01644188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102312764|NCT01644188|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102312765|NCT01644188|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102312766|NCT01644188|Protease Inhibitors|protease inhibitors|mesh-ancestor
102312767|NCT01644188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102312768|NCT01644188|Immunologic Factors|immunologic factors|mesh-ancestor
102312769|NCT01644188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312770|NCT02201953|Sofosbuvir|sofosbuvir|mesh-list
102312771|NCT02201953|Antiviral Agents|antiviral agents|mesh-ancestor
102312772|NCT02201953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102312773|NCT02271854|Diclofenac|diclofenac|mesh-list
102312774|NCT02271854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102312775|NCT02271854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102312776|NCT02271854|Analgesics|analgesics|mesh-ancestor
102312777|NCT02271854|Sensory System Agents|sensory system agents|mesh-ancestor
102312778|NCT02271854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102312779|NCT02271854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312780|NCT02271854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102312781|NCT02271854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102312782|NCT02271854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102312783|NCT02271854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102312784|NCT02271854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312785|NCT02296892|Midazolam|midazolam|mesh-list
102312786|NCT02296892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102312787|NCT02296892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102312788|NCT02296892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102312789|NCT02296892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312790|NCT02296892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102312791|NCT02296892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102312792|NCT02296892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102312793|NCT02296892|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102312794|NCT02296892|Anesthetics, General|anesthetics, general|mesh-ancestor
102312795|NCT02296892|Anesthetics|anesthetics|mesh-ancestor
102312796|NCT02296892|GABA Modulators|gaba modulators|mesh-ancestor
102312797|NCT02296892|GABA Agents|gaba agents|mesh-ancestor
102312798|NCT02296892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102312799|NCT02296892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312800|NCT02168803|Evacetrapib|evacetrapib|mesh-list
102312801|NCT02168803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102312802|NCT02168803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102312803|NCT02168803|Antimetabolites|antimetabolites|mesh-ancestor
102312804|NCT02168803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312805|NCT02168803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102312806|NCT02201329|Azacitidine|azacitidine|mesh-list
102312807|NCT02201329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102312808|NCT02201329|Antimetabolites|antimetabolites|mesh-ancestor
102312809|NCT02201329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312810|NCT02201329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102312811|NCT02201329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102312812|NCT01927419|Nivolumab|nivolumab|mesh-list
102312813|NCT01927419|Ipilimumab|ipilimumab|mesh-list
102312814|NCT01927419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102312815|NCT01927419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102312816|NCT01927419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102312817|NCT01927419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312818|NCT02168491|Insulin Glargine|insulin glargine|mesh-list
102312819|NCT02168491|Lixisenatide|lixisenatide|mesh-list
102312820|NCT02168491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102312821|NCT02168491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312822|NCT01721746|Paclitaxel|paclitaxel|mesh-list
102312823|NCT01721746|Carboplatin|carboplatin|mesh-list
102312824|NCT01721746|Nivolumab|nivolumab|mesh-list
102312825|NCT01721746|Dacarbazine|dacarbazine|mesh-list
102312826|NCT01721746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102312827|NCT01721746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102021606|NCT02887248|Paclitaxel|paclitaxel|mesh-list
102312828|NCT01721746|Tubulin Modulators|tubulin modulators|mesh-ancestor
102312829|NCT01721746|Antimitotic Agents|antimitotic agents|mesh-ancestor
102312830|NCT01721746|Mitosis Modulators|mitosis modulators|mesh-ancestor
102312831|NCT01721746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312832|NCT01721746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102312833|NCT01721746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102312834|NCT01721746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102312835|NCT01721746|Alkylating Agents|alkylating agents|mesh-ancestor
102312836|NCT02225665|Cyclophosphamide|cyclophosphamide|mesh-list
102312837|NCT02225665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102312838|NCT02225665|Immunologic Factors|immunologic factors|mesh-ancestor
102312839|NCT02225665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312840|NCT02225665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102312841|NCT02225665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102312842|NCT02225665|Alkylating Agents|alkylating agents|mesh-ancestor
102312843|NCT02225665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312844|NCT02225665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102312845|NCT02225665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102312846|NCT02225587|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102312847|NCT02225587|Immunologic Factors|immunologic factors|mesh-ancestor
102312848|NCT02225587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312849|NCT02296424|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102312850|NCT02296424|Immunologic Factors|immunologic factors|mesh-ancestor
102312851|NCT02296424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312852|NCT02296190|Etripamil|etripamil|mesh-list
102312853|NCT02296190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102312854|NCT02296190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102312855|NCT02296190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312856|NCT02296190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102312857|NCT02296190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312858|NCT04875026|Fluorouracil|fluorouracil|mesh-list
102312859|NCT04875026|Antimetabolites|antimetabolites|mesh-ancestor
102312860|NCT04875026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312861|NCT04875026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102312862|NCT04875026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102312863|NCT04875026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102312864|NCT04875026|Immunologic Factors|immunologic factors|mesh-ancestor
102312865|NCT04875026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312866|NCT02296112|Trametinib|trametinib|mesh-list
102312867|NCT02296112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102312868|NCT02296112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102312869|NCT02296112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102312870|NCT02296112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312871|NCT02269670|Tamoxifen|tamoxifen|mesh-list
102312872|NCT02269670|Everolimus|everolimus|mesh-list
102312873|NCT02269670|Letrozole|letrozole|mesh-list
102312874|NCT02269670|Fulvestrant|fulvestrant|mesh-list
102312875|NCT02269670|Anastrozole|anastrozole|mesh-list
102312876|NCT02269670|Megestrol|megestrol|mesh-list
102312877|NCT02269670|Megestrol Acetate|megestrol acetate|mesh-list
102312878|NCT02269670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312879|NCT02269670|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102312880|NCT02269670|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102312881|NCT02269670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102312882|NCT02269670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102312883|NCT02269670|Immunologic Factors|immunologic factors|mesh-ancestor
102312884|NCT02269670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312885|NCT02269670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102312886|NCT02269670|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102312887|NCT02269670|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102312888|NCT02269670|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102312889|NCT02269670|Hormone Antagonists|hormone antagonists|mesh-ancestor
102312890|NCT02269670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102312891|NCT02269670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102312892|NCT02269670|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102312893|NCT02269670|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102312894|NCT02269670|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102312895|NCT02269670|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102312896|NCT02269670|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102312897|NCT02269670|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102312898|NCT02269670|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102312899|NCT02269670|Contraceptive Agents|contraceptive agents|mesh-ancestor
102312900|NCT02269670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102312901|NCT02269670|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102312902|NCT02269670|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102312903|NCT02269670|Appetite Stimulants|appetite stimulants|mesh-ancestor
102312904|NCT02269670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102312905|NCT02225353|Progesterone|progesterone|mesh-list
102312906|NCT02225353|Progestins|progestins|mesh-ancestor
102312907|NCT02225353|Hormones|hormones|mesh-ancestor
102312908|NCT02225353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102312909|NCT02225353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312910|NCT01641926|Interferons|interferons|mesh-list
102312911|NCT01641926|Interferon-alpha|interferon-alpha|mesh-list
102312912|NCT01641926|Interferon alpha-2|interferon alpha-2|mesh-list
102312913|NCT01641926|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102312915|NCT01641926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102312916|NCT01641926|Antiviral Agents|antiviral agents|mesh-ancestor
102312917|NCT01641926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102312918|NCT01641926|Immunologic Factors|immunologic factors|mesh-ancestor
102312919|NCT01641926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312920|NCT02294786|Capecitabine|capecitabine|mesh-list
102312921|NCT02294786|Lapatinib|lapatinib|mesh-list
102312922|NCT02294786|Octreotide|octreotide|mesh-list
102312923|NCT02294786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102312924|NCT02294786|Antimetabolites|antimetabolites|mesh-ancestor
102312925|NCT02294786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312926|NCT02294786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102312927|NCT02294786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102312928|NCT02294786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102312929|NCT02294786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102312930|NCT02294786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102312931|NCT04880876|Eluxadoline|eluxadoline|mesh-list
102312932|NCT04880876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102312933|NCT01927341|Panitumumab|panitumumab|mesh-list
102312934|NCT01927341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102312935|NCT01927341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102312936|NCT02294474|Insulin|insulin|mesh-list
102312937|NCT02294474|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102312938|NCT02294474|Insulin Glargine|insulin glargine|mesh-list
102312939|NCT02294474|Insulin Lispro|insulin lispro|mesh-list
102312940|NCT02294474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102312941|NCT02294474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312942|NCT02168101|Ixazomib|ixazomib|mesh-list
102312943|NCT02168101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102312944|NCT02168101|Protease Inhibitors|protease inhibitors|mesh-ancestor
102312945|NCT02168101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102312946|NCT02168101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312947|NCT01956123|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102312948|NCT01956123|Hormones|hormones|mesh-ancestor
102312949|NCT01956123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102312950|NCT01956123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312951|NCT02298179|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102312952|NCT02298179|MF59 oil emulsion|mf59 oil emulsion|mesh-list
102312953|NCT02298179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102312954|NCT02298179|Immunologic Factors|immunologic factors|mesh-ancestor
102312955|NCT02298179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312956|NCT02298179|Antacids|antacids|mesh-ancestor
102312957|NCT02298179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312958|NCT02298179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102312959|NCT02298023|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102312960|NCT02298023|Hemostatics|hemostatics|mesh-ancestor
102312961|NCT02298023|Coagulants|coagulants|mesh-ancestor
102312962|NCT02296931|Magnesium Sulfate|magnesium sulfate|mesh-list
102312963|NCT02296931|Analgesics|analgesics|mesh-ancestor
102312964|NCT02296931|Sensory System Agents|sensory system agents|mesh-ancestor
102312965|NCT02296931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102312966|NCT02296931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312967|NCT02296931|Anesthetics|anesthetics|mesh-ancestor
102312968|NCT02296931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102312969|NCT02296931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102312970|NCT02296931|Anticonvulsants|anticonvulsants|mesh-ancestor
102312971|NCT02296931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102312972|NCT02296931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102312973|NCT02296931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312974|NCT02296931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102312975|NCT02296931|Tocolytic Agents|tocolytic agents|mesh-ancestor
102312976|NCT02296931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102312977|NCT02166697|Candesartan|candesartan|mesh-list
102312978|NCT02166697|Candesartan cilexetil|candesartan cilexetil|mesh-list
102021738|NCT03418675|Dopamine Agents|dopamine agents|mesh-ancestor
102312979|NCT02166697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102312980|NCT02166697|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102312981|NCT02166697|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102312982|NCT02166697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312983|NCT04764721|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102312984|NCT04764721|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102312985|NCT04764721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102312986|NCT02197897|Tamoxifen|tamoxifen|mesh-list
102312987|NCT02197897|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102312988|NCT02197897|Hormone Antagonists|hormone antagonists|mesh-ancestor
102312989|NCT02197897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102312990|NCT02197897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102312991|NCT02197897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102312992|NCT02197897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102312993|NCT02197897|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102312994|NCT02197897|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102312995|NCT02197897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102312997|NCT02196259|Anesthetics, Dissociative|anesthetics, dissociative|mesh-list
102312998|NCT02196259|Anesthetics|anesthetics|mesh-list
102312999|NCT02196259|Analgesics|analgesics|mesh-ancestor
102313000|NCT02196259|Sensory System Agents|sensory system agents|mesh-ancestor
102313001|NCT02196259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102313002|NCT02196259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313003|NCT02196259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102313004|NCT02196259|Anesthetics, General|anesthetics, general|mesh-ancestor
102313005|NCT02196259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102313006|NCT02196259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102313007|NCT02196259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102313008|NCT02196259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102313009|NCT02196259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313010|NCT02294396|Solifenacin Succinate|solifenacin succinate|mesh-list
102313011|NCT02294396|Mirabegron|mirabegron|mesh-list
102313012|NCT02294396|Tolterodine Tartrate|tolterodine tartrate|mesh-list
102313013|NCT02294396|Propiverine|propiverine|mesh-list
102313014|NCT02294396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102313015|NCT02294396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102313016|NCT02294396|Cholinergic Agents|cholinergic agents|mesh-ancestor
102313017|NCT02294396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102313018|NCT02294396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313019|NCT02294396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313020|NCT02294396|Urological Agents|urological agents|mesh-ancestor
102313021|NCT02294396|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102313022|NCT02294396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102313023|NCT02294396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102313024|NCT02294396|Adrenergic Agents|adrenergic agents|mesh-ancestor
102313025|NCT02294396|Parasympatholytics|parasympatholytics|mesh-ancestor
102313026|NCT02294396|Autonomic Agents|autonomic agents|mesh-ancestor
102313027|NCT02294396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102313028|NCT02164981|Nitroprusside|nitroprusside|mesh-list
102313029|NCT02164981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102313030|NCT02164981|Vasodilator Agents|vasodilator agents|mesh-ancestor
102313031|NCT02164981|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102313032|NCT02164981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313033|NCT01908699|Beraprost|beraprost|mesh-list
102313034|NCT01908699|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102313035|NCT01908699|Vasodilator Agents|vasodilator agents|mesh-ancestor
102313036|NCT01363011|Darunavir|darunavir|mesh-list
102313037|NCT01363011|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102313038|NCT01363011|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102313039|NCT01363011|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102313040|NCT01363011|Protease Inhibitors|protease inhibitors|mesh-ancestor
102313041|NCT01363011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102313042|NCT01363011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313043|NCT01363011|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102313044|NCT01363011|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102313045|NCT01363011|Antiviral Agents|antiviral agents|mesh-ancestor
102313046|NCT01363011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102313047|NCT02263547|Teriflunomide|teriflunomide|mesh-list
102313048|NCT02263547|Colestipol|colestipol|mesh-list
102313049|NCT02263547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101556340|NCT05927155|Parasympatholytics|parasympatholytics|mesh-ancestor
102313050|NCT02263547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102313051|NCT02263547|Analgesics|analgesics|mesh-ancestor
102313052|NCT02263547|Sensory System Agents|sensory system agents|mesh-ancestor
102313053|NCT02263547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102313054|NCT02263547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313055|NCT02263547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102313056|NCT02263547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102313057|NCT02263547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102313058|NCT02263547|Immunologic Factors|immunologic factors|mesh-ancestor
102313059|NCT02263547|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102313060|NCT02263547|Antimetabolites|antimetabolites|mesh-ancestor
102313061|NCT02263547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313062|NCT02263547|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102313063|NCT02263547|Sequestering Agents|sequestering agents|mesh-ancestor
102313064|NCT01925703|Ferric gluconate|ferric gluconate|mesh-list
102313065|NCT01925703|Hematinics|hematinics|mesh-ancestor
102313066|NCT01617681|Valsartan|valsartan|mesh-list
102313067|NCT01617681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102313068|NCT01617681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102313069|NCT01617681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102313070|NCT01617681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313071|NCT02263079|Interferons|interferons|mesh-list
102313072|NCT02263079|Interferon-alpha|interferon-alpha|mesh-list
102313073|NCT02263079|Lamivudine|lamivudine|mesh-list
102313074|NCT02263079|Interferon alpha-2|interferon alpha-2|mesh-list
102313075|NCT02263079|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102313076|NCT02263079|Entecavir|entecavir|mesh-list
102313077|NCT02263079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102313078|NCT02263079|Antiviral Agents|antiviral agents|mesh-ancestor
102313079|NCT02263079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102313080|NCT02263079|Immunologic Factors|immunologic factors|mesh-ancestor
102313081|NCT02263079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313082|NCT02263079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102313083|NCT02263079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102313084|NCT02263079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102313085|NCT02263079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313086|NCT02263079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102313087|NCT02263079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102313088|NCT02260817|Choline|choline|mesh-list
102313089|NCT02260817|Lipotropic Agents|lipotropic agents|mesh-ancestor
102313090|NCT02260817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102313091|NCT02260817|Antimetabolites|antimetabolites|mesh-ancestor
102313092|NCT02260817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313093|NCT02260817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102313094|NCT02260817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102313095|NCT02260817|Nootropic Agents|nootropic agents|mesh-ancestor
102313096|NCT04873193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102313097|NCT04873193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102313098|NCT01642589|Vaccines|vaccines|mesh-list
102313099|NCT01642589|Immunologic Factors|immunologic factors|mesh-ancestor
102313100|NCT01642589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313101|NCT01954251|Vaccines|vaccines|mesh-list
102313102|NCT01954251|Immunologic Factors|immunologic factors|mesh-ancestor
102313103|NCT01954251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313104|NCT04643925|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102313105|NCT04643925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102313106|NCT04643925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313107|NCT02257385|Albuterol|albuterol|mesh-list
102313108|NCT02257385|Tiotropium Bromide|tiotropium bromide|mesh-list
102313109|NCT02257385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102313110|NCT02257385|Autonomic Agents|autonomic agents|mesh-ancestor
102313111|NCT02257385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102313112|NCT02257385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313113|NCT02257385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102313114|NCT02257385|Respiratory System Agents|respiratory system agents|mesh-ancestor
102313115|NCT02257385|Parasympatholytics|parasympatholytics|mesh-ancestor
102313116|NCT02257385|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102313117|NCT02257385|Cholinergic Agents|cholinergic agents|mesh-ancestor
101429666|NCT00150293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102313118|NCT02257385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102313119|NCT02257385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313120|NCT02257385|Tocolytic Agents|tocolytic agents|mesh-ancestor
102313121|NCT02257385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102313122|NCT02257385|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102313123|NCT02257385|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102313124|NCT02257385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102313125|NCT02257385|Adrenergic Agents|adrenergic agents|mesh-ancestor
102313127|NCT01629667|Immunologic Factors|immunologic factors|mesh-ancestor
102313128|NCT01629667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313129|NCT01645280|Methotrexate|methotrexate|mesh-list
102313130|NCT01645280|Ustekinumab|ustekinumab|mesh-list
102313131|NCT01645280|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102313132|NCT01645280|Abortifacient Agents|abortifacient agents|mesh-ancestor
102313133|NCT01645280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102313134|NCT01645280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313135|NCT01645280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102313136|NCT01645280|Antimetabolites|antimetabolites|mesh-ancestor
102313137|NCT01645280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313138|NCT01645280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102313139|NCT01645280|Dermatologic Agents|dermatologic agents|mesh-ancestor
102313140|NCT01645280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102313141|NCT01645280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102313142|NCT01645280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102313143|NCT01645280|Immunologic Factors|immunologic factors|mesh-ancestor
102313144|NCT01645280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102313145|NCT01645280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102313146|NCT01629589|Vaccines|vaccines|mesh-list
102313147|NCT01629589|Immunologic Factors|immunologic factors|mesh-ancestor
102313148|NCT01629589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313149|NCT04188223|Vaccines|vaccines|mesh-list
102313150|NCT04188223|Immunologic Factors|immunologic factors|mesh-ancestor
102313151|NCT04188223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313152|NCT02220907|Canagliflozin|canagliflozin|mesh-list
102313153|NCT02220907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102313154|NCT02220907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313155|NCT02220907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102313156|NCT02220907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313157|NCT01601873|Heparin|heparin|mesh-list
102313158|NCT01601873|Anticoagulants|anticoagulants|mesh-ancestor
102313159|NCT01601873|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102313160|NCT01601873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102313161|NCT01601873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313162|NCT02194933|Brexpiprazole|brexpiprazole|mesh-list
102313163|NCT02194933|Serotonin Agents|serotonin agents|mesh-ancestor
102313164|NCT02194933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102313165|NCT02194933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313166|NCT02194933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313167|NCT02194933|Dopamine Agonists|dopamine agonists|mesh-ancestor
102313168|NCT02194933|Dopamine Agents|dopamine agents|mesh-ancestor
102313169|NCT04420247|Hydroxychloroquine|hydroxychloroquine|mesh-list
102313170|NCT04420247|Chloroquine|chloroquine|mesh-list
102313171|NCT04420247|Antimalarials|antimalarials|mesh-ancestor
102313172|NCT04420247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102313173|NCT04420247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102313174|NCT04420247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102313175|NCT04420247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102313176|NCT04420247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313177|NCT04420247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102313178|NCT04420247|Amebicides|amebicides|mesh-ancestor
102313179|NCT01644890|Paclitaxel|paclitaxel|mesh-list
102313180|NCT01644890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102313181|NCT01644890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102313182|NCT01644890|Tubulin Modulators|tubulin modulators|mesh-ancestor
102313183|NCT01644890|Antimitotic Agents|antimitotic agents|mesh-ancestor
102313184|NCT01644890|Mitosis Modulators|mitosis modulators|mesh-ancestor
102313185|NCT01644890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313186|NCT04865237|Remdesivir|remdesivir|mesh-list
102313187|NCT04865237|Antimetabolites|antimetabolites|mesh-ancestor
102313188|NCT04865237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313189|NCT04865237|Antiviral Agents|antiviral agents|mesh-ancestor
102313190|NCT04865237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102313191|NCT01628965|Rotigotine|rotigotine|mesh-list
102313192|NCT01628965|Dopamine Agonists|dopamine agonists|mesh-ancestor
102313193|NCT01628965|Dopamine Agents|dopamine agents|mesh-ancestor
102313194|NCT01628965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102313195|NCT01628965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313196|NCT01628965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313197|NCT01644734|Tiotropium Bromide|tiotropium bromide|mesh-list
102313198|NCT01644734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102313199|NCT01644734|Autonomic Agents|autonomic agents|mesh-ancestor
102313200|NCT01644734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102313201|NCT01644734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313202|NCT01644734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102313203|NCT01644734|Respiratory System Agents|respiratory system agents|mesh-ancestor
102313204|NCT01644734|Parasympatholytics|parasympatholytics|mesh-ancestor
102313205|NCT01644734|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102313206|NCT01644734|Cholinergic Agents|cholinergic agents|mesh-ancestor
102313207|NCT01644734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102313208|NCT01644734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313210|NCT02255279|Immunologic Factors|immunologic factors|mesh-ancestor
102313211|NCT02255279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313212|NCT04865159|Tipifarnib|tipifarnib|mesh-list
102313213|NCT04865159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102313214|NCT02293538|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102313215|NCT02293538|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102313216|NCT02266706|Tazobactam|tazobactam|mesh-list
102313217|NCT02266706|Ceftolozane|ceftolozane|mesh-list
102313218|NCT02266706|Cephalosporins|cephalosporins|mesh-list
102313219|NCT02266706|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
102313220|NCT02266706|Penicillanic Acid|penicillanic acid|mesh-list
102313221|NCT02266706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102313222|NCT02266706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102313223|NCT02266706|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102313224|NCT02266706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102313225|NCT02266706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313226|NCT02266706|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102313227|NCT02292719|Ritonavir|ritonavir|mesh-list
102313228|NCT02292719|Ribavirin|ribavirin|mesh-list
102313229|NCT02292719|Sofosbuvir|sofosbuvir|mesh-list
102313230|NCT02292719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102313231|NCT02292719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102313232|NCT02292719|Protease Inhibitors|protease inhibitors|mesh-ancestor
102313233|NCT02292719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102313234|NCT02292719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313235|NCT02292719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102313236|NCT02292719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102313237|NCT02292719|Antiviral Agents|antiviral agents|mesh-ancestor
102313238|NCT02292719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102313239|NCT02292719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102313240|NCT02292719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102313241|NCT02292719|Antimetabolites|antimetabolites|mesh-ancestor
102313242|NCT02291549|Mometasone Furoate|mometasone furoate|mesh-list
102313243|NCT02291549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102313244|NCT02291549|Dermatologic Agents|dermatologic agents|mesh-ancestor
102313245|NCT02291549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102313246|NCT02264990|Paclitaxel|paclitaxel|mesh-list
102313247|NCT02264990|Carboplatin|carboplatin|mesh-list
102313248|NCT02264990|Pemetrexed|pemetrexed|mesh-list
102313249|NCT02264990|Veliparib|veliparib|mesh-list
102313250|NCT02264990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102313251|NCT02264990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102313252|NCT02264990|Tubulin Modulators|tubulin modulators|mesh-ancestor
102313253|NCT02264990|Antimitotic Agents|antimitotic agents|mesh-ancestor
102313254|NCT02264990|Mitosis Modulators|mitosis modulators|mesh-ancestor
102313255|NCT02264990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313256|NCT02264990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102313257|NCT02264990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102313258|NCT02264990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102313259|NCT02264990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102313260|NCT02289833|Trastuzumab|trastuzumab|mesh-list
102313261|NCT02289833|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102313262|NCT02289833|Maytansine|maytansine|mesh-list
102313263|NCT02289833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102313264|NCT02289833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102313265|NCT02289833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102313266|NCT02289833|Tubulin Modulators|tubulin modulators|mesh-ancestor
102313267|NCT02289833|Antimitotic Agents|antimitotic agents|mesh-ancestor
102313268|NCT02289833|Mitosis Modulators|mitosis modulators|mesh-ancestor
102313269|NCT02289833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313270|NCT02289833|Immunotoxins|immunotoxins|mesh-ancestor
102313271|NCT02289833|Immunoconjugates|immunoconjugates|mesh-ancestor
102313272|NCT02289833|Immunologic Factors|immunologic factors|mesh-ancestor
102313273|NCT02289833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313274|NCT01702558|Capecitabine|capecitabine|mesh-list
102022044|NCT03744767|Spironolactone|spironolactone|mesh-list
102313275|NCT01702558|Trastuzumab|trastuzumab|mesh-list
102313276|NCT01702558|Maytansine|maytansine|mesh-list
102313277|NCT01702558|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102313278|NCT01702558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102313279|NCT01702558|Antimetabolites|antimetabolites|mesh-ancestor
102313280|NCT01702558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313281|NCT01702558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102313282|NCT01702558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102313283|NCT01702558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102313284|NCT01702558|Tubulin Modulators|tubulin modulators|mesh-ancestor
102313285|NCT01702558|Antimitotic Agents|antimitotic agents|mesh-ancestor
102313286|NCT01702558|Mitosis Modulators|mitosis modulators|mesh-ancestor
102313287|NCT01702558|Immunotoxins|immunotoxins|mesh-ancestor
102313288|NCT01702558|Immunoconjugates|immunoconjugates|mesh-ancestor
102313289|NCT01702558|Immunologic Factors|immunologic factors|mesh-ancestor
102313290|NCT01702558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313291|NCT05650775|Methylphenidate|methylphenidate|mesh-list
102313292|NCT05650775|Adderall|adderall|mesh-list
102313293|NCT05650775|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102313294|NCT05650775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313295|NCT05650775|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102313296|NCT05650775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102313297|NCT05650775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102313298|NCT05650775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313299|NCT05650775|Dopamine Agents|dopamine agents|mesh-ancestor
102313300|NCT05650775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102313301|NCT02194465|Spironolactone|spironolactone|mesh-list
102313302|NCT02194465|Tadalafil|tadalafil|mesh-list
102313303|NCT02194465|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
102313304|NCT02194465|Mineralocorticoids|mineralocorticoids|mesh-list
102313305|NCT02194465|Vasodilator Agents|vasodilator agents|mesh-ancestor
102313306|NCT02194465|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102313307|NCT02194465|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102313308|NCT02194465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102313309|NCT02194465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313310|NCT02194465|Urological Agents|urological agents|mesh-ancestor
102313311|NCT02194465|Hormone Antagonists|hormone antagonists|mesh-ancestor
102313312|NCT02194465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102313313|NCT02194465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313314|NCT02194465|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102313315|NCT02194465|Diuretics|diuretics|mesh-ancestor
102313316|NCT02194465|Natriuretic Agents|natriuretic agents|mesh-ancestor
102313317|NCT02194465|Hormones|hormones|mesh-ancestor
102313318|NCT01720264|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102313319|NCT01720264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102313320|NCT01720264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313321|NCT01720264|Incretins|incretins|mesh-ancestor
102313322|NCT01720264|Hormones|hormones|mesh-ancestor
102313323|NCT01720264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102313324|NCT01720264|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102313325|NCT01720264|Protease Inhibitors|protease inhibitors|mesh-ancestor
102313326|NCT01720264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102313327|NCT01720264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313328|NCT04564846|Insulin|insulin|mesh-list
102313329|NCT04564846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102313330|NCT04564846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313331|NCT01702246|Simvastatin|simvastatin|mesh-list
102313332|NCT01702246|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102313333|NCT01702246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102313334|NCT01702246|Antimetabolites|antimetabolites|mesh-ancestor
102313335|NCT01702246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313336|NCT01702246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102313337|NCT01702246|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102313338|NCT01702246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102313339|NCT01631227|Eprosartan|eprosartan|mesh-list
102313340|NCT01631227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102313341|NCT01631227|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
102313342|NCT01631227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102313343|NCT01631227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313344|NCT05645861|Benzocaine|benzocaine|mesh-list
102313345|NCT05645861|Anesthetics, Local|anesthetics, local|mesh-ancestor
102313346|NCT05645861|Anesthetics|anesthetics|mesh-ancestor
102313347|NCT05645861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102313348|NCT05645861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313349|NCT05645861|Sensory System Agents|sensory system agents|mesh-ancestor
102313350|NCT05645861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102313351|NCT01719172|Hemostatics|hemostatics|mesh-list
102313352|NCT01719172|Coagulants|coagulants|mesh-ancestor
102313353|NCT02285855|Metformin|metformin|mesh-list
102313354|NCT02285855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102313355|NCT02285855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313356|NCT02285153|Aspirin|aspirin|mesh-list
102313357|NCT02285153|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
102313358|NCT02285153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102313359|NCT02285153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102313360|NCT02285153|Analgesics|analgesics|mesh-ancestor
102313361|NCT02285153|Sensory System Agents|sensory system agents|mesh-ancestor
102313362|NCT02285153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102313363|NCT02285153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313364|NCT02285153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102313365|NCT02285153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102313366|NCT02285153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102313367|NCT02285153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102313368|NCT02285153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313369|NCT02285153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102313370|NCT02285153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102313371|NCT02285153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102313372|NCT02285153|Antipyretics|antipyretics|mesh-ancestor
102313373|NCT01632241|Belimumab|belimumab|mesh-list
102313374|NCT01632241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102313375|NCT01632241|Immunologic Factors|immunologic factors|mesh-ancestor
102313376|NCT01632241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313377|NCT02263508|Pembrolizumab|pembrolizumab|mesh-list
102313378|NCT02263508|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
102313379|NCT02263508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102313380|NCT02263508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102313381|NCT02263508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102313382|NCT02263508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313383|NCT01741792|Blinatumomab|blinatumomab|mesh-list
102313384|NCT01741792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102313385|NCT02289950|Farletuzumab|farletuzumab|mesh-list
102313386|NCT02289950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102313387|NCT02288312|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102313388|NCT02288312|Anticonvulsants|anticonvulsants|mesh-ancestor
102313389|NCT02288312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102313390|NCT02288312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102313391|NCT02288312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102313392|NCT02288312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313393|NCT01740388|Besifloxacin|besifloxacin|mesh-list
102313394|NCT01740388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102313395|NCT01740388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102313396|NCT01740388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102313397|NCT01740388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102313398|NCT01740388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102313399|NCT01740388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313400|NCT01740388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102313401|NCT01740154|Sunitinib|sunitinib|mesh-list
102313402|NCT01740154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102313403|NCT01740154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102313404|NCT01740154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102313405|NCT01740154|Growth Substances|growth substances|mesh-ancestor
102313406|NCT01740154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313407|NCT01740154|Growth Inhibitors|growth inhibitors|mesh-ancestor
102313408|NCT01740154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102313409|NCT01740154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102313410|NCT01740154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313411|NCT02287610|Prednisone|prednisone|mesh-list
102313412|NCT02287610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102313413|NCT02287610|Glucocorticoids|glucocorticoids|mesh-ancestor
102313414|NCT02287610|Hormones|hormones|mesh-ancestor
102313415|NCT02287610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102313416|NCT02287610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313417|NCT02287610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102313418|NCT02287610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102313419|NCT02262728|Sofosbuvir|sofosbuvir|mesh-list
102313420|NCT02262728|Simeprevir|simeprevir|mesh-list
102313421|NCT02262728|Antiviral Agents|antiviral agents|mesh-ancestor
102313422|NCT02262728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102313423|NCT02262728|Protease Inhibitors|protease inhibitors|mesh-ancestor
102313424|NCT02262728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102313425|NCT02262728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313426|NCT01717768|Testosterone|testosterone|mesh-list
102313427|NCT01717768|Androgens|androgens|mesh-ancestor
102313428|NCT01717768|Hormones|hormones|mesh-ancestor
102313429|NCT01717768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102313430|NCT01717768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313431|NCT02260934|Acetaminophen|acetaminophen|mesh-list
102313432|NCT02260934|Diphenhydramine|diphenhydramine|mesh-list
102313433|NCT02260934|Promethazine|promethazine|mesh-list
102313434|NCT02260934|Prednisone|prednisone|mesh-list
102313435|NCT02260934|Methylprednisolone|methylprednisolone|mesh-list
102313436|NCT02260934|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102313437|NCT02260934|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102313438|NCT02260934|Prednisolone|prednisolone|mesh-list
102313439|NCT02260934|Prednisolone acetate|prednisolone acetate|mesh-list
102313440|NCT02260934|Cyclophosphamide|cyclophosphamide|mesh-list
102313441|NCT02260934|Rituximab|rituximab|mesh-list
102313442|NCT02260934|Belimumab|belimumab|mesh-list
102313443|NCT02260934|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102313444|NCT02260934|Prednisolone phosphate|prednisolone phosphate|mesh-list
102313445|NCT02260934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102313446|NCT02260934|Immunologic Factors|immunologic factors|mesh-ancestor
102313447|NCT02260934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313448|NCT02260934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102313449|NCT02260934|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102313450|NCT02260934|Alkylating Agents|alkylating agents|mesh-ancestor
102313451|NCT02260934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313452|NCT02260934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102313453|NCT02260934|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102313454|NCT02260934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102313455|NCT02260934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102313456|NCT02260934|Glucocorticoids|glucocorticoids|mesh-ancestor
102313457|NCT02260934|Hormones|hormones|mesh-ancestor
102313458|NCT02260934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102313459|NCT02260934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102313460|NCT02260934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102313461|NCT02260934|Analgesics|analgesics|mesh-ancestor
102313462|NCT02260934|Sensory System Agents|sensory system agents|mesh-ancestor
102313463|NCT02260934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102313464|NCT02260934|Antipyretics|antipyretics|mesh-ancestor
102313465|NCT02260934|Antiemetics|antiemetics|mesh-ancestor
102313466|NCT02260934|Autonomic Agents|autonomic agents|mesh-ancestor
102313467|NCT02260934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102313468|NCT02260934|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102313469|NCT02260934|Protective Agents|protective agents|mesh-ancestor
102313470|NCT02260934|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101430019|NCT02716012|Sorafenib|sorafenib|mesh-list
102313471|NCT02260934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102313472|NCT02260934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102313473|NCT02260934|Anesthetics, Local|anesthetics, local|mesh-ancestor
102313474|NCT02260934|Anesthetics|anesthetics|mesh-ancestor
102313475|NCT02260934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102313476|NCT02260934|Histamine Antagonists|histamine antagonists|mesh-ancestor
102313477|NCT02260934|Histamine Agents|histamine agents|mesh-ancestor
102313478|NCT02260934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102313479|NCT02260934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102313480|NCT02260934|Antipruritics|antipruritics|mesh-ancestor
102313481|NCT02260934|Dermatologic Agents|dermatologic agents|mesh-ancestor
102313482|NCT02260388|Mexiletine|mexiletine|mesh-list
102313483|NCT02260388|Pregabalin|pregabalin|mesh-list
102313484|NCT02260388|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102313485|NCT02260388|Nortriptyline|nortriptyline|mesh-list
102313486|NCT02260388|Analgesics|analgesics|mesh-ancestor
102313487|NCT02260388|Sensory System Agents|sensory system agents|mesh-ancestor
102313488|NCT02260388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102313489|NCT02260388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313490|NCT02260388|Anticonvulsants|anticonvulsants|mesh-ancestor
102313491|NCT02260388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102313492|NCT02260388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102313493|NCT02260388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313494|NCT02260388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102313495|NCT02260388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102313496|NCT02260388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102313497|NCT02260388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102313498|NCT02260388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102313499|NCT02260388|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102313500|NCT02260388|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102313501|NCT02260388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102313502|NCT02260388|Antidepressive Agents|antidepressive agents|mesh-ancestor
102313503|NCT02260388|Dopamine Agents|dopamine agents|mesh-ancestor
102313504|NCT02260388|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102313505|NCT02260388|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102313506|NCT02260388|Adrenergic Agents|adrenergic agents|mesh-ancestor
102313507|NCT02260388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102313508|NCT02260388|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102313509|NCT02260388|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102313511|NCT02260154|Alverine|alverine|mesh-list
102313512|NCT02260154|Anticonvulsants|anticonvulsants|mesh-ancestor
102313513|NCT02260154|Parasympatholytics|parasympatholytics|mesh-ancestor
102313514|NCT02260154|Autonomic Agents|autonomic agents|mesh-ancestor
102313515|NCT02260154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102313516|NCT02260154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313517|NCT01643408|Asparaginase|asparaginase|mesh-list
102313518|NCT01643408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102313519|NCT02283788|Moxifloxacin|moxifloxacin|mesh-list
102313520|NCT02283788|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102313521|NCT02283788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102313522|NCT02283788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102313523|NCT02283788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102313524|NCT02283788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102313525|NCT02283788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102313526|NCT02283788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313527|NCT02283788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102313528|NCT02283788|Anticonvulsants|anticonvulsants|mesh-ancestor
102313529|NCT02283788|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102313530|NCT02283788|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102313531|NCT02283788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102313532|NCT01739764|Vemurafenib|vemurafenib|mesh-list
102313533|NCT01739764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102313534|NCT01739764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102313535|NCT01739764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102313536|NCT01739764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313537|NCT01700530|Simvastatin|simvastatin|mesh-list
102313538|NCT01700530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
102313539|NCT01700530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102313540|NCT01700530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102313541|NCT01700530|Antimetabolites|antimetabolites|mesh-ancestor
101307141|NCT02029898|Remifentanil|remifentanil|mesh-list
102313542|NCT01700530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313543|NCT01700530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102313544|NCT01700530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102313545|NCT01717456|Loperamide|loperamide|mesh-list
102313546|NCT01717456|Antidiarrheals|antidiarrheals|mesh-list
102313547|NCT01717456|Laxatives|laxatives|mesh-list
102313548|NCT01717456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102313549|NCT01716754|Omalizumab|omalizumab|mesh-list
102313550|NCT01716754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102313551|NCT01716754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102313552|NCT01716754|Respiratory System Agents|respiratory system agents|mesh-ancestor
102313553|NCT01698814|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
102313554|NCT01698814|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102313555|NCT01698814|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102313556|NCT01698814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102313557|NCT01698814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102313558|NCT01698814|Analgesics|analgesics|mesh-ancestor
102313559|NCT01698814|Sensory System Agents|sensory system agents|mesh-ancestor
102313560|NCT01698814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102313561|NCT01698814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313562|NCT01698814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102313563|NCT01698814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102313564|NCT01698814|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102313565|NCT01698814|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102313566|NCT01698814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102313567|NCT01698814|Histamine Antagonists|histamine antagonists|mesh-ancestor
102313568|NCT01698814|Histamine Agents|histamine agents|mesh-ancestor
102313569|NCT01698814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102313570|NCT01698814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313571|NCT01738594|Romidepsin|romidepsin|mesh-list
102313572|NCT01738594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102313573|NCT01738594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102313574|NCT01738594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102313575|NCT01738594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102313576|NCT01738594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313578|NCT01697956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102313579|NCT01697956|Glucocorticoids|glucocorticoids|mesh-ancestor
102313580|NCT01697956|Hormones|hormones|mesh-ancestor
102313581|NCT01697956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102313582|NCT01697956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313583|NCT01697956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102313584|NCT01697956|Respiratory System Agents|respiratory system agents|mesh-ancestor
102313585|NCT01697800|Tadalafil|tadalafil|mesh-list
102313586|NCT01697800|Vasodilator Agents|vasodilator agents|mesh-ancestor
102313587|NCT01697800|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102313588|NCT01697800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102313589|NCT01697800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102313590|NCT01697800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313591|NCT01697800|Urological Agents|urological agents|mesh-ancestor
102313592|NCT04553770|Trastuzumab|trastuzumab|mesh-list
102313593|NCT04553770|Anastrozole|anastrozole|mesh-list
102313594|NCT04553770|Camptothecin|camptothecin|mesh-list
102313595|NCT04553770|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
102313596|NCT04553770|Immunoconjugates|immunoconjugates|mesh-list
102313597|NCT04553770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102313598|NCT04553770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102313599|NCT04553770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102313600|NCT04553770|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102313601|NCT04553770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102313602|NCT04553770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102313603|NCT04553770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313604|NCT04553770|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102313605|NCT04553770|Hormone Antagonists|hormone antagonists|mesh-ancestor
102313606|NCT04553770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102313607|NCT04553770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313608|NCT04553770|Immunologic Factors|immunologic factors|mesh-ancestor
102313609|NCT04553770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102313610|NCT04553770|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102313611|NCT04553770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102313612|NCT01644500|Glimepiride|glimepiride|mesh-list
102313613|NCT01644500|Dulaglutide|dulaglutide|mesh-list
102313614|NCT01644500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102313615|NCT01644500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102313616|NCT01644500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313617|NCT01644500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102313618|NCT01644500|Immunologic Factors|immunologic factors|mesh-ancestor
102313619|NCT04877834|Dexlansoprazole|dexlansoprazole|mesh-list
102313620|NCT04877834|Lansoprazole|lansoprazole|mesh-list
102313621|NCT04877834|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102313622|NCT04877834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102313623|NCT04877834|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102313624|NCT04877834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102313625|NCT04877834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313626|NCT01604824|Alirocumab|alirocumab|mesh-list
102313627|NCT01604824|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102313628|NCT01604824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102313629|NCT01604824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102313630|NCT01604824|Antimetabolites|antimetabolites|mesh-ancestor
102313631|NCT01604824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313632|NCT01604824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102313633|NCT01604824|Protease Inhibitors|protease inhibitors|mesh-ancestor
102313634|NCT01604824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102313635|NCT01604824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102313636|NCT01716052|Ibuprofen|ibuprofen|mesh-list
102313637|NCT01716052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102313638|NCT01716052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102313639|NCT01716052|Analgesics|analgesics|mesh-ancestor
102313640|NCT01716052|Sensory System Agents|sensory system agents|mesh-ancestor
102313641|NCT01716052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102313642|NCT01716052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313643|NCT01716052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102313644|NCT01716052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102313645|NCT01716052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102313646|NCT01716052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102313647|NCT01716052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313648|NCT01641692|Albuterol|albuterol|mesh-list
102022422|NCT05123820|Anesthetics|anesthetics|mesh-ancestor
102313649|NCT01641692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102313650|NCT01641692|Autonomic Agents|autonomic agents|mesh-ancestor
102313651|NCT01641692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102313652|NCT01641692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313653|NCT01641692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102313654|NCT01641692|Respiratory System Agents|respiratory system agents|mesh-ancestor
102313655|NCT01641692|Tocolytic Agents|tocolytic agents|mesh-ancestor
102313656|NCT01641692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102313657|NCT01641692|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102313658|NCT01641692|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102313659|NCT01641692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102313660|NCT01641692|Adrenergic Agents|adrenergic agents|mesh-ancestor
102313661|NCT01641692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102313662|NCT01641692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313663|NCT01682512|Rituximab|rituximab|mesh-list
102313664|NCT01682512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102313665|NCT01682512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102313666|NCT01682512|Immunologic Factors|immunologic factors|mesh-ancestor
102313667|NCT01682512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313668|NCT01682512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102313669|NCT04863716|Fentanyl|fentanyl|mesh-list
102313670|NCT04863716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102313671|NCT04863716|Narcotics|narcotics|mesh-ancestor
102313672|NCT04863716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102313673|NCT04863716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313674|NCT04863716|Analgesics|analgesics|mesh-ancestor
102313675|NCT04863716|Sensory System Agents|sensory system agents|mesh-ancestor
102313676|NCT04863716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102313677|NCT04863716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102313678|NCT04863716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102313679|NCT04863716|Anesthetics, General|anesthetics, general|mesh-ancestor
102313680|NCT04863716|Anesthetics|anesthetics|mesh-ancestor
102313681|NCT04135352|Pembrolizumab|pembrolizumab|mesh-list
102313682|NCT04135352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102313683|NCT04135352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102313684|NCT04135352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102313685|NCT04135352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313686|NCT01715896|Golimumab|golimumab|mesh-list
102313687|NCT01715896|Mavrilimumab|mavrilimumab|mesh-list
102313688|NCT01715896|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102313689|NCT01715896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102313690|NCT01715896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102313691|NCT01715896|Immunologic Factors|immunologic factors|mesh-ancestor
102313692|NCT01715896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313693|NCT01715896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102313694|NCT05642702|Vitamins|vitamins|mesh-list
102313695|NCT05642702|Ascorbic Acid|ascorbic acid|mesh-list
102313696|NCT05642702|Niacinamide|niacinamide|mesh-list
102313698|NCT05642702|Nicotinic Acids|nicotinic acids|mesh-list
102313699|NCT05642702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102313700|NCT05642702|Micronutrients|micronutrients|mesh-ancestor
102313701|NCT05642702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313702|NCT05642702|Antioxidants|antioxidants|mesh-ancestor
102313703|NCT05642702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313704|NCT05642702|Protective Agents|protective agents|mesh-ancestor
102313705|NCT05642702|Vitamin B Complex|vitamin b complex|mesh-ancestor
102313706|NCT05642702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102313707|NCT05642702|Antimetabolites|antimetabolites|mesh-ancestor
102313708|NCT05642702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102313709|NCT05642702|Vasodilator Agents|vasodilator agents|mesh-ancestor
102313710|NCT05544734|Acetaminophen|acetaminophen|mesh-list
102313711|NCT05544734|Ibuprofen|ibuprofen|mesh-list
102313712|NCT05544734|Hydrocodone|hydrocodone|mesh-list
102313713|NCT05544734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102313714|NCT05544734|Analgesics|analgesics|mesh-ancestor
102313715|NCT05544734|Sensory System Agents|sensory system agents|mesh-ancestor
102313716|NCT05544734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102313717|NCT05544734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313718|NCT05544734|Antipyretics|antipyretics|mesh-ancestor
102313719|NCT05544734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102313720|NCT05544734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102313721|NCT05544734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102313722|NCT05544734|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102313723|NCT05544734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102313724|NCT05544734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313725|NCT05544734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102313726|NCT05544734|Narcotics|narcotics|mesh-ancestor
102313727|NCT05544734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102313728|NCT05544734|Antitussive Agents|antitussive agents|mesh-ancestor
102313729|NCT05544734|Respiratory System Agents|respiratory system agents|mesh-ancestor
102313730|NCT02254772|Ipilimumab|ipilimumab|mesh-list
101655588|NCT05307770|Protective Agents|protective agents|mesh-ancestor
102313731|NCT02254772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102313732|NCT02254772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102313733|NCT02254772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102313734|NCT02254772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313735|NCT01682044|Rituximab|rituximab|mesh-list
102313736|NCT01682044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102313737|NCT01682044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102313738|NCT01682044|Immunologic Factors|immunologic factors|mesh-ancestor
102313739|NCT01682044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313740|NCT01682044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102313741|NCT05640596|Betamethasone|betamethasone|mesh-list
102313742|NCT05640596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102313743|NCT05640596|Glucocorticoids|glucocorticoids|mesh-ancestor
102313744|NCT05640596|Hormones|hormones|mesh-ancestor
102313745|NCT05640596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102313746|NCT05640596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313747|NCT05640596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102313748|NCT05640596|Respiratory System Agents|respiratory system agents|mesh-ancestor
102313749|NCT05651126|Psilocybin|psilocybin|mesh-list
102313750|NCT05651126|Hallucinogens|hallucinogens|mesh-ancestor
102313751|NCT05651126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313752|NCT05651126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102313753|NCT01696942|Mesalamine|mesalamine|mesh-list
101430308|NCT05308030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102313754|NCT01696942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102313755|NCT01696942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313756|NCT01696942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102313757|NCT01696942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102313758|NCT01696942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102313759|NCT01696942|Analgesics|analgesics|mesh-ancestor
102313760|NCT01696942|Sensory System Agents|sensory system agents|mesh-ancestor
102313761|NCT01696942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102313762|NCT05493566|Aldesleukin|aldesleukin|mesh-list
102313763|NCT05493566|Pembrolizumab|pembrolizumab|mesh-list
102313764|NCT05493566|Interleukin-2|interleukin-2|mesh-list
102313765|NCT05493566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102313766|NCT05493566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102313767|NCT05493566|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102313768|NCT05493566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313769|NCT05493566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102313770|NCT05493566|Analgesics|analgesics|mesh-ancestor
102313771|NCT05493566|Sensory System Agents|sensory system agents|mesh-ancestor
102313772|NCT05493566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102313773|NCT05493566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313774|NCT05493566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102313775|NCT05493566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102313776|NCT05493566|Antiviral Agents|antiviral agents|mesh-ancestor
102313777|NCT05493566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102313778|NCT04871204|Octreotide|octreotide|mesh-list
102313779|NCT04871204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102313780|NCT04871204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102313781|NCT04871204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102313782|NCT05650268|Vitamin D|vitamin d|mesh-list
102313783|NCT05650268|Ergocalciferols|ergocalciferols|mesh-list
102313784|NCT05650268|Cholecalciferol|cholecalciferol|mesh-list
102313785|NCT05650268|Vitamins|vitamins|mesh-list
102313786|NCT05650268|Micronutrients|micronutrients|mesh-ancestor
102313787|NCT05650268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313788|NCT05650268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102313789|NCT05650268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102313790|NCT04835870|Prednisone|prednisone|mesh-list
102313791|NCT04835870|Cyclophosphamide|cyclophosphamide|mesh-list
102313792|NCT04835870|Rituximab|rituximab|mesh-list
102313793|NCT04835870|Doxorubicin|doxorubicin|mesh-list
102313794|NCT04835870|Vincristine|vincristine|mesh-list
102313795|NCT04835870|Zanubrutinib|zanubrutinib|mesh-list
102313796|NCT04835870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102313797|NCT04835870|Immunologic Factors|immunologic factors|mesh-ancestor
102313798|NCT04835870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313799|NCT04835870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102313800|NCT04835870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102313801|NCT04835870|Alkylating Agents|alkylating agents|mesh-ancestor
102313802|NCT04835870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313804|NCT04835870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102313805|NCT04835870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102313806|NCT04835870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102313808|NCT04835870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102313809|NCT04835870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102313810|NCT04835870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102313811|NCT04835870|Glucocorticoids|glucocorticoids|mesh-ancestor
102313812|NCT04835870|Hormones|hormones|mesh-ancestor
102313813|NCT04835870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102313814|NCT04835870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102313815|NCT04835870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102313816|NCT04835870|Tubulin Modulators|tubulin modulators|mesh-ancestor
102313817|NCT04835870|Antimitotic Agents|antimitotic agents|mesh-ancestor
102313818|NCT04835870|Mitosis Modulators|mitosis modulators|mesh-ancestor
102313819|NCT04835870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102313820|NCT01639040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102313821|NCT01639040|Immunologic Factors|immunologic factors|mesh-ancestor
102313822|NCT01639040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313823|NCT04834388|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102313824|NCT04834388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102313825|NCT04834310|Clindamycin|clindamycin|mesh-list
102313826|NCT04834310|Clindamycin palmitate|clindamycin palmitate|mesh-list
102313827|NCT04834310|Clindamycin phosphate|clindamycin phosphate|mesh-list
102313828|NCT04834310|Cefazolin|cefazolin|mesh-list
102313829|NCT04834310|Cephalexin|cephalexin|mesh-list
102313830|NCT04834310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102313831|NCT04834310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102313832|NCT04834310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102313833|NCT04834310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102313834|NCT04834310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313835|NCT05372198|Immunomodulating Agents|immunomodulating agents|mesh-list
102313836|NCT05372198|Immunologic Factors|immunologic factors|mesh-ancestor
102313837|NCT05372198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313838|NCT05359406|Tislelizumab|tislelizumab|mesh-list
102313839|NCT05359406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102313840|NCT05359406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102313841|NCT04654208|Palbociclib|palbociclib|mesh-list
102313842|NCT04654208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102313843|NCT04654208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102313844|NCT04654208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102313845|NCT04654208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313846|NCT04652960|Nivolumab|nivolumab|mesh-list
102313847|NCT04652960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102313848|NCT04652960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102313849|NCT04652960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102313850|NCT04652960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313851|NCT05357846|Paclitaxel|paclitaxel|mesh-list
102313852|NCT05357846|Cisplatin|cisplatin|mesh-list
102313853|NCT05357846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102313854|NCT05357846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102313855|NCT05357846|Tubulin Modulators|tubulin modulators|mesh-ancestor
102313856|NCT05357846|Antimitotic Agents|antimitotic agents|mesh-ancestor
102313857|NCT05357846|Mitosis Modulators|mitosis modulators|mesh-ancestor
102313858|NCT05357846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313859|NCT05031494|Paclitaxel|paclitaxel|mesh-list
102313860|NCT05031494|Gemcitabine|gemcitabine|mesh-list
102313861|NCT05031494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102313862|NCT05031494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102313863|NCT05031494|Tubulin Modulators|tubulin modulators|mesh-ancestor
102313864|NCT05031494|Antimitotic Agents|antimitotic agents|mesh-ancestor
102313865|NCT05031494|Mitosis Modulators|mitosis modulators|mesh-ancestor
102313866|NCT05031494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313867|NCT05031494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102313868|NCT05031494|Antimetabolites|antimetabolites|mesh-ancestor
102313869|NCT04844216|Lidocaine|lidocaine|mesh-list
102313870|NCT04844216|Hyaluronic Acid|hyaluronic acid|mesh-list
102313871|NCT04844216|Anesthetics, Local|anesthetics, local|mesh-ancestor
102313872|NCT04844216|Anesthetics|anesthetics|mesh-ancestor
102313873|NCT04844216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102313874|NCT04844216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313875|NCT04844216|Sensory System Agents|sensory system agents|mesh-ancestor
102022648|NCT05032950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102313876|NCT04844216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102313877|NCT04844216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102313878|NCT04844216|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102313879|NCT04844216|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102313880|NCT04844216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102313881|NCT04844216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313882|NCT04844216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102313883|NCT04844216|Immunologic Factors|immunologic factors|mesh-ancestor
102313884|NCT04844216|Viscosupplements|viscosupplements|mesh-ancestor
102313885|NCT04844216|Protective Agents|protective agents|mesh-ancestor
102313886|NCT05345678|Durvalumab|durvalumab|mesh-list
102313887|NCT05345678|Tremelimumab|tremelimumab|mesh-list
102313888|NCT05345678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102313889|NCT05345678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102313890|NCT05327738|Atezolizumab|atezolizumab|mesh-list
101430443|NCT00152048|Eflornithine|eflornithine|mesh-list
102313891|NCT05327738|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102313892|NCT05327738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102313893|NCT05327738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313894|NCT05327738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102313895|NCT05327738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102313896|NCT05327738|Immunologic Factors|immunologic factors|mesh-ancestor
102313897|NCT05327738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313898|NCT04419662|Phenylephrine|phenylephrine|mesh-list
102313899|NCT04419662|Oxymetazoline|oxymetazoline|mesh-list
102313900|NCT04419662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102313901|NCT04419662|Mydriatics|mydriatics|mesh-ancestor
102313902|NCT04419662|Autonomic Agents|autonomic agents|mesh-ancestor
102313903|NCT04419662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102313904|NCT04419662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313905|NCT04419662|Sympathomimetics|sympathomimetics|mesh-ancestor
102313906|NCT04419662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102313907|NCT04419662|Nasal Decongestants|nasal decongestants|mesh-ancestor
102313908|NCT04419662|Respiratory System Agents|respiratory system agents|mesh-ancestor
102313909|NCT04419662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102313910|NCT04419662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102313911|NCT04419662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102313912|NCT04419662|Adrenergic Agents|adrenergic agents|mesh-ancestor
102313913|NCT04419662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102313914|NCT04419662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313915|NCT04419662|Protective Agents|protective agents|mesh-ancestor
102313916|NCT04589546|Niacinamide|niacinamide|mesh-list
102313918|NCT04589546|Nicotinic Acids|nicotinic acids|mesh-list
102313919|NCT04589546|Vitamin B Complex|vitamin b complex|mesh-ancestor
102313920|NCT04589546|Vitamins|vitamins|mesh-ancestor
102313921|NCT04589546|Micronutrients|micronutrients|mesh-ancestor
102313922|NCT04589546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313923|NCT04589546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102313924|NCT04589546|Antimetabolites|antimetabolites|mesh-ancestor
102313925|NCT04589546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313926|NCT04589546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102313927|NCT04589546|Vasodilator Agents|vasodilator agents|mesh-ancestor
102313928|NCT05369468|Dexmedetomidine|dexmedetomidine|mesh-list
102313929|NCT05369468|Bupivacaine|bupivacaine|mesh-list
102313930|NCT05369468|Anesthetics, Local|anesthetics, local|mesh-ancestor
102313931|NCT05369468|Anesthetics|anesthetics|mesh-ancestor
102313932|NCT05369468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102313933|NCT05369468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313934|NCT05369468|Sensory System Agents|sensory system agents|mesh-ancestor
102313935|NCT05369468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102313936|NCT05369468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102313937|NCT05369468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102313938|NCT05369468|Analgesics|analgesics|mesh-ancestor
102313939|NCT05369468|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102313940|NCT05369468|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102313941|NCT05369468|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102313942|NCT05369468|Adrenergic Agents|adrenergic agents|mesh-ancestor
102313943|NCT05369468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102313944|NCT05369468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313945|NCT02164513|Fluticasone|fluticasone|mesh-list
102313946|NCT02164513|Xhance|xhance|mesh-list
102313947|NCT02164513|Bromides|bromides|mesh-list
102313948|NCT02164513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102313949|NCT02164513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102313950|NCT02164513|Autonomic Agents|autonomic agents|mesh-ancestor
102022724|NCT05008575|Immunologic Factors|immunologic factors|mesh-ancestor
102313951|NCT02164513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102313952|NCT02164513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313953|NCT02164513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102313954|NCT02164513|Respiratory System Agents|respiratory system agents|mesh-ancestor
102313955|NCT02164513|Dermatologic Agents|dermatologic agents|mesh-ancestor
102313956|NCT02164513|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102313957|NCT02164513|Anticonvulsants|anticonvulsants|mesh-ancestor
102313958|NCT04532372|Leflunomide|leflunomide|mesh-list
102313959|NCT04532372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102313960|NCT04532372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313961|NCT04532372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102313962|NCT04532372|Immunologic Factors|immunologic factors|mesh-ancestor
102313963|NCT04532372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313964|NCT04513184|Dexamethasone|dexamethasone|mesh-list
102313965|NCT04513184|Dexamethasone acetate|dexamethasone acetate|mesh-list
102313966|NCT04513184|BB 1101|bb 1101|mesh-list
102313967|NCT04513184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102313968|NCT04513184|Antiemetics|antiemetics|mesh-ancestor
102313969|NCT04513184|Autonomic Agents|autonomic agents|mesh-ancestor
102313970|NCT04513184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102313971|NCT04513184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313972|NCT04513184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102313973|NCT04513184|Glucocorticoids|glucocorticoids|mesh-ancestor
102313974|NCT04513184|Hormones|hormones|mesh-ancestor
102313975|NCT04513184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102313976|NCT04513184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102313977|NCT04513184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102313978|NCT04513184|Protease Inhibitors|protease inhibitors|mesh-ancestor
102313979|NCT04513184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102313980|NCT04513184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313981|NCT04756531|Nirmatrelvir|nirmatrelvir|mesh-list
102313982|NCT04756531|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102313983|NCT04756531|Protease Inhibitors|protease inhibitors|mesh-ancestor
102313984|NCT04756531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102313985|NCT04756531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313986|NCT04756531|Antiviral Agents|antiviral agents|mesh-ancestor
102313987|NCT04756531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102313988|NCT02218489|Loteprednol Etabonate|loteprednol etabonate|mesh-list
102313989|NCT02218489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102313990|NCT01713946|Everolimus|everolimus|mesh-list
102313991|NCT01713946|Anticonvulsants|anticonvulsants|mesh-list
102313992|NCT01713946|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102313993|NCT01713946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102313994|NCT01713946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102313995|NCT01713946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102313996|NCT01713946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102313997|NCT01713946|Immunologic Factors|immunologic factors|mesh-ancestor
102313998|NCT01713946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102313999|NCT01713946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102314000|NCT04464512|Sufentanil|sufentanil|mesh-list
102314001|NCT04464512|Buprenorphine|buprenorphine|mesh-list
102314002|NCT04464512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102314003|NCT04464512|Narcotics|narcotics|mesh-ancestor
102314004|NCT04464512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102314005|NCT04464512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314006|NCT04464512|Analgesics|analgesics|mesh-ancestor
102314007|NCT04464512|Sensory System Agents|sensory system agents|mesh-ancestor
102314008|NCT04464512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102314009|NCT04464512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102314010|NCT04464512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102314011|NCT04464512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102314012|NCT04464512|Anesthetics, General|anesthetics, general|mesh-ancestor
102314013|NCT04464512|Anesthetics|anesthetics|mesh-ancestor
102314014|NCT05369234|Sucralfate|sucralfate|mesh-list
102314015|NCT05369234|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102314016|NCT05369234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102314017|NCT04827446|Methamphetamine|methamphetamine|mesh-list
102314018|NCT04827446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102314019|NCT04827446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314020|NCT04827446|Sympathomimetics|sympathomimetics|mesh-ancestor
102314021|NCT04827446|Autonomic Agents|autonomic agents|mesh-ancestor
102314022|NCT04827446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102314023|NCT04827446|Dopamine Agents|dopamine agents|mesh-ancestor
102314024|NCT04827446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102314025|NCT04827446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314026|NCT04827446|Adrenergic Agents|adrenergic agents|mesh-ancestor
102314027|NCT04827446|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102314028|NCT04827446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102314029|NCT04827446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102314030|NCT04827446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102314032|NCT02191579|Botulinum Toxins|botulinum toxins|mesh-list
102314034|NCT02191579|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102314035|NCT02191579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102314036|NCT02191579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102314037|NCT02191579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314038|NCT02191579|Cholinergic Agents|cholinergic agents|mesh-ancestor
102314039|NCT02191579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102314040|NCT02191579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314041|NCT02191579|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102314042|NCT02191579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102314043|NCT02191579|Anticonvulsants|anticonvulsants|mesh-ancestor
102314044|NCT02191579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102314045|NCT05324462|Xultophy|xultophy|mesh-list
102314046|NCT05324462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102314047|NCT05324462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314048|NCT05324462|Incretins|incretins|mesh-ancestor
102314049|NCT05324462|Hormones|hormones|mesh-ancestor
102314050|NCT05324462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102314051|NCT01363700|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
102314052|NCT01363700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102314053|NCT01363700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102314054|NCT01363700|Epinastine|epinastine|mesh-list
102314055|NCT01363700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102314056|NCT01363700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102314057|NCT01363700|Analgesics|analgesics|mesh-ancestor
102314058|NCT01363700|Sensory System Agents|sensory system agents|mesh-ancestor
102314059|NCT01363700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102314060|NCT01363700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314061|NCT01363700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102314062|NCT01363700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102314063|NCT01363700|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102314064|NCT01363700|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102314065|NCT01363700|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102314066|NCT01363700|Histamine Antagonists|histamine antagonists|mesh-ancestor
102314067|NCT01363700|Histamine Agents|histamine agents|mesh-ancestor
102314068|NCT01363700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102314069|NCT01363700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314070|NCT04372706|Pembrolizumab|pembrolizumab|mesh-list
102314071|NCT04372706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102314072|NCT04372706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102314073|NCT04372706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102314074|NCT04372706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314075|NCT04178642|Idarubicin|idarubicin|mesh-list
102314076|NCT04178642|Ethiodized Oil|ethiodized oil|mesh-list
102314077|NCT04178642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102314078|NCT04178642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102314079|NCT04178642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102314080|NCT04178642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102314081|NCT04178642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102314082|NCT04178642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314083|NCT04157894|Milbemycin oxime|milbemycin oxime|mesh-list
102314084|NCT04157894|Anthelmintics|anthelmintics|mesh-ancestor
102314085|NCT04157894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102314086|NCT04157894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102314087|NCT04838288|Tacrolimus|tacrolimus|mesh-list
102314088|NCT04838288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102314089|NCT04838288|Immunologic Factors|immunologic factors|mesh-ancestor
102314090|NCT04838288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314091|NCT04838288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102314092|NCT04838288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102314093|NCT04838288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314094|NCT04327934|Methyltestosterone|methyltestosterone|mesh-list
102314095|NCT04327934|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
102314096|NCT04327934|Testosterone|testosterone|mesh-list
102314097|NCT04327934|Testosterone undecanoate|testosterone undecanoate|mesh-list
102314098|NCT04327934|Testosterone enanthate|testosterone enanthate|mesh-list
102314099|NCT04327934|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102314100|NCT04327934|Hormones|hormones|mesh-ancestor
102314101|NCT04327934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102314102|NCT04327934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314103|NCT04327934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102314104|NCT04327934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102314105|NCT04327934|Anabolic Agents|anabolic agents|mesh-ancestor
102314106|NCT04327934|Androgens|androgens|mesh-ancestor
102314107|NCT04791566|Dexamethasone|dexamethasone|mesh-list
102314108|NCT04791566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102314109|NCT04791566|Antiemetics|antiemetics|mesh-ancestor
102314110|NCT04791566|Autonomic Agents|autonomic agents|mesh-ancestor
102314111|NCT04791566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102314112|NCT04791566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314113|NCT04791566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102314114|NCT04791566|Glucocorticoids|glucocorticoids|mesh-ancestor
102314115|NCT04791566|Hormones|hormones|mesh-ancestor
102314116|NCT04791566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102314117|NCT04791566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102314118|NCT04791566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102314119|NCT04129736|Teriflunomide|teriflunomide|mesh-list
102314120|NCT04129736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102314121|NCT04129736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102314122|NCT04129736|Analgesics|analgesics|mesh-ancestor
102314123|NCT04129736|Sensory System Agents|sensory system agents|mesh-ancestor
102314124|NCT04129736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102314125|NCT04129736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314126|NCT04129736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102314127|NCT04129736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102314128|NCT04129736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102314129|NCT04129736|Immunologic Factors|immunologic factors|mesh-ancestor
102314130|NCT01637402|Prednisone|prednisone|mesh-list
102314131|NCT01637402|Abiraterone Acetate|abiraterone acetate|mesh-list
102314132|NCT01637402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102314133|NCT01637402|Glucocorticoids|glucocorticoids|mesh-ancestor
102314134|NCT01637402|Hormones|hormones|mesh-ancestor
102314135|NCT01637402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102314136|NCT01637402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314137|NCT01637402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102314138|NCT01637402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102314139|NCT01637402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102314140|NCT01637402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102314141|NCT01637402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314142|NCT01637402|Hormone Antagonists|hormone antagonists|mesh-ancestor
102314143|NCT01637402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102314144|NCT04419038|Mitomycins|mitomycins|mesh-list
102314145|NCT04419038|Mitomycin|mitomycin|mesh-list
102314146|NCT04419038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102314147|NCT04419038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102314148|NCT04419038|Alkylating Agents|alkylating agents|mesh-ancestor
102314149|NCT04419038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314150|NCT04419038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102314151|NCT04419038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102314152|NCT04824638|Vaccines|vaccines|mesh-list
102314153|NCT04824638|Immunologic Factors|immunologic factors|mesh-ancestor
102314154|NCT04824638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314155|NCT02217475|Cenicriviroc|cenicriviroc|mesh-list
102314156|NCT02217475|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102314157|NCT02217475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314158|NCT02217475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102314159|NCT02217475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102314160|NCT02217475|Antiviral Agents|antiviral agents|mesh-ancestor
102314161|NCT02217475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102314162|NCT04818944|Tirofiban|tirofiban|mesh-list
102314163|NCT04818944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102314164|NCT04818944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102314165|NCT04818944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314166|NCT04818944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102314167|NCT02189941|Deferiprone|deferiprone|mesh-list
102314168|NCT02189941|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102314169|NCT02189941|Chelating Agents|chelating agents|mesh-ancestor
102314170|NCT02189941|Sequestering Agents|sequestering agents|mesh-ancestor
102314171|NCT02189941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314172|NCT01601132|Colchicine|colchicine|mesh-list
102314173|NCT01601132|Theophylline|theophylline|mesh-list
102314174|NCT01601132|Gout Suppressants|gout suppressants|mesh-ancestor
102314175|NCT01601132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102314176|NCT01601132|Tubulin Modulators|tubulin modulators|mesh-ancestor
102314177|NCT01601132|Antimitotic Agents|antimitotic agents|mesh-ancestor
102314178|NCT01601132|Mitosis Modulators|mitosis modulators|mesh-ancestor
102314179|NCT01601132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314180|NCT01601132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102314181|NCT01601132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102314183|NCT01601132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102314184|NCT01601132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314185|NCT01601132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102314186|NCT01601132|Respiratory System Agents|respiratory system agents|mesh-ancestor
102314187|NCT01601132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102314188|NCT01601132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102314189|NCT01601132|Vasodilator Agents|vasodilator agents|mesh-ancestor
102314190|NCT01601132|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102314191|NCT01601132|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102314192|NCT01601132|Purinergic Agents|purinergic agents|mesh-ancestor
102314193|NCT01601132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102314194|NCT04836962|Dexamethasone|dexamethasone|mesh-list
102314195|NCT04836962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102314196|NCT04836962|Antiemetics|antiemetics|mesh-ancestor
102314197|NCT04836962|Autonomic Agents|autonomic agents|mesh-ancestor
102314198|NCT04836962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102314199|NCT04836962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314200|NCT04836962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102314201|NCT04836962|Glucocorticoids|glucocorticoids|mesh-ancestor
102314202|NCT04836962|Hormones|hormones|mesh-ancestor
102314203|NCT04836962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102314204|NCT04836962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102314205|NCT04836962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102314206|NCT05289440|Esketamine|esketamine|mesh-list
102314207|NCT05289440|Antidepressive Agents|antidepressive agents|mesh-ancestor
102314208|NCT05289440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102314209|NCT04016090|Folic Acid|folic acid|mesh-list
102314210|NCT04016090|Hematinics|hematinics|mesh-ancestor
102314211|NCT04016090|Vitamin B Complex|vitamin b complex|mesh-ancestor
102314212|NCT04016090|Vitamins|vitamins|mesh-ancestor
102314213|NCT04016090|Micronutrients|micronutrients|mesh-ancestor
102314214|NCT04016090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314215|NCT04809974|Niacinamide|niacinamide|mesh-list
102314216|NCT04809974|Vitamins|vitamins|mesh-ancestor
102314217|NCT04809974|Micronutrients|micronutrients|mesh-ancestor
102314218|NCT04809974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314219|NCT04809974|Vitamin B Complex|vitamin b complex|mesh-ancestor
102314220|NCT04691960|Metformin|metformin|mesh-list
102314221|NCT04691960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102314222|NCT04691960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314223|NCT04809038|Magnesium Sulfate|magnesium sulfate|mesh-list
102314224|NCT04809038|Analgesics|analgesics|mesh-ancestor
102314225|NCT04809038|Sensory System Agents|sensory system agents|mesh-ancestor
102314226|NCT04809038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102314227|NCT04809038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314228|NCT04809038|Anesthetics|anesthetics|mesh-ancestor
102314229|NCT04809038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102314230|NCT04809038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102314231|NCT04809038|Anticonvulsants|anticonvulsants|mesh-ancestor
102314232|NCT04809038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102314233|NCT04809038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102314234|NCT04809038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314235|NCT04809038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102314236|NCT04809038|Tocolytic Agents|tocolytic agents|mesh-ancestor
102314237|NCT04809038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102314238|NCT05221190|Lidocaine|lidocaine|mesh-list
102314239|NCT05221190|Anesthetics, Local|anesthetics, local|mesh-ancestor
102314240|NCT05221190|Anesthetics|anesthetics|mesh-ancestor
102314241|NCT05221190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102314242|NCT05221190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314243|NCT05221190|Sensory System Agents|sensory system agents|mesh-ancestor
102314244|NCT05221190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102314245|NCT05221190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102314246|NCT05221190|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102314247|NCT05221190|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102314248|NCT05221190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102314249|NCT05221190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023027|NCT01355757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314250|NCT04816682|Silymarin|silymarin|mesh-list
102314251|NCT04816682|Antioxidants|antioxidants|mesh-ancestor
102314252|NCT04816682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314253|NCT04816682|Protective Agents|protective agents|mesh-ancestor
102314254|NCT04816682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314256|NCT02162719|Ipatasertib|ipatasertib|mesh-list
102314257|NCT02162719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102314258|NCT02162719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102314259|NCT02162719|Tubulin Modulators|tubulin modulators|mesh-ancestor
102314260|NCT02162719|Antimitotic Agents|antimitotic agents|mesh-ancestor
102314261|NCT02162719|Mitosis Modulators|mitosis modulators|mesh-ancestor
102314262|NCT02162719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314263|NCT02162719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102314264|NCT02162719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102314265|NCT04808882|Tinzaparin|tinzaparin|mesh-list
102314266|NCT04808882|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102314267|NCT04808882|Dalteparin|dalteparin|mesh-list
102314268|NCT04808882|Anticoagulants|anticoagulants|mesh-ancestor
102314269|NCT04808882|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102314270|NCT04808882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102314271|NCT04808882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314272|NCT05652374|Nitrofurantoin|nitrofurantoin|mesh-list
102314273|NCT05652374|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102314274|NCT05652374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102314275|NCT05652374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102314276|NCT01636076|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102314277|NCT01636076|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102314278|NCT01636076|Autonomic Agents|autonomic agents|mesh-ancestor
102314279|NCT01636076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102314280|NCT01636076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314281|NCT01636076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102314282|NCT01636076|Respiratory System Agents|respiratory system agents|mesh-ancestor
102314283|NCT01636076|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102314284|NCT01636076|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102314285|NCT01636076|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102314286|NCT01636076|Adrenergic Agents|adrenergic agents|mesh-ancestor
102314287|NCT01636076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102314288|NCT01636076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314289|NCT04794842|Phenol|phenol|mesh-list
102314290|NCT04794842|Tetracaine|tetracaine|mesh-list
102314291|NCT04794842|Anesthetics, Local|anesthetics, local|mesh-ancestor
102314292|NCT04794842|Anesthetics|anesthetics|mesh-ancestor
102314293|NCT04794842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102314294|NCT04794842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314295|NCT04794842|Sensory System Agents|sensory system agents|mesh-ancestor
102314296|NCT04794842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102314297|NCT04794842|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102314298|NCT04794842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102314299|NCT04794842|Disinfectants|disinfectants|mesh-ancestor
102314300|NCT04794842|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102314301|NCT04794842|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102314302|NCT03029000|Lenograstim|lenograstim|mesh-list
102314303|NCT03029000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102314304|NCT03029000|Immunologic Factors|immunologic factors|mesh-ancestor
102314305|NCT03029000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314306|NCT03783182|Betamethasone|betamethasone|mesh-list
102314307|NCT03783182|Betamethasone Valerate|betamethasone valerate|mesh-list
102314308|NCT03783182|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102314309|NCT03783182|Betamethasone benzoate|betamethasone benzoate|mesh-list
102314310|NCT03783182|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102314311|NCT03783182|Glucocorticoids|glucocorticoids|mesh-ancestor
102314312|NCT03783182|Hormones|hormones|mesh-ancestor
102314313|NCT03783182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102314314|NCT03783182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314315|NCT03783182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102314316|NCT03783182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102314317|NCT03783182|Respiratory System Agents|respiratory system agents|mesh-ancestor
102314318|NCT03760484|Fidaxomicin|fidaxomicin|mesh-list
102314319|NCT03760484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102314320|NCT03760484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102314321|NCT05651750|Fluticasone|fluticasone|mesh-list
102314322|NCT05651750|Xhance|xhance|mesh-list
102023106|NCT02427334|Serotonin Agents|serotonin agents|mesh-ancestor
102314323|NCT05651750|Montelukast|montelukast|mesh-list
102314324|NCT05651750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102314325|NCT05651750|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102314326|NCT05651750|Autonomic Agents|autonomic agents|mesh-ancestor
102314327|NCT05651750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102314328|NCT05651750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314329|NCT05651750|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102314330|NCT05651750|Respiratory System Agents|respiratory system agents|mesh-ancestor
102314331|NCT05651750|Dermatologic Agents|dermatologic agents|mesh-ancestor
102314332|NCT05651750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102314333|NCT05651750|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102314334|NCT05651750|Hormone Antagonists|hormone antagonists|mesh-ancestor
102314335|NCT05651750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102314336|NCT05651750|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102314337|NCT05651750|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102314338|NCT05651750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314339|NCT02160145|Tolvaptan|tolvaptan|mesh-list
102314340|NCT02160145|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102314341|NCT02160145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314342|NCT02160145|Natriuretic Agents|natriuretic agents|mesh-ancestor
102314343|NCT02160145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314344|NCT02216071|Ciprofloxacin|ciprofloxacin|mesh-list
102314345|NCT02216071|Dexamethasone|dexamethasone|mesh-list
102314346|NCT02216071|Dexamethasone acetate|dexamethasone acetate|mesh-list
102314347|NCT02216071|BB 1101|bb 1101|mesh-list
102314348|NCT02216071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102314349|NCT02216071|Antiemetics|antiemetics|mesh-ancestor
102314350|NCT02216071|Autonomic Agents|autonomic agents|mesh-ancestor
102314351|NCT02216071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102314352|NCT02216071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314353|NCT02216071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102314354|NCT02216071|Glucocorticoids|glucocorticoids|mesh-ancestor
102314355|NCT02216071|Hormones|hormones|mesh-ancestor
102314356|NCT02216071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102314357|NCT02216071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102314358|NCT02216071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102314359|NCT02216071|Protease Inhibitors|protease inhibitors|mesh-ancestor
102314360|NCT02216071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102314361|NCT02216071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314362|NCT02216071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102314363|NCT02216071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102314364|NCT02216071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102314365|NCT02216071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102314366|NCT02216071|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102314367|NCT02216071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102314368|NCT01681576|Valsartan|valsartan|mesh-list
102314369|NCT01681576|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102314370|NCT01681576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102314371|NCT01681576|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102314372|NCT01681576|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102314373|NCT01681576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314374|NCT02188459|Bupropion|bupropion|mesh-list
102314375|NCT02188459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102314376|NCT02188459|Antidepressive Agents|antidepressive agents|mesh-ancestor
102314377|NCT02188459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102314378|NCT02188459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102314379|NCT02188459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102314380|NCT02188459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102314381|NCT02188459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314382|NCT02188459|Dopamine Agents|dopamine agents|mesh-ancestor
102314383|NCT02188459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102314384|NCT02188459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314385|NCT02188459|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102314386|NCT02188459|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102314387|NCT02188459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102314388|NCT02743364|Simvastatin|simvastatin|mesh-list
102314389|NCT02743364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102314390|NCT02743364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102314391|NCT02743364|Antimetabolites|antimetabolites|mesh-ancestor
102314392|NCT02743364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314393|NCT02743364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102314394|NCT02743364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102314395|NCT02743364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102314396|NCT02214121|Ticagrelor|ticagrelor|mesh-list
102314397|NCT02214121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102314398|NCT02214121|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102314399|NCT02214121|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102314400|NCT02214121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102314401|NCT02214121|Purinergic Agents|purinergic agents|mesh-ancestor
102314402|NCT02214121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102314403|NCT02214121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314404|NCT02214121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314406|NCT01681186|Dexlansoprazole|dexlansoprazole|mesh-list
102314407|NCT01681186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102314408|NCT01681186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102314409|NCT01681186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102314410|NCT01681186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102314411|NCT01681186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314412|NCT01695772|Bevacizumab|bevacizumab|mesh-list
102314413|NCT01695772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102314414|NCT01695772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102314415|NCT01695772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102314416|NCT01695772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102314417|NCT01695772|Growth Substances|growth substances|mesh-ancestor
102314418|NCT01695772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314419|NCT01695772|Growth Inhibitors|growth inhibitors|mesh-ancestor
102314420|NCT02159521|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102314421|NCT02159521|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102314422|NCT02159521|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102314423|NCT02159521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314424|NCT01636934|Minocycline|minocycline|mesh-list
102314425|NCT01636934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102314426|NCT01636934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102314427|NCT01712854|Budesonide|budesonide|mesh-list
102314428|NCT01712854|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
102314429|NCT01712854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102314430|NCT01712854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102314431|NCT01712854|Autonomic Agents|autonomic agents|mesh-ancestor
102314432|NCT01712854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102314433|NCT01712854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430985|NCT00153140|Laxatives|laxatives|mesh-ancestor
102314434|NCT01712854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102314435|NCT01712854|Respiratory System Agents|respiratory system agents|mesh-ancestor
102314436|NCT01712854|Glucocorticoids|glucocorticoids|mesh-ancestor
102314437|NCT01712854|Hormones|hormones|mesh-ancestor
102314438|NCT01712854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102314439|NCT02986594|Aspirin|aspirin|mesh-list
102314440|NCT02986594|Heparin|heparin|mesh-list
102314441|NCT02986594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102314442|NCT02986594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102314443|NCT02986594|Analgesics|analgesics|mesh-ancestor
102314444|NCT02986594|Sensory System Agents|sensory system agents|mesh-ancestor
102314445|NCT02986594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102314446|NCT02986594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314447|NCT02986594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102314448|NCT02986594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102314449|NCT02986594|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102314450|NCT02986594|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102314451|NCT02986594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314452|NCT02986594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102314453|NCT02986594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102314454|NCT02986594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102314455|NCT02986594|Antipyretics|antipyretics|mesh-ancestor
102314456|NCT02986594|Anticoagulants|anticoagulants|mesh-ancestor
102314457|NCT02159365|Dexamethasone|dexamethasone|mesh-list
102314458|NCT02159365|Lenalidomide|lenalidomide|mesh-list
102314459|NCT02159365|Elotuzumab|elotuzumab|mesh-list
102314460|NCT02159365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102314461|NCT02159365|Antiemetics|antiemetics|mesh-ancestor
102314462|NCT02159365|Autonomic Agents|autonomic agents|mesh-ancestor
102314463|NCT02159365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102314464|NCT02159365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314465|NCT02159365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102314466|NCT02159365|Glucocorticoids|glucocorticoids|mesh-ancestor
102314467|NCT02159365|Hormones|hormones|mesh-ancestor
102314468|NCT02159365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102314469|NCT02159365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102314470|NCT02159365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102314471|NCT02159365|Immunologic Factors|immunologic factors|mesh-ancestor
102314472|NCT02159365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102314473|NCT02159365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102314474|NCT02159365|Growth Substances|growth substances|mesh-ancestor
102314475|NCT02159365|Growth Inhibitors|growth inhibitors|mesh-ancestor
102314476|NCT02072200|Prednisone|prednisone|mesh-list
102314477|NCT02072200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102314478|NCT02072200|Glucocorticoids|glucocorticoids|mesh-ancestor
102314479|NCT02072200|Hormones|hormones|mesh-ancestor
102314480|NCT02072200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102314481|NCT02072200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314482|NCT02072200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102314483|NCT02072200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102314484|NCT01691794|Ritonavir|ritonavir|mesh-list
102314485|NCT01691794|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102314486|NCT01691794|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102314487|NCT01691794|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102314488|NCT01691794|Protease Inhibitors|protease inhibitors|mesh-ancestor
102314489|NCT01691794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102314490|NCT01691794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314491|NCT01691794|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102314492|NCT01691794|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102314493|NCT01691794|Antiviral Agents|antiviral agents|mesh-ancestor
102314494|NCT01691794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102314495|NCT01691794|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102314496|NCT01691794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102314497|NCT02159053|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102314498|NCT02159053|Immunologic Factors|immunologic factors|mesh-ancestor
102314499|NCT02159053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314500|NCT02158975|Ixazomib|ixazomib|mesh-list
102314501|NCT02158975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102314502|NCT02158975|Protease Inhibitors|protease inhibitors|mesh-ancestor
102314503|NCT02158975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101431053|NCT00165360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102314504|NCT02158975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314505|NCT02661464|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
102314506|NCT02661464|Antiviral Agents|antiviral agents|mesh-ancestor
102314507|NCT02661464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102314508|NCT02158039|Ethanol|ethanol|mesh-list
102314509|NCT02158039|Lidocaine|lidocaine|mesh-list
102314510|NCT02158039|Anesthetics, Local|anesthetics, local|mesh-ancestor
102314511|NCT02158039|Anesthetics|anesthetics|mesh-ancestor
102314512|NCT02158039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102314513|NCT02158039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314514|NCT02158039|Sensory System Agents|sensory system agents|mesh-ancestor
102314515|NCT02158039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102314516|NCT02158039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102314517|NCT02158039|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102314518|NCT02158039|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102314519|NCT02158039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102314520|NCT02158039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314521|NCT02158039|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102314522|NCT02158039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102314523|NCT03563222|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102314524|NCT03563222|SMOFlipid|smoflipid|mesh-list
102314525|NCT03563222|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102314526|NCT03563222|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102314527|NCT03563222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102314528|NCT04803734|Albuterol|albuterol|mesh-list
102314529|NCT04803734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102314530|NCT04803734|Autonomic Agents|autonomic agents|mesh-ancestor
102314531|NCT04803734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102314532|NCT04803734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314533|NCT04803734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102314534|NCT04803734|Respiratory System Agents|respiratory system agents|mesh-ancestor
102314535|NCT04803734|Tocolytic Agents|tocolytic agents|mesh-ancestor
102314536|NCT04803734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102314537|NCT04803734|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102314538|NCT04803734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102314539|NCT04803734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102314540|NCT04803734|Adrenergic Agents|adrenergic agents|mesh-ancestor
102314541|NCT04803734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102314542|NCT04803734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314543|NCT04802408|Listerine|listerine|mesh-list
102023328|NCT01356615|Heparin|heparin|mesh-list
102314544|NCT04802408|Sodium Fluoride|sodium fluoride|mesh-list
102314545|NCT04802408|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102314546|NCT04802408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102314547|NCT04802408|Cariostatic Agents|cariostatic agents|mesh-ancestor
102314548|NCT04802408|Protective Agents|protective agents|mesh-ancestor
102314549|NCT04802408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314551|NCT02490800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102314552|NCT02490800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314553|NCT02490800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102314554|NCT02490800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102314555|NCT01635764|Adalimumab|adalimumab|mesh-list
102314556|NCT01635764|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102314557|NCT01635764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102314558|NCT01635764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102314559|NCT04810598|Venetoclax|venetoclax|mesh-list
102314560|NCT04810598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102314561|NCT04627064|Belzutifan|belzutifan|mesh-list
102314562|NCT04627064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102314563|NCT04511078|Panitumumab|panitumumab|mesh-list
102314564|NCT04511078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102314565|NCT04511078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102314566|NCT02158052|Tacrolimus|tacrolimus|mesh-list
102314567|NCT02158052|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102314568|NCT02158052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102314569|NCT02158052|Immunologic Factors|immunologic factors|mesh-ancestor
102314570|NCT02158052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314571|NCT02158052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102314572|NCT02158052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102314573|NCT02158052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314574|NCT01635218|Fluoxetine|fluoxetine|mesh-list
102314575|NCT01635218|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102314576|NCT01635218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102314577|NCT01635218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102314578|NCT01635218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314579|NCT01635218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102314580|NCT01635218|Serotonin Agents|serotonin agents|mesh-ancestor
102314581|NCT01635218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314582|NCT01635218|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102314583|NCT01635218|Antidepressive Agents|antidepressive agents|mesh-ancestor
102314584|NCT01635218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102314585|NCT01635218|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102314586|NCT01635218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102314587|NCT01635218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102314588|NCT05351684|Dolutegravir|dolutegravir|mesh-list
102314589|NCT05351684|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102314590|NCT05351684|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102314591|NCT05351684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102314592|NCT05351684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314593|NCT05351684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102314594|NCT05351684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102314595|NCT05351684|Antiviral Agents|antiviral agents|mesh-ancestor
102314596|NCT05351684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102314597|NCT02049866|Denosumab|denosumab|mesh-list
102314598|NCT02049866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102314599|NCT02049866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314600|NCT04787744|Prednisone|prednisone|mesh-list
102314601|NCT04787744|Methylprednisolone|methylprednisolone|mesh-list
102314602|NCT04787744|Docetaxel|docetaxel|mesh-list
102314603|NCT04787744|Leuprolide|leuprolide|mesh-list
102314604|NCT04787744|Goserelin|goserelin|mesh-list
102314605|NCT04787744|Bicalutamide|bicalutamide|mesh-list
102314606|NCT04787744|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102314607|NCT04787744|Flutamide|flutamide|mesh-list
102314608|NCT04787744|Nilutamide|nilutamide|mesh-list
102314609|NCT04787744|Relugolix|relugolix|mesh-list
102314610|NCT04787744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102314611|NCT04787744|Tubulin Modulators|tubulin modulators|mesh-ancestor
102314612|NCT04787744|Antimitotic Agents|antimitotic agents|mesh-ancestor
102314613|NCT04787744|Mitosis Modulators|mitosis modulators|mesh-ancestor
102314614|NCT04787744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314615|NCT04787744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102314616|NCT04787744|Glucocorticoids|glucocorticoids|mesh-ancestor
102314617|NCT04787744|Hormones|hormones|mesh-ancestor
102314618|NCT04787744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102023404|NCT02930343|Hormones|hormones|mesh-ancestor
102314619|NCT04787744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314620|NCT04787744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102314622|NCT04787744|Autonomic Agents|autonomic agents|mesh-ancestor
102314623|NCT04787744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102314624|NCT04787744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102314625|NCT04787744|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102314626|NCT04787744|Protective Agents|protective agents|mesh-ancestor
102314627|NCT04787744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102314628|NCT04787744|Fertility Agents|fertility agents|mesh-ancestor
102314629|NCT04787744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102314630|NCT04787744|Androgen Antagonists|androgen antagonists|mesh-ancestor
102314631|NCT04787744|Hormone Antagonists|hormone antagonists|mesh-ancestor
102314632|NCT04787744|Luteolytic Agents|luteolytic agents|mesh-ancestor
102314633|NCT04787744|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102314634|NCT04787744|Contraceptive Agents|contraceptive agents|mesh-ancestor
102314635|NCT04787744|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102314636|NCT04274894|Testosterone|testosterone|mesh-list
102314637|NCT04274894|Androgens|androgens|mesh-ancestor
102314638|NCT04274894|Hormones|hormones|mesh-ancestor
102314639|NCT04274894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102314640|NCT04274894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314641|NCT04786964|Folic Acid|folic acid|mesh-list
102314642|NCT04786964|Vitamin B 12|vitamin b 12|mesh-list
102314643|NCT04786964|Dexamethasone|dexamethasone|mesh-list
102314644|NCT04786964|Carboplatin|carboplatin|mesh-list
102314645|NCT04786964|Pemetrexed|pemetrexed|mesh-list
102314646|NCT04786964|Vitamins|vitamins|mesh-ancestor
102314647|NCT04786964|Micronutrients|micronutrients|mesh-ancestor
102314648|NCT04786964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314649|NCT04786964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102314650|NCT04786964|Antiemetics|antiemetics|mesh-ancestor
102314651|NCT04786964|Autonomic Agents|autonomic agents|mesh-ancestor
102314652|NCT04786964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102314653|NCT04786964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102314654|NCT04786964|Glucocorticoids|glucocorticoids|mesh-ancestor
102314655|NCT04786964|Hormones|hormones|mesh-ancestor
102314656|NCT04786964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102314657|NCT04786964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102314658|NCT04786964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102314659|NCT04786964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102314660|NCT04786964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314661|NCT04786964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102314662|NCT04786964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102314663|NCT04786964|Hematinics|hematinics|mesh-ancestor
102314664|NCT04786964|Vitamin B Complex|vitamin b complex|mesh-ancestor
102314665|NCT04269200|Paclitaxel|paclitaxel|mesh-list
102314666|NCT04269200|Carboplatin|carboplatin|mesh-list
102314667|NCT04269200|Durvalumab|durvalumab|mesh-list
102314668|NCT04269200|Olaparib|olaparib|mesh-list
102314669|NCT04269200|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102314670|NCT04269200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102314671|NCT04269200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102314672|NCT04269200|Tubulin Modulators|tubulin modulators|mesh-ancestor
102314673|NCT04269200|Antimitotic Agents|antimitotic agents|mesh-ancestor
102314674|NCT04269200|Mitosis Modulators|mitosis modulators|mesh-ancestor
102314675|NCT04269200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314676|NCT04269200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102314677|NCT04269200|Immunologic Factors|immunologic factors|mesh-ancestor
102314678|NCT04269200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314679|NCT04269200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102314680|NCT04269200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102314681|NCT02213263|Rituximab|rituximab|mesh-list
102314682|NCT02213263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102314683|NCT02213263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102314684|NCT02213263|Immunologic Factors|immunologic factors|mesh-ancestor
102314685|NCT02213263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314686|NCT02213263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102314687|NCT04781036|Chlorhexidine|chlorhexidine|mesh-list
102314688|NCT04781036|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102314689|NCT04781036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102314690|NCT04781036|Disinfectants|disinfectants|mesh-ancestor
102314691|NCT04216784|Furosemide|furosemide|mesh-list
102314692|NCT04216784|Diuretics|diuretics|mesh-ancestor
102314693|NCT04216784|Natriuretic Agents|natriuretic agents|mesh-ancestor
102314694|NCT04216784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314695|NCT04216784|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102314696|NCT04216784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101656564|NCT00831103|Valacyclovir|valacyclovir|mesh-list
102314697|NCT04216784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314698|NCT05173298|Bevacizumab|bevacizumab|mesh-list
102314699|NCT05173298|Atezolizumab|atezolizumab|mesh-list
102314700|NCT05173298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102314701|NCT05173298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102314702|NCT05173298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102314703|NCT05173298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102314704|NCT05173298|Growth Substances|growth substances|mesh-ancestor
102314705|NCT05173298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314706|NCT05173298|Growth Inhibitors|growth inhibitors|mesh-ancestor
102314707|NCT05173298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102314708|NCT05173298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314709|NCT05168930|Venetoclax|venetoclax|mesh-list
102314710|NCT05168930|Zanubrutinib|zanubrutinib|mesh-list
102314711|NCT05168930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102314712|NCT05168930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102314713|NCT05168930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102314714|NCT05168930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314715|NCT05170724|Remibrutinib|remibrutinib|mesh-list
102314716|NCT05170724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102314717|NCT05170724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102314718|NCT05170724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314719|NCT01975064|Propofol|propofol|mesh-list
102314720|NCT01975064|Sevoflurane|sevoflurane|mesh-list
102314721|NCT01975064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102314722|NCT01975064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102314723|NCT01975064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314724|NCT01975064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102314725|NCT01975064|Anesthetics, General|anesthetics, general|mesh-ancestor
102314726|NCT01975064|Anesthetics|anesthetics|mesh-ancestor
102314727|NCT01975064|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102314728|NCT01975064|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102314729|NCT02210689|Clindamycin|clindamycin|mesh-list
102314730|NCT02210689|Clindamycin palmitate|clindamycin palmitate|mesh-list
102314731|NCT02210689|Clindamycin phosphate|clindamycin phosphate|mesh-list
102314732|NCT02210689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102314733|NCT02210689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102314734|NCT02210689|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102314735|NCT02210689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102314736|NCT02210689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314737|NCT02209597|Bupropion|bupropion|mesh-list
102314738|NCT02209597|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102314739|NCT02209597|Antidepressive Agents|antidepressive agents|mesh-ancestor
102314740|NCT02209597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102314741|NCT02209597|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102314742|NCT02209597|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102314743|NCT02209597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102314744|NCT02209597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314745|NCT02209597|Dopamine Agents|dopamine agents|mesh-ancestor
102314746|NCT02209597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102314747|NCT02209597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314748|NCT02209597|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102314749|NCT02209597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102314750|NCT02209597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102314751|NCT03965468|Paclitaxel|paclitaxel|mesh-list
102314752|NCT03965468|Carboplatin|carboplatin|mesh-list
102314753|NCT03965468|Durvalumab|durvalumab|mesh-list
102314754|NCT03965468|Tremelimumab|tremelimumab|mesh-list
102314755|NCT03965468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102314756|NCT03965468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102314757|NCT03965468|Tubulin Modulators|tubulin modulators|mesh-ancestor
102314758|NCT03965468|Antimitotic Agents|antimitotic agents|mesh-ancestor
102314759|NCT03965468|Mitosis Modulators|mitosis modulators|mesh-ancestor
102314760|NCT03965468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314761|NCT03965468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102314762|NCT01469156|Ranibizumab|ranibizumab|mesh-list
102314763|NCT01469156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102314764|NCT01469156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102314765|NCT01469156|Growth Substances|growth substances|mesh-ancestor
102314766|NCT01469156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314767|NCT01469156|Growth Inhibitors|growth inhibitors|mesh-ancestor
102314768|NCT01469156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102314769|NCT04191434|Budesonide|budesonide|mesh-list
102023557|NCT02505204|Clonidine|clonidine|mesh-list
101431354|NCT00154076|Topiramate|topiramate|mesh-list
102314770|NCT04191434|Formoterol Fumarate|formoterol fumarate|mesh-list
102314771|NCT04191434|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
102314772|NCT04191434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102314773|NCT04191434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102314774|NCT04191434|Autonomic Agents|autonomic agents|mesh-ancestor
102314775|NCT04191434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102314776|NCT04191434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314777|NCT04191434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102314778|NCT04191434|Respiratory System Agents|respiratory system agents|mesh-ancestor
102314779|NCT04191434|Glucocorticoids|glucocorticoids|mesh-ancestor
102314780|NCT04191434|Hormones|hormones|mesh-ancestor
102314781|NCT04191434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102314782|NCT04191434|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102314783|NCT04191434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102314784|NCT04191434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102314785|NCT04191434|Adrenergic Agents|adrenergic agents|mesh-ancestor
102314786|NCT04191434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102314787|NCT04191434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314788|NCT03835676|Treprostinil|treprostinil|mesh-list
102314789|NCT03835676|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102314790|NCT03651128|Dexamethasone|dexamethasone|mesh-list
102314791|NCT03651128|Lenalidomide|lenalidomide|mesh-list
102314792|NCT03651128|Bortezomib|bortezomib|mesh-list
102314793|NCT03651128|Daratumumab|daratumumab|mesh-list
102314794|NCT03651128|Pomalidomide|pomalidomide|mesh-list
102314795|NCT03651128|Ixazomib|ixazomib|mesh-list
102314796|NCT03651128|Elotuzumab|elotuzumab|mesh-list
102314797|NCT03651128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102314798|NCT03651128|Antiemetics|antiemetics|mesh-ancestor
102314799|NCT03651128|Autonomic Agents|autonomic agents|mesh-ancestor
102314800|NCT03651128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102314801|NCT03651128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314802|NCT03651128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102314803|NCT03651128|Glucocorticoids|glucocorticoids|mesh-ancestor
102314804|NCT03651128|Hormones|hormones|mesh-ancestor
102314805|NCT03651128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102314806|NCT03651128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102314807|NCT03651128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102314808|NCT03651128|Immunologic Factors|immunologic factors|mesh-ancestor
102314809|NCT03651128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102314810|NCT03651128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102314811|NCT03651128|Growth Substances|growth substances|mesh-ancestor
102314812|NCT03651128|Growth Inhibitors|growth inhibitors|mesh-ancestor
102314813|NCT03651128|Protease Inhibitors|protease inhibitors|mesh-ancestor
102314814|NCT03651128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102314815|NCT03651128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314816|NCT00664898|Bortezomib|bortezomib|mesh-list
102314817|NCT00664898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102314818|NCT04827992|Analgesics, Opioid|analgesics, opioid|mesh-list
102314819|NCT04827992|Narcotics|narcotics|mesh-ancestor
102314820|NCT04827992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102314821|NCT04827992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314822|NCT04827992|Analgesics|analgesics|mesh-ancestor
102314823|NCT04827992|Sensory System Agents|sensory system agents|mesh-ancestor
102314824|NCT04827992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102314825|NCT04776980|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102314826|NCT04776980|Hematinics|hematinics|mesh-ancestor
102314827|NCT04776980|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102314828|NCT04776980|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102314829|NCT02187055|Adalimumab|adalimumab|mesh-list
102314830|NCT02187055|Methotrexate|methotrexate|mesh-list
102314831|NCT02187055|Tofacitinib|tofacitinib|mesh-list
102314832|NCT02187055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102314833|NCT02187055|Abortifacient Agents|abortifacient agents|mesh-ancestor
102314834|NCT02187055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102314835|NCT02187055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314836|NCT02187055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102314837|NCT02187055|Antimetabolites|antimetabolites|mesh-ancestor
102314838|NCT02187055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314839|NCT02187055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102314840|NCT02187055|Dermatologic Agents|dermatologic agents|mesh-ancestor
102314841|NCT02187055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102314842|NCT02187055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102314843|NCT02187055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102314844|NCT02187055|Immunologic Factors|immunologic factors|mesh-ancestor
102314845|NCT02187055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102314846|NCT02187055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102314847|NCT02187055|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102314848|NCT02187055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102314849|NCT02187055|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102314850|NCT02187055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102314851|NCT00119366|Iodine|iodine|mesh-list
102314852|NCT00119366|Cyclosporine|cyclosporine|mesh-list
102314853|NCT00119366|Mycophenolic Acid|mycophenolic acid|mesh-list
102314854|NCT00119366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102314855|NCT00119366|Fludarabine|fludarabine|mesh-list
102314856|NCT00119366|Fludarabine phosphate|fludarabine phosphate|mesh-list
102314857|NCT00119366|Antibodies|antibodies|mesh-list
102314858|NCT00119366|Immunoglobulins|immunoglobulins|mesh-list
102314859|NCT00119366|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102314860|NCT00119366|Cyclosporins|cyclosporins|mesh-list
102314861|NCT00119366|Immunologic Factors|immunologic factors|mesh-ancestor
102314862|NCT00119366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314863|NCT00119366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102314864|NCT00119366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102314865|NCT00119366|Antimetabolites|antimetabolites|mesh-ancestor
102314866|NCT00119366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314867|NCT00119366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102314868|NCT00119366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102314869|NCT00119366|Antifungal Agents|antifungal agents|mesh-ancestor
102314870|NCT00119366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102314871|NCT00119366|Dermatologic Agents|dermatologic agents|mesh-ancestor
102314872|NCT00119366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102314873|NCT00119366|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102314874|NCT00119366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102314875|NCT00119366|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102314876|NCT00119366|Antitubercular Agents|antitubercular agents|mesh-ancestor
102314877|NCT00119366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102314878|NCT00119366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102314879|NCT00119366|Trace Elements|trace elements|mesh-ancestor
102314880|NCT00119366|Micronutrients|micronutrients|mesh-ancestor
102314881|NCT02246660|Resveratrol|resveratrol|mesh-list
102314882|NCT02246660|Antioxidants|antioxidants|mesh-ancestor
102314883|NCT02246660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314884|NCT02246660|Protective Agents|protective agents|mesh-ancestor
102314885|NCT02246660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314886|NCT02246660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102314887|NCT02246660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102314888|NCT02246582|Insulin|insulin|mesh-list
102314889|NCT02246582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102314890|NCT02246582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314891|NCT02137369|Dexetimide|dexetimide|mesh-list
102314892|NCT02137369|Citalopram|citalopram|mesh-list
102314893|NCT02137369|Sertraline|sertraline|mesh-list
102314894|NCT02137369|Antidepressive Agents|antidepressive agents|mesh-list
102314895|NCT02137369|Escitalopram|escitalopram|mesh-list
102314896|NCT02137369|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
102314897|NCT02137369|Serotonin|serotonin|mesh-list
102314898|NCT02137369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102314899|NCT02137369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102314900|NCT02137369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314901|NCT02137369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102314902|NCT02137369|Serotonin Agents|serotonin agents|mesh-ancestor
102314903|NCT02137369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314904|NCT02137369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102314905|NCT02137369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102314906|NCT02137369|Parasympatholytics|parasympatholytics|mesh-ancestor
102314907|NCT02137369|Autonomic Agents|autonomic agents|mesh-ancestor
102314908|NCT02137369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102314909|NCT02137369|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102314910|NCT02137369|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102314911|NCT02137369|Cholinergic Agents|cholinergic agents|mesh-ancestor
101431462|NCT02923258|Docetaxel|docetaxel|mesh-list
102314912|NCT02137369|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102314913|NCT02137369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102314914|NCT02137369|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102314915|NCT02155309|Scopolamine|scopolamine|mesh-list
102314916|NCT02155309|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102314917|NCT02155309|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102314918|NCT02155309|Antiemetics|antiemetics|mesh-ancestor
102314919|NCT02155309|Autonomic Agents|autonomic agents|mesh-ancestor
102314920|NCT02155309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102314921|NCT02155309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314922|NCT02155309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102314923|NCT02155309|Mydriatics|mydriatics|mesh-ancestor
102314924|NCT02155309|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102314925|NCT02155309|Cholinergic Agents|cholinergic agents|mesh-ancestor
102314926|NCT02155309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102314927|NCT02155309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314928|NCT02155309|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102314929|NCT02155309|Parasympatholytics|parasympatholytics|mesh-ancestor
102314930|NCT02186821|Ceritinib|ceritinib|mesh-list
102314931|NCT02186821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102314932|NCT02186821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102314933|NCT02186821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102314934|NCT02186821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314935|NCT01710358|Adalimumab|adalimumab|mesh-list
102314936|NCT01710358|Methotrexate|methotrexate|mesh-list
102314937|NCT01710358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102314938|NCT01710358|Abortifacient Agents|abortifacient agents|mesh-ancestor
102314939|NCT01710358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102314940|NCT01710358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314941|NCT01710358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102314942|NCT01710358|Antimetabolites|antimetabolites|mesh-ancestor
102314943|NCT01710358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314944|NCT01710358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102314945|NCT01710358|Dermatologic Agents|dermatologic agents|mesh-ancestor
102314946|NCT01710358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102314947|NCT01710358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102314948|NCT01710358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102314949|NCT01710358|Immunologic Factors|immunologic factors|mesh-ancestor
102314950|NCT01710358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102314951|NCT01710358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102314952|NCT01710358|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102314953|NCT01710358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102314954|NCT01633112|Glatiramer Acetate|glatiramer acetate|mesh-list
102314955|NCT01633112|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102314956|NCT01633112|(T,G)-A-L|(t,g)-a-l|mesh-list
102314957|NCT01633112|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102314958|NCT01633112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314959|NCT01633112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102314960|NCT01633112|Immunologic Factors|immunologic factors|mesh-ancestor
102314961|NCT01633112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314962|NCT01633112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102314963|NCT01633112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102314964|NCT03455270|Palbociclib|palbociclib|mesh-list
102314965|NCT03455270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102314966|NCT03455270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102314967|NCT03455270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102314968|NCT03455270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314969|NCT01691482|Albuterol|albuterol|mesh-list
102314970|NCT01691482|Ipratropium|ipratropium|mesh-list
102314971|NCT01691482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102314972|NCT01691482|Autonomic Agents|autonomic agents|mesh-ancestor
102314973|NCT01691482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102314974|NCT01691482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102314975|NCT01691482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102314976|NCT01691482|Respiratory System Agents|respiratory system agents|mesh-ancestor
102314977|NCT01691482|Tocolytic Agents|tocolytic agents|mesh-ancestor
102314978|NCT01691482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102314979|NCT01691482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102314980|NCT01691482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102314981|NCT01691482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102314982|NCT01691482|Adrenergic Agents|adrenergic agents|mesh-ancestor
102314983|NCT01691482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102314984|NCT01691482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314985|NCT01691482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102314986|NCT01691482|Cholinergic Agents|cholinergic agents|mesh-ancestor
102314987|NCT01710046|Tofacitinib|tofacitinib|mesh-list
102314988|NCT01710046|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102314989|NCT01710046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102314990|NCT01710046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102314991|NCT01710046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314992|NCT02154529|Trastuzumab|trastuzumab|mesh-list
102314993|NCT02154529|XL647|xl647|mesh-list
102314994|NCT02154529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102314995|NCT02154529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102314996|NCT02154529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102314997|NCT02154529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102314998|NCT02154529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102314999|NCT02154139|Leuprolide|leuprolide|mesh-list
102315000|NCT02154139|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102315001|NCT02154139|Fertility Agents|fertility agents|mesh-ancestor
102315002|NCT02154139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102315003|NCT02154139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315004|NCT02154139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102315005|NCT02154139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102315006|NCT02154061|Metronidazole|metronidazole|mesh-list
102315007|NCT02154061|Vancomycin|vancomycin|mesh-list
102315008|NCT02154061|Neomycin|neomycin|mesh-list
102315009|NCT02154061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102315010|NCT02154061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102315011|NCT02154061|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102315012|NCT02154061|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102315013|NCT02154061|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102315014|NCT02154061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102315015|NCT02154061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315016|NCT01907217|Methohexital|methohexital|mesh-list
102315017|NCT01907217|Succinylcholine|succinylcholine|mesh-list
102315018|NCT01907217|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
102315019|NCT01907217|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102315020|NCT01907217|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102315021|NCT01907217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102315022|NCT01907217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315023|NCT01907217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102315024|NCT01907217|Anesthetics, General|anesthetics, general|mesh-ancestor
102315025|NCT01907217|Anesthetics|anesthetics|mesh-ancestor
102315026|NCT01907217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102315027|NCT01953783|Ixazomib|ixazomib|mesh-list
102315028|NCT01953783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102315029|NCT01953783|Protease Inhibitors|protease inhibitors|mesh-ancestor
102315030|NCT01953783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102315031|NCT01953783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315032|NCT02134015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102315033|NCT02134015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102315034|NCT02134015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102315035|NCT02134015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102315036|NCT02134015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315037|NCT04619979|Anesthetics|anesthetics|mesh-list
102315038|NCT04619979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102315039|NCT04619979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315040|NCT01630135|Fluticasone|fluticasone|mesh-list
102315042|NCT01630135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102315043|NCT01630135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102315044|NCT01630135|Autonomic Agents|autonomic agents|mesh-ancestor
102315045|NCT01630135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102315046|NCT01630135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315047|NCT01630135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102315048|NCT01630135|Respiratory System Agents|respiratory system agents|mesh-ancestor
102315049|NCT01630135|Dermatologic Agents|dermatologic agents|mesh-ancestor
102315050|NCT01630135|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102315051|NCT01691248|Fidaxomicin|fidaxomicin|mesh-list
102315052|NCT01691248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102315053|NCT01691248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102315054|NCT01924767|Empagliflozin|empagliflozin|mesh-list
101431601|NCT02920801|Saxagliptin|saxagliptin|mesh-list
102315055|NCT01924767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102315056|NCT01924767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315057|NCT01924767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102315058|NCT01924767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315059|NCT01691092|Ketamine|ketamine|mesh-list
102315060|NCT01691092|Analgesics|analgesics|mesh-ancestor
102315061|NCT01691092|Sensory System Agents|sensory system agents|mesh-ancestor
102315062|NCT01691092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102315063|NCT01691092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315064|NCT01691092|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102315065|NCT01691092|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102315066|NCT01691092|Anesthetics, General|anesthetics, general|mesh-ancestor
102315067|NCT01691092|Anesthetics|anesthetics|mesh-ancestor
101941578|NCT01224093|Rituximab|rituximab|mesh-list
102315068|NCT01691092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102315069|NCT01691092|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102315070|NCT01691092|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102315071|NCT01691092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102315072|NCT01691092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315073|NCT02133001|Esketamine|esketamine|mesh-list
102315074|NCT02133001|Antidepressive Agents|antidepressive agents|mesh-ancestor
102315075|NCT02133001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102315076|NCT01709578|Hydroxychloroquine|hydroxychloroquine|mesh-list
102315077|NCT01709578|Sulfasalazine|sulfasalazine|mesh-list
102315078|NCT01709578|Methotrexate|methotrexate|mesh-list
102315079|NCT01709578|Leflunomide|leflunomide|mesh-list
102315080|NCT01709578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102315081|NCT01709578|Abortifacient Agents|abortifacient agents|mesh-ancestor
102315082|NCT01709578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102315083|NCT01709578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315084|NCT01709578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102315085|NCT01709578|Antimetabolites|antimetabolites|mesh-ancestor
102315086|NCT01709578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315087|NCT01709578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102315088|NCT01709578|Dermatologic Agents|dermatologic agents|mesh-ancestor
102315089|NCT01709578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102315090|NCT01709578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102315091|NCT01709578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102315092|NCT01709578|Immunologic Factors|immunologic factors|mesh-ancestor
102315093|NCT01709578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102315094|NCT01709578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102315095|NCT01709578|Antimalarials|antimalarials|mesh-ancestor
102315096|NCT01709578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102315097|NCT01709578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102315098|NCT01709578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102315099|NCT01709578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102315100|NCT01709578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102315101|NCT01709578|Analgesics|analgesics|mesh-ancestor
102315102|NCT01709578|Sensory System Agents|sensory system agents|mesh-ancestor
102315103|NCT01709578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102315104|NCT01709578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102315105|NCT01709578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102315106|NCT02132767|Digoxin|digoxin|mesh-list
102315107|NCT02132767|Amiodarone|amiodarone|mesh-list
102315108|NCT02132767|Calcium Channel Blockers|calcium channel blockers|mesh-list
102315109|NCT02132767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102315110|NCT02132767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315111|NCT02132767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102315112|NCT02132767|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102315113|NCT02132767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102315114|NCT02132767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315115|NCT02132767|Protective Agents|protective agents|mesh-ancestor
102315116|NCT02132767|Vasodilator Agents|vasodilator agents|mesh-ancestor
102315117|NCT02132767|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102315118|NCT02132767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102315119|NCT02132767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102315120|NCT02132767|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102315121|NCT02132767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102315122|NCT02132767|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101431638|NCT00180882|Immunologic Factors|immunologic factors|mesh-ancestor
102315123|NCT02132767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102315124|NCT02132767|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102315125|NCT02153905|Aldesleukin|aldesleukin|mesh-list
102315126|NCT02153905|Cyclophosphamide|cyclophosphamide|mesh-list
102315127|NCT02153905|Fludarabine|fludarabine|mesh-list
102315128|NCT02153905|Interleukin-2|interleukin-2|mesh-list
102315129|NCT02153905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102315130|NCT02153905|Immunologic Factors|immunologic factors|mesh-ancestor
102315131|NCT02153905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315132|NCT02153905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102315133|NCT02153905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102315134|NCT02153905|Alkylating Agents|alkylating agents|mesh-ancestor
102315135|NCT02153905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315136|NCT02153905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102315137|NCT02153905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102315138|NCT02153905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102315139|NCT02153905|Analgesics|analgesics|mesh-ancestor
102315140|NCT02153905|Sensory System Agents|sensory system agents|mesh-ancestor
102315141|NCT02153905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102315143|NCT02153905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102315144|NCT02153905|Antiviral Agents|antiviral agents|mesh-ancestor
102315145|NCT02153905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102315146|NCT04752631|Tenecteplase|tenecteplase|mesh-list
102315147|NCT04752631|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102315148|NCT04752631|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102315149|NCT04752631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315150|NCT04546672|Neostigmine|neostigmine|mesh-list
102315151|NCT04546672|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102315152|NCT04546672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102315153|NCT04546672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315154|NCT04546672|Cholinergic Agents|cholinergic agents|mesh-ancestor
102315155|NCT04546672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102315156|NCT04546672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315157|NCT04546672|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102315158|NCT04546672|Autonomic Agents|autonomic agents|mesh-ancestor
102315159|NCT04546672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102315161|NCT02244944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102315162|NCT02244944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102315163|NCT02244944|Antimetabolites|antimetabolites|mesh-ancestor
102315164|NCT02244944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315165|NCT02244944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102315166|NCT01689532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102315167|NCT01689532|Immunologic Factors|immunologic factors|mesh-ancestor
102315168|NCT01689532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315169|NCT01591096|Plasminogen|plasminogen|mesh-list
102315170|NCT01591096|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102315171|NCT01591096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102315172|NCT01591096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102315173|NCT01591096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315174|NCT01953003|Capecitabine|capecitabine|mesh-list
102315175|NCT01953003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102315176|NCT01953003|Antimetabolites|antimetabolites|mesh-ancestor
102315177|NCT01953003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315178|NCT01953003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102315179|NCT01709500|Atorvastatin|atorvastatin|mesh-list
102315180|NCT01709500|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102315181|NCT01709500|Simvastatin|simvastatin|mesh-list
102315182|NCT01709500|Alirocumab|alirocumab|mesh-list
102315183|NCT01709500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102315184|NCT01709500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102315185|NCT01709500|Antimetabolites|antimetabolites|mesh-ancestor
102315186|NCT01709500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315187|NCT01709500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102315188|NCT01709500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102315189|NCT01709500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102315190|NCT01709500|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102315191|NCT01709500|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102315192|NCT01709500|Protease Inhibitors|protease inhibitors|mesh-ancestor
102315193|NCT01599806|Ciprofloxacin|ciprofloxacin|mesh-list
102315194|NCT01599806|Ceftazidime|ceftazidime|mesh-list
102315195|NCT01599806|Avibactam|avibactam|mesh-list
102315196|NCT01599806|Doripenem|doripenem|mesh-list
102315197|NCT01599806|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102315198|NCT01599806|Trimethoprim|trimethoprim|mesh-list
102315199|NCT01599806|Sulfamethoxazole|sulfamethoxazole|mesh-list
102315200|NCT01599806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102315201|NCT01599806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102315202|NCT01599806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102315203|NCT01599806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102315204|NCT01599806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102315205|NCT01599806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315206|NCT01599806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102315207|NCT01599806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102315208|NCT01599806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102315209|NCT01599806|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102315210|NCT01599806|Antimalarials|antimalarials|mesh-ancestor
102315211|NCT01599806|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102315212|NCT01599806|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102315213|NCT01599806|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102315214|NCT01599806|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102315215|NCT01599806|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102315216|NCT01599806|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102315218|NCT01599325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102315219|NCT01599325|Antimetabolites|antimetabolites|mesh-ancestor
102315220|NCT01599325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315221|NCT01599325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102315222|NCT01599325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102315223|NCT01924299|Fluconazole|fluconazole|mesh-list
102315224|NCT01924299|Ketoconazole|ketoconazole|mesh-list
102315225|NCT01924299|Antifungal Agents|antifungal agents|mesh-ancestor
102315226|NCT01924299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102315227|NCT01924299|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102315228|NCT01924299|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102315229|NCT01924299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102315230|NCT01924299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315231|NCT01924299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102315232|NCT01924299|Hormone Antagonists|hormone antagonists|mesh-ancestor
102315233|NCT01924299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102315234|NCT01924299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315235|NCT01924299|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102315236|NCT01924299|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102315237|NCT01924299|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102315238|NCT02182999|Ropivacaine|ropivacaine|mesh-list
102315239|NCT02182999|Anesthetics, Local|anesthetics, local|mesh-ancestor
102315240|NCT02182999|Anesthetics|anesthetics|mesh-ancestor
102315241|NCT02182999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102315242|NCT02182999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315243|NCT02182999|Sensory System Agents|sensory system agents|mesh-ancestor
102315244|NCT02182999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102315245|NCT01598311|Vancomycin|vancomycin|mesh-list
102315246|NCT01598311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102315247|NCT01598311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102315248|NCT02208050|4-Aminopyridine|4-aminopyridine|mesh-list
102315249|NCT02208050|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102315250|NCT02208050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102315251|NCT02208050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315252|NCT02978222|Molgramostim|molgramostim|mesh-list
102315253|NCT02978222|Sargramostim|sargramostim|mesh-list
102315254|NCT02978222|Immunologic Factors|immunologic factors|mesh-ancestor
102315255|NCT02978222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315256|NCT02978222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102315257|NCT02181673|Golimumab|golimumab|mesh-list
102315258|NCT02181673|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102315259|NCT02181673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102315260|NCT02181673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102315261|NCT02181673|Immunologic Factors|immunologic factors|mesh-ancestor
102315262|NCT02181673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315263|NCT02152345|Methylprednisolone|methylprednisolone|mesh-list
102315264|NCT02152345|Abatacept|abatacept|mesh-list
102315265|NCT02152345|Tacrolimus|tacrolimus|mesh-list
102315266|NCT02152345|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102315267|NCT02152345|Thymoglobulin|thymoglobulin|mesh-list
102315268|NCT02152345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102315269|NCT02152345|Immunologic Factors|immunologic factors|mesh-ancestor
102315270|NCT02152345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315271|NCT02152345|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102315272|NCT02152345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102315273|NCT02152345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315274|NCT02152345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102315275|NCT02152345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102315276|NCT02152345|Antiemetics|antiemetics|mesh-ancestor
102315277|NCT02152345|Autonomic Agents|autonomic agents|mesh-ancestor
102315278|NCT02152345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102315279|NCT02152345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102315280|NCT02152345|Glucocorticoids|glucocorticoids|mesh-ancestor
102315281|NCT02152345|Hormones|hormones|mesh-ancestor
102315282|NCT02152345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102315283|NCT02152345|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102315284|NCT02152345|Protective Agents|protective agents|mesh-ancestor
102315285|NCT02152345|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102315286|NCT02152345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102315287|NCT02152345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102315288|NCT02180659|Buprenorphine|buprenorphine|mesh-list
102315289|NCT02180659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102315290|NCT02180659|Narcotics|narcotics|mesh-ancestor
102315291|NCT02180659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102315293|NCT02180659|Analgesics|analgesics|mesh-ancestor
102315294|NCT02180659|Sensory System Agents|sensory system agents|mesh-ancestor
102315295|NCT02180659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102315296|NCT02180659|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102315297|NCT02207816|Vaccines|vaccines|mesh-list
102315298|NCT02207816|Immunologic Factors|immunologic factors|mesh-ancestor
102315299|NCT02207816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315300|NCT05156606|Testosterone|testosterone|mesh-list
102315301|NCT05156606|Androgens|androgens|mesh-ancestor
102315302|NCT05156606|Hormones|hormones|mesh-ancestor
102315303|NCT05156606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102315304|NCT05156606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315305|NCT02241512|Ibuprofen|ibuprofen|mesh-list
102315306|NCT02241512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102315307|NCT02241512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102315308|NCT02241512|Analgesics|analgesics|mesh-ancestor
102315309|NCT02241512|Sensory System Agents|sensory system agents|mesh-ancestor
102315310|NCT02241512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102315311|NCT02241512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315312|NCT02241512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102315313|NCT02241512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102315314|NCT02241512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102315315|NCT02241512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102315316|NCT02241512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315317|NCT01709110|Vitamin D|vitamin d|mesh-list
102315318|NCT01709110|Teriparatide|teriparatide|mesh-list
102315319|NCT01709110|Risedronic Acid|risedronic acid|mesh-list
102315320|NCT01709110|Calcium|calcium|mesh-list
102315321|NCT01709110|Vitamins|vitamins|mesh-ancestor
102315322|NCT01709110|Micronutrients|micronutrients|mesh-ancestor
102315323|NCT01709110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315324|NCT01709110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102315325|NCT01709110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102315326|NCT01709110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102315327|NCT01709110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102315328|NCT01709110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315329|NCT02240108|Rifaximin|rifaximin|mesh-list
102315330|NCT02240108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102315331|NCT02240108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102315332|NCT02240108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102315333|NCT01590082|Doxycycline|doxycycline|mesh-list
102315334|NCT01590082|Temozolomide|temozolomide|mesh-list
102315335|NCT01590082|Ipilimumab|ipilimumab|mesh-list
102315336|NCT01590082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102315337|NCT01590082|Alkylating Agents|alkylating agents|mesh-ancestor
101431853|NCT00188604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315338|NCT01590082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315339|NCT01590082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102315340|NCT01590082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102315341|NCT01590082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102315342|NCT01590082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102315343|NCT01590082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102315344|NCT01590082|Antimalarials|antimalarials|mesh-ancestor
102315345|NCT01590082|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102315346|NCT01590082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102315347|NCT02203916|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
102315348|NCT02203916|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102315349|NCT02203916|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102315350|NCT02203916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315351|NCT02179177|Apixaban|apixaban|mesh-list
102315352|NCT02179177|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102315353|NCT02179177|Antithrombins|antithrombins|mesh-ancestor
102315354|NCT02179177|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102315355|NCT02179177|Protease Inhibitors|protease inhibitors|mesh-ancestor
102315356|NCT02179177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102315357|NCT02179177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315358|NCT02179177|Anticoagulants|anticoagulants|mesh-ancestor
102315359|NCT02239094|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102315360|NCT02239094|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102315361|NCT02239094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102315362|NCT02239094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102315363|NCT02239094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315364|NCT02239094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102315365|NCT02239094|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102315366|NCT02239094|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102315367|NCT02239094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102024151|NCT04039503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102315369|NCT02239094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102315370|NCT02239094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315371|NCT02239094|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102315372|NCT02239094|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102315373|NCT02239094|Serotonin Agents|serotonin agents|mesh-ancestor
102315374|NCT02239094|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102315375|NCT02239094|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102315376|NCT02239094|Dopamine Agents|dopamine agents|mesh-ancestor
102315377|NCT02129647|Axitinib|axitinib|mesh-list
102315378|NCT02129647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102315379|NCT02129647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102315380|NCT02129647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102315381|NCT02129647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315382|NCT02238626|Ibudilast|ibudilast|mesh-list
102315383|NCT02238626|Riluzole|riluzole|mesh-list
102315384|NCT02238626|Anticonvulsants|anticonvulsants|mesh-ancestor
102315385|NCT02238626|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102315386|NCT02238626|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102315387|NCT02238626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102315388|NCT02238626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315389|NCT02238626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315390|NCT02238626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102315391|NCT02238626|Protective Agents|protective agents|mesh-ancestor
102315392|NCT02238626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102315393|NCT02238626|Autonomic Agents|autonomic agents|mesh-ancestor
102315394|NCT02238626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102315395|NCT02238626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102315396|NCT02238626|Respiratory System Agents|respiratory system agents|mesh-ancestor
102315397|NCT02238626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102315398|NCT02238626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102315399|NCT02238626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102315400|NCT02238626|Vasodilator Agents|vasodilator agents|mesh-ancestor
102315401|NCT02151643|Iron|iron|mesh-list
102315402|NCT02151643|Trace Elements|trace elements|mesh-ancestor
102315403|NCT02151643|Micronutrients|micronutrients|mesh-ancestor
102315404|NCT02151643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315405|NCT02203838|Risperidone|risperidone|mesh-list
102315406|NCT02203838|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102315407|NCT02203838|Serotonin Agents|serotonin agents|mesh-ancestor
102315408|NCT02203838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102315409|NCT02203838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315410|NCT02203838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315411|NCT02203838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102315412|NCT02203838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102315413|NCT02203838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102315414|NCT02203838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102315415|NCT02203838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102315416|NCT02203838|Dopamine Agents|dopamine agents|mesh-ancestor
102315417|NCT02178709|Leucovorin|leucovorin|mesh-list
102315418|NCT02178709|Oxaliplatin|oxaliplatin|mesh-list
102315419|NCT02178709|Irinotecan|irinotecan|mesh-list
102315420|NCT02178709|Folfirinox|folfirinox|mesh-list
102315421|NCT02178709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102315422|NCT02178709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102315423|NCT02178709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102315424|NCT02178709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102315425|NCT02178709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315426|NCT02178709|Antidotes|antidotes|mesh-ancestor
102315427|NCT02178709|Protective Agents|protective agents|mesh-ancestor
102315428|NCT02178709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315429|NCT02178709|Vitamin B Complex|vitamin b complex|mesh-ancestor
102315430|NCT02178709|Vitamins|vitamins|mesh-ancestor
102315431|NCT02178709|Micronutrients|micronutrients|mesh-ancestor
102315432|NCT02238080|Epoetin Alfa|epoetin alfa|mesh-list
102315433|NCT02238080|Hematinics|hematinics|mesh-ancestor
102315434|NCT02178553|Bupivacaine|bupivacaine|mesh-list
102315435|NCT02178553|Anesthetics, Local|anesthetics, local|mesh-ancestor
102315436|NCT02178553|Anesthetics|anesthetics|mesh-ancestor
102315437|NCT02178553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102315438|NCT02178553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315439|NCT02178553|Sensory System Agents|sensory system agents|mesh-ancestor
102315440|NCT02178553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102315442|NCT01627327|Xhance|xhance|mesh-list
102315443|NCT01627327|Bromides|bromides|mesh-list
102315444|NCT01627327|Tiotropium Bromide|tiotropium bromide|mesh-list
102315445|NCT01627327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102315446|NCT01627327|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102315447|NCT01627327|Autonomic Agents|autonomic agents|mesh-ancestor
102315448|NCT01627327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102315449|NCT01627327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315450|NCT01627327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102315451|NCT01627327|Respiratory System Agents|respiratory system agents|mesh-ancestor
102315452|NCT01627327|Dermatologic Agents|dermatologic agents|mesh-ancestor
102315453|NCT01627327|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102315454|NCT01627327|Parasympatholytics|parasympatholytics|mesh-ancestor
102315455|NCT01627327|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102315456|NCT01627327|Cholinergic Agents|cholinergic agents|mesh-ancestor
102315457|NCT01627327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102315458|NCT01627327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315459|NCT01627327|Anticonvulsants|anticonvulsants|mesh-ancestor
102315461|NCT01627249|Ranibizumab|ranibizumab|mesh-list
102315462|NCT01627249|Aflibercept|aflibercept|mesh-list
102315463|NCT01627249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102315464|NCT01627249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102315465|NCT01627249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102315466|NCT01627249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102315467|NCT01627249|Growth Substances|growth substances|mesh-ancestor
102315468|NCT01627249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315469|NCT01627249|Growth Inhibitors|growth inhibitors|mesh-ancestor
102315470|NCT01688830|Dabigatran|dabigatran|mesh-list
102315471|NCT01688830|Antithrombins|antithrombins|mesh-ancestor
102315472|NCT01688830|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102315473|NCT01688830|Protease Inhibitors|protease inhibitors|mesh-ancestor
102315474|NCT01688830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102315475|NCT01688830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315476|NCT01688830|Anticoagulants|anticoagulants|mesh-ancestor
102315477|NCT01604278|Glycopyrrolate|glycopyrrolate|mesh-list
102315478|NCT01604278|Bromides|bromides|mesh-list
102315479|NCT01604278|Anticonvulsants|anticonvulsants|mesh-ancestor
102315480|NCT01604278|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102315481|NCT01604278|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102315482|NCT01604278|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102315483|NCT01604278|Cholinergic Agents|cholinergic agents|mesh-ancestor
102315484|NCT01604278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102315485|NCT01604278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315486|NCT01604278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315487|NCT01687270|Sofosbuvir|sofosbuvir|mesh-list
102315488|NCT01687270|Ribavirin|ribavirin|mesh-list
102315489|NCT01687270|Antiviral Agents|antiviral agents|mesh-ancestor
102315490|NCT01687270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102315491|NCT01687270|Antimetabolites|antimetabolites|mesh-ancestor
102315492|NCT01687270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315493|NCT01588990|Leucovorin|leucovorin|mesh-list
102315494|NCT01588990|Bevacizumab|bevacizumab|mesh-list
102315495|NCT01588990|Capecitabine|capecitabine|mesh-list
102315496|NCT01588990|Oxaliplatin|oxaliplatin|mesh-list
102315497|NCT01588990|Irinotecan|irinotecan|mesh-list
102315498|NCT01588990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102315499|NCT01588990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102315500|NCT01588990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102315501|NCT01588990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102315502|NCT01588990|Growth Substances|growth substances|mesh-ancestor
102315503|NCT01588990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315504|NCT01588990|Growth Inhibitors|growth inhibitors|mesh-ancestor
102315505|NCT01588990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102315506|NCT01588990|Antimetabolites|antimetabolites|mesh-ancestor
102315507|NCT01588990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315508|NCT01588990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102315509|NCT01588990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102315510|NCT01588990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102315511|NCT01588990|Antidotes|antidotes|mesh-ancestor
102315512|NCT01588990|Protective Agents|protective agents|mesh-ancestor
102315513|NCT01588990|Vitamin B Complex|vitamin b complex|mesh-ancestor
102315514|NCT01588990|Vitamins|vitamins|mesh-ancestor
102315515|NCT01588990|Micronutrients|micronutrients|mesh-ancestor
102315516|NCT02126839|Albuterol|albuterol|mesh-list
102315517|NCT02126839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102315518|NCT02126839|Autonomic Agents|autonomic agents|mesh-ancestor
102315519|NCT02126839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102315520|NCT02126839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315521|NCT02126839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102315522|NCT02126839|Respiratory System Agents|respiratory system agents|mesh-ancestor
102315524|NCT02126839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102315525|NCT02126839|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102315526|NCT02126839|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102315527|NCT02126839|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102315528|NCT02126839|Adrenergic Agents|adrenergic agents|mesh-ancestor
102315529|NCT02126839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102315530|NCT02126839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315531|NCT04747795|Ascorbic Acid|ascorbic acid|mesh-list
102315532|NCT04747795|Vitamins|vitamins|mesh-ancestor
102315533|NCT04747795|Micronutrients|micronutrients|mesh-ancestor
102315534|NCT04747795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315535|NCT04747795|Antioxidants|antioxidants|mesh-ancestor
102315536|NCT04747795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315537|NCT04747795|Protective Agents|protective agents|mesh-ancestor
102315538|NCT02125279|Calcitriol|calcitriol|mesh-list
102315539|NCT02125279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102315540|NCT02125279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315541|NCT02125279|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102315542|NCT02125279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102315543|NCT02125279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315544|NCT02125279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102315545|NCT02125279|Vitamins|vitamins|mesh-ancestor
102315546|NCT02125279|Micronutrients|micronutrients|mesh-ancestor
102315547|NCT02125279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102315548|NCT02124811|Minocycline|minocycline|mesh-list
102315549|NCT02124811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102315550|NCT02124811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102315551|NCT02148445|Nicotine|nicotine|mesh-list
102315552|NCT02148445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102315553|NCT02148445|Autonomic Agents|autonomic agents|mesh-ancestor
102315554|NCT02148445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102315555|NCT02148445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315556|NCT02148445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102315557|NCT02148445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102315558|NCT02148445|Cholinergic Agents|cholinergic agents|mesh-ancestor
102315559|NCT02148445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102315560|NCT02148445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315561|NCT02147587|Tofacitinib|tofacitinib|mesh-list
102315562|NCT02147587|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102315563|NCT02147587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102315564|NCT02147587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102315565|NCT02147587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315566|NCT02147197|Ulipristal acetate|ulipristal acetate|mesh-list
102315567|NCT02147197|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102315568|NCT02147197|Contraceptive Agents|contraceptive agents|mesh-ancestor
102315569|NCT02147197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102315570|NCT02147197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315571|NCT02147197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102315572|NCT04751929|Atezolizumab|atezolizumab|mesh-list
102315573|NCT04751929|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102315574|NCT04751929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315575|NCT04751929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102315576|NCT04751929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102315577|NCT02176291|Buprenorphine|buprenorphine|mesh-list
102315578|NCT02176291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102315579|NCT02176291|Narcotics|narcotics|mesh-ancestor
102315580|NCT02176291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102315581|NCT02176291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315582|NCT02176291|Analgesics|analgesics|mesh-ancestor
102315583|NCT02176291|Sensory System Agents|sensory system agents|mesh-ancestor
102315584|NCT02176291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102315585|NCT02176291|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102315586|NCT02175745|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
102315587|NCT02175745|Dopamine Agents|dopamine agents|mesh-ancestor
102315588|NCT02175745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102315589|NCT02175745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315590|NCT02175745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315591|NCT02175277|Darbepoetin alfa|darbepoetin alfa|mesh-list
102315592|NCT02175277|Hematinics|hematinics|mesh-ancestor
102315593|NCT01568866|Dexamethasone|dexamethasone|mesh-list
102315594|NCT01568866|Bortezomib|bortezomib|mesh-list
102315595|NCT01568866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102315596|NCT01568866|Antiemetics|antiemetics|mesh-ancestor
102315597|NCT01568866|Autonomic Agents|autonomic agents|mesh-ancestor
102315598|NCT01568866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102315599|NCT01568866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315600|NCT01568866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102315601|NCT01568866|Glucocorticoids|glucocorticoids|mesh-ancestor
102315602|NCT01568866|Hormones|hormones|mesh-ancestor
102315603|NCT01568866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102315604|NCT01568866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102315605|NCT01568866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102315606|NCT01567852|Ketamine|ketamine|mesh-list
102315607|NCT01567852|Methohexital|methohexital|mesh-list
102315608|NCT01567852|Analgesics|analgesics|mesh-ancestor
102315609|NCT01567852|Sensory System Agents|sensory system agents|mesh-ancestor
102315610|NCT01567852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102315611|NCT01567852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315612|NCT01567852|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102315613|NCT01567852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102315614|NCT01567852|Anesthetics, General|anesthetics, general|mesh-ancestor
102315615|NCT01567852|Anesthetics|anesthetics|mesh-ancestor
102315616|NCT01567852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102315617|NCT01567852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102315618|NCT01567852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102315619|NCT01567852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101432129|NCT00409383|Paclitaxel|paclitaxel|mesh-list
102315620|NCT01567852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315621|NCT01587274|Acetaminophen|acetaminophen|mesh-list
102315622|NCT01587274|Naproxen|naproxen|mesh-list
102315623|NCT01587274|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
102315624|NCT01587274|Oxycodone|oxycodone|mesh-list
102315625|NCT01587274|Cyclobenzaprine|cyclobenzaprine|mesh-list
102315626|NCT01587274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102315627|NCT01587274|Analgesics|analgesics|mesh-ancestor
102315628|NCT01587274|Sensory System Agents|sensory system agents|mesh-ancestor
102315629|NCT01587274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102315630|NCT01587274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315631|NCT01587274|Antipyretics|antipyretics|mesh-ancestor
102315632|NCT01587274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102315633|NCT01587274|Narcotics|narcotics|mesh-ancestor
102315634|NCT01587274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102315635|NCT01587274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102315636|NCT01587274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102315637|NCT01587274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102315638|NCT01587274|Gout Suppressants|gout suppressants|mesh-ancestor
102315639|NCT01587274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102315640|NCT01587274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102315641|NCT01587274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315642|NCT01587274|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102315643|NCT01587274|Antidepressive Agents|antidepressive agents|mesh-ancestor
102315644|NCT01587274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102315645|NCT01587274|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102315646|NCT01587274|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102315647|NCT01587274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102315648|NCT01587118|Asenapine|asenapine|mesh-list
102315649|NCT01587118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102315650|NCT01587118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102315651|NCT01587118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102315652|NCT01587118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315653|NCT01587118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102315654|NCT01905657|Docetaxel|docetaxel|mesh-list
102315655|NCT01905657|Pembrolizumab|pembrolizumab|mesh-list
102315656|NCT01905657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102315657|NCT01905657|Tubulin Modulators|tubulin modulators|mesh-ancestor
102315658|NCT01905657|Antimitotic Agents|antimitotic agents|mesh-ancestor
102315659|NCT01905657|Mitosis Modulators|mitosis modulators|mesh-ancestor
102315660|NCT01905657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315661|NCT01905657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102315662|NCT01905657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102315663|NCT02202980|Sofosbuvir|sofosbuvir|mesh-list
102315664|NCT02202980|Antiviral Agents|antiviral agents|mesh-ancestor
102315665|NCT02202980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102315666|NCT01952145|Insulin|insulin|mesh-list
102315667|NCT01952145|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102315668|NCT01952145|Insulin Glargine|insulin glargine|mesh-list
102315669|NCT01952145|Liraglutide|liraglutide|mesh-list
102315671|NCT01952145|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102315672|NCT01952145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315673|NCT01952145|Incretins|incretins|mesh-ancestor
102315674|NCT01952145|Hormones|hormones|mesh-ancestor
102315675|NCT01952145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102315676|NCT01923363|Tazobactam|tazobactam|mesh-list
102315677|NCT01923363|Piperacillin|piperacillin|mesh-list
102315678|NCT01923363|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102315679|NCT01923363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102315680|NCT01923363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102315681|NCT01923363|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102315682|NCT01923363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102315683|NCT01923363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315684|NCT01904721|Bimatoprost|bimatoprost|mesh-list
102315685|NCT01904721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102315686|NCT01904721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102315687|NCT01922739|Hydrocodone|hydrocodone|mesh-list
102315688|NCT01922739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102315689|NCT01922739|Narcotics|narcotics|mesh-ancestor
102315690|NCT01922739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102315691|NCT01922739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315692|NCT01922739|Analgesics|analgesics|mesh-ancestor
102315693|NCT01922739|Sensory System Agents|sensory system agents|mesh-ancestor
102315694|NCT01922739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102315695|NCT01922739|Antitussive Agents|antitussive agents|mesh-ancestor
102315696|NCT01922739|Respiratory System Agents|respiratory system agents|mesh-ancestor
102315697|NCT02236988|Thalidomide|thalidomide|mesh-list
102315698|NCT02236988|Apremilast|apremilast|mesh-list
102315699|NCT02236988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102315700|NCT02236988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102315701|NCT02236988|Analgesics|analgesics|mesh-ancestor
102315702|NCT02236988|Sensory System Agents|sensory system agents|mesh-ancestor
102315703|NCT02236988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102315704|NCT02236988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315705|NCT02236988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102315706|NCT02236988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102315707|NCT02236988|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102315708|NCT02236988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102315709|NCT02236988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102315710|NCT02236988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315711|NCT02236988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102315712|NCT02236988|Immunologic Factors|immunologic factors|mesh-ancestor
102315713|NCT02236988|Leprostatic Agents|leprostatic agents|mesh-ancestor
102315714|NCT02236988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102315715|NCT02236988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102315716|NCT02236988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102315717|NCT02236988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102315718|NCT02236988|Growth Substances|growth substances|mesh-ancestor
102315719|NCT02236988|Growth Inhibitors|growth inhibitors|mesh-ancestor
102315720|NCT02236988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102315721|NCT02236520|Chlorthalidone|chlorthalidone|mesh-list
102315722|NCT02236520|Spironolactone|spironolactone|mesh-list
102315723|NCT02236520|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102315724|NCT02236520|Hormone Antagonists|hormone antagonists|mesh-ancestor
102315725|NCT02236520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102315726|NCT02236520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315727|NCT02236520|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102315728|NCT02236520|Diuretics|diuretics|mesh-ancestor
102315729|NCT02236520|Natriuretic Agents|natriuretic agents|mesh-ancestor
102315730|NCT02236520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102315731|NCT02236520|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102315732|NCT02236520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102315733|NCT02236520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315734|NCT04769414|Gemcitabine|gemcitabine|mesh-list
102315735|NCT04769414|Fluorouracil|fluorouracil|mesh-list
102315736|NCT04769414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102315737|NCT04769414|Antimetabolites|antimetabolites|mesh-ancestor
102315738|NCT04769414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315739|NCT04769414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102315740|NCT04769414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102315741|NCT04769414|Immunologic Factors|immunologic factors|mesh-ancestor
102315742|NCT04769414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315743|NCT01922271|Glycopyrrolate|glycopyrrolate|mesh-list
102315744|NCT01922271|Albuterol|albuterol|mesh-list
102315745|NCT01922271|Tiotropium Bromide|tiotropium bromide|mesh-list
102315746|NCT01922271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102315747|NCT01922271|Autonomic Agents|autonomic agents|mesh-ancestor
102315748|NCT01922271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102315749|NCT01922271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315750|NCT01922271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102315752|NCT01922271|Parasympatholytics|parasympatholytics|mesh-ancestor
102315753|NCT01922271|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102315754|NCT01922271|Cholinergic Agents|cholinergic agents|mesh-ancestor
102315755|NCT01922271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102315756|NCT01922271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315757|NCT01922271|Tocolytic Agents|tocolytic agents|mesh-ancestor
102315758|NCT01922271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102315759|NCT01922271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102315760|NCT01922271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102315761|NCT01922271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102315762|NCT01922271|Adrenergic Agents|adrenergic agents|mesh-ancestor
102315763|NCT01922271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102315764|NCT01922271|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102315765|NCT02236130|Acetaminophen|acetaminophen|mesh-list
102315766|NCT02236130|Morphine|morphine|mesh-list
102315767|NCT02236130|Hydrocodone|hydrocodone|mesh-list
102315768|NCT02236130|Analgesics|analgesics|mesh-list
102315769|NCT02236130|Anesthetics|anesthetics|mesh-list
102315770|NCT02236130|Ropivacaine|ropivacaine|mesh-list
102315771|NCT02236130|Anesthetics, Local|anesthetics, local|mesh-list
102315772|NCT02236130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102315773|NCT02236130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315774|NCT02236130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102315775|NCT02236130|Narcotics|narcotics|mesh-ancestor
102315776|NCT02236130|Sensory System Agents|sensory system agents|mesh-ancestor
102315777|NCT02236130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102315778|NCT02236130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102315779|NCT02236130|Antipyretics|antipyretics|mesh-ancestor
102315780|NCT02236130|Antitussive Agents|antitussive agents|mesh-ancestor
102315781|NCT02236130|Respiratory System Agents|respiratory system agents|mesh-ancestor
102315782|NCT05153564|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
102315783|NCT05153564|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
102315784|NCT05153564|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102315785|NCT05153564|Contraceptive Agents|contraceptive agents|mesh-ancestor
102315786|NCT05153564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102315787|NCT05153564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315788|NCT05153564|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102315789|NCT05153564|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102315790|NCT05153564|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102315791|NCT05153564|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102315792|NCT05153564|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102315793|NCT05153564|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
102315794|NCT05153564|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102315795|NCT05153564|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102315796|NCT01641809|Tenofovir|tenofovir|mesh-list
102315797|NCT01641809|Lamivudine|lamivudine|mesh-list
102315798|NCT01641809|Emtricitabine|emtricitabine|mesh-list
102315799|NCT01641809|Efavirenz|efavirenz|mesh-list
102315800|NCT01641809|Abacavir|abacavir|mesh-list
102315801|NCT01641809|Rilpivirine|rilpivirine|mesh-list
102315802|NCT01641809|Cabotegravir|cabotegravir|mesh-list
102315803|NCT01641809|Antiviral Agents|antiviral agents|mesh-ancestor
102315804|NCT01641809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102315805|NCT01641809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102315806|NCT01641809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102315807|NCT01641809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102315808|NCT01641809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315809|NCT01641809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102315810|NCT01641809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102315811|NCT01641809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102315812|NCT01641809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102315813|NCT01641809|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102315814|NCT01641809|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102315815|NCT01641809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102315816|NCT01641809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102315817|NCT01641809|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102315818|NCT01641809|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102315819|NCT01632566|Celecoxib|celecoxib|mesh-list
102315820|NCT01632566|Simvastatin|simvastatin|mesh-list
102315821|NCT01632566|LY3031207|ly3031207|mesh-list
102315822|NCT01632566|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102315823|NCT01632566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102315824|NCT01632566|Antimetabolites|antimetabolites|mesh-ancestor
102024607|NCT03169738|Immunologic Factors|immunologic factors|mesh-ancestor
102315825|NCT01632566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315826|NCT01632566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102315827|NCT01632566|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102315828|NCT01632566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102315829|NCT01632566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102315830|NCT01632566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102315831|NCT01632566|Analgesics|analgesics|mesh-ancestor
102315832|NCT01632566|Sensory System Agents|sensory system agents|mesh-ancestor
102315833|NCT01632566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101307304|NCT02036151|Fluorides|fluorides|mesh-list
102315834|NCT01632566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315835|NCT01632566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102315836|NCT01632566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102315837|NCT01632566|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102315838|NCT01632566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102315839|NCT01632566|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
102315840|NCT01632566|Hormone Antagonists|hormone antagonists|mesh-ancestor
102315841|NCT01632566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102315842|NCT02254304|Interferons|interferons|mesh-list
102315843|NCT02254304|Interferon-beta|interferon-beta|mesh-list
102315844|NCT02254304|Interferon beta-1a|interferon beta-1a|mesh-list
102315845|NCT02254304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102315846|NCT02254304|Antiviral Agents|antiviral agents|mesh-ancestor
102315847|NCT02254304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102315848|NCT02254304|Immunologic Factors|immunologic factors|mesh-ancestor
102315849|NCT02254304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315850|NCT02254304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102315851|NCT05650151|Vitamin D|vitamin d|mesh-list
102315852|NCT05650151|Vitamins|vitamins|mesh-ancestor
102315853|NCT05650151|Micronutrients|micronutrients|mesh-ancestor
102315854|NCT05650151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315855|NCT05650151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102315856|NCT02174731|Epoetin Alfa|epoetin alfa|mesh-list
102315857|NCT02174731|Hematinics|hematinics|mesh-ancestor
102315858|NCT01922037|Omalizumab|omalizumab|mesh-list
102315859|NCT01922037|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102315860|NCT01922037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102315861|NCT01922037|Respiratory System Agents|respiratory system agents|mesh-ancestor
102315862|NCT02282813|Calcitriol|calcitriol|mesh-list
102315863|NCT02282813|Calcifediol|calcifediol|mesh-list
102315864|NCT02282813|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
102315865|NCT02282813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102315866|NCT02282813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315867|NCT02282813|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102315868|NCT02282813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102315869|NCT02282813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315870|NCT02282813|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102315871|NCT02282813|Vitamins|vitamins|mesh-ancestor
102315872|NCT02282813|Micronutrients|micronutrients|mesh-ancestor
102315873|NCT02282813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102315874|NCT05638529|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102315875|NCT05638529|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102315876|NCT05638529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315877|NCT04859465|Doxorubicin|doxorubicin|mesh-list
102315878|NCT04859465|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102315879|NCT04859465|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102315880|NCT04859465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102315881|NCT04859465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102315882|NCT04859465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102315883|NCT04859465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102315884|NCT04859465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102315885|NCT04859465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315886|NCT02121847|Cyclosporine|cyclosporine|mesh-list
102315887|NCT02121847|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102315888|NCT02121847|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102315889|NCT02121847|Lubricant Eye Drops|lubricant eye drops|mesh-list
102315890|NCT02121847|Cyclosporins|cyclosporins|mesh-list
102315892|NCT02121847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315893|NCT02121847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102315894|NCT02121847|Immunologic Factors|immunologic factors|mesh-ancestor
102315895|NCT02121847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315896|NCT02121847|Antifungal Agents|antifungal agents|mesh-ancestor
102315897|NCT02121847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102315898|NCT02121847|Dermatologic Agents|dermatologic agents|mesh-ancestor
102315899|NCT02121847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102315900|NCT02121847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102315901|NCT02121847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102315902|NCT02121847|Laxatives|laxatives|mesh-ancestor
102315903|NCT02121847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102315904|NCT01586806|Dexamethasone|dexamethasone|mesh-list
102315905|NCT01586806|Dexamethasone acetate|dexamethasone acetate|mesh-list
102315906|NCT01586806|Bupivacaine|bupivacaine|mesh-list
102315907|NCT01586806|BB 1101|bb 1101|mesh-list
102315908|NCT01586806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102315909|NCT01586806|Antiemetics|antiemetics|mesh-ancestor
102315910|NCT01586806|Autonomic Agents|autonomic agents|mesh-ancestor
102315911|NCT01586806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102315912|NCT01586806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315913|NCT01586806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102315914|NCT01586806|Glucocorticoids|glucocorticoids|mesh-ancestor
102315915|NCT01586806|Hormones|hormones|mesh-ancestor
102315916|NCT01586806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102315917|NCT01586806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102315918|NCT01586806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102315919|NCT01586806|Protease Inhibitors|protease inhibitors|mesh-ancestor
102315920|NCT01586806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102315921|NCT01586806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315922|NCT01586806|Anesthetics, Local|anesthetics, local|mesh-ancestor
102315923|NCT01586806|Anesthetics|anesthetics|mesh-ancestor
102315924|NCT01586806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102315925|NCT01586806|Sensory System Agents|sensory system agents|mesh-ancestor
102315926|NCT05631041|Silymarin|silymarin|mesh-list
102315927|NCT05631041|Antioxidants|antioxidants|mesh-ancestor
102315928|NCT05631041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315929|NCT05631041|Protective Agents|protective agents|mesh-ancestor
102315930|NCT05631041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315931|NCT02144077|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102315932|NCT02144077|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
102315933|NCT02144077|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102315934|NCT02144077|Dermatologic Agents|dermatologic agents|mesh-ancestor
102315935|NCT05544071|Sertraline|sertraline|mesh-list
102315936|NCT05544071|Antidepressive Agents|antidepressive agents|mesh-ancestor
102315937|NCT05544071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102315938|NCT05544071|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102315939|NCT05544071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102315940|NCT05544071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102315941|NCT05544071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315942|NCT05544071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102315943|NCT05544071|Serotonin Agents|serotonin agents|mesh-ancestor
102315944|NCT05544071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315945|NCT02143843|Bimatoprost|bimatoprost|mesh-list
102315946|NCT02143843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102315947|NCT01586338|Hylan|hylan|mesh-list
102315948|NCT01586338|Viscosupplements|viscosupplements|mesh-ancestor
102315949|NCT01586338|Protective Agents|protective agents|mesh-ancestor
102315950|NCT01586338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315951|NCT02143141|Morphine|morphine|mesh-list
102315952|NCT02143141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102315953|NCT02143141|Narcotics|narcotics|mesh-ancestor
102315954|NCT02143141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102315955|NCT02143141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315956|NCT02143141|Analgesics|analgesics|mesh-ancestor
102315957|NCT02143141|Sensory System Agents|sensory system agents|mesh-ancestor
102315958|NCT02143141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102315959|NCT01566604|Glycopyrrolate|glycopyrrolate|mesh-list
102315960|NCT01566604|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102315961|NCT01566604|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102315962|NCT01566604|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102315963|NCT01566604|Cholinergic Agents|cholinergic agents|mesh-ancestor
102315964|NCT01566604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102315965|NCT01566604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315966|NCT01566604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315968|NCT05497583|Coagulants|coagulants|mesh-ancestor
102315969|NCT02253992|Nivolumab|nivolumab|mesh-list
102315970|NCT02253992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102315971|NCT02253992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102315972|NCT02253992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102315973|NCT02253992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315974|NCT02252588|Chlorhexidine|chlorhexidine|mesh-list
102315975|NCT02252588|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102315976|NCT02252588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102315977|NCT02252588|Disinfectants|disinfectants|mesh-ancestor
102315978|NCT01585558|Tamoxifen|tamoxifen|mesh-list
102315979|NCT01585558|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102315980|NCT01585558|Hormone Antagonists|hormone antagonists|mesh-ancestor
102315981|NCT01585558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102315982|NCT01585558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315983|NCT01585558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102315984|NCT01585558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102315985|NCT01585558|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102315986|NCT01585558|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102315987|NCT01585558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102315988|NCT01585246|Saw palmetto extract|saw palmetto extract|mesh-list
102315989|NCT01585246|Urological Agents|urological agents|mesh-ancestor
102315990|NCT01585168|Memantine|memantine|mesh-list
102315991|NCT01585168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102315992|NCT01585168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102315993|NCT01585168|Dopamine Agents|dopamine agents|mesh-ancestor
102315994|NCT01585168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102315995|NCT01585168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102315996|NCT01585168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102315997|NCT01585168|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102315998|NCT01585168|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102315999|NCT02231918|Pramipexole|pramipexole|mesh-list
102316000|NCT02231918|Antioxidants|antioxidants|mesh-ancestor
102316001|NCT02231918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316002|NCT02231918|Protective Agents|protective agents|mesh-ancestor
102316003|NCT02231918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316004|NCT02231918|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102316005|NCT02231918|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102316006|NCT02231918|Dopamine Agonists|dopamine agonists|mesh-ancestor
102316007|NCT02231918|Dopamine Agents|dopamine agents|mesh-ancestor
102316008|NCT02231918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102316009|NCT02199314|Desflurane|desflurane|mesh-list
102316010|NCT02199314|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102316011|NCT02199314|Anesthetics, General|anesthetics, general|mesh-ancestor
102316012|NCT02199314|Anesthetics|anesthetics|mesh-ancestor
102316013|NCT02199314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102316014|NCT02199314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316015|NCT02199080|Fibrin fragment D|fibrin fragment d|mesh-list
102316016|NCT02199080|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102316017|NCT02199080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102316018|NCT02199080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316019|NCT02199080|Hemostatics|hemostatics|mesh-ancestor
102316020|NCT02199080|Coagulants|coagulants|mesh-ancestor
102316021|NCT02197520|Insulin|insulin|mesh-list
102316022|NCT02197520|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102316023|NCT02197520|Insulin Glargine|insulin glargine|mesh-list
102316024|NCT02197520|Insulin Lispro|insulin lispro|mesh-list
102316025|NCT02197520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102316026|NCT02197520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316027|NCT02230904|Rotigotine|rotigotine|mesh-list
102316028|NCT02230904|Dopamine Agonists|dopamine agonists|mesh-ancestor
102316029|NCT02230904|Dopamine Agents|dopamine agents|mesh-ancestor
102316030|NCT02230904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102316031|NCT02230904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316032|NCT02230904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316033|NCT02196506|Brexpiprazole|brexpiprazole|mesh-list
102316034|NCT02196506|Serotonin Agents|serotonin agents|mesh-ancestor
102316035|NCT02196506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102316036|NCT02196506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316037|NCT02196506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316038|NCT02196506|Dopamine Agonists|dopamine agonists|mesh-ancestor
102316039|NCT02196506|Dopamine Agents|dopamine agents|mesh-ancestor
102316040|NCT02228720|Mometasone Furoate|mometasone furoate|mesh-list
102316041|NCT02228720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102316042|NCT02228720|Dermatologic Agents|dermatologic agents|mesh-ancestor
102316043|NCT02228720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102316044|NCT01640951|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102316045|NCT01640951|Immunologic Factors|immunologic factors|mesh-ancestor
102316046|NCT01640951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316048|NCT02228096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102316049|NCT02228096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102316050|NCT01683994|Prednisone|prednisone|mesh-list
102024843|NCT03169504|Xhance|xhance|mesh-list
102316052|NCT01683994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102316053|NCT01683994|Tubulin Modulators|tubulin modulators|mesh-ancestor
102316054|NCT01683994|Antimitotic Agents|antimitotic agents|mesh-ancestor
102316055|NCT01683994|Mitosis Modulators|mitosis modulators|mesh-ancestor
102316056|NCT01683994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316057|NCT01683994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102316058|NCT01683994|Glucocorticoids|glucocorticoids|mesh-ancestor
102316059|NCT01683994|Hormones|hormones|mesh-ancestor
102316060|NCT01683994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102316061|NCT01683994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316062|NCT01683994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102316063|NCT02247440|Interferons|interferons|mesh-list
102316064|NCT02247440|Ribavirin|ribavirin|mesh-list
102316065|NCT02247440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102316066|NCT02247440|Antiviral Agents|antiviral agents|mesh-ancestor
102316067|NCT02247440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102316068|NCT02247440|Antimetabolites|antimetabolites|mesh-ancestor
102316069|NCT02247440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316070|NCT04844099|Piperaquine|piperaquine|mesh-list
102316071|NCT04844099|Artenimol|artenimol|mesh-list
102316072|NCT04844099|Antimalarials|antimalarials|mesh-ancestor
102316073|NCT04844099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102316074|NCT04844099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102316075|NCT04844099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102316076|NCT04857203|Vitamin D|vitamin d|mesh-list
102316077|NCT04857203|Vitamins|vitamins|mesh-ancestor
102316078|NCT04857203|Micronutrients|micronutrients|mesh-ancestor
102316079|NCT04857203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316080|NCT04857203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102316081|NCT05381597|Fluorouracil|fluorouracil|mesh-list
102316082|NCT05381597|Calcipotriene|calcipotriene|mesh-list
102316083|NCT05381597|Antimetabolites|antimetabolites|mesh-ancestor
102316084|NCT05381597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316085|NCT05381597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102316086|NCT05381597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102316087|NCT05381597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102316088|NCT05381597|Immunologic Factors|immunologic factors|mesh-ancestor
102316089|NCT05381597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316090|NCT05381597|Dermatologic Agents|dermatologic agents|mesh-ancestor
102316091|NCT01683838|4-Aminopyridine|4-aminopyridine|mesh-list
102316092|NCT01683838|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102316093|NCT01683838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102316094|NCT01683838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316095|NCT05417165|Vaccines|vaccines|mesh-list
102316096|NCT05417165|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102316097|NCT05417165|Immunologic Factors|immunologic factors|mesh-ancestor
102316098|NCT05417165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316099|NCT04660643|Tirzepatide|tirzepatide|mesh-list
102316100|NCT04660643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102316101|NCT04660643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316102|NCT04660643|Incretins|incretins|mesh-ancestor
102316103|NCT04660643|Hormones|hormones|mesh-ancestor
102316104|NCT04660643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102316105|NCT04659317|Oxycodone|oxycodone|mesh-list
102316106|NCT04659317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102316107|NCT04659317|Narcotics|narcotics|mesh-ancestor
102316108|NCT04659317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102316109|NCT04659317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316110|NCT04659317|Analgesics|analgesics|mesh-ancestor
102316111|NCT04659317|Sensory System Agents|sensory system agents|mesh-ancestor
102316112|NCT04659317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102316113|NCT03602261|Calcifediol|calcifediol|mesh-list
102316114|NCT03602261|Vitamins|vitamins|mesh-ancestor
102316115|NCT03602261|Micronutrients|micronutrients|mesh-ancestor
102316116|NCT03602261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657982|NCT00841945|Prednisone|prednisone|mesh-list
102316118|NCT02141659|Relugolix|relugolix|mesh-list
102316119|NCT02141659|Androgen Antagonists|androgen antagonists|mesh-ancestor
102316120|NCT02141659|Hormone Antagonists|hormone antagonists|mesh-ancestor
102316121|NCT02141659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102316122|NCT02141659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316123|NCT02121301|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102316124|NCT02121301|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102316125|NCT05422703|Analgesics|analgesics|mesh-list
102316126|NCT05422703|Sensory System Agents|sensory system agents|mesh-ancestor
102316127|NCT05422703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102316128|NCT05422703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316129|NCT02227862|Insulin Glargine|insulin glargine|mesh-list
102316130|NCT02227862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102316131|NCT02227862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316132|NCT02120833|Decanoic acid|decanoic acid|mesh-list
102316133|NCT02120833|Antifungal Agents|antifungal agents|mesh-ancestor
102316134|NCT02120833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102316135|NCT04615949|Cannabidiol|cannabidiol|mesh-list
102316136|NCT04615949|Anticonvulsants|anticonvulsants|mesh-ancestor
102316137|NCT02170207|Lansoprazole|lansoprazole|mesh-list
102316138|NCT02170207|Dexlansoprazole|dexlansoprazole|mesh-list
102316139|NCT02170207|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102316140|NCT02170207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102316141|NCT02170207|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102316142|NCT02170207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102316143|NCT02170207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316144|NCT02227784|Atorvastatin|atorvastatin|mesh-list
102316145|NCT02227784|Ezetimibe|ezetimibe|mesh-list
102316146|NCT02227784|Evacetrapib|evacetrapib|mesh-list
102316147|NCT02227784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102316148|NCT02227784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102316149|NCT02227784|Antimetabolites|antimetabolites|mesh-ancestor
102316150|NCT02227784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316151|NCT02227784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102316152|NCT02227784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102316153|NCT02227784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102316154|NCT04577417|Methylphenidate|methylphenidate|mesh-list
102316155|NCT04577417|Amphetamine|amphetamine|mesh-list
102316156|NCT04577417|Adderall|adderall|mesh-list
102316157|NCT04577417|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
102316158|NCT04577417|Dextroamphetamine|dextroamphetamine|mesh-list
102316159|NCT04577417|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102316160|NCT04577417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316161|NCT04577417|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102316162|NCT04577417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102316163|NCT04577417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102316164|NCT04577417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316165|NCT04577417|Dopamine Agents|dopamine agents|mesh-ancestor
102316166|NCT04577417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102316167|NCT04577417|Sympathomimetics|sympathomimetics|mesh-ancestor
102316168|NCT04577417|Autonomic Agents|autonomic agents|mesh-ancestor
102316169|NCT04577417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102316170|NCT04577417|Adrenergic Agents|adrenergic agents|mesh-ancestor
102316171|NCT04577417|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102316172|NCT01683058|Aripiprazole|aripiprazole|mesh-list
102316173|NCT01683058|Antidepressive Agents|antidepressive agents|mesh-ancestor
102316174|NCT01683058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102316175|NCT01683058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102316176|NCT01683058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102316177|NCT01683058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102316178|NCT01683058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316179|NCT01683058|Dopamine Agonists|dopamine agonists|mesh-ancestor
102316180|NCT01683058|Dopamine Agents|dopamine agents|mesh-ancestor
102316181|NCT01683058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102316182|NCT01683058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316183|NCT01683058|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102316184|NCT01683058|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102316185|NCT01683058|Serotonin Agents|serotonin agents|mesh-ancestor
102316186|NCT01683058|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102316187|NCT01683058|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102316188|NCT01683058|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102316189|NCT01683058|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102316190|NCT02193776|Moxifloxacin|moxifloxacin|mesh-list
102316205|NCT02193776|Leprostatic Agents|leprostatic agents|mesh-ancestor
102316206|NCT02193776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102316207|NCT02193776|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102316208|NCT02193776|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102316209|NCT02193776|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102316210|NCT02193776|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102316211|NCT02193776|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102316212|NCT02193776|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102316213|NCT02193776|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102316214|NCT02193776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102316216|NCT02193776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102316217|NCT04740697|Tamoxifen|tamoxifen|mesh-list
102316218|NCT04740697|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102316219|NCT04740697|Hormone Antagonists|hormone antagonists|mesh-ancestor
102316220|NCT04740697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102316221|NCT04740697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316222|NCT04740697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102316223|NCT04740697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102316224|NCT04740697|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102316225|NCT04740697|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102316226|NCT04740697|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102316227|NCT02170064|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102316228|NCT02170064|Anticonvulsants|anticonvulsants|mesh-ancestor
102316229|NCT02170064|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102316230|NCT02170064|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102316231|NCT02170064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102316232|NCT02170064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316247|NCT02169830|Topiramate|topiramate|mesh-list
102316248|NCT02169830|Nortriptyline|nortriptyline|mesh-list
102316249|NCT02169830|Anticonvulsants|anticonvulsants|mesh-ancestor
102316250|NCT02169830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102316251|NCT02169830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316252|NCT02169830|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102316253|NCT02169830|Antidepressive Agents|antidepressive agents|mesh-ancestor
102316254|NCT02169830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102316255|NCT02169830|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102316256|NCT02169830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102316257|NCT02169830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102316258|NCT02169830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316259|NCT02169830|Adrenergic Agents|adrenergic agents|mesh-ancestor
102316260|NCT02169830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102316261|NCT04854551|Naltrexone|naltrexone|mesh-list
102316262|NCT04854551|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102316263|NCT04854551|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102316264|NCT04854551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316265|NCT04854551|Sensory System Agents|sensory system agents|mesh-ancestor
102316266|NCT04854551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102316267|NCT04536467|Goserelin|goserelin|mesh-list
102316268|NCT04536467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102316269|NCT04536467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102316270|NCT05341349|Pembrolizumab|pembrolizumab|mesh-list
102316271|NCT05341349|Nivolumab|nivolumab|mesh-list
102316272|NCT05341349|Ipilimumab|ipilimumab|mesh-list
102316273|NCT05341349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102316274|NCT05341349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102316275|NCT05341349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102316276|NCT05341349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316277|NCT04530149|Acetaminophen|acetaminophen|mesh-list
102316278|NCT04530149|Bupivacaine|bupivacaine|mesh-list
101432829|NCT00406952|Sertraline|sertraline|mesh-list
102316279|NCT04530149|Anesthetics, Local|anesthetics, local|mesh-ancestor
102316280|NCT04530149|Anesthetics|anesthetics|mesh-ancestor
102316281|NCT04530149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102316282|NCT04530149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316283|NCT04530149|Sensory System Agents|sensory system agents|mesh-ancestor
102316284|NCT04530149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102316285|NCT04530149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102316286|NCT04530149|Analgesics|analgesics|mesh-ancestor
102316287|NCT04530149|Antipyretics|antipyretics|mesh-ancestor
102316288|NCT04525547|Nintedanib|nintedanib|mesh-list
102316289|NCT04525547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102316290|NCT04525547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102316291|NCT04525547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102316292|NCT04525547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316293|NCT02169284|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102316294|NCT02169284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102316295|NCT02169284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102316296|NCT02169284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102316297|NCT02169284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316298|NCT02119819|Metformin|metformin|mesh-list
102316299|NCT02119819|Exenatide|exenatide|mesh-list
102316300|NCT02119819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102316301|NCT02119819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316302|NCT02119819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102316303|NCT02119819|Incretins|incretins|mesh-ancestor
102316304|NCT02119819|Hormones|hormones|mesh-ancestor
102316305|NCT02119819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102316306|NCT04766450|Acetylcysteine|acetylcysteine|mesh-list
102316307|NCT04766450|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102316308|NCT04766450|Antiviral Agents|antiviral agents|mesh-ancestor
102316309|NCT04766450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102316310|NCT04766450|Expectorants|expectorants|mesh-ancestor
102316311|NCT04766450|Respiratory System Agents|respiratory system agents|mesh-ancestor
102316312|NCT04766450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102316313|NCT04766450|Antioxidants|antioxidants|mesh-ancestor
102316314|NCT04766450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316315|NCT04766450|Protective Agents|protective agents|mesh-ancestor
102316316|NCT04766450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316317|NCT04766450|Antidotes|antidotes|mesh-ancestor
102316318|NCT02168816|Moxifloxacin|moxifloxacin|mesh-list
102316319|NCT02168816|Metronidazole|metronidazole|mesh-list
102316320|NCT02168816|Vancomycin|vancomycin|mesh-list
102316321|NCT02168816|Ciprofloxacin|ciprofloxacin|mesh-list
102316322|NCT02168816|Clindamycin|clindamycin|mesh-list
102316323|NCT02168816|Meropenem|meropenem|mesh-list
102316324|NCT02168816|Tazobactam|tazobactam|mesh-list
102316325|NCT02168816|Linezolid|linezolid|mesh-list
102316326|NCT02168816|Piperacillin|piperacillin|mesh-list
102316327|NCT02168816|Daptomycin|daptomycin|mesh-list
102316328|NCT02168816|Cefepime|cefepime|mesh-list
102316329|NCT02168816|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102316330|NCT02168816|Aztreonam|aztreonam|mesh-list
102316331|NCT02168816|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102316332|NCT02168816|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102316333|NCT02168816|Trimethoprim|trimethoprim|mesh-list
102316334|NCT02168816|Sulfamethoxazole|sulfamethoxazole|mesh-list
102316335|NCT02168816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102316336|NCT02168816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102316337|NCT02168816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102316338|NCT02168816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102316339|NCT02168816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316340|NCT02168816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102316341|NCT02168816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102316342|NCT02168816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102316343|NCT02168816|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102316344|NCT02168816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102316345|NCT02168816|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102316346|NCT02168816|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102316347|NCT02168816|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102025138|NCT04450212|Vitamin K|vitamin k|mesh-list
102316349|NCT02168816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102316350|NCT02168816|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102316351|NCT02168816|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102316352|NCT01584232|Insulin Glargine|insulin glargine|mesh-list
102316353|NCT01584232|Dulaglutide|dulaglutide|mesh-list
102316354|NCT01584232|Biguanides|biguanides|mesh-list
102316355|NCT01584232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102316356|NCT01584232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316357|NCT02119663|Capecitabine|capecitabine|mesh-list
102316358|NCT02119663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102316359|NCT02119663|Antimetabolites|antimetabolites|mesh-ancestor
102316360|NCT02119663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316361|NCT02119663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102316362|NCT04481009|Paclitaxel|paclitaxel|mesh-list
102316363|NCT04481009|Gemcitabine|gemcitabine|mesh-list
102316364|NCT04481009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102316365|NCT04481009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102316366|NCT04481009|Tubulin Modulators|tubulin modulators|mesh-ancestor
102316367|NCT04481009|Antimitotic Agents|antimitotic agents|mesh-ancestor
102316368|NCT04481009|Mitosis Modulators|mitosis modulators|mesh-ancestor
102316369|NCT04481009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316370|NCT04481009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102316371|NCT04481009|Antimetabolites|antimetabolites|mesh-ancestor
102316372|NCT05327231|Docetaxel|docetaxel|mesh-list
102316373|NCT05327231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102316374|NCT05327231|Tubulin Modulators|tubulin modulators|mesh-ancestor
102316375|NCT05327231|Antimitotic Agents|antimitotic agents|mesh-ancestor
102316376|NCT05327231|Mitosis Modulators|mitosis modulators|mesh-ancestor
102316377|NCT05327231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316378|NCT04418102|Palmitic Acid|palmitic acid|mesh-list
102316379|NCT04418102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102316380|NCT04418102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316381|NCT01628107|Epoetin Alfa|epoetin alfa|mesh-list
102316382|NCT01628107|Hematinics|hematinics|mesh-ancestor
102316383|NCT04745377|Antibodies|antibodies|mesh-list
102316384|NCT04745377|Immunologic Factors|immunologic factors|mesh-ancestor
102316385|NCT04745377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316386|NCT01583530|Belimumab|belimumab|mesh-list
102316387|NCT01583530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102316388|NCT01583530|Immunologic Factors|immunologic factors|mesh-ancestor
102316389|NCT01583530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316390|NCT01639001|Carboplatin|carboplatin|mesh-list
102316391|NCT01639001|Pemetrexed|pemetrexed|mesh-list
102316392|NCT01639001|Crizotinib|crizotinib|mesh-list
102316393|NCT01639001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102316394|NCT01639001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102316395|NCT01639001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316396|NCT01639001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102316397|NCT01639001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102316398|NCT01639001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102316399|NCT02168270|Ascorbic Acid|ascorbic acid|mesh-list
102316400|NCT02168270|Temozolomide|temozolomide|mesh-list
102316401|NCT02168270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102316402|NCT02168270|Alkylating Agents|alkylating agents|mesh-ancestor
102316403|NCT02168270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316404|NCT02168270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102316405|NCT02168270|Antioxidants|antioxidants|mesh-ancestor
102316406|NCT02168270|Protective Agents|protective agents|mesh-ancestor
102316407|NCT02168270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316408|NCT02168270|Vitamins|vitamins|mesh-ancestor
102316409|NCT02168270|Micronutrients|micronutrients|mesh-ancestor
102316410|NCT02167256|Saracatinib|saracatinib|mesh-list
102316411|NCT02167256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102316412|NCT02167256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102316413|NCT02167256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316414|NCT02166476|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102316415|NCT02166476|Levofloxacin|levofloxacin|mesh-list
102316416|NCT02166476|Meropenem|meropenem|mesh-list
102316417|NCT02166476|Tazobactam|tazobactam|mesh-list
102316418|NCT02166476|Piperacillin|piperacillin|mesh-list
102316419|NCT02166476|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102316420|NCT02166476|Vaborbactam|vaborbactam|mesh-list
102316421|NCT02166476|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
101432971|NCT00157976|Tin etiopurpurin|tin etiopurpurin|mesh-list
102316422|NCT02166476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102316423|NCT02166476|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102316424|NCT02166476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102316425|NCT02166476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102316426|NCT02166476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102316427|NCT02166476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316428|NCT02166476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102316429|NCT02166476|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102316430|NCT02166476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102316431|NCT02224274|Clopidogrel|clopidogrel|mesh-list
102316432|NCT02224274|Ticagrelor|ticagrelor|mesh-list
102316433|NCT02224274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102316434|NCT02224274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102316435|NCT02224274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102316436|NCT02224274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102316437|NCT02224274|Purinergic Agents|purinergic agents|mesh-ancestor
102316438|NCT02224274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102316439|NCT02224274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316440|NCT02224274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316441|NCT05219669|Nalmefene|nalmefene|mesh-list
102316442|NCT05219669|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102316443|NCT05219669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316444|NCT05219669|Sensory System Agents|sensory system agents|mesh-ancestor
102316445|NCT05219669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102316446|NCT04837859|Tislelizumab|tislelizumab|mesh-list
102316447|NCT04837859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102316448|NCT04837859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102316449|NCT04763252|Coal Tar|coal tar|mesh-list
102316450|NCT04763252|Keratolytic Agents|keratolytic agents|mesh-ancestor
102316451|NCT04763252|Dermatologic Agents|dermatologic agents|mesh-ancestor
102316452|NCT05369039|Prednisolone|prednisolone|mesh-list
102316453|NCT05369039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102316454|NCT05369039|Glucocorticoids|glucocorticoids|mesh-ancestor
102316455|NCT05369039|Hormones|hormones|mesh-ancestor
102316456|NCT05369039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102316457|NCT05369039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316458|NCT05369039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102316459|NCT05369039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102316460|NCT04373369|Atezolizumab|atezolizumab|mesh-list
102316461|NCT04373369|Vorolanib|vorolanib|mesh-list
102316462|NCT04373369|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102316463|NCT04373369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316464|NCT04373369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102316465|NCT04373369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102316466|NCT04373369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102316467|NCT04373369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102316468|NCT04285853|Oxycodone|oxycodone|mesh-list
102316469|NCT04285853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102316470|NCT04285853|Narcotics|narcotics|mesh-ancestor
102316471|NCT04285853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102316472|NCT04285853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316473|NCT04285853|Analgesics|analgesics|mesh-ancestor
102316474|NCT04285853|Sensory System Agents|sensory system agents|mesh-ancestor
102316475|NCT04285853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102316476|NCT04791059|Sufentanil|sufentanil|mesh-list
102316477|NCT04791059|Dexmedetomidine|dexmedetomidine|mesh-list
102316478|NCT04791059|Ketamine|ketamine|mesh-list
102316479|NCT04791059|Esketamine|esketamine|mesh-list
102316480|NCT04791059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102316481|NCT04791059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102316482|NCT04791059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316483|NCT04791059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102316484|NCT04791059|Analgesics|analgesics|mesh-ancestor
102316485|NCT04791059|Sensory System Agents|sensory system agents|mesh-ancestor
102316486|NCT04791059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102316487|NCT04791059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102316488|NCT04791059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102316489|NCT04791059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102316490|NCT04791059|Adrenergic Agents|adrenergic agents|mesh-ancestor
101433048|NCT00158171|Vitamins|vitamins|mesh-ancestor
102316491|NCT04791059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102316492|NCT04791059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316493|NCT04791059|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102316494|NCT04791059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102316495|NCT04791059|Anesthetics, General|anesthetics, general|mesh-ancestor
102316496|NCT04791059|Anesthetics|anesthetics|mesh-ancestor
102316497|NCT04791059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102316498|NCT04791059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102316499|NCT04791059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102316500|NCT04791059|Narcotics|narcotics|mesh-ancestor
102316501|NCT04791059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102025289|NCT05166096|Aspirin|aspirin|mesh-list
102316502|NCT04791059|Antidepressive Agents|antidepressive agents|mesh-ancestor
102316503|NCT04791059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102316505|NCT05398913|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102316506|NCT05398913|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
102316507|NCT05398913|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102316508|NCT05398913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102316509|NCT05398913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316510|NCT05398913|Hormones|hormones|mesh-ancestor
102316511|NCT05398913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102316512|NCT05398913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316513|NCT04260347|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102316514|NCT04260347|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102316515|NCT04260347|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102316516|NCT04260347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316517|NCT01583374|Thalidomide|thalidomide|mesh-list
102316518|NCT01583374|Apremilast|apremilast|mesh-list
102316519|NCT01583374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102316520|NCT01583374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102316521|NCT01583374|Analgesics|analgesics|mesh-ancestor
102316522|NCT01583374|Sensory System Agents|sensory system agents|mesh-ancestor
102316523|NCT01583374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102316524|NCT01583374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316525|NCT01583374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102316526|NCT01583374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102316527|NCT01583374|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102316528|NCT01583374|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102316529|NCT01583374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102316530|NCT01583374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316531|NCT01583374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102316532|NCT01583374|Immunologic Factors|immunologic factors|mesh-ancestor
102316533|NCT01583374|Leprostatic Agents|leprostatic agents|mesh-ancestor
102316534|NCT01583374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102316535|NCT01583374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102316536|NCT01583374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102316537|NCT01583374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102316538|NCT01583374|Growth Substances|growth substances|mesh-ancestor
102316539|NCT01583374|Growth Inhibitors|growth inhibitors|mesh-ancestor
102316540|NCT01583374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102316541|NCT04245215|Ustekinumab|ustekinumab|mesh-list
102316542|NCT04245215|Dermatologic Agents|dermatologic agents|mesh-ancestor
102316543|NCT05387759|Moxifloxacin|moxifloxacin|mesh-list
102316544|NCT05387759|Aticaprant|aticaprant|mesh-list
102316545|NCT05387759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102316546|NCT05387759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102316547|NCT05387759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102316548|NCT05387759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102316549|NCT05387759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102316550|NCT05387759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316551|NCT05387759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102316552|NCT05387759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316553|NCT05387759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102316554|NCT05387759|Sensory System Agents|sensory system agents|mesh-ancestor
102316555|NCT05387759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102316556|NCT02222714|Protein C|protein c|mesh-list
102316557|NCT02222714|Anticoagulants|anticoagulants|mesh-ancestor
102316558|NCT02222714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102316559|NCT02222714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102316560|NCT02222714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316561|NCT04809311|Insulin|insulin|mesh-list
102316562|NCT04809311|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102316563|NCT04809311|Glucagon|glucagon|mesh-list
102316564|NCT04809311|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102316565|NCT04809311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102316566|NCT04809311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316567|NCT04809311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102316568|NCT04809311|Hormones|hormones|mesh-ancestor
102316569|NCT04809311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102316570|NCT04809311|Incretins|incretins|mesh-ancestor
102316571|NCT04145219|Immunomodulating Agents|immunomodulating agents|mesh-list
102316572|NCT04145219|Immunologic Factors|immunologic factors|mesh-ancestor
102316573|NCT04145219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316574|NCT03184571|Pembrolizumab|pembrolizumab|mesh-list
102316575|NCT03184571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102316576|NCT03184571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102316577|NCT03184571|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102316578|NCT03184571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316579|NCT02164916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102316580|NCT02164916|Cetuximab|cetuximab|mesh-list
102316581|NCT02164916|Irinotecan|irinotecan|mesh-list
102316582|NCT02164916|Camptothecin|camptothecin|mesh-list
102316583|NCT02164916|Vemurafenib|vemurafenib|mesh-list
102316584|NCT02164916|Antibodies|antibodies|mesh-list
102316585|NCT02164916|Immunoglobulins|immunoglobulins|mesh-list
102316586|NCT02164916|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102316587|NCT02164916|Immunoglobulin G|immunoglobulin g|mesh-list
102316588|NCT02164916|Mitogens|mitogens|mesh-list
102316589|NCT02164916|Immunologic Factors|immunologic factors|mesh-ancestor
102316590|NCT02164916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316591|NCT02164916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102316592|NCT02164916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102316593|NCT02164916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102316594|NCT02164916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102316595|NCT02164916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316596|NCT02164916|Mitosis Modulators|mitosis modulators|mesh-ancestor
102316597|NCT02164916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102316598|NCT02164916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102316599|NCT04091867|Cetuximab|cetuximab|mesh-list
102316600|NCT04091867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102316601|NCT04091867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102316602|NCT04060277|Acetic Acid|acetic acid|mesh-list
102316603|NCT04060277|Letermovir|letermovir|mesh-list
102316604|NCT04060277|Vaccines|vaccines|mesh-list
102316605|NCT04060277|Immunologic Factors|immunologic factors|mesh-ancestor
102316606|NCT04060277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316607|NCT04060277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102316608|NCT04060277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102316609|NCT04060277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102316610|NCT04060277|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102316611|NCT04060277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102316612|NCT04060277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316613|NCT04060277|Antiviral Agents|antiviral agents|mesh-ancestor
102316614|NCT05651789|Propranolol|propranolol|mesh-list
102316615|NCT05651789|Carvedilol|carvedilol|mesh-list
102316616|NCT05651789|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102316617|NCT05651789|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102316618|NCT05651789|Adrenergic Agents|adrenergic agents|mesh-ancestor
102316619|NCT05651789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102316620|NCT05651789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316621|NCT05651789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316622|NCT05651789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102316623|NCT05651789|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102316624|NCT05651789|Vasodilator Agents|vasodilator agents|mesh-ancestor
102316625|NCT05651789|Antioxidants|antioxidants|mesh-ancestor
102316626|NCT05651789|Protective Agents|protective agents|mesh-ancestor
102316627|NCT05651789|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102316628|NCT05651789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102316629|NCT05651789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102316630|NCT05651789|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102316631|NCT05651789|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102316632|NCT02999477|Paclitaxel|paclitaxel|mesh-list
102316633|NCT02999477|Pembrolizumab|pembrolizumab|mesh-list
102316634|NCT02999477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102316635|NCT02999477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102316636|NCT02999477|Tubulin Modulators|tubulin modulators|mesh-ancestor
102316637|NCT02999477|Antimitotic Agents|antimitotic agents|mesh-ancestor
102316638|NCT02999477|Mitosis Modulators|mitosis modulators|mesh-ancestor
102316639|NCT02999477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316640|NCT02999477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102316641|NCT02999477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102316642|NCT02222558|Testosterone|testosterone|mesh-list
102316643|NCT02222558|Androgens|androgens|mesh-ancestor
102316644|NCT02222558|Hormones|hormones|mesh-ancestor
102316645|NCT02222558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102316646|NCT02222558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316647|NCT02975999|Vasopressins|vasopressins|mesh-list
102316648|NCT02975999|Arginine Vasopressin|arginine vasopressin|mesh-list
102316649|NCT02975999|Hemostatics|hemostatics|mesh-ancestor
102316650|NCT02975999|Coagulants|coagulants|mesh-ancestor
102025432|NCT02399800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102316651|NCT02975999|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102316652|NCT02975999|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102316653|NCT02975999|Natriuretic Agents|natriuretic agents|mesh-ancestor
102316654|NCT02975999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316655|NCT02188784|Iron|iron|mesh-list
102316656|NCT02188784|Trace Elements|trace elements|mesh-ancestor
102316657|NCT02188784|Micronutrients|micronutrients|mesh-ancestor
102316658|NCT02188784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316659|NCT02222246|Morphine|morphine|mesh-list
102316660|NCT02222246|Hydromorphone|hydromorphone|mesh-list
102316661|NCT02222246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102316662|NCT02222246|Narcotics|narcotics|mesh-ancestor
102316663|NCT02222246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102316664|NCT02222246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316665|NCT02222246|Analgesics|analgesics|mesh-ancestor
102316666|NCT02222246|Sensory System Agents|sensory system agents|mesh-ancestor
102316667|NCT02222246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102316668|NCT02188160|Loteprednol Etabonate|loteprednol etabonate|mesh-list
102316669|NCT02188160|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102316670|NCT04013555|Acetylcysteine|acetylcysteine|mesh-list
102316671|NCT04013555|Tryptophan|tryptophan|mesh-list
102316672|NCT04013555|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102316673|NCT04013555|Antiviral Agents|antiviral agents|mesh-ancestor
102316674|NCT04013555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102316675|NCT04013555|Expectorants|expectorants|mesh-ancestor
102316676|NCT04013555|Respiratory System Agents|respiratory system agents|mesh-ancestor
102316677|NCT04013555|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102316678|NCT04013555|Antioxidants|antioxidants|mesh-ancestor
102316679|NCT04013555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316680|NCT04013555|Protective Agents|protective agents|mesh-ancestor
102316681|NCT04013555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316682|NCT04013555|Antidotes|antidotes|mesh-ancestor
102316683|NCT04013555|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102316684|NCT04013555|Antidepressive Agents|antidepressive agents|mesh-ancestor
102316685|NCT04013555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102316686|NCT02220998|Sofosbuvir|sofosbuvir|mesh-list
102316687|NCT02220998|Antiviral Agents|antiviral agents|mesh-ancestor
102316688|NCT02220998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102316689|NCT02220920|Canagliflozin|canagliflozin|mesh-list
102316690|NCT02220920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102316691|NCT02220920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316692|NCT02220920|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102316693|NCT02220920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316694|NCT03966053|Trifluoperazine|trifluoperazine|mesh-list
102316695|NCT03966053|Antiemetics|antiemetics|mesh-ancestor
102316696|NCT03966053|Autonomic Agents|autonomic agents|mesh-ancestor
102316697|NCT03966053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102316698|NCT03966053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316699|NCT03966053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102316700|NCT03966053|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102316701|NCT03966053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102316702|NCT03966053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102316703|NCT03966053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102316704|NCT03966053|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102316705|NCT03966053|Dopamine Agents|dopamine agents|mesh-ancestor
102316706|NCT03966053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102316707|NCT03966053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316708|NCT03943901|Prednisone|prednisone|mesh-list
102316709|NCT03943901|Cyclophosphamide|cyclophosphamide|mesh-list
102316710|NCT03943901|Rituximab|rituximab|mesh-list
102316711|NCT03943901|Doxorubicin|doxorubicin|mesh-list
102316712|NCT03943901|Vincristine|vincristine|mesh-list
102316713|NCT03943901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102316714|NCT03943901|Immunologic Factors|immunologic factors|mesh-ancestor
102316715|NCT03943901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316716|NCT03943901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102316717|NCT03943901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102316718|NCT03943901|Alkylating Agents|alkylating agents|mesh-ancestor
102316719|NCT03943901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316720|NCT03943901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102316721|NCT03943901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102316722|NCT03943901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102316723|NCT03943901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102316724|NCT03943901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102316725|NCT03943901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102316726|NCT03943901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102316727|NCT03943901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102316728|NCT03943901|Glucocorticoids|glucocorticoids|mesh-ancestor
102316730|NCT03943901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102316731|NCT03943901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102316732|NCT03943901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102316733|NCT03943901|Tubulin Modulators|tubulin modulators|mesh-ancestor
102316734|NCT03943901|Antimitotic Agents|antimitotic agents|mesh-ancestor
102316735|NCT03943901|Mitosis Modulators|mitosis modulators|mesh-ancestor
102316736|NCT04790279|Amlodipine|amlodipine|mesh-list
102316737|NCT04790279|Nifedipine|nifedipine|mesh-list
102316738|NCT04790279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102316739|NCT04790279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102316740|NCT04790279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102316741|NCT04790279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316742|NCT04790279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102316743|NCT04790279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316744|NCT04790279|Vasodilator Agents|vasodilator agents|mesh-ancestor
102316745|NCT04790279|Tocolytic Agents|tocolytic agents|mesh-ancestor
102316746|NCT04790279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102316747|NCT03877289|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102316748|NCT03877289|Oxybutynin|oxybutynin|mesh-list
102316749|NCT03877289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102316750|NCT03877289|Parasympatholytics|parasympatholytics|mesh-ancestor
102316751|NCT03877289|Autonomic Agents|autonomic agents|mesh-ancestor
102316752|NCT03877289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102316753|NCT03877289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316754|NCT03877289|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102316755|NCT03877289|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102316756|NCT03877289|Cholinergic Agents|cholinergic agents|mesh-ancestor
102316757|NCT03877289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102316758|NCT03877289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316759|NCT03877289|Urological Agents|urological agents|mesh-ancestor
102316760|NCT05554679|Metformin|metformin|mesh-list
102316761|NCT05554679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102316762|NCT05554679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316763|NCT05494619|Immunoglobulins|immunoglobulins|mesh-list
102316764|NCT05494619|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102316765|NCT05494619|Antibodies|antibodies|mesh-list
102316766|NCT05494619|gamma-Globulins|gamma-globulins|mesh-list
102316767|NCT05494619|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102316768|NCT05494619|Immunologic Factors|immunologic factors|mesh-ancestor
102316769|NCT05494619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316770|NCT01634555|Leucovorin|leucovorin|mesh-list
102316771|NCT01634555|Folic Acid|folic acid|mesh-list
102316772|NCT01634555|Fluorouracil|fluorouracil|mesh-list
102316773|NCT01634555|Irinotecan|irinotecan|mesh-list
102316774|NCT01634555|Ramucirumab|ramucirumab|mesh-list
102316775|NCT01634555|Levoleucovorin|levoleucovorin|mesh-list
102316776|NCT01634555|Antimetabolites|antimetabolites|mesh-ancestor
102316777|NCT01634555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316778|NCT01634555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102316779|NCT01634555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102316780|NCT01634555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102316781|NCT01634555|Immunologic Factors|immunologic factors|mesh-ancestor
102316782|NCT01634555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316783|NCT01634555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102316784|NCT01634555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102316785|NCT01634555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102316786|NCT01634555|Antidotes|antidotes|mesh-ancestor
102316787|NCT01634555|Protective Agents|protective agents|mesh-ancestor
102316788|NCT01634555|Vitamin B Complex|vitamin b complex|mesh-ancestor
102316789|NCT01634555|Vitamins|vitamins|mesh-ancestor
102316790|NCT01634555|Micronutrients|micronutrients|mesh-ancestor
102316791|NCT01634555|Hematinics|hematinics|mesh-ancestor
102316792|NCT05355155|Bevacizumab|bevacizumab|mesh-list
102316793|NCT05355155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102316794|NCT05355155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102316795|NCT05355155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102316796|NCT05355155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102316797|NCT05355155|Growth Substances|growth substances|mesh-ancestor
102316798|NCT05355155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316799|NCT05355155|Growth Inhibitors|growth inhibitors|mesh-ancestor
102316800|NCT01634243|Rotigotine|rotigotine|mesh-list
102316801|NCT01634243|Dopamine Agonists|dopamine agonists|mesh-ancestor
102316802|NCT01634243|Dopamine Agents|dopamine agents|mesh-ancestor
102316803|NCT01634243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102316804|NCT01634243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316805|NCT01634243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316807|NCT01542034|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102316808|NCT01542034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102316809|NCT04814615|Daratumumab|daratumumab|mesh-list
102316810|NCT04814615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102316811|NCT03800693|Leucovorin|leucovorin|mesh-list
102316812|NCT03800693|Fluorouracil|fluorouracil|mesh-list
102316813|NCT03800693|Oxaliplatin|oxaliplatin|mesh-list
102316814|NCT03800693|Antimetabolites|antimetabolites|mesh-ancestor
102316815|NCT03800693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316816|NCT03800693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102316817|NCT03800693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102316818|NCT03800693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102316819|NCT03800693|Immunologic Factors|immunologic factors|mesh-ancestor
102316820|NCT03800693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316821|NCT03800693|Antidotes|antidotes|mesh-ancestor
102316822|NCT03800693|Protective Agents|protective agents|mesh-ancestor
102316823|NCT03800693|Vitamin B Complex|vitamin b complex|mesh-ancestor
102316824|NCT03800693|Vitamins|vitamins|mesh-ancestor
102316825|NCT03800693|Micronutrients|micronutrients|mesh-ancestor
102316826|NCT04814537|Bupivacaine|bupivacaine|mesh-list
102316827|NCT04814537|Anesthetics, Local|anesthetics, local|mesh-ancestor
102316828|NCT04814537|Anesthetics|anesthetics|mesh-ancestor
102316829|NCT04814537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102316830|NCT04814537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316831|NCT04814537|Sensory System Agents|sensory system agents|mesh-ancestor
102316832|NCT04814537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102316833|NCT01582282|Psyllium|psyllium|mesh-list
102316834|NCT01582282|Calcium polycarbophil|calcium polycarbophil|mesh-list
102316835|NCT01582282|Cathartics|cathartics|mesh-ancestor
102316836|NCT01582282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102316837|NCT01582282|Antidiarrheals|antidiarrheals|mesh-ancestor
102316838|NCT01599650|Ranibizumab|ranibizumab|mesh-list
102316839|NCT01599650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102316840|NCT01599650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102316841|NCT01599650|Growth Substances|growth substances|mesh-ancestor
102316842|NCT01599650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316843|NCT01599650|Growth Inhibitors|growth inhibitors|mesh-ancestor
102316844|NCT01599650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102316845|NCT03774875|Apremilast|apremilast|mesh-list
102316846|NCT03774875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102316847|NCT03774875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102316848|NCT03774875|Analgesics|analgesics|mesh-ancestor
102316849|NCT03774875|Sensory System Agents|sensory system agents|mesh-ancestor
102316850|NCT03774875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102316851|NCT03774875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316852|NCT03774875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102316853|NCT03774875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102316854|NCT03774875|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102316855|NCT03774875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102316856|NCT03774875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102316857|NCT03774875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316858|NCT01563172|Listerine|listerine|mesh-list
102316859|NCT01563172|Fluorides|fluorides|mesh-list
102316860|NCT01563172|Sodium Fluoride|sodium fluoride|mesh-list
102316861|NCT01563172|Cariostatic Agents|cariostatic agents|mesh-ancestor
102316862|NCT01563172|Protective Agents|protective agents|mesh-ancestor
102316863|NCT01563172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316864|NCT01563172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102316865|NCT01563172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102316866|NCT04755764|Atenolol|atenolol|mesh-list
102316867|NCT04755764|Labetalol|labetalol|mesh-list
102316868|NCT04755764|Nifedipine|nifedipine|mesh-list
102316869|NCT04755764|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102316870|NCT04755764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101941581|NCT01224093|Immunologic Factors|immunologic factors|mesh-ancestor
102316871|NCT04755764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316872|NCT04755764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102316873|NCT04755764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316874|NCT04755764|Vasodilator Agents|vasodilator agents|mesh-ancestor
102316875|NCT04755764|Tocolytic Agents|tocolytic agents|mesh-ancestor
102316876|NCT04755764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102316877|NCT04755764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102316878|NCT04755764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102316879|NCT04755764|Sympatholytics|sympatholytics|mesh-ancestor
102316880|NCT04755764|Autonomic Agents|autonomic agents|mesh-ancestor
102316881|NCT04755764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102316882|NCT04755764|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102316883|NCT04755764|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102316884|NCT04755764|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102316885|NCT04755764|Adrenergic Agents|adrenergic agents|mesh-ancestor
102316886|NCT04755764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102316887|NCT04755764|Sympathomimetics|sympathomimetics|mesh-ancestor
102316888|NCT04755764|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102316889|NCT04755764|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102316890|NCT02161718|Olanzapine|olanzapine|mesh-list
102316891|NCT02161718|Antiemetics|antiemetics|mesh-ancestor
102316892|NCT02161718|Autonomic Agents|autonomic agents|mesh-ancestor
102316893|NCT02161718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102316894|NCT02161718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316895|NCT02161718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102316896|NCT02161718|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102316897|NCT02161718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102316898|NCT02161718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102316899|NCT02161718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102316900|NCT02161718|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102316901|NCT02161718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102316902|NCT02161718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102316903|NCT02161718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316904|NCT02161718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102316905|NCT02161718|Serotonin Agents|serotonin agents|mesh-ancestor
102316906|NCT02074631|Vitamin D|vitamin d|mesh-list
102316907|NCT02074631|Cholecalciferol|cholecalciferol|mesh-list
102316908|NCT02074631|Ergocalciferols|ergocalciferols|mesh-list
102316909|NCT02074631|Pamidronate|pamidronate|mesh-list
102316910|NCT02074631|Calcium|calcium|mesh-list
102316911|NCT02074631|Vitamins|vitamins|mesh-ancestor
102316912|NCT02074631|Micronutrients|micronutrients|mesh-ancestor
102316913|NCT02074631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316914|NCT02074631|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102316915|NCT02074631|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102316916|NCT04813991|Ibuprofen|ibuprofen|mesh-list
102316917|NCT04813991|Oxycodone|oxycodone|mesh-list
102316918|NCT04813991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102316919|NCT04813991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102316920|NCT04813991|Analgesics|analgesics|mesh-ancestor
102316921|NCT04813991|Sensory System Agents|sensory system agents|mesh-ancestor
102316922|NCT04813991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102316923|NCT04813991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316924|NCT04813991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102316925|NCT04813991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102316926|NCT04813991|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102316927|NCT04813991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102316928|NCT04813991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316929|NCT04813991|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102316930|NCT04813991|Narcotics|narcotics|mesh-ancestor
102316931|NCT04813991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102316932|NCT03624101|Ivacaftor|ivacaftor|mesh-list
102316933|NCT03624101|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102316934|NCT03624101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102316935|NCT03624101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316936|NCT02218736|Aticaprant|aticaprant|mesh-list
102316937|NCT02218736|Narcotic Antagonists|narcotic antagonists|mesh-list
102316938|NCT02218736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316939|NCT02218736|Sensory System Agents|sensory system agents|mesh-ancestor
102316940|NCT02218736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102316941|NCT01580488|Calcitriol|calcitriol|mesh-list
102316942|NCT01580488|Calcipotriene|calcipotriene|mesh-list
102316943|NCT01580488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102316944|NCT01580488|Dermatologic Agents|dermatologic agents|mesh-ancestor
102316945|NCT01580488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102316946|NCT01580488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316948|NCT01580488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102316949|NCT01580488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102316950|NCT01580488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102316951|NCT01580488|Vitamins|vitamins|mesh-ancestor
102316952|NCT01580488|Micronutrients|micronutrients|mesh-ancestor
102316953|NCT01580488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102316954|NCT01580020|Dexamethasone|dexamethasone|mesh-list
102316955|NCT01580020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102316956|NCT01580020|Antiemetics|antiemetics|mesh-ancestor
102316957|NCT01580020|Autonomic Agents|autonomic agents|mesh-ancestor
102316958|NCT01580020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102316959|NCT01580020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316960|NCT01580020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102316961|NCT01580020|Glucocorticoids|glucocorticoids|mesh-ancestor
102316962|NCT01580020|Hormones|hormones|mesh-ancestor
102316963|NCT01580020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102316964|NCT01580020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102316965|NCT01580020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102316966|NCT01579318|Interleukin-12|interleukin-12|mesh-list
102316967|NCT01579318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102316968|NCT01579318|Immunologic Factors|immunologic factors|mesh-ancestor
102316969|NCT01579318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316970|NCT01579318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102316971|NCT01579318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102316972|NCT01579318|Growth Substances|growth substances|mesh-ancestor
102316973|NCT01579318|Growth Inhibitors|growth inhibitors|mesh-ancestor
102316974|NCT01579318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102316975|NCT01578850|Etanercept|etanercept|mesh-list
102316976|NCT01578850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102316977|NCT01578850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102316978|NCT01578850|Analgesics|analgesics|mesh-ancestor
102316979|NCT01578850|Sensory System Agents|sensory system agents|mesh-ancestor
102316980|NCT01578850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102316981|NCT01578850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316982|NCT01578850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102316983|NCT01578850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102316984|NCT01578850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102316985|NCT01578850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102316986|NCT01578850|Immunologic Factors|immunologic factors|mesh-ancestor
102316987|NCT01539538|Sufentanil|sufentanil|mesh-list
102316988|NCT01539538|Morphine|morphine|mesh-list
102316989|NCT01539538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102316990|NCT01539538|Narcotics|narcotics|mesh-ancestor
102316991|NCT01539538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102316992|NCT01539538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102316993|NCT01539538|Analgesics|analgesics|mesh-ancestor
102316994|NCT01539538|Sensory System Agents|sensory system agents|mesh-ancestor
102316995|NCT01539538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102316996|NCT01539538|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102316997|NCT01539538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102316998|NCT01539538|Anesthetics, General|anesthetics, general|mesh-ancestor
102316999|NCT01539538|Anesthetics|anesthetics|mesh-ancestor
102317000|NCT01562548|Phenylpropanolamine|phenylpropanolamine|mesh-list
102317001|NCT01562548|Guaifenesin|guaifenesin|mesh-list
102317002|NCT01562548|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
102317003|NCT01562548|Expectorants|expectorants|mesh-ancestor
102317004|NCT01562548|Respiratory System Agents|respiratory system agents|mesh-ancestor
102317005|NCT01562548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102317006|NCT01562548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102317007|NCT01562548|Adrenergic Agents|adrenergic agents|mesh-ancestor
102317008|NCT01562548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102317009|NCT01562548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317010|NCT01562548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317011|NCT01562548|Appetite Depressants|appetite depressants|mesh-ancestor
102317012|NCT01562548|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102317013|NCT01562548|Sympathomimetics|sympathomimetics|mesh-ancestor
102317014|NCT01562548|Autonomic Agents|autonomic agents|mesh-ancestor
102317015|NCT01562548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102317016|NCT01562548|Nasal Decongestants|nasal decongestants|mesh-ancestor
102317017|NCT01562548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102317018|NCT03027934|Ticagrelor|ticagrelor|mesh-list
102317019|NCT03027934|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102317020|NCT03027934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102317021|NCT03027934|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102317022|NCT03027934|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102317023|NCT03027934|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102317024|NCT03027934|Purinergic Agents|purinergic agents|mesh-ancestor
102317025|NCT03027934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102317026|NCT03027934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317027|NCT03027934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317028|NCT01562314|Cannabidiol|cannabidiol|mesh-list
102317029|NCT01562314|Anticonvulsants|anticonvulsants|mesh-ancestor
102317030|NCT01539226|Dapivirine|dapivirine|mesh-list
102317031|NCT01539226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102317032|NCT01539226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102317033|NCT01539226|Antiviral Agents|antiviral agents|mesh-ancestor
102317034|NCT01539226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102317035|NCT01537120|Vildagliptin|vildagliptin|mesh-list
102317036|NCT01537120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102317037|NCT01537120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317038|NCT01537120|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102317039|NCT01537120|Protease Inhibitors|protease inhibitors|mesh-ancestor
102317040|NCT01537120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102317041|NCT01537120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317042|NCT01537042|Rotigotine|rotigotine|mesh-list
102317043|NCT01537042|Dopamine Agonists|dopamine agonists|mesh-ancestor
102317044|NCT01537042|Dopamine Agents|dopamine agents|mesh-ancestor
102317045|NCT01537042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102317046|NCT01537042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317047|NCT01537042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317048|NCT01536574|Ropinirole|ropinirole|mesh-list
102317049|NCT01536574|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102317050|NCT01536574|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102317051|NCT01536574|Dopamine Agonists|dopamine agonists|mesh-ancestor
102317052|NCT01536574|Dopamine Agents|dopamine agents|mesh-ancestor
102317053|NCT01536574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101433676|NCT00541138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102317054|NCT01536574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317055|NCT01536574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317056|NCT04410094|Itraconazole|itraconazole|mesh-list
102317057|NCT04410094|Rifampin|rifampin|mesh-list
102317058|NCT04410094|Lazertinib|lazertinib|mesh-list
102317059|NCT04410094|Antifungal Agents|antifungal agents|mesh-ancestor
102317060|NCT04410094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102317061|NCT04410094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102317062|NCT04410094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102317063|NCT04410094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102317064|NCT04410094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317065|NCT04410094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102317066|NCT04410094|Hormone Antagonists|hormone antagonists|mesh-ancestor
102317067|NCT04410094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102317068|NCT04410094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317069|NCT04410094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102317070|NCT04410094|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102317071|NCT04410094|Antitubercular Agents|antitubercular agents|mesh-ancestor
102317072|NCT04410094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102317073|NCT04410094|Leprostatic Agents|leprostatic agents|mesh-ancestor
102317074|NCT04410094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102317075|NCT04410094|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102317076|NCT04410094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102317077|NCT04410094|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102317078|NCT04410094|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102317079|NCT04410094|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102317080|NCT04410094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102317081|NCT04410094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102317082|NCT01576042|Amiodarone|amiodarone|mesh-list
102317083|NCT01576042|Sotalol|sotalol|mesh-list
102317084|NCT01576042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102317085|NCT01576042|Vasodilator Agents|vasodilator agents|mesh-ancestor
102317086|NCT01576042|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102317087|NCT01576042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102317088|NCT01576042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317089|NCT01576042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102317090|NCT01576042|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102317091|NCT01576042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102317092|NCT01576042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102317093|NCT01576042|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102317094|NCT01576042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102317095|NCT01576042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102317096|NCT01576042|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102317097|NCT01576042|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102317098|NCT01576042|Adrenergic Agents|adrenergic agents|mesh-ancestor
102317099|NCT01576042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102317100|NCT01576042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317101|NCT01576042|Sympatholytics|sympatholytics|mesh-ancestor
102317102|NCT01576042|Autonomic Agents|autonomic agents|mesh-ancestor
102317103|NCT01576042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102317104|NCT01536262|Tiotropium Bromide|tiotropium bromide|mesh-list
102317106|NCT01536262|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102317107|NCT01536262|Autonomic Agents|autonomic agents|mesh-ancestor
102317108|NCT01536262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102317109|NCT01536262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317110|NCT01536262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102317111|NCT01536262|Respiratory System Agents|respiratory system agents|mesh-ancestor
102317112|NCT01536262|Parasympatholytics|parasympatholytics|mesh-ancestor
102317113|NCT01536262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102317114|NCT01536262|Cholinergic Agents|cholinergic agents|mesh-ancestor
102317115|NCT01536262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102317116|NCT01536262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317117|NCT04102618|Trastuzumab|trastuzumab|mesh-list
102317118|NCT04102618|Atezolizumab|atezolizumab|mesh-list
102317119|NCT04102618|Letrozole|letrozole|mesh-list
102317120|NCT04102618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102317121|NCT04102618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102317122|NCT04102618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102317123|NCT04102618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317124|NCT04102618|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102317125|NCT04102618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102317126|NCT04102618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102317127|NCT04102618|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102317128|NCT04102618|Hormone Antagonists|hormone antagonists|mesh-ancestor
102317129|NCT04102618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102317130|NCT04102618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317131|NCT01575028|Bupivacaine|bupivacaine|mesh-list
102317132|NCT01575028|Ropivacaine|ropivacaine|mesh-list
102317133|NCT01575028|Anesthetics, Local|anesthetics, local|mesh-ancestor
102317134|NCT01575028|Anesthetics|anesthetics|mesh-ancestor
102317135|NCT01575028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102317136|NCT01575028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317137|NCT01575028|Sensory System Agents|sensory system agents|mesh-ancestor
102317138|NCT01575028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102317139|NCT04963283|Nivolumab|nivolumab|mesh-list
102317140|NCT04963283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102317141|NCT04963283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102317142|NCT04963283|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102317143|NCT04963283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317144|NCT04443569|Lidocaine|lidocaine|mesh-list
102317145|NCT04443569|Anesthetics, Local|anesthetics, local|mesh-ancestor
102317146|NCT04443569|Anesthetics|anesthetics|mesh-ancestor
102317147|NCT04443569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102317148|NCT04443569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317149|NCT04443569|Sensory System Agents|sensory system agents|mesh-ancestor
102317150|NCT04443569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102317151|NCT04443569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102317152|NCT04443569|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102317153|NCT04443569|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102317154|NCT04443569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102317155|NCT04443569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317156|NCT01792583|Modafinil|modafinil|mesh-list
102317157|NCT01792583|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102317158|NCT01792583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317159|NCT01792583|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102317160|NCT01792583|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102317161|NCT01792583|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102317162|NCT01792583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317163|NCT03508895|Caseins|caseins|mesh-list
102317164|NCT03508895|Chelating Agents|chelating agents|mesh-ancestor
102317165|NCT03508895|Sequestering Agents|sequestering agents|mesh-ancestor
102317166|NCT03508895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317167|NCT04566653|Calcium|calcium|mesh-list
102317168|NCT04566653|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
102317169|NCT04566653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102317170|NCT04566653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317171|NCT04566653|Chelating Agents|chelating agents|mesh-ancestor
102317172|NCT04566653|Sequestering Agents|sequestering agents|mesh-ancestor
102317173|NCT04566653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317174|NCT01574716|Gemcitabine|gemcitabine|mesh-list
102317175|NCT01574716|Docetaxel|docetaxel|mesh-list
102317176|NCT01574716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102317177|NCT01574716|Antimetabolites|antimetabolites|mesh-ancestor
102317178|NCT01574716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317179|NCT01574716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102317180|NCT01574716|Tubulin Modulators|tubulin modulators|mesh-ancestor
102317181|NCT01574716|Antimitotic Agents|antimitotic agents|mesh-ancestor
102317182|NCT01574716|Mitosis Modulators|mitosis modulators|mesh-ancestor
102317183|NCT02161562|Omalizumab|omalizumab|mesh-list
102317184|NCT02161562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101433809|NCT00541918|Propofol|propofol|mesh-list
102317185|NCT02161562|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102317186|NCT02161562|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102317187|NCT02161562|Respiratory System Agents|respiratory system agents|mesh-ancestor
102317188|NCT02161562|Immunologic Factors|immunologic factors|mesh-ancestor
102317189|NCT02161562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317190|NCT01559116|Tiotropium Bromide|tiotropium bromide|mesh-list
102317191|NCT01559116|Olodaterol|olodaterol|mesh-list
102317192|NCT01559116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102317193|NCT01559116|Autonomic Agents|autonomic agents|mesh-ancestor
102317194|NCT01559116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102317195|NCT01559116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317196|NCT01559116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102317197|NCT01559116|Respiratory System Agents|respiratory system agents|mesh-ancestor
102317198|NCT01559116|Parasympatholytics|parasympatholytics|mesh-ancestor
102317199|NCT01559116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102317200|NCT01559116|Cholinergic Agents|cholinergic agents|mesh-ancestor
102317201|NCT01559116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102317202|NCT01559116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317203|NCT01574326|Sevelamer|sevelamer|mesh-list
102317204|NCT01574326|Chelating Agents|chelating agents|mesh-ancestor
102317205|NCT01574326|Sequestering Agents|sequestering agents|mesh-ancestor
102317206|NCT01574326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317207|NCT01574248|Icatibant|icatibant|mesh-list
102317208|NCT01574248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102317209|NCT01574248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102317210|NCT01574248|Analgesics|analgesics|mesh-ancestor
102317211|NCT01574248|Sensory System Agents|sensory system agents|mesh-ancestor
102317212|NCT01574248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102317213|NCT01574248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317214|NCT01574248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102317215|NCT01574248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102317216|NCT01574248|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
102317217|NCT01574248|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
102317218|NCT01574248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317219|NCT01574248|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102317220|NCT01574248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102317221|NCT01574248|Immunologic Factors|immunologic factors|mesh-ancestor
102317222|NCT04761094|Insulin|insulin|mesh-list
102317223|NCT04761094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102317224|NCT04761094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317225|NCT01557946|Citalopram|citalopram|mesh-list
102317226|NCT01557946|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102317227|NCT01557946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102317228|NCT01557946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102317229|NCT01557946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317230|NCT01557946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102317231|NCT01557946|Serotonin Agents|serotonin agents|mesh-ancestor
102317232|NCT01557946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317233|NCT01557946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102317234|NCT01557946|Antidepressive Agents|antidepressive agents|mesh-ancestor
102317235|NCT01557946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102317236|NCT01534078|Doxorubicin|doxorubicin|mesh-list
102317237|NCT01534078|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102317238|NCT01534078|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102317240|NCT01534078|Vinblastine|vinblastine|mesh-list
102317241|NCT01534078|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102317242|NCT01534078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102317243|NCT01534078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102317244|NCT01534078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102317245|NCT01534078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102317246|NCT01534078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317247|NCT01534078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102317248|NCT01534078|Immunotoxins|immunotoxins|mesh-ancestor
102317249|NCT01534078|Immunoconjugates|immunoconjugates|mesh-ancestor
102317250|NCT01534078|Immunologic Factors|immunologic factors|mesh-ancestor
102317251|NCT01534078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317252|NCT01534078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102317253|NCT01534078|Alkylating Agents|alkylating agents|mesh-ancestor
102317254|NCT01534078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102317255|NCT01534078|Tubulin Modulators|tubulin modulators|mesh-ancestor
102317256|NCT01534078|Antimitotic Agents|antimitotic agents|mesh-ancestor
102317257|NCT01534078|Mitosis Modulators|mitosis modulators|mesh-ancestor
102317258|NCT03919942|Chlorhexidine|chlorhexidine|mesh-list
102317259|NCT03919942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102317260|NCT03919942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102317261|NCT03919942|Disinfectants|disinfectants|mesh-ancestor
102317262|NCT02161406|Abatacept|abatacept|mesh-list
102317263|NCT02161406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102317264|NCT02161406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317265|NCT02161406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102317266|NCT02161406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102317267|NCT02161406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102317268|NCT02161406|Immunologic Factors|immunologic factors|mesh-ancestor
102317269|NCT02161406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317270|NCT02161406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102317271|NCT01573000|Tositumomab I-131|tositumomab i-131|mesh-list
102317272|NCT01573000|Antibodies|antibodies|mesh-list
102317273|NCT01573000|Immunoglobulins|immunoglobulins|mesh-list
102317274|NCT01573000|Immunologic Factors|immunologic factors|mesh-ancestor
102317275|NCT01573000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317276|NCT01573000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102317277|NCT01572844|Sodium thiosulfate|sodium thiosulfate|mesh-list
102317278|NCT01572844|Antidotes|antidotes|mesh-ancestor
102317279|NCT01572844|Protective Agents|protective agents|mesh-ancestor
102317280|NCT01572844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317281|NCT01572844|Antioxidants|antioxidants|mesh-ancestor
102317282|NCT01572844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317283|NCT01572844|Antitubercular Agents|antitubercular agents|mesh-ancestor
102317284|NCT01572844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102317285|NCT01572844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102317286|NCT01572844|Chelating Agents|chelating agents|mesh-ancestor
102317287|NCT01572844|Sequestering Agents|sequestering agents|mesh-ancestor
102317288|NCT01533922|Tiotropium Bromide|tiotropium bromide|mesh-list
102317289|NCT01533922|Olodaterol|olodaterol|mesh-list
102317290|NCT01533922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102317291|NCT01533922|Autonomic Agents|autonomic agents|mesh-ancestor
102317292|NCT01533922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102317293|NCT01533922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317294|NCT01533922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102317295|NCT01533922|Respiratory System Agents|respiratory system agents|mesh-ancestor
102317296|NCT01533922|Parasympatholytics|parasympatholytics|mesh-ancestor
102317297|NCT01533922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102317298|NCT01533922|Cholinergic Agents|cholinergic agents|mesh-ancestor
102317299|NCT01533922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102317300|NCT01533922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317301|NCT01533688|Bisacodyl|bisacodyl|mesh-list
102317302|NCT01533688|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102317303|NCT01533688|Cathartics|cathartics|mesh-ancestor
102026113|NCT03583385|Metformin|metformin|mesh-list
102317304|NCT01533688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102317305|NCT01533688|Laxatives|laxatives|mesh-ancestor
102317306|NCT01532908|Sofosbuvir|sofosbuvir|mesh-list
102317307|NCT01532908|Antiviral Agents|antiviral agents|mesh-ancestor
102317308|NCT01532908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102317309|NCT02160626|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102317310|NCT02217878|Morphine|morphine|mesh-list
102317311|NCT02217878|Ticagrelor|ticagrelor|mesh-list
102317312|NCT02217878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102317313|NCT02217878|Narcotics|narcotics|mesh-ancestor
101659181|NCT00858325|Daptomycin|daptomycin|mesh-list
102317314|NCT02217878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102317315|NCT02217878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317316|NCT02217878|Analgesics|analgesics|mesh-ancestor
102317317|NCT02217878|Sensory System Agents|sensory system agents|mesh-ancestor
102317318|NCT02217878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102317319|NCT02217878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102317320|NCT02217878|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102317321|NCT02217878|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102317322|NCT02217878|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102317323|NCT02217878|Purinergic Agents|purinergic agents|mesh-ancestor
102317324|NCT02217878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102317325|NCT02217878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317326|NCT02217566|Prednisone|prednisone|mesh-list
102317327|NCT02217566|Abiraterone Acetate|abiraterone acetate|mesh-list
102317328|NCT02217566|Androgens|androgens|mesh-list
102317329|NCT02217566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102317330|NCT02217566|Glucocorticoids|glucocorticoids|mesh-ancestor
102317331|NCT02217566|Hormones|hormones|mesh-ancestor
102317332|NCT02217566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102317333|NCT02217566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317334|NCT02217566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102317335|NCT02217566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102317336|NCT02217566|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102317337|NCT02217566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102317338|NCT02217566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317339|NCT02217566|Hormone Antagonists|hormone antagonists|mesh-ancestor
102317340|NCT02217566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102317341|NCT02217410|Mycophenolic Acid|mycophenolic acid|mesh-list
102317342|NCT02217410|Tacrolimus|tacrolimus|mesh-list
102317343|NCT02217410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102317344|NCT02217410|Immunologic Factors|immunologic factors|mesh-ancestor
102317345|NCT02217410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317346|NCT02217410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102317347|NCT02217410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102317348|NCT02217410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317349|NCT02217410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102317350|NCT02217410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102317351|NCT02217410|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102317352|NCT02217410|Antitubercular Agents|antitubercular agents|mesh-ancestor
102317353|NCT02217410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102317354|NCT02217410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102317355|NCT02217332|Pramipexole|pramipexole|mesh-list
102317356|NCT02217332|Antioxidants|antioxidants|mesh-ancestor
102317357|NCT02217332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317358|NCT02217332|Protective Agents|protective agents|mesh-ancestor
102317359|NCT02217332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317360|NCT02217332|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102317361|NCT02217332|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102317362|NCT02217332|Dopamine Agonists|dopamine agonists|mesh-ancestor
102317363|NCT02217332|Dopamine Agents|dopamine agents|mesh-ancestor
102317364|NCT02217332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102317365|NCT02184572|Vaccines|vaccines|mesh-list
102317366|NCT02184572|Immunologic Factors|immunologic factors|mesh-ancestor
102317367|NCT02184572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317368|NCT02181842|Pioglitazone|pioglitazone|mesh-list
102317369|NCT02181842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102317370|NCT02181842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317371|NCT01632020|Metformin|metformin|mesh-list
102317372|NCT01632020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102317373|NCT01632020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317374|NCT02181296|Ropivacaine|ropivacaine|mesh-list
102317375|NCT02181296|Anesthetics, Local|anesthetics, local|mesh-ancestor
102317376|NCT02181296|Anesthetics|anesthetics|mesh-ancestor
102317377|NCT02181296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102317378|NCT02181296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317379|NCT02181296|Sensory System Agents|sensory system agents|mesh-ancestor
102317380|NCT02181296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102317381|NCT02158442|Clavulanic Acid|clavulanic acid|mesh-list
102317382|NCT02158442|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
102317383|NCT02158442|Ticarcillin|ticarcillin|mesh-list
102317384|NCT02158442|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102317385|NCT02158442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102317386|NCT02158442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317387|NCT02158442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102317388|NCT02158442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102317389|NCT02158364|Vaccines|vaccines|mesh-list
101434016|NCT00159809|Sildenafil Citrate|sildenafil citrate|mesh-list
102317390|NCT02158364|Immunologic Factors|immunologic factors|mesh-ancestor
102317391|NCT02158364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317392|NCT02180672|Fluticasone|fluticasone|mesh-list
102317393|NCT02180672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102317394|NCT02180672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102317395|NCT02180672|Autonomic Agents|autonomic agents|mesh-ancestor
102317396|NCT02180672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102317397|NCT02180672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317398|NCT02180672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102317399|NCT02180672|Respiratory System Agents|respiratory system agents|mesh-ancestor
102317400|NCT02180672|Dermatologic Agents|dermatologic agents|mesh-ancestor
102317401|NCT02180672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102317402|NCT01920711|Valsartan|valsartan|mesh-list
102317403|NCT01920711|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102317404|NCT01920711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102317405|NCT01920711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102317406|NCT01920711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102317407|NCT01920711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317408|NCT02180438|Tenofovir|tenofovir|mesh-list
102317409|NCT02180438|Emtricitabine|emtricitabine|mesh-list
102317410|NCT02180438|Cobicistat|cobicistat|mesh-list
102317411|NCT02180438|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102317412|NCT02180438|Elvitegravir|elvitegravir|mesh-list
102317413|NCT02180438|Antiviral Agents|antiviral agents|mesh-ancestor
102317414|NCT02180438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102317415|NCT02180438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102317416|NCT02180438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102317417|NCT02180438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102317418|NCT02180438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317419|NCT02180438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102317420|NCT02180438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102317421|NCT02180438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102317422|NCT02180438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102317423|NCT02180438|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102317424|NCT02157116|Docetaxel|docetaxel|mesh-list
102317425|NCT02157116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102317426|NCT02157116|Tubulin Modulators|tubulin modulators|mesh-ancestor
102317427|NCT02157116|Antimitotic Agents|antimitotic agents|mesh-ancestor
102317428|NCT02157116|Mitosis Modulators|mitosis modulators|mesh-ancestor
102317429|NCT02157116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317430|NCT01920555|Midazolam|midazolam|mesh-list
102317431|NCT01920555|Ketamine|ketamine|mesh-list
102317432|NCT01920555|Analgesics|analgesics|mesh-ancestor
102317433|NCT01920555|Sensory System Agents|sensory system agents|mesh-ancestor
102317434|NCT01920555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102317435|NCT01920555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317436|NCT01920555|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102317437|NCT01920555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102317438|NCT01920555|Anesthetics, General|anesthetics, general|mesh-ancestor
102317439|NCT01920555|Anesthetics|anesthetics|mesh-ancestor
102317440|NCT01920555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102317441|NCT01920555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102317442|NCT01920555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102317443|NCT01920555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102317444|NCT01920555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317445|NCT01920555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102317446|NCT01920555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102317447|NCT01920555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102317448|NCT01920555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102317449|NCT01920555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102317450|NCT01920555|GABA Modulators|gaba modulators|mesh-ancestor
102317451|NCT01920555|GABA Agents|gaba agents|mesh-ancestor
102317452|NCT02156804|Nivolumab|nivolumab|mesh-list
102317453|NCT02156804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102317454|NCT02156804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102317455|NCT02156804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102317456|NCT02156804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317457|NCT02156492|Atorvastatin|atorvastatin|mesh-list
102317458|NCT02156492|Simvastatin|simvastatin|mesh-list
102317459|NCT02156492|Evacetrapib|evacetrapib|mesh-list
102317460|NCT02156492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102317461|NCT02156492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102317462|NCT02156492|Antimetabolites|antimetabolites|mesh-ancestor
102317463|NCT02156492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317464|NCT02156492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102317465|NCT02156492|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102317466|NCT02156492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102317467|NCT01920477|Ofatumumab|ofatumumab|mesh-list
102317468|NCT01920477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102317469|NCT04641195|Vitamin D|vitamin d|mesh-list
102317470|NCT04641195|Ergocalciferols|ergocalciferols|mesh-list
102317471|NCT04641195|Cholecalciferol|cholecalciferol|mesh-list
102317472|NCT04641195|Vitamins|vitamins|mesh-list
102317473|NCT04641195|Zinc|zinc|mesh-list
102317474|NCT04641195|Micronutrients|micronutrients|mesh-ancestor
102317475|NCT04641195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317476|NCT04641195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102317477|NCT04641195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102317478|NCT04641195|Trace Elements|trace elements|mesh-ancestor
102317479|NCT02213042|Trastuzumab|trastuzumab|mesh-list
102317480|NCT02213042|Lapatinib|lapatinib|mesh-list
102317481|NCT02213042|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102317482|NCT02213042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102317483|NCT02213042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102317484|NCT02213042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102317485|NCT02213042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102317486|NCT02213042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317487|NCT02213042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102317488|NCT02213042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102317489|NCT02213042|Hormone Antagonists|hormone antagonists|mesh-ancestor
102317490|NCT02213042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102317491|NCT02213042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317492|NCT04418180|Fenofibrate|fenofibrate|mesh-list
102317493|NCT04418180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102317494|NCT04418180|Antimetabolites|antimetabolites|mesh-ancestor
102317495|NCT04418180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317496|NCT04418180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102317497|NCT02212730|Pembrolizumab|pembrolizumab|mesh-list
102317498|NCT02212730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102317499|NCT02212730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102317500|NCT02212730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102317501|NCT02212730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317502|NCT02178956|Paclitaxel|paclitaxel|mesh-list
102317503|NCT02178956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102317504|NCT02178956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102317505|NCT02178956|Tubulin Modulators|tubulin modulators|mesh-ancestor
102317506|NCT02178956|Antimitotic Agents|antimitotic agents|mesh-ancestor
102317507|NCT02178956|Mitosis Modulators|mitosis modulators|mesh-ancestor
102317508|NCT02178956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317509|NCT02211638|Candesartan|candesartan|mesh-list
102317510|NCT02211638|Candesartan cilexetil|candesartan cilexetil|mesh-list
102317511|NCT02211638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102317512|NCT02211638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102317513|NCT02211638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102317514|NCT02211638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317515|NCT02178566|Treprostinil|treprostinil|mesh-list
102317516|NCT02178566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102317517|NCT02211014|Acalabrutinib|acalabrutinib|mesh-list
102317518|NCT02211014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102317519|NCT01631864|Amlodipine|amlodipine|mesh-list
102317520|NCT01631864|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102317521|NCT01631864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102317522|NCT01631864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102317523|NCT01631864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101434158|NCT00544219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102317524|NCT01631864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317525|NCT01631864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102317526|NCT01631864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317527|NCT01631864|Vasodilator Agents|vasodilator agents|mesh-ancestor
102317528|NCT01631864|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102317529|NCT01557244|Fesoterodine|fesoterodine|mesh-list
102317530|NCT01557244|Oxybutynin|oxybutynin|mesh-list
102317531|NCT01557244|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102317532|NCT01557244|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102317533|NCT01557244|Cholinergic Agents|cholinergic agents|mesh-ancestor
102317534|NCT01557244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102317535|NCT01557244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317536|NCT01557244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317538|NCT01557244|Parasympatholytics|parasympatholytics|mesh-ancestor
102317539|NCT01557244|Autonomic Agents|autonomic agents|mesh-ancestor
102317540|NCT01557244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102317541|NCT02177942|Micronutrients|micronutrients|mesh-list
102317542|NCT02177942|Trace Elements|trace elements|mesh-list
102317543|NCT02177942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317544|NCT02155322|Interferons|interferons|mesh-list
102317545|NCT02155322|Interferon-alpha|interferon-alpha|mesh-list
102317546|NCT02155322|Interferon alpha-2|interferon alpha-2|mesh-list
102317547|NCT02155322|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102317548|NCT02155322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102317549|NCT02155322|Antiviral Agents|antiviral agents|mesh-ancestor
102317550|NCT02155322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102317551|NCT02155322|Immunologic Factors|immunologic factors|mesh-ancestor
102317552|NCT02155322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317553|NCT02209454|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
102317554|NCT02209454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102317555|NCT02209454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102317556|NCT02209454|Analgesics|analgesics|mesh-ancestor
102317557|NCT02209454|Sensory System Agents|sensory system agents|mesh-ancestor
102317558|NCT02209454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102317559|NCT02209454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317560|NCT02209454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102317561|NCT02209454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102317562|NCT01557166|Liraglutide|liraglutide|mesh-list
102317563|NCT01557166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102317564|NCT01557166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317565|NCT01557166|Incretins|incretins|mesh-ancestor
102317566|NCT01557166|Hormones|hormones|mesh-ancestor
102317567|NCT01557166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102317568|NCT01556932|Diphenhydramine|diphenhydramine|mesh-list
102317569|NCT01556932|Promethazine|promethazine|mesh-list
102317570|NCT01556932|Lorazepam|lorazepam|mesh-list
102317571|NCT01556932|Haloperidol|haloperidol|mesh-list
102317572|NCT01556932|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102317573|NCT01556932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102317574|NCT01556932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102317575|NCT01556932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317576|NCT01556932|Anesthetics, Local|anesthetics, local|mesh-ancestor
102317577|NCT01556932|Anesthetics|anesthetics|mesh-ancestor
102317578|NCT01556932|Sensory System Agents|sensory system agents|mesh-ancestor
102317579|NCT01556932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102317580|NCT01556932|Antiemetics|antiemetics|mesh-ancestor
102317581|NCT01556932|Autonomic Agents|autonomic agents|mesh-ancestor
102317582|NCT01556932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102317583|NCT01556932|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102317584|NCT01556932|Histamine Antagonists|histamine antagonists|mesh-ancestor
102317585|NCT01556932|Histamine Agents|histamine agents|mesh-ancestor
102317586|NCT01556932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102317587|NCT01556932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317588|NCT01556932|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102317589|NCT01556932|Antipruritics|antipruritics|mesh-ancestor
102317590|NCT01556932|Dermatologic Agents|dermatologic agents|mesh-ancestor
102317591|NCT01556932|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102317592|NCT01556932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102317593|NCT01556932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102317594|NCT01556932|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102317595|NCT01556932|Dopamine Agents|dopamine agents|mesh-ancestor
102317596|NCT01556932|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102317597|NCT01556932|Anticonvulsants|anticonvulsants|mesh-ancestor
102317598|NCT01556932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102317599|NCT01556932|GABA Modulators|gaba modulators|mesh-ancestor
102317600|NCT01556932|GABA Agents|gaba agents|mesh-ancestor
102317601|NCT02985736|Desoximetasone|desoximetasone|mesh-list
102026452|NCT01353508|Valsartan|valsartan|mesh-list
102317602|NCT02985736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102317603|NCT02985736|Glucocorticoids|glucocorticoids|mesh-ancestor
102317604|NCT02985736|Hormones|hormones|mesh-ancestor
102317605|NCT02985736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102317606|NCT02985736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317607|NCT02985658|Cisplatin|cisplatin|mesh-list
102317608|NCT02985658|Vinorelbine|vinorelbine|mesh-list
102317609|NCT02985658|Veliparib|veliparib|mesh-list
102317610|NCT02985658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102317611|NCT02985658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102317612|NCT02985658|Tubulin Modulators|tubulin modulators|mesh-ancestor
102317613|NCT02985658|Antimitotic Agents|antimitotic agents|mesh-ancestor
102317614|NCT02985658|Mitosis Modulators|mitosis modulators|mesh-ancestor
102317615|NCT02985658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317616|NCT02985658|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102317617|NCT02985658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102317619|NCT02177786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102317620|NCT02177786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102317621|NCT02177786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317622|NCT02153918|Metronidazole|metronidazole|mesh-list
102317623|NCT02153918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102317624|NCT02153918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102317625|NCT02153918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102317626|NCT02153918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102317627|NCT04752566|Eculizumab|eculizumab|mesh-list
102317628|NCT04752566|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102317629|NCT04752566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102317630|NCT04752566|Immunologic Factors|immunologic factors|mesh-ancestor
102317631|NCT04752566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317632|NCT01571362|Naltrexone|naltrexone|mesh-list
102317633|NCT01571362|Oxycodone|oxycodone|mesh-list
102317634|NCT01571362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102317635|NCT01571362|Narcotics|narcotics|mesh-ancestor
102317636|NCT01571362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102317637|NCT01571362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317638|NCT01571362|Analgesics|analgesics|mesh-ancestor
102317639|NCT01571362|Sensory System Agents|sensory system agents|mesh-ancestor
102317640|NCT01571362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102317641|NCT01571362|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102317642|NCT01571362|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102317643|NCT01571284|Aflibercept|aflibercept|mesh-list
102317644|NCT01571284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102317645|NCT01571284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102317646|NCT01571284|Growth Substances|growth substances|mesh-ancestor
102317647|NCT01571284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317648|NCT01571284|Growth Inhibitors|growth inhibitors|mesh-ancestor
102317649|NCT01571284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102317650|NCT02137772|Letermovir|letermovir|mesh-list
102317651|NCT02137772|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102317652|NCT02137772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102317653|NCT02137772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317654|NCT02137772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102317655|NCT02137772|Antiviral Agents|antiviral agents|mesh-ancestor
102317656|NCT02137772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102317657|NCT01555138|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102317658|NCT01555138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102317659|NCT01555138|Autonomic Agents|autonomic agents|mesh-ancestor
102317660|NCT01555138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102317661|NCT01555138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317662|NCT01555138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102317663|NCT01555138|Respiratory System Agents|respiratory system agents|mesh-ancestor
102317664|NCT01555138|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102317665|NCT01555138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102317666|NCT01555138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102317667|NCT01555138|Adrenergic Agents|adrenergic agents|mesh-ancestor
102317668|NCT01555138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102317669|NCT01555138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317670|NCT02137226|Adalimumab|adalimumab|mesh-list
102317671|NCT02137226|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102317672|NCT02137226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102317673|NCT02137226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102317674|NCT01530334|Gefitinib|gefitinib|mesh-list
102317675|NCT01530334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102317676|NCT01530334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102317677|NCT01530334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102026487|NCT03087786|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102317678|NCT01530334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317679|NCT01570192|Vancomycin|vancomycin|mesh-list
102317680|NCT01570192|Gentamicins|gentamicins|mesh-list
102317681|NCT01570192|Meropenem|meropenem|mesh-list
102317682|NCT01570192|Linezolid|linezolid|mesh-list
102317683|NCT01570192|Tobramycin|tobramycin|mesh-list
102317684|NCT01570192|Amikacin|amikacin|mesh-list
102317685|NCT01570192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102317686|NCT01570192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102317687|NCT01570192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102317688|NCT01570192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102317689|NCT01570192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317690|NCT02136914|Amantadine|amantadine|mesh-list
102317691|NCT02136914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102317692|NCT02136914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102317693|NCT02136914|Antiviral Agents|antiviral agents|mesh-ancestor
102317694|NCT02136914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102317695|NCT02136914|Dopamine Agents|dopamine agents|mesh-ancestor
102317696|NCT02136914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102317697|NCT02136914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317698|NCT02136914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317699|NCT02136914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102317700|NCT02136914|Analgesics|analgesics|mesh-ancestor
102317701|NCT02136914|Sensory System Agents|sensory system agents|mesh-ancestor
102317702|NCT02136914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102317703|NCT01529632|Glycopyrrolate|glycopyrrolate|mesh-list
102317704|NCT01529632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102317705|NCT01529632|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102317706|NCT01529632|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102317707|NCT01529632|Cholinergic Agents|cholinergic agents|mesh-ancestor
102317708|NCT01529632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102317709|NCT01529632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317710|NCT01529632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317711|NCT01554514|Rituximab|rituximab|mesh-list
102317712|NCT01554514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102317713|NCT01554514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102317714|NCT01554514|Immunologic Factors|immunologic factors|mesh-ancestor
102317715|NCT01554514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317716|NCT01554514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102317717|NCT01553188|Prednisone|prednisone|mesh-list
102317718|NCT01553188|Trebananib|trebananib|mesh-list
102317719|NCT01553188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102317720|NCT01553188|Glucocorticoids|glucocorticoids|mesh-ancestor
102317721|NCT01553188|Hormones|hormones|mesh-ancestor
102317722|NCT01553188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102317723|NCT01553188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317724|NCT01553188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102317725|NCT01553188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102317726|NCT01553188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102317727|NCT01553188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102317728|NCT01553188|Growth Substances|growth substances|mesh-ancestor
102317729|NCT01553188|Growth Inhibitors|growth inhibitors|mesh-ancestor
102317730|NCT02175758|Ribavirin|ribavirin|mesh-list
102317731|NCT02175758|Sofosbuvir|sofosbuvir|mesh-list
102317732|NCT02175758|Antimetabolites|antimetabolites|mesh-ancestor
102317733|NCT02175758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317734|NCT02175758|Antiviral Agents|antiviral agents|mesh-ancestor
102317735|NCT02175758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102317736|NCT01599104|Olmesartan|olmesartan|mesh-list
102317737|NCT01599104|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102317738|NCT01599104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102317739|NCT01599104|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102317740|NCT01599104|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102317741|NCT01599104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317742|NCT01552954|Angiotensin II|angiotensin ii|mesh-list
102317743|NCT01552954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102317744|NCT01518244|Timolol|timolol|mesh-list
102317745|NCT01518244|Brinzolamide|brinzolamide|mesh-list
102317746|NCT01518244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102317747|NCT01518244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317748|NCT01518244|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102317749|NCT01518244|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102317750|NCT01518244|Adrenergic Agents|adrenergic agents|mesh-ancestor
102317751|NCT01518244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102317752|NCT01518244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317753|NCT01518244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102317754|NCT01518244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102317755|NCT01518244|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102317757|NCT01552408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102317758|NCT01552408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102317759|NCT01552408|Growth Substances|growth substances|mesh-ancestor
102317760|NCT01552408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317762|NCT01552408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102317763|NCT04099888|Gemcitabine|gemcitabine|mesh-list
102317764|NCT04099888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102317765|NCT04099888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102317766|NCT04099888|Antimetabolites|antimetabolites|mesh-ancestor
102317767|NCT04099888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317768|NCT02174276|Tenofovir|tenofovir|mesh-list
102317769|NCT02174276|Antiviral Agents|antiviral agents|mesh-ancestor
102317770|NCT02174276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102317771|NCT02174276|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102317772|NCT02174276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102317773|NCT02174276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102317774|NCT02174276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317775|NCT02174276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102317776|NCT02174276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102317777|NCT01527682|Dorzolamide|dorzolamide|mesh-list
102317778|NCT01527682|Latanoprost|latanoprost|mesh-list
102317779|NCT01527682|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102317780|NCT01527682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102317781|NCT01527682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102317782|NCT01527682|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102317783|NCT01527682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102317784|NCT01527682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317785|NCT01516216|Vitamin D|vitamin d|mesh-list
102317786|NCT01516216|Leucovorin|leucovorin|mesh-list
102317787|NCT01516216|Bevacizumab|bevacizumab|mesh-list
102317788|NCT01516216|Fluorouracil|fluorouracil|mesh-list
102317789|NCT01516216|Oxaliplatin|oxaliplatin|mesh-list
102317790|NCT01516216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102317791|NCT01516216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102317792|NCT01516216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102317793|NCT01516216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102317794|NCT01516216|Growth Substances|growth substances|mesh-ancestor
102317795|NCT01516216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317796|NCT01516216|Growth Inhibitors|growth inhibitors|mesh-ancestor
102317797|NCT01516216|Vitamins|vitamins|mesh-ancestor
102317798|NCT01516216|Micronutrients|micronutrients|mesh-ancestor
102317799|NCT01516216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102317800|NCT01516216|Antimetabolites|antimetabolites|mesh-ancestor
102317801|NCT01516216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317802|NCT01516216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102317803|NCT01516216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102317804|NCT01516216|Immunologic Factors|immunologic factors|mesh-ancestor
102317805|NCT01516216|Antidotes|antidotes|mesh-ancestor
102317806|NCT01516216|Protective Agents|protective agents|mesh-ancestor
102317807|NCT01516216|Vitamin B Complex|vitamin b complex|mesh-ancestor
102317808|NCT01950819|Cyclosporine|cyclosporine|mesh-list
102317809|NCT01950819|Prednisone|prednisone|mesh-list
102317810|NCT01950819|Methylprednisolone|methylprednisolone|mesh-list
102317811|NCT01950819|Tacrolimus|tacrolimus|mesh-list
102317812|NCT01950819|Thymoglobulin|thymoglobulin|mesh-list
102317813|NCT01950819|Cyclosporins|cyclosporins|mesh-list
102317814|NCT01950819|Basiliximab|basiliximab|mesh-list
102317815|NCT01950819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102317816|NCT01950819|Glucocorticoids|glucocorticoids|mesh-ancestor
102317817|NCT01950819|Hormones|hormones|mesh-ancestor
102317818|NCT01950819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102317819|NCT01950819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317820|NCT01950819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102317821|NCT01950819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102317822|NCT01950819|Antiemetics|antiemetics|mesh-ancestor
102317823|NCT01950819|Autonomic Agents|autonomic agents|mesh-ancestor
102317824|NCT01950819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102317825|NCT01950819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102317826|NCT01950819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102317827|NCT01950819|Protective Agents|protective agents|mesh-ancestor
102317828|NCT01950819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102317829|NCT01950819|Immunologic Factors|immunologic factors|mesh-ancestor
102317830|NCT01950819|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102317831|NCT01950819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102317832|NCT01950819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317833|NCT01950819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102317834|NCT01950819|Antifungal Agents|antifungal agents|mesh-ancestor
102317835|NCT01950819|Dermatologic Agents|dermatologic agents|mesh-ancestor
102317836|NCT01950819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102317837|NCT01514422|Minocycline|minocycline|mesh-list
102317839|NCT01514422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102317840|NCT01524796|Pregabalin|pregabalin|mesh-list
102317841|NCT01524796|Analgesics|analgesics|mesh-ancestor
102317842|NCT01524796|Sensory System Agents|sensory system agents|mesh-ancestor
102317843|NCT01524796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102317844|NCT01524796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317845|NCT01524796|Anticonvulsants|anticonvulsants|mesh-ancestor
102317846|NCT01524796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102317847|NCT01524796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102317848|NCT01524796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317849|NCT01524796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102317850|NCT01524796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102317851|NCT01524796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102317852|NCT01524796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102317853|NCT01524796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102317854|NCT01547728|Antithrombins|antithrombins|mesh-list
102317855|NCT01547728|Antithrombin III|antithrombin iii|mesh-list
102317856|NCT01547728|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102317857|NCT01547728|Protease Inhibitors|protease inhibitors|mesh-ancestor
102317858|NCT01547728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102317859|NCT01547728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317860|NCT01547728|Anticoagulants|anticoagulants|mesh-ancestor
102317861|NCT01523392|Clopidogrel|clopidogrel|mesh-list
102317862|NCT01523392|Ticagrelor|ticagrelor|mesh-list
102317863|NCT01523392|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102317864|NCT01523392|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102317865|NCT01523392|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102317866|NCT01523392|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102317867|NCT01523392|Purinergic Agents|purinergic agents|mesh-ancestor
102317868|NCT01523392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102317869|NCT01523392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317870|NCT01523392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317871|NCT01512160|Ibuprofen|ibuprofen|mesh-list
102317872|NCT01512160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102317873|NCT01512160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102317874|NCT01512160|Analgesics|analgesics|mesh-ancestor
102317875|NCT01512160|Sensory System Agents|sensory system agents|mesh-ancestor
102317876|NCT01512160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102317877|NCT01512160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317878|NCT01512160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102317879|NCT01512160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102317880|NCT01512160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102317881|NCT01512160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102317882|NCT01512160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317883|NCT01950741|Aflibercept|aflibercept|mesh-list
102317884|NCT01950741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102317885|NCT01950741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102317886|NCT01950741|Growth Substances|growth substances|mesh-ancestor
101434507|NCT00546559|Antimetabolites|antimetabolites|mesh-ancestor
102317887|NCT01950741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317888|NCT01950741|Growth Inhibitors|growth inhibitors|mesh-ancestor
102317889|NCT01950741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102317890|NCT01950273|Rituximab|rituximab|mesh-list
102317891|NCT01950273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102317892|NCT01950273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102317893|NCT01950273|Immunologic Factors|immunologic factors|mesh-ancestor
102317894|NCT01950273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317895|NCT01950273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102317896|NCT01919229|Letrozole|letrozole|mesh-list
102317897|NCT01919229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102317898|NCT01919229|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102317899|NCT01919229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102317900|NCT01919229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102317901|NCT01919229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317902|NCT01919229|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102317903|NCT01919229|Hormone Antagonists|hormone antagonists|mesh-ancestor
102026713|NCT03164668|Antipruritics|antipruritics|mesh-ancestor
102317904|NCT01919229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102317905|NCT01919229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317906|NCT01511536|Prednisone|prednisone|mesh-list
102317907|NCT01511536|Abiraterone Acetate|abiraterone acetate|mesh-list
102317908|NCT01511536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102317909|NCT01511536|Glucocorticoids|glucocorticoids|mesh-ancestor
102317910|NCT01511536|Hormones|hormones|mesh-ancestor
102317911|NCT01511536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102317912|NCT01511536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317913|NCT01511536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102317914|NCT01511536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102317915|NCT01511536|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102317916|NCT01511536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102317917|NCT01511536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317918|NCT01511536|Hormone Antagonists|hormone antagonists|mesh-ancestor
102317919|NCT01511536|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102317920|NCT01510912|Diclofenac|diclofenac|mesh-list
102317921|NCT01510912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102317922|NCT01510912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102317923|NCT01510912|Analgesics|analgesics|mesh-ancestor
102317924|NCT01510912|Sensory System Agents|sensory system agents|mesh-ancestor
102317925|NCT01510912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102317926|NCT01510912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317927|NCT01510912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102317928|NCT01510912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102317929|NCT01510912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102317930|NCT01510912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102317931|NCT01510912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317932|NCT01510756|Sorafenib|sorafenib|mesh-list
102317933|NCT01510756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102317934|NCT01510756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102317935|NCT01510756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102317936|NCT01510756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317937|NCT01522456|Tretinoin|tretinoin|mesh-list
102317938|NCT01522456|Dermatologic Agents|dermatologic agents|mesh-ancestor
102317939|NCT01522456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102317940|NCT01522456|Keratolytic Agents|keratolytic agents|mesh-ancestor
102317941|NCT01521364|Clarithromycin|clarithromycin|mesh-list
102317942|NCT01521364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102317943|NCT01521364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102317944|NCT01521364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102317945|NCT01521364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102317946|NCT01521364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317947|NCT01521364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102317948|NCT01521364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102317949|NCT01545388|Metformin|metformin|mesh-list
102317950|NCT01545388|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102317951|NCT01545388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101434565|NCT00547417|Tadalafil|tadalafil|mesh-list
102317952|NCT01545388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317953|NCT01545388|Incretins|incretins|mesh-ancestor
102317954|NCT01545388|Hormones|hormones|mesh-ancestor
102317955|NCT01545388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102317956|NCT01545388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102317957|NCT01545388|Protease Inhibitors|protease inhibitors|mesh-ancestor
102317958|NCT01545388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102317959|NCT01545388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317960|NCT01545076|Immunoglobulin G|immunoglobulin g|mesh-list
102317961|NCT01545076|Immunologic Factors|immunologic factors|mesh-ancestor
102317962|NCT01545076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317963|NCT01544920|Interferons|interferons|mesh-list
102317964|NCT01544920|Ribavirin|ribavirin|mesh-list
102317965|NCT01544920|Interferon-alpha|interferon-alpha|mesh-list
102317966|NCT01544920|Interferon alpha-2|interferon alpha-2|mesh-list
102317967|NCT01544920|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102317968|NCT01544920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102317969|NCT01544920|Antiviral Agents|antiviral agents|mesh-ancestor
102317970|NCT01544920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102317971|NCT01544920|Antimetabolites|antimetabolites|mesh-ancestor
102317972|NCT01544920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102317973|NCT01544920|Immunologic Factors|immunologic factors|mesh-ancestor
102317974|NCT01544920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317975|NCT01519960|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102317976|NCT01519960|Interferon-alpha|interferon-alpha|mesh-list
102317977|NCT01519960|Antiviral Agents|antiviral agents|mesh-ancestor
102317978|NCT01519960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102317979|NCT01519960|Immunologic Factors|immunologic factors|mesh-ancestor
102317980|NCT01519960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317981|NCT01543204|Etanercept|etanercept|mesh-list
102317982|NCT01543204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102317983|NCT01543204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102317984|NCT01543204|Analgesics|analgesics|mesh-ancestor
102317985|NCT01543204|Sensory System Agents|sensory system agents|mesh-ancestor
102317986|NCT01543204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102317987|NCT01543204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317988|NCT01543204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102317989|NCT01543204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102317990|NCT01543204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102317991|NCT01543204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102317992|NCT01543204|Immunologic Factors|immunologic factors|mesh-ancestor
102317993|NCT01518946|Midodrine|midodrine|mesh-list
102317994|NCT01518946|Sympathomimetics|sympathomimetics|mesh-ancestor
102317995|NCT01518946|Autonomic Agents|autonomic agents|mesh-ancestor
102317996|NCT01518946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102317997|NCT01518946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102317998|NCT01518946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102317999|NCT01518946|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102318000|NCT01518946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102318001|NCT01518946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102318002|NCT01518946|Adrenergic Agents|adrenergic agents|mesh-ancestor
102318003|NCT01518946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102318004|NCT01518946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318005|NCT01507246|Morphine|morphine|mesh-list
102318006|NCT01507246|Bupivacaine|bupivacaine|mesh-list
102318007|NCT01507246|Anesthetics, Local|anesthetics, local|mesh-ancestor
102318008|NCT01507246|Anesthetics|anesthetics|mesh-ancestor
102318009|NCT01507246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102318010|NCT01507246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318011|NCT01507246|Sensory System Agents|sensory system agents|mesh-ancestor
102318012|NCT01507246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102318013|NCT01507246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102318014|NCT01507246|Narcotics|narcotics|mesh-ancestor
102318015|NCT01507246|Analgesics|analgesics|mesh-ancestor
102318016|NCT03870022|Carbon Monoxide|carbon monoxide|mesh-list
102318017|NCT03870022|Antimetabolites|antimetabolites|mesh-ancestor
102318018|NCT03870022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318019|NCT03870022|Gasotransmitters|gasotransmitters|mesh-ancestor
101434637|NCT04983238|Trastuzumab|trastuzumab|mesh-list
102318020|NCT03870022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102318021|NCT03870022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318022|NCT02073448|Adapalene|adapalene|mesh-list
102318023|NCT02073448|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102318024|NCT02073448|Dermatologic Agents|dermatologic agents|mesh-ancestor
102318025|NCT02073448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102318026|NCT02073448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102318027|NCT02073448|Analgesics|analgesics|mesh-ancestor
102318028|NCT02073448|Sensory System Agents|sensory system agents|mesh-ancestor
102318029|NCT02073448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102318030|NCT02073448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318031|NCT02073448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102318032|NCT02073448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102318033|NCT01487200|Triamcinolone|triamcinolone|mesh-list
102318034|NCT01487200|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102318035|NCT01487200|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102318036|NCT01487200|FX006|fx006|mesh-list
102318037|NCT01487200|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102318038|NCT01487200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102318039|NCT01487200|Glucocorticoids|glucocorticoids|mesh-ancestor
102318040|NCT01487200|Hormones|hormones|mesh-ancestor
102318041|NCT01487200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102318042|NCT01487200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318043|NCT01487200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102318044|NCT01487200|Immunologic Factors|immunologic factors|mesh-ancestor
102318045|NCT01487200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102318046|NCT01487200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318047|NCT01505608|Irinotecan|irinotecan|mesh-list
102318048|NCT01505608|Temozolomide|temozolomide|mesh-list
102318049|NCT01505608|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102318050|NCT01505608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102318051|NCT01505608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102318052|NCT01505608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318053|NCT01505608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102318054|NCT01505608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102318055|NCT01505608|Alkylating Agents|alkylating agents|mesh-ancestor
102318056|NCT01486966|Insulin|insulin|mesh-list
102318057|NCT01486966|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102318058|NCT01486966|Metformin|metformin|mesh-list
102318059|NCT01486966|Insulin Aspart|insulin aspart|mesh-list
102318060|NCT01486966|Insulin Detemir|insulin detemir|mesh-list
102318062|NCT01486966|Insulin, Isophane|insulin, isophane|mesh-list
102318063|NCT01486966|Isophane insulin, beef|isophane insulin, beef|mesh-list
102318064|NCT01486966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102318065|NCT01486966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318066|NCT04080076|Tacrolimus|tacrolimus|mesh-list
102318067|NCT04080076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102318068|NCT04080076|Immunologic Factors|immunologic factors|mesh-ancestor
102318069|NCT04080076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318070|NCT04080076|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102318071|NCT04080076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102318072|NCT04080076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318073|NCT01900431|Leucovorin|leucovorin|mesh-list
102318074|NCT01900431|Folic Acid|folic acid|mesh-list
102318075|NCT01900431|Prednisone|prednisone|mesh-list
102318076|NCT01900431|Methotrexate|methotrexate|mesh-list
102318077|NCT01900431|Levoleucovorin|levoleucovorin|mesh-list
102318078|NCT01900431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102318079|NCT01900431|Glucocorticoids|glucocorticoids|mesh-ancestor
102318080|NCT01900431|Hormones|hormones|mesh-ancestor
102318081|NCT01900431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102318082|NCT01900431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318083|NCT01900431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102318084|NCT01900431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102318085|NCT01900431|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102318086|NCT01900431|Abortifacient Agents|abortifacient agents|mesh-ancestor
102318087|NCT01900431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102318088|NCT01900431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102318089|NCT01900431|Antimetabolites|antimetabolites|mesh-ancestor
102318090|NCT01900431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434738|NCT00548509|Vitamin K|vitamin k|mesh-list
102318091|NCT01900431|Dermatologic Agents|dermatologic agents|mesh-ancestor
102318092|NCT01900431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102318093|NCT01900431|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102318094|NCT01900431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102318095|NCT01900431|Immunologic Factors|immunologic factors|mesh-ancestor
102318096|NCT01900431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102318097|NCT01900431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102318098|NCT01900431|Antidotes|antidotes|mesh-ancestor
102318099|NCT01900431|Protective Agents|protective agents|mesh-ancestor
102318100|NCT01900431|Vitamin B Complex|vitamin b complex|mesh-ancestor
102318101|NCT01900431|Vitamins|vitamins|mesh-ancestor
102318102|NCT01900431|Micronutrients|micronutrients|mesh-ancestor
102318103|NCT01900431|Hematinics|hematinics|mesh-ancestor
102318104|NCT01948791|Rivastigmine|rivastigmine|mesh-list
102318105|NCT01948791|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102318106|NCT01948791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102318107|NCT01948791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318108|NCT01948791|Cholinergic Agents|cholinergic agents|mesh-ancestor
102318109|NCT01948791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102318110|NCT01948791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318111|NCT01948791|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102318112|NCT01948791|Protective Agents|protective agents|mesh-ancestor
102318113|NCT01898091|Ascorbic Acid|ascorbic acid|mesh-list
102318114|NCT01898091|Glycerol|glycerol|mesh-list
102318115|NCT01898091|Antioxidants|antioxidants|mesh-ancestor
102318116|NCT01898091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318117|NCT01898091|Protective Agents|protective agents|mesh-ancestor
102318118|NCT01898091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318119|NCT01898091|Vitamins|vitamins|mesh-ancestor
102318120|NCT01898091|Micronutrients|micronutrients|mesh-ancestor
102318121|NCT01898091|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102318122|NCT01947855|Empagliflozin|empagliflozin|mesh-list
102318123|NCT01947855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102318124|NCT01947855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318125|NCT01947855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102318126|NCT01947855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318127|NCT01888497|Diphenhydramine|diphenhydramine|mesh-list
102318128|NCT01888497|Promethazine|promethazine|mesh-list
102318129|NCT01888497|Triazolam|triazolam|mesh-list
102318130|NCT01888497|Gabapentin|gabapentin|mesh-list
102318131|NCT01888497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318132|NCT01888497|Analgesics|analgesics|mesh-ancestor
102318133|NCT01888497|Sensory System Agents|sensory system agents|mesh-ancestor
102318134|NCT01888497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102318135|NCT01888497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318136|NCT01888497|Anticonvulsants|anticonvulsants|mesh-ancestor
102318137|NCT01888497|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102318138|NCT01888497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102318139|NCT01888497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102318140|NCT01888497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102318141|NCT01888497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102318142|NCT01888497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102318143|NCT01888497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102318144|NCT01888497|Antimanic Agents|antimanic agents|mesh-ancestor
102318145|NCT01888497|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102318146|NCT01888497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102318147|NCT01888497|Anesthetics, Local|anesthetics, local|mesh-ancestor
102318148|NCT01888497|Anesthetics|anesthetics|mesh-ancestor
102318149|NCT01888497|Antiemetics|antiemetics|mesh-ancestor
102318150|NCT01888497|Autonomic Agents|autonomic agents|mesh-ancestor
102318151|NCT01888497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102318152|NCT01888497|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102318153|NCT01888497|Histamine Antagonists|histamine antagonists|mesh-ancestor
102318154|NCT01888497|Histamine Agents|histamine agents|mesh-ancestor
102318155|NCT01888497|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102318156|NCT01888497|Antipruritics|antipruritics|mesh-ancestor
102318157|NCT01888497|Dermatologic Agents|dermatologic agents|mesh-ancestor
102318158|NCT01888497|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102318159|NCT01888497|GABA Modulators|gaba modulators|mesh-ancestor
102318160|NCT01888497|GABA Agents|gaba agents|mesh-ancestor
102318161|NCT01485796|Immunoglobulins|immunoglobulins|mesh-list
102318162|NCT01485796|Antibodies|antibodies|mesh-list
102318163|NCT01485796|gamma-Globulins|gamma-globulins|mesh-list
102318164|NCT01485796|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102318165|NCT01485796|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102318166|NCT01485796|Immunologic Factors|immunologic factors|mesh-ancestor
102318167|NCT01485796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318168|NCT01897233|Ivacaftor|ivacaftor|mesh-list
102318169|NCT01897233|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102318170|NCT01897233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102318171|NCT01897233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318172|NCT01887717|Sorafenib|sorafenib|mesh-list
102318173|NCT01887717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102318174|NCT01887717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102318175|NCT01887717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102318176|NCT01887717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318177|NCT01463098|Zolpidem|zolpidem|mesh-list
102318178|NCT01463098|Lemborexant|lemborexant|mesh-list
102318179|NCT01463098|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102318180|NCT01463098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102318181|NCT01463098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102318182|NCT01463098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318183|NCT01463098|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102318184|NCT01463098|GABA Agonists|gaba agonists|mesh-ancestor
102318185|NCT01463098|GABA Agents|gaba agents|mesh-ancestor
102318186|NCT01463098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102318187|NCT01463098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318188|NCT01463098|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102318189|NCT01462942|Bromides|bromides|mesh-list
102318190|NCT01462942|Formoterol Fumarate|formoterol fumarate|mesh-list
102318191|NCT01462942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102318192|NCT01462942|Autonomic Agents|autonomic agents|mesh-ancestor
102318193|NCT01462942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102318194|NCT01462942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318195|NCT01462942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102318196|NCT01462942|Respiratory System Agents|respiratory system agents|mesh-ancestor
102318197|NCT01462942|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102318198|NCT01462942|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102318199|NCT01462942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102318200|NCT01462942|Adrenergic Agents|adrenergic agents|mesh-ancestor
102318201|NCT01462942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102318202|NCT01462942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318203|NCT01462942|Anticonvulsants|anticonvulsants|mesh-ancestor
102318204|NCT01462630|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102318205|NCT01462630|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102318206|NCT01462630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027014|NCT03020966|Acetaminophen|acetaminophen|mesh-list
102318208|NCT01504204|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
102318209|NCT01504204|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102318210|NCT01504204|Dermatologic Agents|dermatologic agents|mesh-ancestor
102318211|NCT01504204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102318212|NCT01504204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102318213|NCT01504204|Analgesics|analgesics|mesh-ancestor
102318214|NCT01504204|Sensory System Agents|sensory system agents|mesh-ancestor
102318215|NCT01504204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102318216|NCT01504204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318217|NCT01504204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102318218|NCT01504204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102318219|NCT01485640|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102318220|NCT01485640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102318221|NCT01485640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102318222|NCT01485640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102318223|NCT01485640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318224|NCT01485640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102318225|NCT01485640|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102318226|NCT01485640|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102318227|NCT01485640|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102318228|NCT01485640|Adrenergic Agents|adrenergic agents|mesh-ancestor
102318229|NCT01485640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102318230|NCT01485640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318231|NCT01485640|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102318232|NCT01485640|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102318233|NCT01485640|Serotonin Agents|serotonin agents|mesh-ancestor
102318234|NCT01485640|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102318235|NCT01485640|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102318236|NCT01485640|Dopamine Agents|dopamine agents|mesh-ancestor
102318237|NCT02118961|Vaccines|vaccines|mesh-list
102318238|NCT02118961|Immunologic Factors|immunologic factors|mesh-ancestor
102318239|NCT02118961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318240|NCT02140645|Linagliptin|linagliptin|mesh-list
102318241|NCT02140645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102318242|NCT02140645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318243|NCT02140645|Incretins|incretins|mesh-ancestor
102318244|NCT02140645|Hormones|hormones|mesh-ancestor
102318245|NCT02140645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102318246|NCT02140645|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102318247|NCT02140645|Protease Inhibitors|protease inhibitors|mesh-ancestor
102318248|NCT02140645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102318249|NCT02140645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318250|NCT02140411|Ranibizumab|ranibizumab|mesh-list
102318251|NCT02140411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102318252|NCT02140411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102318253|NCT02140411|Growth Substances|growth substances|mesh-ancestor
102318254|NCT02140411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318255|NCT02140411|Growth Inhibitors|growth inhibitors|mesh-ancestor
102318256|NCT02140411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102318257|NCT02139943|Canagliflozin|canagliflozin|mesh-list
102318258|NCT02139943|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102318259|NCT02139943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318260|NCT02139943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102318261|NCT02139943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318262|NCT01485172|Ropinirole|ropinirole|mesh-list
102318263|NCT01485172|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102318264|NCT01485172|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102318265|NCT01485172|Dopamine Agonists|dopamine agonists|mesh-ancestor
102318266|NCT01485172|Dopamine Agents|dopamine agents|mesh-ancestor
102318267|NCT01485172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102318268|NCT01485172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318269|NCT01485172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318270|NCT02105701|Ribavirin|ribavirin|mesh-list
102318271|NCT02105701|Grazoprevir|grazoprevir|mesh-list
102318272|NCT02105701|Antimetabolites|antimetabolites|mesh-ancestor
102318273|NCT02105701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318274|NCT02105701|Antiviral Agents|antiviral agents|mesh-ancestor
102318275|NCT02105701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102318276|NCT04411225|Cannabidiol|cannabidiol|mesh-list
102318277|NCT04411225|Anticonvulsants|anticonvulsants|mesh-ancestor
102318278|NCT01502956|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102318279|NCT01502956|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102027094|NCT04923139|Rivaroxaban|rivaroxaban|mesh-list
102318280|NCT01502956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102318281|NCT01502956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318282|NCT01502956|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102318283|NCT01502956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102318284|NCT01502956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318285|NCT01502956|Cholinergic Agents|cholinergic agents|mesh-ancestor
102318288|NCT01502644|Oxycodone|oxycodone|mesh-list
102318289|NCT01502644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102318290|NCT01502644|Narcotics|narcotics|mesh-ancestor
102318291|NCT01502644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102318292|NCT01502644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318293|NCT01502644|Analgesics|analgesics|mesh-ancestor
102318294|NCT01502644|Sensory System Agents|sensory system agents|mesh-ancestor
102318295|NCT01502644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102318296|NCT01462318|Vitamin K|vitamin k|mesh-list
102318297|NCT01462318|Midazolam|midazolam|mesh-list
102318298|NCT01462318|Dextromethorphan|dextromethorphan|mesh-list
102318299|NCT01462318|Caffeine|caffeine|mesh-list
102318300|NCT01462318|Omeprazole|omeprazole|mesh-list
102318301|NCT01462318|Warfarin|warfarin|mesh-list
102318302|NCT01462318|Daclizumab|daclizumab|mesh-list
102318303|NCT01462318|Vitamins|vitamins|mesh-ancestor
102318304|NCT01462318|Micronutrients|micronutrients|mesh-ancestor
102318305|NCT01462318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318306|NCT01462318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102318307|NCT01462318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102318308|NCT01462318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102318309|NCT01462318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102318310|NCT01462318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102318311|NCT01462318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102318312|NCT01462318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102318313|NCT01462318|Anesthetics, General|anesthetics, general|mesh-ancestor
102318314|NCT01462318|Anesthetics|anesthetics|mesh-ancestor
102318315|NCT01462318|GABA Modulators|gaba modulators|mesh-ancestor
102318316|NCT01462318|GABA Agents|gaba agents|mesh-ancestor
102318317|NCT01462318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102318318|NCT01462318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318319|NCT01462318|Anticoagulants|anticoagulants|mesh-ancestor
102318320|NCT01462318|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102318321|NCT01462318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102318322|NCT01462318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102318323|NCT01462318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102318324|NCT01462318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102318325|NCT01462318|Purinergic Agents|purinergic agents|mesh-ancestor
102318326|NCT01462318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102318327|NCT01462318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102318328|NCT01462318|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102318329|NCT01462318|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102318330|NCT01462318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102318331|NCT01462318|Hemostatics|hemostatics|mesh-ancestor
102318332|NCT01462318|Coagulants|coagulants|mesh-ancestor
102318333|NCT01462318|Antitussive Agents|antitussive agents|mesh-ancestor
102318334|NCT01462318|Respiratory System Agents|respiratory system agents|mesh-ancestor
102318335|NCT01462318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102318336|NCT01462318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102318337|NCT01462318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102318338|NCT01462318|Immunologic Factors|immunologic factors|mesh-ancestor
102318339|NCT01485094|Pregabalin|pregabalin|mesh-list
102318340|NCT01485094|Analgesics|analgesics|mesh-ancestor
102318341|NCT01485094|Sensory System Agents|sensory system agents|mesh-ancestor
102318342|NCT01485094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102318343|NCT01485094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318344|NCT01485094|Anticonvulsants|anticonvulsants|mesh-ancestor
102318345|NCT01485094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102318346|NCT01485094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102318347|NCT01485094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318348|NCT01485094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102318349|NCT01485094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102318350|NCT01485094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102318351|NCT01485094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102318352|NCT01485094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102318353|NCT04079686|Cefazolin|cefazolin|mesh-list
102318354|NCT04079686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102318355|NCT04079686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102318356|NCT01502410|Sorafenib|sorafenib|mesh-list
102318357|NCT01502410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102318358|NCT01502410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102318359|NCT01502410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102318360|NCT01502410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318361|NCT04757636|Aflibercept|aflibercept|mesh-list
102318362|NCT04757636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102318363|NCT04757636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102318364|NCT04757636|Growth Substances|growth substances|mesh-ancestor
102318365|NCT04757636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318366|NCT04757636|Growth Inhibitors|growth inhibitors|mesh-ancestor
102318367|NCT04757636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102318368|NCT02132312|Phenylephrine|phenylephrine|mesh-list
102318369|NCT02132312|Oxymetazoline|oxymetazoline|mesh-list
102318370|NCT02132312|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102318371|NCT02132312|Mydriatics|mydriatics|mesh-ancestor
102318372|NCT02132312|Autonomic Agents|autonomic agents|mesh-ancestor
102318373|NCT02132312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102318374|NCT02132312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318375|NCT02132312|Sympathomimetics|sympathomimetics|mesh-ancestor
102318376|NCT02132312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102318377|NCT02132312|Nasal Decongestants|nasal decongestants|mesh-ancestor
102318378|NCT02132312|Respiratory System Agents|respiratory system agents|mesh-ancestor
102318379|NCT02132312|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102318380|NCT02132312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102318381|NCT02132312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102318382|NCT02132312|Adrenergic Agents|adrenergic agents|mesh-ancestor
102318383|NCT02132312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102318384|NCT02132312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318385|NCT02132312|Protective Agents|protective agents|mesh-ancestor
102318386|NCT02150954|Oxytocin|oxytocin|mesh-list
102318387|NCT02150954|Oxytocics|oxytocics|mesh-ancestor
102318388|NCT02150954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102318389|NCT02150954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318390|NCT04188392|Pimavanserin|pimavanserin|mesh-list
102318391|NCT04188392|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102318392|NCT04188392|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102318393|NCT04188392|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102318394|NCT04188392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102318395|NCT04188392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102318396|NCT04188392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318397|NCT04188392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102318398|NCT04188392|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102318399|NCT04188392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102318400|NCT04188392|Serotonin Agents|serotonin agents|mesh-ancestor
102318401|NCT04188392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102318402|NCT04188392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318403|NCT02170298|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102318404|NCT02170298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102318405|NCT02170298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318406|NCT02170298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102318407|NCT02170298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102318408|NCT02170298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102318409|NCT02170298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318410|NCT02170298|Dopamine Agents|dopamine agents|mesh-ancestor
102318411|NCT02170298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102318412|NCT02131064|Carboplatin|carboplatin|mesh-list
102318413|NCT02131064|Docetaxel|docetaxel|mesh-list
102318414|NCT02131064|Trastuzumab|trastuzumab|mesh-list
102318415|NCT02131064|Pertuzumab|pertuzumab|mesh-list
102318416|NCT02131064|Maytansine|maytansine|mesh-list
102318417|NCT02131064|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102318418|NCT02131064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102318419|NCT02131064|Tubulin Modulators|tubulin modulators|mesh-ancestor
102318420|NCT02131064|Antimitotic Agents|antimitotic agents|mesh-ancestor
102318421|NCT02131064|Mitosis Modulators|mitosis modulators|mesh-ancestor
102318422|NCT02131064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318423|NCT02131064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102318424|NCT02131064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102318425|NCT02131064|Immunotoxins|immunotoxins|mesh-ancestor
102318426|NCT02131064|Immunoconjugates|immunoconjugates|mesh-ancestor
102318427|NCT02131064|Immunologic Factors|immunologic factors|mesh-ancestor
102318428|NCT02131064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318429|NCT02130284|Insulin|insulin|mesh-list
102318430|NCT02130284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102027242|NCT03666884|Dermatologic Agents|dermatologic agents|mesh-ancestor
102318431|NCT02130284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102318432|NCT02130284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318433|NCT04749212|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
102318434|NCT04749212|Natriuretic Agents|natriuretic agents|mesh-ancestor
102318435|NCT04749212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318436|NCT04748822|Ethanol|ethanol|mesh-list
102318437|NCT04748822|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102318438|NCT04748822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102318439|NCT04748822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102318440|NCT04748822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318441|NCT04739150|Nintedanib|nintedanib|mesh-list
102318442|NCT04739150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102318443|NCT04739150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102318444|NCT04739150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102318445|NCT04739150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318446|NCT02147132|Nicotine|nicotine|mesh-list
102318447|NCT02147132|Varenicline|varenicline|mesh-list
102318448|NCT02147132|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102318449|NCT02147132|Autonomic Agents|autonomic agents|mesh-ancestor
102318450|NCT02147132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102318451|NCT02147132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318452|NCT02147132|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102318453|NCT02147132|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102318454|NCT02147132|Cholinergic Agents|cholinergic agents|mesh-ancestor
102318455|NCT02147132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102318456|NCT02147132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318457|NCT02146430|Pregabalin|pregabalin|mesh-list
102318458|NCT02146430|Analgesics|analgesics|mesh-ancestor
102318459|NCT02146430|Sensory System Agents|sensory system agents|mesh-ancestor
102318460|NCT02146430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102318461|NCT02146430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318462|NCT02146430|Anticonvulsants|anticonvulsants|mesh-ancestor
102318463|NCT02146430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102318464|NCT02146430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102318465|NCT02146430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318466|NCT02146430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102318467|NCT02146430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102318468|NCT02146430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102318469|NCT02146430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102318470|NCT02146430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102318471|NCT02129192|Amlodipine|amlodipine|mesh-list
102318472|NCT02129192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102318473|NCT02129192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102318474|NCT02129192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102318475|NCT02129192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318476|NCT02129192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102318477|NCT02129192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318478|NCT02129192|Vasodilator Agents|vasodilator agents|mesh-ancestor
102318479|NCT02128490|Naproxen|naproxen|mesh-list
102318480|NCT02128490|Colchicine|colchicine|mesh-list
102318481|NCT02128490|Febuxostat|febuxostat|mesh-list
102318482|NCT02128490|Lansoprazole|lansoprazole|mesh-list
102318483|NCT02128490|Dexlansoprazole|dexlansoprazole|mesh-list
102318484|NCT02128490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102318485|NCT02128490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102318486|NCT02128490|Analgesics|analgesics|mesh-ancestor
102318487|NCT02128490|Sensory System Agents|sensory system agents|mesh-ancestor
102318488|NCT02128490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102318489|NCT02128490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318490|NCT02128490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102318491|NCT02128490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102318492|NCT02128490|Gout Suppressants|gout suppressants|mesh-ancestor
102318493|NCT02128490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102318494|NCT02128490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102318495|NCT02128490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318496|NCT02128490|Tubulin Modulators|tubulin modulators|mesh-ancestor
102318497|NCT02128490|Antimitotic Agents|antimitotic agents|mesh-ancestor
102318498|NCT02128490|Mitosis Modulators|mitosis modulators|mesh-ancestor
102318499|NCT02128490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102318500|NCT02128490|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102318501|NCT02128490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102318502|NCT02128490|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102318503|NCT02105636|Docetaxel|docetaxel|mesh-list
102318504|NCT02105636|Nivolumab|nivolumab|mesh-list
102318505|NCT02105636|Methotrexate|methotrexate|mesh-list
102318506|NCT02105636|Cetuximab|cetuximab|mesh-list
102318507|NCT02105636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102318508|NCT02105636|Tubulin Modulators|tubulin modulators|mesh-ancestor
102318509|NCT02105636|Antimitotic Agents|antimitotic agents|mesh-ancestor
102318510|NCT02105636|Mitosis Modulators|mitosis modulators|mesh-ancestor
102318511|NCT02105636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318512|NCT02105636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102318513|NCT02105636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102318514|NCT02105636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102318515|NCT02105636|Abortifacient Agents|abortifacient agents|mesh-ancestor
102318516|NCT02105636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102318517|NCT02105636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318518|NCT02105636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102318519|NCT02105636|Antimetabolites|antimetabolites|mesh-ancestor
102318520|NCT02105636|Dermatologic Agents|dermatologic agents|mesh-ancestor
102318521|NCT02105636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102318522|NCT02105636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102318523|NCT02105636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102318524|NCT02105636|Immunologic Factors|immunologic factors|mesh-ancestor
102318525|NCT02105636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102318526|NCT02105636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102318527|NCT04748042|Prednisone|prednisone|mesh-list
102318528|NCT04748042|Olaparib|olaparib|mesh-list
102318529|NCT04748042|Androgens|androgens|mesh-list
102318530|NCT04748042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102318531|NCT04748042|Glucocorticoids|glucocorticoids|mesh-ancestor
102318532|NCT04748042|Hormones|hormones|mesh-ancestor
102318533|NCT04748042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102318534|NCT04748042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318535|NCT04748042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102318536|NCT04748042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102318537|NCT04748042|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102318538|NCT04748042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102318539|NCT04748042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318540|NCT01626872|Risperidone|risperidone|mesh-list
102318541|NCT01626872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102318542|NCT01626872|Serotonin Agents|serotonin agents|mesh-ancestor
102318543|NCT01626872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102318544|NCT01626872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318545|NCT01626872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318546|NCT01626872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102318547|NCT01626872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102318548|NCT01626872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102318549|NCT01626872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102318550|NCT01626872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102318551|NCT01626872|Dopamine Agents|dopamine agents|mesh-ancestor
102318552|NCT01598090|Ribavirin|ribavirin|mesh-list
102318553|NCT01598090|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102318554|NCT01598090|Antimetabolites|antimetabolites|mesh-ancestor
102318555|NCT01598090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318556|NCT01598090|Antiviral Agents|antiviral agents|mesh-ancestor
102318557|NCT01598090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102318558|NCT02145182|Eculizumab|eculizumab|mesh-list
102318559|NCT02145182|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102318560|NCT02145182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102318561|NCT02145182|Immunologic Factors|immunologic factors|mesh-ancestor
102318562|NCT02145182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318563|NCT02145026|Epoetin Alfa|epoetin alfa|mesh-list
102318564|NCT02145026|Hematinics|hematinics|mesh-ancestor
102318565|NCT02144012|Docetaxel|docetaxel|mesh-list
102318566|NCT02144012|Trastuzumab|trastuzumab|mesh-list
102318567|NCT02144012|Maytansine|maytansine|mesh-list
102318568|NCT02144012|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102318569|NCT02144012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102318570|NCT02144012|Tubulin Modulators|tubulin modulators|mesh-ancestor
102318571|NCT02144012|Antimitotic Agents|antimitotic agents|mesh-ancestor
102318572|NCT02144012|Mitosis Modulators|mitosis modulators|mesh-ancestor
102318573|NCT02144012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318574|NCT02144012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102318575|NCT02144012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102318576|NCT02144012|Immunotoxins|immunotoxins|mesh-ancestor
102318577|NCT02144012|Immunoconjugates|immunoconjugates|mesh-ancestor
102318578|NCT02144012|Immunologic Factors|immunologic factors|mesh-ancestor
102318579|NCT02144012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318580|NCT02103062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102318581|NCT02103062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102318582|NCT02141672|Cyclosporine|cyclosporine|mesh-list
102318583|NCT02141672|Antifungal Agents|antifungal agents|mesh-ancestor
102318584|NCT02141672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102318585|NCT02141672|Dermatologic Agents|dermatologic agents|mesh-ancestor
102318586|NCT02141672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102318587|NCT02141672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318588|NCT02141672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102318589|NCT02141672|Immunologic Factors|immunologic factors|mesh-ancestor
102318590|NCT02141672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318591|NCT02141672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102318592|NCT02141672|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102318593|NCT01628120|Epoetin Alfa|epoetin alfa|mesh-list
102318594|NCT01628120|Hematinics|hematinics|mesh-ancestor
102318595|NCT02125604|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102318596|NCT02125604|Dermatologic Agents|dermatologic agents|mesh-ancestor
102318597|NCT02125604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102318598|NCT02125604|Immunologic Factors|immunologic factors|mesh-ancestor
102318599|NCT02125604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318600|NCT02124746|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
102318601|NCT02124746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102318602|NCT02124746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102318603|NCT02124746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318604|NCT02123966|Sirolimus|sirolimus|mesh-list
102318605|NCT02123966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102318606|NCT02123966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102318607|NCT02123966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102318608|NCT02123966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102318609|NCT02123966|Antifungal Agents|antifungal agents|mesh-ancestor
102318610|NCT02123966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102318611|NCT02123966|Immunologic Factors|immunologic factors|mesh-ancestor
102318612|NCT02123966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318613|NCT02123576|Pentoxifylline|pentoxifylline|mesh-list
102318614|NCT02123576|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102318615|NCT02123576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102318616|NCT02123576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318617|NCT02123576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102318618|NCT02123576|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102318619|NCT02123576|Protective Agents|protective agents|mesh-ancestor
102318620|NCT02123576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318621|NCT02123576|Vasodilator Agents|vasodilator agents|mesh-ancestor
102318622|NCT02123576|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102318623|NCT02123576|Antioxidants|antioxidants|mesh-ancestor
102318624|NCT05235347|Sotrovimab|sotrovimab|mesh-list
102318625|NCT05235347|Antiviral Agents|antiviral agents|mesh-ancestor
102318626|NCT05235347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102318627|NCT03368729|Trastuzumab|trastuzumab|mesh-list
102318628|NCT03368729|Niraparib|niraparib|mesh-list
102318629|NCT03368729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102318630|NCT03368729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102318631|NCT03368729|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102318632|NCT03368729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102318633|NCT03368729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318634|NCT02140970|Ibuprofen|ibuprofen|mesh-list
102318635|NCT02140970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102318636|NCT02140970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102318637|NCT02140970|Analgesics|analgesics|mesh-ancestor
102318638|NCT02140970|Sensory System Agents|sensory system agents|mesh-ancestor
102318639|NCT02140970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102318640|NCT02140970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318641|NCT02140970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102318642|NCT02140970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102318643|NCT02140970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102318644|NCT02140970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102318645|NCT02140970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318646|NCT02101112|Apixaban|apixaban|mesh-list
102318647|NCT02101112|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102318649|NCT02101112|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102318650|NCT02101112|Protease Inhibitors|protease inhibitors|mesh-ancestor
102318651|NCT02101112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102318652|NCT02101112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318653|NCT02101112|Anticoagulants|anticoagulants|mesh-ancestor
102318654|NCT02139644|Fluticasone|fluticasone|mesh-list
102318656|NCT02139644|Beclomethasone|beclomethasone|mesh-list
102318657|NCT02139644|Albuterol|albuterol|mesh-list
102318658|NCT02139644|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102318659|NCT02139644|Adrenergic Agonists|adrenergic agonists|mesh-list
102318660|NCT02139644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102318661|NCT02139644|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102318662|NCT02139644|Autonomic Agents|autonomic agents|mesh-ancestor
102318663|NCT02139644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102318664|NCT02139644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318665|NCT02139644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102318666|NCT02139644|Respiratory System Agents|respiratory system agents|mesh-ancestor
102318667|NCT02139644|Dermatologic Agents|dermatologic agents|mesh-ancestor
102318668|NCT02139644|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102318669|NCT02139644|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102318670|NCT02139644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102318671|NCT02139644|Adrenergic Agents|adrenergic agents|mesh-ancestor
102318672|NCT02139644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102318673|NCT02139644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318674|NCT02139644|Tocolytic Agents|tocolytic agents|mesh-ancestor
102318675|NCT02139644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102318676|NCT02139644|Glucocorticoids|glucocorticoids|mesh-ancestor
102318678|NCT02139644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102318679|NCT02100644|Lamotrigine|lamotrigine|mesh-list
102318680|NCT02100644|Anticonvulsants|anticonvulsants|mesh-ancestor
102318681|NCT02100644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102318682|NCT02100644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102318683|NCT02100644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318684|NCT02100644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102318685|NCT02100644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318686|NCT02100644|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102318687|NCT02100644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102318688|NCT02100644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102318689|NCT02100644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102318690|NCT02100644|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102318691|NCT02074982|Ustekinumab|ustekinumab|mesh-list
102318692|NCT02074982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102318693|NCT02074982|Immunologic Factors|immunologic factors|mesh-ancestor
102318694|NCT02074982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318695|NCT02074982|Dermatologic Agents|dermatologic agents|mesh-ancestor
102318696|NCT04150913|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
102318697|NCT04150913|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102318698|NCT04150913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102318699|NCT04150913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102318700|NCT04150913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102318701|NCT04798001|Vaccines|vaccines|mesh-list
102318702|NCT04798001|Immunologic Factors|immunologic factors|mesh-ancestor
102318703|NCT04798001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318704|NCT02074514|Sofosbuvir|sofosbuvir|mesh-list
102318705|NCT02074514|Antiviral Agents|antiviral agents|mesh-ancestor
102318706|NCT02074514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102318707|NCT04073303|Botulinum Toxins|botulinum toxins|mesh-list
102318708|NCT04073303|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102318709|NCT04073303|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102318710|NCT04073303|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102318711|NCT04073303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102318712|NCT04073303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318713|NCT04073303|Cholinergic Agents|cholinergic agents|mesh-ancestor
102318714|NCT04073303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102318715|NCT04073303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318716|NCT04073303|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102318717|NCT04073303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102318718|NCT04070573|Aspirin|aspirin|mesh-list
102318719|NCT04070573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102318720|NCT04070573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102318721|NCT04070573|Analgesics|analgesics|mesh-ancestor
102318722|NCT04070573|Sensory System Agents|sensory system agents|mesh-ancestor
102318723|NCT04070573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102318724|NCT04070573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318725|NCT04070573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102318726|NCT04070573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102318727|NCT04070573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102318728|NCT04070573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102318729|NCT04070573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318730|NCT04070573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102318731|NCT04070573|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102318732|NCT04070573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102318733|NCT04070573|Antipyretics|antipyretics|mesh-ancestor
102318734|NCT02099708|Lansoprazole|lansoprazole|mesh-list
102318735|NCT02099708|Dexlansoprazole|dexlansoprazole|mesh-list
102318736|NCT02099708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102318737|NCT02099708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102318738|NCT02099708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102318739|NCT02099708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102318740|NCT02099708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318741|NCT02073656|Sofosbuvir|sofosbuvir|mesh-list
102318742|NCT02073656|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102318743|NCT02073656|Ledipasvir|ledipasvir|mesh-list
102318744|NCT02073656|Antiviral Agents|antiviral agents|mesh-ancestor
102318745|NCT02073656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102318746|NCT04061213|Technetium Tc 99m 1,1-diphosphonopropane-2,3-dicarboxylic acid|technetium tc 99m 1,1-diphosphonopropane-2,3-dicarboxylic acid|mesh-list
102318747|NCT04061213|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102318748|NCT04061213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318749|NCT02209181|Acetaminophen|acetaminophen|mesh-list
102318750|NCT02209181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102318751|NCT02209181|Analgesics|analgesics|mesh-ancestor
102318752|NCT02209181|Sensory System Agents|sensory system agents|mesh-ancestor
102318753|NCT02209181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102318754|NCT02209181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318755|NCT02209181|Antipyretics|antipyretics|mesh-ancestor
102318756|NCT02242487|Levodopa|levodopa|mesh-list
102318757|NCT02242487|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102318758|NCT02242487|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102318759|NCT02242487|Dopamine Agents|dopamine agents|mesh-ancestor
102318760|NCT02242487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102318761|NCT02242487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318762|NCT02242487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318763|NCT02241785|Natalizumab|natalizumab|mesh-list
102318764|NCT02241785|Immunologic Factors|immunologic factors|mesh-ancestor
102318765|NCT02241785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318766|NCT02241551|Paclitaxel|paclitaxel|mesh-list
102318767|NCT02241551|Gemcitabine|gemcitabine|mesh-list
102318768|NCT02241551|Fluorouracil|fluorouracil|mesh-list
102318769|NCT02241551|Oxaliplatin|oxaliplatin|mesh-list
102318770|NCT02241551|Irinotecan|irinotecan|mesh-list
102318771|NCT02241551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102318772|NCT02241551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102318773|NCT02241551|Tubulin Modulators|tubulin modulators|mesh-ancestor
102318774|NCT02241551|Antimitotic Agents|antimitotic agents|mesh-ancestor
102318775|NCT02241551|Mitosis Modulators|mitosis modulators|mesh-ancestor
101435440|NCT04095364|Letrozole|letrozole|mesh-list
102318776|NCT02241551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318777|NCT02241551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102318778|NCT02241551|Antimetabolites|antimetabolites|mesh-ancestor
102318779|NCT02241551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102318780|NCT02241551|Immunologic Factors|immunologic factors|mesh-ancestor
102318781|NCT02241551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318782|NCT02241551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102318783|NCT02241551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102318784|NCT02241551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102318785|NCT02207621|Timolol|timolol|mesh-list
102318786|NCT02207621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102318787|NCT02207621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102318788|NCT02207621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318789|NCT02207621|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102318790|NCT02207621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102318791|NCT02207621|Adrenergic Agents|adrenergic agents|mesh-ancestor
102318792|NCT02207621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102318793|NCT02207621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318794|NCT02207621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102318795|NCT02207621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102318797|NCT02240693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102318798|NCT02240693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102318799|NCT02240693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318800|NCT02239679|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102318801|NCT02239679|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102318802|NCT02239679|Dermatologic Agents|dermatologic agents|mesh-ancestor
102318803|NCT02072096|Metformin|metformin|mesh-list
102318804|NCT02072096|Insulin Glargine|insulin glargine|mesh-list
102318805|NCT02072096|Pioglitazone|pioglitazone|mesh-list
102318806|NCT02072096|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102318807|NCT02072096|Liraglutide|liraglutide|mesh-list
102318808|NCT02072096|Exenatide|exenatide|mesh-list
102318809|NCT02072096|Glimepiride|glimepiride|mesh-list
102318810|NCT02072096|Linagliptin|linagliptin|mesh-list
102318811|NCT02072096|Acarbose|acarbose|mesh-list
102318812|NCT02072096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102318813|NCT02072096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318814|NCT02072096|Incretins|incretins|mesh-ancestor
102318815|NCT02072096|Hormones|hormones|mesh-ancestor
102318816|NCT02072096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102318817|NCT02072096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102318818|NCT02072096|Protease Inhibitors|protease inhibitors|mesh-ancestor
102318819|NCT02072096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102318820|NCT02072096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318821|NCT02072096|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102318822|NCT02072096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102318823|NCT02072096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102318824|NCT02072096|Immunologic Factors|immunologic factors|mesh-ancestor
102318825|NCT02072096|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102318826|NCT01631825|Rotigotine|rotigotine|mesh-list
102318827|NCT01631825|Dopamine Agonists|dopamine agonists|mesh-ancestor
102318828|NCT01631825|Dopamine Agents|dopamine agents|mesh-ancestor
102318829|NCT01631825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102318830|NCT01631825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318831|NCT01631825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318832|NCT02071082|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102318833|NCT02071082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102318834|NCT02071082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102318835|NCT02071082|Antiviral Agents|antiviral agents|mesh-ancestor
102318836|NCT02071082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102318837|NCT03836105|Cemiplimab|cemiplimab|mesh-list
102318838|NCT03836105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102318839|NCT03836105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102318840|NCT02123108|Mycophenolic Acid|mycophenolic acid|mesh-list
102318841|NCT02123108|Tacrolimus|tacrolimus|mesh-list
102318842|NCT02123108|Basiliximab|basiliximab|mesh-list
102318843|NCT02123108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102318844|NCT02123108|Immunologic Factors|immunologic factors|mesh-ancestor
102318845|NCT02123108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318846|NCT02123108|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102318847|NCT02123108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102318848|NCT02123108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318849|NCT02123108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102318850|NCT02123108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102318851|NCT02123108|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102318852|NCT02123108|Antitubercular Agents|antitubercular agents|mesh-ancestor
102318853|NCT02123108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102318854|NCT02123108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102318855|NCT02121392|Bupivacaine|bupivacaine|mesh-list
102318856|NCT02121392|Anesthetics, Local|anesthetics, local|mesh-ancestor
102318857|NCT02121392|Anesthetics|anesthetics|mesh-ancestor
102318858|NCT02121392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102318859|NCT02121392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318860|NCT02121392|Sensory System Agents|sensory system agents|mesh-ancestor
102318861|NCT02121392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102318862|NCT02097056|Donepezil|donepezil|mesh-list
102318863|NCT02097056|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102318864|NCT02097056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102318865|NCT02097056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318866|NCT02097056|Cholinergic Agents|cholinergic agents|mesh-ancestor
102318867|NCT02097056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102318868|NCT02097056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318869|NCT02097056|Nootropic Agents|nootropic agents|mesh-ancestor
102318871|NCT02121002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102318872|NCT02121002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102318873|NCT02121002|Analgesics|analgesics|mesh-ancestor
102318874|NCT02121002|Sensory System Agents|sensory system agents|mesh-ancestor
102318875|NCT02121002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102318876|NCT02121002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318877|NCT02121002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102318878|NCT02121002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102318879|NCT02121002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102318880|NCT02121002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102318881|NCT02121002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318882|NCT02096900|Midazolam|midazolam|mesh-list
102318883|NCT02096900|Zolpidem|zolpidem|mesh-list
102318884|NCT02096900|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102318885|NCT02096900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102318886|NCT02096900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102318887|NCT02096900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318888|NCT02096900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102318889|NCT02096900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102318890|NCT02096900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102318891|NCT02096900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102318892|NCT02096900|Anesthetics, General|anesthetics, general|mesh-ancestor
102318893|NCT02096900|Anesthetics|anesthetics|mesh-ancestor
102318894|NCT02096900|GABA Modulators|gaba modulators|mesh-ancestor
102318895|NCT02096900|GABA Agents|gaba agents|mesh-ancestor
102318896|NCT02096900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102318897|NCT02096900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318898|NCT02096900|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102318899|NCT02096900|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102318900|NCT02096900|GABA Agonists|gaba agonists|mesh-ancestor
102318901|NCT02120924|Azelaic acid|azelaic acid|mesh-list
102318902|NCT02120924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102318903|NCT02120924|Dermatologic Agents|dermatologic agents|mesh-ancestor
102318904|NCT02096744|Clonidine|clonidine|mesh-list
102318905|NCT02096744|Analgesics|analgesics|mesh-ancestor
102318906|NCT02096744|Sensory System Agents|sensory system agents|mesh-ancestor
102318907|NCT02096744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102318908|NCT02096744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318909|NCT02096744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102318910|NCT02096744|Sympatholytics|sympatholytics|mesh-ancestor
102318911|NCT02096744|Autonomic Agents|autonomic agents|mesh-ancestor
102318912|NCT02096744|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102318913|NCT02096744|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101435553|NCT03757585|Antidotes|antidotes|mesh-ancestor
102318914|NCT02096744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102318915|NCT02096744|Adrenergic Agents|adrenergic agents|mesh-ancestor
102318916|NCT02096744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102318917|NCT02096744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318918|NCT02096042|Azacitidine|azacitidine|mesh-list
102318919|NCT02096042|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102318920|NCT02096042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102318921|NCT02096042|Antimetabolites|antimetabolites|mesh-ancestor
102318922|NCT02096042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318923|NCT02096042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102318924|NCT02096042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102318925|NCT02096042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102318926|NCT02096042|Immunotoxins|immunotoxins|mesh-ancestor
102318927|NCT02096042|Immunoconjugates|immunoconjugates|mesh-ancestor
102318928|NCT02096042|Immunologic Factors|immunologic factors|mesh-ancestor
102318929|NCT02096042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318930|NCT02120300|Sofosbuvir|sofosbuvir|mesh-list
102318931|NCT02120300|Antiviral Agents|antiviral agents|mesh-ancestor
102318932|NCT02120300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102318933|NCT02069366|Dronabinol|dronabinol|mesh-list
102318934|NCT02069366|Hallucinogens|hallucinogens|mesh-ancestor
102318935|NCT02069366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318936|NCT02069366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102318937|NCT02069366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102318938|NCT02069366|Analgesics|analgesics|mesh-ancestor
102318939|NCT02069366|Sensory System Agents|sensory system agents|mesh-ancestor
102318940|NCT02069366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102318941|NCT02069366|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102318942|NCT02069366|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102318943|NCT02069366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102318944|NCT02069366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318945|NCT02069366|Hormones|hormones|mesh-ancestor
102318946|NCT02069366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102318947|NCT04732208|Mydriatics|mydriatics|mesh-list
102318948|NCT04732208|Autonomic Agents|autonomic agents|mesh-ancestor
102318949|NCT04732208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102318950|NCT04732208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318951|NCT02068508|Pioglitazone|pioglitazone|mesh-list
102318952|NCT02068508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102318953|NCT02068508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318954|NCT02207231|Adalimumab|adalimumab|mesh-list
102318955|NCT02207231|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102318956|NCT02207231|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102318957|NCT02207231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102318958|NCT02207231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102318959|NCT02207231|Immunologic Factors|immunologic factors|mesh-ancestor
102318960|NCT02207231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318961|NCT02206685|Methadone|methadone|mesh-list
102318962|NCT02206685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102318963|NCT02206685|Narcotics|narcotics|mesh-ancestor
102318964|NCT02206685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102318965|NCT02206685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318966|NCT02206685|Analgesics|analgesics|mesh-ancestor
102318967|NCT02206685|Sensory System Agents|sensory system agents|mesh-ancestor
102318968|NCT02206685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102318969|NCT02206685|Antitussive Agents|antitussive agents|mesh-ancestor
102318970|NCT02206685|Respiratory System Agents|respiratory system agents|mesh-ancestor
102318971|NCT02095106|Calpastatin|calpastatin|mesh-list
102318972|NCT02095106|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
102318973|NCT02095106|Protease Inhibitors|protease inhibitors|mesh-ancestor
102318974|NCT02095106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102318975|NCT02095106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318976|NCT01634165|Insulin Glargine|insulin glargine|mesh-list
102318977|NCT01634165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102318978|NCT01634165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318979|NCT02235311|Pantoprazole|pantoprazole|mesh-list
102318980|NCT02235311|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102318981|NCT02235311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102318982|NCT02235311|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102318983|NCT02235311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102318984|NCT02235311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318985|NCT02235077|Spironolactone|spironolactone|mesh-list
102318986|NCT02235077|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102318987|NCT02235077|Hormone Antagonists|hormone antagonists|mesh-ancestor
102318988|NCT02235077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102318989|NCT02235077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102318990|NCT02235077|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102318991|NCT02235077|Diuretics|diuretics|mesh-ancestor
102318992|NCT02235077|Natriuretic Agents|natriuretic agents|mesh-ancestor
102318993|NCT02234141|Selonsertib|selonsertib|mesh-list
102318994|NCT02234141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102318995|NCT02234141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102318996|NCT02234141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102318997|NCT01896531|Leucovorin|leucovorin|mesh-list
102318998|NCT01896531|Fluorouracil|fluorouracil|mesh-list
102318999|NCT01896531|Oxaliplatin|oxaliplatin|mesh-list
102319000|NCT01896531|Ipatasertib|ipatasertib|mesh-list
102319001|NCT01896531|Antimetabolites|antimetabolites|mesh-ancestor
102319002|NCT01896531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319003|NCT01896531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102319004|NCT01896531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102319005|NCT01896531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102319006|NCT01896531|Immunologic Factors|immunologic factors|mesh-ancestor
102319007|NCT01896531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319008|NCT01896531|Antidotes|antidotes|mesh-ancestor
102319009|NCT01896531|Protective Agents|protective agents|mesh-ancestor
102319010|NCT01896531|Vitamin B Complex|vitamin b complex|mesh-ancestor
102319011|NCT01896531|Vitamins|vitamins|mesh-ancestor
102319012|NCT01896531|Micronutrients|micronutrients|mesh-ancestor
102319013|NCT01896531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102319015|NCT01618305|Lamivudine|lamivudine|mesh-list
102319016|NCT01618305|Zidovudine|zidovudine|mesh-list
102319017|NCT01618305|Efavirenz|efavirenz|mesh-list
102319018|NCT01618305|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
102319019|NCT01618305|Raltegravir Potassium|raltegravir potassium|mesh-list
102319020|NCT01618305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102319021|NCT01618305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102319022|NCT01618305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102319023|NCT01618305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319024|NCT01618305|Antiviral Agents|antiviral agents|mesh-ancestor
102319025|NCT01618305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102319026|NCT01618305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102319027|NCT01618305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102319028|NCT01618305|Antimetabolites|antimetabolites|mesh-ancestor
102319029|NCT01618305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102319030|NCT01618305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102319031|NCT01618305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102319032|NCT01618305|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102319033|NCT01618305|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102319034|NCT01618305|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102319035|NCT01618305|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102319036|NCT01618305|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102319037|NCT01896297|Dabigatran|dabigatran|mesh-list
102319038|NCT01896297|Antithrombins|antithrombins|mesh-ancestor
102319039|NCT01896297|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102319040|NCT01896297|Protease Inhibitors|protease inhibitors|mesh-ancestor
102319041|NCT01896297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102319042|NCT01896297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319043|NCT01896297|Anticoagulants|anticoagulants|mesh-ancestor
102319044|NCT01884675|Ambrisentan|ambrisentan|mesh-list
102319045|NCT01884675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102319046|NCT01884597|Ranibizumab|ranibizumab|mesh-list
102319047|NCT01884597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102319048|NCT01884597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102319049|NCT01884597|Growth Substances|growth substances|mesh-ancestor
102319050|NCT01884597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319051|NCT01884597|Growth Inhibitors|growth inhibitors|mesh-ancestor
102319052|NCT01884597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102319053|NCT01864005|Clopidogrel|clopidogrel|mesh-list
102319054|NCT01864005|Ticagrelor|ticagrelor|mesh-list
102319055|NCT01864005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102319056|NCT01864005|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102319057|NCT01864005|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102319058|NCT01864005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102319059|NCT01864005|Purinergic Agents|purinergic agents|mesh-ancestor
102319060|NCT01864005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102319061|NCT01864005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319062|NCT01864005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319063|NCT01863771|Golimumab|golimumab|mesh-list
102319064|NCT01863771|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102319065|NCT01863771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102319066|NCT01863771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102319067|NCT01863771|Immunologic Factors|immunologic factors|mesh-ancestor
102319068|NCT01863771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319069|NCT01894581|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
102319070|NCT01894581|Hormones|hormones|mesh-ancestor
102319071|NCT01894581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102319072|NCT01894581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319073|NCT02203331|Anastrozole|anastrozole|mesh-list
102319074|NCT02203331|Leuprolide|leuprolide|mesh-list
102319075|NCT02203331|Levonorgestrel|levonorgestrel|mesh-list
102319076|NCT02203331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102319077|NCT02203331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102319078|NCT02203331|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102319079|NCT02203331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102319080|NCT02203331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102319081|NCT02203331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319082|NCT02203331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102319083|NCT02203331|Hormone Antagonists|hormone antagonists|mesh-ancestor
102319084|NCT02203331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102319085|NCT02203331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319086|NCT02203331|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102319087|NCT02203331|Fertility Agents|fertility agents|mesh-ancestor
102319088|NCT02203331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102319089|NCT02203331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102319090|NCT02203331|Contraceptive Agents|contraceptive agents|mesh-ancestor
102319091|NCT02203331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102319092|NCT02203331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102319093|NCT02203331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102319094|NCT01893411|Botulinum Toxins|botulinum toxins|mesh-list
102319095|NCT01893411|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102319096|NCT01893411|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102319097|NCT01893411|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102319098|NCT01893411|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102319099|NCT01893411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102319100|NCT01893411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319101|NCT01893411|Cholinergic Agents|cholinergic agents|mesh-ancestor
102319102|NCT01893411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102319103|NCT01893411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319104|NCT01893411|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102319105|NCT01893411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102319106|NCT01862991|Digoxin|digoxin|mesh-list
102027916|NCT03662516|Estrogens|estrogens|mesh-ancestor
102319107|NCT01862991|Misoprostol|misoprostol|mesh-list
102319108|NCT01862991|Mifepristone|mifepristone|mesh-list
102319109|NCT01862991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102319110|NCT01862991|Abortifacient Agents|abortifacient agents|mesh-ancestor
102319111|NCT01862991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102319112|NCT01862991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319113|NCT01862991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102319114|NCT01862991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102319115|NCT01862991|Oxytocics|oxytocics|mesh-ancestor
102319116|NCT01862991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102319117|NCT01862991|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102319118|NCT01862991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102319119|NCT01862991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319120|NCT01862991|Protective Agents|protective agents|mesh-ancestor
102319121|NCT01862991|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102319122|NCT01862991|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102319123|NCT01862991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102319124|NCT01862991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102319125|NCT01862991|Contraceptive Agents|contraceptive agents|mesh-ancestor
102319126|NCT01862991|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102319127|NCT01862991|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102319128|NCT01862991|Hormone Antagonists|hormone antagonists|mesh-ancestor
102319129|NCT01862991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102319130|NCT01862991|Luteolytic Agents|luteolytic agents|mesh-ancestor
102319131|NCT01862991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102319132|NCT01862991|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102319133|NCT02202551|Amantadine|amantadine|mesh-list
102319134|NCT02202551|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102319135|NCT02202551|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102319136|NCT02202551|Antiviral Agents|antiviral agents|mesh-ancestor
102319137|NCT02202551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102319138|NCT02202551|Dopamine Agents|dopamine agents|mesh-ancestor
102319139|NCT02202551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102319140|NCT02202551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319141|NCT02202551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319142|NCT02202551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102319143|NCT02202551|Analgesics|analgesics|mesh-ancestor
102319144|NCT02202551|Sensory System Agents|sensory system agents|mesh-ancestor
102319145|NCT02202551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102319146|NCT02118337|Nivolumab|nivolumab|mesh-list
102319147|NCT02118337|Durvalumab|durvalumab|mesh-list
102319148|NCT02118337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102319149|NCT02118337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102319150|NCT02118337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102319151|NCT02118337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319152|NCT05131555|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
102319153|NCT05131555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
102319154|NCT05131555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319155|NCT05131555|Histamine Antagonists|histamine antagonists|mesh-ancestor
102319156|NCT05131555|Histamine Agents|histamine agents|mesh-ancestor
102319157|NCT05131555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102319158|NCT05131555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319159|NCT02105467|Grazoprevir|grazoprevir|mesh-list
102319160|NCT02105467|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
102319161|NCT02105467|Antiviral Agents|antiviral agents|mesh-ancestor
102319162|NCT02105467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102319163|NCT02202161|Metformin|metformin|mesh-list
102319164|NCT02202161|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102319165|NCT02202161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102319166|NCT02202161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319167|NCT02202161|Incretins|incretins|mesh-ancestor
102319168|NCT02202161|Hormones|hormones|mesh-ancestor
102319169|NCT02202161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102319170|NCT02202161|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102319171|NCT02202161|Protease Inhibitors|protease inhibitors|mesh-ancestor
102319172|NCT02202161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101435821|NCT00163592|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102319173|NCT02202161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319174|NCT03109847|Metformin|metformin|mesh-list
102319175|NCT03109847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102319176|NCT03109847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319177|NCT01461928|Rituximab|rituximab|mesh-list
102319178|NCT01461928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102319179|NCT01461928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102319180|NCT01461928|Immunologic Factors|immunologic factors|mesh-ancestor
102319181|NCT01461928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319182|NCT01461928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102319184|NCT02623205|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102319185|NCT02623205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102319186|NCT02623205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102319187|NCT02623205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319188|NCT02623205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102319189|NCT02623205|Serotonin Agents|serotonin agents|mesh-ancestor
102319190|NCT02623205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319191|NCT01500694|Guanfacine|guanfacine|mesh-list
102319192|NCT01500694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102319193|NCT01500694|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102319194|NCT01500694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102319195|NCT01500694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102319196|NCT01500694|Adrenergic Agents|adrenergic agents|mesh-ancestor
102319197|NCT01500694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102319198|NCT01500694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319199|NCT01500694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319200|NCT01500382|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102319201|NCT01500382|Tolterodine Tartrate|tolterodine tartrate|mesh-list
102319202|NCT01500382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102319203|NCT01500382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102319204|NCT01500382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102319205|NCT01500382|Cholinergic Agents|cholinergic agents|mesh-ancestor
102319206|NCT01500382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102319207|NCT01500382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319208|NCT01500382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319209|NCT01500382|Urological Agents|urological agents|mesh-ancestor
102319210|NCT02137837|Everolimus|everolimus|mesh-list
102319211|NCT02137837|Fulvestrant|fulvestrant|mesh-list
102319212|NCT02137837|Anastrozole|anastrozole|mesh-list
102319213|NCT02137837|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102319214|NCT02137837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102319215|NCT02137837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102319216|NCT02137837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319217|NCT02137837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102319218|NCT02137837|Immunologic Factors|immunologic factors|mesh-ancestor
102319219|NCT02137837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319220|NCT02137837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102319221|NCT02137837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102319222|NCT02137837|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102319223|NCT02137837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102319224|NCT02137837|Hormone Antagonists|hormone antagonists|mesh-ancestor
102319225|NCT02137837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102319226|NCT02137837|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102319227|NCT02137837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102319228|NCT01483690|Dexamethasone|dexamethasone|mesh-list
102319229|NCT01483690|Dexamethasone acetate|dexamethasone acetate|mesh-list
102319230|NCT01483690|Methotrexate|methotrexate|mesh-list
102319231|NCT01483690|Vincristine|vincristine|mesh-list
102319232|NCT01483690|Decitabine|decitabine|mesh-list
102319233|NCT01483690|Asparaginase|asparaginase|mesh-list
102319234|NCT01483690|Mitoxantrone|mitoxantrone|mesh-list
102319236|NCT01483690|Pegaspargase|pegaspargase|mesh-list
102319237|NCT01483690|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102319238|NCT01483690|BB 1101|bb 1101|mesh-list
102319239|NCT01483690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102319240|NCT01483690|Antiemetics|antiemetics|mesh-ancestor
102319241|NCT01483690|Autonomic Agents|autonomic agents|mesh-ancestor
102319242|NCT01483690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102319243|NCT01483690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319244|NCT01483690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102319245|NCT01483690|Glucocorticoids|glucocorticoids|mesh-ancestor
102319246|NCT01483690|Hormones|hormones|mesh-ancestor
102319247|NCT01483690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102319248|NCT01483690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102319249|NCT01483690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102319250|NCT01483690|Protease Inhibitors|protease inhibitors|mesh-ancestor
102319251|NCT01483690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102319252|NCT01483690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319253|NCT01483690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101836567|NCT00501540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102319254|NCT01483690|Abortifacient Agents|abortifacient agents|mesh-ancestor
102319255|NCT01483690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102319256|NCT01483690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102319257|NCT01483690|Antimetabolites|antimetabolites|mesh-ancestor
102319258|NCT01483690|Dermatologic Agents|dermatologic agents|mesh-ancestor
102319259|NCT01483690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102319260|NCT01483690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102319261|NCT01483690|Immunologic Factors|immunologic factors|mesh-ancestor
102319262|NCT01483690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102319263|NCT01483690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102319264|NCT01483690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102319265|NCT01483690|Tubulin Modulators|tubulin modulators|mesh-ancestor
102319266|NCT01483690|Antimitotic Agents|antimitotic agents|mesh-ancestor
102319267|NCT01483690|Mitosis Modulators|mitosis modulators|mesh-ancestor
102319268|NCT01483690|Analgesics|analgesics|mesh-ancestor
102319269|NCT01483690|Sensory System Agents|sensory system agents|mesh-ancestor
102319270|NCT01483690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102319271|NCT01483690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102319272|NCT01483690|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102319273|NCT01483144|Eflornithine|eflornithine|mesh-list
102319274|NCT01483144|Sulindac|sulindac|mesh-list
102319275|NCT01483144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102319276|NCT01483144|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102319277|NCT01483144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102319278|NCT01483144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102319279|NCT01483144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102319280|NCT01483144|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
102319281|NCT01483144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102319282|NCT01483144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319283|NCT01483144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102319284|NCT01483144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102319285|NCT01483144|Analgesics|analgesics|mesh-ancestor
102319286|NCT01483144|Sensory System Agents|sensory system agents|mesh-ancestor
102319287|NCT01483144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102319288|NCT01483144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319289|NCT01483144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102319290|NCT01483144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102319291|NCT01483144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102319292|NCT01881789|Dexamethasone|dexamethasone|mesh-list
102319293|NCT01881789|Cyclophosphamide|cyclophosphamide|mesh-list
102319294|NCT01881789|Lenalidomide|lenalidomide|mesh-list
102319295|NCT01881789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102319296|NCT01881789|Immunologic Factors|immunologic factors|mesh-ancestor
102319297|NCT01881789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319298|NCT01881789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102319299|NCT01881789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102319300|NCT01881789|Alkylating Agents|alkylating agents|mesh-ancestor
101435968|NCT05807100|Salicylic Acid|salicylic acid|mesh-list
102319301|NCT01881789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319302|NCT01881789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102319303|NCT01881789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102319304|NCT01881789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102319305|NCT01881789|Antiemetics|antiemetics|mesh-ancestor
102319306|NCT01881789|Autonomic Agents|autonomic agents|mesh-ancestor
102319307|NCT01881789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102319308|NCT01881789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102319309|NCT01881789|Glucocorticoids|glucocorticoids|mesh-ancestor
102319310|NCT01881789|Hormones|hormones|mesh-ancestor
102319311|NCT01881789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102319312|NCT01881789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102319313|NCT01881789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102319314|NCT01881789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102319315|NCT01881789|Growth Substances|growth substances|mesh-ancestor
102319316|NCT01881789|Growth Inhibitors|growth inhibitors|mesh-ancestor
102319317|NCT02075203|BCG Vaccine|bcg vaccine|mesh-list
102319318|NCT02075203|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102319319|NCT02075203|Immunologic Factors|immunologic factors|mesh-ancestor
102319320|NCT02075203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319321|NCT01892163|Dexamethasone|dexamethasone|mesh-list
102319322|NCT01892163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102319323|NCT01892163|Antiemetics|antiemetics|mesh-ancestor
102319324|NCT01892163|Autonomic Agents|autonomic agents|mesh-ancestor
102319325|NCT01892163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102319326|NCT01892163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319327|NCT01892163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102319328|NCT01892163|Glucocorticoids|glucocorticoids|mesh-ancestor
102319329|NCT01892163|Hormones|hormones|mesh-ancestor
102319330|NCT01892163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102319331|NCT01892163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102319332|NCT01892163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102319333|NCT01500226|Dexamethasone|dexamethasone|mesh-list
102319334|NCT01500226|Granisetron|granisetron|mesh-list
102319335|NCT01500226|Rolapitant|rolapitant|mesh-list
102319336|NCT01500226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102319337|NCT01500226|Antiemetics|antiemetics|mesh-ancestor
102319338|NCT01500226|Autonomic Agents|autonomic agents|mesh-ancestor
102319339|NCT01500226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102319340|NCT01500226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319341|NCT01500226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102319342|NCT01500226|Glucocorticoids|glucocorticoids|mesh-ancestor
102319343|NCT01500226|Hormones|hormones|mesh-ancestor
102319344|NCT01500226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102319345|NCT01500226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102319346|NCT01500226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102319347|NCT01500226|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102319348|NCT01500226|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102319349|NCT01500226|Serotonin Agents|serotonin agents|mesh-ancestor
102319350|NCT01500226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102319351|NCT01500226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319352|NCT01500226|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102319353|NCT02075047|Ziprasidone|ziprasidone|mesh-list
102319354|NCT02075047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102319355|NCT02075047|Serotonin Agents|serotonin agents|mesh-ancestor
102319356|NCT02075047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102319357|NCT02075047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319358|NCT02075047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319359|NCT02075047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102319360|NCT02075047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102319361|NCT02075047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102319362|NCT02075047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102319363|NCT02075047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102319364|NCT02075047|Dopamine Agents|dopamine agents|mesh-ancestor
102319365|NCT01859793|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102319366|NCT01859793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102319367|NCT01859793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319368|NCT01859793|Incretins|incretins|mesh-ancestor
102319369|NCT01859793|Hormones|hormones|mesh-ancestor
102319370|NCT01859793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102319371|NCT01859793|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102319372|NCT01859793|Protease Inhibitors|protease inhibitors|mesh-ancestor
102319373|NCT01859793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102319374|NCT01859793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319375|NCT01859715|Oxycodone|oxycodone|mesh-list
102319376|NCT01859715|Hydrocodone|hydrocodone|mesh-list
102319377|NCT01859715|Ondansetron|ondansetron|mesh-list
102319378|NCT01859715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102319379|NCT01859715|Narcotics|narcotics|mesh-ancestor
102319380|NCT01859715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102319381|NCT01859715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319382|NCT01859715|Analgesics|analgesics|mesh-ancestor
102319383|NCT01859715|Sensory System Agents|sensory system agents|mesh-ancestor
102319384|NCT01859715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102319385|NCT01859715|Antiemetics|antiemetics|mesh-ancestor
102319386|NCT01859715|Autonomic Agents|autonomic agents|mesh-ancestor
102319387|NCT01859715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102319388|NCT01859715|Antipruritics|antipruritics|mesh-ancestor
102319389|NCT01859715|Dermatologic Agents|dermatologic agents|mesh-ancestor
102319390|NCT01859715|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102319391|NCT01859715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102319392|NCT01859715|Serotonin Agents|serotonin agents|mesh-ancestor
102319393|NCT01859715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102319394|NCT01859715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319395|NCT01859715|Antitussive Agents|antitussive agents|mesh-ancestor
102319396|NCT01859715|Respiratory System Agents|respiratory system agents|mesh-ancestor
102319397|NCT04590495|Cannabidiol|cannabidiol|mesh-list
102319398|NCT04590495|Anticonvulsants|anticonvulsants|mesh-ancestor
102319399|NCT01461538|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102319400|NCT01461538|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102319401|NCT01461538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102319402|NCT01461538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102319403|NCT01461538|Immunotoxins|immunotoxins|mesh-ancestor
102028222|NCT03622502|Narcotics|narcotics|mesh-ancestor
102319404|NCT01461538|Immunoconjugates|immunoconjugates|mesh-ancestor
102319405|NCT01461538|Immunologic Factors|immunologic factors|mesh-ancestor
102319406|NCT01461538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319407|NCT02117479|Capecitabine|capecitabine|mesh-list
102319408|NCT02117479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102319409|NCT02117479|Antimetabolites|antimetabolites|mesh-ancestor
102319410|NCT02117479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319411|NCT02117479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102319412|NCT01482910|Aflibercept|aflibercept|mesh-list
102319413|NCT01482910|Verteporfin|verteporfin|mesh-list
102319414|NCT01482910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102319415|NCT01482910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102319416|NCT01482910|Growth Substances|growth substances|mesh-ancestor
102319417|NCT01482910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319418|NCT01482910|Growth Inhibitors|growth inhibitors|mesh-ancestor
102319419|NCT01482910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102319420|NCT01482910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102319421|NCT01482910|Dermatologic Agents|dermatologic agents|mesh-ancestor
102319422|NCT04077190|Cortisone|cortisone|mesh-list
102319423|NCT04077190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102319424|NCT02103439|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102319425|NCT02103439|Antiviral Agents|antiviral agents|mesh-ancestor
102319426|NCT02103439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102319427|NCT02229539|Diphenhydramine|diphenhydramine|mesh-list
102319428|NCT02229539|Promethazine|promethazine|mesh-list
102319429|NCT02229539|Lidocaine|lidocaine|mesh-list
102319430|NCT02229539|Doxepin|doxepin|mesh-list
102319431|NCT02229539|Antacids|antacids|mesh-list
102319432|NCT02229539|Anesthetics, Local|anesthetics, local|mesh-ancestor
102319433|NCT02229539|Anesthetics|anesthetics|mesh-ancestor
102319434|NCT02229539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102319435|NCT02229539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319436|NCT02229539|Sensory System Agents|sensory system agents|mesh-ancestor
102319437|NCT02229539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102319438|NCT02229539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102319439|NCT02229539|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102319440|NCT02229539|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102319441|NCT02229539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102319442|NCT02229539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319443|NCT02229539|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102319444|NCT02229539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102319445|NCT02229539|Antiemetics|antiemetics|mesh-ancestor
102319446|NCT02229539|Autonomic Agents|autonomic agents|mesh-ancestor
102319447|NCT02229539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102319448|NCT02229539|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102319449|NCT02229539|Histamine Antagonists|histamine antagonists|mesh-ancestor
102319450|NCT02229539|Histamine Agents|histamine agents|mesh-ancestor
102319451|NCT02229539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102319452|NCT02229539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102319453|NCT02229539|Antipruritics|antipruritics|mesh-ancestor
102319454|NCT02229539|Dermatologic Agents|dermatologic agents|mesh-ancestor
102319455|NCT02229539|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102319456|NCT02229539|Antidepressive Agents|antidepressive agents|mesh-ancestor
102319457|NCT02229539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102319458|NCT01835223|Tivozanib|tivozanib|mesh-list
102319459|NCT01835223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102319460|NCT01835223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102319461|NCT01835223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319462|NCT02229383|Exenatide|exenatide|mesh-list
102319463|NCT02229383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102319464|NCT02229383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319465|NCT02229383|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102319466|NCT02229383|Incretins|incretins|mesh-ancestor
102319467|NCT02229383|Hormones|hormones|mesh-ancestor
102319468|NCT02229383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102319469|NCT01499368|Omeprazole|omeprazole|mesh-list
102319470|NCT01499368|Famotidine|famotidine|mesh-list
102319471|NCT01499368|Lafutidine|lafutidine|mesh-list
102319472|NCT01499368|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102319473|NCT01499368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102319474|NCT01499368|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102319475|NCT01499368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102319476|NCT01499368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319477|NCT01499368|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102319478|NCT01499368|Histamine Antagonists|histamine antagonists|mesh-ancestor
102319479|NCT01499368|Histamine Agents|histamine agents|mesh-ancestor
102319480|NCT01499368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102319481|NCT01499368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319482|NCT01835145|Temozolomide|temozolomide|mesh-list
102319483|NCT01835145|Dacarbazine|dacarbazine|mesh-list
102319484|NCT01835145|Imidazole|imidazole|mesh-list
102319485|NCT01835145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102319486|NCT01835145|Alkylating Agents|alkylating agents|mesh-ancestor
102319487|NCT01835145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319488|NCT01835145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102319489|NCT01835145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102319490|NCT02229227|Insulin|insulin|mesh-list
102319491|NCT02229227|Insulin Glargine|insulin glargine|mesh-list
102319492|NCT02229227|Insulin Lispro|insulin lispro|mesh-list
102319493|NCT02229227|rGLP-1 protein|rglp-1 protein|mesh-list
102319494|NCT02229227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102319495|NCT02229227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319496|NCT02229227|Incretins|incretins|mesh-ancestor
102319497|NCT02229227|Hormones|hormones|mesh-ancestor
102319498|NCT02229227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102319499|NCT01499290|Metronidazole|metronidazole|mesh-list
102319500|NCT01499290|Meropenem|meropenem|mesh-list
102319501|NCT01499290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102319502|NCT01499290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102319503|NCT01499290|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102319504|NCT01499290|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102319505|NCT01833897|Cycloserine|cycloserine|mesh-list
102319506|NCT01833897|Ketamine|ketamine|mesh-list
102319507|NCT01833897|Olanzapine|olanzapine|mesh-list
102319508|NCT01833897|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102319509|NCT01833897|Fluoxetine|fluoxetine|mesh-list
102319510|NCT01833897|Analgesics|analgesics|mesh-ancestor
102319511|NCT01833897|Sensory System Agents|sensory system agents|mesh-ancestor
102319512|NCT01833897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102319513|NCT01833897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319514|NCT01833897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102319515|NCT01833897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102319516|NCT01833897|Anesthetics, General|anesthetics, general|mesh-ancestor
102319517|NCT01833897|Anesthetics|anesthetics|mesh-ancestor
102319518|NCT01833897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102319519|NCT01833897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102319520|NCT01833897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102319521|NCT01833897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102319522|NCT01833897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319523|NCT01833897|Antiemetics|antiemetics|mesh-ancestor
102319524|NCT01833897|Autonomic Agents|autonomic agents|mesh-ancestor
102319525|NCT01833897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102319526|NCT01833897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102319527|NCT01833897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102319528|NCT01833897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102319529|NCT01833897|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102319530|NCT01833897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102319531|NCT01833897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102319532|NCT01833897|Serotonin Agents|serotonin agents|mesh-ancestor
102319533|NCT01833897|Antidepressive Agents|antidepressive agents|mesh-ancestor
102319534|NCT01833897|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102319535|NCT01833897|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102319536|NCT01833897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102319537|NCT01833897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102319538|NCT01833897|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102319539|NCT01833897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102319540|NCT01833897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102319541|NCT01833897|Antitubercular Agents|antitubercular agents|mesh-ancestor
102319542|NCT01833897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102319543|NCT01833897|Antimetabolites|antimetabolites|mesh-ancestor
102319545|NCT02226653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102319546|NCT02226653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102319547|NCT02226653|Antimetabolites|antimetabolites|mesh-ancestor
102319548|NCT02226653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319549|NCT02226653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102319550|NCT02201771|Aspirin|aspirin|mesh-list
102319551|NCT02201771|Ticagrelor|ticagrelor|mesh-list
102319552|NCT02201771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102319553|NCT02201771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102319554|NCT02201771|Analgesics|analgesics|mesh-ancestor
102319555|NCT02201771|Sensory System Agents|sensory system agents|mesh-ancestor
102319556|NCT02201771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102319557|NCT02201771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319558|NCT02201771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102319559|NCT02201771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102319560|NCT02201771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102319561|NCT02201771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102319562|NCT02201771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319563|NCT02201771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102319564|NCT02201771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102319565|NCT02201771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102319566|NCT02201771|Antipyretics|antipyretics|mesh-ancestor
102319567|NCT02201771|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102319568|NCT02201771|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102319569|NCT02201771|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102319570|NCT02201771|Purinergic Agents|purinergic agents|mesh-ancestor
102319571|NCT02201771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102319572|NCT01460368|Moxifloxacin|moxifloxacin|mesh-list
102319573|NCT01460368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102319574|NCT01460368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102319575|NCT01460368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102319576|NCT01460368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102319577|NCT01460368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102319578|NCT01460368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319579|NCT01460368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102319580|NCT01460290|Asenapine|asenapine|mesh-list
102319581|NCT01460290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102319582|NCT01460290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102319583|NCT01460290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102319584|NCT01460290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319585|NCT01460290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102319586|NCT01459666|Hemagglutinins|hemagglutinins|mesh-list
102319587|NCT01459666|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102319588|NCT01459666|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102319589|NCT01459666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102319590|NCT01459666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102319591|NCT01459666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319592|NCT01459666|Cholinergic Agents|cholinergic agents|mesh-ancestor
102319593|NCT01459666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102319594|NCT01459666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319595|NCT01459666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102319596|NCT01459666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102319597|NCT01459666|Agglutinins|agglutinins|mesh-ancestor
102319598|NCT01459666|Immunologic Factors|immunologic factors|mesh-ancestor
102319599|NCT01459666|Coagulants|coagulants|mesh-ancestor
102319600|NCT01645475|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
102319601|NCT01645475|Hemostatics|hemostatics|mesh-ancestor
102319602|NCT01645475|Coagulants|coagulants|mesh-ancestor
102319603|NCT01645475|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102319604|NCT01645475|Natriuretic Agents|natriuretic agents|mesh-ancestor
102319605|NCT01645475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319606|NCT04767113|Heparin|heparin|mesh-list
102319607|NCT04767113|Calcium heparin|calcium heparin|mesh-list
102319608|NCT04767113|Anticoagulants|anticoagulants|mesh-ancestor
102319609|NCT04767113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102319610|NCT04767113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102319611|NCT04767113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319613|NCT04774991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102319614|NCT04774991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102319615|NCT02199509|Levetiracetam|levetiracetam|mesh-list
102319616|NCT02199509|Anticonvulsants|anticonvulsants|mesh-ancestor
102319617|NCT02199509|Nootropic Agents|nootropic agents|mesh-ancestor
102319618|NCT01458574|Tofacitinib|tofacitinib|mesh-list
102319619|NCT01458574|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102319620|NCT01458574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102319621|NCT01458574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102319622|NCT01458574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319623|NCT02224703|Cannabidiol|cannabidiol|mesh-list
102319624|NCT02224703|Anticonvulsants|anticonvulsants|mesh-ancestor
102319625|NCT01458106|Factor VIII|factor viii|mesh-list
102319626|NCT01458106|Coagulants|coagulants|mesh-ancestor
102319627|NCT01457950|Denosumab|denosumab|mesh-list
102319628|NCT01457950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102319629|NCT01457950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319630|NCT01499134|Metoprolol|metoprolol|mesh-list
102319631|NCT01499134|Nebivolol|nebivolol|mesh-list
102319632|NCT01499134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102319633|NCT01499134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102319634|NCT01499134|Sympatholytics|sympatholytics|mesh-ancestor
102319635|NCT01499134|Autonomic Agents|autonomic agents|mesh-ancestor
102319636|NCT01499134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102319637|NCT01499134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319638|NCT01499134|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102319639|NCT01499134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102319640|NCT01499134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102319641|NCT01499134|Adrenergic Agents|adrenergic agents|mesh-ancestor
102319642|NCT01499134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102319643|NCT01499134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319644|NCT01499134|Vasodilator Agents|vasodilator agents|mesh-ancestor
102319645|NCT01499134|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102319646|NCT01499134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102319647|NCT01499134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102319648|NCT02198651|Adalimumab|adalimumab|mesh-list
102319649|NCT02198651|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102319650|NCT02198651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102319651|NCT02198651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102319652|NCT03026842|Cytarabine|cytarabine|mesh-list
102319653|NCT03026842|Decitabine|decitabine|mesh-list
102319654|NCT03026842|Daunorubicin|daunorubicin|mesh-list
102319655|NCT03026842|Mitoxantrone|mitoxantrone|mesh-list
102319656|NCT03026842|Aclacinomycins|aclacinomycins|mesh-list
102319657|NCT03026842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102319658|NCT03026842|Antimetabolites|antimetabolites|mesh-ancestor
102319659|NCT03026842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319660|NCT03026842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102319661|NCT03026842|Antiviral Agents|antiviral agents|mesh-ancestor
102319662|NCT03026842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102319663|NCT03026842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102319664|NCT03026842|Immunologic Factors|immunologic factors|mesh-ancestor
102319665|NCT03026842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319666|NCT03026842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102319667|NCT03026842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102319668|NCT03026842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102319669|NCT03026842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102319670|NCT03026842|Analgesics|analgesics|mesh-ancestor
102319671|NCT03026842|Sensory System Agents|sensory system agents|mesh-ancestor
102319672|NCT03026842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102319673|NCT03026842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102319674|NCT01498822|Oxcarbazepine|oxcarbazepine|mesh-list
102319675|NCT01498822|Levetiracetam|levetiracetam|mesh-list
102319676|NCT01498822|Anticonvulsants|anticonvulsants|mesh-ancestor
102319677|NCT01498822|Nootropic Agents|nootropic agents|mesh-ancestor
102319678|NCT01498822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102319679|NCT01498822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102319680|NCT01498822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102319681|NCT01498822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319682|NCT01498822|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102319683|NCT01498822|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102319684|NCT01498120|Rotigotine|rotigotine|mesh-list
102319685|NCT01498120|Dopamine Agonists|dopamine agonists|mesh-ancestor
102319686|NCT01498120|Dopamine Agents|dopamine agents|mesh-ancestor
102319687|NCT01498120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101661596|NCT02805738|Tenofovir|tenofovir|mesh-list
102319688|NCT01498120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319689|NCT01498120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319690|NCT01497262|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102319691|NCT01497262|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102319692|NCT01497262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319693|NCT01497262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102319694|NCT01497262|Immunologic Factors|immunologic factors|mesh-ancestor
102319695|NCT01497262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319696|NCT02224625|Chlorhexidine|chlorhexidine|mesh-list
102319697|NCT02224625|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102319698|NCT02224625|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102319699|NCT02224625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102319700|NCT02224625|Disinfectants|disinfectants|mesh-ancestor
102319701|NCT02224625|Dermatologic Agents|dermatologic agents|mesh-ancestor
102319702|NCT01195493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102319703|NCT02197247|Rifampin|rifampin|mesh-list
102319704|NCT02197247|Osimertinib|osimertinib|mesh-list
102319705|NCT02197247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102319706|NCT02197247|Antitubercular Agents|antitubercular agents|mesh-ancestor
102319707|NCT02197247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102319708|NCT02197247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102028512|NCT03656432|Fluorides|fluorides|mesh-list
102319709|NCT02197247|Leprostatic Agents|leprostatic agents|mesh-ancestor
102319710|NCT02197247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102319711|NCT02197247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102319712|NCT02197247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319713|NCT02197247|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102319714|NCT02197247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102319715|NCT02197247|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102319716|NCT02197247|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102319717|NCT02197247|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102319718|NCT02197247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102319719|NCT02197247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102319720|NCT02197247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102319721|NCT02224157|Budesonide|budesonide|mesh-list
102319722|NCT02224157|Terbutaline|terbutaline|mesh-list
102319723|NCT02224157|Formoterol Fumarate|formoterol fumarate|mesh-list
102319724|NCT02224157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102319725|NCT02224157|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102319726|NCT02224157|Autonomic Agents|autonomic agents|mesh-ancestor
102319727|NCT02224157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102319728|NCT02224157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319729|NCT02224157|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102319730|NCT02224157|Respiratory System Agents|respiratory system agents|mesh-ancestor
102319731|NCT02224157|Glucocorticoids|glucocorticoids|mesh-ancestor
102319732|NCT02224157|Hormones|hormones|mesh-ancestor
102319733|NCT02224157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102319734|NCT02224157|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102319735|NCT02224157|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102319736|NCT02224157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102319737|NCT02224157|Adrenergic Agents|adrenergic agents|mesh-ancestor
102319738|NCT02224157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102319739|NCT02224157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319740|NCT02224157|Sympathomimetics|sympathomimetics|mesh-ancestor
102319741|NCT02224157|Tocolytic Agents|tocolytic agents|mesh-ancestor
102319742|NCT02224157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102319743|NCT02196701|Adalimumab|adalimumab|mesh-list
102319744|NCT02196701|Methotrexate|methotrexate|mesh-list
102319745|NCT02196701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102319746|NCT02196701|Abortifacient Agents|abortifacient agents|mesh-ancestor
102319747|NCT02196701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102319748|NCT02196701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319749|NCT02196701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102319750|NCT02196701|Antimetabolites|antimetabolites|mesh-ancestor
102319751|NCT02196701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319752|NCT02196701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102319753|NCT02196701|Dermatologic Agents|dermatologic agents|mesh-ancestor
102319754|NCT02196701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102319755|NCT02196701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102319756|NCT02196701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102319757|NCT02196701|Immunologic Factors|immunologic factors|mesh-ancestor
102319758|NCT02196701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102319759|NCT02196701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102319760|NCT02196701|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102319761|NCT02196701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102319762|NCT01481116|Glimepiride|glimepiride|mesh-list
102319763|NCT01481116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102319764|NCT01481116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102319765|NCT01481116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319766|NCT01481116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102319767|NCT01481116|Immunologic Factors|immunologic factors|mesh-ancestor
102319768|NCT02222207|Ranibizumab|ranibizumab|mesh-list
102319769|NCT02222207|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102319770|NCT02222207|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102319771|NCT02222207|Growth Substances|growth substances|mesh-ancestor
102319772|NCT02222207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319773|NCT02222207|Growth Inhibitors|growth inhibitors|mesh-ancestor
102319774|NCT02222207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102319775|NCT02195687|Botulinum Toxins|botulinum toxins|mesh-list
102319776|NCT02195687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102319777|NCT02195687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102319778|NCT02195687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102319779|NCT02195687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102319780|NCT02195687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028586|NCT02982590|Anticoagulants|anticoagulants|mesh-ancestor
102319781|NCT02195687|Cholinergic Agents|cholinergic agents|mesh-ancestor
102319782|NCT02195687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102319783|NCT02195687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319784|NCT02195687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102319785|NCT02195687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102319787|NCT02252081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102319788|NCT02252081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319789|NCT01623752|Etanercept|etanercept|mesh-list
102319790|NCT01623752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102319791|NCT01623752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102319792|NCT01623752|Analgesics|analgesics|mesh-ancestor
102319793|NCT01623752|Sensory System Agents|sensory system agents|mesh-ancestor
102319794|NCT01623752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102319795|NCT01623752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319796|NCT01623752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102319797|NCT01623752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102319798|NCT01623752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102319799|NCT01623752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102319800|NCT01623752|Immunologic Factors|immunologic factors|mesh-ancestor
102319801|NCT01623596|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102319802|NCT01623596|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102319803|NCT01623596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319804|NCT01623596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102319805|NCT01623596|Immunologic Factors|immunologic factors|mesh-ancestor
102319806|NCT01623596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319807|NCT02219477|Ritonavir|ritonavir|mesh-list
102319808|NCT02219477|Ribavirin|ribavirin|mesh-list
102319809|NCT02219477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102319810|NCT02219477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102319811|NCT02219477|Protease Inhibitors|protease inhibitors|mesh-ancestor
102319812|NCT02219477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102319813|NCT02219477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319814|NCT02219477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102319815|NCT02219477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102319816|NCT02219477|Antiviral Agents|antiviral agents|mesh-ancestor
102319817|NCT02219477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102319818|NCT02219477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102319819|NCT02219477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102319820|NCT02219477|Antimetabolites|antimetabolites|mesh-ancestor
102319821|NCT02093390|Fluconazole|fluconazole|mesh-list
102319822|NCT02093390|Atorvastatin|atorvastatin|mesh-list
102319823|NCT02093390|Relugolix|relugolix|mesh-list
102319824|NCT02093390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102319825|NCT02093390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102319826|NCT02093390|Antimetabolites|antimetabolites|mesh-ancestor
102319827|NCT02093390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319828|NCT02093390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102319829|NCT02093390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102319830|NCT02093390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102319831|NCT02093390|Antifungal Agents|antifungal agents|mesh-ancestor
102319832|NCT02093390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102319833|NCT02093390|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102319834|NCT02093390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102319835|NCT02093390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102319836|NCT02093390|Hormone Antagonists|hormone antagonists|mesh-ancestor
102319837|NCT02093390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102319838|NCT02093390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319839|NCT02093390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102319840|NCT02093390|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102319841|NCT02093390|Androgen Antagonists|androgen antagonists|mesh-ancestor
102319843|NCT02219087|Anesthetics, Local|anesthetics, local|mesh-ancestor
102319844|NCT02219087|Anesthetics|anesthetics|mesh-ancestor
102319845|NCT02219087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102319846|NCT02219087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319847|NCT02219087|Sensory System Agents|sensory system agents|mesh-ancestor
102319848|NCT02219087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102319849|NCT02248961|Losartan|losartan|mesh-list
102319850|NCT02248961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102319851|NCT02248961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102319852|NCT02248961|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102319853|NCT02248961|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102319854|NCT02248961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319855|NCT02219009|Aripiprazole|aripiprazole|mesh-list
102319856|NCT02219009|Antidepressive Agents|antidepressive agents|mesh-ancestor
102319857|NCT02219009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102319858|NCT02219009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102319859|NCT02219009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102319860|NCT02219009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102319861|NCT02219009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319862|NCT02219009|Dopamine Agonists|dopamine agonists|mesh-ancestor
102319863|NCT02219009|Dopamine Agents|dopamine agents|mesh-ancestor
102319864|NCT02219009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102319865|NCT02219009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319866|NCT02219009|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102319867|NCT02219009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102319868|NCT02219009|Serotonin Agents|serotonin agents|mesh-ancestor
102319869|NCT02219009|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102319870|NCT02219009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102319871|NCT02219009|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102319872|NCT02219009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102319873|NCT01456936|Bupropion|bupropion|mesh-list
102319874|NCT01456936|Nicotine|nicotine|mesh-list
102319875|NCT01456936|Varenicline|varenicline|mesh-list
102319876|NCT01456936|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102319877|NCT01456936|Autonomic Agents|autonomic agents|mesh-ancestor
102319878|NCT01456936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102319879|NCT01456936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319880|NCT01456936|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102319881|NCT01456936|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102319882|NCT01456936|Cholinergic Agents|cholinergic agents|mesh-ancestor
102319883|NCT01456936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102319884|NCT01456936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319885|NCT01456936|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102319886|NCT01456936|Antidepressive Agents|antidepressive agents|mesh-ancestor
102319887|NCT01456936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102319888|NCT01456936|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102319889|NCT01456936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102319890|NCT01456936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102319891|NCT01456936|Dopamine Agents|dopamine agents|mesh-ancestor
102319892|NCT01456936|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102319893|NCT01456936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102319894|NCT01456936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102319895|NCT01456780|Loteprednol Etabonate|loteprednol etabonate|mesh-list
102319896|NCT01456780|Tobramycin|tobramycin|mesh-list
102319897|NCT01456780|Lubricant Eye Drops|lubricant eye drops|mesh-list
102319898|NCT01456780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102319899|NCT01456780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102319900|NCT01456780|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102319901|NCT01456780|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102319902|NCT01456780|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102319903|NCT01480258|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102319904|NCT01480258|Immunologic Factors|immunologic factors|mesh-ancestor
102319905|NCT01480258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319906|NCT01479868|Interferons|interferons|mesh-list
102319907|NCT01479868|Ribavirin|ribavirin|mesh-list
102319908|NCT01479868|Interferon-alpha|interferon-alpha|mesh-list
102319909|NCT01479868|Interferon alpha-2|interferon alpha-2|mesh-list
102319910|NCT01479868|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102319911|NCT01479868|Simeprevir|simeprevir|mesh-list
102319912|NCT01479868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102319913|NCT01479868|Antiviral Agents|antiviral agents|mesh-ancestor
102319914|NCT01479868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102319915|NCT01479868|Antimetabolites|antimetabolites|mesh-ancestor
102319916|NCT01479868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319917|NCT01479868|Immunologic Factors|immunologic factors|mesh-ancestor
102319918|NCT01479868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319919|NCT01479868|Protease Inhibitors|protease inhibitors|mesh-ancestor
102319920|NCT01479868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102319921|NCT01455220|Natalizumab|natalizumab|mesh-list
102319922|NCT01455220|Immunologic Factors|immunologic factors|mesh-ancestor
102319923|NCT01455220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319924|NCT01454596|Aldesleukin|aldesleukin|mesh-list
102319925|NCT01454596|Cyclophosphamide|cyclophosphamide|mesh-list
102319926|NCT01454596|Fludarabine|fludarabine|mesh-list
102319927|NCT01454596|Mitogens|mitogens|mesh-list
102319928|NCT01454596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102319929|NCT01454596|Immunologic Factors|immunologic factors|mesh-ancestor
102319930|NCT01454596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319931|NCT01454596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102319932|NCT01454596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102319933|NCT01454596|Alkylating Agents|alkylating agents|mesh-ancestor
102319934|NCT01454596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319935|NCT01454596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102319936|NCT01454596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102319937|NCT01454596|Mitosis Modulators|mitosis modulators|mesh-ancestor
102319938|NCT01454596|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102319939|NCT01454596|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102319940|NCT01454596|Antiviral Agents|antiviral agents|mesh-ancestor
102319941|NCT01454596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102319942|NCT01454284|Insulin Lispro|insulin lispro|mesh-list
102319943|NCT01454284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102319944|NCT01454284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319945|NCT04541290|Tacrolimus|tacrolimus|mesh-list
102319946|NCT04541290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102319947|NCT04541290|Immunologic Factors|immunologic factors|mesh-ancestor
102319948|NCT04541290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319949|NCT04541290|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102319950|NCT04541290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102319951|NCT04541290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319952|NCT01495702|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102319953|NCT01495702|Antiviral Agents|antiviral agents|mesh-ancestor
102319954|NCT01495702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102319955|NCT01495702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102319956|NCT01495702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102319957|NCT01495000|Denosumab|denosumab|mesh-list
102319958|NCT01495000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102319959|NCT01495000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319960|NCT01494610|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102319961|NCT01494610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102319962|NCT01494610|Autonomic Agents|autonomic agents|mesh-ancestor
102319963|NCT01494610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102319964|NCT01494610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319965|NCT01494610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102319966|NCT01494610|Respiratory System Agents|respiratory system agents|mesh-ancestor
102319967|NCT01494610|Glucocorticoids|glucocorticoids|mesh-ancestor
102319968|NCT01494610|Hormones|hormones|mesh-ancestor
102319969|NCT01494610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102319970|NCT01494610|Sympathomimetics|sympathomimetics|mesh-ancestor
102319971|NCT02116777|Temozolomide|temozolomide|mesh-list
102319972|NCT02116777|Talazoparib|talazoparib|mesh-list
102319973|NCT02116777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102319974|NCT02116777|Alkylating Agents|alkylating agents|mesh-ancestor
102319975|NCT02116777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319976|NCT02116777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102319977|NCT02116777|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102319978|NCT02116777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102319979|NCT01494532|Ropinirole|ropinirole|mesh-list
102319981|NCT01494532|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
102319982|NCT01494532|Dopamine Agents|dopamine agents|mesh-ancestor
102319983|NCT01494532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102319984|NCT01494532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319985|NCT01494532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102319986|NCT01494532|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102319987|NCT01494532|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102319988|NCT01494532|Dopamine Agonists|dopamine agonists|mesh-ancestor
102319989|NCT02191397|Dexetimide|dexetimide|mesh-list
102319990|NCT02191397|Citalopram|citalopram|mesh-list
102319991|NCT02191397|Bupropion|bupropion|mesh-list
102319992|NCT02191397|Escitalopram|escitalopram|mesh-list
102319993|NCT02191397|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102319994|NCT02191397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102319995|NCT02191397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102319996|NCT02191397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102319997|NCT02191397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102319998|NCT02191397|Serotonin Agents|serotonin agents|mesh-ancestor
102319999|NCT02191397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320000|NCT02191397|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102320001|NCT02191397|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102320002|NCT02191397|Parasympatholytics|parasympatholytics|mesh-ancestor
102320003|NCT02191397|Autonomic Agents|autonomic agents|mesh-ancestor
102320004|NCT02191397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102320005|NCT02191397|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102320006|NCT02191397|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102320007|NCT02191397|Cholinergic Agents|cholinergic agents|mesh-ancestor
102320008|NCT02191397|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102320009|NCT02191397|Antidepressive Agents|antidepressive agents|mesh-ancestor
102320010|NCT02191397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102320011|NCT02191397|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102320012|NCT02191397|Dopamine Agents|dopamine agents|mesh-ancestor
102320013|NCT02191397|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102320014|NCT02191397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102320015|NCT02191397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102320017|NCT01630811|Dextromethorphan|dextromethorphan|mesh-list
102320018|NCT01630811|Antitussive Agents|antitussive agents|mesh-ancestor
102320019|NCT01630811|Respiratory System Agents|respiratory system agents|mesh-ancestor
102320020|NCT01630811|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102320021|NCT01630811|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102320022|NCT01630811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102320023|NCT01630811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320024|NCT01630811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320025|NCT01630811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102320026|NCT01630811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102320027|NCT01630811|Adrenergic Agents|adrenergic agents|mesh-ancestor
102320028|NCT01630811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101436764|NCT01527149|Cytarabine|cytarabine|mesh-list
102320029|NCT01630811|Antimalarials|antimalarials|mesh-ancestor
102320030|NCT01630811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102320031|NCT01630811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102320032|NCT01630811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102320033|NCT01630811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102320034|NCT01630811|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102320035|NCT01630811|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102320036|NCT01630811|Cholinergic Agents|cholinergic agents|mesh-ancestor
102320037|NCT01630811|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102320038|NCT01630811|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102320039|NCT01630811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102320040|NCT01630811|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102320041|NCT01630811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102320042|NCT02170025|Riociguat|riociguat|mesh-list
102320043|NCT02170025|Enzyme Activators|enzyme activators|mesh-ancestor
102320044|NCT02170025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320045|NCT02169791|Ixazomib|ixazomib|mesh-list
102320046|NCT02169791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102320047|NCT02169791|Protease Inhibitors|protease inhibitors|mesh-ancestor
102320048|NCT02169791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102320049|NCT02169791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320050|NCT02216357|Ifetroban|ifetroban|mesh-list
102320051|NCT02216357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102320052|NCT01492426|Ribavirin|ribavirin|mesh-list
102320053|NCT01492426|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102320054|NCT01492426|Antimetabolites|antimetabolites|mesh-ancestor
102320055|NCT01492426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320056|NCT01492426|Antiviral Agents|antiviral agents|mesh-ancestor
102320057|NCT01492426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102320058|NCT01453348|Vaccines|vaccines|mesh-list
102320059|NCT01453348|Immunologic Factors|immunologic factors|mesh-ancestor
102320060|NCT01453348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320061|NCT01475734|rGLP-1 protein|rglp-1 protein|mesh-list
102320062|NCT01475734|Incretins|incretins|mesh-ancestor
102320063|NCT01475734|Hormones|hormones|mesh-ancestor
102320064|NCT01475734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102320065|NCT01475734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320066|NCT02189837|Atorvastatin|atorvastatin|mesh-list
102320067|NCT02189837|Evolocumab|evolocumab|mesh-list
102320068|NCT02189837|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102320069|NCT02189837|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102320070|NCT02189837|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102320071|NCT02189837|Antimetabolites|antimetabolites|mesh-ancestor
102320072|NCT02189837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320073|NCT02189837|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102320074|NCT02189837|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102320075|NCT02189837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102320076|NCT02189837|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102320077|NCT02189837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102320078|NCT02189837|Protease Inhibitors|protease inhibitors|mesh-ancestor
102320079|NCT02189837|Immunologic Factors|immunologic factors|mesh-ancestor
102320080|NCT02189837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320081|NCT02216123|Chloroquine|chloroquine|mesh-list
102320082|NCT02216123|Primaquine|primaquine|mesh-list
102320083|NCT02216123|Tafenoquine|tafenoquine|mesh-list
102320084|NCT02216123|Amebicides|amebicides|mesh-ancestor
102320085|NCT02216123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102320086|NCT02216123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102320087|NCT02216123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102320088|NCT02216123|Antimalarials|antimalarials|mesh-ancestor
102320089|NCT02216123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102320090|NCT01490866|Leucovorin|leucovorin|mesh-list
102320091|NCT01490866|Bevacizumab|bevacizumab|mesh-list
102320092|NCT01490866|Fluorouracil|fluorouracil|mesh-list
102320093|NCT01490866|Oxaliplatin|oxaliplatin|mesh-list
102320094|NCT01490866|Axitinib|axitinib|mesh-list
102320095|NCT01490866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102320096|NCT01490866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102320097|NCT01490866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102320098|NCT01490866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102320099|NCT01490866|Growth Substances|growth substances|mesh-ancestor
102320100|NCT01490866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320101|NCT01490866|Growth Inhibitors|growth inhibitors|mesh-ancestor
102320102|NCT01490866|Antimetabolites|antimetabolites|mesh-ancestor
102320103|NCT01490866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320104|NCT01490866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102320105|NCT01490866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102320106|NCT01490866|Immunologic Factors|immunologic factors|mesh-ancestor
102320107|NCT01490866|Antidotes|antidotes|mesh-ancestor
102320108|NCT01490866|Protective Agents|protective agents|mesh-ancestor
102320109|NCT01490866|Vitamin B Complex|vitamin b complex|mesh-ancestor
102320110|NCT01490866|Vitamins|vitamins|mesh-ancestor
102320111|NCT01490866|Micronutrients|micronutrients|mesh-ancestor
102320112|NCT01490866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102320113|NCT01490866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102320114|NCT02215967|Cyclophosphamide|cyclophosphamide|mesh-list
102320115|NCT02215967|Fludarabine|fludarabine|mesh-list
102320116|NCT02215967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102320117|NCT02215967|Immunologic Factors|immunologic factors|mesh-ancestor
102320118|NCT02215967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320119|NCT02215967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102320120|NCT02215967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102320121|NCT02215967|Alkylating Agents|alkylating agents|mesh-ancestor
102320122|NCT02215967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320123|NCT02215967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102320124|NCT02215967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102320125|NCT02168387|Acetylcysteine|acetylcysteine|mesh-list
102320126|NCT02168387|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102320127|NCT02168387|Antiviral Agents|antiviral agents|mesh-ancestor
102320128|NCT02168387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102320129|NCT02168387|Expectorants|expectorants|mesh-ancestor
102320130|NCT02168387|Respiratory System Agents|respiratory system agents|mesh-ancestor
102320131|NCT02168387|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102320132|NCT02168387|Antioxidants|antioxidants|mesh-ancestor
102320133|NCT02168387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320134|NCT02168387|Protective Agents|protective agents|mesh-ancestor
102320135|NCT02168387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320136|NCT02168387|Antidotes|antidotes|mesh-ancestor
102320137|NCT04418219|Interferons|interferons|mesh-list
102320138|NCT04418219|Interferon-alpha|interferon-alpha|mesh-list
102320139|NCT04418219|Interferon alpha-2|interferon alpha-2|mesh-list
102320140|NCT04418219|Cyclophosphamide|cyclophosphamide|mesh-list
102320141|NCT04418219|Pembrolizumab|pembrolizumab|mesh-list
102320142|NCT04418219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102320143|NCT04418219|Immunologic Factors|immunologic factors|mesh-ancestor
102320144|NCT04418219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320145|NCT04418219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102320146|NCT04418219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102320147|NCT04418219|Alkylating Agents|alkylating agents|mesh-ancestor
102320148|NCT04418219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320149|NCT04418219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102320150|NCT04418219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102320151|NCT04418219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102320152|NCT04418219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102028964|NCT04715230|Dopamine Agents|dopamine agents|mesh-ancestor
102320153|NCT04418219|Antiviral Agents|antiviral agents|mesh-ancestor
102320154|NCT04418219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102320155|NCT02167451|Maraviroc|maraviroc|mesh-list
102320156|NCT02167451|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102320157|NCT02167451|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102320158|NCT02167451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320159|NCT02167451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102320160|NCT02167451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102320161|NCT02167451|Antiviral Agents|antiviral agents|mesh-ancestor
102320162|NCT02167451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102320163|NCT02167451|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102320164|NCT02167139|Adalimumab|adalimumab|mesh-list
102320165|NCT02167139|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102320166|NCT02167139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102320167|NCT02167139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102320168|NCT02116309|Indomethacin|indomethacin|mesh-list
102320169|NCT02116309|Epinephrine|epinephrine|mesh-list
102320170|NCT02116309|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102320171|NCT02116309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102320172|NCT02116309|Adrenergic Agents|adrenergic agents|mesh-ancestor
102320173|NCT02116309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102320174|NCT02116309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320175|NCT02116309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320176|NCT02116309|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102320177|NCT02116309|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102320178|NCT02116309|Autonomic Agents|autonomic agents|mesh-ancestor
102320179|NCT02116309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102320180|NCT02116309|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102320181|NCT02116309|Respiratory System Agents|respiratory system agents|mesh-ancestor
102320182|NCT02116309|Mydriatics|mydriatics|mesh-ancestor
102320183|NCT02116309|Sympathomimetics|sympathomimetics|mesh-ancestor
102320184|NCT02116309|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102320185|NCT02116309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102320186|NCT02116309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102320187|NCT02116309|Analgesics|analgesics|mesh-ancestor
102320188|NCT02116309|Sensory System Agents|sensory system agents|mesh-ancestor
102320189|NCT02116309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102320190|NCT02116309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102320191|NCT02116309|Gout Suppressants|gout suppressants|mesh-ancestor
102320192|NCT02116309|Tocolytic Agents|tocolytic agents|mesh-ancestor
102320193|NCT02116309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102320194|NCT02116309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102320195|NCT02116309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102320196|NCT01474486|Ergocalciferols|ergocalciferols|mesh-list
102320197|NCT01474486|Thiamine|thiamine|mesh-list
102320198|NCT01474486|Micronutrients|micronutrients|mesh-list
102320199|NCT01474486|Trace Elements|trace elements|mesh-list
102320200|NCT01474486|Vitamins|vitamins|mesh-ancestor
102320201|NCT01474486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320202|NCT01474486|Vitamin B Complex|vitamin b complex|mesh-ancestor
102320203|NCT01474486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102320204|NCT01474486|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102320205|NCT01451398|Insulin|insulin|mesh-list
102320206|NCT01451398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101662108|NCT00812331|Simeprevir|simeprevir|mesh-list
102320207|NCT01451398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320208|NCT02073565|Everolimus|everolimus|mesh-list
102320209|NCT02073565|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102320210|NCT02073565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102320211|NCT02073565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102320212|NCT02073565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320213|NCT02073565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102320214|NCT02073565|Immunologic Factors|immunologic factors|mesh-ancestor
102320215|NCT02073565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320216|NCT02073565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102320217|NCT02071225|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102320218|NCT02071225|Obinutuzumab|obinutuzumab|mesh-list
102320219|NCT02071225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102320220|NCT02071225|Alkylating Agents|alkylating agents|mesh-ancestor
102320221|NCT02071225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320222|NCT02071225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102320223|NCT02071225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102320224|NCT01450696|Capecitabine|capecitabine|mesh-list
102320225|NCT01450696|Trastuzumab|trastuzumab|mesh-list
102320226|NCT01450696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102320227|NCT01450696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102320228|NCT01450696|Antimetabolites|antimetabolites|mesh-ancestor
102320229|NCT01450696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029034|NCT02373514|Acetaminophen|acetaminophen|mesh-list
102320230|NCT01450696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102320231|NCT02070991|Macitentan|macitentan|mesh-list
102320232|NCT02070991|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
102320233|NCT02070991|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102320234|NCT02070991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320235|NCT02070991|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
102320236|NCT01490086|Aripiprazole|aripiprazole|mesh-list
102320237|NCT01490086|RP5063|rp5063|mesh-list
102320238|NCT01490086|Antidepressive Agents|antidepressive agents|mesh-ancestor
102320239|NCT01490086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102320240|NCT01490086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102320241|NCT01490086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102320242|NCT01490086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102320243|NCT01490086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320244|NCT01490086|Dopamine Agonists|dopamine agonists|mesh-ancestor
102320245|NCT01490086|Dopamine Agents|dopamine agents|mesh-ancestor
102320246|NCT01490086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102320247|NCT01490086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320248|NCT01490086|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102320249|NCT01490086|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102320250|NCT01490086|Serotonin Agents|serotonin agents|mesh-ancestor
102320251|NCT01490086|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102320252|NCT01490086|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102320253|NCT01490086|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102320254|NCT01490086|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102320255|NCT02113579|Fluorides|fluorides|mesh-list
102320256|NCT02113579|Cariostatic Agents|cariostatic agents|mesh-ancestor
102320257|NCT02113579|Protective Agents|protective agents|mesh-ancestor
102320258|NCT02113579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320259|NCT01474018|Bromocriptine|bromocriptine|mesh-list
102320260|NCT01474018|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102320261|NCT01474018|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102320262|NCT01474018|Hormone Antagonists|hormone antagonists|mesh-ancestor
102320263|NCT01474018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102320264|NCT01474018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320265|NCT01474018|Dopamine Agonists|dopamine agonists|mesh-ancestor
102320266|NCT01474018|Dopamine Agents|dopamine agents|mesh-ancestor
102320267|NCT01474018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102320268|NCT01474018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320269|NCT02100475|Insulin|insulin|mesh-list
102320270|NCT02100475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102320271|NCT02100475|Insulin Aspart|insulin aspart|mesh-list
102320272|NCT02100475|Liraglutide|liraglutide|mesh-list
102320273|NCT02100475|Xultophy|xultophy|mesh-list
102320274|NCT02100475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102320275|NCT02100475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320276|NCT02100475|Incretins|incretins|mesh-ancestor
102320277|NCT02100475|Hormones|hormones|mesh-ancestor
102320278|NCT02100475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102320279|NCT04075240|Aspirin|aspirin|mesh-list
102320280|NCT04075240|Rivaroxaban|rivaroxaban|mesh-list
102320281|NCT04075240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102320282|NCT04075240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102320283|NCT04075240|Analgesics|analgesics|mesh-ancestor
102320284|NCT04075240|Sensory System Agents|sensory system agents|mesh-ancestor
102320285|NCT04075240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102320286|NCT04075240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320287|NCT04075240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102320288|NCT04075240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102320289|NCT04075240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102320290|NCT04075240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102320291|NCT04075240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320292|NCT04075240|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102320293|NCT04075240|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102320294|NCT04075240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102320295|NCT04075240|Antipyretics|antipyretics|mesh-ancestor
102320296|NCT04075240|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102320297|NCT04075240|Antithrombins|antithrombins|mesh-ancestor
102320298|NCT04075240|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102320299|NCT04075240|Protease Inhibitors|protease inhibitors|mesh-ancestor
102320300|NCT04075240|Anticoagulants|anticoagulants|mesh-ancestor
102320301|NCT02070757|Meropenem|meropenem|mesh-list
102320302|NCT02070757|Tazobactam|tazobactam|mesh-list
102320303|NCT02070757|Ceftolozane|ceftolozane|mesh-list
102320304|NCT02070757|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
102320305|NCT02070757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102320306|NCT02070757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102320307|NCT02070757|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102320308|NCT02070757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102320309|NCT02070757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320310|NCT02070757|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102320311|NCT02100319|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
102320312|NCT02100319|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102320313|NCT02100319|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102320314|NCT02100319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320315|NCT01625845|Pentoxifylline|pentoxifylline|mesh-list
102320316|NCT01625845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102320317|NCT01625845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102320318|NCT01625845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320319|NCT01625845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102320320|NCT01625845|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102320321|NCT01625845|Protective Agents|protective agents|mesh-ancestor
102320322|NCT01625845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320323|NCT01625845|Vasodilator Agents|vasodilator agents|mesh-ancestor
102320324|NCT01625845|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102320325|NCT01625845|Antioxidants|antioxidants|mesh-ancestor
102320326|NCT01473940|Gemcitabine|gemcitabine|mesh-list
102320327|NCT01473940|Ipilimumab|ipilimumab|mesh-list
102320328|NCT01473940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102320329|NCT01473940|Antibodies|antibodies|mesh-list
102320330|NCT01473940|Immunoglobulins|immunoglobulins|mesh-list
102320331|NCT01473940|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102320332|NCT01473940|Immunologic Factors|immunologic factors|mesh-ancestor
102320333|NCT01473940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320334|NCT01473940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102320335|NCT01473940|Antimetabolites|antimetabolites|mesh-ancestor
102320336|NCT01473940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320337|NCT01473940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102320338|NCT01473940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102320339|NCT01832727|Dexamethasone|dexamethasone|mesh-list
102320340|NCT01832727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102320341|NCT01832727|Antiemetics|antiemetics|mesh-ancestor
102320342|NCT01832727|Autonomic Agents|autonomic agents|mesh-ancestor
102320343|NCT01832727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102320344|NCT01832727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320345|NCT01832727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102320346|NCT01832727|Glucocorticoids|glucocorticoids|mesh-ancestor
102320347|NCT01832727|Hormones|hormones|mesh-ancestor
102320348|NCT01832727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102320349|NCT01832727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102320350|NCT01832727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102320351|NCT01473394|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
102320352|NCT01473394|Antidepressive Agents|antidepressive agents|mesh-ancestor
102320353|NCT01473394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102320354|NCT01473394|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102320355|NCT01473394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102320356|NCT01473394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102320357|NCT01473394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320358|NCT01473394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102320359|NCT01473394|Serotonin Agents|serotonin agents|mesh-ancestor
102320360|NCT01473394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320361|NCT01473394|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102320362|NCT01473394|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102320363|NCT04408144|Dydrogesterone|dydrogesterone|mesh-list
102320364|NCT04408144|Progestins|progestins|mesh-ancestor
102320365|NCT04408144|Hormones|hormones|mesh-ancestor
102320366|NCT04408144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102320367|NCT04408144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320368|NCT01449682|Dexamethasone|dexamethasone|mesh-list
102320369|NCT01449682|Dexamethasone acetate|dexamethasone acetate|mesh-list
102320370|NCT01449682|BB 1101|bb 1101|mesh-list
102320371|NCT01449682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102320372|NCT01449682|Antiemetics|antiemetics|mesh-ancestor
102320373|NCT01449682|Autonomic Agents|autonomic agents|mesh-ancestor
102320374|NCT01449682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102320375|NCT01449682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320376|NCT01449682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102320377|NCT01449682|Glucocorticoids|glucocorticoids|mesh-ancestor
102320378|NCT01449682|Hormones|hormones|mesh-ancestor
102029186|NCT04381936|Aspirin|aspirin|mesh-list
102320379|NCT01449682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102320380|NCT01449682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102320381|NCT01449682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102320382|NCT01449682|Protease Inhibitors|protease inhibitors|mesh-ancestor
102320383|NCT01449682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102320384|NCT01449682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320385|NCT01831791|Dutasteride|dutasteride|mesh-list
102320386|NCT01831791|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102320387|NCT01831791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102320388|NCT01831791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102320389|NCT01831791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320390|NCT01831791|Hormone Antagonists|hormone antagonists|mesh-ancestor
102320391|NCT01831791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102320392|NCT01831791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320393|NCT01857531|Nicotine|nicotine|mesh-list
102320394|NCT01857531|Ganaxolone|ganaxolone|mesh-list
102320395|NCT01857531|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102320396|NCT01857531|Autonomic Agents|autonomic agents|mesh-ancestor
102320397|NCT01857531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102320398|NCT01857531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320399|NCT01857531|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102320400|NCT01857531|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102320401|NCT01857531|Cholinergic Agents|cholinergic agents|mesh-ancestor
102320402|NCT01857531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102320403|NCT01857531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320404|NCT01857531|Neurosteroids|neurosteroids|mesh-ancestor
102320405|NCT01857531|GABA Modulators|gaba modulators|mesh-ancestor
102320406|NCT01857531|GABA Agents|gaba agents|mesh-ancestor
102320407|NCT02166047|Vesatolimod|vesatolimod|mesh-list
102320408|NCT02166047|Antiviral Agents|antiviral agents|mesh-ancestor
102320409|NCT02166047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102320410|NCT01831089|Paclitaxel|paclitaxel|mesh-list
102320411|NCT01831089|Bevacizumab|bevacizumab|mesh-list
102320412|NCT01831089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102320413|NCT01831089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102320414|NCT01831089|Tubulin Modulators|tubulin modulators|mesh-ancestor
102320415|NCT01831089|Antimitotic Agents|antimitotic agents|mesh-ancestor
102320416|NCT01831089|Mitosis Modulators|mitosis modulators|mesh-ancestor
102320417|NCT01831089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320418|NCT01831089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102320419|NCT01831089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102320420|NCT01831089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102320421|NCT01831089|Growth Substances|growth substances|mesh-ancestor
102320422|NCT01831089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320423|NCT01831089|Growth Inhibitors|growth inhibitors|mesh-ancestor
102320424|NCT02111785|Dexamethasone|dexamethasone|mesh-list
102320425|NCT02111785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102320426|NCT02111785|Antiemetics|antiemetics|mesh-ancestor
102320427|NCT02111785|Autonomic Agents|autonomic agents|mesh-ancestor
102320428|NCT02111785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102320429|NCT02111785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320430|NCT02111785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102320431|NCT02111785|Glucocorticoids|glucocorticoids|mesh-ancestor
102320432|NCT02111785|Hormones|hormones|mesh-ancestor
102320433|NCT02111785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102320434|NCT02111785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102320435|NCT02111785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102320436|NCT02068495|Amlodipine|amlodipine|mesh-list
102320437|NCT02068495|Candesartan|candesartan|mesh-list
102320438|NCT02068495|Candesartan cilexetil|candesartan cilexetil|mesh-list
102320439|NCT02068495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102320440|NCT02068495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102320441|NCT02068495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102320442|NCT02068495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320443|NCT02068495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102320444|NCT02068495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320445|NCT02068495|Vasodilator Agents|vasodilator agents|mesh-ancestor
102320446|NCT02068495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102320447|NCT02068495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102320448|NCT02097823|Olanzapine|olanzapine|mesh-list
102320449|NCT02097823|Aprepitant|aprepitant|mesh-list
102320450|NCT02097823|Antiemetics|antiemetics|mesh-ancestor
102320451|NCT02097823|Autonomic Agents|autonomic agents|mesh-ancestor
102320452|NCT02097823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102320453|NCT02097823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320454|NCT02097823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102320455|NCT02097823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102320456|NCT02097823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102320457|NCT02097823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102320458|NCT02097823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102320459|NCT02097823|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102320460|NCT02097823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102320461|NCT02097823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102320462|NCT02097823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320463|NCT02097823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102320464|NCT02097823|Serotonin Agents|serotonin agents|mesh-ancestor
102320465|NCT02097823|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102320466|NCT01857063|Montelukast|montelukast|mesh-list
102320467|NCT01857063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102320468|NCT01857063|Respiratory System Agents|respiratory system agents|mesh-ancestor
102320469|NCT01857063|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102320470|NCT01857063|Hormone Antagonists|hormone antagonists|mesh-ancestor
102320471|NCT01857063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102320472|NCT01857063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320473|NCT01857063|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102320474|NCT01857063|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102320475|NCT01857063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320476|NCT01856907|Metformin|metformin|mesh-list
102320477|NCT01856907|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102320478|NCT01856907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102320479|NCT01856907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320480|NCT01856907|Incretins|incretins|mesh-ancestor
102320481|NCT01856907|Hormones|hormones|mesh-ancestor
102320482|NCT01856907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102320483|NCT01856907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102320484|NCT01856907|Protease Inhibitors|protease inhibitors|mesh-ancestor
102320485|NCT01856907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102320486|NCT01856907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320487|NCT02097745|Rituximab|rituximab|mesh-list
102320488|NCT02097745|Methotrexate|methotrexate|mesh-list
102320489|NCT02097745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102320490|NCT02097745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102320491|NCT02097745|Immunologic Factors|immunologic factors|mesh-ancestor
102320492|NCT02097745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320493|NCT02097745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102320494|NCT02097745|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102320495|NCT02097745|Abortifacient Agents|abortifacient agents|mesh-ancestor
102320496|NCT02097745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102320497|NCT02097745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102320498|NCT02097745|Antimetabolites|antimetabolites|mesh-ancestor
102320499|NCT02097745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320501|NCT02097745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102320502|NCT02097745|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102320503|NCT02097745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102320504|NCT02097745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102320505|NCT02111083|Insulin Lispro|insulin lispro|mesh-list
102320506|NCT02111083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102320507|NCT02111083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320508|NCT01629563|Ulipristal acetate|ulipristal acetate|mesh-list
102320509|NCT01629563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102320510|NCT01629563|Contraceptive Agents|contraceptive agents|mesh-ancestor
102320511|NCT01629563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102320512|NCT01629563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320513|NCT01629563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102320514|NCT02212379|Raltegravir Potassium|raltegravir potassium|mesh-list
102320515|NCT02212379|Etravirine|etravirine|mesh-list
102320516|NCT02212379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102320517|NCT02212379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102320518|NCT02212379|Antiviral Agents|antiviral agents|mesh-ancestor
102320519|NCT02212379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102320520|NCT02212379|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102320521|NCT02212379|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102320522|NCT02212379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102320523|NCT02212379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320524|NCT02212379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102320525|NCT02212379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102320526|NCT02187809|Clobazam|clobazam|mesh-list
102320527|NCT02187809|Anticonvulsants|anticonvulsants|mesh-ancestor
102320528|NCT02187809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102320529|NCT02187809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102320530|NCT02187809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102320531|NCT02187809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320532|NCT02187809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102320533|NCT02187809|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102320534|NCT02187809|GABA Agonists|gaba agonists|mesh-ancestor
102320535|NCT02187809|GABA Agents|gaba agents|mesh-ancestor
102320536|NCT02187809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102320537|NCT02187809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320538|NCT02110225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102320539|NCT02110225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102320540|NCT02110225|Mitogens|mitogens|mesh-list
102320541|NCT02110225|Mitosis Modulators|mitosis modulators|mesh-ancestor
102320542|NCT02110225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320543|NCT04756505|Interleukin-12|interleukin-12|mesh-list
102320544|NCT04756505|Immunoglobulin G|immunoglobulin g|mesh-list
102320545|NCT04756505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102320546|NCT04756505|Immunologic Factors|immunologic factors|mesh-ancestor
102320547|NCT04756505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320548|NCT04756505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102320549|NCT04756505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102320550|NCT04756505|Growth Substances|growth substances|mesh-ancestor
102320551|NCT04756505|Growth Inhibitors|growth inhibitors|mesh-ancestor
102320552|NCT04756505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102320553|NCT04750655|Moxifloxacin|moxifloxacin|mesh-list
102320554|NCT04750655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102320555|NCT04750655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102320556|NCT04750655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102320557|NCT04750655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102320558|NCT04750655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102320559|NCT04750655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320560|NCT04750655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102320561|NCT02162771|Prednisone|prednisone|mesh-list
102320562|NCT02162771|Prednisolone|prednisolone|mesh-list
102320563|NCT02162771|Cyclophosphamide|cyclophosphamide|mesh-list
102320564|NCT02162771|Rituximab|rituximab|mesh-list
102320565|NCT02162771|Vincristine|vincristine|mesh-list
102320566|NCT02162771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102320567|NCT02162771|Immunologic Factors|immunologic factors|mesh-ancestor
102320568|NCT02162771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320569|NCT02162771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102320570|NCT02162771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102320571|NCT02162771|Alkylating Agents|alkylating agents|mesh-ancestor
102320572|NCT02162771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320573|NCT02162771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102320574|NCT02162771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102320575|NCT02162771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102320576|NCT02162771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102320577|NCT02162771|Glucocorticoids|glucocorticoids|mesh-ancestor
102320579|NCT02162771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102320580|NCT02162771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102320581|NCT02162771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102320582|NCT02162771|Tubulin Modulators|tubulin modulators|mesh-ancestor
102320583|NCT02162771|Antimitotic Agents|antimitotic agents|mesh-ancestor
102320584|NCT02162771|Mitosis Modulators|mitosis modulators|mesh-ancestor
102320585|NCT02160041|Infigratinib|infigratinib|mesh-list
102320586|NCT02160041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102320587|NCT02186873|Golimumab|golimumab|mesh-list
102320588|NCT02186873|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102320589|NCT02186873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102320590|NCT02186873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102320591|NCT02186873|Immunologic Factors|immunologic factors|mesh-ancestor
102320592|NCT02186873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320593|NCT02096263|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102320594|NCT02096263|Immunologic Factors|immunologic factors|mesh-ancestor
102320595|NCT02096263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320596|NCT01830543|Aspirin|aspirin|mesh-list
102320597|NCT01830543|Vitamin K|vitamin k|mesh-list
102320598|NCT01830543|Rivaroxaban|rivaroxaban|mesh-list
102320599|NCT01830543|Clopidogrel|clopidogrel|mesh-list
102320600|NCT01830543|Ticagrelor|ticagrelor|mesh-list
102320601|NCT01830543|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102320603|NCT01830543|Micronutrients|micronutrients|mesh-ancestor
102320604|NCT01830543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320605|NCT01830543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102320606|NCT01830543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102320607|NCT01830543|Analgesics|analgesics|mesh-ancestor
102320608|NCT01830543|Sensory System Agents|sensory system agents|mesh-ancestor
102320609|NCT01830543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102320610|NCT01830543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102320611|NCT01830543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102320612|NCT01830543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102320613|NCT01830543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102320614|NCT01830543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320615|NCT01830543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102320616|NCT01830543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102320617|NCT01830543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102320618|NCT01830543|Antipyretics|antipyretics|mesh-ancestor
102320619|NCT01830543|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102320620|NCT01830543|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102320621|NCT01830543|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102320622|NCT01830543|Purinergic Agents|purinergic agents|mesh-ancestor
102320623|NCT01830543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102320624|NCT01830543|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102320625|NCT01830543|Antithrombins|antithrombins|mesh-ancestor
101437385|NCT00165308|Tamoxifen|tamoxifen|mesh-list
102320626|NCT01830543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102320627|NCT01830543|Protease Inhibitors|protease inhibitors|mesh-ancestor
102320628|NCT01830543|Anticoagulants|anticoagulants|mesh-ancestor
102320629|NCT01830543|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102320630|NCT01830543|Hemostatics|hemostatics|mesh-ancestor
102320631|NCT01830543|Coagulants|coagulants|mesh-ancestor
102320632|NCT02109445|Paclitaxel|paclitaxel|mesh-list
102320633|NCT02109445|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102320634|NCT02109445|Gemcitabine|gemcitabine|mesh-list
102320635|NCT02109445|Nirogacestat|nirogacestat|mesh-list
102320636|NCT02109445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102320637|NCT02109445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102320638|NCT02109445|Tubulin Modulators|tubulin modulators|mesh-ancestor
102320639|NCT02109445|Antimitotic Agents|antimitotic agents|mesh-ancestor
102320640|NCT02109445|Mitosis Modulators|mitosis modulators|mesh-ancestor
102320641|NCT02109445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320642|NCT02109445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102320643|NCT02109445|Antimetabolites|antimetabolites|mesh-ancestor
102320644|NCT02109445|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
102320645|NCT02109445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102320646|NCT02109133|Rocuronium|rocuronium|mesh-list
102320647|NCT02109133|Atracurium|atracurium|mesh-list
102320648|NCT02109133|Neostigmine|neostigmine|mesh-list
102320649|NCT02109133|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102320650|NCT02109133|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102320652|NCT02109133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102320653|NCT02109133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320654|NCT02109133|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102320655|NCT02109133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102320656|NCT02109133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320657|NCT02109133|Cholinergic Agents|cholinergic agents|mesh-ancestor
102320658|NCT02109133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102320659|NCT02109133|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102320660|NCT02109133|Autonomic Agents|autonomic agents|mesh-ancestor
102320661|NCT02109133|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102320662|NCT02109133|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102320663|NCT01623271|Gabapentin|gabapentin|mesh-list
102320664|NCT01623271|Analgesics|analgesics|mesh-ancestor
102320665|NCT01623271|Sensory System Agents|sensory system agents|mesh-ancestor
102320666|NCT01623271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102320667|NCT01623271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320668|NCT01623271|Anticonvulsants|anticonvulsants|mesh-ancestor
102320669|NCT01623271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102320670|NCT01623271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102320671|NCT01623271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102320672|NCT01623271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102320673|NCT01623271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102320674|NCT01623271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102320675|NCT01623271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102029483|NCT02372110|Purinergic Agents|purinergic agents|mesh-ancestor
102320676|NCT01623271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320677|NCT01623271|Antimanic Agents|antimanic agents|mesh-ancestor
102320678|NCT02095951|Ethanol|ethanol|mesh-list
102320679|NCT02095951|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102320680|NCT02095951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102320681|NCT02095951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102320682|NCT02095951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320683|NCT02095873|Resveratrol|resveratrol|mesh-list
102320684|NCT02095873|Antioxidants|antioxidants|mesh-ancestor
102320685|NCT02095873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320686|NCT02095873|Protective Agents|protective agents|mesh-ancestor
102320687|NCT02095873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320688|NCT02095873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102320689|NCT02095873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102320690|NCT02094937|Fluticasone|fluticasone|mesh-list
102320691|NCT02094937|Xhance|xhance|mesh-list
102320692|NCT02094937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102320693|NCT02094937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102320694|NCT02094937|Autonomic Agents|autonomic agents|mesh-ancestor
102320695|NCT02094937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102320696|NCT02094937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320697|NCT02094937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102320698|NCT02094937|Respiratory System Agents|respiratory system agents|mesh-ancestor
102320699|NCT02094937|Dermatologic Agents|dermatologic agents|mesh-ancestor
102320700|NCT02094937|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102320701|NCT04724629|Aldesleukin|aldesleukin|mesh-list
102320702|NCT04724629|Colchicine|colchicine|mesh-list
102320703|NCT04724629|Ixekizumab|ixekizumab|mesh-list
102320704|NCT04724629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102320705|NCT04724629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102320706|NCT04724629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102320707|NCT04724629|Antiviral Agents|antiviral agents|mesh-ancestor
102320708|NCT04724629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102320709|NCT04724629|Gout Suppressants|gout suppressants|mesh-ancestor
102320710|NCT04724629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102320711|NCT04724629|Tubulin Modulators|tubulin modulators|mesh-ancestor
102320712|NCT04724629|Antimitotic Agents|antimitotic agents|mesh-ancestor
102320713|NCT04724629|Mitosis Modulators|mitosis modulators|mesh-ancestor
102320714|NCT04724629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320715|NCT04724629|Dermatologic Agents|dermatologic agents|mesh-ancestor
102320716|NCT02186015|Vitamin D|vitamin d|mesh-list
102320717|NCT02186015|Ergocalciferols|ergocalciferols|mesh-list
102320718|NCT02186015|Cholecalciferol|cholecalciferol|mesh-list
102320719|NCT02186015|Vitamins|vitamins|mesh-list
102320720|NCT02186015|Micronutrients|micronutrients|mesh-ancestor
102320721|NCT02186015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320722|NCT02186015|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102320723|NCT02186015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102320724|NCT02066389|Upadacitinib|upadacitinib|mesh-list
102320725|NCT02066389|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102320726|NCT02066389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102320728|NCT02066389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320729|NCT02066389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102320730|NCT02106403|Disinfectants|disinfectants|mesh-list
102320731|NCT02106403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102320732|NCT02133131|Sofosbuvir|sofosbuvir|mesh-list
102320733|NCT02133131|Grazoprevir|grazoprevir|mesh-list
102320734|NCT02133131|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
102320735|NCT02133131|Antiviral Agents|antiviral agents|mesh-ancestor
102320736|NCT02133131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102320737|NCT02106325|Diphenhydramine|diphenhydramine|mesh-list
102320738|NCT02106325|Promethazine|promethazine|mesh-list
102320739|NCT02106325|Ketamine|ketamine|mesh-list
102320740|NCT02106325|Analgesics|analgesics|mesh-ancestor
102320741|NCT02106325|Sensory System Agents|sensory system agents|mesh-ancestor
102320742|NCT02106325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102320743|NCT02106325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320744|NCT02106325|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102320745|NCT02106325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102320746|NCT02106325|Anesthetics, General|anesthetics, general|mesh-ancestor
102320747|NCT02106325|Anesthetics|anesthetics|mesh-ancestor
102320748|NCT02106325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102320749|NCT02106325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102320750|NCT02106325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102320751|NCT02106325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102029561|NCT02359162|Hormones|hormones|mesh-ancestor
102320752|NCT02106325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320753|NCT02106325|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102320754|NCT02106325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102320755|NCT02106325|Anesthetics, Local|anesthetics, local|mesh-ancestor
102320756|NCT02106325|Antiemetics|antiemetics|mesh-ancestor
102320757|NCT02106325|Autonomic Agents|autonomic agents|mesh-ancestor
102320758|NCT02106325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102320759|NCT02106325|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102320760|NCT02106325|Histamine Antagonists|histamine antagonists|mesh-ancestor
102320761|NCT02106325|Histamine Agents|histamine agents|mesh-ancestor
102320762|NCT02106325|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102320763|NCT02106325|Antipruritics|antipruritics|mesh-ancestor
102320764|NCT02106325|Dermatologic Agents|dermatologic agents|mesh-ancestor
102320765|NCT02184611|Bromides|bromides|mesh-list
102320766|NCT02184611|Anticonvulsants|anticonvulsants|mesh-ancestor
102320767|NCT02066311|Nelfinavir|nelfinavir|mesh-list
102320768|NCT02066311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102320769|NCT02066311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102320770|NCT02066311|Protease Inhibitors|protease inhibitors|mesh-ancestor
102320771|NCT02066311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102320772|NCT02066311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320773|NCT02066311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102320774|NCT02066311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102320775|NCT02066311|Antiviral Agents|antiviral agents|mesh-ancestor
102320776|NCT02066311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102320777|NCT01625611|Naltrexone|naltrexone|mesh-list
102320778|NCT01625611|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102320779|NCT01625611|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102320780|NCT01625611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320781|NCT01625611|Sensory System Agents|sensory system agents|mesh-ancestor
102320782|NCT01625611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102320783|NCT02159807|Fentanyl|fentanyl|mesh-list
102320784|NCT02159807|Bupivacaine|bupivacaine|mesh-list
102320785|NCT02159807|Anesthetics, Local|anesthetics, local|mesh-ancestor
102320786|NCT02159807|Anesthetics|anesthetics|mesh-ancestor
102320787|NCT02159807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102320788|NCT02159807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320789|NCT02159807|Sensory System Agents|sensory system agents|mesh-ancestor
102320790|NCT02159807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102320791|NCT02159807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102320792|NCT02159807|Narcotics|narcotics|mesh-ancestor
102320793|NCT02159807|Analgesics|analgesics|mesh-ancestor
102320794|NCT02159807|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102320795|NCT02159807|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102320796|NCT02159807|Anesthetics, General|anesthetics, general|mesh-ancestor
102320797|NCT02183675|Amlodipine|amlodipine|mesh-list
102320798|NCT02183675|Telmisartan|telmisartan|mesh-list
102320799|NCT02183675|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102320800|NCT02183675|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
102320801|NCT02183675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102320802|NCT02183675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102320803|NCT02183675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102320804|NCT02183675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320805|NCT02183675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102320806|NCT02183675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320807|NCT02183675|Vasodilator Agents|vasodilator agents|mesh-ancestor
102320808|NCT02183675|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102320809|NCT02183675|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102320811|NCT02183675|Natriuretic Agents|natriuretic agents|mesh-ancestor
102320812|NCT02183675|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102320813|NCT02183519|Capsaicin|capsaicin|mesh-list
102320814|NCT02183519|Antipruritics|antipruritics|mesh-ancestor
102320815|NCT02183519|Dermatologic Agents|dermatologic agents|mesh-ancestor
102320816|NCT02183519|Sensory System Agents|sensory system agents|mesh-ancestor
102320817|NCT02183519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102320818|NCT02183519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320819|NCT02132195|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102320820|NCT02132195|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
102320821|NCT02132195|beta-Endorphin|beta-endorphin|mesh-list
102320822|NCT02132195|Hormones|hormones|mesh-ancestor
102320823|NCT02132195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102320824|NCT02132195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320825|NCT02132195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102320826|NCT02132195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029633|NCT04473807|Sympatholytics|sympatholytics|mesh-ancestor
102320827|NCT02182895|Saxagliptin|saxagliptin|mesh-list
102320828|NCT02182895|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
102320829|NCT02182895|Incretins|incretins|mesh-ancestor
102320830|NCT02182895|Hormones|hormones|mesh-ancestor
102320831|NCT02182895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102320832|NCT02182895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320833|NCT02182895|Protease Inhibitors|protease inhibitors|mesh-ancestor
102320834|NCT02182895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102320835|NCT02182895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320836|NCT02182895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102320837|NCT01625377|Mycophenolic Acid|mycophenolic acid|mesh-list
102320838|NCT01625377|Everolimus|everolimus|mesh-list
102320839|NCT01625377|Tacrolimus|tacrolimus|mesh-list
102320840|NCT01625377|Basiliximab|basiliximab|mesh-list
102320841|NCT01625377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102320842|NCT01625377|Immunologic Factors|immunologic factors|mesh-ancestor
102320843|NCT01625377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320844|NCT01625377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102320845|NCT01625377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102320846|NCT01625377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320847|NCT01625377|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102320848|NCT01625377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102320849|NCT01625377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102320850|NCT01625377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102320851|NCT01625377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102320852|NCT01625377|Antitubercular Agents|antitubercular agents|mesh-ancestor
102320853|NCT01625377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102320854|NCT01625377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102320855|NCT02132117|Phenylephrine|phenylephrine|mesh-list
102320856|NCT02132117|Oxymetazoline|oxymetazoline|mesh-list
102320857|NCT02132117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102320858|NCT02132117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102320859|NCT02132117|Adrenergic Agents|adrenergic agents|mesh-ancestor
102320860|NCT02132117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102320861|NCT02132117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320862|NCT02132117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320863|NCT02132117|Sympathomimetics|sympathomimetics|mesh-ancestor
102320864|NCT02132117|Autonomic Agents|autonomic agents|mesh-ancestor
102320865|NCT02132117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102320866|NCT02132117|Nasal Decongestants|nasal decongestants|mesh-ancestor
102320867|NCT02132117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102320868|NCT02132117|Respiratory System Agents|respiratory system agents|mesh-ancestor
102320869|NCT02132117|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102320870|NCT02132117|Mydriatics|mydriatics|mesh-ancestor
102320871|NCT02132117|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102320872|NCT02132117|Protective Agents|protective agents|mesh-ancestor
102320873|NCT02047045|Prucalopride|prucalopride|mesh-list
102320874|NCT02047045|Serotonin|serotonin|mesh-list
102320875|NCT02047045|Laxatives|laxatives|mesh-ancestor
102320876|NCT02047045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102320877|NCT02047045|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
102320878|NCT02047045|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102320879|NCT02047045|Serotonin Agents|serotonin agents|mesh-ancestor
102320880|NCT02047045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102320881|NCT02047045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320882|NCT02047045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320883|NCT02131259|Afatinib|afatinib|mesh-list
102320884|NCT02131259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102320885|NCT02131259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102320886|NCT02131259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102320887|NCT02131259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320888|NCT01829295|Mycophenolic Acid|mycophenolic acid|mesh-list
102320889|NCT01829295|Prednisone|prednisone|mesh-list
102320890|NCT01829295|Methotrexate|methotrexate|mesh-list
102320891|NCT01829295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102320892|NCT01829295|Glucocorticoids|glucocorticoids|mesh-ancestor
102320893|NCT01829295|Hormones|hormones|mesh-ancestor
102320894|NCT01829295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102320895|NCT01829295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320896|NCT01829295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102320897|NCT01829295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102320898|NCT01829295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102320899|NCT01829295|Abortifacient Agents|abortifacient agents|mesh-ancestor
102320900|NCT01829295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102320901|NCT01829295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102320902|NCT01829295|Antimetabolites|antimetabolites|mesh-ancestor
102320903|NCT01829295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320904|NCT01829295|Dermatologic Agents|dermatologic agents|mesh-ancestor
102320905|NCT01829295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102320906|NCT01829295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102320907|NCT01829295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102320908|NCT01829295|Immunologic Factors|immunologic factors|mesh-ancestor
102320909|NCT01829295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102320910|NCT01829295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102320911|NCT01829295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102320912|NCT01829295|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102320913|NCT01829295|Antitubercular Agents|antitubercular agents|mesh-ancestor
102320914|NCT01829295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102320915|NCT01829295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102320916|NCT02157935|Formoterol Fumarate|formoterol fumarate|mesh-list
102320917|NCT02157935|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
102320918|NCT02157935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102320919|NCT02157935|Autonomic Agents|autonomic agents|mesh-ancestor
102320920|NCT02157935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102320921|NCT02157935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320922|NCT02157935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102320923|NCT02157935|Respiratory System Agents|respiratory system agents|mesh-ancestor
102320924|NCT02157935|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102320925|NCT02157935|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102320926|NCT02157935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102320927|NCT02157935|Adrenergic Agents|adrenergic agents|mesh-ancestor
102320928|NCT02157935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102320929|NCT02157935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320930|NCT02093221|Protease Inhibitors|protease inhibitors|mesh-list
102320931|NCT02093221|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
102320932|NCT02093221|Protein C Inhibitor|protein c inhibitor|mesh-list
102320933|NCT02093221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102320934|NCT02093221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320935|NCT02093221|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102320936|NCT02093221|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102320937|NCT01623115|Alirocumab|alirocumab|mesh-list
102320938|NCT01623115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102320939|NCT01623115|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102320940|NCT01623115|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102320941|NCT01623115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102320942|NCT01623115|Antimetabolites|antimetabolites|mesh-ancestor
102320943|NCT01623115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320944|NCT01623115|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102320945|NCT01623115|Protease Inhibitors|protease inhibitors|mesh-ancestor
102320946|NCT01623115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102320947|NCT01623115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102320948|NCT01623115|Immunologic Factors|immunologic factors|mesh-ancestor
102320949|NCT01623115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320951|NCT02092285|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102320952|NCT02092285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102320953|NCT02092285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102320954|NCT02092285|Immunologic Factors|immunologic factors|mesh-ancestor
102320955|NCT02092285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320956|NCT02091739|Botulinum Toxins|botulinum toxins|mesh-list
102320957|NCT02091739|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102320958|NCT02091739|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102320959|NCT02091739|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102320960|NCT02091739|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102320961|NCT02091739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102320962|NCT02091739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320963|NCT02091739|Cholinergic Agents|cholinergic agents|mesh-ancestor
102320964|NCT02091739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102320965|NCT02091739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320966|NCT02091739|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102320967|NCT02091739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102320968|NCT02045875|Mometasone Furoate|mometasone furoate|mesh-list
102320969|NCT02045875|Formoterol Fumarate|formoterol fumarate|mesh-list
102320970|NCT02045875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102320971|NCT02045875|Autonomic Agents|autonomic agents|mesh-ancestor
102320972|NCT02045875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102320973|NCT02045875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029785|NCT02368054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102320974|NCT02045875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102320975|NCT02045875|Respiratory System Agents|respiratory system agents|mesh-ancestor
102320976|NCT02045875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102320977|NCT02045875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102320978|NCT02045875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102320979|NCT02045875|Adrenergic Agents|adrenergic agents|mesh-ancestor
102320980|NCT02045875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102320981|NCT02045875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320982|NCT02045875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102320983|NCT02045875|Dermatologic Agents|dermatologic agents|mesh-ancestor
102320984|NCT02045875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102320985|NCT01827267|Sirolimus|sirolimus|mesh-list
102320986|NCT01827267|Temsirolimus|temsirolimus|mesh-list
102320987|NCT01827267|MTOR Inhibitors|mtor inhibitors|mesh-list
102320988|NCT01827267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102320989|NCT01827267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102320990|NCT01827267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102320991|NCT01827267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102320992|NCT01827267|Immunologic Factors|immunologic factors|mesh-ancestor
102320993|NCT01827267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102320994|NCT01827267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102320995|NCT01827267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102320996|NCT01827267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102320997|NCT01827267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102320998|NCT01827267|Antifungal Agents|antifungal agents|mesh-ancestor
102320999|NCT01827111|Paclitaxel|paclitaxel|mesh-list
102321000|NCT01827111|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102321001|NCT01827111|Ipilimumab|ipilimumab|mesh-list
102321002|NCT01827111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102321003|NCT01827111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102321004|NCT01827111|Tubulin Modulators|tubulin modulators|mesh-ancestor
102321005|NCT01827111|Antimitotic Agents|antimitotic agents|mesh-ancestor
102321006|NCT01827111|Mitosis Modulators|mitosis modulators|mesh-ancestor
102321007|NCT01827111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321008|NCT01827111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102321009|NCT01827111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102321010|NCT02064439|Rivaroxaban|rivaroxaban|mesh-list
102321011|NCT02064439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102321012|NCT02064439|Antithrombins|antithrombins|mesh-ancestor
101437778|NCT05124067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102321013|NCT02064439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102321014|NCT02064439|Protease Inhibitors|protease inhibitors|mesh-ancestor
102321015|NCT02064439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102321016|NCT02064439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321017|NCT02064439|Anticoagulants|anticoagulants|mesh-ancestor
102321018|NCT02130557|Imatinib Mesylate|imatinib mesylate|mesh-list
102321019|NCT02130557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102321020|NCT02130557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102321021|NCT02130557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102321022|NCT02130557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321023|NCT01854645|Bromides|bromides|mesh-list
102321024|NCT01854645|Tiotropium Bromide|tiotropium bromide|mesh-list
102321025|NCT01854645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102321026|NCT01854645|Autonomic Agents|autonomic agents|mesh-ancestor
102321027|NCT01854645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102321028|NCT01854645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321029|NCT01854645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102321030|NCT01854645|Respiratory System Agents|respiratory system agents|mesh-ancestor
102321031|NCT01854645|Parasympatholytics|parasympatholytics|mesh-ancestor
102321032|NCT01854645|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102321033|NCT01854645|Cholinergic Agents|cholinergic agents|mesh-ancestor
102321034|NCT01854645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102321035|NCT01854645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321036|NCT01854645|Anticonvulsants|anticonvulsants|mesh-ancestor
102321037|NCT04418089|Simvastatin|simvastatin|mesh-list
102321038|NCT04418089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102321039|NCT04418089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102321040|NCT04418089|Antimetabolites|antimetabolites|mesh-ancestor
102321041|NCT04418089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321042|NCT04418089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102321043|NCT04418089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102321044|NCT04418089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102321045|NCT01825941|Diphenhydramine|diphenhydramine|mesh-list
102321046|NCT01825941|Promethazine|promethazine|mesh-list
101836568|NCT00501540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321047|NCT01825941|Metoclopramide|metoclopramide|mesh-list
102321048|NCT01825941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102321049|NCT01825941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102321050|NCT01825941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102321051|NCT01825941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321052|NCT01825941|Anesthetics, Local|anesthetics, local|mesh-ancestor
102321053|NCT01825941|Anesthetics|anesthetics|mesh-ancestor
102321054|NCT01825941|Sensory System Agents|sensory system agents|mesh-ancestor
102321055|NCT01825941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102321056|NCT01825941|Antiemetics|antiemetics|mesh-ancestor
102321057|NCT01825941|Autonomic Agents|autonomic agents|mesh-ancestor
102321058|NCT01825941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102321059|NCT01825941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102321060|NCT01825941|Histamine Antagonists|histamine antagonists|mesh-ancestor
102321061|NCT01825941|Histamine Agents|histamine agents|mesh-ancestor
102321062|NCT01825941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102321063|NCT01825941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321064|NCT01825941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102321065|NCT01825941|Antipruritics|antipruritics|mesh-ancestor
102321066|NCT01825941|Dermatologic Agents|dermatologic agents|mesh-ancestor
102321067|NCT01825941|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102321068|NCT01825941|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102321069|NCT01825941|Dopamine Agents|dopamine agents|mesh-ancestor
102321070|NCT02044159|Hydrocortisone|hydrocortisone|mesh-list
102321071|NCT02044159|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102321072|NCT02044159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102321073|NCT02180165|Voriconazole|voriconazole|mesh-list
102321074|NCT02180165|Posaconazole|posaconazole|mesh-list
102321075|NCT02180165|Antifungal Agents|antifungal agents|mesh-ancestor
102321076|NCT02180165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102321077|NCT02180165|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102321078|NCT02180165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102321079|NCT02180165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102321080|NCT02180165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321081|NCT02180165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102321082|NCT02180165|Hormone Antagonists|hormone antagonists|mesh-ancestor
102321083|NCT02180165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102321084|NCT02180165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321085|NCT02180165|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102321086|NCT02180165|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102321087|NCT02180165|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102321088|NCT02180165|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102321089|NCT02155985|Aspirin|aspirin|mesh-list
102321090|NCT02155985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102321091|NCT02155985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102321092|NCT02155985|Analgesics|analgesics|mesh-ancestor
102321093|NCT02155985|Sensory System Agents|sensory system agents|mesh-ancestor
102321094|NCT02155985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102321095|NCT02155985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321096|NCT02155985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102321097|NCT02155985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102321098|NCT02155985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102321099|NCT02155985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102321100|NCT02155985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321101|NCT02155985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102321102|NCT02155985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102321103|NCT02155985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102321104|NCT02155985|Antipyretics|antipyretics|mesh-ancestor
102321105|NCT02155829|Riluzole|riluzole|mesh-list
102321106|NCT02155829|Anticonvulsants|anticonvulsants|mesh-ancestor
102321107|NCT02155829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102321108|NCT02155829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102321109|NCT02155829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102321110|NCT02155829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321111|NCT02155829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321112|NCT02155829|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102321113|NCT02155829|Protective Agents|protective agents|mesh-ancestor
102321114|NCT02178995|Methylphenidate|methylphenidate|mesh-list
102321115|NCT02178995|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102321116|NCT02178995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321117|NCT02178995|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102321118|NCT02178995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102321119|NCT02178995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102321120|NCT02178995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321121|NCT02178995|Dopamine Agents|dopamine agents|mesh-ancestor
102321122|NCT02178995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102321123|NCT02154425|Certolizumab Pegol|certolizumab pegol|mesh-list
102321124|NCT02154425|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102321125|NCT02154425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102321126|NCT02154425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102321127|NCT02154425|Immunologic Factors|immunologic factors|mesh-ancestor
102321128|NCT02154425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321129|NCT02154425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102321130|NCT02154347|Mitiglinide|mitiglinide|mesh-list
102321131|NCT02154347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102321132|NCT02154347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321133|NCT01627067|Metformin|metformin|mesh-list
102321134|NCT01627067|Everolimus|everolimus|mesh-list
102321135|NCT01627067|Exemestane|exemestane|mesh-list
102321136|NCT01627067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102321137|NCT01627067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321138|NCT01627067|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102321139|NCT01627067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102321140|NCT01627067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102321141|NCT01627067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321142|NCT01627067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102321143|NCT01627067|Immunologic Factors|immunologic factors|mesh-ancestor
102321144|NCT01627067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102321145|NCT01627067|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102321146|NCT01627067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102321147|NCT01627067|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102321148|NCT01627067|Hormone Antagonists|hormone antagonists|mesh-ancestor
102321149|NCT01627067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102321150|NCT02178059|Terbutaline|terbutaline|mesh-list
102321151|NCT02178059|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102321152|NCT02178059|Autonomic Agents|autonomic agents|mesh-ancestor
102321153|NCT02178059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102321154|NCT02178059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321155|NCT02178059|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102321156|NCT02178059|Respiratory System Agents|respiratory system agents|mesh-ancestor
102321157|NCT02178059|Sympathomimetics|sympathomimetics|mesh-ancestor
102321158|NCT02178059|Tocolytic Agents|tocolytic agents|mesh-ancestor
102321159|NCT02178059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102321160|NCT02178059|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102321161|NCT02178059|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102321162|NCT02178059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102321163|NCT02178059|Adrenergic Agents|adrenergic agents|mesh-ancestor
102321164|NCT02178059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102321165|NCT02178059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321166|NCT02128217|Ribavirin|ribavirin|mesh-list
102321167|NCT02128217|Sofosbuvir|sofosbuvir|mesh-list
102321168|NCT02128217|Ledipasvir|ledipasvir|mesh-list
102321169|NCT02128217|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102321170|NCT02128217|Antimetabolites|antimetabolites|mesh-ancestor
102321171|NCT02128217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321172|NCT02128217|Antiviral Agents|antiviral agents|mesh-ancestor
102321173|NCT02128217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102321174|NCT01628549|Sarecycline|sarecycline|mesh-list
102321175|NCT01628549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102321176|NCT01628549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102321177|NCT01628549|Dermatologic Agents|dermatologic agents|mesh-ancestor
102321178|NCT02127125|Sevelamer|sevelamer|mesh-list
102321179|NCT02127125|Chelating Agents|chelating agents|mesh-ancestor
102321180|NCT02127125|Sequestering Agents|sequestering agents|mesh-ancestor
102321181|NCT02127125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321182|NCT02090413|Aspirin|aspirin|mesh-list
102321183|NCT02090413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102321184|NCT02090413|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102321185|NCT02090413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102321186|NCT02090413|Analgesics|analgesics|mesh-ancestor
102321187|NCT02090413|Sensory System Agents|sensory system agents|mesh-ancestor
102321188|NCT02090413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102321189|NCT02090413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321190|NCT02090413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102321191|NCT02090413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102321192|NCT02090413|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102321193|NCT02090413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102321194|NCT02090413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321195|NCT02090413|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102321196|NCT02090413|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102321198|NCT02090413|Antipyretics|antipyretics|mesh-ancestor
102321199|NCT02090413|Dermatologic Agents|dermatologic agents|mesh-ancestor
102321200|NCT02090413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102321201|NCT02090413|Immunologic Factors|immunologic factors|mesh-ancestor
102321202|NCT02125877|Deferasirox|deferasirox|mesh-list
102321203|NCT02125877|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102321204|NCT02125877|Chelating Agents|chelating agents|mesh-ancestor
102321205|NCT02125877|Sequestering Agents|sequestering agents|mesh-ancestor
102321206|NCT02125877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321207|NCT01598987|Cyclosporine|cyclosporine|mesh-list
102321208|NCT01598987|Everolimus|everolimus|mesh-list
102321209|NCT01598987|Tacrolimus|tacrolimus|mesh-list
102321210|NCT01598987|Cyclosporins|cyclosporins|mesh-list
102321211|NCT01598987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102321212|NCT01598987|Immunologic Factors|immunologic factors|mesh-ancestor
102321213|NCT01598987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321214|NCT01598987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102321215|NCT01598987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102321216|NCT01598987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321217|NCT01598987|Antifungal Agents|antifungal agents|mesh-ancestor
102321218|NCT01598987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102321219|NCT01598987|Dermatologic Agents|dermatologic agents|mesh-ancestor
102321220|NCT01598987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102321221|NCT01598987|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102321222|NCT01598987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102321223|NCT01598987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102321224|NCT02062879|Ketamine|ketamine|mesh-list
102321225|NCT02062879|Hydromorphone|hydromorphone|mesh-list
102321226|NCT02062879|Analgesics|analgesics|mesh-ancestor
102321227|NCT02062879|Sensory System Agents|sensory system agents|mesh-ancestor
102321228|NCT02062879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102321229|NCT02062879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321230|NCT02062879|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102321231|NCT02062879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102321232|NCT02062879|Anesthetics, General|anesthetics, general|mesh-ancestor
102321233|NCT02062879|Anesthetics|anesthetics|mesh-ancestor
102321234|NCT02062879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102321235|NCT02062879|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102321236|NCT02062879|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102321237|NCT02062879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102321238|NCT02062879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321239|NCT02062879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102321240|NCT02062879|Narcotics|narcotics|mesh-ancestor
102321241|NCT02062645|Amlodipine|amlodipine|mesh-list
102321242|NCT02062645|Valsartan|valsartan|mesh-list
102321243|NCT02062645|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
102321244|NCT02062645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102321245|NCT02062645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102321246|NCT02062645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102321247|NCT02062645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321248|NCT02062645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102321249|NCT02062645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321250|NCT02062645|Vasodilator Agents|vasodilator agents|mesh-ancestor
102321251|NCT02062645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102321252|NCT02062645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102321253|NCT04700839|Metformin|metformin|mesh-list
102321254|NCT04700839|Canagliflozin|canagliflozin|mesh-list
102321255|NCT04700839|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102321256|NCT04700839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102321257|NCT04700839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321258|NCT04700839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321259|NCT02043301|Bococizumab|bococizumab|mesh-list
102321260|NCT02043301|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102321261|NCT02043301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102321262|NCT02043301|Antimetabolites|antimetabolites|mesh-ancestor
102321263|NCT02043301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321264|NCT02043301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102321265|NCT01598753|Tramadol|tramadol|mesh-list
102321266|NCT01598753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102321267|NCT01598753|Narcotics|narcotics|mesh-ancestor
102321268|NCT01598753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102321269|NCT01598753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321270|NCT01598753|Analgesics|analgesics|mesh-ancestor
102321271|NCT01598753|Sensory System Agents|sensory system agents|mesh-ancestor
102321272|NCT01598753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102321273|NCT01824693|Mycophenolic Acid|mycophenolic acid|mesh-list
102321274|NCT01824693|Cyclophosphamide|cyclophosphamide|mesh-list
102321275|NCT01824693|Melphalan|melphalan|mesh-list
102321276|NCT01824693|Busulfan|busulfan|mesh-list
102321277|NCT01824693|Mechlorethamine|mechlorethamine|mesh-list
102321278|NCT01824693|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102321279|NCT01824693|Fludarabine|fludarabine|mesh-list
102321280|NCT01824693|Fludarabine phosphate|fludarabine phosphate|mesh-list
102321281|NCT01824693|Tacrolimus|tacrolimus|mesh-list
102321282|NCT01824693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102321283|NCT01824693|Immunologic Factors|immunologic factors|mesh-ancestor
102321284|NCT01824693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321285|NCT01824693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102321286|NCT01824693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102321287|NCT01824693|Alkylating Agents|alkylating agents|mesh-ancestor
102321288|NCT01824693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321289|NCT01824693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102321290|NCT01824693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102321291|NCT01824693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102321292|NCT01824693|Antimetabolites|antimetabolites|mesh-ancestor
102321293|NCT01824693|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102321294|NCT01824693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102321295|NCT01824693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102321296|NCT01824693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102321297|NCT01824693|Antitubercular Agents|antitubercular agents|mesh-ancestor
102321298|NCT01824693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102321299|NCT01824693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102321300|NCT02176655|Aspirin|aspirin|mesh-list
102321301|NCT02176655|Sumatriptan|sumatriptan|mesh-list
102321302|NCT02176655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102321303|NCT02176655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102321304|NCT02176655|Analgesics|analgesics|mesh-ancestor
102321305|NCT02176655|Sensory System Agents|sensory system agents|mesh-ancestor
102321306|NCT02176655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102321307|NCT02176655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321308|NCT02176655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102321309|NCT02176655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102321310|NCT02176655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102321311|NCT02176655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102321312|NCT02176655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321313|NCT02176655|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102321314|NCT02176655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102321315|NCT02176655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102321316|NCT02176655|Antipyretics|antipyretics|mesh-ancestor
102321317|NCT02176655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102321318|NCT02176655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102321319|NCT02176655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102321320|NCT02176655|Serotonin Agents|serotonin agents|mesh-ancestor
102321321|NCT02176655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102321322|NCT01622569|Fluticasone|fluticasone|mesh-list
102321323|NCT01622569|Xhance|xhance|mesh-list
102321324|NCT01622569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102321325|NCT01622569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102321326|NCT01622569|Autonomic Agents|autonomic agents|mesh-ancestor
102321327|NCT01622569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102321328|NCT01622569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321329|NCT01622569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102321330|NCT01622569|Respiratory System Agents|respiratory system agents|mesh-ancestor
102321331|NCT01622569|Dermatologic Agents|dermatologic agents|mesh-ancestor
102321332|NCT01622569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102321333|NCT02152631|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102321334|NCT02152631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102321335|NCT02152631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102321336|NCT02152631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102321337|NCT02152631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321338|NCT04747301|Dinoprostone|dinoprostone|mesh-list
102321339|NCT04747301|Oxytocics|oxytocics|mesh-ancestor
102321340|NCT04747301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102321341|NCT04747301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321342|NCT02152163|Ibuprofen|ibuprofen|mesh-list
102321343|NCT02152163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102321344|NCT02152163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102321345|NCT02152163|Analgesics|analgesics|mesh-ancestor
102321346|NCT02152163|Sensory System Agents|sensory system agents|mesh-ancestor
102321347|NCT02152163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102321348|NCT02152163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321349|NCT02152163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102321350|NCT02152163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102321351|NCT02152163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102321352|NCT02152163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102321353|NCT02152163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321355|NCT02152007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102321356|NCT02152007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102321357|NCT02152007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102321358|NCT02152007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102321359|NCT02152007|Antifungal Agents|antifungal agents|mesh-ancestor
102321360|NCT02152007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102321361|NCT02152007|Immunologic Factors|immunologic factors|mesh-ancestor
102321362|NCT02152007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321363|NCT02151851|Certolizumab Pegol|certolizumab pegol|mesh-list
102321364|NCT02151851|Methotrexate|methotrexate|mesh-list
102321365|NCT02151851|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102321366|NCT02151851|Abortifacient Agents|abortifacient agents|mesh-ancestor
102321367|NCT02151851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102321368|NCT02151851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321369|NCT02151851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102321370|NCT02151851|Antimetabolites|antimetabolites|mesh-ancestor
102321371|NCT02151851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321372|NCT02151851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102321373|NCT02151851|Dermatologic Agents|dermatologic agents|mesh-ancestor
102321374|NCT02151851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102321375|NCT02151851|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102321376|NCT02151851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102321377|NCT02151851|Immunologic Factors|immunologic factors|mesh-ancestor
102321378|NCT02151851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102321379|NCT02151851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102321380|NCT02151851|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102321381|NCT02151851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102321382|NCT02176421|Lidocaine|lidocaine|mesh-list
102321383|NCT02176421|Anesthetics, Local|anesthetics, local|mesh-ancestor
102321384|NCT02176421|Anesthetics|anesthetics|mesh-ancestor
102321385|NCT02176421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102321386|NCT02176421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321387|NCT02176421|Sensory System Agents|sensory system agents|mesh-ancestor
102321388|NCT02176421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102321389|NCT02176421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102321390|NCT02176421|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102321391|NCT02176421|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102321392|NCT02176421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102321393|NCT02176421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321394|NCT02042443|Calcium, Dietary|calcium, dietary|mesh-list
102321395|NCT02042443|Leucovorin|leucovorin|mesh-list
102321396|NCT02042443|Folic Acid|folic acid|mesh-list
102321397|NCT02042443|Fluorouracil|fluorouracil|mesh-list
102321398|NCT02042443|Capecitabine|capecitabine|mesh-list
102321399|NCT02042443|Trametinib|trametinib|mesh-list
102321400|NCT02042443|Calcium|calcium|mesh-list
102321401|NCT02042443|Levoleucovorin|levoleucovorin|mesh-list
102321402|NCT02042443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102321403|NCT02042443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321404|NCT02042443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102321405|NCT02042443|Antimetabolites|antimetabolites|mesh-ancestor
102321406|NCT02042443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321407|NCT02042443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102321408|NCT02042443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102321409|NCT02042443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102321410|NCT02042443|Immunologic Factors|immunologic factors|mesh-ancestor
102321411|NCT02042443|Antidotes|antidotes|mesh-ancestor
102321412|NCT02042443|Protective Agents|protective agents|mesh-ancestor
102321413|NCT02042443|Vitamin B Complex|vitamin b complex|mesh-ancestor
102321414|NCT02042443|Vitamins|vitamins|mesh-ancestor
102321415|NCT02042443|Micronutrients|micronutrients|mesh-ancestor
102321416|NCT02042443|Hematinics|hematinics|mesh-ancestor
102321417|NCT02042443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102321418|NCT02042443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102321419|NCT04747145|Temozolomide|temozolomide|mesh-list
102321420|NCT04747145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102321421|NCT04747145|Alkylating Agents|alkylating agents|mesh-ancestor
102321422|NCT04747145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321423|NCT04747145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102321424|NCT02118896|Tacrolimus|tacrolimus|mesh-list
102321425|NCT02118896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102321426|NCT02118896|Immunologic Factors|immunologic factors|mesh-ancestor
102321427|NCT02118896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321428|NCT02118896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102321429|NCT02118896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102321430|NCT02118896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321431|NCT02124707|Paclitaxel|paclitaxel|mesh-list
102321432|NCT02124707|Carboplatin|carboplatin|mesh-list
102321433|NCT02124707|Cetuximab|cetuximab|mesh-list
102321434|NCT02124707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102321435|NCT02124707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102321436|NCT02124707|Tubulin Modulators|tubulin modulators|mesh-ancestor
102321437|NCT02124707|Antimitotic Agents|antimitotic agents|mesh-ancestor
102321438|NCT02124707|Mitosis Modulators|mitosis modulators|mesh-ancestor
102321439|NCT02124707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321440|NCT02124707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102321441|NCT04723862|Spironolactone|spironolactone|mesh-list
102321442|NCT04723862|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102321443|NCT04723862|Hormone Antagonists|hormone antagonists|mesh-ancestor
102321444|NCT04723862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102321445|NCT04723862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321446|NCT04723862|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102321447|NCT04723862|Diuretics|diuretics|mesh-ancestor
102321448|NCT04723862|Natriuretic Agents|natriuretic agents|mesh-ancestor
102321449|NCT02092220|Pancrelipase|pancrelipase|mesh-list
102321450|NCT02092220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102321451|NCT02066402|Linezolid|linezolid|mesh-list
102321452|NCT02066402|Tedizolid|tedizolid|mesh-list
102321453|NCT02066402|Oxazolidinones|oxazolidinones|mesh-list
102321454|NCT02066402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102321455|NCT02066402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102321456|NCT02066402|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102321457|NCT02066402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102321458|NCT02066402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321459|NCT02060383|Metformin|metformin|mesh-list
102321460|NCT02060383|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102321461|NCT02060383|Liraglutide|liraglutide|mesh-list
102321462|NCT02060383|Pasireotide|pasireotide|mesh-list
102321463|NCT02060383|Somatostatin|somatostatin|mesh-list
102321464|NCT02060383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102321465|NCT02060383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321466|NCT02060383|Incretins|incretins|mesh-ancestor
102321467|NCT02060383|Hormones|hormones|mesh-ancestor
102321468|NCT02060383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102321469|NCT02060383|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102321470|NCT02060383|Protease Inhibitors|protease inhibitors|mesh-ancestor
102321471|NCT02060383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102321472|NCT02060383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321473|NCT02086591|Doxycycline|doxycycline|mesh-list
102321474|NCT02086591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102321475|NCT02086591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102321476|NCT02086591|Antimalarials|antimalarials|mesh-ancestor
102321477|NCT02086591|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102321478|NCT02086591|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102321479|NCT02065622|Adalimumab|adalimumab|mesh-list
102321480|NCT02065622|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102321481|NCT02065622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102321482|NCT02065622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102321483|NCT02117648|Clarithromycin|clarithromycin|mesh-list
102321484|NCT02117648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102321485|NCT02117648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102321486|NCT02117648|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102321487|NCT02117648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102321488|NCT02117648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321489|NCT02117648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102321490|NCT02117648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102321491|NCT02124161|Vaccines|vaccines|mesh-list
102321492|NCT02124161|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102321493|NCT02124161|Immunologic Factors|immunologic factors|mesh-ancestor
102321494|NCT02124161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321495|NCT02117570|Vaccines|vaccines|mesh-list
102321496|NCT02117570|Immunologic Factors|immunologic factors|mesh-ancestor
102321497|NCT02117570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321498|NCT02123459|Cephalexin|cephalexin|mesh-list
102321499|NCT02123459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102321500|NCT02123459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102321501|NCT01853475|Artefenomel|artefenomel|mesh-list
102321502|NCT01853475|Antimalarials|antimalarials|mesh-ancestor
102321503|NCT01853475|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102321504|NCT01853475|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102321505|NCT01853475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102321506|NCT04411160|Nitric Oxide|nitric oxide|mesh-list
102321507|NCT04411160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321508|NCT04411160|Antioxidants|antioxidants|mesh-ancestor
102321509|NCT04411160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321510|NCT04411160|Protective Agents|protective agents|mesh-ancestor
102321511|NCT04411160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102321512|NCT04411160|Autonomic Agents|autonomic agents|mesh-ancestor
102321513|NCT04411160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102321514|NCT04411160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102321515|NCT04411160|Respiratory System Agents|respiratory system agents|mesh-ancestor
102321516|NCT04411160|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102321517|NCT04411160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102321518|NCT04411160|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102321519|NCT04411160|Vasodilator Agents|vasodilator agents|mesh-ancestor
102321520|NCT04411160|Gasotransmitters|gasotransmitters|mesh-ancestor
102321521|NCT02151773|Vaccines|vaccines|mesh-list
102321522|NCT02151773|Immunologic Factors|immunologic factors|mesh-ancestor
102321523|NCT02151773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321524|NCT02151461|Metformin|metformin|mesh-list
102321525|NCT02151461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102321526|NCT02151461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321527|NCT02091986|Budesonide|budesonide|mesh-list
102321528|NCT02091986|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
102321529|NCT02091986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102321530|NCT02091986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102321531|NCT02091986|Autonomic Agents|autonomic agents|mesh-ancestor
102321532|NCT02091986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102321533|NCT02091986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321534|NCT02091986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102321535|NCT02091986|Respiratory System Agents|respiratory system agents|mesh-ancestor
102321536|NCT02091986|Glucocorticoids|glucocorticoids|mesh-ancestor
102321537|NCT02091986|Hormones|hormones|mesh-ancestor
102321538|NCT02091986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102321539|NCT02117024|Paclitaxel|paclitaxel|mesh-list
102321540|NCT02117024|Vinorelbine|vinorelbine|mesh-list
102321541|NCT02117024|Docetaxel|docetaxel|mesh-list
102321542|NCT02117024|Cyclophosphamide|cyclophosphamide|mesh-list
102321543|NCT02117024|Gemcitabine|gemcitabine|mesh-list
102321544|NCT02117024|Pemetrexed|pemetrexed|mesh-list
102321545|NCT02117024|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102321546|NCT02117024|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102321547|NCT02117024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102321548|NCT02117024|Tubulin Modulators|tubulin modulators|mesh-ancestor
102321549|NCT02117024|Antimitotic Agents|antimitotic agents|mesh-ancestor
102321550|NCT02117024|Mitosis Modulators|mitosis modulators|mesh-ancestor
102321551|NCT02117024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321552|NCT02117024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102321553|NCT02117024|Immunologic Factors|immunologic factors|mesh-ancestor
102321554|NCT02117024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321555|NCT02117024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102321556|NCT02117024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102321557|NCT02117024|Alkylating Agents|alkylating agents|mesh-ancestor
102321558|NCT02117024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102321559|NCT02117024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102321561|NCT02117024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102321562|NCT02117024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102321563|NCT02117024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102321564|NCT02117024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102321565|NCT02064920|Donepezil|donepezil|mesh-list
102321566|NCT02064920|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102321567|NCT02064920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102321568|NCT02064920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321569|NCT02064920|Cholinergic Agents|cholinergic agents|mesh-ancestor
102321570|NCT02064920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102030382|NCT03723785|Insulin|insulin|mesh-list
102321571|NCT02064920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321572|NCT02064920|Nootropic Agents|nootropic agents|mesh-ancestor
102321573|NCT02151149|Paclitaxel|paclitaxel|mesh-list
102321574|NCT02151149|Carboplatin|carboplatin|mesh-list
102321575|NCT02151149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102321576|NCT02151149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102321577|NCT02151149|Tubulin Modulators|tubulin modulators|mesh-ancestor
102321578|NCT02151149|Antimitotic Agents|antimitotic agents|mesh-ancestor
102321579|NCT02151149|Mitosis Modulators|mitosis modulators|mesh-ancestor
102321580|NCT02151149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321581|NCT02150213|Dexamethasone|dexamethasone|mesh-list
102321582|NCT02150213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102321583|NCT02150213|Antiemetics|antiemetics|mesh-ancestor
102321584|NCT02150213|Autonomic Agents|autonomic agents|mesh-ancestor
102321585|NCT02150213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102321586|NCT02150213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321587|NCT02150213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102321588|NCT02150213|Glucocorticoids|glucocorticoids|mesh-ancestor
102321589|NCT02150213|Hormones|hormones|mesh-ancestor
102321590|NCT02150213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102321591|NCT02150213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102321592|NCT02150213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102321593|NCT02091362|Metformin|metformin|mesh-list
102321594|NCT02091362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102321595|NCT02091362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321596|NCT02091206|Cannabidiol|cannabidiol|mesh-list
102321597|NCT02091206|Anticonvulsants|anticonvulsants|mesh-ancestor
102321598|NCT02062658|Ketamine|ketamine|mesh-list
102321599|NCT02062658|Analgesics|analgesics|mesh-ancestor
102321600|NCT02062658|Sensory System Agents|sensory system agents|mesh-ancestor
102321601|NCT02062658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102321602|NCT02062658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321603|NCT02062658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101438361|NCT02904304|Sympathomimetics|sympathomimetics|mesh-ancestor
102321604|NCT02062658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102321605|NCT02062658|Anesthetics, General|anesthetics, general|mesh-ancestor
102321606|NCT02062658|Anesthetics|anesthetics|mesh-ancestor
102321607|NCT02062658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102321608|NCT02062658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102321609|NCT02062658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102321610|NCT02062658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102321611|NCT02062658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321612|NCT02115308|Regadenoson|regadenoson|mesh-list
102321613|NCT02115308|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
102321614|NCT02115308|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102321615|NCT02115308|Purinergic Agonists|purinergic agonists|mesh-ancestor
102321616|NCT02115308|Purinergic Agents|purinergic agents|mesh-ancestor
102321617|NCT02115308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102321618|NCT02115308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321619|NCT02115308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321620|NCT02114684|Moxifloxacin|moxifloxacin|mesh-list
102321621|NCT02114684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102321622|NCT02114684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102321623|NCT02114684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102321624|NCT02114684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102321625|NCT02114684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102321626|NCT02114684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321627|NCT02114684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102321628|NCT02090114|Methyltestosterone|methyltestosterone|mesh-list
102321629|NCT02090114|Abiraterone Acetate|abiraterone acetate|mesh-list
102321630|NCT02090114|Testosterone|testosterone|mesh-list
102321631|NCT02090114|Testosterone undecanoate|testosterone undecanoate|mesh-list
102321632|NCT02090114|Testosterone enanthate|testosterone enanthate|mesh-list
102321633|NCT02090114|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102321634|NCT02090114|Androgens|androgens|mesh-ancestor
102321635|NCT02090114|Hormones|hormones|mesh-ancestor
102321636|NCT02090114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102321637|NCT02090114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321638|NCT02090114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102321639|NCT02090114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102321640|NCT02090114|Anabolic Agents|anabolic agents|mesh-ancestor
102321641|NCT02090114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102321642|NCT02090114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102321643|NCT02090114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321644|NCT02090114|Hormone Antagonists|hormone antagonists|mesh-ancestor
102321645|NCT02090114|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102321646|NCT04742036|Paclitaxel|paclitaxel|mesh-list
102321647|NCT04742036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102321648|NCT04742036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102321649|NCT04742036|Tubulin Modulators|tubulin modulators|mesh-ancestor
102321650|NCT04742036|Antimitotic Agents|antimitotic agents|mesh-ancestor
102321651|NCT04742036|Mitosis Modulators|mitosis modulators|mesh-ancestor
102321652|NCT04742036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321653|NCT02111564|Rivaroxaban|rivaroxaban|mesh-list
102321654|NCT02111564|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102321655|NCT02111564|Antithrombins|antithrombins|mesh-ancestor
102321656|NCT02111564|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102321657|NCT02111564|Protease Inhibitors|protease inhibitors|mesh-ancestor
102321658|NCT02111564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102321659|NCT02111564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321660|NCT02111564|Anticoagulants|anticoagulants|mesh-ancestor
102321661|NCT02111096|Metformin|metformin|mesh-list
102321662|NCT02111096|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102321663|NCT02111096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102321664|NCT02111096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321665|NCT02111096|Incretins|incretins|mesh-ancestor
102321666|NCT02111096|Hormones|hormones|mesh-ancestor
102321667|NCT02111096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102321668|NCT02111096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102321669|NCT02111096|Protease Inhibitors|protease inhibitors|mesh-ancestor
102321670|NCT02111096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102321671|NCT02111096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321672|NCT02110706|Rituximab|rituximab|mesh-list
102321673|NCT02110706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102321674|NCT02110706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102321675|NCT02110706|Immunologic Factors|immunologic factors|mesh-ancestor
102321676|NCT02110706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321677|NCT02110706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102321678|NCT02110238|Hyaluronic Acid|hyaluronic acid|mesh-list
102321679|NCT02110238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102321680|NCT02110238|Immunologic Factors|immunologic factors|mesh-ancestor
102321681|NCT02110238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321682|NCT02110238|Viscosupplements|viscosupplements|mesh-ancestor
102321683|NCT02110238|Protective Agents|protective agents|mesh-ancestor
102321684|NCT02107898|Alirocumab|alirocumab|mesh-list
102321685|NCT02107898|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102321686|NCT02107898|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102321687|NCT02107898|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102321688|NCT02107898|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102321689|NCT02107898|Antimetabolites|antimetabolites|mesh-ancestor
102321690|NCT02107898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321691|NCT02107898|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102321692|NCT02107898|Protease Inhibitors|protease inhibitors|mesh-ancestor
102321693|NCT02107898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102321694|NCT02107898|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102321695|NCT02107898|Immunologic Factors|immunologic factors|mesh-ancestor
102321696|NCT02107898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321697|NCT02058836|Botulinum Toxins|botulinum toxins|mesh-list
102321698|NCT02058836|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102321699|NCT02058836|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102321700|NCT02058836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102321701|NCT02058836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321702|NCT02058836|Cholinergic Agents|cholinergic agents|mesh-ancestor
102321703|NCT02058836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102321704|NCT02058836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321705|NCT02058836|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102321706|NCT02058836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102321707|NCT02107274|Azithromycin|azithromycin|mesh-list
102321708|NCT02107274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102321709|NCT02107274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102321710|NCT02173769|Tiotropium Bromide|tiotropium bromide|mesh-list
102321711|NCT02173769|Olodaterol|olodaterol|mesh-list
102321712|NCT02173769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102321713|NCT02173769|Autonomic Agents|autonomic agents|mesh-ancestor
102321714|NCT02173769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102321715|NCT02173769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321716|NCT02173769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102321717|NCT02173769|Respiratory System Agents|respiratory system agents|mesh-ancestor
102321718|NCT02173769|Parasympatholytics|parasympatholytics|mesh-ancestor
102321719|NCT02173769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102321720|NCT02173769|Cholinergic Agents|cholinergic agents|mesh-ancestor
101836569|NCT01014156|Epoprostenol|epoprostenol|mesh-list
102321721|NCT02173769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102321722|NCT02173769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321723|NCT02121509|Metformin|metformin|mesh-list
102321724|NCT02121509|Linagliptin|linagliptin|mesh-list
102321725|NCT02121509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102321726|NCT02121509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321727|NCT02121509|Incretins|incretins|mesh-ancestor
102321728|NCT02121509|Hormones|hormones|mesh-ancestor
102321729|NCT02121509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102321730|NCT02121509|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102321731|NCT02121509|Protease Inhibitors|protease inhibitors|mesh-ancestor
102321732|NCT02121509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102321733|NCT02121509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321734|NCT02149199|Budesonide|budesonide|mesh-list
102321735|NCT02149199|Terbutaline|terbutaline|mesh-list
102321736|NCT02149199|Formoterol Fumarate|formoterol fumarate|mesh-list
102321737|NCT02149199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102321738|NCT02149199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102321739|NCT02149199|Autonomic Agents|autonomic agents|mesh-ancestor
102321740|NCT02149199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102321741|NCT02149199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321742|NCT02149199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102321743|NCT02149199|Respiratory System Agents|respiratory system agents|mesh-ancestor
102321744|NCT02149199|Glucocorticoids|glucocorticoids|mesh-ancestor
102321745|NCT02149199|Hormones|hormones|mesh-ancestor
102321746|NCT02149199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102321747|NCT02149199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102321748|NCT02149199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102321749|NCT02149199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102321750|NCT02149199|Adrenergic Agents|adrenergic agents|mesh-ancestor
102321751|NCT02149199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102321752|NCT02149199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321753|NCT02149199|Sympathomimetics|sympathomimetics|mesh-ancestor
102321754|NCT02149199|Tocolytic Agents|tocolytic agents|mesh-ancestor
102321755|NCT02149199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102321756|NCT02120417|Capecitabine|capecitabine|mesh-list
102321757|NCT02120417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102321758|NCT02120417|Antimetabolites|antimetabolites|mesh-ancestor
102321759|NCT02120417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321760|NCT02120417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102321761|NCT02147561|Botulinum Toxins|botulinum toxins|mesh-list
102321762|NCT02147561|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102321763|NCT02147561|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102321764|NCT02147561|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102321765|NCT02147561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102321766|NCT02147561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321767|NCT02147561|Cholinergic Agents|cholinergic agents|mesh-ancestor
102321768|NCT02147561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102321769|NCT02147561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321770|NCT02147561|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102321771|NCT02147561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102321772|NCT02058368|Tamsulosin|tamsulosin|mesh-list
102321773|NCT02058368|Dutasteride|dutasteride|mesh-list
102321774|NCT02058368|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102321775|NCT02058368|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102321776|NCT02058368|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102321777|NCT02058368|Adrenergic Agents|adrenergic agents|mesh-ancestor
102321778|NCT02058368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102321779|NCT02058368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321780|NCT02058368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321781|NCT02058368|Urological Agents|urological agents|mesh-ancestor
102321782|NCT02058368|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102321783|NCT02058368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102321784|NCT02058368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102321785|NCT02058368|Hormone Antagonists|hormone antagonists|mesh-ancestor
102321786|NCT02058368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102321787|NCT02058290|Morphine|morphine|mesh-list
102321788|NCT02058290|Bupivacaine|bupivacaine|mesh-list
102321789|NCT02058290|Anesthetics, Local|anesthetics, local|mesh-ancestor
102321790|NCT02058290|Anesthetics|anesthetics|mesh-ancestor
102321791|NCT02058290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102321792|NCT02058290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321793|NCT02058290|Sensory System Agents|sensory system agents|mesh-ancestor
102321794|NCT02058290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102321795|NCT02058290|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102321796|NCT02058290|Narcotics|narcotics|mesh-ancestor
102321797|NCT02058290|Analgesics|analgesics|mesh-ancestor
102321798|NCT04718480|Fluvoxamine|fluvoxamine|mesh-list
102321799|NCT04718480|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102321800|NCT04718480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102321801|NCT04718480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102321802|NCT04718480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321803|NCT04718480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102321804|NCT04718480|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102321805|NCT04718480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102321806|NCT04718480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102321807|NCT04718480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321808|NCT04718480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102321809|NCT04718480|Serotonin Agents|serotonin agents|mesh-ancestor
102321810|NCT04718480|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102321811|NCT04718480|Antidepressive Agents|antidepressive agents|mesh-ancestor
102321812|NCT04718480|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102321813|NCT04718480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102321814|NCT04718480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102321815|NCT04718480|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102321816|NCT02106884|Paclitaxel|paclitaxel|mesh-list
102321817|NCT02106884|Gemcitabine|gemcitabine|mesh-list
102321818|NCT02106884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102321819|NCT02106884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102321820|NCT02106884|Tubulin Modulators|tubulin modulators|mesh-ancestor
102321821|NCT02106884|Antimitotic Agents|antimitotic agents|mesh-ancestor
102321822|NCT02106884|Mitosis Modulators|mitosis modulators|mesh-ancestor
102321823|NCT02106884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321824|NCT02106884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102321825|NCT02106884|Antimetabolites|antimetabolites|mesh-ancestor
102321826|NCT02081690|Macitentan|macitentan|mesh-list
102321827|NCT02081690|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
102321828|NCT02081690|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102321829|NCT02081690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321830|NCT02081690|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
102321831|NCT01625000|Risperidone|risperidone|mesh-list
102321832|NCT01625000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102321833|NCT01625000|Serotonin Agents|serotonin agents|mesh-ancestor
102321834|NCT01625000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102321835|NCT01625000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321836|NCT01625000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321837|NCT01625000|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102321838|NCT01625000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102321839|NCT01625000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102321840|NCT01625000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102321841|NCT01625000|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102321842|NCT01625000|Dopamine Agents|dopamine agents|mesh-ancestor
102321843|NCT02057198|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102321844|NCT02057198|Metronidazole|metronidazole|mesh-list
102321845|NCT02057198|Vancomycin|vancomycin|mesh-list
102321846|NCT02057198|Fidaxomicin|fidaxomicin|mesh-list
102321847|NCT02057198|Amebicides|amebicides|mesh-list
102321848|NCT02057198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102321849|NCT02057198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102321850|NCT02057198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102321851|NCT02056340|Atorvastatin|atorvastatin|mesh-list
102321852|NCT02056340|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102321853|NCT02056340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102321854|NCT02056340|Antimetabolites|antimetabolites|mesh-ancestor
102321855|NCT02056340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321856|NCT02056340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102321857|NCT02056340|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102321858|NCT02056340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102321859|NCT04726592|Ketoprofen|ketoprofen|mesh-list
102321860|NCT04726592|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
102321861|NCT04726592|Metoclopramide|metoclopramide|mesh-list
102321862|NCT04726592|Antiemetics|antiemetics|mesh-ancestor
102321863|NCT04726592|Autonomic Agents|autonomic agents|mesh-ancestor
102321864|NCT04726592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102321865|NCT04726592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321866|NCT04726592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102321867|NCT04726592|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102321868|NCT04726592|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102321869|NCT04726592|Dopamine Agents|dopamine agents|mesh-ancestor
102321870|NCT04726592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102030679|NCT05462496|Metronidazole|metronidazole|mesh-list
102321871|NCT04726592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321872|NCT04726592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102321873|NCT04726592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102321874|NCT04726592|Analgesics|analgesics|mesh-ancestor
102321875|NCT04726592|Sensory System Agents|sensory system agents|mesh-ancestor
102321876|NCT04726592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102321877|NCT04726592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102321878|NCT04726592|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102321879|NCT04726592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102321880|NCT04726592|Anticonvulsants|anticonvulsants|mesh-ancestor
102321881|NCT04726592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102321882|NCT04726592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102321883|NCT04726592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102321884|NCT04726592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102321885|NCT04726592|GABA Modulators|gaba modulators|mesh-ancestor
102321886|NCT04726592|GABA Agents|gaba agents|mesh-ancestor
102321887|NCT02046122|Cytarabine|cytarabine|mesh-list
102321888|NCT02046122|Idarubicin|idarubicin|mesh-list
102321889|NCT02046122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102321890|NCT02046122|Antimetabolites|antimetabolites|mesh-ancestor
102321891|NCT02046122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321892|NCT02046122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102321893|NCT02046122|Antiviral Agents|antiviral agents|mesh-ancestor
102321894|NCT02046122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102321895|NCT02046122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102321896|NCT02046122|Immunologic Factors|immunologic factors|mesh-ancestor
102321897|NCT02046122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321898|NCT02046122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102321899|NCT02046122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102321900|NCT02046122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102321901|NCT02046122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102321902|NCT02080832|Dexetimide|dexetimide|mesh-list
102321903|NCT02080832|Citalopram|citalopram|mesh-list
102321904|NCT02080832|Escitalopram|escitalopram|mesh-list
102321905|NCT02080832|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102321906|NCT02080832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102321907|NCT02080832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102321908|NCT02080832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321909|NCT02080832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102321910|NCT02080832|Serotonin Agents|serotonin agents|mesh-ancestor
102321911|NCT02080832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321912|NCT02080832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102321913|NCT02080832|Antidepressive Agents|antidepressive agents|mesh-ancestor
102321914|NCT02080832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102321915|NCT02080832|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102321916|NCT02080832|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102321917|NCT02080832|Parasympatholytics|parasympatholytics|mesh-ancestor
102321918|NCT02080832|Autonomic Agents|autonomic agents|mesh-ancestor
102321919|NCT02080832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102321920|NCT02080832|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102321921|NCT02080832|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102321922|NCT02080832|Cholinergic Agents|cholinergic agents|mesh-ancestor
102321923|NCT02078960|Homoharringtonine|homoharringtonine|mesh-list
102321924|NCT02078960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102321925|NCT02078960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102321926|NCT02078960|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102321927|NCT02078960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102321928|NCT02078960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321929|NCT02078102|Meloxicam|meloxicam|mesh-list
102321930|NCT02078102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321931|NCT02078102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102321932|NCT02078102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102321933|NCT02078102|Analgesics|analgesics|mesh-ancestor
102321934|NCT02078102|Sensory System Agents|sensory system agents|mesh-ancestor
102321935|NCT02078102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102321936|NCT02078102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102321937|NCT02078102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102321938|NCT02078102|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102321939|NCT02078102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102321940|NCT02078102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102321941|NCT02078102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321942|NCT02054702|Aripiprazole|aripiprazole|mesh-list
102321943|NCT02054702|Brexpiprazole|brexpiprazole|mesh-list
102321944|NCT02054702|Antidepressive Agents|antidepressive agents|mesh-ancestor
102030754|NCT03726593|Artesunate|artesunate|mesh-list
102321945|NCT02054702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102321946|NCT02054702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102321947|NCT02054702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102321948|NCT02054702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102321949|NCT02054702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321950|NCT02054702|Dopamine Agonists|dopamine agonists|mesh-ancestor
102321951|NCT02054702|Dopamine Agents|dopamine agents|mesh-ancestor
102321952|NCT02054702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102321953|NCT02054702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321954|NCT02054702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102321955|NCT02054702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102321956|NCT02054702|Serotonin Agents|serotonin agents|mesh-ancestor
102321957|NCT02054702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102321958|NCT02054702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102321959|NCT02054702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102321960|NCT02054702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102321961|NCT02044094|Buprenorphine|buprenorphine|mesh-list
102321962|NCT02044094|Hydromorphone|hydromorphone|mesh-list
102321963|NCT02044094|Naloxone|naloxone|mesh-list
102321964|NCT02044094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102321965|NCT02044094|Narcotics|narcotics|mesh-ancestor
102321966|NCT02044094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102321967|NCT02044094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321968|NCT02044094|Analgesics|analgesics|mesh-ancestor
102321969|NCT02044094|Sensory System Agents|sensory system agents|mesh-ancestor
102321970|NCT02044094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102321971|NCT02044094|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102321972|NCT02053610|Rituximab|rituximab|mesh-list
102321973|NCT02053610|Obinutuzumab|obinutuzumab|mesh-list
102321974|NCT02053610|Chlorambucil|chlorambucil|mesh-list
102321975|NCT02053610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102321976|NCT02053610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102321977|NCT02053610|Immunologic Factors|immunologic factors|mesh-ancestor
102321978|NCT02053610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321979|NCT02053610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102321980|NCT02053610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102321981|NCT02053610|Alkylating Agents|alkylating agents|mesh-ancestor
102321982|NCT02053610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321983|NCT02075606|Lanreotide|lanreotide|mesh-list
102321984|NCT02075606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102321985|NCT04701008|Ketamine|ketamine|mesh-list
102321986|NCT04701008|Analgesics|analgesics|mesh-ancestor
102321987|NCT04701008|Sensory System Agents|sensory system agents|mesh-ancestor
102321988|NCT04701008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102321989|NCT04701008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102321990|NCT04701008|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102321991|NCT04701008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102321992|NCT04701008|Anesthetics, General|anesthetics, general|mesh-ancestor
102321993|NCT04701008|Anesthetics|anesthetics|mesh-ancestor
102321994|NCT04701008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102321995|NCT04701008|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102321996|NCT04701008|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102321997|NCT04701008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102321998|NCT04701008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102321999|NCT04700696|Analgesics, Opioid|analgesics, opioid|mesh-list
102322000|NCT04700696|Narcotics|narcotics|mesh-ancestor
102322001|NCT04700696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102322002|NCT04700696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322003|NCT04700696|Analgesics|analgesics|mesh-ancestor
102322004|NCT04700696|Sensory System Agents|sensory system agents|mesh-ancestor
102322005|NCT04700696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102322006|NCT02052440|Baclofen|baclofen|mesh-list
102322007|NCT02052440|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102322008|NCT02052440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322009|NCT02052440|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102322010|NCT02052440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102322011|NCT02052440|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102322012|NCT02052440|GABA Agonists|gaba agonists|mesh-ancestor
102322013|NCT02052440|GABA Agents|gaba agents|mesh-ancestor
102322014|NCT02052440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102322015|NCT02052440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322016|NCT02049944|Cefazolin|cefazolin|mesh-list
102322017|NCT02049944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102322018|NCT02049944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102322019|NCT01621880|Methylprednisolone|methylprednisolone|mesh-list
102030832|NCT02344888|Clomiphene|clomiphene|mesh-list
102322021|NCT01621880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102322022|NCT01621880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102322023|NCT01621880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102322024|NCT01621880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102322025|NCT01621880|Growth Substances|growth substances|mesh-ancestor
102322026|NCT01621880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322027|NCT01621880|Growth Inhibitors|growth inhibitors|mesh-ancestor
102322028|NCT01621880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102322029|NCT01621880|Antiemetics|antiemetics|mesh-ancestor
102322030|NCT01621880|Autonomic Agents|autonomic agents|mesh-ancestor
102322031|NCT01621880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102322032|NCT01621880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102322033|NCT01621880|Glucocorticoids|glucocorticoids|mesh-ancestor
102322034|NCT01621880|Hormones|hormones|mesh-ancestor
102322035|NCT01621880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102322036|NCT01621880|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102322037|NCT01621880|Protective Agents|protective agents|mesh-ancestor
102322038|NCT02041429|Paclitaxel|paclitaxel|mesh-list
102322039|NCT02041429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102322040|NCT02041429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102322041|NCT02041429|Tubulin Modulators|tubulin modulators|mesh-ancestor
102322042|NCT02041429|Antimitotic Agents|antimitotic agents|mesh-ancestor
102322043|NCT02041429|Mitosis Modulators|mitosis modulators|mesh-ancestor
102322044|NCT02041429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322045|NCT04699981|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102322046|NCT04699981|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102322047|NCT04699981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102322048|NCT04699981|Antitubercular Agents|antitubercular agents|mesh-ancestor
102322049|NCT02083783|Amphetamine|amphetamine|mesh-list
102322050|NCT02083783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102322051|NCT02083783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322052|NCT02083783|Sympathomimetics|sympathomimetics|mesh-ancestor
102322053|NCT02083783|Autonomic Agents|autonomic agents|mesh-ancestor
102322054|NCT02083783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102322055|NCT02083783|Dopamine Agents|dopamine agents|mesh-ancestor
102322056|NCT02083783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102322057|NCT02083783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322058|NCT02083783|Adrenergic Agents|adrenergic agents|mesh-ancestor
102322059|NCT02083783|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102322060|NCT02083783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102322061|NCT02083783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102322062|NCT02083783|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102322063|NCT02059135|Antithrombins|antithrombins|mesh-list
102322064|NCT02059135|Antithrombin III|antithrombin iii|mesh-list
102322065|NCT02059135|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102322066|NCT02059135|Protease Inhibitors|protease inhibitors|mesh-ancestor
102322067|NCT02059135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102322068|NCT02059135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322069|NCT02059135|Anticoagulants|anticoagulants|mesh-ancestor
102322070|NCT04720105|Halobetasol|halobetasol|mesh-list
102322071|NCT04720105|Tazarotene|tazarotene|mesh-list
102322072|NCT04720105|Dermatologic Agents|dermatologic agents|mesh-ancestor
102322073|NCT04720105|Keratolytic Agents|keratolytic agents|mesh-ancestor
102322074|NCT04720105|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102322075|NCT04695769|Ribavirin|ribavirin|mesh-list
102322076|NCT04695769|Sofosbuvir|sofosbuvir|mesh-list
102322077|NCT04695769|Velpatasvir|velpatasvir|mesh-list
102322078|NCT04695769|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102322079|NCT04695769|Antimetabolites|antimetabolites|mesh-ancestor
102322080|NCT04695769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322081|NCT04695769|Antiviral Agents|antiviral agents|mesh-ancestor
102322082|NCT04695769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102322083|NCT02038933|Nivolumab|nivolumab|mesh-list
102322084|NCT02038933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102322085|NCT02038933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102322086|NCT02038933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102322087|NCT02038933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322088|NCT02081599|Insulin|insulin|mesh-list
102322089|NCT02081599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102322090|NCT02081599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322091|NCT02038153|Lenalidomide|lenalidomide|mesh-list
102322092|NCT02038153|Immunologic Factors|immunologic factors|mesh-ancestor
102322093|NCT02038153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322094|NCT02038153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102322095|NCT02038153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102322096|NCT02038153|Growth Substances|growth substances|mesh-ancestor
102322097|NCT02038153|Growth Inhibitors|growth inhibitors|mesh-ancestor
102322098|NCT02038153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102322100|NCT02079805|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
102322101|NCT02079805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102322102|NCT02079805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102322103|NCT02079805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102322104|NCT02079805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322105|NCT02037295|Vancomycin|vancomycin|mesh-list
102322106|NCT02037295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102322107|NCT02037295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102322108|NCT02079649|Dexamethasone|dexamethasone|mesh-list
102322109|NCT02079649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102322110|NCT02079649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102322111|NCT02079649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102322112|NCT02079649|Antiemetics|antiemetics|mesh-ancestor
102322113|NCT02079649|Autonomic Agents|autonomic agents|mesh-ancestor
102322114|NCT02079649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102322115|NCT02079649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322116|NCT02079649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102322117|NCT02079649|Glucocorticoids|glucocorticoids|mesh-ancestor
102322118|NCT02079649|Hormones|hormones|mesh-ancestor
102322119|NCT02079649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102322120|NCT02079649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102322121|NCT02079649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102322122|NCT02036515|Metformin|metformin|mesh-list
102322123|NCT02036515|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102322124|NCT02036515|Glimepiride|glimepiride|mesh-list
102322125|NCT02036515|Ertugliflozin|ertugliflozin|mesh-list
102322126|NCT02036515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102322127|NCT02036515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322128|NCT02036515|Incretins|incretins|mesh-ancestor
102322129|NCT02036515|Hormones|hormones|mesh-ancestor
102322130|NCT02036515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102322131|NCT02036515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102322132|NCT02036515|Protease Inhibitors|protease inhibitors|mesh-ancestor
102322133|NCT02036515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102322134|NCT02036515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322135|NCT02036515|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102322136|NCT02036515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102322137|NCT02036515|Immunologic Factors|immunologic factors|mesh-ancestor
102322138|NCT02036515|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102322139|NCT02078713|Contraceptive Agents|contraceptive agents|mesh-list
102322140|NCT02078713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102322141|NCT02078713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322142|NCT02035267|Deoxycholic Acid|deoxycholic acid|mesh-list
102322143|NCT02035267|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102322144|NCT02035267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102322145|NCT05887479|Botulinum Toxins|botulinum toxins|mesh-list
102322146|NCT05887479|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102322147|NCT05887479|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102322148|NCT05887479|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102322149|NCT05887479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102322150|NCT05887479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322151|NCT05887479|Cholinergic Agents|cholinergic agents|mesh-ancestor
102322152|NCT05887479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102322153|NCT05887479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322154|NCT05887479|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102322155|NCT05887479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102322156|NCT05887375|Glycopyrrolate|glycopyrrolate|mesh-list
102322157|NCT05887375|Bromides|bromides|mesh-list
102322158|NCT05887375|Rocuronium|rocuronium|mesh-list
102322159|NCT05887375|Neostigmine|neostigmine|mesh-list
102322160|NCT05887375|Anticonvulsants|anticonvulsants|mesh-ancestor
102322161|NCT05887375|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102322162|NCT05887375|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102322163|NCT05887375|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102322164|NCT05887375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102322165|NCT05887375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322166|NCT05887375|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102322167|NCT05887375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102322168|NCT05887375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322169|NCT05887375|Cholinergic Agents|cholinergic agents|mesh-ancestor
102322170|NCT05887375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102322171|NCT05887375|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102322172|NCT05887375|Autonomic Agents|autonomic agents|mesh-ancestor
102322173|NCT05887375|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102322174|NCT05887375|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102322175|NCT05887375|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102322176|NCT05887258|Analgesics, Opioid|analgesics, opioid|mesh-list
102322178|NCT05887258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102322179|NCT05887258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322180|NCT05887258|Narcotics|narcotics|mesh-ancestor
102322181|NCT05887258|Analgesics|analgesics|mesh-ancestor
102322182|NCT05887258|Sensory System Agents|sensory system agents|mesh-ancestor
102322183|NCT05887258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102322184|NCT05887219|Azelaic acid|azelaic acid|mesh-list
102322185|NCT05887219|Tranexamic Acid|tranexamic acid|mesh-list
102322186|NCT05887219|Hydroquinone|hydroquinone|mesh-list
102322187|NCT05887219|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102322188|NCT05887219|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102322189|NCT05887219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322190|NCT05887219|Hemostatics|hemostatics|mesh-ancestor
102322191|NCT05887219|Coagulants|coagulants|mesh-ancestor
102322192|NCT05887219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102322193|NCT05887219|Dermatologic Agents|dermatologic agents|mesh-ancestor
102322194|NCT05887219|Antioxidants|antioxidants|mesh-ancestor
102322195|NCT05887219|Protective Agents|protective agents|mesh-ancestor
102322196|NCT05887219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439065|NCT05663866|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101439066|NCT05663866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101439067|NCT05663866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101439074|NCT05654623|Fulvestrant|fulvestrant|mesh-list
101439075|NCT05654623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102322197|NCT05887219|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102322198|NCT05886998|Heparin|heparin|mesh-list
102322199|NCT05886998|Anticoagulants|anticoagulants|mesh-ancestor
102322200|NCT05886998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102322201|NCT05886998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102322202|NCT05886998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322203|NCT05886933|Fexuprazan|fexuprazan|mesh-list
102322204|NCT05886933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102322205|NCT05886829|Chlorpheniramine|chlorpheniramine|mesh-list
102322206|NCT05886829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322207|NCT05886829|Antipruritics|antipruritics|mesh-ancestor
102322208|NCT05886829|Dermatologic Agents|dermatologic agents|mesh-ancestor
102322209|NCT05886829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102322210|NCT05886829|Histamine Antagonists|histamine antagonists|mesh-ancestor
102322211|NCT05886829|Histamine Agents|histamine agents|mesh-ancestor
102322212|NCT05886829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102322213|NCT05886829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322214|NCT05886829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102322216|NCT05886790|Immunologic Factors|immunologic factors|mesh-ancestor
102322217|NCT05886790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322218|NCT05886660|Scopolamine|scopolamine|mesh-list
102322219|NCT05886660|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102322220|NCT05886660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102322221|NCT05886660|Antiemetics|antiemetics|mesh-ancestor
102322222|NCT05886660|Autonomic Agents|autonomic agents|mesh-ancestor
102322223|NCT05886660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102322224|NCT05886660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322225|NCT05886660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102322226|NCT05886660|Mydriatics|mydriatics|mesh-ancestor
102322227|NCT05886660|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102322228|NCT05886660|Cholinergic Agents|cholinergic agents|mesh-ancestor
102322229|NCT05886660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102322230|NCT05886660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322231|NCT05886660|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102322232|NCT05886660|Parasympatholytics|parasympatholytics|mesh-ancestor
102322233|NCT05886465|Bevacizumab|bevacizumab|mesh-list
102322234|NCT05886465|Atezolizumab|atezolizumab|mesh-list
102322235|NCT05886465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102322236|NCT05886465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102322237|NCT05886465|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102322238|NCT05886465|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102322239|NCT05886465|Growth Substances|growth substances|mesh-ancestor
102322240|NCT05886465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322241|NCT05886465|Growth Inhibitors|growth inhibitors|mesh-ancestor
102322242|NCT05886465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102322243|NCT05886465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322244|NCT05886439|Pembrolizumab|pembrolizumab|mesh-list
102322245|NCT05886439|Durvalumab|durvalumab|mesh-list
102322246|NCT05886439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102322247|NCT05886439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102322248|NCT05886439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102322249|NCT05886439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322250|NCT05886257|Bevacizumab|bevacizumab|mesh-list
102322251|NCT05886257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102322252|NCT05886257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102322253|NCT05886257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102322254|NCT05886257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102322255|NCT05886257|Growth Substances|growth substances|mesh-ancestor
102322256|NCT05886257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322257|NCT05886257|Growth Inhibitors|growth inhibitors|mesh-ancestor
102322258|NCT05886192|Vasopressins|vasopressins|mesh-list
102322259|NCT05886192|Arginine Vasopressin|arginine vasopressin|mesh-list
102322260|NCT05886192|Norepinephrine|norepinephrine|mesh-list
102322261|NCT05886192|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102322262|NCT05886192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102322263|NCT05886192|Adrenergic Agents|adrenergic agents|mesh-ancestor
102322264|NCT05886192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102322265|NCT05886192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322266|NCT05886192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322267|NCT05886192|Sympathomimetics|sympathomimetics|mesh-ancestor
102322268|NCT05886192|Autonomic Agents|autonomic agents|mesh-ancestor
102322269|NCT05886192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102322270|NCT05886192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102322271|NCT05886192|Hemostatics|hemostatics|mesh-ancestor
102322272|NCT05886192|Coagulants|coagulants|mesh-ancestor
102322273|NCT05886192|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102322274|NCT05886192|Natriuretic Agents|natriuretic agents|mesh-ancestor
102322275|NCT05886127|Hemostatics|hemostatics|mesh-list
102322276|NCT05886127|Coagulants|coagulants|mesh-ancestor
102322277|NCT05886088|Dapagliflozin|dapagliflozin|mesh-list
102322278|NCT05886088|Linagliptin|linagliptin|mesh-list
102322279|NCT05886088|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102322280|NCT05886088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322281|NCT05886088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102322282|NCT05886088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322283|NCT05886088|Incretins|incretins|mesh-ancestor
102322284|NCT05886088|Hormones|hormones|mesh-ancestor
102322285|NCT05886088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102322286|NCT05886088|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102322287|NCT05886088|Protease Inhibitors|protease inhibitors|mesh-ancestor
102322288|NCT05886088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102322289|NCT05885932|Aspirin|aspirin|mesh-list
102322291|NCT05885932|Clopidogrel|clopidogrel|mesh-list
102322292|NCT05885932|Ticagrelor|ticagrelor|mesh-list
102322293|NCT05885932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102322294|NCT05885932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102322295|NCT05885932|Analgesics|analgesics|mesh-ancestor
102322296|NCT05885932|Sensory System Agents|sensory system agents|mesh-ancestor
102322297|NCT05885932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102322298|NCT05885932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322299|NCT05885932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102322300|NCT05885932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102322301|NCT05885932|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102322302|NCT05885932|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102322303|NCT05885932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322304|NCT05885932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102322305|NCT05885932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102322306|NCT05885932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102322307|NCT05885932|Antipyretics|antipyretics|mesh-ancestor
102322308|NCT05885932|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102322309|NCT05885932|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102322310|NCT05885932|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102322311|NCT05885932|Purinergic Agents|purinergic agents|mesh-ancestor
102322312|NCT05885932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102322313|NCT05885932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102322314|NCT05885932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102322315|NCT05885932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102322316|NCT05885932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102322317|NCT05885932|Antifungal Agents|antifungal agents|mesh-ancestor
102322318|NCT05885932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102322319|NCT05885932|Immunologic Factors|immunologic factors|mesh-ancestor
102322320|NCT05885919|Edaravone|edaravone|mesh-list
101836570|NCT01014156|Tezosentan|tezosentan|mesh-list
102322321|NCT05885919|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102322322|NCT05885919|Antioxidants|antioxidants|mesh-ancestor
102322323|NCT05885919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322324|NCT05885919|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102322325|NCT05885919|Protective Agents|protective agents|mesh-ancestor
102322326|NCT05885919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322327|NCT05885802|Anesthetics|anesthetics|mesh-list
102322328|NCT05885802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102322329|NCT05885802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322330|NCT05885776|Trastuzumab|trastuzumab|mesh-list
102322331|NCT05885776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102322332|NCT05885776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102322333|NCT05885646|Sulthiame|sulthiame|mesh-list
102322334|NCT05885646|Anticonvulsants|anticonvulsants|mesh-ancestor
102322335|NCT05885503|Aflibercept|aflibercept|mesh-list
102322336|NCT05885503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102322337|NCT05885503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102322338|NCT05885503|Growth Substances|growth substances|mesh-ancestor
102322339|NCT05885503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322340|NCT05885503|Growth Inhibitors|growth inhibitors|mesh-ancestor
102322341|NCT05885503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102322342|NCT05884372|Vitamin D|vitamin d|mesh-list
102322343|NCT05884372|Denosumab|denosumab|mesh-list
102322344|NCT05884372|Eldecalcitol|eldecalcitol|mesh-list
102322345|NCT05884372|Calcium|calcium|mesh-list
102322346|NCT05884372|Vitamins|vitamins|mesh-ancestor
102322347|NCT05884372|Micronutrients|micronutrients|mesh-ancestor
102322348|NCT05884372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322349|NCT05884372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102322350|NCT05884372|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102322351|NCT05882643|Iodine|iodine|mesh-list
102322352|NCT05882643|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102322353|NCT05882643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102322354|NCT05882643|Trace Elements|trace elements|mesh-ancestor
102322355|NCT05882643|Micronutrients|micronutrients|mesh-ancestor
102322356|NCT05882643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322357|NCT05877430|Pembrolizumab|pembrolizumab|mesh-list
102322358|NCT05877430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102322359|NCT05877430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102322360|NCT05877430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102322361|NCT05877430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322362|NCT05802056|Calcium, Dietary|calcium, dietary|mesh-list
102322363|NCT05802056|Leucovorin|leucovorin|mesh-list
102322364|NCT05802056|Folic Acid|folic acid|mesh-list
102322365|NCT05802056|Aldesleukin|aldesleukin|mesh-list
102322367|NCT05802056|Oxaliplatin|oxaliplatin|mesh-list
102322368|NCT05802056|Nivolumab|nivolumab|mesh-list
102322369|NCT05802056|Interleukin-2|interleukin-2|mesh-list
102322370|NCT05802056|Calcium|calcium|mesh-list
102322371|NCT05802056|Levoleucovorin|levoleucovorin|mesh-list
102322372|NCT05802056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102322373|NCT05802056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322374|NCT05802056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102322375|NCT05802056|Antimetabolites|antimetabolites|mesh-ancestor
102322376|NCT05802056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322377|NCT05802056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102322378|NCT05802056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102322379|NCT05802056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102322380|NCT05802056|Immunologic Factors|immunologic factors|mesh-ancestor
102322381|NCT05802056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102322382|NCT05802056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102322383|NCT05802056|Antidotes|antidotes|mesh-ancestor
102322384|NCT05802056|Protective Agents|protective agents|mesh-ancestor
102322385|NCT05802056|Vitamin B Complex|vitamin b complex|mesh-ancestor
102322386|NCT05802056|Vitamins|vitamins|mesh-ancestor
102322387|NCT05802056|Micronutrients|micronutrients|mesh-ancestor
102322388|NCT05802056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102322389|NCT05802056|Analgesics|analgesics|mesh-ancestor
102322390|NCT05802056|Sensory System Agents|sensory system agents|mesh-ancestor
102322391|NCT05802056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102322392|NCT05802056|Hematinics|hematinics|mesh-ancestor
102322393|NCT05802056|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102322394|NCT05802056|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102322395|NCT05802056|Antiviral Agents|antiviral agents|mesh-ancestor
102031205|NCT02336854|Tacrolimus|tacrolimus|mesh-list
102322396|NCT05802056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102322397|NCT05794477|Paclitaxel|paclitaxel|mesh-list
102322398|NCT05794477|Carboplatin|carboplatin|mesh-list
102322399|NCT05794477|Pemetrexed|pemetrexed|mesh-list
102322400|NCT05794477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102322401|NCT05794477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102322402|NCT05794477|Tubulin Modulators|tubulin modulators|mesh-ancestor
102322403|NCT05794477|Antimitotic Agents|antimitotic agents|mesh-ancestor
102322404|NCT05794477|Mitosis Modulators|mitosis modulators|mesh-ancestor
102322405|NCT05794477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322406|NCT05794477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102322407|NCT05794477|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102322408|NCT05794477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102322409|NCT05789381|Magnesium Sulfate|magnesium sulfate|mesh-list
102322410|NCT05789381|Analgesics|analgesics|mesh-ancestor
102322411|NCT05789381|Sensory System Agents|sensory system agents|mesh-ancestor
102322412|NCT05789381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102322413|NCT05789381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322414|NCT05789381|Anesthetics|anesthetics|mesh-ancestor
102322415|NCT05789381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102322416|NCT05789381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102322417|NCT05789381|Anticonvulsants|anticonvulsants|mesh-ancestor
102322418|NCT05789381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102322419|NCT05789381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102322420|NCT05789381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322421|NCT05789381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102322422|NCT05789381|Tocolytic Agents|tocolytic agents|mesh-ancestor
102322423|NCT05789381|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102322424|NCT05773989|Clopidogrel|clopidogrel|mesh-list
102322425|NCT05773989|Ticagrelor|ticagrelor|mesh-list
102322426|NCT05773989|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102322427|NCT05773989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322428|NCT05773989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322429|NCT05773989|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102322430|NCT05773989|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102322431|NCT05773989|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102322432|NCT05773989|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102322433|NCT05773989|Purinergic Agents|purinergic agents|mesh-ancestor
102322434|NCT05773989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102322435|NCT05769478|Amifampridine|amifampridine|mesh-list
102322436|NCT05769478|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102322437|NCT05769478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102322438|NCT05769478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322439|NCT05769478|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101664358|NCT01778946|Nicotine|nicotine|mesh-list
102322440|NCT05769478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102322441|NCT05769478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322442|NCT05745701|Cyclosporine|cyclosporine|mesh-list
102322443|NCT05745701|Itraconazole|itraconazole|mesh-list
102322444|NCT05745701|Cyclosporins|cyclosporins|mesh-list
102322445|NCT05745701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102322446|NCT05745701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322447|NCT05745701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102322448|NCT05745701|Immunologic Factors|immunologic factors|mesh-ancestor
102322449|NCT05745701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322450|NCT05745701|Antifungal Agents|antifungal agents|mesh-ancestor
102322451|NCT05745701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102322452|NCT05745701|Dermatologic Agents|dermatologic agents|mesh-ancestor
102322453|NCT05745701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102322454|NCT05745701|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102322455|NCT05745701|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102322456|NCT05745701|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102322457|NCT05745701|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102322458|NCT05745701|Hormone Antagonists|hormone antagonists|mesh-ancestor
102322459|NCT05745701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102322460|NCT05745701|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102322461|NCT05742594|Lazertinib|lazertinib|mesh-list
102322462|NCT05742594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102322463|NCT05742594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102322464|NCT05742594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322465|NCT05741086|Atorvastatin|atorvastatin|mesh-list
102322466|NCT05741086|Evolocumab|evolocumab|mesh-list
102322467|NCT05741086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102322468|NCT05741086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102322469|NCT05741086|Antimetabolites|antimetabolites|mesh-ancestor
102322470|NCT05741086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322471|NCT05741086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102322472|NCT05741086|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102322473|NCT05741086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102322474|NCT05741086|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102322475|NCT05741086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102322476|NCT05741086|Protease Inhibitors|protease inhibitors|mesh-ancestor
102322477|NCT05722262|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
102322478|NCT05722262|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102322479|NCT05722262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322480|NCT05722262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102322481|NCT05722262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322482|NCT05713994|Bevacizumab|bevacizumab|mesh-list
102322483|NCT05713994|Atezolizumab|atezolizumab|mesh-list
102322484|NCT05713994|Sorafenib|sorafenib|mesh-list
102322485|NCT05713994|Apatinib|apatinib|mesh-list
102322486|NCT05713994|Lenvatinib|lenvatinib|mesh-list
102322487|NCT05713994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102322488|NCT05713994|Antibodies|antibodies|mesh-list
102322489|NCT05713994|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102322490|NCT05713994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102322491|NCT05713994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102322492|NCT05713994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102322493|NCT05713994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102322494|NCT05713994|Growth Substances|growth substances|mesh-ancestor
102322495|NCT05713994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322496|NCT05713994|Growth Inhibitors|growth inhibitors|mesh-ancestor
102322497|NCT05713994|Immunologic Factors|immunologic factors|mesh-ancestor
102322498|NCT05713994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102322499|NCT05713994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102322500|NCT05713994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322501|NCT05710887|Nitrous Oxide|nitrous oxide|mesh-list
102322502|NCT05710887|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102322503|NCT05710887|Anesthetics, General|anesthetics, general|mesh-ancestor
102322504|NCT05710887|Anesthetics|anesthetics|mesh-ancestor
102322505|NCT05710887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102322506|NCT05710887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322507|NCT05710887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102322508|NCT05710887|Analgesics|analgesics|mesh-ancestor
102322509|NCT05710887|Sensory System Agents|sensory system agents|mesh-ancestor
102322510|NCT05710887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102322511|NCT05707351|Factor VIII|factor viii|mesh-list
102322512|NCT05707351|BAX 855|bax 855|mesh-list
102322514|NCT05657041|Clopidogrel|clopidogrel|mesh-list
102322515|NCT05657041|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102322516|NCT05657041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102322517|NCT05657041|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102322518|NCT05657041|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102322519|NCT05657041|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102322520|NCT05657041|Purinergic Agents|purinergic agents|mesh-ancestor
102322521|NCT05657041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102322522|NCT05657041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322523|NCT05657041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322524|NCT05656599|Letermovir|letermovir|mesh-list
102322525|NCT05656599|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102322526|NCT05656599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102322527|NCT05656599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322528|NCT05656599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102322529|NCT05656599|Antiviral Agents|antiviral agents|mesh-ancestor
102322530|NCT05656599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102322531|NCT05607420|Alemtuzumab|alemtuzumab|mesh-list
102322532|NCT05607420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102322533|NCT05607420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102322534|NCT05607316|Metformin|metformin|mesh-list
102322535|NCT05607316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102322536|NCT05607316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322537|NCT05605587|Leflunomide|leflunomide|mesh-list
102322538|NCT05605587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102322539|NCT05605587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322540|NCT05605587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102322541|NCT05605587|Immunologic Factors|immunologic factors|mesh-ancestor
102322542|NCT05605587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322543|NCT05586477|Diphenhydramine|diphenhydramine|mesh-list
102031354|NCT03489863|Ticagrelor|ticagrelor|mesh-list
102322544|NCT05586477|Promethazine|promethazine|mesh-list
102322545|NCT05586477|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102322546|NCT05586477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102322547|NCT05586477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102322548|NCT05586477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322549|NCT05586477|Anesthetics, Local|anesthetics, local|mesh-ancestor
102322550|NCT05586477|Anesthetics|anesthetics|mesh-ancestor
102322551|NCT05586477|Sensory System Agents|sensory system agents|mesh-ancestor
102322552|NCT05586477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102322553|NCT05586477|Antiemetics|antiemetics|mesh-ancestor
102322554|NCT05586477|Autonomic Agents|autonomic agents|mesh-ancestor
102322555|NCT05586477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102322556|NCT05586477|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102322557|NCT05586477|Histamine Antagonists|histamine antagonists|mesh-ancestor
102322558|NCT05586477|Histamine Agents|histamine agents|mesh-ancestor
102322559|NCT05586477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102322560|NCT05586477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322561|NCT05586477|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102322562|NCT05586477|Antipruritics|antipruritics|mesh-ancestor
102322563|NCT05586477|Dermatologic Agents|dermatologic agents|mesh-ancestor
102322564|NCT05582993|Factor VIII|factor viii|mesh-list
102322565|NCT05582993|Coagulants|coagulants|mesh-ancestor
102322566|NCT05581758|Sotorasib|sotorasib|mesh-list
102322567|NCT05581758|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102322568|NCT05581758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322569|NCT05581758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102322570|NCT05581758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102322571|NCT05554146|Dronabinol|dronabinol|mesh-list
102322572|NCT05554146|Hallucinogens|hallucinogens|mesh-ancestor
102322573|NCT05554146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322574|NCT05554146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102322575|NCT05554146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102322576|NCT05554146|Analgesics|analgesics|mesh-ancestor
102322577|NCT05554146|Sensory System Agents|sensory system agents|mesh-ancestor
102322578|NCT05554146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102322579|NCT05554146|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102322580|NCT05554146|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102322581|NCT05554146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102322582|NCT05554146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322583|NCT05554146|Hormones|hormones|mesh-ancestor
102322584|NCT05554146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102322585|NCT05553301|Vaccines|vaccines|mesh-list
102322586|NCT05553301|Immunologic Factors|immunologic factors|mesh-ancestor
102322587|NCT05553301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322588|NCT05535738|Fluticasone|fluticasone|mesh-list
102322590|NCT05535738|Adalimumab|adalimumab|mesh-list
102322591|NCT05535738|Triamcinolone|triamcinolone|mesh-list
102322592|NCT05535738|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102322593|NCT05535738|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102322594|NCT05535738|Betamethasone|betamethasone|mesh-list
102322595|NCT05535738|Betamethasone Valerate|betamethasone valerate|mesh-list
102322596|NCT05535738|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102322597|NCT05535738|Betamethasone benzoate|betamethasone benzoate|mesh-list
102322598|NCT05535738|Ustekinumab|ustekinumab|mesh-list
102322599|NCT05535738|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102322600|NCT05535738|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
102322601|NCT05535738|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102322602|NCT05535738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102322603|NCT05535738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102322604|NCT05535738|Autonomic Agents|autonomic agents|mesh-ancestor
102322605|NCT05535738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102322606|NCT05535738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322607|NCT05535738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102322608|NCT05535738|Respiratory System Agents|respiratory system agents|mesh-ancestor
102322609|NCT05535738|Dermatologic Agents|dermatologic agents|mesh-ancestor
102322610|NCT05535738|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102322611|NCT05535738|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102322612|NCT05535738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102322613|NCT05535738|Glucocorticoids|glucocorticoids|mesh-ancestor
102322614|NCT05535738|Hormones|hormones|mesh-ancestor
102322615|NCT05535738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102322616|NCT05535738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102322617|NCT05535738|Immunologic Factors|immunologic factors|mesh-ancestor
102322618|NCT05535738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102322619|NCT05535738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322620|NCT05535738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102322621|NCT05518110|Hydroxychloroquine|hydroxychloroquine|mesh-list
102322622|NCT05518110|Trametinib|trametinib|mesh-list
102322623|NCT05518110|Antimalarials|antimalarials|mesh-ancestor
102322624|NCT05518110|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102322625|NCT05518110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102322626|NCT05518110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102322627|NCT05518110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102322628|NCT05518110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322629|NCT05518110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102322630|NCT05518110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102322631|NCT05518110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102322632|NCT05486481|Dexamethasone|dexamethasone|mesh-list
102322633|NCT05486481|Venetoclax|venetoclax|mesh-list
102322634|NCT05486481|Daratumumab|daratumumab|mesh-list
102322635|NCT05486481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102322636|NCT05486481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102322637|NCT05486481|Antiemetics|antiemetics|mesh-ancestor
102322638|NCT05486481|Autonomic Agents|autonomic agents|mesh-ancestor
102322639|NCT05486481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102322640|NCT05486481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322641|NCT05486481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102322642|NCT05486481|Glucocorticoids|glucocorticoids|mesh-ancestor
102322643|NCT05486481|Hormones|hormones|mesh-ancestor
102322644|NCT05486481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102322645|NCT05486481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102322646|NCT05486481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102322647|NCT05486481|Immunologic Factors|immunologic factors|mesh-ancestor
102322648|NCT05441410|Artesunate|artesunate|mesh-list
102322649|NCT05441410|Pyronaridine|pyronaridine|mesh-list
102322650|NCT05441410|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
102322651|NCT05441410|Antimalarials|antimalarials|mesh-ancestor
102322652|NCT05441410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102322653|NCT05441410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102322654|NCT05441410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102322655|NCT05441410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102322656|NCT05441410|Antiviral Agents|antiviral agents|mesh-ancestor
102322657|NCT05441410|Schistosomicides|schistosomicides|mesh-ancestor
102322658|NCT05441410|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102322659|NCT05441410|Anthelmintics|anthelmintics|mesh-ancestor
102322660|NCT05431595|Valproic Acid|valproic acid|mesh-list
102322661|NCT05431595|Haloperidol|haloperidol|mesh-list
102322662|NCT05431595|Chlorpromazine|chlorpromazine|mesh-list
102322663|NCT05431595|Haloperidol decanoate|haloperidol decanoate|mesh-list
102322664|NCT05431595|Antiemetics|antiemetics|mesh-ancestor
102322665|NCT05431595|Autonomic Agents|autonomic agents|mesh-ancestor
102322666|NCT05431595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102322667|NCT05431595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322668|NCT05431595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102322669|NCT05431595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102322670|NCT05431595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102322671|NCT05431595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102322672|NCT05431595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102322673|NCT05431595|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102322674|NCT05431595|Dopamine Agents|dopamine agents|mesh-ancestor
102322675|NCT05431595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102322676|NCT05431595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322677|NCT05431595|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102322678|NCT05431595|Anticonvulsants|anticonvulsants|mesh-ancestor
102322679|NCT05431595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102322680|NCT05431595|GABA Agents|gaba agents|mesh-ancestor
102322681|NCT05431595|Antimanic Agents|antimanic agents|mesh-ancestor
102322682|NCT05351489|Dexmedetomidine|dexmedetomidine|mesh-list
102322683|NCT05351489|Bupivacaine|bupivacaine|mesh-list
102322684|NCT05351489|Anesthetics, Local|anesthetics, local|mesh-ancestor
102322685|NCT05351489|Anesthetics|anesthetics|mesh-ancestor
102322686|NCT05351489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102322687|NCT05351489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322688|NCT05351489|Sensory System Agents|sensory system agents|mesh-ancestor
102322689|NCT05351489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102322690|NCT05351489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102322691|NCT05351489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102322692|NCT05351489|Analgesics|analgesics|mesh-ancestor
102322693|NCT05351489|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102322694|NCT05351489|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102322695|NCT05351489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102322696|NCT05351489|Adrenergic Agents|adrenergic agents|mesh-ancestor
102322697|NCT05351489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102322698|NCT05351489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322700|NCT05345717|Proteasome Inhibitors|proteasome inhibitors|mesh-list
102322701|NCT05345717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102322702|NCT05345717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322703|NCT05345717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102322704|NCT05345717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102322705|NCT05345717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102322706|NCT05345717|Immunologic Factors|immunologic factors|mesh-ancestor
102322707|NCT05345717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322708|NCT05345717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102322709|NCT05345717|Protease Inhibitors|protease inhibitors|mesh-ancestor
102322710|NCT05345717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102322711|NCT05327127|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
102322712|NCT05327127|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102322713|NCT05327127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322714|NCT05327127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102322715|NCT05327127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322716|NCT05256537|Mycophenolic Acid|mycophenolic acid|mesh-list
102322717|NCT05256537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102322718|NCT05256537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102322719|NCT05256537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102322720|NCT05256537|Antitubercular Agents|antitubercular agents|mesh-ancestor
102322721|NCT05256537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102322722|NCT05256537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102322723|NCT05256537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102322724|NCT05256537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322725|NCT05245968|Sunitinib|sunitinib|mesh-list
102322726|NCT05245968|Imatinib Mesylate|imatinib mesylate|mesh-list
102322727|NCT05245968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102322728|NCT05245968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102322729|NCT05245968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102322730|NCT05245968|Growth Substances|growth substances|mesh-ancestor
102322731|NCT05245968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322732|NCT05245968|Growth Inhibitors|growth inhibitors|mesh-ancestor
102322733|NCT05245968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102322734|NCT05245968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102322735|NCT05245968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322736|NCT05220514|PK 11195|pk 11195|mesh-list
102322737|NCT05220514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102322738|NCT05194969|Petrolatum|petrolatum|mesh-list
102322739|NCT05194969|Emollients|emollients|mesh-ancestor
102322740|NCT05194969|Dermatologic Agents|dermatologic agents|mesh-ancestor
102322741|NCT05181735|Luspatercept|luspatercept|mesh-list
102322742|NCT05181735|Hematinics|hematinics|mesh-ancestor
102322743|NCT05166239|Lenvatinib|lenvatinib|mesh-list
102322744|NCT05166239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102322745|NCT05166239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102322746|NCT05166239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102322747|NCT05166239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102322748|NCT05166239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322749|NCT05166239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102322750|NCT05145296|Daratumumab|daratumumab|mesh-list
102322751|NCT05145296|Abatacept|abatacept|mesh-list
102322752|NCT05145296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102322753|NCT05145296|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102322754|NCT05145296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322755|NCT05145296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102322756|NCT05145296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102322757|NCT05145296|Immunologic Factors|immunologic factors|mesh-ancestor
102322758|NCT05145296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322759|NCT05145296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102322760|NCT05122767|Dolutegravir|dolutegravir|mesh-list
102322761|NCT05122767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102322762|NCT05122767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102322763|NCT05122767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102322764|NCT05122767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322765|NCT05122767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102322766|NCT05122767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102322767|NCT05122767|Antiviral Agents|antiviral agents|mesh-ancestor
102322768|NCT05122767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102322769|NCT05100654|Doxycycline|doxycycline|mesh-list
102322770|NCT05100654|Ciprofloxacin|ciprofloxacin|mesh-list
102031578|NCT03720041|BB 1101|bb 1101|mesh-list
102322771|NCT05100654|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102322772|NCT05100654|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102322773|NCT05100654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102322774|NCT05100654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102322775|NCT05100654|Antimalarials|antimalarials|mesh-ancestor
102322776|NCT05100654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102322777|NCT05100654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102322778|NCT05100654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102322779|NCT05100654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102322780|NCT05100654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102322781|NCT05100654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322782|NCT05100654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102322783|NCT05100654|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102322784|NCT05100654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102322785|NCT05100654|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102322786|NCT05100654|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102322787|NCT05095922|Valsartan|valsartan|mesh-list
102322788|NCT05095922|Calcium Dobesilate|calcium dobesilate|mesh-list
102322789|NCT05095922|Calcium|calcium|mesh-list
102322790|NCT05095922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102322791|NCT05095922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322792|NCT05095922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102322793|NCT05095922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102322794|NCT05095922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102322795|NCT05095922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322796|NCT05095922|Hemostatics|hemostatics|mesh-ancestor
102322797|NCT05095922|Coagulants|coagulants|mesh-ancestor
102322798|NCT05084222|Budesonide|budesonide|mesh-list
102322799|NCT05084222|Albuterol|albuterol|mesh-list
102322800|NCT05084222|Formoterol Fumarate|formoterol fumarate|mesh-list
102322801|NCT05084222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102322802|NCT05084222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102322803|NCT05084222|Autonomic Agents|autonomic agents|mesh-ancestor
102322804|NCT05084222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102322805|NCT05084222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322806|NCT05084222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102322807|NCT05084222|Respiratory System Agents|respiratory system agents|mesh-ancestor
102322808|NCT05084222|Glucocorticoids|glucocorticoids|mesh-ancestor
102322809|NCT05084222|Hormones|hormones|mesh-ancestor
102322810|NCT05084222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102322811|NCT05084222|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102322812|NCT05084222|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102322813|NCT05084222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102322814|NCT05084222|Adrenergic Agents|adrenergic agents|mesh-ancestor
102322815|NCT05084222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102322816|NCT05084222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322817|NCT05084222|Tocolytic Agents|tocolytic agents|mesh-ancestor
102322818|NCT05084222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102322819|NCT05062980|Docetaxel|docetaxel|mesh-list
102322820|NCT05062980|Pembrolizumab|pembrolizumab|mesh-list
102322821|NCT05062980|Ramucirumab|ramucirumab|mesh-list
102322822|NCT05062980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102322823|NCT05062980|Tubulin Modulators|tubulin modulators|mesh-ancestor
102322824|NCT05062980|Antimitotic Agents|antimitotic agents|mesh-ancestor
102322825|NCT05062980|Mitosis Modulators|mitosis modulators|mesh-ancestor
102322826|NCT05062980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322827|NCT05062980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102322828|NCT05062980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102322829|NCT05014412|Dexamethasone|dexamethasone|mesh-list
102322830|NCT05014412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102322831|NCT05014412|Antiemetics|antiemetics|mesh-ancestor
102322832|NCT05014412|Autonomic Agents|autonomic agents|mesh-ancestor
102322833|NCT05014412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102322834|NCT05014412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322835|NCT05014412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102322836|NCT05014412|Glucocorticoids|glucocorticoids|mesh-ancestor
102322837|NCT05014412|Hormones|hormones|mesh-ancestor
102322838|NCT05014412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102322839|NCT05014412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102322840|NCT05014412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102322841|NCT04924322|Enoxaparin|enoxaparin|mesh-list
102322842|NCT04924322|Anticoagulants|anticoagulants|mesh-ancestor
102322843|NCT04924322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102031653|NCT02334046|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102322844|NCT04924322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102322845|NCT04924322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322847|NCT04907253|Antioxidants|antioxidants|mesh-ancestor
102322848|NCT04907253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322849|NCT04907253|Protective Agents|protective agents|mesh-ancestor
102322850|NCT04907253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322851|NCT04902443|Nivolumab|nivolumab|mesh-list
102322852|NCT04902443|Pomalidomide|pomalidomide|mesh-list
102322853|NCT04902443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102322854|NCT04902443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102322855|NCT04902443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102322856|NCT04902443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322857|NCT04902443|Immunologic Factors|immunologic factors|mesh-ancestor
102322858|NCT04902443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322859|NCT04902443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102322860|NCT04902443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102322861|NCT04902443|Growth Substances|growth substances|mesh-ancestor
102322862|NCT04902443|Growth Inhibitors|growth inhibitors|mesh-ancestor
102322863|NCT04898023|Ascorbic Acid|ascorbic acid|mesh-list
102322864|NCT04898023|Antioxidants|antioxidants|mesh-ancestor
102322865|NCT04898023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322866|NCT04898023|Protective Agents|protective agents|mesh-ancestor
102322867|NCT04898023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322868|NCT04898023|Vitamins|vitamins|mesh-ancestor
102322869|NCT04898023|Micronutrients|micronutrients|mesh-ancestor
102322870|NCT04875715|Hydroquinone|hydroquinone|mesh-list
102322871|NCT04875715|Antioxidants|antioxidants|mesh-ancestor
102322872|NCT04875715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322873|NCT04875715|Protective Agents|protective agents|mesh-ancestor
102322874|NCT04875715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322875|NCT04875715|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102322876|NCT04875702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102322877|NCT04875702|Allopurinol|allopurinol|mesh-list
102322878|NCT04875702|Antimetabolites|antimetabolites|mesh-ancestor
102322879|NCT04875702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322880|NCT04875702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102322881|NCT04875702|Gout Suppressants|gout suppressants|mesh-ancestor
102322882|NCT04875702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102322883|NCT04875702|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102322884|NCT04875702|Antioxidants|antioxidants|mesh-ancestor
102322885|NCT04875702|Protective Agents|protective agents|mesh-ancestor
102322886|NCT04875702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322887|NCT04836429|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
102322888|NCT04836429|Trioxsalen|trioxsalen|mesh-list
102322889|NCT04836429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102322890|NCT04836429|Dermatologic Agents|dermatologic agents|mesh-ancestor
102322891|NCT04836429|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102322892|NCT04822467|Ethanol|ethanol|mesh-list
102322893|NCT04822467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102322894|NCT04822467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102322895|NCT04822467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102322896|NCT04822467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322897|NCT04801368|Anesthetics|anesthetics|mesh-list
102322898|NCT04801368|Anesthetics, Local|anesthetics, local|mesh-list
102322899|NCT04801368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102322900|NCT04801368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322901|NCT04801368|Sensory System Agents|sensory system agents|mesh-ancestor
102322902|NCT04801368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102322903|NCT04783935|Cladribine|cladribine|mesh-list
102322904|NCT04783935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102322905|NCT04783935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102322906|NCT04783935|Immunologic Factors|immunologic factors|mesh-ancestor
102322907|NCT04783935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322908|NCT04769713|Ropivacaine|ropivacaine|mesh-list
102322909|NCT04769713|Anesthetics, Local|anesthetics, local|mesh-ancestor
102322910|NCT04769713|Anesthetics|anesthetics|mesh-ancestor
102322911|NCT04769713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102322912|NCT04769713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322913|NCT04769713|Sensory System Agents|sensory system agents|mesh-ancestor
102322914|NCT04769713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102322915|NCT04746235|Decitabine|decitabine|mesh-list
102322916|NCT04746235|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
102322917|NCT04746235|Venetoclax|venetoclax|mesh-list
102322918|NCT04746235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102322920|NCT04746235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322921|NCT04746235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102322922|NCT04746235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102322923|NCT04728581|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102322924|NCT04728581|Mirtazapine|mirtazapine|mesh-list
102322925|NCT04728581|Antidepressive Agents|antidepressive agents|mesh-ancestor
102322926|NCT04728581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102322927|NCT04728581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102322928|NCT04728581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102322929|NCT04728581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102322930|NCT04728581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322931|NCT04728581|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102322932|NCT04728581|Histamine Antagonists|histamine antagonists|mesh-ancestor
102322933|NCT04728581|Histamine Agents|histamine agents|mesh-ancestor
102322934|NCT04728581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102322935|NCT04728581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322936|NCT04728581|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102322937|NCT04728581|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102322938|NCT04728581|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102322939|NCT04728581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102322940|NCT04728581|Adrenergic Agents|adrenergic agents|mesh-ancestor
102322941|NCT04728581|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102322942|NCT04728581|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102322943|NCT04728581|Serotonin Agents|serotonin agents|mesh-ancestor
102322944|NCT04728581|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102322945|NCT04677543|Azithromycin|azithromycin|mesh-list
102322946|NCT04677543|Amikacin|amikacin|mesh-list
102322947|NCT04677543|Ethambutol|ethambutol|mesh-list
102322948|NCT04677543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102322949|NCT04677543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102322950|NCT04677543|Antitubercular Agents|antitubercular agents|mesh-ancestor
102322951|NCT04662840|Anesthetics|anesthetics|mesh-list
102322952|NCT04662840|Anesthetics, Local|anesthetics, local|mesh-list
102322953|NCT04662840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102322954|NCT04662840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322955|NCT04662840|Sensory System Agents|sensory system agents|mesh-ancestor
102322956|NCT04662840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102322957|NCT04544293|Molgramostim|molgramostim|mesh-list
102322958|NCT04544293|Sargramostim|sargramostim|mesh-list
102322959|NCT04544293|Immunologic Factors|immunologic factors|mesh-ancestor
102322960|NCT04544293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322961|NCT04544293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102322962|NCT04413201|Osimertinib|osimertinib|mesh-list
102322964|NCT04413201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102322965|NCT04413201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102322966|NCT04413201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102322967|NCT04413201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102322968|NCT04254627|Etanercept|etanercept|mesh-list
102322969|NCT04254627|Mifepristone|mifepristone|mesh-list
102322970|NCT04254627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102322971|NCT04254627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102322972|NCT04254627|Analgesics|analgesics|mesh-ancestor
102322973|NCT04254627|Sensory System Agents|sensory system agents|mesh-ancestor
102322974|NCT04254627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102322975|NCT04254627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102322976|NCT04254627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102322977|NCT04254627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102322978|NCT04254627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102322979|NCT04254627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102322980|NCT04254627|Immunologic Factors|immunologic factors|mesh-ancestor
102322981|NCT04254627|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102322982|NCT04254627|Abortifacient Agents|abortifacient agents|mesh-ancestor
102322983|NCT04254627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102322984|NCT04254627|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102322985|NCT04254627|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102322986|NCT04254627|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102322987|NCT04254627|Contraceptive Agents|contraceptive agents|mesh-ancestor
102322988|NCT04254627|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102322989|NCT04254627|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102322990|NCT04254627|Hormone Antagonists|hormone antagonists|mesh-ancestor
102322991|NCT04254627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102322992|NCT04254627|Luteolytic Agents|luteolytic agents|mesh-ancestor
102322993|NCT04254627|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102322994|NCT04254627|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102322995|NCT04160052|Azacitidine|azacitidine|mesh-list
102322996|NCT04160052|Venetoclax|venetoclax|mesh-list
102322997|NCT04160052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102322998|NCT04160052|Antimetabolites|antimetabolites|mesh-ancestor
102322999|NCT04160052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323000|NCT04160052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323001|NCT04160052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102323002|NCT04139902|Dostarlimab|dostarlimab|mesh-list
102323003|NCT04139902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323004|NCT04136366|Methotrexate|methotrexate|mesh-list
102323005|NCT04136366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102323006|NCT04136366|Abortifacient Agents|abortifacient agents|mesh-ancestor
102323007|NCT04136366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102323008|NCT04136366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323009|NCT04136366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102323010|NCT04136366|Antimetabolites|antimetabolites|mesh-ancestor
102323011|NCT04136366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323012|NCT04136366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323013|NCT04136366|Dermatologic Agents|dermatologic agents|mesh-ancestor
102323014|NCT04136366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102323015|NCT04136366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102323016|NCT04136366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102323017|NCT04136366|Immunologic Factors|immunologic factors|mesh-ancestor
102323018|NCT04136366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101440003|NCT04692467|Amlodipine|amlodipine|mesh-list
102323019|NCT04136366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102323020|NCT04124432|Nicotine|nicotine|mesh-list
102323021|NCT04124432|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102323022|NCT04124432|Autonomic Agents|autonomic agents|mesh-ancestor
102323023|NCT04124432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102323024|NCT04124432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323025|NCT04124432|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102323026|NCT04124432|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102323027|NCT04124432|Cholinergic Agents|cholinergic agents|mesh-ancestor
102323028|NCT04124432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102323029|NCT04124432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323030|NCT04091217|Bevacizumab|bevacizumab|mesh-list
102323031|NCT04091217|Atezolizumab|atezolizumab|mesh-list
102323032|NCT04091217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102323033|NCT04091217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323034|NCT04091217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102323035|NCT04091217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102323036|NCT04091217|Growth Substances|growth substances|mesh-ancestor
102323037|NCT04091217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323038|NCT04091217|Growth Inhibitors|growth inhibitors|mesh-ancestor
102323039|NCT04091217|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102323040|NCT04091217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323041|NCT04081389|Interferons|interferons|mesh-list
102323042|NCT04081389|Interferon-alpha|interferon-alpha|mesh-list
102323043|NCT04081389|Interferon alpha-2|interferon alpha-2|mesh-list
102323044|NCT04081389|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
102323045|NCT04081389|Celecoxib|celecoxib|mesh-list
102323046|NCT04081389|Paclitaxel|paclitaxel|mesh-list
102323047|NCT04081389|Cyclophosphamide|cyclophosphamide|mesh-list
102323048|NCT04081389|Doxorubicin|doxorubicin|mesh-list
102323049|NCT04081389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102323050|NCT04081389|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102323051|NCT04081389|Daunorubicin|daunorubicin|mesh-list
102323052|NCT04081389|Benzenesulfonamide|benzenesulfonamide|mesh-list
102323053|NCT04081389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102323054|NCT04081389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323055|NCT04081389|Tubulin Modulators|tubulin modulators|mesh-ancestor
102323056|NCT04081389|Antimitotic Agents|antimitotic agents|mesh-ancestor
102323057|NCT04081389|Mitosis Modulators|mitosis modulators|mesh-ancestor
102323058|NCT04081389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323059|NCT04081389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102323060|NCT04081389|Immunologic Factors|immunologic factors|mesh-ancestor
102323061|NCT04081389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323062|NCT04081389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102323063|NCT04081389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102323064|NCT04081389|Alkylating Agents|alkylating agents|mesh-ancestor
102323065|NCT04081389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102323066|NCT04081389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102323067|NCT04081389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102323068|NCT04081389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102323069|NCT04081389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102323070|NCT04081389|Antiviral Agents|antiviral agents|mesh-ancestor
102323071|NCT04081389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102323072|NCT04081389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102323073|NCT04081389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102323074|NCT04081389|Analgesics|analgesics|mesh-ancestor
102323075|NCT04081389|Sensory System Agents|sensory system agents|mesh-ancestor
102323076|NCT04081389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102323077|NCT04081389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102323078|NCT04081389|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102323079|NCT04081389|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102323080|NCT04081389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102323081|NCT04060862|Fulvestrant|fulvestrant|mesh-list
102323082|NCT04060862|Palbociclib|palbociclib|mesh-list
102323083|NCT04060862|Ipatasertib|ipatasertib|mesh-list
102323084|NCT04060862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102323085|NCT04060862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323086|NCT04060862|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102323087|NCT04060862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102323088|NCT04060862|Hormone Antagonists|hormone antagonists|mesh-ancestor
102323089|NCT04060862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102323090|NCT04060862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323091|NCT04060862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102323092|NCT04060862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102323093|NCT04060862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323094|NCT03848845|Pembrolizumab|pembrolizumab|mesh-list
102323095|NCT03848845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102323096|NCT03848845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323097|NCT03848845|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102323098|NCT03848845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323099|NCT03811847|Methylphenidate|methylphenidate|mesh-list
102323100|NCT03811847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102323101|NCT03811847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323102|NCT03811847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102323103|NCT03811847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102323104|NCT03811847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102323105|NCT03811847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323106|NCT03811847|Dopamine Agents|dopamine agents|mesh-ancestor
102323107|NCT03811847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102323108|NCT03809000|Leuprolide|leuprolide|mesh-list
102323109|NCT03809000|Goserelin|goserelin|mesh-list
102323110|NCT03809000|Bicalutamide|bicalutamide|mesh-list
102323111|NCT03809000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102323112|NCT03809000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323113|NCT03809000|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102323114|NCT03809000|Fertility Agents|fertility agents|mesh-ancestor
102323115|NCT03809000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102323116|NCT03809000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102323117|NCT03809000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323118|NCT03809000|Androgen Antagonists|androgen antagonists|mesh-ancestor
102323119|NCT03809000|Hormone Antagonists|hormone antagonists|mesh-ancestor
102323120|NCT03698552|Epratuzumab|epratuzumab|mesh-list
102323121|NCT03698552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102323122|NCT03698552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323123|NCT03600350|Nivolumab|nivolumab|mesh-list
102323124|NCT03600350|Sargramostim|sargramostim|mesh-list
102323125|NCT03600350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102323126|NCT03600350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323127|NCT03600350|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102323128|NCT03600350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323129|NCT03600350|Immunologic Factors|immunologic factors|mesh-ancestor
102323130|NCT03600350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323131|NCT03598595|Hydroxychloroquine|hydroxychloroquine|mesh-list
102323132|NCT03598595|Gemcitabine|gemcitabine|mesh-list
102323133|NCT03598595|Docetaxel|docetaxel|mesh-list
102323134|NCT03598595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102323135|NCT03598595|Antimetabolites|antimetabolites|mesh-ancestor
102323136|NCT03598595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323137|NCT03598595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323138|NCT03598595|Tubulin Modulators|tubulin modulators|mesh-ancestor
102323139|NCT03598595|Antimitotic Agents|antimitotic agents|mesh-ancestor
102323140|NCT03598595|Mitosis Modulators|mitosis modulators|mesh-ancestor
102323141|NCT03598595|Antimalarials|antimalarials|mesh-ancestor
102323142|NCT03598595|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102323143|NCT03598595|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102323144|NCT03598595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102323145|NCT03598595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102323146|NCT03598595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102323147|NCT03590054|Pembrolizumab|pembrolizumab|mesh-list
102323148|NCT03590054|Abexinostat|abexinostat|mesh-list
102323149|NCT03590054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102323150|NCT03590054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323151|NCT03590054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102323152|NCT03590054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323153|NCT03590054|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102323154|NCT03590054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102323155|NCT03568097|Avelumab|avelumab|mesh-list
102323156|NCT03568097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102323157|NCT03568097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323158|NCT03546582|Pembrolizumab|pembrolizumab|mesh-list
102323159|NCT03546582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102323160|NCT03546582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323161|NCT03546582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102323162|NCT03546582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323163|NCT03384238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102323164|NCT03384238|Panitumumab|panitumumab|mesh-list
102323165|NCT03384238|Antibodies|antibodies|mesh-list
102323166|NCT03384238|Immunoglobulins|immunoglobulins|mesh-list
102323167|NCT03384238|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102323168|NCT03384238|Immunologic Factors|immunologic factors|mesh-ancestor
102323169|NCT03384238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323170|NCT03384238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323171|NCT03226249|Deoxyglucose|deoxyglucose|mesh-list
102323172|NCT03226249|Doxorubicin|doxorubicin|mesh-list
102323173|NCT03226249|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102323174|NCT03226249|Pembrolizumab|pembrolizumab|mesh-list
102323175|NCT03226249|Dacarbazine|dacarbazine|mesh-list
102323176|NCT03226249|Vinblastine|vinblastine|mesh-list
102323177|NCT03226249|Imidazole|imidazole|mesh-list
102323178|NCT03226249|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102323179|NCT03226249|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102323180|NCT03226249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323181|NCT03226249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102323182|NCT03226249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102323183|NCT03226249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101665105|NCT04243850|Empagliflozin|empagliflozin|mesh-list
102323184|NCT03226249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323185|NCT03226249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102323186|NCT03226249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102323187|NCT03226249|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102323188|NCT03226249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102323189|NCT03226249|Alkylating Agents|alkylating agents|mesh-ancestor
102323190|NCT03226249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102323191|NCT03226249|Tubulin Modulators|tubulin modulators|mesh-ancestor
102323192|NCT03226249|Antimitotic Agents|antimitotic agents|mesh-ancestor
102323193|NCT03226249|Mitosis Modulators|mitosis modulators|mesh-ancestor
102323194|NCT03226249|Antimetabolites|antimetabolites|mesh-ancestor
102323195|NCT03226249|Antiviral Agents|antiviral agents|mesh-ancestor
102323196|NCT03226249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102323197|NCT03184155|Nicardipine|nicardipine|mesh-list
102323198|NCT03184155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102323199|NCT03184155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102323200|NCT03184155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102323201|NCT03184155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323202|NCT03184155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102323203|NCT03184155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323204|NCT03184155|Vasodilator Agents|vasodilator agents|mesh-ancestor
102323205|NCT03172624|Nivolumab|nivolumab|mesh-list
102323206|NCT03172624|Ipilimumab|ipilimumab|mesh-list
102323207|NCT03172624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102323208|NCT03172624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323209|NCT03172624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102323210|NCT03172624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323211|NCT03101748|Paclitaxel|paclitaxel|mesh-list
102323212|NCT03101748|Cyclophosphamide|cyclophosphamide|mesh-list
102323213|NCT03101748|Doxorubicin|doxorubicin|mesh-list
102323214|NCT03101748|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102323215|NCT03101748|Trastuzumab|trastuzumab|mesh-list
102323216|NCT03101748|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102323217|NCT03101748|Daunorubicin|daunorubicin|mesh-list
102323218|NCT03101748|Pertuzumab|pertuzumab|mesh-list
102323219|NCT03101748|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
102323220|NCT03101748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102323221|NCT03101748|Antibodies|antibodies|mesh-list
102323222|NCT03101748|Immunoglobulins|immunoglobulins|mesh-list
102323223|NCT03101748|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101440203|NCT04487080|Osimertinib|osimertinib|mesh-list
102323224|NCT03101748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102323225|NCT03101748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323226|NCT03101748|Tubulin Modulators|tubulin modulators|mesh-ancestor
102323227|NCT03101748|Antimitotic Agents|antimitotic agents|mesh-ancestor
102323228|NCT03101748|Mitosis Modulators|mitosis modulators|mesh-ancestor
102323229|NCT03101748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323230|NCT03101748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102323231|NCT03101748|Immunologic Factors|immunologic factors|mesh-ancestor
102323232|NCT03101748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323233|NCT03101748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102323234|NCT03101748|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102323235|NCT03101748|Alkylating Agents|alkylating agents|mesh-ancestor
102323236|NCT03101748|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102323237|NCT03101748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102323238|NCT03101748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102323239|NCT03101748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102323240|NCT03101748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102323241|NCT03085147|Olaparib|olaparib|mesh-list
102323242|NCT03085147|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102323243|NCT03085147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102323244|NCT03085147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323245|NCT03085147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323246|NCT03063944|Azacitidine|azacitidine|mesh-list
102323247|NCT03063944|Decitabine|decitabine|mesh-list
102323248|NCT03063944|Venetoclax|venetoclax|mesh-list
102323249|NCT03063944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102323250|NCT03063944|Antimetabolites|antimetabolites|mesh-ancestor
102323251|NCT03063944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323252|NCT03063944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323253|NCT03063944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102323254|NCT03062631|Amifampridine|amifampridine|mesh-list
102323255|NCT03062631|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102323256|NCT03062631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102323257|NCT03062631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323258|NCT03062631|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102323259|NCT03062631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102323260|NCT03062631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323261|NCT02941926|Letrozole|letrozole|mesh-list
102323262|NCT02941926|Leuprolide|leuprolide|mesh-list
102323263|NCT02941926|Goserelin|goserelin|mesh-list
102323264|NCT02941926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323265|NCT02941926|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102323266|NCT02941926|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102323267|NCT02941926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102323268|NCT02941926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323269|NCT02941926|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102323270|NCT02941926|Hormone Antagonists|hormone antagonists|mesh-ancestor
102323271|NCT02941926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102323272|NCT02941926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323273|NCT02941926|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102323274|NCT02941926|Fertility Agents|fertility agents|mesh-ancestor
102323275|NCT02941926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102323276|NCT02941926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102323277|NCT02910700|Nivolumab|nivolumab|mesh-list
102323278|NCT02910700|Trametinib|trametinib|mesh-list
102323279|NCT02910700|Dabrafenib|dabrafenib|mesh-list
102323280|NCT02910700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102323281|NCT02910700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323282|NCT02910700|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102323283|NCT02910700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323284|NCT02910700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102323285|NCT02910700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102323286|NCT02849548|Suvorexant|suvorexant|mesh-list
102323287|NCT02849548|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102323288|NCT02849548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102323289|NCT02849548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102323290|NCT02849548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323291|NCT02849548|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102323292|NCT02849548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102323293|NCT02849548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323294|NCT02780310|Lenvatinib|lenvatinib|mesh-list
102323295|NCT02780310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323296|NCT02780310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102323297|NCT02780310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102323298|NCT02780310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323299|NCT02758431|Methyltestosterone|methyltestosterone|mesh-list
102323300|NCT02758431|Anastrozole|anastrozole|mesh-list
102323301|NCT02758431|Testosterone|testosterone|mesh-list
102323302|NCT02758431|Testosterone undecanoate|testosterone undecanoate|mesh-list
102323303|NCT02758431|Testosterone enanthate|testosterone enanthate|mesh-list
102323304|NCT02758431|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102323305|NCT02758431|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102323306|NCT02758431|Acyline|acyline|mesh-list
102323307|NCT02758431|Hormone Antagonists|hormone antagonists|mesh-list
102323308|NCT02758431|Hormones|hormones|mesh-ancestor
102323309|NCT02758431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102323310|NCT02758431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323311|NCT02758431|Androgens|androgens|mesh-ancestor
102323312|NCT02758431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102323313|NCT02758431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323314|NCT02758431|Anabolic Agents|anabolic agents|mesh-ancestor
102323315|NCT02758431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102323316|NCT02758431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102323317|NCT02758431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323318|NCT02758431|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102323319|NCT02756000|Dobutamine|dobutamine|mesh-list
102323320|NCT02756000|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102323321|NCT02756000|Sympathomimetics|sympathomimetics|mesh-ancestor
102323322|NCT02756000|Autonomic Agents|autonomic agents|mesh-ancestor
102323323|NCT02756000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102323324|NCT02756000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323325|NCT02756000|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102323326|NCT02756000|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102323327|NCT02756000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102323328|NCT02756000|Adrenergic Agents|adrenergic agents|mesh-ancestor
102323329|NCT02756000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102323330|NCT02756000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323331|NCT02756000|Protective Agents|protective agents|mesh-ancestor
102323332|NCT02601365|Molgramostim|molgramostim|mesh-list
102323333|NCT02601365|Sargramostim|sargramostim|mesh-list
102323334|NCT02601365|Immunologic Factors|immunologic factors|mesh-ancestor
102323335|NCT02601365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323336|NCT02601365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323337|NCT02583893|Cytarabine|cytarabine|mesh-list
102323338|NCT02583893|Sirolimus|sirolimus|mesh-list
102323339|NCT02583893|Etoposide|etoposide|mesh-list
102323340|NCT02583893|Mitoxantrone|mitoxantrone|mesh-list
102323341|NCT02583893|Etoposide phosphate|etoposide phosphate|mesh-list
102323342|NCT02583893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102323343|NCT02583893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323344|NCT02583893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102323345|NCT02583893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102323346|NCT02583893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102323347|NCT02583893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323348|NCT02583893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102323349|NCT02583893|Antimetabolites|antimetabolites|mesh-ancestor
102323350|NCT02583893|Antiviral Agents|antiviral agents|mesh-ancestor
102323351|NCT02583893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102323352|NCT02583893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102323353|NCT02583893|Immunologic Factors|immunologic factors|mesh-ancestor
102323354|NCT02583893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323355|NCT02583893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102323356|NCT02583893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102323357|NCT02583893|Antifungal Agents|antifungal agents|mesh-ancestor
102323358|NCT02583893|Analgesics|analgesics|mesh-ancestor
102323359|NCT02583893|Sensory System Agents|sensory system agents|mesh-ancestor
102323360|NCT02583893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102323361|NCT02520154|Paclitaxel|paclitaxel|mesh-list
102323362|NCT02520154|Carboplatin|carboplatin|mesh-list
102323363|NCT02520154|Pembrolizumab|pembrolizumab|mesh-list
102323364|NCT02520154|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102323365|NCT02520154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102323366|NCT02520154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323367|NCT02520154|Tubulin Modulators|tubulin modulators|mesh-ancestor
102032185|NCT03719261|Chitosan|chitosan|mesh-list
102323368|NCT02520154|Antimitotic Agents|antimitotic agents|mesh-ancestor
102323369|NCT02520154|Mitosis Modulators|mitosis modulators|mesh-ancestor
102323370|NCT02520154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323371|NCT02520154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102323372|NCT02520154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102323373|NCT02411448|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102323374|NCT02411448|Gefitinib|gefitinib|mesh-list
102323375|NCT02411448|Osimertinib|osimertinib|mesh-list
102323376|NCT02411448|Ramucirumab|ramucirumab|mesh-list
102323377|NCT02411448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323378|NCT02411448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102323379|NCT02411448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102323380|NCT02411448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323381|NCT02107144|Trimetazidine|trimetazidine|mesh-list
102323382|NCT02107144|Vasodilator Agents|vasodilator agents|mesh-ancestor
102323383|NCT01860170|Cyclophosphamide|cyclophosphamide|mesh-list
102323384|NCT01860170|Bortezomib|bortezomib|mesh-list
102323385|NCT01860170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102323386|NCT01860170|Immunologic Factors|immunologic factors|mesh-ancestor
102323387|NCT01860170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323388|NCT01860170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102323389|NCT01860170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102323390|NCT01860170|Alkylating Agents|alkylating agents|mesh-ancestor
102323391|NCT01860170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323392|NCT01860170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323393|NCT01860170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102323394|NCT01847274|Niraparib|niraparib|mesh-list
102323395|NCT01847274|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102323396|NCT01847274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102323397|NCT01847274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323398|NCT01847274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323399|NCT01697566|Metformin|metformin|mesh-list
102323400|NCT01697566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102323401|NCT01697566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323402|NCT01566695|Azacitidine|azacitidine|mesh-list
102323403|NCT01566695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102323404|NCT01566695|Antimetabolites|antimetabolites|mesh-ancestor
102323405|NCT01566695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323406|NCT01566695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323407|NCT01566695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102323408|NCT01471106|Dasatinib|dasatinib|mesh-list
102323409|NCT01471106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323410|NCT01471106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102323411|NCT01471106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102323412|NCT01471106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323413|NCT01330446|Modafinil|modafinil|mesh-list
102323414|NCT01330446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102323415|NCT01330446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323416|NCT01330446|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102323417|NCT01330446|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102323418|NCT01330446|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102323419|NCT01330446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323420|NCT01258933|Ofatumumab|ofatumumab|mesh-list
102323421|NCT01258933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323422|NCT00866554|Tamoxifen|tamoxifen|mesh-list
102323423|NCT00866554|Bicalutamide|bicalutamide|mesh-list
102323424|NCT00866554|Dutasteride|dutasteride|mesh-list
102323425|NCT00866554|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102323426|NCT00866554|Hormone Antagonists|hormone antagonists|mesh-ancestor
102323427|NCT00866554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102323428|NCT00866554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323429|NCT00866554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102323430|NCT00866554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323431|NCT00866554|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102323432|NCT00866554|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102323433|NCT00866554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102323434|NCT00866554|Androgen Antagonists|androgen antagonists|mesh-ancestor
102323435|NCT00866554|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102323436|NCT00866554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102323437|NCT00866554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102323438|NCT00866554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323439|NCT00645931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
102323440|NCT00645931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102032266|NCT02328118|Triamcinolone|triamcinolone|mesh-list
102323441|NCT00645931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323442|NCT00452023|Interferons|interferons|mesh-list
102323443|NCT00452023|Interferon-alpha|interferon-alpha|mesh-list
102323444|NCT00452023|Interferon alpha-2|interferon alpha-2|mesh-list
102323445|NCT00452023|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102323446|NCT00452023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323447|NCT00452023|Antiviral Agents|antiviral agents|mesh-ancestor
102323448|NCT00452023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102323449|NCT00452023|Immunologic Factors|immunologic factors|mesh-ancestor
102323450|NCT00452023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323451|NCT00442104|Ganaxolone|ganaxolone|mesh-list
102323452|NCT00442104|Neurosteroids|neurosteroids|mesh-ancestor
102323453|NCT00442104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102323454|NCT00442104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323455|NCT00442104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323456|NCT00442104|GABA Modulators|gaba modulators|mesh-ancestor
102323457|NCT00442104|GABA Agents|gaba agents|mesh-ancestor
102323458|NCT00441896|Ganaxolone|ganaxolone|mesh-list
102323459|NCT00441896|Neurosteroids|neurosteroids|mesh-ancestor
102323460|NCT00441896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102323461|NCT00441896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323462|NCT00441896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323463|NCT00441896|GABA Modulators|gaba modulators|mesh-ancestor
102323464|NCT00441896|GABA Agents|gaba agents|mesh-ancestor
102323465|NCT00254423|Dasatinib|dasatinib|mesh-list
102323466|NCT00254423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323467|NCT00254423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102323468|NCT00254423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102323469|NCT00254423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323470|NCT00202800|Gemcitabine|gemcitabine|mesh-list
102323471|NCT00202800|Etoposide|etoposide|mesh-list
102323472|NCT00202800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102323473|NCT00202800|Antimetabolites|antimetabolites|mesh-ancestor
102323474|NCT00202800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323475|NCT00202800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323476|NCT00202800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102323477|NCT00202800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102323478|NCT00202800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102323479|NCT00202800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102323480|NCT00194714|Vaccines|vaccines|mesh-list
102323481|NCT00194714|Immunologic Factors|immunologic factors|mesh-ancestor
102323482|NCT00194714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323483|NCT02034877|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102323484|NCT02034877|Immunologic Factors|immunologic factors|mesh-ancestor
102323485|NCT02034877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323486|NCT02034799|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102323487|NCT02034799|Hemostatics|hemostatics|mesh-ancestor
102323488|NCT02034799|Coagulants|coagulants|mesh-ancestor
102323489|NCT02057575|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102323490|NCT02057575|Latanoprost|latanoprost|mesh-list
102323491|NCT02057575|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102323492|NCT02077465|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102323493|NCT02077465|Immunologic Factors|immunologic factors|mesh-ancestor
102323494|NCT02077465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323495|NCT02034565|Apixaban|apixaban|mesh-list
102323496|NCT02034565|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102323497|NCT02034565|Antithrombins|antithrombins|mesh-ancestor
102323498|NCT02034565|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102323499|NCT02034565|Protease Inhibitors|protease inhibitors|mesh-ancestor
102323500|NCT02034565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102323501|NCT02034565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323502|NCT02034565|Anticoagulants|anticoagulants|mesh-ancestor
102323503|NCT02075515|Vaccines|vaccines|mesh-list
102323504|NCT02075515|Immunologic Factors|immunologic factors|mesh-ancestor
102323505|NCT02075515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323506|NCT04682587|Pembrolizumab|pembrolizumab|mesh-list
102323507|NCT04682587|Avelumab|avelumab|mesh-list
102323508|NCT04682587|Axitinib|axitinib|mesh-list
102323509|NCT04682587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102323510|NCT04682587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323511|NCT04682587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102323512|NCT04682587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323513|NCT04682587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102323514|NCT04682587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102032336|NCT04926454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102323515|NCT04417543|Memantine|memantine|mesh-list
102323516|NCT04417543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102323517|NCT04417543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102323518|NCT04417543|Dopamine Agents|dopamine agents|mesh-ancestor
102323519|NCT04417543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102323520|NCT04417543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323521|NCT04417543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323522|NCT04417543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102323523|NCT04417543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102323524|NCT02021318|Darbepoetin alfa|darbepoetin alfa|mesh-list
102323525|NCT02021318|Hematinics|hematinics|mesh-ancestor
102323526|NCT02020616|Metformin|metformin|mesh-list
102323527|NCT02020616|Exenatide|exenatide|mesh-list
102323528|NCT02020616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102323529|NCT02020616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323530|NCT02020616|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102323531|NCT02020616|Incretins|incretins|mesh-ancestor
102323532|NCT02020616|Hormones|hormones|mesh-ancestor
102323533|NCT02020616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102323534|NCT02048072|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102323535|NCT02048072|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102323536|NCT02048072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323537|NCT02048072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102323538|NCT02048072|Immunologic Factors|immunologic factors|mesh-ancestor
102323539|NCT02048072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323540|NCT01622660|Gemcitabine|gemcitabine|mesh-list
102323541|NCT01622660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102323542|NCT01622660|Antimetabolites|antimetabolites|mesh-ancestor
102323543|NCT01622660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323544|NCT01622660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323545|NCT04697498|Anesthetics|anesthetics|mesh-list
102323546|NCT04697498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102323547|NCT04697498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323548|NCT02019602|Certolizumab Pegol|certolizumab pegol|mesh-list
102323549|NCT02019602|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102323550|NCT02019602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102323551|NCT02019602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102323552|NCT02019602|Immunologic Factors|immunologic factors|mesh-ancestor
102323553|NCT02019602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323554|NCT02019602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102323555|NCT02040428|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102323556|NCT02040428|Hemostatics|hemostatics|mesh-ancestor
102323557|NCT02040428|Coagulants|coagulants|mesh-ancestor
102323558|NCT02018822|Urethane|urethane|mesh-list
102323559|NCT02018822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323560|NCT02018822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102323561|NCT02018822|Anesthetics, General|anesthetics, general|mesh-ancestor
102323562|NCT02018822|Anesthetics|anesthetics|mesh-ancestor
102323563|NCT02018822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102323564|NCT02018822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323565|NCT02055157|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
102323566|NCT02055157|Natriuretic Agents|natriuretic agents|mesh-ancestor
102323567|NCT02055157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323568|NCT02022007|Metformin|metformin|mesh-list
102323569|NCT02022007|Saxagliptin|saxagliptin|mesh-list
102323570|NCT02022007|Biguanides|biguanides|mesh-list
102323571|NCT02022007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
102323572|NCT02022007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101440240|NCT04439539|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102323573|NCT02022007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323574|NCT02022007|Incretins|incretins|mesh-ancestor
102323575|NCT02022007|Hormones|hormones|mesh-ancestor
102323576|NCT02022007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102323577|NCT02022007|Protease Inhibitors|protease inhibitors|mesh-ancestor
102323578|NCT02022007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102323579|NCT02022007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323580|NCT04689919|Rivaroxaban|rivaroxaban|mesh-list
102323581|NCT04689919|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102323582|NCT04689919|Antithrombins|antithrombins|mesh-ancestor
102323583|NCT04689919|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102323584|NCT04689919|Protease Inhibitors|protease inhibitors|mesh-ancestor
102323585|NCT04689919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102323586|NCT04689919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323587|NCT04689919|Anticoagulants|anticoagulants|mesh-ancestor
102323588|NCT04680949|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102323589|NCT04680949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102323590|NCT02053753|Denosumab|denosumab|mesh-list
102323591|NCT02053753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102032411|NCT03114969|Parasympatholytics|parasympatholytics|mesh-ancestor
102323592|NCT02053753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323593|NCT02019979|Metformin|metformin|mesh-list
102323594|NCT02019979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102323595|NCT02019979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323596|NCT02019667|(3-aminopropyl)(n-butyl)phosphinic acid|(3-aminopropyl)(n-butyl)phosphinic acid|mesh-list
102323597|NCT02019667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102323598|NCT02019667|Protective Agents|protective agents|mesh-ancestor
102323599|NCT02019667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323600|NCT02019667|GABA Antagonists|gaba antagonists|mesh-ancestor
102323601|NCT02019667|GABA Agents|gaba agents|mesh-ancestor
102323602|NCT02019667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102323603|NCT02019667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323604|NCT02030821|Tranexamic Acid|tranexamic acid|mesh-list
102323605|NCT02030821|Aminocaproic Acid|aminocaproic acid|mesh-list
102323606|NCT02030821|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102323607|NCT02030821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102323608|NCT02030821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323609|NCT02030821|Hemostatics|hemostatics|mesh-ancestor
102323610|NCT02030821|Coagulants|coagulants|mesh-ancestor
102323611|NCT02052739|Brexanolone|brexanolone|mesh-list
102323612|NCT02052739|Neurosteroids|neurosteroids|mesh-ancestor
102323613|NCT02052739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102323614|NCT02052739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323615|NCT02052739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323616|NCT02052739|GABA Modulators|gaba modulators|mesh-ancestor
102323617|NCT02052739|GABA Agents|gaba agents|mesh-ancestor
102323618|NCT02019277|Paclitaxel|paclitaxel|mesh-list
102323619|NCT02019277|Docetaxel|docetaxel|mesh-list
102323620|NCT02019277|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102323621|NCT02019277|Trastuzumab|trastuzumab|mesh-list
102323622|NCT02019277|Pertuzumab|pertuzumab|mesh-list
102323623|NCT02019277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102323624|NCT02019277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323625|NCT02019277|Tubulin Modulators|tubulin modulators|mesh-ancestor
102323626|NCT02019277|Antimitotic Agents|antimitotic agents|mesh-ancestor
102323627|NCT02019277|Mitosis Modulators|mitosis modulators|mesh-ancestor
102323628|NCT02019277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323629|NCT02019277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102323630|NCT01823835|Palbociclib|palbociclib|mesh-list
102323631|NCT01823835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323632|NCT01823835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102323633|NCT01823835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102323634|NCT01823835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323635|NCT01823679|Capecitabine|capecitabine|mesh-list
102323636|NCT01823679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102323637|NCT01823679|Antimetabolites|antimetabolites|mesh-ancestor
102323638|NCT01823679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323639|NCT01823679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323640|NCT01823289|Itraconazole|itraconazole|mesh-list
102323641|NCT01823289|Antifungal Agents|antifungal agents|mesh-ancestor
102323642|NCT01823289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102323643|NCT01823289|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102323644|NCT01823289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102323645|NCT01823289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102323646|NCT01823289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323647|NCT01823289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102323648|NCT01823289|Hormone Antagonists|hormone antagonists|mesh-ancestor
102323649|NCT01823289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102323650|NCT01823289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323651|NCT01823289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102323652|NCT01822899|Fluticasone|fluticasone|mesh-list
102323653|NCT01822899|Xhance|xhance|mesh-list
102323654|NCT01822899|Bromides|bromides|mesh-list
102323655|NCT01822899|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102323656|NCT01822899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102323657|NCT01822899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102323658|NCT01822899|Autonomic Agents|autonomic agents|mesh-ancestor
102323659|NCT01822899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102323660|NCT01822899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323661|NCT01822899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102323662|NCT01822899|Respiratory System Agents|respiratory system agents|mesh-ancestor
102323663|NCT01822899|Dermatologic Agents|dermatologic agents|mesh-ancestor
102032487|NCT03144856|Apatinib|apatinib|mesh-list
102323664|NCT01822899|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102323665|NCT01822899|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102323666|NCT01822899|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102323667|NCT01822899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102323668|NCT01822899|Adrenergic Agents|adrenergic agents|mesh-ancestor
102323669|NCT01822899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102323670|NCT01822899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323671|NCT01822899|Anticonvulsants|anticonvulsants|mesh-ancestor
102323672|NCT01822821|Acetaminophen|acetaminophen|mesh-list
102323673|NCT01822821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102323674|NCT01822821|Analgesics|analgesics|mesh-ancestor
102323675|NCT01822821|Sensory System Agents|sensory system agents|mesh-ancestor
102323676|NCT01822821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102323677|NCT01822821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323678|NCT01822821|Antipyretics|antipyretics|mesh-ancestor
102323679|NCT01822665|Acetaminophen|acetaminophen|mesh-list
102323680|NCT01822665|Ibuprofen|ibuprofen|mesh-list
102323681|NCT01822665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102323682|NCT01822665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102323683|NCT01822665|Analgesics|analgesics|mesh-ancestor
102323684|NCT01822665|Sensory System Agents|sensory system agents|mesh-ancestor
102323685|NCT01822665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102323686|NCT01822665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323687|NCT01822665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102323688|NCT01822665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102323689|NCT01822665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102323690|NCT01822665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102323691|NCT01822665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323692|NCT01822665|Antipyretics|antipyretics|mesh-ancestor
102323693|NCT01822587|Propranolol|propranolol|mesh-list
102323694|NCT01822587|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102323695|NCT01822587|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102323696|NCT01822587|Adrenergic Agents|adrenergic agents|mesh-ancestor
102323697|NCT01822587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102323698|NCT01822587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323699|NCT01822587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323700|NCT01822587|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102323701|NCT01822587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102323702|NCT01822587|Vasodilator Agents|vasodilator agents|mesh-ancestor
102323703|NCT01821963|Interferons|interferons|mesh-list
102323705|NCT01821963|Interferon-alpha|interferon-alpha|mesh-list
102323706|NCT01821963|Interferon alpha-2|interferon alpha-2|mesh-list
102323707|NCT01821963|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102323708|NCT01821963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323709|NCT01821963|Antiviral Agents|antiviral agents|mesh-ancestor
102323710|NCT01821963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102323711|NCT01821963|Antimetabolites|antimetabolites|mesh-ancestor
102323712|NCT01821963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323713|NCT01821963|Immunologic Factors|immunologic factors|mesh-ancestor
102323714|NCT01821963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323715|NCT01821729|Leucovorin|leucovorin|mesh-list
102323716|NCT01821729|Fluorouracil|fluorouracil|mesh-list
102323717|NCT01821729|Oxaliplatin|oxaliplatin|mesh-list
102323718|NCT01821729|Folfirinox|folfirinox|mesh-list
102323719|NCT01821729|Losartan|losartan|mesh-list
102323720|NCT01821729|Antimetabolites|antimetabolites|mesh-ancestor
102323721|NCT01821729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323722|NCT01821729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102323723|NCT01821729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323724|NCT01821729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102323725|NCT01821729|Immunologic Factors|immunologic factors|mesh-ancestor
102323726|NCT01821729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323727|NCT01821729|Antidotes|antidotes|mesh-ancestor
102323728|NCT01821729|Protective Agents|protective agents|mesh-ancestor
102323729|NCT01821729|Vitamin B Complex|vitamin b complex|mesh-ancestor
102323730|NCT01821729|Vitamins|vitamins|mesh-ancestor
102323731|NCT01821729|Micronutrients|micronutrients|mesh-ancestor
102323732|NCT01821729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102323733|NCT01821729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102323734|NCT01821729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102323735|NCT01821729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102323736|NCT01820637|Paclitaxel|paclitaxel|mesh-list
102323737|NCT01820637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102323738|NCT01820637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323739|NCT01820637|Tubulin Modulators|tubulin modulators|mesh-ancestor
102323740|NCT01820637|Antimitotic Agents|antimitotic agents|mesh-ancestor
102323741|NCT01820637|Mitosis Modulators|mitosis modulators|mesh-ancestor
102323742|NCT01820637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323743|NCT01850823|Mometasone Furoate|mometasone furoate|mesh-list
102323744|NCT01850823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102323745|NCT01850823|Dermatologic Agents|dermatologic agents|mesh-ancestor
102323746|NCT01850823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102323747|NCT01820559|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102323748|NCT01820559|Anticonvulsants|anticonvulsants|mesh-ancestor
102323749|NCT01820559|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102323750|NCT01820559|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102323751|NCT01820559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102323752|NCT01820559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323753|NCT02171429|Adalimumab|adalimumab|mesh-list
102323754|NCT02171429|Etrolizumab|etrolizumab|mesh-list
102323755|NCT02171429|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102323756|NCT02171429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102323757|NCT02171429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102323758|NCT02171429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102323759|NCT02171429|Immunologic Factors|immunologic factors|mesh-ancestor
102323760|NCT02171429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323761|NCT01818141|Vancomycin|vancomycin|mesh-list
102323762|NCT01818141|Fidaxomicin|fidaxomicin|mesh-list
102323763|NCT01818141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102323764|NCT01818141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102323765|NCT01849497|Evolocumab|evolocumab|mesh-list
102323766|NCT01849497|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102323767|NCT01849497|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102323768|NCT01849497|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102323769|NCT01849497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102323770|NCT01849497|Antimetabolites|antimetabolites|mesh-ancestor
102323771|NCT01849497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323772|NCT01849497|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102323773|NCT01849497|Protease Inhibitors|protease inhibitors|mesh-ancestor
102323774|NCT01849497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102323775|NCT01849497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102323776|NCT01849497|Immunologic Factors|immunologic factors|mesh-ancestor
102323777|NCT01849497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323778|NCT04170465|Metformin|metformin|mesh-list
102323779|NCT04170465|Paclitaxel|paclitaxel|mesh-list
102323780|NCT04170465|Cyclophosphamide|cyclophosphamide|mesh-list
102323781|NCT04170465|Doxorubicin|doxorubicin|mesh-list
102323782|NCT04170465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102323783|NCT04170465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323784|NCT04170465|Tubulin Modulators|tubulin modulators|mesh-ancestor
102323785|NCT04170465|Antimitotic Agents|antimitotic agents|mesh-ancestor
102323786|NCT04170465|Mitosis Modulators|mitosis modulators|mesh-ancestor
102323787|NCT04170465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323788|NCT04170465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102323789|NCT04170465|Immunologic Factors|immunologic factors|mesh-ancestor
102323790|NCT04170465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323791|NCT04170465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102323792|NCT04170465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102323793|NCT04170465|Alkylating Agents|alkylating agents|mesh-ancestor
102323794|NCT04170465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102323795|NCT04170465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102323796|NCT04170465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102323797|NCT04170465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102323798|NCT04170465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102323799|NCT04170465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102323800|NCT01816893|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102323801|NCT01816893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323802|NCT01847313|Liraglutide|liraglutide|mesh-list
102323803|NCT01847313|Glucagon|glucagon|mesh-list
102323804|NCT01847313|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102323805|NCT01847313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102323806|NCT01847313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323807|NCT01847313|Incretins|incretins|mesh-ancestor
102323808|NCT01847313|Hormones|hormones|mesh-ancestor
102323809|NCT01847313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102323810|NCT01847313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102323811|NCT02117687|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102323812|NCT02117687|Hyaluronic Acid|hyaluronic acid|mesh-list
102323813|NCT02117687|Glycerol|glycerol|mesh-list
102323814|NCT02117687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102323815|NCT02117687|Immunologic Factors|immunologic factors|mesh-ancestor
102323816|NCT02117687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032629|NCT03651674|Autonomic Agents|autonomic agents|mesh-ancestor
102323817|NCT02117687|Viscosupplements|viscosupplements|mesh-ancestor
102323818|NCT02117687|Protective Agents|protective agents|mesh-ancestor
102323819|NCT02117687|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102323820|NCT02117687|Laxatives|laxatives|mesh-ancestor
102323821|NCT02117687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102323822|NCT04740593|Methamphetamine|methamphetamine|mesh-list
102323823|NCT04740593|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102323824|NCT04740593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323825|NCT04740593|Sympathomimetics|sympathomimetics|mesh-ancestor
102323826|NCT04740593|Autonomic Agents|autonomic agents|mesh-ancestor
102323827|NCT04740593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102323828|NCT04740593|Dopamine Agents|dopamine agents|mesh-ancestor
102323829|NCT04740593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102323830|NCT04740593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323831|NCT04740593|Adrenergic Agents|adrenergic agents|mesh-ancestor
102323832|NCT04740593|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102323833|NCT04740593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102323834|NCT04740593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102323835|NCT04740593|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101440277|NCT04392037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102323836|NCT02141633|Fluticasone|fluticasone|mesh-list
102323837|NCT02141633|Xhance|xhance|mesh-list
102323838|NCT02141633|Albuterol|albuterol|mesh-list
102323839|NCT02141633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102323840|NCT02141633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102323841|NCT02141633|Autonomic Agents|autonomic agents|mesh-ancestor
102323842|NCT02141633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102323843|NCT02141633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323844|NCT02141633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102323845|NCT02141633|Respiratory System Agents|respiratory system agents|mesh-ancestor
102323846|NCT02141633|Dermatologic Agents|dermatologic agents|mesh-ancestor
102323847|NCT02141633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102323848|NCT02141633|Tocolytic Agents|tocolytic agents|mesh-ancestor
102323849|NCT02141633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102323850|NCT02141633|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102323851|NCT02141633|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102323852|NCT02141633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102323853|NCT02141633|Adrenergic Agents|adrenergic agents|mesh-ancestor
102323854|NCT02141633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102323855|NCT02141633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323856|NCT01846611|Dexamethasone|dexamethasone|mesh-list
102323857|NCT01846611|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102323858|NCT01846611|Doxorubicin|doxorubicin|mesh-list
102323859|NCT01846611|Trabectedin|trabectedin|mesh-list
102323860|NCT01846611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102323861|NCT01846611|Antiemetics|antiemetics|mesh-ancestor
102323862|NCT01846611|Autonomic Agents|autonomic agents|mesh-ancestor
102323863|NCT01846611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102323864|NCT01846611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323865|NCT01846611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102323866|NCT01846611|Glucocorticoids|glucocorticoids|mesh-ancestor
102323867|NCT01846611|Hormones|hormones|mesh-ancestor
102323868|NCT01846611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102323869|NCT01846611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102323870|NCT01846611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323871|NCT01846611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102323872|NCT01846611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102323873|NCT01846611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102323874|NCT01846611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102323875|NCT01846611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323876|NCT01846611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102323877|NCT01846611|Alkylating Agents|alkylating agents|mesh-ancestor
102323878|NCT01846299|Ranibizumab|ranibizumab|mesh-list
102323879|NCT01846299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102323880|NCT01846299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102323881|NCT01846299|Growth Substances|growth substances|mesh-ancestor
102323882|NCT01846299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323883|NCT01846299|Growth Inhibitors|growth inhibitors|mesh-ancestor
102323884|NCT01846299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323885|NCT01628393|Ozanimod|ozanimod|mesh-list
102323886|NCT01628393|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102323887|NCT01628393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323888|NCT01628393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102323889|NCT01628393|Immunologic Factors|immunologic factors|mesh-ancestor
102323890|NCT01628393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323891|NCT01846221|Clonidine|clonidine|mesh-list
102323892|NCT01846221|Fentanyl|fentanyl|mesh-list
102323893|NCT01846221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102323895|NCT01846221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102323896|NCT01846221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323897|NCT01846221|Analgesics|analgesics|mesh-ancestor
102323898|NCT01846221|Sensory System Agents|sensory system agents|mesh-ancestor
102323899|NCT01846221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102323900|NCT01846221|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102323901|NCT01846221|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102323902|NCT01846221|Anesthetics, General|anesthetics, general|mesh-ancestor
102323903|NCT01846221|Anesthetics|anesthetics|mesh-ancestor
102323904|NCT01846221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102323905|NCT01846221|Sympatholytics|sympatholytics|mesh-ancestor
102323906|NCT01846221|Autonomic Agents|autonomic agents|mesh-ancestor
102323907|NCT01846221|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102323908|NCT01846221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102323909|NCT01846221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102323910|NCT01846221|Adrenergic Agents|adrenergic agents|mesh-ancestor
102323911|NCT01846221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102323912|NCT01846221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323913|NCT01845831|Metformin|metformin|mesh-list
102323914|NCT01845831|Insulin Glargine|insulin glargine|mesh-list
102323915|NCT01845831|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102323916|NCT01845831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102323917|NCT01845831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323918|NCT01845831|Incretins|incretins|mesh-ancestor
102323919|NCT01845831|Hormones|hormones|mesh-ancestor
102323920|NCT01845831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102323921|NCT01845831|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102323922|NCT01845831|Protease Inhibitors|protease inhibitors|mesh-ancestor
102323923|NCT01845831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102323924|NCT01845831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323925|NCT01844895|Abatacept|abatacept|mesh-list
102323926|NCT01844895|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102323927|NCT01844895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323928|NCT01844895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102323929|NCT01844895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323930|NCT01844895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102323931|NCT01844895|Immunologic Factors|immunologic factors|mesh-ancestor
102323932|NCT01844895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323933|NCT01844895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102323934|NCT02116361|Botulinum Toxins|botulinum toxins|mesh-list
102323935|NCT02116361|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102323936|NCT02116361|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102323937|NCT02116361|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102323938|NCT02116361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102323939|NCT02116361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323940|NCT02116361|Cholinergic Agents|cholinergic agents|mesh-ancestor
102323941|NCT02116361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102323942|NCT02116361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323943|NCT02116361|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102323944|NCT02116361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102323945|NCT04594239|Lidocaine|lidocaine|mesh-list
102323946|NCT04594239|Hyaluronic Acid|hyaluronic acid|mesh-list
102323947|NCT04594239|Anesthetics, Local|anesthetics, local|mesh-ancestor
102323948|NCT04594239|Anesthetics|anesthetics|mesh-ancestor
102323949|NCT04594239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102323950|NCT04594239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323951|NCT04594239|Sensory System Agents|sensory system agents|mesh-ancestor
102323952|NCT04594239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102323953|NCT04594239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102323954|NCT04594239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102323955|NCT04594239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102323956|NCT04594239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102323957|NCT04594239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323958|NCT04594239|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102323959|NCT04594239|Immunologic Factors|immunologic factors|mesh-ancestor
102323960|NCT04594239|Viscosupplements|viscosupplements|mesh-ancestor
102323961|NCT04594239|Protective Agents|protective agents|mesh-ancestor
102323962|NCT04585737|Tenofovir|tenofovir|mesh-list
102323963|NCT04585737|Lamivudine|lamivudine|mesh-list
102323964|NCT04585737|Emtricitabine|emtricitabine|mesh-list
102323965|NCT04585737|Dolutegravir|dolutegravir|mesh-list
102323966|NCT04585737|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
102323967|NCT04585737|Antiviral Agents|antiviral agents|mesh-ancestor
102323968|NCT04585737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102323969|NCT04585737|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102323970|NCT04585737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102323971|NCT04585737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102323972|NCT04585737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323973|NCT04585737|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102323974|NCT04585737|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102323975|NCT04585737|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102323976|NCT04585737|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102323977|NCT01814553|Afatinib|afatinib|mesh-list
102323978|NCT01814553|Loperamide|loperamide|mesh-list
102323979|NCT01814553|Antidiarrheals|antidiarrheals|mesh-list
102323980|NCT01814553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102323981|NCT01814553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102323982|NCT01814553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102323983|NCT01814553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323984|NCT01814553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102323985|NCT02116205|Vaccines|vaccines|mesh-list
102323986|NCT02116205|Immunologic Factors|immunologic factors|mesh-ancestor
102323987|NCT02116205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102323988|NCT01844583|Rifampin|rifampin|mesh-list
102323989|NCT01844583|Esomeprazole|esomeprazole|mesh-list
102323990|NCT01844583|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102323991|NCT01844583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102323992|NCT01844583|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102323993|NCT01844583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102323994|NCT01844583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102323995|NCT01844583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102323996|NCT01844583|Antitubercular Agents|antitubercular agents|mesh-ancestor
102323997|NCT01844583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102323998|NCT01844583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102323999|NCT01844583|Leprostatic Agents|leprostatic agents|mesh-ancestor
102324000|NCT01844583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102324001|NCT01844583|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102324002|NCT01844583|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102324003|NCT01844583|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102324004|NCT01844583|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102324005|NCT01844583|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102324006|NCT01844583|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102324007|NCT04742075|Durvalumab|durvalumab|mesh-list
102324008|NCT04742075|Olaparib|olaparib|mesh-list
102324009|NCT04742075|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102324010|NCT04742075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102324011|NCT04742075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102324012|NCT04742075|Immunologic Factors|immunologic factors|mesh-ancestor
102324013|NCT04742075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324014|NCT04742075|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102324015|NCT04742075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102324016|NCT04742075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324017|NCT02115113|Everolimus|everolimus|mesh-list
102324018|NCT02115113|Tacrolimus|tacrolimus|mesh-list
102324019|NCT02115113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102324020|NCT02115113|Immunologic Factors|immunologic factors|mesh-ancestor
102324021|NCT02115113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324022|NCT02115113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102324023|NCT02115113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102324024|NCT02115113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324025|NCT02115113|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102324026|NCT02115113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102324027|NCT02115113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102324028|NCT02114177|Sofosbuvir|sofosbuvir|mesh-list
102324029|NCT02114177|Simeprevir|simeprevir|mesh-list
102324030|NCT02114177|Antiviral Agents|antiviral agents|mesh-ancestor
102324031|NCT02114177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102324032|NCT02114177|Protease Inhibitors|protease inhibitors|mesh-ancestor
102324033|NCT02114177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102324034|NCT02114177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324035|NCT02138825|Riociguat|riociguat|mesh-list
102324036|NCT02138825|Enzyme Activators|enzyme activators|mesh-ancestor
102324037|NCT02138825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324038|NCT02138747|Mirabegron|mirabegron|mesh-list
102324039|NCT02138747|Tolterodine Tartrate|tolterodine tartrate|mesh-list
102324040|NCT02138747|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102324041|NCT02138747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102324042|NCT02138747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102324043|NCT02138747|Adrenergic Agents|adrenergic agents|mesh-ancestor
102324044|NCT02138747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102324045|NCT02138747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324046|NCT02138747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324047|NCT02138747|Urological Agents|urological agents|mesh-ancestor
102324048|NCT02138747|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102324049|NCT02138747|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102324050|NCT02138747|Cholinergic Agents|cholinergic agents|mesh-ancestor
102324051|NCT02105285|Carteolol|carteolol|mesh-list
102324052|NCT02105285|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102324053|NCT02105285|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102324054|NCT02105285|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102324055|NCT02105285|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102324056|NCT02105285|Adrenergic Agents|adrenergic agents|mesh-ancestor
102324057|NCT02105285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102324058|NCT02105285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324059|NCT02105285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324060|NCT02105285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102324061|NCT02105285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102324062|NCT02105285|Sympatholytics|sympatholytics|mesh-ancestor
102324063|NCT02105285|Autonomic Agents|autonomic agents|mesh-ancestor
102324064|NCT02105285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102324065|NCT01621490|Nivolumab|nivolumab|mesh-list
102324066|NCT01621490|Ipilimumab|ipilimumab|mesh-list
102324067|NCT01621490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102324068|NCT01621490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102324069|NCT01621490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102324070|NCT01621490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324071|NCT02030041|Vitamin D|vitamin d|mesh-list
102324072|NCT02030041|Cholecalciferol|cholecalciferol|mesh-list
102324073|NCT02030041|Simvastatin|simvastatin|mesh-list
102324074|NCT02030041|Vitamins|vitamins|mesh-ancestor
102324075|NCT02030041|Micronutrients|micronutrients|mesh-ancestor
102324076|NCT02030041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324077|NCT02030041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102324078|NCT02030041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102324080|NCT02030041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102324081|NCT02030041|Antimetabolites|antimetabolites|mesh-ancestor
102324082|NCT02030041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324083|NCT02030041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102324084|NCT02030041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102324085|NCT02030041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102324086|NCT01844505|Nivolumab|nivolumab|mesh-list
102324087|NCT01844505|Ipilimumab|ipilimumab|mesh-list
102324088|NCT01844505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102324089|NCT01844505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102324090|NCT01844505|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102324091|NCT01844505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324092|NCT01994720|Aspirin|aspirin|mesh-list
102324093|NCT01994720|Ticagrelor|ticagrelor|mesh-list
102324094|NCT01994720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102324095|NCT01994720|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102324096|NCT01994720|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102324097|NCT01994720|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102324098|NCT01994720|Purinergic Agents|purinergic agents|mesh-ancestor
102324099|NCT01994720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102324100|NCT01994720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324101|NCT01994720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324102|NCT01994720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102324103|NCT01994720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102324104|NCT01994720|Analgesics|analgesics|mesh-ancestor
102324105|NCT01994720|Sensory System Agents|sensory system agents|mesh-ancestor
102324106|NCT01994720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102324107|NCT01994720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102324108|NCT01994720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101440318|NCT04271475|Macitentan|macitentan|mesh-list
102324109|NCT01994720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102324110|NCT01994720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102324111|NCT01994720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102324112|NCT01994720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102324113|NCT01994720|Antipyretics|antipyretics|mesh-ancestor
102324114|NCT01814397|Letrozole|letrozole|mesh-list
102324115|NCT01814397|Anastrozole|anastrozole|mesh-list
102324116|NCT01814397|Exemestane|exemestane|mesh-list
102324117|NCT01814397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102324118|NCT01814397|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102324119|NCT01814397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102324120|NCT01814397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102324121|NCT01814397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324122|NCT01814397|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102324123|NCT01814397|Hormone Antagonists|hormone antagonists|mesh-ancestor
102324124|NCT01814397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102324125|NCT01814397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324126|NCT01814397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102324127|NCT01844115|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
102324128|NCT01844115|Antidepressive Agents|antidepressive agents|mesh-ancestor
102324129|NCT01844115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102324130|NCT01844115|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102324131|NCT01844115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102324132|NCT01844115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102324133|NCT01844115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324134|NCT01844115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102324135|NCT01844115|Serotonin Agents|serotonin agents|mesh-ancestor
102324136|NCT01844115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324137|NCT01844115|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102324138|NCT01844115|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102324139|NCT02018042|Abatacept|abatacept|mesh-list
102324140|NCT02018042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102324141|NCT02018042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324142|NCT02018042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102324143|NCT02018042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102324144|NCT02018042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102324145|NCT02018042|Immunologic Factors|immunologic factors|mesh-ancestor
102324146|NCT02018042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324147|NCT02018042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102324148|NCT02017171|Allopurinol|allopurinol|mesh-list
102324149|NCT02017171|Antimetabolites|antimetabolites|mesh-ancestor
101666073|NCT00945191|Paclitaxel|paclitaxel|mesh-list
102324150|NCT02017171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324152|NCT02017171|Gout Suppressants|gout suppressants|mesh-ancestor
102324153|NCT02017171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102324154|NCT02017171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102324155|NCT02017171|Antioxidants|antioxidants|mesh-ancestor
102324156|NCT02017171|Protective Agents|protective agents|mesh-ancestor
102324157|NCT02017171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324158|NCT04686097|Sclerosing Solutions|sclerosing solutions|mesh-list
102324159|NCT04686097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102324160|NCT02029417|Cytarabine|cytarabine|mesh-list
102324161|NCT02029417|Decitabine|decitabine|mesh-list
102324162|NCT02029417|Azacitidine|azacitidine|mesh-list
102324163|NCT02029417|Homoharringtonine|homoharringtonine|mesh-list
102324164|NCT02029417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102324165|NCT02029417|Antimetabolites|antimetabolites|mesh-ancestor
102324166|NCT02029417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324167|NCT02029417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102324168|NCT02029417|Antiviral Agents|antiviral agents|mesh-ancestor
102324169|NCT02029417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102324170|NCT02029417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102324171|NCT02029417|Immunologic Factors|immunologic factors|mesh-ancestor
102324172|NCT02029417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324173|NCT02029417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102324174|NCT02029417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102324175|NCT02029417|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102324176|NCT02016716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102324177|NCT02016716|Immunologic Factors|immunologic factors|mesh-ancestor
102324178|NCT02016716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324179|NCT02050321|Vemurafenib|vemurafenib|mesh-list
102324180|NCT02050321|Acitretin|acitretin|mesh-list
102324181|NCT02050321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102324182|NCT02050321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102324183|NCT02050321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102324184|NCT02050321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324185|NCT02050321|Keratolytic Agents|keratolytic agents|mesh-ancestor
102324186|NCT02050321|Dermatologic Agents|dermatologic agents|mesh-ancestor
102324187|NCT02017015|Paclitaxel|paclitaxel|mesh-list
102324188|NCT02017015|Gemcitabine|gemcitabine|mesh-list
102324189|NCT02017015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102324190|NCT02017015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033006|NCT05197101|Oxytocin|oxytocin|mesh-list
102324191|NCT02017015|Tubulin Modulators|tubulin modulators|mesh-ancestor
102324192|NCT02017015|Antimitotic Agents|antimitotic agents|mesh-ancestor
102324193|NCT02017015|Mitosis Modulators|mitosis modulators|mesh-ancestor
102324194|NCT02017015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324195|NCT02017015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102324196|NCT02017015|Antimetabolites|antimetabolites|mesh-ancestor
102324197|NCT02016625|Cyclosporine|cyclosporine|mesh-list
102324198|NCT02016625|Tacrolimus|tacrolimus|mesh-list
102324199|NCT02016625|Cyclosporins|cyclosporins|mesh-list
102324200|NCT02016625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102324201|NCT02016625|Immunologic Factors|immunologic factors|mesh-ancestor
102324202|NCT02016625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324203|NCT02016625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102324204|NCT02016625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102324205|NCT02016625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324206|NCT02016625|Antifungal Agents|antifungal agents|mesh-ancestor
102324207|NCT02016625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102324208|NCT02016625|Dermatologic Agents|dermatologic agents|mesh-ancestor
102324209|NCT02016625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102324210|NCT02016482|Adalimumab|adalimumab|mesh-list
102324211|NCT02016482|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102324212|NCT02016482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102324213|NCT02016482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102324214|NCT02028871|Insulin|insulin|mesh-list
102324215|NCT02028871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102324216|NCT02028871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324217|NCT02028715|Acetaminophen|acetaminophen|mesh-list
102324218|NCT02028715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102324219|NCT02028715|Analgesics|analgesics|mesh-ancestor
102324220|NCT02028715|Sensory System Agents|sensory system agents|mesh-ancestor
102324221|NCT02028715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102324222|NCT02028715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324223|NCT02028715|Antipyretics|antipyretics|mesh-ancestor
102324224|NCT02016170|Ticagrelor|ticagrelor|mesh-list
102324225|NCT02016170|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102324226|NCT02016170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102324227|NCT02016170|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102324228|NCT02016170|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102324229|NCT02016170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102324231|NCT02016170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102324232|NCT02016170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324233|NCT02016170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324234|NCT02015546|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
102324235|NCT02015546|Antidepressive Agents|antidepressive agents|mesh-ancestor
102324236|NCT02015546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102324237|NCT02015546|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102324238|NCT02015546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102324239|NCT02015546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102324240|NCT02015546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324241|NCT02015546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102324242|NCT02015546|Serotonin Agents|serotonin agents|mesh-ancestor
102324243|NCT02015546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324244|NCT02015546|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102324245|NCT02015546|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102324246|NCT02038790|Buprenorphine|buprenorphine|mesh-list
102324247|NCT02038790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102324248|NCT02038790|Naloxone|naloxone|mesh-list
102324249|NCT02038790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102324250|NCT02038790|Narcotics|narcotics|mesh-ancestor
102324251|NCT02038790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102324252|NCT02038790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324253|NCT02038790|Analgesics|analgesics|mesh-ancestor
102324254|NCT02038790|Sensory System Agents|sensory system agents|mesh-ancestor
102324255|NCT02038790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102324256|NCT02038790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102324257|NCT02027311|Midazolam|midazolam|mesh-list
102324258|NCT02027311|Meperidine|meperidine|mesh-list
102324259|NCT02027311|Etomidate|etomidate|mesh-list
102324260|NCT02027311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102324261|NCT02027311|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102324262|NCT02027311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102324263|NCT02027311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324264|NCT02027311|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102324265|NCT02027311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102324266|NCT02027311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102324267|NCT02027311|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102324268|NCT02027311|Anesthetics, General|anesthetics, general|mesh-ancestor
102324270|NCT02027311|GABA Modulators|gaba modulators|mesh-ancestor
102324271|NCT02027311|GABA Agents|gaba agents|mesh-ancestor
102324272|NCT02027311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102324273|NCT02027311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324274|NCT02027311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102324275|NCT02027311|Narcotics|narcotics|mesh-ancestor
102324276|NCT02027311|Analgesics|analgesics|mesh-ancestor
102324277|NCT02027311|Sensory System Agents|sensory system agents|mesh-ancestor
102324278|NCT02027311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102324279|NCT02047903|Afatinib|afatinib|mesh-list
102324280|NCT02047903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102324281|NCT02047903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102324282|NCT02047903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102324283|NCT02047903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324284|NCT02026141|Dexmedetomidine|dexmedetomidine|mesh-list
102324285|NCT02026141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102324286|NCT02026141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102324287|NCT02026141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324288|NCT02026141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102324289|NCT02026141|Analgesics|analgesics|mesh-ancestor
102324290|NCT02026141|Sensory System Agents|sensory system agents|mesh-ancestor
102324291|NCT02026141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102324292|NCT02026141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102324293|NCT02026141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102324294|NCT02026141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102324295|NCT02026141|Adrenergic Agents|adrenergic agents|mesh-ancestor
102324296|NCT02026141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102324297|NCT02026141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324298|NCT02025907|Canagliflozin|canagliflozin|mesh-list
102324299|NCT02025907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102324300|NCT02025907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324302|NCT02025907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324303|NCT02025751|Metoclopramide|metoclopramide|mesh-list
102324304|NCT02025751|Antiemetics|antiemetics|mesh-ancestor
102324305|NCT02025751|Autonomic Agents|autonomic agents|mesh-ancestor
102324306|NCT02025751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102324307|NCT02025751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324308|NCT02025751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102324309|NCT02025751|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102324310|NCT02025751|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102324311|NCT02025751|Dopamine Agents|dopamine agents|mesh-ancestor
102324312|NCT02025751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102324313|NCT02025751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324314|NCT01812837|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102324315|NCT01812837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102324316|NCT01812837|Dermatologic Agents|dermatologic agents|mesh-ancestor
102324317|NCT02024971|Metformin|metformin|mesh-list
102324318|NCT02024971|Pioglitazone|pioglitazone|mesh-list
102324319|NCT02024971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102324320|NCT02024971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324321|NCT01843023|Naltrexone|naltrexone|mesh-list
102324322|NCT01843023|Buprenorphine|buprenorphine|mesh-list
102324323|NCT01843023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102324324|NCT01843023|Narcotics|narcotics|mesh-ancestor
102324325|NCT01843023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102324326|NCT01843023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324327|NCT01843023|Analgesics|analgesics|mesh-ancestor
102324328|NCT01843023|Sensory System Agents|sensory system agents|mesh-ancestor
102324329|NCT01843023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102324330|NCT01843023|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102324331|NCT01843023|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102324332|NCT01812759|Fentanyl|fentanyl|mesh-list
102324333|NCT01812759|Hydromorphone|hydromorphone|mesh-list
102324334|NCT01812759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102324335|NCT01812759|Narcotics|narcotics|mesh-ancestor
102324336|NCT01812759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102324337|NCT01812759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324338|NCT01812759|Analgesics|analgesics|mesh-ancestor
102324339|NCT01812759|Sensory System Agents|sensory system agents|mesh-ancestor
102324340|NCT01812759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102033196|NCT03629262|Dsuvia|dsuvia|mesh-list
102324341|NCT01812759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102324342|NCT01812759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102324343|NCT01812759|Anesthetics, General|anesthetics, general|mesh-ancestor
102324344|NCT01812759|Anesthetics|anesthetics|mesh-ancestor
102324345|NCT01812057|Dexamethasone|dexamethasone|mesh-list
102324346|NCT01812057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102324347|NCT01812057|Antiemetics|antiemetics|mesh-ancestor
102324348|NCT01812057|Autonomic Agents|autonomic agents|mesh-ancestor
102324349|NCT01812057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102324350|NCT01812057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324351|NCT01812057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102324352|NCT01812057|Glucocorticoids|glucocorticoids|mesh-ancestor
102324353|NCT01812057|Hormones|hormones|mesh-ancestor
102324354|NCT01812057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102324355|NCT01812057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102324356|NCT01812057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102324357|NCT01842633|Acetaminophen|acetaminophen|mesh-list
102324358|NCT01842633|Ibuprofen|ibuprofen|mesh-list
102324359|NCT01842633|Caffeine|caffeine|mesh-list
102324360|NCT01842633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102324361|NCT01842633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102324362|NCT01842633|Analgesics|analgesics|mesh-ancestor
102324363|NCT01842633|Sensory System Agents|sensory system agents|mesh-ancestor
102324364|NCT01842633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102324365|NCT01842633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307836|NCT02043886|Acarbose|acarbose|mesh-list
102324366|NCT01842633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102324367|NCT01842633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102324368|NCT01842633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102324369|NCT01842633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102324370|NCT01842633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324371|NCT01842633|Antipyretics|antipyretics|mesh-ancestor
102324372|NCT01842633|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102324373|NCT01842633|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102324374|NCT01842633|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102324375|NCT01842633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102324376|NCT01842633|Purinergic Agents|purinergic agents|mesh-ancestor
102324377|NCT01842633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102324379|NCT01841697|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102324380|NCT01841697|Glimepiride|glimepiride|mesh-list
102324381|NCT01841697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102324382|NCT01841697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324383|NCT01841697|Incretins|incretins|mesh-ancestor
102324384|NCT01841697|Hormones|hormones|mesh-ancestor
102324385|NCT01841697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102324386|NCT01841697|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102324387|NCT01841697|Protease Inhibitors|protease inhibitors|mesh-ancestor
102324388|NCT01841697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102324389|NCT01841697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324390|NCT01841697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102324391|NCT01841697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102324392|NCT01841697|Immunologic Factors|immunologic factors|mesh-ancestor
102324393|NCT01809327|Metformin|metformin|mesh-list
102324394|NCT01809327|Canagliflozin|canagliflozin|mesh-list
102324395|NCT01809327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102324396|NCT01809327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324397|NCT01809327|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102324398|NCT01809327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324399|NCT03272139|Bupivacaine|bupivacaine|mesh-list
102324400|NCT03272139|Anesthetics, Local|anesthetics, local|mesh-ancestor
102324401|NCT03272139|Anesthetics|anesthetics|mesh-ancestor
102324402|NCT03272139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102324403|NCT03272139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324404|NCT03272139|Sensory System Agents|sensory system agents|mesh-ancestor
102324405|NCT03272139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102324406|NCT01808313|Ambrisentan|ambrisentan|mesh-list
102324407|NCT01808313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102324408|NCT01840605|Ketotifen|ketotifen|mesh-list
102324409|NCT01840605|Bepotastine besilate|bepotastine besilate|mesh-list
102324410|NCT01840605|Antipruritics|antipruritics|mesh-ancestor
102324411|NCT01840605|Dermatologic Agents|dermatologic agents|mesh-ancestor
102324412|NCT01840605|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102324413|NCT01840605|Histamine Antagonists|histamine antagonists|mesh-ancestor
102324414|NCT01840605|Histamine Agents|histamine agents|mesh-ancestor
102324415|NCT01840605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102324416|NCT01840605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324417|NCT01840605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324419|NCT02023879|Alirocumab|alirocumab|mesh-list
102324420|NCT02023879|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102324421|NCT02023879|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102324422|NCT02023879|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102324423|NCT02023879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102324424|NCT02023879|Antimetabolites|antimetabolites|mesh-ancestor
102324425|NCT02023879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324426|NCT02023879|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102324427|NCT02023879|Protease Inhibitors|protease inhibitors|mesh-ancestor
102324428|NCT02023879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102324429|NCT02023879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102324430|NCT02023879|Immunologic Factors|immunologic factors|mesh-ancestor
102324431|NCT02023879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324432|NCT02014441|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
101440461|NCT04077463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102324433|NCT02014441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102324434|NCT02014441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102324435|NCT02013817|Cyclophosphamide|cyclophosphamide|mesh-list
102324436|NCT02013817|Rituximab|rituximab|mesh-list
102324437|NCT02013817|Fludarabine|fludarabine|mesh-list
102324438|NCT02013817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102324439|NCT02013817|Immunologic Factors|immunologic factors|mesh-ancestor
102324440|NCT02013817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324441|NCT02013817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102324442|NCT02013817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102324443|NCT02013817|Alkylating Agents|alkylating agents|mesh-ancestor
102324444|NCT02013817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324445|NCT02013817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102324446|NCT02013817|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102324447|NCT02013817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102324448|NCT02023099|Ritonavir|ritonavir|mesh-list
102324449|NCT02023099|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102324451|NCT02023099|Protease Inhibitors|protease inhibitors|mesh-ancestor
102324452|NCT02023099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102324453|NCT02023099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324454|NCT02023099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102324455|NCT02023099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102324456|NCT02023099|Antiviral Agents|antiviral agents|mesh-ancestor
102324457|NCT02023099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102324458|NCT02023099|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102324459|NCT02023099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102324460|NCT02013037|Eculizumab|eculizumab|mesh-list
102324461|NCT02013037|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102324462|NCT02013037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102324463|NCT02013037|Immunologic Factors|immunologic factors|mesh-ancestor
102324464|NCT02013037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324465|NCT04416607|Menotropins|menotropins|mesh-list
102324466|NCT04416607|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102324467|NCT04416607|Fertility Agents|fertility agents|mesh-ancestor
102324468|NCT04416607|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102324469|NCT04416607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324470|NCT01967173|Fluticasone|fluticasone|mesh-list
102324471|NCT01967173|Xhance|xhance|mesh-list
102324472|NCT01967173|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102324473|NCT01967173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102324474|NCT01967173|Autonomic Agents|autonomic agents|mesh-ancestor
102324475|NCT01967173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102324476|NCT01967173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324477|NCT01967173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102324478|NCT01967173|Respiratory System Agents|respiratory system agents|mesh-ancestor
102324479|NCT01967173|Glucocorticoids|glucocorticoids|mesh-ancestor
102324480|NCT01967173|Hormones|hormones|mesh-ancestor
102324481|NCT01967173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102324482|NCT01967173|Sympathomimetics|sympathomimetics|mesh-ancestor
102324483|NCT01967173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102324484|NCT01967173|Dermatologic Agents|dermatologic agents|mesh-ancestor
102324485|NCT01967173|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102324486|NCT01993927|Voglibose|voglibose|mesh-list
102324487|NCT01993927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102324488|NCT01993927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324489|NCT01993927|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102324490|NCT01993927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102033298|NCT03410901|Antibodies|antibodies|mesh-list
102324491|NCT01993927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324493|NCT02012959|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102324494|NCT02012959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324495|NCT02012959|Natriuretic Agents|natriuretic agents|mesh-ancestor
102324496|NCT02012959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324497|NCT02012491|Misoprostol|misoprostol|mesh-list
102324498|NCT02012491|Mifepristone|mifepristone|mesh-list
102324499|NCT02012491|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102324500|NCT02012491|Abortifacient Agents|abortifacient agents|mesh-ancestor
102324501|NCT02012491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102324502|NCT02012491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324503|NCT02012491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102324504|NCT02012491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102324505|NCT02012491|Oxytocics|oxytocics|mesh-ancestor
102324506|NCT02012491|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102324507|NCT02012491|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102324508|NCT02012491|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102324509|NCT02012491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102324510|NCT02012491|Contraceptive Agents|contraceptive agents|mesh-ancestor
102324511|NCT02012491|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102324512|NCT02012491|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102324513|NCT02012491|Hormone Antagonists|hormone antagonists|mesh-ancestor
102324514|NCT02012491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102324515|NCT02012491|Luteolytic Agents|luteolytic agents|mesh-ancestor
102324516|NCT02012491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102324517|NCT02012491|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102324518|NCT02038010|Trastuzumab|trastuzumab|mesh-list
102324519|NCT02038010|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102324520|NCT02038010|Maytansine|maytansine|mesh-list
102324521|NCT02038010|Immunoconjugates|immunoconjugates|mesh-list
102324522|NCT02038010|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
102324523|NCT02038010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102324524|NCT02038010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102324525|NCT02038010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102324526|NCT02038010|Tubulin Modulators|tubulin modulators|mesh-ancestor
102324527|NCT02038010|Antimitotic Agents|antimitotic agents|mesh-ancestor
102324528|NCT02038010|Mitosis Modulators|mitosis modulators|mesh-ancestor
102324529|NCT02038010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324530|NCT02038010|Immunotoxins|immunotoxins|mesh-ancestor
102324531|NCT02038010|Immunologic Factors|immunologic factors|mesh-ancestor
102324532|NCT02038010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324533|NCT02038010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102324534|NCT04678154|Vancomycin|vancomycin|mesh-list
102324535|NCT04678154|Tobramycin|tobramycin|mesh-list
102324536|NCT04678154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102324537|NCT04678154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102324538|NCT04178798|Acalabrutinib|acalabrutinib|mesh-list
102324539|NCT04178798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102324540|NCT01989572|Sargramostim|sargramostim|mesh-list
102324541|NCT01989572|Immunologic Factors|immunologic factors|mesh-ancestor
102324542|NCT01989572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324543|NCT01988402|Allopurinol|allopurinol|mesh-list
102324544|NCT01988402|Antimetabolites|antimetabolites|mesh-ancestor
102324545|NCT01988402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324546|NCT01988402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102324547|NCT01988402|Gout Suppressants|gout suppressants|mesh-ancestor
102324548|NCT01988402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102324549|NCT01988402|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102324550|NCT01988402|Antioxidants|antioxidants|mesh-ancestor
102324551|NCT01988402|Protective Agents|protective agents|mesh-ancestor
102324552|NCT01988402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324553|NCT01988090|Vitamin D|vitamin d|mesh-list
102324554|NCT01988090|Ergocalciferols|ergocalciferols|mesh-list
102324555|NCT01988090|Cholecalciferol|cholecalciferol|mesh-list
102324556|NCT01988090|Vitamins|vitamins|mesh-list
102324557|NCT01988090|Micronutrients|micronutrients|mesh-ancestor
102324558|NCT01988090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324559|NCT01988090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102324560|NCT01988090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102324561|NCT02011945|Nivolumab|nivolumab|mesh-list
102324562|NCT02011945|Dasatinib|dasatinib|mesh-list
102324563|NCT02011945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102324564|NCT02011945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102324565|NCT02011945|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102324566|NCT02011945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324567|NCT02011945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102324569|NCT02013830|Bevacizumab|bevacizumab|mesh-list
102324570|NCT02013830|Capecitabine|capecitabine|mesh-list
102324571|NCT02013830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102324572|NCT02013830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102324573|NCT02013830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102324574|NCT02013830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102324575|NCT02013830|Growth Substances|growth substances|mesh-ancestor
102324576|NCT02013830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324577|NCT02013830|Growth Inhibitors|growth inhibitors|mesh-ancestor
102324578|NCT02013830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102324579|NCT02013830|Antimetabolites|antimetabolites|mesh-ancestor
102324580|NCT02013830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324581|NCT02010775|Botulinum Toxins|botulinum toxins|mesh-list
102324582|NCT02010775|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102324583|NCT02010775|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102324584|NCT02010775|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102324585|NCT02010775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102324586|NCT02010775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324587|NCT02010775|Cholinergic Agents|cholinergic agents|mesh-ancestor
101440524|NCT03930953|Rituximab|rituximab|mesh-list
102324588|NCT02010775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102324589|NCT02010775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324590|NCT02010775|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102324591|NCT02010775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102324592|NCT01619059|Metformin|metformin|mesh-list
102324593|NCT01619059|Dapagliflozin|dapagliflozin|mesh-list
102324594|NCT01619059|Saxagliptin|saxagliptin|mesh-list
102324595|NCT01619059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102324596|NCT01619059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324597|NCT01619059|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102324598|NCT01619059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324599|NCT01619059|Incretins|incretins|mesh-ancestor
102324600|NCT01619059|Hormones|hormones|mesh-ancestor
102324601|NCT01619059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102324602|NCT01619059|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102324603|NCT01619059|Protease Inhibitors|protease inhibitors|mesh-ancestor
102324604|NCT01619059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102324605|NCT04691804|Prednisone|prednisone|mesh-list
102324606|NCT04691804|Abiraterone Acetate|abiraterone acetate|mesh-list
102324607|NCT04691804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102324608|NCT04691804|Glucocorticoids|glucocorticoids|mesh-ancestor
102324609|NCT04691804|Hormones|hormones|mesh-ancestor
102324610|NCT04691804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102324611|NCT04691804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324612|NCT04691804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102324613|NCT04691804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102324614|NCT04691804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102324615|NCT04691804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102324616|NCT04691804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324617|NCT04691804|Hormone Antagonists|hormone antagonists|mesh-ancestor
102324618|NCT04691804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102324619|NCT02013206|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102324620|NCT02013206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102324621|NCT02013206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102324622|NCT02013206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102324623|NCT02013206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324624|NCT01807923|Ivacaftor|ivacaftor|mesh-list
102324625|NCT01807923|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102324626|NCT01807923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102324627|NCT01807923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324628|NCT01966003|Paclitaxel|paclitaxel|mesh-list
102324629|NCT01966003|Bevacizumab|bevacizumab|mesh-list
102324630|NCT01966003|Carboplatin|carboplatin|mesh-list
102324631|NCT01966003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102324632|NCT01966003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102324633|NCT01966003|Tubulin Modulators|tubulin modulators|mesh-ancestor
102324634|NCT01966003|Antimitotic Agents|antimitotic agents|mesh-ancestor
102324635|NCT01966003|Mitosis Modulators|mitosis modulators|mesh-ancestor
102324636|NCT01966003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033458|NCT03106077|Maytansine|maytansine|mesh-list
102324637|NCT01966003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102324639|NCT01966003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102324640|NCT01966003|Growth Substances|growth substances|mesh-ancestor
102324641|NCT01966003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324642|NCT01966003|Growth Inhibitors|growth inhibitors|mesh-ancestor
102324643|NCT01839279|Moxifloxacin|moxifloxacin|mesh-list
102324644|NCT01839279|Tizanidine|tizanidine|mesh-list
102324645|NCT01839279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102324646|NCT01839279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102324647|NCT01839279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102324648|NCT01839279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102324649|NCT01839279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102324650|NCT01839279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324651|NCT01839279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102324652|NCT01839279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324653|NCT01839279|Analgesics|analgesics|mesh-ancestor
102324654|NCT01839279|Sensory System Agents|sensory system agents|mesh-ancestor
102324655|NCT01839279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102324656|NCT01839279|Anticonvulsants|anticonvulsants|mesh-ancestor
102324657|NCT01839279|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102324658|NCT01839279|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102324659|NCT01839279|Parasympatholytics|parasympatholytics|mesh-ancestor
102324660|NCT01839279|Autonomic Agents|autonomic agents|mesh-ancestor
102324661|NCT01839279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102324662|NCT01839279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102324663|NCT01839279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102324664|NCT01839279|Adrenergic Agents|adrenergic agents|mesh-ancestor
102324665|NCT01839279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102324666|NCT01965535|Sofosbuvir|sofosbuvir|mesh-list
102324667|NCT01965535|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102324668|NCT01965535|Ledipasvir|ledipasvir|mesh-list
102324669|NCT01965535|Antiviral Agents|antiviral agents|mesh-ancestor
102324670|NCT01965535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102324671|NCT01964755|Leucovorin|leucovorin|mesh-list
102324672|NCT01964755|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
102324673|NCT01964755|Tetrahydrofolates|tetrahydrofolates|mesh-list
102324675|NCT01964755|Rituximab|rituximab|mesh-list
102324676|NCT01964755|Doxorubicin|doxorubicin|mesh-list
102324677|NCT01964755|Methotrexate|methotrexate|mesh-list
102324678|NCT01964755|Hydroxyurea|hydroxyurea|mesh-list
102324679|NCT01964755|Levoleucovorin|levoleucovorin|mesh-list
102324680|NCT01964755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102324681|NCT01964755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102324682|NCT01964755|Immunologic Factors|immunologic factors|mesh-ancestor
102324683|NCT01964755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324684|NCT01964755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102324685|NCT01964755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102324686|NCT01964755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102324687|NCT01964755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102324688|NCT01964755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102324689|NCT01964755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324690|NCT01964755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102324691|NCT01964755|Abortifacient Agents|abortifacient agents|mesh-ancestor
102324692|NCT01964755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102324693|NCT01964755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102324694|NCT01964755|Antimetabolites|antimetabolites|mesh-ancestor
102324695|NCT01964755|Dermatologic Agents|dermatologic agents|mesh-ancestor
102324696|NCT01964755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102324697|NCT01964755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102324698|NCT01964755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102324699|NCT01964755|Antidotes|antidotes|mesh-ancestor
102324700|NCT01964755|Protective Agents|protective agents|mesh-ancestor
102324701|NCT01964755|Vitamin B Complex|vitamin b complex|mesh-ancestor
102324702|NCT01964755|Vitamins|vitamins|mesh-ancestor
102324703|NCT01964755|Micronutrients|micronutrients|mesh-ancestor
102324704|NCT01964755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102324705|NCT01964755|Antiviral Agents|antiviral agents|mesh-ancestor
102324706|NCT01964755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102324707|NCT01964755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102324708|NCT01964755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102324709|NCT01964755|Antisickling Agents|antisickling agents|mesh-ancestor
102324710|NCT01991743|Bupivacaine|bupivacaine|mesh-list
102324711|NCT01991743|Anesthetics, Local|anesthetics, local|mesh-ancestor
102324712|NCT01991743|Anesthetics|anesthetics|mesh-ancestor
102324713|NCT01991743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102324714|NCT01991743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324715|NCT01991743|Sensory System Agents|sensory system agents|mesh-ancestor
102324716|NCT01991743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102324717|NCT01991197|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102324718|NCT01991197|Gliclazide|gliclazide|mesh-list
102324719|NCT01991197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102324720|NCT01991197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324721|NCT01991197|Incretins|incretins|mesh-ancestor
102324722|NCT01991197|Hormones|hormones|mesh-ancestor
102324723|NCT01991197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102324724|NCT01991197|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102324725|NCT01991197|Protease Inhibitors|protease inhibitors|mesh-ancestor
102324726|NCT01991197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102324727|NCT01991197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324728|NCT01990573|Methadone|methadone|mesh-list
102324729|NCT01990573|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102324730|NCT01990573|Narcotics|narcotics|mesh-ancestor
102324731|NCT01990573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102324732|NCT01990573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324733|NCT01990573|Analgesics|analgesics|mesh-ancestor
102324734|NCT01990573|Sensory System Agents|sensory system agents|mesh-ancestor
102324735|NCT01990573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102324736|NCT01990573|Antitussive Agents|antitussive agents|mesh-ancestor
102324737|NCT01990573|Respiratory System Agents|respiratory system agents|mesh-ancestor
102324738|NCT01990339|Lansoprazole|lansoprazole|mesh-list
102324739|NCT01990339|Dexlansoprazole|dexlansoprazole|mesh-list
102324740|NCT01990339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102324741|NCT01990339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102324742|NCT01990339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102324743|NCT01990339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102324744|NCT01990339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324745|NCT02007577|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
102324746|NCT02007577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102324747|NCT02007577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102324748|NCT02007577|Analgesics|analgesics|mesh-ancestor
102324749|NCT02007577|Sensory System Agents|sensory system agents|mesh-ancestor
102324750|NCT02007577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102324751|NCT02007577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324753|NCT02007577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102324754|NCT01990261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102324755|NCT01990261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102324756|NCT01990261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102324757|NCT01990261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102324758|NCT01990261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324759|NCT01962493|Chlorhexidine|chlorhexidine|mesh-list
102324760|NCT01962493|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102324761|NCT01962493|Listerine|listerine|mesh-list
102324762|NCT01962493|Fluorides|fluorides|mesh-list
102324763|NCT01962493|Sodium Fluoride|sodium fluoride|mesh-list
102324764|NCT01962493|Cariostatic Agents|cariostatic agents|mesh-ancestor
102324765|NCT01962493|Protective Agents|protective agents|mesh-ancestor
102324766|NCT01962493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324767|NCT01962493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102324768|NCT01962493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102324769|NCT01962493|Disinfectants|disinfectants|mesh-ancestor
102324770|NCT01962493|Dermatologic Agents|dermatologic agents|mesh-ancestor
102324771|NCT01989169|Midazolam|midazolam|mesh-list
102324772|NCT01989169|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102324773|NCT01989169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102324774|NCT01989169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102324775|NCT01989169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324776|NCT01989169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102324777|NCT01989169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102324778|NCT01989169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102324779|NCT01989169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102324780|NCT01989169|Anesthetics, General|anesthetics, general|mesh-ancestor
102324781|NCT01989169|Anesthetics|anesthetics|mesh-ancestor
102324782|NCT01989169|GABA Modulators|gaba modulators|mesh-ancestor
102324783|NCT01989169|GABA Agents|gaba agents|mesh-ancestor
102324784|NCT01989169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102324785|NCT01989169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324786|NCT01988779|Levofloxacin|levofloxacin|mesh-list
102324787|NCT01988779|Ofloxacin|ofloxacin|mesh-list
102324788|NCT01988779|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102324789|NCT01988779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102324790|NCT01988779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102324791|NCT01988779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102324792|NCT01988779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102324793|NCT01988779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102324794|NCT01988779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324795|NCT01988779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102324796|NCT01988779|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102324797|NCT01988779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102324798|NCT01987765|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102324799|NCT01987765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102324800|NCT01987232|Carboplatin|carboplatin|mesh-list
102324801|NCT01987232|Etoposide|etoposide|mesh-list
102324802|NCT01987232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102324803|NCT01987232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102324804|NCT01987232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102324805|NCT01987232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102324806|NCT01987232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102324807|NCT01987232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324808|NCT04676204|Teriflunomide|teriflunomide|mesh-list
102324809|NCT04676204|Cladribine|cladribine|mesh-list
102324810|NCT04676204|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102324811|NCT04676204|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102324812|NCT04676204|Ozanimod|ozanimod|mesh-list
102324813|NCT04676204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102324814|NCT04676204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102324815|NCT04676204|Immunologic Factors|immunologic factors|mesh-ancestor
102324816|NCT04676204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324817|NCT04676204|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102324818|NCT04676204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324819|NCT04676204|Dermatologic Agents|dermatologic agents|mesh-ancestor
102324820|NCT04676204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102324821|NCT04676204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102324822|NCT04676204|Analgesics|analgesics|mesh-ancestor
102324823|NCT04676204|Sensory System Agents|sensory system agents|mesh-ancestor
101666751|NCT04547166|Bevacizumab|bevacizumab|mesh-list
102324824|NCT04676204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102324825|NCT04676204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102324826|NCT04676204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102324827|NCT02010632|Clopidogrel|clopidogrel|mesh-list
102324828|NCT02010632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102324829|NCT02010632|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102324830|NCT02010632|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102324831|NCT02010632|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102324832|NCT02010632|Purinergic Agents|purinergic agents|mesh-ancestor
102324833|NCT02010632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102324834|NCT02010632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324835|NCT02010632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324836|NCT01986062|Amphetamine|amphetamine|mesh-list
102324837|NCT01986062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102324838|NCT01986062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324839|NCT01986062|Sympathomimetics|sympathomimetics|mesh-ancestor
102324840|NCT01986062|Autonomic Agents|autonomic agents|mesh-ancestor
102324841|NCT01986062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102324842|NCT01986062|Dopamine Agents|dopamine agents|mesh-ancestor
102324843|NCT01986062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102324844|NCT01986062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324845|NCT01986062|Adrenergic Agents|adrenergic agents|mesh-ancestor
102324846|NCT01986062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102324847|NCT01986062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102324848|NCT01986062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102324849|NCT01986062|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102324850|NCT01985126|Acetaminophen|acetaminophen|mesh-list
102324851|NCT01985126|Diphenhydramine|diphenhydramine|mesh-list
102324852|NCT01985126|Promethazine|promethazine|mesh-list
102324853|NCT01985126|Methylprednisolone|methylprednisolone|mesh-list
102324854|NCT01985126|Daratumumab|daratumumab|mesh-list
102324855|NCT01985126|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102324856|NCT01985126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102324857|NCT01985126|Analgesics|analgesics|mesh-ancestor
102324858|NCT01985126|Sensory System Agents|sensory system agents|mesh-ancestor
102324859|NCT01985126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102324860|NCT01985126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324861|NCT01985126|Antipyretics|antipyretics|mesh-ancestor
102324862|NCT01985126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102033682|NCT05588453|Temozolomide|temozolomide|mesh-list
102324864|NCT01985126|Autonomic Agents|autonomic agents|mesh-ancestor
102324865|NCT01985126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102324866|NCT01985126|Glucocorticoids|glucocorticoids|mesh-ancestor
102324867|NCT01985126|Hormones|hormones|mesh-ancestor
102324868|NCT01985126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102324869|NCT01985126|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102324870|NCT01985126|Protective Agents|protective agents|mesh-ancestor
102324871|NCT01985126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102324872|NCT01985126|Immunologic Factors|immunologic factors|mesh-ancestor
102324873|NCT01985126|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102324874|NCT01985126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102324875|NCT01985126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102324876|NCT01985126|Anesthetics, Local|anesthetics, local|mesh-ancestor
102324877|NCT01985126|Anesthetics|anesthetics|mesh-ancestor
102324878|NCT01985126|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102324879|NCT01985126|Histamine Antagonists|histamine antagonists|mesh-ancestor
102324880|NCT01985126|Histamine Agents|histamine agents|mesh-ancestor
102324881|NCT01985126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102324882|NCT01985126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324883|NCT01985126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102324884|NCT01985126|Antipruritics|antipruritics|mesh-ancestor
102324885|NCT01985126|Dermatologic Agents|dermatologic agents|mesh-ancestor
102324886|NCT01984892|Poly ICLC|poly iclc|mesh-list
102324887|NCT01984892|Interferon Inducers|interferon inducers|mesh-ancestor
102324888|NCT01984892|Immunologic Factors|immunologic factors|mesh-ancestor
102324889|NCT01984892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324890|NCT01807221|Eplerenone|eplerenone|mesh-list
102324891|NCT01807221|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102324892|NCT01807221|Hormone Antagonists|hormone antagonists|mesh-ancestor
102324893|NCT01807221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102324894|NCT01807221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324895|NCT01807221|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102324896|NCT01807221|Diuretics|diuretics|mesh-ancestor
102324897|NCT01807221|Natriuretic Agents|natriuretic agents|mesh-ancestor
102324898|NCT01807221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102324899|NCT02031458|Atezolizumab|atezolizumab|mesh-list
102324900|NCT02031458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102324901|NCT02031458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324902|NCT02031458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102324903|NCT02031458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102324904|NCT01806597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102324905|NCT01806597|Immunologic Factors|immunologic factors|mesh-ancestor
102324906|NCT01806597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324907|NCT01610037|Tiotropium Bromide|tiotropium bromide|mesh-list
102324908|NCT01610037|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102324909|NCT01610037|Autonomic Agents|autonomic agents|mesh-ancestor
102324910|NCT01610037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102324911|NCT01610037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324912|NCT01610037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102324913|NCT01610037|Respiratory System Agents|respiratory system agents|mesh-ancestor
102324914|NCT01610037|Parasympatholytics|parasympatholytics|mesh-ancestor
102324915|NCT01610037|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102324916|NCT01610037|Cholinergic Agents|cholinergic agents|mesh-ancestor
102324917|NCT01610037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102324918|NCT01610037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324919|NCT04687514|Dulaglutide|dulaglutide|mesh-list
102324920|NCT04687514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102324921|NCT04687514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324922|NCT01837797|Brexpiprazole|brexpiprazole|mesh-list
102324923|NCT01837797|Serotonin Agents|serotonin agents|mesh-ancestor
102324924|NCT01837797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102324925|NCT01837797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324926|NCT01837797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324927|NCT01837797|Dopamine Agonists|dopamine agonists|mesh-ancestor
102324928|NCT01837797|Dopamine Agents|dopamine agents|mesh-ancestor
102324929|NCT01984424|Atorvastatin|atorvastatin|mesh-list
102324930|NCT01984424|Ezetimibe|ezetimibe|mesh-list
102324931|NCT01984424|Evolocumab|evolocumab|mesh-list
102324932|NCT01984424|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102324933|NCT01984424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102324934|NCT01984424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102324935|NCT01984424|Antimetabolites|antimetabolites|mesh-ancestor
102324936|NCT01984424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324937|NCT01984424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102324938|NCT01984424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102324939|NCT01984424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102324940|NCT01984424|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102324941|NCT01984424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102324942|NCT01984424|Protease Inhibitors|protease inhibitors|mesh-ancestor
102324943|NCT01984424|Immunologic Factors|immunologic factors|mesh-ancestor
102324944|NCT01984424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324945|NCT01837719|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102324946|NCT01837719|Cobicistat|cobicistat|mesh-list
102324947|NCT01837719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102324948|NCT01837719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102324949|NCT01837719|Protease Inhibitors|protease inhibitors|mesh-ancestor
102324950|NCT01837719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102324951|NCT01837719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324952|NCT01837719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102324953|NCT01837719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102324954|NCT01837719|Antiviral Agents|antiviral agents|mesh-ancestor
102324955|NCT01837719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102324956|NCT01837719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102324957|NCT01837719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102324958|NCT01984268|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102324959|NCT01984268|Hormones|hormones|mesh-ancestor
102324960|NCT01984268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102324961|NCT01984268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324962|NCT02009384|Ipilimumab|ipilimumab|mesh-list
102324963|NCT02009384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102324964|NCT02009384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102324965|NCT02009384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102324966|NCT02009384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324967|NCT01805037|Rituximab|rituximab|mesh-list
102324968|NCT01805037|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102324969|NCT01805037|Antibodies|antibodies|mesh-list
102324970|NCT01805037|Immunoglobulins|immunoglobulins|mesh-list
102324971|NCT01805037|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101440605|NCT03914625|Antidotes|antidotes|mesh-ancestor
102324972|NCT01805037|Immunoconjugates|immunoconjugates|mesh-list
102324973|NCT01805037|Immunologic Factors|immunologic factors|mesh-ancestor
102324974|NCT01805037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324975|NCT01805037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102324976|NCT01805037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102324977|NCT01805037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102324978|NCT01805037|Immunotoxins|immunotoxins|mesh-ancestor
102324979|NCT01803711|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
102324980|NCT01803711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102324981|NCT01803711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102324982|NCT01803711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102324983|NCT01803711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324984|NCT01803711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102324985|NCT01803711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102324986|NCT01803711|Antidepressive Agents|antidepressive agents|mesh-ancestor
102324987|NCT01803711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102324988|NCT01836549|Imetelstat|imetelstat|mesh-list
102324989|NCT01836549|Motesanib diphosphate|motesanib diphosphate|mesh-list
102324990|NCT01836549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102324991|NCT01836549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102324992|NCT01836549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102324993|NCT01836471|Fluticasone|fluticasone|mesh-list
102324994|NCT01836471|Xhance|xhance|mesh-list
102324995|NCT01836471|Indoleacetic Acids|indoleacetic acids|mesh-list
102324996|NCT01836471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102324997|NCT01836471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102324998|NCT01836471|Autonomic Agents|autonomic agents|mesh-ancestor
102324999|NCT01836471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102325000|NCT01836471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325001|NCT01836471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102325002|NCT01836471|Respiratory System Agents|respiratory system agents|mesh-ancestor
102325003|NCT01836471|Dermatologic Agents|dermatologic agents|mesh-ancestor
102325004|NCT01836471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102325005|NCT01836471|Plant Growth Regulators|plant growth regulators|mesh-ancestor
102325006|NCT01836471|Growth Substances|growth substances|mesh-ancestor
102325007|NCT02030600|Insulin|insulin|mesh-list
102325008|NCT02030600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102325009|NCT02030600|Insulin Glargine|insulin glargine|mesh-list
102325010|NCT02030600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102325011|NCT02030600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033834|NCT02675946|Pembrolizumab|pembrolizumab|mesh-list
102325012|NCT01802775|Aspirin|aspirin|mesh-list
102325013|NCT01802775|Edoxaban|edoxaban|mesh-list
102325014|NCT01802775|Clopidogrel|clopidogrel|mesh-list
102325015|NCT01802775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102325016|NCT01802775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102325017|NCT01802775|Analgesics|analgesics|mesh-ancestor
102325018|NCT01802775|Sensory System Agents|sensory system agents|mesh-ancestor
102325019|NCT01802775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102325020|NCT01802775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325021|NCT01802775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102325022|NCT01802775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102325023|NCT01802775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102325024|NCT01802775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102325025|NCT01802775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325026|NCT01802775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102325027|NCT01802775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102325028|NCT01802775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102325029|NCT01802775|Antipyretics|antipyretics|mesh-ancestor
102325030|NCT01802775|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102325031|NCT01802775|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102325032|NCT01802775|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102325033|NCT01802775|Purinergic Agents|purinergic agents|mesh-ancestor
102325034|NCT01802775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102325035|NCT01802775|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102325036|NCT01802775|Antithrombins|antithrombins|mesh-ancestor
102325037|NCT01802775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102325038|NCT01802775|Protease Inhibitors|protease inhibitors|mesh-ancestor
102325039|NCT01802775|Anticoagulants|anticoagulants|mesh-ancestor
102325040|NCT01802385|Sertraline|sertraline|mesh-list
102325041|NCT01802385|Antidepressive Agents|antidepressive agents|mesh-ancestor
102325042|NCT01802385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101440626|NCT03913104|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102325043|NCT01802385|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102325044|NCT01802385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102325045|NCT01802385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102325046|NCT01802385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325048|NCT01802385|Serotonin Agents|serotonin agents|mesh-ancestor
102325049|NCT01802385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325050|NCT01773993|Pregabalin|pregabalin|mesh-list
102325051|NCT01773993|Analgesics|analgesics|mesh-ancestor
102325052|NCT01773993|Sensory System Agents|sensory system agents|mesh-ancestor
102325053|NCT01773993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102325054|NCT01773993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325055|NCT01773993|Anticonvulsants|anticonvulsants|mesh-ancestor
102325056|NCT01773993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102325057|NCT01773993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102325058|NCT01773993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325059|NCT01773993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102325060|NCT01773993|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102325061|NCT01773993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102325062|NCT01773993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102325063|NCT01773993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102325064|NCT01802073|Vancomycin|vancomycin|mesh-list
102325065|NCT01802073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102325066|NCT01802073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102325067|NCT01607073|Verapamil|verapamil|mesh-list
102325068|NCT01607073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102325069|NCT01607073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102325070|NCT01607073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102325071|NCT01607073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325072|NCT01607073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102325073|NCT01607073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325074|NCT01607073|Vasodilator Agents|vasodilator agents|mesh-ancestor
102325075|NCT01801917|Siponimod|siponimod|mesh-list
102325076|NCT01801917|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102325077|NCT01801917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325078|NCT01801917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102325079|NCT01801917|Immunologic Factors|immunologic factors|mesh-ancestor
102325080|NCT01801917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325081|NCT02008916|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102325082|NCT02008916|Immunologic Factors|immunologic factors|mesh-ancestor
102325083|NCT02008916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325084|NCT01772823|Tenofovir|tenofovir|mesh-list
102033902|NCT05284136|Hormones|hormones|mesh-ancestor
102325085|NCT01772823|Emtricitabine|emtricitabine|mesh-list
102325086|NCT01772823|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102325087|NCT01772823|Antiviral Agents|antiviral agents|mesh-ancestor
102325088|NCT01772823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102325089|NCT01772823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102325090|NCT01772823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102325091|NCT01772823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102325092|NCT01772823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325093|NCT01772823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102325094|NCT01772823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102325095|NCT04177082|Riboflavin|riboflavin|mesh-list
102325096|NCT04177082|Vitamin B Complex|vitamin b complex|mesh-ancestor
102325097|NCT04177082|Vitamins|vitamins|mesh-ancestor
102325098|NCT04177082|Micronutrients|micronutrients|mesh-ancestor
102325099|NCT04177082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325100|NCT04177082|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102325101|NCT04177082|Dermatologic Agents|dermatologic agents|mesh-ancestor
102325102|NCT01982942|Ibudilast|ibudilast|mesh-list
102325103|NCT01982942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102325104|NCT01982942|Autonomic Agents|autonomic agents|mesh-ancestor
102325105|NCT01982942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102325106|NCT01982942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325107|NCT01982942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102325108|NCT01982942|Respiratory System Agents|respiratory system agents|mesh-ancestor
102325109|NCT01982942|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102325110|NCT01982942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102325111|NCT01982942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325112|NCT01982942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102325113|NCT01982942|Vasodilator Agents|vasodilator agents|mesh-ancestor
102325114|NCT01769469|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102325115|NCT01769469|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102325116|NCT01769469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102325117|NCT01769469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102325118|NCT01769469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325119|NCT01769469|Antiviral Agents|antiviral agents|mesh-ancestor
102325120|NCT01769469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102325121|NCT01769469|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102325122|NCT01769469|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102325123|NCT01769391|Paclitaxel|paclitaxel|mesh-list
102325124|NCT01769391|Carboplatin|carboplatin|mesh-list
102325125|NCT01769391|Necitumumab|necitumumab|mesh-list
102325126|NCT01769391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102325127|NCT01769391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102325128|NCT01769391|Tubulin Modulators|tubulin modulators|mesh-ancestor
102325129|NCT01769391|Antimitotic Agents|antimitotic agents|mesh-ancestor
102325130|NCT01769391|Mitosis Modulators|mitosis modulators|mesh-ancestor
102325131|NCT01769391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325132|NCT01769391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102325133|NCT01767987|Ranolazine|ranolazine|mesh-list
102325134|NCT01767987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102325135|NCT01767987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102325136|NCT01767987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325137|NCT01767909|Insulin|insulin|mesh-list
102325138|NCT01767909|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102325139|NCT01767909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102325140|NCT01767909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325141|NCT02029274|Siponimod|siponimod|mesh-list
102325142|NCT02029274|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102325143|NCT02029274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325144|NCT02029274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102325145|NCT02029274|Immunologic Factors|immunologic factors|mesh-ancestor
102325146|NCT02029274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325147|NCT02008370|Bupivacaine|bupivacaine|mesh-list
102325148|NCT02008370|Anesthetics, Local|anesthetics, local|mesh-ancestor
102325149|NCT02008370|Anesthetics|anesthetics|mesh-ancestor
102325150|NCT02008370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102325151|NCT02008370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325152|NCT02008370|Sensory System Agents|sensory system agents|mesh-ancestor
102325153|NCT02008370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102325154|NCT01981616|Vedolizumab|vedolizumab|mesh-list
102325155|NCT01981616|Vaccines|vaccines|mesh-list
102325156|NCT01981616|Immunologic Factors|immunologic factors|mesh-ancestor
102325157|NCT01981616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033990|NCT01311167|Hormones|hormones|mesh-ancestor
102325158|NCT01981616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102325160|NCT01962103|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102325161|NCT01962103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102325162|NCT01962103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102325163|NCT01962103|Tubulin Modulators|tubulin modulators|mesh-ancestor
102325164|NCT01962103|Antimitotic Agents|antimitotic agents|mesh-ancestor
102325165|NCT01962103|Mitosis Modulators|mitosis modulators|mesh-ancestor
102325166|NCT01962103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325167|NCT01961323|Nebivolol|nebivolol|mesh-list
102325168|NCT01961323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102325169|NCT01961323|Vasodilator Agents|vasodilator agents|mesh-ancestor
102325170|NCT01961323|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102325171|NCT01961323|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102325172|NCT01961323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102325173|NCT01961323|Adrenergic Agents|adrenergic agents|mesh-ancestor
102325174|NCT01961323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102325175|NCT01961323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325176|NCT01961323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325177|NCT04186403|Brexpiprazole|brexpiprazole|mesh-list
102325178|NCT04186403|Serotonin Agents|serotonin agents|mesh-ancestor
102325179|NCT04186403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102325180|NCT04186403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325181|NCT04186403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325182|NCT04186403|Dopamine Agonists|dopamine agonists|mesh-ancestor
102325183|NCT04186403|Dopamine Agents|dopamine agents|mesh-ancestor
102325184|NCT01960855|Upadacitinib|upadacitinib|mesh-list
102325185|NCT01960855|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102325186|NCT01960855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102325187|NCT01960855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102325188|NCT01960855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325189|NCT01960855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102325190|NCT02007434|Loratadine|loratadine|mesh-list
102325191|NCT02007434|Ibuprofen|ibuprofen|mesh-list
102325192|NCT02007434|Lidocaine|lidocaine|mesh-list
102325193|NCT02007434|Epinephrine|epinephrine|mesh-list
102325194|NCT02007434|Deoxycholic Acid|deoxycholic acid|mesh-list
102325195|NCT02007434|Anesthetics, Local|anesthetics, local|mesh-ancestor
102325196|NCT02007434|Anesthetics|anesthetics|mesh-ancestor
102325197|NCT02007434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102325198|NCT02007434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325199|NCT02007434|Sensory System Agents|sensory system agents|mesh-ancestor
102325200|NCT02007434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102325201|NCT02007434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102325202|NCT02007434|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102325203|NCT02007434|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102325204|NCT02007434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102325205|NCT02007434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325206|NCT02007434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102325207|NCT02007434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102325208|NCT02007434|Analgesics|analgesics|mesh-ancestor
102325209|NCT02007434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102325210|NCT02007434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102325211|NCT02007434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102325212|NCT02007434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102325213|NCT02007434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102325214|NCT02007434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102325215|NCT02007434|Adrenergic Agents|adrenergic agents|mesh-ancestor
102325216|NCT02007434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102325217|NCT02007434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102325218|NCT02007434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102325219|NCT02007434|Autonomic Agents|autonomic agents|mesh-ancestor
102325220|NCT02007434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102325221|NCT02007434|Respiratory System Agents|respiratory system agents|mesh-ancestor
102325222|NCT02007434|Mydriatics|mydriatics|mesh-ancestor
102325223|NCT02007434|Sympathomimetics|sympathomimetics|mesh-ancestor
102325224|NCT02007434|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102325225|NCT02007434|Antipruritics|antipruritics|mesh-ancestor
102325226|NCT02007434|Dermatologic Agents|dermatologic agents|mesh-ancestor
102325227|NCT02007434|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102325228|NCT02007434|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102325229|NCT02007434|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102325230|NCT02007434|Histamine Antagonists|histamine antagonists|mesh-ancestor
102325231|NCT02007434|Histamine Agents|histamine agents|mesh-ancestor
102325232|NCT02007434|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102325234|NCT01987453|Sofosbuvir|sofosbuvir|mesh-list
102325235|NCT01987453|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102325236|NCT01987453|Ledipasvir|ledipasvir|mesh-list
102325237|NCT01987453|Antiviral Agents|antiviral agents|mesh-ancestor
102325238|NCT01987453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102325239|NCT02006641|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
102325240|NCT02006641|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102325241|NCT02006641|Serotonin Agents|serotonin agents|mesh-ancestor
102325242|NCT02006641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102325243|NCT02006641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325244|NCT02006641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325245|NCT01959919|Factor VIII|factor viii|mesh-list
102325246|NCT01959919|Coagulants|coagulants|mesh-ancestor
102325247|NCT01986907|Ranibizumab|ranibizumab|mesh-list
102325248|NCT01986907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102325249|NCT01986907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102325250|NCT01986907|Growth Substances|growth substances|mesh-ancestor
102325251|NCT01986907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325252|NCT01986907|Growth Inhibitors|growth inhibitors|mesh-ancestor
102325253|NCT01986907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102325254|NCT01959841|Valacyclovir|valacyclovir|mesh-list
102325255|NCT01959841|Antiviral Agents|antiviral agents|mesh-ancestor
102325256|NCT01959841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102325257|NCT02005627|Immunomodulating Agents|immunomodulating agents|mesh-list
102325258|NCT02005627|Immunologic Factors|immunologic factors|mesh-list
102325259|NCT02005627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325260|NCT02073929|Liraglutide|liraglutide|mesh-list
102325261|NCT02073929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102325262|NCT02073929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325263|NCT02073929|Incretins|incretins|mesh-ancestor
102325264|NCT02073929|Hormones|hormones|mesh-ancestor
102325265|NCT02073929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102325266|NCT02113007|Rituximab|rituximab|mesh-list
102325267|NCT02113007|Temozolomide|temozolomide|mesh-list
102325268|NCT02113007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102325269|NCT02113007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102325270|NCT02113007|Immunologic Factors|immunologic factors|mesh-ancestor
102325271|NCT02113007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325272|NCT02113007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102325273|NCT02113007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102325274|NCT02113007|Alkylating Agents|alkylating agents|mesh-ancestor
102325275|NCT02113007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325276|NCT02005471|Rituximab|rituximab|mesh-list
102325277|NCT02005471|Venetoclax|venetoclax|mesh-list
102325278|NCT02005471|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102325279|NCT02005471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102325280|NCT02005471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102325281|NCT02005471|Immunologic Factors|immunologic factors|mesh-ancestor
102325282|NCT02005471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325283|NCT02005471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102325284|NCT02005471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102325285|NCT02005471|Alkylating Agents|alkylating agents|mesh-ancestor
102325286|NCT02005471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325287|NCT02104505|Tocopherols|tocopherols|mesh-list
102325288|NCT02104505|Vitamin E|vitamin e|mesh-list
102325289|NCT02104505|Tocotrienols|tocotrienols|mesh-list
102325290|NCT02104505|alpha-Tocopherol|alpha-tocopherol|mesh-list
102325291|NCT02104505|gamma-Tocopherol|gamma-tocopherol|mesh-list
102325292|NCT02104505|Antioxidants|antioxidants|mesh-ancestor
102325293|NCT02104505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325294|NCT02104505|Protective Agents|protective agents|mesh-ancestor
102325295|NCT02104505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325296|NCT02104505|Vitamins|vitamins|mesh-ancestor
102325297|NCT02104505|Micronutrients|micronutrients|mesh-ancestor
102325298|NCT02111603|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
102325299|NCT02111603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102325300|NCT02111603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102325301|NCT02111603|Antimetabolites|antimetabolites|mesh-ancestor
102325302|NCT02111603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325303|NCT02111603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102325304|NCT02111369|Propranolol|propranolol|mesh-list
102325305|NCT02111369|Botulinum Toxins|botulinum toxins|mesh-list
102325306|NCT02111369|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102325307|NCT02111369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102325308|NCT02111369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325309|NCT02111369|Cholinergic Agents|cholinergic agents|mesh-ancestor
102325310|NCT02111369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102325311|NCT02111369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325312|NCT02111369|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102325313|NCT02111369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102325314|NCT02111369|Adrenergic Agents|adrenergic agents|mesh-ancestor
102325315|NCT02111369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102325316|NCT02111369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102325317|NCT02111369|Vasodilator Agents|vasodilator agents|mesh-ancestor
102325318|NCT02069093|Dexamethasone|dexamethasone|mesh-list
102325319|NCT02069093|Everolimus|everolimus|mesh-list
102325320|NCT02069093|Exemestane|exemestane|mesh-list
102325321|NCT02069093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102325322|NCT02069093|Antiemetics|antiemetics|mesh-ancestor
102325323|NCT02069093|Autonomic Agents|autonomic agents|mesh-ancestor
102325324|NCT02069093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102325325|NCT02069093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325326|NCT02069093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102325327|NCT02069093|Glucocorticoids|glucocorticoids|mesh-ancestor
102325328|NCT02069093|Hormones|hormones|mesh-ancestor
102325329|NCT02069093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102325330|NCT02069093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102325331|NCT02069093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102325332|NCT02069093|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102325333|NCT02069093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102325334|NCT02069093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102325335|NCT02069093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325336|NCT02069093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102325337|NCT02069093|Immunologic Factors|immunologic factors|mesh-ancestor
102325338|NCT02069093|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102325339|NCT02069093|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102325340|NCT02069093|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102325341|NCT02069093|Hormone Antagonists|hormone antagonists|mesh-ancestor
102325342|NCT02109029|Insulin|insulin|mesh-list
102325343|NCT02109029|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102325344|NCT02109029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102325345|NCT02109029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325346|NCT02007278|Metformin|metformin|mesh-list
102325347|NCT02007278|Glimepiride|glimepiride|mesh-list
102325348|NCT02007278|Vildagliptin|vildagliptin|mesh-list
102325349|NCT02007278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102325350|NCT02007278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325351|NCT02007278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102325352|NCT02007278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102325353|NCT02007278|Immunologic Factors|immunologic factors|mesh-ancestor
102325354|NCT02007278|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102325355|NCT02007278|Protease Inhibitors|protease inhibitors|mesh-ancestor
102325356|NCT02007278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102325357|NCT02007278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325358|NCT02028338|Dapivirine|dapivirine|mesh-list
102325359|NCT02028338|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102325360|NCT02028338|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102325361|NCT02028338|Antiviral Agents|antiviral agents|mesh-ancestor
102325362|NCT02028338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102325363|NCT01625897|Risperidone|risperidone|mesh-list
102325364|NCT01625897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102325365|NCT01625897|Serotonin Agents|serotonin agents|mesh-ancestor
102325366|NCT01625897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102325367|NCT01625897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325368|NCT01625897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325369|NCT01625897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102325370|NCT01625897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102325371|NCT01625897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102325372|NCT01625897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102325373|NCT01625897|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102325374|NCT01625897|Dopamine Agents|dopamine agents|mesh-ancestor
102325375|NCT02106923|Metformin|metformin|mesh-list
102325376|NCT02106923|Empagliflozin|empagliflozin|mesh-list
102325377|NCT02106923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102325378|NCT02106923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325379|NCT02106923|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102325380|NCT02106923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325381|NCT02006732|Tiotropium Bromide|tiotropium bromide|mesh-list
102325382|NCT02006732|Olodaterol|olodaterol|mesh-list
102325383|NCT02006732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102325384|NCT02006732|Autonomic Agents|autonomic agents|mesh-ancestor
102325385|NCT02006732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102325386|NCT02006732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325387|NCT02006732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102325388|NCT02006732|Respiratory System Agents|respiratory system agents|mesh-ancestor
102325390|NCT02006732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102325391|NCT02006732|Cholinergic Agents|cholinergic agents|mesh-ancestor
102325392|NCT02006732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102325393|NCT02006732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325394|NCT02098733|Pioglitazone|pioglitazone|mesh-list
102325395|NCT02098733|Glimepiride|glimepiride|mesh-list
102325396|NCT02098733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102325397|NCT02098733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325398|NCT02098733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102325399|NCT02098733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102325400|NCT02098733|Immunologic Factors|immunologic factors|mesh-ancestor
102325401|NCT02098109|Plerixafor|plerixafor|mesh-list
102325402|NCT02098109|Lenograstim|lenograstim|mesh-list
102325403|NCT02098109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102325404|NCT02098109|Immunologic Factors|immunologic factors|mesh-ancestor
102325405|NCT02098109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325406|NCT02098109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102325407|NCT02098109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102325408|NCT02098109|Antiviral Agents|antiviral agents|mesh-ancestor
102325409|NCT02098109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102325410|NCT02097719|Timolol|timolol|mesh-list
102325411|NCT02097719|Bimatoprost|bimatoprost|mesh-list
102325412|NCT02097719|Travoprost|travoprost|mesh-list
102325413|NCT02097719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325414|NCT02097719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102325415|NCT02097719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102325416|NCT02097719|Adrenergic Agents|adrenergic agents|mesh-ancestor
102325417|NCT02097719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102325418|NCT02097719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325419|NCT02097719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102325420|NCT02097719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102325421|NCT01449370|Serabelisib|serabelisib|mesh-list
102325422|NCT01449370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102325423|NCT01449370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325424|NCT02066129|Fluticasone|fluticasone|mesh-list
102325425|NCT02066129|Xhance|xhance|mesh-list
102325426|NCT02066129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102325427|NCT02066129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102325428|NCT02066129|Autonomic Agents|autonomic agents|mesh-ancestor
102325429|NCT02066129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102325430|NCT02066129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325431|NCT02066129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102325432|NCT02066129|Respiratory System Agents|respiratory system agents|mesh-ancestor
102325433|NCT02066129|Dermatologic Agents|dermatologic agents|mesh-ancestor
102325434|NCT02066129|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102325435|NCT04417985|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102325436|NCT04417985|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102325437|NCT04417985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325438|NCT02106455|Risedronic Acid|risedronic acid|mesh-list
102325439|NCT02106455|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102325440|NCT02106455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102325441|NCT02106455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325442|NCT02106455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102325443|NCT02106455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325444|NCT02106455|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102325445|NCT02006654|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
102325446|NCT02006654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101440740|NCT03712202|Immunotoxins|immunotoxins|mesh-ancestor
102325447|NCT02006654|Serotonin Agents|serotonin agents|mesh-ancestor
102325448|NCT02006654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102325449|NCT02006654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325450|NCT02006654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325451|NCT02006576|Ibuprofen|ibuprofen|mesh-list
102325452|NCT02006576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102325453|NCT02006576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102325454|NCT02006576|Analgesics|analgesics|mesh-ancestor
102325455|NCT02006576|Sensory System Agents|sensory system agents|mesh-ancestor
102325456|NCT02006576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102325457|NCT02006576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325459|NCT02006576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102325460|NCT02006576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102325461|NCT02006576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102325462|NCT02006576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325463|NCT01448824|Ketoconazole|ketoconazole|mesh-list
102325464|NCT01448824|Evacetrapib|evacetrapib|mesh-list
102325465|NCT01448824|Antifungal Agents|antifungal agents|mesh-ancestor
102325466|NCT01448824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102325467|NCT01448824|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102325468|NCT01448824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102325469|NCT01448824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102325470|NCT01448824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325471|NCT01448824|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102325472|NCT01448824|Hormone Antagonists|hormone antagonists|mesh-ancestor
102325473|NCT01448824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102325474|NCT01448824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325475|NCT01448824|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102325476|NCT01448824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102325477|NCT01448824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102325478|NCT01448824|Antimetabolites|antimetabolites|mesh-ancestor
102325479|NCT01448824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102325480|NCT02005562|Cyclosporine|cyclosporine|mesh-list
102325481|NCT02005562|Mycophenolic Acid|mycophenolic acid|mesh-list
102325482|NCT02005562|Methylprednisolone|methylprednisolone|mesh-list
102325483|NCT02005562|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102325484|NCT02005562|Cyclosporins|cyclosporins|mesh-list
102325485|NCT02005562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102325486|NCT02005562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325487|NCT02005562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102325488|NCT02005562|Immunologic Factors|immunologic factors|mesh-ancestor
102325489|NCT02005562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325490|NCT02005562|Antifungal Agents|antifungal agents|mesh-ancestor
102325491|NCT02005562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101307858|NCT02043977|Propofol|propofol|mesh-list
102325492|NCT02005562|Dermatologic Agents|dermatologic agents|mesh-ancestor
102325493|NCT02005562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102325494|NCT02005562|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102325495|NCT02005562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102325496|NCT02005562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102325497|NCT02005562|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102325498|NCT02005562|Antitubercular Agents|antitubercular agents|mesh-ancestor
102325499|NCT02005562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102325500|NCT02005562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102325501|NCT02005562|Antiemetics|antiemetics|mesh-ancestor
102325502|NCT02005562|Autonomic Agents|autonomic agents|mesh-ancestor
102325503|NCT02005562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102325504|NCT02005562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102325505|NCT02005562|Glucocorticoids|glucocorticoids|mesh-ancestor
102325506|NCT02005562|Hormones|hormones|mesh-ancestor
102325507|NCT02005562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102325508|NCT02005562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102325509|NCT02005562|Protective Agents|protective agents|mesh-ancestor
102325510|NCT02005562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102325511|NCT01448044|Interferons|interferons|mesh-list
102325512|NCT01448044|Ribavirin|ribavirin|mesh-list
102325513|NCT01448044|Interferon-alpha|interferon-alpha|mesh-list
102325514|NCT01448044|Interferon alpha-2|interferon alpha-2|mesh-list
102325515|NCT01448044|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102325516|NCT01448044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102325517|NCT01448044|Antiviral Agents|antiviral agents|mesh-ancestor
102325518|NCT01448044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102325519|NCT01448044|Antimetabolites|antimetabolites|mesh-ancestor
102325520|NCT01448044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325521|NCT01448044|Immunologic Factors|immunologic factors|mesh-ancestor
102325522|NCT01448044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325523|NCT01472380|Efavirenz|efavirenz|mesh-list
102325524|NCT01472380|Fenofibric acid|fenofibric acid|mesh-list
102325525|NCT01472380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102325526|NCT01472380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102325527|NCT01472380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102325528|NCT01472380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325529|NCT01472380|Antiviral Agents|antiviral agents|mesh-ancestor
102325530|NCT01472380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102034354|NCT02583048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102325531|NCT01472380|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102325532|NCT01472380|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102325533|NCT01472380|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102325534|NCT01472380|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102325535|NCT01472380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102325536|NCT01472380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102325537|NCT01472380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102325539|NCT01472380|Antimetabolites|antimetabolites|mesh-ancestor
102325540|NCT01472380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102325541|NCT01447576|Antidepressive Agents|antidepressive agents|mesh-list
102325542|NCT01447576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102325543|NCT01447420|Ribavirin|ribavirin|mesh-list
102325544|NCT01447420|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102325545|NCT01447420|Antimetabolites|antimetabolites|mesh-ancestor
102325546|NCT01447420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325547|NCT01447420|Antiviral Agents|antiviral agents|mesh-ancestor
102325548|NCT01447420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102325549|NCT01446874|Chlorhexidine|chlorhexidine|mesh-list
102325550|NCT01446874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102325551|NCT01446874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102325552|NCT01446874|Disinfectants|disinfectants|mesh-ancestor
102325553|NCT01439074|Sulfadiazine|sulfadiazine|mesh-list
102325554|NCT01439074|Silver Sulfadiazine|silver sulfadiazine|mesh-list
102325555|NCT01439074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102325556|NCT01439074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102325557|NCT01439074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102325558|NCT01439074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102325559|NCT01439074|Coccidiostats|coccidiostats|mesh-ancestor
102325560|NCT01439074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102325561|NCT01438840|Maleic acid|maleic acid|mesh-list
102325562|NCT01438840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102325563|NCT01438840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325564|NCT01471054|Dexamethasone|dexamethasone|mesh-list
102325565|NCT01471054|Bevacizumab|bevacizumab|mesh-list
102325566|NCT01471054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102325567|NCT01471054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102325568|NCT01471054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102325569|NCT01471054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102325570|NCT01471054|Growth Substances|growth substances|mesh-ancestor
102325571|NCT01471054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325572|NCT01471054|Growth Inhibitors|growth inhibitors|mesh-ancestor
102325573|NCT01471054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102325574|NCT01471054|Antiemetics|antiemetics|mesh-ancestor
102325575|NCT01471054|Autonomic Agents|autonomic agents|mesh-ancestor
102325576|NCT01471054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102325577|NCT01471054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102325578|NCT01471054|Glucocorticoids|glucocorticoids|mesh-ancestor
102325579|NCT01471054|Hormones|hormones|mesh-ancestor
102325580|NCT01471054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102325581|NCT01471054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102325582|NCT01978184|Hydroxychloroquine|hydroxychloroquine|mesh-list
102325583|NCT01978184|Gemcitabine|gemcitabine|mesh-list
102325584|NCT01978184|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102325585|NCT01978184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102325586|NCT01978184|Antimetabolites|antimetabolites|mesh-ancestor
102325587|NCT01978184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325588|NCT01978184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102325589|NCT01978184|Antimalarials|antimalarials|mesh-ancestor
102325590|NCT01978184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102325591|NCT01978184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102325592|NCT01978184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102325593|NCT01978184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102325594|NCT01978184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102325595|NCT01445548|Sirolimus|sirolimus|mesh-list
102325596|NCT01445548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102325597|NCT01445548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102325598|NCT01445548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102325599|NCT01445548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102325600|NCT01445548|Antifungal Agents|antifungal agents|mesh-ancestor
102325601|NCT01445548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102325602|NCT01445548|Immunologic Factors|immunologic factors|mesh-ancestor
102325603|NCT01445548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325604|NCT01977794|Amlodipine|amlodipine|mesh-list
102325605|NCT01977794|Bisoprolol|bisoprolol|mesh-list
102325606|NCT01977794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102325607|NCT01977794|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102325608|NCT01977794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102325609|NCT01977794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325610|NCT01977794|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102325611|NCT01977794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325612|NCT01977794|Vasodilator Agents|vasodilator agents|mesh-ancestor
102325613|NCT01977794|Sympatholytics|sympatholytics|mesh-ancestor
102325614|NCT01977794|Autonomic Agents|autonomic agents|mesh-ancestor
102325615|NCT01977794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102325616|NCT01977794|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102325617|NCT01977794|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102325618|NCT01977794|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102325619|NCT01977794|Adrenergic Agents|adrenergic agents|mesh-ancestor
102325620|NCT01977794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102325621|NCT02005484|Trastuzumab|trastuzumab|mesh-list
102325622|NCT02005484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102325623|NCT02005484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102325624|NCT01597973|Meropenem|meropenem|mesh-list
102325625|NCT01597973|Colistin|colistin|mesh-list
102325626|NCT01597973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102325627|NCT01597973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102325628|NCT02047253|Acyclovir|acyclovir|mesh-list
102325629|NCT02047253|Dexamethasone|dexamethasone|mesh-list
102325630|NCT02047253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102325631|NCT02047253|Antiemetics|antiemetics|mesh-ancestor
102325632|NCT02047253|Autonomic Agents|autonomic agents|mesh-ancestor
102325633|NCT02047253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102325634|NCT02047253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325635|NCT02047253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102325636|NCT02047253|Glucocorticoids|glucocorticoids|mesh-ancestor
102325637|NCT02047253|Hormones|hormones|mesh-ancestor
102325638|NCT02047253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102325639|NCT02047253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102325640|NCT02047253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102325641|NCT02047253|Antiviral Agents|antiviral agents|mesh-ancestor
102325642|NCT02047253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102325643|NCT02096705|Dapagliflozin|dapagliflozin|mesh-list
102325644|NCT02096705|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102325645|NCT02096705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325646|NCT02096705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102325647|NCT02096705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325648|NCT02096003|Morphine|morphine|mesh-list
102325649|NCT02096003|Hydromorphone|hydromorphone|mesh-list
102325650|NCT02096003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102325651|NCT02096003|Narcotics|narcotics|mesh-ancestor
102325652|NCT02096003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102325653|NCT02096003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325654|NCT02096003|Analgesics|analgesics|mesh-ancestor
102325655|NCT02096003|Sensory System Agents|sensory system agents|mesh-ancestor
102325656|NCT02096003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102325657|NCT02095535|Chlorhexidine|chlorhexidine|mesh-list
102325658|NCT02095535|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102325659|NCT02095535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102325660|NCT02095535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102325661|NCT02095535|Disinfectants|disinfectants|mesh-ancestor
102325662|NCT02095535|Dermatologic Agents|dermatologic agents|mesh-ancestor
102325663|NCT02059187|Insulin|insulin|mesh-list
102325664|NCT02059187|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102325665|NCT02059187|Insulin Glargine|insulin glargine|mesh-list
102325666|NCT02059187|MK-1293|mk-1293|mesh-list
102325667|NCT02059187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102325668|NCT02059187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325669|NCT02059187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102325670|NCT02059187|Antimetabolites|antimetabolites|mesh-ancestor
102325671|NCT02059187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325672|NCT02059187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102325673|NCT02043899|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
102325674|NCT02043899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102325675|NCT02043899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102325676|NCT02043899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325677|NCT02043899|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102325678|NCT01622231|Fluticasone|fluticasone|mesh-list
102325679|NCT01622231|Xhance|xhance|mesh-list
102325680|NCT01622231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102325681|NCT01622231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102034531|NCT04434300|Daptomycin|daptomycin|mesh-list
102325682|NCT01622231|Autonomic Agents|autonomic agents|mesh-ancestor
102325683|NCT01622231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102325684|NCT01622231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325685|NCT01622231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102325686|NCT01622231|Respiratory System Agents|respiratory system agents|mesh-ancestor
102325687|NCT01622231|Dermatologic Agents|dermatologic agents|mesh-ancestor
102325688|NCT01622231|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102325689|NCT02042183|Lubiprostone|lubiprostone|mesh-list
102325690|NCT02042183|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102325691|NCT02042183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102325692|NCT02042183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325693|NCT02058095|Tadalafil|tadalafil|mesh-list
102325694|NCT02058095|Vasodilator Agents|vasodilator agents|mesh-ancestor
102325695|NCT02058095|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102325696|NCT02058095|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102325697|NCT02058095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102325698|NCT02058095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325699|NCT02058095|Urological Agents|urological agents|mesh-ancestor
102325700|NCT02023112|Ritonavir|ritonavir|mesh-list
102325701|NCT02023112|Ribavirin|ribavirin|mesh-list
102325702|NCT02023112|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102325703|NCT02023112|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102325704|NCT02023112|Protease Inhibitors|protease inhibitors|mesh-ancestor
102325705|NCT02023112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102325706|NCT02023112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325707|NCT02023112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102325708|NCT02023112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102325709|NCT02023112|Antiviral Agents|antiviral agents|mesh-ancestor
102325710|NCT02023112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102325711|NCT02023112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102325712|NCT02023112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102325713|NCT02023112|Antimetabolites|antimetabolites|mesh-ancestor
102325714|NCT04670666|Metformin|metformin|mesh-list
102325715|NCT04670666|Empagliflozin|empagliflozin|mesh-list
102325716|NCT04670666|Linagliptin|linagliptin|mesh-list
102325717|NCT04670666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102325718|NCT04670666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325719|NCT04670666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101667636|NCT02538367|Laxatives|laxatives|mesh-ancestor
102325720|NCT04670666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325721|NCT04670666|Incretins|incretins|mesh-ancestor
102325722|NCT04670666|Hormones|hormones|mesh-ancestor
102325723|NCT04670666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102325724|NCT04670666|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102325725|NCT04670666|Protease Inhibitors|protease inhibitors|mesh-ancestor
102325726|NCT04670666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102325727|NCT01976624|Timolol|timolol|mesh-list
102325728|NCT01976624|Bimatoprost|bimatoprost|mesh-list
102325729|NCT01976624|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102325730|NCT01976624|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102325731|NCT01976624|Adrenergic Agents|adrenergic agents|mesh-ancestor
102325732|NCT01976624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102325733|NCT01976624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325734|NCT01976624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325735|NCT01976624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102325736|NCT01976624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102325737|NCT02041091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102325738|NCT02041091|Immunologic Factors|immunologic factors|mesh-ancestor
102325739|NCT02041091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325740|NCT04717973|Vitamin D|vitamin d|mesh-list
102325741|NCT04717973|Vitamins|vitamins|mesh-list
102325742|NCT04717973|Vitamin B 12|vitamin b 12|mesh-list
102325743|NCT04717973|Hydroxocobalamin|hydroxocobalamin|mesh-list
102325744|NCT04717973|Micronutrients|micronutrients|mesh-ancestor
102325745|NCT04717973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325746|NCT04717973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102325747|NCT04717973|Vitamin B Complex|vitamin b complex|mesh-ancestor
102325748|NCT04717973|Hematinics|hematinics|mesh-ancestor
102325749|NCT02057549|Haloperidol|haloperidol|mesh-list
102325750|NCT02057549|Haloperidol decanoate|haloperidol decanoate|mesh-list
102325751|NCT02057549|Antiemetics|antiemetics|mesh-ancestor
102325752|NCT02057549|Autonomic Agents|autonomic agents|mesh-ancestor
102325753|NCT02057549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102325754|NCT02057549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325755|NCT02057549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102325756|NCT02057549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102325757|NCT02057549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102325758|NCT02057549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102325759|NCT02057549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102325760|NCT02057549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102325761|NCT02057549|Dopamine Agents|dopamine agents|mesh-ancestor
102325762|NCT02057549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102325763|NCT02057549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325764|NCT02057549|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102325765|NCT02057393|Methylene Blue|methylene blue|mesh-list
102325766|NCT02057393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102325767|NCT02057393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325768|NCT02040779|Beclomethasone|beclomethasone|mesh-list
102325769|NCT02040779|Albuterol|albuterol|mesh-list
102325770|NCT02040779|Bronchodilator Agents|bronchodilator agents|mesh-list
102325771|NCT02040779|Autonomic Agents|autonomic agents|mesh-ancestor
102325772|NCT02040779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102325773|NCT02040779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325774|NCT02040779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102325775|NCT02040779|Respiratory System Agents|respiratory system agents|mesh-ancestor
102325776|NCT02040779|Tocolytic Agents|tocolytic agents|mesh-ancestor
102325777|NCT02040779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102325778|NCT02040779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102325779|NCT02040779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102325780|NCT02040779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102325781|NCT02040779|Adrenergic Agents|adrenergic agents|mesh-ancestor
102325782|NCT02040779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102325783|NCT02040779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325784|NCT02040779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102325785|NCT02040779|Glucocorticoids|glucocorticoids|mesh-ancestor
102325786|NCT02040779|Hormones|hormones|mesh-ancestor
102325787|NCT02040779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102325788|NCT02056301|Morphine|morphine|mesh-list
102325789|NCT02056301|Hydromorphone|hydromorphone|mesh-list
102325790|NCT02056301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102325791|NCT02056301|Narcotics|narcotics|mesh-ancestor
102325792|NCT02056301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102325793|NCT02056301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325794|NCT02056301|Analgesics|analgesics|mesh-ancestor
102325795|NCT02056301|Sensory System Agents|sensory system agents|mesh-ancestor
102325796|NCT02056301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102325797|NCT01967576|Axitinib|axitinib|mesh-list
102325798|NCT01967576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102325799|NCT01967576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102325800|NCT01967576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102325801|NCT01967576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325802|NCT02003534|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102325803|NCT02003534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102325804|NCT02003534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102325805|NCT02003534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102325806|NCT02003534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102325807|NCT02003534|Adrenergic Agents|adrenergic agents|mesh-ancestor
102325808|NCT02003534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102325809|NCT02003534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325810|NCT02003534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325811|NCT01976312|Ranibizumab|ranibizumab|mesh-list
102325812|NCT01976312|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102325813|NCT01976312|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102325814|NCT01976312|Growth Substances|growth substances|mesh-ancestor
102325815|NCT01976312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325816|NCT01976312|Growth Inhibitors|growth inhibitors|mesh-ancestor
102325817|NCT01976312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102325818|NCT02053493|Isosorbide|isosorbide|mesh-list
102325819|NCT02053493|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
102325820|NCT02053493|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
102325821|NCT02053493|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102325822|NCT02053493|Diuretics|diuretics|mesh-ancestor
102325823|NCT02053493|Natriuretic Agents|natriuretic agents|mesh-ancestor
102325824|NCT02053493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325825|NCT02053493|Vasodilator Agents|vasodilator agents|mesh-ancestor
102325826|NCT02053493|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102325827|NCT02053493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325828|NCT02003144|Eculizumab|eculizumab|mesh-list
102325829|NCT02003144|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102325830|NCT02003144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102325831|NCT02003144|Immunologic Factors|immunologic factors|mesh-ancestor
102325832|NCT02003144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325833|NCT02038907|Vaccines|vaccines|mesh-list
102325834|NCT02038907|Immunologic Factors|immunologic factors|mesh-ancestor
102325835|NCT02038907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325836|NCT02052011|Ranolazine|ranolazine|mesh-list
102325837|NCT02052011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102325838|NCT02052011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102325839|NCT02052011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325840|NCT02051933|Botulinum Toxins|botulinum toxins|mesh-list
102325841|NCT02051933|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102325842|NCT02051933|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102325843|NCT02051933|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102325844|NCT02051933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102325845|NCT02051933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325846|NCT02051933|Cholinergic Agents|cholinergic agents|mesh-ancestor
102325847|NCT02051933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102325848|NCT02051933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325849|NCT02051933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102325850|NCT02051933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102325851|NCT02035553|Pimavanserin|pimavanserin|mesh-list
102325852|NCT02035553|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102325853|NCT02035553|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102325854|NCT02035553|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102325855|NCT02035553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102325856|NCT02035553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102325857|NCT02035553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325858|NCT02035553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102325859|NCT02035553|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102325860|NCT02035553|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102325861|NCT02035553|Serotonin Agents|serotonin agents|mesh-ancestor
102325862|NCT02035553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102325863|NCT02035553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325864|NCT01445080|Sorafenib|sorafenib|mesh-list
102325865|NCT01445080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102325866|NCT01445080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102325867|NCT01445080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101667788|NCT02749890|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102325868|NCT01445080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325869|NCT04709471|Nicotine|nicotine|mesh-list
102325870|NCT04709471|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102325871|NCT04709471|Autonomic Agents|autonomic agents|mesh-ancestor
102325872|NCT04709471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102325873|NCT04709471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325874|NCT04709471|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102325875|NCT04709471|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102325876|NCT04709471|Cholinergic Agents|cholinergic agents|mesh-ancestor
102325877|NCT04709471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102325878|NCT04709471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325879|NCT01959529|Insulin|insulin|mesh-list
102325880|NCT01959529|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102325881|NCT01959529|Insulin Glargine|insulin glargine|mesh-list
102325882|NCT01959529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102325883|NCT01959529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325884|NCT02033369|Pramipexole|pramipexole|mesh-list
102325885|NCT02033369|Antioxidants|antioxidants|mesh-ancestor
102325886|NCT02033369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325887|NCT02033369|Protective Agents|protective agents|mesh-ancestor
102325888|NCT02033369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325889|NCT02033369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102325890|NCT02033369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102325891|NCT02033369|Dopamine Agonists|dopamine agonists|mesh-ancestor
102325892|NCT02033369|Dopamine Agents|dopamine agents|mesh-ancestor
102325893|NCT02033369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102325894|NCT02032901|Sofosbuvir|sofosbuvir|mesh-list
102325895|NCT02032901|Antiviral Agents|antiviral agents|mesh-ancestor
102325896|NCT02032901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102325897|NCT04681469|Niraparib|niraparib|mesh-list
102325898|NCT04681469|Dostarlimab|dostarlimab|mesh-list
102325899|NCT04681469|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102325900|NCT04681469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102325901|NCT04681469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325902|NCT04681469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102325903|NCT01986751|Clonidine|clonidine|mesh-list
102325904|NCT01986751|Ropivacaine|ropivacaine|mesh-list
102325905|NCT01986751|Anesthetics, Local|anesthetics, local|mesh-ancestor
102325906|NCT01986751|Anesthetics|anesthetics|mesh-ancestor
102325907|NCT01986751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102325908|NCT01986751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325909|NCT01986751|Sensory System Agents|sensory system agents|mesh-ancestor
102325910|NCT01986751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102325911|NCT01986751|Analgesics|analgesics|mesh-ancestor
102325912|NCT01986751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102325913|NCT01986751|Sympatholytics|sympatholytics|mesh-ancestor
102325914|NCT01986751|Autonomic Agents|autonomic agents|mesh-ancestor
102325915|NCT01986751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102325916|NCT01986751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102325917|NCT01986751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102325918|NCT01986751|Adrenergic Agents|adrenergic agents|mesh-ancestor
102325919|NCT01986751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102325920|NCT01986751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325921|NCT01438060|Aripiprazole|aripiprazole|mesh-list
102325922|NCT01438060|Antidepressive Agents|antidepressive agents|mesh-ancestor
102325923|NCT01438060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102325924|NCT01438060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102325925|NCT01438060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102325926|NCT01438060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102325927|NCT01438060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325928|NCT01438060|Dopamine Agonists|dopamine agonists|mesh-ancestor
102325929|NCT01438060|Dopamine Agents|dopamine agents|mesh-ancestor
102325930|NCT01438060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102325931|NCT01438060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325932|NCT01438060|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102325933|NCT01438060|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102325934|NCT01438060|Serotonin Agents|serotonin agents|mesh-ancestor
102325935|NCT01438060|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102325936|NCT01438060|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102325937|NCT01438060|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102325938|NCT01438060|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102325939|NCT01444300|4-Aminopyridine|4-aminopyridine|mesh-list
102325940|NCT01444300|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102325941|NCT01444300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102325942|NCT01444300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325943|NCT01443364|Certolizumab Pegol|certolizumab pegol|mesh-list
102325944|NCT01443364|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102325945|NCT01443364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102325946|NCT01443364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102325947|NCT01443364|Immunologic Factors|immunologic factors|mesh-ancestor
102325948|NCT01443364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102325949|NCT01443364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102325950|NCT02020577|Cetuximab|cetuximab|mesh-list
102325951|NCT02020577|Afatinib|afatinib|mesh-list
102325952|NCT02020577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102325953|NCT02020577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102325954|NCT02020577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102325955|NCT02020577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102325956|NCT02020577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325957|NCT02020031|Vancomycin|vancomycin|mesh-list
102325958|NCT02020031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102325959|NCT02020031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102325960|NCT02030405|Ixazomib|ixazomib|mesh-list
102325961|NCT02030405|Proteasome Inhibitors|proteasome inhibitors|mesh-list
102325962|NCT02030405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102325963|NCT02030405|Protease Inhibitors|protease inhibitors|mesh-ancestor
102325964|NCT02030405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102325965|NCT02030405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325966|NCT01975376|Bococizumab|bococizumab|mesh-list
102325967|NCT01975376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102325968|NCT01975376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102325969|NCT01975376|Antimetabolites|antimetabolites|mesh-ancestor
102325970|NCT01975376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325971|NCT01975376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102325972|NCT01443130|Chloroquine|chloroquine|mesh-list
102325973|NCT01443130|Pyrimethamine|pyrimethamine|mesh-list
102325974|NCT01443130|Sulfadoxine|sulfadoxine|mesh-list
102325975|NCT01443130|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
102325976|NCT01443130|Amebicides|amebicides|mesh-ancestor
102325977|NCT01443130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102325978|NCT01443130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102325979|NCT01443130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102325980|NCT01443130|Antimalarials|antimalarials|mesh-ancestor
102325981|NCT01443130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102325982|NCT01443130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102325983|NCT01443130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102325984|NCT01443130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102325985|NCT01443130|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102325986|NCT01436500|Ifetroban|ifetroban|mesh-list
102325987|NCT01436500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102325988|NCT01958827|Adalimumab|adalimumab|mesh-list
102325989|NCT01958827|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102325990|NCT01958827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102325991|NCT01958827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102325992|NCT04670653|Mometasone Furoate|mometasone furoate|mesh-list
102325993|NCT04670653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102325994|NCT04670653|Dermatologic Agents|dermatologic agents|mesh-ancestor
102325995|NCT04670653|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102325996|NCT01436110|Fluticasone|fluticasone|mesh-list
102325997|NCT01436110|Xhance|xhance|mesh-list
102325998|NCT01436110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102325999|NCT01436110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102326000|NCT01436110|Autonomic Agents|autonomic agents|mesh-ancestor
102326001|NCT01436110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102326002|NCT01436110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326003|NCT01436110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102326004|NCT01436110|Respiratory System Agents|respiratory system agents|mesh-ancestor
102326005|NCT01436110|Dermatologic Agents|dermatologic agents|mesh-ancestor
102326006|NCT01436110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102326007|NCT01619852|Lidocaine|lidocaine|mesh-list
102326008|NCT01619852|Anesthetics, Local|anesthetics, local|mesh-ancestor
102326009|NCT01619852|Anesthetics|anesthetics|mesh-ancestor
102326010|NCT01619852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102326011|NCT01619852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326012|NCT01619852|Sensory System Agents|sensory system agents|mesh-ancestor
102326013|NCT01619852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102326014|NCT01619852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102326015|NCT01619852|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102326016|NCT01619852|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102326017|NCT01619852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101667938|NCT04034173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102326018|NCT01619852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326020|NCT04069936|Tadalafil|tadalafil|mesh-list
102326021|NCT04069936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102326022|NCT04069936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102326023|NCT04069936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102326024|NCT04069936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326025|NCT04069936|Vasodilator Agents|vasodilator agents|mesh-ancestor
102326026|NCT04069936|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102326027|NCT04069936|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102326028|NCT04069936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102326029|NCT04069936|Urological Agents|urological agents|mesh-ancestor
102326030|NCT02000882|Capecitabine|capecitabine|mesh-list
102326031|NCT02000882|Trastuzumab|trastuzumab|mesh-list
102326032|NCT02000882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102326033|NCT02000882|Antimetabolites|antimetabolites|mesh-ancestor
102326034|NCT02000882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326035|NCT02000882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102326036|NCT02000882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102326037|NCT04666129|Prednisone|prednisone|mesh-list
102326038|NCT04666129|Methylprednisolone|methylprednisolone|mesh-list
102326039|NCT04666129|Docetaxel|docetaxel|mesh-list
102326040|NCT04666129|Relugolix|relugolix|mesh-list
102326041|NCT04666129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102326042|NCT04666129|Tubulin Modulators|tubulin modulators|mesh-ancestor
102326043|NCT04666129|Antimitotic Agents|antimitotic agents|mesh-ancestor
102326044|NCT04666129|Mitosis Modulators|mitosis modulators|mesh-ancestor
102326045|NCT04666129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326046|NCT04666129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102326047|NCT04666129|Glucocorticoids|glucocorticoids|mesh-ancestor
102326048|NCT04666129|Hormones|hormones|mesh-ancestor
102326049|NCT04666129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102326050|NCT04666129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326051|NCT04666129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102326052|NCT04666129|Antiemetics|antiemetics|mesh-ancestor
102326053|NCT04666129|Autonomic Agents|autonomic agents|mesh-ancestor
102326054|NCT04666129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102326055|NCT04666129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102326056|NCT04666129|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102326057|NCT04666129|Protective Agents|protective agents|mesh-ancestor
102034886|NCT05230368|Decitabine|decitabine|mesh-list
102326058|NCT04666129|Androgen Antagonists|androgen antagonists|mesh-ancestor
102326059|NCT04666129|Hormone Antagonists|hormone antagonists|mesh-ancestor
102326060|NCT04666051|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102326061|NCT04666051|Hemostatics|hemostatics|mesh-ancestor
102326062|NCT04666051|Coagulants|coagulants|mesh-ancestor
102326063|NCT01965704|Ondansetron|ondansetron|mesh-list
102326064|NCT01965704|Antiemetics|antiemetics|mesh-ancestor
102326065|NCT01965704|Autonomic Agents|autonomic agents|mesh-ancestor
102326066|NCT01965704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102326067|NCT01965704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326068|NCT01965704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102326069|NCT01965704|Antipruritics|antipruritics|mesh-ancestor
101440877|NCT03384641|Bedaquiline|bedaquiline|mesh-list
102326070|NCT01965704|Dermatologic Agents|dermatologic agents|mesh-ancestor
102326071|NCT01965704|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102326072|NCT01965704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102326073|NCT01965704|Serotonin Agents|serotonin agents|mesh-ancestor
102326074|NCT01965704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102326075|NCT01965704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326076|NCT02003365|Triamcinolone|triamcinolone|mesh-list
102326077|NCT02003365|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102326078|NCT02003365|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102326079|NCT02003365|FX006|fx006|mesh-list
102326080|NCT02003365|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102326081|NCT02003365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102326082|NCT02003365|Glucocorticoids|glucocorticoids|mesh-ancestor
102326083|NCT02003365|Hormones|hormones|mesh-ancestor
102326084|NCT02003365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102326085|NCT02003365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326086|NCT02003365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102326087|NCT02003365|Immunologic Factors|immunologic factors|mesh-ancestor
102326088|NCT02003365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102326089|NCT02003365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326090|NCT01975220|Metformin|metformin|mesh-list
102326091|NCT01975220|Empagliflozin|empagliflozin|mesh-list
102326092|NCT01975220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102326093|NCT01975220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326094|NCT01975220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102326095|NCT01975220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326096|NCT01974752|Dacarbazine|dacarbazine|mesh-list
102326097|NCT01974752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102326098|NCT01974752|Alkylating Agents|alkylating agents|mesh-ancestor
102326099|NCT01974752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326100|NCT01974752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102326101|NCT01999946|Naltrexone|naltrexone|mesh-list
102326102|NCT01999946|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102326103|NCT01999946|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102326104|NCT01999946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326105|NCT01999946|Sensory System Agents|sensory system agents|mesh-ancestor
102326106|NCT01999946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102326107|NCT01958281|Sofosbuvir|sofosbuvir|mesh-list
102326108|NCT01958281|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102326109|NCT01958281|Antiviral Agents|antiviral agents|mesh-ancestor
102326110|NCT01958281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102326111|NCT02002975|Pioglitazone|pioglitazone|mesh-list
102326112|NCT02002975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102326113|NCT02002975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326114|NCT02001181|Tofacitinib|tofacitinib|mesh-list
102326115|NCT02001181|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102326116|NCT02001181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102326117|NCT02001181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101440882|NCT03377725|Arsenic Trioxide|arsenic trioxide|mesh-list
102326118|NCT02001181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326119|NCT04176055|Haloperidol|haloperidol|mesh-list
102326120|NCT04176055|Haloperidol decanoate|haloperidol decanoate|mesh-list
102326121|NCT04176055|Antiemetics|antiemetics|mesh-ancestor
102326122|NCT04176055|Autonomic Agents|autonomic agents|mesh-ancestor
102326123|NCT04176055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102326124|NCT04176055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326125|NCT04176055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102326126|NCT04176055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102326127|NCT04176055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102326128|NCT04176055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102326129|NCT04176055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102326130|NCT04176055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102034955|NCT01343082|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102326131|NCT04176055|Dopamine Agents|dopamine agents|mesh-ancestor
102326132|NCT04176055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102326133|NCT04176055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326134|NCT04176055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102326135|NCT04659278|Peppermint oil|peppermint oil|mesh-list
102326136|NCT04659278|Antiemetics|antiemetics|mesh-ancestor
102326137|NCT04659278|Autonomic Agents|autonomic agents|mesh-ancestor
102326138|NCT04659278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102326139|NCT04659278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326140|NCT04659278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102326141|NCT04659278|Parasympatholytics|parasympatholytics|mesh-ancestor
102326143|NCT04659044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102326144|NCT04659044|Venetoclax|venetoclax|mesh-list
102326145|NCT04659044|Antibodies|antibodies|mesh-list
102326146|NCT04659044|Immunoglobulins|immunoglobulins|mesh-list
102326147|NCT04659044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102326148|NCT04659044|Immunoconjugates|immunoconjugates|mesh-list
102326149|NCT04659044|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
102326150|NCT04659044|Immunologic Factors|immunologic factors|mesh-ancestor
102326151|NCT04659044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326152|NCT04659044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102326153|NCT04659044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102326154|NCT01999868|Abatacept|abatacept|mesh-list
102326155|NCT01999868|Ustekinumab|ustekinumab|mesh-list
102326156|NCT01999868|Immunoglobulins|immunoglobulins|mesh-list
102326157|NCT01999868|Immunologic Factors|immunologic factors|mesh-ancestor
102326158|NCT01999868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326159|NCT01999868|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102326160|NCT01999868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326161|NCT01999868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102326162|NCT01999868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102326163|NCT01999868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102326164|NCT01999868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102326165|NCT01999868|Dermatologic Agents|dermatologic agents|mesh-ancestor
102326166|NCT03511963|Bevacizumab|bevacizumab|mesh-list
102326167|NCT03511963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102326168|NCT03511963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102326169|NCT03511963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102326170|NCT03511963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102326171|NCT03511963|Growth Substances|growth substances|mesh-ancestor
102326172|NCT03511963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326173|NCT03511963|Growth Inhibitors|growth inhibitors|mesh-ancestor
102326174|NCT01999322|Insulin|insulin|mesh-list
102326175|NCT01999322|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102326176|NCT01999322|Insulin Aspart|insulin aspart|mesh-list
102326177|NCT01999322|Insulin, Long-Acting|insulin, long-acting|mesh-list
102326178|NCT01999322|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102326179|NCT01999322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102326180|NCT01999322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326181|NCT01964924|Trametinib|trametinib|mesh-list
102326182|NCT01964924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102326183|NCT01964924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102326184|NCT01964924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102326185|NCT01964924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326186|NCT01964378|Morphine|morphine|mesh-list
102326187|NCT01964378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102326188|NCT01964378|Narcotics|narcotics|mesh-ancestor
102326189|NCT01964378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102326190|NCT01964378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326191|NCT01964378|Analgesics|analgesics|mesh-ancestor
102326192|NCT01964378|Sensory System Agents|sensory system agents|mesh-ancestor
102326193|NCT01964378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102326194|NCT01442038|Ranolazine|ranolazine|mesh-list
102326195|NCT01442038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102326196|NCT01442038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102326197|NCT01442038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326198|NCT01998919|Carboplatin|carboplatin|mesh-list
102326199|NCT01998919|Gemcitabine|gemcitabine|mesh-list
102326200|NCT01998919|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102326201|NCT01998919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102326202|NCT01998919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102326203|NCT01998919|Antimetabolites|antimetabolites|mesh-ancestor
102326204|NCT01998919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326205|NCT01998919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102326206|NCT01998919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102326207|NCT01964300|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102326208|NCT01964300|Antiviral Agents|antiviral agents|mesh-ancestor
102326209|NCT01964300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102326211|NCT01972724|Pioglitazone|pioglitazone|mesh-list
102326212|NCT01972724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102326213|NCT01972724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326214|NCT01441960|Rocuronium|rocuronium|mesh-list
102326215|NCT01441960|Succinylcholine|succinylcholine|mesh-list
102326216|NCT01441960|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102326217|NCT01441960|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102326218|NCT01441960|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102326219|NCT01441960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102326220|NCT01441960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326221|NCT01441960|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
102326222|NCT01955707|Natalizumab|natalizumab|mesh-list
102326223|NCT01955707|Immunologic Factors|immunologic factors|mesh-ancestor
102326224|NCT01955707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326225|NCT01435798|Dextromethorphan|dextromethorphan|mesh-list
102326226|NCT01435798|Antitussive Agents|antitussive agents|mesh-ancestor
102326227|NCT01435798|Respiratory System Agents|respiratory system agents|mesh-ancestor
102326228|NCT01435798|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102326229|NCT01435798|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102326230|NCT01435798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102326231|NCT01435798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326232|NCT01435798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326233|NCT01955161|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
102326234|NCT01955161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102326235|NCT01955161|Serotonin Agents|serotonin agents|mesh-ancestor
102326236|NCT01955161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102326237|NCT01955161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326238|NCT01955161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326239|NCT01441414|Axitinib|axitinib|mesh-list
102326240|NCT01441414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102326241|NCT01441414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102326242|NCT01441414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102326243|NCT01441414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326244|NCT01954927|Gabapentin|gabapentin|mesh-list
102326245|NCT01954927|Analgesics|analgesics|mesh-ancestor
102326246|NCT01954927|Sensory System Agents|sensory system agents|mesh-ancestor
102326247|NCT01954927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102326248|NCT01954927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326249|NCT01954927|Anticonvulsants|anticonvulsants|mesh-ancestor
102326250|NCT01954927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102326251|NCT01954927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102326252|NCT01954927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102326253|NCT01954927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102326254|NCT01954927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102326255|NCT01954927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102326256|NCT01954927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102326257|NCT01954927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326258|NCT01954927|Antimanic Agents|antimanic agents|mesh-ancestor
102326259|NCT01953913|Afatinib|afatinib|mesh-list
102326260|NCT01953913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102326261|NCT01953913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102326262|NCT01953913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102326263|NCT01953913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326264|NCT01970540|Doxorubicin|doxorubicin|mesh-list
102326265|NCT01970540|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102326266|NCT01970540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102326267|NCT01970540|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102326268|NCT01970540|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102326269|NCT01970540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102326270|NCT01970540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326271|NCT01996826|Bevacizumab|bevacizumab|mesh-list
102326272|NCT01996826|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102326273|NCT01996826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102326274|NCT01996826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102326275|NCT01996826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102326276|NCT01996826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102326277|NCT01996826|Growth Substances|growth substances|mesh-ancestor
102326278|NCT01996826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326279|NCT01996826|Growth Inhibitors|growth inhibitors|mesh-ancestor
102326280|NCT01996826|Laxatives|laxatives|mesh-ancestor
102326281|NCT01996826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102326282|NCT01621178|Insulin|insulin|mesh-list
102326283|NCT01621178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102326284|NCT01621178|Insulin Glargine|insulin glargine|mesh-list
102326285|NCT01621178|Insulin Lispro|insulin lispro|mesh-list
102326286|NCT01621178|Dulaglutide|dulaglutide|mesh-list
102326287|NCT01621178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102326288|NCT01621178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326289|NCT01962974|Golimumab|golimumab|mesh-list
102326290|NCT01962974|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102326291|NCT01962974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102326292|NCT01962974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102326293|NCT01962974|Immunologic Factors|immunologic factors|mesh-ancestor
102326294|NCT01962974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326295|NCT01962896|Sirolimus|sirolimus|mesh-list
102326296|NCT01962896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102326297|NCT01962896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102326298|NCT01962896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102326299|NCT01962896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102326300|NCT01962896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326301|NCT01962896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102326302|NCT01962896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102326303|NCT01962896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102326304|NCT01962896|Antifungal Agents|antifungal agents|mesh-ancestor
102326305|NCT01962896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102326306|NCT01962896|Immunologic Factors|immunologic factors|mesh-ancestor
102326307|NCT01962896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326308|NCT01970462|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101440920|NCT03234972|Hormones|hormones|mesh-ancestor
102326309|NCT01970462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102326310|NCT01970462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326311|NCT01970462|Incretins|incretins|mesh-ancestor
102326312|NCT01970462|Hormones|hormones|mesh-ancestor
102326313|NCT01970462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102326314|NCT01970462|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102326315|NCT01970462|Protease Inhibitors|protease inhibitors|mesh-ancestor
102326316|NCT01970462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102326317|NCT01970462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326319|NCT01958671|Glimepiride|glimepiride|mesh-list
102326320|NCT01958671|Ertugliflozin|ertugliflozin|mesh-list
102326321|NCT01958671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102326322|NCT01958671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326323|NCT01958671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102326324|NCT01958671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102326325|NCT01958671|Immunologic Factors|immunologic factors|mesh-ancestor
102326326|NCT01958671|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102326327|NCT01958671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326328|NCT01995266|Asunaprevir|asunaprevir|mesh-list
102326329|NCT01995266|Protease Inhibitors|protease inhibitors|mesh-ancestor
102326330|NCT01995266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102326331|NCT01995266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326332|NCT01969058|Isotretinoin|isotretinoin|mesh-list
102326333|NCT01969058|Dermatologic Agents|dermatologic agents|mesh-ancestor
102326334|NCT01968980|Bococizumab|bococizumab|mesh-list
102326335|NCT01968980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102326336|NCT01968980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102326337|NCT01968980|Antimetabolites|antimetabolites|mesh-ancestor
102326338|NCT01968980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326339|NCT01968980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102326340|NCT01968434|Carbocysteine|carbocysteine|mesh-list
102326341|NCT01968434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102326342|NCT01968434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102326343|NCT01968434|Expectorants|expectorants|mesh-ancestor
102326344|NCT01968434|Respiratory System Agents|respiratory system agents|mesh-ancestor
102326345|NCT01946438|Vaccines|vaccines|mesh-list
102326346|NCT01946438|Immunologic Factors|immunologic factors|mesh-ancestor
102326347|NCT01946438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326348|NCT01618214|Insulin Aspart|insulin aspart|mesh-list
102326349|NCT01618214|Biphasic Insulins|biphasic insulins|mesh-list
102326350|NCT01618214|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
102326351|NCT01618214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102326352|NCT01618214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326353|NCT01917656|Metformin|metformin|mesh-list
102326354|NCT01917656|Liraglutide|liraglutide|mesh-list
102326355|NCT01917656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102326356|NCT01917656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326357|NCT01917656|Incretins|incretins|mesh-ancestor
102326358|NCT01917656|Hormones|hormones|mesh-ancestor
102326359|NCT01917656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102326360|NCT02018861|Rituximab|rituximab|mesh-list
102326361|NCT02018861|Carboplatin|carboplatin|mesh-list
102326362|NCT02018861|Etoposide|etoposide|mesh-list
102326363|NCT02018861|Ifosfamide|ifosfamide|mesh-list
102326364|NCT02018861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102326365|NCT02018861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102326366|NCT02018861|Immunologic Factors|immunologic factors|mesh-ancestor
102326367|NCT02018861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326368|NCT02018861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102326369|NCT02018861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102326370|NCT02018861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102326371|NCT02018861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102326372|NCT02018861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102326373|NCT02018861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326374|NCT02018861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102326375|NCT02018861|Alkylating Agents|alkylating agents|mesh-ancestor
102326376|NCT02017535|Fluoxetine|fluoxetine|mesh-list
102326377|NCT02017535|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102326378|NCT02017535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102326379|NCT02017535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102326380|NCT02017535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326381|NCT02017535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102326382|NCT02017535|Serotonin Agents|serotonin agents|mesh-ancestor
102326383|NCT02017535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326384|NCT02017535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102326385|NCT02017535|Antidepressive Agents|antidepressive agents|mesh-ancestor
102326386|NCT02017535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102326387|NCT02017535|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102326388|NCT02017535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102326389|NCT02017535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102326390|NCT01944098|Lidocaine|lidocaine|mesh-list
102326392|NCT01944098|Anesthetics|anesthetics|mesh-ancestor
102326393|NCT01944098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102326394|NCT01944098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326395|NCT01944098|Sensory System Agents|sensory system agents|mesh-ancestor
102326396|NCT01944098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102326397|NCT01944098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102326398|NCT01944098|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102326399|NCT01944098|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102326400|NCT01944098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102326401|NCT01944098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326402|NCT01943552|Bromides|bromides|mesh-list
102326403|NCT01943552|Ipratropium|ipratropium|mesh-list
102326404|NCT01943552|Anticonvulsants|anticonvulsants|mesh-ancestor
102326405|NCT01943552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102326406|NCT01943552|Autonomic Agents|autonomic agents|mesh-ancestor
102326407|NCT01943552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102326408|NCT01943552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326409|NCT01943552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102326410|NCT01943552|Respiratory System Agents|respiratory system agents|mesh-ancestor
102326411|NCT01943552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102326412|NCT01943552|Cholinergic Agents|cholinergic agents|mesh-ancestor
102326413|NCT01943552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102326414|NCT01943552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326415|NCT01915940|Timolol|timolol|mesh-list
102326416|NCT01915940|Bimatoprost|bimatoprost|mesh-list
102326417|NCT01915940|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102326418|NCT01915940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102326419|NCT01915940|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102326420|NCT01915940|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102326421|NCT01915940|Adrenergic Agents|adrenergic agents|mesh-ancestor
102326422|NCT01915940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102326423|NCT01915940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326424|NCT01915940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326425|NCT01915940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102326426|NCT01915940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102326427|NCT01914926|Metoprolol|metoprolol|mesh-list
102326428|NCT01914926|Diltiazem|diltiazem|mesh-list
102326429|NCT01914926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102035277|NCT03044886|Vitamin D|vitamin d|mesh-list
102326430|NCT01914926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102326431|NCT01914926|Sympatholytics|sympatholytics|mesh-ancestor
102326432|NCT01914926|Autonomic Agents|autonomic agents|mesh-ancestor
102326433|NCT01914926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102326434|NCT01914926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326435|NCT01914926|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102326436|NCT01914926|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102326437|NCT01914926|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102326438|NCT01914926|Adrenergic Agents|adrenergic agents|mesh-ancestor
102326439|NCT01914926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102326440|NCT01914926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326441|NCT01914926|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102326442|NCT01914926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102326443|NCT01914926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102326444|NCT01914926|Vasodilator Agents|vasodilator agents|mesh-ancestor
102326445|NCT05119166|Niacinamide|niacinamide|mesh-list
102326446|NCT05119166|Niacin|niacin|mesh-list
102326447|NCT05119166|Nicotinic Acids|nicotinic acids|mesh-list
102326448|NCT05119166|Azithromycin|azithromycin|mesh-list
102326449|NCT05119166|Vitamins|vitamins|mesh-ancestor
102326450|NCT05119166|Micronutrients|micronutrients|mesh-ancestor
102326451|NCT05119166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326452|NCT05119166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102326453|NCT05119166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102326454|NCT05119166|Vitamin B Complex|vitamin b complex|mesh-ancestor
102326455|NCT05119166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102326456|NCT05119166|Antimetabolites|antimetabolites|mesh-ancestor
102326457|NCT05119166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326458|NCT05119166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102326459|NCT05119166|Vasodilator Agents|vasodilator agents|mesh-ancestor
102326460|NCT01942148|Aripiprazole|aripiprazole|mesh-list
102326461|NCT01942148|Antidepressive Agents|antidepressive agents|mesh-ancestor
102326462|NCT01942148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102326463|NCT01942148|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102326464|NCT01942148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102326465|NCT01942148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102326466|NCT01942148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326467|NCT01942148|Dopamine Agonists|dopamine agonists|mesh-ancestor
102326468|NCT01942148|Dopamine Agents|dopamine agents|mesh-ancestor
102326469|NCT01942148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102326470|NCT01942148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326471|NCT01942148|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102326472|NCT01942148|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102326473|NCT01942148|Serotonin Agents|serotonin agents|mesh-ancestor
102326474|NCT01942148|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102326475|NCT01942148|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102326476|NCT01942148|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102326477|NCT01942148|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102326478|NCT02030015|Miglustat|miglustat|mesh-list
102326479|NCT02030015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102326480|NCT02030015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326481|NCT02030015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102326482|NCT02030015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102326483|NCT02030015|Antiviral Agents|antiviral agents|mesh-ancestor
102326484|NCT02030015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102326485|NCT02030015|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102326486|NCT02030015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102326487|NCT02030015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326488|NCT02029235|Acetaminophen|acetaminophen|mesh-list
102326489|NCT02029235|Ibuprofen|ibuprofen|mesh-list
102326490|NCT02029235|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
102326491|NCT02029235|Hydrocodone|hydrocodone|mesh-list
102326492|NCT02029235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102326493|NCT02029235|Analgesics|analgesics|mesh-ancestor
102326494|NCT02029235|Sensory System Agents|sensory system agents|mesh-ancestor
102326495|NCT02029235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102326496|NCT02029235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326497|NCT02029235|Antipyretics|antipyretics|mesh-ancestor
102326498|NCT02029235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102326499|NCT02029235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102326500|NCT02029235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102326501|NCT02029235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102326502|NCT02029235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102326503|NCT02029235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326504|NCT02029235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102326505|NCT02029235|Narcotics|narcotics|mesh-ancestor
102326506|NCT02029235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102326507|NCT02029235|Antitussive Agents|antitussive agents|mesh-ancestor
102326508|NCT02029235|Respiratory System Agents|respiratory system agents|mesh-ancestor
102326509|NCT01617434|Liraglutide|liraglutide|mesh-list
102326510|NCT01617434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102326511|NCT01617434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326512|NCT01617434|Incretins|incretins|mesh-ancestor
102326514|NCT01617434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102326515|NCT01940900|Ranibizumab|ranibizumab|mesh-list
102326516|NCT01940900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102326517|NCT01940900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102326518|NCT01940900|Growth Substances|growth substances|mesh-ancestor
102326519|NCT01940900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326520|NCT01940900|Growth Inhibitors|growth inhibitors|mesh-ancestor
102326521|NCT01940900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102326522|NCT01911260|Chelating Agents|chelating agents|mesh-list
102326523|NCT01911260|Sequestering Agents|sequestering agents|mesh-ancestor
102326524|NCT01911260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326525|NCT02015819|Leucovorin|leucovorin|mesh-list
102326526|NCT02015819|Flucytosine|flucytosine|mesh-list
102326527|NCT02015819|Calcium|calcium|mesh-list
102326528|NCT02015819|Levoleucovorin|levoleucovorin|mesh-list
102326529|NCT02015819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102326530|NCT02015819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326531|NCT02015819|Antidotes|antidotes|mesh-ancestor
102326532|NCT02015819|Protective Agents|protective agents|mesh-ancestor
102326533|NCT02015819|Vitamin B Complex|vitamin b complex|mesh-ancestor
102326534|NCT02015819|Vitamins|vitamins|mesh-ancestor
102326535|NCT02015819|Micronutrients|micronutrients|mesh-ancestor
102326536|NCT02015819|Antifungal Agents|antifungal agents|mesh-ancestor
102326537|NCT02015819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102326538|NCT02015819|Antimetabolites|antimetabolites|mesh-ancestor
102326539|NCT02015819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326540|NCT01939496|Canagliflozin|canagliflozin|mesh-list
102326541|NCT01939496|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102326542|NCT01939496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326543|NCT01939496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102326544|NCT01939496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326545|NCT01939028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102326546|NCT01938716|Gemcitabine|gemcitabine|mesh-list
102326547|NCT01938716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102326548|NCT01938716|Antimetabolites|antimetabolites|mesh-ancestor
102326549|NCT01938716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326550|NCT01938716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102326551|NCT01937390|Bromides|bromides|mesh-list
102326552|NCT01937390|Tiotropium Bromide|tiotropium bromide|mesh-list
102326553|NCT01937390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102326554|NCT01937390|Autonomic Agents|autonomic agents|mesh-ancestor
102326555|NCT01937390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102326556|NCT01937390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326557|NCT01937390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102326558|NCT01937390|Respiratory System Agents|respiratory system agents|mesh-ancestor
102326559|NCT01937390|Parasympatholytics|parasympatholytics|mesh-ancestor
102326560|NCT01937390|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102326561|NCT01937390|Cholinergic Agents|cholinergic agents|mesh-ancestor
102326562|NCT01937390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102326563|NCT01937390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326564|NCT01937390|Anticonvulsants|anticonvulsants|mesh-ancestor
102326565|NCT02028767|Metformin|metformin|mesh-list
102326566|NCT02028767|Empagliflozin|empagliflozin|mesh-list
102326567|NCT02028767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102326568|NCT02028767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326569|NCT02028767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102326570|NCT02028767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326571|NCT04683965|Bevacizumab|bevacizumab|mesh-list
102326572|NCT04683965|Pemetrexed|pemetrexed|mesh-list
102326573|NCT04683965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102326574|NCT04683965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102326575|NCT04683965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102326576|NCT04683965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102326577|NCT04683965|Growth Substances|growth substances|mesh-ancestor
102326578|NCT04683965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035402|NCT05205525|Antitubercular Agents|antitubercular agents|mesh-ancestor
102326579|NCT04683965|Growth Inhibitors|growth inhibitors|mesh-ancestor
102326580|NCT04683965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102326581|NCT04683965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326582|NCT04683965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102326583|NCT04683965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102326584|NCT02015195|Ethanol|ethanol|mesh-list
102326585|NCT02015195|Acetic Acid|acetic acid|mesh-list
102326586|NCT02015195|Retinol acetate|retinol acetate|mesh-list
102326587|NCT02015195|Lidocaine|lidocaine|mesh-list
102326588|NCT02015195|Anesthetics, Local|anesthetics, local|mesh-ancestor
102326589|NCT02015195|Anesthetics|anesthetics|mesh-ancestor
102326590|NCT02015195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102326591|NCT02015195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326592|NCT02015195|Sensory System Agents|sensory system agents|mesh-ancestor
102326593|NCT02015195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102326594|NCT02015195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102326595|NCT02015195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102326596|NCT02015195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102326597|NCT02015195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102326598|NCT02015195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326599|NCT02015195|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102326600|NCT02015195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102326601|NCT02015195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102326602|NCT02015195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102326603|NCT02015195|Immunologic Factors|immunologic factors|mesh-ancestor
102326604|NCT02015195|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102326605|NCT02015195|Protective Agents|protective agents|mesh-ancestor
102326606|NCT02015195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102326607|NCT02025725|Metoclopramide|metoclopramide|mesh-list
102326608|NCT02025725|Antiemetics|antiemetics|mesh-ancestor
102326609|NCT02025725|Autonomic Agents|autonomic agents|mesh-ancestor
102326610|NCT02025725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102326611|NCT02025725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326612|NCT02025725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102326613|NCT02025725|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102326614|NCT02025725|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102326615|NCT02025725|Dopamine Agents|dopamine agents|mesh-ancestor
102326616|NCT02025725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102326617|NCT02025725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326618|NCT02025179|Teriparatide|teriparatide|mesh-list
102326619|NCT02025179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102326620|NCT02025179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326621|NCT02025179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102326622|NCT02013791|Cyclosporine|cyclosporine|mesh-list
102326623|NCT02013791|Cyclosporins|cyclosporins|mesh-list
102326624|NCT02013791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102326625|NCT02013791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326626|NCT02013791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102326627|NCT02013791|Immunologic Factors|immunologic factors|mesh-ancestor
102326628|NCT02013791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326629|NCT02013791|Antifungal Agents|antifungal agents|mesh-ancestor
102326630|NCT02013791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102326631|NCT02013791|Dermatologic Agents|dermatologic agents|mesh-ancestor
102326632|NCT02013791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102326633|NCT02013791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102326634|NCT02024867|Trimethoprim|trimethoprim|mesh-list
102326635|NCT02024867|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102326636|NCT02024867|Sulfamethoxazole|sulfamethoxazole|mesh-list
102326637|NCT02024867|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102326638|NCT02024867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102326639|NCT02024867|Antimalarials|antimalarials|mesh-ancestor
102326640|NCT02024867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102326641|NCT02024867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102326642|NCT02024867|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102326643|NCT02024867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102326644|NCT02024867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326645|NCT02024867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102326646|NCT02024867|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102326647|NCT02024867|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102326648|NCT02024867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102326649|NCT02023697|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
102326650|NCT02023697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102326652|NCT01951417|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102326653|NCT01951417|Dermatologic Agents|dermatologic agents|mesh-ancestor
102326654|NCT01951417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102326655|NCT01951417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102326656|NCT01951417|Analgesics|analgesics|mesh-ancestor
102326657|NCT01951417|Sensory System Agents|sensory system agents|mesh-ancestor
102326658|NCT01951417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102326659|NCT01951417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326660|NCT01951417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102326661|NCT01951417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102326662|NCT02023151|Omalizumab|omalizumab|mesh-list
102326663|NCT02023151|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102326664|NCT02023151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102326665|NCT02023151|Respiratory System Agents|respiratory system agents|mesh-ancestor
102326666|NCT01979185|Simvastatin|simvastatin|mesh-list
102326667|NCT01979185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102326668|NCT01979185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102326669|NCT01979185|Antimetabolites|antimetabolites|mesh-ancestor
102326670|NCT01979185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326671|NCT01979185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102326672|NCT01979185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102326673|NCT01979185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102326674|NCT01946425|Vaccines|vaccines|mesh-list
102326675|NCT01946425|Immunologic Factors|immunologic factors|mesh-ancestor
102326676|NCT01946425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326677|NCT01937312|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102326678|NCT01937312|Travoprost|travoprost|mesh-list
102326679|NCT01937312|Brinzolamide|brinzolamide|mesh-list
102326680|NCT01937312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102326681|NCT01937312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102326682|NCT01937312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102326683|NCT01937312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102326684|NCT01937312|Adrenergic Agents|adrenergic agents|mesh-ancestor
102326685|NCT01937312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102326686|NCT01937312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326687|NCT01937312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326688|NCT01937312|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102326690|NCT01909934|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102326691|NCT01909934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102326692|NCT01909934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102326693|NCT01909934|Immunotoxins|immunotoxins|mesh-ancestor
102326694|NCT01909934|Immunoconjugates|immunoconjugates|mesh-ancestor
102326695|NCT01909934|Immunologic Factors|immunologic factors|mesh-ancestor
102326696|NCT01909934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326697|NCT01935128|Everolimus|everolimus|mesh-list
102326698|NCT01935128|Tacrolimus|tacrolimus|mesh-list
102326699|NCT01935128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102326700|NCT01935128|Immunologic Factors|immunologic factors|mesh-ancestor
102326701|NCT01935128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326702|NCT01935128|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102326703|NCT01935128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102326704|NCT01935128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326705|NCT01935128|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102326706|NCT01935128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102326707|NCT01935128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102326708|NCT01934972|Cycloserine|cycloserine|mesh-list
102326709|NCT01934972|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102326710|NCT01934972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102326711|NCT01934972|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102326712|NCT01934972|Antitubercular Agents|antitubercular agents|mesh-ancestor
102326713|NCT01934972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102326714|NCT01934972|Antimetabolites|antimetabolites|mesh-ancestor
102326715|NCT01934972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326716|NCT01959230|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102326717|NCT01959230|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102326718|NCT01959230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102326719|NCT01959230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102326720|NCT01959230|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102326721|NCT01959230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102326722|NCT01959230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102326723|NCT01959230|Adrenergic Agents|adrenergic agents|mesh-ancestor
102326724|NCT01959230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102326725|NCT01959230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326726|NCT01959230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326727|NCT01977937|Gabapentin|gabapentin|mesh-list
102326728|NCT01977937|Analgesics|analgesics|mesh-ancestor
102326729|NCT01977937|Sensory System Agents|sensory system agents|mesh-ancestor
102326730|NCT01977937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102326731|NCT01977937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326732|NCT01977937|Anticonvulsants|anticonvulsants|mesh-ancestor
102326733|NCT01977937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102326734|NCT01977937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102326735|NCT01977937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102326736|NCT01977937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102326737|NCT01977937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102326738|NCT01977937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102326739|NCT01977937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102326740|NCT01977937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326741|NCT01977937|Antimanic Agents|antimanic agents|mesh-ancestor
102326742|NCT02015663|Tobramycin|tobramycin|mesh-list
102326743|NCT02015663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102326744|NCT02015663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102326745|NCT01978093|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102326746|NCT01978093|Immunologic Factors|immunologic factors|mesh-ancestor
102326747|NCT01978093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326748|NCT01951105|Naproxen|naproxen|mesh-list
102326749|NCT01951105|Levodopa|levodopa|mesh-list
102326750|NCT01951105|Carbidopa|carbidopa|mesh-list
102326751|NCT01951105|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102326752|NCT01951105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102326753|NCT01951105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102326754|NCT01951105|Analgesics|analgesics|mesh-ancestor
102326755|NCT01951105|Sensory System Agents|sensory system agents|mesh-ancestor
102326756|NCT01951105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102326757|NCT01951105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326758|NCT01951105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102326759|NCT01951105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102326760|NCT01951105|Gout Suppressants|gout suppressants|mesh-ancestor
102326761|NCT01951105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102326762|NCT01951105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102326763|NCT01951105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326764|NCT01951105|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102326765|NCT01951105|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102326766|NCT01951105|Dopamine Agents|dopamine agents|mesh-ancestor
102326767|NCT01951105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102326768|NCT01951105|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102326769|NCT01951105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102326770|NCT01951105|Immunologic Factors|immunologic factors|mesh-ancestor
102326771|NCT01951105|Dopamine Agonists|dopamine agonists|mesh-ancestor
102326772|NCT01958918|Ranibizumab|ranibizumab|mesh-list
102326773|NCT01958918|Aflibercept|aflibercept|mesh-list
102326774|NCT01958918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102326775|NCT01958918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102326776|NCT01958918|Growth Substances|growth substances|mesh-ancestor
102326777|NCT01958918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326778|NCT01958918|Growth Inhibitors|growth inhibitors|mesh-ancestor
102326779|NCT01958918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102326780|NCT01945489|Botulinum Toxins|botulinum toxins|mesh-list
102326781|NCT01945489|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102326782|NCT01945489|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102326783|NCT01945489|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102326784|NCT01945489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102326785|NCT01945489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326786|NCT01945489|Cholinergic Agents|cholinergic agents|mesh-ancestor
102326787|NCT01945489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102326788|NCT01945489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326789|NCT01945489|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102326790|NCT01945489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102326791|NCT01934894|Lapatinib|lapatinib|mesh-list
102326792|NCT01934894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102326793|NCT01934894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102326794|NCT01934894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102326795|NCT01934894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326796|NCT01950169|Vitamin D|vitamin d|mesh-list
102326797|NCT01950169|Cholecalciferol|cholecalciferol|mesh-list
102326798|NCT01950169|Risedronic Acid|risedronic acid|mesh-list
102326799|NCT01950169|Diphosphonates|diphosphonates|mesh-list
102326800|NCT01950169|Calcium|calcium|mesh-list
102035631|NCT02959892|Dopamine Agonists|dopamine agonists|mesh-ancestor
102326801|NCT01950169|Vitamins|vitamins|mesh-ancestor
102326802|NCT01950169|Micronutrients|micronutrients|mesh-ancestor
102326803|NCT01950169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326804|NCT01950169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102326805|NCT01950169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102326806|NCT01950169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102326807|NCT01950169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102326808|NCT01950169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326810|NCT01909466|Antidepressive Agents|antidepressive agents|mesh-ancestor
102326811|NCT01909466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102326812|NCT01909466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102326813|NCT01909466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102326814|NCT01909466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102326815|NCT01909466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326816|NCT01909466|Dopamine Agonists|dopamine agonists|mesh-ancestor
102326817|NCT01909466|Dopamine Agents|dopamine agents|mesh-ancestor
102326818|NCT01909466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102326819|NCT01909466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326820|NCT01909466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102326821|NCT01909466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102326822|NCT01909466|Serotonin Agents|serotonin agents|mesh-ancestor
102326823|NCT01909466|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102326824|NCT01909466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102326825|NCT01909466|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102326826|NCT01909466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102326827|NCT01977625|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102326828|NCT01977625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102326829|NCT01977625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326830|NCT01977625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102326831|NCT01977625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102326832|NCT01977625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102326833|NCT01977625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326834|NCT01977625|Dopamine Agents|dopamine agents|mesh-ancestor
102326835|NCT01977625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102326837|NCT01995071|Antimetabolites|antimetabolites|mesh-ancestor
102326838|NCT01995071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326839|NCT01995071|Antiviral Agents|antiviral agents|mesh-ancestor
102326840|NCT01995071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102326841|NCT01994837|Venetoclax|venetoclax|mesh-list
102326842|NCT01994837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102326843|NCT02010593|Dapivirine|dapivirine|mesh-list
102326844|NCT02010593|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102326845|NCT02010593|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102326846|NCT02010593|Antiviral Agents|antiviral agents|mesh-ancestor
102326847|NCT02010593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102326848|NCT01994291|Ranibizumab|ranibizumab|mesh-list
102326849|NCT01994291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102326850|NCT01994291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102326851|NCT01994291|Growth Substances|growth substances|mesh-ancestor
102326852|NCT01994291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326853|NCT01994291|Growth Inhibitors|growth inhibitors|mesh-ancestor
102326854|NCT01994291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102326855|NCT04667039|Ranibizumab|ranibizumab|mesh-list
102326856|NCT04667039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102326857|NCT04667039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102326858|NCT04667039|Growth Substances|growth substances|mesh-ancestor
102326859|NCT04667039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326860|NCT04667039|Growth Inhibitors|growth inhibitors|mesh-ancestor
102326861|NCT04667039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102326862|NCT01993823|Clotrimazole|clotrimazole|mesh-list
102326863|NCT01993823|Miconazole|miconazole|mesh-list
102326864|NCT01993823|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102326865|NCT01993823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102326866|NCT01993823|Antifungal Agents|antifungal agents|mesh-ancestor
102326867|NCT01993823|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102326868|NCT01993823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102326869|NCT01993823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102326870|NCT01993823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326871|NCT01993823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102326872|NCT01993823|Hormone Antagonists|hormone antagonists|mesh-ancestor
102326873|NCT01993823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102326874|NCT01993823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326875|NCT01993823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102326876|NCT01993823|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102326877|NCT01993667|Acetazolamide|acetazolamide|mesh-list
102326878|NCT01993667|Anticonvulsants|anticonvulsants|mesh-ancestor
102326879|NCT01993667|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102326880|NCT01993667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102326881|NCT01993667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326882|NCT01993667|Diuretics|diuretics|mesh-ancestor
102326883|NCT01993667|Natriuretic Agents|natriuretic agents|mesh-ancestor
102326884|NCT01993667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326885|NCT01934192|Metoclopramide|metoclopramide|mesh-list
102326886|NCT01934192|Antiemetics|antiemetics|mesh-ancestor
102326887|NCT01934192|Autonomic Agents|autonomic agents|mesh-ancestor
102326888|NCT01934192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102326889|NCT01934192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326890|NCT01934192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102326891|NCT01934192|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102326892|NCT01934192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102326893|NCT01934192|Dopamine Agents|dopamine agents|mesh-ancestor
102326894|NCT01934192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102326895|NCT01934192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326896|NCT01933880|Methylphenidate|methylphenidate|mesh-list
102326897|NCT01933880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102326898|NCT01933880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326899|NCT01933880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102326900|NCT01933880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102326901|NCT01933880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102326902|NCT01933880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326903|NCT01933880|Dopamine Agents|dopamine agents|mesh-ancestor
102326904|NCT01933880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102326905|NCT02008877|Sirolimus|sirolimus|mesh-list
102326906|NCT02008877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102326907|NCT02008877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102326908|NCT02008877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102326909|NCT02008877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102326910|NCT02008877|Antifungal Agents|antifungal agents|mesh-ancestor
102326911|NCT02008877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102326912|NCT02008877|Immunologic Factors|immunologic factors|mesh-ancestor
102326913|NCT02008877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326914|NCT01933334|Pirfenidone|pirfenidone|mesh-list
102326915|NCT01933334|Analgesics|analgesics|mesh-ancestor
102326916|NCT01933334|Sensory System Agents|sensory system agents|mesh-ancestor
102326917|NCT01933334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102326918|NCT01933334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326919|NCT01933334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102326920|NCT01933334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102326921|NCT01933334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102326922|NCT01933334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102326923|NCT01933334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102326924|NCT01908140|Fluticasone|fluticasone|mesh-list
102326925|NCT01908140|Bromides|bromides|mesh-list
102326926|NCT01908140|Formoterol Fumarate|formoterol fumarate|mesh-list
102326927|NCT01908140|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102326928|NCT01908140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102326929|NCT01908140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102326930|NCT01908140|Autonomic Agents|autonomic agents|mesh-ancestor
102326931|NCT01908140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102326932|NCT01908140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326933|NCT01908140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102326934|NCT01908140|Respiratory System Agents|respiratory system agents|mesh-ancestor
102326935|NCT01908140|Dermatologic Agents|dermatologic agents|mesh-ancestor
102326936|NCT01908140|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102326937|NCT01908140|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102326938|NCT01908140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102326939|NCT01908140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102326940|NCT01908140|Adrenergic Agents|adrenergic agents|mesh-ancestor
102326941|NCT01908140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102326942|NCT01908140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326943|NCT01908140|Anticonvulsants|anticonvulsants|mesh-ancestor
102326944|NCT02008565|Loperamide|loperamide|mesh-list
102326945|NCT02008565|Antidiarrheals|antidiarrheals|mesh-list
102326946|NCT02008565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102326947|NCT01931150|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102035778|NCT05627466|Magrolimab|magrolimab|mesh-list
102326948|NCT01931150|Dapsone|dapsone|mesh-list
102326949|NCT01931150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102326950|NCT01931150|Antimalarials|antimalarials|mesh-ancestor
102326951|NCT01931150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102326952|NCT01931150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102326953|NCT01931150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102326954|NCT01931150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102326955|NCT01931150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326956|NCT01931150|Leprostatic Agents|leprostatic agents|mesh-ancestor
102326958|NCT01906346|Anesthetics, Local|anesthetics, local|mesh-ancestor
102326959|NCT01906346|Anesthetics|anesthetics|mesh-ancestor
102326960|NCT01906346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102326961|NCT01906346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326962|NCT01906346|Sensory System Agents|sensory system agents|mesh-ancestor
102326963|NCT01906346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102326964|NCT01906346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102326965|NCT01906346|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102326966|NCT01906346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102326967|NCT01906346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102326968|NCT01906346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326969|NCT01906346|Dopamine Agents|dopamine agents|mesh-ancestor
102326970|NCT01906346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102326971|NCT04645004|Aspirin|aspirin|mesh-list
102326972|NCT04645004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102326973|NCT04645004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102326974|NCT04645004|Analgesics|analgesics|mesh-ancestor
102326975|NCT04645004|Sensory System Agents|sensory system agents|mesh-ancestor
102326976|NCT04645004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102326977|NCT04645004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326978|NCT04645004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102326979|NCT04645004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102326980|NCT04645004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102326981|NCT04645004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102326982|NCT04645004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102326983|NCT04645004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102326984|NCT04645004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102326985|NCT04645004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102326986|NCT04645004|Antipyretics|antipyretics|mesh-ancestor
102326987|NCT01929980|Bortezomib|bortezomib|mesh-list
102326988|NCT01929980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102326989|NCT01363076|Ketorolac|ketorolac|mesh-list
102326990|NCT01363076|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102326991|NCT01363076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102326992|NCT01363076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102326993|NCT01363076|Analgesics|analgesics|mesh-ancestor
102326994|NCT01363076|Sensory System Agents|sensory system agents|mesh-ancestor
102326995|NCT01363076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102326996|NCT01363076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102326997|NCT01363076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102326998|NCT01363076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102326999|NCT01363076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102327000|NCT01363076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102327001|NCT01363076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327002|NCT01929044|Anisodamine|anisodamine|mesh-list
102327003|NCT01929044|Scopolamine|scopolamine|mesh-list
102327004|NCT01929044|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102327005|NCT01929044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102327006|NCT01929044|Antiemetics|antiemetics|mesh-ancestor
102327007|NCT01929044|Autonomic Agents|autonomic agents|mesh-ancestor
102327008|NCT01929044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102327009|NCT01929044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327010|NCT01929044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102327011|NCT01929044|Mydriatics|mydriatics|mesh-ancestor
102327012|NCT01929044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102327013|NCT01929044|Cholinergic Agents|cholinergic agents|mesh-ancestor
102327014|NCT01929044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102327015|NCT01929044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327016|NCT01929044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102327017|NCT01929044|Parasympatholytics|parasympatholytics|mesh-ancestor
102327018|NCT01929044|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102327019|NCT01929044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102327020|NCT01929044|Adrenergic Agents|adrenergic agents|mesh-ancestor
102327021|NCT01929044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102327022|NCT01929044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102327023|NCT01929044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102327024|NCT01929044|Analgesics|analgesics|mesh-ancestor
102327025|NCT01929044|Sensory System Agents|sensory system agents|mesh-ancestor
102327026|NCT01929044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102327027|NCT01929044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102327028|NCT01929044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102327029|NCT01929044|Vasodilator Agents|vasodilator agents|mesh-ancestor
102327030|NCT01929044|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102327031|NCT01929044|Antioxidants|antioxidants|mesh-ancestor
102327032|NCT01929044|Protective Agents|protective agents|mesh-ancestor
102327033|NCT01957202|Levocabastine|levocabastine|mesh-list
102327034|NCT01957202|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102327035|NCT01957202|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102327036|NCT01957202|Histamine Antagonists|histamine antagonists|mesh-ancestor
102327037|NCT01957202|Histamine Agents|histamine agents|mesh-ancestor
102327038|NCT01957202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102327039|NCT01957202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327040|NCT01957202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327041|NCT01616654|Tazarotene|tazarotene|mesh-list
102327042|NCT01616654|Trifarotene|trifarotene|mesh-list
102327043|NCT01616654|Dermatologic Agents|dermatologic agents|mesh-ancestor
102327044|NCT01616654|Keratolytic Agents|keratolytic agents|mesh-ancestor
102327045|NCT01902290|Brodalumab|brodalumab|mesh-list
102327046|NCT01902290|Dermatologic Agents|dermatologic agents|mesh-ancestor
102327047|NCT01467466|Acetylcysteine|acetylcysteine|mesh-list
102327048|NCT01467466|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102327049|NCT01467466|Antiviral Agents|antiviral agents|mesh-ancestor
102327050|NCT01467466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102327051|NCT01467466|Expectorants|expectorants|mesh-ancestor
102327052|NCT01467466|Respiratory System Agents|respiratory system agents|mesh-ancestor
102327053|NCT01467466|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102327054|NCT01467466|Antioxidants|antioxidants|mesh-ancestor
102327055|NCT01467466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327056|NCT01467466|Protective Agents|protective agents|mesh-ancestor
102327057|NCT01467466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327058|NCT01467466|Antidotes|antidotes|mesh-ancestor
102327059|NCT01441180|Sofosbuvir|sofosbuvir|mesh-list
102327060|NCT01441180|Ribavirin|ribavirin|mesh-list
102327061|NCT01441180|Antiviral Agents|antiviral agents|mesh-ancestor
102327062|NCT01441180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102327063|NCT01441180|Antimetabolites|antimetabolites|mesh-ancestor
102327064|NCT01441180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327065|NCT01441102|Dextromethorphan|dextromethorphan|mesh-list
102327066|NCT01441102|Antitussive Agents|antitussive agents|mesh-ancestor
102327067|NCT01441102|Respiratory System Agents|respiratory system agents|mesh-ancestor
102327068|NCT01441102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102327069|NCT01441102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102327070|NCT01441102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102327071|NCT01441102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327072|NCT01441102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327073|NCT04061980|Nivolumab|nivolumab|mesh-list
102327074|NCT04061980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102327075|NCT04061980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102327076|NCT04061980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102327077|NCT04061980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327078|NCT01467076|Alprostadil|alprostadil|mesh-list
102327079|NCT01467076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102327080|NCT01467076|Vasodilator Agents|vasodilator agents|mesh-ancestor
102327081|NCT01467076|Urological Agents|urological agents|mesh-ancestor
102327082|NCT01466062|Palivizumab|palivizumab|mesh-list
102327083|NCT01466062|Antiviral Agents|antiviral agents|mesh-ancestor
102327084|NCT01466062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102327085|NCT04504864|Aspirin|aspirin|mesh-list
102327086|NCT04504864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102327087|NCT04504864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102327088|NCT04504864|Analgesics|analgesics|mesh-ancestor
102327089|NCT04504864|Sensory System Agents|sensory system agents|mesh-ancestor
102327090|NCT04504864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102327091|NCT04504864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327092|NCT04504864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102327093|NCT04504864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102327094|NCT04504864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102327095|NCT04504864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102327096|NCT04504864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035929|NCT05176925|Tislelizumab|tislelizumab|mesh-list
102327097|NCT04504864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102327098|NCT04504864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102327099|NCT04504864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102327100|NCT04504864|Antipyretics|antipyretics|mesh-ancestor
102327101|NCT04060342|Paclitaxel|paclitaxel|mesh-list
102327102|NCT04060342|Gemcitabine|gemcitabine|mesh-list
102327103|NCT04060342|Pembrolizumab|pembrolizumab|mesh-list
102327104|NCT04060342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102327105|NCT04060342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102327106|NCT04060342|Tubulin Modulators|tubulin modulators|mesh-ancestor
102327107|NCT04060342|Antimitotic Agents|antimitotic agents|mesh-ancestor
102327108|NCT04060342|Mitosis Modulators|mitosis modulators|mesh-ancestor
102327109|NCT04060342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327110|NCT04060342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102327111|NCT04060342|Antimetabolites|antimetabolites|mesh-ancestor
102327112|NCT04060342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101441025|NCT03159702|Alkylating Agents|alkylating agents|mesh-ancestor
102327113|NCT04060342|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102327114|NCT01435018|Tenofovir|tenofovir|mesh-list
102327115|NCT01435018|Emtricitabine|emtricitabine|mesh-list
102327116|NCT01435018|Efavirenz|efavirenz|mesh-list
102327117|NCT01435018|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102327118|NCT01435018|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102327119|NCT01435018|Paclitaxel|paclitaxel|mesh-list
102327120|NCT01435018|Etoposide|etoposide|mesh-list
102327121|NCT01435018|Vincristine|vincristine|mesh-list
102327122|NCT01435018|Bleomycin|bleomycin|mesh-list
102327123|NCT01435018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102327124|NCT01435018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102327125|NCT01435018|Tubulin Modulators|tubulin modulators|mesh-ancestor
102327126|NCT01435018|Antimitotic Agents|antimitotic agents|mesh-ancestor
102327127|NCT01435018|Mitosis Modulators|mitosis modulators|mesh-ancestor
102327128|NCT01435018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327129|NCT01435018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102327130|NCT01435018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102327131|NCT01435018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102327132|NCT01435018|Antiviral Agents|antiviral agents|mesh-ancestor
102327133|NCT01435018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102327134|NCT01435018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102327135|NCT01435018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102327136|NCT01435018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102327137|NCT01435018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102327138|NCT01435018|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102327139|NCT01435018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102327140|NCT01435018|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102327141|NCT01435018|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102327142|NCT01435018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102327143|NCT01435018|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102327144|NCT01435018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102327145|NCT01419184|Vancomycin|vancomycin|mesh-list
102327146|NCT01419184|Daptomycin|daptomycin|mesh-list
102327147|NCT01419184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102327148|NCT01419184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102327149|NCT01417156|Nintedanib|nintedanib|mesh-list
101441039|NCT02985957|Prednisone|prednisone|mesh-list
102327150|NCT01417156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102327151|NCT01417156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102327152|NCT01417156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102327153|NCT01417156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327154|NCT01417078|Diazepam|diazepam|mesh-list
102327155|NCT01417078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102327156|NCT01417078|Anticonvulsants|anticonvulsants|mesh-ancestor
102327157|NCT01417078|Antiemetics|antiemetics|mesh-ancestor
102327158|NCT01417078|Autonomic Agents|autonomic agents|mesh-ancestor
102327159|NCT01417078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102327160|NCT01417078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327161|NCT01417078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102327162|NCT01417078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102327163|NCT01417078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102327164|NCT01417078|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102327165|NCT01417078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102327166|NCT01417078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102327167|NCT01417078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102327168|NCT01417078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102327169|NCT01417078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102327170|NCT01417078|Anesthetics, General|anesthetics, general|mesh-ancestor
102327171|NCT01417078|Anesthetics|anesthetics|mesh-ancestor
102327172|NCT01417078|GABA Modulators|gaba modulators|mesh-ancestor
102327173|NCT01417078|GABA Agents|gaba agents|mesh-ancestor
102327174|NCT01417078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102327175|NCT01417078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327176|NCT01954394|Alirocumab|alirocumab|mesh-list
102327177|NCT01954394|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102327178|NCT01954394|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102327179|NCT01954394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102327180|NCT01954394|Antimetabolites|antimetabolites|mesh-ancestor
102327181|NCT01954394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327182|NCT01954394|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102327183|NCT01954394|Protease Inhibitors|protease inhibitors|mesh-ancestor
102327184|NCT01954394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102327185|NCT01954394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102327186|NCT01464424|Bimatoprost|bimatoprost|mesh-list
102327187|NCT01464424|Travoprost|travoprost|mesh-list
102327188|NCT01464424|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102327189|NCT01464424|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102327190|NCT01464424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102327191|NCT01902134|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
102327192|NCT01902134|Tramadol|tramadol|mesh-list
102327193|NCT01902134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102327194|NCT01902134|Narcotics|narcotics|mesh-ancestor
102327195|NCT01902134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102327196|NCT01902134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327197|NCT01902134|Analgesics|analgesics|mesh-ancestor
102327198|NCT01902134|Sensory System Agents|sensory system agents|mesh-ancestor
102327199|NCT01902134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102327200|NCT01902134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102327201|NCT01902134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102327202|NCT01902134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102327203|NCT01902134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102327204|NCT01954082|Inositol|inositol|mesh-list
102327205|NCT01954082|Vitamin B Complex|vitamin b complex|mesh-ancestor
102327206|NCT01954082|Vitamins|vitamins|mesh-ancestor
102327207|NCT01954082|Micronutrients|micronutrients|mesh-ancestor
102327208|NCT01954082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327209|NCT01417000|Cyclophosphamide|cyclophosphamide|mesh-list
102327210|NCT01417000|Pancrelipase|pancrelipase|mesh-list
102327211|NCT01417000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102327212|NCT01417000|Immunologic Factors|immunologic factors|mesh-ancestor
102327213|NCT01417000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327214|NCT01417000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102327215|NCT01417000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102327216|NCT01417000|Alkylating Agents|alkylating agents|mesh-ancestor
102327217|NCT01417000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327218|NCT01417000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102327219|NCT01417000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102327220|NCT01417000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102327222|NCT01415986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102327223|NCT01415986|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102327224|NCT01415986|Dermatologic Agents|dermatologic agents|mesh-ancestor
102327225|NCT01415518|Budesonide|budesonide|mesh-list
102327226|NCT01415518|Theophylline|theophylline|mesh-list
102327227|NCT01415518|Formoterol Fumarate|formoterol fumarate|mesh-list
102327228|NCT01415518|Ipratropium|ipratropium|mesh-list
102327229|NCT01415518|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
102327230|NCT01415518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102327231|NCT01415518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102327232|NCT01415518|Autonomic Agents|autonomic agents|mesh-ancestor
102327233|NCT01415518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102327234|NCT01415518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327235|NCT01415518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102327236|NCT01415518|Respiratory System Agents|respiratory system agents|mesh-ancestor
102327237|NCT01415518|Glucocorticoids|glucocorticoids|mesh-ancestor
102327238|NCT01415518|Hormones|hormones|mesh-ancestor
102327239|NCT01415518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102327240|NCT01415518|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102327241|NCT01415518|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102327242|NCT01415518|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102327243|NCT01415518|Adrenergic Agents|adrenergic agents|mesh-ancestor
102327244|NCT01415518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102327245|NCT01415518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327246|NCT01415518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102327247|NCT01415518|Cholinergic Agents|cholinergic agents|mesh-ancestor
102327248|NCT01415518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102327249|NCT01415518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102327250|NCT01415518|Vasodilator Agents|vasodilator agents|mesh-ancestor
102327251|NCT01415518|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102327252|NCT01415518|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102327253|NCT01415518|Purinergic Agents|purinergic agents|mesh-ancestor
102327254|NCT01393600|Tetrabenazine|tetrabenazine|mesh-list
102327255|NCT01393600|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102327256|NCT01393600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102327257|NCT01393600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102327258|NCT01393600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327259|NCT01393600|Adrenergic Agents|adrenergic agents|mesh-ancestor
102327260|NCT01393600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102327261|NCT01393600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327262|NCT04767178|Acetaminophen|acetaminophen|mesh-list
102327263|NCT04767178|Ibuprofen|ibuprofen|mesh-list
102327264|NCT04767178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102327265|NCT04767178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102327266|NCT04767178|Analgesics|analgesics|mesh-ancestor
102327267|NCT04767178|Sensory System Agents|sensory system agents|mesh-ancestor
102327268|NCT04767178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102327269|NCT04767178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327270|NCT04767178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102327271|NCT04767178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102327272|NCT04767178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102327273|NCT04767178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102327274|NCT04767178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327275|NCT04767178|Antipyretics|antipyretics|mesh-ancestor
102327276|NCT01432600|Dexamethasone|dexamethasone|mesh-list
102327277|NCT01432600|Cyclophosphamide|cyclophosphamide|mesh-list
102327278|NCT01432600|Pomalidomide|pomalidomide|mesh-list
102327279|NCT01432600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102327280|NCT01432600|Immunologic Factors|immunologic factors|mesh-ancestor
102327281|NCT01432600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327282|NCT01432600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102327283|NCT01432600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102327284|NCT01432600|Alkylating Agents|alkylating agents|mesh-ancestor
102327285|NCT01432600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327286|NCT01432600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102327287|NCT01432600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102327288|NCT01432600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102327290|NCT01432600|Autonomic Agents|autonomic agents|mesh-ancestor
102327291|NCT01432600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102327292|NCT01432600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102327293|NCT01432600|Glucocorticoids|glucocorticoids|mesh-ancestor
102327294|NCT01432600|Hormones|hormones|mesh-ancestor
102327295|NCT01432600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102327296|NCT01432600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102327297|NCT01432600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102327298|NCT01432600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102327299|NCT01432600|Growth Substances|growth substances|mesh-ancestor
102327300|NCT01432600|Growth Inhibitors|growth inhibitors|mesh-ancestor
102327301|NCT01432444|Aripiprazole|aripiprazole|mesh-list
102327302|NCT01432444|Antidepressive Agents|antidepressive agents|mesh-ancestor
102327303|NCT01432444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102327304|NCT01432444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102327305|NCT01432444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102327306|NCT01432444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102327307|NCT01432444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327308|NCT01432444|Dopamine Agonists|dopamine agonists|mesh-ancestor
102327309|NCT01432444|Dopamine Agents|dopamine agents|mesh-ancestor
102327310|NCT01432444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102327311|NCT01432444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327312|NCT01432444|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102327313|NCT01432444|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102327314|NCT01432444|Serotonin Agents|serotonin agents|mesh-ancestor
102327315|NCT01432444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102327316|NCT01432444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102327317|NCT01432444|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102327318|NCT01432444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102327319|NCT01415440|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102327320|NCT01415440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102327321|NCT01415440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327322|NCT01415440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102327323|NCT01415440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102327324|NCT01415440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102327325|NCT01415440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327326|NCT01415440|Dopamine Agents|dopamine agents|mesh-ancestor
102327327|NCT01415440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102327329|NCT01932788|Cholecalciferol|cholecalciferol|mesh-list
102327330|NCT01932788|Vitamins|vitamins|mesh-list
102327331|NCT01932788|Micronutrients|micronutrients|mesh-ancestor
101441104|NCT02609776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102327332|NCT01932788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327333|NCT01932788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102327334|NCT01932788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102327335|NCT01431976|Lamotrigine|lamotrigine|mesh-list
102327336|NCT01431976|Anticonvulsants|anticonvulsants|mesh-ancestor
102327337|NCT01431976|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102327338|NCT01431976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102327339|NCT01431976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327340|NCT01431976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102327341|NCT01431976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327342|NCT01431976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102327343|NCT01431976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102327344|NCT01431976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102327345|NCT01431976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102327346|NCT01431976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102327347|NCT01413958|Loratadine|loratadine|mesh-list
102327348|NCT01413958|Phenylephrine|phenylephrine|mesh-list
102327349|NCT01413958|Oxymetazoline|oxymetazoline|mesh-list
102327350|NCT01413958|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102327351|NCT01413958|Mydriatics|mydriatics|mesh-ancestor
102327352|NCT01413958|Autonomic Agents|autonomic agents|mesh-ancestor
102327353|NCT01413958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102327354|NCT01413958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327355|NCT01413958|Sympathomimetics|sympathomimetics|mesh-ancestor
102327356|NCT01413958|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102327357|NCT01413958|Nasal Decongestants|nasal decongestants|mesh-ancestor
102327358|NCT01413958|Respiratory System Agents|respiratory system agents|mesh-ancestor
102327359|NCT01413958|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102327360|NCT01413958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102327361|NCT01413958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102327362|NCT01413958|Adrenergic Agents|adrenergic agents|mesh-ancestor
102327363|NCT01413958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102327364|NCT01413958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327365|NCT01413958|Protective Agents|protective agents|mesh-ancestor
102327366|NCT01413958|Antipruritics|antipruritics|mesh-ancestor
102327367|NCT01413958|Dermatologic Agents|dermatologic agents|mesh-ancestor
102327368|NCT01413958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102327369|NCT01413958|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102327370|NCT01413958|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102327371|NCT01413958|Histamine Antagonists|histamine antagonists|mesh-ancestor
102327372|NCT01413958|Histamine Agents|histamine agents|mesh-ancestor
102327373|NCT01413178|Melphalan|melphalan|mesh-list
102327374|NCT01413178|Busulfan|busulfan|mesh-list
102327375|NCT01413178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102327376|NCT01413178|Alkylating Agents|alkylating agents|mesh-ancestor
102327377|NCT01413178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327378|NCT01413178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102327379|NCT01413178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102327380|NCT01413178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102327381|NCT01413178|Immunologic Factors|immunologic factors|mesh-ancestor
102327382|NCT01413178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327383|NCT01412944|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102327384|NCT01412944|Immunologic Factors|immunologic factors|mesh-ancestor
101441128|NCT02465060|Relatlimab|relatlimab|mesh-list
102327385|NCT01412944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327386|NCT03025906|Valproic Acid|valproic acid|mesh-list
102327387|NCT03025906|Phenobarbital|phenobarbital|mesh-list
102327388|NCT03025906|Anticonvulsants|anticonvulsants|mesh-ancestor
102327389|NCT03025906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102327390|NCT03025906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327391|NCT03025906|GABA Agents|gaba agents|mesh-ancestor
102327392|NCT03025906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102327393|NCT03025906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327394|NCT03025906|Antimanic Agents|antimanic agents|mesh-ancestor
102327395|NCT03025906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102327396|NCT03025906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102036229|NCT03629873|Cytarabine|cytarabine|mesh-list
102327397|NCT03025906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102327398|NCT03025906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102327399|NCT03025906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102327400|NCT03025906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102327401|NCT03025906|GABA Modulators|gaba modulators|mesh-ancestor
102327402|NCT03025906|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102327403|NCT03025906|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102327404|NCT03025906|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102327405|NCT04053712|Glucagon|glucagon|mesh-list
102327406|NCT04053712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102327407|NCT04053712|Hormones|hormones|mesh-ancestor
102327408|NCT04053712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102327409|NCT04053712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327410|NCT01798485|Docetaxel|docetaxel|mesh-list
102327411|NCT01798485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102327412|NCT01798485|Tubulin Modulators|tubulin modulators|mesh-ancestor
102327413|NCT01798485|Antimitotic Agents|antimitotic agents|mesh-ancestor
102327414|NCT01798485|Mitosis Modulators|mitosis modulators|mesh-ancestor
102327415|NCT01798485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327416|NCT01767519|Solifenacin Succinate|solifenacin succinate|mesh-list
102327417|NCT01767519|Botulinum Toxins|botulinum toxins|mesh-list
102327418|NCT01767519|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102327419|NCT01767519|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102327420|NCT01767519|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102327421|NCT01767519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102327422|NCT01767519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327423|NCT01767519|Cholinergic Agents|cholinergic agents|mesh-ancestor
102327424|NCT01767519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102327425|NCT01767519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327426|NCT01767519|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102327427|NCT01767519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102327428|NCT01767519|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102327429|NCT01767519|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102327430|NCT01767519|Urological Agents|urological agents|mesh-ancestor
102327431|NCT01797081|Botulinum Toxins|botulinum toxins|mesh-list
102327432|NCT01797081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102327433|NCT01797081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102327434|NCT01797081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102327435|NCT01797081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102327436|NCT01797081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327437|NCT01797081|Cholinergic Agents|cholinergic agents|mesh-ancestor
102327438|NCT01797081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102327439|NCT01797081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327440|NCT01797081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102327441|NCT01797081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102327442|NCT01794117|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102327443|NCT01794117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102327444|NCT01765569|Vemurafenib|vemurafenib|mesh-list
102327445|NCT01765569|Digoxin|digoxin|mesh-list
102327446|NCT01765569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102327447|NCT01765569|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102327448|NCT01765569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102327449|NCT01765569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327450|NCT01765569|Protective Agents|protective agents|mesh-ancestor
102327451|NCT01765569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327452|NCT01765569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102327453|NCT01765569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102327454|NCT04414605|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102327455|NCT04414605|Immunologic Factors|immunologic factors|mesh-ancestor
102327456|NCT04414605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327457|NCT01609023|Rituximab|rituximab|mesh-list
102327458|NCT01609023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102327459|NCT01609023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102327460|NCT01609023|Immunologic Factors|immunologic factors|mesh-ancestor
102327461|NCT01609023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327462|NCT01609023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102327463|NCT01765179|Methyltestosterone|methyltestosterone|mesh-list
102327464|NCT01765179|Testosterone|testosterone|mesh-list
102327465|NCT01765179|Testosterone undecanoate|testosterone undecanoate|mesh-list
102327466|NCT01765179|Testosterone enanthate|testosterone enanthate|mesh-list
102327467|NCT01765179|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102327468|NCT01765179|Androgens|androgens|mesh-ancestor
102327469|NCT01765179|Hormones|hormones|mesh-ancestor
102036302|NCT04869371|Prednisone|prednisone|mesh-list
102327470|NCT01765179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102327471|NCT01765179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327472|NCT01765179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102327473|NCT01765179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102327474|NCT01765179|Anabolic Agents|anabolic agents|mesh-ancestor
102327475|NCT01793883|Laninamivir|laninamivir|mesh-list
102327476|NCT01793883|Zanamivir|zanamivir|mesh-list
102327477|NCT01793883|Antiviral Agents|antiviral agents|mesh-ancestor
102327478|NCT01793883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102327479|NCT01793883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102327480|NCT01793883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327481|NCT01953692|Pembrolizumab|pembrolizumab|mesh-list
102327482|NCT01953692|Lenalidomide|lenalidomide|mesh-list
102327483|NCT01953692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102327484|NCT01953692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102327485|NCT01953692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102327486|NCT01953692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327487|NCT01953692|Immunologic Factors|immunologic factors|mesh-ancestor
102327488|NCT01953692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327489|NCT01953692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102327490|NCT01953692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102327491|NCT01953692|Growth Substances|growth substances|mesh-ancestor
102327492|NCT01953692|Growth Inhibitors|growth inhibitors|mesh-ancestor
102327493|NCT01791153|Prednisone|prednisone|mesh-list
102327494|NCT01791153|Methotrexate|methotrexate|mesh-list
102327495|NCT01791153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102327496|NCT01791153|Glucocorticoids|glucocorticoids|mesh-ancestor
102327497|NCT01791153|Hormones|hormones|mesh-ancestor
102327498|NCT01791153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102327499|NCT01791153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327500|NCT01791153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102327501|NCT01791153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102327502|NCT01791153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102327503|NCT01791153|Abortifacient Agents|abortifacient agents|mesh-ancestor
102327504|NCT01791153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102327505|NCT01791153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102327506|NCT01791153|Antimetabolites|antimetabolites|mesh-ancestor
102327507|NCT01791153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327508|NCT01791153|Dermatologic Agents|dermatologic agents|mesh-ancestor
102327509|NCT01791153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102327510|NCT01791153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102327511|NCT01791153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102327512|NCT01791153|Immunologic Factors|immunologic factors|mesh-ancestor
102327513|NCT01791153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102327514|NCT01791153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102327515|NCT01926782|Alirocumab|alirocumab|mesh-list
102327516|NCT01926782|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102327517|NCT01926782|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102327518|NCT01926782|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102327519|NCT01926782|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102327520|NCT01926782|Antimetabolites|antimetabolites|mesh-ancestor
102327521|NCT01926782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327522|NCT01926782|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102327523|NCT01926782|Protease Inhibitors|protease inhibitors|mesh-ancestor
102327524|NCT01926782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102327525|NCT01926782|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102327526|NCT01926782|Immunologic Factors|immunologic factors|mesh-ancestor
102327527|NCT01926782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327528|NCT01926626|Moclobemide|moclobemide|mesh-list
102327529|NCT01926626|Nicotine|nicotine|mesh-list
102327530|NCT01926626|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102327531|NCT01926626|Autonomic Agents|autonomic agents|mesh-ancestor
102327532|NCT01926626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102327533|NCT01926626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327534|NCT01926626|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102327535|NCT01926626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102327536|NCT01926626|Cholinergic Agents|cholinergic agents|mesh-ancestor
102327537|NCT01926626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102327538|NCT01926626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327539|NCT01926626|Antidepressive Agents|antidepressive agents|mesh-ancestor
102327540|NCT01926626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102327541|NCT01926626|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102327542|NCT01926626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102327543|NCT01900730|Valproic Acid|valproic acid|mesh-list
102327544|NCT01900730|Anticonvulsants|anticonvulsants|mesh-ancestor
102327545|NCT01900730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102327546|NCT01900730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327547|NCT01900730|GABA Agents|gaba agents|mesh-ancestor
102327548|NCT01900730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102327549|NCT01900730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327550|NCT01900730|Antimanic Agents|antimanic agents|mesh-ancestor
102327551|NCT01900730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102327552|NCT01900730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102327553|NCT01900730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102327554|NCT01952834|Vancomycin|vancomycin|mesh-list
102327555|NCT01952834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102327556|NCT01952834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102327557|NCT01952054|Denosumab|denosumab|mesh-list
102327558|NCT01952054|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102327559|NCT01952054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327560|NCT01925768|Apremilast|apremilast|mesh-list
102327561|NCT01925768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102327562|NCT01925768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102327563|NCT01925768|Analgesics|analgesics|mesh-ancestor
102327564|NCT01925768|Sensory System Agents|sensory system agents|mesh-ancestor
102327565|NCT01925768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102327566|NCT01925768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327567|NCT01925768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102327568|NCT01925768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101441171|NCT02365597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102327569|NCT01925768|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102327570|NCT01925768|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102327571|NCT01925768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102327572|NCT01925768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327573|NCT01431274|Tiotropium Bromide|tiotropium bromide|mesh-list
102327574|NCT01431274|Olodaterol|olodaterol|mesh-list
102327575|NCT01431274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102327576|NCT01431274|Autonomic Agents|autonomic agents|mesh-ancestor
102327577|NCT01431274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102327578|NCT01431274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327579|NCT01431274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102327580|NCT01431274|Respiratory System Agents|respiratory system agents|mesh-ancestor
102327581|NCT01431274|Parasympatholytics|parasympatholytics|mesh-ancestor
102327582|NCT01431274|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102327583|NCT01431274|Cholinergic Agents|cholinergic agents|mesh-ancestor
102327584|NCT01431274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102327585|NCT01431274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327586|NCT01991795|Ticagrelor|ticagrelor|mesh-list
102327587|NCT01991795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102327588|NCT01991795|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102327589|NCT01991795|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102327590|NCT01991795|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102327591|NCT01991795|Purinergic Agents|purinergic agents|mesh-ancestor
102327592|NCT01991795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102327593|NCT01991795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327594|NCT01991795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327595|NCT02076100|Ruzasvir|ruzasvir|mesh-list
102327596|NCT02076100|Antiviral Agents|antiviral agents|mesh-ancestor
102327597|NCT02076100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102327598|NCT01411774|Cycloserine|cycloserine|mesh-list
102327599|NCT01411774|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102327600|NCT01411774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102327601|NCT01411774|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102327602|NCT01411774|Antitubercular Agents|antitubercular agents|mesh-ancestor
102327603|NCT01411774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102327604|NCT01411774|Antimetabolites|antimetabolites|mesh-ancestor
102327605|NCT01411774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327606|NCT01410604|Metformin|metformin|mesh-list
102327607|NCT01410604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102327608|NCT01410604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327609|NCT01410448|Cyclosporine|cyclosporine|mesh-list
102327610|NCT01410448|Mycophenolic Acid|mycophenolic acid|mesh-list
102327611|NCT01410448|Everolimus|everolimus|mesh-list
102327612|NCT01410448|Cyclosporins|cyclosporins|mesh-list
102327613|NCT01410448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102327614|NCT01410448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327615|NCT01410448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102327616|NCT01410448|Immunologic Factors|immunologic factors|mesh-ancestor
102327617|NCT01410448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036459|NCT04689347|Antidotes|antidotes|mesh-ancestor
102327618|NCT01410448|Antifungal Agents|antifungal agents|mesh-ancestor
102327619|NCT01410448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102327620|NCT01410448|Dermatologic Agents|dermatologic agents|mesh-ancestor
102327621|NCT01410448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102327622|NCT01410448|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102327623|NCT01410448|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102327624|NCT01410448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102327625|NCT01410448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102327626|NCT01410448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102327627|NCT01410448|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102327628|NCT01410448|Antitubercular Agents|antitubercular agents|mesh-ancestor
102327629|NCT01410448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102327630|NCT04037176|Omalizumab|omalizumab|mesh-list
102327631|NCT04037176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102327632|NCT04037176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102327633|NCT04037176|Respiratory System Agents|respiratory system agents|mesh-ancestor
102327634|NCT01430104|Teriparatide|teriparatide|mesh-list
102327635|NCT01430104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102327636|NCT01430104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327637|NCT01430104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102327638|NCT01990859|Ipilimumab|ipilimumab|mesh-list
102327639|NCT01990859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102327640|NCT01990859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102327641|NCT01990859|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102327642|NCT01990859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327643|NCT02093897|Factor VIII|factor viii|mesh-list
102327644|NCT02093897|Coagulants|coagulants|mesh-ancestor
102327645|NCT01976845|Midazolam|midazolam|mesh-list
102327646|NCT01976845|Propofol|propofol|mesh-list
102327647|NCT01976845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102327648|NCT01976845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102327649|NCT01976845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327650|NCT01976845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102327651|NCT01976845|Anesthetics, General|anesthetics, general|mesh-ancestor
102327652|NCT01976845|Anesthetics|anesthetics|mesh-ancestor
102327653|NCT01976845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102327654|NCT01976845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102327655|NCT01976845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102327656|NCT01976845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102327657|NCT01976845|GABA Modulators|gaba modulators|mesh-ancestor
102327658|NCT01976845|GABA Agents|gaba agents|mesh-ancestor
102327659|NCT01976845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102327660|NCT01976845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327661|NCT01989689|Etanercept|etanercept|mesh-list
102327662|NCT01989689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102327663|NCT01989689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102327664|NCT01989689|Analgesics|analgesics|mesh-ancestor
102327665|NCT01989689|Sensory System Agents|sensory system agents|mesh-ancestor
102327666|NCT01989689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102327667|NCT01989689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327668|NCT01989689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102327669|NCT01989689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102327670|NCT01989689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102327671|NCT01989689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102327672|NCT01989689|Immunologic Factors|immunologic factors|mesh-ancestor
102327673|NCT01942993|Vemurafenib|vemurafenib|mesh-list
102327674|NCT01942993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102327675|NCT01942993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102327676|NCT01942993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102327677|NCT01942993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327678|NCT01989455|Deferiprone|deferiprone|mesh-list
102327679|NCT01989455|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102327680|NCT01989455|Chelating Agents|chelating agents|mesh-ancestor
102327681|NCT01989455|Sequestering Agents|sequestering agents|mesh-ancestor
102327682|NCT01989455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327683|NCT01987895|Vancomycin|vancomycin|mesh-list
102327684|NCT01987895|Oxazolidinones|oxazolidinones|mesh-list
102327685|NCT01987895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102327686|NCT01987895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102327687|NCT01987895|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102327688|NCT01987895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102327689|NCT01987895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327690|NCT01618669|Regadenoson|regadenoson|mesh-list
102327691|NCT01618669|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
102327692|NCT01618669|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102327693|NCT01618669|Purinergic Agonists|purinergic agonists|mesh-ancestor
102327694|NCT01618669|Purinergic Agents|purinergic agents|mesh-ancestor
102327695|NCT01618669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102327696|NCT01618669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327697|NCT01618669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327698|NCT01390948|Bevacizumab|bevacizumab|mesh-list
102327699|NCT01390948|Temozolomide|temozolomide|mesh-list
102327700|NCT01390948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102327701|NCT01390948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102327702|NCT01390948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102327703|NCT01390948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102327704|NCT01390948|Growth Substances|growth substances|mesh-ancestor
102327705|NCT01390948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327706|NCT01390948|Growth Inhibitors|growth inhibitors|mesh-ancestor
102327707|NCT01390948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102327708|NCT01390948|Alkylating Agents|alkylating agents|mesh-ancestor
102327709|NCT01390948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327710|NCT03842722|Protoporphyrin IX|protoporphyrin ix|mesh-list
102327711|NCT03842722|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102327712|NCT03842722|Dermatologic Agents|dermatologic agents|mesh-ancestor
102327713|NCT01429792|Ribavirin|ribavirin|mesh-list
102327714|NCT01429792|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102327715|NCT01429792|Antimetabolites|antimetabolites|mesh-ancestor
102327716|NCT01429792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327717|NCT01429792|Antiviral Agents|antiviral agents|mesh-ancestor
102327718|NCT01429792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102327719|NCT01940887|Bevacizumab|bevacizumab|mesh-list
102327720|NCT01940887|Aflibercept|aflibercept|mesh-list
102327721|NCT01940887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102327722|NCT01940887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102327723|NCT01940887|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102327724|NCT01940887|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102327725|NCT01940887|Growth Substances|growth substances|mesh-ancestor
102327726|NCT01940887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327727|NCT01940887|Growth Inhibitors|growth inhibitors|mesh-ancestor
102327728|NCT01925612|Prednisone|prednisone|mesh-list
102327729|NCT01925612|Cyclophosphamide|cyclophosphamide|mesh-list
102327730|NCT01925612|Rituximab|rituximab|mesh-list
102327731|NCT01925612|Doxorubicin|doxorubicin|mesh-list
102327732|NCT01925612|Vincristine|vincristine|mesh-list
102327733|NCT01925612|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102327734|NCT01925612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102327735|NCT01925612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102327736|NCT01925612|Immunologic Factors|immunologic factors|mesh-ancestor
102327737|NCT01925612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327738|NCT01925612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102327739|NCT01925612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102327740|NCT01925612|Alkylating Agents|alkylating agents|mesh-ancestor
102327741|NCT01925612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327742|NCT01925612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102327743|NCT01925612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102327744|NCT01925612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102327745|NCT01925612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102327746|NCT01925612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102327747|NCT01925612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102327748|NCT01925612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102327749|NCT01925612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102327750|NCT01925612|Glucocorticoids|glucocorticoids|mesh-ancestor
102327751|NCT01925612|Hormones|hormones|mesh-ancestor
102327752|NCT01925612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102327753|NCT01925612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102327754|NCT01925612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102327755|NCT01925612|Tubulin Modulators|tubulin modulators|mesh-ancestor
102327756|NCT01925612|Antimitotic Agents|antimitotic agents|mesh-ancestor
102327757|NCT01925612|Mitosis Modulators|mitosis modulators|mesh-ancestor
102327758|NCT01925612|Immunotoxins|immunotoxins|mesh-ancestor
102327759|NCT01925612|Immunoconjugates|immunoconjugates|mesh-ancestor
102327760|NCT02093663|Mesalamine|mesalamine|mesh-list
102327761|NCT02093663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102327762|NCT02093663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102327763|NCT02093663|Analgesics|analgesics|mesh-ancestor
102327764|NCT02093663|Sensory System Agents|sensory system agents|mesh-ancestor
102327765|NCT02093663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102327766|NCT02093663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327767|NCT02093663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102327768|NCT02093663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102327769|NCT01408888|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102327770|NCT01408888|Dulaglutide|dulaglutide|mesh-list
102327771|NCT01408888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102327772|NCT01408888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327773|NCT01408888|Incretins|incretins|mesh-ancestor
102327774|NCT01408888|Hormones|hormones|mesh-ancestor
102327775|NCT01408888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102327776|NCT01408888|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102327777|NCT01408888|Protease Inhibitors|protease inhibitors|mesh-ancestor
102327778|NCT01408888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102327779|NCT01408888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327780|NCT01918033|Desloratadine|desloratadine|mesh-list
102327781|NCT01918033|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102327782|NCT01918033|Cholinergic Agents|cholinergic agents|mesh-ancestor
102327783|NCT01918033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102327784|NCT01918033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327785|NCT01918033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327786|NCT01918033|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102327787|NCT01918033|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102327788|NCT01918033|Histamine Antagonists|histamine antagonists|mesh-ancestor
102327789|NCT01918033|Histamine Agents|histamine agents|mesh-ancestor
102327790|NCT01408732|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
102327791|NCT01408732|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102327792|NCT01408732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102327793|NCT01390402|Aldesleukin|aldesleukin|mesh-list
102327794|NCT01390402|Methotrexate|methotrexate|mesh-list
102327795|NCT01390402|Fludarabine phosphate|fludarabine phosphate|mesh-list
102327796|NCT01390402|Fludarabine|fludarabine|mesh-list
102327797|NCT01390402|Busulfan|busulfan|mesh-list
102327798|NCT01390402|Interleukin-2|interleukin-2|mesh-list
102327799|NCT01390402|Tacrolimus|tacrolimus|mesh-list
102327800|NCT01390402|Thymoglobulin|thymoglobulin|mesh-list
102327801|NCT01390402|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102327802|NCT01390402|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102327803|NCT01390402|Abortifacient Agents|abortifacient agents|mesh-ancestor
102327804|NCT01390402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102327805|NCT01390402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327806|NCT01390402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102327807|NCT01390402|Antimetabolites|antimetabolites|mesh-ancestor
102327808|NCT01390402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327809|NCT01390402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102327810|NCT01390402|Dermatologic Agents|dermatologic agents|mesh-ancestor
102327811|NCT01390402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102327812|NCT01390402|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102327813|NCT01390402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102327814|NCT01390402|Immunologic Factors|immunologic factors|mesh-ancestor
102327815|NCT01390402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102327816|NCT01390402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102327817|NCT01390402|Antiviral Agents|antiviral agents|mesh-ancestor
102327818|NCT01390402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102327819|NCT01390402|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102327820|NCT01390402|Alkylating Agents|alkylating agents|mesh-ancestor
102327821|NCT01390402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102327822|NCT01390402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102327823|NCT01390402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102327824|NCT01390402|Analgesics|analgesics|mesh-ancestor
102327825|NCT01390402|Sensory System Agents|sensory system agents|mesh-ancestor
102327826|NCT01390402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102327827|NCT01390402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102327828|NCT01390402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102327829|NCT04661683|Charcoal|charcoal|mesh-list
102327830|NCT04661683|Antidotes|antidotes|mesh-ancestor
102327831|NCT04661683|Protective Agents|protective agents|mesh-ancestor
102327832|NCT04661683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327833|NCT01428076|Polidocanol|polidocanol|mesh-list
102327834|NCT01428076|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102327835|NCT01428076|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102327836|NCT01900652|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102327837|NCT01900652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102327838|NCT01900652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102327839|NCT01900652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102327840|NCT01900652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327841|NCT02093351|Tamoxifen|tamoxifen|mesh-list
102327842|NCT02093351|Letrozole|letrozole|mesh-list
102327843|NCT02093351|Olaparib|olaparib|mesh-list
102327844|NCT02093351|Anastrozole|anastrozole|mesh-list
102327845|NCT02093351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102327846|NCT02093351|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102327847|NCT02093351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102327848|NCT02093351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102327849|NCT02093351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327850|NCT02093351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102327851|NCT02093351|Hormone Antagonists|hormone antagonists|mesh-ancestor
102327852|NCT02093351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102327853|NCT02093351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327854|NCT02093351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102327855|NCT02093351|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102327856|NCT02093351|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102327857|NCT02093351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102327858|NCT02093351|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102327860|NCT02078284|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102327861|NCT02078284|Protective Agents|protective agents|mesh-ancestor
102327862|NCT02078284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327863|NCT02078284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102327864|NCT02078284|Antioxidants|antioxidants|mesh-ancestor
102327865|NCT02078284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327866|NCT02092961|Adalimumab|adalimumab|mesh-list
102327867|NCT02092961|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102327868|NCT02092961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102327869|NCT02092961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102327870|NCT01940497|Paclitaxel|paclitaxel|mesh-list
102327871|NCT01940497|Docetaxel|docetaxel|mesh-list
102327872|NCT01940497|Doxorubicin|doxorubicin|mesh-list
102327873|NCT01940497|Trastuzumab|trastuzumab|mesh-list
102327874|NCT01940497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102327875|NCT01940497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102327876|NCT01940497|Tubulin Modulators|tubulin modulators|mesh-ancestor
102327877|NCT01940497|Antimitotic Agents|antimitotic agents|mesh-ancestor
102327878|NCT01940497|Mitosis Modulators|mitosis modulators|mesh-ancestor
102327879|NCT01940497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327880|NCT01940497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102327881|NCT01940497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102327882|NCT01940497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102327883|NCT01940497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102327884|NCT01940497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102327885|NCT01987505|Rituximab|rituximab|mesh-list
102327886|NCT01987505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102327887|NCT01987505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102327888|NCT01987505|Immunologic Factors|immunologic factors|mesh-ancestor
102327889|NCT01987505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327890|NCT01987505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102327891|NCT01923896|Cycloserine|cycloserine|mesh-list
102327892|NCT01923896|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102327893|NCT01923896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102327894|NCT01923896|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102327895|NCT01923896|Antitubercular Agents|antitubercular agents|mesh-ancestor
102327896|NCT01923896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102327897|NCT01923896|Antimetabolites|antimetabolites|mesh-ancestor
102327898|NCT01923896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327899|NCT01938625|Cyclosporine|cyclosporine|mesh-list
102327900|NCT01938625|Ribavirin|ribavirin|mesh-list
102327901|NCT01938625|Simeprevir|simeprevir|mesh-list
102327902|NCT01938625|Tacrolimus|tacrolimus|mesh-list
102327903|NCT01938625|Cyclosporins|cyclosporins|mesh-list
102327904|NCT01938625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102327905|NCT01938625|Immunologic Factors|immunologic factors|mesh-ancestor
102327906|NCT01938625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327907|NCT01938625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102327908|NCT01938625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102327909|NCT01938625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327910|NCT01938625|Antifungal Agents|antifungal agents|mesh-ancestor
102327911|NCT01938625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102327912|NCT01938625|Dermatologic Agents|dermatologic agents|mesh-ancestor
102327913|NCT01938625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102327914|NCT01938625|Antimetabolites|antimetabolites|mesh-ancestor
102327915|NCT01938625|Antiviral Agents|antiviral agents|mesh-ancestor
102327916|NCT01938625|Protease Inhibitors|protease inhibitors|mesh-ancestor
102327917|NCT01975675|Sofosbuvir|sofosbuvir|mesh-list
102327918|NCT01975675|Antiviral Agents|antiviral agents|mesh-ancestor
102327919|NCT01975675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102327920|NCT01975285|Dexamethasone|dexamethasone|mesh-list
102327921|NCT01975285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102327922|NCT01975285|Antiemetics|antiemetics|mesh-ancestor
102327923|NCT01975285|Autonomic Agents|autonomic agents|mesh-ancestor
102327924|NCT01975285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102327925|NCT01975285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327926|NCT01975285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102327927|NCT01975285|Glucocorticoids|glucocorticoids|mesh-ancestor
102327928|NCT01975285|Hormones|hormones|mesh-ancestor
102327929|NCT01975285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102327930|NCT01975285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102327931|NCT01975285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102327932|NCT01974817|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102327933|NCT01974817|Immunologic Factors|immunologic factors|mesh-ancestor
102327934|NCT01974817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327936|NCT04624399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102327937|NCT04624399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327938|NCT04624399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102327939|NCT04624399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102327940|NCT01915849|Licogliflozin|licogliflozin|mesh-list
102327941|NCT01915849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102327942|NCT01915849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327943|NCT01915849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102327944|NCT01915849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327945|NCT01915303|Cabergoline|cabergoline|mesh-list
102327946|NCT01915303|Pasireotide|pasireotide|mesh-list
102327947|NCT01915303|Hormones|hormones|mesh-ancestor
102327948|NCT01915303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102327949|NCT01915303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327950|NCT01915303|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102327951|NCT01915303|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102327952|NCT01915303|Dopamine Agonists|dopamine agonists|mesh-ancestor
102327953|NCT01915303|Dopamine Agents|dopamine agents|mesh-ancestor
102327954|NCT01915303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102327955|NCT01915303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327956|NCT01987427|Phentermine|phentermine|mesh-list
102327957|NCT01987427|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102327958|NCT01987427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327959|NCT01987427|Appetite Depressants|appetite depressants|mesh-ancestor
102327960|NCT01987427|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102327961|NCT01987427|Sympathomimetics|sympathomimetics|mesh-ancestor
102327962|NCT01987427|Autonomic Agents|autonomic agents|mesh-ancestor
102327963|NCT01987427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102327964|NCT01987427|Adrenergic Agents|adrenergic agents|mesh-ancestor
102327965|NCT01987427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102327966|NCT01987427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327967|NCT01937299|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102327968|NCT01937299|Travoprost|travoprost|mesh-list
102327969|NCT01937299|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102327970|NCT01937299|Brinzolamide|brinzolamide|mesh-list
102327971|NCT01937299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102327972|NCT01937299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102327973|NCT01937299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102327974|NCT01937299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102327975|NCT01937299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102327976|NCT01937299|Adrenergic Agents|adrenergic agents|mesh-ancestor
102327977|NCT01937299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102327978|NCT01937299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327979|NCT01937299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327980|NCT01937299|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102327981|NCT01937299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102327982|NCT01606761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102327983|NCT01606761|Immunologic Factors|immunologic factors|mesh-ancestor
102327984|NCT01606761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327985|NCT01597557|Magnesium Sulfate|magnesium sulfate|mesh-list
102327986|NCT01597557|Analgesics|analgesics|mesh-ancestor
102327987|NCT01597557|Sensory System Agents|sensory system agents|mesh-ancestor
102327988|NCT01597557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102327989|NCT01597557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102327990|NCT01597557|Anesthetics|anesthetics|mesh-ancestor
102327991|NCT01597557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102327992|NCT01597557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102327993|NCT01597557|Anticonvulsants|anticonvulsants|mesh-ancestor
102327994|NCT01597557|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102036824|NCT03649711|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102327995|NCT01597557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102327996|NCT01597557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102327997|NCT01597557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102327999|NCT01597557|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102328001|NCT01914757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102328002|NCT01914757|Respiratory System Agents|respiratory system agents|mesh-ancestor
102328003|NCT02003573|Decitabine|decitabine|mesh-list
102328004|NCT02003573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102328005|NCT02003573|Antimetabolites|antimetabolites|mesh-ancestor
102328006|NCT02003573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328007|NCT02003573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102328008|NCT02003573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102328009|NCT01789281|Everolimus|everolimus|mesh-list
102328010|NCT01789281|Octreotide|octreotide|mesh-list
102328011|NCT01789281|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102328012|NCT01789281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102328013|NCT01789281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102328014|NCT01789281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328015|NCT01789281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102328016|NCT01789281|Immunologic Factors|immunologic factors|mesh-ancestor
102328017|NCT01789281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328018|NCT01789281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102328019|NCT01789281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102328020|NCT01789281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102328021|NCT01789203|Ciprofloxacin|ciprofloxacin|mesh-list
102328022|NCT01789203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102328023|NCT01789203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102328024|NCT01789203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102328025|NCT01789203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102328026|NCT01789203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101441393|NCT00980460|Cisplatin|cisplatin|mesh-list
102328027|NCT01789203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328028|NCT01789203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102328029|NCT01789203|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102328030|NCT01789203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102328031|NCT01789047|Topiramate|topiramate|mesh-list
102328032|NCT01789047|Amantadine|amantadine|mesh-list
102328033|NCT01789047|Anticonvulsants|anticonvulsants|mesh-ancestor
102328034|NCT01789047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102328035|NCT01789047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328036|NCT01789047|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102328037|NCT01789047|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102328038|NCT01789047|Antiviral Agents|antiviral agents|mesh-ancestor
102328039|NCT01789047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102328040|NCT01789047|Dopamine Agents|dopamine agents|mesh-ancestor
102328041|NCT01789047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102328042|NCT01789047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328043|NCT01789047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102328044|NCT01789047|Analgesics|analgesics|mesh-ancestor
102328045|NCT01789047|Sensory System Agents|sensory system agents|mesh-ancestor
102328046|NCT01789047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102328047|NCT01617187|Olanzapine|olanzapine|mesh-list
102328048|NCT01617187|Asenapine|asenapine|mesh-list
102328049|NCT01617187|Antiemetics|antiemetics|mesh-ancestor
102328050|NCT01617187|Autonomic Agents|autonomic agents|mesh-ancestor
102328051|NCT01617187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102328052|NCT01617187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328053|NCT01617187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102328054|NCT01617187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102328055|NCT01617187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102328056|NCT01617187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102328057|NCT01617187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102328058|NCT01617187|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102328059|NCT01617187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102328060|NCT01617187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102328061|NCT01617187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328062|NCT01617187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102328063|NCT01617187|Serotonin Agents|serotonin agents|mesh-ancestor
102328064|NCT01759407|Epinephrine|epinephrine|mesh-list
102328065|NCT01759407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102328066|NCT01759407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102328067|NCT01759407|Adrenergic Agents|adrenergic agents|mesh-ancestor
102328068|NCT01759407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102328069|NCT01759407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328070|NCT01759407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328071|NCT01759407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102328072|NCT01759407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102328073|NCT01759407|Autonomic Agents|autonomic agents|mesh-ancestor
102328074|NCT01759407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102328075|NCT01759407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102328076|NCT01759407|Respiratory System Agents|respiratory system agents|mesh-ancestor
102328077|NCT01759407|Mydriatics|mydriatics|mesh-ancestor
102328078|NCT01759407|Sympathomimetics|sympathomimetics|mesh-ancestor
102328079|NCT01759407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102328080|NCT01787331|Itraconazole|itraconazole|mesh-list
102328081|NCT01787331|Antifungal Agents|antifungal agents|mesh-ancestor
102328082|NCT01787331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102328083|NCT01787331|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102328084|NCT01787331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102328085|NCT01787331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102328086|NCT01787331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328087|NCT01787331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102328088|NCT01787331|Hormone Antagonists|hormone antagonists|mesh-ancestor
102328089|NCT01787331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102328090|NCT01787331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328091|NCT01787331|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102328092|NCT01787097|Formoterol Fumarate|formoterol fumarate|mesh-list
102328093|NCT01787097|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
102328094|NCT01787097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102328095|NCT01787097|Autonomic Agents|autonomic agents|mesh-ancestor
102328096|NCT01787097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102328097|NCT01787097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328098|NCT01787097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102328099|NCT01787097|Respiratory System Agents|respiratory system agents|mesh-ancestor
102328100|NCT01787097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102328101|NCT01787097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102328102|NCT01787097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102328103|NCT01787097|Adrenergic Agents|adrenergic agents|mesh-ancestor
102328104|NCT01787097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102328105|NCT01787097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328106|NCT01757691|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102328107|NCT01757691|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102328108|NCT01757691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328109|NCT01757691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102328110|NCT01757691|Immunologic Factors|immunologic factors|mesh-ancestor
102328111|NCT01757691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328112|NCT01786707|Metformin|metformin|mesh-list
102328113|NCT01786707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102328114|NCT01786707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328115|NCT01786551|Eplerenone|eplerenone|mesh-list
102328116|NCT01786551|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102328117|NCT01786551|Hormone Antagonists|hormone antagonists|mesh-ancestor
102328118|NCT01786551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102328119|NCT01786551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328120|NCT01786551|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102328121|NCT01786551|Diuretics|diuretics|mesh-ancestor
102328122|NCT01786551|Natriuretic Agents|natriuretic agents|mesh-ancestor
102328123|NCT01786551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102328124|NCT01973569|Denosumab|denosumab|mesh-list
102328125|NCT01973569|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102328126|NCT01973569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328127|NCT01951586|Zoledronic Acid|zoledronic acid|mesh-list
102328128|NCT01951586|Denosumab|denosumab|mesh-list
102328129|NCT01951586|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102328130|NCT01951586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328131|NCT04643678|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102328132|NCT04643678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102328133|NCT04641728|Pembrolizumab|pembrolizumab|mesh-list
102328134|NCT04641728|Olaparib|olaparib|mesh-list
102328135|NCT04641728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102328136|NCT04641728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102328137|NCT04641728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102328138|NCT04641728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036971|NCT00442338|Aminophylline|aminophylline|mesh-list
102328139|NCT04641728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102328140|NCT04641728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102328141|NCT01756833|Doxycycline|doxycycline|mesh-list
102328142|NCT01756833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102328143|NCT01756833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102328144|NCT01756833|Antimalarials|antimalarials|mesh-ancestor
102328145|NCT01756833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102328146|NCT01756833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102328147|NCT01785615|Atorvastatin|atorvastatin|mesh-list
102328148|NCT01785615|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102328149|NCT01785615|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102328150|NCT01785615|Antimetabolites|antimetabolites|mesh-ancestor
102328151|NCT01785615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328152|NCT01785615|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102328153|NCT01785615|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102328154|NCT01785615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102328155|NCT04172779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102328156|NCT04172779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102328157|NCT04172779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102328158|NCT04172779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102328159|NCT04172779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328160|NCT01784523|Hydroxychloroquine|hydroxychloroquine|mesh-list
102328161|NCT01784523|Antimalarials|antimalarials|mesh-ancestor
102328162|NCT01784523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102328163|NCT01784523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102328164|NCT01784523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102328165|NCT01784523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102328166|NCT01784523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328167|NCT01784523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102328168|NCT01784211|Insulin Glargine|insulin glargine|mesh-list
102328169|NCT01784211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102328170|NCT01784211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328172|NCT01783821|Formoterol Fumarate|formoterol fumarate|mesh-list
102328173|NCT01783821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102328174|NCT01783821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102328175|NCT01783821|Autonomic Agents|autonomic agents|mesh-ancestor
102328176|NCT01783821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102328177|NCT01783821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328178|NCT01783821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102328179|NCT01783821|Respiratory System Agents|respiratory system agents|mesh-ancestor
102328180|NCT01783821|Glucocorticoids|glucocorticoids|mesh-ancestor
102328182|NCT01783821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102328183|NCT01783821|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102328184|NCT01783821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102328185|NCT01783821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102328186|NCT01783821|Adrenergic Agents|adrenergic agents|mesh-ancestor
102328187|NCT01783821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102328188|NCT01783821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328189|NCT01608087|Bevacizumab|bevacizumab|mesh-list
102328190|NCT01608087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102328191|NCT01608087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102328192|NCT01608087|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102328193|NCT01608087|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102328194|NCT01608087|Growth Substances|growth substances|mesh-ancestor
102328195|NCT01608087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328196|NCT01608087|Growth Inhibitors|growth inhibitors|mesh-ancestor
102328197|NCT01912963|Trastuzumab|trastuzumab|mesh-list
102328198|NCT01912963|Pertuzumab|pertuzumab|mesh-list
102328199|NCT01912963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102328200|NCT01912963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102328201|NCT01912807|Ondansetron|ondansetron|mesh-list
102328202|NCT01912807|Antiemetics|antiemetics|mesh-ancestor
102328203|NCT01912807|Autonomic Agents|autonomic agents|mesh-ancestor
102328204|NCT01912807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102328205|NCT01912807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328206|NCT01912807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102328207|NCT01912807|Antipruritics|antipruritics|mesh-ancestor
102328208|NCT01912807|Dermatologic Agents|dermatologic agents|mesh-ancestor
102328209|NCT01912807|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102328210|NCT01912807|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102328211|NCT01912807|Serotonin Agents|serotonin agents|mesh-ancestor
102328212|NCT01912807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102037050|NCT01667133|Ponatinib|ponatinib|mesh-list
102328213|NCT01912807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328214|NCT01782885|Acetaminophen|acetaminophen|mesh-list
102328215|NCT01782885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102328216|NCT01782885|Analgesics|analgesics|mesh-ancestor
102328217|NCT01782885|Sensory System Agents|sensory system agents|mesh-ancestor
102328218|NCT01782885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102328219|NCT01782885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328220|NCT01782885|Antipyretics|antipyretics|mesh-ancestor
101441439|NCT00799864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102328221|NCT01754493|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102328222|NCT01754493|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102328223|NCT01754493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102328224|NCT01754493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102328225|NCT01754493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328226|NCT01754493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102328227|NCT01754493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328228|NCT01754493|Analgesics|analgesics|mesh-ancestor
102328229|NCT01754493|Sensory System Agents|sensory system agents|mesh-ancestor
102328230|NCT01754493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102328231|NCT01754493|Antidepressive Agents|antidepressive agents|mesh-ancestor
102328232|NCT01754493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102328233|NCT01754493|Dopamine Agents|dopamine agents|mesh-ancestor
102328234|NCT01972789|Ranibizumab|ranibizumab|mesh-list
102328235|NCT01972789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102328236|NCT01972789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102328237|NCT01972789|Growth Substances|growth substances|mesh-ancestor
102328238|NCT01972789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328239|NCT01972789|Growth Inhibitors|growth inhibitors|mesh-ancestor
102328240|NCT01972789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102328241|NCT01910389|Tadalafil|tadalafil|mesh-list
102328242|NCT01910389|Vasodilator Agents|vasodilator agents|mesh-ancestor
102328243|NCT01910389|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102328244|NCT01910389|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102328245|NCT01910389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102328246|NCT01910389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328247|NCT01910389|Urological Agents|urological agents|mesh-ancestor
102328248|NCT01970995|Menthol|menthol|mesh-list
102328249|NCT01970995|Antipruritics|antipruritics|mesh-ancestor
102328250|NCT01970995|Dermatologic Agents|dermatologic agents|mesh-ancestor
102328251|NCT01970527|Ipilimumab|ipilimumab|mesh-list
102328252|NCT01970527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102328253|NCT01970527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102328254|NCT01970527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102328255|NCT01970527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328256|NCT01408576|Epratuzumab|epratuzumab|mesh-list
102328257|NCT01408576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102328258|NCT01408576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102328259|NCT01427920|Insulin Aspart|insulin aspart|mesh-list
102328260|NCT01427920|Biphasic Insulins|biphasic insulins|mesh-list
102328261|NCT01427920|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
102328262|NCT01427920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102328263|NCT01427920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328264|NCT01427608|Olanzapine|olanzapine|mesh-list
102328265|NCT01427608|Sertraline|sertraline|mesh-list
102328266|NCT01427608|Antiemetics|antiemetics|mesh-ancestor
102328267|NCT01427608|Autonomic Agents|autonomic agents|mesh-ancestor
102328268|NCT01427608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102328269|NCT01427608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328270|NCT01427608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102328271|NCT01427608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102328272|NCT01427608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101670258|NCT03644667|Hormones|hormones|mesh-ancestor
102328273|NCT01427608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102328274|NCT01427608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102328275|NCT01427608|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102328276|NCT01427608|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102328277|NCT01427608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102328278|NCT01427608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328279|NCT01427608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102328280|NCT01427608|Serotonin Agents|serotonin agents|mesh-ancestor
102328281|NCT01427608|Antidepressive Agents|antidepressive agents|mesh-ancestor
102328283|NCT01408030|Tranexamic Acid|tranexamic acid|mesh-list
102328284|NCT01408030|Endothelial Growth Factors|endothelial growth factors|mesh-list
102328285|NCT01408030|Estrogens|estrogens|mesh-list
102328286|NCT01408030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102328287|NCT01408030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102328288|NCT01408030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102328289|NCT01408030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102328291|NCT01408030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328292|NCT01408030|Growth Inhibitors|growth inhibitors|mesh-ancestor
102328293|NCT01408030|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102328294|NCT01408030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102328295|NCT01408030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328296|NCT01408030|Hemostatics|hemostatics|mesh-ancestor
102328297|NCT01408030|Coagulants|coagulants|mesh-ancestor
102328298|NCT01408030|Hormones|hormones|mesh-ancestor
102328299|NCT01408030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102328300|NCT02985424|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102328301|NCT02985424|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102328302|NCT02985424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328303|NCT01897532|Linagliptin|linagliptin|mesh-list
102328304|NCT01897532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102328305|NCT01897532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328306|NCT01897532|Incretins|incretins|mesh-ancestor
102328307|NCT01897532|Hormones|hormones|mesh-ancestor
102328308|NCT01897532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102328309|NCT01897532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102328310|NCT01897532|Protease Inhibitors|protease inhibitors|mesh-ancestor
102328311|NCT01897532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102328312|NCT01897532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328313|NCT04641026|Deuterium Oxide|deuterium oxide|mesh-list
102328314|NCT04641026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102328315|NCT04641026|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102328316|NCT04641026|Protective Agents|protective agents|mesh-ancestor
102328317|NCT04641026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328318|NCT04173416|Analgesics, Opioid|analgesics, opioid|mesh-list
102328319|NCT04173416|Narcotics|narcotics|mesh-ancestor
102328320|NCT04173416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102328321|NCT04173416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328322|NCT04173416|Analgesics|analgesics|mesh-ancestor
102328323|NCT04173416|Sensory System Agents|sensory system agents|mesh-ancestor
102328324|NCT04173416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102328325|NCT01896128|Modafinil|modafinil|mesh-list
102328326|NCT01896128|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102328327|NCT01896128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328328|NCT01896128|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102328329|NCT01896128|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102328330|NCT01896128|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102328331|NCT01896128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328332|NCT01949870|Gemcitabine|gemcitabine|mesh-list
102328333|NCT01949870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102328334|NCT01949870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102328335|NCT01949870|Antimetabolites|antimetabolites|mesh-ancestor
102328336|NCT01949870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328337|NCT01922258|Brexpiprazole|brexpiprazole|mesh-list
102328338|NCT01922258|Serotonin Agents|serotonin agents|mesh-ancestor
102328339|NCT01922258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102328340|NCT01922258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328341|NCT01922258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328342|NCT01922258|Dopamine Agonists|dopamine agonists|mesh-ancestor
102328343|NCT01922258|Dopamine Agents|dopamine agents|mesh-ancestor
102328344|NCT01406938|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102328345|NCT01406938|Immunologic Factors|immunologic factors|mesh-ancestor
102328346|NCT01406938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328347|NCT01405924|Dexamethasone|dexamethasone|mesh-list
102328348|NCT01405924|Fosaprepitant|fosaprepitant|mesh-list
102328349|NCT01405924|Aprepitant|aprepitant|mesh-list
102328350|NCT01405924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102328351|NCT01405924|Antiemetics|antiemetics|mesh-ancestor
102328352|NCT01405924|Autonomic Agents|autonomic agents|mesh-ancestor
102328353|NCT01405924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102328354|NCT01405924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328355|NCT01405924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102328356|NCT01405924|Glucocorticoids|glucocorticoids|mesh-ancestor
102328357|NCT01405924|Hormones|hormones|mesh-ancestor
102328358|NCT01405924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102328359|NCT01405924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102328360|NCT01405924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102328361|NCT01405924|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102328362|NCT01405924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102328363|NCT01405924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328365|NCT01426438|Niacin|niacin|mesh-list
102328366|NCT01426438|Fenofibrate|fenofibrate|mesh-list
102328367|NCT01426438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102328368|NCT01426438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102328369|NCT01426438|Analgesics|analgesics|mesh-ancestor
102328370|NCT01426438|Sensory System Agents|sensory system agents|mesh-ancestor
102328371|NCT01426438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102328372|NCT01426438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328373|NCT01426438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102328374|NCT01426438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102328375|NCT01426438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102328376|NCT01426438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102328377|NCT01426438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328378|NCT01426438|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102328379|NCT01426438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102328380|NCT01426438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102328381|NCT01426438|Antipyretics|antipyretics|mesh-ancestor
102328382|NCT01426438|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102328383|NCT01426438|Antimetabolites|antimetabolites|mesh-ancestor
102328384|NCT01426438|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102328385|NCT01426438|Vasodilator Agents|vasodilator agents|mesh-ancestor
102328386|NCT01426438|Vitamin B Complex|vitamin b complex|mesh-ancestor
102328387|NCT01426438|Vitamins|vitamins|mesh-ancestor
102328388|NCT01426438|Micronutrients|micronutrients|mesh-ancestor
102328389|NCT01782495|Ritonavir|ritonavir|mesh-list
102328390|NCT01782495|Ribavirin|ribavirin|mesh-list
102328391|NCT01782495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102328392|NCT01782495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102328393|NCT01782495|Protease Inhibitors|protease inhibitors|mesh-ancestor
102328394|NCT01782495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102328395|NCT01782495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328396|NCT01782495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102328397|NCT01782495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102328398|NCT01782495|Antiviral Agents|antiviral agents|mesh-ancestor
102328399|NCT01782495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102328400|NCT01782495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102328401|NCT01782495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102328402|NCT01782495|Antimetabolites|antimetabolites|mesh-ancestor
102328403|NCT01922102|Ranibizumab|ranibizumab|mesh-list
102328404|NCT01922102|Verteporfin|verteporfin|mesh-list
102328405|NCT01922102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102328406|NCT01922102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102328407|NCT01922102|Growth Substances|growth substances|mesh-ancestor
102328408|NCT01922102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328409|NCT01922102|Growth Inhibitors|growth inhibitors|mesh-ancestor
102328410|NCT01922102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102328411|NCT01922102|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102328412|NCT01922102|Dermatologic Agents|dermatologic agents|mesh-ancestor
102328413|NCT01405768|Lidocaine|lidocaine|mesh-list
102328414|NCT01405768|Anesthetics, Local|anesthetics, local|mesh-ancestor
102328415|NCT01405768|Anesthetics|anesthetics|mesh-ancestor
102328416|NCT01405768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102328417|NCT01405768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328418|NCT01405768|Sensory System Agents|sensory system agents|mesh-ancestor
102328419|NCT01405768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102328420|NCT01405768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101670409|NCT02684162|Guadecitabine|guadecitabine|mesh-list
102328421|NCT01405768|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102328422|NCT01405768|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102328423|NCT01405768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102328424|NCT01405768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328425|NCT01913353|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
102328426|NCT01913353|Antiviral Agents|antiviral agents|mesh-ancestor
102328427|NCT01913353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102328428|NCT01754259|Ranolazine|ranolazine|mesh-list
102328429|NCT01754259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102328430|NCT01754259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102328431|NCT01754259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328432|NCT01405456|Eplerenone|eplerenone|mesh-list
102328433|NCT01405456|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102328434|NCT01405456|Hormone Antagonists|hormone antagonists|mesh-ancestor
102328435|NCT01405456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102328436|NCT01405456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328437|NCT01405456|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102328438|NCT01405456|Diuretics|diuretics|mesh-ancestor
102328439|NCT01405456|Natriuretic Agents|natriuretic agents|mesh-ancestor
102328440|NCT01405456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102328441|NCT01404208|Cycloserine|cycloserine|mesh-list
102328442|NCT01404208|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102328443|NCT01404208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102328444|NCT01404208|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102328445|NCT01404208|Antitubercular Agents|antitubercular agents|mesh-ancestor
102328446|NCT01404208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102328447|NCT01404208|Antimetabolites|antimetabolites|mesh-ancestor
102328448|NCT01404208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328449|NCT01617668|Paclitaxel|paclitaxel|mesh-list
102328450|NCT01617668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102328451|NCT01617668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102328452|NCT01617668|Tubulin Modulators|tubulin modulators|mesh-ancestor
102328453|NCT01617668|Antimitotic Agents|antimitotic agents|mesh-ancestor
102328454|NCT01617668|Mitosis Modulators|mitosis modulators|mesh-ancestor
102328455|NCT01617668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328456|NCT01895270|Isradipine|isradipine|mesh-list
102328457|NCT01895270|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102328458|NCT01895270|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102328459|NCT01895270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102328460|NCT01895270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328461|NCT01895270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102328462|NCT01895270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328463|NCT01895270|Vasodilator Agents|vasodilator agents|mesh-ancestor
102328464|NCT01424644|Vaccines|vaccines|mesh-list
102328465|NCT01424644|Immunologic Factors|immunologic factors|mesh-ancestor
102328466|NCT01424644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328467|NCT01403116|Methyltestosterone|methyltestosterone|mesh-list
102328468|NCT01403116|Testosterone|testosterone|mesh-list
102328469|NCT01403116|Testosterone undecanoate|testosterone undecanoate|mesh-list
102328470|NCT01403116|Testosterone enanthate|testosterone enanthate|mesh-list
102328471|NCT01403116|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102328472|NCT01403116|Androgens|androgens|mesh-ancestor
102328473|NCT01403116|Hormones|hormones|mesh-ancestor
102328474|NCT01403116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102328475|NCT01403116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328476|NCT01403116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102328477|NCT01403116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102328478|NCT01403116|Anabolic Agents|anabolic agents|mesh-ancestor
102328479|NCT01753401|Prednisone|prednisone|mesh-list
102328480|NCT01753401|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102328481|NCT01753401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102328482|NCT01753401|Glucocorticoids|glucocorticoids|mesh-ancestor
102328483|NCT01753401|Hormones|hormones|mesh-ancestor
102328484|NCT01753401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102328485|NCT01753401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328486|NCT01753401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102328487|NCT01753401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102328488|NCT01894568|Insulin|insulin|mesh-list
102328489|NCT01894568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102328490|NCT01894568|Insulin Glargine|insulin glargine|mesh-list
102328491|NCT01894568|Pioglitazone|pioglitazone|mesh-list
102328492|NCT01894568|Biguanides|biguanides|mesh-list
102328493|NCT01894568|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102328494|NCT01894568|Meglitinide|meglitinide|mesh-list
102328495|NCT01894568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328496|NCT01920152|Hyaluronic Acid|hyaluronic acid|mesh-list
102328497|NCT01920152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102328498|NCT01920152|Immunologic Factors|immunologic factors|mesh-ancestor
102328499|NCT01920152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328500|NCT01920152|Viscosupplements|viscosupplements|mesh-ancestor
102328501|NCT01920152|Protective Agents|protective agents|mesh-ancestor
102328502|NCT01752933|Guadecitabine|guadecitabine|mesh-list
102328503|NCT01752933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102328504|NCT01752855|Adalimumab|adalimumab|mesh-list
102328505|NCT01752855|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102328506|NCT01752855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102328507|NCT01752855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102328508|NCT01402492|Naltrexone|naltrexone|mesh-list
102328509|NCT01402492|Buprenorphine|buprenorphine|mesh-list
102328510|NCT01402492|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102328512|NCT01402492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102328513|NCT01402492|Narcotics|narcotics|mesh-ancestor
102328514|NCT01402492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102328515|NCT01402492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328516|NCT01402492|Analgesics|analgesics|mesh-ancestor
102328517|NCT01402492|Sensory System Agents|sensory system agents|mesh-ancestor
102328518|NCT01402492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102328519|NCT01402492|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102328520|NCT01402492|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102328521|NCT01894256|Olaparib|olaparib|mesh-list
102328522|NCT01894256|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102328523|NCT01894256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102328524|NCT01894256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328525|NCT01894256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102328526|NCT01780935|Ranibizumab|ranibizumab|mesh-list
102328527|NCT01780935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102328528|NCT01780935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102328529|NCT01780935|Growth Substances|growth substances|mesh-ancestor
102328530|NCT01780935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328531|NCT01780935|Growth Inhibitors|growth inhibitors|mesh-ancestor
102328532|NCT01780935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102328533|NCT01422538|Mannitol|mannitol|mesh-list
102328534|NCT01422538|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102328535|NCT01422538|Diuretics|diuretics|mesh-ancestor
102328536|NCT01422538|Natriuretic Agents|natriuretic agents|mesh-ancestor
102328537|NCT01422538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328538|NCT01422382|Diltiazem|diltiazem|mesh-list
102328539|NCT01422382|Pitavastatin|pitavastatin|mesh-list
102328540|NCT01422382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102328541|NCT01422382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102328542|NCT01422382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102328543|NCT01422382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328544|NCT01422382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102328545|NCT01422382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328546|NCT01422382|Vasodilator Agents|vasodilator agents|mesh-ancestor
102328547|NCT01422382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102328548|NCT01422382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102328549|NCT01422382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102328550|NCT01422382|Antimetabolites|antimetabolites|mesh-ancestor
102328551|NCT01422382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102328552|NCT01422382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102328553|NCT01401322|Lenalidomide|lenalidomide|mesh-list
102328554|NCT01401322|Immunologic Factors|immunologic factors|mesh-ancestor
102328555|NCT01401322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328556|NCT01401322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102328557|NCT01401322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102328558|NCT01401322|Growth Substances|growth substances|mesh-ancestor
102328559|NCT01401322|Growth Inhibitors|growth inhibitors|mesh-ancestor
102328560|NCT01401322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102328562|NCT01401010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102328563|NCT01401010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102328564|NCT01400932|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102328565|NCT01400932|Dermatologic Agents|dermatologic agents|mesh-ancestor
102328566|NCT01890746|Cytarabine|cytarabine|mesh-list
102328567|NCT01890746|Daunorubicin|daunorubicin|mesh-list
102328568|NCT01890746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102328569|NCT01890746|Antimetabolites|antimetabolites|mesh-ancestor
102328570|NCT01890746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328571|NCT01890746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102328572|NCT01890746|Antiviral Agents|antiviral agents|mesh-ancestor
102328573|NCT01890746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102328574|NCT01890746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102328575|NCT01890746|Immunologic Factors|immunologic factors|mesh-ancestor
102328576|NCT01890746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328577|NCT01890746|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102328578|NCT01890746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102328579|NCT01890746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102328580|NCT01890746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102328581|NCT01422304|Atropine|atropine|mesh-list
102328582|NCT01422304|Glycopyrrolate|glycopyrrolate|mesh-list
102328583|NCT01422304|Neostigmine|neostigmine|mesh-list
102328584|NCT01422304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102328585|NCT01422304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102328586|NCT01422304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102328587|NCT01422304|Autonomic Agents|autonomic agents|mesh-ancestor
102328588|NCT01422304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102328589|NCT01422304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328590|NCT01422304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102328591|NCT01422304|Respiratory System Agents|respiratory system agents|mesh-ancestor
102328592|NCT01422304|Mydriatics|mydriatics|mesh-ancestor
102328593|NCT01422304|Parasympatholytics|parasympatholytics|mesh-ancestor
102328594|NCT01422304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102328595|NCT01422304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102328596|NCT01422304|Cholinergic Agents|cholinergic agents|mesh-ancestor
102328597|NCT01422304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102328598|NCT01422304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328599|NCT01422304|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102328600|NCT01422304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102328601|NCT01422304|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102328602|NCT01387516|Nicotine|nicotine|mesh-list
102328603|NCT01387516|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102328604|NCT01387516|Autonomic Agents|autonomic agents|mesh-ancestor
102328605|NCT01387516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102328606|NCT01387516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328607|NCT01387516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102328608|NCT01387516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102328609|NCT01387516|Cholinergic Agents|cholinergic agents|mesh-ancestor
102328610|NCT01387516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102328611|NCT01387516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328612|NCT01421134|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102328613|NCT01421134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102328614|NCT01421134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102328615|NCT01421134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102328616|NCT01421134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328617|NCT01421134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102328618|NCT01421134|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102328619|NCT01421134|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102328620|NCT01421134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102328621|NCT01421134|Adrenergic Agents|adrenergic agents|mesh-ancestor
102328622|NCT01421134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102328623|NCT01421134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328624|NCT01421134|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102328625|NCT01421134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102328626|NCT01421134|Serotonin Agents|serotonin agents|mesh-ancestor
102328627|NCT01421134|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102328628|NCT01421134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102328629|NCT01421134|Dopamine Agents|dopamine agents|mesh-ancestor
102328630|NCT01894022|Ambrisentan|ambrisentan|mesh-list
102328631|NCT01894022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102328632|NCT01386970|Lamivudine|lamivudine|mesh-list
102328633|NCT01386970|Zidovudine|zidovudine|mesh-list
102328634|NCT01386970|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
102328635|NCT01386970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102328636|NCT01386970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102328637|NCT01386970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102328638|NCT01386970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328639|NCT01386970|Antiviral Agents|antiviral agents|mesh-ancestor
102328640|NCT01386970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102328641|NCT01386970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102328642|NCT01386970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102328643|NCT01386970|Antimetabolites|antimetabolites|mesh-ancestor
102328644|NCT01385566|Vaccines|vaccines|mesh-list
102328645|NCT01385566|Immunologic Factors|immunologic factors|mesh-ancestor
102328646|NCT01385566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328647|NCT05365984|Carbon Monoxide|carbon monoxide|mesh-list
102328648|NCT05365984|Antimetabolites|antimetabolites|mesh-ancestor
102328649|NCT05365984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328650|NCT05365984|Gasotransmitters|gasotransmitters|mesh-ancestor
102328651|NCT05365984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102328652|NCT05365984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328653|NCT01780545|Docetaxel|docetaxel|mesh-list
102328654|NCT01780545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102328655|NCT01780545|Tubulin Modulators|tubulin modulators|mesh-ancestor
102328656|NCT01780545|Antimitotic Agents|antimitotic agents|mesh-ancestor
102328657|NCT01780545|Mitosis Modulators|mitosis modulators|mesh-ancestor
102037488|NCT03207451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102328658|NCT01780545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328659|NCT01780389|Milnacipran|milnacipran|mesh-list
102328660|NCT01780389|Levomilnacipran|levomilnacipran|mesh-list
102328661|NCT01780389|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102328662|NCT01780389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102328663|NCT01780389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102328664|NCT01780389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328665|NCT01780389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102328666|NCT01780389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328667|NCT01780389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102328668|NCT01780389|Analgesics|analgesics|mesh-ancestor
102328669|NCT01780389|Sensory System Agents|sensory system agents|mesh-ancestor
102328670|NCT01780389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102328671|NCT01780389|Antidepressive Agents|antidepressive agents|mesh-ancestor
102328672|NCT01780389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102328673|NCT01778985|Estrogens|estrogens|mesh-list
102328674|NCT01778985|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
102328675|NCT01778985|Hormones|hormones|mesh-ancestor
102328676|NCT01778985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102328677|NCT01778985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328678|NCT01865084|Tadalafil|tadalafil|mesh-list
102328679|NCT01865084|Vasodilator Agents|vasodilator agents|mesh-ancestor
102328680|NCT01865084|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102328681|NCT01865084|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102328682|NCT01865084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102328683|NCT01865084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328684|NCT01865084|Urological Agents|urological agents|mesh-ancestor
102328685|NCT01385098|Calcium, Dietary|calcium, dietary|mesh-list
102328686|NCT01385098|Vitamin D|vitamin d|mesh-list
102328687|NCT01385098|Ergocalciferols|ergocalciferols|mesh-list
102328688|NCT01385098|Cholecalciferol|cholecalciferol|mesh-list
102328689|NCT01385098|Vitamins|vitamins|mesh-list
102328690|NCT01385098|Calcium|calcium|mesh-list
102328691|NCT01385098|Micronutrients|micronutrients|mesh-ancestor
102328692|NCT01385098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328693|NCT01385098|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102328694|NCT01385098|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102328695|NCT01398514|Escitalopram|escitalopram|mesh-list
102328696|NCT01398514|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102328697|NCT01398514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102328698|NCT01398514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102328699|NCT01398514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328700|NCT01398514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102328701|NCT01398514|Serotonin Agents|serotonin agents|mesh-ancestor
102328702|NCT01398514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328703|NCT03025282|Betamethasone|betamethasone|mesh-list
102328704|NCT03025282|Betamethasone Valerate|betamethasone valerate|mesh-list
102328705|NCT03025282|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102328706|NCT03025282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102328707|NCT03025282|Glucocorticoids|glucocorticoids|mesh-ancestor
102328708|NCT03025282|Hormones|hormones|mesh-ancestor
102328709|NCT03025282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102328710|NCT03025282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328711|NCT03025282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102328712|NCT03025282|Respiratory System Agents|respiratory system agents|mesh-ancestor
102328713|NCT01778049|Empagliflozin|empagliflozin|mesh-list
102328714|NCT01778049|Linagliptin|linagliptin|mesh-list
102328715|NCT01778049|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102328716|NCT01778049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328717|NCT01778049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102328718|NCT01778049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328719|NCT01778049|Incretins|incretins|mesh-ancestor
102328720|NCT01778049|Hormones|hormones|mesh-ancestor
102328721|NCT01778049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102328722|NCT01778049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102328723|NCT01778049|Protease Inhibitors|protease inhibitors|mesh-ancestor
102328724|NCT01778049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102328725|NCT01777581|Milnacipran|milnacipran|mesh-list
102328726|NCT01777581|Levomilnacipran|levomilnacipran|mesh-list
102328727|NCT01777581|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102328728|NCT01777581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102328729|NCT01777581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102328730|NCT01777581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037562|NCT03701022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102328731|NCT01777581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102328732|NCT01777581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328733|NCT01777581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102328734|NCT01777581|Analgesics|analgesics|mesh-ancestor
102328735|NCT01777581|Sensory System Agents|sensory system agents|mesh-ancestor
102328736|NCT01777581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102328737|NCT01777581|Antidepressive Agents|antidepressive agents|mesh-ancestor
102328738|NCT01777581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102328739|NCT01864148|Interferons|interferons|mesh-list
102328740|NCT01864148|Interferon-beta|interferon-beta|mesh-list
102328741|NCT01864148|Interferon beta-1a|interferon beta-1a|mesh-list
102328742|NCT01864148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102328743|NCT01864148|Antiviral Agents|antiviral agents|mesh-ancestor
102328744|NCT01864148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102328745|NCT01864148|Immunologic Factors|immunologic factors|mesh-ancestor
102328746|NCT01864148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328747|NCT01864148|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102328748|NCT01890122|Metformin|metformin|mesh-list
102328749|NCT01890122|Alogliptin|alogliptin|mesh-list
102328750|NCT01890122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102328751|NCT01890122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328752|NCT01890122|Incretins|incretins|mesh-ancestor
102328753|NCT01890122|Hormones|hormones|mesh-ancestor
102328754|NCT01890122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102328755|NCT01890122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102328756|NCT01890122|Protease Inhibitors|protease inhibitors|mesh-ancestor
102328757|NCT01890122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102328758|NCT01890122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328759|NCT01397890|Budesonide|budesonide|mesh-list
102328760|NCT01397890|Formoterol Fumarate|formoterol fumarate|mesh-list
102328761|NCT01397890|Tiotropium Bromide|tiotropium bromide|mesh-list
102328762|NCT01397890|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
102328763|NCT01397890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102328764|NCT01397890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102328765|NCT01397890|Autonomic Agents|autonomic agents|mesh-ancestor
102328766|NCT01397890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102328767|NCT01397890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328768|NCT01397890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102328769|NCT01397890|Respiratory System Agents|respiratory system agents|mesh-ancestor
102328770|NCT01397890|Glucocorticoids|glucocorticoids|mesh-ancestor
102328771|NCT01397890|Hormones|hormones|mesh-ancestor
102328772|NCT01397890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102328773|NCT01397890|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102328774|NCT01397890|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102328775|NCT01397890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102328776|NCT01397890|Adrenergic Agents|adrenergic agents|mesh-ancestor
102328777|NCT01397890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102328778|NCT01397890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328779|NCT01397890|Parasympatholytics|parasympatholytics|mesh-ancestor
102328780|NCT01397890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102328781|NCT01397890|Cholinergic Agents|cholinergic agents|mesh-ancestor
102328783|NCT01777269|Dutasteride|dutasteride|mesh-list
102328784|NCT01777269|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102328785|NCT01777269|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102328786|NCT01777269|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102328787|NCT01777269|Adrenergic Agents|adrenergic agents|mesh-ancestor
102328788|NCT01777269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102328789|NCT01777269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328790|NCT01777269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328791|NCT01777269|Urological Agents|urological agents|mesh-ancestor
102328792|NCT01777269|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102328793|NCT01777269|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102328794|NCT01777269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102328795|NCT01777269|Hormone Antagonists|hormone antagonists|mesh-ancestor
102328796|NCT01777269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102328797|NCT04024696|Abexinostat|abexinostat|mesh-list
102328798|NCT04024696|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102328799|NCT04024696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102328800|NCT04024696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328801|NCT01777191|Ixekizumab|ixekizumab|mesh-list
102328802|NCT01777191|Dermatologic Agents|dermatologic agents|mesh-ancestor
102328803|NCT01896050|Tamoxifen|tamoxifen|mesh-list
101836571|NCT01014156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102328804|NCT01896050|Letrozole|letrozole|mesh-list
102328805|NCT01896050|Anastrozole|anastrozole|mesh-list
102328806|NCT01896050|Exemestane|exemestane|mesh-list
102328807|NCT01896050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102328808|NCT01896050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102328809|NCT01896050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102328810|NCT01896050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102328811|NCT01896050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328812|NCT01896050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102328813|NCT01896050|Hormone Antagonists|hormone antagonists|mesh-ancestor
102328814|NCT01896050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102328815|NCT01896050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328816|NCT01896050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102328817|NCT01896050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102328818|NCT01896050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102328819|NCT01896050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102328820|NCT01775787|Menthol|menthol|mesh-list
102328821|NCT01775787|Nicotine|nicotine|mesh-list
102328822|NCT01775787|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102328823|NCT01775787|Autonomic Agents|autonomic agents|mesh-ancestor
102328824|NCT01775787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102328825|NCT01775787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328826|NCT01775787|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102328827|NCT01775787|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102328828|NCT01775787|Cholinergic Agents|cholinergic agents|mesh-ancestor
102328829|NCT01775787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102328830|NCT01775787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328831|NCT01775787|Antipruritics|antipruritics|mesh-ancestor
102328832|NCT01775787|Dermatologic Agents|dermatologic agents|mesh-ancestor
102328833|NCT01775475|Prednisone|prednisone|mesh-list
102328834|NCT01775475|Cyclophosphamide|cyclophosphamide|mesh-list
102328835|NCT01775475|Lomustine|lomustine|mesh-list
102328836|NCT01775475|Doxorubicin|doxorubicin|mesh-list
102328837|NCT01775475|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102328838|NCT01775475|Etoposide|etoposide|mesh-list
102328839|NCT01775475|Vincristine|vincristine|mesh-list
102328840|NCT01775475|Etoposide phosphate|etoposide phosphate|mesh-list
102328841|NCT01775475|Procarbazine|procarbazine|mesh-list
102328842|NCT01775475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102328843|NCT01775475|Immunologic Factors|immunologic factors|mesh-ancestor
102328844|NCT01775475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328845|NCT01775475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102328846|NCT01775475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102328847|NCT01775475|Alkylating Agents|alkylating agents|mesh-ancestor
102328848|NCT01775475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328849|NCT01775475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102328850|NCT01775475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102328851|NCT01775475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102328852|NCT01775475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102328853|NCT01775475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102328854|NCT01775475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102328855|NCT01775475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102328856|NCT01775475|Glucocorticoids|glucocorticoids|mesh-ancestor
102328857|NCT01775475|Hormones|hormones|mesh-ancestor
102328858|NCT01775475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102328859|NCT01775475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102328860|NCT01775475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102328861|NCT01775475|Tubulin Modulators|tubulin modulators|mesh-ancestor
102328862|NCT01775475|Antimitotic Agents|antimitotic agents|mesh-ancestor
102328863|NCT01775475|Mitosis Modulators|mitosis modulators|mesh-ancestor
102328864|NCT01774929|Fentanyl|fentanyl|mesh-list
102328865|NCT01774929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102328866|NCT01774929|Narcotics|narcotics|mesh-ancestor
102328867|NCT01774929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102328868|NCT01774929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328869|NCT01774929|Analgesics|analgesics|mesh-ancestor
102328870|NCT01774929|Sensory System Agents|sensory system agents|mesh-ancestor
102328871|NCT01774929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102328872|NCT01774929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102328873|NCT01774929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102328874|NCT01774929|Anesthetics, General|anesthetics, general|mesh-ancestor
102328875|NCT01774929|Anesthetics|anesthetics|mesh-ancestor
102328876|NCT01774305|Dexmedetomidine|dexmedetomidine|mesh-list
102328877|NCT01774305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102328878|NCT01774305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102328879|NCT01774305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328880|NCT01774305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102328881|NCT01774305|Analgesics|analgesics|mesh-ancestor
102328882|NCT01774305|Sensory System Agents|sensory system agents|mesh-ancestor
102328883|NCT01774305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102328884|NCT01774305|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102328885|NCT01774305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102328886|NCT01774305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102328887|NCT01774305|Adrenergic Agents|adrenergic agents|mesh-ancestor
102328888|NCT01774305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102328889|NCT01774305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328890|NCT01397422|Amantadine|amantadine|mesh-list
102328891|NCT01397422|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102328892|NCT01397422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102328893|NCT01397422|Antiviral Agents|antiviral agents|mesh-ancestor
102328894|NCT01397422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102328895|NCT01397422|Dopamine Agents|dopamine agents|mesh-ancestor
102328896|NCT01397422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102328897|NCT01397422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328898|NCT01397422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328899|NCT01397422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102328900|NCT01397422|Analgesics|analgesics|mesh-ancestor
102328901|NCT01397422|Sensory System Agents|sensory system agents|mesh-ancestor
102328902|NCT01397422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102328903|NCT01736475|Factor VIII|factor viii|mesh-list
102328904|NCT01736475|BAX 855|bax 855|mesh-list
102328905|NCT01736475|Coagulants|coagulants|mesh-ancestor
102328906|NCT01863680|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102328907|NCT01863680|Hormones|hormones|mesh-list
102328908|NCT01863680|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102328909|NCT01863680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102328910|NCT01863680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328911|NCT01863680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102328912|NCT01747629|Albuterol|albuterol|mesh-list
102328913|NCT01747629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102328914|NCT01747629|Autonomic Agents|autonomic agents|mesh-ancestor
102328915|NCT01747629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102328916|NCT01747629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328917|NCT01747629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102328918|NCT01747629|Respiratory System Agents|respiratory system agents|mesh-ancestor
102328919|NCT01747629|Tocolytic Agents|tocolytic agents|mesh-ancestor
102328920|NCT01747629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102328921|NCT01747629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102328922|NCT01747629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102328923|NCT01747629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102328924|NCT01747629|Adrenergic Agents|adrenergic agents|mesh-ancestor
102328925|NCT01747629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102328926|NCT01747629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328927|NCT01863368|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102328928|NCT01863368|Lubricant Eye Drops|lubricant eye drops|mesh-list
102328929|NCT01863368|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102328930|NCT01886690|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102328931|NCT01886690|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102328932|NCT01886690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102328934|NCT01886690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102328935|NCT01885208|Exenatide|exenatide|mesh-list
102328936|NCT01885208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102328937|NCT01885208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328938|NCT01885208|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102328939|NCT01885208|Incretins|incretins|mesh-ancestor
102328940|NCT01885208|Hormones|hormones|mesh-ancestor
102328941|NCT01885208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102328942|NCT01859702|Moxifloxacin|moxifloxacin|mesh-list
102328943|NCT01859702|Dexamethasone|dexamethasone|mesh-list
102328944|NCT01859702|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102328945|NCT01859702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102328946|NCT01859702|Antiemetics|antiemetics|mesh-ancestor
102328947|NCT01859702|Autonomic Agents|autonomic agents|mesh-ancestor
102328948|NCT01859702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102328949|NCT01859702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328950|NCT01859702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102328951|NCT01859702|Glucocorticoids|glucocorticoids|mesh-ancestor
102328952|NCT01859702|Hormones|hormones|mesh-ancestor
102328953|NCT01859702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102328954|NCT01859702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102328955|NCT01859702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102328956|NCT01859702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102328957|NCT01859702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102328958|NCT01859702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102328959|NCT01859702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102328960|NCT01859702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102328961|NCT01859702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102328962|NCT01859702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328963|NCT01747551|Leucovorin|leucovorin|mesh-list
102328964|NCT01747551|Fluorouracil|fluorouracil|mesh-list
102328965|NCT01747551|Oxaliplatin|oxaliplatin|mesh-list
102328966|NCT01747551|Aflibercept|aflibercept|mesh-list
102328967|NCT01747551|Antimetabolites|antimetabolites|mesh-ancestor
102328968|NCT01747551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328969|NCT01747551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102328970|NCT01747551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102328971|NCT01747551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102328972|NCT01747551|Immunologic Factors|immunologic factors|mesh-ancestor
102328973|NCT01747551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328974|NCT01747551|Antidotes|antidotes|mesh-ancestor
102328975|NCT01747551|Protective Agents|protective agents|mesh-ancestor
102328976|NCT01747551|Vitamin B Complex|vitamin b complex|mesh-ancestor
102328977|NCT01747551|Vitamins|vitamins|mesh-ancestor
102328978|NCT01747551|Micronutrients|micronutrients|mesh-ancestor
102328979|NCT01747551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102328980|NCT01747551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102328981|NCT01747551|Growth Substances|growth substances|mesh-ancestor
102328982|NCT01747551|Growth Inhibitors|growth inhibitors|mesh-ancestor
102328983|NCT01859390|Antioxidants|antioxidants|mesh-list
102328984|NCT01859390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328985|NCT01859390|Protective Agents|protective agents|mesh-ancestor
102328986|NCT01859390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102328987|NCT01858766|Ribavirin|ribavirin|mesh-list
102328988|NCT01858766|Antiviral Agents|antiviral agents|mesh-ancestor
102328989|NCT01858766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102328990|NCT01858766|Antimetabolites|antimetabolites|mesh-ancestor
102328991|NCT01858766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102328992|NCT01745367|Paclitaxel|paclitaxel|mesh-list
102328993|NCT01745367|Tivozanib|tivozanib|mesh-list
102328994|NCT01745367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102328995|NCT01745367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102328996|NCT01745367|Tubulin Modulators|tubulin modulators|mesh-ancestor
102328997|NCT01745367|Antimitotic Agents|antimitotic agents|mesh-ancestor
102328998|NCT01745367|Mitosis Modulators|mitosis modulators|mesh-ancestor
102328999|NCT01745367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329000|NCT01745367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102329001|NCT01745367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102329002|NCT01733121|Tetrabenazine|tetrabenazine|mesh-list
102329003|NCT01733121|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102329004|NCT01733121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102329005|NCT01733121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102329006|NCT01733121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329007|NCT01733121|Adrenergic Agents|adrenergic agents|mesh-ancestor
102329008|NCT01733121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102329009|NCT01733121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329010|NCT01383928|Dexamethasone|dexamethasone|mesh-list
102329011|NCT01383928|Lenalidomide|lenalidomide|mesh-list
102329012|NCT01383928|Ixazomib|ixazomib|mesh-list
102329013|NCT01383928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102329014|NCT01383928|Antiemetics|antiemetics|mesh-ancestor
102329015|NCT01383928|Autonomic Agents|autonomic agents|mesh-ancestor
102329016|NCT01383928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102329017|NCT01383928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329018|NCT01383928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102329019|NCT01383928|Glucocorticoids|glucocorticoids|mesh-ancestor
102329020|NCT01383928|Hormones|hormones|mesh-ancestor
102329021|NCT01383928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102329022|NCT01383928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102329023|NCT01383928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329024|NCT01383928|Immunologic Factors|immunologic factors|mesh-ancestor
102329025|NCT01383928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102329026|NCT01383928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102329027|NCT01383928|Growth Substances|growth substances|mesh-ancestor
102329028|NCT01383928|Growth Inhibitors|growth inhibitors|mesh-ancestor
102329029|NCT01383928|Protease Inhibitors|protease inhibitors|mesh-ancestor
102037859|NCT03695952|Nivolumab|nivolumab|mesh-list
102329030|NCT01383928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102329031|NCT01383928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329033|NCT04023604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102329034|NCT05368012|Dexamethasone|dexamethasone|mesh-list
102329035|NCT05368012|Bupivacaine|bupivacaine|mesh-list
102329036|NCT05368012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102329037|NCT05368012|Antiemetics|antiemetics|mesh-ancestor
102329038|NCT05368012|Autonomic Agents|autonomic agents|mesh-ancestor
102329039|NCT05368012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102329040|NCT05368012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329041|NCT05368012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102329042|NCT05368012|Glucocorticoids|glucocorticoids|mesh-ancestor
102329043|NCT05368012|Hormones|hormones|mesh-ancestor
102329044|NCT05368012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102329045|NCT05368012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102329046|NCT05368012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329047|NCT05368012|Anesthetics, Local|anesthetics, local|mesh-ancestor
102329048|NCT05368012|Anesthetics|anesthetics|mesh-ancestor
102329049|NCT05368012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102329050|NCT05368012|Sensory System Agents|sensory system agents|mesh-ancestor
102329051|NCT05893225|Metformin|metformin|mesh-list
102329052|NCT05893225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102329053|NCT05893225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329054|NCT05893147|Lactams|lactams|mesh-list
102329055|NCT05893147|Cephalosporins|cephalosporins|mesh-list
102329056|NCT05893147|beta-Lactams|beta-lactams|mesh-list
102329057|NCT05893147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102329058|NCT05893147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102329059|NCT05893108|Triamcinolone|triamcinolone|mesh-list
102329060|NCT05893108|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102329061|NCT05893108|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102329062|NCT05893108|Losartan|losartan|mesh-list
102329063|NCT05893108|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102329064|NCT05893108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102329065|NCT05893108|Glucocorticoids|glucocorticoids|mesh-ancestor
102329066|NCT05893108|Hormones|hormones|mesh-ancestor
102329067|NCT05893108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102329068|NCT05893108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329069|NCT05893108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102329070|NCT05893108|Immunologic Factors|immunologic factors|mesh-ancestor
102329071|NCT05893108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102329072|NCT05893108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329073|NCT05893108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102329074|NCT05893108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102329075|NCT05893108|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102329076|NCT05893108|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102329077|NCT05892887|Bupivacaine|bupivacaine|mesh-list
102329078|NCT05892887|Anesthetics, Local|anesthetics, local|mesh-ancestor
102329079|NCT05892887|Anesthetics|anesthetics|mesh-ancestor
102329080|NCT05892887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102329081|NCT05892887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329082|NCT05892887|Sensory System Agents|sensory system agents|mesh-ancestor
102329083|NCT05892887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102329084|NCT05892770|Zinc|zinc|mesh-list
102329085|NCT05892770|Botulinum Toxins|botulinum toxins|mesh-list
102329086|NCT05892770|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102329087|NCT05892770|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102329088|NCT05892770|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102329089|NCT05892770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102329090|NCT05892770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329091|NCT05892770|Cholinergic Agents|cholinergic agents|mesh-ancestor
102329092|NCT05892770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102329093|NCT05892770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329094|NCT05892770|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102329095|NCT05892770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102329096|NCT05892770|Trace Elements|trace elements|mesh-ancestor
102329097|NCT05892770|Micronutrients|micronutrients|mesh-ancestor
102329098|NCT05892744|Sertraline|sertraline|mesh-list
102329099|NCT05892744|Antidepressive Agents|antidepressive agents|mesh-ancestor
102329100|NCT05892744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102329101|NCT05892744|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102329102|NCT05892744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102329103|NCT05892744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102329104|NCT05892744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329105|NCT05892744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102329106|NCT05892744|Serotonin Agents|serotonin agents|mesh-ancestor
102329107|NCT05892744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329108|NCT05892705|Dexmedetomidine|dexmedetomidine|mesh-list
102329109|NCT05892705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102329110|NCT05892705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102329111|NCT05892705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329112|NCT05892705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102329113|NCT05892705|Analgesics|analgesics|mesh-ancestor
102329114|NCT05892705|Sensory System Agents|sensory system agents|mesh-ancestor
102329115|NCT05892705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102329116|NCT05892705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102329117|NCT05892705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102329118|NCT05892705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102329119|NCT05892705|Adrenergic Agents|adrenergic agents|mesh-ancestor
102329120|NCT05892705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102329121|NCT05892705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329122|NCT05892471|Propofol|propofol|mesh-list
102329123|NCT05892471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102329124|NCT05892471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102329125|NCT05892471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329126|NCT05892471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102329127|NCT05892471|Anesthetics, General|anesthetics, general|mesh-ancestor
102329128|NCT05892471|Anesthetics|anesthetics|mesh-ancestor
102329129|NCT05892068|Tucatinib|tucatinib|mesh-list
102329130|NCT05892068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329131|NCT05892068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102329132|NCT05892068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102329133|NCT05892068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329134|NCT05892042|Rivaroxaban|rivaroxaban|mesh-list
102329135|NCT05892042|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102329136|NCT05892042|Antithrombins|antithrombins|mesh-ancestor
102329137|NCT05892042|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102329138|NCT05892042|Protease Inhibitors|protease inhibitors|mesh-ancestor
102329139|NCT05892042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102329140|NCT05892042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329141|NCT05892042|Anticoagulants|anticoagulants|mesh-ancestor
102329142|NCT05891613|Bupivacaine|bupivacaine|mesh-list
102329143|NCT05891613|Anesthetics, Local|anesthetics, local|mesh-ancestor
102329144|NCT05891613|Anesthetics|anesthetics|mesh-ancestor
102329145|NCT05891613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102329146|NCT05891613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329147|NCT05891613|Sensory System Agents|sensory system agents|mesh-ancestor
102329148|NCT05891613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102329149|NCT05891561|Pertuzumab|pertuzumab|mesh-list
102329150|NCT05891561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102329161|NCT05889949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329162|NCT05889949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102329163|NCT05889949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102329164|NCT05889949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329166|NCT05887804|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102329167|NCT05887804|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102329168|NCT05887804|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102329169|NCT05887804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102329170|NCT05887804|Glucocorticoids|glucocorticoids|mesh-ancestor
102329171|NCT05887804|Hormones|hormones|mesh-ancestor
102329172|NCT05887804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102329173|NCT05887804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329174|NCT05887804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102329175|NCT05887804|Immunologic Factors|immunologic factors|mesh-ancestor
102329176|NCT05887804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102329177|NCT05887804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329178|NCT05875272|Hemostatics|hemostatics|mesh-list
102329179|NCT05875272|Coagulants|coagulants|mesh-ancestor
102329180|NCT05808725|Amlodipine|amlodipine|mesh-list
102329181|NCT05808725|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102329182|NCT05808725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102329183|NCT05808725|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102329184|NCT05808725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102329185|NCT05808725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329186|NCT05808725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102329187|NCT05808725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329188|NCT05808725|Vasodilator Agents|vasodilator agents|mesh-ancestor
102329189|NCT05792540|Dapagliflozin|dapagliflozin|mesh-list
102329190|NCT05792540|Fluoxetine|fluoxetine|mesh-list
102329191|NCT05792540|Atorvastatin|atorvastatin|mesh-list
102329192|NCT05792540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102329193|NCT05792540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102329194|NCT05792540|Antimetabolites|antimetabolites|mesh-ancestor
102329195|NCT05792540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329196|NCT05792540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102329197|NCT05792540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102329198|NCT05792540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102329199|NCT05792540|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102329200|NCT05792540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102329201|NCT05792540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329202|NCT05792540|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102329203|NCT05792540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102329204|NCT05792540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102329205|NCT05792540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102329206|NCT05792540|Serotonin Agents|serotonin agents|mesh-ancestor
102329207|NCT05792540|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102329208|NCT05792540|Antidepressive Agents|antidepressive agents|mesh-ancestor
102329209|NCT05792540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102329210|NCT05792540|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102329211|NCT05792540|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102329212|NCT05781711|Metformin|metformin|mesh-list
102329213|NCT05781711|Levodopa|levodopa|mesh-list
102329214|NCT05781711|Carbidopa|carbidopa|mesh-list
102329215|NCT05781711|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102329216|NCT05781711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102329217|NCT05781711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329218|NCT05781711|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102329219|NCT05781711|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102329220|NCT05781711|Dopamine Agents|dopamine agents|mesh-ancestor
102329221|NCT05781711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102329222|NCT05781711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329223|NCT05781711|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102329224|NCT05781711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102329225|NCT05781711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102329226|NCT05781711|Immunologic Factors|immunologic factors|mesh-ancestor
102329227|NCT05781711|Dopamine Agonists|dopamine agonists|mesh-ancestor
102329228|NCT05780879|Venetoclax|venetoclax|mesh-list
102329229|NCT05780879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329230|NCT05780307|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102329231|NCT05780307|Immunologic Factors|immunologic factors|mesh-ancestor
102329232|NCT05780307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329233|NCT05776134|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
102329234|NCT05776134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102329235|NCT05776134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329236|NCT05746208|Pembrolizumab|pembrolizumab|mesh-list
102329237|NCT05746208|Lenvatinib|lenvatinib|mesh-list
102329238|NCT05746208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102329239|NCT05746208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329240|NCT05746208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102329241|NCT05746208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329242|NCT05746208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102329243|NCT05746208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102329244|NCT05742958|Morphine|morphine|mesh-list
102329245|NCT05742958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102329246|NCT05742958|Narcotics|narcotics|mesh-ancestor
102329247|NCT05742958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102329248|NCT05742958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329249|NCT05742958|Analgesics|analgesics|mesh-ancestor
102329250|NCT05742958|Sensory System Agents|sensory system agents|mesh-ancestor
102329251|NCT05742958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102329252|NCT05710666|Trastuzumab|trastuzumab|mesh-list
102329253|NCT05710666|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
102329254|NCT05710666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102038083|NCT03257631|Growth Substances|growth substances|mesh-ancestor
102329255|NCT05710666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329256|NCT05710666|Immunoconjugates|immunoconjugates|mesh-ancestor
102329257|NCT05710666|Immunologic Factors|immunologic factors|mesh-ancestor
102329258|NCT05710666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329259|NCT05701215|Venetoclax|venetoclax|mesh-list
102329260|NCT05701215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329261|NCT05700214|Lidocaine|lidocaine|mesh-list
102329262|NCT05700214|Ropivacaine|ropivacaine|mesh-list
102329263|NCT05700214|Anesthetics, Local|anesthetics, local|mesh-ancestor
102329264|NCT05700214|Anesthetics|anesthetics|mesh-ancestor
102329265|NCT05700214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102329266|NCT05700214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329267|NCT05700214|Sensory System Agents|sensory system agents|mesh-ancestor
102329268|NCT05700214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102329269|NCT05700214|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102329270|NCT05700214|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102329271|NCT05700214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102329272|NCT05700214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102329273|NCT05700214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329274|NCT05700045|Dexmedetomidine|dexmedetomidine|mesh-list
102329275|NCT05700045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102329276|NCT05700045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102329277|NCT05700045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329278|NCT05700045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102329279|NCT05700045|Analgesics|analgesics|mesh-ancestor
102329280|NCT05700045|Sensory System Agents|sensory system agents|mesh-ancestor
102329281|NCT05700045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102329282|NCT05700045|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102329283|NCT05700045|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102329284|NCT05700045|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102329285|NCT05700045|Adrenergic Agents|adrenergic agents|mesh-ancestor
102329286|NCT05700045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102329287|NCT05700045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329294|NCT05676294|Olanzapine|olanzapine|mesh-list
102329295|NCT05676294|Antiemetics|antiemetics|mesh-ancestor
102329296|NCT05676294|Autonomic Agents|autonomic agents|mesh-ancestor
102329297|NCT05676294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102329298|NCT05676294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329299|NCT05676294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102329300|NCT05676294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102329301|NCT05676294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102329302|NCT05676294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102329303|NCT05676294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102329304|NCT05676294|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102329305|NCT05676294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102329306|NCT05676294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102329307|NCT05676294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329308|NCT05676294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102329309|NCT05676294|Serotonin Agents|serotonin agents|mesh-ancestor
102329310|NCT05659576|Sucralfate|sucralfate|mesh-list
102329311|NCT05659576|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102329312|NCT05659576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102329313|NCT05638867|Aspirin|aspirin|mesh-list
102329314|NCT05638867|Rivaroxaban|rivaroxaban|mesh-list
102329315|NCT05638867|Clopidogrel|clopidogrel|mesh-list
102329316|NCT05638867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102329317|NCT05638867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102329318|NCT05638867|Analgesics|analgesics|mesh-ancestor
102329319|NCT05638867|Sensory System Agents|sensory system agents|mesh-ancestor
102329320|NCT05638867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102329321|NCT05638867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329322|NCT05638867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102329323|NCT05638867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102329324|NCT05638867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102329325|NCT05638867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102329326|NCT05638867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329327|NCT05638867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102329328|NCT05638867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102329329|NCT05638867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102329330|NCT05638867|Antipyretics|antipyretics|mesh-ancestor
102329331|NCT05638867|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102329332|NCT05638867|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102329333|NCT05638867|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102329334|NCT05638867|Purinergic Agents|purinergic agents|mesh-ancestor
102329335|NCT05638867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102329336|NCT05638867|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102329337|NCT05638867|Antithrombins|antithrombins|mesh-ancestor
102329338|NCT05638867|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102329339|NCT05638867|Protease Inhibitors|protease inhibitors|mesh-ancestor
102329340|NCT05638867|Anticoagulants|anticoagulants|mesh-ancestor
102329341|NCT05607407|Methimazole|methimazole|mesh-list
102329342|NCT05607407|Antithyroid Agents|antithyroid agents|mesh-ancestor
102329343|NCT05607407|Hormone Antagonists|hormone antagonists|mesh-ancestor
102329344|NCT05607407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102329345|NCT05607407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329346|NCT05600686|Prednisone|prednisone|mesh-list
102329347|NCT05600686|Cortisone|cortisone|mesh-list
102329348|NCT05600686|Cyclophosphamide|cyclophosphamide|mesh-list
102329349|NCT05600686|Rituximab|rituximab|mesh-list
102329350|NCT05600686|Doxorubicin|doxorubicin|mesh-list
102329351|NCT05600686|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102329352|NCT05600686|Etoposide|etoposide|mesh-list
102329353|NCT05600686|Vincristine|vincristine|mesh-list
102329354|NCT05600686|Etoposide phosphate|etoposide phosphate|mesh-list
102329355|NCT05600686|Daunorubicin|daunorubicin|mesh-list
102329356|NCT05600686|Podophyllotoxin|podophyllotoxin|mesh-list
102329357|NCT05600686|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
102329358|NCT05600686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102329359|NCT05600686|Antibodies|antibodies|mesh-list
102329360|NCT05600686|Immunoglobulins|immunoglobulins|mesh-list
101441633|NCT00168857|Losartan|losartan|mesh-list
102329361|NCT05600686|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102329362|NCT05600686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102329363|NCT05600686|Immunologic Factors|immunologic factors|mesh-ancestor
102329364|NCT05600686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329365|NCT05600686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102329366|NCT05600686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102329367|NCT05600686|Alkylating Agents|alkylating agents|mesh-ancestor
102329368|NCT05600686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329369|NCT05600686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329370|NCT05600686|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102329371|NCT05600686|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102329372|NCT05600686|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102329373|NCT05600686|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102329374|NCT05600686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102329375|NCT05600686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102329376|NCT05600686|Glucocorticoids|glucocorticoids|mesh-ancestor
102329377|NCT05600686|Hormones|hormones|mesh-ancestor
102329378|NCT05600686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102329379|NCT05600686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102329380|NCT05600686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102329381|NCT05600686|Tubulin Modulators|tubulin modulators|mesh-ancestor
102329382|NCT05600686|Antimitotic Agents|antimitotic agents|mesh-ancestor
102329383|NCT05600686|Mitosis Modulators|mitosis modulators|mesh-ancestor
102329384|NCT05600686|Keratolytic Agents|keratolytic agents|mesh-ancestor
102329385|NCT05600686|Dermatologic Agents|dermatologic agents|mesh-ancestor
102329386|NCT05585034|Pembrolizumab|pembrolizumab|mesh-list
102329387|NCT05585034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102329388|NCT05585034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329389|NCT05585034|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102329390|NCT05585034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329391|NCT05565378|Pembrolizumab|pembrolizumab|mesh-list
102329392|NCT05565378|Dostarlimab|dostarlimab|mesh-list
102329393|NCT05565378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102329394|NCT05565378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329395|NCT05565378|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102329396|NCT05565378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329397|NCT05564338|Tislelizumab|tislelizumab|mesh-list
102329398|NCT05564338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102329399|NCT05564338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329400|NCT05545384|Rituximab|rituximab|mesh-list
102329401|NCT05545384|Azathioprine|azathioprine|mesh-list
102329402|NCT05545384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102038236|NCT03158805|Hormones|hormones|mesh-ancestor
102329403|NCT05545384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329404|NCT05545384|Immunologic Factors|immunologic factors|mesh-ancestor
102329405|NCT05545384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329406|NCT05545384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102329407|NCT05545384|Antimetabolites|antimetabolites|mesh-ancestor
102329408|NCT05545384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329409|NCT05545384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102329410|NCT05545384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102329412|NCT05536284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102329413|NCT05536284|Sympatholytics|sympatholytics|mesh-ancestor
102329414|NCT05536284|Autonomic Agents|autonomic agents|mesh-ancestor
102329415|NCT05536284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102329416|NCT05536284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329417|NCT05536284|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102329418|NCT05536284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102329419|NCT05536284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102329420|NCT05536284|Adrenergic Agents|adrenergic agents|mesh-ancestor
102329421|NCT05536284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102329422|NCT05536284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329423|NCT05456490|Bupivacaine|bupivacaine|mesh-list
102329424|NCT05456490|Anesthetics, Local|anesthetics, local|mesh-ancestor
102329425|NCT05456490|Anesthetics|anesthetics|mesh-ancestor
102329426|NCT05456490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102329427|NCT05456490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329428|NCT05456490|Sensory System Agents|sensory system agents|mesh-ancestor
102329429|NCT05456490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102329430|NCT05409391|Insulin|insulin|mesh-list
102329431|NCT05409391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102329432|NCT05409391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329433|NCT05401110|Osimertinib|osimertinib|mesh-list
102329434|NCT05401110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329435|NCT05401110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102329436|NCT05401110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102329437|NCT05401110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329438|NCT05394493|Avelumab|avelumab|mesh-list
102329439|NCT05394493|Axitinib|axitinib|mesh-list
102329440|NCT05394493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102329441|NCT05394493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329442|NCT05394493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102329443|NCT05394493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102329444|NCT05394493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329445|NCT05372354|Dexamethasone|dexamethasone|mesh-list
102329446|NCT05372354|Trametinib|trametinib|mesh-list
102329447|NCT05372354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102329448|NCT05372354|Antiemetics|antiemetics|mesh-ancestor
102329449|NCT05372354|Autonomic Agents|autonomic agents|mesh-ancestor
102329450|NCT05372354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102329451|NCT05372354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329452|NCT05372354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102329453|NCT05372354|Glucocorticoids|glucocorticoids|mesh-ancestor
102329454|NCT05372354|Hormones|hormones|mesh-ancestor
102329455|NCT05372354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102329456|NCT05372354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102329457|NCT05372354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329458|NCT05372354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102329459|NCT05372354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102329460|NCT05372354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329461|NCT05367063|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102329462|NCT05367063|Canagliflozin|canagliflozin|mesh-list
102329463|NCT05367063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102329464|NCT05367063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329465|NCT05367063|Incretins|incretins|mesh-ancestor
102329466|NCT05367063|Hormones|hormones|mesh-ancestor
102329467|NCT05367063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102329468|NCT05367063|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102329469|NCT05367063|Protease Inhibitors|protease inhibitors|mesh-ancestor
102329470|NCT05367063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102329471|NCT05367063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329472|NCT05367063|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102329473|NCT05358548|Paclitaxel|paclitaxel|mesh-list
102329474|NCT05358548|Carboplatin|carboplatin|mesh-list
102329475|NCT05358548|Pembrolizumab|pembrolizumab|mesh-list
102329476|NCT05358548|Fluorouracil|fluorouracil|mesh-list
102329477|NCT05358548|Pemetrexed|pemetrexed|mesh-list
102329478|NCT05358548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102329479|NCT05358548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329480|NCT05358548|Tubulin Modulators|tubulin modulators|mesh-ancestor
102329481|NCT05358548|Antimitotic Agents|antimitotic agents|mesh-ancestor
102329482|NCT05358548|Mitosis Modulators|mitosis modulators|mesh-ancestor
102329483|NCT05358548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329484|NCT05358548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102329485|NCT05358548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102329486|NCT05358548|Antimetabolites|antimetabolites|mesh-ancestor
102329487|NCT05358548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102329488|NCT05358548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102329489|NCT05358548|Immunologic Factors|immunologic factors|mesh-ancestor
102329490|NCT05358548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329491|NCT05358548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102329492|NCT05358548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102329493|NCT05358548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102329494|NCT05358249|Cetuximab|cetuximab|mesh-list
102329495|NCT05358249|Trametinib|trametinib|mesh-list
102329496|NCT05358249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102329497|NCT05358249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329498|NCT05358249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102329499|NCT05358249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102329500|NCT05358249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329501|NCT05274477|4-Aminopyridine|4-aminopyridine|mesh-list
102329502|NCT05274477|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102329503|NCT05274477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102329504|NCT05274477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329505|NCT05262556|Nivolumab|nivolumab|mesh-list
102329506|NCT05262556|Ipilimumab|ipilimumab|mesh-list
102329507|NCT05262556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102329508|NCT05262556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329509|NCT05262556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102329510|NCT05262556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329511|NCT05244070|Cyclophosphamide|cyclophosphamide|mesh-list
102329512|NCT05244070|Fludarabine|fludarabine|mesh-list
102329513|NCT05244070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102329514|NCT05244070|Immunologic Factors|immunologic factors|mesh-ancestor
102329515|NCT05244070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329516|NCT05244070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102329517|NCT05244070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102329518|NCT05244070|Alkylating Agents|alkylating agents|mesh-ancestor
102329519|NCT05244070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329520|NCT05244070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329521|NCT05244070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102329522|NCT05236777|Natalizumab|natalizumab|mesh-list
102329523|NCT05236777|Immunologic Factors|immunologic factors|mesh-ancestor
102329524|NCT05236777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329525|NCT05222607|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102329526|NCT05222607|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102329527|NCT05222607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102329528|NCT05222607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329529|NCT05222607|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102329530|NCT05222607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102329531|NCT05222607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329532|NCT05222607|Cholinergic Agents|cholinergic agents|mesh-ancestor
102329533|NCT05222607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102329534|NCT05205486|Cefazolin|cefazolin|mesh-list
102329535|NCT05205486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102329536|NCT05205486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102329537|NCT05167409|Pembrolizumab|pembrolizumab|mesh-list
102329538|NCT05167409|Cetuximab|cetuximab|mesh-list
102329539|NCT05167409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102329540|NCT05167409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329541|NCT05167409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102329542|NCT05167409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329543|NCT05161195|Tamoxifen|tamoxifen|mesh-list
102329544|NCT05161195|Letrozole|letrozole|mesh-list
102329545|NCT05161195|Fulvestrant|fulvestrant|mesh-list
102329546|NCT05161195|Anastrozole|anastrozole|mesh-list
102329547|NCT05161195|Goserelin|goserelin|mesh-list
102329548|NCT05161195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329549|NCT05161195|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102329550|NCT05161195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102329551|NCT05161195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102329552|NCT05161195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329553|NCT05161195|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102329554|NCT05161195|Hormone Antagonists|hormone antagonists|mesh-ancestor
102329555|NCT05161195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102329556|NCT05161195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329557|NCT05161195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102329558|NCT05161195|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102329559|NCT05161195|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102329560|NCT05161195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102329561|NCT05161195|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102329562|NCT05096117|ASP8062|asp8062|mesh-list
102329563|NCT05096117|Analgesics|analgesics|mesh-ancestor
102329564|NCT05096117|Sensory System Agents|sensory system agents|mesh-ancestor
102329565|NCT05096117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102329566|NCT05096117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329567|NCT05096117|GABA Modulators|gaba modulators|mesh-ancestor
102329568|NCT05096117|GABA Agents|gaba agents|mesh-ancestor
102329569|NCT05096117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102329570|NCT05096117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329571|NCT05072093|Tenofovir|tenofovir|mesh-list
102329572|NCT05072093|Emtricitabine|emtricitabine|mesh-list
102329573|NCT05072093|Cabotegravir|cabotegravir|mesh-list
102329574|NCT05072093|Doxycycline|doxycycline|mesh-list
102329575|NCT05072093|Antiviral Agents|antiviral agents|mesh-ancestor
102329576|NCT05072093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102329577|NCT05072093|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101441662|NCT02901379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102329578|NCT05072093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102329579|NCT05072093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102329580|NCT05072093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329581|NCT05072093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102329582|NCT05072093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102329583|NCT05072093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102329584|NCT05072093|Antimalarials|antimalarials|mesh-ancestor
102329585|NCT05072093|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102329586|NCT05072093|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102329587|NCT05072093|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102329588|NCT05072093|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102329589|NCT05047718|Vaccines|vaccines|mesh-list
102329590|NCT05047718|Immunologic Factors|immunologic factors|mesh-ancestor
102329591|NCT05047718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329592|NCT05027633|Carboplatin|carboplatin|mesh-list
102329593|NCT05027633|Docetaxel|docetaxel|mesh-list
102329594|NCT05027633|Pembrolizumab|pembrolizumab|mesh-list
102329595|NCT05027633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329596|NCT05027633|Tubulin Modulators|tubulin modulators|mesh-ancestor
102329597|NCT05027633|Antimitotic Agents|antimitotic agents|mesh-ancestor
102329598|NCT05027633|Mitosis Modulators|mitosis modulators|mesh-ancestor
102329599|NCT05027633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329600|NCT05027633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102329601|NCT05027633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102329602|NCT04979052|Interferons|interferons|mesh-list
102329603|NCT04979052|Interferon-gamma|interferon-gamma|mesh-list
102329604|NCT04979052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329605|NCT04979052|Antiviral Agents|antiviral agents|mesh-ancestor
102329606|NCT04979052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102329607|NCT04978584|Prednisone|prednisone|mesh-list
102329608|NCT04978584|Cortisone|cortisone|mesh-list
102329609|NCT04978584|Cyclophosphamide|cyclophosphamide|mesh-list
102329610|NCT04978584|Rituximab|rituximab|mesh-list
102329611|NCT04978584|Doxorubicin|doxorubicin|mesh-list
102329612|NCT04978584|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102329613|NCT04978584|Vincristine|vincristine|mesh-list
102329614|NCT04978584|Lenalidomide|lenalidomide|mesh-list
102329615|NCT04978584|Acalabrutinib|acalabrutinib|mesh-list
102329616|NCT04978584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102329617|NCT04978584|Antibodies|antibodies|mesh-list
102329618|NCT04978584|Immunoglobulins|immunoglobulins|mesh-list
102329619|NCT04978584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102329620|NCT04978584|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102329621|NCT04978584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102329622|NCT04978584|Immunologic Factors|immunologic factors|mesh-ancestor
102329623|NCT04978584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329624|NCT04978584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102329625|NCT04978584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102329626|NCT04978584|Alkylating Agents|alkylating agents|mesh-ancestor
102329627|NCT04978584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329628|NCT04978584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329629|NCT04978584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102038457|NCT02451111|Rituximab|rituximab|mesh-list
102329630|NCT04978584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102329631|NCT04978584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102329632|NCT04978584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102329633|NCT04978584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102329634|NCT04978584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102329635|NCT04978584|Glucocorticoids|glucocorticoids|mesh-ancestor
102329636|NCT04978584|Hormones|hormones|mesh-ancestor
102329637|NCT04978584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102329638|NCT04978584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102329639|NCT04978584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102329640|NCT04978584|Tubulin Modulators|tubulin modulators|mesh-ancestor
102329641|NCT04978584|Antimitotic Agents|antimitotic agents|mesh-ancestor
102329642|NCT04978584|Mitosis Modulators|mitosis modulators|mesh-ancestor
102329643|NCT04978584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102329644|NCT04978584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102329645|NCT04978584|Growth Substances|growth substances|mesh-ancestor
102329646|NCT04978584|Growth Inhibitors|growth inhibitors|mesh-ancestor
102329647|NCT04978584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102329648|NCT04954820|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102329649|NCT04954820|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102329650|NCT04954820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329651|NCT04950608|Psilocybin|psilocybin|mesh-list
102329652|NCT04950608|Hallucinogens|hallucinogens|mesh-ancestor
102329653|NCT04950608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329654|NCT04950608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102329655|NCT04940052|Trametinib|trametinib|mesh-list
102329656|NCT04940052|Dabrafenib|dabrafenib|mesh-list
102329657|NCT04940052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329658|NCT04940052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102329659|NCT04940052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102329660|NCT04940052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329661|NCT04898621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102329662|NCT04892446|Dexamethasone|dexamethasone|mesh-list
102329663|NCT04892446|Bortezomib|bortezomib|mesh-list
102329664|NCT04892446|Daratumumab|daratumumab|mesh-list
102329665|NCT04892446|Pomalidomide|pomalidomide|mesh-list
102329666|NCT04892446|Magrolimab|magrolimab|mesh-list
102329667|NCT04892446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102329668|NCT04892446|Antiemetics|antiemetics|mesh-ancestor
102329669|NCT04892446|Autonomic Agents|autonomic agents|mesh-ancestor
102329670|NCT04892446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102329671|NCT04892446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329672|NCT04892446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102329673|NCT04892446|Glucocorticoids|glucocorticoids|mesh-ancestor
102329674|NCT04892446|Hormones|hormones|mesh-ancestor
102329675|NCT04892446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102329676|NCT04892446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102329677|NCT04892446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329678|NCT04892446|Immunologic Factors|immunologic factors|mesh-ancestor
102329679|NCT04892446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102329680|NCT04892446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102329681|NCT04892446|Growth Substances|growth substances|mesh-ancestor
102329682|NCT04892446|Growth Inhibitors|growth inhibitors|mesh-ancestor
102329683|NCT04892446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102329684|NCT04851613|Fulvestrant|fulvestrant|mesh-list
102329685|NCT04851613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102329686|NCT04851613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329687|NCT04851613|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102329688|NCT04851613|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102329689|NCT04851613|Hormone Antagonists|hormone antagonists|mesh-ancestor
102329690|NCT04851613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102329691|NCT04851613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329692|NCT04820933|Tenofovir|tenofovir|mesh-list
102329693|NCT04820933|Emtricitabine|emtricitabine|mesh-list
102329694|NCT04820933|Antiviral Agents|antiviral agents|mesh-ancestor
102329695|NCT04820933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102329696|NCT04820933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102329697|NCT04820933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102329698|NCT04820933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102329699|NCT04820933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329700|NCT04820933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102329701|NCT04820933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102329702|NCT04702880|Carboplatin|carboplatin|mesh-list
102329703|NCT04702880|Nivolumab|nivolumab|mesh-list
102329704|NCT04702880|Etoposide|etoposide|mesh-list
102329705|NCT04702880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329706|NCT04702880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102329707|NCT04702880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102329708|NCT04702880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329709|NCT04702880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102329710|NCT04702880|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102329711|NCT04702880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102329712|NCT04702880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102329714|NCT04677816|Cholecalciferol|cholecalciferol|mesh-list
102329715|NCT04677816|Vitamins|vitamins|mesh-ancestor
102329716|NCT04677816|Micronutrients|micronutrients|mesh-ancestor
102329717|NCT04677816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329718|NCT04677816|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102329719|NCT04677816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102329720|NCT04628026|Venetoclax|venetoclax|mesh-list
102329721|NCT04628026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329722|NCT04605861|Liraglutide|liraglutide|mesh-list
102329723|NCT04605861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102329724|NCT04605861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329725|NCT04605861|Incretins|incretins|mesh-ancestor
102329726|NCT04605861|Hormones|hormones|mesh-ancestor
102329727|NCT04605861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102329728|NCT04564443|Calcium|calcium|mesh-list
102329729|NCT04564443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102329730|NCT04564443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329731|NCT04538742|Paclitaxel|paclitaxel|mesh-list
102329732|NCT04538742|Trastuzumab|trastuzumab|mesh-list
102329733|NCT04538742|Durvalumab|durvalumab|mesh-list
102329734|NCT04538742|Pertuzumab|pertuzumab|mesh-list
102329735|NCT04538742|Tucatinib|tucatinib|mesh-list
102329736|NCT04538742|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
102329737|NCT04538742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102329738|NCT04538742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329739|NCT04538742|Tubulin Modulators|tubulin modulators|mesh-ancestor
102329740|NCT04538742|Antimitotic Agents|antimitotic agents|mesh-ancestor
102329741|NCT04538742|Mitosis Modulators|mitosis modulators|mesh-ancestor
102329742|NCT04538742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329743|NCT04538742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102329744|NCT04538742|Immunoconjugates|immunoconjugates|mesh-ancestor
102329745|NCT04538742|Immunologic Factors|immunologic factors|mesh-ancestor
102329746|NCT04538742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329747|NCT04538742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102329748|NCT04538742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102329749|NCT04530630|Emtricitabine|emtricitabine|mesh-list
102329750|NCT04530630|Antiviral Agents|antiviral agents|mesh-ancestor
102329751|NCT04530630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102329752|NCT04530630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102329753|NCT04530630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102329754|NCT04530630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102329755|NCT04530630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329756|NCT04530630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102329757|NCT04530630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102329758|NCT04469764|Letrozole|letrozole|mesh-list
102329759|NCT04469764|Anastrozole|anastrozole|mesh-list
102329760|NCT04469764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329761|NCT04469764|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101441747|NCT00178620|Reteplase|reteplase|mesh-list
102329762|NCT04469764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102329763|NCT04469764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102329764|NCT04469764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329765|NCT04469764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102329766|NCT04469764|Hormone Antagonists|hormone antagonists|mesh-ancestor
102329767|NCT04469764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102329768|NCT04469764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329769|NCT04469764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102329770|NCT04450173|Venetoclax|venetoclax|mesh-list
102329771|NCT04450173|Obinutuzumab|obinutuzumab|mesh-list
102329772|NCT04450173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329773|NCT04450173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102329774|NCT04439292|Trametinib|trametinib|mesh-list
102329775|NCT04439292|Dabrafenib|dabrafenib|mesh-list
102329776|NCT04439292|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
102329777|NCT04439292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329778|NCT04439292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102329779|NCT04439292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102329780|NCT04439292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329781|NCT04439292|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102329782|NCT04439292|Protective Agents|protective agents|mesh-ancestor
102329783|NCT04439292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329784|NCT04439292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102329785|NCT04439292|Antioxidants|antioxidants|mesh-ancestor
102329786|NCT04439188|GSK2636771|gsk2636771|mesh-list
102329787|NCT04439188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329788|NCT04439188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102329789|NCT04439188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102329790|NCT04439188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329791|NCT04439149|GSK2636771|gsk2636771|mesh-list
102329792|NCT04439149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329793|NCT04439149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102329794|NCT04439149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102329795|NCT04439149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329796|NCT04416737|Insulin|insulin|mesh-list
102329797|NCT04416737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102329798|NCT04416737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329799|NCT04364607|Neostigmine|neostigmine|mesh-list
102329800|NCT04364607|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102329801|NCT04364607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102329802|NCT04364607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329803|NCT04364607|Cholinergic Agents|cholinergic agents|mesh-ancestor
102329804|NCT04364607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102329805|NCT04364607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329806|NCT04364607|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102329807|NCT04364607|Autonomic Agents|autonomic agents|mesh-ancestor
102329808|NCT04364607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102329809|NCT04348383|Defibrotide|defibrotide|mesh-list
102329810|NCT04348383|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102329811|NCT04348383|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102329812|NCT04348383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329813|NCT04348383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102329814|NCT04323202|Pembrolizumab|pembrolizumab|mesh-list
102329815|NCT04323202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102329816|NCT04323202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329817|NCT04323202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102329818|NCT04323202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329819|NCT04305691|Ixazomib|ixazomib|mesh-list
102329820|NCT04305691|Glycine|glycine|mesh-list
102329821|NCT04305691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329822|NCT04305691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329823|NCT04305691|Protease Inhibitors|protease inhibitors|mesh-ancestor
102329824|NCT04305691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102329825|NCT04305691|Glycine Agents|glycine agents|mesh-ancestor
102329826|NCT04305691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102329827|NCT04305691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329828|NCT04263792|Trimethoprim|trimethoprim|mesh-list
102329829|NCT04263792|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102329830|NCT04263792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102329831|NCT04263792|Antimalarials|antimalarials|mesh-ancestor
102329832|NCT04263792|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102329833|NCT04263792|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102329834|NCT04263792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102329835|NCT04263792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102329836|NCT04263792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329837|NCT04263792|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102329838|NCT04263792|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102329839|NCT04263792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102329840|NCT04230564|Azacitidine|azacitidine|mesh-list
102329841|NCT04230564|Venetoclax|venetoclax|mesh-list
102329842|NCT04230564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102329843|NCT04230564|Antimetabolites|antimetabolites|mesh-ancestor
102329844|NCT04230564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329845|NCT04230564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329846|NCT04230564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102329847|NCT04218409|Oxycodone|oxycodone|mesh-list
102329848|NCT04218409|Oxytocin|oxytocin|mesh-list
102329849|NCT04218409|Oxytocics|oxytocics|mesh-ancestor
102329850|NCT04218409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102329851|NCT04218409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329852|NCT04218409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102329853|NCT04218409|Narcotics|narcotics|mesh-ancestor
102329854|NCT04218409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102329855|NCT04218409|Analgesics|analgesics|mesh-ancestor
102329856|NCT04218409|Sensory System Agents|sensory system agents|mesh-ancestor
102329857|NCT04218409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102329858|NCT04085172|Guanfacine|guanfacine|mesh-list
102329859|NCT04085172|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102329860|NCT04085172|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102329861|NCT04085172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102329862|NCT04085172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102329863|NCT04085172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329864|NCT04085172|Adrenergic Agents|adrenergic agents|mesh-ancestor
102329865|NCT04085172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102329866|NCT04085172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329867|NCT04085172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102329868|NCT04085172|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102329869|NCT04085172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102329870|NCT04085172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102329871|NCT04081545|Analgesics, Opioid|analgesics, opioid|mesh-list
102329872|NCT04081545|Analgesics|analgesics|mesh-list
102329873|NCT04081545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
102329874|NCT04081545|Anesthetics|anesthetics|mesh-list
102329875|NCT04081545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102329876|NCT04081545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329877|NCT04081545|Narcotics|narcotics|mesh-ancestor
102329878|NCT04081545|Sensory System Agents|sensory system agents|mesh-ancestor
102329879|NCT04081545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102329880|NCT04076527|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102329881|NCT04076527|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102329882|NCT04076527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102329883|NCT04064697|Valganciclovir|valganciclovir|mesh-list
102329884|NCT04064697|Antiviral Agents|antiviral agents|mesh-ancestor
102329885|NCT04064697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102329886|NCT03980561|Varenicline|varenicline|mesh-list
102329887|NCT03980561|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102329888|NCT03980561|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102329889|NCT03980561|Cholinergic Agents|cholinergic agents|mesh-ancestor
102329890|NCT03980561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102329891|NCT03980561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329892|NCT03980561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329893|NCT03927157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102329894|NCT03927157|Immunologic Factors|immunologic factors|mesh-ancestor
102329895|NCT03927157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329896|NCT03921424|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102329897|NCT03921424|Immunologic Factors|immunologic factors|mesh-ancestor
102329898|NCT03921424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329900|NCT03896230|Analgesics|analgesics|mesh-ancestor
102329901|NCT03896230|Sensory System Agents|sensory system agents|mesh-ancestor
102329902|NCT03896230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102329903|NCT03896230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329904|NCT03896230|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102329905|NCT03896230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102329906|NCT03896230|Anesthetics, General|anesthetics, general|mesh-ancestor
102329907|NCT03896230|Anesthetics|anesthetics|mesh-ancestor
102329908|NCT03896230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102329909|NCT03896230|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102329910|NCT03896230|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102329911|NCT03896230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102329912|NCT03896230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329913|NCT03878316|Oxytocin|oxytocin|mesh-list
102329914|NCT03878316|Oxytocics|oxytocics|mesh-ancestor
102329915|NCT03878316|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102329916|NCT03878316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329917|NCT03854929|Azithromycin|azithromycin|mesh-list
102329918|NCT03854929|Ciprofloxacin|ciprofloxacin|mesh-list
102329919|NCT03854929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102329920|NCT03854929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102329921|NCT03854929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102329922|NCT03854929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102329923|NCT03854929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102329924|NCT03854929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329925|NCT03854929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329926|NCT03854929|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102329927|NCT03854929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102329928|NCT03852628|Naltrexone|naltrexone|mesh-list
102329929|NCT03852628|Buprenorphine|buprenorphine|mesh-list
102329931|NCT03852628|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102329932|NCT03852628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329933|NCT03852628|Sensory System Agents|sensory system agents|mesh-ancestor
102329934|NCT03852628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102329935|NCT03852628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102329936|NCT03852628|Narcotics|narcotics|mesh-ancestor
102329937|NCT03852628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102329938|NCT03852628|Analgesics|analgesics|mesh-ancestor
102329939|NCT03826524|Epinephrine|epinephrine|mesh-list
102329940|NCT03826524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102329941|NCT03826524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102329942|NCT03826524|Adrenergic Agents|adrenergic agents|mesh-ancestor
102329943|NCT03826524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102329944|NCT03826524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329945|NCT03826524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329946|NCT03826524|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102329947|NCT03826524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102329948|NCT03826524|Autonomic Agents|autonomic agents|mesh-ancestor
102329949|NCT03826524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102329950|NCT03826524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102329951|NCT03826524|Respiratory System Agents|respiratory system agents|mesh-ancestor
102329952|NCT03826524|Mydriatics|mydriatics|mesh-ancestor
102329953|NCT03826524|Sympathomimetics|sympathomimetics|mesh-ancestor
102329954|NCT03826524|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102329955|NCT03798678|Dexamethasone|dexamethasone|mesh-list
102329956|NCT03798678|Dexamethasone acetate|dexamethasone acetate|mesh-list
102329957|NCT03798678|Ichthammol|ichthammol|mesh-list
102329958|NCT03798678|BB 1101|bb 1101|mesh-list
102329959|NCT03798678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102329960|NCT03798678|Antiemetics|antiemetics|mesh-ancestor
102329961|NCT03798678|Autonomic Agents|autonomic agents|mesh-ancestor
102329962|NCT03798678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102329963|NCT03798678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329964|NCT03798678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102329965|NCT03798678|Glucocorticoids|glucocorticoids|mesh-ancestor
102329966|NCT03798678|Hormones|hormones|mesh-ancestor
102329967|NCT03798678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102329968|NCT03798678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102329969|NCT03798678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329970|NCT03798678|Protease Inhibitors|protease inhibitors|mesh-ancestor
102329972|NCT03798678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329973|NCT03798678|Dermatologic Agents|dermatologic agents|mesh-ancestor
102329974|NCT03770260|Ixazomib|ixazomib|mesh-list
102329975|NCT03770260|Enzyme Inhibitors|enzyme inhibitors|mesh-list
102329976|NCT03770260|Pevonedistat|pevonedistat|mesh-list
102329977|NCT03770260|Glycine|glycine|mesh-list
102329978|NCT03770260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329979|NCT03770260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329980|NCT03770260|Protease Inhibitors|protease inhibitors|mesh-ancestor
102329981|NCT03770260|Glycine Agents|glycine agents|mesh-ancestor
102329982|NCT03770260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102329983|NCT03770260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102329984|NCT03741426|Durvalumab|durvalumab|mesh-list
102329985|NCT03741426|Olaparib|olaparib|mesh-list
102329986|NCT03741426|Cediranib|cediranib|mesh-list
102329987|NCT03741426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102329988|NCT03741426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329989|NCT03741426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102329990|NCT03741426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102329991|NCT03741426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102329992|NCT03741426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102329993|NCT03698162|Bevacizumab|bevacizumab|mesh-list
102329994|NCT03698162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102329995|NCT03698162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102329996|NCT03698162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102329997|NCT03698162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102329998|NCT03698162|Growth Substances|growth substances|mesh-ancestor
102329999|NCT03698162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330000|NCT03698162|Growth Inhibitors|growth inhibitors|mesh-ancestor
102330001|NCT03623633|Denosumab|denosumab|mesh-list
102330002|NCT03623633|Alendronate|alendronate|mesh-list
102038837|NCT03082014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102330003|NCT03623633|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
102330004|NCT03623633|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102330005|NCT03623633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330007|NCT03623633|Hormone Antagonists|hormone antagonists|mesh-ancestor
102330008|NCT03623633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102330009|NCT03623633|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102330010|NCT03623633|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102330011|NCT03602976|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102330012|NCT03602976|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102330013|NCT03602976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102330014|NCT03554174|Psilocybin|psilocybin|mesh-list
102330015|NCT03554174|Hallucinogens|hallucinogens|mesh-ancestor
102330016|NCT03554174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330017|NCT03554174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102330018|NCT03508440|Prednisone|prednisone|mesh-list
102330019|NCT03508440|Prednisolone|prednisolone|mesh-list
102330020|NCT03508440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102330021|NCT03508440|Glucocorticoids|glucocorticoids|mesh-ancestor
102330022|NCT03508440|Hormones|hormones|mesh-ancestor
102330023|NCT03508440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102330024|NCT03508440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330025|NCT03508440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102330026|NCT03508440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330027|NCT03474107|Paclitaxel|paclitaxel|mesh-list
102330028|NCT03474107|Docetaxel|docetaxel|mesh-list
102330029|NCT03474107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102330030|NCT03474107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330031|NCT03474107|Tubulin Modulators|tubulin modulators|mesh-ancestor
102330032|NCT03474107|Antimitotic Agents|antimitotic agents|mesh-ancestor
102330033|NCT03474107|Mitosis Modulators|mitosis modulators|mesh-ancestor
102330034|NCT03474107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330035|NCT03445845|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
102330036|NCT03445845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102330037|NCT03422861|Nabilone|nabilone|mesh-list
102330038|NCT03422861|Antiemetics|antiemetics|mesh-ancestor
102330039|NCT03422861|Autonomic Agents|autonomic agents|mesh-ancestor
102330040|NCT03422861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102330041|NCT03422861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330042|NCT03422861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102330043|NCT03422861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102330044|NCT03422861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102330045|NCT03422861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102330046|NCT03422861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102330048|NCT03421496|Vigabatrin|vigabatrin|mesh-list
102330049|NCT03421496|Anticonvulsants|anticonvulsants|mesh-ancestor
102330050|NCT03421496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102330051|NCT03421496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330052|NCT03421496|GABA Agents|gaba agents|mesh-ancestor
102330053|NCT03421496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102330054|NCT03421496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330055|NCT03421353|Paclitaxel|paclitaxel|mesh-list
102330056|NCT03421353|Carboplatin|carboplatin|mesh-list
102330057|NCT03421353|Gemcitabine|gemcitabine|mesh-list
102330058|NCT03421353|Durvalumab|durvalumab|mesh-list
102330059|NCT03421353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102330060|NCT03421353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330061|NCT03421353|Tubulin Modulators|tubulin modulators|mesh-ancestor
102330062|NCT03421353|Antimitotic Agents|antimitotic agents|mesh-ancestor
102330063|NCT03421353|Mitosis Modulators|mitosis modulators|mesh-ancestor
102330064|NCT03421353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330065|NCT03421353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102330066|NCT03421353|Antimetabolites|antimetabolites|mesh-ancestor
102330067|NCT03421353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102330068|NCT03401320|Letrozole|letrozole|mesh-list
102330069|NCT03401320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330070|NCT03401320|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102330071|NCT03401320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102330072|NCT03401320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102330073|NCT03401320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330074|NCT03401320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102330075|NCT03401320|Hormone Antagonists|hormone antagonists|mesh-ancestor
102330076|NCT03401320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102330077|NCT03401320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330078|NCT03278106|Trifluridine|trifluridine|mesh-list
102330079|NCT03278106|Antimetabolites|antimetabolites|mesh-ancestor
102330080|NCT03278106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330081|NCT03278106|Antiviral Agents|antiviral agents|mesh-ancestor
102330082|NCT03278106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102330083|NCT03255252|Cisplatin|cisplatin|mesh-list
102330084|NCT03255252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330085|NCT03203525|Leucovorin|leucovorin|mesh-list
102330086|NCT03203525|Sirolimus|sirolimus|mesh-list
102330087|NCT03203525|Bevacizumab|bevacizumab|mesh-list
102330088|NCT03203525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102330089|NCT03203525|Doxorubicin|doxorubicin|mesh-list
102330090|NCT03203525|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102330091|NCT03203525|Fluorouracil|fluorouracil|mesh-list
102330092|NCT03203525|Oxaliplatin|oxaliplatin|mesh-list
102330093|NCT03203525|Temsirolimus|temsirolimus|mesh-list
102330094|NCT03203525|MTOR Inhibitors|mtor inhibitors|mesh-list
102330095|NCT03203525|Endothelial Growth Factors|endothelial growth factors|mesh-list
102330096|NCT03203525|Antibodies|antibodies|mesh-list
102330097|NCT03203525|Immunoglobulins|immunoglobulins|mesh-list
102330098|NCT03203525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102330099|NCT03203525|Immunoglobulin G|immunoglobulin g|mesh-list
102330100|NCT03203525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330101|NCT03203525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102330102|NCT03203525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102330103|NCT03203525|Growth Substances|growth substances|mesh-ancestor
102330104|NCT03203525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330105|NCT03203525|Growth Inhibitors|growth inhibitors|mesh-ancestor
102330106|NCT03203525|Immunologic Factors|immunologic factors|mesh-ancestor
102330107|NCT03203525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102330108|NCT03203525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102330109|NCT03203525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102330110|NCT03203525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102330111|NCT03203525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330112|NCT03203525|Antimetabolites|antimetabolites|mesh-ancestor
102330113|NCT03203525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102330114|NCT03203525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102330115|NCT03203525|Antidotes|antidotes|mesh-ancestor
102330116|NCT03203525|Protective Agents|protective agents|mesh-ancestor
102330117|NCT03203525|Vitamin B Complex|vitamin b complex|mesh-ancestor
102330118|NCT03203525|Vitamins|vitamins|mesh-ancestor
102330119|NCT03203525|Micronutrients|micronutrients|mesh-ancestor
102330120|NCT03203525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102330121|NCT03203525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101672129|NCT04136756|Rituximab|rituximab|mesh-list
102330123|NCT03203525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102330124|NCT03192215|Aspirin|aspirin|mesh-list
102330125|NCT03192215|Apixaban|apixaban|mesh-list
102330126|NCT03192215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102330127|NCT03192215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102330128|NCT03192215|Analgesics|analgesics|mesh-ancestor
102330129|NCT03192215|Sensory System Agents|sensory system agents|mesh-ancestor
102330130|NCT03192215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102330131|NCT03192215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330132|NCT03192215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102330133|NCT03192215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102330134|NCT03192215|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102330135|NCT03192215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102330136|NCT03192215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330137|NCT03192215|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102330138|NCT03192215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102330139|NCT03192215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102330140|NCT03192215|Antipyretics|antipyretics|mesh-ancestor
102330141|NCT03192215|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102330142|NCT03192215|Antithrombins|antithrombins|mesh-ancestor
102330143|NCT03192215|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102330144|NCT03192215|Protease Inhibitors|protease inhibitors|mesh-ancestor
102330145|NCT03192215|Anticoagulants|anticoagulants|mesh-ancestor
102330146|NCT03118986|Olanzapine|olanzapine|mesh-list
102330147|NCT03118986|Antiemetics|antiemetics|mesh-ancestor
102330148|NCT03118986|Autonomic Agents|autonomic agents|mesh-ancestor
102330149|NCT03118986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102330150|NCT03118986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330151|NCT03118986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102330152|NCT03118986|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102330153|NCT03118986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102330154|NCT03118986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102330155|NCT03118986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102330156|NCT03118986|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102330157|NCT03118986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102330158|NCT03118986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102330159|NCT03118986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330160|NCT03118986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102330161|NCT03118986|Serotonin Agents|serotonin agents|mesh-ancestor
102330163|NCT03052608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330164|NCT03052608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102330165|NCT03052608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102330166|NCT03052608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330167|NCT03031730|Dexamethasone|dexamethasone|mesh-list
102330168|NCT03031730|Dexamethasone acetate|dexamethasone acetate|mesh-list
102330169|NCT03031730|Lenalidomide|lenalidomide|mesh-list
102330170|NCT03031730|Ichthammol|ichthammol|mesh-list
102330171|NCT03031730|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102330172|NCT03031730|BB 1101|bb 1101|mesh-list
102330173|NCT03031730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102330174|NCT03031730|Antiemetics|antiemetics|mesh-ancestor
102330175|NCT03031730|Autonomic Agents|autonomic agents|mesh-ancestor
102330176|NCT03031730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102330177|NCT03031730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330178|NCT03031730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102330179|NCT03031730|Glucocorticoids|glucocorticoids|mesh-ancestor
102330180|NCT03031730|Hormones|hormones|mesh-ancestor
102330181|NCT03031730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102330182|NCT03031730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102330183|NCT03031730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330184|NCT03031730|Protease Inhibitors|protease inhibitors|mesh-ancestor
102330185|NCT03031730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102330186|NCT03031730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330187|NCT03031730|Immunologic Factors|immunologic factors|mesh-ancestor
102330188|NCT03031730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102330189|NCT03031730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102330190|NCT03031730|Growth Substances|growth substances|mesh-ancestor
102330191|NCT03031730|Growth Inhibitors|growth inhibitors|mesh-ancestor
102330192|NCT03031730|Dermatologic Agents|dermatologic agents|mesh-ancestor
102330193|NCT02914639|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102330194|NCT02914639|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102330195|NCT02865018|Cetirizine|cetirizine|mesh-list
102330196|NCT02865018|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101941611|NCT01227915|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102330197|NCT02865018|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102330198|NCT02865018|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102330199|NCT02865018|Histamine Antagonists|histamine antagonists|mesh-ancestor
102330200|NCT02865018|Histamine Agents|histamine agents|mesh-ancestor
102330201|NCT02865018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102330202|NCT02865018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330203|NCT02865018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330204|NCT02795143|Isotretinoin|isotretinoin|mesh-list
102330205|NCT02795143|Dermatologic Agents|dermatologic agents|mesh-ancestor
102330206|NCT02790736|Propranolol|propranolol|mesh-list
102330207|NCT02790736|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102330208|NCT02790736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102330209|NCT02790736|Adrenergic Agents|adrenergic agents|mesh-ancestor
102330210|NCT02790736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102330211|NCT02790736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330212|NCT02790736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330213|NCT02790736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102330214|NCT02790736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102330215|NCT02790736|Vasodilator Agents|vasodilator agents|mesh-ancestor
102330216|NCT02773238|Deoxyglucose|deoxyglucose|mesh-list
102330217|NCT02773238|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102330218|NCT02773238|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
102330219|NCT02773238|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
102330220|NCT02773238|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102330221|NCT02773238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330222|NCT02773238|Antimetabolites|antimetabolites|mesh-ancestor
102330223|NCT02773238|Antiviral Agents|antiviral agents|mesh-ancestor
102330224|NCT02773238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102330225|NCT02704208|Nicotine|nicotine|mesh-list
102330226|NCT02704208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102330227|NCT02704208|Autonomic Agents|autonomic agents|mesh-ancestor
102330228|NCT02704208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102330229|NCT02704208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330230|NCT02704208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102330231|NCT02704208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102330232|NCT02704208|Cholinergic Agents|cholinergic agents|mesh-ancestor
102330234|NCT02704208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330235|NCT02553460|Leucovorin|leucovorin|mesh-list
102330236|NCT02553460|Cytarabine|cytarabine|mesh-list
102330237|NCT02553460|Dexamethasone|dexamethasone|mesh-list
102330238|NCT02553460|Hydrocortisone|hydrocortisone|mesh-list
102330239|NCT02553460|Cyclophosphamide|cyclophosphamide|mesh-list
102330240|NCT02553460|Methotrexate|methotrexate|mesh-list
102330241|NCT02553460|Etoposide|etoposide|mesh-list
102330242|NCT02553460|Vincristine|vincristine|mesh-list
102330243|NCT02553460|Bortezomib|bortezomib|mesh-list
102330244|NCT02553460|Asparaginase|asparaginase|mesh-list
102330245|NCT02553460|Mitoxantrone|mitoxantrone|mesh-list
102330246|NCT02553460|Mercaptopurine|mercaptopurine|mesh-list
102330247|NCT02553460|Vorinostat|vorinostat|mesh-list
102330248|NCT02553460|Pegaspargase|pegaspargase|mesh-list
102330249|NCT02553460|Levoleucovorin|levoleucovorin|mesh-list
102330250|NCT02553460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102330251|NCT02553460|Immunologic Factors|immunologic factors|mesh-ancestor
102330252|NCT02553460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330253|NCT02553460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102330254|NCT02553460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102330255|NCT02553460|Alkylating Agents|alkylating agents|mesh-ancestor
102330256|NCT02553460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330257|NCT02553460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330258|NCT02553460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102330259|NCT02553460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102330260|NCT02553460|Antiemetics|antiemetics|mesh-ancestor
102330261|NCT02553460|Autonomic Agents|autonomic agents|mesh-ancestor
102330262|NCT02553460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102330263|NCT02553460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102330264|NCT02553460|Glucocorticoids|glucocorticoids|mesh-ancestor
102330265|NCT02553460|Hormones|hormones|mesh-ancestor
102330266|NCT02553460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102330267|NCT02553460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102330268|NCT02553460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102330269|NCT02553460|Abortifacient Agents|abortifacient agents|mesh-ancestor
102330270|NCT02553460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102330271|NCT02553460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102330272|NCT02553460|Antimetabolites|antimetabolites|mesh-ancestor
102330273|NCT02553460|Dermatologic Agents|dermatologic agents|mesh-ancestor
102330274|NCT02553460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102330275|NCT02553460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102330276|NCT02553460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102330277|NCT02553460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102330278|NCT02553460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102330279|NCT02553460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102330280|NCT02553460|Antiviral Agents|antiviral agents|mesh-ancestor
102330281|NCT02553460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102330282|NCT02553460|Antidotes|antidotes|mesh-ancestor
102330283|NCT02553460|Protective Agents|protective agents|mesh-ancestor
102330284|NCT02553460|Vitamin B Complex|vitamin b complex|mesh-ancestor
102330285|NCT02553460|Vitamins|vitamins|mesh-ancestor
102330286|NCT02553460|Micronutrients|micronutrients|mesh-ancestor
102330287|NCT02553460|Tubulin Modulators|tubulin modulators|mesh-ancestor
102330288|NCT02553460|Antimitotic Agents|antimitotic agents|mesh-ancestor
102330289|NCT02553460|Mitosis Modulators|mitosis modulators|mesh-ancestor
102330290|NCT02553460|Analgesics|analgesics|mesh-ancestor
102330291|NCT02553460|Sensory System Agents|sensory system agents|mesh-ancestor
102330292|NCT02553460|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102330293|NCT02530034|Antibodies|antibodies|mesh-list
102330294|NCT02530034|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102330295|NCT02530034|Immunologic Factors|immunologic factors|mesh-ancestor
102330296|NCT02530034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330297|NCT02516670|Vitamins|vitamins|mesh-list
102330298|NCT02516670|Ascorbic Acid|ascorbic acid|mesh-list
102330299|NCT02516670|Docetaxel|docetaxel|mesh-list
102330300|NCT02516670|Micronutrients|micronutrients|mesh-ancestor
102330301|NCT02516670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330302|NCT02516670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330303|NCT02516670|Tubulin Modulators|tubulin modulators|mesh-ancestor
102330304|NCT02516670|Antimitotic Agents|antimitotic agents|mesh-ancestor
102330305|NCT02516670|Mitosis Modulators|mitosis modulators|mesh-ancestor
102330306|NCT02516670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330307|NCT02516670|Antioxidants|antioxidants|mesh-ancestor
102330308|NCT02516670|Protective Agents|protective agents|mesh-ancestor
102330309|NCT02315898|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102330310|NCT02315898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102330311|NCT02315898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102330312|NCT02315898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330313|NCT02315326|Rituximab|rituximab|mesh-list
102330314|NCT02315326|Methotrexate|methotrexate|mesh-list
102330315|NCT02315326|Procarbazine|procarbazine|mesh-list
101441887|NCT00169559|Fenofibrate|fenofibrate|mesh-list
102330316|NCT02315326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102330317|NCT02315326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330318|NCT02315326|Immunologic Factors|immunologic factors|mesh-ancestor
102330319|NCT02315326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330320|NCT02315326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102330321|NCT02315326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102330322|NCT02315326|Abortifacient Agents|abortifacient agents|mesh-ancestor
102330323|NCT02315326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102330324|NCT02315326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102330325|NCT02315326|Antimetabolites|antimetabolites|mesh-ancestor
102330326|NCT02315326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330327|NCT02315326|Dermatologic Agents|dermatologic agents|mesh-ancestor
102330328|NCT02315326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102330329|NCT02315326|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102330330|NCT02315326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102330331|NCT02315326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102330332|NCT02280525|Cytarabine|cytarabine|mesh-list
102330333|NCT02280525|Cyclophosphamide|cyclophosphamide|mesh-list
102330334|NCT02280525|Rituximab|rituximab|mesh-list
102330335|NCT02280525|Fludarabine|fludarabine|mesh-list
102330336|NCT02280525|Fludarabine phosphate|fludarabine phosphate|mesh-list
102330337|NCT02280525|Lenalidomide|lenalidomide|mesh-list
102330338|NCT02280525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102330339|NCT02280525|Immunologic Factors|immunologic factors|mesh-ancestor
102330340|NCT02280525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330341|NCT02280525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102330342|NCT02280525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102330343|NCT02280525|Alkylating Agents|alkylating agents|mesh-ancestor
102330344|NCT02280525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330345|NCT02280525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330346|NCT02280525|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102330347|NCT02280525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102330348|NCT02280525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102330349|NCT02280525|Antimetabolites|antimetabolites|mesh-ancestor
101672364|NCT03384277|Rituximab|rituximab|mesh-list
102330350|NCT02280525|Antiviral Agents|antiviral agents|mesh-ancestor
102330351|NCT02280525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102330352|NCT02280525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102330353|NCT02280525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102330354|NCT02280525|Growth Substances|growth substances|mesh-ancestor
102330355|NCT02280525|Growth Inhibitors|growth inhibitors|mesh-ancestor
102330356|NCT02157883|Itraconazole|itraconazole|mesh-list
102330357|NCT02157883|Osimertinib|osimertinib|mesh-list
102330358|NCT02157883|Antifungal Agents|antifungal agents|mesh-ancestor
102330359|NCT02157883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102330360|NCT02157883|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102330361|NCT02157883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102330362|NCT02157883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102330363|NCT02157883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330364|NCT02157883|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102330365|NCT02157883|Hormone Antagonists|hormone antagonists|mesh-ancestor
102330366|NCT02157883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102330367|NCT02157883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330368|NCT02157883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102330369|NCT02157883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330370|NCT02157883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102330371|NCT02101944|Dexamethasone|dexamethasone|mesh-list
102330372|NCT02101944|Dexamethasone acetate|dexamethasone acetate|mesh-list
102330373|NCT02101944|Ichthammol|ichthammol|mesh-list
102330374|NCT02101944|BB 1101|bb 1101|mesh-list
102330375|NCT02101944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102330376|NCT02101944|Antiemetics|antiemetics|mesh-ancestor
102330377|NCT02101944|Autonomic Agents|autonomic agents|mesh-ancestor
102330378|NCT02101944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102330379|NCT02101944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330380|NCT02101944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102330381|NCT02101944|Glucocorticoids|glucocorticoids|mesh-ancestor
102330382|NCT02101944|Hormones|hormones|mesh-ancestor
102241622|NCT04911959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330383|NCT02101944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102330384|NCT02101944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102330385|NCT02101944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330386|NCT02101944|Protease Inhibitors|protease inhibitors|mesh-ancestor
102330387|NCT02101944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102330388|NCT02101944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330389|NCT02101944|Dermatologic Agents|dermatologic agents|mesh-ancestor
102330390|NCT02091141|Trastuzumab|trastuzumab|mesh-list
102330391|NCT02091141|Atezolizumab|atezolizumab|mesh-list
102330392|NCT02091141|Pertuzumab|pertuzumab|mesh-list
102330393|NCT02091141|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102330394|NCT02091141|Vemurafenib|vemurafenib|mesh-list
102330395|NCT02091141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102330396|NCT02091141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330397|NCT02091141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102330398|NCT02091141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102330399|NCT02091141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330400|NCT02091141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102330401|NCT02066181|Sorafenib|sorafenib|mesh-list
102330402|NCT02066181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330403|NCT02066181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102330404|NCT02066181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102330405|NCT02066181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330406|NCT01972217|Prednisone|prednisone|mesh-list
102330407|NCT01972217|Prednisolone|prednisolone|mesh-list
102330408|NCT01972217|Olaparib|olaparib|mesh-list
102330409|NCT01972217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102330410|NCT01972217|Glucocorticoids|glucocorticoids|mesh-ancestor
102330411|NCT01972217|Hormones|hormones|mesh-ancestor
102330412|NCT01972217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102330413|NCT01972217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330414|NCT01972217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102330415|NCT01972217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330416|NCT01972217|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102330417|NCT01972217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102330418|NCT01972217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330419|NCT01970865|Crizotinib|crizotinib|mesh-list
102330420|NCT01970865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330421|NCT01970865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102330422|NCT01970865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101672429|NCT03188705|Antipyretics|antipyretics|mesh-ancestor
102330423|NCT01970865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330424|NCT01928576|Nivolumab|nivolumab|mesh-list
102330425|NCT01928576|Azacitidine|azacitidine|mesh-list
102330426|NCT01928576|Entinostat|entinostat|mesh-list
102330427|NCT01928576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102330428|NCT01928576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330429|NCT01928576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102330430|NCT01928576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330431|NCT01928576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102330432|NCT01928576|Antimetabolites|antimetabolites|mesh-ancestor
102330433|NCT01928576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102330434|NCT01928576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102330435|NCT01869114|Sirolimus|sirolimus|mesh-list
102330436|NCT01869114|Azacitidine|azacitidine|mesh-list
102330437|NCT01869114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102330438|NCT01869114|Antimetabolites|antimetabolites|mesh-ancestor
102330439|NCT01869114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330440|NCT01869114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330441|NCT01869114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102330442|NCT01869114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102330443|NCT01869114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102330444|NCT01869114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102330445|NCT01869114|Antifungal Agents|antifungal agents|mesh-ancestor
102330446|NCT01869114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102330447|NCT01869114|Immunologic Factors|immunologic factors|mesh-ancestor
102330448|NCT01869114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330449|NCT01843751|Buprenorphine|buprenorphine|mesh-list
102330450|NCT01843751|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102330451|NCT01843751|Naloxone|naloxone|mesh-list
102330452|NCT01843751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102330453|NCT01843751|Narcotics|narcotics|mesh-ancestor
102330454|NCT01843751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102330455|NCT01843751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330456|NCT01843751|Analgesics|analgesics|mesh-ancestor
102330457|NCT01843751|Sensory System Agents|sensory system agents|mesh-ancestor
102330458|NCT01843751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102330459|NCT01843751|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102330460|NCT01756248|Aflibercept|aflibercept|mesh-list
102330461|NCT01756248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102330462|NCT01756248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102330463|NCT01756248|Growth Substances|growth substances|mesh-ancestor
102330464|NCT01756248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330465|NCT01756248|Growth Inhibitors|growth inhibitors|mesh-ancestor
102330466|NCT01756248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330468|NCT01744652|Crizotinib|crizotinib|mesh-list
102330469|NCT01744652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330470|NCT01744652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102330471|NCT01744652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102330472|NCT01744652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330473|NCT01711541|Paclitaxel|paclitaxel|mesh-list
102330474|NCT01711541|Cisplatin|cisplatin|mesh-list
102330475|NCT01711541|Carboplatin|carboplatin|mesh-list
102330476|NCT01711541|Fluorouracil|fluorouracil|mesh-list
102330477|NCT01711541|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102330478|NCT01711541|Hydroxyurea|hydroxyurea|mesh-list
102330479|NCT01711541|Veliparib|veliparib|mesh-list
102330480|NCT01711541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102330481|NCT01711541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330482|NCT01711541|Tubulin Modulators|tubulin modulators|mesh-ancestor
102330483|NCT01711541|Antimitotic Agents|antimitotic agents|mesh-ancestor
102330484|NCT01711541|Mitosis Modulators|mitosis modulators|mesh-ancestor
102330485|NCT01711541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330486|NCT01711541|Antimetabolites|antimetabolites|mesh-ancestor
102330487|NCT01711541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102330488|NCT01711541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102330489|NCT01711541|Immunologic Factors|immunologic factors|mesh-ancestor
102330490|NCT01711541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330491|NCT01711541|Antisickling Agents|antisickling agents|mesh-ancestor
102330492|NCT01711541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102330493|NCT01711541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102330494|NCT01711541|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102330495|NCT01370512|Droxidopa|droxidopa|mesh-list
102330496|NCT01370512|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
102330497|NCT01370512|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102330498|NCT01370512|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102330499|NCT01370512|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102330500|NCT01370512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102330501|NCT01370512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330502|NCT01370512|Cholinergic Agents|cholinergic agents|mesh-ancestor
102330503|NCT01370512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102330504|NCT01370512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330505|NCT00215813|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
102330507|NCT00215813|Antiviral Agents|antiviral agents|mesh-ancestor
102330508|NCT00215813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102330509|NCT00215813|Interferon Inducers|interferon inducers|mesh-ancestor
102330510|NCT00215813|Immunologic Factors|immunologic factors|mesh-ancestor
102330511|NCT00215813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330512|NCT00179465|Tiagabine|tiagabine|mesh-list
102330513|NCT00179465|Antipsychotic Agents|antipsychotic agents|mesh-list
102330514|NCT00179465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102330515|NCT00179465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102330516|NCT00179465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330517|NCT00179465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102330518|NCT00179465|Anticonvulsants|anticonvulsants|mesh-ancestor
102330519|NCT00179465|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
102330520|NCT00179465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102330521|NCT00179465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102330522|NCT00179465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330523|NCT00179465|GABA Agents|gaba agents|mesh-ancestor
102330524|NCT00179465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102330525|NCT00134030|Interferons|interferons|mesh-list
102330526|NCT00134030|Interferon-alpha|interferon-alpha|mesh-list
102330527|NCT00134030|Interferon alpha-2|interferon alpha-2|mesh-list
102330528|NCT00134030|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102330529|NCT00134030|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
102330530|NCT00134030|Cisplatin|cisplatin|mesh-list
102330531|NCT00134030|Doxorubicin|doxorubicin|mesh-list
102330532|NCT00134030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102330533|NCT00134030|Methotrexate|methotrexate|mesh-list
102330534|NCT00134030|Etoposide|etoposide|mesh-list
102330535|NCT00134030|Etoposide phosphate|etoposide phosphate|mesh-list
102330536|NCT00134030|Ifosfamide|ifosfamide|mesh-list
102330537|NCT00134030|Isophosphamide mustard|isophosphamide mustard|mesh-list
102330538|NCT00134030|Podophyllotoxin|podophyllotoxin|mesh-list
102330539|NCT00134030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330540|NCT00134030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102330541|NCT00134030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102330542|NCT00134030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102330543|NCT00134030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102330544|NCT00134030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330545|NCT00134030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102330546|NCT00134030|Abortifacient Agents|abortifacient agents|mesh-ancestor
102330547|NCT00134030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102330548|NCT00134030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330549|NCT00134030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102330550|NCT00134030|Antimetabolites|antimetabolites|mesh-ancestor
102330551|NCT00134030|Dermatologic Agents|dermatologic agents|mesh-ancestor
102330552|NCT00134030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102330553|NCT00134030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102330554|NCT00134030|Immunologic Factors|immunologic factors|mesh-ancestor
102330555|NCT00134030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102330556|NCT00134030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102330557|NCT00134030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102330558|NCT00134030|Antiviral Agents|antiviral agents|mesh-ancestor
102330559|NCT00134030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102330560|NCT00134030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102330561|NCT00134030|Alkylating Agents|alkylating agents|mesh-ancestor
102330562|NCT00134030|Keratolytic Agents|keratolytic agents|mesh-ancestor
102330563|NCT00134030|Tubulin Modulators|tubulin modulators|mesh-ancestor
102330564|NCT00134030|Antimitotic Agents|antimitotic agents|mesh-ancestor
102330565|NCT00134030|Mitosis Modulators|mitosis modulators|mesh-ancestor
102330566|NCT01382446|Chlorhexidine|chlorhexidine|mesh-list
102330567|NCT01382446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102330568|NCT01382446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102330569|NCT01382446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102330570|NCT01382446|Disinfectants|disinfectants|mesh-ancestor
102330571|NCT01382446|Dermatologic Agents|dermatologic agents|mesh-ancestor
102330572|NCT01381900|Metformin|metformin|mesh-list
102330573|NCT01381900|Canagliflozin|canagliflozin|mesh-list
102330574|NCT01381900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102330575|NCT01381900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330576|NCT01381900|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102330577|NCT01381900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330578|NCT01744197|Lidocaine|lidocaine|mesh-list
102330579|NCT01744197|Tetracaine|tetracaine|mesh-list
102330580|NCT01744197|Anesthetics, Local|anesthetics, local|mesh-ancestor
102330581|NCT01744197|Anesthetics|anesthetics|mesh-ancestor
102330582|NCT01744197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102330583|NCT01744197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330584|NCT01744197|Sensory System Agents|sensory system agents|mesh-ancestor
102330585|NCT01744197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102330586|NCT01744197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102330587|NCT01744197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102330588|NCT01744197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102330589|NCT01744197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102330590|NCT01744197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330591|NCT04565301|Dexamethasone|dexamethasone|mesh-list
102330592|NCT04565301|Neostigmine|neostigmine|mesh-list
102330593|NCT04565301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102330594|NCT04565301|Antiemetics|antiemetics|mesh-ancestor
102330595|NCT04565301|Autonomic Agents|autonomic agents|mesh-ancestor
102330596|NCT04565301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102330597|NCT04565301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330598|NCT04565301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102330599|NCT04565301|Glucocorticoids|glucocorticoids|mesh-ancestor
102330600|NCT04565301|Hormones|hormones|mesh-ancestor
102330601|NCT04565301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102330602|NCT04565301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102330603|NCT04565301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330604|NCT04565301|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102330605|NCT04565301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102330606|NCT04565301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330607|NCT04565301|Cholinergic Agents|cholinergic agents|mesh-ancestor
102330608|NCT04565301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102330609|NCT04565301|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102330610|NCT01743027|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
102330611|NCT01743027|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102330612|NCT01743027|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102330613|NCT01743027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102330614|NCT01743027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102330615|NCT01743027|Analgesics|analgesics|mesh-ancestor
102330616|NCT01743027|Sensory System Agents|sensory system agents|mesh-ancestor
102330617|NCT01743027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102330618|NCT01743027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330619|NCT01743027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102330620|NCT01743027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102330621|NCT01743027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102330622|NCT01743027|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102330623|NCT01743027|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102330624|NCT01743027|Histamine Antagonists|histamine antagonists|mesh-ancestor
102330625|NCT01743027|Histamine Agents|histamine agents|mesh-ancestor
102330626|NCT01743027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102330627|NCT01743027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330628|NCT01380730|Evolocumab|evolocumab|mesh-list
102330629|NCT01380730|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102330630|NCT01380730|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102330631|NCT01380730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102330632|NCT01380730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102330633|NCT01380730|Antimetabolites|antimetabolites|mesh-ancestor
102330634|NCT01380730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330635|NCT01380730|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102330636|NCT01380730|Protease Inhibitors|protease inhibitors|mesh-ancestor
102330637|NCT01380730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102330638|NCT01380730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102330639|NCT01380730|Immunologic Factors|immunologic factors|mesh-ancestor
102330640|NCT01380730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330641|NCT04010968|Venetoclax|venetoclax|mesh-list
102330642|NCT04010968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330643|NCT01395784|Pioglitazone|pioglitazone|mesh-list
102330644|NCT01395784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102330645|NCT01395784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330646|NCT01380184|Sirolimus|sirolimus|mesh-list
102330647|NCT01380184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102330648|NCT01380184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102330649|NCT01380184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102330650|NCT01380184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330651|NCT01380184|Antifungal Agents|antifungal agents|mesh-ancestor
102330652|NCT01380184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102330653|NCT01380184|Immunologic Factors|immunologic factors|mesh-ancestor
102330654|NCT01380184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330655|NCT00002826|Paclitaxel|paclitaxel|mesh-list
102330656|NCT00002826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102330657|NCT00002826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330658|NCT00002826|Tubulin Modulators|tubulin modulators|mesh-ancestor
102330659|NCT00002826|Antimitotic Agents|antimitotic agents|mesh-ancestor
102330660|NCT00002826|Mitosis Modulators|mitosis modulators|mesh-ancestor
102330661|NCT00002826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330662|NCT01395316|Alemtuzumab|alemtuzumab|mesh-list
102330663|NCT01395316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102330664|NCT01395316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330665|NCT04331938|Anesthetics|anesthetics|mesh-list
102330666|NCT04331938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102330667|NCT04331938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330668|NCT01731951|Imetelstat|imetelstat|mesh-list
102330669|NCT01731951|Motesanib diphosphate|motesanib diphosphate|mesh-list
102330670|NCT01731951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102330671|NCT01731951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330672|NCT01731951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102330673|NCT01741545|Interferons|interferons|mesh-list
102330674|NCT01741545|Ribavirin|ribavirin|mesh-list
102330675|NCT01741545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330676|NCT01741545|Antiviral Agents|antiviral agents|mesh-ancestor
102330677|NCT01741545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102330678|NCT01741545|Antimetabolites|antimetabolites|mesh-ancestor
102330679|NCT01741545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330680|NCT01884350|Apixaban|apixaban|mesh-list
102330681|NCT01884350|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102330682|NCT01884350|Antithrombins|antithrombins|mesh-ancestor
102330683|NCT01884350|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102330684|NCT01884350|Protease Inhibitors|protease inhibitors|mesh-ancestor
102330685|NCT01884350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102330686|NCT01884350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330687|NCT01884350|Anticoagulants|anticoagulants|mesh-ancestor
102330688|NCT01614795|Sirolimus|sirolimus|mesh-list
102330689|NCT01614795|Temsirolimus|temsirolimus|mesh-list
102330690|NCT01614795|MTOR Inhibitors|mtor inhibitors|mesh-list
102330691|NCT01614795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102330692|NCT01614795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102330693|NCT01614795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102330694|NCT01614795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102330695|NCT01614795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330696|NCT01614795|Antifungal Agents|antifungal agents|mesh-ancestor
102330697|NCT01614795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102330698|NCT01614795|Immunologic Factors|immunologic factors|mesh-ancestor
102330699|NCT01614795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330700|NCT01614795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102330701|NCT01614795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102330702|NCT01614795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330703|NCT01834586|Anesthetics|anesthetics|mesh-list
102330704|NCT01834586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102330705|NCT01834586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330706|NCT01614093|Oxytocin|oxytocin|mesh-list
102330707|NCT01614093|Oxytocics|oxytocics|mesh-ancestor
102330708|NCT01614093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102330709|NCT01614093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330710|NCT04559607|Apatinib|apatinib|mesh-list
102330711|NCT04559607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330712|NCT04559607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102330713|NCT04559607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102330714|NCT04559607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330715|NCT01834274|Metformin|metformin|mesh-list
102330716|NCT01834274|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102330717|NCT01834274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102330718|NCT01834274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330719|NCT01834274|Incretins|incretins|mesh-ancestor
102330720|NCT01834274|Hormones|hormones|mesh-ancestor
102330721|NCT01834274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102330722|NCT01834274|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102330723|NCT01834274|Protease Inhibitors|protease inhibitors|mesh-ancestor
102330724|NCT01834274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102330725|NCT01834274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330726|NCT01739595|Enclomiphene|enclomiphene|mesh-list
102330727|NCT01739595|Clomiphene|clomiphene|mesh-list
102330728|NCT01739595|Zuclomiphene|zuclomiphene|mesh-list
102330729|NCT01739595|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102330730|NCT01739595|Hormone Antagonists|hormone antagonists|mesh-ancestor
102330731|NCT01739595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102330732|NCT01739595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330733|NCT01739595|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102330734|NCT01739595|Fertility Agents|fertility agents|mesh-ancestor
102330735|NCT01739595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102330736|NCT01739595|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102330737|NCT01739595|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102330738|NCT01738971|Progestins|progestins|mesh-list
102330739|NCT01738971|Hormones|hormones|mesh-ancestor
102330740|NCT01738971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102330741|NCT01738971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330742|NCT01738503|Buprenorphine|buprenorphine|mesh-list
102330743|NCT01738503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102330744|NCT01738503|Narcotics|narcotics|mesh-ancestor
102330745|NCT01738503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102330746|NCT01738503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330747|NCT01738503|Analgesics|analgesics|mesh-ancestor
102330748|NCT01738503|Sensory System Agents|sensory system agents|mesh-ancestor
102330749|NCT01738503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102330750|NCT01738503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102330751|NCT01738191|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102330752|NCT01738191|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102330753|NCT01738191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102330754|NCT01738191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102330755|NCT01738191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330756|NCT01738191|Adrenergic Agents|adrenergic agents|mesh-ancestor
102330757|NCT01738191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102330758|NCT01738191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330759|NCT01737879|Epoetin Alfa|epoetin alfa|mesh-list
102330760|NCT01737879|Hematinics|hematinics|mesh-ancestor
102330761|NCT01605825|4-Aminopyridine|4-aminopyridine|mesh-list
102330762|NCT01605825|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102330763|NCT01605825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102039598|NCT03616262|Lidocaine|lidocaine|mesh-list
102330764|NCT01605825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330766|NCT01726335|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102330767|NCT01726335|Serotonin Agents|serotonin agents|mesh-ancestor
102330768|NCT01726335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102330769|NCT01726335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330770|NCT01726335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330771|NCT01726335|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102330772|NCT01726335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102330773|NCT01726335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102330774|NCT01726335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102330775|NCT01726335|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102330776|NCT01726335|Dopamine Agents|dopamine agents|mesh-ancestor
102330777|NCT01726023|Metronidazole|metronidazole|mesh-list
102330778|NCT01726023|Meropenem|meropenem|mesh-list
102330779|NCT01726023|Ceftazidime|ceftazidime|mesh-list
102330780|NCT01726023|Avibactam|avibactam|mesh-list
102330781|NCT01726023|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
102330782|NCT01726023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102330783|NCT01726023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102330784|NCT01726023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102330785|NCT01726023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102330786|NCT01726023|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102330787|NCT01726023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102330788|NCT01726023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330789|NCT01877187|Ethiodized Oil|ethiodized oil|mesh-list
102330790|NCT01877187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330791|NCT04609761|Immunoglobulins|immunoglobulins|mesh-list
102330792|NCT04609761|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102330793|NCT04609761|Antibodies|antibodies|mesh-list
102330794|NCT04609761|gamma-Globulins|gamma-globulins|mesh-list
102330795|NCT04609761|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102330796|NCT04609761|Immunologic Factors|immunologic factors|mesh-ancestor
102330797|NCT04609761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330798|NCT01858532|Atrasentan|atrasentan|mesh-list
102330799|NCT01858532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330800|NCT01858532|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
102330801|NCT01858532|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102330802|NCT01858532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330803|NCT04613960|Magnesium Sulfate|magnesium sulfate|mesh-list
102330804|NCT04613960|Analgesics|analgesics|mesh-ancestor
102330805|NCT04613960|Sensory System Agents|sensory system agents|mesh-ancestor
102330806|NCT04613960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102330807|NCT04613960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330808|NCT04613960|Anesthetics|anesthetics|mesh-ancestor
102330809|NCT04613960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102330810|NCT04613960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102330811|NCT04613960|Anticonvulsants|anticonvulsants|mesh-ancestor
102330812|NCT04613960|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102330813|NCT04613960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102330814|NCT04613960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330815|NCT04613960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102330816|NCT04613960|Tocolytic Agents|tocolytic agents|mesh-ancestor
102330817|NCT04613960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102330823|NCT01857206|Vaccines|vaccines|mesh-list
102330824|NCT01857206|Immunologic Factors|immunologic factors|mesh-ancestor
102330825|NCT01857206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330826|NCT01882088|Psyllium|psyllium|mesh-list
102330827|NCT01882088|Cathartics|cathartics|mesh-ancestor
102330828|NCT01882088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102330829|NCT01722669|Quercetin|quercetin|mesh-list
102330830|NCT01722669|Antioxidants|antioxidants|mesh-ancestor
102330831|NCT01722669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330832|NCT01722669|Protective Agents|protective agents|mesh-ancestor
102330833|NCT01722669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330834|NCT01707147|Linagliptin|linagliptin|mesh-list
102330835|NCT01707147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102330836|NCT01707147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330837|NCT01707147|Incretins|incretins|mesh-ancestor
102330838|NCT01707147|Hormones|hormones|mesh-ancestor
102330839|NCT01707147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102330840|NCT01707147|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102330841|NCT01707147|Protease Inhibitors|protease inhibitors|mesh-ancestor
102330842|NCT01707147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102330843|NCT01707147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330844|NCT01876251|Docetaxel|docetaxel|mesh-list
102330845|NCT01876251|Nirogacestat|nirogacestat|mesh-list
102330846|NCT01876251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330847|NCT01876251|Tubulin Modulators|tubulin modulators|mesh-ancestor
102330848|NCT01876251|Antimitotic Agents|antimitotic agents|mesh-ancestor
102330849|NCT01876251|Mitosis Modulators|mitosis modulators|mesh-ancestor
102330850|NCT01876251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330851|NCT01876251|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
102330852|NCT01876251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102330853|NCT01875237|Methylprednisolone|methylprednisolone|mesh-list
102330854|NCT01875237|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102330855|NCT01875237|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102330856|NCT01875237|Prednisolone|prednisolone|mesh-list
102330857|NCT01875237|Prednisolone acetate|prednisolone acetate|mesh-list
102330858|NCT01875237|Methotrexate|methotrexate|mesh-list
102330859|NCT01875237|Fludarabine phosphate|fludarabine phosphate|mesh-list
102330860|NCT01875237|Fludarabine|fludarabine|mesh-list
102330861|NCT01875237|Melphalan|melphalan|mesh-list
102330862|NCT01875237|Alemtuzumab|alemtuzumab|mesh-list
102330863|NCT01875237|Tacrolimus|tacrolimus|mesh-list
102330864|NCT01875237|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102330865|NCT01875237|Prednisolone phosphate|prednisolone phosphate|mesh-list
102330866|NCT01875237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102330867|NCT01875237|Abortifacient Agents|abortifacient agents|mesh-ancestor
102330868|NCT01875237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102330869|NCT01875237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330870|NCT01875237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102330871|NCT01875237|Antimetabolites|antimetabolites|mesh-ancestor
102330872|NCT01875237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330873|NCT01875237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330874|NCT01875237|Dermatologic Agents|dermatologic agents|mesh-ancestor
102330875|NCT01875237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102330876|NCT01875237|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102330877|NCT01875237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102330878|NCT01875237|Immunologic Factors|immunologic factors|mesh-ancestor
102330879|NCT01875237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102330880|NCT01875237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102330881|NCT01875237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102330882|NCT01875237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102330883|NCT01875237|Antiemetics|antiemetics|mesh-ancestor
102330884|NCT01875237|Autonomic Agents|autonomic agents|mesh-ancestor
102330885|NCT01875237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102330886|NCT01875237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102330887|NCT01875237|Glucocorticoids|glucocorticoids|mesh-ancestor
102330888|NCT01875237|Hormones|hormones|mesh-ancestor
102330889|NCT01875237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102330890|NCT01875237|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102330891|NCT01875237|Protective Agents|protective agents|mesh-ancestor
102330892|NCT01875237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102330893|NCT01875237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102330894|NCT01875237|Alkylating Agents|alkylating agents|mesh-ancestor
102330895|NCT01875237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102330896|NCT01875237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102330897|NCT01874535|Esomeprazole|esomeprazole|mesh-list
102330898|NCT01874535|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102330899|NCT01874535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102330900|NCT01874535|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102330901|NCT01874535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102330902|NCT01874535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330903|NCT01722045|Aflibercept|aflibercept|mesh-list
102330904|NCT01722045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102330905|NCT01722045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102330906|NCT01722045|Growth Substances|growth substances|mesh-ancestor
102330907|NCT01722045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330908|NCT01722045|Growth Inhibitors|growth inhibitors|mesh-ancestor
102330909|NCT01722045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330910|NCT01721109|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102330911|NCT01721109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102039745|NCT04056702|Ivacaftor|ivacaftor|mesh-list
102330912|NCT01721109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102330913|NCT01721109|Antiviral Agents|antiviral agents|mesh-ancestor
102330914|NCT01721109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102330915|NCT01874145|Glatiramer Acetate|glatiramer acetate|mesh-list
102330917|NCT01874145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102330918|NCT01874145|Immunologic Factors|immunologic factors|mesh-ancestor
102330919|NCT01874145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330920|NCT01874145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102330921|NCT01874145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102330922|NCT04415385|Apatinib|apatinib|mesh-list
102330923|NCT04415385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330924|NCT04415385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102330925|NCT04415385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102330926|NCT04415385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330927|NCT01720797|Chlorhexidine|chlorhexidine|mesh-list
102330928|NCT01720797|Anesthetics|anesthetics|mesh-list
102330929|NCT01720797|Anesthetics, Local|anesthetics, local|mesh-list
102330930|NCT01720797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102330931|NCT01720797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330932|NCT01720797|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102330933|NCT01720797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102330934|NCT01720797|Disinfectants|disinfectants|mesh-ancestor
102330935|NCT01720797|Sensory System Agents|sensory system agents|mesh-ancestor
102330936|NCT01720797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102330937|NCT01831466|Tofacitinib|tofacitinib|mesh-list
102330938|NCT01831466|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102330939|NCT01831466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102330940|NCT01831466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102330941|NCT01831466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330942|NCT01881230|Paclitaxel|paclitaxel|mesh-list
102330943|NCT01881230|Carboplatin|carboplatin|mesh-list
102330944|NCT01881230|Gemcitabine|gemcitabine|mesh-list
102330945|NCT01881230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102330946|NCT01881230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330947|NCT01881230|Tubulin Modulators|tubulin modulators|mesh-ancestor
102330949|NCT01881230|Mitosis Modulators|mitosis modulators|mesh-ancestor
102330950|NCT01881230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330951|NCT01881230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102330952|NCT01881230|Antimetabolites|antimetabolites|mesh-ancestor
102330953|NCT01856114|Fentanyl|fentanyl|mesh-list
102330954|NCT01856114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102330955|NCT01856114|Narcotics|narcotics|mesh-ancestor
102330956|NCT01856114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102330957|NCT01856114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330958|NCT01856114|Analgesics|analgesics|mesh-ancestor
102330959|NCT01856114|Sensory System Agents|sensory system agents|mesh-ancestor
102330960|NCT01856114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102330961|NCT01856114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101441992|NCT00196599|Emtricitabine|emtricitabine|mesh-list
102330962|NCT01856114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102330963|NCT01856114|Anesthetics, General|anesthetics, general|mesh-ancestor
102330964|NCT01856114|Anesthetics|anesthetics|mesh-ancestor
102330965|NCT01614470|Ivacaftor|ivacaftor|mesh-list
102330966|NCT01614470|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102330967|NCT01614470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102330968|NCT01614470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330969|NCT01880528|Lisinopril|lisinopril|mesh-list
102330970|NCT01880528|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102330971|NCT01880528|Protease Inhibitors|protease inhibitors|mesh-ancestor
102330972|NCT01880528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102330973|NCT01880528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330974|NCT01880528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102330975|NCT01880528|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102330976|NCT01880528|Protective Agents|protective agents|mesh-ancestor
102330977|NCT01880528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330978|NCT01854944|Brexpiprazole|brexpiprazole|mesh-list
102330979|NCT01854944|Serotonin Agents|serotonin agents|mesh-ancestor
102330980|NCT01854944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102330981|NCT01854944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330982|NCT01854944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330983|NCT01854944|Dopamine Agonists|dopamine agonists|mesh-ancestor
102330984|NCT01854944|Dopamine Agents|dopamine agents|mesh-ancestor
102330985|NCT01854710|Moxifloxacin|moxifloxacin|mesh-list
102330986|NCT01854710|Loxapine|loxapine|mesh-list
102330987|NCT01854710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102330988|NCT01854710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102330989|NCT01854710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102330990|NCT01854710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102330991|NCT01854710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102330992|NCT01854710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102330993|NCT01854710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102330994|NCT01854710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102330995|NCT01854710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102330996|NCT01854710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102330997|NCT01854710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102330998|NCT01854710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102330999|NCT01854710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102331000|NCT01854710|Dopamine Agents|dopamine agents|mesh-ancestor
102331001|NCT01854710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102331002|NCT01828034|Gemcitabine|gemcitabine|mesh-list
102331003|NCT01828034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102331004|NCT01828034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102331005|NCT01828034|Antimetabolites|antimetabolites|mesh-ancestor
102331006|NCT01828034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331007|NCT01853696|Loteprednol Etabonate|loteprednol etabonate|mesh-list
102331008|NCT01853696|Prednisolone|prednisolone|mesh-list
102331009|NCT01853696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102331010|NCT01853696|Methylprednisolone|methylprednisolone|mesh-list
102331011|NCT01853696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102331012|NCT01853696|Prednisolone acetate|prednisolone acetate|mesh-list
102331013|NCT01853696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102331014|NCT01853696|Prednisolone phosphate|prednisolone phosphate|mesh-list
102331015|NCT01853696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102331016|NCT01853696|Glucocorticoids|glucocorticoids|mesh-ancestor
102331017|NCT01853696|Hormones|hormones|mesh-ancestor
102331018|NCT01853696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102331019|NCT01853696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331020|NCT01853696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102331021|NCT01853696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102331022|NCT01853696|Antiemetics|antiemetics|mesh-ancestor
102331023|NCT01853696|Autonomic Agents|autonomic agents|mesh-ancestor
102331024|NCT01853696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102331025|NCT01853696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102331026|NCT01853696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102331027|NCT01853696|Protective Agents|protective agents|mesh-ancestor
102331028|NCT01853696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102331029|NCT01719861|Desipramine|desipramine|mesh-list
102331030|NCT01719861|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102331031|NCT01719861|Antidepressive Agents|antidepressive agents|mesh-ancestor
102331032|NCT01719861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102331033|NCT01719861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102331034|NCT01719861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331035|NCT01719861|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102331036|NCT01719861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102331037|NCT01719861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102331038|NCT01719861|Adrenergic Agents|adrenergic agents|mesh-ancestor
102331039|NCT01719861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102331040|NCT01719861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331041|NCT01853618|Tremelimumab|tremelimumab|mesh-list
102331042|NCT01853618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102331043|NCT01719783|Vaccines|vaccines|mesh-list
102331044|NCT01719783|Immunologic Factors|immunologic factors|mesh-ancestor
102331045|NCT01719783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331046|NCT01878890|Efavirenz|efavirenz|mesh-list
102331047|NCT01878890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102331048|NCT01878890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102331049|NCT01878890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102331050|NCT01878890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331051|NCT01878890|Antiviral Agents|antiviral agents|mesh-ancestor
102331052|NCT01878890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102331053|NCT01878890|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102331054|NCT01878890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102331055|NCT01878890|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102331056|NCT01878890|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102331057|NCT01878890|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102331058|NCT01878890|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102331059|NCT01827332|Oxytocin|oxytocin|mesh-list
102331060|NCT01827332|Oxytocics|oxytocics|mesh-ancestor
102331061|NCT01827332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102331062|NCT01827332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331063|NCT01719003|Metformin|metformin|mesh-list
102331064|NCT01719003|Empagliflozin|empagliflozin|mesh-list
102331065|NCT01719003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102331066|NCT01719003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331067|NCT01719003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102331068|NCT01719003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331069|NCT01853228|Cytarabine|cytarabine|mesh-list
102331070|NCT01853228|Decitabine|decitabine|mesh-list
102331071|NCT01853228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102331072|NCT01853228|Antimetabolites|antimetabolites|mesh-ancestor
102331073|NCT01853228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331074|NCT01853228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102331075|NCT01853228|Antiviral Agents|antiviral agents|mesh-ancestor
102331076|NCT01853228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102331077|NCT01853228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102331078|NCT01853228|Immunologic Factors|immunologic factors|mesh-ancestor
102331079|NCT01853228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331080|NCT01853228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102331081|NCT01705587|Teriparatide|teriparatide|mesh-list
102331082|NCT01705587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102331083|NCT01705587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331084|NCT01705587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102331085|NCT01705509|Ranolazine|ranolazine|mesh-list
102331086|NCT01705509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102331087|NCT01705509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102331088|NCT01705509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331089|NCT01853072|Prednisolone|prednisolone|mesh-list
102331090|NCT01853072|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102331091|NCT01853072|Methylprednisolone|methylprednisolone|mesh-list
102331092|NCT01853072|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102331093|NCT01853072|Prednisolone acetate|prednisolone acetate|mesh-list
102331094|NCT01853072|Nepafenac|nepafenac|mesh-list
102331095|NCT01853072|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102331096|NCT01853072|Prednisolone phosphate|prednisolone phosphate|mesh-list
102331097|NCT01853072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102331098|NCT01853072|Glucocorticoids|glucocorticoids|mesh-ancestor
102331099|NCT01853072|Hormones|hormones|mesh-ancestor
102241623|NCT03070665|Norepinephrine|norepinephrine|mesh-list
102241624|NCT03070665|Ephedrine|ephedrine|mesh-list
102331100|NCT01853072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102331101|NCT01853072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331102|NCT01853072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102331103|NCT01853072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102331104|NCT01853072|Antiemetics|antiemetics|mesh-ancestor
102331105|NCT01853072|Autonomic Agents|autonomic agents|mesh-ancestor
102331106|NCT01853072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102331107|NCT01853072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102331108|NCT01853072|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102331109|NCT01853072|Protective Agents|protective agents|mesh-ancestor
102331110|NCT01853072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102331111|NCT01853072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102331112|NCT01853072|Analgesics|analgesics|mesh-ancestor
102331113|NCT01853072|Sensory System Agents|sensory system agents|mesh-ancestor
102331114|NCT01853072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102331115|NCT01717287|Raltegravir Potassium|raltegravir potassium|mesh-list
102331116|NCT01717287|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102331117|NCT01717287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102331118|NCT01717287|Antiviral Agents|antiviral agents|mesh-ancestor
102331119|NCT01717287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102331120|NCT01717287|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102331121|NCT01717287|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102331122|NCT01717287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102331123|NCT01717287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331124|NCT01827254|Sunitinib|sunitinib|mesh-list
102331125|NCT01827254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102331126|NCT01827254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102331127|NCT01827254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102331128|NCT01827254|Growth Substances|growth substances|mesh-ancestor
102331129|NCT01827254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331130|NCT01827254|Growth Inhibitors|growth inhibitors|mesh-ancestor
102331131|NCT01827254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102331132|NCT01827254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102331133|NCT01827254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331134|NCT01824602|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
101836572|NCT01014156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102331135|NCT01824602|Anticonvulsants|anticonvulsants|mesh-ancestor
102331136|NCT01824602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102331137|NCT01824602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102331138|NCT01824602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102331139|NCT01824602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331141|NCT01704651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102331142|NCT04609592|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102331143|NCT04609592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331144|NCT04609592|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102331145|NCT01876082|Methotrexate|methotrexate|mesh-list
102331146|NCT01876082|Vinblastine|vinblastine|mesh-list
102331147|NCT01876082|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102331148|NCT01876082|Abortifacient Agents|abortifacient agents|mesh-ancestor
102331149|NCT01876082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102331150|NCT01876082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331151|NCT01876082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102331152|NCT01876082|Antimetabolites|antimetabolites|mesh-ancestor
102331153|NCT01876082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331154|NCT01876082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102331155|NCT01876082|Dermatologic Agents|dermatologic agents|mesh-ancestor
102331156|NCT01876082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102331157|NCT01876082|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102331158|NCT01876082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102331159|NCT01876082|Immunologic Factors|immunologic factors|mesh-ancestor
102331160|NCT01876082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102331161|NCT01876082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102331162|NCT01876082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102331163|NCT01876082|Tubulin Modulators|tubulin modulators|mesh-ancestor
102331164|NCT01876082|Antimitotic Agents|antimitotic agents|mesh-ancestor
102331165|NCT01876082|Mitosis Modulators|mitosis modulators|mesh-ancestor
102331166|NCT01716585|Ribavirin|ribavirin|mesh-list
102331167|NCT01716585|Antimetabolites|antimetabolites|mesh-ancestor
102331168|NCT01716585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331169|NCT01716585|Antiviral Agents|antiviral agents|mesh-ancestor
102331170|NCT01716585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102331172|NCT01852292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102331173|NCT01852292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102331174|NCT01852292|Tubulin Modulators|tubulin modulators|mesh-ancestor
102331175|NCT01852292|Antimitotic Agents|antimitotic agents|mesh-ancestor
102331176|NCT01852292|Mitosis Modulators|mitosis modulators|mesh-ancestor
102331177|NCT01852292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331178|NCT01715805|Cariprazine|cariprazine|mesh-list
102331179|NCT01715805|Antidepressive Agents|antidepressive agents|mesh-list
102331180|NCT01715805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102331181|NCT01715805|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102331182|NCT01715805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102331183|NCT01715805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102331184|NCT01715805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331185|NCT01852214|Ticagrelor|ticagrelor|mesh-list
102331186|NCT01852214|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102331187|NCT01852214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102331188|NCT01852214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102331189|NCT01852214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102331190|NCT01852214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102331191|NCT01852214|Purinergic Agents|purinergic agents|mesh-ancestor
102331192|NCT01852214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102331193|NCT01852214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331194|NCT01852214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331195|NCT04594772|Paclitaxel|paclitaxel|mesh-list
102331196|NCT04594772|Gemcitabine|gemcitabine|mesh-list
102331197|NCT04594772|Fluorouracil|fluorouracil|mesh-list
102331198|NCT04594772|Oxaliplatin|oxaliplatin|mesh-list
102331199|NCT04594772|Irinotecan|irinotecan|mesh-list
102331200|NCT04594772|Folfirinox|folfirinox|mesh-list
102331201|NCT04594772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102331202|NCT04594772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102331203|NCT04594772|Tubulin Modulators|tubulin modulators|mesh-ancestor
102331204|NCT04594772|Antimitotic Agents|antimitotic agents|mesh-ancestor
102331205|NCT04594772|Mitosis Modulators|mitosis modulators|mesh-ancestor
102331206|NCT04594772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331207|NCT04594772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102331208|NCT04594772|Antimetabolites|antimetabolites|mesh-ancestor
102331209|NCT04594772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102331210|NCT04594772|Immunologic Factors|immunologic factors|mesh-ancestor
102331211|NCT04594772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331212|NCT04594772|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102331213|NCT04594772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102331214|NCT04594772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102331215|NCT01393990|Tamoxifen|tamoxifen|mesh-list
102331216|NCT01393990|Midazolam|midazolam|mesh-list
102331217|NCT01393990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101442029|NCT02896621|Vasodilator Agents|vasodilator agents|mesh-ancestor
102331218|NCT01393990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102331219|NCT01393990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102331220|NCT01393990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331221|NCT01393990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102331222|NCT01393990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102331223|NCT01393990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102331224|NCT01393990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102331225|NCT01393990|Anesthetics, General|anesthetics, general|mesh-ancestor
102331226|NCT01393990|Anesthetics|anesthetics|mesh-ancestor
102331227|NCT01393990|GABA Modulators|gaba modulators|mesh-ancestor
102331228|NCT01393990|GABA Agents|gaba agents|mesh-ancestor
102331229|NCT01393990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102331230|NCT01393990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331231|NCT01393990|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102331232|NCT01393990|Hormone Antagonists|hormone antagonists|mesh-ancestor
102331233|NCT01393990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102331234|NCT01393990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102331235|NCT01393990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102331236|NCT01393990|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102331237|NCT01393990|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102331238|NCT01393990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102331239|NCT00210184|Leucovorin|leucovorin|mesh-list
102331240|NCT00210184|Fluorouracil|fluorouracil|mesh-list
102331241|NCT00210184|Irinotecan|irinotecan|mesh-list
102331242|NCT00210184|Antimetabolites|antimetabolites|mesh-ancestor
102331243|NCT00210184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331244|NCT00210184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102331245|NCT00210184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102331246|NCT00210184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102331248|NCT00210184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331249|NCT00210184|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102331250|NCT00210184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102331251|NCT00210184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102331252|NCT00210184|Antidotes|antidotes|mesh-ancestor
102331253|NCT00210184|Protective Agents|protective agents|mesh-ancestor
102331254|NCT00210184|Vitamin B Complex|vitamin b complex|mesh-ancestor
102331255|NCT00210184|Vitamins|vitamins|mesh-ancestor
102331256|NCT00210184|Micronutrients|micronutrients|mesh-ancestor
102331257|NCT00210964|Linezolid|linezolid|mesh-list
102331258|NCT00210964|Ceftazidime|ceftazidime|mesh-list
102331259|NCT00210964|Ceftobiprole|ceftobiprole|mesh-list
102331260|NCT00210964|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
102331261|NCT00210964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102331262|NCT00210964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102331263|NCT00210964|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102331264|NCT00210964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102331265|NCT00210964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331266|NCT05630638|Dolutegravir|dolutegravir|mesh-list
102331267|NCT05630638|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102331268|NCT05630638|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102331269|NCT05630638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102331270|NCT05630638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331271|NCT05630638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102331272|NCT05630638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102331273|NCT05630638|Antiviral Agents|antiviral agents|mesh-ancestor
102331274|NCT05630638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102331275|NCT03593434|Xenon|xenon|mesh-list
102331276|NCT03593434|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102331277|NCT03593434|Anesthetics, General|anesthetics, general|mesh-ancestor
102331278|NCT03593434|Anesthetics|anesthetics|mesh-ancestor
102331279|NCT03593434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102331280|NCT03593434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331281|NCT03792958|Vorolanib|vorolanib|mesh-list
102331282|NCT03792958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102331283|NCT03792958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102331284|NCT03792958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331285|NCT03989362|Ipilimumab|ipilimumab|mesh-list
102331286|NCT03989362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102331287|NCT03989362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102331288|NCT03989362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102331289|NCT03989362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331290|NCT03599596|Pyrimethamine|pyrimethamine|mesh-list
102331291|NCT03599596|Sulfadoxine|sulfadoxine|mesh-list
102331292|NCT03599596|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
102331293|NCT03599596|Antimalarials|antimalarials|mesh-ancestor
102331294|NCT03599596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102331295|NCT03599596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102331296|NCT03599596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102331297|NCT03599596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102331298|NCT03599596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102331299|NCT03599596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331300|NCT03599596|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102331301|NCT04407130|Doxycycline|doxycycline|mesh-list
102331302|NCT04407130|Ivermectin|ivermectin|mesh-list
102331303|NCT04407130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102331304|NCT04407130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102331305|NCT04407130|Antimalarials|antimalarials|mesh-ancestor
102331306|NCT04407130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102331307|NCT04407130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102331308|NCT03599284|Clopidogrel|clopidogrel|mesh-list
102331309|NCT03599284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102331310|NCT03599284|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102331311|NCT03599284|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102331312|NCT03599284|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102331313|NCT03599284|Purinergic Agents|purinergic agents|mesh-ancestor
102331314|NCT03599284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102331315|NCT03599284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331316|NCT03599284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331317|NCT03024814|Acetaminophen|acetaminophen|mesh-list
102331318|NCT03024814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102331319|NCT03024814|Analgesics|analgesics|mesh-ancestor
102331320|NCT03024814|Sensory System Agents|sensory system agents|mesh-ancestor
102331321|NCT03024814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102331322|NCT03024814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331323|NCT03024814|Antipyretics|antipyretics|mesh-ancestor
102331324|NCT03024502|Clotrimazole|clotrimazole|mesh-list
102331325|NCT03024502|Miconazole|miconazole|mesh-list
102331326|NCT03024502|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102331327|NCT03024502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102331328|NCT03024502|Antifungal Agents|antifungal agents|mesh-ancestor
102331329|NCT03024502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102331330|NCT03024502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102331331|NCT03024502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102331332|NCT03024502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331333|NCT03024502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102331334|NCT03024502|Hormone Antagonists|hormone antagonists|mesh-ancestor
102331335|NCT03024502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102331336|NCT03024502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331337|NCT03024502|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102331338|NCT03024502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102331339|NCT03024580|Tamoxifen|tamoxifen|mesh-list
102331340|NCT03024580|Letrozole|letrozole|mesh-list
102331341|NCT03024580|Fulvestrant|fulvestrant|mesh-list
102331342|NCT03024580|Anastrozole|anastrozole|mesh-list
102331343|NCT03024580|Exemestane|exemestane|mesh-list
102331344|NCT03024580|Megestrol|megestrol|mesh-list
102331345|NCT03024580|Megestrol Acetate|megestrol acetate|mesh-list
102331346|NCT03024580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102331347|NCT03024580|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102331348|NCT03024580|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102331349|NCT03024580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102331350|NCT03024580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331351|NCT03024580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102331352|NCT03024580|Hormone Antagonists|hormone antagonists|mesh-ancestor
102331353|NCT03024580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101442061|NCT02896582|Antimetabolites|antimetabolites|mesh-ancestor
102331354|NCT03024580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331355|NCT03024580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102331356|NCT03024580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102331357|NCT03024580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102040203|NCT02887183|Valsartan|valsartan|mesh-list
102331358|NCT03024580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102331359|NCT03024580|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102331360|NCT03024580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102331361|NCT03024580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102331362|NCT03024580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102331363|NCT03024580|Contraceptive Agents|contraceptive agents|mesh-ancestor
102331364|NCT03024580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102331365|NCT03024580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102331366|NCT03024580|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102331367|NCT03024580|Appetite Stimulants|appetite stimulants|mesh-ancestor
102331368|NCT03024580|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102331369|NCT01851590|Terbinafine|terbinafine|mesh-list
102331370|NCT01851590|Amorolfine|amorolfine|mesh-list
102331371|NCT01851590|Antifungal Agents|antifungal agents|mesh-ancestor
102331372|NCT01851590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102331373|NCT01851590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102331374|NCT01851590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331375|NCT03598816|Durvalumab|durvalumab|mesh-list
102331376|NCT03598816|Tremelimumab|tremelimumab|mesh-list
102331377|NCT03598816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102331378|NCT03598816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102331379|NCT05633758|Metolazone|metolazone|mesh-list
102331380|NCT05633758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102331381|NCT05633758|Diuretics|diuretics|mesh-ancestor
102331382|NCT05633758|Natriuretic Agents|natriuretic agents|mesh-ancestor
102331383|NCT05633758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331384|NCT05633758|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102331385|NCT05633758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102331386|NCT05633758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331387|NCT03598738|Esomeprazole|esomeprazole|mesh-list
102331388|NCT03598738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102331389|NCT03598738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102331390|NCT03598738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102331391|NCT03598738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102331392|NCT03598738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331393|NCT03594214|Vitamin D|vitamin d|mesh-list
102331395|NCT03594214|Micronutrients|micronutrients|mesh-ancestor
102331396|NCT03594214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331397|NCT03594214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102331398|NCT04003948|Ibogaine|ibogaine|mesh-list
102331399|NCT04003948|Hallucinogens|hallucinogens|mesh-ancestor
102331400|NCT04003948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331401|NCT04003948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102331402|NCT04003948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102331403|NCT04003948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102331404|NCT04003948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102331405|NCT04003948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331406|NCT03598582|Epoetin Alfa|epoetin alfa|mesh-list
102331407|NCT03598582|Hematinics|hematinics|mesh-ancestor
102331408|NCT01852058|Botulinum Toxins|botulinum toxins|mesh-list
102331409|NCT01852058|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102331410|NCT01852058|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102331411|NCT01852058|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102331412|NCT01852058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102331413|NCT01852058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331414|NCT01852058|Cholinergic Agents|cholinergic agents|mesh-ancestor
102331415|NCT01852058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102331416|NCT01852058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331417|NCT01852058|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102331418|NCT01852058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102331419|NCT03593668|Metformin|metformin|mesh-list
102331420|NCT03593668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102331421|NCT03593668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331422|NCT03598348|Capecitabine|capecitabine|mesh-list
102331423|NCT03598348|Apatinib|apatinib|mesh-list
102331424|NCT03598348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102331425|NCT03598348|Antimetabolites|antimetabolites|mesh-ancestor
102331426|NCT03598348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331427|NCT03598348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102331428|NCT03598348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102331429|NCT03598348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102331430|NCT03976258|Naltrexone|naltrexone|mesh-list
102331431|NCT03976258|Buprenorphine|buprenorphine|mesh-list
102331432|NCT03976258|Methadone|methadone|mesh-list
102331433|NCT03976258|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102331434|NCT03976258|Heroin|heroin|mesh-list
102331435|NCT03976258|Naloxone|naloxone|mesh-list
102331437|NCT03976258|Narcotics|narcotics|mesh-ancestor
102331438|NCT03976258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102331439|NCT03976258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331440|NCT03976258|Analgesics|analgesics|mesh-ancestor
101442108|NCT00169949|Serotonin Agents|serotonin agents|mesh-ancestor
102331441|NCT03976258|Sensory System Agents|sensory system agents|mesh-ancestor
102331442|NCT03976258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102331443|NCT03976258|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102331444|NCT03976258|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102331445|NCT03976258|Antitussive Agents|antitussive agents|mesh-ancestor
102331446|NCT03976258|Respiratory System Agents|respiratory system agents|mesh-ancestor
102331447|NCT03598192|Sufentanil|sufentanil|mesh-list
102331448|NCT03598192|Dsuvia|dsuvia|mesh-list
102331449|NCT03598192|Ropivacaine|ropivacaine|mesh-list
102331450|NCT03598192|Anesthetics, Local|anesthetics, local|mesh-ancestor
102331451|NCT03598192|Anesthetics|anesthetics|mesh-ancestor
102331452|NCT03598192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102331453|NCT03598192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331454|NCT03598192|Sensory System Agents|sensory system agents|mesh-ancestor
102331455|NCT03598192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102331456|NCT03598192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102331457|NCT03598192|Narcotics|narcotics|mesh-ancestor
102331458|NCT03598192|Analgesics|analgesics|mesh-ancestor
102331459|NCT03598192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102331460|NCT03598192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102331461|NCT03598192|Anesthetics, General|anesthetics, general|mesh-ancestor
102331462|NCT04003246|Durvalumab|durvalumab|mesh-list
102331463|NCT04003246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102331464|NCT04003246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102331465|NCT04003246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102331466|NCT04003246|Immunologic Factors|immunologic factors|mesh-ancestor
102331467|NCT04003246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331468|NCT00218296|Lobeline|lobeline|mesh-list
102331469|NCT00218296|Nicotine|nicotine|mesh-list
102331470|NCT00218296|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102331471|NCT00218296|Autonomic Agents|autonomic agents|mesh-ancestor
101673479|NCT00608699|Antimetabolites|antimetabolites|mesh-ancestor
102331472|NCT00218296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102331473|NCT00218296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331474|NCT00218296|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102331475|NCT00218296|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102331476|NCT00218296|Cholinergic Agents|cholinergic agents|mesh-ancestor
102331477|NCT00218296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102331478|NCT00218296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331479|NCT00218296|Respiratory System Agents|respiratory system agents|mesh-ancestor
102331480|NCT00217672|Bevacizumab|bevacizumab|mesh-list
102331481|NCT00217672|Docetaxel|docetaxel|mesh-list
102331482|NCT00217672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102331483|NCT00217672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102331484|NCT00217672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102331485|NCT00217672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102331486|NCT00217672|Growth Substances|growth substances|mesh-ancestor
102331487|NCT00217672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331488|NCT00217672|Growth Inhibitors|growth inhibitors|mesh-ancestor
102331489|NCT00217672|Tubulin Modulators|tubulin modulators|mesh-ancestor
102331490|NCT00217672|Antimitotic Agents|antimitotic agents|mesh-ancestor
102331491|NCT00217672|Mitosis Modulators|mitosis modulators|mesh-ancestor
102331492|NCT00217672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331493|NCT00216736|Dexamethasone|dexamethasone|mesh-list
102331494|NCT00216736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102331495|NCT00216736|Antiemetics|antiemetics|mesh-ancestor
102331496|NCT00216736|Autonomic Agents|autonomic agents|mesh-ancestor
102331497|NCT00216736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102331498|NCT00216736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331499|NCT00216736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102331500|NCT00216736|Glucocorticoids|glucocorticoids|mesh-ancestor
102331501|NCT00216736|Hormones|hormones|mesh-ancestor
102331502|NCT00216736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102331503|NCT00216736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102331504|NCT00216736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102331505|NCT01850030|Progesterone|progesterone|mesh-list
102331506|NCT01850030|Dydrogesterone|dydrogesterone|mesh-list
102331507|NCT01850030|Progestins|progestins|mesh-ancestor
102331508|NCT01850030|Hormones|hormones|mesh-ancestor
102331509|NCT01850030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102331510|NCT01850030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331511|NCT00215644|Capecitabine|capecitabine|mesh-list
102331512|NCT00215644|Epirubicin|epirubicin|mesh-list
102331514|NCT00215644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102331515|NCT00215644|Antimetabolites|antimetabolites|mesh-ancestor
102331516|NCT00215644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331517|NCT00215644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102331518|NCT00215644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102331519|NCT00215644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102331520|NCT00215644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102331521|NCT00213148|Anastrozole|anastrozole|mesh-list
102331522|NCT00213148|Citric Acid|citric acid|mesh-list
102331523|NCT00213148|Sodium Citrate|sodium citrate|mesh-list
102331524|NCT00213148|Clomiphene|clomiphene|mesh-list
102331525|NCT00213148|Enclomiphene|enclomiphene|mesh-list
102331526|NCT00213148|Zuclomiphene|zuclomiphene|mesh-list
102331527|NCT00213148|Anticoagulants|anticoagulants|mesh-ancestor
102331528|NCT00213148|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102331529|NCT00213148|Chelating Agents|chelating agents|mesh-ancestor
102331530|NCT00213148|Sequestering Agents|sequestering agents|mesh-ancestor
102331531|NCT00213148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331532|NCT00213148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102331533|NCT00213148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102331534|NCT00213148|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102331535|NCT00213148|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102331536|NCT00213148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102331537|NCT00213148|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102331538|NCT00213148|Hormone Antagonists|hormone antagonists|mesh-ancestor
102331539|NCT00213148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102331540|NCT00213148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331541|NCT00213148|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102331542|NCT00213148|Fertility Agents|fertility agents|mesh-ancestor
102331543|NCT00213148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102331544|NCT00213148|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102331545|NCT00213148|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102331546|NCT01704261|Metformin|metformin|mesh-list
102331547|NCT01704261|Glimepiride|glimepiride|mesh-list
102331548|NCT01704261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102331549|NCT01704261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331550|NCT01704261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102331551|NCT01704261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102331553|NCT00212758|Hormones|hormones|mesh-list
102331554|NCT00212758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102331555|NCT00212758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331556|NCT01824290|Tadalafil|tadalafil|mesh-list
102331557|NCT01824290|Vasodilator Agents|vasodilator agents|mesh-ancestor
102331558|NCT01824290|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102331559|NCT01824290|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102331560|NCT01824290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102331561|NCT01824290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331562|NCT01824290|Urological Agents|urological agents|mesh-ancestor
102331563|NCT03592342|Clobetasol|clobetasol|mesh-list
102331564|NCT03592342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102331565|NCT03592342|Glucocorticoids|glucocorticoids|mesh-ancestor
102331566|NCT03592342|Hormones|hormones|mesh-ancestor
102331567|NCT03592342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102331568|NCT03592342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331569|NCT01715415|Ribavirin|ribavirin|mesh-list
102331570|NCT01715415|Antimetabolites|antimetabolites|mesh-ancestor
102331571|NCT01715415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331572|NCT01715415|Antiviral Agents|antiviral agents|mesh-ancestor
102331573|NCT01715415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102331574|NCT00211510|Insulin|insulin|mesh-list
102331575|NCT00211510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102331576|NCT00211510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331577|NCT04198636|Denosumab|denosumab|mesh-list
102331578|NCT04198636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102331579|NCT04198636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331580|NCT04414995|Acetaminophen|acetaminophen|mesh-list
102331581|NCT04414995|Ibuprofen|ibuprofen|mesh-list
102331582|NCT04414995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102331583|NCT04414995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102331584|NCT04414995|Analgesics|analgesics|mesh-ancestor
102331585|NCT04414995|Sensory System Agents|sensory system agents|mesh-ancestor
102331586|NCT04414995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101836573|NCT01014156|Vasodilator Agents|vasodilator agents|mesh-ancestor
102331587|NCT04414995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331588|NCT04414995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102331589|NCT04414995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102331590|NCT04414995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102331591|NCT04414995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102331592|NCT04414995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331593|NCT04414995|Antipyretics|antipyretics|mesh-ancestor
102331594|NCT01869699|Acetaminophen|acetaminophen|mesh-list
102331595|NCT01869699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102331596|NCT01869699|Analgesics|analgesics|mesh-ancestor
102331597|NCT01869699|Sensory System Agents|sensory system agents|mesh-ancestor
102331598|NCT01869699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102331599|NCT01869699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331600|NCT01869699|Antipyretics|antipyretics|mesh-ancestor
102331601|NCT01875848|Buprenorphine|buprenorphine|mesh-list
102331602|NCT01875848|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102331603|NCT01875848|Naloxone|naloxone|mesh-list
102331604|NCT01875848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102331605|NCT01875848|Narcotics|narcotics|mesh-ancestor
102331606|NCT01875848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102331607|NCT01875848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331608|NCT01875848|Analgesics|analgesics|mesh-ancestor
102331609|NCT01875848|Sensory System Agents|sensory system agents|mesh-ancestor
102331610|NCT01875848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102331611|NCT01875848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102331612|NCT03591172|Propolis|propolis|mesh-list
102331613|NCT03591172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102331614|NCT04197622|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102331615|NCT04197622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102331616|NCT04197622|Diuretics|diuretics|mesh-ancestor
102331617|NCT04197622|Natriuretic Agents|natriuretic agents|mesh-ancestor
102331618|NCT04197622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331619|NCT04197622|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102331620|NCT04197622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102331621|NCT04197622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331622|NCT03595930|Fluticasone|fluticasone|mesh-list
102331623|NCT03595930|Xhance|xhance|mesh-list
102331624|NCT03595930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102331625|NCT03595930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102331626|NCT03595930|Autonomic Agents|autonomic agents|mesh-ancestor
102331627|NCT03595930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102331628|NCT03595930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331629|NCT03595930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102331630|NCT03595930|Respiratory System Agents|respiratory system agents|mesh-ancestor
102331631|NCT03595930|Dermatologic Agents|dermatologic agents|mesh-ancestor
102331632|NCT03595930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102331633|NCT03595852|Cefazolin|cefazolin|mesh-list
102331634|NCT03595852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102331635|NCT03595852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102331636|NCT04191382|Letrozole|letrozole|mesh-list
102331637|NCT04191382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102331638|NCT04191382|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102331639|NCT04191382|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102331640|NCT04191382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102331641|NCT04191382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331642|NCT04191382|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102331643|NCT04191382|Hormone Antagonists|hormone antagonists|mesh-ancestor
102331644|NCT04191382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102331645|NCT04191382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331646|NCT01703091|Docetaxel|docetaxel|mesh-list
102331647|NCT01703091|Ramucirumab|ramucirumab|mesh-list
102331648|NCT01703091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102331649|NCT01703091|Tubulin Modulators|tubulin modulators|mesh-ancestor
102331650|NCT01703091|Antimitotic Agents|antimitotic agents|mesh-ancestor
102331651|NCT01703091|Mitosis Modulators|mitosis modulators|mesh-ancestor
102331652|NCT01703091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331653|NCT04196998|Tenofovir|tenofovir|mesh-list
102331654|NCT04196998|Entecavir|entecavir|mesh-list
102331655|NCT04196998|Antiviral Agents|antiviral agents|mesh-ancestor
102331656|NCT04196998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102331657|NCT04196998|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102331658|NCT04196998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102331659|NCT04196998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102331660|NCT04196998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331661|NCT04196998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102331662|NCT04196998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102331663|NCT04196452|Ipilimumab|ipilimumab|mesh-list
102331664|NCT04196452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102331665|NCT04196452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102331666|NCT04196452|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102331667|NCT04196452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331668|NCT01867671|Immunomodulating Agents|immunomodulating agents|mesh-list
102331669|NCT01867671|Immunologic Factors|immunologic factors|mesh-list
102331670|NCT01867671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331671|NCT03967054|Ivermectin|ivermectin|mesh-list
102331672|NCT03967054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102331673|NCT03967054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102331674|NCT01702311|Insulin Aspart|insulin aspart|mesh-list
102331675|NCT01702311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102331676|NCT01702311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331677|NCT04196608|Tazobactam|tazobactam|mesh-list
102331678|NCT04196608|Imipenem|imipenem|mesh-list
102331679|NCT04196608|Ceftolozane|ceftolozane|mesh-list
102331680|NCT04196608|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
102331681|NCT04196608|Relebactam|relebactam|mesh-list
102331682|NCT04196608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102331683|NCT04196608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102331684|NCT04196608|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102331685|NCT04196608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102331686|NCT04196608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331687|NCT04196608|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102331688|NCT04022200|Paclitaxel|paclitaxel|mesh-list
102331689|NCT04022200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102331690|NCT04022200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102331691|NCT04022200|Tubulin Modulators|tubulin modulators|mesh-ancestor
102331692|NCT04022200|Antimitotic Agents|antimitotic agents|mesh-ancestor
102331693|NCT04022200|Mitosis Modulators|mitosis modulators|mesh-ancestor
102331694|NCT04022200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331695|NCT04552743|Plerixafor|plerixafor|mesh-list
102331696|NCT04552743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102331697|NCT04552743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102331698|NCT04552743|Antiviral Agents|antiviral agents|mesh-ancestor
102331699|NCT04552743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102331700|NCT03590080|Methylprednisolone|methylprednisolone|mesh-list
102331701|NCT03590080|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102331702|NCT03590080|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102331704|NCT03590080|Prednisolone acetate|prednisolone acetate|mesh-list
102331705|NCT03590080|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102331706|NCT03590080|Prednisolone phosphate|prednisolone phosphate|mesh-list
102331707|NCT03590080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101449219|NCT00122876|Talaporfin|talaporfin|mesh-list
102331708|NCT03590080|Antiemetics|antiemetics|mesh-ancestor
102331709|NCT03590080|Autonomic Agents|autonomic agents|mesh-ancestor
102331710|NCT03590080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102331711|NCT03590080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331712|NCT03590080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102331713|NCT03590080|Glucocorticoids|glucocorticoids|mesh-ancestor
102331714|NCT03590080|Hormones|hormones|mesh-ancestor
102331715|NCT03590080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102331716|NCT03590080|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102331717|NCT03590080|Protective Agents|protective agents|mesh-ancestor
102331718|NCT03590080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102331719|NCT03590080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102331720|NCT04028362|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
102331721|NCT04028362|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102331722|NCT04028362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102331723|NCT04028362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331724|NCT03594058|Solabegron|solabegron|mesh-list
102331725|NCT03594058|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102331726|NCT03594058|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102331727|NCT03594058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102331728|NCT03594058|Adrenergic Agents|adrenergic agents|mesh-ancestor
102331729|NCT03594058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102331730|NCT03594058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331731|NCT03594058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331732|NCT03970720|Metoclopramide|metoclopramide|mesh-list
102331733|NCT03970720|Antiemetics|antiemetics|mesh-ancestor
102331734|NCT03970720|Autonomic Agents|autonomic agents|mesh-ancestor
102331735|NCT03970720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102331736|NCT03970720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331737|NCT03970720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102331738|NCT03970720|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102331739|NCT03970720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102331740|NCT03970720|Dopamine Agents|dopamine agents|mesh-ancestor
102331741|NCT03970720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102331742|NCT03970720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331743|NCT04028830|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102331744|NCT04028830|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102331745|NCT04028830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102331746|NCT04028830|Antitubercular Agents|antitubercular agents|mesh-ancestor
102331747|NCT04194658|Letrozole|letrozole|mesh-list
102331748|NCT04194658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102331749|NCT04194658|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102331750|NCT04194658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102331751|NCT04194658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102331752|NCT04194658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331753|NCT04194658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102331754|NCT04194658|Hormone Antagonists|hormone antagonists|mesh-ancestor
102331755|NCT04194658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102331756|NCT04194658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331757|NCT04028518|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102331758|NCT04028518|Plasminogen|plasminogen|mesh-list
102331759|NCT04028518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102331760|NCT04028518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102331761|NCT04028518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331762|NCT04747678|Ivermectin|ivermectin|mesh-list
102331763|NCT04747678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102331764|NCT04747678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102331765|NCT04027972|Glycopyrrolate|glycopyrrolate|mesh-list
102331766|NCT04027972|Neostigmine|neostigmine|mesh-list
102331767|NCT04027972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102331768|NCT04027972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102331769|NCT04027972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331770|NCT04027972|Cholinergic Agents|cholinergic agents|mesh-ancestor
102331771|NCT04027972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102331772|NCT04027972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331773|NCT04027972|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102331774|NCT04027972|Autonomic Agents|autonomic agents|mesh-ancestor
102331775|NCT04027972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102331776|NCT04027972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102331777|NCT04027972|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102331778|NCT04027972|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102331779|NCT04191928|Apixaban|apixaban|mesh-list
102331780|NCT04191928|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102331781|NCT04191928|Antithrombins|antithrombins|mesh-ancestor
102331782|NCT04191928|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102331783|NCT04191928|Protease Inhibitors|protease inhibitors|mesh-ancestor
102331784|NCT04191928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102331785|NCT04191928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331786|NCT04191928|Anticoagulants|anticoagulants|mesh-ancestor
102331787|NCT04199494|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102331788|NCT04199494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102331789|NCT04027192|Midazolam|midazolam|mesh-list
102331790|NCT04027192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102331791|NCT04027192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102331792|NCT04027192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102331793|NCT04027192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331794|NCT04027192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102331795|NCT04027192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102331796|NCT04027192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102331797|NCT04027192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102331798|NCT04027192|Anesthetics, General|anesthetics, general|mesh-ancestor
102331799|NCT04027192|Anesthetics|anesthetics|mesh-ancestor
102331800|NCT04027192|GABA Modulators|gaba modulators|mesh-ancestor
102331801|NCT04027192|GABA Agents|gaba agents|mesh-ancestor
102331802|NCT04027192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102331803|NCT04027192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331804|NCT04406506|Erythromycin|erythromycin|mesh-list
102331805|NCT04406506|Erythromycin Estolate|erythromycin estolate|mesh-list
102331806|NCT04406506|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
102331807|NCT04406506|Erythromycin stearate|erythromycin stearate|mesh-list
102331808|NCT04406506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102331809|NCT04406506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102331810|NCT04406506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102331811|NCT04406506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102331812|NCT04406506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102331813|NCT04406506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331814|NCT03828292|Dexamethasone|dexamethasone|mesh-list
102331815|NCT03828292|Bortezomib|bortezomib|mesh-list
102331816|NCT03828292|Pomalidomide|pomalidomide|mesh-list
102331817|NCT03828292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102331818|NCT03828292|Antiemetics|antiemetics|mesh-ancestor
102331819|NCT03828292|Autonomic Agents|autonomic agents|mesh-ancestor
102331820|NCT03828292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102331821|NCT03828292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331822|NCT03828292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102331823|NCT03828292|Glucocorticoids|glucocorticoids|mesh-ancestor
102331824|NCT03828292|Hormones|hormones|mesh-ancestor
102331825|NCT03828292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102331826|NCT03828292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102331827|NCT03828292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102331828|NCT03828292|Immunologic Factors|immunologic factors|mesh-ancestor
102331829|NCT03828292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102331830|NCT03828292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102331831|NCT03828292|Growth Substances|growth substances|mesh-ancestor
102331832|NCT03828292|Growth Inhibitors|growth inhibitors|mesh-ancestor
102331833|NCT04191694|Ondansetron|ondansetron|mesh-list
102331834|NCT04191694|Antiemetics|antiemetics|mesh-ancestor
102331835|NCT04191694|Autonomic Agents|autonomic agents|mesh-ancestor
102331836|NCT04191694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102331837|NCT04191694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331838|NCT04191694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102331839|NCT04191694|Antipruritics|antipruritics|mesh-ancestor
102331840|NCT04191694|Dermatologic Agents|dermatologic agents|mesh-ancestor
102331841|NCT04191694|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102331842|NCT04191694|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102331843|NCT04191694|Serotonin Agents|serotonin agents|mesh-ancestor
102331844|NCT04191694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102331845|NCT04191694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331846|NCT04026022|Fentanyl|fentanyl|mesh-list
102331847|NCT04026022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102331848|NCT04026022|Narcotics|narcotics|mesh-ancestor
102331849|NCT04026022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102331850|NCT04026022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331851|NCT04026022|Analgesics|analgesics|mesh-ancestor
102331852|NCT04026022|Sensory System Agents|sensory system agents|mesh-ancestor
102331853|NCT04026022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102331854|NCT04026022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102331855|NCT04026022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102331856|NCT04026022|Anesthetics, General|anesthetics, general|mesh-ancestor
102331857|NCT04026022|Anesthetics|anesthetics|mesh-ancestor
102331858|NCT04020406|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102331859|NCT04020406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102331860|NCT04020328|Prednisone|prednisone|mesh-list
102331861|NCT04020328|Leflunomide|leflunomide|mesh-list
102331862|NCT04020328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102331863|NCT04020328|Glucocorticoids|glucocorticoids|mesh-ancestor
102331864|NCT04020328|Hormones|hormones|mesh-ancestor
102331865|NCT04020328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102331866|NCT04020328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331867|NCT04020328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102331868|NCT04020328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102331869|NCT04020328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102331870|NCT04020328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331871|NCT04020328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102331872|NCT04020328|Immunologic Factors|immunologic factors|mesh-ancestor
102331873|NCT04020094|Atezolizumab|atezolizumab|mesh-list
102331874|NCT04020094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102331875|NCT04020094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331876|NCT04020094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102331877|NCT04020094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102331878|NCT02080468|Norgestimate|norgestimate|mesh-list
102331879|NCT02080468|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102331880|NCT02080468|Contraceptive Agents|contraceptive agents|mesh-ancestor
102331881|NCT02080468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102331882|NCT02080468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331883|NCT02080468|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102331884|NCT02080468|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102331885|NCT02080468|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102331886|NCT04020016|Nalbuphine|nalbuphine|mesh-list
102331887|NCT04020016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102331888|NCT04020016|Narcotics|narcotics|mesh-ancestor
102331889|NCT04020016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102331890|NCT04020016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331891|NCT04020016|Analgesics|analgesics|mesh-ancestor
102331892|NCT04020016|Sensory System Agents|sensory system agents|mesh-ancestor
102331893|NCT04020016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102331894|NCT01874054|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102331895|NCT01874054|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102331896|NCT01874054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102331897|NCT01874054|Alkylating Agents|alkylating agents|mesh-ancestor
102331898|NCT01874054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331899|NCT01874054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102331900|NCT01874054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102331901|NCT01874054|Immunotoxins|immunotoxins|mesh-ancestor
102331902|NCT01874054|Immunoconjugates|immunoconjugates|mesh-ancestor
102331903|NCT01874054|Immunologic Factors|immunologic factors|mesh-ancestor
102331904|NCT01874054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331905|NCT04029610|Lidocaine|lidocaine|mesh-list
102331906|NCT04029610|Epinephrine|epinephrine|mesh-list
102331907|NCT04029610|Racepinephrine|racepinephrine|mesh-list
102331908|NCT04029610|Epinephryl borate|epinephryl borate|mesh-list
102331909|NCT04029610|Anesthetics, Local|anesthetics, local|mesh-ancestor
102331910|NCT04029610|Anesthetics|anesthetics|mesh-ancestor
102331911|NCT04029610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102331912|NCT04029610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331913|NCT04029610|Sensory System Agents|sensory system agents|mesh-ancestor
102331914|NCT04029610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102331915|NCT04029610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102331916|NCT04029610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102331917|NCT04029610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102331918|NCT04029610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101442183|NCT00409851|Amlodipine|amlodipine|mesh-list
102331919|NCT04029610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331920|NCT04029610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102331921|NCT04029610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102331922|NCT04029610|Adrenergic Agents|adrenergic agents|mesh-ancestor
102331923|NCT04029610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102331924|NCT04029610|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102331925|NCT04029610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102331927|NCT04029610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102331928|NCT04029610|Respiratory System Agents|respiratory system agents|mesh-ancestor
102331929|NCT04029610|Mydriatics|mydriatics|mesh-ancestor
102331930|NCT04029610|Sympathomimetics|sympathomimetics|mesh-ancestor
102331931|NCT04029610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102331932|NCT04026880|Methyltestosterone|methyltestosterone|mesh-list
102331933|NCT04026880|Testosterone|testosterone|mesh-list
102331934|NCT04026880|Testosterone undecanoate|testosterone undecanoate|mesh-list
102331935|NCT04026880|Testosterone enanthate|testosterone enanthate|mesh-list
102331936|NCT04026880|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102331937|NCT04026880|Androgens|androgens|mesh-ancestor
102331938|NCT04026880|Hormones|hormones|mesh-ancestor
102331939|NCT04026880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102331940|NCT04026880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331941|NCT04026880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102331942|NCT04026880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102331943|NCT04026880|Anabolic Agents|anabolic agents|mesh-ancestor
102331944|NCT04024384|Daratumumab|daratumumab|mesh-list
102331945|NCT04024384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102331946|NCT04023760|Apixaban|apixaban|mesh-list
102331947|NCT04023760|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102331948|NCT04023760|Antithrombins|antithrombins|mesh-ancestor
102331949|NCT04023760|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102331950|NCT04023760|Protease Inhibitors|protease inhibitors|mesh-ancestor
102331951|NCT04023760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102331952|NCT04023760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331953|NCT04023760|Anticoagulants|anticoagulants|mesh-ancestor
102331954|NCT04020718|Nicotine|nicotine|mesh-list
102331955|NCT04020718|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102331956|NCT04020718|Autonomic Agents|autonomic agents|mesh-ancestor
102331957|NCT04020718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102331958|NCT04020718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331959|NCT04020718|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102331960|NCT04020718|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102331961|NCT04020718|Cholinergic Agents|cholinergic agents|mesh-ancestor
102331962|NCT04020718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102331963|NCT04020718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331964|NCT04027348|Dexamethasone|dexamethasone|mesh-list
101836574|NCT00322348|Goserelin|goserelin|mesh-list
102331966|NCT04027348|Metoclopramide|metoclopramide|mesh-list
102331967|NCT04027348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102331968|NCT04027348|Antiemetics|antiemetics|mesh-ancestor
102331969|NCT04027348|Autonomic Agents|autonomic agents|mesh-ancestor
102331970|NCT04027348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102331971|NCT04027348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331972|NCT04027348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102331973|NCT04027348|Glucocorticoids|glucocorticoids|mesh-ancestor
102331974|NCT04027348|Hormones|hormones|mesh-ancestor
102331975|NCT04027348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102331976|NCT04027348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102331977|NCT04027348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102331978|NCT04027348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102331979|NCT04027348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102331980|NCT04027348|Dopamine Agents|dopamine agents|mesh-ancestor
102331981|NCT04027348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102331982|NCT04027348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331983|NCT04195204|Tropisetron|tropisetron|mesh-list
102331984|NCT04195204|Antiemetics|antiemetics|mesh-ancestor
102331985|NCT04195204|Autonomic Agents|autonomic agents|mesh-ancestor
102331986|NCT04195204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102331987|NCT04195204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102331988|NCT04195204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102331989|NCT04195204|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102331990|NCT04195204|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102331991|NCT04195204|Serotonin Agents|serotonin agents|mesh-ancestor
102331992|NCT04195204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102331993|NCT04195204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102331994|NCT04023292|Tamoxifen|tamoxifen|mesh-list
102331995|NCT04023292|Letrozole|letrozole|mesh-list
102331996|NCT04023292|Exemestane|exemestane|mesh-list
102331997|NCT04023292|Anastrozole|anastrozole|mesh-list
101674001|NCT02799758|Antimetabolites|antimetabolites|mesh-ancestor
102331998|NCT04023292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102331999|NCT04023292|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102332000|NCT04023292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102332001|NCT04023292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102332002|NCT04023292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332003|NCT04023292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102332004|NCT04023292|Hormone Antagonists|hormone antagonists|mesh-ancestor
102332005|NCT04023292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102332006|NCT04023292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332007|NCT04023292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102332008|NCT04023292|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102332009|NCT04023292|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102332010|NCT04023292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102332011|NCT03022240|Ondansetron|ondansetron|mesh-list
102332012|NCT03022240|Propofol|propofol|mesh-list
102332013|NCT03022240|Sevoflurane|sevoflurane|mesh-list
102332014|NCT03022240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102332015|NCT03022240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102332016|NCT03022240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332017|NCT03022240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102332018|NCT03022240|Anesthetics, General|anesthetics, general|mesh-ancestor
102332019|NCT03022240|Anesthetics|anesthetics|mesh-ancestor
102332020|NCT03022240|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102332021|NCT03022240|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102332022|NCT03022240|Antiemetics|antiemetics|mesh-ancestor
102332023|NCT03022240|Autonomic Agents|autonomic agents|mesh-ancestor
102332024|NCT03022240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102332025|NCT03022240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102332026|NCT03022240|Antipruritics|antipruritics|mesh-ancestor
102332027|NCT03022240|Dermatologic Agents|dermatologic agents|mesh-ancestor
102332028|NCT03022240|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102332029|NCT03022240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102332030|NCT03022240|Serotonin Agents|serotonin agents|mesh-ancestor
102332031|NCT03022240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102332032|NCT03022240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332033|NCT02704390|Methylphenidate|methylphenidate|mesh-list
102332034|NCT02704390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102332035|NCT02704390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332036|NCT02704390|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102332037|NCT02704390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102040876|NCT01381497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102332038|NCT02704390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102332039|NCT02704390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332040|NCT02704390|Dopamine Agents|dopamine agents|mesh-ancestor
102332041|NCT02704390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102332042|NCT04147390|Mycophenolic Acid|mycophenolic acid|mesh-list
102332043|NCT04147390|Tacrolimus|tacrolimus|mesh-list
102332044|NCT04147390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102332045|NCT04147390|Immunologic Factors|immunologic factors|mesh-ancestor
102332046|NCT04147390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332047|NCT04147390|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102332048|NCT04147390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102332049|NCT04147390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332050|NCT04147390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102332051|NCT04147390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102332052|NCT04147390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102332053|NCT04147390|Antitubercular Agents|antitubercular agents|mesh-ancestor
102332054|NCT04147390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102332055|NCT04147390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102332056|NCT02708680|Atezolizumab|atezolizumab|mesh-list
102332057|NCT02708680|Entinostat|entinostat|mesh-list
102332058|NCT02708680|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101449546|NCT00123539|Estrogens|estrogens|mesh-list
102332059|NCT02708680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332060|NCT02708680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102332061|NCT02708680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102332062|NCT02708680|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102332063|NCT02708680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102332064|NCT03932656|Psychotropic Drugs|psychotropic drugs|mesh-list
102332065|NCT03931642|Blinatumomab|blinatumomab|mesh-list
102332066|NCT03931642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102332067|NCT04021420|Nivolumab|nivolumab|mesh-list
102332068|NCT04021420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102332069|NCT04021420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102332086|NCT02080780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102332087|NCT02080780|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102332088|NCT02080780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102332089|NCT02080780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332090|NCT02080780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102332091|NCT02080780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102332092|NCT02080780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102332093|NCT02080780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102332094|NCT02080780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102332095|NCT02080780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102332096|NCT02080780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332097|NCT02080780|Vasodilator Agents|vasodilator agents|mesh-ancestor
102332099|NCT01871558|Vildagliptin|vildagliptin|mesh-list
102332100|NCT01871558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102332101|NCT01871558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332102|NCT01871558|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102332103|NCT01871558|Protease Inhibitors|protease inhibitors|mesh-ancestor
102332104|NCT01871558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102332105|NCT01871558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332106|NCT01711359|Folic Acid|folic acid|mesh-list
102332107|NCT01711359|Methotrexate|methotrexate|mesh-list
102332108|NCT01711359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102332109|NCT01711359|Abortifacient Agents|abortifacient agents|mesh-ancestor
102332110|NCT01711359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102040949|NCT03187301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102332111|NCT01711359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332112|NCT01711359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102332113|NCT01711359|Antimetabolites|antimetabolites|mesh-ancestor
102332114|NCT01711359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332115|NCT01711359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102332116|NCT01711359|Dermatologic Agents|dermatologic agents|mesh-ancestor
102332117|NCT01711359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102332118|NCT01711359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102332119|NCT01711359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102332120|NCT01711359|Immunologic Factors|immunologic factors|mesh-ancestor
102332121|NCT01711359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102332122|NCT01711359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102332123|NCT01711359|Hematinics|hematinics|mesh-ancestor
102332124|NCT01711359|Vitamin B Complex|vitamin b complex|mesh-ancestor
102332125|NCT01711359|Vitamins|vitamins|mesh-ancestor
102332126|NCT01711359|Micronutrients|micronutrients|mesh-ancestor
101674160|NCT04405999|Bromhexine|bromhexine|mesh-list
102332148|NCT04140136|Antioxidants|antioxidants|mesh-ancestor
102332149|NCT04140136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332150|NCT04140136|Protective Agents|protective agents|mesh-ancestor
102332151|NCT04140136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332152|NCT04140136|Vitamins|vitamins|mesh-ancestor
102332153|NCT04140136|Micronutrients|micronutrients|mesh-ancestor
102332154|NCT04146532|Aspirin|aspirin|mesh-list
102332155|NCT04146532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102332156|NCT04146532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102332157|NCT04146532|Analgesics|analgesics|mesh-ancestor
102332158|NCT04146532|Sensory System Agents|sensory system agents|mesh-ancestor
102332159|NCT04146532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102332160|NCT04146532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332161|NCT04146532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102332162|NCT04146532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102332163|NCT04146532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102332164|NCT04146532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102332165|NCT04146532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332166|NCT04146532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102332167|NCT04146532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102332168|NCT04146532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102332169|NCT04146532|Antipyretics|antipyretics|mesh-ancestor
102332170|NCT03929224|Bacitracin|bacitracin|mesh-list
102332171|NCT03929224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102332172|NCT03929224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102332173|NCT03929224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102332174|NCT04146610|Antibodies|antibodies|mesh-list
102332175|NCT04146610|Immunoconjugates|immunoconjugates|mesh-list
102332176|NCT04146610|Immunologic Factors|immunologic factors|mesh-ancestor
102332177|NCT04146610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332178|NCT04146376|Tranexamic Acid|tranexamic acid|mesh-list
102332179|NCT04146376|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102332180|NCT04146376|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102332181|NCT04146376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332182|NCT04146376|Hemostatics|hemostatics|mesh-ancestor
102332183|NCT04146376|Coagulants|coagulants|mesh-ancestor
102332184|NCT01710657|Lacosamide|lacosamide|mesh-list
102332185|NCT01710657|Anticonvulsants|anticonvulsants|mesh-ancestor
102041030|NCT03287375|Cisplatin|cisplatin|mesh-list
102332186|NCT01710657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102332187|NCT01710657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102332188|NCT01710657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102332189|NCT01710657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332190|NCT03021772|Dexamethasone|dexamethasone|mesh-list
102332191|NCT03021772|Neostigmine|neostigmine|mesh-list
102332192|NCT03021772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102332193|NCT03021772|Antiemetics|antiemetics|mesh-ancestor
102332194|NCT03021772|Autonomic Agents|autonomic agents|mesh-ancestor
102332195|NCT03021772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102332196|NCT03021772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332197|NCT03021772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102332198|NCT03021772|Glucocorticoids|glucocorticoids|mesh-ancestor
102332199|NCT03021772|Hormones|hormones|mesh-ancestor
102332200|NCT03021772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102332201|NCT03021772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102332202|NCT03021772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102332203|NCT03021772|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102332204|NCT03021772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102332205|NCT03021772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332206|NCT03021772|Cholinergic Agents|cholinergic agents|mesh-ancestor
102332207|NCT03021772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102332208|NCT03021772|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102332209|NCT04149262|Insulin Aspart|insulin aspart|mesh-list
102332210|NCT04149262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102332211|NCT04149262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332212|NCT05581420|Ferrous fumarate|ferrous fumarate|mesh-list
102332213|NCT05581420|Trace Elements|trace elements|mesh-ancestor
102332214|NCT05581420|Micronutrients|micronutrients|mesh-ancestor
102332215|NCT05581420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332216|NCT03904498|Tolcapone|tolcapone|mesh-list
102332217|NCT03904498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102332218|NCT03904498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102332219|NCT03904498|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102332220|NCT03904498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102332221|NCT03904498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332222|NCT04405960|Alfacalcidol|alfacalcidol|mesh-list
102332223|NCT04405960|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
102332224|NCT04405960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102332225|NCT04405960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332226|NCT04405960|Vitamins|vitamins|mesh-ancestor
102332227|NCT04405960|Micronutrients|micronutrients|mesh-ancestor
102332228|NCT03945604|Apatinib|apatinib|mesh-list
102332229|NCT03945604|Fluzoparib|fluzoparib|mesh-list
102332230|NCT03945604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102332231|NCT03945604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102332232|NCT03945604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102332233|NCT03945604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332234|NCT03945604|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102332235|NCT03944434|Leuprolide|leuprolide|mesh-list
102332236|NCT03944434|Goserelin|goserelin|mesh-list
102332237|NCT03944434|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102332238|NCT03944434|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102332239|NCT03944434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102332240|NCT03944434|Fertility Agents|fertility agents|mesh-ancestor
102332241|NCT03944434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102332242|NCT03944434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332243|NCT03944434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102332244|NCT03944434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102332245|NCT03944434|Luteolytic Agents|luteolytic agents|mesh-ancestor
102332246|NCT03944434|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102332247|NCT03944434|Contraceptive Agents|contraceptive agents|mesh-ancestor
102332248|NCT03944434|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102332249|NCT03944434|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102332250|NCT03944434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102332251|NCT03944434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332252|NCT03944434|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102332253|NCT03944434|Hormone Antagonists|hormone antagonists|mesh-ancestor
102332254|NCT03944434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102332255|NCT03944356|Trametinib|trametinib|mesh-list
102332256|NCT03944356|Dabrafenib|dabrafenib|mesh-list
102332257|NCT03944356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102332258|NCT03944356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102332259|NCT03944356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102332260|NCT03944356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332261|NCT01701063|Ribavirin|ribavirin|mesh-list
102332262|NCT01701063|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102332263|NCT01701063|Antimetabolites|antimetabolites|mesh-ancestor
102332264|NCT01701063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332265|NCT01701063|Antiviral Agents|antiviral agents|mesh-ancestor
102332266|NCT01701063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102332268|NCT03920722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102332269|NCT03920722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102332270|NCT03920722|Immunologic Factors|immunologic factors|mesh-ancestor
102332271|NCT03920722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332272|NCT03920722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102332273|NCT05580094|Anesthetics|anesthetics|mesh-list
102332274|NCT05580094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102332275|NCT05580094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332276|NCT05589766|Niacinamide|niacinamide|mesh-list
102332277|NCT05589766|Niacin|niacin|mesh-list
102332278|NCT05589766|Nicotinic Acids|nicotinic acids|mesh-list
102332279|NCT05589766|Vitamin B Complex|vitamin b complex|mesh-ancestor
102332280|NCT05589766|Vitamins|vitamins|mesh-ancestor
102332281|NCT05589766|Micronutrients|micronutrients|mesh-ancestor
102332282|NCT05589766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332283|NCT05589766|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102332284|NCT05589766|Antimetabolites|antimetabolites|mesh-ancestor
102332285|NCT05589766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332286|NCT05589766|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102332287|NCT05589766|Vasodilator Agents|vasodilator agents|mesh-ancestor
102332288|NCT05586100|Cetuximab|cetuximab|mesh-list
102332289|NCT05586100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102332290|NCT05586100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102332291|NCT05585086|Peppermint oil|peppermint oil|mesh-list
102332292|NCT05585086|Antiemetics|antiemetics|mesh-ancestor
102332293|NCT05585086|Autonomic Agents|autonomic agents|mesh-ancestor
102332294|NCT05585086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102332295|NCT05585086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332296|NCT05585086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102332297|NCT05585086|Parasympatholytics|parasympatholytics|mesh-ancestor
102332299|NCT01710501|Ribavirin|ribavirin|mesh-list
102332300|NCT01710501|Interferon-alpha|interferon-alpha|mesh-list
102332301|NCT01710501|Interferon alpha-2|interferon alpha-2|mesh-list
102332302|NCT01710501|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102332303|NCT01710501|Grazoprevir|grazoprevir|mesh-list
102332304|NCT01710501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102332305|NCT01710501|Antiviral Agents|antiviral agents|mesh-ancestor
102332306|NCT01710501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102332307|NCT01710501|Antimetabolites|antimetabolites|mesh-ancestor
102332308|NCT01710501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332309|NCT01710501|Immunologic Factors|immunologic factors|mesh-ancestor
102332310|NCT01710501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332311|NCT05583058|Hormones|hormones|mesh-list
102332312|NCT05583058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102332313|NCT05583058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332314|NCT01700829|Midazolam|midazolam|mesh-list
102332315|NCT01700829|Ketamine|ketamine|mesh-list
102332316|NCT01700829|Analgesics|analgesics|mesh-ancestor
102332317|NCT01700829|Sensory System Agents|sensory system agents|mesh-ancestor
102332318|NCT01700829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102332319|NCT01700829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332320|NCT01700829|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102332321|NCT01700829|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102332322|NCT01700829|Anesthetics, General|anesthetics, general|mesh-ancestor
102332323|NCT01700829|Anesthetics|anesthetics|mesh-ancestor
102332324|NCT01700829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102332325|NCT01700829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102332326|NCT01700829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102332327|NCT01700829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102332328|NCT01700829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332329|NCT01700829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102332330|NCT01700829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102332331|NCT01700829|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102332332|NCT01700829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102332333|NCT01700829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102332334|NCT01700829|GABA Modulators|gaba modulators|mesh-ancestor
102332335|NCT01700829|GABA Agents|gaba agents|mesh-ancestor
102332336|NCT04143880|Progesterone|progesterone|mesh-list
102332337|NCT04143880|Progestins|progestins|mesh-ancestor
102332338|NCT04143880|Hormones|hormones|mesh-ancestor
102332339|NCT04143880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102332340|NCT04143880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332341|NCT04144192|Lidocaine|lidocaine|mesh-list
102332342|NCT04144192|Anesthetics, Local|anesthetics, local|mesh-ancestor
102332343|NCT04144192|Anesthetics|anesthetics|mesh-ancestor
102332344|NCT04144192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102332345|NCT04144192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332346|NCT04144192|Sensory System Agents|sensory system agents|mesh-ancestor
102332347|NCT04144192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102332348|NCT04144192|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102332349|NCT04144192|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102332350|NCT04144192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102332351|NCT04144192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102332352|NCT04144192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332353|NCT01710345|Sufentanil|sufentanil|mesh-list
102332354|NCT01710345|Dsuvia|dsuvia|mesh-list
102332355|NCT01710345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102332356|NCT01710345|Narcotics|narcotics|mesh-ancestor
102332357|NCT01710345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102332358|NCT01710345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332359|NCT01710345|Analgesics|analgesics|mesh-ancestor
102332360|NCT01710345|Sensory System Agents|sensory system agents|mesh-ancestor
102332361|NCT01710345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102332362|NCT01710345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102332363|NCT01710345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102332364|NCT01710345|Anesthetics, General|anesthetics, general|mesh-ancestor
102332365|NCT01710345|Anesthetics|anesthetics|mesh-ancestor
102332366|NCT03022006|Grazoprevir|grazoprevir|mesh-list
102332367|NCT03022006|Antiviral Agents|antiviral agents|mesh-ancestor
102332368|NCT03022006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102332369|NCT04143256|Menthol|menthol|mesh-list
102332370|NCT04143256|Antipruritics|antipruritics|mesh-ancestor
102332371|NCT04143256|Dermatologic Agents|dermatologic agents|mesh-ancestor
102332372|NCT04143412|Ramipril|ramipril|mesh-list
102332373|NCT04143412|Eplerenone|eplerenone|mesh-list
102332374|NCT04143412|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102332375|NCT04143412|Protease Inhibitors|protease inhibitors|mesh-ancestor
102332376|NCT04143412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102332377|NCT04143412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332378|NCT04143412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102332379|NCT04143412|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102332380|NCT04143412|Hormone Antagonists|hormone antagonists|mesh-ancestor
102332381|NCT04143412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102332382|NCT04143412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332383|NCT04143412|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102332384|NCT04143412|Diuretics|diuretics|mesh-ancestor
102332385|NCT04143412|Natriuretic Agents|natriuretic agents|mesh-ancestor
102332386|NCT05582278|Lenvatinib|lenvatinib|mesh-list
102332387|NCT05582278|Tislelizumab|tislelizumab|mesh-list
102332388|NCT05582278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102332389|NCT05582278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102332390|NCT05582278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102332391|NCT05582278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102332392|NCT05582278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332393|NCT05582278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102332394|NCT01710033|Tofacitinib|tofacitinib|mesh-list
102332395|NCT01710033|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102332396|NCT01710033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102332397|NCT01710033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102332398|NCT01710033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332399|NCT01822496|Paclitaxel|paclitaxel|mesh-list
102332400|NCT01822496|Etoposide|etoposide|mesh-list
102332401|NCT01822496|Podophyllotoxin|podophyllotoxin|mesh-list
102332402|NCT01822496|Cisplatin|cisplatin|mesh-list
102332403|NCT01822496|Carboplatin|carboplatin|mesh-list
102332404|NCT01822496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102332405|NCT01822496|Etoposide phosphate|etoposide phosphate|mesh-list
102332406|NCT01822496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102332407|NCT01822496|Crizotinib|crizotinib|mesh-list
102332408|NCT01822496|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102332409|NCT01822496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102332410|NCT01822496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102332411|NCT01822496|Tubulin Modulators|tubulin modulators|mesh-ancestor
102332412|NCT01822496|Antimitotic Agents|antimitotic agents|mesh-ancestor
102041252|NCT05030129|Vasodilator Agents|vasodilator agents|mesh-ancestor
102332413|NCT01822496|Mitosis Modulators|mitosis modulators|mesh-ancestor
102332414|NCT01822496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332415|NCT01822496|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102332416|NCT01822496|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102332417|NCT01822496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102332418|NCT01822496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102332419|NCT01822496|Keratolytic Agents|keratolytic agents|mesh-ancestor
102332420|NCT01822496|Dermatologic Agents|dermatologic agents|mesh-ancestor
102332421|NCT01867047|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102332422|NCT01867047|Protease Inhibitors|protease inhibitors|mesh-ancestor
102332423|NCT01867047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102332424|NCT01867047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332425|NCT03588988|Dexmedetomidine|dexmedetomidine|mesh-list
102332426|NCT03588988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102332427|NCT03588988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102332428|NCT03588988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332429|NCT03588988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102332430|NCT03588988|Analgesics|analgesics|mesh-ancestor
102332431|NCT03588988|Sensory System Agents|sensory system agents|mesh-ancestor
102332432|NCT03588988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102332433|NCT03588988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102332434|NCT03588988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102332435|NCT03588988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102332436|NCT03588988|Adrenergic Agents|adrenergic agents|mesh-ancestor
102332437|NCT03588988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102332438|NCT03588988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332439|NCT04414137|Daptomycin|daptomycin|mesh-list
102332440|NCT04414137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102332441|NCT04414137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102332442|NCT01821560|Baclofen|baclofen|mesh-list
102332443|NCT01821560|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102332444|NCT01821560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332445|NCT01821560|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102332446|NCT01821560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102332447|NCT01821560|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102332448|NCT01821560|GABA Agonists|gaba agonists|mesh-ancestor
102332449|NCT01821560|GABA Agents|gaba agents|mesh-ancestor
102332450|NCT01821560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102332451|NCT01821560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332452|NCT05580328|Hematoporphyrins|hematoporphyrins|mesh-list
102332453|NCT05580328|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102332454|NCT05580328|Dermatologic Agents|dermatologic agents|mesh-ancestor
102332455|NCT03588676|Melatonin|melatonin|mesh-list
102332456|NCT03588676|Antioxidants|antioxidants|mesh-ancestor
102332457|NCT03588676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332458|NCT03588676|Protective Agents|protective agents|mesh-ancestor
102332459|NCT03588676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332460|NCT03588676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102332461|NCT01846442|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
102332462|NCT01846442|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102332463|NCT01846442|Immunologic Factors|immunologic factors|mesh-ancestor
102332464|NCT01846442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332465|NCT01709721|Hydromorphone|hydromorphone|mesh-list
102332466|NCT01709721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102332467|NCT01709721|Narcotics|narcotics|mesh-ancestor
102332468|NCT01709721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102332469|NCT01709721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332470|NCT01709721|Analgesics|analgesics|mesh-ancestor
102332471|NCT01709721|Sensory System Agents|sensory system agents|mesh-ancestor
102332472|NCT01709721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102332473|NCT01866657|Phenylephrine|phenylephrine|mesh-list
102332474|NCT01866657|Dopamine|dopamine|mesh-list
102332475|NCT01866657|Ephedrine|ephedrine|mesh-list
102332476|NCT01866657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
102332477|NCT01866657|Propofol|propofol|mesh-list
102332478|NCT01866657|Sevoflurane|sevoflurane|mesh-list
102332479|NCT01866657|Anesthetics|anesthetics|mesh-ancestor
102332480|NCT01866657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102332481|NCT01866657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332482|NCT01866657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102332483|NCT01866657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102332484|NCT01866657|Anesthetics, General|anesthetics, general|mesh-ancestor
102332485|NCT01866657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102332486|NCT01866657|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102332487|NCT01866657|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102332488|NCT01866657|Mydriatics|mydriatics|mesh-ancestor
102332489|NCT01866657|Autonomic Agents|autonomic agents|mesh-ancestor
102332490|NCT01866657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102332492|NCT01866657|Nasal Decongestants|nasal decongestants|mesh-ancestor
102332493|NCT01866657|Respiratory System Agents|respiratory system agents|mesh-ancestor
102332494|NCT01866657|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102332495|NCT01866657|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102332496|NCT01866657|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102332497|NCT01866657|Adrenergic Agents|adrenergic agents|mesh-ancestor
102332498|NCT01866657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102332499|NCT01866657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332500|NCT01866657|Protective Agents|protective agents|mesh-ancestor
102332501|NCT01866657|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102332502|NCT01866657|Dopamine Agents|dopamine agents|mesh-ancestor
102332503|NCT03584152|Acetaminophen|acetaminophen|mesh-list
102332504|NCT03584152|Ibuprofen|ibuprofen|mesh-list
102332505|NCT03584152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102332506|NCT03584152|Analgesics|analgesics|mesh-ancestor
102332507|NCT03584152|Sensory System Agents|sensory system agents|mesh-ancestor
102332508|NCT03584152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102332509|NCT03584152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332510|NCT03584152|Antipyretics|antipyretics|mesh-ancestor
102332511|NCT03584152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102332512|NCT03584152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102332513|NCT03584152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102332514|NCT03584152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102332515|NCT03584152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102332516|NCT03584152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332517|NCT03589690|Thioctic Acid|thioctic acid|mesh-list
102332518|NCT03589690|Antioxidants|antioxidants|mesh-ancestor
102332519|NCT03589690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332520|NCT03589690|Protective Agents|protective agents|mesh-ancestor
102332521|NCT03589690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332522|NCT03589690|Vitamin B Complex|vitamin b complex|mesh-ancestor
102332523|NCT03589690|Vitamins|vitamins|mesh-ancestor
102332524|NCT03589690|Micronutrients|micronutrients|mesh-ancestor
102332525|NCT03587194|Apremilast|apremilast|mesh-list
102332526|NCT03587194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102332527|NCT03587194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102332528|NCT03587194|Analgesics|analgesics|mesh-ancestor
102332529|NCT03587194|Sensory System Agents|sensory system agents|mesh-ancestor
102332530|NCT03587194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102332531|NCT03587194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332532|NCT03587194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102332533|NCT03587194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102332534|NCT03587194|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102332535|NCT03587194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102332536|NCT03587194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102332537|NCT03587194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332538|NCT01699815|Acetaminophen|acetaminophen|mesh-list
102332539|NCT01699815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102332540|NCT01699815|Analgesics|analgesics|mesh-ancestor
102332541|NCT01699815|Sensory System Agents|sensory system agents|mesh-ancestor
102332542|NCT01699815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102332543|NCT01699815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332544|NCT01699815|Antipyretics|antipyretics|mesh-ancestor
102332545|NCT03589222|Dexamethasone|dexamethasone|mesh-list
102332546|NCT03589222|Bortezomib|bortezomib|mesh-list
102332547|NCT03589222|Daratumumab|daratumumab|mesh-list
102332548|NCT03589222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102332549|NCT03589222|Antiemetics|antiemetics|mesh-ancestor
102332550|NCT03589222|Autonomic Agents|autonomic agents|mesh-ancestor
102332551|NCT03589222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102332552|NCT03589222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332553|NCT03589222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102332554|NCT03589222|Glucocorticoids|glucocorticoids|mesh-ancestor
102332555|NCT03589222|Hormones|hormones|mesh-ancestor
102332556|NCT03589222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102332557|NCT03589222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102332558|NCT03589222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102332559|NCT01846208|Immunomodulating Agents|immunomodulating agents|mesh-list
102332560|NCT01846208|Immunologic Factors|immunologic factors|mesh-ancestor
102332561|NCT01846208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332562|NCT03589066|Rotigotine|rotigotine|mesh-list
102332563|NCT03589066|Dopamine Agonists|dopamine agonists|mesh-ancestor
102332564|NCT03589066|Dopamine Agents|dopamine agents|mesh-ancestor
102332565|NCT03589066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102332566|NCT03589066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332567|NCT03589066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332568|NCT03020368|Diclofenac|diclofenac|mesh-list
102332569|NCT03020368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102332570|NCT03020368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102332571|NCT03020368|Analgesics|analgesics|mesh-ancestor
102332572|NCT03020368|Sensory System Agents|sensory system agents|mesh-ancestor
102332573|NCT03020368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102332574|NCT03020368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332575|NCT03020368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102332576|NCT03020368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102332577|NCT03020368|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102332578|NCT03020368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102332579|NCT03020368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332580|NCT03891706|Interleukin-2|interleukin-2|mesh-list
102332581|NCT03891706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102332582|NCT03891706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102332583|NCT03891706|Analgesics|analgesics|mesh-ancestor
102332584|NCT03891706|Sensory System Agents|sensory system agents|mesh-ancestor
102332585|NCT03891706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102332586|NCT03891706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332587|NCT03581422|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102332588|NCT03581422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102332589|NCT03581422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332590|NCT05702944|Phenoxybenzamine|phenoxybenzamine|mesh-list
102332591|NCT05702944|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102332592|NCT05702944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102332593|NCT05702944|Adrenergic Agents|adrenergic agents|mesh-ancestor
102332594|NCT05702944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102332595|NCT05702944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332596|NCT05702944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332597|NCT05702944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102332598|NCT05702944|Vasodilator Agents|vasodilator agents|mesh-ancestor
102332599|NCT03580876|Azathioprine|azathioprine|mesh-list
102332600|NCT03580876|Antimetabolites|antimetabolites|mesh-ancestor
102332601|NCT03580876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332602|NCT03580876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102332603|NCT03580876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102332604|NCT03580876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102332605|NCT03580876|Immunologic Factors|immunologic factors|mesh-ancestor
102332606|NCT03580876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332607|NCT03580876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102332608|NCT03586024|Pembrolizumab|pembrolizumab|mesh-list
102332609|NCT03586024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102332610|NCT03586024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102332611|NCT03586024|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102332612|NCT03586024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332613|NCT03585556|Prednisolone|prednisolone|mesh-list
102332614|NCT03585556|Ranibizumab|ranibizumab|mesh-list
102332615|NCT03585556|Aflibercept|aflibercept|mesh-list
102332616|NCT03585556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102332617|NCT03585556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102332618|NCT03585556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102332619|NCT03585556|Growth Substances|growth substances|mesh-ancestor
102332620|NCT03585556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332621|NCT03585556|Growth Inhibitors|growth inhibitors|mesh-ancestor
102332622|NCT03585556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102332623|NCT03585556|Glucocorticoids|glucocorticoids|mesh-ancestor
102332624|NCT03585556|Hormones|hormones|mesh-ancestor
102332625|NCT03585556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102332626|NCT03585556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102332627|NCT05702398|Vitamins|vitamins|mesh-list
102332628|NCT05702398|Vitamin A|vitamin a|mesh-list
102332629|NCT05702398|Niacin|niacin|mesh-list
102332630|NCT05702398|Niacinamide|niacinamide|mesh-list
102332631|NCT05702398|Nicotinic Acids|nicotinic acids|mesh-list
102332632|NCT05702398|Micronutrients|micronutrients|mesh-ancestor
102332633|NCT05702398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332634|NCT05702398|Vitamin B Complex|vitamin b complex|mesh-ancestor
102332635|NCT05702398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332636|NCT05702398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102332637|NCT05702398|Antimetabolites|antimetabolites|mesh-ancestor
102332638|NCT05702398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102332639|NCT05702398|Vasodilator Agents|vasodilator agents|mesh-ancestor
102332640|NCT01709409|Poractant alfa|poractant alfa|mesh-list
102332642|NCT01709409|Respiratory System Agents|respiratory system agents|mesh-ancestor
102332643|NCT01698879|Gemtuzumab|gemtuzumab|mesh-list
102332644|NCT01698879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102332645|NCT01698879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102332646|NCT01698879|Immunotoxins|immunotoxins|mesh-ancestor
102332647|NCT01698879|Immunoconjugates|immunoconjugates|mesh-ancestor
102332648|NCT01698879|Immunologic Factors|immunologic factors|mesh-ancestor
102332649|NCT01698879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332650|NCT02335294|Morphine|morphine|mesh-list
102332651|NCT02335294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102332652|NCT02335294|Narcotics|narcotics|mesh-ancestor
102332653|NCT02335294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102332654|NCT02335294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332655|NCT02335294|Analgesics|analgesics|mesh-ancestor
102332656|NCT02335294|Sensory System Agents|sensory system agents|mesh-ancestor
102332657|NCT02335294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102332658|NCT01698801|Dexamethasone|dexamethasone|mesh-list
102332659|NCT01698801|Lenalidomide|lenalidomide|mesh-list
102332660|NCT01698801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102332661|NCT01698801|Antiemetics|antiemetics|mesh-ancestor
102332662|NCT01698801|Autonomic Agents|autonomic agents|mesh-ancestor
102332663|NCT01698801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102332664|NCT01698801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332665|NCT01698801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102332666|NCT01698801|Glucocorticoids|glucocorticoids|mesh-ancestor
102332667|NCT01698801|Hormones|hormones|mesh-ancestor
102332668|NCT01698801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102332669|NCT01698801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102332670|NCT01698801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102332671|NCT01698801|Immunologic Factors|immunologic factors|mesh-ancestor
102332672|NCT01698801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102332673|NCT01698801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102332674|NCT01698801|Growth Substances|growth substances|mesh-ancestor
102332675|NCT01698801|Growth Inhibitors|growth inhibitors|mesh-ancestor
102332677|NCT03735628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102332678|NCT03735628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102332679|NCT03735628|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102332680|NCT03735628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332681|NCT01682811|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102332682|NCT01682811|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102332683|NCT01682811|Dermatologic Agents|dermatologic agents|mesh-ancestor
102332684|NCT03580018|Tranexamic Acid|tranexamic acid|mesh-list
102332685|NCT03580018|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102332686|NCT03580018|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102332687|NCT03580018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332688|NCT03580018|Hemostatics|hemostatics|mesh-ancestor
102332689|NCT03580018|Coagulants|coagulants|mesh-ancestor
102332690|NCT03584854|Carboprost|carboprost|mesh-list
102332691|NCT03584854|Dinoprost|dinoprost|mesh-list
102332692|NCT03584854|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
102332693|NCT03584854|Methylergonovine|methylergonovine|mesh-list
102332694|NCT03584854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102332695|NCT03584854|Abortifacient Agents|abortifacient agents|mesh-ancestor
102332696|NCT03584854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102332697|NCT03584854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332698|NCT03584854|Oxytocics|oxytocics|mesh-ancestor
102332699|NCT03584698|Evening primrose oil|evening primrose oil|mesh-list
102332700|NCT03584698|Misoprostol|misoprostol|mesh-list
102332701|NCT03584698|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102332702|NCT03584698|Abortifacient Agents|abortifacient agents|mesh-ancestor
102332703|NCT03584698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102332704|NCT03584698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332705|NCT03584698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102332706|NCT03584698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102332707|NCT03584698|Oxytocics|oxytocics|mesh-ancestor
102332708|NCT03584698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102332709|NCT03584698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102332710|NCT03584698|Analgesics|analgesics|mesh-ancestor
102332711|NCT03584698|Sensory System Agents|sensory system agents|mesh-ancestor
102332712|NCT03584698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101442255|NCT00170456|Antacids|antacids|mesh-ancestor
102332713|NCT03584698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102332714|NCT03584698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102332715|NCT03584698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102332716|NCT03584698|Antimetabolites|antimetabolites|mesh-ancestor
102332717|NCT03584698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332718|NCT03584698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102332719|NCT03584698|Dermatologic Agents|dermatologic agents|mesh-ancestor
102332720|NCT03582124|Panitumumab|panitumumab|mesh-list
102332721|NCT03582124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102332722|NCT03582124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102332723|NCT01682031|Selenium|selenium|mesh-list
102332724|NCT01682031|Antioxidants|antioxidants|mesh-ancestor
102332725|NCT01682031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332726|NCT01682031|Protective Agents|protective agents|mesh-ancestor
102332727|NCT01682031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332728|NCT01682031|Trace Elements|trace elements|mesh-ancestor
102332729|NCT01682031|Micronutrients|micronutrients|mesh-ancestor
102332730|NCT03020134|Ritonavir|ritonavir|mesh-list
102332731|NCT03020134|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102332732|NCT03020134|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102332733|NCT03020134|Protease Inhibitors|protease inhibitors|mesh-ancestor
102332734|NCT03020134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102332735|NCT03020134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332736|NCT03020134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102332737|NCT03020134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102332738|NCT03020134|Antiviral Agents|antiviral agents|mesh-ancestor
102332739|NCT03020134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102332740|NCT03020134|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102332741|NCT03020134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102332742|NCT03020056|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102332743|NCT03020056|Antioxidants|antioxidants|mesh-list
102332744|NCT03020056|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102332745|NCT03020056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332746|NCT03020056|Protective Agents|protective agents|mesh-ancestor
102332747|NCT03020056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332748|NCT03026062|Durvalumab|durvalumab|mesh-list
102332749|NCT03026062|Ipilimumab|ipilimumab|mesh-list
102332750|NCT03026062|Tremelimumab|tremelimumab|mesh-list
102332751|NCT03026062|Immunoglobulins|immunoglobulins|mesh-list
102332752|NCT03026062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102332753|NCT03026062|Immunoglobulin G|immunoglobulin g|mesh-list
102332754|NCT03026062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102332755|NCT03026062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102332756|NCT03026062|Immunologic Factors|immunologic factors|mesh-ancestor
102332757|NCT03026062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332758|NCT03026062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102332759|NCT03026062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332760|NCT03584074|Celecoxib|celecoxib|mesh-list
102332761|NCT03584074|Pregabalin|pregabalin|mesh-list
102332762|NCT03584074|Analgesics|analgesics|mesh-ancestor
102332763|NCT03584074|Sensory System Agents|sensory system agents|mesh-ancestor
102332764|NCT03584074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102332765|NCT03584074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332766|NCT03584074|Anticonvulsants|anticonvulsants|mesh-ancestor
102332767|NCT03584074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102332768|NCT03584074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102332769|NCT03584074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332770|NCT03584074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102332771|NCT03584074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102332772|NCT03584074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102332773|NCT03584074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102332774|NCT03584074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102332775|NCT03584074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102332776|NCT03584074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102332777|NCT03584074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102332778|NCT03584074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102332779|NCT03584074|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102332780|NCT03584074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102332781|NCT03584074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102332782|NCT03583138|Buprenorphine|buprenorphine|mesh-list
102332783|NCT03583138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102332784|NCT03583138|Narcotics|narcotics|mesh-ancestor
102332785|NCT03583138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102332786|NCT03583138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332787|NCT03583138|Analgesics|analgesics|mesh-ancestor
102332788|NCT03583138|Sensory System Agents|sensory system agents|mesh-ancestor
102332789|NCT03583138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102332790|NCT03583138|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102332791|NCT03153514|Obinutuzumab|obinutuzumab|mesh-list
102332792|NCT03153514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102332793|NCT03153514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102332794|NCT03020602|Ubiquinone|ubiquinone|mesh-list
102332795|NCT03020602|Coenzyme Q10|coenzyme q10|mesh-list
102332796|NCT03020602|Micronutrients|micronutrients|mesh-ancestor
102332797|NCT03020602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332798|NCT03020602|Vitamins|vitamins|mesh-ancestor
102332799|NCT01567527|Aripiprazole|aripiprazole|mesh-list
102332800|NCT01567527|Antidepressive Agents|antidepressive agents|mesh-ancestor
102332801|NCT01567527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102332802|NCT01567527|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102332803|NCT01567527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102332804|NCT01567527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102332805|NCT01567527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332806|NCT01567527|Dopamine Agonists|dopamine agonists|mesh-ancestor
102332807|NCT01567527|Dopamine Agents|dopamine agents|mesh-ancestor
102332808|NCT01567527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102332809|NCT01567527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332810|NCT01567527|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102332811|NCT01567527|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102332812|NCT01567527|Serotonin Agents|serotonin agents|mesh-ancestor
102332813|NCT01567527|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102332814|NCT01567527|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102332815|NCT01567527|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102332816|NCT01567527|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102332817|NCT03159988|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
102332818|NCT03159988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102332819|NCT03159988|Vasodilator Agents|vasodilator agents|mesh-ancestor
102332820|NCT03159598|Urethane|urethane|mesh-list
102332821|NCT03159598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102332822|NCT03159598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102332823|NCT03159598|Anesthetics, General|anesthetics, general|mesh-ancestor
102332824|NCT03159598|Anesthetics|anesthetics|mesh-ancestor
101674831|NCT06005688|Analgesics|analgesics|mesh-ancestor
102332825|NCT03159598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102332826|NCT03159598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332827|NCT01818752|Prednisone|prednisone|mesh-list
102332828|NCT01818752|Bortezomib|bortezomib|mesh-list
102332829|NCT01818752|Melphalan|melphalan|mesh-list
102332830|NCT01818752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102332831|NCT01818752|Glucocorticoids|glucocorticoids|mesh-ancestor
102332832|NCT01818752|Hormones|hormones|mesh-ancestor
102332833|NCT01818752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102332834|NCT01818752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332835|NCT01818752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102332836|NCT01818752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102332837|NCT01818752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102332838|NCT01818752|Alkylating Agents|alkylating agents|mesh-ancestor
102332839|NCT01818752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332840|NCT01818752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102332841|NCT01818752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102332842|NCT01818752|Immunologic Factors|immunologic factors|mesh-ancestor
102332843|NCT03582280|Calcium Carbonate|calcium carbonate|mesh-list
102332844|NCT03582280|Calcium|calcium|mesh-list
102332845|NCT03582280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102332846|NCT03582280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332847|NCT03582280|Antacids|antacids|mesh-ancestor
102332848|NCT03582280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332849|NCT03582280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102332850|NCT03159754|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102332851|NCT03159754|Metronidazole|metronidazole|mesh-list
102332852|NCT03159754|Ciprofloxacin|ciprofloxacin|mesh-list
102332853|NCT03159754|Tazobactam|tazobactam|mesh-list
102332854|NCT03159754|Piperacillin|piperacillin|mesh-list
102332855|NCT03159754|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102332856|NCT03159754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102332857|NCT03159754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102332858|NCT03159754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102332859|NCT03159754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102332860|NCT03159754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102332861|NCT03159754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102332862|NCT03159754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332863|NCT03159754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102332864|NCT03159754|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102332865|NCT03159754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102332866|NCT03159754|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102332867|NCT05701384|Lazertinib|lazertinib|mesh-list
102332868|NCT05701384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102332869|NCT05701384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102332870|NCT05701384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332871|NCT01362608|Triamcinolone|triamcinolone|mesh-list
102332872|NCT01362608|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102332873|NCT01362608|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102332874|NCT01362608|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102332875|NCT01362608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102332876|NCT01362608|Glucocorticoids|glucocorticoids|mesh-ancestor
102332877|NCT01362608|Hormones|hormones|mesh-ancestor
102332878|NCT01362608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102332879|NCT01362608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332880|NCT01362608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102332881|NCT01362608|Immunologic Factors|immunologic factors|mesh-ancestor
102332882|NCT01362608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102332883|NCT01362608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332884|NCT03581968|Pancrelipase|pancrelipase|mesh-list
102332885|NCT03581968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102332886|NCT03158584|Morphine|morphine|mesh-list
102332887|NCT03158584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102332888|NCT03158584|Narcotics|narcotics|mesh-ancestor
102332889|NCT03158584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102332890|NCT03158584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332891|NCT03158584|Analgesics|analgesics|mesh-ancestor
102332892|NCT03158584|Sensory System Agents|sensory system agents|mesh-ancestor
102332893|NCT03158584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102332894|NCT04765228|Doxorubicin|doxorubicin|mesh-list
102332895|NCT04765228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102332896|NCT04765228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102332897|NCT04765228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102332898|NCT04765228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102332899|NCT04765228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102332900|NCT04765228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102332901|NCT04765228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332902|NCT01818596|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102332903|NCT01818596|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102332904|NCT01818596|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102332905|NCT01818596|Antiviral Agents|antiviral agents|mesh-ancestor
102332906|NCT01818596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102332907|NCT04140448|Ranibizumab|ranibizumab|mesh-list
102332908|NCT04140448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102332909|NCT04140448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102332910|NCT04140448|Growth Substances|growth substances|mesh-ancestor
102332911|NCT04140448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332912|NCT04140448|Growth Inhibitors|growth inhibitors|mesh-ancestor
102332913|NCT04140448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102332914|NCT03156322|Fentanyl|fentanyl|mesh-list
102332915|NCT03156322|Bupivacaine|bupivacaine|mesh-list
102332916|NCT03156322|Anesthetics, Local|anesthetics, local|mesh-ancestor
102332917|NCT03156322|Anesthetics|anesthetics|mesh-ancestor
102332918|NCT03156322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102332919|NCT03156322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332920|NCT03156322|Sensory System Agents|sensory system agents|mesh-ancestor
102332921|NCT03156322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102332922|NCT03156322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102332923|NCT03156322|Narcotics|narcotics|mesh-ancestor
102332924|NCT03156322|Analgesics|analgesics|mesh-ancestor
102332925|NCT03156322|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102332926|NCT03156322|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102332927|NCT03156322|Anesthetics, General|anesthetics, general|mesh-ancestor
102332928|NCT03156088|Neurotransmitter Agents|neurotransmitter agents|mesh-list
102332929|NCT03156088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332930|NCT03156088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332931|NCT04140058|Ondansetron|ondansetron|mesh-list
102332932|NCT04140058|Antiemetics|antiemetics|mesh-ancestor
102332933|NCT04140058|Autonomic Agents|autonomic agents|mesh-ancestor
102332934|NCT04140058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102332935|NCT04140058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332936|NCT04140058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102332937|NCT04140058|Antipruritics|antipruritics|mesh-ancestor
102332938|NCT04140058|Dermatologic Agents|dermatologic agents|mesh-ancestor
102332939|NCT04140058|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102332940|NCT04140058|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102332941|NCT04140058|Serotonin Agents|serotonin agents|mesh-ancestor
102332942|NCT04140058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102332943|NCT04140058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332944|NCT04146298|Cyclophosphamide|cyclophosphamide|mesh-list
102332945|NCT04146298|Fludarabine|fludarabine|mesh-list
102332947|NCT04146298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102332948|NCT04146298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102332949|NCT04146298|Immunologic Factors|immunologic factors|mesh-ancestor
102332950|NCT04146298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332951|NCT04146298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102332952|NCT04146298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102332953|NCT04146298|Alkylating Agents|alkylating agents|mesh-ancestor
102332954|NCT04146298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332955|NCT04146298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102332956|NCT04146298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102332957|NCT02899078|Nivolumab|nivolumab|mesh-list
102332958|NCT02899078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102332959|NCT02899078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102332960|NCT02899078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102332961|NCT02899078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332962|NCT01670734|Alirocumab|alirocumab|mesh-list
102332963|NCT01670734|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102332964|NCT01670734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102332965|NCT01670734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102332966|NCT01670734|Antimetabolites|antimetabolites|mesh-ancestor
102332967|NCT01670734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332968|NCT01670734|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102332969|NCT01670734|Protease Inhibitors|protease inhibitors|mesh-ancestor
102332970|NCT01670734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102332971|NCT01670734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102332972|NCT01670890|Cisplatin|cisplatin|mesh-list
102332974|NCT01670890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102332975|NCT01670890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102332976|NCT01670890|Alkylating Agents|alkylating agents|mesh-ancestor
102332977|NCT01670890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332978|NCT04551196|Acetaminophen|acetaminophen|mesh-list
102332979|NCT04551196|Ibuprofen|ibuprofen|mesh-list
102332980|NCT04551196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102332981|NCT04551196|Analgesics|analgesics|mesh-ancestor
102332982|NCT04551196|Sensory System Agents|sensory system agents|mesh-ancestor
102332983|NCT04551196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102332984|NCT04551196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332985|NCT04551196|Antipyretics|antipyretics|mesh-ancestor
102332986|NCT04551196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102332987|NCT04551196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102332988|NCT04551196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102332989|NCT04551196|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102332990|NCT04551196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241625|NCT03070665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102332991|NCT04551196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102332992|NCT01923298|Estradiol|estradiol|mesh-list
102332993|NCT01923298|Estrogens|estrogens|mesh-ancestor
102332994|NCT01923298|Hormones|hormones|mesh-ancestor
102332995|NCT01923298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102332996|NCT01923298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102332997|NCT05212246|Imiquimod|imiquimod|mesh-list
102332998|NCT05212246|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102332999|NCT05212246|Immunologic Factors|immunologic factors|mesh-ancestor
102333000|NCT05212246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333001|NCT05212246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102333002|NCT05212246|Interferon Inducers|interferon inducers|mesh-ancestor
102333003|NCT04297618|Lifitegrast|lifitegrast|mesh-list
102333004|NCT04297618|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102333005|NCT04297618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102333006|NCT03154918|Dexamethasone|dexamethasone|mesh-list
102333007|NCT03154918|Gemcitabine|gemcitabine|mesh-list
102333008|NCT03154918|Etoposide|etoposide|mesh-list
102333009|NCT03154918|Ifosfamide|ifosfamide|mesh-list
102333010|NCT03154918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102333011|NCT03154918|Antiemetics|antiemetics|mesh-ancestor
102333012|NCT03154918|Autonomic Agents|autonomic agents|mesh-ancestor
102333013|NCT03154918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102333014|NCT03154918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333015|NCT03154918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102333016|NCT03154918|Glucocorticoids|glucocorticoids|mesh-ancestor
102333017|NCT03154918|Hormones|hormones|mesh-ancestor
102333018|NCT03154918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102333019|NCT03154918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102333020|NCT03154918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102333021|NCT03154918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102333022|NCT03154918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333023|NCT03154918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102333024|NCT03154918|Antimetabolites|antimetabolites|mesh-ancestor
102333025|NCT03154918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102333026|NCT03154918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102333027|NCT03154918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102333028|NCT03154918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102333029|NCT03154918|Alkylating Agents|alkylating agents|mesh-ancestor
102333030|NCT01671904|Rituximab|rituximab|mesh-list
102333031|NCT01671904|Obinutuzumab|obinutuzumab|mesh-list
102333032|NCT01671904|Venetoclax|venetoclax|mesh-list
102333033|NCT01671904|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102333034|NCT01671904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102333035|NCT01671904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102333036|NCT01671904|Immunologic Factors|immunologic factors|mesh-ancestor
102333037|NCT01671904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333038|NCT01671904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102333039|NCT01671904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102333040|NCT01671904|Alkylating Agents|alkylating agents|mesh-ancestor
102333041|NCT01671904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333042|NCT01671982|Tenofovir|tenofovir|mesh-list
102333043|NCT01671982|Antiviral Agents|antiviral agents|mesh-ancestor
102333044|NCT01671982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102333045|NCT01671982|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102333046|NCT01671982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102333047|NCT01671982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102333048|NCT01671982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333050|NCT01671982|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102333051|NCT04040452|Ketorolac|ketorolac|mesh-list
102333052|NCT04040452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102333053|NCT04040452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102333054|NCT04040452|Analgesics|analgesics|mesh-ancestor
102333055|NCT04040452|Sensory System Agents|sensory system agents|mesh-ancestor
102333056|NCT04040452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102333057|NCT04040452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333058|NCT04040452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102333059|NCT04040452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102333060|NCT04040452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102333061|NCT04040452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102333062|NCT04040452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333063|NCT04027894|Rifamycins|rifamycins|mesh-list
102333064|NCT04027894|Rifamycin SV|rifamycin sv|mesh-list
102333065|NCT04027894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102333066|NCT04027894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102333067|NCT04027894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102333068|NCT02564068|Oxytocin|oxytocin|mesh-list
102333069|NCT02564068|Oxytocics|oxytocics|mesh-ancestor
102333070|NCT02564068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102333071|NCT02564068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333072|NCT03154528|Vitamin D|vitamin d|mesh-list
102333073|NCT03154528|Vitamins|vitamins|mesh-ancestor
102333074|NCT03154528|Micronutrients|micronutrients|mesh-ancestor
102333075|NCT03154528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333076|NCT03154528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102333077|NCT03154372|Metronidazole|metronidazole|mesh-list
102333078|NCT03154372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102333079|NCT03154372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102333080|NCT03154372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102333081|NCT03154372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102333082|NCT01676506|Ranibizumab|ranibizumab|mesh-list
102333083|NCT01676506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102333084|NCT01676506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102333085|NCT01676506|Growth Substances|growth substances|mesh-ancestor
102333086|NCT01676506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333087|NCT01676506|Growth Inhibitors|growth inhibitors|mesh-ancestor
102333088|NCT01676506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102333089|NCT03154294|Paclitaxel|paclitaxel|mesh-list
102333090|NCT03154294|Serabelisib|serabelisib|mesh-list
102333091|NCT03154294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102333092|NCT03154294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102333093|NCT03154294|Tubulin Modulators|tubulin modulators|mesh-ancestor
102333094|NCT03154294|Antimitotic Agents|antimitotic agents|mesh-ancestor
102333095|NCT03154294|Mitosis Modulators|mitosis modulators|mesh-ancestor
102333096|NCT03154294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333097|NCT03154294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102333098|NCT03154606|Calcium|calcium|mesh-list
102333099|NCT03154606|Caseins|caseins|mesh-list
102333100|NCT03154606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102333101|NCT03154606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333102|NCT03154606|Chelating Agents|chelating agents|mesh-ancestor
102333103|NCT03154606|Sequestering Agents|sequestering agents|mesh-ancestor
102333104|NCT03154606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333105|NCT01672450|Ipilimumab|ipilimumab|mesh-list
102333106|NCT01672450|Interleukin-2|interleukin-2|mesh-list
102333107|NCT01672450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102333108|NCT01672450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102333109|NCT01672450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102333110|NCT01672450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333111|NCT01672450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102333112|NCT01672450|Analgesics|analgesics|mesh-ancestor
102333113|NCT01672450|Sensory System Agents|sensory system agents|mesh-ancestor
102333114|NCT01672450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102333115|NCT01672450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333116|NCT01854268|Capsaicin|capsaicin|mesh-list
102333117|NCT01854268|Antipruritics|antipruritics|mesh-ancestor
102333118|NCT01854268|Dermatologic Agents|dermatologic agents|mesh-ancestor
102333119|NCT01854268|Sensory System Agents|sensory system agents|mesh-ancestor
102333120|NCT01854268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102333121|NCT01854268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333122|NCT01672606|Rocuronium|rocuronium|mesh-list
101675130|NCT06003608|Levodopa|levodopa|mesh-list
102333123|NCT01672606|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102333124|NCT01672606|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102333125|NCT01672606|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102333126|NCT01672606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102333127|NCT01672606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333129|NCT01594281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102333130|NCT01594281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102333131|NCT01594281|Growth Substances|growth substances|mesh-ancestor
102333132|NCT01594281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333133|NCT01594281|Growth Inhibitors|growth inhibitors|mesh-ancestor
102333134|NCT01594281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102333135|NCT04964050|Captopril, hydrochlorothiazide drug combination|captopril, hydrochlorothiazide drug combination|mesh-list
102333136|NCT04964050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102333137|NCT04964050|Protease Inhibitors|protease inhibitors|mesh-ancestor
102333138|NCT04964050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102333139|NCT04964050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333140|NCT04964050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102333141|NCT04964050|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102333142|NCT04964050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102333143|NCT04964050|Diuretics|diuretics|mesh-ancestor
102333144|NCT04964050|Natriuretic Agents|natriuretic agents|mesh-ancestor
102333145|NCT04964050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333146|NCT03526900|Atezolizumab|atezolizumab|mesh-list
102333147|NCT03526900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102333148|NCT03526900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333149|NCT03526900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102333150|NCT03526900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102333151|NCT03420742|Midazolam|midazolam|mesh-list
102333152|NCT03420742|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102333153|NCT03420742|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102333154|NCT03420742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102333155|NCT03420742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333156|NCT03420742|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102333157|NCT03420742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102333158|NCT03420742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102333159|NCT03420742|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102333160|NCT03420742|Anesthetics, General|anesthetics, general|mesh-ancestor
102333161|NCT03420742|Anesthetics|anesthetics|mesh-ancestor
102333162|NCT03420742|GABA Modulators|gaba modulators|mesh-ancestor
102333163|NCT03420742|GABA Agents|gaba agents|mesh-ancestor
102333164|NCT03420742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102333165|NCT03420742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333166|NCT01818284|Plerixafor|plerixafor|mesh-list
102333167|NCT01818284|Lenograstim|lenograstim|mesh-list
102042013|NCT02232087|Glucocorticoids|glucocorticoids|mesh-ancestor
102333168|NCT01818284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102333169|NCT01818284|Immunologic Factors|immunologic factors|mesh-ancestor
102333170|NCT01818284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333171|NCT01818284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102333172|NCT01818284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102333173|NCT01818284|Antiviral Agents|antiviral agents|mesh-ancestor
102333174|NCT01818284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102333175|NCT02081014|Glucagon|glucagon|mesh-list
102333176|NCT02081014|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102333177|NCT02081014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102333178|NCT02081014|Hormones|hormones|mesh-ancestor
102333179|NCT02081014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102333180|NCT02081014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333181|NCT02081014|Incretins|incretins|mesh-ancestor
102333182|NCT03025594|Ketorolac|ketorolac|mesh-list
102333183|NCT03025594|Epinephrine|epinephrine|mesh-list
102333184|NCT03025594|Levobupivacaine|levobupivacaine|mesh-list
102333185|NCT03025594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102333186|NCT03025594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102333187|NCT03025594|Adrenergic Agents|adrenergic agents|mesh-ancestor
102333188|NCT03025594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102333189|NCT03025594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333190|NCT03025594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333191|NCT03025594|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102333192|NCT03025594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102333193|NCT03025594|Autonomic Agents|autonomic agents|mesh-ancestor
102333194|NCT03025594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102333195|NCT03025594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102333196|NCT03025594|Respiratory System Agents|respiratory system agents|mesh-ancestor
102333197|NCT03025594|Mydriatics|mydriatics|mesh-ancestor
102333198|NCT03025594|Sympathomimetics|sympathomimetics|mesh-ancestor
102333199|NCT03025594|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102333200|NCT03025594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102333201|NCT03025594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102333202|NCT03025594|Analgesics|analgesics|mesh-ancestor
102333203|NCT03025594|Sensory System Agents|sensory system agents|mesh-ancestor
102333204|NCT03025594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102333205|NCT03025594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102333206|NCT03025594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102333207|NCT03025594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102333208|NCT03025594|Anesthetics, Local|anesthetics, local|mesh-ancestor
102333209|NCT03025594|Anesthetics|anesthetics|mesh-ancestor
102333210|NCT03025594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102333211|NCT04404946|Phenylephrine|phenylephrine|mesh-list
102333212|NCT04404946|Oxymetazoline|oxymetazoline|mesh-list
102333213|NCT04404946|Norepinephrine|norepinephrine|mesh-list
102333214|NCT04404946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102333215|NCT04404946|Mydriatics|mydriatics|mesh-ancestor
102333216|NCT04404946|Autonomic Agents|autonomic agents|mesh-ancestor
102333217|NCT04404946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102333218|NCT04404946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333219|NCT04404946|Sympathomimetics|sympathomimetics|mesh-ancestor
102333220|NCT04404946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102333221|NCT04404946|Nasal Decongestants|nasal decongestants|mesh-ancestor
102333222|NCT04404946|Respiratory System Agents|respiratory system agents|mesh-ancestor
102333223|NCT04404946|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102333224|NCT04404946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102333225|NCT04404946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102333226|NCT04404946|Adrenergic Agents|adrenergic agents|mesh-ancestor
102333227|NCT04404946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102333228|NCT04404946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333229|NCT04404946|Protective Agents|protective agents|mesh-ancestor
102333230|NCT01673542|Lidocaine|lidocaine|mesh-list
102333231|NCT01673542|Prilocaine|prilocaine|mesh-list
102333232|NCT01673542|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
102333233|NCT01673542|Anesthetics, Local|anesthetics, local|mesh-ancestor
102333234|NCT01673542|Anesthetics|anesthetics|mesh-ancestor
102333235|NCT01673542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102333236|NCT01673542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333237|NCT01673542|Sensory System Agents|sensory system agents|mesh-ancestor
102333238|NCT01673542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102333239|NCT01673542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102333240|NCT01673542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102333241|NCT01673542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102333242|NCT01673542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102333243|NCT01673542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333244|NCT01673542|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
102333246|NCT04804540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102333247|NCT01610492|Belimumab|belimumab|mesh-list
102333248|NCT01610492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102333249|NCT01610492|Immunologic Factors|immunologic factors|mesh-ancestor
102333250|NCT01610492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333251|NCT01817582|Loteprednol Etabonate|loteprednol etabonate|mesh-list
102333252|NCT01817582|Cyclosporine|cyclosporine|mesh-list
102333253|NCT01817582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102333254|NCT01817582|Lubricant Eye Drops|lubricant eye drops|mesh-list
102333255|NCT01817582|Cyclosporins|cyclosporins|mesh-list
102333256|NCT01817582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102333257|NCT01817582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333258|NCT01817582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102333259|NCT01817582|Immunologic Factors|immunologic factors|mesh-ancestor
102333260|NCT01817582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333261|NCT01817582|Antifungal Agents|antifungal agents|mesh-ancestor
102333262|NCT01817582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102333263|NCT01817582|Dermatologic Agents|dermatologic agents|mesh-ancestor
102333264|NCT01817582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102333265|NCT01817582|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102333266|NCT01817582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102333267|NCT01817582|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102333268|NCT01594125|Nintedanib|nintedanib|mesh-list
102333269|NCT01594125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102333270|NCT01594125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102333271|NCT01594125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241626|NCT03070665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102333272|NCT01594125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333273|NCT01592409|Dronabinol|dronabinol|mesh-list
102333274|NCT01592409|Hallucinogens|hallucinogens|mesh-ancestor
102333275|NCT01592409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333276|NCT01592409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102333277|NCT01592409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102333278|NCT01592409|Analgesics|analgesics|mesh-ancestor
102333279|NCT01592409|Sensory System Agents|sensory system agents|mesh-ancestor
102333280|NCT01592409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102333281|NCT01592409|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102333282|NCT01592409|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102333283|NCT01592409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102333284|NCT01592409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333285|NCT01592409|Hormones|hormones|mesh-ancestor
102333286|NCT01592409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102333287|NCT02081638|Aspirin|aspirin|mesh-list
102333288|NCT02081638|Atorvastatin|atorvastatin|mesh-list
102333289|NCT02081638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102333290|NCT02081638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102333291|NCT02081638|Analgesics|analgesics|mesh-ancestor
102333292|NCT02081638|Sensory System Agents|sensory system agents|mesh-ancestor
102333293|NCT02081638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102333294|NCT02081638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333295|NCT02081638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102333296|NCT02081638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102333297|NCT02081638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102333298|NCT02081638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102333299|NCT02081638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333300|NCT02081638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102333301|NCT02081638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102333302|NCT02081638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102333303|NCT02081638|Antipyretics|antipyretics|mesh-ancestor
102333304|NCT02081638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102333305|NCT02081638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102333306|NCT02081638|Antimetabolites|antimetabolites|mesh-ancestor
102333307|NCT02081638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102333308|NCT02081638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102333309|NCT04603508|Calcium, Dietary|calcium, dietary|mesh-list
102333310|NCT04603508|Empagliflozin|empagliflozin|mesh-list
102333311|NCT04603508|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102333312|NCT04603508|Calcium|calcium|mesh-list
102333313|NCT04603508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102333314|NCT04603508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333315|NCT04603508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102333316|NCT04603508|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102333317|NCT04603508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102333318|NCT04603508|Antimetabolites|antimetabolites|mesh-ancestor
102333319|NCT04603508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333320|NCT04603508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102333321|NCT04603508|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102333322|NCT04603508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102333323|NCT04603508|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102333324|NCT04603508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102333325|NCT01674166|Prucalopride|prucalopride|mesh-list
102333326|NCT01674166|Laxatives|laxatives|mesh-ancestor
102333327|NCT01674166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102333328|NCT01674166|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
102333329|NCT01674166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102333330|NCT01674166|Serotonin Agents|serotonin agents|mesh-ancestor
102333331|NCT01674166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102333332|NCT01674166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333333|NCT01674166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333334|NCT02235688|Gemcitabine|gemcitabine|mesh-list
102333335|NCT02235688|Doxorubicin|doxorubicin|mesh-list
102333336|NCT02235688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102333337|NCT02235688|Antimetabolites|antimetabolites|mesh-ancestor
102333338|NCT02235688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333339|NCT02235688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102333340|NCT02235688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102241627|NCT03070665|Adrenergic Agents|adrenergic agents|mesh-ancestor
102333341|NCT02235688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102333342|NCT02235688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102333343|NCT02235688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102333344|NCT03152578|Capsaicin|capsaicin|mesh-list
102333345|NCT03152578|Antipruritics|antipruritics|mesh-ancestor
102333346|NCT03152578|Dermatologic Agents|dermatologic agents|mesh-ancestor
102333347|NCT03152578|Sensory System Agents|sensory system agents|mesh-ancestor
102333348|NCT03152578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102333349|NCT03152578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333350|NCT01065532|Paclitaxel|paclitaxel|mesh-list
102333351|NCT01065532|Everolimus|everolimus|mesh-list
102333352|NCT01065532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102333353|NCT01065532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102333354|NCT01065532|Tubulin Modulators|tubulin modulators|mesh-ancestor
102333355|NCT01065532|Antimitotic Agents|antimitotic agents|mesh-ancestor
102333356|NCT01065532|Mitosis Modulators|mitosis modulators|mesh-ancestor
102333357|NCT01065532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333358|NCT01065532|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102333359|NCT01065532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102333360|NCT01065532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102333361|NCT01065532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102333362|NCT01065532|Immunologic Factors|immunologic factors|mesh-ancestor
102333363|NCT01065532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333364|NCT04764916|Bupivacaine|bupivacaine|mesh-list
102333365|NCT04764916|Anesthetics, Local|anesthetics, local|mesh-ancestor
102333366|NCT04764916|Anesthetics|anesthetics|mesh-ancestor
102333367|NCT04764916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102333368|NCT04764916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333369|NCT04764916|Sensory System Agents|sensory system agents|mesh-ancestor
102333370|NCT04764916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102333371|NCT01674868|Fluoxetine|fluoxetine|mesh-list
102333372|NCT01674868|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102333373|NCT01674868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102333374|NCT01674868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102333375|NCT01674868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333376|NCT01674868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102333377|NCT01674868|Serotonin Agents|serotonin agents|mesh-ancestor
102333378|NCT01674868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333379|NCT01674868|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102333380|NCT01674868|Antidepressive Agents|antidepressive agents|mesh-ancestor
102333381|NCT01674868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102333382|NCT01674868|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102333383|NCT01674868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102333384|NCT01674868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102333385|NCT01674946|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
102333386|NCT01674946|Bile Acids and Salts|bile acids and salts|mesh-list
102333387|NCT01674946|Cathartics|cathartics|mesh-ancestor
102333388|NCT01674946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102333389|NCT01675024|Rotigotine|rotigotine|mesh-list
102333390|NCT01675024|Dopamine Agonists|dopamine agonists|mesh-ancestor
102333391|NCT01675024|Dopamine Agents|dopamine agents|mesh-ancestor
102333392|NCT01675024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102333393|NCT01675024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333394|NCT01675024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333396|NCT03883828|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102333397|NCT03883828|Mupirocin|mupirocin|mesh-list
102333398|NCT03883828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102333399|NCT03883828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102333400|NCT03883828|Disinfectants|disinfectants|mesh-ancestor
102333401|NCT03883828|Dermatologic Agents|dermatologic agents|mesh-ancestor
102333402|NCT03883828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102333403|NCT03883828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102333404|NCT03883828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102333405|NCT03883828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333406|NCT02081950|Enoxaparin|enoxaparin|mesh-list
102333407|NCT02081950|Enoxaparin sodium|enoxaparin sodium|mesh-list
102333408|NCT02081950|Anticoagulants|anticoagulants|mesh-ancestor
102333409|NCT02081950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102333410|NCT02081950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102333411|NCT02081950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333412|NCT01675648|Lofexidine|lofexidine|mesh-list
102333413|NCT01675648|Clonidine|clonidine|mesh-list
102333414|NCT01675648|Diazepam|diazepam|mesh-list
102333415|NCT01675648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102333416|NCT01675648|Anticonvulsants|anticonvulsants|mesh-ancestor
102333417|NCT01675648|Antiemetics|antiemetics|mesh-ancestor
102333418|NCT01675648|Autonomic Agents|autonomic agents|mesh-ancestor
102333419|NCT01675648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102333420|NCT01675648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333422|NCT01675648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102333423|NCT01675648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102333424|NCT01675648|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102333425|NCT01675648|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102333426|NCT01675648|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102333427|NCT01675648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102333428|NCT01675648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102333429|NCT01675648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102333430|NCT01675648|Anesthetics, General|anesthetics, general|mesh-ancestor
102333431|NCT01675648|Anesthetics|anesthetics|mesh-ancestor
102333432|NCT01675648|GABA Modulators|gaba modulators|mesh-ancestor
102333433|NCT01675648|GABA Agents|gaba agents|mesh-ancestor
102333434|NCT01675648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102333435|NCT01675648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333436|NCT01675648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102333437|NCT01675648|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102333438|NCT01675648|Sensory System Agents|sensory system agents|mesh-ancestor
102333439|NCT01675648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102333440|NCT01675648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102333441|NCT01675648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102333442|NCT01675648|Adrenergic Agents|adrenergic agents|mesh-ancestor
102333443|NCT01675648|Analgesics|analgesics|mesh-ancestor
102333444|NCT01675648|Sympatholytics|sympatholytics|mesh-ancestor
102333445|NCT01566435|Paclitaxel|paclitaxel|mesh-list
102333446|NCT01566435|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102333447|NCT01566435|Fluorouracil|fluorouracil|mesh-list
102333448|NCT01566435|Cetuximab|cetuximab|mesh-list
102333449|NCT01566435|Antibodies|antibodies|mesh-list
102333450|NCT01566435|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102333451|NCT01566435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102333452|NCT01566435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102333453|NCT01566435|Tubulin Modulators|tubulin modulators|mesh-ancestor
102333454|NCT01566435|Antimitotic Agents|antimitotic agents|mesh-ancestor
102333455|NCT01566435|Mitosis Modulators|mitosis modulators|mesh-ancestor
102333456|NCT01566435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333457|NCT01566435|Immunologic Factors|immunologic factors|mesh-ancestor
102333458|NCT01566435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333459|NCT01566435|Antimetabolites|antimetabolites|mesh-ancestor
102333460|NCT01566435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102333461|NCT01566435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102333462|NCT01566435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102333463|NCT01675804|Methylphenidate|methylphenidate|mesh-list
102333464|NCT01675804|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102333465|NCT01675804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333466|NCT01675804|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102333467|NCT01675804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102333468|NCT01675804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102333469|NCT01675804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333470|NCT01675804|Dopamine Agents|dopamine agents|mesh-ancestor
102333471|NCT01675804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102333472|NCT01696695|Capecitabine|capecitabine|mesh-list
102333473|NCT01696695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102333474|NCT01696695|Antimetabolites|antimetabolites|mesh-ancestor
102333475|NCT01696695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333476|NCT01696695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102333477|NCT05261386|Betadex|betadex|mesh-list
102333478|NCT05261386|Sequestering Agents|sequestering agents|mesh-ancestor
102333479|NCT05261386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333480|NCT03899805|Pembrolizumab|pembrolizumab|mesh-list
102333481|NCT03899805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102333482|NCT03899805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102333483|NCT03899805|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102333484|NCT03899805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333485|NCT03861988|Ketamine|ketamine|mesh-list
102333486|NCT03861988|Analgesics|analgesics|mesh-ancestor
102333487|NCT03861988|Sensory System Agents|sensory system agents|mesh-ancestor
102333488|NCT03861988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102333489|NCT03861988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333490|NCT03861988|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102333491|NCT03861988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102333492|NCT03861988|Anesthetics, General|anesthetics, general|mesh-ancestor
102333493|NCT03861988|Anesthetics|anesthetics|mesh-ancestor
102333494|NCT03861988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102333495|NCT03861988|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102333496|NCT03861988|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102333497|NCT03861988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102333498|NCT03861988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333499|NCT03755440|Antibodies|antibodies|mesh-list
102333500|NCT03755440|Immunologic Factors|immunologic factors|mesh-ancestor
102333501|NCT03755440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333502|NCT03749902|Misoprostol|misoprostol|mesh-list
102333503|NCT03749902|Oxytocin|oxytocin|mesh-list
102333504|NCT03749902|Oxytocics|oxytocics|mesh-ancestor
102333505|NCT03749902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102333506|NCT03749902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333507|NCT03749902|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102333508|NCT03749902|Abortifacient Agents|abortifacient agents|mesh-ancestor
102333509|NCT03749902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102333510|NCT03749902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102333511|NCT01565889|Ritonavir|ritonavir|mesh-list
102333512|NCT01565889|Ribavirin|ribavirin|mesh-list
102333513|NCT01565889|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102333514|NCT01565889|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102333515|NCT01565889|Protease Inhibitors|protease inhibitors|mesh-ancestor
102333516|NCT01565889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102333517|NCT01565889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333518|NCT01565889|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102333519|NCT01565889|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102333520|NCT01565889|Antiviral Agents|antiviral agents|mesh-ancestor
102333521|NCT01565889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102333522|NCT01565889|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102333523|NCT01565889|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102333524|NCT01565889|Antimetabolites|antimetabolites|mesh-ancestor
102333525|NCT01696071|Tiotropium Bromide|tiotropium bromide|mesh-list
102333526|NCT01696071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102333527|NCT01696071|Autonomic Agents|autonomic agents|mesh-ancestor
102333528|NCT01696071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102333529|NCT01696071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333530|NCT01696071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102333531|NCT01696071|Respiratory System Agents|respiratory system agents|mesh-ancestor
102333532|NCT01696071|Parasympatholytics|parasympatholytics|mesh-ancestor
102333533|NCT01696071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102333534|NCT01696071|Cholinergic Agents|cholinergic agents|mesh-ancestor
102333535|NCT01696071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102333536|NCT01696071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333537|NCT01591863|Fidaxomicin|fidaxomicin|mesh-list
102333538|NCT01591863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102333539|NCT01591863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102333540|NCT01591785|Retapamulin|retapamulin|mesh-list
102333541|NCT01591785|Petrolatum|petrolatum|mesh-list
102042380|NCT03825302|Mannitol|mannitol|mesh-list
102333542|NCT01591785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102333543|NCT01591785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102333544|NCT01591785|Emollients|emollients|mesh-ancestor
102333545|NCT01591785|Dermatologic Agents|dermatologic agents|mesh-ancestor
102333546|NCT03660046|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102333547|NCT03660046|Levonorgestrel|levonorgestrel|mesh-list
102333548|NCT03660046|Medroxyprogesterone|medroxyprogesterone|mesh-list
102333549|NCT03660046|Etonogestrel|etonogestrel|mesh-list
102333550|NCT03660046|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102333551|NCT03660046|Contraceptive Agents|contraceptive agents|mesh-ancestor
102333552|NCT03660046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102333553|NCT03660046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333554|NCT03660046|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102333555|NCT03660046|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102333556|NCT03660046|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102333557|NCT03660046|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102333558|NCT03660046|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102333559|NCT03660046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102333560|NCT03660046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102333561|NCT03654040|Cyclophosphamide|cyclophosphamide|mesh-list
102333562|NCT03654040|Everolimus|everolimus|mesh-list
101675578|NCT05568888|Thrombin|thrombin|mesh-list
102333563|NCT03654040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102333564|NCT03654040|Immunologic Factors|immunologic factors|mesh-ancestor
102333565|NCT03654040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333566|NCT03654040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102333567|NCT03654040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102333568|NCT03654040|Alkylating Agents|alkylating agents|mesh-ancestor
102333569|NCT03654040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333570|NCT03654040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102333571|NCT03654040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102333572|NCT03654040|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102333573|NCT03654040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102333574|NCT03654040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102333575|NCT03844048|Venetoclax|venetoclax|mesh-list
102333576|NCT03844048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102333577|NCT03833440|Docetaxel|docetaxel|mesh-list
102333578|NCT03833440|Durvalumab|durvalumab|mesh-list
102333579|NCT03833440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102333580|NCT03833440|Tubulin Modulators|tubulin modulators|mesh-ancestor
102333581|NCT03833440|Antimitotic Agents|antimitotic agents|mesh-ancestor
102333582|NCT03833440|Mitosis Modulators|mitosis modulators|mesh-ancestor
102333583|NCT03833440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333584|NCT03833440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102333585|NCT01677442|Anesthetics|anesthetics|mesh-list
102333586|NCT01677442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102333587|NCT01677442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333588|NCT01695135|Prednisone|prednisone|mesh-list
102333589|NCT01695135|Abiraterone Acetate|abiraterone acetate|mesh-list
102333590|NCT01695135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102333591|NCT01695135|Glucocorticoids|glucocorticoids|mesh-ancestor
102333592|NCT01695135|Hormones|hormones|mesh-ancestor
102333593|NCT01695135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102333594|NCT01695135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333595|NCT01695135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102333596|NCT01695135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102333597|NCT01695135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102333598|NCT01695135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102333599|NCT01695135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333600|NCT01695135|Hormone Antagonists|hormone antagonists|mesh-ancestor
102333601|NCT01695135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102333602|NCT01590771|Metformin|metformin|mesh-list
102333603|NCT01590771|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102333604|NCT01590771|Glimepiride|glimepiride|mesh-list
102333605|NCT01590771|Gliclazide|gliclazide|mesh-list
102333606|NCT01590771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102333607|NCT01590771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333608|NCT01590771|Incretins|incretins|mesh-ancestor
102333609|NCT01590771|Hormones|hormones|mesh-ancestor
102333610|NCT01590771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102333611|NCT01590771|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102333612|NCT01590771|Protease Inhibitors|protease inhibitors|mesh-ancestor
102333613|NCT01590771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102333614|NCT01590771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333615|NCT01590771|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102333616|NCT01590771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102333617|NCT01590771|Immunologic Factors|immunologic factors|mesh-ancestor
102333618|NCT04764058|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
102333619|NCT04764058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102333620|NCT04764058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102333621|NCT04764058|Protease Inhibitors|protease inhibitors|mesh-ancestor
102333622|NCT04764058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102333623|NCT04764058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333624|NCT03735316|Vitamin B 12|vitamin b 12|mesh-list
102333625|NCT03735316|Hydroxocobalamin|hydroxocobalamin|mesh-list
102333626|NCT03735316|Vitamins|vitamins|mesh-ancestor
102333627|NCT03735316|Micronutrients|micronutrients|mesh-ancestor
102333628|NCT03735316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333629|NCT03735316|Vitamin B Complex|vitamin b complex|mesh-ancestor
102333630|NCT03735316|Hematinics|hematinics|mesh-ancestor
102333631|NCT01694433|Vitamin D|vitamin d|mesh-list
102333632|NCT01694433|Calcitriol|calcitriol|mesh-list
102333633|NCT01694433|Calcipotriene|calcipotriene|mesh-list
102333634|NCT01694433|Vitamins|vitamins|mesh-ancestor
102333635|NCT01694433|Micronutrients|micronutrients|mesh-ancestor
102333636|NCT01694433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333637|NCT01694433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102333638|NCT01694433|Dermatologic Agents|dermatologic agents|mesh-ancestor
102333639|NCT01694433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102333640|NCT01694433|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102333641|NCT01694433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102333642|NCT01694433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333643|NCT01694433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102333644|NCT01693185|Midazolam|midazolam|mesh-list
102333645|NCT01693185|Meperidine|meperidine|mesh-list
102333646|NCT01693185|Remifentanil|remifentanil|mesh-list
102333647|NCT01693185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102333648|NCT01693185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102333649|NCT01693185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102333650|NCT01693185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333651|NCT01693185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102333652|NCT01693185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102333653|NCT01693185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102333654|NCT01693185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102333655|NCT01693185|Anesthetics, General|anesthetics, general|mesh-ancestor
102333656|NCT01693185|Anesthetics|anesthetics|mesh-ancestor
102333657|NCT01693185|GABA Modulators|gaba modulators|mesh-ancestor
102333658|NCT01693185|GABA Agents|gaba agents|mesh-ancestor
102333659|NCT01693185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102333660|NCT01693185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333661|NCT01693185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102333662|NCT01693185|Narcotics|narcotics|mesh-ancestor
102333663|NCT01693185|Analgesics|analgesics|mesh-ancestor
102333664|NCT01693185|Sensory System Agents|sensory system agents|mesh-ancestor
102333665|NCT01693185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102333666|NCT03824938|Aspirin|aspirin|mesh-list
102333667|NCT03824938|Acetaminophen|acetaminophen|mesh-list
102333668|NCT03824938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102333669|NCT03824938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102333670|NCT03824938|Analgesics|analgesics|mesh-ancestor
102333671|NCT03824938|Sensory System Agents|sensory system agents|mesh-ancestor
102333672|NCT03824938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102333673|NCT03824938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333674|NCT03824938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102333675|NCT03824938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102333676|NCT03824938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102333677|NCT03824938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102333678|NCT03824938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333679|NCT03824938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102333680|NCT03824938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102333681|NCT03824938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102333682|NCT03824938|Antipyretics|antipyretics|mesh-ancestor
102333683|NCT03630640|Nivolumab|nivolumab|mesh-list
102333684|NCT03630640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102333685|NCT03630640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102333686|NCT03630640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102333687|NCT03630640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333688|NCT03820726|Nintedanib|nintedanib|mesh-list
102333689|NCT03820726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102333690|NCT03820726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102333691|NCT03820726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102333692|NCT03820726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333693|NCT03625726|Thrombin|thrombin|mesh-list
102042534|NCT01314833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102333694|NCT03625726|Hemostatics|hemostatics|mesh-ancestor
102333695|NCT03625726|Coagulants|coagulants|mesh-ancestor
102333696|NCT03814954|Epinephrine|epinephrine|mesh-list
102333697|NCT03814954|Albuterol|albuterol|mesh-list
102333698|NCT03814954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102333699|NCT03814954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102333700|NCT03814954|Adrenergic Agents|adrenergic agents|mesh-ancestor
102333701|NCT03814954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102333702|NCT03814954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333703|NCT03814954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333704|NCT03814954|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102333705|NCT03814954|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102333706|NCT03814954|Autonomic Agents|autonomic agents|mesh-ancestor
102333707|NCT03814954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102333708|NCT03814954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102333709|NCT03814954|Respiratory System Agents|respiratory system agents|mesh-ancestor
102333710|NCT03814954|Mydriatics|mydriatics|mesh-ancestor
102333711|NCT03814954|Sympathomimetics|sympathomimetics|mesh-ancestor
102333712|NCT03814954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102333713|NCT03814954|Tocolytic Agents|tocolytic agents|mesh-ancestor
102333714|NCT03814954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102333715|NCT03814954|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102333717|NCT03813160|Lenabasum|lenabasum|mesh-list
102333718|NCT03813160|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102333719|NCT03813160|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102333720|NCT03813160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102333721|NCT03813160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333722|NCT03813160|Hormones|hormones|mesh-ancestor
102333723|NCT03813160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102333724|NCT03813160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333725|NCT03813160|Hallucinogens|hallucinogens|mesh-ancestor
102333726|NCT03813160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102333727|NCT03813160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102333728|NCT03813160|Analgesics|analgesics|mesh-ancestor
102333729|NCT03813160|Sensory System Agents|sensory system agents|mesh-ancestor
102333730|NCT03813160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102333731|NCT03619252|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102333732|NCT03619252|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102333733|NCT03619252|Immunologic Factors|immunologic factors|mesh-ancestor
102333734|NCT03619252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333735|NCT03619252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102333736|NCT03807856|Dabigatran|dabigatran|mesh-list
102333737|NCT03807856|Antithrombins|antithrombins|mesh-ancestor
102333738|NCT03807856|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102333739|NCT03807856|Protease Inhibitors|protease inhibitors|mesh-ancestor
102333740|NCT03807856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102333741|NCT03807856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333742|NCT03807856|Anticoagulants|anticoagulants|mesh-ancestor
102333743|NCT03806530|Gabapentin|gabapentin|mesh-list
102333744|NCT03806530|Ropinirole|ropinirole|mesh-list
102333745|NCT03806530|Analgesics|analgesics|mesh-ancestor
102333746|NCT03806530|Sensory System Agents|sensory system agents|mesh-ancestor
102333747|NCT03806530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102333748|NCT03806530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333749|NCT03806530|Anticonvulsants|anticonvulsants|mesh-ancestor
102333750|NCT03806530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102333751|NCT03806530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102333752|NCT03806530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102333753|NCT03806530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102333754|NCT03806530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102333755|NCT03806530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102333756|NCT03806530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102333757|NCT03806530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333758|NCT03806530|Antimanic Agents|antimanic agents|mesh-ancestor
102333759|NCT03806530|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102333760|NCT03806530|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102333761|NCT03806530|Dopamine Agonists|dopamine agonists|mesh-ancestor
102333762|NCT03806530|Dopamine Agents|dopamine agents|mesh-ancestor
102333763|NCT00003820|Rituximab|rituximab|mesh-list
102333764|NCT00003820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102333765|NCT00003820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102333766|NCT00003820|Immunologic Factors|immunologic factors|mesh-ancestor
102333767|NCT00003820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333768|NCT00003820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102333769|NCT01693029|Epoetin Alfa|epoetin alfa|mesh-list
102333770|NCT01693029|Hematinics|hematinics|mesh-ancestor
102333771|NCT01589445|Metformin|metformin|mesh-list
102333772|NCT01589445|Pioglitazone|pioglitazone|mesh-list
102333773|NCT01589445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102333774|NCT01589445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333775|NCT01561989|Vitamin D|vitamin d|mesh-list
102333776|NCT01561989|Cholecalciferol|cholecalciferol|mesh-list
102333777|NCT01561989|Vaccines|vaccines|mesh-list
102333778|NCT01561989|Immunologic Factors|immunologic factors|mesh-ancestor
102333779|NCT01561989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333780|NCT01561989|Vitamins|vitamins|mesh-ancestor
102333781|NCT01561989|Micronutrients|micronutrients|mesh-ancestor
102333782|NCT01561989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102333783|NCT01561989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102333784|NCT00004054|Paclitaxel|paclitaxel|mesh-list
102333785|NCT00004054|Etoposide|etoposide|mesh-list
102333786|NCT00004054|Bicalutamide|bicalutamide|mesh-list
102333787|NCT00004054|Flutamide|flutamide|mesh-list
102333788|NCT00004054|Estramustine|estramustine|mesh-list
102333789|NCT00004054|Warfarin|warfarin|mesh-list
102333790|NCT00004054|Hormones|hormones|mesh-list
101675800|NCT05306340|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102333791|NCT00004054|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
102333792|NCT00004054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102333793|NCT00004054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102333794|NCT00004054|Tubulin Modulators|tubulin modulators|mesh-ancestor
102333795|NCT00004054|Antimitotic Agents|antimitotic agents|mesh-ancestor
102333796|NCT00004054|Mitosis Modulators|mitosis modulators|mesh-ancestor
102333797|NCT00004054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333798|NCT00004054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102333799|NCT00004054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102333800|NCT00004054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102333801|NCT00004054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102333802|NCT00004054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333803|NCT00004054|Anticoagulants|anticoagulants|mesh-ancestor
102333804|NCT00004054|Androgen Antagonists|androgen antagonists|mesh-ancestor
102333805|NCT00004054|Hormone Antagonists|hormone antagonists|mesh-ancestor
102333806|NCT00004054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102333807|NCT00004054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102333808|NCT00004054|Alkylating Agents|alkylating agents|mesh-ancestor
102333809|NCT01587885|Omeprazole|omeprazole|mesh-list
102333810|NCT01587885|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102333811|NCT01587885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102333812|NCT01587885|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102333813|NCT01587885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102333814|NCT01587885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333815|NCT03802240|Pemetrexed|pemetrexed|mesh-list
102333816|NCT03802240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102333817|NCT03802240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102333818|NCT03802240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333819|NCT03802240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102333820|NCT03802240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102333821|NCT03710122|Vancomycin|vancomycin|mesh-list
102333822|NCT03710122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102333823|NCT03710122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102333824|NCT01587651|Ticagrelor|ticagrelor|mesh-list
102333825|NCT01587651|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102333826|NCT01587651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102333827|NCT01587651|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102333828|NCT01587651|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102333829|NCT01587651|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102333830|NCT01587651|Purinergic Agents|purinergic agents|mesh-ancestor
102333831|NCT01587651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102333832|NCT01587651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333833|NCT01587651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333834|NCT04763434|Dexamethasone|dexamethasone|mesh-list
102333835|NCT04763434|Dexmedetomidine|dexmedetomidine|mesh-list
102333836|NCT04763434|Ropivacaine|ropivacaine|mesh-list
102333837|NCT04763434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102333838|NCT04763434|Antiemetics|antiemetics|mesh-ancestor
102333839|NCT04763434|Autonomic Agents|autonomic agents|mesh-ancestor
102333840|NCT04763434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102333841|NCT04763434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333842|NCT04763434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102333843|NCT04763434|Glucocorticoids|glucocorticoids|mesh-ancestor
102333844|NCT04763434|Hormones|hormones|mesh-ancestor
102333845|NCT04763434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102042739|NCT02238704|Iron|iron|mesh-list
102333846|NCT04763434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102333847|NCT04763434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102333848|NCT04763434|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102333849|NCT04763434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102333850|NCT04763434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102333852|NCT04763434|Sensory System Agents|sensory system agents|mesh-ancestor
102333853|NCT04763434|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102333854|NCT04763434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102333855|NCT04763434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102333856|NCT04763434|Adrenergic Agents|adrenergic agents|mesh-ancestor
102333857|NCT04763434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102333858|NCT04763434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333859|NCT04763434|Anesthetics, Local|anesthetics, local|mesh-ancestor
102333860|NCT04763434|Anesthetics|anesthetics|mesh-ancestor
102333861|NCT04762966|Metformin|metformin|mesh-list
102333862|NCT04762966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101675876|NCT05259839|Dexamethasone|dexamethasone|mesh-list
102333863|NCT04762966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333864|NCT03602560|Seladelpar|seladelpar|mesh-list
102333865|NCT03602560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102333866|NCT03602560|Antimetabolites|antimetabolites|mesh-ancestor
102333867|NCT03602560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333868|NCT03602560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102333869|NCT03797326|Pembrolizumab|pembrolizumab|mesh-list
102333870|NCT03797326|Lenvatinib|lenvatinib|mesh-list
102333871|NCT03797326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102333872|NCT03797326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102333873|NCT03797326|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102333874|NCT03797326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333875|NCT03797326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102333876|NCT03797326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102333877|NCT00779116|Cetirizine|cetirizine|mesh-list
102333878|NCT00779116|Desloratadine|desloratadine|mesh-list
102333879|NCT00779116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102333880|NCT00779116|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102333881|NCT00779116|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102333882|NCT00779116|Histamine Antagonists|histamine antagonists|mesh-ancestor
102333883|NCT00779116|Histamine Agents|histamine agents|mesh-ancestor
102333884|NCT00779116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102333885|NCT00779116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333886|NCT00779116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333887|NCT00779116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102333888|NCT00779116|Cholinergic Agents|cholinergic agents|mesh-ancestor
102333889|NCT01691781|Lisinopril|lisinopril|mesh-list
102333890|NCT01691781|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102333891|NCT01691781|Protease Inhibitors|protease inhibitors|mesh-ancestor
102333892|NCT01691781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102333893|NCT01691781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333894|NCT01691781|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102333895|NCT01691781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102333896|NCT01691781|Protective Agents|protective agents|mesh-ancestor
102333897|NCT01691781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333898|NCT01561755|Immunoglobulins|immunoglobulins|mesh-list
102333899|NCT01561755|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102333900|NCT01561755|Antibodies|antibodies|mesh-list
102333901|NCT01561755|gamma-Globulins|gamma-globulins|mesh-list
102333902|NCT01561755|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102333903|NCT01561755|Immunologic Factors|immunologic factors|mesh-ancestor
102333904|NCT01561755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333905|NCT03789214|Suvorexant|suvorexant|mesh-list
102333906|NCT03789214|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102333907|NCT03789214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102333908|NCT03789214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102333909|NCT03789214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333910|NCT03789214|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102333911|NCT03789214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102333912|NCT03789214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333913|NCT04124367|Cerebrolysin|cerebrolysin|mesh-list
102333914|NCT04124367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102333915|NCT04124367|Protective Agents|protective agents|mesh-ancestor
102333916|NCT04124367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333917|NCT04124367|Nootropic Agents|nootropic agents|mesh-ancestor
102333918|NCT01560507|Bupropion|bupropion|mesh-list
102333919|NCT01560507|Nicotine|nicotine|mesh-list
102333920|NCT01560507|Varenicline|varenicline|mesh-list
102333921|NCT01560507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102333922|NCT01560507|Autonomic Agents|autonomic agents|mesh-ancestor
102333923|NCT01560507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102333924|NCT01560507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333925|NCT01560507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102333926|NCT01560507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102333927|NCT01560507|Cholinergic Agents|cholinergic agents|mesh-ancestor
102333928|NCT01560507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102333929|NCT01560507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333930|NCT01560507|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102333931|NCT01560507|Antidepressive Agents|antidepressive agents|mesh-ancestor
102333932|NCT01560507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102333933|NCT01560507|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102333934|NCT01560507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102333935|NCT01560507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102333936|NCT01560507|Dopamine Agents|dopamine agents|mesh-ancestor
102333937|NCT01560507|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102333938|NCT01560507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102333939|NCT01560507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102333941|NCT03694834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102333942|NCT03694834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102333943|NCT03694834|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102333944|NCT03694834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333945|NCT03587740|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102333946|NCT03587740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102333947|NCT03587740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102333948|NCT03587740|Immunotoxins|immunotoxins|mesh-ancestor
102333949|NCT03587740|Immunoconjugates|immunoconjugates|mesh-ancestor
102333950|NCT03587740|Immunologic Factors|immunologic factors|mesh-ancestor
102333951|NCT03587740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333952|NCT03587740|Tubulin Modulators|tubulin modulators|mesh-ancestor
102333953|NCT03587740|Antimitotic Agents|antimitotic agents|mesh-ancestor
102333954|NCT03587740|Mitosis Modulators|mitosis modulators|mesh-ancestor
102333955|NCT03587740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333956|NCT03586414|Ubiquinone|ubiquinone|mesh-list
102333957|NCT03586414|Micronutrients|micronutrients|mesh-ancestor
102333958|NCT03586414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333959|NCT03684538|Zinc|zinc|mesh-list
102333960|NCT03684538|Trace Elements|trace elements|mesh-ancestor
102333961|NCT03684538|Micronutrients|micronutrients|mesh-ancestor
102333962|NCT03684538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333963|NCT03682978|Baclofen|baclofen|mesh-list
102333964|NCT03682978|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102333965|NCT03682978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333966|NCT03682978|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102333967|NCT03682978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102333968|NCT03682978|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102333969|NCT03682978|GABA Agonists|gaba agonists|mesh-ancestor
102333970|NCT03682978|GABA Agents|gaba agents|mesh-ancestor
102333971|NCT03682978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102333972|NCT03682978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333973|NCT03676192|Bevacizumab|bevacizumab|mesh-list
102333974|NCT03676192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102333975|NCT03676192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102333976|NCT03676192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102333977|NCT03676192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102333978|NCT03676192|Growth Substances|growth substances|mesh-ancestor
102333979|NCT03676192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333980|NCT03676192|Growth Inhibitors|growth inhibitors|mesh-ancestor
102333981|NCT01584843|Botulinum Toxins|botulinum toxins|mesh-list
102333982|NCT01584843|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102333983|NCT01584843|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102333984|NCT01584843|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102333985|NCT01584843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102333986|NCT01584843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333987|NCT01584843|Cholinergic Agents|cholinergic agents|mesh-ancestor
102333988|NCT01584843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102333989|NCT01584843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102333990|NCT01584843|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102333991|NCT01584843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102333992|NCT03580408|Nivolumab|nivolumab|mesh-list
102333993|NCT03580408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102333994|NCT03580408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102333995|NCT03580408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102333996|NCT03580408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102333997|NCT03775096|Carvedilol|carvedilol|mesh-list
102333998|NCT03775096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102333999|NCT03775096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102334000|NCT03775096|Adrenergic Agents|adrenergic agents|mesh-ancestor
102334001|NCT03775096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102334002|NCT03775096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334003|NCT03775096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334004|NCT03775096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102334005|NCT03775096|Antioxidants|antioxidants|mesh-ancestor
102334006|NCT03775096|Protective Agents|protective agents|mesh-ancestor
102334007|NCT03775096|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102334008|NCT03775096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102334009|NCT03775096|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102334010|NCT03775096|Vasodilator Agents|vasodilator agents|mesh-ancestor
102334011|NCT03775096|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102334012|NCT03775096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102334013|NCT03772834|Methylphenidate|methylphenidate|mesh-list
102334014|NCT03772834|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102334015|NCT03772834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334016|NCT03772834|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102334017|NCT03772834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102334018|NCT03772834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102334019|NCT03772834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334020|NCT03772834|Dopamine Agents|dopamine agents|mesh-ancestor
102334021|NCT03772834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102334022|NCT03675256|Vaccines|vaccines|mesh-list
102334023|NCT03675256|Immunologic Factors|immunologic factors|mesh-ancestor
102334024|NCT03675256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334025|NCT03766750|Dapagliflozin|dapagliflozin|mesh-list
102334026|NCT03766750|Linagliptin|linagliptin|mesh-list
102334027|NCT03766750|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102334028|NCT03766750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334029|NCT03766750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102334030|NCT03766750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334031|NCT03766750|Incretins|incretins|mesh-ancestor
102334032|NCT03766750|Hormones|hormones|mesh-ancestor
102334033|NCT03766750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102334034|NCT03766750|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102334035|NCT03766750|Protease Inhibitors|protease inhibitors|mesh-ancestor
102334036|NCT03766750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102334037|NCT04762810|Cyclophosphamide|cyclophosphamide|mesh-list
102334038|NCT04762810|Glucocorticoids|glucocorticoids|mesh-list
102334039|NCT04762810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102334040|NCT04762810|Immunologic Factors|immunologic factors|mesh-ancestor
102334041|NCT04762810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334042|NCT04762810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102334043|NCT04762810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102334044|NCT04762810|Alkylating Agents|alkylating agents|mesh-ancestor
102334045|NCT04762810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334046|NCT04762810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102334047|NCT04762810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102334048|NCT04762810|Hormones|hormones|mesh-ancestor
102334049|NCT04762810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102334050|NCT03674242|Carboplatin|carboplatin|mesh-list
102334051|NCT03674242|Gemcitabine|gemcitabine|mesh-list
102334052|NCT03674242|Asparaginase|asparaginase|mesh-list
102334053|NCT03674242|Eryaspase|eryaspase|mesh-list
102334054|NCT03674242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102334055|NCT03674242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102334056|NCT03674242|Antimetabolites|antimetabolites|mesh-ancestor
102334057|NCT03674242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334058|NCT04761952|Infliximab|infliximab|mesh-list
102334059|NCT04761952|Azathioprine|azathioprine|mesh-list
102334060|NCT04761952|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102334061|NCT04761952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102334062|NCT04761952|Dermatologic Agents|dermatologic agents|mesh-ancestor
102334063|NCT04761952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102334064|NCT04761952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102334065|NCT04761952|Antimetabolites|antimetabolites|mesh-ancestor
102334066|NCT04761952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334067|NCT04761952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102334068|NCT04761952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102334069|NCT04761952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102334070|NCT04761952|Immunologic Factors|immunologic factors|mesh-ancestor
102334071|NCT04761952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334073|NCT03673072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102334074|NCT03673072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102334075|NCT03673072|Antimetabolites|antimetabolites|mesh-ancestor
102334076|NCT03673072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334077|NCT01690299|Etanercept|etanercept|mesh-list
102334078|NCT01690299|Apremilast|apremilast|mesh-list
102334079|NCT01690299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102334080|NCT01690299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102334081|NCT01690299|Analgesics|analgesics|mesh-ancestor
102334082|NCT01690299|Sensory System Agents|sensory system agents|mesh-ancestor
102334083|NCT01690299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102334084|NCT01690299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334085|NCT01690299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102334086|NCT01690299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102334087|NCT01690299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102334088|NCT01690299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102334089|NCT01690299|Immunologic Factors|immunologic factors|mesh-ancestor
102334090|NCT01690299|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102334091|NCT01690299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102334092|NCT01690299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102334093|NCT01690299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334094|NCT03570814|Azithromycin|azithromycin|mesh-list
102334095|NCT03570814|Ivermectin|ivermectin|mesh-list
102334096|NCT03570814|Albendazole|albendazole|mesh-list
102334097|NCT03570814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102334098|NCT03570814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102334099|NCT03570814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102334100|NCT03570814|Anthelmintics|anthelmintics|mesh-ancestor
102334101|NCT03570814|Anticestodal Agents|anticestodal agents|mesh-ancestor
102334102|NCT03570814|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102334103|NCT03570814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102334104|NCT03570814|Tubulin Modulators|tubulin modulators|mesh-ancestor
102334105|NCT03570814|Antimitotic Agents|antimitotic agents|mesh-ancestor
102334106|NCT03570814|Mitosis Modulators|mitosis modulators|mesh-ancestor
102334107|NCT03570814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334108|NCT03570814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102334109|NCT00723736|Desloratadine|desloratadine|mesh-list
102334110|NCT00723736|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102334111|NCT00723736|Cholinergic Agents|cholinergic agents|mesh-ancestor
102334112|NCT00723736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102334113|NCT00723736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334114|NCT00723736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334115|NCT00723736|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102334116|NCT00723736|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102334117|NCT00723736|Histamine Antagonists|histamine antagonists|mesh-ancestor
102334118|NCT00723736|Histamine Agents|histamine agents|mesh-ancestor
102334119|NCT00305344|Vaccines|vaccines|mesh-list
102334120|NCT00305344|Immunologic Factors|immunologic factors|mesh-ancestor
102334121|NCT00305344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334122|NCT01690143|Melphalan|melphalan|mesh-list
102334123|NCT01690143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102334124|NCT01690143|Alkylating Agents|alkylating agents|mesh-ancestor
102334125|NCT01690143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334126|NCT01690143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102334127|NCT01690143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102334128|NCT01690143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102334129|NCT01690143|Immunologic Factors|immunologic factors|mesh-ancestor
102334130|NCT01690143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334131|NCT05347498|Febuxostat|febuxostat|mesh-list
102334132|NCT05347498|Gout Suppressants|gout suppressants|mesh-ancestor
102334133|NCT05347498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102334134|NCT01677364|Oxytocin|oxytocin|mesh-list
102334135|NCT01677364|Oxytocics|oxytocics|mesh-ancestor
102334136|NCT01677364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102334137|NCT01677364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334138|NCT03563248|Nivolumab|nivolumab|mesh-list
102334139|NCT03563248|Folfirinox|folfirinox|mesh-list
102334140|NCT03563248|Losartan|losartan|mesh-list
102334141|NCT03563248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102042989|NCT03647670|Midazolam|midazolam|mesh-list
102334142|NCT03563248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102334143|NCT03563248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102334144|NCT03563248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334145|NCT03563248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102334146|NCT03563248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102334147|NCT03563248|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102334148|NCT03563248|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102334149|NCT04403776|Tofacitinib|tofacitinib|mesh-list
102334150|NCT04403776|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102334151|NCT04403776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102334152|NCT04403776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102334153|NCT04403776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334154|NCT03559348|Leucovorin|leucovorin|mesh-list
102334155|NCT03559348|Gemcitabine|gemcitabine|mesh-list
102334156|NCT03559348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102334157|NCT03559348|Antimetabolites|antimetabolites|mesh-ancestor
102334158|NCT03559348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334159|NCT03559348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102334160|NCT03559348|Antidotes|antidotes|mesh-ancestor
102334161|NCT03559348|Protective Agents|protective agents|mesh-ancestor
102334162|NCT03559348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334163|NCT03559348|Vitamin B Complex|vitamin b complex|mesh-ancestor
102334164|NCT03559348|Vitamins|vitamins|mesh-ancestor
102334165|NCT03559348|Micronutrients|micronutrients|mesh-ancestor
102334166|NCT04762030|Paclitaxel|paclitaxel|mesh-list
102334167|NCT04762030|Carboplatin|carboplatin|mesh-list
102334168|NCT04762030|Durvalumab|durvalumab|mesh-list
102334169|NCT04762030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102334170|NCT04762030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102334171|NCT04762030|Tubulin Modulators|tubulin modulators|mesh-ancestor
102334172|NCT04762030|Antimitotic Agents|antimitotic agents|mesh-ancestor
102334173|NCT04762030|Mitosis Modulators|mitosis modulators|mesh-ancestor
102334174|NCT04762030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334175|NCT04762030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102334176|NCT01559259|Acetaminophen|acetaminophen|mesh-list
102334177|NCT01559259|Ibuprofen|ibuprofen|mesh-list
102334178|NCT01559259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102334179|NCT01559259|Analgesics|analgesics|mesh-ancestor
102334180|NCT01559259|Sensory System Agents|sensory system agents|mesh-ancestor
102334181|NCT01559259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102334182|NCT01559259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334183|NCT01559259|Antipyretics|antipyretics|mesh-ancestor
102334184|NCT01559259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102334185|NCT01559259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102334186|NCT01559259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102334187|NCT01559259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102334188|NCT01559259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102334189|NCT01559259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334190|NCT03088306|Acetaminophen|acetaminophen|mesh-list
102334191|NCT03088306|Fentanyl|fentanyl|mesh-list
102334192|NCT03088306|Ketamine|ketamine|mesh-list
102334193|NCT03088306|Gabapentin|gabapentin|mesh-list
102334194|NCT03088306|Hydromorphone|hydromorphone|mesh-list
102334195|NCT03088306|Anesthetics|anesthetics|mesh-ancestor
102334196|NCT03088306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102334197|NCT03088306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334198|NCT03088306|Analgesics|analgesics|mesh-ancestor
102334199|NCT03088306|Sensory System Agents|sensory system agents|mesh-ancestor
102334200|NCT03088306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102334201|NCT03088306|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102334202|NCT03088306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102334203|NCT03088306|Anesthetics, General|anesthetics, general|mesh-ancestor
102334204|NCT03088306|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102334205|NCT03088306|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102334206|NCT03088306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102334207|NCT03088306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334208|NCT03088306|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102334209|NCT03088306|Narcotics|narcotics|mesh-ancestor
102334210|NCT03088306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102334211|NCT03088306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102334212|NCT03088306|Antipyretics|antipyretics|mesh-ancestor
102334213|NCT03088306|Anticonvulsants|anticonvulsants|mesh-ancestor
102334214|NCT03088306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102334215|NCT03088306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102334216|NCT03088306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102334217|NCT03088306|Antimanic Agents|antimanic agents|mesh-ancestor
102334218|NCT01672762|Ipragliflozin|ipragliflozin|mesh-list
102334219|NCT01672762|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102334220|NCT01672762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334222|NCT01672762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334223|NCT03088384|Ketamine|ketamine|mesh-list
102334224|NCT03088384|Analgesics|analgesics|mesh-ancestor
102334225|NCT03088384|Sensory System Agents|sensory system agents|mesh-ancestor
102334226|NCT03088384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102334227|NCT03088384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334228|NCT03088384|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102334229|NCT03088384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102334230|NCT03088384|Anesthetics, General|anesthetics, general|mesh-ancestor
102334231|NCT03088384|Anesthetics|anesthetics|mesh-ancestor
102334232|NCT03088384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102334233|NCT03088384|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102334234|NCT03088384|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102334235|NCT03088384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102334236|NCT03088384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334237|NCT01677598|Ustekinumab|ustekinumab|mesh-list
102334238|NCT01677598|Dermatologic Agents|dermatologic agents|mesh-ancestor
102334239|NCT01677754|Memantine|memantine|mesh-list
102334240|NCT01677754|Rivastigmine|rivastigmine|mesh-list
102334241|NCT01677754|Donepezil|donepezil|mesh-list
102334242|NCT01677754|Galantamine|galantamine|mesh-list
102334243|NCT01677754|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102334244|NCT01677754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102334245|NCT01677754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334246|NCT01677754|Cholinergic Agents|cholinergic agents|mesh-ancestor
102334247|NCT01677754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102334248|NCT01677754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334249|NCT01677754|Nootropic Agents|nootropic agents|mesh-ancestor
102334250|NCT01677754|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102334251|NCT01677754|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102334252|NCT01677754|Dopamine Agents|dopamine agents|mesh-ancestor
102334253|NCT01677754|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102334254|NCT01677754|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102334255|NCT01677754|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102334256|NCT01677754|Autonomic Agents|autonomic agents|mesh-ancestor
102334257|NCT01677754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102334258|NCT01677754|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102334259|NCT01677754|Protective Agents|protective agents|mesh-ancestor
102334260|NCT01670500|Cyclophosphamide|cyclophosphamide|mesh-list
102334261|NCT01670500|Cisplatin|cisplatin|mesh-list
102334262|NCT01670500|Doxorubicin|doxorubicin|mesh-list
102334263|NCT01670500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102334264|NCT01670500|Immunologic Factors|immunologic factors|mesh-ancestor
102334265|NCT01670500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334266|NCT01670500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102334267|NCT01670500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102334268|NCT01670500|Alkylating Agents|alkylating agents|mesh-ancestor
102334269|NCT01670500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334270|NCT01670500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102334271|NCT01670500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102334272|NCT01670500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102334273|NCT01670500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102334274|NCT01670500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102334275|NCT01670500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102334276|NCT01678612|Copper|copper|mesh-list
102334277|NCT01678612|Trace Elements|trace elements|mesh-ancestor
102334278|NCT01678612|Micronutrients|micronutrients|mesh-ancestor
102334279|NCT01678612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334280|NCT03525574|Ivacaftor|ivacaftor|mesh-list
102334281|NCT03525574|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102334282|NCT03525574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102334283|NCT03525574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334284|NCT02402920|Cisplatin|cisplatin|mesh-list
102334285|NCT02402920|Carboplatin|carboplatin|mesh-list
102334286|NCT02402920|Pembrolizumab|pembrolizumab|mesh-list
102334287|NCT02402920|Etoposide|etoposide|mesh-list
102334288|NCT02402920|Etoposide phosphate|etoposide phosphate|mesh-list
102334289|NCT02402920|Podophyllotoxin|podophyllotoxin|mesh-list
102334290|NCT02402920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102334291|NCT02402920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102334292|NCT02402920|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102334293|NCT02402920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334294|NCT02402920|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102334295|NCT02402920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102334296|NCT02402920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102334297|NCT02402920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102334298|NCT02402920|Keratolytic Agents|keratolytic agents|mesh-ancestor
102334299|NCT02402920|Dermatologic Agents|dermatologic agents|mesh-ancestor
102334300|NCT02402920|Tubulin Modulators|tubulin modulators|mesh-ancestor
102334302|NCT02402920|Mitosis Modulators|mitosis modulators|mesh-ancestor
102334303|NCT02405260|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102334304|NCT02405260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102334305|NCT02405260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334306|NCT02405260|Incretins|incretins|mesh-ancestor
102334307|NCT02405260|Hormones|hormones|mesh-ancestor
102334308|NCT02405260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102334309|NCT02405260|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102334310|NCT02405260|Protease Inhibitors|protease inhibitors|mesh-ancestor
102334311|NCT02405260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102334312|NCT02405260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334313|NCT03519646|Eliglustat|eliglustat|mesh-list
102334314|NCT03519646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102334315|NCT03519646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334316|NCT02984722|Metformin|metformin|mesh-list
102334317|NCT02984722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102334318|NCT02984722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334319|NCT02401750|Naltrexone|naltrexone|mesh-list
102334320|NCT02401750|Oxycodone|oxycodone|mesh-list
102334321|NCT02401750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102334322|NCT02401750|Narcotics|narcotics|mesh-ancestor
102334323|NCT02401750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102334324|NCT02401750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334325|NCT02401750|Analgesics|analgesics|mesh-ancestor
102334326|NCT02401750|Sensory System Agents|sensory system agents|mesh-ancestor
102334327|NCT02401750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102334328|NCT02401750|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102334329|NCT02401750|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102334330|NCT03087136|polysaccharide-K|polysaccharide-k|mesh-list
102334331|NCT03087136|Antibodies|antibodies|mesh-list
102334332|NCT03087136|Immunologic Factors|immunologic factors|mesh-ancestor
102334333|NCT03087136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334334|NCT03087136|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102334335|NCT03087136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102334336|NCT03087136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102334337|NCT03087136|Antiviral Agents|antiviral agents|mesh-ancestor
102334338|NCT03087136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102334339|NCT03087136|Interferon Inducers|interferon inducers|mesh-ancestor
102334340|NCT03087136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102334341|NCT03087136|Protective Agents|protective agents|mesh-ancestor
102334342|NCT01689519|Vemurafenib|vemurafenib|mesh-list
102334343|NCT01689519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102334344|NCT01689519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102334345|NCT01689519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102334346|NCT01689519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334347|NCT01689363|Histamine|histamine|mesh-list
102334348|NCT01689363|Histamine Agonists|histamine agonists|mesh-ancestor
102334349|NCT01689363|Histamine Agents|histamine agents|mesh-ancestor
102334350|NCT01689363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101676399|NCT04194203|Bevacizumab|bevacizumab|mesh-list
102334351|NCT01689363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334352|NCT01689363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334354|NCT03455140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102334355|NCT03502018|Bupivacaine|bupivacaine|mesh-list
102334356|NCT03502018|Anesthetics, Local|anesthetics, local|mesh-ancestor
102334357|NCT03502018|Anesthetics|anesthetics|mesh-ancestor
102334358|NCT03502018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102334359|NCT03502018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334360|NCT03502018|Sensory System Agents|sensory system agents|mesh-ancestor
102334361|NCT03502018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102334362|NCT01689207|Aztreonam|aztreonam|mesh-list
102334363|NCT01689207|Avibactam|avibactam|mesh-list
102334364|NCT01689207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102334365|NCT01689207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102334366|NCT01689207|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102334367|NCT01689207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102334368|NCT01689207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334369|NCT00089284|Rituximab|rituximab|mesh-list
102334370|NCT00089284|Motexafin gadolinium|motexafin gadolinium|mesh-list
102334371|NCT00089284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102334372|NCT00089284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102334373|NCT00089284|Immunologic Factors|immunologic factors|mesh-ancestor
102334374|NCT00089284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334375|NCT00089284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102334376|NCT00089284|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102334377|NCT00089284|Dermatologic Agents|dermatologic agents|mesh-ancestor
102334378|NCT01688973|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102334379|NCT01688973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102334380|NCT01688973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102334381|NCT01688973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102334382|NCT01688973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334384|NCT00087646|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102334385|NCT00087646|Interferon-alpha|interferon-alpha|mesh-list
102334386|NCT00087646|Antimetabolites|antimetabolites|mesh-ancestor
102334387|NCT00087646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334388|NCT00087646|Antiviral Agents|antiviral agents|mesh-ancestor
102334389|NCT00087646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102334390|NCT00087646|Immunologic Factors|immunologic factors|mesh-ancestor
102334391|NCT00087646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334392|NCT03492658|Methotrexate|methotrexate|mesh-list
102334393|NCT03492658|Abatacept|abatacept|mesh-list
102334394|NCT03492658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102334395|NCT03492658|Abortifacient Agents|abortifacient agents|mesh-ancestor
102334396|NCT03492658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102334397|NCT03492658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334398|NCT03492658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102334399|NCT03492658|Antimetabolites|antimetabolites|mesh-ancestor
102334400|NCT03492658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334401|NCT03492658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102334402|NCT03492658|Dermatologic Agents|dermatologic agents|mesh-ancestor
102334403|NCT03492658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102334404|NCT03492658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102334405|NCT03492658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102334406|NCT03492658|Immunologic Factors|immunologic factors|mesh-ancestor
102334407|NCT03492658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102334408|NCT03492658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102334409|NCT03492658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102334410|NCT03492658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102334411|NCT03085654|Oxytocin|oxytocin|mesh-list
102334412|NCT03085654|Oxytocics|oxytocics|mesh-ancestor
102334413|NCT03085654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102334414|NCT03085654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334415|NCT00087568|Ribavirin|ribavirin|mesh-list
102334416|NCT00087568|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102334417|NCT00087568|Antimetabolites|antimetabolites|mesh-ancestor
102334418|NCT00087568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334419|NCT00087568|Antiviral Agents|antiviral agents|mesh-ancestor
102334420|NCT00087568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102334421|NCT04402762|Enoxaparin|enoxaparin|mesh-list
102334422|NCT04402762|Enoxaparin sodium|enoxaparin sodium|mesh-list
102334423|NCT04402762|Anticoagulants|anticoagulants|mesh-ancestor
102334424|NCT04402762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102334425|NCT04402762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101676483|NCT04078568|Analgesics|analgesics|mesh-ancestor
102334426|NCT04402762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334428|NCT00085540|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102334429|NCT00085540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102334430|NCT00085540|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102334431|NCT00085540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102334432|NCT00085540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334433|NCT01688739|Erenumab|erenumab|mesh-list
102334434|NCT01688739|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
102334435|NCT01688739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334436|NCT01688739|Analgesics|analgesics|mesh-ancestor
102334437|NCT01688739|Sensory System Agents|sensory system agents|mesh-ancestor
102334438|NCT01688739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102334439|NCT01688739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334440|NCT00084838|Calcium, Dietary|calcium, dietary|mesh-list
102334441|NCT00084838|Leucovorin|leucovorin|mesh-list
102334442|NCT00084838|Cytarabine|cytarabine|mesh-list
102334443|NCT00084838|Dactinomycin|dactinomycin|mesh-list
102334444|NCT00084838|Hydrocortisone|hydrocortisone|mesh-list
102043282|NCT03621618|Sympathomimetics|sympathomimetics|mesh-ancestor
102334445|NCT00084838|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102334446|NCT00084838|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102334447|NCT00084838|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102334448|NCT00084838|Cyclophosphamide|cyclophosphamide|mesh-list
102334449|NCT00084838|Temozolomide|temozolomide|mesh-list
102334450|NCT00084838|Cisplatin|cisplatin|mesh-list
102334451|NCT00084838|Doxorubicin|doxorubicin|mesh-list
102334452|NCT00084838|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102334453|NCT00084838|Methotrexate|methotrexate|mesh-list
102334454|NCT00084838|Etoposide|etoposide|mesh-list
102334455|NCT00084838|Vincristine|vincristine|mesh-list
102334456|NCT00084838|Dexrazoxane|dexrazoxane|mesh-list
102334457|NCT00084838|Razoxane|razoxane|mesh-list
102334458|NCT00084838|Lenograstim|lenograstim|mesh-list
102334459|NCT00084838|Calcium|calcium|mesh-list
102334460|NCT00084838|Levoleucovorin|levoleucovorin|mesh-list
102334461|NCT00084838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102334462|NCT00084838|Immunologic Factors|immunologic factors|mesh-ancestor
101442383|NCT00170885|Everolimus|everolimus|mesh-list
102334463|NCT00084838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334464|NCT00084838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102334465|NCT00084838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102334466|NCT00084838|Alkylating Agents|alkylating agents|mesh-ancestor
102334467|NCT00084838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334468|NCT00084838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102334469|NCT00084838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102334470|NCT00084838|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102334471|NCT00084838|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102334472|NCT00084838|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102334473|NCT00084838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102334474|NCT00084838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102334475|NCT00084838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102334476|NCT00084838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102334477|NCT00084838|Abortifacient Agents|abortifacient agents|mesh-ancestor
102334478|NCT00084838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102334479|NCT00084838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102334480|NCT00084838|Antimetabolites|antimetabolites|mesh-ancestor
102334481|NCT00084838|Dermatologic Agents|dermatologic agents|mesh-ancestor
102334482|NCT00084838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102334483|NCT00084838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102334484|NCT00084838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102334485|NCT00084838|Antiviral Agents|antiviral agents|mesh-ancestor
102334486|NCT00084838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102334487|NCT00084838|Antidotes|antidotes|mesh-ancestor
102334488|NCT00084838|Protective Agents|protective agents|mesh-ancestor
102334489|NCT00084838|Vitamin B Complex|vitamin b complex|mesh-ancestor
102334490|NCT00084838|Vitamins|vitamins|mesh-ancestor
102334491|NCT00084838|Micronutrients|micronutrients|mesh-ancestor
102334492|NCT00084838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102334493|NCT00084838|Tubulin Modulators|tubulin modulators|mesh-ancestor
102334494|NCT00084838|Antimitotic Agents|antimitotic agents|mesh-ancestor
102334495|NCT00084838|Mitosis Modulators|mitosis modulators|mesh-ancestor
102334496|NCT00084838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102334497|NCT00084838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102334498|NCT00084838|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102334499|NCT00084838|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102334500|NCT01558089|Etanercept|etanercept|mesh-list
102334501|NCT01558089|Methotrexate|methotrexate|mesh-list
102334502|NCT01558089|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102334503|NCT01558089|Abortifacient Agents|abortifacient agents|mesh-ancestor
102334504|NCT01558089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102334505|NCT01558089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334506|NCT01558089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102334507|NCT01558089|Antimetabolites|antimetabolites|mesh-ancestor
102334508|NCT01558089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334509|NCT01558089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102334510|NCT01558089|Dermatologic Agents|dermatologic agents|mesh-ancestor
102334511|NCT01558089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102334512|NCT01558089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102334513|NCT01558089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102334514|NCT01558089|Immunologic Factors|immunologic factors|mesh-ancestor
102334515|NCT01558089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102334516|NCT01558089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102334517|NCT01558089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102334518|NCT01558089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102334519|NCT01558089|Analgesics|analgesics|mesh-ancestor
102334520|NCT01558089|Sensory System Agents|sensory system agents|mesh-ancestor
102334521|NCT01558089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102334522|NCT01558089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102334523|NCT01558089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102334524|NCT00084682|Romidepsin|romidepsin|mesh-list
102334525|NCT00084682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102334526|NCT00084682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102334527|NCT00084682|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102334528|NCT00084682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102334529|NCT00084682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334530|NCT01556997|Amlodipine|amlodipine|mesh-list
102334531|NCT01556997|Perindopril|perindopril|mesh-list
102334532|NCT01556997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102334533|NCT01556997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102334534|NCT01556997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102334535|NCT01556997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334536|NCT01556997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102334537|NCT01556997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334538|NCT01556997|Vasodilator Agents|vasodilator agents|mesh-ancestor
102334539|NCT01556997|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102334540|NCT01556997|Protease Inhibitors|protease inhibitors|mesh-ancestor
102334541|NCT01556997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102334542|NCT00082888|Tipifarnib|tipifarnib|mesh-list
102334543|NCT00082888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102334544|NCT03409588|Riociguat|riociguat|mesh-list
102334545|NCT03409588|Enzyme Activators|enzyme activators|mesh-ancestor
102334546|NCT03409588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334547|NCT03085186|Crizotinib|crizotinib|mesh-list
102334548|NCT03085186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102334549|NCT03085186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102334550|NCT03085186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102334551|NCT03085186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334552|NCT03084952|Meglumine Antimoniate|meglumine antimoniate|mesh-list
102334553|NCT03084952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102334554|NCT03084952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102334555|NCT03084952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102334556|NCT00082810|Fulvestrant|fulvestrant|mesh-list
102334557|NCT00082810|Tipifarnib|tipifarnib|mesh-list
102334558|NCT00082810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102334559|NCT00082810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102334560|NCT00082810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102334561|NCT00082810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102334562|NCT00082810|Hormone Antagonists|hormone antagonists|mesh-ancestor
102334563|NCT00082810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102334564|NCT00082810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334565|NCT03480334|Nivolumab|nivolumab|mesh-list
102334566|NCT03480334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102334567|NCT03480334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102334568|NCT03480334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102334569|NCT03480334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334570|NCT03085030|Antioxidants|antioxidants|mesh-list
102334571|NCT03085030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334572|NCT03085030|Protective Agents|protective agents|mesh-ancestor
102334573|NCT03085030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334574|NCT03443128|Vinorelbine|vinorelbine|mesh-list
102334575|NCT03443128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102334576|NCT03443128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102334577|NCT03443128|Tubulin Modulators|tubulin modulators|mesh-ancestor
102334578|NCT03443128|Antimitotic Agents|antimitotic agents|mesh-ancestor
102334579|NCT03443128|Mitosis Modulators|mitosis modulators|mesh-ancestor
102334580|NCT03443128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334581|NCT03437746|Methylprednisolone|methylprednisolone|mesh-list
102334582|NCT03437746|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102334583|NCT03437746|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102334584|NCT03437746|Prednisolone|prednisolone|mesh-list
102334585|NCT03437746|Prednisolone acetate|prednisolone acetate|mesh-list
102334586|NCT03437746|Anesthetics|anesthetics|mesh-list
102334587|NCT03437746|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102334588|NCT03437746|Prednisolone phosphate|prednisolone phosphate|mesh-list
102334589|NCT03437746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102334590|NCT03437746|Antiemetics|antiemetics|mesh-ancestor
102334591|NCT03437746|Autonomic Agents|autonomic agents|mesh-ancestor
102334592|NCT03437746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102334593|NCT03437746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334594|NCT03437746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102334595|NCT03437746|Glucocorticoids|glucocorticoids|mesh-ancestor
102334596|NCT03437746|Hormones|hormones|mesh-ancestor
102334597|NCT03437746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102334598|NCT03437746|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102334599|NCT03437746|Protective Agents|protective agents|mesh-ancestor
102334600|NCT03437746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102334601|NCT03437746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102334602|NCT03437746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102334603|NCT03084250|Tenofovir|tenofovir|mesh-list
102334604|NCT03084250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102334605|NCT03084250|Entecavir|entecavir|mesh-list
102334606|NCT03084250|Adefovir|adefovir|mesh-list
102334607|NCT03084250|Antiviral Agents|antiviral agents|mesh-ancestor
102334608|NCT03084250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102334609|NCT03084250|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102334610|NCT03084250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102334611|NCT03084250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102334612|NCT03084250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334613|NCT03084250|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102334614|NCT03084250|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102334615|NCT01688037|Tetrabenazine|tetrabenazine|mesh-list
102334616|NCT01688037|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102334617|NCT01688037|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102334618|NCT01688037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102334619|NCT01688037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334620|NCT01688037|Adrenergic Agents|adrenergic agents|mesh-ancestor
102334621|NCT01688037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102334622|NCT01688037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334623|NCT03084328|Vitamin D|vitamin d|mesh-list
102334624|NCT03084328|Vitamins|vitamins|mesh-ancestor
102334625|NCT03084328|Micronutrients|micronutrients|mesh-ancestor
102334626|NCT03084328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334627|NCT03084328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102334628|NCT03435718|Albendazole|albendazole|mesh-list
102334629|NCT03435718|Oxfendazole|oxfendazole|mesh-list
102334630|NCT03435718|Anthelmintics|anthelmintics|mesh-ancestor
102334631|NCT03435718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102334632|NCT03435718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102334633|NCT03435718|Anticestodal Agents|anticestodal agents|mesh-ancestor
102334634|NCT03435718|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102334635|NCT03435718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102334636|NCT03435718|Tubulin Modulators|tubulin modulators|mesh-ancestor
102334637|NCT03435718|Antimitotic Agents|antimitotic agents|mesh-ancestor
102334638|NCT03435718|Mitosis Modulators|mitosis modulators|mesh-ancestor
102334639|NCT03435718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334640|NCT03435718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102334641|NCT03435718|Antinematodal Agents|antinematodal agents|mesh-ancestor
102334642|NCT01678690|Gemcitabine|gemcitabine|mesh-list
102334643|NCT01678690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102334644|NCT01678690|Antimetabolites|antimetabolites|mesh-ancestor
102334645|NCT01678690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334646|NCT01678690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102334647|NCT01679080|Zoledronic Acid|zoledronic acid|mesh-list
102334648|NCT01679080|Teriparatide|teriparatide|mesh-list
102334649|NCT01679080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102334650|NCT01679080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334651|NCT01679080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102334652|NCT03083782|Cyclosporine|cyclosporine|mesh-list
102334653|NCT03083782|Apixaban|apixaban|mesh-list
102334654|NCT03083782|Tacrolimus|tacrolimus|mesh-list
102334655|NCT03083782|Cyclosporins|cyclosporins|mesh-list
102334656|NCT03083782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102334657|NCT03083782|Immunologic Factors|immunologic factors|mesh-ancestor
102334658|NCT03083782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334659|NCT03083782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102334660|NCT03083782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102334661|NCT03083782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334662|NCT03083782|Antifungal Agents|antifungal agents|mesh-ancestor
102334663|NCT03083782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102334664|NCT03083782|Dermatologic Agents|dermatologic agents|mesh-ancestor
102334665|NCT03083782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102334666|NCT03083782|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102334667|NCT03083782|Antithrombins|antithrombins|mesh-ancestor
102334668|NCT03083782|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102334669|NCT03083782|Protease Inhibitors|protease inhibitors|mesh-ancestor
102334670|NCT03083782|Anticoagulants|anticoagulants|mesh-ancestor
102334671|NCT03471442|Bupivacaine|bupivacaine|mesh-list
102334672|NCT03471442|Ropivacaine|ropivacaine|mesh-list
102334673|NCT03471442|Anesthetics, Local|anesthetics, local|mesh-list
102334674|NCT03471442|Anesthetics|anesthetics|mesh-list
102334675|NCT03471442|Anesthetics, General|anesthetics, general|mesh-list
102334676|NCT03471442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102334677|NCT03471442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334678|NCT03471442|Sensory System Agents|sensory system agents|mesh-ancestor
102334679|NCT03471442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102334680|NCT01679392|Ropivacaine|ropivacaine|mesh-list
102334681|NCT01679392|Anesthetics, Local|anesthetics, local|mesh-ancestor
102334682|NCT01679392|Anesthetics|anesthetics|mesh-ancestor
102334683|NCT01679392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102334684|NCT01679392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334685|NCT01679392|Sensory System Agents|sensory system agents|mesh-ancestor
102334686|NCT01679392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102334687|NCT03083080|Epinephrine|epinephrine|mesh-list
102334688|NCT03083080|Ropivacaine|ropivacaine|mesh-list
102334689|NCT03083080|Anesthetics, Local|anesthetics, local|mesh-ancestor
102334690|NCT03083080|Anesthetics|anesthetics|mesh-ancestor
102334691|NCT03083080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102334692|NCT03083080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334693|NCT03083080|Sensory System Agents|sensory system agents|mesh-ancestor
102334694|NCT03083080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102334695|NCT03083080|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102334696|NCT03083080|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102334697|NCT03083080|Adrenergic Agents|adrenergic agents|mesh-ancestor
102334698|NCT03083080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102334699|NCT03083080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334700|NCT03083080|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102334701|NCT03083080|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102334702|NCT03083080|Autonomic Agents|autonomic agents|mesh-ancestor
102334703|NCT03083080|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102334704|NCT03083080|Respiratory System Agents|respiratory system agents|mesh-ancestor
102334705|NCT03083080|Mydriatics|mydriatics|mesh-ancestor
102334706|NCT03083080|Sympathomimetics|sympathomimetics|mesh-ancestor
102334707|NCT03083080|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102334708|NCT03087760|Pembrolizumab|pembrolizumab|mesh-list
102334709|NCT03087760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102334710|NCT03087760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102334711|NCT03087760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102334712|NCT03087760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334713|NCT03082300|Naquotinib|naquotinib|mesh-list
102334714|NCT03082300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102334715|NCT03082300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102334716|NCT03082300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102334717|NCT03082300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334718|NCT01679860|Alemtuzumab|alemtuzumab|mesh-list
102334719|NCT01679860|Immunomodulating Agents|immunomodulating agents|mesh-list
102334720|NCT01679860|Immunologic Factors|immunologic factors|mesh-list
102334721|NCT01679860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334722|NCT01679860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102334723|NCT01679860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102334724|NCT05346952|Carboplatin|carboplatin|mesh-list
102334725|NCT05346952|Pemetrexed|pemetrexed|mesh-list
102334726|NCT05346952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102334727|NCT05346952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102334728|NCT05346952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334729|NCT05346952|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102334730|NCT05346952|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102334731|NCT03081442|Misoprostol|misoprostol|mesh-list
102334732|NCT03081442|Contraceptive Agents|contraceptive agents|mesh-list
102334733|NCT03081442|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102334734|NCT03081442|Abortifacient Agents|abortifacient agents|mesh-ancestor
102334735|NCT03081442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102334736|NCT03081442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334737|NCT03081442|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102334738|NCT03081442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102334739|NCT03081442|Oxytocics|oxytocics|mesh-ancestor
102334740|NCT03431194|Midodrine|midodrine|mesh-list
102334741|NCT03431194|Sympathomimetics|sympathomimetics|mesh-ancestor
102334742|NCT03431194|Autonomic Agents|autonomic agents|mesh-ancestor
102334743|NCT03431194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102334744|NCT03431194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334745|NCT03431194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102334746|NCT03431194|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102334747|NCT03431194|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102334748|NCT03431194|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102334749|NCT03431194|Adrenergic Agents|adrenergic agents|mesh-ancestor
102334750|NCT03431194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102334751|NCT03431194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334752|NCT03080740|Metronidazole|metronidazole|mesh-list
102334753|NCT03080740|Clindamycin|clindamycin|mesh-list
102334754|NCT03080740|Clindamycin palmitate|clindamycin palmitate|mesh-list
102334755|NCT03080740|Clindamycin phosphate|clindamycin phosphate|mesh-list
102334756|NCT03080740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102334757|NCT03080740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102334758|NCT03080740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102334759|NCT03080740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102334760|NCT03080740|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102334761|NCT03080740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102334762|NCT03080740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334763|NCT03081832|Oxytocin|oxytocin|mesh-list
102334764|NCT03081832|Oxytocics|oxytocics|mesh-ancestor
102334765|NCT03081832|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102334766|NCT03081832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334767|NCT05345938|Mitoxantrone|mitoxantrone|mesh-list
102334768|NCT05345938|Analgesics|analgesics|mesh-ancestor
102334769|NCT05345938|Sensory System Agents|sensory system agents|mesh-ancestor
102334770|NCT05345938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102334771|NCT05345938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334772|NCT05345938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102334773|NCT05345938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102334774|NCT05345938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102334775|NCT05345938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102334776|NCT05345938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334777|NCT03080350|Fentanyl|fentanyl|mesh-list
102334778|NCT03080350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102334779|NCT03080350|Narcotics|narcotics|mesh-ancestor
102334780|NCT03080350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102334781|NCT03080350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334782|NCT03080350|Analgesics|analgesics|mesh-ancestor
102334783|NCT03080350|Sensory System Agents|sensory system agents|mesh-ancestor
102334784|NCT03080350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102334785|NCT03080350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102334786|NCT03080350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102334787|NCT03080350|Anesthetics, General|anesthetics, general|mesh-ancestor
102334788|NCT03080350|Anesthetics|anesthetics|mesh-ancestor
102334789|NCT03080194|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102334790|NCT03080194|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102334791|NCT03080194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102334792|NCT03080194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102334793|NCT03080194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334794|NCT03080194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102334795|NCT03080194|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102334796|NCT03080194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102334797|NCT03080194|Serotonin Agents|serotonin agents|mesh-ancestor
102334798|NCT03080194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102334799|NCT03080194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334800|NCT03080194|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102334801|NCT03080194|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102334802|NCT03080194|Dopamine Agents|dopamine agents|mesh-ancestor
102334803|NCT01610336|Gefitinib|gefitinib|mesh-list
102334804|NCT01610336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102334805|NCT01610336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102334806|NCT01610336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102334807|NCT01610336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334808|NCT03323866|Mometasone Furoate|mometasone furoate|mesh-list
102334809|NCT03323866|Budesonide|budesonide|mesh-list
102334810|NCT03323866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102334811|NCT03323866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102334812|NCT03323866|Autonomic Agents|autonomic agents|mesh-ancestor
102334813|NCT03323866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102334814|NCT03323866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334815|NCT03323866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102334816|NCT03323866|Respiratory System Agents|respiratory system agents|mesh-ancestor
102334817|NCT03323866|Glucocorticoids|glucocorticoids|mesh-ancestor
102334818|NCT03323866|Hormones|hormones|mesh-ancestor
102334819|NCT03323866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102334820|NCT03323866|Dermatologic Agents|dermatologic agents|mesh-ancestor
102334821|NCT03323866|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102334822|NCT05688670|Ropivacaine|ropivacaine|mesh-list
102043658|NCT03642600|Folic Acid|folic acid|mesh-list
102334823|NCT05688670|Anesthetics|anesthetics|mesh-ancestor
102334824|NCT05688670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102334825|NCT05688670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334826|NCT05688670|Anesthetics, Local|anesthetics, local|mesh-ancestor
102334827|NCT05688670|Sensory System Agents|sensory system agents|mesh-ancestor
102334828|NCT05688670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102334829|NCT05684848|Resveratrol|resveratrol|mesh-list
102334830|NCT05684848|Antioxidants|antioxidants|mesh-ancestor
102334831|NCT05684848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334832|NCT05684848|Protective Agents|protective agents|mesh-ancestor
102334833|NCT05684848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334834|NCT05684848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102334835|NCT05684848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102334836|NCT03366298|Epinephrine|epinephrine|mesh-list
102334837|NCT03366298|Racepinephrine|racepinephrine|mesh-list
102334838|NCT03366298|Epinephryl borate|epinephryl borate|mesh-list
102334839|NCT03366298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102334840|NCT03366298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102334841|NCT03366298|Adrenergic Agents|adrenergic agents|mesh-ancestor
102334842|NCT03366298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102334843|NCT03366298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334844|NCT03366298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334845|NCT03366298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102334846|NCT03366298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102334847|NCT03366298|Autonomic Agents|autonomic agents|mesh-ancestor
102334848|NCT03366298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102334849|NCT03366298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102334850|NCT03366298|Respiratory System Agents|respiratory system agents|mesh-ancestor
102334851|NCT03366298|Mydriatics|mydriatics|mesh-ancestor
102334852|NCT03366298|Sympathomimetics|sympathomimetics|mesh-ancestor
102334853|NCT03366298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102334854|NCT05688436|Interferons|interferons|mesh-list
102334855|NCT05688436|Interferon-beta|interferon-beta|mesh-list
102334856|NCT05688436|Alemtuzumab|alemtuzumab|mesh-list
102334857|NCT05688436|Glatiramer Acetate|glatiramer acetate|mesh-list
102334858|NCT05688436|Ocrelizumab|ocrelizumab|mesh-list
102334859|NCT05688436|Natalizumab|natalizumab|mesh-list
102334860|NCT05688436|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102334861|NCT05688436|(T,G)-A-L|(t,g)-a-l|mesh-list
102334862|NCT05688436|Siponimod|siponimod|mesh-list
102334863|NCT05688436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102334864|NCT05688436|Antiviral Agents|antiviral agents|mesh-ancestor
102334865|NCT05688436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102334866|NCT05688436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102334867|NCT05688436|Immunologic Factors|immunologic factors|mesh-ancestor
102334868|NCT05688436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334869|NCT05688436|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102334870|NCT05688436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334871|NCT05688436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102334872|NCT05688436|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102334873|NCT05688436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102334874|NCT05688202|Acetaminophen|acetaminophen|mesh-list
102334875|NCT05688202|Lidocaine|lidocaine|mesh-list
102334876|NCT05688202|Prilocaine|prilocaine|mesh-list
102334877|NCT05688202|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
102334878|NCT05688202|Anesthetics, Local|anesthetics, local|mesh-ancestor
102334879|NCT05688202|Anesthetics|anesthetics|mesh-ancestor
102334880|NCT05688202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102334881|NCT05688202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334882|NCT05688202|Sensory System Agents|sensory system agents|mesh-ancestor
102334883|NCT05688202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102334884|NCT05688202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102334885|NCT05688202|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102334886|NCT05688202|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102334887|NCT05688202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102334888|NCT05688202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334889|NCT05688202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102334890|NCT05688202|Analgesics|analgesics|mesh-ancestor
102334891|NCT05688202|Antipyretics|antipyretics|mesh-ancestor
102334892|NCT05688202|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
102334893|NCT05688124|Esomeprazole|esomeprazole|mesh-list
102334894|NCT05688124|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102334895|NCT05688124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102334896|NCT05688124|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102334897|NCT05688124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102334898|NCT05688124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334900|NCT01842620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102334901|NCT01842620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334902|NCT04760704|Antibodies|antibodies|mesh-list
102334903|NCT04760704|Immunologic Factors|immunologic factors|mesh-ancestor
102334904|NCT04760704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334905|NCT01931839|Ivacaftor|ivacaftor|mesh-list
102334906|NCT01931839|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102334907|NCT01931839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102334908|NCT01931839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334909|NCT01842308|Melphalan|melphalan|mesh-list
102334910|NCT01842308|Mechlorethamine|mechlorethamine|mesh-list
102334911|NCT01842308|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102334912|NCT01842308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102334913|NCT01842308|Alkylating Agents|alkylating agents|mesh-ancestor
102334914|NCT01842308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334915|NCT01842308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102334916|NCT01842308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102334917|NCT01842308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102334918|NCT01842308|Immunologic Factors|immunologic factors|mesh-ancestor
102334919|NCT01842308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334920|NCT01931059|Risperidone|risperidone|mesh-list
102334921|NCT01931059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102334922|NCT01931059|Serotonin Agents|serotonin agents|mesh-ancestor
102334923|NCT01931059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102334924|NCT01931059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334925|NCT01931059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334926|NCT01931059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102334927|NCT01931059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102334928|NCT01931059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102334929|NCT01931059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102334930|NCT01931059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102334931|NCT01931059|Dopamine Agents|dopamine agents|mesh-ancestor
102334932|NCT01841762|Macitentan|macitentan|mesh-list
102334933|NCT01841762|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
102334934|NCT01841762|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102334935|NCT01841762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334936|NCT01841762|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
102334937|NCT03301636|Pembrolizumab|pembrolizumab|mesh-list
102334938|NCT03301636|Nivolumab|nivolumab|mesh-list
102334939|NCT03301636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102334940|NCT03301636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102334941|NCT03301636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102334942|NCT03301636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334943|NCT04602494|Varenicline|varenicline|mesh-list
102334944|NCT04602494|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102334945|NCT04602494|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102334946|NCT04602494|Cholinergic Agents|cholinergic agents|mesh-ancestor
102334947|NCT04602494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102334948|NCT04602494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334949|NCT04602494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334950|NCT05640232|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102334951|NCT05640232|Parasympatholytics|parasympatholytics|mesh-ancestor
102334952|NCT05640232|Autonomic Agents|autonomic agents|mesh-ancestor
102334953|NCT05640232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102334954|NCT05640232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334955|NCT05640232|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102334956|NCT05640232|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102334957|NCT05640232|Cholinergic Agents|cholinergic agents|mesh-ancestor
102334958|NCT05640232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102334959|NCT05640232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334960|NCT01970371|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102334961|NCT01970371|Meropenem|meropenem|mesh-list
102334962|NCT01970371|Colistin|colistin|mesh-list
102334963|NCT01970371|Tigecycline|tigecycline|mesh-list
102334964|NCT01970371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102334965|NCT01970371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102334966|NCT01970371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102334967|NCT01970371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334968|NCT04171700|Rucaparib|rucaparib|mesh-list
102334969|NCT04171700|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102334970|NCT04171700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102334971|NCT04171700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334972|NCT04171700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102334974|NCT05604742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102334975|NCT05604742|Immunologic Factors|immunologic factors|mesh-ancestor
102334976|NCT05604742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334977|NCT03350386|Oxaprozin|oxaprozin|mesh-list
102334978|NCT03350386|Dotinurad|dotinurad|mesh-list
102334979|NCT03350386|Uricosuric Agents|uricosuric agents|mesh-ancestor
102334980|NCT03350386|Gout Suppressants|gout suppressants|mesh-ancestor
102334981|NCT03350386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102334982|NCT03350386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102334983|NCT03350386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102334984|NCT03350386|Analgesics|analgesics|mesh-ancestor
102334985|NCT03350386|Sensory System Agents|sensory system agents|mesh-ancestor
102334986|NCT03350386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102334987|NCT03350386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102334988|NCT03350386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102334989|NCT03350386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102334990|NCT03350386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102334991|NCT03350386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102334992|NCT05567458|Luspatercept|luspatercept|mesh-list
102334993|NCT05567458|Hematinics|hematinics|mesh-ancestor
102334994|NCT03344692|Alirocumab|alirocumab|mesh-list
102334995|NCT03344692|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102334996|NCT03344692|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102334997|NCT03344692|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102334998|NCT03344692|Antimetabolites|antimetabolites|mesh-ancestor
102334999|NCT03344692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335000|NCT03344692|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102335001|NCT03344692|Protease Inhibitors|protease inhibitors|mesh-ancestor
102335002|NCT03344692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102335003|NCT03344692|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102335004|NCT05305924|Fulvestrant|fulvestrant|mesh-list
102335005|NCT05305924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102335006|NCT05305924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102335007|NCT05305924|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102335008|NCT05305924|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102335009|NCT05305924|Hormone Antagonists|hormone antagonists|mesh-ancestor
102335010|NCT05305924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102335011|NCT05305924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335012|NCT05548582|Acetaminophen|acetaminophen|mesh-list
102335013|NCT05548582|Ibuprofen|ibuprofen|mesh-list
102335014|NCT05548582|Oxycodone|oxycodone|mesh-list
102335015|NCT05548582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102335016|NCT05548582|Analgesics|analgesics|mesh-ancestor
102335017|NCT05548582|Sensory System Agents|sensory system agents|mesh-ancestor
102335018|NCT05548582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102335019|NCT05548582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335020|NCT05548582|Antipyretics|antipyretics|mesh-ancestor
102335021|NCT05548582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102335022|NCT05548582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102335023|NCT05548582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102335024|NCT05548582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102335025|NCT05548582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102335026|NCT05548582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335027|NCT05548582|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102335028|NCT05548582|Narcotics|narcotics|mesh-ancestor
102335029|NCT05548582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102335030|NCT01839188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102335031|NCT01839188|Immunologic Factors|immunologic factors|mesh-ancestor
102335032|NCT01839188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335033|NCT05223088|Oxaliplatin|oxaliplatin|mesh-list
102335034|NCT05223088|Apatinib|apatinib|mesh-list
102335035|NCT05223088|Tislelizumab|tislelizumab|mesh-list
102335036|NCT05223088|Tegafur|tegafur|mesh-list
102335037|NCT05223088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102335038|NCT05223088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102335039|NCT05223088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102335040|NCT05223088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335041|NCT05223088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102335042|NCT05223088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102335043|NCT05223088|Antimetabolites|antimetabolites|mesh-ancestor
102335044|NCT01838876|Cariprazine|cariprazine|mesh-list
102335045|NCT01838876|Antidepressive Agents|antidepressive agents|mesh-list
102335046|NCT01838876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102335047|NCT01838876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102335048|NCT01838876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102335049|NCT01838876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102335050|NCT01838876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335051|NCT03279250|Prednisone|prednisone|mesh-list
102335052|NCT03279250|Cortisone|cortisone|mesh-list
102335053|NCT03279250|Abiraterone Acetate|abiraterone acetate|mesh-list
102335054|NCT03279250|Hormones|hormones|mesh-list
102335055|NCT03279250|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
102335056|NCT03279250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102335057|NCT03279250|Glucocorticoids|glucocorticoids|mesh-ancestor
102335058|NCT03279250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102335059|NCT03279250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335060|NCT03279250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102335061|NCT03279250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102335062|NCT03279250|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102335063|NCT03279250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102335064|NCT03279250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335065|NCT03279250|Hormone Antagonists|hormone antagonists|mesh-ancestor
102335066|NCT03279250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102335067|NCT01838642|Ponatinib|ponatinib|mesh-list
102335068|NCT01838642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102335069|NCT01838642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102335070|NCT01838642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102335071|NCT01838642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335072|NCT05181046|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102335073|NCT05181046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102335074|NCT01813058|Tranexamic Acid|tranexamic acid|mesh-list
102335075|NCT01813058|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102335076|NCT01813058|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102335077|NCT01813058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335078|NCT01813058|Hemostatics|hemostatics|mesh-ancestor
102335079|NCT01813058|Coagulants|coagulants|mesh-ancestor
102335080|NCT05491330|Ritonavir|ritonavir|mesh-list
101442434|NCT00171002|Valsartan|valsartan|mesh-list
102335081|NCT05491330|Nirmatrelvir|nirmatrelvir|mesh-list
102335082|NCT05491330|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
102335083|NCT05491330|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102335084|NCT05491330|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102335085|NCT05491330|Protease Inhibitors|protease inhibitors|mesh-ancestor
102335086|NCT05491330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102335087|NCT05491330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335088|NCT05491330|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102335089|NCT05491330|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102335090|NCT05491330|Antiviral Agents|antiviral agents|mesh-ancestor
102335091|NCT05491330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102335092|NCT05491330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102335093|NCT05491330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102335094|NCT01811732|Vancomycin|vancomycin|mesh-list
102335095|NCT01811732|Aztreonam|aztreonam|mesh-list
102335096|NCT01811732|Delafloxacin|delafloxacin|mesh-list
102335097|NCT01811732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102335098|NCT01811732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102335099|NCT05139004|Fludarabine|fludarabine|mesh-list
102335100|NCT05139004|Fludarabine phosphate|fludarabine phosphate|mesh-list
102335102|NCT05139004|Mechlorethamine|mechlorethamine|mesh-list
102335103|NCT05139004|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102335104|NCT05139004|Basiliximab|basiliximab|mesh-list
102335105|NCT05139004|Mitogens|mitogens|mesh-list
102335106|NCT05139004|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
102335107|NCT05139004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102335108|NCT05139004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102335109|NCT05139004|Antimetabolites|antimetabolites|mesh-ancestor
102335110|NCT05139004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335111|NCT05139004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102335112|NCT05139004|Immunologic Factors|immunologic factors|mesh-ancestor
102335113|NCT05139004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335114|NCT05139004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102335115|NCT05139004|Alkylating Agents|alkylating agents|mesh-ancestor
102335116|NCT05139004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102335117|NCT05139004|Mitosis Modulators|mitosis modulators|mesh-ancestor
102335118|NCT05139004|Chelating Agents|chelating agents|mesh-ancestor
102335119|NCT05139004|Sequestering Agents|sequestering agents|mesh-ancestor
102335120|NCT01811186|Oxycodone|oxycodone|mesh-list
102335121|NCT01811186|Naloxone|naloxone|mesh-list
102335122|NCT01811186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101836575|NCT00322348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102335123|NCT01811186|Narcotics|narcotics|mesh-ancestor
102335124|NCT01811186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102335125|NCT01811186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335126|NCT01811186|Analgesics|analgesics|mesh-ancestor
102335127|NCT01811186|Sensory System Agents|sensory system agents|mesh-ancestor
102335128|NCT01811186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102335129|NCT01811186|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102335130|NCT01866098|Naltrexone|naltrexone|mesh-list
102335131|NCT01866098|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102335132|NCT01866098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102335133|NCT01866098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335134|NCT01866098|Sensory System Agents|sensory system agents|mesh-ancestor
102335135|NCT01866098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102335136|NCT04885972|Triamcinolone|triamcinolone|mesh-list
102335137|NCT04885972|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102335138|NCT04885972|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102335139|NCT04885972|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102335140|NCT04885972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102335141|NCT04885972|Glucocorticoids|glucocorticoids|mesh-ancestor
102335142|NCT04885972|Hormones|hormones|mesh-ancestor
102335143|NCT04885972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102335144|NCT04885972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335145|NCT04885972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102335146|NCT04885972|Immunologic Factors|immunologic factors|mesh-ancestor
102335147|NCT04885972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102335148|NCT04885972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335149|NCT04039750|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102335150|NCT04039750|Clindamycin|clindamycin|mesh-list
102335151|NCT04039750|Gentamicins|gentamicins|mesh-list
102335152|NCT04039750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102335153|NCT04039750|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102335154|NCT04039750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102335155|NCT04039750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335156|NCT03985540|Methamphetamine|methamphetamine|mesh-list
102335157|NCT03985540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102335158|NCT03985540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335159|NCT03985540|Sympathomimetics|sympathomimetics|mesh-ancestor
102335160|NCT03985540|Autonomic Agents|autonomic agents|mesh-ancestor
102335161|NCT03985540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102335162|NCT03985540|Dopamine Agents|dopamine agents|mesh-ancestor
102335163|NCT03985540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102335164|NCT03985540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335165|NCT03985540|Adrenergic Agents|adrenergic agents|mesh-ancestor
102335166|NCT03985540|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102335167|NCT03985540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102335168|NCT03985540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102335169|NCT03985540|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102335170|NCT04858360|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
102335171|NCT04858360|Anesthetics, Local|anesthetics, local|mesh-ancestor
102335172|NCT04858360|Anesthetics|anesthetics|mesh-ancestor
102335173|NCT04858360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102335174|NCT04858360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335175|NCT04858360|Sensory System Agents|sensory system agents|mesh-ancestor
102335176|NCT04858360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102335177|NCT04858360|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
102335178|NCT01865552|Etanercept|etanercept|mesh-list
102335179|NCT01865552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102335180|NCT01865552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102335181|NCT01865552|Analgesics|analgesics|mesh-ancestor
102335182|NCT01865552|Sensory System Agents|sensory system agents|mesh-ancestor
102335183|NCT01865552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102335184|NCT01865552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335185|NCT01865552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102335186|NCT01865552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102335187|NCT01865552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102335188|NCT01865552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102335189|NCT01865552|Immunologic Factors|immunologic factors|mesh-ancestor
102335190|NCT01809314|Epoetin Alfa|epoetin alfa|mesh-list
102335191|NCT01809314|Hematinics|hematinics|mesh-ancestor
102335192|NCT03943498|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102335193|NCT03943498|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102335194|NCT03943498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335195|NCT03943498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102335196|NCT03943498|Immunologic Factors|immunologic factors|mesh-ancestor
102335197|NCT03943498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335199|NCT05185024|Trace Elements|trace elements|mesh-ancestor
102335200|NCT05185024|Micronutrients|micronutrients|mesh-ancestor
102335201|NCT05185024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335202|NCT01808690|Metformin|metformin|mesh-list
102335203|NCT01808690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102335204|NCT01808690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335205|NCT04583618|Vaccines|vaccines|mesh-list
102335206|NCT04583618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102335207|NCT04583618|Immunologic Factors|immunologic factors|mesh-ancestor
102335208|NCT04583618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335209|NCT04413734|Cisplatin|cisplatin|mesh-list
102335210|NCT04413734|Gemcitabine|gemcitabine|mesh-list
102335211|NCT04413734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102335212|NCT04413734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102335213|NCT04413734|Antimetabolites|antimetabolites|mesh-ancestor
102335214|NCT04413734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335215|NCT03229798|Sumatriptan|sumatriptan|mesh-list
102335216|NCT03229798|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102335217|NCT03229798|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102335218|NCT03229798|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102335219|NCT03229798|Serotonin Agents|serotonin agents|mesh-ancestor
102335220|NCT03229798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102335221|NCT03229798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335222|NCT03229798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335223|NCT04805944|Dolutegravir|dolutegravir|mesh-list
102335224|NCT04805944|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102335225|NCT04805944|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102335226|NCT04805944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102335227|NCT04805944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335228|NCT04805944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102335229|NCT04805944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102335230|NCT04805944|Antiviral Agents|antiviral agents|mesh-ancestor
102335231|NCT04805944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102335232|NCT03906292|Niacinamide|niacinamide|mesh-list
102335233|NCT03906292|Imatinib Mesylate|imatinib mesylate|mesh-list
102335234|NCT03906292|Dasatinib|dasatinib|mesh-list
102335235|NCT03906292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102335236|NCT03906292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102335237|NCT03906292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102335238|NCT03906292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335239|NCT03906292|Vitamin B Complex|vitamin b complex|mesh-ancestor
102335240|NCT03906292|Vitamins|vitamins|mesh-ancestor
102335241|NCT03906292|Micronutrients|micronutrients|mesh-ancestor
102335242|NCT03906292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335243|NCT03229174|Droxidopa|droxidopa|mesh-list
102335244|NCT03229174|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102335245|NCT03229174|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102335246|NCT03227926|Panitumumab|panitumumab|mesh-list
102335247|NCT03227926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102335248|NCT03227926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102335249|NCT03615742|Budesonide|budesonide|mesh-list
102335250|NCT03615742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102335251|NCT03615742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102335252|NCT03615742|Autonomic Agents|autonomic agents|mesh-ancestor
102335253|NCT03615742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102335254|NCT03615742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335255|NCT03615742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102335256|NCT03615742|Respiratory System Agents|respiratory system agents|mesh-ancestor
102335257|NCT03615742|Glucocorticoids|glucocorticoids|mesh-ancestor
102335258|NCT03615742|Hormones|hormones|mesh-ancestor
102335259|NCT03615742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102335260|NCT01363297|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
102335261|NCT01363297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102335262|NCT01363297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102335263|NCT01363297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102335264|NCT01363297|Immunotoxins|immunotoxins|mesh-ancestor
102335265|NCT01363297|Immunoconjugates|immunoconjugates|mesh-ancestor
102335266|NCT01363297|Immunologic Factors|immunologic factors|mesh-ancestor
102335267|NCT01363297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335268|NCT04756804|Ethanol|ethanol|mesh-list
102335269|NCT04756804|Chlorhexidine|chlorhexidine|mesh-list
102335270|NCT04756804|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102335271|NCT04756804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102335272|NCT04756804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102335273|NCT04756804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102335274|NCT04756804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335275|NCT04756804|Disinfectants|disinfectants|mesh-ancestor
102335276|NCT04756804|Dermatologic Agents|dermatologic agents|mesh-ancestor
102335277|NCT03199924|Diclofenac|diclofenac|mesh-list
102335278|NCT03199924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102335279|NCT03199924|Lidocaine|lidocaine|mesh-list
102335280|NCT03199924|Magnesium Sulfate|magnesium sulfate|mesh-list
102335281|NCT03199924|Anesthetics, Local|anesthetics, local|mesh-ancestor
102335282|NCT03199924|Anesthetics|anesthetics|mesh-ancestor
102335283|NCT03199924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102335284|NCT03199924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335285|NCT03199924|Sensory System Agents|sensory system agents|mesh-ancestor
102335286|NCT03199924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102335287|NCT03199924|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102335288|NCT03199924|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102335289|NCT03199924|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102335290|NCT03199924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102335291|NCT03199924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335292|NCT03199924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102335293|NCT03199924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102335294|NCT03199924|Analgesics|analgesics|mesh-ancestor
102335295|NCT03199924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102335296|NCT03199924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102335297|NCT03199924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102335298|NCT03199924|Anticonvulsants|anticonvulsants|mesh-ancestor
102335299|NCT03199924|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102335300|NCT03199924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102335301|NCT03199924|Tocolytic Agents|tocolytic agents|mesh-ancestor
102335302|NCT03199924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102335303|NCT03199300|Trastuzumab|trastuzumab|mesh-list
102335304|NCT03199300|Bleomycin|bleomycin|mesh-list
102335305|NCT03199300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102335306|NCT03199300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102335307|NCT03199300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102335308|NCT04746430|Dexamethasone|dexamethasone|mesh-list
102335309|NCT04746430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102335310|NCT04746430|Antiemetics|antiemetics|mesh-ancestor
102335311|NCT04746430|Autonomic Agents|autonomic agents|mesh-ancestor
102335312|NCT04746430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102335313|NCT04746430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335314|NCT04746430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102335315|NCT04746430|Glucocorticoids|glucocorticoids|mesh-ancestor
102335316|NCT04746430|Hormones|hormones|mesh-ancestor
102335317|NCT04746430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102335318|NCT04746430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102335319|NCT04746430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102335320|NCT03642028|Suvorexant|suvorexant|mesh-list
102335321|NCT03642028|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102335322|NCT03642028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102335323|NCT03642028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102335324|NCT03642028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335326|NCT03642028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102335327|NCT03642028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335328|NCT04402138|Acalabrutinib|acalabrutinib|mesh-list
102335329|NCT04402138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102335330|NCT03197662|Oxytocin|oxytocin|mesh-list
102335331|NCT03197662|Oxytocics|oxytocics|mesh-ancestor
102335332|NCT03197662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102335333|NCT03197662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335334|NCT03247582|Edoxaban|edoxaban|mesh-list
102335335|NCT03247582|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102335336|NCT03247582|Antithrombins|antithrombins|mesh-ancestor
102335337|NCT03247582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102335338|NCT03247582|Protease Inhibitors|protease inhibitors|mesh-ancestor
102335339|NCT03247582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102335340|NCT03247582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335341|NCT03247582|Anticoagulants|anticoagulants|mesh-ancestor
102335342|NCT01808612|Fluoxetine|fluoxetine|mesh-list
102335343|NCT01808612|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102335344|NCT01808612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102335345|NCT01808612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102335346|NCT01808612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335347|NCT01808612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102335348|NCT01808612|Serotonin Agents|serotonin agents|mesh-ancestor
102335349|NCT01808612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335350|NCT01808612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102335351|NCT01808612|Antidepressive Agents|antidepressive agents|mesh-ancestor
102335352|NCT01808612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102335353|NCT01808612|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102335354|NCT01808612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102335355|NCT01808612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102335356|NCT01908829|Solifenacin Succinate|solifenacin succinate|mesh-list
102335357|NCT01908829|Mirabegron|mirabegron|mesh-list
102335358|NCT01908829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102335359|NCT01908829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102335360|NCT01908829|Cholinergic Agents|cholinergic agents|mesh-ancestor
102335361|NCT01908829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102335362|NCT01908829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335363|NCT01908829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335364|NCT01908829|Urological Agents|urological agents|mesh-ancestor
102335365|NCT01908829|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102335366|NCT01908829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102335367|NCT01908829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102335368|NCT01908829|Adrenergic Agents|adrenergic agents|mesh-ancestor
102335369|NCT01773122|Dapsone|dapsone|mesh-list
102335370|NCT01773122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102335371|NCT01773122|Antimalarials|antimalarials|mesh-ancestor
102335372|NCT01773122|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102335373|NCT01773122|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102335374|NCT01773122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102335375|NCT01773122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102335376|NCT01773122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335377|NCT01773122|Leprostatic Agents|leprostatic agents|mesh-ancestor
102335378|NCT01773122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102335379|NCT01808534|Isophosphamide mustard|isophosphamide mustard|mesh-list
102335380|NCT01808534|Ifosfamide|ifosfamide|mesh-list
102335381|NCT01808534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102335382|NCT01808534|Alkylating Agents|alkylating agents|mesh-ancestor
102335383|NCT01808534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335384|NCT01808534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102335385|NCT03221140|Anti-Infective Agents|anti-infective agents|mesh-list
102335386|NCT03221140|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102335387|NCT03218800|Ertapenem|ertapenem|mesh-list
102335388|NCT03218800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102335389|NCT03218800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102335390|NCT01802216|Minocycline|minocycline|mesh-list
102335391|NCT01802216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102335392|NCT01802216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102335393|NCT03621904|Tamoxifen|tamoxifen|mesh-list
102335394|NCT03621904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-list
102335395|NCT03621904|Antineoplastic Agents|antineoplastic agents|mesh-list
102335396|NCT03621904|Progesterone|progesterone|mesh-list
102335397|NCT03621904|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102335398|NCT03621904|Progestins|progestins|mesh-ancestor
102335399|NCT03621904|Hormones|hormones|mesh-ancestor
102335400|NCT03621904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102335401|NCT03621904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335402|NCT03621904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102335403|NCT03621904|Hormone Antagonists|hormone antagonists|mesh-ancestor
102335404|NCT03621904|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102335405|NCT03621904|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102335406|NCT03621904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102335407|NCT03621904|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102335408|NCT03621904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102335409|NCT03621904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335411|NCT01808144|Lesinurad|lesinurad|mesh-list
102335412|NCT01808144|Gout Suppressants|gout suppressants|mesh-ancestor
102335413|NCT01808144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102335414|NCT01808144|Uricosuric Agents|uricosuric agents|mesh-ancestor
102335415|NCT02085070|Pembrolizumab|pembrolizumab|mesh-list
102335416|NCT02085070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102335417|NCT02085070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102335418|NCT02085070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102335419|NCT02085070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335420|NCT01604343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102335421|NCT01604343|Immunologic Factors|immunologic factors|mesh-ancestor
102335422|NCT01604343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335423|NCT01801436|Bortezomib|bortezomib|mesh-list
102335424|NCT01801436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102335425|NCT01771250|Insulin|insulin|mesh-list
102335426|NCT01771250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102335427|NCT01771250|Insulin Glargine|insulin glargine|mesh-list
102335428|NCT01771250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102335429|NCT01771250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335430|NCT03568708|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102335431|NCT03568708|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102335432|NCT03568708|Estradiol|estradiol|mesh-list
102335433|NCT03568708|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102335434|NCT03568708|Estrogens|estrogens|mesh-list
102335435|NCT03568708|Hormones|hormones|mesh-ancestor
102335436|NCT03568708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102335437|NCT03568708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335438|NCT03568708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102335439|NCT03568708|Contraceptive Agents|contraceptive agents|mesh-ancestor
102335440|NCT03568708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102335441|NCT03568708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102335442|NCT04305106|Bevacizumab|bevacizumab|mesh-list
102335443|NCT04305106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102335444|NCT04305106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102335445|NCT04305106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102335446|NCT04305106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102335447|NCT04305106|Growth Substances|growth substances|mesh-ancestor
102335448|NCT04305106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335449|NCT04305106|Growth Inhibitors|growth inhibitors|mesh-ancestor
102335450|NCT01770392|Rifampin|rifampin|mesh-list
102335451|NCT01770392|Nintedanib|nintedanib|mesh-list
102335452|NCT01770392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102335453|NCT01770392|Antitubercular Agents|antitubercular agents|mesh-ancestor
102335454|NCT01770392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102335455|NCT01770392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102335456|NCT01770392|Leprostatic Agents|leprostatic agents|mesh-ancestor
102335457|NCT01770392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102335458|NCT01770392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102335459|NCT01770392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335460|NCT01770392|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102335461|NCT01770392|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102335462|NCT01770392|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102335463|NCT01770392|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102335464|NCT01770392|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102335465|NCT01770392|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102335466|NCT01770392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102335467|NCT01770392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102335468|NCT01603641|Botulinum Toxins|botulinum toxins|mesh-list
102335469|NCT01603641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102335470|NCT01603641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102335471|NCT01603641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102335472|NCT01603641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102335473|NCT01603641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335475|NCT01603641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102335476|NCT01603641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335477|NCT01603641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102335478|NCT01603641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102335479|NCT03492112|Sofosbuvir|sofosbuvir|mesh-list
102335480|NCT03492112|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102335481|NCT03492112|Velpatasvir|velpatasvir|mesh-list
102335482|NCT03492112|Antiviral Agents|antiviral agents|mesh-ancestor
102335483|NCT03492112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102335484|NCT01556763|Antipsychotic Agents|antipsychotic agents|mesh-list
102335485|NCT01556763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102335486|NCT01556763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102335487|NCT01556763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335488|NCT01556763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102335489|NCT04397458|Dexamethasone|dexamethasone|mesh-list
102335490|NCT04397458|Bupivacaine|bupivacaine|mesh-list
102335491|NCT04397458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102335492|NCT04397458|Antiemetics|antiemetics|mesh-ancestor
102335493|NCT04397458|Autonomic Agents|autonomic agents|mesh-ancestor
102335494|NCT04397458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102335495|NCT04397458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044341|NCT01332929|Bevacizumab|bevacizumab|mesh-list
102335496|NCT04397458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102335497|NCT04397458|Glucocorticoids|glucocorticoids|mesh-ancestor
102335498|NCT04397458|Hormones|hormones|mesh-ancestor
102335499|NCT04397458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102335500|NCT04397458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102335501|NCT04397458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102335502|NCT04397458|Anesthetics, Local|anesthetics, local|mesh-ancestor
102335503|NCT04397458|Anesthetics|anesthetics|mesh-ancestor
102335504|NCT04397458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102335505|NCT04397458|Sensory System Agents|sensory system agents|mesh-ancestor
102335506|NCT04398316|Lidocaine|lidocaine|mesh-list
102335507|NCT04398316|Hydromorphone|hydromorphone|mesh-list
102335508|NCT04398316|Anesthetics, Local|anesthetics, local|mesh-ancestor
102335509|NCT04398316|Anesthetics|anesthetics|mesh-ancestor
102335510|NCT04398316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102335511|NCT04398316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335512|NCT04398316|Sensory System Agents|sensory system agents|mesh-ancestor
102335513|NCT04398316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102335514|NCT04398316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102335515|NCT04398316|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102335516|NCT04398316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102335517|NCT04398316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102335518|NCT04398316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335519|NCT04398316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102335520|NCT04398316|Narcotics|narcotics|mesh-ancestor
102335521|NCT04398316|Analgesics|analgesics|mesh-ancestor
102335522|NCT01576575|Rifampin|rifampin|mesh-list
102335523|NCT01576575|Ketoconazole|ketoconazole|mesh-list
102335524|NCT01576575|Buprenorphine|buprenorphine|mesh-list
102335525|NCT01576575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102335526|NCT01576575|Narcotics|narcotics|mesh-ancestor
102335527|NCT01576575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102335528|NCT01576575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335529|NCT01576575|Analgesics|analgesics|mesh-ancestor
102335530|NCT01576575|Sensory System Agents|sensory system agents|mesh-ancestor
102335531|NCT01576575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102335532|NCT01576575|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102335533|NCT01576575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102335534|NCT01576575|Antitubercular Agents|antitubercular agents|mesh-ancestor
102335535|NCT01576575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102335536|NCT01576575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102335537|NCT01576575|Leprostatic Agents|leprostatic agents|mesh-ancestor
102335538|NCT01576575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102335539|NCT01576575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102335540|NCT01576575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335541|NCT01576575|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102335542|NCT01576575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102335543|NCT01576575|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102335544|NCT01576575|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102335545|NCT01576575|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102335546|NCT01576575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102335547|NCT01576575|Antifungal Agents|antifungal agents|mesh-ancestor
102335548|NCT01576575|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102335549|NCT01576575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102335550|NCT01576575|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102335551|NCT01576575|Hormone Antagonists|hormone antagonists|mesh-ancestor
102335552|NCT01576575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102335553|NCT01576575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102335554|NCT05051566|Esomeprazole|esomeprazole|mesh-list
102335555|NCT05051566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102335556|NCT05051566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102335557|NCT05051566|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102335558|NCT05051566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102335559|NCT05051566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335560|NCT01576341|Epoetin Alfa|epoetin alfa|mesh-list
102335561|NCT01576341|Hematinics|hematinics|mesh-ancestor
102335562|NCT04226248|Rivastigmine|rivastigmine|mesh-list
102335563|NCT04226248|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102335564|NCT04226248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102335565|NCT04226248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335566|NCT04226248|Cholinergic Agents|cholinergic agents|mesh-ancestor
102335567|NCT04226248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102335568|NCT04226248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335569|NCT04226248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102335570|NCT04226248|Protective Agents|protective agents|mesh-ancestor
102335571|NCT04398004|Clarithromycin|clarithromycin|mesh-list
102335572|NCT04398004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102335573|NCT04398004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102335574|NCT04398004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102335575|NCT04398004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102335576|NCT04398004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335577|NCT04398004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102335578|NCT04398004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102335579|NCT01687413|Cisplatin|cisplatin|mesh-list
102335580|NCT01687413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102335581|NCT01555671|Meperidine|meperidine|mesh-list
102335582|NCT01555671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102335583|NCT01555671|Narcotics|narcotics|mesh-ancestor
102335584|NCT01555671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102335585|NCT01555671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335586|NCT01555671|Analgesics|analgesics|mesh-ancestor
102335587|NCT01555671|Sensory System Agents|sensory system agents|mesh-ancestor
102335588|NCT01555671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102335589|NCT01555671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102335590|NCT03226756|Nivolumab|nivolumab|mesh-list
102335591|NCT03226756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102335592|NCT03226756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102335593|NCT03226756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102335594|NCT03226756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335595|NCT01807598|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102335596|NCT01807598|Immunoconjugates|immunoconjugates|mesh-list
102335597|NCT01807598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102335598|NCT01807598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102335599|NCT01807598|Immunotoxins|immunotoxins|mesh-ancestor
102335600|NCT01807598|Immunologic Factors|immunologic factors|mesh-ancestor
102335601|NCT01807598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335602|NCT01801280|Mycophenolic Acid|mycophenolic acid|mesh-list
102335603|NCT01801280|Pantoprazole|pantoprazole|mesh-list
102335604|NCT01801280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102335605|NCT01801280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102335606|NCT01801280|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102335607|NCT01801280|Antitubercular Agents|antitubercular agents|mesh-ancestor
102335608|NCT01801280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102335609|NCT01801280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102335610|NCT01801280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102335611|NCT01801280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335612|NCT01801280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102335613|NCT01801280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102335614|NCT01801280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102335615|NCT01769456|Tenofovir|tenofovir|mesh-list
102335616|NCT01769456|Emtricitabine|emtricitabine|mesh-list
102335617|NCT01769456|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102335618|NCT01769456|Antiviral Agents|antiviral agents|mesh-ancestor
102335619|NCT01769456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102335620|NCT01769456|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102335621|NCT01769456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102335623|NCT01769456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335624|NCT01769456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102335625|NCT01769456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102335626|NCT01769378|Glimepiride|glimepiride|mesh-list
102335627|NCT01769378|Dulaglutide|dulaglutide|mesh-list
102335628|NCT01769378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102335629|NCT01769378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102335630|NCT01769378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335631|NCT01769378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102335632|NCT01769378|Immunologic Factors|immunologic factors|mesh-ancestor
102335633|NCT01807520|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102335634|NCT01807520|Immunologic Factors|immunologic factors|mesh-ancestor
102335635|NCT01807520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335636|NCT01555125|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102335637|NCT01555125|Immunologic Factors|immunologic factors|mesh-ancestor
102335638|NCT01555125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335639|NCT01768286|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102335640|NCT01768286|Ledipasvir|ledipasvir|mesh-list
102335641|NCT01768286|Antiviral Agents|antiviral agents|mesh-ancestor
102335642|NCT01768286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102044485|NCT03564704|Cytarabine|cytarabine|mesh-list
102335643|NCT01800968|Liraglutide|liraglutide|mesh-list
102335644|NCT01800968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102335645|NCT01800968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335646|NCT01800968|Incretins|incretins|mesh-ancestor
102335647|NCT01800968|Hormones|hormones|mesh-ancestor
102335648|NCT01800968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102335649|NCT01687257|Sofosbuvir|sofosbuvir|mesh-list
102335650|NCT01687257|Antiviral Agents|antiviral agents|mesh-ancestor
102335651|NCT01687257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102335652|NCT01806740|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
102335653|NCT01806740|Chelating Agents|chelating agents|mesh-ancestor
102335654|NCT01806740|Sequestering Agents|sequestering agents|mesh-ancestor
102335655|NCT01806740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335656|NCT01687101|Menthol|menthol|mesh-list
102335657|NCT01687101|Antipruritics|antipruritics|mesh-ancestor
102335658|NCT01687101|Dermatologic Agents|dermatologic agents|mesh-ancestor
102335659|NCT01968967|Bococizumab|bococizumab|mesh-list
102335660|NCT01968967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102335661|NCT01968967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102335662|NCT01968967|Antimetabolites|antimetabolites|mesh-ancestor
102335663|NCT01968967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335664|NCT01968967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102335665|NCT01806662|Ustekinumab|ustekinumab|mesh-list
102335666|NCT01806662|Dermatologic Agents|dermatologic agents|mesh-ancestor
102335667|NCT01930045|Raltegravir Potassium|raltegravir potassium|mesh-list
102335668|NCT01930045|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
102335669|NCT01930045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102335670|NCT01930045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102335671|NCT01930045|Antiviral Agents|antiviral agents|mesh-ancestor
102335672|NCT01930045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102335673|NCT01930045|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102335674|NCT01930045|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102335675|NCT01930045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102335676|NCT01930045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335677|NCT01930045|Antacids|antacids|mesh-ancestor
102335678|NCT01930045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102335679|NCT04631263|Hyaluronic Acid|hyaluronic acid|mesh-list
102335680|NCT04631263|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102335681|NCT04631263|Immunologic Factors|immunologic factors|mesh-ancestor
102335682|NCT04631263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335683|NCT04631263|Viscosupplements|viscosupplements|mesh-ancestor
102335684|NCT04631263|Protective Agents|protective agents|mesh-ancestor
102335685|NCT01929343|Lidocaine|lidocaine|mesh-list
102335686|NCT01929343|Anesthetics, Local|anesthetics, local|mesh-ancestor
102335687|NCT01929343|Anesthetics|anesthetics|mesh-ancestor
102335688|NCT01929343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102335689|NCT01929343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335690|NCT01929343|Sensory System Agents|sensory system agents|mesh-ancestor
102335691|NCT01929343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102335692|NCT01929343|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102335693|NCT01929343|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102335694|NCT01929343|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102335695|NCT01929343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102335696|NCT01929343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335697|NCT01806584|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
102335698|NCT01806584|Hemostatics|hemostatics|mesh-ancestor
102335699|NCT01806584|Coagulants|coagulants|mesh-ancestor
102335700|NCT01798706|Lixisenatide|lixisenatide|mesh-list
102335701|NCT01798706|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102335702|NCT01798706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335703|NCT01767194|Sirolimus|sirolimus|mesh-list
102335704|NCT01767194|Irinotecan|irinotecan|mesh-list
102335705|NCT01767194|Camptothecin|camptothecin|mesh-list
102335706|NCT01767194|Temozolomide|temozolomide|mesh-list
102335707|NCT01767194|Temsirolimus|temsirolimus|mesh-list
102335708|NCT01767194|Dinutuximab|dinutuximab|mesh-list
102335709|NCT01767194|MTOR Inhibitors|mtor inhibitors|mesh-list
102335710|NCT01767194|Sargramostim|sargramostim|mesh-list
101442488|NCT05349448|Triamcinolone|triamcinolone|mesh-list
102335711|NCT01767194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102335712|NCT01767194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102335713|NCT01767194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102335714|NCT01767194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335715|NCT01767194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102335716|NCT01767194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102335717|NCT01767194|Alkylating Agents|alkylating agents|mesh-ancestor
102335718|NCT01767194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102335719|NCT01767194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102335720|NCT01767194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102335721|NCT01767194|Antifungal Agents|antifungal agents|mesh-ancestor
102335722|NCT01767194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102335723|NCT01767194|Immunologic Factors|immunologic factors|mesh-ancestor
102335724|NCT01767194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335725|NCT01767194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102335726|NCT01767194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102335727|NCT01575873|Denosumab|denosumab|mesh-list
102335728|NCT01575873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102335729|NCT01575873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335730|NCT04276636|Calcium Carbonate|calcium carbonate|mesh-list
102335731|NCT04276636|Antacids|antacids|mesh-ancestor
102335732|NCT04276636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335733|NCT04276636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102335734|NCT00002644|Tamoxifen|tamoxifen|mesh-list
102335735|NCT00002644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102335736|NCT00002644|Hormone Antagonists|hormone antagonists|mesh-ancestor
102335737|NCT00002644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102335738|NCT00002644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335739|NCT00002644|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102335740|NCT00002644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102335741|NCT00002644|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102335742|NCT00002644|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102335743|NCT00002644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102335744|NCT01575561|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102335745|NCT01575561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102335746|NCT01575561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102335747|NCT01575561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102335748|NCT01575561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335749|NCT01575561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102335750|NCT01575561|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102335751|NCT01575561|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102335752|NCT01575561|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102335753|NCT01575561|Adrenergic Agents|adrenergic agents|mesh-ancestor
102335754|NCT01575561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102335755|NCT01575561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335756|NCT01575561|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102335757|NCT01575561|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102335758|NCT01575561|Serotonin Agents|serotonin agents|mesh-ancestor
102335759|NCT01575561|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102335760|NCT01575561|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102335761|NCT01575561|Dopamine Agents|dopamine agents|mesh-ancestor
102335762|NCT03021460|Pembrolizumab|pembrolizumab|mesh-list
102335763|NCT03021460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102335764|NCT03021460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102335765|NCT03021460|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102335766|NCT03021460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335767|NCT04397770|Temozolomide|temozolomide|mesh-list
102335769|NCT04397770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102335770|NCT04397770|Alkylating Agents|alkylating agents|mesh-ancestor
102335771|NCT04397770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335772|NCT04397770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102335773|NCT04397770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102335774|NCT04397770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102335775|NCT03082846|Temozolomide|temozolomide|mesh-list
102335776|NCT03082846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102335777|NCT03082846|Alkylating Agents|alkylating agents|mesh-ancestor
102335778|NCT03082846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335779|NCT03082846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102335780|NCT01609790|Bevacizumab|bevacizumab|mesh-list
102335781|NCT01609790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102335782|NCT01609790|Trebananib|trebananib|mesh-list
102335783|NCT01609790|Endothelial Growth Factors|endothelial growth factors|mesh-list
102335784|NCT01609790|Antibodies|antibodies|mesh-list
102335785|NCT01609790|Immunoglobulins|immunoglobulins|mesh-list
102335786|NCT01609790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102335787|NCT01609790|Immunoglobulin G|immunoglobulin g|mesh-list
102335788|NCT01609790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102335789|NCT01609790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102335790|NCT01609790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102335791|NCT01609790|Growth Substances|growth substances|mesh-ancestor
102335792|NCT01609790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335794|NCT01609790|Immunologic Factors|immunologic factors|mesh-ancestor
102335795|NCT01767116|Ribavirin|ribavirin|mesh-list
102335796|NCT01767116|Antimetabolites|antimetabolites|mesh-ancestor
102335797|NCT01767116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335798|NCT01767116|Antiviral Agents|antiviral agents|mesh-ancestor
102335799|NCT01767116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102335800|NCT01574703|Bupropion|bupropion|mesh-list
102335801|NCT01574703|Nicotine|nicotine|mesh-list
102335802|NCT01574703|Varenicline|varenicline|mesh-list
102335803|NCT01574703|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102335804|NCT01574703|Autonomic Agents|autonomic agents|mesh-ancestor
102335805|NCT01574703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102335806|NCT01574703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335807|NCT01574703|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102335808|NCT01574703|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102335809|NCT01574703|Cholinergic Agents|cholinergic agents|mesh-ancestor
102335810|NCT01574703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102335811|NCT01574703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335812|NCT01574703|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102335813|NCT01574703|Antidepressive Agents|antidepressive agents|mesh-ancestor
102335814|NCT01574703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102335815|NCT01574703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102335816|NCT01574703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102335817|NCT01574703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102335818|NCT01574703|Dopamine Agents|dopamine agents|mesh-ancestor
102335819|NCT01574703|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102335820|NCT01574703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102335821|NCT01574703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102335822|NCT01686633|Fluticasone|fluticasone|mesh-list
102335823|NCT01686633|Xhance|xhance|mesh-list
102335824|NCT01686633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102335825|NCT01686633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102335826|NCT01686633|Autonomic Agents|autonomic agents|mesh-ancestor
102335827|NCT01686633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102335828|NCT01686633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335829|NCT01686633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102335830|NCT01686633|Respiratory System Agents|respiratory system agents|mesh-ancestor
102335831|NCT01686633|Dermatologic Agents|dermatologic agents|mesh-ancestor
102335832|NCT01686633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102335833|NCT03180034|Vaccines|vaccines|mesh-list
102335834|NCT03180034|Immunologic Factors|immunologic factors|mesh-ancestor
102335835|NCT03180034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335836|NCT03141424|Fluticasone|fluticasone|mesh-list
102335837|NCT03141424|Mometasone Furoate|mometasone furoate|mesh-list
102335838|NCT03141424|Ciclesonide|ciclesonide|mesh-list
102335839|NCT03141424|Budesonide|budesonide|mesh-list
102335840|NCT03141424|Beclomethasone|beclomethasone|mesh-list
102335841|NCT03141424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102335842|NCT03141424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102335843|NCT03141424|Autonomic Agents|autonomic agents|mesh-ancestor
102335844|NCT03141424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102335845|NCT03141424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335847|NCT03141424|Respiratory System Agents|respiratory system agents|mesh-ancestor
102335848|NCT03141424|Dermatologic Agents|dermatologic agents|mesh-ancestor
102335849|NCT03141424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102335850|NCT03141424|Glucocorticoids|glucocorticoids|mesh-ancestor
102335851|NCT03141424|Hormones|hormones|mesh-ancestor
102335852|NCT03141424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102335853|NCT03614494|Piroxicam|piroxicam|mesh-list
102335854|NCT03614494|Levonorgestrel|levonorgestrel|mesh-list
102335855|NCT03614494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102335856|NCT03614494|Contraceptive Agents|contraceptive agents|mesh-ancestor
102335857|NCT03614494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102335858|NCT03614494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335859|NCT03614494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102335860|NCT03614494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102335861|NCT03614494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102335862|NCT03614494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102335863|NCT03614494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102335864|NCT03614494|Analgesics|analgesics|mesh-ancestor
102335865|NCT03614494|Sensory System Agents|sensory system agents|mesh-ancestor
102335866|NCT03614494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102335867|NCT03614494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102335868|NCT03614494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102335869|NCT03614494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102335870|NCT03614494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102335871|NCT03614494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335872|NCT03028155|Oxaliplatin|oxaliplatin|mesh-list
102335873|NCT03028155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102335874|NCT05245708|Oxytocin|oxytocin|mesh-list
102335875|NCT05245708|Oxytocics|oxytocics|mesh-ancestor
102335876|NCT05245708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102335877|NCT05245708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335878|NCT01922596|Ropivacaine|ropivacaine|mesh-list
102335879|NCT01922596|Anesthetics, Local|anesthetics, local|mesh-ancestor
102335880|NCT01922596|Anesthetics|anesthetics|mesh-ancestor
102335881|NCT01922596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102335882|NCT01922596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335883|NCT01922596|Sensory System Agents|sensory system agents|mesh-ancestor
102335884|NCT01922596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102335885|NCT01573767|Fluticasone|fluticasone|mesh-list
102335886|NCT01573767|Xhance|xhance|mesh-list
102335887|NCT01573767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102335888|NCT01573767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102335889|NCT01573767|Autonomic Agents|autonomic agents|mesh-ancestor
102335890|NCT01573767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102335891|NCT01573767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335892|NCT01573767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102335893|NCT01573767|Respiratory System Agents|respiratory system agents|mesh-ancestor
102335894|NCT01573767|Dermatologic Agents|dermatologic agents|mesh-ancestor
102335895|NCT01573767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102335896|NCT03133546|Bevacizumab|bevacizumab|mesh-list
102335897|NCT03133546|Osimertinib|osimertinib|mesh-list
102335898|NCT03133546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102335899|NCT03133546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102335900|NCT03133546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102335901|NCT03133546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102335902|NCT03133546|Growth Substances|growth substances|mesh-ancestor
102335903|NCT03133546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335904|NCT03133546|Growth Inhibitors|growth inhibitors|mesh-ancestor
102335905|NCT03133546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102335906|NCT03133546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102335907|NCT03133546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102335908|NCT01551303|Oxytocin|oxytocin|mesh-list
102335909|NCT01551303|Oxytocics|oxytocics|mesh-ancestor
102335910|NCT01551303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102335911|NCT01551303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335912|NCT01685073|Zolpidem|zolpidem|mesh-list
102335913|NCT01685073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102335914|NCT01685073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102335915|NCT01685073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102335916|NCT01685073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335917|NCT01685073|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102335918|NCT01685073|GABA Agonists|gaba agonists|mesh-ancestor
102335919|NCT01685073|GABA Agents|gaba agents|mesh-ancestor
102335946|NCT05929937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102335948|NCT05929794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102335949|NCT05929794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102335950|NCT05929794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102335951|NCT05929794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101630154|NCT00616785|Irinotecan|irinotecan|mesh-list
102335980|NCT05929755|Methylprednisolone|methylprednisolone|mesh-list
102335981|NCT05929755|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102335982|NCT05929755|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102335983|NCT05929755|Prednisolone|prednisolone|mesh-list
102335984|NCT05929755|Prednisolone acetate|prednisolone acetate|mesh-list
102335985|NCT05929755|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102335986|NCT05929755|Prednisolone phosphate|prednisolone phosphate|mesh-list
102335987|NCT05929755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102335988|NCT05929755|Antiemetics|antiemetics|mesh-ancestor
102335989|NCT05929755|Autonomic Agents|autonomic agents|mesh-ancestor
102335990|NCT05929755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102335991|NCT05929755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102335992|NCT05929755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102335993|NCT05929755|Glucocorticoids|glucocorticoids|mesh-ancestor
102335994|NCT05929755|Hormones|hormones|mesh-ancestor
102335995|NCT05929755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102335997|NCT05929755|Protective Agents|protective agents|mesh-ancestor
102335998|NCT05929755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102335999|NCT05929755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336000|NCT05929664|Cemiplimab|cemiplimab|mesh-list
102336001|NCT05929664|Immunoglobulins|immunoglobulins|mesh-list
102336002|NCT05929664|Immunoglobulin G|immunoglobulin g|mesh-list
102336003|NCT05929664|Immunologic Factors|immunologic factors|mesh-ancestor
102336004|NCT05929664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336005|NCT05929664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102336006|NCT05929664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336007|NCT05929456|Cetuximab|cetuximab|mesh-list
102336008|NCT05929456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102336009|NCT05929456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336010|NCT05929339|Oxytocin|oxytocin|mesh-list
102336011|NCT05929339|Oxytocics|oxytocics|mesh-ancestor
102336012|NCT05929339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102336013|NCT05929339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336014|NCT05928988|Itraconazole|itraconazole|mesh-list
102336015|NCT05928988|Antifungal Agents|antifungal agents|mesh-ancestor
102336016|NCT05928988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102336017|NCT05928988|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102044863|NCT01346917|Lidocaine|lidocaine|mesh-list
102336018|NCT05928988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102336019|NCT05928988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102336020|NCT05928988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336021|NCT05928988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102336022|NCT05928988|Hormone Antagonists|hormone antagonists|mesh-ancestor
102336023|NCT05928988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102336024|NCT05928988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336025|NCT05928988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102336026|NCT05928780|Fluzoparib|fluzoparib|mesh-list
102336027|NCT05928780|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102336028|NCT05928780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102336029|NCT05928780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336030|NCT05928780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336031|NCT05928741|Vitamin D|vitamin d|mesh-list
102336032|NCT05928741|Cholecalciferol|cholecalciferol|mesh-list
102336033|NCT05928741|Vitamins|vitamins|mesh-ancestor
102336034|NCT05928741|Micronutrients|micronutrients|mesh-ancestor
102336035|NCT05928741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336036|NCT05928741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102336037|NCT05928741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102336038|NCT05928728|Colchicine|colchicine|mesh-list
102336039|NCT05928728|Gout Suppressants|gout suppressants|mesh-ancestor
102336040|NCT05928728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102336041|NCT05928728|Tubulin Modulators|tubulin modulators|mesh-ancestor
102336042|NCT05928728|Antimitotic Agents|antimitotic agents|mesh-ancestor
102336043|NCT05928728|Mitosis Modulators|mitosis modulators|mesh-ancestor
102336044|NCT05928728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336045|NCT05928728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336046|NCT05928689|Propranolol|propranolol|mesh-list
102336047|NCT05928689|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102336048|NCT05928689|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101442508|NCT05349448|Hormones|hormones|mesh-ancestor
102336049|NCT05928689|Adrenergic Agents|adrenergic agents|mesh-ancestor
102336050|NCT05928689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102336051|NCT05928689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336052|NCT05928689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336053|NCT05928689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102336054|NCT05928689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102336055|NCT05928689|Vasodilator Agents|vasodilator agents|mesh-ancestor
102336056|NCT05928546|Quercetin|quercetin|mesh-list
102336057|NCT05928546|Antioxidants|antioxidants|mesh-ancestor
102336058|NCT05928546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336059|NCT05928546|Protective Agents|protective agents|mesh-ancestor
102336060|NCT05928546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336061|NCT05928039|Adalimumab|adalimumab|mesh-list
102336062|NCT05928039|Infliximab|infliximab|mesh-list
102336063|NCT05928039|Interleukin-12|interleukin-12|mesh-list
102336064|NCT05928039|Interleukin-23|interleukin-23|mesh-list
102336065|NCT05928039|Ustekinumab|ustekinumab|mesh-list
102336066|NCT05928039|Vedolizumab|vedolizumab|mesh-list
102336067|NCT05928039|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102336068|NCT05928039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102336069|NCT05928039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102336070|NCT05928039|Dermatologic Agents|dermatologic agents|mesh-ancestor
102336071|NCT05928039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102336072|NCT05928039|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102336073|NCT05928039|Immunologic Factors|immunologic factors|mesh-ancestor
102336074|NCT05928039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336075|NCT05928039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102336076|NCT05928039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102336077|NCT05928039|Growth Substances|growth substances|mesh-ancestor
102336078|NCT05928039|Growth Inhibitors|growth inhibitors|mesh-ancestor
102336079|NCT05928039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336080|NCT05928000|Tenofovir|tenofovir|mesh-list
102336081|NCT05928000|Entecavir|entecavir|mesh-list
102336082|NCT05928000|Antiviral Agents|antiviral agents|mesh-ancestor
102336083|NCT05928000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102336084|NCT05928000|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102336085|NCT05928000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102336086|NCT05928000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102336087|NCT05928000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336088|NCT05928000|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102336089|NCT05928000|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102336090|NCT05927714|Hemostatics|hemostatics|mesh-list
102336091|NCT05927714|Coagulants|coagulants|mesh-ancestor
102336092|NCT05927233|Methylprednisolone|methylprednisolone|mesh-list
102336093|NCT05927233|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102336094|NCT05927233|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102336095|NCT05927233|Prednisolone|prednisolone|mesh-list
102336096|NCT05927233|Prednisolone acetate|prednisolone acetate|mesh-list
102336097|NCT05927233|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102336098|NCT05927233|Prednisolone phosphate|prednisolone phosphate|mesh-list
102336099|NCT05927233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102336100|NCT05927233|Antiemetics|antiemetics|mesh-ancestor
102336101|NCT05927233|Autonomic Agents|autonomic agents|mesh-ancestor
102336102|NCT05927233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102336103|NCT05927233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336104|NCT05927233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102336105|NCT05927233|Glucocorticoids|glucocorticoids|mesh-ancestor
102336106|NCT05927233|Hormones|hormones|mesh-ancestor
102336107|NCT05927233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102336108|NCT05927233|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102336109|NCT05927233|Protective Agents|protective agents|mesh-ancestor
102336110|NCT05927233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102336111|NCT05927233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336126|NCT05887609|Olaparib|olaparib|mesh-list
102336127|NCT05887609|Maytansine|maytansine|mesh-list
102336128|NCT05887609|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
102336129|NCT05887609|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102336130|NCT05887609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102336131|NCT05887609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336132|NCT05887609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336133|NCT05887609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102336134|NCT05887609|Tubulin Modulators|tubulin modulators|mesh-ancestor
102336135|NCT05887609|Antimitotic Agents|antimitotic agents|mesh-ancestor
102336136|NCT05887609|Mitosis Modulators|mitosis modulators|mesh-ancestor
102336137|NCT05887609|Immunoconjugates|immunoconjugates|mesh-ancestor
102336138|NCT05887609|Immunologic Factors|immunologic factors|mesh-ancestor
102336139|NCT05887609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336140|NCT05873218|Ephedrine|ephedrine|mesh-list
102336141|NCT05873218|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102336142|NCT05873218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336143|NCT05873218|Sympathomimetics|sympathomimetics|mesh-ancestor
102336144|NCT05873218|Autonomic Agents|autonomic agents|mesh-ancestor
102336145|NCT05873218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102336146|NCT05873218|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102336147|NCT05873218|Adrenergic Agents|adrenergic agents|mesh-ancestor
102336148|NCT05873218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102336149|NCT05873218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336150|NCT05872204|Letrozole|letrozole|mesh-list
102336151|NCT05872204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336152|NCT05872204|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102336153|NCT05872204|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102336154|NCT05872204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102336155|NCT05872204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336156|NCT05872204|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102336157|NCT05872204|Hormone Antagonists|hormone antagonists|mesh-ancestor
102336158|NCT05872204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102336159|NCT05872204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336160|NCT05864625|Propofol|propofol|mesh-list
102336161|NCT05864625|Sevoflurane|sevoflurane|mesh-list
102336162|NCT05864625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102336163|NCT05864625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102336164|NCT05864625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336165|NCT05864625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102336166|NCT05864625|Anesthetics, General|anesthetics, general|mesh-ancestor
102336167|NCT05864625|Anesthetics|anesthetics|mesh-ancestor
102336168|NCT05864625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102336169|NCT05864625|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102336171|NCT05839366|Propofol|propofol|mesh-list
102336172|NCT05839366|Esketamine|esketamine|mesh-list
102336173|NCT05839366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102336174|NCT05839366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102336175|NCT05839366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336176|NCT05839366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102336177|NCT05839366|Anesthetics, General|anesthetics, general|mesh-ancestor
102336178|NCT05839366|Anesthetics|anesthetics|mesh-ancestor
102336179|NCT05839366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102336180|NCT05839366|Narcotics|narcotics|mesh-ancestor
102336181|NCT05839366|Analgesics|analgesics|mesh-ancestor
102336182|NCT05839366|Sensory System Agents|sensory system agents|mesh-ancestor
102336183|NCT05839366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102336184|NCT05839366|Antidepressive Agents|antidepressive agents|mesh-ancestor
102336185|NCT05839366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102336186|NCT05839158|Mupirocin|mupirocin|mesh-list
102336187|NCT05839158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102336188|NCT05839158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102336189|NCT05839158|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102336190|NCT05839158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102336191|NCT05839158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336192|NCT05827549|Blinatumomab|blinatumomab|mesh-list
102336193|NCT05827549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336194|NCT05820685|Dronabinol|dronabinol|mesh-list
102336195|NCT05820685|Hallucinogens|hallucinogens|mesh-ancestor
102336196|NCT05820685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336197|NCT05820685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102336198|NCT05820685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102336199|NCT05820685|Analgesics|analgesics|mesh-ancestor
102336200|NCT05820685|Sensory System Agents|sensory system agents|mesh-ancestor
102336201|NCT05820685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102336202|NCT05820685|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102336203|NCT05820685|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102336204|NCT05820685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102336205|NCT05820685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336206|NCT05820685|Hormones|hormones|mesh-ancestor
102336207|NCT05820685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102336208|NCT05754710|Tofacitinib|tofacitinib|mesh-list
102336209|NCT05754710|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102336210|NCT05754710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102336211|NCT05754710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102336212|NCT05754710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336213|NCT05704933|Nivolumab|nivolumab|mesh-list
102336214|NCT05704933|Ipilimumab|ipilimumab|mesh-list
102336215|NCT05704933|Relatlimab|relatlimab|mesh-list
102336216|NCT05704933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102336217|NCT05704933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336218|NCT05704933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102336219|NCT05704933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336220|NCT05694364|Cyclophosphamide|cyclophosphamide|mesh-list
102336221|NCT05694364|Fludarabine|fludarabine|mesh-list
102336222|NCT05694364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102336223|NCT05694364|Immunologic Factors|immunologic factors|mesh-ancestor
102336224|NCT05694364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336225|NCT05694364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102336226|NCT05694364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102336227|NCT05694364|Alkylating Agents|alkylating agents|mesh-ancestor
102336228|NCT05694364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336229|NCT05694364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336230|NCT05694364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102336231|NCT05676476|Antihypertensive Agents|antihypertensive agents|mesh-list
102336232|NCT05660525|Nicotine|nicotine|mesh-list
102336233|NCT05660525|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102336234|NCT05660525|Autonomic Agents|autonomic agents|mesh-ancestor
102336235|NCT05660525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102336236|NCT05660525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336237|NCT05660525|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102336238|NCT05660525|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102336239|NCT05660525|Cholinergic Agents|cholinergic agents|mesh-ancestor
102336240|NCT05660525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102336241|NCT05660525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336242|NCT05648110|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
102336243|NCT05648110|Antiviral Agents|antiviral agents|mesh-ancestor
102045078|NCT01354964|Micronutrients|micronutrients|mesh-ancestor
102336244|NCT05648110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102336245|NCT05595642|Astegolimab|astegolimab|mesh-list
102336246|NCT05595642|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102336247|NCT05595642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102336248|NCT05595642|Antiviral Agents|antiviral agents|mesh-ancestor
102336249|NCT05595642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102336250|NCT05497804|Dexamethasone|dexamethasone|mesh-list
102336251|NCT05497804|Dexamethasone acetate|dexamethasone acetate|mesh-list
102336252|NCT05497804|Lenalidomide|lenalidomide|mesh-list
102336253|NCT05497804|Daratumumab|daratumumab|mesh-list
102336254|NCT05497804|Ichthammol|ichthammol|mesh-list
102336255|NCT05497804|BB 1101|bb 1101|mesh-list
102336256|NCT05497804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102336257|NCT05497804|Antiemetics|antiemetics|mesh-ancestor
102336258|NCT05497804|Autonomic Agents|autonomic agents|mesh-ancestor
102336259|NCT05497804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102336260|NCT05497804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336261|NCT05497804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102336262|NCT05497804|Glucocorticoids|glucocorticoids|mesh-ancestor
102336263|NCT05497804|Hormones|hormones|mesh-ancestor
102336264|NCT05497804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102336265|NCT05497804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102336266|NCT05497804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336267|NCT05497804|Protease Inhibitors|protease inhibitors|mesh-ancestor
102336268|NCT05497804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102336269|NCT05497804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336270|NCT05497804|Immunologic Factors|immunologic factors|mesh-ancestor
102336271|NCT05497804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102336272|NCT05497804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102336273|NCT05497804|Growth Substances|growth substances|mesh-ancestor
102336274|NCT05497804|Growth Inhibitors|growth inhibitors|mesh-ancestor
102336275|NCT05497804|Dermatologic Agents|dermatologic agents|mesh-ancestor
102336276|NCT05490511|Cannabidiol|cannabidiol|mesh-list
102336277|NCT05490511|Tacrolimus|tacrolimus|mesh-list
102336278|NCT05490511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102336279|NCT05490511|Immunologic Factors|immunologic factors|mesh-ancestor
102336280|NCT05490511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336281|NCT05490511|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102336282|NCT05490511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102336283|NCT05490511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336284|NCT05490511|Anticonvulsants|anticonvulsants|mesh-ancestor
102336285|NCT05441280|Pimavanserin|pimavanserin|mesh-list
102336286|NCT05441280|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102336287|NCT05441280|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102336288|NCT05441280|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102336289|NCT05441280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102336290|NCT05441280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102336291|NCT05441280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336292|NCT05441280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102336293|NCT05441280|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102336294|NCT05441280|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102336296|NCT05441280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102336297|NCT05441280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336298|NCT05429502|Temozolomide|temozolomide|mesh-list
102336299|NCT05429502|Topotecan|topotecan|mesh-list
102336300|NCT05429502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102336301|NCT05429502|Alkylating Agents|alkylating agents|mesh-ancestor
102336302|NCT05429502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336303|NCT05429502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336304|NCT05429502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102336305|NCT05429502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102336306|NCT05429502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102336307|NCT05413161|Omalizumab|omalizumab|mesh-list
102336308|NCT05413161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102336309|NCT05413161|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102336310|NCT05413161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102336311|NCT05413161|Respiratory System Agents|respiratory system agents|mesh-ancestor
102336312|NCT05413161|Immunologic Factors|immunologic factors|mesh-ancestor
102336313|NCT05413161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336314|NCT05413122|Nicotine|nicotine|mesh-list
102336315|NCT05413122|Varenicline|varenicline|mesh-list
102336316|NCT05413122|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102336317|NCT05413122|Autonomic Agents|autonomic agents|mesh-ancestor
102336318|NCT05413122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102045155|NCT03138655|Vedolizumab|vedolizumab|mesh-list
102336319|NCT05413122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336320|NCT05413122|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102336321|NCT05413122|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102336322|NCT05413122|Cholinergic Agents|cholinergic agents|mesh-ancestor
102336323|NCT05413122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102336324|NCT05413122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336325|NCT05378750|Diuretics|diuretics|mesh-list
102336326|NCT05378750|Natriuretic Agents|natriuretic agents|mesh-ancestor
102336327|NCT05378750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336328|NCT05366816|Sunitinib|sunitinib|mesh-list
102336329|NCT05366816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336330|NCT05366816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102336331|NCT05366816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102336332|NCT05366816|Growth Substances|growth substances|mesh-ancestor
102336333|NCT05366816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336334|NCT05366816|Growth Inhibitors|growth inhibitors|mesh-ancestor
102336335|NCT05366816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102336336|NCT05366816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102336337|NCT05366816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336338|NCT05362955|Fluorouracil|fluorouracil|mesh-list
102336339|NCT05362955|Antimetabolites|antimetabolites|mesh-ancestor
102336340|NCT05362955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336341|NCT05362955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102336342|NCT05362955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336343|NCT05362955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102336344|NCT05362955|Immunologic Factors|immunologic factors|mesh-ancestor
102336345|NCT05362955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336346|NCT05343169|Naloxone|naloxone|mesh-list
102336347|NCT05343169|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102336348|NCT05343169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336349|NCT05343169|Sensory System Agents|sensory system agents|mesh-ancestor
102336350|NCT05343169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102336351|NCT05319587|Cytarabine|cytarabine|mesh-list
102336352|NCT05319587|Annamycin|annamycin|mesh-list
102336353|NCT05319587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102336354|NCT05319587|Antimetabolites|antimetabolites|mesh-ancestor
102336355|NCT05319587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336356|NCT05319587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336357|NCT05319587|Antiviral Agents|antiviral agents|mesh-ancestor
102336358|NCT05319587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102336359|NCT05319587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102336360|NCT05319587|Immunologic Factors|immunologic factors|mesh-ancestor
102336361|NCT05319587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336362|NCT05319587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102336363|NCT05316116|Siltuximab|siltuximab|mesh-list
102336364|NCT05316116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336365|NCT05269706|Cannabidiol|cannabidiol|mesh-list
102336366|NCT05269706|Anticonvulsants|anticonvulsants|mesh-ancestor
102336367|NCT05257824|Aspirin|aspirin|mesh-list
102336368|NCT05257824|Clopidogrel|clopidogrel|mesh-list
102336369|NCT05257824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102336371|NCT05257824|Analgesics|analgesics|mesh-ancestor
102336372|NCT05257824|Sensory System Agents|sensory system agents|mesh-ancestor
102336373|NCT05257824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102336374|NCT05257824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336375|NCT05257824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102336376|NCT05257824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102336377|NCT05257824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102336378|NCT05257824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102336379|NCT05257824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336380|NCT05257824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102336381|NCT05257824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102336382|NCT05257824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102336383|NCT05257824|Antipyretics|antipyretics|mesh-ancestor
102336384|NCT05257824|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102336385|NCT05257824|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102336386|NCT05257824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102336387|NCT05257824|Purinergic Agents|purinergic agents|mesh-ancestor
102336388|NCT05257824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102336389|NCT05228314|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102336390|NCT05228314|Vaccines|vaccines|mesh-list
102336391|NCT05228314|Aluminum sulfate|aluminum sulfate|mesh-list
102336392|NCT05228314|Immunologic Factors|immunologic factors|mesh-ancestor
102336393|NCT05228314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336394|NCT05228314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102336395|NCT05228314|Antacids|antacids|mesh-ancestor
102336396|NCT05228314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336397|NCT05228314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102336398|NCT05216328|Magnesium Hydroxide|magnesium hydroxide|mesh-list
102336399|NCT05216328|Antacids|antacids|mesh-ancestor
102336400|NCT05216328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336401|NCT05216328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102336402|NCT05183854|Vaccines|vaccines|mesh-list
102336403|NCT05183854|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102336404|NCT05183854|Immunologic Factors|immunologic factors|mesh-ancestor
102336405|NCT05183854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336406|NCT05167760|Apraclonidine|apraclonidine|mesh-list
102336407|NCT05167760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102336408|NCT05167760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102336409|NCT05167760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102336410|NCT05167760|Adrenergic Agents|adrenergic agents|mesh-ancestor
102336411|NCT05167760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102336412|NCT05167760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336413|NCT05167760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336414|NCT05127590|Pembrolizumab|pembrolizumab|mesh-list
102336415|NCT05127590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102336416|NCT05127590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336417|NCT05127590|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102336418|NCT05127590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336419|NCT05116891|Leucovorin|leucovorin|mesh-list
102336420|NCT05116891|Cisplatin|cisplatin|mesh-list
102336421|NCT05116891|Gemcitabine|gemcitabine|mesh-list
102336422|NCT05116891|Docetaxel|docetaxel|mesh-list
102336423|NCT05116891|Fluorouracil|fluorouracil|mesh-list
102336424|NCT05116891|Oxaliplatin|oxaliplatin|mesh-list
102336425|NCT05116891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336426|NCT05116891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102336427|NCT05116891|Antimetabolites|antimetabolites|mesh-ancestor
102336428|NCT05116891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336429|NCT05116891|Tubulin Modulators|tubulin modulators|mesh-ancestor
102336430|NCT05116891|Antimitotic Agents|antimitotic agents|mesh-ancestor
102336431|NCT05116891|Mitosis Modulators|mitosis modulators|mesh-ancestor
102336432|NCT05116891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102336433|NCT05116891|Immunologic Factors|immunologic factors|mesh-ancestor
102336434|NCT05116891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336435|NCT05116891|Antidotes|antidotes|mesh-ancestor
102336436|NCT05116891|Protective Agents|protective agents|mesh-ancestor
102336437|NCT05116891|Vitamin B Complex|vitamin b complex|mesh-ancestor
102336438|NCT05116891|Vitamins|vitamins|mesh-ancestor
102336439|NCT05116891|Micronutrients|micronutrients|mesh-ancestor
102336440|NCT05069038|Palbociclib|palbociclib|mesh-list
102336441|NCT05069038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336442|NCT05069038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102336443|NCT05069038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102336444|NCT05069038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336445|NCT05060549|Cariprazine|cariprazine|mesh-list
102336446|NCT05060549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102336447|NCT05060549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102336448|NCT05060549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102336449|NCT05060549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336450|NCT05060549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102336451|NCT05020912|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102336452|NCT05020912|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102336453|NCT05020912|Dermatologic Agents|dermatologic agents|mesh-ancestor
102336454|NCT04983030|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
102336455|NCT04983030|Antiviral Agents|antiviral agents|mesh-ancestor
102336456|NCT04983030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102336457|NCT04973566|Hydroxychloroquine|hydroxychloroquine|mesh-list
102336458|NCT04973566|Etanercept|etanercept|mesh-list
102336459|NCT04973566|Antimalarials|antimalarials|mesh-ancestor
102336460|NCT04973566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102336461|NCT04973566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102336462|NCT04973566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102336463|NCT04973566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102336464|NCT04973566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336465|NCT04973566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102336466|NCT04973566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102336467|NCT04973566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102336468|NCT04973566|Analgesics|analgesics|mesh-ancestor
102336469|NCT04973566|Sensory System Agents|sensory system agents|mesh-ancestor
102336470|NCT04973566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102336471|NCT04973566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336472|NCT04973566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102336473|NCT04973566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102336474|NCT04973566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102336475|NCT04973566|Immunologic Factors|immunologic factors|mesh-ancestor
102336476|NCT04965155|Dexamethasone|dexamethasone|mesh-list
102336477|NCT04965155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102336478|NCT04965155|Antiemetics|antiemetics|mesh-ancestor
102336479|NCT04965155|Autonomic Agents|autonomic agents|mesh-ancestor
102336480|NCT04965155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102336481|NCT04965155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336482|NCT04965155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102336483|NCT04965155|Glucocorticoids|glucocorticoids|mesh-ancestor
102336484|NCT04965155|Hormones|hormones|mesh-ancestor
102336485|NCT04965155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102336486|NCT04965155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102336487|NCT04965155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336491|NCT04863885|Nivolumab|nivolumab|mesh-list
102336492|NCT04863885|Ipilimumab|ipilimumab|mesh-list
102336493|NCT04863885|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
102336494|NCT04863885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102336495|NCT04863885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336496|NCT04863885|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102336497|NCT04863885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336498|NCT04863885|Immunoconjugates|immunoconjugates|mesh-ancestor
102336499|NCT04863885|Immunologic Factors|immunologic factors|mesh-ancestor
102336500|NCT04863885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336501|NCT04856189|Pembrolizumab|pembrolizumab|mesh-list
102336502|NCT04856189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102336503|NCT04856189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336504|NCT04856189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102336505|NCT04856189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336506|NCT04855929|Ipilimumab|ipilimumab|mesh-list
102336507|NCT04855929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102336508|NCT04855929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336509|NCT04855929|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102336510|NCT04855929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336511|NCT04810078|Nivolumab|nivolumab|mesh-list
102336512|NCT04810078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102336513|NCT04810078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336514|NCT04810078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102336515|NCT04810078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336516|NCT04779242|Moxifloxacin|moxifloxacin|mesh-list
102336517|NCT04779242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102336518|NCT04779242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102336519|NCT04779242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102336520|NCT04779242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102336521|NCT04779242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102336522|NCT04779242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336523|NCT04779242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336524|NCT04760496|Oxytocin|oxytocin|mesh-list
102336525|NCT04760496|Oxytocics|oxytocics|mesh-ancestor
102336526|NCT04760496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102336527|NCT04760496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336528|NCT04724837|Dapagliflozin|dapagliflozin|mesh-list
102336529|NCT04724837|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102336530|NCT04724837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336531|NCT04724837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102336532|NCT04724837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336533|NCT04722822|Vaccines|vaccines|mesh-list
102336534|NCT04722822|Immunologic Factors|immunologic factors|mesh-ancestor
102336535|NCT04722822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336536|NCT04690192|Gemcitabine|gemcitabine|mesh-list
102336537|NCT04690192|Melphalan|melphalan|mesh-list
102336538|NCT04690192|Busulfan|busulfan|mesh-list
102336539|NCT04690192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102336540|NCT04690192|Antimetabolites|antimetabolites|mesh-ancestor
102336541|NCT04690192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336542|NCT04690192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336543|NCT04690192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102045375|NCT03009487|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102336544|NCT04690192|Alkylating Agents|alkylating agents|mesh-ancestor
102336545|NCT04690192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102336546|NCT04690192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102336547|NCT04690192|Immunologic Factors|immunologic factors|mesh-ancestor
102336548|NCT04690192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336549|NCT04682431|Pembrolizumab|pembrolizumab|mesh-list
102336550|NCT04682431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102336551|NCT04682431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336552|NCT04682431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102336553|NCT04682431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336554|NCT04631029|Carboplatin|carboplatin|mesh-list
102336555|NCT04631029|Etoposide|etoposide|mesh-list
102336556|NCT04631029|Etoposide phosphate|etoposide phosphate|mesh-list
102336557|NCT04631029|Atezolizumab|atezolizumab|mesh-list
102336558|NCT04631029|Podophyllotoxin|podophyllotoxin|mesh-list
102336559|NCT04631029|Entinostat|entinostat|mesh-list
102336560|NCT04631029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102336561|NCT04631029|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
102336562|NCT04631029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336563|NCT04631029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102336564|NCT04631029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102336565|NCT04631029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102336566|NCT04631029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102336567|NCT04631029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336568|NCT04631029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102336569|NCT04631029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102336570|NCT04631029|Immunologic Factors|immunologic factors|mesh-ancestor
102336571|NCT04631029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336572|NCT04631029|Keratolytic Agents|keratolytic agents|mesh-ancestor
102336573|NCT04631029|Dermatologic Agents|dermatologic agents|mesh-ancestor
102336574|NCT04631029|Tubulin Modulators|tubulin modulators|mesh-ancestor
102336575|NCT04631029|Antimitotic Agents|antimitotic agents|mesh-ancestor
102336576|NCT04631029|Mitosis Modulators|mitosis modulators|mesh-ancestor
102336577|NCT04567784|Cannabidiol|cannabidiol|mesh-list
102336578|NCT04567784|Anticonvulsants|anticonvulsants|mesh-ancestor
102336579|NCT04563507|Letrozole|letrozole|mesh-list
102336580|NCT04563507|Palbociclib|palbociclib|mesh-list
102336581|NCT04563507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336582|NCT04563507|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102336583|NCT04563507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102336584|NCT04563507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102336585|NCT04563507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336586|NCT04563507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102336587|NCT04563507|Hormone Antagonists|hormone antagonists|mesh-ancestor
102336588|NCT04563507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102336589|NCT04563507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336590|NCT04563507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102336591|NCT04515641|Islatravir|islatravir|mesh-list
102336592|NCT04515641|Antiviral Agents|antiviral agents|mesh-ancestor
102336593|NCT04515641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102336594|NCT04515641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102336595|NCT04515641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336596|NCT04515641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102336597|NCT04515641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102336598|NCT04515641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102336599|NCT04474366|Ropivacaine|ropivacaine|mesh-list
102336600|NCT04474366|Anesthetics, Local|anesthetics, local|mesh-ancestor
102336601|NCT04474366|Anesthetics|anesthetics|mesh-ancestor
102336602|NCT04474366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102336603|NCT04474366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336604|NCT04474366|Sensory System Agents|sensory system agents|mesh-ancestor
102336605|NCT04474366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102336606|NCT04465643|Nivolumab|nivolumab|mesh-list
102336607|NCT04465643|Ipilimumab|ipilimumab|mesh-list
102336608|NCT04465643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102336609|NCT04465643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336610|NCT04465643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102336611|NCT04465643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336612|NCT04431453|Remdesivir|remdesivir|mesh-list
102336613|NCT04431453|Antimetabolites|antimetabolites|mesh-ancestor
102336614|NCT04431453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336615|NCT04431453|Antiviral Agents|antiviral agents|mesh-ancestor
102336616|NCT04431453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102336622|NCT04422431|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
102336623|NCT04422431|Choline|choline|mesh-list
102336624|NCT04422431|Lipotropic Agents|lipotropic agents|mesh-ancestor
102336625|NCT04422431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102336626|NCT04422431|Antimetabolites|antimetabolites|mesh-ancestor
102336627|NCT04422431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336628|NCT04422431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102336629|NCT04422431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102336630|NCT04422431|Nootropic Agents|nootropic agents|mesh-ancestor
102336631|NCT04422431|Chelating Agents|chelating agents|mesh-ancestor
102336632|NCT04422431|Sequestering Agents|sequestering agents|mesh-ancestor
102336633|NCT04422431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102336634|NCT04422431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102336635|NCT04422431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102336636|NCT04422431|Growth Substances|growth substances|mesh-ancestor
102336637|NCT04422431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336638|NCT04422431|Growth Inhibitors|growth inhibitors|mesh-ancestor
102336639|NCT04422431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336640|NCT04416451|Rituximab|rituximab|mesh-list
102336641|NCT04416451|Venetoclax|venetoclax|mesh-list
102336642|NCT04416451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102336643|NCT04416451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336644|NCT04416451|Immunologic Factors|immunologic factors|mesh-ancestor
102336645|NCT04416451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336646|NCT04416451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102336647|NCT04406649|Dihydroergotamine|dihydroergotamine|mesh-list
102336648|NCT04406649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102336649|NCT04406649|Dopamine Agonists|dopamine agonists|mesh-ancestor
102336650|NCT04406649|Dopamine Agents|dopamine agents|mesh-ancestor
102336651|NCT04406649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102336652|NCT04406649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336653|NCT04406649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336654|NCT04406649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102336655|NCT04406649|Analgesics|analgesics|mesh-ancestor
102336656|NCT04406649|Sensory System Agents|sensory system agents|mesh-ancestor
102336657|NCT04406649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102336658|NCT04316390|Vitamins|vitamins|mesh-list
102336659|NCT04316390|Ascorbic Acid|ascorbic acid|mesh-list
102336660|NCT04316390|Micronutrients|micronutrients|mesh-ancestor
102336661|NCT04316390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336662|NCT04316390|Antioxidants|antioxidants|mesh-ancestor
102336663|NCT04316390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336664|NCT04316390|Protective Agents|protective agents|mesh-ancestor
102336665|NCT04236414|Olaparib|olaparib|mesh-list
102336666|NCT04236414|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102336667|NCT04236414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102336668|NCT04236414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336669|NCT04236414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336670|NCT04228042|Infigratinib|infigratinib|mesh-list
102336671|NCT04228042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336672|NCT04208178|Trastuzumab|trastuzumab|mesh-list
102336673|NCT04208178|Pertuzumab|pertuzumab|mesh-list
102336674|NCT04208178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102336675|NCT04208178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336676|NCT04171817|Chlorhexidine|chlorhexidine|mesh-list
102336677|NCT04171817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102336678|NCT04171817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102336679|NCT04171817|Disinfectants|disinfectants|mesh-ancestor
102336680|NCT04163952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102336681|NCT04163952|Panitumumab|panitumumab|mesh-list
102336682|NCT04163952|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
102336683|NCT04163952|Antibodies|antibodies|mesh-list
102336684|NCT04163952|Immunoglobulins|immunoglobulins|mesh-list
102336685|NCT04163952|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102336686|NCT04163952|Immunologic Factors|immunologic factors|mesh-ancestor
102336687|NCT04163952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336688|NCT04163952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336689|NCT04152863|Pembrolizumab|pembrolizumab|mesh-list
102336690|NCT04152863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102336691|NCT04152863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336692|NCT04152863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102336693|NCT04152863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045524|NCT01543633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102336694|NCT04129554|Tenofovir|tenofovir|mesh-list
102336695|NCT04129554|Entecavir|entecavir|mesh-list
102336696|NCT04129554|JNJ-56136379|jnj-56136379|mesh-list
102336697|NCT04129554|Antiviral Agents|antiviral agents|mesh-ancestor
102336698|NCT04129554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102336699|NCT04129554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102336700|NCT04129554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102336701|NCT04129554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102336702|NCT04129554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336703|NCT04129554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102336704|NCT04129554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102336705|NCT04109729|Nivolumab|nivolumab|mesh-list
102336706|NCT04109729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102336707|NCT04109729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336708|NCT04109729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102336709|NCT04109729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336710|NCT04106856|Losartan|losartan|mesh-list
102336711|NCT04106856|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102336712|NCT04106856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101442544|NCT00171431|Serotonin Agents|serotonin agents|mesh-ancestor
102336713|NCT04106856|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102336714|NCT04106856|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102336715|NCT04106856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336716|NCT04098666|Metformin|metformin|mesh-list
102336717|NCT04098666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102336718|NCT04098666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336719|NCT04049513|Cyclophosphamide|cyclophosphamide|mesh-list
102336720|NCT04049513|Fludarabine|fludarabine|mesh-list
102336721|NCT04049513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102336722|NCT04049513|Immunologic Factors|immunologic factors|mesh-ancestor
102336723|NCT04049513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336724|NCT04049513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102336725|NCT04049513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102336726|NCT04049513|Alkylating Agents|alkylating agents|mesh-ancestor
102336727|NCT04049513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336728|NCT04049513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336729|NCT04049513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102336730|NCT04002180|Vedolizumab|vedolizumab|mesh-list
102336731|NCT04002180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102336732|NCT03997123|Paclitaxel|paclitaxel|mesh-list
102336733|NCT03997123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102336734|NCT03997123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336735|NCT03997123|Tubulin Modulators|tubulin modulators|mesh-ancestor
102336736|NCT03997123|Antimitotic Agents|antimitotic agents|mesh-ancestor
102336737|NCT03997123|Mitosis Modulators|mitosis modulators|mesh-ancestor
102336738|NCT03997123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336739|NCT03968419|Pembrolizumab|pembrolizumab|mesh-list
102336740|NCT03968419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102336741|NCT03968419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336742|NCT03968419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102336743|NCT03968419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336744|NCT03924986|Tislelizumab|tislelizumab|mesh-list
102336745|NCT03924986|Gemcitabine|gemcitabine|mesh-list
102336746|NCT03924986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336747|NCT03924986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102336748|NCT03924986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102336749|NCT03924986|Antimetabolites|antimetabolites|mesh-ancestor
102336750|NCT03924986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336759|NCT03904550|Rocuronium|rocuronium|mesh-list
102336760|NCT03904550|Cisatracurium|cisatracurium|mesh-list
102336761|NCT03904550|Neostigmine|neostigmine|mesh-list
102336762|NCT03904550|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102336763|NCT03904550|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102336764|NCT03904550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102336765|NCT03904550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102336766|NCT03904550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336767|NCT03904550|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102336768|NCT03904550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102336769|NCT03904550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336770|NCT03904550|Cholinergic Agents|cholinergic agents|mesh-ancestor
102336771|NCT03904550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102336772|NCT03904550|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102336773|NCT03904550|Autonomic Agents|autonomic agents|mesh-ancestor
102336774|NCT03866577|Immunoglobulins|immunoglobulins|mesh-list
102336775|NCT03866577|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102336776|NCT03866577|Antibodies|antibodies|mesh-list
102336777|NCT03866577|gamma-Globulins|gamma-globulins|mesh-list
102336778|NCT03866577|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102336779|NCT03866577|Immunologic Factors|immunologic factors|mesh-ancestor
102336780|NCT03866577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336781|NCT03834883|Ibutilide|ibutilide|mesh-list
102336782|NCT03834883|Progesterone|progesterone|mesh-list
102336783|NCT03834883|Progestins|progestins|mesh-ancestor
102336784|NCT03834883|Hormones|hormones|mesh-ancestor
102336785|NCT03834883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102336786|NCT03834883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336787|NCT03834883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102336788|NCT03822468|Letrozole|letrozole|mesh-list
102336789|NCT03822468|Anastrozole|anastrozole|mesh-list
102336790|NCT03822468|Goserelin|goserelin|mesh-list
102336791|NCT03822468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336792|NCT03822468|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101442550|NCT01330030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102336793|NCT03822468|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102336794|NCT03822468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102336795|NCT03822468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336796|NCT03822468|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102336797|NCT03822468|Hormone Antagonists|hormone antagonists|mesh-ancestor
102336798|NCT03822468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102336799|NCT03822468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336800|NCT03822468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102336801|NCT03816332|Prednisone|prednisone|mesh-list
102336802|NCT03816332|Cortisone|cortisone|mesh-list
102336803|NCT03816332|Nivolumab|nivolumab|mesh-list
102336804|NCT03816332|Ipilimumab|ipilimumab|mesh-list
102336805|NCT03816332|Tacrolimus|tacrolimus|mesh-list
102336806|NCT03816332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102336807|NCT03816332|Glucocorticoids|glucocorticoids|mesh-ancestor
102336808|NCT03816332|Hormones|hormones|mesh-ancestor
102336809|NCT03816332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102336810|NCT03816332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336811|NCT03816332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102336812|NCT03816332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336813|NCT03816332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102336814|NCT03816332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102336815|NCT03816332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336816|NCT03816332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102336817|NCT03816332|Immunologic Factors|immunologic factors|mesh-ancestor
102336818|NCT03816332|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102336819|NCT03816332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102336821|NCT03810807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336822|NCT03810807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102336823|NCT03810807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102336824|NCT03810807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336825|NCT03759288|Adalimumab|adalimumab|mesh-list
102336826|NCT03759288|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102336827|NCT03759288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102336828|NCT03759288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102336829|NCT03693014|Pembrolizumab|pembrolizumab|mesh-list
102336830|NCT03693014|Nivolumab|nivolumab|mesh-list
102336831|NCT03693014|Ipilimumab|ipilimumab|mesh-list
102336832|NCT03693014|Atezolizumab|atezolizumab|mesh-list
102336833|NCT03693014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102336834|NCT03693014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336835|NCT03693014|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102336836|NCT03693014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336837|NCT03684980|Leucovorin|leucovorin|mesh-list
102336838|NCT03684980|Rituximab|rituximab|mesh-list
102336839|NCT03684980|Methotrexate|methotrexate|mesh-list
102336840|NCT03684980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102336841|NCT03684980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336842|NCT03684980|Immunologic Factors|immunologic factors|mesh-ancestor
102045690|NCT01065012|Udenafil|udenafil|mesh-list
102336843|NCT03684980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336844|NCT03684980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102336845|NCT03684980|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102336846|NCT03684980|Abortifacient Agents|abortifacient agents|mesh-ancestor
102336847|NCT03684980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102336848|NCT03684980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102336849|NCT03684980|Antimetabolites|antimetabolites|mesh-ancestor
102336850|NCT03684980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336851|NCT03684980|Dermatologic Agents|dermatologic agents|mesh-ancestor
102336852|NCT03684980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102336853|NCT03684980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102336854|NCT03684980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102336855|NCT03684980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102336856|NCT03684980|Antidotes|antidotes|mesh-ancestor
102336857|NCT03684980|Protective Agents|protective agents|mesh-ancestor
102336858|NCT03684980|Vitamin B Complex|vitamin b complex|mesh-ancestor
102336859|NCT03684980|Vitamins|vitamins|mesh-ancestor
102336860|NCT03684980|Micronutrients|micronutrients|mesh-ancestor
102336861|NCT03672487|Benzonidazole|benzonidazole|mesh-list
102336862|NCT03672487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102336863|NCT03672487|Immunologic Factors|immunologic factors|mesh-ancestor
102336864|NCT03672487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336865|NCT03672487|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102336866|NCT03672487|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102336867|NCT03672487|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102336868|NCT03672487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102336869|NCT03666559|Azacitidine|azacitidine|mesh-list
102336870|NCT03666559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102336871|NCT03666559|Antimetabolites|antimetabolites|mesh-ancestor
102336872|NCT03666559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336873|NCT03666559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336874|NCT03666559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102336875|NCT03662022|Rifampin|rifampin|mesh-list
102336876|NCT03662022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102336877|NCT03662022|Antitubercular Agents|antitubercular agents|mesh-ancestor
102336878|NCT03662022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102336879|NCT03662022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102336880|NCT03662022|Leprostatic Agents|leprostatic agents|mesh-ancestor
102336881|NCT03662022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102336882|NCT03662022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102336883|NCT03662022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336884|NCT03662022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102336885|NCT03662022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102336886|NCT03662022|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102336887|NCT03662022|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102336888|NCT03662022|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102336889|NCT03662022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102336890|NCT03660826|Durvalumab|durvalumab|mesh-list
102336891|NCT03660826|Olaparib|olaparib|mesh-list
102336892|NCT03660826|Cediranib|cediranib|mesh-list
102336893|NCT03660826|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102336894|NCT03660826|Immunoglobulins|immunoglobulins|mesh-list
102336895|NCT03660826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102336896|NCT03660826|Immunoglobulin G|immunoglobulin g|mesh-list
102336897|NCT03660826|Maleic acid|maleic acid|mesh-list
102336898|NCT03660826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102336899|NCT03660826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336900|NCT03660826|Immunologic Factors|immunologic factors|mesh-ancestor
102336901|NCT03660826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336902|NCT03660826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102336903|NCT03660826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336904|NCT03660826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102336905|NCT03648996|Allopurinol|allopurinol|mesh-list
102336906|NCT03648996|Antimetabolites|antimetabolites|mesh-ancestor
102336907|NCT03648996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336908|NCT03648996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102336909|NCT03648996|Gout Suppressants|gout suppressants|mesh-ancestor
102336910|NCT03648996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102336911|NCT03648996|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102336912|NCT03648996|Antioxidants|antioxidants|mesh-ancestor
102336913|NCT03648996|Protective Agents|protective agents|mesh-ancestor
102336914|NCT03648996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336915|NCT03611738|Docetaxel|docetaxel|mesh-list
102336916|NCT03611738|Ceritinib|ceritinib|mesh-list
102336917|NCT03611738|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102336918|NCT03611738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336919|NCT03611738|Tubulin Modulators|tubulin modulators|mesh-ancestor
102336920|NCT03611738|Antimitotic Agents|antimitotic agents|mesh-ancestor
102336921|NCT03611738|Mitosis Modulators|mitosis modulators|mesh-ancestor
102336922|NCT03611738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336923|NCT03611738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102336924|NCT03611738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102336925|NCT03585465|Cyclophosphamide|cyclophosphamide|mesh-list
102336926|NCT03585465|Capecitabine|capecitabine|mesh-list
102336928|NCT03585465|Vinblastine|vinblastine|mesh-list
102336929|NCT03585465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102336930|NCT03585465|Immunologic Factors|immunologic factors|mesh-ancestor
102336931|NCT03585465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336932|NCT03585465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102336933|NCT03585465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102336934|NCT03585465|Alkylating Agents|alkylating agents|mesh-ancestor
102336935|NCT03585465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336936|NCT03585465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336937|NCT03585465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102336938|NCT03585465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102336939|NCT03585465|Antimetabolites|antimetabolites|mesh-ancestor
102336940|NCT03585465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102336941|NCT03585465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102336942|NCT03585465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102336943|NCT03585465|Tubulin Modulators|tubulin modulators|mesh-ancestor
102336944|NCT03585465|Antimitotic Agents|antimitotic agents|mesh-ancestor
102336945|NCT03585465|Mitosis Modulators|mitosis modulators|mesh-ancestor
102336946|NCT03523312|Capecitabine|capecitabine|mesh-list
102336947|NCT03523312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102336948|NCT03523312|Antimetabolites|antimetabolites|mesh-ancestor
102336949|NCT03523312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336950|NCT03523312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336951|NCT03471624|Tenofovir|tenofovir|mesh-list
102336952|NCT03471624|Antiviral Agents|antiviral agents|mesh-ancestor
102336953|NCT03471624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102336954|NCT03471624|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102336955|NCT03471624|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102336956|NCT03471624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102336957|NCT03471624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336958|NCT03471624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102336959|NCT03471624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102336960|NCT03471143|Betadex|betadex|mesh-list
102336961|NCT03471143|Sequestering Agents|sequestering agents|mesh-ancestor
102336962|NCT03471143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336963|NCT03459807|Antihypertensive Agents|antihypertensive agents|mesh-list
102336964|NCT03449238|Pembrolizumab|pembrolizumab|mesh-list
102336965|NCT03449238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102336966|NCT03449238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336967|NCT03449238|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102336968|NCT03449238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336969|NCT03439293|Dexamethasone|dexamethasone|mesh-list
102336970|NCT03439293|Daratumumab|daratumumab|mesh-list
102336971|NCT03439293|Ixazomib|ixazomib|mesh-list
102336972|NCT03439293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102336973|NCT03439293|Antiemetics|antiemetics|mesh-ancestor
102336974|NCT03439293|Autonomic Agents|autonomic agents|mesh-ancestor
102336975|NCT03439293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102336976|NCT03439293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102336977|NCT03439293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102336978|NCT03439293|Glucocorticoids|glucocorticoids|mesh-ancestor
102336979|NCT03439293|Hormones|hormones|mesh-ancestor
102336980|NCT03439293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102336981|NCT03439293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102336982|NCT03439293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336983|NCT03439293|Protease Inhibitors|protease inhibitors|mesh-ancestor
102336984|NCT03439293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102336985|NCT03439293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336986|NCT03423979|Paclitaxel|paclitaxel|mesh-list
102336987|NCT03423979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102336988|NCT03423979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102336989|NCT03423979|Tubulin Modulators|tubulin modulators|mesh-ancestor
102336990|NCT03423979|Antimitotic Agents|antimitotic agents|mesh-ancestor
102336991|NCT03423979|Mitosis Modulators|mitosis modulators|mesh-ancestor
102336992|NCT03423979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102336993|NCT03404778|Cimetidine|cimetidine|mesh-list
102336994|NCT03404778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102336995|NCT03404778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102336996|NCT03404778|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102336997|NCT03404778|Histamine Antagonists|histamine antagonists|mesh-ancestor
102336998|NCT03404778|Histamine Agents|histamine agents|mesh-ancestor
102336999|NCT03404778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102337000|NCT03404778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337001|NCT03404778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337002|NCT03404778|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102337003|NCT03404778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102337004|NCT03404778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102337005|NCT03258554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102337006|NCT03258554|Cetuximab|cetuximab|mesh-list
102337007|NCT03258554|Durvalumab|durvalumab|mesh-list
102337008|NCT03258554|Antibodies|antibodies|mesh-list
102337009|NCT03258554|Immunoglobulins|immunoglobulins|mesh-list
102337010|NCT03258554|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102337011|NCT03258554|Immunoglobulin G|immunoglobulin g|mesh-list
102337012|NCT03258554|Immunologic Factors|immunologic factors|mesh-ancestor
102337013|NCT03258554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337014|NCT03258554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337015|NCT03239210|Ondansetron|ondansetron|mesh-list
102337016|NCT03239210|Antiemetics|antiemetics|mesh-ancestor
102337017|NCT03239210|Autonomic Agents|autonomic agents|mesh-ancestor
102337018|NCT03239210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102337019|NCT03239210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337020|NCT03239210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102337021|NCT03239210|Antipruritics|antipruritics|mesh-ancestor
102337022|NCT03239210|Dermatologic Agents|dermatologic agents|mesh-ancestor
102337023|NCT03239210|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102337024|NCT03239210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102337025|NCT03239210|Serotonin Agents|serotonin agents|mesh-ancestor
102337026|NCT03239210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102337027|NCT03239210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337028|NCT03196466|Topiramate|topiramate|mesh-list
102337029|NCT03196466|Pregabalin|pregabalin|mesh-list
102337030|NCT03196466|Lamotrigine|lamotrigine|mesh-list
102337031|NCT03196466|Zonisamide|zonisamide|mesh-list
102337032|NCT03196466|Lacosamide|lacosamide|mesh-list
102337033|NCT03196466|Carbamazepine|carbamazepine|mesh-list
102337034|NCT03196466|Phenytoin|phenytoin|mesh-list
102337035|NCT03196466|Oxcarbazepine|oxcarbazepine|mesh-list
102337036|NCT03196466|Rufinamide|rufinamide|mesh-list
102337037|NCT03196466|Cannabidiol|cannabidiol|mesh-list
102337038|NCT03196466|Levetiracetam|levetiracetam|mesh-list
102337039|NCT03196466|Valproic Acid|valproic acid|mesh-list
102337040|NCT03196466|Brivaracetam|brivaracetam|mesh-list
102337041|NCT03196466|Phenobarbital|phenobarbital|mesh-list
102337042|NCT03196466|Clobazam|clobazam|mesh-list
102337043|NCT03196466|Ethosuximide|ethosuximide|mesh-list
102337044|NCT03196466|Stiripentol|stiripentol|mesh-list
102337045|NCT03196466|Tiagabine|tiagabine|mesh-list
102337046|NCT03196466|Primidone|primidone|mesh-list
102337047|NCT03196466|Felbamate|felbamate|mesh-list
102337048|NCT03196466|Analgesics|analgesics|mesh-ancestor
102337049|NCT03196466|Sensory System Agents|sensory system agents|mesh-ancestor
102337050|NCT03196466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102337051|NCT03196466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337052|NCT03196466|Anticonvulsants|anticonvulsants|mesh-ancestor
102337053|NCT03196466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102337054|NCT03196466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102337055|NCT03196466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337056|NCT03196466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102337057|NCT03196466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102337058|NCT03196466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102337059|NCT03196466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102337060|NCT03196466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102337061|NCT03196466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102337062|NCT03196466|Nootropic Agents|nootropic agents|mesh-ancestor
102337063|NCT03196466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102337064|NCT03196466|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102337065|NCT03196466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102337066|NCT03196466|GABA Agents|gaba agents|mesh-ancestor
102337067|NCT03196466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102337068|NCT03196466|Antimanic Agents|antimanic agents|mesh-ancestor
102337069|NCT03196466|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102337070|NCT03196466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102337071|NCT03196466|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102337072|NCT03196466|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102337073|NCT03196466|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102337074|NCT03196466|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102337075|NCT03196466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102337076|NCT03196466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102337077|NCT03196466|GABA Modulators|gaba modulators|mesh-ancestor
101442565|NCT00171509|Cyclosporine|cyclosporine|mesh-list
102337078|NCT03196466|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102337079|NCT03196466|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102337080|NCT03196466|GABA Agonists|gaba agonists|mesh-ancestor
102337081|NCT03196466|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
102337082|NCT03196466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102337083|NCT03184870|Leucovorin|leucovorin|mesh-list
102337084|NCT03184870|Paclitaxel|paclitaxel|mesh-list
102337085|NCT03184870|Gemcitabine|gemcitabine|mesh-list
102337086|NCT03184870|Fluorouracil|fluorouracil|mesh-list
102337087|NCT03184870|Nivolumab|nivolumab|mesh-list
102337088|NCT03184870|Irinotecan|irinotecan|mesh-list
102337089|NCT03184870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102337090|NCT03184870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337091|NCT03184870|Tubulin Modulators|tubulin modulators|mesh-ancestor
102337092|NCT03184870|Antimitotic Agents|antimitotic agents|mesh-ancestor
102337093|NCT03184870|Mitosis Modulators|mitosis modulators|mesh-ancestor
102337094|NCT03184870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337095|NCT03184870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102337096|NCT03184870|Antimetabolites|antimetabolites|mesh-ancestor
102337097|NCT03184870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102337098|NCT03184870|Immunologic Factors|immunologic factors|mesh-ancestor
102337099|NCT03184870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337100|NCT03184870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102337101|NCT03184870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102337102|NCT03184870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102337103|NCT03184870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102337104|NCT03184870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102337105|NCT03184870|Antidotes|antidotes|mesh-ancestor
102337106|NCT03184870|Protective Agents|protective agents|mesh-ancestor
102337107|NCT03184870|Vitamin B Complex|vitamin b complex|mesh-ancestor
102337108|NCT03184870|Vitamins|vitamins|mesh-ancestor
102337109|NCT03184870|Micronutrients|micronutrients|mesh-ancestor
102337110|NCT03122522|Nivolumab|nivolumab|mesh-list
102337111|NCT03122522|Ipilimumab|ipilimumab|mesh-list
102337112|NCT03122522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102337113|NCT03122522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337114|NCT03122522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102337115|NCT03122522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337116|NCT03118232|Chlorhexidine|chlorhexidine|mesh-list
102337117|NCT03118232|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102337118|NCT03118232|Povidone-Iodine|povidone-iodine|mesh-list
102337119|NCT03118232|Povidone|povidone|mesh-list
102337120|NCT03118232|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102337121|NCT03118232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102337122|NCT03118232|Disinfectants|disinfectants|mesh-ancestor
102337123|NCT03118232|Dermatologic Agents|dermatologic agents|mesh-ancestor
102337124|NCT03118232|Plasma Substitutes|plasma substitutes|mesh-ancestor
102337125|NCT03118232|Blood Substitutes|blood substitutes|mesh-ancestor
102337126|NCT03108846|Escitalopram|escitalopram|mesh-list
102337127|NCT03108846|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102337128|NCT03108846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102337129|NCT03108846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102337130|NCT03108846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337131|NCT03108846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102337132|NCT03108846|Serotonin Agents|serotonin agents|mesh-ancestor
102337133|NCT03108846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337134|NCT03103971|Cyclophosphamide|cyclophosphamide|mesh-list
102337135|NCT03103971|Fludarabine|fludarabine|mesh-list
102337136|NCT03103971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102337137|NCT03103971|Immunologic Factors|immunologic factors|mesh-ancestor
102337138|NCT03103971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337139|NCT03103971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102337140|NCT03103971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102337141|NCT03103971|Alkylating Agents|alkylating agents|mesh-ancestor
102337142|NCT03103971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337143|NCT03103971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337144|NCT03103971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102337145|NCT03086343|Abatacept|abatacept|mesh-list
102337146|NCT03086343|Upadacitinib|upadacitinib|mesh-list
102337147|NCT03086343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102337148|NCT03086343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337149|NCT03086343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102337150|NCT03086343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337151|NCT03086343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102337152|NCT03086343|Immunologic Factors|immunologic factors|mesh-ancestor
102337153|NCT03086343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337154|NCT03086343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102337155|NCT03086343|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102337156|NCT03086343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102337157|NCT03086343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102337158|NCT02904226|Pembrolizumab|pembrolizumab|mesh-list
102337159|NCT02904226|Nivolumab|nivolumab|mesh-list
102337160|NCT02904226|Ipilimumab|ipilimumab|mesh-list
102337161|NCT02904226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102337162|NCT02904226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337163|NCT02904226|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102337164|NCT02904226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337165|NCT02775695|Doxycycline|doxycycline|mesh-list
102337166|NCT02775695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102337167|NCT02775695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102337168|NCT02775695|Antimalarials|antimalarials|mesh-ancestor
102337169|NCT02775695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102337170|NCT02775695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102337171|NCT02679040|Trastuzumab|trastuzumab|mesh-list
102337172|NCT02679040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102337173|NCT02679040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337174|NCT02610075|Adavosertib|adavosertib|mesh-list
102337175|NCT02610075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102337176|NCT02610075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337177|NCT02599454|Atezolizumab|atezolizumab|mesh-list
102337178|NCT02599454|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102337179|NCT02599454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337180|NCT02599454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102337181|NCT02599454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337182|NCT02595879|Deoxyglucose|deoxyglucose|mesh-list
102337183|NCT02595879|Cisplatin|cisplatin|mesh-list
102337184|NCT02595879|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102337185|NCT02595879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337186|NCT02595879|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102337187|NCT02595879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337188|NCT02595879|Antimetabolites|antimetabolites|mesh-ancestor
102337189|NCT02595879|Antiviral Agents|antiviral agents|mesh-ancestor
102337190|NCT02595879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102337191|NCT02584933|Ceritinib|ceritinib|mesh-list
102337192|NCT02584933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337193|NCT02584933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102337194|NCT02584933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102337195|NCT02584933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337196|NCT02559856|Rivaroxaban|rivaroxaban|mesh-list
102337197|NCT02559856|Apixaban|apixaban|mesh-list
102337198|NCT02559856|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102337199|NCT02559856|Antithrombins|antithrombins|mesh-ancestor
102337200|NCT02559856|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102337201|NCT02559856|Protease Inhibitors|protease inhibitors|mesh-ancestor
102337202|NCT02559856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102337203|NCT02559856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337204|NCT02559856|Anticoagulants|anticoagulants|mesh-ancestor
102337205|NCT02482311|Adavosertib|adavosertib|mesh-list
102337206|NCT02482311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102337207|NCT02482311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337208|NCT02453282|Paclitaxel|paclitaxel|mesh-list
102337209|NCT02453282|Cisplatin|cisplatin|mesh-list
102337210|NCT02453282|Carboplatin|carboplatin|mesh-list
102337211|NCT02453282|Gemcitabine|gemcitabine|mesh-list
102337212|NCT02453282|Pemetrexed|pemetrexed|mesh-list
102337213|NCT02453282|Durvalumab|durvalumab|mesh-list
102337214|NCT02453282|Tremelimumab|tremelimumab|mesh-list
102337215|NCT02453282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102337216|NCT02453282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102337217|NCT02453282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337218|NCT02453282|Tubulin Modulators|tubulin modulators|mesh-ancestor
102337219|NCT02453282|Antimitotic Agents|antimitotic agents|mesh-ancestor
102337220|NCT02453282|Mitosis Modulators|mitosis modulators|mesh-ancestor
102337221|NCT02453282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337222|NCT02453282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102337223|NCT02453282|Antimetabolites|antimetabolites|mesh-ancestor
102337224|NCT02453282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102337225|NCT02453282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102337226|NCT02453282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102337227|NCT02453282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102337228|NCT02453282|Immunologic Factors|immunologic factors|mesh-ancestor
102337229|NCT02453282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337230|NCT02437318|Fulvestrant|fulvestrant|mesh-list
102337231|NCT02437318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102337232|NCT02437318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337233|NCT02437318|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102337234|NCT02437318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102337235|NCT02437318|Hormone Antagonists|hormone antagonists|mesh-ancestor
102337236|NCT02437318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102337237|NCT02437318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337238|NCT02344680|Anti-HIV Agents|anti-hiv agents|mesh-list
102337239|NCT02344680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102337240|NCT02344680|Antiviral Agents|antiviral agents|mesh-ancestor
102337241|NCT02344680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102337243|NCT02338609|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102337244|NCT02338609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102337245|NCT02338609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102337246|NCT02338609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337247|NCT02338609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102337248|NCT02338609|Immunologic Factors|immunologic factors|mesh-ancestor
102337249|NCT02338609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337250|NCT02338609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337251|NCT02125461|Durvalumab|durvalumab|mesh-list
102337252|NCT02125461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102337253|NCT02125461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337254|NCT01933932|Docetaxel|docetaxel|mesh-list
102337255|NCT01933932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337256|NCT01933932|Tubulin Modulators|tubulin modulators|mesh-ancestor
102337257|NCT01933932|Antimitotic Agents|antimitotic agents|mesh-ancestor
102337258|NCT01933932|Mitosis Modulators|mitosis modulators|mesh-ancestor
102337259|NCT01933932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337260|NCT01466686|Temozolomide|temozolomide|mesh-list
102337261|NCT01466686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102337262|NCT01466686|Alkylating Agents|alkylating agents|mesh-ancestor
102337263|NCT01466686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337264|NCT01466686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337265|NCT01093196|Dexamethasone|dexamethasone|mesh-list
102337266|NCT01093196|Prednisone|prednisone|mesh-list
102337267|NCT01093196|Cyclophosphamide|cyclophosphamide|mesh-list
102337268|NCT01093196|Melphalan|melphalan|mesh-list
102337269|NCT01093196|Lenalidomide|lenalidomide|mesh-list
101941621|NCT02899156|Protective Agents|protective agents|mesh-ancestor
102337270|NCT01093196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102337271|NCT01093196|Immunologic Factors|immunologic factors|mesh-ancestor
102337272|NCT01093196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337273|NCT01093196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102337274|NCT01093196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102337275|NCT01093196|Alkylating Agents|alkylating agents|mesh-ancestor
101442591|NCT00611572|Antidotes|antidotes|mesh-ancestor
102337276|NCT01093196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337277|NCT01093196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337278|NCT01093196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102337279|NCT01093196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102337280|NCT01093196|Antiemetics|antiemetics|mesh-ancestor
102337281|NCT01093196|Autonomic Agents|autonomic agents|mesh-ancestor
102337282|NCT01093196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102337283|NCT01093196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102337284|NCT01093196|Glucocorticoids|glucocorticoids|mesh-ancestor
102337285|NCT01093196|Hormones|hormones|mesh-ancestor
102337286|NCT01093196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102337287|NCT01093196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102337288|NCT01093196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102337289|NCT01093196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102337290|NCT01093196|Growth Substances|growth substances|mesh-ancestor
102337291|NCT01093196|Growth Inhibitors|growth inhibitors|mesh-ancestor
102337292|NCT01091831|Dexamethasone|dexamethasone|mesh-list
102337293|NCT01091831|Cyclophosphamide|cyclophosphamide|mesh-list
102337294|NCT01091831|Melphalan|melphalan|mesh-list
102337295|NCT01091831|Lenalidomide|lenalidomide|mesh-list
102337296|NCT01091831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102337297|NCT01091831|Immunologic Factors|immunologic factors|mesh-ancestor
102337298|NCT01091831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337299|NCT01091831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102337300|NCT01091831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102337301|NCT01091831|Alkylating Agents|alkylating agents|mesh-ancestor
102337302|NCT01091831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337303|NCT01091831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337304|NCT01091831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102337305|NCT01091831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102337306|NCT01091831|Antiemetics|antiemetics|mesh-ancestor
102337307|NCT01091831|Autonomic Agents|autonomic agents|mesh-ancestor
102337308|NCT01091831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102337309|NCT01091831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102337310|NCT01091831|Glucocorticoids|glucocorticoids|mesh-ancestor
102337311|NCT01091831|Hormones|hormones|mesh-ancestor
102337312|NCT01091831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102337313|NCT01091831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102337314|NCT01091831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102337315|NCT01091831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102337316|NCT01091831|Growth Substances|growth substances|mesh-ancestor
102337317|NCT01091831|Growth Inhibitors|growth inhibitors|mesh-ancestor
102337318|NCT00093834|Cyclophosphamide|cyclophosphamide|mesh-list
102337319|NCT00093834|Doxorubicin|doxorubicin|mesh-list
102337320|NCT00093834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102337321|NCT00093834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102337322|NCT00093834|Immunologic Factors|immunologic factors|mesh-ancestor
102337323|NCT00093834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337324|NCT00093834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102337325|NCT00093834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102337326|NCT00093834|Alkylating Agents|alkylating agents|mesh-ancestor
102337327|NCT00093834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337328|NCT00093834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337329|NCT00093834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102337330|NCT00093834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102337331|NCT00093834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102337332|NCT00093834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102337333|NCT00093834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102337334|NCT01550289|Vaccines|vaccines|mesh-list
102337335|NCT01550289|Immunologic Factors|immunologic factors|mesh-ancestor
102337336|NCT01550289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337337|NCT01968031|Istradefylline|istradefylline|mesh-list
102337338|NCT01968031|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
102337339|NCT01968031|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102337340|NCT01968031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102337341|NCT01968031|Purinergic Agents|purinergic agents|mesh-ancestor
102337342|NCT01968031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102337343|NCT01968031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337344|NCT01968031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337345|NCT01684215|Letrozole|letrozole|mesh-list
102337346|NCT01684215|Palbociclib|palbociclib|mesh-list
101442600|NCT00197340|Anesthetics|anesthetics|mesh-ancestor
102337347|NCT01684215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337348|NCT01684215|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102337349|NCT01684215|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102337350|NCT01684215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102337351|NCT01684215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337352|NCT01684215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102337353|NCT01684215|Hormone Antagonists|hormone antagonists|mesh-ancestor
102337354|NCT01684215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102337355|NCT01684215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337356|NCT01684215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102337357|NCT01908205|Oxytocin|oxytocin|mesh-list
102337358|NCT01908205|Oxytocics|oxytocics|mesh-ancestor
102337359|NCT01908205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102337360|NCT01908205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337361|NCT03911739|Buprenorphine|buprenorphine|mesh-list
102337362|NCT03911739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102337363|NCT03911739|Narcotics|narcotics|mesh-ancestor
102337364|NCT03911739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102337365|NCT03911739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337366|NCT03911739|Analgesics|analgesics|mesh-ancestor
102337367|NCT03911739|Sensory System Agents|sensory system agents|mesh-ancestor
102337368|NCT03911739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102337369|NCT03911739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102337370|NCT01549041|Asenapine|asenapine|mesh-list
102337371|NCT01549041|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102337372|NCT01549041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102337373|NCT01549041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102337374|NCT01549041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337375|NCT01549041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102337376|NCT01907815|Trametinib|trametinib|mesh-list
102337377|NCT01907815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337378|NCT01907815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102337379|NCT01907815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102337380|NCT01907815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337381|NCT01548573|Thalidomide|thalidomide|mesh-list
102337382|NCT01548573|Dexamethasone|dexamethasone|mesh-list
102337383|NCT01548573|Cyclophosphamide|cyclophosphamide|mesh-list
102337384|NCT01548573|Melphalan|melphalan|mesh-list
102337385|NCT01548573|Doxorubicin|doxorubicin|mesh-list
102337386|NCT01548573|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102337387|NCT01548573|Etoposide|etoposide|mesh-list
102337388|NCT01548573|Etoposide phosphate|etoposide phosphate|mesh-list
102337389|NCT01548573|Bortezomib|bortezomib|mesh-list
102337390|NCT01548573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102337391|NCT01548573|Immunologic Factors|immunologic factors|mesh-ancestor
102337392|NCT01548573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337393|NCT01548573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102337394|NCT01548573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102337395|NCT01548573|Alkylating Agents|alkylating agents|mesh-ancestor
102337396|NCT01548573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337397|NCT01548573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337398|NCT01548573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102337399|NCT01548573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102337400|NCT01548573|Antiemetics|antiemetics|mesh-ancestor
102337401|NCT01548573|Autonomic Agents|autonomic agents|mesh-ancestor
102337402|NCT01548573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102337403|NCT01548573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102337404|NCT01548573|Glucocorticoids|glucocorticoids|mesh-ancestor
102337405|NCT01548573|Hormones|hormones|mesh-ancestor
102337406|NCT01548573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102337407|NCT01548573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102337408|NCT01548573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102337409|NCT01548573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102337410|NCT01548573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102337411|NCT01548573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102337412|NCT01548573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102337413|NCT01548573|Leprostatic Agents|leprostatic agents|mesh-ancestor
102337414|NCT01548573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102337415|NCT01548573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102337416|NCT01548573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102337417|NCT01548573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102337418|NCT01548573|Growth Substances|growth substances|mesh-ancestor
102337419|NCT01548573|Growth Inhibitors|growth inhibitors|mesh-ancestor
102337420|NCT01570491|Anesthetics|anesthetics|mesh-list
102337421|NCT01570491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102337422|NCT01570491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337423|NCT01518153|Methotrexate|methotrexate|mesh-list
102337424|NCT01518153|Fludarabine phosphate|fludarabine phosphate|mesh-list
102337425|NCT01518153|Fludarabine|fludarabine|mesh-list
102337426|NCT01518153|Melphalan|melphalan|mesh-list
102337427|NCT01518153|Alemtuzumab|alemtuzumab|mesh-list
102337428|NCT01518153|Tacrolimus|tacrolimus|mesh-list
102337429|NCT01518153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102337430|NCT01518153|Abortifacient Agents|abortifacient agents|mesh-ancestor
102337431|NCT01518153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102337432|NCT01518153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337433|NCT01518153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102337434|NCT01518153|Antimetabolites|antimetabolites|mesh-ancestor
102337435|NCT01518153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337436|NCT01518153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337437|NCT01518153|Dermatologic Agents|dermatologic agents|mesh-ancestor
102337438|NCT01518153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102337439|NCT01518153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102337440|NCT01518153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102337441|NCT01518153|Immunologic Factors|immunologic factors|mesh-ancestor
102337442|NCT01518153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102337443|NCT01518153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102337444|NCT01518153|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102337445|NCT01518153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102337446|NCT01518153|Alkylating Agents|alkylating agents|mesh-ancestor
102337447|NCT01518153|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102337448|NCT01518153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102337449|NCT04620343|Anesthetics|anesthetics|mesh-list
102337450|NCT04620343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102337451|NCT04620343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046278|NCT03618264|Ropivacaine|ropivacaine|mesh-list
102337452|NCT01517373|Glimepiride|glimepiride|mesh-list
102337453|NCT01517373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102337454|NCT01517373|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102337455|NCT01517373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337456|NCT01517373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102337457|NCT01517373|Immunologic Factors|immunologic factors|mesh-ancestor
102337458|NCT01517295|Hydrocodone|hydrocodone|mesh-list
102337459|NCT01517295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102337460|NCT01517295|Narcotics|narcotics|mesh-ancestor
102337461|NCT01517295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102337462|NCT01517295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337463|NCT01517295|Analgesics|analgesics|mesh-ancestor
102337464|NCT01517295|Sensory System Agents|sensory system agents|mesh-ancestor
102337465|NCT01517295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102337466|NCT01517295|Antitussive Agents|antitussive agents|mesh-ancestor
102337467|NCT01517295|Respiratory System Agents|respiratory system agents|mesh-ancestor
102337468|NCT01548417|Mifepristone|mifepristone|mesh-list
102337469|NCT01548417|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102337470|NCT01548417|Abortifacient Agents|abortifacient agents|mesh-ancestor
102337471|NCT01548417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102337472|NCT01548417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337473|NCT01548417|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102337474|NCT01548417|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102337475|NCT01548417|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102337476|NCT01548417|Contraceptive Agents|contraceptive agents|mesh-ancestor
102337477|NCT01548417|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102337478|NCT01548417|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102337479|NCT01548417|Hormone Antagonists|hormone antagonists|mesh-ancestor
102337480|NCT01548417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102337481|NCT01548417|Luteolytic Agents|luteolytic agents|mesh-ancestor
102337482|NCT01548417|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102337483|NCT01548417|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102337484|NCT01546857|Gabapentin|gabapentin|mesh-list
102337485|NCT01546857|Analgesics|analgesics|mesh-ancestor
102337486|NCT01546857|Sensory System Agents|sensory system agents|mesh-ancestor
102337487|NCT01546857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102337488|NCT01546857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337489|NCT01546857|Anticonvulsants|anticonvulsants|mesh-ancestor
102337490|NCT01546857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102337491|NCT01546857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102337492|NCT01546857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102337493|NCT01546857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102337494|NCT01546857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102337495|NCT01546857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102337496|NCT01546857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102337497|NCT01546857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337498|NCT01546857|Antimanic Agents|antimanic agents|mesh-ancestor
102337499|NCT01516749|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102337500|NCT01516749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102337501|NCT01515423|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102337502|NCT01515423|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102337503|NCT01515423|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102337504|NCT01515423|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102337505|NCT00637000|Buprenorphine|buprenorphine|mesh-list
102337506|NCT00637000|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102337507|NCT00637000|Naloxone|naloxone|mesh-list
102337508|NCT00637000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102337509|NCT00637000|Narcotics|narcotics|mesh-ancestor
102337510|NCT00637000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102337511|NCT00637000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337512|NCT00637000|Analgesics|analgesics|mesh-ancestor
102337513|NCT00637000|Sensory System Agents|sensory system agents|mesh-ancestor
102337514|NCT00637000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102337515|NCT00637000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102337516|NCT01515189|Ipilimumab|ipilimumab|mesh-list
102337517|NCT01515189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102337518|NCT01515189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337519|NCT01515189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102337520|NCT01515189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337521|NCT01546623|Leuprolide|leuprolide|mesh-list
102337522|NCT01546623|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102337523|NCT01546623|Fertility Agents|fertility agents|mesh-ancestor
102337524|NCT01546623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102337525|NCT01546623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046354|NCT01342835|Propofol|propofol|mesh-list
102337526|NCT01546623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102337527|NCT01546623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337528|NCT00636610|Bevacizumab|bevacizumab|mesh-list
102337529|NCT00636610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102337530|NCT00636610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337531|NCT00636610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102337532|NCT00636610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102337533|NCT00636610|Growth Substances|growth substances|mesh-ancestor
102337534|NCT00636610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337535|NCT00636610|Growth Inhibitors|growth inhibitors|mesh-ancestor
102337536|NCT00635050|Paclitaxel|paclitaxel|mesh-list
102337537|NCT00635050|Cyclophosphamide|cyclophosphamide|mesh-list
102337538|NCT00635050|Bevacizumab|bevacizumab|mesh-list
102337539|NCT00635050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102337540|NCT00635050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337541|NCT00635050|Tubulin Modulators|tubulin modulators|mesh-ancestor
102337542|NCT00635050|Antimitotic Agents|antimitotic agents|mesh-ancestor
102337543|NCT00635050|Mitosis Modulators|mitosis modulators|mesh-ancestor
102337544|NCT00635050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337545|NCT00635050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102337546|NCT00635050|Immunologic Factors|immunologic factors|mesh-ancestor
102337547|NCT00635050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337548|NCT00635050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102337549|NCT00635050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102337550|NCT00635050|Alkylating Agents|alkylating agents|mesh-ancestor
102337551|NCT00635050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102337552|NCT00635050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102337553|NCT00635050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102337554|NCT00635050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102337555|NCT00635050|Growth Substances|growth substances|mesh-ancestor
102337556|NCT00635050|Growth Inhibitors|growth inhibitors|mesh-ancestor
102337557|NCT05240404|Immunomodulating Agents|immunomodulating agents|mesh-list
102337558|NCT05240404|Immunologic Factors|immunologic factors|mesh-ancestor
102337559|NCT05240404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337560|NCT01923376|Lactulose|lactulose|mesh-list
102337561|NCT01923376|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
102337562|NCT01923376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102337563|NCT01923376|Laxatives|laxatives|mesh-ancestor
102337565|NCT05245786|Antibodies|antibodies|mesh-list
102337566|NCT05245786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102337567|NCT05245786|Immunologic Factors|immunologic factors|mesh-ancestor
102337568|NCT05245786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337569|NCT05245786|Trace Elements|trace elements|mesh-ancestor
102337570|NCT05245786|Micronutrients|micronutrients|mesh-ancestor
102337571|NCT00634504|Leucovorin|leucovorin|mesh-list
102337572|NCT00634504|Methotrexate|methotrexate|mesh-list
102337573|NCT00634504|Levoleucovorin|levoleucovorin|mesh-list
102337574|NCT00634504|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102337575|NCT00634504|Abortifacient Agents|abortifacient agents|mesh-ancestor
102337576|NCT00634504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102337577|NCT00634504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337578|NCT00634504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102337579|NCT00634504|Antimetabolites|antimetabolites|mesh-ancestor
102337580|NCT00634504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337581|NCT00634504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337582|NCT00634504|Dermatologic Agents|dermatologic agents|mesh-ancestor
102337583|NCT00634504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102337584|NCT00634504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102337585|NCT00634504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102337586|NCT00634504|Immunologic Factors|immunologic factors|mesh-ancestor
102337587|NCT00634504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102337588|NCT00634504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102337589|NCT00634504|Antidotes|antidotes|mesh-ancestor
102337590|NCT00634504|Protective Agents|protective agents|mesh-ancestor
102337591|NCT00634504|Vitamin B Complex|vitamin b complex|mesh-ancestor
102337592|NCT00634504|Vitamins|vitamins|mesh-ancestor
102337593|NCT00634504|Micronutrients|micronutrients|mesh-ancestor
102337594|NCT03101254|Vemurafenib|vemurafenib|mesh-list
102337595|NCT03101254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337596|NCT03101254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102337597|NCT03101254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102337598|NCT03101254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337599|NCT00634114|Esomeprazole|esomeprazole|mesh-list
102046434|NCT01358383|Analgesics|analgesics|mesh-ancestor
102337600|NCT00634114|Omeprazole|omeprazole|mesh-list
102337601|NCT00634114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102337602|NCT00634114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102337603|NCT00634114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102337604|NCT00634114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102337605|NCT00634114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337606|NCT00634036|Pioglitazone|pioglitazone|mesh-list
102337607|NCT00634036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102337608|NCT00634036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337609|NCT05241496|Lidocaine|lidocaine|mesh-list
102337610|NCT05241496|Anesthetics, Local|anesthetics, local|mesh-ancestor
102337611|NCT05241496|Anesthetics|anesthetics|mesh-ancestor
102337612|NCT05241496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102337613|NCT05241496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337614|NCT05241496|Sensory System Agents|sensory system agents|mesh-ancestor
102337615|NCT05241496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102337616|NCT05241496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102337617|NCT05241496|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102337618|NCT05241496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102337619|NCT05241496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102337620|NCT05241496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337621|NCT01545375|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102337622|NCT01545375|Immunologic Factors|immunologic factors|mesh-ancestor
102337623|NCT01545375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337624|NCT01539837|Deferiprone|deferiprone|mesh-list
102337625|NCT01539837|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102337626|NCT01539837|Chelating Agents|chelating agents|mesh-ancestor
102337627|NCT01539837|Sequestering Agents|sequestering agents|mesh-ancestor
102337628|NCT01539837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337629|NCT03156790|Asparaginase|asparaginase|mesh-list
102337630|NCT03156790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337631|NCT03153202|Pembrolizumab|pembrolizumab|mesh-list
102337632|NCT03153202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102337633|NCT03153202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337634|NCT03153202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102337635|NCT03153202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337636|NCT04410081|Lazertinib|lazertinib|mesh-list
102337637|NCT04410081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102337638|NCT04410081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102337639|NCT04410081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337641|NCT01923844|Beractant|beractant|mesh-list
102337642|NCT01923844|Respiratory System Agents|respiratory system agents|mesh-ancestor
102337643|NCT01924000|Minoxidil|minoxidil|mesh-list
102337644|NCT01924000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102337645|NCT01924000|Vasodilator Agents|vasodilator agents|mesh-ancestor
102337646|NCT01924078|Capecitabine|capecitabine|mesh-list
102337647|NCT01924078|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102337648|NCT01924078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102337649|NCT01924078|Antimetabolites|antimetabolites|mesh-ancestor
102337650|NCT01924078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337651|NCT01924078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337652|NCT01924078|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102337653|NCT01924078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102337654|NCT01924078|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102337655|NCT01924078|Hormone Antagonists|hormone antagonists|mesh-ancestor
102337656|NCT01924078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102337657|NCT01924078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337658|NCT00630994|Decitabine|decitabine|mesh-list
102337659|NCT00630994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102337660|NCT00630994|Antimetabolites|antimetabolites|mesh-ancestor
102337661|NCT00630994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337662|NCT00630994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337663|NCT00630994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102337664|NCT01924234|Morphine|morphine|mesh-list
102337665|NCT01924234|Remifentanil|remifentanil|mesh-list
102337666|NCT01924234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102337667|NCT01924234|Narcotics|narcotics|mesh-ancestor
102337668|NCT01924234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102337669|NCT01924234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337670|NCT01924234|Analgesics|analgesics|mesh-ancestor
102337671|NCT01924234|Sensory System Agents|sensory system agents|mesh-ancestor
102337672|NCT01924234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102337673|NCT00630058|Interferon-alpha|interferon-alpha|mesh-list
102337674|NCT00630058|Interferon alpha-2|interferon alpha-2|mesh-list
102337675|NCT00630058|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
102337676|NCT00630058|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102337677|NCT00630058|Antiviral Agents|antiviral agents|mesh-ancestor
102337678|NCT00630058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102337679|NCT00630058|Immunologic Factors|immunologic factors|mesh-ancestor
102337680|NCT00630058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337681|NCT00630058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337682|NCT01927198|Verinurad|verinurad|mesh-list
102337683|NCT01927198|Gout Suppressants|gout suppressants|mesh-ancestor
102337684|NCT01927198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102337685|NCT01924468|Haloperidol|haloperidol|mesh-list
102337686|NCT01924468|Haloperidol decanoate|haloperidol decanoate|mesh-list
102337687|NCT01924468|Methylphenidate|methylphenidate|mesh-list
102337688|NCT01924468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102337689|NCT01924468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337690|NCT01924468|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102337691|NCT01924468|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102337692|NCT01924468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102337693|NCT01924468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337694|NCT01924468|Dopamine Agents|dopamine agents|mesh-ancestor
102337695|NCT01924468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102337696|NCT01924468|Antiemetics|antiemetics|mesh-ancestor
102337697|NCT01924468|Autonomic Agents|autonomic agents|mesh-ancestor
102337698|NCT01924468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102337699|NCT01924468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102337700|NCT01924468|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101442632|NCT00171665|Analgesics|analgesics|mesh-ancestor
102337701|NCT01924468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102337702|NCT01924468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102337703|NCT01924468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102337704|NCT01924468|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102337705|NCT01924468|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102337706|NCT01923064|Ethiodized Oil|ethiodized oil|mesh-list
102337707|NCT01923064|Polidocanol|polidocanol|mesh-list
102337708|NCT01923064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337709|NCT01923064|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102337710|NCT01923064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102337711|NCT01924624|Thalidomide|thalidomide|mesh-list
102337712|NCT01924624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102337713|NCT01924624|Immunologic Factors|immunologic factors|mesh-ancestor
102337714|NCT01924624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337715|NCT01924624|Leprostatic Agents|leprostatic agents|mesh-ancestor
102337716|NCT01924624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102337717|NCT01924624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102337718|NCT01924624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102337719|NCT01924624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102337721|NCT01924624|Growth Inhibitors|growth inhibitors|mesh-ancestor
102337722|NCT01924624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337723|NCT01929382|Interferons|interferons|mesh-list
102337724|NCT01929382|Interferon-gamma|interferon-gamma|mesh-list
102337725|NCT01929382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337726|NCT01929382|Antiviral Agents|antiviral agents|mesh-ancestor
102337727|NCT01929382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102337728|NCT00989950|Methylphenidate|methylphenidate|mesh-list
102337729|NCT00989950|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102337730|NCT00989950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337731|NCT00989950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102337732|NCT00989950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102337733|NCT00989950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102337734|NCT00989950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337735|NCT00989950|Dopamine Agents|dopamine agents|mesh-ancestor
102337736|NCT00989950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102337737|NCT03121456|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102337738|NCT03121456|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102337739|NCT03121456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337740|NCT01925092|Mifepristone|mifepristone|mesh-list
102337741|NCT01925092|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102337742|NCT01925092|Abortifacient Agents|abortifacient agents|mesh-ancestor
102337743|NCT01925092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102337744|NCT01925092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337745|NCT01925092|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102337746|NCT01925092|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102337747|NCT01925092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102337748|NCT01925092|Contraceptive Agents|contraceptive agents|mesh-ancestor
102337749|NCT01925092|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102337750|NCT01925092|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102337751|NCT01925092|Hormone Antagonists|hormone antagonists|mesh-ancestor
102337752|NCT01925092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102337753|NCT01925092|Luteolytic Agents|luteolytic agents|mesh-ancestor
102337754|NCT01925092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102337755|NCT01925092|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102337757|NCT01905943|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102337758|NCT01905943|Chlorambucil|chlorambucil|mesh-list
102337759|NCT01905943|Fludarabine|fludarabine|mesh-list
102337760|NCT01905943|Obinutuzumab|obinutuzumab|mesh-list
102337761|NCT01905943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102337762|NCT01905943|Immunologic Factors|immunologic factors|mesh-ancestor
102337763|NCT01905943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337764|NCT01905943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102337765|NCT01905943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102337766|NCT01905943|Alkylating Agents|alkylating agents|mesh-ancestor
102337767|NCT01905943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337768|NCT01905943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337769|NCT01905943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102337770|NCT01905943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102337771|NCT01929031|Ibuprofen|ibuprofen|mesh-list
102337772|NCT01929031|Caffeine|caffeine|mesh-list
102337773|NCT01929031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102337774|NCT01929031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102337775|NCT01929031|Analgesics|analgesics|mesh-ancestor
102337776|NCT01929031|Sensory System Agents|sensory system agents|mesh-ancestor
102337777|NCT01929031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102337778|NCT01929031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337779|NCT01929031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102337780|NCT01929031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102337781|NCT01929031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102337782|NCT01929031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102337783|NCT01929031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337784|NCT01929031|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102337785|NCT01929031|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102337786|NCT01929031|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102337787|NCT01929031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102337788|NCT01929031|Purinergic Agents|purinergic agents|mesh-ancestor
102337789|NCT01929031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102337790|NCT00989092|Darbepoetin alfa|darbepoetin alfa|mesh-list
102337791|NCT00989092|Hematinics|hematinics|mesh-ancestor
102337792|NCT00988858|Pemetrexed|pemetrexed|mesh-list
102337793|NCT00988858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337794|NCT00988858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102337795|NCT00988858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337796|NCT00988858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102337797|NCT00988858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102337798|NCT01920334|Zolpidem|zolpidem|mesh-list
102337799|NCT01920334|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102337800|NCT01920334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102337801|NCT01920334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102337802|NCT01920334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337803|NCT01920334|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102337804|NCT01920334|GABA Agonists|gaba agonists|mesh-ancestor
102337805|NCT01920334|GABA Agents|gaba agents|mesh-ancestor
102337806|NCT01920334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102337807|NCT01920334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337808|NCT03096418|Paclitaxel|paclitaxel|mesh-list
102337809|NCT03096418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102337810|NCT03096418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337811|NCT03096418|Tubulin Modulators|tubulin modulators|mesh-ancestor
102337812|NCT03096418|Antimitotic Agents|antimitotic agents|mesh-ancestor
102337813|NCT03096418|Mitosis Modulators|mitosis modulators|mesh-ancestor
102337814|NCT03096418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337815|NCT00986986|Niacin|niacin|mesh-list
102337816|NCT00986986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102337817|NCT00986986|Antimetabolites|antimetabolites|mesh-ancestor
102337818|NCT00986986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337819|NCT00986986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102337820|NCT00986986|Vasodilator Agents|vasodilator agents|mesh-ancestor
102337821|NCT00986986|Vitamin B Complex|vitamin b complex|mesh-ancestor
102337822|NCT00986986|Vitamins|vitamins|mesh-ancestor
102337823|NCT00986986|Micronutrients|micronutrients|mesh-ancestor
102337824|NCT00986986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337825|NCT01928719|Nicotine|nicotine|mesh-list
102337826|NCT01928719|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102337827|NCT01928719|Autonomic Agents|autonomic agents|mesh-ancestor
102337828|NCT01928719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102337829|NCT01928719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337830|NCT01928719|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102337831|NCT01928719|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102337832|NCT01928719|Cholinergic Agents|cholinergic agents|mesh-ancestor
102337833|NCT01928719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102337834|NCT01928719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337835|NCT00986674|Paclitaxel|paclitaxel|mesh-list
102337836|NCT00986674|Carboplatin|carboplatin|mesh-list
102337837|NCT00986674|Cetuximab|cetuximab|mesh-list
102337838|NCT00986674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102337839|NCT00986674|Antibodies|antibodies|mesh-list
102337840|NCT00986674|Immunoglobulins|immunoglobulins|mesh-list
102337841|NCT00986674|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102337842|NCT00986674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102337843|NCT00986674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337844|NCT00986674|Tubulin Modulators|tubulin modulators|mesh-ancestor
102337845|NCT00986674|Antimitotic Agents|antimitotic agents|mesh-ancestor
102337846|NCT00986674|Mitosis Modulators|mitosis modulators|mesh-ancestor
102337847|NCT00986674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337848|NCT00986674|Immunologic Factors|immunologic factors|mesh-ancestor
102337849|NCT00986674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337850|NCT00986440|Efatutazone|efatutazone|mesh-list
102337851|NCT00986440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337852|NCT01904149|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
102337853|NCT01904149|Tramadol|tramadol|mesh-list
102337854|NCT01904149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102337855|NCT01904149|Narcotics|narcotics|mesh-ancestor
102337856|NCT01904149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102337857|NCT01904149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337858|NCT01904149|Analgesics|analgesics|mesh-ancestor
102337859|NCT01904149|Sensory System Agents|sensory system agents|mesh-ancestor
102337860|NCT01904149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102337861|NCT01904149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102337862|NCT01904149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102337863|NCT01904149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102337864|NCT01904149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102337865|NCT01925638|Ketoconazole|ketoconazole|mesh-list
102337866|NCT01925638|Antifungal Agents|antifungal agents|mesh-ancestor
102337867|NCT01925638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102337868|NCT01925638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102337869|NCT01925638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102337870|NCT01925638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102337871|NCT01925638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337872|NCT01925638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102337873|NCT01925638|Hormone Antagonists|hormone antagonists|mesh-ancestor
102337874|NCT01925638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102337875|NCT01925638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337876|NCT01925638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102337877|NCT00985738|Dutasteride|dutasteride|mesh-list
102337878|NCT00985738|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102337879|NCT00985738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102337880|NCT00985738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102337881|NCT00985738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337882|NCT00985738|Hormone Antagonists|hormone antagonists|mesh-ancestor
102337883|NCT00985738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102337884|NCT00985738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337885|NCT00985504|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102337886|NCT00985504|Escitalopram|escitalopram|mesh-list
102337887|NCT00985504|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102337888|NCT00985504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102337889|NCT00985504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102337890|NCT00985504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337891|NCT00985504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102337892|NCT00985504|Serotonin Agents|serotonin agents|mesh-ancestor
102337893|NCT00985504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337894|NCT00985504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102337895|NCT00985504|Antidepressive Agents|antidepressive agents|mesh-ancestor
102337896|NCT00985504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102337897|NCT00985504|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102337899|NCT00985504|Sensory System Agents|sensory system agents|mesh-ancestor
102337900|NCT00985504|Dopamine Agents|dopamine agents|mesh-ancestor
102337902|NCT01921192|Hematinics|hematinics|mesh-ancestor
102337903|NCT01921192|Vitamin B Complex|vitamin b complex|mesh-ancestor
102337904|NCT01921192|Vitamins|vitamins|mesh-ancestor
102337905|NCT01921192|Micronutrients|micronutrients|mesh-ancestor
102337906|NCT01921192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337907|NCT04275388|Interferons|interferons|mesh-list
102337908|NCT04275388|Ritonavir|ritonavir|mesh-list
102337909|NCT04275388|Lopinavir|lopinavir|mesh-list
102337910|NCT04275388|Interferon-alpha|interferon-alpha|mesh-list
102337911|NCT04275388|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
102337912|NCT04275388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337913|NCT04275388|Antiviral Agents|antiviral agents|mesh-ancestor
102337914|NCT04275388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102337915|NCT04275388|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102337916|NCT04275388|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102337917|NCT04275388|Protease Inhibitors|protease inhibitors|mesh-ancestor
102337918|NCT04275388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102337919|NCT04275388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337920|NCT04275388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102337921|NCT04275388|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102337922|NCT04275388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102337923|NCT04275388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102337924|NCT04275388|Immunologic Factors|immunologic factors|mesh-ancestor
102337925|NCT04275388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337926|NCT01921426|Avasopasem manganese|avasopasem manganese|mesh-list
102337927|NCT01921426|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102337928|NCT01921426|Antioxidants|antioxidants|mesh-ancestor
102337929|NCT01921426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337930|NCT01921426|Protective Agents|protective agents|mesh-ancestor
102337931|NCT01921426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337932|NCT01921582|Methylphenidate|methylphenidate|mesh-list
102337933|NCT01921582|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102337934|NCT01921582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337935|NCT01921582|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102337936|NCT01921582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102337937|NCT01921582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102337938|NCT01921582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337939|NCT01921582|Dopamine Agents|dopamine agents|mesh-ancestor
102337940|NCT01921582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102337941|NCT00985426|Vaccines|vaccines|mesh-list
102337942|NCT00985426|Immunologic Factors|immunologic factors|mesh-ancestor
102337943|NCT00985426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337944|NCT00985192|Everolimus|everolimus|mesh-list
102337945|NCT00985192|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102337946|NCT00985192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102337947|NCT00985192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102337948|NCT00985192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337949|NCT00985192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102337950|NCT00985192|Immunologic Factors|immunologic factors|mesh-ancestor
102337951|NCT00985192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337952|NCT00985192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102337953|NCT03390010|Misoprostol|misoprostol|mesh-list
102337954|NCT03390010|Carboprost|carboprost|mesh-list
102337955|NCT03390010|Oxytocin|oxytocin|mesh-list
102337956|NCT03390010|Methylergonovine|methylergonovine|mesh-list
102337957|NCT03390010|Carboprost tromethamine|carboprost tromethamine|mesh-list
102337958|NCT03390010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102337959|NCT03390010|Abortifacient Agents|abortifacient agents|mesh-ancestor
102337960|NCT03390010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102337961|NCT03390010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337962|NCT03390010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102337963|NCT03390010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102337964|NCT03390010|Oxytocics|oxytocics|mesh-ancestor
102337965|NCT00984568|Aminosalicylic Acid|aminosalicylic acid|mesh-list
102337966|NCT00984568|Prednisolone|prednisolone|mesh-list
102337967|NCT00984568|Infliximab|infliximab|mesh-list
102337968|NCT00984568|Mesalamine|mesalamine|mesh-list
102337969|NCT00984568|Azathioprine|azathioprine|mesh-list
102337970|NCT00984568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102337971|NCT00984568|Glucocorticoids|glucocorticoids|mesh-ancestor
102337972|NCT00984568|Hormones|hormones|mesh-ancestor
102337973|NCT00984568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102337974|NCT00984568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102337975|NCT00984568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102337977|NCT00984568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102337978|NCT00984568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102337979|NCT00984568|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102337980|NCT00984568|Dermatologic Agents|dermatologic agents|mesh-ancestor
102337981|NCT00984568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102337982|NCT00984568|Antimetabolites|antimetabolites|mesh-ancestor
102337983|NCT00984568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337984|NCT00984568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102337985|NCT00984568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102337986|NCT00984568|Immunologic Factors|immunologic factors|mesh-ancestor
102337987|NCT00984568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102337988|NCT00984568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102337989|NCT00984568|Analgesics|analgesics|mesh-ancestor
102337990|NCT00984568|Sensory System Agents|sensory system agents|mesh-ancestor
102337991|NCT00984568|Antitubercular Agents|antitubercular agents|mesh-ancestor
102337992|NCT00984568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102337993|NCT00984568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102337994|NCT02984176|Simethicone|simethicone|mesh-list
102337995|NCT02984176|Antifoaming Agents|antifoaming agents|mesh-ancestor
102337996|NCT02984176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102337997|NCT02984176|Emollients|emollients|mesh-ancestor
102337998|NCT02984176|Dermatologic Agents|dermatologic agents|mesh-ancestor
102337999|NCT01921738|Azithromycin|azithromycin|mesh-list
102338000|NCT01921738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102338001|NCT01921738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102338002|NCT01921816|Dialysis Solutions|dialysis solutions|mesh-list
102338003|NCT01921816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102338004|NCT00984256|Atovaquone|atovaquone|mesh-list
102338005|NCT00984256|Proguanil|proguanil|mesh-list
102338006|NCT00984256|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
102338007|NCT00984256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102338008|NCT00984256|Antimalarials|antimalarials|mesh-ancestor
102338009|NCT00984256|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102338010|NCT00984256|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102338011|NCT00984256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102338012|NCT00984256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338013|NCT00984256|Antimetabolites|antimetabolites|mesh-ancestor
102338014|NCT00984022|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102338016|NCT00984022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102338017|NCT01890265|Pirfenidone|pirfenidone|mesh-list
102338018|NCT01890265|Nintedanib|nintedanib|mesh-list
102338019|NCT01890265|Immunoglobulins|immunoglobulins|mesh-list
102338020|NCT01890265|Antibodies|antibodies|mesh-list
102338021|NCT01890265|Immunoglobulin G|immunoglobulin g|mesh-list
102338022|NCT01890265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102338023|NCT01890265|Immunologic Factors|immunologic factors|mesh-ancestor
102338024|NCT01890265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338025|NCT01890265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102338026|NCT01890265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102338027|NCT01890265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102338028|NCT01890265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338029|NCT01890265|Analgesics|analgesics|mesh-ancestor
102338030|NCT01890265|Sensory System Agents|sensory system agents|mesh-ancestor
102338031|NCT01890265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102338032|NCT01890265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102338033|NCT01890265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102338034|NCT01890265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102338035|NCT01890265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102338036|NCT01926652|Amlodipine|amlodipine|mesh-list
102338037|NCT01926652|Candesartan|candesartan|mesh-list
102338038|NCT01926652|Candesartan cilexetil|candesartan cilexetil|mesh-list
102338039|NCT01926652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102338040|NCT01926652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102338041|NCT01926652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102338042|NCT01926652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338043|NCT01926652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102338044|NCT01926652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338045|NCT01926652|Vasodilator Agents|vasodilator agents|mesh-ancestor
102338046|NCT01926652|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102338047|NCT01926652|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102338048|NCT01928329|Exenatide|exenatide|mesh-list
102338049|NCT01928329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101442653|NCT05223478|Phentolamine|phentolamine|mesh-list
102338050|NCT01928329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338051|NCT01928329|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102338052|NCT01928329|Incretins|incretins|mesh-ancestor
102338053|NCT01928329|Hormones|hormones|mesh-ancestor
102338054|NCT01928329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102338055|NCT01890109|Erenumab|erenumab|mesh-list
102338056|NCT01890109|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
102338057|NCT01890109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338058|NCT01890109|Analgesics|analgesics|mesh-ancestor
102338059|NCT01890109|Sensory System Agents|sensory system agents|mesh-ancestor
102338060|NCT01890109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102338061|NCT01890109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338062|NCT03069976|Metronidazole|metronidazole|mesh-list
102338063|NCT03069976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102338064|NCT03069976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102338065|NCT03069976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102338066|NCT03069976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102338067|NCT00982930|Tobramycin|tobramycin|mesh-list
102338068|NCT00982930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102338069|NCT00982930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102338070|NCT03088540|Paclitaxel|paclitaxel|mesh-list
102338071|NCT03088540|Carboplatin|carboplatin|mesh-list
102338072|NCT03088540|Gemcitabine|gemcitabine|mesh-list
102338073|NCT03088540|Pemetrexed|pemetrexed|mesh-list
102338074|NCT03088540|Cemiplimab|cemiplimab|mesh-list
102338075|NCT03088540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102338076|NCT03088540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102338077|NCT03088540|Tubulin Modulators|tubulin modulators|mesh-ancestor
102338078|NCT03088540|Antimitotic Agents|antimitotic agents|mesh-ancestor
102338079|NCT03088540|Mitosis Modulators|mitosis modulators|mesh-ancestor
102338080|NCT03088540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338081|NCT03088540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102338082|NCT03088540|Antimetabolites|antimetabolites|mesh-ancestor
102338083|NCT03088540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102338084|NCT03088540|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102338085|NCT03088540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102338086|NCT03088540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102338087|NCT01903993|Docetaxel|docetaxel|mesh-list
102338088|NCT01903993|Atezolizumab|atezolizumab|mesh-list
102338089|NCT01903993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102338090|NCT01903993|Tubulin Modulators|tubulin modulators|mesh-ancestor
102338091|NCT01903993|Antimitotic Agents|antimitotic agents|mesh-ancestor
102338092|NCT01903993|Mitosis Modulators|mitosis modulators|mesh-ancestor
102338093|NCT01903993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338094|NCT01903993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102338095|NCT01903993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102338096|NCT00980044|Tramadol|tramadol|mesh-list
102338097|NCT00980044|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102338098|NCT00980044|Narcotics|narcotics|mesh-ancestor
102338099|NCT00980044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102338100|NCT00980044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338101|NCT00980044|Analgesics|analgesics|mesh-ancestor
102338102|NCT00980044|Sensory System Agents|sensory system agents|mesh-ancestor
102338103|NCT00980044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102338104|NCT03049306|Propranolol|propranolol|mesh-list
102338105|NCT03049306|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102338106|NCT03049306|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102338107|NCT03049306|Adrenergic Agents|adrenergic agents|mesh-ancestor
102338108|NCT03049306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102338109|NCT03049306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338110|NCT03049306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338111|NCT03049306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102338112|NCT03049306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102338113|NCT03049306|Vasodilator Agents|vasodilator agents|mesh-ancestor
102338114|NCT01927588|Prednisone|prednisone|mesh-list
102338115|NCT01927588|Everolimus|everolimus|mesh-list
102338116|NCT01927588|Tacrolimus|tacrolimus|mesh-list
102338117|NCT01927588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102338118|NCT01927588|Glucocorticoids|glucocorticoids|mesh-ancestor
102338119|NCT01927588|Hormones|hormones|mesh-ancestor
102338120|NCT01927588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102338121|NCT01927588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338122|NCT01927588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102338123|NCT01927588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102338124|NCT01927588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102338125|NCT01927588|Immunologic Factors|immunologic factors|mesh-ancestor
102338127|NCT01927588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102338128|NCT01927588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338129|NCT01927588|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102338130|NCT01927588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102338131|NCT05601466|Cytarabine|cytarabine|mesh-list
102338132|NCT05601466|Cyclophosphamide|cyclophosphamide|mesh-list
102338133|NCT05601466|Fludarabine|fludarabine|mesh-list
102338134|NCT05601466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102338135|NCT05601466|Immunologic Factors|immunologic factors|mesh-ancestor
102338136|NCT05601466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338137|NCT05601466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102338138|NCT05601466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102338139|NCT05601466|Alkylating Agents|alkylating agents|mesh-ancestor
102338140|NCT05601466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338141|NCT05601466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102338142|NCT05601466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102338143|NCT05601466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102338144|NCT05601466|Antimetabolites|antimetabolites|mesh-ancestor
102338145|NCT05601466|Antiviral Agents|antiviral agents|mesh-ancestor
102338146|NCT05601466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102338147|NCT01903837|Naltrexone|naltrexone|mesh-list
102338148|NCT01903837|Olanzapine|olanzapine|mesh-list
102338149|NCT01903837|ALKS-33|alks-33|mesh-list
102338150|NCT01903837|Antiemetics|antiemetics|mesh-ancestor
102338151|NCT01903837|Autonomic Agents|autonomic agents|mesh-ancestor
102338152|NCT01903837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102338153|NCT01903837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338154|NCT01903837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102338155|NCT01903837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102338156|NCT01903837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102338157|NCT01903837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102338158|NCT01903837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102338159|NCT01903837|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102338160|NCT01903837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102338161|NCT01903837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102338162|NCT01903837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338163|NCT01903837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102338164|NCT01903837|Serotonin Agents|serotonin agents|mesh-ancestor
102338165|NCT01903837|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102338166|NCT01903837|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102338168|NCT00982696|Analgesics, Opioid|analgesics, opioid|mesh-list
102338169|NCT00982696|Mitogens|mitogens|mesh-list
102338170|NCT00982696|Enkephalins|enkephalins|mesh-list
102338171|NCT00982696|Opioid Peptides|opioid peptides|mesh-list
102338172|NCT00982696|Narcotics|narcotics|mesh-ancestor
102338173|NCT00982696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102338174|NCT00982696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338175|NCT00982696|Analgesics|analgesics|mesh-ancestor
102338176|NCT00982696|Sensory System Agents|sensory system agents|mesh-ancestor
102338177|NCT00982696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102338178|NCT00982696|Mitosis Modulators|mitosis modulators|mesh-ancestor
102338179|NCT00982696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338180|NCT00982696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102338181|NCT00981526|Telmisartan|telmisartan|mesh-list
102338182|NCT00981526|Olanzapine|olanzapine|mesh-list
102338183|NCT00981526|Clozapine|clozapine|mesh-list
102338184|NCT00981526|Antiemetics|antiemetics|mesh-ancestor
102338185|NCT00981526|Autonomic Agents|autonomic agents|mesh-ancestor
102338186|NCT00981526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102338187|NCT00981526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338188|NCT00981526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102338189|NCT00981526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102338190|NCT00981526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102338191|NCT00981526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102338192|NCT00981526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102338193|NCT00981526|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102338194|NCT00981526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102338195|NCT00981526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102338196|NCT00981526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338197|NCT00981526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102338198|NCT00981526|Serotonin Agents|serotonin agents|mesh-ancestor
102047029|NCT05095857|Antidepressive Agents|antidepressive agents|mesh-ancestor
102338199|NCT00981526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102338200|NCT00981526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102338201|NCT00981526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102338202|NCT00981526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102338204|NCT00981526|GABA Agents|gaba agents|mesh-ancestor
102338205|NCT04274920|Calcium|calcium|mesh-list
102338206|NCT04274920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102338207|NCT04274920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338208|NCT04274608|Botulinum Toxins|botulinum toxins|mesh-list
102338209|NCT04274608|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102338210|NCT04274608|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102338211|NCT04274608|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102338212|NCT04274608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102338213|NCT04274608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338214|NCT04274608|Cholinergic Agents|cholinergic agents|mesh-ancestor
102338215|NCT04274608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102338216|NCT04274608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338217|NCT04274608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102338218|NCT04274608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102338219|NCT05607940|Chrysarobin|chrysarobin|mesh-list
102338220|NCT05607940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102338221|NCT05607940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102338222|NCT05607940|Analgesics|analgesics|mesh-ancestor
102338223|NCT05607940|Sensory System Agents|sensory system agents|mesh-ancestor
102338224|NCT05607940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102338225|NCT05607940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338226|NCT05607940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102338227|NCT05607940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102338228|NCT04394728|Trabectedin|trabectedin|mesh-list
102338229|NCT04394728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102338230|NCT04394728|Alkylating Agents|alkylating agents|mesh-ancestor
102338231|NCT04394728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338232|NCT04394728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102338233|NCT05600608|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
102338234|NCT05600608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338235|NCT01616173|Dexamethasone|dexamethasone|mesh-list
102338236|NCT01616173|Dexamethasone acetate|dexamethasone acetate|mesh-list
102338237|NCT01616173|BB 1101|bb 1101|mesh-list
102338238|NCT01616173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102338239|NCT01616173|Antiemetics|antiemetics|mesh-ancestor
102338240|NCT01616173|Autonomic Agents|autonomic agents|mesh-ancestor
102338241|NCT01616173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102338242|NCT01616173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338244|NCT01616173|Glucocorticoids|glucocorticoids|mesh-ancestor
102338245|NCT01616173|Hormones|hormones|mesh-ancestor
102338246|NCT01616173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102338247|NCT01616173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102338248|NCT01616173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102338249|NCT01616173|Protease Inhibitors|protease inhibitors|mesh-ancestor
102338250|NCT01616173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102338251|NCT01616173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338252|NCT05609500|Warfarin|warfarin|mesh-list
102338253|NCT05609500|Anticoagulants|anticoagulants|mesh-ancestor
102338254|NCT03044314|Nitric Oxide|nitric oxide|mesh-list
102338255|NCT03044314|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102338256|NCT03044314|Autonomic Agents|autonomic agents|mesh-ancestor
102338257|NCT03044314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102338258|NCT03044314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338259|NCT03044314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102338260|NCT03044314|Respiratory System Agents|respiratory system agents|mesh-ancestor
102338261|NCT03044314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102338262|NCT03044314|Antioxidants|antioxidants|mesh-ancestor
102338263|NCT03044314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338264|NCT03044314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102338265|NCT03044314|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102338266|NCT03044314|Vasodilator Agents|vasodilator agents|mesh-ancestor
102338267|NCT03044314|Gasotransmitters|gasotransmitters|mesh-ancestor
102338268|NCT03044314|Protective Agents|protective agents|mesh-ancestor
102338269|NCT05608642|Prednisolone|prednisolone|mesh-list
102338270|NCT05608642|Lidocaine|lidocaine|mesh-list
102338271|NCT05608642|Anesthetics, Local|anesthetics, local|mesh-ancestor
102338272|NCT05608642|Anesthetics|anesthetics|mesh-ancestor
102338273|NCT05608642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102338274|NCT05608642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338275|NCT05608642|Sensory System Agents|sensory system agents|mesh-ancestor
102338276|NCT05608642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102338277|NCT05608642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102338278|NCT05608642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102338279|NCT05608642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102338280|NCT05608642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102338281|NCT05608642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338282|NCT05608642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102338283|NCT05608642|Glucocorticoids|glucocorticoids|mesh-ancestor
102338284|NCT05608642|Hormones|hormones|mesh-ancestor
102338285|NCT05608642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102338286|NCT05608642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102338287|NCT05608642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102338288|NCT05608564|Amoxicillin|amoxicillin|mesh-list
102338289|NCT05608564|Metronidazole|metronidazole|mesh-list
102338290|NCT05608564|Tazobactam|tazobactam|mesh-list
102338291|NCT05608564|Piperacillin|piperacillin|mesh-list
102338292|NCT05608564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102338293|NCT05608564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102338294|NCT05608564|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102338295|NCT05608564|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102338296|NCT05608564|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102338297|NCT05608564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102338298|NCT05608564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338299|NCT03036904|Prednisone|prednisone|mesh-list
102338300|NCT03036904|Cyclophosphamide|cyclophosphamide|mesh-list
102338301|NCT03036904|Rituximab|rituximab|mesh-list
102338302|NCT03036904|Doxorubicin|doxorubicin|mesh-list
102338303|NCT03036904|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102338304|NCT03036904|Etoposide|etoposide|mesh-list
102338305|NCT03036904|Vincristine|vincristine|mesh-list
102338306|NCT03036904|Venetoclax|venetoclax|mesh-list
102338307|NCT03036904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102338308|NCT03036904|Immunologic Factors|immunologic factors|mesh-ancestor
102338309|NCT03036904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338310|NCT03036904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102338311|NCT03036904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102338312|NCT03036904|Alkylating Agents|alkylating agents|mesh-ancestor
102338313|NCT03036904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338314|NCT03036904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102338315|NCT03036904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102338316|NCT03036904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102338317|NCT03036904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102338318|NCT03036904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102338319|NCT03036904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102338321|NCT03036904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102338322|NCT03036904|Glucocorticoids|glucocorticoids|mesh-ancestor
102338323|NCT03036904|Hormones|hormones|mesh-ancestor
102338324|NCT03036904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102338325|NCT03036904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102338326|NCT03036904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102338327|NCT03036904|Tubulin Modulators|tubulin modulators|mesh-ancestor
102338328|NCT03036904|Antimitotic Agents|antimitotic agents|mesh-ancestor
102338329|NCT03036904|Mitosis Modulators|mitosis modulators|mesh-ancestor
102338330|NCT05604898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102338331|NCT05604898|Antibodies|antibodies|mesh-list
102338332|NCT05604898|Immunoglobulins|immunoglobulins|mesh-list
102338333|NCT05604898|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102338334|NCT05604898|Immunologic Factors|immunologic factors|mesh-ancestor
102338335|NCT05604898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338336|NCT05604898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102338337|NCT04392700|Tenofovir|tenofovir|mesh-list
102338338|NCT04392700|Entecavir|entecavir|mesh-list
102338339|NCT04392700|Antiviral Agents|antiviral agents|mesh-ancestor
102338340|NCT04392700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102338341|NCT04392700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102338342|NCT04392700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102338343|NCT04392700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102338344|NCT04392700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338345|NCT04392700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102338346|NCT04392700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102047177|NCT05250245|Tolterodine Tartrate|tolterodine tartrate|mesh-list
102338347|NCT03828058|Tacrolimus|tacrolimus|mesh-list
102338348|NCT03828058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102338350|NCT03828058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338351|NCT03828058|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102338352|NCT03828058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102338353|NCT03828058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338354|NCT01513551|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102338355|NCT01513551|Immunologic Factors|immunologic factors|mesh-ancestor
102338356|NCT01513551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338357|NCT03827122|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102338358|NCT03827122|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102338359|NCT03827122|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102338360|NCT03827122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102338361|NCT03827122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338362|NCT03827122|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102338363|NCT03827122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102338364|NCT03827122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338365|NCT03827122|Cholinergic Agents|cholinergic agents|mesh-ancestor
102338366|NCT03827122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102338367|NCT03827200|Ambrisentan|ambrisentan|mesh-list
102338368|NCT03827200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102338369|NCT02983630|Penicillins|penicillins|mesh-list
102338370|NCT02983630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102338371|NCT02983630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102338372|NCT03827278|Itraconazole|itraconazole|mesh-list
102338373|NCT03827278|Voriconazole|voriconazole|mesh-list
102338374|NCT03827278|Amphotericin B|amphotericin b|mesh-list
102338375|NCT03827278|Antifungal Agents|antifungal agents|mesh-ancestor
102338376|NCT03827278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102338377|NCT03827278|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102338378|NCT03827278|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102338379|NCT03827278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102338380|NCT03827278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338381|NCT03827278|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102338382|NCT03827278|Hormone Antagonists|hormone antagonists|mesh-ancestor
102338383|NCT03827278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102338384|NCT03827278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338385|NCT03827278|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102338386|NCT03827278|Amebicides|amebicides|mesh-ancestor
102338387|NCT03827278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102338388|NCT03827278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102338389|NCT03827278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102338390|NCT01513473|Insulin|insulin|mesh-list
102338391|NCT01513473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102338392|NCT01513473|Insulin Aspart|insulin aspart|mesh-list
102338393|NCT01513473|Insulin Detemir|insulin detemir|mesh-list
102338394|NCT01513473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102338395|NCT01513473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338396|NCT03109990|Dexmedetomidine|dexmedetomidine|mesh-list
102338397|NCT03109990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102338398|NCT03109990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102338399|NCT03109990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338400|NCT03109990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102338401|NCT03109990|Analgesics|analgesics|mesh-ancestor
102338402|NCT03109990|Sensory System Agents|sensory system agents|mesh-ancestor
102338403|NCT03109990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102338404|NCT03109990|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102338405|NCT03109990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102338406|NCT03109990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102338407|NCT03109990|Adrenergic Agents|adrenergic agents|mesh-ancestor
102338408|NCT03109990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102338409|NCT03109990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338410|NCT03071536|Furosemide|furosemide|mesh-list
102338411|NCT03071536|Diuretics|diuretics|mesh-ancestor
102338412|NCT03071536|Natriuretic Agents|natriuretic agents|mesh-ancestor
102338413|NCT03071536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338414|NCT03071536|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102338415|NCT03071536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102338416|NCT03071536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338417|NCT01513317|Siltuximab|siltuximab|mesh-list
102338418|NCT01513317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102338419|NCT03825250|Valproic Acid|valproic acid|mesh-list
102338420|NCT03825250|Anticonvulsants|anticonvulsants|mesh-ancestor
102338421|NCT03825250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102338422|NCT03825250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338423|NCT03825250|GABA Agents|gaba agents|mesh-ancestor
102338424|NCT03825250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102338425|NCT03825250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338426|NCT03825250|Antimanic Agents|antimanic agents|mesh-ancestor
102338427|NCT03825250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102338428|NCT03825250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102338429|NCT03825250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102338430|NCT03825328|Paclitaxel|paclitaxel|mesh-list
102338431|NCT03825328|Gemcitabine|gemcitabine|mesh-list
102338432|NCT03825328|Oxaliplatin|oxaliplatin|mesh-list
102338433|NCT03825328|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102338434|NCT03825328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102338435|NCT03825328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102338436|NCT03825328|Tubulin Modulators|tubulin modulators|mesh-ancestor
102338437|NCT03825328|Antimitotic Agents|antimitotic agents|mesh-ancestor
102338438|NCT03825328|Mitosis Modulators|mitosis modulators|mesh-ancestor
102338439|NCT03825328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338440|NCT03825328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102338441|NCT03825328|Antimetabolites|antimetabolites|mesh-ancestor
102338442|NCT03825016|Diclofenac|diclofenac|mesh-list
102338443|NCT03825016|Lidocaine|lidocaine|mesh-list
102338444|NCT03825016|Anesthetics, Local|anesthetics, local|mesh-ancestor
102338445|NCT03825016|Anesthetics|anesthetics|mesh-ancestor
102338446|NCT03825016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102338447|NCT03825016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338448|NCT03825016|Sensory System Agents|sensory system agents|mesh-ancestor
102338449|NCT03825016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102338450|NCT03825016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102338451|NCT03825016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102338452|NCT03825016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102338453|NCT03825016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102338454|NCT03825016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338455|NCT03825016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102338456|NCT03825016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102338457|NCT03825016|Analgesics|analgesics|mesh-ancestor
102338458|NCT03825016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102338459|NCT03825016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102338460|NCT03825016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102338461|NCT03825016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102338462|NCT03043924|Cyproterone Acetate|cyproterone acetate|mesh-list
102338463|NCT03043924|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102338464|NCT03043924|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102338465|NCT03043924|Levonorgestrel|levonorgestrel|mesh-list
102338466|NCT03043924|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102338467|NCT03043924|Estradiol|estradiol|mesh-list
102338468|NCT03043924|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102338469|NCT03043924|Cyproterone|cyproterone|mesh-list
102338470|NCT03043924|Estrogens|estrogens|mesh-ancestor
102338471|NCT03043924|Hormones|hormones|mesh-ancestor
102338472|NCT03043924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102338473|NCT03043924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338474|NCT03043924|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102338475|NCT03043924|Contraceptive Agents|contraceptive agents|mesh-ancestor
102338476|NCT03043924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102338477|NCT03043924|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102338478|NCT03043924|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102338479|NCT03043924|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102338480|NCT03043924|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102338481|NCT03043924|Androgen Antagonists|androgen antagonists|mesh-ancestor
102338482|NCT03043924|Hormone Antagonists|hormone antagonists|mesh-ancestor
102338483|NCT03043924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102338484|NCT03043924|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102338485|NCT03824314|Fentanyl|fentanyl|mesh-list
102338486|NCT03824314|Midazolam|midazolam|mesh-list
102338487|NCT03824314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102338488|NCT03824314|Narcotics|narcotics|mesh-ancestor
102338489|NCT03824314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102338490|NCT03824314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338491|NCT03824314|Analgesics|analgesics|mesh-ancestor
102338492|NCT03824314|Sensory System Agents|sensory system agents|mesh-ancestor
102338493|NCT03824314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102338494|NCT03824314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102338495|NCT03824314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102338496|NCT03824314|Anesthetics, General|anesthetics, general|mesh-ancestor
102047332|NCT01356121|Midazolam|midazolam|mesh-list
102338497|NCT03824314|Anesthetics|anesthetics|mesh-ancestor
102338498|NCT03824314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102338499|NCT03824314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102338500|NCT03824314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102338501|NCT03824314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102338502|NCT03824314|GABA Modulators|gaba modulators|mesh-ancestor
102338503|NCT03824314|GABA Agents|gaba agents|mesh-ancestor
102338504|NCT03824314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102338505|NCT03824314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338506|NCT03824002|Insulin|insulin|mesh-list
102338507|NCT03824002|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102338508|NCT03824002|Metformin|metformin|mesh-list
102338509|NCT03824002|Insulin Glargine|insulin glargine|mesh-list
102338510|NCT03824002|Insulin Aspart|insulin aspart|mesh-list
102338511|NCT03824002|Dulaglutide|dulaglutide|mesh-list
102338512|NCT03824002|Repaglinide|repaglinide|mesh-list
102338513|NCT03824002|Insulin, Long-Acting|insulin, long-acting|mesh-list
102338514|NCT03824002|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102338515|NCT03824002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102338516|NCT03824002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338517|NCT03823846|Flurbiprofen|flurbiprofen|mesh-list
102338518|NCT03823846|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
102338519|NCT03823846|Parecoxib|parecoxib|mesh-list
102338520|NCT03823846|Dezocine|dezocine|mesh-list
102338521|NCT03823846|Analgesics|analgesics|mesh-ancestor
102338522|NCT03823846|Sensory System Agents|sensory system agents|mesh-ancestor
102338523|NCT03823846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102338524|NCT03823846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338525|NCT03823846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102338526|NCT03823846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102338527|NCT03823846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102338528|NCT03823846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102338529|NCT03823846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102338530|NCT03823846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102338531|NCT03823846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338532|NCT03823846|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102338533|NCT03823846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102338534|NCT03823846|Narcotics|narcotics|mesh-ancestor
102338535|NCT03823846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102338536|NCT02908750|Fexofenadine|fexofenadine|mesh-list
102338537|NCT02908750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338538|NCT02908750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102338539|NCT02908750|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102338540|NCT02908750|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102338541|NCT02908750|Histamine Antagonists|histamine antagonists|mesh-ancestor
102338542|NCT02908750|Histamine Agents|histamine agents|mesh-ancestor
102338543|NCT02908750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102338544|NCT02908750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338545|NCT03823612|Calcium|calcium|mesh-list
102338546|NCT03823612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102338547|NCT03823612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338548|NCT02810704|Aspirin|aspirin|mesh-list
102338549|NCT02810704|Warfarin|warfarin|mesh-list
102338550|NCT02810704|Rivaroxaban|rivaroxaban|mesh-list
102338551|NCT02810704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102338552|NCT02810704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102338553|NCT02810704|Analgesics|analgesics|mesh-ancestor
102338554|NCT02810704|Sensory System Agents|sensory system agents|mesh-ancestor
102338555|NCT02810704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102338556|NCT02810704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338557|NCT02810704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102338558|NCT02810704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102338559|NCT02810704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102338560|NCT02810704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102338561|NCT02810704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338562|NCT02810704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102338563|NCT02810704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102338564|NCT02810704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102338565|NCT02810704|Antipyretics|antipyretics|mesh-ancestor
102338566|NCT02810704|Anticoagulants|anticoagulants|mesh-ancestor
102338567|NCT02810704|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102338568|NCT02810704|Antithrombins|antithrombins|mesh-ancestor
102338569|NCT02810704|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102338570|NCT02810704|Protease Inhibitors|protease inhibitors|mesh-ancestor
102338571|NCT02735902|Aspirin|aspirin|mesh-list
102338572|NCT02735902|Vitamin K|vitamin k|mesh-list
102338573|NCT02735902|Anticoagulants|anticoagulants|mesh-list
102338574|NCT02735902|Vitamins|vitamins|mesh-ancestor
102338576|NCT02735902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338577|NCT02735902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102338578|NCT02735902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102338579|NCT02735902|Analgesics|analgesics|mesh-ancestor
102338580|NCT02735902|Sensory System Agents|sensory system agents|mesh-ancestor
102338581|NCT02735902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102338582|NCT02735902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102338583|NCT02735902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102338584|NCT02735902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102338585|NCT02735902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102338586|NCT02735902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338587|NCT02735902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102338588|NCT02735902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102338589|NCT02735902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102338590|NCT02735902|Antipyretics|antipyretics|mesh-ancestor
102338591|NCT02735902|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102338592|NCT02735902|Hemostatics|hemostatics|mesh-ancestor
102338593|NCT02735902|Coagulants|coagulants|mesh-ancestor
102338594|NCT02926222|Lomustine|lomustine|mesh-list
102338595|NCT02926222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102338596|NCT02926222|Alkylating Agents|alkylating agents|mesh-ancestor
102338597|NCT02926222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338598|NCT02926222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102338599|NCT04273282|Moxifloxacin|moxifloxacin|mesh-list
102338600|NCT04273282|Dexamethasone|dexamethasone|mesh-list
102338601|NCT04273282|Prednisolone|prednisolone|mesh-list
102338602|NCT04273282|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102338603|NCT04273282|Methylprednisolone|methylprednisolone|mesh-list
102338604|NCT04273282|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102338605|NCT04273282|Prednisolone acetate|prednisolone acetate|mesh-list
102338606|NCT04273282|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102338607|NCT04273282|Prednisolone phosphate|prednisolone phosphate|mesh-list
102338608|NCT04273282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102338609|NCT04273282|Antiemetics|antiemetics|mesh-ancestor
102338610|NCT04273282|Autonomic Agents|autonomic agents|mesh-ancestor
102338611|NCT04273282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102338612|NCT04273282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338613|NCT04273282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102338614|NCT04273282|Glucocorticoids|glucocorticoids|mesh-ancestor
102338615|NCT04273282|Hormones|hormones|mesh-ancestor
102338616|NCT04273282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102338617|NCT04273282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102338618|NCT04273282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102338619|NCT04273282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102338620|NCT04273282|Protective Agents|protective agents|mesh-ancestor
102338621|NCT04273282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102338622|NCT04273282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102338623|NCT04273282|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102338624|NCT04273282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102338625|NCT04273282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102338626|NCT04273282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338627|NCT01454440|Eptifibatide|eptifibatide|mesh-list
102338628|NCT01454440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102338629|NCT01454518|Anesthetics|anesthetics|mesh-list
102338630|NCT01454518|Anesthetics, Local|anesthetics, local|mesh-list
102338631|NCT01454518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102338632|NCT01454518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338633|NCT01454518|Sensory System Agents|sensory system agents|mesh-ancestor
102338634|NCT01454518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102338635|NCT02983084|Copper|copper|mesh-list
102338636|NCT02983084|Nickel|nickel|mesh-list
102338637|NCT02983084|Trace Elements|trace elements|mesh-ancestor
102338638|NCT02983084|Micronutrients|micronutrients|mesh-ancestor
102338639|NCT02983084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338640|NCT01455142|Insulin|insulin|mesh-list
102338641|NCT01455142|Insulin Aspart|insulin aspart|mesh-list
102338642|NCT01455142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102338643|NCT01455142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338644|NCT01455532|Carboplatin|carboplatin|mesh-list
102338645|NCT01455532|Gemcitabine|gemcitabine|mesh-list
102338646|NCT01455532|Doxorubicin|doxorubicin|mesh-list
102338647|NCT01455532|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102338648|NCT01455532|Iniparib|iniparib|mesh-list
102338649|NCT01455532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102338650|NCT01455532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102338651|NCT01455532|Antimetabolites|antimetabolites|mesh-ancestor
102338652|NCT01455532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338653|NCT01455532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102338654|NCT01455532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102338655|NCT01455532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102338656|NCT01455532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102338657|NCT01455532|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102338658|NCT01455922|Glimepiride|glimepiride|mesh-list
102338660|NCT01455922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102338661|NCT01455922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102338662|NCT01455922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338663|NCT01455922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102338664|NCT01455922|Immunologic Factors|immunologic factors|mesh-ancestor
102338665|NCT01455922|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102338666|NCT01455922|Incretins|incretins|mesh-ancestor
102338667|NCT01455922|Hormones|hormones|mesh-ancestor
102338668|NCT01455922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102338669|NCT01456234|Oseltamivir|oseltamivir|mesh-list
102338670|NCT01456234|Antiviral Agents|antiviral agents|mesh-ancestor
102338671|NCT01456234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102338672|NCT01456234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102338673|NCT01456234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338674|NCT01456312|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102338675|NCT01456312|Entecavir|entecavir|mesh-list
102338676|NCT01456312|Antiviral Agents|antiviral agents|mesh-ancestor
102338677|NCT01456312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102338678|NCT02542696|Apomorphine|apomorphine|mesh-list
102338679|NCT02542696|Emetics|emetics|mesh-ancestor
102338680|NCT02542696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338681|NCT02542696|Autonomic Agents|autonomic agents|mesh-ancestor
102338682|NCT02542696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102338683|NCT02542696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102338684|NCT02542696|Dopamine Agonists|dopamine agonists|mesh-ancestor
102338685|NCT02542696|Dopamine Agents|dopamine agents|mesh-ancestor
102338686|NCT02542696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102338687|NCT02542696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338688|NCT01456468|Tretinoin|tretinoin|mesh-list
102338689|NCT01456468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102338690|NCT01456468|Keratolytic Agents|keratolytic agents|mesh-ancestor
102338691|NCT01456468|Dermatologic Agents|dermatologic agents|mesh-ancestor
102338692|NCT01456546|Proguanil|proguanil|mesh-list
102338693|NCT01456546|Clopidogrel|clopidogrel|mesh-list
102338694|NCT01456546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102338695|NCT01456546|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102338696|NCT01456546|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102338697|NCT01456546|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102338698|NCT01456546|Purinergic Agents|purinergic agents|mesh-ancestor
102338699|NCT01456546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102338700|NCT01456546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338701|NCT01456546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338702|NCT01456546|Antimalarials|antimalarials|mesh-ancestor
102338703|NCT01456546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102338704|NCT01456546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102338705|NCT01456546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102338706|NCT01456546|Antimetabolites|antimetabolites|mesh-ancestor
102338707|NCT01456624|Megestrol Acetate|megestrol acetate|mesh-list
102338708|NCT01456624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102338709|NCT01456624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102338710|NCT01456624|Appetite Stimulants|appetite stimulants|mesh-ancestor
102338711|NCT01456624|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102338712|NCT01456624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338713|NCT01457716|Budesonide|budesonide|mesh-list
102338714|NCT01457716|Formoterol Fumarate|formoterol fumarate|mesh-list
102338715|NCT01457716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102338716|NCT01457716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102338717|NCT01457716|Autonomic Agents|autonomic agents|mesh-ancestor
102338718|NCT01457716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102338719|NCT01457716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338720|NCT01457716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102338721|NCT01457716|Respiratory System Agents|respiratory system agents|mesh-ancestor
102338722|NCT01457716|Glucocorticoids|glucocorticoids|mesh-ancestor
102338723|NCT01457716|Hormones|hormones|mesh-ancestor
102338724|NCT01457716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102338725|NCT01457716|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102047555|NCT02072720|Growth Substances|growth substances|mesh-ancestor
102338726|NCT01457716|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102338727|NCT01457716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102338728|NCT01457716|Adrenergic Agents|adrenergic agents|mesh-ancestor
102338729|NCT01457716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102338730|NCT01457716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338731|NCT02880982|Vitamin D|vitamin d|mesh-list
102338732|NCT02880982|Cholecalciferol|cholecalciferol|mesh-list
102338733|NCT02880982|Vitamins|vitamins|mesh-ancestor
102338734|NCT02880982|Micronutrients|micronutrients|mesh-ancestor
102338735|NCT02880982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338736|NCT02880982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102338737|NCT02880982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102338738|NCT01458964|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102338739|NCT01458964|Antidepressive Agents|antidepressive agents|mesh-ancestor
102338740|NCT01458964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101442727|NCT00553930|Interferons|interferons|mesh-list
102338741|NCT01458964|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102338742|NCT01458964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102338743|NCT01458964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102338744|NCT01458964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338745|NCT01459198|Vaccines|vaccines|mesh-list
102338746|NCT01459198|Immunologic Factors|immunologic factors|mesh-ancestor
102338747|NCT01459198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338748|NCT02490904|Eplerenone|eplerenone|mesh-list
102338749|NCT02490904|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102338750|NCT02490904|Hormone Antagonists|hormone antagonists|mesh-ancestor
102338751|NCT02490904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102338752|NCT02490904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338753|NCT02490904|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102338754|NCT02490904|Diuretics|diuretics|mesh-ancestor
102338755|NCT02490904|Natriuretic Agents|natriuretic agents|mesh-ancestor
102338756|NCT02490904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102338757|NCT04390984|Apatinib|apatinib|mesh-list
102338758|NCT04390984|Gefitinib|gefitinib|mesh-list
102338759|NCT04390984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102338760|NCT04390984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102338761|NCT04390984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102338762|NCT04390984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338763|NCT02873806|Tobramycin|tobramycin|mesh-list
102338764|NCT02873806|Dexamethasone|dexamethasone|mesh-list
102338765|NCT02873806|Travoprost|travoprost|mesh-list
102338766|NCT02873806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102338767|NCT02873806|Antiemetics|antiemetics|mesh-ancestor
102338768|NCT02873806|Autonomic Agents|autonomic agents|mesh-ancestor
101680823|NCT02692248|Antimetabolites|antimetabolites|mesh-ancestor
102338769|NCT02873806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102338770|NCT02873806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338771|NCT02873806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102338772|NCT02873806|Glucocorticoids|glucocorticoids|mesh-ancestor
102338773|NCT02873806|Hormones|hormones|mesh-ancestor
102338774|NCT02873806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102338775|NCT02873806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102338776|NCT02873806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102338777|NCT02873806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102338778|NCT02873806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102338779|NCT02873806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102338780|NCT01890772|Vitamin D|vitamin d|mesh-list
102338781|NCT01890772|Ribavirin|ribavirin|mesh-list
102338782|NCT01890772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102338783|NCT01890772|Vitamins|vitamins|mesh-ancestor
102338784|NCT01890772|Micronutrients|micronutrients|mesh-ancestor
102338785|NCT01890772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338786|NCT01890772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102338787|NCT01890772|Antimetabolites|antimetabolites|mesh-ancestor
101442729|NCT00553930|Interferon-alpha|interferon-alpha|mesh-list
102338788|NCT01890772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338789|NCT01890772|Antiviral Agents|antiviral agents|mesh-ancestor
102338790|NCT01890772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102338791|NCT01891084|Acetaminophen|acetaminophen|mesh-list
102338792|NCT01891084|Ibuprofen|ibuprofen|mesh-list
102338793|NCT01891084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102338794|NCT01891084|Analgesics|analgesics|mesh-ancestor
102338795|NCT01891084|Sensory System Agents|sensory system agents|mesh-ancestor
102338796|NCT01891084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102338797|NCT01891084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338798|NCT01891084|Antipyretics|antipyretics|mesh-ancestor
102338799|NCT01891084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102338800|NCT01891084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102338801|NCT01891084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102338802|NCT01891084|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102338803|NCT01891084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102338804|NCT01891084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338805|NCT01891708|Bevacizumab|bevacizumab|mesh-list
102338806|NCT01891708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102338807|NCT01891708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102338808|NCT01891708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102338809|NCT01891708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102338810|NCT01891708|Growth Substances|growth substances|mesh-ancestor
102338811|NCT01891708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338812|NCT01891708|Growth Inhibitors|growth inhibitors|mesh-ancestor
102338813|NCT01892098|Zinc Sulfate|zinc sulfate|mesh-list
102338814|NCT01892098|Astringents|astringents|mesh-ancestor
102338815|NCT01892098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338816|NCT01892098|Dermatologic Agents|dermatologic agents|mesh-ancestor
102338817|NCT01892176|Ubiquinone|ubiquinone|mesh-list
102338818|NCT01892176|Coenzyme Q10|coenzyme q10|mesh-list
102338819|NCT01892176|Micronutrients|micronutrients|mesh-ancestor
102338820|NCT01892176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338821|NCT01892176|Vitamins|vitamins|mesh-ancestor
102338822|NCT01892254|Metformin|metformin|mesh-list
102338823|NCT01892254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102338824|NCT01892254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338825|NCT01892332|Lidocaine|lidocaine|mesh-list
102338826|NCT01892332|Fentanyl|fentanyl|mesh-list
102338827|NCT01892332|Anesthetics, Local|anesthetics, local|mesh-ancestor
102338828|NCT01892332|Anesthetics|anesthetics|mesh-ancestor
102338829|NCT01892332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102338830|NCT01892332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338831|NCT01892332|Sensory System Agents|sensory system agents|mesh-ancestor
102338832|NCT01892332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102338833|NCT01892332|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102338834|NCT01892332|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102338835|NCT01892332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102338836|NCT01892332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102338837|NCT01892332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338838|NCT01892332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102338839|NCT01892332|Narcotics|narcotics|mesh-ancestor
102338840|NCT01892332|Analgesics|analgesics|mesh-ancestor
102338841|NCT01892332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102338842|NCT01892332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102338843|NCT01892332|Anesthetics, General|anesthetics, general|mesh-ancestor
102338844|NCT01892488|Sultamicillin|sultamicillin|mesh-list
102338845|NCT01892488|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
102338846|NCT01892488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102338847|NCT01892488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102338848|NCT01892488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102338849|NCT01892488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338850|NCT02809690|Clevudine|clevudine|mesh-list
102338851|NCT02809690|Antiviral Agents|antiviral agents|mesh-ancestor
102338852|NCT02809690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102338853|NCT01892644|Deferasirox|deferasirox|mesh-list
102338854|NCT01892644|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102338855|NCT01892644|Chelating Agents|chelating agents|mesh-ancestor
102338856|NCT01892644|Sequestering Agents|sequestering agents|mesh-ancestor
102338857|NCT01892644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338858|NCT01901653|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
102338859|NCT01901653|Immunoconjugates|immunoconjugates|mesh-ancestor
102338860|NCT01901653|Immunologic Factors|immunologic factors|mesh-ancestor
102338861|NCT01901653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338862|NCT01925989|Insulin Glargine|insulin glargine|mesh-list
102338863|NCT01925989|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102338864|NCT01925989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338865|NCT01901419|Nitroglycerin|nitroglycerin|mesh-list
102338866|NCT01901419|Vasodilator Agents|vasodilator agents|mesh-ancestor
102338867|NCT02798536|Paclitaxel|paclitaxel|mesh-list
102338868|NCT02798536|LMB-100|lmb-100|mesh-list
102338869|NCT02798536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102338870|NCT02798536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102338871|NCT02798536|Tubulin Modulators|tubulin modulators|mesh-ancestor
102338872|NCT02798536|Antimitotic Agents|antimitotic agents|mesh-ancestor
102338873|NCT02798536|Mitosis Modulators|mitosis modulators|mesh-ancestor
102338874|NCT02798536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338875|NCT02798536|Immunoconjugates|immunoconjugates|mesh-ancestor
102338876|NCT02798536|Immunologic Factors|immunologic factors|mesh-ancestor
102338877|NCT02798536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338878|NCT04758286|Anesthetics|anesthetics|mesh-list
102338879|NCT04758286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102338880|NCT04758286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338881|NCT01453660|Cisplatin|cisplatin|mesh-list
102338882|NCT01453660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102338883|NCT01615939|Bupivacaine|bupivacaine|mesh-list
102338884|NCT01615939|Ropivacaine|ropivacaine|mesh-list
102338885|NCT01615939|Anesthetics, Local|anesthetics, local|mesh-ancestor
102338886|NCT01615939|Anesthetics|anesthetics|mesh-ancestor
102338887|NCT01615939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102338888|NCT01615939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338889|NCT01615939|Sensory System Agents|sensory system agents|mesh-ancestor
102338890|NCT01615939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102338891|NCT02789878|Prednisone|prednisone|mesh-list
102338892|NCT02789878|Goserelin|goserelin|mesh-list
102338893|NCT02789878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102338894|NCT02789878|Glucocorticoids|glucocorticoids|mesh-ancestor
102338895|NCT02789878|Hormones|hormones|mesh-ancestor
102338896|NCT02789878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102338897|NCT02789878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338898|NCT02789878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102338899|NCT02789878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102338900|NCT01901185|Etanercept|etanercept|mesh-list
102338901|NCT01901185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102338902|NCT01901185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102338903|NCT01901185|Analgesics|analgesics|mesh-ancestor
102338904|NCT01901185|Sensory System Agents|sensory system agents|mesh-ancestor
102338905|NCT01901185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102338906|NCT01901185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338907|NCT01901185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102338908|NCT01901185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102338909|NCT01901185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102338910|NCT01901185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102338911|NCT01901185|Immunologic Factors|immunologic factors|mesh-ancestor
102338912|NCT01893424|Dronabinol|dronabinol|mesh-list
102338913|NCT01893424|Nabiximols|nabiximols|mesh-list
102338914|NCT01893424|Cannabidiol|cannabidiol|mesh-list
102338915|NCT01893424|Piperine|piperine|mesh-list
102338916|NCT01893424|Anticonvulsants|anticonvulsants|mesh-ancestor
102338917|NCT01893424|Hallucinogens|hallucinogens|mesh-ancestor
102338918|NCT01893424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338919|NCT01893424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102338920|NCT01893424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102338921|NCT01893424|Analgesics|analgesics|mesh-ancestor
102338922|NCT01893424|Sensory System Agents|sensory system agents|mesh-ancestor
102338923|NCT01893424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102338924|NCT01893424|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102338925|NCT01893424|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102338926|NCT01893424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102338927|NCT01893424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338928|NCT01893424|Hormones|hormones|mesh-ancestor
102338929|NCT01893424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102338930|NCT01893424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102338931|NCT01893424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102338932|NCT02788708|Paclitaxel|paclitaxel|mesh-list
102338933|NCT02788708|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102338934|NCT02788708|Lenvatinib|lenvatinib|mesh-list
102338935|NCT02788708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102338936|NCT02788708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102338937|NCT02788708|Tubulin Modulators|tubulin modulators|mesh-ancestor
102338938|NCT02788708|Antimitotic Agents|antimitotic agents|mesh-ancestor
102338939|NCT02788708|Mitosis Modulators|mitosis modulators|mesh-ancestor
102338940|NCT02788708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338941|NCT02788708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102338942|NCT02788708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102338943|NCT01888003|Epoetin Alfa|epoetin alfa|mesh-list
102338944|NCT01888003|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102338945|NCT01888003|Hematinics|hematinics|mesh-ancestor
102338946|NCT02784496|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
102338947|NCT02784496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102338948|NCT02784496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102338949|NCT02784496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338950|NCT02780128|Ceritinib|ceritinib|mesh-list
102338951|NCT02780128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102338952|NCT02780128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102338953|NCT02780128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102338954|NCT02780128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338955|NCT02773732|Ciprofloxacin|ciprofloxacin|mesh-list
102338957|NCT02773732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102338958|NCT02773732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102338959|NCT02773732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102338960|NCT02773732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102338961|NCT02773732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102338962|NCT02773732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338963|NCT02773732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102338964|NCT02773732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102338965|NCT02773732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102338966|NCT02773732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102338967|NCT02769520|Pembrolizumab|pembrolizumab|mesh-list
102338968|NCT02769520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102338969|NCT02769520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102338970|NCT02769520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102338971|NCT02769520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338972|NCT02735122|Acetaminophen|acetaminophen|mesh-list
102338973|NCT02735122|Ibuprofen|ibuprofen|mesh-list
102338974|NCT02735122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102338975|NCT02735122|Analgesics|analgesics|mesh-ancestor
102338976|NCT02735122|Sensory System Agents|sensory system agents|mesh-ancestor
102338977|NCT02735122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102338978|NCT02735122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338979|NCT02735122|Antipyretics|antipyretics|mesh-ancestor
102338980|NCT02735122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102338981|NCT02735122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102338982|NCT02735122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102338983|NCT02735122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102338984|NCT02735122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102338985|NCT02735122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338986|NCT02718118|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102338987|NCT02718118|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102338988|NCT02718118|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102338989|NCT02718118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102338990|NCT02718118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102338991|NCT02718118|Cholinergic Agents|cholinergic agents|mesh-ancestor
102338992|NCT02718118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102338993|NCT02718118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102338994|NCT02718118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102338995|NCT02718118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102338996|NCT02717962|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
102338997|NCT02717962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102338998|NCT02717962|Alkylating Agents|alkylating agents|mesh-ancestor
102338999|NCT02717962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339000|NCT02717962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102339002|NCT01893658|Prednisone|prednisone|mesh-list
102339003|NCT01893658|Prednisolone|prednisolone|mesh-list
102339004|NCT01893658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102339005|NCT01893658|Glucocorticoids|glucocorticoids|mesh-ancestor
102339006|NCT01893658|Hormones|hormones|mesh-ancestor
102339007|NCT01893658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102339008|NCT01893658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339009|NCT01893658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102339010|NCT01893658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102339011|NCT01893658|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102339012|NCT01893658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102339013|NCT01893658|Respiratory System Agents|respiratory system agents|mesh-ancestor
102339014|NCT02703610|Acetaminophen|acetaminophen|mesh-list
102339015|NCT02703610|Ibuprofen|ibuprofen|mesh-list
102339016|NCT02703610|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
102339017|NCT02703610|Oxycodone|oxycodone|mesh-list
102339018|NCT02703610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102339019|NCT02703610|Analgesics|analgesics|mesh-ancestor
102339020|NCT02703610|Sensory System Agents|sensory system agents|mesh-ancestor
102339021|NCT02703610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102339022|NCT02703610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339023|NCT02703610|Antipyretics|antipyretics|mesh-ancestor
102339024|NCT02703610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102339025|NCT02703610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102339026|NCT02703610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102339027|NCT02703610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102339028|NCT02703610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102339029|NCT02703610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339030|NCT02703610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102339031|NCT02703610|Narcotics|narcotics|mesh-ancestor
102339032|NCT02703610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102339033|NCT02688556|Cyclosporine|cyclosporine|mesh-list
102339034|NCT02688556|Cyclosporins|cyclosporins|mesh-list
102339035|NCT02688556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102339036|NCT02688556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339037|NCT02688556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102339038|NCT02688556|Immunologic Factors|immunologic factors|mesh-ancestor
102339039|NCT02688556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339040|NCT02688556|Antifungal Agents|antifungal agents|mesh-ancestor
102339041|NCT02688556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102339042|NCT02688556|Dermatologic Agents|dermatologic agents|mesh-ancestor
102339043|NCT02688556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102339044|NCT02688556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102339045|NCT02684032|Letrozole|letrozole|mesh-list
102339046|NCT02684032|Fulvestrant|fulvestrant|mesh-list
102339047|NCT02684032|Palbociclib|palbociclib|mesh-list
102339048|NCT02684032|Gedatolisib|gedatolisib|mesh-list
102339049|NCT02684032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102339050|NCT02684032|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102339051|NCT02684032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102339052|NCT02684032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102339053|NCT02684032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339054|NCT02684032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102339055|NCT02684032|Hormone Antagonists|hormone antagonists|mesh-ancestor
102339056|NCT02684032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102339057|NCT02684032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339058|NCT02684032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102339059|NCT02684032|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102339060|NCT02684032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102339061|NCT02388178|Fluorides|fluorides|mesh-list
102339062|NCT02388178|Cariostatic Agents|cariostatic agents|mesh-ancestor
102339063|NCT02388178|Protective Agents|protective agents|mesh-ancestor
102339064|NCT02388178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339065|NCT02384668|Vitamin D|vitamin d|mesh-list
102339066|NCT02384668|Cholecalciferol|cholecalciferol|mesh-list
102339067|NCT02384668|Vitamins|vitamins|mesh-ancestor
102339068|NCT02384668|Micronutrients|micronutrients|mesh-ancestor
102339069|NCT02384668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339070|NCT02384668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102339071|NCT02384668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102339072|NCT01898923|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102339074|NCT01898923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102339075|NCT01924429|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102339076|NCT01924429|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102339077|NCT01924429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339078|NCT01924429|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102339079|NCT01924429|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102339080|NCT01924429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102339081|NCT01924429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339082|NCT01924429|Dopamine Agents|dopamine agents|mesh-ancestor
102339083|NCT01924429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102339084|NCT01886287|Octreotide|octreotide|mesh-list
102339085|NCT01886287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102339086|NCT01886287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102339087|NCT01886287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102339088|NCT02707588|Pembrolizumab|pembrolizumab|mesh-list
102339089|NCT02707588|Cetuximab|cetuximab|mesh-list
102339090|NCT02707588|Antibodies|antibodies|mesh-list
102339091|NCT02707588|Immunoglobulins|immunoglobulins|mesh-list
102339092|NCT02707588|Immunologic Factors|immunologic factors|mesh-ancestor
102339093|NCT02707588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339094|NCT02707588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102339095|NCT02707588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102339096|NCT02707588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102339097|NCT02707588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339098|NCT05602480|Vaccines|vaccines|mesh-list
102339099|NCT05602480|Immunologic Factors|immunologic factors|mesh-ancestor
102339100|NCT05602480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339101|NCT05600296|Levobupivacaine|levobupivacaine|mesh-list
102339102|NCT05600296|Anesthetics, Local|anesthetics, local|mesh-ancestor
102339103|NCT05600296|Anesthetics|anesthetics|mesh-ancestor
102339104|NCT05600296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102339105|NCT05600296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339106|NCT05600296|Sensory System Agents|sensory system agents|mesh-ancestor
102339107|NCT05600296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102339108|NCT05604586|Acetylcysteine|acetylcysteine|mesh-list
102339109|NCT05604586|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102339110|NCT05604586|Antiviral Agents|antiviral agents|mesh-ancestor
102339111|NCT05604586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102339112|NCT05604586|Expectorants|expectorants|mesh-ancestor
102339113|NCT05604586|Respiratory System Agents|respiratory system agents|mesh-ancestor
102339114|NCT05604586|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102339115|NCT05604586|Antioxidants|antioxidants|mesh-ancestor
102339116|NCT05604586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339117|NCT05604586|Protective Agents|protective agents|mesh-ancestor
102339118|NCT05604586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339119|NCT05604586|Antidotes|antidotes|mesh-ancestor
102339120|NCT05604118|Aspirin|aspirin|mesh-list
102339121|NCT05604118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102339122|NCT05604118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102339123|NCT05604118|Analgesics|analgesics|mesh-ancestor
102339124|NCT05604118|Sensory System Agents|sensory system agents|mesh-ancestor
102339125|NCT05604118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102339126|NCT05604118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339127|NCT05604118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102339128|NCT05604118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102339129|NCT05604118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102339130|NCT05604118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102339131|NCT05604118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339132|NCT05604118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102339133|NCT05604118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102339134|NCT05604118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102339135|NCT05604118|Antipyretics|antipyretics|mesh-ancestor
102339136|NCT05603884|Cytarabine|cytarabine|mesh-list
102339137|NCT05603884|Azacitidine|azacitidine|mesh-list
102339138|NCT05603884|Venetoclax|venetoclax|mesh-list
102339139|NCT05603884|Mitoxantrone|mitoxantrone|mesh-list
102339140|NCT05603884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102339141|NCT05603884|Antimetabolites|antimetabolites|mesh-ancestor
102339142|NCT05603884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339143|NCT05603884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102339144|NCT05603884|Antiviral Agents|antiviral agents|mesh-ancestor
102339145|NCT05603884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102339146|NCT05603884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102339147|NCT05603884|Immunologic Factors|immunologic factors|mesh-ancestor
102339148|NCT05603884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339149|NCT05603884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102339150|NCT05603884|Analgesics|analgesics|mesh-ancestor
102339151|NCT05603884|Sensory System Agents|sensory system agents|mesh-ancestor
102339152|NCT05603884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102339153|NCT05603884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102339154|NCT05603884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102339156|NCT05603650|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102339157|NCT05603650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102339158|NCT03337594|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
102339159|NCT03337594|Chelating Agents|chelating agents|mesh-ancestor
102339160|NCT03337594|Sequestering Agents|sequestering agents|mesh-ancestor
102339161|NCT03337594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339162|NCT03313804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102339163|NCT03313804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339164|NCT03313804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102339165|NCT03313804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102339166|NCT04393792|Povidone-Iodine|povidone-iodine|mesh-list
102339167|NCT04393792|Povidone|povidone|mesh-list
102339168|NCT04393792|Plasma Substitutes|plasma substitutes|mesh-ancestor
102339169|NCT04393792|Blood Substitutes|blood substitutes|mesh-ancestor
102339170|NCT04393792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102339171|NCT04393792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102339172|NCT01896895|Botulinum Toxins|botulinum toxins|mesh-list
102339173|NCT01896895|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102339174|NCT01896895|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102339175|NCT01896895|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102339176|NCT01896895|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102339177|NCT01896895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102048008|NCT02079974|Pravastatin|pravastatin|mesh-list
102339178|NCT01896895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339179|NCT01896895|Cholinergic Agents|cholinergic agents|mesh-ancestor
102339180|NCT01896895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102339181|NCT01896895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339182|NCT01896895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102339183|NCT01896895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102339184|NCT02315872|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102339185|NCT02315872|Hormones|hormones|mesh-ancestor
102339186|NCT02315872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102339187|NCT02315872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339188|NCT04127500|Dexmedetomidine|dexmedetomidine|mesh-list
102339189|NCT04127500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102339190|NCT04127500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102339191|NCT04127500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339192|NCT04127500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102339193|NCT04127500|Analgesics|analgesics|mesh-ancestor
102339194|NCT04127500|Sensory System Agents|sensory system agents|mesh-ancestor
102339195|NCT04127500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102339196|NCT04127500|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102339197|NCT04127500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102339198|NCT04127500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102339199|NCT04127500|Adrenergic Agents|adrenergic agents|mesh-ancestor
102339200|NCT04127500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102339201|NCT04127500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339202|NCT03017326|Carboplatin|carboplatin|mesh-list
102339203|NCT03017326|Gemcitabine|gemcitabine|mesh-list
102339204|NCT03017326|Doxorubicin|doxorubicin|mesh-list
102339205|NCT03017326|Fluorouracil|fluorouracil|mesh-list
102339206|NCT03017326|Oxaliplatin|oxaliplatin|mesh-list
102339207|NCT03017326|Irinotecan|irinotecan|mesh-list
102339208|NCT03017326|Etoposide|etoposide|mesh-list
102339209|NCT03017326|Vincristine|vincristine|mesh-list
102339210|NCT03017326|Sorafenib|sorafenib|mesh-list
102339211|NCT03017326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102339212|NCT03017326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102339213|NCT03017326|Antimetabolites|antimetabolites|mesh-ancestor
102339214|NCT03017326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339215|NCT03017326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102339216|NCT03017326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102339217|NCT03017326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102339218|NCT03017326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102339219|NCT03017326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102339220|NCT03017326|Immunologic Factors|immunologic factors|mesh-ancestor
102339221|NCT03017326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339222|NCT03017326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102339223|NCT03017326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102339224|NCT03017326|Tubulin Modulators|tubulin modulators|mesh-ancestor
102339225|NCT03017326|Antimitotic Agents|antimitotic agents|mesh-ancestor
102339226|NCT03017326|Mitosis Modulators|mitosis modulators|mesh-ancestor
102339227|NCT03017326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102339228|NCT04126330|Vitamin D|vitamin d|mesh-list
102339229|NCT04126330|Vitamins|vitamins|mesh-ancestor
102339230|NCT04126330|Micronutrients|micronutrients|mesh-ancestor
102339231|NCT04126330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339232|NCT04126330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102339233|NCT04126720|Vitamin E|vitamin e|mesh-list
102339234|NCT04126720|Vitamins|vitamins|mesh-ancestor
102339235|NCT04126720|Micronutrients|micronutrients|mesh-ancestor
102339236|NCT04126720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339237|NCT04126720|Antioxidants|antioxidants|mesh-ancestor
102339238|NCT04126720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339239|NCT04126720|Protective Agents|protective agents|mesh-ancestor
102339240|NCT04126252|Sildenafil Citrate|sildenafil citrate|mesh-list
102339241|NCT04126252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339242|NCT04126252|Vasodilator Agents|vasodilator agents|mesh-ancestor
102339243|NCT04126252|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102339244|NCT04126252|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102339245|NCT04126252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102339246|NCT04126252|Urological Agents|urological agents|mesh-ancestor
102339247|NCT04125862|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102339248|NCT04125862|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102339249|NCT04125862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339250|NCT03007732|Ascorbic Acid|ascorbic acid|mesh-list
102339251|NCT03007732|Prednisone|prednisone|mesh-list
102339252|NCT03007732|Pembrolizumab|pembrolizumab|mesh-list
102339253|NCT03007732|Leuprolide|leuprolide|mesh-list
102339254|NCT03007732|Abiraterone Acetate|abiraterone acetate|mesh-list
102339255|NCT03007732|Methyltestosterone|methyltestosterone|mesh-list
102339256|NCT03007732|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
102339257|NCT03007732|Androgens|androgens|mesh-list
102339258|NCT03007732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102339259|NCT03007732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102339260|NCT03007732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102339261|NCT03007732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339262|NCT03007732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102339263|NCT03007732|Glucocorticoids|glucocorticoids|mesh-ancestor
102339264|NCT03007732|Hormones|hormones|mesh-ancestor
102339265|NCT03007732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102339266|NCT03007732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339267|NCT03007732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102339268|NCT03007732|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102339269|NCT03007732|Fertility Agents|fertility agents|mesh-ancestor
102339270|NCT03007732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102339271|NCT03007732|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102339272|NCT03007732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102339273|NCT03007732|Hormone Antagonists|hormone antagonists|mesh-ancestor
102339274|NCT03007732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102339275|NCT03007732|Antioxidants|antioxidants|mesh-ancestor
102339276|NCT03007732|Protective Agents|protective agents|mesh-ancestor
102339277|NCT03007732|Vitamins|vitamins|mesh-ancestor
102339278|NCT03007732|Micronutrients|micronutrients|mesh-ancestor
102339279|NCT03007732|Estrogens|estrogens|mesh-ancestor
102339280|NCT03007732|Anabolic Agents|anabolic agents|mesh-ancestor
102339281|NCT03007420|Lidocaine|lidocaine|mesh-list
102339282|NCT03007420|Anesthetics, Local|anesthetics, local|mesh-ancestor
102339283|NCT03007420|Anesthetics|anesthetics|mesh-ancestor
102339284|NCT03007420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102339285|NCT03007420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339286|NCT03007420|Sensory System Agents|sensory system agents|mesh-ancestor
102339287|NCT03007420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102339288|NCT03007420|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102339289|NCT03007420|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102339290|NCT03007420|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102339291|NCT03007420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102339292|NCT03007420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339293|NCT04125706|Metronidazole|metronidazole|mesh-list
102339294|NCT04125706|Minocycline|minocycline|mesh-list
102339295|NCT04125706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102339296|NCT04125706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102339297|NCT04125706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102339298|NCT04125706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102339299|NCT03005782|Cemiplimab|cemiplimab|mesh-list
102339300|NCT03005782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102339301|NCT03005782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102339302|NCT04125394|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102339303|NCT04125394|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102339304|NCT04125082|Insulin|insulin|mesh-list
102339305|NCT04125082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102339306|NCT04125082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102339307|NCT04125082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339308|NCT04393246|Dapagliflozin|dapagliflozin|mesh-list
102339309|NCT04393246|Ambrisentan|ambrisentan|mesh-list
102339310|NCT04393246|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102339311|NCT04393246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339312|NCT04393246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102339313|NCT04393246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339314|NCT04393246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102339315|NCT04124302|Insulin|insulin|mesh-list
102339316|NCT04124302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102339317|NCT04124302|Insulin Aspart|insulin aspart|mesh-list
102339318|NCT04124302|Insulin Lispro|insulin lispro|mesh-list
102339319|NCT04124302|Insulin glulisine|insulin glulisine|mesh-list
102339320|NCT04124302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102339321|NCT04124302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339322|NCT04124068|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102339323|NCT04124068|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102339324|NCT04124068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102339325|NCT04411069|Droperidol|droperidol|mesh-list
102339326|NCT04411069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102339327|NCT04411069|Antiemetics|antiemetics|mesh-ancestor
102339328|NCT04411069|Autonomic Agents|autonomic agents|mesh-ancestor
102339329|NCT04411069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102339330|NCT04411069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339331|NCT04411069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102339333|NCT04411069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102339334|NCT04411069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102339335|NCT04411069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102339336|NCT04411069|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102339337|NCT04411069|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102339338|NCT04411069|Dopamine Agents|dopamine agents|mesh-ancestor
102339339|NCT04411069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102339340|NCT04411069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339341|NCT03003130|Hyaluronic Acid|hyaluronic acid|mesh-list
102339342|NCT03003130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102339343|NCT03003130|Immunologic Factors|immunologic factors|mesh-ancestor
101442798|NCT04958122|Penicillins|penicillins|mesh-list
102339344|NCT03003130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339345|NCT03003130|Viscosupplements|viscosupplements|mesh-ancestor
102339346|NCT03003130|Protective Agents|protective agents|mesh-ancestor
102339347|NCT01884571|Mycophenolic Acid|mycophenolic acid|mesh-list
102339348|NCT01884571|Prednisone|prednisone|mesh-list
102339349|NCT01884571|Methylprednisolone|methylprednisolone|mesh-list
102339350|NCT01884571|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102339351|NCT01884571|Tacrolimus|tacrolimus|mesh-list
102339352|NCT01884571|Basiliximab|basiliximab|mesh-list
102339353|NCT01884571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102339354|NCT01884571|Glucocorticoids|glucocorticoids|mesh-ancestor
102339355|NCT01884571|Hormones|hormones|mesh-ancestor
102339356|NCT01884571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102339357|NCT01884571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339358|NCT01884571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102339359|NCT01884571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102339360|NCT01884571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102339361|NCT01884571|Immunologic Factors|immunologic factors|mesh-ancestor
102339362|NCT01884571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102339363|NCT01884571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102339364|NCT01884571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339365|NCT01884571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102339366|NCT01884571|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102339367|NCT01884571|Antitubercular Agents|antitubercular agents|mesh-ancestor
102339368|NCT01884571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102339369|NCT01884571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102339370|NCT01884571|Antiemetics|antiemetics|mesh-ancestor
102339371|NCT01884571|Autonomic Agents|autonomic agents|mesh-ancestor
102339372|NCT01884571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102339373|NCT01884571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102339374|NCT01884571|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102339375|NCT01884571|Protective Agents|protective agents|mesh-ancestor
102339376|NCT01884337|Apixaban|apixaban|mesh-list
102339377|NCT01884337|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102339378|NCT01884337|Antithrombins|antithrombins|mesh-ancestor
102339379|NCT01884337|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102339380|NCT01884337|Protease Inhibitors|protease inhibitors|mesh-ancestor
102339381|NCT01884337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102339382|NCT01884337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339383|NCT01884337|Anticoagulants|anticoagulants|mesh-ancestor
102339384|NCT04123288|ACT-709478|act-709478|mesh-list
102339385|NCT04123288|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102339386|NCT04123288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102339387|NCT04123288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339388|NCT04123288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102339389|NCT04123288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339390|NCT04123210|Vitamin A|vitamin a|mesh-list
102339391|NCT04123210|Vitamins|vitamins|mesh-ancestor
102339392|NCT04123210|Micronutrients|micronutrients|mesh-ancestor
102339393|NCT04123210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339394|NCT01922089|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102339395|NCT01922089|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102339396|NCT01922089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339397|NCT04121416|Sufentanil|sufentanil|mesh-list
102339398|NCT04121416|Oxycodone|oxycodone|mesh-list
102339399|NCT04121416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102339400|NCT04121416|Narcotics|narcotics|mesh-ancestor
102339401|NCT04121416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102339402|NCT04121416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339403|NCT04121416|Analgesics|analgesics|mesh-ancestor
102048251|NCT02079350|Polygeline|polygeline|mesh-list
102339404|NCT04121416|Sensory System Agents|sensory system agents|mesh-ancestor
102339405|NCT04121416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102339406|NCT04121416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102339407|NCT04121416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102339408|NCT04121416|Anesthetics, General|anesthetics, general|mesh-ancestor
102339409|NCT04121416|Anesthetics|anesthetics|mesh-ancestor
102339410|NCT04121338|Bupivacaine|bupivacaine|mesh-list
102339411|NCT04121338|Anesthetics, Local|anesthetics, local|mesh-ancestor
102339412|NCT04121338|Anesthetics|anesthetics|mesh-ancestor
102339413|NCT04121338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102339414|NCT04121338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339415|NCT04121338|Sensory System Agents|sensory system agents|mesh-ancestor
102339416|NCT04121338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102339417|NCT01896193|Sofosbuvir|sofosbuvir|mesh-list
102339418|NCT01896193|Antiviral Agents|antiviral agents|mesh-ancestor
102339419|NCT01896193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102339420|NCT01922011|Vancomycin|vancomycin|mesh-list
102339421|NCT01922011|Daptomycin|daptomycin|mesh-list
102339422|NCT01922011|Nafcillin|nafcillin|mesh-list
102339423|NCT01922011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102339424|NCT01922011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102339425|NCT04127968|Vitamin A|vitamin a|mesh-list
102339426|NCT04127968|Vitamins|vitamins|mesh-ancestor
102339427|NCT04127968|Micronutrients|micronutrients|mesh-ancestor
102339428|NCT04127968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339429|NCT01921387|Cytarabine|cytarabine|mesh-list
102339430|NCT01921387|Etoposide|etoposide|mesh-list
102339431|NCT01921387|Podophyllotoxin|podophyllotoxin|mesh-list
102339432|NCT01921387|Etoposide phosphate|etoposide phosphate|mesh-list
102339433|NCT01921387|Melphalan|melphalan|mesh-list
102339434|NCT01921387|Mechlorethamine|mechlorethamine|mesh-list
102339435|NCT01921387|Carmustine|carmustine|mesh-list
102339436|NCT01921387|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102339437|NCT01921387|Antibodies|antibodies|mesh-list
102339438|NCT01921387|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102339439|NCT01921387|Immunologic Factors|immunologic factors|mesh-ancestor
102339440|NCT01921387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339441|NCT01921387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102339442|NCT01921387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102339443|NCT01921387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102339444|NCT01921387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102339445|NCT01921387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102339446|NCT01921387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339447|NCT01921387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102339448|NCT01921387|Antimetabolites|antimetabolites|mesh-ancestor
102339449|NCT01921387|Antiviral Agents|antiviral agents|mesh-ancestor
102339450|NCT01921387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102339451|NCT01921387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102339452|NCT01921387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102339453|NCT01921387|Alkylating Agents|alkylating agents|mesh-ancestor
102339454|NCT01921387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102339455|NCT01921387|Keratolytic Agents|keratolytic agents|mesh-ancestor
102339456|NCT01921387|Dermatologic Agents|dermatologic agents|mesh-ancestor
102339457|NCT01921387|Tubulin Modulators|tubulin modulators|mesh-ancestor
102339458|NCT01921387|Antimitotic Agents|antimitotic agents|mesh-ancestor
102339459|NCT01921387|Mitosis Modulators|mitosis modulators|mesh-ancestor
102339460|NCT04129996|Paclitaxel|paclitaxel|mesh-list
102339461|NCT04129996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102339462|NCT04129996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102339463|NCT04129996|Tubulin Modulators|tubulin modulators|mesh-ancestor
102339464|NCT04129996|Antimitotic Agents|antimitotic agents|mesh-ancestor
102339465|NCT04129996|Mitosis Modulators|mitosis modulators|mesh-ancestor
102339466|NCT04129996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339467|NCT04129216|Tamoxifen|tamoxifen|mesh-list
102339468|NCT04129216|Letrozole|letrozole|mesh-list
102339469|NCT04129216|Exemestane|exemestane|mesh-list
102339470|NCT04129216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339471|NCT04129216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102339472|NCT04129216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102339473|NCT04129216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102339474|NCT04129216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102339475|NCT04129216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102339476|NCT04129216|Hormone Antagonists|hormone antagonists|mesh-ancestor
102339477|NCT04129216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102339478|NCT04129216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048306|NCT02083328|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102339479|NCT04129216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102339480|NCT04129216|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102339481|NCT04129216|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102339482|NCT04129216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102339484|NCT01895335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102339485|NCT01895335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102339486|NCT01895335|Analgesics|analgesics|mesh-ancestor
102339487|NCT01895335|Sensory System Agents|sensory system agents|mesh-ancestor
102339488|NCT01895335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102339489|NCT01895335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339490|NCT01895335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102339491|NCT01895335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102339492|NCT01895335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102339493|NCT01895335|Immunologic Factors|immunologic factors|mesh-ancestor
102339494|NCT02980510|Leucovorin|leucovorin|mesh-list
102339495|NCT02980510|Folic Acid|folic acid|mesh-list
102339496|NCT02980510|Oxaliplatin|oxaliplatin|mesh-list
102339497|NCT02980510|Irinotecan|irinotecan|mesh-list
102339498|NCT02980510|Panitumumab|panitumumab|mesh-list
102339499|NCT02980510|Fluorouracil|fluorouracil|mesh-list
102339500|NCT02980510|Levoleucovorin|levoleucovorin|mesh-list
102339501|NCT02980510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102339502|NCT02980510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102339503|NCT02980510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102339504|NCT02980510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102339505|NCT02980510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339506|NCT02980510|Antidotes|antidotes|mesh-ancestor
102339507|NCT02980510|Protective Agents|protective agents|mesh-ancestor
102339508|NCT02980510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339509|NCT02980510|Vitamin B Complex|vitamin b complex|mesh-ancestor
102339510|NCT02980510|Vitamins|vitamins|mesh-ancestor
102339511|NCT02980510|Micronutrients|micronutrients|mesh-ancestor
102339512|NCT02980510|Hematinics|hematinics|mesh-ancestor
102339513|NCT02980510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102339514|NCT02980510|Antimetabolites|antimetabolites|mesh-ancestor
102339515|NCT02980510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102339516|NCT02980510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102339517|NCT02980510|Immunologic Factors|immunologic factors|mesh-ancestor
102339518|NCT03829696|Misoprostol|misoprostol|mesh-list
102339519|NCT03829696|Mifepristone|mifepristone|mesh-list
102339520|NCT03829696|Ulipristal acetate|ulipristal acetate|mesh-list
102339521|NCT03829696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102339522|NCT03829696|Abortifacient Agents|abortifacient agents|mesh-ancestor
102339523|NCT03829696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102339524|NCT03829696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339525|NCT03829696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102339526|NCT03829696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102339527|NCT03829696|Oxytocics|oxytocics|mesh-ancestor
102339528|NCT03829696|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102339529|NCT03829696|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102339530|NCT03829696|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102339531|NCT03829696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102339532|NCT03829696|Contraceptive Agents|contraceptive agents|mesh-ancestor
102339533|NCT03829696|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102339534|NCT03829696|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102339535|NCT03829696|Hormone Antagonists|hormone antagonists|mesh-ancestor
102339536|NCT03829696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102339537|NCT03829696|Luteolytic Agents|luteolytic agents|mesh-ancestor
102339538|NCT03829696|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102339539|NCT03829696|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102339540|NCT03829774|Acetaminophen|acetaminophen|mesh-list
102339541|NCT03829774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102339542|NCT03829774|Analgesics|analgesics|mesh-ancestor
102339543|NCT03829774|Sensory System Agents|sensory system agents|mesh-ancestor
102339544|NCT03829774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102339545|NCT03829774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339546|NCT03829774|Antipyretics|antipyretics|mesh-ancestor
102339548|NCT02974738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102339549|NCT02972398|Acetylcysteine|acetylcysteine|mesh-list
102339550|NCT02972398|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102339551|NCT02972398|Antiviral Agents|antiviral agents|mesh-ancestor
102339552|NCT02972398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102339553|NCT02972398|Expectorants|expectorants|mesh-ancestor
102339554|NCT02972398|Respiratory System Agents|respiratory system agents|mesh-ancestor
102339555|NCT02972398|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102048379|NCT02083640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102339556|NCT02972398|Antioxidants|antioxidants|mesh-ancestor
102339557|NCT02972398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339558|NCT02972398|Protective Agents|protective agents|mesh-ancestor
102339559|NCT02972398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339560|NCT02972398|Antidotes|antidotes|mesh-ancestor
102339561|NCT01617655|Alirocumab|alirocumab|mesh-list
102339562|NCT01617655|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102339563|NCT01617655|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102339564|NCT01617655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102339565|NCT01617655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102339566|NCT01617655|Antimetabolites|antimetabolites|mesh-ancestor
102339567|NCT01617655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339568|NCT01617655|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102339569|NCT01617655|Protease Inhibitors|protease inhibitors|mesh-ancestor
102339570|NCT01617655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102339571|NCT01617655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102339572|NCT01617655|Immunologic Factors|immunologic factors|mesh-ancestor
102339573|NCT01617655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339574|NCT02965768|Naltrexone|naltrexone|mesh-list
102339575|NCT02965768|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102339576|NCT02965768|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102339577|NCT02965768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339578|NCT02965768|Sensory System Agents|sensory system agents|mesh-ancestor
102339579|NCT02965768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102339580|NCT01895101|Tranexamic Acid|tranexamic acid|mesh-list
102339581|NCT01895101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102339582|NCT01895101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102339583|NCT01895101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339584|NCT01895101|Hemostatics|hemostatics|mesh-ancestor
102339585|NCT01895101|Coagulants|coagulants|mesh-ancestor
102339586|NCT03828682|Mycophenolic Acid|mycophenolic acid|mesh-list
102339587|NCT03828682|Prednisone|prednisone|mesh-list
102339588|NCT03828682|Methylprednisolone|methylprednisolone|mesh-list
102339589|NCT03828682|Tacrolimus|tacrolimus|mesh-list
102339590|NCT03828682|Thymoglobulin|thymoglobulin|mesh-list
102339591|NCT03828682|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102339592|NCT03828682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102339593|NCT03828682|Glucocorticoids|glucocorticoids|mesh-ancestor
102339594|NCT03828682|Hormones|hormones|mesh-ancestor
102339595|NCT03828682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102339596|NCT03828682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339597|NCT03828682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102339598|NCT03828682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102339599|NCT03828682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102339600|NCT03828682|Immunologic Factors|immunologic factors|mesh-ancestor
102339601|NCT03828682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102339602|NCT03828682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102339603|NCT03828682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339604|NCT03828682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102339605|NCT03828682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102339606|NCT03828682|Antitubercular Agents|antitubercular agents|mesh-ancestor
102339607|NCT03828682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102339608|NCT03828682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102339609|NCT03828682|Antiemetics|antiemetics|mesh-ancestor
102339610|NCT03828682|Autonomic Agents|autonomic agents|mesh-ancestor
102339611|NCT03828682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102339612|NCT03828682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102339613|NCT03828682|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102339614|NCT03828682|Protective Agents|protective agents|mesh-ancestor
102339615|NCT03483649|Bevacizumab|bevacizumab|mesh-list
102339616|NCT03483649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102339617|NCT03483649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102339618|NCT03483649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101442831|NCT00172055|Zoledronic Acid|zoledronic acid|mesh-list
102339619|NCT03483649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102339620|NCT03483649|Growth Substances|growth substances|mesh-ancestor
102339621|NCT03483649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339622|NCT03483649|Growth Inhibitors|growth inhibitors|mesh-ancestor
102339623|NCT03822520|Moxifloxacin|moxifloxacin|mesh-list
102339624|NCT03822520|Celecoxib|celecoxib|mesh-list
102339625|NCT03822520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102339626|NCT03822520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102339627|NCT03822520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102339628|NCT03822520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102339629|NCT03822520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102339630|NCT03822520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339631|NCT03822520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102339632|NCT03822520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339633|NCT03822520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102339634|NCT03822520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102339635|NCT03822520|Analgesics|analgesics|mesh-ancestor
102339636|NCT03822520|Sensory System Agents|sensory system agents|mesh-ancestor
102339637|NCT03822520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102339638|NCT03822520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102339639|NCT03822520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102339640|NCT03822520|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102339641|NCT03822520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102339642|NCT01894477|Fludarabine|fludarabine|mesh-list
102339643|NCT01894477|Fludarabine phosphate|fludarabine phosphate|mesh-list
102339644|NCT01894477|Treosulfan|treosulfan|mesh-list
102339645|NCT01894477|Busulfan|busulfan|mesh-list
102339646|NCT01894477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102339647|NCT01894477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102339648|NCT01894477|Antimetabolites|antimetabolites|mesh-ancestor
102339649|NCT01894477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339650|NCT01894477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102339651|NCT01894477|Immunologic Factors|immunologic factors|mesh-ancestor
102339652|NCT01894477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339653|NCT01894477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102339654|NCT01894477|Alkylating Agents|alkylating agents|mesh-ancestor
102339655|NCT01894477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102339656|NCT04391998|Metronidazole|metronidazole|mesh-list
102339657|NCT04391998|Albendazole|albendazole|mesh-list
102339658|NCT04391998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102339659|NCT04391998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102339660|NCT04391998|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102339661|NCT04391998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102339662|NCT04391998|Anthelmintics|anthelmintics|mesh-ancestor
102339663|NCT04391998|Anticestodal Agents|anticestodal agents|mesh-ancestor
102339664|NCT04391998|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102339665|NCT04391998|Tubulin Modulators|tubulin modulators|mesh-ancestor
102339666|NCT04391998|Antimitotic Agents|antimitotic agents|mesh-ancestor
102339667|NCT04391998|Mitosis Modulators|mitosis modulators|mesh-ancestor
102339668|NCT04391998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339669|NCT04391998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102339670|NCT03820180|Fluticasone|fluticasone|mesh-list
102339671|NCT03820180|Xhance|xhance|mesh-list
102339672|NCT03820180|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102339673|NCT03820180|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102339674|NCT03820180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102339675|NCT03820180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102339676|NCT03820180|Autonomic Agents|autonomic agents|mesh-ancestor
102339677|NCT03820180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102339678|NCT03820180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339679|NCT03820180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102339680|NCT03820180|Respiratory System Agents|respiratory system agents|mesh-ancestor
102339681|NCT03820180|Dermatologic Agents|dermatologic agents|mesh-ancestor
102339682|NCT03820180|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102339683|NCT03820180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102339684|NCT03820180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102339685|NCT03820180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102339686|NCT03820180|Adrenergic Agents|adrenergic agents|mesh-ancestor
102339687|NCT03820180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102339688|NCT03820180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339689|NCT03820180|Glucocorticoids|glucocorticoids|mesh-ancestor
102339691|NCT03820180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102339692|NCT03820180|Sympathomimetics|sympathomimetics|mesh-ancestor
102339693|NCT01894243|Olaparib|olaparib|mesh-list
102339694|NCT01894243|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102339695|NCT01894243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102339696|NCT01894243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339697|NCT01894243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102339698|NCT01450384|Pemetrexed|pemetrexed|mesh-list
102339699|NCT01450384|Sorafenib|sorafenib|mesh-list
102339700|NCT01450384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102339701|NCT01450384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102339702|NCT01450384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339703|NCT01450384|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102339704|NCT01450384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102339705|NCT01450384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102339706|NCT01450462|Vitamin D|vitamin d|mesh-list
102339707|NCT01450462|Cholecalciferol|cholecalciferol|mesh-list
102339708|NCT01450462|Vitamins|vitamins|mesh-ancestor
102339709|NCT01450462|Micronutrients|micronutrients|mesh-ancestor
102339710|NCT01450462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339711|NCT01450462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102339712|NCT01450462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102339713|NCT01450774|Beclomethasone|beclomethasone|mesh-list
102339714|NCT01450774|Formoterol Fumarate|formoterol fumarate|mesh-list
102339715|NCT01450774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102339716|NCT01450774|Autonomic Agents|autonomic agents|mesh-ancestor
102339717|NCT01450774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102339718|NCT01450774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339719|NCT01450774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102339720|NCT01450774|Respiratory System Agents|respiratory system agents|mesh-ancestor
102339721|NCT01450774|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102339722|NCT01450774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102339723|NCT01450774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102339724|NCT01450774|Adrenergic Agents|adrenergic agents|mesh-ancestor
102339725|NCT01450774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102339726|NCT01450774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339727|NCT01450774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102339728|NCT01450774|Glucocorticoids|glucocorticoids|mesh-ancestor
102339729|NCT01450774|Hormones|hormones|mesh-ancestor
102339730|NCT01450774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102339731|NCT01450930|Hydrocortisone|hydrocortisone|mesh-list
102339732|NCT01450930|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102339733|NCT01450930|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102339734|NCT01450930|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102339735|NCT01450930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102339736|NCT01451086|Vaccines|vaccines|mesh-list
102339737|NCT01451086|Immunologic Factors|immunologic factors|mesh-ancestor
102339738|NCT01451086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339739|NCT01451710|Prednisone|prednisone|mesh-list
102339740|NCT01451710|Prednisolone|prednisolone|mesh-list
102339741|NCT01451710|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102339742|NCT01451710|Methylprednisolone|methylprednisolone|mesh-list
102339743|NCT01451710|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102339744|NCT01451710|Prednisolone acetate|prednisolone acetate|mesh-list
102339745|NCT01451710|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102339746|NCT01451710|Prednisolone phosphate|prednisolone phosphate|mesh-list
102339747|NCT01451710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102339748|NCT01451710|Glucocorticoids|glucocorticoids|mesh-ancestor
102339749|NCT01451710|Hormones|hormones|mesh-ancestor
102339750|NCT01451710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102339751|NCT01451710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339752|NCT01451710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102339753|NCT01451710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102339754|NCT01451710|Antiemetics|antiemetics|mesh-ancestor
102339755|NCT01451710|Autonomic Agents|autonomic agents|mesh-ancestor
102339756|NCT01451710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102339757|NCT01451710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102339758|NCT01451710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102339759|NCT01451710|Protective Agents|protective agents|mesh-ancestor
102339760|NCT01451788|Thrombin|thrombin|mesh-list
102339761|NCT01451788|Hemostatics|hemostatics|mesh-ancestor
102339762|NCT01451788|Coagulants|coagulants|mesh-ancestor
102339763|NCT01452100|Prednisone|prednisone|mesh-list
102339764|NCT01452100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102339765|NCT01452100|Glucocorticoids|glucocorticoids|mesh-ancestor
102339766|NCT01452100|Hormones|hormones|mesh-ancestor
102339767|NCT01452100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102339768|NCT01452100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339769|NCT01452100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102339770|NCT01452100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102339771|NCT01452334|BMS-936559|bms-936559|mesh-list
102339772|NCT01452334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102339773|NCT01452334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102339774|NCT01452568|Aspirin|aspirin|mesh-list
102339775|NCT01452568|Salicylic Acid|salicylic acid|mesh-list
102339776|NCT01452568|Salicylates|salicylates|mesh-list
102339777|NCT01452568|Warfarin|warfarin|mesh-list
102339778|NCT01452568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102339779|NCT01452568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102339780|NCT01452568|Analgesics|analgesics|mesh-ancestor
102339781|NCT01452568|Sensory System Agents|sensory system agents|mesh-ancestor
102339782|NCT01452568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102339783|NCT01452568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339784|NCT01452568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102339785|NCT01452568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102339786|NCT01452568|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102339787|NCT01452568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102339788|NCT01452568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339789|NCT01452568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102339790|NCT01452568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102339791|NCT01452568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102339793|NCT01452568|Anticoagulants|anticoagulants|mesh-ancestor
102339794|NCT01452568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102339795|NCT01452568|Antifungal Agents|antifungal agents|mesh-ancestor
102339796|NCT01452568|Keratolytic Agents|keratolytic agents|mesh-ancestor
102339797|NCT01452568|Dermatologic Agents|dermatologic agents|mesh-ancestor
102339798|NCT01452724|Lansoprazole|lansoprazole|mesh-list
102339799|NCT01452724|Dexlansoprazole|dexlansoprazole|mesh-list
102339800|NCT01452724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102339801|NCT01452724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102339802|NCT01452724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102339803|NCT01452724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102339804|NCT01452724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339805|NCT02620072|Insulin|insulin|mesh-list
102339806|NCT02620072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102339807|NCT02620072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339808|NCT01452880|Remifentanil|remifentanil|mesh-list
102339809|NCT01452880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102339810|NCT01452880|Narcotics|narcotics|mesh-ancestor
102339811|NCT01452880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102339812|NCT01452880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339813|NCT01452880|Analgesics|analgesics|mesh-ancestor
102339814|NCT01452880|Sensory System Agents|sensory system agents|mesh-ancestor
102339815|NCT01452880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102339816|NCT01453192|Raltegravir Potassium|raltegravir potassium|mesh-list
102339817|NCT01453192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102339818|NCT01453192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102339819|NCT01453192|Antiviral Agents|antiviral agents|mesh-ancestor
102339820|NCT01453192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102339821|NCT01453192|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102339822|NCT01453192|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102339823|NCT01453192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102339824|NCT01453192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339825|NCT01453426|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102339826|NCT01453426|Dermatologic Agents|dermatologic agents|mesh-ancestor
102339827|NCT01453426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102339828|NCT01453426|Immunologic Factors|immunologic factors|mesh-ancestor
102339829|NCT01453426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339830|NCT01453504|Everolimus|everolimus|mesh-list
102339831|NCT01453504|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102339832|NCT01453504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102339833|NCT01453504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102339834|NCT01453504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339835|NCT01453504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102339836|NCT01453504|Immunologic Factors|immunologic factors|mesh-ancestor
102339837|NCT01453504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339838|NCT01453504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102339839|NCT01453582|Propolis|propolis|mesh-list
102339840|NCT01453582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102339841|NCT01453738|Plasma-lyte 148|plasma-lyte 148|mesh-list
102339842|NCT01453738|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102339843|NCT01453738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102339844|NCT04847752|Aspirin|aspirin|mesh-list
102339845|NCT04847752|Warfarin|warfarin|mesh-list
102339846|NCT04847752|Rivaroxaban|rivaroxaban|mesh-list
102339847|NCT04847752|Dabigatran|dabigatran|mesh-list
102339848|NCT04847752|Anticoagulants|anticoagulants|mesh-list
102339849|NCT04847752|Clopidogrel|clopidogrel|mesh-list
102339850|NCT04847752|Atorvastatin|atorvastatin|mesh-list
102339851|NCT04847752|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102339852|NCT04847752|Evolocumab|evolocumab|mesh-list
102339853|NCT04847752|Alirocumab|alirocumab|mesh-list
102339854|NCT04847752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
102339855|NCT04847752|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
102339856|NCT04847752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102339857|NCT04847752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102339858|NCT04847752|Analgesics|analgesics|mesh-ancestor
102339859|NCT04847752|Sensory System Agents|sensory system agents|mesh-ancestor
102339860|NCT04847752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102339861|NCT04847752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339862|NCT04847752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102339863|NCT04847752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102339864|NCT04847752|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102339865|NCT04847752|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102339866|NCT04847752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339867|NCT04847752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102339868|NCT04847752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102339869|NCT04847752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102339871|NCT04847752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102339872|NCT04847752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102339873|NCT04847752|Antimetabolites|antimetabolites|mesh-ancestor
102339874|NCT04847752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102339875|NCT04847752|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102339876|NCT04847752|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102339877|NCT04847752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102339878|NCT04847752|Purinergic Agents|purinergic agents|mesh-ancestor
102339879|NCT04847752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102339880|NCT04847752|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102339881|NCT04847752|Antithrombins|antithrombins|mesh-ancestor
102339882|NCT04847752|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102339883|NCT04847752|Protease Inhibitors|protease inhibitors|mesh-ancestor
102339884|NCT04847206|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
102339885|NCT04847206|3,4-Methylenedioxyamphetamine|3,4-methylenedioxyamphetamine|mesh-list
102339886|NCT04847206|Hallucinogens|hallucinogens|mesh-ancestor
102339887|NCT04847206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339888|NCT04847206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102339889|NCT04847206|Serotonin Agents|serotonin agents|mesh-ancestor
101442854|NCT00202293|Chlorpromazine|chlorpromazine|mesh-list
102339890|NCT04847206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102339891|NCT04847206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339892|NCT04847206|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102339893|NCT04847206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102339894|NCT04847206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102339895|NCT04847206|Adrenergic Agents|adrenergic agents|mesh-ancestor
102339896|NCT02864914|Empagliflozin|empagliflozin|mesh-list
102339897|NCT02864914|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
102339898|NCT02864914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102339899|NCT02864914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339900|NCT02864914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102339901|NCT02864914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339902|NCT02864914|Protease Inhibitors|protease inhibitors|mesh-ancestor
102339903|NCT02864914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102339904|NCT04840264|Docetaxel|docetaxel|mesh-list
102339905|NCT04840264|Fluorouracil|fluorouracil|mesh-list
102339906|NCT04840264|Oxaliplatin|oxaliplatin|mesh-list
102339907|NCT04840264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102339908|NCT04840264|Tubulin Modulators|tubulin modulators|mesh-ancestor
102339909|NCT04840264|Antimitotic Agents|antimitotic agents|mesh-ancestor
102339910|NCT04840264|Mitosis Modulators|mitosis modulators|mesh-ancestor
102339911|NCT04840264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339912|NCT04840264|Antimetabolites|antimetabolites|mesh-ancestor
102339913|NCT04840264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102339914|NCT04840264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102339915|NCT04840264|Immunologic Factors|immunologic factors|mesh-ancestor
102339916|NCT04840264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339917|NCT04841434|Methotrexate|methotrexate|mesh-list
102339918|NCT04841434|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102339919|NCT04841434|Abortifacient Agents|abortifacient agents|mesh-ancestor
102339920|NCT04841434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102339921|NCT04841434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339922|NCT04841434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102339923|NCT04841434|Antimetabolites|antimetabolites|mesh-ancestor
102339924|NCT04841434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339925|NCT04841434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102339926|NCT04841434|Dermatologic Agents|dermatologic agents|mesh-ancestor
102339927|NCT04841434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102339928|NCT04841434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102339929|NCT04841434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102339930|NCT04841434|Immunologic Factors|immunologic factors|mesh-ancestor
102339931|NCT04841434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102339932|NCT04841434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102339933|NCT02849470|Complement Factor H|complement factor h|mesh-list
102339934|NCT02849470|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102339935|NCT02849470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102339936|NCT02849470|Immunologic Factors|immunologic factors|mesh-ancestor
102339937|NCT02849470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339938|NCT05024188|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102339939|NCT05024188|Metronidazole|metronidazole|mesh-list
102339940|NCT05024188|Ciprofloxacin|ciprofloxacin|mesh-list
102339941|NCT05024188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102339942|NCT05024188|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102339943|NCT05024188|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102339944|NCT05024188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102339945|NCT05024188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102339946|NCT05024188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102339947|NCT05024188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339948|NCT05024188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102339949|NCT05024188|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102339950|NCT05024188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102339951|NCT04390594|Nafamostat|nafamostat|mesh-list
102339952|NCT04390594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102339953|NCT04390594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102339954|NCT04390594|Analgesics|analgesics|mesh-ancestor
102339955|NCT04390594|Sensory System Agents|sensory system agents|mesh-ancestor
102339956|NCT04390594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102339957|NCT04390594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339958|NCT04390594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102339959|NCT04390594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102339960|NCT04390594|Anticoagulants|anticoagulants|mesh-ancestor
102339961|NCT04390594|Protease Inhibitors|protease inhibitors|mesh-ancestor
102339962|NCT04390594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102339963|NCT04390594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339964|NCT04390594|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102339965|NCT04390594|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102339966|NCT04390594|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102339967|NCT04390594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102339968|NCT04390594|Immunologic Factors|immunologic factors|mesh-ancestor
102339969|NCT05024422|Pyridoxine|pyridoxine|mesh-list
102339970|NCT05024422|Vitamin B 6|vitamin b 6|mesh-list
102339971|NCT05024422|Cabergoline|cabergoline|mesh-list
102339972|NCT05024422|Vitamins|vitamins|mesh-ancestor
102339973|NCT05024422|Micronutrients|micronutrients|mesh-ancestor
102339974|NCT05024422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339975|NCT05024422|Vitamin B Complex|vitamin b complex|mesh-ancestor
102339976|NCT05024422|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102339977|NCT05024422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102339978|NCT05024422|Dopamine Agonists|dopamine agonists|mesh-ancestor
102339979|NCT05024422|Dopamine Agents|dopamine agents|mesh-ancestor
102339980|NCT05024422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102339981|NCT05024422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339982|NCT02819596|Durvalumab|durvalumab|mesh-list
102339984|NCT02819596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102339985|NCT02819596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102339987|NCT02818894|Bupivacaine|bupivacaine|mesh-list
102339988|NCT02818894|Anesthetics, Local|anesthetics, local|mesh-ancestor
102339989|NCT02818894|Anesthetics|anesthetics|mesh-ancestor
102339990|NCT02818894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102339991|NCT02818894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102339992|NCT02818894|Sensory System Agents|sensory system agents|mesh-ancestor
102339993|NCT02818894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102339994|NCT02818894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102339995|NCT02818894|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102339996|NCT02818894|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102339997|NCT02818894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102339998|NCT02818894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102339999|NCT05586568|Itraconazole|itraconazole|mesh-list
102340000|NCT05586568|Rifampin|rifampin|mesh-list
102340001|NCT05586568|Esomeprazole|esomeprazole|mesh-list
102340002|NCT05586568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102340003|NCT05586568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102340004|NCT05586568|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102340005|NCT05586568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102340006|NCT05586568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340007|NCT05586568|Antifungal Agents|antifungal agents|mesh-ancestor
102340008|NCT05586568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102340009|NCT05586568|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102340010|NCT05586568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102048829|NCT02791490|Metformin|metformin|mesh-list
102340011|NCT05586568|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102340012|NCT05586568|Hormone Antagonists|hormone antagonists|mesh-ancestor
102340013|NCT05586568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102340014|NCT05586568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340015|NCT05586568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102340016|NCT05586568|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102340017|NCT05586568|Antitubercular Agents|antitubercular agents|mesh-ancestor
102340018|NCT05586568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102340019|NCT05586568|Leprostatic Agents|leprostatic agents|mesh-ancestor
102340020|NCT05586568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102340021|NCT05586568|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102340022|NCT05586568|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102340023|NCT05586568|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102340024|NCT05586568|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102340025|NCT05586568|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102340026|NCT05586568|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102340027|NCT02632708|Cytarabine|cytarabine|mesh-list
102340028|NCT02632708|Etoposide|etoposide|mesh-list
102340029|NCT02632708|Daunorubicin|daunorubicin|mesh-list
102340030|NCT02632708|Mitoxantrone|mitoxantrone|mesh-list
102340031|NCT02632708|Idarubicin|idarubicin|mesh-list
102340032|NCT02632708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102340033|NCT02632708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102340034|NCT02632708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102340035|NCT02632708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102340036|NCT02632708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102340037|NCT02632708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340038|NCT02632708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102340039|NCT02632708|Antimetabolites|antimetabolites|mesh-ancestor
102340040|NCT02632708|Antiviral Agents|antiviral agents|mesh-ancestor
102340041|NCT02632708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102340042|NCT02632708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102340043|NCT02632708|Immunologic Factors|immunologic factors|mesh-ancestor
102340044|NCT02632708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340045|NCT02632708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102340046|NCT02632708|Analgesics|analgesics|mesh-ancestor
102340047|NCT02632708|Sensory System Agents|sensory system agents|mesh-ancestor
102340048|NCT02632708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102340049|NCT02624908|Canagliflozin|canagliflozin|mesh-list
102340050|NCT02624908|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102340051|NCT02624908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340052|NCT02624908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102340053|NCT02624908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340054|NCT02614534|Mitomycins|mitomycins|mesh-list
102340055|NCT02614534|Mitomycin|mitomycin|mesh-list
102340056|NCT02614534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102340057|NCT02614534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102340058|NCT02614534|Alkylating Agents|alkylating agents|mesh-ancestor
102340059|NCT02614534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340060|NCT02614534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102340061|NCT02614534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102340062|NCT02587000|Ulipristal acetate|ulipristal acetate|mesh-list
102340063|NCT02587000|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102340064|NCT02587000|Contraceptive Agents|contraceptive agents|mesh-ancestor
102340065|NCT02587000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102340066|NCT02587000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340067|NCT02587000|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102340068|NCT04757818|Cetylpyridinium|cetylpyridinium|mesh-list
102340069|NCT04757818|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102340070|NCT04757818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102340071|NCT02556424|Dexamethasone|dexamethasone|mesh-list
102340072|NCT02556424|Triamcinolone|triamcinolone|mesh-list
102340073|NCT02556424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102340074|NCT02556424|Antiemetics|antiemetics|mesh-ancestor
102340075|NCT02556424|Autonomic Agents|autonomic agents|mesh-ancestor
102340076|NCT02556424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102340077|NCT02556424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340078|NCT02556424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102340079|NCT02556424|Glucocorticoids|glucocorticoids|mesh-ancestor
102340080|NCT02556424|Hormones|hormones|mesh-ancestor
102340081|NCT02556424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102340082|NCT02556424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102340083|NCT02556424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102340084|NCT02543944|Clonidine|clonidine|mesh-list
102340085|NCT02543944|Naltrexone|naltrexone|mesh-list
102340086|NCT02543944|Buprenorphine|buprenorphine|mesh-list
102340087|NCT02543944|Gabapentin|gabapentin|mesh-list
102340088|NCT02543944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102340089|NCT02543944|Narcotics|narcotics|mesh-ancestor
102340090|NCT02543944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102340091|NCT02543944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340092|NCT02543944|Analgesics|analgesics|mesh-ancestor
102340093|NCT02543944|Sensory System Agents|sensory system agents|mesh-ancestor
102340094|NCT02543944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102340095|NCT02543944|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102340096|NCT02543944|Anticonvulsants|anticonvulsants|mesh-ancestor
102340097|NCT02543944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102340098|NCT02543944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102340099|NCT02543944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102340100|NCT02543944|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102340101|NCT02543944|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102340102|NCT02543944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102340103|NCT02543944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340104|NCT02543944|Antimanic Agents|antimanic agents|mesh-ancestor
102340105|NCT02543944|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102340106|NCT02543944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102340107|NCT02543944|Sympatholytics|sympatholytics|mesh-ancestor
102340108|NCT02543944|Autonomic Agents|autonomic agents|mesh-ancestor
102340109|NCT02543944|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102340110|NCT02543944|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102340111|NCT02543944|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102340112|NCT02543944|Adrenergic Agents|adrenergic agents|mesh-ancestor
102340113|NCT02531308|Metformin|metformin|mesh-list
102340114|NCT02531308|Prednisone|prednisone|mesh-list
102340115|NCT02531308|Cyclophosphamide|cyclophosphamide|mesh-list
102340116|NCT02531308|Rituximab|rituximab|mesh-list
102340117|NCT02531308|Doxorubicin|doxorubicin|mesh-list
102340118|NCT02531308|Vincristine|vincristine|mesh-list
102340119|NCT02531308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102340120|NCT02531308|Immunologic Factors|immunologic factors|mesh-ancestor
102340121|NCT02531308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340122|NCT02531308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102340123|NCT02531308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102340124|NCT02531308|Alkylating Agents|alkylating agents|mesh-ancestor
102340125|NCT02531308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340126|NCT02531308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102340127|NCT02531308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102340128|NCT02531308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102340129|NCT02531308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102340130|NCT02531308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102340131|NCT02531308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102340132|NCT02531308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102340133|NCT02531308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102340134|NCT02531308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102340135|NCT02531308|Glucocorticoids|glucocorticoids|mesh-ancestor
102340136|NCT02531308|Hormones|hormones|mesh-ancestor
102340137|NCT02531308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102340138|NCT02531308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102340139|NCT02531308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102340140|NCT02531308|Tubulin Modulators|tubulin modulators|mesh-ancestor
102340141|NCT02531308|Antimitotic Agents|antimitotic agents|mesh-ancestor
102340142|NCT02531308|Mitosis Modulators|mitosis modulators|mesh-ancestor
102340143|NCT02523976|Cytarabine|cytarabine|mesh-list
102340144|NCT02523976|Dexamethasone|dexamethasone|mesh-list
102340145|NCT02523976|Prednisone|prednisone|mesh-list
102340146|NCT02523976|Cyclophosphamide|cyclophosphamide|mesh-list
102340147|NCT02523976|Methotrexate|methotrexate|mesh-list
102340148|NCT02523976|Etoposide|etoposide|mesh-list
102340149|NCT02523976|Vincristine|vincristine|mesh-list
102340150|NCT02523976|Daunorubicin|daunorubicin|mesh-list
102340151|NCT02523976|Dasatinib|dasatinib|mesh-list
102340152|NCT02523976|Mitoxantrone|mitoxantrone|mesh-list
102340153|NCT02523976|Mercaptopurine|mercaptopurine|mesh-list
102340154|NCT02523976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102340155|NCT02523976|Immunologic Factors|immunologic factors|mesh-ancestor
102340156|NCT02523976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340157|NCT02523976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102340158|NCT02523976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102340159|NCT02523976|Alkylating Agents|alkylating agents|mesh-ancestor
102340160|NCT02523976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340161|NCT02523976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102340162|NCT02523976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102340163|NCT02523976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102340164|NCT02523976|Antiemetics|antiemetics|mesh-ancestor
102340165|NCT02523976|Autonomic Agents|autonomic agents|mesh-ancestor
102340166|NCT02523976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102340167|NCT02523976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102340168|NCT02523976|Glucocorticoids|glucocorticoids|mesh-ancestor
102340169|NCT02523976|Hormones|hormones|mesh-ancestor
102340170|NCT02523976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102340171|NCT02523976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102340172|NCT02523976|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102340173|NCT02523976|Abortifacient Agents|abortifacient agents|mesh-ancestor
102340174|NCT02523976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102340175|NCT02523976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102340176|NCT02523976|Antimetabolites|antimetabolites|mesh-ancestor
102340177|NCT02523976|Dermatologic Agents|dermatologic agents|mesh-ancestor
102340178|NCT02523976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102340179|NCT02523976|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102340180|NCT02523976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102340181|NCT02523976|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102340182|NCT02523976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102340183|NCT02523976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102340184|NCT02523976|Antiviral Agents|antiviral agents|mesh-ancestor
102340185|NCT02523976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102340186|NCT02523976|Tubulin Modulators|tubulin modulators|mesh-ancestor
102340187|NCT02523976|Antimitotic Agents|antimitotic agents|mesh-ancestor
102340188|NCT02523976|Mitosis Modulators|mitosis modulators|mesh-ancestor
102340189|NCT02523976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102340190|NCT02523976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102340191|NCT02523976|Analgesics|analgesics|mesh-ancestor
102340192|NCT02523976|Sensory System Agents|sensory system agents|mesh-ancestor
102340193|NCT02493322|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102340194|NCT02493322|Olmesartan|olmesartan|mesh-list
102340195|NCT02493322|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
102340196|NCT02493322|Chlorthalidone|chlorthalidone|mesh-list
102340197|NCT02493322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102340198|NCT02493322|Diuretics|diuretics|mesh-ancestor
102340199|NCT02493322|Natriuretic Agents|natriuretic agents|mesh-ancestor
102340200|NCT02493322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340201|NCT02493322|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102340202|NCT02493322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102340203|NCT02493322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340204|NCT02493322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102340205|NCT02493322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102340206|NCT04757974|Fostemsavir|fostemsavir|mesh-list
102340207|NCT04757974|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102340209|NCT04757974|Antiviral Agents|antiviral agents|mesh-ancestor
102340210|NCT04757974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102340211|NCT04757974|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102340212|NCT04757974|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102340213|NCT04757974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340214|NCT04757506|Naltrexone|naltrexone|mesh-list
102340215|NCT04757506|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102340216|NCT04757506|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102340217|NCT04757506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340218|NCT04757506|Sensory System Agents|sensory system agents|mesh-ancestor
102340219|NCT04757506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102340220|NCT02477644|Olaparib|olaparib|mesh-list
102340221|NCT02477644|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102340222|NCT02477644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102340223|NCT02477644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340224|NCT02477644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102340225|NCT02466334|Calcitonin|calcitonin|mesh-list
102340226|NCT02466334|Salmon calcitonin|salmon calcitonin|mesh-list
102340227|NCT02466334|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
102340228|NCT02466334|Katacalcin|katacalcin|mesh-list
102340229|NCT02466334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102340230|NCT02466334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340231|NCT02466334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102340232|NCT02466334|Vasodilator Agents|vasodilator agents|mesh-ancestor
102340233|NCT02460874|Glyburide|glyburide|mesh-list
102340234|NCT02460874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102340235|NCT02460874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340236|NCT02443324|Pembrolizumab|pembrolizumab|mesh-list
102340237|NCT02443324|Ramucirumab|ramucirumab|mesh-list
102340238|NCT02443324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102340239|NCT02443324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102340240|NCT02443324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102340241|NCT02443324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340242|NCT01894048|Beclomethasone|beclomethasone|mesh-list
102340243|NCT01894048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102340244|NCT01894048|Glucocorticoids|glucocorticoids|mesh-ancestor
102340245|NCT01894048|Hormones|hormones|mesh-ancestor
102340246|NCT01894048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102340247|NCT01894048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340248|NCT01894048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102340249|NCT01894048|Respiratory System Agents|respiratory system agents|mesh-ancestor
102340250|NCT02420860|Lenalidomide|lenalidomide|mesh-list
102340251|NCT02420860|Elotuzumab|elotuzumab|mesh-list
102340252|NCT02420860|Immunologic Factors|immunologic factors|mesh-ancestor
102340253|NCT02420860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340254|NCT02420860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102340255|NCT02420860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102340256|NCT02420860|Growth Substances|growth substances|mesh-ancestor
102340257|NCT02420860|Growth Inhibitors|growth inhibitors|mesh-ancestor
102340258|NCT02420860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102340259|NCT02420314|Ascorbic Acid|ascorbic acid|mesh-list
102340260|NCT02420314|Paclitaxel|paclitaxel|mesh-list
102340261|NCT02420314|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102340262|NCT02420314|Carboplatin|carboplatin|mesh-list
102340263|NCT02420314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102340264|NCT02420314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102340265|NCT02420314|Tubulin Modulators|tubulin modulators|mesh-ancestor
102340266|NCT02420314|Antimitotic Agents|antimitotic agents|mesh-ancestor
102340267|NCT02420314|Mitosis Modulators|mitosis modulators|mesh-ancestor
102340268|NCT02420314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340269|NCT02420314|Vitamins|vitamins|mesh-ancestor
102340270|NCT02420314|Micronutrients|micronutrients|mesh-ancestor
102340271|NCT02420314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340272|NCT02420314|Antioxidants|antioxidants|mesh-ancestor
102340273|NCT02420314|Protective Agents|protective agents|mesh-ancestor
102340274|NCT02403778|Ipilimumab|ipilimumab|mesh-list
102340275|NCT02403778|Tretinoin|tretinoin|mesh-list
102340276|NCT02403778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102340277|NCT02403778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102340278|NCT02403778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102340279|NCT02403778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340280|NCT02403778|Keratolytic Agents|keratolytic agents|mesh-ancestor
102340281|NCT02403778|Dermatologic Agents|dermatologic agents|mesh-ancestor
102340282|NCT01539291|Idelalisib|idelalisib|mesh-list
102340284|NCT01539291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102340285|NCT01539291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340286|NCT04746040|Fluticasone|fluticasone|mesh-list
102340287|NCT04746040|Xhance|xhance|mesh-list
102340288|NCT04746040|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102340289|NCT04746040|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102340290|NCT04746040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102340291|NCT04746040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102340292|NCT04746040|Autonomic Agents|autonomic agents|mesh-ancestor
102340293|NCT04746040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102340294|NCT04746040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340295|NCT04746040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102340296|NCT04746040|Respiratory System Agents|respiratory system agents|mesh-ancestor
102340297|NCT04746040|Dermatologic Agents|dermatologic agents|mesh-ancestor
102340298|NCT04746040|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102340299|NCT04746040|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102340300|NCT04746040|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102340301|NCT04746040|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102340302|NCT04746040|Adrenergic Agents|adrenergic agents|mesh-ancestor
102340303|NCT04746040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102340304|NCT04746040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340305|NCT04746040|Glucocorticoids|glucocorticoids|mesh-ancestor
102340306|NCT04746040|Hormones|hormones|mesh-ancestor
102340307|NCT04746040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102340308|NCT04746040|Sympathomimetics|sympathomimetics|mesh-ancestor
102340309|NCT02400814|Atezolizumab|atezolizumab|mesh-list
102340310|NCT02400814|Antibodies|antibodies|mesh-list
102340311|NCT02400814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102340312|NCT02400814|Immunologic Factors|immunologic factors|mesh-ancestor
102340313|NCT02400814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340314|NCT02400814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102340315|NCT02400814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340316|NCT02400814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102340318|NCT02398240|Rituximab|rituximab|mesh-list
102340319|NCT02398240|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102340320|NCT02398240|Doxorubicin|doxorubicin|mesh-list
102340321|NCT02398240|Vincristine|vincristine|mesh-list
102340322|NCT02398240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102340323|NCT02398240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102340324|NCT02398240|Immunologic Factors|immunologic factors|mesh-ancestor
102340325|NCT02398240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340326|NCT02398240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102340327|NCT02398240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102340328|NCT02398240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102340329|NCT02398240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102340330|NCT02398240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102340331|NCT02398240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340332|NCT02398240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102340333|NCT02398240|Tubulin Modulators|tubulin modulators|mesh-ancestor
102340334|NCT02398240|Antimitotic Agents|antimitotic agents|mesh-ancestor
102340335|NCT02398240|Mitosis Modulators|mitosis modulators|mesh-ancestor
102340336|NCT02398240|Immunotoxins|immunotoxins|mesh-ancestor
102340337|NCT02398240|Immunoconjugates|immunoconjugates|mesh-ancestor
102340338|NCT02022280|Lansoprazole|lansoprazole|mesh-list
102340339|NCT02022280|Dexlansoprazole|dexlansoprazole|mesh-list
102340340|NCT02022280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102340341|NCT02022280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102340342|NCT02022280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102340343|NCT02022280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102340344|NCT02022280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340345|NCT02363374|Leucovorin|leucovorin|mesh-list
102340346|NCT02363374|Folic Acid|folic acid|mesh-list
102340347|NCT02363374|Fluorouracil|fluorouracil|mesh-list
102340348|NCT02363374|Oxaliplatin|oxaliplatin|mesh-list
102340349|NCT02363374|Levoleucovorin|levoleucovorin|mesh-list
102340350|NCT02363374|Antimetabolites|antimetabolites|mesh-ancestor
101442921|NCT00197886|Sympathomimetics|sympathomimetics|mesh-ancestor
102340351|NCT02363374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340352|NCT02363374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102340353|NCT02363374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102340354|NCT02363374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102340355|NCT02363374|Immunologic Factors|immunologic factors|mesh-ancestor
102340356|NCT02363374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340357|NCT02363374|Antidotes|antidotes|mesh-ancestor
102340358|NCT02363374|Protective Agents|protective agents|mesh-ancestor
102340359|NCT02363374|Vitamin B Complex|vitamin b complex|mesh-ancestor
102340360|NCT02363374|Vitamins|vitamins|mesh-ancestor
102340361|NCT02363374|Micronutrients|micronutrients|mesh-ancestor
102340362|NCT02363374|Hematinics|hematinics|mesh-ancestor
102340363|NCT01511445|Silicon|silicon|mesh-list
102340364|NCT01511445|Trace Elements|trace elements|mesh-ancestor
102340365|NCT01511445|Micronutrients|micronutrients|mesh-ancestor
102340366|NCT01511445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340367|NCT02344186|Liraglutide|liraglutide|mesh-list
102340368|NCT02344186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102340369|NCT02344186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340370|NCT02344186|Incretins|incretins|mesh-ancestor
102340371|NCT02344186|Hormones|hormones|mesh-ancestor
102340372|NCT02344186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102340373|NCT01537887|Moxifloxacin|moxifloxacin|mesh-list
102340374|NCT01537887|Evacetrapib|evacetrapib|mesh-list
102340375|NCT01537887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102340376|NCT01537887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102340377|NCT01537887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102340378|NCT01537887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102340379|NCT01537887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102340380|NCT01537887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340381|NCT01537887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102340382|NCT01537887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102340383|NCT01537887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102340384|NCT01537887|Antimetabolites|antimetabolites|mesh-ancestor
102340385|NCT01537887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102340386|NCT02305264|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102340387|NCT02305264|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102340388|NCT02305264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340389|NCT02297698|Trastuzumab|trastuzumab|mesh-list
102340390|NCT02297698|Sargramostim|sargramostim|mesh-list
102049208|NCT02092532|Growth Inhibitors|growth inhibitors|mesh-ancestor
102340391|NCT02297698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102340392|NCT02297698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102340393|NCT02297698|Immunologic Factors|immunologic factors|mesh-ancestor
102340394|NCT02297698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340395|NCT01487577|Mycophenolic Acid|mycophenolic acid|mesh-list
102340396|NCT01487577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102340397|NCT01487577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102340398|NCT01487577|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102340399|NCT01487577|Antitubercular Agents|antitubercular agents|mesh-ancestor
102340400|NCT01487577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102340401|NCT01487577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102340402|NCT01487577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102340403|NCT01487577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340405|NCT01928056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102340406|NCT01928056|Respiratory System Agents|respiratory system agents|mesh-ancestor
102340407|NCT01928056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102340408|NCT01928056|Hormone Antagonists|hormone antagonists|mesh-ancestor
102340409|NCT01928056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102340410|NCT01928056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340411|NCT01928056|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102340412|NCT01928056|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102340413|NCT01928056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340414|NCT05585866|Anesthetics|anesthetics|mesh-list
102340415|NCT05585866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102340416|NCT05585866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340417|NCT01992952|Fulvestrant|fulvestrant|mesh-list
102340418|NCT01992952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102340419|NCT01992952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102340420|NCT01992952|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102340421|NCT01992952|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102340422|NCT01992952|Hormone Antagonists|hormone antagonists|mesh-ancestor
102340423|NCT01992952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102340424|NCT01992952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340425|NCT01928134|Calcium Carbonate|calcium carbonate|mesh-list
102340426|NCT01928134|Calcium|calcium|mesh-list
102340427|NCT01928134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102340428|NCT01928134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340429|NCT01928134|Antacids|antacids|mesh-ancestor
102340430|NCT01928134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340431|NCT01928134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102340432|NCT02285140|Vancomycin|vancomycin|mesh-list
102340433|NCT02285140|Cefazolin|cefazolin|mesh-list
102340434|NCT02285140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102340435|NCT02285140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102340436|NCT04756882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102340437|NCT04756882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102340438|NCT04756882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102340439|NCT04756882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102340440|NCT04756882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340441|NCT04756882|Cholinergic Agents|cholinergic agents|mesh-ancestor
102340442|NCT04756882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102340443|NCT04756882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340444|NCT04756882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102340445|NCT04756882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102340446|NCT04756492|Cyclosporine|cyclosporine|mesh-list
102340447|NCT04756492|Antifungal Agents|antifungal agents|mesh-ancestor
102340448|NCT04756492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102340449|NCT04756492|Dermatologic Agents|dermatologic agents|mesh-ancestor
102340450|NCT04756492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102340451|NCT04756492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340452|NCT04756492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102340453|NCT04756492|Immunologic Factors|immunologic factors|mesh-ancestor
102340454|NCT04756492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340455|NCT04756492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102340456|NCT04756492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102340457|NCT01536951|Moxifloxacin|moxifloxacin|mesh-list
102340458|NCT01536951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102340459|NCT01536951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102340460|NCT01536951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102340461|NCT01536951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102340462|NCT01536951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102340463|NCT01536951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340464|NCT01536951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102340465|NCT04767633|Magnesium Sulfate|magnesium sulfate|mesh-list
102340466|NCT04767633|Analgesics|analgesics|mesh-ancestor
102340467|NCT04767633|Sensory System Agents|sensory system agents|mesh-ancestor
102340468|NCT04767633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102340469|NCT04767633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340470|NCT04767633|Anesthetics|anesthetics|mesh-ancestor
102340471|NCT04767633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102340472|NCT04767633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102340473|NCT04767633|Anticonvulsants|anticonvulsants|mesh-ancestor
102340474|NCT04767633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102340475|NCT04767633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102340476|NCT04767633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340477|NCT04767633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102340478|NCT04767633|Tocolytic Agents|tocolytic agents|mesh-ancestor
102340479|NCT04767633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102340480|NCT01928914|Moxifloxacin|moxifloxacin|mesh-list
102340481|NCT01928914|Tafenoquine|tafenoquine|mesh-list
102340482|NCT01928914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102340483|NCT01928914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102340484|NCT01928914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102340485|NCT01928914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102340486|NCT01928914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102340487|NCT01928914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340488|NCT01928914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102340489|NCT01928914|Antimalarials|antimalarials|mesh-ancestor
102340490|NCT01928914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102340491|NCT01928914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102340492|NCT02249104|Adapalene|adapalene|mesh-list
102340493|NCT02249104|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
102340494|NCT02249104|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102340495|NCT02249104|Dermatologic Agents|dermatologic agents|mesh-ancestor
102340496|NCT02249104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102340497|NCT02249104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102340498|NCT02249104|Analgesics|analgesics|mesh-ancestor
102340499|NCT02249104|Sensory System Agents|sensory system agents|mesh-ancestor
102340500|NCT02249104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102340501|NCT02249104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340502|NCT02249104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102340503|NCT02249104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102340504|NCT01929070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102340505|NCT01929070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102340507|NCT01929070|Antimetabolites|antimetabolites|mesh-ancestor
102340508|NCT01929070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340509|NCT01929070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102340510|NCT01929070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102340511|NCT01929070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102340512|NCT01536561|Tositumomab I-131|tositumomab i-131|mesh-list
102340513|NCT01536561|Antibodies|antibodies|mesh-list
102340514|NCT01536561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102340515|NCT01536561|Antibodies, Anti-Idiotypic|antibodies, anti-idiotypic|mesh-list
102340516|NCT01536561|Immunologic Factors|immunologic factors|mesh-ancestor
102340517|NCT01536561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340518|NCT01536561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102340519|NCT02236312|Botulinum Toxins|botulinum toxins|mesh-list
102340520|NCT02236312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102340521|NCT02236312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102340522|NCT02236312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102340523|NCT02236312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102340524|NCT02236312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340525|NCT02236312|Cholinergic Agents|cholinergic agents|mesh-ancestor
102340526|NCT02236312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102340527|NCT02236312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340528|NCT02236312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102340529|NCT02236312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102340530|NCT01916278|Lidocaine|lidocaine|mesh-list
102340531|NCT01916278|Anesthetics, Local|anesthetics, local|mesh-ancestor
102340532|NCT01916278|Anesthetics|anesthetics|mesh-ancestor
102340533|NCT01916278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102340534|NCT01916278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340535|NCT01916278|Sensory System Agents|sensory system agents|mesh-ancestor
102340536|NCT01916278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102340537|NCT01916278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102340538|NCT01916278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102340539|NCT01916278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102340540|NCT01916278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102340541|NCT01916278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340542|NCT03084640|Pembrolizumab|pembrolizumab|mesh-list
102340543|NCT03084640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102340544|NCT03084640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102340545|NCT03084640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102340546|NCT03084640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340547|NCT04409691|Sirolimus|sirolimus|mesh-list
102340548|NCT04409691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102340549|NCT04409691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102340550|NCT04409691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102340551|NCT04409691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102340552|NCT04409691|Antifungal Agents|antifungal agents|mesh-ancestor
102340553|NCT04409691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102340554|NCT04409691|Immunologic Factors|immunologic factors|mesh-ancestor
102340555|NCT04409691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340556|NCT02223208|Prednisone|prednisone|mesh-list
102340557|NCT02223208|Cyclophosphamide|cyclophosphamide|mesh-list
102340558|NCT02223208|Doxorubicin|doxorubicin|mesh-list
102340559|NCT02223208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102340560|NCT02223208|Etoposide|etoposide|mesh-list
102340561|NCT02223208|Etoposide phosphate|etoposide phosphate|mesh-list
102340562|NCT02223208|Romidepsin|romidepsin|mesh-list
102340563|NCT02223208|Vincristine|vincristine|mesh-list
102340564|NCT02223208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102340565|NCT02223208|Immunologic Factors|immunologic factors|mesh-ancestor
102340566|NCT02223208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340567|NCT02223208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102340568|NCT02223208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102340569|NCT02223208|Alkylating Agents|alkylating agents|mesh-ancestor
102340570|NCT02223208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340571|NCT02223208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102340572|NCT02223208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102340573|NCT02223208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102340574|NCT02223208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102340575|NCT02223208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102340576|NCT02223208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102340577|NCT02223208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102340578|NCT02223208|Glucocorticoids|glucocorticoids|mesh-ancestor
102340580|NCT02223208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102340581|NCT02223208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102340582|NCT02223208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102340583|NCT02223208|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102340584|NCT02223208|Tubulin Modulators|tubulin modulators|mesh-ancestor
102340585|NCT02223208|Antimitotic Agents|antimitotic agents|mesh-ancestor
102340586|NCT02223208|Mitosis Modulators|mitosis modulators|mesh-ancestor
102340587|NCT02219776|Chlorhexidine|chlorhexidine|mesh-list
102340588|NCT02219776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102340589|NCT02219776|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102340590|NCT02219776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102340591|NCT02219776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102340592|NCT02219776|Disinfectants|disinfectants|mesh-ancestor
102340593|NCT02219776|Dermatologic Agents|dermatologic agents|mesh-ancestor
102340594|NCT01487265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102340595|NCT01487265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102340596|NCT01487265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102340597|NCT01487265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102340598|NCT01487265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340599|NCT01516606|Clarithromycin|clarithromycin|mesh-list
102340600|NCT01516606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102340601|NCT01516606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102340602|NCT01516606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102340603|NCT01516606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102340604|NCT01516606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340605|NCT01516606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102340606|NCT01516606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102340607|NCT02209636|Ascorbic Acid|ascorbic acid|mesh-list
102340608|NCT02209636|Nitroglycerin|nitroglycerin|mesh-list
102340609|NCT02209636|Vitamins|vitamins|mesh-ancestor
102340610|NCT02209636|Micronutrients|micronutrients|mesh-ancestor
102340611|NCT02209636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340613|NCT02209636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340614|NCT02209636|Protective Agents|protective agents|mesh-ancestor
102340615|NCT02209636|Vasodilator Agents|vasodilator agents|mesh-ancestor
102340616|NCT01508325|Metoprolol|metoprolol|mesh-list
102340617|NCT01508325|Bisoprolol|bisoprolol|mesh-list
102340618|NCT01508325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102340619|NCT01508325|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102340620|NCT01508325|Sympatholytics|sympatholytics|mesh-ancestor
102340621|NCT01508325|Autonomic Agents|autonomic agents|mesh-ancestor
102340622|NCT01508325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102340623|NCT01508325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340624|NCT01508325|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102340625|NCT01508325|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102340626|NCT01508325|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102340627|NCT01508325|Adrenergic Agents|adrenergic agents|mesh-ancestor
102340628|NCT01508325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102340629|NCT01508325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340630|NCT01514344|Rituximab|rituximab|mesh-list
102340631|NCT01514344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102340632|NCT01514344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102340633|NCT01514344|Immunologic Factors|immunologic factors|mesh-ancestor
102340634|NCT01514344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340635|NCT01514344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102340636|NCT01506856|Paclitaxel|paclitaxel|mesh-list
102340637|NCT01506856|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102340638|NCT01506856|Carboplatin|carboplatin|mesh-list
102340639|NCT01506856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102340640|NCT01506856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102340641|NCT01506856|Tubulin Modulators|tubulin modulators|mesh-ancestor
102340642|NCT01506856|Antimitotic Agents|antimitotic agents|mesh-ancestor
102340643|NCT01506856|Mitosis Modulators|mitosis modulators|mesh-ancestor
102340644|NCT01506856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340645|NCT02191930|Cyclophosphamide|cyclophosphamide|mesh-list
102340646|NCT02191930|Doxorubicin|doxorubicin|mesh-list
102340647|NCT02191930|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102340648|NCT02191930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102340649|NCT02191930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102340650|NCT02191930|Immunologic Factors|immunologic factors|mesh-ancestor
102340651|NCT02191930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340652|NCT02191930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102340653|NCT02191930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102340654|NCT02191930|Alkylating Agents|alkylating agents|mesh-ancestor
102340655|NCT02191930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340656|NCT02191930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102340657|NCT02191930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102340658|NCT02191930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102340659|NCT02191930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102340660|NCT02191930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102340661|NCT02191930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102340662|NCT02191930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102340664|NCT02191930|Immunoconjugates|immunoconjugates|mesh-ancestor
102340665|NCT01536015|Rotigotine|rotigotine|mesh-list
102340666|NCT01536015|Dopamine Agonists|dopamine agonists|mesh-ancestor
102340667|NCT01536015|Dopamine Agents|dopamine agents|mesh-ancestor
102340668|NCT01536015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102340669|NCT01536015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340670|NCT01536015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340671|NCT01865110|Prednisone|prednisone|mesh-list
102340672|NCT01865110|Rituximab|rituximab|mesh-list
102340673|NCT01865110|Lenalidomide|lenalidomide|mesh-list
102340674|NCT01865110|Cyclophosphamide|cyclophosphamide|mesh-list
102340675|NCT01865110|Vincristine|vincristine|mesh-list
102340676|NCT01865110|Doxorubicin|doxorubicin|mesh-list
102340677|NCT01865110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102340678|NCT01865110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102340679|NCT01865110|Immunologic Factors|immunologic factors|mesh-ancestor
102340680|NCT01865110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340681|NCT01865110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102340682|NCT01865110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102340683|NCT01865110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102340684|NCT01865110|Growth Substances|growth substances|mesh-ancestor
102340685|NCT01865110|Growth Inhibitors|growth inhibitors|mesh-ancestor
102340686|NCT01865110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102049535|NCT02099240|Analgesics|analgesics|mesh-ancestor
102340687|NCT01865110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102340688|NCT01865110|Alkylating Agents|alkylating agents|mesh-ancestor
102340689|NCT01865110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340690|NCT01865110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102340691|NCT01865110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102340692|NCT01865110|Glucocorticoids|glucocorticoids|mesh-ancestor
102340693|NCT01865110|Hormones|hormones|mesh-ancestor
102340694|NCT01865110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102340695|NCT01865110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102340696|NCT01865110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102340697|NCT01865110|Tubulin Modulators|tubulin modulators|mesh-ancestor
102340698|NCT01865110|Antimitotic Agents|antimitotic agents|mesh-ancestor
102340699|NCT01865110|Mitosis Modulators|mitosis modulators|mesh-ancestor
102340700|NCT01865110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102340701|NCT01865110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102340702|NCT01865110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102340703|NCT01865110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102340704|NCT01484691|Budesonide|budesonide|mesh-list
102340705|NCT01484691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102340706|NCT01484691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102340707|NCT01484691|Autonomic Agents|autonomic agents|mesh-ancestor
102340708|NCT01484691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102340709|NCT01484691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340710|NCT01484691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102340711|NCT01484691|Respiratory System Agents|respiratory system agents|mesh-ancestor
102340712|NCT01484691|Glucocorticoids|glucocorticoids|mesh-ancestor
102340713|NCT01484691|Hormones|hormones|mesh-ancestor
102340714|NCT01484691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102340715|NCT01464034|Dexamethasone|dexamethasone|mesh-list
102340716|NCT01464034|Pomalidomide|pomalidomide|mesh-list
102340717|NCT01464034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102340718|NCT01464034|Antiemetics|antiemetics|mesh-ancestor
102340719|NCT01464034|Autonomic Agents|autonomic agents|mesh-ancestor
102340720|NCT01464034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102340721|NCT01464034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340722|NCT01464034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102340723|NCT01464034|Glucocorticoids|glucocorticoids|mesh-ancestor
102340724|NCT01464034|Hormones|hormones|mesh-ancestor
102340725|NCT01464034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102340726|NCT01464034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102340727|NCT01464034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102340728|NCT01464034|Immunologic Factors|immunologic factors|mesh-ancestor
102340729|NCT01464034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102340730|NCT01464034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102340731|NCT01464034|Growth Substances|growth substances|mesh-ancestor
102340732|NCT01464034|Growth Inhibitors|growth inhibitors|mesh-ancestor
102340733|NCT01535235|Lisinopril|lisinopril|mesh-list
102340734|NCT01535235|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102340735|NCT01535235|Protease Inhibitors|protease inhibitors|mesh-ancestor
102340736|NCT01535235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102340737|NCT01535235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340738|NCT01535235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102340739|NCT01535235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102340740|NCT01535235|Protective Agents|protective agents|mesh-ancestor
102340741|NCT01535235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340742|NCT02317744|Naltrexone|naltrexone|mesh-list
102340743|NCT02317744|Bupropion|bupropion|mesh-list
102340744|NCT02317744|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102340745|NCT02317744|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102340746|NCT02317744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340747|NCT02317744|Sensory System Agents|sensory system agents|mesh-ancestor
102340748|NCT02317744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102340749|NCT02317744|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102340750|NCT02317744|Antidepressive Agents|antidepressive agents|mesh-ancestor
102340751|NCT02317744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102340752|NCT02317744|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102340753|NCT02317744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102340754|NCT02317744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102340755|NCT02317744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340756|NCT02317744|Dopamine Agents|dopamine agents|mesh-ancestor
102340757|NCT02317744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102340758|NCT02317744|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102049612|NCT02099474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102340759|NCT02317744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102340761|NCT01810588|Mycophenolic Acid|mycophenolic acid|mesh-list
102340762|NCT01810588|Rituximab|rituximab|mesh-list
102340763|NCT01810588|Fludarabine|fludarabine|mesh-list
102340764|NCT01810588|Fludarabine phosphate|fludarabine phosphate|mesh-list
102340765|NCT01810588|Melphalan|melphalan|mesh-list
102340766|NCT01810588|Tacrolimus|tacrolimus|mesh-list
102340767|NCT01810588|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102340768|NCT01810588|Thymoglobulin|thymoglobulin|mesh-list
102340769|NCT01810588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102340770|NCT01810588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102340771|NCT01810588|Immunologic Factors|immunologic factors|mesh-ancestor
102340772|NCT01810588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340773|NCT01810588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102340774|NCT01810588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102340775|NCT01810588|Antimetabolites|antimetabolites|mesh-ancestor
102340776|NCT01810588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340777|NCT01810588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102340778|NCT01810588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102340779|NCT01810588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102340780|NCT01810588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102340781|NCT01810588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102340782|NCT01810588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102340783|NCT01810588|Antitubercular Agents|antitubercular agents|mesh-ancestor
102340784|NCT01810588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102340785|NCT01810588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102340786|NCT01810588|Alkylating Agents|alkylating agents|mesh-ancestor
102340787|NCT01810588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102340788|NCT05577442|Trastuzumab|trastuzumab|mesh-list
102340789|NCT05577442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102340790|NCT05577442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102340791|NCT01895764|Adalimumab|adalimumab|mesh-list
102340792|NCT01895764|Methotrexate|methotrexate|mesh-list
102340793|NCT01895764|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102340794|NCT01895764|Abortifacient Agents|abortifacient agents|mesh-ancestor
102340795|NCT01895764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102340796|NCT01895764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340797|NCT01895764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102340798|NCT01895764|Antimetabolites|antimetabolites|mesh-ancestor
102340799|NCT01895764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340800|NCT01895764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102340801|NCT01895764|Dermatologic Agents|dermatologic agents|mesh-ancestor
102340802|NCT01895764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102340803|NCT01895764|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102340804|NCT01895764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102340805|NCT01895764|Immunologic Factors|immunologic factors|mesh-ancestor
102340806|NCT01895764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102340807|NCT01895764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102340808|NCT01895764|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102340809|NCT01895764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102340811|NCT01894360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102340812|NCT01894360|Immunologic Factors|immunologic factors|mesh-ancestor
102340813|NCT01894360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340814|NCT01483599|Adalimumab|adalimumab|mesh-list
102340815|NCT01483599|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102340816|NCT01483599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102340817|NCT01483599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102340818|NCT01407562|Paclitaxel|paclitaxel|mesh-list
102340819|NCT01407562|Carboplatin|carboplatin|mesh-list
102340820|NCT01407562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102340821|NCT01407562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102340822|NCT01407562|Tubulin Modulators|tubulin modulators|mesh-ancestor
102340823|NCT01407562|Antimitotic Agents|antimitotic agents|mesh-ancestor
102340824|NCT01407562|Mitosis Modulators|mitosis modulators|mesh-ancestor
102340825|NCT01407562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340826|NCT01406548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102340827|NCT01406548|Immunologic Factors|immunologic factors|mesh-ancestor
102340828|NCT01406548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340829|NCT01393522|Milnacipran|milnacipran|mesh-list
102340830|NCT01393522|Levomilnacipran|levomilnacipran|mesh-list
102340831|NCT01393522|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101442977|NCT02907307|Clotrimazole|clotrimazole|mesh-list
102340832|NCT01393522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102340833|NCT01393522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102340834|NCT01393522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340835|NCT01393522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102340836|NCT01393522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340837|NCT01393522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102340838|NCT01393522|Analgesics|analgesics|mesh-ancestor
102340839|NCT01393522|Sensory System Agents|sensory system agents|mesh-ancestor
102340840|NCT01393522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102340841|NCT01393522|Antidepressive Agents|antidepressive agents|mesh-ancestor
102340842|NCT01393522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102340843|NCT02086786|Risperidone|risperidone|mesh-list
102340844|NCT02086786|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102340845|NCT02086786|Serotonin Agents|serotonin agents|mesh-ancestor
102340846|NCT02086786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102340847|NCT02086786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340848|NCT02086786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340849|NCT02086786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102340850|NCT02086786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102340851|NCT02086786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102340852|NCT02086786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102340853|NCT02086786|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102340854|NCT02086786|Dopamine Agents|dopamine agents|mesh-ancestor
102340855|NCT01787500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102340856|NCT01787500|Cetuximab|cetuximab|mesh-list
102340857|NCT01787500|Irinotecan|irinotecan|mesh-list
102340858|NCT01787500|Camptothecin|camptothecin|mesh-list
102340859|NCT01787500|Vemurafenib|vemurafenib|mesh-list
102340860|NCT01787500|Antibodies|antibodies|mesh-list
102340861|NCT01787500|Immunoglobulins|immunoglobulins|mesh-list
102340862|NCT01787500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102340863|NCT01787500|Immunologic Factors|immunologic factors|mesh-ancestor
102340864|NCT01787500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340865|NCT01787500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102340866|NCT01787500|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102340867|NCT01787500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102340868|NCT01787500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102340869|NCT01787500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340870|NCT01787500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102340871|NCT01787500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102340872|NCT02108158|Botulinum Toxins|botulinum toxins|mesh-list
102340873|NCT02108158|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102340874|NCT02108158|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102340875|NCT02108158|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102340876|NCT02108158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101941627|NCT01131429|Cisplatin|cisplatin|mesh-list
102340877|NCT02108158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340878|NCT02108158|Cholinergic Agents|cholinergic agents|mesh-ancestor
102340879|NCT02108158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102340880|NCT02108158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340881|NCT02108158|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102340882|NCT02108158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102340883|NCT01895218|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
102340884|NCT01895218|Hematinics|hematinics|mesh-ancestor
102340885|NCT01895998|Albuterol|albuterol|mesh-list
102340886|NCT01895998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102340887|NCT01895998|Autonomic Agents|autonomic agents|mesh-ancestor
102340888|NCT01895998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102340889|NCT01895998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340890|NCT01895998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102340891|NCT01895998|Respiratory System Agents|respiratory system agents|mesh-ancestor
102340892|NCT01895998|Tocolytic Agents|tocolytic agents|mesh-ancestor
102340893|NCT01895998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102340894|NCT01895998|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102340895|NCT01895998|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102340896|NCT01895998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102340897|NCT01895998|Adrenergic Agents|adrenergic agents|mesh-ancestor
102340898|NCT01895998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102340899|NCT01895998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340900|NCT01895296|Pasireotide|pasireotide|mesh-list
102340901|NCT01895296|Hormones|hormones|mesh-ancestor
102340902|NCT01895296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102340903|NCT01895296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340904|NCT01276600|Tenofovir|tenofovir|mesh-list
102340905|NCT01276600|Emtricitabine|emtricitabine|mesh-list
102340906|NCT01276600|Antiviral Agents|antiviral agents|mesh-ancestor
102340907|NCT01276600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102340908|NCT01276600|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102340909|NCT01276600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102340910|NCT01276600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102340911|NCT01276600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340913|NCT01276600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102340914|NCT02040376|Metformin|metformin|mesh-list
102340915|NCT02040376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102340916|NCT02040376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340917|NCT04755868|Talazoparib|talazoparib|mesh-list
102340918|NCT04755868|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102340919|NCT04755868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102340920|NCT04755868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340921|NCT04755868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102340922|NCT01659658|Thalidomide|thalidomide|mesh-list
102340923|NCT01659658|Dexamethasone|dexamethasone|mesh-list
102340924|NCT01659658|Cyclophosphamide|cyclophosphamide|mesh-list
102340925|NCT01659658|Melphalan|melphalan|mesh-list
102340926|NCT01659658|Lenalidomide|lenalidomide|mesh-list
102340927|NCT01659658|Ixazomib|ixazomib|mesh-list
102340928|NCT01659658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102340929|NCT01659658|Immunologic Factors|immunologic factors|mesh-ancestor
102340930|NCT01659658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340931|NCT01659658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102340932|NCT01659658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102340933|NCT01659658|Alkylating Agents|alkylating agents|mesh-ancestor
102340934|NCT01659658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340935|NCT01659658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102340936|NCT01659658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102340937|NCT01659658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102340938|NCT01659658|Antiemetics|antiemetics|mesh-ancestor
102340939|NCT01659658|Autonomic Agents|autonomic agents|mesh-ancestor
102340940|NCT01659658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102340941|NCT01659658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102340942|NCT01659658|Glucocorticoids|glucocorticoids|mesh-ancestor
102340943|NCT01659658|Hormones|hormones|mesh-ancestor
102340944|NCT01659658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102340945|NCT01659658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102340946|NCT01659658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102340947|NCT01659658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102340948|NCT01659658|Growth Substances|growth substances|mesh-ancestor
102340949|NCT01659658|Growth Inhibitors|growth inhibitors|mesh-ancestor
102340950|NCT01659658|Leprostatic Agents|leprostatic agents|mesh-ancestor
102340951|NCT01659658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102340952|NCT01659658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102340953|NCT01659658|Protease Inhibitors|protease inhibitors|mesh-ancestor
102340954|NCT01659658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102340955|NCT01621906|Alovudine|alovudine|mesh-list
102340956|NCT01621906|Antiviral Agents|antiviral agents|mesh-ancestor
102340957|NCT01621906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102340958|NCT01615510|Tapentadol|tapentadol|mesh-list
102340959|NCT01615510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102340960|NCT01615510|Narcotics|narcotics|mesh-ancestor
102340961|NCT01615510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102340962|NCT01615510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340963|NCT01615510|Analgesics|analgesics|mesh-ancestor
102340964|NCT01615510|Sensory System Agents|sensory system agents|mesh-ancestor
102340965|NCT01615510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102340966|NCT01615510|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102340967|NCT01615510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102340968|NCT01615510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102340969|NCT01615510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340970|NCT01615510|Adrenergic Agents|adrenergic agents|mesh-ancestor
102340971|NCT01615510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102340972|NCT00530062|Albuterol|albuterol|mesh-list
102340973|NCT00530062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102340974|NCT00530062|Autonomic Agents|autonomic agents|mesh-ancestor
102340975|NCT00530062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102340976|NCT00530062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340977|NCT00530062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102340978|NCT00530062|Respiratory System Agents|respiratory system agents|mesh-ancestor
102340979|NCT00530062|Tocolytic Agents|tocolytic agents|mesh-ancestor
102340980|NCT00530062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102340981|NCT00530062|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102340982|NCT00530062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102340983|NCT00530062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102340984|NCT00530062|Adrenergic Agents|adrenergic agents|mesh-ancestor
102340985|NCT00530062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102340986|NCT00530062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102340987|NCT01209364|Methylprednisolone|methylprednisolone|mesh-list
102340988|NCT01209364|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102340989|NCT01209364|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102340990|NCT01209364|Prednisolone|prednisolone|mesh-list
102340991|NCT01209364|Prednisolone acetate|prednisolone acetate|mesh-list
102340992|NCT01209364|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102340993|NCT01209364|Prednisolone phosphate|prednisolone phosphate|mesh-list
102340994|NCT01209364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102340995|NCT01209364|Antiemetics|antiemetics|mesh-ancestor
102340996|NCT01209364|Autonomic Agents|autonomic agents|mesh-ancestor
102340997|NCT01209364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102340998|NCT01209364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102340999|NCT01209364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102341000|NCT01209364|Glucocorticoids|glucocorticoids|mesh-ancestor
102341001|NCT01209364|Hormones|hormones|mesh-ancestor
102341002|NCT01209364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102341003|NCT01209364|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102341004|NCT01209364|Protective Agents|protective agents|mesh-ancestor
102341005|NCT01209364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102341006|NCT01209364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102341007|NCT05080192|Fenofibrate|fenofibrate|mesh-list
102341008|NCT05080192|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102341009|NCT05080192|Antimetabolites|antimetabolites|mesh-ancestor
102341010|NCT05080192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341011|NCT05080192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102341012|NCT00479128|Gemcitabine|gemcitabine|mesh-list
102341013|NCT00479128|Doxorubicin|doxorubicin|mesh-list
102341014|NCT00479128|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102341015|NCT00479128|Bortezomib|bortezomib|mesh-list
102341016|NCT00479128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102341017|NCT00479128|Antimetabolites|antimetabolites|mesh-ancestor
102341018|NCT00479128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341019|NCT00479128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102341020|NCT00479128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102341021|NCT00479128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102341022|NCT00479128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102341023|NCT00479128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102341024|NCT00472966|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
102341025|NCT00472966|Tretinoin|tretinoin|mesh-list
102341026|NCT00472966|Glycolic acid|glycolic acid|mesh-list
101683068|NCT02718950|Hormones|hormones|mesh-ancestor
102341027|NCT00472966|Hydroquinone|hydroquinone|mesh-list
102341028|NCT00472966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102341029|NCT00472966|Keratolytic Agents|keratolytic agents|mesh-ancestor
102341030|NCT00472966|Dermatologic Agents|dermatologic agents|mesh-ancestor
102341031|NCT00472966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102341032|NCT00472966|Glucocorticoids|glucocorticoids|mesh-ancestor
102341033|NCT00472966|Hormones|hormones|mesh-ancestor
102341034|NCT00472966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102341035|NCT00472966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341036|NCT00472966|Antioxidants|antioxidants|mesh-ancestor
102341037|NCT00472966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341038|NCT00472966|Protective Agents|protective agents|mesh-ancestor
101442992|NCT00553345|Vitamin E|vitamin e|mesh-list
102341039|NCT00472966|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102341040|NCT01573780|Gemcitabine|gemcitabine|mesh-list
102341041|NCT01573780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102341042|NCT01573780|Antimetabolites|antimetabolites|mesh-ancestor
102341043|NCT01573780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341044|NCT01573780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102341045|NCT01547260|Gemcitabine|gemcitabine|mesh-list
102341046|NCT01547260|Lenalidomide|lenalidomide|mesh-list
102341047|NCT01547260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102341048|NCT01547260|Antimetabolites|antimetabolites|mesh-ancestor
102341049|NCT01547260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341050|NCT01547260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102341051|NCT01547260|Immunologic Factors|immunologic factors|mesh-ancestor
102341052|NCT01547260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341053|NCT01547260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102341054|NCT01547260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102341055|NCT01547260|Growth Substances|growth substances|mesh-ancestor
102341056|NCT01547260|Growth Inhibitors|growth inhibitors|mesh-ancestor
102341057|NCT04205266|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102341058|NCT04205266|Hematinics|hematinics|mesh-ancestor
102341059|NCT04205266|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102341060|NCT04205266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102341061|NCT01896388|Ifenprodil|ifenprodil|mesh-list
102341062|NCT01896388|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102341063|NCT01896388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102341064|NCT01896388|Adrenergic Agents|adrenergic agents|mesh-ancestor
102341065|NCT01896388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102341066|NCT01896388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341067|NCT01896388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341068|NCT01896388|Vasodilator Agents|vasodilator agents|mesh-ancestor
102341069|NCT01896388|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102341070|NCT01896388|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102341071|NCT01125436|Vitamin D|vitamin d|mesh-list
102341072|NCT01125436|Cholecalciferol|cholecalciferol|mesh-list
102341073|NCT01125436|Vitamins|vitamins|mesh-ancestor
102341074|NCT01125436|Micronutrients|micronutrients|mesh-ancestor
102341075|NCT01125436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341076|NCT01125436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102341077|NCT01125436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102341078|NCT04755322|Aspirin|aspirin|mesh-list
102341079|NCT04755322|Folic Acid|folic acid|mesh-list
102341080|NCT04755322|Hydroxychloroquine|hydroxychloroquine|mesh-list
102341081|NCT04755322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102341082|NCT04755322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102341083|NCT04755322|Analgesics|analgesics|mesh-ancestor
102341084|NCT04755322|Sensory System Agents|sensory system agents|mesh-ancestor
102341085|NCT04755322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102341086|NCT04755322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341087|NCT04755322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102341088|NCT04755322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102341089|NCT04755322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102341090|NCT04755322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102341091|NCT04755322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341092|NCT04755322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102341093|NCT04755322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102341094|NCT04755322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102341095|NCT04755322|Antipyretics|antipyretics|mesh-ancestor
102341096|NCT04755322|Antimalarials|antimalarials|mesh-ancestor
102341097|NCT04755322|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102341098|NCT04755322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102341099|NCT04755322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102341100|NCT04755322|Hematinics|hematinics|mesh-ancestor
102341101|NCT04755322|Vitamin B Complex|vitamin b complex|mesh-ancestor
102341102|NCT04755322|Vitamins|vitamins|mesh-ancestor
102341103|NCT04755322|Micronutrients|micronutrients|mesh-ancestor
102341105|NCT00436540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102341106|NCT00436540|Glucocorticoids|glucocorticoids|mesh-ancestor
102341107|NCT00436540|Hormones|hormones|mesh-ancestor
102341108|NCT00436540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102341109|NCT00436540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341110|NCT00425230|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102341111|NCT00425230|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102341112|NCT00425230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102341113|NCT00425230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102341114|NCT00425230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341115|NCT00425230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102341116|NCT00425230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341117|NCT00425230|Analgesics|analgesics|mesh-ancestor
102341118|NCT00425230|Sensory System Agents|sensory system agents|mesh-ancestor
102341119|NCT00425230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102341120|NCT00425230|Antidepressive Agents|antidepressive agents|mesh-ancestor
102341121|NCT00425230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102341122|NCT00425230|Dopamine Agents|dopamine agents|mesh-ancestor
102341123|NCT04634578|Bevacizumab|bevacizumab|mesh-list
102341124|NCT04634578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102341125|NCT04634578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102341126|NCT04634578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102341127|NCT04634578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102341128|NCT04634578|Growth Substances|growth substances|mesh-ancestor
102341129|NCT04634578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341130|NCT04634578|Growth Inhibitors|growth inhibitors|mesh-ancestor
102341131|NCT01066858|Tenofovir|tenofovir|mesh-list
102341132|NCT01066858|Antiviral Agents|antiviral agents|mesh-ancestor
102341133|NCT01066858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102341134|NCT01066858|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102341135|NCT01066858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102341136|NCT01066858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102341137|NCT01066858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341138|NCT01066858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102341139|NCT01066858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102341140|NCT04777552|Diazepam|diazepam|mesh-list
102341141|NCT04777552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102341142|NCT04777552|Anticonvulsants|anticonvulsants|mesh-ancestor
102341143|NCT04777552|Antiemetics|antiemetics|mesh-ancestor
102341144|NCT04777552|Autonomic Agents|autonomic agents|mesh-ancestor
102341145|NCT04777552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102341146|NCT04777552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341147|NCT04777552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102341148|NCT04777552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102341149|NCT04777552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102341150|NCT04777552|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102341151|NCT04777552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102341152|NCT04777552|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102341153|NCT04777552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102341154|NCT04777552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102341155|NCT04777552|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102341156|NCT04777552|Anesthetics, General|anesthetics, general|mesh-ancestor
102341157|NCT04777552|Anesthetics|anesthetics|mesh-ancestor
102341158|NCT04777552|GABA Modulators|gaba modulators|mesh-ancestor
102341159|NCT04777552|GABA Agents|gaba agents|mesh-ancestor
102341160|NCT04777552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102341161|NCT04777552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341162|NCT01506609|Paclitaxel|paclitaxel|mesh-list
102341163|NCT01506609|Carboplatin|carboplatin|mesh-list
102341164|NCT01506609|Temozolomide|temozolomide|mesh-list
102341165|NCT01506609|Veliparib|veliparib|mesh-list
102341166|NCT01506609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102341167|NCT01506609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102341168|NCT01506609|Tubulin Modulators|tubulin modulators|mesh-ancestor
102341169|NCT01506609|Antimitotic Agents|antimitotic agents|mesh-ancestor
102341170|NCT01506609|Mitosis Modulators|mitosis modulators|mesh-ancestor
102341171|NCT01506609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341172|NCT01506609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102341173|NCT01506609|Alkylating Agents|alkylating agents|mesh-ancestor
102341174|NCT01506609|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102341175|NCT01506609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102341176|NCT04777162|Tislelizumab|tislelizumab|mesh-list
101683221|NCT02694224|Paclitaxel|paclitaxel|mesh-list
102341177|NCT04777162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102341179|NCT03027219|Alprostadil|alprostadil|mesh-list
102341180|NCT03027219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102341181|NCT03027219|Vasodilator Agents|vasodilator agents|mesh-ancestor
102341182|NCT03027219|Urological Agents|urological agents|mesh-ancestor
102341183|NCT04776772|Complement System Proteins|complement system proteins|mesh-list
102341184|NCT04776772|Immunologic Factors|immunologic factors|mesh-ancestor
102341185|NCT04776772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341186|NCT01506453|Gabapentin|gabapentin|mesh-list
102341187|NCT01506453|Analgesics|analgesics|mesh-ancestor
102341188|NCT01506453|Sensory System Agents|sensory system agents|mesh-ancestor
102341189|NCT01506453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102341190|NCT01506453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341191|NCT01506453|Anticonvulsants|anticonvulsants|mesh-ancestor
102341192|NCT01506453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102341193|NCT01506453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102341194|NCT01506453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102341195|NCT01506453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102341196|NCT01506453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102341197|NCT01506453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102341198|NCT01506453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102341199|NCT01506453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341200|NCT01506453|Antimanic Agents|antimanic agents|mesh-ancestor
102341201|NCT04389580|Tamoxifen|tamoxifen|mesh-list
102341202|NCT04389580|Isotretinoin|isotretinoin|mesh-list
102341203|NCT04389580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102341204|NCT04389580|Hormone Antagonists|hormone antagonists|mesh-ancestor
102341205|NCT04389580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102341206|NCT04389580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341207|NCT04389580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102341208|NCT04389580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102341209|NCT04389580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102341210|NCT04389580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102341211|NCT04389580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102341212|NCT04389580|Dermatologic Agents|dermatologic agents|mesh-ancestor
102341214|NCT00199108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102341215|NCT00199108|Antiemetics|antiemetics|mesh-ancestor
102341216|NCT00199108|Autonomic Agents|autonomic agents|mesh-ancestor
102341217|NCT00199108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102341218|NCT00199108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341219|NCT00199108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102341220|NCT00199108|Glucocorticoids|glucocorticoids|mesh-ancestor
102341221|NCT00199108|Hormones|hormones|mesh-ancestor
102341222|NCT00199108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102341223|NCT00199108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102341224|NCT00199108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102341225|NCT01504971|Rabeprazole|rabeprazole|mesh-list
102341226|NCT01504971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102341227|NCT01504971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102341228|NCT01504971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102341229|NCT01504971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102341230|NCT01504971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341231|NCT04753918|Ethiodized Oil|ethiodized oil|mesh-list
102341232|NCT04753918|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
102341233|NCT04753918|Trioxsalen|trioxsalen|mesh-list
102341234|NCT04753918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102341235|NCT04753918|Dermatologic Agents|dermatologic agents|mesh-ancestor
102341236|NCT04753918|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102341237|NCT04161664|Paclitaxel|paclitaxel|mesh-list
102341238|NCT04161664|Carboplatin|carboplatin|mesh-list
102341239|NCT04161664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102341240|NCT04161664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102341241|NCT04161664|Tubulin Modulators|tubulin modulators|mesh-ancestor
102341242|NCT04161664|Antimitotic Agents|antimitotic agents|mesh-ancestor
102341243|NCT04161664|Mitosis Modulators|mitosis modulators|mesh-ancestor
102341244|NCT04161664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341245|NCT00936832|Leucovorin|leucovorin|mesh-list
102341246|NCT00936832|Fluorouracil|fluorouracil|mesh-list
102341247|NCT00936832|Irinotecan|irinotecan|mesh-list
102341248|NCT00936832|Sunitinib|sunitinib|mesh-list
102341249|NCT00936832|Calcium|calcium|mesh-list
102341250|NCT00936832|Levoleucovorin|levoleucovorin|mesh-list
102341251|NCT00936832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102341252|NCT00936832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341253|NCT00936832|Antimetabolites|antimetabolites|mesh-ancestor
102341254|NCT00936832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341255|NCT00936832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102341256|NCT00936832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102341257|NCT00936832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102341258|NCT00936832|Immunologic Factors|immunologic factors|mesh-ancestor
102341259|NCT00936832|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102341260|NCT00936832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102341261|NCT00936832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102341262|NCT00936832|Antidotes|antidotes|mesh-ancestor
102341263|NCT00936832|Protective Agents|protective agents|mesh-ancestor
102341264|NCT00936832|Vitamin B Complex|vitamin b complex|mesh-ancestor
102341266|NCT00936832|Micronutrients|micronutrients|mesh-ancestor
102341267|NCT00936832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102341268|NCT00936832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102341269|NCT00936832|Growth Substances|growth substances|mesh-ancestor
102341270|NCT00936832|Growth Inhibitors|growth inhibitors|mesh-ancestor
102341271|NCT00936832|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102341272|NCT01479621|Fluticasone|fluticasone|mesh-list
102341273|NCT01479621|Xhance|xhance|mesh-list
102341274|NCT01479621|Albuterol|albuterol|mesh-list
102341275|NCT01479621|Adrenergic Agonists|adrenergic agonists|mesh-list
102341276|NCT01479621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102341277|NCT01479621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102341278|NCT01479621|Autonomic Agents|autonomic agents|mesh-ancestor
102341279|NCT01479621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102341280|NCT01479621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050159|NCT02103764|Hormones|hormones|mesh-ancestor
102341281|NCT01479621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102341282|NCT01479621|Respiratory System Agents|respiratory system agents|mesh-ancestor
102341283|NCT01479621|Dermatologic Agents|dermatologic agents|mesh-ancestor
102341284|NCT01479621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102341285|NCT01479621|Tocolytic Agents|tocolytic agents|mesh-ancestor
102341286|NCT01479621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102341287|NCT01479621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102341288|NCT01479621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102341289|NCT01479621|Adrenergic Agents|adrenergic agents|mesh-ancestor
102341290|NCT01479621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102341291|NCT01479621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341292|NCT04776226|Citalopram|citalopram|mesh-list
102341293|NCT04776226|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102341294|NCT04776226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102341295|NCT04776226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102341296|NCT04776226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341297|NCT04776226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102341298|NCT04776226|Serotonin Agents|serotonin agents|mesh-ancestor
102341299|NCT04776226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341300|NCT04776226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102341301|NCT04776226|Antidepressive Agents|antidepressive agents|mesh-ancestor
102341302|NCT04776226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102341303|NCT02319304|Leucovorin|leucovorin|mesh-list
102341304|NCT02319304|Fluorouracil|fluorouracil|mesh-list
102341305|NCT02319304|Oxaliplatin|oxaliplatin|mesh-list
102341306|NCT02319304|Antimetabolites|antimetabolites|mesh-ancestor
102341307|NCT02319304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341308|NCT02319304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102341309|NCT02319304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102341310|NCT02319304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102341311|NCT02319304|Immunologic Factors|immunologic factors|mesh-ancestor
102341312|NCT02319304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341313|NCT02319304|Antidotes|antidotes|mesh-ancestor
102341314|NCT02319304|Protective Agents|protective agents|mesh-ancestor
102341315|NCT02319304|Vitamin B Complex|vitamin b complex|mesh-ancestor
102341316|NCT02319304|Vitamins|vitamins|mesh-ancestor
102341317|NCT02319304|Micronutrients|micronutrients|mesh-ancestor
102341318|NCT00885664|Ritonavir|ritonavir|mesh-list
102341319|NCT00885664|Lopinavir|lopinavir|mesh-list
102341320|NCT00885664|Tenofovir|tenofovir|mesh-list
102341321|NCT00885664|Emtricitabine|emtricitabine|mesh-list
102341322|NCT00885664|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102341323|NCT00885664|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102341324|NCT00885664|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102341325|NCT00885664|Protease Inhibitors|protease inhibitors|mesh-ancestor
102341326|NCT00885664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102341327|NCT00885664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341328|NCT00885664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102341329|NCT00885664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102341330|NCT00885664|Antiviral Agents|antiviral agents|mesh-ancestor
102341331|NCT00885664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102341332|NCT00885664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102341333|NCT00885664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102341334|NCT00885664|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102341335|NCT00885664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102341337|NCT04784104|Racepinephrine|racepinephrine|mesh-list
102341338|NCT04784104|Bupivacaine|bupivacaine|mesh-list
102341339|NCT04784104|Prilocaine|prilocaine|mesh-list
102341340|NCT04784104|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102341341|NCT04784104|Epinephryl borate|epinephryl borate|mesh-list
102341342|NCT04784104|Anesthetics, Local|anesthetics, local|mesh-ancestor
102341343|NCT04784104|Anesthetics|anesthetics|mesh-ancestor
102341344|NCT04784104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102341345|NCT04784104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341346|NCT04784104|Sensory System Agents|sensory system agents|mesh-ancestor
102341347|NCT04784104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102341348|NCT04784104|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102341349|NCT04784104|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102341350|NCT04784104|Adrenergic Agents|adrenergic agents|mesh-ancestor
102341351|NCT04784104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102341352|NCT04784104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341353|NCT04784104|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102341354|NCT04784104|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102341355|NCT04784104|Autonomic Agents|autonomic agents|mesh-ancestor
102341356|NCT04784104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102341357|NCT04784104|Respiratory System Agents|respiratory system agents|mesh-ancestor
102341358|NCT04784104|Mydriatics|mydriatics|mesh-ancestor
102341359|NCT04784104|Sympathomimetics|sympathomimetics|mesh-ancestor
102341360|NCT04784104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102050219|NCT01941589|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102341361|NCT00880594|Desipramine|desipramine|mesh-list
102341362|NCT00880594|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102341363|NCT00880594|Antidepressive Agents|antidepressive agents|mesh-ancestor
102341364|NCT00880594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102341365|NCT00880594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102341366|NCT00880594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341367|NCT00880594|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102341368|NCT00880594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102341369|NCT00880594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102341370|NCT00880594|Adrenergic Agents|adrenergic agents|mesh-ancestor
102341371|NCT00880594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102341372|NCT00880594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341373|NCT04783870|Dapagliflozin|dapagliflozin|mesh-list
102341374|NCT04783870|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102341375|NCT04783870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341376|NCT04783870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102341377|NCT04783870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341378|NCT04783636|Leuprolide|leuprolide|mesh-list
102341379|NCT04783636|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102341380|NCT04783636|Fertility Agents|fertility agents|mesh-ancestor
102341381|NCT04783636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102341382|NCT04783636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341383|NCT04783636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102341384|NCT04783636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102341385|NCT00820846|Vaccines|vaccines|mesh-list
102341386|NCT00820846|Immunologic Factors|immunologic factors|mesh-ancestor
102341387|NCT00820846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341388|NCT03364348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102341389|NCT03364348|Trastuzumab|trastuzumab|mesh-list
102341390|NCT03364348|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102341391|NCT03364348|Maytansine|maytansine|mesh-list
102341392|NCT03364348|Antibodies|antibodies|mesh-list
102341393|NCT03364348|Immunoglobulins|immunoglobulins|mesh-list
102341394|NCT03364348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102341395|NCT03364348|Immunoglobulin G|immunoglobulin g|mesh-list
102341396|NCT03364348|Immunoconjugates|immunoconjugates|mesh-list
102341397|NCT03364348|Immunologic Factors|immunologic factors|mesh-ancestor
102341398|NCT03364348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341399|NCT03364348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102341400|NCT03364348|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102341401|NCT03364348|Tubulin Modulators|tubulin modulators|mesh-ancestor
102341402|NCT03364348|Antimitotic Agents|antimitotic agents|mesh-ancestor
102341403|NCT03364348|Mitosis Modulators|mitosis modulators|mesh-ancestor
102341404|NCT03364348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341405|NCT03364348|Immunotoxins|immunotoxins|mesh-ancestor
102341406|NCT04782622|Apatinib|apatinib|mesh-list
102341407|NCT04782622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102341408|NCT04782622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102341409|NCT04782622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102341410|NCT04782622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341411|NCT04775212|Sevoflurane|sevoflurane|mesh-list
102341412|NCT04775212|Desflurane|desflurane|mesh-list
102341413|NCT04775212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102341414|NCT04775212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102341415|NCT04775212|Anesthetics, General|anesthetics, general|mesh-ancestor
102341416|NCT04775212|Anesthetics|anesthetics|mesh-ancestor
102341417|NCT04775212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102341418|NCT04775212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341419|NCT04774822|Mydriatics|mydriatics|mesh-list
102341420|NCT04774822|Autonomic Agents|autonomic agents|mesh-ancestor
102341421|NCT04774822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102341422|NCT04774822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341423|NCT04782388|Alprazolam|alprazolam|mesh-list
102341424|NCT04782388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102341425|NCT04782388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102341426|NCT04782388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341427|NCT04782388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102341428|NCT04782388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102341429|NCT04782388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102341430|NCT04782388|GABA Modulators|gaba modulators|mesh-ancestor
102341431|NCT04782388|GABA Agents|gaba agents|mesh-ancestor
102341432|NCT04782388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102341433|NCT04782388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341434|NCT04782076|Dabigatran|dabigatran|mesh-list
102050301|NCT05617521|Caffeine|caffeine|mesh-list
102341435|NCT04782076|Antithrombins|antithrombins|mesh-ancestor
102341436|NCT04782076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102341437|NCT04782076|Protease Inhibitors|protease inhibitors|mesh-ancestor
102341438|NCT04782076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102341439|NCT04782076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341440|NCT04782076|Anticoagulants|anticoagulants|mesh-ancestor
102341441|NCT04782310|Pregabalin|pregabalin|mesh-list
102341442|NCT04782310|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102341443|NCT04782310|Analgesics|analgesics|mesh-ancestor
102341444|NCT04782310|Sensory System Agents|sensory system agents|mesh-ancestor
102341445|NCT04782310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102341446|NCT04782310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341447|NCT04782310|Anticonvulsants|anticonvulsants|mesh-ancestor
102341448|NCT04782310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102341449|NCT04782310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102341450|NCT04782310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341451|NCT04782310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102341452|NCT04782310|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102341453|NCT04782310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102341454|NCT04782310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102341455|NCT04782310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102341456|NCT04782310|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102341457|NCT04782310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102341458|NCT04782310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102341459|NCT04782310|Antidepressive Agents|antidepressive agents|mesh-ancestor
102341460|NCT04782310|Dopamine Agents|dopamine agents|mesh-ancestor
102341461|NCT03300544|Leucovorin|leucovorin|mesh-list
102341462|NCT03300544|Fluorouracil|fluorouracil|mesh-list
102341463|NCT03300544|Capecitabine|capecitabine|mesh-list
102341464|NCT03300544|Oxaliplatin|oxaliplatin|mesh-list
102341465|NCT03300544|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
102341466|NCT03300544|Antimetabolites|antimetabolites|mesh-ancestor
102341467|NCT03300544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341468|NCT03300544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102341469|NCT03300544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101528390|NCT04971356|Antipyretics|antipyretics|mesh-ancestor
102341470|NCT03300544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102341471|NCT03300544|Immunologic Factors|immunologic factors|mesh-ancestor
102341472|NCT03300544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341473|NCT03300544|Antidotes|antidotes|mesh-ancestor
102341474|NCT03300544|Protective Agents|protective agents|mesh-ancestor
102341475|NCT03300544|Vitamin B Complex|vitamin b complex|mesh-ancestor
102341477|NCT03300544|Micronutrients|micronutrients|mesh-ancestor
102341478|NCT03300544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102341479|NCT03249844|Methylprednisolone|methylprednisolone|mesh-list
102341480|NCT03249844|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102341481|NCT03249844|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102341482|NCT03249844|Prednisolone|prednisolone|mesh-list
102341483|NCT03249844|Prednisolone acetate|prednisolone acetate|mesh-list
102341484|NCT03249844|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102341485|NCT03249844|Prednisolone phosphate|prednisolone phosphate|mesh-list
102341486|NCT03249844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102341487|NCT03249844|Antiemetics|antiemetics|mesh-ancestor
102341488|NCT03249844|Autonomic Agents|autonomic agents|mesh-ancestor
102341489|NCT03249844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102341490|NCT03249844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341491|NCT03249844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102341492|NCT03249844|Glucocorticoids|glucocorticoids|mesh-ancestor
102341493|NCT03249844|Hormones|hormones|mesh-ancestor
102341494|NCT03249844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102341495|NCT03249844|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102341496|NCT03249844|Protective Agents|protective agents|mesh-ancestor
102341497|NCT03249844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102341498|NCT03249844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102341499|NCT00637624|Acetylcysteine|acetylcysteine|mesh-list
102341500|NCT00637624|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102341501|NCT00637624|Antiviral Agents|antiviral agents|mesh-ancestor
102341502|NCT00637624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102341503|NCT00637624|Expectorants|expectorants|mesh-ancestor
102341504|NCT00637624|Respiratory System Agents|respiratory system agents|mesh-ancestor
102341505|NCT00637624|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102341506|NCT00637624|Antioxidants|antioxidants|mesh-ancestor
102341507|NCT00637624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341508|NCT00637624|Protective Agents|protective agents|mesh-ancestor
102341509|NCT00637624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341510|NCT00637624|Antidotes|antidotes|mesh-ancestor
102341511|NCT01479465|Leucovorin|leucovorin|mesh-list
102341512|NCT01479465|Fluorouracil|fluorouracil|mesh-list
102341513|NCT01479465|Irinotecan|irinotecan|mesh-list
102341514|NCT01479465|Antimetabolites|antimetabolites|mesh-ancestor
102341515|NCT01479465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341516|NCT01479465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102341517|NCT01479465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102341518|NCT01479465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102341519|NCT01479465|Immunologic Factors|immunologic factors|mesh-ancestor
102341520|NCT01479465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341521|NCT01479465|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102341522|NCT01479465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102341523|NCT01479465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102341524|NCT01479465|Antidotes|antidotes|mesh-ancestor
102341525|NCT01479465|Protective Agents|protective agents|mesh-ancestor
102341526|NCT01479465|Vitamin B Complex|vitamin b complex|mesh-ancestor
102341527|NCT01479465|Vitamins|vitamins|mesh-ancestor
102341528|NCT01479465|Micronutrients|micronutrients|mesh-ancestor
102341529|NCT02428192|Nivolumab|nivolumab|mesh-list
102341530|NCT02428192|Ipilimumab|ipilimumab|mesh-list
102341531|NCT02428192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102341532|NCT02428192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102341533|NCT02428192|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102341534|NCT02428192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341535|NCT04781686|Docetaxel|docetaxel|mesh-list
102341536|NCT04781686|Apatinib|apatinib|mesh-list
102341537|NCT04781686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102341538|NCT04781686|Tubulin Modulators|tubulin modulators|mesh-ancestor
102341539|NCT04781686|Antimitotic Agents|antimitotic agents|mesh-ancestor
102341540|NCT04781686|Mitosis Modulators|mitosis modulators|mesh-ancestor
102341541|NCT04781686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341542|NCT04781686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102341543|NCT04781686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102341544|NCT02390284|Timolol|timolol|mesh-list
102341545|NCT02390284|Bimatoprost|bimatoprost|mesh-list
102341546|NCT02390284|Travoprost|travoprost|mesh-list
102341547|NCT02390284|Dorzolamide|dorzolamide|mesh-list
102341548|NCT02390284|Acetazolamide|acetazolamide|mesh-list
102341549|NCT02390284|Methazolamide|methazolamide|mesh-list
102341550|NCT02390284|Latanoprost|latanoprost|mesh-list
102341551|NCT02390284|Brinzolamide|brinzolamide|mesh-list
102341552|NCT02390284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102341553|NCT02390284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102341554|NCT02390284|Adrenergic Agents|adrenergic agents|mesh-ancestor
102341555|NCT02390284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102341556|NCT02390284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341557|NCT02390284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341558|NCT02390284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102341559|NCT02390284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102341560|NCT02390284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102341561|NCT02390284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102341562|NCT02390284|Anticonvulsants|anticonvulsants|mesh-ancestor
102341563|NCT02390284|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102341564|NCT02390284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102341565|NCT02390284|Diuretics|diuretics|mesh-ancestor
102341566|NCT02390284|Natriuretic Agents|natriuretic agents|mesh-ancestor
102341567|NCT04780750|Docetaxel|docetaxel|mesh-list
102341568|NCT04780750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102341569|NCT04780750|Tubulin Modulators|tubulin modulators|mesh-ancestor
102341570|NCT04780750|Antimitotic Agents|antimitotic agents|mesh-ancestor
102341571|NCT04780750|Mitosis Modulators|mitosis modulators|mesh-ancestor
102341572|NCT04780750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341573|NCT04780984|Bromides|bromides|mesh-list
102341574|NCT04780984|Tiotropium Bromide|tiotropium bromide|mesh-list
102341575|NCT04780984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102341576|NCT04780984|Autonomic Agents|autonomic agents|mesh-ancestor
102341577|NCT04780984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102341578|NCT04780984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341579|NCT04780984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102341580|NCT04780984|Respiratory System Agents|respiratory system agents|mesh-ancestor
102341581|NCT04780984|Parasympatholytics|parasympatholytics|mesh-ancestor
102341582|NCT04780984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102341583|NCT04780984|Cholinergic Agents|cholinergic agents|mesh-ancestor
102341584|NCT04780984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102341585|NCT04780984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341586|NCT04780984|Anticonvulsants|anticonvulsants|mesh-ancestor
102341587|NCT02090374|Vitamin D|vitamin d|mesh-list
102341588|NCT02090374|Poly ICLC|poly iclc|mesh-list
102341589|NCT02090374|Vitamins|vitamins|mesh-ancestor
102341590|NCT02090374|Micronutrients|micronutrients|mesh-ancestor
102341591|NCT02090374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341592|NCT02090374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102341594|NCT02090374|Immunologic Factors|immunologic factors|mesh-ancestor
102341595|NCT02222740|Hydrocodone|hydrocodone|mesh-list
102341596|NCT02222740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102341597|NCT02222740|Narcotics|narcotics|mesh-ancestor
102341598|NCT02222740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102341599|NCT02222740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341600|NCT02222740|Analgesics|analgesics|mesh-ancestor
102341601|NCT02222740|Sensory System Agents|sensory system agents|mesh-ancestor
102341602|NCT02222740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102341603|NCT02222740|Antitussive Agents|antitussive agents|mesh-ancestor
102341604|NCT02222740|Respiratory System Agents|respiratory system agents|mesh-ancestor
102341605|NCT04780438|Dapagliflozin|dapagliflozin|mesh-list
102341606|NCT04780438|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102341607|NCT04780438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341608|NCT04780438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102341609|NCT04780438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341610|NCT04779892|Infliximab|infliximab|mesh-list
102341611|NCT04779892|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102341612|NCT04779892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102341613|NCT04779892|Dermatologic Agents|dermatologic agents|mesh-ancestor
102341614|NCT04779892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102341615|NCT04779892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102341616|NCT04389424|Tamoxifen|tamoxifen|mesh-list
102341617|NCT04389424|Anastrozole|anastrozole|mesh-list
102341618|NCT04389424|Exemestane|exemestane|mesh-list
102341619|NCT04389424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102341620|NCT04389424|Hormone Antagonists|hormone antagonists|mesh-ancestor
102341621|NCT04389424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102341622|NCT04389424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341623|NCT04389424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102341624|NCT04389424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102341625|NCT04389424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102341626|NCT04389424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102341627|NCT04389424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102341628|NCT04389424|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102341629|NCT04389424|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102341630|NCT04389424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102341631|NCT04389424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341632|NCT04771390|Selitrectinib|selitrectinib|mesh-list
102341633|NCT04771390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102341634|NCT04771390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341635|NCT04779502|Chlorhexidine|chlorhexidine|mesh-list
102341636|NCT04779502|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102341637|NCT04779502|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102341638|NCT04779502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102341639|NCT04779502|Disinfectants|disinfectants|mesh-ancestor
102341640|NCT04779502|Dermatologic Agents|dermatologic agents|mesh-ancestor
102341641|NCT05411380|Capecitabine|capecitabine|mesh-list
102341643|NCT05411380|Fulvestrant|fulvestrant|mesh-list
102341644|NCT05411380|Anastrozole|anastrozole|mesh-list
102341645|NCT05411380|Exemestane|exemestane|mesh-list
102341646|NCT05411380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102341647|NCT05411380|Antimetabolites|antimetabolites|mesh-ancestor
102341648|NCT05411380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341649|NCT05411380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102341650|NCT05411380|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102341651|NCT05411380|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102341652|NCT05411380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102341653|NCT05411380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102341654|NCT05411380|Hormone Antagonists|hormone antagonists|mesh-ancestor
102341655|NCT05411380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102341656|NCT05411380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341657|NCT05411380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102341658|NCT05411380|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102341659|NCT04779580|Anesthetics|anesthetics|mesh-list
102341660|NCT04779580|Anesthetics, Local|anesthetics, local|mesh-list
102341661|NCT04779580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102341662|NCT04779580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341663|NCT04779580|Sensory System Agents|sensory system agents|mesh-ancestor
102050518|NCT02106104|Incretins|incretins|mesh-ancestor
102341664|NCT04779580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102341665|NCT04770688|Osimertinib|osimertinib|mesh-list
102341666|NCT04770688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102341667|NCT04770688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102341668|NCT04770688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102341669|NCT04770688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341670|NCT05390476|Capecitabine|capecitabine|mesh-list
102341671|NCT05390476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102341672|NCT05390476|Antimetabolites|antimetabolites|mesh-ancestor
102341673|NCT05390476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341674|NCT05390476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102341675|NCT05324332|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102341676|NCT05324332|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102341677|NCT05324332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341678|NCT04769908|Lenvatinib|lenvatinib|mesh-list
102341679|NCT04769908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102341680|NCT04769908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102341681|NCT04769908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102341682|NCT04769908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341683|NCT00054028|Suramin|suramin|mesh-list
102341684|NCT00054028|Paclitaxel|paclitaxel|mesh-list
102341685|NCT00054028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102341686|NCT00054028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102341687|NCT00054028|Tubulin Modulators|tubulin modulators|mesh-ancestor
102341688|NCT00054028|Antimitotic Agents|antimitotic agents|mesh-ancestor
102341689|NCT00054028|Mitosis Modulators|mitosis modulators|mesh-ancestor
102341690|NCT00054028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341691|NCT00054028|Antinematodal Agents|antinematodal agents|mesh-ancestor
102341692|NCT00054028|Anthelmintics|anthelmintics|mesh-ancestor
102341693|NCT00054028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102341694|NCT00054028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102341695|NCT00054028|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102341696|NCT00054028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102341697|NCT00058240|Alvocidib|alvocidib|mesh-list
102341698|NCT00058240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102341699|NCT00058240|Growth Inhibitors|growth inhibitors|mesh-ancestor
102341700|NCT00058240|Growth Substances|growth substances|mesh-ancestor
102341701|NCT00058240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341702|NCT00058240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101683740|NCT02642367|Rocuronium|rocuronium|mesh-list
102341703|NCT00058240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102341704|NCT00058240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341706|NCT03026907|Alitretinoin|alitretinoin|mesh-list
102341707|NCT03026907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102341708|NCT03026907|Dermatologic Agents|dermatologic agents|mesh-ancestor
102341709|NCT03026907|Antimetabolites|antimetabolites|mesh-ancestor
102341710|NCT03026907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341711|NCT03026907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102341712|NCT03026907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102341713|NCT03026907|Immunologic Factors|immunologic factors|mesh-ancestor
102341714|NCT03026907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341715|NCT03026907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102341716|NCT00060424|Cyclosporine|cyclosporine|mesh-list
102341717|NCT00060424|Mycophenolic Acid|mycophenolic acid|mesh-list
102341718|NCT00060424|Fludarabine|fludarabine|mesh-list
102341719|NCT00060424|Fludarabine phosphate|fludarabine phosphate|mesh-list
102341720|NCT00060424|Cyclosporins|cyclosporins|mesh-list
102341721|NCT00060424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102341722|NCT00060424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102341723|NCT00060424|Antimetabolites|antimetabolites|mesh-ancestor
102341724|NCT00060424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341725|NCT00060424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102341726|NCT00060424|Immunologic Factors|immunologic factors|mesh-ancestor
102341727|NCT00060424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341728|NCT00060424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102341729|NCT00060424|Antifungal Agents|antifungal agents|mesh-ancestor
102341730|NCT00060424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102341731|NCT00060424|Dermatologic Agents|dermatologic agents|mesh-ancestor
102341732|NCT00060424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102341733|NCT00060424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102341734|NCT00060424|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102341735|NCT00060424|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102341736|NCT00060424|Antitubercular Agents|antitubercular agents|mesh-ancestor
102341737|NCT00060424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102050625|NCT01376713|Ofatumumab|ofatumumab|mesh-list
102341738|NCT00062764|Pioglitazone|pioglitazone|mesh-list
102341739|NCT00062764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102341740|NCT00062764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341741|NCT00063232|Metformin|metformin|mesh-list
102341742|NCT00063232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102341743|NCT00063232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341744|NCT00063622|Vitamin E|vitamin e|mesh-list
102341745|NCT00063622|Pioglitazone|pioglitazone|mesh-list
102341746|NCT00063622|Vitamins|vitamins|mesh-ancestor
102341747|NCT00063622|Micronutrients|micronutrients|mesh-ancestor
102341748|NCT00063622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341749|NCT00063622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102341750|NCT00063622|Antioxidants|antioxidants|mesh-ancestor
102341751|NCT00063622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341752|NCT00063622|Protective Agents|protective agents|mesh-ancestor
102341753|NCT05605756|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102341754|NCT05605756|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102341755|NCT05605756|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102341756|NCT05605756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102341757|NCT05605756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341758|NCT05605756|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101528409|NCT01214044|Dexetimide|dexetimide|mesh-list
102341759|NCT05605756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102341760|NCT05605756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341761|NCT05605756|Cholinergic Agents|cholinergic agents|mesh-ancestor
102341762|NCT05605756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102341763|NCT00153166|Pioglitazone|pioglitazone|mesh-list
102341764|NCT00153166|Atorvastatin|atorvastatin|mesh-list
102341765|NCT00153166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102341766|NCT00153166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102341767|NCT00153166|Antimetabolites|antimetabolites|mesh-ancestor
102341768|NCT00153166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341769|NCT00153166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102341770|NCT00153166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102341771|NCT00153166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102341772|NCT00153166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102341773|NCT00153166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341774|NCT00156910|Botulinum Toxins|botulinum toxins|mesh-list
102341775|NCT00156910|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102341776|NCT00156910|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101683822|NCT00885495|Ritonavir|ritonavir|mesh-list
102341777|NCT00156910|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102341778|NCT00156910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102341779|NCT00156910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341780|NCT00156910|Cholinergic Agents|cholinergic agents|mesh-ancestor
102341781|NCT00156910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102341782|NCT00156910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341783|NCT00156910|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102341784|NCT00156910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102341785|NCT01475721|Fluticasone|fluticasone|mesh-list
102341786|NCT01475721|Xhance|xhance|mesh-list
102341787|NCT01475721|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102341788|NCT01475721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102341789|NCT01475721|Autonomic Agents|autonomic agents|mesh-ancestor
102341790|NCT01475721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102341791|NCT01475721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341792|NCT01475721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102341793|NCT01475721|Respiratory System Agents|respiratory system agents|mesh-ancestor
102341794|NCT01475721|Glucocorticoids|glucocorticoids|mesh-ancestor
102341795|NCT01475721|Hormones|hormones|mesh-ancestor
102341796|NCT01475721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102341797|NCT01475721|Sympathomimetics|sympathomimetics|mesh-ancestor
102341798|NCT01475721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102341799|NCT01475721|Dermatologic Agents|dermatologic agents|mesh-ancestor
102341800|NCT01475721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102341801|NCT00065806|Atorvastatin|atorvastatin|mesh-list
102341802|NCT00065806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102341803|NCT00065806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102341804|NCT00065806|Antimetabolites|antimetabolites|mesh-ancestor
102341805|NCT00065806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341806|NCT00065806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102341807|NCT00065806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102341808|NCT00065806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102341809|NCT00068770|Celecoxib|celecoxib|mesh-list
102341810|NCT00068770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102341811|NCT00068770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102341812|NCT00068770|Analgesics|analgesics|mesh-ancestor
102341813|NCT00068770|Sensory System Agents|sensory system agents|mesh-ancestor
102341814|NCT00068770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102341815|NCT00068770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341816|NCT00068770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102341817|NCT00068770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102341818|NCT00068770|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102341819|NCT00068770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101443014|NCT00198198|Dopamine Agents|dopamine agents|mesh-ancestor
102341820|NCT00068770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102341821|NCT00068770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341822|NCT01475331|Ethanol|ethanol|mesh-list
102341823|NCT01475331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102341824|NCT01475331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102341825|NCT01475331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102341826|NCT01475331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341827|NCT01500213|Dexamethasone|dexamethasone|mesh-list
102341828|NCT01500213|Granisetron|granisetron|mesh-list
102341829|NCT01500213|Rolapitant|rolapitant|mesh-list
102341830|NCT01500213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102341831|NCT01500213|Antiemetics|antiemetics|mesh-ancestor
102341832|NCT01500213|Autonomic Agents|autonomic agents|mesh-ancestor
102341833|NCT01500213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102341834|NCT01500213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341835|NCT01500213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102341836|NCT01500213|Glucocorticoids|glucocorticoids|mesh-ancestor
102341837|NCT01500213|Hormones|hormones|mesh-ancestor
102341838|NCT01500213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102341839|NCT01500213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102341840|NCT01500213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102341841|NCT01500213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102341842|NCT01500213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102341843|NCT01500213|Serotonin Agents|serotonin agents|mesh-ancestor
102341844|NCT01500213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102341845|NCT01500213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341846|NCT01500213|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102341847|NCT00069160|Docetaxel|docetaxel|mesh-list
102341848|NCT00069160|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
102341849|NCT00069160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102341850|NCT00069160|Tubulin Modulators|tubulin modulators|mesh-ancestor
102341851|NCT00069160|Antimitotic Agents|antimitotic agents|mesh-ancestor
102341852|NCT00069160|Mitosis Modulators|mitosis modulators|mesh-ancestor
102341853|NCT00069160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341854|NCT00069160|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102341855|NCT00071890|Aldesleukin|aldesleukin|mesh-list
102341856|NCT00071890|Interleukin-2|interleukin-2|mesh-list
101836576|NCT00322348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101836577|NCT01014234|Cyclosporine|cyclosporine|mesh-list
101836578|NCT01014234|Sirolimus|sirolimus|mesh-list
101836579|NCT01014234|Cyclosporins|cyclosporins|mesh-list
101836580|NCT01014234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101836581|NCT01014234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836582|NCT01014234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101836583|NCT01014234|Immunologic Factors|immunologic factors|mesh-ancestor
101836584|NCT01014234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836585|NCT01014234|Antifungal Agents|antifungal agents|mesh-ancestor
101836586|NCT01014234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101836587|NCT01014234|Dermatologic Agents|dermatologic agents|mesh-ancestor
101836588|NCT01014234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101836589|NCT01014234|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101836590|NCT01014234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101836591|NCT01014234|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101836592|NCT01014234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101836593|NCT00501228|Lenograstim|lenograstim|mesh-list
101836594|NCT00501228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101836595|NCT00501228|Immunologic Factors|immunologic factors|mesh-ancestor
101836596|NCT00501228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836597|NCT00308620|Chloroquine|chloroquine|mesh-list
101836598|NCT00308620|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
101836599|NCT00308620|Amebicides|amebicides|mesh-ancestor
101836600|NCT00308620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101836601|NCT00308620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101836602|NCT00308620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101836603|NCT00308620|Antimalarials|antimalarials|mesh-ancestor
101836604|NCT00308620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101836605|NCT00308620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101836606|NCT00308620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101836607|NCT00308620|Analgesics|analgesics|mesh-ancestor
101836608|NCT00308620|Sensory System Agents|sensory system agents|mesh-ancestor
102341857|NCT00071890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102341858|NCT00071890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102341859|NCT00071890|Analgesics|analgesics|mesh-ancestor
102341860|NCT00071890|Sensory System Agents|sensory system agents|mesh-ancestor
102341861|NCT00071890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102341862|NCT00071890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341863|NCT00071890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102341864|NCT00071890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102341865|NCT00071890|Antiviral Agents|antiviral agents|mesh-ancestor
102341866|NCT00071890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102341867|NCT01475253|Lidocaine|lidocaine|mesh-list
102341868|NCT01475253|Anesthetics, Local|anesthetics, local|mesh-ancestor
102341869|NCT01475253|Anesthetics|anesthetics|mesh-ancestor
102341870|NCT01475253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102341871|NCT01475253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341872|NCT01475253|Sensory System Agents|sensory system agents|mesh-ancestor
102341873|NCT01475253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102341874|NCT01475253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102341875|NCT01475253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102341876|NCT01475253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102341877|NCT01475253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102341878|NCT01475253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341879|NCT00072514|Dexamethasone|dexamethasone|mesh-list
102341880|NCT00072514|Rituximab|rituximab|mesh-list
102341881|NCT00072514|Carboplatin|carboplatin|mesh-list
102341882|NCT00072514|Gemcitabine|gemcitabine|mesh-list
102341883|NCT00072514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102341884|NCT00072514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102341885|NCT00072514|Immunologic Factors|immunologic factors|mesh-ancestor
102341886|NCT00072514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341887|NCT00072514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102341888|NCT00072514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102341889|NCT00072514|Antiemetics|antiemetics|mesh-ancestor
102341890|NCT00072514|Autonomic Agents|autonomic agents|mesh-ancestor
102341891|NCT00072514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102341892|NCT00072514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102341893|NCT00072514|Glucocorticoids|glucocorticoids|mesh-ancestor
102341894|NCT00072514|Hormones|hormones|mesh-ancestor
102341895|NCT00072514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102341896|NCT00072514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102341897|NCT00072514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102341898|NCT00072514|Antimetabolites|antimetabolites|mesh-ancestor
102341899|NCT00072514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341900|NCT00074308|Bevacizumab|bevacizumab|mesh-list
102341901|NCT00074308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102341902|NCT00074308|Imatinib Mesylate|imatinib mesylate|mesh-list
102341903|NCT00074308|Antibodies|antibodies|mesh-list
102341904|NCT00074308|Immunoglobulins|immunoglobulins|mesh-list
102341905|NCT00074308|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102341906|NCT00074308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102341907|NCT00074308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102341908|NCT00074308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102341909|NCT00074308|Growth Substances|growth substances|mesh-ancestor
102341910|NCT00074308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341911|NCT00074308|Growth Inhibitors|growth inhibitors|mesh-ancestor
102341912|NCT00074308|Immunologic Factors|immunologic factors|mesh-ancestor
102341913|NCT00074308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102341914|NCT00074308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102341915|NCT00074308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341916|NCT00166036|Atorvastatin|atorvastatin|mesh-list
102341917|NCT00166036|Pravastatin|pravastatin|mesh-list
102341918|NCT00166036|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102341919|NCT00166036|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102341920|NCT00166036|Antimetabolites|antimetabolites|mesh-ancestor
102341921|NCT00166036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341922|NCT00166036|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102341923|NCT00166036|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102341924|NCT00166036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102341925|NCT00167206|Cyclophosphamide|cyclophosphamide|mesh-list
102341926|NCT00167206|Fludarabine|fludarabine|mesh-list
102341927|NCT00167206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102341928|NCT00167206|Immunologic Factors|immunologic factors|mesh-ancestor
102341929|NCT00167206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341930|NCT00167206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102341931|NCT00167206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102341932|NCT00167206|Alkylating Agents|alkylating agents|mesh-ancestor
102341933|NCT00167206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341934|NCT00167206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102341935|NCT00167206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102341936|NCT01474551|Vemurafenib|vemurafenib|mesh-list
102341937|NCT01474551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102341938|NCT01474551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102341939|NCT01474551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102341940|NCT01474551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341941|NCT01499667|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102341942|NCT01499667|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102341943|NCT01499667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341944|NCT01499667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102341945|NCT01499667|Immunologic Factors|immunologic factors|mesh-ancestor
102341946|NCT01499667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341947|NCT00168298|Dexamethasone|dexamethasone|mesh-list
102341948|NCT00168298|Dexamethasone acetate|dexamethasone acetate|mesh-list
102341949|NCT00168298|BB 1101|bb 1101|mesh-list
102341950|NCT00168298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102341951|NCT00168298|Antiemetics|antiemetics|mesh-ancestor
102341952|NCT00168298|Autonomic Agents|autonomic agents|mesh-ancestor
102341953|NCT00168298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102341954|NCT00168298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341955|NCT00168298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102341956|NCT00168298|Glucocorticoids|glucocorticoids|mesh-ancestor
102341957|NCT00168298|Hormones|hormones|mesh-ancestor
102341958|NCT00168298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102341959|NCT00168298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102341960|NCT00168298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102341961|NCT00168298|Protease Inhibitors|protease inhibitors|mesh-ancestor
102341962|NCT00168298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102341963|NCT00168298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341964|NCT00076258|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
102341965|NCT00076258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102341966|NCT00076258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102341967|NCT00076258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341968|NCT00076258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102341969|NCT00076258|Serotonin Agents|serotonin agents|mesh-ancestor
102341970|NCT00076258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341971|NCT00078286|Sertraline|sertraline|mesh-list
102341972|NCT00078286|Antidepressive Agents|antidepressive agents|mesh-ancestor
102341973|NCT00078286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102341974|NCT00078286|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102341975|NCT00078286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102341976|NCT00078286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102341977|NCT00078286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341978|NCT00078286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102341979|NCT00078286|Serotonin Agents|serotonin agents|mesh-ancestor
102341980|NCT00078286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341981|NCT00078754|Valproic Acid|valproic acid|mesh-list
102341982|NCT00078754|Fluoxetine|fluoxetine|mesh-list
102341983|NCT00078754|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102341984|NCT00078754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102341985|NCT00078754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102341986|NCT00078754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102341987|NCT00078754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102341988|NCT00078754|Serotonin Agents|serotonin agents|mesh-ancestor
102341989|NCT00078754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102341990|NCT00078754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102341991|NCT00078754|Antidepressive Agents|antidepressive agents|mesh-ancestor
102341992|NCT00078754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102341993|NCT00078754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102341994|NCT00078754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102341995|NCT00078754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102341996|NCT00078754|Anticonvulsants|anticonvulsants|mesh-ancestor
102341997|NCT00078754|GABA Agents|gaba agents|mesh-ancestor
102341998|NCT00078754|Antimanic Agents|antimanic agents|mesh-ancestor
102341999|NCT00078754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102342000|NCT00078754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102342001|NCT00081328|Metformin|metformin|mesh-list
102342002|NCT00081328|Rosiglitazone|rosiglitazone|mesh-list
102050866|NCT03119701|Interferons|interferons|mesh-list
102342003|NCT00081328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102342004|NCT00081328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342006|NCT01499355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102342007|NCT01499355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342008|NCT01499355|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102342009|NCT01499355|Antitubercular Agents|antitubercular agents|mesh-ancestor
102342010|NCT01499355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102342011|NCT01499355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102342012|NCT01499355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102342013|NCT01499355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342014|NCT00083122|Cisplatin|cisplatin|mesh-list
102342015|NCT00083122|Alvocidib|alvocidib|mesh-list
102342016|NCT00083122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342017|NCT00083122|Growth Inhibitors|growth inhibitors|mesh-ancestor
102342018|NCT00083122|Growth Substances|growth substances|mesh-ancestor
102342019|NCT00083122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342020|NCT00083122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102342021|NCT00083122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102342022|NCT00083122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342023|NCT01474239|Bevacizumab|bevacizumab|mesh-list
102342024|NCT01474239|Fotemustine|fotemustine|mesh-list
102342025|NCT01474239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102342026|NCT01474239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342027|NCT01474239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102342028|NCT01474239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102342029|NCT01474239|Growth Substances|growth substances|mesh-ancestor
102342030|NCT01474239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342031|NCT01474239|Growth Inhibitors|growth inhibitors|mesh-ancestor
102342032|NCT01473381|Dexetimide|dexetimide|mesh-list
102342033|NCT01473381|Citalopram|citalopram|mesh-list
102342034|NCT01473381|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
102342035|NCT01473381|Escitalopram|escitalopram|mesh-list
102342036|NCT01473381|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102342037|NCT01473381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102342038|NCT01473381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101941630|NCT01131429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342039|NCT01473381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342040|NCT01473381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102342041|NCT01473381|Serotonin Agents|serotonin agents|mesh-ancestor
102342042|NCT01473381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342043|NCT01473381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102342044|NCT01473381|Antidepressive Agents|antidepressive agents|mesh-ancestor
102342045|NCT01473381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102342046|NCT01473381|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102342047|NCT01473381|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102342048|NCT01473381|Parasympatholytics|parasympatholytics|mesh-ancestor
102342049|NCT01473381|Autonomic Agents|autonomic agents|mesh-ancestor
102342050|NCT01473381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102342051|NCT01473381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102342052|NCT01473381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102342053|NCT01473381|Cholinergic Agents|cholinergic agents|mesh-ancestor
102342054|NCT01473381|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102342055|NCT01473381|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102342056|NCT00168454|Botulinum Toxins|botulinum toxins|mesh-list
102342057|NCT00168454|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102342058|NCT00168454|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102342059|NCT00168454|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102342060|NCT00168454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102342061|NCT00168454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342062|NCT00168454|Cholinergic Agents|cholinergic agents|mesh-ancestor
102342063|NCT00168454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102342064|NCT00168454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342065|NCT00168454|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102342066|NCT00168454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102342067|NCT01499277|Vancomycin|vancomycin|mesh-list
102342068|NCT01499277|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
102342069|NCT01499277|Aztreonam|aztreonam|mesh-list
102342070|NCT01499277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102342071|NCT01499277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102342072|NCT00176800|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
102342073|NCT00176800|Chelating Agents|chelating agents|mesh-ancestor
102342074|NCT00176800|Sequestering Agents|sequestering agents|mesh-ancestor
102342075|NCT00176800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342076|NCT00176800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102342077|NCT00176800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102342078|NCT00176800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102342079|NCT00176800|Growth Substances|growth substances|mesh-ancestor
102342080|NCT00176800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342081|NCT00176800|Growth Inhibitors|growth inhibitors|mesh-ancestor
102342082|NCT00176800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342083|NCT00176878|Fludarabine|fludarabine|mesh-list
102342084|NCT00176878|Fludarabine phosphate|fludarabine phosphate|mesh-list
102342085|NCT00176878|Busulfan|busulfan|mesh-list
102342086|NCT00176878|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102342087|NCT00176878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342088|NCT00176878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102342089|NCT00176878|Antimetabolites|antimetabolites|mesh-ancestor
102342090|NCT00176878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342091|NCT00176878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102342092|NCT00176878|Immunologic Factors|immunologic factors|mesh-ancestor
102342093|NCT00176878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342094|NCT00176878|Alkylating Agents|alkylating agents|mesh-ancestor
102342095|NCT00176878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102342096|NCT00176878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102342097|NCT01898182|Kinetin|kinetin|mesh-list
102342098|NCT01898182|Plant Growth Regulators|plant growth regulators|mesh-ancestor
102342099|NCT01898182|Growth Substances|growth substances|mesh-ancestor
102342100|NCT01898182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342101|NCT01499199|Dolutegravir|dolutegravir|mesh-list
102342102|NCT01499199|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102342103|NCT01499199|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102342104|NCT01499199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102342105|NCT01499199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342106|NCT01499199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102342107|NCT01499199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102342108|NCT01499199|Antiviral Agents|antiviral agents|mesh-ancestor
102342109|NCT01499199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102342110|NCT00090844|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102342111|NCT00090844|Luteolytic Agents|luteolytic agents|mesh-ancestor
102342112|NCT00090844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102342113|NCT00090844|Contraceptive Agents|contraceptive agents|mesh-ancestor
102342114|NCT00090844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102342115|NCT00090844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342116|NCT00090844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102342117|NCT00090844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102342118|NCT00090844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342119|NCT01897012|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102342120|NCT01897012|Romidepsin|romidepsin|mesh-list
102342121|NCT01897012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102342122|NCT01897012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102342123|NCT01897012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342124|NCT01897012|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102342125|NCT01897012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102342126|NCT01897012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342127|NCT01498887|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102342128|NCT01498887|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102342129|NCT01498887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342130|NCT01498887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102342131|NCT01498887|Immunologic Factors|immunologic factors|mesh-ancestor
102342132|NCT01498887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342133|NCT01498185|Dapagliflozin|dapagliflozin|mesh-list
102342134|NCT01498185|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102342135|NCT01498185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342136|NCT01498185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102342137|NCT01498185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342138|NCT01527357|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102342139|NCT01527357|Fibrin Foam|fibrin foam|mesh-list
102342140|NCT01527357|Hemostatics|hemostatics|mesh-ancestor
102342141|NCT01527357|Coagulants|coagulants|mesh-ancestor
102342142|NCT00181714|Methylphenidate|methylphenidate|mesh-list
102342143|NCT00181714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102342144|NCT00181714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342145|NCT00181714|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102342146|NCT00181714|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102342147|NCT00181714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102342148|NCT00181714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342149|NCT00181714|Dopamine Agents|dopamine agents|mesh-ancestor
102342150|NCT00181714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102342151|NCT01472835|Fentanyl|fentanyl|mesh-list
102342152|NCT01472835|Midazolam|midazolam|mesh-list
102342153|NCT01472835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102342154|NCT01472835|Narcotics|narcotics|mesh-ancestor
102342155|NCT01472835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102342156|NCT01472835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342157|NCT01472835|Analgesics|analgesics|mesh-ancestor
102342158|NCT01472835|Sensory System Agents|sensory system agents|mesh-ancestor
102342159|NCT01472835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102342160|NCT01472835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102342161|NCT01472835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102342162|NCT01472835|Anesthetics, General|anesthetics, general|mesh-ancestor
102342163|NCT01472835|Anesthetics|anesthetics|mesh-ancestor
102342164|NCT01472835|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102342165|NCT01472835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102342166|NCT01472835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102342167|NCT01472835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102342168|NCT01472835|GABA Modulators|gaba modulators|mesh-ancestor
102342169|NCT01472835|GABA Agents|gaba agents|mesh-ancestor
102342170|NCT01472835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102342171|NCT01472835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342172|NCT00185692|Acetaminophen|acetaminophen|mesh-list
102342173|NCT00185692|Cyclosporine|cyclosporine|mesh-list
102342174|NCT00185692|Mycophenolic Acid|mycophenolic acid|mesh-list
102342175|NCT00185692|Methylprednisolone|methylprednisolone|mesh-list
102342176|NCT00185692|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102342177|NCT00185692|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102342178|NCT00185692|Prednisolone|prednisolone|mesh-list
102342179|NCT00185692|Prednisolone acetate|prednisolone acetate|mesh-list
102342180|NCT00185692|Hydrocortisone|hydrocortisone|mesh-list
102342181|NCT00185692|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102342182|NCT00185692|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102342183|NCT00185692|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102342184|NCT00185692|Cyclosporins|cyclosporins|mesh-list
102342185|NCT00185692|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102342186|NCT00185692|Lenograstim|lenograstim|mesh-list
102342187|NCT00185692|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102342188|NCT00185692|Prednisolone phosphate|prednisolone phosphate|mesh-list
102342189|NCT00185692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102342190|NCT00185692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342191|NCT00185692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102342192|NCT00185692|Immunologic Factors|immunologic factors|mesh-ancestor
102342193|NCT00185692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342194|NCT00185692|Antifungal Agents|antifungal agents|mesh-ancestor
102342195|NCT00185692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102342196|NCT00185692|Dermatologic Agents|dermatologic agents|mesh-ancestor
102342197|NCT00185692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102342198|NCT00185692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102342199|NCT00185692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102342200|NCT00185692|Analgesics|analgesics|mesh-ancestor
102342201|NCT00185692|Sensory System Agents|sensory system agents|mesh-ancestor
102342202|NCT00185692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102342203|NCT00185692|Antipyretics|antipyretics|mesh-ancestor
102342204|NCT00185692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102342205|NCT00185692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342206|NCT00185692|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102342207|NCT00185692|Antitubercular Agents|antitubercular agents|mesh-ancestor
102342208|NCT00185692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102342209|NCT00185692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102342210|NCT00185692|Antiemetics|antiemetics|mesh-ancestor
102342211|NCT00185692|Autonomic Agents|autonomic agents|mesh-ancestor
102342212|NCT00185692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102342213|NCT00185692|Glucocorticoids|glucocorticoids|mesh-ancestor
102342215|NCT00185692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102342216|NCT00185692|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102342217|NCT00185692|Protective Agents|protective agents|mesh-ancestor
102342218|NCT00185692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102342219|NCT00185692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102342220|NCT01526733|Insulin|insulin|mesh-list
102342221|NCT01526733|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102342222|NCT01526733|Insulin Aspart|insulin aspart|mesh-list
102342223|NCT01526733|Insulin Lispro|insulin lispro|mesh-list
102342224|NCT01526733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102342225|NCT01526733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342226|NCT00094900|Rilonacept|rilonacept|mesh-list
102342227|NCT00094900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102342228|NCT00096460|Cyclophosphamide|cyclophosphamide|mesh-list
102342229|NCT00096460|Carmustine|carmustine|mesh-list
102342230|NCT00096460|Rituximab|rituximab|mesh-list
102342231|NCT00096460|Methotrexate|methotrexate|mesh-list
102342232|NCT00096460|Fludarabine|fludarabine|mesh-list
102342233|NCT00096460|Etoposide|etoposide|mesh-list
102342234|NCT00096460|Tacrolimus|tacrolimus|mesh-list
102342235|NCT00096460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102342236|NCT00096460|Immunologic Factors|immunologic factors|mesh-ancestor
102342237|NCT00096460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342238|NCT00096460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102342239|NCT00096460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102342240|NCT00096460|Alkylating Agents|alkylating agents|mesh-ancestor
102342241|NCT00096460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342242|NCT00096460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342243|NCT00096460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102342244|NCT00096460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102342245|NCT00096460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102342246|NCT00096460|Abortifacient Agents|abortifacient agents|mesh-ancestor
102342247|NCT00096460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102342248|NCT00096460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102342249|NCT00096460|Antimetabolites|antimetabolites|mesh-ancestor
102342250|NCT00096460|Dermatologic Agents|dermatologic agents|mesh-ancestor
102342251|NCT00096460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102342252|NCT00096460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102342253|NCT00096460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102342254|NCT00096460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102342255|NCT00096460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102342256|NCT00096460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102342257|NCT00096460|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102342258|NCT00006178|Sirolimus|sirolimus|mesh-list
102342259|NCT00006178|Thymoglobulin|thymoglobulin|mesh-list
102342260|NCT00006178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102342261|NCT00006178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102342262|NCT00006178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102342263|NCT00006178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342264|NCT00006178|Antifungal Agents|antifungal agents|mesh-ancestor
102342265|NCT00006178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102342266|NCT00006178|Immunologic Factors|immunologic factors|mesh-ancestor
102342267|NCT00006178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342268|NCT00097708|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
102342269|NCT00097708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102342270|NCT00097708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102342271|NCT00097708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342272|NCT00097708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102342273|NCT00098956|Topotecan|topotecan|mesh-list
102342274|NCT00098956|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
102342275|NCT00098956|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102342276|NCT00098956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102342277|NCT00098956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102342278|NCT00098956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342279|NCT00098956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342280|NCT00098956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102342281|NCT02197156|Acetaminophen|acetaminophen|mesh-list
102342282|NCT02197156|Hydrocodone|hydrocodone|mesh-list
102342283|NCT02197156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102342284|NCT02197156|Analgesics|analgesics|mesh-ancestor
102342285|NCT02197156|Sensory System Agents|sensory system agents|mesh-ancestor
102342286|NCT02197156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102342287|NCT02197156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342288|NCT02197156|Antipyretics|antipyretics|mesh-ancestor
102342289|NCT02197156|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102342290|NCT02197156|Narcotics|narcotics|mesh-ancestor
102342291|NCT02197156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102342292|NCT02197156|Antitussive Agents|antitussive agents|mesh-ancestor
102342293|NCT02197156|Respiratory System Agents|respiratory system agents|mesh-ancestor
102342294|NCT00187720|Metformin|metformin|mesh-list
102342295|NCT00187720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102342296|NCT00187720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342297|NCT00006244|Interferons|interferons|mesh-list
102342298|NCT00006244|Interferon-alpha|interferon-alpha|mesh-list
102342299|NCT00006244|Aldesleukin|aldesleukin|mesh-list
102342300|NCT00006244|Interferon alpha-2|interferon alpha-2|mesh-list
102342301|NCT00006244|Melphalan|melphalan|mesh-list
102342302|NCT00006244|Interleukin-2|interleukin-2|mesh-list
102342303|NCT00006244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342304|NCT00006244|Antiviral Agents|antiviral agents|mesh-ancestor
102342305|NCT00006244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102342306|NCT00006244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102342307|NCT00006244|Alkylating Agents|alkylating agents|mesh-ancestor
102342308|NCT00006244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342309|NCT00006244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102342310|NCT00006244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102342311|NCT00006244|Immunologic Factors|immunologic factors|mesh-ancestor
102342312|NCT00006244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342313|NCT00006244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102342314|NCT00006244|Analgesics|analgesics|mesh-ancestor
102342315|NCT00006244|Sensory System Agents|sensory system agents|mesh-ancestor
102342316|NCT00006244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102342317|NCT00006244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102342318|NCT00006244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102342319|NCT01525875|Magnesium Oxide|magnesium oxide|mesh-list
102342320|NCT01525875|Antacids|antacids|mesh-ancestor
102342321|NCT01525875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342322|NCT01525875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102342323|NCT01525641|Pramipexole|pramipexole|mesh-list
102342324|NCT01525641|Antioxidants|antioxidants|mesh-ancestor
102342325|NCT01525641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342326|NCT01525641|Protective Agents|protective agents|mesh-ancestor
102342327|NCT01525641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342328|NCT01525641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102342329|NCT01525641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102342330|NCT01525641|Dopamine Agonists|dopamine agonists|mesh-ancestor
102342331|NCT01525641|Dopamine Agents|dopamine agents|mesh-ancestor
102342332|NCT01525641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102342333|NCT00006400|Hydroxyurea|hydroxyurea|mesh-list
102342334|NCT00006400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342335|NCT00006400|Antisickling Agents|antisickling agents|mesh-ancestor
102342336|NCT00006400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102342337|NCT00006400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342338|NCT00006400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102342339|NCT01496469|Febuxostat|febuxostat|mesh-list
102342340|NCT01496469|Gout Suppressants|gout suppressants|mesh-ancestor
102342341|NCT01496469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102342342|NCT00189436|Budesonide|budesonide|mesh-list
102342343|NCT00189436|Albuterol|albuterol|mesh-list
102342344|NCT00189436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102342345|NCT00189436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102342346|NCT00189436|Autonomic Agents|autonomic agents|mesh-ancestor
102342347|NCT00189436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102342348|NCT00189436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342349|NCT00189436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102342350|NCT00189436|Respiratory System Agents|respiratory system agents|mesh-ancestor
102342351|NCT00189436|Glucocorticoids|glucocorticoids|mesh-ancestor
102342352|NCT00189436|Hormones|hormones|mesh-ancestor
102342353|NCT00189436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102342354|NCT00189436|Tocolytic Agents|tocolytic agents|mesh-ancestor
102342355|NCT00189436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102342356|NCT00189436|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102342357|NCT00189436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102342358|NCT00189436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102342359|NCT00189436|Adrenergic Agents|adrenergic agents|mesh-ancestor
102342360|NCT00189436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102342361|NCT00189436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342362|NCT01471353|Capecitabine|capecitabine|mesh-list
102342363|NCT01471353|Sorafenib|sorafenib|mesh-list
102342364|NCT01471353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102342365|NCT01471353|Antimetabolites|antimetabolites|mesh-ancestor
102342366|NCT01471353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342367|NCT01471353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342368|NCT01471353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102342369|NCT01471353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102342370|NCT01525407|Atorvastatin|atorvastatin|mesh-list
102342371|NCT01525407|Calcium|calcium|mesh-list
102342372|NCT01525407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102342373|NCT01525407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342374|NCT01525407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102342375|NCT01525407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102342376|NCT01525407|Antimetabolites|antimetabolites|mesh-ancestor
102342377|NCT01525407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342378|NCT01525407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102342379|NCT01525407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102342380|NCT01525407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102051218|NCT02117726|Anesthetics|anesthetics|mesh-ancestor
102342381|NCT01471197|Pemetrexed|pemetrexed|mesh-list
102342382|NCT01471197|Ipilimumab|ipilimumab|mesh-list
102342383|NCT01471197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342384|NCT01471197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102342385|NCT01471197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342386|NCT01471197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102342387|NCT01471197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102342388|NCT01471197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102342389|NCT01471197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102342390|NCT04408989|Bevacizumab|bevacizumab|mesh-list
102342391|NCT04408989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102342392|NCT04408989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342393|NCT04408989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102342394|NCT04408989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102342395|NCT04408989|Growth Substances|growth substances|mesh-ancestor
102342396|NCT04408989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342397|NCT04408989|Growth Inhibitors|growth inhibitors|mesh-ancestor
102342398|NCT00011986|Paclitaxel|paclitaxel|mesh-list
102342399|NCT00011986|Carboplatin|carboplatin|mesh-list
102342400|NCT00011986|Gemcitabine|gemcitabine|mesh-list
102342401|NCT00011986|Doxorubicin|doxorubicin|mesh-list
102342402|NCT00011986|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102342403|NCT00011986|Topotecan|topotecan|mesh-list
102342404|NCT00011986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102342405|NCT00011986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342406|NCT00011986|Tubulin Modulators|tubulin modulators|mesh-ancestor
102342407|NCT00011986|Antimitotic Agents|antimitotic agents|mesh-ancestor
102342408|NCT00011986|Mitosis Modulators|mitosis modulators|mesh-ancestor
102342409|NCT00011986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342410|NCT00011986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102342411|NCT00011986|Antimetabolites|antimetabolites|mesh-ancestor
102342412|NCT00011986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102342413|NCT00011986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102342414|NCT00011986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102342415|NCT00011986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102342416|NCT00011986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102342417|NCT01898416|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102342418|NCT01898416|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102342419|NCT01898416|Dermatologic Agents|dermatologic agents|mesh-ancestor
102342420|NCT01524783|Everolimus|everolimus|mesh-list
102342421|NCT01524783|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102342422|NCT01524783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102342423|NCT01524783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102342424|NCT01524783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342425|NCT01524783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102342426|NCT01524783|Immunologic Factors|immunologic factors|mesh-ancestor
102342427|NCT01524783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342428|NCT01524783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342429|NCT01494987|Glimepiride|glimepiride|mesh-list
102342430|NCT01494987|Ranolazine|ranolazine|mesh-list
102342431|NCT01494987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102342432|NCT01494987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102342433|NCT01494987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342434|NCT01494987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102342435|NCT01494987|Immunologic Factors|immunologic factors|mesh-ancestor
102342436|NCT01494987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102342437|NCT01494987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102342438|NCT01494987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342439|NCT04409769|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
102342440|NCT04409769|Ceftobiprole|ceftobiprole|mesh-list
102342441|NCT04409769|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
102342442|NCT04409769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102342443|NCT04409769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102342444|NCT01524627|Varenicline|varenicline|mesh-list
102342445|NCT01524627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102342446|NCT01524627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102342447|NCT01524627|Cholinergic Agents|cholinergic agents|mesh-ancestor
102342448|NCT01524627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102342449|NCT01524627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342450|NCT01524627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342451|NCT01469637|Sulfamethoxazole|sulfamethoxazole|mesh-list
102342452|NCT01469637|Mesalamine|mesalamine|mesh-list
102342453|NCT01469637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102342454|NCT01469637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102342455|NCT01469637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102051283|NCT04045795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342456|NCT01469637|Analgesics|analgesics|mesh-ancestor
102342457|NCT01469637|Sensory System Agents|sensory system agents|mesh-ancestor
102342458|NCT01469637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102342459|NCT01469637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342460|NCT01469637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102342461|NCT01469637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102342462|NCT04409223|Sunitinib|sunitinib|mesh-list
102342463|NCT04409223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342464|NCT04409223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102342465|NCT04409223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102342466|NCT04409223|Growth Substances|growth substances|mesh-ancestor
102342467|NCT04409223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342468|NCT04409223|Growth Inhibitors|growth inhibitors|mesh-ancestor
102342469|NCT04409223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102342470|NCT04409223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102342471|NCT04409223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342472|NCT00012298|Rituximab|rituximab|mesh-list
102342473|NCT00012298|Oprelvekin|oprelvekin|mesh-list
102342474|NCT00012298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102342475|NCT00012298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102342476|NCT00012298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342477|NCT00012298|Immunologic Factors|immunologic factors|mesh-ancestor
102342478|NCT00012298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342479|NCT00012298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102342480|NCT00193258|Bevacizumab|bevacizumab|mesh-list
102342481|NCT00193258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102342482|NCT00193258|Imatinib Mesylate|imatinib mesylate|mesh-list
102342483|NCT00193258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102342484|NCT00193258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342485|NCT00193258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102342486|NCT00193258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102342487|NCT00193258|Growth Substances|growth substances|mesh-ancestor
102342488|NCT00193258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342489|NCT00193258|Growth Inhibitors|growth inhibitors|mesh-ancestor
102342490|NCT00193258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102342491|NCT00193258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102342492|NCT00193258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342493|NCT00029536|Progesterone|progesterone|mesh-list
102342494|NCT00029536|Progestins|progestins|mesh-ancestor
102342495|NCT00029536|Hormones|hormones|mesh-ancestor
102342496|NCT00029536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102342497|NCT00029536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342498|NCT00193492|Bevacizumab|bevacizumab|mesh-list
102342499|NCT00193492|Rituximab|rituximab|mesh-list
102342500|NCT00193492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102342501|NCT00193492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342502|NCT00193492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102342503|NCT00193492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102342504|NCT00193492|Growth Substances|growth substances|mesh-ancestor
102342505|NCT00193492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342506|NCT00193492|Growth Inhibitors|growth inhibitors|mesh-ancestor
102342507|NCT00193492|Immunologic Factors|immunologic factors|mesh-ancestor
102342508|NCT00193492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102342509|NCT00194116|Valproic Acid|valproic acid|mesh-list
102342510|NCT00194116|Anticonvulsants|anticonvulsants|mesh-ancestor
102342511|NCT00194116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102342512|NCT00194116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342513|NCT00194116|GABA Agents|gaba agents|mesh-ancestor
102342514|NCT00194116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102342515|NCT00194116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342516|NCT00194116|Antimanic Agents|antimanic agents|mesh-ancestor
102342517|NCT00194116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102342518|NCT00194116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102342519|NCT00194116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102342520|NCT02096458|Dexlansoprazole|dexlansoprazole|mesh-list
102342521|NCT02096458|Lansoprazole|lansoprazole|mesh-list
102342522|NCT02096458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102342523|NCT02096458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102342524|NCT02096458|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102342525|NCT02096458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102342526|NCT02096458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342527|NCT00194896|Rosiglitazone|rosiglitazone|mesh-list
102342528|NCT00194896|Glyburide|glyburide|mesh-list
102342529|NCT00194896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102342530|NCT00194896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342531|NCT04348474|Azithromycin|azithromycin|mesh-list
102342532|NCT04348474|Hydroxychloroquine|hydroxychloroquine|mesh-list
102342533|NCT04348474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102342534|NCT04348474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102342535|NCT04348474|Antimalarials|antimalarials|mesh-ancestor
102342536|NCT04348474|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102342537|NCT04348474|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102342538|NCT04348474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102342539|NCT04348474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342540|NCT04348474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102342542|NCT00107536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342543|NCT00107536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102342544|NCT00107536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102342545|NCT00107536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342546|NCT00108550|Gabapentin|gabapentin|mesh-list
102342547|NCT00108550|Analgesics|analgesics|mesh-ancestor
102342548|NCT00108550|Sensory System Agents|sensory system agents|mesh-ancestor
102342549|NCT00108550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102342550|NCT00108550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342551|NCT00108550|Anticonvulsants|anticonvulsants|mesh-ancestor
102342552|NCT00108550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102342553|NCT00108550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102342554|NCT00108550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102342555|NCT00108550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102342556|NCT00108550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102342557|NCT00108550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102342558|NCT00108550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102342559|NCT00108550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342560|NCT00108550|Antimanic Agents|antimanic agents|mesh-ancestor
102342561|NCT02093962|Pemetrexed|pemetrexed|mesh-list
102342562|NCT02093962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342563|NCT02093962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102342564|NCT02093962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342565|NCT02093962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102342566|NCT02093962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102342567|NCT00200902|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102342568|NCT00200902|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102342569|NCT00200902|Escitalopram|escitalopram|mesh-list
102342570|NCT00200902|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102342571|NCT00200902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102342572|NCT00200902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102342573|NCT00200902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342574|NCT00200902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102342575|NCT00200902|Serotonin Agents|serotonin agents|mesh-ancestor
102342576|NCT00200902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342577|NCT00200902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102342578|NCT00200902|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102342579|NCT00200902|Antidepressive Agents|antidepressive agents|mesh-ancestor
102342580|NCT00200902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102342581|NCT00200902|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102342582|NCT00200902|Analgesics|analgesics|mesh-ancestor
102342583|NCT00200902|Sensory System Agents|sensory system agents|mesh-ancestor
102342584|NCT00200902|Dopamine Agents|dopamine agents|mesh-ancestor
102342585|NCT00201448|Vaccines|vaccines|mesh-list
102342586|NCT00201448|Immunologic Factors|immunologic factors|mesh-ancestor
102342587|NCT00201448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342588|NCT00201760|Gemcitabine|gemcitabine|mesh-list
102342589|NCT00201760|Trastuzumab|trastuzumab|mesh-list
102342590|NCT00201760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342591|NCT00201760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102342592|NCT00201760|Antimetabolites|antimetabolites|mesh-ancestor
102342593|NCT00201760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342594|NCT00201760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102342595|NCT00201838|Etanercept|etanercept|mesh-list
102342596|NCT00201838|Gemcitabine|gemcitabine|mesh-list
102342597|NCT00201838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102342598|NCT00201838|Antimetabolites|antimetabolites|mesh-ancestor
102342599|NCT00201838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342600|NCT00201838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342601|NCT00201838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102342602|NCT00201838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102342603|NCT00201838|Analgesics|analgesics|mesh-ancestor
102342604|NCT00201838|Sensory System Agents|sensory system agents|mesh-ancestor
102342605|NCT00201838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102342606|NCT00201838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342607|NCT00201838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102342608|NCT00201838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102342609|NCT00201838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102342610|NCT00201838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102342611|NCT00201838|Immunologic Factors|immunologic factors|mesh-ancestor
102342612|NCT00040846|Cyclosporine|cyclosporine|mesh-list
102342613|NCT00040846|Mycophenolic Acid|mycophenolic acid|mesh-list
102342614|NCT00040846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102342615|NCT00040846|Alemtuzumab|alemtuzumab|mesh-list
102342616|NCT00040846|Fludarabine|fludarabine|mesh-list
102342617|NCT00040846|Fludarabine phosphate|fludarabine phosphate|mesh-list
102342618|NCT00040846|Antibodies|antibodies|mesh-list
102342619|NCT00040846|Immunoglobulins|immunoglobulins|mesh-list
102342620|NCT00040846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102342621|NCT00040846|Cyclosporins|cyclosporins|mesh-list
102342622|NCT00040846|Immunologic Factors|immunologic factors|mesh-ancestor
102342623|NCT00040846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342624|NCT00040846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342625|NCT00040846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102342626|NCT00040846|Antimetabolites|antimetabolites|mesh-ancestor
102342627|NCT00040846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342628|NCT00040846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102342629|NCT00040846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102342630|NCT00040846|Antifungal Agents|antifungal agents|mesh-ancestor
102342631|NCT00040846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102342632|NCT00040846|Dermatologic Agents|dermatologic agents|mesh-ancestor
102342633|NCT00040846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102342634|NCT00040846|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102342635|NCT00040846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102342636|NCT00040846|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102342637|NCT00040846|Antitubercular Agents|antitubercular agents|mesh-ancestor
102342638|NCT00040846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102342639|NCT00041938|Aspirin|aspirin|mesh-list
102342640|NCT00041938|Warfarin|warfarin|mesh-list
102342641|NCT00041938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102342642|NCT00041938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102342643|NCT00041938|Analgesics|analgesics|mesh-ancestor
102342644|NCT00041938|Sensory System Agents|sensory system agents|mesh-ancestor
102342645|NCT00041938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102342646|NCT00041938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342647|NCT00041938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102342648|NCT00041938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102342649|NCT00041938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102342650|NCT00041938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102342651|NCT00041938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342652|NCT00041938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102342653|NCT00041938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102342654|NCT00041938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102342655|NCT00041938|Antipyretics|antipyretics|mesh-ancestor
102342656|NCT00041938|Anticoagulants|anticoagulants|mesh-ancestor
102342657|NCT00202930|Rituximab|rituximab|mesh-list
102342658|NCT00202930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102342659|NCT00202930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342660|NCT00202930|Immunologic Factors|immunologic factors|mesh-ancestor
102342661|NCT00202930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342662|NCT00202930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102342663|NCT00044044|Haloperidol|haloperidol|mesh-list
102342664|NCT00044044|Haloperidol decanoate|haloperidol decanoate|mesh-list
102342665|NCT00044044|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102342666|NCT00044044|Antiemetics|antiemetics|mesh-ancestor
102342667|NCT00044044|Autonomic Agents|autonomic agents|mesh-ancestor
102342668|NCT00044044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102342669|NCT00044044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342670|NCT00044044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102342671|NCT00044044|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102342672|NCT00044044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102342673|NCT00044044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102342674|NCT00044044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102342675|NCT00044044|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102342676|NCT00044044|Dopamine Agents|dopamine agents|mesh-ancestor
102342677|NCT00044044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102342678|NCT00044044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342679|NCT00044044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102342680|NCT00044044|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102342681|NCT00044044|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102342682|NCT00044044|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102342683|NCT00044044|Adrenergic Agents|adrenergic agents|mesh-ancestor
102342684|NCT00044044|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102342685|NCT00044044|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102342686|NCT00044044|Serotonin Agents|serotonin agents|mesh-ancestor
102342687|NCT00044044|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102342688|NCT00112918|Leucovorin|leucovorin|mesh-list
102342689|NCT00112918|Bevacizumab|bevacizumab|mesh-list
102342690|NCT00112918|Fluorouracil|fluorouracil|mesh-list
102342691|NCT00112918|Capecitabine|capecitabine|mesh-list
102342692|NCT00112918|Oxaliplatin|oxaliplatin|mesh-list
102342693|NCT00112918|Calcium|calcium|mesh-list
102342694|NCT00112918|Levoleucovorin|levoleucovorin|mesh-list
102342695|NCT00112918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102342696|NCT00112918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342697|NCT00112918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102342698|NCT00112918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102342699|NCT00112918|Growth Substances|growth substances|mesh-ancestor
102342700|NCT00112918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342701|NCT00112918|Growth Inhibitors|growth inhibitors|mesh-ancestor
102342702|NCT00112918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102342703|NCT00112918|Antimetabolites|antimetabolites|mesh-ancestor
102342704|NCT00112918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342705|NCT00112918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102342706|NCT00112918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102342707|NCT00112918|Immunologic Factors|immunologic factors|mesh-ancestor
102342708|NCT00112918|Antidotes|antidotes|mesh-ancestor
102342709|NCT00112918|Protective Agents|protective agents|mesh-ancestor
102342710|NCT00112918|Vitamin B Complex|vitamin b complex|mesh-ancestor
102342711|NCT00112918|Vitamins|vitamins|mesh-ancestor
102342712|NCT00112918|Micronutrients|micronutrients|mesh-ancestor
102342713|NCT00046228|Reteplase|reteplase|mesh-list
102342714|NCT00046228|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102342715|NCT00046228|Abciximab|abciximab|mesh-list
102342716|NCT00046228|Anticoagulants|anticoagulants|mesh-ancestor
102342717|NCT00046228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102342718|NCT00046228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102342719|NCT00046228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102342720|NCT00046228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342721|NCT00205504|Moxifloxacin|moxifloxacin|mesh-list
102342722|NCT00205504|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102342723|NCT00205504|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102342724|NCT00205504|Contraceptive Agents|contraceptive agents|mesh-ancestor
102342725|NCT00205504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102342726|NCT00205504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342727|NCT00205504|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102342728|NCT00205504|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102342729|NCT00205504|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102342730|NCT00205504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102342731|NCT00205504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102342732|NCT00205504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102342733|NCT00205504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102342734|NCT00205504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102342735|NCT00205504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342736|NCT00205504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342737|NCT00113230|Bevacizumab|bevacizumab|mesh-list
102342738|NCT00113230|Capecitabine|capecitabine|mesh-list
102342739|NCT00113230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102342740|NCT00113230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342741|NCT00113230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102342742|NCT00113230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102342743|NCT00113230|Growth Substances|growth substances|mesh-ancestor
102342744|NCT00113230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342745|NCT00113230|Growth Inhibitors|growth inhibitors|mesh-ancestor
102342746|NCT00113230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102342747|NCT00113230|Antimetabolites|antimetabolites|mesh-ancestor
102342748|NCT00113230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342749|NCT00049036|Prednisone|prednisone|mesh-list
102342750|NCT00049036|Cyclophosphamide|cyclophosphamide|mesh-list
102342751|NCT00049036|Rituximab|rituximab|mesh-list
102342752|NCT00049036|Doxorubicin|doxorubicin|mesh-list
102342753|NCT00049036|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102342754|NCT00049036|Etoposide|etoposide|mesh-list
102342755|NCT00049036|Vincristine|vincristine|mesh-list
102342756|NCT00049036|Etoposide phosphate|etoposide phosphate|mesh-list
102342757|NCT00049036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102342758|NCT00049036|Immunologic Factors|immunologic factors|mesh-ancestor
102342759|NCT00049036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342760|NCT00049036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102342761|NCT00049036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102342762|NCT00049036|Alkylating Agents|alkylating agents|mesh-ancestor
102342763|NCT00049036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342764|NCT00049036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342765|NCT00049036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102342766|NCT00049036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102342767|NCT00049036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102342768|NCT00049036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102342769|NCT00049036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102342770|NCT00049036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102342771|NCT00049036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102342772|NCT00049036|Glucocorticoids|glucocorticoids|mesh-ancestor
102342773|NCT00049036|Hormones|hormones|mesh-ancestor
102342774|NCT00049036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102342775|NCT00049036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102342776|NCT00049036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102342777|NCT00049036|Tubulin Modulators|tubulin modulators|mesh-ancestor
102342778|NCT00049036|Antimitotic Agents|antimitotic agents|mesh-ancestor
102342779|NCT00049036|Mitosis Modulators|mitosis modulators|mesh-ancestor
102342780|NCT00049504|Mycophenolic Acid|mycophenolic acid|mesh-list
102342781|NCT00049504|Cyclophosphamide|cyclophosphamide|mesh-list
102342782|NCT00049504|Fludarabine|fludarabine|mesh-list
102342783|NCT00049504|Fludarabine phosphate|fludarabine phosphate|mesh-list
102342784|NCT00049504|Tacrolimus|tacrolimus|mesh-list
102342785|NCT00049504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102342786|NCT00049504|Immunologic Factors|immunologic factors|mesh-ancestor
102342787|NCT00049504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342788|NCT00049504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102342789|NCT00049504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102342790|NCT00049504|Alkylating Agents|alkylating agents|mesh-ancestor
102342791|NCT00049504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342792|NCT00049504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342793|NCT00049504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102342794|NCT00049504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102342795|NCT00049504|Antimetabolites|antimetabolites|mesh-ancestor
102342796|NCT00049504|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102342797|NCT00049504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102342798|NCT00049504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102342799|NCT00049504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102342800|NCT00049504|Antitubercular Agents|antitubercular agents|mesh-ancestor
102342801|NCT00049504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102342802|NCT00049504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102342803|NCT00050986|Temozolomide|temozolomide|mesh-list
102342804|NCT00050986|Tipifarnib|tipifarnib|mesh-list
102342805|NCT00050986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102342806|NCT00050986|Alkylating Agents|alkylating agents|mesh-ancestor
102342807|NCT00050986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342808|NCT00050986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342809|NCT00118144|Bortezomib|bortezomib|mesh-list
102342810|NCT00118144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342811|NCT00118378|Modafinil|modafinil|mesh-list
102342812|NCT00118378|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102342813|NCT00118378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342814|NCT00118378|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102342815|NCT00118378|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102342816|NCT00118378|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102342817|NCT00118378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342818|NCT00217438|Melphalan|melphalan|mesh-list
102342819|NCT00217438|Amifostine|amifostine|mesh-list
102342820|NCT00217438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102342821|NCT00217438|Alkylating Agents|alkylating agents|mesh-ancestor
102342822|NCT00217438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342823|NCT00217438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342824|NCT00217438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102342825|NCT00217438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102342826|NCT00217438|Immunologic Factors|immunologic factors|mesh-ancestor
102342827|NCT00217438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342828|NCT00217438|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102342829|NCT00217438|Protective Agents|protective agents|mesh-ancestor
102342830|NCT04480450|Rituximab|rituximab|mesh-list
102342831|NCT04480450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102342832|NCT04480450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342833|NCT04480450|Immunologic Factors|immunologic factors|mesh-ancestor
102342834|NCT04480450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342835|NCT04480450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102342836|NCT00217594|Alemtuzumab|alemtuzumab|mesh-list
102342837|NCT00217594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102342838|NCT00217594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342839|NCT00052078|Sertraline|sertraline|mesh-list
102342840|NCT00052078|Antidepressive Agents|antidepressive agents|mesh-ancestor
102342841|NCT00052078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102342842|NCT00052078|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102342843|NCT00052078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102342844|NCT00052078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102241628|NCT03070665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102342845|NCT00052078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342846|NCT00052078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102342847|NCT00052078|Serotonin Agents|serotonin agents|mesh-ancestor
102342848|NCT00052078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342849|NCT05820347|Rocuronium|rocuronium|mesh-list
102342850|NCT05820347|Succinylcholine|succinylcholine|mesh-list
102342851|NCT05820347|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102342852|NCT05820347|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102342853|NCT05820347|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102342854|NCT05820347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102342855|NCT05820347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342856|NCT05820347|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
102342857|NCT05820256|Caseins|caseins|mesh-list
102342858|NCT05820256|Chelating Agents|chelating agents|mesh-ancestor
102342859|NCT05820256|Sequestering Agents|sequestering agents|mesh-ancestor
102342860|NCT05820256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342861|NCT05820048|Lansoprazole|lansoprazole|mesh-list
102342862|NCT05820048|Dexlansoprazole|dexlansoprazole|mesh-list
102342863|NCT05820048|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102342864|NCT05820048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102342865|NCT05820048|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102342866|NCT05820048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102342867|NCT05820048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342869|NCT05819983|Permethrin|permethrin|mesh-list
102342870|NCT05819983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102342871|NCT05819983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102342872|NCT05819983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102342873|NCT05819983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342874|NCT05819970|Allyl sulfide|allyl sulfide|mesh-list
102342875|NCT05819970|Antioxidants|antioxidants|mesh-ancestor
102342876|NCT05819970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342877|NCT05819970|Protective Agents|protective agents|mesh-ancestor
102342878|NCT05819970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342879|NCT05819970|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102342880|NCT05819970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342881|NCT05819970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102342882|NCT05819970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102342883|NCT05819632|Curcumin|curcumin|mesh-list
102342884|NCT05819632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102342885|NCT05819632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102342886|NCT05819632|Analgesics|analgesics|mesh-ancestor
102342887|NCT05819632|Sensory System Agents|sensory system agents|mesh-ancestor
102342888|NCT05819632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102342889|NCT05819632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342890|NCT05819632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102342891|NCT05819632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102342892|NCT05819632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342893|NCT05819632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102342894|NCT05819632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342895|NCT05819229|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102342896|NCT05819229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102342897|NCT05819060|Bevacizumab|bevacizumab|mesh-list
102342898|NCT05819060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102342899|NCT05819060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342900|NCT05819060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102342901|NCT05819060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102342902|NCT05819060|Growth Substances|growth substances|mesh-ancestor
102342903|NCT05819060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342904|NCT05819060|Growth Inhibitors|growth inhibitors|mesh-ancestor
102342905|NCT05818995|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102342906|NCT05818995|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
102342907|NCT05818995|Calcium Channel Blockers|calcium channel blockers|mesh-list
102342908|NCT05818995|Angiotensin II|angiotensin ii|mesh-list
102342909|NCT05818995|Giapreza|giapreza|mesh-list
102342910|NCT05818995|Enzyme Inhibitors|enzyme inhibitors|mesh-list
102342911|NCT05818995|Angiotensinogen|angiotensinogen|mesh-list
102342912|NCT05818995|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102342913|NCT05818995|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
102342914|NCT05818995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102342915|NCT05818995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342916|NCT05818995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342917|NCT05818995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102342918|NCT05818995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102342919|NCT05818995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102342920|NCT05818995|Protease Inhibitors|protease inhibitors|mesh-ancestor
102342921|NCT05818995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102342922|NCT05818982|Irinotecan|irinotecan|mesh-list
102342923|NCT05818982|Afatinib|afatinib|mesh-list
102342924|NCT05818982|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102342925|NCT05818982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102342926|NCT05818982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102342927|NCT05818982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342928|NCT05818982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342929|NCT05818982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102342930|NCT05818670|Tadalafil|tadalafil|mesh-list
102342931|NCT05818670|Tamsulosin|tamsulosin|mesh-list
102342932|NCT05818670|Vasodilator Agents|vasodilator agents|mesh-ancestor
102342933|NCT05818670|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102342934|NCT05818670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102342935|NCT05818670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102342936|NCT05818670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342937|NCT05818670|Urological Agents|urological agents|mesh-ancestor
102342938|NCT05818670|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102342939|NCT05818670|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102342940|NCT05818670|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102342941|NCT05818670|Adrenergic Agents|adrenergic agents|mesh-ancestor
102342942|NCT05818670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102342943|NCT05818670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342944|NCT05816512|Chlorhexidine|chlorhexidine|mesh-list
102342945|NCT05816512|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102342946|NCT05816512|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102342947|NCT05816512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102342948|NCT05816512|Disinfectants|disinfectants|mesh-ancestor
102342949|NCT05816512|Dermatologic Agents|dermatologic agents|mesh-ancestor
102342950|NCT05816499|Docetaxel|docetaxel|mesh-list
102342951|NCT05816499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342952|NCT05816499|Tubulin Modulators|tubulin modulators|mesh-ancestor
102342953|NCT05816499|Antimitotic Agents|antimitotic agents|mesh-ancestor
102342954|NCT05816499|Mitosis Modulators|mitosis modulators|mesh-ancestor
102342955|NCT05816499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342956|NCT05816343|Orlistat|orlistat|mesh-list
102342957|NCT05816343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102342958|NCT05816343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342959|NCT05816343|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102342960|NCT05816343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102342961|NCT05816226|Hydrocortisone|hydrocortisone|mesh-list
102342962|NCT05816226|Diclofenac|diclofenac|mesh-list
102342963|NCT05816226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102342964|NCT05816226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102342965|NCT05816226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102342966|NCT05816226|Analgesics|analgesics|mesh-ancestor
102342967|NCT05816226|Sensory System Agents|sensory system agents|mesh-ancestor
102342968|NCT05816226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102342969|NCT05816226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102342970|NCT05816226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102342971|NCT05816226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102342972|NCT05816226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102342973|NCT05816226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342974|NCT05816070|Ofloxacin|ofloxacin|mesh-list
102342975|NCT05816070|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102342976|NCT05816070|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102342977|NCT05816070|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102342978|NCT05816070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102342979|NCT05816070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102342980|NCT05816070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102342981|NCT05816070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102342982|NCT05816070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102342983|NCT05816070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342984|NCT05816070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342985|NCT05816070|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102342986|NCT05816070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102342987|NCT05815927|Pembrolizumab|pembrolizumab|mesh-list
102342988|NCT05815927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102342989|NCT05815927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102342990|NCT05815927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102342991|NCT05815927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102342992|NCT05815901|Febuxostat|febuxostat|mesh-list
102342993|NCT05815901|Gout Suppressants|gout suppressants|mesh-ancestor
102342994|NCT05815901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102342995|NCT05815784|Atropine|atropine|mesh-list
102342996|NCT05815784|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102342997|NCT05815784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102342998|NCT05815784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102342999|NCT05815784|Autonomic Agents|autonomic agents|mesh-ancestor
102343000|NCT05815784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102343001|NCT05815784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343002|NCT05815784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102343003|NCT05815784|Respiratory System Agents|respiratory system agents|mesh-ancestor
102343004|NCT05815784|Mydriatics|mydriatics|mesh-ancestor
102343005|NCT05815784|Parasympatholytics|parasympatholytics|mesh-ancestor
102343006|NCT05815784|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102343007|NCT05815784|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102343008|NCT05815784|Cholinergic Agents|cholinergic agents|mesh-ancestor
102343009|NCT05815784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102343010|NCT05815784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343011|NCT05815719|Hormones|hormones|mesh-list
102343012|NCT05815719|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102343013|NCT05815719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102343014|NCT05815719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343016|NCT05815654|Sensory System Agents|sensory system agents|mesh-ancestor
102343017|NCT05815654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102343018|NCT05815654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343019|NCT05815303|Capecitabine|capecitabine|mesh-list
102343020|NCT05815303|Oxaliplatin|oxaliplatin|mesh-list
102343021|NCT05815303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102343022|NCT05815303|Antimetabolites|antimetabolites|mesh-ancestor
102343023|NCT05815303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343024|NCT05815303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343025|NCT05814874|Selenium|selenium|mesh-list
102343026|NCT05814874|Antioxidants|antioxidants|mesh-ancestor
102343027|NCT05814874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343028|NCT05814874|Protective Agents|protective agents|mesh-ancestor
102343029|NCT05814874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343030|NCT05814874|Trace Elements|trace elements|mesh-ancestor
102343031|NCT05814874|Micronutrients|micronutrients|mesh-ancestor
102343032|NCT05814770|Spironolactone|spironolactone|mesh-list
102343033|NCT05814770|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102343034|NCT05814770|Hormone Antagonists|hormone antagonists|mesh-ancestor
102343035|NCT05814770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102343036|NCT05814770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343037|NCT05814770|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102343038|NCT05814770|Diuretics|diuretics|mesh-ancestor
102343039|NCT05814770|Natriuretic Agents|natriuretic agents|mesh-ancestor
102343040|NCT05814731|Cytarabine|cytarabine|mesh-list
102343041|NCT05814731|Cyclophosphamide|cyclophosphamide|mesh-list
102343042|NCT05814731|Busulfan|busulfan|mesh-list
102343043|NCT05814731|Semustine|semustine|mesh-list
102343044|NCT05814731|Mitoxantrone|mitoxantrone|mesh-list
102343045|NCT05814731|Thymoglobulin|thymoglobulin|mesh-list
102343046|NCT05814731|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102343047|NCT05814731|Immunoglobulins|immunoglobulins|mesh-list
102343048|NCT05814731|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102343049|NCT05814731|Antibodies|antibodies|mesh-list
102343050|NCT05814731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102343051|NCT05814731|Immunologic Factors|immunologic factors|mesh-ancestor
102343052|NCT05814731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343053|NCT05814731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102343054|NCT05814731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102343055|NCT05814731|Alkylating Agents|alkylating agents|mesh-ancestor
102051890|NCT05810909|Calcium|calcium|mesh-list
102343056|NCT05814731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343057|NCT05814731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343058|NCT05814731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102343059|NCT05814731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102343060|NCT05814731|Antimetabolites|antimetabolites|mesh-ancestor
102343061|NCT05814731|Antiviral Agents|antiviral agents|mesh-ancestor
102343062|NCT05814731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102343063|NCT05814731|Analgesics|analgesics|mesh-ancestor
102343064|NCT05814731|Sensory System Agents|sensory system agents|mesh-ancestor
102343065|NCT05814731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102343066|NCT05814731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102343067|NCT05814731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102343068|NCT05814731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102343069|NCT05814718|Cytarabine|cytarabine|mesh-list
102343070|NCT05814718|Etoposide|etoposide|mesh-list
102343071|NCT05814718|Mitoxantrone|mitoxantrone|mesh-list
102343072|NCT05814718|Etoposide phosphate|etoposide phosphate|mesh-list
102343073|NCT05814718|Melphalan|melphalan|mesh-list
102343074|NCT05814718|Carmustine|carmustine|mesh-list
102343075|NCT05814718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102343076|NCT05814718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343077|NCT05814718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102343078|NCT05814718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102343079|NCT05814718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102343080|NCT05814718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343081|NCT05814718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102343082|NCT05814718|Antimetabolites|antimetabolites|mesh-ancestor
102343083|NCT05814718|Antiviral Agents|antiviral agents|mesh-ancestor
102343084|NCT05814718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102343085|NCT05814718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102343086|NCT05814718|Immunologic Factors|immunologic factors|mesh-ancestor
102343087|NCT05814718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343088|NCT05814718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102343089|NCT05814718|Alkylating Agents|alkylating agents|mesh-ancestor
102343090|NCT05814718|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102343091|NCT05814718|Analgesics|analgesics|mesh-ancestor
102343092|NCT05814718|Sensory System Agents|sensory system agents|mesh-ancestor
102343093|NCT05814718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102343094|NCT05814601|Norepinephrine|norepinephrine|mesh-list
102343095|NCT05814601|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102343096|NCT05814601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102343097|NCT05814601|Adrenergic Agents|adrenergic agents|mesh-ancestor
102343098|NCT05814601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102343099|NCT05814601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343100|NCT05814601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343101|NCT05814601|Sympathomimetics|sympathomimetics|mesh-ancestor
102343102|NCT05814601|Autonomic Agents|autonomic agents|mesh-ancestor
102343103|NCT05814601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102343104|NCT05814601|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102343105|NCT05797662|Propranolol|propranolol|mesh-list
102343106|NCT05797662|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102343107|NCT05797662|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102343108|NCT05797662|Adrenergic Agents|adrenergic agents|mesh-ancestor
102343109|NCT05797662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101443131|NCT00203034|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102343110|NCT05797662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343111|NCT05797662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343112|NCT05797662|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102343113|NCT05797662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102343114|NCT05797662|Vasodilator Agents|vasodilator agents|mesh-ancestor
102343115|NCT05795257|Dimercaprol|dimercaprol|mesh-list
102343116|NCT05795257|Chelating Agents|chelating agents|mesh-ancestor
102343117|NCT05795257|Sequestering Agents|sequestering agents|mesh-ancestor
102343118|NCT05795257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343119|NCT05786378|Anesthetics|anesthetics|mesh-list
102343120|NCT05786378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102343121|NCT05786378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343122|NCT05779241|Risperidone|risperidone|mesh-list
102343123|NCT05779241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102343124|NCT05779241|Serotonin Agents|serotonin agents|mesh-ancestor
102343125|NCT05779241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102343126|NCT05779241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343127|NCT05779241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343128|NCT05779241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102343129|NCT05779241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102343130|NCT05779241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102343131|NCT05779241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102343132|NCT05779241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102343133|NCT05779241|Dopamine Agents|dopamine agents|mesh-ancestor
102343134|NCT05766358|Tirzepatide|tirzepatide|mesh-list
102343135|NCT05766358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102343136|NCT05766358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343137|NCT05766358|Incretins|incretins|mesh-ancestor
102343138|NCT05766358|Hormones|hormones|mesh-ancestor
102343139|NCT05766358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102343140|NCT05757557|Nitric Oxide|nitric oxide|mesh-list
102343141|NCT05757557|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102343142|NCT05757557|Autonomic Agents|autonomic agents|mesh-ancestor
102343143|NCT05757557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102343144|NCT05757557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343145|NCT05757557|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102343146|NCT05757557|Respiratory System Agents|respiratory system agents|mesh-ancestor
102343147|NCT05757557|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102343148|NCT05757557|Antioxidants|antioxidants|mesh-ancestor
102343149|NCT05757557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343150|NCT05757557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102343151|NCT05757557|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102343152|NCT05757557|Vasodilator Agents|vasodilator agents|mesh-ancestor
102343153|NCT05757557|Gasotransmitters|gasotransmitters|mesh-ancestor
102343154|NCT05757557|Protective Agents|protective agents|mesh-ancestor
102343155|NCT05751317|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102343156|NCT05751317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102343157|NCT05716984|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
102343158|NCT05716984|Natriuretic Agents|natriuretic agents|mesh-ancestor
102343159|NCT05716984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343160|NCT05700344|Avelumab|avelumab|mesh-list
101941632|NCT01131429|Antimitotic Agents|antimitotic agents|mesh-ancestor
102343161|NCT05700344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102343162|NCT05700344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343164|NCT05688904|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102343165|NCT05688904|Antidepressive Agents|antidepressive agents|mesh-ancestor
102343166|NCT05688904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102343167|NCT05688904|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102343168|NCT05688904|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102343169|NCT05688904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102343170|NCT05688904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343171|NCT05688904|Adrenergic Agents|adrenergic agents|mesh-ancestor
102343172|NCT05688904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102343173|NCT05688904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343174|NCT05687357|Paclitaxel|paclitaxel|mesh-list
102343175|NCT05687357|Oxaliplatin|oxaliplatin|mesh-list
102343176|NCT05687357|Tislelizumab|tislelizumab|mesh-list
102343177|NCT05687357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102343178|NCT05687357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343179|NCT05687357|Tubulin Modulators|tubulin modulators|mesh-ancestor
102343180|NCT05687357|Antimitotic Agents|antimitotic agents|mesh-ancestor
102343181|NCT05687357|Mitosis Modulators|mitosis modulators|mesh-ancestor
102343182|NCT05687357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343183|NCT05687357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102343184|NCT05679492|Meplazumab|meplazumab|mesh-list
102343185|NCT05679492|Antiviral Agents|antiviral agents|mesh-ancestor
102343186|NCT05679492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102343187|NCT05675943|Antibodies|antibodies|mesh-list
102343188|NCT05675943|Immunologic Factors|immunologic factors|mesh-ancestor
102343189|NCT05675943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343190|NCT05619289|Vitamin D|vitamin d|mesh-list
102343191|NCT05619289|Ergocalciferols|ergocalciferols|mesh-list
102343192|NCT05619289|Vitamins|vitamins|mesh-ancestor
102343193|NCT05619289|Micronutrients|micronutrients|mesh-ancestor
102343194|NCT05619289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343195|NCT05619289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102343196|NCT05619289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102343197|NCT05618002|Clonidine|clonidine|mesh-list
102343198|NCT05618002|Lemborexant|lemborexant|mesh-list
102343199|NCT05618002|Zopiclone|zopiclone|mesh-list
102343200|NCT05618002|Analgesics|analgesics|mesh-ancestor
102343201|NCT05618002|Sensory System Agents|sensory system agents|mesh-ancestor
102343202|NCT05618002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102343203|NCT05618002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343204|NCT05618002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102052041|NCT05548660|Analgesics|analgesics|mesh-list
102343205|NCT05618002|Sympatholytics|sympatholytics|mesh-ancestor
102343206|NCT05618002|Autonomic Agents|autonomic agents|mesh-ancestor
102343207|NCT05618002|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102343208|NCT05618002|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102343209|NCT05618002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102343210|NCT05618002|Adrenergic Agents|adrenergic agents|mesh-ancestor
102343211|NCT05618002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102343212|NCT05618002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343213|NCT05618002|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102343214|NCT05618002|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102343215|NCT05618002|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102343216|NCT05618002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102343217|NCT05608005|MF59 oil emulsion|mf59 oil emulsion|mesh-list
102343218|NCT05608005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102343219|NCT05608005|Immunologic Factors|immunologic factors|mesh-ancestor
102343220|NCT05608005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343221|NCT05605470|Vaccines|vaccines|mesh-list
102343222|NCT05605470|Immunologic Factors|immunologic factors|mesh-ancestor
102343223|NCT05605470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343224|NCT05604222|Mirabegron|mirabegron|mesh-list
102343225|NCT05604222|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102343226|NCT05604222|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102343227|NCT05604222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102343228|NCT05604222|Adrenergic Agents|adrenergic agents|mesh-ancestor
102343229|NCT05604222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102343230|NCT05604222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343231|NCT05604222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343232|NCT05604222|Urological Agents|urological agents|mesh-ancestor
102343233|NCT05603910|Pembrolizumab|pembrolizumab|mesh-list
102343234|NCT05603910|Lenvatinib|lenvatinib|mesh-list
102343245|NCT05565222|Temocillin|temocillin|mesh-list
102343246|NCT05565222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102343247|NCT05565222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102343248|NCT05565222|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102343249|NCT05565222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102343250|NCT05565222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343251|NCT05562492|Insulin|insulin|mesh-list
102343252|NCT05562492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102343253|NCT05562492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343265|NCT05483491|Aldesleukin|aldesleukin|mesh-list
102343266|NCT05483491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343267|NCT05483491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102343268|NCT05483491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102343269|NCT05483491|Antiviral Agents|antiviral agents|mesh-ancestor
102343270|NCT05483491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102343271|NCT05482789|Exenatide|exenatide|mesh-list
102343272|NCT05482789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102343273|NCT05482789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343274|NCT05482789|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102343275|NCT05482789|Incretins|incretins|mesh-ancestor
102343276|NCT05482789|Hormones|hormones|mesh-ancestor
102343277|NCT05482789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102343278|NCT05474950|Minocycline|minocycline|mesh-list
102343279|NCT05474950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102343280|NCT05474950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102343281|NCT05664386|Propofol|propofol|mesh-list
102343282|NCT05664386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102343283|NCT05664386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102343284|NCT05664386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343285|NCT05664386|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102343286|NCT05664386|Anesthetics, General|anesthetics, general|mesh-ancestor
102343287|NCT05664386|Anesthetics|anesthetics|mesh-ancestor
102343288|NCT05461404|Emollients|emollients|mesh-list
102343289|NCT05461404|Dermatologic Agents|dermatologic agents|mesh-ancestor
102343290|NCT05449392|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
102343291|NCT05449392|Petrolatum|petrolatum|mesh-list
102343292|NCT05449392|Emollients|emollients|mesh-ancestor
102343293|NCT05449392|Dermatologic Agents|dermatologic agents|mesh-ancestor
102343294|NCT05449392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102343295|NCT05449392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102343296|NCT05449392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102343297|NCT05445076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102343298|NCT05445076|Antibodies|antibodies|mesh-list
102343299|NCT05445076|Immunoglobulins|immunoglobulins|mesh-list
102343300|NCT05445076|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102343301|NCT05445076|Immunologic Factors|immunologic factors|mesh-ancestor
102343302|NCT05445076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343303|NCT05445076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343304|NCT05405439|Prednisone|prednisone|mesh-list
102343305|NCT05405439|Abiraterone Acetate|abiraterone acetate|mesh-list
102343306|NCT05405439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102343307|NCT05405439|Glucocorticoids|glucocorticoids|mesh-ancestor
102343308|NCT05405439|Hormones|hormones|mesh-ancestor
102343309|NCT05405439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102343310|NCT05405439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343311|NCT05405439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102343312|NCT05405439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343313|NCT05405439|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102343314|NCT05405439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102343315|NCT05405439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343316|NCT05405439|Hormone Antagonists|hormone antagonists|mesh-ancestor
102343317|NCT05405439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102343318|NCT05389722|Itraconazole|itraconazole|mesh-list
102343319|NCT05389722|Rifampin|rifampin|mesh-list
102343320|NCT05389722|Digoxin|digoxin|mesh-list
102343321|NCT05389722|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102343322|NCT05389722|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102343323|NCT05389722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102343324|NCT05389722|Antimetabolites|antimetabolites|mesh-ancestor
102343325|NCT05389722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343326|NCT05389722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102343327|NCT05389722|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102343328|NCT05389722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102343329|NCT05389722|Antifungal Agents|antifungal agents|mesh-ancestor
102343330|NCT05389722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102343331|NCT05389722|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102343332|NCT05389722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102343333|NCT05389722|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102343334|NCT05389722|Hormone Antagonists|hormone antagonists|mesh-ancestor
102343335|NCT05389722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102343336|NCT05389722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343337|NCT05389722|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102343338|NCT05389722|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102343339|NCT05389722|Antitubercular Agents|antitubercular agents|mesh-ancestor
102343340|NCT05389722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102343341|NCT05389722|Leprostatic Agents|leprostatic agents|mesh-ancestor
102343342|NCT05389722|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102343343|NCT05389722|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102343344|NCT05389722|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102343345|NCT05389722|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102343346|NCT05389722|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102343347|NCT05389722|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102343348|NCT05389722|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102343349|NCT05389722|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102343350|NCT05389722|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102343351|NCT05389722|Protective Agents|protective agents|mesh-ancestor
102343352|NCT05383170|Pembrolizumab|pembrolizumab|mesh-list
102343353|NCT05383170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102343354|NCT05383170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343355|NCT05383170|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102343356|NCT05383170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343357|NCT05378464|Trastuzumab|trastuzumab|mesh-list
102343358|NCT05378464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102343359|NCT05378464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343360|NCT05373680|Metformin|metformin|mesh-list
102343361|NCT05373680|Empagliflozin|empagliflozin|mesh-list
102343362|NCT05373680|Biguanides|biguanides|mesh-list
102343363|NCT05373680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102343364|NCT05373680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343365|NCT05373680|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102343366|NCT05373680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343367|NCT05353348|Iron|iron|mesh-list
102343368|NCT05353348|Ascorbic Acid|ascorbic acid|mesh-list
102343369|NCT05353348|Epoetin Alfa|epoetin alfa|mesh-list
102343370|NCT05353348|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102343371|NCT05353348|Trace Elements|trace elements|mesh-ancestor
102343372|NCT05353348|Micronutrients|micronutrients|mesh-ancestor
102343373|NCT05353348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343374|NCT05353348|Antioxidants|antioxidants|mesh-ancestor
102343375|NCT05353348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343376|NCT05353348|Protective Agents|protective agents|mesh-ancestor
102343377|NCT05353348|Vitamins|vitamins|mesh-ancestor
102343378|NCT05353348|Hematinics|hematinics|mesh-ancestor
102343379|NCT05304520|Natalizumab|natalizumab|mesh-list
102343380|NCT05304520|Immunologic Factors|immunologic factors|mesh-ancestor
102343381|NCT05304520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343382|NCT05300152|Antibodies|antibodies|mesh-list
102343383|NCT05300152|Immunoglobulins|immunoglobulins|mesh-list
102343384|NCT05300152|Immunologic Factors|immunologic factors|mesh-ancestor
102343392|NCT05294263|Varenicline|varenicline|mesh-list
102343393|NCT05294263|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102343394|NCT05294263|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102343395|NCT05294263|Cholinergic Agents|cholinergic agents|mesh-ancestor
102343396|NCT05294263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102343397|NCT05294263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343398|NCT05294263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343399|NCT05265728|Natalizumab|natalizumab|mesh-list
102343400|NCT05265728|Immunologic Factors|immunologic factors|mesh-ancestor
102343401|NCT05265728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343402|NCT05261594|Caffeine|caffeine|mesh-list
102343403|NCT05261594|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102343404|NCT05261594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343405|NCT05261594|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102343406|NCT05261594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102343407|NCT05261594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343408|NCT05261594|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102343409|NCT05261594|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102343410|NCT05261594|Purinergic Agents|purinergic agents|mesh-ancestor
102343411|NCT05261594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102343412|NCT05256290|Temozolomide|temozolomide|mesh-list
102343413|NCT05256290|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102343414|NCT05256290|Alkylating Agents|alkylating agents|mesh-ancestor
101443151|NCT00198432|Vinorelbine|vinorelbine|mesh-list
102343415|NCT05256290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343416|NCT05256290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343417|NCT05242965|Vaccines|vaccines|mesh-list
102343418|NCT05242965|Sargramostim|sargramostim|mesh-list
102343419|NCT05242965|Immunologic Factors|immunologic factors|mesh-ancestor
102343420|NCT05242965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343421|NCT05241288|Albuterol|albuterol|mesh-list
102343422|NCT05241288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102343423|NCT05241288|Autonomic Agents|autonomic agents|mesh-ancestor
101837167|NCT02532400|Goserelin|goserelin|mesh-list
102343424|NCT05241288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102343425|NCT05241288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343426|NCT05241288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102343427|NCT05241288|Respiratory System Agents|respiratory system agents|mesh-ancestor
102343428|NCT05241288|Tocolytic Agents|tocolytic agents|mesh-ancestor
102343429|NCT05241288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102343430|NCT05241288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102343431|NCT05241288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102343433|NCT05241288|Adrenergic Agents|adrenergic agents|mesh-ancestor
102343434|NCT05241288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102343435|NCT05241288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343436|NCT05220748|Pembrolizumab|pembrolizumab|mesh-list
102343437|NCT05220748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102343438|NCT05220748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343439|NCT05220748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102343440|NCT05220748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343441|NCT05180357|Benralizumab|benralizumab|mesh-list
102343442|NCT05180357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102343443|NCT05180357|Respiratory System Agents|respiratory system agents|mesh-ancestor
102343444|NCT05144542|Nicotine|nicotine|mesh-list
102343445|NCT05144542|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102343446|NCT05144542|Autonomic Agents|autonomic agents|mesh-ancestor
101837218|NCT01060618|Antiviral Agents|antiviral agents|mesh-ancestor
102343447|NCT05144542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102343448|NCT05144542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343449|NCT05144542|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102343450|NCT05144542|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102343451|NCT05144542|Cholinergic Agents|cholinergic agents|mesh-ancestor
102343452|NCT05144542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102343453|NCT05144542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343454|NCT05141708|Talazoparib|talazoparib|mesh-list
102343455|NCT05141708|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102343456|NCT05141708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101837343|NCT00510146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102343457|NCT05141708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343459|NCT05137119|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102343460|NCT05137119|Vancomycin|vancomycin|mesh-list
102343461|NCT05137119|Clindamycin|clindamycin|mesh-list
102343462|NCT05137119|Cefazolin|cefazolin|mesh-list
102343463|NCT05137119|Daptomycin|daptomycin|mesh-list
102343464|NCT05137119|Penicillins|penicillins|mesh-list
102343465|NCT05137119|Penicillin G|penicillin g|mesh-list
102343466|NCT05137119|Lincomycin|lincomycin|mesh-list
102343467|NCT05137119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102343468|NCT05137119|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102343469|NCT05137119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102343470|NCT05137119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343471|NCT05117489|Cortisone|cortisone|mesh-list
102343472|NCT05117489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102343473|NCT05085808|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102343474|NCT05085808|Trazodone|trazodone|mesh-list
102343475|NCT05085808|Antidepressive Agents|antidepressive agents|mesh-ancestor
102343476|NCT05085808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102343477|NCT05085808|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101837776|NCT01015664|Sirolimus|sirolimus|mesh-list
102343478|NCT05085808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102343479|NCT05085808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102343480|NCT05085808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343481|NCT05085808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102343482|NCT05085808|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102343483|NCT05085808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102343484|NCT05085808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101837920|NCT04034862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102343485|NCT05085808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343486|NCT05085808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102343488|NCT05085808|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102343489|NCT05081609|Pembrolizumab|pembrolizumab|mesh-list
102343490|NCT05081609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102343491|NCT05081609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343492|NCT05081609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102343493|NCT05081609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343494|NCT05078944|Donepezil|donepezil|mesh-list
102343495|NCT05078944|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102343496|NCT05078944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102343497|NCT05078944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343498|NCT05078944|Cholinergic Agents|cholinergic agents|mesh-ancestor
102343499|NCT05078944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102343500|NCT05078944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343501|NCT05078944|Nootropic Agents|nootropic agents|mesh-ancestor
102343502|NCT05076019|Atorvastatin|atorvastatin|mesh-list
102343503|NCT05076019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102343504|NCT05076019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102343505|NCT05076019|Antimetabolites|antimetabolites|mesh-ancestor
102343506|NCT05076019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343508|NCT05076019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101838341|NCT01041729|Atorvastatin|atorvastatin|mesh-list
102343509|NCT05076019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102343510|NCT05071937|Talazoparib|talazoparib|mesh-list
102343511|NCT05071937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101838413|NCT03980002|Thalidomide|thalidomide|mesh-list
102343512|NCT05071937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102343513|NCT05071937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343514|NCT05071937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343515|NCT05063097|Carbon Monoxide|carbon monoxide|mesh-list
102343516|NCT05063097|Antimetabolites|antimetabolites|mesh-ancestor
101838555|NCT00465972|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102343517|NCT05063097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343518|NCT05063097|Gasotransmitters|gasotransmitters|mesh-ancestor
101838629|NCT00412893|Voriconazole|voriconazole|mesh-list
102343519|NCT05063097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102343520|NCT05063097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343521|NCT05059470|Pembrolizumab|pembrolizumab|mesh-list
102343522|NCT05059470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102343523|NCT05059470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343524|NCT05059470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102343525|NCT05059470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343526|NCT05036005|Pertuzumab|pertuzumab|mesh-list
102343527|NCT05036005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102343528|NCT05036005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343529|NCT05033769|Paclitaxel|paclitaxel|mesh-list
102343530|NCT05033769|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102343531|NCT05033769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102343532|NCT05033769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343533|NCT05033769|Tubulin Modulators|tubulin modulators|mesh-ancestor
102343534|NCT05033769|Antimitotic Agents|antimitotic agents|mesh-ancestor
102343535|NCT05033769|Mitosis Modulators|mitosis modulators|mesh-ancestor
102343536|NCT05033769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343538|NCT05019846|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102343539|NCT05019846|Androgen Antagonists|androgen antagonists|mesh-ancestor
102343540|NCT05019846|Hormone Antagonists|hormone antagonists|mesh-ancestor
102343541|NCT05019846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102343542|NCT05019846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343543|NCT05019846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343544|NCT05019846|Luteolytic Agents|luteolytic agents|mesh-ancestor
102343545|NCT05019846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102343546|NCT05019846|Contraceptive Agents|contraceptive agents|mesh-ancestor
102343547|NCT05019846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102343548|NCT05019846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102343549|NCT05019846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102343550|NCT05004025|Nivolumab|nivolumab|mesh-list
102343551|NCT05004025|Ipilimumab|ipilimumab|mesh-list
102343552|NCT05004025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102343553|NCT05004025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343554|NCT05004025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102343555|NCT05004025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343556|NCT04998240|Myeloma Proteins|myeloma proteins|mesh-list
102343557|NCT04998240|Paraproteins|paraproteins|mesh-list
102343558|NCT04998240|Immunologic Factors|immunologic factors|mesh-ancestor
102343559|NCT04998240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343560|NCT04996823|Ipilimumab|ipilimumab|mesh-list
102343561|NCT04996823|Axitinib|axitinib|mesh-list
102343562|NCT04996823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102343563|NCT04996823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343564|NCT04996823|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102343565|NCT04996823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343566|NCT04996823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102343568|NCT04984759|Primaquine|primaquine|mesh-list
102343569|NCT04984759|Tafenoquine|tafenoquine|mesh-list
102343570|NCT04984759|Antimalarials|antimalarials|mesh-ancestor
102343571|NCT04984759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102343572|NCT04984759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102343573|NCT04984759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102343574|NCT04955743|Pembrolizumab|pembrolizumab|mesh-list
102343575|NCT04955743|Lenvatinib|lenvatinib|mesh-list
102343576|NCT04955743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102343577|NCT04955743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343578|NCT04955743|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101839088|NCT00490490|Iodine|iodine|mesh-list
101839096|NCT00490490|Hemostatics|hemostatics|mesh-ancestor
102343579|NCT04955743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343580|NCT04955743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102343581|NCT04955743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102343582|NCT04952324|Folic Acid|folic acid|mesh-list
102343583|NCT04952324|Vitamin B 12|vitamin b 12|mesh-list
102343584|NCT04952324|Hydroxocobalamin|hydroxocobalamin|mesh-list
102343586|NCT04952324|Micronutrients|micronutrients|mesh-ancestor
101839225|NCT00560573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102343587|NCT04952324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343588|NCT04952324|Hematinics|hematinics|mesh-ancestor
102343589|NCT04952324|Vitamin B Complex|vitamin b complex|mesh-ancestor
102343590|NCT04951726|Neostigmine|neostigmine|mesh-list
102343591|NCT04951726|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102343592|NCT04951726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102343593|NCT04951726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343594|NCT04951726|Cholinergic Agents|cholinergic agents|mesh-ancestor
101839452|NCT00942617|Aspirin|aspirin|mesh-list
102343595|NCT04951726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102343596|NCT04951726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343597|NCT04951726|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102343598|NCT04951726|Autonomic Agents|autonomic agents|mesh-ancestor
102343599|NCT04951726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102343600|NCT04950764|Seladelpar|seladelpar|mesh-list
102343601|NCT04950764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102343602|NCT04950764|Antimetabolites|antimetabolites|mesh-ancestor
102343603|NCT04950764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343604|NCT04950764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102343605|NCT04948892|Anesthetics|anesthetics|mesh-list
102343606|NCT04948892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102343607|NCT04948892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343608|NCT04943341|Triamcinolone|triamcinolone|mesh-list
101839587|NCT01045083|Dopamine Agents|dopamine agents|mesh-ancestor
102343609|NCT04943341|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102343610|NCT04943341|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102343611|NCT04943341|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102343612|NCT04943341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102343613|NCT04943341|Glucocorticoids|glucocorticoids|mesh-ancestor
102343614|NCT04943341|Hormones|hormones|mesh-ancestor
102343615|NCT04943341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102343616|NCT04943341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343617|NCT04943341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102343618|NCT04943341|Immunologic Factors|immunologic factors|mesh-ancestor
101839797|NCT00467142|Vitamins|vitamins|mesh-ancestor
102343619|NCT04943341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102343620|NCT04943341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343621|NCT04941664|Levobupivacaine|levobupivacaine|mesh-list
102343622|NCT04941664|Anesthetics, Local|anesthetics, local|mesh-ancestor
102343623|NCT04941664|Anesthetics|anesthetics|mesh-ancestor
102343624|NCT04941664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102343625|NCT04941664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343626|NCT04941664|Sensory System Agents|sensory system agents|mesh-ancestor
101839937|NCT00299104|Antimetabolites|antimetabolites|mesh-ancestor
102343627|NCT04941664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102343628|NCT04930562|Belumosudil|belumosudil|mesh-list
102343629|NCT04930562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102343630|NCT04930562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102343631|NCT04930562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343632|NCT04926571|Dexamethasone|dexamethasone|mesh-list
102343633|NCT04926571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102343634|NCT04926571|Antiemetics|antiemetics|mesh-ancestor
102343635|NCT04926571|Autonomic Agents|autonomic agents|mesh-ancestor
102343636|NCT04926571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101840227|NCT00452400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102343637|NCT04926571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343638|NCT04926571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102343639|NCT04926571|Glucocorticoids|glucocorticoids|mesh-ancestor
102343641|NCT04926571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102343642|NCT04926571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102343643|NCT04926571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343644|NCT04919382|Temozolomide|temozolomide|mesh-list
102343645|NCT04919382|Atezolizumab|atezolizumab|mesh-list
102343646|NCT04919382|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102343647|NCT04919382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102343648|NCT04919382|Alkylating Agents|alkylating agents|mesh-ancestor
102343649|NCT04919382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840587|NCT00312208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102343650|NCT04919382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343651|NCT04919382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102343652|NCT04919382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102343653|NCT04919382|Immunologic Factors|immunologic factors|mesh-ancestor
102343654|NCT04919382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343655|NCT04918823|Cyclosporine|cyclosporine|mesh-list
102343656|NCT04918823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102343657|NCT04918823|Cyclosporins|cyclosporins|mesh-list
102343658|NCT04918823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840873|NCT02748707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102343659|NCT04918823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343660|NCT04918823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102343661|NCT04918823|Immunologic Factors|immunologic factors|mesh-ancestor
102343662|NCT04918823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343663|NCT04918823|Antifungal Agents|antifungal agents|mesh-ancestor
102343664|NCT04918823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102343665|NCT04918823|Dermatologic Agents|dermatologic agents|mesh-ancestor
102343666|NCT04918823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102343667|NCT04918823|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102343668|NCT04918823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102343670|NCT04909073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343671|NCT04909073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102343672|NCT04909073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102343673|NCT04909073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343674|NCT04833855|Omalizumab|omalizumab|mesh-list
102343675|NCT04833855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102343676|NCT04833855|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102343677|NCT04833855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102343678|NCT04833855|Respiratory System Agents|respiratory system agents|mesh-ancestor
102343679|NCT04833855|Immunologic Factors|immunologic factors|mesh-ancestor
102343680|NCT04833855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343681|NCT04792385|Drospirenone|drospirenone|mesh-list
102343682|NCT04792385|Contraceptive Agents|contraceptive agents|mesh-list
102343683|NCT04792385|Contraceptives, Oral|contraceptives, oral|mesh-list
102343684|NCT04792385|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
101443174|NCT02072161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102343685|NCT04792385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102343686|NCT04792385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343687|NCT04792385|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102343688|NCT04792385|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102343689|NCT04792385|Hormone Antagonists|hormone antagonists|mesh-ancestor
102343690|NCT04792385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101841365|NCT00964535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102343691|NCT04792385|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102343692|NCT04792385|Diuretics|diuretics|mesh-ancestor
102343693|NCT04792385|Natriuretic Agents|natriuretic agents|mesh-ancestor
102343694|NCT04785651|Tranexamic Acid|tranexamic acid|mesh-list
102343695|NCT04785651|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102343696|NCT04785651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102343697|NCT04785651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343699|NCT04785651|Coagulants|coagulants|mesh-ancestor
102343700|NCT04780204|Tenofovir|tenofovir|mesh-list
102343701|NCT04780204|Antiviral Agents|antiviral agents|mesh-ancestor
102343702|NCT04780204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102343703|NCT04780204|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102343704|NCT04780204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102343705|NCT04780204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102343706|NCT04780204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343707|NCT04780204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102343708|NCT04780204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102343709|NCT04763564|Liraglutide|liraglutide|mesh-list
102343710|NCT04763564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101841941|NCT00975767|Tubulin Modulators|tubulin modulators|mesh-ancestor
102343711|NCT04763564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343712|NCT04763564|Incretins|incretins|mesh-ancestor
102343713|NCT04763564|Hormones|hormones|mesh-ancestor
101842011|NCT03923933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343714|NCT04763564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102343715|NCT04748588|Sotrovimab|sotrovimab|mesh-list
102343716|NCT04748588|Bamlanivimab|bamlanivimab|mesh-list
102343717|NCT04748588|Antiviral Agents|antiviral agents|mesh-ancestor
102343718|NCT04748588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102343719|NCT04741997|Nivolumab|nivolumab|mesh-list
101842157|NCT00271024|Sensory System Agents|sensory system agents|mesh-ancestor
102343720|NCT04741997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101842229|NCT00981773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102343721|NCT04741997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343722|NCT04741997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101842360|NCT00364611|Bevacizumab|bevacizumab|mesh-list
102343723|NCT04741997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842516|NCT00543725|Efavirenz|efavirenz|mesh-list
102343725|NCT04735510|Cyclosporins|cyclosporins|mesh-list
102343726|NCT04735510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102343727|NCT04735510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343728|NCT04735510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102343729|NCT04735510|Immunologic Factors|immunologic factors|mesh-ancestor
102343730|NCT04735510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343731|NCT04735510|Antifungal Agents|antifungal agents|mesh-ancestor
102343732|NCT04735510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102343733|NCT04735510|Dermatologic Agents|dermatologic agents|mesh-ancestor
102343734|NCT04735510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102343735|NCT04735510|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102343737|NCT04696523|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101842647|NCT00363051|Everolimus|everolimus|mesh-list
102343738|NCT04696523|Anesthetics, General|anesthetics, general|mesh-ancestor
102343739|NCT04696523|Anesthetics|anesthetics|mesh-ancestor
102343740|NCT04696523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102343741|NCT04696523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343742|NCT04655222|Interferons|interferons|mesh-list
102343743|NCT04655222|Interferon-beta|interferon-beta|mesh-list
102343744|NCT04655222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343745|NCT04655222|Antiviral Agents|antiviral agents|mesh-ancestor
101842789|NCT00456846|Paclitaxel|paclitaxel|mesh-list
102343746|NCT04655222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102343747|NCT04655222|Immunologic Factors|immunologic factors|mesh-ancestor
102343748|NCT04655222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343749|NCT04652440|Tislelizumab|tislelizumab|mesh-list
102343750|NCT04652440|Antibodies|antibodies|mesh-list
102343751|NCT04652440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102343752|NCT04652440|Immunologic Factors|immunologic factors|mesh-ancestor
102343753|NCT04652440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343754|NCT04652440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102343755|NCT04652440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343756|NCT04615013|Leucovorin|leucovorin|mesh-list
102343757|NCT04615013|Paclitaxel|paclitaxel|mesh-list
102343758|NCT04615013|Docetaxel|docetaxel|mesh-list
102343759|NCT04615013|Carboplatin|carboplatin|mesh-list
102343760|NCT04615013|Fluorouracil|fluorouracil|mesh-list
102343761|NCT04615013|Capecitabine|capecitabine|mesh-list
102343762|NCT04615013|Oxaliplatin|oxaliplatin|mesh-list
102343763|NCT04615013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102343764|NCT04615013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102343765|NCT04615013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343766|NCT04615013|Tubulin Modulators|tubulin modulators|mesh-ancestor
102343767|NCT04615013|Antimitotic Agents|antimitotic agents|mesh-ancestor
102343768|NCT04615013|Mitosis Modulators|mitosis modulators|mesh-ancestor
101843147|NCT00370071|Immunologic Factors|immunologic factors|mesh-ancestor
102343769|NCT04615013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343770|NCT04615013|Antimetabolites|antimetabolites|mesh-ancestor
102343771|NCT04615013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102343772|NCT04615013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102343773|NCT04615013|Immunologic Factors|immunologic factors|mesh-ancestor
102343774|NCT04615013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343775|NCT04615013|Antidotes|antidotes|mesh-ancestor
102343776|NCT04615013|Protective Agents|protective agents|mesh-ancestor
101843278|NCT01019642|Vitamins|vitamins|mesh-ancestor
102343777|NCT04615013|Vitamin B Complex|vitamin b complex|mesh-ancestor
102343778|NCT04615013|Vitamins|vitamins|mesh-ancestor
102343779|NCT04615013|Micronutrients|micronutrients|mesh-ancestor
102343780|NCT04612725|Benralizumab|benralizumab|mesh-list
102343781|NCT04612725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102343782|NCT04612725|Respiratory System Agents|respiratory system agents|mesh-ancestor
102343783|NCT04604067|Acalabrutinib|acalabrutinib|mesh-list
102343784|NCT04604067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343785|NCT04592744|Vasopressins|vasopressins|mesh-list
102343786|NCT04592744|Epinephrine|epinephrine|mesh-list
102343787|NCT04592744|Norepinephrine|norepinephrine|mesh-list
102343788|NCT04592744|Angiotensin II|angiotensin ii|mesh-list
102343789|NCT04592744|Giapreza|giapreza|mesh-list
102343790|NCT04592744|Angiotensinogen|angiotensinogen|mesh-list
102343791|NCT04592744|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101843495|NCT00984347|Oxytocin|oxytocin|mesh-list
102343792|NCT04592744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102343793|NCT04592744|Adrenergic Agents|adrenergic agents|mesh-ancestor
102343794|NCT04592744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101843634|NCT00541229|Incretins|incretins|mesh-ancestor
102343795|NCT04592744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343796|NCT04592744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843707|NCT01017926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102343797|NCT04592744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102343798|NCT04592744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102343799|NCT04592744|Autonomic Agents|autonomic agents|mesh-ancestor
102343800|NCT04592744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102343801|NCT04592744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102343802|NCT04592744|Respiratory System Agents|respiratory system agents|mesh-ancestor
102343803|NCT04592744|Mydriatics|mydriatics|mesh-ancestor
102343804|NCT04592744|Sympathomimetics|sympathomimetics|mesh-ancestor
102343805|NCT04592744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102343806|NCT04592744|Hemostatics|hemostatics|mesh-ancestor
102343807|NCT04592744|Coagulants|coagulants|mesh-ancestor
102343808|NCT04592744|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102343809|NCT04592744|Natriuretic Agents|natriuretic agents|mesh-ancestor
101843993|NCT01071304|Midazolam|midazolam|mesh-list
102343810|NCT04592744|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102343811|NCT04592744|Protease Inhibitors|protease inhibitors|mesh-ancestor
102343812|NCT04592744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102343813|NCT04585711|Etanercept|etanercept|mesh-list
102343814|NCT04585711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102343815|NCT04585711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102343816|NCT04585711|Analgesics|analgesics|mesh-ancestor
102343817|NCT04585711|Sensory System Agents|sensory system agents|mesh-ancestor
101844288|NCT02534337|Leucovorin|leucovorin|mesh-list
102343818|NCT04585711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102343819|NCT04585711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343820|NCT04585711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102343822|NCT04585711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102343823|NCT04585711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102343824|NCT04585711|Immunologic Factors|immunologic factors|mesh-ancestor
102343825|NCT04581824|Pembrolizumab|pembrolizumab|mesh-list
102343826|NCT04581824|Dostarlimab|dostarlimab|mesh-list
102343827|NCT04581824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102343828|NCT04581824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101844666|NCT05590559|Morphine|morphine|mesh-list
102343829|NCT04581824|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102343830|NCT04581824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343831|NCT04559334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102343832|NCT04551495|Letrozole|letrozole|mesh-list
102343833|NCT04551495|Goserelin|goserelin|mesh-list
102343834|NCT04551495|Entrectinib|entrectinib|mesh-list
102343835|NCT04551495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343836|NCT04551495|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101844800|NCT03896477|Vaccines|vaccines|mesh-list
102343837|NCT04551495|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102343838|NCT04551495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101844868|NCT05440487|Chelating Agents|chelating agents|mesh-list
102343839|NCT04551495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343840|NCT04551495|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102343841|NCT04551495|Hormone Antagonists|hormone antagonists|mesh-ancestor
102343842|NCT04551495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101845016|NCT04994561|Niacinamide|niacinamide|mesh-list
102343843|NCT04551495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343844|NCT04551495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102343845|NCT04551495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102343846|NCT04545424|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
102343847|NCT04545424|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102343848|NCT04545424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101845163|NCT00438672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343849|NCT04545424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343851|NCT04501718|Temozolomide|temozolomide|mesh-list
102343852|NCT04501718|Apatinib|apatinib|mesh-list
102343853|NCT04501718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102343854|NCT04501718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343855|NCT04501718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102343856|NCT04501718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102343857|NCT04501718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102343858|NCT04501718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343859|NCT04501718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102343860|NCT04501718|Alkylating Agents|alkylating agents|mesh-ancestor
102343861|NCT04501718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102343863|NCT04501705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343864|NCT04501705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102343865|NCT04501705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102343866|NCT04501705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343867|NCT04463394|Vasopressins|vasopressins|mesh-list
102343868|NCT04463394|Arginine Vasopressin|arginine vasopressin|mesh-list
102343869|NCT04463394|Hemostatics|hemostatics|mesh-ancestor
102343870|NCT04463394|Coagulants|coagulants|mesh-ancestor
102343871|NCT04463394|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102343872|NCT04463394|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102343873|NCT04463394|Natriuretic Agents|natriuretic agents|mesh-ancestor
102343874|NCT04463394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343875|NCT04454905|Apatinib|apatinib|mesh-list
102343876|NCT04454905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343877|NCT04454905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102343878|NCT04454905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102343879|NCT04454905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343880|NCT04436601|Lactulose|lactulose|mesh-list
102343881|NCT04436601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102343882|NCT04373785|Temozolomide|temozolomide|mesh-list
102343883|NCT04373785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102343884|NCT04373785|Alkylating Agents|alkylating agents|mesh-ancestor
102343885|NCT04373785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343886|NCT04373785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343887|NCT04312997|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
102343888|NCT04312997|Respiratory System Agents|respiratory system agents|mesh-ancestor
102343889|NCT04309552|Alovudine|alovudine|mesh-list
102343890|NCT04309552|Antiviral Agents|antiviral agents|mesh-ancestor
102343891|NCT04309552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102343892|NCT04275180|Argatroban|argatroban|mesh-list
102343893|NCT04275180|Antithrombins|antithrombins|mesh-ancestor
102343894|NCT04275180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102343895|NCT04275180|Protease Inhibitors|protease inhibitors|mesh-ancestor
102343896|NCT04275180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102343897|NCT04275180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343898|NCT04275180|Anticoagulants|anticoagulants|mesh-ancestor
102343899|NCT04275180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102343900|NCT04271332|Baclofen|baclofen|mesh-list
102343901|NCT04271332|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102343902|NCT04271332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343903|NCT04271332|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102343904|NCT04271332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102343905|NCT04271332|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102343906|NCT04271332|GABA Agonists|gaba agonists|mesh-ancestor
102343907|NCT04271332|GABA Agents|gaba agents|mesh-ancestor
102343908|NCT04271332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102343909|NCT04271332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343910|NCT04267978|Irinotecan|irinotecan|mesh-list
102343911|NCT04267978|Temozolomide|temozolomide|mesh-list
102343912|NCT04267978|Endostatins|endostatins|mesh-list
102343913|NCT04267978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102343914|NCT04267978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102343915|NCT04267978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102343916|NCT04267978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343917|NCT04267978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343918|NCT04267978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102343919|NCT04267978|Alkylating Agents|alkylating agents|mesh-ancestor
102343920|NCT04267978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102343921|NCT04267978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102343922|NCT04267978|Growth Substances|growth substances|mesh-ancestor
102343923|NCT04267978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343924|NCT04267978|Growth Inhibitors|growth inhibitors|mesh-ancestor
102343925|NCT04230252|Acetaminophen|acetaminophen|mesh-list
102343926|NCT04230252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102343927|NCT04230252|Analgesics|analgesics|mesh-ancestor
102343928|NCT04230252|Sensory System Agents|sensory system agents|mesh-ancestor
102343929|NCT04230252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102343930|NCT04230252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343931|NCT04230252|Antipyretics|antipyretics|mesh-ancestor
102343932|NCT04217317|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102343933|NCT04217317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102343934|NCT04217317|Alkylating Agents|alkylating agents|mesh-ancestor
102343935|NCT04217317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343936|NCT04217317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343937|NCT04189263|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102343938|NCT04189263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102343939|NCT04189263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102343940|NCT04189263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845713|NCT04001465|Miotics|miotics|mesh-ancestor
102343941|NCT04189263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102343942|NCT04189263|Hormone Antagonists|hormone antagonists|mesh-ancestor
102343943|NCT04189263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102343944|NCT04189263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343945|NCT04140396|Lidocaine|lidocaine|mesh-list
102343946|NCT04140396|Anesthetics, Local|anesthetics, local|mesh-ancestor
102343947|NCT04140396|Anesthetics|anesthetics|mesh-ancestor
102343948|NCT04140396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102343949|NCT04140396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343950|NCT04140396|Sensory System Agents|sensory system agents|mesh-ancestor
102343951|NCT04140396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102343952|NCT04140396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102343953|NCT04140396|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102343954|NCT04140396|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102343955|NCT04140396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101845736|NCT00992381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102343956|NCT04140396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343958|NCT04117178|Donepezil|donepezil|mesh-list
102343959|NCT04117178|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102343960|NCT04117178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102343961|NCT04117178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343962|NCT04117178|Cholinergic Agents|cholinergic agents|mesh-ancestor
102343963|NCT04117178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102343964|NCT04117178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343965|NCT04117178|Nootropic Agents|nootropic agents|mesh-ancestor
102343966|NCT04117178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102343967|NCT04117178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102343968|NCT04117178|Dopamine Agents|dopamine agents|mesh-ancestor
102343969|NCT04117178|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102343970|NCT04117178|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102343971|NCT04099836|Bevacizumab|bevacizumab|mesh-list
102343972|NCT04099836|Atezolizumab|atezolizumab|mesh-list
101845875|NCT00995423|Paclitaxel|paclitaxel|mesh-list
102343973|NCT04099836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102343974|NCT04099836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343975|NCT04099836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102343976|NCT04099836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102343977|NCT04099836|Growth Substances|growth substances|mesh-ancestor
102343978|NCT04099836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343979|NCT04099836|Growth Inhibitors|growth inhibitors|mesh-ancestor
102343980|NCT04099836|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102343981|NCT04099836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102343982|NCT04094961|Dexamethasone|dexamethasone|mesh-list
102343983|NCT04094961|Dexamethasone acetate|dexamethasone acetate|mesh-list
102343984|NCT04094961|Pomalidomide|pomalidomide|mesh-list
102343985|NCT04094961|Ixazomib|ixazomib|mesh-list
102343986|NCT04094961|BB 1101|bb 1101|mesh-list
102343987|NCT04094961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102343988|NCT04094961|Antiemetics|antiemetics|mesh-ancestor
102343989|NCT04094961|Autonomic Agents|autonomic agents|mesh-ancestor
102343990|NCT04094961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102343991|NCT04094961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102343992|NCT04094961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102343994|NCT04094961|Hormones|hormones|mesh-ancestor
102343995|NCT04094961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102343996|NCT04094961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102343997|NCT04094961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102343998|NCT04094961|Protease Inhibitors|protease inhibitors|mesh-ancestor
102343999|NCT04094961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102344000|NCT04094961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344001|NCT04094961|Immunologic Factors|immunologic factors|mesh-ancestor
102344002|NCT04094961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102344003|NCT04094961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102344004|NCT04094961|Growth Substances|growth substances|mesh-ancestor
102344005|NCT04094961|Growth Inhibitors|growth inhibitors|mesh-ancestor
102344006|NCT04025216|Cyclophosphamide|cyclophosphamide|mesh-list
102344007|NCT04025216|Fludarabine|fludarabine|mesh-list
102344008|NCT04025216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102344009|NCT04025216|Immunologic Factors|immunologic factors|mesh-ancestor
102344010|NCT04025216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344011|NCT04025216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102344012|NCT04025216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102344013|NCT04025216|Alkylating Agents|alkylating agents|mesh-ancestor
102344014|NCT04025216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344015|NCT04025216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344016|NCT04025216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102344017|NCT04020185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102344018|NCT04020185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344019|NCT04020185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101846337|NCT00997607|Vaccines|vaccines|mesh-list
102344020|NCT04020185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344021|NCT03991936|Triamcinolone|triamcinolone|mesh-list
102344022|NCT03991936|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101846413|NCT05239637|Heparin|heparin|mesh-list
101846472|NCT00530777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102344023|NCT03991936|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101846548|NCT00999791|Diclofenac|diclofenac|mesh-list
102344024|NCT03991936|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102344025|NCT03991936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102344026|NCT03991936|Glucocorticoids|glucocorticoids|mesh-ancestor
102344027|NCT03991936|Hormones|hormones|mesh-ancestor
102344028|NCT03991936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101846622|NCT01009073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344029|NCT03991936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344030|NCT03991936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102344031|NCT03991936|Immunologic Factors|immunologic factors|mesh-ancestor
102344032|NCT03991936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102344033|NCT03991936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344034|NCT03982082|Coal Tar|coal tar|mesh-list
102344035|NCT03982082|Keratolytic Agents|keratolytic agents|mesh-ancestor
102344036|NCT03982082|Dermatologic Agents|dermatologic agents|mesh-ancestor
102344037|NCT03979599|Magnesium Sulfate|magnesium sulfate|mesh-list
102344038|NCT03979599|Levobupivacaine|levobupivacaine|mesh-list
102344040|NCT03979599|Sensory System Agents|sensory system agents|mesh-ancestor
102344041|NCT03979599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102344042|NCT03979599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344044|NCT03979599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102344045|NCT03979599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102344046|NCT03979599|Anticonvulsants|anticonvulsants|mesh-ancestor
102344047|NCT03979599|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102344048|NCT03979599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102344049|NCT03979599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344050|NCT03979599|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102344052|NCT03979599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102344053|NCT03979599|Anesthetics, Local|anesthetics, local|mesh-ancestor
102344054|NCT03966651|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102344055|NCT03966651|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102344056|NCT03966651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344057|NCT03946514|Losartan|losartan|mesh-list
102344058|NCT03946514|Amlodipine|amlodipine|mesh-list
102344059|NCT03946514|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102344060|NCT03946514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102344061|NCT03946514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102344062|NCT03946514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102344063|NCT03946514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344064|NCT03946514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102344065|NCT03946514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344066|NCT03946514|Vasodilator Agents|vasodilator agents|mesh-ancestor
102344067|NCT03946514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102344068|NCT03946514|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102344069|NCT03946514|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102344070|NCT03946514|Diuretics|diuretics|mesh-ancestor
102344071|NCT03946514|Natriuretic Agents|natriuretic agents|mesh-ancestor
102344072|NCT03946514|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102344073|NCT03935958|Curcumin|curcumin|mesh-list
102344074|NCT03935958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101847545|NCT01027520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102344075|NCT03935958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102344077|NCT03935958|Sensory System Agents|sensory system agents|mesh-ancestor
102344078|NCT03935958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102344079|NCT03935958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344080|NCT03935958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101847687|NCT01323374|Dopamine Agents|dopamine agents|mesh-ancestor
102344081|NCT03935958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102344082|NCT03935958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344083|NCT03935958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102344084|NCT03935958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344085|NCT03935295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102344086|NCT03935295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101847904|NCT00449930|Incretins|incretins|mesh-ancestor
102344087|NCT03935295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102344088|NCT03935295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102344089|NCT03935295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848062|NCT00418938|Vitamins|vitamins|mesh-ancestor
102344090|NCT03935295|Cholinergic Agents|cholinergic agents|mesh-ancestor
101307964|NCT02044952|Mesalamine|mesalamine|mesh-list
102344091|NCT03935295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102344092|NCT03935295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344093|NCT03935295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102344094|NCT03935295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101848246|NCT01030094|Topiramate|topiramate|mesh-list
102344096|NCT03915444|Gemcitabine|gemcitabine|mesh-list
102344097|NCT03915444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102344098|NCT03915444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344099|NCT03915444|Tubulin Modulators|tubulin modulators|mesh-ancestor
102344100|NCT03915444|Antimitotic Agents|antimitotic agents|mesh-ancestor
102344101|NCT03915444|Mitosis Modulators|mitosis modulators|mesh-ancestor
102344102|NCT03915444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344103|NCT03915444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102344104|NCT03915444|Antimetabolites|antimetabolites|mesh-ancestor
102344105|NCT03892785|Prednisone|prednisone|mesh-list
102344106|NCT03892785|Methotrexate|methotrexate|mesh-list
102344107|NCT03892785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102344108|NCT03892785|Glucocorticoids|glucocorticoids|mesh-ancestor
102344109|NCT03892785|Hormones|hormones|mesh-ancestor
102344110|NCT03892785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102344111|NCT03892785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344112|NCT03892785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101848416|NCT00439556|Podophyllotoxin|podophyllotoxin|mesh-list
102344113|NCT03892785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101848483|NCT00455312|Methylprednisolone|methylprednisolone|mesh-list
102344114|NCT03892785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102344115|NCT03892785|Abortifacient Agents|abortifacient agents|mesh-ancestor
102344116|NCT03892785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102344117|NCT03892785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102344118|NCT03892785|Antimetabolites|antimetabolites|mesh-ancestor
102344119|NCT03892785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344120|NCT03892785|Dermatologic Agents|dermatologic agents|mesh-ancestor
102344121|NCT03892785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102344122|NCT03892785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102344123|NCT03892785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102344124|NCT03892785|Immunologic Factors|immunologic factors|mesh-ancestor
102344125|NCT03892785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102344126|NCT03892785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102344127|NCT03869034|Leucovorin|leucovorin|mesh-list
102344128|NCT03869034|Fluorouracil|fluorouracil|mesh-list
102344129|NCT03869034|Oxaliplatin|oxaliplatin|mesh-list
102344130|NCT03869034|Antimetabolites|antimetabolites|mesh-ancestor
102344131|NCT03869034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344132|NCT03869034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102344133|NCT03869034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344134|NCT03869034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102344135|NCT03869034|Immunologic Factors|immunologic factors|mesh-ancestor
101848564|NCT00444626|Immunologic Factors|immunologic factors|mesh-ancestor
102344136|NCT03869034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344138|NCT03869034|Protective Agents|protective agents|mesh-ancestor
102344139|NCT03869034|Vitamin B Complex|vitamin b complex|mesh-ancestor
102344140|NCT03869034|Vitamins|vitamins|mesh-ancestor
102344141|NCT03869034|Micronutrients|micronutrients|mesh-ancestor
102344142|NCT03841097|Tacrolimus|tacrolimus|mesh-list
102344143|NCT03841097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102344144|NCT03841097|Immunologic Factors|immunologic factors|mesh-ancestor
101848755|NCT00436280|Rituximab|rituximab|mesh-list
102344145|NCT03841097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344146|NCT03841097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102344147|NCT03841097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102344148|NCT03841097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344149|NCT03831425|Ubiquinone|ubiquinone|mesh-list
102344150|NCT03831425|Coenzyme Q10|coenzyme q10|mesh-list
102344151|NCT03831425|Micronutrients|micronutrients|mesh-ancestor
102344152|NCT03831425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344153|NCT03831425|Vitamins|vitamins|mesh-ancestor
102344154|NCT03807765|Nivolumab|nivolumab|mesh-list
102344155|NCT03807765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101848973|NCT00276016|Ephedrine|ephedrine|mesh-list
102344156|NCT03807765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443203|NCT02057380|Autonomic Agents|autonomic agents|mesh-ancestor
102344157|NCT03807765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102344158|NCT03807765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344159|NCT03804944|Pembrolizumab|pembrolizumab|mesh-list
102344160|NCT03804944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101849112|NCT00433160|Teriparatide|teriparatide|mesh-list
102344161|NCT03804944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344162|NCT03804944|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102344163|NCT03804944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344165|NCT03790111|Gemcitabine|gemcitabine|mesh-list
101849178|NCT01323608|Vitamin D|vitamin d|mesh-list
102344166|NCT03790111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344167|NCT03790111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102344168|NCT03790111|Antimetabolites|antimetabolites|mesh-ancestor
102344169|NCT03790111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344170|NCT03780543|Tenofovir|tenofovir|mesh-list
102344171|NCT03780543|Entecavir|entecavir|mesh-list
101849390|NCT00408408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102344172|NCT03780543|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
102344174|NCT03780543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102344175|NCT03780543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101849545|NCT00406692|Zonisamide|zonisamide|mesh-list
102344176|NCT03780543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102344177|NCT03780543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344179|NCT03780543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102344180|NCT03772314|Modafinil|modafinil|mesh-list
102344181|NCT03772314|Amphetamine|amphetamine|mesh-list
102344183|NCT03772314|Dextroamphetamine|dextroamphetamine|mesh-list
102344184|NCT03772314|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102344185|NCT03772314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344186|NCT03772314|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102344187|NCT03772314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102344188|NCT03772314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102344189|NCT03772314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344190|NCT03772314|Sympathomimetics|sympathomimetics|mesh-ancestor
102344191|NCT03772314|Autonomic Agents|autonomic agents|mesh-ancestor
101849827|NCT03980379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344192|NCT03772314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102344194|NCT03772314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102344195|NCT03772314|Adrenergic Agents|adrenergic agents|mesh-ancestor
101849963|NCT00290511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102344196|NCT03772314|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102344197|NCT03772314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102344198|NCT03772314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101850107|NCT00292461|Zonisamide|zonisamide|mesh-list
102344199|NCT03772314|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102344200|NCT03760575|Pembrolizumab|pembrolizumab|mesh-list
102344201|NCT03760575|Pemetrexed|pemetrexed|mesh-list
102344202|NCT03760575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344203|NCT03760575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102344204|NCT03760575|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101850254|NCT01045980|Vitamin D|vitamin d|mesh-list
102344205|NCT03760575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344206|NCT03760575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102344207|NCT03760575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102344208|NCT03760575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102344209|NCT03738579|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102344210|NCT03738579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102344211|NCT03720522|Adenosine|adenosine|mesh-list
102344212|NCT03720522|Analgesics|analgesics|mesh-ancestor
102344213|NCT03720522|Sensory System Agents|sensory system agents|mesh-ancestor
101443213|NCT02052778|Futibatinib|futibatinib|mesh-list
102344214|NCT03720522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102344215|NCT03720522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344216|NCT03720522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102344217|NCT03720522|Vasodilator Agents|vasodilator agents|mesh-ancestor
102344218|NCT03720522|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102344219|NCT03720522|Purinergic Agonists|purinergic agonists|mesh-ancestor
102344220|NCT03720522|Purinergic Agents|purinergic agents|mesh-ancestor
102344221|NCT03720522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102344222|NCT03720522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344223|NCT03699631|Methotrexate|methotrexate|mesh-list
102344224|NCT03699631|Tacrolimus|tacrolimus|mesh-list
102344225|NCT03699631|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102344226|NCT03699631|Abortifacient Agents|abortifacient agents|mesh-ancestor
102344227|NCT03699631|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102344228|NCT03699631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344229|NCT03699631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102344231|NCT03699631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344232|NCT03699631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344233|NCT03699631|Dermatologic Agents|dermatologic agents|mesh-ancestor
102344234|NCT03699631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102344235|NCT03699631|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102344236|NCT03699631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102344237|NCT03699631|Immunologic Factors|immunologic factors|mesh-ancestor
102344238|NCT03699631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102344239|NCT03699631|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102344240|NCT03699631|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102344241|NCT03686488|Ramucirumab|ramucirumab|mesh-list
102344242|NCT03686488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344243|NCT03686150|Vitamin D|vitamin d|mesh-list
102344244|NCT03686150|Cholecalciferol|cholecalciferol|mesh-list
102344245|NCT03686150|Vitamins|vitamins|mesh-ancestor
102344247|NCT03686150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344248|NCT03686150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102344249|NCT03686150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101850989|NCT00268983|Iodine|iodine|mesh-list
102344251|NCT03678233|Androgens|androgens|mesh-ancestor
102344252|NCT03678233|Hormones|hormones|mesh-ancestor
101851020|NCT00257608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102344253|NCT03678233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102344254|NCT03678233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344255|NCT03629327|Aspirin|aspirin|mesh-list
102344256|NCT03629327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101851167|NCT00423098|Prednisone|prednisone|mesh-list
102344259|NCT03629327|Sensory System Agents|sensory system agents|mesh-ancestor
101851238|NCT01046838|Sildenafil Citrate|sildenafil citrate|mesh-list
102344260|NCT03629327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102344261|NCT03629327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344262|NCT03629327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102344263|NCT03629327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102344264|NCT03629327|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102344265|NCT03629327|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102344266|NCT03629327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344267|NCT03629327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102344268|NCT03629327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102344269|NCT03629327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102344270|NCT03629327|Antipyretics|antipyretics|mesh-ancestor
102344271|NCT03628209|Nivolumab|nivolumab|mesh-list
102344272|NCT03628209|Azacitidine|azacitidine|mesh-list
102344273|NCT03628209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102344274|NCT03628209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443229|NCT02046694|Antioxidants|antioxidants|mesh-ancestor
102344275|NCT03628209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101851312|NCT00422942|Antimetabolites|antimetabolites|mesh-ancestor
102344276|NCT03628209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344277|NCT03628209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102344278|NCT03628209|Antimetabolites|antimetabolites|mesh-ancestor
102344279|NCT03628209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102344281|NCT03618641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102344282|NCT03618641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344283|NCT03618641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101851506|NCT00403130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102344284|NCT03618641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344285|NCT03617718|Glycine|glycine|mesh-list
102344286|NCT03617718|Glycine Agents|glycine agents|mesh-ancestor
102344287|NCT03617718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102344288|NCT03617718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344289|NCT03617718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344290|NCT03610061|Durvalumab|durvalumab|mesh-list
102344291|NCT03610061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102344292|NCT03610061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344293|NCT03606642|Clopidogrel|clopidogrel|mesh-list
102344294|NCT03606642|Ticagrelor|ticagrelor|mesh-list
102344295|NCT03606642|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102344296|NCT03606642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851579|NCT00371826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102344297|NCT03606642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344298|NCT03606642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102344299|NCT03606642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102344300|NCT03606642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102344301|NCT03606642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102344302|NCT03606642|Purinergic Agents|purinergic agents|mesh-ancestor
102344303|NCT03606642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102344304|NCT03530124|Vaccines|vaccines|mesh-list
102344305|NCT03530124|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102344306|NCT03530124|Immunologic Factors|immunologic factors|mesh-ancestor
102344307|NCT03530124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344308|NCT03527043|Escitalopram|escitalopram|mesh-list
102344309|NCT03527043|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102344310|NCT03527043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102344311|NCT03527043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102344312|NCT03527043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344313|NCT03527043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102344314|NCT03527043|Serotonin Agents|serotonin agents|mesh-ancestor
101852216|NCT00203242|GABA Agents|gaba agents|mesh-ancestor
102344315|NCT03527043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344316|NCT03458221|Itraconazole|itraconazole|mesh-list
102344317|NCT03458221|Everolimus|everolimus|mesh-list
102344318|NCT03458221|Letrozole|letrozole|mesh-list
102344319|NCT03458221|Bicalutamide|bicalutamide|mesh-list
101852288|NCT01073332|Antioxidants|antioxidants|mesh-list
102344320|NCT03458221|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102344321|NCT03458221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102344322|NCT03458221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102344323|NCT03458221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344324|NCT03458221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102344325|NCT03458221|Immunologic Factors|immunologic factors|mesh-ancestor
102344326|NCT03458221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852507|NCT02286414|Anticoagulants|anticoagulants|mesh-ancestor
102344327|NCT03458221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344328|NCT03458221|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102344329|NCT03458221|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102344330|NCT03458221|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102344331|NCT03458221|Hormone Antagonists|hormone antagonists|mesh-ancestor
102344332|NCT03458221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102344333|NCT03458221|Antifungal Agents|antifungal agents|mesh-ancestor
102344334|NCT03458221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102344335|NCT03458221|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102344336|NCT03458221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102344337|NCT03458221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102344338|NCT03458221|Androgen Antagonists|androgen antagonists|mesh-ancestor
102344339|NCT03451487|Acetaminophen|acetaminophen|mesh-list
101852871|NCT00186628|Anesthetics|anesthetics|mesh-ancestor
102344340|NCT03451487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102344341|NCT03451487|Analgesics|analgesics|mesh-ancestor
102344342|NCT03451487|Sensory System Agents|sensory system agents|mesh-ancestor
101853015|NCT01050348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102344343|NCT03451487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102344344|NCT03451487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344345|NCT03451487|Antipyretics|antipyretics|mesh-ancestor
102344346|NCT03410030|Ascorbic Acid|ascorbic acid|mesh-list
102344347|NCT03410030|Paclitaxel|paclitaxel|mesh-list
102344348|NCT03410030|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102344349|NCT03410030|Cisplatin|cisplatin|mesh-list
102344350|NCT03410030|Gemcitabine|gemcitabine|mesh-list
102344351|NCT03410030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102344352|NCT03410030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344353|NCT03410030|Tubulin Modulators|tubulin modulators|mesh-ancestor
102344354|NCT03410030|Antimitotic Agents|antimitotic agents|mesh-ancestor
102344355|NCT03410030|Mitosis Modulators|mitosis modulators|mesh-ancestor
102344356|NCT03410030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344357|NCT03410030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102344359|NCT03410030|Antioxidants|antioxidants|mesh-ancestor
102344360|NCT03410030|Protective Agents|protective agents|mesh-ancestor
102344361|NCT03410030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344362|NCT03410030|Vitamins|vitamins|mesh-ancestor
101853378|NCT03966898|Letrozole|letrozole|mesh-list
102344364|NCT03382301|Cyclosporine|cyclosporine|mesh-list
102344365|NCT03382301|Cyclosporins|cyclosporins|mesh-list
102344366|NCT03382301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101853530|NCT01055964|Tacrolimus|tacrolimus|mesh-list
102344367|NCT03382301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344368|NCT03382301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101573478|NCT02765815|Mydriatics|mydriatics|mesh-ancestor
101573592|NCT04224649|Lidocaine|lidocaine|mesh-list
102344369|NCT03382301|Immunologic Factors|immunologic factors|mesh-ancestor
102344370|NCT03382301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344371|NCT03382301|Antifungal Agents|antifungal agents|mesh-ancestor
102344372|NCT03382301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102344373|NCT03382301|Dermatologic Agents|dermatologic agents|mesh-ancestor
102344374|NCT03382301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102344375|NCT03382301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102344376|NCT03290391|Naltrexone|naltrexone|mesh-list
102344377|NCT03290391|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102344378|NCT03290391|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102344379|NCT03290391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344380|NCT03290391|Sensory System Agents|sensory system agents|mesh-ancestor
102344381|NCT03290391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102344382|NCT03280030|Midostaurin|midostaurin|mesh-list
102344383|NCT03280030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101854185|NCT01071525|Niacin|niacin|mesh-list
102344384|NCT03280030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102344385|NCT03280030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102344386|NCT03280030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344387|NCT03263481|Secretin|secretin|mesh-list
101854244|NCT00390416|Antidotes|antidotes|mesh-ancestor
102344388|NCT03263481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102344389|NCT03263481|Hormones|hormones|mesh-ancestor
102344390|NCT03263481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102344391|NCT03263481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344392|NCT03245892|Paclitaxel|paclitaxel|mesh-list
102344393|NCT03245892|Carboplatin|carboplatin|mesh-list
102344394|NCT03245892|Nivolumab|nivolumab|mesh-list
102344395|NCT03245892|Ipilimumab|ipilimumab|mesh-list
102344396|NCT03245892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101854376|NCT00369278|Mycophenolic Acid|mycophenolic acid|mesh-list
102344397|NCT03245892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344398|NCT03245892|Tubulin Modulators|tubulin modulators|mesh-ancestor
102344399|NCT03245892|Antimitotic Agents|antimitotic agents|mesh-ancestor
102344400|NCT03245892|Mitosis Modulators|mitosis modulators|mesh-ancestor
102344401|NCT03245892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344402|NCT03245892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102344403|NCT03245892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102344404|NCT03204188|Pembrolizumab|pembrolizumab|mesh-list
102344405|NCT03204188|Fludarabine|fludarabine|mesh-list
102344406|NCT03204188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102344407|NCT03204188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101854661|NCT03968146|Anesthetics|anesthetics|mesh-ancestor
102344408|NCT03204188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102344409|NCT03204188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344410|NCT03194867|Cemiplimab|cemiplimab|mesh-list
102344411|NCT03194867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102344412|NCT03194867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344413|NCT03138720|Paclitaxel|paclitaxel|mesh-list
102344414|NCT03138720|Cisplatin|cisplatin|mesh-list
101854948|NCT01054872|Vaccines|vaccines|mesh-list
102344416|NCT03138720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102344417|NCT03138720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102344418|NCT03138720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344419|NCT03138720|Tubulin Modulators|tubulin modulators|mesh-ancestor
102344420|NCT03138720|Antimitotic Agents|antimitotic agents|mesh-ancestor
102344422|NCT03138720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344423|NCT03138720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102344424|NCT03138720|Antimetabolites|antimetabolites|mesh-ancestor
102344425|NCT03131726|Simvastatin|simvastatin|mesh-list
102344426|NCT03131726|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102344427|NCT03131726|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102344428|NCT03131726|Antimetabolites|antimetabolites|mesh-ancestor
102344429|NCT03131726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344430|NCT03131726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102344431|NCT03131726|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102344432|NCT03131726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102344433|NCT03112590|Interferons|interferons|mesh-list
102344434|NCT03112590|Interferon-gamma|interferon-gamma|mesh-list
102344435|NCT03112590|Paclitaxel|paclitaxel|mesh-list
102344436|NCT03112590|Trastuzumab|trastuzumab|mesh-list
102344437|NCT03112590|Pertuzumab|pertuzumab|mesh-list
102344438|NCT03112590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102344439|NCT03112590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344440|NCT03112590|Tubulin Modulators|tubulin modulators|mesh-ancestor
102344441|NCT03112590|Antimitotic Agents|antimitotic agents|mesh-ancestor
102344442|NCT03112590|Mitosis Modulators|mitosis modulators|mesh-ancestor
102344443|NCT03112590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344444|NCT03112590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102344446|NCT03112590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102344447|NCT03085394|Tranexamic Acid|tranexamic acid|mesh-list
101855602|NCT00523991|Tiotropium Bromide|tiotropium bromide|mesh-list
101855672|NCT03741894|Chlorhexidine|chlorhexidine|mesh-list
102344448|NCT03085394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102344449|NCT03085394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102344450|NCT03085394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344451|NCT03085394|Hemostatics|hemostatics|mesh-ancestor
102344452|NCT03085394|Coagulants|coagulants|mesh-ancestor
102344453|NCT03065621|Palbociclib|palbociclib|mesh-list
102344454|NCT03065621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344455|NCT03065621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102344456|NCT03065621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101855747|NCT00112294|Carboplatin|carboplatin|mesh-list
102344457|NCT03065621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344458|NCT03060434|Acetaminophen|acetaminophen|mesh-list
102344459|NCT03060434|Ibuprofen|ibuprofen|mesh-list
102344460|NCT03060434|Pregabalin|pregabalin|mesh-list
102344461|NCT03060434|Pentoxifylline|pentoxifylline|mesh-list
102344462|NCT03060434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102344463|NCT03060434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102344464|NCT03060434|Analgesics|analgesics|mesh-ancestor
102344465|NCT03060434|Sensory System Agents|sensory system agents|mesh-ancestor
102344466|NCT03060434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102344467|NCT03060434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344468|NCT03060434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102344469|NCT03060434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102344470|NCT03060434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102344471|NCT03060434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102344472|NCT03060434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344473|NCT03060434|Anticonvulsants|anticonvulsants|mesh-ancestor
102344474|NCT03060434|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102344475|NCT03060434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102344476|NCT03060434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102344477|NCT03060434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102344478|NCT03060434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102344479|NCT03060434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102053305|NCT02322814|Tubulin Modulators|tubulin modulators|mesh-ancestor
102344480|NCT03060434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102344481|NCT03060434|Antipyretics|antipyretics|mesh-ancestor
102344482|NCT03060434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102344483|NCT03060434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102344484|NCT03060434|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102344485|NCT03060434|Protective Agents|protective agents|mesh-ancestor
102344486|NCT03060434|Vasodilator Agents|vasodilator agents|mesh-ancestor
102344487|NCT03060434|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102344488|NCT03060434|Antioxidants|antioxidants|mesh-ancestor
102344489|NCT03021486|Haloperidol|haloperidol|mesh-list
102344490|NCT03021486|Chlorpromazine|chlorpromazine|mesh-list
102344491|NCT03021486|Haloperidol decanoate|haloperidol decanoate|mesh-list
102344492|NCT03021486|Antiemetics|antiemetics|mesh-ancestor
102344493|NCT03021486|Autonomic Agents|autonomic agents|mesh-ancestor
102344494|NCT03021486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102344495|NCT03021486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344496|NCT03021486|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102344497|NCT03021486|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102344498|NCT03021486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102344499|NCT03021486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102344500|NCT03021486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102344501|NCT03021486|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102344502|NCT03021486|Dopamine Agents|dopamine agents|mesh-ancestor
102344503|NCT03021486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102344504|NCT03021486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344505|NCT03021486|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102344506|NCT02949128|Ravulizumab|ravulizumab|mesh-list
102344507|NCT02949128|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102344508|NCT02949128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102344509|NCT02949128|Immunologic Factors|immunologic factors|mesh-ancestor
102344510|NCT02949128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344511|NCT02944617|Micronutrients|micronutrients|mesh-list
102344512|NCT02944617|Trace Elements|trace elements|mesh-list
102344513|NCT02944617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344514|NCT02923115|Enoxaparin|enoxaparin|mesh-list
102344515|NCT02923115|Anticoagulants|anticoagulants|mesh-ancestor
102344516|NCT02923115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102344517|NCT02923115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102344518|NCT02923115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344519|NCT02910583|Venetoclax|venetoclax|mesh-list
102344520|NCT02910583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344521|NCT02820857|Bevacizumab|bevacizumab|mesh-list
102344522|NCT02820857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102344523|NCT02820857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344524|NCT02820857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102344525|NCT02820857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102344526|NCT02820857|Growth Substances|growth substances|mesh-ancestor
102344527|NCT02820857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344528|NCT02820857|Growth Inhibitors|growth inhibitors|mesh-ancestor
102344529|NCT02790710|Propranolol|propranolol|mesh-list
102344530|NCT02790710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102344531|NCT02790710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102344532|NCT02790710|Adrenergic Agents|adrenergic agents|mesh-ancestor
102344533|NCT02790710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102344534|NCT02790710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344535|NCT02790710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344536|NCT02790710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102344537|NCT02790710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102344538|NCT02790710|Vasodilator Agents|vasodilator agents|mesh-ancestor
102344540|NCT02779855|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
102344541|NCT02779855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102344542|NCT02779855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344543|NCT02779855|Tubulin Modulators|tubulin modulators|mesh-ancestor
102344544|NCT02779855|Antimitotic Agents|antimitotic agents|mesh-ancestor
102344545|NCT02779855|Mitosis Modulators|mitosis modulators|mesh-ancestor
102344546|NCT02779855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344547|NCT02779855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102344548|NCT02661035|Mycophenolic Acid|mycophenolic acid|mesh-list
102344549|NCT02661035|Cyclophosphamide|cyclophosphamide|mesh-list
102344550|NCT02661035|Fludarabine|fludarabine|mesh-list
102344552|NCT02661035|Tacrolimus|tacrolimus|mesh-list
102344553|NCT02661035|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102344554|NCT02661035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102344555|NCT02661035|Immunologic Factors|immunologic factors|mesh-ancestor
102344556|NCT02661035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344557|NCT02661035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102344558|NCT02661035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102344559|NCT02661035|Alkylating Agents|alkylating agents|mesh-ancestor
102344560|NCT02661035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344561|NCT02661035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344562|NCT02661035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102344563|NCT02661035|Antimetabolites|antimetabolites|mesh-ancestor
102344564|NCT02661035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102344565|NCT02661035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102344566|NCT02661035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102344567|NCT02661035|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102344568|NCT02661035|Antitubercular Agents|antitubercular agents|mesh-ancestor
102344569|NCT02661035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102344570|NCT02661035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102344571|NCT02661035|Gout Suppressants|gout suppressants|mesh-ancestor
102344572|NCT02661035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102344573|NCT02661035|Antioxidants|antioxidants|mesh-ancestor
102344574|NCT02661035|Protective Agents|protective agents|mesh-ancestor
102344575|NCT02648477|Doxorubicin|doxorubicin|mesh-list
102344576|NCT02648477|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102344577|NCT02648477|Pembrolizumab|pembrolizumab|mesh-list
102344578|NCT02648477|Letrozole|letrozole|mesh-list
102344579|NCT02648477|Anastrozole|anastrozole|mesh-list
102344580|NCT02648477|Exemestane|exemestane|mesh-list
102344581|NCT02648477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102344582|NCT02648477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344583|NCT02648477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102344584|NCT02648477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102344585|NCT02648477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102344586|NCT02648477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856243|NCT00174447|Dopamine Agents|dopamine agents|mesh-ancestor
102344587|NCT02648477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102344588|NCT02648477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102344589|NCT02648477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102344590|NCT02648477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102344591|NCT02648477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102344592|NCT02648477|Hormone Antagonists|hormone antagonists|mesh-ancestor
102344593|NCT02648477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102344594|NCT02648477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344595|NCT02648477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102344596|NCT02604732|Aspirin|aspirin|mesh-list
102344597|NCT02604732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102344598|NCT02604732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102344599|NCT02604732|Analgesics|analgesics|mesh-ancestor
102344600|NCT02604732|Sensory System Agents|sensory system agents|mesh-ancestor
102344601|NCT02604732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102344602|NCT02604732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344603|NCT02604732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102344604|NCT02604732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102344605|NCT02604732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102344606|NCT02604732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102344607|NCT02604732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344608|NCT02604732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102344609|NCT02604732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102344610|NCT02604732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102344611|NCT02604732|Antipyretics|antipyretics|mesh-ancestor
102344612|NCT02444429|Methylprednisolone|methylprednisolone|mesh-list
102344613|NCT02444429|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102344614|NCT02444429|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102344615|NCT02444429|Prednisolone|prednisolone|mesh-list
102344616|NCT02444429|Prednisolone acetate|prednisolone acetate|mesh-list
102344617|NCT02444429|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102344618|NCT02444429|Prednisolone phosphate|prednisolone phosphate|mesh-list
102344619|NCT02444429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102344620|NCT02444429|Antiemetics|antiemetics|mesh-ancestor
102344621|NCT02444429|Autonomic Agents|autonomic agents|mesh-ancestor
102344622|NCT02444429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102344623|NCT02444429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344624|NCT02444429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102344625|NCT02444429|Glucocorticoids|glucocorticoids|mesh-ancestor
102344626|NCT02444429|Hormones|hormones|mesh-ancestor
102344627|NCT02444429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102344628|NCT02444429|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102344629|NCT02444429|Protective Agents|protective agents|mesh-ancestor
102344630|NCT02444429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102344631|NCT02444429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344632|NCT02318342|Warfarin|warfarin|mesh-list
102344633|NCT02318342|Anticoagulants|anticoagulants|mesh-ancestor
102344634|NCT02134184|Vaccines|vaccines|mesh-list
102344635|NCT02134184|Immunologic Factors|immunologic factors|mesh-ancestor
102344636|NCT02134184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344637|NCT02029846|Metformin|metformin|mesh-list
102344638|NCT02029846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
102344639|NCT02029846|Incretins|incretins|mesh-list
102344640|NCT02029846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102344641|NCT02029846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344642|NCT02029846|Protease Inhibitors|protease inhibitors|mesh-ancestor
102344643|NCT02029846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102344644|NCT02029846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344645|NCT02029846|Hormones|hormones|mesh-ancestor
102344646|NCT02029846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102344647|NCT06018623|Anesthetics|anesthetics|mesh-list
102344648|NCT06018623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102344649|NCT06018623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344650|NCT06018597|Sevoflurane|sevoflurane|mesh-list
102344651|NCT06018597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102344652|NCT06018597|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102344653|NCT06018597|Anesthetics, General|anesthetics, general|mesh-ancestor
102344654|NCT06018597|Anesthetics|anesthetics|mesh-ancestor
102344655|NCT06018597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102344656|NCT06018597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344657|NCT06018467|Niacinamide|niacinamide|mesh-list
102344658|NCT06018467|Niacin|niacin|mesh-list
102344659|NCT06018467|Nicotinic Acids|nicotinic acids|mesh-list
102344660|NCT06018467|Dasatinib|dasatinib|mesh-list
102344661|NCT06018467|Quercetin|quercetin|mesh-list
102344662|NCT06018467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344663|NCT06018467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102344664|NCT06018467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102344665|NCT06018467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344666|NCT06018467|Vitamin B Complex|vitamin b complex|mesh-ancestor
102344667|NCT06018467|Vitamins|vitamins|mesh-ancestor
102344668|NCT06018467|Micronutrients|micronutrients|mesh-ancestor
102344669|NCT06018467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344670|NCT06018467|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102344671|NCT06018467|Antimetabolites|antimetabolites|mesh-ancestor
102344672|NCT06018467|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102344673|NCT06018467|Vasodilator Agents|vasodilator agents|mesh-ancestor
102344674|NCT06018467|Antioxidants|antioxidants|mesh-ancestor
102344675|NCT06018467|Protective Agents|protective agents|mesh-ancestor
102344676|NCT06018337|Paclitaxel|paclitaxel|mesh-list
102344677|NCT06018337|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102344678|NCT06018337|Capecitabine|capecitabine|mesh-list
102344679|NCT06018337|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102344680|NCT06018337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344681|NCT06018337|Tubulin Modulators|tubulin modulators|mesh-ancestor
102344682|NCT06018337|Antimitotic Agents|antimitotic agents|mesh-ancestor
102344683|NCT06018337|Mitosis Modulators|mitosis modulators|mesh-ancestor
102344684|NCT06018337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344685|NCT06018337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102344686|NCT06018337|Antimetabolites|antimetabolites|mesh-ancestor
102344687|NCT06018207|Midazolam|midazolam|mesh-list
102344688|NCT06018207|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102344689|NCT06018207|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102344690|NCT06018207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102344691|NCT06018207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344692|NCT06018207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102344693|NCT06018207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102344694|NCT06018207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102344695|NCT06018207|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102344696|NCT06018207|Anesthetics, General|anesthetics, general|mesh-ancestor
102344697|NCT06018207|Anesthetics|anesthetics|mesh-ancestor
102344698|NCT06018207|GABA Modulators|gaba modulators|mesh-ancestor
102344699|NCT06018207|GABA Agents|gaba agents|mesh-ancestor
102344700|NCT06018207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102344701|NCT06018207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344702|NCT06018116|Avelumab|avelumab|mesh-list
102344703|NCT06018116|Bicalutamide|bicalutamide|mesh-list
102344704|NCT06018116|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102344705|NCT06018116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102344706|NCT06018116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344707|NCT06018116|Immunologic Factors|immunologic factors|mesh-ancestor
102344708|NCT06018116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344709|NCT06018116|Androgen Antagonists|androgen antagonists|mesh-ancestor
102344710|NCT06018116|Hormone Antagonists|hormone antagonists|mesh-ancestor
102344711|NCT06018116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102344713|NCT06018025|Immunologic Factors|immunologic factors|mesh-ancestor
102344714|NCT06018025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344715|NCT06017921|Eszopiclone|eszopiclone|mesh-list
102344716|NCT06017921|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102344717|NCT06017921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102344718|NCT06017921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344719|NCT06017895|Doxepin|doxepin|mesh-list
102344720|NCT06017895|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102344721|NCT06017895|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102344722|NCT06017895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102344723|NCT06017895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344724|NCT06017895|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102344725|NCT06017895|Antidepressive Agents|antidepressive agents|mesh-ancestor
102344726|NCT06017895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102344727|NCT06017895|Histamine Antagonists|histamine antagonists|mesh-ancestor
102344728|NCT06017895|Histamine Agents|histamine agents|mesh-ancestor
102344729|NCT06017895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102344730|NCT06017895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344731|NCT06017817|Anti-Infective Agents|anti-infective agents|mesh-list
102344732|NCT06017726|Insulin|insulin|mesh-list
102344733|NCT06017726|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102344734|NCT06017726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344735|NCT06017583|Capecitabine|capecitabine|mesh-list
102344736|NCT06017583|Oxaliplatin|oxaliplatin|mesh-list
102344737|NCT06017583|Tislelizumab|tislelizumab|mesh-list
102344738|NCT06017583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102344739|NCT06017583|Antimetabolites|antimetabolites|mesh-ancestor
102344740|NCT06017583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344741|NCT06017583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344742|NCT06017583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102344743|NCT06017479|Levofloxacin|levofloxacin|mesh-list
102344744|NCT06017479|Fosfomycin|fosfomycin|mesh-list
102344745|NCT06017479|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102344746|NCT06017479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102344747|NCT06017479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102344748|NCT06017479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102344749|NCT06017479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102344750|NCT06017479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102344751|NCT06017479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344752|NCT06017479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344753|NCT06017479|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102344754|NCT06017479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102344755|NCT06017362|Lubricant Eye Drops|lubricant eye drops|mesh-list
102344756|NCT06017362|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102344757|NCT06017362|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102344758|NCT06017323|Paclitaxel|paclitaxel|mesh-list
102344759|NCT06017323|Gemcitabine|gemcitabine|mesh-list
102344760|NCT06017323|Proglumide|proglumide|mesh-list
102344761|NCT06017323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102344762|NCT06017323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344763|NCT06017323|Tubulin Modulators|tubulin modulators|mesh-ancestor
102344764|NCT06017323|Antimitotic Agents|antimitotic agents|mesh-ancestor
102344765|NCT06017323|Mitosis Modulators|mitosis modulators|mesh-ancestor
102344766|NCT06017323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344767|NCT06017323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102344768|NCT06017323|Antimetabolites|antimetabolites|mesh-ancestor
102344769|NCT06017323|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102344770|NCT06017323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102344772|NCT06017297|Durvalumab|durvalumab|mesh-list
102344773|NCT06017297|Tremelimumab|tremelimumab|mesh-list
102344774|NCT06017297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344775|NCT06017297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102344776|NCT06017297|Antimetabolites|antimetabolites|mesh-ancestor
102344777|NCT06017297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344778|NCT06017297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102344779|NCT06017284|Thalidomide|thalidomide|mesh-list
102344780|NCT06017284|Paclitaxel|paclitaxel|mesh-list
102344781|NCT06017284|Gemcitabine|gemcitabine|mesh-list
102344782|NCT06017284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102344783|NCT06017284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102053632|NCT02983747|Loxoprofen|loxoprofen|mesh-list
102344785|NCT06017284|Antimitotic Agents|antimitotic agents|mesh-ancestor
102344786|NCT06017284|Mitosis Modulators|mitosis modulators|mesh-ancestor
102344787|NCT06017284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344788|NCT06017284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102344789|NCT06017284|Antimetabolites|antimetabolites|mesh-ancestor
102344790|NCT06017284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102344791|NCT06017284|Immunologic Factors|immunologic factors|mesh-ancestor
102344792|NCT06017284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344793|NCT06017284|Leprostatic Agents|leprostatic agents|mesh-ancestor
102344794|NCT06017284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102344795|NCT06017284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102344796|NCT06017284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102344797|NCT06017284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101856845|NCT00358826|Atreleuton|atreleuton|mesh-list
102344798|NCT06017284|Growth Substances|growth substances|mesh-ancestor
102344799|NCT06017284|Growth Inhibitors|growth inhibitors|mesh-ancestor
102344800|NCT06017167|Dexamethasone|dexamethasone|mesh-list
102344801|NCT06017167|Dexamethasone acetate|dexamethasone acetate|mesh-list
102344802|NCT06017167|Dexmedetomidine|dexmedetomidine|mesh-list
102344803|NCT06017167|Ondansetron|ondansetron|mesh-list
102344805|NCT06017167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102344806|NCT06017167|Antiemetics|antiemetics|mesh-ancestor
102344807|NCT06017167|Autonomic Agents|autonomic agents|mesh-ancestor
102344808|NCT06017167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102344809|NCT06017167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344810|NCT06017167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102344811|NCT06017167|Glucocorticoids|glucocorticoids|mesh-ancestor
102344812|NCT06017167|Hormones|hormones|mesh-ancestor
101856895|NCT00506285|Dopamine Agents|dopamine agents|mesh-ancestor
102344813|NCT06017167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102344814|NCT06017167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102344815|NCT06017167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344816|NCT06017167|Protease Inhibitors|protease inhibitors|mesh-ancestor
102344817|NCT06017167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102344818|NCT06017167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344819|NCT06017167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102344820|NCT06017167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102344821|NCT06017167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102344822|NCT06017167|Analgesics|analgesics|mesh-ancestor
102344823|NCT06017167|Sensory System Agents|sensory system agents|mesh-ancestor
102344824|NCT06017167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102344825|NCT06017167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102344826|NCT06017167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102344827|NCT06017167|Adrenergic Agents|adrenergic agents|mesh-ancestor
102344828|NCT06017167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102344829|NCT06017167|Antipruritics|antipruritics|mesh-ancestor
102344830|NCT06017167|Dermatologic Agents|dermatologic agents|mesh-ancestor
102344831|NCT06017167|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102344832|NCT06017167|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102344833|NCT06017167|Serotonin Agents|serotonin agents|mesh-ancestor
102344835|NCT06017141|Propofol|propofol|mesh-list
102344836|NCT06017141|Sevoflurane|sevoflurane|mesh-list
102344837|NCT06017141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102344838|NCT06017141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102344839|NCT06017141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856956|NCT01010243|Hormones|hormones|mesh-ancestor
102344840|NCT06017141|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102344841|NCT06017141|Anesthetics, General|anesthetics, general|mesh-ancestor
102344842|NCT06017141|Anesthetics|anesthetics|mesh-ancestor
102344843|NCT06017141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102344844|NCT06017141|Narcotics|narcotics|mesh-ancestor
102344845|NCT06017141|Analgesics|analgesics|mesh-ancestor
102344846|NCT06017141|Sensory System Agents|sensory system agents|mesh-ancestor
102344847|NCT06017141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102344848|NCT06017141|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102344849|NCT06017141|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101443318|NCT00410553|Gemcitabine|gemcitabine|mesh-list
102344850|NCT06017141|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102344852|NCT06017037|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102344853|NCT06017037|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102344854|NCT06017037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102344855|NCT06017037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344856|NCT06017037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102344857|NCT06017037|Serotonin Agents|serotonin agents|mesh-ancestor
102344858|NCT06017037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344859|NCT06017037|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102344860|NCT06017037|Antidepressive Agents|antidepressive agents|mesh-ancestor
102344861|NCT06017037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102344862|NCT06016985|Caffeine|caffeine|mesh-list
102344863|NCT06016985|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102344864|NCT06016985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344865|NCT06016985|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102344866|NCT06016985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102344867|NCT06016985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344868|NCT06016985|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102344869|NCT06016985|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102344870|NCT06016985|Purinergic Agents|purinergic agents|mesh-ancestor
102344871|NCT06016985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102344872|NCT06016972|Timolol|timolol|mesh-list
102344873|NCT06016972|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102344874|NCT06016972|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102344875|NCT06016972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344876|NCT06016972|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102344877|NCT06016972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102344878|NCT06016972|Adrenergic Agents|adrenergic agents|mesh-ancestor
102344879|NCT06016972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102344880|NCT06016972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344881|NCT06016972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102344882|NCT06016972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102344883|NCT06016920|Pembrolizumab|pembrolizumab|mesh-list
102344884|NCT06016920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102344885|NCT06016920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344886|NCT06016920|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102344887|NCT06016920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344888|NCT06016855|Copper|copper|mesh-list
102344889|NCT06016855|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102344890|NCT06016855|Trace Elements|trace elements|mesh-ancestor
102344891|NCT06016855|Micronutrients|micronutrients|mesh-ancestor
102344892|NCT06016855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344893|NCT06016855|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102344894|NCT06016855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344895|NCT06016738|Letrozole|letrozole|mesh-list
102344896|NCT06016738|Fulvestrant|fulvestrant|mesh-list
102344897|NCT06016738|Anastrozole|anastrozole|mesh-list
102344898|NCT06016738|Exemestane|exemestane|mesh-list
102344899|NCT06016738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344900|NCT06016738|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102344901|NCT06016738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102344902|NCT06016738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102344903|NCT06016738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344904|NCT06016738|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102344905|NCT06016738|Hormone Antagonists|hormone antagonists|mesh-ancestor
101857131|NCT00357500|Growth Substances|growth substances|mesh-ancestor
102344906|NCT06016738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102344907|NCT06016738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344908|NCT06016738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102344909|NCT06016738|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102344910|NCT06016634|Alendronate|alendronate|mesh-list
102344911|NCT06016634|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102344912|NCT06016634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344914|NCT06012331|Mitosis Modulators|mitosis modulators|mesh-ancestor
102344915|NCT06012331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344916|NCT06011330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101443321|NCT00410553|Antimetabolites|antimetabolites|mesh-ancestor
102344922|NCT06011330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344923|NCT06007391|Niacinamide|niacinamide|mesh-list
102344924|NCT06007391|Niacin|niacin|mesh-list
102344925|NCT06007391|Nicotinic Acids|nicotinic acids|mesh-list
102344926|NCT06007391|Vitamin B Complex|vitamin b complex|mesh-ancestor
102344927|NCT06007391|Vitamins|vitamins|mesh-ancestor
102344928|NCT06007391|Micronutrients|micronutrients|mesh-ancestor
102344929|NCT06007391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344930|NCT06007391|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102344931|NCT06007391|Antimetabolites|antimetabolites|mesh-ancestor
102344932|NCT06007391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344933|NCT06007391|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102344934|NCT06007391|Vasodilator Agents|vasodilator agents|mesh-ancestor
102344936|NCT06005480|Mepivacaine|mepivacaine|mesh-list
102344937|NCT06005480|Anesthetics, Local|anesthetics, local|mesh-ancestor
102344938|NCT06005480|Anesthetics|anesthetics|mesh-ancestor
102344939|NCT06005480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102344940|NCT06005480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344941|NCT06005480|Sensory System Agents|sensory system agents|mesh-ancestor
102344942|NCT06005480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102344943|NCT05997563|Progesterone|progesterone|mesh-list
102344944|NCT05997563|Progestins|progestins|mesh-ancestor
102344945|NCT05997563|Hormones|hormones|mesh-ancestor
102344946|NCT05997563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102344947|NCT05997563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344953|NCT05980572|Triamcinolone|triamcinolone|mesh-list
102344954|NCT05980572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102344955|NCT05980572|Aceclofenac|aceclofenac|mesh-list
102344956|NCT05980572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
102344963|NCT05980572|Sensory System Agents|sensory system agents|mesh-ancestor
102344964|NCT05980572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102344965|NCT05980572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102344972|NCT05956821|Bevacizumab|bevacizumab|mesh-list
102344973|NCT05956821|Cetuximab|cetuximab|mesh-list
102344974|NCT05956821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102344975|NCT05956821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344976|NCT05956821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102344977|NCT05956821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102344978|NCT05956821|Growth Substances|growth substances|mesh-ancestor
102344979|NCT05956821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344980|NCT05956821|Growth Inhibitors|growth inhibitors|mesh-ancestor
102344982|NCT05952453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102344983|NCT05936606|Clopidogrel|clopidogrel|mesh-list
102344984|NCT05936606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102344985|NCT05936606|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102344986|NCT05936606|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102344987|NCT05936606|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102344988|NCT05936606|Purinergic Agents|purinergic agents|mesh-ancestor
102344989|NCT05936606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102344990|NCT05936606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102344991|NCT05936606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102344992|NCT05936086|Cyclosporine|cyclosporine|mesh-list
102344993|NCT05936086|Dexamethasone|dexamethasone|mesh-list
102344994|NCT05936086|Etoposide|etoposide|mesh-list
102344995|NCT05936086|Cyclophosphamide|cyclophosphamide|mesh-list
102345002|NCT05936086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102345003|NCT05936086|Glucocorticoids|glucocorticoids|mesh-ancestor
102345005|NCT05936086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101443338|NCT00410631|Ifosfamide|ifosfamide|mesh-list
102345006|NCT05936086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102345007|NCT05936086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102345008|NCT05936086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102345009|NCT05936086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102345010|NCT05936086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102345011|NCT05936086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102345012|NCT05936086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345013|NCT05936086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102345014|NCT05936086|Immunologic Factors|immunologic factors|mesh-ancestor
102345015|NCT05936086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102345016|NCT05936086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102345017|NCT05936086|Alkylating Agents|alkylating agents|mesh-ancestor
102345018|NCT05936086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102345019|NCT05936086|Antifungal Agents|antifungal agents|mesh-ancestor
102345020|NCT05936086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102345021|NCT05936086|Dermatologic Agents|dermatologic agents|mesh-ancestor
102345022|NCT05936086|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102345023|NCT05932511|Ascorbic Acid|ascorbic acid|mesh-list
102345024|NCT05932511|Antioxidants|antioxidants|mesh-ancestor
102345025|NCT05932511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345026|NCT05932511|Protective Agents|protective agents|mesh-ancestor
102345027|NCT05932511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345028|NCT05932511|Vitamins|vitamins|mesh-ancestor
102345029|NCT05932511|Micronutrients|micronutrients|mesh-ancestor
102345036|NCT05918822|Maribavir|maribavir|mesh-list
102345037|NCT05918822|Rabeprazole|rabeprazole|mesh-list
102345085|NCT05896163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102345086|NCT05896163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102345087|NCT05895955|Vaccines|vaccines|mesh-list
102345088|NCT05895955|Immunologic Factors|immunologic factors|mesh-ancestor
102345089|NCT05895955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345090|NCT05889013|Nitric Oxide|nitric oxide|mesh-list
102345091|NCT05889013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102345092|NCT05889013|Autonomic Agents|autonomic agents|mesh-ancestor
102345093|NCT05889013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102345094|NCT05889013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345095|NCT05889013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101443347|NCT00410631|Vindesine|vindesine|mesh-list
102345096|NCT05889013|Respiratory System Agents|respiratory system agents|mesh-ancestor
102345097|NCT05889013|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102345098|NCT05889013|Antioxidants|antioxidants|mesh-ancestor
102345099|NCT05889013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345100|NCT05889013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102345101|NCT05889013|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102345102|NCT05889013|Vasodilator Agents|vasodilator agents|mesh-ancestor
102345103|NCT05889013|Gasotransmitters|gasotransmitters|mesh-ancestor
102345104|NCT05889013|Protective Agents|protective agents|mesh-ancestor
102345106|NCT05883644|Tremelimumab|tremelimumab|mesh-list
102345107|NCT05883644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102345108|NCT05883644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102345109|NCT05882903|Betamethasone|betamethasone|mesh-list
102345110|NCT05882903|Betamethasone Valerate|betamethasone valerate|mesh-list
102345111|NCT05882903|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102345112|NCT05882903|Betamethasone benzoate|betamethasone benzoate|mesh-list
102345113|NCT05882903|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102345114|NCT05882903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101857806|NCT00503399|Teriparatide|teriparatide|mesh-list
102345120|NCT05882903|Respiratory System Agents|respiratory system agents|mesh-ancestor
102345126|NCT05873712|Cyclophosphamide|cyclophosphamide|mesh-list
102345127|NCT05873712|Fludarabine|fludarabine|mesh-list
102345128|NCT05873712|Zanubrutinib|zanubrutinib|mesh-list
102345129|NCT05873712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102345130|NCT05873712|Immunologic Factors|immunologic factors|mesh-ancestor
102345131|NCT05873712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345132|NCT05873712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102345133|NCT05873712|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102345134|NCT05873712|Alkylating Agents|alkylating agents|mesh-ancestor
102345135|NCT05873712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345136|NCT05873712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102345137|NCT05873712|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102345138|NCT05873712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102345139|NCT05873712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102345140|NCT05872451|Bromides|bromides|mesh-list
102345141|NCT05872451|Rocuronium|rocuronium|mesh-list
102345142|NCT05872451|Anticonvulsants|anticonvulsants|mesh-ancestor
102345143|NCT05872451|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102345144|NCT05872451|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102345145|NCT05872451|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102345146|NCT05872451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102345147|NCT05872451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345148|NCT05871606|Nitrous Oxide|nitrous oxide|mesh-list
102345149|NCT05871606|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102345150|NCT05871606|Anesthetics, General|anesthetics, general|mesh-ancestor
102345151|NCT05871606|Anesthetics|anesthetics|mesh-ancestor
102345152|NCT05871606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102345153|NCT05871606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345154|NCT05871606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102345155|NCT05871606|Analgesics|analgesics|mesh-ancestor
102345156|NCT05871606|Sensory System Agents|sensory system agents|mesh-ancestor
101443389|NCT01893190|Vasodilator Agents|vasodilator agents|mesh-ancestor
102345157|NCT05871606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102345159|NCT05868577|Anesthetics, Local|anesthetics, local|mesh-list
102345160|NCT05868577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102345161|NCT05868577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345162|NCT05868577|Sensory System Agents|sensory system agents|mesh-ancestor
102345163|NCT05868577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102345164|NCT05863312|Temazepam|temazepam|mesh-list
102345165|NCT05863312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102345166|NCT05863312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102345167|NCT05863312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345168|NCT05863312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102345169|NCT05863312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102345170|NCT05863312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102345171|NCT05863312|GABA Modulators|gaba modulators|mesh-ancestor
102345172|NCT05863312|GABA Agents|gaba agents|mesh-ancestor
102345173|NCT05863312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102345174|NCT05863312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345175|NCT05861921|Lithium Carbonate|lithium carbonate|mesh-list
102345176|NCT05861921|Antidepressive Agents|antidepressive agents|mesh-ancestor
102345177|NCT05861921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102345178|NCT05861921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102345179|NCT05861921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345180|NCT05861921|Antimanic Agents|antimanic agents|mesh-ancestor
102345181|NCT05861921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102345182|NCT05861921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102345183|NCT05861921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345184|NCT05854498|Bevacizumab|bevacizumab|mesh-list
102345185|NCT05854498|Irinotecan|irinotecan|mesh-list
102345186|NCT05854498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102345187|NCT05854498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102345188|NCT05854498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102345189|NCT05854498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102345190|NCT05854498|Growth Substances|growth substances|mesh-ancestor
102345191|NCT05854498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345192|NCT05854498|Growth Inhibitors|growth inhibitors|mesh-ancestor
102345193|NCT05854498|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102345194|NCT05854498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102345195|NCT05854498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102345196|NCT05854498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345197|NCT05851898|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102345198|NCT05851898|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102345199|NCT05851898|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102345200|NCT05851898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102345201|NCT05851898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345202|NCT05851898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102345203|NCT05851898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345204|NCT05851898|Analgesics|analgesics|mesh-ancestor
102345205|NCT05851898|Sensory System Agents|sensory system agents|mesh-ancestor
102345206|NCT05851898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102345207|NCT05851898|Antidepressive Agents|antidepressive agents|mesh-ancestor
102345208|NCT05851898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102345209|NCT05851898|Dopamine Agents|dopamine agents|mesh-ancestor
102345210|NCT05851781|Acetaminophen|acetaminophen|mesh-list
102345211|NCT05851781|Lacosamide|lacosamide|mesh-list
102345212|NCT05851781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102345213|NCT05851781|Analgesics|analgesics|mesh-ancestor
102345214|NCT05851781|Sensory System Agents|sensory system agents|mesh-ancestor
102345215|NCT05851781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102345216|NCT05851781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345217|NCT05851781|Antipyretics|antipyretics|mesh-ancestor
102345218|NCT05851781|Anticonvulsants|anticonvulsants|mesh-ancestor
102345219|NCT05851781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102345220|NCT05851781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102345238|NCT05841472|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102345239|NCT05831449|Ropivacaine|ropivacaine|mesh-list
102345240|NCT05831449|Anesthetics, Local|anesthetics, local|mesh-list
102345241|NCT05831449|Anesthetics|anesthetics|mesh-list
102345242|NCT05831449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102345243|NCT05831449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345244|NCT05831449|Sensory System Agents|sensory system agents|mesh-ancestor
102345245|NCT05831449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102345246|NCT05829356|Vaccines|vaccines|mesh-list
102345247|NCT05829356|Immunologic Factors|immunologic factors|mesh-ancestor
102345248|NCT05829356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345249|NCT05821725|Hyaluronic Acid|hyaluronic acid|mesh-list
102345250|NCT05821725|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102345251|NCT05821725|Immunologic Factors|immunologic factors|mesh-ancestor
102345252|NCT05821725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345253|NCT05821725|Viscosupplements|viscosupplements|mesh-ancestor
102345254|NCT05821725|Protective Agents|protective agents|mesh-ancestor
102345255|NCT05818124|Oseltamivir|oseltamivir|mesh-list
102345256|NCT05818124|Molnupiravir|molnupiravir|mesh-list
102345257|NCT05818124|Antiviral Agents|antiviral agents|mesh-ancestor
102345258|NCT05818124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102345259|NCT05818124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102345260|NCT05818124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345261|NCT05814627|Adalimumab|adalimumab|mesh-list
102345262|NCT05814627|Upadacitinib|upadacitinib|mesh-list
102345263|NCT05814627|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102345264|NCT05814627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102345265|NCT05814627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102345266|NCT05814627|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102345267|NCT05814627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102345268|NCT05814627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102345269|NCT05814627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345270|NCT05813847|Anesthetics|anesthetics|mesh-list
102345271|NCT05813847|Anesthetics, Local|anesthetics, local|mesh-list
102345272|NCT05813847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102345273|NCT05813847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345274|NCT05813847|Sensory System Agents|sensory system agents|mesh-ancestor
102345275|NCT05813847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102345276|NCT05810233|Ascorbic Acid|ascorbic acid|mesh-list
102345277|NCT05810233|Vitamins|vitamins|mesh-ancestor
102345278|NCT05810233|Micronutrients|micronutrients|mesh-ancestor
102345279|NCT05810233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345280|NCT05810233|Antioxidants|antioxidants|mesh-ancestor
102345281|NCT05810233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345282|NCT05810233|Protective Agents|protective agents|mesh-ancestor
102345283|NCT05805891|Bortezomib|bortezomib|mesh-list
102345324|NCT05761405|Mannitol|mannitol|mesh-list
102345325|NCT05761405|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102345326|NCT05761405|Diuretics|diuretics|mesh-ancestor
102345327|NCT05761405|Natriuretic Agents|natriuretic agents|mesh-ancestor
102345328|NCT05761405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345329|NCT05761405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102345330|NCT05761405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102345331|NCT05739474|Vaccines|vaccines|mesh-list
102345332|NCT05739474|Immunologic Factors|immunologic factors|mesh-ancestor
102345333|NCT05739474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345334|NCT05736562|Vitamins|vitamins|mesh-list
102345335|NCT05736562|Micronutrients|micronutrients|mesh-ancestor
102345336|NCT05736562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345337|NCT05724134|Insulin|insulin|mesh-list
102345338|NCT05724134|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102345339|NCT05724134|Octreotide|octreotide|mesh-list
102345340|NCT05724134|Glucagon|glucagon|mesh-list
102345341|NCT05724134|Hormones|hormones|mesh-list
102345342|NCT05724134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102345343|NCT05724134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345344|NCT05724134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102345345|NCT05724134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102345346|NCT05724134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102345376|NCT05691478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345377|NCT05691478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102345378|NCT05691478|Antimetabolites|antimetabolites|mesh-ancestor
102345379|NCT05691478|Dermatologic Agents|dermatologic agents|mesh-ancestor
102345380|NCT05691478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102345381|NCT05691478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102345382|NCT05691478|Immunologic Factors|immunologic factors|mesh-ancestor
102345383|NCT05691478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102345384|NCT05691478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102345385|NCT05690698|Haloperidol|haloperidol|mesh-list
102345386|NCT05690698|Haloperidol decanoate|haloperidol decanoate|mesh-list
102345387|NCT05690698|Antiemetics|antiemetics|mesh-ancestor
102345388|NCT05690698|Autonomic Agents|autonomic agents|mesh-ancestor
102345389|NCT05690698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102345390|NCT05690698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345391|NCT05690698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102345392|NCT05690698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102345393|NCT05690698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102345394|NCT05690698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102345395|NCT05690698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102345396|NCT05690698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102345397|NCT05690698|Dopamine Agents|dopamine agents|mesh-ancestor
102345398|NCT05690698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102345399|NCT05690698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345400|NCT05690698|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102345401|NCT05687058|Empagliflozin|empagliflozin|mesh-list
102345402|NCT05687058|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102345403|NCT05687058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345404|NCT05687058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102345405|NCT05687058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345406|NCT05675410|Deoxyglucose|deoxyglucose|mesh-list
102345407|NCT05675410|Prednisone|prednisone|mesh-list
102345408|NCT05675410|Prednisolone|prednisolone|mesh-list
102345409|NCT05675410|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102345410|NCT05675410|Methylprednisolone|methylprednisolone|mesh-list
102345411|NCT05675410|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102345412|NCT05675410|Prednisolone acetate|prednisolone acetate|mesh-list
102345413|NCT05675410|Hydrocortisone|hydrocortisone|mesh-list
102345414|NCT05675410|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102345415|NCT05675410|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102345416|NCT05675410|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102345417|NCT05675410|Cortisone|cortisone|mesh-list
102345418|NCT05675410|Cyclophosphamide|cyclophosphamide|mesh-list
102345419|NCT05675410|Dacarbazine|dacarbazine|mesh-list
102345420|NCT05675410|Doxorubicin|doxorubicin|mesh-list
102345421|NCT05675410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102345422|NCT05675410|Nivolumab|nivolumab|mesh-list
102345423|NCT05675410|Etoposide|etoposide|mesh-list
101858543|NCT00319020|Bosentan|bosentan|mesh-list
102345425|NCT05675410|Vincristine|vincristine|mesh-list
102345426|NCT05675410|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102345427|NCT05675410|Bleomycin|bleomycin|mesh-list
102345428|NCT05675410|Vinblastine|vinblastine|mesh-list
102345429|NCT05675410|Podophyllotoxin|podophyllotoxin|mesh-list
102345430|NCT05675410|Procarbazine|procarbazine|mesh-list
102345431|NCT05675410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102345432|NCT05675410|Antibodies|antibodies|mesh-list
102345433|NCT05675410|Immunoglobulins|immunoglobulins|mesh-list
102345434|NCT05675410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102345435|NCT05675410|Imidazole|imidazole|mesh-list
102345436|NCT05675410|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102345437|NCT05675410|Prednisolone phosphate|prednisolone phosphate|mesh-list
102345438|NCT05675410|Immunoconjugates|immunoconjugates|mesh-list
102345439|NCT05675410|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102345440|NCT05675410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102345441|NCT05675410|Immunologic Factors|immunologic factors|mesh-ancestor
102345442|NCT05675410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345443|NCT05675410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102345444|NCT05675410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102345445|NCT05675410|Alkylating Agents|alkylating agents|mesh-ancestor
102345446|NCT05675410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345447|NCT05675410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102345448|NCT05675410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102345449|NCT05675410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102345450|NCT05675410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102345451|NCT05675410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102345452|NCT05675410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102345453|NCT05675410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102345454|NCT05675410|Glucocorticoids|glucocorticoids|mesh-ancestor
102345455|NCT05675410|Hormones|hormones|mesh-ancestor
102345456|NCT05675410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102345457|NCT05675410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102345458|NCT05675410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102345459|NCT05675410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102345460|NCT05675410|Tubulin Modulators|tubulin modulators|mesh-ancestor
102345461|NCT05675410|Antimitotic Agents|antimitotic agents|mesh-ancestor
102345462|NCT05675410|Mitosis Modulators|mitosis modulators|mesh-ancestor
102345463|NCT05675410|Antiemetics|antiemetics|mesh-ancestor
102345464|NCT05675410|Autonomic Agents|autonomic agents|mesh-ancestor
101858644|NCT00346268|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102345465|NCT05675410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102345466|NCT05675410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102345467|NCT05675410|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102345468|NCT05675410|Protective Agents|protective agents|mesh-ancestor
102345469|NCT05675410|Immunotoxins|immunotoxins|mesh-ancestor
102345470|NCT05675410|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102345471|NCT05675410|Keratolytic Agents|keratolytic agents|mesh-ancestor
102345472|NCT05675410|Dermatologic Agents|dermatologic agents|mesh-ancestor
102345473|NCT05675410|Antimetabolites|antimetabolites|mesh-ancestor
102345474|NCT05675410|Antiviral Agents|antiviral agents|mesh-ancestor
102345475|NCT05675410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102345476|NCT05673200|Paclitaxel|paclitaxel|mesh-list
102345477|NCT05673200|Pembrolizumab|pembrolizumab|mesh-list
102345478|NCT05673200|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102345479|NCT05673200|Decitabine|decitabine|mesh-list
101443492|NCT00555100|Antiemetics|antiemetics|mesh-ancestor
102345480|NCT05673200|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
102345481|NCT05673200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102345482|NCT05673200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102345483|NCT05673200|Tubulin Modulators|tubulin modulators|mesh-ancestor
102345484|NCT05673200|Antimitotic Agents|antimitotic agents|mesh-ancestor
102345485|NCT05673200|Mitosis Modulators|mitosis modulators|mesh-ancestor
102345486|NCT05673200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345487|NCT05673200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102345488|NCT05673200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102345489|NCT05673200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102345490|NCT05673200|Antimetabolites|antimetabolites|mesh-ancestor
102345491|NCT05673200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102345492|NCT05665465|Nicotine|nicotine|mesh-list
102345493|NCT05665465|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102345494|NCT05665465|Autonomic Agents|autonomic agents|mesh-ancestor
102345495|NCT05665465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102345496|NCT05665465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345497|NCT05665465|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102345498|NCT05665465|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102345499|NCT05665465|Cholinergic Agents|cholinergic agents|mesh-ancestor
102345500|NCT05665465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102345501|NCT05665465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345502|NCT05661279|Anesthetics|anesthetics|mesh-list
102345503|NCT05661279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102345504|NCT05661279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345505|NCT05658484|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102345506|NCT05658484|Dermatologic Agents|dermatologic agents|mesh-ancestor
102345509|NCT05658484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345528|NCT05636189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345530|NCT05629702|Nabiximols|nabiximols|mesh-list
102345531|NCT05629702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102345532|NCT05629702|Alkylating Agents|alkylating agents|mesh-ancestor
102345533|NCT05629702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345534|NCT05629702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102345535|NCT05629702|Analgesics|analgesics|mesh-ancestor
102345536|NCT05629702|Sensory System Agents|sensory system agents|mesh-ancestor
102345537|NCT05629702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102345538|NCT05629702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345539|NCT05626998|Dexmedetomidine|dexmedetomidine|mesh-list
102345541|NCT05626998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102345542|NCT05626998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101859252|NCT00324038|Codeine|codeine|mesh-list
102345543|NCT05626998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345544|NCT05626998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101859301|NCT00313014|Oxycodone|oxycodone|mesh-list
102345546|NCT05626998|Sensory System Agents|sensory system agents|mesh-ancestor
102345547|NCT05626998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101859369|NCT00224133|Silodosin|silodosin|mesh-list
102345548|NCT05626998|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102345549|NCT05626998|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102345550|NCT05626998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102345551|NCT05626998|Adrenergic Agents|adrenergic agents|mesh-ancestor
102345552|NCT05626998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102345553|NCT05626998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345554|NCT05626998|Anticonvulsants|anticonvulsants|mesh-ancestor
102345555|NCT05626998|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102345556|NCT05626998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102345557|NCT05626998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102345558|NCT05626998|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102345559|NCT05626998|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102345560|NCT05626998|Antimanic Agents|antimanic agents|mesh-ancestor
102345561|NCT05605535|Paclitaxel|paclitaxel|mesh-list
102345562|NCT05605535|Carboplatin|carboplatin|mesh-list
102345563|NCT05605535|Oregovomab|oregovomab|mesh-list
102345564|NCT05605535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102345565|NCT05605535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102345566|NCT05605535|Tubulin Modulators|tubulin modulators|mesh-ancestor
102345567|NCT05605535|Antimitotic Agents|antimitotic agents|mesh-ancestor
102345568|NCT05605535|Mitosis Modulators|mitosis modulators|mesh-ancestor
102345569|NCT05605535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345570|NCT05605535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102345571|NCT05601882|Upadacitinib|upadacitinib|mesh-list
102345572|NCT05601882|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102345574|NCT05601882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101859716|NCT03986294|Micronutrients|micronutrients|mesh-ancestor
102345575|NCT05601882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859792|NCT03982862|Glucocorticoids|glucocorticoids|mesh-ancestor
102345576|NCT05601882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102345577|NCT05597839|Nivolumab|nivolumab|mesh-list
102345578|NCT05597839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102345579|NCT05597839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102345580|NCT05597839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102345581|NCT05597839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345582|NCT05592223|Rifampin|rifampin|mesh-list
102345583|NCT05592223|Isoniazid|isoniazid|mesh-list
102345584|NCT05592223|BCG Vaccine|bcg vaccine|mesh-list
102345585|NCT05592223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102345587|NCT05592223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102345588|NCT05592223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102345589|NCT05592223|Leprostatic Agents|leprostatic agents|mesh-ancestor
101860079|NCT03980496|Omeprazole|omeprazole|mesh-list
102345590|NCT05592223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102345591|NCT05592223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102345592|NCT05592223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345593|NCT05592223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102345594|NCT05592223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102345595|NCT05592223|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102345596|NCT05592223|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102345597|NCT05592223|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102345598|NCT05592223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102345599|NCT05592223|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102345600|NCT05592223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102345601|NCT05592223|Antimetabolites|antimetabolites|mesh-ancestor
102345602|NCT05592223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102345603|NCT05592223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102345604|NCT05592223|Immunologic Factors|immunologic factors|mesh-ancestor
101860510|NCT03978494|Tacrolimus|tacrolimus|mesh-list
102345605|NCT05592223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345606|NCT05582174|Esomeprazole|esomeprazole|mesh-list
101860580|NCT00299130|Glucocorticoids|glucocorticoids|mesh-ancestor
101860655|NCT03979248|Rabeprazole|rabeprazole|mesh-list
102345608|NCT05582174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101860729|NCT00298272|Antiemetics|antiemetics|mesh-ancestor
102345609|NCT05582174|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102345610|NCT05582174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101860803|NCT01068132|Cetuximab|cetuximab|mesh-list
102345611|NCT05582174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345612|NCT05578976|Prednisone|prednisone|mesh-list
102345613|NCT05578976|Cyclophosphamide|cyclophosphamide|mesh-list
102345615|NCT05578976|Doxorubicin|doxorubicin|mesh-list
102345616|NCT05578976|Vincristine|vincristine|mesh-list
102345617|NCT05578976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102345618|NCT05578976|Immunologic Factors|immunologic factors|mesh-ancestor
102345619|NCT05578976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860954|NCT00495755|Alemtuzumab|alemtuzumab|mesh-list
102345620|NCT05578976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102345621|NCT05578976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102345622|NCT05578976|Alkylating Agents|alkylating agents|mesh-ancestor
102345623|NCT05578976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345624|NCT05578976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101861090|NCT00270894|Docetaxel|docetaxel|mesh-list
102345625|NCT05578976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102345626|NCT05578976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101861174|NCT00295022|Histamine Agents|histamine agents|mesh-ancestor
102345627|NCT05578976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102345628|NCT05578976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102345629|NCT05578976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102345630|NCT05578976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102345631|NCT05578976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101861313|NCT03975036|Antibodies|antibodies|mesh-list
102345632|NCT05578976|Glucocorticoids|glucocorticoids|mesh-ancestor
102345633|NCT05578976|Hormones|hormones|mesh-ancestor
102345634|NCT05578976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102345635|NCT05578976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102345636|NCT05578976|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102345637|NCT05578976|Tubulin Modulators|tubulin modulators|mesh-ancestor
101861524|NCT00316082|Metformin|metformin|mesh-list
102345638|NCT05578976|Antimitotic Agents|antimitotic agents|mesh-ancestor
102345639|NCT05578976|Mitosis Modulators|mitosis modulators|mesh-ancestor
102345640|NCT05578664|Pembrolizumab|pembrolizumab|mesh-list
102345641|NCT05578664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102345642|NCT05578664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101861679|NCT01084486|Metformin|metformin|mesh-list
102345643|NCT05578664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102345644|NCT05578664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345645|NCT05555901|Bevacizumab|bevacizumab|mesh-list
102345646|NCT05555901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102345647|NCT05555901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102345648|NCT05555901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102345649|NCT05555901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102345650|NCT05555901|Growth Substances|growth substances|mesh-ancestor
102345651|NCT05555901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345652|NCT05555901|Growth Inhibitors|growth inhibitors|mesh-ancestor
102345653|NCT05554354|Fulvestrant|fulvestrant|mesh-list
102345654|NCT05554354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102345656|NCT05554354|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102345657|NCT05554354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102345658|NCT05554354|Hormone Antagonists|hormone antagonists|mesh-ancestor
102345659|NCT05554354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102345660|NCT05554354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345661|NCT05554328|Olaparib|olaparib|mesh-list
101861817|NCT01082458|Remifentanil|remifentanil|mesh-list
102345662|NCT05554328|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102345663|NCT05554328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102345664|NCT05554328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345665|NCT05554328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102345666|NCT05545969|Pembrolizumab|pembrolizumab|mesh-list
102345667|NCT05545969|Lenvatinib|lenvatinib|mesh-list
102345668|NCT05545969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102345669|NCT05545969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102345670|NCT05545969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102345671|NCT05545969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345672|NCT05545969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102345673|NCT05545969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102345674|NCT05541341|Tisagenlecleucel|tisagenlecleucel|mesh-list
101862238|NCT03961828|Sofosbuvir|sofosbuvir|mesh-list
102345675|NCT05541341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102345676|NCT05541341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102345677|NCT05538910|Nicotine|nicotine|mesh-list
102345678|NCT05538910|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102345679|NCT05538910|Autonomic Agents|autonomic agents|mesh-ancestor
102345680|NCT05538910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102345681|NCT05538910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345683|NCT05538910|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102345684|NCT05538910|Cholinergic Agents|cholinergic agents|mesh-ancestor
102345685|NCT05538910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102345686|NCT05538910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345687|NCT05538208|Mycophenolic Acid|mycophenolic acid|mesh-list
102345688|NCT05538208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101862454|NCT00263328|Tacrolimus|tacrolimus|mesh-list
101862522|NCT01072890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102345689|NCT05538208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102345690|NCT05538208|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102345691|NCT05538208|Antitubercular Agents|antitubercular agents|mesh-ancestor
102345692|NCT05538208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101443507|NCT00555139|Alprazolam|alprazolam|mesh-list
102345693|NCT05538208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102345694|NCT05538208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102345695|NCT05538208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345697|NCT05533775|Obinutuzumab|obinutuzumab|mesh-list
102345698|NCT05533775|Carboplatin|carboplatin|mesh-list
102345699|NCT05533775|Etoposide|etoposide|mesh-list
102345700|NCT05533775|Ifosfamide|ifosfamide|mesh-list
102345701|NCT05533775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102345702|NCT05533775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102345703|NCT05533775|Immunologic Factors|immunologic factors|mesh-ancestor
102345704|NCT05533775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345705|NCT05533775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102345706|NCT05533775|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102345707|NCT05533775|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102345708|NCT05533775|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102345709|NCT05533775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102345710|NCT05533775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345711|NCT05533775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102345712|NCT05533775|Alkylating Agents|alkylating agents|mesh-ancestor
102345713|NCT05529069|Venetoclax|venetoclax|mesh-list
102345714|NCT05529069|Pirtobrutinib|pirtobrutinib|mesh-list
102345715|NCT05529069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863113|NCT01327066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102345716|NCT05529069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102345717|NCT05529069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102345718|NCT05529069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345719|NCT05526755|Osimertinib|osimertinib|mesh-list
102345720|NCT05526755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102345721|NCT05526755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102345722|NCT05526755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102345723|NCT05526755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345724|NCT05521828|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102345725|NCT05521828|Dydrogesterone|dydrogesterone|mesh-list
102345726|NCT05521828|Hormones|hormones|mesh-ancestor
102345727|NCT05521828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101863391|NCT00062374|Cisplatin|cisplatin|mesh-list
102345728|NCT05521828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345730|NCT05514197|Ascorbic Acid|ascorbic acid|mesh-list
102345731|NCT05514197|Antioxidants|antioxidants|mesh-ancestor
101863460|NCT00291668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102345732|NCT05514197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345733|NCT05514197|Protective Agents|protective agents|mesh-ancestor
102345734|NCT05514197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345735|NCT05514197|Vitamins|vitamins|mesh-ancestor
102345736|NCT05514197|Micronutrients|micronutrients|mesh-ancestor
102345737|NCT05507580|Upadacitinib|upadacitinib|mesh-list
102345738|NCT05507580|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102345739|NCT05507580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102345740|NCT05507580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102345741|NCT05507580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345742|NCT05507580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102345743|NCT05447026|Anti-Infective Agents|anti-infective agents|mesh-list
102345744|NCT05447026|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102345745|NCT05436418|Sirolimus|sirolimus|mesh-list
102345746|NCT05436418|Cyclophosphamide|cyclophosphamide|mesh-list
102345747|NCT05436418|Melphalan|melphalan|mesh-list
102345748|NCT05436418|Fludarabine|fludarabine|mesh-list
101863823|NCT00281840|Bevacizumab|bevacizumab|mesh-list
102345749|NCT05436418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102345750|NCT05436418|Immunologic Factors|immunologic factors|mesh-ancestor
102345751|NCT05436418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345752|NCT05436418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102345753|NCT05436418|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102345754|NCT05436418|Alkylating Agents|alkylating agents|mesh-ancestor
102345755|NCT05436418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345756|NCT05436418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102345757|NCT05436418|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102345758|NCT05436418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102345759|NCT05436418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102345760|NCT05436418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102345761|NCT05436418|Antifungal Agents|antifungal agents|mesh-ancestor
102345763|NCT05421065|Psilocybin|psilocybin|mesh-list
102345764|NCT05421065|Analgesics|analgesics|mesh-ancestor
102345765|NCT05421065|Sensory System Agents|sensory system agents|mesh-ancestor
102345766|NCT05421065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102345767|NCT05421065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345768|NCT05421065|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102345769|NCT05421065|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102345770|NCT05421065|Anesthetics, General|anesthetics, general|mesh-ancestor
102345771|NCT05421065|Anesthetics|anesthetics|mesh-ancestor
102345772|NCT05421065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101864099|NCT00268346|Gefitinib|gefitinib|mesh-list
102345773|NCT05421065|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102345774|NCT05421065|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102345775|NCT05421065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102345776|NCT05421065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345777|NCT05421065|Hallucinogens|hallucinogens|mesh-ancestor
102345778|NCT05421065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102345780|NCT05418972|Relatlimab|relatlimab|mesh-list
102345781|NCT05418972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102345782|NCT05418972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102345783|NCT05418972|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101864454|NCT00238238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102345784|NCT05418972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345785|NCT05416333|Azelaic acid|azelaic acid|mesh-list
102345786|NCT05416333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101864529|NCT00265382|Ziprasidone|ziprasidone|mesh-list
102345787|NCT05416333|Dermatologic Agents|dermatologic agents|mesh-ancestor
102345789|NCT05409066|Lenalidomide|lenalidomide|mesh-list
102345790|NCT05409066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102345792|NCT05409066|Immunologic Factors|immunologic factors|mesh-ancestor
102345793|NCT05409066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345794|NCT05409066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102345795|NCT05409066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101864813|NCT01097512|Gemcitabine|gemcitabine|mesh-list
102345796|NCT05409066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102345797|NCT05409066|Growth Substances|growth substances|mesh-ancestor
102345798|NCT05409066|Growth Inhibitors|growth inhibitors|mesh-ancestor
101864884|NCT01323257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102345799|NCT05399173|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
102345800|NCT05399173|Hemostatics|hemostatics|mesh-ancestor
102345801|NCT05399173|Coagulants|coagulants|mesh-ancestor
101864968|NCT03567473|Mydriatics|mydriatics|mesh-ancestor
102345802|NCT05399173|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101865031|NCT03995147|Pembrolizumab|pembrolizumab|mesh-list
102345803|NCT05399173|Natriuretic Agents|natriuretic agents|mesh-ancestor
102345804|NCT05399173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345805|NCT05388877|Dabrafenib|dabrafenib|mesh-list
101865120|NCT03357419|Cephalexin|cephalexin|mesh-list
102345806|NCT05388877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101865177|NCT00435461|Fluticasone|fluticasone|mesh-list
102345807|NCT05388877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102345808|NCT05388877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101865250|NCT01029743|Analgesics|analgesics|mesh-ancestor
102345816|NCT05371899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102345817|NCT05371899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102345818|NCT05371899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345819|NCT05369052|Linezolid|linezolid|mesh-list
102345820|NCT05369052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102345821|NCT05369052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102345822|NCT05369052|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102345823|NCT05369052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101443518|NCT00203463|Topiramate|topiramate|mesh-list
101865390|NCT00005908|Hormone Antagonists|hormone antagonists|mesh-ancestor
102345824|NCT05369052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345826|NCT05339256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102345827|NCT05339256|Narcotics|narcotics|mesh-ancestor
102345828|NCT05339256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102345829|NCT05339256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345830|NCT05339256|Analgesics|analgesics|mesh-ancestor
102345831|NCT05339256|Sensory System Agents|sensory system agents|mesh-ancestor
102345832|NCT05339256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102345833|NCT05339256|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102345834|NCT05338671|Anesthetics|anesthetics|mesh-list
102345835|NCT05338671|Anesthetics, Local|anesthetics, local|mesh-list
102345836|NCT05338671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102345838|NCT05338671|Sensory System Agents|sensory system agents|mesh-ancestor
101865468|NCT00004888|Docetaxel|docetaxel|mesh-list
102345839|NCT05338671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102345840|NCT05335993|Niraparib|niraparib|mesh-list
102345841|NCT05335993|Oregovomab|oregovomab|mesh-list
102345842|NCT05335993|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102345843|NCT05335993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101865596|NCT01077999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102345844|NCT05335993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865673|NCT00126555|Gefitinib|gefitinib|mesh-list
102345846|NCT05335993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102345848|NCT05327023|Sirolimus|sirolimus|mesh-list
101865823|NCT01099462|Ibuprofen|ibuprofen|mesh-list
102345849|NCT05327023|Cyclophosphamide|cyclophosphamide|mesh-list
102345850|NCT05327023|Busulfan|busulfan|mesh-list
102345851|NCT05327023|Fludarabine|fludarabine|mesh-list
102345852|NCT05327023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102345853|NCT05327023|Immunologic Factors|immunologic factors|mesh-ancestor
102345854|NCT05327023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345855|NCT05327023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102345856|NCT05327023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102345857|NCT05327023|Alkylating Agents|alkylating agents|mesh-ancestor
102345858|NCT05327023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345859|NCT05327023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102345860|NCT05327023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102345861|NCT05327023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102345862|NCT05327023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102345863|NCT05327023|Antitubercular Agents|antitubercular agents|mesh-ancestor
102345864|NCT05327023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102345865|NCT05327023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102345866|NCT05327023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102345867|NCT05327023|Antifungal Agents|antifungal agents|mesh-ancestor
102345868|NCT05322707|Budesonide|budesonide|mesh-list
102345869|NCT05322707|Formoterol Fumarate|formoterol fumarate|mesh-list
102345870|NCT05322707|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
102345871|NCT05322707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102345872|NCT05322707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102345873|NCT05322707|Autonomic Agents|autonomic agents|mesh-ancestor
102345874|NCT05322707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102345875|NCT05322707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345876|NCT05322707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101866018|NCT00026494|Tubulin Modulators|tubulin modulators|mesh-ancestor
102345877|NCT05322707|Respiratory System Agents|respiratory system agents|mesh-ancestor
102345879|NCT05322707|Hormones|hormones|mesh-ancestor
102345880|NCT05322707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102345881|NCT05322707|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102345882|NCT05322707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102345883|NCT05322707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102345884|NCT05322707|Adrenergic Agents|adrenergic agents|mesh-ancestor
102345885|NCT05322707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102345886|NCT05322707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345887|NCT05320887|Nicotine|nicotine|mesh-list
102345888|NCT05320887|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101866169|NCT01582646|Terbutaline|terbutaline|mesh-list
102345889|NCT05320887|Autonomic Agents|autonomic agents|mesh-ancestor
102345890|NCT05320887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102345891|NCT05320887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345892|NCT05320887|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102345893|NCT05320887|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101866224|NCT03815175|Antipyretics|antipyretics|mesh-ancestor
102345894|NCT05320887|Cholinergic Agents|cholinergic agents|mesh-ancestor
102345895|NCT05320887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102345896|NCT05320887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345897|NCT05316233|Hyaluronic Acid|hyaluronic acid|mesh-list
101866307|NCT00180674|Warfarin|warfarin|mesh-list
102345898|NCT05316233|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102345899|NCT05316233|Immunologic Factors|immunologic factors|mesh-ancestor
102345900|NCT05316233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345901|NCT05316233|Viscosupplements|viscosupplements|mesh-ancestor
102345902|NCT05316233|Protective Agents|protective agents|mesh-ancestor
102345910|NCT05282121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345912|NCT05282121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345913|NCT05267600|Prednisone|prednisone|mesh-list
102345914|NCT05267600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102345915|NCT05267600|Glucocorticoids|glucocorticoids|mesh-ancestor
102345916|NCT05267600|Hormones|hormones|mesh-ancestor
102345917|NCT05267600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101866569|NCT00073528|Letrozole|letrozole|mesh-list
102345918|NCT05267600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345919|NCT05267600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102345920|NCT05267600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102345921|NCT05251636|Aflibercept|aflibercept|mesh-list
102345922|NCT05251636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101866642|NCT00072280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102345923|NCT05251636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101866713|NCT01107106|Ulipristal acetate|ulipristal acetate|mesh-list
102345924|NCT05251636|Growth Substances|growth substances|mesh-ancestor
102345925|NCT05251636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345926|NCT05251636|Growth Inhibitors|growth inhibitors|mesh-ancestor
102345927|NCT05251636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102345929|NCT05226663|Cariostatic Agents|cariostatic agents|mesh-ancestor
102345930|NCT05226663|Protective Agents|protective agents|mesh-ancestor
101866859|NCT01104844|Acetaminophen|acetaminophen|mesh-list
101866927|NCT03947242|Antimitotic Agents|antimitotic agents|mesh-ancestor
102345931|NCT05226663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345932|NCT05214820|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102345933|NCT05214820|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
102345934|NCT05214820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345935|NCT05191797|Atezolizumab|atezolizumab|mesh-list
102345936|NCT05191797|Immunoglobulins|immunoglobulins|mesh-list
102345937|NCT05191797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102345938|NCT05191797|Immunoglobulin G|immunoglobulin g|mesh-list
101443558|NCT03454984|Guadecitabine|guadecitabine|mesh-list
102345939|NCT05191797|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102345940|NCT05191797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345941|NCT05191797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102345942|NCT05191797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102345943|NCT05191797|Immunologic Factors|immunologic factors|mesh-ancestor
101867219|NCT01210066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102345944|NCT05191797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345945|NCT05163522|Midazolam|midazolam|mesh-list
102345946|NCT05163522|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102345947|NCT05163522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102345948|NCT05163522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102345949|NCT05163522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345950|NCT05163522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102345951|NCT05163522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102345952|NCT05163522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102345953|NCT05163522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102345954|NCT05163522|Anesthetics, General|anesthetics, general|mesh-ancestor
102345955|NCT05163522|Anesthetics|anesthetics|mesh-ancestor
102345956|NCT05163522|GABA Modulators|gaba modulators|mesh-ancestor
102345957|NCT05163522|GABA Agents|gaba agents|mesh-ancestor
102345958|NCT05163522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102345959|NCT05163522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867428|NCT01114048|Thalidomide|thalidomide|mesh-list
102345961|NCT05142735|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102345962|NCT05142735|Antiviral Agents|antiviral agents|mesh-ancestor
102345963|NCT05142735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102345964|NCT05142735|Expectorants|expectorants|mesh-ancestor
102345965|NCT05142735|Respiratory System Agents|respiratory system agents|mesh-ancestor
102345966|NCT05142735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102345967|NCT05142735|Antioxidants|antioxidants|mesh-ancestor
102345968|NCT05142735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345969|NCT05142735|Protective Agents|protective agents|mesh-ancestor
102345970|NCT05142735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345971|NCT05142735|Antidotes|antidotes|mesh-ancestor
102345972|NCT05134363|Dexmedetomidine|dexmedetomidine|mesh-list
102345973|NCT05134363|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102345974|NCT05134363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102345975|NCT05134363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345976|NCT05134363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102345977|NCT05134363|Analgesics|analgesics|mesh-ancestor
102345978|NCT05134363|Sensory System Agents|sensory system agents|mesh-ancestor
102345979|NCT05134363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102345980|NCT05134363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102345981|NCT05134363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102345982|NCT05134363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102345983|NCT05134363|Adrenergic Agents|adrenergic agents|mesh-ancestor
101867557|NCT01121848|Leucovorin|leucovorin|mesh-list
102345984|NCT05134363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102345985|NCT05134363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345987|NCT05130268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102345989|NCT05115110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102345990|NCT05115110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102345991|NCT05115110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102345992|NCT05107674|Paclitaxel|paclitaxel|mesh-list
102345993|NCT05107674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102345994|NCT05107674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102345995|NCT05107674|Tubulin Modulators|tubulin modulators|mesh-ancestor
101867631|NCT01124500|Dopamine Agents|dopamine agents|mesh-ancestor
102345996|NCT05107674|Antimitotic Agents|antimitotic agents|mesh-ancestor
102345997|NCT05107674|Mitosis Modulators|mitosis modulators|mesh-ancestor
102345998|NCT05107674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102345999|NCT05070104|Bevacizumab|bevacizumab|mesh-list
102346000|NCT05070104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102346001|NCT05070104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101867768|NCT01125124|Silver Nitrate|silver nitrate|mesh-list
102346002|NCT05070104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102346003|NCT05070104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102346004|NCT05070104|Growth Substances|growth substances|mesh-ancestor
102346005|NCT05070104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346006|NCT05070104|Growth Inhibitors|growth inhibitors|mesh-ancestor
102346008|NCT05049863|Irinotecan|irinotecan|mesh-list
102346009|NCT05049863|Allopurinol|allopurinol|mesh-list
102346010|NCT05049863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102346011|NCT05049863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102346012|NCT05049863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102346013|NCT05049863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346014|NCT05049863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346015|NCT05049863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102346016|NCT05049863|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102346017|NCT05049863|Antitubercular Agents|antitubercular agents|mesh-ancestor
102346018|NCT05049863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102346019|NCT05049863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102346020|NCT05049863|Antimetabolites|antimetabolites|mesh-ancestor
102346021|NCT05049863|Gout Suppressants|gout suppressants|mesh-ancestor
102346022|NCT05049863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102346023|NCT05049863|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102346024|NCT05049863|Antioxidants|antioxidants|mesh-ancestor
102346025|NCT05049863|Protective Agents|protective agents|mesh-ancestor
102346026|NCT05049863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346027|NCT05020899|Nicotine|nicotine|mesh-list
102346028|NCT05020899|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102346033|NCT05020899|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102346034|NCT05020899|Cholinergic Agents|cholinergic agents|mesh-ancestor
102346035|NCT05020899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102346036|NCT05020899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346037|NCT04978493|Ustekinumab|ustekinumab|mesh-list
102346038|NCT04978493|Dermatologic Agents|dermatologic agents|mesh-ancestor
102346039|NCT04954287|Vaccines|vaccines|mesh-list
102346040|NCT04954287|Immunologic Factors|immunologic factors|mesh-ancestor
102346041|NCT04954287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346042|NCT04934748|Phenylephrine|phenylephrine|mesh-list
102346043|NCT04934748|Oxymetazoline|oxymetazoline|mesh-list
102346044|NCT04934748|Norepinephrine|norepinephrine|mesh-list
102346045|NCT04934748|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102346046|NCT04934748|Mydriatics|mydriatics|mesh-ancestor
102346047|NCT04934748|Autonomic Agents|autonomic agents|mesh-ancestor
102346048|NCT04934748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102346049|NCT04934748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346050|NCT04934748|Sympathomimetics|sympathomimetics|mesh-ancestor
102346051|NCT04934748|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102346052|NCT04934748|Nasal Decongestants|nasal decongestants|mesh-ancestor
102346053|NCT04934748|Respiratory System Agents|respiratory system agents|mesh-ancestor
102346054|NCT04934748|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102346055|NCT04934748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102346056|NCT04934748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102346057|NCT04934748|Adrenergic Agents|adrenergic agents|mesh-ancestor
102346058|NCT04934748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102346059|NCT04934748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054897|NCT01567735|Simeprevir|simeprevir|mesh-list
102346060|NCT04934748|Protective Agents|protective agents|mesh-ancestor
102346080|NCT04856319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102346081|NCT04854499|Carboplatin|carboplatin|mesh-list
102346082|NCT04854499|Docetaxel|docetaxel|mesh-list
102346083|NCT04854499|Pembrolizumab|pembrolizumab|mesh-list
102346084|NCT04854499|Magrolimab|magrolimab|mesh-list
102346085|NCT04854499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346086|NCT04854499|Tubulin Modulators|tubulin modulators|mesh-ancestor
102346087|NCT04854499|Antimitotic Agents|antimitotic agents|mesh-ancestor
102346088|NCT04854499|Mitosis Modulators|mitosis modulators|mesh-ancestor
102346089|NCT04854499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346090|NCT04854499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102346091|NCT04854499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102346093|NCT04830813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346094|NCT04830813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102346095|NCT04830813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102346096|NCT04830813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346097|NCT04789408|Cyclophosphamide|cyclophosphamide|mesh-list
102346098|NCT04789408|Fludarabine|fludarabine|mesh-list
102346099|NCT04789408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102346100|NCT04789408|Immunologic Factors|immunologic factors|mesh-ancestor
102346101|NCT04789408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346102|NCT04789408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102346103|NCT04789408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102346104|NCT04789408|Alkylating Agents|alkylating agents|mesh-ancestor
102346105|NCT04789408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346106|NCT04789408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346107|NCT04789408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102346108|NCT04788108|Dydrogesterone|dydrogesterone|mesh-list
102346109|NCT04788108|Progestins|progestins|mesh-ancestor
102346110|NCT04788108|Hormones|hormones|mesh-ancestor
102346111|NCT04788108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102346112|NCT04788108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346114|NCT04759586|Prednisolone|prednisolone|mesh-list
102346115|NCT04759586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102346116|NCT04759586|Methylprednisolone|methylprednisolone|mesh-list
102346117|NCT04759586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102346118|NCT04759586|Prednisolone acetate|prednisolone acetate|mesh-list
102346119|NCT04759586|Hydrocortisone|hydrocortisone|mesh-list
102346120|NCT04759586|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102346121|NCT04759586|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102346122|NCT04759586|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102346123|NCT04759586|Cortisone|cortisone|mesh-list
102346124|NCT04759586|Cyclophosphamide|cyclophosphamide|mesh-list
102346125|NCT04759586|Rituximab|rituximab|mesh-list
102346126|NCT04759586|Doxorubicin|doxorubicin|mesh-list
102346127|NCT04759586|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102346128|NCT04759586|Nivolumab|nivolumab|mesh-list
102346129|NCT04759586|Etoposide|etoposide|mesh-list
102346130|NCT04759586|Vincristine|vincristine|mesh-list
102346131|NCT04759586|Etoposide phosphate|etoposide phosphate|mesh-list
102346132|NCT04759586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102346133|NCT04759586|Antibodies|antibodies|mesh-list
102346134|NCT04759586|Immunoglobulins|immunoglobulins|mesh-list
102346135|NCT04759586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102346137|NCT04759586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102346138|NCT04759586|Prednisolone phosphate|prednisolone phosphate|mesh-list
102346139|NCT04759586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102346140|NCT04759586|Immunologic Factors|immunologic factors|mesh-ancestor
102346141|NCT04759586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346142|NCT04759586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102346143|NCT04759586|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102346144|NCT04759586|Alkylating Agents|alkylating agents|mesh-ancestor
102346145|NCT04759586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346146|NCT04759586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346147|NCT04759586|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102346148|NCT04759586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102346149|NCT04759586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102346150|NCT04759586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102346151|NCT04759586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102346152|NCT04759586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102346153|NCT04759586|Glucocorticoids|glucocorticoids|mesh-ancestor
102346154|NCT04759586|Hormones|hormones|mesh-ancestor
102346155|NCT04759586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102346156|NCT04759586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102346157|NCT04759586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102346158|NCT04759586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102346159|NCT04759586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102346160|NCT04759586|Tubulin Modulators|tubulin modulators|mesh-ancestor
102346161|NCT04759586|Antimitotic Agents|antimitotic agents|mesh-ancestor
102346162|NCT04759586|Mitosis Modulators|mitosis modulators|mesh-ancestor
102346163|NCT04759586|Antiemetics|antiemetics|mesh-ancestor
102346164|NCT04759586|Autonomic Agents|autonomic agents|mesh-ancestor
102346165|NCT04759586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102346166|NCT04759586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102346167|NCT04759586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102346168|NCT04759586|Protective Agents|protective agents|mesh-ancestor
102346169|NCT04752696|Leucovorin|leucovorin|mesh-list
102346170|NCT04752696|Fluorouracil|fluorouracil|mesh-list
102346171|NCT04752696|Irinotecan|irinotecan|mesh-list
102346172|NCT04752696|Onvansertib|onvansertib|mesh-list
102346173|NCT04752696|Antimetabolites|antimetabolites|mesh-ancestor
102346174|NCT04752696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346175|NCT04752696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102346176|NCT04752696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346177|NCT04752696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102346178|NCT04752696|Immunologic Factors|immunologic factors|mesh-ancestor
102346179|NCT04752696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346180|NCT04752696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102346181|NCT04752696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102346182|NCT04752696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102346183|NCT04752696|Antidotes|antidotes|mesh-ancestor
102346184|NCT04752696|Protective Agents|protective agents|mesh-ancestor
102346185|NCT04752696|Vitamin B Complex|vitamin b complex|mesh-ancestor
102346186|NCT04752696|Vitamins|vitamins|mesh-ancestor
102346187|NCT04752696|Micronutrients|micronutrients|mesh-ancestor
102346188|NCT04752696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102346189|NCT04741438|Nivolumab|nivolumab|mesh-list
102346190|NCT04741438|Ipilimumab|ipilimumab|mesh-list
102346191|NCT04741438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101868697|NCT01130506|Cytarabine|cytarabine|mesh-list
102346193|NCT04741438|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102346194|NCT04741438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346195|NCT04731961|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102346196|NCT04731961|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102346197|NCT04731961|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102346198|NCT04731961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102346199|NCT04731961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346200|NCT04731961|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101868764|NCT01230034|Ramipril|ramipril|mesh-list
102346201|NCT04731961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102346202|NCT04731961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346203|NCT04731961|Cholinergic Agents|cholinergic agents|mesh-ancestor
102346204|NCT04731961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102346205|NCT04665739|Everolimus|everolimus|mesh-list
102346206|NCT04665739|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102346207|NCT04665739|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102346208|NCT04665739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102346209|NCT04665739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102346210|NCT04665739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346211|NCT04665739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102055055|NCT05179772|Serotonin Agents|serotonin agents|mesh-ancestor
102346212|NCT04665739|Immunologic Factors|immunologic factors|mesh-ancestor
102346213|NCT04665739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346214|NCT04665739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346215|NCT04665739|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102346216|NCT04662255|Acalabrutinib|acalabrutinib|mesh-list
102346217|NCT04662255|Zanubrutinib|zanubrutinib|mesh-list
102346218|NCT04662255|Pirtobrutinib|pirtobrutinib|mesh-list
102346219|NCT04662255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346220|NCT04662255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102346221|NCT04662255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102346222|NCT04662255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346224|NCT04648540|Celecoxib|celecoxib|mesh-list
102346225|NCT04648540|Ketorolac|ketorolac|mesh-list
102346226|NCT04648540|Lidocaine|lidocaine|mesh-list
102346227|NCT04648540|Pregabalin|pregabalin|mesh-list
102346228|NCT04648540|Fentanyl|fentanyl|mesh-list
102346229|NCT04648540|Dexmedetomidine|dexmedetomidine|mesh-list
102346230|NCT04648540|Morphine|morphine|mesh-list
102346231|NCT04648540|Anesthetics, Local|anesthetics, local|mesh-ancestor
102346232|NCT04648540|Anesthetics|anesthetics|mesh-ancestor
102346233|NCT04648540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102346234|NCT04648540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346235|NCT04648540|Sensory System Agents|sensory system agents|mesh-ancestor
102346236|NCT04648540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102346237|NCT04648540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102346238|NCT04648540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102346239|NCT04648540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101443586|NCT01773928|Vaccines|vaccines|mesh-list
102346240|NCT04648540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102346241|NCT04648540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346242|NCT04648540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102346243|NCT04648540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102346244|NCT04648540|Analgesics|analgesics|mesh-ancestor
101868959|NCT03769090|Albuterol|albuterol|mesh-list
102346245|NCT04648540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102346246|NCT04648540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102346247|NCT04648540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102346248|NCT04648540|Adrenergic Agents|adrenergic agents|mesh-ancestor
102346249|NCT04648540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102346250|NCT04648540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102346251|NCT04648540|Narcotics|narcotics|mesh-ancestor
102346252|NCT04648540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102346253|NCT04648540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102346254|NCT04648540|Anesthetics, General|anesthetics, general|mesh-ancestor
102346255|NCT04648540|Antipyretics|antipyretics|mesh-ancestor
102346256|NCT04648540|Anticonvulsants|anticonvulsants|mesh-ancestor
102346257|NCT04648540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102346258|NCT04648540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102346259|NCT04648540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102346260|NCT04648540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102346261|NCT04648540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102346262|NCT04648540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102346263|NCT04648540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102346264|NCT04648540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102346265|NCT04648540|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102346266|NCT04648540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102346267|NCT04648540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102346268|NCT04645823|Lidocaine|lidocaine|mesh-list
102346269|NCT04645823|Fentanyl|fentanyl|mesh-list
102346270|NCT04645823|Citric Acid|citric acid|mesh-list
102346271|NCT04645823|Sodium Citrate|sodium citrate|mesh-list
102346272|NCT04645823|Anesthetics, Local|anesthetics, local|mesh-ancestor
102346273|NCT04645823|Anesthetics|anesthetics|mesh-ancestor
102346274|NCT04645823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102346275|NCT04645823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346276|NCT04645823|Sensory System Agents|sensory system agents|mesh-ancestor
102346277|NCT04645823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102346278|NCT04645823|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102346279|NCT04645823|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102346280|NCT04645823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102346281|NCT04645823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102346282|NCT04645823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346283|NCT04645823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102346284|NCT04645823|Narcotics|narcotics|mesh-ancestor
102346285|NCT04645823|Analgesics|analgesics|mesh-ancestor
102346286|NCT04645823|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102346287|NCT04645823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102346288|NCT04645823|Anesthetics, General|anesthetics, general|mesh-ancestor
102346289|NCT04645823|Anticoagulants|anticoagulants|mesh-ancestor
102346290|NCT04645823|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102346291|NCT04645823|Chelating Agents|chelating agents|mesh-ancestor
102346292|NCT04645823|Sequestering Agents|sequestering agents|mesh-ancestor
102346293|NCT04624230|Tofacitinib|tofacitinib|mesh-list
101588992|NCT00658099|Insulin|insulin|mesh-list
102346294|NCT04624230|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102346295|NCT04624230|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102346296|NCT04624230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102346297|NCT04624230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346298|NCT04594382|Analgesics, Opioid|analgesics, opioid|mesh-list
102346299|NCT04594382|Narcotics|narcotics|mesh-ancestor
102346300|NCT04594382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102346301|NCT04594382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346302|NCT04594382|Analgesics|analgesics|mesh-ancestor
102346303|NCT04594382|Sensory System Agents|sensory system agents|mesh-ancestor
102346304|NCT04594382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102346306|NCT04558112|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101869254|NCT01236586|Hormones|hormones|mesh-ancestor
102346307|NCT04558112|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102346308|NCT04558112|Dopamine Agents|dopamine agents|mesh-ancestor
101869329|NCT02685826|Glucocorticoids|glucocorticoids|mesh-ancestor
102346309|NCT04558112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102346310|NCT04558112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346311|NCT04558112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346312|NCT04548752|Pembrolizumab|pembrolizumab|mesh-list
102346313|NCT04548752|Olaparib|olaparib|mesh-list
102346314|NCT04548752|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102346315|NCT04548752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102346316|NCT04548752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346317|NCT04548752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102346318|NCT04548752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346319|NCT04548752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102346320|NCT04546230|Anesthetics|anesthetics|mesh-list
102346321|NCT04546230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102346322|NCT04546230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346323|NCT04546178|Antipsychotic Agents|antipsychotic agents|mesh-list
102346324|NCT04546178|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102346325|NCT04546178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101869612|NCT00113295|Paroxetine|paroxetine|mesh-list
102346326|NCT04546178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346327|NCT04546178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102346328|NCT04495621|Cetuximab|cetuximab|mesh-list
102346329|NCT04495621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101869756|NCT01141894|Sympathomimetics|sympathomimetics|mesh-ancestor
102346330|NCT04495621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346332|NCT04473482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102346333|NCT04473482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102346334|NCT04473482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102346335|NCT04473482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346336|NCT04469686|Hydrocortisone|hydrocortisone|mesh-list
102346337|NCT04469686|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102346338|NCT04469686|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101869969|NCT01238926|Vitamins|vitamins|mesh-list
102346339|NCT04469686|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102346340|NCT04469686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102346341|NCT04440735|Atezolizumab|atezolizumab|mesh-list
102346342|NCT04440735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101870118|NCT01146028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102346343|NCT04440735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870188|NCT03106324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102346344|NCT04440735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101443624|NCT01756924|Antimalarials|antimalarials|mesh-ancestor
102346345|NCT04440735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101870334|NCT01251172|Melphalan|melphalan|mesh-list
102346348|NCT04439318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101870403|NCT01582542|Coagulants|coagulants|mesh-ancestor
102346349|NCT04439318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102346350|NCT04439318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102346351|NCT04439318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346352|NCT04439318|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102346353|NCT04439318|Protective Agents|protective agents|mesh-ancestor
102346354|NCT04439318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346355|NCT04439318|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102346356|NCT04439318|Antioxidants|antioxidants|mesh-ancestor
102346357|NCT04438512|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
102346358|NCT04438512|Hallucinogens|hallucinogens|mesh-ancestor
102346359|NCT04438512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346360|NCT04438512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102346361|NCT04438512|Serotonin Agents|serotonin agents|mesh-ancestor
102346362|NCT04438512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102346363|NCT04438512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346364|NCT04438512|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102346365|NCT04438512|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102346366|NCT04438512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102346367|NCT04438512|Adrenergic Agents|adrenergic agents|mesh-ancestor
102346368|NCT04434092|Eculizumab|eculizumab|mesh-list
102346369|NCT04434092|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102346370|NCT04434092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102346371|NCT04434092|Immunologic Factors|immunologic factors|mesh-ancestor
102346372|NCT04434092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346374|NCT04422392|Carboplatin|carboplatin|mesh-list
102346375|NCT04422392|Pemetrexed|pemetrexed|mesh-list
102346376|NCT04422392|Antibodies|antibodies|mesh-list
102346377|NCT04422392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102346378|NCT04422392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346379|NCT04422392|Tubulin Modulators|tubulin modulators|mesh-ancestor
102346380|NCT04422392|Antimitotic Agents|antimitotic agents|mesh-ancestor
102346381|NCT04422392|Mitosis Modulators|mitosis modulators|mesh-ancestor
102346382|NCT04422392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346383|NCT04422392|Immunologic Factors|immunologic factors|mesh-ancestor
102346384|NCT04422392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346385|NCT04422392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102346386|NCT04422392|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102346387|NCT04422392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102346388|NCT04414761|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102346389|NCT04414761|Medroxyprogesterone|medroxyprogesterone|mesh-list
102346391|NCT04414761|Progesterone|progesterone|mesh-list
102346392|NCT04414761|Dydrogesterone|dydrogesterone|mesh-list
102346393|NCT04414761|Ganirelix|ganirelix|mesh-list
102346394|NCT04414761|Progestins|progestins|mesh-ancestor
102346395|NCT04414761|Hormones|hormones|mesh-ancestor
102346396|NCT04414761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102346397|NCT04414761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346398|NCT04414761|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102346399|NCT04414761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102346400|NCT04414761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102346402|NCT04414761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102346403|NCT04414761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102346404|NCT04414761|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102346405|NCT04414761|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102346406|NCT04414761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102346407|NCT04414761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346408|NCT04414761|Hormone Antagonists|hormone antagonists|mesh-ancestor
102346409|NCT04414761|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102346416|NCT04400994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101871164|NCT01259050|Micronutrients|micronutrients|mesh-ancestor
101871300|NCT01152346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346433|NCT04367688|Antiviral Agents|antiviral agents|mesh-ancestor
102346434|NCT04367688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102346435|NCT04367688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102346436|NCT04367688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102346437|NCT04367688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101871526|NCT01152736|Nicotine|nicotine|mesh-list
102346448|NCT04318678|Fludarabine|fludarabine|mesh-list
102346449|NCT04318678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102346450|NCT04318678|Immunologic Factors|immunologic factors|mesh-ancestor
102346451|NCT04318678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346452|NCT04318678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102346453|NCT04318678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102346454|NCT04318678|Alkylating Agents|alkylating agents|mesh-ancestor
102346455|NCT04318678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346456|NCT04318678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346457|NCT04318678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102346458|NCT04318678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102346459|NCT04307238|Anesthetics|anesthetics|mesh-list
102346460|NCT04307238|Propofol|propofol|mesh-list
102346461|NCT04307238|Sevoflurane|sevoflurane|mesh-list
102346462|NCT04307238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102346463|NCT04307238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346464|NCT04307238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102346465|NCT04307238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102346466|NCT04307238|Anesthetics, General|anesthetics, general|mesh-ancestor
102346467|NCT04307238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102346468|NCT04307238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102346470|NCT04284774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346471|NCT04267848|Paclitaxel|paclitaxel|mesh-list
102346472|NCT04267848|Cisplatin|cisplatin|mesh-list
102346473|NCT04267848|Carboplatin|carboplatin|mesh-list
102346474|NCT04267848|Gemcitabine|gemcitabine|mesh-list
102346476|NCT04267848|Pemetrexed|pemetrexed|mesh-list
102346477|NCT04267848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102346478|NCT04267848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102346479|NCT04267848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346480|NCT04267848|Tubulin Modulators|tubulin modulators|mesh-ancestor
102346481|NCT04267848|Antimitotic Agents|antimitotic agents|mesh-ancestor
102346482|NCT04267848|Mitosis Modulators|mitosis modulators|mesh-ancestor
102346483|NCT04267848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346484|NCT04267848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102346485|NCT04267848|Antimetabolites|antimetabolites|mesh-ancestor
102346486|NCT04267848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102346488|NCT04267848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102346489|NCT04267848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101872138|NCT01166932|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102346490|NCT04267848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102346491|NCT04224571|Rituximab|rituximab|mesh-list
102346492|NCT04224571|Bortezomib|bortezomib|mesh-list
102346493|NCT04224571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102346494|NCT04224571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346495|NCT04224571|Immunologic Factors|immunologic factors|mesh-ancestor
102346496|NCT04224571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346497|NCT04224571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102346498|NCT04222062|Carmustine|carmustine|mesh-list
101872434|NCT01275508|Adalimumab|adalimumab|mesh-list
102346499|NCT04222062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102346500|NCT04222062|Alkylating Agents|alkylating agents|mesh-ancestor
101872576|NCT01168804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102346501|NCT04222062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346502|NCT04222062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346503|NCT04198766|Pembrolizumab|pembrolizumab|mesh-list
102346504|NCT04198766|Antibodies|antibodies|mesh-list
102346505|NCT04198766|Immunologic Factors|immunologic factors|mesh-ancestor
102346506|NCT04198766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346507|NCT04198766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102346508|NCT04198766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346509|NCT04198766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102346510|NCT04198766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873091|NCT01164826|Analgesics|analgesics|mesh-ancestor
102346512|NCT04195555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346513|NCT04195555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102346514|NCT04195555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346516|NCT04186598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102346517|NCT04186598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102346518|NCT04186598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346519|NCT04186598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102346520|NCT04186598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346521|NCT04186598|Vasodilator Agents|vasodilator agents|mesh-ancestor
102346522|NCT04186598|Tocolytic Agents|tocolytic agents|mesh-ancestor
102346523|NCT04186598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102346524|NCT04181060|Bevacizumab|bevacizumab|mesh-list
102346525|NCT04181060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102346526|NCT04181060|Osimertinib|osimertinib|mesh-list
102346527|NCT04181060|Endothelial Growth Factors|endothelial growth factors|mesh-list
102346529|NCT04181060|Immunoglobulins|immunoglobulins|mesh-list
102346530|NCT04181060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102346531|NCT04181060|Immunoglobulin G|immunoglobulin g|mesh-list
102346532|NCT04181060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346533|NCT04181060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102346534|NCT04181060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102346535|NCT04181060|Growth Substances|growth substances|mesh-ancestor
102346536|NCT04181060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346537|NCT04181060|Growth Inhibitors|growth inhibitors|mesh-ancestor
102346538|NCT04181060|Immunologic Factors|immunologic factors|mesh-ancestor
101873229|NCT01178320|Antimetabolites|antimetabolites|mesh-ancestor
102346547|NCT04103398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346548|NCT04103398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102346549|NCT04103398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102346550|NCT04103398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346551|NCT04103398|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102346553|NCT04103398|Hormones|hormones|mesh-ancestor
102346554|NCT04103398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102346555|NCT04103398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346556|NCT04103398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101873289|NCT01175746|Analgesics|analgesics|mesh-ancestor
102346578|NCT04067726|Micronutrients|micronutrients|mesh-ancestor
102346579|NCT04067726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346580|NCT04067726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102346581|NCT04067726|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102346583|NCT04064840|Luteolytic Agents|luteolytic agents|mesh-ancestor
101873620|NCT00149214|Immunologic Factors|immunologic factors|mesh-ancestor
102346584|NCT04064840|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101873695|NCT02444728|Antimalarials|antimalarials|mesh-ancestor
102346585|NCT04064840|Contraceptive Agents|contraceptive agents|mesh-ancestor
102346586|NCT04064840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102346587|NCT04064840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346588|NCT04064840|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102346589|NCT04064840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102346592|NCT04050462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102346593|NCT04050462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346594|NCT04050462|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102346595|NCT04050462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346596|NCT04048161|Mycophenolic Acid|mycophenolic acid|mesh-list
102346597|NCT04048161|Tacrolimus|tacrolimus|mesh-list
101873982|NCT01185262|Growth Substances|growth substances|mesh-ancestor
102346598|NCT04048161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102346599|NCT04048161|Immunologic Factors|immunologic factors|mesh-ancestor
102346600|NCT04048161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346601|NCT04048161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102346602|NCT04048161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102346603|NCT04048161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346604|NCT04048161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102346605|NCT04048161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346606|NCT04048161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102346607|NCT04048161|Antitubercular Agents|antitubercular agents|mesh-ancestor
102346608|NCT04048161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102346609|NCT04048161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102346610|NCT04042740|Ribavirin|ribavirin|mesh-list
101874203|NCT03849664|Riboflavin|riboflavin|mesh-list
102346611|NCT04042740|Antimetabolites|antimetabolites|mesh-ancestor
102346612|NCT04042740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346613|NCT04042740|Antiviral Agents|antiviral agents|mesh-ancestor
102346614|NCT04042740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102346615|NCT04007744|Pembrolizumab|pembrolizumab|mesh-list
102346616|NCT04007744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102346617|NCT04007744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346618|NCT04007744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102346619|NCT04007744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346620|NCT03994874|Furosemide|furosemide|mesh-list
102346621|NCT03994874|Dialysis Solutions|dialysis solutions|mesh-list
102346622|NCT03994874|Diuretics|diuretics|mesh-list
102346623|NCT03994874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
102346624|NCT03994874|Natriuretic Agents|natriuretic agents|mesh-ancestor
102346625|NCT03994874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346626|NCT03994874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101874558|NCT01189864|Diclofenac|diclofenac|mesh-list
102346627|NCT03994874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346628|NCT03994874|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102346629|NCT03983850|Mycophenolic Acid|mycophenolic acid|mesh-list
102346630|NCT03983850|Sirolimus|sirolimus|mesh-list
102346631|NCT03983850|Cyclophosphamide|cyclophosphamide|mesh-list
102346632|NCT03983850|Busulfan|busulfan|mesh-list
102346633|NCT03983850|Fludarabine|fludarabine|mesh-list
102346634|NCT03983850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102346635|NCT03983850|Immunologic Factors|immunologic factors|mesh-ancestor
102346636|NCT03983850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346637|NCT03983850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102346638|NCT03983850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102346639|NCT03983850|Alkylating Agents|alkylating agents|mesh-ancestor
102346640|NCT03983850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346641|NCT03983850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346642|NCT03983850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102346643|NCT03983850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102346644|NCT03983850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102346645|NCT03983850|Antitubercular Agents|antitubercular agents|mesh-ancestor
102346646|NCT03983850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102346647|NCT03983850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102346648|NCT03983850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102346649|NCT03983850|Antifungal Agents|antifungal agents|mesh-ancestor
102346651|NCT03934814|Pembrolizumab|pembrolizumab|mesh-list
102346652|NCT03934814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102346653|NCT03934814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346654|NCT03934814|Immunologic Factors|immunologic factors|mesh-ancestor
102346655|NCT03934814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346656|NCT03934814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102346657|NCT03934814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102346658|NCT03934814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346659|NCT03924856|Gemcitabine|gemcitabine|mesh-list
102346660|NCT03924856|Pembrolizumab|pembrolizumab|mesh-list
102346661|NCT03924856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346662|NCT03924856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102346663|NCT03924856|Antimetabolites|antimetabolites|mesh-ancestor
102346664|NCT03924856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346665|NCT03924856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102346666|NCT03924856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102346667|NCT03919799|Belumosudil|belumosudil|mesh-list
102346668|NCT03919799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102346669|NCT03919799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102346670|NCT03919799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346671|NCT03871257|Carboplatin|carboplatin|mesh-list
102346672|NCT03871257|Vincristine|vincristine|mesh-list
102346673|NCT03871257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101875251|NCT03829930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346674|NCT03871257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102346675|NCT03871257|Tubulin Modulators|tubulin modulators|mesh-ancestor
102346676|NCT03871257|Antimitotic Agents|antimitotic agents|mesh-ancestor
102346677|NCT03871257|Mitosis Modulators|mitosis modulators|mesh-ancestor
102346678|NCT03871257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346679|NCT03866837|Micronutrients|micronutrients|mesh-list
102346680|NCT03866837|Trace Elements|trace elements|mesh-list
102346681|NCT03866837|Lactoferrin|lactoferrin|mesh-list
102346682|NCT03866837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346683|NCT03866837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102346684|NCT03809624|Pembrolizumab|pembrolizumab|mesh-list
102346685|NCT03809624|Antibodies|antibodies|mesh-list
101640746|NCT03221257|Analgesics|analgesics|mesh-ancestor
102346686|NCT03809624|Immunologic Factors|immunologic factors|mesh-ancestor
102346687|NCT03809624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346688|NCT03809624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102346689|NCT03809624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346690|NCT03809624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102346691|NCT03809624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346692|NCT03793179|Carboplatin|carboplatin|mesh-list
102346693|NCT03793179|Pembrolizumab|pembrolizumab|mesh-list
102346694|NCT03793179|Pemetrexed|pemetrexed|mesh-list
102346695|NCT03793179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346696|NCT03793179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102346697|NCT03793179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102346698|NCT03793179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346699|NCT03793179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102346700|NCT03793179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102346701|NCT03793179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102346702|NCT03793166|Nivolumab|nivolumab|mesh-list
102346703|NCT03793166|Ipilimumab|ipilimumab|mesh-list
102346704|NCT03793166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101875600|NCT05345002|Tretinoin|tretinoin|mesh-list
102346706|NCT03793166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102346707|NCT03793166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346724|NCT03701308|Daunorubicin|daunorubicin|mesh-list
102346725|NCT03701308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102346726|NCT03701308|Antimetabolites|antimetabolites|mesh-ancestor
102346727|NCT03701308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346728|NCT03701308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346729|NCT03701308|Antiviral Agents|antiviral agents|mesh-ancestor
102346730|NCT03701308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102346731|NCT03701308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102346732|NCT03701308|Immunologic Factors|immunologic factors|mesh-ancestor
102346733|NCT03701308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346734|NCT03701308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102346735|NCT03701308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102346736|NCT03701308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102346737|NCT03701308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102346738|NCT03697811|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102346739|NCT03697811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102346741|NCT03691649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102346742|NCT03691649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102346743|NCT03691649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346744|NCT03691649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102346745|NCT03691649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102346746|NCT03691649|Adrenergic Agents|adrenergic agents|mesh-ancestor
102346747|NCT03691649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102346748|NCT03691649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346750|NCT03691649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102346751|NCT03689946|Listerine|listerine|mesh-list
102346752|NCT03689946|Evolocumab|evolocumab|mesh-list
102346753|NCT03689946|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
102346754|NCT03689946|Fluorides|fluorides|mesh-list
102346755|NCT03689946|Sodium Fluoride|sodium fluoride|mesh-list
102346756|NCT03689946|Cariostatic Agents|cariostatic agents|mesh-ancestor
102346757|NCT03689946|Protective Agents|protective agents|mesh-ancestor
102346758|NCT03689946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346759|NCT03689946|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102346760|NCT03689946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102346761|NCT03689946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102346762|NCT03689946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102346763|NCT03689946|Antimetabolites|antimetabolites|mesh-ancestor
102346764|NCT03689946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346765|NCT03689946|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102346766|NCT03689946|Protease Inhibitors|protease inhibitors|mesh-ancestor
102346767|NCT03689946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102346768|NCT03689946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102346769|NCT03655002|Cyclophosphamide|cyclophosphamide|mesh-list
102346770|NCT03655002|Nivolumab|nivolumab|mesh-list
102346771|NCT03655002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102346772|NCT03655002|Immunologic Factors|immunologic factors|mesh-ancestor
102346773|NCT03655002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876199|NCT03819790|Lixisenatide|lixisenatide|mesh-list
102346774|NCT03655002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102346775|NCT03655002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102346776|NCT03655002|Alkylating Agents|alkylating agents|mesh-ancestor
102346777|NCT03655002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346778|NCT03655002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346779|NCT03655002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102346780|NCT03655002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102346781|NCT03655002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102346782|NCT03606980|Dexamethasone|dexamethasone|mesh-list
102346783|NCT03606980|Dexamethasone acetate|dexamethasone acetate|mesh-list
102346784|NCT03606980|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102346785|NCT03606980|BB 1101|bb 1101|mesh-list
102346786|NCT03606980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102346787|NCT03606980|Antiemetics|antiemetics|mesh-ancestor
102346788|NCT03606980|Autonomic Agents|autonomic agents|mesh-ancestor
102346789|NCT03606980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102346790|NCT03606980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346791|NCT03606980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102346792|NCT03606980|Glucocorticoids|glucocorticoids|mesh-ancestor
102346793|NCT03606980|Hormones|hormones|mesh-ancestor
102346794|NCT03606980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102346795|NCT03606980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102346796|NCT03606980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346797|NCT03606980|Protease Inhibitors|protease inhibitors|mesh-ancestor
102346798|NCT03606980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102346799|NCT03606980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346800|NCT03598257|Olaparib|olaparib|mesh-list
102346801|NCT03598257|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102346802|NCT03598257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102346803|NCT03598257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346804|NCT03598257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346805|NCT03596424|Dexmedetomidine|dexmedetomidine|mesh-list
102346806|NCT03596424|Ketamine|ketamine|mesh-list
102346807|NCT03596424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102346808|NCT03596424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102346809|NCT03596424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346810|NCT03596424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102346811|NCT03596424|Analgesics|analgesics|mesh-ancestor
101876415|NCT03799822|Anticoagulants|anticoagulants|mesh-ancestor
101836609|NCT00308620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102346812|NCT03596424|Sensory System Agents|sensory system agents|mesh-ancestor
102346813|NCT03596424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102346814|NCT03596424|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102346815|NCT03596424|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102346816|NCT03596424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102346817|NCT03596424|Adrenergic Agents|adrenergic agents|mesh-ancestor
102346818|NCT03596424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102346819|NCT03596424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346820|NCT03596424|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102346821|NCT03596424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102346822|NCT03596424|Anesthetics, General|anesthetics, general|mesh-ancestor
102346824|NCT03596424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102346825|NCT03596424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102346826|NCT03586999|Nivolumab|nivolumab|mesh-list
102346827|NCT03586999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102346828|NCT03586999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346829|NCT03586999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102346830|NCT03586999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346831|NCT03547908|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102346832|NCT03547908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102346833|NCT03547908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102346834|NCT03547908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102346835|NCT03547908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346836|NCT03547908|Antiviral Agents|antiviral agents|mesh-ancestor
102346837|NCT03547908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102346838|NCT03547908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102346839|NCT03547908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102346840|NCT03546894|Ceritinib|ceritinib|mesh-list
102346841|NCT03546894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346842|NCT03546894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102346843|NCT03546894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101876873|NCT01304836|Antiemetics|antiemetics|mesh-ancestor
102346844|NCT03546894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346845|NCT03531918|Cytarabine|cytarabine|mesh-list
102346846|NCT03531918|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
102346847|NCT03531918|Mitoxantrone|mitoxantrone|mesh-list
102346848|NCT03531918|Cladribine|cladribine|mesh-list
102346849|NCT03531918|Gemtuzumab|gemtuzumab|mesh-list
102346850|NCT03531918|Calicheamicins|calicheamicins|mesh-list
102346851|NCT03531918|Lenograstim|lenograstim|mesh-list
102346852|NCT03531918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101877104|NCT03717064|Pitavastatin|pitavastatin|mesh-list
102346853|NCT03531918|Antimetabolites|antimetabolites|mesh-ancestor
102346854|NCT03531918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346855|NCT03531918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346856|NCT03531918|Antiviral Agents|antiviral agents|mesh-ancestor
102346857|NCT03531918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102346858|NCT03531918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102346859|NCT03531918|Immunologic Factors|immunologic factors|mesh-ancestor
101877248|NCT03777124|Pemetrexed|pemetrexed|mesh-list
102346860|NCT03531918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346861|NCT03531918|Analgesics|analgesics|mesh-ancestor
102346862|NCT03531918|Sensory System Agents|sensory system agents|mesh-ancestor
102346863|NCT03531918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102346864|NCT03531918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102346865|NCT03531918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102346866|NCT03531918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102346867|NCT03531918|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102346868|NCT03531918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102346869|NCT03531918|Immunotoxins|immunotoxins|mesh-ancestor
102346870|NCT03531918|Immunoconjugates|immunoconjugates|mesh-ancestor
102346871|NCT03531918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102346872|NCT03531645|Fulvestrant|fulvestrant|mesh-list
102346873|NCT03531645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102346874|NCT03531645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346875|NCT03531645|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102346876|NCT03531645|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102346877|NCT03531645|Hormone Antagonists|hormone antagonists|mesh-ancestor
101877307|NCT02043587|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102346878|NCT03531645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102346879|NCT03531645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346880|NCT03509012|Paclitaxel|paclitaxel|mesh-list
102346881|NCT03509012|Etoposide|etoposide|mesh-list
102346882|NCT03509012|Cisplatin|cisplatin|mesh-list
102346883|NCT03509012|Carboplatin|carboplatin|mesh-list
102346884|NCT03509012|Etoposide phosphate|etoposide phosphate|mesh-list
102346885|NCT03509012|Pemetrexed|pemetrexed|mesh-list
102346887|NCT03509012|Tremelimumab|tremelimumab|mesh-list
102346888|NCT03509012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102346889|NCT03509012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346890|NCT03509012|Tubulin Modulators|tubulin modulators|mesh-ancestor
102346891|NCT03509012|Antimitotic Agents|antimitotic agents|mesh-ancestor
102346892|NCT03509012|Mitosis Modulators|mitosis modulators|mesh-ancestor
101877669|NCT05531890|Hormones|hormones|mesh-ancestor
102346893|NCT03509012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346894|NCT03509012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102346895|NCT03509012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102346896|NCT03509012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102346897|NCT03509012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102346898|NCT03509012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102346899|NCT03509012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102346901|NCT03499704|Pioglitazone|pioglitazone|mesh-list
102346902|NCT03499704|Dapagliflozin|dapagliflozin|mesh-list
102346903|NCT03499704|Alogliptin|alogliptin|mesh-list
102346904|NCT03499704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102346905|NCT03499704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346906|NCT03499704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102346907|NCT03499704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346908|NCT03499704|Incretins|incretins|mesh-ancestor
102346909|NCT03499704|Hormones|hormones|mesh-ancestor
102346910|NCT03499704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102346911|NCT03499704|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102346912|NCT03499704|Protease Inhibitors|protease inhibitors|mesh-ancestor
102346913|NCT03499704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102346914|NCT03498612|Pembrolizumab|pembrolizumab|mesh-list
102346915|NCT03498612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102346916|NCT03498612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346917|NCT03498612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102346918|NCT03498612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346919|NCT03462719|Venetoclax|venetoclax|mesh-list
102346920|NCT03462719|Obinutuzumab|obinutuzumab|mesh-list
102346921|NCT03462719|Chlorambucil|chlorambucil|mesh-list
102346922|NCT03462719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101877800|NCT01035983|Serotonin Agents|serotonin agents|mesh-ancestor
102346923|NCT03462719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101877847|NCT01039181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346924|NCT03462719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102346925|NCT03462719|Alkylating Agents|alkylating agents|mesh-ancestor
102346926|NCT03462719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346927|NCT03412877|Aldesleukin|aldesleukin|mesh-list
102346928|NCT03412877|Cyclophosphamide|cyclophosphamide|mesh-list
102346929|NCT03412877|Pembrolizumab|pembrolizumab|mesh-list
102346930|NCT03412877|Fludarabine|fludarabine|mesh-list
102346931|NCT03412877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102346932|NCT03412877|Immunologic Factors|immunologic factors|mesh-ancestor
102346933|NCT03412877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346934|NCT03412877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102346935|NCT03412877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102346936|NCT03412877|Alkylating Agents|alkylating agents|mesh-ancestor
102346937|NCT03412877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346938|NCT03412877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346939|NCT03412877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102346940|NCT03412877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102346941|NCT03412877|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102346942|NCT03412877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102346943|NCT03412877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102346944|NCT03412877|Antiviral Agents|antiviral agents|mesh-ancestor
102346945|NCT03412877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102346947|NCT03362515|Diuretics|diuretics|mesh-ancestor
102346948|NCT03362515|Natriuretic Agents|natriuretic agents|mesh-ancestor
102346949|NCT03362515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346950|NCT03362515|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102346951|NCT03362515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102346952|NCT03362515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346953|NCT03292926|Dexamethasone|dexamethasone|mesh-list
102346954|NCT03292926|Dexamethasone acetate|dexamethasone acetate|mesh-list
102346955|NCT03292926|Bupivacaine|bupivacaine|mesh-list
102346956|NCT03292926|BB 1101|bb 1101|mesh-list
102346957|NCT03292926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102346958|NCT03292926|Antiemetics|antiemetics|mesh-ancestor
102346959|NCT03292926|Autonomic Agents|autonomic agents|mesh-ancestor
102055806|NCT05489211|Hormones|hormones|mesh-ancestor
102346960|NCT03292926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101878567|NCT01079286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102346961|NCT03292926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346962|NCT03292926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102346964|NCT03292926|Hormones|hormones|mesh-ancestor
102346965|NCT03292926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102346966|NCT03292926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102346967|NCT03292926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346968|NCT03292926|Protease Inhibitors|protease inhibitors|mesh-ancestor
102346969|NCT03292926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102346970|NCT03292926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346971|NCT03292926|Anesthetics, Local|anesthetics, local|mesh-ancestor
102346972|NCT03292926|Anesthetics|anesthetics|mesh-ancestor
101443772|NCT00555256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102346973|NCT03292926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102346974|NCT03292926|Sensory System Agents|sensory system agents|mesh-ancestor
102346975|NCT03288324|Tofacitinib|tofacitinib|mesh-list
102346976|NCT03288324|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102346977|NCT03288324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102346978|NCT03288324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102346979|NCT03288324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346980|NCT03283878|Cefazolin|cefazolin|mesh-list
102346981|NCT03283878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102346982|NCT03283878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102346984|NCT03245151|Lenvatinib|lenvatinib|mesh-list
102346985|NCT03245151|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102346986|NCT03245151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102346987|NCT03245151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102346988|NCT03245151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346989|NCT03245151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102346990|NCT03245151|Immunologic Factors|immunologic factors|mesh-ancestor
102346991|NCT03245151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102346992|NCT03245151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346993|NCT03216343|Chiauranib|chiauranib|mesh-list
102346994|NCT03216343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102346995|NCT03216343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102346996|NCT03216343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878757|NCT02652052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878830|NCT03778996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102346997|NCT03216343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102346998|NCT03202628|Dexamethasone|dexamethasone|mesh-list
102346999|NCT03202628|Dexamethasone acetate|dexamethasone acetate|mesh-list
102347000|NCT03202628|Pomalidomide|pomalidomide|mesh-list
102347003|NCT03202628|BB 1101|bb 1101|mesh-list
102347004|NCT03202628|Glycine|glycine|mesh-list
102347005|NCT03202628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102347006|NCT03202628|Antiemetics|antiemetics|mesh-ancestor
102347007|NCT03202628|Autonomic Agents|autonomic agents|mesh-ancestor
101879123|NCT03963648|Gasotransmitters|gasotransmitters|mesh-ancestor
102347008|NCT03202628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102347009|NCT03202628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347010|NCT03202628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102347011|NCT03202628|Glucocorticoids|glucocorticoids|mesh-ancestor
102347012|NCT03202628|Hormones|hormones|mesh-ancestor
102347013|NCT03202628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102347014|NCT03202628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102347015|NCT03202628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347016|NCT03202628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347017|NCT03202628|Protease Inhibitors|protease inhibitors|mesh-ancestor
102347018|NCT03202628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102347019|NCT03202628|Immunologic Factors|immunologic factors|mesh-ancestor
102347020|NCT03202628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102347021|NCT03202628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102347022|NCT03202628|Growth Substances|growth substances|mesh-ancestor
102347023|NCT03202628|Growth Inhibitors|growth inhibitors|mesh-ancestor
102347024|NCT03202628|Dermatologic Agents|dermatologic agents|mesh-ancestor
102347025|NCT03202628|Glycine Agents|glycine agents|mesh-ancestor
102347026|NCT03202628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102347028|NCT03165734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347029|NCT03165734|Antisickling Agents|antisickling agents|mesh-ancestor
102347030|NCT03165734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102347031|NCT03165734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347032|NCT03165734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102347033|NCT03099174|Letrozole|letrozole|mesh-list
102347034|NCT03099174|Fulvestrant|fulvestrant|mesh-list
102347035|NCT03099174|Anastrozole|anastrozole|mesh-list
102347036|NCT03099174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347037|NCT03099174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102347038|NCT03099174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102347039|NCT03099174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102347040|NCT03099174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347041|NCT03099174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102347042|NCT03099174|Hormone Antagonists|hormone antagonists|mesh-ancestor
102347043|NCT03099174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102347044|NCT03099174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347045|NCT03099174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101879260|NCT00116844|Valacyclovir|valacyclovir|mesh-list
102347046|NCT03099174|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102347047|NCT03096275|Glucocorticoids|glucocorticoids|mesh-list
102347049|NCT03096275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102347050|NCT03096275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347051|NCT03075527|Durvalumab|durvalumab|mesh-list
102347052|NCT03075527|Tremelimumab|tremelimumab|mesh-list
102347053|NCT03075527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102347054|NCT03075527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347055|NCT03070223|Pitavastatin|pitavastatin|mesh-list
102347056|NCT03070223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102347057|NCT03070223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102347058|NCT03070223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102347059|NCT03070223|Antimetabolites|antimetabolites|mesh-ancestor
102347060|NCT03070223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347061|NCT03070223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102347062|NCT03070223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102347063|NCT03012321|Prednisone|prednisone|mesh-list
102347064|NCT03012321|Olaparib|olaparib|mesh-list
102347065|NCT03012321|Abiraterone Acetate|abiraterone acetate|mesh-list
102347066|NCT03012321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102347067|NCT03012321|Glucocorticoids|glucocorticoids|mesh-ancestor
102347068|NCT03012321|Hormones|hormones|mesh-ancestor
101879820|NCT00127166|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102347069|NCT03012321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102347070|NCT03012321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347071|NCT03012321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101879890|NCT03746158|Analgesics|analgesics|mesh-ancestor
102347072|NCT03012321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101879960|NCT01078142|Sirolimus|sirolimus|mesh-list
102347073|NCT03012321|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102347074|NCT03012321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102347075|NCT03012321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347076|NCT03012321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102347077|NCT03012321|Hormone Antagonists|hormone antagonists|mesh-ancestor
101880106|NCT04238650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102347078|NCT03012321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102347079|NCT02997228|Leucovorin|leucovorin|mesh-list
102347080|NCT02997228|Bevacizumab|bevacizumab|mesh-list
102347081|NCT02997228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102347082|NCT02997228|Atezolizumab|atezolizumab|mesh-list
102347083|NCT02997228|Fluorouracil|fluorouracil|mesh-list
102347084|NCT02997228|Oxaliplatin|oxaliplatin|mesh-list
102347085|NCT02997228|Endothelial Growth Factors|endothelial growth factors|mesh-list
102347086|NCT02997228|Antibodies|antibodies|mesh-list
102347087|NCT02997228|Immunoglobulins|immunoglobulins|mesh-list
102347088|NCT02997228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102347089|NCT02997228|Immunoglobulin G|immunoglobulin g|mesh-list
102347090|NCT02997228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347091|NCT02997228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102347092|NCT02997228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102347093|NCT02997228|Growth Substances|growth substances|mesh-ancestor
101880543|NCT00112502|Analgesics|analgesics|mesh-ancestor
102347094|NCT02997228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347096|NCT02997228|Immunologic Factors|immunologic factors|mesh-ancestor
102347097|NCT02997228|Antimetabolites|antimetabolites|mesh-ancestor
101880693|NCT00094458|Infliximab|infliximab|mesh-list
102347098|NCT02997228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347099|NCT02997228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102347100|NCT02997228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102347101|NCT02997228|Antidotes|antidotes|mesh-ancestor
102347102|NCT02997228|Protective Agents|protective agents|mesh-ancestor
102347103|NCT02997228|Vitamin B Complex|vitamin b complex|mesh-ancestor
102347105|NCT02997228|Micronutrients|micronutrients|mesh-ancestor
102347106|NCT02997228|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102347107|NCT02985593|KHK4083|khk4083|mesh-list
102347108|NCT02985593|Dermatologic Agents|dermatologic agents|mesh-ancestor
102347109|NCT02955082|Carboplatin|carboplatin|mesh-list
102347110|NCT02955082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347111|NCT02858921|Pembrolizumab|pembrolizumab|mesh-list
102347113|NCT02858921|Dabrafenib|dabrafenib|mesh-list
102347114|NCT02858921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101881160|NCT01079624|Hormones|hormones|mesh-ancestor
102347115|NCT02858921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347116|NCT02858921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101881195|NCT01086332|Protease Inhibitors|protease inhibitors|mesh-ancestor
102347117|NCT02858921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347118|NCT02858921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102347119|NCT02858921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102347120|NCT02645149|Trametinib|trametinib|mesh-list
102347121|NCT02645149|Ceritinib|ceritinib|mesh-list
102347122|NCT02645149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347123|NCT02645149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102347124|NCT02645149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102347125|NCT02645149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347126|NCT02588651|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102347127|NCT02588651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102347128|NCT02588651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347129|NCT02588651|Immunotoxins|immunotoxins|mesh-ancestor
102347130|NCT02588651|Immunoconjugates|immunoconjugates|mesh-ancestor
102347131|NCT02588651|Immunologic Factors|immunologic factors|mesh-ancestor
102347132|NCT02588651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347133|NCT02523859|Propofol|propofol|mesh-list
102347134|NCT02523859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101881408|NCT01045889|Hormones|hormones|mesh-ancestor
102347135|NCT02523859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102347136|NCT02523859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347137|NCT02523859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102347138|NCT02523859|Anesthetics, General|anesthetics, general|mesh-ancestor
102347139|NCT02523859|Anesthetics|anesthetics|mesh-ancestor
102347140|NCT02421939|Cytarabine|cytarabine|mesh-list
102347141|NCT02421939|Fludarabine|fludarabine|mesh-list
102347142|NCT02421939|Etoposide|etoposide|mesh-list
102347143|NCT02421939|Azacitidine|azacitidine|mesh-list
102347144|NCT02421939|Mitoxantrone|mitoxantrone|mesh-list
102347145|NCT02421939|Idarubicin|idarubicin|mesh-list
102347146|NCT02421939|Lenograstim|lenograstim|mesh-list
102347147|NCT02421939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347148|NCT02421939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102347149|NCT02421939|Antimetabolites|antimetabolites|mesh-ancestor
102347150|NCT02421939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347151|NCT02421939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102347152|NCT02421939|Immunologic Factors|immunologic factors|mesh-ancestor
101881477|NCT00094302|Spironolactone|spironolactone|mesh-list
102347153|NCT02421939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347154|NCT02421939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101881534|NCT01090830|Growth Substances|growth substances|mesh-ancestor
102347155|NCT02421939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102347156|NCT02421939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102347157|NCT02421939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102347158|NCT02421939|Antiviral Agents|antiviral agents|mesh-ancestor
101881755|NCT00099632|Antiviral Agents|antiviral agents|mesh-ancestor
102347159|NCT02421939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102347160|NCT02421939|Analgesics|analgesics|mesh-ancestor
102347161|NCT02421939|Sensory System Agents|sensory system agents|mesh-ancestor
101881830|NCT00098774|Antiviral Agents|antiviral agents|mesh-ancestor
102347162|NCT02421939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102347163|NCT02421939|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102347164|NCT02421939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102347165|NCT02370329|Interferons|interferons|mesh-list
102347166|NCT02370329|Interferon-alpha|interferon-alpha|mesh-list
102347167|NCT02370329|Interferon alpha-2|interferon alpha-2|mesh-list
102347168|NCT02370329|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
102347169|NCT02370329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102347170|NCT02370329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347171|NCT02370329|Antiviral Agents|antiviral agents|mesh-ancestor
101882132|NCT03624946|Antibodies|antibodies|mesh-list
102347172|NCT02370329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101882216|NCT00380393|Vaccines|vaccines|mesh-list
102347173|NCT02370329|Immunologic Factors|immunologic factors|mesh-ancestor
102347174|NCT02370329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347175|NCT02229422|Obinutuzumab|obinutuzumab|mesh-list
102347176|NCT02229422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102347177|NCT02229422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347178|NCT02227199|Carboplatin|carboplatin|mesh-list
102347179|NCT02227199|Etoposide|etoposide|mesh-list
102347180|NCT02227199|Etoposide phosphate|etoposide phosphate|mesh-list
102347181|NCT02227199|Ifosfamide|ifosfamide|mesh-list
102347182|NCT02227199|Isophosphamide mustard|isophosphamide mustard|mesh-list
102347183|NCT02227199|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102347184|NCT02227199|Podophyllotoxin|podophyllotoxin|mesh-list
102347185|NCT02227199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102347186|NCT02227199|Antibodies|antibodies|mesh-list
102347187|NCT02227199|Immunoglobulins|immunoglobulins|mesh-list
102347188|NCT02227199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102347189|NCT02227199|Immunoconjugates|immunoconjugates|mesh-list
101882404|NCT03964935|Antioxidants|antioxidants|mesh-ancestor
102347190|NCT02227199|Immunologic Factors|immunologic factors|mesh-ancestor
102347191|NCT02227199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347193|NCT02227199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102347194|NCT02227199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102347195|NCT02227199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102347197|NCT02227199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882627|NCT01087437|Calcium|calcium|mesh-list
102347198|NCT02227199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102347199|NCT02227199|Alkylating Agents|alkylating agents|mesh-ancestor
102347200|NCT02227199|Immunotoxins|immunotoxins|mesh-ancestor
102347201|NCT02227199|Keratolytic Agents|keratolytic agents|mesh-ancestor
102347202|NCT02227199|Dermatologic Agents|dermatologic agents|mesh-ancestor
102347203|NCT02227199|Tubulin Modulators|tubulin modulators|mesh-ancestor
102347204|NCT02227199|Antimitotic Agents|antimitotic agents|mesh-ancestor
102347205|NCT02227199|Mitosis Modulators|mitosis modulators|mesh-ancestor
102347206|NCT02176148|Fluocinonide|fluocinonide|mesh-list
102347207|NCT02176148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102347208|NCT02176148|Glucocorticoids|glucocorticoids|mesh-ancestor
102347209|NCT02176148|Hormones|hormones|mesh-ancestor
101883061|NCT01087983|Metformin|metformin|mesh-list
102347210|NCT02176148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102347211|NCT02176148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347212|NCT02176148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102347213|NCT02087865|Donepezil|donepezil|mesh-list
101883212|NCT05665348|Growth Substances|growth substances|mesh-ancestor
102347214|NCT02087865|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102347215|NCT02087865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102347216|NCT02087865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347217|NCT02087865|Cholinergic Agents|cholinergic agents|mesh-ancestor
102347218|NCT02087865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102347219|NCT02087865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347220|NCT02087865|Nootropic Agents|nootropic agents|mesh-ancestor
102347221|NCT01980823|Metformin|metformin|mesh-list
102347222|NCT01980823|Atorvastatin|atorvastatin|mesh-list
102347223|NCT01980823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102347224|NCT01980823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347225|NCT01980823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102347226|NCT01980823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102347227|NCT01980823|Antimetabolites|antimetabolites|mesh-ancestor
102347228|NCT01980823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347229|NCT01980823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102347230|NCT01980823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102347231|NCT01980823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102347232|NCT01972347|Trametinib|trametinib|mesh-list
102347233|NCT01972347|Dabrafenib|dabrafenib|mesh-list
102347234|NCT01972347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347235|NCT01972347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102347236|NCT01972347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102347237|NCT01972347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347238|NCT01889992|Sirolimus|sirolimus|mesh-list
102347239|NCT01889992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102347240|NCT01889992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102347241|NCT01889992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102347242|NCT01889992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347243|NCT01889992|Antifungal Agents|antifungal agents|mesh-ancestor
102347244|NCT01889992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102347245|NCT01889992|Immunologic Factors|immunologic factors|mesh-ancestor
102347246|NCT01889992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347247|NCT01858740|Methotrexate|methotrexate|mesh-list
102347248|NCT01858740|Fludarabine phosphate|fludarabine phosphate|mesh-list
102347249|NCT01858740|Fludarabine|fludarabine|mesh-list
102347251|NCT01858740|Tacrolimus|tacrolimus|mesh-list
101883545|NCT05868317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347252|NCT01858740|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102347253|NCT01858740|Abortifacient Agents|abortifacient agents|mesh-ancestor
102347254|NCT01858740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102347255|NCT01858740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347256|NCT01858740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102347257|NCT01858740|Antimetabolites|antimetabolites|mesh-ancestor
101883687|NCT05518799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102347258|NCT01858740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347259|NCT01858740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347260|NCT01858740|Dermatologic Agents|dermatologic agents|mesh-ancestor
102347261|NCT01858740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102347262|NCT01858740|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102347263|NCT01858740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101883908|NCT04507438|Donepezil|donepezil|mesh-list
102347264|NCT01858740|Immunologic Factors|immunologic factors|mesh-ancestor
102347265|NCT01858740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101883980|NCT04175470|Tocotrienols|tocotrienols|mesh-list
102347266|NCT01858740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102347268|NCT01858740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102347269|NCT01858740|Alkylating Agents|alkylating agents|mesh-ancestor
102347270|NCT01858740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102347271|NCT01848639|Spironolactone|spironolactone|mesh-list
102347272|NCT01848639|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102347273|NCT01848639|Hormone Antagonists|hormone antagonists|mesh-ancestor
102347274|NCT01848639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102347275|NCT01848639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347276|NCT01848639|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102347277|NCT01848639|Diuretics|diuretics|mesh-ancestor
102347278|NCT01848639|Natriuretic Agents|natriuretic agents|mesh-ancestor
102347279|NCT01839734|Lubiprostone|lubiprostone|mesh-list
102347280|NCT01839734|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102347281|NCT01839734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102347282|NCT01839734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347283|NCT01682083|Trametinib|trametinib|mesh-list
102347284|NCT01682083|Dabrafenib|dabrafenib|mesh-list
102347286|NCT01682083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102347287|NCT01682083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101884571|NCT05586074|Decitabine|decitabine|mesh-list
102347288|NCT01682083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347289|NCT01511068|Sargramostim|sargramostim|mesh-list
102347290|NCT01511068|Immunologic Factors|immunologic factors|mesh-ancestor
102347291|NCT01511068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347292|NCT01180790|Interferons|interferons|mesh-list
102347293|NCT01180790|Ribavirin|ribavirin|mesh-list
102347294|NCT01180790|Interferon-alpha|interferon-alpha|mesh-list
102347295|NCT01180790|Interferon alpha-2|interferon alpha-2|mesh-list
102347296|NCT01180790|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102347297|NCT01180790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347298|NCT01180790|Antiviral Agents|antiviral agents|mesh-ancestor
102347299|NCT01180790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101884935|NCT04781959|Lenograstim|lenograstim|mesh-list
102347300|NCT01180790|Antimetabolites|antimetabolites|mesh-ancestor
102347301|NCT01180790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347302|NCT01180790|Immunologic Factors|immunologic factors|mesh-ancestor
102347303|NCT01180790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347304|NCT01112306|Selexipag|selexipag|mesh-list
102347305|NCT01112306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102347306|NCT00721526|Disulfiram|disulfiram|mesh-list
102347307|NCT00721526|Lorazepam|lorazepam|mesh-list
102347308|NCT00721526|Anticonvulsants|anticonvulsants|mesh-ancestor
102347309|NCT00721526|Antiemetics|antiemetics|mesh-ancestor
102347310|NCT00721526|Autonomic Agents|autonomic agents|mesh-ancestor
102347311|NCT00721526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102347312|NCT00721526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347313|NCT00721526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102347314|NCT00721526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102347315|NCT00721526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102347316|NCT00721526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102347317|NCT00721526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102347319|NCT00721526|GABA Modulators|gaba modulators|mesh-ancestor
102347320|NCT00721526|GABA Agents|gaba agents|mesh-ancestor
102347321|NCT00721526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101885547|NCT05930912|Analgesics|analgesics|mesh-ancestor
102347322|NCT00721526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443902|NCT04676659|Tenecteplase|tenecteplase|mesh-list
102347323|NCT00721526|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102347324|NCT00721526|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
102347325|NCT00721526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102347326|NCT00679042|Exenatide|exenatide|mesh-list
102347327|NCT00679042|Sirolimus|sirolimus|mesh-list
102347328|NCT00679042|Etanercept|etanercept|mesh-list
102347329|NCT00679042|Tacrolimus|tacrolimus|mesh-list
102347330|NCT00679042|Basiliximab|basiliximab|mesh-list
101885702|NCT05925894|Mydriatics|mydriatics|mesh-list
102347331|NCT00679042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102347332|NCT00679042|Immunologic Factors|immunologic factors|mesh-ancestor
101885764|NCT05894564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102347333|NCT00679042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347334|NCT00679042|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102347335|NCT00679042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102347336|NCT00679042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347337|NCT00679042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102347338|NCT00679042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102347339|NCT00679042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102347340|NCT00679042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347341|NCT00679042|Antifungal Agents|antifungal agents|mesh-ancestor
102347342|NCT00679042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102347343|NCT00679042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102347344|NCT00679042|Analgesics|analgesics|mesh-ancestor
102347345|NCT00679042|Sensory System Agents|sensory system agents|mesh-ancestor
102347346|NCT00679042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102347347|NCT00679042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102347348|NCT00679042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102347349|NCT00679042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102347350|NCT00679042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102347351|NCT00679042|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102347352|NCT00679042|Incretins|incretins|mesh-ancestor
102347353|NCT00679042|Hormones|hormones|mesh-ancestor
101885970|NCT05709977|Histamine Agents|histamine agents|mesh-ancestor
102347354|NCT00679042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102347356|NCT00670358|Cyclophosphamide|cyclophosphamide|mesh-list
102347357|NCT00670358|Rituximab|rituximab|mesh-list
102347358|NCT00670358|Doxorubicin|doxorubicin|mesh-list
102347359|NCT00670358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102347360|NCT00670358|Vincristine|vincristine|mesh-list
102347361|NCT00670358|Lenalidomide|lenalidomide|mesh-list
102347362|NCT00670358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102347363|NCT00670358|Immunologic Factors|immunologic factors|mesh-ancestor
102347364|NCT00670358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347365|NCT00670358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102347366|NCT00670358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102347367|NCT00670358|Alkylating Agents|alkylating agents|mesh-ancestor
101886184|NCT05542615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102347368|NCT00670358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347369|NCT00670358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347370|NCT00670358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101886338|NCT05416021|Dapivirine|dapivirine|mesh-list
102347371|NCT00670358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102347372|NCT00670358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102347373|NCT00670358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102347374|NCT00670358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102347375|NCT00670358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102347376|NCT00670358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102347377|NCT00670358|Glucocorticoids|glucocorticoids|mesh-ancestor
102347378|NCT00670358|Hormones|hormones|mesh-ancestor
102347379|NCT00670358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101886401|NCT05363553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886409|NCT05332561|Trastuzumab|trastuzumab|mesh-list
101886410|NCT05332561|Atezolizumab|atezolizumab|mesh-list
101886411|NCT05332561|Pertuzumab|pertuzumab|mesh-list
101886412|NCT05332561|Olaparib|olaparib|mesh-list
101886413|NCT05332561|Ipatasertib|ipatasertib|mesh-list
101886414|NCT05332561|Inavolisib|inavolisib|mesh-list
101886415|NCT05332561|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
101886416|NCT05332561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101886417|NCT05332561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101886418|NCT05332561|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101886419|NCT05332561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886420|NCT05332561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101886421|NCT05332561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101886422|NCT05332561|Immunoconjugates|immunoconjugates|mesh-ancestor
101886423|NCT05332561|Immunologic Factors|immunologic factors|mesh-ancestor
101886424|NCT05332561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886425|NCT05332561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101886426|NCT05332561|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
101886448|NCT05303935|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102347380|NCT00670358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102347381|NCT00670358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101886478|NCT05280769|Lobeline|lobeline|mesh-list
102347382|NCT00670358|Tubulin Modulators|tubulin modulators|mesh-ancestor
102347383|NCT00670358|Antimitotic Agents|antimitotic agents|mesh-ancestor
102347384|NCT00670358|Mitosis Modulators|mitosis modulators|mesh-ancestor
102347385|NCT00670358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102347386|NCT00670358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102347387|NCT00670358|Growth Substances|growth substances|mesh-ancestor
102347388|NCT00670358|Growth Inhibitors|growth inhibitors|mesh-ancestor
102347389|NCT00569127|Interferons|interferons|mesh-list
102347390|NCT00569127|Interferon-alpha|interferon-alpha|mesh-list
102347391|NCT00569127|Interferon alpha-2|interferon alpha-2|mesh-list
102347393|NCT00569127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102347394|NCT00569127|Octreotide|octreotide|mesh-list
102347395|NCT00569127|Endothelial Growth Factors|endothelial growth factors|mesh-list
102347396|NCT00569127|Antibodies|antibodies|mesh-list
102347397|NCT00569127|Immunoglobulins|immunoglobulins|mesh-list
102347398|NCT00569127|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102347399|NCT00569127|Immunoglobulin G|immunoglobulin g|mesh-list
102347400|NCT00569127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102347401|NCT00569127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101886908|NCT04898114|Anesthetics|anesthetics|mesh-ancestor
102347402|NCT00569127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102347403|NCT00569127|Growth Substances|growth substances|mesh-ancestor
102347404|NCT00569127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347405|NCT00569127|Growth Inhibitors|growth inhibitors|mesh-ancestor
102347406|NCT00569127|Immunologic Factors|immunologic factors|mesh-ancestor
102347407|NCT00569127|Antiviral Agents|antiviral agents|mesh-ancestor
102347408|NCT00569127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102347409|NCT00569127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102347410|NCT00569127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102347412|NCT00505063|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102347413|NCT00505063|Immunologic Factors|immunologic factors|mesh-ancestor
102347414|NCT00505063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102347415|NCT00350272|Tenofovir|tenofovir|mesh-list
102347417|NCT00350272|Efavirenz|efavirenz|mesh-list
102056266|NCT05193227|Lidocaine|lidocaine|mesh-list
102347418|NCT00350272|Dexelvucitabine|dexelvucitabine|mesh-list
102347419|NCT00350272|Antiviral Agents|antiviral agents|mesh-ancestor
102347420|NCT00350272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102347421|NCT00350272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101887590|NCT03991884|Prednisone|prednisone|mesh-list
102347422|NCT00350272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102347423|NCT00350272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102347424|NCT00350272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102347425|NCT00350272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101887821|NCT03651206|Niraparib|niraparib|mesh-list
102056922|NCT05759429|Protective Agents|protective agents|mesh-ancestor
102057374|NCT03378466|Heparin|heparin|mesh-list
102057822|NCT05107219|Linaclotide|linaclotide|mesh-list
102057896|NCT01568749|Analgesics|analgesics|mesh-ancestor
101836610|NCT00308620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058264|NCT03663335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102058565|NCT05071703|Topotecan|topotecan|mesh-list
102058940|NCT02409290|Moxifloxacin|moxifloxacin|mesh-list
102059015|NCT02142140|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
102059095|NCT03265145|Cholinergic Agents|cholinergic agents|mesh-list
102059166|NCT05959616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102059314|NCT05901350|Dopamine Agents|dopamine agents|mesh-ancestor
102059388|NCT05789173|Analgesics|analgesics|mesh-ancestor
102059692|NCT05065021|Paclitaxel|paclitaxel|mesh-list
102059838|NCT04704999|Antimalarials|antimalarials|mesh-ancestor
102060367|NCT03141359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102060819|NCT05084651|Itraconazole|itraconazole|mesh-list
102061272|NCT04429685|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102061420|NCT01381367|Immunologic Factors|immunologic factors|mesh-ancestor
101888321|NCT02633059|Ixazomib|ixazomib|mesh-list
102061793|NCT02770820|Sensory System Agents|sensory system agents|mesh-ancestor
101888414|NCT02341989|Etoposide|etoposide|mesh-list
101836611|NCT00308620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102063160|NCT02165930|Naltrexone|naltrexone|mesh-list
101836613|NCT00308620|Antinematodal Agents|antinematodal agents|mesh-ancestor
101836614|NCT00308620|Anthelmintics|anthelmintics|mesh-ancestor
102063896|NCT02183090|Meloxicam|meloxicam|mesh-list
102064427|NCT02256722|Propranolol|propranolol|mesh-list
101836615|NCT00492752|Sorafenib|sorafenib|mesh-list
102064934|NCT03675555|Dexamethasone|dexamethasone|mesh-list
102065005|NCT02060604|Analgesics|analgesics|mesh-ancestor
102065153|NCT03623529|Angiotensin II|angiotensin ii|mesh-list
101888459|NCT02244125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101888460|NCT02244125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101888461|NCT02244125|Growth Substances|growth substances|mesh-ancestor
101888462|NCT02244125|Growth Inhibitors|growth inhibitors|mesh-ancestor
101888463|NCT02243878|Ranibizumab|ranibizumab|mesh-list
101888464|NCT02243878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101888465|NCT02243878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101888466|NCT02243878|Growth Substances|growth substances|mesh-ancestor
101888470|NCT02199236|Capecitabine|capecitabine|mesh-list
102065835|NCT04088513|Antipyretics|antipyretics|mesh-ancestor
102066291|NCT02071212|Ticagrelor|ticagrelor|mesh-list
101836616|NCT00492752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102066737|NCT02225834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102066962|NCT02220530|Anesthetics|anesthetics|mesh-ancestor
102067033|NCT02230982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101836617|NCT00492752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102067556|NCT04459286|Ritonavir|ritonavir|mesh-list
101836618|NCT00492752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102067925|NCT03847519|Pembrolizumab|pembrolizumab|mesh-list
101888621|NCT01334944|Ibuprofen|ibuprofen|mesh-list
102067997|NCT02262650|Telmisartan|telmisartan|mesh-list
102068231|NCT04477018|Iron|iron|mesh-list
102068597|NCT02265770|Mitosis Modulators|mitosis modulators|mesh-ancestor
102068680|NCT01371578|Ribavirin|ribavirin|mesh-list
102068897|NCT05095480|Antimetabolites|antimetabolites|mesh-ancestor
102069046|NCT02090790|Autonomic Agents|autonomic agents|mesh-ancestor
102069643|NCT04437160|Cyclophosphamide|cyclophosphamide|mesh-list
102069722|NCT01110902|Agomelatine|agomelatine|mesh-list
102070035|NCT00803114|Morphine|morphine|mesh-list
102070467|NCT00959036|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102070837|NCT05105698|Dapagliflozin|dapagliflozin|mesh-list
102071591|NCT00640484|Autonomic Agents|autonomic agents|mesh-ancestor
102072033|NCT02774590|Timolol|timolol|mesh-list
102072184|NCT04056897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102072407|NCT03673228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102073231|NCT00113438|Paclitaxel|paclitaxel|mesh-list
101836619|NCT00492752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836620|NCT00308308|Insulin|insulin|mesh-list
101836621|NCT00308308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102074588|NCT02115204|Docetaxel|docetaxel|mesh-list
102074954|NCT02116842|Analgesics|analgesics|mesh-ancestor
102075799|NCT05606965|Vaccines|vaccines|mesh-list
101836622|NCT00308308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836623|NCT00505934|Levetiracetam|levetiracetam|mesh-list
101888970|NCT00003910|Methotrexate|methotrexate|mesh-list
102076681|NCT02969655|Glycine|glycine|mesh-list
102076988|NCT03648333|Vitamins|vitamins|mesh-ancestor
101836626|NCT02532790|Prednisone|prednisone|mesh-list
102077717|NCT02294162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102079085|NCT01896011|Teriparatide|teriparatide|mesh-list
102079583|NCT01597258|Crizotinib|crizotinib|mesh-list
101836627|NCT02532790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102081246|NCT05243446|Losartan|losartan|mesh-list
102081636|NCT04475224|Mitogens|mitogens|mesh-list
102081924|NCT04435210|Hydralazine|hydralazine|mesh-list
101836628|NCT02532790|Glucocorticoids|glucocorticoids|mesh-ancestor
101836629|NCT02532790|Hormones|hormones|mesh-ancestor
102082441|NCT02777190|Misoprostol|misoprostol|mesh-list
102083046|NCT03491072|Narcotics|narcotics|mesh-ancestor
102083347|NCT02872311|Immunologic Factors|immunologic factors|mesh-ancestor
102083421|NCT03614013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083719|NCT02150070|Immunoconjugates|immunoconjugates|mesh-ancestor
102084470|NCT05013112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102084544|NCT03081676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102085138|NCT03072082|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102085213|NCT04986982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102085364|NCT04682288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102085508|NCT03893318|Lidocaine|lidocaine|mesh-list
102085584|NCT00548912|Diuretics|diuretics|mesh-ancestor
102085659|NCT04994314|Fluorides|fluorides|mesh-list
102086025|NCT03597087|Anesthetics|anesthetics|mesh-list
102086549|NCT03539328|Antimetabolites|antimetabolites|mesh-ancestor
102086697|NCT03209401|Niraparib|niraparib|mesh-list
102087521|NCT02180334|Incretins|incretins|mesh-ancestor
102087678|NCT02631538|Rituximab|rituximab|mesh-list
102087821|NCT02182752|Tramadol|tramadol|mesh-list
102087891|NCT02186574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102087968|NCT03064906|Pancrelipase|pancrelipase|mesh-list
102088422|NCT02187588|Ibuprofen|ibuprofen|mesh-list
102088639|NCT03266146|Prednisolone|prednisolone|mesh-list
102088940|NCT03702985|Irinotecan|irinotecan|mesh-list
102089017|NCT02188368|Antiemetics|antiemetics|mesh-ancestor
102089311|NCT04622995|Anesthetics|anesthetics|mesh-ancestor
102089382|NCT02197104|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102089604|NCT02201238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102089751|NCT04059679|Antipyretics|antipyretics|mesh-ancestor
102090587|NCT02226588|Misoprostol|misoprostol|mesh-list
102090807|NCT05956600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102090954|NCT05951504|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102091761|NCT04677049|Niacin|niacin|mesh-list
102092160|NCT03333395|Albuterol|albuterol|mesh-list
102092843|NCT04945954|Immunologic Factors|immunologic factors|mesh-ancestor
102092998|NCT02624050|Propofol|propofol|mesh-list
102093226|NCT04294550|Naloxegol|naloxegol|mesh-list
102093683|NCT03562533|Paclitaxel|paclitaxel|mesh-list
102094145|NCT06015750|Vitamins|vitamins|mesh-ancestor
102094883|NCT05564377|Leucovorin|leucovorin|mesh-list
101890193|NCT03485950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102095034|NCT05369832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102095489|NCT04697628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102096019|NCT03837899|Durvalumab|durvalumab|mesh-list
102096401|NCT02711826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102096478|NCT02621021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101836630|NCT02532790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101836631|NCT02532790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890408|NCT01100060|Sensory System Agents|sensory system agents|mesh-ancestor
101836632|NCT02532790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101836633|NCT02532790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101836634|NCT00505778|Mesalamine|mesalamine|mesh-list
101836635|NCT00505778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101836636|NCT00505778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101836637|NCT00505778|Analgesics|analgesics|mesh-ancestor
101836638|NCT00505778|Sensory System Agents|sensory system agents|mesh-ancestor
101836639|NCT00505778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101890627|NCT00048932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101836640|NCT00505778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836641|NCT00505778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101836642|NCT00505778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101836643|NCT00308074|Aripiprazole|aripiprazole|mesh-list
101836644|NCT00308074|Antidepressive Agents|antidepressive agents|mesh-ancestor
101836645|NCT00308074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101836646|NCT00308074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101836647|NCT00308074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101836648|NCT00308074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101567224|NCT01108809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567226|NCT01253408|Hallucinogens|hallucinogens|mesh-ancestor
101567227|NCT01253408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567228|NCT01253408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101567229|NCT01253408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101567230|NCT01253408|Analgesics|analgesics|mesh-ancestor
101567231|NCT01253408|Sensory System Agents|sensory system agents|mesh-ancestor
101567232|NCT01253408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101567233|NCT01253408|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101567234|NCT01253408|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101567235|NCT01253408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101567236|NCT01253408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567237|NCT01253408|Hormones|hormones|mesh-ancestor
101567238|NCT01253408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101567239|NCT05506982|Psilocybin|psilocybin|mesh-list
101567240|NCT05506982|Hallucinogens|hallucinogens|mesh-ancestor
101567241|NCT05506982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567242|NCT05506982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101567243|NCT02879643|Vincristine|vincristine|mesh-list
101567244|NCT02879643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101567245|NCT02879643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101567246|NCT02879643|Tubulin Modulators|tubulin modulators|mesh-ancestor
101567247|NCT02879643|Antimitotic Agents|antimitotic agents|mesh-ancestor
101567248|NCT02879643|Mitosis Modulators|mitosis modulators|mesh-ancestor
101567249|NCT02879643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567250|NCT02879721|Candesartan|candesartan|mesh-list
101567251|NCT02879721|Candesartan cilexetil|candesartan cilexetil|mesh-list
101567252|NCT02879721|Enalapril|enalapril|mesh-list
101567253|NCT02879721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101567254|NCT02879721|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101567255|NCT02879721|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101567256|NCT02879721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567257|NCT02879721|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101567258|NCT02879721|Protease Inhibitors|protease inhibitors|mesh-ancestor
101567259|NCT02879721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101567260|NCT01253174|Tetrahydrofolates|tetrahydrofolates|mesh-list
101567262|NCT01253174|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101567263|NCT01253174|Hormone Antagonists|hormone antagonists|mesh-ancestor
101567264|NCT01253174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101567265|NCT01253174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567266|NCT01253174|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101567268|NCT01253174|Natriuretic Agents|natriuretic agents|mesh-ancestor
101567269|NCT01253174|Vitamin B Complex|vitamin b complex|mesh-ancestor
101567270|NCT01253174|Vitamins|vitamins|mesh-ancestor
101567271|NCT01253174|Micronutrients|micronutrients|mesh-ancestor
101891471|NCT05842096|Antibodies|antibodies|mesh-list
101567272|NCT01108731|Milnacipran|milnacipran|mesh-list
101567273|NCT01108731|Levomilnacipran|levomilnacipran|mesh-list
101891548|NCT05841303|Ascorbic Acid|ascorbic acid|mesh-list
101567274|NCT01108731|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101567275|NCT01108731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101567276|NCT01108731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101567277|NCT01108731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567278|NCT01108731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101567279|NCT01108731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567280|NCT01108731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101567281|NCT01108731|Analgesics|analgesics|mesh-ancestor
101567282|NCT01108731|Sensory System Agents|sensory system agents|mesh-ancestor
101567283|NCT01108731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101567284|NCT01108731|Antidepressive Agents|antidepressive agents|mesh-ancestor
101567285|NCT01108731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101567286|NCT04308525|Analgesics, Opioid|analgesics, opioid|mesh-list
101567287|NCT04308525|Narcotics|narcotics|mesh-ancestor
101567288|NCT04308525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101567289|NCT04308525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567291|NCT04308525|Sensory System Agents|sensory system agents|mesh-ancestor
101567292|NCT04308525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101567293|NCT01108341|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101567294|NCT01108341|Ofatumumab|ofatumumab|mesh-list
101567295|NCT01108341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101567296|NCT01108341|Alkylating Agents|alkylating agents|mesh-ancestor
101567297|NCT01108341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567298|NCT01108341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101567299|NCT01252940|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
101567301|NCT01252940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101567302|NCT01252940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101892135|NCT03917914|Bisoprolol|bisoprolol|mesh-list
101567303|NCT01252940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101567304|NCT01252940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101567305|NCT01252940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567306|NCT01252940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101567307|NCT01252940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101567308|NCT01252238|Amlodipine|amlodipine|mesh-list
101567309|NCT01252238|Valsartan|valsartan|mesh-list
101567310|NCT01252238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101892196|NCT03798626|Antimetabolites|antimetabolites|mesh-ancestor
101567311|NCT01252238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101567312|NCT01252238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101892265|NCT03623321|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101567313|NCT01252238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567314|NCT01252238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101567315|NCT01252238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567316|NCT01252238|Vasodilator Agents|vasodilator agents|mesh-ancestor
101567317|NCT01252238|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101567318|NCT01252238|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101567319|NCT01101321|Oxycodone|oxycodone|mesh-list
101567320|NCT01101321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101567321|NCT01101321|Narcotics|narcotics|mesh-ancestor
101567322|NCT01101321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101567323|NCT01101321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567324|NCT01101321|Analgesics|analgesics|mesh-ancestor
101567325|NCT01101321|Sensory System Agents|sensory system agents|mesh-ancestor
101567326|NCT01101321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101567327|NCT04309929|Analgesics|analgesics|mesh-list
101567328|NCT04309929|Sensory System Agents|sensory system agents|mesh-ancestor
101567329|NCT04309929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101892493|NCT01674140|Fertility Agents|fertility agents|mesh-ancestor
101567330|NCT04309929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567331|NCT01101165|Oxycodone|oxycodone|mesh-list
101567332|NCT01101165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101567333|NCT01101165|Narcotics|narcotics|mesh-ancestor
101567334|NCT01101165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101567335|NCT01101165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567336|NCT01101165|Analgesics|analgesics|mesh-ancestor
101567337|NCT01101165|Sensory System Agents|sensory system agents|mesh-ancestor
101567338|NCT01101165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101567339|NCT01100853|Naltrexone|naltrexone|mesh-list
101567340|NCT01100853|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101567341|NCT01100853|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101892767|NCT03404518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101567342|NCT01100853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567343|NCT01100853|Sensory System Agents|sensory system agents|mesh-ancestor
101892848|NCT01051115|Dasatinib|dasatinib|mesh-list
101567344|NCT01100853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101567345|NCT02879097|Paclitaxel|paclitaxel|mesh-list
101567346|NCT02879097|Carboplatin|carboplatin|mesh-list
101567348|NCT02879097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101567349|NCT02879097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101567350|NCT02879097|Tubulin Modulators|tubulin modulators|mesh-ancestor
101567351|NCT02879097|Antimitotic Agents|antimitotic agents|mesh-ancestor
101567352|NCT02879097|Mitosis Modulators|mitosis modulators|mesh-ancestor
101567353|NCT02879097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567354|NCT02879097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101567356|NCT02879097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101567357|NCT02879097|Growth Substances|growth substances|mesh-ancestor
101567358|NCT02879097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567359|NCT02879097|Growth Inhibitors|growth inhibitors|mesh-ancestor
101567360|NCT02878863|Peoniflorin|peoniflorin|mesh-list
101567361|NCT02878863|Silymarin|silymarin|mesh-list
101893490|NCT00350207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101893564|NCT01209026|Xhance|xhance|mesh-list
101567363|NCT02878863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567364|NCT02878863|Protective Agents|protective agents|mesh-ancestor
101567365|NCT02878863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567366|NCT02878863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101567367|NCT02878863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101567368|NCT02878863|Analgesics|analgesics|mesh-ancestor
101567369|NCT02878863|Sensory System Agents|sensory system agents|mesh-ancestor
101567370|NCT02878863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101567371|NCT02878863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101567372|NCT02878863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101567373|NCT02881125|Paclitaxel|paclitaxel|mesh-list
101567374|NCT02881125|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101567375|NCT02881125|Nortriptyline|nortriptyline|mesh-list
101893646|NCT01209416|Acipimox|acipimox|mesh-list
101567376|NCT02881125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101567377|NCT02881125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101567378|NCT02881125|Tubulin Modulators|tubulin modulators|mesh-ancestor
101567379|NCT02881125|Antimitotic Agents|antimitotic agents|mesh-ancestor
101567380|NCT02881125|Mitosis Modulators|mitosis modulators|mesh-ancestor
101567381|NCT02881125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567382|NCT02881125|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101567383|NCT02881125|Antidepressive Agents|antidepressive agents|mesh-ancestor
101567384|NCT02881125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101567385|NCT02881125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101567386|NCT02881125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101567387|NCT02881125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101567388|NCT02881125|Adrenergic Agents|adrenergic agents|mesh-ancestor
101567389|NCT02881125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101893828|NCT00346151|Sirolimus|sirolimus|mesh-list
101567390|NCT02881125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567391|NCT01107405|Loteprednol Etabonate|loteprednol etabonate|mesh-list
101567392|NCT01107405|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101567393|NCT01097577|Pregabalin|pregabalin|mesh-list
101567394|NCT01097577|Analgesics|analgesics|mesh-ancestor
101567395|NCT01097577|Sensory System Agents|sensory system agents|mesh-ancestor
101567396|NCT01097577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101567398|NCT01097577|Anticonvulsants|anticonvulsants|mesh-ancestor
101567399|NCT01097577|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101567400|NCT01097577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101894115|NCT03939884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101567401|NCT01097577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567402|NCT01097577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101567403|NCT01097577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101567404|NCT01097577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101567405|NCT01097577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101567406|NCT01097577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101567407|NCT01097421|Pramipexole|pramipexole|mesh-list
101567408|NCT01097421|Antioxidants|antioxidants|mesh-ancestor
101567409|NCT01097421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567410|NCT01097421|Protective Agents|protective agents|mesh-ancestor
101567411|NCT01097421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567412|NCT01097421|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101567413|NCT01097421|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101567414|NCT01097421|Dopamine Agonists|dopamine agonists|mesh-ancestor
101567415|NCT01097421|Dopamine Agents|dopamine agents|mesh-ancestor
101567416|NCT01097421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101567417|NCT01251614|Adalimumab|adalimumab|mesh-list
101567418|NCT01251614|Methotrexate|methotrexate|mesh-list
101567419|NCT01251614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101567420|NCT01251614|Abortifacient Agents|abortifacient agents|mesh-ancestor
101567421|NCT01251614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101567422|NCT01251614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567423|NCT01251614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101567424|NCT01251614|Antimetabolites|antimetabolites|mesh-ancestor
101567425|NCT01251614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567426|NCT01251614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101567427|NCT01251614|Dermatologic Agents|dermatologic agents|mesh-ancestor
101567428|NCT01251614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101567429|NCT01251614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101567430|NCT01251614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101567431|NCT01251614|Immunologic Factors|immunologic factors|mesh-ancestor
101567432|NCT01251614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101894466|NCT01116596|Acetaminophen|acetaminophen|mesh-list
101567433|NCT01251614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101567434|NCT01251614|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101567435|NCT01251614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101567436|NCT01106625|Metformin|metformin|mesh-list
101567437|NCT01106625|Canagliflozin|canagliflozin|mesh-list
101567438|NCT01106625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101567439|NCT01106625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567440|NCT01106625|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101443935|NCT01652482|Vitamins|vitamins|mesh-ancestor
101567441|NCT01106625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567442|NCT01251380|Botulinum Toxins|botulinum toxins|mesh-list
101894743|NCT03937544|Fludarabine|fludarabine|mesh-list
101567443|NCT01251380|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101567445|NCT01251380|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101567446|NCT01251380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101567447|NCT01251380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567448|NCT01251380|Cholinergic Agents|cholinergic agents|mesh-ancestor
101567449|NCT01251380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101567450|NCT01251380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567451|NCT01251380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101567452|NCT01251380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101567454|NCT01251146|Bisoprolol|bisoprolol|mesh-list
101567455|NCT01251146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101567456|NCT01251146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101567457|NCT01251146|Sympatholytics|sympatholytics|mesh-ancestor
101567458|NCT01251146|Autonomic Agents|autonomic agents|mesh-ancestor
101567459|NCT01251146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101567460|NCT01251146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567461|NCT01251146|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101567462|NCT01251146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101567463|NCT01251146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101567464|NCT01251146|Adrenergic Agents|adrenergic agents|mesh-ancestor
101567465|NCT01251146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101895322|NCT01220102|Adapalene|adapalene|mesh-list
101567466|NCT01251146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567467|NCT02878707|Dexmedetomidine|dexmedetomidine|mesh-list
101567468|NCT02878707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101567469|NCT02878707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101567470|NCT02878707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567471|NCT02878707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101567472|NCT02878707|Analgesics|analgesics|mesh-ancestor
101567473|NCT02878707|Sensory System Agents|sensory system agents|mesh-ancestor
101567474|NCT02878707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101567475|NCT02878707|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101567476|NCT02878707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101567477|NCT02878707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101567478|NCT02878707|Adrenergic Agents|adrenergic agents|mesh-ancestor
101567479|NCT02878707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101567480|NCT02878707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567481|NCT01096017|Albuterol|albuterol|mesh-list
101567482|NCT01096017|Terbutaline|terbutaline|mesh-list
101567483|NCT01096017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101567484|NCT01096017|Autonomic Agents|autonomic agents|mesh-ancestor
101567485|NCT01096017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101567486|NCT01096017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567487|NCT01096017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101567488|NCT01096017|Respiratory System Agents|respiratory system agents|mesh-ancestor
101567489|NCT01096017|Tocolytic Agents|tocolytic agents|mesh-ancestor
101567490|NCT01096017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101224373|NCT01523431|Antidotes|antidotes|mesh-ancestor
101567491|NCT01096017|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101567492|NCT01096017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101567493|NCT01096017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101567494|NCT01096017|Adrenergic Agents|adrenergic agents|mesh-ancestor
101567495|NCT01096017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101567496|NCT01096017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567497|NCT01096017|Sympathomimetics|sympathomimetics|mesh-ancestor
101567498|NCT00626223|Folic Acid|folic acid|mesh-list
101567500|NCT00626223|Vitamin B Complex|vitamin b complex|mesh-ancestor
101567501|NCT00626223|Vitamins|vitamins|mesh-ancestor
101567502|NCT00626223|Micronutrients|micronutrients|mesh-ancestor
101567503|NCT00626223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567505|NCT01106157|Immunologic Factors|immunologic factors|mesh-ancestor
101567506|NCT01106157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567507|NCT01106157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101567508|NCT04828005|Naloxone|naloxone|mesh-list
101567509|NCT04828005|Nalmefene|nalmefene|mesh-list
101567510|NCT04828005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101567511|NCT04828005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567512|NCT04828005|Sensory System Agents|sensory system agents|mesh-ancestor
101567513|NCT04828005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101567514|NCT02878161|Prednisone|prednisone|mesh-list
101567515|NCT02878161|Methylprednisolone|methylprednisolone|mesh-list
101567516|NCT02878161|Adalimumab|adalimumab|mesh-list
101567517|NCT02878161|Infliximab|infliximab|mesh-list
101567518|NCT02878161|Etanercept|etanercept|mesh-list
101567519|NCT02878161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101567520|NCT02878161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101567521|NCT02878161|Methotrexate|methotrexate|mesh-list
101567522|NCT02878161|Glucocorticoids|glucocorticoids|mesh-list
101567523|NCT02878161|Leflunomide|leflunomide|mesh-list
101567524|NCT02878161|Hormones|hormones|mesh-ancestor
101896388|NCT03918590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101567525|NCT02878161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101567527|NCT02878161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101567528|NCT02878161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101896536|NCT03140176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101567529|NCT02878161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101567530|NCT02878161|Abortifacient Agents|abortifacient agents|mesh-ancestor
101567531|NCT02878161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101567532|NCT02878161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101896608|NCT01133366|Warfarin|warfarin|mesh-list
101567534|NCT02878161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896682|NCT01136252|Adalimumab|adalimumab|mesh-list
101567535|NCT02878161|Dermatologic Agents|dermatologic agents|mesh-ancestor
101567536|NCT02878161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101567537|NCT02878161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101567538|NCT02878161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101567539|NCT02878161|Immunologic Factors|immunologic factors|mesh-ancestor
101567540|NCT02878161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101567541|NCT02878161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101567542|NCT02878161|Antiemetics|antiemetics|mesh-ancestor
101567543|NCT02878161|Autonomic Agents|autonomic agents|mesh-ancestor
101567544|NCT02878161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101567545|NCT02878161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101567546|NCT02878161|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101567547|NCT02878161|Protective Agents|protective agents|mesh-ancestor
101567548|NCT02878161|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101567549|NCT02878161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101567550|NCT02878161|Analgesics|analgesics|mesh-ancestor
101567551|NCT02878161|Sensory System Agents|sensory system agents|mesh-ancestor
101567552|NCT01093755|Omeprazole|omeprazole|mesh-list
101567553|NCT01093755|Dexlansoprazole|dexlansoprazole|mesh-list
101567554|NCT01093755|Lansoprazole|lansoprazole|mesh-list
101567555|NCT01093755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101567556|NCT01093755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101567557|NCT01093755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101567558|NCT01093755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101567559|NCT01093755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567560|NCT01092663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101567561|NCT01092663|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
101567562|NCT01092663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101567563|NCT01092663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567564|NCT01092663|Incretins|incretins|mesh-ancestor
101567565|NCT01092663|Hormones|hormones|mesh-ancestor
101567566|NCT01092663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101567567|NCT01092663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101567568|NCT01092663|Protease Inhibitors|protease inhibitors|mesh-ancestor
101567569|NCT01092663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101567570|NCT01092663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567571|NCT01092663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101567572|NCT01092663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101567573|NCT01092663|Antimetabolites|antimetabolites|mesh-ancestor
101567574|NCT01092663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101567575|NCT01078623|Formoterol Fumarate|formoterol fumarate|mesh-list
101567576|NCT01078623|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101567577|NCT01078623|Autonomic Agents|autonomic agents|mesh-ancestor
101567578|NCT01078623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101567579|NCT01078623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567580|NCT01078623|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101567581|NCT01078623|Respiratory System Agents|respiratory system agents|mesh-ancestor
101443944|NCT00174629|Tubulin Modulators|tubulin modulators|mesh-ancestor
101567582|NCT01078623|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101567583|NCT01078623|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101567584|NCT01078623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101567585|NCT01078623|Adrenergic Agents|adrenergic agents|mesh-ancestor
101897614|NCT01237028|Vitamins|vitamins|mesh-ancestor
101567586|NCT01078623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101567587|NCT01078623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567589|NCT01092507|Immunologic Factors|immunologic factors|mesh-ancestor
101567590|NCT01092507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567591|NCT01078545|Leuprolide|leuprolide|mesh-list
101567592|NCT01078545|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101567593|NCT01078545|Fertility Agents|fertility agents|mesh-ancestor
101567594|NCT01078545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101897948|NCT01092624|Solifenacin Succinate|solifenacin succinate|mesh-list
101567595|NCT01078545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567596|NCT01078545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101567597|NCT01078545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101567599|NCT01091259|Irinotecan|irinotecan|mesh-list
101898094|NCT03908372|Antimitotic Agents|antimitotic agents|mesh-ancestor
101567600|NCT01091259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101567601|NCT01091259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101567602|NCT01091259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101567603|NCT01091259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101567604|NCT01091259|Growth Substances|growth substances|mesh-ancestor
101567605|NCT01091259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567606|NCT01091259|Growth Inhibitors|growth inhibitors|mesh-ancestor
101567607|NCT01091259|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101898313|NCT02527772|Vitamins|vitamins|mesh-ancestor
101567608|NCT01091259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101567609|NCT01091259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101567610|NCT01091259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567611|NCT01078389|Febuxostat|febuxostat|mesh-list
101567612|NCT01078389|Gout Suppressants|gout suppressants|mesh-ancestor
101567613|NCT01078389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101567614|NCT01090323|Deferasirox|deferasirox|mesh-list
101567615|NCT01090323|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101567616|NCT01090323|Chelating Agents|chelating agents|mesh-ancestor
101567617|NCT01090323|Sequestering Agents|sequestering agents|mesh-ancestor
101567618|NCT01090323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567619|NCT02876991|Listerine|listerine|mesh-list
101567620|NCT02876991|Fluorides|fluorides|mesh-list
101567621|NCT02876991|Sodium Fluoride|sodium fluoride|mesh-list
101567622|NCT02876991|Cariostatic Agents|cariostatic agents|mesh-ancestor
101567623|NCT02876991|Protective Agents|protective agents|mesh-ancestor
101567624|NCT02876991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567625|NCT02876991|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101567626|NCT02876991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101567627|NCT01201356|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101567628|NCT01201356|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101567629|NCT01201356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567630|NCT01201356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101567631|NCT01201356|Immunologic Factors|immunologic factors|mesh-ancestor
101567632|NCT01201356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567633|NCT00637611|Fexofenadine|fexofenadine|mesh-list
101567634|NCT00637611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101567635|NCT00637611|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101567636|NCT00637611|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101567637|NCT00637611|Histamine Antagonists|histamine antagonists|mesh-ancestor
101567638|NCT00637611|Histamine Agents|histamine agents|mesh-ancestor
101567639|NCT00637611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101567640|NCT00637611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567641|NCT00637611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567643|NCT00626535|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101567644|NCT00626535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101567645|NCT00626535|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101567646|NCT00626535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101567647|NCT00626535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567648|NCT01200810|Bicalutamide|bicalutamide|mesh-list
101567649|NCT01200810|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
101567650|NCT01200810|Androgen Antagonists|androgen antagonists|mesh-ancestor
101567651|NCT01200810|Hormone Antagonists|hormone antagonists|mesh-ancestor
101567652|NCT01200810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101567653|NCT01200810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567654|NCT01200810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101567655|NCT01200810|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101567656|NCT01200810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101567657|NCT01200810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567658|NCT01200342|Paclitaxel|paclitaxel|mesh-list
101567659|NCT01200342|Carboplatin|carboplatin|mesh-list
101567660|NCT01200342|Oblimersen|oblimersen|mesh-list
101567661|NCT01200342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101567662|NCT01200342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101567663|NCT01200342|Tubulin Modulators|tubulin modulators|mesh-ancestor
101567664|NCT01200342|Antimitotic Agents|antimitotic agents|mesh-ancestor
101567665|NCT01200342|Mitosis Modulators|mitosis modulators|mesh-ancestor
101567666|NCT01200342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567668|NCT01198548|Cholecalciferol|cholecalciferol|mesh-list
101567669|NCT01198548|Leucovorin|leucovorin|mesh-list
101567670|NCT01198548|Bevacizumab|bevacizumab|mesh-list
101567671|NCT01198548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101567672|NCT01198548|Fluorouracil|fluorouracil|mesh-list
101567673|NCT01198548|Oxaliplatin|oxaliplatin|mesh-list
101567674|NCT01198548|Antibodies|antibodies|mesh-list
101567675|NCT01198548|Immunoglobulins|immunoglobulins|mesh-list
101567676|NCT01198548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101567677|NCT01198548|Levoleucovorin|levoleucovorin|mesh-list
101567678|NCT01198548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101567679|NCT01198548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101567680|NCT01198548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101567681|NCT01198548|Growth Substances|growth substances|mesh-ancestor
101567682|NCT01198548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567683|NCT01198548|Growth Inhibitors|growth inhibitors|mesh-ancestor
101567685|NCT01198548|Micronutrients|micronutrients|mesh-ancestor
101567686|NCT01198548|Immunologic Factors|immunologic factors|mesh-ancestor
101567687|NCT01198548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101567688|NCT01198548|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101567689|NCT01198548|Antimetabolites|antimetabolites|mesh-ancestor
101567690|NCT01198548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567691|NCT01198548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101567692|NCT01198548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101567693|NCT01198548|Antidotes|antidotes|mesh-ancestor
101567694|NCT01198548|Protective Agents|protective agents|mesh-ancestor
101567695|NCT01198548|Vitamin B Complex|vitamin b complex|mesh-ancestor
101567696|NCT00977938|Aspirin|aspirin|mesh-list
101567697|NCT00977938|Clopidogrel|clopidogrel|mesh-list
101567698|NCT00977938|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101567699|NCT00977938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101567700|NCT00977938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101567701|NCT00977938|Analgesics|analgesics|mesh-ancestor
101567702|NCT00977938|Sensory System Agents|sensory system agents|mesh-ancestor
101567703|NCT00977938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101567704|NCT00977938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567705|NCT00977938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101567706|NCT00977938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101567707|NCT00977938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101567708|NCT00977938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101567709|NCT00977938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567710|NCT00977938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101567711|NCT00977938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101567712|NCT00977938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101567713|NCT00977938|Antipyretics|antipyretics|mesh-ancestor
101567714|NCT00977938|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101224588|NCT01524705|Exenatide|exenatide|mesh-list
101567715|NCT00977938|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101567716|NCT00977938|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101567717|NCT00977938|Purinergic Agents|purinergic agents|mesh-ancestor
101567718|NCT00977938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101443957|NCT00555334|Lamivudine|lamivudine|mesh-list
101567719|NCT00977548|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101567720|NCT00977548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101567721|NCT00977548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101567722|NCT00977548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101567723|NCT00977548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567725|NCT04290208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101567726|NCT04290208|Analgesics|analgesics|mesh-ancestor
101567727|NCT04290208|Sensory System Agents|sensory system agents|mesh-ancestor
101567728|NCT04290208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101567729|NCT04290208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567730|NCT04290208|Antipyretics|antipyretics|mesh-ancestor
101567731|NCT03223597|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
101567732|NCT03223597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101567733|NCT01090011|Cetuximab|cetuximab|mesh-list
101567734|NCT01090011|Afatinib|afatinib|mesh-list
101567735|NCT01090011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101567736|NCT01090011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101567737|NCT01090011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101567738|NCT01090011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101567739|NCT01090011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567740|NCT02877615|S44819|s44819|mesh-list
101567741|NCT02877615|GABA-A Receptor Antagonists|gaba-a receptor antagonists|mesh-ancestor
101567742|NCT02877615|GABA Antagonists|gaba antagonists|mesh-ancestor
101567743|NCT02877615|GABA Agents|gaba agents|mesh-ancestor
101567744|NCT02877615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101567745|NCT02877615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567746|NCT02877615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567748|NCT02437279|Ipilimumab|ipilimumab|mesh-list
101567749|NCT02437279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101567750|NCT02437279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101567751|NCT02437279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101567752|NCT02437279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567753|NCT01251653|Gemcitabine|gemcitabine|mesh-list
101567754|NCT01251653|Docetaxel|docetaxel|mesh-list
101567755|NCT01251653|Afatinib|afatinib|mesh-list
101567756|NCT01251653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101567757|NCT01251653|Antimetabolites|antimetabolites|mesh-ancestor
101567758|NCT01251653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567759|NCT01251653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101567760|NCT01251653|Tubulin Modulators|tubulin modulators|mesh-ancestor
101567761|NCT01251653|Antimitotic Agents|antimitotic agents|mesh-ancestor
101567762|NCT01251653|Mitosis Modulators|mitosis modulators|mesh-ancestor
101567763|NCT01251653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101567764|NCT01251653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101567765|NCT00910663|Mycophenolic Acid|mycophenolic acid|mesh-list
101567766|NCT00910663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101567767|NCT00910663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101567768|NCT00910663|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101567769|NCT00910663|Antitubercular Agents|antitubercular agents|mesh-ancestor
101567770|NCT00910663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101567771|NCT00910663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101567772|NCT00910663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101567773|NCT00910663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567774|NCT01077375|Milnacipran|milnacipran|mesh-list
101567775|NCT01077375|Levomilnacipran|levomilnacipran|mesh-list
101567776|NCT01077375|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101567777|NCT01077375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101567778|NCT01077375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101567779|NCT01077375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567780|NCT01077375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101567781|NCT01077375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567782|NCT01077375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101567783|NCT01077375|Analgesics|analgesics|mesh-ancestor
101567784|NCT01077375|Sensory System Agents|sensory system agents|mesh-ancestor
101567785|NCT01077375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101567786|NCT01077375|Antidepressive Agents|antidepressive agents|mesh-ancestor
101567787|NCT01077375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101567788|NCT02877771|Insulin|insulin|mesh-list
101567789|NCT02877771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101567790|NCT02877771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567791|NCT04306653|Betamethasone|betamethasone|mesh-list
101567792|NCT04306653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101567793|NCT04306653|Glucocorticoids|glucocorticoids|mesh-ancestor
101567794|NCT04306653|Hormones|hormones|mesh-ancestor
101567795|NCT04306653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101567796|NCT04306653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567797|NCT04306653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101567798|NCT04306653|Respiratory System Agents|respiratory system agents|mesh-ancestor
101567799|NCT04306731|Trimethoprim|trimethoprim|mesh-list
101567800|NCT04306731|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101567801|NCT04306731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101567802|NCT04306731|Antimalarials|antimalarials|mesh-ancestor
101567803|NCT04306731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101567804|NCT04306731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101567805|NCT04306731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101567806|NCT04306731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101567807|NCT04306731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567808|NCT04306731|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101567809|NCT04306731|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101567810|NCT04306731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101567811|NCT02877537|Albuterol|albuterol|mesh-list
101567812|NCT02877537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101567813|NCT02877537|Autonomic Agents|autonomic agents|mesh-ancestor
101567814|NCT02877537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101567815|NCT02877537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567816|NCT02877537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101567817|NCT02877537|Respiratory System Agents|respiratory system agents|mesh-ancestor
101567818|NCT02877537|Tocolytic Agents|tocolytic agents|mesh-ancestor
101567819|NCT02877537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101567820|NCT02877537|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101567821|NCT02877537|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101567822|NCT02877537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101567823|NCT02877537|Adrenergic Agents|adrenergic agents|mesh-ancestor
101567824|NCT02877537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101567825|NCT02877537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567826|NCT01250873|Sertraline|sertraline|mesh-list
101567827|NCT01250873|Antidepressive Agents|antidepressive agents|mesh-ancestor
101567828|NCT01250873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101567829|NCT01250873|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101567830|NCT01250873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101567831|NCT01250873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101567832|NCT01250873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567833|NCT01250873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101567834|NCT01250873|Serotonin Agents|serotonin agents|mesh-ancestor
101567835|NCT01250873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567836|NCT02888327|Oseltamivir|oseltamivir|mesh-list
101567837|NCT02888327|Digoxin|digoxin|mesh-list
101567838|NCT02888327|Midazolam|midazolam|mesh-list
101567839|NCT02888327|Pitavastatin|pitavastatin|mesh-list
101567840|NCT02888327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101567841|NCT02888327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101567842|NCT02888327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101567843|NCT02888327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567844|NCT02888327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101567845|NCT02888327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101567846|NCT02888327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101567847|NCT02888327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101567848|NCT02888327|Anesthetics, General|anesthetics, general|mesh-ancestor
101567849|NCT02888327|Anesthetics|anesthetics|mesh-ancestor
101567850|NCT02888327|GABA Modulators|gaba modulators|mesh-ancestor
101567851|NCT02888327|GABA Agents|gaba agents|mesh-ancestor
101567852|NCT02888327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101567853|NCT02888327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567854|NCT02888327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101567855|NCT02888327|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101567856|NCT02888327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101567857|NCT02888327|Protective Agents|protective agents|mesh-ancestor
101567858|NCT02888327|Antiviral Agents|antiviral agents|mesh-ancestor
101567859|NCT02888327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101567860|NCT02888327|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101567861|NCT02888327|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101567862|NCT02888327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101567863|NCT02888327|Antimetabolites|antimetabolites|mesh-ancestor
101567864|NCT02888327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101567865|NCT01248065|Vitamin D|vitamin d|mesh-list
101567866|NCT01248065|Cholecalciferol|cholecalciferol|mesh-list
101567867|NCT01248065|Ciclesonide|ciclesonide|mesh-list
101567868|NCT01248065|Vitamins|vitamins|mesh-ancestor
101567869|NCT01248065|Micronutrients|micronutrients|mesh-ancestor
101567870|NCT01248065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567871|NCT01248065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101567872|NCT01248065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101567873|NCT01248065|Glucocorticoids|glucocorticoids|mesh-ancestor
101567874|NCT01248065|Hormones|hormones|mesh-ancestor
101567875|NCT01248065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101567876|NCT01248065|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101567877|NCT01250756|Vaccines|vaccines|mesh-list
101567878|NCT01250756|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101567879|NCT01250756|Immunologic Factors|immunologic factors|mesh-ancestor
101567880|NCT01250756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567881|NCT00977470|Hydroxychloroquine|hydroxychloroquine|mesh-list
101567882|NCT00977470|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101567883|NCT00977470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101567884|NCT00977470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101567885|NCT00977470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101567886|NCT00977470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567887|NCT00977470|Antimalarials|antimalarials|mesh-ancestor
101567888|NCT00977470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101567889|NCT00977470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101567890|NCT00977470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101567891|NCT00977470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101567892|NCT02865304|Endostar protein|endostar protein|mesh-list
101567893|NCT02865304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101567894|NCT02865304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101567895|NCT02865304|Growth Substances|growth substances|mesh-ancestor
101567896|NCT02865304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567897|NCT02865304|Growth Inhibitors|growth inhibitors|mesh-ancestor
101567898|NCT02865304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101567899|NCT04075474|Listerine|listerine|mesh-list
101567900|NCT04075474|Fluorides|fluorides|mesh-list
101567901|NCT04075474|Sodium Fluoride|sodium fluoride|mesh-list
101567902|NCT04075474|Cariostatic Agents|cariostatic agents|mesh-ancestor
101567903|NCT04075474|Protective Agents|protective agents|mesh-ancestor
101567904|NCT04075474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567905|NCT04075474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101567906|NCT04075474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101567908|NCT02866396|Analgesics|analgesics|mesh-ancestor
101567909|NCT02866396|Sensory System Agents|sensory system agents|mesh-ancestor
101567910|NCT02866396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101567911|NCT02866396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567912|NCT02866396|Anticonvulsants|anticonvulsants|mesh-ancestor
101567913|NCT02866396|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101567914|NCT02866396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101567915|NCT02866396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567916|NCT02866396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101567917|NCT02866396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101567918|NCT02866396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101567919|NCT02866396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101567920|NCT02866396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101567921|NCT01087203|Tanezumab|tanezumab|mesh-list
101567922|NCT01087203|Analgesics|analgesics|mesh-ancestor
101567923|NCT01087203|Sensory System Agents|sensory system agents|mesh-ancestor
101567924|NCT01087203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101567925|NCT01087203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567926|NCT01246583|Tofacitinib|tofacitinib|mesh-list
101567927|NCT01246583|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101567928|NCT01246583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101567929|NCT01246583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101567930|NCT01246583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567931|NCT00626613|Risperidone|risperidone|mesh-list
101567932|NCT00626613|Galantamine|galantamine|mesh-list
101567933|NCT00626613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101567934|NCT00626613|Serotonin Agents|serotonin agents|mesh-ancestor
101567935|NCT00626613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101567936|NCT00626613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567937|NCT00626613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224832|NCT01526174|Golimumab|golimumab|mesh-list
101567938|NCT00626613|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101567939|NCT00626613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101567940|NCT00626613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101567941|NCT00626613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101567942|NCT00626613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101567943|NCT00626613|Dopamine Agents|dopamine agents|mesh-ancestor
101567944|NCT00626613|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101567945|NCT00626613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101567946|NCT00626613|Cholinergic Agents|cholinergic agents|mesh-ancestor
101567947|NCT00626613|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101567948|NCT00626613|Autonomic Agents|autonomic agents|mesh-ancestor
101567949|NCT00626613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101567950|NCT00626613|Nootropic Agents|nootropic agents|mesh-ancestor
101567951|NCT01080807|Modafinil|modafinil|mesh-list
101567952|NCT01080807|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101567953|NCT01080807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567954|NCT01080807|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101567955|NCT01080807|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101567956|NCT01080807|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101567957|NCT01080807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567958|NCT01079949|Cetrorelix|cetrorelix|mesh-list
101567959|NCT01079949|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101567960|NCT01079949|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101567961|NCT01079949|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101567962|NCT01079949|Fertility Agents|fertility agents|mesh-ancestor
101567963|NCT01079949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101567964|NCT01079949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567965|NCT01079949|Hormone Antagonists|hormone antagonists|mesh-ancestor
101567966|NCT01079949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101567967|NCT01079949|Hormones|hormones|mesh-ancestor
101567968|NCT00910429|Riociguat|riociguat|mesh-list
101567969|NCT00910429|Enzyme Activators|enzyme activators|mesh-ancestor
101567970|NCT00910429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567971|NCT03432949|Dexamethasone|dexamethasone|mesh-list
101567972|NCT03432949|Dexamethasone acetate|dexamethasone acetate|mesh-list
101567973|NCT03432949|BB 1101|bb 1101|mesh-list
101567974|NCT03432949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101567975|NCT03432949|Antiemetics|antiemetics|mesh-ancestor
101567976|NCT03432949|Autonomic Agents|autonomic agents|mesh-ancestor
101567977|NCT03432949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101567978|NCT03432949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567979|NCT03432949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101567980|NCT03432949|Glucocorticoids|glucocorticoids|mesh-ancestor
101567981|NCT03432949|Hormones|hormones|mesh-ancestor
101567982|NCT03432949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101567983|NCT03432949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101567984|NCT03432949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101567985|NCT03432949|Protease Inhibitors|protease inhibitors|mesh-ancestor
101567986|NCT03432949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101567987|NCT03432949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567988|NCT00909727|Ivacaftor|ivacaftor|mesh-list
101567989|NCT00909727|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101567990|NCT00909727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101567991|NCT00909727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567992|NCT00977080|Cinacalcet|cinacalcet|mesh-list
101567993|NCT00977080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101567994|NCT00977080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567995|NCT00977080|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101567996|NCT00977080|Hormone Antagonists|hormone antagonists|mesh-ancestor
101567997|NCT00977080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101567998|NCT04289194|Hydrogen Peroxide|hydrogen peroxide|mesh-list
101567999|NCT04289194|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101568000|NCT04289194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101568001|NCT04083157|Imiquimod|imiquimod|mesh-list
101568002|NCT04083157|Vaccines|vaccines|mesh-list
101568003|NCT04083157|Immunologic Factors|immunologic factors|mesh-ancestor
101568004|NCT04083157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568005|NCT04083157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101568006|NCT04083157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101568007|NCT04083157|Interferon Inducers|interferon inducers|mesh-ancestor
101568008|NCT00975286|Metformin|metformin|mesh-list
101568009|NCT00975286|Insulin Glargine|insulin glargine|mesh-list
101568010|NCT00975286|Lixisenatide|lixisenatide|mesh-list
101568011|NCT00975286|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
101568012|NCT00975286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101224886|NCT01526460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101568014|NCT00907777|Vaccines|vaccines|mesh-list
101568015|NCT00907777|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101568016|NCT00907777|Immunologic Factors|immunologic factors|mesh-ancestor
101568017|NCT00907777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568018|NCT03741517|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101568019|NCT03741517|Edotreotide|edotreotide|mesh-list
101568020|NCT03741517|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101568021|NCT03741517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568022|NCT02864758|Vitamin K|vitamin k|mesh-list
101568023|NCT02864758|Rivaroxaban|rivaroxaban|mesh-list
101568024|NCT02864758|Dabigatran|dabigatran|mesh-list
101568025|NCT02864758|Vitamins|vitamins|mesh-ancestor
101568026|NCT02864758|Micronutrients|micronutrients|mesh-ancestor
101568027|NCT02864758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568028|NCT02864758|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101568029|NCT02864758|Antithrombins|antithrombins|mesh-ancestor
101568030|NCT02864758|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101568031|NCT02864758|Protease Inhibitors|protease inhibitors|mesh-ancestor
101568032|NCT02864758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101568033|NCT02864758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568034|NCT02864758|Anticoagulants|anticoagulants|mesh-ancestor
101568035|NCT02864758|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101568036|NCT02864758|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101568037|NCT02864758|Hemostatics|hemostatics|mesh-ancestor
101568038|NCT02864758|Coagulants|coagulants|mesh-ancestor
101568039|NCT04204798|Dexmedetomidine|dexmedetomidine|mesh-list
101568040|NCT04204798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101568041|NCT04204798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101568042|NCT04204798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568043|NCT04204798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101568044|NCT04204798|Analgesics|analgesics|mesh-ancestor
101568045|NCT04204798|Sensory System Agents|sensory system agents|mesh-ancestor
101568046|NCT04204798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101568047|NCT04204798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101568048|NCT04204798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101568049|NCT04204798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101568050|NCT04204798|Adrenergic Agents|adrenergic agents|mesh-ancestor
101568051|NCT04204798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101568052|NCT04204798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568053|NCT00908011|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101568054|NCT00908011|Ezetimibe|ezetimibe|mesh-list
101568055|NCT00908011|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101568056|NCT00908011|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101568057|NCT00908011|Antimetabolites|antimetabolites|mesh-ancestor
101568058|NCT00908011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568059|NCT00908011|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101568060|NCT00908011|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101568061|NCT00908011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101568062|NCT00976456|Bevacizumab|bevacizumab|mesh-list
101568063|NCT00976456|Carboplatin|carboplatin|mesh-list
101568064|NCT00976456|Pemetrexed|pemetrexed|mesh-list
101568065|NCT00976456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101568066|NCT00976456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101568067|NCT00976456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101568068|NCT00976456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101568069|NCT00976456|Growth Substances|growth substances|mesh-ancestor
101568070|NCT00976456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568071|NCT00976456|Growth Inhibitors|growth inhibitors|mesh-ancestor
101568072|NCT00976456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101568073|NCT00976456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568074|NCT00976456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101568075|NCT00976456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101568076|NCT01243151|Bococizumab|bococizumab|mesh-list
101568077|NCT01243151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101568078|NCT01243151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101568079|NCT01243151|Antimetabolites|antimetabolites|mesh-ancestor
101568080|NCT01243151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568081|NCT01243151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101568082|NCT00629512|Esomeprazole|esomeprazole|mesh-list
101568083|NCT00629512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101568084|NCT00629512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101568085|NCT00629512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101224994|NCT01526850|Hormones|hormones|mesh-ancestor
101568086|NCT00629512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101568087|NCT00629512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568088|NCT01711021|Amphetamine|amphetamine|mesh-list
101568089|NCT01711021|Dextroamphetamine|dextroamphetamine|mesh-list
101568090|NCT01711021|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101568091|NCT01711021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568092|NCT01711021|Sympathomimetics|sympathomimetics|mesh-ancestor
101568093|NCT01711021|Autonomic Agents|autonomic agents|mesh-ancestor
101568094|NCT01711021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101568095|NCT01711021|Dopamine Agents|dopamine agents|mesh-ancestor
101568096|NCT01711021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101568097|NCT01711021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568098|NCT01711021|Adrenergic Agents|adrenergic agents|mesh-ancestor
101568099|NCT01711021|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101568100|NCT01711021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101568101|NCT01711021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101568102|NCT01711021|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101568103|NCT05517265|Acalabrutinib|acalabrutinib|mesh-list
101568104|NCT05517265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101568105|NCT02864602|Dexamethasone|dexamethasone|mesh-list
101568106|NCT02864602|Dexamethasone acetate|dexamethasone acetate|mesh-list
101568107|NCT02864602|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101568108|NCT02864602|BB 1101|bb 1101|mesh-list
101568109|NCT02864602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101568110|NCT02864602|Antiemetics|antiemetics|mesh-ancestor
101568111|NCT02864602|Autonomic Agents|autonomic agents|mesh-ancestor
101568112|NCT02864602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101568113|NCT02864602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568114|NCT02864602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101568115|NCT02864602|Glucocorticoids|glucocorticoids|mesh-ancestor
101568116|NCT02864602|Hormones|hormones|mesh-ancestor
101568117|NCT02864602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101568118|NCT02864602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101568119|NCT02864602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101568120|NCT02864602|Protease Inhibitors|protease inhibitors|mesh-ancestor
101568121|NCT02864602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101568122|NCT02864602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568123|NCT00993148|Ritonavir|ritonavir|mesh-list
101568124|NCT00993148|Darunavir|darunavir|mesh-list
101568125|NCT00993148|Maraviroc|maraviroc|mesh-list
101568126|NCT00993148|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101568127|NCT00993148|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101568128|NCT00993148|Protease Inhibitors|protease inhibitors|mesh-ancestor
101568130|NCT00993148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568131|NCT00993148|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101568132|NCT00993148|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101444001|NCT01235923|Hematinics|hematinics|mesh-ancestor
101568133|NCT00993148|Antiviral Agents|antiviral agents|mesh-ancestor
101568134|NCT00993148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101568135|NCT00993148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101568136|NCT00993148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101568137|NCT00993148|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101568138|NCT00993148|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101568139|NCT00993148|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101568140|NCT03401047|Estradiol|estradiol|mesh-list
101568141|NCT03401047|Estrogens|estrogens|mesh-ancestor
101568142|NCT03401047|Hormones|hormones|mesh-ancestor
101568143|NCT03401047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101568144|NCT03401047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568145|NCT03384589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101568146|NCT03384589|Immunologic Factors|immunologic factors|mesh-ancestor
101568147|NCT03384589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568148|NCT03531073|Methotrexate|methotrexate|mesh-list
101568149|NCT03531073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101568150|NCT03531073|Abortifacient Agents|abortifacient agents|mesh-ancestor
101568151|NCT03531073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101568152|NCT03531073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568153|NCT03531073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101568154|NCT03531073|Antimetabolites|antimetabolites|mesh-ancestor
101568155|NCT03531073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568156|NCT03531073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101568157|NCT03531073|Dermatologic Agents|dermatologic agents|mesh-ancestor
101568158|NCT03531073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101568159|NCT03531073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101225041|NCT01527032|Hormones|hormones|mesh-ancestor
101568160|NCT03531073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101568161|NCT03531073|Immunologic Factors|immunologic factors|mesh-ancestor
101568162|NCT03531073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101568163|NCT03531073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101568164|NCT00907153|Vitamin D|vitamin d|mesh-list
101568165|NCT00907153|Vitamins|vitamins|mesh-ancestor
101568166|NCT00907153|Micronutrients|micronutrients|mesh-ancestor
101568167|NCT00907153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568168|NCT00907153|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101568169|NCT00904033|Calcitriol|calcitriol|mesh-list
101568170|NCT00904033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101568171|NCT00904033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568172|NCT00904033|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101568173|NCT00904033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101568174|NCT00904033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568175|NCT00904033|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101568176|NCT00904033|Vitamins|vitamins|mesh-ancestor
101568177|NCT00904033|Micronutrients|micronutrients|mesh-ancestor
101568178|NCT00904033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101568179|NCT05175625|Myeloma Proteins|myeloma proteins|mesh-list
101568180|NCT05175625|Paraproteins|paraproteins|mesh-list
101568181|NCT05175625|Immunologic Factors|immunologic factors|mesh-ancestor
101568182|NCT05175625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568183|NCT02555839|Thalidomide|thalidomide|mesh-list
101568184|NCT02555839|Dexamethasone|dexamethasone|mesh-list
101568185|NCT02555839|Dexamethasone acetate|dexamethasone acetate|mesh-list
101568186|NCT02555839|Bortezomib|bortezomib|mesh-list
101568187|NCT02555839|Pomalidomide|pomalidomide|mesh-list
101568188|NCT02555839|BB 1101|bb 1101|mesh-list
101568189|NCT02555839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101568190|NCT02555839|Antiemetics|antiemetics|mesh-ancestor
101568191|NCT02555839|Autonomic Agents|autonomic agents|mesh-ancestor
101568192|NCT02555839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101568193|NCT02555839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568194|NCT02555839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101568195|NCT02555839|Glucocorticoids|glucocorticoids|mesh-ancestor
101568196|NCT02555839|Hormones|hormones|mesh-ancestor
101568197|NCT02555839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101568198|NCT02555839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101568199|NCT02555839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101568200|NCT02555839|Protease Inhibitors|protease inhibitors|mesh-ancestor
101568201|NCT02555839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101898392|NCT00314327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101568202|NCT02555839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568204|NCT02555839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101568205|NCT02555839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101568206|NCT02555839|Growth Substances|growth substances|mesh-ancestor
101568207|NCT02555839|Growth Inhibitors|growth inhibitors|mesh-ancestor
101568208|NCT02555839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101568209|NCT02555839|Leprostatic Agents|leprostatic agents|mesh-ancestor
101568210|NCT02555839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101568211|NCT02555839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101568212|NCT01241591|Etanercept|etanercept|mesh-list
101568213|NCT01241591|Tofacitinib|tofacitinib|mesh-list
101568214|NCT01241591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101568215|NCT01241591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101568216|NCT01241591|Analgesics|analgesics|mesh-ancestor
101568217|NCT01241591|Sensory System Agents|sensory system agents|mesh-ancestor
101568218|NCT01241591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101568219|NCT01241591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568220|NCT01241591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101568221|NCT01241591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101568222|NCT01241591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101568223|NCT01241591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101568224|NCT01241591|Immunologic Factors|immunologic factors|mesh-ancestor
101568225|NCT01241591|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101568226|NCT01241591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101568227|NCT01241591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101568228|NCT01241591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568229|NCT04319705|Azithromycin|azithromycin|mesh-list
101568230|NCT04319705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101568231|NCT04319705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101568232|NCT00906373|Sorafenib|sorafenib|mesh-list
101568233|NCT00906373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101568234|NCT00906373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101568235|NCT00906373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101568236|NCT00906373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101568237|NCT00906373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568238|NCT00906373|Immunologic Factors|immunologic factors|mesh-ancestor
101568239|NCT00906373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568240|NCT02850445|Olanzapine|olanzapine|mesh-list
101568241|NCT02850445|Antiemetics|antiemetics|mesh-ancestor
101568242|NCT02850445|Autonomic Agents|autonomic agents|mesh-ancestor
101568243|NCT02850445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101568244|NCT02850445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568245|NCT02850445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101568246|NCT02850445|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101568247|NCT02850445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101568248|NCT02850445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101568249|NCT02850445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101568250|NCT02850445|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101568251|NCT02850445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101568252|NCT02850445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101568253|NCT02850445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568254|NCT02850445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101568255|NCT02850445|Serotonin Agents|serotonin agents|mesh-ancestor
101568256|NCT04220203|Capecitabine|capecitabine|mesh-list
101568257|NCT04220203|Trastuzumab|trastuzumab|mesh-list
101568258|NCT04220203|Tucatinib|tucatinib|mesh-list
101568259|NCT04220203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101568260|NCT04220203|Antimetabolites|antimetabolites|mesh-ancestor
101568261|NCT04220203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568262|NCT04220203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101568263|NCT04220203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101568264|NCT04220203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101568265|NCT04220203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101568267|NCT02850211|Celecoxib|celecoxib|mesh-list
101568268|NCT02850211|Tramadol|tramadol|mesh-list
101568269|NCT02850211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101568270|NCT02850211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101568271|NCT02850211|Analgesics|analgesics|mesh-ancestor
101568272|NCT02850211|Sensory System Agents|sensory system agents|mesh-ancestor
101568273|NCT02850211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101568274|NCT02850211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568275|NCT02850211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101568276|NCT02850211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101568277|NCT02850211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101568278|NCT02850211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101568279|NCT02850211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568280|NCT02850211|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101568281|NCT02850211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101568282|NCT02850211|Narcotics|narcotics|mesh-ancestor
101568283|NCT02850211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101568284|NCT02850289|Interferons|interferons|mesh-list
101568286|NCT02850289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101568287|NCT02850289|Antiviral Agents|antiviral agents|mesh-ancestor
101568288|NCT02850289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101568289|NCT02850289|Antimetabolites|antimetabolites|mesh-ancestor
101568290|NCT02850289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568291|NCT05331781|Morphine|morphine|mesh-list
101568292|NCT05331781|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101568293|NCT05331781|Narcotics|narcotics|mesh-ancestor
101568294|NCT05331781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101568295|NCT05331781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568296|NCT05331781|Analgesics|analgesics|mesh-ancestor
101568297|NCT05331781|Sensory System Agents|sensory system agents|mesh-ancestor
101568298|NCT05331781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101568299|NCT04202887|Fentanyl|fentanyl|mesh-list
101568300|NCT04202887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101568301|NCT04202887|Narcotics|narcotics|mesh-ancestor
101568302|NCT04202887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101568303|NCT04202887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568304|NCT04202887|Analgesics|analgesics|mesh-ancestor
101568305|NCT04202887|Sensory System Agents|sensory system agents|mesh-ancestor
101568306|NCT04202887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101568307|NCT04202887|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101568308|NCT04202887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101568309|NCT04202887|Anesthetics, General|anesthetics, general|mesh-ancestor
101568310|NCT04202887|Anesthetics|anesthetics|mesh-ancestor
101568311|NCT05324215|Fentanyl|fentanyl|mesh-list
101225191|NCT01527864|Paclitaxel|paclitaxel|mesh-list
101568313|NCT05324215|Narcotics|narcotics|mesh-ancestor
101568314|NCT05324215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101568315|NCT05324215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568316|NCT05324215|Analgesics|analgesics|mesh-ancestor
101568317|NCT05324215|Sensory System Agents|sensory system agents|mesh-ancestor
101568318|NCT05324215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101568319|NCT05324215|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101568320|NCT05324215|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101568321|NCT05324215|Anesthetics, General|anesthetics, general|mesh-ancestor
101568322|NCT05324215|Anesthetics|anesthetics|mesh-ancestor
101568323|NCT00905437|Pregabalin|pregabalin|mesh-list
101568324|NCT00905437|Analgesics|analgesics|mesh-ancestor
101568325|NCT00905437|Sensory System Agents|sensory system agents|mesh-ancestor
101568326|NCT00905437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101568327|NCT00905437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568328|NCT00905437|Anticonvulsants|anticonvulsants|mesh-ancestor
101568329|NCT00905437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101568330|NCT00905437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101568331|NCT00905437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568332|NCT00905437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101568333|NCT00905437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101568334|NCT00905437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101568335|NCT00905437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101568336|NCT00905437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101568337|NCT05007691|Salicylic Acid|salicylic acid|mesh-list
101568338|NCT05007691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101568339|NCT05007691|Antifungal Agents|antifungal agents|mesh-ancestor
101568340|NCT05007691|Keratolytic Agents|keratolytic agents|mesh-ancestor
101568341|NCT05007691|Dermatologic Agents|dermatologic agents|mesh-ancestor
101568342|NCT01238861|Benralizumab|benralizumab|mesh-list
101568343|NCT01238861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101568344|NCT01238861|Respiratory System Agents|respiratory system agents|mesh-ancestor
101568345|NCT02888561|Dobutamine|dobutamine|mesh-list
101568346|NCT02888561|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101568347|NCT02888561|Sympathomimetics|sympathomimetics|mesh-ancestor
101568348|NCT02888561|Autonomic Agents|autonomic agents|mesh-ancestor
101568349|NCT02888561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101568350|NCT02888561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568351|NCT02888561|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101568352|NCT02888561|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101690621|NCT04165512|Hormones|hormones|mesh-ancestor
101568353|NCT02888561|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101568354|NCT02888561|Adrenergic Agents|adrenergic agents|mesh-ancestor
101568355|NCT02888561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101568356|NCT02888561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568357|NCT02888561|Protective Agents|protective agents|mesh-ancestor
101568358|NCT04319549|Sodium Hypochlorite|sodium hypochlorite|mesh-list
101568360|NCT04319549|Ketorolac|ketorolac|mesh-list
101568361|NCT04319549|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101568362|NCT04319549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101568363|NCT04319549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101568364|NCT04319549|Analgesics|analgesics|mesh-ancestor
101568365|NCT04319549|Sensory System Agents|sensory system agents|mesh-ancestor
101568366|NCT04319549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101568367|NCT04319549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568368|NCT04319549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101568369|NCT04319549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101568370|NCT04319549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101568371|NCT04319549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101568372|NCT04319549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568373|NCT04319549|Disinfectants|disinfectants|mesh-ancestor
101568374|NCT04319549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101568375|NCT00903409|Simvastatin|simvastatin|mesh-list
101568376|NCT00903409|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101568377|NCT00903409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101568378|NCT00903409|Antimetabolites|antimetabolites|mesh-ancestor
101568379|NCT00903409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568380|NCT00903409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101568381|NCT00903409|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101568382|NCT00903409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101568383|NCT01237223|Amlodipine|amlodipine|mesh-list
101568384|NCT01237223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101568385|NCT01237223|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101568386|NCT01237223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101568387|NCT01237223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568388|NCT01237223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101568390|NCT01237223|Vasodilator Agents|vasodilator agents|mesh-ancestor
101568391|NCT01236365|Atorvastatin|atorvastatin|mesh-list
101568392|NCT01236365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101568393|NCT01236365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101568394|NCT01236365|Antimetabolites|antimetabolites|mesh-ancestor
101568395|NCT01236365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568396|NCT01236365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101568397|NCT01236365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101568398|NCT01236365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101568399|NCT00903331|Macitentan|macitentan|mesh-list
101568400|NCT00903331|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101568401|NCT00903331|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101444034|NCT00712582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101568402|NCT00903331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568403|NCT00903331|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
101568404|NCT01235741|Pramlintide|pramlintide|mesh-list
101568405|NCT01235741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101568406|NCT01235741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568407|NCT02849353|Immunomodulating Agents|immunomodulating agents|mesh-list
101568408|NCT02849353|Immunologic Factors|immunologic factors|mesh-ancestor
101568409|NCT02849353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568410|NCT01235507|Methotrexate|methotrexate|mesh-list
101568411|NCT01235507|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101568412|NCT01235507|Abortifacient Agents|abortifacient agents|mesh-ancestor
101568413|NCT01235507|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101568414|NCT01235507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568415|NCT01235507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101568416|NCT01235507|Antimetabolites|antimetabolites|mesh-ancestor
101568417|NCT01235507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568418|NCT01235507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101568419|NCT01235507|Dermatologic Agents|dermatologic agents|mesh-ancestor
101568420|NCT01235507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101568421|NCT01235507|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101568422|NCT01235507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101568423|NCT01235507|Immunologic Factors|immunologic factors|mesh-ancestor
101568424|NCT01235507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101568425|NCT01235507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101568426|NCT01868269|Dexamethasone|dexamethasone|mesh-list
101568427|NCT01868269|Dexamethasone acetate|dexamethasone acetate|mesh-list
101568428|NCT01868269|Cyclophosphamide|cyclophosphamide|mesh-list
101568430|NCT01868269|BB 1101|bb 1101|mesh-list
101568431|NCT01868269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101568432|NCT01868269|Immunologic Factors|immunologic factors|mesh-ancestor
101568433|NCT01868269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568434|NCT01868269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101568435|NCT01868269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101568436|NCT01868269|Alkylating Agents|alkylating agents|mesh-ancestor
101568437|NCT01868269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568438|NCT01868269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101568439|NCT01868269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101568440|NCT01868269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101568441|NCT01868269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101568442|NCT01868269|Antiemetics|antiemetics|mesh-ancestor
101568443|NCT01868269|Autonomic Agents|autonomic agents|mesh-ancestor
101568444|NCT01868269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101568445|NCT01868269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101568446|NCT01868269|Glucocorticoids|glucocorticoids|mesh-ancestor
101568447|NCT01868269|Hormones|hormones|mesh-ancestor
101568448|NCT01868269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101568449|NCT01868269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101568450|NCT01868269|Protease Inhibitors|protease inhibitors|mesh-ancestor
101568451|NCT01868269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101568452|NCT01235351|Clopidogrel|clopidogrel|mesh-list
101568453|NCT01235351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101568454|NCT01235351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101568455|NCT01235351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101568456|NCT01235351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101568457|NCT01235351|Purinergic Agents|purinergic agents|mesh-ancestor
101568458|NCT01235351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101568459|NCT01235351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568460|NCT01235351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568461|NCT01234883|Plasma-lyte 148|plasma-lyte 148|mesh-list
101568462|NCT01234883|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101568463|NCT01234883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101568464|NCT01234649|Metformin|metformin|mesh-list
101568465|NCT01234649|Liraglutide|liraglutide|mesh-list
101568466|NCT01234649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101568467|NCT01234649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568468|NCT01234649|Incretins|incretins|mesh-ancestor
101568469|NCT01234649|Hormones|hormones|mesh-ancestor
101568470|NCT01234649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101568471|NCT02876679|Cyclosporine|cyclosporine|mesh-list
101568472|NCT02876679|Mycophenolic Acid|mycophenolic acid|mesh-list
101568473|NCT02876679|Cyclophosphamide|cyclophosphamide|mesh-list
101568474|NCT02876679|Cyclosporins|cyclosporins|mesh-list
101568475|NCT02876679|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101568476|NCT02876679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101568477|NCT02876679|Immunologic Factors|immunologic factors|mesh-ancestor
101568478|NCT02876679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568479|NCT02876679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101568480|NCT02876679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101568481|NCT02876679|Alkylating Agents|alkylating agents|mesh-ancestor
101568482|NCT02876679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568483|NCT02876679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101568484|NCT02876679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101568485|NCT02876679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101568486|NCT02876679|Antifungal Agents|antifungal agents|mesh-ancestor
101568487|NCT02876679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101568488|NCT02876679|Dermatologic Agents|dermatologic agents|mesh-ancestor
101568489|NCT02876679|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101568490|NCT02876679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101568491|NCT02876679|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101568492|NCT02876679|Antitubercular Agents|antitubercular agents|mesh-ancestor
101568493|NCT02876679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101568495|NCT01075815|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101568496|NCT01075815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101568497|NCT01075815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568498|NCT01072149|Fluticasone|fluticasone|mesh-list
101568500|NCT01072149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101568501|NCT01072149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101568502|NCT01072149|Autonomic Agents|autonomic agents|mesh-ancestor
101568503|NCT01072149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101568504|NCT01072149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568505|NCT01072149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101568506|NCT01072149|Respiratory System Agents|respiratory system agents|mesh-ancestor
101568507|NCT01072149|Dermatologic Agents|dermatologic agents|mesh-ancestor
101568508|NCT01072149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101568509|NCT04413253|Dexamethasone|dexamethasone|mesh-list
101568510|NCT04413253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101568511|NCT04413253|Lifitegrast|lifitegrast|mesh-list
101568512|NCT04413253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101568513|NCT04413253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101568514|NCT04413253|Antiemetics|antiemetics|mesh-ancestor
101568515|NCT04413253|Autonomic Agents|autonomic agents|mesh-ancestor
101568516|NCT04413253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101568517|NCT04413253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568518|NCT04413253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101568519|NCT04413253|Glucocorticoids|glucocorticoids|mesh-ancestor
101568520|NCT04413253|Hormones|hormones|mesh-ancestor
101568521|NCT04413253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101568522|NCT04413253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101568523|NCT04413253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101568524|NCT01679119|Prednisolone|prednisolone|mesh-list
101568525|NCT01679119|Cyclophosphamide|cyclophosphamide|mesh-list
101568526|NCT01679119|Rituximab|rituximab|mesh-list
101568527|NCT01679119|Gemcitabine|gemcitabine|mesh-list
101568528|NCT01679119|Vincristine|vincristine|mesh-list
101568529|NCT01679119|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
101568530|NCT01679119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101568531|NCT01679119|Immunologic Factors|immunologic factors|mesh-ancestor
101568532|NCT01679119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568533|NCT01679119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101568534|NCT01679119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101568535|NCT01679119|Alkylating Agents|alkylating agents|mesh-ancestor
101568536|NCT01679119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568537|NCT01679119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101568538|NCT01679119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101568539|NCT01679119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101568540|NCT01679119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101568541|NCT01679119|Antimetabolites|antimetabolites|mesh-ancestor
101568542|NCT01679119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101568543|NCT01679119|Tubulin Modulators|tubulin modulators|mesh-ancestor
101568544|NCT01679119|Antimitotic Agents|antimitotic agents|mesh-ancestor
101568545|NCT01679119|Mitosis Modulators|mitosis modulators|mesh-ancestor
101568546|NCT01679119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101568547|NCT01679119|Glucocorticoids|glucocorticoids|mesh-ancestor
101568548|NCT01679119|Hormones|hormones|mesh-ancestor
101568549|NCT01679119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101568550|NCT01679119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101568551|NCT01679119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101568552|NCT01679119|Immunotoxins|immunotoxins|mesh-ancestor
101568553|NCT01679119|Immunoconjugates|immunoconjugates|mesh-ancestor
101568554|NCT04778787|Dapagliflozin|dapagliflozin|mesh-list
101568555|NCT04778787|Digoxin|digoxin|mesh-list
101568556|NCT04778787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
101568557|NCT04778787|Vasodilator Agents|vasodilator agents|mesh-list
101568558|NCT04778787|Diuretics|diuretics|mesh-list
101568559|NCT04778787|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
101568560|NCT04778787|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101568561|NCT04778787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568562|NCT04778787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101568563|NCT04778787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568564|NCT04778787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101568565|NCT04778787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101568567|NCT04778787|Protective Agents|protective agents|mesh-ancestor
101568568|NCT04778787|Natriuretic Agents|natriuretic agents|mesh-ancestor
101568569|NCT04778787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101568570|NCT04304157|Dexmedetomidine|dexmedetomidine|mesh-list
101568571|NCT04304157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101568572|NCT04304157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101568573|NCT04304157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568574|NCT04304157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101568575|NCT04304157|Analgesics|analgesics|mesh-ancestor
101568576|NCT04304157|Sensory System Agents|sensory system agents|mesh-ancestor
101568577|NCT04304157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101690818|NCT02638896|Analgesics|analgesics|mesh-ancestor
101568578|NCT04304157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101568579|NCT04304157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101568580|NCT04304157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101568581|NCT04304157|Adrenergic Agents|adrenergic agents|mesh-ancestor
101568582|NCT04304157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101568583|NCT04304157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568584|NCT04937413|Evolocumab|evolocumab|mesh-list
101568585|NCT04937413|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101568586|NCT04937413|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101568587|NCT04937413|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101568588|NCT04937413|Antimetabolites|antimetabolites|mesh-ancestor
101568589|NCT04937413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568590|NCT04937413|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101568591|NCT04937413|Protease Inhibitors|protease inhibitors|mesh-ancestor
101568592|NCT04937413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101568593|NCT04937413|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101568594|NCT02875587|Cabergoline|cabergoline|mesh-list
101568595|NCT02875587|Calcium|calcium|mesh-list
101568596|NCT02875587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101568597|NCT02875587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568598|NCT02875587|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101568599|NCT02875587|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101568600|NCT02875587|Dopamine Agonists|dopamine agonists|mesh-ancestor
101568601|NCT02875587|Dopamine Agents|dopamine agents|mesh-ancestor
101568602|NCT02875587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101568603|NCT02875587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568604|NCT01070979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101568605|NCT01070979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101568606|NCT01070979|Estradiol|estradiol|mesh-list
101568607|NCT01070979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101568608|NCT01070979|Estrogens|estrogens|mesh-list
101568609|NCT01070979|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101568610|NCT01070979|Hormones|hormones|mesh-ancestor
101568611|NCT01070979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101568612|NCT01070979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568613|NCT01070979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101568614|NCT01070979|Contraceptive Agents|contraceptive agents|mesh-ancestor
101568615|NCT01070979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101568616|NCT01070979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101568617|NCT01234337|Capecitabine|capecitabine|mesh-list
101568618|NCT01234337|Sorafenib|sorafenib|mesh-list
101568619|NCT01234337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101568620|NCT01234337|Antimetabolites|antimetabolites|mesh-ancestor
101568621|NCT01234337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568622|NCT01234337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101568623|NCT01234337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101568624|NCT01234337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101568625|NCT02848963|Ketamine|ketamine|mesh-list
101568626|NCT02848963|Propofol|propofol|mesh-list
101568627|NCT02848963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101568628|NCT02848963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101643057|NCT00720382|Mometasone Furoate|mometasone furoate|mesh-list
101568629|NCT02848963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568630|NCT02848963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101568631|NCT02848963|Anesthetics, General|anesthetics, general|mesh-ancestor
101568632|NCT02848963|Anesthetics|anesthetics|mesh-ancestor
101568633|NCT02848963|Analgesics|analgesics|mesh-ancestor
101568634|NCT02848963|Sensory System Agents|sensory system agents|mesh-ancestor
101568635|NCT02848963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101568636|NCT02848963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101568637|NCT02848963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101568638|NCT02848963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101568639|NCT02848963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101568640|NCT02848963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568641|NCT01070043|Amlodipine|amlodipine|mesh-list
101568642|NCT01070043|Valsartan|valsartan|mesh-list
101568643|NCT01070043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101568644|NCT01070043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101568645|NCT01070043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101568646|NCT01070043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568647|NCT01070043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101568648|NCT01070043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568649|NCT01070043|Vasodilator Agents|vasodilator agents|mesh-ancestor
101568650|NCT01070043|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101568651|NCT01070043|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101568652|NCT01074255|Aprepitant|aprepitant|mesh-list
101568653|NCT01074255|Antiemetics|antiemetics|mesh-ancestor
101568654|NCT01074255|Autonomic Agents|autonomic agents|mesh-ancestor
101568655|NCT01074255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101568656|NCT01074255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568657|NCT01074255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101568658|NCT01074255|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101568659|NCT01074255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101568660|NCT01074255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568661|NCT02962063|Paclitaxel|paclitaxel|mesh-list
101568662|NCT02962063|Carboplatin|carboplatin|mesh-list
101568663|NCT02962063|Durvalumab|durvalumab|mesh-list
101568664|NCT02962063|Tremelimumab|tremelimumab|mesh-list
101568665|NCT02962063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101568666|NCT02962063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101568667|NCT02962063|Tubulin Modulators|tubulin modulators|mesh-ancestor
101568668|NCT02962063|Antimitotic Agents|antimitotic agents|mesh-ancestor
101568669|NCT02962063|Mitosis Modulators|mitosis modulators|mesh-ancestor
101568670|NCT02962063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568671|NCT02962063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101568672|NCT01073943|Bisacodyl|bisacodyl|mesh-list
101568673|NCT01073943|Picosulfate sodium|picosulfate sodium|mesh-list
101568674|NCT01073943|Cathartics|cathartics|mesh-ancestor
101568675|NCT01073943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101568676|NCT01073943|Laxatives|laxatives|mesh-ancestor
101568677|NCT01073865|Goserelin|goserelin|mesh-list
101568678|NCT01073865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101568679|NCT01073865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101568680|NCT04862065|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
101568681|NCT04862065|Immunologic Factors|immunologic factors|mesh-ancestor
101568682|NCT04862065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225569|NCT01529528|Anagliptin|anagliptin|mesh-list
101568683|NCT01064635|Letrozole|letrozole|mesh-list
101568684|NCT01064635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101568685|NCT01064635|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101568686|NCT01064635|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101568687|NCT01064635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101568688|NCT01064635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568689|NCT01064635|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101568690|NCT01064635|Hormone Antagonists|hormone antagonists|mesh-ancestor
101568691|NCT01064635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101568692|NCT01064635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568693|NCT04697485|Eplerenone|eplerenone|mesh-list
101568694|NCT04697485|Bumetanide|bumetanide|mesh-list
101568695|NCT04697485|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101568696|NCT04697485|Hormone Antagonists|hormone antagonists|mesh-ancestor
101568697|NCT04697485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101568698|NCT04697485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568699|NCT04697485|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101568700|NCT04697485|Diuretics|diuretics|mesh-ancestor
101568701|NCT04697485|Natriuretic Agents|natriuretic agents|mesh-ancestor
101568702|NCT04697485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101568703|NCT04697485|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101568704|NCT04697485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101568705|NCT04697485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568706|NCT01073631|Voriconazole|voriconazole|mesh-list
101568707|NCT01073631|Antifungal Agents|antifungal agents|mesh-ancestor
101568708|NCT01073631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101568709|NCT01073631|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101568710|NCT01073631|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101568711|NCT01073631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101568712|NCT01073631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568713|NCT01073631|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101568714|NCT01073631|Hormone Antagonists|hormone antagonists|mesh-ancestor
101568715|NCT01073631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101568716|NCT01073631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568717|NCT01073631|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101568719|NCT00626769|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101568720|NCT00626769|Protective Agents|protective agents|mesh-ancestor
101568721|NCT00626769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568722|NCT00626769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101568723|NCT00626769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101568724|NCT00626769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101568725|NCT00626769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568726|NCT00626769|Phytoestrogens|phytoestrogens|mesh-ancestor
101568727|NCT00626769|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101568728|NCT00626769|Estrogens|estrogens|mesh-ancestor
101568729|NCT00626769|Hormones|hormones|mesh-ancestor
101568730|NCT00626769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101568731|NCT02875743|Posaconazole|posaconazole|mesh-list
101568732|NCT02875743|Antifungal Agents|antifungal agents|mesh-ancestor
101568733|NCT02875743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101568734|NCT02875743|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101568735|NCT02875743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101568736|NCT02875743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101568737|NCT02875743|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101568738|NCT02875743|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101568739|NCT02875743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101568740|NCT02875743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568741|NCT02875743|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101568742|NCT02875743|Hormone Antagonists|hormone antagonists|mesh-ancestor
101568743|NCT02875743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101568744|NCT02875743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568745|NCT01073163|Rituximab|rituximab|mesh-list
101568746|NCT01073163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101568747|NCT01073163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101568748|NCT01073163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101568749|NCT01073163|Immunologic Factors|immunologic factors|mesh-ancestor
101568750|NCT01073163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568751|NCT01073163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101568752|NCT01073163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101568753|NCT01073163|Alkylating Agents|alkylating agents|mesh-ancestor
101568754|NCT01073163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568755|NCT02875821|Metformin|metformin|mesh-list
101568756|NCT02875821|Pioglitazone|pioglitazone|mesh-list
101568757|NCT02875821|Ipragliflozin|ipragliflozin|mesh-list
101568758|NCT02875821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101568759|NCT02875821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568760|NCT02875821|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101568761|NCT02875821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568762|NCT04304313|Sildenafil Citrate|sildenafil citrate|mesh-list
101568763|NCT04304313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568764|NCT04304313|Vasodilator Agents|vasodilator agents|mesh-ancestor
101568765|NCT04304313|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101568766|NCT04304313|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101568767|NCT04304313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101568768|NCT04304313|Urological Agents|urological agents|mesh-ancestor
101568769|NCT01072929|Modafinil|modafinil|mesh-list
101568770|NCT01072929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101568771|NCT01072929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568772|NCT01072929|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101568773|NCT01072929|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101568774|NCT01072929|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101568775|NCT01072929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568776|NCT04753749|Aspirin|aspirin|mesh-list
101568777|NCT04753749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101568778|NCT04753749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101568779|NCT04753749|Analgesics|analgesics|mesh-ancestor
101568780|NCT04753749|Sensory System Agents|sensory system agents|mesh-ancestor
101568781|NCT04753749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101568782|NCT04753749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568783|NCT04753749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101568784|NCT04753749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101568785|NCT04753749|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101568786|NCT04753749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101568787|NCT04753749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568788|NCT04753749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101568789|NCT04753749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101568790|NCT04753749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101568791|NCT04753749|Antipyretics|antipyretics|mesh-ancestor
101568792|NCT04305015|Analgesics, Opioid|analgesics, opioid|mesh-list
101568793|NCT04305015|Narcotics|narcotics|mesh-ancestor
101568794|NCT04305015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101568795|NCT04305015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568796|NCT04305015|Analgesics|analgesics|mesh-ancestor
101568797|NCT04305015|Sensory System Agents|sensory system agents|mesh-ancestor
101568798|NCT04305015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101568799|NCT01231607|Finasteride|finasteride|mesh-list
101568800|NCT01231607|Dutasteride|dutasteride|mesh-list
101568801|NCT01231607|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101568802|NCT01231607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101568803|NCT01231607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101568804|NCT01231607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568805|NCT01231607|Hormone Antagonists|hormone antagonists|mesh-ancestor
101568806|NCT01231607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101568807|NCT01231607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568808|NCT01231607|Urological Agents|urological agents|mesh-ancestor
101568809|NCT01231373|Polidocanol|polidocanol|mesh-list
101568810|NCT01231373|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
101568811|NCT01231373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101568812|NCT00975130|Golimumab|golimumab|mesh-list
101568813|NCT00975130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101568814|NCT00975130|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101568815|NCT00975130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101568816|NCT00975130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101568817|NCT00975130|Immunologic Factors|immunologic factors|mesh-ancestor
101568818|NCT00975130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568819|NCT01230827|Golimumab|golimumab|mesh-list
101568820|NCT01230827|Methotrexate|methotrexate|mesh-list
101568821|NCT01230827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101568822|NCT01230827|Abortifacient Agents|abortifacient agents|mesh-ancestor
101568823|NCT01230827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101568824|NCT01230827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568825|NCT01230827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101568826|NCT01230827|Antimetabolites|antimetabolites|mesh-ancestor
101568827|NCT01230827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568829|NCT01230827|Dermatologic Agents|dermatologic agents|mesh-ancestor
101568830|NCT01230827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101568831|NCT01230827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101568832|NCT01230827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101568833|NCT01230827|Immunologic Factors|immunologic factors|mesh-ancestor
101568834|NCT01230827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101568835|NCT01230827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101568836|NCT01230827|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101568837|NCT01230827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101568838|NCT01230749|Pioglitazone|pioglitazone|mesh-list
101568839|NCT01230749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101568840|NCT01230749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568841|NCT00903175|Everolimus|everolimus|mesh-list
101568842|NCT00903175|Sunitinib|sunitinib|mesh-list
101568843|NCT00903175|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101568844|NCT00903175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101568845|NCT00903175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101568846|NCT00903175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568847|NCT00903175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101568848|NCT00903175|Immunologic Factors|immunologic factors|mesh-ancestor
101568849|NCT00903175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568850|NCT00903175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101568851|NCT00903175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101568852|NCT00903175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101568853|NCT00903175|Growth Substances|growth substances|mesh-ancestor
101568854|NCT00903175|Growth Inhibitors|growth inhibitors|mesh-ancestor
101568855|NCT01229735|Topiramate|topiramate|mesh-list
101568856|NCT01229735|Levetiracetam|levetiracetam|mesh-list
101568857|NCT01229735|Anticonvulsants|anticonvulsants|mesh-ancestor
101568858|NCT01229735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101568859|NCT01229735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568860|NCT01229735|Nootropic Agents|nootropic agents|mesh-ancestor
101568861|NCT03866200|Resveratrol|resveratrol|mesh-list
101568863|NCT03866200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568864|NCT03866200|Protective Agents|protective agents|mesh-ancestor
101568865|NCT03866200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568866|NCT03866200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101568867|NCT03866200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101568868|NCT02848183|Cytarabine|cytarabine|mesh-list
101568869|NCT02848183|Etoposide|etoposide|mesh-list
101568870|NCT02848183|Mitoxantrone|mitoxantrone|mesh-list
101568871|NCT02848183|Idarubicin|idarubicin|mesh-list
101568872|NCT02848183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101568873|NCT02848183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101568874|NCT02848183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101568875|NCT02848183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101568876|NCT02848183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101568877|NCT02848183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568878|NCT02848183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101568879|NCT02848183|Antimetabolites|antimetabolites|mesh-ancestor
101568880|NCT02848183|Antiviral Agents|antiviral agents|mesh-ancestor
101568881|NCT02848183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101568882|NCT02848183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101568883|NCT02848183|Immunologic Factors|immunologic factors|mesh-ancestor
101568884|NCT02848183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568885|NCT02848183|Analgesics|analgesics|mesh-ancestor
101568886|NCT02848183|Sensory System Agents|sensory system agents|mesh-ancestor
101568887|NCT02848183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101568888|NCT02848183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101568889|NCT00974974|Levodopa|levodopa|mesh-list
101568890|NCT00974974|Carbidopa|carbidopa|mesh-list
101568891|NCT00974974|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101568892|NCT00974974|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101568893|NCT00974974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101568894|NCT00974974|Dopamine Agents|dopamine agents|mesh-ancestor
101568895|NCT00974974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101568896|NCT00974974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568897|NCT00974974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568898|NCT00974974|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101568899|NCT00974974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101568900|NCT00974974|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101568901|NCT00974974|Immunologic Factors|immunologic factors|mesh-ancestor
101568902|NCT00974974|Dopamine Agonists|dopamine agonists|mesh-ancestor
101568903|NCT02848417|Curcumin|curcumin|mesh-list
101568904|NCT02848417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101568905|NCT02848417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101568906|NCT02848417|Analgesics|analgesics|mesh-ancestor
101568907|NCT02848417|Sensory System Agents|sensory system agents|mesh-ancestor
101568908|NCT02848417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101568909|NCT02848417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568910|NCT02848417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101568911|NCT02848417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101568912|NCT02848417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101568913|NCT02848417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101568914|NCT02848417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568915|NCT02847403|Exenatide|exenatide|mesh-list
101568916|NCT02847403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101568917|NCT02847403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568918|NCT02847403|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101568919|NCT02847403|Incretins|incretins|mesh-ancestor
101568920|NCT02847403|Hormones|hormones|mesh-ancestor
101568921|NCT02847403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101568922|NCT02848339|Aspirin|aspirin|mesh-list
101568923|NCT02848339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101568924|NCT02848339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101568925|NCT02848339|Analgesics|analgesics|mesh-ancestor
101568926|NCT02848339|Sensory System Agents|sensory system agents|mesh-ancestor
101568927|NCT02848339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101568928|NCT02848339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568929|NCT02848339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101568930|NCT02848339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101568931|NCT02848339|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101568932|NCT02848339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101568933|NCT02848339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568934|NCT02848339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101568935|NCT02848339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101568936|NCT02848339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101568937|NCT02848339|Antipyretics|antipyretics|mesh-ancestor
101568938|NCT02847481|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101568939|NCT02847481|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101568940|NCT02847481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101568941|NCT02847481|Antitubercular Agents|antitubercular agents|mesh-ancestor
101568942|NCT04216303|Chrysarobin|chrysarobin|mesh-list
101568943|NCT04216303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101568944|NCT04216303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101568945|NCT04216303|Analgesics|analgesics|mesh-ancestor
101568946|NCT04216303|Sensory System Agents|sensory system agents|mesh-ancestor
101568947|NCT04216303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101568948|NCT04216303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568949|NCT04216303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101568950|NCT04216303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101568951|NCT02847013|Bupivacaine|bupivacaine|mesh-list
101568952|NCT02847013|Anesthetics, Local|anesthetics, local|mesh-ancestor
101568953|NCT02847013|Anesthetics|anesthetics|mesh-ancestor
101568954|NCT02847013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101568955|NCT02847013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568956|NCT02847013|Sensory System Agents|sensory system agents|mesh-ancestor
101568957|NCT02847013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101568958|NCT02847091|Ipragliflozin|ipragliflozin|mesh-list
101568959|NCT02847091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101568960|NCT02847091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568961|NCT02847091|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101568962|NCT02847091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568963|NCT02846935|Decitabine|decitabine|mesh-list
101568964|NCT02846935|Tetrahydrouridine|tetrahydrouridine|mesh-list
101568965|NCT02846935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101568966|NCT02846935|Antimetabolites|antimetabolites|mesh-ancestor
101568967|NCT02846935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568968|NCT02846935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101568969|NCT02846935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101568970|NCT02844673|Hydroxyurea|hydroxyurea|mesh-list
101568971|NCT02844673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101568972|NCT02844673|Antisickling Agents|antisickling agents|mesh-ancestor
101568973|NCT02844673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101568974|NCT02844673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568975|NCT02844673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101568976|NCT00992992|Tositumomab I-131|tositumomab i-131|mesh-list
101568977|NCT00992992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101568978|NCT04201951|Tranexamic Acid|tranexamic acid|mesh-list
101568979|NCT04201951|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101568980|NCT04201951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101568981|NCT04201951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568982|NCT04201951|Hemostatics|hemostatics|mesh-ancestor
101568983|NCT04201951|Coagulants|coagulants|mesh-ancestor
101568984|NCT04753723|Gentamicins|gentamicins|mesh-list
101568985|NCT04753723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101568986|NCT04753723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101568987|NCT04753723|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101568988|NCT04753723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101568989|NCT04753723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568990|NCT04751851|Oxymetazoline|oxymetazoline|mesh-list
101568991|NCT04751851|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101568992|NCT04751851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101568993|NCT04751851|Adrenergic Agents|adrenergic agents|mesh-ancestor
101568994|NCT04751851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101568995|NCT04751851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101568996|NCT04751851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101568997|NCT04751851|Sympathomimetics|sympathomimetics|mesh-ancestor
101568998|NCT04751851|Autonomic Agents|autonomic agents|mesh-ancestor
101568999|NCT04751851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101569000|NCT04751851|Nasal Decongestants|nasal decongestants|mesh-ancestor
101569001|NCT04751851|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101569002|NCT04751851|Respiratory System Agents|respiratory system agents|mesh-ancestor
101569003|NCT02844517|Pancrelipase|pancrelipase|mesh-list
101569004|NCT02844517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101569005|NCT03901729|Furosemide|furosemide|mesh-list
101569006|NCT03901729|Diuretics|diuretics|mesh-ancestor
101569007|NCT03901729|Natriuretic Agents|natriuretic agents|mesh-ancestor
101569008|NCT03901729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569009|NCT03901729|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101569010|NCT03901729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101569011|NCT03901729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569012|NCT02846857|Insulin|insulin|mesh-list
101569013|NCT02846857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101569015|NCT02846857|Hormones|hormones|mesh-list
101569016|NCT02846857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101569017|NCT02846857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569018|NCT02846857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101569019|NCT02846857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101569020|NCT04672525|Rifampin|rifampin|mesh-list
101569021|NCT04672525|Rifabutin|rifabutin|mesh-list
101569022|NCT04672525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101569023|NCT04672525|Antitubercular Agents|antitubercular agents|mesh-ancestor
101569024|NCT04672525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101569025|NCT04672525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101569026|NCT04672525|Leprostatic Agents|leprostatic agents|mesh-ancestor
101569027|NCT04672525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101569028|NCT04672525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101569029|NCT04672525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569030|NCT04672525|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101569031|NCT04672525|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101569032|NCT04672525|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101569033|NCT04672525|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101569034|NCT04672525|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101569035|NCT04672525|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101569036|NCT00992446|Cytarabine|cytarabine|mesh-list
101569037|NCT00992446|Rituximab|rituximab|mesh-list
101569038|NCT00992446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101569039|NCT00992446|Etoposide|etoposide|mesh-list
101569040|NCT00992446|Etoposide phosphate|etoposide phosphate|mesh-list
101569041|NCT00992446|Bortezomib|bortezomib|mesh-list
101569042|NCT00992446|Melphalan|melphalan|mesh-list
101569043|NCT00992446|Mechlorethamine|mechlorethamine|mesh-list
101569044|NCT00992446|Vorinostat|vorinostat|mesh-list
101569045|NCT00992446|Carmustine|carmustine|mesh-list
101569046|NCT00992446|Podophyllotoxin|podophyllotoxin|mesh-list
101569047|NCT00992446|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
101569048|NCT00992446|Antibodies|antibodies|mesh-list
101569049|NCT00992446|Immunoglobulins|immunoglobulins|mesh-list
101569050|NCT00992446|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101569051|NCT00992446|Immunologic Factors|immunologic factors|mesh-ancestor
101569052|NCT00992446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225946|NCT01531647|Ritonavir|ritonavir|mesh-list
101569053|NCT00992446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101569054|NCT00992446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101569055|NCT00992446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101569056|NCT00992446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101569057|NCT00992446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101569058|NCT00992446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101569059|NCT00992446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569060|NCT00992446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101569061|NCT00992446|Antimetabolites|antimetabolites|mesh-ancestor
101569062|NCT00992446|Antiviral Agents|antiviral agents|mesh-ancestor
101569063|NCT00992446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101569064|NCT00992446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101569065|NCT00992446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101569066|NCT00992446|Alkylating Agents|alkylating agents|mesh-ancestor
101569067|NCT00992446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101569068|NCT00992446|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101569069|NCT00992446|Keratolytic Agents|keratolytic agents|mesh-ancestor
101569070|NCT00992446|Dermatologic Agents|dermatologic agents|mesh-ancestor
101569071|NCT00992446|Tubulin Modulators|tubulin modulators|mesh-ancestor
101569072|NCT00992446|Antimitotic Agents|antimitotic agents|mesh-ancestor
101569073|NCT00992446|Mitosis Modulators|mitosis modulators|mesh-ancestor
101569074|NCT04452565|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101569075|NCT04452565|Dexamethasone|dexamethasone|mesh-list
101569076|NCT04452565|Dexamethasone acetate|dexamethasone acetate|mesh-list
101569078|NCT04452565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101569079|NCT04452565|Antiemetics|antiemetics|mesh-ancestor
101569080|NCT04452565|Autonomic Agents|autonomic agents|mesh-ancestor
101569081|NCT04452565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101569082|NCT04452565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569083|NCT04452565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101569084|NCT04452565|Glucocorticoids|glucocorticoids|mesh-ancestor
101569085|NCT04452565|Hormones|hormones|mesh-ancestor
101569086|NCT04452565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101569087|NCT04452565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101569088|NCT04452565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101569089|NCT04452565|Protease Inhibitors|protease inhibitors|mesh-ancestor
101691331|NCT00602420|Naproxen|naproxen|mesh-list
101569090|NCT04452565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101569091|NCT04452565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569092|NCT04452565|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101569093|NCT04452565|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101569094|NCT04452565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101569095|NCT04452565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101569096|NCT04452565|Antiviral Agents|antiviral agents|mesh-ancestor
101569097|NCT04452565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101569098|NCT02863120|Bupivacaine|bupivacaine|mesh-list
101569099|NCT02863120|Ropivacaine|ropivacaine|mesh-list
101569100|NCT02863120|Anesthetics, Local|anesthetics, local|mesh-ancestor
101569101|NCT02863120|Anesthetics|anesthetics|mesh-ancestor
101569102|NCT02863120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101569103|NCT02863120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569104|NCT02863120|Sensory System Agents|sensory system agents|mesh-ancestor
101569105|NCT02863120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101569106|NCT03823534|Acetaminophen|acetaminophen|mesh-list
101569107|NCT03823534|Ketorolac|ketorolac|mesh-list
101569108|NCT03823534|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
101569109|NCT03823534|Morphine|morphine|mesh-list
101569110|NCT03823534|Oxycodone|oxycodone|mesh-list
101569111|NCT03823534|Hydrocodone|hydrocodone|mesh-list
101569112|NCT03823534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101569113|NCT03823534|Narcotics|narcotics|mesh-ancestor
101569114|NCT03823534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101569115|NCT03823534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569116|NCT03823534|Analgesics|analgesics|mesh-ancestor
101569117|NCT03823534|Sensory System Agents|sensory system agents|mesh-ancestor
101569118|NCT03823534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101569119|NCT03823534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101569120|NCT03823534|Antipyretics|antipyretics|mesh-ancestor
101569121|NCT03823534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101569122|NCT03823534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101569123|NCT03823534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101569124|NCT03823534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101569125|NCT03823534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101569126|NCT03823534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569127|NCT03823534|Antitussive Agents|antitussive agents|mesh-ancestor
101569128|NCT03823534|Respiratory System Agents|respiratory system agents|mesh-ancestor
101226011|NCT01531855|Insulin|insulin|mesh-list
101569129|NCT02846701|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101569130|NCT02846701|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101569131|NCT02846701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101569132|NCT02846701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101569133|NCT02846701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569134|NCT02846701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101569135|NCT02846701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569136|NCT02846701|Analgesics|analgesics|mesh-ancestor
101569137|NCT02846701|Sensory System Agents|sensory system agents|mesh-ancestor
101569138|NCT02846701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101569139|NCT02846701|Antidepressive Agents|antidepressive agents|mesh-ancestor
101569140|NCT02846701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101569141|NCT02846701|Dopamine Agents|dopamine agents|mesh-ancestor
101569142|NCT04327063|Ropivacaine|ropivacaine|mesh-list
101569143|NCT04327063|Anesthetics, Local|anesthetics, local|mesh-ancestor
101569144|NCT04327063|Anesthetics|anesthetics|mesh-ancestor
101569145|NCT04327063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101569146|NCT04327063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569147|NCT04327063|Sensory System Agents|sensory system agents|mesh-ancestor
101569148|NCT04327063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101569149|NCT04565431|Natalizumab|natalizumab|mesh-list
101569150|NCT04565431|Immunologic Factors|immunologic factors|mesh-ancestor
101569151|NCT04565431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569152|NCT04292704|Clotrimazole|clotrimazole|mesh-list
101569153|NCT04292704|Miconazole|miconazole|mesh-list
101569154|NCT04292704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101569155|NCT04292704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101569156|NCT04292704|Antifungal Agents|antifungal agents|mesh-ancestor
101569157|NCT04292704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101569158|NCT04292704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101569159|NCT04292704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101569160|NCT04292704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569161|NCT04292704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101569162|NCT04292704|Hormone Antagonists|hormone antagonists|mesh-ancestor
101569163|NCT04292704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101569164|NCT04292704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569165|NCT04292704|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101569166|NCT04292704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101569167|NCT05242783|Terlipressin|terlipressin|mesh-list
101569168|NCT05242783|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101569169|NCT05242783|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101569170|NCT03987685|Topotecan|topotecan|mesh-list
101569171|NCT03987685|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101569172|NCT03987685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101444160|NCT04675177|Polidocanol|polidocanol|mesh-list
101569173|NCT03987685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101569174|NCT03987685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569175|NCT03987685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101569176|NCT00900757|Palonosetron|palonosetron|mesh-list
101569177|NCT00900757|Antiemetics|antiemetics|mesh-ancestor
101569178|NCT00900757|Autonomic Agents|autonomic agents|mesh-ancestor
101569179|NCT00900757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101569180|NCT00900757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569181|NCT00900757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101569182|NCT00900757|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101569183|NCT00900757|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101569184|NCT00900757|Serotonin Agents|serotonin agents|mesh-ancestor
101569185|NCT00900757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101569186|NCT00900757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569187|NCT04136743|Dexamethasone|dexamethasone|mesh-list
101569188|NCT04136743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101569189|NCT04136743|Antiemetics|antiemetics|mesh-ancestor
101569190|NCT04136743|Autonomic Agents|autonomic agents|mesh-ancestor
101569191|NCT04136743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101569192|NCT04136743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569193|NCT04136743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101569194|NCT04136743|Glucocorticoids|glucocorticoids|mesh-ancestor
101569195|NCT04136743|Hormones|hormones|mesh-ancestor
101569196|NCT04136743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101569197|NCT04136743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101569198|NCT04136743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101569199|NCT03931057|Midazolam|midazolam|mesh-list
101569200|NCT03931057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101569201|NCT03931057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101569202|NCT03931057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101569203|NCT03931057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569204|NCT03931057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101569205|NCT03931057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101569206|NCT03931057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101569207|NCT03931057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101569208|NCT03931057|Anesthetics, General|anesthetics, general|mesh-ancestor
101569209|NCT03931057|Anesthetics|anesthetics|mesh-ancestor
101569210|NCT03931057|GABA Modulators|gaba modulators|mesh-ancestor
101569211|NCT03931057|GABA Agents|gaba agents|mesh-ancestor
101569212|NCT03931057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101569213|NCT03931057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569214|NCT02846155|Simethicone|simethicone|mesh-list
101569215|NCT02846155|Antifoaming Agents|antifoaming agents|mesh-ancestor
101569216|NCT02846155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569217|NCT02846155|Emollients|emollients|mesh-ancestor
101569218|NCT02846155|Dermatologic Agents|dermatologic agents|mesh-ancestor
101569219|NCT02845843|Interferons|interferons|mesh-list
101569220|NCT02845843|Ritonavir|ritonavir|mesh-list
101569221|NCT02845843|Lopinavir|lopinavir|mesh-list
101569222|NCT02845843|Interferon-beta|interferon-beta|mesh-list
101569223|NCT02845843|Interferon beta-1b|interferon beta-1b|mesh-list
101569224|NCT02845843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101569225|NCT02845843|Antiviral Agents|antiviral agents|mesh-ancestor
101569226|NCT02845843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101569227|NCT02845843|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101569228|NCT02845843|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101569229|NCT02845843|Protease Inhibitors|protease inhibitors|mesh-ancestor
101569230|NCT02845843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101569231|NCT02845843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569233|NCT02845843|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101569234|NCT02845843|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101569235|NCT02845843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101569236|NCT02845843|Immunologic Factors|immunologic factors|mesh-ancestor
101569237|NCT02845843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569238|NCT02845843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101569239|NCT02845999|Cyclophosphamide|cyclophosphamide|mesh-list
101569240|NCT02845999|Fludarabine|fludarabine|mesh-list
101569242|NCT02845999|Interleukin-2|interleukin-2|mesh-list
101569243|NCT02845999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101569244|NCT02845999|Immunologic Factors|immunologic factors|mesh-ancestor
101569245|NCT02845999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569246|NCT02845999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101569247|NCT02845999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101569248|NCT02845999|Alkylating Agents|alkylating agents|mesh-ancestor
101569249|NCT02845999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569250|NCT02845999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101569251|NCT02845999|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101569252|NCT02845999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101569253|NCT02845999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101569254|NCT02845999|Analgesics|analgesics|mesh-ancestor
101569255|NCT02845999|Sensory System Agents|sensory system agents|mesh-ancestor
101569256|NCT02845999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101569258|NCT05337085|Dexmedetomidine|dexmedetomidine|mesh-list
101569259|NCT05337085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101569260|NCT05337085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101569261|NCT05337085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569262|NCT05337085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101569263|NCT05337085|Analgesics|analgesics|mesh-ancestor
101569264|NCT05337085|Sensory System Agents|sensory system agents|mesh-ancestor
101569265|NCT05337085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101569266|NCT05337085|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101569267|NCT05337085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101569268|NCT05337085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101569269|NCT05337085|Adrenergic Agents|adrenergic agents|mesh-ancestor
101569270|NCT05337085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101569271|NCT05337085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569272|NCT05337085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101569273|NCT05337085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101569274|NCT05337085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101569275|NCT05337085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101569276|NCT05337085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101226200|NCT01533272|Tenofovir|tenofovir|mesh-list
101569278|NCT05337085|Anesthetics|anesthetics|mesh-ancestor
101569279|NCT05337085|GABA Modulators|gaba modulators|mesh-ancestor
101569280|NCT05337085|GABA Agents|gaba agents|mesh-ancestor
101569281|NCT02845765|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
101569282|NCT02845765|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101569283|NCT02845765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101569284|NCT02845765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569285|NCT01723579|Estradiol|estradiol|mesh-list
101569286|NCT01723579|Estrogens|estrogens|mesh-ancestor
101569287|NCT01723579|Hormones|hormones|mesh-ancestor
101569288|NCT01723579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101569289|NCT01723579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569290|NCT00901927|Rituximab|rituximab|mesh-list
101569291|NCT00901927|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101569292|NCT00901927|Mitoxantrone|mitoxantrone|mesh-list
101569293|NCT00901927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101569294|NCT00901927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101569295|NCT00901927|Immunologic Factors|immunologic factors|mesh-ancestor
101569296|NCT00901927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569297|NCT00901927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101569298|NCT00901927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101569299|NCT00901927|Alkylating Agents|alkylating agents|mesh-ancestor
101569300|NCT00901927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569301|NCT00901927|Analgesics|analgesics|mesh-ancestor
101569302|NCT00901927|Sensory System Agents|sensory system agents|mesh-ancestor
101569303|NCT00901927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101569304|NCT00901927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101569305|NCT00901927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101569306|NCT00901927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101569307|NCT05335837|Anesthetics|anesthetics|mesh-list
101569308|NCT05335837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101569309|NCT05335837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569310|NCT00903721|Mometasone Furoate|mometasone furoate|mesh-list
101569311|NCT00903721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101569312|NCT00903721|Dermatologic Agents|dermatologic agents|mesh-ancestor
101898402|NCT03897452|Analgesics|analgesics|mesh-ancestor
101569313|NCT00903721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101569314|NCT02845219|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
101569315|NCT02845219|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
101569316|NCT02845219|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101569317|NCT02845219|Contraceptive Agents|contraceptive agents|mesh-ancestor
101569318|NCT02845219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101569319|NCT02845219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569320|NCT02845219|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101569321|NCT02845219|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101569322|NCT02845219|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101569323|NCT02845219|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101569324|NCT02845219|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101569325|NCT02845219|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
101569326|NCT02845219|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101569327|NCT02845219|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101569329|NCT00968968|Lapatinib|lapatinib|mesh-list
101569330|NCT00968968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101569331|NCT00968968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101569332|NCT00968968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101569333|NCT00968968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101569334|NCT00968968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569335|NCT00973102|Estrogens|estrogens|mesh-list
101569336|NCT00973102|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101569337|NCT00973102|Hormones|hormones|mesh-ancestor
101569338|NCT00973102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101569339|NCT00973102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569340|NCT03691090|Paclitaxel|paclitaxel|mesh-list
101569341|NCT03691090|Cisplatin|cisplatin|mesh-list
101569342|NCT03691090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101569343|NCT03691090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101569344|NCT03691090|Tubulin Modulators|tubulin modulators|mesh-ancestor
101569345|NCT03691090|Antimitotic Agents|antimitotic agents|mesh-ancestor
101569346|NCT03691090|Mitosis Modulators|mitosis modulators|mesh-ancestor
101569347|NCT03691090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569348|NCT00783211|Fexofenadine|fexofenadine|mesh-list
101569349|NCT00783211|Desloratadine|desloratadine|mesh-list
101569350|NCT00783211|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101569351|NCT00783211|Cholinergic Agents|cholinergic agents|mesh-ancestor
101569352|NCT00783211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101569353|NCT00783211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569354|NCT00783211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569355|NCT00783211|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101569356|NCT00783211|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101569357|NCT00783211|Histamine Antagonists|histamine antagonists|mesh-ancestor
101569358|NCT00783211|Histamine Agents|histamine agents|mesh-ancestor
101569359|NCT00783211|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101569360|NCT03679546|Infliximab|infliximab|mesh-list
101569361|NCT03679546|Vedolizumab|vedolizumab|mesh-list
101569362|NCT03679546|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101569363|NCT03679546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101569364|NCT03679546|Dermatologic Agents|dermatologic agents|mesh-ancestor
101569365|NCT03679546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101569366|NCT03679546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101569367|NCT00779545|Mometasone Furoate|mometasone furoate|mesh-list
101569368|NCT00779545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101569369|NCT00779545|Dermatologic Agents|dermatologic agents|mesh-ancestor
101569370|NCT00779545|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101569371|NCT02842567|Vitamin E|vitamin e|mesh-list
101569372|NCT02842567|Tocopherols|tocopherols|mesh-list
101569373|NCT02842567|alpha-Tocopherol|alpha-tocopherol|mesh-list
101569374|NCT02842567|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
101569375|NCT02842567|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
101569376|NCT02842567|Vitamins|vitamins|mesh-ancestor
101569377|NCT02842567|Micronutrients|micronutrients|mesh-ancestor
101569378|NCT02842567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569379|NCT02842567|Antioxidants|antioxidants|mesh-ancestor
101569380|NCT02842567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569381|NCT02842567|Protective Agents|protective agents|mesh-ancestor
101569382|NCT02842567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101569383|NCT02842567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101569384|NCT02842567|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101569385|NCT02842567|Disinfectants|disinfectants|mesh-ancestor
101569386|NCT00705211|Ezetimibe|ezetimibe|mesh-list
101569387|NCT00705211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101569388|NCT00705211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101569389|NCT00705211|Antimetabolites|antimetabolites|mesh-ancestor
101569390|NCT00705211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569391|NCT00705211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101569392|NCT02839213|Scopolamine|scopolamine|mesh-list
101569393|NCT02839213|Bromides|bromides|mesh-list
101569394|NCT02839213|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101569395|NCT02839213|Anticonvulsants|anticonvulsants|mesh-ancestor
101569396|NCT02839213|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101569397|NCT02839213|Antiemetics|antiemetics|mesh-ancestor
101569398|NCT02839213|Autonomic Agents|autonomic agents|mesh-ancestor
101569399|NCT02839213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101569400|NCT02839213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569401|NCT02839213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101569402|NCT02839213|Mydriatics|mydriatics|mesh-ancestor
101569403|NCT02839213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101569404|NCT02839213|Cholinergic Agents|cholinergic agents|mesh-ancestor
101569405|NCT02839213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101569406|NCT02839213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569407|NCT02839213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101569408|NCT02839213|Parasympatholytics|parasympatholytics|mesh-ancestor
101569409|NCT05334043|Curcumin|curcumin|mesh-list
101569410|NCT05334043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101569411|NCT05334043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101569412|NCT05334043|Analgesics|analgesics|mesh-ancestor
101569413|NCT05334043|Sensory System Agents|sensory system agents|mesh-ancestor
101569414|NCT05334043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101569415|NCT05334043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569416|NCT05334043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101569417|NCT05334043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101569418|NCT05334043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101569419|NCT05334043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101569420|NCT05334043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569421|NCT02838823|Antibodies|antibodies|mesh-list
101569422|NCT02838823|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101569423|NCT02838823|Immunologic Factors|immunologic factors|mesh-ancestor
101226322|NCT01533740|Antimetabolites|antimetabolites|mesh-ancestor
101569424|NCT02838823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569425|NCT00156091|Olanzapine|olanzapine|mesh-list
101569426|NCT00156091|Asenapine|asenapine|mesh-list
101569427|NCT00156091|Antiemetics|antiemetics|mesh-ancestor
101569428|NCT00156091|Autonomic Agents|autonomic agents|mesh-ancestor
101569429|NCT00156091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101569430|NCT00156091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569431|NCT00156091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101569432|NCT00156091|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101569433|NCT00156091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101569434|NCT00156091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101569435|NCT00156091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101569436|NCT00156091|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101569437|NCT00156091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101569438|NCT00156091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101569439|NCT00156091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569440|NCT00156091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101569441|NCT00156091|Serotonin Agents|serotonin agents|mesh-ancestor
101569442|NCT00140959|Losartan|losartan|mesh-list
101569443|NCT00140959|Atenolol|atenolol|mesh-list
101569444|NCT00140959|Amlodipine|amlodipine|mesh-list
101569445|NCT00140959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101569446|NCT00140959|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101569447|NCT00140959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101569448|NCT00140959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569449|NCT00140959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101569450|NCT00140959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569451|NCT00140959|Vasodilator Agents|vasodilator agents|mesh-ancestor
101569452|NCT00140959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101569453|NCT00140959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101569454|NCT00140959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101569455|NCT00140959|Adrenergic Agents|adrenergic agents|mesh-ancestor
101569456|NCT00140959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101569457|NCT00140959|Autonomic Agents|autonomic agents|mesh-ancestor
101818775|NCT01049464|Anesthetics|anesthetics|mesh-ancestor
101569458|NCT00140959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101569459|NCT00140959|Sympatholytics|sympatholytics|mesh-ancestor
101569460|NCT00140959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101569461|NCT00140959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101569462|NCT00140959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101569464|NCT00095017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101569465|NCT00095017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101569466|NCT00095017|Analgesics|analgesics|mesh-ancestor
101569467|NCT00095017|Sensory System Agents|sensory system agents|mesh-ancestor
101569468|NCT00095017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101569469|NCT00095017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569470|NCT00095017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101569471|NCT00095017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101569472|NCT00095017|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101569473|NCT00095017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101569474|NCT00095017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101569475|NCT00095017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569476|NCT00092755|Ibuprofen|ibuprofen|mesh-list
101569477|NCT00092755|Etoricoxib|etoricoxib|mesh-list
101569478|NCT00092755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101569479|NCT00092755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101569480|NCT00092755|Analgesics|analgesics|mesh-ancestor
101569481|NCT00092755|Sensory System Agents|sensory system agents|mesh-ancestor
101569482|NCT00092755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101569483|NCT00092755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569484|NCT00092755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101569485|NCT00092755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101569486|NCT00092755|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101569487|NCT00092755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101569488|NCT00092755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569489|NCT00092755|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101569490|NCT00899431|Rituximab|rituximab|mesh-list
101569491|NCT00899431|Fludarabine|fludarabine|mesh-list
101569492|NCT00899431|Fludarabine phosphate|fludarabine phosphate|mesh-list
101569493|NCT00899431|Lenalidomide|lenalidomide|mesh-list
101569494|NCT00899431|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101569495|NCT00899431|Allopurinol|allopurinol|mesh-list
101569496|NCT00899431|Thymoglobulin|thymoglobulin|mesh-list
101569497|NCT00899431|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101569498|NCT00899431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101569499|NCT00899431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101226392|NCT01534312|Mesalamine|mesalamine|mesh-list
101569500|NCT00899431|Immunologic Factors|immunologic factors|mesh-ancestor
101569501|NCT00899431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569502|NCT00899431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101569503|NCT00899431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101569504|NCT00899431|Antimetabolites|antimetabolites|mesh-ancestor
101569505|NCT00899431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569506|NCT00899431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101569507|NCT00899431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101569508|NCT00899431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101569509|NCT00899431|Growth Substances|growth substances|mesh-ancestor
101569510|NCT00899431|Growth Inhibitors|growth inhibitors|mesh-ancestor
101569511|NCT00899431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101569512|NCT00899431|Alkylating Agents|alkylating agents|mesh-ancestor
101569513|NCT00899431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101569514|NCT00899431|Gout Suppressants|gout suppressants|mesh-ancestor
101569515|NCT00899431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101569516|NCT00899431|Antioxidants|antioxidants|mesh-ancestor
101569517|NCT00899431|Protective Agents|protective agents|mesh-ancestor
101569518|NCT00898807|Citalopram|citalopram|mesh-list
101569519|NCT00898807|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101569520|NCT00898807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101569521|NCT00898807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101569522|NCT00898807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569523|NCT00898807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101569524|NCT00898807|Serotonin Agents|serotonin agents|mesh-ancestor
101569525|NCT00898807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569526|NCT00898807|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101569527|NCT00898807|Antidepressive Agents|antidepressive agents|mesh-ancestor
101569528|NCT00898807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101569529|NCT01229267|Vaccines|vaccines|mesh-list
101569530|NCT01229267|Immunologic Factors|immunologic factors|mesh-ancestor
101569531|NCT01229267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569533|NCT00897715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101569535|NCT01229111|Fluorouracil|fluorouracil|mesh-list
101569536|NCT01229111|Oxaliplatin|oxaliplatin|mesh-list
101569537|NCT01229111|Cediranib|cediranib|mesh-list
101569538|NCT01229111|Calcium|calcium|mesh-list
101569539|NCT01229111|Levoleucovorin|levoleucovorin|mesh-list
101569540|NCT01229111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101569541|NCT01229111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569542|NCT01229111|Antimetabolites|antimetabolites|mesh-ancestor
101569543|NCT01229111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569544|NCT01229111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101569545|NCT01229111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101569546|NCT01229111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101569547|NCT01229111|Immunologic Factors|immunologic factors|mesh-ancestor
101569548|NCT01229111|Antidotes|antidotes|mesh-ancestor
101569549|NCT01229111|Protective Agents|protective agents|mesh-ancestor
101569550|NCT01229111|Vitamin B Complex|vitamin b complex|mesh-ancestor
101569551|NCT01229111|Vitamins|vitamins|mesh-ancestor
101569552|NCT01229111|Micronutrients|micronutrients|mesh-ancestor
101569553|NCT01229111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101569554|NCT01229111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101569555|NCT02843815|Immunomodulating Agents|immunomodulating agents|mesh-list
101569556|NCT02843815|Immunologic Factors|immunologic factors|mesh-ancestor
101569557|NCT02843815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569558|NCT01228175|Riboflavin|riboflavin|mesh-list
101569559|NCT01228175|Varenicline|varenicline|mesh-list
101569560|NCT01228175|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101569561|NCT01228175|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101569562|NCT01228175|Cholinergic Agents|cholinergic agents|mesh-ancestor
101569563|NCT01228175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101569564|NCT01228175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569565|NCT01228175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569566|NCT01228175|Vitamin B Complex|vitamin b complex|mesh-ancestor
101569567|NCT01228175|Vitamins|vitamins|mesh-ancestor
101569568|NCT01228175|Micronutrients|micronutrients|mesh-ancestor
101569569|NCT01228175|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101569570|NCT01228175|Dermatologic Agents|dermatologic agents|mesh-ancestor
101569571|NCT01228019|Niacin|niacin|mesh-list
101569572|NCT01228019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101569573|NCT01228019|Antimetabolites|antimetabolites|mesh-ancestor
101569574|NCT01228019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569575|NCT01228019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101569576|NCT01228019|Vasodilator Agents|vasodilator agents|mesh-ancestor
101569578|NCT01228019|Vitamins|vitamins|mesh-ancestor
101569579|NCT01228019|Micronutrients|micronutrients|mesh-ancestor
101569580|NCT01228019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569581|NCT01227707|Leucovorin|leucovorin|mesh-list
101569582|NCT01227707|Bevacizumab|bevacizumab|mesh-list
101569583|NCT01227707|Fluorouracil|fluorouracil|mesh-list
101569584|NCT01227707|Capecitabine|capecitabine|mesh-list
101569585|NCT01227707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101569586|NCT01227707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101569587|NCT01227707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101569588|NCT01227707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101569589|NCT01227707|Growth Substances|growth substances|mesh-ancestor
101569590|NCT01227707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569591|NCT01227707|Growth Inhibitors|growth inhibitors|mesh-ancestor
101569592|NCT01227707|Antimetabolites|antimetabolites|mesh-ancestor
101569593|NCT01227707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569594|NCT01227707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101569595|NCT01227707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101569596|NCT01227707|Immunologic Factors|immunologic factors|mesh-ancestor
101569597|NCT01227707|Antidotes|antidotes|mesh-ancestor
101569598|NCT01227707|Protective Agents|protective agents|mesh-ancestor
101569599|NCT01227707|Vitamin B Complex|vitamin b complex|mesh-ancestor
101569600|NCT01227707|Vitamins|vitamins|mesh-ancestor
101569601|NCT01227707|Micronutrients|micronutrients|mesh-ancestor
101569602|NCT00633373|Cyclosporine|cyclosporine|mesh-list
101569603|NCT00633373|Cyclosporins|cyclosporins|mesh-list
101569604|NCT00633373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101569605|NCT00633373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569606|NCT00633373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101569607|NCT00633373|Immunologic Factors|immunologic factors|mesh-ancestor
101569608|NCT00633373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569609|NCT00633373|Antifungal Agents|antifungal agents|mesh-ancestor
101569610|NCT00633373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101569611|NCT00633373|Dermatologic Agents|dermatologic agents|mesh-ancestor
101569612|NCT00633373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101569613|NCT00633373|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101569614|NCT05334745|Hyaluronic Acid|hyaluronic acid|mesh-list
101569615|NCT05334745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101569616|NCT05334745|Immunologic Factors|immunologic factors|mesh-ancestor
101569617|NCT05334745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569618|NCT05334745|Viscosupplements|viscosupplements|mesh-ancestor
101569619|NCT05334745|Protective Agents|protective agents|mesh-ancestor
101569620|NCT02838589|Exenatide|exenatide|mesh-list
101569621|NCT02838589|Glucagon|glucagon|mesh-list
101569622|NCT02838589|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101569623|NCT02838589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101569624|NCT02838589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569625|NCT02838589|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101569626|NCT02838589|Incretins|incretins|mesh-ancestor
101569627|NCT02838589|Hormones|hormones|mesh-ancestor
101569628|NCT02838589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101569629|NCT02838589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101569630|NCT02839135|Scopolamine|scopolamine|mesh-list
101569631|NCT02839135|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101569632|NCT02839135|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101569633|NCT02839135|Antiemetics|antiemetics|mesh-ancestor
101569634|NCT02839135|Autonomic Agents|autonomic agents|mesh-ancestor
101569635|NCT02839135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101569636|NCT02839135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569637|NCT02839135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101569638|NCT02839135|Mydriatics|mydriatics|mesh-ancestor
101569639|NCT02839135|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101569640|NCT02839135|Cholinergic Agents|cholinergic agents|mesh-ancestor
101569641|NCT02839135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101569642|NCT02839135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569643|NCT02839135|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101569644|NCT02839135|Parasympatholytics|parasympatholytics|mesh-ancestor
101569645|NCT00895843|Ibuprofen|ibuprofen|mesh-list
101569646|NCT00895843|Epinephrine|epinephrine|mesh-list
101569647|NCT00895843|Bupivacaine|bupivacaine|mesh-list
101226549|NCT01535170|Lactoferrin|lactoferrin|mesh-list
101569648|NCT00895843|Anesthetics, Local|anesthetics, local|mesh-ancestor
101569649|NCT00895843|Anesthetics|anesthetics|mesh-ancestor
101569650|NCT00895843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101569651|NCT00895843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569652|NCT00895843|Sensory System Agents|sensory system agents|mesh-ancestor
101569653|NCT00895843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101569654|NCT00895843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101569655|NCT00895843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101569657|NCT00895843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101569658|NCT00895843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101569659|NCT00895843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101569660|NCT00895843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101569661|NCT00895843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569662|NCT00895843|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101569663|NCT00895843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101569664|NCT00895843|Adrenergic Agents|adrenergic agents|mesh-ancestor
101569665|NCT00895843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101569666|NCT00895843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101569667|NCT00895843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101569668|NCT00895843|Autonomic Agents|autonomic agents|mesh-ancestor
101569669|NCT00895843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101569670|NCT00895843|Respiratory System Agents|respiratory system agents|mesh-ancestor
101569671|NCT00895843|Mydriatics|mydriatics|mesh-ancestor
101569672|NCT00895843|Sympathomimetics|sympathomimetics|mesh-ancestor
101569673|NCT00895843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101569674|NCT05333809|Pembrolizumab|pembrolizumab|mesh-list
101569675|NCT05333809|Disitamab vedotin|disitamab vedotin|mesh-list
101569676|NCT05333809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101569677|NCT05333809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101569678|NCT05333809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101569679|NCT05333809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569680|NCT05333809|Immunoconjugates|immunoconjugates|mesh-ancestor
101569681|NCT05333809|Immunologic Factors|immunologic factors|mesh-ancestor
101569682|NCT05333809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569683|NCT05333731|Oxytocin|oxytocin|mesh-list
101569684|NCT05333731|Oxytocics|oxytocics|mesh-ancestor
101569685|NCT05333731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101569686|NCT05333731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569687|NCT02843581|Immunomodulating Agents|immunomodulating agents|mesh-list
101569688|NCT02843581|Immunologic Factors|immunologic factors|mesh-ancestor
101569689|NCT02843581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569691|NCT00895453|Itraconazole|itraconazole|mesh-list
101569692|NCT00895453|Antifungal Agents|antifungal agents|mesh-ancestor
101569693|NCT00895453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101569694|NCT00895453|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101569695|NCT00895453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101569696|NCT00895453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101569697|NCT00895453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569698|NCT00895453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101569699|NCT00895453|Hormone Antagonists|hormone antagonists|mesh-ancestor
101569700|NCT00895453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101569701|NCT00895453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569702|NCT00895453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101569703|NCT00895453|Trace Elements|trace elements|mesh-ancestor
101569704|NCT00895453|Micronutrients|micronutrients|mesh-ancestor
101569706|NCT00893737|Sumatriptan|sumatriptan|mesh-list
101569707|NCT00893737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101569708|NCT00893737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101569709|NCT00893737|Analgesics|analgesics|mesh-ancestor
101569710|NCT00893737|Sensory System Agents|sensory system agents|mesh-ancestor
101569711|NCT00893737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101569712|NCT00893737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569713|NCT00893737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101569714|NCT00893737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101569715|NCT00893737|Gout Suppressants|gout suppressants|mesh-ancestor
101569716|NCT00893737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101569717|NCT00893737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101569718|NCT00893737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569719|NCT00893737|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101569720|NCT00893737|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101569721|NCT00893737|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101569722|NCT00893737|Serotonin Agents|serotonin agents|mesh-ancestor
101569723|NCT00893737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101569724|NCT00893113|Alfuzosin|alfuzosin|mesh-list
101569725|NCT00893113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101569726|NCT00893113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101226615|NCT01535768|Travoprost|travoprost|mesh-list
101569728|NCT00893113|Adrenergic Agents|adrenergic agents|mesh-ancestor
101569729|NCT00893113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101569730|NCT00893113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569731|NCT00893113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569732|NCT00893113|Urological Agents|urological agents|mesh-ancestor
101569733|NCT02840929|Esomeprazole|esomeprazole|mesh-list
101569734|NCT02840929|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101569735|NCT02840929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101569736|NCT02840929|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101569737|NCT02840929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101569738|NCT02840929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569739|NCT02838121|Zoledronic Acid|zoledronic acid|mesh-list
101569740|NCT02838121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101569741|NCT02838121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569742|NCT02837965|Doxycycline|doxycycline|mesh-list
101569743|NCT02837965|Prednisone|prednisone|mesh-list
101569744|NCT02837965|Methotrexate|methotrexate|mesh-list
101569745|NCT02837965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101569746|NCT02837965|Glucocorticoids|glucocorticoids|mesh-ancestor
101569747|NCT02837965|Hormones|hormones|mesh-ancestor
101569748|NCT02837965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101569749|NCT02837965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569750|NCT02837965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101569751|NCT02837965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101569752|NCT02837965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101569753|NCT02837965|Abortifacient Agents|abortifacient agents|mesh-ancestor
101569754|NCT02837965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101569755|NCT02837965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101569756|NCT02837965|Antimetabolites|antimetabolites|mesh-ancestor
101569757|NCT02837965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569758|NCT02837965|Dermatologic Agents|dermatologic agents|mesh-ancestor
101569759|NCT02837965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101569760|NCT02837965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101569761|NCT02837965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101569762|NCT02837965|Immunologic Factors|immunologic factors|mesh-ancestor
101569763|NCT02837965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101569764|NCT02837965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101569766|NCT02837965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101569767|NCT02837965|Antimalarials|antimalarials|mesh-ancestor
101569768|NCT02837965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101569769|NCT02837965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101569770|NCT00892957|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101569771|NCT00892957|Thrombin|thrombin|mesh-list
101569772|NCT00892957|Aprotinin|aprotinin|mesh-list
101569773|NCT00892957|Hemostatics|hemostatics|mesh-ancestor
101569774|NCT00892957|Coagulants|coagulants|mesh-ancestor
101569775|NCT00892957|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101569776|NCT00892957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101569777|NCT00892957|Protease Inhibitors|protease inhibitors|mesh-ancestor
101569778|NCT00892957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101569779|NCT00892957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569780|NCT05322733|Cyclophosphamide|cyclophosphamide|mesh-list
101569781|NCT05322733|Fludarabine|fludarabine|mesh-list
101569782|NCT05322733|Obinutuzumab|obinutuzumab|mesh-list
101569783|NCT05322733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101569784|NCT05322733|Immunologic Factors|immunologic factors|mesh-ancestor
101569785|NCT05322733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569786|NCT05322733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101569787|NCT05322733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101569788|NCT05322733|Alkylating Agents|alkylating agents|mesh-ancestor
101569789|NCT05322733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569790|NCT05322733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101569791|NCT05322733|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101569792|NCT05322733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101569793|NCT00968812|Metformin|metformin|mesh-list
101569794|NCT00968812|Glimepiride|glimepiride|mesh-list
101569795|NCT00968812|Canagliflozin|canagliflozin|mesh-list
101569796|NCT00968812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101569797|NCT00968812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569798|NCT00968812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101569799|NCT00968812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101569800|NCT00968812|Immunologic Factors|immunologic factors|mesh-ancestor
101569801|NCT00968812|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101569802|NCT00968812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569804|NCT02834845|Desflurane|desflurane|mesh-list
101569805|NCT02834845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101569806|NCT02834845|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101569807|NCT02834845|Anesthetics, General|anesthetics, general|mesh-ancestor
101569808|NCT02834845|Anesthetics|anesthetics|mesh-ancestor
101569809|NCT02834845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101569810|NCT02834845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569811|NCT05197192|Venetoclax|venetoclax|mesh-list
101569812|NCT05197192|Obinutuzumab|obinutuzumab|mesh-list
101569813|NCT05197192|Acalabrutinib|acalabrutinib|mesh-list
101569814|NCT05197192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101569815|NCT05197192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101569816|NCT00992056|Metoprolol|metoprolol|mesh-list
101569817|NCT00992056|Nebivolol|nebivolol|mesh-list
101569818|NCT00992056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101569819|NCT00992056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101569820|NCT00992056|Sympatholytics|sympatholytics|mesh-ancestor
101569821|NCT00992056|Autonomic Agents|autonomic agents|mesh-ancestor
101569822|NCT00992056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101569823|NCT00992056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569824|NCT00992056|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101569825|NCT00992056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101569826|NCT00992056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101569827|NCT00992056|Adrenergic Agents|adrenergic agents|mesh-ancestor
101569828|NCT00992056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101569829|NCT00992056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569830|NCT00992056|Vasodilator Agents|vasodilator agents|mesh-ancestor
101569831|NCT00992056|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101569832|NCT00992056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101569833|NCT00992056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101569834|NCT00967798|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101569835|NCT00967798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101569836|NCT00967798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569837|NCT00967798|Incretins|incretins|mesh-ancestor
101569838|NCT00967798|Hormones|hormones|mesh-ancestor
101836649|NCT00308074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898407|NCT03897452|Anesthetics, General|anesthetics, general|mesh-ancestor
101569839|NCT00967798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101569840|NCT00967798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101569841|NCT00967798|Protease Inhibitors|protease inhibitors|mesh-ancestor
101569842|NCT00967798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101569843|NCT00967798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569844|NCT04248205|Ketamine|ketamine|mesh-list
101569845|NCT04248205|Analgesics|analgesics|mesh-ancestor
101569846|NCT04248205|Sensory System Agents|sensory system agents|mesh-ancestor
101569847|NCT04248205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101569848|NCT04248205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569849|NCT04248205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101569850|NCT04248205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101569851|NCT04248205|Anesthetics, General|anesthetics, general|mesh-ancestor
101569852|NCT04248205|Anesthetics|anesthetics|mesh-ancestor
101569853|NCT04248205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101569854|NCT04248205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101569855|NCT04248205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101569856|NCT04248205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101569857|NCT04248205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569858|NCT02833831|Moxifloxacin|moxifloxacin|mesh-list
101569859|NCT02833831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101569860|NCT02833831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101569861|NCT02833831|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101569862|NCT02833831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101569863|NCT02833831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101569864|NCT02833831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569865|NCT02833831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101569866|NCT02833987|Warfarin|warfarin|mesh-list
101569867|NCT02833987|Rivaroxaban|rivaroxaban|mesh-list
101569868|NCT02833987|Dabigatran|dabigatran|mesh-list
101569869|NCT02833987|Apixaban|apixaban|mesh-list
101569870|NCT02833987|Anticoagulants|anticoagulants|mesh-ancestor
101569871|NCT02833987|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101569872|NCT02833987|Antithrombins|antithrombins|mesh-ancestor
101569873|NCT02833987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101226758|NCT01536314|Memantine|memantine|mesh-list
101569874|NCT02833987|Protease Inhibitors|protease inhibitors|mesh-ancestor
101569875|NCT02833987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101569876|NCT02833987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569877|NCT02837185|Botulinum Toxins|botulinum toxins|mesh-list
101569878|NCT02837185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101569879|NCT02837185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101569880|NCT02837185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569881|NCT02837185|Cholinergic Agents|cholinergic agents|mesh-ancestor
101569882|NCT02837185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101569883|NCT02837185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569884|NCT00965458|Alefacept|alefacept|mesh-list
101569885|NCT00965458|Dermatologic Agents|dermatologic agents|mesh-ancestor
101569886|NCT00965458|Immunologic Factors|immunologic factors|mesh-ancestor
101569887|NCT00965458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569888|NCT04249531|Amikacin|amikacin|mesh-list
101569889|NCT04249531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101569890|NCT04249531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101569891|NCT02836639|Etoposide|etoposide|mesh-list
101569892|NCT02836639|Busulfan|busulfan|mesh-list
101569893|NCT02836639|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101569894|NCT02836639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101569895|NCT02836639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101569896|NCT02836639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101569897|NCT02836639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101569898|NCT02836639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101569899|NCT02836639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569900|NCT02836639|Alkylating Agents|alkylating agents|mesh-ancestor
101569901|NCT02836639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101569902|NCT02836639|Immunologic Factors|immunologic factors|mesh-ancestor
101569903|NCT02836639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569904|NCT02836639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101569905|NCT02836639|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101569906|NCT00972244|Dapagliflozin|dapagliflozin|mesh-list
101569907|NCT00972244|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101569908|NCT00972244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569909|NCT00972244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101898408|NCT03897452|Anesthetics|anesthetics|mesh-ancestor
101569910|NCT00972244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569912|NCT05333419|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101569913|NCT05333419|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101569915|NCT02836795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101569916|NCT02836795|Immunologic Factors|immunologic factors|mesh-ancestor
101569917|NCT02836795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569918|NCT02836483|Linezolid|linezolid|mesh-list
101569919|NCT02836483|Delpazolid|delpazolid|mesh-list
101569920|NCT02836483|Oxazolidinones|oxazolidinones|mesh-list
101569921|NCT02836483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101569922|NCT02836483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101569923|NCT02836483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101569924|NCT02836483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101444311|NCT00204438|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101569925|NCT02836483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569926|NCT02836171|Itraconazole|itraconazole|mesh-list
101569927|NCT02836171|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
101569928|NCT02836171|Apatinib|apatinib|mesh-list
101569929|NCT02836171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101569930|NCT02836171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101569931|NCT02836171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101569932|NCT02836171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569933|NCT02836171|Antifungal Agents|antifungal agents|mesh-ancestor
101569934|NCT02836171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101569935|NCT02836171|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101569936|NCT02836171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101569937|NCT02836171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101569938|NCT02836171|Hormone Antagonists|hormone antagonists|mesh-ancestor
101569939|NCT02836171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101569940|NCT02836171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569941|NCT02836171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101569942|NCT00971932|Carboplatin|carboplatin|mesh-list
101569943|NCT00971932|Fluorouracil|fluorouracil|mesh-list
101569944|NCT00971932|Cetuximab|cetuximab|mesh-list
101569945|NCT00971932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101569946|NCT00971932|Antimetabolites|antimetabolites|mesh-ancestor
101569947|NCT00971932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569948|NCT00971932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101569949|NCT00971932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101569950|NCT00971932|Immunologic Factors|immunologic factors|mesh-ancestor
101569951|NCT00971932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569952|NCT00971932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101569953|NCT04400929|Molgramostim|molgramostim|mesh-list
101569954|NCT04400929|Sargramostim|sargramostim|mesh-list
101569955|NCT04400929|Immunologic Factors|immunologic factors|mesh-ancestor
101569956|NCT04400929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569957|NCT04400929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101569958|NCT05170672|Abatacept|abatacept|mesh-list
101569959|NCT05170672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101569960|NCT05170672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569961|NCT05170672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101569962|NCT05170672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101569963|NCT05170672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101569964|NCT05170672|Immunologic Factors|immunologic factors|mesh-ancestor
101569965|NCT05170672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569966|NCT05170672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101569967|NCT00970684|Bevacizumab|bevacizumab|mesh-list
101569968|NCT00970684|Gemcitabine|gemcitabine|mesh-list
101569969|NCT00970684|Docetaxel|docetaxel|mesh-list
101569970|NCT00970684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101569971|NCT00970684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101569972|NCT00970684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101569973|NCT00970684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101569974|NCT00970684|Growth Substances|growth substances|mesh-ancestor
101569975|NCT00970684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569976|NCT00970684|Growth Inhibitors|growth inhibitors|mesh-ancestor
101569977|NCT00970684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101569978|NCT00970684|Antimetabolites|antimetabolites|mesh-ancestor
101569979|NCT00970684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569980|NCT00970684|Tubulin Modulators|tubulin modulators|mesh-ancestor
101569981|NCT00970684|Antimitotic Agents|antimitotic agents|mesh-ancestor
101569982|NCT00970684|Mitosis Modulators|mitosis modulators|mesh-ancestor
101569983|NCT00967330|Bevacizumab|bevacizumab|mesh-list
101569984|NCT00967330|Irinotecan|irinotecan|mesh-list
101569985|NCT00967330|Temozolomide|temozolomide|mesh-list
101569986|NCT00967330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101569987|NCT00967330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101569988|NCT00967330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101569989|NCT00967330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101569990|NCT00967330|Growth Substances|growth substances|mesh-ancestor
101569991|NCT00967330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101569992|NCT00967330|Growth Inhibitors|growth inhibitors|mesh-ancestor
101569993|NCT00967330|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101569994|NCT00967330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101569995|NCT00967330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101569996|NCT00967330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101569997|NCT00967330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101569998|NCT00967330|Alkylating Agents|alkylating agents|mesh-ancestor
101569999|NCT02863276|Insulin|insulin|mesh-list
101570000|NCT02863276|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101570001|NCT02863276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101570002|NCT02863276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570003|NCT04286152|Mirabegron|mirabegron|mesh-list
101570004|NCT04286152|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101570005|NCT04286152|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101570006|NCT04286152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101570007|NCT04286152|Adrenergic Agents|adrenergic agents|mesh-ancestor
101570008|NCT04286152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101570009|NCT04286152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570010|NCT04286152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570011|NCT04286152|Urological Agents|urological agents|mesh-ancestor
101570012|NCT00966940|Travoprost|travoprost|mesh-list
101570013|NCT00966940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101570014|NCT00966940|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101570015|NCT00966940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101570016|NCT00965848|Doripenem|doripenem|mesh-list
101570017|NCT00965848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101570018|NCT00965848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101570019|NCT03447574|Ethanol|ethanol|mesh-list
101570020|NCT03447574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101570021|NCT03447574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101570022|NCT03447574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101570023|NCT03447574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570024|NCT04284826|Mitomycins|mitomycins|mesh-list
101226910|NCT01537354|Poractant alfa|poractant alfa|mesh-list
101570025|NCT04284826|Mitomycin|mitomycin|mesh-list
101570026|NCT04284826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101570027|NCT04284826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101570028|NCT04284826|Alkylating Agents|alkylating agents|mesh-ancestor
101570029|NCT04284826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570030|NCT04284826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101570031|NCT04284826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101570032|NCT04285528|Lidocaine|lidocaine|mesh-list
101570033|NCT04285528|Fentanyl|fentanyl|mesh-list
101570034|NCT04285528|Ketamine|ketamine|mesh-list
101570035|NCT04285528|Propofol|propofol|mesh-list
101570036|NCT04285528|Anesthetics, Local|anesthetics, local|mesh-ancestor
101570037|NCT04285528|Anesthetics|anesthetics|mesh-ancestor
101570038|NCT04285528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101570039|NCT04285528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570040|NCT04285528|Sensory System Agents|sensory system agents|mesh-ancestor
101570041|NCT04285528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101570042|NCT04285528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101570043|NCT04285528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101570044|NCT04285528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101570045|NCT04285528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101570046|NCT04285528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570047|NCT04285528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101570048|NCT04285528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101570049|NCT04285528|Anesthetics, General|anesthetics, general|mesh-ancestor
101570050|NCT04285528|Analgesics|analgesics|mesh-ancestor
101570051|NCT04285528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101570052|NCT04285528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101570053|NCT04285528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101570054|NCT04285528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101570055|NCT04285528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101570056|NCT04285528|Narcotics|narcotics|mesh-ancestor
101570057|NCT04285528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101570058|NCT00629824|Interferons|interferons|mesh-list
101570059|NCT00629824|Ribavirin|ribavirin|mesh-list
101570060|NCT00629824|Interferon-alpha|interferon-alpha|mesh-list
101570061|NCT00629824|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101570062|NCT00629824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101570063|NCT00629824|Antiviral Agents|antiviral agents|mesh-ancestor
101570064|NCT00629824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101570065|NCT00629824|Antimetabolites|antimetabolites|mesh-ancestor
101444349|NCT04171453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101570066|NCT00629824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570067|NCT00629824|Immunologic Factors|immunologic factors|mesh-ancestor
101570068|NCT00629824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570069|NCT00961636|Niacin|niacin|mesh-list
101570070|NCT00961636|Niacinamide|niacinamide|mesh-list
101570071|NCT00961636|Nicotinic Acids|nicotinic acids|mesh-list
101570072|NCT00961636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101570073|NCT00961636|Antimetabolites|antimetabolites|mesh-ancestor
101570074|NCT00961636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570075|NCT00961636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101570076|NCT00961636|Vasodilator Agents|vasodilator agents|mesh-ancestor
101570077|NCT00961636|Vitamin B Complex|vitamin b complex|mesh-ancestor
101570078|NCT00961636|Vitamins|vitamins|mesh-ancestor
101570079|NCT00961636|Micronutrients|micronutrients|mesh-ancestor
101570080|NCT00961636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570081|NCT00964678|Carvedilol|carvedilol|mesh-list
101570082|NCT00964678|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101570083|NCT00964678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101570084|NCT00964678|Adrenergic Agents|adrenergic agents|mesh-ancestor
101570085|NCT00964678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101570086|NCT00964678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570087|NCT00964678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570088|NCT00964678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101570089|NCT00964678|Antioxidants|antioxidants|mesh-ancestor
101570090|NCT00964678|Protective Agents|protective agents|mesh-ancestor
101570091|NCT00964678|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101570092|NCT00964678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101570093|NCT00964678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101570094|NCT00964678|Vasodilator Agents|vasodilator agents|mesh-ancestor
101570095|NCT00964678|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101570096|NCT00964678|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101570097|NCT00964366|Clindamycin|clindamycin|mesh-list
101570098|NCT00964366|Clindamycin palmitate|clindamycin palmitate|mesh-list
101570099|NCT00964366|Clindamycin phosphate|clindamycin phosphate|mesh-list
101570100|NCT00964366|Dapsone|dapsone|mesh-list
101570101|NCT00964366|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101570102|NCT00964366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101570103|NCT00964366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101570104|NCT00964366|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101570105|NCT00964366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101570106|NCT00964366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570107|NCT00964366|Dermatologic Agents|dermatologic agents|mesh-ancestor
101570108|NCT00964366|Antimalarials|antimalarials|mesh-ancestor
101570109|NCT00964366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101570110|NCT00964366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101570111|NCT00964366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101570112|NCT00964366|Leprostatic Agents|leprostatic agents|mesh-ancestor
101570113|NCT03545464|Prednisone|prednisone|mesh-list
101570114|NCT03545464|Levocetirizine|levocetirizine|mesh-list
101570115|NCT03545464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101570116|NCT03545464|Glucocorticoids|glucocorticoids|mesh-ancestor
101570117|NCT03545464|Hormones|hormones|mesh-ancestor
101570118|NCT03545464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101570119|NCT03545464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570120|NCT03545464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101570121|NCT03545464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101570122|NCT03545464|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101570123|NCT03545464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101570124|NCT03545464|Histamine Antagonists|histamine antagonists|mesh-ancestor
101570125|NCT03545464|Histamine Agents|histamine agents|mesh-ancestor
101570126|NCT03545464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101570127|NCT03545464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570128|NCT04284514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101570129|NCT04284514|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101570130|NCT02860936|Lenvatinib|lenvatinib|mesh-list
101570131|NCT02860936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101570132|NCT02860936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101570133|NCT02860936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101570134|NCT02860936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570136|NCT00630214|Vitamin D|vitamin d|mesh-list
101570137|NCT00630214|Ergocalciferols|ergocalciferols|mesh-list
101570138|NCT00630214|Cholecalciferol|cholecalciferol|mesh-list
101570139|NCT00630214|Vitamins|vitamins|mesh-list
101570140|NCT00630214|Calcium Carbonate|calcium carbonate|mesh-list
101570141|NCT00630214|Calcium|calcium|mesh-list
101570142|NCT00630214|Micronutrients|micronutrients|mesh-ancestor
101570143|NCT00630214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570144|NCT00630214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101570145|NCT00630214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101570146|NCT00630214|Antacids|antacids|mesh-ancestor
101570147|NCT00630214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570148|NCT00630214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101570149|NCT02860858|Aflibercept|aflibercept|mesh-list
101570150|NCT02860858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101570151|NCT02860858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101570152|NCT02860858|Growth Substances|growth substances|mesh-ancestor
101570153|NCT02860858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570154|NCT02860858|Growth Inhibitors|growth inhibitors|mesh-ancestor
101570155|NCT02860858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101570156|NCT00960076|Metformin|metformin|mesh-list
101570157|NCT00960076|Saxagliptin|saxagliptin|mesh-list
101570158|NCT00960076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101570159|NCT00960076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570160|NCT00960076|Incretins|incretins|mesh-ancestor
101570161|NCT00960076|Hormones|hormones|mesh-ancestor
101570162|NCT00960076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101570163|NCT00960076|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101570164|NCT00960076|Protease Inhibitors|protease inhibitors|mesh-ancestor
101570165|NCT00960076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101570166|NCT00960076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570167|NCT04281082|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101570168|NCT04281082|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101570169|NCT04281082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101570170|NCT04284202|Dasatinib|dasatinib|mesh-list
101570171|NCT04284202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101570172|NCT04284202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101570173|NCT04284202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101570174|NCT04284202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570175|NCT01227629|Warfarin|warfarin|mesh-list
101570176|NCT01227629|Dabigatran|dabigatran|mesh-list
101570177|NCT01227629|Anticoagulants|anticoagulants|mesh-ancestor
101570178|NCT01227629|Antithrombins|antithrombins|mesh-ancestor
101570179|NCT01227629|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101570180|NCT01227629|Protease Inhibitors|protease inhibitors|mesh-ancestor
101570181|NCT01227629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101570182|NCT01227629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570183|NCT00963820|Ixazomib|ixazomib|mesh-list
101570184|NCT00963820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570185|NCT00963820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101570186|NCT00963820|Protease Inhibitors|protease inhibitors|mesh-ancestor
101570187|NCT00963820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101570188|NCT03241186|Nivolumab|nivolumab|mesh-list
101570189|NCT03241186|Ipilimumab|ipilimumab|mesh-list
101570190|NCT03241186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101570191|NCT03241186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101570192|NCT03241186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101570193|NCT03241186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570194|NCT01227395|Azithromycin|azithromycin|mesh-list
101570195|NCT01227395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101570196|NCT01227395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101570197|NCT03237286|Ketamine|ketamine|mesh-list
101570198|NCT03237286|Analgesics|analgesics|mesh-ancestor
101570199|NCT03237286|Sensory System Agents|sensory system agents|mesh-ancestor
101570200|NCT03237286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101570201|NCT03237286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570202|NCT03237286|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101570203|NCT03237286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101570204|NCT03237286|Anesthetics, General|anesthetics, general|mesh-ancestor
101570205|NCT03237286|Anesthetics|anesthetics|mesh-ancestor
101570206|NCT03237286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101570207|NCT03237286|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101570208|NCT03237286|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101570209|NCT03237286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101444355|NCT04111315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101570210|NCT03237286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570211|NCT01226459|Minoxidil|minoxidil|mesh-list
101570212|NCT01226459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101570213|NCT01226459|Vasodilator Agents|vasodilator agents|mesh-ancestor
101570214|NCT01225991|Milnacipran|milnacipran|mesh-list
101570215|NCT01225991|Levomilnacipran|levomilnacipran|mesh-list
101570216|NCT01225991|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101570217|NCT01225991|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101570218|NCT01225991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101570219|NCT01225991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570220|NCT01225991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101570221|NCT01225991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570222|NCT01225991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101570223|NCT01225991|Analgesics|analgesics|mesh-ancestor
101570224|NCT01225991|Sensory System Agents|sensory system agents|mesh-ancestor
101570225|NCT01225991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101570226|NCT01225991|Antidepressive Agents|antidepressive agents|mesh-ancestor
101570227|NCT01225991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101570229|NCT04283110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101570230|NCT04283110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101570231|NCT04283110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101570232|NCT04283110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570233|NCT04283110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101570234|NCT04283110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101570235|NCT04283110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101570236|NCT04283110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101570237|NCT04283110|Anesthetics, General|anesthetics, general|mesh-ancestor
101570238|NCT04283110|Anesthetics|anesthetics|mesh-ancestor
101570239|NCT04283110|GABA Modulators|gaba modulators|mesh-ancestor
101570240|NCT04283110|GABA Agents|gaba agents|mesh-ancestor
101570241|NCT04283110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101570242|NCT04283110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570243|NCT02860780|Prexasertib|prexasertib|mesh-list
101570244|NCT02860780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101570245|NCT02860780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101570246|NCT02860780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570247|NCT01225835|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101570248|NCT01225835|Cetrorelix|cetrorelix|mesh-list
101570249|NCT01225835|Menotropins|menotropins|mesh-list
101570250|NCT01225835|Progesterone|progesterone|mesh-list
101570251|NCT01225835|Progestins|progestins|mesh-ancestor
101570252|NCT01225835|Hormones|hormones|mesh-ancestor
101227137|NCT01538667|Ciprofloxacin|ciprofloxacin|mesh-list
101570253|NCT01225835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101570254|NCT01225835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570255|NCT01225835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101570256|NCT01225835|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101570257|NCT01225835|Fertility Agents|fertility agents|mesh-ancestor
101570258|NCT01225835|Hormone Antagonists|hormone antagonists|mesh-ancestor
101570259|NCT04282096|Caseins|caseins|mesh-list
101570260|NCT04282096|Chelating Agents|chelating agents|mesh-ancestor
101570261|NCT04282096|Sequestering Agents|sequestering agents|mesh-ancestor
101570262|NCT04282096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570263|NCT02899000|Doxycycline|doxycycline|mesh-list
101570264|NCT02899000|Adapalene|adapalene|mesh-list
101570265|NCT02899000|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101570266|NCT02899000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101570267|NCT02899000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101570268|NCT02899000|Antimalarials|antimalarials|mesh-ancestor
101570269|NCT02899000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101570270|NCT02899000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101570271|NCT02899000|Dermatologic Agents|dermatologic agents|mesh-ancestor
101570272|NCT02899000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101570273|NCT02899000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101570274|NCT02899000|Analgesics|analgesics|mesh-ancestor
101570275|NCT02899000|Sensory System Agents|sensory system agents|mesh-ancestor
101570276|NCT02899000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101570277|NCT02899000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570278|NCT02899000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101570279|NCT02899000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101570280|NCT04281862|Prednisolone|prednisolone|mesh-list
101570281|NCT04281862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101570282|NCT04281862|Glucocorticoids|glucocorticoids|mesh-ancestor
101570283|NCT04281862|Hormones|hormones|mesh-ancestor
101570284|NCT04281862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101570285|NCT04281862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570286|NCT04281862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101570289|NCT03122002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570290|NCT03122002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570291|NCT03122002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101570292|NCT03122002|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101570293|NCT03122002|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101570294|NCT03122002|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101570295|NCT03122002|Purinergic Agents|purinergic agents|mesh-ancestor
101570296|NCT03122002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101570297|NCT02861482|Oxytocin|oxytocin|mesh-list
101570298|NCT02861482|Carboprost tromethamine|carboprost tromethamine|mesh-list
101570299|NCT02861482|Oxytocics|oxytocics|mesh-ancestor
101570300|NCT02861482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101570301|NCT02861482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570302|NCT02861716|Fentanyl|fentanyl|mesh-list
101570303|NCT02861716|Dexmedetomidine|dexmedetomidine|mesh-list
101570304|NCT02861716|Bupivacaine|bupivacaine|mesh-list
101570305|NCT02861716|Anesthetics, Local|anesthetics, local|mesh-ancestor
101570306|NCT02861716|Anesthetics|anesthetics|mesh-ancestor
101570307|NCT02861716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101570308|NCT02861716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570309|NCT02861716|Sensory System Agents|sensory system agents|mesh-ancestor
101570310|NCT02861716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101570311|NCT02861716|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101570312|NCT02861716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101570313|NCT02861716|Analgesics|analgesics|mesh-ancestor
101570314|NCT02861716|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101570315|NCT02861716|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101570316|NCT02861716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101570317|NCT02861716|Adrenergic Agents|adrenergic agents|mesh-ancestor
101570318|NCT02861716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101570319|NCT02861716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570320|NCT02861716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101570321|NCT02861716|Narcotics|narcotics|mesh-ancestor
101570322|NCT02861716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101570323|NCT02861716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101570324|NCT02861716|Anesthetics, General|anesthetics, general|mesh-ancestor
101570325|NCT00960934|Vitamin D|vitamin d|mesh-list
101570326|NCT00960934|Cholecalciferol|cholecalciferol|mesh-list
101570327|NCT00960934|Calcium Carbonate|calcium carbonate|mesh-list
101570328|NCT00960934|Calcium|calcium|mesh-list
101570330|NCT00960934|Micronutrients|micronutrients|mesh-ancestor
101570331|NCT00960934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570332|NCT00960934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101570333|NCT00960934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101570334|NCT00960934|Antacids|antacids|mesh-ancestor
101570335|NCT00960934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570336|NCT00960934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101570337|NCT00892177|Bevacizumab|bevacizumab|mesh-list
101570338|NCT00892177|Dasatinib|dasatinib|mesh-list
101570339|NCT00892177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101570340|NCT00892177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101570341|NCT00892177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101570342|NCT00892177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101570343|NCT00892177|Growth Substances|growth substances|mesh-ancestor
101570344|NCT00892177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570345|NCT00892177|Growth Inhibitors|growth inhibitors|mesh-ancestor
101570346|NCT00892177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101570347|NCT00892177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101570348|NCT00892177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570349|NCT00962104|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101570350|NCT00962104|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101570351|NCT00962104|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101570352|NCT00962104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101570353|NCT00962104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570354|NCT00962104|Adrenergic Agents|adrenergic agents|mesh-ancestor
101570355|NCT00962104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101570356|NCT00962104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570357|NCT02821000|Pembrolizumab|pembrolizumab|mesh-list
101570358|NCT02821000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101570359|NCT02821000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101570360|NCT02821000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101570361|NCT02821000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570362|NCT02860624|Esomeprazole|esomeprazole|mesh-list
101570363|NCT02860624|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101570364|NCT02860624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101570365|NCT02860624|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101570366|NCT02860624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101570367|NCT02860624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570368|NCT00892099|Vitamin D|vitamin d|mesh-list
101570369|NCT00892099|Ergocalciferols|ergocalciferols|mesh-list
101570370|NCT00892099|Cholecalciferol|cholecalciferol|mesh-list
101570371|NCT00892099|Vitamins|vitamins|mesh-list
101570372|NCT00892099|Micronutrients|micronutrients|mesh-ancestor
101570373|NCT00892099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570374|NCT00892099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101570375|NCT00892099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101570376|NCT00960856|Fenofibric acid|fenofibric acid|mesh-list
101570377|NCT00960856|Fenofibrate|fenofibrate|mesh-list
101570378|NCT00960856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101570379|NCT00960856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101570380|NCT00960856|Antimetabolites|antimetabolites|mesh-ancestor
101570381|NCT00960856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570382|NCT00960856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101570383|NCT00958438|Rilonacept|rilonacept|mesh-list
101570384|NCT00958438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101570385|NCT02835469|Menotropins|menotropins|mesh-list
101570386|NCT02835469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101570387|NCT02835469|Fertility Agents|fertility agents|mesh-ancestor
101570388|NCT02835469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101570389|NCT02835469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570390|NCT02832973|Ramipril|ramipril|mesh-list
101570391|NCT02832973|Bisoprolol|bisoprolol|mesh-list
101570392|NCT02832973|Amiloride|amiloride|mesh-list
101570393|NCT02832973|Furosemide|furosemide|mesh-list
101570394|NCT02832973|Spironolactone|spironolactone|mesh-list
101570395|NCT02832973|Diuretics|diuretics|mesh-list
101570396|NCT02832973|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101570397|NCT02832973|Natriuretic Agents|natriuretic agents|mesh-ancestor
101570398|NCT02832973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570399|NCT02832973|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101570400|NCT02832973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101570401|NCT02832973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227286|NCT01539265|Silodosin|silodosin|mesh-list
101570402|NCT02832973|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101570403|NCT02832973|Hormone Antagonists|hormone antagonists|mesh-ancestor
101570404|NCT02832973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101570405|NCT02832973|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101570406|NCT02832973|Protease Inhibitors|protease inhibitors|mesh-ancestor
101570407|NCT02832973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101570408|NCT02832973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101570409|NCT02832973|Sympatholytics|sympatholytics|mesh-ancestor
101570410|NCT02832973|Autonomic Agents|autonomic agents|mesh-ancestor
101570411|NCT02832973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101570412|NCT02832973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101570413|NCT02832973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101570414|NCT02832973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101570415|NCT02832973|Adrenergic Agents|adrenergic agents|mesh-ancestor
101570416|NCT02832973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101570417|NCT02832973|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
101570418|NCT02832973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101570419|NCT02832973|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101570420|NCT02831491|Docetaxel|docetaxel|mesh-list
101570421|NCT02831491|Ramucirumab|ramucirumab|mesh-list
101570422|NCT02831491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101570423|NCT02831491|Tubulin Modulators|tubulin modulators|mesh-ancestor
101570424|NCT02831491|Antimitotic Agents|antimitotic agents|mesh-ancestor
101570425|NCT02831491|Mitosis Modulators|mitosis modulators|mesh-ancestor
101570426|NCT02831491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570427|NCT02860234|Capecitabine|capecitabine|mesh-list
101570428|NCT02860234|Oxaliplatin|oxaliplatin|mesh-list
101570429|NCT02860234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101570430|NCT02860234|Antimetabolites|antimetabolites|mesh-ancestor
101570431|NCT02860234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570432|NCT02860234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101570433|NCT00630370|ATI 7505|ati 7505|mesh-list
101570434|NCT00630370|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101570435|NCT00630370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101570436|NCT00630370|Serotonin Agents|serotonin agents|mesh-ancestor
101570437|NCT00630370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101570438|NCT00630370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570439|NCT00630370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570440|NCT04281706|Propofol|propofol|mesh-list
101570441|NCT04281706|Etomidate|etomidate|mesh-list
101570442|NCT04281706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101570443|NCT04281706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101570444|NCT04281706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570445|NCT04281706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101570446|NCT04281706|Anesthetics, General|anesthetics, general|mesh-ancestor
101570447|NCT04281706|Anesthetics|anesthetics|mesh-ancestor
101570448|NCT02835391|Surgiflo|surgiflo|mesh-list
101570449|NCT02835391|Hemostatics|hemostatics|mesh-ancestor
101570450|NCT02835391|Coagulants|coagulants|mesh-ancestor
101570451|NCT02831101|Sufentanil|sufentanil|mesh-list
101570452|NCT02831101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101570453|NCT02831101|Narcotics|narcotics|mesh-ancestor
101570454|NCT02831101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101570455|NCT02831101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570456|NCT02831101|Analgesics|analgesics|mesh-ancestor
101570457|NCT02831101|Sensory System Agents|sensory system agents|mesh-ancestor
101570458|NCT02831101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101570459|NCT02831101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101570460|NCT02831101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101570461|NCT02831101|Anesthetics, General|anesthetics, general|mesh-ancestor
101570462|NCT02831101|Anesthetics|anesthetics|mesh-ancestor
101570463|NCT04245787|Fluorides|fluorides|mesh-list
101570464|NCT04245787|Cariostatic Agents|cariostatic agents|mesh-ancestor
101570465|NCT04245787|Protective Agents|protective agents|mesh-ancestor
101570466|NCT04245787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570467|NCT02831179|Capecitabine|capecitabine|mesh-list
101570468|NCT02831179|Temozolomide|temozolomide|mesh-list
101570469|NCT02831179|Veliparib|veliparib|mesh-list
101570470|NCT02831179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101570471|NCT02831179|Antimetabolites|antimetabolites|mesh-ancestor
101570472|NCT02831179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570473|NCT02831179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101570474|NCT02831179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101570475|NCT02831179|Alkylating Agents|alkylating agents|mesh-ancestor
101570476|NCT02831179|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101570477|NCT02831179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101570478|NCT02830789|Calcium, Dietary|calcium, dietary|mesh-list
101570479|NCT02830789|Calcium Carbonate|calcium carbonate|mesh-list
101570480|NCT02830789|Calcium|calcium|mesh-list
101570481|NCT02830789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101570482|NCT02830789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570483|NCT02830789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101570484|NCT02830789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570485|NCT02830789|Antacids|antacids|mesh-ancestor
101570486|NCT02830789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101570487|NCT04243993|Calcium|calcium|mesh-list
101570488|NCT04243993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101570489|NCT04243993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570490|NCT04245319|Acitretin|acitretin|mesh-list
101570491|NCT04245319|Keratolytic Agents|keratolytic agents|mesh-ancestor
101570492|NCT04245319|Dermatologic Agents|dermatologic agents|mesh-ancestor
101570493|NCT02828059|Ropivacaine|ropivacaine|mesh-list
101570494|NCT02828059|Anesthetics, Local|anesthetics, local|mesh-ancestor
101570495|NCT02828059|Anesthetics|anesthetics|mesh-ancestor
101570496|NCT02828059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101570497|NCT02828059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570498|NCT02828059|Sensory System Agents|sensory system agents|mesh-ancestor
101570499|NCT02828059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101570500|NCT02827903|Metformin|metformin|mesh-list
101570501|NCT02827903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101570502|NCT02827903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101570503|NCT02827903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570504|NCT02827903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101570505|NCT02827903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101570506|NCT02827903|Antimetabolites|antimetabolites|mesh-ancestor
101570507|NCT02827903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570508|NCT02827903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101570509|NCT02827903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101570510|NCT02827903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101570511|NCT01243424|Glimepiride|glimepiride|mesh-list
101570512|NCT01243424|Linagliptin|linagliptin|mesh-list
101570513|NCT01243424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101570514|NCT01243424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101570515|NCT01243424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570516|NCT01243424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101570517|NCT01243424|Immunologic Factors|immunologic factors|mesh-ancestor
101570518|NCT01243424|Incretins|incretins|mesh-ancestor
101570519|NCT01243424|Hormones|hormones|mesh-ancestor
101570520|NCT01243424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101444409|NCT00554125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101570521|NCT01243424|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101570522|NCT01243424|Protease Inhibitors|protease inhibitors|mesh-ancestor
101570523|NCT01243424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101570524|NCT01243424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570525|NCT02831023|Pyrimethamine|pyrimethamine|mesh-list
101570526|NCT02831023|Piperaquine|piperaquine|mesh-list
101570527|NCT02831023|Primaquine|primaquine|mesh-list
101570528|NCT02831023|Sulfadoxine|sulfadoxine|mesh-list
101570529|NCT02831023|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101570530|NCT02831023|Amodiaquine|amodiaquine|mesh-list
101570531|NCT02831023|Artenimol|artenimol|mesh-list
101570532|NCT02831023|Methylene Blue|methylene blue|mesh-list
101570533|NCT02831023|Antimalarials|antimalarials|mesh-ancestor
101570534|NCT02831023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101570535|NCT02831023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101570536|NCT02831023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101570537|NCT02831023|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101570538|NCT02831023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101570539|NCT02831023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570540|NCT02831023|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101570541|NCT04244695|Dexamethasone|dexamethasone|mesh-list
101570542|NCT04244695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101570543|NCT04244695|Antiemetics|antiemetics|mesh-ancestor
101570544|NCT04244695|Autonomic Agents|autonomic agents|mesh-ancestor
101570545|NCT04244695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101570546|NCT04244695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570547|NCT04244695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101570548|NCT04244695|Glucocorticoids|glucocorticoids|mesh-ancestor
101570549|NCT04244695|Hormones|hormones|mesh-ancestor
101570550|NCT04244695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101227440|NCT01540084|Propofol|propofol|mesh-list
101570551|NCT04244695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101570552|NCT04244695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101570553|NCT00887809|Bevacizumab|bevacizumab|mesh-list
101570555|NCT00887809|Docetaxel|docetaxel|mesh-list
101570556|NCT00887809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101570557|NCT00887809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101570558|NCT00887809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101570559|NCT00887809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101570560|NCT00887809|Growth Substances|growth substances|mesh-ancestor
101570561|NCT00887809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570562|NCT00887809|Growth Inhibitors|growth inhibitors|mesh-ancestor
101570563|NCT00887809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101570564|NCT00887809|Antimetabolites|antimetabolites|mesh-ancestor
101570565|NCT00887809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570566|NCT00887809|Tubulin Modulators|tubulin modulators|mesh-ancestor
101570567|NCT00887809|Antimitotic Agents|antimitotic agents|mesh-ancestor
101570568|NCT00887809|Mitosis Modulators|mitosis modulators|mesh-ancestor
101570569|NCT02827747|Vitamin A|vitamin a|mesh-list
101570570|NCT02827747|Antioxidants|antioxidants|mesh-list
101570571|NCT02827747|Vitamins|vitamins|mesh-ancestor
101570572|NCT02827747|Micronutrients|micronutrients|mesh-ancestor
101570573|NCT02827747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570574|NCT02827747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570575|NCT02827747|Protective Agents|protective agents|mesh-ancestor
101570576|NCT04281628|Ketamine|ketamine|mesh-list
101570577|NCT04281628|Analgesics|analgesics|mesh-ancestor
101570578|NCT04281628|Sensory System Agents|sensory system agents|mesh-ancestor
101570579|NCT04281628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101570580|NCT04281628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570581|NCT04281628|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101570582|NCT04281628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101570583|NCT04281628|Anesthetics, General|anesthetics, general|mesh-ancestor
101570584|NCT04281628|Anesthetics|anesthetics|mesh-ancestor
101692818|NCT04182932|Vaccines|vaccines|mesh-list
101570585|NCT04281628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101570586|NCT04281628|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101570587|NCT04281628|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101570588|NCT04281628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101570589|NCT04281628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570591|NCT00886795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101570592|NCT00886795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570593|NCT00886795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101570594|NCT00886795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101570595|NCT00886795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101570596|NCT00886795|Immunologic Factors|immunologic factors|mesh-ancestor
101570597|NCT00886795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570598|NCT00886795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101570599|NCT02783482|Immunoglobulins|immunoglobulins|mesh-list
101570600|NCT02783482|gamma-Globulins|gamma-globulins|mesh-list
101570601|NCT02783482|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101570602|NCT02783482|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101570603|NCT02783482|Immunologic Factors|immunologic factors|mesh-ancestor
101570604|NCT02783482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570606|NCT00953680|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101570607|NCT00953680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101570608|NCT00953680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101570609|NCT00953680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101570610|NCT00953680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101570611|NCT00953680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570612|NCT00953680|Diuretics|diuretics|mesh-ancestor
101570613|NCT00953680|Natriuretic Agents|natriuretic agents|mesh-ancestor
101570614|NCT00953680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570615|NCT00953680|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101570616|NCT00953680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101570617|NCT00890929|Lenalidomide|lenalidomide|mesh-list
101570618|NCT00890929|Azacitidine|azacitidine|mesh-list
101570619|NCT00890929|Immunologic Factors|immunologic factors|mesh-ancestor
101570620|NCT00890929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570621|NCT00890929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101570622|NCT00890929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101570623|NCT00890929|Growth Substances|growth substances|mesh-ancestor
101570624|NCT00890929|Growth Inhibitors|growth inhibitors|mesh-ancestor
101570625|NCT00890929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101570626|NCT00890929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101570627|NCT00890929|Antimetabolites|antimetabolites|mesh-ancestor
101570628|NCT00890929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570629|NCT00890929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101570630|NCT04246567|Fentanyl|fentanyl|mesh-list
101570631|NCT04246567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101570632|NCT04246567|Narcotics|narcotics|mesh-ancestor
101570633|NCT04246567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101570634|NCT04246567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570635|NCT04246567|Analgesics|analgesics|mesh-ancestor
101570636|NCT04246567|Sensory System Agents|sensory system agents|mesh-ancestor
101570637|NCT04246567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101570638|NCT04246567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101570639|NCT04246567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101570640|NCT04246567|Anesthetics, General|anesthetics, general|mesh-ancestor
101570641|NCT04246567|Anesthetics|anesthetics|mesh-ancestor
101570642|NCT02830243|Sevoflurane|sevoflurane|mesh-list
101570643|NCT02830243|Desflurane|desflurane|mesh-list
101570644|NCT02830243|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101570645|NCT02830243|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101570646|NCT02830243|Anesthetics, General|anesthetics, general|mesh-ancestor
101570647|NCT02830243|Anesthetics|anesthetics|mesh-ancestor
101570648|NCT02830243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101570649|NCT02830243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570650|NCT00889603|Donepezil|donepezil|mesh-list
101570651|NCT00889603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101444441|NCT00175955|Levetiracetam|levetiracetam|mesh-list
101570652|NCT00889603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101570653|NCT00889603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570654|NCT00889603|Cholinergic Agents|cholinergic agents|mesh-ancestor
101570655|NCT00889603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101570656|NCT00889603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570657|NCT00889603|Nootropic Agents|nootropic agents|mesh-ancestor
101570658|NCT02829385|Apatinib|apatinib|mesh-list
101692902|NCT00963313|Adalimumab|adalimumab|mesh-list
101570659|NCT02829385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101570660|NCT02829385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101570662|NCT02829385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570663|NCT02826343|Xenon|xenon|mesh-list
101570664|NCT02826343|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101570665|NCT02826343|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101570666|NCT02826343|Anesthetics, General|anesthetics, general|mesh-ancestor
101570667|NCT02826343|Anesthetics|anesthetics|mesh-ancestor
101570668|NCT02826343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101570669|NCT02826343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570670|NCT02826343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101570671|NCT02826343|Autonomic Agents|autonomic agents|mesh-ancestor
101570672|NCT02826343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101570673|NCT02826343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101570674|NCT02826343|Respiratory System Agents|respiratory system agents|mesh-ancestor
101570675|NCT02826343|Glucocorticoids|glucocorticoids|mesh-ancestor
101570677|NCT02826343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101570678|NCT02826343|Sympathomimetics|sympathomimetics|mesh-ancestor
101570679|NCT05660785|Cyclosporine|cyclosporine|mesh-list
101570680|NCT05660785|Cyclosporins|cyclosporins|mesh-list
101570681|NCT05660785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101570682|NCT05660785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570683|NCT05660785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101570684|NCT05660785|Immunologic Factors|immunologic factors|mesh-ancestor
101570685|NCT05660785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570686|NCT05660785|Antifungal Agents|antifungal agents|mesh-ancestor
101570687|NCT05660785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101570688|NCT05660785|Dermatologic Agents|dermatologic agents|mesh-ancestor
101570689|NCT05660785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101570690|NCT05660785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101570691|NCT04246255|Lidocaine|lidocaine|mesh-list
101570692|NCT04246255|Anesthetics, Local|anesthetics, local|mesh-ancestor
101570693|NCT04246255|Anesthetics|anesthetics|mesh-ancestor
101570694|NCT04246255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101570695|NCT04246255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570696|NCT04246255|Sensory System Agents|sensory system agents|mesh-ancestor
101570697|NCT04246255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101570698|NCT04246255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101570699|NCT04246255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101570700|NCT04246255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101570701|NCT04246255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101570702|NCT04246255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570703|NCT02825953|Pulmonary Surfactants|pulmonary surfactants|mesh-list
101570704|NCT02825953|Respiratory System Agents|respiratory system agents|mesh-ancestor
101570705|NCT05217589|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101570706|NCT05217589|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
101570707|NCT05217589|beta-Endorphin|beta-endorphin|mesh-list
101570708|NCT05217589|Hormones|hormones|mesh-ancestor
101570709|NCT05217589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101570710|NCT05217589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570711|NCT05217589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101570712|NCT05217589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570713|NCT05210725|Rivaroxaban|rivaroxaban|mesh-list
101570714|NCT05210725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101570715|NCT05210725|Antithrombins|antithrombins|mesh-ancestor
101570716|NCT05210725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101570717|NCT05210725|Protease Inhibitors|protease inhibitors|mesh-ancestor
101570718|NCT05210725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101570719|NCT05210725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570720|NCT05210725|Anticoagulants|anticoagulants|mesh-ancestor
101570721|NCT02826031|Hyaluronic Acid|hyaluronic acid|mesh-list
101570722|NCT02826031|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101570723|NCT02826031|Immunologic Factors|immunologic factors|mesh-ancestor
101570724|NCT02826031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570725|NCT02826031|Viscosupplements|viscosupplements|mesh-ancestor
101570726|NCT02826031|Protective Agents|protective agents|mesh-ancestor
101570727|NCT02829697|Ropivacaine|ropivacaine|mesh-list
101570728|NCT02829697|Anesthetics, Local|anesthetics, local|mesh-ancestor
101570729|NCT02829697|Anesthetics|anesthetics|mesh-ancestor
101570730|NCT02829697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101570731|NCT02829697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570732|NCT02829697|Sensory System Agents|sensory system agents|mesh-ancestor
101570733|NCT02829697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101570735|NCT02829151|Cilostazol|cilostazol|mesh-list
101570736|NCT02829151|Clopidogrel|clopidogrel|mesh-list
101570737|NCT02829151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101570738|NCT02829151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101570739|NCT02829151|Analgesics|analgesics|mesh-ancestor
101570740|NCT02829151|Sensory System Agents|sensory system agents|mesh-ancestor
101570741|NCT02829151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101570742|NCT02829151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570743|NCT02829151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101570744|NCT02829151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101570745|NCT02829151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101570746|NCT02829151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101570747|NCT02829151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570748|NCT02829151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101570749|NCT02829151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101570750|NCT02829151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101570751|NCT02829151|Antipyretics|antipyretics|mesh-ancestor
101570752|NCT02829151|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101570753|NCT02829151|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101570754|NCT02829151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101570755|NCT02829151|Purinergic Agents|purinergic agents|mesh-ancestor
101570756|NCT02829151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101570757|NCT02829151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101570758|NCT02829151|Autonomic Agents|autonomic agents|mesh-ancestor
101570759|NCT02829151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101570760|NCT02829151|Respiratory System Agents|respiratory system agents|mesh-ancestor
101570761|NCT02829151|Vasodilator Agents|vasodilator agents|mesh-ancestor
101570762|NCT02829151|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101570763|NCT02829151|Protective Agents|protective agents|mesh-ancestor
101570764|NCT02829151|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101570765|NCT02829151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101570766|NCT02825719|Tranexamic Acid|tranexamic acid|mesh-list
101570767|NCT02825719|Ulipristal acetate|ulipristal acetate|mesh-list
101570768|NCT02825719|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101570769|NCT02825719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101570770|NCT02825719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570771|NCT02825719|Hemostatics|hemostatics|mesh-ancestor
101570772|NCT02825719|Coagulants|coagulants|mesh-ancestor
101570773|NCT02825719|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101570774|NCT02825719|Contraceptive Agents|contraceptive agents|mesh-ancestor
101570775|NCT02825719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101570776|NCT02825719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570777|NCT02825719|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101570778|NCT04241653|Sevoflurane|sevoflurane|mesh-list
101570779|NCT04241653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101570780|NCT04241653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101570781|NCT04241653|Anesthetics, General|anesthetics, general|mesh-ancestor
101570782|NCT04241653|Anesthetics|anesthetics|mesh-ancestor
101570783|NCT04241653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101570784|NCT04241653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570785|NCT04241731|Cetuximab|cetuximab|mesh-list
101570786|NCT04241731|Raltitrexed|raltitrexed|mesh-list
101570787|NCT04241731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101570788|NCT04241731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101570789|NCT04241731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101570790|NCT04241731|Antimetabolites|antimetabolites|mesh-ancestor
101570791|NCT04241731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444471|NCT03291886|Entinostat|entinostat|mesh-list
101570792|NCT04241731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101570793|NCT04241731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101570794|NCT04241887|Anesthetics|anesthetics|mesh-list
101570795|NCT04241887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101570796|NCT04241887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570797|NCT02825797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101570798|NCT02825797|Antibodies|antibodies|mesh-list
101570799|NCT02825797|Immunoglobulins|immunoglobulins|mesh-list
101570800|NCT02825797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101570801|NCT02825797|Immunologic Factors|immunologic factors|mesh-ancestor
101570802|NCT02825797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570803|NCT02825797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101570804|NCT02824315|Simeprevir|simeprevir|mesh-list
101570805|NCT02824315|Odalasvir|odalasvir|mesh-list
101570806|NCT02824315|Antiviral Agents|antiviral agents|mesh-ancestor
101570808|NCT02824315|Protease Inhibitors|protease inhibitors|mesh-ancestor
101570809|NCT02824315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101570810|NCT02824315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570811|NCT04242433|Antiviral Agents|antiviral agents|mesh-list
101570812|NCT04242433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101570813|NCT02823925|Zoledronic Acid|zoledronic acid|mesh-list
101570814|NCT02823925|Pamidronate|pamidronate|mesh-list
101570815|NCT02823925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101570816|NCT02823925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570817|NCT04201249|Piroxicam|piroxicam|mesh-list
101570818|NCT04201249|Lidocaine|lidocaine|mesh-list
101570819|NCT04201249|Anesthetics, Local|anesthetics, local|mesh-ancestor
101570820|NCT04201249|Anesthetics|anesthetics|mesh-ancestor
101570821|NCT04201249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101570822|NCT04201249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570823|NCT04201249|Sensory System Agents|sensory system agents|mesh-ancestor
101570824|NCT04201249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101570825|NCT04201249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101570826|NCT04201249|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101570827|NCT04201249|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101570828|NCT04201249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101570829|NCT04201249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570830|NCT04201249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101570831|NCT04201249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101570832|NCT04201249|Analgesics|analgesics|mesh-ancestor
101570833|NCT04201249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101570834|NCT04201249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101570835|NCT04201249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101570836|NCT04201249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101570837|NCT00633685|Fluoxetine|fluoxetine|mesh-list
101570838|NCT00633685|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101570839|NCT00633685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101570840|NCT00633685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101570841|NCT00633685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570842|NCT00633685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101570843|NCT00633685|Serotonin Agents|serotonin agents|mesh-ancestor
101570844|NCT00633685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570845|NCT00633685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101570846|NCT00633685|Antidepressive Agents|antidepressive agents|mesh-ancestor
101570847|NCT00633685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101570848|NCT00633685|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101570849|NCT00633685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101570850|NCT00633685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101570851|NCT02823691|Metformin|metformin|mesh-list
101570853|NCT02823691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101570854|NCT02823691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570855|NCT02823691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101570856|NCT02825095|Lidocaine|lidocaine|mesh-list
101570857|NCT02825095|Anesthetics, Local|anesthetics, local|mesh-ancestor
101570858|NCT02825095|Anesthetics|anesthetics|mesh-ancestor
101570859|NCT02825095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101570860|NCT02825095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570861|NCT02825095|Sensory System Agents|sensory system agents|mesh-ancestor
101570862|NCT02825095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101570863|NCT02825095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101570864|NCT02825095|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101570865|NCT02825095|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101570866|NCT02825095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101570867|NCT02825095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570868|NCT04195009|Anesthetics|anesthetics|mesh-list
101570869|NCT04195009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101570870|NCT04195009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570871|NCT05660083|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
101570872|NCT05660083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101570873|NCT05660083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570874|NCT02822131|Sevelamer|sevelamer|mesh-list
101570875|NCT02822131|Chelating Agents|chelating agents|mesh-ancestor
101570876|NCT02822131|Sequestering Agents|sequestering agents|mesh-ancestor
101570877|NCT02822131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570878|NCT04239625|Vitamin A|vitamin a|mesh-list
101570879|NCT04239625|Retinol acetate|retinol acetate|mesh-list
101570880|NCT04239625|Vitamins|vitamins|mesh-ancestor
101570881|NCT04239625|Micronutrients|micronutrients|mesh-ancestor
101570882|NCT04239625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570883|NCT04239625|Protective Agents|protective agents|mesh-ancestor
101570884|NCT04239625|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101570885|NCT04239625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101570886|NCT04239625|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101570887|NCT04239625|Immunologic Factors|immunologic factors|mesh-ancestor
101570888|NCT02821897|Anesthetics|anesthetics|mesh-list
101570889|NCT02821897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101570890|NCT02821897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570891|NCT02820493|Vedolizumab|vedolizumab|mesh-list
101570892|NCT02820493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101570893|NCT05659459|Pioglitazone|pioglitazone|mesh-list
101570894|NCT05659459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101570895|NCT05659459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570896|NCT02820259|Tacrolimus|tacrolimus|mesh-list
101570897|NCT02820259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101570898|NCT02820259|Immunologic Factors|immunologic factors|mesh-ancestor
101570899|NCT02820259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570900|NCT02820259|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101570901|NCT02820259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101570902|NCT02820259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570903|NCT00633763|Fallypride|fallypride|mesh-list
101570904|NCT00633763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101570905|NCT00633763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101570906|NCT00633763|Dopamine Agents|dopamine agents|mesh-ancestor
101570907|NCT00633763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101570908|NCT00633763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570909|NCT00633763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570910|NCT02820025|Doxapram|doxapram|mesh-list
101570911|NCT02820025|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101570912|NCT02820025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570913|NCT02820025|Respiratory System Agents|respiratory system agents|mesh-ancestor
101570914|NCT02819869|Metformin|metformin|mesh-list
101570915|NCT02819869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101570916|NCT02819869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570917|NCT02820883|Vaccines|vaccines|mesh-list
101570918|NCT02820883|Immunologic Factors|immunologic factors|mesh-ancestor
101570919|NCT02820883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570920|NCT02819089|Dexmedetomidine|dexmedetomidine|mesh-list
101570921|NCT02819089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101570922|NCT02819089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101570923|NCT02819089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570924|NCT02819089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101570925|NCT02819089|Analgesics|analgesics|mesh-ancestor
101227812|NCT01542138|Niacin|niacin|mesh-list
101570926|NCT02819089|Sensory System Agents|sensory system agents|mesh-ancestor
101570927|NCT02819089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101570928|NCT02819089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101570929|NCT02819089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101570930|NCT02819089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101570931|NCT02819089|Adrenergic Agents|adrenergic agents|mesh-ancestor
101570932|NCT02819089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101444478|NCT03291886|Hormone Antagonists|hormone antagonists|mesh-ancestor
101570933|NCT02819089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570934|NCT04238923|Vancomycin|vancomycin|mesh-list
101570935|NCT04238923|Gentamicins|gentamicins|mesh-list
101570936|NCT04238923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101570937|NCT04238923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101570938|NCT04238923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101570939|NCT04238923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101570940|NCT04238923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570941|NCT02815657|Valsartan|valsartan|mesh-list
101570942|NCT02815657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101570943|NCT02815657|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101570944|NCT02815657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101570945|NCT02815657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570946|NCT04597333|Dinoprostone|dinoprostone|mesh-list
101570947|NCT04597333|Oxytocics|oxytocics|mesh-ancestor
101570948|NCT04597333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101570949|NCT04597333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570950|NCT00957580|Niacinamide|niacinamide|mesh-list
101570951|NCT00957580|Vitamin B Complex|vitamin b complex|mesh-ancestor
101570952|NCT00957580|Vitamins|vitamins|mesh-ancestor
101570953|NCT00957580|Micronutrients|micronutrients|mesh-ancestor
101570954|NCT00957580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570956|NCT00957424|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101570957|NCT00957424|Autonomic Agents|autonomic agents|mesh-ancestor
101570958|NCT00957424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101570959|NCT00957424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570960|NCT00957424|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101570961|NCT00957424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101570962|NCT00957424|Cholinergic Agents|cholinergic agents|mesh-ancestor
101570963|NCT00957424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101570964|NCT00957424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570965|NCT02818621|Dexmedetomidine|dexmedetomidine|mesh-list
101570966|NCT02818621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101570967|NCT02818621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101570968|NCT02818621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570969|NCT02818621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101570970|NCT02818621|Analgesics|analgesics|mesh-ancestor
101570971|NCT02818621|Sensory System Agents|sensory system agents|mesh-ancestor
101570972|NCT02818621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101570973|NCT02818621|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101570974|NCT02818621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101570975|NCT02818621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101570976|NCT02818621|Adrenergic Agents|adrenergic agents|mesh-ancestor
101570977|NCT02818621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101570978|NCT02818621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570979|NCT04642651|Dexmedetomidine|dexmedetomidine|mesh-list
101570980|NCT04642651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101570981|NCT04642651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101570982|NCT04642651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101570983|NCT04642651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101570984|NCT04642651|Analgesics|analgesics|mesh-ancestor
101570985|NCT04642651|Sensory System Agents|sensory system agents|mesh-ancestor
101570986|NCT04642651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101570987|NCT04642651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101570988|NCT04642651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101570989|NCT04642651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101570990|NCT04642651|Adrenergic Agents|adrenergic agents|mesh-ancestor
101570991|NCT04642651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101570992|NCT04642651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570993|NCT01061151|Ritonavir|ritonavir|mesh-list
101570994|NCT01061151|Lopinavir|lopinavir|mesh-list
101570995|NCT01061151|Tenofovir|tenofovir|mesh-list
101570996|NCT01061151|Lamivudine|lamivudine|mesh-list
101570997|NCT01061151|Emtricitabine|emtricitabine|mesh-list
101570998|NCT01061151|Zidovudine|zidovudine|mesh-list
101570999|NCT01061151|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101571001|NCT01061151|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101571002|NCT01061151|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101571003|NCT01061151|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101571004|NCT01061151|Protease Inhibitors|protease inhibitors|mesh-ancestor
101571005|NCT01061151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101571006|NCT01061151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571007|NCT01061151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101571008|NCT01061151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101571009|NCT01061151|Antiviral Agents|antiviral agents|mesh-ancestor
101571010|NCT01061151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101571011|NCT01061151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101571012|NCT01061151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101571013|NCT01061151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101571014|NCT01061151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101571015|NCT01061151|Antimetabolites|antimetabolites|mesh-ancestor
101571016|NCT01061151|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101571017|NCT01061151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101571018|NCT04472143|Granisetron|granisetron|mesh-list
101571019|NCT04472143|Antiemetics|antiemetics|mesh-ancestor
101571020|NCT04472143|Autonomic Agents|autonomic agents|mesh-ancestor
101571021|NCT04472143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101571022|NCT04472143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571023|NCT04472143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101571024|NCT04472143|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101571025|NCT04472143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101571026|NCT04472143|Serotonin Agents|serotonin agents|mesh-ancestor
101571027|NCT04472143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101571028|NCT04472143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571029|NCT01241552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101571030|NCT01241552|Immunologic Factors|immunologic factors|mesh-ancestor
101571031|NCT01241552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571032|NCT04748523|Mirtazapine|mirtazapine|mesh-list
101571033|NCT04748523|Antidepressive Agents|antidepressive agents|mesh-ancestor
101571034|NCT04748523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101571035|NCT04748523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101571036|NCT04748523|Histamine Antagonists|histamine antagonists|mesh-ancestor
101571037|NCT04748523|Histamine Agents|histamine agents|mesh-ancestor
101571038|NCT04748523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101571039|NCT04748523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571040|NCT04748523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571041|NCT04748523|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101571042|NCT04748523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101571043|NCT04748523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101571044|NCT04748523|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101571045|NCT04748523|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101571046|NCT04748523|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101571047|NCT04748523|Adrenergic Agents|adrenergic agents|mesh-ancestor
101571048|NCT04748523|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101571049|NCT04748523|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101571050|NCT04748523|Serotonin Agents|serotonin agents|mesh-ancestor
101571051|NCT04748523|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101571052|NCT02817217|Valsartan|valsartan|mesh-list
101571053|NCT02817217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101571054|NCT02817217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101571055|NCT02817217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101571056|NCT02817217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571057|NCT00948922|Fludarabine|fludarabine|mesh-list
101571058|NCT00948922|Bortezomib|bortezomib|mesh-list
101571059|NCT00948922|Melphalan|melphalan|mesh-list
101571060|NCT00948922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101571061|NCT00948922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571062|NCT00948922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101571063|NCT00948922|Immunologic Factors|immunologic factors|mesh-ancestor
101571064|NCT00948922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571065|NCT00948922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101571066|NCT00948922|Alkylating Agents|alkylating agents|mesh-ancestor
101571067|NCT00948922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101571068|NCT00634309|Candesartan|candesartan|mesh-list
101571069|NCT00634309|Candesartan cilexetil|candesartan cilexetil|mesh-list
101571070|NCT00634309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101571071|NCT00634309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101571072|NCT00634309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101571073|NCT00634309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571074|NCT01239992|Niacin|niacin|mesh-list
101571075|NCT01239992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101571076|NCT01239992|Antimetabolites|antimetabolites|mesh-ancestor
101571077|NCT01239992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571078|NCT01239992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101571079|NCT01239992|Vasodilator Agents|vasodilator agents|mesh-ancestor
101571080|NCT01239992|Vitamin B Complex|vitamin b complex|mesh-ancestor
101571081|NCT01239992|Vitamins|vitamins|mesh-ancestor
101571082|NCT01239992|Micronutrients|micronutrients|mesh-ancestor
101571083|NCT01239992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571084|NCT02816905|Fluorometholone|fluorometholone|mesh-list
101571085|NCT02816905|Dexamethasone|dexamethasone|mesh-list
101571086|NCT02816905|Rimexolone|rimexolone|mesh-list
101571087|NCT02816905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101571088|NCT02816905|Antiemetics|antiemetics|mesh-ancestor
101571089|NCT02816905|Autonomic Agents|autonomic agents|mesh-ancestor
101571090|NCT02816905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101571091|NCT02816905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571092|NCT02816905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101571093|NCT02816905|Glucocorticoids|glucocorticoids|mesh-ancestor
101571094|NCT02816905|Hormones|hormones|mesh-ancestor
101571095|NCT02816905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101571096|NCT02816905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101571097|NCT02816905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101571098|NCT02816905|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101571099|NCT01072539|Tigecycline|tigecycline|mesh-list
101571100|NCT01072539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101571101|NCT01072539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101571102|NCT01072539|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101571103|NCT01072539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101571104|NCT01072539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571105|NCT05517590|Tranexamic Acid|tranexamic acid|mesh-list
101571106|NCT05517590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101571107|NCT05517590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101571108|NCT05517590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571109|NCT05517590|Hemostatics|hemostatics|mesh-ancestor
101571111|NCT05654077|Cyclophosphamide|cyclophosphamide|mesh-list
101571112|NCT05654077|Fludarabine|fludarabine|mesh-list
101571113|NCT05654077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101571114|NCT05654077|Immunologic Factors|immunologic factors|mesh-ancestor
101571115|NCT05654077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571116|NCT05654077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101571117|NCT05654077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101571118|NCT05654077|Alkylating Agents|alkylating agents|mesh-ancestor
101571119|NCT05654077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571120|NCT05654077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101571121|NCT05654077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101571122|NCT04303767|Calcium|calcium|mesh-list
101571123|NCT04303767|Caseins|caseins|mesh-list
101571124|NCT04303767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101571125|NCT04303767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571126|NCT04303767|Chelating Agents|chelating agents|mesh-ancestor
101571127|NCT04303767|Sequestering Agents|sequestering agents|mesh-ancestor
101571128|NCT04303767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571129|NCT02874963|Ethanol|ethanol|mesh-list
101571130|NCT02874963|Listerine|listerine|mesh-list
101571131|NCT02874963|Thymol|thymol|mesh-list
101571132|NCT02874963|Eucalyptol|eucalyptol|mesh-list
101571133|NCT02874963|Salicylates|salicylates|mesh-list
101571134|NCT02874963|Methyl salicylate|methyl salicylate|mesh-list
101571135|NCT02874963|Menthol|menthol|mesh-list
101571136|NCT02874963|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101571137|NCT02874963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101571138|NCT02874963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101571139|NCT02874963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571140|NCT02874963|Antipruritics|antipruritics|mesh-ancestor
101571141|NCT02874963|Dermatologic Agents|dermatologic agents|mesh-ancestor
101571142|NCT02874963|Protective Agents|protective agents|mesh-ancestor
101571143|NCT02874963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101571144|NCT02874963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101571145|NCT02874963|Analgesics|analgesics|mesh-ancestor
101228033|NCT01543724|Lithium Carbonate|lithium carbonate|mesh-list
101571146|NCT02874963|Sensory System Agents|sensory system agents|mesh-ancestor
101571147|NCT02874963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101571148|NCT02874963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101571149|NCT02874963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101571150|NCT02874963|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101571151|NCT02874963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101571152|NCT02874963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571153|NCT02874963|Antifungal Agents|antifungal agents|mesh-ancestor
101571154|NCT02874963|Antitussive Agents|antitussive agents|mesh-ancestor
101571155|NCT02874963|Respiratory System Agents|respiratory system agents|mesh-ancestor
101571156|NCT02874963|Insect Repellents|insect repellents|mesh-ancestor
101571157|NCT02818309|Lesogaberan|lesogaberan|mesh-list
101571158|NCT02818309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101571159|NCT02818309|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101571160|NCT02818309|GABA Agonists|gaba agonists|mesh-ancestor
101571161|NCT02818309|GABA Agents|gaba agents|mesh-ancestor
101571162|NCT02818309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101571163|NCT02818309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571164|NCT02818309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571165|NCT01238822|Methylphenidate|methylphenidate|mesh-list
101571166|NCT01238822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101571167|NCT01238822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571168|NCT01238822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101571169|NCT01238822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101571170|NCT01238822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101571171|NCT01238822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571172|NCT01238822|Dopamine Agents|dopamine agents|mesh-ancestor
101571173|NCT01238822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101571174|NCT02818387|Midazolam|midazolam|mesh-list
101571175|NCT02818387|Remifentanil|remifentanil|mesh-list
101571176|NCT02818387|Propofol|propofol|mesh-list
101571177|NCT02818387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101571178|NCT02818387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101571179|NCT02818387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571180|NCT02818387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101571181|NCT02818387|Anesthetics, General|anesthetics, general|mesh-ancestor
101571182|NCT02818387|Anesthetics|anesthetics|mesh-ancestor
101571183|NCT02818387|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101571184|NCT02818387|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101571185|NCT02818387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101571186|NCT02818387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101571187|NCT02818387|GABA Modulators|gaba modulators|mesh-ancestor
101571188|NCT02818387|GABA Agents|gaba agents|mesh-ancestor
101571189|NCT02818387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101571190|NCT02818387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571191|NCT02818387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101571192|NCT02818387|Narcotics|narcotics|mesh-ancestor
101571193|NCT02818387|Analgesics|analgesics|mesh-ancestor
101571194|NCT02818387|Sensory System Agents|sensory system agents|mesh-ancestor
101571195|NCT02818387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101571196|NCT05296629|Doxycycline|doxycycline|mesh-list
101571197|NCT05296629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101571198|NCT05296629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101571199|NCT05296629|Antimalarials|antimalarials|mesh-ancestor
101571200|NCT05296629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101571201|NCT05296629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101571202|NCT01238588|Sevelamer|sevelamer|mesh-list
101571203|NCT01238588|Chelating Agents|chelating agents|mesh-ancestor
101571204|NCT01238588|Sequestering Agents|sequestering agents|mesh-ancestor
101571205|NCT01238588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571206|NCT00627003|Cabergoline|cabergoline|mesh-list
101571207|NCT00627003|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101571208|NCT00627003|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101571209|NCT00627003|Dopamine Agonists|dopamine agonists|mesh-ancestor
101571210|NCT00627003|Dopamine Agents|dopamine agents|mesh-ancestor
101571211|NCT00627003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101571212|NCT00627003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571213|NCT00627003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571214|NCT04238221|Doxofylline|doxofylline|mesh-list
101571215|NCT04238221|Antitussive Agents|antitussive agents|mesh-ancestor
101571216|NCT04238221|Respiratory System Agents|respiratory system agents|mesh-ancestor
101571217|NCT04238221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101571218|NCT04238221|Autonomic Agents|autonomic agents|mesh-ancestor
101571219|NCT04238221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101571220|NCT04238221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571221|NCT04238221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101571222|NCT04238221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101571223|NCT04238221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101571224|NCT04238221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571225|NCT01047501|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
101571226|NCT01047501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101571227|NCT01047501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101571228|NCT01238120|Ibuprofen|ibuprofen|mesh-list
101571229|NCT01238120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101571230|NCT01238120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101571231|NCT01238120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101571232|NCT01238120|Analgesics|analgesics|mesh-ancestor
101571233|NCT01238120|Sensory System Agents|sensory system agents|mesh-ancestor
101571234|NCT01238120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101571235|NCT01238120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571236|NCT01238120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101571237|NCT01238120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101571238|NCT01238120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101571239|NCT01238120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571240|NCT02816593|Hydrogen Peroxide|hydrogen peroxide|mesh-list
101571241|NCT02816593|Carbamide Peroxide|carbamide peroxide|mesh-list
101571242|NCT02816593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101571243|NCT02816593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101571244|NCT04237987|Cyclosporine|cyclosporine|mesh-list
101571245|NCT04237987|Aldesleukin|aldesleukin|mesh-list
101571246|NCT04237987|Interleukin-2|interleukin-2|mesh-list
101571247|NCT04237987|Cyclosporins|cyclosporins|mesh-list
101571248|NCT04237987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101571249|NCT04237987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571250|NCT04237987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101571251|NCT04237987|Immunologic Factors|immunologic factors|mesh-ancestor
101571252|NCT04237987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571253|NCT04237987|Antifungal Agents|antifungal agents|mesh-ancestor
101571254|NCT04237987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101571255|NCT04237987|Dermatologic Agents|dermatologic agents|mesh-ancestor
101571256|NCT04237987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101571257|NCT04237987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101571258|NCT04237987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101571259|NCT04237987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101571261|NCT04237987|Sensory System Agents|sensory system agents|mesh-ancestor
101571262|NCT04237987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101571264|NCT04237987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101571265|NCT04237987|Antiviral Agents|antiviral agents|mesh-ancestor
101571266|NCT04551547|Vaccines|vaccines|mesh-list
101571267|NCT04551547|Immunologic Factors|immunologic factors|mesh-ancestor
101571268|NCT04551547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571269|NCT01045707|Insulin|insulin|mesh-list
101571270|NCT01045707|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101571271|NCT01045707|Insulin Glargine|insulin glargine|mesh-list
101571272|NCT01045707|Insulin Aspart|insulin aspart|mesh-list
101571273|NCT01045707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101571274|NCT01045707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571275|NCT04533997|Furosemide|furosemide|mesh-list
101571276|NCT04533997|Diuretics|diuretics|mesh-ancestor
101571277|NCT04533997|Natriuretic Agents|natriuretic agents|mesh-ancestor
101571278|NCT04533997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571279|NCT04533997|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101571280|NCT04533997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101571281|NCT04533997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571282|NCT02874807|Empagliflozin|empagliflozin|mesh-list
101571283|NCT02874807|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101571284|NCT02874807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571285|NCT02874807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101571286|NCT02874807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571287|NCT01054599|Memantine|memantine|mesh-list
101571288|NCT01054599|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101571289|NCT01054599|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101571290|NCT01054599|Dopamine Agents|dopamine agents|mesh-ancestor
101571291|NCT01054599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101571292|NCT01054599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571293|NCT01054599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571294|NCT01054599|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101571295|NCT01054599|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101571296|NCT05635201|Anesthetics|anesthetics|mesh-list
101571297|NCT05635201|Propofol|propofol|mesh-list
101571298|NCT05635201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101571299|NCT05635201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571300|NCT05635201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101571301|NCT05635201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101571302|NCT05635201|Anesthetics, General|anesthetics, general|mesh-ancestor
101571304|NCT02813863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101571305|NCT02813863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571306|NCT02874729|Dimercaprol|dimercaprol|mesh-list
101571307|NCT02874729|Chelating Agents|chelating agents|mesh-ancestor
101571308|NCT02874729|Sequestering Agents|sequestering agents|mesh-ancestor
101571309|NCT02874729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571310|NCT04275661|Magnesium Sulfate|magnesium sulfate|mesh-list
101571311|NCT04275661|Ketamine|ketamine|mesh-list
101571312|NCT04275661|Levobupivacaine|levobupivacaine|mesh-list
101571313|NCT04275661|Analgesics|analgesics|mesh-ancestor
101571314|NCT04275661|Sensory System Agents|sensory system agents|mesh-ancestor
101571315|NCT04275661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101571316|NCT04275661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571317|NCT04275661|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101571318|NCT04275661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101571319|NCT04275661|Anesthetics, General|anesthetics, general|mesh-ancestor
101571320|NCT04275661|Anesthetics|anesthetics|mesh-ancestor
101571321|NCT04275661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101571322|NCT04275661|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101571323|NCT04275661|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101444542|NCT00176540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645759|NCT02583022|Pimecrolimus|pimecrolimus|mesh-list
101571324|NCT04275661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101571325|NCT04275661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571326|NCT04275661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101571327|NCT04275661|Anticonvulsants|anticonvulsants|mesh-ancestor
101571328|NCT04275661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101571329|NCT04275661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101571330|NCT04275661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101571331|NCT04275661|Tocolytic Agents|tocolytic agents|mesh-ancestor
101571332|NCT04275661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101571333|NCT04275661|Anesthetics, Local|anesthetics, local|mesh-ancestor
101571335|NCT00948766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101571336|NCT00948766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101571337|NCT00948766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571338|NCT00948766|Cholinergic Agents|cholinergic agents|mesh-ancestor
101571339|NCT00948766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101571340|NCT00948766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571341|NCT00948766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101571342|NCT00948766|Protective Agents|protective agents|mesh-ancestor
101571343|NCT01053663|Oseltamivir|oseltamivir|mesh-list
101571344|NCT01053663|Antiviral Agents|antiviral agents|mesh-ancestor
101571345|NCT01053663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101571346|NCT01053663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101571347|NCT01053663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571348|NCT01235546|Azithromycin|azithromycin|mesh-list
101571349|NCT01235546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101571350|NCT01235546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101571351|NCT01053429|Ziprasidone|ziprasidone|mesh-list
101571352|NCT01053429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101571353|NCT01053429|Serotonin Agents|serotonin agents|mesh-ancestor
101571354|NCT01053429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101571355|NCT01053429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571356|NCT01053429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571357|NCT01053429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101571358|NCT01053429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101571359|NCT01053429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101571360|NCT01053429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101571361|NCT01053429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101571362|NCT01053429|Dopamine Agents|dopamine agents|mesh-ancestor
101571363|NCT01233284|Bromides|bromides|mesh-list
101571364|NCT01233284|Tiotropium Bromide|tiotropium bromide|mesh-list
101571365|NCT01233284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101571366|NCT01233284|Autonomic Agents|autonomic agents|mesh-ancestor
101571367|NCT01233284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101571368|NCT01233284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571369|NCT01233284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101571370|NCT01233284|Respiratory System Agents|respiratory system agents|mesh-ancestor
101571371|NCT01233284|Parasympatholytics|parasympatholytics|mesh-ancestor
101571372|NCT01233284|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101571373|NCT01233284|Cholinergic Agents|cholinergic agents|mesh-ancestor
101571374|NCT01233284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101571375|NCT01233284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571376|NCT01233284|Anticonvulsants|anticonvulsants|mesh-ancestor
101571378|NCT00948688|Fluorouracil|fluorouracil|mesh-list
101571379|NCT00948688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101571380|NCT00948688|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101571381|NCT00948688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101571382|NCT00948688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571383|NCT00948688|Antimetabolites|antimetabolites|mesh-ancestor
101571384|NCT00948688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101571385|NCT00948688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101571386|NCT00948688|Immunologic Factors|immunologic factors|mesh-ancestor
101571387|NCT00948688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571388|NCT02188264|Cyclosporine|cyclosporine|mesh-list
101571389|NCT02188264|Cyclosporins|cyclosporins|mesh-list
101571390|NCT02188264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101571391|NCT02188264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571392|NCT02188264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101571393|NCT02188264|Immunologic Factors|immunologic factors|mesh-ancestor
101645837|NCT00770263|Sirolimus|sirolimus|mesh-list
101571394|NCT02188264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571395|NCT02188264|Antifungal Agents|antifungal agents|mesh-ancestor
101571396|NCT02188264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101571397|NCT02188264|Dermatologic Agents|dermatologic agents|mesh-ancestor
101571398|NCT02188264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101571399|NCT02188264|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101571400|NCT01233050|Ethanol|ethanol|mesh-list
101571401|NCT01233050|Chlorhexidine|chlorhexidine|mesh-list
101571402|NCT01233050|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101571403|NCT01233050|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101571404|NCT01233050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101571405|NCT01233050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101571406|NCT01233050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571407|NCT01233050|Disinfectants|disinfectants|mesh-ancestor
101571408|NCT01233050|Dermatologic Agents|dermatologic agents|mesh-ancestor
101571410|NCT01049217|Analgesics|analgesics|mesh-ancestor
101571411|NCT01049217|Sensory System Agents|sensory system agents|mesh-ancestor
101571412|NCT01049217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101571413|NCT01049217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571414|NCT01049217|Anticonvulsants|anticonvulsants|mesh-ancestor
101571415|NCT01049217|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101571416|NCT01049217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101571417|NCT01049217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571418|NCT01049217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101571419|NCT01049217|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101571420|NCT01049217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101571421|NCT01049217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101571422|NCT01049217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101571423|NCT01232738|Rasagiline|rasagiline|mesh-list
101571424|NCT01232738|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101571425|NCT01232738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101571426|NCT01232738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571427|NCT01232738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101571428|NCT01232738|Protective Agents|protective agents|mesh-ancestor
101571429|NCT01232738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571430|NCT00957268|Alogliptin|alogliptin|mesh-list
101571431|NCT00957268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101571432|NCT00957268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571433|NCT00957268|Incretins|incretins|mesh-ancestor
101571434|NCT00957268|Hormones|hormones|mesh-ancestor
101571435|NCT00957268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101571436|NCT00957268|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101571437|NCT00957268|Protease Inhibitors|protease inhibitors|mesh-ancestor
101571438|NCT00957268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101571439|NCT00957268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571440|NCT02888444|Varenicline|varenicline|mesh-list
101571441|NCT02888444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101571442|NCT02888444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101571443|NCT02888444|Cholinergic Agents|cholinergic agents|mesh-ancestor
101571444|NCT02888444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101571445|NCT02888444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571446|NCT02888444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571447|NCT01230788|Rituximab|rituximab|mesh-list
101571448|NCT01230788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101571449|NCT01230788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101571450|NCT01230788|Immunologic Factors|immunologic factors|mesh-ancestor
101571451|NCT01230788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571452|NCT01230788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101571453|NCT01230710|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101571454|NCT01230710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101571455|NCT01230710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101571456|NCT01230710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101571457|NCT01230710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571458|NCT00627081|Remifentanil|remifentanil|mesh-list
101571459|NCT00627081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101571460|NCT00627081|Narcotics|narcotics|mesh-ancestor
101571461|NCT00627081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101571462|NCT00627081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571463|NCT00627081|Analgesics|analgesics|mesh-ancestor
101571464|NCT00627081|Sensory System Agents|sensory system agents|mesh-ancestor
101571465|NCT00627081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101571466|NCT02888054|Allopurinol|allopurinol|mesh-list
101571467|NCT02888054|Lesinurad|lesinurad|mesh-list
101571468|NCT02888054|Antimetabolites|antimetabolites|mesh-ancestor
101571469|NCT02888054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571470|NCT02888054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101571471|NCT02888054|Gout Suppressants|gout suppressants|mesh-ancestor
101571472|NCT02888054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101693705|NCT00960349|Cediranib|cediranib|mesh-list
101571473|NCT02888054|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101571474|NCT02888054|Antioxidants|antioxidants|mesh-ancestor
101571475|NCT02888054|Protective Agents|protective agents|mesh-ancestor
101571476|NCT02888054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571477|NCT02888054|Uricosuric Agents|uricosuric agents|mesh-ancestor
101571478|NCT01040793|Olodaterol|olodaterol|mesh-list
101571479|NCT01040793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101571480|NCT01040793|Autonomic Agents|autonomic agents|mesh-ancestor
101571481|NCT01040793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101571482|NCT01040793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571483|NCT01040793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101571484|NCT01040793|Respiratory System Agents|respiratory system agents|mesh-ancestor
101571485|NCT02811055|Aprepitant|aprepitant|mesh-list
101571486|NCT02811055|Antiemetics|antiemetics|mesh-ancestor
101571487|NCT02811055|Autonomic Agents|autonomic agents|mesh-ancestor
101571488|NCT02811055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101571489|NCT02811055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571490|NCT02811055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101571491|NCT02811055|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101571492|NCT02811055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101571493|NCT02811055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571494|NCT04192903|Cisplatin|cisplatin|mesh-list
101571495|NCT04192903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101571496|NCT02810899|Dexmedetomidine|dexmedetomidine|mesh-list
101571497|NCT02810899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101571498|NCT02810899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101571499|NCT02810899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571500|NCT02810899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101571501|NCT02810899|Analgesics|analgesics|mesh-ancestor
101571502|NCT02810899|Sensory System Agents|sensory system agents|mesh-ancestor
101571503|NCT02810899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101571504|NCT02810899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101571505|NCT02810899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101571506|NCT02810899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101571507|NCT02810899|Adrenergic Agents|adrenergic agents|mesh-ancestor
101571508|NCT02810899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101571509|NCT02810899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571510|NCT04237129|Insulin Aspart|insulin aspart|mesh-list
101571511|NCT04237129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101571512|NCT04237129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571513|NCT02810587|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101571514|NCT02810587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101571515|NCT02810275|Leucovorin|leucovorin|mesh-list
101571516|NCT02810275|Folic Acid|folic acid|mesh-list
101571517|NCT02810275|Levoleucovorin|levoleucovorin|mesh-list
101571518|NCT02810275|Antidotes|antidotes|mesh-ancestor
101571519|NCT02810275|Protective Agents|protective agents|mesh-ancestor
101571520|NCT02810275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571521|NCT02810275|Vitamin B Complex|vitamin b complex|mesh-ancestor
101571522|NCT02810275|Vitamins|vitamins|mesh-ancestor
101571523|NCT02810275|Micronutrients|micronutrients|mesh-ancestor
101571524|NCT02810275|Hematinics|hematinics|mesh-ancestor
101571525|NCT00948064|Azacitidine|azacitidine|mesh-list
101571526|NCT00948064|Vorinostat|vorinostat|mesh-list
101571527|NCT00948064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101571528|NCT00948064|Antimetabolites|antimetabolites|mesh-ancestor
101571529|NCT00948064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571530|NCT00948064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101571531|NCT00948064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101571532|NCT00948064|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101571533|NCT02813239|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101571534|NCT02813239|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101571535|NCT02813239|Luteolytic Agents|luteolytic agents|mesh-ancestor
101571536|NCT02813239|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101645967|NCT00606866|Sorafenib|sorafenib|mesh-list
101571537|NCT02813239|Contraceptive Agents|contraceptive agents|mesh-ancestor
101571538|NCT02813239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101571539|NCT02813239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571540|NCT02813239|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101571541|NCT02813239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101571542|NCT02813239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101571543|NCT02858206|Paclitaxel|paclitaxel|mesh-list
101571544|NCT02858206|Nimotuzumab|nimotuzumab|mesh-list
101571545|NCT02858206|Nedaplatin|nedaplatin|mesh-list
101571546|NCT02858206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101571547|NCT02858206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101571548|NCT02858206|Tubulin Modulators|tubulin modulators|mesh-ancestor
101571549|NCT02858206|Antimitotic Agents|antimitotic agents|mesh-ancestor
101571550|NCT02858206|Mitosis Modulators|mitosis modulators|mesh-ancestor
101571551|NCT02858206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571552|NCT02858206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101571553|NCT02815189|Acetaminophen|acetaminophen|mesh-list
101571554|NCT02815189|Ibuprofen|ibuprofen|mesh-list
101571555|NCT02815189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101571556|NCT02815189|Analgesics|analgesics|mesh-ancestor
101571557|NCT02815189|Sensory System Agents|sensory system agents|mesh-ancestor
101571558|NCT02815189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101571559|NCT02815189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571560|NCT02815189|Antipyretics|antipyretics|mesh-ancestor
101571561|NCT02815189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101571562|NCT02815189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101571563|NCT02815189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101571564|NCT02815189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101571565|NCT02815189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101571566|NCT02815189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571567|NCT02809963|Eplerenone|eplerenone|mesh-list
101571568|NCT02809963|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101571569|NCT02809963|Hormone Antagonists|hormone antagonists|mesh-ancestor
101571570|NCT02809963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101571571|NCT02809963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571572|NCT02809963|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101571573|NCT02809963|Diuretics|diuretics|mesh-ancestor
101571574|NCT02809963|Natriuretic Agents|natriuretic agents|mesh-ancestor
101571575|NCT02809963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101571576|NCT02815111|Acetaminophen|acetaminophen|mesh-list
101571577|NCT02815111|Lidocaine|lidocaine|mesh-list
101571578|NCT02815111|Ketamine|ketamine|mesh-list
101571579|NCT02815111|Gabapentin|gabapentin|mesh-list
101571580|NCT02815111|Anesthetics, Local|anesthetics, local|mesh-ancestor
101571581|NCT02815111|Anesthetics|anesthetics|mesh-ancestor
101571582|NCT02815111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101444565|NCT02827435|Bromides|bromides|mesh-list
101444566|NCT02827435|Rocuronium|rocuronium|mesh-list
101444567|NCT02827435|Anticonvulsants|anticonvulsants|mesh-ancestor
101444568|NCT02827435|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101444581|NCT00176618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101444582|NCT00176618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101444583|NCT00176618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101571583|NCT02815111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571584|NCT02815111|Sensory System Agents|sensory system agents|mesh-ancestor
101571585|NCT02815111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101571586|NCT02815111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101571587|NCT02815111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101571588|NCT02815111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101571589|NCT02815111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101571590|NCT02815111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571591|NCT02815111|Analgesics|analgesics|mesh-ancestor
101571592|NCT02815111|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101571593|NCT02815111|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101571594|NCT02815111|Anesthetics, General|anesthetics, general|mesh-ancestor
101571595|NCT02815111|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101571596|NCT02815111|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101571597|NCT02815111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101571598|NCT02815111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101571599|NCT02815111|Antipyretics|antipyretics|mesh-ancestor
101571600|NCT02815111|Anticonvulsants|anticonvulsants|mesh-ancestor
101571601|NCT02815111|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101571602|NCT02815111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101571603|NCT02815111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101571604|NCT02815111|Antimanic Agents|antimanic agents|mesh-ancestor
101571605|NCT04236895|Insulin Glargine|insulin glargine|mesh-list
101571606|NCT04236895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101571607|NCT04236895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571608|NCT02809729|Cefazolin|cefazolin|mesh-list
101571609|NCT02809729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101571610|NCT02809729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101571611|NCT04303377|Evolocumab|evolocumab|mesh-list
101571612|NCT04303377|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101571613|NCT04303377|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101571614|NCT04303377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101571615|NCT04303377|Antimetabolites|antimetabolites|mesh-ancestor
101571616|NCT04303377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571617|NCT04303377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101571618|NCT04303377|Protease Inhibitors|protease inhibitors|mesh-ancestor
101571619|NCT04303377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101571620|NCT04303377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101571621|NCT00953524|Vaccines|vaccines|mesh-list
101571622|NCT00953524|Immunologic Factors|immunologic factors|mesh-ancestor
101571623|NCT00953524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571625|NCT02809573|Cyclophosphamide|cyclophosphamide|mesh-list
101571626|NCT02809573|Vincristine|vincristine|mesh-list
101571627|NCT02809573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101571628|NCT02809573|Immunologic Factors|immunologic factors|mesh-ancestor
101571629|NCT02809573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571630|NCT02809573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101571631|NCT02809573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101571632|NCT02809573|Alkylating Agents|alkylating agents|mesh-ancestor
101571633|NCT02809573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571634|NCT02809573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101571635|NCT02809573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101571636|NCT02809573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101571637|NCT02809573|Glucocorticoids|glucocorticoids|mesh-ancestor
101571638|NCT02809573|Hormones|hormones|mesh-ancestor
101571639|NCT02809573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101571640|NCT02809573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101571641|NCT02809573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101571642|NCT02809573|Tubulin Modulators|tubulin modulators|mesh-ancestor
101571643|NCT02809573|Antimitotic Agents|antimitotic agents|mesh-ancestor
101571644|NCT02809573|Mitosis Modulators|mitosis modulators|mesh-ancestor
101571645|NCT04388683|Nitric Oxide|nitric oxide|mesh-list
101571646|NCT04388683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101571647|NCT04388683|Autonomic Agents|autonomic agents|mesh-ancestor
101571648|NCT04388683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101571649|NCT04388683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571650|NCT04388683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101444600|NCT00554164|Prednisone|prednisone|mesh-list
101571651|NCT04388683|Respiratory System Agents|respiratory system agents|mesh-ancestor
101571652|NCT04388683|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101571653|NCT04388683|Antioxidants|antioxidants|mesh-ancestor
101571654|NCT04388683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571655|NCT04388683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101571656|NCT04388683|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101571657|NCT04388683|Vasodilator Agents|vasodilator agents|mesh-ancestor
101571658|NCT04388683|Gasotransmitters|gasotransmitters|mesh-ancestor
101571659|NCT04388683|Protective Agents|protective agents|mesh-ancestor
101571660|NCT01040403|Bromides|bromides|mesh-list
101571661|NCT01040403|Tiotropium Bromide|tiotropium bromide|mesh-list
101571662|NCT01040403|Olodaterol|olodaterol|mesh-list
101571663|NCT01040403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101571664|NCT01040403|Autonomic Agents|autonomic agents|mesh-ancestor
101571665|NCT01040403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101571666|NCT01040403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571667|NCT01040403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101571668|NCT01040403|Respiratory System Agents|respiratory system agents|mesh-ancestor
101571669|NCT01040403|Parasympatholytics|parasympatholytics|mesh-ancestor
101571670|NCT01040403|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101571671|NCT01040403|Cholinergic Agents|cholinergic agents|mesh-ancestor
101571672|NCT01040403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101571673|NCT01040403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571674|NCT01040403|Anticonvulsants|anticonvulsants|mesh-ancestor
101571675|NCT00957034|Testosterone|testosterone|mesh-list
101571676|NCT00957034|Androgens|androgens|mesh-ancestor
101571678|NCT00957034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101571679|NCT00957034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571680|NCT02812693|Pembrolizumab|pembrolizumab|mesh-list
101571681|NCT02812693|Imatinib Mesylate|imatinib mesylate|mesh-list
101571682|NCT02812693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101571683|NCT02812693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101571684|NCT02812693|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101571685|NCT02812693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571686|NCT02812693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101571687|NCT02812693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101571688|NCT04270552|Broncho-Vaxom|broncho-vaxom|mesh-list
101571689|NCT04270552|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101571690|NCT04270552|Immunologic Factors|immunologic factors|mesh-ancestor
101571691|NCT04270552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571692|NCT04237597|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
101571693|NCT04237597|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101571694|NCT04237597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571695|NCT04237597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101898425|NCT01257464|Incretins|incretins|mesh-ancestor
101571696|NCT04237597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571697|NCT02689999|Rabeprazole|rabeprazole|mesh-list
101571698|NCT02689999|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101571699|NCT02689999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101571700|NCT02689999|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101571701|NCT02689999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101571702|NCT02689999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571703|NCT02809105|Linaclotide|linaclotide|mesh-list
101571704|NCT02809105|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
101571705|NCT02809105|Enzyme Activators|enzyme activators|mesh-ancestor
101571706|NCT02809105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571707|NCT02809105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101571708|NCT00953056|Vaccines|vaccines|mesh-list
101571709|NCT00953056|Immunologic Factors|immunologic factors|mesh-ancestor
101571710|NCT00953056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571711|NCT02811289|Mirabegron|mirabegron|mesh-list
101571712|NCT02811289|Glycerol|glycerol|mesh-list
101571713|NCT02811289|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101836650|NCT00308074|Dopamine Agonists|dopamine agonists|mesh-ancestor
101571714|NCT02811289|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101571715|NCT02811289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101571716|NCT02811289|Adrenergic Agents|adrenergic agents|mesh-ancestor
101571717|NCT02811289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101571718|NCT02811289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571719|NCT02811289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571720|NCT02811289|Urological Agents|urological agents|mesh-ancestor
101571721|NCT02811289|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101571722|NCT02811289|Protective Agents|protective agents|mesh-ancestor
101571723|NCT02808949|Dapivirine|dapivirine|mesh-list
101571724|NCT02808949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101571725|NCT02808949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101571726|NCT02808949|Antiviral Agents|antiviral agents|mesh-ancestor
101571727|NCT02808949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101571728|NCT04207177|Mycophenolic Acid|mycophenolic acid|mesh-list
101571729|NCT04207177|Tacrolimus|tacrolimus|mesh-list
101571730|NCT04207177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101571731|NCT04207177|Immunologic Factors|immunologic factors|mesh-ancestor
101571732|NCT04207177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571733|NCT04207177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101571734|NCT04207177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101571735|NCT04207177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571736|NCT04207177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101571737|NCT04207177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101571738|NCT04207177|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101571739|NCT04207177|Antitubercular Agents|antitubercular agents|mesh-ancestor
101571740|NCT04207177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101571741|NCT04207177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101571742|NCT02812147|Droxidopa|droxidopa|mesh-list
101571743|NCT02812147|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101571744|NCT02812147|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101571745|NCT04303065|Dexamethasone|dexamethasone|mesh-list
101571746|NCT04303065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101571747|NCT04303065|Antiemetics|antiemetics|mesh-ancestor
101571748|NCT04303065|Autonomic Agents|autonomic agents|mesh-ancestor
101228635|NCT01547520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101571749|NCT04303065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101571750|NCT04303065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571751|NCT04303065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101571753|NCT04303065|Hormones|hormones|mesh-ancestor
101571754|NCT04303065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101571755|NCT04303065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101571756|NCT04303065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101571757|NCT02814877|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101571758|NCT02814877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101571759|NCT00952822|Factor VIII|factor viii|mesh-list
101571760|NCT00952822|Coagulants|coagulants|mesh-ancestor
101571761|NCT02854072|Gemcitabine|gemcitabine|mesh-list
101571762|NCT02854072|Capecitabine|capecitabine|mesh-list
101571763|NCT02854072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101571764|NCT02854072|Antimetabolites|antimetabolites|mesh-ancestor
101571765|NCT02854072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571766|NCT02854072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101571767|NCT02537314|Benzocaine|benzocaine|mesh-list
101571768|NCT02537314|Anesthetics, Local|anesthetics, local|mesh-ancestor
101571769|NCT02537314|Anesthetics|anesthetics|mesh-ancestor
101898426|NCT01257464|Hormones|hormones|mesh-ancestor
101571770|NCT02537314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101571771|NCT02537314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571772|NCT02537314|Sensory System Agents|sensory system agents|mesh-ancestor
101571773|NCT02537314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101571774|NCT00631150|Levetiracetam|levetiracetam|mesh-list
101571775|NCT00631150|Anticonvulsants|anticonvulsants|mesh-ancestor
101571776|NCT00631150|Nootropic Agents|nootropic agents|mesh-ancestor
101571777|NCT04278040|Melphalan|melphalan|mesh-list
101571778|NCT04278040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101571779|NCT04278040|Alkylating Agents|alkylating agents|mesh-ancestor
101571780|NCT04278040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571781|NCT04278040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101571782|NCT04278040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101571783|NCT04278040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101571784|NCT04278040|Immunologic Factors|immunologic factors|mesh-ancestor
101571785|NCT04278040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571786|NCT02856724|Dinoprostone|dinoprostone|mesh-list
101571787|NCT02856724|Oxytocics|oxytocics|mesh-ancestor
101571788|NCT02856724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101571789|NCT02856724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571790|NCT02808325|Polygeline|polygeline|mesh-list
101571791|NCT02808325|Plasma Substitutes|plasma substitutes|mesh-ancestor
101571792|NCT02808325|Blood Substitutes|blood substitutes|mesh-ancestor
101571793|NCT00955474|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101571795|NCT00955474|Sertraline|sertraline|mesh-list
101571796|NCT00955474|Escitalopram|escitalopram|mesh-list
101571797|NCT00955474|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101571798|NCT00955474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101571799|NCT00955474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101571800|NCT00955474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571801|NCT00955474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101571802|NCT00955474|Serotonin Agents|serotonin agents|mesh-ancestor
101571803|NCT00955474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571804|NCT00955474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101571805|NCT00955474|Antidepressive Agents|antidepressive agents|mesh-ancestor
101571806|NCT00955474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101571807|NCT00955474|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101571808|NCT00955474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101571809|NCT00955474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101571810|NCT02808247|Ifosfamide|ifosfamide|mesh-list
101571811|NCT02808247|Nintedanib|nintedanib|mesh-list
101571812|NCT02808247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101571813|NCT02808247|Alkylating Agents|alkylating agents|mesh-ancestor
101571814|NCT02808247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571815|NCT02808247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101571816|NCT02808247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101571817|NCT02808247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101571818|NCT02808091|Bortezomib|bortezomib|mesh-list
101571819|NCT02808091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101571820|NCT02811991|Acetaminophen|acetaminophen|mesh-list
101571821|NCT02811991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101228722|NCT01548209|Analgesics|analgesics|mesh-ancestor
101571822|NCT02811991|Analgesics|analgesics|mesh-ancestor
101571823|NCT02811991|Sensory System Agents|sensory system agents|mesh-ancestor
101571824|NCT02811991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101571825|NCT02811991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571826|NCT02811991|Antipyretics|antipyretics|mesh-ancestor
101571827|NCT04237675|Anesthetics|anesthetics|mesh-list
101571828|NCT04237675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101571829|NCT04237675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571830|NCT05598853|Nivolumab|nivolumab|mesh-list
101571831|NCT05598853|Ipilimumab|ipilimumab|mesh-list
101571832|NCT05598853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101571833|NCT05598853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101571834|NCT05598853|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101571835|NCT05598853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571836|NCT01229150|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101571837|NCT01229150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101571838|NCT01229150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101571839|NCT01229150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101571840|NCT01229150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571841|NCT02804815|Aspirin|aspirin|mesh-list
101571842|NCT02804815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101571843|NCT02804815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101571844|NCT02804815|Analgesics|analgesics|mesh-ancestor
101571845|NCT02804815|Sensory System Agents|sensory system agents|mesh-ancestor
101571846|NCT02804815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101571847|NCT02804815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571848|NCT02804815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101571849|NCT02804815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101571850|NCT02804815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101571851|NCT02804815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101571852|NCT02804815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571853|NCT02804815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101571854|NCT02804815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101571855|NCT02804815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101571856|NCT02804815|Antipyretics|antipyretics|mesh-ancestor
101571857|NCT04017247|Oxytocin|oxytocin|mesh-list
101571858|NCT04017247|Oxytocics|oxytocics|mesh-ancestor
101571859|NCT04017247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101571860|NCT04017247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571861|NCT02814409|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101571862|NCT02814409|Plasminogen|plasminogen|mesh-list
101571863|NCT02814409|Tenecteplase|tenecteplase|mesh-list
101571864|NCT02814409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101571865|NCT02814409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101571866|NCT02814409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571867|NCT01227902|Ezogabine|ezogabine|mesh-list
101571868|NCT01227902|Anticonvulsants|anticonvulsants|mesh-ancestor
101571869|NCT01227902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101571870|NCT01227902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571871|NCT00946192|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101571872|NCT00946192|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101571873|NCT00946192|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101571874|NCT00946192|Desogestrel|desogestrel|mesh-list
101571875|NCT00946192|Estradiol|estradiol|mesh-list
101571876|NCT00946192|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101571877|NCT00946192|Progesterone|progesterone|mesh-list
101571878|NCT00946192|Estrogens|estrogens|mesh-ancestor
101571879|NCT00946192|Hormones|hormones|mesh-ancestor
101571880|NCT00946192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101571881|NCT00946192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571882|NCT00946192|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101571883|NCT00946192|Contraceptive Agents|contraceptive agents|mesh-ancestor
101571884|NCT00946192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101571885|NCT00946192|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101571886|NCT00946192|Progestins|progestins|mesh-ancestor
101571887|NCT00946192|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101571888|NCT00946192|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101571889|NCT00946192|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101571890|NCT01037127|Trametinib|trametinib|mesh-list
101571891|NCT01037127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101571892|NCT01037127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101571893|NCT01037127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101571894|NCT01037127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571895|NCT02806999|Insulin|insulin|mesh-list
101571896|NCT02806999|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101571897|NCT02806999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101228782|NCT01548560|Dapivirine|dapivirine|mesh-list
101571898|NCT02806999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571900|NCT00946114|Vasodilator Agents|vasodilator agents|mesh-ancestor
101571901|NCT00946114|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101571902|NCT00946114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101571903|NCT00946114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101571904|NCT00946114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571905|NCT00946114|Urological Agents|urological agents|mesh-ancestor
101571906|NCT00627471|Insulin|insulin|mesh-list
101571907|NCT00627471|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101571908|NCT00627471|Insulin Glargine|insulin glargine|mesh-list
101571909|NCT00627471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101571910|NCT00627471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571911|NCT04302441|Capecitabine|capecitabine|mesh-list
101571912|NCT04302441|Vinorelbine|vinorelbine|mesh-list
101571913|NCT04302441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101571914|NCT04302441|Antimetabolites|antimetabolites|mesh-ancestor
101571915|NCT04302441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571916|NCT04302441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101571917|NCT04302441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101571918|NCT04302441|Tubulin Modulators|tubulin modulators|mesh-ancestor
101444630|NCT02572141|Levoleucovorin|levoleucovorin|mesh-list
101571919|NCT04302441|Antimitotic Agents|antimitotic agents|mesh-ancestor
101571920|NCT04302441|Mitosis Modulators|mitosis modulators|mesh-ancestor
101571921|NCT02800447|Procarbazine|procarbazine|mesh-list
101571922|NCT02800447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101571923|NCT05520619|Paclitaxel|paclitaxel|mesh-list
101571924|NCT05520619|Tislelizumab|tislelizumab|mesh-list
101571925|NCT05520619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101571926|NCT05520619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101571927|NCT05520619|Tubulin Modulators|tubulin modulators|mesh-ancestor
101571928|NCT05520619|Antimitotic Agents|antimitotic agents|mesh-ancestor
101571929|NCT05520619|Mitosis Modulators|mitosis modulators|mesh-ancestor
101571930|NCT05520619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571931|NCT05520619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101571932|NCT01038921|Melatonin|melatonin|mesh-list
101571933|NCT01038921|Antioxidants|antioxidants|mesh-ancestor
101571934|NCT01038921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571935|NCT01038921|Protective Agents|protective agents|mesh-ancestor
101571936|NCT01038921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571937|NCT01038921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101571939|NCT02856568|Gemcitabine|gemcitabine|mesh-list
101571940|NCT02856568|Ricolinostat|ricolinostat|mesh-list
101571941|NCT02856568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101571942|NCT02856568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101571943|NCT02856568|Antimetabolites|antimetabolites|mesh-ancestor
101571944|NCT02856568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571945|NCT02856568|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101571946|NCT02856568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101571948|NCT04081831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101571949|NCT04081831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101571950|NCT04081831|Analgesics|analgesics|mesh-ancestor
101571951|NCT04081831|Sensory System Agents|sensory system agents|mesh-ancestor
101571952|NCT04081831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101571953|NCT04081831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571954|NCT04081831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101571955|NCT04081831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101571956|NCT04081831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101571957|NCT04081831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101571958|NCT04081831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571959|NCT04081831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101571960|NCT04081831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101571961|NCT04081831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101571962|NCT04081831|Antipyretics|antipyretics|mesh-ancestor
101571963|NCT01081912|Hydrocodone|hydrocodone|mesh-list
101571964|NCT01081912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101571965|NCT01081912|Narcotics|narcotics|mesh-ancestor
101571966|NCT01081912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101571967|NCT01081912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571968|NCT01081912|Analgesics|analgesics|mesh-ancestor
101571969|NCT01081912|Sensory System Agents|sensory system agents|mesh-ancestor
101571970|NCT01081912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101571971|NCT01081912|Antitussive Agents|antitussive agents|mesh-ancestor
101228859|NCT01548950|Bosentan|bosentan|mesh-list
101571972|NCT01081912|Respiratory System Agents|respiratory system agents|mesh-ancestor
101571973|NCT01038609|Acetaminophen|acetaminophen|mesh-list
101571974|NCT01038609|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
101571975|NCT01038609|Morphine|morphine|mesh-list
101571976|NCT01038609|Hydrocodone|hydrocodone|mesh-list
101571977|NCT01038609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101571978|NCT01038609|Narcotics|narcotics|mesh-ancestor
101571979|NCT01038609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101571980|NCT01038609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101571981|NCT01038609|Analgesics|analgesics|mesh-ancestor
101571982|NCT01038609|Sensory System Agents|sensory system agents|mesh-ancestor
101571983|NCT01038609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101571984|NCT01038609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101571985|NCT01038609|Antipyretics|antipyretics|mesh-ancestor
101571986|NCT01038609|Antitussive Agents|antitussive agents|mesh-ancestor
101571987|NCT01038609|Respiratory System Agents|respiratory system agents|mesh-ancestor
101571988|NCT01038609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101571989|NCT01038609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101571990|NCT01038609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101571991|NCT02857582|Metronidazole|metronidazole|mesh-list
101571992|NCT02857582|Vancomycin|vancomycin|mesh-list
101571993|NCT02857582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101571994|NCT02857582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101571995|NCT02857582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101571996|NCT02857582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101571998|NCT04301895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101571999|NCT04301895|Narcotics|narcotics|mesh-ancestor
101572000|NCT04301895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101572001|NCT04301895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572002|NCT04301895|Analgesics|analgesics|mesh-ancestor
101572003|NCT04301895|Sensory System Agents|sensory system agents|mesh-ancestor
101572004|NCT04301895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101572005|NCT02853526|Propranolol|propranolol|mesh-list
101572006|NCT02853526|Warfarin|warfarin|mesh-list
101572007|NCT02853526|Anticoagulants|anticoagulants|mesh-ancestor
101572008|NCT02853526|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101572009|NCT02853526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101572010|NCT02853526|Adrenergic Agents|adrenergic agents|mesh-ancestor
101572011|NCT02853526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101572012|NCT02853526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572013|NCT02853526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572014|NCT02853526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101572015|NCT02853526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101572016|NCT02853526|Vasodilator Agents|vasodilator agents|mesh-ancestor
101572017|NCT00630682|Dextroamphetamine|dextroamphetamine|mesh-list
101572018|NCT00630682|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101572019|NCT00630682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572020|NCT00630682|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101572021|NCT00630682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101572022|NCT00630682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101572023|NCT00630682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572024|NCT00630682|Dopamine Agents|dopamine agents|mesh-ancestor
101572025|NCT00630682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101572026|NCT04269460|Bupivacaine|bupivacaine|mesh-list
101572027|NCT04269460|Anesthetics, Local|anesthetics, local|mesh-ancestor
101572028|NCT04269460|Anesthetics|anesthetics|mesh-ancestor
101572029|NCT04269460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101572030|NCT04269460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572031|NCT04269460|Sensory System Agents|sensory system agents|mesh-ancestor
101572032|NCT04269460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101572033|NCT04236115|Felypressin|felypressin|mesh-list
101572034|NCT04236115|Carticaine|carticaine|mesh-list
101572035|NCT04236115|Anesthetics, Local|anesthetics, local|mesh-ancestor
101572036|NCT04236115|Anesthetics|anesthetics|mesh-ancestor
101572037|NCT04236115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101572038|NCT04236115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572039|NCT04236115|Sensory System Agents|sensory system agents|mesh-ancestor
101572040|NCT04236115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101572041|NCT04236115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101572042|NCT02853370|Rituximab|rituximab|mesh-list
101572043|NCT02853370|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101572044|NCT02853370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101572045|NCT02853370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101228929|NCT01549431|Glucocorticoids|glucocorticoids|mesh-ancestor
101572046|NCT02853370|Immunologic Factors|immunologic factors|mesh-ancestor
101572047|NCT02853370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572048|NCT02853370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101572049|NCT02853370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101572050|NCT02853370|Alkylating Agents|alkylating agents|mesh-ancestor
101572051|NCT02853370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572052|NCT02690155|Vitamin K|vitamin k|mesh-list
101572053|NCT02690155|Rivaroxaban|rivaroxaban|mesh-list
101572054|NCT02690155|Vitamins|vitamins|mesh-ancestor
101572055|NCT02690155|Micronutrients|micronutrients|mesh-ancestor
101572056|NCT02690155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572057|NCT02690155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101572058|NCT02690155|Antithrombins|antithrombins|mesh-ancestor
101572059|NCT02690155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101572060|NCT02690155|Protease Inhibitors|protease inhibitors|mesh-ancestor
101572061|NCT02690155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101572062|NCT02690155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572063|NCT02690155|Anticoagulants|anticoagulants|mesh-ancestor
101572064|NCT02690155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101572065|NCT02690155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101572066|NCT02690155|Hemostatics|hemostatics|mesh-ancestor
101572067|NCT02690155|Coagulants|coagulants|mesh-ancestor
101572068|NCT02806375|Cyclophosphamide|cyclophosphamide|mesh-list
101572069|NCT02806375|Busulfan|busulfan|mesh-list
101572071|NCT02806375|Fludarabine phosphate|fludarabine phosphate|mesh-list
101572072|NCT02806375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101572073|NCT02806375|Immunologic Factors|immunologic factors|mesh-ancestor
101572074|NCT02806375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572075|NCT02806375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101572076|NCT02806375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101572077|NCT02806375|Alkylating Agents|alkylating agents|mesh-ancestor
101572078|NCT02806375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572079|NCT02806375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101572080|NCT02806375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101572081|NCT02806375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101572082|NCT02806375|Antimetabolites|antimetabolites|mesh-ancestor
101572083|NCT04273984|Misoprostol|misoprostol|mesh-list
101572084|NCT04273984|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101572086|NCT04273984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101572087|NCT04273984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572088|NCT04273984|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101572089|NCT04273984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101572090|NCT04273984|Oxytocics|oxytocics|mesh-ancestor
101572091|NCT00943852|Losartan|losartan|mesh-list
101572092|NCT00943852|Isosorbide|isosorbide|mesh-list
101572093|NCT00943852|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
101572094|NCT00943852|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
101572095|NCT00943852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101572096|NCT00943852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101572097|NCT00943852|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101572098|NCT00943852|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101572099|NCT00943852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572100|NCT00943852|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101572101|NCT00943852|Diuretics|diuretics|mesh-ancestor
101572102|NCT00943852|Natriuretic Agents|natriuretic agents|mesh-ancestor
101572103|NCT00943852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572104|NCT00943852|Vasodilator Agents|vasodilator agents|mesh-ancestor
101572105|NCT00943852|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101572106|NCT02853136|Fluvoxamine|fluvoxamine|mesh-list
101572107|NCT02853136|BI 409306|bi 409306|mesh-list
101572108|NCT02853136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101572109|NCT02853136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101572110|NCT02853136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101572111|NCT02853136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572112|NCT02853136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101572113|NCT02853136|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101572114|NCT02853136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101572115|NCT02853136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101572116|NCT02853136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572117|NCT02853136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101572118|NCT02853136|Serotonin Agents|serotonin agents|mesh-ancestor
101572119|NCT02853136|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101572120|NCT02853136|Antidepressive Agents|antidepressive agents|mesh-ancestor
101572121|NCT02853136|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101572122|NCT02853136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101572123|NCT02853136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101572124|NCT02853136|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101572125|NCT02853136|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101572126|NCT02806141|Colistin|colistin|mesh-list
101572127|NCT02806141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101572128|NCT02806141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101572129|NCT00952276|Vaccines|vaccines|mesh-list
101572130|NCT00952276|Immunologic Factors|immunologic factors|mesh-ancestor
101572131|NCT00952276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572132|NCT02805829|Trastuzumab|trastuzumab|mesh-list
101572133|NCT02805829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101572134|NCT02805829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101572135|NCT02856178|Caspofungin|caspofungin|mesh-list
101572136|NCT02856178|Olorofim|olorofim|mesh-list
101572137|NCT02856178|Antifungal Agents|antifungal agents|mesh-ancestor
101572138|NCT02856178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101572139|NCT02856178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101572140|NCT02856178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572141|NCT02800135|Furosemide|furosemide|mesh-list
101572142|NCT02800135|Diuretics|diuretics|mesh-ancestor
101572143|NCT02800135|Natriuretic Agents|natriuretic agents|mesh-ancestor
101572144|NCT02800135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572145|NCT02800135|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101572147|NCT02800135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572148|NCT02799901|Nivolumab|nivolumab|mesh-list
101572149|NCT02799901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101572150|NCT02799901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101572151|NCT02799901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101572152|NCT02799901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572153|NCT02802163|Dexamethasone|dexamethasone|mesh-list
101572154|NCT02802163|Lenalidomide|lenalidomide|mesh-list
101572155|NCT02802163|Panobinostat|panobinostat|mesh-list
101572156|NCT02802163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101572157|NCT02802163|Antiemetics|antiemetics|mesh-ancestor
101572158|NCT02802163|Autonomic Agents|autonomic agents|mesh-ancestor
101572159|NCT02802163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101572160|NCT02802163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572161|NCT02802163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101572162|NCT02802163|Glucocorticoids|glucocorticoids|mesh-ancestor
101572163|NCT02802163|Hormones|hormones|mesh-ancestor
101572164|NCT02802163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101572165|NCT02802163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101572166|NCT02802163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101572167|NCT02802163|Immunologic Factors|immunologic factors|mesh-ancestor
101572168|NCT02802163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101572169|NCT02802163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101572170|NCT02802163|Growth Substances|growth substances|mesh-ancestor
101572171|NCT02802163|Growth Inhibitors|growth inhibitors|mesh-ancestor
101572172|NCT02802163|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101572173|NCT02802163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101572174|NCT02802163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572176|NCT02805049|Micafungin|micafungin|mesh-list
101572177|NCT02805049|Echinocandins|echinocandins|mesh-list
101572178|NCT02805049|Antifungal Agents|antifungal agents|mesh-ancestor
101572179|NCT02805049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101572180|NCT02805049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101572181|NCT02805049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572182|NCT02799589|Dexmedetomidine|dexmedetomidine|mesh-list
101572183|NCT02799589|Remifentanil|remifentanil|mesh-list
101572184|NCT02799589|Ropivacaine|ropivacaine|mesh-list
101572185|NCT02799589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101572186|NCT02799589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101572187|NCT02799589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572188|NCT02799589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101572189|NCT02799589|Analgesics|analgesics|mesh-ancestor
101572190|NCT02799589|Sensory System Agents|sensory system agents|mesh-ancestor
101572191|NCT02799589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101572192|NCT02799589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101572193|NCT02799589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101572194|NCT02799589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101572195|NCT02799589|Adrenergic Agents|adrenergic agents|mesh-ancestor
101229081|NCT01550354|Narcotics|narcotics|mesh-ancestor
101444665|NCT00554242|Vitamins|vitamins|mesh-ancestor
101572196|NCT02799589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101572197|NCT02799589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572198|NCT02799589|Anesthetics, Local|anesthetics, local|mesh-ancestor
101572199|NCT02799589|Anesthetics|anesthetics|mesh-ancestor
101572200|NCT02799589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101572201|NCT02799589|Narcotics|narcotics|mesh-ancestor
101572202|NCT02856100|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
101572203|NCT02856100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572204|NCT02801383|Interferons|interferons|mesh-list
101572205|NCT02801383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101572206|NCT02801383|Antiviral Agents|antiviral agents|mesh-ancestor
101572207|NCT02801383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101572208|NCT02799355|Interferons|interferons|mesh-list
101572209|NCT02799355|Ribavirin|ribavirin|mesh-list
101572210|NCT02799355|Sofosbuvir|sofosbuvir|mesh-list
101572211|NCT02799355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101572212|NCT02799355|Antiviral Agents|antiviral agents|mesh-ancestor
101572213|NCT02799355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101572214|NCT02799355|Antimetabolites|antimetabolites|mesh-ancestor
101572215|NCT02799355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572216|NCT02801305|Diltiazem|diltiazem|mesh-list
101572217|NCT02801305|Nitroglycerin|nitroglycerin|mesh-list
101572218|NCT02801305|Petrolatum|petrolatum|mesh-list
101572219|NCT02801305|Vasodilator Agents|vasodilator agents|mesh-ancestor
101572221|NCT02801305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101572222|NCT02801305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101572223|NCT02801305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572224|NCT02801305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101572225|NCT02801305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572226|NCT02801305|Emollients|emollients|mesh-ancestor
101572227|NCT02801305|Dermatologic Agents|dermatologic agents|mesh-ancestor
101572228|NCT00637975|Pregabalin|pregabalin|mesh-list
101572229|NCT00637975|Oxycodone|oxycodone|mesh-list
101572230|NCT00637975|Analgesics|analgesics|mesh-ancestor
101572231|NCT00637975|Sensory System Agents|sensory system agents|mesh-ancestor
101572232|NCT00637975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101572233|NCT00637975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572234|NCT00637975|Anticonvulsants|anticonvulsants|mesh-ancestor
101572235|NCT00637975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101572236|NCT00637975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101572237|NCT00637975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572238|NCT00637975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101572239|NCT00637975|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101572240|NCT00637975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101572241|NCT00637975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101572242|NCT00637975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101572243|NCT00637975|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101572244|NCT00637975|Narcotics|narcotics|mesh-ancestor
101572246|NCT02801227|Dinoprostone|dinoprostone|mesh-list
101572247|NCT02801227|Oxytocics|oxytocics|mesh-ancestor
101572248|NCT02801227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101572249|NCT02801227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572250|NCT02795299|Folic Acid|folic acid|mesh-list
101572251|NCT02795299|Methotrexate|methotrexate|mesh-list
101572252|NCT02795299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101572253|NCT02795299|Abortifacient Agents|abortifacient agents|mesh-ancestor
101572254|NCT02795299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101572255|NCT02795299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572256|NCT02795299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101572257|NCT02795299|Antimetabolites|antimetabolites|mesh-ancestor
101572258|NCT02795299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572259|NCT02795299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101572260|NCT02795299|Dermatologic Agents|dermatologic agents|mesh-ancestor
101572261|NCT02795299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101572262|NCT02795299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101572263|NCT02795299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101572264|NCT02795299|Immunologic Factors|immunologic factors|mesh-ancestor
101572265|NCT02795299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101572266|NCT02795299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101572267|NCT02795299|Hematinics|hematinics|mesh-ancestor
101572268|NCT02795299|Vitamin B Complex|vitamin b complex|mesh-ancestor
101572269|NCT02795299|Vitamins|vitamins|mesh-ancestor
101572270|NCT02795299|Micronutrients|micronutrients|mesh-ancestor
101572271|NCT02799277|Testosterone|testosterone|mesh-list
101572272|NCT02799277|Androgens|androgens|mesh-ancestor
101572273|NCT02799277|Hormones|hormones|mesh-ancestor
101572274|NCT02799277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101572275|NCT02799277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572276|NCT01198002|Methotrexate|methotrexate|mesh-list
101572277|NCT01198002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101572278|NCT01198002|Abortifacient Agents|abortifacient agents|mesh-ancestor
101572279|NCT01198002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101572280|NCT01198002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572281|NCT01198002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101572282|NCT01198002|Antimetabolites|antimetabolites|mesh-ancestor
101572283|NCT01198002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572284|NCT01198002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101572285|NCT01198002|Dermatologic Agents|dermatologic agents|mesh-ancestor
101572286|NCT01198002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101572287|NCT01198002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101572288|NCT01198002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101572289|NCT01198002|Immunologic Factors|immunologic factors|mesh-ancestor
101572290|NCT01198002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101572291|NCT01198002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101572292|NCT02795065|Enoxaparin|enoxaparin|mesh-list
101572293|NCT02795065|Bemiparin|bemiparin|mesh-list
101572294|NCT02795065|Anticoagulants|anticoagulants|mesh-ancestor
101572295|NCT02795065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101572296|NCT02795065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101572297|NCT02795065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572298|NCT04233697|Romidepsin|romidepsin|mesh-list
101572299|NCT04233697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101572300|NCT04233697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101572301|NCT04233697|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101572302|NCT04233697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101572303|NCT04233697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572304|NCT03826303|Ethanol|ethanol|mesh-list
101572305|NCT03826303|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101572306|NCT03826303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101572307|NCT03826303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101572308|NCT03826303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572309|NCT02798653|Progesterone|progesterone|mesh-list
101572311|NCT02798653|Hormones|hormones|mesh-ancestor
101572312|NCT02798653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101572313|NCT02798653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572314|NCT03863587|Ramucirumab|ramucirumab|mesh-list
101572315|NCT03863587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101572316|NCT04233463|Budesonide|budesonide|mesh-list
101572317|NCT04233463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101572318|NCT04233463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101572319|NCT04233463|Autonomic Agents|autonomic agents|mesh-ancestor
101572320|NCT04233463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101572321|NCT04233463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572322|NCT04233463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101572323|NCT04233463|Respiratory System Agents|respiratory system agents|mesh-ancestor
101572324|NCT04233463|Glucocorticoids|glucocorticoids|mesh-ancestor
101572326|NCT04233463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101572327|NCT02793739|Hyaluronic Acid|hyaluronic acid|mesh-list
101572328|NCT02793739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101572329|NCT02793739|Immunologic Factors|immunologic factors|mesh-ancestor
101572330|NCT02793739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572331|NCT02793739|Viscosupplements|viscosupplements|mesh-ancestor
101572332|NCT02793739|Protective Agents|protective agents|mesh-ancestor
101572333|NCT02793505|Metformin|metformin|mesh-list
101572334|NCT02793505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101572335|NCT02793505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572336|NCT02793193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101572337|NCT02793193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101572338|NCT02793193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101572339|NCT02793193|Antitubercular Agents|antitubercular agents|mesh-ancestor
101572340|NCT04234321|Mitogens|mitogens|mesh-list
101572341|NCT04234321|Mitosis Modulators|mitosis modulators|mesh-ancestor
101572342|NCT04234321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572343|NCT02797717|Prednisone|prednisone|mesh-list
101572344|NCT02797717|Cyclophosphamide|cyclophosphamide|mesh-list
101572345|NCT02797717|Dacarbazine|dacarbazine|mesh-list
101572346|NCT02797717|Doxorubicin|doxorubicin|mesh-list
101572347|NCT02797717|Etoposide|etoposide|mesh-list
101572348|NCT02797717|Vincristine|vincristine|mesh-list
101572349|NCT02797717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101572350|NCT02797717|Immunologic Factors|immunologic factors|mesh-ancestor
101572351|NCT02797717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572352|NCT02797717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101572353|NCT02797717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101572354|NCT02797717|Alkylating Agents|alkylating agents|mesh-ancestor
101572355|NCT02797717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572356|NCT02797717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101572357|NCT02797717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101572358|NCT02797717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101572359|NCT02797717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101572360|NCT02797717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101572361|NCT02797717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101572362|NCT02797717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101572364|NCT02797717|Hormones|hormones|mesh-ancestor
101572365|NCT02797717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101572366|NCT02797717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101572367|NCT02797717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101572368|NCT02797717|Tubulin Modulators|tubulin modulators|mesh-ancestor
101572369|NCT02797717|Antimitotic Agents|antimitotic agents|mesh-ancestor
101572370|NCT02797717|Mitosis Modulators|mitosis modulators|mesh-ancestor
101572371|NCT04235569|Enoxaparin|enoxaparin|mesh-list
101572372|NCT04235569|Warfarin|warfarin|mesh-list
101572374|NCT04235569|Anticoagulants|anticoagulants|mesh-ancestor
101572375|NCT04235569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101572376|NCT04235569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101572377|NCT04235569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572378|NCT01197378|Cysteamine|cysteamine|mesh-list
101572379|NCT01197378|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
101572380|NCT01197378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572381|NCT02792491|Prednisone|prednisone|mesh-list
101572382|NCT02792491|Cyclophosphamide|cyclophosphamide|mesh-list
101572383|NCT02792491|Rituximab|rituximab|mesh-list
101572384|NCT02792491|Doxorubicin|doxorubicin|mesh-list
101572385|NCT02792491|Vincristine|vincristine|mesh-list
101572386|NCT02792491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101572387|NCT02792491|Immunologic Factors|immunologic factors|mesh-ancestor
101572388|NCT02792491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572389|NCT02792491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101572390|NCT02792491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101572391|NCT02792491|Alkylating Agents|alkylating agents|mesh-ancestor
101572392|NCT02792491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572393|NCT02792491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101572394|NCT02792491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101572395|NCT02792491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101572396|NCT02792491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101572397|NCT02792491|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101572398|NCT02792491|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101572399|NCT02792491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101572400|NCT02792491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101572401|NCT02792491|Glucocorticoids|glucocorticoids|mesh-ancestor
101572402|NCT02792491|Hormones|hormones|mesh-ancestor
101572403|NCT02792491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101572404|NCT02792491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101572405|NCT02792491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101572406|NCT02792491|Tubulin Modulators|tubulin modulators|mesh-ancestor
101572407|NCT02792491|Antimitotic Agents|antimitotic agents|mesh-ancestor
101572408|NCT02792491|Mitosis Modulators|mitosis modulators|mesh-ancestor
101572409|NCT02792803|Latanoprost|latanoprost|mesh-list
101572410|NCT02792803|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101572411|NCT02792803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101572412|NCT02797249|Aspirin|aspirin|mesh-list
101572413|NCT02797249|Salicylic Acid|salicylic acid|mesh-list
101572414|NCT02797249|Salicylates|salicylates|mesh-list
101572415|NCT02797249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101572416|NCT02797249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101572417|NCT02797249|Analgesics|analgesics|mesh-ancestor
101572418|NCT02797249|Sensory System Agents|sensory system agents|mesh-ancestor
101572419|NCT02797249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101572420|NCT02797249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572421|NCT02797249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101572422|NCT02797249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101572423|NCT02797249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101572424|NCT02797249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101572425|NCT02797249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572426|NCT02797249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101572427|NCT02797249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101572428|NCT02797249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101572430|NCT02797249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101572431|NCT02797249|Antifungal Agents|antifungal agents|mesh-ancestor
101572432|NCT02797249|Keratolytic Agents|keratolytic agents|mesh-ancestor
101572433|NCT02797249|Dermatologic Agents|dermatologic agents|mesh-ancestor
101572434|NCT02792335|Warfarin|warfarin|mesh-list
101572435|NCT02792335|Rivaroxaban|rivaroxaban|mesh-list
101572436|NCT02792335|Dabigatran|dabigatran|mesh-list
101572437|NCT02792335|Apixaban|apixaban|mesh-list
101572438|NCT02792335|Anticoagulants|anticoagulants|mesh-ancestor
101572439|NCT02792335|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101572440|NCT02792335|Antithrombins|antithrombins|mesh-ancestor
101572441|NCT02792335|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101572442|NCT02792335|Protease Inhibitors|protease inhibitors|mesh-ancestor
101572443|NCT02792335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101572444|NCT02792335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572445|NCT01197300|Zoledronic Acid|zoledronic acid|mesh-list
101572446|NCT01197300|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101572447|NCT01197300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572448|NCT04200235|Dexmedetomidine|dexmedetomidine|mesh-list
101572449|NCT04200235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101572450|NCT04200235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101572451|NCT04200235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572452|NCT04200235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101572454|NCT04200235|Sensory System Agents|sensory system agents|mesh-ancestor
101572455|NCT04200235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101572456|NCT04200235|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101572457|NCT04200235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101572458|NCT04200235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101572459|NCT04200235|Adrenergic Agents|adrenergic agents|mesh-ancestor
101572460|NCT04200235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101572461|NCT04200235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572462|NCT02791243|Finasteride|finasteride|mesh-list
101572463|NCT02791243|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101572464|NCT02791243|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101572465|NCT02791243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101572466|NCT02791243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572467|NCT02791243|Hormone Antagonists|hormone antagonists|mesh-ancestor
101572468|NCT02791243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101572469|NCT02791243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572470|NCT02791243|Urological Agents|urological agents|mesh-ancestor
101572471|NCT02797015|Ozanimod|ozanimod|mesh-list
101572472|NCT02797015|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101444694|NCT00176774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101572473|NCT02797015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572475|NCT02797015|Immunologic Factors|immunologic factors|mesh-ancestor
101572476|NCT02797015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572477|NCT03803761|Fulvestrant|fulvestrant|mesh-list
101572478|NCT03803761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101572479|NCT03803761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101572480|NCT03803761|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101572481|NCT03803761|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101572482|NCT03803761|Hormone Antagonists|hormone antagonists|mesh-ancestor
101572483|NCT03803761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101572484|NCT03803761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572485|NCT02796547|Levobupivacaine|levobupivacaine|mesh-list
101572486|NCT02796547|Anesthetics, Local|anesthetics, local|mesh-ancestor
101572487|NCT02796547|Anesthetics|anesthetics|mesh-ancestor
101572488|NCT02796547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101572489|NCT02796547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572490|NCT02796547|Sensory System Agents|sensory system agents|mesh-ancestor
101572491|NCT02796547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101572492|NCT01196988|Vaccines|vaccines|mesh-list
101572493|NCT01196988|Immunologic Factors|immunologic factors|mesh-ancestor
101572494|NCT01196988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572495|NCT02796469|Pentoxifylline|pentoxifylline|mesh-list
101572496|NCT02796469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101229383|NCT01552629|Cyclosporine|cyclosporine|mesh-list
101572497|NCT02796469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101572498|NCT02796469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572499|NCT02796469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101572500|NCT02796469|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101572501|NCT02796469|Protective Agents|protective agents|mesh-ancestor
101572502|NCT02796469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572503|NCT02796469|Vasodilator Agents|vasodilator agents|mesh-ancestor
101572504|NCT02796469|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101572505|NCT02796469|Antioxidants|antioxidants|mesh-ancestor
101572506|NCT02796157|Everolimus|everolimus|mesh-list
101572507|NCT02796157|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101572508|NCT02796157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101572509|NCT02796157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101572510|NCT02796157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572511|NCT02796157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101572512|NCT02796157|Immunologic Factors|immunologic factors|mesh-ancestor
101572513|NCT02796157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572514|NCT02796157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101572515|NCT01196052|Trastuzumab|trastuzumab|mesh-list
101572516|NCT01196052|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101572517|NCT01196052|Maytansine|maytansine|mesh-list
101572518|NCT01196052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101572519|NCT01196052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101572520|NCT01196052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101694743|NCT02787317|Antithrombins|antithrombins|mesh-ancestor
101572521|NCT01196052|Tubulin Modulators|tubulin modulators|mesh-ancestor
101572522|NCT01196052|Antimitotic Agents|antimitotic agents|mesh-ancestor
101572523|NCT01196052|Mitosis Modulators|mitosis modulators|mesh-ancestor
101572524|NCT01196052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572526|NCT01196052|Immunoconjugates|immunoconjugates|mesh-ancestor
101572527|NCT01196052|Immunologic Factors|immunologic factors|mesh-ancestor
101572528|NCT01196052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572529|NCT02689921|Trastuzumab|trastuzumab|mesh-list
101572530|NCT02689921|Pertuzumab|pertuzumab|mesh-list
101572531|NCT02689921|Letrozole|letrozole|mesh-list
101572532|NCT02689921|Anastrozole|anastrozole|mesh-list
101572533|NCT02689921|Leuprolide|leuprolide|mesh-list
101572534|NCT02689921|Exemestane|exemestane|mesh-list
101572535|NCT02689921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101572536|NCT02689921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101572537|NCT02689921|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101572538|NCT02689921|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101572539|NCT02689921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101572540|NCT02689921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572541|NCT02689921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101572542|NCT02689921|Hormone Antagonists|hormone antagonists|mesh-ancestor
101572543|NCT02689921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101836651|NCT00308074|Dopamine Agents|dopamine agents|mesh-ancestor
101572544|NCT02689921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572545|NCT02689921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101572546|NCT02689921|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101572547|NCT02689921|Fertility Agents|fertility agents|mesh-ancestor
101572548|NCT02689921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101572549|NCT03116425|Pantothenic Acid|pantothenic acid|mesh-list
101572550|NCT03116425|Vitamin B Complex|vitamin b complex|mesh-ancestor
101572551|NCT03116425|Vitamins|vitamins|mesh-ancestor
101572552|NCT03116425|Micronutrients|micronutrients|mesh-ancestor
101572553|NCT03116425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572554|NCT01195662|Dapagliflozin|dapagliflozin|mesh-list
101572555|NCT01195662|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101572556|NCT01195662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572557|NCT01195662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101572558|NCT01195662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572559|NCT02786407|Botulinum Toxins|botulinum toxins|mesh-list
101572560|NCT02786407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101572561|NCT02786407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101572562|NCT02786407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101572563|NCT02786407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101572564|NCT02786407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572565|NCT02786407|Cholinergic Agents|cholinergic agents|mesh-ancestor
101572566|NCT02786407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101572567|NCT02786407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572568|NCT02786407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101572569|NCT02786407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101572570|NCT03028519|Vitamin D|vitamin d|mesh-list
101572571|NCT03028519|Cholecalciferol|cholecalciferol|mesh-list
101572573|NCT03028519|Micronutrients|micronutrients|mesh-ancestor
101572574|NCT03028519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572575|NCT03028519|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101572576|NCT03028519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101572577|NCT02786641|Cisplatin|cisplatin|mesh-list
101572578|NCT02786641|Docetaxel|docetaxel|mesh-list
101572579|NCT02786641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101572580|NCT02786641|Tubulin Modulators|tubulin modulators|mesh-ancestor
101572581|NCT02786641|Antimitotic Agents|antimitotic agents|mesh-ancestor
101572582|NCT02786641|Mitosis Modulators|mitosis modulators|mesh-ancestor
101572583|NCT02786641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572584|NCT02787967|Beclomethasone|beclomethasone|mesh-list
101572585|NCT02787967|Formoterol Fumarate|formoterol fumarate|mesh-list
101572586|NCT02787967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101572587|NCT02787967|Autonomic Agents|autonomic agents|mesh-ancestor
101572588|NCT02787967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101572589|NCT02787967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572590|NCT02787967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101572591|NCT02787967|Respiratory System Agents|respiratory system agents|mesh-ancestor
101572592|NCT02787967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101572593|NCT02787967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101572594|NCT02787967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101572595|NCT02787967|Adrenergic Agents|adrenergic agents|mesh-ancestor
101572596|NCT02787967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101572597|NCT02787967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572598|NCT02787967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101572599|NCT02787967|Glucocorticoids|glucocorticoids|mesh-ancestor
101572600|NCT02787967|Hormones|hormones|mesh-ancestor
101572601|NCT02787967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101572602|NCT02788123|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
101572603|NCT02788123|Pantoprazole|pantoprazole|mesh-list
101572604|NCT02788123|Bismuth|bismuth|mesh-list
101572605|NCT02788123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101572606|NCT02788123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101572607|NCT02788123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101572608|NCT02788123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101572609|NCT02788123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572610|NCT02788123|Antacids|antacids|mesh-ancestor
101572611|NCT02788123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101572612|NCT01194804|Eculizumab|eculizumab|mesh-list
101572613|NCT01194804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101572614|NCT01194804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101572615|NCT01194804|Immunologic Factors|immunologic factors|mesh-ancestor
101572616|NCT01194804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572617|NCT02785549|Acetaminophen|acetaminophen|mesh-list
101572618|NCT02785549|Amoxicillin|amoxicillin|mesh-list
101572619|NCT02785549|Clavulanic Acids|clavulanic acids|mesh-list
101572620|NCT02785549|Clavulanic Acid|clavulanic acid|mesh-list
101572621|NCT02785549|Ibuprofen|ibuprofen|mesh-list
101572622|NCT02785549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101572623|NCT02785549|Analgesics|analgesics|mesh-ancestor
101572624|NCT02785549|Sensory System Agents|sensory system agents|mesh-ancestor
101572625|NCT02785549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101572626|NCT02785549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572627|NCT02785549|Antipyretics|antipyretics|mesh-ancestor
101572628|NCT02785549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101572629|NCT02785549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101572630|NCT02785549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101572631|NCT02785549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101572632|NCT02785549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101572633|NCT02785549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572634|NCT02785549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101572635|NCT02785549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101572636|NCT02785549|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101572637|NCT02785705|Vaccines|vaccines|mesh-list
101572638|NCT02785705|Immunologic Factors|immunologic factors|mesh-ancestor
101572639|NCT02785705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572640|NCT02821507|Sirolimus|sirolimus|mesh-list
101572641|NCT02821507|Cyclophosphamide|cyclophosphamide|mesh-list
101572642|NCT02821507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101572643|NCT02821507|Immunologic Factors|immunologic factors|mesh-ancestor
101572644|NCT02821507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572645|NCT02821507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101572646|NCT02821507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101572647|NCT02821507|Alkylating Agents|alkylating agents|mesh-ancestor
101572648|NCT02821507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572649|NCT02821507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101572650|NCT02821507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101572651|NCT02821507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101572652|NCT02821507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101572653|NCT02821507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101572654|NCT02821507|Antifungal Agents|antifungal agents|mesh-ancestor
101572655|NCT02785393|Doxazosin|doxazosin|mesh-list
101572656|NCT02785393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101572657|NCT02785393|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101572658|NCT02785393|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101572659|NCT02785393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101572660|NCT02785393|Adrenergic Agents|adrenergic agents|mesh-ancestor
101572661|NCT02785393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101572662|NCT02785393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572663|NCT02785393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572664|NCT02787031|Anesthetics|anesthetics|mesh-list
101572665|NCT02787031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101572666|NCT02787031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572667|NCT02784223|Choline|choline|mesh-list
101572668|NCT02784223|Lipotropic Agents|lipotropic agents|mesh-ancestor
101572669|NCT02784223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101572670|NCT02784223|Antimetabolites|antimetabolites|mesh-ancestor
101572671|NCT02784223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572672|NCT02784223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101572673|NCT02784223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101572674|NCT02784223|Nootropic Agents|nootropic agents|mesh-ancestor
101572675|NCT05262751|Nintedanib|nintedanib|mesh-list
101572676|NCT05262751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101572677|NCT05262751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101572678|NCT05262751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101572679|NCT05262751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572680|NCT04231123|Anesthetics|anesthetics|mesh-list
101572681|NCT04231123|Anesthetics, Local|anesthetics, local|mesh-list
101572682|NCT04231123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101572683|NCT04231123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572684|NCT04231123|Sensory System Agents|sensory system agents|mesh-ancestor
101572685|NCT04231123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101572686|NCT04231279|Secretin|secretin|mesh-list
101572687|NCT04231279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101572688|NCT04231279|Hormones|hormones|mesh-ancestor
101572689|NCT04231279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101572690|NCT04231279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572691|NCT02782273|Ketorolac|ketorolac|mesh-list
101572692|NCT02782273|Morphine|morphine|mesh-list
101572693|NCT02782273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101572694|NCT02782273|Narcotics|narcotics|mesh-ancestor
101572695|NCT02782273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101572696|NCT02782273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572698|NCT02782273|Sensory System Agents|sensory system agents|mesh-ancestor
101572699|NCT02782273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101572700|NCT02782273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101572701|NCT02782273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101572702|NCT02782273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101572703|NCT02782273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101572704|NCT02782273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101572705|NCT02782273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101572706|NCT02782273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572707|NCT05342389|Apatinib|apatinib|mesh-list
101572708|NCT05342389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101572709|NCT05342389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101572710|NCT05342389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101572711|NCT05342389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572712|NCT02268175|Prednisone|prednisone|mesh-list
101572713|NCT02268175|Leuprolide|leuprolide|mesh-list
101572714|NCT02268175|Abiraterone Acetate|abiraterone acetate|mesh-list
101572715|NCT02268175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101572716|NCT02268175|Glucocorticoids|glucocorticoids|mesh-ancestor
101572717|NCT02268175|Hormones|hormones|mesh-ancestor
101572718|NCT02268175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101572719|NCT02268175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572720|NCT02268175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101572721|NCT02268175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101572722|NCT02268175|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101572723|NCT02268175|Fertility Agents|fertility agents|mesh-ancestor
101572724|NCT02268175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101572725|NCT02268175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101572726|NCT02268175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101572727|NCT02268175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572728|NCT02268175|Hormone Antagonists|hormone antagonists|mesh-ancestor
101572729|NCT02268175|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101572730|NCT02783989|4-hydroxyphenylethanol|4-hydroxyphenylethanol|mesh-list
101572731|NCT02783989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101572732|NCT02783989|Antioxidants|antioxidants|mesh-ancestor
101444732|NCT00410982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101572733|NCT02783989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572734|NCT02783989|Protective Agents|protective agents|mesh-ancestor
101572735|NCT02783989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572736|NCT02782429|Ketamine|ketamine|mesh-list
101572737|NCT02782429|Analgesics|analgesics|mesh-ancestor
101572738|NCT02782429|Sensory System Agents|sensory system agents|mesh-ancestor
101572739|NCT02782429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101572740|NCT02782429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572741|NCT02782429|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101572742|NCT02782429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101572743|NCT02782429|Anesthetics, General|anesthetics, general|mesh-ancestor
101572744|NCT02782429|Anesthetics|anesthetics|mesh-ancestor
101572745|NCT02782429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101572746|NCT02782429|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101572747|NCT02782429|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101572748|NCT02782429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101572749|NCT02782429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572750|NCT04229719|Melatonin|melatonin|mesh-list
101572751|NCT04229719|Antioxidants|antioxidants|mesh-ancestor
101572752|NCT04229719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572753|NCT04229719|Protective Agents|protective agents|mesh-ancestor
101572754|NCT04229719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572755|NCT04229719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101572756|NCT01855867|Tenofovir|tenofovir|mesh-list
101572757|NCT01855867|Emtricitabine|emtricitabine|mesh-list
101572758|NCT01855867|Antiviral Agents|antiviral agents|mesh-ancestor
101572759|NCT01855867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101572760|NCT01855867|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101572761|NCT01855867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101572762|NCT01855867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101572763|NCT01855867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572764|NCT01855867|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101572765|NCT01855867|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101572766|NCT02689843|Metformin|metformin|mesh-list
101572767|NCT02689843|Pioglitazone|pioglitazone|mesh-list
101572769|NCT02689843|Spironolactone|spironolactone|mesh-list
101572770|NCT02689843|Cyproterone|cyproterone|mesh-list
101572771|NCT02689843|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101572772|NCT02689843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572773|NCT02689843|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101572774|NCT02689843|Hormone Antagonists|hormone antagonists|mesh-ancestor
101572775|NCT02689843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101572776|NCT02689843|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101572777|NCT02689843|Diuretics|diuretics|mesh-ancestor
101572778|NCT02689843|Natriuretic Agents|natriuretic agents|mesh-ancestor
101572779|NCT02689843|Androgen Antagonists|androgen antagonists|mesh-ancestor
101572780|NCT02689843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101572781|NCT02689843|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101572782|NCT02689843|Contraceptive Agents|contraceptive agents|mesh-ancestor
101572783|NCT02689843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101572784|NCT05166577|Valganciclovir|valganciclovir|mesh-list
101572785|NCT05166577|Pembrolizumab|pembrolizumab|mesh-list
101572786|NCT05166577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101572787|NCT05166577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101572788|NCT05166577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101572789|NCT05166577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572790|NCT05166577|Antiviral Agents|antiviral agents|mesh-ancestor
101572791|NCT05166577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101572792|NCT05341999|Ibuprofen|ibuprofen|mesh-list
101572793|NCT05341999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101572794|NCT05341999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101572795|NCT05341999|Analgesics|analgesics|mesh-ancestor
101572796|NCT05341999|Sensory System Agents|sensory system agents|mesh-ancestor
101572797|NCT05341999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101572798|NCT05341999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572799|NCT05341999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101572800|NCT05341999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101572801|NCT05341999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101572802|NCT05341999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101572803|NCT05341999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572804|NCT02781805|Alendronate|alendronate|mesh-list
101572805|NCT02781805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101572806|NCT02781805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572807|NCT02781493|Prucalopride|prucalopride|mesh-list
101572808|NCT02781493|Laxatives|laxatives|mesh-ancestor
101572809|NCT02781493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101572810|NCT02781493|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101572811|NCT02781493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101572812|NCT02781493|Serotonin Agents|serotonin agents|mesh-ancestor
101572813|NCT02781493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101572814|NCT02781493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572815|NCT02781493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572816|NCT02783053|Metformin|metformin|mesh-list
101572817|NCT02783053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101572818|NCT02783053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572819|NCT02782819|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101572821|NCT02781415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101572822|NCT02781415|Narcotics|narcotics|mesh-ancestor
101572823|NCT02781415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101572824|NCT02781415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572825|NCT02781415|Analgesics|analgesics|mesh-ancestor
101572826|NCT02781415|Sensory System Agents|sensory system agents|mesh-ancestor
101572827|NCT02781415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101572828|NCT02785003|Acetaminophen|acetaminophen|mesh-list
101572829|NCT02785003|Ketamine|ketamine|mesh-list
101572830|NCT02785003|Morphine|morphine|mesh-list
101572831|NCT02785003|Narcotics|narcotics|mesh-list
101572832|NCT02785003|Alvimopan|alvimopan|mesh-list
101572833|NCT02785003|Analgesics|analgesics|mesh-ancestor
101572834|NCT02785003|Sensory System Agents|sensory system agents|mesh-ancestor
101572835|NCT02785003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101572836|NCT02785003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572837|NCT02785003|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101572838|NCT02785003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101572839|NCT02785003|Anesthetics, General|anesthetics, general|mesh-ancestor
101572840|NCT02785003|Anesthetics|anesthetics|mesh-ancestor
101572841|NCT02785003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101572842|NCT02785003|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101572843|NCT02785003|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101572844|NCT02785003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101572845|NCT02785003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572846|NCT02785003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101572847|NCT02785003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101572848|NCT02785003|Antipyretics|antipyretics|mesh-ancestor
101572849|NCT02785003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101572850|NCT05297617|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101572851|NCT05297617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101572852|NCT05297617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101572853|NCT05297617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572854|NCT05297617|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101572855|NCT05297617|Hormone Antagonists|hormone antagonists|mesh-ancestor
101572856|NCT05297617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101572857|NCT05297617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572858|NCT02782897|Immunoglobulins|immunoglobulins|mesh-list
101572859|NCT02782897|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101572860|NCT02782897|Antibodies|antibodies|mesh-list
101572861|NCT02782897|Immunologic Factors|immunologic factors|mesh-ancestor
101572862|NCT02782897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572863|NCT00638131|Bosentan|bosentan|mesh-list
101572864|NCT00638131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101572865|NCT00638131|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101572866|NCT00638131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572867|NCT02780245|Tranexamic Acid|tranexamic acid|mesh-list
101229756|NCT01555710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101572868|NCT02780245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101572869|NCT02780245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101572870|NCT02780245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572871|NCT02780245|Hemostatics|hemostatics|mesh-ancestor
101572872|NCT02780245|Coagulants|coagulants|mesh-ancestor
101572873|NCT05340985|Vitamin D|vitamin d|mesh-list
101572874|NCT05340985|Ergocalciferols|ergocalciferols|mesh-list
101572875|NCT05340985|Cholecalciferol|cholecalciferol|mesh-list
101572876|NCT05340985|Calcifediol|calcifediol|mesh-list
101572877|NCT05340985|Vitamins|vitamins|mesh-list
101572878|NCT05340985|Dehydrocholesterols|dehydrocholesterols|mesh-list
101572879|NCT05340985|7-dehydrocholesterol|7-dehydrocholesterol|mesh-list
101572880|NCT05340985|Micronutrients|micronutrients|mesh-ancestor
101572881|NCT05340985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572882|NCT05340985|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101572883|NCT05340985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101572884|NCT05340985|Provitamins|provitamins|mesh-ancestor
101572885|NCT02784457|Cetrorelix|cetrorelix|mesh-list
101572886|NCT02784457|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101572887|NCT02784457|Fertility Agents|fertility agents|mesh-ancestor
101572888|NCT02784457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101572889|NCT02784457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572890|NCT02784457|Hormone Antagonists|hormone antagonists|mesh-ancestor
101572891|NCT02784457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101572892|NCT02780323|Celecoxib|celecoxib|mesh-list
101572893|NCT02780323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101572894|NCT02780323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101572895|NCT02780323|Analgesics|analgesics|mesh-ancestor
101572896|NCT02780323|Sensory System Agents|sensory system agents|mesh-ancestor
101572897|NCT02780323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101572898|NCT02780323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572899|NCT02780323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101572900|NCT02780323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101572901|NCT02780323|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101572902|NCT02780323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101572903|NCT02780323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101572904|NCT02780323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572905|NCT05331859|Insulin|insulin|mesh-list
101572906|NCT05331859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101572907|NCT05331859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572908|NCT04229407|Vitamins|vitamins|mesh-list
101572909|NCT04229407|Vitamin B Complex|vitamin b complex|mesh-list
101572910|NCT04229407|Micronutrients|micronutrients|mesh-ancestor
101572911|NCT04229407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572912|NCT04231435|Metformin|metformin|mesh-list
101572913|NCT04231435|Digoxin|digoxin|mesh-list
101572914|NCT04231435|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101572915|NCT04231435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101572916|NCT04231435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572917|NCT04231435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101572918|NCT04231435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101572919|NCT04231435|Antimetabolites|antimetabolites|mesh-ancestor
101572920|NCT04231435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572921|NCT04231435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101572922|NCT04231435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101572923|NCT04231435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101572924|NCT04231435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101572925|NCT04231435|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101572926|NCT04231435|Protective Agents|protective agents|mesh-ancestor
101572927|NCT05340439|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
101572928|NCT05340439|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101572929|NCT05340439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101572930|NCT05340439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572931|NCT05340439|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101572932|NCT05340439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101572933|NCT05340439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572934|NCT05340439|Cholinergic Agents|cholinergic agents|mesh-ancestor
101572935|NCT05340439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101572936|NCT01194414|Antirheumatic Agents|antirheumatic agents|mesh-list
101572937|NCT02173405|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101572938|NCT02173405|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101572939|NCT02173405|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101572940|NCT02173405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101572941|NCT02173405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572942|NCT02173405|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101572943|NCT02173405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101572944|NCT02173405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572946|NCT02173405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101572947|NCT05322031|Aripiprazole|aripiprazole|mesh-list
101572948|NCT05322031|Antidepressive Agents|antidepressive agents|mesh-ancestor
101572949|NCT05322031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101572950|NCT05322031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101572951|NCT05322031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101572952|NCT05322031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101572953|NCT05322031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572954|NCT05322031|Dopamine Agonists|dopamine agonists|mesh-ancestor
101572955|NCT05322031|Dopamine Agents|dopamine agents|mesh-ancestor
101572956|NCT05322031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101572957|NCT05322031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572958|NCT05322031|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101572959|NCT05322031|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101572960|NCT05322031|Serotonin Agents|serotonin agents|mesh-ancestor
101572961|NCT05322031|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101572962|NCT05322031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101572963|NCT05322031|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101572964|NCT05322031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101572965|NCT02780011|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101572966|NCT02780011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101572967|NCT02780011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101572969|NCT02780011|Immunoconjugates|immunoconjugates|mesh-ancestor
101572970|NCT02780011|Immunologic Factors|immunologic factors|mesh-ancestor
101572971|NCT02780011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572972|NCT02780479|Dexamethasone|dexamethasone|mesh-list
101572973|NCT02780479|Prednisone|prednisone|mesh-list
101572974|NCT02780479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101572975|NCT02780479|Antiemetics|antiemetics|mesh-ancestor
101572976|NCT02780479|Autonomic Agents|autonomic agents|mesh-ancestor
101572977|NCT02780479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101572978|NCT02780479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572979|NCT02780479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101572980|NCT02780479|Glucocorticoids|glucocorticoids|mesh-ancestor
101572981|NCT02780479|Hormones|hormones|mesh-ancestor
101572982|NCT02780479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101572983|NCT02780479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101572984|NCT02780479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101572985|NCT05252923|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
101572986|NCT05252923|Anticoagulants|anticoagulants|mesh-ancestor
101572987|NCT05252923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101572988|NCT05252923|Antimetabolites|antimetabolites|mesh-ancestor
101572989|NCT05252923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572990|NCT05252923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101572991|NCT05252923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101572992|NCT05252923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101572993|NCT05252923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101444769|NCT00554476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101572994|NCT05252923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572995|NCT05097079|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
101572996|NCT05097079|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101572997|NCT05097079|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101572998|NCT05097079|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101572999|NCT05097079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101573000|NCT05097079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573001|NCT05097079|Cholinergic Agents|cholinergic agents|mesh-ancestor
101573002|NCT05097079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101573003|NCT05097079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573004|NCT05097079|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101573005|NCT05097079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101573006|NCT02779387|Goserelin|goserelin|mesh-list
101573007|NCT02779387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101573008|NCT02779387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101573009|NCT04228315|Primaquine|primaquine|mesh-list
101573010|NCT04228315|Antimalarials|antimalarials|mesh-ancestor
101573011|NCT04228315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101573012|NCT04228315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101573013|NCT04228315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101573014|NCT04228393|Mercaptopurine|mercaptopurine|mesh-list
101573015|NCT04228393|Antimetabolites|antimetabolites|mesh-ancestor
101573016|NCT04228393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573017|NCT04228393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101573018|NCT04228393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101573020|NCT04228393|Immunologic Factors|immunologic factors|mesh-ancestor
101573021|NCT04228393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573022|NCT04228393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101573023|NCT04228393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101573024|NCT02779777|Tipifarnib|tipifarnib|mesh-list
101573025|NCT02779777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101573026|NCT05069545|Insulin|insulin|mesh-list
101573027|NCT05069545|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101573028|NCT05069545|Insulin Aspart|insulin aspart|mesh-list
101573029|NCT05069545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101573030|NCT05069545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573031|NCT05279833|Sotalol|sotalol|mesh-list
101573032|NCT05279833|Dronedarone|dronedarone|mesh-list
101573033|NCT05279833|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101573034|NCT05279833|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101573035|NCT05279833|Adrenergic Agents|adrenergic agents|mesh-ancestor
101573036|NCT05279833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101573037|NCT05279833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573038|NCT05279833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573039|NCT05279833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101573040|NCT05279833|Sympatholytics|sympatholytics|mesh-ancestor
101573041|NCT05279833|Autonomic Agents|autonomic agents|mesh-ancestor
101573042|NCT05279833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101573043|NCT01880359|Nimorazole|nimorazole|mesh-list
101573044|NCT01880359|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
101573045|NCT01880359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101573046|NCT01880359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101573047|NCT01880359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101573048|NCT04975555|Siltuximab|siltuximab|mesh-list
101573049|NCT04975555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101573050|NCT05338489|Itraconazole|itraconazole|mesh-list
101573051|NCT05338489|Rifampin|rifampin|mesh-list
101573052|NCT05338489|Antifungal Agents|antifungal agents|mesh-ancestor
101573053|NCT05338489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101573054|NCT05338489|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101573055|NCT05338489|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101573056|NCT05338489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101573057|NCT05338489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573058|NCT05338489|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101573059|NCT05338489|Hormone Antagonists|hormone antagonists|mesh-ancestor
101573060|NCT05338489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101573061|NCT05338489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573062|NCT05338489|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101573063|NCT05338489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101573064|NCT05338489|Antitubercular Agents|antitubercular agents|mesh-ancestor
101573065|NCT05338489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101573066|NCT05338489|Leprostatic Agents|leprostatic agents|mesh-ancestor
101573067|NCT05338489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101573068|NCT05338489|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101573069|NCT05338489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101573070|NCT05338489|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101573071|NCT05338489|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101573072|NCT05338489|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101573073|NCT05338489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101573075|NCT05266417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101573076|NCT05266417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573077|NCT02779465|Vitamin D|vitamin d|mesh-list
101573078|NCT02779465|Cholecalciferol|cholecalciferol|mesh-list
101573079|NCT02779465|Vitamins|vitamins|mesh-ancestor
101573080|NCT02779465|Micronutrients|micronutrients|mesh-ancestor
101573081|NCT02779465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573082|NCT02779465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101573083|NCT02779465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101573084|NCT02776189|Midazolam|midazolam|mesh-list
101573085|NCT02776189|Dexmedetomidine|dexmedetomidine|mesh-list
101573086|NCT02776189|Propofol|propofol|mesh-list
101573087|NCT02776189|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101573088|NCT02776189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101573089|NCT02776189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573090|NCT02776189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101573091|NCT02776189|Analgesics|analgesics|mesh-ancestor
101573092|NCT02776189|Sensory System Agents|sensory system agents|mesh-ancestor
101229987|NCT05840692|Escitalopram|escitalopram|mesh-list
101573093|NCT02776189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101573094|NCT02776189|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101573095|NCT02776189|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101573096|NCT02776189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101573097|NCT02776189|Adrenergic Agents|adrenergic agents|mesh-ancestor
101573098|NCT02776189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101573099|NCT02776189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573100|NCT02776189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101573101|NCT02776189|Anesthetics, General|anesthetics, general|mesh-ancestor
101573102|NCT02776189|Anesthetics|anesthetics|mesh-ancestor
101573103|NCT02776189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101573104|NCT02776189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101573105|NCT02776189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101573106|NCT02776189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101573107|NCT02776189|GABA Modulators|gaba modulators|mesh-ancestor
101573108|NCT02776189|GABA Agents|gaba agents|mesh-ancestor
101573109|NCT01194258|Insulin|insulin|mesh-list
101573110|NCT01194258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101573111|NCT01194258|Insulin Glargine|insulin glargine|mesh-list
101573112|NCT01194258|Insulin Aspart|insulin aspart|mesh-list
101573114|NCT01194258|Insulin glulisine|insulin glulisine|mesh-list
101573115|NCT01194258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101573116|NCT01194258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573117|NCT04883437|Obinutuzumab|obinutuzumab|mesh-list
101573118|NCT04883437|Acalabrutinib|acalabrutinib|mesh-list
101573119|NCT04883437|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101573120|NCT04883437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101573121|NCT04883437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101573122|NCT04883437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101573123|NCT04883437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101573124|NCT04883437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573125|NCT02775877|Letrozole|letrozole|mesh-list
101573126|NCT02775877|Clomiphene|clomiphene|mesh-list
101573127|NCT02775877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101573128|NCT02775877|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101573129|NCT02775877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101573130|NCT02775877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101573131|NCT02775877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573132|NCT02775877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101444791|NCT02335918|Nivolumab|nivolumab|mesh-list
101573133|NCT02775877|Hormone Antagonists|hormone antagonists|mesh-ancestor
101573134|NCT02775877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101573135|NCT02775877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573136|NCT02775877|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101573137|NCT02775877|Fertility Agents|fertility agents|mesh-ancestor
101573138|NCT02775877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101573139|NCT02775877|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101573140|NCT02775877|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101573141|NCT02777671|Gliclazide|gliclazide|mesh-list
101573142|NCT02777671|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
101573143|NCT02777671|Anticonvulsants|anticonvulsants|mesh-ancestor
101573144|NCT02777671|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101573145|NCT02777671|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101573146|NCT02777671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101573147|NCT02777671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573148|NCT02777671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101573149|NCT02777671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573150|NCT02778919|Leuprolide|leuprolide|mesh-list
101573151|NCT02778919|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101573152|NCT02778919|Fertility Agents|fertility agents|mesh-ancestor
101573153|NCT02778919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101573154|NCT02778919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573155|NCT02778919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101573156|NCT02778919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101573157|NCT02779153|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101573158|NCT02779153|Hormones|hormones|mesh-ancestor
101573159|NCT02779153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101573160|NCT02779153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573161|NCT04226443|Midazolam|midazolam|mesh-list
101573162|NCT04226443|Remifentanil|remifentanil|mesh-list
101573163|NCT04226443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101573164|NCT04226443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101573165|NCT04226443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101230058|NCT05840172|Benzocaine|benzocaine|mesh-list
101573166|NCT04226443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573167|NCT04226443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101573168|NCT04226443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101573169|NCT04226443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101573170|NCT04226443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101573171|NCT04226443|Anesthetics, General|anesthetics, general|mesh-ancestor
101573172|NCT04226443|Anesthetics|anesthetics|mesh-ancestor
101573173|NCT04226443|GABA Modulators|gaba modulators|mesh-ancestor
101573174|NCT04226443|GABA Agents|gaba agents|mesh-ancestor
101573175|NCT04226443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101573176|NCT04226443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573177|NCT04226443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101573178|NCT04226443|Narcotics|narcotics|mesh-ancestor
101573179|NCT04226443|Analgesics|analgesics|mesh-ancestor
101573180|NCT04226443|Sensory System Agents|sensory system agents|mesh-ancestor
101573181|NCT04226443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101573182|NCT02776891|Citric Acid|citric acid|mesh-list
101573183|NCT02776891|Sodium Citrate|sodium citrate|mesh-list
101573184|NCT02776891|Gallium citrate|gallium citrate|mesh-list
101573185|NCT02776891|Anticoagulants|anticoagulants|mesh-ancestor
101573186|NCT02776891|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101573187|NCT02776891|Chelating Agents|chelating agents|mesh-ancestor
101573188|NCT02776891|Sequestering Agents|sequestering agents|mesh-ancestor
101573189|NCT02776891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573190|NCT02776891|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101573192|NCT02776813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101573193|NCT02776813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101573194|NCT02776813|Immunologic Factors|immunologic factors|mesh-ancestor
101573195|NCT02776813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573196|NCT02776813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101573197|NCT05157997|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
101573198|NCT05157997|Antibodies|antibodies|mesh-list
101573199|NCT05157997|Immunologic Factors|immunologic factors|mesh-ancestor
101573200|NCT05157997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573201|NCT05157997|Antiviral Agents|antiviral agents|mesh-ancestor
101573202|NCT05157997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101573203|NCT02773147|Pyridoxine|pyridoxine|mesh-list
101573204|NCT02773147|Vitamin B 12|vitamin b 12|mesh-list
101573205|NCT02773147|Hydroxocobalamin|hydroxocobalamin|mesh-list
101573206|NCT02773147|Hematinics|hematinics|mesh-ancestor
101573207|NCT02773147|Vitamin B Complex|vitamin b complex|mesh-ancestor
101573209|NCT02773147|Micronutrients|micronutrients|mesh-ancestor
101573210|NCT02773147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573211|NCT02773927|Metformin|metformin|mesh-list
101573212|NCT02773927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101573213|NCT02773927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573214|NCT02773459|Capecitabine|capecitabine|mesh-list
101573215|NCT02773459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101573216|NCT02773459|Antimetabolites|antimetabolites|mesh-ancestor
101573217|NCT02773459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573218|NCT02773459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101573219|NCT04818229|Moxifloxacin|moxifloxacin|mesh-list
101836652|NCT00308074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101573220|NCT04818229|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101573221|NCT04818229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101573222|NCT04818229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101573223|NCT04818229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101573224|NCT04818229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101573225|NCT04818229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101573226|NCT04818229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573227|NCT04818229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101573228|NCT04818229|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101573229|NCT04818229|Contraceptive Agents|contraceptive agents|mesh-ancestor
101573230|NCT04818229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101573231|NCT04818229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573232|NCT04818229|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101573233|NCT04818229|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101573234|NCT04818229|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101573235|NCT04771741|Acetaminophen|acetaminophen|mesh-list
101573237|NCT04771741|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101573238|NCT04771741|Meloxicam|meloxicam|mesh-list
101573239|NCT04771741|Pregabalin|pregabalin|mesh-list
101573240|NCT04771741|Cyclobenzaprine|cyclobenzaprine|mesh-list
101573241|NCT04771741|Analgesics|analgesics|mesh-ancestor
101573242|NCT04771741|Sensory System Agents|sensory system agents|mesh-ancestor
101573243|NCT04771741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101573244|NCT04771741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573245|NCT04771741|Anticonvulsants|anticonvulsants|mesh-ancestor
101573246|NCT04771741|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101573247|NCT04771741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101573248|NCT04771741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573249|NCT04771741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101573250|NCT04771741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101573251|NCT04771741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101573252|NCT04771741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101573253|NCT04771741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101573254|NCT04771741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101573255|NCT04771741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101573256|NCT04771741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101573257|NCT04771741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101573258|NCT04771741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101573259|NCT04771741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101573260|NCT04771741|Antipyretics|antipyretics|mesh-ancestor
101573261|NCT04771741|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101573262|NCT04771741|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101573264|NCT04771741|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101573265|NCT04771741|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101573267|NCT02772601|Midazolam|midazolam|mesh-list
101573268|NCT02772601|Caffeine|caffeine|mesh-list
101573269|NCT02772601|Omeprazole|omeprazole|mesh-list
101573270|NCT02772601|Warfarin|warfarin|mesh-list
101573271|NCT02772601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101444831|NCT02309671|Hormones|hormones|mesh-ancestor
101573272|NCT02772601|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101573273|NCT02772601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101573274|NCT02772601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573275|NCT02772601|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101573276|NCT02772601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101573277|NCT02772601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101573278|NCT02772601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101573279|NCT02772601|Anesthetics, General|anesthetics, general|mesh-ancestor
101573280|NCT02772601|Anesthetics|anesthetics|mesh-ancestor
101573281|NCT02772601|GABA Modulators|gaba modulators|mesh-ancestor
101573282|NCT02772601|GABA Agents|gaba agents|mesh-ancestor
101573283|NCT02772601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101573284|NCT02772601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573285|NCT02772601|Anticoagulants|anticoagulants|mesh-ancestor
101573286|NCT02772601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101573287|NCT02772601|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101573288|NCT02772601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101573289|NCT02772601|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101573290|NCT02772601|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101573291|NCT02772601|Purinergic Agents|purinergic agents|mesh-ancestor
101573292|NCT02772601|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101573293|NCT02772601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101573294|NCT02772601|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101573295|NCT02772601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101573296|NCT02772601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101573297|NCT02772601|Sympatholytics|sympatholytics|mesh-ancestor
101573298|NCT02772601|Autonomic Agents|autonomic agents|mesh-ancestor
101573299|NCT02772601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101573300|NCT02772601|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101573301|NCT02772601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101573302|NCT02772601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101573303|NCT02772601|Adrenergic Agents|adrenergic agents|mesh-ancestor
101573304|NCT02772211|Cycloserine|cycloserine|mesh-list
101573305|NCT02772211|Ketamine|ketamine|mesh-list
101573306|NCT02772211|Analgesics|analgesics|mesh-ancestor
101573307|NCT02772211|Sensory System Agents|sensory system agents|mesh-ancestor
101573308|NCT02772211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101573309|NCT02772211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573310|NCT02772211|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101573311|NCT02772211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101573312|NCT02772211|Anesthetics, General|anesthetics, general|mesh-ancestor
101573313|NCT02772211|Anesthetics|anesthetics|mesh-ancestor
101573314|NCT02772211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101573315|NCT02772211|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101573316|NCT02772211|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101230205|NCT05839054|Dopamine Agents|dopamine agents|mesh-ancestor
101573317|NCT02772211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101573318|NCT02772211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573319|NCT02772211|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101573320|NCT02772211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101573321|NCT02772211|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101573322|NCT02772211|Antitubercular Agents|antitubercular agents|mesh-ancestor
101573323|NCT02772211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101573324|NCT02772211|Antimetabolites|antimetabolites|mesh-ancestor
101573325|NCT04225195|Amphotericin B|amphotericin b|mesh-list
101573326|NCT04225195|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101573327|NCT04225195|Cholesteryl sulfate|cholesteryl sulfate|mesh-list
101573328|NCT04225195|Amebicides|amebicides|mesh-ancestor
101573329|NCT04225195|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101573330|NCT04225195|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101573331|NCT04225195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101573332|NCT04225195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101573333|NCT04225195|Antifungal Agents|antifungal agents|mesh-ancestor
101573334|NCT04225195|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101573335|NCT04225195|Protease Inhibitors|protease inhibitors|mesh-ancestor
101573336|NCT04225195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101573337|NCT04225195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573338|NCT04225195|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101573339|NCT04225195|Protective Agents|protective agents|mesh-ancestor
101573340|NCT04225195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573341|NCT04225195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101573342|NCT02771509|Mitogens|mitogens|mesh-list
101573343|NCT02771509|Mitosis Modulators|mitosis modulators|mesh-ancestor
101573344|NCT02771509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573345|NCT02696941|Metformin|metformin|mesh-list
101573346|NCT02696941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
101573347|NCT02696941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101573348|NCT02696941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573349|NCT02696941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573350|NCT02767375|Fluorouracil|fluorouracil|mesh-list
101573351|NCT02767375|Oxaliplatin|oxaliplatin|mesh-list
101573352|NCT02767375|Antimetabolites|antimetabolites|mesh-ancestor
101573353|NCT02767375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573354|NCT02767375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101573355|NCT02767375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101573356|NCT02767375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101573358|NCT02767375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573359|NCT02767219|Dexamethasone|dexamethasone|mesh-list
101573360|NCT02767219|Bevacizumab|bevacizumab|mesh-list
101573361|NCT02767219|Fluorouracil|fluorouracil|mesh-list
101573362|NCT02767219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101573363|NCT02767219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101573364|NCT02767219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101573365|NCT02767219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101573366|NCT02767219|Growth Substances|growth substances|mesh-ancestor
101573367|NCT02767219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573368|NCT02767219|Growth Inhibitors|growth inhibitors|mesh-ancestor
101573369|NCT02767219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101573370|NCT02767219|Antiemetics|antiemetics|mesh-ancestor
101573371|NCT02767219|Autonomic Agents|autonomic agents|mesh-ancestor
101573372|NCT02767219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101573373|NCT02767219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101573374|NCT02767219|Glucocorticoids|glucocorticoids|mesh-ancestor
101573375|NCT02767219|Hormones|hormones|mesh-ancestor
101573376|NCT02767219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101573377|NCT02767219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101573378|NCT02767219|Antimetabolites|antimetabolites|mesh-ancestor
101573379|NCT02767219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573380|NCT02767219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101573381|NCT02767219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101573382|NCT02767219|Immunologic Factors|immunologic factors|mesh-ancestor
101573383|NCT02771587|Ethanol|ethanol|mesh-list
101573384|NCT02771587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101573385|NCT02771587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101573386|NCT02771587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101573387|NCT02771587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573388|NCT02771743|Cyclophosphamide|cyclophosphamide|mesh-list
101573389|NCT02771743|Ifosfamide|ifosfamide|mesh-list
101573390|NCT02771743|Carboplatin|carboplatin|mesh-list
101573391|NCT02771743|Doxorubicin|doxorubicin|mesh-list
101573392|NCT02771743|Etoposide|etoposide|mesh-list
101573393|NCT02771743|Interleukin-2|interleukin-2|mesh-list
101230280|NCT05782361|Pembrolizumab|pembrolizumab|mesh-list
101573394|NCT02771743|Isotretinoin|isotretinoin|mesh-list
101573395|NCT02771743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101573396|NCT02771743|Immunologic Factors|immunologic factors|mesh-ancestor
101573397|NCT02771743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573398|NCT02771743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101573399|NCT02771743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101573400|NCT02771743|Alkylating Agents|alkylating agents|mesh-ancestor
101573401|NCT02771743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573402|NCT02771743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101573403|NCT02771743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101573404|NCT02771743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101573405|NCT02771743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101573406|NCT02771743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101573407|NCT02771743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101573408|NCT02771743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101573409|NCT02771743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101573410|NCT02771743|Analgesics|analgesics|mesh-ancestor
101573411|NCT02771743|Sensory System Agents|sensory system agents|mesh-ancestor
101573412|NCT02771743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101573414|NCT02762851|Vaccines|vaccines|mesh-list
101573415|NCT02762851|Immunologic Factors|immunologic factors|mesh-ancestor
101573416|NCT02762851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573417|NCT02767063|Pioglitazone|pioglitazone|mesh-list
101573418|NCT02767063|Avelumab|avelumab|mesh-list
101573419|NCT02767063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101573420|NCT02767063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573421|NCT02767063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101573422|NCT02767063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101573423|NCT04224103|Nitric Oxide|nitric oxide|mesh-list
101573424|NCT04224103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101573425|NCT04224103|Autonomic Agents|autonomic agents|mesh-ancestor
101573426|NCT04224103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101573427|NCT04224103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573428|NCT04224103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101573429|NCT04224103|Respiratory System Agents|respiratory system agents|mesh-ancestor
101573430|NCT04224103|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101573431|NCT04224103|Antioxidants|antioxidants|mesh-ancestor
101510761|NCT00526760|Dexmedetomidine|dexmedetomidine|mesh-list
101573432|NCT04224103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573433|NCT04224103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101573434|NCT04224103|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101573435|NCT04224103|Vasodilator Agents|vasodilator agents|mesh-ancestor
101573436|NCT04224103|Gasotransmitters|gasotransmitters|mesh-ancestor
101573437|NCT04224103|Protective Agents|protective agents|mesh-ancestor
101573438|NCT02766439|Etanercept|etanercept|mesh-list
101573439|NCT02766439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101573440|NCT02766439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101573441|NCT02766439|Analgesics|analgesics|mesh-ancestor
101573442|NCT02766439|Sensory System Agents|sensory system agents|mesh-ancestor
101573443|NCT02766439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101573444|NCT02766439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573445|NCT02766439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101573446|NCT02766439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101573447|NCT02766439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101573448|NCT02766439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101573449|NCT02766439|Immunologic Factors|immunologic factors|mesh-ancestor
101573450|NCT02765971|Picosulfate sodium|picosulfate sodium|mesh-list
101573451|NCT02765971|Cathartics|cathartics|mesh-ancestor
101573452|NCT02765971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101573453|NCT02765815|Ketorolac|ketorolac|mesh-list
101573454|NCT02765815|Epinephrine|epinephrine|mesh-list
101573455|NCT02765815|Racepinephrine|racepinephrine|mesh-list
101573456|NCT02765815|Morphine|morphine|mesh-list
101573457|NCT02765815|Bupivacaine|bupivacaine|mesh-list
101573458|NCT02765815|Epinephryl borate|epinephryl borate|mesh-list
101573459|NCT02765815|Anesthetics, Local|anesthetics, local|mesh-ancestor
101573460|NCT02765815|Anesthetics|anesthetics|mesh-ancestor
101573461|NCT02765815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101573462|NCT02765815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573463|NCT02765815|Sensory System Agents|sensory system agents|mesh-ancestor
101573464|NCT02765815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101573465|NCT02765815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101573466|NCT02765815|Narcotics|narcotics|mesh-ancestor
101573467|NCT02765815|Analgesics|analgesics|mesh-ancestor
101573468|NCT02765815|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101573469|NCT02765815|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101573470|NCT02765815|Adrenergic Agents|adrenergic agents|mesh-ancestor
101573471|NCT02765815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101573472|NCT02765815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573473|NCT02765815|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101573474|NCT02765815|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101573475|NCT02765815|Autonomic Agents|autonomic agents|mesh-ancestor
101573476|NCT02765815|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101573477|NCT02765815|Respiratory System Agents|respiratory system agents|mesh-ancestor
101573479|NCT02765815|Sympathomimetics|sympathomimetics|mesh-ancestor
101573480|NCT02765815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101573481|NCT02765815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101573482|NCT02765815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101573483|NCT02765815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101573484|NCT02765815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101573485|NCT02765815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101573486|NCT02765815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101573487|NCT02765347|Metformin|metformin|mesh-list
101573488|NCT02765347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101573489|NCT02765347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573490|NCT02770885|Dulaglutide|dulaglutide|mesh-list
101573491|NCT02770885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101573492|NCT02770885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573493|NCT02770651|Everolimus|everolimus|mesh-list
101573494|NCT02770651|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101573495|NCT02770651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101573496|NCT02770651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101573497|NCT02770651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573498|NCT02770651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101573499|NCT02770651|Immunologic Factors|immunologic factors|mesh-ancestor
101573500|NCT02770651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573501|NCT02770651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101573502|NCT02770729|Moxifloxacin|moxifloxacin|mesh-list
101573503|NCT02770729|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101573504|NCT02770729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101573505|NCT02770729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101573506|NCT02770729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101573507|NCT02770729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101830330|NCT05327010|Talazoparib|talazoparib|mesh-list
101573509|NCT02770729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573510|NCT02770729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101573511|NCT02770729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101573512|NCT02770729|Contraceptive Agents|contraceptive agents|mesh-ancestor
101573513|NCT02770729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101573514|NCT02770729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573515|NCT02770729|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101573516|NCT02770729|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101573517|NCT02770729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101573518|NCT02770105|Caffeine|caffeine|mesh-list
101573519|NCT02770105|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101573520|NCT02770105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573521|NCT02770105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101573522|NCT02770105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101573523|NCT02770105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573524|NCT02770105|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101573525|NCT02770105|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101573526|NCT02770105|Purinergic Agents|purinergic agents|mesh-ancestor
101573527|NCT02770105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101573529|NCT02769793|Benserazide|benserazide|mesh-list
101573530|NCT02769793|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
101573531|NCT02769793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101573532|NCT02769793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101573533|NCT02769793|Dopamine Agents|dopamine agents|mesh-ancestor
101573534|NCT02769793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101444906|NCT00204984|Hydralazine|hydralazine|mesh-list
101573535|NCT02769793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573536|NCT02769793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573537|NCT02769793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101573538|NCT02769325|Ketorolac|ketorolac|mesh-list
101573539|NCT02769325|Atropine|atropine|mesh-list
101573540|NCT02769325|Morphine|morphine|mesh-list
101573541|NCT02769325|Propofol|propofol|mesh-list
101573542|NCT02769325|Sevoflurane|sevoflurane|mesh-list
101573543|NCT02769325|Rocuronium|rocuronium|mesh-list
101573544|NCT02769325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101573545|NCT02769325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101573546|NCT02769325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573547|NCT02769325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101573548|NCT02769325|Anesthetics, General|anesthetics, general|mesh-ancestor
101573549|NCT02769325|Anesthetics|anesthetics|mesh-ancestor
101573550|NCT02769325|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101573551|NCT02769325|Narcotics|narcotics|mesh-ancestor
101573552|NCT02769325|Analgesics|analgesics|mesh-ancestor
101573553|NCT02769325|Sensory System Agents|sensory system agents|mesh-ancestor
101573554|NCT02769325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101573555|NCT02769325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101573556|NCT02769325|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101573557|NCT02769325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101573558|NCT02769325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101573559|NCT02769325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101573560|NCT02769325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101573561|NCT02769325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101573562|NCT02769325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101573563|NCT02769325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573564|NCT02769325|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101573565|NCT02769325|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101573566|NCT02769325|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101573567|NCT02769325|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101573568|NCT02769325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101573569|NCT02769325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101573570|NCT02769325|Autonomic Agents|autonomic agents|mesh-ancestor
101573571|NCT02769325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101573572|NCT02769325|Respiratory System Agents|respiratory system agents|mesh-ancestor
101573573|NCT02769325|Mydriatics|mydriatics|mesh-ancestor
101573574|NCT02769325|Parasympatholytics|parasympatholytics|mesh-ancestor
101573575|NCT02769325|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101573576|NCT02769325|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101573577|NCT02769325|Cholinergic Agents|cholinergic agents|mesh-ancestor
101573578|NCT02769325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101573579|NCT02770261|Candesartan|candesartan|mesh-list
101573580|NCT02770261|Candesartan cilexetil|candesartan cilexetil|mesh-list
101573581|NCT02770261|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101573582|NCT02770261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101573583|NCT02770261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101573584|NCT02770261|Antimetabolites|antimetabolites|mesh-ancestor
101573585|NCT02770261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573586|NCT02770261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101573587|NCT02770261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101573588|NCT02770261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101573589|NCT02770261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101573590|NCT02770261|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101573591|NCT02770261|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101573593|NCT04224649|Hyaluronic Acid|hyaluronic acid|mesh-list
101573594|NCT04224649|Anesthetics, Local|anesthetics, local|mesh-ancestor
101573595|NCT04224649|Anesthetics|anesthetics|mesh-ancestor
101573596|NCT04224649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101573597|NCT04224649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096762|NCT04977778|Fluorides|fluorides|mesh-list
101573598|NCT04224649|Sensory System Agents|sensory system agents|mesh-ancestor
101573599|NCT04224649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101573600|NCT04224649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101573601|NCT04224649|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101573602|NCT04224649|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101573603|NCT04224649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101573604|NCT04224649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573605|NCT04224649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101573606|NCT04224649|Immunologic Factors|immunologic factors|mesh-ancestor
101573607|NCT04224649|Viscosupplements|viscosupplements|mesh-ancestor
101573608|NCT04224649|Protective Agents|protective agents|mesh-ancestor
101573609|NCT02769169|Ranibizumab|ranibizumab|mesh-list
101573610|NCT02769169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101573611|NCT02769169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101573612|NCT02769169|Growth Substances|growth substances|mesh-ancestor
101573613|NCT02769169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573614|NCT02769169|Growth Inhibitors|growth inhibitors|mesh-ancestor
101573615|NCT02769169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101573616|NCT02769013|Praziquantel|praziquantel|mesh-list
101573617|NCT02769013|Anthelmintics|anthelmintics|mesh-ancestor
101573618|NCT02769013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101573620|NCT02768545|Ezetimibe|ezetimibe|mesh-list
101573621|NCT02768545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101573622|NCT02768545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101573623|NCT02768545|Antimetabolites|antimetabolites|mesh-ancestor
101573624|NCT02768545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573625|NCT02768545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101573626|NCT02764723|Bupivacaine|bupivacaine|mesh-list
101573627|NCT02764723|Ropivacaine|ropivacaine|mesh-list
101573628|NCT02764723|Anesthetics, Local|anesthetics, local|mesh-ancestor
101573629|NCT02764723|Anesthetics|anesthetics|mesh-ancestor
101573630|NCT02764723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101573631|NCT02764723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573632|NCT02764723|Sensory System Agents|sensory system agents|mesh-ancestor
101573633|NCT02764723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101573634|NCT04664959|Denosumab|denosumab|mesh-list
101573635|NCT04664959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101573636|NCT04664959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573637|NCT00951496|Paclitaxel|paclitaxel|mesh-list
101573638|NCT00951496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101573640|NCT00951496|Cisplatin|cisplatin|mesh-list
101573641|NCT00951496|Carboplatin|carboplatin|mesh-list
101573642|NCT00951496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101573643|NCT00951496|Endothelial Growth Factors|endothelial growth factors|mesh-list
101573644|NCT00951496|Antibodies|antibodies|mesh-list
101573645|NCT00951496|Immunoglobulins|immunoglobulins|mesh-list
101573646|NCT00951496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101573647|NCT00951496|Immunoglobulin G|immunoglobulin g|mesh-list
101573648|NCT00951496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101573649|NCT00951496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101573650|NCT00951496|Tubulin Modulators|tubulin modulators|mesh-ancestor
101573651|NCT00951496|Antimitotic Agents|antimitotic agents|mesh-ancestor
101573652|NCT00951496|Mitosis Modulators|mitosis modulators|mesh-ancestor
101573653|NCT00951496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573654|NCT00951496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101573655|NCT00951496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101573656|NCT00951496|Growth Substances|growth substances|mesh-ancestor
101510975|NCT02924454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573657|NCT00951496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573658|NCT00951496|Growth Inhibitors|growth inhibitors|mesh-ancestor
101573659|NCT00951496|Immunologic Factors|immunologic factors|mesh-ancestor
101573660|NCT02764411|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101573661|NCT02764411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101573662|NCT02764411|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101573663|NCT02764411|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101573664|NCT02764411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101573665|NCT02764411|Adrenergic Agents|adrenergic agents|mesh-ancestor
101573666|NCT02764411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101573667|NCT02764411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573668|NCT02764411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573669|NCT02768077|Melatonin|melatonin|mesh-list
101573670|NCT02768077|Antioxidants|antioxidants|mesh-ancestor
101573671|NCT02768077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573672|NCT02768077|Protective Agents|protective agents|mesh-ancestor
101573673|NCT02768077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573674|NCT02768077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101573675|NCT01193244|Prednisone|prednisone|mesh-list
101573676|NCT01193244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101573677|NCT01193244|Glucocorticoids|glucocorticoids|mesh-ancestor
101573678|NCT01193244|Hormones|hormones|mesh-ancestor
101573679|NCT01193244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101573680|NCT01193244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573681|NCT01193244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101573682|NCT01193244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101573683|NCT04224337|Doxorubicin|doxorubicin|mesh-list
101573684|NCT04224337|Durvalumab|durvalumab|mesh-list
101573685|NCT04224337|Ifosfamide|ifosfamide|mesh-list
101573686|NCT04224337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101573687|NCT04224337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101573688|NCT04224337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101573689|NCT04224337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101573690|NCT04224337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101573691|NCT04224337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573692|NCT04224337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101230590|NCT04901715|Albuterol|albuterol|mesh-list
101573722|NCT01192152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101573723|NCT01192152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573724|NCT01192152|Incretins|incretins|mesh-ancestor
101573725|NCT01192152|Hormones|hormones|mesh-ancestor
101573726|NCT01192152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101573727|NCT01192152|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101573728|NCT01192152|Protease Inhibitors|protease inhibitors|mesh-ancestor
101573729|NCT01192152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101573730|NCT01192152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573731|NCT04572451|Nivolumab|nivolumab|mesh-list
101573732|NCT04572451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101573733|NCT04572451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101573734|NCT04572451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101573735|NCT04572451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573736|NCT02758249|Propofol|propofol|mesh-list
101573737|NCT02758249|Sevoflurane|sevoflurane|mesh-list
101573738|NCT02758249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101573739|NCT02758249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101573740|NCT02758249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573741|NCT02758249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101573742|NCT02758249|Anesthetics, General|anesthetics, general|mesh-ancestor
101573743|NCT02758249|Anesthetics|anesthetics|mesh-ancestor
101573744|NCT02758249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101573745|NCT02758249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101573746|NCT02758405|Fentanyl|fentanyl|mesh-list
101573747|NCT02758405|Bupivacaine|bupivacaine|mesh-list
101573748|NCT02758405|Anesthetics, Local|anesthetics, local|mesh-ancestor
101573749|NCT02758405|Anesthetics|anesthetics|mesh-ancestor
101573750|NCT02758405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101573751|NCT02758405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573752|NCT02758405|Sensory System Agents|sensory system agents|mesh-ancestor
101573753|NCT02758405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101573754|NCT02758405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101573755|NCT02758405|Narcotics|narcotics|mesh-ancestor
101830331|NCT05327010|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101573756|NCT02758405|Analgesics|analgesics|mesh-ancestor
101573757|NCT02758405|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101573758|NCT02758405|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101573759|NCT02758405|Anesthetics, General|anesthetics, general|mesh-ancestor
101573760|NCT02758327|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101573761|NCT02758327|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101573762|NCT02758327|Lubricant Eye Drops|lubricant eye drops|mesh-list
101573763|NCT02758327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101573765|NCT02758327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101573766|NCT02763475|Cyclophosphamide|cyclophosphamide|mesh-list
101573767|NCT02763475|Fludarabine|fludarabine|mesh-list
101573768|NCT02763475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101573769|NCT02763475|Immunologic Factors|immunologic factors|mesh-ancestor
101573770|NCT02763475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573771|NCT02763475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101573772|NCT02763475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101573773|NCT02763475|Alkylating Agents|alkylating agents|mesh-ancestor
101573774|NCT02763475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573775|NCT02763475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101573776|NCT02763475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101573777|NCT02762383|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101573778|NCT02762383|Antiviral Agents|antiviral agents|mesh-ancestor
101573779|NCT02762383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101573780|NCT02758015|Betaine|betaine|mesh-list
101573781|NCT02758015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101573782|NCT02758015|Lipotropic Agents|lipotropic agents|mesh-ancestor
101573783|NCT02758015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101573784|NCT02758015|Antimetabolites|antimetabolites|mesh-ancestor
101573785|NCT02758015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573786|NCT02758015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101573787|NCT02757703|Terlipressin|terlipressin|mesh-list
101573788|NCT02757703|Pantoprazole|pantoprazole|mesh-list
101573789|NCT02757703|Somatostatin|somatostatin|mesh-list
101573790|NCT02757703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101573791|NCT02757703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101573792|NCT02757703|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101573793|NCT02757703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101573794|NCT02757703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573795|NCT02757703|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101573796|NCT02757703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101573797|NCT02757703|Hormones|hormones|mesh-ancestor
101573798|NCT02757703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101573799|NCT02757703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573800|NCT02763007|Pioglitazone|pioglitazone|mesh-list
101573801|NCT02763007|Alogliptin|alogliptin|mesh-list
101573802|NCT02763007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101573803|NCT02763007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573804|NCT02763007|Incretins|incretins|mesh-ancestor
101573805|NCT02763007|Hormones|hormones|mesh-ancestor
101573806|NCT02763007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101573807|NCT02763007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101573808|NCT02763007|Protease Inhibitors|protease inhibitors|mesh-ancestor
101573809|NCT02763007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101573810|NCT02763007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573811|NCT00635323|Capecitabine|capecitabine|mesh-list
101573812|NCT00635323|Irinotecan|irinotecan|mesh-list
101573813|NCT00635323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101573815|NCT00635323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573816|NCT00635323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101573817|NCT00635323|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101573818|NCT00635323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101573819|NCT00635323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101573820|NCT01191840|Vancomycin|vancomycin|mesh-list
101573821|NCT01191840|Cefazolin|cefazolin|mesh-list
101573822|NCT01191840|Daptomycin|daptomycin|mesh-list
101573823|NCT01191840|Cloxacillin|cloxacillin|mesh-list
101573824|NCT01191840|Oxacillin|oxacillin|mesh-list
101573825|NCT01191840|Nafcillin|nafcillin|mesh-list
101573826|NCT01191840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101573827|NCT01191840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101573828|NCT02752555|Antioxidants|antioxidants|mesh-list
101573829|NCT02752555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573830|NCT02752555|Protective Agents|protective agents|mesh-ancestor
101573831|NCT02752555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573832|NCT00624546|Lansoprazole|lansoprazole|mesh-list
101573833|NCT00624546|Dexlansoprazole|dexlansoprazole|mesh-list
101573835|NCT00624546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101573836|NCT00624546|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101573837|NCT00624546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101573838|NCT00624546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573839|NCT02757469|Drospirenone|drospirenone|mesh-list
101573840|NCT02757469|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101573841|NCT02757469|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
101573842|NCT02757469|Estradiol|estradiol|mesh-list
101573843|NCT02757469|Estrogens|estrogens|mesh-ancestor
101573844|NCT02757469|Hormones|hormones|mesh-ancestor
101573845|NCT02757469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101573846|NCT02757469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573847|NCT02757469|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101573848|NCT02757469|Contraceptive Agents|contraceptive agents|mesh-ancestor
101573849|NCT02757469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101573850|NCT02757469|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101573851|NCT02757469|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101573852|NCT02757469|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102096763|NCT04977778|Tin Fluorides|tin fluorides|mesh-list
101573853|NCT02757469|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101573854|NCT02757469|Hormone Antagonists|hormone antagonists|mesh-ancestor
101573855|NCT02757469|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101573856|NCT02757469|Diuretics|diuretics|mesh-ancestor
101573857|NCT02757469|Natriuretic Agents|natriuretic agents|mesh-ancestor
101573858|NCT02757391|Aldesleukin|aldesleukin|mesh-list
101573859|NCT02757391|Cyclophosphamide|cyclophosphamide|mesh-list
101573860|NCT02757391|Pembrolizumab|pembrolizumab|mesh-list
101573861|NCT02757391|Interleukin-2|interleukin-2|mesh-list
101573862|NCT02757391|Immunologic Factors|immunologic factors|mesh-list
101573863|NCT02757391|Immunomodulating Agents|immunomodulating agents|mesh-list
101573864|NCT02757391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101573865|NCT02757391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573866|NCT02757391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101573867|NCT02757391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101573868|NCT02757391|Alkylating Agents|alkylating agents|mesh-ancestor
101573869|NCT02757391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573870|NCT02757391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101573871|NCT02757391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101573872|NCT02757391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101573873|NCT02757391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101573874|NCT02757391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101573875|NCT02757391|Analgesics|analgesics|mesh-ancestor
101573876|NCT02757391|Sensory System Agents|sensory system agents|mesh-ancestor
101573877|NCT02757391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101573878|NCT02757391|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101573879|NCT02757391|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101573880|NCT02757391|Antiviral Agents|antiviral agents|mesh-ancestor
101573881|NCT02757391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101573882|NCT04564417|Pembrolizumab|pembrolizumab|mesh-list
101573883|NCT04564417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101573884|NCT04564417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101573885|NCT04564417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101573886|NCT04564417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573887|NCT02757079|Melatonin|melatonin|mesh-list
101573888|NCT02757079|Antioxidants|antioxidants|mesh-ancestor
101941642|NCT03645304|Sensory System Agents|sensory system agents|mesh-ancestor
101308049|NCT02045368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101573889|NCT02757079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573890|NCT02757079|Protective Agents|protective agents|mesh-ancestor
101573891|NCT02757079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573892|NCT02757079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101573893|NCT02768389|Bevacizumab|bevacizumab|mesh-list
101573894|NCT02768389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101573895|NCT02768389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101573896|NCT02768389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101573897|NCT02768389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101573898|NCT02768389|Growth Substances|growth substances|mesh-ancestor
101573899|NCT02768389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573900|NCT02768389|Growth Inhibitors|growth inhibitors|mesh-ancestor
101573901|NCT04529005|Angiotensin II|angiotensin ii|mesh-list
101573903|NCT04529005|Angiotensinogen|angiotensinogen|mesh-list
101573904|NCT04529005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101573905|NCT04529005|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101573906|NCT04529005|Protease Inhibitors|protease inhibitors|mesh-ancestor
101573907|NCT04529005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101573908|NCT04529005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573909|NCT05357040|Nitrous Oxide|nitrous oxide|mesh-list
101573910|NCT05357040|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101573911|NCT05357040|Anesthetics, General|anesthetics, general|mesh-ancestor
101573912|NCT05357040|Anesthetics|anesthetics|mesh-ancestor
101573913|NCT05357040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101573914|NCT05357040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573915|NCT05357040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101573916|NCT05357040|Analgesics|analgesics|mesh-ancestor
101573917|NCT05357040|Sensory System Agents|sensory system agents|mesh-ancestor
101573918|NCT05357040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101573919|NCT00943072|Aflibercept|aflibercept|mesh-list
101573920|NCT00943072|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101573921|NCT00943072|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101573922|NCT00943072|Growth Substances|growth substances|mesh-ancestor
101573923|NCT00943072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573924|NCT00943072|Growth Inhibitors|growth inhibitors|mesh-ancestor
101573925|NCT00943072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101573926|NCT04222855|Diltiazem|diltiazem|mesh-list
101573927|NCT04222855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102096764|NCT04977778|Cariostatic Agents|cariostatic agents|mesh-ancestor
101573928|NCT04222855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101573929|NCT04222855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101573930|NCT04222855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573931|NCT04222855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101573932|NCT04222855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573933|NCT04222855|Vasodilator Agents|vasodilator agents|mesh-ancestor
101573934|NCT00942994|Amlodipine|amlodipine|mesh-list
101573935|NCT00942994|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101573936|NCT00942994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101573937|NCT00942994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101573938|NCT00942994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101573939|NCT00942994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573940|NCT00942994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101573941|NCT00942994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573942|NCT00942994|Vasodilator Agents|vasodilator agents|mesh-ancestor
101573943|NCT00942994|Diuretics|diuretics|mesh-ancestor
101573944|NCT00942994|Natriuretic Agents|natriuretic agents|mesh-ancestor
101573945|NCT00942994|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101573946|NCT04268602|Anesthetics|anesthetics|mesh-list
101573947|NCT04268602|Anesthetics, Local|anesthetics, local|mesh-list
101573948|NCT04268602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101573949|NCT04268602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573950|NCT04268602|Sensory System Agents|sensory system agents|mesh-ancestor
101573951|NCT04268602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101573952|NCT04314336|Coal Tar|coal tar|mesh-list
101573953|NCT04314336|Keratolytic Agents|keratolytic agents|mesh-ancestor
101573954|NCT04314336|Dermatologic Agents|dermatologic agents|mesh-ancestor
101573955|NCT00624702|Maleic acid|maleic acid|mesh-list
101573956|NCT00624702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101573957|NCT00624702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573958|NCT02756377|Chlorhexidine|chlorhexidine|mesh-list
101573959|NCT02756377|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101573960|NCT02756377|Cetylpyridinium|cetylpyridinium|mesh-list
102154365|NCT02237755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154366|NCT02237755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102154367|NCT02237755|Hormone Antagonists|hormone antagonists|mesh-ancestor
102154368|NCT02237755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102154369|NCT02237755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154370|NCT02237755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102154371|NCT02237755|Fertility Agents|fertility agents|mesh-ancestor
102154372|NCT02237755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102154373|NCT02237755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102154374|NCT02237755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102154375|NCT04524897|Triamcinolone|triamcinolone|mesh-list
102154376|NCT04524897|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102154377|NCT04524897|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102154378|NCT04524897|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102154379|NCT04524897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102154380|NCT04524897|Glucocorticoids|glucocorticoids|mesh-ancestor
102154381|NCT04524897|Hormones|hormones|mesh-ancestor
102154382|NCT04524897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102154383|NCT04524897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154384|NCT04524897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102154385|NCT04524897|Immunologic Factors|immunologic factors|mesh-ancestor
102154386|NCT04524897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102154387|NCT04524897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154388|NCT03364569|Tranexamic Acid|tranexamic acid|mesh-list
102154389|NCT03364569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102154390|NCT03364569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102154391|NCT03364569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154392|NCT03364569|Hemostatics|hemostatics|mesh-ancestor
102154393|NCT03364569|Coagulants|coagulants|mesh-ancestor
102154394|NCT03363477|Enoxaparin|enoxaparin|mesh-list
102154395|NCT03363477|Enoxaparin sodium|enoxaparin sodium|mesh-list
102154396|NCT03363477|Anticoagulants|anticoagulants|mesh-ancestor
102154397|NCT03363477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102154398|NCT03363477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102154399|NCT03363477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154400|NCT03593707|Metformin|metformin|mesh-list
102154401|NCT03593707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102154402|NCT03593707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154403|NCT03592537|Fentanyl|fentanyl|mesh-list
102154404|NCT03592537|Midazolam|midazolam|mesh-list
102154405|NCT03592537|Bupivacaine|bupivacaine|mesh-list
102154406|NCT03592537|Anesthetics, Local|anesthetics, local|mesh-ancestor
102154407|NCT03592537|Anesthetics|anesthetics|mesh-ancestor
102154408|NCT03592537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102154409|NCT03592537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154410|NCT03592537|Sensory System Agents|sensory system agents|mesh-ancestor
102154411|NCT03592537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102154412|NCT03592537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102154413|NCT03592537|Narcotics|narcotics|mesh-ancestor
102154414|NCT03592537|Analgesics|analgesics|mesh-ancestor
102154415|NCT03592537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102154416|NCT03592537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102154417|NCT03592537|Anesthetics, General|anesthetics, general|mesh-ancestor
102154418|NCT03592537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102154419|NCT03592537|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102154420|NCT03592537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102154421|NCT03592537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102154422|NCT03592537|GABA Modulators|gaba modulators|mesh-ancestor
102154423|NCT03592537|GABA Agents|gaba agents|mesh-ancestor
102154424|NCT03592537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102154425|NCT03592537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154426|NCT03362853|Moxifloxacin|moxifloxacin|mesh-list
102154427|NCT03362853|Nemonoxacin|nemonoxacin|mesh-list
102154428|NCT03362853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102154429|NCT03362853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102154430|NCT03362853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101863307|NCT01095172|Antiemetics|antiemetics|mesh-ancestor
102154431|NCT03362853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102154432|NCT03362853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102154433|NCT03362853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154434|NCT03362853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102154435|NCT02849743|Oxytocin|oxytocin|mesh-list
102154436|NCT02849743|Oxytocics|oxytocics|mesh-ancestor
102154437|NCT02849743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102154438|NCT02849743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154439|NCT05063006|Methamphetamine|methamphetamine|mesh-list
102154441|NCT05063006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154442|NCT05063006|Sympathomimetics|sympathomimetics|mesh-ancestor
102154443|NCT05063006|Autonomic Agents|autonomic agents|mesh-ancestor
102154444|NCT05063006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102154445|NCT05063006|Dopamine Agents|dopamine agents|mesh-ancestor
102154446|NCT05063006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102154447|NCT05063006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154448|NCT05063006|Adrenergic Agents|adrenergic agents|mesh-ancestor
102154449|NCT05063006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102154450|NCT05063006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102154451|NCT05063006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102154452|NCT05063006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102154453|NCT03587077|Isosorbide|isosorbide|mesh-list
102154454|NCT03587077|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
102154455|NCT03587077|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
102154456|NCT03587077|Misoprostol|misoprostol|mesh-list
102154457|NCT03587077|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102154458|NCT03587077|Abortifacient Agents|abortifacient agents|mesh-ancestor
102154459|NCT03587077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102154460|NCT03587077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154461|NCT03587077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102154462|NCT03587077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102154463|NCT03587077|Oxytocics|oxytocics|mesh-ancestor
102154464|NCT03587077|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102154465|NCT03587077|Diuretics|diuretics|mesh-ancestor
102154466|NCT03587077|Natriuretic Agents|natriuretic agents|mesh-ancestor
102154467|NCT03587077|Vasodilator Agents|vasodilator agents|mesh-ancestor
102154468|NCT03587077|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102154469|NCT03587077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154470|NCT02238457|Losartan|losartan|mesh-list
102154471|NCT02238457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102154472|NCT02238457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102154473|NCT02238457|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102154474|NCT02238457|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102154475|NCT02238457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154476|NCT02238535|Iloprost|iloprost|mesh-list
102154477|NCT02238535|Warfarin|warfarin|mesh-list
102154478|NCT02238535|Anticoagulants|anticoagulants|mesh-ancestor
102154479|NCT02238535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102154480|NCT02238535|Vasodilator Agents|vasodilator agents|mesh-ancestor
102154481|NCT03362697|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102154482|NCT03362697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102154483|NCT03909074|Vaccines|vaccines|mesh-list
102154484|NCT03909074|Immunologic Factors|immunologic factors|mesh-ancestor
102154485|NCT03909074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154486|NCT03138668|Ropivacaine|ropivacaine|mesh-list
102154487|NCT03138668|Anesthetics, Local|anesthetics, local|mesh-ancestor
102154488|NCT03138668|Anesthetics|anesthetics|mesh-ancestor
102154489|NCT03138668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102154490|NCT03138668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154491|NCT03138668|Sensory System Agents|sensory system agents|mesh-ancestor
102154492|NCT03138668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102154493|NCT03371043|Analgesics|analgesics|mesh-list
102154494|NCT03371043|Sensory System Agents|sensory system agents|mesh-ancestor
102154495|NCT03371043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102154496|NCT03371043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154497|NCT03600961|Sirolimus|sirolimus|mesh-list
102154498|NCT03600961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102154499|NCT03600961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102154500|NCT03600961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102154501|NCT03600961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102154502|NCT03600961|Antifungal Agents|antifungal agents|mesh-ancestor
102154503|NCT03600961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102154504|NCT03600961|Immunologic Factors|immunologic factors|mesh-ancestor
101863389|NCT00062374|Deoxyglucose|deoxyglucose|mesh-list
102154505|NCT03600961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154506|NCT05013242|Goserelin|goserelin|mesh-list
102154507|NCT05013242|Dienogest|dienogest|mesh-list
102154508|NCT05013242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102154509|NCT05013242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102154510|NCT05013242|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102154511|NCT05013242|Contraceptive Agents|contraceptive agents|mesh-ancestor
102154512|NCT05013242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102154513|NCT05013242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154514|NCT05013242|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102154515|NCT05013242|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102154516|NCT05013242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102154517|NCT05013242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102154518|NCT05013242|Hormone Antagonists|hormone antagonists|mesh-ancestor
102154519|NCT05013242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102154520|NCT05089604|Tacrolimus|tacrolimus|mesh-list
102154521|NCT05089604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102154522|NCT05089604|Immunologic Factors|immunologic factors|mesh-ancestor
102154523|NCT05089604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154524|NCT05089604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102154525|NCT05089604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102154526|NCT05089604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154527|NCT03590275|Folfirinox|folfirinox|mesh-list
102154528|NCT03590275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102154529|NCT05089448|Amlodipine|amlodipine|mesh-list
102154530|NCT05089448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102154531|NCT05089448|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102154532|NCT05089448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102154533|NCT05089448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154534|NCT05089448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102154535|NCT05089448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154536|NCT05089448|Vasodilator Agents|vasodilator agents|mesh-ancestor
102154537|NCT00601003|Nifurtimox|nifurtimox|mesh-list
102154538|NCT00601003|Cyclophosphamide|cyclophosphamide|mesh-list
102154539|NCT00601003|Topotecan|topotecan|mesh-list
102154540|NCT00601003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102154541|NCT00601003|Immunologic Factors|immunologic factors|mesh-ancestor
102154542|NCT00601003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154543|NCT00601003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102154544|NCT00601003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102154545|NCT00601003|Alkylating Agents|alkylating agents|mesh-ancestor
102154546|NCT00601003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154547|NCT00601003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102154548|NCT00601003|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102154549|NCT00601003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102154550|NCT00601003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102154551|NCT00601003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102154552|NCT00601003|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102154553|NCT00601003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102154554|NCT00601003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102154555|NCT00601003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102154556|NCT02849509|Vitamin K|vitamin k|mesh-list
102154557|NCT02849509|Dabigatran|dabigatran|mesh-list
102154558|NCT02849509|Vitamins|vitamins|mesh-ancestor
102154559|NCT02849509|Micronutrients|micronutrients|mesh-ancestor
102154560|NCT02849509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154561|NCT02849509|Antithrombins|antithrombins|mesh-ancestor
102154562|NCT02849509|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102154563|NCT02849509|Protease Inhibitors|protease inhibitors|mesh-ancestor
102154564|NCT02849509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102154565|NCT02849509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154566|NCT02849509|Anticoagulants|anticoagulants|mesh-ancestor
102154567|NCT02849509|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102154568|NCT02849509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102154569|NCT02849509|Hemostatics|hemostatics|mesh-ancestor
102154570|NCT02849509|Coagulants|coagulants|mesh-ancestor
102154571|NCT00151424|Olanzapine|olanzapine|mesh-list
102154572|NCT00151424|Asenapine|asenapine|mesh-list
102154573|NCT00151424|Antiemetics|antiemetics|mesh-ancestor
102154574|NCT00151424|Autonomic Agents|autonomic agents|mesh-ancestor
102154575|NCT00151424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102154576|NCT00151424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154577|NCT00151424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102154578|NCT00151424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102154579|NCT00151424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102154580|NCT00151424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102154581|NCT00151424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102154582|NCT00151424|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102154583|NCT00151424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101696381|NCT02671864|Incretins|incretins|mesh-list
102154584|NCT00151424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102154585|NCT00151424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154586|NCT00151424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102154587|NCT00151424|Serotonin Agents|serotonin agents|mesh-ancestor
102154588|NCT03600727|Dexmedetomidine|dexmedetomidine|mesh-list
102154589|NCT03600727|Propofol|propofol|mesh-list
102154590|NCT03600727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102154591|NCT03600727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102154592|NCT03600727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154593|NCT03600727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102154594|NCT03600727|Analgesics|analgesics|mesh-ancestor
102154595|NCT03600727|Sensory System Agents|sensory system agents|mesh-ancestor
102154596|NCT03600727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102154597|NCT03600727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102154598|NCT03600727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102154599|NCT03600727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102154600|NCT03600727|Adrenergic Agents|adrenergic agents|mesh-ancestor
102154601|NCT03600727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102154602|NCT03600727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154603|NCT03600727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102154604|NCT03600727|Anesthetics, General|anesthetics, general|mesh-ancestor
102154605|NCT03600727|Anesthetics|anesthetics|mesh-ancestor
102154606|NCT02733133|Testosterone|testosterone|mesh-list
102154607|NCT02733133|Androgens|androgens|mesh-ancestor
102154608|NCT02733133|Hormones|hormones|mesh-ancestor
102154609|NCT02733133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102154610|NCT02733133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154611|NCT03584893|Dehydrocholesterols|dehydrocholesterols|mesh-list
102154612|NCT03584893|Provitamins|provitamins|mesh-ancestor
102154613|NCT03584893|Vitamins|vitamins|mesh-ancestor
102154614|NCT03584893|Micronutrients|micronutrients|mesh-ancestor
102154615|NCT03584893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154616|NCT03362073|Ketamine|ketamine|mesh-list
102154617|NCT03362073|Analgesics|analgesics|mesh-ancestor
102154618|NCT03362073|Sensory System Agents|sensory system agents|mesh-ancestor
102154619|NCT03362073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102154620|NCT03362073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154621|NCT03362073|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102154622|NCT03362073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102154623|NCT03362073|Anesthetics, General|anesthetics, general|mesh-ancestor
102154624|NCT03362073|Anesthetics|anesthetics|mesh-ancestor
102154625|NCT03362073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102154626|NCT03362073|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102154627|NCT03362073|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102154628|NCT03362073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102154629|NCT03362073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154630|NCT03582865|Tamoxifen|tamoxifen|mesh-list
102154631|NCT03582865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102154632|NCT03582865|Hormone Antagonists|hormone antagonists|mesh-ancestor
102154633|NCT03582865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102154634|NCT03582865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154635|NCT03582865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102154636|NCT03582865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102154637|NCT03582865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102154638|NCT03582865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102154639|NCT03582865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102154640|NCT03136406|Leucovorin|leucovorin|mesh-list
102154641|NCT03136406|Paclitaxel|paclitaxel|mesh-list
102154642|NCT03136406|Cyclophosphamide|cyclophosphamide|mesh-list
102154643|NCT03136406|Bevacizumab|bevacizumab|mesh-list
102154644|NCT03136406|Fluorouracil|fluorouracil|mesh-list
102154645|NCT03136406|Capecitabine|capecitabine|mesh-list
102154646|NCT03136406|Oxaliplatin|oxaliplatin|mesh-list
102154647|NCT03136406|Avelumab|avelumab|mesh-list
102154648|NCT03136406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102154649|NCT03136406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102154650|NCT03136406|Tubulin Modulators|tubulin modulators|mesh-ancestor
102154651|NCT03136406|Antimitotic Agents|antimitotic agents|mesh-ancestor
102154652|NCT03136406|Mitosis Modulators|mitosis modulators|mesh-ancestor
102154653|NCT03136406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154654|NCT03136406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102154655|NCT03136406|Immunologic Factors|immunologic factors|mesh-ancestor
102154656|NCT03136406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154657|NCT03136406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102154658|NCT03136406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102154659|NCT03136406|Alkylating Agents|alkylating agents|mesh-ancestor
102154660|NCT03136406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102154661|NCT03136406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102154662|NCT03136406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102154663|NCT03136406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102154664|NCT03136406|Growth Substances|growth substances|mesh-ancestor
102154665|NCT03136406|Growth Inhibitors|growth inhibitors|mesh-ancestor
102154666|NCT03136406|Antimetabolites|antimetabolites|mesh-ancestor
102154667|NCT03136406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102154668|NCT03136406|Antidotes|antidotes|mesh-ancestor
102154669|NCT03136406|Protective Agents|protective agents|mesh-ancestor
102154670|NCT03136406|Vitamin B Complex|vitamin b complex|mesh-ancestor
102154671|NCT03136406|Vitamins|vitamins|mesh-ancestor
102154672|NCT03136406|Micronutrients|micronutrients|mesh-ancestor
102154673|NCT03590197|Melatonin|melatonin|mesh-list
102154674|NCT03590197|Antioxidants|antioxidants|mesh-ancestor
102154675|NCT03590197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154676|NCT03590197|Protective Agents|protective agents|mesh-ancestor
102154677|NCT03590197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154678|NCT03590197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102154679|NCT03357315|Immunomodulating Agents|immunomodulating agents|mesh-list
102154680|NCT03357315|Immunologic Factors|immunologic factors|mesh-ancestor
102154681|NCT03357315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154682|NCT05057468|Cyclosporine|cyclosporine|mesh-list
102154683|NCT05057468|Rituximab|rituximab|mesh-list
102154684|NCT05057468|Cyclosporins|cyclosporins|mesh-list
102154685|NCT05057468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102154686|NCT05057468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102154687|NCT05057468|Immunologic Factors|immunologic factors|mesh-ancestor
102154688|NCT05057468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154689|NCT05057468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102154690|NCT05057468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102154691|NCT05057468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154692|NCT05057468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102154693|NCT05057468|Antifungal Agents|antifungal agents|mesh-ancestor
102154694|NCT05057468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102154695|NCT05057468|Dermatologic Agents|dermatologic agents|mesh-ancestor
102154696|NCT05057468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102154697|NCT02518503|Atorvastatin|atorvastatin|mesh-list
102154698|NCT02518503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102154699|NCT02518503|Simvastatin|simvastatin|mesh-list
102154700|NCT02518503|Pravastatin|pravastatin|mesh-list
102154701|NCT02518503|Lovastatin|lovastatin|mesh-list
102154702|NCT02518503|L 647318|l 647318|mesh-list
102154703|NCT02518503|Dihydromevinolin|dihydromevinolin|mesh-list
102154704|NCT02518503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102154705|NCT02518503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102154706|NCT02518503|Antimetabolites|antimetabolites|mesh-ancestor
102154707|NCT02518503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154708|NCT02518503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102154709|NCT02518503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102154710|NCT02518503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102154711|NCT03600493|Lidocaine|lidocaine|mesh-list
102154712|NCT03600493|Dexmedetomidine|dexmedetomidine|mesh-list
102154713|NCT03600493|Anesthetics, Local|anesthetics, local|mesh-ancestor
102154714|NCT03600493|Anesthetics|anesthetics|mesh-ancestor
102154715|NCT03600493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102154716|NCT03600493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154717|NCT03600493|Sensory System Agents|sensory system agents|mesh-ancestor
102154718|NCT03600493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102154719|NCT03600493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102154720|NCT03600493|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102154721|NCT03600493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102154722|NCT03600493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102154723|NCT03600493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154724|NCT03600493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102154725|NCT03600493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102154726|NCT03600493|Analgesics|analgesics|mesh-ancestor
102154727|NCT03600493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102154728|NCT03600493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102154729|NCT03600493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102154730|NCT03600493|Adrenergic Agents|adrenergic agents|mesh-ancestor
102154731|NCT03600493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102154732|NCT03138356|Metformin|metformin|mesh-list
102154733|NCT03138356|Dapagliflozin|dapagliflozin|mesh-list
102154734|NCT03138356|Saxagliptin|saxagliptin|mesh-list
102154735|NCT03138356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102154736|NCT03138356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154737|NCT03138356|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102154738|NCT03138356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154739|NCT03138356|Incretins|incretins|mesh-ancestor
102154740|NCT03138356|Hormones|hormones|mesh-ancestor
102154741|NCT03138356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102154742|NCT03138356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102154743|NCT03138356|Protease Inhibitors|protease inhibitors|mesh-ancestor
102154744|NCT03138356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102154745|NCT03137966|Deferoxamine|deferoxamine|mesh-list
102154746|NCT03137966|Siderophores|siderophores|mesh-ancestor
102154747|NCT03137966|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102154748|NCT03137966|Chelating Agents|chelating agents|mesh-ancestor
102154749|NCT03137966|Sequestering Agents|sequestering agents|mesh-ancestor
102154750|NCT03137966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154751|NCT02853305|Carboplatin|carboplatin|mesh-list
102154752|NCT02853305|Gemcitabine|gemcitabine|mesh-list
102154753|NCT02853305|Pembrolizumab|pembrolizumab|mesh-list
102154754|NCT02853305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102154755|NCT02853305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102154756|NCT02853305|Antimetabolites|antimetabolites|mesh-ancestor
102154757|NCT02853305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154758|NCT02853305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102154759|NCT02853305|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102154760|NCT04521387|Hyaluronic Acid|hyaluronic acid|mesh-list
102154761|NCT04521387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102154762|NCT04521387|Immunologic Factors|immunologic factors|mesh-ancestor
102154763|NCT04521387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154764|NCT04521387|Viscosupplements|viscosupplements|mesh-ancestor
102154765|NCT04521387|Protective Agents|protective agents|mesh-ancestor
102154766|NCT03579979|Methylene Blue|methylene blue|mesh-list
102154767|NCT03579979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102154768|NCT03579979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154769|NCT04509219|Methylprednisolone|methylprednisolone|mesh-list
102154770|NCT04509219|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102154771|NCT04509219|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102154772|NCT04509219|Prednisolone|prednisolone|mesh-list
102154773|NCT04509219|Prednisolone acetate|prednisolone acetate|mesh-list
102154774|NCT04509219|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102154775|NCT04509219|Prednisolone phosphate|prednisolone phosphate|mesh-list
102154776|NCT04509219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102154777|NCT04509219|Antiemetics|antiemetics|mesh-ancestor
102154778|NCT04509219|Autonomic Agents|autonomic agents|mesh-ancestor
102154779|NCT04509219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102154780|NCT04509219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154781|NCT04509219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102154782|NCT04509219|Glucocorticoids|glucocorticoids|mesh-ancestor
102154783|NCT04509219|Hormones|hormones|mesh-ancestor
102154784|NCT04509219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102154785|NCT04509219|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102154786|NCT04509219|Protective Agents|protective agents|mesh-ancestor
102154787|NCT04509219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102154788|NCT04509219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102154789|NCT04444635|Fentanyl|fentanyl|mesh-list
102154790|NCT04444635|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102154791|NCT04444635|Narcotics|narcotics|mesh-ancestor
102154792|NCT04444635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102154793|NCT04444635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154794|NCT04444635|Analgesics|analgesics|mesh-ancestor
102154795|NCT04444635|Sensory System Agents|sensory system agents|mesh-ancestor
102154796|NCT04444635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102154797|NCT04444635|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102154798|NCT04444635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102154799|NCT04444635|Anesthetics, General|anesthetics, general|mesh-ancestor
102154800|NCT04444635|Anesthetics|anesthetics|mesh-ancestor
102154801|NCT03033446|Nivolumab|nivolumab|mesh-list
102154802|NCT03033446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102154803|NCT03033446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102154804|NCT03033446|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102154805|NCT03033446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154806|NCT03579823|Adalimumab|adalimumab|mesh-list
102154807|NCT03579823|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102154808|NCT03579823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102154809|NCT03579823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102154811|NCT04444011|Clarithromycin|clarithromycin|mesh-list
102154812|NCT04444011|Bismuth|bismuth|mesh-list
102154813|NCT04444011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102154814|NCT04444011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102154815|NCT04444011|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102154816|NCT04444011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102154817|NCT04444011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154818|NCT04444011|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102154819|NCT04444011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102154820|NCT04444011|Antacids|antacids|mesh-ancestor
102154821|NCT04444011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102154822|NCT04443387|Vitamin D|vitamin d|mesh-list
102154823|NCT04443387|Vitamins|vitamins|mesh-ancestor
102154824|NCT04443387|Micronutrients|micronutrients|mesh-ancestor
102154825|NCT04443387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154826|NCT04443387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102154827|NCT02316236|Dexmedetomidine|dexmedetomidine|mesh-list
102154828|NCT02316236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102154829|NCT02316236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102154830|NCT02316236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154831|NCT02316236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102154832|NCT02316236|Analgesics|analgesics|mesh-ancestor
102154833|NCT02316236|Sensory System Agents|sensory system agents|mesh-ancestor
102154834|NCT02316236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102154835|NCT02316236|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102154836|NCT02316236|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102154837|NCT02316236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102154838|NCT02316236|Adrenergic Agents|adrenergic agents|mesh-ancestor
102154839|NCT02316236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102154840|NCT02316236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154841|NCT04521075|Nivolumab|nivolumab|mesh-list
102154842|NCT04521075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102154843|NCT04521075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102154844|NCT04521075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102154845|NCT04521075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154846|NCT03577249|Dialysis Solutions|dialysis solutions|mesh-list
102154847|NCT03577249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102154848|NCT03601091|Midazolam|midazolam|mesh-list
102154849|NCT03601091|Dexmedetomidine|dexmedetomidine|mesh-list
102154850|NCT03601091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102154851|NCT03601091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102154852|NCT03601091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154853|NCT03601091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102154854|NCT03601091|Analgesics|analgesics|mesh-ancestor
102154855|NCT03601091|Sensory System Agents|sensory system agents|mesh-ancestor
102154856|NCT03601091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102154857|NCT03601091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102154858|NCT03601091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102154859|NCT03601091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102154860|NCT03601091|Adrenergic Agents|adrenergic agents|mesh-ancestor
102154861|NCT03601091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102154862|NCT03601091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154863|NCT03601091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102154864|NCT03601091|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102154865|NCT03601091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102154866|NCT03601091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102154867|NCT03601091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102154868|NCT03601091|Anesthetics, General|anesthetics, general|mesh-ancestor
102154869|NCT03601091|Anesthetics|anesthetics|mesh-ancestor
102154870|NCT03601091|GABA Modulators|gaba modulators|mesh-ancestor
102154871|NCT03601091|GABA Agents|gaba agents|mesh-ancestor
102154872|NCT04508829|Antibodies|antibodies|mesh-list
102154873|NCT04508829|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102154874|NCT04508829|Immunologic Factors|immunologic factors|mesh-ancestor
102154875|NCT04508829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154876|NCT04521309|Antibodies|antibodies|mesh-list
102154877|NCT04521309|Immunologic Factors|immunologic factors|mesh-ancestor
102154878|NCT04521309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154879|NCT02267252|Antibodies|antibodies|mesh-list
102154880|NCT02267252|Immunologic Factors|immunologic factors|mesh-ancestor
102154881|NCT02267252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154882|NCT04521153|Apatinib|apatinib|mesh-list
101863755|NCT00454805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102154883|NCT04521153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102154884|NCT04521153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102154885|NCT04521153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102154886|NCT04521153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154887|NCT04362566|Bupivacaine|bupivacaine|mesh-list
102154888|NCT04362566|Anesthetics, Local|anesthetics, local|mesh-ancestor
102154889|NCT04362566|Anesthetics|anesthetics|mesh-ancestor
102154890|NCT04362566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102154891|NCT04362566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154892|NCT04362566|Sensory System Agents|sensory system agents|mesh-ancestor
102154893|NCT04362566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102154894|NCT03579589|Neostigmine|neostigmine|mesh-list
102154895|NCT03579589|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102154896|NCT03579589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102154897|NCT03579589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154898|NCT03579589|Cholinergic Agents|cholinergic agents|mesh-ancestor
102154899|NCT03579589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102154900|NCT03579589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154901|NCT03579589|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102154902|NCT03579589|Autonomic Agents|autonomic agents|mesh-ancestor
102154903|NCT03579589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102154904|NCT03600857|Misoprostol|misoprostol|mesh-list
102154905|NCT03600857|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102154906|NCT03600857|Abortifacient Agents|abortifacient agents|mesh-ancestor
102154907|NCT03600857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102154908|NCT03600857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154909|NCT03600857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102154910|NCT03600857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102154911|NCT03600857|Oxytocics|oxytocics|mesh-ancestor
102154912|NCT02229968|Aminocaproic Acid|aminocaproic acid|mesh-list
102154913|NCT02229968|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102154914|NCT02229968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102154915|NCT02229968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154916|NCT02229968|Hemostatics|hemostatics|mesh-ancestor
102154917|NCT02229968|Coagulants|coagulants|mesh-ancestor
102154918|NCT03600623|Paclitaxel|paclitaxel|mesh-list
102154919|NCT03600623|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102154920|NCT03600623|Gemcitabine|gemcitabine|mesh-list
102154921|NCT03600623|Fluorouracil|fluorouracil|mesh-list
102154922|NCT03600623|Oxaliplatin|oxaliplatin|mesh-list
102154923|NCT03600623|Irinotecan|irinotecan|mesh-list
102154924|NCT03600623|Folfirinox|folfirinox|mesh-list
102154925|NCT03600623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102154926|NCT03600623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102154927|NCT03600623|Tubulin Modulators|tubulin modulators|mesh-ancestor
102154928|NCT03600623|Antimitotic Agents|antimitotic agents|mesh-ancestor
102154929|NCT03600623|Mitosis Modulators|mitosis modulators|mesh-ancestor
102154930|NCT03600623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154931|NCT03600623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102154932|NCT03600623|Antimetabolites|antimetabolites|mesh-ancestor
102154933|NCT03600623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102154934|NCT03600623|Immunologic Factors|immunologic factors|mesh-ancestor
102154935|NCT03600623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154936|NCT03600623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102154937|NCT03600623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102154938|NCT03600623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102154939|NCT02848729|Acetaminophen|acetaminophen|mesh-list
102154940|NCT02848729|Morphine|morphine|mesh-list
102154941|NCT02848729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102154942|NCT02848729|Narcotics|narcotics|mesh-ancestor
102154943|NCT02848729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102154944|NCT02848729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154945|NCT02848729|Analgesics|analgesics|mesh-ancestor
102154946|NCT02848729|Sensory System Agents|sensory system agents|mesh-ancestor
102154947|NCT02848729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102154948|NCT02848729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102154949|NCT02848729|Antipyretics|antipyretics|mesh-ancestor
102154950|NCT03600467|Seviteronel|seviteronel|mesh-list
102154951|NCT03600467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102154952|NCT03600467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102154953|NCT03600467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102154954|NCT03600467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102154955|NCT05737784|Pramoxine|pramoxine|mesh-list
102154956|NCT05737784|Anesthetics, Local|anesthetics, local|mesh-ancestor
102154957|NCT05737784|Anesthetics|anesthetics|mesh-ancestor
102154958|NCT05737784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102154960|NCT05737784|Sensory System Agents|sensory system agents|mesh-ancestor
102154961|NCT05737784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102154962|NCT04520919|Anesthetics|anesthetics|mesh-list
102154963|NCT04520919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102154964|NCT04520919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154965|NCT03600311|Vitamin D|vitamin d|mesh-list
102154966|NCT03600311|Calcium|calcium|mesh-list
102154967|NCT03600311|Vitamins|vitamins|mesh-ancestor
102154968|NCT03600311|Micronutrients|micronutrients|mesh-ancestor
102154969|NCT03600311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154970|NCT03600311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102154971|NCT03600311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102154972|NCT04562324|Antipsychotic Agents|antipsychotic agents|mesh-list
102154973|NCT04562324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
102154974|NCT04562324|Antidepressive Agents|antidepressive agents|mesh-list
102154975|NCT04562324|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
102154976|NCT04562324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102154977|NCT04562324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102154978|NCT04562324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102154979|NCT04562324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154980|NCT03603119|Dexamethasone|dexamethasone|mesh-list
102154981|NCT03603119|Midazolam|midazolam|mesh-list
102154982|NCT03603119|Ondansetron|ondansetron|mesh-list
102154983|NCT03603119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102154984|NCT03603119|Antiemetics|antiemetics|mesh-ancestor
102154985|NCT03603119|Autonomic Agents|autonomic agents|mesh-ancestor
102154986|NCT03603119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102154987|NCT03603119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102154988|NCT03603119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102154989|NCT03603119|Glucocorticoids|glucocorticoids|mesh-ancestor
102154990|NCT03603119|Hormones|hormones|mesh-ancestor
102154991|NCT03603119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102154992|NCT03603119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102154993|NCT03603119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102154994|NCT03603119|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102154995|NCT03603119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102154996|NCT03603119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102154997|NCT03603119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102154998|NCT03603119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102154999|NCT03603119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102155000|NCT03603119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102155001|NCT03603119|Anesthetics, General|anesthetics, general|mesh-ancestor
102155002|NCT03603119|Anesthetics|anesthetics|mesh-ancestor
102155003|NCT03603119|GABA Modulators|gaba modulators|mesh-ancestor
102155004|NCT03603119|GABA Agents|gaba agents|mesh-ancestor
102155005|NCT03603119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102155006|NCT03603119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155007|NCT03603119|Antipruritics|antipruritics|mesh-ancestor
102155008|NCT03603119|Dermatologic Agents|dermatologic agents|mesh-ancestor
102155009|NCT03603119|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102155010|NCT03603119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102155011|NCT03603119|Serotonin Agents|serotonin agents|mesh-ancestor
102155012|NCT03356769|Aspirin|aspirin|mesh-list
102155013|NCT03356769|Anticonvulsants|anticonvulsants|mesh-list
102155014|NCT03356769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102155015|NCT03356769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102155016|NCT03356769|Analgesics|analgesics|mesh-ancestor
102155017|NCT03356769|Sensory System Agents|sensory system agents|mesh-ancestor
102155018|NCT03356769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102155019|NCT03356769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155020|NCT03356769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102155021|NCT03356769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102155022|NCT03356769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102155023|NCT03356769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102155024|NCT03356769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155025|NCT03356769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102155026|NCT03356769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102155027|NCT03356769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102155028|NCT03356769|Antipyretics|antipyretics|mesh-ancestor
102155029|NCT04508439|Heparin|heparin|mesh-list
102155030|NCT04508439|Enoxaparin|enoxaparin|mesh-list
102155031|NCT04508439|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102155032|NCT04508439|Tinzaparin|tinzaparin|mesh-list
102155033|NCT04508439|Dalteparin|dalteparin|mesh-list
102155035|NCT04508439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102155036|NCT04508439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101863903|NCT01095640|Adapalene|adapalene|mesh-list
102155037|NCT04508439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155038|NCT02237651|Anesthetics|anesthetics|mesh-list
102155039|NCT02237651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102155040|NCT02237651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155041|NCT02237729|Adalimumab|adalimumab|mesh-list
102155042|NCT02237729|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102155043|NCT02237729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102155044|NCT02237729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102155045|NCT02238119|Formoterol Fumarate|formoterol fumarate|mesh-list
102155046|NCT02238119|Tiotropium Bromide|tiotropium bromide|mesh-list
102155047|NCT02238119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102155048|NCT02238119|Autonomic Agents|autonomic agents|mesh-ancestor
102155049|NCT02238119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102155050|NCT02238119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155051|NCT02238119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102155052|NCT02238119|Respiratory System Agents|respiratory system agents|mesh-ancestor
102155053|NCT02238119|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102155054|NCT02238119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102155055|NCT02238119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102155056|NCT02238119|Adrenergic Agents|adrenergic agents|mesh-ancestor
102155057|NCT02238119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102155058|NCT02238119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155059|NCT02238119|Parasympatholytics|parasympatholytics|mesh-ancestor
102155060|NCT02238119|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102155061|NCT02238119|Cholinergic Agents|cholinergic agents|mesh-ancestor
102155062|NCT03354117|Meloxicam|meloxicam|mesh-list
102155063|NCT03354117|Ulipristal acetate|ulipristal acetate|mesh-list
102155064|NCT03354117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102155065|NCT03354117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102155066|NCT03354117|Analgesics|analgesics|mesh-ancestor
102155067|NCT03354117|Sensory System Agents|sensory system agents|mesh-ancestor
102155068|NCT03354117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102155069|NCT03354117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155070|NCT03354117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102155071|NCT03354117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102155072|NCT03354117|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102155073|NCT03354117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102155074|NCT03354117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102155075|NCT03354117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155076|NCT03354117|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102155077|NCT03354117|Contraceptive Agents|contraceptive agents|mesh-ancestor
102155078|NCT03354117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102155079|NCT03354117|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102155080|NCT03360981|Incretins|incretins|mesh-list
102155081|NCT03360981|Hormones|hormones|mesh-ancestor
102155082|NCT03360981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102155083|NCT03360981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155084|NCT03597815|Aflibercept|aflibercept|mesh-list
102155085|NCT03597815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102155086|NCT03597815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102155087|NCT03597815|Growth Substances|growth substances|mesh-ancestor
102155088|NCT03597815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155089|NCT03597815|Growth Inhibitors|growth inhibitors|mesh-ancestor
102155090|NCT03597815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102155091|NCT03595085|Streptokinase|streptokinase|mesh-list
102155092|NCT03595085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102155093|NCT03595085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102155094|NCT03595085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155095|NCT00158756|Vaccines|vaccines|mesh-list
102155096|NCT00158756|Immunologic Factors|immunologic factors|mesh-ancestor
102155097|NCT00158756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155098|NCT03353883|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102155099|NCT03353883|Luteolytic Agents|luteolytic agents|mesh-ancestor
102155100|NCT03353883|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102155101|NCT03353883|Contraceptive Agents|contraceptive agents|mesh-ancestor
102155102|NCT03353883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102155103|NCT03353883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155104|NCT03353883|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102155105|NCT03353883|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102155106|NCT03353883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102155107|NCT03885713|Adalimumab|adalimumab|mesh-list
102155108|NCT03885713|Infliximab|infliximab|mesh-list
102155109|NCT03885713|Golimumab|golimumab|mesh-list
101863976|NCT01070732|Antipyretics|antipyretics|mesh-ancestor
102155110|NCT03885713|Ustekinumab|ustekinumab|mesh-list
102155111|NCT03885713|Vedolizumab|vedolizumab|mesh-list
102155112|NCT03885713|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102155113|NCT03885713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102155114|NCT03885713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102155115|NCT03885713|Dermatologic Agents|dermatologic agents|mesh-ancestor
102155116|NCT03885713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102155117|NCT03885713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102155118|NCT03885713|Immunologic Factors|immunologic factors|mesh-ancestor
102155119|NCT03885713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155120|NCT04519125|Tenofovir|tenofovir|mesh-list
102155121|NCT04519125|Emtricitabine|emtricitabine|mesh-list
102155122|NCT04519125|Antiviral Agents|antiviral agents|mesh-ancestor
102155123|NCT04519125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102155124|NCT04519125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102155125|NCT04519125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102155126|NCT04519125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102155127|NCT04519125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155128|NCT04519125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102155129|NCT04519125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102155130|NCT02730195|Pioglitazone|pioglitazone|mesh-list
102155131|NCT02730195|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102155132|NCT02730195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102155133|NCT02730195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155134|NCT02730195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102155135|NCT02730195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102155136|NCT02730195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155137|NCT03360279|Paclitaxel|paclitaxel|mesh-list
102155138|NCT03360279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102155139|NCT03360279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102155140|NCT03360279|Tubulin Modulators|tubulin modulators|mesh-ancestor
102155141|NCT03360279|Antimitotic Agents|antimitotic agents|mesh-ancestor
102155142|NCT03360279|Mitosis Modulators|mitosis modulators|mesh-ancestor
102155143|NCT03360279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155144|NCT03353103|Listerine|listerine|mesh-list
102155145|NCT03353103|Fluorides|fluorides|mesh-list
102155146|NCT03353103|Sodium Fluoride|sodium fluoride|mesh-list
102155147|NCT03353103|Cariostatic Agents|cariostatic agents|mesh-ancestor
102155148|NCT03353103|Protective Agents|protective agents|mesh-ancestor
102155149|NCT03353103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155150|NCT03353103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102155151|NCT03353103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102155152|NCT03360123|Midazolam|midazolam|mesh-list
102155153|NCT03360123|Triazolam|triazolam|mesh-list
102155154|NCT03360123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102155155|NCT03360123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102155156|NCT03360123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102155157|NCT03360123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155158|NCT03360123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102155159|NCT03360123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102155160|NCT03360123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102155161|NCT03360123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102155162|NCT03360123|Anesthetics, General|anesthetics, general|mesh-ancestor
102155163|NCT03360123|Anesthetics|anesthetics|mesh-ancestor
102155164|NCT03360123|GABA Modulators|gaba modulators|mesh-ancestor
102155165|NCT03360123|GABA Agents|gaba agents|mesh-ancestor
102155166|NCT03360123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102155167|NCT03360123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155168|NCT03360045|Tranexamic Acid|tranexamic acid|mesh-list
102155169|NCT03360045|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
102155170|NCT03360045|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102155171|NCT03360045|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101573961|NCT02756377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102155172|NCT03360045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155173|NCT03360045|Hemostatics|hemostatics|mesh-ancestor
102155174|NCT03360045|Coagulants|coagulants|mesh-ancestor
102155175|NCT03353025|Dopamine|dopamine|mesh-list
102155176|NCT03353025|Dopamine Agonists|dopamine agonists|mesh-list
102155177|NCT03353025|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102155178|NCT03353025|Sympathomimetics|sympathomimetics|mesh-ancestor
102155179|NCT03353025|Autonomic Agents|autonomic agents|mesh-ancestor
102155180|NCT03353025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102155181|NCT03353025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155182|NCT03353025|Dopamine Agents|dopamine agents|mesh-ancestor
102155183|NCT03353025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102155184|NCT03353025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155185|NCT03353025|Protective Agents|protective agents|mesh-ancestor
102155186|NCT03359967|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102155187|NCT03359967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102155188|NCT03359967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155189|NCT04506957|Chrysarobin|chrysarobin|mesh-list
102155190|NCT04506957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102155191|NCT04506957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102155192|NCT04506957|Analgesics|analgesics|mesh-ancestor
102155193|NCT04506957|Sensory System Agents|sensory system agents|mesh-ancestor
102155194|NCT04506957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102155195|NCT04506957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155196|NCT04506957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102155197|NCT04506957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102155198|NCT04516395|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102155199|NCT04516395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102155200|NCT04516395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102155201|NCT04516395|Antitubercular Agents|antitubercular agents|mesh-ancestor
102155202|NCT03352947|Trametinib|trametinib|mesh-list
102155203|NCT03352947|Dabrafenib|dabrafenib|mesh-list
102155204|NCT03352947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102155205|NCT03352947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102155206|NCT03352947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102155207|NCT03352947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155208|NCT02730351|Fluticasone|fluticasone|mesh-list
102155209|NCT02730351|Xhance|xhance|mesh-list
102155210|NCT02730351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102155211|NCT02730351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102155212|NCT02730351|Autonomic Agents|autonomic agents|mesh-ancestor
102155213|NCT02730351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102155214|NCT02730351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155215|NCT02730351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102155216|NCT02730351|Respiratory System Agents|respiratory system agents|mesh-ancestor
102155217|NCT02730351|Dermatologic Agents|dermatologic agents|mesh-ancestor
102155218|NCT02730351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102155219|NCT03359655|Scopolamine|scopolamine|mesh-list
102155220|NCT03359655|Bromides|bromides|mesh-list
102155221|NCT03359655|Misoprostol|misoprostol|mesh-list
102155222|NCT03359655|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102155223|NCT03359655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102155224|NCT03359655|Abortifacient Agents|abortifacient agents|mesh-ancestor
102155225|NCT03359655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102155226|NCT03359655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155227|NCT03359655|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102155228|NCT03359655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102155229|NCT03359655|Oxytocics|oxytocics|mesh-ancestor
102155230|NCT03359655|Anticonvulsants|anticonvulsants|mesh-ancestor
102155231|NCT03359655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102155232|NCT03359655|Antiemetics|antiemetics|mesh-ancestor
102155233|NCT03359655|Autonomic Agents|autonomic agents|mesh-ancestor
102155234|NCT03359655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102155235|NCT03359655|Mydriatics|mydriatics|mesh-ancestor
102155236|NCT03359655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102155237|NCT03359655|Cholinergic Agents|cholinergic agents|mesh-ancestor
102155238|NCT03359655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102155239|NCT03359655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155240|NCT03359655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102155241|NCT03359655|Parasympatholytics|parasympatholytics|mesh-ancestor
102155242|NCT03352869|Metformin|metformin|mesh-list
102155243|NCT03352869|Exenatide|exenatide|mesh-list
102155244|NCT03352869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102155245|NCT03352869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155246|NCT03352869|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102155248|NCT03352869|Hormones|hormones|mesh-ancestor
102155249|NCT03352869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102155250|NCT03359499|Trimebutine|trimebutine|mesh-list
102155251|NCT03359499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102155252|NCT03359499|Parasympatholytics|parasympatholytics|mesh-ancestor
102155253|NCT03359499|Autonomic Agents|autonomic agents|mesh-ancestor
102155254|NCT03359499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102155255|NCT03359499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155256|NCT03352479|Analgesics, Opioid|analgesics, opioid|mesh-list
102155257|NCT03352479|Narcotics|narcotics|mesh-ancestor
102155258|NCT03352479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102155259|NCT03352479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155260|NCT03352479|Analgesics|analgesics|mesh-ancestor
102155261|NCT03352479|Sensory System Agents|sensory system agents|mesh-ancestor
101864137|NCT00276614|Bortezomib|bortezomib|mesh-list
102155262|NCT03352479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102155263|NCT03355053|Dexmedetomidine|dexmedetomidine|mesh-list
102155264|NCT03355053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102155265|NCT03355053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102155266|NCT03355053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155267|NCT03355053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102155268|NCT03355053|Analgesics|analgesics|mesh-ancestor
102155269|NCT03355053|Sensory System Agents|sensory system agents|mesh-ancestor
102155270|NCT03355053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102155271|NCT03355053|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102155272|NCT03355053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102155273|NCT03355053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102155274|NCT03355053|Adrenergic Agents|adrenergic agents|mesh-ancestor
102155275|NCT03355053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102155276|NCT03355053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155277|NCT03354897|Torsemide|torsemide|mesh-list
102155278|NCT03354897|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102155279|NCT03354897|Diuretics|diuretics|mesh-ancestor
102155280|NCT03354897|Natriuretic Agents|natriuretic agents|mesh-ancestor
102155281|NCT03354897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155282|NCT03354897|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102155283|NCT03354897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102155284|NCT03354897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155285|NCT03358953|Nicotine|nicotine|mesh-list
102155286|NCT03358953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102155287|NCT03358953|Autonomic Agents|autonomic agents|mesh-ancestor
102155288|NCT03358953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102155289|NCT03358953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155290|NCT03358953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102155291|NCT03358953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102155292|NCT03358953|Cholinergic Agents|cholinergic agents|mesh-ancestor
102155293|NCT03358953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102155294|NCT03358953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155295|NCT04509999|Bicalutamide|bicalutamide|mesh-list
102155296|NCT04509999|Androgen Antagonists|androgen antagonists|mesh-ancestor
102155297|NCT04509999|Hormone Antagonists|hormone antagonists|mesh-ancestor
102155298|NCT04509999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102155299|NCT04509999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155300|NCT04509999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102155301|NCT04505943|Isoniazid|isoniazid|mesh-list
102155302|NCT04505943|Misoprostol|misoprostol|mesh-list
102155303|NCT04505943|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102155304|NCT04505943|Abortifacient Agents|abortifacient agents|mesh-ancestor
102155305|NCT04505943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102155306|NCT04505943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155307|NCT04505943|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102155308|NCT04505943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102155309|NCT04505943|Oxytocics|oxytocics|mesh-ancestor
102155310|NCT04505943|Antitubercular Agents|antitubercular agents|mesh-ancestor
102155311|NCT04505943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102155312|NCT04505943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102155313|NCT04505943|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102155314|NCT04505943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102155315|NCT04505943|Antimetabolites|antimetabolites|mesh-ancestor
102155316|NCT04505943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155317|NCT04505943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102155318|NCT03358719|Poly I-C|poly i-c|mesh-list
102155319|NCT03358719|Nivolumab|nivolumab|mesh-list
102155320|NCT03358719|Decitabine|decitabine|mesh-list
102155321|NCT03358719|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102155322|NCT03358719|Poly ICLC|poly iclc|mesh-list
102155323|NCT03358719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102155324|NCT03358719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102155325|NCT03358719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102155326|NCT03358719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155327|NCT03358719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102155328|NCT03358719|Antimetabolites|antimetabolites|mesh-ancestor
102155329|NCT03358719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102155330|NCT03358719|Interferon Inducers|interferon inducers|mesh-ancestor
102155331|NCT03358719|Immunologic Factors|immunologic factors|mesh-ancestor
102155332|NCT03358719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155333|NCT03358719|Laxatives|laxatives|mesh-ancestor
102155334|NCT03358719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102155335|NCT03358719|Antiviral Agents|antiviral agents|mesh-ancestor
101864200|NCT00044512|Sorafenib|sorafenib|mesh-list
102155336|NCT03358719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102155337|NCT04505475|Hemostatics|hemostatics|mesh-list
102155338|NCT04505475|Coagulants|coagulants|mesh-ancestor
102155339|NCT01376349|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
102155340|NCT01376349|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102155341|NCT01376349|Immunologic Factors|immunologic factors|mesh-ancestor
102155342|NCT01376349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155343|NCT03350373|Dotinurad|dotinurad|mesh-list
102155344|NCT03350373|Uricosuric Agents|uricosuric agents|mesh-ancestor
102155345|NCT03350373|Gout Suppressants|gout suppressants|mesh-ancestor
102155346|NCT03350373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102155347|NCT03350295|Nifurtimox|nifurtimox|mesh-list
102155348|NCT03350295|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102155349|NCT03350295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102155350|NCT03350295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102155351|NCT03350295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102155352|NCT03349983|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
102155353|NCT03349983|Antiviral Agents|antiviral agents|mesh-ancestor
102155354|NCT03349983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102155355|NCT03349827|Apatinib|apatinib|mesh-list
102155356|NCT03349827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102155357|NCT03349827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102155358|NCT03349827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102155359|NCT03349827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155360|NCT04503915|Estrogens|estrogens|mesh-list
102155361|NCT04503915|Hormones|hormones|mesh-ancestor
102155362|NCT04503915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102155363|NCT04503915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155364|NCT04504851|Rifampin|rifampin|mesh-list
102155365|NCT04504851|Isoniazid|isoniazid|mesh-list
102155366|NCT04504851|Pyrazinamide|pyrazinamide|mesh-list
102155367|NCT04504851|Ethambutol|ethambutol|mesh-list
102155368|NCT04504851|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102155369|NCT04504851|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102155370|NCT04504851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102155371|NCT04504851|Antimetabolites|antimetabolites|mesh-ancestor
102155372|NCT04504851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155373|NCT04504851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102155374|NCT04504851|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102155375|NCT04504851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102155376|NCT04504851|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102155377|NCT04504851|Antitubercular Agents|antitubercular agents|mesh-ancestor
102155378|NCT04504851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102155379|NCT04504851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102155380|NCT04504851|Leprostatic Agents|leprostatic agents|mesh-ancestor
102155381|NCT04504851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102155382|NCT04504851|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102155383|NCT04504851|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102155384|NCT04504851|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102155385|NCT04504851|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102155386|NCT04504851|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102155387|NCT04504851|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102155388|NCT04504851|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102155389|NCT05509257|Naltrexone|naltrexone|mesh-list
102155390|NCT05509257|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102155391|NCT05509257|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102155392|NCT05509257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155393|NCT05509257|Sensory System Agents|sensory system agents|mesh-ancestor
102155394|NCT05509257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102155395|NCT03349359|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102155396|NCT03349359|Antiviral Agents|antiviral agents|mesh-ancestor
102155397|NCT03349359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102155398|NCT03030261|Dexamethasone|dexamethasone|mesh-list
102155399|NCT03030261|Pomalidomide|pomalidomide|mesh-list
102155400|NCT03030261|Elotuzumab|elotuzumab|mesh-list
102155401|NCT03030261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102155402|NCT03030261|Antiemetics|antiemetics|mesh-ancestor
102155403|NCT03030261|Autonomic Agents|autonomic agents|mesh-ancestor
102155404|NCT03030261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102155405|NCT03030261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155406|NCT03030261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102155407|NCT03030261|Glucocorticoids|glucocorticoids|mesh-ancestor
102155408|NCT03030261|Hormones|hormones|mesh-ancestor
102155409|NCT03030261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102155410|NCT03030261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102155411|NCT03030261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102155412|NCT03030261|Immunologic Factors|immunologic factors|mesh-ancestor
102155413|NCT03030261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102155414|NCT03030261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102155415|NCT03030261|Growth Substances|growth substances|mesh-ancestor
102155416|NCT03030261|Growth Inhibitors|growth inhibitors|mesh-ancestor
102155417|NCT02176161|Metformin|metformin|mesh-list
102155418|NCT02176161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102155419|NCT02176161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155420|NCT03348735|Lidocaine|lidocaine|mesh-list
102155421|NCT03348735|Pregabalin|pregabalin|mesh-list
102155422|NCT03348735|Capsaicin|capsaicin|mesh-list
102155423|NCT03348735|Anesthetics, Local|anesthetics, local|mesh-ancestor
102155424|NCT03348735|Anesthetics|anesthetics|mesh-ancestor
102155425|NCT03348735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102155426|NCT03348735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155427|NCT03348735|Sensory System Agents|sensory system agents|mesh-ancestor
102155428|NCT03348735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102155429|NCT03348735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102155430|NCT03348735|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102155431|NCT03348735|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102155432|NCT03348735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102155433|NCT03348735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155434|NCT03348735|Analgesics|analgesics|mesh-ancestor
102155435|NCT03348735|Anticonvulsants|anticonvulsants|mesh-ancestor
102155436|NCT03348735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102155437|NCT03348735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102155438|NCT03348735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102155439|NCT03348735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102155440|NCT03348735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102155441|NCT03348735|Antipruritics|antipruritics|mesh-ancestor
102155442|NCT03348735|Dermatologic Agents|dermatologic agents|mesh-ancestor
102155443|NCT01700673|Azacitidine|azacitidine|mesh-list
102155444|NCT01700673|Sargramostim|sargramostim|mesh-list
102155445|NCT01700673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102155446|NCT01700673|Antimetabolites|antimetabolites|mesh-ancestor
102155447|NCT01700673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155448|NCT01700673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102155449|NCT01700673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102155450|NCT01700673|Immunologic Factors|immunologic factors|mesh-ancestor
102155451|NCT01700673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155452|NCT03898154|Dexamethasone|dexamethasone|mesh-list
102155453|NCT03898154|Methylprednisolone|methylprednisolone|mesh-list
102155454|NCT03898154|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102155455|NCT03898154|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102155456|NCT03898154|Prednisolone|prednisolone|mesh-list
102155457|NCT03898154|Prednisolone acetate|prednisolone acetate|mesh-list
102155458|NCT03898154|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102155459|NCT03898154|Prednisolone phosphate|prednisolone phosphate|mesh-list
102155460|NCT03898154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102155461|NCT03898154|Antiemetics|antiemetics|mesh-ancestor
102155462|NCT03898154|Autonomic Agents|autonomic agents|mesh-ancestor
102155463|NCT03898154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102155464|NCT03898154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155465|NCT03898154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102155466|NCT03898154|Glucocorticoids|glucocorticoids|mesh-ancestor
102155467|NCT03898154|Hormones|hormones|mesh-ancestor
102155468|NCT03898154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102155469|NCT03898154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101898439|NCT01149356|Exemestane|exemestane|mesh-list
102155471|NCT03898154|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102155472|NCT03898154|Protective Agents|protective agents|mesh-ancestor
102155473|NCT02517957|Loperamide|loperamide|mesh-list
102155474|NCT02517957|Antidiarrheals|antidiarrheals|mesh-list
102155475|NCT02517957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102155476|NCT03348267|Caseins|caseins|mesh-list
102155477|NCT03348267|Chelating Agents|chelating agents|mesh-ancestor
102155478|NCT03348267|Sequestering Agents|sequestering agents|mesh-ancestor
102155479|NCT03348267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155480|NCT03136796|Meropenem|meropenem|mesh-list
102155481|NCT03136796|Piperacillin|piperacillin|mesh-list
102155482|NCT03136796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102155483|NCT03136796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102155484|NCT05243745|Fluorides|fluorides|mesh-list
102155485|NCT05243745|Cariostatic Agents|cariostatic agents|mesh-ancestor
102155486|NCT05243745|Protective Agents|protective agents|mesh-ancestor
102155487|NCT05243745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155488|NCT04500717|Carboplatin|carboplatin|mesh-list
102155489|NCT04500717|Pemetrexed|pemetrexed|mesh-list
102155490|NCT04500717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102155491|NCT04500717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102155492|NCT04500717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155493|NCT04500717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102155494|NCT04500717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102155495|NCT01680458|Fluconazole|fluconazole|mesh-list
102155496|NCT01680458|Antifungal Agents|antifungal agents|mesh-ancestor
102155497|NCT01680458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102155498|NCT01680458|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102155499|NCT01680458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102155500|NCT01680458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102155501|NCT01680458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155502|NCT01680458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102155503|NCT01680458|Hormone Antagonists|hormone antagonists|mesh-ancestor
102155504|NCT01680458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102155505|NCT01680458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155506|NCT01680458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102155507|NCT01680458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102155508|NCT03346317|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102155509|NCT03346317|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102155510|NCT03346317|Estradiol|estradiol|mesh-list
102155511|NCT03346317|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102155512|NCT03346317|Dydrogesterone|dydrogesterone|mesh-list
102155513|NCT03346317|Estrogens|estrogens|mesh-ancestor
102155514|NCT03346317|Hormones|hormones|mesh-ancestor
102155515|NCT03346317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101308057|NCT02045589|Gemcitabine|gemcitabine|mesh-list
102155516|NCT03346317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155517|NCT03346317|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102155518|NCT03346317|Contraceptive Agents|contraceptive agents|mesh-ancestor
102155519|NCT03346317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102155520|NCT03346317|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102155521|NCT03346317|Progestins|progestins|mesh-ancestor
102155522|NCT01550432|Acetylcysteine|acetylcysteine|mesh-list
102155523|NCT01550432|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102155524|NCT01550432|Antiviral Agents|antiviral agents|mesh-ancestor
102155525|NCT01550432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102155526|NCT01550432|Expectorants|expectorants|mesh-ancestor
102155527|NCT01550432|Respiratory System Agents|respiratory system agents|mesh-ancestor
102155528|NCT01550432|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102155529|NCT01550432|Antioxidants|antioxidants|mesh-ancestor
102155530|NCT01550432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155531|NCT01550432|Protective Agents|protective agents|mesh-ancestor
102155532|NCT01550432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155533|NCT01550432|Antidotes|antidotes|mesh-ancestor
102155534|NCT04502277|Fluconazole|fluconazole|mesh-list
102155535|NCT04502277|Antifungal Agents|antifungal agents|mesh-ancestor
102155536|NCT04502277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102155537|NCT04502277|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102155538|NCT04502277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102155539|NCT04502277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102155540|NCT04502277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155541|NCT04502277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102155542|NCT04502277|Hormone Antagonists|hormone antagonists|mesh-ancestor
102155543|NCT04502277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102155544|NCT04502277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155545|NCT04502277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102155546|NCT04502277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102155548|NCT05730608|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102155549|NCT05730608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155550|NCT02517489|Hydrocortisone|hydrocortisone|mesh-list
102155551|NCT02517489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102155552|NCT04850144|Bromides|bromides|mesh-list
102155553|NCT04850144|Tiotropium Bromide|tiotropium bromide|mesh-list
102155554|NCT04850144|Charcoal|charcoal|mesh-list
102155555|NCT04850144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102155556|NCT04850144|Autonomic Agents|autonomic agents|mesh-ancestor
102155557|NCT04850144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102155558|NCT04850144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155559|NCT04850144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102155560|NCT04850144|Respiratory System Agents|respiratory system agents|mesh-ancestor
102155561|NCT04850144|Parasympatholytics|parasympatholytics|mesh-ancestor
102155562|NCT04850144|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102155563|NCT04850144|Cholinergic Agents|cholinergic agents|mesh-ancestor
102155564|NCT04850144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102155565|NCT04850144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155566|NCT04850144|Anticonvulsants|anticonvulsants|mesh-ancestor
102155567|NCT04850144|Antidotes|antidotes|mesh-ancestor
102155568|NCT04850144|Protective Agents|protective agents|mesh-ancestor
102155569|NCT04590794|Plasminogen|plasminogen|mesh-list
102155570|NCT04590794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102155571|NCT04590794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102155572|NCT04590794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155573|NCT00709761|Paclitaxel|paclitaxel|mesh-list
102155574|NCT00709761|Lapatinib|lapatinib|mesh-list
102155575|NCT00709761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102155576|NCT00709761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102155577|NCT00709761|Tubulin Modulators|tubulin modulators|mesh-ancestor
102155578|NCT00709761|Antimitotic Agents|antimitotic agents|mesh-ancestor
102155579|NCT00709761|Mitosis Modulators|mitosis modulators|mesh-ancestor
102155580|NCT00709761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155581|NCT00709761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102155582|NCT00709761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102155583|NCT03346083|Betrixaban|betrixaban|mesh-list
102155584|NCT03346083|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102155585|NCT03346083|Antithrombins|antithrombins|mesh-ancestor
102155586|NCT03346083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102155587|NCT03346083|Protease Inhibitors|protease inhibitors|mesh-ancestor
102155588|NCT03346083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102155589|NCT03346083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155590|NCT03346083|Anticoagulants|anticoagulants|mesh-ancestor
102155591|NCT05584683|Amoxicillin|amoxicillin|mesh-list
102155592|NCT05584683|Clavulanic Acid|clavulanic acid|mesh-list
102155593|NCT05584683|Clavulanic Acids|clavulanic acids|mesh-list
102155594|NCT05584683|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102155595|NCT05584683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102155596|NCT05584683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102155597|NCT05584683|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102155598|NCT05584683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102155599|NCT05584683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155600|NCT02516631|Misoprostol|misoprostol|mesh-list
102155601|NCT02516631|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102155602|NCT02516631|Abortifacient Agents|abortifacient agents|mesh-ancestor
102155603|NCT02516631|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102155604|NCT02516631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155605|NCT02516631|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102155606|NCT02516631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102155607|NCT02516631|Oxytocics|oxytocics|mesh-ancestor
102155608|NCT02516475|Zinc Sulfate|zinc sulfate|mesh-list
102155609|NCT02516475|Astringents|astringents|mesh-ancestor
102155610|NCT02516475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155611|NCT02516475|Dermatologic Agents|dermatologic agents|mesh-ancestor
102155612|NCT05083286|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102155613|NCT05083286|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102155614|NCT05083286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102155615|NCT05083286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102155617|NCT05083286|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102155618|NCT05083286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102155619|NCT05083286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155620|NCT05083286|Cholinergic Agents|cholinergic agents|mesh-ancestor
102155621|NCT05083286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102155622|NCT03423680|Aripiprazole|aripiprazole|mesh-list
102155623|NCT03423680|Antidepressive Agents|antidepressive agents|mesh-ancestor
102155624|NCT03423680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102155625|NCT03423680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102155626|NCT03423680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102155627|NCT03423680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102155628|NCT03423680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155629|NCT03423680|Dopamine Agonists|dopamine agonists|mesh-ancestor
102155630|NCT03423680|Dopamine Agents|dopamine agents|mesh-ancestor
102155631|NCT03423680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102155632|NCT03423680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155633|NCT03423680|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102155634|NCT03423680|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102155635|NCT03423680|Serotonin Agents|serotonin agents|mesh-ancestor
102155636|NCT03423680|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101864499|NCT01072604|Antipyretics|antipyretics|mesh-ancestor
102155637|NCT03423680|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102155638|NCT03423680|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102155639|NCT03423680|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102155641|NCT04443543|Capecitabine|capecitabine|mesh-list
102155642|NCT04443543|Oxaliplatin|oxaliplatin|mesh-list
102155643|NCT04443543|Irinotecan|irinotecan|mesh-list
102155644|NCT04443543|Tislelizumab|tislelizumab|mesh-list
102155645|NCT04443543|Antimetabolites|antimetabolites|mesh-ancestor
102155646|NCT04443543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155647|NCT04443543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102155648|NCT04443543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102155649|NCT04443543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102155650|NCT04443543|Immunologic Factors|immunologic factors|mesh-ancestor
102155651|NCT04443543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155652|NCT04443543|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102155653|NCT04443543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102155654|NCT04443543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102155655|NCT04443543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102155656|NCT02516085|Metformin|metformin|mesh-list
102155657|NCT02516085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102155658|NCT02516085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155659|NCT02515929|Proanthocyanidin|proanthocyanidin|mesh-list
102155660|NCT02515929|Procyanidin|procyanidin|mesh-list
102155661|NCT02515929|Antioxidants|antioxidants|mesh-ancestor
102155662|NCT02515929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155663|NCT02515929|Protective Agents|protective agents|mesh-ancestor
102155664|NCT02515929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155665|NCT02515929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102155666|NCT02515929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102155667|NCT02515929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102155668|NCT03347721|Lidocaine|lidocaine|mesh-list
102155669|NCT03347721|Anesthetics, Local|anesthetics, local|mesh-ancestor
102155670|NCT03347721|Anesthetics|anesthetics|mesh-ancestor
102155671|NCT03347721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102155672|NCT03347721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155673|NCT03347721|Sensory System Agents|sensory system agents|mesh-ancestor
102155674|NCT03347721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102155675|NCT03347721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102155676|NCT03347721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102155677|NCT03347721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102155678|NCT03347721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102155679|NCT03347721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155680|NCT02848651|Atezolizumab|atezolizumab|mesh-list
102155681|NCT02848651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102155682|NCT02848651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155683|NCT02848651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102155684|NCT02848651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102155685|NCT00709059|Ribavirin|ribavirin|mesh-list
102155686|NCT00709059|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102155687|NCT00709059|Interferon-alpha|interferon-alpha|mesh-list
102155688|NCT00709059|Antimetabolites|antimetabolites|mesh-ancestor
102155689|NCT00709059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155690|NCT00709059|Antiviral Agents|antiviral agents|mesh-ancestor
102155691|NCT00709059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102155692|NCT00709059|Immunologic Factors|immunologic factors|mesh-ancestor
102155693|NCT00709059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155694|NCT04500561|Gemcitabine|gemcitabine|mesh-list
102155695|NCT04500561|Oxaliplatin|oxaliplatin|mesh-list
102155696|NCT04500561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102155697|NCT04500561|Antimetabolites|antimetabolites|mesh-ancestor
102155698|NCT04500561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155699|NCT04500561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102155700|NCT04507256|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
102155701|NCT04507256|Antiviral Agents|antiviral agents|mesh-ancestor
102155702|NCT04507256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102155703|NCT04968015|Cytarabine|cytarabine|mesh-list
102155704|NCT04968015|Venetoclax|venetoclax|mesh-list
102155705|NCT04968015|Idarubicin|idarubicin|mesh-list
102155706|NCT04968015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102155707|NCT04968015|Antimetabolites|antimetabolites|mesh-ancestor
102155708|NCT04968015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155709|NCT04968015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102155710|NCT04968015|Antiviral Agents|antiviral agents|mesh-ancestor
102155711|NCT04968015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102155712|NCT04968015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102155713|NCT04968015|Immunologic Factors|immunologic factors|mesh-ancestor
102155714|NCT04968015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155715|NCT04968015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102155716|NCT04968015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102155717|NCT04968015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102155718|NCT04968015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102155719|NCT05094596|Montelukast|montelukast|mesh-list
102155720|NCT05094596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102155721|NCT05094596|Respiratory System Agents|respiratory system agents|mesh-ancestor
102155722|NCT05094596|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102155723|NCT05094596|Hormone Antagonists|hormone antagonists|mesh-ancestor
102155724|NCT05094596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102155725|NCT05094596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155726|NCT05094596|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102155727|NCT05094596|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102155728|NCT05094596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155729|NCT01678820|Metformin|metformin|mesh-list
102155730|NCT01678820|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102155731|NCT01678820|Glimepiride|glimepiride|mesh-list
102155732|NCT01678820|Simvastatin|simvastatin|mesh-list
102155733|NCT01678820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102155734|NCT01678820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155735|NCT01678820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102155736|NCT01678820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102155737|NCT01678820|Antimetabolites|antimetabolites|mesh-ancestor
102155738|NCT01678820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155739|NCT01678820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102155740|NCT01678820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102155741|NCT01678820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102155742|NCT01678820|Incretins|incretins|mesh-ancestor
102155743|NCT01678820|Hormones|hormones|mesh-ancestor
102155744|NCT01678820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102155745|NCT01678820|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102155746|NCT01678820|Protease Inhibitors|protease inhibitors|mesh-ancestor
102155747|NCT01678820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102155748|NCT01678820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102155749|NCT01678820|Immunologic Factors|immunologic factors|mesh-ancestor
102155750|NCT02515695|Interferons|interferons|mesh-list
102155751|NCT02515695|Interferon-beta|interferon-beta|mesh-list
102155752|NCT02515695|Interferon beta-1a|interferon beta-1a|mesh-list
102155753|NCT02515695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102155754|NCT02515695|Antiviral Agents|antiviral agents|mesh-ancestor
102155755|NCT02515695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102155756|NCT02515695|Immunologic Factors|immunologic factors|mesh-ancestor
102155757|NCT02515695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155758|NCT02515695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102155759|NCT03346629|Misoprostol|misoprostol|mesh-list
102155760|NCT03346629|Mifepristone|mifepristone|mesh-list
101697552|NCT00987103|Tacrolimus|tacrolimus|mesh-list
102155761|NCT03346629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102155762|NCT03346629|Abortifacient Agents|abortifacient agents|mesh-ancestor
102155763|NCT03346629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101445162|NCT00200616|Anti-Infective Agents|anti-infective agents|mesh-list
102155764|NCT03346629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155765|NCT03346629|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102155766|NCT03346629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102155768|NCT03346629|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102155769|NCT03346629|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102155770|NCT03346629|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102155771|NCT03346629|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102155772|NCT03346629|Contraceptive Agents|contraceptive agents|mesh-ancestor
102155773|NCT03346629|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102155774|NCT03346629|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102155775|NCT03346629|Hormone Antagonists|hormone antagonists|mesh-ancestor
102155776|NCT03346629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102155777|NCT03346629|Luteolytic Agents|luteolytic agents|mesh-ancestor
102155778|NCT03346629|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102155779|NCT03346629|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102155780|NCT04501965|Azithromycin|azithromycin|mesh-list
102155781|NCT04501965|Hydroxychloroquine|hydroxychloroquine|mesh-list
102155782|NCT04501965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102155783|NCT04501965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102155784|NCT04501965|Antimalarials|antimalarials|mesh-ancestor
102155785|NCT04501965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102155786|NCT04501965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102155787|NCT04501965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102155788|NCT04501965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155789|NCT04501965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102155790|NCT04437836|Rifampin|rifampin|mesh-list
102155791|NCT04437836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102155792|NCT04437836|Antitubercular Agents|antitubercular agents|mesh-ancestor
102155793|NCT04437836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102155794|NCT04437836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102155795|NCT04437836|Leprostatic Agents|leprostatic agents|mesh-ancestor
102155796|NCT04437836|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102155797|NCT04437836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102155798|NCT04437836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155799|NCT04437836|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102155800|NCT04437836|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102155801|NCT04437836|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102155802|NCT04437836|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102155803|NCT04437836|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102155804|NCT04437836|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102155805|NCT03122067|Oxytocin|oxytocin|mesh-list
102155806|NCT03122067|Oxytocics|oxytocics|mesh-ancestor
102155807|NCT03122067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102155808|NCT03122067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155809|NCT04536194|Dopamine|dopamine|mesh-list
102155810|NCT04536194|Norepinephrine|norepinephrine|mesh-list
102155811|NCT04536194|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102155812|NCT04536194|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102155813|NCT04536194|Adrenergic Agents|adrenergic agents|mesh-ancestor
102155814|NCT04536194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102155815|NCT04536194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155816|NCT04536194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155817|NCT04536194|Sympathomimetics|sympathomimetics|mesh-ancestor
102155818|NCT04536194|Autonomic Agents|autonomic agents|mesh-ancestor
102155819|NCT04536194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102155820|NCT04536194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102155821|NCT04536194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102155822|NCT04536194|Dopamine Agents|dopamine agents|mesh-ancestor
102155823|NCT04536194|Protective Agents|protective agents|mesh-ancestor
102155824|NCT03122769|Metformin|metformin|mesh-list
102155825|NCT03122769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102155826|NCT03122769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155827|NCT03121833|Endostar protein|endostar protein|mesh-list
102155828|NCT03121833|Endostatins|endostatins|mesh-list
102155829|NCT03121833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102155830|NCT03121833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102155831|NCT03121833|Growth Substances|growth substances|mesh-ancestor
102155832|NCT03121833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155833|NCT03121833|Growth Inhibitors|growth inhibitors|mesh-ancestor
101697626|NCT02630862|Aspirin|aspirin|mesh-list
102155841|NCT03046862|Gemcitabine|gemcitabine|mesh-list
102155842|NCT03046862|Durvalumab|durvalumab|mesh-list
102155843|NCT03046862|Tremelimumab|tremelimumab|mesh-list
102155844|NCT03046862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102155845|NCT03046862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102155846|NCT03046862|Antimetabolites|antimetabolites|mesh-ancestor
102155847|NCT03046862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155848|NCT03046862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102155849|NCT05590923|Dexamethasone|dexamethasone|mesh-list
102155850|NCT05590923|Olanzapine|olanzapine|mesh-list
102155851|NCT05590923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102155852|NCT05590923|Antiemetics|antiemetics|mesh-ancestor
102155853|NCT05590923|Autonomic Agents|autonomic agents|mesh-ancestor
102155854|NCT05590923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102155855|NCT05590923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155856|NCT05590923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102155857|NCT05590923|Glucocorticoids|glucocorticoids|mesh-ancestor
102155858|NCT05590923|Hormones|hormones|mesh-ancestor
102155859|NCT05590923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102155860|NCT05590923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102155861|NCT05590923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102155862|NCT05590923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102155863|NCT05590923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102155864|NCT05590923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102155865|NCT05590923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102155866|NCT05590923|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102155867|NCT05590923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102155868|NCT05590923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102155869|NCT05590923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155870|NCT05590923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102155871|NCT05590923|Serotonin Agents|serotonin agents|mesh-ancestor
102155872|NCT02643056|Panitumumab|panitumumab|mesh-list
102155873|NCT02643056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102155874|NCT02643056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102155875|NCT02515617|Silver Sulfadiazine|silver sulfadiazine|mesh-list
102155876|NCT02515617|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102155877|NCT02515617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102155885|NCT04413422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
102155886|NCT04413422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102155887|NCT04413422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155888|NCT02238145|Ipratropium|ipratropium|mesh-list
102155889|NCT02238145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102155890|NCT02238145|Autonomic Agents|autonomic agents|mesh-ancestor
102155891|NCT02238145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102155892|NCT02238145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155893|NCT02238145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102155894|NCT02238145|Respiratory System Agents|respiratory system agents|mesh-ancestor
102155895|NCT02238145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102155896|NCT02238145|Cholinergic Agents|cholinergic agents|mesh-ancestor
102155897|NCT02238145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102155898|NCT02238145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155899|NCT04550637|Apixaban|apixaban|mesh-list
102155900|NCT04550637|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102155901|NCT04550637|Antithrombins|antithrombins|mesh-ancestor
102155902|NCT04550637|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102155903|NCT04550637|Protease Inhibitors|protease inhibitors|mesh-ancestor
102155904|NCT04550637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102155905|NCT04550637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155906|NCT04550637|Anticoagulants|anticoagulants|mesh-ancestor
102155907|NCT03345303|Bortezomib|bortezomib|mesh-list
102155909|NCT03574909|Aspirin|aspirin|mesh-list
102155910|NCT03574909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102155911|NCT03574909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102155912|NCT03574909|Analgesics|analgesics|mesh-ancestor
102155913|NCT03574909|Sensory System Agents|sensory system agents|mesh-ancestor
102155914|NCT03574909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102155915|NCT03574909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649898|NCT05832619|Serotonin|serotonin|mesh-list
102155916|NCT03574909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102155917|NCT03574909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102155918|NCT03574909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102155919|NCT03574909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102155920|NCT03574909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155921|NCT03574909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102155922|NCT03574909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102155923|NCT03574909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102155924|NCT03574909|Antipyretics|antipyretics|mesh-ancestor
102155925|NCT03579043|Cocaine|cocaine|mesh-list
102155926|NCT03579043|Anesthetics, Local|anesthetics, local|mesh-ancestor
102155927|NCT03579043|Anesthetics|anesthetics|mesh-ancestor
102155928|NCT03579043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102155929|NCT03579043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155930|NCT03579043|Sensory System Agents|sensory system agents|mesh-ancestor
102155931|NCT03579043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102155932|NCT03579043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102155933|NCT03579043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102155934|NCT03579043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102155935|NCT03579043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102155936|NCT03579043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155937|NCT03579043|Dopamine Agents|dopamine agents|mesh-ancestor
102155938|NCT03579043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102155939|NCT02660138|Hemagglutinins|hemagglutinins|mesh-list
102155940|NCT02660138|Botulinum Toxins|botulinum toxins|mesh-list
102155941|NCT02660138|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102155942|NCT02660138|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102155943|NCT02660138|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102155944|NCT02660138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102155945|NCT02660138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155946|NCT02660138|Cholinergic Agents|cholinergic agents|mesh-ancestor
102155947|NCT02660138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102155948|NCT02660138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155949|NCT02660138|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102155950|NCT02660138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102155951|NCT02660138|Agglutinins|agglutinins|mesh-ancestor
102155952|NCT02660138|Immunologic Factors|immunologic factors|mesh-ancestor
102155953|NCT02660138|Coagulants|coagulants|mesh-ancestor
102155954|NCT03576469|Complement C1s|complement c1s|mesh-list
102155955|NCT03576469|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
102155956|NCT03576469|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
102155957|NCT03576469|Immunologic Factors|immunologic factors|mesh-ancestor
102155958|NCT03576469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155959|NCT03576469|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102155960|NCT03576469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102155961|NCT05036876|Insulin Glargine|insulin glargine|mesh-list
102155962|NCT05036876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102155963|NCT05036876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155964|NCT05097950|Acetaminophen|acetaminophen|mesh-list
102155965|NCT05097950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102155966|NCT05097950|Analgesics|analgesics|mesh-ancestor
102155967|NCT05097950|Sensory System Agents|sensory system agents|mesh-ancestor
102155968|NCT05097950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102155969|NCT05097950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155970|NCT05097950|Antipyretics|antipyretics|mesh-ancestor
102155971|NCT05097248|Doxorubicin|doxorubicin|mesh-list
102155972|NCT05097248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102155973|NCT05097248|Losartan|losartan|mesh-list
102155974|NCT05097248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102155975|NCT05097248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102155976|NCT05097248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102155977|NCT05097248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102155978|NCT05097248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102155979|NCT05097248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155980|NCT05097248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102155981|NCT05097248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102155982|NCT05097248|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102155983|NCT05097248|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102155984|NCT01603394|Pregabalin|pregabalin|mesh-list
102155985|NCT01603394|Analgesics|analgesics|mesh-ancestor
102155986|NCT01603394|Sensory System Agents|sensory system agents|mesh-ancestor
102155987|NCT01603394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102155988|NCT01603394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102155989|NCT01603394|Anticonvulsants|anticonvulsants|mesh-ancestor
102155990|NCT01603394|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102155991|NCT01603394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102155992|NCT01603394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102155993|NCT01603394|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102155994|NCT01603394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102155995|NCT01603394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102155996|NCT01603394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102155997|NCT01603394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102155998|NCT04682522|Metronidazole|metronidazole|mesh-list
102155999|NCT04682522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102156000|NCT04682522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102156001|NCT04682522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102156002|NCT04682522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102156003|NCT02837432|Hydrocortisone|hydrocortisone|mesh-list
102156004|NCT02837432|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102156005|NCT02837432|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102156006|NCT02837432|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102156007|NCT02837432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102156008|NCT02729025|Evolocumab|evolocumab|mesh-list
101864869|NCT01323257|Ritonavir|ritonavir|mesh-list
102156009|NCT02729025|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102156010|NCT02729025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102156011|NCT02729025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102156012|NCT02729025|Antimetabolites|antimetabolites|mesh-ancestor
102156013|NCT02729025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156014|NCT02729025|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102156015|NCT02729025|Protease Inhibitors|protease inhibitors|mesh-ancestor
102156016|NCT02729025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102156017|NCT02729025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102156018|NCT05599971|Fluorouracil|fluorouracil|mesh-list
102156019|NCT05599971|Digoxin|digoxin|mesh-list
102156020|NCT05599971|Furosemide|furosemide|mesh-list
102156021|NCT05599971|Antimetabolites|antimetabolites|mesh-ancestor
102156022|NCT05599971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156023|NCT05599971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102156024|NCT05599971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102156025|NCT05599971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102156026|NCT05599971|Immunologic Factors|immunologic factors|mesh-ancestor
102156027|NCT05599971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156028|NCT05599971|Diuretics|diuretics|mesh-ancestor
102156029|NCT05599971|Natriuretic Agents|natriuretic agents|mesh-ancestor
102156030|NCT05599971|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102156031|NCT05599971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102156032|NCT05599971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102156033|NCT05599971|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102156034|NCT05599971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102156035|NCT05599971|Protective Agents|protective agents|mesh-ancestor
102156036|NCT02511873|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-list
102156037|NCT02511873|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102156038|NCT02511873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102156039|NCT02511873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156040|NCT02511873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156041|NCT02511795|Olaparib|olaparib|mesh-list
102156042|NCT02511795|Adavosertib|adavosertib|mesh-list
102156043|NCT02511795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102156044|NCT02511795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102156045|NCT02511795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156046|NCT02511795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102156047|NCT04796636|Ascorbic Acid|ascorbic acid|mesh-list
102156048|NCT04796636|Antioxidants|antioxidants|mesh-ancestor
102156049|NCT04796636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156050|NCT04796636|Protective Agents|protective agents|mesh-ancestor
102156051|NCT04796636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156052|NCT04796636|Vitamins|vitamins|mesh-ancestor
102156053|NCT04796636|Micronutrients|micronutrients|mesh-ancestor
102156054|NCT04501809|Misoprostol|misoprostol|mesh-list
102156055|NCT04501809|Oxytocin|oxytocin|mesh-list
102156056|NCT04501809|Oxytocics|oxytocics|mesh-ancestor
102156057|NCT04501809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102156058|NCT04501809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156059|NCT04501809|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102156060|NCT04501809|Abortifacient Agents|abortifacient agents|mesh-ancestor
102156061|NCT04501809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102156062|NCT04501809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102156063|NCT04718636|Moxifloxacin|moxifloxacin|mesh-list
102156064|NCT04718636|Contraceptive Agents|contraceptive agents|mesh-list
102156065|NCT04718636|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102156066|NCT04718636|Contraceptives, Oral|contraceptives, oral|mesh-list
102156067|NCT04718636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102156068|NCT04718636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156069|NCT04718636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102156070|NCT04718636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102156071|NCT04718636|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102156072|NCT04718636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102156073|NCT04718636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102156074|NCT04718636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102156075|NCT04718636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102156076|NCT04718636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102156077|NCT04718636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156078|NCT04718636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102156079|NCT02514681|Paclitaxel|paclitaxel|mesh-list
102156080|NCT02514681|Vinorelbine|vinorelbine|mesh-list
102156081|NCT02514681|Docetaxel|docetaxel|mesh-list
102156082|NCT02514681|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102156083|NCT02514681|Gemcitabine|gemcitabine|mesh-list
102156084|NCT02514681|Capecitabine|capecitabine|mesh-list
102156085|NCT02514681|Trastuzumab|trastuzumab|mesh-list
102156086|NCT02514681|Pertuzumab|pertuzumab|mesh-list
102156087|NCT02514681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102156088|NCT02514681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102156089|NCT02514681|Tubulin Modulators|tubulin modulators|mesh-ancestor
102156090|NCT02514681|Antimitotic Agents|antimitotic agents|mesh-ancestor
102156091|NCT02514681|Mitosis Modulators|mitosis modulators|mesh-ancestor
102156092|NCT02514681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156093|NCT02514681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102156094|NCT02514681|Antimetabolites|antimetabolites|mesh-ancestor
102156095|NCT02514681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102156096|NCT02511639|Everolimus|everolimus|mesh-list
102156097|NCT02511639|Letrozole|letrozole|mesh-list
102156098|NCT02511639|Anastrozole|anastrozole|mesh-list
102156099|NCT02511639|Exemestane|exemestane|mesh-list
102156100|NCT02511639|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102156101|NCT02511639|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102156102|NCT02511639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102156103|NCT02511639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102156104|NCT02511639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156105|NCT02511639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102156106|NCT02511639|Immunologic Factors|immunologic factors|mesh-ancestor
102156107|NCT02511639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156108|NCT02511639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102156109|NCT02511639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102156110|NCT02511639|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102156111|NCT02511639|Hormone Antagonists|hormone antagonists|mesh-ancestor
102156112|NCT02511639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102156113|NCT02511639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102156114|NCT02514603|Prexasertib|prexasertib|mesh-list
102156115|NCT02514603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102156116|NCT02514603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102156117|NCT02514603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156118|NCT02511483|Propranolol|propranolol|mesh-list
102156119|NCT02511483|Morphine|morphine|mesh-list
102156120|NCT02511483|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102156121|NCT02511483|Narcotics|narcotics|mesh-ancestor
102156122|NCT02511483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102156123|NCT02511483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156124|NCT02511483|Analgesics|analgesics|mesh-ancestor
102156125|NCT02511483|Sensory System Agents|sensory system agents|mesh-ancestor
102156126|NCT02511483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102156127|NCT02511483|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102156128|NCT02511483|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102156129|NCT02511483|Adrenergic Agents|adrenergic agents|mesh-ancestor
102156130|NCT02511483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102156131|NCT02511483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156132|NCT02511483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102156133|NCT02511483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102156134|NCT02511483|Vasodilator Agents|vasodilator agents|mesh-ancestor
102156135|NCT04429802|Prucalopride|prucalopride|mesh-list
102156136|NCT04429802|Laxatives|laxatives|mesh-ancestor
102156137|NCT04429802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102156138|NCT04429802|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
102156139|NCT04429802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102156140|NCT04429802|Serotonin Agents|serotonin agents|mesh-ancestor
102156141|NCT04429802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102156142|NCT04429802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156143|NCT04429802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156144|NCT02511405|Bevacizumab|bevacizumab|mesh-list
102156145|NCT02511405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102156146|NCT02511405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102156147|NCT02511405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102156148|NCT02511405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102156149|NCT02511405|Growth Substances|growth substances|mesh-ancestor
102156150|NCT02511405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156151|NCT02511405|Growth Inhibitors|growth inhibitors|mesh-ancestor
102156152|NCT04387760|Hydroxychloroquine|hydroxychloroquine|mesh-list
102156153|NCT04387760|Favipiravir|favipiravir|mesh-list
102156154|NCT04387760|Antimalarials|antimalarials|mesh-ancestor
102156155|NCT04387760|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102156156|NCT04387760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101865025|NCT00437645|Vasodilator Agents|vasodilator agents|mesh-ancestor
102156157|NCT04387760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102156158|NCT04387760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102156159|NCT04387760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156160|NCT04387760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102156161|NCT04387760|Antiviral Agents|antiviral agents|mesh-ancestor
102156162|NCT05091086|Zoledronic Acid|zoledronic acid|mesh-list
102156163|NCT05091086|Denosumab|denosumab|mesh-list
102156164|NCT05091086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102156165|NCT05091086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156166|NCT05091008|Sofosbuvir|sofosbuvir|mesh-list
102156167|NCT05091008|Ledipasvir|ledipasvir|mesh-list
102156168|NCT05091008|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102156169|NCT05091008|Antiviral Agents|antiviral agents|mesh-ancestor
102156170|NCT05091008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102156171|NCT02918084|Letrozole|letrozole|mesh-list
102156172|NCT02918084|Anastrozole|anastrozole|mesh-list
102156173|NCT02918084|Exemestane|exemestane|mesh-list
102156174|NCT02918084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102156175|NCT02918084|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102156176|NCT02918084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102156177|NCT02918084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102156178|NCT02918084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156179|NCT02918084|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102156180|NCT02918084|Hormone Antagonists|hormone antagonists|mesh-ancestor
102156181|NCT02918084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102156182|NCT02918084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156183|NCT02918084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102156184|NCT01603082|Clopidogrel|clopidogrel|mesh-list
102156185|NCT01603082|Ticagrelor|ticagrelor|mesh-list
102156186|NCT01603082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102156187|NCT01603082|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102156188|NCT01603082|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102156189|NCT01603082|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102156190|NCT01603082|Purinergic Agents|purinergic agents|mesh-ancestor
102156191|NCT01603082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102156192|NCT01603082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156193|NCT01603082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156194|NCT04499313|Dexamethasone|dexamethasone|mesh-list
102156195|NCT04499313|Methylprednisolone|methylprednisolone|mesh-list
102156196|NCT04499313|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102156197|NCT04499313|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102156198|NCT04499313|Prednisolone|prednisolone|mesh-list
102156199|NCT04499313|Prednisolone acetate|prednisolone acetate|mesh-list
102156200|NCT04499313|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102156201|NCT04499313|Prednisolone phosphate|prednisolone phosphate|mesh-list
102156202|NCT04499313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102156203|NCT04499313|Antiemetics|antiemetics|mesh-ancestor
102156204|NCT04499313|Autonomic Agents|autonomic agents|mesh-ancestor
102156205|NCT04499313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102156206|NCT04499313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156207|NCT04499313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102156208|NCT04499313|Glucocorticoids|glucocorticoids|mesh-ancestor
102156209|NCT04499313|Hormones|hormones|mesh-ancestor
102156210|NCT04499313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102156211|NCT04499313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102156212|NCT04499313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102156213|NCT04499313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102156214|NCT04499313|Protective Agents|protective agents|mesh-ancestor
102156215|NCT04331756|Anesthetics|anesthetics|mesh-list
102156216|NCT04331756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102156217|NCT04331756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156218|NCT02510781|Carboplatin|carboplatin|mesh-list
102156219|NCT02510781|Docetaxel|docetaxel|mesh-list
102156220|NCT02510781|Trastuzumab|trastuzumab|mesh-list
102156221|NCT02510781|Epirubicin|epirubicin|mesh-list
102156222|NCT02510781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102156223|NCT02510781|Tubulin Modulators|tubulin modulators|mesh-ancestor
102156224|NCT02510781|Antimitotic Agents|antimitotic agents|mesh-ancestor
102156225|NCT02510781|Mitosis Modulators|mitosis modulators|mesh-ancestor
102156226|NCT02510781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156227|NCT02510781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102156228|NCT02510781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102156229|NCT02510781|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102156230|NCT02510781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102156231|NCT02510781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102156232|NCT03121599|Alovudine|alovudine|mesh-list
101865095|NCT00436553|Ranibizumab|ranibizumab|mesh-list
102156233|NCT03121599|Antiviral Agents|antiviral agents|mesh-ancestor
102156234|NCT03121599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102156235|NCT03576079|Salicylic Acid|salicylic acid|mesh-list
102156236|NCT03576079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102156237|NCT03576079|Antifungal Agents|antifungal agents|mesh-ancestor
102156238|NCT03576079|Keratolytic Agents|keratolytic agents|mesh-ancestor
102156239|NCT03576079|Dermatologic Agents|dermatologic agents|mesh-ancestor
102156240|NCT04181606|Esmolol|esmolol|mesh-list
102156241|NCT04181606|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102156242|NCT04181606|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102156243|NCT04181606|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102156244|NCT04181606|Adrenergic Agents|adrenergic agents|mesh-ancestor
102156245|NCT04181606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102156246|NCT04181606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156247|NCT04181606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156248|NCT04499235|Mometasone Furoate|mometasone furoate|mesh-list
102156249|NCT04499235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102156250|NCT04499235|Dermatologic Agents|dermatologic agents|mesh-ancestor
102156251|NCT04499235|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102156252|NCT02510469|Apatinib|apatinib|mesh-list
102156253|NCT02510469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102156254|NCT02510469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102156255|NCT02510469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102156256|NCT02510469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156257|NCT02510235|Hyaluronic Acid|hyaluronic acid|mesh-list
102156258|NCT02510235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102156259|NCT02510235|Immunologic Factors|immunologic factors|mesh-ancestor
102156260|NCT02510235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156261|NCT02510235|Viscosupplements|viscosupplements|mesh-ancestor
102156262|NCT02510235|Protective Agents|protective agents|mesh-ancestor
102156263|NCT05081336|Alirocumab|alirocumab|mesh-list
102156264|NCT05081336|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102156265|NCT05081336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102156266|NCT05081336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102156267|NCT05081336|Antimetabolites|antimetabolites|mesh-ancestor
102156268|NCT05081336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156269|NCT05081336|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102156270|NCT05081336|Protease Inhibitors|protease inhibitors|mesh-ancestor
102156271|NCT05081336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102156272|NCT05081336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102156273|NCT03578497|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102156274|NCT03578497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102156275|NCT03710876|Celecoxib|celecoxib|mesh-list
102156276|NCT03710876|Gemcitabine|gemcitabine|mesh-list
102156277|NCT03710876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102156279|NCT03710876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156280|NCT03710876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102156281|NCT03710876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101445247|NCT04653415|Hormones|hormones|mesh-ancestor
102156282|NCT03710876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102156283|NCT03710876|Analgesics|analgesics|mesh-ancestor
102156284|NCT03710876|Sensory System Agents|sensory system agents|mesh-ancestor
102156285|NCT03710876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102156286|NCT03710876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156287|NCT03710876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102156288|NCT03710876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102156289|NCT03710876|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102156290|NCT03710876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102156291|NCT03710876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102156292|NCT02513433|Bupivacaine|bupivacaine|mesh-list
102156293|NCT02513433|Ropivacaine|ropivacaine|mesh-list
102156294|NCT02513433|Levobupivacaine|levobupivacaine|mesh-list
102156295|NCT02513433|Anesthetics, Local|anesthetics, local|mesh-ancestor
102156296|NCT02513433|Anesthetics|anesthetics|mesh-ancestor
102156297|NCT02513433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102156298|NCT02513433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156299|NCT02513433|Sensory System Agents|sensory system agents|mesh-ancestor
102156300|NCT02513433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102156301|NCT02510157|Dexamethasone|dexamethasone|mesh-list
102156302|NCT02510157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102156303|NCT02510157|Antiemetics|antiemetics|mesh-ancestor
102156304|NCT02510157|Autonomic Agents|autonomic agents|mesh-ancestor
102156305|NCT02510157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102156306|NCT02510157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156307|NCT02510157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101865174|NCT00436007|Vaccines|vaccines|mesh-list
102156308|NCT02510157|Glucocorticoids|glucocorticoids|mesh-ancestor
102156309|NCT02510157|Hormones|hormones|mesh-ancestor
102156310|NCT02510157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102156311|NCT02510157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102156312|NCT02510157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102156313|NCT03345147|Vitamins|vitamins|mesh-list
102156314|NCT03345147|Vitamin A|vitamin a|mesh-list
102156315|NCT03345147|Retinol palmitate|retinol palmitate|mesh-list
102156316|NCT03345147|Micronutrients|micronutrients|mesh-ancestor
102156317|NCT03345147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156318|NCT03345147|Antioxidants|antioxidants|mesh-ancestor
102156319|NCT03345147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156320|NCT03345147|Protective Agents|protective agents|mesh-ancestor
102156321|NCT03345147|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102156322|NCT03345147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102156323|NCT03662919|Adalimumab|adalimumab|mesh-list
102156324|NCT03662919|Infliximab|infliximab|mesh-list
102156325|NCT03662919|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102156326|NCT03662919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102156327|NCT03662919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102156328|NCT03662919|Dermatologic Agents|dermatologic agents|mesh-ancestor
102156329|NCT03662919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102156330|NCT05375240|Ceftriaxone|ceftriaxone|mesh-list
102156331|NCT05375240|Propranolol|propranolol|mesh-list
102156332|NCT05375240|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102156333|NCT05375240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102156334|NCT05375240|Adrenergic Agents|adrenergic agents|mesh-ancestor
102156335|NCT05375240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102156336|NCT05375240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156337|NCT05375240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156338|NCT05375240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102156339|NCT05375240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102156340|NCT05375240|Vasodilator Agents|vasodilator agents|mesh-ancestor
102156341|NCT05375240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102156342|NCT05375240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102156343|NCT00406393|Sirolimus|sirolimus|mesh-list
102156344|NCT00406393|Methotrexate|methotrexate|mesh-list
102156345|NCT00406393|Tacrolimus|tacrolimus|mesh-list
102156346|NCT00406393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102156347|NCT00406393|Abortifacient Agents|abortifacient agents|mesh-ancestor
102156348|NCT00406393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102156349|NCT00406393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156350|NCT00406393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102156351|NCT00406393|Antimetabolites|antimetabolites|mesh-ancestor
102156352|NCT00406393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156353|NCT00406393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102156354|NCT00406393|Dermatologic Agents|dermatologic agents|mesh-ancestor
102156355|NCT00406393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102156356|NCT00406393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102156357|NCT00406393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102156358|NCT00406393|Immunologic Factors|immunologic factors|mesh-ancestor
102156359|NCT00406393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102156360|NCT00406393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102156361|NCT00406393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102156362|NCT00406393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102156363|NCT00406393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102156364|NCT00406393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102156365|NCT00406393|Antifungal Agents|antifungal agents|mesh-ancestor
102156366|NCT02513355|Cisplatin|cisplatin|mesh-list
102156367|NCT02513355|Endostar protein|endostar protein|mesh-list
102156368|NCT02513355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102156369|NCT02513355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102156370|NCT02513355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102156371|NCT02513355|Growth Substances|growth substances|mesh-ancestor
102156372|NCT02513355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156373|NCT02513355|Growth Inhibitors|growth inhibitors|mesh-ancestor
102156374|NCT03574285|Sarpogrelate|sarpogrelate|mesh-list
102156375|NCT03574285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102156376|NCT03574285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102156377|NCT03574285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156378|NCT03574285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102156379|NCT03574285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102156380|NCT03574285|Serotonin Agents|serotonin agents|mesh-ancestor
102156381|NCT03574285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102156382|NCT03574285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156383|NCT02509923|Rabeprazole|rabeprazole|mesh-list
102156384|NCT02509923|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102156385|NCT02509923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102156386|NCT02509923|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102156387|NCT02509923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102156388|NCT02509923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156390|NCT03578263|Carbetocin|carbetocin|mesh-list
102156391|NCT03578263|Ergonovine|ergonovine|mesh-list
102156392|NCT03578263|Oxytocics|oxytocics|mesh-ancestor
102156393|NCT03578263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102156394|NCT03578263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156395|NCT03572257|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102156396|NCT03572257|Antidepressive Agents|antidepressive agents|mesh-ancestor
102156397|NCT03572257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102156398|NCT03572257|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102156399|NCT03572257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102156400|NCT03572257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102156401|NCT03572257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156402|NCT02845375|Neostigmine|neostigmine|mesh-list
102156403|NCT02845375|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102156404|NCT02845375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102156405|NCT02845375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156406|NCT02845375|Cholinergic Agents|cholinergic agents|mesh-ancestor
102156407|NCT02845375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102156408|NCT02845375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156409|NCT02845375|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102156410|NCT02845375|Autonomic Agents|autonomic agents|mesh-ancestor
102156411|NCT02845375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102156412|NCT02979860|Oxymetazoline|oxymetazoline|mesh-list
102156413|NCT02979860|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102156414|NCT02979860|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102156415|NCT02979860|Adrenergic Agents|adrenergic agents|mesh-ancestor
102156416|NCT02979860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102156417|NCT02979860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156418|NCT02979860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156419|NCT02979860|Sympathomimetics|sympathomimetics|mesh-ancestor
102156420|NCT02979860|Autonomic Agents|autonomic agents|mesh-ancestor
102156421|NCT02979860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102156422|NCT02979860|Nasal Decongestants|nasal decongestants|mesh-ancestor
102156423|NCT02979860|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102156424|NCT02979860|Respiratory System Agents|respiratory system agents|mesh-ancestor
102156425|NCT03344679|Magnesium Sulfate|magnesium sulfate|mesh-list
102156426|NCT03344679|Adenosine|adenosine|mesh-list
102156427|NCT03344679|Bupivacaine|bupivacaine|mesh-list
102156428|NCT03344679|Anesthetics, Local|anesthetics, local|mesh-ancestor
102156429|NCT03344679|Anesthetics|anesthetics|mesh-ancestor
102156430|NCT03344679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102156431|NCT03344679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156432|NCT03344679|Sensory System Agents|sensory system agents|mesh-ancestor
102156433|NCT03344679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102156434|NCT03344679|Analgesics|analgesics|mesh-ancestor
102156435|NCT03344679|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102156436|NCT03344679|Anticonvulsants|anticonvulsants|mesh-ancestor
102156437|NCT03344679|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102156438|NCT03344679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102156439|NCT03344679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156440|NCT03344679|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102156441|NCT03344679|Tocolytic Agents|tocolytic agents|mesh-ancestor
102156442|NCT03344679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102156443|NCT03344679|Vasodilator Agents|vasodilator agents|mesh-ancestor
102156444|NCT03344679|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102156445|NCT03344679|Purinergic Agonists|purinergic agonists|mesh-ancestor
102156446|NCT03344679|Purinergic Agents|purinergic agents|mesh-ancestor
102156447|NCT03344679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102156448|NCT02259829|Amlodipine|amlodipine|mesh-list
102156449|NCT02259829|Telmisartan|telmisartan|mesh-list
102156450|NCT02259829|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
102156451|NCT02259829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102156452|NCT02259829|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102156453|NCT02259829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102156454|NCT02259829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156455|NCT02259829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102156456|NCT02259829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156457|NCT02259829|Vasodilator Agents|vasodilator agents|mesh-ancestor
102156458|NCT02259829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102156459|NCT02259829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102156460|NCT03344523|Iron protein succinylate|iron protein succinylate|mesh-list
102156461|NCT03344523|Hematinics|hematinics|mesh-ancestor
102156462|NCT02658734|Trastuzumab|trastuzumab|mesh-list
102156463|NCT02658734|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102156464|NCT02658734|Maytansine|maytansine|mesh-list
102156465|NCT02658734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102156466|NCT02658734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102156467|NCT02658734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102156468|NCT02658734|Tubulin Modulators|tubulin modulators|mesh-ancestor
102156469|NCT02658734|Antimitotic Agents|antimitotic agents|mesh-ancestor
102156470|NCT02658734|Mitosis Modulators|mitosis modulators|mesh-ancestor
102156471|NCT02658734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156472|NCT02658734|Immunotoxins|immunotoxins|mesh-ancestor
102156473|NCT02658734|Immunoconjugates|immunoconjugates|mesh-ancestor
102156474|NCT02658734|Immunologic Factors|immunologic factors|mesh-ancestor
102156475|NCT02658734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156476|NCT03344445|Anesthetics|anesthetics|mesh-list
102156477|NCT03344445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102156478|NCT03344445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156479|NCT04501107|Insulin|insulin|mesh-list
102156480|NCT04501107|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102156481|NCT04501107|Insulin Lispro|insulin lispro|mesh-list
102156482|NCT04501107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102156483|NCT04501107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156484|NCT03143985|Pomalidomide|pomalidomide|mesh-list
102156485|NCT03143985|Vactosertib|vactosertib|mesh-list
102156486|NCT03143985|Immunologic Factors|immunologic factors|mesh-ancestor
102156487|NCT03143985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156488|NCT03143985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102156489|NCT03143985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102156490|NCT03143985|Growth Substances|growth substances|mesh-ancestor
102156491|NCT03143985|Growth Inhibitors|growth inhibitors|mesh-ancestor
102156492|NCT03143985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102156493|NCT03143985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102156494|NCT03143985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102156495|NCT03143985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156496|NCT02605148|Vitamin D|vitamin d|mesh-list
102156497|NCT02605148|Vitamins|vitamins|mesh-ancestor
102156498|NCT02605148|Micronutrients|micronutrients|mesh-ancestor
102156499|NCT02605148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156500|NCT02605148|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102156501|NCT02395640|Capecitabine|capecitabine|mesh-list
102156502|NCT02395640|Oxaliplatin|oxaliplatin|mesh-list
102156503|NCT02395640|Epirubicin|epirubicin|mesh-list
102156504|NCT02395640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102156505|NCT02395640|Antimetabolites|antimetabolites|mesh-ancestor
102156506|NCT02395640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156507|NCT02395640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102156508|NCT02395640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102156509|NCT02395640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102156510|NCT02395640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102156511|NCT02395640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102156512|NCT02509143|Ramosetron|ramosetron|mesh-list
102156513|NCT02509143|Antiemetics|antiemetics|mesh-list
102156514|NCT02509143|Autonomic Agents|autonomic agents|mesh-ancestor
102156515|NCT02509143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102156516|NCT02509143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156517|NCT02509143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102156518|NCT02509143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102156519|NCT02509143|Serotonin Agents|serotonin agents|mesh-ancestor
102156520|NCT02509143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102156521|NCT02509143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156522|NCT05100446|Amoxicillin|amoxicillin|mesh-list
102156523|NCT05100446|Esomeprazole|esomeprazole|mesh-list
102156524|NCT05100446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102156525|NCT05100446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102156526|NCT05100446|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102156527|NCT05100446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102156528|NCT05100446|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102156529|NCT05100446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102156530|NCT05100446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156531|NCT02506803|Paclitaxel|paclitaxel|mesh-list
102156532|NCT02506803|Gemcitabine|gemcitabine|mesh-list
102156533|NCT02506803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102156534|NCT02506803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102156535|NCT02506803|Tubulin Modulators|tubulin modulators|mesh-ancestor
102156536|NCT02506803|Antimitotic Agents|antimitotic agents|mesh-ancestor
102156537|NCT02506803|Mitosis Modulators|mitosis modulators|mesh-ancestor
102156538|NCT02506803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156539|NCT02506803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102156540|NCT02506803|Antimetabolites|antimetabolites|mesh-ancestor
102156541|NCT02844439|XL647|xl647|mesh-list
102156542|NCT02844439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102156543|NCT02844439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102156544|NCT02844439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102156545|NCT02844439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156546|NCT04531592|Valproic Acid|valproic acid|mesh-list
102156547|NCT04531592|Anticonvulsants|anticonvulsants|mesh-ancestor
102156548|NCT04531592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102156549|NCT04531592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156550|NCT04531592|GABA Agents|gaba agents|mesh-ancestor
102156551|NCT04531592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102156552|NCT04531592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156553|NCT04531592|Antimanic Agents|antimanic agents|mesh-ancestor
102156554|NCT04531592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102156555|NCT04531592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102156556|NCT04531592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102156557|NCT03571711|Meropenem|meropenem|mesh-list
102156558|NCT03571711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102156559|NCT03571711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102156560|NCT03570541|Acetaminophen|acetaminophen|mesh-list
102156561|NCT03570541|Morphine|morphine|mesh-list
102156562|NCT03570541|Ropivacaine|ropivacaine|mesh-list
102156563|NCT03570541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102156564|NCT03570541|Narcotics|narcotics|mesh-ancestor
102156565|NCT03570541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102156566|NCT03570541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156567|NCT03570541|Analgesics|analgesics|mesh-ancestor
102156568|NCT03570541|Sensory System Agents|sensory system agents|mesh-ancestor
102156569|NCT03570541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102156570|NCT03570541|Anesthetics, Local|anesthetics, local|mesh-ancestor
102156571|NCT03570541|Anesthetics|anesthetics|mesh-ancestor
102156572|NCT03570541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102156573|NCT03570541|Antipyretics|antipyretics|mesh-ancestor
102156574|NCT00708435|Protein C|protein c|mesh-list
102156575|NCT00708435|Protein S|protein s|mesh-list
102156576|NCT00708435|Anticoagulants|anticoagulants|mesh-ancestor
102156577|NCT00708435|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102156578|NCT00708435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102156579|NCT00708435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156581|NCT02508753|Tazobactam|tazobactam|mesh-list
102156582|NCT02508753|Ceftolozane|ceftolozane|mesh-list
102156583|NCT02508753|Cephalosporins|cephalosporins|mesh-list
102156584|NCT02508753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102156585|NCT02508753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102156586|NCT02508753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102156587|NCT02508753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102156588|NCT02508753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102156589|NCT02508753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156590|NCT02508753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102156591|NCT02508753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102156592|NCT02506647|Insulin|insulin|mesh-list
102156593|NCT02506647|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102156594|NCT02506647|Insulin Glargine|insulin glargine|mesh-list
102156595|NCT02506647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102156596|NCT02506647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156597|NCT02571530|Trastuzumab|trastuzumab|mesh-list
102156598|NCT02571530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102156599|NCT02571530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102156600|NCT04379024|Bazedoxifene|bazedoxifene|mesh-list
102156601|NCT04379024|Estrogens|estrogens|mesh-list
102156602|NCT04379024|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
102156603|NCT04379024|Hormones|hormones|mesh-ancestor
102156604|NCT04379024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102156605|NCT04379024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156606|NCT04379024|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102156607|NCT04379024|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102156608|NCT04379024|Hormone Antagonists|hormone antagonists|mesh-ancestor
102156609|NCT04379024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102156610|NCT04497831|Morphine|morphine|mesh-list
102156611|NCT04497831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102156612|NCT04497831|Narcotics|narcotics|mesh-ancestor
102156613|NCT04497831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102156614|NCT04497831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156615|NCT04497831|Analgesics|analgesics|mesh-ancestor
102156616|NCT04497831|Sensory System Agents|sensory system agents|mesh-ancestor
102156617|NCT04497831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102156618|NCT04498689|Paclitaxel|paclitaxel|mesh-list
102156619|NCT04498689|Gemcitabine|gemcitabine|mesh-list
102156620|NCT04498689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102156621|NCT04498689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102156622|NCT04498689|Tubulin Modulators|tubulin modulators|mesh-ancestor
102156623|NCT04498689|Antimitotic Agents|antimitotic agents|mesh-ancestor
102156624|NCT04498689|Mitosis Modulators|mitosis modulators|mesh-ancestor
102156625|NCT04498689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156626|NCT04498689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102156627|NCT04498689|Antimetabolites|antimetabolites|mesh-ancestor
102156628|NCT05103098|Misoprostol|misoprostol|mesh-list
102156629|NCT05103098|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102156630|NCT05103098|Abortifacient Agents|abortifacient agents|mesh-ancestor
102156631|NCT05103098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102156632|NCT05103098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156633|NCT05103098|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102156634|NCT05103098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102156635|NCT05103098|Oxytocics|oxytocics|mesh-ancestor
102156636|NCT04272008|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102156637|NCT04272008|Estradiol|estradiol|mesh-list
102156638|NCT04272008|Estrogens|estrogens|mesh-ancestor
102156639|NCT04272008|Hormones|hormones|mesh-ancestor
102156640|NCT04272008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102156641|NCT04272008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156642|NCT04272008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102156643|NCT04272008|Contraceptive Agents|contraceptive agents|mesh-ancestor
102156644|NCT04272008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102156645|NCT04272008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102156646|NCT04272008|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102156647|NCT04272008|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102156648|NCT05103020|Bevacizumab|bevacizumab|mesh-list
102156649|NCT05103020|Cetuximab|cetuximab|mesh-list
102156650|NCT05103020|Oxaliplatin|oxaliplatin|mesh-list
102156651|NCT05103020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102156652|NCT05103020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102156653|NCT05103020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102156654|NCT05103020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102156655|NCT05103020|Growth Substances|growth substances|mesh-ancestor
102156656|NCT05103020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156657|NCT05103020|Growth Inhibitors|growth inhibitors|mesh-ancestor
102156658|NCT02501109|Aripiprazole|aripiprazole|mesh-list
102156659|NCT02501109|Antidepressive Agents|antidepressive agents|mesh-ancestor
102156660|NCT02501109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102156661|NCT02501109|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102156662|NCT02501109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102156663|NCT02501109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102156664|NCT02501109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445330|NCT00205764|Melphalan|melphalan|mesh-list
102156665|NCT02501109|Dopamine Agonists|dopamine agonists|mesh-ancestor
102156666|NCT02501109|Dopamine Agents|dopamine agents|mesh-ancestor
102156667|NCT02501109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102156668|NCT02501109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156669|NCT02501109|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102156670|NCT02501109|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102156671|NCT02501109|Serotonin Agents|serotonin agents|mesh-ancestor
102156672|NCT02501109|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102156673|NCT02501109|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102156674|NCT02501109|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102156675|NCT02501109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102156676|NCT05060666|Ivermectin|ivermectin|mesh-list
102156677|NCT05060666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102156678|NCT05060666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102156679|NCT02506335|Cholic Acids|cholic acids|mesh-list
102156680|NCT02506335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102156681|NCT01353859|Methotrexate|methotrexate|mesh-list
102156682|NCT01353859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102156683|NCT01353859|Abortifacient Agents|abortifacient agents|mesh-ancestor
102156684|NCT01353859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102156685|NCT01353859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156686|NCT01353859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102156687|NCT01353859|Antimetabolites|antimetabolites|mesh-ancestor
102156688|NCT01353859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156689|NCT01353859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102156690|NCT01353859|Dermatologic Agents|dermatologic agents|mesh-ancestor
102156691|NCT01353859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102156692|NCT01353859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102156693|NCT01353859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102156694|NCT01353859|Immunologic Factors|immunologic factors|mesh-ancestor
102156695|NCT01353859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102156696|NCT01353859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102156697|NCT02238197|Ipratropium|ipratropium|mesh-list
102156698|NCT02238197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102156699|NCT02238197|Autonomic Agents|autonomic agents|mesh-ancestor
102156700|NCT02238197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102156701|NCT02238197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156702|NCT02238197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102156703|NCT02238197|Respiratory System Agents|respiratory system agents|mesh-ancestor
102156704|NCT02238197|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102156705|NCT02238197|Cholinergic Agents|cholinergic agents|mesh-ancestor
102156706|NCT02238197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102156707|NCT02238197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156708|NCT03592199|Sunitinib|sunitinib|mesh-list
102156709|NCT03592199|Axitinib|axitinib|mesh-list
102156710|NCT03592199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102156711|NCT03592199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102156712|NCT03592199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102156713|NCT03592199|Growth Substances|growth substances|mesh-ancestor
102156714|NCT03592199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156715|NCT03592199|Growth Inhibitors|growth inhibitors|mesh-ancestor
102156716|NCT03592199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102156717|NCT03592199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102156718|NCT03592199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156719|NCT02245867|Antibodies|antibodies|mesh-list
102156720|NCT02245867|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102156721|NCT02245867|Immunologic Factors|immunologic factors|mesh-ancestor
102156722|NCT02245867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156723|NCT03139916|Temozolomide|temozolomide|mesh-list
102156724|NCT03139916|Bavituximab|bavituximab|mesh-list
101898452|NCT01149356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102156725|NCT03139916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102156726|NCT03139916|Alkylating Agents|alkylating agents|mesh-ancestor
102156727|NCT03139916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156728|NCT03139916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102156729|NCT03139916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102156730|NCT02507583|Insulin|insulin|mesh-list
102156731|NCT02507583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102156732|NCT02507583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445339|NCT00558142|Acetylcysteine|acetylcysteine|mesh-list
102156733|NCT02506023|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
102156734|NCT02506023|Hemostatics|hemostatics|mesh-ancestor
102156735|NCT02506023|Coagulants|coagulants|mesh-ancestor
102156736|NCT02506023|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102156737|NCT02506023|Natriuretic Agents|natriuretic agents|mesh-ancestor
102156738|NCT02506023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156739|NCT02246179|Lidocaine|lidocaine|mesh-list
102156740|NCT02246179|Epinephrine|epinephrine|mesh-list
102156741|NCT02246179|Prilocaine|prilocaine|mesh-list
102156742|NCT02246179|Carticaine|carticaine|mesh-list
102156743|NCT02246179|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
102156744|NCT02246179|Anesthetics, Local|anesthetics, local|mesh-ancestor
102156745|NCT02246179|Anesthetics|anesthetics|mesh-ancestor
102156746|NCT02246179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102156747|NCT02246179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156748|NCT02246179|Sensory System Agents|sensory system agents|mesh-ancestor
102156749|NCT02246179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102156750|NCT02246179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102156751|NCT02246179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102156752|NCT02246179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102156753|NCT02246179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102156754|NCT02246179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156755|NCT02246179|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102156756|NCT02246179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102156757|NCT02246179|Adrenergic Agents|adrenergic agents|mesh-ancestor
102156758|NCT02246179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102156759|NCT02246179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102156760|NCT02246179|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102156761|NCT02246179|Autonomic Agents|autonomic agents|mesh-ancestor
102156762|NCT02246179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102156763|NCT02246179|Respiratory System Agents|respiratory system agents|mesh-ancestor
102156764|NCT02246179|Mydriatics|mydriatics|mesh-ancestor
102156765|NCT02246179|Sympathomimetics|sympathomimetics|mesh-ancestor
102156766|NCT02246179|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102156767|NCT02246179|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
102156768|NCT02238275|Telmisartan|telmisartan|mesh-list
102156769|NCT02238275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102156770|NCT02238275|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102156771|NCT02238275|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102156772|NCT02238275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156773|NCT04495101|Protease Inhibitors|protease inhibitors|mesh-list
102156774|NCT04495101|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
102156775|NCT04495101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102156776|NCT04495101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156777|NCT04495101|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102156778|NCT04495101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102156779|NCT04394117|Losartan|losartan|mesh-list
102156780|NCT04394117|Valsartan|valsartan|mesh-list
102156781|NCT04394117|Telmisartan|telmisartan|mesh-list
102156782|NCT04394117|Candesartan|candesartan|mesh-list
102156783|NCT04394117|Olmesartan|olmesartan|mesh-list
102156784|NCT04394117|Irbesartan|irbesartan|mesh-list
102156785|NCT04394117|Eprosartan|eprosartan|mesh-list
102156786|NCT04394117|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
102156787|NCT04394117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102156788|NCT04394117|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102156789|NCT04394117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156790|NCT04394117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102156791|NCT04394117|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
102156792|NCT02500563|Caseins|caseins|mesh-list
102156793|NCT02500563|Chelating Agents|chelating agents|mesh-ancestor
102156794|NCT02500563|Sequestering Agents|sequestering agents|mesh-ancestor
102156795|NCT02500563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156796|NCT02500329|Acarbose|acarbose|mesh-list
102156797|NCT02500329|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102156798|NCT02500329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102156799|NCT02500329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156800|NCT02500329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102156801|NCT02500329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156802|NCT02243137|Aspirin|aspirin|mesh-list
102156803|NCT02243137|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
102156804|NCT02243137|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102156805|NCT02243137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102156806|NCT02243137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102156807|NCT02243137|Analgesics|analgesics|mesh-ancestor
102156808|NCT02243137|Sensory System Agents|sensory system agents|mesh-ancestor
102156809|NCT02243137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102156810|NCT02243137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156811|NCT02243137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102156812|NCT02243137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102156813|NCT02243137|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102156814|NCT02243137|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102156815|NCT02243137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156816|NCT02243137|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102156817|NCT02243137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102156818|NCT02243137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102156819|NCT02243137|Antipyretics|antipyretics|mesh-ancestor
102156820|NCT03343977|Docetaxel|docetaxel|mesh-list
102156821|NCT03343977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102156822|NCT03343977|Tubulin Modulators|tubulin modulators|mesh-ancestor
102156823|NCT03343977|Antimitotic Agents|antimitotic agents|mesh-ancestor
102156824|NCT03343977|Mitosis Modulators|mitosis modulators|mesh-ancestor
102156825|NCT03343977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156826|NCT02850965|Adalimumab|adalimumab|mesh-list
102156827|NCT02850965|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102156828|NCT02850965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102156829|NCT02850965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102156830|NCT03571087|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102156831|NCT03571087|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102156832|NCT03571087|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102156833|NCT03571087|Antimetabolites|antimetabolites|mesh-ancestor
102156834|NCT03571087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156835|NCT03571087|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102156836|NCT03571087|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102156837|NCT03571087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102156838|NCT04557644|Dermatologic Agents|dermatologic agents|mesh-list
102156839|NCT01375959|Resveratrol|resveratrol|mesh-list
102156840|NCT01375959|Antioxidants|antioxidants|mesh-ancestor
102156841|NCT01375959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156842|NCT01375959|Protective Agents|protective agents|mesh-ancestor
102156843|NCT01375959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156844|NCT01375959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102156845|NCT01375959|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102156846|NCT02238353|Fluticasone|fluticasone|mesh-list
102156847|NCT02238353|Azelastine|azelastine|mesh-list
102156848|NCT02238353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102156849|NCT02238353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102156850|NCT02238353|Autonomic Agents|autonomic agents|mesh-ancestor
102156851|NCT02238353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102156852|NCT02238353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156853|NCT02238353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102156854|NCT02238353|Respiratory System Agents|respiratory system agents|mesh-ancestor
102156855|NCT02238353|Dermatologic Agents|dermatologic agents|mesh-ancestor
102156856|NCT02238353|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102156857|NCT02238353|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
102156858|NCT02238353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102156859|NCT02238353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156860|NCT02238353|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102156861|NCT02238353|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102156862|NCT02238353|Histamine Antagonists|histamine antagonists|mesh-ancestor
102156863|NCT02238353|Histamine Agents|histamine agents|mesh-ancestor
102156864|NCT02238353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102156865|NCT04482686|Vitamin D|vitamin d|mesh-list
102156866|NCT04482686|Cholecalciferol|cholecalciferol|mesh-list
102156867|NCT04482686|Vitamins|vitamins|mesh-list
102156868|NCT04482686|Ascorbic Acid|ascorbic acid|mesh-list
102156869|NCT04482686|Zinc|zinc|mesh-list
102156870|NCT04482686|Doxycycline|doxycycline|mesh-list
102156871|NCT04482686|Ivermectin|ivermectin|mesh-list
102156872|NCT04482686|Zinc Sulfate|zinc sulfate|mesh-list
101898456|NCT01148576|Vitamins|vitamins|mesh-ancestor
102156873|NCT04482686|Micronutrients|micronutrients|mesh-ancestor
102156874|NCT04482686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156875|NCT04482686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102156876|NCT04482686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102156877|NCT04482686|Trace Elements|trace elements|mesh-ancestor
102156879|NCT04482686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156880|NCT04482686|Protective Agents|protective agents|mesh-ancestor
102156881|NCT04482686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102156882|NCT04482686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102156883|NCT04482686|Antimalarials|antimalarials|mesh-ancestor
102156884|NCT04482686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102156885|NCT04482686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102156886|NCT04482686|Astringents|astringents|mesh-ancestor
102156887|NCT04482686|Dermatologic Agents|dermatologic agents|mesh-ancestor
102156888|NCT03580889|Atropine|atropine|mesh-list
102156889|NCT03580889|Glycopyrrolate|glycopyrrolate|mesh-list
102156890|NCT03580889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102156891|NCT03580889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102156892|NCT03580889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102156893|NCT03580889|Autonomic Agents|autonomic agents|mesh-ancestor
102156894|NCT03580889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102156895|NCT03580889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156896|NCT03580889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102156897|NCT03580889|Respiratory System Agents|respiratory system agents|mesh-ancestor
102156898|NCT03580889|Mydriatics|mydriatics|mesh-ancestor
102156899|NCT03580889|Parasympatholytics|parasympatholytics|mesh-ancestor
102156900|NCT03580889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102156901|NCT03580889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102156902|NCT03580889|Cholinergic Agents|cholinergic agents|mesh-ancestor
102156903|NCT03580889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102156904|NCT03580889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156905|NCT02500017|Melatonin|melatonin|mesh-list
102156906|NCT02500017|Antioxidants|antioxidants|mesh-ancestor
102156907|NCT02500017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156908|NCT02500017|Protective Agents|protective agents|mesh-ancestor
102156909|NCT02500017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156910|NCT02500017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102156911|NCT02505633|Lidocaine|lidocaine|mesh-list
102156912|NCT02505633|Epinephrine|epinephrine|mesh-list
102156913|NCT02505633|Racepinephrine|racepinephrine|mesh-list
102156914|NCT02505633|Epinephryl borate|epinephryl borate|mesh-list
102156915|NCT02505633|Anesthetics, Local|anesthetics, local|mesh-ancestor
102156916|NCT02505633|Anesthetics|anesthetics|mesh-ancestor
102156917|NCT02505633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102156918|NCT02505633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156919|NCT02505633|Sensory System Agents|sensory system agents|mesh-ancestor
102156920|NCT02505633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102156921|NCT02505633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102156922|NCT02505633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102156923|NCT02505633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102156924|NCT02505633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102156925|NCT02505633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156926|NCT02505633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102156927|NCT02505633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102156928|NCT02505633|Adrenergic Agents|adrenergic agents|mesh-ancestor
102156929|NCT02505633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102156930|NCT02505633|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102156931|NCT02505633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102156932|NCT02505633|Autonomic Agents|autonomic agents|mesh-ancestor
102156933|NCT02505633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102156934|NCT02505633|Respiratory System Agents|respiratory system agents|mesh-ancestor
102156935|NCT02505633|Mydriatics|mydriatics|mesh-ancestor
102156936|NCT02505633|Sympathomimetics|sympathomimetics|mesh-ancestor
102156937|NCT02505633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102156938|NCT03587441|Neostigmine|neostigmine|mesh-list
102156939|NCT03587441|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102156940|NCT03587441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102156941|NCT03587441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156942|NCT03587441|Cholinergic Agents|cholinergic agents|mesh-ancestor
102156943|NCT03587441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102156944|NCT03587441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156945|NCT03587441|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102156946|NCT03587441|Autonomic Agents|autonomic agents|mesh-ancestor
102156947|NCT03587441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102156948|NCT05102396|Mandelic Acids|mandelic acids|mesh-list
102156949|NCT05102396|Oxybutynin|oxybutynin|mesh-list
102156950|NCT05102396|Parasympatholytics|parasympatholytics|mesh-ancestor
102156951|NCT05102396|Autonomic Agents|autonomic agents|mesh-ancestor
102156952|NCT05102396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102156953|NCT05102396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156954|NCT05102396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102156955|NCT05102396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102156956|NCT05102396|Cholinergic Agents|cholinergic agents|mesh-ancestor
102156957|NCT05102396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102156958|NCT05102396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156959|NCT05102396|Urological Agents|urological agents|mesh-ancestor
102156960|NCT05102396|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102156961|NCT05102396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102156962|NCT01165645|Ritonavir|ritonavir|mesh-list
102156963|NCT01165645|Lopinavir|lopinavir|mesh-list
102156964|NCT01165645|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102156965|NCT01165645|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102156966|NCT01165645|Protease Inhibitors|protease inhibitors|mesh-ancestor
102156967|NCT01165645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102156968|NCT01165645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156969|NCT01165645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102156970|NCT01165645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102156971|NCT01165645|Antiviral Agents|antiviral agents|mesh-ancestor
102156972|NCT01165645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102156973|NCT01165645|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102156974|NCT01165645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102156975|NCT03579875|Methylprednisolone|methylprednisolone|mesh-list
102156976|NCT03579875|Cyclophosphamide|cyclophosphamide|mesh-list
102156977|NCT03579875|Busulfan|busulfan|mesh-list
102156978|NCT03579875|Rituximab|rituximab|mesh-list
102156979|NCT03579875|Fludarabine|fludarabine|mesh-list
102156980|NCT03579875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102156981|NCT03579875|Immunologic Factors|immunologic factors|mesh-ancestor
102156982|NCT03579875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102156983|NCT03579875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102156984|NCT03579875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102156985|NCT03579875|Alkylating Agents|alkylating agents|mesh-ancestor
102156986|NCT03579875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102156987|NCT03579875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102156988|NCT03579875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102156989|NCT03579875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102156990|NCT03579875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102156991|NCT03579875|Antiemetics|antiemetics|mesh-ancestor
102156992|NCT03579875|Autonomic Agents|autonomic agents|mesh-ancestor
102156993|NCT03579875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102156994|NCT03579875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102156995|NCT03579875|Glucocorticoids|glucocorticoids|mesh-ancestor
102156996|NCT03579875|Hormones|hormones|mesh-ancestor
102156997|NCT03579875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102156998|NCT03579875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102156999|NCT03579875|Protective Agents|protective agents|mesh-ancestor
102157000|NCT03569995|Cytarabine|cytarabine|mesh-list
102157001|NCT03569995|Rituximab|rituximab|mesh-list
102157002|NCT03569995|Methotrexate|methotrexate|mesh-list
102157003|NCT03569995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102157004|NCT03569995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102157005|NCT03569995|Immunologic Factors|immunologic factors|mesh-ancestor
102157006|NCT03569995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157007|NCT03569995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102157008|NCT03569995|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102157009|NCT03569995|Abortifacient Agents|abortifacient agents|mesh-ancestor
102157010|NCT03569995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102157011|NCT03569995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102157012|NCT03569995|Antimetabolites|antimetabolites|mesh-ancestor
102157013|NCT03569995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157014|NCT03569995|Dermatologic Agents|dermatologic agents|mesh-ancestor
102157015|NCT03569995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102157016|NCT03569995|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102157017|NCT03569995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102157018|NCT03569995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102157019|NCT03569995|Antiviral Agents|antiviral agents|mesh-ancestor
102157020|NCT03569995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102157021|NCT02238431|Leuprolide|leuprolide|mesh-list
102157022|NCT02238431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102157023|NCT02238431|Fertility Agents|fertility agents|mesh-ancestor
102157024|NCT02238431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102157025|NCT02238431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157026|NCT02238431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102157027|NCT02238431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102157028|NCT05122598|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
102157029|NCT05122598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157030|NCT02238509|Trastuzumab|trastuzumab|mesh-list
102157031|NCT02238509|Lapatinib|lapatinib|mesh-list
102157032|NCT02238509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102157033|NCT02238509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102157034|NCT02238509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102157035|NCT02238509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102157036|NCT02238509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157037|NCT03579914|Metoprolol|metoprolol|mesh-list
102157038|NCT03579914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102157039|NCT03579914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102157040|NCT03579914|Sympatholytics|sympatholytics|mesh-ancestor
102157041|NCT03579914|Autonomic Agents|autonomic agents|mesh-ancestor
102157042|NCT03579914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102157043|NCT03579914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157044|NCT03579914|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102157045|NCT03579914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102157046|NCT03579914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102157047|NCT03579914|Adrenergic Agents|adrenergic agents|mesh-ancestor
102157048|NCT03579914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102157049|NCT03579914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157050|NCT03573037|Anticoagulants|anticoagulants|mesh-list
102157051|NCT05354635|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102157052|NCT05354635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102157053|NCT03585413|Micronutrients|micronutrients|mesh-list
102157054|NCT03585413|Trace Elements|trace elements|mesh-list
102157055|NCT03585413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157056|NCT03569683|Hyaluronic Acid|hyaluronic acid|mesh-list
102157057|NCT03569683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102157058|NCT03569683|Immunologic Factors|immunologic factors|mesh-ancestor
102157059|NCT03569683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157060|NCT03569683|Viscosupplements|viscosupplements|mesh-ancestor
102157061|NCT03569683|Protective Agents|protective agents|mesh-ancestor
102157062|NCT00708201|Alvimopan|alvimopan|mesh-list
102157063|NCT00708201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102157064|NCT03572959|Triamcinolone|triamcinolone|mesh-list
102157065|NCT03572959|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102157066|NCT03572959|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101865932|NCT03801928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102157067|NCT03572959|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102157068|NCT03572959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102157069|NCT03572959|Glucocorticoids|glucocorticoids|mesh-ancestor
102157070|NCT03572959|Hormones|hormones|mesh-ancestor
102157071|NCT03572959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102157072|NCT03572959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157073|NCT03572959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102157074|NCT03572959|Immunologic Factors|immunologic factors|mesh-ancestor
102157075|NCT03572959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102157076|NCT03572959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157077|NCT02500251|Rituximab|rituximab|mesh-list
102157078|NCT02500251|Bortezomib|bortezomib|mesh-list
102157079|NCT02500251|Belimumab|belimumab|mesh-list
102157080|NCT02500251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102157081|NCT02500251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102157082|NCT02500251|Immunologic Factors|immunologic factors|mesh-ancestor
102157083|NCT02500251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157084|NCT02500251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102157085|NCT02500251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102157086|NCT03568513|Curcumin|curcumin|mesh-list
102157087|NCT03568513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102157088|NCT03568513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102157089|NCT03568513|Analgesics|analgesics|mesh-ancestor
102157090|NCT03568513|Sensory System Agents|sensory system agents|mesh-ancestor
102157091|NCT03568513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102157092|NCT03568513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157093|NCT03568513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102157094|NCT03568513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102157095|NCT03568513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102157096|NCT03568513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101898457|NCT01148576|Micronutrients|micronutrients|mesh-ancestor
102157097|NCT03568513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157099|NCT02982668|Mosapride|mosapride|mesh-list
102157100|NCT02982668|Antiemetics|antiemetics|mesh-ancestor
102157101|NCT02982668|Autonomic Agents|autonomic agents|mesh-ancestor
102157102|NCT02982668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102157103|NCT02982668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157104|NCT02982668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102157105|NCT02982668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102157106|NCT02982668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102157107|NCT02982668|Dopamine Agents|dopamine agents|mesh-ancestor
102157108|NCT02982668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102157109|NCT02982668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157110|NCT02982668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102157111|NCT02982668|Serotonin Agents|serotonin agents|mesh-ancestor
102157112|NCT02398526|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
102157113|NCT02398526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102157114|NCT05354479|Acetaminophen|acetaminophen|mesh-list
102157115|NCT05354479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102157116|NCT05354479|Analgesics|analgesics|mesh-ancestor
102157117|NCT05354479|Sensory System Agents|sensory system agents|mesh-ancestor
102157118|NCT05354479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102157119|NCT05354479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157120|NCT05354479|Antipyretics|antipyretics|mesh-ancestor
102157121|NCT02505399|Clopidogrel|clopidogrel|mesh-list
102157122|NCT02505399|Ticagrelor|ticagrelor|mesh-list
102157123|NCT02505399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102157124|NCT02505399|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102157125|NCT02505399|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102157126|NCT02505399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102157127|NCT02505399|Purinergic Agents|purinergic agents|mesh-ancestor
102157128|NCT02505399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102157129|NCT02505399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157130|NCT02505399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157131|NCT02728089|Tazobactam|tazobactam|mesh-list
102157132|NCT02728089|Ceftolozane|ceftolozane|mesh-list
102157133|NCT02728089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102157134|NCT02728089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102157135|NCT02728089|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102157136|NCT02728089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102157137|NCT02728089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157138|NCT05110118|Bevacizumab|bevacizumab|mesh-list
102157139|NCT05110118|Endothelial Growth Factors|endothelial growth factors|mesh-list
102157140|NCT05110118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102157141|NCT05110118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102157142|NCT05110118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102157143|NCT05110118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102157144|NCT05110118|Growth Substances|growth substances|mesh-ancestor
102157145|NCT05110118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157146|NCT05110118|Growth Inhibitors|growth inhibitors|mesh-ancestor
102157147|NCT03572647|Epoetin Alfa|epoetin alfa|mesh-list
102157148|NCT03572647|Hematinics|hematinics|mesh-ancestor
102157149|NCT02495181|Aflibercept|aflibercept|mesh-list
102157150|NCT02495181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102157151|NCT02495181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102157152|NCT02495181|Growth Substances|growth substances|mesh-ancestor
102157153|NCT02495181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157154|NCT02495181|Growth Inhibitors|growth inhibitors|mesh-ancestor
102157155|NCT02495181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102157156|NCT02499861|Decitabine|decitabine|mesh-list
102157157|NCT02499861|Genistein|genistein|mesh-list
102157158|NCT02499861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102157159|NCT02499861|Antimetabolites|antimetabolites|mesh-ancestor
102157160|NCT02499861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157161|NCT02499861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102157162|NCT02499861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102157163|NCT02499861|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102157164|NCT02499861|Protective Agents|protective agents|mesh-ancestor
102157165|NCT02499861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157166|NCT02499861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102157167|NCT02499861|Phytoestrogens|phytoestrogens|mesh-ancestor
102157168|NCT02499861|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102157169|NCT02499861|Estrogens|estrogens|mesh-ancestor
102157170|NCT02499861|Hormones|hormones|mesh-ancestor
101898458|NCT01148576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157171|NCT02499861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102157172|NCT05505435|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102157173|NCT05505435|Medroxyprogesterone|medroxyprogesterone|mesh-list
102157174|NCT05505435|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102157175|NCT05505435|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102157176|NCT05505435|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102157177|NCT05505435|Contraceptive Agents|contraceptive agents|mesh-ancestor
102157178|NCT05505435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102157179|NCT05505435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157180|NCT05505435|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102157181|NCT05505435|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102157182|NCT05505435|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102157183|NCT05505435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102157184|NCT05505435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102157185|NCT02840461|Ivermectin|ivermectin|mesh-list
102157186|NCT02840461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102157187|NCT02840461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102157188|NCT05108714|Lidocaine|lidocaine|mesh-list
102157189|NCT05108714|Anesthetics, Local|anesthetics, local|mesh-ancestor
102157190|NCT05108714|Anesthetics|anesthetics|mesh-ancestor
102157191|NCT05108714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102157192|NCT05108714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157193|NCT05108714|Sensory System Agents|sensory system agents|mesh-ancestor
102157194|NCT05108714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102157195|NCT05108714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102157196|NCT05108714|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102157197|NCT05108714|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102157198|NCT05108714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102157199|NCT05108714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157200|NCT02495415|Fenretinide|fenretinide|mesh-list
102157201|NCT02495415|Retinamide|retinamide|mesh-list
102157202|NCT02495415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102157203|NCT02495415|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102157204|NCT02495415|Protective Agents|protective agents|mesh-ancestor
102157205|NCT02495415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157206|NCT02505009|Tenofovir|tenofovir|mesh-list
102157207|NCT02505009|Entecavir|entecavir|mesh-list
102157208|NCT02505009|Antiviral Agents|antiviral agents|mesh-ancestor
102157209|NCT02505009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102157210|NCT02505009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102157211|NCT02505009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102157212|NCT02505009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102157213|NCT02505009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157214|NCT02505009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102157215|NCT02505009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102157216|NCT05353543|Antidepressive Agents|antidepressive agents|mesh-list
102157217|NCT05353543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102157218|NCT02499627|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102157219|NCT02499627|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102157220|NCT02499627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102157221|NCT02499627|Alkylating Agents|alkylating agents|mesh-ancestor
102157222|NCT02499627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157223|NCT02499627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102157224|NCT02499627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102157225|NCT02499627|Immunotoxins|immunotoxins|mesh-ancestor
102157226|NCT02499627|Immunoconjugates|immunoconjugates|mesh-ancestor
102157227|NCT02499627|Immunologic Factors|immunologic factors|mesh-ancestor
102157228|NCT02499627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157229|NCT03567655|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102157230|NCT03567655|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102157231|NCT03567655|Contraceptive Agents|contraceptive agents|mesh-ancestor
102157232|NCT03567655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102157233|NCT03567655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157234|NCT03567655|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102157235|NCT03567655|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102157236|NCT03567655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102157237|NCT03567655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102157238|NCT02505087|Acetylcysteine|acetylcysteine|mesh-list
102157239|NCT02505087|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102157240|NCT02505087|Antiviral Agents|antiviral agents|mesh-ancestor
102157241|NCT02505087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102157242|NCT02505087|Expectorants|expectorants|mesh-ancestor
102157243|NCT02505087|Respiratory System Agents|respiratory system agents|mesh-ancestor
102157244|NCT02505087|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102157245|NCT02505087|Antioxidants|antioxidants|mesh-ancestor
102157246|NCT02505087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157247|NCT02505087|Protective Agents|protective agents|mesh-ancestor
102157248|NCT02505087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157249|NCT02505087|Antidotes|antidotes|mesh-ancestor
102157250|NCT02839681|Maytansine|maytansine|mesh-list
102157251|NCT02839681|Anetumab ravtansine|anetumab ravtansine|mesh-list
102157252|NCT02839681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102157253|NCT02839681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102157254|NCT02839681|Tubulin Modulators|tubulin modulators|mesh-ancestor
102157255|NCT02839681|Antimitotic Agents|antimitotic agents|mesh-ancestor
102157256|NCT02839681|Mitosis Modulators|mitosis modulators|mesh-ancestor
102157257|NCT02839681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157258|NCT02839681|Immunoconjugates|immunoconjugates|mesh-ancestor
102157259|NCT02839681|Immunologic Factors|immunologic factors|mesh-ancestor
102157260|NCT02839681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157261|NCT02504463|Naltrexone|naltrexone|mesh-list
102157262|NCT02504463|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102157263|NCT02504463|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102157264|NCT02504463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157265|NCT02504463|Sensory System Agents|sensory system agents|mesh-ancestor
102157266|NCT02504463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102157267|NCT03566329|Lidocaine|lidocaine|mesh-list
102157268|NCT03566329|Magnesium Sulfate|magnesium sulfate|mesh-list
102157269|NCT03566329|Anesthetics, Local|anesthetics, local|mesh-ancestor
102157270|NCT03566329|Anesthetics|anesthetics|mesh-ancestor
102157271|NCT03566329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102157272|NCT03566329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157273|NCT03566329|Sensory System Agents|sensory system agents|mesh-ancestor
102157274|NCT03566329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102157275|NCT03566329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102157276|NCT03566329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102157277|NCT03566329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102157278|NCT03566329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102157279|NCT03566329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157280|NCT03566329|Analgesics|analgesics|mesh-ancestor
102157281|NCT03566329|Anticonvulsants|anticonvulsants|mesh-ancestor
102157282|NCT03566329|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102157283|NCT03566329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102157284|NCT03566329|Tocolytic Agents|tocolytic agents|mesh-ancestor
102157285|NCT03566329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102157286|NCT02499237|Zoledronic Acid|zoledronic acid|mesh-list
102157287|NCT02499237|Denosumab|denosumab|mesh-list
102157288|NCT02499237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102157289|NCT02499237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157290|NCT02499393|Magnesium Sulfate|magnesium sulfate|mesh-list
102157291|NCT02499393|Analgesics|analgesics|mesh-ancestor
102157292|NCT02499393|Sensory System Agents|sensory system agents|mesh-ancestor
102157293|NCT02499393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102157294|NCT02499393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157295|NCT02499393|Anesthetics|anesthetics|mesh-ancestor
102157296|NCT02499393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102157297|NCT02499393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102157298|NCT02499393|Anticonvulsants|anticonvulsants|mesh-ancestor
102157299|NCT02499393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102157300|NCT02499393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102157301|NCT02499393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157302|NCT02499393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102157303|NCT02499393|Tocolytic Agents|tocolytic agents|mesh-ancestor
102157304|NCT02499393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102157305|NCT02504307|Sirolimus|sirolimus|mesh-list
102157306|NCT02504307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102157307|NCT02504307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102157308|NCT02504307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102157309|NCT02504307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102157310|NCT02504307|Antifungal Agents|antifungal agents|mesh-ancestor
102157311|NCT02504307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102157312|NCT02504307|Immunologic Factors|immunologic factors|mesh-ancestor
102157313|NCT02504307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157314|NCT02504229|Oxaliplatin|oxaliplatin|mesh-list
102157315|NCT02504229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102157316|NCT03567343|Melatonin|melatonin|mesh-list
102157317|NCT03567343|Antioxidants|antioxidants|mesh-ancestor
102157318|NCT03567343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157319|NCT03567343|Protective Agents|protective agents|mesh-ancestor
102157320|NCT03567343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157321|NCT03567343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102157323|NCT04595864|Oxaliplatin|oxaliplatin|mesh-list
102157324|NCT04595864|Calcium|calcium|mesh-list
102157325|NCT04595864|Levoleucovorin|levoleucovorin|mesh-list
102157326|NCT04595864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102157327|NCT04595864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157328|NCT04595864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102157329|NCT04595864|Antidotes|antidotes|mesh-ancestor
102157330|NCT04595864|Protective Agents|protective agents|mesh-ancestor
102157331|NCT04595864|Vitamin B Complex|vitamin b complex|mesh-ancestor
102157332|NCT04595864|Vitamins|vitamins|mesh-ancestor
102157333|NCT04595864|Micronutrients|micronutrients|mesh-ancestor
102157334|NCT04583462|Metformin|metformin|mesh-list
102157335|NCT04583462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102157336|NCT04583462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157337|NCT04456322|Cisplatin|cisplatin|mesh-list
102157338|NCT04456322|Nimotuzumab|nimotuzumab|mesh-list
102157339|NCT04456322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102157340|NCT04456322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102157341|NCT02503761|Meropenem|meropenem|mesh-list
102157342|NCT02503761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102157343|NCT02503761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102157344|NCT04305548|Trabectedin|trabectedin|mesh-list
102157345|NCT04305548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102157346|NCT04305548|Alkylating Agents|alkylating agents|mesh-ancestor
102157347|NCT04305548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157348|NCT04305548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102157349|NCT04097912|Aspirin|aspirin|mesh-list
102157350|NCT04097912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102157351|NCT04097912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102157352|NCT04097912|Analgesics|analgesics|mesh-ancestor
102157353|NCT04097912|Sensory System Agents|sensory system agents|mesh-ancestor
102157354|NCT04097912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102157355|NCT04097912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157356|NCT04097912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102157357|NCT04097912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102157358|NCT04097912|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102157359|NCT04097912|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102157360|NCT04097912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157361|NCT04097912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102157362|NCT04097912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101866229|NCT01080027|Antiviral Agents|antiviral agents|mesh-ancestor
102157363|NCT04097912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102157364|NCT04097912|Antipyretics|antipyretics|mesh-ancestor
102157365|NCT04966676|Nivolumab|nivolumab|mesh-list
102157366|NCT04966676|Ipilimumab|ipilimumab|mesh-list
102157367|NCT04966676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102157368|NCT04966676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102157369|NCT04966676|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102157370|NCT04966676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157371|NCT03340779|Dobutamine|dobutamine|mesh-list
102157372|NCT03340779|Norepinephrine|norepinephrine|mesh-list
102157373|NCT03340779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102157374|NCT03340779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102157375|NCT03340779|Adrenergic Agents|adrenergic agents|mesh-ancestor
102157376|NCT03340779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102157377|NCT03340779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157378|NCT03340779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157379|NCT03340779|Sympathomimetics|sympathomimetics|mesh-ancestor
102157380|NCT03340779|Autonomic Agents|autonomic agents|mesh-ancestor
102157381|NCT03340779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102157382|NCT03340779|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102157383|NCT03340779|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102157384|NCT03340779|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102157385|NCT03340779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102157386|NCT03340779|Protective Agents|protective agents|mesh-ancestor
102157387|NCT04040738|Anesthetics|anesthetics|mesh-list
102157388|NCT04040738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102157389|NCT04040738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157390|NCT05104424|Insulin Aspart|insulin aspart|mesh-list
102157391|NCT05104424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102157392|NCT05104424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157394|NCT05087732|Anesthetics, Local|anesthetics, local|mesh-ancestor
102157395|NCT05087732|Anesthetics|anesthetics|mesh-ancestor
102157396|NCT05087732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102157397|NCT05087732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157398|NCT05087732|Sensory System Agents|sensory system agents|mesh-ancestor
102157399|NCT05087732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102157400|NCT05087732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102157401|NCT05087732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102157402|NCT05087732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102157403|NCT05087732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102157404|NCT05087732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157405|NCT03340701|Progesterone|progesterone|mesh-list
102157406|NCT03340701|Progestins|progestins|mesh-ancestor
102157407|NCT03340701|Hormones|hormones|mesh-ancestor
102157408|NCT03340701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102157409|NCT03340701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157410|NCT02498535|Nitric Oxide|nitric oxide|mesh-list
102157411|NCT02498535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102157412|NCT02498535|Autonomic Agents|autonomic agents|mesh-ancestor
102157413|NCT02498535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102157414|NCT02498535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157415|NCT02498535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102157416|NCT02498535|Respiratory System Agents|respiratory system agents|mesh-ancestor
102157417|NCT02498535|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102157418|NCT02498535|Antioxidants|antioxidants|mesh-ancestor
102157419|NCT02498535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157420|NCT02498535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102157421|NCT02498535|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102157422|NCT02498535|Vasodilator Agents|vasodilator agents|mesh-ancestor
102157423|NCT02498535|Gasotransmitters|gasotransmitters|mesh-ancestor
102157424|NCT02498535|Protective Agents|protective agents|mesh-ancestor
102157425|NCT04727138|Midazolam|midazolam|mesh-list
102157426|NCT04727138|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102157427|NCT04727138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102157428|NCT04727138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102157429|NCT04727138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157430|NCT04727138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102157431|NCT04727138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102157432|NCT04727138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102157433|NCT04727138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102157434|NCT04727138|Anesthetics, General|anesthetics, general|mesh-ancestor
102157435|NCT04727138|Anesthetics|anesthetics|mesh-ancestor
102157436|NCT04727138|GABA Modulators|gaba modulators|mesh-ancestor
102157437|NCT04727138|GABA Agents|gaba agents|mesh-ancestor
102157438|NCT04727138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102157439|NCT04727138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157440|NCT02498457|Calcium|calcium|mesh-list
102157441|NCT02498457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102157442|NCT02498457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157443|NCT02498301|Rifaximin|rifaximin|mesh-list
102157444|NCT02498301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102157445|NCT02498301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102157446|NCT02498301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102157447|NCT03343665|Nivolumab|nivolumab|mesh-list
102157448|NCT03343665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102157449|NCT03343665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102157450|NCT03343665|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102157451|NCT03343665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157453|NCT02733614|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102157454|NCT02733614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157455|NCT02733614|Natriuretic Agents|natriuretic agents|mesh-ancestor
102157456|NCT02733614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157457|NCT04674254|Bevacizumab|bevacizumab|mesh-list
102157458|NCT04674254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102157459|NCT04674254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102157460|NCT04674254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102157461|NCT04674254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102157462|NCT04674254|Growth Substances|growth substances|mesh-ancestor
102157463|NCT04674254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157464|NCT04674254|Growth Inhibitors|growth inhibitors|mesh-ancestor
102157465|NCT03342807|Insulin|insulin|mesh-list
102157466|NCT03342807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102157467|NCT03342807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157468|NCT02570672|Metformin|metformin|mesh-list
102157469|NCT02570672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102157470|NCT02570672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157471|NCT03339921|Botulinum Toxins|botulinum toxins|mesh-list
102157472|NCT03339921|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102157473|NCT03339921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102157474|NCT03339921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157475|NCT03339921|Cholinergic Agents|cholinergic agents|mesh-ancestor
102157476|NCT03339921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102157477|NCT03339921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157478|NCT04593914|Protective Agents|protective agents|mesh-list
102157479|NCT04593914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157480|NCT04523090|Nitazoxanide|nitazoxanide|mesh-list
102157481|NCT04523090|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102157482|NCT04523090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102157483|NCT03342651|Vitamin D|vitamin d|mesh-list
102157484|NCT03342651|Vitamins|vitamins|mesh-ancestor
102157485|NCT03342651|Micronutrients|micronutrients|mesh-ancestor
102157486|NCT03342651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157487|NCT03342651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102157488|NCT04819568|Terlipressin|terlipressin|mesh-list
102157489|NCT04819568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102157490|NCT04819568|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102157491|NCT02502981|Chlorthalidone|chlorthalidone|mesh-list
102157492|NCT02502981|Spironolactone|spironolactone|mesh-list
102157493|NCT02502981|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
102157494|NCT02502981|Diuretics|diuretics|mesh-list
102157495|NCT02502981|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
102157496|NCT02502981|Mineralocorticoids|mineralocorticoids|mesh-list
102157497|NCT02502981|Hormone Antagonists|hormone antagonists|mesh-ancestor
102157498|NCT02502981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102157499|NCT02502981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157500|NCT02502981|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102157501|NCT02502981|Natriuretic Agents|natriuretic agents|mesh-ancestor
102157502|NCT02502981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102157503|NCT02502981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102157504|NCT02502981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157505|NCT02502981|Hormones|hormones|mesh-ancestor
102157506|NCT04230746|Trimethoprim|trimethoprim|mesh-list
102157507|NCT04230746|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102157508|NCT04230746|Sulfamethoxazole|sulfamethoxazole|mesh-list
102157509|NCT04230746|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102157510|NCT04230746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102157511|NCT04230746|Antimalarials|antimalarials|mesh-ancestor
102157512|NCT04230746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102157513|NCT04230746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102157514|NCT04230746|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102157515|NCT04230746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102157516|NCT04230746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157517|NCT04230746|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102157518|NCT04230746|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102157519|NCT04230746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102157520|NCT04230746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102157521|NCT04633772|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
102157522|NCT04633772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102157523|NCT04633772|Vasodilator Agents|vasodilator agents|mesh-ancestor
102157524|NCT05111444|Paclitaxel|paclitaxel|mesh-list
102157525|NCT05111444|Capecitabine|capecitabine|mesh-list
102157526|NCT05111444|Oxaliplatin|oxaliplatin|mesh-list
102157527|NCT05111444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102157528|NCT05111444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102157529|NCT05111444|Tubulin Modulators|tubulin modulators|mesh-ancestor
102157530|NCT05111444|Antimitotic Agents|antimitotic agents|mesh-ancestor
102157531|NCT05111444|Mitosis Modulators|mitosis modulators|mesh-ancestor
102157532|NCT05111444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157533|NCT05111444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102157534|NCT05111444|Antimetabolites|antimetabolites|mesh-ancestor
102157535|NCT03769688|Metronidazole|metronidazole|mesh-list
102157536|NCT03769688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102157537|NCT03769688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102157538|NCT03769688|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102157539|NCT03769688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102157540|NCT02502825|Methacholine Chloride|methacholine chloride|mesh-list
102157541|NCT02502825|Miotics|miotics|mesh-ancestor
102157542|NCT02502825|Autonomic Agents|autonomic agents|mesh-ancestor
102157543|NCT02502825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102157544|NCT02502825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157545|NCT02502825|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102157546|NCT02502825|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
102157547|NCT02502825|Respiratory System Agents|respiratory system agents|mesh-ancestor
102157548|NCT02502825|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102157549|NCT02502825|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102157550|NCT02502825|Cholinergic Agents|cholinergic agents|mesh-ancestor
102157551|NCT02502825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102157552|NCT02502825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157553|NCT02498145|Nicotine|nicotine|mesh-list
102157554|NCT02498145|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102157555|NCT02498145|Autonomic Agents|autonomic agents|mesh-ancestor
102157556|NCT02498145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102157557|NCT02498145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157558|NCT02498145|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102157559|NCT02498145|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102157560|NCT02498145|Cholinergic Agents|cholinergic agents|mesh-ancestor
102157561|NCT02498145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102157562|NCT02498145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157563|NCT02497911|Bupivacaine|bupivacaine|mesh-list
102157564|NCT02497911|Anesthetics, Local|anesthetics, local|mesh-ancestor
102157565|NCT02497911|Anesthetics|anesthetics|mesh-ancestor
102157566|NCT02497911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102157567|NCT02497911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157568|NCT02497911|Sensory System Agents|sensory system agents|mesh-ancestor
102157569|NCT02497911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102157570|NCT02497833|Tretinoin|tretinoin|mesh-list
102157571|NCT02497833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102157572|NCT02497833|Keratolytic Agents|keratolytic agents|mesh-ancestor
102157573|NCT02497833|Dermatologic Agents|dermatologic agents|mesh-ancestor
102157574|NCT02493933|Acetylcysteine|acetylcysteine|mesh-list
102157575|NCT02493933|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102157576|NCT02493933|Phytoestrogens|phytoestrogens|mesh-list
102157577|NCT02493933|Antiviral Agents|antiviral agents|mesh-ancestor
102157578|NCT02493933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102157579|NCT02493933|Expectorants|expectorants|mesh-ancestor
102157580|NCT02493933|Respiratory System Agents|respiratory system agents|mesh-ancestor
102157581|NCT02493933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102157582|NCT02493933|Antioxidants|antioxidants|mesh-ancestor
102157583|NCT02493933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157584|NCT02493933|Protective Agents|protective agents|mesh-ancestor
102157585|NCT02493933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157586|NCT02493933|Antidotes|antidotes|mesh-ancestor
102157587|NCT02493933|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102157588|NCT02493933|Estrogens|estrogens|mesh-ancestor
102157589|NCT02493933|Hormones|hormones|mesh-ancestor
101866452|NCT01103518|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102157590|NCT02493933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102157591|NCT04153604|Doxycycline|doxycycline|mesh-list
102157592|NCT04153604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102157593|NCT04153604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102157594|NCT04153604|Antimalarials|antimalarials|mesh-ancestor
102157595|NCT04153604|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102157596|NCT04153604|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102157597|NCT03338205|Ketamine|ketamine|mesh-list
102157598|NCT03338205|Analgesics|analgesics|mesh-ancestor
102157599|NCT03338205|Sensory System Agents|sensory system agents|mesh-ancestor
102157600|NCT03338205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102157601|NCT03338205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157602|NCT03338205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102157603|NCT03338205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102157604|NCT03338205|Anesthetics, General|anesthetics, general|mesh-ancestor
102157605|NCT03338205|Anesthetics|anesthetics|mesh-ancestor
102157606|NCT03338205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102157607|NCT03338205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102157608|NCT03338205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102157609|NCT03338205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102157610|NCT03338205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157611|NCT04314050|Dexmedetomidine|dexmedetomidine|mesh-list
102157612|NCT04314050|Tramadol|tramadol|mesh-list
102157613|NCT04314050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102157614|NCT04314050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102157615|NCT04314050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157616|NCT04314050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102157617|NCT04314050|Analgesics|analgesics|mesh-ancestor
102157618|NCT04314050|Sensory System Agents|sensory system agents|mesh-ancestor
102157619|NCT04314050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102157620|NCT04314050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102157621|NCT04314050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102157622|NCT04314050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102157623|NCT04314050|Adrenergic Agents|adrenergic agents|mesh-ancestor
102157624|NCT04314050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102157625|NCT04314050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157626|NCT04314050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102157627|NCT04314050|Narcotics|narcotics|mesh-ancestor
102157628|NCT03343509|Metronidazole|metronidazole|mesh-list
102157629|NCT03343509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102157630|NCT03343509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102157631|NCT03343509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102157632|NCT03343509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102157633|NCT04516148|Clindamycin|clindamycin|mesh-list
102157634|NCT04516148|Clindamycin palmitate|clindamycin palmitate|mesh-list
102157635|NCT04516148|Clindamycin phosphate|clindamycin phosphate|mesh-list
102157636|NCT04516148|Cefazolin|cefazolin|mesh-list
102157637|NCT04516148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102157638|NCT04516148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102157639|NCT04516148|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102157640|NCT04516148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102157641|NCT04516148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157642|NCT02497365|Cefazolin|cefazolin|mesh-list
102157643|NCT02497365|Tobramycin|tobramycin|mesh-list
102157644|NCT02497365|Besifloxacin|besifloxacin|mesh-list
102157645|NCT02497365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102157646|NCT02497365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102157647|NCT02497365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102157648|NCT02497365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102157649|NCT02497365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102157650|NCT02497365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157651|NCT02497365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102157652|NCT02497053|Pemetrexed|pemetrexed|mesh-list
102157653|NCT02497053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102157654|NCT02497053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102157655|NCT02497053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157656|NCT02497053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102157657|NCT02497053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102157658|NCT03120975|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102157659|NCT03120975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102157660|NCT03337581|Dexmedetomidine|dexmedetomidine|mesh-list
102157661|NCT03337581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102157662|NCT03337581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102157663|NCT03337581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157664|NCT03337581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102157665|NCT03337581|Analgesics|analgesics|mesh-ancestor
102157666|NCT03337581|Sensory System Agents|sensory system agents|mesh-ancestor
102157667|NCT03337581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102157668|NCT03337581|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102157669|NCT03337581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102157670|NCT03337581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102157671|NCT03337581|Adrenergic Agents|adrenergic agents|mesh-ancestor
102157672|NCT03337581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102157673|NCT03337581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157674|NCT02496975|Cyclosporine|cyclosporine|mesh-list
102157675|NCT02496975|Cyclosporins|cyclosporins|mesh-list
102157676|NCT02496975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102157677|NCT02496975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157678|NCT02496975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102157679|NCT02496975|Immunologic Factors|immunologic factors|mesh-ancestor
102157680|NCT02496975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157681|NCT02496975|Antifungal Agents|antifungal agents|mesh-ancestor
102157682|NCT02496975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102157683|NCT02496975|Dermatologic Agents|dermatologic agents|mesh-ancestor
102157684|NCT02496975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102157685|NCT02496975|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102157686|NCT03337503|Dronabinol|dronabinol|mesh-list
102157687|NCT03337503|Hallucinogens|hallucinogens|mesh-ancestor
102157688|NCT03337503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157689|NCT03337503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102157690|NCT03337503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102157691|NCT03337503|Analgesics|analgesics|mesh-ancestor
102157692|NCT03337503|Sensory System Agents|sensory system agents|mesh-ancestor
102157693|NCT03337503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102157694|NCT03337503|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102157695|NCT03337503|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102157696|NCT03337503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102157697|NCT03337503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157698|NCT03337503|Hormones|hormones|mesh-ancestor
102157699|NCT03337503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102157700|NCT01675622|Morphine|morphine|mesh-list
102157701|NCT01675622|Oxycodone|oxycodone|mesh-list
102157702|NCT01675622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102157703|NCT01675622|Narcotics|narcotics|mesh-ancestor
102157704|NCT01675622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102157705|NCT01675622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157706|NCT01675622|Analgesics|analgesics|mesh-ancestor
102157707|NCT01675622|Sensory System Agents|sensory system agents|mesh-ancestor
102157708|NCT01675622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102157709|NCT02496741|Metformin|metformin|mesh-list
102157710|NCT02496741|Chloroquine|chloroquine|mesh-list
102157711|NCT02496741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102157712|NCT02496741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157713|NCT02496741|Amebicides|amebicides|mesh-ancestor
102157714|NCT02496741|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102157715|NCT02496741|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102157716|NCT02496741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102157717|NCT02496741|Antimalarials|antimalarials|mesh-ancestor
102157718|NCT02496741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102157719|NCT04496037|Rituximab|rituximab|mesh-list
102157720|NCT04496037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102157721|NCT04496037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102157722|NCT04496037|Immunologic Factors|immunologic factors|mesh-ancestor
102157723|NCT04496037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157724|NCT04496037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102157725|NCT02493465|Everolimus|everolimus|mesh-list
102157726|NCT02493465|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102157727|NCT02493465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102157728|NCT02493465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102157729|NCT02493465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157730|NCT02493465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102157731|NCT02493465|Immunologic Factors|immunologic factors|mesh-ancestor
102157732|NCT02493465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157733|NCT02493465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102157734|NCT03342261|Antiviral Agents|antiviral agents|mesh-list
102157735|NCT03342261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102157736|NCT04495569|Antibodies|antibodies|mesh-list
102157737|NCT04495569|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102157738|NCT04495569|Immunologic Factors|immunologic factors|mesh-ancestor
102157739|NCT04495569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866623|NCT00072280|Mesna|mesna|mesh-list
102157740|NCT03337191|Morphine|morphine|mesh-list
102157741|NCT03337191|Levobupivacaine|levobupivacaine|mesh-list
102157742|NCT03337191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102157743|NCT03337191|Narcotics|narcotics|mesh-ancestor
102157744|NCT03337191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102157745|NCT03337191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157746|NCT03337191|Analgesics|analgesics|mesh-ancestor
102157747|NCT03337191|Sensory System Agents|sensory system agents|mesh-ancestor
102157748|NCT03337191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102157749|NCT03337191|Anesthetics, Local|anesthetics, local|mesh-ancestor
102157750|NCT03337191|Anesthetics|anesthetics|mesh-ancestor
102157751|NCT04494243|Rabeprazole|rabeprazole|mesh-list
102157752|NCT04494243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102157753|NCT04494243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102157754|NCT04494243|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102157755|NCT04494243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102157756|NCT04494243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157757|NCT03337035|Oxytocin|oxytocin|mesh-list
102157758|NCT03337035|Oxytocics|oxytocics|mesh-ancestor
102157759|NCT03337035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102157760|NCT03337035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157761|NCT03330717|Anesthetics|anesthetics|mesh-list
102157762|NCT03330717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102157763|NCT03330717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157765|NCT02655224|Androgen Antagonists|androgen antagonists|mesh-ancestor
102157766|NCT02655224|Hormone Antagonists|hormone antagonists|mesh-ancestor
102157767|NCT02655224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102157768|NCT02655224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157769|NCT04494321|Budesonide|budesonide|mesh-list
102157770|NCT04494321|Formoterol Fumarate|formoterol fumarate|mesh-list
102157771|NCT04494321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102157772|NCT04494321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102157773|NCT04494321|Autonomic Agents|autonomic agents|mesh-ancestor
102157774|NCT04494321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102157775|NCT04494321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157776|NCT04494321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102157777|NCT04494321|Respiratory System Agents|respiratory system agents|mesh-ancestor
102157778|NCT04494321|Glucocorticoids|glucocorticoids|mesh-ancestor
102157779|NCT04494321|Hormones|hormones|mesh-ancestor
102157780|NCT04494321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102157781|NCT04494321|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102157782|NCT04494321|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102157783|NCT04494321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102157784|NCT04494321|Adrenergic Agents|adrenergic agents|mesh-ancestor
102157785|NCT04494321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102157786|NCT04494321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157787|NCT03330171|Vaccines|vaccines|mesh-list
102157788|NCT03330171|Immunologic Factors|immunologic factors|mesh-ancestor
102157789|NCT03330171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157790|NCT05118542|Methimazole|methimazole|mesh-list
102157791|NCT05118542|Propylthiouracil|propylthiouracil|mesh-list
102157792|NCT05118542|Antithyroid Agents|antithyroid agents|mesh-ancestor
102157793|NCT05118542|Hormone Antagonists|hormone antagonists|mesh-ancestor
102157794|NCT05118542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102157795|NCT05118542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157796|NCT05118542|Antimetabolites|antimetabolites|mesh-ancestor
102157797|NCT05118542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157798|NCT03336801|Propofol|propofol|mesh-list
102157799|NCT03336801|Sevoflurane|sevoflurane|mesh-list
102157800|NCT03336801|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102157801|NCT03336801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102157802|NCT03336801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157803|NCT03336801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102157804|NCT03336801|Anesthetics, General|anesthetics, general|mesh-ancestor
102157805|NCT03336801|Anesthetics|anesthetics|mesh-ancestor
102157806|NCT03336801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102157807|NCT03336801|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102157808|NCT05115578|Midazolam|midazolam|mesh-list
102157809|NCT05115578|Remifentanil|remifentanil|mesh-list
102157810|NCT05115578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102157811|NCT05115578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102157812|NCT05115578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102157813|NCT05115578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157814|NCT05115578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102157815|NCT05115578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102157816|NCT05115578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102157817|NCT05115578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102157818|NCT05115578|Anesthetics, General|anesthetics, general|mesh-ancestor
102157819|NCT05115578|Anesthetics|anesthetics|mesh-ancestor
102157820|NCT05115578|GABA Modulators|gaba modulators|mesh-ancestor
102157821|NCT05115578|GABA Agents|gaba agents|mesh-ancestor
102157822|NCT05115578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102157823|NCT05115578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157824|NCT05115578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102157825|NCT05115578|Narcotics|narcotics|mesh-ancestor
102157826|NCT05115578|Analgesics|analgesics|mesh-ancestor
102157827|NCT05115578|Sensory System Agents|sensory system agents|mesh-ancestor
102157828|NCT05115578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102157829|NCT02636036|Nivolumab|nivolumab|mesh-list
102157830|NCT02636036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102157831|NCT02636036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102157832|NCT02636036|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102157833|NCT02636036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157834|NCT03329781|Curcumin|curcumin|mesh-list
102157835|NCT03329781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102157836|NCT03329781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102157837|NCT03329781|Analgesics|analgesics|mesh-ancestor
102157838|NCT03329781|Sensory System Agents|sensory system agents|mesh-ancestor
102157839|NCT03329781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102157840|NCT03329781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157841|NCT03329781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102157842|NCT03329781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102157843|NCT03329781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102157844|NCT03329781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102157845|NCT03329781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157846|NCT02437604|Fluticasone|fluticasone|mesh-list
102157847|NCT02437604|Xhance|xhance|mesh-list
102157848|NCT02437604|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102157849|NCT02437604|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102157850|NCT02437604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102157851|NCT02437604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102157852|NCT02437604|Autonomic Agents|autonomic agents|mesh-ancestor
102157853|NCT02437604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102157854|NCT02437604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157855|NCT02437604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102157856|NCT02437604|Respiratory System Agents|respiratory system agents|mesh-ancestor
102157857|NCT02437604|Dermatologic Agents|dermatologic agents|mesh-ancestor
102157858|NCT02437604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102157859|NCT02437604|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102157860|NCT02437604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102157861|NCT02437604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102157862|NCT02437604|Adrenergic Agents|adrenergic agents|mesh-ancestor
102157863|NCT02437604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102157864|NCT02437604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157865|NCT02437604|Glucocorticoids|glucocorticoids|mesh-ancestor
102157866|NCT02437604|Hormones|hormones|mesh-ancestor
102157867|NCT02437604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102157868|NCT02437604|Sympathomimetics|sympathomimetics|mesh-ancestor
102157869|NCT03329547|Cefixime|cefixime|mesh-list
102157870|NCT03329547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102157871|NCT03329547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102157872|NCT05463627|Metformin|metformin|mesh-list
102157873|NCT05463627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102157874|NCT05463627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157875|NCT01975298|Interferons|interferons|mesh-list
102157876|NCT01975298|Interferon beta-1a|interferon beta-1a|mesh-list
102157877|NCT01975298|Interferon-beta|interferon-beta|mesh-list
102157878|NCT01975298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102157879|NCT01975298|Antiviral Agents|antiviral agents|mesh-ancestor
102157880|NCT01975298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102157881|NCT01975298|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102157882|NCT01975298|Immunologic Factors|immunologic factors|mesh-ancestor
102157883|NCT01975298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157884|NCT03324867|Insulin|insulin|mesh-list
102157885|NCT03324867|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102157886|NCT03324867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102157887|NCT03324867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157888|NCT05084534|Midodrine|midodrine|mesh-list
102157889|NCT05084534|Sympathomimetics|sympathomimetics|mesh-ancestor
102157890|NCT05084534|Autonomic Agents|autonomic agents|mesh-ancestor
102157891|NCT05084534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102157898|NCT05084534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102157899|NCT05084534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157900|NCT04645316|Propofol|propofol|mesh-list
102157901|NCT04645316|Sevoflurane|sevoflurane|mesh-list
102157902|NCT04645316|Desflurane|desflurane|mesh-list
102157903|NCT04645316|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102157904|NCT04645316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102157905|NCT04645316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157906|NCT04645316|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102157907|NCT04645316|Anesthetics, General|anesthetics, general|mesh-ancestor
102157908|NCT04645316|Anesthetics|anesthetics|mesh-ancestor
102157909|NCT04645316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102157910|NCT04645316|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102157911|NCT00659126|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102157912|NCT00659126|Hematinics|hematinics|mesh-ancestor
102157913|NCT00659126|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102157914|NCT00659126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102157922|NCT02491515|Denosumab|denosumab|mesh-list
102157923|NCT02491515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102157924|NCT02491515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157925|NCT05113628|Methylene Blue|methylene blue|mesh-list
102157926|NCT05113628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102157927|NCT05113628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157929|NCT04247750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102157930|NCT04247750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102157931|NCT04247750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102157932|NCT04247750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102157933|NCT04247750|Antifungal Agents|antifungal agents|mesh-ancestor
102157934|NCT04247750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102157935|NCT04247750|Immunologic Factors|immunologic factors|mesh-ancestor
102157936|NCT04247750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157937|NCT04513808|Anesthetics|anesthetics|mesh-list
102157938|NCT04513808|Propofol|propofol|mesh-list
102157939|NCT04513808|Sevoflurane|sevoflurane|mesh-list
102157940|NCT04513808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102157941|NCT04513808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157942|NCT04513808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102157943|NCT04513808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102157944|NCT04513808|Anesthetics, General|anesthetics, general|mesh-ancestor
102157945|NCT04513808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102157946|NCT04513808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102157947|NCT02493231|Ketamine|ketamine|mesh-list
102157948|NCT02493231|Nefopam|nefopam|mesh-list
102157949|NCT02493231|Analgesics|analgesics|mesh-ancestor
102157950|NCT02493231|Sensory System Agents|sensory system agents|mesh-ancestor
102157951|NCT02493231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102157952|NCT02493231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157953|NCT02493231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102157954|NCT02493231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102157955|NCT02493231|Anesthetics, General|anesthetics, general|mesh-ancestor
102157956|NCT02493231|Anesthetics|anesthetics|mesh-ancestor
102157957|NCT02493231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102157958|NCT02493231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102157959|NCT02493231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102157960|NCT02493231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102157961|NCT02493231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102157962|NCT02493231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102157963|NCT05112692|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102157964|NCT05112692|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102157965|NCT05112692|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102157966|NCT05112692|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102157967|NCT05112692|Cetrorelix|cetrorelix|mesh-list
102157968|NCT05112692|Menotropins|menotropins|mesh-list
102157969|NCT05112692|Estradiol|estradiol|mesh-list
102157970|NCT05112692|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102157971|NCT05112692|Progesterone|progesterone|mesh-list
102157972|NCT05112692|Dydrogesterone|dydrogesterone|mesh-list
102157973|NCT05112692|Estrogens|estrogens|mesh-ancestor
102157974|NCT05112692|Hormones|hormones|mesh-ancestor
102157975|NCT05112692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102157976|NCT05112692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157977|NCT05112692|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102157978|NCT05112692|Contraceptive Agents|contraceptive agents|mesh-ancestor
102157979|NCT05112692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102157980|NCT05112692|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102157981|NCT05112692|Progestins|progestins|mesh-ancestor
102157982|NCT05112692|Luteolytic Agents|luteolytic agents|mesh-ancestor
102157983|NCT05112692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102157984|NCT05112692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102157985|NCT05112692|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102157986|NCT05112692|Fertility Agents|fertility agents|mesh-ancestor
102157987|NCT05112692|Hormone Antagonists|hormone antagonists|mesh-ancestor
102157988|NCT03328533|Phenylephrine|phenylephrine|mesh-list
102157989|NCT03328533|Oxymetazoline|oxymetazoline|mesh-list
102157990|NCT03328533|Norepinephrine|norepinephrine|mesh-list
102157991|NCT03328533|Bupivacaine|bupivacaine|mesh-list
102157992|NCT03328533|Anesthetics, Local|anesthetics, local|mesh-ancestor
102157993|NCT03328533|Anesthetics|anesthetics|mesh-ancestor
102157994|NCT03328533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102157995|NCT03328533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102157996|NCT03328533|Sensory System Agents|sensory system agents|mesh-ancestor
102157997|NCT03328533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102157998|NCT03328533|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102157999|NCT03328533|Mydriatics|mydriatics|mesh-ancestor
102158000|NCT03328533|Autonomic Agents|autonomic agents|mesh-ancestor
102158001|NCT03328533|Sympathomimetics|sympathomimetics|mesh-ancestor
102158002|NCT03328533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102158004|NCT03328533|Respiratory System Agents|respiratory system agents|mesh-ancestor
102158005|NCT03328533|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102158006|NCT03328533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102158007|NCT03328533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102158008|NCT03328533|Adrenergic Agents|adrenergic agents|mesh-ancestor
102158009|NCT03328533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102158010|NCT03328533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158011|NCT03328533|Protective Agents|protective agents|mesh-ancestor
102158012|NCT05117372|Immunomodulating Agents|immunomodulating agents|mesh-list
102158013|NCT05117372|Immunologic Factors|immunologic factors|mesh-ancestor
102158014|NCT05117372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158015|NCT03324243|Cytarabine|cytarabine|mesh-list
102158016|NCT03324243|Fludarabine|fludarabine|mesh-list
102158017|NCT03324243|Crenolanib|crenolanib|mesh-list
102158018|NCT03324243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102158019|NCT03324243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102158020|NCT03324243|Antimetabolites|antimetabolites|mesh-ancestor
102158021|NCT03324243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158022|NCT03324243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102158023|NCT03324243|Immunologic Factors|immunologic factors|mesh-ancestor
102158024|NCT03324243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158025|NCT03324243|Antiviral Agents|antiviral agents|mesh-ancestor
102158026|NCT03324243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102158027|NCT03328299|Dexmedetomidine|dexmedetomidine|mesh-list
102158028|NCT03328299|Bupivacaine|bupivacaine|mesh-list
102158029|NCT03328299|Anesthetics, Local|anesthetics, local|mesh-ancestor
102158030|NCT03328299|Anesthetics|anesthetics|mesh-ancestor
102158031|NCT03328299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102158032|NCT03328299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158033|NCT03328299|Sensory System Agents|sensory system agents|mesh-ancestor
102158034|NCT03328299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102158035|NCT03328299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102158036|NCT03328299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102158037|NCT03328299|Analgesics|analgesics|mesh-ancestor
102158038|NCT03328299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102158039|NCT03328299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102158040|NCT03328299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102158041|NCT03328299|Adrenergic Agents|adrenergic agents|mesh-ancestor
102158042|NCT03328299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102158043|NCT03328299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158044|NCT03564301|Metronidazole|metronidazole|mesh-list
101445505|NCT00560092|Tocolytic Agents|tocolytic agents|mesh-ancestor
102158045|NCT03564301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102158046|NCT03564301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102158047|NCT03564301|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102158048|NCT03564301|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102158049|NCT05079854|Moxifloxacin|moxifloxacin|mesh-list
102158050|NCT05079854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102158051|NCT05079854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102158052|NCT05079854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102158053|NCT05079854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102158054|NCT05079854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102158055|NCT05079854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158056|NCT05079854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102158057|NCT03327987|Vaccines|vaccines|mesh-list
102158058|NCT03327987|Immunologic Factors|immunologic factors|mesh-ancestor
102158059|NCT03327987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158060|NCT03335241|Doxorubicin|doxorubicin|mesh-list
102158061|NCT03335241|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102158062|NCT03335241|Fludarabine|fludarabine|mesh-list
102158063|NCT03335241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102158064|NCT03335241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102158065|NCT03335241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102158066|NCT03335241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102158067|NCT03335241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102158068|NCT03335241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158069|NCT03327831|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102158070|NCT03327831|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102158071|NCT03327831|Dermatologic Agents|dermatologic agents|mesh-ancestor
102158072|NCT03120663|Amoxicillin|amoxicillin|mesh-list
102158073|NCT03120663|Clindamycin|clindamycin|mesh-list
102158074|NCT03120663|Meropenem|meropenem|mesh-list
102158075|NCT03120663|Tazobactam|tazobactam|mesh-list
102158076|NCT03120663|Piperacillin|piperacillin|mesh-list
102158077|NCT03120663|Clavulanic Acids|clavulanic acids|mesh-list
102158078|NCT03120663|Clavulanic Acid|clavulanic acid|mesh-list
102158079|NCT03120663|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102158080|NCT03120663|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102158082|NCT03120663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102158083|NCT03120663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102158084|NCT03120663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102158085|NCT03120663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158086|NCT03120663|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102158087|NCT02578394|Methylprednisolone|methylprednisolone|mesh-list
102158088|NCT02578394|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102158089|NCT02578394|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102158090|NCT02578394|Prednisolone|prednisolone|mesh-list
102158091|NCT02578394|Prednisolone acetate|prednisolone acetate|mesh-list
102158092|NCT02578394|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102158093|NCT02578394|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102158094|NCT02578394|Prednisolone phosphate|prednisolone phosphate|mesh-list
102158095|NCT02578394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102158096|NCT02578394|Antiemetics|antiemetics|mesh-ancestor
102158097|NCT02578394|Autonomic Agents|autonomic agents|mesh-ancestor
102158098|NCT02578394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102158099|NCT02578394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158100|NCT02578394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102158101|NCT02578394|Glucocorticoids|glucocorticoids|mesh-ancestor
102158102|NCT02578394|Hormones|hormones|mesh-ancestor
102158103|NCT02578394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102158104|NCT02578394|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102158105|NCT02578394|Protective Agents|protective agents|mesh-ancestor
102158106|NCT02578394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102158107|NCT02578394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102158108|NCT02578394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102158109|NCT04493229|Oxytocin|oxytocin|mesh-list
102158110|NCT04493229|Oxytocics|oxytocics|mesh-ancestor
102158111|NCT04493229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102158112|NCT04493229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158113|NCT03120273|Lansoprazole|lansoprazole|mesh-list
102158114|NCT03120273|Dexlansoprazole|dexlansoprazole|mesh-list
102158115|NCT03120273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102158116|NCT03120273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102158117|NCT03120273|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102158118|NCT03120273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102158119|NCT03120273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158120|NCT02122718|Allopurinol|allopurinol|mesh-list
102158121|NCT02122718|Antimetabolites|antimetabolites|mesh-ancestor
102158122|NCT02122718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158123|NCT02122718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102158124|NCT02122718|Gout Suppressants|gout suppressants|mesh-ancestor
102158125|NCT02122718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102158126|NCT02122718|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102158127|NCT02122718|Antioxidants|antioxidants|mesh-ancestor
102158128|NCT02122718|Protective Agents|protective agents|mesh-ancestor
102158129|NCT02122718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158130|NCT04513652|Carticaine|carticaine|mesh-list
102158131|NCT04513652|Anesthetics, Local|anesthetics, local|mesh-ancestor
102158132|NCT04513652|Anesthetics|anesthetics|mesh-ancestor
102158133|NCT04513652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102158134|NCT04513652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158135|NCT04513652|Sensory System Agents|sensory system agents|mesh-ancestor
102158136|NCT04513652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102158137|NCT00706797|Etanercept|etanercept|mesh-list
102158138|NCT00706797|Methotrexate|methotrexate|mesh-list
102158139|NCT00706797|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102158140|NCT00706797|Abortifacient Agents|abortifacient agents|mesh-ancestor
102158141|NCT00706797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102158142|NCT00706797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158143|NCT00706797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102158144|NCT00706797|Antimetabolites|antimetabolites|mesh-ancestor
102158145|NCT00706797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158146|NCT00706797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102158147|NCT00706797|Dermatologic Agents|dermatologic agents|mesh-ancestor
102158148|NCT00706797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102158149|NCT00706797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102158150|NCT00706797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102158151|NCT00706797|Immunologic Factors|immunologic factors|mesh-ancestor
102158152|NCT00706797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102158154|NCT00706797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102158155|NCT00706797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102158156|NCT00706797|Analgesics|analgesics|mesh-ancestor
102158157|NCT00706797|Sensory System Agents|sensory system agents|mesh-ancestor
102158158|NCT00706797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102158159|NCT00706797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102158160|NCT00706797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102158161|NCT03323697|Escitalopram|escitalopram|mesh-list
102158162|NCT03323697|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102158163|NCT03323697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102158164|NCT03323697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102158165|NCT03323697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158166|NCT03323697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102158167|NCT03323697|Serotonin Agents|serotonin agents|mesh-ancestor
102158168|NCT03323697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158169|NCT00706641|Dasatinib|dasatinib|mesh-list
102158170|NCT00706641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102158171|NCT00706641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102158172|NCT00706641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102158173|NCT00706641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158174|NCT03335085|Oxytocin|oxytocin|mesh-list
102158175|NCT03335085|Oxytocics|oxytocics|mesh-ancestor
102158176|NCT03335085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102158177|NCT03335085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158178|NCT03323619|Anesthetics|anesthetics|mesh-list
102158179|NCT03323619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102158180|NCT03323619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158181|NCT03323541|Lenograstim|lenograstim|mesh-list
102158182|NCT03323541|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102158183|NCT03323541|Immunologic Factors|immunologic factors|mesh-ancestor
102158184|NCT03323541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158185|NCT03335007|Aceclofenac|aceclofenac|mesh-list
102158186|NCT03335007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102158187|NCT03335007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102158188|NCT03335007|Analgesics|analgesics|mesh-ancestor
102158189|NCT03335007|Sensory System Agents|sensory system agents|mesh-ancestor
102158190|NCT03335007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102158191|NCT03335007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158192|NCT03335007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102158193|NCT03335007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102158194|NCT01362530|Ondansetron|ondansetron|mesh-list
102158195|NCT01362530|Aprepitant|aprepitant|mesh-list
102158196|NCT01362530|Fosaprepitant|fosaprepitant|mesh-list
102158205|NCT01362530|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102158206|NCT01362530|Serotonin Agents|serotonin agents|mesh-ancestor
102158207|NCT01362530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102158208|NCT01362530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158209|NCT01362530|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102158210|NCT04494399|Interferons|interferons|mesh-list
102158211|NCT04494399|Ribavirin|ribavirin|mesh-list
102158212|NCT04494399|Interferon-beta|interferon-beta|mesh-list
102158213|NCT04494399|Interferon beta-1b|interferon beta-1b|mesh-list
102158214|NCT04494399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102158215|NCT04494399|Antiviral Agents|antiviral agents|mesh-ancestor
102158216|NCT04494399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102158217|NCT04494399|Antimetabolites|antimetabolites|mesh-ancestor
102158218|NCT04494399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158219|NCT04494399|Immunologic Factors|immunologic factors|mesh-ancestor
102158220|NCT04494399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158221|NCT04494399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102158222|NCT01758614|Aspirin|aspirin|mesh-list
102158223|NCT01758614|Clopidogrel|clopidogrel|mesh-list
102158224|NCT01758614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102158225|NCT01758614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102158226|NCT01758614|Analgesics|analgesics|mesh-ancestor
102158227|NCT01758614|Sensory System Agents|sensory system agents|mesh-ancestor
102158228|NCT01758614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102158229|NCT01758614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158230|NCT01758614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102158231|NCT01758614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102158232|NCT01758614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102158233|NCT01758614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101573962|NCT02756377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102158234|NCT01758614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158236|NCT01758614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102158237|NCT01758614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102158238|NCT01758614|Antipyretics|antipyretics|mesh-ancestor
102158239|NCT01758614|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102158240|NCT01758614|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102158241|NCT01758614|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102158242|NCT01758614|Purinergic Agents|purinergic agents|mesh-ancestor
102158243|NCT01758614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102158244|NCT02490657|Iloprost|iloprost|mesh-list
102158245|NCT02490657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102158246|NCT02490657|Vasodilator Agents|vasodilator agents|mesh-ancestor
102158247|NCT04323566|Rituximab|rituximab|mesh-list
102158248|NCT04323566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102158249|NCT04323566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102158250|NCT04323566|Immunologic Factors|immunologic factors|mesh-ancestor
102158251|NCT04323566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158252|NCT04323566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102158253|NCT03109119|Propofol|propofol|mesh-list
102158254|NCT03109119|Sevoflurane|sevoflurane|mesh-list
102158255|NCT03109119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102158256|NCT03109119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102158257|NCT03109119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158258|NCT03109119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102158259|NCT03109119|Anesthetics, General|anesthetics, general|mesh-ancestor
102158260|NCT03109119|Anesthetics|anesthetics|mesh-ancestor
102158261|NCT03109119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102158262|NCT03109119|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102158271|NCT03326661|Clindamycin|clindamycin|mesh-list
102158272|NCT03326661|Clindamycin palmitate|clindamycin palmitate|mesh-list
102158273|NCT03326661|Clindamycin phosphate|clindamycin phosphate|mesh-list
102158275|NCT03326661|Metronidazole|metronidazole|mesh-list
102158276|NCT03326661|Penicillin V|penicillin v|mesh-list
102158277|NCT03326661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102158278|NCT03326661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102158279|NCT03326661|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102158280|NCT03326661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102158281|NCT03326661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158282|NCT03326661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102158283|NCT03326661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102158284|NCT03333915|Pamiparib|pamiparib|mesh-list
102158285|NCT03333915|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102158286|NCT03333915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102158287|NCT03333915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158288|NCT03333915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102158289|NCT04261478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
102158290|NCT02654054|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102158291|NCT02654054|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102158292|NCT02654054|Norethindrone|norethindrone|mesh-list
102158293|NCT02654054|Norethindrone Acetate|norethindrone acetate|mesh-list
102158294|NCT02654054|Estradiol|estradiol|mesh-list
102158295|NCT02654054|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102158296|NCT02654054|Estrogens|estrogens|mesh-ancestor
102158297|NCT02654054|Hormones|hormones|mesh-ancestor
102158298|NCT02654054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102158299|NCT02654054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158300|NCT02654054|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102158301|NCT02654054|Contraceptive Agents|contraceptive agents|mesh-ancestor
102158302|NCT02654054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102158303|NCT02654054|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102158304|NCT02654054|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102158305|NCT02654054|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102158306|NCT02654054|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102158307|NCT03186404|Atorvastatin|atorvastatin|mesh-list
101445535|NCT00560209|Landiolol|landiolol|mesh-list
102158308|NCT03186404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102158309|NCT03186404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102158310|NCT03186404|Antimetabolites|antimetabolites|mesh-ancestor
102158311|NCT03186404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158312|NCT03186404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102158313|NCT03186404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102158314|NCT03186404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102158315|NCT02492373|Clobetasol|clobetasol|mesh-list
102158316|NCT02492373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102158318|NCT02492373|Hormones|hormones|mesh-ancestor
102158319|NCT02492373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102158320|NCT02492373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158321|NCT03073070|Biotin|biotin|mesh-list
102158322|NCT03073070|Vitamin B Complex|vitamin b complex|mesh-ancestor
102158323|NCT03073070|Vitamins|vitamins|mesh-ancestor
102158324|NCT03073070|Micronutrients|micronutrients|mesh-ancestor
102158325|NCT03073070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158326|NCT02905214|Sirolimus|sirolimus|mesh-list
102158327|NCT02905214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102158328|NCT02905214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102158329|NCT02905214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102158330|NCT02905214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102158331|NCT02905214|Antifungal Agents|antifungal agents|mesh-ancestor
102158332|NCT02905214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102158333|NCT02905214|Immunologic Factors|immunologic factors|mesh-ancestor
102158334|NCT02905214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158335|NCT03333603|Esomeprazole|esomeprazole|mesh-list
102158336|NCT03333603|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102158337|NCT03333603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102158338|NCT03333603|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102158339|NCT03333603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102158340|NCT03333603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158341|NCT03333525|Insulin|insulin|mesh-list
102158342|NCT03333525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102158343|NCT03333525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158344|NCT03333369|Levodopa|levodopa|mesh-list
102158345|NCT03333369|Benserazide|benserazide|mesh-list
102158346|NCT03333369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102158347|NCT03333369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101867205|NCT03943186|Immunologic Factors|immunologic factors|mesh-ancestor
102158348|NCT03333369|Dopamine Agents|dopamine agents|mesh-ancestor
102158349|NCT03333369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102158350|NCT03333369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158351|NCT03333369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158352|NCT03333369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102158354|NCT03325803|Prilocaine|prilocaine|mesh-list
102158355|NCT03325803|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
102158356|NCT03325803|Anesthetics, Local|anesthetics, local|mesh-ancestor
102158357|NCT03325803|Anesthetics|anesthetics|mesh-ancestor
102158358|NCT03325803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102158359|NCT03325803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158360|NCT03325803|Sensory System Agents|sensory system agents|mesh-ancestor
102158361|NCT03325803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102158362|NCT03325803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102158363|NCT03325803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102158364|NCT03325803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102158365|NCT03325803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102158366|NCT03325803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158367|NCT03325803|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
102158368|NCT05465343|Aflutinib|aflutinib|mesh-list
102158369|NCT05465343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102158370|NCT05465343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102158371|NCT05465343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158372|NCT03325491|Acipimox|acipimox|mesh-list
102158373|NCT03325491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102158374|NCT03325491|Antimetabolites|antimetabolites|mesh-ancestor
102158375|NCT03325491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158376|NCT03325491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102158377|NCT04150562|Avelumab|avelumab|mesh-list
102158378|NCT04150562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102158379|NCT04150562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102158380|NCT03325413|Anesthetics|anesthetics|mesh-list
102158381|NCT03325413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102158382|NCT03325413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158383|NCT03325335|Midazolam|midazolam|mesh-list
102158384|NCT03325335|Remifentanil|remifentanil|mesh-list
102158385|NCT03325335|Propofol|propofol|mesh-list
102158386|NCT03325335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102158387|NCT03325335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102158388|NCT03325335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158389|NCT03325335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102158390|NCT03325335|Anesthetics, General|anesthetics, general|mesh-ancestor
102158391|NCT03325335|Anesthetics|anesthetics|mesh-ancestor
102158392|NCT03325335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102158393|NCT03325335|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102158394|NCT03325335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102158395|NCT03325335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102158396|NCT03325335|GABA Modulators|gaba modulators|mesh-ancestor
102158397|NCT03325335|GABA Agents|gaba agents|mesh-ancestor
102158398|NCT03325335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102158399|NCT03325335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158400|NCT03325335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102158401|NCT03325335|Narcotics|narcotics|mesh-ancestor
102158402|NCT03325335|Analgesics|analgesics|mesh-ancestor
102158403|NCT03325335|Sensory System Agents|sensory system agents|mesh-ancestor
102158404|NCT03325335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102158405|NCT05114720|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102158406|NCT05114720|Moxifloxacin|moxifloxacin|mesh-list
102158407|NCT05114720|Cyclophosphamide|cyclophosphamide|mesh-list
102158408|NCT05114720|Docetaxel|docetaxel|mesh-list
102158409|NCT05114720|Doxorubicin|doxorubicin|mesh-list
102158410|NCT05114720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102158411|NCT05114720|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102158412|NCT05114720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102158413|NCT05114720|Immunologic Factors|immunologic factors|mesh-ancestor
102158414|NCT05114720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158415|NCT05114720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102158416|NCT05114720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102158417|NCT05114720|Alkylating Agents|alkylating agents|mesh-ancestor
102158418|NCT05114720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158419|NCT05114720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102158420|NCT05114720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102158421|NCT05114720|Tubulin Modulators|tubulin modulators|mesh-ancestor
102158422|NCT05114720|Antimitotic Agents|antimitotic agents|mesh-ancestor
102158423|NCT05114720|Mitosis Modulators|mitosis modulators|mesh-ancestor
102158424|NCT05114720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102158425|NCT05114720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102158426|NCT05114720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102158427|NCT05114720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102158428|NCT05114720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102158429|NCT05114720|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102158430|NCT05114720|Contraceptive Agents|contraceptive agents|mesh-ancestor
102158431|NCT05114720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102158432|NCT05114720|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102158433|NCT05114720|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102158434|NCT05114720|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102158435|NCT04493463|Methylprednisolone|methylprednisolone|mesh-list
102158436|NCT04493463|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102158437|NCT04493463|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102158438|NCT04493463|Prednisolone|prednisolone|mesh-list
102158439|NCT04493463|Prednisolone acetate|prednisolone acetate|mesh-list
102158440|NCT04493463|Ropivacaine|ropivacaine|mesh-list
102158441|NCT04493463|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102158442|NCT04493463|Prednisolone phosphate|prednisolone phosphate|mesh-list
102158443|NCT04493463|Anesthetics, Local|anesthetics, local|mesh-ancestor
102158444|NCT04493463|Anesthetics|anesthetics|mesh-ancestor
101445576|NCT00560443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102158445|NCT04493463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102158446|NCT04493463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158447|NCT04493463|Sensory System Agents|sensory system agents|mesh-ancestor
102158448|NCT04493463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102158449|NCT04493463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102158450|NCT04493463|Antiemetics|antiemetics|mesh-ancestor
102158451|NCT04493463|Autonomic Agents|autonomic agents|mesh-ancestor
102158452|NCT04493463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102158453|NCT04493463|Glucocorticoids|glucocorticoids|mesh-ancestor
102158455|NCT04493463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102158456|NCT04493463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102158457|NCT04493463|Protective Agents|protective agents|mesh-ancestor
102158458|NCT04493463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102158459|NCT04493463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102158460|NCT04493073|Mitomycins|mitomycins|mesh-list
102158461|NCT04493073|Mitomycin|mitomycin|mesh-list
102158462|NCT04493073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102158463|NCT04493073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102158464|NCT04493073|Alkylating Agents|alkylating agents|mesh-ancestor
102158465|NCT04493073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158466|NCT04493073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102158467|NCT04493073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102158468|NCT00748904|Rifaximin|rifaximin|mesh-list
102158469|NCT00748904|Lactulose|lactulose|mesh-list
102158470|NCT00748904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102158471|NCT00748904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102158472|NCT00748904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102158473|NCT03321903|Charcoal|charcoal|mesh-list
102158474|NCT03321903|Antidotes|antidotes|mesh-ancestor
102158475|NCT03321903|Protective Agents|protective agents|mesh-ancestor
102158476|NCT03321903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158477|NCT04411550|Pertuzumab|pertuzumab|mesh-list
102158478|NCT04411550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102158479|NCT04411550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102158480|NCT03321825|Lidocaine|lidocaine|mesh-list
102158481|NCT03321825|Hyaluronic Acid|hyaluronic acid|mesh-list
102158482|NCT03321825|Anesthetics, Local|anesthetics, local|mesh-ancestor
102158483|NCT03321825|Anesthetics|anesthetics|mesh-ancestor
102158484|NCT03321825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102158485|NCT03321825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158486|NCT03321825|Sensory System Agents|sensory system agents|mesh-ancestor
102158487|NCT03321825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102158488|NCT03321825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102158489|NCT03321825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102158490|NCT03321825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102158491|NCT03321825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102158492|NCT03321825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158493|NCT03321825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102158494|NCT03321825|Immunologic Factors|immunologic factors|mesh-ancestor
102158495|NCT03321825|Viscosupplements|viscosupplements|mesh-ancestor
102158496|NCT03321825|Protective Agents|protective agents|mesh-ancestor
102158497|NCT02492217|Adalimumab|adalimumab|mesh-list
102158498|NCT02492217|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102158499|NCT02492217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102158500|NCT02492217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102158502|NCT05229536|Immunologic Factors|immunologic factors|mesh-ancestor
102158503|NCT05229536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158504|NCT04810910|Molgramostim|molgramostim|mesh-list
102158505|NCT04810910|Sargramostim|sargramostim|mesh-list
102158506|NCT04810910|Immunologic Factors|immunologic factors|mesh-ancestor
102158507|NCT04810910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158508|NCT04810910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102158509|NCT04562558|Leucovorin|leucovorin|mesh-list
102158510|NCT04562558|Dactinomycin|dactinomycin|mesh-list
102158511|NCT04562558|Methotrexate|methotrexate|mesh-list
102158512|NCT04562558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158513|NCT04562558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102158514|NCT04562558|Abortifacient Agents|abortifacient agents|mesh-ancestor
102158515|NCT04562558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101445595|NCT00179114|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102158516|NCT04562558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102158517|NCT04562558|Antimetabolites|antimetabolites|mesh-ancestor
102158518|NCT04562558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158519|NCT04562558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102158520|NCT04562558|Dermatologic Agents|dermatologic agents|mesh-ancestor
102158521|NCT04562558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102158522|NCT04562558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102158523|NCT04562558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102158524|NCT04562558|Immunologic Factors|immunologic factors|mesh-ancestor
102158525|NCT04562558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102158526|NCT04562558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102158527|NCT04562558|Antidotes|antidotes|mesh-ancestor
102158528|NCT04562558|Protective Agents|protective agents|mesh-ancestor
102158529|NCT04562558|Vitamin B Complex|vitamin b complex|mesh-ancestor
102158530|NCT04562558|Vitamins|vitamins|mesh-ancestor
102158531|NCT04562558|Micronutrients|micronutrients|mesh-ancestor
102158532|NCT04562558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102158533|NCT04562558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102158534|NCT04562558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102158535|NCT04562558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102158536|NCT03320187|Nitroglycerin|nitroglycerin|mesh-list
102158537|NCT03320187|Dinoprostone|dinoprostone|mesh-list
102158538|NCT03320187|Vasodilator Agents|vasodilator agents|mesh-ancestor
102158539|NCT03320187|Oxytocics|oxytocics|mesh-ancestor
102158540|NCT03320187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102158541|NCT03320187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158542|NCT03320109|Vitamin D|vitamin d|mesh-list
102158543|NCT03320109|Ergocalciferols|ergocalciferols|mesh-list
102158544|NCT03320109|Cholecalciferol|cholecalciferol|mesh-list
102158545|NCT03320109|Vitamins|vitamins|mesh-list
102158546|NCT03320109|Micronutrients|micronutrients|mesh-ancestor
102158547|NCT03320109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158548|NCT03320109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102158549|NCT03320109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102158550|NCT04529876|Abatacept|abatacept|mesh-list
102158551|NCT04529876|Tofacitinib|tofacitinib|mesh-list
102158552|NCT04529876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102158553|NCT04529876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158554|NCT04529876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102158555|NCT04529876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102158556|NCT04529876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102158557|NCT04529876|Immunologic Factors|immunologic factors|mesh-ancestor
102158558|NCT04529876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158559|NCT04529876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102158560|NCT04529876|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102158561|NCT04529876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102158562|NCT04529876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102158563|NCT03320031|Insulin Lispro|insulin lispro|mesh-list
102158564|NCT03320031|Linagliptin|linagliptin|mesh-list
102158565|NCT03320031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102158566|NCT03320031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158567|NCT03320031|Incretins|incretins|mesh-ancestor
102158568|NCT03320031|Hormones|hormones|mesh-ancestor
102158569|NCT03320031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102158570|NCT03320031|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102158571|NCT03320031|Protease Inhibitors|protease inhibitors|mesh-ancestor
102158572|NCT03320031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102158573|NCT03320031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158574|NCT04510922|Droxidopa|droxidopa|mesh-list
102158575|NCT04510922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102158576|NCT04510922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102158578|NCT05465031|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102158579|NCT05465031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102158580|NCT05465031|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102158581|NCT05465031|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102158582|NCT05465031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158583|NCT04510844|Evolocumab|evolocumab|mesh-list
102158584|NCT04510844|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102158585|NCT04510844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102158586|NCT04510844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102158587|NCT04510844|Antimetabolites|antimetabolites|mesh-ancestor
101445602|NCT00201318|Vincristine|vincristine|mesh-list
102158588|NCT04510844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158589|NCT04510844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102158590|NCT04510844|Protease Inhibitors|protease inhibitors|mesh-ancestor
102158591|NCT04510844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102158592|NCT04510844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102158593|NCT05464953|Triamcinolone|triamcinolone|mesh-list
102158594|NCT05464953|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102158595|NCT05464953|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102158596|NCT05464953|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102158597|NCT05464953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102158598|NCT05464953|Glucocorticoids|glucocorticoids|mesh-ancestor
102158599|NCT05464953|Hormones|hormones|mesh-ancestor
102158600|NCT05464953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102158601|NCT05464953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158602|NCT05464953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102158603|NCT05464953|Immunologic Factors|immunologic factors|mesh-ancestor
102158604|NCT05464953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102158605|NCT05464953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158606|NCT02491749|Anesthetics|anesthetics|mesh-list
102158607|NCT02491749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102158608|NCT02491749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158609|NCT04408898|Pembrolizumab|pembrolizumab|mesh-list
102158610|NCT04408898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102158611|NCT04408898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102158612|NCT04408898|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102158613|NCT04408898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158614|NCT02490345|Gabapentin|gabapentin|mesh-list
102158615|NCT02490345|Analgesics|analgesics|mesh-ancestor
102158616|NCT02490345|Sensory System Agents|sensory system agents|mesh-ancestor
102158617|NCT02490345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102158618|NCT02490345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158619|NCT02490345|Anticonvulsants|anticonvulsants|mesh-ancestor
102158620|NCT02490345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102158621|NCT02490345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102158622|NCT02490345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102158623|NCT02490345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102158624|NCT02490345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102158625|NCT02490345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102158626|NCT02490345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102158627|NCT02490345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158628|NCT02490345|Antimanic Agents|antimanic agents|mesh-ancestor
102158629|NCT03331263|Chlorhexidine|chlorhexidine|mesh-list
102158630|NCT03331263|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102158631|NCT03331263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102158632|NCT03331263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102158633|NCT03331263|Disinfectants|disinfectants|mesh-ancestor
102158634|NCT03331263|Dermatologic Agents|dermatologic agents|mesh-ancestor
102158635|NCT03319563|Epinephrine|epinephrine|mesh-list
102158636|NCT03319563|Anesthetics|anesthetics|mesh-list
102158637|NCT03319563|Anesthetics, Local|anesthetics, local|mesh-list
102158638|NCT03319563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102158639|NCT03319563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158640|NCT03319563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102158641|NCT03319563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102158642|NCT03319563|Adrenergic Agents|adrenergic agents|mesh-ancestor
102158643|NCT03319563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102158644|NCT03319563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158645|NCT03319563|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102158646|NCT03319563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102158647|NCT03319563|Autonomic Agents|autonomic agents|mesh-ancestor
102158648|NCT03319563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102158649|NCT03319563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102158650|NCT03319563|Respiratory System Agents|respiratory system agents|mesh-ancestor
102158651|NCT03319563|Mydriatics|mydriatics|mesh-ancestor
102158652|NCT03319563|Sympathomimetics|sympathomimetics|mesh-ancestor
102158653|NCT03319563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102158654|NCT03319563|Sensory System Agents|sensory system agents|mesh-ancestor
102158655|NCT02485119|Anetumab ravtansine|anetumab ravtansine|mesh-list
102158656|NCT02485119|Immunoconjugates|immunoconjugates|mesh-ancestor
102158657|NCT02485119|Immunologic Factors|immunologic factors|mesh-ancestor
102158658|NCT02485119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158659|NCT02484573|Propranolol|propranolol|mesh-list
102158660|NCT02484573|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102158661|NCT02484573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102158662|NCT02484573|Adrenergic Agents|adrenergic agents|mesh-ancestor
102158663|NCT02484573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102158664|NCT02484573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158665|NCT02484573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158666|NCT02484573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102158667|NCT02484573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102158668|NCT02484573|Vasodilator Agents|vasodilator agents|mesh-ancestor
102158669|NCT02489955|Tobramycin|tobramycin|mesh-list
102158670|NCT02489955|Amikacin|amikacin|mesh-list
102158671|NCT02489955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102158672|NCT02489955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102158673|NCT03734744|Vitamin D|vitamin d|mesh-list
102158674|NCT03734744|Cholecalciferol|cholecalciferol|mesh-list
102158675|NCT03734744|Vitamins|vitamins|mesh-ancestor
102158676|NCT03734744|Micronutrients|micronutrients|mesh-ancestor
102158677|NCT03734744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158678|NCT03734744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102158679|NCT03734744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102158680|NCT03576716|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
102158681|NCT03576716|Calcifediol|calcifediol|mesh-list
102158682|NCT03576716|Vitamins|vitamins|mesh-ancestor
102158683|NCT03576716|Micronutrients|micronutrients|mesh-ancestor
102158684|NCT03576716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158685|NCT03576716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102158686|NCT02487381|Dronabinol|dronabinol|mesh-list
102158687|NCT02487381|Cannabidiol|cannabidiol|mesh-list
102158688|NCT02487381|Anticonvulsants|anticonvulsants|mesh-ancestor
102158689|NCT02487381|Hallucinogens|hallucinogens|mesh-ancestor
102158690|NCT02487381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158691|NCT02487381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102158692|NCT02487381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102158693|NCT02487381|Analgesics|analgesics|mesh-ancestor
102158694|NCT02487381|Sensory System Agents|sensory system agents|mesh-ancestor
102158695|NCT02487381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102158696|NCT02487381|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102158697|NCT02487381|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102158698|NCT02487381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102158699|NCT02487381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158700|NCT02487381|Hormones|hormones|mesh-ancestor
102158701|NCT02487381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102158702|NCT02487849|Carboplatin|carboplatin|mesh-list
102158703|NCT02487849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102158704|NCT02484339|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
102158705|NCT02484339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102158706|NCT04021550|Thioctic Acid|thioctic acid|mesh-list
102158707|NCT04021550|Telmisartan|telmisartan|mesh-list
102158708|NCT04021550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102158709|NCT04021550|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102158710|NCT04021550|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102158711|NCT04021550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158712|NCT04021550|Antioxidants|antioxidants|mesh-ancestor
102158713|NCT04021550|Protective Agents|protective agents|mesh-ancestor
102158714|NCT04021550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158715|NCT04021550|Vitamin B Complex|vitamin b complex|mesh-ancestor
102158716|NCT04021550|Vitamins|vitamins|mesh-ancestor
102158717|NCT04021550|Micronutrients|micronutrients|mesh-ancestor
102158718|NCT02489487|Ritonavir|ritonavir|mesh-list
102158719|NCT02489487|Darunavir|darunavir|mesh-list
102158720|NCT02489487|Raltegravir Potassium|raltegravir potassium|mesh-list
102158721|NCT02489487|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102158722|NCT02489487|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102158723|NCT02489487|Protease Inhibitors|protease inhibitors|mesh-ancestor
102158724|NCT02489487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102158725|NCT02489487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158726|NCT02489487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102158727|NCT02489487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102158728|NCT02489487|Antiviral Agents|antiviral agents|mesh-ancestor
102158729|NCT02489487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101445611|NCT00201318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102158730|NCT02489487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102158731|NCT02489487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102158732|NCT02489487|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102158733|NCT02489487|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102158734|NCT02096354|Irinotecan|irinotecan|mesh-list
102158735|NCT02096354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102158736|NCT02096354|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102158737|NCT02096354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102158738|NCT02096354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102158739|NCT02096354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158740|NCT03177746|Tadalafil|tadalafil|mesh-list
102158741|NCT03177746|Vasodilator Agents|vasodilator agents|mesh-ancestor
102158742|NCT03177746|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102158743|NCT03177746|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102158744|NCT03177746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102158745|NCT03177746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158746|NCT03177746|Urological Agents|urological agents|mesh-ancestor
102158747|NCT02484027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102158748|NCT02484027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102158749|NCT02484027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102158750|NCT02484027|Antimetabolites|antimetabolites|mesh-ancestor
102158751|NCT02484027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158752|NCT02484027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102158753|NCT02484027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102158754|NCT02484027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102158755|NCT02483715|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102158756|NCT02483715|Amoxicillin|amoxicillin|mesh-list
102158757|NCT02483715|Metronidazole|metronidazole|mesh-list
102158758|NCT02483715|Tetracycline|tetracycline|mesh-list
102158759|NCT02483715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102158760|NCT02483715|Rabeprazole|rabeprazole|mesh-list
102158761|NCT02483715|Bismuth|bismuth|mesh-list
102158762|NCT02483715|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
102158763|NCT02483715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102158764|NCT02483715|Antitubercular Agents|antitubercular agents|mesh-ancestor
102158765|NCT02483715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102158766|NCT02483715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102158767|NCT02483715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102158768|NCT02483715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102158769|NCT02483715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102158770|NCT02483715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158771|NCT02483715|Antacids|antacids|mesh-ancestor
102158772|NCT02483715|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102158773|NCT02483793|Tamsulosin|tamsulosin|mesh-list
102158774|NCT02483793|Oxybutynin|oxybutynin|mesh-list
102158775|NCT02483793|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102158776|NCT02483793|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102158777|NCT02483793|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102158778|NCT02483793|Adrenergic Agents|adrenergic agents|mesh-ancestor
102158779|NCT02483793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102158780|NCT02483793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158781|NCT02483793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158782|NCT02483793|Urological Agents|urological agents|mesh-ancestor
102158783|NCT02483793|Parasympatholytics|parasympatholytics|mesh-ancestor
102158784|NCT02483793|Autonomic Agents|autonomic agents|mesh-ancestor
102158785|NCT02483793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102158786|NCT02483793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102158787|NCT02483793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102158788|NCT02483793|Cholinergic Agents|cholinergic agents|mesh-ancestor
102158789|NCT03200288|Hyaluronic Acid|hyaluronic acid|mesh-list
102158790|NCT03200288|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102158791|NCT03200288|Immunologic Factors|immunologic factors|mesh-ancestor
102158792|NCT03200288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158793|NCT03200288|Viscosupplements|viscosupplements|mesh-ancestor
102158794|NCT03200288|Protective Agents|protective agents|mesh-ancestor
102158795|NCT03318471|Magnesium Sulfate|magnesium sulfate|mesh-list
102158796|NCT03318471|Analgesics|analgesics|mesh-ancestor
102158797|NCT03318471|Sensory System Agents|sensory system agents|mesh-ancestor
102158798|NCT03318471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101867653|NCT01118884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102158799|NCT03318471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158800|NCT03318471|Anesthetics|anesthetics|mesh-ancestor
102158801|NCT03318471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102158802|NCT03318471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102158803|NCT03318471|Anticonvulsants|anticonvulsants|mesh-ancestor
102158804|NCT03318471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102158805|NCT03318471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102158806|NCT03318471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158807|NCT03318471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102158808|NCT03318471|Tocolytic Agents|tocolytic agents|mesh-ancestor
102158809|NCT03318471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102158810|NCT04234022|Pomalidomide|pomalidomide|mesh-list
102158811|NCT04234022|Immunologic Factors|immunologic factors|mesh-ancestor
102158812|NCT04234022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158813|NCT04234022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102158814|NCT04234022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102158815|NCT04234022|Growth Substances|growth substances|mesh-ancestor
102158816|NCT04234022|Growth Inhibitors|growth inhibitors|mesh-ancestor
102158817|NCT04234022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102158818|NCT02489409|Gemcitabine|gemcitabine|mesh-list
102158819|NCT02489409|Vinorelbine|vinorelbine|mesh-list
102158820|NCT02489409|Endostatins|endostatins|mesh-list
102158821|NCT02489409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102158822|NCT02489409|Antimetabolites|antimetabolites|mesh-ancestor
102158823|NCT02489409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158824|NCT02489409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102158825|NCT02489409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102158826|NCT02489409|Tubulin Modulators|tubulin modulators|mesh-ancestor
102158827|NCT02489409|Antimitotic Agents|antimitotic agents|mesh-ancestor
102158828|NCT02489409|Mitosis Modulators|mitosis modulators|mesh-ancestor
102158829|NCT02489409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102158830|NCT02489409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102158831|NCT02489409|Growth Substances|growth substances|mesh-ancestor
102158832|NCT02489409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158833|NCT02489409|Growth Inhibitors|growth inhibitors|mesh-ancestor
102158834|NCT03930602|Fluvoxamine|fluvoxamine|mesh-list
102158835|NCT03930602|Deucravacitinib|deucravacitinib|mesh-list
102158836|NCT03930602|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102158837|NCT03930602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102158838|NCT03930602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102158839|NCT03930602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158840|NCT03930602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102158841|NCT03930602|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102158842|NCT03930602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102158843|NCT03930602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102158844|NCT03930602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158845|NCT03930602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102158846|NCT03930602|Serotonin Agents|serotonin agents|mesh-ancestor
102158847|NCT03930602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102158848|NCT03930602|Antidepressive Agents|antidepressive agents|mesh-ancestor
102158849|NCT03930602|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102158850|NCT03930602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102158851|NCT03930602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102158852|NCT03930602|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102158853|NCT03930602|Dermatologic Agents|dermatologic agents|mesh-ancestor
102158854|NCT03930602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102158855|NCT02483871|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102158856|NCT02483871|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102158857|NCT02483871|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102158858|NCT02483871|Antimetabolites|antimetabolites|mesh-ancestor
102158859|NCT02483871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158860|NCT02483871|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102158861|NCT02483871|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102158862|NCT02483871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102158864|NCT02489019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102158865|NCT02489019|Narcotics|narcotics|mesh-ancestor
102158866|NCT02489019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102158867|NCT02489019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158868|NCT02489019|Analgesics|analgesics|mesh-ancestor
102158869|NCT02489019|Sensory System Agents|sensory system agents|mesh-ancestor
102158870|NCT02489019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102158871|NCT02489019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102158872|NCT02489019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101867747|NCT01217086|Infliximab|infliximab|mesh-list
102158873|NCT02489019|Anesthetics, General|anesthetics, general|mesh-ancestor
102158874|NCT02489019|Anesthetics|anesthetics|mesh-ancestor
102158875|NCT02604446|Oxycodone|oxycodone|mesh-list
102158876|NCT02604446|Tapentadol|tapentadol|mesh-list
102158877|NCT02604446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102158878|NCT02604446|Narcotics|narcotics|mesh-ancestor
102158879|NCT02604446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102158880|NCT02604446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158881|NCT02604446|Analgesics|analgesics|mesh-ancestor
102158882|NCT02604446|Sensory System Agents|sensory system agents|mesh-ancestor
102158883|NCT02604446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102158884|NCT02604446|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102158885|NCT02604446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102158886|NCT02604446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102158887|NCT02604446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158888|NCT02604446|Adrenergic Agents|adrenergic agents|mesh-ancestor
102158889|NCT02604446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102158890|NCT02847637|Factor VIII|factor viii|mesh-list
102158891|NCT02847637|Coagulants|coagulants|mesh-ancestor
102158892|NCT02652260|Tenofovir|tenofovir|mesh-list
102158893|NCT02652260|Lamivudine|lamivudine|mesh-list
102158894|NCT02652260|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102158895|NCT02652260|Antiviral Agents|antiviral agents|mesh-ancestor
102158896|NCT02652260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102158897|NCT02652260|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102158898|NCT02652260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102158899|NCT02652260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102158900|NCT02652260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158901|NCT02652260|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102158902|NCT02652260|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102158903|NCT01710176|Gemcitabine|gemcitabine|mesh-list
102158904|NCT01710176|Docetaxel|docetaxel|mesh-list
102158905|NCT01710176|Etoposide|etoposide|mesh-list
102158906|NCT01710176|Epirubicin|epirubicin|mesh-list
102158907|NCT01710176|Ifosfamide|ifosfamide|mesh-list
102158908|NCT01710176|Isophosphamide mustard|isophosphamide mustard|mesh-list
102158909|NCT01710176|Dacarbazine|dacarbazine|mesh-list
102158910|NCT01710176|Trabectedin|trabectedin|mesh-list
102158911|NCT01710176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102158912|NCT01710176|Antimetabolites|antimetabolites|mesh-ancestor
101700663|NCT04216355|Azacitidine|azacitidine|mesh-list
102158913|NCT01710176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158914|NCT01710176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102158915|NCT01710176|Tubulin Modulators|tubulin modulators|mesh-ancestor
102158916|NCT01710176|Antimitotic Agents|antimitotic agents|mesh-ancestor
102158917|NCT01710176|Mitosis Modulators|mitosis modulators|mesh-ancestor
102158918|NCT01710176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102158919|NCT01710176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102158920|NCT01710176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102158921|NCT01710176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102158922|NCT01710176|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102158923|NCT01710176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102158924|NCT01710176|Alkylating Agents|alkylating agents|mesh-ancestor
102158925|NCT00584246|Pregabalin|pregabalin|mesh-list
102158926|NCT00584246|Analgesics|analgesics|mesh-ancestor
102158927|NCT00584246|Sensory System Agents|sensory system agents|mesh-ancestor
102158928|NCT00584246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102158929|NCT00584246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158930|NCT00584246|Anticonvulsants|anticonvulsants|mesh-ancestor
102158931|NCT00584246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102158932|NCT00584246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102158933|NCT00584246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158934|NCT00584246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102158935|NCT00584246|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102158936|NCT00584246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102158937|NCT00584246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101445622|NCT00201318|Antiviral Agents|antiviral agents|mesh-ancestor
102158938|NCT00584246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102158939|NCT05124314|Misoprostol|misoprostol|mesh-list
102158940|NCT05124314|Mifepristone|mifepristone|mesh-list
102158941|NCT05124314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102158942|NCT05124314|Abortifacient Agents|abortifacient agents|mesh-ancestor
102158943|NCT05124314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102158944|NCT05124314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158945|NCT05124314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102158946|NCT05124314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102158947|NCT05124314|Oxytocics|oxytocics|mesh-ancestor
102158948|NCT05124314|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102158949|NCT05124314|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102158950|NCT05124314|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102158951|NCT05124314|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102158952|NCT05124314|Contraceptive Agents|contraceptive agents|mesh-ancestor
102158953|NCT05124314|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102158954|NCT05124314|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102158955|NCT05124314|Hormone Antagonists|hormone antagonists|mesh-ancestor
102158956|NCT05124314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102158957|NCT05124314|Luteolytic Agents|luteolytic agents|mesh-ancestor
102158958|NCT05124314|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102158959|NCT05124314|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102158960|NCT03320967|Arginine Vasopressin|arginine vasopressin|mesh-list
102158961|NCT03320967|Hemostatics|hemostatics|mesh-ancestor
102158962|NCT03320967|Coagulants|coagulants|mesh-ancestor
102158963|NCT03320967|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102158964|NCT03320967|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102158965|NCT03320967|Natriuretic Agents|natriuretic agents|mesh-ancestor
102158966|NCT03320967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158967|NCT02483325|Fludarabine|fludarabine|mesh-list
102158968|NCT02483325|Busulfan|busulfan|mesh-list
102158969|NCT02483325|Thymoglobulin|thymoglobulin|mesh-list
102158970|NCT02483325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102158971|NCT02483325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158972|NCT02483325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102158973|NCT02483325|Immunologic Factors|immunologic factors|mesh-ancestor
102158974|NCT02483325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158975|NCT02483325|Alkylating Agents|alkylating agents|mesh-ancestor
102158976|NCT02483325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102158977|NCT02483325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102158978|NCT04211090|Carboplatin|carboplatin|mesh-list
102158979|NCT04211090|Pemetrexed|pemetrexed|mesh-list
102158980|NCT04211090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102158981|NCT04211090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102158982|NCT04211090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158983|NCT04211090|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102158984|NCT04211090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102158985|NCT02486445|Rivaroxaban|rivaroxaban|mesh-list
102158986|NCT02486445|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102158987|NCT02486445|Antithrombins|antithrombins|mesh-ancestor
102158988|NCT02486445|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102158989|NCT02486445|Protease Inhibitors|protease inhibitors|mesh-ancestor
102158990|NCT02486445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102158991|NCT02486445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102158992|NCT02486445|Anticoagulants|anticoagulants|mesh-ancestor
102158993|NCT02836873|Bexagliflozin|bexagliflozin|mesh-list
102158994|NCT02836873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102158995|NCT02836873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102158996|NCT04538534|Nicardipine|nicardipine|mesh-list
102158997|NCT04538534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102158998|NCT04538534|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102158999|NCT04538534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102159000|NCT04538534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159001|NCT04538534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102159002|NCT04538534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159003|NCT04538534|Vasodilator Agents|vasodilator agents|mesh-ancestor
102159004|NCT03318159|Posaconazole|posaconazole|mesh-list
102159005|NCT03318159|Antifungal Agents|antifungal agents|mesh-ancestor
102159006|NCT03318159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102159007|NCT03318159|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102159008|NCT03318159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102159009|NCT03318159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102159010|NCT03318159|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102159011|NCT03318159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102159012|NCT03318159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102159013|NCT03318159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159014|NCT03318159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102159015|NCT03318159|Hormone Antagonists|hormone antagonists|mesh-ancestor
102159016|NCT03318159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102159017|NCT03318159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159018|NCT03315507|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
102159019|NCT03315507|Vasodilator Agents|vasodilator agents|mesh-ancestor
102159020|NCT02724410|Amoxicillin|amoxicillin|mesh-list
102159021|NCT02724410|Clavulanic Acid|clavulanic acid|mesh-list
102159022|NCT02724410|Clavulanic Acids|clavulanic acids|mesh-list
102159023|NCT02724410|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102159024|NCT02724410|Ertapenem|ertapenem|mesh-list
102159025|NCT02724410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102159026|NCT02724410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102159027|NCT02724410|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102159028|NCT02724410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102159029|NCT02724410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159030|NCT02486601|Paclitaxel|paclitaxel|mesh-list
102159031|NCT02486601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102159032|NCT02486601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102159033|NCT02486601|Tubulin Modulators|tubulin modulators|mesh-ancestor
102159034|NCT02486601|Antimitotic Agents|antimitotic agents|mesh-ancestor
102159035|NCT02486601|Mitosis Modulators|mitosis modulators|mesh-ancestor
102159036|NCT02486601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159037|NCT02487069|Cyclosporine|cyclosporine|mesh-list
102159038|NCT02487069|Mycophenolic Acid|mycophenolic acid|mesh-list
102159039|NCT02487069|Methotrexate|methotrexate|mesh-list
102159040|NCT02487069|Cyclosporins|cyclosporins|mesh-list
102159041|NCT02487069|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102159042|NCT02487069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102159043|NCT02487069|Abortifacient Agents|abortifacient agents|mesh-ancestor
102159044|NCT02487069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102159045|NCT02487069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159046|NCT02487069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102159047|NCT02487069|Antimetabolites|antimetabolites|mesh-ancestor
102159048|NCT02487069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159049|NCT02487069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102159050|NCT02487069|Dermatologic Agents|dermatologic agents|mesh-ancestor
102159051|NCT02487069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102159052|NCT02487069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102159053|NCT02487069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102159054|NCT02487069|Immunologic Factors|immunologic factors|mesh-ancestor
102159055|NCT02487069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102159056|NCT02487069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102159057|NCT02487069|Antifungal Agents|antifungal agents|mesh-ancestor
102159058|NCT02487069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102159059|NCT02487069|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102159060|NCT02487069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102159061|NCT02487069|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102159062|NCT02487069|Antitubercular Agents|antitubercular agents|mesh-ancestor
102159063|NCT02487069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102159064|NCT03564379|JNJ-42165279|jnj-42165279|mesh-list
102159065|NCT03564379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102159066|NCT03564379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159067|NCT03317847|Dexamethasone|dexamethasone|mesh-list
102159068|NCT03317847|Bromfenac|bromfenac|mesh-list
102159069|NCT03317847|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102159070|NCT03317847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102159071|NCT03317847|Antiemetics|antiemetics|mesh-ancestor
102159072|NCT03317847|Autonomic Agents|autonomic agents|mesh-ancestor
102159073|NCT03317847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102159074|NCT03317847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159075|NCT03317847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102159076|NCT03317847|Glucocorticoids|glucocorticoids|mesh-ancestor
102159077|NCT03317847|Hormones|hormones|mesh-ancestor
102159078|NCT03317847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102159079|NCT03317847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102159080|NCT03317847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102159081|NCT03317847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102159082|NCT03317847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102159083|NCT03317847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102159084|NCT03317847|Analgesics|analgesics|mesh-ancestor
102159085|NCT03317847|Sensory System Agents|sensory system agents|mesh-ancestor
102159086|NCT03317847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102159087|NCT01342081|Timolol|timolol|mesh-list
102159088|NCT01342081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102159089|NCT01342081|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102159090|NCT01342081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102159091|NCT01342081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102159092|NCT01342081|Adrenergic Agents|adrenergic agents|mesh-ancestor
102159093|NCT01342081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102159094|NCT01342081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159095|NCT01342081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159096|NCT01342081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102159097|NCT01342081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102159098|NCT03563833|Anesthetics|anesthetics|mesh-list
102159099|NCT03563833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102159100|NCT03563833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159101|NCT02483169|Aspirin|aspirin|mesh-list
102159102|NCT02483169|Cilostazol|cilostazol|mesh-list
102159103|NCT02483169|Probucol|probucol|mesh-list
102159104|NCT02483169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102159105|NCT02483169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102159106|NCT02483169|Analgesics|analgesics|mesh-ancestor
102159107|NCT02483169|Sensory System Agents|sensory system agents|mesh-ancestor
102159108|NCT02483169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102159109|NCT02483169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159110|NCT02483169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102159111|NCT02483169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102159112|NCT02483169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102159113|NCT02483169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102159114|NCT02483169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159115|NCT02483169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102159116|NCT02483169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102159117|NCT02483169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102159118|NCT02483169|Antipyretics|antipyretics|mesh-ancestor
102159119|NCT02483169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102159120|NCT02483169|Autonomic Agents|autonomic agents|mesh-ancestor
102159121|NCT02483169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102159122|NCT02483169|Respiratory System Agents|respiratory system agents|mesh-ancestor
102159123|NCT02483169|Vasodilator Agents|vasodilator agents|mesh-ancestor
102159124|NCT02483169|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102159125|NCT02483169|Protective Agents|protective agents|mesh-ancestor
102159126|NCT02483169|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102159127|NCT02483169|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102159128|NCT02483169|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102159129|NCT02483169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102159130|NCT02483169|Antimetabolites|antimetabolites|mesh-ancestor
102159131|NCT02483169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102159132|NCT02483169|Antioxidants|antioxidants|mesh-ancestor
102159133|NCT02489097|Nitrous Oxide|nitrous oxide|mesh-list
102159134|NCT02489097|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102159135|NCT02489097|Anesthetics, General|anesthetics, general|mesh-ancestor
102159136|NCT02489097|Anesthetics|anesthetics|mesh-ancestor
102159137|NCT02489097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102159138|NCT02489097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159139|NCT02489097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102159140|NCT02489097|Analgesics|analgesics|mesh-ancestor
102159141|NCT02489097|Sensory System Agents|sensory system agents|mesh-ancestor
102159142|NCT02489097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102159143|NCT02203682|Doxycycline|doxycycline|mesh-list
102159144|NCT02203682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102159145|NCT02203682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102159146|NCT02203682|Antimalarials|antimalarials|mesh-ancestor
102159147|NCT02203682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102159148|NCT02203682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102159149|NCT02256800|Leucovorin|leucovorin|mesh-list
102159150|NCT02256800|Bevacizumab|bevacizumab|mesh-list
102159151|NCT02256800|Irinotecan|irinotecan|mesh-list
102159152|NCT02256800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102159153|NCT02256800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102159154|NCT02256800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102159155|NCT02256800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102159156|NCT02256800|Growth Substances|growth substances|mesh-ancestor
102159157|NCT02256800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159158|NCT02256800|Growth Inhibitors|growth inhibitors|mesh-ancestor
102159159|NCT02256800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102159160|NCT02256800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102159161|NCT02256800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102159162|NCT02256800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159163|NCT02256800|Antidotes|antidotes|mesh-ancestor
102159164|NCT02256800|Protective Agents|protective agents|mesh-ancestor
102159165|NCT02256800|Vitamin B Complex|vitamin b complex|mesh-ancestor
102159166|NCT02256800|Vitamins|vitamins|mesh-ancestor
102159167|NCT02256800|Micronutrients|micronutrients|mesh-ancestor
102159168|NCT01341457|Gemcitabine|gemcitabine|mesh-list
102159169|NCT01341457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102159170|NCT01341457|Antimetabolites|antimetabolites|mesh-ancestor
102159171|NCT01341457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159172|NCT01341457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102159173|NCT02488473|Dexmedetomidine|dexmedetomidine|mesh-list
102159174|NCT02488473|Ropivacaine|ropivacaine|mesh-list
102159175|NCT02488473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102159176|NCT02488473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102159177|NCT02488473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159178|NCT02488473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102159180|NCT02488473|Sensory System Agents|sensory system agents|mesh-ancestor
102159181|NCT02488473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102159182|NCT02488473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102159183|NCT02488473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102159184|NCT02488473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102159185|NCT02488473|Adrenergic Agents|adrenergic agents|mesh-ancestor
102159186|NCT02488473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102159187|NCT02488473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159188|NCT02488473|Anesthetics, Local|anesthetics, local|mesh-ancestor
102159189|NCT02488473|Anesthetics|anesthetics|mesh-ancestor
102159190|NCT05128292|Selenium|selenium|mesh-list
102159191|NCT05128292|Antioxidants|antioxidants|mesh-ancestor
102159192|NCT05128292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159193|NCT05128292|Protective Agents|protective agents|mesh-ancestor
102159194|NCT05128292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159195|NCT05128292|Trace Elements|trace elements|mesh-ancestor
102159196|NCT05128292|Micronutrients|micronutrients|mesh-ancestor
102159197|NCT05127980|Antibodies|antibodies|mesh-list
102159198|NCT05127980|Autoantibodies|autoantibodies|mesh-list
102159199|NCT05127980|Immunologic Factors|immunologic factors|mesh-ancestor
102159200|NCT05127980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159201|NCT03971708|Lidocaine|lidocaine|mesh-list
102159202|NCT03971708|Ropivacaine|ropivacaine|mesh-list
102159203|NCT03971708|Anesthetics, Local|anesthetics, local|mesh-ancestor
102159204|NCT03971708|Anesthetics|anesthetics|mesh-ancestor
102159205|NCT03971708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102159206|NCT03971708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159207|NCT03971708|Sensory System Agents|sensory system agents|mesh-ancestor
102159208|NCT03971708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102159209|NCT03971708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102159210|NCT03971708|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102159211|NCT03971708|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102159212|NCT03971708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102159213|NCT03971708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159214|NCT02832037|BI 425809|bi 425809|mesh-list
102159215|NCT02832037|Nootropic Agents|nootropic agents|mesh-ancestor
102159216|NCT03966014|Amoxicillin|amoxicillin|mesh-list
102159217|NCT03966014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102159218|NCT03966014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102159219|NCT02482857|Aspirin|aspirin|mesh-list
102159220|NCT02482857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102159221|NCT02482857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102159222|NCT02482857|Analgesics|analgesics|mesh-ancestor
102159223|NCT02482857|Sensory System Agents|sensory system agents|mesh-ancestor
102159224|NCT02482857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102159225|NCT02482857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159226|NCT02482857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102159227|NCT02482857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102159228|NCT02482857|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102159229|NCT02482857|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102159230|NCT02482857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159231|NCT02482857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102159232|NCT02482857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102159233|NCT02482857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102159234|NCT02482857|Antipyretics|antipyretics|mesh-ancestor
102159235|NCT02480049|Montelukast|montelukast|mesh-list
102159236|NCT02480049|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102159237|NCT02480049|Respiratory System Agents|respiratory system agents|mesh-ancestor
102159238|NCT02480049|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102159239|NCT02480049|Hormone Antagonists|hormone antagonists|mesh-ancestor
102159240|NCT02480049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102159241|NCT02480049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159242|NCT02480049|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102159243|NCT02480049|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102159244|NCT02480049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159245|NCT02479971|Clindamycin|clindamycin|mesh-list
102159246|NCT02479971|Clindamycin palmitate|clindamycin palmitate|mesh-list
102159247|NCT02479971|Clindamycin phosphate|clindamycin phosphate|mesh-list
102159248|NCT02479971|Gentamicins|gentamicins|mesh-list
102159249|NCT02479971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102159250|NCT02479971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102159251|NCT02479971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102159252|NCT02479971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102159253|NCT02479971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159254|NCT02486133|Ritonavir|ritonavir|mesh-list
102159255|NCT02486133|Darunavir|darunavir|mesh-list
102159256|NCT02486133|Tenofovir|tenofovir|mesh-list
102159257|NCT02486133|Lamivudine|lamivudine|mesh-list
102159258|NCT02486133|Emtricitabine|emtricitabine|mesh-list
102159259|NCT02486133|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102159260|NCT02486133|Dolutegravir|dolutegravir|mesh-list
102159261|NCT02486133|Abacavir|abacavir|mesh-list
102159262|NCT02486133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102159263|NCT02486133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102159264|NCT02486133|Protease Inhibitors|protease inhibitors|mesh-ancestor
102159265|NCT02486133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102159266|NCT02486133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159267|NCT02486133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102159268|NCT02486133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102159269|NCT02486133|Antiviral Agents|antiviral agents|mesh-ancestor
102159270|NCT02486133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102159271|NCT02486133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102159272|NCT02486133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102159273|NCT02486133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102159274|NCT02486133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102159275|NCT02486133|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102159276|NCT02486133|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102159277|NCT02486055|Coenzyme Q10|coenzyme q10|mesh-list
102159278|NCT02486055|Micronutrients|micronutrients|mesh-ancestor
102159279|NCT02486055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159280|NCT02486055|Vitamins|vitamins|mesh-ancestor
102159281|NCT02486289|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
102159282|NCT02486289|Chelating Agents|chelating agents|mesh-ancestor
102159283|NCT02486289|Sequestering Agents|sequestering agents|mesh-ancestor
101573963|NCT02756377|Disinfectants|disinfectants|mesh-ancestor
102159284|NCT02486289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159286|NCT02485821|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102159287|NCT02485821|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102159288|NCT02485821|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102159289|NCT02485821|Estradiol|estradiol|mesh-list
102159290|NCT02485821|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102159291|NCT02485821|Estrogens|estrogens|mesh-ancestor
102159292|NCT02485821|Hormones|hormones|mesh-ancestor
102159293|NCT02485821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102159294|NCT02485821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159295|NCT02485821|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102159296|NCT02485821|Contraceptive Agents|contraceptive agents|mesh-ancestor
102159297|NCT02485821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102159298|NCT02485821|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102159299|NCT02485821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102159300|NCT02485821|Abortifacient Agents|abortifacient agents|mesh-ancestor
102159301|NCT02485821|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102159302|NCT02485821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102159303|NCT02485821|Oxytocics|oxytocics|mesh-ancestor
102159304|NCT02485821|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102159305|NCT02485821|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102159306|NCT02479815|Micronutrients|micronutrients|mesh-list
102159307|NCT02479815|Trace Elements|trace elements|mesh-list
102159308|NCT02479815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159309|NCT04119830|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
102159310|NCT04119830|Pembrolizumab|pembrolizumab|mesh-list
102159311|NCT04119830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102159312|NCT04119830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102159313|NCT04119830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102159314|NCT04119830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159315|NCT04119830|Antiviral Agents|antiviral agents|mesh-ancestor
102159316|NCT04119830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102159317|NCT04049786|Metoprolol|metoprolol|mesh-list
102159318|NCT04049786|Carvedilol|carvedilol|mesh-list
102159319|NCT04049786|Midazolam|midazolam|mesh-list
102159320|NCT04049786|Simvastatin|simvastatin|mesh-list
102159321|NCT04049786|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102159322|NCT04049786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102159323|NCT04049786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102159324|NCT04049786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159325|NCT04049786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102159326|NCT04049786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102159327|NCT04049786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102159328|NCT04049786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102159329|NCT04049786|Anesthetics, General|anesthetics, general|mesh-ancestor
102159331|NCT04049786|GABA Modulators|gaba modulators|mesh-ancestor
102159332|NCT04049786|GABA Agents|gaba agents|mesh-ancestor
102159333|NCT04049786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102159334|NCT04049786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159335|NCT04049786|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102159336|NCT04049786|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102159337|NCT04049786|Antimetabolites|antimetabolites|mesh-ancestor
102159338|NCT04049786|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102159339|NCT04049786|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102159340|NCT04049786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102159341|NCT04049786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102159342|NCT04049786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102159343|NCT04049786|Sympatholytics|sympatholytics|mesh-ancestor
102159344|NCT04049786|Autonomic Agents|autonomic agents|mesh-ancestor
102159345|NCT04049786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102159346|NCT04049786|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102159347|NCT04049786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102159348|NCT04049786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102159349|NCT04049786|Adrenergic Agents|adrenergic agents|mesh-ancestor
102159350|NCT04049786|Antioxidants|antioxidants|mesh-ancestor
102159351|NCT04049786|Protective Agents|protective agents|mesh-ancestor
102159352|NCT04049786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102159353|NCT04049786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102159354|NCT04049786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102159355|NCT04049786|Vasodilator Agents|vasodilator agents|mesh-ancestor
102159356|NCT04049786|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102159357|NCT04049786|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102159358|NCT02482077|Sofosbuvir|sofosbuvir|mesh-list
102159359|NCT02482077|Antiviral Agents|antiviral agents|mesh-ancestor
102159360|NCT02482077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102159361|NCT03316599|Paclitaxel|paclitaxel|mesh-list
102159362|NCT03316599|Gemcitabine|gemcitabine|mesh-list
102159363|NCT03316599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102159364|NCT03316599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102159365|NCT03316599|Tubulin Modulators|tubulin modulators|mesh-ancestor
102159366|NCT03316599|Antimitotic Agents|antimitotic agents|mesh-ancestor
102159367|NCT03316599|Mitosis Modulators|mitosis modulators|mesh-ancestor
102159368|NCT03316599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159369|NCT03316599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102159370|NCT03316599|Antimetabolites|antimetabolites|mesh-ancestor
102159371|NCT02482155|Ibuprofen|ibuprofen|mesh-list
102159372|NCT02482155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102159373|NCT02482155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102159374|NCT02482155|Analgesics|analgesics|mesh-ancestor
102159375|NCT02482155|Sensory System Agents|sensory system agents|mesh-ancestor
102159376|NCT02482155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102159377|NCT02482155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159378|NCT02482155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102159379|NCT02482155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102159380|NCT02482155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102159381|NCT02482155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102159382|NCT02482155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159383|NCT01675154|Orlistat|orlistat|mesh-list
102159384|NCT01675154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102159385|NCT01675154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159386|NCT01675154|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102159387|NCT01675154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102159388|NCT02485431|Deflazacort|deflazacort|mesh-list
102159389|NCT02485431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102159390|NCT02485431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102159391|NCT02485431|Immunologic Factors|immunologic factors|mesh-ancestor
102159392|NCT02485431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159393|NCT02744755|Adalimumab|adalimumab|mesh-list
102159394|NCT02744755|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101445701|NCT04634500|Dapagliflozin|dapagliflozin|mesh-list
102159395|NCT02744755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102159396|NCT02744755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102159397|NCT03314493|Spironolactone|spironolactone|mesh-list
102159398|NCT03314493|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102159399|NCT03314493|Hormone Antagonists|hormone antagonists|mesh-ancestor
102159400|NCT03314493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102159401|NCT03314493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159402|NCT03314493|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102159403|NCT03314493|Diuretics|diuretics|mesh-ancestor
102159404|NCT03314493|Natriuretic Agents|natriuretic agents|mesh-ancestor
102159405|NCT03912350|Balovaptan|balovaptan|mesh-list
102159406|NCT03912350|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102159407|NCT03912350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159408|NCT03912350|Natriuretic Agents|natriuretic agents|mesh-ancestor
102159409|NCT03912350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159410|NCT03829514|Fenofibrate|fenofibrate|mesh-list
102159411|NCT03829514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102159412|NCT03829514|Antimetabolites|antimetabolites|mesh-ancestor
102159413|NCT03829514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159414|NCT03829514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102159415|NCT03801200|Apatinib|apatinib|mesh-list
102159416|NCT03801200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102159417|NCT03801200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102159418|NCT03801200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102159419|NCT03801200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159420|NCT02485041|Mirodenafil|mirodenafil|mesh-list
102159421|NCT02485041|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102159422|NCT02485041|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102159423|NCT02485041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102159424|NCT02485041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159425|NCT02484963|Zolpidem|zolpidem|mesh-list
102159426|NCT02484963|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102159427|NCT02484963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102159428|NCT02484963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102159429|NCT02484963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159430|NCT02484963|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102159432|NCT02484963|GABA Agents|gaba agents|mesh-ancestor
102159433|NCT02484963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102159434|NCT02484963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159435|NCT05713773|Caffeine|caffeine|mesh-list
102159436|NCT05713773|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102159437|NCT05713773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159438|NCT05713773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102159439|NCT05713773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102159440|NCT05713773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159441|NCT05713773|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102159442|NCT05713773|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102159443|NCT05713773|Purinergic Agents|purinergic agents|mesh-ancestor
102159444|NCT05713773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102159445|NCT05708053|Metformin|metformin|mesh-list
102159446|NCT05708053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102159447|NCT05708053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159448|NCT02829775|Interferons|interferons|mesh-list
102159449|NCT02829775|Interferon-alpha|interferon-alpha|mesh-list
102159450|NCT02829775|Interferon alpha-2|interferon alpha-2|mesh-list
102159451|NCT02829775|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102159452|NCT02829775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102159453|NCT02829775|Antiviral Agents|antiviral agents|mesh-ancestor
102159454|NCT02829775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102159455|NCT02829775|Immunologic Factors|immunologic factors|mesh-ancestor
102159456|NCT02829775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159457|NCT02476773|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102159458|NCT02476773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102159459|NCT02476773|Immunologic Factors|immunologic factors|mesh-ancestor
101445704|NCT04634500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102159460|NCT02476773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159461|NCT02476773|Antacids|antacids|mesh-ancestor
102159462|NCT02476773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159463|NCT02476773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102159464|NCT04500860|Tadalafil|tadalafil|mesh-list
102159465|NCT04500860|Tolterodine Tartrate|tolterodine tartrate|mesh-list
102159466|NCT04500860|Vasodilator Agents|vasodilator agents|mesh-ancestor
102159467|NCT04500860|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102159468|NCT04500860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102159469|NCT04500860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102159470|NCT04500860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159471|NCT04500860|Urological Agents|urological agents|mesh-ancestor
101868328|NCT00258440|Hematinics|hematinics|mesh-ancestor
102159472|NCT04500860|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102159473|NCT04500860|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102159474|NCT04500860|Cholinergic Agents|cholinergic agents|mesh-ancestor
102159475|NCT04500860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102159476|NCT04500860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159477|NCT02479503|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102159478|NCT02479503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102159480|NCT02479581|Dexamethasone|dexamethasone|mesh-list
102159481|NCT02479581|Methylprednisolone|methylprednisolone|mesh-list
102159482|NCT02479581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102159483|NCT02479581|Scopolamine|scopolamine|mesh-list
102159484|NCT02479581|Morphine|morphine|mesh-list
102159485|NCT02479581|Anesthetics|anesthetics|mesh-list
102159486|NCT02479581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102159487|NCT02479581|Antiemetics|antiemetics|mesh-ancestor
102159488|NCT02479581|Autonomic Agents|autonomic agents|mesh-ancestor
102159489|NCT02479581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102159490|NCT02479581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159491|NCT02479581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102159492|NCT02479581|Glucocorticoids|glucocorticoids|mesh-ancestor
102159493|NCT02479581|Hormones|hormones|mesh-ancestor
102159494|NCT02479581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102159495|NCT02479581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102159496|NCT02479581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102159497|NCT02479581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159498|NCT02479581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102159499|NCT02479581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102159500|NCT02479581|Narcotics|narcotics|mesh-ancestor
102159501|NCT02479581|Analgesics|analgesics|mesh-ancestor
102159502|NCT02479581|Sensory System Agents|sensory system agents|mesh-ancestor
102159503|NCT02479581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102159504|NCT02479581|Protective Agents|protective agents|mesh-ancestor
101701313|NCT03823300|Faricimab|faricimab|mesh-list
102159505|NCT02479581|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102159506|NCT02479581|Mydriatics|mydriatics|mesh-ancestor
102159507|NCT02479581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102159508|NCT02479581|Cholinergic Agents|cholinergic agents|mesh-ancestor
102159509|NCT02479581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102159510|NCT02479581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102159511|NCT02479581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102159512|NCT02479581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102159513|NCT02479347|Chlorhexidine|chlorhexidine|mesh-list
102159514|NCT02479347|Povidone-Iodine|povidone-iodine|mesh-list
102159515|NCT02479347|Povidone|povidone|mesh-list
102159516|NCT02479347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102159517|NCT02479347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102159518|NCT02479347|Disinfectants|disinfectants|mesh-ancestor
102159519|NCT02479347|Plasma Substitutes|plasma substitutes|mesh-ancestor
102159520|NCT02479347|Blood Substitutes|blood substitutes|mesh-ancestor
101445740|NCT00179231|Serotonin Agents|serotonin agents|mesh-ancestor
102159521|NCT05125718|Anti-Infective Agents|anti-infective agents|mesh-list
102159522|NCT05125718|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102159523|NCT02481609|Acetylcysteine|acetylcysteine|mesh-list
102159524|NCT02481609|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102159525|NCT02481609|Antiviral Agents|antiviral agents|mesh-ancestor
102159526|NCT02481609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102159527|NCT02481609|Expectorants|expectorants|mesh-ancestor
102159528|NCT02481609|Respiratory System Agents|respiratory system agents|mesh-ancestor
102159529|NCT02481609|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102159530|NCT02481609|Antioxidants|antioxidants|mesh-ancestor
102159531|NCT02481609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159532|NCT02481609|Protective Agents|protective agents|mesh-ancestor
102159533|NCT02481609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159534|NCT02481609|Antidotes|antidotes|mesh-ancestor
102159535|NCT05373225|Acetic Acid|acetic acid|mesh-list
102159536|NCT05373225|Retinol acetate|retinol acetate|mesh-list
102159537|NCT05373225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102159538|NCT05373225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102159539|NCT05373225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102159540|NCT05373225|Immunologic Factors|immunologic factors|mesh-ancestor
102159541|NCT05373225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159542|NCT05373225|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102159543|NCT05373225|Protective Agents|protective agents|mesh-ancestor
102159544|NCT05373225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102159545|NCT01355575|Rifaximin|rifaximin|mesh-list
102159546|NCT01355575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102159547|NCT01355575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102159548|NCT01355575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102159549|NCT05125640|Progesterone|progesterone|mesh-list
102159550|NCT05125640|Progestins|progestins|mesh-ancestor
102159551|NCT05125640|Hormones|hormones|mesh-ancestor
102159552|NCT05125640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102159553|NCT05125640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159554|NCT03314259|Tamsulosin|tamsulosin|mesh-list
102159555|NCT03314259|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102159556|NCT03314259|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102159557|NCT03314259|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102159558|NCT03314259|Adrenergic Agents|adrenergic agents|mesh-ancestor
102159559|NCT03314259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102159560|NCT03314259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159561|NCT03314259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159562|NCT03314259|Urological Agents|urological agents|mesh-ancestor
102159563|NCT05125328|Remifentanil|remifentanil|mesh-list
102159564|NCT05125328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102159565|NCT05125328|Narcotics|narcotics|mesh-ancestor
102159566|NCT05125328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102159567|NCT05125328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159568|NCT05125328|Analgesics|analgesics|mesh-ancestor
102159569|NCT05125328|Sensory System Agents|sensory system agents|mesh-ancestor
102159570|NCT05125328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102159571|NCT02481453|Sirolimus|sirolimus|mesh-list
102159572|NCT02481453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102159573|NCT02481453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102159574|NCT02481453|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102159575|NCT02481453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102159576|NCT02481453|Antifungal Agents|antifungal agents|mesh-ancestor
102159577|NCT02481453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102159578|NCT02481453|Immunologic Factors|immunologic factors|mesh-ancestor
102159579|NCT02481453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159580|NCT02825251|Insulin|insulin|mesh-list
101701335|NCT02734511|Propofol|propofol|mesh-list
102159581|NCT02825251|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102159582|NCT02825251|Insulin Aspart|insulin aspart|mesh-list
102159583|NCT02825251|Insulin, Long-Acting|insulin, long-acting|mesh-list
102159584|NCT02825251|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102159585|NCT02825251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102159586|NCT02825251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159588|NCT03563365|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102159589|NCT03563365|Resveratrol|resveratrol|mesh-list
102159590|NCT03563365|Antioxidants|antioxidants|mesh-ancestor
102159591|NCT03563365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159592|NCT03563365|Protective Agents|protective agents|mesh-ancestor
102159593|NCT03563365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159594|NCT03563365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102159595|NCT03563365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102159596|NCT03563365|Dermatologic Agents|dermatologic agents|mesh-ancestor
102159597|NCT03563365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102159598|NCT03563365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102159599|NCT03563365|Analgesics|analgesics|mesh-ancestor
102159600|NCT03563365|Sensory System Agents|sensory system agents|mesh-ancestor
102159601|NCT03563365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102159602|NCT03563365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102159603|NCT03563365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102159604|NCT02475915|Tenofovir|tenofovir|mesh-list
102159605|NCT02475915|Emtricitabine|emtricitabine|mesh-list
102159606|NCT02475915|Efavirenz|efavirenz|mesh-list
102159607|NCT02475915|Maraviroc|maraviroc|mesh-list
102159608|NCT02475915|Darunavir|darunavir|mesh-list
102159609|NCT02475915|Hydroxychloroquine|hydroxychloroquine|mesh-list
102159610|NCT02475915|Vorinostat|vorinostat|mesh-list
102159611|NCT02475915|Antiviral Agents|antiviral agents|mesh-ancestor
102159612|NCT02475915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102159613|NCT02475915|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102159614|NCT02475915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102159615|NCT02475915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102159616|NCT02475915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159617|NCT02475915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102159618|NCT02475915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102159619|NCT02475915|Antimalarials|antimalarials|mesh-ancestor
102159620|NCT02475915|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102159621|NCT02475915|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102159622|NCT02475915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102159623|NCT02475915|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102159624|NCT02475915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102159625|NCT02475915|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102159626|NCT02475915|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102159627|NCT02475915|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102159628|NCT02475915|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102159629|NCT02475915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102159630|NCT02475915|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102159631|NCT02475915|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102159632|NCT02475915|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102159633|NCT02475915|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102159634|NCT02475915|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102159635|NCT02475915|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102159636|NCT02475915|Protease Inhibitors|protease inhibitors|mesh-ancestor
102159637|NCT05124457|Insulin|insulin|mesh-list
102159638|NCT05124457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102159639|NCT05124457|Insulin Detemir|insulin detemir|mesh-list
102159640|NCT05124457|Isophane Insulin, Human|isophane insulin, human|mesh-list
102159641|NCT05124457|Insulin, Isophane|insulin, isophane|mesh-list
102159642|NCT05124457|Isophane insulin, beef|isophane insulin, beef|mesh-list
102159643|NCT05124457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102159644|NCT05124457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159645|NCT03833323|Treprostinil|treprostinil|mesh-list
102159646|NCT03833323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102159647|NCT03110575|Cyclobenzaprine|cyclobenzaprine|mesh-list
102159648|NCT03110575|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102159649|NCT03110575|Antidepressive Agents|antidepressive agents|mesh-ancestor
102159650|NCT03110575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102159651|NCT03110575|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102159652|NCT03110575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159653|NCT03110575|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102159654|NCT03110575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102159655|NCT03110575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102159656|NCT03110575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102159657|NCT02824627|Oxytocin|oxytocin|mesh-list
102159658|NCT02824627|Oxytocics|oxytocics|mesh-ancestor
102159659|NCT02824627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102159660|NCT02824627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159661|NCT05384847|Hormones|hormones|mesh-list
102159662|NCT05384847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102159663|NCT05384847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159664|NCT02478879|Teriparatide|teriparatide|mesh-list
102159665|NCT02478879|Parathyroid Hormone|parathyroid hormone|mesh-list
102159666|NCT02478879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159667|NCT02478879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102159668|NCT02478879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102159669|NCT02478645|Ramosetron|ramosetron|mesh-list
102159670|NCT02478645|Antiemetics|antiemetics|mesh-ancestor
102159671|NCT02478645|Autonomic Agents|autonomic agents|mesh-ancestor
102159672|NCT02478645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102159673|NCT02478645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159674|NCT02478645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102159675|NCT02478645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102159676|NCT02478645|Serotonin Agents|serotonin agents|mesh-ancestor
102159677|NCT02478645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102159678|NCT02478645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159679|NCT05871957|Vitamin D|vitamin d|mesh-list
102159680|NCT05871957|Ergocalciferols|ergocalciferols|mesh-list
102159681|NCT05871957|Cholecalciferol|cholecalciferol|mesh-list
102159682|NCT05871957|Vitamins|vitamins|mesh-list
102159683|NCT05871957|Micronutrients|micronutrients|mesh-ancestor
102159684|NCT05871957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159685|NCT05871957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102159686|NCT05871957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102159687|NCT05871073|Dexamethasone|dexamethasone|mesh-list
102159688|NCT05871073|Ropivacaine|ropivacaine|mesh-list
102159689|NCT05871073|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102159690|NCT05871073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102159691|NCT05871073|Antiemetics|antiemetics|mesh-ancestor
102159692|NCT05871073|Autonomic Agents|autonomic agents|mesh-ancestor
102159693|NCT05871073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102159694|NCT05871073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159695|NCT05871073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102159696|NCT05871073|Glucocorticoids|glucocorticoids|mesh-ancestor
102159697|NCT05871073|Hormones|hormones|mesh-ancestor
102159698|NCT05871073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102159699|NCT05871073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102159700|NCT05871073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102159701|NCT05871073|Anesthetics, Local|anesthetics, local|mesh-ancestor
102159702|NCT05871073|Anesthetics|anesthetics|mesh-ancestor
102159703|NCT05871073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102159704|NCT05871073|Sensory System Agents|sensory system agents|mesh-ancestor
102159705|NCT05871021|Bevacizumab|bevacizumab|mesh-list
102159706|NCT05871021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102159707|NCT05871021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102159708|NCT05871021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102159709|NCT05871021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102159710|NCT05871021|Growth Substances|growth substances|mesh-ancestor
102159711|NCT05871021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159712|NCT05871021|Growth Inhibitors|growth inhibitors|mesh-ancestor
102159713|NCT05870969|Liver Extracts|liver extracts|mesh-list
102159714|NCT05870969|Hematinics|hematinics|mesh-ancestor
102159715|NCT05870917|Dexamethasone|dexamethasone|mesh-list
102159716|NCT05870917|Lenalidomide|lenalidomide|mesh-list
102159717|NCT05870917|Bortezomib|bortezomib|mesh-list
102159718|NCT05870917|Venetoclax|venetoclax|mesh-list
102159719|NCT05870917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102159720|NCT05870917|Antiemetics|antiemetics|mesh-ancestor
102159721|NCT05870917|Autonomic Agents|autonomic agents|mesh-ancestor
102159722|NCT05870917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102159723|NCT05870917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159724|NCT05870917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102159725|NCT05870917|Glucocorticoids|glucocorticoids|mesh-ancestor
102159726|NCT05870917|Hormones|hormones|mesh-ancestor
102159727|NCT05870917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102159728|NCT05870917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102159729|NCT05870917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102159730|NCT05870917|Immunologic Factors|immunologic factors|mesh-ancestor
102159731|NCT05870917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102159732|NCT05870917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102159734|NCT05870917|Growth Inhibitors|growth inhibitors|mesh-ancestor
102159735|NCT05870761|Niraparib|niraparib|mesh-list
102159736|NCT05870761|Dostarlimab|dostarlimab|mesh-list
102159737|NCT05870761|Immunoglobulins|immunoglobulins|mesh-list
102159738|NCT05870761|Immunoglobulin G|immunoglobulin g|mesh-list
102159739|NCT05870761|Immunologic Factors|immunologic factors|mesh-ancestor
102159740|NCT05870761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159741|NCT05870761|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102159742|NCT05870761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102159743|NCT05870761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159744|NCT05870761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102159745|NCT05870553|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
102159746|NCT05870553|Laxatives|laxatives|mesh-ancestor
102159747|NCT05870553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102159748|NCT05870501|Midazolam|midazolam|mesh-list
102159749|NCT05870501|Ketamine|ketamine|mesh-list
102159750|NCT05870501|Analgesics|analgesics|mesh-ancestor
102159751|NCT05870501|Sensory System Agents|sensory system agents|mesh-ancestor
102159752|NCT05870501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102159753|NCT05870501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159754|NCT05870501|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102159755|NCT05870501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101445818|NCT04723238|Analgesics|analgesics|mesh-ancestor
102159756|NCT05870501|Anesthetics, General|anesthetics, general|mesh-ancestor
102159757|NCT05870501|Anesthetics|anesthetics|mesh-ancestor
102159758|NCT05870501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102159759|NCT05870501|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102159760|NCT05870501|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102159761|NCT05870501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102159762|NCT05870501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159763|NCT05870501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102159764|NCT05870501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102159765|NCT05870501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102159766|NCT05870501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102159767|NCT05870501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102159768|NCT05870501|GABA Modulators|gaba modulators|mesh-ancestor
102159769|NCT05870501|GABA Agents|gaba agents|mesh-ancestor
102159770|NCT05870475|Interferons|interferons|mesh-list
102159771|NCT05870475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102159772|NCT05870475|Antiviral Agents|antiviral agents|mesh-ancestor
102159773|NCT05870475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102159774|NCT05870436|Choline|choline|mesh-list
102159775|NCT05870436|Methacholine Chloride|methacholine chloride|mesh-list
102159776|NCT05870436|Lipotropic Agents|lipotropic agents|mesh-ancestor
102159777|NCT05870436|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102159778|NCT05870436|Antimetabolites|antimetabolites|mesh-ancestor
102159779|NCT05870436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159780|NCT05870436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102159781|NCT05870436|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102159782|NCT05870436|Nootropic Agents|nootropic agents|mesh-ancestor
102159783|NCT05870436|Miotics|miotics|mesh-ancestor
102159784|NCT05870436|Autonomic Agents|autonomic agents|mesh-ancestor
102159785|NCT05870436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102159786|NCT05870436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159787|NCT05870436|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102159788|NCT05870436|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
102159789|NCT05870436|Respiratory System Agents|respiratory system agents|mesh-ancestor
102159790|NCT05870436|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102159791|NCT05870436|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102159792|NCT05870436|Cholinergic Agents|cholinergic agents|mesh-ancestor
102159793|NCT05870436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102159794|NCT05870423|Olaparib|olaparib|mesh-list
102159795|NCT05870423|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102159796|NCT05870423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102159797|NCT05870423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159798|NCT05870423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102159799|NCT05870358|Melatonin|melatonin|mesh-list
102159800|NCT05870358|Antioxidants|antioxidants|mesh-ancestor
102159801|NCT05870358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159802|NCT05870358|Protective Agents|protective agents|mesh-ancestor
102159803|NCT05870358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159804|NCT05870358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102159805|NCT05870111|Choline|choline|mesh-list
102159806|NCT05870111|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
102159808|NCT05870111|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102159809|NCT05870111|Antimetabolites|antimetabolites|mesh-ancestor
102159810|NCT05870111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159811|NCT05870111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102159812|NCT05870111|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102159813|NCT05870111|Nootropic Agents|nootropic agents|mesh-ancestor
102159814|NCT05870059|Chlorhexidine|chlorhexidine|mesh-list
102159815|NCT05870059|Propolis|propolis|mesh-list
102159816|NCT05870059|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102159817|NCT05870059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102159818|NCT05870059|Disinfectants|disinfectants|mesh-ancestor
102159819|NCT05870007|Atorvastatin|atorvastatin|mesh-list
102159820|NCT05870007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102159821|NCT05870007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102159822|NCT05870007|Antimetabolites|antimetabolites|mesh-ancestor
102159823|NCT05870007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159824|NCT05870007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102159825|NCT05870007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102159826|NCT05870007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102159827|NCT05869955|Cyclophosphamide|cyclophosphamide|mesh-list
102159828|NCT05869955|Fludarabine|fludarabine|mesh-list
102159829|NCT05869955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102159830|NCT05869955|Immunologic Factors|immunologic factors|mesh-ancestor
101445824|NCT00201786|Pentostatin|pentostatin|mesh-list
102159831|NCT05869955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159832|NCT05869955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102159833|NCT05869955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102159834|NCT05869955|Alkylating Agents|alkylating agents|mesh-ancestor
102159835|NCT05869955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159836|NCT05869955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102159837|NCT05869955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102159838|NCT05868226|Trastuzumab|trastuzumab|mesh-list
102159839|NCT05868226|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
102159840|NCT05868226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102159841|NCT05868226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102159842|NCT05868226|Immunoconjugates|immunoconjugates|mesh-ancestor
102159843|NCT05868226|Immunologic Factors|immunologic factors|mesh-ancestor
102159844|NCT05868226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159845|NCT05866653|Lidocaine|lidocaine|mesh-list
102159846|NCT05866653|Anesthetics, Local|anesthetics, local|mesh-ancestor
102159847|NCT05866653|Anesthetics|anesthetics|mesh-ancestor
102159848|NCT05866653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102159849|NCT05866653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159850|NCT05866653|Sensory System Agents|sensory system agents|mesh-ancestor
102159851|NCT05866653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102159852|NCT05866653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102159853|NCT05866653|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102159854|NCT05866653|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102159855|NCT05866653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102159856|NCT05866653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159857|NCT05790577|Niacinamide|niacinamide|mesh-list
102159858|NCT05790577|Niacin|niacin|mesh-list
102159859|NCT05790577|Nicotinic Acids|nicotinic acids|mesh-list
102159860|NCT05790577|Metformin|metformin|mesh-list
102159861|NCT05790577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102159862|NCT05790577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159863|NCT05790577|Vitamin B Complex|vitamin b complex|mesh-ancestor
102159864|NCT05790577|Vitamins|vitamins|mesh-ancestor
102159865|NCT05790577|Micronutrients|micronutrients|mesh-ancestor
102159866|NCT05790577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102159867|NCT05790577|Antimetabolites|antimetabolites|mesh-ancestor
102159868|NCT05790577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159869|NCT05790577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102159870|NCT05790577|Vasodilator Agents|vasodilator agents|mesh-ancestor
102159871|NCT05789589|Dexamethasone|dexamethasone|mesh-list
102159872|NCT05789589|Methylprednisolone|methylprednisolone|mesh-list
102159873|NCT05789589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102159874|NCT05789589|Antiemetics|antiemetics|mesh-ancestor
102159875|NCT05789589|Autonomic Agents|autonomic agents|mesh-ancestor
102159876|NCT05789589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102159877|NCT05789589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159878|NCT05789589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102159879|NCT05789589|Glucocorticoids|glucocorticoids|mesh-ancestor
102159880|NCT05789589|Hormones|hormones|mesh-ancestor
101573964|NCT02756377|Dermatologic Agents|dermatologic agents|mesh-ancestor
102159881|NCT05789589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102159882|NCT05789589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102159883|NCT05789589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102159884|NCT05789589|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102159885|NCT05789589|Protective Agents|protective agents|mesh-ancestor
102159886|NCT05778838|Midodrine|midodrine|mesh-list
102159887|NCT05778838|Sympathomimetics|sympathomimetics|mesh-ancestor
102159888|NCT05778838|Autonomic Agents|autonomic agents|mesh-ancestor
102159889|NCT05778838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102159890|NCT05778838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159891|NCT05778838|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102159892|NCT05778838|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102159893|NCT05778838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102159894|NCT05778838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102159895|NCT05778838|Adrenergic Agents|adrenergic agents|mesh-ancestor
102159896|NCT05778838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102159897|NCT05778838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159898|NCT05760248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102159899|NCT05757544|Ganaxolone|ganaxolone|mesh-list
102159900|NCT05757544|Neurosteroids|neurosteroids|mesh-ancestor
102159901|NCT05757544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102159902|NCT05757544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159903|NCT05757544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159904|NCT05757544|GABA Modulators|gaba modulators|mesh-ancestor
102159905|NCT05757544|GABA Agents|gaba agents|mesh-ancestor
102159906|NCT05688943|Anesthetics|anesthetics|mesh-list
102159907|NCT05688943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102159908|NCT05688943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159909|NCT05666310|Zoledronic Acid|zoledronic acid|mesh-list
102159910|NCT05666310|Denosumab|denosumab|mesh-list
102159911|NCT05666310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102159912|NCT05666310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159913|NCT05638919|Antiviral Agents|antiviral agents|mesh-list
102159914|NCT05638919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102159915|NCT05631405|Dexamethasone|dexamethasone|mesh-list
102159916|NCT05631405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102159917|NCT05631405|Antiemetics|antiemetics|mesh-ancestor
102159918|NCT05631405|Autonomic Agents|autonomic agents|mesh-ancestor
102159919|NCT05631405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102159920|NCT05631405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159921|NCT05631405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102159922|NCT05631405|Glucocorticoids|glucocorticoids|mesh-ancestor
102159923|NCT05631405|Hormones|hormones|mesh-ancestor
102159924|NCT05631405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102159925|NCT05631405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102159926|NCT05631405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102159927|NCT05621655|Vaccines|vaccines|mesh-list
102159928|NCT05621655|Immunologic Factors|immunologic factors|mesh-ancestor
102159929|NCT05621655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159930|NCT05619653|Prednisolone|prednisolone|mesh-list
102159931|NCT05619653|Losartan|losartan|mesh-list
102159932|NCT05619653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102159933|NCT05619653|Glucocorticoids|glucocorticoids|mesh-ancestor
102159934|NCT05619653|Hormones|hormones|mesh-ancestor
102159935|NCT05619653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102159936|NCT05619653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159937|NCT05619653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102159938|NCT05619653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102159939|NCT05619653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102159940|NCT05619653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102159941|NCT05619653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102159942|NCT05619653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102159943|NCT05619653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159944|NCT05586971|Allopurinol|allopurinol|mesh-list
102159945|NCT05586971|Antimetabolites|antimetabolites|mesh-ancestor
102159946|NCT05586971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159947|NCT05586971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102159948|NCT05586971|Gout Suppressants|gout suppressants|mesh-ancestor
102159949|NCT05586971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102159950|NCT05586971|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102159951|NCT05586971|Antioxidants|antioxidants|mesh-ancestor
102159952|NCT05586971|Protective Agents|protective agents|mesh-ancestor
102159953|NCT05586971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159954|NCT05553522|Capecitabine|capecitabine|mesh-list
102159955|NCT05553522|Trastuzumab|trastuzumab|mesh-list
102159957|NCT05553522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102159959|NCT05553522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159960|NCT05553522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102159961|NCT05553522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102159962|NCT05553522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102159963|NCT05553522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102159964|NCT05586724|Norethindrone|norethindrone|mesh-list
102159965|NCT05586724|Norethindrone Acetate|norethindrone acetate|mesh-list
102159966|NCT05586724|Progesterone|progesterone|mesh-list
102159967|NCT05586724|Estrogens|estrogens|mesh-list
102159968|NCT05586724|Progestins|progestins|mesh-ancestor
102159969|NCT05586724|Hormones|hormones|mesh-ancestor
102159970|NCT05586724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102159971|NCT05586724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102159972|NCT05586724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102159973|NCT05586724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102159974|NCT05586724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102159975|NCT05586724|Contraceptive Agents|contraceptive agents|mesh-ancestor
102159976|NCT05586724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102159977|NCT05586724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102159978|NCT05586724|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102159979|NCT05508152|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102159980|NCT05508152|Amoxicillin|amoxicillin|mesh-list
102159981|NCT05508152|Clavulanic Acid|clavulanic acid|mesh-list
102159982|NCT05508152|Clavulanic Acids|clavulanic acids|mesh-list
102159983|NCT05508152|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102159984|NCT05508152|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102159985|NCT05508152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102159986|NCT05508152|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102159987|NCT05508152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102159988|NCT05508152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159989|NCT05485558|Acetylcysteine|acetylcysteine|mesh-list
102159990|NCT05485558|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102159991|NCT05485558|Antiviral Agents|antiviral agents|mesh-ancestor
102159992|NCT05485558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102159993|NCT05485558|Expectorants|expectorants|mesh-ancestor
102159994|NCT05485558|Respiratory System Agents|respiratory system agents|mesh-ancestor
102159995|NCT05485558|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102159996|NCT05485558|Antioxidants|antioxidants|mesh-ancestor
102159997|NCT05485558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102159998|NCT05485558|Protective Agents|protective agents|mesh-ancestor
102159999|NCT05485558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160000|NCT05485558|Antidotes|antidotes|mesh-ancestor
102160001|NCT05485155|Protease Inhibitors|protease inhibitors|mesh-list
102160002|NCT05485155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102160003|NCT05485155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160004|NCT05457556|Mycophenolic Acid|mycophenolic acid|mesh-list
102160005|NCT05457556|Cyclophosphamide|cyclophosphamide|mesh-list
102160006|NCT05457556|Melphalan|melphalan|mesh-list
102160007|NCT05457556|Busulfan|busulfan|mesh-list
102160008|NCT05457556|Mechlorethamine|mechlorethamine|mesh-list
102160009|NCT05457556|Thiotepa|thiotepa|mesh-list
102160010|NCT05457556|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102160012|NCT05457556|Methotrexate|methotrexate|mesh-list
102160013|NCT05457556|Fludarabine|fludarabine|mesh-list
102160014|NCT05457556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102160015|NCT05457556|Tacrolimus|tacrolimus|mesh-list
102160016|NCT05457556|Thymoglobulin|thymoglobulin|mesh-list
102160017|NCT05457556|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102160018|NCT05457556|Antibodies|antibodies|mesh-list
102160019|NCT05457556|Immunoglobulins|immunoglobulins|mesh-list
102160020|NCT05457556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102160021|NCT05457556|gamma-Globulins|gamma-globulins|mesh-list
102160022|NCT05457556|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102160023|NCT05457556|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102160024|NCT05457556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102160025|NCT05457556|Immunologic Factors|immunologic factors|mesh-ancestor
102160026|NCT05457556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445857|NCT00186810|Busulfan|busulfan|mesh-list
102160027|NCT05457556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102160028|NCT05457556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102160029|NCT05457556|Alkylating Agents|alkylating agents|mesh-ancestor
102160030|NCT05457556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160031|NCT05457556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102160032|NCT05457556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102160033|NCT05457556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102160034|NCT05457556|Abortifacient Agents|abortifacient agents|mesh-ancestor
102160035|NCT05457556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102160036|NCT05457556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102160037|NCT05457556|Antimetabolites|antimetabolites|mesh-ancestor
102160038|NCT05457556|Dermatologic Agents|dermatologic agents|mesh-ancestor
102160039|NCT05457556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102160040|NCT05457556|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102160041|NCT05457556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102160042|NCT05457556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102160043|NCT05457556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102160044|NCT05457556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102160045|NCT05457556|Antitubercular Agents|antitubercular agents|mesh-ancestor
102160046|NCT05457556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102160047|NCT05457556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102160048|NCT05447286|Oxycodone|oxycodone|mesh-list
102160049|NCT05447286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102160050|NCT05447286|Narcotics|narcotics|mesh-ancestor
102160051|NCT05447286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102160052|NCT05447286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160053|NCT05447286|Analgesics|analgesics|mesh-ancestor
102160054|NCT05447286|Sensory System Agents|sensory system agents|mesh-ancestor
102160055|NCT05447286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102160056|NCT05411237|Paclitaxel|paclitaxel|mesh-list
102160057|NCT05411237|Doxorubicin|doxorubicin|mesh-list
102160058|NCT05411237|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102160059|NCT05411237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102160060|NCT05411237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102160061|NCT05411237|Tubulin Modulators|tubulin modulators|mesh-ancestor
102160062|NCT05411237|Antimitotic Agents|antimitotic agents|mesh-ancestor
102160063|NCT05411237|Mitosis Modulators|mitosis modulators|mesh-ancestor
102160064|NCT05411237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160065|NCT05411237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102160066|NCT05411237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102160067|NCT05411237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102160068|NCT05411237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102160069|NCT05389462|Gemcitabine|gemcitabine|mesh-list
102160070|NCT05389462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102160071|NCT05389462|Antimetabolites|antimetabolites|mesh-ancestor
102160072|NCT05389462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160073|NCT05389462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102160074|NCT05383196|Paclitaxel|paclitaxel|mesh-list
102160075|NCT05383196|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102160076|NCT05383196|Onvansertib|onvansertib|mesh-list
102160077|NCT05383196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102160078|NCT05383196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102160079|NCT05383196|Tubulin Modulators|tubulin modulators|mesh-ancestor
102160080|NCT05383196|Antimitotic Agents|antimitotic agents|mesh-ancestor
102160081|NCT05383196|Mitosis Modulators|mitosis modulators|mesh-ancestor
102160082|NCT05383196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160083|NCT05383196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102160084|NCT05383196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102160085|NCT05382338|Sodium thiosulfate|sodium thiosulfate|mesh-list
102160086|NCT05382338|Cyclophosphamide|cyclophosphamide|mesh-list
102160088|NCT05382338|Cisplatin|cisplatin|mesh-list
102160089|NCT05382338|Vincristine|vincristine|mesh-list
102160091|NCT05382338|Antidotes|antidotes|mesh-list
102160092|NCT05382338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102160093|NCT05382338|Immunologic Factors|immunologic factors|mesh-ancestor
102160094|NCT05382338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160095|NCT05382338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102160096|NCT05382338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102160097|NCT05382338|Alkylating Agents|alkylating agents|mesh-ancestor
102160098|NCT05382338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160099|NCT05382338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102160100|NCT05382338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102160101|NCT05382338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102160102|NCT05382338|Tubulin Modulators|tubulin modulators|mesh-ancestor
102160103|NCT05382338|Antimitotic Agents|antimitotic agents|mesh-ancestor
102160104|NCT05382338|Mitosis Modulators|mitosis modulators|mesh-ancestor
102160105|NCT05382338|Protective Agents|protective agents|mesh-ancestor
102160106|NCT05382338|Antioxidants|antioxidants|mesh-ancestor
102160107|NCT05382338|Antitubercular Agents|antitubercular agents|mesh-ancestor
102160108|NCT05382338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102160109|NCT05382338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102160110|NCT05382338|Chelating Agents|chelating agents|mesh-ancestor
102160111|NCT05382338|Sequestering Agents|sequestering agents|mesh-ancestor
102160112|NCT05347238|Dopamine|dopamine|mesh-list
102160113|NCT05347238|Norepinephrine|norepinephrine|mesh-list
102160114|NCT05347238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102160115|NCT05347238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102160116|NCT05347238|Adrenergic Agents|adrenergic agents|mesh-ancestor
102160117|NCT05347238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102160118|NCT05347238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160119|NCT05347238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160120|NCT05347238|Sympathomimetics|sympathomimetics|mesh-ancestor
102160121|NCT05347238|Autonomic Agents|autonomic agents|mesh-ancestor
102160122|NCT05347238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102160123|NCT05347238|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102160124|NCT05347238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102160125|NCT05347238|Dopamine Agents|dopamine agents|mesh-ancestor
102160126|NCT05347238|Protective Agents|protective agents|mesh-ancestor
102160127|NCT05340582|Acetaminophen|acetaminophen|mesh-list
102160128|NCT05340582|Ibuprofen|ibuprofen|mesh-list
102160129|NCT05340582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102160130|NCT05340582|Analgesics|analgesics|mesh-ancestor
102160131|NCT05340582|Sensory System Agents|sensory system agents|mesh-ancestor
102160132|NCT05340582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102160133|NCT05340582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160134|NCT05340582|Antipyretics|antipyretics|mesh-ancestor
102160135|NCT05340582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102160136|NCT05340582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102160137|NCT05340582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102160138|NCT05340582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102160139|NCT05340582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102160140|NCT05340582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160141|NCT05324501|Lomustine|lomustine|mesh-list
102160142|NCT05324501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102160143|NCT05324501|Alkylating Agents|alkylating agents|mesh-ancestor
102160144|NCT05324501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160145|NCT05324501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102160146|NCT05304585|Dactinomycin|dactinomycin|mesh-list
102160147|NCT05304585|Cactinomycin|cactinomycin|mesh-list
102160148|NCT05304585|Cyclophosphamide|cyclophosphamide|mesh-list
102160149|NCT05304585|Vincristine|vincristine|mesh-list
102160150|NCT05304585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102160151|NCT05304585|Immunologic Factors|immunologic factors|mesh-ancestor
102160152|NCT05304585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160153|NCT05304585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102160154|NCT05304585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102160155|NCT05304585|Alkylating Agents|alkylating agents|mesh-ancestor
102160156|NCT05304585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160157|NCT05304585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102160158|NCT05304585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102160159|NCT05304585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102160160|NCT05304585|Tubulin Modulators|tubulin modulators|mesh-ancestor
101869004|NCT01231594|Trametinib|trametinib|mesh-list
102160161|NCT05304585|Antimitotic Agents|antimitotic agents|mesh-ancestor
102160162|NCT05304585|Mitosis Modulators|mitosis modulators|mesh-ancestor
102160163|NCT05304585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102160164|NCT05304585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102160165|NCT05304585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102160166|NCT05304585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102160167|NCT05304585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102160168|NCT05304585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102160169|NCT05285605|Ulipristal acetate|ulipristal acetate|mesh-list
102160170|NCT05285605|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102160171|NCT05285605|Contraceptive Agents|contraceptive agents|mesh-ancestor
102160172|NCT05285605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102160173|NCT05285605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160174|NCT05285605|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102160175|NCT05245474|Tislelizumab|tislelizumab|mesh-list
102160176|NCT05245474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102160177|NCT05245474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102160178|NCT05245474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102160179|NCT05245474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160180|NCT05179733|Rituximab|rituximab|mesh-list
102160181|NCT05179733|Lenalidomide|lenalidomide|mesh-list
102160182|NCT05179733|Zanubrutinib|zanubrutinib|mesh-list
102160183|NCT05179733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102160184|NCT05179733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102160186|NCT05179733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160187|NCT05179733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102160188|NCT05179733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102160189|NCT05179733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102160190|NCT05179733|Growth Substances|growth substances|mesh-ancestor
102160191|NCT05179733|Growth Inhibitors|growth inhibitors|mesh-ancestor
102160192|NCT05179733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102160193|NCT05179733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102160194|NCT05179733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160195|NCT05170334|Belinostat|belinostat|mesh-list
102160196|NCT05170334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102160197|NCT05170334|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102160198|NCT05170334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102160199|NCT05170334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160200|NCT05083247|Paclitaxel|paclitaxel|mesh-list
102160201|NCT05083247|Gemcitabine|gemcitabine|mesh-list
102160202|NCT05083247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102160203|NCT05083247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102160204|NCT05083247|Tubulin Modulators|tubulin modulators|mesh-ancestor
102160205|NCT05083247|Antimitotic Agents|antimitotic agents|mesh-ancestor
102160206|NCT05083247|Mitosis Modulators|mitosis modulators|mesh-ancestor
102160207|NCT05083247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160208|NCT05083247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102160209|NCT05083247|Antimetabolites|antimetabolites|mesh-ancestor
102160210|NCT05076110|Acetaminophen|acetaminophen|mesh-list
102160211|NCT05076110|Ibuprofen|ibuprofen|mesh-list
102160212|NCT05076110|Oxycodone|oxycodone|mesh-list
102160213|NCT05076110|Gabapentin|gabapentin|mesh-list
102160214|NCT05076110|Methocarbamol|methocarbamol|mesh-list
102160215|NCT05076110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102160216|NCT05076110|Analgesics|analgesics|mesh-ancestor
102160217|NCT05076110|Sensory System Agents|sensory system agents|mesh-ancestor
102160218|NCT05076110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102160219|NCT05076110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160220|NCT05076110|Antipyretics|antipyretics|mesh-ancestor
102160221|NCT05076110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102160222|NCT05076110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102160223|NCT05076110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102160224|NCT05076110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102160225|NCT05076110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102160226|NCT05076110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160227|NCT05076110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102160228|NCT05076110|Narcotics|narcotics|mesh-ancestor
102160229|NCT05076110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102160230|NCT05076110|Anticonvulsants|anticonvulsants|mesh-ancestor
102160231|NCT05076110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102160232|NCT05076110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102160233|NCT05076110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102160234|NCT05076110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102160235|NCT05076110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102160236|NCT05076110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102160237|NCT05076110|Antimanic Agents|antimanic agents|mesh-ancestor
102160238|NCT05076110|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102160239|NCT05076110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102160240|NCT05063838|Anesthetics|anesthetics|mesh-list
102160241|NCT05063838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102160242|NCT05063838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160243|NCT05174650|Atezolizumab|atezolizumab|mesh-list
102160244|NCT05174650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102160245|NCT05174650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160246|NCT05174650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102160247|NCT05174650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102160248|NCT05014828|Lenvatinib|lenvatinib|mesh-list
102160249|NCT05014828|Tislelizumab|tislelizumab|mesh-list
102160250|NCT05014828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102160251|NCT05014828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102160252|NCT05014828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102160253|NCT05014828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160254|NCT05014828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102160255|NCT05007821|Linezolid|linezolid|mesh-list
102160256|NCT05007821|Bedaquiline|bedaquiline|mesh-list
102160257|NCT05007821|Diarylquinolines|diarylquinolines|mesh-list
102160258|NCT05007821|Clofazimine|clofazimine|mesh-list
102160259|NCT05007821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102160260|NCT05007821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102160261|NCT05007821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102160262|NCT05007821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102160263|NCT05007821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160264|NCT05007821|Antitubercular Agents|antitubercular agents|mesh-ancestor
102160265|NCT05007821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102160266|NCT05007821|Leprostatic Agents|leprostatic agents|mesh-ancestor
102160267|NCT04994132|Dactinomycin|dactinomycin|mesh-list
102160268|NCT04994132|Cactinomycin|cactinomycin|mesh-list
102160269|NCT04994132|Cyclophosphamide|cyclophosphamide|mesh-list
102160270|NCT04994132|Vincristine|vincristine|mesh-list
102160271|NCT04994132|Vinorelbine|vinorelbine|mesh-list
102160272|NCT04994132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102160273|NCT04994132|Immunologic Factors|immunologic factors|mesh-ancestor
102160274|NCT04994132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160275|NCT04994132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102160276|NCT04994132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102160277|NCT04994132|Alkylating Agents|alkylating agents|mesh-ancestor
102160278|NCT04994132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160279|NCT04994132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102160280|NCT04994132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102160281|NCT04994132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102160282|NCT04994132|Tubulin Modulators|tubulin modulators|mesh-ancestor
102160283|NCT04994132|Antimitotic Agents|antimitotic agents|mesh-ancestor
102160284|NCT04994132|Mitosis Modulators|mitosis modulators|mesh-ancestor
102160285|NCT04994132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102160286|NCT04994132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102160287|NCT04994132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102160288|NCT04994132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102160289|NCT04994132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102160290|NCT04994132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102160291|NCT04986579|Trastuzumab|trastuzumab|mesh-list
102160292|NCT04986579|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
102160293|NCT04986579|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
102160294|NCT04986579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102160295|NCT04986579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102160296|NCT04986579|Immunoconjugates|immunoconjugates|mesh-ancestor
102160297|NCT04986579|Immunologic Factors|immunologic factors|mesh-ancestor
102160298|NCT04986579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160300|NCT04940065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102160301|NCT04939441|Tenofovir|tenofovir|mesh-list
102160302|NCT04939441|Antiviral Agents|antiviral agents|mesh-ancestor
102160303|NCT04939441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102160304|NCT04939441|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102160305|NCT04939441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102160306|NCT04939441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102160307|NCT04939441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160308|NCT04939441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102160309|NCT04939441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102160310|NCT04937738|Leucovorin|leucovorin|mesh-list
102160311|NCT04937738|Docetaxel|docetaxel|mesh-list
102160312|NCT04937738|Fluorouracil|fluorouracil|mesh-list
102160313|NCT04937738|Capecitabine|capecitabine|mesh-list
102160314|NCT04937738|Oxaliplatin|oxaliplatin|mesh-list
102160315|NCT04937738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102160316|NCT04937738|Tubulin Modulators|tubulin modulators|mesh-ancestor
102160317|NCT04937738|Antimitotic Agents|antimitotic agents|mesh-ancestor
102160318|NCT04937738|Mitosis Modulators|mitosis modulators|mesh-ancestor
102160319|NCT04937738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160320|NCT04937738|Antimetabolites|antimetabolites|mesh-ancestor
102160321|NCT04937738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102160322|NCT04937738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102160323|NCT04937738|Immunologic Factors|immunologic factors|mesh-ancestor
102160324|NCT04937738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160325|NCT04937738|Antidotes|antidotes|mesh-ancestor
102160326|NCT04937738|Protective Agents|protective agents|mesh-ancestor
102160327|NCT04937738|Vitamin B Complex|vitamin b complex|mesh-ancestor
102160328|NCT04937738|Vitamins|vitamins|mesh-ancestor
102160329|NCT04937738|Micronutrients|micronutrients|mesh-ancestor
102160330|NCT04908189|Apremilast|apremilast|mesh-list
102160331|NCT04908189|Deucravacitinib|deucravacitinib|mesh-list
102160332|NCT04908189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102160333|NCT04908189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102160334|NCT04908189|Analgesics|analgesics|mesh-ancestor
102160335|NCT04908189|Sensory System Agents|sensory system agents|mesh-ancestor
102160336|NCT04908189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102160342|NCT04908189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102160343|NCT04908189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160344|NCT04908189|Dermatologic Agents|dermatologic agents|mesh-ancestor
102160345|NCT04908189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102160346|NCT04860505|Doxycycline|doxycycline|mesh-list
102160347|NCT04860505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102160348|NCT04860505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102160349|NCT04860505|Antimalarials|antimalarials|mesh-ancestor
102160350|NCT04860505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102160351|NCT04860505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102160357|NCT04816643|Vaccines|vaccines|mesh-list
102160358|NCT04816643|Immunologic Factors|immunologic factors|mesh-ancestor
102160359|NCT04816643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160360|NCT04810559|Antibodies|antibodies|mesh-list
102160361|NCT04810559|Immunologic Factors|immunologic factors|mesh-ancestor
102160362|NCT04810559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160363|NCT04799288|Teriflunomide|teriflunomide|mesh-list
102160364|NCT04799288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102160365|NCT04799288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102160366|NCT04799288|Analgesics|analgesics|mesh-ancestor
102160367|NCT04799288|Sensory System Agents|sensory system agents|mesh-ancestor
102160368|NCT04799288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102160369|NCT04799288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160370|NCT04799288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102160371|NCT04799288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102160372|NCT04799288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102160373|NCT04799288|Immunologic Factors|immunologic factors|mesh-ancestor
102160374|NCT04799054|Pembrolizumab|pembrolizumab|mesh-list
102160375|NCT04799054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102160376|NCT04799054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102160377|NCT04799054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102160378|NCT04799054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160379|NCT04724018|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
102160380|NCT04724018|Immunoconjugates|immunoconjugates|mesh-ancestor
102160381|NCT04724018|Immunologic Factors|immunologic factors|mesh-ancestor
102160382|NCT04724018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160383|NCT04713592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102160384|NCT04713592|Immunologic Factors|immunologic factors|mesh-ancestor
102160385|NCT04713592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869238|NCT05195944|Incretins|incretins|mesh-ancestor
102160386|NCT04687176|Arsenic Trioxide|arsenic trioxide|mesh-list
102160387|NCT04687176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102160388|NCT04684368|Carboplatin|carboplatin|mesh-list
102160389|NCT04684368|Etoposide|etoposide|mesh-list
102160390|NCT04684368|Etoposide phosphate|etoposide phosphate|mesh-list
102160391|NCT04684368|Ifosfamide|ifosfamide|mesh-list
102160392|NCT04684368|Isophosphamide mustard|isophosphamide mustard|mesh-list
102160393|NCT04684368|Thiotepa|thiotepa|mesh-list
102160394|NCT04684368|Podophyllotoxin|podophyllotoxin|mesh-list
102160395|NCT04684368|Lenograstim|lenograstim|mesh-list
102160397|NCT04684368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102160398|NCT04684368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102160399|NCT04684368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102160400|NCT04684368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102160401|NCT04684368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102160402|NCT04684368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160403|NCT04684368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102160404|NCT04684368|Immunologic Factors|immunologic factors|mesh-ancestor
102160405|NCT04684368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160406|NCT04684368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102160407|NCT04684368|Alkylating Agents|alkylating agents|mesh-ancestor
102160408|NCT04684368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102160409|NCT04684368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102160410|NCT04684368|Protective Agents|protective agents|mesh-ancestor
102160411|NCT04684368|Keratolytic Agents|keratolytic agents|mesh-ancestor
102160412|NCT04684368|Dermatologic Agents|dermatologic agents|mesh-ancestor
102160413|NCT04684368|Tubulin Modulators|tubulin modulators|mesh-ancestor
102160414|NCT04684368|Antimitotic Agents|antimitotic agents|mesh-ancestor
102160415|NCT04684368|Mitosis Modulators|mitosis modulators|mesh-ancestor
102160416|NCT04653831|Pirfenidone|pirfenidone|mesh-list
102160417|NCT04653831|Analgesics|analgesics|mesh-ancestor
102160418|NCT04653831|Sensory System Agents|sensory system agents|mesh-ancestor
102160419|NCT04653831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102160420|NCT04653831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160421|NCT04653831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102160422|NCT04653831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102160423|NCT04653831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102160424|NCT04653831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102160425|NCT04653831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102160426|NCT04570956|Tamoxifen|tamoxifen|mesh-list
102160427|NCT04570956|Afimoxifene|afimoxifene|mesh-list
102160428|NCT04570956|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102160429|NCT04570956|Hormone Antagonists|hormone antagonists|mesh-ancestor
102160430|NCT04570956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102160431|NCT04570956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160432|NCT04570956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102160433|NCT04570956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102160434|NCT04570956|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102160435|NCT04570956|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102160436|NCT04570956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102160437|NCT04512638|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102160438|NCT04512638|Amoxicillin|amoxicillin|mesh-list
102160439|NCT04512638|Chlorhexidine|chlorhexidine|mesh-list
102160440|NCT04512638|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102160441|NCT04512638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102160442|NCT04512638|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102160443|NCT04512638|Disinfectants|disinfectants|mesh-ancestor
102160444|NCT04512638|Dermatologic Agents|dermatologic agents|mesh-ancestor
102160445|NCT04510428|Immunoglobulins|immunoglobulins|mesh-list
102160446|NCT04510428|Antibodies|antibodies|mesh-list
102160447|NCT04510428|gamma-Globulins|gamma-globulins|mesh-list
102160448|NCT04510428|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102160449|NCT04510428|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102160450|NCT04510428|Immunologic Factors|immunologic factors|mesh-ancestor
102160451|NCT04510428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160452|NCT04437303|Anticoagulants|anticoagulants|mesh-list
102160453|NCT04436107|Lenalidomide|lenalidomide|mesh-list
102160454|NCT04436107|Zanubrutinib|zanubrutinib|mesh-list
102160455|NCT04436107|Immunologic Factors|immunologic factors|mesh-ancestor
102160456|NCT04436107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160457|NCT04436107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102160458|NCT04436107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102160459|NCT04436107|Growth Substances|growth substances|mesh-ancestor
102160460|NCT04436107|Growth Inhibitors|growth inhibitors|mesh-ancestor
102160461|NCT04436107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102160462|NCT04436107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102160463|NCT04436107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102160464|NCT04436107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160465|NCT04411693|Dexamethasone|dexamethasone|mesh-list
102160466|NCT04411693|Aflibercept|aflibercept|mesh-list
102160467|NCT04411693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102160468|NCT04411693|Antiemetics|antiemetics|mesh-ancestor
102160469|NCT04411693|Autonomic Agents|autonomic agents|mesh-ancestor
102160470|NCT04411693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102160471|NCT04411693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160472|NCT04411693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102160473|NCT04411693|Glucocorticoids|glucocorticoids|mesh-ancestor
102160474|NCT04411693|Hormones|hormones|mesh-ancestor
102160475|NCT04411693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102160476|NCT04411693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102160477|NCT04411693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102160478|NCT04411693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102160479|NCT04411693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102160480|NCT04411693|Growth Substances|growth substances|mesh-ancestor
102160481|NCT04411693|Growth Inhibitors|growth inhibitors|mesh-ancestor
102160482|NCT04385277|Vitamin A|vitamin a|mesh-list
102160483|NCT04385277|Irinotecan|irinotecan|mesh-list
102160484|NCT04385277|Temozolomide|temozolomide|mesh-list
102160485|NCT04385277|Tretinoin|tretinoin|mesh-list
102160486|NCT04385277|Dinutuximab|dinutuximab|mesh-list
102160487|NCT04385277|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
102160488|NCT04385277|Isotretinoin|isotretinoin|mesh-list
102160489|NCT04385277|Sargramostim|sargramostim|mesh-list
102160490|NCT04385277|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102160491|NCT04385277|Vitamins|vitamins|mesh-ancestor
102160492|NCT04385277|Micronutrients|micronutrients|mesh-ancestor
102160493|NCT04385277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160494|NCT04385277|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102160495|NCT04385277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102160496|NCT04385277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102160497|NCT04385277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160498|NCT04385277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102160499|NCT04385277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102160500|NCT04385277|Alkylating Agents|alkylating agents|mesh-ancestor
102160501|NCT04385277|Immunologic Factors|immunologic factors|mesh-ancestor
102160502|NCT04385277|Keratolytic Agents|keratolytic agents|mesh-ancestor
102160503|NCT04385277|Dermatologic Agents|dermatologic agents|mesh-ancestor
102160504|NCT04385277|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102160505|NCT04380740|Abatacept|abatacept|mesh-list
102160506|NCT04380740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102160507|NCT04380740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160508|NCT04380740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102160509|NCT04380740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102160510|NCT04380740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102160511|NCT04380740|Immunologic Factors|immunologic factors|mesh-ancestor
102160512|NCT04380740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160513|NCT04380740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102160514|NCT04274335|Tranexamic Acid|tranexamic acid|mesh-list
102160515|NCT04274335|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102160516|NCT04274335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102160517|NCT04274335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160518|NCT04274335|Hemostatics|hemostatics|mesh-ancestor
102160519|NCT04274335|Coagulants|coagulants|mesh-ancestor
102160520|NCT04267887|Ascorbic Acid|ascorbic acid|mesh-list
102160521|NCT04267887|Prednisone|prednisone|mesh-list
102160522|NCT04267887|Cortisone|cortisone|mesh-list
102160523|NCT04267887|Methyltestosterone|methyltestosterone|mesh-list
102160524|NCT04267887|Abiraterone Acetate|abiraterone acetate|mesh-list
102160525|NCT04267887|Hormones|hormones|mesh-list
102160526|NCT04267887|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
102160527|NCT04267887|Androgens|androgens|mesh-list
102160528|NCT04267887|Androgen Antagonists|androgen antagonists|mesh-list
102160529|NCT04267887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102160530|NCT04267887|Glucocorticoids|glucocorticoids|mesh-ancestor
102160531|NCT04267887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102160532|NCT04267887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160533|NCT04267887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102160534|NCT04267887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102160535|NCT04267887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102160536|NCT04267887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101445887|NCT00561067|Prednisolone phosphate|prednisolone phosphate|mesh-list
102160537|NCT04267887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160538|NCT04267887|Hormone Antagonists|hormone antagonists|mesh-ancestor
102160539|NCT04267887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102160540|NCT04267887|Antioxidants|antioxidants|mesh-ancestor
102160541|NCT04267887|Protective Agents|protective agents|mesh-ancestor
102160542|NCT04267887|Vitamins|vitamins|mesh-ancestor
101869378|NCT01234324|Panitumumab|panitumumab|mesh-list
102160543|NCT04267887|Micronutrients|micronutrients|mesh-ancestor
102160544|NCT04267887|Estrogens|estrogens|mesh-ancestor
102160545|NCT04267887|Anabolic Agents|anabolic agents|mesh-ancestor
102160556|NCT04238767|Dolutegravir|dolutegravir|mesh-list
102160557|NCT04238767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102160558|NCT04238767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102160559|NCT04238767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102160560|NCT04238767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160561|NCT04238767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102160562|NCT04238767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102160563|NCT04238767|Antiviral Agents|antiviral agents|mesh-ancestor
102160564|NCT04238767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102160565|NCT04232553|Mirikizumab|mirikizumab|mesh-list
102160566|NCT04232553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102160567|NCT04232553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102160568|NCT04232553|Analgesics|analgesics|mesh-ancestor
102160569|NCT04232553|Sensory System Agents|sensory system agents|mesh-ancestor
102160570|NCT04232553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102160571|NCT04232553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160572|NCT04232553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102160573|NCT04232553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102160574|NCT04232553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102160575|NCT04232553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102160576|NCT04195399|Imidazole|imidazole|mesh-list
102160577|NCT04195399|Nirogacestat|nirogacestat|mesh-list
102160578|NCT04195399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102160579|NCT04195399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160580|NCT04195399|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
102160581|NCT04177355|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102160582|NCT04177355|1018 oligonucleotide|1018 oligonucleotide|mesh-list
102160583|NCT04177355|MEDI9197|medi9197|mesh-list
102160584|NCT04177355|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102160585|NCT04177355|Immunologic Factors|immunologic factors|mesh-ancestor
102160586|NCT04177355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160587|NCT04177355|Antacids|antacids|mesh-ancestor
102160588|NCT04177355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160589|NCT04177355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102160590|NCT04166110|Oxymetazoline|oxymetazoline|mesh-list
102160591|NCT04166110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102160592|NCT04166110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102160593|NCT04166110|Adrenergic Agents|adrenergic agents|mesh-ancestor
102160594|NCT04166110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102160595|NCT04166110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160596|NCT04166110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160597|NCT04166110|Sympathomimetics|sympathomimetics|mesh-ancestor
102160598|NCT04166110|Autonomic Agents|autonomic agents|mesh-ancestor
102160599|NCT04166110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102160600|NCT04166110|Nasal Decongestants|nasal decongestants|mesh-ancestor
102160601|NCT04166110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102160602|NCT04166110|Respiratory System Agents|respiratory system agents|mesh-ancestor
102160603|NCT04126200|Dexamethasone|dexamethasone|mesh-list
102160604|NCT04126200|Lenalidomide|lenalidomide|mesh-list
102160605|NCT04126200|Pomalidomide|pomalidomide|mesh-list
102160606|NCT04126200|Dostarlimab|dostarlimab|mesh-list
102160607|NCT04126200|Nirogacestat|nirogacestat|mesh-list
102160608|NCT04126200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102160609|NCT04126200|Antiemetics|antiemetics|mesh-ancestor
102160610|NCT04126200|Autonomic Agents|autonomic agents|mesh-ancestor
101445895|NCT00561067|Hormones|hormones|mesh-ancestor
102160611|NCT04126200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102160612|NCT04126200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160613|NCT04126200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102160614|NCT04126200|Glucocorticoids|glucocorticoids|mesh-ancestor
102160615|NCT04126200|Hormones|hormones|mesh-ancestor
102160616|NCT04126200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102160617|NCT04126200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102160618|NCT04126200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102160619|NCT04126200|Immunologic Factors|immunologic factors|mesh-ancestor
102160620|NCT04126200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102160621|NCT04126200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102160622|NCT04126200|Growth Substances|growth substances|mesh-ancestor
102160623|NCT04126200|Growth Inhibitors|growth inhibitors|mesh-ancestor
102160624|NCT04126200|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
102160625|NCT04126200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102160626|NCT04126200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160627|NCT04063865|Everolimus|everolimus|mesh-list
102160628|NCT04063865|Tacrolimus|tacrolimus|mesh-list
102160629|NCT04063865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102160630|NCT04063865|Immunologic Factors|immunologic factors|mesh-ancestor
102160631|NCT04063865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160632|NCT04063865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102160633|NCT04063865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102160634|NCT04063865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160635|NCT04063865|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102160636|NCT04063865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102160637|NCT04063865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102160638|NCT04045665|Anticoagulants|anticoagulants|mesh-list
102160639|NCT04015700|Coal Tar|coal tar|mesh-list
102160641|NCT04015700|Immunologic Factors|immunologic factors|mesh-ancestor
102160642|NCT04015700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160643|NCT04015700|Keratolytic Agents|keratolytic agents|mesh-ancestor
102160644|NCT04015700|Dermatologic Agents|dermatologic agents|mesh-ancestor
102160645|NCT04004416|Lorazepam|lorazepam|mesh-list
102160646|NCT04004416|Anticonvulsants|anticonvulsants|mesh-ancestor
102160647|NCT04004416|Antiemetics|antiemetics|mesh-ancestor
102160648|NCT04004416|Autonomic Agents|autonomic agents|mesh-ancestor
102160649|NCT04004416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102160650|NCT04004416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160651|NCT04004416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102160652|NCT04004416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102160653|NCT04004416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102160654|NCT04004416|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102160655|NCT04004416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102160656|NCT04004416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102160657|NCT04004416|GABA Modulators|gaba modulators|mesh-ancestor
102160658|NCT04004416|GABA Agents|gaba agents|mesh-ancestor
102160659|NCT04004416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102160660|NCT04004416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160661|NCT03996265|Bupropion|bupropion|mesh-list
102160662|NCT03996265|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102160663|NCT03996265|Antidepressive Agents|antidepressive agents|mesh-ancestor
102160664|NCT03996265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102160665|NCT03996265|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102160666|NCT03996265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102160667|NCT03996265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102160668|NCT03996265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160669|NCT03996265|Dopamine Agents|dopamine agents|mesh-ancestor
102160670|NCT03996265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102160671|NCT03996265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160672|NCT03996265|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102160673|NCT03996265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102160674|NCT03996265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102160675|NCT03994211|Itraconazole|itraconazole|mesh-list
102160676|NCT03994211|Rifampin|rifampin|mesh-list
102160677|NCT03994211|Pamiparib|pamiparib|mesh-list
102160678|NCT03994211|Antifungal Agents|antifungal agents|mesh-ancestor
102160679|NCT03994211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102160680|NCT03994211|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102160681|NCT03994211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102160682|NCT03994211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102160683|NCT03994211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160684|NCT03994211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102160685|NCT03994211|Hormone Antagonists|hormone antagonists|mesh-ancestor
102160686|NCT03994211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102160687|NCT03994211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160688|NCT03994211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102160689|NCT03994211|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102160690|NCT03994211|Antitubercular Agents|antitubercular agents|mesh-ancestor
102160691|NCT03994211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102160692|NCT03994211|Leprostatic Agents|leprostatic agents|mesh-ancestor
102160693|NCT03994211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102160694|NCT03994211|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102160695|NCT03994211|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102160696|NCT03994211|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102160697|NCT03994211|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102160698|NCT03994211|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102160699|NCT03994211|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102160700|NCT03994211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102160701|NCT03994211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102160702|NCT03959085|Calcium, Dietary|calcium, dietary|mesh-list
102160703|NCT03959085|Leucovorin|leucovorin|mesh-list
102160704|NCT03959085|Folic Acid|folic acid|mesh-list
102160705|NCT03959085|Cytarabine|cytarabine|mesh-list
102160706|NCT03959085|Dexamethasone|dexamethasone|mesh-list
102160707|NCT03959085|Dexamethasone acetate|dexamethasone acetate|mesh-list
102160708|NCT03959085|Prednisolone|prednisolone|mesh-list
102160709|NCT03959085|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102160710|NCT03959085|Methylprednisolone|methylprednisolone|mesh-list
102160711|NCT03959085|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102160712|NCT03959085|Prednisolone acetate|prednisolone acetate|mesh-list
102160713|NCT03959085|Hydrocortisone|hydrocortisone|mesh-list
101573965|NCT02199184|Prednisone|prednisone|mesh-list
101898723|NCT03893864|Vitamins|vitamins|mesh-ancestor
101573967|NCT02199184|Cyclophosphamide|cyclophosphamide|mesh-list
102160714|NCT03959085|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102160715|NCT03959085|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101573968|NCT02199184|Rituximab|rituximab|mesh-list
101899459|NCT01265576|Etodolac|etodolac|mesh-list
101899605|NCT03882788|Anesthetics|anesthetics|mesh-ancestor
102160716|NCT03959085|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102160717|NCT03959085|Cyclophosphamide|cyclophosphamide|mesh-list
102160718|NCT03959085|Doxorubicin|doxorubicin|mesh-list
102160719|NCT03959085|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102160720|NCT03959085|Methotrexate|methotrexate|mesh-list
102160721|NCT03959085|Vincristine|vincristine|mesh-list
102160722|NCT03959085|Daunorubicin|daunorubicin|mesh-list
102160723|NCT03959085|Asparaginase|asparaginase|mesh-list
102160724|NCT03959085|Mercaptopurine|mercaptopurine|mesh-list
102160725|NCT03959085|Pegaspargase|pegaspargase|mesh-list
102160726|NCT03959085|Thioguanine|thioguanine|mesh-list
102160727|NCT03959085|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
102160728|NCT03959085|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102160729|NCT03959085|Prednisolone phosphate|prednisolone phosphate|mesh-list
102160730|NCT03959085|BB 1101|bb 1101|mesh-list
102160731|NCT03959085|Calcium|calcium|mesh-list
102160732|NCT03959085|2-Aminopurine|2-aminopurine|mesh-list
102160733|NCT03959085|Levoleucovorin|levoleucovorin|mesh-list
102160734|NCT03959085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102160735|NCT03959085|Immunologic Factors|immunologic factors|mesh-ancestor
102160736|NCT03959085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160737|NCT03959085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101573969|NCT02199184|Doxorubicin|doxorubicin|mesh-list
102160738|NCT03959085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102160739|NCT03959085|Alkylating Agents|alkylating agents|mesh-ancestor
102160740|NCT03959085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160741|NCT03959085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102160742|NCT03959085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102160743|NCT03959085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102160744|NCT03959085|Antiemetics|antiemetics|mesh-ancestor
102160745|NCT03959085|Autonomic Agents|autonomic agents|mesh-ancestor
102160746|NCT03959085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102160747|NCT03959085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102160748|NCT03959085|Glucocorticoids|glucocorticoids|mesh-ancestor
102160749|NCT03959085|Hormones|hormones|mesh-ancestor
102160750|NCT03959085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102160751|NCT03959085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102160752|NCT03959085|Protease Inhibitors|protease inhibitors|mesh-ancestor
102160753|NCT03959085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102160754|NCT03959085|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102160755|NCT03959085|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102160756|NCT03959085|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102160757|NCT03959085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102160758|NCT03959085|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102160759|NCT03959085|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102160760|NCT03959085|Abortifacient Agents|abortifacient agents|mesh-ancestor
102160761|NCT03959085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102160762|NCT03959085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102160763|NCT03959085|Antimetabolites|antimetabolites|mesh-ancestor
102160764|NCT03959085|Dermatologic Agents|dermatologic agents|mesh-ancestor
102160765|NCT03959085|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102160766|NCT03959085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102160767|NCT03959085|Antiviral Agents|antiviral agents|mesh-ancestor
102160768|NCT03959085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102160769|NCT03959085|Antidotes|antidotes|mesh-ancestor
102160770|NCT03959085|Protective Agents|protective agents|mesh-ancestor
102160771|NCT03959085|Vitamin B Complex|vitamin b complex|mesh-ancestor
102160772|NCT03959085|Vitamins|vitamins|mesh-ancestor
102160774|NCT03959085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102160775|NCT03959085|Tubulin Modulators|tubulin modulators|mesh-ancestor
102160776|NCT03959085|Antimitotic Agents|antimitotic agents|mesh-ancestor
102160777|NCT03959085|Mitosis Modulators|mitosis modulators|mesh-ancestor
102160778|NCT03959085|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102160779|NCT03959085|Hematinics|hematinics|mesh-ancestor
102160780|NCT03959085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102160781|NCT03959085|Immunotoxins|immunotoxins|mesh-ancestor
102160782|NCT03959085|Immunoconjugates|immunoconjugates|mesh-ancestor
102160783|NCT03952637|Sirolimus|sirolimus|mesh-list
102160784|NCT03952637|Prednisone|prednisone|mesh-list
102160785|NCT03952637|Methylprednisolone|methylprednisolone|mesh-list
102160786|NCT03952637|Rituximab|rituximab|mesh-list
102160787|NCT03952637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102160788|NCT03952637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102160789|NCT03952637|Immunologic Factors|immunologic factors|mesh-ancestor
102160790|NCT03952637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160791|NCT03952637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102160792|NCT03952637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102160793|NCT03952637|Glucocorticoids|glucocorticoids|mesh-ancestor
102160794|NCT03952637|Hormones|hormones|mesh-ancestor
102160795|NCT03952637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102160796|NCT03952637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102160797|NCT03952637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102160798|NCT03952637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102160799|NCT03952637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102160800|NCT03952637|Antifungal Agents|antifungal agents|mesh-ancestor
102160801|NCT03952637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102160802|NCT03952637|Antiemetics|antiemetics|mesh-ancestor
102160803|NCT03952637|Autonomic Agents|autonomic agents|mesh-ancestor
102160804|NCT03952637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102160805|NCT03952637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102160806|NCT03952637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102160807|NCT03952637|Protective Agents|protective agents|mesh-ancestor
102160808|NCT03950609|Everolimus|everolimus|mesh-list
102160809|NCT03950609|Lenvatinib|lenvatinib|mesh-list
102160810|NCT03950609|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102160811|NCT03950609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102160812|NCT03950609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102160813|NCT03950609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160814|NCT03950609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102160815|NCT03950609|Immunologic Factors|immunologic factors|mesh-ancestor
102160816|NCT03950609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160817|NCT03950609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102160818|NCT03930732|Cholinergic Agents|cholinergic agents|mesh-list
102160819|NCT03930732|Muscarinic Antagonists|muscarinic antagonists|mesh-list
102160820|NCT03930732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102160821|NCT03930732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160822|NCT03930732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160823|NCT03930732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102160824|NCT03910660|Pembrolizumab|pembrolizumab|mesh-list
102160825|NCT03910660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102160826|NCT03910660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102160827|NCT03910660|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102160828|NCT03910660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160829|NCT03875378|Estrogens|estrogens|mesh-list
102160830|NCT03875378|Hormones|hormones|mesh-ancestor
102160831|NCT03875378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102160832|NCT03875378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160833|NCT03823768|Tacrolimus|tacrolimus|mesh-list
102160834|NCT03823768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102160835|NCT03823768|Immunologic Factors|immunologic factors|mesh-ancestor
102160836|NCT03823768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160837|NCT03823768|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102160838|NCT03823768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102160839|NCT03823768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160840|NCT03818607|Eculizumab|eculizumab|mesh-list
102160841|NCT03818607|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102160842|NCT03818607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102160843|NCT03818607|Immunologic Factors|immunologic factors|mesh-ancestor
102160844|NCT03818607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160845|NCT03817398|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102160846|NCT03817398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101869674|NCT00424775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102160847|NCT03817398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102160848|NCT03817398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160850|NCT03796156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102160851|NCT03796156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102160852|NCT03796156|Analgesics|analgesics|mesh-ancestor
102160853|NCT03796156|Sensory System Agents|sensory system agents|mesh-ancestor
102160854|NCT03796156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102160855|NCT03796156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160856|NCT03796156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102160857|NCT03796156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102160858|NCT03796156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102160859|NCT03796156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102160860|NCT03796156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160861|NCT03796156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102160862|NCT03796156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102160863|NCT03796156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102160864|NCT03796156|Antipyretics|antipyretics|mesh-ancestor
102160865|NCT03794349|Eflornithine|eflornithine|mesh-list
102160866|NCT03794349|Irinotecan|irinotecan|mesh-list
102160867|NCT03794349|Camptothecin|camptothecin|mesh-list
102160868|NCT03794349|Temozolomide|temozolomide|mesh-list
102160869|NCT03794349|Dinutuximab|dinutuximab|mesh-list
102160870|NCT03794349|Sargramostim|sargramostim|mesh-list
102160871|NCT03794349|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102160872|NCT03794349|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102160873|NCT03794349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102160874|NCT03794349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102160875|NCT03794349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160876|NCT03794349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102160877|NCT03794349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102160878|NCT03794349|Alkylating Agents|alkylating agents|mesh-ancestor
102160879|NCT03794349|Immunologic Factors|immunologic factors|mesh-ancestor
102160880|NCT03794349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160881|NCT03794349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102160882|NCT03794349|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102160883|NCT03794349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102160884|NCT03794349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102160886|NCT03794349|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
102160887|NCT03737292|Bupivacaine|bupivacaine|mesh-list
102160888|NCT03737292|Anesthetics, Local|anesthetics, local|mesh-ancestor
102160889|NCT03737292|Anesthetics|anesthetics|mesh-ancestor
102160890|NCT03737292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102160891|NCT03737292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160892|NCT03737292|Sensory System Agents|sensory system agents|mesh-ancestor
102160893|NCT03737292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102160894|NCT03710460|Metformin|metformin|mesh-list
102160895|NCT03710460|Dapagliflozin|dapagliflozin|mesh-list
102160896|NCT03710460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102160897|NCT03710460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160898|NCT03710460|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102160899|NCT03710460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160900|NCT03650894|Nivolumab|nivolumab|mesh-list
102160901|NCT03650894|Ipilimumab|ipilimumab|mesh-list
102160902|NCT03650894|Bicalutamide|bicalutamide|mesh-list
102160903|NCT03650894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102160904|NCT03650894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102160905|NCT03650894|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102160906|NCT03650894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160907|NCT03650894|Androgen Antagonists|androgen antagonists|mesh-ancestor
102160908|NCT03650894|Hormone Antagonists|hormone antagonists|mesh-ancestor
102160909|NCT03650894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102160910|NCT03650894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160911|NCT03606694|Metformin|metformin|mesh-list
102160912|NCT03606694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102160913|NCT03606694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160914|NCT03544281|Dexamethasone|dexamethasone|mesh-list
102160915|NCT03544281|Lenalidomide|lenalidomide|mesh-list
102160916|NCT03544281|Bortezomib|bortezomib|mesh-list
102160917|NCT03544281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102160918|NCT03544281|Antiemetics|antiemetics|mesh-ancestor
102160919|NCT03544281|Autonomic Agents|autonomic agents|mesh-ancestor
102160920|NCT03544281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102160921|NCT03544281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160922|NCT03544281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102160923|NCT03544281|Glucocorticoids|glucocorticoids|mesh-ancestor
102160924|NCT03544281|Hormones|hormones|mesh-ancestor
102160925|NCT03544281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102160926|NCT03544281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102160927|NCT03544281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102160928|NCT03544281|Immunologic Factors|immunologic factors|mesh-ancestor
102160929|NCT03544281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102160930|NCT03544281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102160931|NCT03544281|Growth Substances|growth substances|mesh-ancestor
102160932|NCT03544281|Growth Inhibitors|growth inhibitors|mesh-ancestor
102160933|NCT03519945|Mirikizumab|mirikizumab|mesh-list
102160934|NCT03519945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102160935|NCT03519945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102160936|NCT03519945|Analgesics|analgesics|mesh-ancestor
102160937|NCT03519945|Sensory System Agents|sensory system agents|mesh-ancestor
102160938|NCT03519945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102160939|NCT03519945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160940|NCT03519945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102160941|NCT03519945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102160942|NCT03519945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102160943|NCT03519945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102160944|NCT03432741|Deoxyglucose|deoxyglucose|mesh-list
102160945|NCT03432741|Rituximab|rituximab|mesh-list
102160946|NCT03432741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102160947|NCT03432741|Pembrolizumab|pembrolizumab|mesh-list
102160948|NCT03432741|Nivolumab|nivolumab|mesh-list
102160949|NCT03432741|Trastuzumab|trastuzumab|mesh-list
102160950|NCT03432741|Obinutuzumab|obinutuzumab|mesh-list
102160951|NCT03432741|Gemcitabine|gemcitabine|mesh-list
102160952|NCT03432741|Daratumumab|daratumumab|mesh-list
102160953|NCT03432741|Romidepsin|romidepsin|mesh-list
102160954|NCT03432741|Belinostat|belinostat|mesh-list
102160955|NCT03432741|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
102160956|NCT03432741|Antibodies|antibodies|mesh-list
102160957|NCT03432741|Immunoglobulins|immunoglobulins|mesh-list
102160958|NCT03432741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102160959|NCT03432741|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102160960|NCT03432741|Immunologic Factors|immunologic factors|mesh-ancestor
102160961|NCT03432741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160962|NCT03432741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102160963|NCT03432741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102160964|NCT03432741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102160965|NCT03432741|Antimetabolites|antimetabolites|mesh-ancestor
102160966|NCT03432741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160967|NCT03432741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102160968|NCT03432741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102160969|NCT03432741|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102160970|NCT03432741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102160971|NCT03432741|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102160972|NCT03432741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102160973|NCT03432741|Antiviral Agents|antiviral agents|mesh-ancestor
102160974|NCT03387579|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102160976|NCT03387579|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102160977|NCT03387579|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102160978|NCT03387579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102160979|NCT03366272|Rituximab|rituximab|mesh-list
102160980|NCT03366272|Nivolumab|nivolumab|mesh-list
102160981|NCT03366272|Gemcitabine|gemcitabine|mesh-list
102160982|NCT03366272|Oxaliplatin|oxaliplatin|mesh-list
102160983|NCT03366272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102160984|NCT03366272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102160985|NCT03366272|Immunologic Factors|immunologic factors|mesh-ancestor
102160986|NCT03366272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102160987|NCT03366272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102160988|NCT03366272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102160989|NCT03366272|Antimetabolites|antimetabolites|mesh-ancestor
102160990|NCT03366272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102160991|NCT03366272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102160992|NCT03339635|Methyltestosterone|methyltestosterone|mesh-list
102160993|NCT03339635|Testosterone|testosterone|mesh-list
102160994|NCT03339635|Testosterone undecanoate|testosterone undecanoate|mesh-list
102160995|NCT03339635|Testosterone enanthate|testosterone enanthate|mesh-list
102160996|NCT03339635|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102160997|NCT03339635|Androgens|androgens|mesh-ancestor
102160998|NCT03339635|Hormones|hormones|mesh-ancestor
102160999|NCT03339635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102161000|NCT03339635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161001|NCT03339635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102161003|NCT03339635|Anabolic Agents|anabolic agents|mesh-ancestor
102161004|NCT03322215|Capecitabine|capecitabine|mesh-list
102161005|NCT03322215|Fulvestrant|fulvestrant|mesh-list
102161006|NCT03322215|Palbociclib|palbociclib|mesh-list
102161007|NCT03322215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102161008|NCT03322215|Antimetabolites|antimetabolites|mesh-ancestor
102161009|NCT03322215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161010|NCT03322215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102161011|NCT03322215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102161012|NCT03322215|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102161013|NCT03322215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102161014|NCT03322215|Hormone Antagonists|hormone antagonists|mesh-ancestor
102161015|NCT03322215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102161016|NCT03322215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161017|NCT03322215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102161018|NCT03322215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102161019|NCT03300817|Poly ICLC|poly iclc|mesh-list
102161020|NCT03300817|Interferon Inducers|interferon inducers|mesh-ancestor
102161021|NCT03300817|Immunologic Factors|immunologic factors|mesh-ancestor
102161022|NCT03300817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161023|NCT03271372|Avelumab|avelumab|mesh-list
102161024|NCT03271372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102161025|NCT03271372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102161026|NCT03271372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102161027|NCT03271372|Immunologic Factors|immunologic factors|mesh-ancestor
102161028|NCT03271372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161029|NCT03246750|Cisplatin|cisplatin|mesh-list
102161030|NCT03246750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102161031|NCT03126916|Vitamin A|vitamin a|mesh-list
102161032|NCT03126916|Cyclophosphamide|cyclophosphamide|mesh-list
102161033|NCT03126916|Melphalan|melphalan|mesh-list
102161034|NCT03126916|Busulfan|busulfan|mesh-list
102161035|NCT03126916|Thiotepa|thiotepa|mesh-list
102161036|NCT03126916|Cisplatin|cisplatin|mesh-list
102161037|NCT03126916|Carboplatin|carboplatin|mesh-list
102161038|NCT03126916|Doxorubicin|doxorubicin|mesh-list
101445945|NCT00561223|Iloprost|iloprost|mesh-list
102161039|NCT03126916|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102161040|NCT03126916|Etoposide|etoposide|mesh-list
102161041|NCT03126916|Vincristine|vincristine|mesh-list
102161042|NCT03126916|Topotecan|topotecan|mesh-list
102161043|NCT03126916|Tretinoin|tretinoin|mesh-list
102161044|NCT03126916|Etoposide phosphate|etoposide phosphate|mesh-list
102161045|NCT03126916|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
102161046|NCT03126916|Dinutuximab|dinutuximab|mesh-list
102161047|NCT03126916|Dexrazoxane|dexrazoxane|mesh-list
102161048|NCT03126916|Razoxane|razoxane|mesh-list
102161049|NCT03126916|Isotretinoin|isotretinoin|mesh-list
102161050|NCT03126916|Sargramostim|sargramostim|mesh-list
102161051|NCT03126916|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102161052|NCT03126916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102161053|NCT03126916|Immunologic Factors|immunologic factors|mesh-ancestor
102161054|NCT03126916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161055|NCT03126916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102161056|NCT03126916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102161057|NCT03126916|Alkylating Agents|alkylating agents|mesh-ancestor
102161058|NCT03126916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161059|NCT03126916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102161060|NCT03126916|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102161061|NCT03126916|Vitamins|vitamins|mesh-ancestor
102161062|NCT03126916|Micronutrients|micronutrients|mesh-ancestor
102161063|NCT03126916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102161064|NCT03126916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102161065|NCT03126916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102161066|NCT03126916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102161067|NCT03126916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102161068|NCT03126916|Tubulin Modulators|tubulin modulators|mesh-ancestor
102161069|NCT03126916|Antimitotic Agents|antimitotic agents|mesh-ancestor
102161070|NCT03126916|Mitosis Modulators|mitosis modulators|mesh-ancestor
102161071|NCT03126916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102161072|NCT03126916|Keratolytic Agents|keratolytic agents|mesh-ancestor
102161073|NCT03126916|Dermatologic Agents|dermatologic agents|mesh-ancestor
102161074|NCT03126916|Protective Agents|protective agents|mesh-ancestor
101869917|NCT02445131|Idelalisib|idelalisib|mesh-list
102161075|NCT03126916|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102161076|NCT03126916|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102161077|NCT03094884|Paclitaxel|paclitaxel|mesh-list
102161078|NCT03094884|Carboplatin|carboplatin|mesh-list
102161079|NCT03094884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102161080|NCT03094884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102161081|NCT03094884|Tubulin Modulators|tubulin modulators|mesh-ancestor
102161082|NCT03094884|Antimitotic Agents|antimitotic agents|mesh-ancestor
102161083|NCT03094884|Mitosis Modulators|mitosis modulators|mesh-ancestor
102161084|NCT03094884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161085|NCT03074513|Bevacizumab|bevacizumab|mesh-list
102161086|NCT03074513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102161087|NCT03074513|Atezolizumab|atezolizumab|mesh-list
102161088|NCT03074513|Endothelial Growth Factors|endothelial growth factors|mesh-list
102161089|NCT03074513|Antibodies|antibodies|mesh-list
102161090|NCT03074513|Immunoglobulins|immunoglobulins|mesh-list
102161091|NCT03074513|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102161092|NCT03074513|Immunoglobulin G|immunoglobulin g|mesh-list
102161093|NCT03074513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102161094|NCT03074513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102161095|NCT03074513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102161096|NCT03074513|Growth Substances|growth substances|mesh-ancestor
102161097|NCT03074513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161098|NCT03074513|Growth Inhibitors|growth inhibitors|mesh-ancestor
102161099|NCT03074513|Immunologic Factors|immunologic factors|mesh-ancestor
102161100|NCT03074513|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102161101|NCT03074513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161102|NCT03067181|Cisplatin|cisplatin|mesh-list
102161103|NCT03067181|Carboplatin|carboplatin|mesh-list
102161104|NCT03067181|Etoposide|etoposide|mesh-list
102161105|NCT03067181|Etoposide phosphate|etoposide phosphate|mesh-list
102161106|NCT03067181|Bleomycin|bleomycin|mesh-list
102161107|NCT03067181|Podophyllotoxin|podophyllotoxin|mesh-list
102161108|NCT03067181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102161109|NCT03067181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102161110|NCT03067181|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102161111|NCT03067181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102161112|NCT03067181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102161113|NCT03067181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161114|NCT03067181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102161115|NCT03067181|Keratolytic Agents|keratolytic agents|mesh-ancestor
102161116|NCT03067181|Dermatologic Agents|dermatologic agents|mesh-ancestor
102161117|NCT03067181|Tubulin Modulators|tubulin modulators|mesh-ancestor
102161118|NCT03067181|Antimitotic Agents|antimitotic agents|mesh-ancestor
102161119|NCT03067181|Mitosis Modulators|mitosis modulators|mesh-ancestor
102161121|NCT03029390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102161122|NCT03029390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161123|NCT02981628|Calcium, Dietary|calcium, dietary|mesh-list
102161124|NCT02981628|Leucovorin|leucovorin|mesh-list
102161125|NCT02981628|Folic Acid|folic acid|mesh-list
102161126|NCT02981628|Cytarabine|cytarabine|mesh-list
102161127|NCT02981628|Cyclophosphamide|cyclophosphamide|mesh-list
102161128|NCT02981628|Methotrexate|methotrexate|mesh-list
102161129|NCT02981628|Vincristine|vincristine|mesh-list
102161130|NCT02981628|Asparaginase|asparaginase|mesh-list
102161131|NCT02981628|Pegaspargase|pegaspargase|mesh-list
102161132|NCT02981628|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
102161133|NCT02981628|Calcium|calcium|mesh-list
102161134|NCT02981628|Levoleucovorin|levoleucovorin|mesh-list
102161135|NCT02981628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102161136|NCT02981628|Immunologic Factors|immunologic factors|mesh-ancestor
102161137|NCT02981628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161138|NCT02981628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102161139|NCT02981628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102161140|NCT02981628|Alkylating Agents|alkylating agents|mesh-ancestor
102161141|NCT02981628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161142|NCT02981628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102161143|NCT02981628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102161144|NCT02981628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102161145|NCT02981628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102161146|NCT02981628|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102161147|NCT02981628|Abortifacient Agents|abortifacient agents|mesh-ancestor
102161148|NCT02981628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102161149|NCT02981628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102161150|NCT02981628|Antimetabolites|antimetabolites|mesh-ancestor
102161151|NCT02981628|Dermatologic Agents|dermatologic agents|mesh-ancestor
102161152|NCT02981628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102161153|NCT02981628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102161154|NCT02981628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102161155|NCT02981628|Antiviral Agents|antiviral agents|mesh-ancestor
102161156|NCT02981628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102161157|NCT02981628|Antidotes|antidotes|mesh-ancestor
102161158|NCT02981628|Protective Agents|protective agents|mesh-ancestor
102161159|NCT02981628|Vitamin B Complex|vitamin b complex|mesh-ancestor
102161160|NCT02981628|Vitamins|vitamins|mesh-ancestor
102161161|NCT02981628|Micronutrients|micronutrients|mesh-ancestor
102161162|NCT02981628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102161163|NCT02981628|Tubulin Modulators|tubulin modulators|mesh-ancestor
102161164|NCT02981628|Antimitotic Agents|antimitotic agents|mesh-ancestor
102161165|NCT02981628|Mitosis Modulators|mitosis modulators|mesh-ancestor
102161166|NCT02981628|Hematinics|hematinics|mesh-ancestor
102161167|NCT02981628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102161168|NCT02981628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102161169|NCT02981628|Immunotoxins|immunotoxins|mesh-ancestor
102161170|NCT02981628|Immunoconjugates|immunoconjugates|mesh-ancestor
102161171|NCT02873962|Bevacizumab|bevacizumab|mesh-list
102161172|NCT02873962|Nivolumab|nivolumab|mesh-list
102161173|NCT02873962|Rucaparib|rucaparib|mesh-list
102161174|NCT02873962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102161175|NCT02873962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102161176|NCT02873962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102161177|NCT02873962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102161178|NCT02873962|Growth Substances|growth substances|mesh-ancestor
102161179|NCT02873962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161180|NCT02873962|Growth Inhibitors|growth inhibitors|mesh-ancestor
102161181|NCT02873962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102161182|NCT02873962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161183|NCT02873962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102161184|NCT02873962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102161185|NCT02822144|Lidocaine|lidocaine|mesh-list
102161186|NCT02822144|Remifentanil|remifentanil|mesh-list
102161187|NCT02822144|Propofol|propofol|mesh-list
102161188|NCT02822144|Etomidate|etomidate|mesh-list
102161189|NCT02822144|Succinylcholine|succinylcholine|mesh-list
102161190|NCT02822144|Anesthetics, Local|anesthetics, local|mesh-ancestor
102161191|NCT02822144|Anesthetics|anesthetics|mesh-ancestor
102161192|NCT02822144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102161193|NCT02822144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161194|NCT02822144|Sensory System Agents|sensory system agents|mesh-ancestor
101702918|NCT02974049|Ivermectin|ivermectin|mesh-list
102161195|NCT02822144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102161196|NCT02822144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102161197|NCT02822144|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102161198|NCT02822144|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102161199|NCT02822144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102161200|NCT02822144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161201|NCT02822144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102161202|NCT02822144|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102161203|NCT02822144|Anesthetics, General|anesthetics, general|mesh-ancestor
102161204|NCT02822144|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102161206|NCT02822144|Analgesics|analgesics|mesh-ancestor
102161207|NCT02822144|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
102161208|NCT02822144|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102161209|NCT02822144|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102161210|NCT02725060|Phenylephrine|phenylephrine|mesh-list
102161211|NCT02725060|Isoproterenol|isoproterenol|mesh-list
102161212|NCT02725060|Oxymetazoline|oxymetazoline|mesh-list
102161213|NCT02725060|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102161214|NCT02725060|Mydriatics|mydriatics|mesh-ancestor
102161215|NCT02725060|Autonomic Agents|autonomic agents|mesh-ancestor
102161216|NCT02725060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102161217|NCT02725060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161218|NCT02725060|Sympathomimetics|sympathomimetics|mesh-ancestor
102161219|NCT02725060|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102161220|NCT02725060|Nasal Decongestants|nasal decongestants|mesh-ancestor
102161221|NCT02725060|Respiratory System Agents|respiratory system agents|mesh-ancestor
102161222|NCT02725060|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102161223|NCT02725060|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102161224|NCT02725060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102161225|NCT02725060|Adrenergic Agents|adrenergic agents|mesh-ancestor
102161226|NCT02725060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102161227|NCT02725060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161228|NCT02725060|Protective Agents|protective agents|mesh-ancestor
102161229|NCT02725060|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102161230|NCT02725060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102161231|NCT02725060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102161232|NCT02724579|Cyclophosphamide|cyclophosphamide|mesh-list
102161233|NCT02724579|Lomustine|lomustine|mesh-list
102161234|NCT02724579|Cisplatin|cisplatin|mesh-list
102161236|NCT02724579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102161237|NCT02724579|Immunologic Factors|immunologic factors|mesh-ancestor
102161238|NCT02724579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161239|NCT02724579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102161240|NCT02724579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102161241|NCT02724579|Alkylating Agents|alkylating agents|mesh-ancestor
102161242|NCT02724579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161243|NCT02724579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102161244|NCT02724579|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102161245|NCT02724579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102161246|NCT02724579|Tubulin Modulators|tubulin modulators|mesh-ancestor
102161247|NCT02724579|Antimitotic Agents|antimitotic agents|mesh-ancestor
102161248|NCT02724579|Mitosis Modulators|mitosis modulators|mesh-ancestor
102161249|NCT02565680|Prednisone|prednisone|mesh-list
102161250|NCT02565680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102161251|NCT02565680|Glucocorticoids|glucocorticoids|mesh-ancestor
102161252|NCT02565680|Hormones|hormones|mesh-ancestor
102161253|NCT02565680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102161254|NCT02565680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161255|NCT02565680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102161256|NCT02565680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102161257|NCT02521285|Aspirin|aspirin|mesh-list
102161258|NCT02521285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102161259|NCT02521285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102161260|NCT02521285|Analgesics|analgesics|mesh-ancestor
102161261|NCT02521285|Sensory System Agents|sensory system agents|mesh-ancestor
102161262|NCT02521285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102161263|NCT02521285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161264|NCT02521285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102161265|NCT02521285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102161266|NCT02521285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102161267|NCT02521285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102161268|NCT02521285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161269|NCT02521285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102161270|NCT02521285|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102161271|NCT02521285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102161272|NCT02521285|Antipyretics|antipyretics|mesh-ancestor
102161273|NCT02422615|Fulvestrant|fulvestrant|mesh-list
102161274|NCT02422615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102161275|NCT02422615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102161276|NCT02422615|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102161277|NCT02422615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102161278|NCT02422615|Hormone Antagonists|hormone antagonists|mesh-ancestor
102161279|NCT02422615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102161280|NCT02422615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161281|NCT02382406|Paclitaxel|paclitaxel|mesh-list
102161282|NCT02382406|Carboplatin|carboplatin|mesh-list
102161283|NCT02382406|Pembrolizumab|pembrolizumab|mesh-list
102161284|NCT02382406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102161285|NCT02382406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102161286|NCT02382406|Tubulin Modulators|tubulin modulators|mesh-ancestor
102161287|NCT02382406|Antimitotic Agents|antimitotic agents|mesh-ancestor
102161288|NCT02382406|Mitosis Modulators|mitosis modulators|mesh-ancestor
102161289|NCT02382406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161290|NCT02382406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102161291|NCT02382406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102161292|NCT02134327|Midazolam|midazolam|mesh-list
102161293|NCT02134327|Dexmedetomidine|dexmedetomidine|mesh-list
102161294|NCT02134327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102161295|NCT02134327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102161296|NCT02134327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161297|NCT02134327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102161298|NCT02134327|Analgesics|analgesics|mesh-ancestor
102161299|NCT02134327|Sensory System Agents|sensory system agents|mesh-ancestor
102161300|NCT02134327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102161301|NCT02134327|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102161302|NCT02134327|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102161303|NCT02134327|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102161304|NCT02134327|Adrenergic Agents|adrenergic agents|mesh-ancestor
102161305|NCT02134327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102161306|NCT02134327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870123|NCT03530800|Hallucinogens|hallucinogens|mesh-ancestor
102161307|NCT02134327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102161308|NCT02134327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102161309|NCT02134327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102161310|NCT02134327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102161311|NCT02134327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102161312|NCT02134327|Anesthetics, General|anesthetics, general|mesh-ancestor
102161313|NCT02134327|Anesthetics|anesthetics|mesh-ancestor
102161314|NCT02134327|GABA Modulators|gaba modulators|mesh-ancestor
102161315|NCT02134327|GABA Agents|gaba agents|mesh-ancestor
102161316|NCT02101268|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
102161317|NCT02101268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102161318|NCT02101268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102161319|NCT02101268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161320|NCT01880515|Tetracycline|tetracycline|mesh-list
102161321|NCT01880515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102161322|NCT01880515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102161323|NCT01880515|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102161324|NCT01880515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102161325|NCT01880515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161326|NCT01780883|Melatonin|melatonin|mesh-list
102161327|NCT01780883|Antioxidants|antioxidants|mesh-ancestor
102161328|NCT01780883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161329|NCT01780883|Protective Agents|protective agents|mesh-ancestor
102161330|NCT01780883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161331|NCT01780883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102161332|NCT01668719|Dexamethasone|dexamethasone|mesh-list
102161333|NCT01668719|Dexamethasone acetate|dexamethasone acetate|mesh-list
102161334|NCT01668719|Lenalidomide|lenalidomide|mesh-list
102161335|NCT01668719|Bortezomib|bortezomib|mesh-list
102161336|NCT01668719|Elotuzumab|elotuzumab|mesh-list
102161337|NCT01668719|Ichthammol|ichthammol|mesh-list
102161338|NCT01668719|BB 1101|bb 1101|mesh-list
102161339|NCT01668719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102161340|NCT01668719|Antiemetics|antiemetics|mesh-ancestor
102161341|NCT01668719|Autonomic Agents|autonomic agents|mesh-ancestor
101573970|NCT02199184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102161342|NCT01668719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102161343|NCT01668719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161344|NCT01668719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102161345|NCT01668719|Glucocorticoids|glucocorticoids|mesh-ancestor
102161346|NCT01668719|Hormones|hormones|mesh-ancestor
102161347|NCT01668719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102161348|NCT01668719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102161349|NCT01668719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102161350|NCT01668719|Immunologic Factors|immunologic factors|mesh-ancestor
102161351|NCT01668719|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102161352|NCT01668719|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102161353|NCT01668719|Growth Substances|growth substances|mesh-ancestor
102161354|NCT01668719|Growth Inhibitors|growth inhibitors|mesh-ancestor
102161355|NCT01668719|Protease Inhibitors|protease inhibitors|mesh-ancestor
102161356|NCT01668719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102161357|NCT01668719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161358|NCT01668719|Dermatologic Agents|dermatologic agents|mesh-ancestor
102161359|NCT01642901|Zoledronic Acid|zoledronic acid|mesh-list
102161360|NCT01642901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102161361|NCT01642901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161362|NCT01488045|Fentanyl|fentanyl|mesh-list
102161363|NCT01488045|Midazolam|midazolam|mesh-list
102161364|NCT01488045|Propofol|propofol|mesh-list
102161365|NCT01488045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102161366|NCT01488045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102161367|NCT01488045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161368|NCT01488045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102161369|NCT01488045|Anesthetics, General|anesthetics, general|mesh-ancestor
102161370|NCT01488045|Anesthetics|anesthetics|mesh-ancestor
102161371|NCT01488045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102161372|NCT01488045|Narcotics|narcotics|mesh-ancestor
102161373|NCT01488045|Analgesics|analgesics|mesh-ancestor
102161374|NCT01488045|Sensory System Agents|sensory system agents|mesh-ancestor
102161375|NCT01488045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102161376|NCT01488045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102161377|NCT01488045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102161378|NCT01488045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102161379|NCT01488045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102161380|NCT01488045|GABA Modulators|gaba modulators|mesh-ancestor
102161381|NCT01488045|GABA Agents|gaba agents|mesh-ancestor
102161382|NCT01488045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101445986|NCT00180050|Glucocorticoids|glucocorticoids|mesh-ancestor
102161383|NCT01488045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161384|NCT01404754|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
102161385|NCT01404754|Hallucinogens|hallucinogens|mesh-ancestor
102161386|NCT01404754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161387|NCT01404754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102161388|NCT01404754|Serotonin Agents|serotonin agents|mesh-ancestor
102161389|NCT01404754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102161390|NCT01404754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161391|NCT01404754|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102161392|NCT01404754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102161393|NCT01404754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102161394|NCT01404754|Adrenergic Agents|adrenergic agents|mesh-ancestor
102161395|NCT01090479|Chlorhexidine|chlorhexidine|mesh-list
102161396|NCT01090479|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102161397|NCT01090479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102161398|NCT01090479|Disinfectants|disinfectants|mesh-ancestor
102161400|NCT00946712|Bevacizumab|bevacizumab|mesh-list
102161401|NCT00946712|Carboplatin|carboplatin|mesh-list
102161402|NCT00946712|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102161403|NCT00946712|Cetuximab|cetuximab|mesh-list
102161404|NCT00946712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102161405|NCT00946712|Endothelial Growth Factors|endothelial growth factors|mesh-list
102161406|NCT00946712|Antibodies|antibodies|mesh-list
102161407|NCT00946712|Immunoglobulins|immunoglobulins|mesh-list
102161408|NCT00946712|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102161409|NCT00946712|Immunoglobulin G|immunoglobulin g|mesh-list
102161410|NCT00946712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102161411|NCT00946712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102161412|NCT00946712|Tubulin Modulators|tubulin modulators|mesh-ancestor
102161413|NCT00946712|Antimitotic Agents|antimitotic agents|mesh-ancestor
102161414|NCT00946712|Mitosis Modulators|mitosis modulators|mesh-ancestor
102161415|NCT00946712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161416|NCT00946712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102161417|NCT00946712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102161418|NCT00946712|Growth Substances|growth substances|mesh-ancestor
102161419|NCT00946712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161420|NCT00946712|Growth Inhibitors|growth inhibitors|mesh-ancestor
102161421|NCT00946712|Immunologic Factors|immunologic factors|mesh-ancestor
102161423|NCT00656669|Cyclophosphamide|cyclophosphamide|mesh-list
102161424|NCT00656669|Doxorubicin|doxorubicin|mesh-list
102161425|NCT00656669|Sunitinib|sunitinib|mesh-list
102161426|NCT00656669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102161427|NCT00656669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102161428|NCT00656669|Tubulin Modulators|tubulin modulators|mesh-ancestor
102161429|NCT00656669|Antimitotic Agents|antimitotic agents|mesh-ancestor
102161430|NCT00656669|Mitosis Modulators|mitosis modulators|mesh-ancestor
102161431|NCT00656669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161432|NCT00656669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102161433|NCT00656669|Immunologic Factors|immunologic factors|mesh-ancestor
102161434|NCT00656669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161435|NCT00656669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102161436|NCT00656669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102161437|NCT00656669|Alkylating Agents|alkylating agents|mesh-ancestor
102161438|NCT00656669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102161439|NCT00656669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102161440|NCT00656669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102161441|NCT00656669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102161442|NCT00656669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102161443|NCT00656669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102161444|NCT00656669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102161445|NCT00656669|Growth Substances|growth substances|mesh-ancestor
102161446|NCT00656669|Growth Inhibitors|growth inhibitors|mesh-ancestor
102161447|NCT00656669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102161448|NCT00494728|Nicotine|nicotine|mesh-list
102161449|NCT00494728|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102161450|NCT00494728|Autonomic Agents|autonomic agents|mesh-ancestor
102161451|NCT00494728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102161452|NCT00494728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161453|NCT00494728|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102161454|NCT00494728|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102161455|NCT00494728|Cholinergic Agents|cholinergic agents|mesh-ancestor
102161456|NCT00494728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102161457|NCT00494728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161458|NCT00470704|Trastuzumab|trastuzumab|mesh-list
102161459|NCT00470704|Lapatinib|lapatinib|mesh-list
102161460|NCT00470704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102161461|NCT00470704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102161462|NCT00470704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102161463|NCT00470704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102161464|NCT00470704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161466|NCT00412594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102161467|NCT00412594|Cladribine|cladribine|mesh-list
102161468|NCT00412594|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
102161469|NCT00412594|Antibodies|antibodies|mesh-list
102161470|NCT00412594|Immunoglobulins|immunoglobulins|mesh-list
102161471|NCT00412594|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102161472|NCT00412594|Immunologic Factors|immunologic factors|mesh-ancestor
102161473|NCT00412594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161474|NCT00412594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102161475|NCT00412594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102161476|NCT00412594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102161477|NCT00412594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102161478|NCT00412594|Antimetabolites|antimetabolites|mesh-ancestor
102161479|NCT00412594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161480|NCT03829579|Esketamine|esketamine|mesh-list
102161481|NCT03829579|Antidepressive Agents|antidepressive agents|mesh-ancestor
102161482|NCT03829579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102161483|NCT04759339|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102161484|NCT04759339|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102161485|NCT01362296|Docetaxel|docetaxel|mesh-list
102161486|NCT01362296|Trametinib|trametinib|mesh-list
102161487|NCT01362296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102161488|NCT01362296|Tubulin Modulators|tubulin modulators|mesh-ancestor
102161489|NCT01362296|Antimitotic Agents|antimitotic agents|mesh-ancestor
102161490|NCT01362296|Mitosis Modulators|mitosis modulators|mesh-ancestor
102161491|NCT01362296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161492|NCT01362296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102161493|NCT01362296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102161494|NCT01338415|Bosentan|bosentan|mesh-list
102161495|NCT01338415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102161497|NCT01338415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161498|NCT04353128|Melatonin|melatonin|mesh-list
102161499|NCT04353128|Antioxidants|antioxidants|mesh-ancestor
102161500|NCT04353128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161501|NCT04353128|Protective Agents|protective agents|mesh-ancestor
102161502|NCT04353128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161503|NCT04353128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102161504|NCT04263350|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102161505|NCT04263350|Cobicistat|cobicistat|mesh-list
102161506|NCT04263350|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102161507|NCT04263350|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102161508|NCT04263350|Protease Inhibitors|protease inhibitors|mesh-ancestor
102161509|NCT04263350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102161510|NCT04263350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161511|NCT04263350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102161512|NCT04263350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102161513|NCT04263350|Antiviral Agents|antiviral agents|mesh-ancestor
102161514|NCT04263350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102161515|NCT04263350|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102161516|NCT04263350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102161517|NCT03562585|Antibodies|antibodies|mesh-list
102161518|NCT03562585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102161519|NCT03562585|Immunologic Factors|immunologic factors|mesh-ancestor
102161520|NCT03562585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161521|NCT04578535|Immunoglobulins|immunoglobulins|mesh-list
102161522|NCT04578535|Immunologic Factors|immunologic factors|mesh-ancestor
102161523|NCT04578535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161524|NCT05124938|Hormones|hormones|mesh-list
102161525|NCT05124938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102161526|NCT05124938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161527|NCT02259985|Itasetron|itasetron|mesh-list
102161528|NCT02259985|Antiemetics|antiemetics|mesh-ancestor
102161529|NCT02259985|Autonomic Agents|autonomic agents|mesh-ancestor
102161530|NCT02259985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102161531|NCT02259985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161532|NCT02259985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102161533|NCT02259985|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102161534|NCT02259985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102161535|NCT02259985|Serotonin Agents|serotonin agents|mesh-ancestor
102161536|NCT02259985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102161537|NCT02259985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161538|NCT01371643|Octreotide|octreotide|mesh-list
102161539|NCT01371643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102161540|NCT01371643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102161541|NCT01371643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102161542|NCT03023462|Droperidol|droperidol|mesh-list
102161543|NCT03023462|Oxycodone|oxycodone|mesh-list
102161544|NCT03023462|Ondansetron|ondansetron|mesh-list
102161545|NCT03023462|Ropivacaine|ropivacaine|mesh-list
102161546|NCT03023462|Anesthetics, Local|anesthetics, local|mesh-ancestor
102161547|NCT03023462|Anesthetics|anesthetics|mesh-ancestor
102161548|NCT03023462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102161549|NCT03023462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161550|NCT03023462|Sensory System Agents|sensory system agents|mesh-ancestor
102161551|NCT03023462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102161552|NCT03023462|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102161553|NCT03023462|Narcotics|narcotics|mesh-ancestor
102161554|NCT03023462|Analgesics|analgesics|mesh-ancestor
102161555|NCT03023462|Antiemetics|antiemetics|mesh-ancestor
102161556|NCT03023462|Autonomic Agents|autonomic agents|mesh-ancestor
102161557|NCT03023462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102161558|NCT03023462|Antipruritics|antipruritics|mesh-ancestor
102161559|NCT03023462|Dermatologic Agents|dermatologic agents|mesh-ancestor
102161560|NCT03023462|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102161561|NCT03023462|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102161562|NCT03023462|Serotonin Agents|serotonin agents|mesh-ancestor
102161563|NCT03023462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102161564|NCT03023462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161565|NCT03023462|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102161566|NCT03023462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102161567|NCT03023462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102161568|NCT03023462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102161569|NCT03023462|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102161570|NCT03023462|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102161571|NCT03023462|Dopamine Agents|dopamine agents|mesh-ancestor
102161572|NCT02824952|Osimertinib|osimertinib|mesh-list
102161573|NCT02824952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102161574|NCT02824952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102161575|NCT02824952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102161576|NCT02824952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161577|NCT01371565|Mifepristone|mifepristone|mesh-list
102161578|NCT01371565|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102161579|NCT01371565|Abortifacient Agents|abortifacient agents|mesh-ancestor
102161580|NCT01371565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102161581|NCT01371565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161582|NCT01371565|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102161583|NCT01371565|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102161584|NCT01371565|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102161585|NCT01371565|Contraceptive Agents|contraceptive agents|mesh-ancestor
102161586|NCT01371565|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102161587|NCT01371565|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102161588|NCT01371565|Hormone Antagonists|hormone antagonists|mesh-ancestor
102161589|NCT01371565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102161590|NCT01371565|Luteolytic Agents|luteolytic agents|mesh-ancestor
102161591|NCT01371565|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102161592|NCT01371565|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102161593|NCT02821819|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
102161594|NCT02821819|Hormones|hormones|mesh-ancestor
102161595|NCT02821819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102161596|NCT02821819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161597|NCT04500548|Nivolumab|nivolumab|mesh-list
102161598|NCT04500548|Ipilimumab|ipilimumab|mesh-list
102161599|NCT04500548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102161600|NCT04500548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102161601|NCT04500548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102161602|NCT04500548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161603|NCT05707819|Antibodies|antibodies|mesh-list
102161604|NCT05707819|Immunologic Factors|immunologic factors|mesh-ancestor
102161605|NCT05707819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161606|NCT03034538|Zonisamide|zonisamide|mesh-list
102161607|NCT03034538|Anticonvulsants|anticonvulsants|mesh-ancestor
102161608|NCT03034538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102161609|NCT03034538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102161610|NCT03034538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161611|NCT03034538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102161612|NCT03034538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161614|NCT02468180|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102161615|NCT02468180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102161616|NCT01836068|Enfuvirtide|enfuvirtide|mesh-list
102161617|NCT01836068|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102161618|NCT01836068|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102161619|NCT01836068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161620|NCT01836068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102161621|NCT01836068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102161622|NCT01836068|Antiviral Agents|antiviral agents|mesh-ancestor
102161623|NCT01836068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102161624|NCT05053880|Pembrolizumab|pembrolizumab|mesh-list
102161625|NCT05053880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102161626|NCT05053880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102161627|NCT05053880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102161628|NCT05053880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161629|NCT00094016|Beclomethasone|beclomethasone|mesh-list
102161630|NCT00094016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102161631|NCT00094016|Glucocorticoids|glucocorticoids|mesh-ancestor
102161632|NCT00094016|Hormones|hormones|mesh-ancestor
102161633|NCT00094016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102161634|NCT00094016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161635|NCT00094016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102161636|NCT00094016|Respiratory System Agents|respiratory system agents|mesh-ancestor
102161637|NCT05134298|Meropenem|meropenem|mesh-list
102161638|NCT05134298|Tazobactam|tazobactam|mesh-list
102161639|NCT05134298|Piperacillin|piperacillin|mesh-list
102161640|NCT05134298|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102161641|NCT05134298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102161642|NCT05134298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101573971|NCT02199184|Etoposide|etoposide|mesh-list
102161643|NCT05134298|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102161644|NCT05134298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102161645|NCT05134298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161646|NCT05134220|Calcium|calcium|mesh-list
102161647|NCT05134220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102161648|NCT05134220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161649|NCT03562507|Nivolumab|nivolumab|mesh-list
102161650|NCT03562507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102161651|NCT03562507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102161652|NCT03562507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102161653|NCT03562507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161654|NCT03954379|Dexamethasone|dexamethasone|mesh-list
102161655|NCT03954379|Dexamethasone acetate|dexamethasone acetate|mesh-list
102161656|NCT03954379|Analgesics|analgesics|mesh-list
102161657|NCT03954379|Anesthetics|anesthetics|mesh-list
102161658|NCT03954379|Anesthetics, Local|anesthetics, local|mesh-list
102161659|NCT03954379|BB 1101|bb 1101|mesh-list
102161660|NCT03954379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102161661|NCT03954379|Antiemetics|antiemetics|mesh-ancestor
102161662|NCT03954379|Autonomic Agents|autonomic agents|mesh-ancestor
102161663|NCT03954379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102161664|NCT03954379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161665|NCT03954379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102161666|NCT03954379|Glucocorticoids|glucocorticoids|mesh-ancestor
102161667|NCT03954379|Hormones|hormones|mesh-ancestor
102161668|NCT03954379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102161669|NCT03954379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102161670|NCT03954379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102161671|NCT03954379|Protease Inhibitors|protease inhibitors|mesh-ancestor
102161672|NCT03954379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102161673|NCT03954379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161674|NCT03954379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102161675|NCT03954379|Sensory System Agents|sensory system agents|mesh-ancestor
102161676|NCT02036125|Methylprednisolone|methylprednisolone|mesh-list
102161677|NCT02036125|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102161678|NCT02036125|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102161679|NCT02036125|Prednisolone|prednisolone|mesh-list
102161680|NCT02036125|Prednisolone acetate|prednisolone acetate|mesh-list
102161681|NCT02036125|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102161682|NCT02036125|Prednisolone phosphate|prednisolone phosphate|mesh-list
101870509|NCT01148446|Glucocorticoids|glucocorticoids|mesh-ancestor
102161683|NCT02036125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102161685|NCT02036125|Autonomic Agents|autonomic agents|mesh-ancestor
102161686|NCT02036125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102161687|NCT02036125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161688|NCT02036125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102161689|NCT02036125|Glucocorticoids|glucocorticoids|mesh-ancestor
102161690|NCT02036125|Hormones|hormones|mesh-ancestor
102161691|NCT02036125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102161692|NCT02036125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102161693|NCT02036125|Protective Agents|protective agents|mesh-ancestor
102161694|NCT02036125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102161695|NCT02036125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102161696|NCT05133752|Nemonoxacin|nemonoxacin|mesh-list
102161697|NCT05133752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102161698|NCT05133752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102161699|NCT02818777|Cannabidiol|cannabidiol|mesh-list
102161700|NCT02818777|Anticonvulsants|anticonvulsants|mesh-ancestor
102161701|NCT05128916|Terbinafine|terbinafine|mesh-list
102161702|NCT05128916|Antifungal Agents|antifungal agents|mesh-ancestor
102161703|NCT05128916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102161704|NCT05128916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102161705|NCT05128916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161706|NCT05133050|Ramipril|ramipril|mesh-list
102161707|NCT05133050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102161708|NCT05133050|Protease Inhibitors|protease inhibitors|mesh-ancestor
102161709|NCT05133050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102161710|NCT05133050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161711|NCT05133050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102161712|NCT02817841|Drospirenone|drospirenone|mesh-list
102161713|NCT02817841|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102161714|NCT02817841|Hormone Antagonists|hormone antagonists|mesh-ancestor
102161715|NCT02817841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102161716|NCT02817841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161717|NCT02817841|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102161718|NCT02817841|Diuretics|diuretics|mesh-ancestor
102161719|NCT02817841|Natriuretic Agents|natriuretic agents|mesh-ancestor
102161720|NCT05132270|Thalidomide|thalidomide|mesh-list
102161721|NCT05132270|Hydroxyurea|hydroxyurea|mesh-list
102161722|NCT05132270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102161723|NCT05132270|Immunologic Factors|immunologic factors|mesh-ancestor
102161724|NCT05132270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161725|NCT05132270|Leprostatic Agents|leprostatic agents|mesh-ancestor
102161726|NCT05132270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102161727|NCT05132270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102161728|NCT05132270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102161729|NCT05132270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102161730|NCT05132270|Growth Substances|growth substances|mesh-ancestor
102161731|NCT05132270|Growth Inhibitors|growth inhibitors|mesh-ancestor
102161732|NCT05132270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102161733|NCT05132270|Antisickling Agents|antisickling agents|mesh-ancestor
102161734|NCT05132270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102161735|NCT05132270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161736|NCT05132270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102161737|NCT02814565|Cyclobenzaprine|cyclobenzaprine|mesh-list
102161738|NCT02814565|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102161739|NCT02814565|Antidepressive Agents|antidepressive agents|mesh-ancestor
102161740|NCT02814565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102161741|NCT02814565|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102161742|NCT02814565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161743|NCT02814565|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102161744|NCT02814565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102161745|NCT02814565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102161746|NCT02814565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102161748|NCT05121038|Fluorouracil|fluorouracil|mesh-list
102161749|NCT05121038|Oxaliplatin|oxaliplatin|mesh-list
102161750|NCT05121038|Irinotecan|irinotecan|mesh-list
102161751|NCT05121038|Panitumumab|panitumumab|mesh-list
102161752|NCT05121038|Folfirinox|folfirinox|mesh-list
102161753|NCT05121038|Antimetabolites|antimetabolites|mesh-ancestor
102161754|NCT05121038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161755|NCT05121038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102161756|NCT05121038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102161757|NCT05121038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102161758|NCT05121038|Immunologic Factors|immunologic factors|mesh-ancestor
102161759|NCT05121038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161760|NCT05121038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102161761|NCT05121038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102161762|NCT05121038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102161764|NCT05121038|Protective Agents|protective agents|mesh-ancestor
102161765|NCT05121038|Vitamin B Complex|vitamin b complex|mesh-ancestor
102161766|NCT05121038|Vitamins|vitamins|mesh-ancestor
102161767|NCT05121038|Micronutrients|micronutrients|mesh-ancestor
102161768|NCT05121038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102161769|NCT05097794|Indapamide|indapamide|mesh-list
102161770|NCT05097794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102161771|NCT05097794|Diuretics|diuretics|mesh-ancestor
102161772|NCT05097794|Natriuretic Agents|natriuretic agents|mesh-ancestor
102161773|NCT05097794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161774|NCT05097794|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102161775|NCT05097794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102161776|NCT05097794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161777|NCT02036281|Substance P|substance p|mesh-list
102161778|NCT02036281|Neurokinin A|neurokinin a|mesh-list
102161779|NCT02036281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102161780|NCT02036281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161781|NCT02036281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161782|NCT02036359|Docetaxel|docetaxel|mesh-list
102161783|NCT02036359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102161784|NCT02036359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102161785|NCT02036359|Tubulin Modulators|tubulin modulators|mesh-ancestor
102161786|NCT02036359|Antimitotic Agents|antimitotic agents|mesh-ancestor
102161787|NCT02036359|Mitosis Modulators|mitosis modulators|mesh-ancestor
102161788|NCT02036359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161789|NCT02036359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102161790|NCT02036359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102161791|NCT02036437|Misoprostol|misoprostol|mesh-list
102161792|NCT02036437|Dinoprostone|dinoprostone|mesh-list
102161793|NCT02036437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102161794|NCT02036437|Abortifacient Agents|abortifacient agents|mesh-ancestor
102161795|NCT02036437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102161796|NCT02036437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161797|NCT02036437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102161798|NCT02036437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102161799|NCT02036437|Oxytocics|oxytocics|mesh-ancestor
102161800|NCT05027360|Nitroprusside|nitroprusside|mesh-list
102161801|NCT05027360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102161802|NCT05027360|Vasodilator Agents|vasodilator agents|mesh-ancestor
102161803|NCT05027360|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102161804|NCT05027360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161805|NCT02036983|Anesthetics|anesthetics|mesh-list
102161806|NCT02036983|Anesthetics, Local|anesthetics, local|mesh-list
102161807|NCT02036983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102161808|NCT02036983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161809|NCT02036983|Sensory System Agents|sensory system agents|mesh-ancestor
102161810|NCT02036983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102161811|NCT05020652|Hydroxyurea|hydroxyurea|mesh-list
102161812|NCT05020652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102161813|NCT05020652|Antisickling Agents|antisickling agents|mesh-ancestor
102161814|NCT05020652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102161815|NCT05020652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161816|NCT05020652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102161818|NCT05689177|Immunologic Factors|immunologic factors|mesh-ancestor
102161819|NCT05689177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161820|NCT04818320|Favipiravir|favipiravir|mesh-list
102161821|NCT04818320|Antiviral Agents|antiviral agents|mesh-ancestor
102161822|NCT04818320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102161823|NCT02475135|Tenofovir|tenofovir|mesh-list
102161824|NCT02475135|Emtricitabine|emtricitabine|mesh-list
102161825|NCT02475135|Darunavir|darunavir|mesh-list
102161826|NCT02475135|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102161827|NCT02475135|Cobicistat|cobicistat|mesh-list
102161828|NCT02475135|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
102161829|NCT02475135|Elvitegravir|elvitegravir|mesh-list
102161830|NCT02475135|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
102161831|NCT02475135|Antiviral Agents|antiviral agents|mesh-ancestor
101870651|NCT01148992|Lofexidine|lofexidine|mesh-list
102161832|NCT02475135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102161834|NCT02475135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102161835|NCT02475135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102161836|NCT02475135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161837|NCT02475135|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102161838|NCT02475135|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102161839|NCT02475135|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102161840|NCT02475135|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102161841|NCT02475135|Protease Inhibitors|protease inhibitors|mesh-ancestor
102161842|NCT02475135|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102161843|NCT02475135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102161844|NCT02475135|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102161845|NCT05161754|Hemostatics|hemostatics|mesh-list
102161846|NCT05161754|Coagulants|coagulants|mesh-ancestor
102161847|NCT05118620|Bupivacaine|bupivacaine|mesh-list
102161848|NCT05118620|Anesthetics, Local|anesthetics, local|mesh-ancestor
102161849|NCT05118620|Anesthetics|anesthetics|mesh-ancestor
102161850|NCT05118620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102161851|NCT05118620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161852|NCT05118620|Sensory System Agents|sensory system agents|mesh-ancestor
102161853|NCT05118620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102161854|NCT02814643|Benralizumab|benralizumab|mesh-list
102161855|NCT02814643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102161856|NCT02814643|Respiratory System Agents|respiratory system agents|mesh-ancestor
102161857|NCT05080790|Zoledronic Acid|zoledronic acid|mesh-list
102161858|NCT05080790|Interleukin-2|interleukin-2|mesh-list
102161859|NCT05080790|Dinutuximab|dinutuximab|mesh-list
102161860|NCT05080790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102161861|NCT05080790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102161862|NCT05080790|Analgesics|analgesics|mesh-ancestor
102161863|NCT05080790|Sensory System Agents|sensory system agents|mesh-ancestor
102161864|NCT05080790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102161865|NCT05080790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161866|NCT05080790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102161867|NCT02036827|Bromides|bromides|mesh-list
102161868|NCT02036827|Rocuronium|rocuronium|mesh-list
102161869|NCT02036827|Anticonvulsants|anticonvulsants|mesh-ancestor
102161870|NCT02036827|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102161871|NCT02036827|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102161872|NCT02036827|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102161873|NCT02036827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102161874|NCT02036827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161875|NCT02475213|Pembrolizumab|pembrolizumab|mesh-list
102161876|NCT02475213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102161877|NCT02475213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102161878|NCT02475213|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102161879|NCT02475213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161880|NCT05328440|Fulvestrant|fulvestrant|mesh-list
102161881|NCT05328440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102161882|NCT05328440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102161883|NCT05328440|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102161884|NCT05328440|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102161885|NCT05328440|Hormone Antagonists|hormone antagonists|mesh-ancestor
101446011|NCT00575419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102161886|NCT05328440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102161887|NCT05328440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161888|NCT05256056|Bupivacaine|bupivacaine|mesh-list
102161889|NCT05256056|Anesthetics, Local|anesthetics, local|mesh-ancestor
102161890|NCT05256056|Anesthetics|anesthetics|mesh-ancestor
102161891|NCT05256056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102161892|NCT05256056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161893|NCT05256056|Sensory System Agents|sensory system agents|mesh-ancestor
102161894|NCT05256056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102161895|NCT05360511|Epoetin Alfa|epoetin alfa|mesh-list
102161896|NCT05360511|Hematinics|hematinics|mesh-ancestor
102161897|NCT02724111|Rocuronium|rocuronium|mesh-list
102161898|NCT02724111|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102161899|NCT02724111|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102161900|NCT02724111|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102161901|NCT02724111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102161902|NCT02724111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161903|NCT02480751|Beraprost|beraprost|mesh-list
102161904|NCT02480751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102161905|NCT02480751|Vasodilator Agents|vasodilator agents|mesh-ancestor
102161906|NCT04227314|Apremilast|apremilast|mesh-list
102161907|NCT04227314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102161909|NCT04227314|Analgesics|analgesics|mesh-ancestor
102161910|NCT04227314|Sensory System Agents|sensory system agents|mesh-ancestor
102161911|NCT04227314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102161912|NCT04227314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161913|NCT04227314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102161914|NCT04227314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102161915|NCT04227314|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102161916|NCT04227314|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102161917|NCT04227314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102161918|NCT04227314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161919|NCT04223648|Nivolumab|nivolumab|mesh-list
102161920|NCT04223648|Ipilimumab|ipilimumab|mesh-list
102161921|NCT04223648|Durvalumab|durvalumab|mesh-list
102161922|NCT04223648|Tremelimumab|tremelimumab|mesh-list
102161923|NCT04223648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102161924|NCT04223648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102161925|NCT04223648|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102161926|NCT04223648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161927|NCT02814175|Adalimumab|adalimumab|mesh-list
102161928|NCT02814175|Methotrexate|methotrexate|mesh-list
102161929|NCT02814175|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102161930|NCT02814175|Abortifacient Agents|abortifacient agents|mesh-ancestor
102161931|NCT02814175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102161932|NCT02814175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161933|NCT02814175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102161934|NCT02814175|Antimetabolites|antimetabolites|mesh-ancestor
102161935|NCT02814175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161936|NCT02814175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102161937|NCT02814175|Dermatologic Agents|dermatologic agents|mesh-ancestor
102161938|NCT02814175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102161939|NCT02814175|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102161940|NCT02814175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102161941|NCT02814175|Immunologic Factors|immunologic factors|mesh-ancestor
102161942|NCT02814175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102161943|NCT02814175|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102161944|NCT02814175|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102161945|NCT02814175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102161947|NCT02475057|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
102161948|NCT02475057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102161949|NCT02475057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161950|NCT02474667|Mitogens|mitogens|mesh-list
102161951|NCT02474667|Mitosis Modulators|mitosis modulators|mesh-ancestor
102161952|NCT02474667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161953|NCT03096080|XL647|xl647|mesh-list
102161954|NCT03096080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102161955|NCT03096080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102161956|NCT03096080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102161957|NCT03096080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161958|NCT01335997|Niacin|niacin|mesh-list
102161959|NCT01335997|Niacinamide|niacinamide|mesh-list
102161960|NCT01335997|Nicotinic Acids|nicotinic acids|mesh-list
102161961|NCT01335997|Simvastatin|simvastatin|mesh-list
102161962|NCT01335997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102161963|NCT01335997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102161964|NCT01335997|Antimetabolites|antimetabolites|mesh-ancestor
102161965|NCT01335997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161966|NCT01335997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102161967|NCT01335997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102161968|NCT01335997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102161969|NCT01335997|Vasodilator Agents|vasodilator agents|mesh-ancestor
102161970|NCT01335997|Vitamin B Complex|vitamin b complex|mesh-ancestor
102161971|NCT01335997|Vitamins|vitamins|mesh-ancestor
102161972|NCT01335997|Micronutrients|micronutrients|mesh-ancestor
102161973|NCT01335997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161974|NCT02048215|Ephedrine|ephedrine|mesh-list
102161975|NCT02048215|Caffeine|caffeine|mesh-list
102161976|NCT02048215|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102161977|NCT02048215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161978|NCT02048215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102161979|NCT02048215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101870794|NCT01150786|Antioxidants|antioxidants|mesh-ancestor
102161980|NCT02048215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161981|NCT02048215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102161982|NCT02048215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102161983|NCT02048215|Purinergic Agents|purinergic agents|mesh-ancestor
102161984|NCT02048215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102161986|NCT02048215|Autonomic Agents|autonomic agents|mesh-ancestor
102161987|NCT02048215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102161988|NCT02048215|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102161989|NCT02048215|Adrenergic Agents|adrenergic agents|mesh-ancestor
102161990|NCT04849832|Fesoterodine|fesoterodine|mesh-list
102161991|NCT04849832|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102161992|NCT04849832|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102161993|NCT04849832|Cholinergic Agents|cholinergic agents|mesh-ancestor
102161994|NCT04849832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102161995|NCT04849832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102161996|NCT04849832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102161997|NCT04849832|Urological Agents|urological agents|mesh-ancestor
102161998|NCT02048293|Remifentanil|remifentanil|mesh-list
102161999|NCT02048293|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102162000|NCT02048293|Narcotics|narcotics|mesh-ancestor
102162001|NCT02048293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102162002|NCT02048293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162003|NCT02048293|Analgesics|analgesics|mesh-ancestor
102162004|NCT02048293|Sensory System Agents|sensory system agents|mesh-ancestor
102162005|NCT02048293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102162006|NCT02050009|Metformin|metformin|mesh-list
102162007|NCT02050009|Paclitaxel|paclitaxel|mesh-list
102162008|NCT02050009|Carboplatin|carboplatin|mesh-list
102162009|NCT02050009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102162010|NCT02050009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102162011|NCT02050009|Tubulin Modulators|tubulin modulators|mesh-ancestor
102162012|NCT02050009|Antimitotic Agents|antimitotic agents|mesh-ancestor
102162013|NCT02050009|Mitosis Modulators|mitosis modulators|mesh-ancestor
102162014|NCT02050009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162015|NCT02050009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102162016|NCT02050009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162018|NCT04495088|Folic Acid|folic acid|mesh-list
102162019|NCT04495088|Capecitabine|capecitabine|mesh-list
102162020|NCT04495088|Fluorouracil|fluorouracil|mesh-list
102162021|NCT04495088|Oxaliplatin|oxaliplatin|mesh-list
102162022|NCT04495088|Levoleucovorin|levoleucovorin|mesh-list
102162023|NCT04495088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102162024|NCT04495088|Antimetabolites|antimetabolites|mesh-ancestor
102162025|NCT04495088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162026|NCT04495088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102162027|NCT04495088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102162028|NCT04495088|Immunologic Factors|immunologic factors|mesh-ancestor
102162029|NCT04495088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162030|NCT04495088|Antidotes|antidotes|mesh-ancestor
102162031|NCT04495088|Protective Agents|protective agents|mesh-ancestor
102162032|NCT04495088|Vitamin B Complex|vitamin b complex|mesh-ancestor
102162033|NCT04495088|Vitamins|vitamins|mesh-ancestor
102162034|NCT04495088|Micronutrients|micronutrients|mesh-ancestor
102162035|NCT04495088|Hematinics|hematinics|mesh-ancestor
102162036|NCT04717154|Nivolumab|nivolumab|mesh-list
102162037|NCT04717154|Ipilimumab|ipilimumab|mesh-list
102162038|NCT04717154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102162039|NCT04717154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102162040|NCT04717154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102162041|NCT04717154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162042|NCT02474511|Anesthetics|anesthetics|mesh-list
102162043|NCT02474511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102162044|NCT02474511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162045|NCT03108963|Metformin|metformin|mesh-list
102162046|NCT03108963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102162047|NCT03108963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162048|NCT04697654|Hydroxychloroquine|hydroxychloroquine|mesh-list
102162049|NCT04697654|Antimalarials|antimalarials|mesh-ancestor
102162050|NCT04697654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102162051|NCT04697654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102162052|NCT04697654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102162053|NCT04697654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102162054|NCT04697654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162055|NCT04697654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102162056|NCT02474433|Misoprostol|misoprostol|mesh-list
102162057|NCT02474433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102162058|NCT02474433|Abortifacient Agents|abortifacient agents|mesh-ancestor
102162059|NCT02474433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102162060|NCT02474433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162061|NCT02474433|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102162062|NCT02474433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102162063|NCT02474433|Oxytocics|oxytocics|mesh-ancestor
102162064|NCT04812002|Bevacizumab|bevacizumab|mesh-list
102162065|NCT04812002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102162066|NCT04812002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102162067|NCT04812002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102162068|NCT04812002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102162069|NCT04812002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102162070|NCT04812002|Growth Substances|growth substances|mesh-ancestor
102162071|NCT04812002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162072|NCT04812002|Growth Inhibitors|growth inhibitors|mesh-ancestor
102162073|NCT04812002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162074|NCT03424460|Hemostatics|hemostatics|mesh-list
102162075|NCT03424460|Coagulants|coagulants|mesh-ancestor
102162076|NCT05712837|Salicylic Acid|salicylic acid|mesh-list
102162077|NCT05712837|Salicylates|salicylates|mesh-list
102162078|NCT05712837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102162079|NCT05712837|Antifungal Agents|antifungal agents|mesh-ancestor
102162080|NCT05712837|Keratolytic Agents|keratolytic agents|mesh-ancestor
102162081|NCT05712837|Dermatologic Agents|dermatologic agents|mesh-ancestor
102162082|NCT05712837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102162083|NCT05712837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102162084|NCT05712837|Analgesics|analgesics|mesh-ancestor
102162085|NCT05712837|Sensory System Agents|sensory system agents|mesh-ancestor
102162086|NCT05712837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102162087|NCT05712837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162088|NCT05712837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102162089|NCT05712837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102162090|NCT05712837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102162091|NCT05712837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101573972|NCT02199184|Vincristine|vincristine|mesh-list
102162092|NCT05712837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162093|NCT02472249|Norepinephrine|norepinephrine|mesh-list
102162094|NCT02472249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102162095|NCT02472249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102162096|NCT02472249|Adrenergic Agents|adrenergic agents|mesh-ancestor
102162097|NCT02472249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102162098|NCT02472249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162099|NCT02472249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162100|NCT02472249|Sympathomimetics|sympathomimetics|mesh-ancestor
102162101|NCT02472249|Autonomic Agents|autonomic agents|mesh-ancestor
102162102|NCT02472249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102162103|NCT02472249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102162104|NCT02313194|Buspirone|buspirone|mesh-list
102162105|NCT02313194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102162106|NCT02313194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102162107|NCT02313194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102162108|NCT02313194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162109|NCT02313194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102162110|NCT02313194|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102162111|NCT02313194|Serotonin Agents|serotonin agents|mesh-ancestor
102162112|NCT02313194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102162113|NCT02313194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162114|NCT04435652|Paclitaxel|paclitaxel|mesh-list
102162115|NCT04435652|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102162116|NCT04435652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102162117|NCT04435652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102162118|NCT04435652|Tubulin Modulators|tubulin modulators|mesh-ancestor
102162119|NCT04435652|Antimitotic Agents|antimitotic agents|mesh-ancestor
102162120|NCT04435652|Mitosis Modulators|mitosis modulators|mesh-ancestor
102162121|NCT04435652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162122|NCT02473887|Ondansetron|ondansetron|mesh-list
102162123|NCT02473887|Antiemetics|antiemetics|mesh-ancestor
102162124|NCT02473887|Autonomic Agents|autonomic agents|mesh-ancestor
102162125|NCT02473887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102162126|NCT02473887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162127|NCT02473887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102162128|NCT02473887|Antipruritics|antipruritics|mesh-ancestor
102162129|NCT02473887|Dermatologic Agents|dermatologic agents|mesh-ancestor
102162130|NCT02473887|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102162131|NCT02473887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102162132|NCT02473887|Serotonin Agents|serotonin agents|mesh-ancestor
102162133|NCT02473887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102162134|NCT02473887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162135|NCT02478021|Hydrocortisone|hydrocortisone|mesh-list
102162136|NCT02478021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102162137|NCT00071552|Fluticasone|fluticasone|mesh-list
102162138|NCT00071552|Xhance|xhance|mesh-list
102162139|NCT00071552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102162140|NCT00071552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102162141|NCT00071552|Autonomic Agents|autonomic agents|mesh-ancestor
102162142|NCT00071552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102162143|NCT00071552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162144|NCT00071552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102162145|NCT00071552|Respiratory System Agents|respiratory system agents|mesh-ancestor
102162146|NCT00071552|Dermatologic Agents|dermatologic agents|mesh-ancestor
102162147|NCT00071552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102162148|NCT05164263|Empagliflozin|empagliflozin|mesh-list
102162149|NCT05164263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102162150|NCT05164263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162151|NCT05164263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102162152|NCT05164263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162153|NCT04767711|Prednisolone|prednisolone|mesh-list
102162154|NCT04767711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102162155|NCT04767711|Glucocorticoids|glucocorticoids|mesh-ancestor
102162156|NCT04767711|Hormones|hormones|mesh-ancestor
101446046|NCT00575614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102162157|NCT04767711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102162158|NCT04767711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162159|NCT04767711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102162160|NCT04767711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102162161|NCT02473809|Liraglutide|liraglutide|mesh-list
102162162|NCT02473809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102162163|NCT02473809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162164|NCT02473809|Incretins|incretins|mesh-ancestor
102162165|NCT02473809|Hormones|hormones|mesh-ancestor
102162166|NCT02473809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102162167|NCT03976934|Tamsulosin|tamsulosin|mesh-list
102162168|NCT03976934|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102162169|NCT03976934|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102162170|NCT03976934|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102162171|NCT03976934|Adrenergic Agents|adrenergic agents|mesh-ancestor
102162172|NCT03976934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102162173|NCT03976934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162174|NCT03976934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162175|NCT03976934|Urological Agents|urological agents|mesh-ancestor
102162176|NCT02416180|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102162177|NCT02416180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102162178|NCT02416180|Autonomic Agents|autonomic agents|mesh-ancestor
102162179|NCT02416180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102162180|NCT02416180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162181|NCT02416180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102162182|NCT02416180|Respiratory System Agents|respiratory system agents|mesh-ancestor
102162183|NCT02416180|Glucocorticoids|glucocorticoids|mesh-ancestor
102162184|NCT02416180|Hormones|hormones|mesh-ancestor
102162185|NCT02416180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102162186|NCT02416180|Sympathomimetics|sympathomimetics|mesh-ancestor
102162187|NCT02473575|Caffeine|caffeine|mesh-list
102162188|NCT02473575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102162189|NCT02473575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162190|NCT02473575|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102162191|NCT02473575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102162192|NCT02473575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162193|NCT02473575|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102162194|NCT02473575|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102162195|NCT02473575|Purinergic Agents|purinergic agents|mesh-ancestor
102162196|NCT02473575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102162197|NCT03770546|Betamethasone|betamethasone|mesh-list
102162198|NCT03770546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102162199|NCT03770546|Glucocorticoids|glucocorticoids|mesh-ancestor
102162200|NCT03770546|Hormones|hormones|mesh-ancestor
102162201|NCT03770546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102162202|NCT03770546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162203|NCT03770546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102162204|NCT03770546|Respiratory System Agents|respiratory system agents|mesh-ancestor
102162206|NCT05341323|Bupivacaine|bupivacaine|mesh-list
102162207|NCT05341323|Anesthetics, Local|anesthetics, local|mesh-ancestor
102162208|NCT05341323|Anesthetics|anesthetics|mesh-ancestor
102162209|NCT05341323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102162210|NCT05341323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162211|NCT05341323|Sensory System Agents|sensory system agents|mesh-ancestor
102162212|NCT05341323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102162213|NCT05341323|Analgesics|analgesics|mesh-ancestor
102162214|NCT05341323|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102162215|NCT05341323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102162216|NCT05341323|Anesthetics, General|anesthetics, general|mesh-ancestor
102162217|NCT05341323|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102162218|NCT05341323|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102162219|NCT05341323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102162220|NCT05341323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162221|NCT04622865|Quercetin|quercetin|mesh-list
102162222|NCT04622865|Antioxidants|antioxidants|mesh-ancestor
102162223|NCT04622865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162224|NCT04622865|Protective Agents|protective agents|mesh-ancestor
102162225|NCT04622865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162226|NCT02473185|Methylphenidate|methylphenidate|mesh-list
102162227|NCT02473185|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102162228|NCT02473185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162229|NCT02473185|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102162230|NCT02473185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102162231|NCT02473185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102162232|NCT02473185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162233|NCT02473185|Dopamine Agents|dopamine agents|mesh-ancestor
102162234|NCT02473185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102162235|NCT02445586|Docetaxel|docetaxel|mesh-list
102162236|NCT02445586|Trastuzumab|trastuzumab|mesh-list
102162237|NCT02445586|Pertuzumab|pertuzumab|mesh-list
102162238|NCT02445586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102162239|NCT02445586|Tubulin Modulators|tubulin modulators|mesh-ancestor
102162240|NCT02445586|Antimitotic Agents|antimitotic agents|mesh-ancestor
102162241|NCT02445586|Mitosis Modulators|mitosis modulators|mesh-ancestor
102162242|NCT02445586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162243|NCT02445586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102162245|NCT02471547|Mitomycin|mitomycin|mesh-list
102162246|NCT02471547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102162247|NCT02471547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102162248|NCT02471547|Alkylating Agents|alkylating agents|mesh-ancestor
102162249|NCT02471547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162250|NCT02471547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102162251|NCT02471547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102162252|NCT02477631|Deferiprone|deferiprone|mesh-list
102162253|NCT02477631|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102162254|NCT02477631|Chelating Agents|chelating agents|mesh-ancestor
102162255|NCT02477631|Sequestering Agents|sequestering agents|mesh-ancestor
102162256|NCT02477631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162257|NCT01674062|Trastuzumab|trastuzumab|mesh-list
102162258|NCT01674062|Pertuzumab|pertuzumab|mesh-list
102162259|NCT01674062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102162260|NCT01674062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102162261|NCT02472873|Ethanol|ethanol|mesh-list
102162262|NCT02472873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102162263|NCT02472873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102162264|NCT02472873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102162265|NCT02472873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162266|NCT02472886|Sofosbuvir|sofosbuvir|mesh-list
102162267|NCT02472886|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102162268|NCT02472886|Ledipasvir|ledipasvir|mesh-list
102162269|NCT02472886|Antiviral Agents|antiviral agents|mesh-ancestor
102162270|NCT02472886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102162271|NCT04570839|Nivolumab|nivolumab|mesh-list
102162272|NCT04570839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102162273|NCT04570839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102162274|NCT04570839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102162275|NCT04570839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162276|NCT05283356|Ticagrelor|ticagrelor|mesh-list
102162277|NCT05283356|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102162278|NCT05283356|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102162279|NCT05283356|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102162280|NCT05283356|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102162281|NCT05283356|Purinergic Agents|purinergic agents|mesh-ancestor
102162282|NCT05283356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102162283|NCT05283356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162284|NCT05283356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162285|NCT02472652|Aripiprazole|aripiprazole|mesh-list
102162286|NCT02472652|Antidepressive Agents|antidepressive agents|mesh-ancestor
102162287|NCT02472652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102162288|NCT02472652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102162289|NCT02472652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102162290|NCT02472652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102162291|NCT02472652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162292|NCT02472652|Dopamine Agonists|dopamine agonists|mesh-ancestor
102162293|NCT02472652|Dopamine Agents|dopamine agents|mesh-ancestor
102162294|NCT02472652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102162295|NCT02472652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162296|NCT02472652|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102162297|NCT02472652|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102162298|NCT02472652|Serotonin Agents|serotonin agents|mesh-ancestor
102162299|NCT02472652|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102162300|NCT02472652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102162301|NCT02472652|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102162302|NCT02472652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102162303|NCT05243186|Methylphenidate|methylphenidate|mesh-list
102162304|NCT05243186|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102162305|NCT05243186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162306|NCT05243186|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102162307|NCT05243186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102162308|NCT05243186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102162309|NCT05243186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162310|NCT05243186|Dopamine Agents|dopamine agents|mesh-ancestor
102162311|NCT05243186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102162312|NCT02808182|Niacin|niacin|mesh-list
102162313|NCT02808182|Nicotinic Acids|nicotinic acids|mesh-list
102162314|NCT02808182|Niacinamide|niacinamide|mesh-list
102162315|NCT02808182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102162316|NCT02808182|Antimetabolites|antimetabolites|mesh-ancestor
102162317|NCT02808182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162318|NCT02808182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102162319|NCT02808182|Vasodilator Agents|vasodilator agents|mesh-ancestor
102162320|NCT02808182|Vitamin B Complex|vitamin b complex|mesh-ancestor
102162321|NCT02808182|Vitamins|vitamins|mesh-ancestor
102162322|NCT02808182|Micronutrients|micronutrients|mesh-ancestor
102162323|NCT02808182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162324|NCT04695704|Montelukast|montelukast|mesh-list
102162325|NCT04695704|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102162326|NCT04695704|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102162327|NCT04695704|Respiratory System Agents|respiratory system agents|mesh-ancestor
102162328|NCT04695704|Hormone Antagonists|hormone antagonists|mesh-ancestor
102162329|NCT04695704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102162330|NCT04695704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162331|NCT04695704|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102162332|NCT04695704|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102162333|NCT04695704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162334|NCT02051569|Tryptophan|tryptophan|mesh-list
102162335|NCT02051569|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102162336|NCT02051569|Antidepressive Agents|antidepressive agents|mesh-ancestor
102162337|NCT02051569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102162338|NCT02591420|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102162339|NCT02591420|Antiviral Agents|antiviral agents|mesh-ancestor
102162340|NCT02591420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102162341|NCT05217758|Mifepristone|mifepristone|mesh-list
102162342|NCT05217758|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102162343|NCT05217758|Abortifacient Agents|abortifacient agents|mesh-ancestor
102162344|NCT05217758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102162345|NCT05217758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162346|NCT05217758|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102162347|NCT05217758|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102162348|NCT05217758|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102162349|NCT05217758|Contraceptive Agents|contraceptive agents|mesh-ancestor
102162350|NCT05217758|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101871169|NCT00255840|Nevirapine|nevirapine|mesh-list
102162351|NCT05217758|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102162352|NCT05217758|Hormone Antagonists|hormone antagonists|mesh-ancestor
102162353|NCT05217758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102162354|NCT05217758|Luteolytic Agents|luteolytic agents|mesh-ancestor
102162355|NCT05217758|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102162356|NCT05217758|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102162357|NCT02051023|Fluorometholone|fluorometholone|mesh-list
102162358|NCT02051023|Lubricant Eye Drops|lubricant eye drops|mesh-list
102162359|NCT02051023|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102162360|NCT02051023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101446061|NCT00576238|Hormones|hormones|mesh-ancestor
102162361|NCT02051023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102162362|NCT02051023|Glucocorticoids|glucocorticoids|mesh-ancestor
102162363|NCT02051023|Hormones|hormones|mesh-ancestor
102162364|NCT02051023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102162365|NCT02051023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162366|NCT02051023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102162367|NCT02415556|Insulin|insulin|mesh-list
102162368|NCT02415556|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102162369|NCT02415556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102162370|NCT02415556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162371|NCT05192798|Paclitaxel|paclitaxel|mesh-list
102162372|NCT05192798|Bevacizumab|bevacizumab|mesh-list
102162373|NCT05192798|Apatinib|apatinib|mesh-list
102162374|NCT05192798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102162375|NCT05192798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102162376|NCT05192798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102162377|NCT05192798|Tubulin Modulators|tubulin modulators|mesh-ancestor
102162378|NCT05192798|Antimitotic Agents|antimitotic agents|mesh-ancestor
102162379|NCT05192798|Mitosis Modulators|mitosis modulators|mesh-ancestor
102162380|NCT05192798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162381|NCT05192798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102162382|NCT05192798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102162383|NCT05192798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102162384|NCT05192798|Growth Substances|growth substances|mesh-ancestor
102162385|NCT05192798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162386|NCT05192798|Growth Inhibitors|growth inhibitors|mesh-ancestor
102162387|NCT05192798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102162388|NCT05192798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102162389|NCT02048683|Sevoflurane|sevoflurane|mesh-list
102162390|NCT02048683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102162391|NCT02048683|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102162392|NCT02048683|Anesthetics, General|anesthetics, general|mesh-ancestor
102162393|NCT02048683|Anesthetics|anesthetics|mesh-ancestor
102162394|NCT02048683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102162395|NCT02048683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162396|NCT03108807|Fibrin fragment D|fibrin fragment d|mesh-list
102162397|NCT03108807|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102162398|NCT03108807|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102162399|NCT03108807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162400|NCT03108807|Hemostatics|hemostatics|mesh-ancestor
102162401|NCT03108807|Coagulants|coagulants|mesh-ancestor
102162402|NCT02048761|Metformin|metformin|mesh-list
102162403|NCT02048761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102162404|NCT02048761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162405|NCT03108729|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102162406|NCT03108729|Anticonvulsants|anticonvulsants|mesh-ancestor
102162407|NCT03108729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102162408|NCT03108729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102162409|NCT03108729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102162410|NCT03108729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162411|NCT02048917|Bupropion|bupropion|mesh-list
102162412|NCT02048917|Varenicline|varenicline|mesh-list
102162413|NCT02048917|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102162414|NCT02048917|Antidepressive Agents|antidepressive agents|mesh-ancestor
102162415|NCT02048917|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102162416|NCT02048917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102162417|NCT02048917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102162418|NCT02048917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102162419|NCT02048917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162420|NCT02048917|Dopamine Agents|dopamine agents|mesh-ancestor
102162421|NCT02048917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102162422|NCT02048917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162423|NCT02048917|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101871246|NCT00186186|GABA Agents|gaba agents|mesh-ancestor
102162424|NCT02048917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102162425|NCT02048917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102162426|NCT02048917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102162427|NCT02048917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102162428|NCT02048917|Cholinergic Agents|cholinergic agents|mesh-ancestor
102162429|NCT02472717|Liraglutide|liraglutide|mesh-list
102162430|NCT02472717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102162431|NCT02472717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162432|NCT02472717|Incretins|incretins|mesh-ancestor
102162433|NCT02472717|Hormones|hormones|mesh-ancestor
102162434|NCT02472717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102162435|NCT02049073|Methylprednisolone|methylprednisolone|mesh-list
102162436|NCT02049073|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102162437|NCT02049073|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102162438|NCT02049073|Prednisolone|prednisolone|mesh-list
102162439|NCT02049073|Prednisolone acetate|prednisolone acetate|mesh-list
102162440|NCT02049073|Zonisamide|zonisamide|mesh-list
102162441|NCT02049073|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102162442|NCT02049073|Prednisolone phosphate|prednisolone phosphate|mesh-list
102162443|NCT02049073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102162444|NCT02049073|Antiemetics|antiemetics|mesh-ancestor
102162445|NCT02049073|Autonomic Agents|autonomic agents|mesh-ancestor
102162446|NCT02049073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102162447|NCT02049073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162448|NCT02049073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102162449|NCT02049073|Glucocorticoids|glucocorticoids|mesh-ancestor
102162450|NCT02049073|Hormones|hormones|mesh-ancestor
102162451|NCT02049073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102162452|NCT02049073|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102162453|NCT02049073|Protective Agents|protective agents|mesh-ancestor
102162454|NCT02049073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102162455|NCT02049073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102162456|NCT02049073|Anticonvulsants|anticonvulsants|mesh-ancestor
102162457|NCT02049073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102162458|NCT02049073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102162459|NCT02049073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162460|NCT02049073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102162461|NCT04518345|Azacitidine|azacitidine|mesh-list
102162462|NCT04518345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102162463|NCT04518345|Antimetabolites|antimetabolites|mesh-ancestor
102162464|NCT04518345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162465|NCT04518345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102162466|NCT04518345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102162467|NCT02260063|Epinastine|epinastine|mesh-list
102162468|NCT02260063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102162469|NCT02260063|Histamine Antagonists|histamine antagonists|mesh-ancestor
102162470|NCT02260063|Histamine Agents|histamine agents|mesh-ancestor
102162471|NCT02260063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102162472|NCT02260063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162473|NCT02260063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162474|NCT04398914|Paclitaxel|paclitaxel|mesh-list
102162475|NCT04398914|Trastuzumab|trastuzumab|mesh-list
102162476|NCT04398914|Pertuzumab|pertuzumab|mesh-list
102162477|NCT04398914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102162478|NCT04398914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102162479|NCT04398914|Tubulin Modulators|tubulin modulators|mesh-ancestor
102162480|NCT04398914|Antimitotic Agents|antimitotic agents|mesh-ancestor
102162481|NCT04398914|Mitosis Modulators|mitosis modulators|mesh-ancestor
102162482|NCT04398914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162483|NCT04398914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102162484|NCT03561649|Adalimumab|adalimumab|mesh-list
102162485|NCT03561649|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102162486|NCT03561649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102162487|NCT03561649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102162488|NCT02807623|Ibuprofen|ibuprofen|mesh-list
102162489|NCT02807623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102162490|NCT02807623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102162491|NCT02807623|Analgesics|analgesics|mesh-ancestor
102162492|NCT02807623|Sensory System Agents|sensory system agents|mesh-ancestor
102162493|NCT02807623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102162494|NCT02807623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162495|NCT02807623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102162496|NCT02807623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102162497|NCT02807623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102162498|NCT02807623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101446066|NCT00576394|Insulin|insulin|mesh-list
102162499|NCT02807623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162500|NCT05137964|Vitamin D|vitamin d|mesh-list
102162501|NCT05137964|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
102162502|NCT05137964|Vitamins|vitamins|mesh-ancestor
102162503|NCT05137964|Micronutrients|micronutrients|mesh-ancestor
102162504|NCT05137964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162505|NCT05137964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102162506|NCT04374578|Dulaglutide|dulaglutide|mesh-list
102162507|NCT04374578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102162508|NCT04374578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162509|NCT02470923|Nicotine|nicotine|mesh-list
102162510|NCT02470923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102162511|NCT02470923|Autonomic Agents|autonomic agents|mesh-ancestor
102162512|NCT02470923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102162513|NCT02470923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162515|NCT02470923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102162516|NCT02470923|Cholinergic Agents|cholinergic agents|mesh-ancestor
102162517|NCT02470923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102162518|NCT02470923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162519|NCT02049229|Everolimus|everolimus|mesh-list
102162520|NCT02049229|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102162521|NCT02049229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102162522|NCT02049229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102162523|NCT02049229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162524|NCT02049229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102162525|NCT02049229|Immunologic Factors|immunologic factors|mesh-ancestor
102162526|NCT02049229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162527|NCT02049229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102162528|NCT02805907|Calcifediol|calcifediol|mesh-list
102162529|NCT02805907|Vitamins|vitamins|mesh-ancestor
102162530|NCT02805907|Micronutrients|micronutrients|mesh-ancestor
102162531|NCT02805907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162532|NCT02805907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102162533|NCT02477397|Fluticasone|fluticasone|mesh-list
102162535|NCT02477397|Budesonide|budesonide|mesh-list
102162536|NCT02477397|Formoterol Fumarate|formoterol fumarate|mesh-list
102162537|NCT02477397|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102162538|NCT02477397|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102162539|NCT02477397|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
102162540|NCT02477397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102162541|NCT02477397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102162542|NCT02477397|Autonomic Agents|autonomic agents|mesh-ancestor
102162543|NCT02477397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102162544|NCT02477397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162545|NCT02477397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102162546|NCT02477397|Respiratory System Agents|respiratory system agents|mesh-ancestor
102162547|NCT02477397|Dermatologic Agents|dermatologic agents|mesh-ancestor
102162548|NCT02477397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102162549|NCT02477397|Glucocorticoids|glucocorticoids|mesh-ancestor
102162550|NCT02477397|Hormones|hormones|mesh-ancestor
102162551|NCT02477397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102162552|NCT02477397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102162553|NCT02477397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102162554|NCT02477397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102162555|NCT02477397|Adrenergic Agents|adrenergic agents|mesh-ancestor
102162556|NCT02477397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102162557|NCT02477397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162558|NCT02477397|Sympathomimetics|sympathomimetics|mesh-ancestor
102162559|NCT02051413|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102162560|NCT02051413|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102162561|NCT02051413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102162562|NCT02051413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102162563|NCT02051413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162564|NCT02051413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102162565|NCT02051413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162566|NCT02051413|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102162567|NCT02051413|Antidepressive Agents|antidepressive agents|mesh-ancestor
102162568|NCT02051413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102162569|NCT02470767|Anticoagulants|anticoagulants|mesh-list
102162570|NCT02049541|Rituximab|rituximab|mesh-list
101446073|NCT00576433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102162571|NCT02049541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101871420|NCT01261156|Diltiazem|diltiazem|mesh-list
102162572|NCT02049541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102162574|NCT02049541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162575|NCT02049541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102162576|NCT02470611|Alendronate|alendronate|mesh-list
102162577|NCT02470611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102162578|NCT02470611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162579|NCT05305898|Metformin|metformin|mesh-list
102162580|NCT05305898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102162581|NCT05305898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162582|NCT05580861|Sulfasalazine|sulfasalazine|mesh-list
102162583|NCT05580861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102162584|NCT05580861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102162585|NCT05580861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102162586|NCT05580861|Analgesics|analgesics|mesh-ancestor
102162587|NCT05580861|Sensory System Agents|sensory system agents|mesh-ancestor
102162588|NCT05580861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102162589|NCT05580861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162590|NCT05580861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102162591|NCT05580861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102162592|NCT05580861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102162593|NCT02469831|Rocuronium|rocuronium|mesh-list
102162594|NCT02469831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102162595|NCT02469831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102162596|NCT02469831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102162597|NCT02469831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102162598|NCT02469831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162599|NCT02995005|Tenofovir|tenofovir|mesh-list
102162600|NCT02995005|Antiviral Agents|antiviral agents|mesh-ancestor
102162601|NCT02995005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102162602|NCT02995005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102162603|NCT02995005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102162604|NCT02995005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102162605|NCT02995005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162606|NCT02995005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102162607|NCT02995005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102162608|NCT03561415|Posaconazole|posaconazole|mesh-list
102162609|NCT03561415|Antifungal Agents|antifungal agents|mesh-ancestor
102162610|NCT03561415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102162611|NCT03561415|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102162612|NCT03561415|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102162613|NCT03561415|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102162614|NCT03561415|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102162615|NCT03561415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102162616|NCT03561415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102162617|NCT03561415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162618|NCT03561415|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102162619|NCT03561415|Hormone Antagonists|hormone antagonists|mesh-ancestor
102162620|NCT03561415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102162621|NCT03561415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162622|NCT02477007|Acetaminophen|acetaminophen|mesh-list
102162623|NCT02477007|Ibuprofen|ibuprofen|mesh-list
102162624|NCT02477007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102162625|NCT02477007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102162626|NCT02477007|Analgesics|analgesics|mesh-ancestor
102162627|NCT02477007|Sensory System Agents|sensory system agents|mesh-ancestor
102162628|NCT02477007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102162629|NCT02477007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162630|NCT02477007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102162631|NCT02477007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102162632|NCT02477007|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102162633|NCT02477007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102162634|NCT02477007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162635|NCT02477007|Antipyretics|antipyretics|mesh-ancestor
102162636|NCT02052973|Propolis|propolis|mesh-list
102162637|NCT02052973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102162638|NCT04347434|Atorvastatin|atorvastatin|mesh-list
102162639|NCT04347434|Ezetimibe|ezetimibe|mesh-list
102162640|NCT04347434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102162641|NCT04347434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102162642|NCT04347434|Antimetabolites|antimetabolites|mesh-ancestor
102162643|NCT04347434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162644|NCT04347434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101871468|NCT03887260|Anesthetics, General|anesthetics, general|mesh-ancestor
102162645|NCT04347434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102162647|NCT02053519|Vitamin D|vitamin d|mesh-list
102162648|NCT02053519|Cholecalciferol|cholecalciferol|mesh-list
102162649|NCT02053519|Vitamins|vitamins|mesh-ancestor
102162650|NCT02053519|Micronutrients|micronutrients|mesh-ancestor
102162651|NCT02053519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162652|NCT02053519|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102162653|NCT02053519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102162654|NCT02053597|Paclitaxel|paclitaxel|mesh-list
102162655|NCT02053597|Doxorubicin|doxorubicin|mesh-list
102162656|NCT02053597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102162657|NCT02053597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102162658|NCT02053597|Tubulin Modulators|tubulin modulators|mesh-ancestor
102162659|NCT02053597|Antimitotic Agents|antimitotic agents|mesh-ancestor
102162660|NCT02053597|Mitosis Modulators|mitosis modulators|mesh-ancestor
102162661|NCT02053597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162662|NCT02053597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102162663|NCT02053597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102162664|NCT02053597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102162665|NCT02053597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102162666|NCT02801617|Latanoprost|latanoprost|mesh-list
102162667|NCT02801617|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102162668|NCT02801617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102162669|NCT02056249|Norepinephrine|norepinephrine|mesh-list
102162670|NCT02056249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102162671|NCT02056249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102162672|NCT02056249|Adrenergic Agents|adrenergic agents|mesh-ancestor
102162673|NCT02056249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102162674|NCT02056249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162675|NCT02056249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162676|NCT02056249|Sympathomimetics|sympathomimetics|mesh-ancestor
102162677|NCT02056249|Autonomic Agents|autonomic agents|mesh-ancestor
102162678|NCT02056249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102162679|NCT02056249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102162680|NCT04140968|Progesterone|progesterone|mesh-list
102162681|NCT04140968|Progestins|progestins|mesh-ancestor
102162682|NCT04140968|Hormones|hormones|mesh-ancestor
102162683|NCT04140968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102162684|NCT04140968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162685|NCT04383938|Pembrolizumab|pembrolizumab|mesh-list
102162686|NCT04383938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102162687|NCT04383938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102162688|NCT04383938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102162689|NCT04383938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162690|NCT01334515|Isotretinoin|isotretinoin|mesh-list
102162691|NCT01334515|Sargramostim|sargramostim|mesh-list
102162692|NCT01334515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162693|NCT01334515|Immunologic Factors|immunologic factors|mesh-ancestor
102162694|NCT01334515|Dermatologic Agents|dermatologic agents|mesh-ancestor
102162695|NCT02415400|Aspirin|aspirin|mesh-list
102162696|NCT02415400|Vitamin K|vitamin k|mesh-list
102162697|NCT02415400|Apixaban|apixaban|mesh-list
102162698|NCT02415400|Vitamins|vitamins|mesh-ancestor
102162699|NCT02415400|Micronutrients|micronutrients|mesh-ancestor
102162700|NCT02415400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162701|NCT02415400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102162702|NCT02415400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102162703|NCT02415400|Analgesics|analgesics|mesh-ancestor
102162704|NCT02415400|Sensory System Agents|sensory system agents|mesh-ancestor
102162705|NCT02415400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102162706|NCT02415400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102162707|NCT02415400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102162708|NCT02415400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102162709|NCT02415400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102162710|NCT02415400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162711|NCT02415400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102162712|NCT02415400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102162713|NCT02415400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102162714|NCT02415400|Antipyretics|antipyretics|mesh-ancestor
102162715|NCT02415400|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102162716|NCT02415400|Antithrombins|antithrombins|mesh-ancestor
102162717|NCT02415400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101871548|NCT01261546|Dexamethasone|dexamethasone|mesh-list
102162718|NCT02415400|Protease Inhibitors|protease inhibitors|mesh-ancestor
102162719|NCT02415400|Anticoagulants|anticoagulants|mesh-ancestor
102162720|NCT02415400|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102162722|NCT02415400|Coagulants|coagulants|mesh-ancestor
102162723|NCT02053675|Vasopressins|vasopressins|mesh-list
102162724|NCT02053675|Arginine Vasopressin|arginine vasopressin|mesh-list
102162725|NCT02053675|Hemostatics|hemostatics|mesh-ancestor
102162726|NCT02053675|Coagulants|coagulants|mesh-ancestor
102162727|NCT02053675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102162728|NCT02053675|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102162729|NCT02053675|Natriuretic Agents|natriuretic agents|mesh-ancestor
102162730|NCT02053675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162731|NCT02037997|Docetaxel|docetaxel|mesh-list
102162732|NCT02037997|Pemetrexed|pemetrexed|mesh-list
102162733|NCT02037997|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102162734|NCT02037997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102162735|NCT02037997|Tubulin Modulators|tubulin modulators|mesh-ancestor
102162736|NCT02037997|Antimitotic Agents|antimitotic agents|mesh-ancestor
102162737|NCT02037997|Mitosis Modulators|mitosis modulators|mesh-ancestor
102162738|NCT02037997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162739|NCT02037997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102162740|NCT02037997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102162741|NCT02037997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102162742|NCT02037997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102162743|NCT02056405|Mosapride|mosapride|mesh-list
102162744|NCT02056405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102162745|NCT02056405|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102162746|NCT02056405|Serotonin Agents|serotonin agents|mesh-ancestor
102162747|NCT02056405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102162748|NCT02056405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162749|NCT02056405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162750|NCT02056717|Dexamethasone|dexamethasone|mesh-list
102162751|NCT02056717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102162752|NCT02056717|Antiemetics|antiemetics|mesh-ancestor
102162753|NCT02056717|Autonomic Agents|autonomic agents|mesh-ancestor
102162754|NCT02056717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102162755|NCT02056717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162756|NCT02056717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102162757|NCT02056717|Glucocorticoids|glucocorticoids|mesh-ancestor
102162758|NCT02056717|Hormones|hormones|mesh-ancestor
102162759|NCT02056717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102162760|NCT02056717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102162761|NCT02056717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102162762|NCT04194801|Fisogatinib|fisogatinib|mesh-list
102162763|NCT04194801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102162764|NCT02802865|Letrozole|letrozole|mesh-list
102162765|NCT02802865|Clomiphene|clomiphene|mesh-list
102162766|NCT02802865|Enclomiphene|enclomiphene|mesh-list
102162767|NCT02802865|Zuclomiphene|zuclomiphene|mesh-list
102162768|NCT02802865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162769|NCT02802865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102162770|NCT02802865|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102162771|NCT02802865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102162772|NCT02802865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102162773|NCT02802865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102162774|NCT02802865|Hormone Antagonists|hormone antagonists|mesh-ancestor
102162775|NCT02802865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102162776|NCT02802865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162777|NCT02802865|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102162778|NCT02802865|Fertility Agents|fertility agents|mesh-ancestor
102162779|NCT02802865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102162780|NCT02802865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102162781|NCT02802865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102162782|NCT02414932|Midazolam|midazolam|mesh-list
102162783|NCT02414932|Ketamine|ketamine|mesh-list
102162784|NCT02414932|Analgesics|analgesics|mesh-ancestor
102162785|NCT02414932|Sensory System Agents|sensory system agents|mesh-ancestor
102162786|NCT02414932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102162787|NCT02414932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162788|NCT02414932|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102162789|NCT02414932|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102162790|NCT02414932|Anesthetics, General|anesthetics, general|mesh-ancestor
102162791|NCT02414932|Anesthetics|anesthetics|mesh-ancestor
102162792|NCT02414932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102162793|NCT02414932|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102162794|NCT02414932|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102162795|NCT02414932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102162796|NCT02414932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162797|NCT02414932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102162798|NCT02414932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102162799|NCT02414932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102162800|NCT02414932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102162801|NCT02414932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102162802|NCT02414932|GABA Modulators|gaba modulators|mesh-ancestor
102162803|NCT02414932|GABA Agents|gaba agents|mesh-ancestor
102162804|NCT02476929|Nitrous Oxide|nitrous oxide|mesh-list
102162805|NCT02476929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102162806|NCT02476929|Anesthetics, General|anesthetics, general|mesh-ancestor
102162807|NCT02476929|Anesthetics|anesthetics|mesh-ancestor
102162808|NCT02476929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102162809|NCT02476929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162811|NCT02476929|Analgesics|analgesics|mesh-ancestor
102162812|NCT02476929|Sensory System Agents|sensory system agents|mesh-ancestor
102162813|NCT02476929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102162814|NCT02054143|Sevoflurane|sevoflurane|mesh-list
102162815|NCT02054143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102162816|NCT02054143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102162817|NCT02054143|Anesthetics, General|anesthetics, general|mesh-ancestor
102162818|NCT02054143|Anesthetics|anesthetics|mesh-ancestor
102162819|NCT02054143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102162820|NCT02054143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162821|NCT02058667|Paclitaxel|paclitaxel|mesh-list
102162822|NCT02058667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102162823|NCT02058667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102162824|NCT02058667|Tubulin Modulators|tubulin modulators|mesh-ancestor
102162825|NCT02058667|Antimitotic Agents|antimitotic agents|mesh-ancestor
102162826|NCT02058667|Mitosis Modulators|mitosis modulators|mesh-ancestor
102162827|NCT02058667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162828|NCT02470455|Atorvastatin|atorvastatin|mesh-list
102162829|NCT02470455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102162830|NCT02470455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102162831|NCT02470455|Antimetabolites|antimetabolites|mesh-ancestor
102162832|NCT02470455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162833|NCT02470455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102162834|NCT02470455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102162835|NCT02470455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102162836|NCT02057263|Alendronate|alendronate|mesh-list
102162837|NCT02057263|Diphosphonates|diphosphonates|mesh-list
102162838|NCT02057263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102162839|NCT02057263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162840|NCT05550909|Artesunate|artesunate|mesh-list
102162841|NCT05550909|Lumefantrine|lumefantrine|mesh-list
102162842|NCT05550909|Artemether|artemether|mesh-list
102162843|NCT05550909|Primaquine|primaquine|mesh-list
102162844|NCT05550909|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102162845|NCT05550909|Amodiaquine|amodiaquine|mesh-list
102162846|NCT05550909|Amodiaquine, artesunate drug combination|amodiaquine, artesunate drug combination|mesh-list
102162847|NCT05550909|Antimalarials|antimalarials|mesh-ancestor
102162848|NCT05550909|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102162849|NCT05550909|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102162850|NCT05550909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102162851|NCT05550909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102162852|NCT05550909|Antiviral Agents|antiviral agents|mesh-ancestor
102162853|NCT05550909|Schistosomicides|schistosomicides|mesh-ancestor
102162854|NCT05550909|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102162855|NCT05550909|Anthelmintics|anthelmintics|mesh-ancestor
102162856|NCT02054299|Thiamine|thiamine|mesh-list
102162857|NCT02054299|Proguanil|proguanil|mesh-list
102162858|NCT02054299|Sumatriptan|sumatriptan|mesh-list
102162859|NCT02054299|Amitriptyline|amitriptyline|mesh-list
102162860|NCT02054299|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
102162861|NCT02054299|Fenoterol|fenoterol|mesh-list
102162862|NCT02054299|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102162863|NCT02054299|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102162864|NCT02054299|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102162865|NCT02054299|Serotonin Agents|serotonin agents|mesh-ancestor
102162866|NCT02054299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102162867|NCT02054299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162868|NCT02054299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162869|NCT02054299|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102162870|NCT02054299|Antidepressive Agents|antidepressive agents|mesh-ancestor
102162871|NCT02054299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102162872|NCT02054299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102162873|NCT02054299|Analgesics|analgesics|mesh-ancestor
102162874|NCT02054299|Sensory System Agents|sensory system agents|mesh-ancestor
102162875|NCT02054299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102162876|NCT02054299|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102162877|NCT02054299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102162878|NCT02054299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102162879|NCT02054299|Adrenergic Agents|adrenergic agents|mesh-ancestor
102162880|NCT02054299|Vitamin B Complex|vitamin b complex|mesh-ancestor
102162881|NCT02054299|Vitamins|vitamins|mesh-ancestor
102162882|NCT02054299|Micronutrients|micronutrients|mesh-ancestor
101573973|NCT02199184|Etoposide phosphate|etoposide phosphate|mesh-list
102162883|NCT02054299|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102162884|NCT02054299|Antimalarials|antimalarials|mesh-ancestor
102162885|NCT02054299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102162886|NCT02054299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102162887|NCT02054299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102162888|NCT02054299|Antimetabolites|antimetabolites|mesh-ancestor
102162889|NCT02054299|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102162890|NCT02054299|Autonomic Agents|autonomic agents|mesh-ancestor
102162891|NCT02054299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102162892|NCT02054299|Respiratory System Agents|respiratory system agents|mesh-ancestor
102162893|NCT02054299|Sympathomimetics|sympathomimetics|mesh-ancestor
102162894|NCT02054299|Tocolytic Agents|tocolytic agents|mesh-ancestor
102162895|NCT02054299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102162896|NCT02054299|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102162897|NCT02054299|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102162898|NCT02054299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102162899|NCT02058823|Amlodipine|amlodipine|mesh-list
102162900|NCT02058823|Valsartan|valsartan|mesh-list
102162901|NCT02058823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102162902|NCT02058823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102162903|NCT02058823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102162904|NCT02058823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162905|NCT02058823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102162906|NCT02058823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162907|NCT02058823|Vasodilator Agents|vasodilator agents|mesh-ancestor
102162908|NCT02058823|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102162909|NCT02058823|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102162910|NCT00704535|Ezetimibe|ezetimibe|mesh-list
102162911|NCT00704535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102162912|NCT00704535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102162913|NCT00704535|Antimetabolites|antimetabolites|mesh-ancestor
102162914|NCT00704535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162915|NCT00704535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102162916|NCT02058901|Sunitinib|sunitinib|mesh-list
102162917|NCT02058901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102162918|NCT02058901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102162919|NCT02058901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102162920|NCT02058901|Growth Substances|growth substances|mesh-ancestor
102162921|NCT02058901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162922|NCT02058901|Growth Inhibitors|growth inhibitors|mesh-ancestor
102162923|NCT02058901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102162924|NCT02058901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102162925|NCT02058901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162926|NCT01955499|Lenalidomide|lenalidomide|mesh-list
102162927|NCT01955499|Immunologic Factors|immunologic factors|mesh-ancestor
102162928|NCT01955499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162929|NCT01955499|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102162930|NCT01955499|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102162931|NCT01955499|Growth Substances|growth substances|mesh-ancestor
102162932|NCT01955499|Growth Inhibitors|growth inhibitors|mesh-ancestor
102162933|NCT01955499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102162934|NCT02058979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102162935|NCT02058979|Cefazolin|cefazolin|mesh-list
102162936|NCT02058979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102162937|NCT02057887|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102162938|NCT02057887|Antiviral Agents|antiviral agents|mesh-ancestor
102162939|NCT02057887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102162940|NCT03893955|Paclitaxel|paclitaxel|mesh-list
102162941|NCT03893955|Carboplatin|carboplatin|mesh-list
102162942|NCT03893955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102162943|NCT03893955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102162944|NCT03893955|Tubulin Modulators|tubulin modulators|mesh-ancestor
102162945|NCT03893955|Antimitotic Agents|antimitotic agents|mesh-ancestor
102162946|NCT03893955|Mitosis Modulators|mitosis modulators|mesh-ancestor
102162947|NCT03893955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162948|NCT02648204|Dulaglutide|dulaglutide|mesh-list
102162949|NCT02648204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102162950|NCT02648204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162951|NCT03310749|Metformin|metformin|mesh-list
102162952|NCT03310749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102162953|NCT03310749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162954|NCT01217931|Bevacizumab|bevacizumab|mesh-list
102162955|NCT01217931|Everolimus|everolimus|mesh-list
102162956|NCT01217931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102162957|NCT01217931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102162958|NCT01217931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102162959|NCT01217931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102162960|NCT01217931|Growth Substances|growth substances|mesh-ancestor
102162961|NCT01217931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162962|NCT01217931|Growth Inhibitors|growth inhibitors|mesh-ancestor
102162963|NCT01217931|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102162964|NCT01217931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102162965|NCT01217931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102162966|NCT01217931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162967|NCT01217931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102162968|NCT01217931|Immunologic Factors|immunologic factors|mesh-ancestor
102162969|NCT05291325|Linaclotide|linaclotide|mesh-list
102162970|NCT05291325|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102162971|NCT05291325|Enzyme Activators|enzyme activators|mesh-ancestor
102162972|NCT05291325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162973|NCT05291325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102162974|NCT03310593|Cannabidiol|cannabidiol|mesh-list
102162975|NCT03310593|Anticonvulsants|anticonvulsants|mesh-ancestor
102162976|NCT05304338|Chlorhexidine|chlorhexidine|mesh-list
102162977|NCT05304338|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102162978|NCT05304338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102162979|NCT05304338|Disinfectants|disinfectants|mesh-ancestor
102162980|NCT02058199|Rivaroxaban|rivaroxaban|mesh-list
102162981|NCT02058199|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102162982|NCT02058199|Antithrombins|antithrombins|mesh-ancestor
102162983|NCT02058199|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102162984|NCT02058199|Protease Inhibitors|protease inhibitors|mesh-ancestor
102162985|NCT02058199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102162986|NCT02058199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162987|NCT02058199|Anticoagulants|anticoagulants|mesh-ancestor
102162988|NCT02058277|Aprepitant|aprepitant|mesh-list
102162989|NCT02058277|Antiemetics|antiemetics|mesh-ancestor
102162990|NCT02058277|Autonomic Agents|autonomic agents|mesh-ancestor
102162991|NCT02058277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102162992|NCT02058277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102162993|NCT02058277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102162994|NCT02058277|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102162995|NCT02058277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102162996|NCT02058277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102162997|NCT04813562|Vaccines|vaccines|mesh-list
102162998|NCT04813562|Immunologic Factors|immunologic factors|mesh-ancestor
102162999|NCT04813562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163000|NCT03314025|Tamsulosin|tamsulosin|mesh-list
102163001|NCT03314025|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102163002|NCT03314025|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102163003|NCT03314025|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102163004|NCT03314025|Adrenergic Agents|adrenergic agents|mesh-ancestor
102163005|NCT03314025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102163006|NCT03314025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163007|NCT03314025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163008|NCT03314025|Urological Agents|urological agents|mesh-ancestor
102163009|NCT02055079|Sirolimus|sirolimus|mesh-list
102163010|NCT02055079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102163011|NCT02055079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102163012|NCT02055079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102163013|NCT02055079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102163014|NCT02055079|Antifungal Agents|antifungal agents|mesh-ancestor
102163015|NCT02055079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102163016|NCT02055079|Immunologic Factors|immunologic factors|mesh-ancestor
102163017|NCT02055079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163018|NCT02470065|Afatinib|afatinib|mesh-list
102163019|NCT02470065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102163020|NCT02470065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102163021|NCT02470065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102163022|NCT02470065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163023|NCT03313869|Vitamin E|vitamin e|mesh-list
101871848|NCT01160068|Metformin|metformin|mesh-list
102163025|NCT03313869|Vitamins|vitamins|mesh-ancestor
102163026|NCT03313869|Micronutrients|micronutrients|mesh-ancestor
102163027|NCT03313869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163028|NCT03313869|Antioxidants|antioxidants|mesh-ancestor
102163029|NCT03313869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163030|NCT03313869|Protective Agents|protective agents|mesh-ancestor
102163031|NCT03313869|Trace Elements|trace elements|mesh-ancestor
102163032|NCT00705159|Loteprednol Etabonate|loteprednol etabonate|mesh-list
102163033|NCT00705159|Tobramycin|tobramycin|mesh-list
102163034|NCT00705159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102163035|NCT00705159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102163036|NCT00705159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102163037|NCT01673984|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102163038|NCT01673984|Goserelin|goserelin|mesh-list
102163039|NCT01673984|Luteolytic Agents|luteolytic agents|mesh-ancestor
102163040|NCT01673984|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102163041|NCT01673984|Contraceptive Agents|contraceptive agents|mesh-ancestor
102163042|NCT01673984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102163043|NCT01673984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163044|NCT01673984|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102163045|NCT01673984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102163046|NCT01673984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102163047|NCT03313791|Caseins|caseins|mesh-list
102163048|NCT03313791|Chelating Agents|chelating agents|mesh-ancestor
102163049|NCT03313791|Sequestering Agents|sequestering agents|mesh-ancestor
102163050|NCT03313791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163051|NCT03310047|Lidocaine|lidocaine|mesh-list
102163052|NCT03310047|Anesthetics, Local|anesthetics, local|mesh-ancestor
102163053|NCT03310047|Anesthetics|anesthetics|mesh-ancestor
102163054|NCT03310047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102163055|NCT03310047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163056|NCT03310047|Sensory System Agents|sensory system agents|mesh-ancestor
102163057|NCT03310047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102163058|NCT03310047|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102163059|NCT03310047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102163060|NCT03310047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102163061|NCT03310047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102163062|NCT03310047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163063|NCT03313557|Adavosertib|adavosertib|mesh-list
102163064|NCT03313557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102163065|NCT03313557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163066|NCT04103216|Nitazoxanide|nitazoxanide|mesh-list
102163067|NCT04103216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102163068|NCT04103216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102163069|NCT03313479|Dexmedetomidine|dexmedetomidine|mesh-list
102163070|NCT03313479|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102163071|NCT03313479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102163072|NCT03313479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163073|NCT03313479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102163074|NCT03313479|Analgesics|analgesics|mesh-ancestor
102163075|NCT03313479|Sensory System Agents|sensory system agents|mesh-ancestor
102163076|NCT03313479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102163077|NCT03313479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102163078|NCT03313479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102163079|NCT03313479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102163080|NCT03313479|Adrenergic Agents|adrenergic agents|mesh-ancestor
102163081|NCT03313479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102163082|NCT03313479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163083|NCT04079738|Ixazomib|ixazomib|mesh-list
102163084|NCT04079738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102163085|NCT04079738|Protease Inhibitors|protease inhibitors|mesh-ancestor
102163086|NCT04079738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102163087|NCT04079738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163088|NCT03313401|Aflibercept|aflibercept|mesh-list
102163089|NCT03313401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102163090|NCT03313401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102163091|NCT03313401|Growth Substances|growth substances|mesh-ancestor
102163092|NCT03313401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163093|NCT03313401|Growth Inhibitors|growth inhibitors|mesh-ancestor
102163094|NCT03313401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102163095|NCT05278065|Nicotine|nicotine|mesh-list
102163096|NCT05278065|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101871924|NCT01160302|Curcumin|curcumin|mesh-list
102163097|NCT05278065|Autonomic Agents|autonomic agents|mesh-ancestor
102163098|NCT05278065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102163099|NCT05278065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163101|NCT05278065|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102163102|NCT05278065|Cholinergic Agents|cholinergic agents|mesh-ancestor
102163103|NCT05278065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102163104|NCT05278065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163105|NCT03313323|Ipilimumab|ipilimumab|mesh-list
102163106|NCT03313323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102163107|NCT03313323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102163108|NCT03313323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102163109|NCT03313323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163110|NCT05302232|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102163111|NCT05302232|Methylprednisolone|methylprednisolone|mesh-list
102163112|NCT05302232|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102163113|NCT05302232|Prednisolone|prednisolone|mesh-list
102163114|NCT05302232|Prednisolone acetate|prednisolone acetate|mesh-list
102163115|NCT05302232|Lidocaine|lidocaine|mesh-list
102163116|NCT05302232|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102163117|NCT05302232|Prednisolone phosphate|prednisolone phosphate|mesh-list
102163118|NCT05302232|Anesthetics, Local|anesthetics, local|mesh-ancestor
102163119|NCT05302232|Anesthetics|anesthetics|mesh-ancestor
102163120|NCT05302232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102163121|NCT05302232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163122|NCT05302232|Sensory System Agents|sensory system agents|mesh-ancestor
102163123|NCT05302232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102163124|NCT05302232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102163125|NCT05302232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102163126|NCT05302232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102163127|NCT05302232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102163128|NCT05302232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163129|NCT05302232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102163130|NCT05302232|Antiemetics|antiemetics|mesh-ancestor
102163131|NCT05302232|Autonomic Agents|autonomic agents|mesh-ancestor
102163132|NCT05302232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102163133|NCT05302232|Glucocorticoids|glucocorticoids|mesh-ancestor
102163134|NCT05302232|Hormones|hormones|mesh-ancestor
102163135|NCT05302232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102163136|NCT05302232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102163137|NCT05302232|Protective Agents|protective agents|mesh-ancestor
102163138|NCT05302232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102163139|NCT05302232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102163140|NCT02468661|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102163141|NCT02468661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102163142|NCT02468661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102163143|NCT02468661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102163144|NCT02468661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163145|NCT03304431|Lidocaine|lidocaine|mesh-list
102163146|NCT03304431|Anesthetics, Local|anesthetics, local|mesh-ancestor
102163147|NCT03304431|Anesthetics|anesthetics|mesh-ancestor
102163148|NCT03304431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102163149|NCT03304431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163150|NCT03304431|Sensory System Agents|sensory system agents|mesh-ancestor
102163151|NCT03304431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102163152|NCT03304431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102163153|NCT03304431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102163154|NCT03304431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102163155|NCT03304431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102163156|NCT03304431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163157|NCT04741334|Anticoagulants|anticoagulants|mesh-list
102163158|NCT04741334|Dicumarol|dicumarol|mesh-list
102163159|NCT04741334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
102163160|NCT04741334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102163161|NCT04741334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163162|NCT04741334|Uncoupling Agents|uncoupling agents|mesh-ancestor
102163163|NCT03309735|Progesterone|progesterone|mesh-list
102163164|NCT03309735|Dydrogesterone|dydrogesterone|mesh-list
102163165|NCT03309735|Progestins|progestins|mesh-ancestor
102163166|NCT03309735|Hormones|hormones|mesh-ancestor
102163167|NCT03309735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102163168|NCT03309735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163169|NCT02926586|Cytarabine|cytarabine|mesh-list
102163170|NCT02926586|Fludarabine|fludarabine|mesh-list
102163171|NCT02926586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102163172|NCT02926586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102163173|NCT02926586|Antimetabolites|antimetabolites|mesh-ancestor
102163174|NCT02926586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163175|NCT02926586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102163176|NCT02926586|Immunologic Factors|immunologic factors|mesh-ancestor
102163177|NCT02926586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163178|NCT02926586|Antiviral Agents|antiviral agents|mesh-ancestor
102163179|NCT02926586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102163180|NCT04490967|Salicylic Acid|salicylic acid|mesh-list
102163181|NCT04490967|Salicylates|salicylates|mesh-list
102163182|NCT04490967|Silybin|silybin|mesh-list
102163183|NCT04490967|Silymarin|silymarin|mesh-list
102163184|NCT04490967|Antioxidants|antioxidants|mesh-ancestor
102163185|NCT04490967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163186|NCT04490967|Protective Agents|protective agents|mesh-ancestor
102163187|NCT04490967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163188|NCT04490967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102163189|NCT04490967|Antifungal Agents|antifungal agents|mesh-ancestor
102163190|NCT04490967|Keratolytic Agents|keratolytic agents|mesh-ancestor
102163191|NCT04490967|Dermatologic Agents|dermatologic agents|mesh-ancestor
102163192|NCT04490967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102163193|NCT04490967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102163194|NCT04490967|Analgesics|analgesics|mesh-ancestor
102163195|NCT04490967|Sensory System Agents|sensory system agents|mesh-ancestor
102163196|NCT04490967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102163197|NCT04490967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102163198|NCT04490967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102163199|NCT04490967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102163200|NCT04490967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102163201|NCT04490967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102163202|NCT04490967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102163203|NCT03312855|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
102163204|NCT03312855|Immunologic Factors|immunologic factors|mesh-ancestor
102163205|NCT03312855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163206|NCT03312777|Tramadol|tramadol|mesh-list
102163207|NCT03312777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102163208|NCT03312777|Narcotics|narcotics|mesh-ancestor
102163209|NCT03312777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102163210|NCT03312777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163211|NCT03312777|Analgesics|analgesics|mesh-ancestor
102163212|NCT03312777|Sensory System Agents|sensory system agents|mesh-ancestor
102163213|NCT03312777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102163214|NCT02332928|Melatonin|melatonin|mesh-list
102163215|NCT02332928|Antioxidants|antioxidants|mesh-ancestor
102163216|NCT02332928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163217|NCT02332928|Protective Agents|protective agents|mesh-ancestor
102163218|NCT02332928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163219|NCT02332928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102163220|NCT03738878|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102163221|NCT03738878|Valsartan|valsartan|mesh-list
102163222|NCT03738878|Bradykinin|bradykinin|mesh-list
102163223|NCT03738878|Kininogens|kininogens|mesh-list
102163224|NCT03738878|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102163225|NCT03738878|Substance P|substance p|mesh-list
102163226|NCT03738878|Neurokinin A|neurokinin a|mesh-list
102163227|NCT03738878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102163228|NCT03738878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163229|NCT03738878|Incretins|incretins|mesh-ancestor
102163230|NCT03738878|Hormones|hormones|mesh-ancestor
102163231|NCT03738878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102163232|NCT03738878|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102163233|NCT03738878|Protease Inhibitors|protease inhibitors|mesh-ancestor
102163234|NCT03738878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102163235|NCT03738878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163236|NCT03738878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102163237|NCT03738878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102163238|NCT03738878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102163239|NCT03738878|Vasodilator Agents|vasodilator agents|mesh-ancestor
102163240|NCT03738878|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
102163241|NCT03738878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102163242|NCT04682834|Probenecid|probenecid|mesh-list
102163243|NCT04682834|Uricosuric Agents|uricosuric agents|mesh-ancestor
102163244|NCT04682834|Gout Suppressants|gout suppressants|mesh-ancestor
102163245|NCT04682834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102163246|NCT00703677|Lithium Carbonate|lithium carbonate|mesh-list
102163247|NCT00703677|Antidepressive Agents|antidepressive agents|mesh-ancestor
102163248|NCT00703677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102163249|NCT00703677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102163250|NCT00703677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163252|NCT00703677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102163253|NCT00703677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102163254|NCT00703677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163255|NCT05426252|Sirolimus|sirolimus|mesh-list
102163256|NCT05426252|Abatacept|abatacept|mesh-list
102163257|NCT05426252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102163258|NCT05426252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102163259|NCT05426252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102163260|NCT05426252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102163261|NCT05426252|Antifungal Agents|antifungal agents|mesh-ancestor
102163262|NCT05426252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102163263|NCT05426252|Immunologic Factors|immunologic factors|mesh-ancestor
102163264|NCT05426252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163265|NCT05426252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163266|NCT05426252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102163267|NCT05426252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102163268|NCT05426252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102163269|NCT01506986|Metronidazole|metronidazole|mesh-list
102163270|NCT01506986|Clarithromycin|clarithromycin|mesh-list
102163271|NCT01506986|Lansoprazole|lansoprazole|mesh-list
102163272|NCT01506986|Dexlansoprazole|dexlansoprazole|mesh-list
102163273|NCT01506986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102163274|NCT01506986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102163275|NCT01506986|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102163276|NCT01506986|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102163277|NCT01506986|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102163278|NCT01506986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102163279|NCT01506986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163280|NCT01506986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102163281|NCT01506986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102163282|NCT01506986|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102163283|NCT01506986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102163284|NCT01506986|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102163285|NCT02714894|Clozapine|clozapine|mesh-list
102163286|NCT02714894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102163287|NCT02714894|Serotonin Agents|serotonin agents|mesh-ancestor
102163288|NCT02714894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102163289|NCT02714894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163290|NCT02714894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163291|NCT02714894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102163292|NCT02714894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102163293|NCT02714894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102163294|NCT02714894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102163295|NCT02714894|GABA Antagonists|gaba antagonists|mesh-ancestor
102163296|NCT02714894|GABA Agents|gaba agents|mesh-ancestor
102163297|NCT03303651|Analgesics, Opioid|analgesics, opioid|mesh-list
102163298|NCT03303651|Narcotics|narcotics|mesh-ancestor
102163299|NCT03303651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102163300|NCT03303651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163301|NCT03303651|Analgesics|analgesics|mesh-ancestor
102163302|NCT03303651|Sensory System Agents|sensory system agents|mesh-ancestor
102163303|NCT03303651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102163304|NCT03312153|Sodium Hypochlorite|sodium hypochlorite|mesh-list
102163305|NCT03312153|Eusol|eusol|mesh-list
102163306|NCT03312153|Disinfectants|disinfectants|mesh-ancestor
102163307|NCT03312153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102163308|NCT03303573|Epoetin Alfa|epoetin alfa|mesh-list
102163309|NCT03303573|Hematinics|hematinics|mesh-ancestor
102163310|NCT03303495|Leucovorin|leucovorin|mesh-list
102163311|NCT03303495|Bevacizumab|bevacizumab|mesh-list
102163312|NCT03303495|Fluorouracil|fluorouracil|mesh-list
102163313|NCT03303495|Irinotecan|irinotecan|mesh-list
102163314|NCT03303495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102163315|NCT03303495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102163316|NCT03303495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102163317|NCT03303495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102163318|NCT03303495|Growth Substances|growth substances|mesh-ancestor
102163319|NCT03303495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163320|NCT03303495|Growth Inhibitors|growth inhibitors|mesh-ancestor
102163321|NCT03303495|Antimetabolites|antimetabolites|mesh-ancestor
102163322|NCT03303495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163323|NCT03303495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102163324|NCT03303495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102163325|NCT03303495|Immunologic Factors|immunologic factors|mesh-ancestor
102163326|NCT03303495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102163327|NCT03303495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102163328|NCT03303495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102163329|NCT03303495|Antidotes|antidotes|mesh-ancestor
102163330|NCT03303495|Protective Agents|protective agents|mesh-ancestor
102163331|NCT03303495|Vitamin B Complex|vitamin b complex|mesh-ancestor
102163332|NCT03303495|Vitamins|vitamins|mesh-ancestor
102163333|NCT03303495|Micronutrients|micronutrients|mesh-ancestor
102163334|NCT03308955|Tramadol|tramadol|mesh-list
102163335|NCT03308955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102163336|NCT03308955|Narcotics|narcotics|mesh-ancestor
102163337|NCT03308955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102163338|NCT03308955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163339|NCT03308955|Analgesics|analgesics|mesh-ancestor
102163340|NCT03308955|Sensory System Agents|sensory system agents|mesh-ancestor
102163341|NCT03308955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102163342|NCT03311607|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102163343|NCT03311607|Antifungal Agents|antifungal agents|mesh-ancestor
102163344|NCT03311607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102163345|NCT03311607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102163346|NCT03311607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102163347|NCT03308643|Oxytocin|oxytocin|mesh-list
102163348|NCT03308643|Oxytocics|oxytocics|mesh-ancestor
102163349|NCT03308643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102163350|NCT03308643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163351|NCT03302871|Botulinum Toxins|botulinum toxins|mesh-list
102163352|NCT03302871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102163353|NCT03302871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102163354|NCT03302871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102163355|NCT03302871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102163356|NCT03302871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163357|NCT03302871|Cholinergic Agents|cholinergic agents|mesh-ancestor
102163358|NCT03302871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102163359|NCT03302871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163360|NCT03302871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102163361|NCT03302871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102163362|NCT03311139|Fibrinolytic Agents|fibrinolytic agents|mesh-list
102163363|NCT03311139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102163364|NCT03311139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163365|NCT03308487|Vitamin D|vitamin d|mesh-list
102163366|NCT03308487|Ergocalciferols|ergocalciferols|mesh-list
102163367|NCT03308487|Cholecalciferol|cholecalciferol|mesh-list
102163368|NCT03308487|Vitamins|vitamins|mesh-list
102163369|NCT03308487|Micronutrients|micronutrients|mesh-ancestor
102163370|NCT03308487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163371|NCT03308487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102163372|NCT03308487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102163373|NCT03308331|Nicotine|nicotine|mesh-list
102163374|NCT03308331|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102163375|NCT03308331|Autonomic Agents|autonomic agents|mesh-ancestor
102163376|NCT03308331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102163377|NCT03308331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163378|NCT03308331|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102163379|NCT03308331|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102163380|NCT03308331|Cholinergic Agents|cholinergic agents|mesh-ancestor
102163381|NCT03308331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102163382|NCT03308331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163383|NCT02414854|Albuterol|albuterol|mesh-list
102163384|NCT02414854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102163385|NCT02414854|Autonomic Agents|autonomic agents|mesh-ancestor
102163386|NCT02414854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102163387|NCT02414854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163388|NCT02414854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102163389|NCT02414854|Respiratory System Agents|respiratory system agents|mesh-ancestor
102163390|NCT02414854|Tocolytic Agents|tocolytic agents|mesh-ancestor
102163391|NCT02414854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102163392|NCT02414854|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102163393|NCT02414854|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102163394|NCT02414854|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102163395|NCT02414854|Adrenergic Agents|adrenergic agents|mesh-ancestor
102163396|NCT02414854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102163397|NCT02414854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163398|NCT03308253|Vancomycin|vancomycin|mesh-list
102163399|NCT03308253|Tobramycin|tobramycin|mesh-list
102163400|NCT03308253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102163401|NCT03308253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102163402|NCT02467023|Lidocaine|lidocaine|mesh-list
102163403|NCT02467023|Fentanyl|fentanyl|mesh-list
102163404|NCT02467023|Midazolam|midazolam|mesh-list
102163405|NCT02467023|Anesthetics, Local|anesthetics, local|mesh-ancestor
102163406|NCT02467023|Anesthetics|anesthetics|mesh-ancestor
102163407|NCT02467023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102163408|NCT02467023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163409|NCT02467023|Sensory System Agents|sensory system agents|mesh-ancestor
102163410|NCT02467023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102163411|NCT02467023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102163412|NCT02467023|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102163413|NCT02467023|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102163414|NCT02467023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102163415|NCT02467023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163416|NCT02467023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102163417|NCT02467023|Narcotics|narcotics|mesh-ancestor
102163418|NCT02467023|Analgesics|analgesics|mesh-ancestor
102163419|NCT02467023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102163420|NCT02467023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102163421|NCT02467023|Anesthetics, General|anesthetics, general|mesh-ancestor
102163422|NCT02467023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102163423|NCT02467023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102163424|NCT02467023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102163425|NCT02467023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102163426|NCT02467023|GABA Modulators|gaba modulators|mesh-ancestor
102163427|NCT02467023|GABA Agents|gaba agents|mesh-ancestor
102163428|NCT02467023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102163429|NCT02055703|Itraconazole|itraconazole|mesh-list
102163430|NCT02055703|Rifampin|rifampin|mesh-list
102163431|NCT02055703|Digoxin|digoxin|mesh-list
102163432|NCT02055703|Donepezil|donepezil|mesh-list
102163433|NCT02055703|Antifungal Agents|antifungal agents|mesh-ancestor
102163434|NCT02055703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102163435|NCT02055703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102163436|NCT02055703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102163437|NCT02055703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102163438|NCT02055703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163439|NCT02055703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102163440|NCT02055703|Hormone Antagonists|hormone antagonists|mesh-ancestor
102163441|NCT02055703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102163442|NCT02055703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163443|NCT02055703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102163444|NCT02055703|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102163445|NCT02055703|Cholinergic Agents|cholinergic agents|mesh-ancestor
102163446|NCT02055703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102163447|NCT02055703|Nootropic Agents|nootropic agents|mesh-ancestor
102163448|NCT02055703|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102163449|NCT02055703|Antitubercular Agents|antitubercular agents|mesh-ancestor
102163450|NCT02055703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102163451|NCT02055703|Leprostatic Agents|leprostatic agents|mesh-ancestor
102163452|NCT02055703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102163453|NCT02055703|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102163454|NCT02055703|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102163455|NCT02055703|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102163456|NCT02055703|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102163457|NCT02055703|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102163458|NCT02055703|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102163459|NCT02055703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102163460|NCT02055703|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102163461|NCT02055703|Protective Agents|protective agents|mesh-ancestor
102163462|NCT02058433|Paclitaxel|paclitaxel|mesh-list
102163463|NCT02058433|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102163464|NCT02058433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102163465|NCT02058433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102163466|NCT02058433|Tubulin Modulators|tubulin modulators|mesh-ancestor
102163467|NCT02058433|Antimitotic Agents|antimitotic agents|mesh-ancestor
102163468|NCT02058433|Mitosis Modulators|mitosis modulators|mesh-ancestor
102163469|NCT02058433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163470|NCT03561181|Vaccines|vaccines|mesh-list
102163471|NCT03561181|Immunologic Factors|immunologic factors|mesh-ancestor
102163472|NCT03561181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163473|NCT02060149|Minocycline|minocycline|mesh-list
102163474|NCT02060149|Sulbactam|sulbactam|mesh-list
102163475|NCT02060149|Cefoperazone|cefoperazone|mesh-list
102163476|NCT02060149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102163477|NCT02060149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102163478|NCT02060149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102163479|NCT02060149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102163480|NCT02060149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102163481|NCT02060149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163482|NCT03302403|Cyclophosphamide|cyclophosphamide|mesh-list
102163483|NCT03302403|Fludarabine|fludarabine|mesh-list
102163484|NCT03302403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102163485|NCT03302403|Immunologic Factors|immunologic factors|mesh-ancestor
102163486|NCT03302403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163487|NCT03302403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102163488|NCT03302403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102163489|NCT03302403|Alkylating Agents|alkylating agents|mesh-ancestor
101446148|NCT00202020|Antipyretics|antipyretics|mesh-ancestor
102163490|NCT03302403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163491|NCT03302403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102163492|NCT03302403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102163493|NCT02038621|Paclitaxel|paclitaxel|mesh-list
102163494|NCT02038621|Capecitabine|capecitabine|mesh-list
102163495|NCT02038621|Oxaliplatin|oxaliplatin|mesh-list
102163496|NCT02038621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102163497|NCT02038621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102163498|NCT02038621|Tubulin Modulators|tubulin modulators|mesh-ancestor
102163499|NCT02038621|Antimitotic Agents|antimitotic agents|mesh-ancestor
102163500|NCT02038621|Mitosis Modulators|mitosis modulators|mesh-ancestor
102163501|NCT02038621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163502|NCT02038621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102163503|NCT02038621|Antimetabolites|antimetabolites|mesh-ancestor
102163504|NCT03332498|Pembrolizumab|pembrolizumab|mesh-list
102163505|NCT03332498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102163506|NCT03332498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102163507|NCT03332498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102163508|NCT03332498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163509|NCT05727969|Dexmedetomidine|dexmedetomidine|mesh-list
102163510|NCT05727969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102163511|NCT05727969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102163512|NCT05727969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163513|NCT05727969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102163514|NCT05727969|Analgesics|analgesics|mesh-ancestor
102163515|NCT05727969|Sensory System Agents|sensory system agents|mesh-ancestor
102163516|NCT05727969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102163517|NCT05727969|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102163518|NCT05727969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102163519|NCT05727969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102163520|NCT05727969|Adrenergic Agents|adrenergic agents|mesh-ancestor
102163521|NCT05727969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102163522|NCT05727969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163523|NCT01334125|Metformin|metformin|mesh-list
102163524|NCT01334125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102163525|NCT01334125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163526|NCT02414152|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102163527|NCT02414152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102163528|NCT01333501|Interferons|interferons|mesh-list
102163529|NCT01333501|Interferon-beta|interferon-beta|mesh-list
102163530|NCT01333501|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102163531|NCT01333501|Interferon beta-1b|interferon beta-1b|mesh-list
102163532|NCT01333501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102163533|NCT01333501|Antiviral Agents|antiviral agents|mesh-ancestor
102163534|NCT01333501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102163535|NCT01333501|Immunologic Factors|immunologic factors|mesh-ancestor
102163536|NCT01333501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163537|NCT01333501|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102163538|NCT01333501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163539|NCT01333501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102163540|NCT01333501|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102163541|NCT01362140|Darbepoetin alfa|darbepoetin alfa|mesh-list
102163543|NCT03307941|Fluorouracil|fluorouracil|mesh-list
102163544|NCT03307941|Oxaliplatin|oxaliplatin|mesh-list
102163545|NCT03307941|Antimetabolites|antimetabolites|mesh-ancestor
102163546|NCT03307941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163547|NCT03307941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101872366|NCT01273402|Antibodies|antibodies|mesh-list
102163548|NCT03307941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102163549|NCT03307941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102163550|NCT03307941|Immunologic Factors|immunologic factors|mesh-ancestor
102163551|NCT03307941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163552|NCT03307863|Topiramate|topiramate|mesh-list
102163553|NCT03307863|Carbamazepine|carbamazepine|mesh-list
102163554|NCT03307863|Anticonvulsants|anticonvulsants|mesh-ancestor
102163555|NCT03307863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101446159|NCT00577018|Laxatives|laxatives|mesh-ancestor
102163556|NCT03307863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163557|NCT03307863|Antimanic Agents|antimanic agents|mesh-ancestor
102163558|NCT03307863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102163559|NCT03307863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102163560|NCT03307863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102163561|NCT03307863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102163562|NCT03307863|Analgesics|analgesics|mesh-ancestor
102163563|NCT03307863|Sensory System Agents|sensory system agents|mesh-ancestor
102163564|NCT03307863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102163565|NCT03307863|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102163566|NCT03307863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102163567|NCT03307863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163568|NCT03307863|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102163569|NCT03307863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102163570|NCT04656470|Dexmedetomidine|dexmedetomidine|mesh-list
102163571|NCT04656470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102163572|NCT04656470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102163573|NCT04656470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163574|NCT04656470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102163575|NCT04656470|Analgesics|analgesics|mesh-ancestor
102163576|NCT04656470|Sensory System Agents|sensory system agents|mesh-ancestor
102163577|NCT04656470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102163578|NCT04656470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102163579|NCT04656470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102163580|NCT04656470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102163581|NCT04656470|Adrenergic Agents|adrenergic agents|mesh-ancestor
102163582|NCT04656470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102163583|NCT04656470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163584|NCT05391074|Vitamins|vitamins|mesh-list
102163585|NCT05391074|Micronutrients|micronutrients|mesh-ancestor
102163586|NCT05391074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163587|NCT05373212|Insulin Lispro|insulin lispro|mesh-list
102163588|NCT05373212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102163589|NCT05373212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163590|NCT02467647|Thalidomide|thalidomide|mesh-list
102163591|NCT02467647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102163592|NCT02467647|Immunologic Factors|immunologic factors|mesh-ancestor
102163593|NCT02467647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163594|NCT02467647|Leprostatic Agents|leprostatic agents|mesh-ancestor
102163595|NCT02467647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102163596|NCT02467647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102163597|NCT02467647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102163598|NCT02467647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102163599|NCT02467647|Growth Substances|growth substances|mesh-ancestor
102163600|NCT02467647|Growth Inhibitors|growth inhibitors|mesh-ancestor
102163601|NCT02467647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102163602|NCT03263936|Cytarabine|cytarabine|mesh-list
102163603|NCT03263936|Fludarabine|fludarabine|mesh-list
102163604|NCT03263936|Decitabine|decitabine|mesh-list
102163605|NCT03263936|Vorinostat|vorinostat|mesh-list
102163606|NCT03263936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102163607|NCT03263936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102163608|NCT03263936|Antimetabolites|antimetabolites|mesh-ancestor
102163609|NCT03263936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163610|NCT03263936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102163611|NCT03263936|Immunologic Factors|immunologic factors|mesh-ancestor
102163612|NCT03263936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163613|NCT03263936|Antiviral Agents|antiviral agents|mesh-ancestor
102163614|NCT03263936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102163615|NCT03263936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102163616|NCT03263936|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102163617|NCT03307551|Propofol|propofol|mesh-list
102163618|NCT03307551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102163619|NCT03307551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102163620|NCT03307551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163621|NCT03307551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102163622|NCT03307551|Anesthetics, General|anesthetics, general|mesh-ancestor
101872445|NCT01073670|Antipyretics|antipyretics|mesh-ancestor
102163623|NCT03307551|Anesthetics|anesthetics|mesh-ancestor
102163624|NCT02060305|Bevacizumab|bevacizumab|mesh-list
102163625|NCT02060305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102163626|NCT02060305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102163627|NCT02060305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102163628|NCT02060305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102163629|NCT02060305|Growth Substances|growth substances|mesh-ancestor
102163630|NCT02060305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163631|NCT02060305|Growth Inhibitors|growth inhibitors|mesh-ancestor
102163632|NCT03561025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102163633|NCT03561025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102163634|NCT03561025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163635|NCT02059759|Aldesleukin|aldesleukin|mesh-list
102163636|NCT02059759|Interleukin-2|interleukin-2|mesh-list
102163637|NCT02059759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102163638|NCT02059759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102163639|NCT02059759|Analgesics|analgesics|mesh-ancestor
102163640|NCT02059759|Sensory System Agents|sensory system agents|mesh-ancestor
102163641|NCT02059759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102163642|NCT02059759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163643|NCT02059759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102163644|NCT02059759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102163645|NCT02059759|Antiviral Agents|antiviral agents|mesh-ancestor
102163646|NCT02059759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102163647|NCT03103022|Acetaminophen|acetaminophen|mesh-list
102163648|NCT03103022|Ibuprofen|ibuprofen|mesh-list
102163649|NCT03103022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102163650|NCT03103022|Analgesics|analgesics|mesh-ancestor
102163651|NCT03103022|Sensory System Agents|sensory system agents|mesh-ancestor
102163652|NCT03103022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102163653|NCT03103022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163654|NCT03103022|Antipyretics|antipyretics|mesh-ancestor
102163655|NCT03103022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102163656|NCT03103022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102163657|NCT03103022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102163658|NCT03103022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102163659|NCT03103022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102163660|NCT03103022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163661|NCT00702507|Miconazole|miconazole|mesh-list
102163662|NCT00702507|Clotrimazole|clotrimazole|mesh-list
102163663|NCT00702507|Antifungal Agents|antifungal agents|mesh-ancestor
102163664|NCT00702507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102163665|NCT00702507|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102163666|NCT00702507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102163667|NCT00702507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102163668|NCT00702507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163669|NCT00702507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102163670|NCT00702507|Hormone Antagonists|hormone antagonists|mesh-ancestor
102163671|NCT00702507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102163672|NCT00702507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163673|NCT00702507|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102163674|NCT00702507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102163675|NCT00702507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102163676|NCT03324932|Denosumab|denosumab|mesh-list
102163677|NCT03324932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102163678|NCT03324932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163679|NCT03301233|Sildenafil Citrate|sildenafil citrate|mesh-list
102163680|NCT03301233|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102163681|NCT03301233|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102163682|NCT03301233|Estradiol|estradiol|mesh-list
102163683|NCT03301233|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102163684|NCT03301233|Estrogens|estrogens|mesh-ancestor
102163685|NCT03301233|Hormones|hormones|mesh-ancestor
102163686|NCT03301233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102163687|NCT03301233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163688|NCT03301233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102163689|NCT03301233|Contraceptive Agents|contraceptive agents|mesh-ancestor
102163690|NCT03301233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102163691|NCT03301233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102163692|NCT03301233|Vasodilator Agents|vasodilator agents|mesh-ancestor
102163693|NCT03301233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102163694|NCT03301233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102163695|NCT03301233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102163696|NCT03301233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163697|NCT03301233|Urological Agents|urological agents|mesh-ancestor
102163698|NCT02581748|Trastuzumab|trastuzumab|mesh-list
102163699|NCT02581748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102163700|NCT02581748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102163701|NCT01003028|Remifentanil|remifentanil|mesh-list
102163702|NCT01003028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102163703|NCT01003028|Narcotics|narcotics|mesh-ancestor
102163704|NCT01003028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102163705|NCT01003028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163706|NCT01003028|Analgesics|analgesics|mesh-ancestor
102163707|NCT01003028|Sensory System Agents|sensory system agents|mesh-ancestor
102163708|NCT01003028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102163709|NCT03113942|Thalidomide|thalidomide|mesh-list
102163710|NCT03113942|Pomalidomide|pomalidomide|mesh-list
102163711|NCT03113942|Immunologic Factors|immunologic factors|mesh-ancestor
102163712|NCT03113942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163713|NCT03113942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102163714|NCT03113942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102163715|NCT03113942|Growth Substances|growth substances|mesh-ancestor
102163716|NCT03113942|Growth Inhibitors|growth inhibitors|mesh-ancestor
102163717|NCT03113942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102163718|NCT03113942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102163719|NCT03113942|Leprostatic Agents|leprostatic agents|mesh-ancestor
102163720|NCT03113942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102163721|NCT03113942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102163722|NCT04786340|Pirenzepine|pirenzepine|mesh-list
102163723|NCT04786340|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102163724|NCT04786340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102163725|NCT04786340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102163726|NCT04786340|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102163727|NCT04786340|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102163728|NCT04786340|Cholinergic Agents|cholinergic agents|mesh-ancestor
102163729|NCT04786340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102163730|NCT04786340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163731|NCT04786340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163732|NCT03104270|Dexamethasone|dexamethasone|mesh-list
102163733|NCT03104270|Pomalidomide|pomalidomide|mesh-list
102163734|NCT03104270|Elotuzumab|elotuzumab|mesh-list
102163735|NCT03104270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102163736|NCT03104270|Antiemetics|antiemetics|mesh-ancestor
102163737|NCT03104270|Autonomic Agents|autonomic agents|mesh-ancestor
102163738|NCT03104270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102163739|NCT03104270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163740|NCT03104270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102163741|NCT03104270|Glucocorticoids|glucocorticoids|mesh-ancestor
102163742|NCT03104270|Hormones|hormones|mesh-ancestor
102163743|NCT03104270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102163744|NCT03104270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102163745|NCT03104270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102163746|NCT03104270|Immunologic Factors|immunologic factors|mesh-ancestor
102163747|NCT03104270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102163748|NCT03104270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102163749|NCT03104270|Growth Substances|growth substances|mesh-ancestor
102163750|NCT03104270|Growth Inhibitors|growth inhibitors|mesh-ancestor
102163751|NCT03300765|Apatinib|apatinib|mesh-list
102163752|NCT03300765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102163753|NCT03300765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102163754|NCT03300765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102163755|NCT03300765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163756|NCT04064918|Timolol|timolol|mesh-list
102163757|NCT04064918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163758|NCT04064918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102163759|NCT04064918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102163760|NCT04064918|Adrenergic Agents|adrenergic agents|mesh-ancestor
102163761|NCT04064918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102163762|NCT04064918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163763|NCT04064918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102163764|NCT04064918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102163765|NCT02467946|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102163766|NCT02467946|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102163767|NCT02467946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102163768|NCT02467946|Alkylating Agents|alkylating agents|mesh-ancestor
102163769|NCT02467946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163770|NCT02467946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102163771|NCT02467946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102163772|NCT02467946|Immunotoxins|immunotoxins|mesh-ancestor
102163773|NCT02467946|Immunoconjugates|immunoconjugates|mesh-ancestor
102163774|NCT02467946|Immunologic Factors|immunologic factors|mesh-ancestor
102163775|NCT02467946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163776|NCT04688294|Valsartan|valsartan|mesh-list
102163777|NCT04688294|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102163778|NCT04688294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102163779|NCT04688294|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102163780|NCT04688294|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102163781|NCT04688294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163782|NCT03300609|Calcium, Dietary|calcium, dietary|mesh-list
102163783|NCT03300609|Leucovorin|leucovorin|mesh-list
102163784|NCT03300609|Folic Acid|folic acid|mesh-list
102163785|NCT03300609|Tetrahydrofolates|tetrahydrofolates|mesh-list
102163786|NCT03300609|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
102163787|NCT03300609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102163788|NCT03300609|Panitumumab|panitumumab|mesh-list
102163789|NCT03300609|Fluorouracil|fluorouracil|mesh-list
102163790|NCT03300609|Capecitabine|capecitabine|mesh-list
102163791|NCT03300609|Oxaliplatin|oxaliplatin|mesh-list
102163792|NCT03300609|Antibodies|antibodies|mesh-list
102163793|NCT03300609|Immunoglobulins|immunoglobulins|mesh-list
102163794|NCT03300609|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102163795|NCT03300609|Calcium|calcium|mesh-list
102163796|NCT03300609|Levoleucovorin|levoleucovorin|mesh-list
102163797|NCT03300609|Immunologic Factors|immunologic factors|mesh-ancestor
102163798|NCT03300609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163799|NCT03300609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102163800|NCT03300609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102163801|NCT03300609|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102163802|NCT03300609|Antimetabolites|antimetabolites|mesh-ancestor
102163803|NCT03300609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163804|NCT03300609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102163805|NCT03300609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102163806|NCT03300609|Antidotes|antidotes|mesh-ancestor
102163807|NCT03300609|Protective Agents|protective agents|mesh-ancestor
102163808|NCT03300609|Vitamin B Complex|vitamin b complex|mesh-ancestor
102163809|NCT03300609|Vitamins|vitamins|mesh-ancestor
102163810|NCT03300609|Micronutrients|micronutrients|mesh-ancestor
102163811|NCT03300609|Hematinics|hematinics|mesh-ancestor
102163812|NCT00583778|Ipratropium|ipratropium|mesh-list
102163813|NCT00583778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102163814|NCT00583778|Autonomic Agents|autonomic agents|mesh-ancestor
102163815|NCT00583778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102163816|NCT00583778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163817|NCT00583778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102163818|NCT00583778|Respiratory System Agents|respiratory system agents|mesh-ancestor
102163819|NCT00583778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102163820|NCT00583778|Cholinergic Agents|cholinergic agents|mesh-ancestor
102163821|NCT00583778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102163822|NCT00583778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163823|NCT03300531|Betamethasone|betamethasone|mesh-list
102163824|NCT03300531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102163825|NCT03300531|Glucocorticoids|glucocorticoids|mesh-ancestor
102163826|NCT03300531|Hormones|hormones|mesh-ancestor
102163827|NCT03300531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102163828|NCT03300531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163829|NCT03300531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102163830|NCT03300531|Respiratory System Agents|respiratory system agents|mesh-ancestor
102163831|NCT02467335|Fostemsavir|fostemsavir|mesh-list
102163832|NCT02467335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102163833|NCT02467335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102163834|NCT02467335|Antiviral Agents|antiviral agents|mesh-ancestor
102163835|NCT02467335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102163836|NCT02467335|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102163837|NCT02467335|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102163838|NCT02467335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163840|NCT02809820|Carvedilol|carvedilol|mesh-list
102163841|NCT02809820|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102163842|NCT02809820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102163843|NCT02809820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102163844|NCT02809820|Sympatholytics|sympatholytics|mesh-ancestor
102163845|NCT02809820|Autonomic Agents|autonomic agents|mesh-ancestor
102163846|NCT02809820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102163847|NCT02809820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163848|NCT02809820|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102163849|NCT02809820|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102163850|NCT02809820|Adrenergic Agents|adrenergic agents|mesh-ancestor
102163851|NCT02809820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102163852|NCT02809820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163853|NCT02809820|Antioxidants|antioxidants|mesh-ancestor
102163854|NCT02809820|Protective Agents|protective agents|mesh-ancestor
102163855|NCT02809820|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102163856|NCT02809820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102163857|NCT02809820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102163858|NCT02809820|Vasodilator Agents|vasodilator agents|mesh-ancestor
102163859|NCT02809820|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102163860|NCT02809820|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102163861|NCT04491357|Calcium, Dietary|calcium, dietary|mesh-list
102163862|NCT04491357|Calcium|calcium|mesh-list
102163863|NCT04491357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102163864|NCT04491357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163865|NCT04491357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102163866|NCT01673594|Naltrexone|naltrexone|mesh-list
102163867|NCT01673594|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102163868|NCT01673594|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102163869|NCT01673594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163870|NCT01673594|Sensory System Agents|sensory system agents|mesh-ancestor
102163871|NCT01673594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102163872|NCT03249207|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102163873|NCT03249207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102163874|NCT02786498|Vitamin D|vitamin d|mesh-list
102163875|NCT02786498|Cholecalciferol|cholecalciferol|mesh-list
102163876|NCT02786498|Vitamins|vitamins|mesh-ancestor
102163877|NCT02786498|Micronutrients|micronutrients|mesh-ancestor
102163878|NCT02786498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163879|NCT02786498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102163880|NCT02786498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102163881|NCT03891914|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102163882|NCT03891914|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102163883|NCT03891914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163884|NCT02597660|Hormones|hormones|mesh-list
102163885|NCT02597660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102163886|NCT02597660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163887|NCT02419664|Edotreotide|edotreotide|mesh-list
102163888|NCT02419664|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102163889|NCT02419664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163890|NCT03102476|Insulin Lispro|insulin lispro|mesh-list
102163891|NCT03102476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102163892|NCT03102476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163893|NCT04435574|Lactoferrin|lactoferrin|mesh-list
102163894|NCT04435574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102163895|NCT03104426|Darbepoetin alfa|darbepoetin alfa|mesh-list
102163896|NCT03104426|Hematinics|hematinics|mesh-ancestor
102163897|NCT02163356|Ketoconazole|ketoconazole|mesh-list
102163898|NCT02163356|Vincristine|vincristine|mesh-list
102163899|NCT02163356|Fenretinide|fenretinide|mesh-list
102163900|NCT02163356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102163901|NCT02163356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102163902|NCT02163356|Tubulin Modulators|tubulin modulators|mesh-ancestor
102163903|NCT02163356|Antimitotic Agents|antimitotic agents|mesh-ancestor
102163904|NCT02163356|Mitosis Modulators|mitosis modulators|mesh-ancestor
102163905|NCT02163356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163906|NCT02163356|Antifungal Agents|antifungal agents|mesh-ancestor
102163907|NCT02163356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102163908|NCT02163356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102163909|NCT02163356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102163910|NCT02163356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102163911|NCT02163356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102163912|NCT02163356|Hormone Antagonists|hormone antagonists|mesh-ancestor
102163913|NCT02163356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102163914|NCT02163356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163915|NCT02163356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102163916|NCT02163356|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102163917|NCT02163356|Protective Agents|protective agents|mesh-ancestor
102163918|NCT02021006|Amoxicillin|amoxicillin|mesh-list
102163919|NCT02021006|Clavulanic Acid|clavulanic acid|mesh-list
102163920|NCT02021006|Clavulanic Acids|clavulanic acids|mesh-list
102163921|NCT02021006|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101872738|NCT01163500|Coenzyme Q10|coenzyme q10|mesh-list
102163922|NCT02021006|Nitrofurantoin|nitrofurantoin|mesh-list
102163924|NCT02021006|Trimethoprim|trimethoprim|mesh-list
102163925|NCT02021006|Sulfamethoxazole|sulfamethoxazole|mesh-list
102163926|NCT02021006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102163927|NCT02021006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102163928|NCT02021006|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102163929|NCT02021006|Antimalarials|antimalarials|mesh-ancestor
102163930|NCT02021006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102163931|NCT02021006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102163932|NCT02021006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102163933|NCT02021006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102163934|NCT02021006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163935|NCT02021006|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102163936|NCT02021006|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102163937|NCT02021006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102163938|NCT02021006|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102163939|NCT04412642|Methoxyflurane|methoxyflurane|mesh-list
102163940|NCT04412642|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102163941|NCT04412642|Anesthetics, General|anesthetics, general|mesh-ancestor
102163942|NCT04412642|Anesthetics|anesthetics|mesh-ancestor
102163943|NCT04412642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102163944|NCT04412642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163945|NCT03867110|Atorvastatin|atorvastatin|mesh-list
102163946|NCT03867110|Ezetimibe|ezetimibe|mesh-list
102163947|NCT03867110|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102163948|NCT03867110|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102163949|NCT03867110|Antimetabolites|antimetabolites|mesh-ancestor
102163950|NCT03867110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163951|NCT03867110|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102163952|NCT03867110|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102163953|NCT03867110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102163954|NCT03865082|Nivolumab|nivolumab|mesh-list
102163955|NCT03865082|Ipilimumab|ipilimumab|mesh-list
102163956|NCT03865082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102163957|NCT03865082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102163958|NCT03865082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102163959|NCT03865082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163960|NCT03102398|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
102163961|NCT03102398|Vasodilator Agents|vasodilator agents|mesh-ancestor
102163962|NCT03102398|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102163963|NCT03102398|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102163964|NCT03102398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102163965|NCT03102398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163966|NCT03102398|Urological Agents|urological agents|mesh-ancestor
102163967|NCT01187810|Cytarabine|cytarabine|mesh-list
102163968|NCT01187810|Methotrexate|methotrexate|mesh-list
102163969|NCT01187810|Fenretinide|fenretinide|mesh-list
102163970|NCT01187810|Retinamide|retinamide|mesh-list
102163971|NCT01187810|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102163972|NCT01187810|Abortifacient Agents|abortifacient agents|mesh-ancestor
102163973|NCT01187810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102163974|NCT01187810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446189|NCT00187005|Daunorubicin|daunorubicin|mesh-list
102163975|NCT01187810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102163976|NCT01187810|Antimetabolites|antimetabolites|mesh-ancestor
102163977|NCT01187810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102163978|NCT01187810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102163979|NCT01187810|Dermatologic Agents|dermatologic agents|mesh-ancestor
102163980|NCT01187810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102163981|NCT01187810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102163982|NCT01187810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102163984|NCT01187810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102163985|NCT01187810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102163986|NCT01187810|Antiviral Agents|antiviral agents|mesh-ancestor
102163987|NCT01187810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102163988|NCT01187810|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102163989|NCT01187810|Protective Agents|protective agents|mesh-ancestor
102163990|NCT03104036|Mesalamine|mesalamine|mesh-list
102163991|NCT03104036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102163992|NCT03104036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102163993|NCT03104036|Analgesics|analgesics|mesh-ancestor
102163994|NCT03104036|Sensory System Agents|sensory system agents|mesh-ancestor
102163995|NCT03104036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102163996|NCT03104036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102163997|NCT03104036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102163998|NCT03104036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102163999|NCT03449888|Calcium, Dietary|calcium, dietary|mesh-list
102164000|NCT03449888|Calcium|calcium|mesh-list
102164001|NCT03449888|Regadenoson|regadenoson|mesh-list
102164002|NCT03449888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102164003|NCT03449888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164004|NCT03449888|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102164005|NCT03449888|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
102164006|NCT03449888|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102164007|NCT03449888|Purinergic Agonists|purinergic agonists|mesh-ancestor
102164008|NCT03449888|Purinergic Agents|purinergic agents|mesh-ancestor
102164009|NCT03449888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102164010|NCT03449888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164011|NCT03308396|Durvalumab|durvalumab|mesh-list
102164012|NCT03308396|Guadecitabine|guadecitabine|mesh-list
102164013|NCT03308396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102164014|NCT03308396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102164015|NCT02720523|Upadacitinib|upadacitinib|mesh-list
102164016|NCT02720523|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102164017|NCT02720523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102164018|NCT02720523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102164019|NCT02720523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164020|NCT02720523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102164021|NCT02646332|Amoxicillin|amoxicillin|mesh-list
102164022|NCT02646332|Metronidazole|metronidazole|mesh-list
102164023|NCT02646332|Clarithromycin|clarithromycin|mesh-list
102164024|NCT02646332|Dexlansoprazole|dexlansoprazole|mesh-list
102164025|NCT02646332|Lansoprazole|lansoprazole|mesh-list
102164026|NCT02646332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102164027|NCT02646332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102164028|NCT02646332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102164029|NCT02646332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102164030|NCT02646332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102164031|NCT02646332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102164032|NCT02646332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164033|NCT02646332|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102164034|NCT02646332|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102164035|NCT02646332|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102164036|NCT02646332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102164037|NCT02646332|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102164038|NCT00015002|Betamethasone|betamethasone|mesh-list
102164039|NCT00015002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102164040|NCT00015002|Glucocorticoids|glucocorticoids|mesh-ancestor
102164041|NCT00015002|Hormones|hormones|mesh-ancestor
102164042|NCT00015002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102164043|NCT00015002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164044|NCT00015002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102164045|NCT00015002|Respiratory System Agents|respiratory system agents|mesh-ancestor
102164046|NCT03103412|Tofacitinib|tofacitinib|mesh-list
102164047|NCT03103412|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102164048|NCT03103412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102164049|NCT03103412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102164050|NCT03103412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164051|NCT02061007|Misonidazole|misonidazole|mesh-list
102164052|NCT02061007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102164053|NCT02061007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102164054|NCT02061007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102164055|NCT02061007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102164056|NCT02086604|Lenalidomide|lenalidomide|mesh-list
102164057|NCT02086604|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102164058|NCT02086604|Immunologic Factors|immunologic factors|mesh-ancestor
102164059|NCT02086604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164060|NCT02086604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102164061|NCT02086604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102164062|NCT02086604|Growth Substances|growth substances|mesh-ancestor
102164063|NCT02086604|Growth Inhibitors|growth inhibitors|mesh-ancestor
102164064|NCT02086604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102164065|NCT02086604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102164066|NCT02086604|Immunotoxins|immunotoxins|mesh-ancestor
102164067|NCT02086604|Immunoconjugates|immunoconjugates|mesh-ancestor
102164068|NCT03103568|Tolbutamide|tolbutamide|mesh-list
102164069|NCT03103568|Metoprolol|metoprolol|mesh-list
102164070|NCT03103568|Furosemide|furosemide|mesh-list
102164071|NCT03103568|Chlorzoxazone|chlorzoxazone|mesh-list
102164072|NCT03103568|Nitisinone|nitisinone|mesh-list
102164073|NCT03103568|Diuretics|diuretics|mesh-ancestor
102164074|NCT03103568|Natriuretic Agents|natriuretic agents|mesh-ancestor
102164075|NCT03103568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164076|NCT03103568|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102164077|NCT03103568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102164078|NCT03103568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164079|NCT03103568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102164080|NCT03103568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102164081|NCT03103568|Sympatholytics|sympatholytics|mesh-ancestor
102164082|NCT03103568|Autonomic Agents|autonomic agents|mesh-ancestor
102164083|NCT03103568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102164084|NCT03103568|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102164085|NCT03103568|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102164086|NCT03103568|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102164087|NCT03103568|Adrenergic Agents|adrenergic agents|mesh-ancestor
102164088|NCT03103568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102164089|NCT03103568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102164090|NCT03103568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102164091|NCT03103568|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102164092|NCT03103568|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102164093|NCT05654467|Vaccines|vaccines|mesh-list
102164094|NCT05654467|Immunologic Factors|immunologic factors|mesh-ancestor
102164095|NCT05654467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164096|NCT03101072|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102164097|NCT03101072|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102164098|NCT03101072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102164099|NCT03101072|Antitubercular Agents|antitubercular agents|mesh-ancestor
102164100|NCT02925195|Vitamin D|vitamin d|mesh-list
102164101|NCT02925195|Cholecalciferol|cholecalciferol|mesh-list
102164102|NCT02925195|Vitamins|vitamins|mesh-ancestor
102164103|NCT02925195|Micronutrients|micronutrients|mesh-ancestor
102164104|NCT02925195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164105|NCT02925195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102164106|NCT02925195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102164107|NCT03103646|Itraconazole|itraconazole|mesh-list
102164108|NCT03103646|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
102164109|NCT03103646|Antifungal Agents|antifungal agents|mesh-ancestor
102164110|NCT03103646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102164111|NCT03103646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102164112|NCT03103646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102164113|NCT03103646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102164114|NCT03103646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164115|NCT03103646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102164116|NCT03103646|Hormone Antagonists|hormone antagonists|mesh-ancestor
101446199|NCT00187005|Alkylating Agents|alkylating agents|mesh-ancestor
102164117|NCT03103646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102164118|NCT03103646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164119|NCT03103646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102164120|NCT01554410|Gemcitabine|gemcitabine|mesh-list
102164121|NCT01554410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102164122|NCT01554410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102164123|NCT01554410|Antimetabolites|antimetabolites|mesh-ancestor
102164124|NCT01554410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164125|NCT01499888|Sirolimus|sirolimus|mesh-list
102164126|NCT01499888|Alemtuzumab|alemtuzumab|mesh-list
102164127|NCT01499888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102164128|NCT01499888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102164129|NCT01499888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102164130|NCT01499888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102164131|NCT01499888|Antifungal Agents|antifungal agents|mesh-ancestor
102164132|NCT01499888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102164133|NCT01499888|Immunologic Factors|immunologic factors|mesh-ancestor
102164134|NCT01499888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164135|NCT01499888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102164136|NCT03299829|Trientine|trientine|mesh-list
102164137|NCT03299829|Chelating Agents|chelating agents|mesh-ancestor
102164138|NCT03299829|Sequestering Agents|sequestering agents|mesh-ancestor
102164139|NCT03299829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164140|NCT04968158|Acetaminophen|acetaminophen|mesh-list
102164141|NCT04968158|Etoricoxib|etoricoxib|mesh-list
102164142|NCT04968158|Tramadol|tramadol|mesh-list
102164143|NCT04968158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102164144|NCT04968158|Analgesics|analgesics|mesh-ancestor
102164145|NCT04968158|Sensory System Agents|sensory system agents|mesh-ancestor
102164146|NCT04968158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102164147|NCT04968158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164148|NCT04968158|Antipyretics|antipyretics|mesh-ancestor
102164149|NCT04968158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102164150|NCT04968158|Narcotics|narcotics|mesh-ancestor
102164151|NCT04968158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102164152|NCT04968158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102164153|NCT04968158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102164154|NCT04968158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102164155|NCT04968158|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102164156|NCT04968158|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102164157|NCT04968158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102164158|NCT04968158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164159|NCT02059915|Oxycodone|oxycodone|mesh-list
102164160|NCT02059915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102164161|NCT02059915|Narcotics|narcotics|mesh-ancestor
102164162|NCT02059915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102164163|NCT02059915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164164|NCT02059915|Analgesics|analgesics|mesh-ancestor
102164165|NCT02059915|Sensory System Agents|sensory system agents|mesh-ancestor
102164166|NCT02059915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102164167|NCT02471404|Dapagliflozin|dapagliflozin|mesh-list
102164168|NCT02471404|Glimepiride|glimepiride|mesh-list
102164169|NCT02471404|Saxagliptin|saxagliptin|mesh-list
102164170|NCT02471404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102164171|NCT02471404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164172|NCT02471404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102164173|NCT02471404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446204|NCT00187005|Antiemetics|antiemetics|mesh-ancestor
102164174|NCT02471404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102164175|NCT02471404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102164176|NCT02471404|Immunologic Factors|immunologic factors|mesh-ancestor
102164177|NCT02471404|Incretins|incretins|mesh-ancestor
102164178|NCT02471404|Hormones|hormones|mesh-ancestor
102164179|NCT02471404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102164180|NCT02471404|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102164181|NCT02471404|Protease Inhibitors|protease inhibitors|mesh-ancestor
102164182|NCT02471404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102164183|NCT00835094|Mometasone Furoate|mometasone furoate|mesh-list
102164184|NCT00835094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102164185|NCT00835094|Dermatologic Agents|dermatologic agents|mesh-ancestor
102164186|NCT00835094|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102164187|NCT02061475|Lidocaine|lidocaine|mesh-list
102164188|NCT02061475|Anesthetics, Local|anesthetics, local|mesh-ancestor
102164189|NCT02061475|Anesthetics|anesthetics|mesh-ancestor
102164190|NCT02061475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102164191|NCT02061475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164192|NCT02061475|Sensory System Agents|sensory system agents|mesh-ancestor
102164193|NCT02061475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102164194|NCT02061475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102164195|NCT02061475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102164196|NCT02061475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102164197|NCT02061475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102164198|NCT02061475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164199|NCT03100994|Bupivacaine|bupivacaine|mesh-list
102164200|NCT03100994|Anesthetics, Local|anesthetics, local|mesh-ancestor
102164201|NCT03100994|Anesthetics|anesthetics|mesh-ancestor
102164202|NCT03100994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102164203|NCT03100994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164204|NCT03100994|Sensory System Agents|sensory system agents|mesh-ancestor
102164205|NCT03100994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102164206|NCT04160936|Bupivacaine|bupivacaine|mesh-list
102164207|NCT04160936|Anesthetics, Local|anesthetics, local|mesh-ancestor
102164208|NCT04160936|Anesthetics|anesthetics|mesh-ancestor
102164209|NCT04160936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102164210|NCT04160936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164211|NCT04160936|Sensory System Agents|sensory system agents|mesh-ancestor
102164212|NCT04160936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102164213|NCT03103334|Methotrexate|methotrexate|mesh-list
102164214|NCT03103334|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102164215|NCT03103334|Abortifacient Agents|abortifacient agents|mesh-ancestor
102164216|NCT03103334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102164217|NCT03103334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164218|NCT03103334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102164219|NCT03103334|Antimetabolites|antimetabolites|mesh-ancestor
102164220|NCT03103334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164221|NCT03103334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102164223|NCT03103334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102164224|NCT03103334|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102164225|NCT03103334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102164226|NCT03103334|Immunologic Factors|immunologic factors|mesh-ancestor
102164227|NCT03103334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102164228|NCT03103334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102164229|NCT02471014|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102164230|NCT02471014|Immunologic Factors|immunologic factors|mesh-ancestor
102164231|NCT02471014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164232|NCT00795158|Desloratadine|desloratadine|mesh-list
102164233|NCT00795158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102164234|NCT00795158|Cholinergic Agents|cholinergic agents|mesh-ancestor
102164235|NCT00795158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102164236|NCT00795158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164237|NCT00795158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164238|NCT00795158|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102164239|NCT00795158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102164240|NCT00795158|Histamine Antagonists|histamine antagonists|mesh-ancestor
102164241|NCT00795158|Histamine Agents|histamine agents|mesh-ancestor
102164242|NCT02063269|Rivastigmine|rivastigmine|mesh-list
102164243|NCT02063269|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102164244|NCT02063269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102164245|NCT02063269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164246|NCT02063269|Cholinergic Agents|cholinergic agents|mesh-ancestor
102164247|NCT02063269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102164248|NCT02063269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164249|NCT02063269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102164250|NCT02063269|Protective Agents|protective agents|mesh-ancestor
102164251|NCT00794846|Cetirizine|cetirizine|mesh-list
102164252|NCT00794846|Desloratadine|desloratadine|mesh-list
102164253|NCT00794846|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102164254|NCT00794846|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102164255|NCT00794846|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102164256|NCT00794846|Histamine Antagonists|histamine antagonists|mesh-ancestor
102164257|NCT00794846|Histamine Agents|histamine agents|mesh-ancestor
102164258|NCT00794846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102164259|NCT00794846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164260|NCT00794846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164261|NCT00794846|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102164262|NCT00794846|Cholinergic Agents|cholinergic agents|mesh-ancestor
102164263|NCT00794768|Fexofenadine|fexofenadine|mesh-list
102164264|NCT00794768|Desloratadine|desloratadine|mesh-list
102164265|NCT00794768|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102164266|NCT00794768|Cholinergic Agents|cholinergic agents|mesh-ancestor
102164267|NCT00794768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102164268|NCT00794768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164269|NCT00794768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164270|NCT00794768|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102164271|NCT00794768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102164272|NCT00794768|Histamine Antagonists|histamine antagonists|mesh-ancestor
102164273|NCT00794768|Histamine Agents|histamine agents|mesh-ancestor
102164274|NCT00794768|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102164275|NCT02060851|Iron|iron|mesh-list
102164276|NCT02060851|Trace Elements|trace elements|mesh-ancestor
102164277|NCT02060851|Micronutrients|micronutrients|mesh-ancestor
102164278|NCT02060851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164279|NCT00779636|Desloratadine|desloratadine|mesh-list
102164280|NCT00779636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102164282|NCT00779636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102164283|NCT00779636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164284|NCT00779636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164285|NCT00779636|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102164286|NCT00779636|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102164287|NCT00779636|Histamine Antagonists|histamine antagonists|mesh-ancestor
102164288|NCT00779636|Histamine Agents|histamine agents|mesh-ancestor
102164289|NCT02060929|Esketamine|esketamine|mesh-list
102164290|NCT02060929|Antidepressive Agents|antidepressive agents|mesh-ancestor
102164291|NCT02060929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102164292|NCT00757562|Desloratadine|desloratadine|mesh-list
102164293|NCT00757562|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102164294|NCT00757562|Cholinergic Agents|cholinergic agents|mesh-ancestor
102164295|NCT00757562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102164296|NCT00757562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164297|NCT00757562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164298|NCT00757562|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102164299|NCT00757562|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102164300|NCT00757562|Histamine Antagonists|histamine antagonists|mesh-ancestor
102164301|NCT00757562|Histamine Agents|histamine agents|mesh-ancestor
102164302|NCT03299517|Lidocaine|lidocaine|mesh-list
102164303|NCT03299517|Amiodarone|amiodarone|mesh-list
102164304|NCT03299517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
102164305|NCT03299517|Anesthetics, Local|anesthetics, local|mesh-ancestor
102164306|NCT03299517|Anesthetics|anesthetics|mesh-ancestor
102164307|NCT03299517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102164308|NCT03299517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164309|NCT03299517|Sensory System Agents|sensory system agents|mesh-ancestor
102164310|NCT03299517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102164311|NCT03299517|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102164312|NCT03299517|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102164313|NCT03299517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102164314|NCT03299517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164315|NCT03299517|Vasodilator Agents|vasodilator agents|mesh-ancestor
102164316|NCT03299517|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102164317|NCT03299517|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102164318|NCT03299517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102164319|NCT03299517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102164320|NCT03299517|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102164321|NCT03299517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102164322|NCT03299517|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102164323|NCT00651404|Ezetimibe|ezetimibe|mesh-list
102164324|NCT00651404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102164325|NCT00651404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102164326|NCT00651404|Antimetabolites|antimetabolites|mesh-ancestor
102164327|NCT00651404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164328|NCT00651404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102164329|NCT00651014|Ezetimibe|ezetimibe|mesh-list
102164330|NCT00651014|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102164331|NCT00651014|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102164332|NCT00651014|Antimetabolites|antimetabolites|mesh-ancestor
102164333|NCT00651014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164334|NCT00651014|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102164335|NCT04435418|Apixaban|apixaban|mesh-list
102164336|NCT04435418|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102164337|NCT04435418|Antithrombins|antithrombins|mesh-ancestor
102164338|NCT04435418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102164339|NCT04435418|Protease Inhibitors|protease inhibitors|mesh-ancestor
102164340|NCT04435418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102164341|NCT04435418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164342|NCT04435418|Anticoagulants|anticoagulants|mesh-ancestor
102164343|NCT02062255|Aspirin|aspirin|mesh-list
102164344|NCT02062255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102164345|NCT02062255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102164346|NCT02062255|Analgesics|analgesics|mesh-ancestor
102164347|NCT02062255|Sensory System Agents|sensory system agents|mesh-ancestor
102164348|NCT02062255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102164349|NCT02062255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164350|NCT02062255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102164351|NCT02062255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102164352|NCT02062255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102164353|NCT02062255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102164354|NCT02062255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164355|NCT02062255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102164356|NCT02062255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102164357|NCT02062255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102164358|NCT02062255|Antipyretics|antipyretics|mesh-ancestor
102164359|NCT02739542|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102164360|NCT02739542|Dermatologic Agents|dermatologic agents|mesh-ancestor
102164361|NCT02739542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102164362|NCT02739542|Immunologic Factors|immunologic factors|mesh-ancestor
102164363|NCT02739542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164364|NCT02466477|Psychotropic Drugs|psychotropic drugs|mesh-list
102164365|NCT05547243|Vaccines|vaccines|mesh-list
102164366|NCT05547243|Immunologic Factors|immunologic factors|mesh-ancestor
102164367|NCT05547243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164368|NCT03100604|Sevoflurane|sevoflurane|mesh-list
101873223|NCT01178320|Niacin|niacin|mesh-list
102164370|NCT03100604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102164371|NCT03100604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102164372|NCT03100604|Anesthetics, General|anesthetics, general|mesh-ancestor
102164373|NCT03100604|Anesthetics|anesthetics|mesh-ancestor
102164374|NCT03100604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102164375|NCT03100604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164376|NCT00398294|Simvastatin|simvastatin|mesh-list
102164377|NCT00398294|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102164378|NCT00398294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102164379|NCT00398294|Antimetabolites|antimetabolites|mesh-ancestor
102164380|NCT00398294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164381|NCT00398294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101446293|NCT00577837|Risedronic Acid|risedronic acid|mesh-list
102164382|NCT00398294|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102164383|NCT00398294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102164384|NCT04823403|Nivolumab|nivolumab|mesh-list
102164385|NCT04823403|Ipilimumab|ipilimumab|mesh-list
102164386|NCT04823403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102164387|NCT04823403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102164388|NCT04823403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102164389|NCT04823403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164390|NCT03493646|Azacitidine|azacitidine|mesh-list
102164391|NCT03493646|Cc-486|cc-486|mesh-list
102164392|NCT03493646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102164393|NCT03493646|Antimetabolites|antimetabolites|mesh-ancestor
102164394|NCT03493646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164395|NCT03493646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102164396|NCT03493646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102164397|NCT05519865|Tislelizumab|tislelizumab|mesh-list
102164398|NCT05519865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102164399|NCT05519865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102164400|NCT05500443|Vitamin K|vitamin k|mesh-list
102164401|NCT05500443|Vitamin K 2|vitamin k 2|mesh-list
102164402|NCT05500443|Menaquinone 7|menaquinone 7|mesh-list
102164403|NCT05500443|Vitamins|vitamins|mesh-ancestor
102164404|NCT05500443|Micronutrients|micronutrients|mesh-ancestor
102164405|NCT05500443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164406|NCT05500443|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102164407|NCT05500443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102164408|NCT05500443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164409|NCT05500443|Hemostatics|hemostatics|mesh-ancestor
102164410|NCT05500443|Coagulants|coagulants|mesh-ancestor
102164411|NCT05244200|Insulin|insulin|mesh-list
102164412|NCT05244200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102164413|NCT05244200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164414|NCT03451370|Bevacizumab|bevacizumab|mesh-list
102164415|NCT03451370|Capecitabine|capecitabine|mesh-list
102164416|NCT03451370|Oxaliplatin|oxaliplatin|mesh-list
102164417|NCT03451370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102164418|NCT03451370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102164419|NCT03451370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102164420|NCT03451370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102164421|NCT03451370|Growth Substances|growth substances|mesh-ancestor
102164422|NCT03451370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164423|NCT03451370|Growth Inhibitors|growth inhibitors|mesh-ancestor
102164424|NCT03451370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102164425|NCT03451370|Antimetabolites|antimetabolites|mesh-ancestor
102164426|NCT03451370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164427|NCT03991832|Durvalumab|durvalumab|mesh-list
102164428|NCT03991832|Olaparib|olaparib|mesh-list
102164429|NCT03991832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102164430|NCT03991832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102164431|NCT03991832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102164432|NCT03991832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102164433|NCT03991832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164434|NCT01361594|Insulin|insulin|mesh-list
102164435|NCT01361594|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102164436|NCT01361594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102164437|NCT01361594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164438|NCT04435028|Ketotifen|ketotifen|mesh-list
102164439|NCT04435028|Antipruritics|antipruritics|mesh-ancestor
102164440|NCT04435028|Dermatologic Agents|dermatologic agents|mesh-ancestor
102164441|NCT04435028|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102164442|NCT04435028|Histamine Antagonists|histamine antagonists|mesh-ancestor
102164443|NCT04435028|Histamine Agents|histamine agents|mesh-ancestor
102164444|NCT04435028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102164445|NCT04435028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164446|NCT04435028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164447|NCT04435028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102164448|NCT03945812|Lenograstim|lenograstim|mesh-list
102164449|NCT03945812|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102164450|NCT03945812|Immunologic Factors|immunologic factors|mesh-ancestor
102164451|NCT03945812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164452|NCT05060198|Lumefantrine|lumefantrine|mesh-list
102164453|NCT05060198|Artemether|artemether|mesh-list
102164454|NCT05060198|Piperaquine|piperaquine|mesh-list
102164455|NCT05060198|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102164456|NCT05060198|Artenimol|artenimol|mesh-list
102164457|NCT05060198|Antimalarials|antimalarials|mesh-ancestor
102164458|NCT05060198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102164459|NCT05060198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102164460|NCT05060198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102164461|NCT04478084|Vaccines|vaccines|mesh-list
102164462|NCT04478084|Immunoglobulins|immunoglobulins|mesh-list
102164463|NCT04478084|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102164464|NCT04478084|Antibodies|antibodies|mesh-list
102164465|NCT04478084|Immunologic Factors|immunologic factors|mesh-ancestor
102164466|NCT04478084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164467|NCT03098888|Dimercaprol|dimercaprol|mesh-list
102164468|NCT03098888|Chelating Agents|chelating agents|mesh-ancestor
102164469|NCT03098888|Sequestering Agents|sequestering agents|mesh-ancestor
102164470|NCT03098888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164471|NCT03098810|Zinc Sulfate|zinc sulfate|mesh-list
102164472|NCT03098810|Astringents|astringents|mesh-ancestor
102164473|NCT03098810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164474|NCT03098810|Dermatologic Agents|dermatologic agents|mesh-ancestor
102164475|NCT02464761|Verteporfin|verteporfin|mesh-list
102164476|NCT02464761|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102164477|NCT02464761|Dermatologic Agents|dermatologic agents|mesh-ancestor
102164478|NCT02462889|Aflibercept|aflibercept|mesh-list
102164479|NCT02462889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102164480|NCT02462889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102164481|NCT02462889|Growth Substances|growth substances|mesh-ancestor
102164482|NCT02462889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164483|NCT02462889|Growth Inhibitors|growth inhibitors|mesh-ancestor
102164484|NCT02462889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102164485|NCT02462577|Morphine|morphine|mesh-list
102164486|NCT02462577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102164487|NCT02462577|Narcotics|narcotics|mesh-ancestor
102164488|NCT02462577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102164489|NCT02462577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164490|NCT02462577|Analgesics|analgesics|mesh-ancestor
102164491|NCT02462577|Sensory System Agents|sensory system agents|mesh-ancestor
102164492|NCT02462577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102164493|NCT02462499|Eplerenone|eplerenone|mesh-list
102164494|NCT02462499|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102164495|NCT02462499|Hormone Antagonists|hormone antagonists|mesh-ancestor
102164496|NCT02462499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102164497|NCT02462499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164498|NCT02462499|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102164499|NCT02462499|Diuretics|diuretics|mesh-ancestor
102164500|NCT02462499|Natriuretic Agents|natriuretic agents|mesh-ancestor
102164501|NCT02462499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102164502|NCT02464683|Vitamin D|vitamin d|mesh-list
102164503|NCT02464683|Vitamins|vitamins|mesh-ancestor
102164504|NCT02464683|Micronutrients|micronutrients|mesh-ancestor
102164505|NCT02464683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164506|NCT02464683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102164507|NCT02061631|Dexamethasone|dexamethasone|mesh-list
102164508|NCT02061631|Dexamethasone acetate|dexamethasone acetate|mesh-list
102164509|NCT02061631|Docetaxel|docetaxel|mesh-list
102164510|NCT02061631|BB 1101|bb 1101|mesh-list
102164511|NCT02061631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102164512|NCT02061631|Antiemetics|antiemetics|mesh-ancestor
102164513|NCT02061631|Autonomic Agents|autonomic agents|mesh-ancestor
102164514|NCT02061631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102164515|NCT02061631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164516|NCT02061631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102164517|NCT02061631|Glucocorticoids|glucocorticoids|mesh-ancestor
102164518|NCT02061631|Hormones|hormones|mesh-ancestor
102164519|NCT02061631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102164520|NCT02061631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102164521|NCT02061631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102164522|NCT02061631|Protease Inhibitors|protease inhibitors|mesh-ancestor
102164523|NCT02061631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102164524|NCT02061631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164525|NCT02061631|Tubulin Modulators|tubulin modulators|mesh-ancestor
102164526|NCT02061631|Antimitotic Agents|antimitotic agents|mesh-ancestor
102164527|NCT02061631|Mitosis Modulators|mitosis modulators|mesh-ancestor
102164529|NCT03098342|Methylene Blue|methylene blue|mesh-list
102164530|NCT03098342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102164531|NCT03098342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164532|NCT03098342|Antifungal Agents|antifungal agents|mesh-ancestor
102164533|NCT03098342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102164534|NCT05059418|Clonazepam|clonazepam|mesh-list
102164535|NCT05059418|Capsaicin|capsaicin|mesh-list
102164536|NCT05059418|Antipruritics|antipruritics|mesh-ancestor
102164537|NCT05059418|Dermatologic Agents|dermatologic agents|mesh-ancestor
102164538|NCT05059418|Sensory System Agents|sensory system agents|mesh-ancestor
102164539|NCT05059418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102164540|NCT05059418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164541|NCT05059418|Anticonvulsants|anticonvulsants|mesh-ancestor
102164542|NCT05059418|GABA Modulators|gaba modulators|mesh-ancestor
102164543|NCT05059418|GABA Agents|gaba agents|mesh-ancestor
102164544|NCT05059418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102164545|NCT05059418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164546|NCT02062333|Dexmedetomidine|dexmedetomidine|mesh-list
102164547|NCT02062333|Esmolol|esmolol|mesh-list
102164548|NCT02062333|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102164549|NCT02062333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102164550|NCT02062333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164551|NCT02062333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102164552|NCT02062333|Analgesics|analgesics|mesh-ancestor
102164553|NCT02062333|Sensory System Agents|sensory system agents|mesh-ancestor
102164554|NCT02062333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102164555|NCT02062333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102164556|NCT02062333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102164557|NCT02062333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102164558|NCT02062333|Adrenergic Agents|adrenergic agents|mesh-ancestor
102164559|NCT02062333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102164560|NCT02062333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164561|NCT02062333|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102164562|NCT02062333|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102164563|NCT02062333|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102164564|NCT05014724|Rozanolixizumab|rozanolixizumab|mesh-list
102164565|NCT05014724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102164566|NCT05014724|Immunologic Factors|immunologic factors|mesh-ancestor
102164567|NCT05014724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164568|NCT05010668|Lenvatinib|lenvatinib|mesh-list
102164569|NCT05010668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102164570|NCT05010668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102164571|NCT05010668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102164572|NCT05010668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164573|NCT02063425|Fluoxetine|fluoxetine|mesh-list
102164574|NCT02063425|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102164575|NCT02063425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102164576|NCT02063425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102164577|NCT02063425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164578|NCT02063425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102164579|NCT02063425|Serotonin Agents|serotonin agents|mesh-ancestor
101573974|NCT02199184|Ofatumumab|ofatumumab|mesh-list
102164580|NCT02063425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164581|NCT02063425|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102164582|NCT02063425|Antidepressive Agents|antidepressive agents|mesh-ancestor
102164584|NCT02063425|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102164585|NCT02063425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102164586|NCT02063425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102164587|NCT05071118|Pregabalin|pregabalin|mesh-list
102164588|NCT05071118|Analgesics|analgesics|mesh-ancestor
102164589|NCT05071118|Sensory System Agents|sensory system agents|mesh-ancestor
102164590|NCT05071118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102164591|NCT05071118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164592|NCT05071118|Anticonvulsants|anticonvulsants|mesh-ancestor
102164593|NCT05071118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101446321|NCT00187122|Etoposide|etoposide|mesh-list
102164594|NCT05071118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102164595|NCT05071118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164596|NCT05071118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102164598|NCT05071118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102164599|NCT05071118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102164600|NCT05071118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102164601|NCT03559400|Gentamicins|gentamicins|mesh-list
102164602|NCT03559400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102164603|NCT03559400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102164604|NCT03559400|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102164605|NCT03559400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102164606|NCT03559400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164607|NCT03464019|Etripamil|etripamil|mesh-list
102164608|NCT03464019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102164609|NCT03464019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102164610|NCT03464019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164611|NCT03464019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102164612|NCT03464019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164613|NCT05070416|Lithium Carbonate|lithium carbonate|mesh-list
102164614|NCT05070416|Antidepressive Agents|antidepressive agents|mesh-ancestor
102164615|NCT05070416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102164616|NCT05070416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102164617|NCT05070416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164618|NCT05070416|Antimanic Agents|antimanic agents|mesh-ancestor
102164619|NCT05070416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102164620|NCT05070416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102164621|NCT05070416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164622|NCT05069870|Itraconazole|itraconazole|mesh-list
102164623|NCT05069870|Rifampin|rifampin|mesh-list
102164624|NCT05069870|Gemfibrozil|gemfibrozil|mesh-list
102164625|NCT05069870|Antifungal Agents|antifungal agents|mesh-ancestor
102164626|NCT05069870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102164627|NCT05069870|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102164628|NCT05069870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102164629|NCT05069870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102164630|NCT05069870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164631|NCT05069870|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102164632|NCT05069870|Hormone Antagonists|hormone antagonists|mesh-ancestor
102164633|NCT05069870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102164634|NCT05069870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164635|NCT05069870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102164636|NCT05069870|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102164637|NCT05069870|Antitubercular Agents|antitubercular agents|mesh-ancestor
102164638|NCT05069870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102164639|NCT05069870|Leprostatic Agents|leprostatic agents|mesh-ancestor
102164640|NCT05069870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102164641|NCT05069870|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102164642|NCT05069870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102164643|NCT05069870|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102164644|NCT05069870|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102164645|NCT05069870|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102164646|NCT05069870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102164647|NCT05069870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102164648|NCT05069870|Antimetabolites|antimetabolites|mesh-ancestor
102164649|NCT05069870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102164650|NCT05069870|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102164651|NCT05275491|Calcium|calcium|mesh-list
102164652|NCT05275491|Parathyroid Hormone|parathyroid hormone|mesh-list
102164653|NCT05275491|Hormones|hormones|mesh-list
102164654|NCT05275491|Mitogens|mitogens|mesh-list
102164655|NCT05275491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102164656|NCT05275491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164657|NCT05275491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102164658|NCT05275491|Mitosis Modulators|mitosis modulators|mesh-ancestor
102164659|NCT05275491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164660|NCT02976753|Factor VIII|factor viii|mesh-list
102164661|NCT02976753|Coagulants|coagulants|mesh-ancestor
102164662|NCT04559529|Levetiracetam|levetiracetam|mesh-list
102164663|NCT04559529|Anticonvulsants|anticonvulsants|mesh-ancestor
102164664|NCT04559529|Nootropic Agents|nootropic agents|mesh-ancestor
102164665|NCT04490421|Etoposide|etoposide|mesh-list
102164666|NCT04490421|Apatinib|apatinib|mesh-list
102164667|NCT04490421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102164668|NCT04490421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102164669|NCT04490421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102164670|NCT04490421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102164671|NCT04490421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102164672|NCT04490421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164673|NCT04490421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102164674|NCT04542291|Dapagliflozin|dapagliflozin|mesh-list
102164675|NCT04542291|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102164676|NCT04542291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164677|NCT04542291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102164678|NCT04542291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164679|NCT02462109|Lorazepam|lorazepam|mesh-list
102164680|NCT02462109|Anticonvulsants|anticonvulsants|mesh-ancestor
102164681|NCT02462109|Antiemetics|antiemetics|mesh-ancestor
102164682|NCT02462109|Autonomic Agents|autonomic agents|mesh-ancestor
102164683|NCT02462109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102164684|NCT02462109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164685|NCT02462109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102164686|NCT02462109|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102164687|NCT02462109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102164688|NCT02462109|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102164689|NCT02462109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102164690|NCT02462109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102164691|NCT02462109|GABA Modulators|gaba modulators|mesh-ancestor
102164692|NCT02462109|GABA Agents|gaba agents|mesh-ancestor
102164693|NCT02462109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102164694|NCT02462109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164695|NCT02063581|Ipatasertib|ipatasertib|mesh-list
102164696|NCT02063581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102164697|NCT02063581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102164698|NCT02063581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102164699|NCT02063581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164700|NCT02056899|Gabapentin|gabapentin|mesh-list
102164701|NCT02056899|Analgesics|analgesics|mesh-ancestor
102164702|NCT02056899|Sensory System Agents|sensory system agents|mesh-ancestor
102164703|NCT02056899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102164704|NCT02056899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164705|NCT02056899|Anticonvulsants|anticonvulsants|mesh-ancestor
102164706|NCT02056899|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102164707|NCT02056899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102164708|NCT02056899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102164709|NCT02056899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102164710|NCT02056899|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102164711|NCT02056899|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102164712|NCT02056899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102164713|NCT02056899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164714|NCT02056899|Antimanic Agents|antimanic agents|mesh-ancestor
102164715|NCT02462265|Mitoxantrone|mitoxantrone|mesh-list
102164716|NCT02462265|Antineoplastic Agents|antineoplastic agents|mesh-list
102164717|NCT02462265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164718|NCT02462265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164719|NCT02462265|Analgesics|analgesics|mesh-ancestor
102164720|NCT02462265|Sensory System Agents|sensory system agents|mesh-ancestor
102164721|NCT02462265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102164722|NCT02462265|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102164723|NCT02462265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102164724|NCT02462265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102164725|NCT02461875|Cabergoline|cabergoline|mesh-list
102164726|NCT02461875|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102164727|NCT02461875|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102164728|NCT02461875|Dopamine Agonists|dopamine agonists|mesh-ancestor
102164729|NCT02461875|Dopamine Agents|dopamine agents|mesh-ancestor
102164730|NCT02461875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102164731|NCT02461875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164732|NCT02461875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164734|NCT02461719|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102164735|NCT02461719|Cyclosporins|cyclosporins|mesh-list
102164736|NCT02461719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102164737|NCT02461719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164738|NCT02461719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102164739|NCT02461719|Immunologic Factors|immunologic factors|mesh-ancestor
102164740|NCT02461719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164741|NCT02461719|Antifungal Agents|antifungal agents|mesh-ancestor
102164742|NCT02461719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102164743|NCT02461719|Dermatologic Agents|dermatologic agents|mesh-ancestor
102164744|NCT02461719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102164745|NCT02461719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102164746|NCT02461719|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102164747|NCT04322643|Pembrolizumab|pembrolizumab|mesh-list
102164748|NCT04322643|Nivolumab|nivolumab|mesh-list
102164749|NCT04322643|Atezolizumab|atezolizumab|mesh-list
102164750|NCT04322643|Durvalumab|durvalumab|mesh-list
102164751|NCT04322643|Avelumab|avelumab|mesh-list
102164752|NCT04322643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102164753|NCT04322643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102164754|NCT04322643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102164755|NCT04322643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164756|NCT02796391|Nicotine|nicotine|mesh-list
102164757|NCT02796391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102164758|NCT02796391|Autonomic Agents|autonomic agents|mesh-ancestor
102164759|NCT02796391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102164760|NCT02796391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164761|NCT02796391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102164762|NCT02796391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102164763|NCT02796391|Cholinergic Agents|cholinergic agents|mesh-ancestor
102164764|NCT02796391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102164765|NCT02796391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164766|NCT02064049|Sofosbuvir|sofosbuvir|mesh-list
102164767|NCT02064049|Velpatasvir|velpatasvir|mesh-list
102164768|NCT02064049|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102164769|NCT02064049|Antiviral Agents|antiviral agents|mesh-ancestor
102164770|NCT02064049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102164771|NCT02064829|Paclitaxel|paclitaxel|mesh-list
102164772|NCT02064829|genexol-PM|genexol-pm|mesh-list
102164773|NCT02064829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102164774|NCT02064829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102164775|NCT02064829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102164776|NCT02064829|Tubulin Modulators|tubulin modulators|mesh-ancestor
102164777|NCT02064829|Antimitotic Agents|antimitotic agents|mesh-ancestor
102164778|NCT02064829|Mitosis Modulators|mitosis modulators|mesh-ancestor
102164779|NCT02064829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164780|NCT02064517|Calcium|calcium|mesh-list
102164781|NCT02064517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102164782|NCT02064517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164783|NCT02067949|Simvastatin|simvastatin|mesh-list
102164784|NCT02067949|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102164785|NCT02067949|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102164786|NCT02067949|Antimetabolites|antimetabolites|mesh-ancestor
102164787|NCT02067949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164788|NCT02067949|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102164789|NCT02067949|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102164790|NCT02067949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102164791|NCT02068339|Oltipraz|oltipraz|mesh-list
102164792|NCT02068339|Antiviral Agents|antiviral agents|mesh-ancestor
102164793|NCT02068339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102164794|NCT02068339|Schistosomicides|schistosomicides|mesh-ancestor
102164795|NCT02068339|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102164796|NCT02068339|Anthelmintics|anthelmintics|mesh-ancestor
102164797|NCT02068339|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102164798|NCT02068339|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102164799|NCT02068339|Protective Agents|protective agents|mesh-ancestor
102164800|NCT02068339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164801|NCT02068339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102164802|NCT02068339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102164803|NCT02068339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102164804|NCT02068339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102164805|NCT02068339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164806|NCT02065843|Midazolam|midazolam|mesh-list
102164807|NCT02065843|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102164808|NCT02065843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102164809|NCT02065843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102164810|NCT02065843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164811|NCT02065843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102164812|NCT02065843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102164813|NCT02065843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102164814|NCT02065843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102164815|NCT02065843|Anesthetics, General|anesthetics, general|mesh-ancestor
102164816|NCT02065843|Anesthetics|anesthetics|mesh-ancestor
102164817|NCT02065843|GABA Modulators|gaba modulators|mesh-ancestor
101873664|NCT00114972|Paclitaxel|paclitaxel|mesh-list
102164818|NCT02065843|GABA Agents|gaba agents|mesh-ancestor
102164819|NCT02065843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102164820|NCT02065843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164821|NCT02066077|Propofol|propofol|mesh-list
102164822|NCT02066077|Etomidate|etomidate|mesh-list
102164823|NCT02066077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102164824|NCT02066077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102164825|NCT02066077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164826|NCT02066077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102164827|NCT02066077|Anesthetics, General|anesthetics, general|mesh-ancestor
102164828|NCT02066077|Anesthetics|anesthetics|mesh-ancestor
102164829|NCT03350815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102164830|NCT03350815|Immunologic Factors|immunologic factors|mesh-ancestor
102164831|NCT03350815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164832|NCT02065063|Palbociclib|palbociclib|mesh-list
102164833|NCT02065063|Trametinib|trametinib|mesh-list
102164834|NCT02065063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102164835|NCT02065063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102164836|NCT02065063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102164837|NCT02065063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164838|NCT02069197|Orlistat|orlistat|mesh-list
102164839|NCT02069197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102164840|NCT02069197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164841|NCT02069197|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102164842|NCT02069197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102164843|NCT02069431|Oxytocin|oxytocin|mesh-list
102164844|NCT02069431|Oxytocics|oxytocics|mesh-ancestor
102164845|NCT02069431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102164846|NCT02069431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164847|NCT01652872|Darbepoetin alfa|darbepoetin alfa|mesh-list
102164848|NCT01652872|Hematinics|hematinics|mesh-ancestor
102164849|NCT02065219|Bupivacaine|bupivacaine|mesh-list
102164850|NCT02065219|Anesthetics, Local|anesthetics, local|mesh-ancestor
102164851|NCT02065219|Anesthetics|anesthetics|mesh-ancestor
102164852|NCT02065219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102164853|NCT02065219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164854|NCT02065219|Sensory System Agents|sensory system agents|mesh-ancestor
102164855|NCT02065219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102164856|NCT03560011|Immunoglobulins|immunoglobulins|mesh-list
102164857|NCT03560011|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102164858|NCT03560011|Antibodies|antibodies|mesh-list
102164859|NCT03560011|Immunologic Factors|immunologic factors|mesh-ancestor
102164860|NCT03560011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164861|NCT02069665|Ribavirin|ribavirin|mesh-list
102164862|NCT02069665|Ibuprofen|ibuprofen|mesh-list
102164863|NCT02069665|Phenylpropanolamine|phenylpropanolamine|mesh-list
102164864|NCT02069665|Albuterol|albuterol|mesh-list
102164865|NCT02069665|Guaifenesin|guaifenesin|mesh-list
102164866|NCT02069665|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
102164867|NCT02069665|Antimetabolites|antimetabolites|mesh-ancestor
102164868|NCT02069665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164869|NCT02069665|Antiviral Agents|antiviral agents|mesh-ancestor
102164870|NCT02069665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102164871|NCT02069665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102164872|NCT02069665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102164873|NCT02069665|Analgesics|analgesics|mesh-ancestor
102164874|NCT02069665|Sensory System Agents|sensory system agents|mesh-ancestor
102164875|NCT02069665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102164876|NCT02069665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164877|NCT02069665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102164878|NCT02069665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102164879|NCT02069665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102164880|NCT02069665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102164881|NCT02069665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102164882|NCT02069665|Autonomic Agents|autonomic agents|mesh-ancestor
102164883|NCT02069665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102164884|NCT02069665|Respiratory System Agents|respiratory system agents|mesh-ancestor
102164885|NCT02069665|Tocolytic Agents|tocolytic agents|mesh-ancestor
102164886|NCT02069665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102164887|NCT02069665|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102164888|NCT02069665|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102164889|NCT02069665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102164890|NCT02069665|Adrenergic Agents|adrenergic agents|mesh-ancestor
102164891|NCT02069665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102164892|NCT02069665|Expectorants|expectorants|mesh-ancestor
101873724|NCT03739528|Glucocorticoids|glucocorticoids|mesh-ancestor
102164893|NCT02069665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102164894|NCT02069665|Appetite Depressants|appetite depressants|mesh-ancestor
102164895|NCT02069665|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102164896|NCT02069665|Sympathomimetics|sympathomimetics|mesh-ancestor
102164897|NCT02069665|Nasal Decongestants|nasal decongestants|mesh-ancestor
102164898|NCT02069665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102164899|NCT04938856|Lamotrigine|lamotrigine|mesh-list
102164900|NCT04938856|Anticonvulsants|anticonvulsants|mesh-ancestor
102164901|NCT04938856|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102164902|NCT04938856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102164903|NCT04938856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164904|NCT04938856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102164905|NCT04938856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164906|NCT04938856|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102164907|NCT04938856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102164908|NCT04938856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102164909|NCT04938856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102164910|NCT04938856|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102164912|NCT02461329|Plasma Substitutes|plasma substitutes|mesh-ancestor
102164913|NCT02461329|Blood Substitutes|blood substitutes|mesh-ancestor
102164914|NCT02463825|Pimozide|pimozide|mesh-list
102164915|NCT02463825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102164916|NCT02463825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102164917|NCT02463825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102164918|NCT02463825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164919|NCT02463825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102164920|NCT02463825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102164921|NCT02463825|Dopamine Agents|dopamine agents|mesh-ancestor
102164922|NCT02463825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102164923|NCT02463825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164924|NCT02463825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102164925|NCT02069977|Aripiprazole|aripiprazole|mesh-list
102164926|NCT02069977|Antidepressive Agents|antidepressive agents|mesh-ancestor
102164927|NCT02069977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102164928|NCT02069977|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102164929|NCT02069977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102164930|NCT02069977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102164931|NCT02069977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164932|NCT02069977|Dopamine Agonists|dopamine agonists|mesh-ancestor
102164933|NCT02069977|Dopamine Agents|dopamine agents|mesh-ancestor
102164934|NCT02069977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102164935|NCT02069977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164936|NCT02069977|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102164937|NCT02069977|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102164938|NCT02069977|Serotonin Agents|serotonin agents|mesh-ancestor
102164939|NCT02069977|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102164940|NCT02069977|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102164941|NCT02069977|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102164942|NCT02069977|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102164943|NCT04490031|Ketamine|ketamine|mesh-list
102164944|NCT04490031|Analgesics|analgesics|mesh-ancestor
102164945|NCT04490031|Sensory System Agents|sensory system agents|mesh-ancestor
102164946|NCT04490031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102164947|NCT04490031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164948|NCT04490031|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102164949|NCT04490031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102164950|NCT04490031|Anesthetics, General|anesthetics, general|mesh-ancestor
102164951|NCT04490031|Anesthetics|anesthetics|mesh-ancestor
102164952|NCT04490031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102164953|NCT04490031|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102164954|NCT04490031|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102164955|NCT04490031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102164956|NCT04490031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164957|NCT02443402|Insulin|insulin|mesh-list
102164958|NCT02443402|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102164959|NCT02443402|Insulin Glargine|insulin glargine|mesh-list
102164960|NCT02443402|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102164961|NCT02443402|Insulin Aspart|insulin aspart|mesh-list
102164962|NCT02443402|Insulin Lispro|insulin lispro|mesh-list
102164963|NCT02443402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102164964|NCT02443402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164965|NCT02443402|Incretins|incretins|mesh-ancestor
102164966|NCT02443402|Hormones|hormones|mesh-ancestor
102164967|NCT02443402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101873795|NCT01180348|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102164968|NCT02443402|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102164969|NCT02443402|Protease Inhibitors|protease inhibitors|mesh-ancestor
102164970|NCT02443402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102164971|NCT02443402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164972|NCT02067013|Ranibizumab|ranibizumab|mesh-list
102164973|NCT02067013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102164974|NCT02067013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102164975|NCT02067013|Growth Substances|growth substances|mesh-ancestor
102164976|NCT02067013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164977|NCT02067013|Growth Inhibitors|growth inhibitors|mesh-ancestor
102164978|NCT02067013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102164979|NCT03298581|Clobetasol|clobetasol|mesh-list
102164980|NCT03298581|Halobetasol|halobetasol|mesh-list
102164981|NCT03298581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102164982|NCT03298581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102164983|NCT03298581|Glucocorticoids|glucocorticoids|mesh-ancestor
102164984|NCT03298581|Hormones|hormones|mesh-ancestor
102164985|NCT03298581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102164986|NCT03298581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164987|NCT01370005|Empagliflozin|empagliflozin|mesh-list
102164988|NCT01370005|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102164989|NCT01370005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164990|NCT01370005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102164991|NCT01370005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102164992|NCT02070133|Simvastatin|simvastatin|mesh-list
102164993|NCT02070133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102164994|NCT02070133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102164995|NCT02070133|Antimetabolites|antimetabolites|mesh-ancestor
102164996|NCT02070133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102164997|NCT02070133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102164998|NCT02070133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102164999|NCT02070133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102165000|NCT02070289|PF-06372865|pf-06372865|mesh-list
102165001|NCT02070289|GABA Modulators|gaba modulators|mesh-ancestor
102165002|NCT02070289|GABA Agents|gaba agents|mesh-ancestor
102165003|NCT02070289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101446362|NCT00180635|Pimagedine|pimagedine|mesh-list
102165004|NCT02070289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165005|NCT02070289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165006|NCT02071927|Azacitidine|azacitidine|mesh-list
102165007|NCT02071927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102165008|NCT02071927|Antimetabolites|antimetabolites|mesh-ancestor
102165009|NCT02071927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165010|NCT02071927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102165011|NCT02071927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102165012|NCT02072083|Dexmedetomidine|dexmedetomidine|mesh-list
102165013|NCT02072083|Ketamine|ketamine|mesh-list
102165014|NCT02072083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102165015|NCT02072083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102165016|NCT02072083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165017|NCT02072083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102165018|NCT02072083|Analgesics|analgesics|mesh-ancestor
102165019|NCT02072083|Sensory System Agents|sensory system agents|mesh-ancestor
102165020|NCT02072083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102165021|NCT02072083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102165022|NCT02072083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102165023|NCT02072083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102165024|NCT02072083|Adrenergic Agents|adrenergic agents|mesh-ancestor
102165025|NCT02072083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102165026|NCT02072083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165027|NCT02072083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102165028|NCT02072083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102165029|NCT02072083|Anesthetics, General|anesthetics, general|mesh-ancestor
102165030|NCT02072083|Anesthetics|anesthetics|mesh-ancestor
102165031|NCT02072083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102165032|NCT02072083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102165033|NCT02070679|Vitamin E|vitamin e|mesh-list
102165034|NCT02070679|Tocopherols|tocopherols|mesh-list
102165035|NCT02070679|alpha-Tocopherol|alpha-tocopherol|mesh-list
102165036|NCT02070679|Vitamins|vitamins|mesh-ancestor
102165037|NCT02070679|Micronutrients|micronutrients|mesh-ancestor
102165038|NCT02070679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165039|NCT02070679|Antioxidants|antioxidants|mesh-ancestor
102165040|NCT02070679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165041|NCT02070679|Protective Agents|protective agents|mesh-ancestor
102165042|NCT02412436|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102165043|NCT02412436|Medroxyprogesterone|medroxyprogesterone|mesh-list
102165044|NCT02412436|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102165045|NCT02412436|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102165046|NCT02412436|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102165047|NCT02412436|Contraceptive Agents|contraceptive agents|mesh-ancestor
102165048|NCT02412436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102165049|NCT02412436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165050|NCT02412436|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102165051|NCT02412436|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102165052|NCT02412436|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102165053|NCT02412436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102165054|NCT02412436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102165055|NCT02067715|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102165056|NCT02067715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102165057|NCT02067715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102165058|NCT02072317|Raltitrexed|raltitrexed|mesh-list
102165059|NCT02072317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102165060|NCT02072317|Antimetabolites|antimetabolites|mesh-ancestor
102165061|NCT02072317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165062|NCT02072317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102165063|NCT02072317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102165064|NCT02072317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102165065|NCT01651000|Calcifediol|calcifediol|mesh-list
102165067|NCT01651000|Micronutrients|micronutrients|mesh-ancestor
102165068|NCT01651000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165069|NCT01651000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102165070|NCT02469610|Bupivacaine|bupivacaine|mesh-list
102165071|NCT02469610|Anesthetics, Local|anesthetics, local|mesh-ancestor
102165072|NCT02469610|Anesthetics|anesthetics|mesh-ancestor
102165073|NCT02469610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101308109|NCT02045849|Hormone Antagonists|hormone antagonists|mesh-ancestor
102165074|NCT02469610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165075|NCT02469610|Sensory System Agents|sensory system agents|mesh-ancestor
102165076|NCT02469610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102165077|NCT02071069|Fluorouracil|fluorouracil|mesh-list
102165078|NCT02071069|Irinotecan|irinotecan|mesh-list
102165079|NCT02071069|Cetuximab|cetuximab|mesh-list
102165080|NCT02071069|Antimetabolites|antimetabolites|mesh-ancestor
102165081|NCT02071069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165082|NCT02071069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102165083|NCT02071069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102165084|NCT02071069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102165085|NCT02071069|Immunologic Factors|immunologic factors|mesh-ancestor
102165086|NCT02071069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165087|NCT02071069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102165088|NCT02071069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102165089|NCT02071069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102165090|NCT02071069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102165091|NCT02076373|Epoetin Alfa|epoetin alfa|mesh-list
102165092|NCT02076373|Hematinics|hematinics|mesh-ancestor
102165093|NCT02072785|Vincristine|vincristine|mesh-list
102165094|NCT02072785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102165095|NCT02072785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102165096|NCT02072785|Tubulin Modulators|tubulin modulators|mesh-ancestor
102165097|NCT02072785|Antimitotic Agents|antimitotic agents|mesh-ancestor
102165098|NCT02072785|Mitosis Modulators|mitosis modulators|mesh-ancestor
101573975|NCT02199184|Podophyllotoxin|podophyllotoxin|mesh-list
102165099|NCT02072785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165100|NCT02469298|Oseltamivir|oseltamivir|mesh-list
102165101|NCT02469298|Antiviral Agents|antiviral agents|mesh-ancestor
102165102|NCT02469298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102165103|NCT02469298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102165104|NCT02469298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165105|NCT02076451|DS-8273a|ds-8273a|mesh-list
102165106|NCT02076451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102165107|NCT02076451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102165108|NCT02071303|Celecoxib|celecoxib|mesh-list
102165109|NCT02071303|Tramadol|tramadol|mesh-list
102165110|NCT02071303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102165111|NCT02071303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102165112|NCT02071303|Analgesics|analgesics|mesh-ancestor
102165113|NCT02071303|Sensory System Agents|sensory system agents|mesh-ancestor
102165114|NCT02071303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102165115|NCT02071303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165116|NCT02071303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102165117|NCT02071303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102165118|NCT02071303|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102165119|NCT02071303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102165120|NCT02071303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102165121|NCT02071303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165122|NCT02071303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102165124|NCT02071303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102165125|NCT02076529|Ramosetron|ramosetron|mesh-list
102165126|NCT02076529|Antiemetics|antiemetics|mesh-ancestor
102165127|NCT02076529|Autonomic Agents|autonomic agents|mesh-ancestor
102165128|NCT02076529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102165129|NCT02076529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165130|NCT02076529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102165131|NCT02076529|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102165132|NCT02076529|Serotonin Agents|serotonin agents|mesh-ancestor
102165133|NCT02076529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102165134|NCT02076529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165135|NCT02411578|Glucagon|glucagon|mesh-list
102165136|NCT02411578|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102165137|NCT02411578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102165138|NCT02411578|Hormones|hormones|mesh-ancestor
102165139|NCT02411578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102165140|NCT02411578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165141|NCT02411578|Incretins|incretins|mesh-ancestor
102165142|NCT02076685|Isoniazid|isoniazid|mesh-list
102165143|NCT02076685|Antitubercular Agents|antitubercular agents|mesh-ancestor
102165144|NCT02076685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102165145|NCT02076685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102165146|NCT02076685|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102165147|NCT02076685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102165148|NCT02076685|Antimetabolites|antimetabolites|mesh-ancestor
102165149|NCT02076685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165150|NCT02076685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102165151|NCT05077917|Cromolyn Sodium|cromolyn sodium|mesh-list
102165152|NCT05077917|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
102165153|NCT05077917|Immunologic Factors|immunologic factors|mesh-ancestor
102165154|NCT05077917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165155|NCT05077917|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102165156|NCT05077917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102165158|NCT05077917|Respiratory System Agents|respiratory system agents|mesh-ancestor
102165159|NCT02071459|Droxidopa|droxidopa|mesh-list
102165160|NCT02071459|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102165161|NCT02071459|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102165162|NCT02463747|Vancomycin|vancomycin|mesh-list
102165163|NCT02463747|Meropenem|meropenem|mesh-list
102165164|NCT02463747|Tazobactam|tazobactam|mesh-list
102165165|NCT02463747|Piperacillin|piperacillin|mesh-list
102165166|NCT02463747|Ceftazidime|ceftazidime|mesh-list
102165167|NCT02463747|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102165168|NCT02463747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102165169|NCT02463747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102165170|NCT02463747|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102165171|NCT02463747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102165172|NCT02463747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165173|NCT02071537|Chloroquine|chloroquine|mesh-list
102165174|NCT02071537|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
102165175|NCT02071537|Carboplatin|carboplatin|mesh-list
102165176|NCT02071537|Gemcitabine|gemcitabine|mesh-list
102165177|NCT02071537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102165178|NCT02071537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102165179|NCT02071537|Antimetabolites|antimetabolites|mesh-ancestor
102165180|NCT02071537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165181|NCT02071537|Amebicides|amebicides|mesh-ancestor
102165182|NCT02071537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102165183|NCT02071537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102165184|NCT02071537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102165185|NCT02071537|Antimalarials|antimalarials|mesh-ancestor
102165186|NCT02071537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102165187|NCT02071537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102165188|NCT02071537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102165189|NCT02071537|Analgesics|analgesics|mesh-ancestor
102165190|NCT02071537|Sensory System Agents|sensory system agents|mesh-ancestor
102165191|NCT02071537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102165192|NCT02071537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165193|NCT02071537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102165194|NCT02071537|Filaricides|filaricides|mesh-ancestor
102165195|NCT02071537|Antinematodal Agents|antinematodal agents|mesh-ancestor
102165196|NCT02071537|Anthelmintics|anthelmintics|mesh-ancestor
102165197|NCT02076841|Interferons|interferons|mesh-list
102165198|NCT02076841|Interferon-beta|interferon-beta|mesh-list
102165199|NCT02076841|Interferon beta-1a|interferon beta-1a|mesh-list
102165200|NCT02076841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102165201|NCT02076841|Antiviral Agents|antiviral agents|mesh-ancestor
102165202|NCT02076841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102165203|NCT02076841|Immunologic Factors|immunologic factors|mesh-ancestor
102165204|NCT02076841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165205|NCT02076841|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102165206|NCT02442310|Deferiprone|deferiprone|mesh-list
102165207|NCT02442310|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102165208|NCT02442310|Chelating Agents|chelating agents|mesh-ancestor
102165209|NCT02442310|Sequestering Agents|sequestering agents|mesh-ancestor
102165210|NCT02442310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165212|NCT02071615|Methylphenidate|methylphenidate|mesh-list
102165213|NCT02071615|Modafinil|modafinil|mesh-list
102165214|NCT02071615|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101308118|NCT02045914|Calcium Ionophores|calcium ionophores|mesh-list
102165215|NCT02071615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165216|NCT02071615|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102165217|NCT02071615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102165218|NCT02071615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165219|NCT02071615|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102165220|NCT02071615|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102165221|NCT02071615|Purinergic Agents|purinergic agents|mesh-ancestor
102165222|NCT02071615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102165223|NCT02071615|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102165224|NCT02071615|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102165225|NCT02071615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102165226|NCT02071615|Dopamine Agents|dopamine agents|mesh-ancestor
102165227|NCT02071615|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102165228|NCT02071615|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102165229|NCT02071615|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102165230|NCT02077231|Vitamins|vitamins|mesh-list
102165231|NCT02077231|Vitamin A|vitamin a|mesh-list
102165232|NCT02077231|Retinol palmitate|retinol palmitate|mesh-list
102165233|NCT02077231|Micronutrients|micronutrients|mesh-ancestor
102165234|NCT02077231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165235|NCT02077231|Antioxidants|antioxidants|mesh-ancestor
102165236|NCT02077231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165237|NCT02077231|Protective Agents|protective agents|mesh-ancestor
102165238|NCT02077231|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102165239|NCT02077231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102165240|NCT02077309|Linagliptin|linagliptin|mesh-list
102165241|NCT02077309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102165242|NCT02077309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165243|NCT02077309|Incretins|incretins|mesh-ancestor
102165244|NCT02077309|Hormones|hormones|mesh-ancestor
102165245|NCT02077309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102165246|NCT02077309|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102165247|NCT02077309|Protease Inhibitors|protease inhibitors|mesh-ancestor
102165248|NCT02077309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102165249|NCT02077309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165250|NCT01369849|Rituximab|rituximab|mesh-list
102165251|NCT01369849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102165252|NCT01369849|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102165253|NCT01369849|Antibodies|antibodies|mesh-list
102165254|NCT01369849|Immunoglobulins|immunoglobulins|mesh-list
102165255|NCT01369849|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102165256|NCT01369849|Immunologic Factors|immunologic factors|mesh-ancestor
102165257|NCT01369849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165258|NCT01369849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102165259|NCT01369849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102165260|NCT01369849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102165261|NCT01369849|Alkylating Agents|alkylating agents|mesh-ancestor
102165262|NCT01369849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165263|NCT02716779|Interferons|interferons|mesh-list
102165264|NCT02716779|Ribavirin|ribavirin|mesh-list
102165265|NCT02716779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102165266|NCT02716779|Antiviral Agents|antiviral agents|mesh-ancestor
102165267|NCT02716779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102165268|NCT02716779|Antimetabolites|antimetabolites|mesh-ancestor
102165269|NCT02716779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165271|NCT02074189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102165272|NCT02074189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102165273|NCT02074189|Antimetabolites|antimetabolites|mesh-ancestor
102165274|NCT02074189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165275|NCT02463591|Thrombin|thrombin|mesh-list
102165276|NCT02463591|Hemostatics|hemostatics|mesh-ancestor
102165277|NCT02463591|Coagulants|coagulants|mesh-ancestor
102165278|NCT02079961|Micronutrients|micronutrients|mesh-list
102165279|NCT02079961|Trace Elements|trace elements|mesh-list
102165280|NCT02079961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165281|NCT03298347|Caffeine|caffeine|mesh-list
102165282|NCT03298347|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102165283|NCT03298347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165284|NCT03298347|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102165285|NCT03298347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102165286|NCT03298347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165287|NCT03298347|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102165288|NCT03298347|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102165289|NCT03298347|Purinergic Agents|purinergic agents|mesh-ancestor
102165290|NCT03298347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102165291|NCT02074267|Gabapentin|gabapentin|mesh-list
102165292|NCT02074267|Analgesics|analgesics|mesh-ancestor
102165293|NCT02074267|Sensory System Agents|sensory system agents|mesh-ancestor
102165294|NCT02074267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102165295|NCT02074267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165296|NCT02074267|Anticonvulsants|anticonvulsants|mesh-ancestor
102165297|NCT02074267|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102165298|NCT02074267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102165299|NCT02074267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102165300|NCT02074267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102165301|NCT02074267|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102165302|NCT02074267|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102165303|NCT02074267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102165304|NCT02074267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165305|NCT02074267|Antimanic Agents|antimanic agents|mesh-ancestor
102165306|NCT02077777|Aminosalicylic Acid|aminosalicylic acid|mesh-list
102165307|NCT02077777|Mesalamine|mesalamine|mesh-list
102165308|NCT02077777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102165309|NCT02077777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102165310|NCT02077777|Analgesics|analgesics|mesh-ancestor
102165311|NCT02077777|Sensory System Agents|sensory system agents|mesh-ancestor
102165312|NCT02077777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102165313|NCT02077777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165314|NCT02077777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102165315|NCT02077777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102165316|NCT02077777|Antitubercular Agents|antitubercular agents|mesh-ancestor
102165317|NCT02077777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102165318|NCT02077777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102165319|NCT05036421|Empagliflozin|empagliflozin|mesh-list
102165320|NCT05036421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102165321|NCT05036421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165322|NCT05036421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102165323|NCT05036421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165324|NCT03298191|Magnesium Sulfate|magnesium sulfate|mesh-list
102165325|NCT03298191|Calcium Channel Blockers|calcium channel blockers|mesh-list
102165326|NCT03298191|Ritodrine|ritodrine|mesh-list
102165327|NCT03298191|Calcium|calcium|mesh-list
102165328|NCT03298191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102165329|NCT03298191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165330|NCT03298191|Analgesics|analgesics|mesh-ancestor
102165331|NCT03298191|Sensory System Agents|sensory system agents|mesh-ancestor
102165332|NCT03298191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102165333|NCT03298191|Anesthetics|anesthetics|mesh-ancestor
102165334|NCT03298191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102165335|NCT03298191|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102165336|NCT03298191|Anticonvulsants|anticonvulsants|mesh-ancestor
102165337|NCT03298191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102165338|NCT03298191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165339|NCT03298191|Tocolytic Agents|tocolytic agents|mesh-ancestor
102165340|NCT03298191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102165341|NCT03298191|Sympathomimetics|sympathomimetics|mesh-ancestor
102165342|NCT03298191|Autonomic Agents|autonomic agents|mesh-ancestor
102165343|NCT03298191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102165344|NCT03298191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102165345|NCT03298191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102165346|NCT03298191|Adrenergic Agents|adrenergic agents|mesh-ancestor
102165347|NCT03298191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102165348|NCT01369615|Oxycodone|oxycodone|mesh-list
102165349|NCT01369615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102165350|NCT01369615|Narcotics|narcotics|mesh-ancestor
102165351|NCT01369615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101446375|NCT00578266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102165352|NCT01369615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165353|NCT01369615|Analgesics|analgesics|mesh-ancestor
102165354|NCT01369615|Sensory System Agents|sensory system agents|mesh-ancestor
102165355|NCT01369615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102165356|NCT02077933|Everolimus|everolimus|mesh-list
102165357|NCT02077933|Exemestane|exemestane|mesh-list
102165358|NCT02077933|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102165359|NCT02077933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102165360|NCT02077933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102165361|NCT02077933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165362|NCT02077933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102165363|NCT02077933|Immunologic Factors|immunologic factors|mesh-ancestor
102165364|NCT02077933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165365|NCT02077933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102165366|NCT02077933|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102165367|NCT02077933|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102165368|NCT02077933|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102165369|NCT02077933|Hormone Antagonists|hormone antagonists|mesh-ancestor
102165370|NCT02077933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102165371|NCT02078089|Oxcarbazepine|oxcarbazepine|mesh-list
102165372|NCT02078089|Morphine|morphine|mesh-list
102165373|NCT02078089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102165374|NCT02078089|Narcotics|narcotics|mesh-ancestor
102165375|NCT02078089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102165376|NCT02078089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165377|NCT02078089|Analgesics|analgesics|mesh-ancestor
102165378|NCT02078089|Sensory System Agents|sensory system agents|mesh-ancestor
102165379|NCT02078089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102165380|NCT02078089|Anticonvulsants|anticonvulsants|mesh-ancestor
102165381|NCT02078089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102165382|NCT02078089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102165383|NCT02078089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102165384|NCT02078089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165385|NCT02078089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102165386|NCT02078089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102165387|NCT02074891|Tenofovir|tenofovir|mesh-list
102165388|NCT02074891|Antiviral Agents|antiviral agents|mesh-ancestor
102165389|NCT02074891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102165390|NCT02074891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102165391|NCT02074891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102165392|NCT02074891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102165393|NCT02074891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165394|NCT02074891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102165395|NCT02074891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102165396|NCT02078167|Policosanol|policosanol|mesh-list
102165397|NCT02078167|Red yeast rice|red yeast rice|mesh-list
102165398|NCT02078167|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102165399|NCT02078167|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102165400|NCT02078167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102165401|NCT02078167|Antimetabolites|antimetabolites|mesh-ancestor
102165402|NCT02078167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165403|NCT02078167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102165404|NCT02078167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102165405|NCT02078167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102165406|NCT02078323|Linaclotide|linaclotide|mesh-list
102165407|NCT02078323|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102165408|NCT02078323|Enzyme Activators|enzyme activators|mesh-ancestor
102165409|NCT02078323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165410|NCT02078323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102165411|NCT02075749|Triamcinolone|triamcinolone|mesh-list
102165412|NCT02075749|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102165413|NCT02075749|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102165414|NCT02075749|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102165415|NCT02075749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102165416|NCT02075749|Glucocorticoids|glucocorticoids|mesh-ancestor
102165417|NCT02075749|Hormones|hormones|mesh-ancestor
102165418|NCT02075749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102165419|NCT02075749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165420|NCT02075749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102165421|NCT02075749|Immunologic Factors|immunologic factors|mesh-ancestor
102165422|NCT02075749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102165423|NCT02075749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165424|NCT02081287|Inositol|inositol|mesh-list
102165425|NCT02081287|Lamotrigine|lamotrigine|mesh-list
102165426|NCT02081287|Anticonvulsants|anticonvulsants|mesh-ancestor
102165427|NCT02081287|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102165428|NCT02081287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102165429|NCT02081287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165430|NCT02081287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102165431|NCT02081287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165432|NCT02081287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102165433|NCT02081287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102165434|NCT02081287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102165435|NCT02081287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102165436|NCT02081287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102165437|NCT02081287|Vitamin B Complex|vitamin b complex|mesh-ancestor
102165438|NCT02081287|Vitamins|vitamins|mesh-ancestor
102165439|NCT02081287|Micronutrients|micronutrients|mesh-ancestor
102165440|NCT02078791|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102165441|NCT02078791|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102165442|NCT02078791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102165443|NCT02078791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102165444|NCT02078791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165445|NCT02078791|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102165446|NCT02078791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102165447|NCT02078791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165448|NCT02078791|Cholinergic Agents|cholinergic agents|mesh-ancestor
102165449|NCT02078791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102165450|NCT04918069|Capsaicin|capsaicin|mesh-list
102165451|NCT04918069|Antipruritics|antipruritics|mesh-ancestor
102165452|NCT04918069|Dermatologic Agents|dermatologic agents|mesh-ancestor
102165453|NCT04918069|Sensory System Agents|sensory system agents|mesh-ancestor
102165454|NCT04918069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102165455|NCT04918069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165457|NCT02083315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102165458|NCT02083315|Narcotics|narcotics|mesh-ancestor
102165459|NCT02083315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102165460|NCT02083315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165461|NCT02083315|Analgesics|analgesics|mesh-ancestor
102165462|NCT02083315|Sensory System Agents|sensory system agents|mesh-ancestor
102165463|NCT02083315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102165464|NCT03559387|Lenograstim|lenograstim|mesh-list
102165465|NCT03559387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102165466|NCT03559387|Immunologic Factors|immunologic factors|mesh-ancestor
102165467|NCT03559387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165468|NCT05519059|Paclitaxel|paclitaxel|mesh-list
102165469|NCT05519059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102165470|NCT05519059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102165471|NCT05519059|Tubulin Modulators|tubulin modulators|mesh-ancestor
102165472|NCT05519059|Antimitotic Agents|antimitotic agents|mesh-ancestor
102165473|NCT05519059|Mitosis Modulators|mitosis modulators|mesh-ancestor
102165474|NCT05519059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165475|NCT02079337|Rocuronium|rocuronium|mesh-list
102165476|NCT02079337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102165477|NCT02079337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102165478|NCT02079337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102165479|NCT02079337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102165480|NCT02079337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165481|NCT02083627|Fidaxomicin|fidaxomicin|mesh-list
102165482|NCT02083627|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102165483|NCT02083627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102165484|NCT02083627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102165485|NCT02083627|Antimetabolites|antimetabolites|mesh-ancestor
102165486|NCT02083627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165487|NCT02083627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102165488|NCT02083627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102165489|NCT02083627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102165490|NCT02083627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101874319|NCT05671276|Rivaroxaban|rivaroxaban|mesh-list
102165491|NCT02083627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102165492|NCT02079727|Celecoxib|celecoxib|mesh-list
102165493|NCT02079727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102165494|NCT02079727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102165495|NCT02079727|Analgesics|analgesics|mesh-ancestor
102165496|NCT02079727|Sensory System Agents|sensory system agents|mesh-ancestor
102165497|NCT02079727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102165498|NCT02079727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165499|NCT02079727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102165500|NCT02079727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102165501|NCT02079727|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102165502|NCT02079727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102165503|NCT02079727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102165504|NCT02079727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165505|NCT02082067|Ketorolac|ketorolac|mesh-list
102165506|NCT02082067|Morphine|morphine|mesh-list
102165507|NCT02082067|Anesthetics|anesthetics|mesh-list
102165508|NCT02082067|Ropivacaine|ropivacaine|mesh-list
102165509|NCT02082067|Levobupivacaine|levobupivacaine|mesh-list
102165510|NCT02082067|Anesthetics, Local|anesthetics, local|mesh-list
102165511|NCT02082067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102165512|NCT02082067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165513|NCT02082067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102165514|NCT02082067|Narcotics|narcotics|mesh-ancestor
102165515|NCT02082067|Analgesics|analgesics|mesh-ancestor
102165516|NCT02082067|Sensory System Agents|sensory system agents|mesh-ancestor
102165517|NCT02082067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102165518|NCT02082067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102165519|NCT02082067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102165520|NCT02082067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102165521|NCT02082067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102165522|NCT02082067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102165523|NCT02082067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102165524|NCT02082067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165525|NCT02084563|Cytarabine|cytarabine|mesh-list
102165526|NCT02084563|Decitabine|decitabine|mesh-list
102165528|NCT02084563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102165529|NCT02084563|Antimetabolites|antimetabolites|mesh-ancestor
102165530|NCT02084563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165531|NCT02084563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102165532|NCT02084563|Antiviral Agents|antiviral agents|mesh-ancestor
102165533|NCT02084563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102165534|NCT02084563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102165535|NCT02084563|Immunologic Factors|immunologic factors|mesh-ancestor
102165536|NCT02084563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165537|NCT02084563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102165538|NCT02084563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102165539|NCT02084563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102165540|NCT02084563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102165541|NCT02084719|Antibodies|antibodies|mesh-list
102165542|NCT02084719|Immunologic Factors|immunologic factors|mesh-ancestor
102165543|NCT02084719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165544|NCT02084875|Tofacitinib|tofacitinib|mesh-list
102165545|NCT02084875|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102165546|NCT02084875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102165547|NCT02084875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102165548|NCT02084875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165549|NCT02689453|Alemtuzumab|alemtuzumab|mesh-list
102165550|NCT02689453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102165551|NCT02689453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102165552|NCT02084953|Moxifloxacin|moxifloxacin|mesh-list
102165553|NCT02084953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102165554|NCT02084953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102165555|NCT02084953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102165556|NCT02084953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102165557|NCT02084953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102165558|NCT02084953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165559|NCT02084953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102165560|NCT02082613|Polidocanol|polidocanol|mesh-list
102165561|NCT02082613|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102165562|NCT02082613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102165563|NCT02085109|Theobromine|theobromine|mesh-list
102165564|NCT02085109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102165565|NCT02085109|Autonomic Agents|autonomic agents|mesh-ancestor
102165566|NCT02085109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102165567|NCT02085109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165568|NCT02085109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102165569|NCT02085109|Respiratory System Agents|respiratory system agents|mesh-ancestor
102165570|NCT02085109|Vasodilator Agents|vasodilator agents|mesh-ancestor
102165571|NCT03557983|Fenofibrate|fenofibrate|mesh-list
102165572|NCT03557983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102165573|NCT03557983|Antimetabolites|antimetabolites|mesh-ancestor
102165574|NCT03557983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165575|NCT03557983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102165576|NCT03558919|Solifenacin Succinate|solifenacin succinate|mesh-list
102165578|NCT03558919|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102165579|NCT03558919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102165580|NCT03558919|Cholinergic Agents|cholinergic agents|mesh-ancestor
102165581|NCT03558919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102165582|NCT03558919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165583|NCT03558919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165584|NCT03558919|Urological Agents|urological agents|mesh-ancestor
102165585|NCT03558919|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102165586|NCT03558919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102165587|NCT03558919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102165588|NCT03558919|Adrenergic Agents|adrenergic agents|mesh-ancestor
102165589|NCT02085577|Acetaminophen|acetaminophen|mesh-list
102165590|NCT02085577|Sufentanil|sufentanil|mesh-list
102165591|NCT02085577|Ketamine|ketamine|mesh-list
102165592|NCT02085577|Morphine|morphine|mesh-list
102165593|NCT02085577|Dsuvia|dsuvia|mesh-list
102165594|NCT02085577|Ondansetron|ondansetron|mesh-list
102165595|NCT02085577|Analgesics|analgesics|mesh-ancestor
102165596|NCT02085577|Sensory System Agents|sensory system agents|mesh-ancestor
102165597|NCT02085577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102165598|NCT02085577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165599|NCT02085577|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102165600|NCT02085577|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102165601|NCT02085577|Anesthetics, General|anesthetics, general|mesh-ancestor
102165602|NCT02085577|Anesthetics|anesthetics|mesh-ancestor
101899889|NCT01167062|Adrenergic Agents|adrenergic agents|mesh-ancestor
102165603|NCT02085577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102165604|NCT02085577|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102165605|NCT02085577|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102165606|NCT02085577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102165607|NCT02085577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165609|NCT02085577|Narcotics|narcotics|mesh-ancestor
102165610|NCT02085577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102165611|NCT02085577|Antipyretics|antipyretics|mesh-ancestor
102165612|NCT02085577|Antiemetics|antiemetics|mesh-ancestor
102165613|NCT02085577|Autonomic Agents|autonomic agents|mesh-ancestor
102165614|NCT02085577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102165615|NCT02085577|Antipruritics|antipruritics|mesh-ancestor
102165616|NCT02085577|Dermatologic Agents|dermatologic agents|mesh-ancestor
102165617|NCT02085577|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102165618|NCT02085577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102165619|NCT02085577|Serotonin Agents|serotonin agents|mesh-ancestor
102165620|NCT02085577|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102165621|NCT02085655|Thalidomide|thalidomide|mesh-list
102165622|NCT02085655|Dexamethasone|dexamethasone|mesh-list
102165623|NCT02085655|Gemcitabine|gemcitabine|mesh-list
102165624|NCT02085655|Oxaliplatin|oxaliplatin|mesh-list
102165625|NCT02085655|Methotrexate|methotrexate|mesh-list
102165626|NCT02085655|Pegaspargase|pegaspargase|mesh-list
102165627|NCT02085655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102165628|NCT02085655|Antiemetics|antiemetics|mesh-ancestor
102165629|NCT02085655|Autonomic Agents|autonomic agents|mesh-ancestor
102165630|NCT02085655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102165631|NCT02085655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165632|NCT02085655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102165633|NCT02085655|Glucocorticoids|glucocorticoids|mesh-ancestor
102165634|NCT02085655|Hormones|hormones|mesh-ancestor
102165635|NCT02085655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102165636|NCT02085655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102165637|NCT02085655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102165638|NCT02085655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102165639|NCT02085655|Antimetabolites|antimetabolites|mesh-ancestor
102165640|NCT02085655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165641|NCT02085655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102165642|NCT02085655|Abortifacient Agents|abortifacient agents|mesh-ancestor
102165643|NCT02085655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102165644|NCT02085655|Dermatologic Agents|dermatologic agents|mesh-ancestor
102165645|NCT02085655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102165646|NCT02085655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102165647|NCT02085655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102165648|NCT02085655|Immunologic Factors|immunologic factors|mesh-ancestor
102165649|NCT02085655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102165650|NCT02085655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102165651|NCT02085655|Leprostatic Agents|leprostatic agents|mesh-ancestor
102165652|NCT02085655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102165653|NCT02085655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102165654|NCT02085655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102165655|NCT02085655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102165656|NCT02085655|Growth Substances|growth substances|mesh-ancestor
102165657|NCT02085655|Growth Inhibitors|growth inhibitors|mesh-ancestor
102165658|NCT02085967|Itraconazole|itraconazole|mesh-list
102165659|NCT02085967|Rifampin|rifampin|mesh-list
102165660|NCT02085967|Midazolam|midazolam|mesh-list
102165661|NCT02085967|Bupropion|bupropion|mesh-list
102165662|NCT02085967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102165663|NCT02085967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102165664|NCT02085967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102165665|NCT02085967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165666|NCT02085967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102165667|NCT02085967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102165668|NCT02085967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102165669|NCT02085967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102165670|NCT02085967|Anesthetics, General|anesthetics, general|mesh-ancestor
102165671|NCT02085967|Anesthetics|anesthetics|mesh-ancestor
102165672|NCT02085967|GABA Modulators|gaba modulators|mesh-ancestor
102165673|NCT02085967|GABA Agents|gaba agents|mesh-ancestor
102165674|NCT02085967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102165675|NCT02085967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165676|NCT02085967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102165677|NCT02085967|Antidepressive Agents|antidepressive agents|mesh-ancestor
102165678|NCT02085967|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102165679|NCT02085967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102165680|NCT02085967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102165681|NCT02085967|Dopamine Agents|dopamine agents|mesh-ancestor
102165682|NCT02085967|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102165683|NCT02085967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102165684|NCT02085967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102165685|NCT02085967|Antifungal Agents|antifungal agents|mesh-ancestor
102165686|NCT02085967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102165687|NCT02085967|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102165688|NCT02085967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102165689|NCT02085967|Hormone Antagonists|hormone antagonists|mesh-ancestor
102165690|NCT02085967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102165691|NCT02085967|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102165692|NCT02085967|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102165693|NCT02085967|Antitubercular Agents|antitubercular agents|mesh-ancestor
102165694|NCT02085967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102165695|NCT02085967|Leprostatic Agents|leprostatic agents|mesh-ancestor
102165696|NCT02085967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102165697|NCT02085967|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102165698|NCT02085967|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102165699|NCT02085967|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102165700|NCT02085967|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102165701|NCT02085967|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102165702|NCT02085967|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102165703|NCT02091505|Ranibizumab|ranibizumab|mesh-list
102165704|NCT02091505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102165705|NCT02091505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102165706|NCT02091505|Growth Substances|growth substances|mesh-ancestor
102165707|NCT02091505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165708|NCT02091505|Growth Inhibitors|growth inhibitors|mesh-ancestor
102165709|NCT02091505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102165710|NCT02091817|Oxytocin|oxytocin|mesh-list
102165711|NCT02091817|Oxytocics|oxytocics|mesh-ancestor
102165712|NCT02091817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102165713|NCT02091817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165714|NCT02086279|Hormones|hormones|mesh-list
102165715|NCT02086279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102165716|NCT02086279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165717|NCT02091973|Everolimus|everolimus|mesh-list
102165718|NCT02091973|Tacrolimus|tacrolimus|mesh-list
102165719|NCT02091973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102165720|NCT02091973|Immunologic Factors|immunologic factors|mesh-ancestor
102165721|NCT02091973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165722|NCT02091973|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102165723|NCT02091973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102165724|NCT02091973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165725|NCT02091973|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102165726|NCT02091973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102165727|NCT02091973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102165728|NCT03558295|Anticoagulants|anticoagulants|mesh-list
102165729|NCT02089399|Olmesartan|olmesartan|mesh-list
102165730|NCT02089399|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102165731|NCT02089399|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102165732|NCT02089399|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102165733|NCT02089399|Antimetabolites|antimetabolites|mesh-ancestor
102165734|NCT02089399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165735|NCT02089399|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102165736|NCT02089399|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102165737|NCT02089399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102165738|NCT02089399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102165739|NCT02089399|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102165740|NCT02089399|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102165741|NCT03557437|Amoxicillin|amoxicillin|mesh-list
102165742|NCT03557437|Metronidazole|metronidazole|mesh-list
102165743|NCT03557437|Potassium Citrate|potassium citrate|mesh-list
102165744|NCT03557437|Esomeprazole|esomeprazole|mesh-list
102165745|NCT03557437|Bismuth|bismuth|mesh-list
102165746|NCT03557437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165747|NCT03557437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102165748|NCT03557437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102165749|NCT03557437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102165750|NCT03557437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102165751|NCT03557437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102165752|NCT03557437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102165753|NCT03557437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102165754|NCT03557437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102165755|NCT03557437|Antacids|antacids|mesh-ancestor
102165756|NCT03557437|Diuretics|diuretics|mesh-ancestor
102165757|NCT03557437|Natriuretic Agents|natriuretic agents|mesh-ancestor
102165758|NCT03557437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165759|NCT03557437|Expectorants|expectorants|mesh-ancestor
102165760|NCT03557437|Respiratory System Agents|respiratory system agents|mesh-ancestor
102165761|NCT02089633|BCT-100|bct-100|mesh-list
102165762|NCT02089633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102165763|NCT02086747|Acetaminophen|acetaminophen|mesh-list
102165764|NCT02086747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102165765|NCT02086747|Analgesics|analgesics|mesh-ancestor
102165766|NCT02086747|Sensory System Agents|sensory system agents|mesh-ancestor
102165767|NCT02086747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102165768|NCT02086747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165769|NCT02086747|Antipyretics|antipyretics|mesh-ancestor
102165770|NCT02086825|Rifaximin|rifaximin|mesh-list
102165771|NCT02086825|Lactulose|lactulose|mesh-list
102165772|NCT02086825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102165773|NCT02086825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102165774|NCT02086825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102165775|NCT02086903|Clopidogrel|clopidogrel|mesh-list
102165776|NCT02086903|Ticagrelor|ticagrelor|mesh-list
102165777|NCT02086903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101446408|NCT00187161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102165778|NCT02086903|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102165779|NCT02086903|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102165780|NCT02086903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102165781|NCT02086903|Purinergic Agents|purinergic agents|mesh-ancestor
102165782|NCT02086903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102165783|NCT02086903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165784|NCT02086903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165785|NCT02087215|Boron|boron|mesh-list
102165786|NCT02087215|Trace Elements|trace elements|mesh-ancestor
102165787|NCT02087215|Micronutrients|micronutrients|mesh-ancestor
102165788|NCT02087215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165789|NCT02087527|Dexamethasone|dexamethasone|mesh-list
102165790|NCT02087527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102165791|NCT02087527|Antiemetics|antiemetics|mesh-ancestor
102165792|NCT02087527|Autonomic Agents|autonomic agents|mesh-ancestor
102165793|NCT02087527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102165794|NCT02087527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165795|NCT02087527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102165796|NCT02087527|Glucocorticoids|glucocorticoids|mesh-ancestor
102165797|NCT02087527|Hormones|hormones|mesh-ancestor
102165798|NCT02087527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102165799|NCT02087527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102165800|NCT02087527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102165801|NCT02087683|Vitamin D|vitamin d|mesh-list
102165802|NCT02087683|Vitamins|vitamins|mesh-ancestor
102165803|NCT02087683|Micronutrients|micronutrients|mesh-ancestor
102165804|NCT02087683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165805|NCT02087683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102165806|NCT02092363|Paclitaxel|paclitaxel|mesh-list
102165807|NCT02092363|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102165808|NCT02092363|Carboplatin|carboplatin|mesh-list
102165809|NCT02092363|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
102165810|NCT02092363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102165811|NCT02092363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102165812|NCT02092363|Tubulin Modulators|tubulin modulators|mesh-ancestor
102165813|NCT02092363|Antimitotic Agents|antimitotic agents|mesh-ancestor
102165814|NCT02092363|Mitosis Modulators|mitosis modulators|mesh-ancestor
102165815|NCT02092363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165816|NCT02092363|Immunologic Factors|immunologic factors|mesh-ancestor
102165817|NCT02092363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165818|NCT03558139|Avelumab|avelumab|mesh-list
102165819|NCT03558139|Magrolimab|magrolimab|mesh-list
102165820|NCT03558139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102165821|NCT03558139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102165822|NCT02089867|Ezetimibe|ezetimibe|mesh-list
102165823|NCT02089867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102165824|NCT02089867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102165825|NCT02089867|Antimetabolites|antimetabolites|mesh-ancestor
102165826|NCT02089867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165827|NCT02089867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102165829|NCT02092597|Linagliptin|linagliptin|mesh-list
102165830|NCT02092597|Gliclazide|gliclazide|mesh-list
102165831|NCT02092597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102165832|NCT02092597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165833|NCT02092597|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102165834|NCT02092597|Incretins|incretins|mesh-ancestor
102165835|NCT02092597|Hormones|hormones|mesh-ancestor
102165836|NCT02092597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102165837|NCT02092597|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102165838|NCT02092597|Protease Inhibitors|protease inhibitors|mesh-ancestor
102165839|NCT02092597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102165840|NCT02092597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165841|NCT02090101|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102165842|NCT02090101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102165843|NCT02093143|Remifentanil|remifentanil|mesh-list
102165844|NCT02093143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102165845|NCT02093143|Narcotics|narcotics|mesh-ancestor
102165846|NCT02093143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102165847|NCT02093143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165848|NCT02093143|Analgesics|analgesics|mesh-ancestor
102165849|NCT02093143|Sensory System Agents|sensory system agents|mesh-ancestor
102165850|NCT02093143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102165851|NCT02093299|Clopidogrel|clopidogrel|mesh-list
102165852|NCT02093299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102165853|NCT02093299|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102165854|NCT02093299|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102165855|NCT02093299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102165856|NCT02093299|Purinergic Agents|purinergic agents|mesh-ancestor
102165857|NCT02093299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102165858|NCT02093299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165859|NCT02093299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165860|NCT00454753|Dasatinib|dasatinib|mesh-list
102165861|NCT00454753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102165862|NCT00454753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102165863|NCT00454753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102165864|NCT00454753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165865|NCT02093533|Eculizumab|eculizumab|mesh-list
102165866|NCT02093533|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102165867|NCT02093533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102165868|NCT02093533|Immunologic Factors|immunologic factors|mesh-ancestor
102165869|NCT02093533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165870|NCT03297879|Metformin|metformin|mesh-list
102165871|NCT03297879|Exenatide|exenatide|mesh-list
102165872|NCT03297879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102165873|NCT03297879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165874|NCT03297879|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102165875|NCT03297879|Incretins|incretins|mesh-ancestor
102165876|NCT03297879|Hormones|hormones|mesh-ancestor
102165877|NCT03297879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102165878|NCT02093845|Everolimus|everolimus|mesh-list
102165879|NCT02093845|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102165880|NCT02093845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102165881|NCT02093845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102165882|NCT02093845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165883|NCT02093845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102165884|NCT02093845|Immunologic Factors|immunologic factors|mesh-ancestor
102165885|NCT02093845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165886|NCT02093845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102165887|NCT04489797|Acalabrutinib|acalabrutinib|mesh-list
102165888|NCT04489797|Rabeprazole|rabeprazole|mesh-list
102165889|NCT04489797|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102165890|NCT04489797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102165891|NCT04489797|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102165892|NCT04489797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102165893|NCT04489797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165894|NCT04489797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102165895|NCT02094001|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102165896|NCT02094001|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102165897|NCT02094001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165898|NCT02096419|Clopidogrel|clopidogrel|mesh-list
102165899|NCT02096419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102165900|NCT02096419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102165901|NCT02096419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102165902|NCT02096419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102165903|NCT02096419|Purinergic Agents|purinergic agents|mesh-ancestor
102165904|NCT02096419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102165905|NCT02096419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165906|NCT02096419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165908|NCT02094157|Calcium heparin|calcium heparin|mesh-list
102165909|NCT02094157|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102165910|NCT02094157|Tinzaparin|tinzaparin|mesh-list
102165911|NCT02094157|Dalteparin|dalteparin|mesh-list
102165912|NCT02094157|Warfarin|warfarin|mesh-list
102165913|NCT02094157|Anticoagulants|anticoagulants|mesh-ancestor
102165914|NCT02094157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102165915|NCT02094157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102165916|NCT02094157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165917|NCT02094313|Atorvastatin|atorvastatin|mesh-list
102165918|NCT02094313|Anticholesteremic Agents|anticholesteremic agents|mesh-list
102165919|NCT02094313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102165920|NCT02094313|Antimetabolites|antimetabolites|mesh-ancestor
102165921|NCT02094313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165922|NCT02094313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102165923|NCT02094313|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102165924|NCT02094313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102165925|NCT02094391|Ipilimumab|ipilimumab|mesh-list
102165926|NCT02094391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102165927|NCT02094391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102165928|NCT02094391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102165929|NCT02094391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165930|NCT02094469|Cilostazol|cilostazol|mesh-list
102165931|NCT02094469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102165932|NCT02094469|Autonomic Agents|autonomic agents|mesh-ancestor
102165933|NCT02094469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102165934|NCT02094469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165935|NCT02094469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102165936|NCT02094469|Respiratory System Agents|respiratory system agents|mesh-ancestor
102165937|NCT02094469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102165938|NCT02094469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102165939|NCT02094469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165940|NCT02094469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102165941|NCT02094469|Vasodilator Agents|vasodilator agents|mesh-ancestor
102165942|NCT02094469|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102165943|NCT02094469|Protective Agents|protective agents|mesh-ancestor
102165944|NCT02094469|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102165945|NCT02094469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102165946|NCT02094469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102165947|NCT02094703|Levofloxacin|levofloxacin|mesh-list
102165948|NCT02094703|Solifenacin Succinate|solifenacin succinate|mesh-list
102165949|NCT02094703|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102165950|NCT02094703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102165951|NCT02094703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102165952|NCT02094703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102165953|NCT02094703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102165954|NCT02094703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102165955|NCT02094703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165956|NCT02094703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102165957|NCT02094703|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102165958|NCT02094703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102165959|NCT02094703|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102165960|NCT02094703|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102165961|NCT02094703|Cholinergic Agents|cholinergic agents|mesh-ancestor
102165962|NCT02094703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102165963|NCT02094703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165964|NCT02094703|Urological Agents|urological agents|mesh-ancestor
102165965|NCT02098837|Dolutegravir|dolutegravir|mesh-list
102165966|NCT02098837|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102165967|NCT02098837|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102165968|NCT02098837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102165969|NCT02098837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165970|NCT02098837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102165971|NCT02098837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102165972|NCT02098837|Antiviral Agents|antiviral agents|mesh-ancestor
102165973|NCT02098837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102165974|NCT02098915|Metoclopramide|metoclopramide|mesh-list
102165975|NCT02098915|Antiemetics|antiemetics|mesh-ancestor
102165976|NCT02098915|Autonomic Agents|autonomic agents|mesh-ancestor
102165977|NCT02098915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102165978|NCT02098915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165979|NCT02098915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102165980|NCT02098915|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102165981|NCT02098915|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102165982|NCT02098915|Dopamine Agents|dopamine agents|mesh-ancestor
102165983|NCT02098915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102165984|NCT02098915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165985|NCT03556033|Dapagliflozin|dapagliflozin|mesh-list
102165986|NCT03556033|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102165987|NCT03556033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165988|NCT03556033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102165989|NCT03556033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165990|NCT05046860|Dalbavancin|dalbavancin|mesh-list
102165991|NCT05046860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102165992|NCT05046860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102165993|NCT02095405|Caffeine|caffeine|mesh-list
102165994|NCT02095405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102165995|NCT02095405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102165996|NCT02095405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102165997|NCT02095405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102165998|NCT02095405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102165999|NCT02095405|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102166000|NCT02095405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102166001|NCT02095405|Purinergic Agents|purinergic agents|mesh-ancestor
102166002|NCT02095405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102166003|NCT04434482|Temozolomide|temozolomide|mesh-list
102166004|NCT04434482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102166005|NCT04434482|Alkylating Agents|alkylating agents|mesh-ancestor
102166006|NCT04434482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166007|NCT04434482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102166008|NCT02096965|Tolvaptan|tolvaptan|mesh-list
102166009|NCT02096965|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102166010|NCT02096965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166011|NCT02096965|Natriuretic Agents|natriuretic agents|mesh-ancestor
102166012|NCT02096965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166013|NCT02097043|Tedizolid phosphate|tedizolid phosphate|mesh-list
102166014|NCT02097043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102166015|NCT02097043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102166016|NCT05069246|Chlorhexidine|chlorhexidine|mesh-list
102166017|NCT05069246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102166018|NCT05069246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102166019|NCT05069246|Disinfectants|disinfectants|mesh-ancestor
102166020|NCT02095717|Curcumin|curcumin|mesh-list
102166021|NCT02095717|Docetaxel|docetaxel|mesh-list
102166022|NCT02095717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102166023|NCT02095717|Tubulin Modulators|tubulin modulators|mesh-ancestor
102166024|NCT02095717|Antimitotic Agents|antimitotic agents|mesh-ancestor
102166025|NCT02095717|Mitosis Modulators|mitosis modulators|mesh-ancestor
102166026|NCT02095717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166027|NCT02095717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102166028|NCT02095717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102166029|NCT02095717|Analgesics|analgesics|mesh-ancestor
102166030|NCT02095717|Sensory System Agents|sensory system agents|mesh-ancestor
102166031|NCT02095717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102166032|NCT02095717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166033|NCT02095717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102166034|NCT02095717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102166035|NCT02095717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102166036|NCT03099824|Avasopasem manganese|avasopasem manganese|mesh-list
102166037|NCT03099824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102166038|NCT03099824|Antioxidants|antioxidants|mesh-ancestor
102166039|NCT03099824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166040|NCT03099824|Protective Agents|protective agents|mesh-ancestor
102166041|NCT03099824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166042|NCT02718417|Paclitaxel|paclitaxel|mesh-list
102166043|NCT02718417|Carboplatin|carboplatin|mesh-list
102166044|NCT02718417|Avelumab|avelumab|mesh-list
102166045|NCT02718417|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102166046|NCT02718417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102166047|NCT02718417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102166048|NCT02718417|Tubulin Modulators|tubulin modulators|mesh-ancestor
102166049|NCT02718417|Antimitotic Agents|antimitotic agents|mesh-ancestor
102166050|NCT02718417|Mitosis Modulators|mitosis modulators|mesh-ancestor
102166051|NCT02718417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166052|NCT02718417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102166053|NCT02718417|Immunologic Factors|immunologic factors|mesh-ancestor
102166054|NCT02718417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166056|NCT05067530|Carboplatin|carboplatin|mesh-list
102166057|NCT05067530|Palbociclib|palbociclib|mesh-list
102166058|NCT05067530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102166059|NCT05067530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102166060|NCT05067530|Tubulin Modulators|tubulin modulators|mesh-ancestor
102166061|NCT05067530|Antimitotic Agents|antimitotic agents|mesh-ancestor
102166062|NCT05067530|Mitosis Modulators|mitosis modulators|mesh-ancestor
102166063|NCT05067530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166064|NCT05067530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102166065|NCT05067530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102166066|NCT02640404|Vaccines|vaccines|mesh-list
102166067|NCT02640404|Immunologic Factors|immunologic factors|mesh-ancestor
102166068|NCT02640404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166069|NCT03097406|Imidacloprid|imidacloprid|mesh-list
102166070|NCT03097406|Cholinergic Agents|cholinergic agents|mesh-ancestor
102166071|NCT03097406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102166072|NCT03097406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166073|NCT03097406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166074|NCT03099590|Puerarin|puerarin|mesh-list
102166075|NCT03099590|Vasodilator Agents|vasodilator agents|mesh-ancestor
102166076|NCT05054426|Methotrexate|methotrexate|mesh-list
102166077|NCT05054426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102166078|NCT05054426|Abortifacient Agents|abortifacient agents|mesh-ancestor
102166079|NCT05054426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102166080|NCT05054426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166081|NCT05054426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102166082|NCT05054426|Antimetabolites|antimetabolites|mesh-ancestor
102166083|NCT05054426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166084|NCT05054426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102166085|NCT05054426|Dermatologic Agents|dermatologic agents|mesh-ancestor
102166086|NCT05054426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102166087|NCT05054426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102166088|NCT05054426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102166089|NCT05054426|Immunologic Factors|immunologic factors|mesh-ancestor
102166090|NCT05054426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102166091|NCT05054426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102166092|NCT00701727|Ezetimibe|ezetimibe|mesh-list
102166093|NCT00701727|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102166094|NCT00701727|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102166095|NCT00701727|Antimetabolites|antimetabolites|mesh-ancestor
102166096|NCT00701727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166097|NCT00701727|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102166098|NCT02463513|Vitamins|vitamins|mesh-list
102166099|NCT02463513|Riboflavin|riboflavin|mesh-list
102166100|NCT02463513|Vitamin B Complex|vitamin b complex|mesh-list
102166101|NCT02463513|Micronutrients|micronutrients|mesh-ancestor
102166102|NCT02463513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166103|NCT02463513|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102166104|NCT02463513|Dermatologic Agents|dermatologic agents|mesh-ancestor
102166105|NCT04990323|Vidarabine|vidarabine|mesh-list
102166106|NCT04990323|Cyclophosphamide|cyclophosphamide|mesh-list
102166107|NCT04990323|Busulfan|busulfan|mesh-list
102166108|NCT04990323|Thiotepa|thiotepa|mesh-list
102166109|NCT04990323|Fludarabine|fludarabine|mesh-list
102166110|NCT04990323|Fludarabine phosphate|fludarabine phosphate|mesh-list
102166111|NCT04990323|Clofarabine|clofarabine|mesh-list
102166112|NCT04990323|Tacrolimus|tacrolimus|mesh-list
102166113|NCT04990323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102166114|NCT04990323|Immunologic Factors|immunologic factors|mesh-ancestor
102166115|NCT04990323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166116|NCT04990323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102166117|NCT04990323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102166118|NCT04990323|Alkylating Agents|alkylating agents|mesh-ancestor
102166119|NCT04990323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166120|NCT04990323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102166121|NCT04990323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102166122|NCT04990323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102166123|NCT04990323|Antimetabolites|antimetabolites|mesh-ancestor
102166124|NCT04990323|Antiviral Agents|antiviral agents|mesh-ancestor
102166125|NCT04990323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102166126|NCT04990323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102166127|NCT04990323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102166128|NCT04155008|Dexamethasone|dexamethasone|mesh-list
102166129|NCT04155008|Dronabinol|dronabinol|mesh-list
102166130|NCT04155008|Mirtazapine|mirtazapine|mesh-list
101446426|NCT00187161|Antimitotic Agents|antimitotic agents|mesh-ancestor
102166131|NCT04155008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102166132|NCT04155008|Antiemetics|antiemetics|mesh-ancestor
102166133|NCT04155008|Autonomic Agents|autonomic agents|mesh-ancestor
102166134|NCT04155008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102166135|NCT04155008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166136|NCT04155008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102166137|NCT04155008|Glucocorticoids|glucocorticoids|mesh-ancestor
102166138|NCT04155008|Hormones|hormones|mesh-ancestor
102166139|NCT04155008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102166140|NCT04155008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102166141|NCT04155008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102166142|NCT04155008|Antidepressive Agents|antidepressive agents|mesh-ancestor
102166143|NCT04155008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102166144|NCT04155008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102166145|NCT04155008|Histamine Antagonists|histamine antagonists|mesh-ancestor
102166146|NCT04155008|Histamine Agents|histamine agents|mesh-ancestor
102166147|NCT04155008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102166148|NCT04155008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166149|NCT04155008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102166150|NCT04155008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102166151|NCT04155008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102166152|NCT04155008|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102166153|NCT04155008|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102166154|NCT04155008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102166155|NCT04155008|Adrenergic Agents|adrenergic agents|mesh-ancestor
102166156|NCT04155008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102166157|NCT04155008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102166158|NCT04155008|Serotonin Agents|serotonin agents|mesh-ancestor
102166159|NCT04155008|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102166160|NCT04155008|Hallucinogens|hallucinogens|mesh-ancestor
102166161|NCT04155008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102166162|NCT04155008|Analgesics|analgesics|mesh-ancestor
102166163|NCT04155008|Sensory System Agents|sensory system agents|mesh-ancestor
102166164|NCT04155008|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102166165|NCT04155008|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102166166|NCT05044364|Clevidipine|clevidipine|mesh-list
102166167|NCT05044364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102166168|NCT05044364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102166169|NCT05044364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166170|NCT05044364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102166171|NCT05044364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166173|NCT03993717|Immunologic Factors|immunologic factors|mesh-ancestor
102166174|NCT03993717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166175|NCT04150640|Pembrolizumab|pembrolizumab|mesh-list
102166176|NCT04150640|Nivolumab|nivolumab|mesh-list
102166177|NCT04150640|Trastuzumab|trastuzumab|mesh-list
102166178|NCT04150640|Fluorouracil|fluorouracil|mesh-list
102166179|NCT04150640|Oxaliplatin|oxaliplatin|mesh-list
102166180|NCT04150640|Irinotecan|irinotecan|mesh-list
102166181|NCT04150640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102166182|NCT04150640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102166183|NCT04150640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102166184|NCT04150640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166185|NCT04150640|Antimetabolites|antimetabolites|mesh-ancestor
102166186|NCT04150640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102166187|NCT04150640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102166188|NCT04150640|Immunologic Factors|immunologic factors|mesh-ancestor
102166189|NCT04150640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166190|NCT04150640|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102166191|NCT04150640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102166192|NCT04150640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102166193|NCT05054114|Interferons|interferons|mesh-list
102166194|NCT05054114|Interferon-gamma|interferon-gamma|mesh-list
102166195|NCT05054114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102166196|NCT05054114|Antiviral Agents|antiviral agents|mesh-ancestor
102166197|NCT05054114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102166198|NCT04665531|Ropivacaine|ropivacaine|mesh-list
102166199|NCT04665531|Anesthetics, Local|anesthetics, local|mesh-ancestor
102166200|NCT04665531|Anesthetics|anesthetics|mesh-ancestor
102166201|NCT04665531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102166202|NCT04665531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166203|NCT04665531|Sensory System Agents|sensory system agents|mesh-ancestor
102166204|NCT04665531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102166205|NCT01369069|Insulin|insulin|mesh-list
102166206|NCT01369069|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102166207|NCT01369069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102166208|NCT01369069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166209|NCT02097511|Metoprolol|metoprolol|mesh-list
102166210|NCT02097511|Sarpogrelate|sarpogrelate|mesh-list
102166211|NCT02097511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102166212|NCT02097511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102166213|NCT02097511|Sympatholytics|sympatholytics|mesh-ancestor
102166214|NCT02097511|Autonomic Agents|autonomic agents|mesh-ancestor
102166215|NCT02097511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102166216|NCT02097511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166217|NCT02097511|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102166218|NCT02097511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102166219|NCT02097511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102166220|NCT02097511|Adrenergic Agents|adrenergic agents|mesh-ancestor
102166221|NCT02097511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102166222|NCT02097511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166223|NCT02097511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102166224|NCT02097511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102166225|NCT02097511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102166226|NCT02097511|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102166227|NCT02097511|Serotonin Agents|serotonin agents|mesh-ancestor
102166228|NCT03957681|Brodalumab|brodalumab|mesh-list
102166229|NCT03957681|Dermatologic Agents|dermatologic agents|mesh-ancestor
102166230|NCT05043740|Evolocumab|evolocumab|mesh-list
102166231|NCT05043740|Alirocumab|alirocumab|mesh-list
102166232|NCT05043740|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102166233|NCT05043740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102166234|NCT05043740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102166235|NCT05043740|Antimetabolites|antimetabolites|mesh-ancestor
102166236|NCT05043740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166237|NCT05043740|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102166238|NCT05043740|Protease Inhibitors|protease inhibitors|mesh-ancestor
102166239|NCT05043740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102166240|NCT05043740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102166241|NCT03928275|Aldesleukin|aldesleukin|mesh-list
102166242|NCT03928275|Interleukin-2|interleukin-2|mesh-list
102166243|NCT03928275|BCG Vaccine|bcg vaccine|mesh-list
102166244|NCT03928275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102166245|NCT03928275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102166246|NCT03928275|Analgesics|analgesics|mesh-ancestor
102166247|NCT03928275|Sensory System Agents|sensory system agents|mesh-ancestor
102166248|NCT03928275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102166249|NCT03928275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166250|NCT03928275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102166251|NCT03928275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102166252|NCT03928275|Antiviral Agents|antiviral agents|mesh-ancestor
102166253|NCT03928275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102166254|NCT03928275|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102166255|NCT03928275|Immunologic Factors|immunologic factors|mesh-ancestor
102166256|NCT05043896|Tadalafil|tadalafil|mesh-list
102166257|NCT05043896|Vasodilator Agents|vasodilator agents|mesh-ancestor
102166258|NCT05043896|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102166259|NCT05043896|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102166260|NCT05043896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102166261|NCT05043896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166262|NCT05043896|Urological Agents|urological agents|mesh-ancestor
102166263|NCT02099617|Oxymetazoline|oxymetazoline|mesh-list
102166264|NCT02099617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102166265|NCT02099617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102166266|NCT02099617|Adrenergic Agents|adrenergic agents|mesh-ancestor
102166267|NCT02099617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102166268|NCT02099617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166269|NCT02099617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166270|NCT02099617|Sympathomimetics|sympathomimetics|mesh-ancestor
102166271|NCT02099617|Autonomic Agents|autonomic agents|mesh-ancestor
102166272|NCT02099617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102166273|NCT02099617|Nasal Decongestants|nasal decongestants|mesh-ancestor
102166274|NCT02099617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102166275|NCT02099617|Respiratory System Agents|respiratory system agents|mesh-ancestor
102166276|NCT03096704|Vitamin D|vitamin d|mesh-list
102166277|NCT03096704|Vitamins|vitamins|mesh-ancestor
102166278|NCT03096704|Micronutrients|micronutrients|mesh-ancestor
102166279|NCT03096704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166280|NCT03096704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102166281|NCT02099695|Oxybutynin|oxybutynin|mesh-list
102166282|NCT02099695|Parasympatholytics|parasympatholytics|mesh-ancestor
102166283|NCT02099695|Autonomic Agents|autonomic agents|mesh-ancestor
102166284|NCT02099695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102166285|NCT02099695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166286|NCT02099695|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102166287|NCT02099695|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102166288|NCT02099695|Cholinergic Agents|cholinergic agents|mesh-ancestor
102166289|NCT02099695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102166290|NCT02099695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166291|NCT02099695|Urological Agents|urological agents|mesh-ancestor
102166292|NCT05066516|Dapagliflozin|dapagliflozin|mesh-list
102166293|NCT05066516|Linagliptin|linagliptin|mesh-list
102166294|NCT05066516|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102166295|NCT05066516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166296|NCT05066516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102166297|NCT05066516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166298|NCT05066516|Incretins|incretins|mesh-ancestor
102166299|NCT05066516|Hormones|hormones|mesh-ancestor
102166300|NCT05066516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102166301|NCT05066516|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102166302|NCT05066516|Protease Inhibitors|protease inhibitors|mesh-ancestor
102166303|NCT05066516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102166304|NCT02097589|Atorvastatin|atorvastatin|mesh-list
102166305|NCT02097589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102166306|NCT02097589|Immunologic Factors|immunologic factors|mesh-ancestor
102166307|NCT02097589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166308|NCT02097589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102166309|NCT02097589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102166310|NCT02097589|Antimetabolites|antimetabolites|mesh-ancestor
102166311|NCT02097589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166312|NCT02097589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102166313|NCT02097589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102166314|NCT02097589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102166315|NCT03836001|Serlopitant|serlopitant|mesh-list
102166316|NCT03836001|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102166317|NCT03836001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102166318|NCT03836001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166319|NCT03836001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166320|NCT02465866|Promethazine|promethazine|mesh-list
102166321|NCT02465866|Antipruritics|antipruritics|mesh-ancestor
101875152|NCT02966314|Omalizumab|omalizumab|mesh-list
102166323|NCT02465866|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102166324|NCT02465866|Histamine Antagonists|histamine antagonists|mesh-ancestor
102166325|NCT02465866|Histamine Agents|histamine agents|mesh-ancestor
102166326|NCT02465866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102166327|NCT02465866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166328|NCT02465866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166329|NCT02465866|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102166330|NCT05052008|Erenumab|erenumab|mesh-list
102166331|NCT05052008|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
102166332|NCT05052008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166333|NCT05052008|Analgesics|analgesics|mesh-ancestor
102166334|NCT05052008|Sensory System Agents|sensory system agents|mesh-ancestor
102166335|NCT05052008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102166336|NCT05052008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166337|NCT05066360|Hormones|hormones|mesh-list
102166338|NCT05066360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102166339|NCT05066360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166340|NCT02439970|Valganciclovir|valganciclovir|mesh-list
102166341|NCT02439970|Brincidofovir|brincidofovir|mesh-list
102166342|NCT02439970|Antiviral Agents|antiviral agents|mesh-ancestor
102166343|NCT02439970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102166344|NCT03290859|Propofol|propofol|mesh-list
102166345|NCT03290859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102166346|NCT03290859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102166347|NCT03290859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166348|NCT03290859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102166350|NCT03290859|Anesthetics|anesthetics|mesh-ancestor
102166351|NCT05065658|Posaconazole|posaconazole|mesh-list
102166352|NCT05065658|Antifungal Agents|antifungal agents|mesh-ancestor
102166353|NCT05065658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102166354|NCT05065658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102166355|NCT05065658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102166356|NCT05065658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102166357|NCT05065658|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102166358|NCT05065658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102166359|NCT05065658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102166360|NCT05065658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166361|NCT05065658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102166362|NCT05065658|Hormone Antagonists|hormone antagonists|mesh-ancestor
102166363|NCT05065658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102166364|NCT05065658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166365|NCT02102815|Dexamethasone|dexamethasone|mesh-list
102166366|NCT02102815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102166367|NCT02102815|Antiemetics|antiemetics|mesh-ancestor
102166368|NCT02102815|Autonomic Agents|autonomic agents|mesh-ancestor
102166369|NCT02102815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102166370|NCT02102815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166371|NCT02102815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102166372|NCT02102815|Glucocorticoids|glucocorticoids|mesh-ancestor
102166373|NCT02102815|Hormones|hormones|mesh-ancestor
102166374|NCT02102815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102166375|NCT02102815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102166376|NCT02102815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102166377|NCT04935112|Pantoprazole|pantoprazole|mesh-list
102166378|NCT04935112|Famotidine|famotidine|mesh-list
102166379|NCT04935112|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102166380|NCT04935112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102166381|NCT04935112|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102166382|NCT04935112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102166383|NCT04935112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166384|NCT04935112|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102166385|NCT04935112|Histamine Antagonists|histamine antagonists|mesh-ancestor
102166386|NCT04935112|Histamine Agents|histamine agents|mesh-ancestor
102166387|NCT04935112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102166388|NCT04935112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166389|NCT02102971|Liver Extracts|liver extracts|mesh-list
102166390|NCT02102971|Hematinics|hematinics|mesh-ancestor
102166391|NCT03555487|Choline|choline|mesh-list
102166392|NCT03555487|Lipotropic Agents|lipotropic agents|mesh-ancestor
102166393|NCT03555487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102166394|NCT03555487|Antimetabolites|antimetabolites|mesh-ancestor
101875218|NCT01204450|MTOR Inhibitors|mtor inhibitors|mesh-list
102166395|NCT03555487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166396|NCT03555487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102166397|NCT03555487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102166399|NCT05043194|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102166400|NCT05043194|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102166401|NCT05043194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102166402|NCT02103049|Ezetimibe|ezetimibe|mesh-list
102166403|NCT02103049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102166404|NCT02103049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102166405|NCT02103049|Antimetabolites|antimetabolites|mesh-ancestor
102166406|NCT02103049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166407|NCT02103049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102166408|NCT03099278|Ezetimibe|ezetimibe|mesh-list
102166409|NCT03099278|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102166410|NCT03099278|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102166411|NCT03099278|Antimetabolites|antimetabolites|mesh-ancestor
102166412|NCT03099278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166413|NCT03099278|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102166414|NCT02103205|Iron|iron|mesh-list
102166415|NCT02103205|Lactoferrin|lactoferrin|mesh-list
102166416|NCT02103205|Trace Elements|trace elements|mesh-ancestor
102166417|NCT02103205|Micronutrients|micronutrients|mesh-ancestor
102166418|NCT02103205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166419|NCT02103205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102166420|NCT03290703|Rabeprazole|rabeprazole|mesh-list
102166421|NCT03290703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102166422|NCT03290703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102166423|NCT03290703|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102166424|NCT03290703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102166425|NCT03290703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166427|NCT02408068|Hydrocortisone|hydrocortisone|mesh-list
102166428|NCT02408068|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102166429|NCT02408068|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102166430|NCT02408068|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102166431|NCT02408068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102166432|NCT02408068|Antiemetics|antiemetics|mesh-ancestor
102166433|NCT02408068|Autonomic Agents|autonomic agents|mesh-ancestor
102166434|NCT02408068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102166435|NCT02408068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166436|NCT02408068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102166437|NCT02408068|Glucocorticoids|glucocorticoids|mesh-ancestor
102166438|NCT02408068|Hormones|hormones|mesh-ancestor
102166439|NCT02408068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102166440|NCT02408068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102166441|NCT02408068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102166442|NCT02465853|Hyaluronic Acid|hyaluronic acid|mesh-list
102166443|NCT02465853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102166444|NCT02465853|Immunologic Factors|immunologic factors|mesh-ancestor
102166445|NCT02465853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166446|NCT02465853|Viscosupplements|viscosupplements|mesh-ancestor
102166447|NCT02465853|Protective Agents|protective agents|mesh-ancestor
102166448|NCT02465385|Linaclotide|linaclotide|mesh-list
102166449|NCT02465385|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102166450|NCT02465385|Enzyme Activators|enzyme activators|mesh-ancestor
102166451|NCT02465385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166452|NCT02465385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102166453|NCT05050604|Choline|choline|mesh-list
102166454|NCT05050604|Lipotropic Agents|lipotropic agents|mesh-ancestor
102166455|NCT05050604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102166456|NCT05050604|Antimetabolites|antimetabolites|mesh-ancestor
102166457|NCT05050604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166458|NCT05050604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102166459|NCT05050604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102166460|NCT05050604|Nootropic Agents|nootropic agents|mesh-ancestor
102166461|NCT03290625|Dexmedetomidine|dexmedetomidine|mesh-list
102166462|NCT03290625|Ketamine|ketamine|mesh-list
102166463|NCT03290625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102166464|NCT03290625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102166465|NCT03290625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166466|NCT03290625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102166467|NCT03290625|Analgesics|analgesics|mesh-ancestor
102166468|NCT03290625|Sensory System Agents|sensory system agents|mesh-ancestor
102166469|NCT03290625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101875298|NCT01204840|Hormones|hormones|mesh-list
102166470|NCT03290625|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102166471|NCT03290625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102166472|NCT03290625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102166473|NCT03290625|Adrenergic Agents|adrenergic agents|mesh-ancestor
101446467|NCT00180791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102166474|NCT03290625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102166475|NCT03290625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166476|NCT03290625|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102166477|NCT03290625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102166478|NCT03290625|Anesthetics, General|anesthetics, general|mesh-ancestor
102166479|NCT03290625|Anesthetics|anesthetics|mesh-ancestor
102166480|NCT03290625|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102166481|NCT03290625|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102166482|NCT02250781|TIC10 compound|tic10 compound|mesh-list
102166483|NCT02250781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102166484|NCT03099122|Mycophenolic Acid|mycophenolic acid|mesh-list
102166485|NCT03099122|Prednisone|prednisone|mesh-list
102166486|NCT03099122|Methylprednisolone|methylprednisolone|mesh-list
102166487|NCT03099122|Tacrolimus|tacrolimus|mesh-list
102166488|NCT03099122|Thymoglobulin|thymoglobulin|mesh-list
102166489|NCT03099122|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102166490|NCT03099122|Immunoglobulins|immunoglobulins|mesh-list
102166491|NCT03099122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102166492|NCT03099122|Glucocorticoids|glucocorticoids|mesh-ancestor
102166493|NCT03099122|Hormones|hormones|mesh-ancestor
102166494|NCT03099122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102166495|NCT03099122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166496|NCT03099122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102166497|NCT03099122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102166498|NCT03099122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102166499|NCT03099122|Immunologic Factors|immunologic factors|mesh-ancestor
102166500|NCT03099122|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102166501|NCT03099122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102166502|NCT03099122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166503|NCT03099122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102166504|NCT03099122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102166505|NCT03099122|Antitubercular Agents|antitubercular agents|mesh-ancestor
102166506|NCT03099122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102166507|NCT03099122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102166508|NCT03099122|Antiemetics|antiemetics|mesh-ancestor
102166509|NCT03099122|Autonomic Agents|autonomic agents|mesh-ancestor
102166510|NCT03099122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102166511|NCT03099122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102166512|NCT03099122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102166513|NCT03099122|Protective Agents|protective agents|mesh-ancestor
102166514|NCT04335201|Defibrotide|defibrotide|mesh-list
102166515|NCT04335201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102166516|NCT04335201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102166517|NCT04335201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166518|NCT04335201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102166519|NCT03295851|Iron|iron|mesh-list
102166520|NCT03295851|Ferrous fumarate|ferrous fumarate|mesh-list
102166521|NCT03295851|Trace Elements|trace elements|mesh-ancestor
102166522|NCT03295851|Micronutrients|micronutrients|mesh-ancestor
102166523|NCT03295851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166524|NCT03096470|Anesthetics|anesthetics|mesh-list
102166525|NCT03096470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102166526|NCT03096470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166527|NCT02100553|Itraconazole|itraconazole|mesh-list
102166528|NCT02100553|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
102166529|NCT02100553|Antifungal Agents|antifungal agents|mesh-ancestor
102166530|NCT02100553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102166531|NCT02100553|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102166532|NCT02100553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102166533|NCT02100553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102166534|NCT02100553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166535|NCT02100553|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102166536|NCT02100553|Hormone Antagonists|hormone antagonists|mesh-ancestor
102166537|NCT02100553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102166538|NCT02100553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166539|NCT02100553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102166540|NCT02100787|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102166541|NCT02100787|Laxatives|laxatives|mesh-ancestor
102166542|NCT02100787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101875372|NCT01205074|Ethanol|ethanol|mesh-list
102166543|NCT03295695|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102166544|NCT03295695|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102166545|NCT03295695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166546|NCT04718805|Darunavir|darunavir|mesh-list
102166547|NCT04718805|Cobicistat|cobicistat|mesh-list
102166548|NCT04718805|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
102166549|NCT04718805|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102166550|NCT04718805|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102166551|NCT04718805|Protease Inhibitors|protease inhibitors|mesh-ancestor
102166552|NCT04718805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102166553|NCT04718805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166554|NCT04718805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102166555|NCT04718805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102166556|NCT04718805|Antiviral Agents|antiviral agents|mesh-ancestor
102166557|NCT04718805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102166558|NCT04718805|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102166559|NCT04718805|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102166560|NCT05042336|Lenvatinib|lenvatinib|mesh-list
102166561|NCT05042336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102166562|NCT05042336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102166563|NCT05042336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102166564|NCT05042336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166565|NCT03096392|Insulin|insulin|mesh-list
102166566|NCT03096392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102166567|NCT03096392|Insulin Lispro|insulin lispro|mesh-list
102166568|NCT03096392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102166569|NCT03096392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166570|NCT05042024|N-Methylaspartate|n-methylaspartate|mesh-list
102166571|NCT05042024|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
102166572|NCT05042024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102166573|NCT05042024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102166574|NCT05042024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166575|NCT05042024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166576|NCT02460393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102166577|NCT02460393|Antibodies|antibodies|mesh-list
102166578|NCT02460393|Immunoglobulins|immunoglobulins|mesh-list
102166579|NCT02460393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102166580|NCT02460393|Immunologic Factors|immunologic factors|mesh-ancestor
102166581|NCT02460393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166582|NCT02460393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102166583|NCT02250859|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102166584|NCT02250859|Minocycline|minocycline|mesh-list
102166585|NCT02250859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102166586|NCT03295461|Chlorhexidine|chlorhexidine|mesh-list
102166587|NCT03295461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102166588|NCT03295461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102166589|NCT03295461|Disinfectants|disinfectants|mesh-ancestor
102166590|NCT03295383|Cyclophosphamide|cyclophosphamide|mesh-list
102166591|NCT03295383|Rituximab|rituximab|mesh-list
102166592|NCT03295383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102166593|NCT03295383|Immunologic Factors|immunologic factors|mesh-ancestor
102166594|NCT03295383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166595|NCT03295383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102166596|NCT03295383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102166597|NCT03295383|Alkylating Agents|alkylating agents|mesh-ancestor
102166598|NCT03295383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166599|NCT03295383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102166600|NCT03295383|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102166601|NCT03295383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102166602|NCT02101255|Fluorides|fluorides|mesh-list
102166603|NCT02101255|Cariostatic Agents|cariostatic agents|mesh-ancestor
102166604|NCT02101255|Protective Agents|protective agents|mesh-ancestor
102166605|NCT02101255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166606|NCT05063318|Itraconazole|itraconazole|mesh-list
102166607|NCT05063318|Antifungal Agents|antifungal agents|mesh-ancestor
102166608|NCT05063318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102166609|NCT05063318|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102166610|NCT05063318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102166611|NCT05063318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102166612|NCT05063318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166613|NCT05063318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102166614|NCT05063318|Hormone Antagonists|hormone antagonists|mesh-ancestor
102166615|NCT05063318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102166616|NCT05063318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166617|NCT05063318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102166618|NCT02104297|Remifentanil|remifentanil|mesh-list
102166619|NCT02104297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102166620|NCT02104297|Narcotics|narcotics|mesh-ancestor
102166621|NCT02104297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102166622|NCT02104297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166623|NCT02104297|Analgesics|analgesics|mesh-ancestor
102166624|NCT02104297|Sensory System Agents|sensory system agents|mesh-ancestor
102166625|NCT02104297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102166626|NCT02106481|Ropivacaine|ropivacaine|mesh-list
102166627|NCT02106481|Anesthetics, Local|anesthetics, local|mesh-ancestor
102166628|NCT02106481|Anesthetics|anesthetics|mesh-ancestor
102166629|NCT02106481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102166630|NCT02106481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166631|NCT02106481|Sensory System Agents|sensory system agents|mesh-ancestor
102166632|NCT02106481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102166633|NCT02106559|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
102166634|NCT02106559|Trioxsalen|trioxsalen|mesh-list
102166635|NCT02106559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102166636|NCT02106559|Dermatologic Agents|dermatologic agents|mesh-ancestor
102166637|NCT02106559|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102166638|NCT05047874|Methylprednisolone|methylprednisolone|mesh-list
102166639|NCT05047874|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102166640|NCT05047874|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102166641|NCT05047874|Prednisolone|prednisolone|mesh-list
102166642|NCT05047874|Prednisolone acetate|prednisolone acetate|mesh-list
102166643|NCT05047874|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102166644|NCT05047874|Prednisolone phosphate|prednisolone phosphate|mesh-list
102166645|NCT05047874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102166646|NCT05047874|Antiemetics|antiemetics|mesh-ancestor
102166647|NCT05047874|Autonomic Agents|autonomic agents|mesh-ancestor
102166648|NCT05047874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102166649|NCT05047874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166650|NCT05047874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102166651|NCT05047874|Glucocorticoids|glucocorticoids|mesh-ancestor
102166652|NCT05047874|Hormones|hormones|mesh-ancestor
102166653|NCT05047874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102166654|NCT05047874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102166655|NCT05047874|Protective Agents|protective agents|mesh-ancestor
102166656|NCT05047874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102166657|NCT05047874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102166658|NCT04488705|Albuterol|albuterol|mesh-list
102166659|NCT04488705|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102166660|NCT04488705|Autonomic Agents|autonomic agents|mesh-ancestor
102166661|NCT04488705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102166662|NCT04488705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166663|NCT04488705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102166664|NCT04488705|Respiratory System Agents|respiratory system agents|mesh-ancestor
102166665|NCT04488705|Tocolytic Agents|tocolytic agents|mesh-ancestor
102166666|NCT04488705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102166667|NCT04488705|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102166668|NCT04488705|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102166669|NCT04488705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102166670|NCT04488705|Adrenergic Agents|adrenergic agents|mesh-ancestor
102166671|NCT04488705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102166672|NCT04488705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166673|NCT02106637|Varenicline|varenicline|mesh-list
102166674|NCT02106637|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102166675|NCT02106637|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102166676|NCT02106637|Cholinergic Agents|cholinergic agents|mesh-ancestor
102166677|NCT02106637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102166678|NCT02106637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166679|NCT02106637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166680|NCT05047328|Inolimomab|inolimomab|mesh-list
102166681|NCT05047328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102166682|NCT05047328|Immunologic Factors|immunologic factors|mesh-ancestor
102166683|NCT05047328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166684|NCT02104609|Levonorgestrel|levonorgestrel|mesh-list
102166685|NCT02104609|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102166686|NCT02104609|Contraceptive Agents|contraceptive agents|mesh-ancestor
102166687|NCT02104609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102166688|NCT02104609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166689|NCT02104609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102166690|NCT02104609|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102166691|NCT02104609|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102166692|NCT02106793|Mitomycins|mitomycins|mesh-list
102166693|NCT02106793|Mitomycin|mitomycin|mesh-list
102166694|NCT02106793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102166695|NCT02106793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102166696|NCT02106793|Alkylating Agents|alkylating agents|mesh-ancestor
102166697|NCT02106793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166698|NCT02106793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102166699|NCT02106793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102166700|NCT02104843|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102166701|NCT02104843|Asunaprevir|asunaprevir|mesh-list
102166702|NCT02104843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102166703|NCT02104843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102166704|NCT02104843|Antimetabolites|antimetabolites|mesh-ancestor
102166705|NCT02104843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166706|NCT02104843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102166707|NCT02104843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102166708|NCT02104843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102166709|NCT02104843|Protease Inhibitors|protease inhibitors|mesh-ancestor
102166710|NCT05041790|Choline|choline|mesh-list
102166711|NCT05041790|Lipotropic Agents|lipotropic agents|mesh-ancestor
102166712|NCT05041790|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102166713|NCT05041790|Antimetabolites|antimetabolites|mesh-ancestor
102166714|NCT05041790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166715|NCT05041790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102166716|NCT05041790|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102166717|NCT05041790|Nootropic Agents|nootropic agents|mesh-ancestor
102166718|NCT02105077|Anesthetics|anesthetics|mesh-list
102166719|NCT02105077|Xenon|xenon|mesh-list
102166720|NCT02105077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102166721|NCT02105077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166722|NCT02105077|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102166723|NCT02105077|Anesthetics, General|anesthetics, general|mesh-ancestor
102166724|NCT02101567|Oxytocin|oxytocin|mesh-list
102166725|NCT02101567|Carbetocin|carbetocin|mesh-list
102166726|NCT02101567|Oxytocics|oxytocics|mesh-ancestor
102166727|NCT02101567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102166728|NCT02101567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166729|NCT02106871|Sildenafil Citrate|sildenafil citrate|mesh-list
102166730|NCT02106871|Vasodilator Agents|vasodilator agents|mesh-ancestor
102166731|NCT02106871|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102166732|NCT02106871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102166733|NCT02106871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102166734|NCT02106871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166735|NCT02106871|Urological Agents|urological agents|mesh-ancestor
102166736|NCT02251015|Salicylic Acid|salicylic acid|mesh-list
102166737|NCT02251015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102166738|NCT02251015|Antifungal Agents|antifungal agents|mesh-ancestor
102166739|NCT02251015|Keratolytic Agents|keratolytic agents|mesh-ancestor
102166740|NCT02251015|Dermatologic Agents|dermatologic agents|mesh-ancestor
102166741|NCT03288597|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102166742|NCT03288597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102166743|NCT03288597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166744|NCT02407990|Tislelizumab|tislelizumab|mesh-list
102166745|NCT02407990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102166746|NCT02407990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102166747|NCT02105155|Tacrolimus|tacrolimus|mesh-list
102166748|NCT02105155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102166749|NCT02105155|Immunologic Factors|immunologic factors|mesh-ancestor
102166750|NCT02105155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166751|NCT02105155|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102166752|NCT02105155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102166753|NCT02105155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166754|NCT03294525|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102166755|NCT03294525|Mirtazapine|mirtazapine|mesh-list
102166756|NCT03294525|Antidepressive Agents|antidepressive agents|mesh-list
102166757|NCT03294525|Escitalopram|escitalopram|mesh-list
102166758|NCT03294525|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102166759|NCT03294525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102166760|NCT03294525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102166761|NCT03294525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166762|NCT03294525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102166763|NCT03294525|Serotonin Agents|serotonin agents|mesh-ancestor
102166764|NCT03294525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166765|NCT03294525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102166766|NCT03294525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102166767|NCT03294525|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102166768|NCT03294525|Analgesics|analgesics|mesh-ancestor
102166769|NCT03294525|Sensory System Agents|sensory system agents|mesh-ancestor
102166770|NCT03294525|Dopamine Agents|dopamine agents|mesh-ancestor
102166771|NCT03294525|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102166772|NCT03294525|Histamine Antagonists|histamine antagonists|mesh-ancestor
102166773|NCT03294525|Histamine Agents|histamine agents|mesh-ancestor
102166774|NCT03294525|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102166775|NCT03294525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102166776|NCT03294525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102166777|NCT03294525|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102166778|NCT03294525|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102166779|NCT03294525|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102166780|NCT03294525|Adrenergic Agents|adrenergic agents|mesh-ancestor
102166781|NCT03294525|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102166782|NCT03294525|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102166783|NCT03294525|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102166784|NCT05036174|Diphenhydramine|diphenhydramine|mesh-list
102166785|NCT05036174|Promethazine|promethazine|mesh-list
102166786|NCT05036174|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102166787|NCT05036174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102166788|NCT05036174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102166789|NCT05036174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166790|NCT05036174|Anesthetics, Local|anesthetics, local|mesh-ancestor
102166791|NCT05036174|Anesthetics|anesthetics|mesh-ancestor
102166792|NCT05036174|Sensory System Agents|sensory system agents|mesh-ancestor
102166793|NCT05036174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102166794|NCT05036174|Antiemetics|antiemetics|mesh-ancestor
102166795|NCT05036174|Autonomic Agents|autonomic agents|mesh-ancestor
102166796|NCT05036174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102166797|NCT05036174|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102166798|NCT05036174|Histamine Antagonists|histamine antagonists|mesh-ancestor
102166799|NCT05036174|Histamine Agents|histamine agents|mesh-ancestor
102166800|NCT05036174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102166801|NCT05036174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166802|NCT05036174|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102166803|NCT05036174|Antipruritics|antipruritics|mesh-ancestor
102166804|NCT05036174|Dermatologic Agents|dermatologic agents|mesh-ancestor
102166805|NCT03283059|Donepezil|donepezil|mesh-list
102166806|NCT03283059|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102166807|NCT03283059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102166808|NCT03283059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166809|NCT03283059|Cholinergic Agents|cholinergic agents|mesh-ancestor
102166810|NCT03283059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102166811|NCT03283059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166812|NCT03283059|Nootropic Agents|nootropic agents|mesh-ancestor
102166813|NCT05060588|Valsartan|valsartan|mesh-list
102166814|NCT05060588|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102166815|NCT05060588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102166816|NCT05060588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102166817|NCT05060588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102166818|NCT05060588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166819|NCT02105311|Benzalkonium Compounds|benzalkonium compounds|mesh-list
102166820|NCT02105311|Travoprost|travoprost|mesh-list
102166821|NCT02105311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102166822|NCT02105311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102166823|NCT02105311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102166824|NCT03554395|Antibodies|antibodies|mesh-list
102166825|NCT03554395|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102166826|NCT03554395|Immunologic Factors|immunologic factors|mesh-ancestor
102166827|NCT03554395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166828|NCT03282825|Paclitaxel|paclitaxel|mesh-list
102166829|NCT03282825|Decitabine|decitabine|mesh-list
102166830|NCT03282825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102166831|NCT03282825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102166832|NCT03282825|Tubulin Modulators|tubulin modulators|mesh-ancestor
102166833|NCT03282825|Antimitotic Agents|antimitotic agents|mesh-ancestor
102166834|NCT03282825|Mitosis Modulators|mitosis modulators|mesh-ancestor
102166835|NCT03282825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166836|NCT03282825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102166837|NCT03282825|Antimetabolites|antimetabolites|mesh-ancestor
102166838|NCT03282825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102166839|NCT02105623|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102166840|NCT02105623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102166841|NCT02105623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102166842|NCT02105623|Antimetabolites|antimetabolites|mesh-ancestor
102166843|NCT02105623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166844|NCT02105623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102166845|NCT02105623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102166846|NCT02105623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102166848|NCT05039606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102166849|NCT03288051|Dobutamine|dobutamine|mesh-list
102166850|NCT03288051|Norepinephrine|norepinephrine|mesh-list
102166851|NCT03288051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102166852|NCT03288051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102166853|NCT03288051|Adrenergic Agents|adrenergic agents|mesh-ancestor
102166854|NCT03288051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102166855|NCT03288051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166856|NCT03288051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166857|NCT03288051|Sympathomimetics|sympathomimetics|mesh-ancestor
102166858|NCT03288051|Autonomic Agents|autonomic agents|mesh-ancestor
102166859|NCT03288051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102166860|NCT03288051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102166861|NCT03288051|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102166862|NCT03288051|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102166863|NCT03288051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102166864|NCT03288051|Protective Agents|protective agents|mesh-ancestor
102166865|NCT05035472|Phenylephrine|phenylephrine|mesh-list
102166866|NCT05035472|Oxymetazoline|oxymetazoline|mesh-list
102166867|NCT05035472|Norepinephrine|norepinephrine|mesh-list
102166868|NCT05035472|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
102166869|NCT05035472|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102166870|NCT05035472|Mydriatics|mydriatics|mesh-ancestor
102166871|NCT05035472|Autonomic Agents|autonomic agents|mesh-ancestor
102166872|NCT05035472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102166873|NCT05035472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166874|NCT05035472|Sympathomimetics|sympathomimetics|mesh-ancestor
102166875|NCT05035472|Nasal Decongestants|nasal decongestants|mesh-ancestor
102166876|NCT05035472|Respiratory System Agents|respiratory system agents|mesh-ancestor
102166877|NCT05035472|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102166878|NCT05035472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102166879|NCT05035472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102166880|NCT05035472|Adrenergic Agents|adrenergic agents|mesh-ancestor
102166881|NCT05035472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101446503|NCT00202176|Cholinergic Agents|cholinergic agents|mesh-ancestor
102166882|NCT05035472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166883|NCT05035472|Protective Agents|protective agents|mesh-ancestor
102166884|NCT02460627|Lidocaine|lidocaine|mesh-list
102166885|NCT02460627|Anesthetics, Local|anesthetics, local|mesh-ancestor
102166886|NCT02460627|Anesthetics|anesthetics|mesh-ancestor
102166887|NCT02460627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102166888|NCT02460627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166889|NCT02460627|Sensory System Agents|sensory system agents|mesh-ancestor
102166890|NCT02460627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102166891|NCT02460627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102166892|NCT02460627|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102166893|NCT02460627|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102166894|NCT02460627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102166895|NCT02460627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166896|NCT02107729|Lidocaine|lidocaine|mesh-list
102166897|NCT02107729|Anesthetics, Local|anesthetics, local|mesh-ancestor
102166898|NCT02107729|Anesthetics|anesthetics|mesh-ancestor
102166899|NCT02107729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102166900|NCT02107729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166901|NCT02107729|Sensory System Agents|sensory system agents|mesh-ancestor
102166902|NCT02107729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102166903|NCT02107729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102166904|NCT02107729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102166905|NCT02107729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102166906|NCT02107729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102166907|NCT02107729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166908|NCT03282513|Ivosidenib|ivosidenib|mesh-list
102166909|NCT03282513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102166910|NCT03282513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102166911|NCT03282513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166912|NCT02107807|Lactitol|lactitol|mesh-list
102166913|NCT02107807|Vaccines|vaccines|mesh-list
102166914|NCT02107807|Immunologic Factors|immunologic factors|mesh-ancestor
102166915|NCT02107807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166916|NCT02107807|Cathartics|cathartics|mesh-ancestor
102166917|NCT02107807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102166918|NCT01673282|Lacosamide|lacosamide|mesh-list
102166919|NCT01673282|Anticonvulsants|anticonvulsants|mesh-ancestor
102166920|NCT01673282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102166921|NCT01673282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102166922|NCT01673282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102166923|NCT01673282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166924|NCT02113735|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102166925|NCT02113735|Hormones|hormones|mesh-ancestor
102166926|NCT02113735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102166927|NCT02113735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166928|NCT02113813|Naquotinib|naquotinib|mesh-list
102166929|NCT02113813|Midazolam|midazolam|mesh-list
102166930|NCT02113813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102166931|NCT02113813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102166932|NCT02113813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102166933|NCT02113813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166934|NCT02113813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102166935|NCT02113813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102166936|NCT02113813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102166937|NCT02113813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102166938|NCT02113813|Anesthetics, General|anesthetics, general|mesh-ancestor
102166939|NCT02113813|Anesthetics|anesthetics|mesh-ancestor
102166940|NCT02113813|GABA Modulators|gaba modulators|mesh-ancestor
102166941|NCT02113813|GABA Agents|gaba agents|mesh-ancestor
102166942|NCT02113813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102166943|NCT02113813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166944|NCT02113813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102166945|NCT02113813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102166946|NCT02113813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102166947|NCT03095144|Anesthetics|anesthetics|mesh-list
102166948|NCT03095144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102166949|NCT03095144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166950|NCT03095222|Ketamine|ketamine|mesh-list
102166951|NCT03095222|Analgesics|analgesics|mesh-ancestor
102166952|NCT03095222|Sensory System Agents|sensory system agents|mesh-ancestor
102166953|NCT03095222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102166954|NCT03095222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166955|NCT03095222|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102166956|NCT03095222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102166957|NCT03095222|Anesthetics, General|anesthetics, general|mesh-ancestor
102166958|NCT03095222|Anesthetics|anesthetics|mesh-ancestor
102166959|NCT03095222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102166960|NCT03095222|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102166961|NCT03095222|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102166962|NCT03095222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102166963|NCT03095222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166964|NCT02113891|Eculizumab|eculizumab|mesh-list
102166965|NCT02113891|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102166966|NCT02113891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102166967|NCT02113891|Immunologic Factors|immunologic factors|mesh-ancestor
102166968|NCT02113891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102166969|NCT03095378|Anti-Infective Agents|anti-infective agents|mesh-list
102166970|NCT03095378|Tetracycline|tetracycline|mesh-list
102166971|NCT03095378|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102166972|NCT03095378|Citric Acid|citric acid|mesh-list
102166973|NCT03095378|Sodium Citrate|sodium citrate|mesh-list
102166974|NCT03095378|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102166975|NCT03095378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102166976|NCT03095378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166977|NCT03095378|Anticoagulants|anticoagulants|mesh-ancestor
102166978|NCT03095378|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102166979|NCT03095378|Chelating Agents|chelating agents|mesh-ancestor
102166980|NCT03095378|Sequestering Agents|sequestering agents|mesh-ancestor
102166981|NCT05025098|Azacitidine|azacitidine|mesh-list
102166982|NCT05025098|Venetoclax|venetoclax|mesh-list
102166983|NCT05025098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102166984|NCT05025098|Antimetabolites|antimetabolites|mesh-ancestor
102166985|NCT05025098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102166986|NCT05025098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102166987|NCT05025098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101875817|NCT00149630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102166988|NCT05038202|Mometasone Furoate|mometasone furoate|mesh-list
102166989|NCT05038202|Bromides|bromides|mesh-list
102166990|NCT05038202|Anticonvulsants|anticonvulsants|mesh-ancestor
102166991|NCT05038202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102166992|NCT05038202|Dermatologic Agents|dermatologic agents|mesh-ancestor
102166993|NCT05038202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102166994|NCT02114359|Cisplatin|cisplatin|mesh-list
102166995|NCT02114359|Fluorouracil|fluorouracil|mesh-list
102166996|NCT02114359|Capecitabine|capecitabine|mesh-list
102166997|NCT02114359|Oxaliplatin|oxaliplatin|mesh-list
102166998|NCT02114359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102166999|NCT02114359|Antimetabolites|antimetabolites|mesh-ancestor
102167000|NCT02114359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167001|NCT02114359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102167002|NCT02114359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102167003|NCT02114359|Immunologic Factors|immunologic factors|mesh-ancestor
102167004|NCT02114359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167005|NCT02110303|Ticagrelor|ticagrelor|mesh-list
102167006|NCT02110303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102167007|NCT02110303|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102167008|NCT02110303|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102167009|NCT02110303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102167010|NCT02110303|Purinergic Agents|purinergic agents|mesh-ancestor
102167011|NCT02110303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102167012|NCT02110303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167013|NCT02110303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167014|NCT03093740|Sofosbuvir|sofosbuvir|mesh-list
102167015|NCT03093740|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
102167016|NCT03093740|Antiviral Agents|antiviral agents|mesh-ancestor
102167017|NCT03093740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102167018|NCT02108353|Melatonin|melatonin|mesh-list
102167019|NCT02108353|Antioxidants|antioxidants|mesh-ancestor
102167020|NCT02108353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167021|NCT02108353|Protective Agents|protective agents|mesh-ancestor
102167022|NCT02108353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167023|NCT02108353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102167024|NCT04157751|Empagliflozin|empagliflozin|mesh-list
102167025|NCT04157751|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102167026|NCT04157751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167027|NCT04157751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102167028|NCT04157751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167029|NCT02114671|Ciprofloxacin|ciprofloxacin|mesh-list
102167030|NCT02114671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102167031|NCT02114671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102167032|NCT02114671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102167033|NCT02114671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102167034|NCT02114671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102167035|NCT02114671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167036|NCT02114671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102167037|NCT02114671|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102167038|NCT02114671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102167039|NCT02110459|Murepavadin|murepavadin|mesh-list
102167040|NCT02110459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102167041|NCT02110459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102167042|NCT03287505|Aripiprazole|aripiprazole|mesh-list
102167043|NCT03287505|Antidepressive Agents|antidepressive agents|mesh-ancestor
102167044|NCT03287505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102167045|NCT03287505|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102167046|NCT03287505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102167047|NCT03287505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102167048|NCT03287505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167049|NCT03287505|Dopamine Agonists|dopamine agonists|mesh-ancestor
102167050|NCT03287505|Dopamine Agents|dopamine agents|mesh-ancestor
102167051|NCT03287505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102167052|NCT03287505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167053|NCT03287505|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102167054|NCT03287505|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102167055|NCT03287505|Serotonin Agents|serotonin agents|mesh-ancestor
102167056|NCT03287505|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102167057|NCT03287505|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102167058|NCT03287505|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102167059|NCT03287505|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102167060|NCT03090698|Triamcinolone|triamcinolone|mesh-list
102167061|NCT03090698|Hylan|hylan|mesh-list
102167062|NCT03090698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102167063|NCT03090698|Glucocorticoids|glucocorticoids|mesh-ancestor
102167064|NCT03090698|Hormones|hormones|mesh-ancestor
102167065|NCT03090698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102167066|NCT03090698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167067|NCT03090698|Viscosupplements|viscosupplements|mesh-ancestor
102167068|NCT03090698|Protective Agents|protective agents|mesh-ancestor
102167070|NCT03293511|Oxytocics|oxytocics|mesh-ancestor
102167071|NCT03293511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102167072|NCT03293511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167073|NCT02251171|Ritonavir|ritonavir|mesh-list
102167074|NCT02251171|Tipranavir|tipranavir|mesh-list
102167075|NCT02251171|Rifabutin|rifabutin|mesh-list
102167076|NCT02251171|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102167077|NCT02251171|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102167078|NCT02251171|Protease Inhibitors|protease inhibitors|mesh-ancestor
102167079|NCT02251171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102167080|NCT02251171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167081|NCT02251171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102167082|NCT02251171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102167083|NCT02251171|Antiviral Agents|antiviral agents|mesh-ancestor
102167084|NCT02251171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102167085|NCT02251171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102167086|NCT02251171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102167087|NCT02251171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102167088|NCT02251171|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102167089|NCT02251171|Antitubercular Agents|antitubercular agents|mesh-ancestor
102167090|NCT02110537|Flecainide|flecainide|mesh-list
102167091|NCT02110537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102167092|NCT02110537|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102167093|NCT02110537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102167094|NCT02110537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102167095|NCT02110537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167096|NCT03293277|Dexmedetomidine|dexmedetomidine|mesh-list
102167097|NCT03293277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102167098|NCT03293277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102167099|NCT03293277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167100|NCT03293277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102167101|NCT03293277|Analgesics|analgesics|mesh-ancestor
102167102|NCT03293277|Sensory System Agents|sensory system agents|mesh-ancestor
102167103|NCT03293277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102167104|NCT03293277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102167105|NCT03293277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102167106|NCT03293277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102167107|NCT03293277|Adrenergic Agents|adrenergic agents|mesh-ancestor
102167108|NCT03293277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102167109|NCT03293277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167110|NCT02108743|Albuterol|albuterol|mesh-list
102167111|NCT02108743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102167112|NCT02108743|Autonomic Agents|autonomic agents|mesh-ancestor
102167113|NCT02108743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102167114|NCT02108743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167115|NCT02108743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102167116|NCT02108743|Respiratory System Agents|respiratory system agents|mesh-ancestor
102167117|NCT02108743|Tocolytic Agents|tocolytic agents|mesh-ancestor
102167118|NCT02108743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102167119|NCT02108743|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102167120|NCT02108743|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102167121|NCT02108743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102167122|NCT02108743|Adrenergic Agents|adrenergic agents|mesh-ancestor
102167123|NCT02108743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101446582|NCT04576975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102167124|NCT02108743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167125|NCT03292965|Neostigmine|neostigmine|mesh-list
102167126|NCT03292965|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102167127|NCT03292965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102167128|NCT03292965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167129|NCT03292965|Cholinergic Agents|cholinergic agents|mesh-ancestor
102167130|NCT03292965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102167131|NCT03292965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167132|NCT03292965|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102167133|NCT03292965|Autonomic Agents|autonomic agents|mesh-ancestor
102167134|NCT03292965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102167135|NCT05024084|Anesthetics|anesthetics|mesh-list
102167136|NCT05024084|Sevoflurane|sevoflurane|mesh-list
102167137|NCT05024084|Desflurane|desflurane|mesh-list
102167138|NCT05024084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102167139|NCT05024084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167140|NCT05024084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102167141|NCT05024084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102167142|NCT05024084|Anesthetics, General|anesthetics, general|mesh-ancestor
102167143|NCT02109289|Etanercept|etanercept|mesh-list
102167144|NCT02109289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102167145|NCT02109289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102167146|NCT02109289|Analgesics|analgesics|mesh-ancestor
102167147|NCT02109289|Sensory System Agents|sensory system agents|mesh-ancestor
102167148|NCT02109289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102167149|NCT02109289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167150|NCT02109289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102167151|NCT02109289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102167152|NCT02109289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102167153|NCT02109289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102167154|NCT02109289|Immunologic Factors|immunologic factors|mesh-ancestor
102167155|NCT03292731|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
102167156|NCT03292731|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
102167157|NCT03292731|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102167158|NCT03292731|Hormone Antagonists|hormone antagonists|mesh-ancestor
102167159|NCT03292731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102167160|NCT03292731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167161|NCT03292731|Progestins|progestins|mesh-ancestor
102167162|NCT03292731|Hormones|hormones|mesh-ancestor
102167163|NCT03553303|Valsartan|valsartan|mesh-list
102167164|NCT03553303|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102167165|NCT03553303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102167166|NCT03553303|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102167167|NCT03553303|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102167168|NCT03553303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167169|NCT03286959|Calcium|calcium|mesh-list
102167170|NCT03286959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102167171|NCT03286959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167172|NCT03292575|Anticoagulants|anticoagulants|mesh-list
102167173|NCT02115529|Nabilone|nabilone|mesh-list
102167174|NCT02115529|Antiemetics|antiemetics|mesh-ancestor
102167175|NCT02115529|Autonomic Agents|autonomic agents|mesh-ancestor
102167176|NCT02115529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102167177|NCT02115529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167178|NCT02115529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102167179|NCT02115529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102167180|NCT02115529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102167181|NCT02115529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102167182|NCT02115529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102167183|NCT01652716|Exenatide|exenatide|mesh-list
102167184|NCT01652716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102167185|NCT01652716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167186|NCT01652716|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102167187|NCT01652716|Incretins|incretins|mesh-ancestor
102167188|NCT01652716|Hormones|hormones|mesh-ancestor
102167189|NCT01652716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102167190|NCT02459613|Annexin A5|annexin a5|mesh-list
102167191|NCT02459613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102167192|NCT02459613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167193|NCT02251249|Acetaminophen|acetaminophen|mesh-list
102167194|NCT02251249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102167195|NCT02251249|Analgesics|analgesics|mesh-ancestor
102167196|NCT02251249|Sensory System Agents|sensory system agents|mesh-ancestor
102167197|NCT02251249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102167198|NCT02251249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167199|NCT02251249|Antipyretics|antipyretics|mesh-ancestor
102167200|NCT05017766|Anti-Infective Agents|anti-infective agents|mesh-list
102167201|NCT05017766|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102167202|NCT03292263|Nivolumab|nivolumab|mesh-list
102167203|NCT03292263|Melphalan|melphalan|mesh-list
102167204|NCT03292263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102167205|NCT03292263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102167206|NCT03292263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102167207|NCT03292263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167208|NCT03292263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102167209|NCT03292263|Alkylating Agents|alkylating agents|mesh-ancestor
102167210|NCT03292263|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102167211|NCT03292263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102167212|NCT03292263|Immunologic Factors|immunologic factors|mesh-ancestor
101876039|NCT03967392|Lidocaine|lidocaine|mesh-list
102167213|NCT03292263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167214|NCT02115763|Caffeine|caffeine|mesh-list
102167215|NCT02115763|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102167216|NCT02115763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167217|NCT02115763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102167218|NCT02115763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102167219|NCT02115763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167220|NCT02115763|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102167221|NCT02115763|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102167222|NCT02115763|Purinergic Agents|purinergic agents|mesh-ancestor
102167223|NCT02115763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102167224|NCT03286803|Vaccines|vaccines|mesh-list
102167225|NCT03286803|Immunologic Factors|immunologic factors|mesh-ancestor
102167226|NCT03286803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167227|NCT03292185|Insulin|insulin|mesh-list
102167228|NCT03292185|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102167229|NCT03292185|Liraglutide|liraglutide|mesh-list
102167230|NCT03292185|Insulin, Long-Acting|insulin, long-acting|mesh-list
102167231|NCT03292185|Xultophy|xultophy|mesh-list
102167232|NCT03292185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102167233|NCT03292185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167235|NCT03292185|Hormones|hormones|mesh-ancestor
102167236|NCT03292185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102167237|NCT04239339|Escitalopram|escitalopram|mesh-list
102167238|NCT04239339|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102167239|NCT04239339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102167240|NCT04239339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102167241|NCT04239339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167242|NCT04239339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102167243|NCT04239339|Serotonin Agents|serotonin agents|mesh-ancestor
102167244|NCT04239339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167245|NCT02109679|Metformin|metformin|mesh-list
102167246|NCT02109679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102167247|NCT02109679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167248|NCT05023304|Prednisolone|prednisolone|mesh-list
102167249|NCT05023304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102167250|NCT05023304|Glucocorticoids|glucocorticoids|mesh-ancestor
102167251|NCT05023304|Hormones|hormones|mesh-ancestor
102167252|NCT05023304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102167253|NCT05023304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167254|NCT05023304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102167255|NCT05023304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102167256|NCT02109913|Everolimus|everolimus|mesh-list
102167257|NCT02109913|Exemestane|exemestane|mesh-list
102167258|NCT02109913|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102167259|NCT02109913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102167260|NCT02109913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102167261|NCT02109913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167262|NCT02109913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102167263|NCT02109913|Immunologic Factors|immunologic factors|mesh-ancestor
102167264|NCT02109913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167265|NCT02109913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102167266|NCT02109913|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102167267|NCT02109913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102167268|NCT02109913|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102167269|NCT02109913|Hormone Antagonists|hormone antagonists|mesh-ancestor
102167270|NCT02109913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102167271|NCT02116231|Cisplatin|cisplatin|mesh-list
102167272|NCT02116231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102167273|NCT02111161|Immunoglobulins|immunoglobulins|mesh-list
102167274|NCT02111161|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102167275|NCT02111161|Immunoglobulin G|immunoglobulin g|mesh-list
102167276|NCT02111161|gamma-Globulins|gamma-globulins|mesh-list
102167277|NCT02111161|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102167278|NCT02111161|Immunologic Factors|immunologic factors|mesh-ancestor
102167279|NCT02111161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167280|NCT02116465|Levodopa|levodopa|mesh-list
102167281|NCT02116465|Carbidopa|carbidopa|mesh-list
102167282|NCT02116465|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102167283|NCT02116465|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102167284|NCT02116465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102167285|NCT02116465|Dopamine Agents|dopamine agents|mesh-ancestor
102167286|NCT02116465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102167287|NCT02116465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167288|NCT02116465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167289|NCT02116465|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102167290|NCT02116465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102167291|NCT02116465|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102167292|NCT02116465|Immunologic Factors|immunologic factors|mesh-ancestor
102167293|NCT02116465|Dopamine Agonists|dopamine agonists|mesh-ancestor
102167294|NCT02119039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102167295|NCT02119039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102167296|NCT02119117|Coenzyme Q10|coenzyme q10|mesh-list
102167297|NCT02119117|Vitamins|vitamins|mesh-ancestor
102167298|NCT02119117|Micronutrients|micronutrients|mesh-ancestor
102167299|NCT02119117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167300|NCT05016128|Ketamine|ketamine|mesh-list
102167301|NCT05016128|Esketamine|esketamine|mesh-list
102167302|NCT05016128|Analgesics|analgesics|mesh-ancestor
102167303|NCT05016128|Sensory System Agents|sensory system agents|mesh-ancestor
102167304|NCT05016128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102167305|NCT05016128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167306|NCT05016128|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102167307|NCT05016128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102167308|NCT05016128|Anesthetics, General|anesthetics, general|mesh-ancestor
102167309|NCT05016128|Anesthetics|anesthetics|mesh-ancestor
102167310|NCT05016128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102167311|NCT05016128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102167312|NCT05016128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102167313|NCT05016128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102167314|NCT05016128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167315|NCT05016128|Antidepressive Agents|antidepressive agents|mesh-ancestor
102167316|NCT05016128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102167317|NCT02111317|Verapamil|verapamil|mesh-list
102167318|NCT02111317|Peficitinib|peficitinib|mesh-list
102167319|NCT02111317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102167320|NCT02111317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102167321|NCT02111317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102167322|NCT02111317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167323|NCT02111317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102167324|NCT02111317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167325|NCT02111317|Vasodilator Agents|vasodilator agents|mesh-ancestor
102167326|NCT02111317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102167327|NCT02111317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102167328|NCT02111317|Immunologic Factors|immunologic factors|mesh-ancestor
102167329|NCT03553615|Ivermectin|ivermectin|mesh-list
102167330|NCT03553615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102167331|NCT03553615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102167332|NCT05016206|Moxifloxacin|moxifloxacin|mesh-list
102167333|NCT05016206|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102167334|NCT05016206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102167335|NCT05016206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102167336|NCT05016206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102167337|NCT05016206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102167338|NCT05016206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102167339|NCT05016206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167340|NCT05016206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102167341|NCT05016206|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102167342|NCT05016206|Contraceptive Agents|contraceptive agents|mesh-ancestor
102167343|NCT05016206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102167344|NCT05016206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167345|NCT05016206|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102167346|NCT05016206|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102167347|NCT05016206|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102167348|NCT02111473|Testosterone|testosterone|mesh-list
102167349|NCT02111473|Androgens|androgens|mesh-ancestor
102167350|NCT02111473|Hormones|hormones|mesh-ancestor
102167351|NCT02111473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102167352|NCT02111473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167353|NCT02111551|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
102167354|NCT02111551|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102167355|NCT02111551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102167356|NCT02111551|Cholinergic Agents|cholinergic agents|mesh-ancestor
102167357|NCT02111551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102167358|NCT02111551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167359|NCT02111551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167360|NCT02119273|Prednisone|prednisone|mesh-list
102167361|NCT02119273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102167362|NCT02119273|Glucocorticoids|glucocorticoids|mesh-ancestor
102167363|NCT02119273|Hormones|hormones|mesh-ancestor
102167364|NCT02119273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102167365|NCT02119273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167366|NCT02119273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102167367|NCT02119273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102167368|NCT05029076|Liraglutide|liraglutide|mesh-list
102167369|NCT05029076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102167370|NCT05029076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167371|NCT05029076|Incretins|incretins|mesh-ancestor
102167372|NCT05029076|Hormones|hormones|mesh-ancestor
102167373|NCT05029076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102167374|NCT05016440|Lisinopril|lisinopril|mesh-list
102167375|NCT05016440|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102167376|NCT05016440|Protease Inhibitors|protease inhibitors|mesh-ancestor
102167377|NCT05016440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101573976|NCT02199184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102167378|NCT05016440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167379|NCT05016440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102167380|NCT05016440|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102167381|NCT05016440|Protective Agents|protective agents|mesh-ancestor
102167382|NCT05016440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167383|NCT02111629|Fluconazole|fluconazole|mesh-list
102167384|NCT02111629|Secnidazole|secnidazole|mesh-list
102167385|NCT02111629|Antifungal Agents|antifungal agents|mesh-ancestor
102167386|NCT02111629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102167387|NCT02111629|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102167388|NCT02111629|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102167389|NCT02111629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102167390|NCT02111629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167391|NCT02111629|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101446604|NCT00181025|Melphalan|melphalan|mesh-list
102167392|NCT02111629|Hormone Antagonists|hormone antagonists|mesh-ancestor
102167393|NCT02111629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102167394|NCT02111629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167395|NCT02111629|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102167396|NCT02111629|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102167397|NCT02111629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102167398|NCT02111629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102167399|NCT02111707|Indomethacin|indomethacin|mesh-list
102167400|NCT02111707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102167401|NCT02111707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102167402|NCT02111707|Analgesics|analgesics|mesh-ancestor
102167403|NCT02111707|Sensory System Agents|sensory system agents|mesh-ancestor
102167404|NCT02111707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102167405|NCT02111707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167406|NCT02111707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102167407|NCT02111707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102167408|NCT02111707|Gout Suppressants|gout suppressants|mesh-ancestor
102167409|NCT02111707|Tocolytic Agents|tocolytic agents|mesh-ancestor
102167410|NCT02111707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102167411|NCT02111707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102167412|NCT02111707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102167413|NCT02111707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167414|NCT03552601|Methamphetamine|methamphetamine|mesh-list
102167415|NCT03552601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102167416|NCT03552601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167417|NCT03552601|Sympathomimetics|sympathomimetics|mesh-ancestor
102167418|NCT03552601|Autonomic Agents|autonomic agents|mesh-ancestor
102167419|NCT03552601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102167420|NCT03552601|Dopamine Agents|dopamine agents|mesh-ancestor
102167421|NCT03552601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102167422|NCT03552601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167423|NCT03552601|Adrenergic Agents|adrenergic agents|mesh-ancestor
102167424|NCT03552601|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102167425|NCT03552601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102167426|NCT03552601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102167427|NCT03552601|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102167428|NCT05021588|Anticoagulants|anticoagulants|mesh-list
102167429|NCT03087890|Trimethoprim|trimethoprim|mesh-list
102167430|NCT03087890|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102167431|NCT03087890|Sulfamethoxazole|sulfamethoxazole|mesh-list
102167432|NCT03087890|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102167433|NCT03087890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102167434|NCT03087890|Antimalarials|antimalarials|mesh-ancestor
102167435|NCT03087890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102167436|NCT03087890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102167437|NCT03087890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102167438|NCT03087890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102167439|NCT03087890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167440|NCT03087890|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102167441|NCT03087890|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102167442|NCT03087890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102167443|NCT03087890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102167445|NCT02112019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102167446|NCT02117401|Midazolam|midazolam|mesh-list
102167447|NCT02117401|Ketamine|ketamine|mesh-list
102167448|NCT02117401|Remifentanil|remifentanil|mesh-list
102167449|NCT02117401|Propofol|propofol|mesh-list
102167450|NCT02117401|Mivacurium|mivacurium|mesh-list
102167451|NCT02117401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102167452|NCT02117401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102167453|NCT02117401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167454|NCT02117401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102167455|NCT02117401|Anesthetics, General|anesthetics, general|mesh-ancestor
102167456|NCT02117401|Anesthetics|anesthetics|mesh-ancestor
102167457|NCT02117401|Analgesics|analgesics|mesh-ancestor
102167458|NCT02117401|Sensory System Agents|sensory system agents|mesh-ancestor
102167459|NCT02117401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102167460|NCT02117401|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102167461|NCT02117401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101446611|NCT00181025|Immunologic Factors|immunologic factors|mesh-ancestor
102167462|NCT02117401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102167463|NCT02117401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102167464|NCT02117401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167465|NCT02117401|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102167466|NCT02117401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102167467|NCT02117401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102167468|NCT02117401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102167469|NCT02117401|GABA Modulators|gaba modulators|mesh-ancestor
102167470|NCT02117401|GABA Agents|gaba agents|mesh-ancestor
102167471|NCT02117401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102167472|NCT02117401|Narcotics|narcotics|mesh-ancestor
102167473|NCT02117401|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102167474|NCT02117401|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102167475|NCT02117401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102167476|NCT04434404|Silymarin|silymarin|mesh-list
102167477|NCT04434404|Antioxidants|antioxidants|mesh-ancestor
102167478|NCT04434404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167479|NCT04434404|Protective Agents|protective agents|mesh-ancestor
102167480|NCT04434404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167481|NCT02251483|Immunoglobulins|immunoglobulins|mesh-list
102167482|NCT02251483|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102167483|NCT02251483|Antibodies|antibodies|mesh-list
102167484|NCT02251483|Immunologic Factors|immunologic factors|mesh-ancestor
102167485|NCT02251483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167486|NCT02117869|Furocoumarins|furocoumarins|mesh-list
102167487|NCT02117869|Dermatologic Agents|dermatologic agents|mesh-ancestor
102167488|NCT02117869|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102167489|NCT02120599|Folic Acid|folic acid|mesh-list
102167490|NCT02120599|Hematinics|hematinics|mesh-ancestor
102167491|NCT02120599|Vitamin B Complex|vitamin b complex|mesh-ancestor
102167492|NCT02120599|Vitamins|vitamins|mesh-ancestor
102167493|NCT02120599|Micronutrients|micronutrients|mesh-ancestor
102167494|NCT02120599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167495|NCT02112097|Etanercept|etanercept|mesh-list
102167496|NCT02112097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102167497|NCT02112097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102167498|NCT02112097|Analgesics|analgesics|mesh-ancestor
102167499|NCT02112097|Sensory System Agents|sensory system agents|mesh-ancestor
102167500|NCT02112097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102167501|NCT02112097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167502|NCT02112097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102167503|NCT02112097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102167504|NCT02112097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102167505|NCT02112097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102167506|NCT02112097|Immunologic Factors|immunologic factors|mesh-ancestor
102167507|NCT02112175|Lenalidomide|lenalidomide|mesh-list
102167508|NCT02112175|Immunologic Factors|immunologic factors|mesh-ancestor
102167509|NCT02112175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876340|NCT00144170|Protease Inhibitors|protease inhibitors|mesh-list
102167510|NCT02112175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102167511|NCT02112175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102167512|NCT02112175|Growth Substances|growth substances|mesh-ancestor
102167513|NCT02112175|Growth Inhibitors|growth inhibitors|mesh-ancestor
102167514|NCT02112175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102167516|NCT03553537|Cyclophosphamide|cyclophosphamide|mesh-list
102167517|NCT03553537|Doxorubicin|doxorubicin|mesh-list
102167518|NCT03553537|Vincristine|vincristine|mesh-list
102167519|NCT03553537|Decitabine|decitabine|mesh-list
102167520|NCT03553537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102167521|NCT03553537|Immunologic Factors|immunologic factors|mesh-ancestor
102167522|NCT03553537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167523|NCT03553537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102167524|NCT03553537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102167525|NCT03553537|Alkylating Agents|alkylating agents|mesh-ancestor
102167526|NCT03553537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167527|NCT03553537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102167528|NCT03553537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102167529|NCT03553537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102167530|NCT03553537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102167531|NCT03553537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102167532|NCT03553537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102167533|NCT03553537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102167534|NCT03553537|Glucocorticoids|glucocorticoids|mesh-ancestor
102167536|NCT03553537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101446613|NCT00209313|Acyclovir|acyclovir|mesh-list
102167537|NCT03553537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102167538|NCT03553537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102167539|NCT03553537|Tubulin Modulators|tubulin modulators|mesh-ancestor
102167540|NCT03553537|Antimitotic Agents|antimitotic agents|mesh-ancestor
102167541|NCT03553537|Mitosis Modulators|mitosis modulators|mesh-ancestor
102167542|NCT03553537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102167543|NCT03553537|Antimetabolites|antimetabolites|mesh-ancestor
102167544|NCT04434170|Valsartan|valsartan|mesh-list
102167545|NCT04434170|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102167546|NCT04434170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102167547|NCT04434170|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102167548|NCT04434170|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102167549|NCT04434170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167550|NCT03086174|Antibodies|antibodies|mesh-list
102167551|NCT03086174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102167552|NCT03086174|Immunologic Factors|immunologic factors|mesh-ancestor
102167553|NCT03086174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167554|NCT03085784|Aflibercept|aflibercept|mesh-list
102167555|NCT03085784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102167556|NCT03085784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102167557|NCT03085784|Growth Substances|growth substances|mesh-ancestor
102167558|NCT03085784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167559|NCT03085784|Growth Inhibitors|growth inhibitors|mesh-ancestor
102167560|NCT03085784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102167561|NCT05021276|Basiliximab|basiliximab|mesh-list
102167562|NCT05021276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102167563|NCT05021276|Immunologic Factors|immunologic factors|mesh-ancestor
102167564|NCT05021276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167565|NCT05014490|Etoricoxib|etoricoxib|mesh-list
102167566|NCT05014490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102167567|NCT05014490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102167568|NCT05014490|Analgesics|analgesics|mesh-ancestor
102167569|NCT05014490|Sensory System Agents|sensory system agents|mesh-ancestor
102167570|NCT05014490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102167571|NCT05014490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167572|NCT05014490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102167573|NCT05014490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102167574|NCT05014490|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102167575|NCT05014490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102167576|NCT05014490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102167577|NCT05014490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167578|NCT05020964|Trastuzumab|trastuzumab|mesh-list
102167579|NCT05020964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102167580|NCT05020964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102167581|NCT05014100|Lenalidomide|lenalidomide|mesh-list
102167582|NCT05014100|Immunologic Factors|immunologic factors|mesh-ancestor
102167583|NCT05014100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167584|NCT05014100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102167585|NCT05014100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102167586|NCT05014100|Growth Substances|growth substances|mesh-ancestor
102167587|NCT05014100|Growth Inhibitors|growth inhibitors|mesh-ancestor
102167588|NCT05014100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102167589|NCT05027126|Folic Acid|folic acid|mesh-list
102167590|NCT05027126|Vitamin B Complex|vitamin b complex|mesh-list
102167591|NCT05027126|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
102167592|NCT05027126|Vitamins|vitamins|mesh-ancestor
102167593|NCT05027126|Micronutrients|micronutrients|mesh-ancestor
102167594|NCT05027126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167595|NCT05027126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102167596|NCT05027126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102167597|NCT05027126|Analgesics|analgesics|mesh-ancestor
102167598|NCT05027126|Sensory System Agents|sensory system agents|mesh-ancestor
102167599|NCT05027126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102167600|NCT05027126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102167602|NCT05027126|Hematinics|hematinics|mesh-ancestor
102167603|NCT02120677|Itraconazole|itraconazole|mesh-list
102167604|NCT02120677|Antifungal Agents|antifungal agents|mesh-ancestor
102167605|NCT02120677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102167606|NCT02120677|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102167607|NCT02120677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101446616|NCT00582634|Docetaxel|docetaxel|mesh-list
102167608|NCT02120677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102167609|NCT02120677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167610|NCT02120677|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102167611|NCT02120677|Hormone Antagonists|hormone antagonists|mesh-ancestor
102167612|NCT02120677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102167613|NCT02120677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167614|NCT02120677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102167615|NCT02120911|Trastuzumab|trastuzumab|mesh-list
102167616|NCT02120911|Pertuzumab|pertuzumab|mesh-list
102167617|NCT02120911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102167618|NCT02120911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102167619|NCT02112487|Macitentan|macitentan|mesh-list
102167620|NCT02112487|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
102167621|NCT02112487|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102167622|NCT02112487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167623|NCT02112487|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
102167624|NCT03094442|Dexamethasone|dexamethasone|mesh-list
102167625|NCT03094442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102167626|NCT03094442|Antiemetics|antiemetics|mesh-ancestor
102167627|NCT03094442|Autonomic Agents|autonomic agents|mesh-ancestor
102167628|NCT03094442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102167629|NCT03094442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167630|NCT03094442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102167631|NCT03094442|Glucocorticoids|glucocorticoids|mesh-ancestor
102167632|NCT03094442|Hormones|hormones|mesh-ancestor
102167633|NCT03094442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102167634|NCT03094442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102167635|NCT03094442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102167636|NCT02406742|Obinutuzumab|obinutuzumab|mesh-list
102167637|NCT02406742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102167638|NCT02406742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102167639|NCT02112643|Selenium|selenium|mesh-list
102167640|NCT02112643|Selenic Acid|selenic acid|mesh-list
102167641|NCT02112643|Antioxidants|antioxidants|mesh-ancestor
102167642|NCT02112643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167643|NCT02112643|Protective Agents|protective agents|mesh-ancestor
102167644|NCT02112643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167645|NCT02112643|Trace Elements|trace elements|mesh-ancestor
102167646|NCT02112643|Micronutrients|micronutrients|mesh-ancestor
102167647|NCT02112721|Vitamin D|vitamin d|mesh-list
102167648|NCT02112721|Vitamins|vitamins|mesh-ancestor
102167649|NCT02112721|Micronutrients|micronutrients|mesh-ancestor
102167650|NCT02112721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167651|NCT02112721|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102167652|NCT02112799|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102167653|NCT02112799|Antiviral Agents|antiviral agents|mesh-ancestor
102167654|NCT02112799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102167655|NCT02122939|Escitalopram|escitalopram|mesh-list
102167656|NCT02122939|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102167657|NCT02122939|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102167658|NCT02122939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102167659|NCT02122939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167660|NCT02122939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102167661|NCT02122939|Serotonin Agents|serotonin agents|mesh-ancestor
102167662|NCT02122939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167663|NCT04434248|Ritonavir|ritonavir|mesh-list
102167664|NCT04434248|Lopinavir|lopinavir|mesh-list
102167665|NCT04434248|Hydroxychloroquine|hydroxychloroquine|mesh-list
102167666|NCT04434248|Chloroquine|chloroquine|mesh-list
102167667|NCT04434248|Favipiravir|favipiravir|mesh-list
102167668|NCT04434248|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102167669|NCT04434248|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101899901|NCT03874364|Lidocaine|lidocaine|mesh-list
102167670|NCT04434248|Protease Inhibitors|protease inhibitors|mesh-ancestor
102167671|NCT04434248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102167672|NCT04434248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167673|NCT04434248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102167674|NCT04434248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102167675|NCT04434248|Antiviral Agents|antiviral agents|mesh-ancestor
102167676|NCT04434248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102167677|NCT04434248|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102167678|NCT04434248|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102167679|NCT04434248|Antimalarials|antimalarials|mesh-ancestor
102167680|NCT04434248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102167681|NCT04434248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102167682|NCT04434248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102167683|NCT04434248|Amebicides|amebicides|mesh-ancestor
102167684|NCT02121457|Selenium|selenium|mesh-list
102167685|NCT02121457|Antioxidants|antioxidants|mesh-ancestor
102167686|NCT02121457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167687|NCT02121457|Protective Agents|protective agents|mesh-ancestor
102167688|NCT02121457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167689|NCT02121457|Trace Elements|trace elements|mesh-ancestor
102167690|NCT02121457|Micronutrients|micronutrients|mesh-ancestor
102167691|NCT02251795|Aspirin|aspirin|mesh-list
102167692|NCT02251795|Ritonavir|ritonavir|mesh-list
102167693|NCT02251795|Darunavir|darunavir|mesh-list
102167694|NCT02251795|Tipranavir|tipranavir|mesh-list
102167695|NCT02251795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102167696|NCT02251795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102167697|NCT02251795|Analgesics|analgesics|mesh-ancestor
102167698|NCT02251795|Sensory System Agents|sensory system agents|mesh-ancestor
102167699|NCT02251795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102167700|NCT02251795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167701|NCT02251795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102167702|NCT02251795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102167703|NCT02251795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102167704|NCT02251795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102167705|NCT02251795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167706|NCT02251795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102167707|NCT02251795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102167708|NCT02251795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102167709|NCT02251795|Antipyretics|antipyretics|mesh-ancestor
102167710|NCT02251795|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102167711|NCT02251795|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102167712|NCT02251795|Protease Inhibitors|protease inhibitors|mesh-ancestor
102167713|NCT02251795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102167714|NCT02251795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102167715|NCT02251795|Antiviral Agents|antiviral agents|mesh-ancestor
102167716|NCT02251795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102167717|NCT02251795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102167718|NCT02251795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102167719|NCT05013164|Leucovorin|leucovorin|mesh-list
102167720|NCT05013164|Folic Acid|folic acid|mesh-list
102167721|NCT05013164|Levoleucovorin|levoleucovorin|mesh-list
102167722|NCT05013164|Antidotes|antidotes|mesh-ancestor
102167723|NCT05013164|Protective Agents|protective agents|mesh-ancestor
102167724|NCT05013164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167725|NCT05013164|Vitamin B Complex|vitamin b complex|mesh-ancestor
102167726|NCT05013164|Vitamins|vitamins|mesh-ancestor
102167727|NCT05013164|Micronutrients|micronutrients|mesh-ancestor
102167728|NCT05013164|Hematinics|hematinics|mesh-ancestor
102167729|NCT02251951|Paclitaxel|paclitaxel|mesh-list
102167730|NCT02251951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102167731|NCT02251951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102167732|NCT02251951|Tubulin Modulators|tubulin modulators|mesh-ancestor
101876566|NCT00141102|Omeprazole|omeprazole|mesh-list
102167733|NCT02251951|Antimitotic Agents|antimitotic agents|mesh-ancestor
102167734|NCT02251951|Mitosis Modulators|mitosis modulators|mesh-ancestor
102167735|NCT02251951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167736|NCT03091868|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102167737|NCT03091868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102167738|NCT03091868|Immunologic Factors|immunologic factors|mesh-ancestor
102167739|NCT03091868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167740|NCT03091868|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102167741|NCT03091868|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102167742|NCT03091868|Dopamine Agonists|dopamine agonists|mesh-ancestor
102167743|NCT03091868|Dopamine Agents|dopamine agents|mesh-ancestor
102167745|NCT03091868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167746|NCT02121613|Tamsulosin|tamsulosin|mesh-list
102167747|NCT02121613|Saw palmetto extract|saw palmetto extract|mesh-list
102167748|NCT02121613|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102167749|NCT02121613|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102167750|NCT02121613|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102167751|NCT02121613|Adrenergic Agents|adrenergic agents|mesh-ancestor
102167752|NCT02121613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102167753|NCT02121613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167754|NCT02121613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167755|NCT02121613|Urological Agents|urological agents|mesh-ancestor
102167756|NCT03091712|Insulin|insulin|mesh-list
102167757|NCT03091712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102167758|NCT03091712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167759|NCT03552211|Biotin|biotin|mesh-list
102167760|NCT03552211|Vitamin B Complex|vitamin b complex|mesh-ancestor
102167761|NCT03552211|Vitamins|vitamins|mesh-ancestor
102167762|NCT03552211|Micronutrients|micronutrients|mesh-ancestor
102167763|NCT03552211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167764|NCT02113267|Mometasone Furoate|mometasone furoate|mesh-list
102167765|NCT02113267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102167766|NCT02113267|Dermatologic Agents|dermatologic agents|mesh-ancestor
102167767|NCT02113267|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102167768|NCT03281187|Methyltestosterone|methyltestosterone|mesh-list
102167769|NCT03281187|Testosterone|testosterone|mesh-list
102167770|NCT03281187|Testosterone undecanoate|testosterone undecanoate|mesh-list
102167771|NCT03281187|Testosterone enanthate|testosterone enanthate|mesh-list
102167772|NCT03281187|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102167773|NCT03281187|Androgens|androgens|mesh-ancestor
102167774|NCT03281187|Hormones|hormones|mesh-ancestor
102167775|NCT03281187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102167776|NCT03281187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167777|NCT03281187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102167778|NCT03281187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102167779|NCT03281187|Anabolic Agents|anabolic agents|mesh-ancestor
102167780|NCT03291249|Omeprazole|omeprazole|mesh-list
102167781|NCT03291249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102167782|NCT03291249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102167783|NCT03291249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102167784|NCT03291249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102167785|NCT03291249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167786|NCT05013320|Glycopyrrolate|glycopyrrolate|mesh-list
102167787|NCT05013320|Dexmedetomidine|dexmedetomidine|mesh-list
102167788|NCT05013320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102167789|NCT05013320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102167790|NCT05013320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167791|NCT05013320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102167792|NCT05013320|Analgesics|analgesics|mesh-ancestor
102167793|NCT05013320|Sensory System Agents|sensory system agents|mesh-ancestor
102167794|NCT05013320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102167795|NCT05013320|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102167796|NCT05013320|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102167797|NCT05013320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102167798|NCT05013320|Adrenergic Agents|adrenergic agents|mesh-ancestor
102167799|NCT05013320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102167800|NCT05013320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167801|NCT05013320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102167802|NCT05013320|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102167803|NCT05013320|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102167804|NCT05013320|Cholinergic Agents|cholinergic agents|mesh-ancestor
102167805|NCT02437162|Golimumab|golimumab|mesh-list
102167806|NCT02437162|Ustekinumab|ustekinumab|mesh-list
102167807|NCT02437162|Dermatologic Agents|dermatologic agents|mesh-ancestor
102167808|NCT02437162|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102167809|NCT02437162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102167810|NCT02437162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102167811|NCT02437162|Immunologic Factors|immunologic factors|mesh-ancestor
102167812|NCT02437162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167813|NCT03291093|Flutemetamol|flutemetamol|mesh-list
102167814|NCT03291093|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102167815|NCT03291093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167817|NCT02123563|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102167818|NCT02123563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102167820|NCT02122003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102167821|NCT02122003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102167822|NCT02122003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102167823|NCT02122003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167824|NCT03079388|Azithromycin|azithromycin|mesh-list
102167825|NCT03079388|Pyrimethamine|pyrimethamine|mesh-list
102167826|NCT03079388|Sulfadoxine|sulfadoxine|mesh-list
102167827|NCT03079388|Albendazole|albendazole|mesh-list
102167828|NCT03079388|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
102167829|NCT03079388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102167830|NCT03079388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102167831|NCT03079388|Antimalarials|antimalarials|mesh-ancestor
102167832|NCT03079388|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102167833|NCT03079388|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102167834|NCT03079388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102167835|NCT03079388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102167836|NCT03079388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167837|NCT03079388|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102167838|NCT03079388|Anthelmintics|anthelmintics|mesh-ancestor
102167839|NCT03079388|Anticestodal Agents|anticestodal agents|mesh-ancestor
102167840|NCT03079388|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102167841|NCT03079388|Tubulin Modulators|tubulin modulators|mesh-ancestor
102167842|NCT03079388|Antimitotic Agents|antimitotic agents|mesh-ancestor
102167843|NCT03079388|Mitosis Modulators|mitosis modulators|mesh-ancestor
102167844|NCT03079388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102167845|NCT03079544|Asparaginase|asparaginase|mesh-list
102167846|NCT03079544|Pegaspargase|pegaspargase|mesh-list
102167847|NCT03079544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102167848|NCT03286101|Ivermectin|ivermectin|mesh-list
102167849|NCT03286101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102167850|NCT03286101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102167851|NCT02437084|Atorvastatin|atorvastatin|mesh-list
102167852|NCT02437084|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102167853|NCT02437084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102167854|NCT02437084|Antimetabolites|antimetabolites|mesh-ancestor
102167855|NCT02437084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167856|NCT02437084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102167857|NCT02437084|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102167858|NCT02437084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102167859|NCT05009498|Vitamin D|vitamin d|mesh-list
102167860|NCT05009498|Cholecalciferol|cholecalciferol|mesh-list
102167861|NCT05009498|Vitamins|vitamins|mesh-ancestor
102167862|NCT05009498|Micronutrients|micronutrients|mesh-ancestor
102167863|NCT05009498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167864|NCT05009498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102167865|NCT05009498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102167866|NCT02406586|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
102167867|NCT02406586|Carvedilol|carvedilol|mesh-list
102167868|NCT02406586|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102167869|NCT02406586|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102167870|NCT02406586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102167871|NCT02406586|Adrenergic Agents|adrenergic agents|mesh-ancestor
102167872|NCT02406586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102167873|NCT02406586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167874|NCT02406586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167875|NCT02406586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102167876|NCT02406586|Antioxidants|antioxidants|mesh-ancestor
102167877|NCT02406586|Protective Agents|protective agents|mesh-ancestor
102167878|NCT02406586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102167879|NCT02406586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102167880|NCT02406586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102167881|NCT02406586|Vasodilator Agents|vasodilator agents|mesh-ancestor
102167882|NCT02406586|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102167883|NCT02406586|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102167884|NCT02406586|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102167885|NCT02406586|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102167886|NCT02406586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102167887|NCT02406586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101876719|NCT00254540|Sunitinib|sunitinib|mesh-list
102167888|NCT02406586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102167889|NCT02406586|Analgesics|analgesics|mesh-ancestor
102167890|NCT02406586|Sensory System Agents|sensory system agents|mesh-ancestor
102167891|NCT02406586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102167892|NCT02406586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102167893|NCT02406586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102167894|NCT03091166|Dexmedetomidine|dexmedetomidine|mesh-list
102167895|NCT03091166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102167896|NCT03091166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102167897|NCT03091166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167898|NCT03091166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102167899|NCT03091166|Analgesics|analgesics|mesh-ancestor
102167900|NCT03091166|Sensory System Agents|sensory system agents|mesh-ancestor
102167901|NCT03091166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102167902|NCT03091166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102167903|NCT03091166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102167904|NCT03091166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102167905|NCT03091166|Adrenergic Agents|adrenergic agents|mesh-ancestor
102167906|NCT03091166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102167907|NCT03091166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167908|NCT02122393|Sertraline|sertraline|mesh-list
102167909|NCT02122393|Antidepressive Agents|antidepressive agents|mesh-ancestor
102167910|NCT02122393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102167911|NCT02122393|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102167912|NCT02122393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102167913|NCT02122393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102167914|NCT02122393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167915|NCT02122393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102167916|NCT02122393|Serotonin Agents|serotonin agents|mesh-ancestor
102167917|NCT02122393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167918|NCT03821883|Aspirin|aspirin|mesh-list
102167919|NCT03821883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102167920|NCT03821883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102167921|NCT03821883|Analgesics|analgesics|mesh-ancestor
102167922|NCT03821883|Sensory System Agents|sensory system agents|mesh-ancestor
102167923|NCT03821883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102167924|NCT03821883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167925|NCT03821883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102167926|NCT03821883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102167927|NCT03821883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102167928|NCT03821883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102167929|NCT03821883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167930|NCT03821883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102167931|NCT03821883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102167932|NCT03821883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102167933|NCT03821883|Antipyretics|antipyretics|mesh-ancestor
102167934|NCT03080480|Pioglitazone|pioglitazone|mesh-list
102167935|NCT03080480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102167936|NCT03080480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167937|NCT02126761|Vaccines|vaccines|mesh-list
102167938|NCT02126761|Immunologic Factors|immunologic factors|mesh-ancestor
102167939|NCT02126761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167940|NCT02788357|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102167941|NCT02788357|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102167942|NCT02788357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102167943|NCT02788357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102167944|NCT02788357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167945|NCT02788357|Adrenergic Agents|adrenergic agents|mesh-ancestor
102167946|NCT02788357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102167947|NCT02788357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167948|NCT03280641|Warfarin|warfarin|mesh-list
102167949|NCT03280641|Dabigatran|dabigatran|mesh-list
102167950|NCT03280641|Anticoagulants|anticoagulants|mesh-ancestor
102167951|NCT03280641|Antithrombins|antithrombins|mesh-ancestor
102167952|NCT03280641|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102167953|NCT03280641|Protease Inhibitors|protease inhibitors|mesh-ancestor
102167954|NCT03280641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102167955|NCT03280641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167956|NCT03285165|Propofol|propofol|mesh-list
102167957|NCT03285165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102167958|NCT03285165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102167959|NCT03285165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167960|NCT03285165|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102167961|NCT03285165|Anesthetics, General|anesthetics, general|mesh-ancestor
102167962|NCT03285165|Anesthetics|anesthetics|mesh-ancestor
102167964|NCT03285087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102167965|NCT03285087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102167966|NCT03285087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167967|NCT03285087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102167968|NCT03285087|Analgesics|analgesics|mesh-ancestor
102167969|NCT03285087|Sensory System Agents|sensory system agents|mesh-ancestor
102167970|NCT03285087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102167971|NCT03285087|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102167972|NCT03285087|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102167973|NCT03285087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102167974|NCT03285087|Adrenergic Agents|adrenergic agents|mesh-ancestor
102167975|NCT03285087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102167976|NCT03285087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102167977|NCT02122627|Vitamin D|vitamin d|mesh-list
102167978|NCT02122627|Ergocalciferols|ergocalciferols|mesh-list
102167979|NCT02122627|Cholecalciferol|cholecalciferol|mesh-list
102167980|NCT02122627|Vitamins|vitamins|mesh-list
102167981|NCT02122627|Micronutrients|micronutrients|mesh-ancestor
102167982|NCT02122627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167983|NCT02122627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102167984|NCT02122627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102167985|NCT02122705|Remifentanil|remifentanil|mesh-list
102167986|NCT02122705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102167987|NCT02122705|Narcotics|narcotics|mesh-ancestor
102167988|NCT02122705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102167989|NCT02122705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102167990|NCT02122705|Analgesics|analgesics|mesh-ancestor
102167991|NCT02122705|Sensory System Agents|sensory system agents|mesh-ancestor
102167992|NCT02122705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102167993|NCT05011916|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102167994|NCT05011916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102167995|NCT03384225|Cytarabine|cytarabine|mesh-list
102167996|NCT03384225|Fludarabine|fludarabine|mesh-list
102167997|NCT03384225|Busulfan|busulfan|mesh-list
102167998|NCT03384225|Cladribine|cladribine|mesh-list
102167999|NCT03384225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102168000|NCT03384225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102168001|NCT03384225|Antimetabolites|antimetabolites|mesh-ancestor
102168002|NCT03384225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168003|NCT03384225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102168004|NCT03384225|Immunologic Factors|immunologic factors|mesh-ancestor
102168005|NCT03384225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168006|NCT03384225|Antiviral Agents|antiviral agents|mesh-ancestor
102168007|NCT03384225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102168008|NCT03384225|Alkylating Agents|alkylating agents|mesh-ancestor
102168009|NCT03384225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102168010|NCT03384225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102168011|NCT05019326|Andrographolide|andrographolide|mesh-list
102168012|NCT05019326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102168013|NCT05019326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102168014|NCT05019326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102168015|NCT05019326|Analgesics|analgesics|mesh-ancestor
102168016|NCT05019326|Sensory System Agents|sensory system agents|mesh-ancestor
102168017|NCT05019326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102168018|NCT05019326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168019|NCT05019326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102168020|NCT05019326|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102168021|NCT05019326|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102168022|NCT05019326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102168023|NCT05019326|Antiviral Agents|antiviral agents|mesh-ancestor
102168024|NCT05019326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102168025|NCT05008250|Metoprolol|metoprolol|mesh-list
102168026|NCT05008250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102168027|NCT05008250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102168028|NCT05008250|Sympatholytics|sympatholytics|mesh-ancestor
102168029|NCT05008250|Autonomic Agents|autonomic agents|mesh-ancestor
102168030|NCT05008250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102168031|NCT05008250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168032|NCT05008250|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102168033|NCT05008250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102168034|NCT05008250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102168035|NCT05008250|Adrenergic Agents|adrenergic agents|mesh-ancestor
102168036|NCT05008250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101876860|NCT01304836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102168037|NCT05008250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899913|NCT01163396|Leucovorin|leucovorin|mesh-list
102168039|NCT03079076|Anesthetics, Local|anesthetics, local|mesh-ancestor
102168040|NCT03079076|Anesthetics|anesthetics|mesh-ancestor
102168041|NCT03079076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102168042|NCT03079076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168043|NCT03079076|Sensory System Agents|sensory system agents|mesh-ancestor
102168044|NCT03079076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102168045|NCT03271749|Anesthetics|anesthetics|mesh-list
102168046|NCT03271749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102168047|NCT03271749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168048|NCT03280407|Leucovorin|leucovorin|mesh-list
102168049|NCT03280407|Capecitabine|capecitabine|mesh-list
102168050|NCT03280407|Oxaliplatin|oxaliplatin|mesh-list
102168051|NCT03280407|Levoleucovorin|levoleucovorin|mesh-list
102168052|NCT03280407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102168053|NCT03280407|Antimetabolites|antimetabolites|mesh-ancestor
102168054|NCT03280407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168055|NCT03280407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102168056|NCT03280407|Antidotes|antidotes|mesh-ancestor
102168057|NCT03280407|Protective Agents|protective agents|mesh-ancestor
102168058|NCT03280407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168059|NCT03280407|Vitamin B Complex|vitamin b complex|mesh-ancestor
102168060|NCT03280407|Vitamins|vitamins|mesh-ancestor
102168061|NCT03280407|Micronutrients|micronutrients|mesh-ancestor
102168063|NCT03078842|Trace Elements|trace elements|mesh-ancestor
102168064|NCT03078842|Micronutrients|micronutrients|mesh-ancestor
102168065|NCT03078842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168066|NCT05007860|Vaccines|vaccines|mesh-list
102168067|NCT05007860|Immunologic Factors|immunologic factors|mesh-ancestor
102168068|NCT05007860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168069|NCT03270033|Dexamethasone|dexamethasone|mesh-list
102168070|NCT03270033|Dexamethasone acetate|dexamethasone acetate|mesh-list
102168071|NCT03270033|Dexmedetomidine|dexmedetomidine|mesh-list
102168072|NCT03270033|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102168073|NCT03270033|BB 1101|bb 1101|mesh-list
102168074|NCT03270033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102168075|NCT03270033|Antiemetics|antiemetics|mesh-ancestor
102168076|NCT03270033|Autonomic Agents|autonomic agents|mesh-ancestor
102168077|NCT03270033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102168078|NCT03270033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168079|NCT03270033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102168080|NCT03270033|Glucocorticoids|glucocorticoids|mesh-ancestor
102168081|NCT03270033|Hormones|hormones|mesh-ancestor
102168082|NCT03270033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102168083|NCT03270033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102168084|NCT03270033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102168085|NCT03270033|Protease Inhibitors|protease inhibitors|mesh-ancestor
102168086|NCT03270033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102168087|NCT03270033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168088|NCT03270033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102168089|NCT03270033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102168090|NCT03270033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102168091|NCT03270033|Analgesics|analgesics|mesh-ancestor
102168092|NCT03270033|Sensory System Agents|sensory system agents|mesh-ancestor
102168093|NCT03270033|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102168094|NCT03270033|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102168095|NCT03270033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102168096|NCT03270033|Adrenergic Agents|adrenergic agents|mesh-ancestor
102168097|NCT03270033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102168098|NCT04959812|Sufentanil|sufentanil|mesh-list
102168099|NCT04959812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102168100|NCT04959812|Narcotics|narcotics|mesh-ancestor
102168101|NCT04959812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102168102|NCT04959812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168103|NCT04959812|Analgesics|analgesics|mesh-ancestor
102168104|NCT04959812|Sensory System Agents|sensory system agents|mesh-ancestor
102168105|NCT04959812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102168106|NCT04959812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102168107|NCT04959812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102168108|NCT04959812|Anesthetics, General|anesthetics, general|mesh-ancestor
102168109|NCT04959812|Anesthetics|anesthetics|mesh-ancestor
102168110|NCT03280095|Acetaminophen|acetaminophen|mesh-list
102168111|NCT03280095|Codeine|codeine|mesh-list
101876935|NCT00139776|Celecoxib|celecoxib|mesh-list
102168112|NCT03280095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102168113|NCT03280095|Analgesics|analgesics|mesh-ancestor
102168114|NCT03280095|Sensory System Agents|sensory system agents|mesh-ancestor
102168115|NCT03280095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102168116|NCT03280095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168118|NCT03280095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102168119|NCT03280095|Narcotics|narcotics|mesh-ancestor
102168120|NCT03280095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102168121|NCT03280095|Antitussive Agents|antitussive agents|mesh-ancestor
102168122|NCT03280095|Respiratory System Agents|respiratory system agents|mesh-ancestor
102168123|NCT04463030|Vitamins|vitamins|mesh-list
102168124|NCT04463030|Ascorbic Acid|ascorbic acid|mesh-list
102168125|NCT04463030|Micronutrients|micronutrients|mesh-ancestor
102168126|NCT04463030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168127|NCT04463030|Antioxidants|antioxidants|mesh-ancestor
102168128|NCT04463030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168129|NCT04463030|Protective Agents|protective agents|mesh-ancestor
102168130|NCT03269721|Carbon Monoxide|carbon monoxide|mesh-list
102168131|NCT03269721|Antimetabolites|antimetabolites|mesh-ancestor
102168132|NCT03269721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168133|NCT03269721|Gasotransmitters|gasotransmitters|mesh-ancestor
102168134|NCT03269721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102168135|NCT03269721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168136|NCT05010356|Insulin|insulin|mesh-list
102168137|NCT05010356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102168138|NCT05010356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168139|NCT03269955|Thrombin|thrombin|mesh-list
102168140|NCT03269955|Hemostatics|hemostatics|mesh-ancestor
102168141|NCT03269955|Coagulants|coagulants|mesh-ancestor
102168142|NCT05006846|Analgesics, Opioid|analgesics, opioid|mesh-list
102168143|NCT05006846|Narcotics|narcotics|mesh-ancestor
102168144|NCT05006846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102168145|NCT05006846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168146|NCT05006846|Analgesics|analgesics|mesh-ancestor
102168147|NCT05006846|Sensory System Agents|sensory system agents|mesh-ancestor
102168148|NCT05006846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102168149|NCT02457520|Isotretinoin|isotretinoin|mesh-list
102168150|NCT02457520|Dermatologic Agents|dermatologic agents|mesh-ancestor
102168151|NCT02457585|Infliximab|infliximab|mesh-list
102168152|NCT02457585|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
102168153|NCT02457585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102168154|NCT02457585|Dermatologic Agents|dermatologic agents|mesh-ancestor
102168155|NCT02457585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102168156|NCT02457585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102168157|NCT02457507|Vitamin B 12|vitamin b 12|mesh-list
102168158|NCT02457507|Hydroxocobalamin|hydroxocobalamin|mesh-list
102168159|NCT02457507|Vitamins|vitamins|mesh-ancestor
102168160|NCT02457507|Micronutrients|micronutrients|mesh-ancestor
102168161|NCT02457507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168162|NCT02457507|Vitamin B Complex|vitamin b complex|mesh-ancestor
102168163|NCT02457507|Hematinics|hematinics|mesh-ancestor
102168164|NCT03265197|Lidocaine|lidocaine|mesh-list
102168165|NCT03265197|Anesthetics, Local|anesthetics, local|mesh-ancestor
102168166|NCT03265197|Anesthetics|anesthetics|mesh-ancestor
102168167|NCT03265197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102168168|NCT03265197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168169|NCT03265197|Sensory System Agents|sensory system agents|mesh-ancestor
102168170|NCT03265197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102168171|NCT03265197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102168172|NCT03265197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102168173|NCT03265197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102168174|NCT03265197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102168175|NCT03265197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168176|NCT03078374|Warfarin|warfarin|mesh-list
102168177|NCT03078374|Anticoagulants|anticoagulants|mesh-ancestor
102168178|NCT04944836|Clomiphene|clomiphene|mesh-list
102168179|NCT04944836|Enclomiphene|enclomiphene|mesh-list
102168180|NCT04944836|Zuclomiphene|zuclomiphene|mesh-list
102168181|NCT04944836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102168182|NCT04944836|Hormone Antagonists|hormone antagonists|mesh-ancestor
102168183|NCT04944836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102168184|NCT04944836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168185|NCT04944836|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102168186|NCT04944836|Fertility Agents|fertility agents|mesh-ancestor
102168187|NCT04944836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102168188|NCT04944836|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102168189|NCT04944836|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102168190|NCT02788279|Atezolizumab|atezolizumab|mesh-list
102168191|NCT02788279|Antibodies|antibodies|mesh-list
102168192|NCT02788279|Immunologic Factors|immunologic factors|mesh-ancestor
102168193|NCT02788279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168194|NCT02788279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102168195|NCT02788279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168196|NCT02788279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102168197|NCT02788279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102168198|NCT03268863|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
102168200|NCT03264651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102168201|NCT03264651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102168202|NCT03264651|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102168203|NCT03264651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102168204|NCT03264651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102168205|NCT03264651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168206|NCT03264651|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102168207|NCT03264651|Hormone Antagonists|hormone antagonists|mesh-ancestor
102168208|NCT03264651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102168209|NCT03264651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168210|NCT03078062|Dexamethasone|dexamethasone|mesh-list
102168211|NCT03078062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102168212|NCT03078062|Antiemetics|antiemetics|mesh-ancestor
102168213|NCT03078062|Autonomic Agents|autonomic agents|mesh-ancestor
102168214|NCT03078062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102168215|NCT03078062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168216|NCT03078062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102168217|NCT03078062|Glucocorticoids|glucocorticoids|mesh-ancestor
102168218|NCT03078062|Hormones|hormones|mesh-ancestor
102168219|NCT03078062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102168220|NCT03078062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102168221|NCT03078062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102168222|NCT02435992|Ozanimod|ozanimod|mesh-list
102168223|NCT02435992|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102168224|NCT02435992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168225|NCT02435992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102168226|NCT02435992|Immunologic Factors|immunologic factors|mesh-ancestor
102168227|NCT02435992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168228|NCT02457351|Itraconazole|itraconazole|mesh-list
102168229|NCT02457351|Antifungal Agents|antifungal agents|mesh-ancestor
102168230|NCT02457351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102168231|NCT02457351|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102168232|NCT02457351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102168233|NCT02457351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102168234|NCT02457351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168235|NCT02457351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102168236|NCT02457351|Hormone Antagonists|hormone antagonists|mesh-ancestor
102168237|NCT02457351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102168238|NCT02457351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168239|NCT02457351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102168240|NCT02788513|BI 425809|bi 425809|mesh-list
102168241|NCT02788513|Nootropic Agents|nootropic agents|mesh-ancestor
102168242|NCT03077828|Carboplatin|carboplatin|mesh-list
102168243|NCT03077828|Pembrolizumab|pembrolizumab|mesh-list
102168244|NCT03077828|Etoposide|etoposide|mesh-list
102168245|NCT03077828|Etoposide phosphate|etoposide phosphate|mesh-list
102168246|NCT03077828|Ifosfamide|ifosfamide|mesh-list
102168247|NCT03077828|Isophosphamide mustard|isophosphamide mustard|mesh-list
102168248|NCT03077828|Podophyllotoxin|podophyllotoxin|mesh-list
102168249|NCT03077828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102168250|NCT03077828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102168251|NCT03077828|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102168252|NCT03077828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168253|NCT03077828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102168254|NCT03077828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102168255|NCT03077828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102168256|NCT03077828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102168257|NCT03077828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102168258|NCT03077828|Alkylating Agents|alkylating agents|mesh-ancestor
102168259|NCT03077828|Keratolytic Agents|keratolytic agents|mesh-ancestor
102168260|NCT03077828|Dermatologic Agents|dermatologic agents|mesh-ancestor
102168261|NCT03077828|Tubulin Modulators|tubulin modulators|mesh-ancestor
102168262|NCT03077828|Antimitotic Agents|antimitotic agents|mesh-ancestor
101877089|NCT05694130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102168263|NCT03077828|Mitosis Modulators|mitosis modulators|mesh-ancestor
102168265|NCT02126995|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102168267|NCT04459052|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102168268|NCT04459052|Antiviral Agents|antiviral agents|mesh-ancestor
102168269|NCT04459052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102168270|NCT04459052|Expectorants|expectorants|mesh-ancestor
102168271|NCT04459052|Respiratory System Agents|respiratory system agents|mesh-ancestor
102168272|NCT04459052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102168273|NCT04459052|Antioxidants|antioxidants|mesh-ancestor
102168274|NCT04459052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168275|NCT04459052|Protective Agents|protective agents|mesh-ancestor
102168276|NCT04459052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168277|NCT04459052|Antidotes|antidotes|mesh-ancestor
102168278|NCT05257291|Melatonin|melatonin|mesh-list
102168279|NCT05257291|Antioxidants|antioxidants|mesh-ancestor
102168280|NCT05257291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168281|NCT05257291|Protective Agents|protective agents|mesh-ancestor
102168282|NCT05257291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168283|NCT05257291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102168284|NCT04930900|Epinephrine|epinephrine|mesh-list
102168285|NCT04930900|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102168286|NCT04930900|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102168287|NCT04930900|Adrenergic Agents|adrenergic agents|mesh-ancestor
102168288|NCT04930900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102168289|NCT04930900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168290|NCT04930900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168291|NCT04930900|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102168292|NCT04930900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102168293|NCT04930900|Autonomic Agents|autonomic agents|mesh-ancestor
102168294|NCT04930900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102168295|NCT04930900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102168296|NCT04930900|Respiratory System Agents|respiratory system agents|mesh-ancestor
102168297|NCT04930900|Mydriatics|mydriatics|mesh-ancestor
101446685|NCT00583180|Capsaicin|capsaicin|mesh-list
102168298|NCT04930900|Sympathomimetics|sympathomimetics|mesh-ancestor
102168299|NCT04930900|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102168300|NCT02458209|Bococizumab|bococizumab|mesh-list
102168301|NCT02458209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102168302|NCT02458209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102168303|NCT02458209|Antimetabolites|antimetabolites|mesh-ancestor
102168304|NCT02458209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168305|NCT02458209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102168306|NCT02127151|Talazoparib|talazoparib|mesh-list
102168307|NCT02127151|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102168308|NCT02127151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102168309|NCT02127151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168310|NCT02127151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102168311|NCT03077516|Meloxicam|meloxicam|mesh-list
102168312|NCT03077516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102168313|NCT03077516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102168314|NCT03077516|Analgesics|analgesics|mesh-ancestor
102168315|NCT03077516|Sensory System Agents|sensory system agents|mesh-ancestor
102168316|NCT03077516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102168317|NCT03077516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168318|NCT03077516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102168319|NCT03077516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102168320|NCT03077516|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102168321|NCT03077516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102168322|NCT03077516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102168323|NCT03077516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168324|NCT02435914|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102168325|NCT02435914|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102168326|NCT04993040|Paclitaxel|paclitaxel|mesh-list
102168327|NCT04993040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102168328|NCT04993040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102168329|NCT04993040|Tubulin Modulators|tubulin modulators|mesh-ancestor
102168330|NCT04993040|Antimitotic Agents|antimitotic agents|mesh-ancestor
102168331|NCT04993040|Mitosis Modulators|mitosis modulators|mesh-ancestor
102168332|NCT04993040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168333|NCT03072992|Curcumin|curcumin|mesh-list
102168334|NCT03072992|Paclitaxel|paclitaxel|mesh-list
102168335|NCT03072992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102168336|NCT03072992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102168337|NCT03072992|Tubulin Modulators|tubulin modulators|mesh-ancestor
102168338|NCT03072992|Antimitotic Agents|antimitotic agents|mesh-ancestor
102168339|NCT03072992|Mitosis Modulators|mitosis modulators|mesh-ancestor
102168340|NCT03072992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168341|NCT03072992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102168342|NCT03072992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102168343|NCT03072992|Analgesics|analgesics|mesh-ancestor
102168344|NCT03072992|Sensory System Agents|sensory system agents|mesh-ancestor
102168345|NCT03072992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102168346|NCT03072992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168347|NCT03072992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102168348|NCT03072992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102168349|NCT03072992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102168350|NCT03267771|Progesterone|progesterone|mesh-list
102168351|NCT03267771|Dydrogesterone|dydrogesterone|mesh-list
102168352|NCT03267771|Progestins|progestins|mesh-ancestor
102168353|NCT03267771|Hormones|hormones|mesh-ancestor
102168354|NCT03267771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102168355|NCT03267771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168356|NCT03073304|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102168357|NCT03550651|Chlorhexidine|chlorhexidine|mesh-list
102168358|NCT03550651|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102168359|NCT03550651|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102168360|NCT03550651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102168361|NCT03550651|Disinfectants|disinfectants|mesh-ancestor
102168362|NCT03550651|Dermatologic Agents|dermatologic agents|mesh-ancestor
102168363|NCT02456961|Riboflavin|riboflavin|mesh-list
102168364|NCT02456961|Vitamin B Complex|vitamin b complex|mesh-ancestor
102168365|NCT02456961|Vitamins|vitamins|mesh-ancestor
102168366|NCT02456961|Micronutrients|micronutrients|mesh-ancestor
102168367|NCT02456961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168368|NCT02456961|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102168369|NCT02456961|Dermatologic Agents|dermatologic agents|mesh-ancestor
102168370|NCT03551197|Budesonide|budesonide|mesh-list
102168371|NCT03551197|Formoterol Fumarate|formoterol fumarate|mesh-list
102168372|NCT03551197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102168373|NCT03551197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102168374|NCT03551197|Autonomic Agents|autonomic agents|mesh-ancestor
102168375|NCT03551197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102168376|NCT03551197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168377|NCT03551197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102168378|NCT03551197|Respiratory System Agents|respiratory system agents|mesh-ancestor
102168379|NCT03551197|Glucocorticoids|glucocorticoids|mesh-ancestor
102168380|NCT03551197|Hormones|hormones|mesh-ancestor
102168381|NCT03551197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102168382|NCT03551197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102168383|NCT03551197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102168384|NCT03551197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102168385|NCT03551197|Adrenergic Agents|adrenergic agents|mesh-ancestor
102168386|NCT03551197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102168387|NCT03551197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168388|NCT02435836|Aripiprazole|aripiprazole|mesh-list
102168389|NCT02435836|Antidepressive Agents|antidepressive agents|mesh-ancestor
102168390|NCT02435836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102168391|NCT02435836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102168392|NCT02435836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102168393|NCT02435836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102168394|NCT02435836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168395|NCT02435836|Dopamine Agonists|dopamine agonists|mesh-ancestor
102168396|NCT02435836|Dopamine Agents|dopamine agents|mesh-ancestor
102168397|NCT02435836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102168398|NCT02435836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168399|NCT02435836|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102168400|NCT02435836|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102168401|NCT02435836|Serotonin Agents|serotonin agents|mesh-ancestor
102168402|NCT02435836|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102168403|NCT02435836|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102168404|NCT02435836|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102168405|NCT02435836|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102168406|NCT02127463|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102168407|NCT02127463|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102168408|NCT05075265|Methadone|methadone|mesh-list
102168409|NCT05075265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102168410|NCT05075265|Narcotics|narcotics|mesh-ancestor
102168411|NCT05075265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102168412|NCT05075265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168414|NCT05075265|Sensory System Agents|sensory system agents|mesh-ancestor
102168415|NCT05075265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102168416|NCT05075265|Antitussive Agents|antitussive agents|mesh-ancestor
102168417|NCT05075265|Respiratory System Agents|respiratory system agents|mesh-ancestor
102168418|NCT02127541|Exenatide|exenatide|mesh-list
102168419|NCT02127541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102168420|NCT02127541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168421|NCT02127541|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102168422|NCT02127541|Incretins|incretins|mesh-ancestor
102168423|NCT02127541|Hormones|hormones|mesh-ancestor
102168424|NCT02127541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102168425|NCT03263871|Micronutrients|micronutrients|mesh-list
102168426|NCT03263871|Trace Elements|trace elements|mesh-list
102168427|NCT03263871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168428|NCT04992182|Vaccines|vaccines|mesh-list
102168429|NCT04992182|Immunologic Factors|immunologic factors|mesh-ancestor
102168430|NCT04992182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168431|NCT02124655|Chlorhexidine|chlorhexidine|mesh-list
102168432|NCT02124655|Listerine|listerine|mesh-list
102168433|NCT02124655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102168434|NCT02124655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102168435|NCT02124655|Disinfectants|disinfectants|mesh-ancestor
102168436|NCT03263715|Glucocorticoids|glucocorticoids|mesh-list
102168437|NCT03263715|Hormones|hormones|mesh-ancestor
102168438|NCT03263715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102168439|NCT03263715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168440|NCT02457039|Cyclophosphamide|cyclophosphamide|mesh-list
102168441|NCT02457039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102168442|NCT02457039|Immunologic Factors|immunologic factors|mesh-ancestor
102168443|NCT02457039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168444|NCT02457039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102168445|NCT02457039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102168446|NCT02457039|Alkylating Agents|alkylating agents|mesh-ancestor
102168447|NCT02457039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168448|NCT02457039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102168449|NCT02457039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102168450|NCT03266991|Isoniazid|isoniazid|mesh-list
102168451|NCT03266991|Rifapentine|rifapentine|mesh-list
102168452|NCT03266991|Antitubercular Agents|antitubercular agents|mesh-ancestor
102168453|NCT03266991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102168454|NCT03266991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102168455|NCT03266991|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102168456|NCT03266991|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102168457|NCT03266991|Antimetabolites|antimetabolites|mesh-ancestor
102168458|NCT03266991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168459|NCT03266991|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102168460|NCT03266991|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102168461|NCT03266991|Leprostatic Agents|leprostatic agents|mesh-ancestor
102168462|NCT02456740|Erenumab|erenumab|mesh-list
102168463|NCT02456740|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
102168464|NCT02456740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168465|NCT02456740|Analgesics|analgesics|mesh-ancestor
102168466|NCT02456740|Sensory System Agents|sensory system agents|mesh-ancestor
102168467|NCT02456740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102168468|NCT02456740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168469|NCT03768115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102168470|NCT03768115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102168471|NCT03266601|Interferons|interferons|mesh-list
102168472|NCT03266601|Ribavirin|ribavirin|mesh-list
102168473|NCT03266601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102168474|NCT03266601|Antiviral Agents|antiviral agents|mesh-ancestor
102168475|NCT03266601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102168476|NCT03266601|Antimetabolites|antimetabolites|mesh-ancestor
102168477|NCT03266601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168478|NCT02124733|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102168479|NCT02124733|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102168480|NCT02124733|Dermatologic Agents|dermatologic agents|mesh-ancestor
102168481|NCT02458755|Atorvastatin|atorvastatin|mesh-list
102168482|NCT02458755|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102168483|NCT02458755|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102168484|NCT02458755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102168485|NCT02458755|Antimetabolites|antimetabolites|mesh-ancestor
102168486|NCT02458755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168487|NCT02458755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102168488|NCT02458755|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102168489|NCT02458755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102168490|NCT04462406|Pembrolizumab|pembrolizumab|mesh-list
102168491|NCT04462406|Nivolumab|nivolumab|mesh-list
102168492|NCT04462406|Ipilimumab|ipilimumab|mesh-list
102168493|NCT04462406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102168494|NCT04462406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102168495|NCT04462406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102168496|NCT04462406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168497|NCT02400580|Acetaminophen|acetaminophen|mesh-list
102168498|NCT02400580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102168499|NCT02400580|Analgesics|analgesics|mesh-ancestor
102168500|NCT02400580|Sensory System Agents|sensory system agents|mesh-ancestor
102168501|NCT02400580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102168502|NCT02400580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168503|NCT02400580|Antipyretics|antipyretics|mesh-ancestor
102168504|NCT03262857|Lidocaine|lidocaine|mesh-list
102168505|NCT03262857|Magnesium Sulfate|magnesium sulfate|mesh-list
102168506|NCT03262857|Anesthetics, Local|anesthetics, local|mesh-ancestor
102168507|NCT03262857|Anesthetics|anesthetics|mesh-ancestor
102168508|NCT03262857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102168509|NCT03262857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168510|NCT03262857|Sensory System Agents|sensory system agents|mesh-ancestor
102168511|NCT03262857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102168512|NCT03262857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102168513|NCT03262857|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102168514|NCT03262857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102168515|NCT03262857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102168516|NCT03262857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168517|NCT03262857|Analgesics|analgesics|mesh-ancestor
102168518|NCT03262857|Anticonvulsants|anticonvulsants|mesh-ancestor
102168519|NCT03262857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102168520|NCT03262857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102168521|NCT03262857|Tocolytic Agents|tocolytic agents|mesh-ancestor
102168522|NCT03262857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102168523|NCT02127697|Glycopyrrolate|glycopyrrolate|mesh-list
102168524|NCT02127697|Albuterol|albuterol|mesh-list
102168525|NCT02127697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102168526|NCT02127697|Autonomic Agents|autonomic agents|mesh-ancestor
102168527|NCT02127697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102168528|NCT02127697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168529|NCT02127697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102168530|NCT02127697|Respiratory System Agents|respiratory system agents|mesh-ancestor
102168531|NCT02127697|Tocolytic Agents|tocolytic agents|mesh-ancestor
102168532|NCT02127697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102168533|NCT02127697|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102168534|NCT02127697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102168535|NCT02127697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102168536|NCT02127697|Adrenergic Agents|adrenergic agents|mesh-ancestor
102168537|NCT02127697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102168538|NCT02127697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168539|NCT02127697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102168540|NCT02127697|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102168541|NCT02127697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102168542|NCT02127697|Cholinergic Agents|cholinergic agents|mesh-ancestor
102168543|NCT02127775|Lesinurad|lesinurad|mesh-list
102168544|NCT02127775|Gout Suppressants|gout suppressants|mesh-ancestor
102168545|NCT02127775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102168546|NCT02127775|Uricosuric Agents|uricosuric agents|mesh-ancestor
102168547|NCT02252341|Acetylcysteine|acetylcysteine|mesh-list
102168548|NCT02252341|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102168549|NCT02252341|Antiviral Agents|antiviral agents|mesh-ancestor
102168550|NCT02252341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102168551|NCT02252341|Expectorants|expectorants|mesh-ancestor
102168552|NCT02252341|Respiratory System Agents|respiratory system agents|mesh-ancestor
102168553|NCT02252341|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102168554|NCT02252341|Antioxidants|antioxidants|mesh-ancestor
102168555|NCT02252341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168556|NCT02252341|Protective Agents|protective agents|mesh-ancestor
102168557|NCT02252341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168559|NCT02127853|Gabapentin|gabapentin|mesh-list
102168560|NCT02127853|Analgesics|analgesics|mesh-ancestor
102168561|NCT02127853|Sensory System Agents|sensory system agents|mesh-ancestor
101877389|NCT01039025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102168562|NCT02127853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102168563|NCT02127853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168564|NCT02127853|Anticonvulsants|anticonvulsants|mesh-ancestor
102168565|NCT02127853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102168566|NCT02127853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102168567|NCT02127853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102168568|NCT02127853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102168569|NCT02127853|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102168570|NCT02127853|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102168571|NCT02127853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102168572|NCT02127853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168573|NCT02127853|Antimanic Agents|antimanic agents|mesh-ancestor
102168574|NCT03266445|Buprenorphine|buprenorphine|mesh-list
102168575|NCT03266445|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102168576|NCT03266445|Naloxone|naloxone|mesh-list
102168577|NCT03266445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102168578|NCT03266445|Narcotics|narcotics|mesh-ancestor
102168579|NCT03266445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102168580|NCT03266445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168581|NCT03266445|Analgesics|analgesics|mesh-ancestor
102168582|NCT03266445|Sensory System Agents|sensory system agents|mesh-ancestor
101446703|NCT00181532|Analgesics|analgesics|mesh-ancestor
102168583|NCT03266445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102168584|NCT03266445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102168585|NCT01367119|Ketamine|ketamine|mesh-list
102168586|NCT01367119|Methohexital|methohexital|mesh-list
102168587|NCT01367119|Analgesics|analgesics|mesh-ancestor
102168588|NCT01367119|Sensory System Agents|sensory system agents|mesh-ancestor
102168589|NCT01367119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102168590|NCT01367119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168591|NCT01367119|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102168592|NCT01367119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102168593|NCT01367119|Anesthetics, General|anesthetics, general|mesh-ancestor
102168594|NCT01367119|Anesthetics|anesthetics|mesh-ancestor
102168595|NCT01367119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102168596|NCT01367119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102168597|NCT01367119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102168598|NCT01367119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102168599|NCT01367119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168600|NCT02252107|Decitabine|decitabine|mesh-list
102168601|NCT02252107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102168602|NCT02252107|Antimetabolites|antimetabolites|mesh-ancestor
102168603|NCT02252107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168604|NCT02252107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102168605|NCT02252107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102168606|NCT03262545|Apatinib|apatinib|mesh-list
102168607|NCT03262545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102168608|NCT03262545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102168609|NCT03262545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102168610|NCT03262545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168611|NCT03262077|Methylene Blue|methylene blue|mesh-list
102168612|NCT03262077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102168613|NCT03262077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168614|NCT03265899|Lactitol|lactitol|mesh-list
102168615|NCT03265899|Oxytocin|oxytocin|mesh-list
102168616|NCT03265899|Oxytocics|oxytocics|mesh-ancestor
102168617|NCT03265899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102168618|NCT03265899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168619|NCT03265899|Cathartics|cathartics|mesh-ancestor
102168620|NCT03265899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102168621|NCT04459988|Ocrelizumab|ocrelizumab|mesh-list
102168622|NCT04459988|Immunologic Factors|immunologic factors|mesh-ancestor
102168623|NCT04459988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168624|NCT02125201|Fentanyl|fentanyl|mesh-list
102168625|NCT02125201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102168626|NCT02125201|Narcotics|narcotics|mesh-ancestor
102168627|NCT02125201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102168628|NCT02125201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168629|NCT02125201|Analgesics|analgesics|mesh-ancestor
102168630|NCT02125201|Sensory System Agents|sensory system agents|mesh-ancestor
101710386|NCT00685022|Albuterol|albuterol|mesh-list
102168631|NCT02125201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102168632|NCT02125201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102168633|NCT02125201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102168634|NCT02125201|Anesthetics, General|anesthetics, general|mesh-ancestor
102168635|NCT02125201|Anesthetics|anesthetics|mesh-ancestor
102168636|NCT02125357|Abiraterone Acetate|abiraterone acetate|mesh-list
102168637|NCT02125357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102168638|NCT02125357|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102168639|NCT02125357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102168640|NCT02125357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168641|NCT02125357|Hormone Antagonists|hormone antagonists|mesh-ancestor
102168642|NCT02125357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102168643|NCT02125357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168644|NCT02125357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102168645|NCT03074942|Reslizumab|reslizumab|mesh-list
102168646|NCT03074942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102168647|NCT03074942|Respiratory System Agents|respiratory system agents|mesh-ancestor
102168648|NCT02125435|ASP2408|asp2408|mesh-list
102168649|NCT02125435|Immunoconjugates|immunoconjugates|mesh-ancestor
102168650|NCT02125435|Immunologic Factors|immunologic factors|mesh-ancestor
102168651|NCT02125435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168652|NCT02458911|Paclitaxel|paclitaxel|mesh-list
102168653|NCT02458911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102168654|NCT02458911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102168655|NCT02458911|Tubulin Modulators|tubulin modulators|mesh-ancestor
102168656|NCT02458911|Antimitotic Agents|antimitotic agents|mesh-ancestor
102168657|NCT02458911|Mitosis Modulators|mitosis modulators|mesh-ancestor
102168658|NCT02458911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168659|NCT03075020|Carbon Monoxide|carbon monoxide|mesh-list
102168660|NCT03075020|Antimetabolites|antimetabolites|mesh-ancestor
102168661|NCT03075020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168662|NCT03075020|Gasotransmitters|gasotransmitters|mesh-ancestor
102168663|NCT03075020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102168664|NCT03075020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168665|NCT04998344|Vaccines|vaccines|mesh-list
102168666|NCT04998344|Immunologic Factors|immunologic factors|mesh-ancestor
102168667|NCT04998344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168668|NCT02128243|Leucovorin|leucovorin|mesh-list
102168669|NCT02128243|Cisplatin|cisplatin|mesh-list
102168670|NCT02128243|Docetaxel|docetaxel|mesh-list
102168671|NCT02128243|Fluorouracil|fluorouracil|mesh-list
102168672|NCT02128243|Capecitabine|capecitabine|mesh-list
102168673|NCT02128243|Oxaliplatin|oxaliplatin|mesh-list
102168674|NCT02128243|Epirubicin|epirubicin|mesh-list
102168675|NCT02128243|Levoleucovorin|levoleucovorin|mesh-list
102168676|NCT02128243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102168677|NCT02128243|Tubulin Modulators|tubulin modulators|mesh-ancestor
102168678|NCT02128243|Antimitotic Agents|antimitotic agents|mesh-ancestor
102168679|NCT02128243|Mitosis Modulators|mitosis modulators|mesh-ancestor
102168680|NCT02128243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168681|NCT02128243|Antimetabolites|antimetabolites|mesh-ancestor
102168682|NCT02128243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102168683|NCT02128243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102168684|NCT02128243|Immunologic Factors|immunologic factors|mesh-ancestor
102168685|NCT02128243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168686|NCT02128243|Antidotes|antidotes|mesh-ancestor
102168687|NCT02128243|Protective Agents|protective agents|mesh-ancestor
102168688|NCT02128243|Vitamin B Complex|vitamin b complex|mesh-ancestor
102168689|NCT02128243|Vitamins|vitamins|mesh-ancestor
102168690|NCT02128243|Micronutrients|micronutrients|mesh-ancestor
102168691|NCT02128243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102168692|NCT02128243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102168693|NCT02128243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102168694|NCT02128243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102168695|NCT03072290|Triamcinolone|triamcinolone|mesh-list
102168696|NCT03072290|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102168697|NCT03072290|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102168698|NCT03072290|Lidocaine|lidocaine|mesh-list
102168699|NCT03072290|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102168700|NCT03072290|Anesthetics, Local|anesthetics, local|mesh-ancestor
102168701|NCT03072290|Anesthetics|anesthetics|mesh-ancestor
102168702|NCT03072290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102168703|NCT03072290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168704|NCT03072290|Sensory System Agents|sensory system agents|mesh-ancestor
102168705|NCT03072290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102168706|NCT03072290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102168707|NCT03072290|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102168709|NCT03072290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102168710|NCT03072290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168711|NCT03072290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102168712|NCT03072290|Glucocorticoids|glucocorticoids|mesh-ancestor
102168713|NCT03072290|Hormones|hormones|mesh-ancestor
102168714|NCT03072290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102168715|NCT03072290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102168716|NCT03072290|Immunologic Factors|immunologic factors|mesh-ancestor
102168717|NCT03072290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102168718|NCT02132689|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102168719|NCT02132689|Fibrinolytic Agents|fibrinolytic agents|mesh-list
102168720|NCT02132689|Heparin|heparin|mesh-list
102168721|NCT02132689|Calcium heparin|calcium heparin|mesh-list
102168722|NCT02132689|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102168723|NCT02132689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168724|NCT02132689|Anticoagulants|anticoagulants|mesh-ancestor
102168725|NCT02128321|Repaglinide|repaglinide|mesh-list
102168726|NCT02128321|Isavuconazole|isavuconazole|mesh-list
102168727|NCT02128321|Caffeine|caffeine|mesh-list
102168728|NCT02128321|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102168729|NCT02128321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168730|NCT02128321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102168731|NCT02128321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102168732|NCT02128321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168733|NCT02128321|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102168734|NCT02128321|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102168735|NCT02128321|Purinergic Agents|purinergic agents|mesh-ancestor
102168736|NCT02128321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102168737|NCT02128321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102168738|NCT02128321|Antifungal Agents|antifungal agents|mesh-ancestor
102168739|NCT02128321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102168740|NCT02457975|Ranibizumab|ranibizumab|mesh-list
102168741|NCT02457975|Aflibercept|aflibercept|mesh-list
102168742|NCT02457975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102168743|NCT02457975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102168744|NCT02457975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102168745|NCT02457975|Growth Substances|growth substances|mesh-ancestor
102168746|NCT02457975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168747|NCT02457975|Growth Inhibitors|growth inhibitors|mesh-ancestor
102168748|NCT03074864|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102168749|NCT03074864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102168750|NCT03074864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102168751|NCT03074864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102168752|NCT03074864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168753|NCT02125903|Ropivacaine|ropivacaine|mesh-list
102168754|NCT02125903|Anesthetics, Local|anesthetics, local|mesh-ancestor
102168755|NCT02125903|Anesthetics|anesthetics|mesh-ancestor
102168756|NCT02125903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102168757|NCT02125903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168758|NCT02125903|Sensory System Agents|sensory system agents|mesh-ancestor
102168759|NCT02125903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102168760|NCT04997564|Tenofovir|tenofovir|mesh-list
102168761|NCT04997564|Sofosbuvir|sofosbuvir|mesh-list
102168762|NCT04997564|Velpatasvir|velpatasvir|mesh-list
102168763|NCT04997564|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102168764|NCT04997564|Antiviral Agents|antiviral agents|mesh-ancestor
102168765|NCT04997564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102168766|NCT04997564|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102168767|NCT04997564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102168768|NCT04997564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102168769|NCT04997564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168770|NCT04997564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102168771|NCT04997564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102168772|NCT03842943|Pembrolizumab|pembrolizumab|mesh-list
102168773|NCT03842943|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
102168774|NCT03842943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102168775|NCT03842943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102168776|NCT03842943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102168777|NCT03842943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168778|NCT02126137|Ezetimibe|ezetimibe|mesh-list
102168779|NCT02126137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102168780|NCT02126137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102168781|NCT02126137|Antimetabolites|antimetabolites|mesh-ancestor
102168782|NCT02126137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168783|NCT02126137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102168784|NCT02126293|Zinc|zinc|mesh-list
102168785|NCT02126293|Trace Elements|trace elements|mesh-ancestor
102168786|NCT02126293|Micronutrients|micronutrients|mesh-ancestor
102168787|NCT02126293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168788|NCT03261921|Dexamethasone|dexamethasone|mesh-list
102168789|NCT03261921|Dexmedetomidine|dexmedetomidine|mesh-list
102168790|NCT03261921|Bupivacaine|bupivacaine|mesh-list
102168791|NCT03261921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102168792|NCT03261921|Antiemetics|antiemetics|mesh-ancestor
102168793|NCT03261921|Autonomic Agents|autonomic agents|mesh-ancestor
102168794|NCT03261921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102168795|NCT03261921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168796|NCT03261921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102168797|NCT03261921|Glucocorticoids|glucocorticoids|mesh-ancestor
102168798|NCT03261921|Hormones|hormones|mesh-ancestor
102168799|NCT03261921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102168800|NCT03261921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102168801|NCT03261921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102168802|NCT03261921|Anesthetics, Local|anesthetics, local|mesh-ancestor
102168803|NCT03261921|Anesthetics|anesthetics|mesh-ancestor
102168804|NCT03261921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102168805|NCT03261921|Sensory System Agents|sensory system agents|mesh-ancestor
102168806|NCT03261921|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102168807|NCT03261921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102168808|NCT03261921|Analgesics|analgesics|mesh-ancestor
102168809|NCT03261921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102168810|NCT03261921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102168811|NCT03261921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102168812|NCT03261921|Adrenergic Agents|adrenergic agents|mesh-ancestor
102168813|NCT03261921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102168814|NCT03261921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168815|NCT02635724|Peramivir|peramivir|mesh-list
102168816|NCT02635724|Antiviral Agents|antiviral agents|mesh-ancestor
102168817|NCT02635724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102168818|NCT02635724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102168819|NCT02635724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168820|NCT02133469|Vaccines|vaccines|mesh-list
102168821|NCT02133469|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102168822|NCT02133469|Immunologic Factors|immunologic factors|mesh-ancestor
102168823|NCT02133469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168824|NCT03905265|Moxidectin|moxidectin|mesh-list
102168825|NCT03905265|Anthelmintics|anthelmintics|mesh-ancestor
102168826|NCT03905265|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102168827|NCT03905265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102168828|NCT03905265|Antinematodal Agents|antinematodal agents|mesh-ancestor
102168829|NCT05001854|Fludrocortisone|fludrocortisone|mesh-list
102168830|NCT05001854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102168831|NCT02126527|Sirolimus|sirolimus|mesh-list
102168832|NCT02126527|Auranofin|auranofin|mesh-list
102168833|NCT02126527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102168834|NCT02126527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102168835|NCT02126527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102168836|NCT02126527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102168837|NCT02126527|Antifungal Agents|antifungal agents|mesh-ancestor
102168838|NCT02126527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102168839|NCT02126527|Immunologic Factors|immunologic factors|mesh-ancestor
102168840|NCT02126527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168841|NCT02126527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102168842|NCT02133625|Pioglitazone|pioglitazone|mesh-list
102168843|NCT02133625|Carboplatin|carboplatin|mesh-list
102168844|NCT02133625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102168845|NCT02133625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102168846|NCT02133625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168847|NCT02260687|Aflibercept|aflibercept|mesh-list
102168848|NCT02260687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102168849|NCT02260687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102168850|NCT02260687|Growth Substances|growth substances|mesh-ancestor
102168851|NCT02260687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168852|NCT02260687|Growth Inhibitors|growth inhibitors|mesh-ancestor
102168853|NCT02260687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102168854|NCT03071822|Dexamethasone|dexamethasone|mesh-list
102168855|NCT03071822|Gemcitabine|gemcitabine|mesh-list
102168856|NCT03071822|Etoposide|etoposide|mesh-list
102168857|NCT03071822|Asparaginase|asparaginase|mesh-list
102168858|NCT03071822|Ifosfamide|ifosfamide|mesh-list
102168859|NCT03071822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102168860|NCT03071822|Antiemetics|antiemetics|mesh-ancestor
102168861|NCT03071822|Autonomic Agents|autonomic agents|mesh-ancestor
102168862|NCT03071822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102168863|NCT03071822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168864|NCT03071822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102168865|NCT03071822|Glucocorticoids|glucocorticoids|mesh-ancestor
101877690|NCT03774706|Hemostatics|hemostatics|mesh-ancestor
102168867|NCT03071822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102168868|NCT03071822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102168869|NCT03071822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102168870|NCT03071822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102168871|NCT03071822|Antimetabolites|antimetabolites|mesh-ancestor
102168872|NCT03071822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168873|NCT03071822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102168874|NCT03071822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102168875|NCT03071822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102168876|NCT03071822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102168877|NCT03071822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102168878|NCT03071822|Alkylating Agents|alkylating agents|mesh-ancestor
102168879|NCT04991012|Triamcinolone|triamcinolone|mesh-list
102168880|NCT04991012|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102168881|NCT04991012|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102168882|NCT04991012|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102168883|NCT04991012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102168884|NCT04991012|Glucocorticoids|glucocorticoids|mesh-ancestor
102168885|NCT04991012|Hormones|hormones|mesh-ancestor
102168886|NCT04991012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102168887|NCT04991012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168888|NCT04991012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102168889|NCT04991012|Immunologic Factors|immunologic factors|mesh-ancestor
102168890|NCT04991012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102168891|NCT04991012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168892|NCT02252731|Warfarin|warfarin|mesh-list
102168893|NCT02252731|Anticoagulants|anticoagulants|mesh-ancestor
102168894|NCT02128633|Listerine|listerine|mesh-list
102168895|NCT02128633|Fluorides|fluorides|mesh-list
102168896|NCT02128633|Sodium Fluoride|sodium fluoride|mesh-list
102168897|NCT02128633|Cariostatic Agents|cariostatic agents|mesh-ancestor
102168898|NCT02128633|Protective Agents|protective agents|mesh-ancestor
102168899|NCT02128633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168900|NCT02128633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102168901|NCT02128633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102168902|NCT02126683|Hydroxychloroquine|hydroxychloroquine|mesh-list
102168903|NCT02126683|Antimalarials|antimalarials|mesh-ancestor
102168904|NCT02126683|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102168905|NCT02126683|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102168906|NCT02126683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102168907|NCT02126683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102168908|NCT02126683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168909|NCT02126683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102168910|NCT03252561|Anesthetics|anesthetics|mesh-list
102168911|NCT03252561|Anesthetics, Local|anesthetics, local|mesh-list
102168912|NCT03252561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102168913|NCT03252561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168914|NCT03252561|Sensory System Agents|sensory system agents|mesh-ancestor
102168915|NCT03252561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102168916|NCT02252263|Elotuzumab|elotuzumab|mesh-list
102168917|NCT02252263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102168918|NCT04996550|Metoprolol|metoprolol|mesh-list
102168919|NCT04996550|Carvedilol|carvedilol|mesh-list
102168920|NCT04996550|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102168921|NCT04996550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102168922|NCT04996550|Sympatholytics|sympatholytics|mesh-ancestor
102168923|NCT04996550|Autonomic Agents|autonomic agents|mesh-ancestor
102168924|NCT04996550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102168925|NCT04996550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168926|NCT04996550|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102168927|NCT04996550|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102168928|NCT04996550|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102168929|NCT04996550|Adrenergic Agents|adrenergic agents|mesh-ancestor
102168930|NCT04996550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102168931|NCT04996550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168932|NCT04996550|Antioxidants|antioxidants|mesh-ancestor
102168933|NCT04996550|Protective Agents|protective agents|mesh-ancestor
102168934|NCT04996550|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102168935|NCT04996550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102168936|NCT04996550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102168937|NCT04996550|Vasodilator Agents|vasodilator agents|mesh-ancestor
102168938|NCT04996550|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102168939|NCT04996550|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102168940|NCT03252171|Immunomodulating Agents|immunomodulating agents|mesh-list
102168941|NCT03252171|Immunologic Factors|immunologic factors|mesh-ancestor
102168942|NCT03252171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168943|NCT02133937|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102168944|NCT02133937|Immunologic Factors|immunologic factors|mesh-ancestor
102168945|NCT02133937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168946|NCT02135965|Caffeine|caffeine|mesh-list
102168947|NCT02135965|Albuterol|albuterol|mesh-list
102168948|NCT02135965|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102168949|NCT02135965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168950|NCT02135965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102168951|NCT02135965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102168952|NCT02135965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168953|NCT02135965|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102168954|NCT02135965|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102168955|NCT02135965|Purinergic Agents|purinergic agents|mesh-ancestor
102168956|NCT02135965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102168957|NCT02135965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102168958|NCT02135965|Autonomic Agents|autonomic agents|mesh-ancestor
102168959|NCT02135965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102168960|NCT02135965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102168961|NCT02135965|Respiratory System Agents|respiratory system agents|mesh-ancestor
102168962|NCT02135965|Tocolytic Agents|tocolytic agents|mesh-ancestor
102168963|NCT02135965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102168964|NCT02135965|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102168965|NCT02135965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102168966|NCT02135965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102168967|NCT02135965|Adrenergic Agents|adrenergic agents|mesh-ancestor
102168968|NCT02455401|Remifentanil|remifentanil|mesh-list
102168969|NCT02455401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102168970|NCT02455401|Narcotics|narcotics|mesh-ancestor
102168971|NCT02455401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102168972|NCT02455401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168973|NCT02455401|Analgesics|analgesics|mesh-ancestor
102168974|NCT02455401|Sensory System Agents|sensory system agents|mesh-ancestor
102168975|NCT02455401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102168976|NCT03260829|Ascorbic Acid|ascorbic acid|mesh-list
102168977|NCT03260829|Vitamins|vitamins|mesh-ancestor
102168978|NCT03260829|Micronutrients|micronutrients|mesh-ancestor
102168979|NCT03260829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168980|NCT03260829|Antioxidants|antioxidants|mesh-ancestor
102168981|NCT03260829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102168982|NCT03260829|Protective Agents|protective agents|mesh-ancestor
102168983|NCT02134093|Midazolam|midazolam|mesh-list
102168984|NCT02134093|Sufentanil|sufentanil|mesh-list
102168985|NCT02134093|Dexmedetomidine|dexmedetomidine|mesh-list
102168986|NCT02134093|Remifentanil|remifentanil|mesh-list
102168987|NCT02134093|Anesthetics|anesthetics|mesh-list
102168988|NCT02134093|Propofol|propofol|mesh-list
102168989|NCT02134093|Etomidate|etomidate|mesh-list
102168990|NCT02134093|Vecuronium Bromide|vecuronium bromide|mesh-list
102168991|NCT02134093|Rocuronium|rocuronium|mesh-list
102168992|NCT02134093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102168993|NCT02134093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102168994|NCT02134093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102168995|NCT02134093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102168996|NCT02134093|Analgesics|analgesics|mesh-ancestor
102168997|NCT02134093|Sensory System Agents|sensory system agents|mesh-ancestor
102168998|NCT02134093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102168999|NCT02134093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102169000|NCT02134093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102169001|NCT02134093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102169002|NCT02134093|Adrenergic Agents|adrenergic agents|mesh-ancestor
102169003|NCT02134093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102169004|NCT02134093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169005|NCT02134093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102169006|NCT02134093|Anesthetics, General|anesthetics, general|mesh-ancestor
102169007|NCT02134093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102169008|NCT02134093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102169009|NCT02134093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102169010|NCT02134093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102169011|NCT02134093|GABA Modulators|gaba modulators|mesh-ancestor
102169012|NCT02134093|GABA Agents|gaba agents|mesh-ancestor
102169013|NCT02134093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102169014|NCT02134093|Narcotics|narcotics|mesh-ancestor
102169015|NCT02134093|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102169016|NCT02134093|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102169017|NCT02134093|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101877843|NCT01039181|Vitamin D|vitamin d|mesh-list
102169018|NCT02134093|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102169019|NCT02134093|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102169020|NCT02134093|Cholinergic Agents|cholinergic agents|mesh-ancestor
102169021|NCT03074786|Tenofovir|tenofovir|mesh-list
102169022|NCT03074786|Emtricitabine|emtricitabine|mesh-list
102169023|NCT03074786|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102169024|NCT03074786|Dapivirine|dapivirine|mesh-list
102169025|NCT03074786|Antiviral Agents|antiviral agents|mesh-ancestor
102169026|NCT03074786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102169027|NCT03074786|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102169028|NCT03074786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102169029|NCT03074786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102169030|NCT03074786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169031|NCT03074786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102169032|NCT03074786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102169033|NCT03070028|Phenol|phenol|mesh-list
102169034|NCT03070028|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102169035|NCT03070028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102169036|NCT03070028|Disinfectants|disinfectants|mesh-ancestor
102169037|NCT03070028|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102169038|NCT03070028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102169039|NCT03260439|Tramadol|tramadol|mesh-list
102169040|NCT03260439|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102169041|NCT03260439|Narcotics|narcotics|mesh-ancestor
102169042|NCT03260439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102169043|NCT03260439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169044|NCT03260439|Analgesics|analgesics|mesh-ancestor
102169045|NCT03260439|Sensory System Agents|sensory system agents|mesh-ancestor
102169046|NCT03260439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102169047|NCT02634788|Buprenorphine|buprenorphine|mesh-list
102169048|NCT02634788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102169049|NCT02634788|Narcotics|narcotics|mesh-ancestor
102169050|NCT02634788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102169051|NCT02634788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169052|NCT02634788|Analgesics|analgesics|mesh-ancestor
102169053|NCT02634788|Sensory System Agents|sensory system agents|mesh-ancestor
102169054|NCT02634788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102169055|NCT02634788|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102169056|NCT03260283|Fentanyl|fentanyl|mesh-list
102169057|NCT03260283|Meperidine|meperidine|mesh-list
102169058|NCT03260283|Ropivacaine|ropivacaine|mesh-list
102169059|NCT03260283|Anesthetics, Local|anesthetics, local|mesh-ancestor
102169060|NCT03260283|Anesthetics|anesthetics|mesh-ancestor
102169061|NCT03260283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102169062|NCT03260283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169063|NCT03260283|Sensory System Agents|sensory system agents|mesh-ancestor
102169064|NCT03260283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102169065|NCT03260283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102169066|NCT03260283|Narcotics|narcotics|mesh-ancestor
102169067|NCT03260283|Analgesics|analgesics|mesh-ancestor
102169068|NCT03260283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102169069|NCT03260283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102169070|NCT03260283|Anesthetics, General|anesthetics, general|mesh-ancestor
102169071|NCT03251469|Tranexamic Acid|tranexamic acid|mesh-list
102169072|NCT03251469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102169073|NCT03251469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102169074|NCT03251469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169075|NCT03251469|Hemostatics|hemostatics|mesh-ancestor
102169076|NCT03251469|Coagulants|coagulants|mesh-ancestor
102169077|NCT04986644|Hyaluronic Acid|hyaluronic acid|mesh-list
102169078|NCT04986644|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102169079|NCT04986644|Immunologic Factors|immunologic factors|mesh-ancestor
102169080|NCT04986644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169081|NCT04986644|Viscosupplements|viscosupplements|mesh-ancestor
102169082|NCT04986644|Protective Agents|protective agents|mesh-ancestor
102169083|NCT02785939|Docetaxel|docetaxel|mesh-list
102169084|NCT02785939|Palbociclib|palbociclib|mesh-list
102169085|NCT02785939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102169086|NCT02785939|Tubulin Modulators|tubulin modulators|mesh-ancestor
102169087|NCT02785939|Antimitotic Agents|antimitotic agents|mesh-ancestor
102169088|NCT02785939|Mitosis Modulators|mitosis modulators|mesh-ancestor
102169089|NCT02785939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169090|NCT02785939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102169091|NCT02785939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102169092|NCT03583229|Aspirin|aspirin|mesh-list
102169093|NCT03583229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102169094|NCT03583229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102169095|NCT03583229|Analgesics|analgesics|mesh-ancestor
102169096|NCT03583229|Sensory System Agents|sensory system agents|mesh-ancestor
102169097|NCT03583229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102169098|NCT03583229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169099|NCT03583229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102169100|NCT03583229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102169101|NCT03583229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102169102|NCT03583229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102169103|NCT03583229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169104|NCT03583229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102169105|NCT03583229|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102169106|NCT03583229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102169108|NCT02259803|Amlodipine|amlodipine|mesh-list
102169109|NCT02259803|Telmisartan|telmisartan|mesh-list
102169110|NCT02259803|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
102169111|NCT02259803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102169112|NCT02259803|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102169113|NCT02259803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102169114|NCT02259803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169115|NCT02259803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102169116|NCT02259803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169117|NCT02259803|Vasodilator Agents|vasodilator agents|mesh-ancestor
102169118|NCT02259803|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102169119|NCT02259803|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102169120|NCT03260049|Antiviral Agents|antiviral agents|mesh-list
102169121|NCT03260049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102169122|NCT03069950|Leucovorin|leucovorin|mesh-list
102169123|NCT03069950|Dexamethasone|dexamethasone|mesh-list
102169124|NCT03069950|Fluorouracil|fluorouracil|mesh-list
102169125|NCT03069950|Irinotecan|irinotecan|mesh-list
102169126|NCT03069950|Panitumumab|panitumumab|mesh-list
102169127|NCT03069950|Floxuridine|floxuridine|mesh-list
102169128|NCT03069950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102169129|NCT03069950|Antiemetics|antiemetics|mesh-ancestor
102169130|NCT03069950|Autonomic Agents|autonomic agents|mesh-ancestor
102169131|NCT03069950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102169132|NCT03069950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169133|NCT03069950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102169134|NCT03069950|Glucocorticoids|glucocorticoids|mesh-ancestor
102169135|NCT03069950|Hormones|hormones|mesh-ancestor
102169136|NCT03069950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102169137|NCT03069950|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102169138|NCT03069950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102169139|NCT03069950|Antimetabolites|antimetabolites|mesh-ancestor
102169140|NCT03069950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169141|NCT03069950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102169142|NCT03069950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102169143|NCT03069950|Immunologic Factors|immunologic factors|mesh-ancestor
102169144|NCT03069950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102169145|NCT03069950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102169146|NCT03069950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102169147|NCT03069950|Antidotes|antidotes|mesh-ancestor
102169148|NCT03069950|Protective Agents|protective agents|mesh-ancestor
102169149|NCT03069950|Vitamin B Complex|vitamin b complex|mesh-ancestor
102169150|NCT03069950|Vitamins|vitamins|mesh-ancestor
102169151|NCT03069950|Micronutrients|micronutrients|mesh-ancestor
102169152|NCT03069950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102169153|NCT04913870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
102169154|NCT04913870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169155|NCT03577457|Oxytocin|oxytocin|mesh-list
102169156|NCT03577457|Oxytocics|oxytocics|mesh-ancestor
102169157|NCT03577457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102169158|NCT03577457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169159|NCT02455245|Carboplatin|carboplatin|mesh-list
102169160|NCT02455245|Vincristine|vincristine|mesh-list
102169161|NCT02455245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102169162|NCT02455245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102169163|NCT02455245|Tubulin Modulators|tubulin modulators|mesh-ancestor
102169164|NCT02455245|Antimitotic Agents|antimitotic agents|mesh-ancestor
102169165|NCT02455245|Mitosis Modulators|mitosis modulators|mesh-ancestor
102169166|NCT02455245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169167|NCT03537599|Daratumumab|daratumumab|mesh-list
102169168|NCT03537599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102169169|NCT04986254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102169170|NCT04986254|Meropenem|meropenem|mesh-list
102169171|NCT04986254|Ceftriaxone|ceftriaxone|mesh-list
102169172|NCT04986254|Tazobactam|tazobactam|mesh-list
102169173|NCT04986254|Piperacillin|piperacillin|mesh-list
102169174|NCT04986254|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102169175|NCT04986254|Penicillin G|penicillin g|mesh-list
102169176|NCT04986254|Penicillin G Benzathine|penicillin g benzathine|mesh-list
102169177|NCT04986254|Penicillin G Procaine|penicillin g procaine|mesh-list
102169178|NCT04986254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102169179|NCT04986254|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102169180|NCT04986254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102169181|NCT04986254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169182|NCT03257943|Ivermectin|ivermectin|mesh-list
102169183|NCT03257943|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102169184|NCT03257943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102169185|NCT04996160|Dexamethasone|dexamethasone|mesh-list
102169186|NCT04996160|Dexamethasone acetate|dexamethasone acetate|mesh-list
102169187|NCT04996160|Doxorubicin|doxorubicin|mesh-list
102169188|NCT04996160|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102169189|NCT04996160|Bortezomib|bortezomib|mesh-list
102169190|NCT04996160|Palbociclib|palbociclib|mesh-list
102169191|NCT04996160|BB 1101|bb 1101|mesh-list
102169192|NCT04996160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102169193|NCT04996160|Antiemetics|antiemetics|mesh-ancestor
102169194|NCT04996160|Autonomic Agents|autonomic agents|mesh-ancestor
102169195|NCT04996160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102169196|NCT04996160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169197|NCT04996160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102169198|NCT04996160|Glucocorticoids|glucocorticoids|mesh-ancestor
102169199|NCT04996160|Hormones|hormones|mesh-ancestor
102169200|NCT04996160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102169201|NCT04996160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102169202|NCT04996160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102169203|NCT04996160|Protease Inhibitors|protease inhibitors|mesh-ancestor
102169204|NCT04996160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102169205|NCT04996160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169206|NCT04996160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102169207|NCT04996160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102169208|NCT04996160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102169209|NCT04996160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102169210|NCT04986098|Paclitaxel|paclitaxel|mesh-list
102169211|NCT04986098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102169212|NCT04986098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102169213|NCT04986098|Tubulin Modulators|tubulin modulators|mesh-ancestor
102169214|NCT04986098|Antimitotic Agents|antimitotic agents|mesh-ancestor
102169215|NCT04986098|Mitosis Modulators|mitosis modulators|mesh-ancestor
102169216|NCT04986098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169217|NCT02239445|Dexmedetomidine|dexmedetomidine|mesh-list
102169218|NCT02239445|Chloral Hydrate|chloral hydrate|mesh-list
102169219|NCT02239445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102169220|NCT02239445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102169221|NCT02239445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169222|NCT02239445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102169223|NCT02239445|Analgesics|analgesics|mesh-ancestor
101446759|NCT00181688|Anastrozole|anastrozole|mesh-list
102169224|NCT02239445|Sensory System Agents|sensory system agents|mesh-ancestor
102169225|NCT02239445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102169226|NCT02239445|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102169227|NCT02239445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102169228|NCT02239445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102169229|NCT02239445|Adrenergic Agents|adrenergic agents|mesh-ancestor
102169230|NCT02239445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101573977|NCT02199184|Antibodies|antibodies|mesh-list
102169231|NCT02239445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169232|NCT03071042|Docetaxel|docetaxel|mesh-list
102169233|NCT03071042|Apatinib|apatinib|mesh-list
102169234|NCT03071042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102169235|NCT03071042|Tubulin Modulators|tubulin modulators|mesh-ancestor
102169236|NCT03071042|Antimitotic Agents|antimitotic agents|mesh-ancestor
102169237|NCT03071042|Mitosis Modulators|mitosis modulators|mesh-ancestor
102169238|NCT03071042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169239|NCT03071042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102169240|NCT03071042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102169241|NCT03582605|Amoxicillin|amoxicillin|mesh-list
102169242|NCT03582605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102169243|NCT03582605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102169244|NCT04433546|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
102169245|NCT04433546|Vasodilator Agents|vasodilator agents|mesh-ancestor
102169246|NCT04989140|Dexamethasone|dexamethasone|mesh-list
102169247|NCT04989140|Pomalidomide|pomalidomide|mesh-list
102169248|NCT04989140|Ixazomib|ixazomib|mesh-list
102169249|NCT04989140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101878098|NCT03762148|Iron|iron|mesh-list
102169251|NCT04989140|Autonomic Agents|autonomic agents|mesh-ancestor
102169252|NCT04989140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102169253|NCT04989140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169254|NCT04989140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102169255|NCT04989140|Glucocorticoids|glucocorticoids|mesh-ancestor
102169256|NCT04989140|Hormones|hormones|mesh-ancestor
102169257|NCT04989140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102169258|NCT04989140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102169259|NCT04989140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102169260|NCT04989140|Immunologic Factors|immunologic factors|mesh-ancestor
102169261|NCT04989140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102169262|NCT04989140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102169263|NCT04989140|Growth Substances|growth substances|mesh-ancestor
102169264|NCT04989140|Growth Inhibitors|growth inhibitors|mesh-ancestor
102169265|NCT04989140|Protease Inhibitors|protease inhibitors|mesh-ancestor
102169266|NCT04989140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102169267|NCT04989140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169268|NCT03246009|Lenograstim|lenograstim|mesh-list
102169269|NCT03246009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102169270|NCT03246009|Immunologic Factors|immunologic factors|mesh-ancestor
102169271|NCT03246009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169272|NCT03246399|Lorecivivint|lorecivivint|mesh-list
102169273|NCT03246399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102169274|NCT02134249|Cabergoline|cabergoline|mesh-list
102169275|NCT02134249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102169276|NCT02134249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102169277|NCT02134249|Dopamine Agonists|dopamine agonists|mesh-ancestor
102169278|NCT02134249|Dopamine Agents|dopamine agents|mesh-ancestor
102169279|NCT02134249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102169280|NCT02134249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169281|NCT02134249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169282|NCT03245853|Riboflavin|riboflavin|mesh-list
102169283|NCT03245853|Flavin Mononucleotide|flavin mononucleotide|mesh-list
102169284|NCT03245853|Vitamin B Complex|vitamin b complex|mesh-ancestor
102169285|NCT03245853|Vitamins|vitamins|mesh-ancestor
102169286|NCT03245853|Micronutrients|micronutrients|mesh-ancestor
102169287|NCT03245853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169288|NCT03245853|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102169289|NCT03245853|Dermatologic Agents|dermatologic agents|mesh-ancestor
102169290|NCT03574649|Paclitaxel|paclitaxel|mesh-list
102169291|NCT03574649|Docetaxel|docetaxel|mesh-list
102169292|NCT03574649|Cyclophosphamide|cyclophosphamide|mesh-list
102169293|NCT03574649|Carboplatin|carboplatin|mesh-list
102169294|NCT03574649|Fluorouracil|fluorouracil|mesh-list
102169295|NCT03574649|Avelumab|avelumab|mesh-list
102169296|NCT03574649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102169297|NCT03574649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102169298|NCT03574649|Tubulin Modulators|tubulin modulators|mesh-ancestor
102169299|NCT03574649|Antimitotic Agents|antimitotic agents|mesh-ancestor
102169300|NCT03574649|Mitosis Modulators|mitosis modulators|mesh-ancestor
102169301|NCT03574649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169302|NCT03574649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102169303|NCT03574649|Immunologic Factors|immunologic factors|mesh-ancestor
102169304|NCT03574649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169305|NCT03574649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102169306|NCT03574649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102169308|NCT03574649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102169309|NCT03574649|Antimetabolites|antimetabolites|mesh-ancestor
102169310|NCT03574649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102169311|NCT03574649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102169312|NCT02128945|Fludarabine|fludarabine|mesh-list
102169313|NCT02128945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102169314|NCT02136277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102169315|NCT03073928|Ropivacaine|ropivacaine|mesh-list
102169316|NCT03073928|Anesthetics, Local|anesthetics, local|mesh-ancestor
102169317|NCT03073928|Anesthetics|anesthetics|mesh-ancestor
102169318|NCT03073928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102169319|NCT03073928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169320|NCT03073928|Sensory System Agents|sensory system agents|mesh-ancestor
102169321|NCT03073928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102169322|NCT02134405|Esomeprazole|esomeprazole|mesh-list
101878139|NCT03767296|Autonomic Agents|autonomic agents|mesh-ancestor
102169323|NCT02134405|Rebamipide|rebamipide|mesh-list
102169324|NCT02134405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102169325|NCT02134405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102169326|NCT02134405|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102169327|NCT02134405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102169328|NCT02134405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169329|NCT02134405|Antioxidants|antioxidants|mesh-ancestor
102169330|NCT02134405|Protective Agents|protective agents|mesh-ancestor
102169331|NCT02134405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169332|NCT03574415|Fexuprazan|fexuprazan|mesh-list
102169333|NCT03574415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102169334|NCT02456025|Tacrolimus|tacrolimus|mesh-list
102169335|NCT02456025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102169336|NCT02456025|Immunologic Factors|immunologic factors|mesh-ancestor
102169337|NCT02456025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169338|NCT02456025|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102169339|NCT02456025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102169340|NCT02456025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169341|NCT02134483|Parathyroid Hormone|parathyroid hormone|mesh-list
102169342|NCT02134483|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102169343|NCT02134483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169344|NCT02136511|Rituximab|rituximab|mesh-list
102169345|NCT02136511|Idelalisib|idelalisib|mesh-list
102169346|NCT02136511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102169347|NCT02136511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102169348|NCT02136511|Immunologic Factors|immunologic factors|mesh-ancestor
102169349|NCT02136511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169350|NCT02136511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102169351|NCT02136511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102169352|NCT02136511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169353|NCT02136589|Diclofenac|diclofenac|mesh-list
102169354|NCT02136589|Travoprost|travoprost|mesh-list
102169355|NCT02136589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102169356|NCT02136589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102169357|NCT02136589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102169358|NCT02136589|Analgesics|analgesics|mesh-ancestor
102169359|NCT02136589|Sensory System Agents|sensory system agents|mesh-ancestor
102169360|NCT02136589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102169361|NCT02136589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169362|NCT02136589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102169363|NCT02136589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102169364|NCT02136589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102169365|NCT02136589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102169366|NCT02136589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169367|NCT02134639|Edotreotide|edotreotide|mesh-list
102169368|NCT02134639|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102169369|NCT02134639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169370|NCT02129101|Azacitidine|azacitidine|mesh-list
102169371|NCT02129101|Decitabine|decitabine|mesh-list
102169372|NCT02129101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102169373|NCT02129101|Antimetabolites|antimetabolites|mesh-ancestor
102169374|NCT02129101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169375|NCT02129101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102169376|NCT02129101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102169377|NCT02134717|Maraviroc|maraviroc|mesh-list
102169378|NCT02134717|Dimercaprol|dimercaprol|mesh-list
102169379|NCT02134717|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102169380|NCT02134717|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102169381|NCT02134717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169382|NCT02134717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102169383|NCT02134717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102169384|NCT02134717|Antiviral Agents|antiviral agents|mesh-ancestor
102169385|NCT02134717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102169386|NCT02134717|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102169387|NCT02134717|Chelating Agents|chelating agents|mesh-ancestor
102169388|NCT02134717|Sequestering Agents|sequestering agents|mesh-ancestor
102169389|NCT03245385|Halobetasol|halobetasol|mesh-list
102169390|NCT03245385|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102169391|NCT02136823|Isradipine|isradipine|mesh-list
102169392|NCT02136823|Riluzole|riluzole|mesh-list
102169393|NCT02136823|Memantine|memantine|mesh-list
102169394|NCT02136823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102169395|NCT02136823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102169396|NCT02136823|Dopamine Agents|dopamine agents|mesh-ancestor
102169397|NCT02136823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102169398|NCT02136823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169399|NCT02136823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169400|NCT02136823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101878223|NCT01446016|Taxane|taxane|mesh-list
102169401|NCT02136823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102169402|NCT02136823|Anticonvulsants|anticonvulsants|mesh-ancestor
102169403|NCT02136823|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102169404|NCT02136823|Protective Agents|protective agents|mesh-ancestor
102169405|NCT02136823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102169406|NCT02136823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102169407|NCT02136823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102169408|NCT02136823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102169409|NCT02136823|Vasodilator Agents|vasodilator agents|mesh-ancestor
102169410|NCT03250143|Cyclosporine|cyclosporine|mesh-list
102169411|NCT03250143|Azathioprine|azathioprine|mesh-list
102169412|NCT03250143|Cyclosporins|cyclosporins|mesh-list
102169413|NCT03250143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102169414|NCT03250143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169415|NCT03250143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102169416|NCT03250143|Immunologic Factors|immunologic factors|mesh-ancestor
102169417|NCT03250143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169418|NCT03250143|Antifungal Agents|antifungal agents|mesh-ancestor
102169419|NCT03250143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102169420|NCT03250143|Dermatologic Agents|dermatologic agents|mesh-ancestor
102169421|NCT03250143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102169422|NCT03250143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102169423|NCT03250143|Antimetabolites|antimetabolites|mesh-ancestor
102169424|NCT03250143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102169425|NCT03250143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102169426|NCT03073850|Anticoagulants|anticoagulants|mesh-list
102169427|NCT03073850|Edoxaban|edoxaban|mesh-list
102169428|NCT03073850|Clopidogrel|clopidogrel|mesh-list
102169429|NCT03073850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169430|NCT03073850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446779|NCT00181727|GABA Agents|gaba agents|mesh-ancestor
102169431|NCT03073850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102169432|NCT03073850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102169433|NCT03073850|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102169434|NCT03073850|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102169435|NCT03073850|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102169436|NCT03073850|Purinergic Agents|purinergic agents|mesh-ancestor
102169437|NCT03073850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102169438|NCT03073850|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102169439|NCT03073850|Antithrombins|antithrombins|mesh-ancestor
102169440|NCT03073850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102169441|NCT03073850|Protease Inhibitors|protease inhibitors|mesh-ancestor
102169442|NCT03257319|Morphine|morphine|mesh-list
102169443|NCT03257319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102169444|NCT03257319|Narcotics|narcotics|mesh-ancestor
102169445|NCT03257319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102169446|NCT03257319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169447|NCT03257319|Analgesics|analgesics|mesh-ancestor
102169448|NCT03257319|Sensory System Agents|sensory system agents|mesh-ancestor
102169449|NCT03257319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102169450|NCT03070574|Aminosalicylic Acid|aminosalicylic acid|mesh-list
102169451|NCT03070574|Mesalamine|mesalamine|mesh-list
102169452|NCT03070574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102169453|NCT03070574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102169454|NCT03070574|Analgesics|analgesics|mesh-ancestor
102169455|NCT03070574|Sensory System Agents|sensory system agents|mesh-ancestor
102169456|NCT03070574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102169457|NCT03070574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169458|NCT03070574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102169460|NCT03070574|Antitubercular Agents|antitubercular agents|mesh-ancestor
102169461|NCT03070574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102169462|NCT03070574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102169463|NCT03257241|Cytarabine|cytarabine|mesh-list
102169464|NCT03257241|Fludarabine|fludarabine|mesh-list
102169465|NCT03257241|Daunorubicin|daunorubicin|mesh-list
102169466|NCT03257241|Mitoxantrone|mitoxantrone|mesh-list
102169467|NCT03257241|Idarubicin|idarubicin|mesh-list
102169468|NCT03257241|Cladribine|cladribine|mesh-list
102169469|NCT03257241|Lenograstim|lenograstim|mesh-list
102169470|NCT03257241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102169471|NCT03257241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102169472|NCT03257241|Antimetabolites|antimetabolites|mesh-ancestor
102169473|NCT03257241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169474|NCT03257241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102169475|NCT03257241|Immunologic Factors|immunologic factors|mesh-ancestor
102169476|NCT03257241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169477|NCT03257241|Antiviral Agents|antiviral agents|mesh-ancestor
102169478|NCT03257241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102169479|NCT03257241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102169480|NCT03257241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102169481|NCT03257241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102169482|NCT03257241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102169483|NCT03257241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102169485|NCT03257241|Sensory System Agents|sensory system agents|mesh-ancestor
102169486|NCT03257241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102169487|NCT02129179|Glucagon|glucagon|mesh-list
102169488|NCT02129179|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102169489|NCT02129179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102169490|NCT02129179|Hormones|hormones|mesh-ancestor
102169491|NCT02129179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102169492|NCT02129179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169493|NCT02129179|Incretins|incretins|mesh-ancestor
102169494|NCT02129257|Leucovorin|leucovorin|mesh-list
102169495|NCT02129257|Folic Acid|folic acid|mesh-list
102169496|NCT02129257|Fluorouracil|fluorouracil|mesh-list
102169497|NCT02129257|Irinotecan|irinotecan|mesh-list
102169498|NCT02129257|Aflibercept|aflibercept|mesh-list
102169499|NCT02129257|Levoleucovorin|levoleucovorin|mesh-list
102169500|NCT02129257|Antimetabolites|antimetabolites|mesh-ancestor
102169501|NCT02129257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169502|NCT02129257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102169503|NCT02129257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102169504|NCT02129257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102169505|NCT02129257|Immunologic Factors|immunologic factors|mesh-ancestor
101446785|NCT00181727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102169506|NCT02129257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169507|NCT02129257|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102169508|NCT02129257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102169509|NCT02129257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102169510|NCT02129257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102169511|NCT02129257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102169512|NCT02129257|Growth Substances|growth substances|mesh-ancestor
102169513|NCT02129257|Growth Inhibitors|growth inhibitors|mesh-ancestor
102169514|NCT02129257|Antidotes|antidotes|mesh-ancestor
102169515|NCT02129257|Protective Agents|protective agents|mesh-ancestor
102169516|NCT02129257|Vitamin B Complex|vitamin b complex|mesh-ancestor
102169517|NCT02129257|Vitamins|vitamins|mesh-ancestor
102169518|NCT02129257|Micronutrients|micronutrients|mesh-ancestor
102169519|NCT02129257|Hematinics|hematinics|mesh-ancestor
102169520|NCT03245307|Apatinib|apatinib|mesh-list
102169521|NCT03245307|Nifedipine|nifedipine|mesh-list
102169522|NCT03245307|Warfarin|warfarin|mesh-list
102169523|NCT03245307|Anticoagulants|anticoagulants|mesh-ancestor
102169524|NCT03245307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102169525|NCT03245307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102169526|NCT03245307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102169527|NCT03245307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169528|NCT03245307|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102169529|NCT03245307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102169530|NCT03245307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102169531|NCT03245307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169532|NCT03245307|Vasodilator Agents|vasodilator agents|mesh-ancestor
102169533|NCT03245307|Tocolytic Agents|tocolytic agents|mesh-ancestor
102169535|NCT02136979|Propofol|propofol|mesh-list
102169536|NCT02136979|Sevoflurane|sevoflurane|mesh-list
102169537|NCT02136979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102169538|NCT02136979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102169539|NCT02136979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169540|NCT02136979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102169541|NCT02136979|Anesthetics, General|anesthetics, general|mesh-ancestor
102169542|NCT02136979|Anesthetics|anesthetics|mesh-ancestor
102169543|NCT02136979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102169544|NCT02136979|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102169545|NCT02455011|Volagidemab|volagidemab|mesh-list
102169546|NCT02455011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102169547|NCT02455011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169548|NCT03249285|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102169549|NCT03249285|Perindopril|perindopril|mesh-list
102169550|NCT03249285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102169551|NCT03249285|Diuretics|diuretics|mesh-ancestor
102169552|NCT03249285|Natriuretic Agents|natriuretic agents|mesh-ancestor
102169553|NCT03249285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878374|NCT00105066|Metformin|metformin|mesh-list
102169554|NCT03249285|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102169555|NCT03249285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102169556|NCT03249285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169557|NCT03249285|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102169558|NCT03249285|Protease Inhibitors|protease inhibitors|mesh-ancestor
102169559|NCT03249285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102169561|NCT03249519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102169562|NCT04983524|Propolis|propolis|mesh-list
102169563|NCT04983524|Calcium|calcium|mesh-list
102169564|NCT04983524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102169565|NCT04983524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169566|NCT04983524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102169567|NCT03576911|Ubiquinone|ubiquinone|mesh-list
102169568|NCT03576911|Coenzyme Q10|coenzyme q10|mesh-list
102169569|NCT03576911|Micronutrients|micronutrients|mesh-ancestor
102169570|NCT03576911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169571|NCT03576911|Vitamins|vitamins|mesh-ancestor
102169572|NCT02634320|Aripiprazole|aripiprazole|mesh-list
102169573|NCT02634320|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
102169574|NCT02634320|Antidepressive Agents|antidepressive agents|mesh-ancestor
102169575|NCT02634320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102169576|NCT02634320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102169577|NCT02634320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102169578|NCT02634320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102169579|NCT02634320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169580|NCT02634320|Dopamine Agonists|dopamine agonists|mesh-ancestor
102169581|NCT02634320|Dopamine Agents|dopamine agents|mesh-ancestor
102169582|NCT02634320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102169583|NCT02634320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169584|NCT02634320|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102169585|NCT02634320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102169586|NCT02634320|Serotonin Agents|serotonin agents|mesh-ancestor
102169587|NCT02634320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102169588|NCT02634320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102169589|NCT02634320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102169590|NCT02634320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102169591|NCT02435680|Carboplatin|carboplatin|mesh-list
102169592|NCT02435680|Gemcitabine|gemcitabine|mesh-list
102169593|NCT02435680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102169594|NCT02435680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102169595|NCT02435680|Antimetabolites|antimetabolites|mesh-ancestor
102169596|NCT02435680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169597|NCT04988048|Vaccines|vaccines|mesh-list
102169598|NCT04988048|Immunologic Factors|immunologic factors|mesh-ancestor
102169599|NCT04988048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169600|NCT04982900|Aflutinib|aflutinib|mesh-list
102169601|NCT04982900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102169602|NCT04982900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102169603|NCT04982900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169604|NCT03256071|Decitabine|decitabine|mesh-list
102169605|NCT03256071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102169606|NCT03256071|Antimetabolites|antimetabolites|mesh-ancestor
102169607|NCT03256071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169608|NCT03256071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102169609|NCT03256071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102169611|NCT04912856|Anticonvulsants|anticonvulsants|mesh-ancestor
102169612|NCT04912856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102169613|NCT04912856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169614|NCT03248817|Phenylephrine|phenylephrine|mesh-list
102169615|NCT03248817|Oxymetazoline|oxymetazoline|mesh-list
102169616|NCT03248817|Bupivacaine|bupivacaine|mesh-list
102169617|NCT03248817|Anesthetics, Local|anesthetics, local|mesh-ancestor
102169618|NCT03248817|Anesthetics|anesthetics|mesh-ancestor
102169619|NCT03248817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102169620|NCT03248817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169621|NCT03248817|Sensory System Agents|sensory system agents|mesh-ancestor
102169622|NCT03248817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102169623|NCT03248817|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102169624|NCT03248817|Mydriatics|mydriatics|mesh-ancestor
102169625|NCT03248817|Autonomic Agents|autonomic agents|mesh-ancestor
102169626|NCT03248817|Sympathomimetics|sympathomimetics|mesh-ancestor
102169627|NCT03248817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102169628|NCT03248817|Nasal Decongestants|nasal decongestants|mesh-ancestor
102169629|NCT03248817|Respiratory System Agents|respiratory system agents|mesh-ancestor
101878451|NCT03965442|Esmolol|esmolol|mesh-list
102169630|NCT03248817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102169631|NCT03248817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102169632|NCT03248817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102169633|NCT03248817|Adrenergic Agents|adrenergic agents|mesh-ancestor
102169634|NCT03248817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102169635|NCT03248817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169636|NCT03248817|Protective Agents|protective agents|mesh-ancestor
102169637|NCT03647774|Naltrexone|naltrexone|mesh-list
102169638|NCT03647774|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102169639|NCT03647774|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102169640|NCT03647774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169641|NCT03647774|Sensory System Agents|sensory system agents|mesh-ancestor
102169642|NCT03647774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102169643|NCT03248973|Ampicillin|ampicillin|mesh-list
102169644|NCT03248973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102169645|NCT03248973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102169646|NCT02832531|Aspirin|aspirin|mesh-list
102169647|NCT02832531|Rivaroxaban|rivaroxaban|mesh-list
102169648|NCT02832531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102169649|NCT02832531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102169650|NCT02832531|Analgesics|analgesics|mesh-ancestor
102169651|NCT02832531|Sensory System Agents|sensory system agents|mesh-ancestor
102169652|NCT02832531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102169653|NCT02832531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169654|NCT02832531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102169655|NCT02832531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102169656|NCT02832531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102169657|NCT02832531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102169658|NCT02832531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169659|NCT02832531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102169660|NCT02832531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102169661|NCT02832531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102169662|NCT02832531|Antipyretics|antipyretics|mesh-ancestor
102169663|NCT02832531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102169664|NCT02832531|Antithrombins|antithrombins|mesh-ancestor
102169665|NCT02832531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102169666|NCT02832531|Protease Inhibitors|protease inhibitors|mesh-ancestor
102169667|NCT02832531|Anticoagulants|anticoagulants|mesh-ancestor
102169668|NCT03248427|Paclitaxel|paclitaxel|mesh-list
102169669|NCT03248427|Cyclophosphamide|cyclophosphamide|mesh-list
102169670|NCT03248427|Doxorubicin|doxorubicin|mesh-list
102169671|NCT03248427|Letrozole|letrozole|mesh-list
102169672|NCT03248427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102169673|NCT03248427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102169674|NCT03248427|Tubulin Modulators|tubulin modulators|mesh-ancestor
102169675|NCT03248427|Antimitotic Agents|antimitotic agents|mesh-ancestor
102169676|NCT03248427|Mitosis Modulators|mitosis modulators|mesh-ancestor
102169677|NCT03248427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169678|NCT03248427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102169679|NCT03248427|Immunologic Factors|immunologic factors|mesh-ancestor
102169680|NCT03248427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169681|NCT03248427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102169682|NCT03248427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102169683|NCT03248427|Alkylating Agents|alkylating agents|mesh-ancestor
101711432|NCT04138238|Sirolimus|sirolimus|mesh-list
102169684|NCT03248427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102169685|NCT03248427|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102169686|NCT03248427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102169687|NCT03248427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102169689|NCT03248427|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102169690|NCT03248427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102169691|NCT03248427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102169692|NCT03248427|Hormone Antagonists|hormone antagonists|mesh-ancestor
102169693|NCT03248427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102169694|NCT03248349|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102169695|NCT03248349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102169696|NCT03243903|Insulin|insulin|mesh-list
102169697|NCT03243903|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102169698|NCT03243903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102169699|NCT03243903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169700|NCT03576677|Simendan|simendan|mesh-list
102169701|NCT03576677|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102169702|NCT03576677|Vasodilator Agents|vasodilator agents|mesh-ancestor
102169703|NCT03576677|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102169704|NCT03576677|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102169705|NCT03576677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102169706|NCT03576677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169707|NCT03576677|Protective Agents|protective agents|mesh-ancestor
102169708|NCT03576677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169709|NCT03247257|Lidocaine|lidocaine|mesh-list
102169710|NCT03247257|Anesthetics|anesthetics|mesh-list
102169711|NCT03247257|Propofol|propofol|mesh-list
102169712|NCT03247257|Anesthetics, Local|anesthetics, local|mesh-ancestor
102169713|NCT03247257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102169714|NCT03247257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169715|NCT03247257|Sensory System Agents|sensory system agents|mesh-ancestor
102169716|NCT03247257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102169717|NCT03247257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102169718|NCT03247257|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102169719|NCT03247257|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102169720|NCT03247257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102169721|NCT03247257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169722|NCT03247257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102169723|NCT03247257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102169724|NCT03247257|Anesthetics, General|anesthetics, general|mesh-ancestor
102169725|NCT03576599|Zoledronic Acid|zoledronic acid|mesh-list
102169726|NCT03576599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102169727|NCT03576599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169728|NCT02239835|Ritonavir|ritonavir|mesh-list
102169729|NCT02239835|Saquinavir|saquinavir|mesh-list
102169730|NCT02239835|Tipranavir|tipranavir|mesh-list
102169731|NCT02239835|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102169732|NCT02239835|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102169733|NCT02239835|Protease Inhibitors|protease inhibitors|mesh-ancestor
102169734|NCT02239835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102169735|NCT02239835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169736|NCT02239835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102169737|NCT02239835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102169738|NCT02239835|Antiviral Agents|antiviral agents|mesh-ancestor
102169739|NCT02239835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102169740|NCT02239835|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102169741|NCT02239835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102169742|NCT02239913|Topiramate|topiramate|mesh-list
102169743|NCT02239913|Phentermine|phentermine|mesh-list
102169744|NCT02239913|Cocaine|cocaine|mesh-list
101446818|NCT00411372|Hormones|hormones|mesh-ancestor
102169745|NCT02239913|Anticonvulsants|anticonvulsants|mesh-ancestor
102169746|NCT02239913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102169747|NCT02239913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169748|NCT02239913|Anesthetics, Local|anesthetics, local|mesh-ancestor
102169749|NCT02239913|Anesthetics|anesthetics|mesh-ancestor
102169750|NCT02239913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102169751|NCT02239913|Sensory System Agents|sensory system agents|mesh-ancestor
102169752|NCT02239913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102169753|NCT02239913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102169754|NCT02239913|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102169755|NCT02239913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102169756|NCT02239913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102169757|NCT02239913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169758|NCT02239913|Dopamine Agents|dopamine agents|mesh-ancestor
102169759|NCT02239913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102169760|NCT02239913|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102169761|NCT02239913|Appetite Depressants|appetite depressants|mesh-ancestor
102169762|NCT02239913|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102169763|NCT02239913|Sympathomimetics|sympathomimetics|mesh-ancestor
102169764|NCT02239913|Autonomic Agents|autonomic agents|mesh-ancestor
102169765|NCT02239913|Adrenergic Agents|adrenergic agents|mesh-ancestor
102169767|NCT03576287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102169768|NCT03576287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102169769|NCT03576287|Analgesics|analgesics|mesh-ancestor
102169770|NCT03576287|Sensory System Agents|sensory system agents|mesh-ancestor
102169771|NCT03576287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102169772|NCT03576287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169773|NCT03576287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102169774|NCT03576287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102169775|NCT03576287|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102169776|NCT03576287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102169777|NCT03576287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102169778|NCT03576287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169779|NCT02455869|Alendronate|alendronate|mesh-list
102169780|NCT02455869|Atorvastatin|atorvastatin|mesh-list
102169781|NCT02455869|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102169782|NCT02455869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102169783|NCT02455869|Antimetabolites|antimetabolites|mesh-ancestor
102169784|NCT02455869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169785|NCT02455869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102169786|NCT02455869|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102169787|NCT02455869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102169788|NCT02455869|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102169789|NCT02455869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169790|NCT03246555|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102169791|NCT03246555|Perindopril|perindopril|mesh-list
102169792|NCT03246555|Indapamide|indapamide|mesh-list
102169793|NCT03246555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102169794|NCT03246555|Diuretics|diuretics|mesh-ancestor
102169795|NCT03246555|Natriuretic Agents|natriuretic agents|mesh-ancestor
102169796|NCT03246555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169797|NCT03246555|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102169798|NCT03246555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102169799|NCT03246555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169800|NCT03246555|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102169801|NCT03246555|Protease Inhibitors|protease inhibitors|mesh-ancestor
102169802|NCT03246555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102169803|NCT03576053|Lidocaine|lidocaine|mesh-list
102169804|NCT03576053|Serotonin|serotonin|mesh-list
102169805|NCT03576053|Histamine|histamine|mesh-list
102169806|NCT03576053|Anesthetics, Local|anesthetics, local|mesh-ancestor
102169807|NCT03576053|Anesthetics|anesthetics|mesh-ancestor
102169808|NCT03576053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102169809|NCT03576053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169810|NCT03576053|Sensory System Agents|sensory system agents|mesh-ancestor
102169811|NCT03576053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102169812|NCT03576053|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102169813|NCT03576053|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102169814|NCT03576053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102169815|NCT03576053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102169816|NCT03576053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169817|NCT03576053|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102169818|NCT03576053|Serotonin Agents|serotonin agents|mesh-ancestor
102169819|NCT03576053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102169820|NCT03576053|Histamine Agonists|histamine agonists|mesh-ancestor
102169821|NCT03576053|Histamine Agents|histamine agents|mesh-ancestor
102169822|NCT03242967|Darbepoetin alfa|darbepoetin alfa|mesh-list
102169823|NCT03242967|Hematinics|hematinics|mesh-ancestor
102169824|NCT03239457|Mitogens|mitogens|mesh-list
102169825|NCT03239457|Mitosis Modulators|mitosis modulators|mesh-ancestor
102169826|NCT03239457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169827|NCT00075803|Fluconazole|fluconazole|mesh-list
102169828|NCT00075803|Voriconazole|voriconazole|mesh-list
102169829|NCT00075803|Antifungal Agents|antifungal agents|mesh-ancestor
102169830|NCT00075803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102169831|NCT00075803|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101711606|NCT00500539|Omalizumab|omalizumab|mesh-list
102169832|NCT00075803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102169833|NCT00075803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102169834|NCT00075803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169835|NCT00075803|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102169836|NCT00075803|Hormone Antagonists|hormone antagonists|mesh-ancestor
102169837|NCT00075803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102169838|NCT00075803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169839|NCT00075803|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102169840|NCT00075803|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102169841|NCT00075803|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102169842|NCT03242499|Lovastatin|lovastatin|mesh-list
102169843|NCT03242499|L 647318|l 647318|mesh-list
102169844|NCT03242499|Dihydromevinolin|dihydromevinolin|mesh-list
102169845|NCT03242499|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102169846|NCT03242499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102169847|NCT03242499|Antimetabolites|antimetabolites|mesh-ancestor
102169848|NCT03242499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169849|NCT03242499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102169850|NCT03242499|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102169851|NCT03242499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102169852|NCT02523911|Magnesium Sulfate|magnesium sulfate|mesh-list
102169853|NCT02523911|Simethicone|simethicone|mesh-list
102169854|NCT02523911|Sodium sulfate|sodium sulfate|mesh-list
102169855|NCT02523911|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102169856|NCT02523911|Analgesics|analgesics|mesh-ancestor
102169857|NCT02523911|Sensory System Agents|sensory system agents|mesh-ancestor
102169858|NCT02523911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102169859|NCT02523911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169860|NCT02523911|Anesthetics|anesthetics|mesh-ancestor
102169861|NCT02523911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102169862|NCT02523911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102169863|NCT02523911|Anticonvulsants|anticonvulsants|mesh-ancestor
102169864|NCT02523911|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102169865|NCT02523911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102169866|NCT02523911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169867|NCT02523911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102169868|NCT02523911|Tocolytic Agents|tocolytic agents|mesh-ancestor
102169869|NCT02523911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102169870|NCT02523911|Antifoaming Agents|antifoaming agents|mesh-ancestor
102169871|NCT02523911|Emollients|emollients|mesh-ancestor
102169872|NCT02523911|Dermatologic Agents|dermatologic agents|mesh-ancestor
102169873|NCT02523911|Cathartics|cathartics|mesh-ancestor
102169874|NCT02523911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102169875|NCT03572231|Solifenacin Succinate|solifenacin succinate|mesh-list
102169876|NCT03572231|Mirabegron|mirabegron|mesh-list
102169877|NCT03572231|Tolterodine Tartrate|tolterodine tartrate|mesh-list
102169878|NCT03572231|Fesoterodine|fesoterodine|mesh-list
102169879|NCT03572231|Oxybutynin|oxybutynin|mesh-list
102169880|NCT03572231|Darifenacin|darifenacin|mesh-list
102169881|NCT03572231|Propiverine|propiverine|mesh-list
102169882|NCT03572231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102169883|NCT03572231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102169884|NCT03572231|Cholinergic Agents|cholinergic agents|mesh-ancestor
102169885|NCT03572231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102169886|NCT03572231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169887|NCT03572231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169888|NCT03572231|Urological Agents|urological agents|mesh-ancestor
102169889|NCT03572231|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102169890|NCT03572231|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102169891|NCT03572231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102169892|NCT03572231|Adrenergic Agents|adrenergic agents|mesh-ancestor
102169893|NCT03572231|Parasympatholytics|parasympatholytics|mesh-ancestor
102169894|NCT03572231|Autonomic Agents|autonomic agents|mesh-ancestor
102169895|NCT03572231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102169896|NCT02135029|Atorvastatin|atorvastatin|mesh-list
102169897|NCT02135029|Bococizumab|bococizumab|mesh-list
102169898|NCT02135029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102169899|NCT02135029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102169900|NCT02135029|Antimetabolites|antimetabolites|mesh-ancestor
102169901|NCT02135029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169902|NCT02135029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102169903|NCT02135029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101899938|NCT01269788|Fluoxetine|fluoxetine|mesh-list
102169904|NCT02135029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102169905|NCT03573245|Tranexamic Acid|tranexamic acid|mesh-list
102169906|NCT03573245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102169907|NCT03573245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102169908|NCT03573245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169909|NCT03573245|Hemostatics|hemostatics|mesh-ancestor
102169910|NCT03573245|Coagulants|coagulants|mesh-ancestor
102169911|NCT02241161|Bacteriocins|bacteriocins|mesh-list
102169912|NCT02241161|Antioxidants|antioxidants|mesh-list
102169913|NCT02241161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169914|NCT02241161|Protective Agents|protective agents|mesh-ancestor
102169915|NCT02241161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169916|NCT02241161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102169917|NCT02241161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102169918|NCT02135263|Enalapril|enalapril|mesh-list
102169919|NCT02135263|Methylphenidate|methylphenidate|mesh-list
102169920|NCT02135263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102169921|NCT02135263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169922|NCT02135263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102169923|NCT02135263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102169924|NCT02135263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102169925|NCT02135263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169926|NCT02135263|Dopamine Agents|dopamine agents|mesh-ancestor
102169927|NCT02135263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102169928|NCT02135263|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101878741|NCT03966378|Antioxidants|antioxidants|mesh-ancestor
102169929|NCT02135263|Protease Inhibitors|protease inhibitors|mesh-ancestor
102169930|NCT02135263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102169931|NCT02135263|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102169932|NCT02135341|Botulinum Toxins|botulinum toxins|mesh-list
102169933|NCT02135341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102169934|NCT02135341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102169935|NCT02135341|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102169936|NCT02135341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102169937|NCT02135341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102169938|NCT02135341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169939|NCT02135341|Cholinergic Agents|cholinergic agents|mesh-ancestor
102169940|NCT02135341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102169941|NCT02135341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169942|NCT02135341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102169943|NCT02135341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102169944|NCT02239523|Denosumab|denosumab|mesh-list
102169945|NCT02239523|Teriparatide|teriparatide|mesh-list
102169946|NCT02239523|Diphosphonates|diphosphonates|mesh-list
102169947|NCT02239523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102169948|NCT02239523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169949|NCT02239523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102169950|NCT02137213|Naloxone|naloxone|mesh-list
102169951|NCT02137213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102169952|NCT02137213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169953|NCT02137213|Sensory System Agents|sensory system agents|mesh-ancestor
102169954|NCT02137213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102169955|NCT03571919|Lidocaine|lidocaine|mesh-list
102169956|NCT03571919|Anesthetics, Local|anesthetics, local|mesh-ancestor
102169957|NCT03571919|Anesthetics|anesthetics|mesh-ancestor
102169958|NCT03571919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102169959|NCT03571919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169960|NCT03571919|Sensory System Agents|sensory system agents|mesh-ancestor
102169961|NCT03571919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102169962|NCT03571919|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102169963|NCT03571919|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102169964|NCT03571919|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102169965|NCT03571919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102169966|NCT03571919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102169967|NCT02252809|Methylprednisolone|methylprednisolone|mesh-list
102169968|NCT02252809|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102169969|NCT02252809|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102169970|NCT02252809|Prednisolone|prednisolone|mesh-list
102169971|NCT02252809|Prednisolone acetate|prednisolone acetate|mesh-list
102169972|NCT02252809|Adalimumab|adalimumab|mesh-list
102169973|NCT02252809|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102169974|NCT02252809|Prednisolone phosphate|prednisolone phosphate|mesh-list
102169975|NCT02252809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102169976|NCT02252809|Antiemetics|antiemetics|mesh-ancestor
102169977|NCT02252809|Autonomic Agents|autonomic agents|mesh-ancestor
102169978|NCT02252809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102169979|NCT02252809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169980|NCT02252809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102169981|NCT02252809|Glucocorticoids|glucocorticoids|mesh-ancestor
102169982|NCT02252809|Hormones|hormones|mesh-ancestor
102169983|NCT02252809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102169984|NCT02252809|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102169985|NCT02252809|Protective Agents|protective agents|mesh-ancestor
102169986|NCT02252809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102169987|NCT02252809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102169988|NCT02252809|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102169989|NCT02252809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102169990|NCT02137525|Fentanyl|fentanyl|mesh-list
102169991|NCT02137525|Morphine|morphine|mesh-list
102169992|NCT02137525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102169993|NCT02137525|Narcotics|narcotics|mesh-ancestor
102169994|NCT02137525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102169995|NCT02137525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102169996|NCT02137525|Analgesics|analgesics|mesh-ancestor
102169997|NCT02137525|Sensory System Agents|sensory system agents|mesh-ancestor
102169998|NCT02137525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102169999|NCT02137525|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102170000|NCT02137525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102170001|NCT02137525|Anesthetics, General|anesthetics, general|mesh-ancestor
102170002|NCT02137525|Anesthetics|anesthetics|mesh-ancestor
102170003|NCT02137681|Rituximab|rituximab|mesh-list
102170004|NCT02137681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102170005|NCT02137681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102170006|NCT02137681|Immunologic Factors|immunologic factors|mesh-ancestor
102170007|NCT02137681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170008|NCT02137681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102170009|NCT02842073|Naltrexone|naltrexone|mesh-list
102170010|NCT02842073|Bupropion|bupropion|mesh-list
102170011|NCT02842073|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102170012|NCT02842073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102170013|NCT02842073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170014|NCT02842073|Sensory System Agents|sensory system agents|mesh-ancestor
102170015|NCT02842073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102170016|NCT02842073|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102170017|NCT02842073|Antidepressive Agents|antidepressive agents|mesh-ancestor
102170018|NCT02842073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102170019|NCT02842073|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102170020|NCT02842073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102170021|NCT02842073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102170022|NCT02842073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170023|NCT02842073|Dopamine Agents|dopamine agents|mesh-ancestor
102170024|NCT02842073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102170025|NCT02842073|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102170026|NCT02842073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102170027|NCT02842073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102170028|NCT02135887|Leucovorin|leucovorin|mesh-list
102170029|NCT02135887|Folic Acid|folic acid|mesh-list
102170030|NCT02135887|Fluorouracil|fluorouracil|mesh-list
102170031|NCT02135887|Oxaliplatin|oxaliplatin|mesh-list
102170032|NCT02135887|Levoleucovorin|levoleucovorin|mesh-list
102170033|NCT02135887|Antimetabolites|antimetabolites|mesh-ancestor
102170034|NCT02135887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170035|NCT02135887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102170036|NCT02135887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102170037|NCT02135887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102170038|NCT02135887|Immunologic Factors|immunologic factors|mesh-ancestor
102170039|NCT02135887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170040|NCT02135887|Antidotes|antidotes|mesh-ancestor
102170041|NCT02135887|Protective Agents|protective agents|mesh-ancestor
102170042|NCT02135887|Vitamin B Complex|vitamin b complex|mesh-ancestor
102170043|NCT02135887|Vitamins|vitamins|mesh-ancestor
102170044|NCT02135887|Micronutrients|micronutrients|mesh-ancestor
102170045|NCT02135887|Hematinics|hematinics|mesh-ancestor
102170046|NCT02137993|Olanzapine|olanzapine|mesh-list
102170047|NCT02137993|Antiemetics|antiemetics|mesh-ancestor
102170048|NCT02137993|Autonomic Agents|autonomic agents|mesh-ancestor
102170049|NCT02137993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102170050|NCT02137993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170051|NCT02137993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102170052|NCT02137993|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102170053|NCT02137993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102170054|NCT02137993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102170055|NCT02137993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102170056|NCT02137993|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102170057|NCT02137993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102170058|NCT02137993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102170059|NCT02137993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170060|NCT02137993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102170061|NCT02137993|Serotonin Agents|serotonin agents|mesh-ancestor
102170062|NCT05579119|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102170063|NCT05579119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102170064|NCT05579119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170065|NCT05579119|Incretins|incretins|mesh-ancestor
102170067|NCT05579119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102170068|NCT05579119|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102170069|NCT05579119|Protease Inhibitors|protease inhibitors|mesh-ancestor
102170070|NCT05579119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102170071|NCT05579119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170072|NCT02245841|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102170073|NCT02245841|Hormones|hormones|mesh-ancestor
102170074|NCT02245841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102170075|NCT02245841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170076|NCT05709041|Anesthetics|anesthetics|mesh-list
102170077|NCT05709041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102170078|NCT05709041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878892|NCT00131352|Hylan|hylan|mesh-list
102170079|NCT02784535|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102170080|NCT02784535|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102170081|NCT02784535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102170082|NCT02784535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102170083|NCT02784535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170084|NCT02784535|Adrenergic Agents|adrenergic agents|mesh-ancestor
102170085|NCT02784535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102170086|NCT02784535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170087|NCT03570281|Enoxaparin|enoxaparin|mesh-list
102170088|NCT03570281|Edoxaban|edoxaban|mesh-list
102170089|NCT03570281|Anticoagulants|anticoagulants|mesh-ancestor
102170090|NCT03570281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102170091|NCT03570281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102170092|NCT03570281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170093|NCT03570281|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102170094|NCT03570281|Antithrombins|antithrombins|mesh-ancestor
102170095|NCT03570281|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102170096|NCT03570281|Protease Inhibitors|protease inhibitors|mesh-ancestor
102170097|NCT03570281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102170098|NCT02242799|Artesunate|artesunate|mesh-list
102170099|NCT02242799|Lumefantrine|lumefantrine|mesh-list
102170100|NCT02242799|Artemether|artemether|mesh-list
102170101|NCT02242799|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102170102|NCT02242799|Amodiaquine|amodiaquine|mesh-list
102170103|NCT02242799|Dolutegravir|dolutegravir|mesh-list
102170104|NCT02242799|Antimalarials|antimalarials|mesh-ancestor
102170105|NCT02242799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102170106|NCT02242799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102170107|NCT02242799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102170108|NCT02242799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102170109|NCT02242799|Antiviral Agents|antiviral agents|mesh-ancestor
102170110|NCT02242799|Schistosomicides|schistosomicides|mesh-ancestor
102170111|NCT02242799|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102170112|NCT02242799|Anthelmintics|anthelmintics|mesh-ancestor
102170113|NCT02242799|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102170114|NCT02242799|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102170115|NCT02242799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102170116|NCT02242799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170117|NCT02242799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102170118|NCT02242799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102170119|NCT02138383|Paclitaxel|paclitaxel|mesh-list
102170120|NCT02138383|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102170121|NCT02138383|Gemcitabine|gemcitabine|mesh-list
102170122|NCT02138383|Androgens|androgens|mesh-list
102170123|NCT02138383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102170124|NCT02138383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102170125|NCT02138383|Tubulin Modulators|tubulin modulators|mesh-ancestor
101711881|NCT00688298|Imidacloprid|imidacloprid|mesh-list
102170127|NCT02138383|Mitosis Modulators|mitosis modulators|mesh-ancestor
102170128|NCT02138383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170129|NCT02138383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102170130|NCT02138383|Antimetabolites|antimetabolites|mesh-ancestor
102170131|NCT02138383|Hormones|hormones|mesh-ancestor
102170132|NCT02138383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102170133|NCT02138383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170134|NCT02243735|Ferrous fumarate|ferrous fumarate|mesh-list
102170135|NCT02243735|Trace Elements|trace elements|mesh-ancestor
102170136|NCT02243735|Micronutrients|micronutrients|mesh-ancestor
102170137|NCT02243735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170138|NCT02138539|Hydroquinone|hydroquinone|mesh-list
102170139|NCT02138539|Antioxidants|antioxidants|mesh-ancestor
102170140|NCT02138539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170141|NCT02138539|Protective Agents|protective agents|mesh-ancestor
102170142|NCT02138539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170143|NCT02138539|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102170144|NCT02252419|Acetaminophen|acetaminophen|mesh-list
102170145|NCT02252419|Dexamethasone|dexamethasone|mesh-list
102170146|NCT02252419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102170147|NCT02252419|Antiemetics|antiemetics|mesh-ancestor
102170148|NCT02252419|Autonomic Agents|autonomic agents|mesh-ancestor
102170149|NCT02252419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102170150|NCT02252419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170151|NCT02252419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102170152|NCT02252419|Glucocorticoids|glucocorticoids|mesh-ancestor
102170153|NCT02252419|Hormones|hormones|mesh-ancestor
102170154|NCT02252419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102170155|NCT02252419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102170156|NCT02252419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102170157|NCT02252419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102170158|NCT02252419|Analgesics|analgesics|mesh-ancestor
102170159|NCT02252419|Sensory System Agents|sensory system agents|mesh-ancestor
102170160|NCT02252419|Antipyretics|antipyretics|mesh-ancestor
102170161|NCT02252497|Tranexamic Acid|tranexamic acid|mesh-list
102170162|NCT02252497|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102170163|NCT02252497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102170164|NCT02252497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170165|NCT02252497|Hemostatics|hemostatics|mesh-ancestor
102170166|NCT02252497|Coagulants|coagulants|mesh-ancestor
102170167|NCT02138773|Tamsulosin|tamsulosin|mesh-list
102170168|NCT02138773|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102170169|NCT02138773|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102170170|NCT02138773|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102170171|NCT02138773|Adrenergic Agents|adrenergic agents|mesh-ancestor
102170172|NCT02138773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102170173|NCT02138773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170174|NCT02138773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170175|NCT02138773|Urological Agents|urological agents|mesh-ancestor
102170176|NCT01367275|Irinotecan|irinotecan|mesh-list
102170177|NCT01367275|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102170178|NCT01367275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102170179|NCT01367275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102170180|NCT01367275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170181|NCT01367275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102170182|NCT02138929|Everolimus|everolimus|mesh-list
102170183|NCT02138929|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102170184|NCT02138929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102170185|NCT02138929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102170186|NCT02138929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170187|NCT02138929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102170188|NCT02138929|Immunologic Factors|immunologic factors|mesh-ancestor
102170189|NCT02138929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170190|NCT02138929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102170191|NCT02253199|Dexmedetomidine|dexmedetomidine|mesh-list
102170192|NCT02253199|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102170193|NCT02253199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102170194|NCT02253199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170195|NCT02253199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102170196|NCT02253199|Analgesics|analgesics|mesh-ancestor
102170197|NCT02253199|Sensory System Agents|sensory system agents|mesh-ancestor
102170198|NCT02253199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101573978|NCT02199184|Immunoglobulins|immunoglobulins|mesh-list
102170199|NCT02253199|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102170200|NCT02253199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102170201|NCT02253199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102170202|NCT02253199|Adrenergic Agents|adrenergic agents|mesh-ancestor
102170203|NCT02253199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102170204|NCT02253199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170205|NCT02842853|Vaccines|vaccines|mesh-list
102170206|NCT02842853|Immunologic Factors|immunologic factors|mesh-ancestor
102170207|NCT02842853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170208|NCT02139241|Ramosetron|ramosetron|mesh-list
102170209|NCT02139241|Antiemetics|antiemetics|mesh-ancestor
102170210|NCT02139241|Autonomic Agents|autonomic agents|mesh-ancestor
102170211|NCT02139241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102170212|NCT02139241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170213|NCT02139241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102170214|NCT02139241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102170215|NCT02139241|Serotonin Agents|serotonin agents|mesh-ancestor
102170216|NCT02139241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102170217|NCT02139241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170218|NCT03569579|Memantine|memantine|mesh-list
102170219|NCT03569579|Donepezil|donepezil|mesh-list
102170220|NCT03569579|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102170221|NCT03569579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102170222|NCT03569579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170223|NCT03569579|Cholinergic Agents|cholinergic agents|mesh-ancestor
102170224|NCT03569579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102170225|NCT03569579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170226|NCT03569579|Nootropic Agents|nootropic agents|mesh-ancestor
102170227|NCT03569579|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102170228|NCT03569579|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102170229|NCT03569579|Dopamine Agents|dopamine agents|mesh-ancestor
102170230|NCT03569579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102170231|NCT03569579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102170232|NCT02130661|Itraconazole|itraconazole|mesh-list
102170233|NCT02130661|Antifungal Agents|antifungal agents|mesh-ancestor
102170234|NCT02130661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102170235|NCT02130661|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102170236|NCT02130661|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102170237|NCT02130661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102170238|NCT02130661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170239|NCT02130661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102170240|NCT02130661|Hormone Antagonists|hormone antagonists|mesh-ancestor
102170241|NCT02130661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102170242|NCT02130661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170243|NCT02130661|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102170244|NCT02130739|Fentanyl|fentanyl|mesh-list
102170245|NCT02130739|Propofol|propofol|mesh-list
102170246|NCT02130739|Ropivacaine|ropivacaine|mesh-list
102170247|NCT02130739|Anesthetics|anesthetics|mesh-ancestor
102170248|NCT02130739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102170249|NCT02130739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170250|NCT02130739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102170251|NCT02130739|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102170252|NCT02130739|Anesthetics, General|anesthetics, general|mesh-ancestor
102170253|NCT02130739|Anesthetics, Local|anesthetics, local|mesh-ancestor
102170254|NCT02130739|Sensory System Agents|sensory system agents|mesh-ancestor
102170255|NCT02130739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102170256|NCT02130739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102170257|NCT02130739|Narcotics|narcotics|mesh-ancestor
102170258|NCT02130739|Analgesics|analgesics|mesh-ancestor
102170259|NCT02130739|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102170260|NCT02248493|Acetaminophen|acetaminophen|mesh-list
102170261|NCT02248493|Ketoprofen|ketoprofen|mesh-list
102170262|NCT02248493|Morphine|morphine|mesh-list
102170263|NCT02248493|Tramadol|tramadol|mesh-list
102170264|NCT02248493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102170265|NCT02248493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102170266|NCT02248493|Narcotics|narcotics|mesh-ancestor
102170267|NCT02248493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102170268|NCT02248493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170269|NCT02248493|Analgesics|analgesics|mesh-ancestor
102170270|NCT02248493|Sensory System Agents|sensory system agents|mesh-ancestor
102170271|NCT02248493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102170272|NCT02248493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102170273|NCT02248493|Antipyretics|antipyretics|mesh-ancestor
102170274|NCT02248493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102170275|NCT02248493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102170276|NCT02248493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102170277|NCT02248493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102170278|NCT02248493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102170279|NCT02248493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170280|NCT05577871|Dexmedetomidine|dexmedetomidine|mesh-list
102170281|NCT05577871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102170282|NCT05577871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102170283|NCT05577871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170284|NCT05577871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102170285|NCT05577871|Analgesics|analgesics|mesh-ancestor
102170286|NCT05577871|Sensory System Agents|sensory system agents|mesh-ancestor
102170287|NCT05577871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102170288|NCT05577871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102170289|NCT05577871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102170290|NCT05577871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102170291|NCT05577871|Adrenergic Agents|adrenergic agents|mesh-ancestor
102170292|NCT05577871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101879118|NCT03963648|Antioxidants|antioxidants|mesh-ancestor
102170293|NCT05577871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170294|NCT03140423|Mupirocin|mupirocin|mesh-list
102170295|NCT03140423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102170296|NCT03140423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102170297|NCT03140423|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102170298|NCT03140423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102170299|NCT03140423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170300|NCT02130817|Mycophenolic Acid|mycophenolic acid|mesh-list
102170301|NCT02130817|Dexamethasone|dexamethasone|mesh-list
102170302|NCT02130817|Prednisone|prednisone|mesh-list
102170303|NCT02130817|Abatacept|abatacept|mesh-list
102170304|NCT02130817|Tacrolimus|tacrolimus|mesh-list
102170305|NCT02130817|Thymoglobulin|thymoglobulin|mesh-list
102170306|NCT02130817|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102170307|NCT02130817|Immunoglobulins|immunoglobulins|mesh-list
102170308|NCT02130817|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102170309|NCT02130817|Immunoglobulin G|immunoglobulin g|mesh-list
102170310|NCT02130817|gamma-Globulins|gamma-globulins|mesh-list
102170311|NCT02130817|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102170312|NCT02130817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102170313|NCT02130817|Antiemetics|antiemetics|mesh-ancestor
102170314|NCT02130817|Autonomic Agents|autonomic agents|mesh-ancestor
102170315|NCT02130817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102170316|NCT02130817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170317|NCT02130817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102170318|NCT02130817|Glucocorticoids|glucocorticoids|mesh-ancestor
102170319|NCT02130817|Hormones|hormones|mesh-ancestor
102170320|NCT02130817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102170321|NCT02130817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102170322|NCT02130817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102170323|NCT02130817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102170324|NCT02130817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170325|NCT02130817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102170326|NCT02130817|Immunologic Factors|immunologic factors|mesh-ancestor
102170327|NCT02130817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102170328|NCT02130817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102170329|NCT02130817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102170330|NCT02130817|Antitubercular Agents|antitubercular agents|mesh-ancestor
102170331|NCT02130817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102170332|NCT02130817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102170333|NCT02130817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102170334|NCT02130817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102170335|NCT02130817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102170336|NCT02400346|Brexpiprazole|brexpiprazole|mesh-list
102170337|NCT02400346|Serotonin Agents|serotonin agents|mesh-ancestor
102170338|NCT02400346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102170339|NCT02400346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170340|NCT02400346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170341|NCT02400346|Dopamine Agonists|dopamine agonists|mesh-ancestor
102170342|NCT02400346|Dopamine Agents|dopamine agents|mesh-ancestor
102170343|NCT02130973|Denosumab|denosumab|mesh-list
102170344|NCT02130973|Teriparatide|teriparatide|mesh-list
102170345|NCT02130973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102170346|NCT02130973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573979|NCT02199184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102170347|NCT02130973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102170348|NCT02456662|Ondansetron|ondansetron|mesh-list
102170349|NCT02456662|Antiemetics|antiemetics|mesh-ancestor
102170350|NCT02456662|Autonomic Agents|autonomic agents|mesh-ancestor
102170351|NCT02456662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102170352|NCT02456662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170353|NCT02456662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102170354|NCT02456662|Antipruritics|antipruritics|mesh-ancestor
102170355|NCT02456662|Dermatologic Agents|dermatologic agents|mesh-ancestor
102170356|NCT02456662|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102170357|NCT02456662|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102170358|NCT02456662|Serotonin Agents|serotonin agents|mesh-ancestor
102170359|NCT02456662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102170360|NCT02456662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170361|NCT03548311|Vitamin B 12|vitamin b 12|mesh-list
102170362|NCT03548311|Vitamin B Complex|vitamin b complex|mesh-ancestor
102170363|NCT03548311|Vitamins|vitamins|mesh-ancestor
102170364|NCT03548311|Micronutrients|micronutrients|mesh-ancestor
102170365|NCT03548311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170366|NCT01653262|Brivaracetam|brivaracetam|mesh-list
102170367|NCT01653262|Anticonvulsants|anticonvulsants|mesh-ancestor
102170368|NCT02455336|Fenofibrate|fenofibrate|mesh-list
102170369|NCT02455336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102170370|NCT02455336|Antimetabolites|antimetabolites|mesh-ancestor
102170371|NCT02455336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170372|NCT02455336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102170373|NCT02253121|Insulin|insulin|mesh-list
102170374|NCT02253121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102170375|NCT02253121|Dapagliflozin|dapagliflozin|mesh-list
102170376|NCT02253121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102170377|NCT02253121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170378|NCT02253121|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102170379|NCT02253121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170380|NCT03548233|BCG Vaccine|bcg vaccine|mesh-list
102170381|NCT03548233|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102170382|NCT03548233|Immunologic Factors|immunologic factors|mesh-ancestor
102170383|NCT03548233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170384|NCT03568721|Acetaminophen|acetaminophen|mesh-list
102170385|NCT03568721|Ibuprofen|ibuprofen|mesh-list
102170386|NCT03568721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102170387|NCT03568721|Analgesics|analgesics|mesh-ancestor
102170388|NCT03568721|Sensory System Agents|sensory system agents|mesh-ancestor
102170389|NCT03568721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102170390|NCT03568721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170391|NCT03568721|Antipyretics|antipyretics|mesh-ancestor
102170392|NCT03568721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102170393|NCT03568721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102170394|NCT03568721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102170395|NCT03568721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102170396|NCT03568721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102170397|NCT03568721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170398|NCT05354375|Immunomodulating Agents|immunomodulating agents|mesh-list
102170399|NCT05354375|Immunologic Factors|immunologic factors|mesh-ancestor
102170400|NCT05354375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170401|NCT03566303|Vitamin K|vitamin k|mesh-list
102170402|NCT03566303|Warfarin|warfarin|mesh-list
102170403|NCT03566303|Rivaroxaban|rivaroxaban|mesh-list
102170404|NCT03566303|Vitamins|vitamins|mesh-ancestor
102170405|NCT03566303|Micronutrients|micronutrients|mesh-ancestor
102170406|NCT03566303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170407|NCT03566303|Anticoagulants|anticoagulants|mesh-ancestor
102170408|NCT03566303|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102170409|NCT03566303|Antithrombins|antithrombins|mesh-ancestor
102170410|NCT03566303|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102170411|NCT03566303|Protease Inhibitors|protease inhibitors|mesh-ancestor
102170412|NCT03566303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102170413|NCT03566303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170414|NCT03566303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102170415|NCT03566303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102170416|NCT03566303|Hemostatics|hemostatics|mesh-ancestor
102170417|NCT03566303|Coagulants|coagulants|mesh-ancestor
102170418|NCT02140333|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102170419|NCT02140333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102170420|NCT02140333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102170421|NCT02140333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102170422|NCT02140333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170423|NCT05936528|Lactoferrin|lactoferrin|mesh-list
102170424|NCT05936528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102170425|NCT05936216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
102170426|NCT05936216|Immunologic Factors|immunologic factors|mesh-ancestor
102170427|NCT05936216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170428|NCT05936190|Lidocaine|lidocaine|mesh-list
102170429|NCT05936190|Anesthetics, Local|anesthetics, local|mesh-ancestor
102170430|NCT05936190|Anesthetics|anesthetics|mesh-ancestor
102170431|NCT05936190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102170432|NCT05936190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170433|NCT05936190|Sensory System Agents|sensory system agents|mesh-ancestor
102170434|NCT05936190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102170435|NCT05936190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102170436|NCT05936190|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102170437|NCT05936190|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102170438|NCT05936190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102170439|NCT05936190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170440|NCT05936060|Plasma-lyte 148|plasma-lyte 148|mesh-list
102170441|NCT05936060|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102170442|NCT05936060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102170443|NCT05936021|Darbepoetin alfa|darbepoetin alfa|mesh-list
102170444|NCT05936021|Hematinics|hematinics|mesh-ancestor
102170445|NCT05935930|Propofol|propofol|mesh-list
102170446|NCT05935930|Sevoflurane|sevoflurane|mesh-list
102170447|NCT05935930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102170448|NCT05935930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102170449|NCT05935930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170450|NCT05935930|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102170451|NCT05935930|Anesthetics, General|anesthetics, general|mesh-ancestor
102170452|NCT05935930|Anesthetics|anesthetics|mesh-ancestor
102170453|NCT05935930|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102170454|NCT05935930|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102170455|NCT05935917|Brincidofovir|brincidofovir|mesh-list
102170456|NCT05935917|Antiviral Agents|antiviral agents|mesh-ancestor
102170457|NCT05935917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102170458|NCT05935748|Palbociclib|palbociclib|mesh-list
102170459|NCT05935748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102170460|NCT05935748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102170461|NCT05935748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102170462|NCT05935748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170463|NCT05935579|Durvalumab|durvalumab|mesh-list
102170464|NCT05935579|Lenvatinib|lenvatinib|mesh-list
102170465|NCT05935579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102170466|NCT05935579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102170467|NCT05935579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102170468|NCT05935579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102170469|NCT05935579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170470|NCT05935553|Baclofen|baclofen|mesh-list
102170471|NCT05935553|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102170472|NCT05935553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170473|NCT05935553|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102170474|NCT05935553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102170475|NCT05935553|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102170476|NCT05935553|GABA Agonists|gaba agonists|mesh-ancestor
102170477|NCT05935553|GABA Agents|gaba agents|mesh-ancestor
102170478|NCT05935553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102170479|NCT05935553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170480|NCT05935449|Lidocaine|lidocaine|mesh-list
102170481|NCT05935449|Anesthetics, Local|anesthetics, local|mesh-ancestor
102170482|NCT05935449|Anesthetics|anesthetics|mesh-ancestor
102170483|NCT05935449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102170484|NCT05935449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170485|NCT05935449|Sensory System Agents|sensory system agents|mesh-ancestor
102170486|NCT05935449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102170487|NCT05935449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102170488|NCT05935449|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102170489|NCT05935449|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102170490|NCT05935449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102170491|NCT05935449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170492|NCT05935306|Ibuprofen|ibuprofen|mesh-list
102170493|NCT05935306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102170494|NCT05935306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102170495|NCT05935306|Analgesics|analgesics|mesh-ancestor
102170496|NCT05935306|Sensory System Agents|sensory system agents|mesh-ancestor
102170497|NCT05935306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102170498|NCT05935306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170499|NCT05935306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102170500|NCT05935306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102170501|NCT05935306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102170502|NCT05935306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102170503|NCT05935306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170504|NCT05935293|Dexmedetomidine|dexmedetomidine|mesh-list
102170505|NCT05935293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102170506|NCT05935293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102170507|NCT05935293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170508|NCT05935293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102170509|NCT05935293|Analgesics|analgesics|mesh-ancestor
102170510|NCT05935293|Sensory System Agents|sensory system agents|mesh-ancestor
102170511|NCT05935293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102170512|NCT05935293|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102170513|NCT05935293|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102170514|NCT05935293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102170515|NCT05935293|Adrenergic Agents|adrenergic agents|mesh-ancestor
102170516|NCT05935293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102170517|NCT05935293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170518|NCT05935280|Lidocaine|lidocaine|mesh-list
101879354|NCT04790812|Celecoxib|celecoxib|mesh-list
102170519|NCT05935280|Sodium Channel Blockers|sodium channel blockers|mesh-list
102170520|NCT05935280|Anesthetics, Local|anesthetics, local|mesh-ancestor
102170521|NCT05935280|Anesthetics|anesthetics|mesh-ancestor
102170522|NCT05935280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102170523|NCT05935280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170524|NCT05935280|Sensory System Agents|sensory system agents|mesh-ancestor
102170525|NCT05935280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102170526|NCT05935280|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102170527|NCT05935280|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102170528|NCT05935280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102170529|NCT05935280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170533|NCT05934812|Oxytocin|oxytocin|mesh-list
102170534|NCT05934812|Oxytocics|oxytocics|mesh-ancestor
102170535|NCT05934812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102170536|NCT05934812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170537|NCT05934799|Clopidogrel|clopidogrel|mesh-list
102170538|NCT05934799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102170539|NCT05934799|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102170540|NCT05934799|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102170541|NCT05934799|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102170542|NCT05934799|Purinergic Agents|purinergic agents|mesh-ancestor
102170543|NCT05934799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102170544|NCT05934799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170545|NCT05934799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170546|NCT05934669|Midazolam|midazolam|mesh-list
102170547|NCT05934669|Dexmedetomidine|dexmedetomidine|mesh-list
102170548|NCT05934669|Ketamine|ketamine|mesh-list
102170549|NCT05934669|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102170550|NCT05934669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102170551|NCT05934669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170552|NCT05934669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102170553|NCT05934669|Analgesics|analgesics|mesh-ancestor
102170554|NCT05934669|Sensory System Agents|sensory system agents|mesh-ancestor
102170555|NCT05934669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102170556|NCT05934669|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102170557|NCT05934669|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102170558|NCT05934669|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102170559|NCT05934669|Adrenergic Agents|adrenergic agents|mesh-ancestor
102170560|NCT05934669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102170561|NCT05934669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170562|NCT05934669|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102170563|NCT05934669|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102170564|NCT05934669|Anesthetics, General|anesthetics, general|mesh-ancestor
102170565|NCT05934669|Anesthetics|anesthetics|mesh-ancestor
102170566|NCT05934669|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102170567|NCT05934669|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102170568|NCT05934669|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102170569|NCT05934669|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102170570|NCT05934669|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102170571|NCT05934669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102170572|NCT05934669|GABA Modulators|gaba modulators|mesh-ancestor
102170573|NCT05934669|GABA Agents|gaba agents|mesh-ancestor
102170574|NCT05934552|Lactulose|lactulose|mesh-list
102170575|NCT05934552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102170576|NCT05934500|Cannabidiol|cannabidiol|mesh-list
102170577|NCT05934500|Anticonvulsants|anticonvulsants|mesh-ancestor
102170578|NCT05934448|Cyclophosphamide|cyclophosphamide|mesh-list
102170579|NCT05934448|Pembrolizumab|pembrolizumab|mesh-list
102170580|NCT05934448|Fludarabine|fludarabine|mesh-list
102170581|NCT05934448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102170582|NCT05934448|Immunologic Factors|immunologic factors|mesh-ancestor
102170583|NCT05934448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170584|NCT05934448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102170585|NCT05934448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102170586|NCT05934448|Alkylating Agents|alkylating agents|mesh-ancestor
102170587|NCT05934448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170588|NCT05934448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102170589|NCT05934448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102170590|NCT05934448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102170591|NCT05934448|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102170592|NCT05934409|Niacin|niacin|mesh-list
101879423|NCT03757156|Antipyretics|antipyretics|mesh-ancestor
102170593|NCT05934409|Nicotinic Acids|nicotinic acids|mesh-list
102170594|NCT05934409|Niacinamide|niacinamide|mesh-list
102170595|NCT05934409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102170596|NCT05934409|Antimetabolites|antimetabolites|mesh-ancestor
102170597|NCT05934409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170598|NCT05934409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102170599|NCT05934409|Vasodilator Agents|vasodilator agents|mesh-ancestor
102170600|NCT05934409|Vitamin B Complex|vitamin b complex|mesh-ancestor
102170601|NCT05934409|Vitamins|vitamins|mesh-ancestor
102170602|NCT05934409|Micronutrients|micronutrients|mesh-ancestor
102170603|NCT05934409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170604|NCT05933538|Cariprazine|cariprazine|mesh-list
102170605|NCT05933538|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102170606|NCT05933538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102170607|NCT05933538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102170608|NCT05933538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170609|NCT05933538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102170610|NCT05932238|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102170611|NCT05932199|Carboplatin|carboplatin|mesh-list
102170612|NCT05932199|Pemetrexed|pemetrexed|mesh-list
102170613|NCT05932199|Durvalumab|durvalumab|mesh-list
102170614|NCT05932199|Tremelimumab|tremelimumab|mesh-list
102170615|NCT05932199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102170616|NCT05932199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102170617|NCT05932199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102170618|NCT05932199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170619|NCT05932199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102170620|NCT05932199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102170621|NCT05932199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102170622|NCT05932199|Immunologic Factors|immunologic factors|mesh-ancestor
102170623|NCT05932199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170624|NCT05924776|Immunomodulating Agents|immunomodulating agents|mesh-list
102170625|NCT05924776|Immunologic Factors|immunologic factors|mesh-ancestor
102170626|NCT05924776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170627|NCT05922124|Meropenem|meropenem|mesh-list
102170628|NCT05922124|Colistin|colistin|mesh-list
102170629|NCT05922124|Ampicillin|ampicillin|mesh-list
102170630|NCT05922124|Sulbactam|sulbactam|mesh-list
102170631|NCT05922124|Sultamicillin|sultamicillin|mesh-list
102170632|NCT05922124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102170633|NCT05922124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102170634|NCT05922124|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102170635|NCT05922124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102170636|NCT05922124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170637|NCT05919888|Povidone-Iodine|povidone-iodine|mesh-list
102170638|NCT05919888|Povidone|povidone|mesh-list
102170639|NCT05919888|Plasma Substitutes|plasma substitutes|mesh-ancestor
102170640|NCT05919888|Blood Substitutes|blood substitutes|mesh-ancestor
102170641|NCT05919888|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102170642|NCT05919888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102170643|NCT05916053|Vitamin D|vitamin d|mesh-list
102170644|NCT05916053|Vitamins|vitamins|mesh-ancestor
102170645|NCT05916053|Micronutrients|micronutrients|mesh-ancestor
102170646|NCT05916053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170647|NCT05916053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102170648|NCT05909644|Efavirenz|efavirenz|mesh-list
101446925|NCT00585442|Vitamin D|vitamin d|mesh-list
102170649|NCT05909644|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102170650|NCT05909644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102170651|NCT05909644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102170652|NCT05909644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170653|NCT05909644|Antiviral Agents|antiviral agents|mesh-ancestor
102170654|NCT05909644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102170655|NCT05909644|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102170656|NCT05909644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102170657|NCT05909644|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102170658|NCT05909644|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102170659|NCT05909644|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102170660|NCT05909644|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102170661|NCT05901519|Prednisone|prednisone|mesh-list
102170662|NCT05901519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102170663|NCT05901519|Glucocorticoids|glucocorticoids|mesh-ancestor
102170664|NCT05901519|Hormones|hormones|mesh-ancestor
102170665|NCT05901519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102170666|NCT05901519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170667|NCT05901519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102170668|NCT05901519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101879491|NCT00128102|Vorinostat|vorinostat|mesh-list
102170669|NCT05892393|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102170670|NCT05892393|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102170671|NCT05892393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170672|NCT05880849|Choline|choline|mesh-list
102170673|NCT05880849|Lipotropic Agents|lipotropic agents|mesh-ancestor
102170674|NCT05880849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102170675|NCT05880849|Antimetabolites|antimetabolites|mesh-ancestor
102170676|NCT05880849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170677|NCT05880849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102170678|NCT05880849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102170679|NCT05880849|Nootropic Agents|nootropic agents|mesh-ancestor
102170680|NCT05879419|Benzocaine|benzocaine|mesh-list
102170681|NCT05879419|Anesthetics, Local|anesthetics, local|mesh-ancestor
102170682|NCT05879419|Anesthetics|anesthetics|mesh-ancestor
102170683|NCT05879419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102170684|NCT05879419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170685|NCT05879419|Sensory System Agents|sensory system agents|mesh-ancestor
102170686|NCT05879419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102170687|NCT05878691|Pembrolizumab|pembrolizumab|mesh-list
102170688|NCT05878691|Atezolizumab|atezolizumab|mesh-list
102170689|NCT05878691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102170690|NCT05878691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102170691|NCT05878691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102170692|NCT05878691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170693|NCT05876572|Naloxone|naloxone|mesh-list
102170694|NCT05876572|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102170695|NCT05876572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170696|NCT05876572|Sensory System Agents|sensory system agents|mesh-ancestor
102170697|NCT05876572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102170698|NCT05825391|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
102170699|NCT05820594|BCG Vaccine|bcg vaccine|mesh-list
102170700|NCT05820594|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102170701|NCT05820594|Immunologic Factors|immunologic factors|mesh-ancestor
102170702|NCT05820594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170703|NCT05807932|Mycophenolic Acid|mycophenolic acid|mesh-list
102170704|NCT05807932|Venetoclax|venetoclax|mesh-list
102170705|NCT05807932|Amsacrine|amsacrine|mesh-list
102170706|NCT05807932|Tacrolimus|tacrolimus|mesh-list
102170707|NCT05807932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102170708|NCT05807932|Immunologic Factors|immunologic factors|mesh-ancestor
102170709|NCT05807932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170710|NCT05807932|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102170711|NCT05807932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102170712|NCT05807932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170713|NCT05807932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102170714|NCT05807932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102170715|NCT05807932|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102170716|NCT05807932|Antitubercular Agents|antitubercular agents|mesh-ancestor
102170717|NCT05807932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102170718|NCT05807932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102170719|NCT05793060|Dexamethasone|dexamethasone|mesh-list
102170720|NCT05793060|Dexamethasone acetate|dexamethasone acetate|mesh-list
102170721|NCT05793060|Dexmedetomidine|dexmedetomidine|mesh-list
102170722|NCT05793060|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102170723|NCT05793060|BB 1101|bb 1101|mesh-list
102170724|NCT05793060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102170725|NCT05793060|Antiemetics|antiemetics|mesh-ancestor
102170726|NCT05793060|Autonomic Agents|autonomic agents|mesh-ancestor
102170727|NCT05793060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102170728|NCT05793060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170729|NCT05793060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102170730|NCT05793060|Glucocorticoids|glucocorticoids|mesh-ancestor
102170731|NCT05793060|Hormones|hormones|mesh-ancestor
102170732|NCT05793060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102170733|NCT05793060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102170734|NCT05793060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102170735|NCT05793060|Protease Inhibitors|protease inhibitors|mesh-ancestor
102170736|NCT05793060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102170737|NCT05793060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170738|NCT05793060|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102170739|NCT05793060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102170740|NCT05793060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102170741|NCT05793060|Analgesics|analgesics|mesh-ancestor
102170742|NCT05793060|Sensory System Agents|sensory system agents|mesh-ancestor
102170743|NCT05793060|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102170744|NCT05793060|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102170745|NCT05793060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102170746|NCT05793060|Adrenergic Agents|adrenergic agents|mesh-ancestor
102170747|NCT05793060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102170748|NCT05790499|Atorvastatin|atorvastatin|mesh-list
102170749|NCT05790499|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102170750|NCT05790499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102170751|NCT05790499|Antimetabolites|antimetabolites|mesh-ancestor
102170752|NCT05790499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170753|NCT05790499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102170754|NCT05790499|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102170755|NCT05790499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102170756|NCT05785065|Mycophenolic Acid|mycophenolic acid|mesh-list
102170757|NCT05785065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102170758|NCT05785065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102170759|NCT05785065|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102170760|NCT05785065|Antitubercular Agents|antitubercular agents|mesh-ancestor
102170761|NCT05785065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102170762|NCT05785065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102170763|NCT05785065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102170764|NCT05785065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170765|NCT05775380|Pioglitazone|pioglitazone|mesh-list
102170766|NCT05775380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102170767|NCT05775380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170768|NCT05772169|Mifepristone|mifepristone|mesh-list
102170769|NCT05772169|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102170770|NCT05772169|Abortifacient Agents|abortifacient agents|mesh-ancestor
102170771|NCT05772169|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102170772|NCT05772169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170773|NCT05772169|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102170774|NCT05772169|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102170775|NCT05772169|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102170776|NCT05772169|Contraceptive Agents|contraceptive agents|mesh-ancestor
102170777|NCT05772169|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102170778|NCT05772169|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101446936|NCT00585520|Progesterone|progesterone|mesh-list
102170779|NCT05772169|Hormone Antagonists|hormone antagonists|mesh-ancestor
102170780|NCT05772169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102170781|NCT05772169|Luteolytic Agents|luteolytic agents|mesh-ancestor
102170782|NCT05772169|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102170783|NCT05772169|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102170784|NCT05714007|Ferrous succinate|ferrous succinate|mesh-list
102170785|NCT05714007|Hematinics|hematinics|mesh-ancestor
102170786|NCT05704543|Buprenorphine|buprenorphine|mesh-list
102170787|NCT05704543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102170788|NCT05704543|Narcotics|narcotics|mesh-ancestor
102170789|NCT05704543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102170790|NCT05704543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170791|NCT05704543|Analgesics|analgesics|mesh-ancestor
102170792|NCT05704543|Sensory System Agents|sensory system agents|mesh-ancestor
102170793|NCT05704543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102170794|NCT05704543|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102170795|NCT05672524|Trastuzumab|trastuzumab|mesh-list
102170797|NCT05672524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102170798|NCT05672524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102170799|NCT05672524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102170800|NCT05672524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102170801|NCT05672524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170802|NCT05663710|Nivolumab|nivolumab|mesh-list
102170803|NCT05663710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102170804|NCT05663710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102170805|NCT05663710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102170806|NCT05663710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170807|NCT05662202|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102170808|NCT05662202|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102170809|NCT05662202|Dermatologic Agents|dermatologic agents|mesh-ancestor
102170810|NCT05643170|Xanomeline|xanomeline|mesh-list
102170811|NCT05643170|Trospium chloride|trospium chloride|mesh-list
102170812|NCT05643170|Parasympatholytics|parasympatholytics|mesh-ancestor
102170813|NCT05643170|Autonomic Agents|autonomic agents|mesh-ancestor
102170814|NCT05643170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102170815|NCT05643170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170816|NCT05643170|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101879642|NCT00095940|Lapatinib|lapatinib|mesh-list
102170827|NCT05635916|Anesthetics, Local|anesthetics, local|mesh-ancestor
102170828|NCT05635916|Anesthetics|anesthetics|mesh-ancestor
102170829|NCT05635916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102170830|NCT05635916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170831|NCT05635916|Sensory System Agents|sensory system agents|mesh-ancestor
102170832|NCT05635916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102170833|NCT05633771|Adalimumab|adalimumab|mesh-list
102170834|NCT05633771|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102170835|NCT05633771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102170836|NCT05633771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102170837|NCT05633381|Temozolomide|temozolomide|mesh-list
102170838|NCT05633381|Trabectedin|trabectedin|mesh-list
102170839|NCT05633381|Olaparib|olaparib|mesh-list
102170840|NCT05633381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102170841|NCT05633381|Alkylating Agents|alkylating agents|mesh-ancestor
102170842|NCT05633381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170843|NCT05633381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102170844|NCT05633381|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102170845|NCT05633381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102170846|NCT05613062|Oren gedoku to|oren gedoku to|mesh-list
102170847|NCT05613062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102170848|NCT05613062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102170849|NCT05613062|Analgesics|analgesics|mesh-ancestor
102170850|NCT05613062|Sensory System Agents|sensory system agents|mesh-ancestor
102170851|NCT05613062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102170852|NCT05613062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170853|NCT05613062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102170854|NCT05613062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102170865|NCT05600322|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102170866|NCT05600322|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102170867|NCT05600322|Dermatologic Agents|dermatologic agents|mesh-ancestor
102170868|NCT05576350|Ethanol|ethanol|mesh-list
102170869|NCT05576350|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102170870|NCT05576350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102170871|NCT05576350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102170872|NCT05576350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170873|NCT05513586|Immunoglobulins|immunoglobulins|mesh-list
102170874|NCT05513586|Immunologic Factors|immunologic factors|mesh-ancestor
102170875|NCT05513586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170876|NCT05511415|Dexmedetomidine|dexmedetomidine|mesh-list
102170877|NCT05511415|Oxytocin|oxytocin|mesh-list
102170878|NCT05511415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102170879|NCT05511415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102170880|NCT05511415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170881|NCT05511415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102170882|NCT05511415|Analgesics|analgesics|mesh-ancestor
102170883|NCT05511415|Sensory System Agents|sensory system agents|mesh-ancestor
101712638|NCT00286169|Amrubicin|amrubicin|mesh-list
102170884|NCT05511415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102170885|NCT05511415|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102170886|NCT05511415|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102170887|NCT05511415|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102170888|NCT05511415|Adrenergic Agents|adrenergic agents|mesh-ancestor
102170889|NCT05511415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102170890|NCT05511415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170891|NCT05511415|Oxytocics|oxytocics|mesh-ancestor
102170892|NCT05511415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102170894|NCT05505825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102170895|NCT05505825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102170896|NCT05505825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102170897|NCT05505825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170898|NCT05485012|Analgesics, Opioid|analgesics, opioid|mesh-list
102170899|NCT05485012|Narcotics|narcotics|mesh-ancestor
102170900|NCT05485012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102170901|NCT05485012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170902|NCT05485012|Analgesics|analgesics|mesh-ancestor
102170903|NCT05485012|Sensory System Agents|sensory system agents|mesh-ancestor
102170904|NCT05485012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102170905|NCT05457959|Poly I-C|poly i-c|mesh-list
102170906|NCT05457959|Nivolumab|nivolumab|mesh-list
102170907|NCT05457959|Ipilimumab|ipilimumab|mesh-list
102170908|NCT05457959|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102170909|NCT05457959|Vaccines|vaccines|mesh-list
102170910|NCT05457959|Poly ICLC|poly iclc|mesh-list
102170911|NCT05457959|Immunologic Factors|immunologic factors|mesh-ancestor
102170912|NCT05457959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170913|NCT05457959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102170914|NCT05457959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102170915|NCT05457959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102170916|NCT05457959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170917|NCT05457959|Interferon Inducers|interferon inducers|mesh-ancestor
102170918|NCT05457959|Laxatives|laxatives|mesh-ancestor
102170919|NCT05457959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102170920|NCT05457959|Antiviral Agents|antiviral agents|mesh-ancestor
102170921|NCT05457959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102170922|NCT05422612|Fluoxetine|fluoxetine|mesh-list
102170923|NCT05422612|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
102170924|NCT05422612|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102170925|NCT05422612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102170926|NCT05422612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102170927|NCT05422612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170928|NCT05422612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102170929|NCT05422612|Serotonin Agents|serotonin agents|mesh-ancestor
102170930|NCT05422612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170931|NCT05422612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102170932|NCT05422612|Antidepressive Agents|antidepressive agents|mesh-ancestor
102170933|NCT05422612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102170934|NCT05422612|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102170935|NCT05422612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102170936|NCT05422612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102170937|NCT05422612|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102170938|NCT05422612|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102170939|NCT05403385|Carboplatin|carboplatin|mesh-list
102170940|NCT05403385|Pemetrexed|pemetrexed|mesh-list
102170941|NCT05403385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102170942|NCT05403385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102170943|NCT05403385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170944|NCT05403385|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102170945|NCT05403385|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102170946|NCT05400369|Moxifloxacin|moxifloxacin|mesh-list
102170947|NCT05400369|Sitafloxacin|sitafloxacin|mesh-list
102170948|NCT05400369|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102170949|NCT05400369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102170950|NCT05400369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102170951|NCT05400369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102170952|NCT05400369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102170953|NCT05400369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102170954|NCT05400369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170955|NCT05400369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102170956|NCT05400369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102170957|NCT05400369|Contraceptive Agents|contraceptive agents|mesh-ancestor
102170958|NCT05400369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102170959|NCT05400369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170960|NCT05400369|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102170961|NCT05400369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102170962|NCT05400369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102170963|NCT05350215|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102170964|NCT05350215|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102170965|NCT05350215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102170966|NCT05350215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102170967|NCT05350215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170968|NCT05350215|Adrenergic Agents|adrenergic agents|mesh-ancestor
102170969|NCT05350215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102170970|NCT05350215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102170971|NCT05258747|Olaparib|olaparib|mesh-list
102170972|NCT05258747|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102170973|NCT05258747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102170974|NCT05258747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170975|NCT05258747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102170976|NCT05169684|Docetaxel|docetaxel|mesh-list
102170977|NCT05169684|Nivolumab|nivolumab|mesh-list
102170978|NCT05169684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102170979|NCT05169684|Tubulin Modulators|tubulin modulators|mesh-ancestor
102170980|NCT05169684|Antimitotic Agents|antimitotic agents|mesh-ancestor
102170981|NCT05169684|Mitosis Modulators|mitosis modulators|mesh-ancestor
102170982|NCT05169684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170983|NCT05169684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102170984|NCT05169684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102170985|NCT05127395|Acyclovir|acyclovir|mesh-list
102170986|NCT05127395|Antiviral Agents|antiviral agents|mesh-ancestor
102170987|NCT05127395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102170988|NCT05109234|Brivaracetam|brivaracetam|mesh-list
102170989|NCT05109234|Anticonvulsants|anticonvulsants|mesh-ancestor
102170990|NCT05094336|Docetaxel|docetaxel|mesh-list
102170991|NCT05094336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102170992|NCT05094336|Tubulin Modulators|tubulin modulators|mesh-ancestor
102170993|NCT05094336|Antimitotic Agents|antimitotic agents|mesh-ancestor
102170994|NCT05094336|Mitosis Modulators|mitosis modulators|mesh-ancestor
102170995|NCT05094336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102170999|NCT05071053|Ramucirumab|ramucirumab|mesh-list
102171000|NCT05071053|Maytansine|maytansine|mesh-list
102171001|NCT05071053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171002|NCT05071053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102171003|NCT05071053|Tubulin Modulators|tubulin modulators|mesh-ancestor
102171004|NCT05071053|Antimitotic Agents|antimitotic agents|mesh-ancestor
102171005|NCT05071053|Mitosis Modulators|mitosis modulators|mesh-ancestor
102171006|NCT05071053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171007|NCT05041062|Nivolumab|nivolumab|mesh-list
102171008|NCT05041062|Ipilimumab|ipilimumab|mesh-list
102171009|NCT05041062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102171010|NCT05041062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171011|NCT05041062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102171012|NCT05041062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171013|NCT05022342|Fulvestrant|fulvestrant|mesh-list
102171014|NCT05022342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102171015|NCT05022342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171016|NCT05022342|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102171017|NCT05022342|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102171018|NCT05022342|Hormone Antagonists|hormone antagonists|mesh-ancestor
102171019|NCT05022342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102171020|NCT05022342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171021|NCT05019716|Cisplatin|cisplatin|mesh-list
102171022|NCT05019716|Etoposide|etoposide|mesh-list
102171023|NCT05019716|Etoposide phosphate|etoposide phosphate|mesh-list
102171024|NCT05019716|Podophyllotoxin|podophyllotoxin|mesh-list
102171025|NCT05019716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171026|NCT05019716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102171027|NCT05019716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102171028|NCT05019716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102171029|NCT05019716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101573980|NCT02199184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102171030|NCT05019716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171031|NCT05019716|Keratolytic Agents|keratolytic agents|mesh-ancestor
102171032|NCT05019716|Dermatologic Agents|dermatologic agents|mesh-ancestor
102171033|NCT05019716|Tubulin Modulators|tubulin modulators|mesh-ancestor
102171034|NCT05019716|Antimitotic Agents|antimitotic agents|mesh-ancestor
102171035|NCT05019716|Mitosis Modulators|mitosis modulators|mesh-ancestor
102171036|NCT05008224|Prednisone|prednisone|mesh-list
102171037|NCT05008224|Cyclophosphamide|cyclophosphamide|mesh-list
102171038|NCT05008224|Dacarbazine|dacarbazine|mesh-list
102171039|NCT05008224|Doxorubicin|doxorubicin|mesh-list
102171040|NCT05008224|Pembrolizumab|pembrolizumab|mesh-list
102171041|NCT05008224|Etoposide|etoposide|mesh-list
102171042|NCT05008224|Etoposide phosphate|etoposide phosphate|mesh-list
102171043|NCT05008224|Vincristine|vincristine|mesh-list
102171044|NCT05008224|Bleomycin|bleomycin|mesh-list
102171045|NCT05008224|Vinblastine|vinblastine|mesh-list
102171046|NCT05008224|Procarbazine|procarbazine|mesh-list
102171047|NCT05008224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102171048|NCT05008224|Immunologic Factors|immunologic factors|mesh-ancestor
102171049|NCT05008224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171050|NCT05008224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102171051|NCT05008224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102171052|NCT05008224|Alkylating Agents|alkylating agents|mesh-ancestor
102171053|NCT05008224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171054|NCT05008224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171055|NCT05008224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102171056|NCT05008224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102171057|NCT05008224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102171058|NCT05008224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102171059|NCT05008224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102171060|NCT05008224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102171061|NCT05008224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102171062|NCT05008224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102171063|NCT05008224|Glucocorticoids|glucocorticoids|mesh-ancestor
102171064|NCT05008224|Hormones|hormones|mesh-ancestor
102171065|NCT05008224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102171066|NCT05008224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102171067|NCT05008224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102171068|NCT05008224|Tubulin Modulators|tubulin modulators|mesh-ancestor
102171069|NCT05008224|Antimitotic Agents|antimitotic agents|mesh-ancestor
102171070|NCT05008224|Mitosis Modulators|mitosis modulators|mesh-ancestor
102171071|NCT04995029|Buprenorphine|buprenorphine|mesh-list
102171072|NCT04995029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102171073|NCT04995029|Narcotics|narcotics|mesh-ancestor
102171074|NCT04995029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102171075|NCT04995029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171076|NCT04995029|Analgesics|analgesics|mesh-ancestor
102171077|NCT04995029|Sensory System Agents|sensory system agents|mesh-ancestor
102171078|NCT04995029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102171079|NCT04995029|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102171080|NCT04980495|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102171081|NCT04971226|Imatinib Mesylate|imatinib mesylate|mesh-list
102171082|NCT04971226|Dasatinib|dasatinib|mesh-list
102171083|NCT04971226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171084|NCT04971226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102171085|NCT04971226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102171086|NCT04971226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171087|NCT04967196|Nivolumab|nivolumab|mesh-list
102171088|NCT04967196|Ipilimumab|ipilimumab|mesh-list
102171089|NCT04967196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102171090|NCT04967196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171091|NCT04967196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102171092|NCT04967196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171093|NCT04964466|Becaplermin|becaplermin|mesh-list
102171094|NCT04964466|Anticoagulants|anticoagulants|mesh-ancestor
102171095|NCT04964466|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
102171096|NCT04964466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102171097|NCT04964466|Growth Substances|growth substances|mesh-ancestor
102171098|NCT04964466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171099|NCT04950270|Arginine Vasopressin|arginine vasopressin|mesh-list
102171100|NCT04950270|Hemostatics|hemostatics|mesh-ancestor
102171101|NCT04950270|Coagulants|coagulants|mesh-ancestor
102171102|NCT04950270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102171103|NCT04950270|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102171104|NCT04950270|Natriuretic Agents|natriuretic agents|mesh-ancestor
102171105|NCT04950270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171106|NCT04820179|Atezolizumab|atezolizumab|mesh-list
102171107|NCT04820179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102171108|NCT04820179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171109|NCT04820179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102171110|NCT04820179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171111|NCT04804553|Apremilast|apremilast|mesh-list
102171112|NCT04804553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102171113|NCT04804553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102171114|NCT04804553|Analgesics|analgesics|mesh-ancestor
102171115|NCT04804553|Sensory System Agents|sensory system agents|mesh-ancestor
102171116|NCT04804553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102171117|NCT04804553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171118|NCT04804553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102171119|NCT04804553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102171120|NCT04804553|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102171121|NCT04804553|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102171122|NCT04804553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102171123|NCT04804553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171124|NCT04802876|Tislelizumab|tislelizumab|mesh-list
102171125|NCT04802876|Spartalizumab|spartalizumab|mesh-list
102171126|NCT04802876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102171127|NCT04802876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171128|NCT04802876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102171129|NCT04802876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171130|NCT04789928|Gentamicins|gentamicins|mesh-list
102171131|NCT04789928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102171132|NCT04789928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102171133|NCT04789928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102171134|NCT04789928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102171135|NCT04789928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171136|NCT04762992|Enoxaparin|enoxaparin|mesh-list
102171137|NCT04762992|Anticoagulants|anticoagulants|mesh-ancestor
102171138|NCT04762992|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102171139|NCT04762992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102171140|NCT04762992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171141|NCT04738942|Vedolizumab|vedolizumab|mesh-list
102171142|NCT04738942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102171143|NCT04738123|Xanomeline|xanomeline|mesh-list
101446979|NCT03452722|Plasminogen|plasminogen|mesh-list
102171144|NCT04738123|Trospium chloride|trospium chloride|mesh-list
102171145|NCT04738123|Parasympatholytics|parasympatholytics|mesh-ancestor
102171146|NCT04738123|Autonomic Agents|autonomic agents|mesh-ancestor
102171147|NCT04738123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102171148|NCT04738123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171149|NCT04738123|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102171150|NCT04738123|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102171151|NCT04738123|Cholinergic Agents|cholinergic agents|mesh-ancestor
102171152|NCT04738123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102171153|NCT04738123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171154|NCT04738123|Urological Agents|urological agents|mesh-ancestor
102171155|NCT04738123|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102171156|NCT04738123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102171157|NCT04738123|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102171158|NCT04738123|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102171159|NCT04715191|Cyclophosphamide|cyclophosphamide|mesh-list
102171160|NCT04715191|Fludarabine|fludarabine|mesh-list
102171161|NCT04715191|Fludarabine phosphate|fludarabine phosphate|mesh-list
102171162|NCT04715191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102171163|NCT04715191|Immunologic Factors|immunologic factors|mesh-ancestor
102171164|NCT04715191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171165|NCT04715191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102171166|NCT04715191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102171167|NCT04715191|Alkylating Agents|alkylating agents|mesh-ancestor
102171168|NCT04715191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171169|NCT04715191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171170|NCT04715191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102171171|NCT04715191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102171172|NCT04715191|Antimetabolites|antimetabolites|mesh-ancestor
102171173|NCT04704453|Amitriptyline|amitriptyline|mesh-list
102171174|NCT04704453|Capsaicin|capsaicin|mesh-list
102171175|NCT04704453|Antipruritics|antipruritics|mesh-ancestor
102171176|NCT04704453|Dermatologic Agents|dermatologic agents|mesh-ancestor
102171177|NCT04704453|Sensory System Agents|sensory system agents|mesh-ancestor
102171178|NCT04704453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102171179|NCT04704453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573981|NCT02199184|Immunologic Factors|immunologic factors|mesh-ancestor
102171180|NCT04704453|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102171181|NCT04704453|Antidepressive Agents|antidepressive agents|mesh-ancestor
102171182|NCT04704453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102171183|NCT04704453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102171184|NCT04704453|Analgesics|analgesics|mesh-ancestor
102171185|NCT04704453|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102171186|NCT04704453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102171187|NCT04704453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102171188|NCT04704453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171189|NCT04704453|Adrenergic Agents|adrenergic agents|mesh-ancestor
102171190|NCT04704453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102171191|NCT04695847|Antibodies|antibodies|mesh-list
102171192|NCT04695847|Immunoglobulins|immunoglobulins|mesh-list
102171193|NCT04695847|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102171194|NCT04695847|Immunoconjugates|immunoconjugates|mesh-list
102171195|NCT04695847|Immunologic Factors|immunologic factors|mesh-ancestor
102171196|NCT04695847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171197|NCT04682353|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102171198|NCT04682353|Medroxyprogesterone|medroxyprogesterone|mesh-list
102171199|NCT04682353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102171200|NCT04682353|Contraceptive Agents|contraceptive agents|mesh-ancestor
102171201|NCT04682353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102171202|NCT04682353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171203|NCT04682353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102171204|NCT04682353|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102171205|NCT04682353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102171206|NCT04682353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171207|NCT04682353|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102171208|NCT04682353|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102171209|NCT04682353|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102171211|NCT04675333|Pembrolizumab|pembrolizumab|mesh-list
102171212|NCT04675333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171213|NCT04675333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102171214|NCT04675333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102171215|NCT04675333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171216|NCT04674813|Cyclophosphamide|cyclophosphamide|mesh-list
102171217|NCT04674813|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102171218|NCT04674813|Fludarabine|fludarabine|mesh-list
102171219|NCT04674813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102171220|NCT04674813|Immunologic Factors|immunologic factors|mesh-ancestor
102171221|NCT04674813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171222|NCT04674813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102171223|NCT04674813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102171224|NCT04674813|Alkylating Agents|alkylating agents|mesh-ancestor
102171225|NCT04674813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171226|NCT04674813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171227|NCT04674813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102171228|NCT04665050|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102171229|NCT04665050|Immunologic Factors|immunologic factors|mesh-ancestor
102171230|NCT04665050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171231|NCT04581395|Rocuronium|rocuronium|mesh-list
102171232|NCT04581395|Succinylcholine|succinylcholine|mesh-list
102171233|NCT04581395|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102171234|NCT04581395|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102171235|NCT04581395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102171236|NCT04581395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102171237|NCT04581395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171238|NCT04581395|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
102171239|NCT04572100|Paclitaxel|paclitaxel|mesh-list
102171240|NCT04572100|Carboplatin|carboplatin|mesh-list
102171241|NCT04572100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102171242|NCT04572100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171243|NCT04572100|Tubulin Modulators|tubulin modulators|mesh-ancestor
102171244|NCT04572100|Antimitotic Agents|antimitotic agents|mesh-ancestor
102171245|NCT04572100|Mitosis Modulators|mitosis modulators|mesh-ancestor
102171246|NCT04572100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171247|NCT04564625|Vitamin D|vitamin d|mesh-list
102171248|NCT04564625|Vitamins|vitamins|mesh-ancestor
102171249|NCT04564625|Micronutrients|micronutrients|mesh-ancestor
102171250|NCT04564625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171251|NCT04564625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102171252|NCT04560322|Venetoclax|venetoclax|mesh-list
102171253|NCT04560322|Obinutuzumab|obinutuzumab|mesh-list
102171255|NCT04560322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171256|NCT04560322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102171257|NCT04538352|Insulin|insulin|mesh-list
102171258|NCT04538352|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102171259|NCT04538352|Insulin Aspart|insulin aspart|mesh-list
102171260|NCT04538352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102171261|NCT04538352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171262|NCT04504734|Bucillamine|bucillamine|mesh-list
102171263|NCT04504734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102171264|NCT04504734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102171265|NCT04504734|Analgesics|analgesics|mesh-ancestor
101880098|NCT00112580|Ipilimumab|ipilimumab|mesh-list
102171266|NCT04504734|Sensory System Agents|sensory system agents|mesh-ancestor
102171267|NCT04504734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102171268|NCT04504734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171269|NCT04504734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102171270|NCT04504734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102171272|NCT04504734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171273|NCT04504734|Protective Agents|protective agents|mesh-ancestor
102171274|NCT04469842|Mycophenolic Acid|mycophenolic acid|mesh-list
102171275|NCT04469842|Prednisone|prednisone|mesh-list
102171276|NCT04469842|Azathioprine|azathioprine|mesh-list
102171277|NCT04469842|Tacrolimus|tacrolimus|mesh-list
102171278|NCT04469842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102171279|NCT04469842|Glucocorticoids|glucocorticoids|mesh-ancestor
102171280|NCT04469842|Hormones|hormones|mesh-ancestor
102171281|NCT04469842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102171282|NCT04469842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171283|NCT04469842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102171284|NCT04469842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171285|NCT04469842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102171286|NCT04469842|Immunologic Factors|immunologic factors|mesh-ancestor
102171287|NCT04469842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102171288|NCT04469842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102171289|NCT04469842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171290|NCT04469842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102171291|NCT04469842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102171292|NCT04469842|Antitubercular Agents|antitubercular agents|mesh-ancestor
102171293|NCT04469842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102171294|NCT04469842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102171295|NCT04469842|Antimetabolites|antimetabolites|mesh-ancestor
102171296|NCT04469842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102171297|NCT04469842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102171298|NCT04439227|Adavosertib|adavosertib|mesh-list
102171299|NCT04439227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102171300|NCT04439227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171301|NCT04416633|Durvalumab|durvalumab|mesh-list
102171302|NCT04416633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102171303|NCT04416633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171304|NCT04388774|Ketamine|ketamine|mesh-list
102171305|NCT04388774|Analgesics|analgesics|mesh-ancestor
102171306|NCT04388774|Sensory System Agents|sensory system agents|mesh-ancestor
102171307|NCT04388774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102171308|NCT04388774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171309|NCT04388774|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102171310|NCT04388774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102171311|NCT04388774|Anesthetics, General|anesthetics, general|mesh-ancestor
102171312|NCT04388774|Anesthetics|anesthetics|mesh-ancestor
102171313|NCT04388774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102171314|NCT04388774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102171315|NCT04388774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102171316|NCT04388774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102171317|NCT04388774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171318|NCT04305041|Pembrolizumab|pembrolizumab|mesh-list
102171319|NCT04305041|Lenvatinib|lenvatinib|mesh-list
102171320|NCT04305041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102171321|NCT04305041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171322|NCT04305041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102171323|NCT04305041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171324|NCT04305041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102171325|NCT04305041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102171326|NCT04303169|Pembrolizumab|pembrolizumab|mesh-list
102171327|NCT04303169|Tretinoin|tretinoin|mesh-list
102171328|NCT04303169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102171329|NCT04303169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171330|NCT04303169|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102171331|NCT04303169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171332|NCT04303169|Keratolytic Agents|keratolytic agents|mesh-ancestor
102171333|NCT04303169|Dermatologic Agents|dermatologic agents|mesh-ancestor
102171334|NCT04274426|Paclitaxel|paclitaxel|mesh-list
102171335|NCT04274426|Maytansine|maytansine|mesh-list
102171336|NCT04274426|Carboplatin|carboplatin|mesh-list
102171337|NCT04274426|Gemcitabine|gemcitabine|mesh-list
102171338|NCT04274426|Doxorubicin|doxorubicin|mesh-list
102171339|NCT04274426|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102171340|NCT04274426|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
102171341|NCT04274426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102171342|NCT04274426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171344|NCT04274426|Antimitotic Agents|antimitotic agents|mesh-ancestor
102171345|NCT04274426|Mitosis Modulators|mitosis modulators|mesh-ancestor
102171346|NCT04274426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171347|NCT04274426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102171348|NCT04274426|Antimetabolites|antimetabolites|mesh-ancestor
102171349|NCT04274426|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102171350|NCT04274426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102171351|NCT04274426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102171352|NCT04274426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102171353|NCT04274426|Immunoconjugates|immunoconjugates|mesh-ancestor
102171354|NCT04274426|Immunologic Factors|immunologic factors|mesh-ancestor
102171355|NCT04274426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171356|NCT04267614|Etanercept|etanercept|mesh-list
102171357|NCT04267614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102171358|NCT04267614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102171359|NCT04267614|Analgesics|analgesics|mesh-ancestor
102171360|NCT04267614|Sensory System Agents|sensory system agents|mesh-ancestor
102171361|NCT04267614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102171362|NCT04267614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171363|NCT04267614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102171364|NCT04267614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102171365|NCT04267614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102171366|NCT04267614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102171367|NCT04267614|Immunologic Factors|immunologic factors|mesh-ancestor
102171368|NCT04175431|Prednisone|prednisone|mesh-list
102171369|NCT04175431|Abiraterone Acetate|abiraterone acetate|mesh-list
102171370|NCT04175431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102171371|NCT04175431|Glucocorticoids|glucocorticoids|mesh-ancestor
102171372|NCT04175431|Hormones|hormones|mesh-ancestor
102171373|NCT04175431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102171374|NCT04175431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171375|NCT04175431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102171376|NCT04175431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171377|NCT04175431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102171378|NCT04175431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102171379|NCT04175431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171380|NCT04175431|Hormone Antagonists|hormone antagonists|mesh-ancestor
102171381|NCT04175431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102171382|NCT04170309|Ceftobiprole|ceftobiprole|mesh-list
102171383|NCT04170309|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
102171384|NCT04170309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102171385|NCT04170309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102171386|NCT04164212|Vaccines|vaccines|mesh-list
102171387|NCT04164212|Immunologic Factors|immunologic factors|mesh-ancestor
102171388|NCT04164212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171389|NCT04112199|Terlipressin|terlipressin|mesh-list
102171390|NCT04112199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102171391|NCT04112199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102171392|NCT04102020|Azacitidine|azacitidine|mesh-list
102171393|NCT04102020|Venetoclax|venetoclax|mesh-list
102171395|NCT04102020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102171396|NCT04102020|Antimetabolites|antimetabolites|mesh-ancestor
102171397|NCT04102020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171398|NCT04102020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171399|NCT04102020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102171400|NCT04089904|Pembrolizumab|pembrolizumab|mesh-list
102171401|NCT04089904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102171402|NCT04089904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171403|NCT04089904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102171404|NCT04089904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171405|NCT04068831|Avelumab|avelumab|mesh-list
102171406|NCT04068831|Talazoparib|talazoparib|mesh-list
102171407|NCT04068831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102171408|NCT04068831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171409|NCT04068831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102171410|NCT04068831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102171411|NCT04068831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171412|NCT04055428|Valsartan|valsartan|mesh-list
102171413|NCT04055428|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101880250|NCT03743896|Capsaicin|capsaicin|mesh-list
102171414|NCT04055428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102171415|NCT04055428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102171416|NCT04055428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102171417|NCT04055428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171418|NCT03998488|Psyllium|psyllium|mesh-list
102171419|NCT03998488|Calcium polycarbophil|calcium polycarbophil|mesh-list
102171420|NCT03998488|Cathartics|cathartics|mesh-ancestor
102171421|NCT03998488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102171422|NCT03998488|Antidiarrheals|antidiarrheals|mesh-ancestor
102171423|NCT03963960|Dialysis Solutions|dialysis solutions|mesh-list
102171424|NCT03963960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102171425|NCT03923374|Buprenorphine|buprenorphine|mesh-list
102171426|NCT03923374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102171427|NCT03923374|Narcotics|narcotics|mesh-ancestor
102171428|NCT03923374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101446993|NCT00408551|Antimetabolites|antimetabolites|mesh-ancestor
102171429|NCT03923374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171430|NCT03923374|Analgesics|analgesics|mesh-ancestor
102171431|NCT03923374|Sensory System Agents|sensory system agents|mesh-ancestor
102171432|NCT03923374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102171433|NCT03923374|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102171434|NCT03912428|Celecoxib|celecoxib|mesh-list
102171435|NCT03912428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102171436|NCT03912428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102171437|NCT03912428|Analgesics|analgesics|mesh-ancestor
102171438|NCT03912428|Sensory System Agents|sensory system agents|mesh-ancestor
102171439|NCT03912428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102171440|NCT03912428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171441|NCT03912428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102171442|NCT03912428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102171443|NCT03912428|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102171444|NCT03912428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102171445|NCT03912428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102171446|NCT03912428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171447|NCT03911973|Talazoparib|talazoparib|mesh-list
102171448|NCT03911973|Gedatolisib|gedatolisib|mesh-list
102171449|NCT03911973|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102171450|NCT03911973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102171451|NCT03911973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171452|NCT03911973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171453|NCT03911973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102171454|NCT03910972|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102171455|NCT03910972|Vaccines|vaccines|mesh-list
102171456|NCT03910972|Immunologic Factors|immunologic factors|mesh-ancestor
102171457|NCT03910972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171458|NCT03910972|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102171459|NCT03910972|Antacids|antacids|mesh-ancestor
102171460|NCT03910972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171461|NCT03910972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102171462|NCT03861702|Irinotecan|irinotecan|mesh-list
102171463|NCT03861702|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102171464|NCT03861702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102171465|NCT03861702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102171466|NCT03861702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171467|NCT03861702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171468|NCT03829462|Irinotecan|irinotecan|mesh-list
102171469|NCT03829462|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102171470|NCT03829462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102171471|NCT03829462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102171472|NCT03829462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171473|NCT03829462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171474|NCT03781128|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
102171475|NCT03781128|Hallucinogens|hallucinogens|mesh-ancestor
102171476|NCT03781128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171477|NCT03781128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102171478|NCT03781128|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102171479|NCT03781128|Serotonin Agents|serotonin agents|mesh-ancestor
102171480|NCT03781128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102171481|NCT03781128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171482|NCT03781128|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102171483|NCT03774641|Lamotrigine|lamotrigine|mesh-list
102171484|NCT03774641|Anticonvulsants|anticonvulsants|mesh-ancestor
102171485|NCT03774641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102171486|NCT03774641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102171487|NCT03774641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171488|NCT03774641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102171489|NCT03774641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171490|NCT03774641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102171491|NCT03774641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102171492|NCT03774641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102171493|NCT03774641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102171494|NCT03774641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102171495|NCT03747939|Thalidomide|thalidomide|mesh-list
102171496|NCT03747939|Apremilast|apremilast|mesh-list
102171497|NCT03747939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102171498|NCT03747939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102171499|NCT03747939|Analgesics|analgesics|mesh-ancestor
102171500|NCT03747939|Sensory System Agents|sensory system agents|mesh-ancestor
102171501|NCT03747939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102171502|NCT03747939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171503|NCT03747939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102171504|NCT03747939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102171505|NCT03747939|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102171506|NCT03747939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102171507|NCT03747939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102171508|NCT03747939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171509|NCT03747939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102171510|NCT03747939|Immunologic Factors|immunologic factors|mesh-ancestor
102171511|NCT03747939|Leprostatic Agents|leprostatic agents|mesh-ancestor
102171512|NCT03747939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102171513|NCT03747939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102171514|NCT03747939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102171515|NCT03747939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102171516|NCT03747939|Growth Substances|growth substances|mesh-ancestor
102171517|NCT03747939|Growth Inhibitors|growth inhibitors|mesh-ancestor
102171518|NCT03747939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171519|NCT03716349|Anesthetics|anesthetics|mesh-list
102171520|NCT03716349|Anesthetics, Local|anesthetics, local|mesh-list
102171521|NCT03716349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102171522|NCT03716349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171523|NCT03716349|Sensory System Agents|sensory system agents|mesh-ancestor
102171524|NCT03716349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102171525|NCT03682536|Epoetin Alfa|epoetin alfa|mesh-list
102171526|NCT03682536|Luspatercept|luspatercept|mesh-list
102171527|NCT03682536|Hematinics|hematinics|mesh-ancestor
102171528|NCT03653338|Rituximab|rituximab|mesh-list
102171529|NCT03653338|Alemtuzumab|alemtuzumab|mesh-list
102171530|NCT03653338|Fludarabine|fludarabine|mesh-list
102171531|NCT03653338|Thiotepa|thiotepa|mesh-list
102171532|NCT03653338|Hydroxyurea|hydroxyurea|mesh-list
102171533|NCT03653338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102171534|NCT03653338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171535|NCT03653338|Immunologic Factors|immunologic factors|mesh-ancestor
102171536|NCT03653338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171537|NCT03653338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102171538|NCT03653338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171539|NCT03653338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102171540|NCT03653338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102171541|NCT03653338|Alkylating Agents|alkylating agents|mesh-ancestor
102171542|NCT03653338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102171543|NCT03653338|Antisickling Agents|antisickling agents|mesh-ancestor
102171544|NCT03653338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102171545|NCT03653338|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102171546|NCT03610724|Tisagenlecleucel|tisagenlecleucel|mesh-list
102171547|NCT03610724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102171548|NCT03610724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171549|NCT03576755|Spironolactone|spironolactone|mesh-list
102171550|NCT03576755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102171551|NCT03576755|Hormone Antagonists|hormone antagonists|mesh-ancestor
102171552|NCT03576755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102171553|NCT03576755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171554|NCT03576755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102171555|NCT03576755|Diuretics|diuretics|mesh-ancestor
102171556|NCT03576755|Natriuretic Agents|natriuretic agents|mesh-ancestor
102171557|NCT03572049|Itraconazole|itraconazole|mesh-list
102171558|NCT03572049|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
102171559|NCT03572049|Antifungal Agents|antifungal agents|mesh-ancestor
102171560|NCT03572049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102171561|NCT03572049|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101880400|NCT00069108|Leucovorin|leucovorin|mesh-list
102171562|NCT03572049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102171563|NCT03572049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102171564|NCT03572049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171565|NCT03572049|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102171566|NCT03572049|Hormone Antagonists|hormone antagonists|mesh-ancestor
102171567|NCT03572049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102171568|NCT03572049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171569|NCT03572049|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102171570|NCT03556332|Dexamethasone|dexamethasone|mesh-list
102171571|NCT03556332|Lenalidomide|lenalidomide|mesh-list
102171572|NCT03556332|Daratumumab|daratumumab|mesh-list
102171573|NCT03556332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102171574|NCT03556332|Antiemetics|antiemetics|mesh-ancestor
102171575|NCT03556332|Autonomic Agents|autonomic agents|mesh-ancestor
102171576|NCT03556332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102171577|NCT03556332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171578|NCT03556332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102171579|NCT03556332|Glucocorticoids|glucocorticoids|mesh-ancestor
102171580|NCT03556332|Hormones|hormones|mesh-ancestor
102171581|NCT03556332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102171582|NCT03556332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102171583|NCT03556332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171584|NCT03556332|Immunologic Factors|immunologic factors|mesh-ancestor
102171585|NCT03556332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102171586|NCT03556332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102171587|NCT03556332|Growth Substances|growth substances|mesh-ancestor
102171588|NCT03556332|Growth Inhibitors|growth inhibitors|mesh-ancestor
102171589|NCT03555877|Letrozole|letrozole|mesh-list
102171590|NCT03555877|Fulvestrant|fulvestrant|mesh-list
102171591|NCT03555877|Anastrozole|anastrozole|mesh-list
102171592|NCT03555877|Exemestane|exemestane|mesh-list
102171593|NCT03555877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171594|NCT03555877|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102171595|NCT03555877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102171596|NCT03555877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102171597|NCT03555877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171598|NCT03555877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102171599|NCT03555877|Hormone Antagonists|hormone antagonists|mesh-ancestor
102171600|NCT03555877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102171601|NCT03555877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171602|NCT03555877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102171603|NCT03555877|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102171604|NCT03481972|Doxycycline|doxycycline|mesh-list
102171605|NCT03481972|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
102171606|NCT03481972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102171607|NCT03481972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102171608|NCT03481972|Antimalarials|antimalarials|mesh-ancestor
102171609|NCT03481972|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102171610|NCT03481972|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102171611|NCT03481972|Antiviral Agents|antiviral agents|mesh-ancestor
102171612|NCT03481972|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102171613|NCT03481972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102171614|NCT03472560|Avelumab|avelumab|mesh-list
102171615|NCT03472560|Axitinib|axitinib|mesh-list
102171616|NCT03472560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102171617|NCT03472560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171618|NCT03472560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102171619|NCT03472560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102171620|NCT03472560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171621|NCT03397004|Doxycycline|doxycycline|mesh-list
102171622|NCT03397004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102171623|NCT03397004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102171624|NCT03397004|Antimalarials|antimalarials|mesh-ancestor
102171625|NCT03397004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102171626|NCT03397004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102171627|NCT03340675|Ifetroban|ifetroban|mesh-list
102171628|NCT03340675|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102171629|NCT03336216|Leucovorin|leucovorin|mesh-list
102171630|NCT03336216|Paclitaxel|paclitaxel|mesh-list
102171631|NCT03336216|Gemcitabine|gemcitabine|mesh-list
102171632|NCT03336216|Fluorouracil|fluorouracil|mesh-list
102171633|NCT03336216|Oxaliplatin|oxaliplatin|mesh-list
102171634|NCT03336216|Nivolumab|nivolumab|mesh-list
102171635|NCT03336216|Irinotecan|irinotecan|mesh-list
102171636|NCT03336216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102171637|NCT03336216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171638|NCT03336216|Tubulin Modulators|tubulin modulators|mesh-ancestor
102171645|NCT03336216|Immunologic Factors|immunologic factors|mesh-ancestor
102171646|NCT03336216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171647|NCT03336216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102171648|NCT03336216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102171649|NCT03336216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101447005|NCT00408551|Vitamins|vitamins|mesh-ancestor
102171650|NCT03336216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102171651|NCT03336216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102171652|NCT03336216|Antidotes|antidotes|mesh-ancestor
102171653|NCT03336216|Protective Agents|protective agents|mesh-ancestor
102171654|NCT03336216|Vitamin B Complex|vitamin b complex|mesh-ancestor
102171655|NCT03336216|Vitamins|vitamins|mesh-ancestor
102171656|NCT03336216|Micronutrients|micronutrients|mesh-ancestor
102171657|NCT03319940|Pembrolizumab|pembrolizumab|mesh-list
102171658|NCT03319940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102171659|NCT03319940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171660|NCT03319940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102171661|NCT03319940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171662|NCT03298815|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102171663|NCT03298815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102171664|NCT03269994|Tazobactam|tazobactam|mesh-list
102171665|NCT03269994|Piperacillin|piperacillin|mesh-list
102171666|NCT03269994|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102171667|NCT03269994|Cefoxitin|cefoxitin|mesh-list
102171668|NCT03269994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102171669|NCT03269994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102171670|NCT03269994|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102171671|NCT03269994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102171672|NCT03269994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171679|NCT03148327|Durvalumab|durvalumab|mesh-list
102171680|NCT03148327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102171681|NCT03148327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171682|NCT03065387|Everolimus|everolimus|mesh-list
102171683|NCT03065387|Palbociclib|palbociclib|mesh-list
102171684|NCT03065387|Trametinib|trametinib|mesh-list
102171685|NCT03065387|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102171686|NCT03065387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102171687|NCT03065387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102171688|NCT03065387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171689|NCT03065387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102171690|NCT03065387|Immunologic Factors|immunologic factors|mesh-ancestor
102171691|NCT03065387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171692|NCT03065387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171693|NCT03063606|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
102171694|NCT03063606|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102171695|NCT03062358|Pembrolizumab|pembrolizumab|mesh-list
102171696|NCT03062358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102171697|NCT03062358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171698|NCT03062358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102171699|NCT03062358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171700|NCT02903537|Vitamin D|vitamin d|mesh-list
102171701|NCT02903537|Cholecalciferol|cholecalciferol|mesh-list
102171702|NCT02903537|Interferons|interferons|mesh-list
102171703|NCT02903537|Interferon-beta|interferon-beta|mesh-list
102171704|NCT02903537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171705|NCT02903537|Antiviral Agents|antiviral agents|mesh-ancestor
102171706|NCT02903537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102171707|NCT02903537|Immunologic Factors|immunologic factors|mesh-ancestor
102171708|NCT02903537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171709|NCT02903537|Vitamins|vitamins|mesh-ancestor
102171710|NCT02903537|Micronutrients|micronutrients|mesh-ancestor
102171711|NCT02903537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102171712|NCT02903537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102171714|NCT02706873|Upadacitinib|upadacitinib|mesh-list
102171715|NCT02706873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102171716|NCT02706873|Abortifacient Agents|abortifacient agents|mesh-ancestor
102171717|NCT02706873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102171718|NCT02706873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171719|NCT02706873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102171720|NCT02706873|Antimetabolites|antimetabolites|mesh-ancestor
102171721|NCT02706873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171722|NCT02706873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171723|NCT02706873|Dermatologic Agents|dermatologic agents|mesh-ancestor
102171724|NCT02706873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102171725|NCT02706873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102171726|NCT02706873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102171727|NCT02706873|Immunologic Factors|immunologic factors|mesh-ancestor
102171728|NCT02706873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102171729|NCT02706873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102171730|NCT02706873|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102171731|NCT02706873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102171732|NCT02677038|Olaparib|olaparib|mesh-list
102171733|NCT02677038|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102171734|NCT02677038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102171735|NCT02677038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171736|NCT02677038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171737|NCT02668666|Tamoxifen|tamoxifen|mesh-list
102171738|NCT02668666|Palbociclib|palbociclib|mesh-list
102171739|NCT02668666|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102171740|NCT02668666|Hormone Antagonists|hormone antagonists|mesh-ancestor
102171741|NCT02668666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102171742|NCT02668666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171743|NCT02668666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102171744|NCT02668666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171745|NCT02668666|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102171746|NCT02668666|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102171747|NCT02668666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102171748|NCT02668666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102171749|NCT02668666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102171750|NCT02668666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171751|NCT02625961|Pembrolizumab|pembrolizumab|mesh-list
102171752|NCT02625961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102171753|NCT02625961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171754|NCT02625961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102171755|NCT02625961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171756|NCT02584634|Avelumab|avelumab|mesh-list
102171757|NCT02584634|Crizotinib|crizotinib|mesh-list
102171758|NCT02584634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102171759|NCT02584634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171760|NCT02584634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102171761|NCT02584634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102171762|NCT02584634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171763|NCT02570542|Cytarabine|cytarabine|mesh-list
102171764|NCT02570542|Plerixafor|plerixafor|mesh-list
102171765|NCT02570542|Etoposide|etoposide|mesh-list
102171766|NCT02570542|Melphalan|melphalan|mesh-list
102171767|NCT02570542|Carmustine|carmustine|mesh-list
102171768|NCT02570542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102171769|NCT02570542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171770|NCT02570542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102171771|NCT02570542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102171772|NCT02570542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102171773|NCT02570542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171774|NCT02570542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102171775|NCT02570542|Antimetabolites|antimetabolites|mesh-ancestor
102171776|NCT02570542|Antiviral Agents|antiviral agents|mesh-ancestor
102171777|NCT02570542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102171778|NCT02570542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102171779|NCT02570542|Immunologic Factors|immunologic factors|mesh-ancestor
102171780|NCT02570542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171781|NCT02570542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102171782|NCT02570542|Alkylating Agents|alkylating agents|mesh-ancestor
102171783|NCT02570542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102171784|NCT02570542|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102171785|NCT02570542|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102171786|NCT02513563|Paclitaxel|paclitaxel|mesh-list
102171787|NCT02513563|Carboplatin|carboplatin|mesh-list
102171788|NCT02513563|Adavosertib|adavosertib|mesh-list
102171789|NCT02513563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102171790|NCT02513563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171791|NCT02513563|Tubulin Modulators|tubulin modulators|mesh-ancestor
102171792|NCT02513563|Antimitotic Agents|antimitotic agents|mesh-ancestor
102171793|NCT02513563|Mitosis Modulators|mitosis modulators|mesh-ancestor
102171794|NCT02513563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171795|NCT02513563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102171796|NCT02386826|Bevacizumab|bevacizumab|mesh-list
102171797|NCT02386826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102171798|NCT02386826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171799|NCT02386826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102171800|NCT02386826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102171801|NCT02386826|Growth Substances|growth substances|mesh-ancestor
102171802|NCT02386826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171803|NCT02386826|Growth Inhibitors|growth inhibitors|mesh-ancestor
102171804|NCT02365441|Imatinib Mesylate|imatinib mesylate|mesh-list
102171805|NCT02365441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171806|NCT02365441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102171807|NCT02365441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102171808|NCT02365441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171809|NCT02124941|Acetylcysteine|acetylcysteine|mesh-list
102171810|NCT02124941|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102171811|NCT02124941|Antiviral Agents|antiviral agents|mesh-ancestor
102171812|NCT02124941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102171813|NCT02124941|Expectorants|expectorants|mesh-ancestor
102171814|NCT02124941|Respiratory System Agents|respiratory system agents|mesh-ancestor
102171815|NCT02124941|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102171816|NCT02124941|Antioxidants|antioxidants|mesh-ancestor
102171817|NCT02124941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171818|NCT02124941|Protective Agents|protective agents|mesh-ancestor
102171819|NCT02124941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171820|NCT02124941|Antidotes|antidotes|mesh-ancestor
102171821|NCT02114229|Cyclophosphamide|cyclophosphamide|mesh-list
102171822|NCT02114229|Carboplatin|carboplatin|mesh-list
102171823|NCT02114229|Methotrexate|methotrexate|mesh-list
102171824|NCT02114229|Etoposide|etoposide|mesh-list
102171825|NCT02114229|Etoposide phosphate|etoposide phosphate|mesh-list
102171826|NCT02114229|Vincristine|vincristine|mesh-list
102171827|NCT02114229|Topotecan|topotecan|mesh-list
102171828|NCT02114229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102171829|NCT02114229|Immunologic Factors|immunologic factors|mesh-ancestor
102171830|NCT02114229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171831|NCT02114229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102171832|NCT02114229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102171833|NCT02114229|Alkylating Agents|alkylating agents|mesh-ancestor
102171834|NCT02114229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171835|NCT02114229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171836|NCT02114229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102171837|NCT02114229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102171838|NCT02114229|Abortifacient Agents|abortifacient agents|mesh-ancestor
102171839|NCT02114229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102171840|NCT02114229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102171841|NCT02114229|Antimetabolites|antimetabolites|mesh-ancestor
102171842|NCT02114229|Dermatologic Agents|dermatologic agents|mesh-ancestor
102171843|NCT02114229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102171844|NCT02114229|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102171845|NCT02114229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102171846|NCT02114229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102171847|NCT02114229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102171848|NCT02114229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102171849|NCT02114229|Tubulin Modulators|tubulin modulators|mesh-ancestor
102171850|NCT02114229|Antimitotic Agents|antimitotic agents|mesh-ancestor
102171851|NCT02114229|Mitosis Modulators|mitosis modulators|mesh-ancestor
102171852|NCT02114229|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102171853|NCT02000622|Olaparib|olaparib|mesh-list
102171854|NCT02000622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102171855|NCT02000622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102171856|NCT02000622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171857|NCT02000622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171858|NCT01871766|Dactinomycin|dactinomycin|mesh-list
102171859|NCT01871766|Cyclophosphamide|cyclophosphamide|mesh-list
102171860|NCT01871766|Ifosfamide|ifosfamide|mesh-list
102171861|NCT01871766|Bevacizumab|bevacizumab|mesh-list
102171862|NCT01871766|Doxorubicin|doxorubicin|mesh-list
102171863|NCT01871766|Irinotecan|irinotecan|mesh-list
102171864|NCT01871766|Etoposide|etoposide|mesh-list
102171865|NCT01871766|Etoposide phosphate|etoposide phosphate|mesh-list
102171866|NCT01871766|Vincristine|vincristine|mesh-list
102171868|NCT01871766|Dexrazoxane|dexrazoxane|mesh-list
102171869|NCT01871766|Razoxane|razoxane|mesh-list
102171870|NCT01871766|Mitogens|mitogens|mesh-list
102171871|NCT01871766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102171872|NCT01871766|Immunologic Factors|immunologic factors|mesh-ancestor
102171873|NCT01871766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171874|NCT01871766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102171875|NCT01871766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102171876|NCT01871766|Alkylating Agents|alkylating agents|mesh-ancestor
102171877|NCT01871766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171878|NCT01871766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171879|NCT01871766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102171880|NCT01871766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102171881|NCT01871766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102171882|NCT01871766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102171883|NCT01871766|Growth Substances|growth substances|mesh-ancestor
102171884|NCT01871766|Growth Inhibitors|growth inhibitors|mesh-ancestor
102171885|NCT01871766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102171886|NCT01871766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102171887|NCT01871766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102171888|NCT01871766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102171889|NCT01871766|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102171890|NCT01871766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102171891|NCT01871766|Tubulin Modulators|tubulin modulators|mesh-ancestor
102171892|NCT01871766|Antimitotic Agents|antimitotic agents|mesh-ancestor
102171893|NCT01871766|Mitosis Modulators|mitosis modulators|mesh-ancestor
102171894|NCT01871766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102171895|NCT01871766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102171896|NCT01871766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102171897|NCT01871766|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102171898|NCT01871766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102171899|NCT01871766|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102171900|NCT01871766|Protective Agents|protective agents|mesh-ancestor
102171901|NCT01868451|Doxorubicin|doxorubicin|mesh-list
102171902|NCT01868451|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102171903|NCT01868451|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102171904|NCT01868451|Dacarbazine|dacarbazine|mesh-list
102171905|NCT01868451|Vinblastine|vinblastine|mesh-list
102171906|NCT01868451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102171907|NCT01868451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171908|NCT01868451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102171909|NCT01868451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102171910|NCT01868451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102171911|NCT01868451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171912|NCT01868451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102171913|NCT01868451|Immunotoxins|immunotoxins|mesh-ancestor
102171914|NCT01868451|Immunoconjugates|immunoconjugates|mesh-ancestor
102171915|NCT01868451|Immunologic Factors|immunologic factors|mesh-ancestor
102171916|NCT01868451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171917|NCT01868451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102171918|NCT01868451|Alkylating Agents|alkylating agents|mesh-ancestor
102171919|NCT01868451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102171920|NCT01868451|Tubulin Modulators|tubulin modulators|mesh-ancestor
102171921|NCT01868451|Antimitotic Agents|antimitotic agents|mesh-ancestor
102171922|NCT01868451|Mitosis Modulators|mitosis modulators|mesh-ancestor
102171923|NCT01767675|Carboplatin|carboplatin|mesh-list
102171924|NCT01767675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171925|NCT01597388|Fulvestrant|fulvestrant|mesh-list
102171926|NCT01597388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102171927|NCT01597388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171928|NCT01597388|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102171929|NCT01597388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102171930|NCT01597388|Hormone Antagonists|hormone antagonists|mesh-ancestor
102171931|NCT01597388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102171932|NCT01597388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171933|NCT01275729|Furosemide|furosemide|mesh-list
102171934|NCT01275729|Diuretics|diuretics|mesh-ancestor
102171935|NCT01275729|Natriuretic Agents|natriuretic agents|mesh-ancestor
102171936|NCT01275729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171937|NCT01275729|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101880761|NCT00394589|Infliximab|infliximab|mesh-list
102171938|NCT01275729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102171939|NCT01275729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171948|NCT01107626|Paclitaxel|paclitaxel|mesh-list
102171949|NCT01107626|Bevacizumab|bevacizumab|mesh-list
102171950|NCT01107626|Carboplatin|carboplatin|mesh-list
102171951|NCT01107626|Pemetrexed|pemetrexed|mesh-list
102171952|NCT01107626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102171953|NCT01107626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171954|NCT01107626|Tubulin Modulators|tubulin modulators|mesh-ancestor
102171955|NCT01107626|Antimitotic Agents|antimitotic agents|mesh-ancestor
102171956|NCT01107626|Mitosis Modulators|mitosis modulators|mesh-ancestor
102171957|NCT01107626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171958|NCT01107626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102171959|NCT01107626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102171960|NCT01107626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102171961|NCT01107626|Growth Substances|growth substances|mesh-ancestor
102171962|NCT01107626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171963|NCT01107626|Growth Inhibitors|growth inhibitors|mesh-ancestor
102171964|NCT01107626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102171965|NCT01107626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102171966|NCT01107626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102171967|NCT01082224|Motexafin gadolinium|motexafin gadolinium|mesh-list
102171968|NCT01082224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171969|NCT01082224|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102171970|NCT01082224|Dermatologic Agents|dermatologic agents|mesh-ancestor
102171971|NCT00828009|Paclitaxel|paclitaxel|mesh-list
102171972|NCT00828009|Cyclophosphamide|cyclophosphamide|mesh-list
102171973|NCT00828009|Bevacizumab|bevacizumab|mesh-list
102171974|NCT00828009|Carboplatin|carboplatin|mesh-list
102171975|NCT00828009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102171976|NCT00828009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102171977|NCT00828009|Tubulin Modulators|tubulin modulators|mesh-ancestor
102171978|NCT00828009|Antimitotic Agents|antimitotic agents|mesh-ancestor
102171979|NCT00828009|Mitosis Modulators|mitosis modulators|mesh-ancestor
102171980|NCT00828009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102171981|NCT00828009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102171982|NCT00828009|Immunologic Factors|immunologic factors|mesh-ancestor
102171983|NCT00828009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102171984|NCT00828009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102171985|NCT00828009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102171986|NCT00828009|Alkylating Agents|alkylating agents|mesh-ancestor
102171987|NCT00828009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102171988|NCT00828009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102171989|NCT00828009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102171990|NCT00828009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102171991|NCT00828009|Growth Substances|growth substances|mesh-ancestor
102171992|NCT00828009|Growth Inhibitors|growth inhibitors|mesh-ancestor
102171993|NCT00578721|Aspirin|aspirin|mesh-list
102171994|NCT00578721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102171995|NCT00578721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102171996|NCT00578721|Analgesics|analgesics|mesh-ancestor
102171997|NCT00578721|Sensory System Agents|sensory system agents|mesh-ancestor
102171998|NCT00578721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102171999|NCT00578721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172000|NCT00578721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102172001|NCT00578721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102172002|NCT00578721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102172003|NCT00578721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102172004|NCT00578721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172005|NCT00578721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102172006|NCT00578721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102172007|NCT00578721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102172008|NCT00578721|Antipyretics|antipyretics|mesh-ancestor
102172009|NCT00539591|Interferons|interferons|mesh-list
102172010|NCT00539591|Interferon-alpha|interferon-alpha|mesh-list
102172011|NCT00539591|Interferon alpha-2|interferon alpha-2|mesh-list
102172012|NCT00539591|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102172013|NCT00539591|Temozolomide|temozolomide|mesh-list
102172014|NCT00539591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102172016|NCT00539591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102172017|NCT00539591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102172018|NCT00539591|Alkylating Agents|alkylating agents|mesh-ancestor
102172019|NCT00539591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172020|NCT00539591|Immunologic Factors|immunologic factors|mesh-ancestor
102172021|NCT00539591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172022|NCT00357890|Insulin|insulin|mesh-list
102172023|NCT00357890|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102172024|NCT00357890|Insulin Glargine|insulin glargine|mesh-list
102172025|NCT00357890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102172026|NCT00357890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172027|NCT00068393|Gemcitabine|gemcitabine|mesh-list
102172028|NCT00068393|Doxorubicin|doxorubicin|mesh-list
102172029|NCT00068393|Lenograstim|lenograstim|mesh-list
102172030|NCT00068393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102172031|NCT00068393|Antimetabolites|antimetabolites|mesh-ancestor
102172032|NCT00068393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172033|NCT00068393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102172034|NCT00068393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102172035|NCT00068393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102172036|NCT00068393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102172037|NCT00068393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102172038|NCT00068393|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102172039|NCT00068393|Immunologic Factors|immunologic factors|mesh-ancestor
102172040|NCT00068393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172041|NCT00062010|Interferons|interferons|mesh-list
102172042|NCT00062010|Interferon-alpha|interferon-alpha|mesh-list
102172043|NCT00062010|Interferon alpha-2|interferon alpha-2|mesh-list
102172044|NCT00062010|Paclitaxel|paclitaxel|mesh-list
102172045|NCT00062010|Tretinoin|tretinoin|mesh-list
102172046|NCT00062010|Isotretinoin|isotretinoin|mesh-list
102172047|NCT00062010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102172048|NCT00062010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102172049|NCT00062010|Tubulin Modulators|tubulin modulators|mesh-ancestor
102172050|NCT00062010|Antimitotic Agents|antimitotic agents|mesh-ancestor
102172051|NCT00062010|Mitosis Modulators|mitosis modulators|mesh-ancestor
102172052|NCT00062010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172053|NCT00062010|Antiviral Agents|antiviral agents|mesh-ancestor
102172054|NCT00062010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102172055|NCT00062010|Immunologic Factors|immunologic factors|mesh-ancestor
102172056|NCT00062010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172057|NCT00062010|Keratolytic Agents|keratolytic agents|mesh-ancestor
102172058|NCT00062010|Dermatologic Agents|dermatologic agents|mesh-ancestor
102172059|NCT00061568|Sirolimus|sirolimus|mesh-list
102172060|NCT00061568|Alemtuzumab|alemtuzumab|mesh-list
102172061|NCT00061568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102172062|NCT00061568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102172063|NCT00061568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102172064|NCT00061568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102172065|NCT00061568|Antifungal Agents|antifungal agents|mesh-ancestor
102172066|NCT00061568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102172067|NCT00061568|Immunologic Factors|immunologic factors|mesh-ancestor
102172068|NCT00061568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172069|NCT00061568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102172070|NCT00047008|Cisplatin|cisplatin|mesh-list
102172071|NCT00047008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102172072|NCT03567941|Acetaminophen|acetaminophen|mesh-list
102172073|NCT03567941|Hydrocodone|hydrocodone|mesh-list
102172074|NCT03567941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102172075|NCT03567941|Analgesics|analgesics|mesh-ancestor
102172076|NCT03567941|Sensory System Agents|sensory system agents|mesh-ancestor
102172077|NCT03567941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102172078|NCT03567941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172079|NCT03567941|Antipyretics|antipyretics|mesh-ancestor
102172080|NCT03567941|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102172081|NCT03567941|Narcotics|narcotics|mesh-ancestor
102172082|NCT03567941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102172083|NCT03567941|Antitussive Agents|antitussive agents|mesh-ancestor
102172084|NCT03567941|Respiratory System Agents|respiratory system agents|mesh-ancestor
102172085|NCT02140489|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102172086|NCT02140489|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102172088|NCT02140489|Antimetabolites|antimetabolites|mesh-ancestor
102172089|NCT02140489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880918|NCT00401843|Bortezomib|bortezomib|mesh-list
102172090|NCT02140489|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102172091|NCT02140489|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102172092|NCT02140489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102172093|NCT03566225|Metformin|metformin|mesh-list
102172094|NCT03566225|Pioglitazone|pioglitazone|mesh-list
102172095|NCT03566225|Clomiphene|clomiphene|mesh-list
102172096|NCT03566225|Enclomiphene|enclomiphene|mesh-list
102172097|NCT03566225|Zuclomiphene|zuclomiphene|mesh-list
102172098|NCT03566225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102172099|NCT03566225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172100|NCT03566225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102172101|NCT03566225|Hormone Antagonists|hormone antagonists|mesh-ancestor
102172102|NCT03566225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102172103|NCT03566225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102172104|NCT03566225|Fertility Agents|fertility agents|mesh-ancestor
102172105|NCT03566225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102172106|NCT03566225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102172107|NCT03566225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102172108|NCT02397694|Dolutegravir|dolutegravir|mesh-list
102172109|NCT02397694|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102172110|NCT02397694|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102172111|NCT02397694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102172112|NCT02397694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172113|NCT02397694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102172114|NCT02397694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102172115|NCT02397694|Antiviral Agents|antiviral agents|mesh-ancestor
102172116|NCT02397694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102172117|NCT03566069|Oxytocin|oxytocin|mesh-list
102172118|NCT03566069|Oxytocics|oxytocics|mesh-ancestor
102172119|NCT03566069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102172120|NCT03566069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172121|NCT03567629|Calcium, Dietary|calcium, dietary|mesh-list
102172122|NCT03567629|Leucovorin|leucovorin|mesh-list
102172123|NCT03567629|Bevacizumab|bevacizumab|mesh-list
102172124|NCT03567629|Cetuximab|cetuximab|mesh-list
102172125|NCT03567629|Fluorouracil|fluorouracil|mesh-list
102172126|NCT03567629|Capecitabine|capecitabine|mesh-list
102172127|NCT03567629|Oxaliplatin|oxaliplatin|mesh-list
102172128|NCT03567629|Irinotecan|irinotecan|mesh-list
102172129|NCT03567629|Calcium|calcium|mesh-list
102172130|NCT03567629|Levoleucovorin|levoleucovorin|mesh-list
102172131|NCT03567629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102172132|NCT03567629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102172133|NCT03567629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102172134|NCT03567629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102172135|NCT03567629|Growth Substances|growth substances|mesh-ancestor
102172136|NCT03567629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172137|NCT03567629|Growth Inhibitors|growth inhibitors|mesh-ancestor
102172138|NCT03567629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102172139|NCT03567629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102172140|NCT03567629|Antimetabolites|antimetabolites|mesh-ancestor
102172141|NCT03567629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172142|NCT03567629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102172143|NCT03567629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102172144|NCT03567629|Immunologic Factors|immunologic factors|mesh-ancestor
102172145|NCT03567629|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102172146|NCT03567629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102172147|NCT03567629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102172148|NCT03567629|Antidotes|antidotes|mesh-ancestor
102172149|NCT03567629|Protective Agents|protective agents|mesh-ancestor
102172150|NCT03567629|Vitamin B Complex|vitamin b complex|mesh-ancestor
102172151|NCT03567629|Vitamins|vitamins|mesh-ancestor
102172152|NCT03567629|Micronutrients|micronutrients|mesh-ancestor
102172153|NCT02783599|Doxorubicin|doxorubicin|mesh-list
102172154|NCT02783599|Olaratumab|olaratumab|mesh-list
102172155|NCT02783599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102172156|NCT02783599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102172157|NCT02783599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102172158|NCT02783599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102172159|NCT02783599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102172160|NCT02783599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172161|NCT03567395|Melatonin|melatonin|mesh-list
102172162|NCT03567395|Antioxidants|antioxidants|mesh-ancestor
101713898|NCT00857948|Ivermectin|ivermectin|mesh-list
102172169|NCT03565133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102172170|NCT03565133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102172171|NCT03565133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102172172|NCT03565133|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102172173|NCT03565133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172174|NCT03565133|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102172175|NCT03565133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102172176|NCT03565133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102172177|NCT03565133|Analgesics|analgesics|mesh-ancestor
102172178|NCT03565133|Sensory System Agents|sensory system agents|mesh-ancestor
102172179|NCT05353673|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102172180|NCT05353673|Danazol|danazol|mesh-list
102172181|NCT05353673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102172182|NCT05353673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172183|NCT05353673|Incretins|incretins|mesh-ancestor
102172184|NCT05353673|Hormones|hormones|mesh-ancestor
102172185|NCT05353673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102172186|NCT05353673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102172187|NCT05353673|Protease Inhibitors|protease inhibitors|mesh-ancestor
102172188|NCT05353673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102172189|NCT05353673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172190|NCT05353673|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102172191|NCT05353673|Hormone Antagonists|hormone antagonists|mesh-ancestor
102172192|NCT05353205|Flumatinib|flumatinib|mesh-list
102172193|NCT05353205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102172194|NCT05353205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102172195|NCT05353205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172202|NCT03068234|Pirfenidone|pirfenidone|mesh-list
102172203|NCT03068234|Analgesics|analgesics|mesh-ancestor
102172204|NCT03068234|Sensory System Agents|sensory system agents|mesh-ancestor
102172205|NCT03068234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102172206|NCT03068234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172207|NCT03068234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102172208|NCT03068234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102172209|NCT03068234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102172210|NCT03068234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102172211|NCT03068234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102172212|NCT05339399|Oxytocin|oxytocin|mesh-list
102172213|NCT05339399|Oxytocics|oxytocics|mesh-ancestor
102172214|NCT05339399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102172215|NCT05339399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172216|NCT05634824|Immunoglobulins|immunoglobulins|mesh-list
102172217|NCT05634824|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102172218|NCT05634824|Antibodies|antibodies|mesh-list
102172219|NCT05634824|gamma-Globulins|gamma-globulins|mesh-list
102172220|NCT05634824|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102172221|NCT05634824|Immunologic Factors|immunologic factors|mesh-ancestor
102172222|NCT05634824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172223|NCT02454478|Everolimus|everolimus|mesh-list
102172224|NCT02454478|Lenvatinib|lenvatinib|mesh-list
102172225|NCT02454478|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102172226|NCT02454478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102172227|NCT02454478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102172228|NCT02454478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172229|NCT02454478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102172230|NCT02454478|Immunologic Factors|immunologic factors|mesh-ancestor
102172231|NCT02454478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172232|NCT02454478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102172233|NCT02359097|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102172234|NCT02359097|Hematinics|hematinics|mesh-ancestor
102172235|NCT02359097|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102172236|NCT02359097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102172237|NCT05284214|Ipilimumab|ipilimumab|mesh-list
102172238|NCT05284214|Sargramostim|sargramostim|mesh-list
102172239|NCT05284214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102172241|NCT05284214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102172242|NCT05284214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881064|NCT00119678|Prednisone|prednisone|mesh-list
102172243|NCT05284214|Immunologic Factors|immunologic factors|mesh-ancestor
102172244|NCT05284214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172245|NCT03563963|Lidocaine|lidocaine|mesh-list
102172246|NCT03563963|Ropivacaine|ropivacaine|mesh-list
102172247|NCT03563963|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102172248|NCT03563963|Anesthetics, Local|anesthetics, local|mesh-ancestor
102172249|NCT03563963|Anesthetics|anesthetics|mesh-ancestor
102172250|NCT03563963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102172251|NCT03563963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172252|NCT03563963|Sensory System Agents|sensory system agents|mesh-ancestor
102172253|NCT03563963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102172254|NCT03563963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102172255|NCT03563963|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102172256|NCT03563963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102172257|NCT03563963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102172258|NCT03563963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172259|NCT03066518|Melatonin|melatonin|mesh-list
102172260|NCT03066518|Antioxidants|antioxidants|mesh-ancestor
102172261|NCT03066518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172262|NCT03066518|Protective Agents|protective agents|mesh-ancestor
102172263|NCT03066518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172264|NCT03066518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102172265|NCT03069248|Interferons|interferons|mesh-list
102172266|NCT03069248|Interferon-alpha|interferon-alpha|mesh-list
102172267|NCT03069248|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
102172268|NCT03069248|Rituximab|rituximab|mesh-list
102172269|NCT03069248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102172270|NCT03069248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102172271|NCT03069248|Immunologic Factors|immunologic factors|mesh-ancestor
102172272|NCT03069248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172273|NCT03069248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102172274|NCT03069248|Antiviral Agents|antiviral agents|mesh-ancestor
102172275|NCT03069248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102172276|NCT05730062|Oxycodone|oxycodone|mesh-list
102172277|NCT05730062|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102172278|NCT05730062|Narcotics|narcotics|mesh-ancestor
102172279|NCT05730062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102172280|NCT05730062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172281|NCT05730062|Analgesics|analgesics|mesh-ancestor
102172282|NCT05730062|Sensory System Agents|sensory system agents|mesh-ancestor
102172283|NCT05730062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102172284|NCT03068936|Cisplatin|cisplatin|mesh-list
102172285|NCT03068936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102172286|NCT05017610|Lomustine|lomustine|mesh-list
102172287|NCT05017610|Methimazole|methimazole|mesh-list
102172288|NCT05017610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102172289|NCT05017610|Alkylating Agents|alkylating agents|mesh-ancestor
102172290|NCT05017610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172291|NCT05017610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102172292|NCT05017610|Antithyroid Agents|antithyroid agents|mesh-ancestor
102172293|NCT05017610|Hormone Antagonists|hormone antagonists|mesh-ancestor
102172294|NCT05017610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102172295|NCT05017610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172296|NCT02431468|Bryostatin 1|bryostatin 1|mesh-list
102172297|NCT02431468|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102172298|NCT02431468|Immunologic Factors|immunologic factors|mesh-ancestor
102172299|NCT02431468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172300|NCT02431468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102172301|NCT04454528|Pembrolizumab|pembrolizumab|mesh-list
102172302|NCT04454528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102172303|NCT04454528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102172304|NCT04454528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102172305|NCT04454528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172306|NCT02452762|Vitamin D|vitamin d|mesh-list
102172307|NCT02452762|Cholecalciferol|cholecalciferol|mesh-list
102172308|NCT02452762|Vitamins|vitamins|mesh-ancestor
102172309|NCT02452762|Micronutrients|micronutrients|mesh-ancestor
102172310|NCT02452762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172311|NCT02452762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102172312|NCT02452762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102172313|NCT04886414|Hand Sanitizers|hand sanitizers|mesh-list
102172314|NCT04886414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102172315|NCT04886414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102172316|NCT04886414|Disinfectants|disinfectants|mesh-ancestor
102172317|NCT05633420|Artesunate|artesunate|mesh-list
102172318|NCT05633420|Pyronaridine|pyronaridine|mesh-list
101881157|NCT01079624|Glucagon|glucagon|mesh-list
102172319|NCT05633420|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
102172321|NCT05633420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102172322|NCT05633420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102172323|NCT05633420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102172324|NCT05633420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102172325|NCT05633420|Antiviral Agents|antiviral agents|mesh-ancestor
102172326|NCT05633420|Schistosomicides|schistosomicides|mesh-ancestor
102172327|NCT05633420|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102172328|NCT05633420|Anthelmintics|anthelmintics|mesh-ancestor
102172329|NCT05729594|Bimatoprost|bimatoprost|mesh-list
102172330|NCT05729594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102172331|NCT02631746|Nivolumab|nivolumab|mesh-list
102172332|NCT02631746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102172333|NCT02631746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102172334|NCT02631746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102172335|NCT02631746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172336|NCT04699058|Antibodies|antibodies|mesh-list
102172337|NCT04699058|Immunologic Factors|immunologic factors|mesh-ancestor
102172338|NCT04699058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172339|NCT05487092|Letrozole|letrozole|mesh-list
102172340|NCT05487092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102172341|NCT05487092|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102172342|NCT05487092|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102172343|NCT05487092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102172344|NCT05487092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172345|NCT05487092|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102172346|NCT05487092|Hormone Antagonists|hormone antagonists|mesh-ancestor
102172347|NCT05487092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102172348|NCT05487092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172349|NCT05728892|Melatonin|melatonin|mesh-list
102172350|NCT05728892|Antioxidants|antioxidants|mesh-ancestor
102172351|NCT05728892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172352|NCT05728892|Protective Agents|protective agents|mesh-ancestor
102172353|NCT05728892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172354|NCT05728892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102172355|NCT03067688|Amlodipine|amlodipine|mesh-list
102172356|NCT03067688|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
102172357|NCT03067688|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102172358|NCT03067688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102172359|NCT03067688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102172360|NCT03067688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102172361|NCT03067688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172362|NCT03067688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102172363|NCT03067688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172364|NCT03067688|Vasodilator Agents|vasodilator agents|mesh-ancestor
102172365|NCT03067688|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102172366|NCT03067688|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102172367|NCT03067688|Antimetabolites|antimetabolites|mesh-ancestor
102172368|NCT03067688|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102172369|NCT03067688|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102172370|NCT03067688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102172371|NCT03067688|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102172372|NCT03067688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102172373|NCT02396758|Plasminogen|plasminogen|mesh-list
102172374|NCT02396758|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102172375|NCT02396758|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102172376|NCT02396758|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102172377|NCT02396758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172378|NCT05728424|Amoxicillin|amoxicillin|mesh-list
102172379|NCT05728424|Levofloxacin|levofloxacin|mesh-list
102172380|NCT05728424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102172381|NCT05728424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102172382|NCT05728424|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102172383|NCT05728424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102172384|NCT05728424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102172385|NCT05728424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102172386|NCT05728424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172387|NCT05728424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102172388|NCT05728424|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102172389|NCT05728424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102172390|NCT05728268|Paclitaxel|paclitaxel|mesh-list
102172391|NCT05728268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102172392|NCT05728268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102172393|NCT05728268|Tubulin Modulators|tubulin modulators|mesh-ancestor
102172394|NCT05728268|Antimitotic Agents|antimitotic agents|mesh-ancestor
102172395|NCT05728268|Mitosis Modulators|mitosis modulators|mesh-ancestor
102172396|NCT05728268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172397|NCT04882358|Dapagliflozin|dapagliflozin|mesh-list
102172398|NCT04882358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102172399|NCT04882358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172400|NCT04882358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102172401|NCT04882358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172402|NCT04926844|Midazolam|midazolam|mesh-list
102172403|NCT04926844|Levetiracetam|levetiracetam|mesh-list
102172404|NCT04926844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102172405|NCT04926844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102172406|NCT04926844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102172407|NCT04926844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172408|NCT04926844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102172409|NCT04926844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102172410|NCT04926844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102172411|NCT04926844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102172412|NCT04926844|Anesthetics, General|anesthetics, general|mesh-ancestor
102172413|NCT04926844|Anesthetics|anesthetics|mesh-ancestor
102172414|NCT04926844|GABA Modulators|gaba modulators|mesh-ancestor
102172415|NCT04926844|GABA Agents|gaba agents|mesh-ancestor
102172416|NCT04926844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102172417|NCT04926844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172418|NCT04926844|Anticonvulsants|anticonvulsants|mesh-ancestor
102172419|NCT04926844|Nootropic Agents|nootropic agents|mesh-ancestor
102172420|NCT05482256|Listerine|listerine|mesh-list
102172421|NCT05482256|Sodium Fluoride|sodium fluoride|mesh-list
102172422|NCT05482256|Cariostatic Agents|cariostatic agents|mesh-ancestor
102172423|NCT05482256|Protective Agents|protective agents|mesh-ancestor
102172424|NCT05482256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172425|NCT05482256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102172426|NCT05482256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102172427|NCT01651936|Methotrexate|methotrexate|mesh-list
102172428|NCT01651936|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102172429|NCT01651936|Abortifacient Agents|abortifacient agents|mesh-ancestor
102172430|NCT01651936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102172431|NCT01651936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172432|NCT01651936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102172433|NCT01651936|Antimetabolites|antimetabolites|mesh-ancestor
102172434|NCT01651936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172435|NCT01651936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102172436|NCT01651936|Dermatologic Agents|dermatologic agents|mesh-ancestor
102172437|NCT01651936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102172438|NCT01651936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102172439|NCT01651936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102172440|NCT01651936|Immunologic Factors|immunologic factors|mesh-ancestor
102172441|NCT01651936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102172442|NCT01651936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102172443|NCT04075916|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102172444|NCT04075916|Antiviral Agents|antiviral agents|mesh-ancestor
102172445|NCT04075916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102172446|NCT03065504|Turmeric extract|turmeric extract|mesh-list
102172447|NCT03065504|Antioxidants|antioxidants|mesh-ancestor
102172448|NCT03065504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172449|NCT03065504|Protective Agents|protective agents|mesh-ancestor
102172450|NCT03065504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172451|NCT02630966|Vedolizumab|vedolizumab|mesh-list
102172452|NCT02630966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102172453|NCT05724212|Interferons|interferons|mesh-list
102172454|NCT05724212|Interferon-gamma|interferon-gamma|mesh-list
102172455|NCT05724212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102172456|NCT05724212|Antiviral Agents|antiviral agents|mesh-ancestor
102172457|NCT05724212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102172458|NCT01651780|Heparin|heparin|mesh-list
102172459|NCT01651780|Calcium heparin|calcium heparin|mesh-list
102172460|NCT01651780|Bivalirudin|bivalirudin|mesh-list
102172461|NCT01651780|Anticoagulants|anticoagulants|mesh-ancestor
102172462|NCT01651780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102172463|NCT01651780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102172464|NCT01651780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172465|NCT01651780|Antithrombins|antithrombins|mesh-ancestor
102172466|NCT01651780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102172467|NCT01651780|Protease Inhibitors|protease inhibitors|mesh-ancestor
102172468|NCT01651780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102172469|NCT02394730|Vorapaxar|vorapaxar|mesh-list
102172470|NCT02394730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102172471|NCT05376878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102172472|NCT05376878|Trastuzumab|trastuzumab|mesh-list
102172473|NCT05376878|Camptothecin|camptothecin|mesh-list
102172474|NCT05376878|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
102172475|NCT05376878|Antibodies|antibodies|mesh-list
102172476|NCT05376878|Immunoglobulins|immunoglobulins|mesh-list
102172477|NCT05376878|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102172478|NCT05376878|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
102172479|NCT05376878|Immunoconjugates|immunoconjugates|mesh-list
102172480|NCT05376878|Immunologic Factors|immunologic factors|mesh-ancestor
102172481|NCT05376878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172482|NCT05376878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101447117|NCT00209703|Antidotes|antidotes|mesh-ancestor
102172483|NCT05376878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172484|NCT05376878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102172485|NCT05376878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102172486|NCT05376878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102172487|NCT05376878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102172488|NCT02430532|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102172489|NCT02430532|Dermatologic Agents|dermatologic agents|mesh-ancestor
102172490|NCT02430532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102172491|NCT02430532|Immunologic Factors|immunologic factors|mesh-ancestor
102172492|NCT02430532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172493|NCT05357612|Pimavanserin|pimavanserin|mesh-list
102172494|NCT05357612|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102172495|NCT05357612|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102172496|NCT05357612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102172497|NCT05357612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102172498|NCT05357612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102172499|NCT05357612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172500|NCT05357612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102172501|NCT05357612|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102172502|NCT05357612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102172503|NCT05357612|Serotonin Agents|serotonin agents|mesh-ancestor
102172504|NCT05357612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102172505|NCT05357612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172506|NCT02394340|Luliconazole|luliconazole|mesh-list
102172507|NCT02394340|Omeprazole|omeprazole|mesh-list
102172508|NCT02394340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102172509|NCT02394340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102172510|NCT02394340|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102172511|NCT02394340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102172512|NCT02394340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172513|NCT02394340|Antifungal Agents|antifungal agents|mesh-ancestor
102172514|NCT02394340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102172515|NCT01672736|Dexamethasone|dexamethasone|mesh-list
102172516|NCT01672736|Dexamethasone acetate|dexamethasone acetate|mesh-list
102172517|NCT01672736|Bortezomib|bortezomib|mesh-list
102172518|NCT01672736|BB 1101|bb 1101|mesh-list
102172519|NCT01672736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102172520|NCT01672736|Antiemetics|antiemetics|mesh-ancestor
102172521|NCT01672736|Autonomic Agents|autonomic agents|mesh-ancestor
102172522|NCT01672736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102172523|NCT01672736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172524|NCT01672736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102172525|NCT01672736|Glucocorticoids|glucocorticoids|mesh-ancestor
102172526|NCT01672736|Hormones|hormones|mesh-ancestor
102172527|NCT01672736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102172528|NCT01672736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102172529|NCT01672736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102172530|NCT01672736|Protease Inhibitors|protease inhibitors|mesh-ancestor
102172531|NCT01672736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102172532|NCT01672736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172533|NCT03065660|Mifepristone|mifepristone|mesh-list
102172534|NCT03065660|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102172535|NCT03065660|Abortifacient Agents|abortifacient agents|mesh-ancestor
102172536|NCT03065660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102172537|NCT03065660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172538|NCT03065660|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102172539|NCT03065660|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102172540|NCT03065660|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101881372|NCT00084656|Ipilimumab|ipilimumab|mesh-list
102172541|NCT03065660|Contraceptive Agents|contraceptive agents|mesh-ancestor
102172542|NCT03065660|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102172543|NCT03065660|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102172544|NCT03065660|Hormone Antagonists|hormone antagonists|mesh-ancestor
102172545|NCT03065660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102172546|NCT03065660|Luteolytic Agents|luteolytic agents|mesh-ancestor
102172547|NCT03065660|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101447130|NCT00216606|Topiramate|topiramate|mesh-list
102172548|NCT03065660|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102172549|NCT03893630|Aspirin|aspirin|mesh-list
102172550|NCT03893630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102172551|NCT03893630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102172552|NCT03893630|Analgesics|analgesics|mesh-ancestor
102172553|NCT03893630|Sensory System Agents|sensory system agents|mesh-ancestor
102172554|NCT03893630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102172555|NCT03893630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172556|NCT03893630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102172557|NCT03893630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102172558|NCT03893630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102172559|NCT03893630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102172560|NCT03893630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172561|NCT03893630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102172562|NCT03893630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102172563|NCT03893630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102172564|NCT03893630|Antipyretics|antipyretics|mesh-ancestor
102172565|NCT03065816|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
102172566|NCT03065816|Antacids|antacids|mesh-ancestor
102172567|NCT03065816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172568|NCT03065816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102172569|NCT05619848|Midazolam|midazolam|mesh-list
102172570|NCT05619848|Remifentanil|remifentanil|mesh-list
102172571|NCT05619848|Bromides|bromides|mesh-list
102172572|NCT05619848|Propofol|propofol|mesh-list
102172573|NCT05619848|Etomidate|etomidate|mesh-list
102172574|NCT05619848|Rocuronium|rocuronium|mesh-list
102172575|NCT05619848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102172576|NCT05619848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102172577|NCT05619848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172578|NCT05619848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102172579|NCT05619848|Anesthetics, General|anesthetics, general|mesh-ancestor
102172580|NCT05619848|Anesthetics|anesthetics|mesh-ancestor
102172581|NCT05619848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102172582|NCT05619848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102172583|NCT05619848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102172584|NCT05619848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102172585|NCT05619848|GABA Modulators|gaba modulators|mesh-ancestor
102172586|NCT05619848|GABA Agents|gaba agents|mesh-ancestor
102172587|NCT05619848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102172588|NCT05619848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172589|NCT05619848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102172590|NCT05619848|Narcotics|narcotics|mesh-ancestor
102172591|NCT05619848|Analgesics|analgesics|mesh-ancestor
102172592|NCT05619848|Sensory System Agents|sensory system agents|mesh-ancestor
102172593|NCT05619848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102172594|NCT05619848|Anticonvulsants|anticonvulsants|mesh-ancestor
102172595|NCT05619848|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102172596|NCT05619848|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102172597|NCT05619848|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102172598|NCT01560637|Treprostinil|treprostinil|mesh-list
102172599|NCT01560637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102172600|NCT04447352|Leucovorin|leucovorin|mesh-list
102172601|NCT04447352|Docetaxel|docetaxel|mesh-list
102172602|NCT04447352|Fluorouracil|fluorouracil|mesh-list
102172603|NCT04447352|Oxaliplatin|oxaliplatin|mesh-list
102172604|NCT04447352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102172605|NCT04447352|Tubulin Modulators|tubulin modulators|mesh-ancestor
102172606|NCT04447352|Antimitotic Agents|antimitotic agents|mesh-ancestor
102172607|NCT04447352|Mitosis Modulators|mitosis modulators|mesh-ancestor
102172608|NCT04447352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172609|NCT04447352|Antimetabolites|antimetabolites|mesh-ancestor
102172610|NCT04447352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102172611|NCT04447352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102172612|NCT04447352|Immunologic Factors|immunologic factors|mesh-ancestor
102172613|NCT04447352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172614|NCT04447352|Antidotes|antidotes|mesh-ancestor
102172615|NCT04447352|Protective Agents|protective agents|mesh-ancestor
102172616|NCT04447352|Vitamin B Complex|vitamin b complex|mesh-ancestor
101881435|NCT00373529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102172618|NCT04447352|Micronutrients|micronutrients|mesh-ancestor
102172619|NCT04157036|Ibuprofen|ibuprofen|mesh-list
102172620|NCT04157036|Methylprednisolone|methylprednisolone|mesh-list
102172621|NCT04157036|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102172622|NCT04157036|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102172623|NCT04157036|Prednisolone|prednisolone|mesh-list
102172624|NCT04157036|Prednisolone acetate|prednisolone acetate|mesh-list
102172625|NCT04157036|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102172626|NCT04157036|Prednisolone phosphate|prednisolone phosphate|mesh-list
102172627|NCT04157036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102172628|NCT04157036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102172629|NCT04157036|Analgesics|analgesics|mesh-ancestor
102172630|NCT04157036|Sensory System Agents|sensory system agents|mesh-ancestor
102172631|NCT04157036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102172632|NCT04157036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172633|NCT04157036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102172634|NCT04157036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102172635|NCT04157036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102172636|NCT04157036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102172637|NCT04157036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172638|NCT04157036|Antiemetics|antiemetics|mesh-ancestor
102172639|NCT04157036|Autonomic Agents|autonomic agents|mesh-ancestor
102172640|NCT04157036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102172641|NCT04157036|Glucocorticoids|glucocorticoids|mesh-ancestor
102172642|NCT04157036|Hormones|hormones|mesh-ancestor
102172643|NCT04157036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102172644|NCT04157036|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102172645|NCT04157036|Protective Agents|protective agents|mesh-ancestor
102172646|NCT04157036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102172647|NCT04157036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102172648|NCT03547375|Apatinib|apatinib|mesh-list
102172649|NCT03547375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102172650|NCT03547375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102172651|NCT03547375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102172652|NCT03547375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172653|NCT01353911|Interferons|interferons|mesh-list
102172654|NCT01353911|Ribavirin|ribavirin|mesh-list
102172655|NCT01353911|Interferon-alpha|interferon-alpha|mesh-list
102172656|NCT01353911|Interferon alpha-2|interferon alpha-2|mesh-list
102172657|NCT01353911|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102172658|NCT01353911|Grazoprevir|grazoprevir|mesh-list
102172659|NCT01353911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102172660|NCT01353911|Antiviral Agents|antiviral agents|mesh-ancestor
102172661|NCT01353911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102172662|NCT01353911|Antimetabolites|antimetabolites|mesh-ancestor
102172663|NCT01353911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172664|NCT01353911|Immunologic Factors|immunologic factors|mesh-ancestor
102172665|NCT01353911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172666|NCT05575297|Rifampin|rifampin|mesh-list
102172667|NCT05575297|Methotrexate|methotrexate|mesh-list
102172668|NCT05575297|Febuxostat|febuxostat|mesh-list
102172669|NCT05575297|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102172670|NCT05575297|Abortifacient Agents|abortifacient agents|mesh-ancestor
102172671|NCT05575297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102172672|NCT05575297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172673|NCT05575297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102172674|NCT05575297|Antimetabolites|antimetabolites|mesh-ancestor
102172675|NCT05575297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172676|NCT05575297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102172677|NCT05575297|Dermatologic Agents|dermatologic agents|mesh-ancestor
102172678|NCT05575297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102172679|NCT05575297|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102172680|NCT05575297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102172681|NCT05575297|Immunologic Factors|immunologic factors|mesh-ancestor
102172682|NCT05575297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102172683|NCT05575297|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102172684|NCT05575297|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102172685|NCT05575297|Antitubercular Agents|antitubercular agents|mesh-ancestor
102172686|NCT05575297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102172687|NCT05575297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102172688|NCT05575297|Leprostatic Agents|leprostatic agents|mesh-ancestor
102172689|NCT05575297|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102172690|NCT05575297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102172691|NCT05575297|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101881514|NCT00384293|Vitamins|vitamins|mesh-ancestor
102172692|NCT05575297|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102172693|NCT05575297|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102172694|NCT05575297|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102172695|NCT05575297|Gout Suppressants|gout suppressants|mesh-ancestor
102172696|NCT01671488|Mitomycins|mitomycins|mesh-list
102172697|NCT01671488|Mitomycin|mitomycin|mesh-list
102172698|NCT01671488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102172699|NCT01671488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102172700|NCT01671488|Alkylating Agents|alkylating agents|mesh-ancestor
102172701|NCT01671488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172702|NCT01671488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102172703|NCT01671488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102172704|NCT05400889|Tofacitinib|tofacitinib|mesh-list
102172705|NCT05400889|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102172706|NCT05400889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102172707|NCT05400889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102172708|NCT05400889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172709|NCT05395117|Digoxin|digoxin|mesh-list
102172710|NCT05395117|Midazolam|midazolam|mesh-list
102172711|NCT05395117|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102172712|NCT05395117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102172713|NCT05395117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102172714|NCT05395117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102172715|NCT05395117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172716|NCT05395117|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102172717|NCT05395117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102172718|NCT05395117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102172719|NCT05395117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102172720|NCT05395117|Anesthetics, General|anesthetics, general|mesh-ancestor
102172721|NCT05395117|Anesthetics|anesthetics|mesh-ancestor
102172722|NCT05395117|GABA Modulators|gaba modulators|mesh-ancestor
102172723|NCT05395117|GABA Agents|gaba agents|mesh-ancestor
102172724|NCT05395117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102172725|NCT05395117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172726|NCT05395117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102172727|NCT05395117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102172728|NCT05395117|Antimetabolites|antimetabolites|mesh-ancestor
102172729|NCT05395117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102172730|NCT05395117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102172731|NCT05395117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102172732|NCT05395117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102172733|NCT05395117|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102172734|NCT05395117|Protective Agents|protective agents|mesh-ancestor
102172735|NCT05325229|Bevacizumab|bevacizumab|mesh-list
102172736|NCT05325229|Docetaxel|docetaxel|mesh-list
102172737|NCT05325229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102172738|NCT05325229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102172739|NCT05325229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102172740|NCT05325229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102172741|NCT05325229|Growth Substances|growth substances|mesh-ancestor
102172742|NCT05325229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172743|NCT05325229|Growth Inhibitors|growth inhibitors|mesh-ancestor
102172744|NCT05325229|Tubulin Modulators|tubulin modulators|mesh-ancestor
102172745|NCT05325229|Antimitotic Agents|antimitotic agents|mesh-ancestor
102172746|NCT05325229|Mitosis Modulators|mitosis modulators|mesh-ancestor
102172747|NCT05325229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172748|NCT05573581|Botulinum Toxins|botulinum toxins|mesh-list
102172749|NCT05573581|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102172750|NCT05573581|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102172751|NCT05573581|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102172752|NCT05573581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102172753|NCT05573581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172754|NCT05573581|Cholinergic Agents|cholinergic agents|mesh-ancestor
102172755|NCT05573581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102172756|NCT05573581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172757|NCT05573581|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102172758|NCT05573581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102172759|NCT01358357|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102172760|NCT01358357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102172761|NCT01358357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102172762|NCT01358357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102172763|NCT01358357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172764|NCT01358357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102172765|NCT01358357|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102172766|NCT01358357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102172767|NCT01358357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102172768|NCT01358357|Adrenergic Agents|adrenergic agents|mesh-ancestor
102172769|NCT01358357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102172770|NCT01358357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172771|NCT01358357|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102172772|NCT01358357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102172773|NCT01358357|Serotonin Agents|serotonin agents|mesh-ancestor
102172774|NCT01358357|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102172775|NCT01358357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102172776|NCT01358357|Dopamine Agents|dopamine agents|mesh-ancestor
102172777|NCT05573425|Tazarotene|tazarotene|mesh-list
102172778|NCT05573425|Dermatologic Agents|dermatologic agents|mesh-ancestor
102172779|NCT05573425|Keratolytic Agents|keratolytic agents|mesh-ancestor
102172780|NCT02253901|Ritonavir|ritonavir|mesh-list
102172781|NCT02253901|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102172782|NCT02253901|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102172783|NCT02253901|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102172784|NCT02253901|Protease Inhibitors|protease inhibitors|mesh-ancestor
102172785|NCT02253901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102172786|NCT02253901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172787|NCT02253901|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102172788|NCT02253901|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102172789|NCT02253901|Antiviral Agents|antiviral agents|mesh-ancestor
102172790|NCT02253901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102172791|NCT02253901|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102172792|NCT02253901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102172793|NCT02253901|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102172794|NCT02253901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102172795|NCT03546283|Cardiac Glycosides|cardiac glycosides|mesh-list
102172796|NCT03546283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102172797|NCT03546283|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102172798|NCT03546283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102172799|NCT03546283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172800|NCT03546283|Protective Agents|protective agents|mesh-ancestor
102172801|NCT03546283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172802|NCT02831387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102172803|NCT02831387|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102172804|NCT03547219|Escitalopram|escitalopram|mesh-list
102172805|NCT03547219|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102172806|NCT03547219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102172807|NCT03547219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102172808|NCT03547219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172809|NCT03547219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102172810|NCT03547219|Serotonin Agents|serotonin agents|mesh-ancestor
102172811|NCT03547219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172812|NCT04069819|Cilostazol|cilostazol|mesh-list
102172813|NCT04069819|Escitalopram|escitalopram|mesh-list
102172814|NCT04069819|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102172815|NCT04069819|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102172816|NCT04069819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102172817|NCT04069819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172818|NCT04069819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102172819|NCT04069819|Serotonin Agents|serotonin agents|mesh-ancestor
102172820|NCT04069819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172821|NCT04069819|Autonomic Agents|autonomic agents|mesh-ancestor
102172822|NCT04069819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102172823|NCT04069819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102172824|NCT04069819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102172825|NCT04069819|Respiratory System Agents|respiratory system agents|mesh-ancestor
102172826|NCT04069819|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102172827|NCT04069819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102172828|NCT04069819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102172829|NCT04069819|Vasodilator Agents|vasodilator agents|mesh-ancestor
102172830|NCT04069819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102172831|NCT04069819|Protective Agents|protective agents|mesh-ancestor
102172832|NCT04069819|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102172833|NCT04069819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102172834|NCT04069819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102172835|NCT04084496|Folfirinox|folfirinox|mesh-list
102172836|NCT04084496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102172837|NCT02831855|Methotrexate|methotrexate|mesh-list
102172838|NCT02831855|Tofacitinib|tofacitinib|mesh-list
102172839|NCT02831855|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102172840|NCT02831855|Abortifacient Agents|abortifacient agents|mesh-ancestor
102172841|NCT02831855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102172842|NCT02831855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172843|NCT02831855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102172844|NCT02831855|Antimetabolites|antimetabolites|mesh-ancestor
102172845|NCT02831855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172846|NCT02831855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102172847|NCT02831855|Dermatologic Agents|dermatologic agents|mesh-ancestor
102172848|NCT02831855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102172849|NCT02831855|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102172850|NCT02831855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102172851|NCT02831855|Immunologic Factors|immunologic factors|mesh-ancestor
102172852|NCT02831855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102172853|NCT02831855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102172854|NCT02831855|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102172855|NCT02831855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102172856|NCT04071626|Ertugliflozin|ertugliflozin|mesh-list
102172857|NCT04071626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102172858|NCT04071626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172859|NCT04071626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102172860|NCT04071626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172861|NCT01356407|Picosulfate sodium|picosulfate sodium|mesh-list
102172862|NCT01356407|Cathartics|cathartics|mesh-ancestor
102172863|NCT01356407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102172864|NCT00109837|Leucovorin|leucovorin|mesh-list
102172865|NCT00109837|Cytarabine|cytarabine|mesh-list
102172866|NCT00109837|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102172867|NCT00109837|Dexamethasone|dexamethasone|mesh-list
102172868|NCT00109837|Prednisone|prednisone|mesh-list
102172869|NCT00109837|Cyclophosphamide|cyclophosphamide|mesh-list
102172870|NCT00109837|Doxorubicin|doxorubicin|mesh-list
102172871|NCT00109837|Methotrexate|methotrexate|mesh-list
102172872|NCT00109837|Vincristine|vincristine|mesh-list
102172873|NCT00109837|Daunorubicin|daunorubicin|mesh-list
102172874|NCT00109837|Asparaginase|asparaginase|mesh-list
102172875|NCT00109837|Mitoxantrone|mitoxantrone|mesh-list
102172876|NCT00109837|Mercaptopurine|mercaptopurine|mesh-list
102172877|NCT00109837|Thioguanine|thioguanine|mesh-list
102172878|NCT00109837|Allopurinol|allopurinol|mesh-list
102172879|NCT00109837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102172880|NCT00109837|Immunologic Factors|immunologic factors|mesh-ancestor
102172881|NCT00109837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172882|NCT00109837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102172883|NCT00109837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102172884|NCT00109837|Alkylating Agents|alkylating agents|mesh-ancestor
102172885|NCT00109837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172886|NCT00109837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102172887|NCT00109837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102172888|NCT00109837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102172889|NCT00109837|Antiemetics|antiemetics|mesh-ancestor
102172890|NCT00109837|Autonomic Agents|autonomic agents|mesh-ancestor
102172891|NCT00109837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102172892|NCT00109837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102172893|NCT00109837|Glucocorticoids|glucocorticoids|mesh-ancestor
102172894|NCT00109837|Hormones|hormones|mesh-ancestor
102172895|NCT00109837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102172896|NCT00109837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102172897|NCT00109837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102172898|NCT00109837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102172899|NCT00109837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102172900|NCT00109837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102172901|NCT00109837|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102172902|NCT00109837|Abortifacient Agents|abortifacient agents|mesh-ancestor
102172903|NCT00109837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102172904|NCT00109837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102172906|NCT00109837|Dermatologic Agents|dermatologic agents|mesh-ancestor
102172907|NCT00109837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102172908|NCT00109837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102172909|NCT00109837|Antiviral Agents|antiviral agents|mesh-ancestor
102172910|NCT00109837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102172911|NCT00109837|Antidotes|antidotes|mesh-ancestor
102172912|NCT00109837|Protective Agents|protective agents|mesh-ancestor
102172913|NCT00109837|Vitamin B Complex|vitamin b complex|mesh-ancestor
102172914|NCT00109837|Vitamins|vitamins|mesh-ancestor
101881739|NCT00099632|Ritonavir|ritonavir|mesh-list
102172915|NCT00109837|Micronutrients|micronutrients|mesh-ancestor
102172916|NCT00109837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102172917|NCT00109837|Tubulin Modulators|tubulin modulators|mesh-ancestor
102172918|NCT00109837|Antimitotic Agents|antimitotic agents|mesh-ancestor
102172919|NCT00109837|Mitosis Modulators|mitosis modulators|mesh-ancestor
102172920|NCT00109837|Analgesics|analgesics|mesh-ancestor
102172921|NCT00109837|Sensory System Agents|sensory system agents|mesh-ancestor
102172922|NCT00109837|Gout Suppressants|gout suppressants|mesh-ancestor
102172923|NCT00109837|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102172924|NCT00109837|Antioxidants|antioxidants|mesh-ancestor
102172925|NCT00109837|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102172926|NCT00109837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102172927|NCT00109837|Antimalarials|antimalarials|mesh-ancestor
102172928|NCT00109837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102172929|NCT00109837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102172930|NCT05229445|Insulin|insulin|mesh-list
102172931|NCT05229445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102172932|NCT05229445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172933|NCT01671332|Suramin|suramin|mesh-list
102172934|NCT01671332|Docetaxel|docetaxel|mesh-list
102172935|NCT01671332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102172936|NCT01671332|Tubulin Modulators|tubulin modulators|mesh-ancestor
102172937|NCT01671332|Antimitotic Agents|antimitotic agents|mesh-ancestor
102172938|NCT01671332|Mitosis Modulators|mitosis modulators|mesh-ancestor
102172939|NCT01671332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172940|NCT01671332|Antinematodal Agents|antinematodal agents|mesh-ancestor
102172941|NCT01671332|Anthelmintics|anthelmintics|mesh-ancestor
102172942|NCT01671332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102172943|NCT01671332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102172944|NCT01671332|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102172945|NCT01671332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102172946|NCT03063242|Sargramostim|sargramostim|mesh-list
102172947|NCT03063242|Immunologic Factors|immunologic factors|mesh-ancestor
102172948|NCT03063242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172949|NCT03897062|Suvorexant|suvorexant|mesh-list
102172950|NCT03897062|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102172951|NCT03897062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102172952|NCT03897062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102172953|NCT03897062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172954|NCT03897062|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102172955|NCT03897062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101447175|NCT00588016|Antifungal Agents|antifungal agents|mesh-ancestor
102172956|NCT03897062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172957|NCT00100802|Temozolomide|temozolomide|mesh-list
102172958|NCT00100802|Lomustine|lomustine|mesh-list
102172959|NCT00100802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102172960|NCT00100802|Alkylating Agents|alkylating agents|mesh-ancestor
102172961|NCT00100802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172962|NCT00100802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102172963|NCT01355159|Folic Acid|folic acid|mesh-list
102172964|NCT01355159|Hematinics|hematinics|mesh-ancestor
102172965|NCT01355159|Vitamin B Complex|vitamin b complex|mesh-ancestor
102172966|NCT01355159|Vitamins|vitamins|mesh-ancestor
102172967|NCT01355159|Micronutrients|micronutrients|mesh-ancestor
102172968|NCT01355159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172969|NCT04661852|Cyclophosphamide|cyclophosphamide|mesh-list
102172970|NCT04661852|Topotecan|topotecan|mesh-list
102172971|NCT04661852|Mitogens|mitogens|mesh-list
102172972|NCT04661852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102172973|NCT04661852|Immunologic Factors|immunologic factors|mesh-ancestor
102172974|NCT04661852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102172975|NCT04661852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102172976|NCT04661852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102172977|NCT04661852|Alkylating Agents|alkylating agents|mesh-ancestor
102172978|NCT04661852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172979|NCT04661852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102172980|NCT04661852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102172981|NCT04661852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102172982|NCT04661852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102172983|NCT04661852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102172984|NCT04661852|Mitosis Modulators|mitosis modulators|mesh-ancestor
102172986|NCT02630186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102172987|NCT02630186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102172988|NCT02630186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102172989|NCT02630186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102172990|NCT00002462|Cobalt|cobalt|mesh-list
102172991|NCT00002462|Prednisone|prednisone|mesh-list
102172992|NCT00002462|Doxorubicin|doxorubicin|mesh-list
102172994|NCT00002462|Bleomycin|bleomycin|mesh-list
102172995|NCT00002462|Vincristine|vincristine|mesh-list
102172996|NCT00002462|Vinblastine|vinblastine|mesh-list
102172997|NCT00002462|Procarbazine|procarbazine|mesh-list
102172998|NCT00002462|Mechlorethamine|mechlorethamine|mesh-list
102172999|NCT00002462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102173000|NCT00002462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102173001|NCT00002462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102173002|NCT00002462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102173003|NCT00002462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102173004|NCT00002462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173005|NCT00002462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102173006|NCT00002462|Glucocorticoids|glucocorticoids|mesh-ancestor
102173007|NCT00002462|Hormones|hormones|mesh-ancestor
102173008|NCT00002462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102173009|NCT00002462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173010|NCT00002462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102173011|NCT00002462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102173012|NCT00002462|Tubulin Modulators|tubulin modulators|mesh-ancestor
102173013|NCT00002462|Antimitotic Agents|antimitotic agents|mesh-ancestor
102173014|NCT00002462|Mitosis Modulators|mitosis modulators|mesh-ancestor
102173015|NCT00002462|Trace Elements|trace elements|mesh-ancestor
102173016|NCT00002462|Micronutrients|micronutrients|mesh-ancestor
102173017|NCT00002462|Alkylating Agents|alkylating agents|mesh-ancestor
102173018|NCT00002462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102173019|NCT01669928|Antihypertensive Agents|antihypertensive agents|mesh-list
102173020|NCT01669928|Calcium Channel Blockers|calcium channel blockers|mesh-list
102173021|NCT01669928|Angiotensin II|angiotensin ii|mesh-list
102173022|NCT01669928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102173023|NCT01669928|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
102173024|NCT01669928|Renin Inhibitors|renin inhibitors|mesh-list
102173025|NCT01669928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102173026|NCT01669928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173027|NCT01669928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173028|NCT01669928|Protease Inhibitors|protease inhibitors|mesh-ancestor
102173029|NCT01669928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102173030|NCT01669928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102173031|NCT01669928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102173032|NCT01995578|Azacitidine|azacitidine|mesh-list
102173033|NCT01995578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102173034|NCT01995578|Antimetabolites|antimetabolites|mesh-ancestor
102173035|NCT01995578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173036|NCT01995578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102173037|NCT01995578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102173038|NCT04440176|Vaccines|vaccines|mesh-list
102173039|NCT04440176|Immunologic Factors|immunologic factors|mesh-ancestor
102173040|NCT04440176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173041|NCT03595592|Paclitaxel|paclitaxel|mesh-list
102173042|NCT03595592|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102173043|NCT03595592|Cyclophosphamide|cyclophosphamide|mesh-list
102173044|NCT03595592|Carboplatin|carboplatin|mesh-list
102173045|NCT03595592|Doxorubicin|doxorubicin|mesh-list
102173046|NCT03595592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102173047|NCT03595592|Trastuzumab|trastuzumab|mesh-list
102173048|NCT03595592|Atezolizumab|atezolizumab|mesh-list
102173049|NCT03595592|Pertuzumab|pertuzumab|mesh-list
102173050|NCT03595592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102173051|NCT03595592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102173052|NCT03595592|Tubulin Modulators|tubulin modulators|mesh-ancestor
102173053|NCT03595592|Antimitotic Agents|antimitotic agents|mesh-ancestor
102173054|NCT03595592|Mitosis Modulators|mitosis modulators|mesh-ancestor
102173055|NCT03595592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173056|NCT03595592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102173057|NCT03595592|Immunologic Factors|immunologic factors|mesh-ancestor
102173058|NCT03595592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173059|NCT03595592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102173060|NCT03595592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102173061|NCT03595592|Alkylating Agents|alkylating agents|mesh-ancestor
102173062|NCT03595592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102173063|NCT03595592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102173064|NCT03595592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102173065|NCT03595592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102173066|NCT03595592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102173067|NCT03595592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102173068|NCT03595592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102173069|NCT01355081|Vortioxetine|vortioxetine|mesh-list
102173070|NCT01355081|Antidepressive Agents|antidepressive agents|mesh-ancestor
102173071|NCT01355081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102173072|NCT01355081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102173073|NCT01355081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102173074|NCT01355081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102173075|NCT01355081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173076|NCT01355081|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102173077|NCT01355081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102173078|NCT01355081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102173079|NCT01355081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173080|NCT01355081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102173081|NCT01355081|Serotonin Agents|serotonin agents|mesh-ancestor
102173082|NCT01355081|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102173083|NCT01355081|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102173084|NCT01355081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102173085|NCT01355081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102173086|NCT02259959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102173087|NCT02259959|Tiotropium Bromide|tiotropium bromide|mesh-list
102173088|NCT02259959|Olodaterol|olodaterol|mesh-list
102173089|NCT02259959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102173090|NCT02259959|Autonomic Agents|autonomic agents|mesh-ancestor
102173091|NCT02259959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102173092|NCT02259959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173093|NCT02259959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102173094|NCT02259959|Respiratory System Agents|respiratory system agents|mesh-ancestor
102173095|NCT02259959|Parasympatholytics|parasympatholytics|mesh-ancestor
101447182|NCT00588016|Hormone Antagonists|hormone antagonists|mesh-ancestor
102173096|NCT02259959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102173097|NCT02259959|Cholinergic Agents|cholinergic agents|mesh-ancestor
102173098|NCT02259959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102173099|NCT02259959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173100|NCT03062462|Clopidogrel|clopidogrel|mesh-list
102173101|NCT03062462|Ticagrelor|ticagrelor|mesh-list
102173102|NCT03062462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102173103|NCT03062462|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102173104|NCT03062462|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102173105|NCT03062462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102173106|NCT03062462|Purinergic Agents|purinergic agents|mesh-ancestor
102173107|NCT03062462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102173108|NCT03062462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173109|NCT03062462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173110|NCT04433078|Doxycycline|doxycycline|mesh-list
102173111|NCT04433078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102173112|NCT04433078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102173113|NCT04433078|Antimalarials|antimalarials|mesh-ancestor
102173114|NCT04433078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102173115|NCT04433078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102173116|NCT04458311|Abiraterone Acetate|abiraterone acetate|mesh-list
102173117|NCT04458311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102173118|NCT04458311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102173119|NCT04458311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102173120|NCT04458311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173121|NCT04458311|Hormone Antagonists|hormone antagonists|mesh-ancestor
102173122|NCT04458311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102173123|NCT04458311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173124|NCT04458311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102173125|NCT05212571|Ketamine|ketamine|mesh-list
102173126|NCT05212571|Esketamine|esketamine|mesh-list
102173127|NCT05212571|Analgesics|analgesics|mesh-ancestor
102173128|NCT05212571|Sensory System Agents|sensory system agents|mesh-ancestor
102173129|NCT05212571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102173130|NCT05212571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173131|NCT05212571|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102173132|NCT05212571|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102173133|NCT05212571|Anesthetics, General|anesthetics, general|mesh-ancestor
102173134|NCT05212571|Anesthetics|anesthetics|mesh-ancestor
102173135|NCT05212571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102173136|NCT05212571|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102173137|NCT05212571|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102173138|NCT05212571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102173139|NCT05212571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173140|NCT05212571|Antidepressive Agents|antidepressive agents|mesh-ancestor
102173141|NCT05212571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102173142|NCT04368533|Fluorides|fluorides|mesh-list
102173143|NCT04368533|Cariostatic Agents|cariostatic agents|mesh-ancestor
102173144|NCT04368533|Protective Agents|protective agents|mesh-ancestor
102173145|NCT04368533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173146|NCT02627144|Interferons|interferons|mesh-list
102173147|NCT02627144|Interferon-alpha|interferon-alpha|mesh-list
102173148|NCT02627144|Interferon alpha-2|interferon alpha-2|mesh-list
102173149|NCT02627144|Bevacizumab|bevacizumab|mesh-list
102173150|NCT02627144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102173151|NCT02627144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102173152|NCT02627144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102173153|NCT02627144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102173154|NCT02627144|Growth Substances|growth substances|mesh-ancestor
102173155|NCT02627144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173156|NCT02627144|Growth Inhibitors|growth inhibitors|mesh-ancestor
102173157|NCT02627144|Antiviral Agents|antiviral agents|mesh-ancestor
102173158|NCT02627144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102173159|NCT02627144|Immunologic Factors|immunologic factors|mesh-ancestor
102173160|NCT04586335|Olaparib|olaparib|mesh-list
102173161|NCT04586335|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102173162|NCT04586335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102173163|NCT04586335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173164|NCT04586335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102173165|NCT04981886|Bimatoprost|bimatoprost|mesh-list
102173166|NCT04981886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102173167|NCT03873727|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102173168|NCT03873727|Immunologic Factors|immunologic factors|mesh-ancestor
102173169|NCT03873727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173170|NCT04548440|Paclitaxel|paclitaxel|mesh-list
102173171|NCT04548440|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102173172|NCT04548440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102173173|NCT04548440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102173174|NCT04548440|Tubulin Modulators|tubulin modulators|mesh-ancestor
102173175|NCT04548440|Antimitotic Agents|antimitotic agents|mesh-ancestor
102173176|NCT04548440|Mitosis Modulators|mitosis modulators|mesh-ancestor
102173177|NCT04548440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173178|NCT03742921|Romidepsin|romidepsin|mesh-list
102173179|NCT03742921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102173180|NCT03742921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102173181|NCT03742921|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102173182|NCT03742921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102173183|NCT03742921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173184|NCT02626520|Paclitaxel|paclitaxel|mesh-list
102173185|NCT02626520|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102173186|NCT02626520|Gemcitabine|gemcitabine|mesh-list
102173187|NCT02626520|Fluorouracil|fluorouracil|mesh-list
102173188|NCT02626520|Irinotecan|irinotecan|mesh-list
102173189|NCT02626520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102173190|NCT02626520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102173191|NCT02626520|Tubulin Modulators|tubulin modulators|mesh-ancestor
102173192|NCT02626520|Antimitotic Agents|antimitotic agents|mesh-ancestor
102173193|NCT02626520|Mitosis Modulators|mitosis modulators|mesh-ancestor
102173194|NCT02626520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173195|NCT02626520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102173196|NCT02626520|Antimetabolites|antimetabolites|mesh-ancestor
102173197|NCT02626520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102173198|NCT02626520|Immunologic Factors|immunologic factors|mesh-ancestor
102173199|NCT02626520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173200|NCT02626520|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102173201|NCT02626520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102173202|NCT02626520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102173203|NCT03063710|Olaparib|olaparib|mesh-list
102173204|NCT03063710|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102173205|NCT03063710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102173206|NCT03063710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173207|NCT03063710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102173208|NCT05084521|Famotidine|famotidine|mesh-list
102173209|NCT05084521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102173210|NCT05084521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102173211|NCT05084521|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102173212|NCT05084521|Histamine Antagonists|histamine antagonists|mesh-ancestor
102173213|NCT05084521|Histamine Agents|histamine agents|mesh-ancestor
102173214|NCT05084521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102173215|NCT05084521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173216|NCT05084521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173217|NCT05069857|Apatinib|apatinib|mesh-list
102173218|NCT05069857|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102173219|NCT05069857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102173220|NCT05069857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102173221|NCT05069857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102173222|NCT05069857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173223|NCT05069857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102173224|NCT02971891|Furosemide|furosemide|mesh-list
102173225|NCT02971891|Diuretics|diuretics|mesh-ancestor
102173226|NCT02971891|Natriuretic Agents|natriuretic agents|mesh-ancestor
102173227|NCT02971891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173228|NCT02971891|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102173229|NCT02971891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102173230|NCT02971891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173231|NCT05063851|Memantine|memantine|mesh-list
102173232|NCT05063851|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102173233|NCT05063851|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102173234|NCT05063851|Dopamine Agents|dopamine agents|mesh-ancestor
102173235|NCT05063851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102173236|NCT05063851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173237|NCT05063851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173238|NCT05063851|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102173239|NCT05063851|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102173240|NCT03359161|Furosemide|furosemide|mesh-list
102173241|NCT03359161|Diuretics|diuretics|mesh-ancestor
102173242|NCT03359161|Natriuretic Agents|natriuretic agents|mesh-ancestor
102173243|NCT03359161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173244|NCT03359161|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102173245|NCT03359161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102173246|NCT03359161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173247|NCT05030623|Tadalafil|tadalafil|mesh-list
102173248|NCT05030623|Vasodilator Agents|vasodilator agents|mesh-ancestor
102173249|NCT05030623|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102173250|NCT05030623|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102173251|NCT05030623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102173252|NCT05030623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173253|NCT05030623|Urological Agents|urological agents|mesh-ancestor
102173254|NCT04986631|Topiramate|topiramate|mesh-list
102173255|NCT04986631|Anticonvulsants|anticonvulsants|mesh-ancestor
102173256|NCT04986631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102173257|NCT04986631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173258|NCT03277339|Paroxetine|paroxetine|mesh-list
102173259|NCT03277339|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102173260|NCT03277339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102173261|NCT03277339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102173262|NCT03277339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173263|NCT03277339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102173264|NCT03277339|Serotonin Agents|serotonin agents|mesh-ancestor
102173265|NCT03277339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173266|NCT03277339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102173267|NCT03277339|Antidepressive Agents|antidepressive agents|mesh-ancestor
102173268|NCT03277339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102173269|NCT03277339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102173270|NCT03277339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102173271|NCT03277339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102173272|NCT03145675|Enoxaparin|enoxaparin|mesh-list
102173273|NCT03145675|Enoxaparin sodium|enoxaparin sodium|mesh-list
102173274|NCT03145675|Anticoagulants|anticoagulants|mesh-ancestor
102173275|NCT03145675|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102173276|NCT03145675|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102173277|NCT03145675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173278|NCT04251715|Leucovorin|leucovorin|mesh-list
102173279|NCT04251715|Dexamethasone|dexamethasone|mesh-list
102173280|NCT04251715|Dexamethasone acetate|dexamethasone acetate|mesh-list
102173281|NCT04251715|Fluorouracil|fluorouracil|mesh-list
102173282|NCT04251715|Oxaliplatin|oxaliplatin|mesh-list
102173283|NCT04251715|Irinotecan|irinotecan|mesh-list
102173284|NCT04251715|Floxuridine|floxuridine|mesh-list
102173285|NCT04251715|BB 1101|bb 1101|mesh-list
102173286|NCT04251715|Deoxyuridine|deoxyuridine|mesh-list
102173287|NCT04251715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101882123|NCT03664024|Pemetrexed|pemetrexed|mesh-list
102173288|NCT04251715|Antiemetics|antiemetics|mesh-ancestor
102173289|NCT04251715|Autonomic Agents|autonomic agents|mesh-ancestor
102173290|NCT04251715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102173291|NCT04251715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173292|NCT04251715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102173293|NCT04251715|Glucocorticoids|glucocorticoids|mesh-ancestor
102173294|NCT04251715|Hormones|hormones|mesh-ancestor
102173295|NCT04251715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102173296|NCT04251715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102173297|NCT04251715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102173298|NCT04251715|Protease Inhibitors|protease inhibitors|mesh-ancestor
102173299|NCT04251715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102173300|NCT04251715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173301|NCT04251715|Antimetabolites|antimetabolites|mesh-ancestor
102173302|NCT04251715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102173303|NCT04251715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102173304|NCT04251715|Immunologic Factors|immunologic factors|mesh-ancestor
102173305|NCT04251715|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102173306|NCT04251715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102173307|NCT04251715|Antidotes|antidotes|mesh-ancestor
102173308|NCT04251715|Protective Agents|protective agents|mesh-ancestor
102173309|NCT04251715|Vitamin B Complex|vitamin b complex|mesh-ancestor
102173310|NCT04251715|Vitamins|vitamins|mesh-ancestor
102173311|NCT04251715|Micronutrients|micronutrients|mesh-ancestor
102173312|NCT04042727|Dexmedetomidine|dexmedetomidine|mesh-list
102173313|NCT04042727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102173314|NCT04042727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102173315|NCT04042727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173316|NCT04042727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102173317|NCT04042727|Analgesics|analgesics|mesh-ancestor
102173318|NCT04042727|Sensory System Agents|sensory system agents|mesh-ancestor
102173319|NCT04042727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102173320|NCT04042727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102173321|NCT04042727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102173322|NCT04042727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102173323|NCT04042727|Adrenergic Agents|adrenergic agents|mesh-ancestor
102173324|NCT04042727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102173325|NCT04042727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173326|NCT02035943|Insulin|insulin|mesh-list
102173327|NCT02035943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102173328|NCT02035943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102173329|NCT02035943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173330|NCT03819413|Antibodies|antibodies|mesh-list
102173331|NCT03819413|Immunoglobulins|immunoglobulins|mesh-list
102173332|NCT03819413|Immunologic Factors|immunologic factors|mesh-ancestor
102173333|NCT03819413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173334|NCT04099901|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102173335|NCT04099901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102173336|NCT02394028|Etrolizumab|etrolizumab|mesh-list
102173337|NCT02394028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102173338|NCT02394028|Immunologic Factors|immunologic factors|mesh-ancestor
102173339|NCT02394028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173340|NCT04079621|Primaquine|primaquine|mesh-list
102173341|NCT04079621|Antimalarials|antimalarials|mesh-ancestor
102173342|NCT04079621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102173343|NCT04079621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102173344|NCT04079621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102173345|NCT02819297|Laxatives|laxatives|mesh-list
102173346|NCT02819297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102173347|NCT05134441|Calcium, Dietary|calcium, dietary|mesh-list
102173348|NCT05134441|Calcium|calcium|mesh-list
101715089|NCT02666651|Tolvaptan|tolvaptan|mesh-list
102173349|NCT05134441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102173350|NCT05134441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173351|NCT05134441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102173353|NCT03063788|Trace Elements|trace elements|mesh-ancestor
102173354|NCT03063788|Micronutrients|micronutrients|mesh-ancestor
102173355|NCT03063788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173356|NCT02821715|Flecainide|flecainide|mesh-list
102173357|NCT02821715|Modafinil|modafinil|mesh-list
102173358|NCT02821715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102173359|NCT02821715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173360|NCT02821715|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102173361|NCT02821715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101882200|NCT03734614|Aspirin|aspirin|mesh-list
102173362|NCT02821715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102173363|NCT02821715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173364|NCT02821715|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102173365|NCT02821715|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102173366|NCT02821715|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102173367|NCT02821715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102173368|NCT03545347|Nandrolone Decanoate|nandrolone decanoate|mesh-list
102173369|NCT03545347|Nandrolone|nandrolone|mesh-list
102173370|NCT03545347|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
102173371|NCT03545347|Androgens|androgens|mesh-ancestor
102173372|NCT03545347|Hormones|hormones|mesh-ancestor
102173373|NCT03545347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102173374|NCT03545347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173375|NCT03545347|Anabolic Agents|anabolic agents|mesh-ancestor
102173376|NCT03545347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102173377|NCT02815397|Metformin|metformin|mesh-list
102173378|NCT02815397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102173379|NCT02815397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173380|NCT04980404|Decitabine|decitabine|mesh-list
102173381|NCT04980404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102173382|NCT04980404|Antimetabolites|antimetabolites|mesh-ancestor
102173383|NCT04980404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173384|NCT04980404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102173385|NCT04980404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102173386|NCT02427958|Leuprolide|leuprolide|mesh-list
102173387|NCT02427958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102173388|NCT02427958|Fertility Agents|fertility agents|mesh-ancestor
102173389|NCT02427958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102173390|NCT02427958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173391|NCT02427958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102173392|NCT02427958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102173393|NCT03715127|Psilocybin|psilocybin|mesh-list
102173394|NCT03715127|Hallucinogens|hallucinogens|mesh-ancestor
102173395|NCT03715127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173396|NCT03715127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102173397|NCT02260037|Epinastine|epinastine|mesh-list
102173398|NCT02260037|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102173399|NCT02260037|Histamine Antagonists|histamine antagonists|mesh-ancestor
102173400|NCT02260037|Histamine Agents|histamine agents|mesh-ancestor
102173401|NCT02260037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102173402|NCT02260037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173403|NCT02260037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173404|NCT02036489|Prednisone|prednisone|mesh-list
102173405|NCT02036489|Vincristine|vincristine|mesh-list
102173406|NCT02036489|Daunorubicin|daunorubicin|mesh-list
102173407|NCT02036489|Asparaginase|asparaginase|mesh-list
102173408|NCT02036489|Mercaptopurine|mercaptopurine|mesh-list
102173409|NCT02036489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102173410|NCT02036489|Glucocorticoids|glucocorticoids|mesh-ancestor
102173411|NCT02036489|Hormones|hormones|mesh-ancestor
102173412|NCT02036489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102173413|NCT02036489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173414|NCT02036489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102173415|NCT02036489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102173416|NCT02036489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102173417|NCT02036489|Tubulin Modulators|tubulin modulators|mesh-ancestor
102173418|NCT02036489|Antimitotic Agents|antimitotic agents|mesh-ancestor
102173419|NCT02036489|Mitosis Modulators|mitosis modulators|mesh-ancestor
102173420|NCT02036489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173421|NCT02036489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102173422|NCT02036489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102173423|NCT02036489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102173424|NCT02036489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102173426|NCT02036489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102173427|NCT02036489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102173428|NCT02036489|Immunologic Factors|immunologic factors|mesh-ancestor
102173429|NCT02036489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102173430|NCT02392624|Omalizumab|omalizumab|mesh-list
102173431|NCT02392624|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102173432|NCT02392624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102173433|NCT02392624|Respiratory System Agents|respiratory system agents|mesh-ancestor
102173434|NCT02047565|Edoxaban|edoxaban|mesh-list
101667327|NCT02750670|Hormones|hormones|mesh-ancestor
102173435|NCT02047565|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102173436|NCT02047565|Antithrombins|antithrombins|mesh-ancestor
102173437|NCT02047565|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102173438|NCT02047565|Protease Inhibitors|protease inhibitors|mesh-ancestor
102173439|NCT02047565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102173440|NCT02047565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173441|NCT02047565|Anticoagulants|anticoagulants|mesh-ancestor
102173442|NCT03063866|Fentanyl|fentanyl|mesh-list
102173443|NCT03063866|Midazolam|midazolam|mesh-list
102173444|NCT03063866|Propofol|propofol|mesh-list
102173445|NCT03063866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102173446|NCT03063866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102173447|NCT03063866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173448|NCT03063866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102173449|NCT03063866|Anesthetics, General|anesthetics, general|mesh-ancestor
102173450|NCT03063866|Anesthetics|anesthetics|mesh-ancestor
102173451|NCT03063866|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102173452|NCT03063866|Narcotics|narcotics|mesh-ancestor
102173453|NCT03063866|Analgesics|analgesics|mesh-ancestor
102173454|NCT03063866|Sensory System Agents|sensory system agents|mesh-ancestor
102173455|NCT03063866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102173456|NCT03063866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102173457|NCT03063866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102173458|NCT03063866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102173459|NCT03063866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102173460|NCT03063866|GABA Modulators|gaba modulators|mesh-ancestor
102173461|NCT03063866|GABA Agents|gaba agents|mesh-ancestor
102173462|NCT03063866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102173463|NCT03063866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173464|NCT02037191|Methotrexate|methotrexate|mesh-list
102173465|NCT02037191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102173466|NCT02037191|Abortifacient Agents|abortifacient agents|mesh-ancestor
102173467|NCT02037191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102173468|NCT02037191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173469|NCT02037191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102173470|NCT02037191|Antimetabolites|antimetabolites|mesh-ancestor
102173471|NCT02037191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173472|NCT02037191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102173473|NCT02037191|Dermatologic Agents|dermatologic agents|mesh-ancestor
102173474|NCT02037191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102173475|NCT02037191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102173476|NCT02037191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102173477|NCT02037191|Immunologic Factors|immunologic factors|mesh-ancestor
102173478|NCT02037191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102173479|NCT02037191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102173480|NCT04980170|Amoxicillin|amoxicillin|mesh-list
102173481|NCT04980170|Clindamycin|clindamycin|mesh-list
102173482|NCT04980170|Clindamycin palmitate|clindamycin palmitate|mesh-list
102173483|NCT04980170|Clindamycin phosphate|clindamycin phosphate|mesh-list
102173484|NCT04980170|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102173485|NCT04980170|Clavulanic Acids|clavulanic acids|mesh-list
102173486|NCT04980170|Clavulanic Acid|clavulanic acid|mesh-list
102173487|NCT04980170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102173488|NCT04980170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102173489|NCT04980170|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102173490|NCT04980170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102173491|NCT04980170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173492|NCT04980170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102173493|NCT02387164|Vitamin D|vitamin d|mesh-list
102173494|NCT02387164|Cholecalciferol|cholecalciferol|mesh-list
102173495|NCT02387164|Vitamins|vitamins|mesh-ancestor
102173496|NCT02387164|Micronutrients|micronutrients|mesh-ancestor
102173497|NCT02387164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715233|NCT02665871|Vaccines|vaccines|mesh-list
102173498|NCT02387164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102173499|NCT02387164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102173500|NCT02047799|Calcitriol|calcitriol|mesh-list
102173501|NCT02047799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102173502|NCT02047799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173503|NCT02047799|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102173504|NCT02047799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102173505|NCT02047799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173506|NCT02047799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102173507|NCT02047799|Vitamins|vitamins|mesh-ancestor
102173508|NCT02047799|Micronutrients|micronutrients|mesh-ancestor
102173509|NCT02047799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102173510|NCT02048189|Insulin Detemir|insulin detemir|mesh-list
102173511|NCT02048189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102173512|NCT02048189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173513|NCT02392234|Ivacaftor|ivacaftor|mesh-list
102173514|NCT02392234|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102173515|NCT02392234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102173516|NCT02392234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173518|NCT02036723|Ranibizumab|ranibizumab|mesh-list
102173519|NCT02036723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102173520|NCT02036723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102173521|NCT02036723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102173522|NCT02036723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102173523|NCT02036723|Growth Substances|growth substances|mesh-ancestor
102173524|NCT02036723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173525|NCT02036723|Growth Inhibitors|growth inhibitors|mesh-ancestor
102173526|NCT02036879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102173527|NCT02036879|Norethindrone|norethindrone|mesh-list
102173528|NCT02036879|Norethindrone Acetate|norethindrone acetate|mesh-list
102173529|NCT02036879|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
102173530|NCT02036879|Estradiol|estradiol|mesh-list
102173531|NCT02036879|Estrogens|estrogens|mesh-ancestor
102173532|NCT02036879|Hormones|hormones|mesh-ancestor
102173533|NCT02036879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102173534|NCT02036879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173535|NCT02036879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102173536|NCT02036879|Contraceptive Agents|contraceptive agents|mesh-ancestor
102173537|NCT02036879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102173538|NCT02036879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102173539|NCT02036879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102173540|NCT02036879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102173541|NCT02036879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102173542|NCT02036879|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102173543|NCT02036879|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
102173544|NCT02048345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102173545|NCT02963090|Pembrolizumab|pembrolizumab|mesh-list
102173546|NCT02963090|Topotecan|topotecan|mesh-list
102173547|NCT02963090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102173548|NCT02963090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102173549|NCT02963090|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102173550|NCT02963090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173551|NCT02963090|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102173552|NCT02963090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102173553|NCT02963090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102173554|NCT02048423|Ketamine|ketamine|mesh-list
102173555|NCT02048423|Analgesics|analgesics|mesh-ancestor
102173556|NCT02048423|Sensory System Agents|sensory system agents|mesh-ancestor
102173557|NCT02048423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102173558|NCT02048423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173559|NCT02048423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102173560|NCT02048423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102173561|NCT02048423|Anesthetics, General|anesthetics, general|mesh-ancestor
102173562|NCT02048423|Anesthetics|anesthetics|mesh-ancestor
102173563|NCT02048423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102173564|NCT02048423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102173565|NCT02048423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102173566|NCT02048423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102173567|NCT02048423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173568|NCT02037035|Ketamine|ketamine|mesh-list
102173569|NCT02037035|Analgesics|analgesics|mesh-ancestor
102173570|NCT02037035|Sensory System Agents|sensory system agents|mesh-ancestor
102173571|NCT02037035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102173572|NCT02037035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173573|NCT02037035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102173574|NCT02037035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102173575|NCT02037035|Anesthetics, General|anesthetics, general|mesh-ancestor
102173576|NCT02037035|Anesthetics|anesthetics|mesh-ancestor
102173577|NCT02037035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102173578|NCT02037035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102173579|NCT02037035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102173580|NCT02037035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102173581|NCT02037035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173582|NCT04979468|Lamivudine|lamivudine|mesh-list
102173583|NCT04979468|Dolutegravir|dolutegravir|mesh-list
102173584|NCT04979468|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102173585|NCT04979468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102173586|NCT04979468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102173587|NCT04979468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173588|NCT04979468|Antiviral Agents|antiviral agents|mesh-ancestor
102173589|NCT04979468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102173590|NCT04979468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102173591|NCT04979468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102173592|NCT04979468|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102173593|NCT04979468|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102173594|NCT03562169|Thalidomide|thalidomide|mesh-list
102173595|NCT03562169|Dexamethasone|dexamethasone|mesh-list
102173596|NCT03562169|Ixazomib|ixazomib|mesh-list
102173597|NCT03562169|Glycine|glycine|mesh-list
102173598|NCT03562169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102173599|NCT03562169|Antiemetics|antiemetics|mesh-ancestor
102173600|NCT03562169|Autonomic Agents|autonomic agents|mesh-ancestor
102173601|NCT03562169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102173602|NCT03562169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173603|NCT03562169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102173604|NCT03562169|Glucocorticoids|glucocorticoids|mesh-ancestor
102173605|NCT03562169|Hormones|hormones|mesh-ancestor
102173606|NCT03562169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102173607|NCT03562169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102173608|NCT03562169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102173609|NCT03562169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102173610|NCT03562169|Immunologic Factors|immunologic factors|mesh-ancestor
102173611|NCT03562169|Leprostatic Agents|leprostatic agents|mesh-ancestor
102173612|NCT03562169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102173613|NCT03562169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102173614|NCT03562169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102173615|NCT03562169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102173616|NCT03562169|Growth Substances|growth substances|mesh-ancestor
102173617|NCT03562169|Growth Inhibitors|growth inhibitors|mesh-ancestor
102173618|NCT03562169|Protease Inhibitors|protease inhibitors|mesh-ancestor
102173619|NCT03562169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102173620|NCT03562169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173621|NCT03562169|Glycine Agents|glycine agents|mesh-ancestor
102173622|NCT03562169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102173623|NCT02427802|Gentamicins|gentamicins|mesh-list
102173624|NCT02427802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102173625|NCT02427802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102173626|NCT02427802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102173627|NCT02427802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102173628|NCT02427802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173629|NCT02050529|Labetalol|labetalol|mesh-list
102173630|NCT02050529|Hydralazine|hydralazine|mesh-list
102173631|NCT02050529|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102173632|NCT02050529|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102173633|NCT02050529|Adrenergic Agents|adrenergic agents|mesh-ancestor
102173634|NCT02050529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102173635|NCT02050529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173636|NCT02050529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173637|NCT02050529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102173638|NCT02050529|Sympathomimetics|sympathomimetics|mesh-ancestor
102173639|NCT02050529|Autonomic Agents|autonomic agents|mesh-ancestor
102173640|NCT02050529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102173641|NCT02050529|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102173642|NCT02050529|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102173643|NCT02050529|Vasodilator Agents|vasodilator agents|mesh-ancestor
102173644|NCT02427646|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102173645|NCT02427646|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102173646|NCT02427646|Botulinum Toxins|botulinum toxins|mesh-list
102173647|NCT02427646|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102173648|NCT02427646|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102173649|NCT02427646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102173650|NCT02427646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173651|NCT02427646|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102173652|NCT02427646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102173653|NCT02427646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173654|NCT02427646|Cholinergic Agents|cholinergic agents|mesh-ancestor
102173655|NCT02427646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102173656|NCT02048969|Flumazenil|flumazenil|mesh-list
102173657|NCT02048969|Antidotes|antidotes|mesh-ancestor
102173658|NCT02048969|Protective Agents|protective agents|mesh-ancestor
102173659|NCT02048969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173660|NCT02048969|GABA Modulators|gaba modulators|mesh-ancestor
102173661|NCT02048969|GABA Agents|gaba agents|mesh-ancestor
102173662|NCT02048969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102173663|NCT02048969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173664|NCT03561935|Propafenone|propafenone|mesh-list
102173665|NCT03561935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102173666|NCT03561935|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102173667|NCT03561935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102173668|NCT03561935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102173669|NCT03561935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173670|NCT02808143|Pembrolizumab|pembrolizumab|mesh-list
102173671|NCT02808143|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102173672|NCT02808143|BCG Vaccine|bcg vaccine|mesh-list
102173673|NCT02808143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102173674|NCT02808143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102173675|NCT02808143|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102173676|NCT02808143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173677|NCT02808143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101447274|NCT00182663|Thalidomide|thalidomide|mesh-list
102173678|NCT02808143|Immunologic Factors|immunologic factors|mesh-ancestor
102173679|NCT02808143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173680|NCT02620280|Paclitaxel|paclitaxel|mesh-list
102173681|NCT02620280|Carboplatin|carboplatin|mesh-list
102173682|NCT02620280|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102173683|NCT02620280|Atezolizumab|atezolizumab|mesh-list
102173684|NCT02620280|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102173685|NCT02620280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102173686|NCT02620280|Tubulin Modulators|tubulin modulators|mesh-ancestor
102173687|NCT02620280|Antimitotic Agents|antimitotic agents|mesh-ancestor
102173688|NCT02620280|Mitosis Modulators|mitosis modulators|mesh-ancestor
102173689|NCT02620280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173690|NCT02620280|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102173691|NCT02620280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102173692|NCT02806973|Glucagon|glucagon|mesh-list
102173693|NCT02806973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102173694|NCT02806973|Hormones|hormones|mesh-ancestor
102173695|NCT02806973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102173696|NCT02806973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173697|NCT02049203|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
102173698|NCT02049203|Enzyme Activators|enzyme activators|mesh-ancestor
102173699|NCT02049203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173700|NCT02037737|Abatacept|abatacept|mesh-list
102173701|NCT02037737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102173702|NCT02037737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173703|NCT02037737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102173704|NCT02037737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102173705|NCT02037737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102173706|NCT02037737|Immunologic Factors|immunologic factors|mesh-ancestor
102173707|NCT02037737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173708|NCT02037737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102173709|NCT02037503|Ketamine|ketamine|mesh-list
102173710|NCT02037503|Analgesics|analgesics|mesh-ancestor
102173711|NCT02037503|Sensory System Agents|sensory system agents|mesh-ancestor
102173712|NCT02037503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102173713|NCT02037503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173714|NCT02037503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102173715|NCT02037503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102173716|NCT02037503|Anesthetics, General|anesthetics, general|mesh-ancestor
102173717|NCT02037503|Anesthetics|anesthetics|mesh-ancestor
102173718|NCT02037503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102173719|NCT02037503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102173720|NCT02037503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102173721|NCT02037503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102173722|NCT02037503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173723|NCT02049671|Hormones|hormones|mesh-list
102173724|NCT02049671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102173725|NCT02049671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173726|NCT02037815|Mannitol|mannitol|mesh-list
102173727|NCT02037815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102173728|NCT02037815|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102173729|NCT02037815|Diuretics|diuretics|mesh-ancestor
102173730|NCT02037815|Natriuretic Agents|natriuretic agents|mesh-ancestor
102173731|NCT02037815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173732|NCT02051621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
102173733|NCT02806505|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102173734|NCT02806505|Antiviral Agents|antiviral agents|mesh-ancestor
102173735|NCT02806505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102173736|NCT02053727|Abatacept|abatacept|mesh-list
102173737|NCT02053727|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102173738|NCT02053727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173739|NCT02053727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102173740|NCT02053727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102173741|NCT02053727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102173742|NCT02053727|Immunologic Factors|immunologic factors|mesh-ancestor
102173743|NCT02053727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173744|NCT02053727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102173745|NCT02051153|Modafinil|modafinil|mesh-list
102173746|NCT02051153|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102173747|NCT02051153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173748|NCT02051153|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102173749|NCT02051153|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102173750|NCT02051153|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102173751|NCT02051153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173752|NCT02807363|Leuprolide|leuprolide|mesh-list
102173753|NCT02807363|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102173754|NCT02807363|Fertility Agents|fertility agents|mesh-ancestor
102173755|NCT02807363|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102173756|NCT02807363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173757|NCT02807363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102173758|NCT02807363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102173759|NCT02051231|Oxytocin|oxytocin|mesh-list
102173760|NCT02051231|Oxytocics|oxytocics|mesh-ancestor
102173761|NCT02051231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102173762|NCT02051231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173763|NCT02051387|Cannabidiol|cannabidiol|mesh-list
102173764|NCT02051387|Olanzapine|olanzapine|mesh-list
102173765|NCT02051387|Risperidone|risperidone|mesh-list
102173766|NCT02051387|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102173767|NCT02051387|Amisulpride|amisulpride|mesh-list
102173768|NCT02051387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102173769|NCT02051387|Serotonin Agents|serotonin agents|mesh-ancestor
102173770|NCT02051387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102173771|NCT02051387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173772|NCT02051387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173773|NCT02051387|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102173774|NCT02051387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102173775|NCT02051387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102173776|NCT02051387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102173777|NCT02051387|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102173778|NCT02051387|Dopamine Agents|dopamine agents|mesh-ancestor
102173779|NCT02051387|Antiemetics|antiemetics|mesh-ancestor
102173780|NCT02051387|Autonomic Agents|autonomic agents|mesh-ancestor
102173781|NCT02051387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102173782|NCT02051387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102173783|NCT02051387|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102173784|NCT02051387|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102173785|NCT02051387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102173787|NCT02051387|Anticonvulsants|anticonvulsants|mesh-ancestor
102173788|NCT02051387|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102173789|NCT02052167|Methotrexate|methotrexate|mesh-list
102173790|NCT02052167|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102173791|NCT02052167|Abortifacient Agents|abortifacient agents|mesh-ancestor
102173792|NCT02052167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102173793|NCT02052167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173794|NCT02052167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102173795|NCT02052167|Antimetabolites|antimetabolites|mesh-ancestor
102173796|NCT02052167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173797|NCT02052167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102173798|NCT02052167|Dermatologic Agents|dermatologic agents|mesh-ancestor
102173799|NCT02052167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102173800|NCT02052167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102173801|NCT02052167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102173802|NCT02052167|Immunologic Factors|immunologic factors|mesh-ancestor
102173803|NCT02052167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102173804|NCT02052167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102173805|NCT03524417|Immunoglobulins|immunoglobulins|mesh-list
102173806|NCT03524417|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101882643|NCT03597022|Anticoagulants|anticoagulants|mesh-ancestor
102173807|NCT03524417|Antibodies|antibodies|mesh-list
102173808|NCT03524417|Immunologic Factors|immunologic factors|mesh-ancestor
102173809|NCT03524417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173810|NCT02054429|Insulin|insulin|mesh-list
102173811|NCT02054429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102173812|NCT02054429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102173813|NCT02054429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173814|NCT03806543|Vancomycin|vancomycin|mesh-list
102173815|NCT03806543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102173816|NCT03806543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102173817|NCT02052323|Artesunate|artesunate|mesh-list
102173818|NCT02052323|Mefloquine|mefloquine|mesh-list
102173819|NCT02052323|Antimalarials|antimalarials|mesh-ancestor
102173820|NCT02052323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102173821|NCT02052323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102173822|NCT02052323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102173823|NCT02052323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102173824|NCT02052323|Antiviral Agents|antiviral agents|mesh-ancestor
102173825|NCT02052323|Schistosomicides|schistosomicides|mesh-ancestor
102173826|NCT02052323|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102173827|NCT02052323|Anthelmintics|anthelmintics|mesh-ancestor
102173828|NCT02056223|Acetaminophen|acetaminophen|mesh-list
102173829|NCT02056223|Ibuprofen|ibuprofen|mesh-list
102173830|NCT02056223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102173831|NCT02056223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102173832|NCT02056223|Analgesics|analgesics|mesh-ancestor
102173833|NCT02056223|Sensory System Agents|sensory system agents|mesh-ancestor
102173834|NCT02056223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102173835|NCT02056223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173836|NCT02056223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102173837|NCT02056223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102173838|NCT02056223|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102173839|NCT02056223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102173840|NCT02056223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173841|NCT02056223|Antipyretics|antipyretics|mesh-ancestor
102173842|NCT02056379|Dexamethasone|dexamethasone|mesh-list
102173843|NCT02056379|Budesonide|budesonide|mesh-list
102173844|NCT02056379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102173845|NCT02056379|Antiemetics|antiemetics|mesh-ancestor
102173846|NCT02056379|Autonomic Agents|autonomic agents|mesh-ancestor
102173847|NCT02056379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102173848|NCT02056379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173849|NCT02056379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102173850|NCT02056379|Glucocorticoids|glucocorticoids|mesh-ancestor
102173851|NCT02056379|Hormones|hormones|mesh-ancestor
102173852|NCT02056379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102173853|NCT02056379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101447324|NCT00588835|Hormones|hormones|mesh-ancestor
102173854|NCT02056379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102173855|NCT02056379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102173856|NCT02056379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102173857|NCT02056379|Respiratory System Agents|respiratory system agents|mesh-ancestor
102173858|NCT02383966|Carboplatin|carboplatin|mesh-list
102173859|NCT02383966|Fluorouracil|fluorouracil|mesh-list
102173860|NCT02383966|Cetuximab|cetuximab|mesh-list
102173861|NCT02383966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102173862|NCT02383966|Antimetabolites|antimetabolites|mesh-ancestor
102173863|NCT02383966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173864|NCT02383966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102173865|NCT02383966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102173866|NCT02383966|Immunologic Factors|immunologic factors|mesh-ancestor
102173867|NCT02383966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173868|NCT02383966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102173869|NCT02054663|Clopidogrel|clopidogrel|mesh-list
102173870|NCT02054663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102173871|NCT02054663|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102173872|NCT02054663|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102173873|NCT02054663|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102173874|NCT02054663|Purinergic Agents|purinergic agents|mesh-ancestor
102173875|NCT02054663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102173876|NCT02054663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173877|NCT02054663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173878|NCT02054975|Vitamin D|vitamin d|mesh-list
102173879|NCT02054975|Ergocalciferols|ergocalciferols|mesh-list
102173880|NCT02054975|Cholecalciferol|cholecalciferol|mesh-list
102173881|NCT02054975|Vitamins|vitamins|mesh-list
102173882|NCT02054975|Micronutrients|micronutrients|mesh-ancestor
102173883|NCT02054975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173884|NCT02054975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102173885|NCT02054975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102173886|NCT02055131|Aspirin|aspirin|mesh-list
102173887|NCT02055131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102173888|NCT02055131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102173889|NCT02055131|Analgesics|analgesics|mesh-ancestor
102173890|NCT02055131|Sensory System Agents|sensory system agents|mesh-ancestor
102173891|NCT02055131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102173892|NCT02055131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173893|NCT02055131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102173894|NCT02055131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102173895|NCT02055131|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102173896|NCT02055131|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102173897|NCT02055131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173898|NCT02055131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102173899|NCT02055131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102173900|NCT02055131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102173901|NCT02055131|Antipyretics|antipyretics|mesh-ancestor
102173902|NCT02056847|Calcium, Dietary|calcium, dietary|mesh-list
102173903|NCT02056847|Pitavastatin|pitavastatin|mesh-list
102173904|NCT02056847|Calcium|calcium|mesh-list
102173905|NCT02056847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102173906|NCT02056847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173907|NCT02056847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102173908|NCT02056847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102173909|NCT02056847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102173910|NCT02056847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102173911|NCT02056847|Antimetabolites|antimetabolites|mesh-ancestor
102173912|NCT02056847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173913|NCT02056847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102173914|NCT02056847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102173915|NCT02052713|Tamsulosin|tamsulosin|mesh-list
102173916|NCT02052713|Dutasteride|dutasteride|mesh-list
102173917|NCT02052713|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102173918|NCT02052713|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102173919|NCT02052713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102173920|NCT02052713|Adrenergic Agents|adrenergic agents|mesh-ancestor
102173921|NCT02052713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102173922|NCT02052713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173923|NCT02052713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173924|NCT02052713|Urological Agents|urological agents|mesh-ancestor
102173925|NCT02052713|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102173926|NCT02052713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102173927|NCT02052713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102173928|NCT02052713|Hormone Antagonists|hormone antagonists|mesh-ancestor
102173929|NCT02052713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102173930|NCT02057003|Sofosbuvir|sofosbuvir|mesh-list
102173931|NCT02057003|Grazoprevir|grazoprevir|mesh-list
102173932|NCT02057003|Ledipasvir|ledipasvir|mesh-list
102173933|NCT02057003|Velpatasvir|velpatasvir|mesh-list
102173934|NCT02057003|Simeprevir|simeprevir|mesh-list
102173935|NCT02057003|Antiviral Agents|antiviral agents|mesh-ancestor
102173936|NCT02057003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102173937|NCT02057003|Protease Inhibitors|protease inhibitors|mesh-ancestor
102173938|NCT02057003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102173939|NCT02057003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173940|NCT02426086|Niacinamide|niacinamide|mesh-list
102173941|NCT02426086|Imetelstat|imetelstat|mesh-list
102173942|NCT02426086|Motesanib diphosphate|motesanib diphosphate|mesh-list
102173943|NCT02426086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102173944|NCT02426086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173945|NCT02426086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102173946|NCT02426086|Vitamin B Complex|vitamin b complex|mesh-ancestor
102173947|NCT02426086|Vitamins|vitamins|mesh-ancestor
102173948|NCT02426086|Micronutrients|micronutrients|mesh-ancestor
102173949|NCT02426086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173950|NCT02055911|Ranibizumab|ranibizumab|mesh-list
102173951|NCT02055911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102173952|NCT02055911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102173953|NCT02055911|Growth Substances|growth substances|mesh-ancestor
102173954|NCT02055911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173955|NCT02055911|Growth Inhibitors|growth inhibitors|mesh-ancestor
102173956|NCT02055911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102173957|NCT02422264|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102173958|NCT02422264|Immunologic Factors|immunologic factors|mesh-ancestor
102173959|NCT02422264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173960|NCT02390362|Rituximab|rituximab|mesh-list
102173961|NCT02390362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102173962|NCT02390362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102173963|NCT02390362|Immunologic Factors|immunologic factors|mesh-ancestor
102173964|NCT02390362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173965|NCT02390362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102173966|NCT02389816|Vortioxetine|vortioxetine|mesh-list
102173967|NCT02389816|Antidepressive Agents|antidepressive agents|mesh-ancestor
102173968|NCT02389816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102173969|NCT02389816|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102173970|NCT02389816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102173971|NCT02389816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102173972|NCT02389816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102173973|NCT02389816|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102173974|NCT02389816|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102173975|NCT02389816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102173976|NCT02389816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173977|NCT02389816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102173978|NCT02389816|Serotonin Agents|serotonin agents|mesh-ancestor
102173979|NCT02389816|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102173980|NCT02389816|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102173981|NCT02389816|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102173982|NCT02389816|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102173983|NCT02388724|Lansoprazole|lansoprazole|mesh-list
102173984|NCT02388724|Dexlansoprazole|dexlansoprazole|mesh-list
102173985|NCT02388724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102173986|NCT02388724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102173987|NCT02388724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102173988|NCT02388724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102173989|NCT02388724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102173990|NCT02382640|Febuxostat|febuxostat|mesh-list
102173991|NCT02382640|Gout Suppressants|gout suppressants|mesh-ancestor
102173992|NCT02382640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102173993|NCT02801669|Edoxaban|edoxaban|mesh-list
102173994|NCT02801669|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102173995|NCT02801669|Antithrombins|antithrombins|mesh-ancestor
102173996|NCT02801669|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102173997|NCT02801669|Protease Inhibitors|protease inhibitors|mesh-ancestor
102173998|NCT02801669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102173999|NCT02801669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174000|NCT02801669|Anticoagulants|anticoagulants|mesh-ancestor
102174001|NCT02804399|Rifampin|rifampin|mesh-list
102174002|NCT02804399|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102174003|NCT02804399|Antitubercular Agents|antitubercular agents|mesh-ancestor
102174004|NCT02804399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102174005|NCT02804399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102174006|NCT02804399|Leprostatic Agents|leprostatic agents|mesh-ancestor
102174007|NCT02804399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102174008|NCT02804399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101573982|NCT02199184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174009|NCT02804399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174010|NCT02804399|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102174011|NCT02804399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102174012|NCT02804399|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102174013|NCT02804399|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102174014|NCT02804399|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102174015|NCT02804399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102174016|NCT05614037|Felodipine|felodipine|mesh-list
102174017|NCT05614037|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102174018|NCT05614037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102174019|NCT05614037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102174020|NCT05614037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102174021|NCT05614037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174022|NCT05614037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102174023|NCT05614037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174024|NCT05614037|Vasodilator Agents|vasodilator agents|mesh-ancestor
102174025|NCT02058875|Cyclosporine|cyclosporine|mesh-list
102174026|NCT02058875|Mycophenolic Acid|mycophenolic acid|mesh-list
102174027|NCT02058875|Prednisone|prednisone|mesh-list
102174028|NCT02058875|Cyclosporins|cyclosporins|mesh-list
102174029|NCT02058875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102174030|NCT02058875|Glucocorticoids|glucocorticoids|mesh-ancestor
102174031|NCT02058875|Hormones|hormones|mesh-ancestor
102174032|NCT02058875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102174033|NCT02058875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174034|NCT02058875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102174035|NCT02058875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102174036|NCT02058875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102174037|NCT02058875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174038|NCT02058875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102174039|NCT02058875|Immunologic Factors|immunologic factors|mesh-ancestor
102174040|NCT02058875|Antifungal Agents|antifungal agents|mesh-ancestor
102174041|NCT02058875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102174042|NCT02058875|Dermatologic Agents|dermatologic agents|mesh-ancestor
102174043|NCT02058875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102174044|NCT02058875|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102174045|NCT02058875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102174046|NCT02058875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102174047|NCT02058875|Antitubercular Agents|antitubercular agents|mesh-ancestor
102174048|NCT02058875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102174049|NCT02059031|Cabotegravir|cabotegravir|mesh-list
102174050|NCT02059031|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102174051|NCT02059031|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102174052|NCT02059031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102174053|NCT02059031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174054|NCT02059031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102174055|NCT02059031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102174056|NCT02059031|Antiviral Agents|antiviral agents|mesh-ancestor
102174057|NCT02059031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102174058|NCT01333865|Memantine|memantine|mesh-list
102174059|NCT01333865|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102174060|NCT01333865|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102174061|NCT01333865|Dopamine Agents|dopamine agents|mesh-ancestor
102174062|NCT01333865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102174063|NCT01333865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174064|NCT01333865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174065|NCT01333865|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102174066|NCT01333865|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102174067|NCT04978688|Relugolix|relugolix|mesh-list
102174068|NCT04978688|Androgen Antagonists|androgen antagonists|mesh-ancestor
102174069|NCT04978688|Hormone Antagonists|hormone antagonists|mesh-ancestor
102174070|NCT04978688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102174071|NCT04978688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174072|NCT03062072|Antineoplastic Agents|antineoplastic agents|mesh-list
102174073|NCT04434326|Vorolanib|vorolanib|mesh-list
102174074|NCT04434326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102174075|NCT04434326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102174076|NCT04434326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174077|NCT01333397|Botulinum Toxins|botulinum toxins|mesh-list
102174078|NCT01333397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102174079|NCT01333397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102174080|NCT01333397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102174081|NCT01333397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102174082|NCT01333397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174083|NCT01333397|Cholinergic Agents|cholinergic agents|mesh-ancestor
102174084|NCT01333397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102174085|NCT01333397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174086|NCT01333397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102174087|NCT01333397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102174088|NCT02172872|Decitabine|decitabine|mesh-list
102174089|NCT02172872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102174090|NCT02172872|Antimetabolites|antimetabolites|mesh-ancestor
102174091|NCT02172872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174092|NCT02172872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102174093|NCT02172872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102174094|NCT02059655|Benzalkonium Compounds|benzalkonium compounds|mesh-list
102174095|NCT02059655|Bimatoprost|bimatoprost|mesh-list
102174096|NCT02059655|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102174097|NCT02059655|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102174098|NCT02059655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102174099|NCT02059655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102174100|NCT02059655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102174101|NCT05636501|Prednisolone|prednisolone|mesh-list
102174102|NCT05636501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102174103|NCT05636501|Glucocorticoids|glucocorticoids|mesh-ancestor
102174104|NCT05636501|Hormones|hormones|mesh-ancestor
102174105|NCT05636501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102174106|NCT05636501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174107|NCT05636501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102174108|NCT05636501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102174109|NCT02058173|Chloroquine|chloroquine|mesh-list
102174110|NCT02058173|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
102174111|NCT02058173|Amebicides|amebicides|mesh-ancestor
102174112|NCT02058173|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102174113|NCT02058173|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102174114|NCT02058173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102174115|NCT02058173|Antimalarials|antimalarials|mesh-ancestor
102174116|NCT02058173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102174117|NCT02058173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102174118|NCT02058173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102174119|NCT02058173|Analgesics|analgesics|mesh-ancestor
102174120|NCT02058173|Sensory System Agents|sensory system agents|mesh-ancestor
102174121|NCT02058173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102174122|NCT02058173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174123|NCT02058173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102174124|NCT02058173|Filaricides|filaricides|mesh-ancestor
102174125|NCT02058173|Antinematodal Agents|antinematodal agents|mesh-ancestor
102174126|NCT02058173|Anthelmintics|anthelmintics|mesh-ancestor
102174127|NCT02060201|Dapagliflozin|dapagliflozin|mesh-list
102174128|NCT02060201|Saxagliptin|saxagliptin|mesh-list
102174129|NCT02060201|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102174130|NCT02060201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174131|NCT02060201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102174132|NCT02060201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174133|NCT02060201|Incretins|incretins|mesh-ancestor
102174134|NCT02060201|Hormones|hormones|mesh-ancestor
102174135|NCT02060201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102174136|NCT02060201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102174137|NCT02060201|Protease Inhibitors|protease inhibitors|mesh-ancestor
102174138|NCT02060201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102174139|NCT03561233|Omeprazole|omeprazole|mesh-list
102174140|NCT03561233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102174141|NCT03561233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102174142|NCT03561233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102174143|NCT03561233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102174144|NCT03561233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174145|NCT02058407|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102174146|NCT02058485|Midazolam|midazolam|mesh-list
102174147|NCT02058485|Dexmedetomidine|dexmedetomidine|mesh-list
102174148|NCT02058485|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102174149|NCT02058485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102174150|NCT02058485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174151|NCT02058485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102174152|NCT02058485|Analgesics|analgesics|mesh-ancestor
102174153|NCT02058485|Sensory System Agents|sensory system agents|mesh-ancestor
102174154|NCT02058485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102174155|NCT02058485|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102174157|NCT02058485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102174158|NCT02058485|Adrenergic Agents|adrenergic agents|mesh-ancestor
102174159|NCT02058485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102174160|NCT02058485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174161|NCT02058485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102174162|NCT02058485|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102174163|NCT02058485|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102174164|NCT02058485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102174165|NCT02058485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102174166|NCT02058485|Anesthetics, General|anesthetics, general|mesh-ancestor
102174167|NCT02058485|Anesthetics|anesthetics|mesh-ancestor
102174168|NCT02058485|GABA Modulators|gaba modulators|mesh-ancestor
102174169|NCT02058485|GABA Agents|gaba agents|mesh-ancestor
102174170|NCT02060279|Carotenoids|carotenoids|mesh-list
102174171|NCT02060279|Antioxidants|antioxidants|mesh-ancestor
102174172|NCT02060279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174173|NCT02060279|Protective Agents|protective agents|mesh-ancestor
102174174|NCT02060279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174175|NCT02058641|Darapladib|darapladib|mesh-list
102174176|NCT02058641|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
102174177|NCT02058641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102174178|NCT02058641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883018|NCT03591874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102174179|NCT02059889|Deoxyglucose|deoxyglucose|mesh-list
102174180|NCT02059889|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102174181|NCT02059889|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102174182|NCT02059889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174183|NCT02059889|Antimetabolites|antimetabolites|mesh-ancestor
102174184|NCT02059889|Antiviral Agents|antiviral agents|mesh-ancestor
102174185|NCT02059889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102174186|NCT02059967|Paclitaxel|paclitaxel|mesh-list
102174187|NCT02059967|Carboplatin|carboplatin|mesh-list
102174188|NCT02059967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102174189|NCT02059967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102174190|NCT02059967|Tubulin Modulators|tubulin modulators|mesh-ancestor
102174191|NCT02059967|Antimitotic Agents|antimitotic agents|mesh-ancestor
102174192|NCT02059967|Mitosis Modulators|mitosis modulators|mesh-ancestor
102174193|NCT02059967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174194|NCT02061137|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102174195|NCT02061137|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102174196|NCT02061137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174197|NCT02061137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102174198|NCT02061137|Immunologic Factors|immunologic factors|mesh-ancestor
102174199|NCT02061137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174200|NCT02061449|Romidepsin|romidepsin|mesh-list
102174201|NCT02061449|Poly ICLC|poly iclc|mesh-list
102174202|NCT02061449|Interferon Inducers|interferon inducers|mesh-ancestor
102174203|NCT02061449|Immunologic Factors|immunologic factors|mesh-ancestor
102174204|NCT02061449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174205|NCT02061449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102174206|NCT02061449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102174207|NCT02061449|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102174208|NCT02061449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102174209|NCT02061449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174210|NCT02060591|Bupivacaine|bupivacaine|mesh-list
102174211|NCT02060591|Anesthetics, Local|anesthetics, local|mesh-ancestor
102174212|NCT02060591|Anesthetics|anesthetics|mesh-ancestor
102174213|NCT02060591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102174214|NCT02060591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174215|NCT02060591|Sensory System Agents|sensory system agents|mesh-ancestor
102174216|NCT02060591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102174217|NCT02060669|Capecitabine|capecitabine|mesh-list
102174218|NCT02060669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102174219|NCT02060669|Antimetabolites|antimetabolites|mesh-ancestor
102174220|NCT02060669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174221|NCT02060669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102174222|NCT04428008|Thymalfasin|thymalfasin|mesh-list
102174223|NCT04428008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102174224|NCT04428008|Immunologic Factors|immunologic factors|mesh-ancestor
102174225|NCT04428008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174226|NCT02046590|Propofol|propofol|mesh-list
102174228|NCT02046590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102174229|NCT02046590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174230|NCT02046590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102174231|NCT02046590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102174232|NCT02046590|Anesthetics, General|anesthetics, general|mesh-ancestor
102174233|NCT02796755|Riluzole|riluzole|mesh-list
102174234|NCT02796755|Anticonvulsants|anticonvulsants|mesh-ancestor
102174235|NCT02796755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102174236|NCT02796755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102174237|NCT02796755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102174238|NCT02796755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174239|NCT02796755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174240|NCT02796755|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102174241|NCT02796755|Protective Agents|protective agents|mesh-ancestor
102174242|NCT02061917|Lobeline|lobeline|mesh-list
102174243|NCT02061917|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102174244|NCT02061917|Autonomic Agents|autonomic agents|mesh-ancestor
102174245|NCT02061917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102174246|NCT02061917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174247|NCT02061917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102174248|NCT02061917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102174249|NCT02061917|Cholinergic Agents|cholinergic agents|mesh-ancestor
102174250|NCT02061917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102174251|NCT02061917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883096|NCT01081353|Aspirin|aspirin|mesh-list
102174252|NCT02061917|Respiratory System Agents|respiratory system agents|mesh-ancestor
102174253|NCT03560375|Empagliflozin|empagliflozin|mesh-list
102174254|NCT03560375|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102174255|NCT03560375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174256|NCT03560375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102174257|NCT03560375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174258|NCT02382016|Macitentan|macitentan|mesh-list
102174259|NCT02382016|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
102174260|NCT02382016|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102174261|NCT02382016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174262|NCT02382016|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
102174263|NCT02422186|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102174264|NCT02422186|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102174265|NCT02422186|Sertraline|sertraline|mesh-list
102174266|NCT02422186|Antidepressive Agents|antidepressive agents|mesh-list
102174267|NCT02422186|Esketamine|esketamine|mesh-list
102174268|NCT02422186|Escitalopram|escitalopram|mesh-list
102174269|NCT02422186|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102174270|NCT02422186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102174271|NCT02422186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102174272|NCT02422186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174273|NCT02422186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102174274|NCT02422186|Serotonin Agents|serotonin agents|mesh-ancestor
102174275|NCT02422186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174276|NCT02422186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102174277|NCT02422186|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102174278|NCT02422186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102174279|NCT02422186|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102174280|NCT02422186|Analgesics|analgesics|mesh-ancestor
102174281|NCT02422186|Sensory System Agents|sensory system agents|mesh-ancestor
102174282|NCT02422186|Dopamine Agents|dopamine agents|mesh-ancestor
102174283|NCT02796677|Bromides|bromides|mesh-list
102174284|NCT02796677|Formoterol Fumarate|formoterol fumarate|mesh-list
102174285|NCT02796677|Tiotropium Bromide|tiotropium bromide|mesh-list
102174286|NCT02796677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102174287|NCT02796677|Autonomic Agents|autonomic agents|mesh-ancestor
102174288|NCT02796677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102174289|NCT02796677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174290|NCT02796677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102174291|NCT02796677|Respiratory System Agents|respiratory system agents|mesh-ancestor
102174292|NCT02796677|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102174293|NCT02796677|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102174294|NCT02796677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102174295|NCT02796677|Adrenergic Agents|adrenergic agents|mesh-ancestor
102174296|NCT02796677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102174297|NCT02796677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174298|NCT02796677|Parasympatholytics|parasympatholytics|mesh-ancestor
102174299|NCT02796677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102174300|NCT02796677|Cholinergic Agents|cholinergic agents|mesh-ancestor
102174301|NCT02796677|Anticonvulsants|anticonvulsants|mesh-ancestor
102174302|NCT04973462|Oseltamivir|oseltamivir|mesh-list
102174303|NCT04973462|Antiviral Agents|antiviral agents|mesh-ancestor
102174304|NCT04973462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102174305|NCT04973462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102174306|NCT04973462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174307|NCT02378506|Etanercept|etanercept|mesh-list
102174308|NCT02378506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102174309|NCT02378506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102174310|NCT02378506|Analgesics|analgesics|mesh-ancestor
102174311|NCT02378506|Sensory System Agents|sensory system agents|mesh-ancestor
102174312|NCT02378506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102174313|NCT02378506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174314|NCT02378506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102174315|NCT02378506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102174316|NCT02378506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102174317|NCT02378506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102174318|NCT02378506|Immunologic Factors|immunologic factors|mesh-ancestor
102174319|NCT02794883|Durvalumab|durvalumab|mesh-list
102174320|NCT02794883|Ipilimumab|ipilimumab|mesh-list
102174321|NCT02794883|Tremelimumab|tremelimumab|mesh-list
102174322|NCT02794883|Immunoglobulins|immunoglobulins|mesh-list
102174323|NCT02794883|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102174324|NCT02794883|Immunoglobulin G|immunoglobulin g|mesh-list
101883170|NCT00075218|Sunitinib|sunitinib|mesh-list
102174325|NCT02794883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102174326|NCT02794883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102174327|NCT02794883|Immunologic Factors|immunologic factors|mesh-ancestor
102174328|NCT02794883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174329|NCT02794883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102174330|NCT02794883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174332|NCT02063789|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102174333|NCT02063789|Antibodies|antibodies|mesh-list
102174334|NCT02063789|Immunologic Factors|immunologic factors|mesh-ancestor
102174335|NCT02063789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174336|NCT02063945|Risperidone|risperidone|mesh-list
102174337|NCT02063945|Methylphenidate|methylphenidate|mesh-list
102174338|NCT02063945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102174339|NCT02063945|Serotonin Agents|serotonin agents|mesh-ancestor
102174340|NCT02063945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102174341|NCT02063945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174342|NCT02063945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174343|NCT02063945|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102174344|NCT02063945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102174345|NCT02063945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102174346|NCT02063945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102174347|NCT02063945|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102174348|NCT02063945|Dopamine Agents|dopamine agents|mesh-ancestor
102174349|NCT02063945|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101447397|NCT00589186|Celecoxib|celecoxib|mesh-list
102174350|NCT02063945|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102174351|NCT02063945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102174352|NCT02063945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102174353|NCT02064023|Insulin|insulin|mesh-list
102174354|NCT02064023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102174355|NCT02064023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102174356|NCT02064023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174357|NCT02064725|10-carboxymethyl-9-acridanone|10-carboxymethyl-9-acridanone|mesh-list
102174358|NCT02064725|Interferon Inducers|interferon inducers|mesh-ancestor
102174359|NCT02064725|Immunologic Factors|immunologic factors|mesh-ancestor
102174360|NCT02064725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174361|NCT01370603|Atorvastatin|atorvastatin|mesh-list
102174362|NCT01370603|Ezetimibe|ezetimibe|mesh-list
102174363|NCT01370603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102174364|NCT01370603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102174365|NCT01370603|Antimetabolites|antimetabolites|mesh-ancestor
102174366|NCT01370603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174367|NCT01370603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102174368|NCT01370603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102174369|NCT01370603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102174370|NCT02659397|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
102174371|NCT02659397|Atorvastatin|atorvastatin|mesh-list
102174372|NCT02659397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102174373|NCT02659397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102174374|NCT02659397|Antimetabolites|antimetabolites|mesh-ancestor
102174375|NCT02659397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174376|NCT02659397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102174377|NCT02659397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102174378|NCT02659397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102174379|NCT02659397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102174380|NCT02659397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174381|NCT02347072|Glycopyrrolate|glycopyrrolate|mesh-list
102174382|NCT02347072|Bromides|bromides|mesh-list
102174383|NCT02347072|Formoterol Fumarate|formoterol fumarate|mesh-list
102174384|NCT02347072|Tiotropium Bromide|tiotropium bromide|mesh-list
102174385|NCT02347072|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102174386|NCT02347072|Autonomic Agents|autonomic agents|mesh-ancestor
102174387|NCT02347072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102174388|NCT02347072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174389|NCT02347072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102174390|NCT02347072|Respiratory System Agents|respiratory system agents|mesh-ancestor
102174391|NCT02347072|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102174392|NCT02347072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102174393|NCT02347072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102174394|NCT02347072|Adrenergic Agents|adrenergic agents|mesh-ancestor
102174395|NCT02347072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102174396|NCT02347072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174397|NCT02347072|Parasympatholytics|parasympatholytics|mesh-ancestor
102174398|NCT02347072|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102174399|NCT02347072|Cholinergic Agents|cholinergic agents|mesh-ancestor
102174400|NCT02347072|Anticonvulsants|anticonvulsants|mesh-ancestor
102174401|NCT02347072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102174402|NCT02347072|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102174403|NCT02064491|Paclitaxel|paclitaxel|mesh-list
102174404|NCT02064491|Docetaxel|docetaxel|mesh-list
102174405|NCT02064491|Cisplatin|cisplatin|mesh-list
102174406|NCT02064491|Carboplatin|carboplatin|mesh-list
102174407|NCT02064491|Pemetrexed|pemetrexed|mesh-list
102174408|NCT02064491|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102174409|NCT02064491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102174410|NCT02064491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102174411|NCT02064491|Tubulin Modulators|tubulin modulators|mesh-ancestor
102174412|NCT02064491|Antimitotic Agents|antimitotic agents|mesh-ancestor
102174413|NCT02064491|Mitosis Modulators|mitosis modulators|mesh-ancestor
102174414|NCT02064491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174415|NCT02064491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102174416|NCT02064491|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102174417|NCT02064491|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102174418|NCT02064491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102174419|NCT02064881|Metformin|metformin|mesh-list
102174420|NCT02064881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102174421|NCT02064881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174422|NCT02346370|Docetaxel|docetaxel|mesh-list
102174423|NCT02346370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102174424|NCT02346370|Tubulin Modulators|tubulin modulators|mesh-ancestor
102174425|NCT02346370|Antimitotic Agents|antimitotic agents|mesh-ancestor
102174426|NCT02346370|Mitosis Modulators|mitosis modulators|mesh-ancestor
102174427|NCT02346370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174428|NCT02065739|Itraconazole|itraconazole|mesh-list
102174429|NCT02065739|JNJ-42165279|jnj-42165279|mesh-list
102174430|NCT02065739|Antifungal Agents|antifungal agents|mesh-ancestor
102174431|NCT02065739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102174432|NCT02065739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102174433|NCT02065739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102174434|NCT02065739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102174435|NCT02065739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174436|NCT02065739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102174437|NCT02065739|Hormone Antagonists|hormone antagonists|mesh-ancestor
102174438|NCT02065739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102174439|NCT02065739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174440|NCT02065739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102174441|NCT02068079|Vemurafenib|vemurafenib|mesh-list
102174442|NCT02068079|Trientine|trientine|mesh-list
102174443|NCT02068079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102174444|NCT02068079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102174445|NCT02068079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101573983|NCT02199184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102174446|NCT02068079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174447|NCT02068079|Chelating Agents|chelating agents|mesh-ancestor
102174448|NCT02068079|Sequestering Agents|sequestering agents|mesh-ancestor
102174450|NCT02793947|Morphine|morphine|mesh-list
102174451|NCT02793947|Ropivacaine|ropivacaine|mesh-list
102174452|NCT02793947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102174453|NCT02793947|Narcotics|narcotics|mesh-ancestor
102174454|NCT02793947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102174455|NCT02793947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174456|NCT02793947|Analgesics|analgesics|mesh-ancestor
102174457|NCT02793947|Sensory System Agents|sensory system agents|mesh-ancestor
102174458|NCT02793947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102174459|NCT02793947|Anesthetics, Local|anesthetics, local|mesh-ancestor
102174460|NCT02793947|Anesthetics|anesthetics|mesh-ancestor
102174461|NCT02793947|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102174462|NCT02793947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102174463|NCT02793947|Adrenergic Agents|adrenergic agents|mesh-ancestor
102174464|NCT02793947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102174465|NCT02793947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174466|NCT02793947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102174467|NCT02793947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102174468|NCT02793947|Autonomic Agents|autonomic agents|mesh-ancestor
102174469|NCT02793947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102174470|NCT02793947|Respiratory System Agents|respiratory system agents|mesh-ancestor
102174471|NCT02793947|Mydriatics|mydriatics|mesh-ancestor
102174472|NCT02793947|Sympathomimetics|sympathomimetics|mesh-ancestor
102174473|NCT02793947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102174474|NCT02068235|Ponesimod|ponesimod|mesh-list
102174475|NCT02068235|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102174476|NCT02068235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174477|NCT02068235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102174478|NCT02068235|Immunologic Factors|immunologic factors|mesh-ancestor
102174479|NCT02068235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174480|NCT01370213|Interleukin-2|interleukin-2|mesh-list
102174481|NCT01370213|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102174482|NCT01370213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102174483|NCT01370213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102174484|NCT01370213|Analgesics|analgesics|mesh-ancestor
102174485|NCT01370213|Sensory System Agents|sensory system agents|mesh-ancestor
102174486|NCT01370213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102174487|NCT01370213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174488|NCT01370213|Immunologic Factors|immunologic factors|mesh-ancestor
102174489|NCT01370213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102174490|NCT02066207|Atorvastatin|atorvastatin|mesh-list
102174491|NCT02066207|Fenofibrate|fenofibrate|mesh-list
102174492|NCT02066207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102174493|NCT02066207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102174494|NCT02066207|Antimetabolites|antimetabolites|mesh-ancestor
102174495|NCT02066207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174496|NCT02066207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102174497|NCT02066207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102174498|NCT02066207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102174499|NCT01370525|Esomeprazole|esomeprazole|mesh-list
102174500|NCT01370525|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102174501|NCT01370525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102174502|NCT01370525|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102174503|NCT01370525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102174504|NCT01370525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174505|NCT02065349|ASP8477|asp8477|mesh-list
102174506|NCT02065349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102174507|NCT02065349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174508|NCT02068625|Rasagiline|rasagiline|mesh-list
102174509|NCT02068625|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102174510|NCT02068625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102174511|NCT02068625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174512|NCT02068625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102174513|NCT02068625|Protective Agents|protective agents|mesh-ancestor
102174514|NCT02068625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174515|NCT02068859|Diclofenac|diclofenac|mesh-list
102174516|NCT02068859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102174517|NCT02068859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102174518|NCT02068859|Analgesics|analgesics|mesh-ancestor
102174519|NCT02068859|Sensory System Agents|sensory system agents|mesh-ancestor
102174520|NCT02068859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102174521|NCT02068859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174522|NCT02068859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102174523|NCT02068859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102174524|NCT02068859|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102174525|NCT02068859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102174526|NCT02068859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174527|NCT02068937|Furosemide|furosemide|mesh-list
102174528|NCT02068937|Diuretics|diuretics|mesh-ancestor
102174529|NCT02068937|Natriuretic Agents|natriuretic agents|mesh-ancestor
102174530|NCT02068937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174531|NCT02068937|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102174532|NCT02068937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101447457|NCT00589927|Cilostazol|cilostazol|mesh-list
102174533|NCT02068937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174534|NCT02066675|Trabectedin|trabectedin|mesh-list
102174535|NCT02066675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102174536|NCT02066675|Alkylating Agents|alkylating agents|mesh-ancestor
102174537|NCT02066675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174538|NCT02066675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102174539|NCT02072135|Bupivacaine|bupivacaine|mesh-list
102174540|NCT02072135|Anesthetics, Local|anesthetics, local|mesh-ancestor
102174541|NCT02072135|Anesthetics|anesthetics|mesh-ancestor
102174542|NCT02072135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102174543|NCT02072135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174544|NCT02072135|Sensory System Agents|sensory system agents|mesh-ancestor
102174545|NCT02072135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102174546|NCT02067065|Propofol|propofol|mesh-list
101883396|NCT05781997|Mydriatics|mydriatics|mesh-list
102174547|NCT02067065|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102174548|NCT02067065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102174549|NCT02067065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174550|NCT02067065|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102174551|NCT02067065|Anesthetics, General|anesthetics, general|mesh-ancestor
102174552|NCT02067065|Anesthetics|anesthetics|mesh-ancestor
102174553|NCT02067143|Cytarabine|cytarabine|mesh-list
102174554|NCT02067143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102174555|NCT02067143|Antimetabolites|antimetabolites|mesh-ancestor
102174556|NCT02067143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174557|NCT02067143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102174558|NCT02067143|Antiviral Agents|antiviral agents|mesh-ancestor
102174559|NCT02067143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102174560|NCT02067143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102174561|NCT02067143|Immunologic Factors|immunologic factors|mesh-ancestor
102174562|NCT02067143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174563|NCT02072213|Tamsulosin|tamsulosin|mesh-list
102174564|NCT02072213|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102174565|NCT02072213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102174566|NCT02072213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102174567|NCT02072213|Adrenergic Agents|adrenergic agents|mesh-ancestor
102174568|NCT02072213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102174569|NCT02072213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174570|NCT02072213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174571|NCT02072213|Urological Agents|urological agents|mesh-ancestor
102174572|NCT02072291|Nifedipine|nifedipine|mesh-list
102174573|NCT02072291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102174574|NCT02072291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102174575|NCT02072291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174576|NCT02072291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102174577|NCT02072291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174578|NCT02072291|Vasodilator Agents|vasodilator agents|mesh-ancestor
102174579|NCT02072291|Tocolytic Agents|tocolytic agents|mesh-ancestor
102174580|NCT02072291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102174581|NCT02072525|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102174582|NCT02072525|Immunologic Factors|immunologic factors|mesh-ancestor
102174583|NCT02072525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174584|NCT03059888|Abatacept|abatacept|mesh-list
102174585|NCT03059888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102174586|NCT03059888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174587|NCT03059888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102174588|NCT03059888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102174589|NCT03059888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102174590|NCT03059888|Immunologic Factors|immunologic factors|mesh-ancestor
102174591|NCT03059888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174592|NCT03059888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102174593|NCT04976816|Triamcinolone|triamcinolone|mesh-list
102174594|NCT04976816|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102174595|NCT04976816|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102174596|NCT04976816|Betamethasone|betamethasone|mesh-list
102174597|NCT04976816|Betamethasone Valerate|betamethasone valerate|mesh-list
102174598|NCT04976816|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102174599|NCT04976816|Betamethasone benzoate|betamethasone benzoate|mesh-list
101668520|NCT02748330|Antipyretics|antipyretics|mesh-ancestor
102174600|NCT04976816|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102174601|NCT04976816|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102174602|NCT04976816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102174603|NCT04976816|Glucocorticoids|glucocorticoids|mesh-ancestor
102174604|NCT04976816|Hormones|hormones|mesh-ancestor
102174605|NCT04976816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102174606|NCT04976816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174607|NCT04976816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102174608|NCT04976816|Immunologic Factors|immunologic factors|mesh-ancestor
102174609|NCT04976816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102174610|NCT04976816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174611|NCT04976816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102174612|NCT04976816|Respiratory System Agents|respiratory system agents|mesh-ancestor
102174613|NCT03061838|Rituximab|rituximab|mesh-list
102174614|NCT03061838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102174615|NCT03061838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102174616|NCT03061838|Immunologic Factors|immunologic factors|mesh-ancestor
102174617|NCT03061838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174618|NCT03061838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102174619|NCT04964180|Indomethacin|indomethacin|mesh-list
102174621|NCT04964180|Anesthetics, Local|anesthetics, local|mesh-ancestor
102174622|NCT04964180|Anesthetics|anesthetics|mesh-ancestor
102174623|NCT04964180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102174624|NCT04964180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174625|NCT04964180|Sensory System Agents|sensory system agents|mesh-ancestor
102174626|NCT04964180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102174627|NCT04964180|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102174628|NCT04964180|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102174629|NCT04964180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102174630|NCT04964180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102174631|NCT04964180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174632|NCT04964180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102174633|NCT04964180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102174634|NCT04964180|Analgesics|analgesics|mesh-ancestor
102174635|NCT04964180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102174636|NCT04964180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102174637|NCT04964180|Gout Suppressants|gout suppressants|mesh-ancestor
102174638|NCT04964180|Tocolytic Agents|tocolytic agents|mesh-ancestor
102174639|NCT04964180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102174640|NCT04964180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102174641|NCT04964180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102174642|NCT02067377|Immunoglobulins|immunoglobulins|mesh-list
102174643|NCT02067377|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102174644|NCT02067377|Antibodies|antibodies|mesh-list
102174645|NCT02067377|Immunologic Factors|immunologic factors|mesh-ancestor
102174646|NCT02067377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174647|NCT02073149|Iron|iron|mesh-list
102174648|NCT02073149|Fe(III)-EDTA|fe(iii)-edta|mesh-list
102174649|NCT02073149|Trace Elements|trace elements|mesh-ancestor
102174650|NCT02073149|Micronutrients|micronutrients|mesh-ancestor
102174651|NCT02073149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174652|NCT02073149|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102174653|NCT02073149|Chelating Agents|chelating agents|mesh-ancestor
102174654|NCT02073149|Sequestering Agents|sequestering agents|mesh-ancestor
102174655|NCT02073149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174656|NCT02625974|Nifurtimox|nifurtimox|mesh-list
102174657|NCT02625974|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102174658|NCT02625974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102174659|NCT02625974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102174660|NCT02625974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102174661|NCT02067767|Lamivudine|lamivudine|mesh-list
102174662|NCT02067767|Abacavir|abacavir|mesh-list
102174663|NCT02067767|Dolutegravir|dolutegravir|mesh-list
102174664|NCT02067767|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102174665|NCT02067767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102174666|NCT02067767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102174667|NCT02067767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174669|NCT02067767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102174670|NCT02067767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102174671|NCT02067767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102174672|NCT02067767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102174673|NCT02067767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102174674|NCT02073227|Metformin|metformin|mesh-list
102174675|NCT02073227|Canagliflozin|canagliflozin|mesh-list
102174676|NCT02073227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102174677|NCT02073227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174678|NCT02073227|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102174679|NCT02073227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174680|NCT03060044|Fluticasone|fluticasone|mesh-list
102174681|NCT03060044|Xhance|xhance|mesh-list
102174682|NCT03060044|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102174683|NCT03060044|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102174684|NCT03060044|Charcoal|charcoal|mesh-list
102174685|NCT03060044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102174686|NCT03060044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102174687|NCT03060044|Autonomic Agents|autonomic agents|mesh-ancestor
102174688|NCT03060044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102174689|NCT03060044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174690|NCT03060044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102174691|NCT03060044|Respiratory System Agents|respiratory system agents|mesh-ancestor
102174692|NCT03060044|Dermatologic Agents|dermatologic agents|mesh-ancestor
102174693|NCT03060044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102174694|NCT03060044|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102174695|NCT03060044|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102174697|NCT03060044|Adrenergic Agents|adrenergic agents|mesh-ancestor
102174698|NCT03060044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102174699|NCT03060044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174700|NCT03060044|Glucocorticoids|glucocorticoids|mesh-ancestor
102174701|NCT03060044|Hormones|hormones|mesh-ancestor
102174702|NCT03060044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102174703|NCT03060044|Sympathomimetics|sympathomimetics|mesh-ancestor
102174704|NCT03060044|Antidotes|antidotes|mesh-ancestor
102174705|NCT03060044|Protective Agents|protective agents|mesh-ancestor
102174706|NCT02070653|Ticagrelor|ticagrelor|mesh-list
102174707|NCT02070653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102174708|NCT02070653|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102174709|NCT02070653|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102174710|NCT02070653|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102174711|NCT02070653|Purinergic Agents|purinergic agents|mesh-ancestor
102174712|NCT02070653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102174713|NCT02070653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174714|NCT02070653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174715|NCT04831892|Isosorbide|isosorbide|mesh-list
102174716|NCT04831892|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
102174717|NCT04831892|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
102174718|NCT04831892|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102174719|NCT04831892|Diuretics|diuretics|mesh-ancestor
102174720|NCT04831892|Natriuretic Agents|natriuretic agents|mesh-ancestor
102174721|NCT04831892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174722|NCT04831892|Vasodilator Agents|vasodilator agents|mesh-ancestor
102174723|NCT04831892|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102174724|NCT04831892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174725|NCT02073773|Levodopa|levodopa|mesh-list
102174726|NCT02073773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102174727|NCT02073773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102174728|NCT02073773|Dopamine Agents|dopamine agents|mesh-ancestor
102174729|NCT02073773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102174730|NCT02073773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174731|NCT02073773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174732|NCT03062150|Cycloserine|cycloserine|mesh-list
102174733|NCT03062150|Fludrocortisone|fludrocortisone|mesh-list
102174734|NCT03062150|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102174735|NCT03062150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102174736|NCT03062150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102174737|NCT03062150|Antitubercular Agents|antitubercular agents|mesh-ancestor
102174738|NCT03062150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102174739|NCT03062150|Antimetabolites|antimetabolites|mesh-ancestor
102174740|NCT03062150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174741|NCT03062150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102174742|NCT03061916|Chlorhexidine|chlorhexidine|mesh-list
102174743|NCT03061916|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102174744|NCT03061916|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102174745|NCT03061916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102174746|NCT03061916|Disinfectants|disinfectants|mesh-ancestor
102174747|NCT03061916|Dermatologic Agents|dermatologic agents|mesh-ancestor
102174748|NCT02076659|Methotrexate|methotrexate|mesh-list
102174749|NCT02076659|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102174750|NCT02076659|Abortifacient Agents|abortifacient agents|mesh-ancestor
102174751|NCT02076659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102174752|NCT02076659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174753|NCT02076659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102174754|NCT02076659|Antimetabolites|antimetabolites|mesh-ancestor
102174755|NCT02076659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174756|NCT02076659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102174757|NCT02076659|Dermatologic Agents|dermatologic agents|mesh-ancestor
102174758|NCT02076659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102174759|NCT02076659|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102174760|NCT02076659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102174761|NCT02076659|Immunologic Factors|immunologic factors|mesh-ancestor
102174762|NCT02076659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102174763|NCT02076659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102174764|NCT04975724|Citalopram|citalopram|mesh-list
102174765|NCT04975724|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102174766|NCT04975724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102174767|NCT04975724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102174768|NCT04975724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174769|NCT04975724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102174770|NCT04975724|Serotonin Agents|serotonin agents|mesh-ancestor
102174771|NCT04975724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174772|NCT04975724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102174773|NCT04975724|Antidepressive Agents|antidepressive agents|mesh-ancestor
102174774|NCT04975724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102174775|NCT02076815|Anagrelide|anagrelide|mesh-list
102174776|NCT02076815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102174777|NCT02076815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102174778|NCT02076815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174779|NCT02076815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102174780|NCT02071043|Capecitabine|capecitabine|mesh-list
102174781|NCT02071043|Oxaliplatin|oxaliplatin|mesh-list
102174782|NCT02071043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102174783|NCT02071043|Antimetabolites|antimetabolites|mesh-ancestor
102174784|NCT02071043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174785|NCT02071043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102174786|NCT02076893|Ibuprofen|ibuprofen|mesh-list
102174787|NCT02076893|Gabapentin|gabapentin|mesh-list
102174788|NCT02076893|Tramadol|tramadol|mesh-list
102174789|NCT02076893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102174790|NCT02076893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102174791|NCT02076893|Analgesics|analgesics|mesh-ancestor
102174792|NCT02076893|Sensory System Agents|sensory system agents|mesh-ancestor
102174793|NCT02076893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102174794|NCT02076893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174795|NCT02076893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102174796|NCT02076893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102174797|NCT02076893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102174798|NCT02076893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102174799|NCT02076893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174800|NCT02076893|Anticonvulsants|anticonvulsants|mesh-ancestor
102174801|NCT02076893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102174802|NCT02076893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102174803|NCT02076893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102174804|NCT02076893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102174805|NCT02076893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102174806|NCT02076893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102174807|NCT02076893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102174808|NCT02076893|Antimanic Agents|antimanic agents|mesh-ancestor
102174809|NCT02076893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102174810|NCT02076893|Narcotics|narcotics|mesh-ancestor
102174811|NCT02074163|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102174812|NCT02074163|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102174813|NCT02074163|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102174814|NCT02074163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102174815|NCT02074163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174816|NCT02074163|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102174817|NCT02074163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102174818|NCT02074163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174819|NCT02074163|Cholinergic Agents|cholinergic agents|mesh-ancestor
102174820|NCT02074163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102174821|NCT04963088|Capecitabine|capecitabine|mesh-list
102174822|NCT04963088|Oxaliplatin|oxaliplatin|mesh-list
102174823|NCT04963088|Tislelizumab|tislelizumab|mesh-list
102174824|NCT04963088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102174825|NCT04963088|Antimetabolites|antimetabolites|mesh-ancestor
102174826|NCT04963088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174827|NCT04963088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102174828|NCT04963088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102174829|NCT02074319|Methotrexate|methotrexate|mesh-list
102174830|NCT02074319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102174831|NCT02074319|Abortifacient Agents|abortifacient agents|mesh-ancestor
102174832|NCT02074319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102174833|NCT02074319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174834|NCT02074319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102174835|NCT02074319|Antimetabolites|antimetabolites|mesh-ancestor
102174836|NCT02074319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174837|NCT02074319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102174838|NCT02074319|Dermatologic Agents|dermatologic agents|mesh-ancestor
102174839|NCT02074319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102174840|NCT02074319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102174841|NCT02074319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101883694|NCT05447702|Paclitaxel|paclitaxel|mesh-list
102174842|NCT02074319|Immunologic Factors|immunologic factors|mesh-ancestor
102174843|NCT02074319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102174844|NCT02074319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102174845|NCT04975022|Insulin|insulin|mesh-list
102174846|NCT04975022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102174847|NCT04975022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174848|NCT03061604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102174849|NCT03061604|Ceftriaxone|ceftriaxone|mesh-list
102174850|NCT03061604|Octreotide|octreotide|mesh-list
102174851|NCT03061604|Hemostatics|hemostatics|mesh-list
102174852|NCT03061604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102174853|NCT03061604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102174854|NCT03061604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102174855|NCT03061604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102174856|NCT03061604|Coagulants|coagulants|mesh-ancestor
102174857|NCT04974944|Paclitaxel|paclitaxel|mesh-list
102174858|NCT04974944|Bevacizumab|bevacizumab|mesh-list
102174859|NCT04974944|Carboplatin|carboplatin|mesh-list
102174860|NCT04974944|Apatinib|apatinib|mesh-list
102174861|NCT04974944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102174862|NCT04974944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102174863|NCT04974944|Tubulin Modulators|tubulin modulators|mesh-ancestor
102174864|NCT04974944|Antimitotic Agents|antimitotic agents|mesh-ancestor
102174865|NCT04974944|Mitosis Modulators|mitosis modulators|mesh-ancestor
102174866|NCT04974944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447484|NCT00590278|Raltitrexed|raltitrexed|mesh-list
102174867|NCT04974944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102174868|NCT04974944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102174869|NCT04974944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102174870|NCT04974944|Growth Substances|growth substances|mesh-ancestor
102174871|NCT04974944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174872|NCT04974944|Growth Inhibitors|growth inhibitors|mesh-ancestor
102174873|NCT04974944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102174874|NCT04974944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102174875|NCT04962386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102174876|NCT04962386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102174877|NCT04962386|Hormones|hormones|mesh-list
102174878|NCT04962386|Estradiol|estradiol|mesh-list
102174879|NCT04962386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102174880|NCT04962386|Progesterone|progesterone|mesh-list
102174881|NCT04962386|Estrogens|estrogens|mesh-list
101573984|NCT02199184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102174882|NCT04962386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102174883|NCT04962386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174884|NCT04962386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102174885|NCT04962386|Contraceptive Agents|contraceptive agents|mesh-ancestor
102174886|NCT04962386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102174887|NCT04962386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102174888|NCT04962386|Progestins|progestins|mesh-ancestor
102174889|NCT02071355|Simeprevir|simeprevir|mesh-list
102174890|NCT02071355|Antiviral Agents|antiviral agents|mesh-ancestor
102174891|NCT02071355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102174892|NCT02071355|Protease Inhibitors|protease inhibitors|mesh-ancestor
102174893|NCT02071355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102174894|NCT02071355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174895|NCT02071433|Iodine|iodine|mesh-list
102174896|NCT02071433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102174897|NCT02071433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102174898|NCT02071433|Trace Elements|trace elements|mesh-ancestor
102174899|NCT02071433|Micronutrients|micronutrients|mesh-ancestor
102174900|NCT02071433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174901|NCT04962308|Vaccines|vaccines|mesh-list
102174902|NCT04962308|Immunologic Factors|immunologic factors|mesh-ancestor
102174903|NCT04962308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174904|NCT02071589|Nifedipine|nifedipine|mesh-list
102174905|NCT02071589|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102174906|NCT02071589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102174907|NCT02071589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174908|NCT02071589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102174909|NCT02071589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174910|NCT02071589|Vasodilator Agents|vasodilator agents|mesh-ancestor
102174911|NCT02071589|Tocolytic Agents|tocolytic agents|mesh-ancestor
102174912|NCT02071589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102174913|NCT02077751|Biotin|biotin|mesh-list
102174914|NCT02077751|Vitamin B Complex|vitamin b complex|mesh-ancestor
102174915|NCT02077751|Vitamins|vitamins|mesh-ancestor
102174916|NCT02077751|Micronutrients|micronutrients|mesh-ancestor
102174917|NCT02077751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174918|NCT04961684|Amorolfine|amorolfine|mesh-list
102174919|NCT04961684|Antifungal Agents|antifungal agents|mesh-ancestor
102174920|NCT04961684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102174921|NCT03061058|Docetaxel|docetaxel|mesh-list
102174922|NCT03061058|Oxaliplatin|oxaliplatin|mesh-list
102174923|NCT03061058|Irinotecan|irinotecan|mesh-list
102174924|NCT03061058|Pemetrexed|pemetrexed|mesh-list
102174925|NCT03061058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102174926|NCT03061058|Tubulin Modulators|tubulin modulators|mesh-ancestor
102174927|NCT03061058|Antimitotic Agents|antimitotic agents|mesh-ancestor
102174928|NCT03061058|Mitosis Modulators|mitosis modulators|mesh-ancestor
102174929|NCT03061058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174930|NCT03061058|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102174931|NCT03061058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102174932|NCT03061058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102174933|NCT03061058|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102174934|NCT03061058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102174935|NCT04961918|Durvalumab|durvalumab|mesh-list
102174936|NCT04961918|Lenvatinib|lenvatinib|mesh-list
102174937|NCT04961918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102174938|NCT04961918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102174939|NCT04961918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102174940|NCT04961918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102174941|NCT04961918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174942|NCT04954040|Azithromycin|azithromycin|mesh-list
102174943|NCT04954040|Hydroxychloroquine|hydroxychloroquine|mesh-list
102174944|NCT04954040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102174945|NCT04954040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102174946|NCT04954040|Antimalarials|antimalarials|mesh-ancestor
102174947|NCT04954040|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102174948|NCT04954040|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102174949|NCT04954040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102174950|NCT04954040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174951|NCT04954040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102174952|NCT04424654|Methyltestosterone|methyltestosterone|mesh-list
102174953|NCT04424654|Testosterone|testosterone|mesh-list
102174954|NCT04424654|Testosterone undecanoate|testosterone undecanoate|mesh-list
102174955|NCT04424654|Testosterone enanthate|testosterone enanthate|mesh-list
102174956|NCT04424654|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102174957|NCT04424654|Androgens|androgens|mesh-ancestor
102174958|NCT04424654|Hormones|hormones|mesh-ancestor
102174959|NCT04424654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102174960|NCT04424654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174961|NCT04424654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102174962|NCT04424654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102174963|NCT04424654|Anabolic Agents|anabolic agents|mesh-ancestor
102174964|NCT04968392|Dexmedetomidine|dexmedetomidine|mesh-list
102174965|NCT04968392|Levobupivacaine|levobupivacaine|mesh-list
102174966|NCT04968392|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102174967|NCT04968392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102174968|NCT04968392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174969|NCT04968392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102174970|NCT04968392|Analgesics|analgesics|mesh-ancestor
102174971|NCT04968392|Sensory System Agents|sensory system agents|mesh-ancestor
102174972|NCT04968392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102174973|NCT04968392|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102174974|NCT04968392|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102174975|NCT04968392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102174976|NCT04968392|Adrenergic Agents|adrenergic agents|mesh-ancestor
102174977|NCT04968392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102174978|NCT04968392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174979|NCT04968392|Anesthetics, Local|anesthetics, local|mesh-ancestor
102174980|NCT04968392|Anesthetics|anesthetics|mesh-ancestor
102174981|NCT02792699|Rituximab|rituximab|mesh-list
102174982|NCT02792699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102174983|NCT02792699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102174984|NCT02792699|Immunologic Factors|immunologic factors|mesh-ancestor
102174985|NCT02792699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102174986|NCT02792699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102174987|NCT04968002|Apatinib|apatinib|mesh-list
102174988|NCT04968002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102174989|NCT04968002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102174990|NCT04968002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102174991|NCT04968002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174992|NCT04961138|Lenvatinib|lenvatinib|mesh-list
102174993|NCT04961138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102174994|NCT04961138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102174995|NCT04961138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102174996|NCT04961138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102174998|NCT03061136|Anticonvulsants|anticonvulsants|mesh-ancestor
102174999|NCT03061136|GABA Modulators|gaba modulators|mesh-ancestor
102175000|NCT03061136|GABA Agents|gaba agents|mesh-ancestor
102175001|NCT03061136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102175002|NCT03061136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175003|NCT03061136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175004|NCT04952792|Apixaban|apixaban|mesh-list
102175005|NCT04952792|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102175006|NCT04952792|Antithrombins|antithrombins|mesh-ancestor
102175007|NCT04952792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102175008|NCT04952792|Protease Inhibitors|protease inhibitors|mesh-ancestor
102175009|NCT04952792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102175010|NCT04952792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175011|NCT04952792|Anticoagulants|anticoagulants|mesh-ancestor
102175012|NCT02075333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102175013|NCT02080169|Fentanyl|fentanyl|mesh-list
102175014|NCT02080169|Midazolam|midazolam|mesh-list
102175015|NCT02080169|Dexmedetomidine|dexmedetomidine|mesh-list
102175016|NCT02080169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102175017|NCT02080169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102175018|NCT02080169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175019|NCT02080169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102175020|NCT02080169|Analgesics|analgesics|mesh-ancestor
102175021|NCT02080169|Sensory System Agents|sensory system agents|mesh-ancestor
102175022|NCT02080169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102175023|NCT02080169|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102175024|NCT02080169|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102175025|NCT02080169|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102175026|NCT02080169|Adrenergic Agents|adrenergic agents|mesh-ancestor
102175027|NCT02080169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102175028|NCT02080169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175029|NCT02080169|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102175030|NCT02080169|Narcotics|narcotics|mesh-ancestor
102175031|NCT02080169|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102175032|NCT02080169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102175033|NCT02080169|Anesthetics, General|anesthetics, general|mesh-ancestor
102175034|NCT02080169|Anesthetics|anesthetics|mesh-ancestor
102175035|NCT02080169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102175036|NCT02080169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102175037|NCT02080169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102175038|NCT02080169|GABA Modulators|gaba modulators|mesh-ancestor
102175039|NCT02080169|GABA Agents|gaba agents|mesh-ancestor
102175040|NCT02078063|Mepivacaine|mepivacaine|mesh-list
102175041|NCT02078063|Anesthetics, Local|anesthetics, local|mesh-ancestor
102175042|NCT02078063|Anesthetics|anesthetics|mesh-ancestor
102175043|NCT02078063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102175044|NCT02078063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447515|NCT00590629|Niacin|niacin|mesh-list
102175045|NCT02078063|Sensory System Agents|sensory system agents|mesh-ancestor
102175046|NCT02078063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102175047|NCT04951856|Evolocumab|evolocumab|mesh-list
102175048|NCT04951856|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102175049|NCT04951856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102175050|NCT04951856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102175051|NCT04951856|Antimetabolites|antimetabolites|mesh-ancestor
102175052|NCT04951856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175053|NCT04951856|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102175054|NCT04951856|Protease Inhibitors|protease inhibitors|mesh-ancestor
102175055|NCT04951856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102175056|NCT04951856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102175057|NCT04951232|Cinepazide|cinepazide|mesh-list
102175058|NCT04951232|Vasodilator Agents|vasodilator agents|mesh-ancestor
102175059|NCT04959578|Epoetin Alfa|epoetin alfa|mesh-list
102175060|NCT04959578|Darbepoetin alfa|darbepoetin alfa|mesh-list
102175061|NCT04959578|Hematinics|hematinics|mesh-ancestor
102175062|NCT04959500|Temozolomide|temozolomide|mesh-list
102175063|NCT04959500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102175064|NCT04959500|Alkylating Agents|alkylating agents|mesh-ancestor
102175065|NCT04959500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175066|NCT04959500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102175067|NCT02076191|Decitabine|decitabine|mesh-list
101883917|NCT04505670|Zinc Oxide|zinc oxide|mesh-list
102175068|NCT02076191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102175069|NCT02076191|Antimetabolites|antimetabolites|mesh-ancestor
102175070|NCT02076191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175071|NCT02076191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102175072|NCT02076191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102175073|NCT02080715|Tolcapone|tolcapone|mesh-list
102175074|NCT02080715|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102175075|NCT02080715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102175076|NCT02080715|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102175077|NCT02080715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102175078|NCT02080715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175079|NCT04965662|Tenofovir|tenofovir|mesh-list
102175080|NCT04965662|Emtricitabine|emtricitabine|mesh-list
102175081|NCT04965662|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102175082|NCT04965662|Maraviroc|maraviroc|mesh-list
102175083|NCT04965662|Antiviral Agents|antiviral agents|mesh-ancestor
102175084|NCT04965662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102175085|NCT04965662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102175086|NCT04965662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102175087|NCT04965662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102175088|NCT04965662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175089|NCT04965662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102175090|NCT04965662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102175091|NCT04965662|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102175092|NCT04965662|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102175093|NCT04965662|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102175094|NCT02078609|Midostaurin|midostaurin|mesh-list
102175095|NCT02078609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102175096|NCT02078609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102175097|NCT02078609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102175098|NCT02078609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175099|NCT04957940|SMOFlipid|smoflipid|mesh-list
102175100|NCT04957940|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102175101|NCT04957940|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102175102|NCT04957940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102175103|NCT03060278|Nicotine|nicotine|mesh-list
102175104|NCT03060278|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102175105|NCT03060278|Autonomic Agents|autonomic agents|mesh-ancestor
101573985|NCT02199184|Alkylating Agents|alkylating agents|mesh-ancestor
102175106|NCT03060278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102175107|NCT03060278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175108|NCT03060278|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102175109|NCT03060278|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102175110|NCT03060278|Cholinergic Agents|cholinergic agents|mesh-ancestor
102175111|NCT03060278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101447546|NCT00590785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102175112|NCT03060278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175113|NCT02083991|Prednisolone|prednisolone|mesh-list
102175114|NCT02083991|Thymoglobulin|thymoglobulin|mesh-list
102175115|NCT02083991|Basiliximab|basiliximab|mesh-list
102175116|NCT02083991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102175117|NCT02083991|Glucocorticoids|glucocorticoids|mesh-ancestor
102175118|NCT02083991|Hormones|hormones|mesh-ancestor
102175119|NCT02083991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102175120|NCT02083991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175121|NCT02083991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102175122|NCT02083991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102175123|NCT02083991|Immunologic Factors|immunologic factors|mesh-ancestor
102175124|NCT02083991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102175125|NCT02081027|Riluzole|riluzole|mesh-list
102175126|NCT02081027|Anticonvulsants|anticonvulsants|mesh-ancestor
102175127|NCT02081027|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102175128|NCT02081027|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102175129|NCT02081027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102175130|NCT02081027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175131|NCT02081027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175132|NCT02081027|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102175133|NCT02081027|Protective Agents|protective agents|mesh-ancestor
102175134|NCT04948034|Tislelizumab|tislelizumab|mesh-list
102175135|NCT04948034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102175136|NCT04948034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102175137|NCT04947956|Apatinib|apatinib|mesh-list
102175138|NCT04947956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102175139|NCT04947956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102175140|NCT04947956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102175141|NCT04947956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175142|NCT03254511|Enoxaparin|enoxaparin|mesh-list
102175143|NCT03254511|Enoxaparin sodium|enoxaparin sodium|mesh-list
102175144|NCT03254511|Anticoagulants|anticoagulants|mesh-ancestor
102175145|NCT03254511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102175146|NCT03254511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102175147|NCT03254511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175149|NCT04947566|Naproxen|naproxen|mesh-list
102175150|NCT04947566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102175151|NCT04947566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102175152|NCT04947566|Analgesics|analgesics|mesh-ancestor
102175153|NCT04947566|Sensory System Agents|sensory system agents|mesh-ancestor
102175154|NCT04947566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102175155|NCT04947566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175156|NCT04947566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102175157|NCT04947566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102175158|NCT04947566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102175159|NCT04947566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102175160|NCT04947566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175161|NCT04947566|Gout Suppressants|gout suppressants|mesh-ancestor
102175162|NCT03241875|Pregabalin|pregabalin|mesh-list
102175163|NCT03241875|Gabapentin|gabapentin|mesh-list
102175164|NCT03241875|Analgesics|analgesics|mesh-ancestor
102175165|NCT03241875|Sensory System Agents|sensory system agents|mesh-ancestor
102175166|NCT03241875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102175167|NCT03241875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175168|NCT03241875|Anticonvulsants|anticonvulsants|mesh-ancestor
102175169|NCT03241875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102175170|NCT03241875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102175171|NCT03241875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175172|NCT03241875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102175173|NCT03241875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102175174|NCT03241875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102175175|NCT03241875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102175176|NCT03241875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102175177|NCT03241875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102175178|NCT03241875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102175179|NCT03241875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102175181|NCT03058094|Pemetrexed|pemetrexed|mesh-list
102175182|NCT03058094|Abivertinib|abivertinib|mesh-list
102175183|NCT03058094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102175184|NCT03058094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102175185|NCT03058094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175186|NCT03058094|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102175187|NCT03058094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102175188|NCT03058094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102175189|NCT04413266|Curcumin|curcumin|mesh-list
102175190|NCT04413266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102175191|NCT04413266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102175192|NCT04413266|Analgesics|analgesics|mesh-ancestor
102175193|NCT04413266|Sensory System Agents|sensory system agents|mesh-ancestor
102175194|NCT04413266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102175195|NCT04413266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175196|NCT04413266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102175197|NCT04413266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102175198|NCT04413266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102175199|NCT04413266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102175200|NCT04413266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175201|NCT04944524|Methotrexate|methotrexate|mesh-list
102175202|NCT04944524|Tofacitinib|tofacitinib|mesh-list
102175203|NCT04944524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102175204|NCT04944524|Abortifacient Agents|abortifacient agents|mesh-ancestor
102175205|NCT04944524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102175206|NCT04944524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175207|NCT04944524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102175208|NCT04944524|Antimetabolites|antimetabolites|mesh-ancestor
102175209|NCT04944524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175210|NCT04944524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102175211|NCT04944524|Dermatologic Agents|dermatologic agents|mesh-ancestor
102175212|NCT04944524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102175213|NCT04944524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102175214|NCT04944524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102175215|NCT04944524|Immunologic Factors|immunologic factors|mesh-ancestor
102175216|NCT04944524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102175217|NCT04944524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102175218|NCT04944524|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101884069|NCT03878524|Sunitinib|sunitinib|mesh-list
102175219|NCT04944524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102175220|NCT04412876|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102175221|NCT04412876|Imipramine|imipramine|mesh-list
102175222|NCT04412876|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102175223|NCT04412876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102175224|NCT04412876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102175225|NCT04412876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175226|NCT04412876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102175227|NCT04412876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175228|NCT04412876|Analgesics|analgesics|mesh-ancestor
102175229|NCT04412876|Sensory System Agents|sensory system agents|mesh-ancestor
102175230|NCT04412876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102175231|NCT04412876|Antidepressive Agents|antidepressive agents|mesh-ancestor
102175232|NCT04412876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102175233|NCT04412876|Dopamine Agents|dopamine agents|mesh-ancestor
102175234|NCT04412876|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102175235|NCT04412876|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102175236|NCT04412876|Adrenergic Agents|adrenergic agents|mesh-ancestor
102175237|NCT03241563|Triamcinolone|triamcinolone|mesh-list
102175238|NCT03241563|Deoxycholic Acid|deoxycholic acid|mesh-list
102175239|NCT03241563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102175240|NCT03241563|Glucocorticoids|glucocorticoids|mesh-ancestor
102175241|NCT03241563|Hormones|hormones|mesh-ancestor
102175242|NCT03241563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102175243|NCT03241563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175244|NCT03241563|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102175245|NCT03241563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102175246|NCT03241641|Tenofovir|tenofovir|mesh-list
102175247|NCT03241641|Antiviral Agents|antiviral agents|mesh-ancestor
102175248|NCT03241641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102175249|NCT03241641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102175250|NCT03241641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102175251|NCT03241641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102175252|NCT03241641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175253|NCT03241641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102175254|NCT03241641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102175255|NCT04486521|Siltuximab|siltuximab|mesh-list
102175256|NCT04486521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102175257|NCT04955834|Insulin|insulin|mesh-list
102175258|NCT04955834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102175259|NCT04955834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175260|NCT03241407|Triclosan|triclosan|mesh-list
102175261|NCT03241407|Fluorides|fluorides|mesh-list
102175262|NCT03241407|Cariostatic Agents|cariostatic agents|mesh-ancestor
102175263|NCT03241407|Protective Agents|protective agents|mesh-ancestor
102175264|NCT03241407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175265|NCT03241407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102175266|NCT03241407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102175267|NCT03241407|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102175268|NCT03241407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102175269|NCT03241407|Antimetabolites|antimetabolites|mesh-ancestor
102175270|NCT03241407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175271|NCT03241407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102175272|NCT03238131|Ivermectin|ivermectin|mesh-list
102175273|NCT03238131|Albendazole|albendazole|mesh-list
102175274|NCT03238131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102175275|NCT03238131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102175276|NCT03238131|Anthelmintics|anthelmintics|mesh-ancestor
102175277|NCT03238131|Anticestodal Agents|anticestodal agents|mesh-ancestor
102175278|NCT03238131|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102175279|NCT03238131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102175280|NCT03238131|Tubulin Modulators|tubulin modulators|mesh-ancestor
102175281|NCT03238131|Antimitotic Agents|antimitotic agents|mesh-ancestor
102175282|NCT03238131|Mitosis Modulators|mitosis modulators|mesh-ancestor
102175283|NCT03238131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175284|NCT03238131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102175285|NCT01369433|Sirolimus|sirolimus|mesh-list
102175286|NCT01369433|Paclitaxel|paclitaxel|mesh-list
102175287|NCT01369433|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102175288|NCT01369433|Capecitabine|capecitabine|mesh-list
102175289|NCT01369433|Temsirolimus|temsirolimus|mesh-list
102175290|NCT01369433|MTOR Inhibitors|mtor inhibitors|mesh-list
102175291|NCT01369433|Tivozanib|tivozanib|mesh-list
102175292|NCT01369433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102175293|NCT01369433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102175294|NCT01369433|Tubulin Modulators|tubulin modulators|mesh-ancestor
102175295|NCT01369433|Antimitotic Agents|antimitotic agents|mesh-ancestor
102175296|NCT01369433|Mitosis Modulators|mitosis modulators|mesh-ancestor
102175297|NCT01369433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175298|NCT01369433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102175299|NCT01369433|Antimetabolites|antimetabolites|mesh-ancestor
102175300|NCT01369433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102175301|NCT01369433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102175302|NCT01369433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102175303|NCT01369433|Immunologic Factors|immunologic factors|mesh-ancestor
102175304|NCT01369433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175305|NCT01369433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102175306|NCT01369433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102175307|NCT01369433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102175308|NCT01369433|Antifungal Agents|antifungal agents|mesh-ancestor
102175310|NCT04946162|Vasodilator Agents|vasodilator agents|mesh-ancestor
102175311|NCT04946162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102175312|NCT04946162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102175313|NCT04946162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102175314|NCT04946162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175315|NCT04946162|Urological Agents|urological agents|mesh-ancestor
102175316|NCT02084225|Lidocaine|lidocaine|mesh-list
102175317|NCT02084225|Anesthetics, Local|anesthetics, local|mesh-ancestor
102175318|NCT02084225|Anesthetics|anesthetics|mesh-ancestor
102175319|NCT02084225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102175320|NCT02084225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175321|NCT02084225|Sensory System Agents|sensory system agents|mesh-ancestor
102175322|NCT02084225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102175323|NCT02084225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102175324|NCT02084225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102175325|NCT02084225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102175326|NCT02084225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102175327|NCT02084225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175329|NCT04945694|Propofol|propofol|mesh-list
102175330|NCT04945694|Sevoflurane|sevoflurane|mesh-list
102175331|NCT04945694|Atracurium|atracurium|mesh-list
102175332|NCT04945694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102175333|NCT04945694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102175334|NCT04945694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175335|NCT04945694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102175336|NCT04945694|Anesthetics, General|anesthetics, general|mesh-ancestor
102175337|NCT04945694|Anesthetics|anesthetics|mesh-ancestor
102175338|NCT04945694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102175339|NCT04945694|Narcotics|narcotics|mesh-ancestor
102175340|NCT04945694|Analgesics|analgesics|mesh-ancestor
102175341|NCT04945694|Sensory System Agents|sensory system agents|mesh-ancestor
102175342|NCT04945694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102175343|NCT04945694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102175344|NCT04945694|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102175345|NCT04945694|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102175346|NCT04945694|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102175347|NCT04945694|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102175348|NCT04945694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102175349|NCT04945694|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102175350|NCT04945694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102175351|NCT04945694|Cholinergic Agents|cholinergic agents|mesh-ancestor
102175352|NCT04945694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102175353|NCT04945694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175354|NCT02084303|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102175355|NCT02084303|Hematinics|hematinics|mesh-ancestor
102175356|NCT02084303|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102175357|NCT02084303|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102175358|NCT02420847|Gemcitabine|gemcitabine|mesh-list
102175359|NCT02420847|Doxorubicin|doxorubicin|mesh-list
102175360|NCT02420847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102175361|NCT02420847|Ixazomib|ixazomib|mesh-list
102175362|NCT02420847|Glycine|glycine|mesh-list
102175363|NCT02420847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102175364|NCT02420847|Antimetabolites|antimetabolites|mesh-ancestor
102175365|NCT02420847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175366|NCT02420847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102175367|NCT02420847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102175368|NCT02420847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101884224|NCT03560934|Dronabinol|dronabinol|mesh-list
102175369|NCT02420847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102175370|NCT02420847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102175371|NCT02420847|Protease Inhibitors|protease inhibitors|mesh-ancestor
102175373|NCT02420847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102175374|NCT02420847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175375|NCT03253887|Ethanol|ethanol|mesh-list
102175376|NCT03253887|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102175377|NCT03253887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102175378|NCT03253887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102175379|NCT03253887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175380|NCT02453607|Infliximab|infliximab|mesh-list
102175381|NCT02453607|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102175382|NCT02453607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102175383|NCT02453607|Dermatologic Agents|dermatologic agents|mesh-ancestor
102175384|NCT02453607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102175385|NCT02453607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102175386|NCT02453529|Nafithromycin|nafithromycin|mesh-list
102175387|NCT02453529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102175388|NCT02453529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102175389|NCT02453529|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102175390|NCT02453529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102175391|NCT02453529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175392|NCT03241017|Durvalumab|durvalumab|mesh-list
102175393|NCT03241017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102175394|NCT03241017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102175395|NCT03237741|Rabeprazole|rabeprazole|mesh-list
102175396|NCT03237741|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102175397|NCT03237741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102175398|NCT03237741|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102175399|NCT03237741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102175400|NCT03237741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175401|NCT03240939|Tadalafil|tadalafil|mesh-list
102175402|NCT03240939|Dutasteride|dutasteride|mesh-list
102175403|NCT03240939|Vasodilator Agents|vasodilator agents|mesh-ancestor
102175404|NCT03240939|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102175405|NCT03240939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102175406|NCT03240939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102175407|NCT03240939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175408|NCT03240939|Urological Agents|urological agents|mesh-ancestor
102175409|NCT03240939|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102175410|NCT03240939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102175411|NCT03240939|Hormone Antagonists|hormone antagonists|mesh-ancestor
102175412|NCT03240939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102175413|NCT03240939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175414|NCT02624492|Rituximab|rituximab|mesh-list
102175415|NCT02624492|BI 836826|bi 836826|mesh-list
102175416|NCT02624492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102175417|NCT02624492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102175418|NCT02624492|Immunologic Factors|immunologic factors|mesh-ancestor
102175419|NCT02624492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175420|NCT02624492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102175421|NCT03240783|Dexamethasone|dexamethasone|mesh-list
102175422|NCT03240783|Dexamethasone acetate|dexamethasone acetate|mesh-list
102175423|NCT03240783|Betamethasone|betamethasone|mesh-list
102175424|NCT03240783|BB 1101|bb 1101|mesh-list
102175425|NCT03240783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102175426|NCT03240783|Antiemetics|antiemetics|mesh-ancestor
102175427|NCT03240783|Autonomic Agents|autonomic agents|mesh-ancestor
102175428|NCT03240783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102175429|NCT03240783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175430|NCT03240783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102175431|NCT03240783|Glucocorticoids|glucocorticoids|mesh-ancestor
102175432|NCT03240783|Hormones|hormones|mesh-ancestor
102175433|NCT03240783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102175434|NCT03240783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102175435|NCT03240783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102175436|NCT03240783|Protease Inhibitors|protease inhibitors|mesh-ancestor
102175437|NCT03240783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102175438|NCT03240783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175439|NCT03240783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102175440|NCT03240783|Respiratory System Agents|respiratory system agents|mesh-ancestor
102175441|NCT03237507|Paclitaxel|paclitaxel|mesh-list
102175442|NCT03237507|Oxaliplatin|oxaliplatin|mesh-list
102175443|NCT03237507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102175444|NCT03237507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102175445|NCT03237507|Tubulin Modulators|tubulin modulators|mesh-ancestor
102175446|NCT03237507|Antimitotic Agents|antimitotic agents|mesh-ancestor
102175447|NCT03237507|Mitosis Modulators|mitosis modulators|mesh-ancestor
102175448|NCT03237507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175449|NCT04945226|Finasteride|finasteride|mesh-list
102175450|NCT04945226|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102175451|NCT04945226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102175452|NCT04945226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102175453|NCT04945226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175454|NCT04945226|Hormone Antagonists|hormone antagonists|mesh-ancestor
102175455|NCT04945226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102175456|NCT04945226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175457|NCT04945226|Urological Agents|urological agents|mesh-ancestor
102175458|NCT01975831|Durvalumab|durvalumab|mesh-list
102175459|NCT01975831|Tremelimumab|tremelimumab|mesh-list
102175460|NCT01975831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102175461|NCT01975831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102175462|NCT04945070|Insulin|insulin|mesh-list
102175463|NCT04945070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102175464|NCT04945070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175465|NCT03240471|Calpastatin|calpastatin|mesh-list
102175466|NCT03240471|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
102175467|NCT03240471|Protease Inhibitors|protease inhibitors|mesh-ancestor
102175468|NCT03240471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102175469|NCT03240471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175470|NCT04942652|Itraconazole|itraconazole|mesh-list
102175471|NCT04942652|Esomeprazole|esomeprazole|mesh-list
102175472|NCT04942652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102175473|NCT04942652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102175474|NCT04942652|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102175475|NCT04942652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101899984|NCT01269866|Analgesics|analgesics|mesh-ancestor
102175476|NCT04942652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175477|NCT04942652|Antifungal Agents|antifungal agents|mesh-ancestor
102175478|NCT04942652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102175479|NCT04942652|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102175480|NCT04942652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102175481|NCT04942652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102175482|NCT04942652|Hormone Antagonists|hormone antagonists|mesh-ancestor
102175483|NCT04942652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102175484|NCT04942652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175485|NCT04942652|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102175486|NCT03240549|Bevacizumab|bevacizumab|mesh-list
102175487|NCT03240549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102175488|NCT03240549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102175489|NCT03240549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102175490|NCT03240549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102175491|NCT03240549|Growth Substances|growth substances|mesh-ancestor
102175492|NCT03240549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175493|NCT03240549|Growth Inhibitors|growth inhibitors|mesh-ancestor
102175494|NCT04933292|Mycophenolic Acid|mycophenolic acid|mesh-list
102175495|NCT04933292|Methylprednisolone|methylprednisolone|mesh-list
102175496|NCT04933292|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102175497|NCT04933292|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102175498|NCT04933292|Prednisolone|prednisolone|mesh-list
102175499|NCT04933292|Prednisolone acetate|prednisolone acetate|mesh-list
102175500|NCT04933292|Azathioprine|azathioprine|mesh-list
102175501|NCT04933292|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102175502|NCT04933292|Prednisolone phosphate|prednisolone phosphate|mesh-list
102175503|NCT04933292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102175504|NCT04933292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102175505|NCT04933292|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102175506|NCT04933292|Antitubercular Agents|antitubercular agents|mesh-ancestor
102175507|NCT04933292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102175508|NCT04933292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102175509|NCT04933292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102175510|NCT04933292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175511|NCT04933292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102175512|NCT04933292|Antiemetics|antiemetics|mesh-ancestor
102175513|NCT04933292|Autonomic Agents|autonomic agents|mesh-ancestor
102175514|NCT04933292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102175515|NCT04933292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175516|NCT04933292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102175517|NCT04933292|Glucocorticoids|glucocorticoids|mesh-ancestor
102175519|NCT04933292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102175520|NCT04933292|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102175521|NCT04933292|Protective Agents|protective agents|mesh-ancestor
102175522|NCT04933292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102175523|NCT04933292|Antimetabolites|antimetabolites|mesh-ancestor
102175524|NCT04933292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102175525|NCT04933292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102175526|NCT04933292|Immunologic Factors|immunologic factors|mesh-ancestor
102175527|NCT04933292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102175528|NCT04942496|Chlorhexidine|chlorhexidine|mesh-list
102175529|NCT04942496|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102175530|NCT04942496|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102175531|NCT04942496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102175532|NCT04942496|Disinfectants|disinfectants|mesh-ancestor
102175533|NCT04942496|Dermatologic Agents|dermatologic agents|mesh-ancestor
102175534|NCT03237117|Hormones|hormones|mesh-list
102175535|NCT03237117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102175536|NCT03237117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175537|NCT03239691|ACT-709478|act-709478|mesh-list
102175538|NCT03239691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102175539|NCT03239691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102175540|NCT03239691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175541|NCT03239691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102175542|NCT03239691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175543|NCT04944602|Omalizumab|omalizumab|mesh-list
102175544|NCT04944602|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102175545|NCT04944602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102175546|NCT04944602|Respiratory System Agents|respiratory system agents|mesh-ancestor
102175547|NCT03253107|Trastuzumab|trastuzumab|mesh-list
102175548|NCT03253107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102175549|NCT03253107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102175550|NCT03236883|Gemcitabine|gemcitabine|mesh-list
102175551|NCT03236883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102175552|NCT03236883|Antimetabolites|antimetabolites|mesh-ancestor
102175553|NCT03236883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175554|NCT03236883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102175555|NCT03236961|Moxifloxacin|moxifloxacin|mesh-list
102175556|NCT03236961|Metronidazole|metronidazole|mesh-list
102175557|NCT03236961|Levofloxacin|levofloxacin|mesh-list
102175558|NCT03236961|Ertapenem|ertapenem|mesh-list
102175559|NCT03236961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102175560|NCT03236961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102175561|NCT03236961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102175562|NCT03236961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102175563|NCT03236961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102175564|NCT03236961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175565|NCT03236961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102175566|NCT03236961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102175567|NCT03236961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102175568|NCT03236961|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102175569|NCT03236961|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102175570|NCT03236961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102175571|NCT05234619|Ketorolac|ketorolac|mesh-list
102175572|NCT05234619|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102175573|NCT05234619|Lidocaine|lidocaine|mesh-list
102175574|NCT05234619|Anesthetics, Local|anesthetics, local|mesh-ancestor
102175575|NCT05234619|Anesthetics|anesthetics|mesh-ancestor
102175576|NCT05234619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102175577|NCT05234619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175578|NCT05234619|Sensory System Agents|sensory system agents|mesh-ancestor
102175579|NCT05234619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102175580|NCT05234619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102175581|NCT05234619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102175582|NCT05234619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102175583|NCT05234619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102175584|NCT05234619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175585|NCT05234619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102175586|NCT05234619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102175587|NCT05234619|Analgesics|analgesics|mesh-ancestor
102175588|NCT05234619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102175589|NCT05234619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102175590|NCT05234619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102175591|NCT05234619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102175592|NCT04921904|Ramucirumab|ramucirumab|mesh-list
102175593|NCT04921904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102175595|NCT02622386|Vitamins|vitamins|mesh-ancestor
102175596|NCT02622386|Micronutrients|micronutrients|mesh-ancestor
102175597|NCT02622386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175598|NCT02622386|Vitamin B Complex|vitamin b complex|mesh-ancestor
102175599|NCT02622386|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102175600|NCT02622386|Dermatologic Agents|dermatologic agents|mesh-ancestor
101447584|NCT00476593|Hormones|hormones|mesh-ancestor
102175601|NCT04427618|Tranexamic Acid|tranexamic acid|mesh-list
102175602|NCT04427618|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102175603|NCT04427618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102175604|NCT04427618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175605|NCT04427618|Hemostatics|hemostatics|mesh-ancestor
102175606|NCT04427618|Coagulants|coagulants|mesh-ancestor
102175607|NCT03236727|Dexmedetomidine|dexmedetomidine|mesh-list
102175608|NCT03236727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102175609|NCT03236727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102175610|NCT03236727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175611|NCT03236727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102175612|NCT03236727|Analgesics|analgesics|mesh-ancestor
102175613|NCT03236727|Sensory System Agents|sensory system agents|mesh-ancestor
102175614|NCT03236727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102175615|NCT03236727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102175616|NCT03236727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102175617|NCT03236727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102175618|NCT03236727|Adrenergic Agents|adrenergic agents|mesh-ancestor
102175619|NCT03236727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102175620|NCT03236727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175621|NCT03236493|PF-06700841|pf-06700841|mesh-list
102175622|NCT03236493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102175623|NCT03236493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102175624|NCT03236493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175625|NCT04921124|Teriparatide|teriparatide|mesh-list
102175626|NCT04921124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102175627|NCT04921124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175628|NCT04921124|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102175629|NCT04921046|Lidocaine|lidocaine|mesh-list
102175630|NCT04921046|Midazolam|midazolam|mesh-list
102175631|NCT04921046|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102175632|NCT04921046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102175633|NCT04921046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102175634|NCT04921046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175635|NCT04921046|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102175636|NCT04921046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102175637|NCT04921046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102175638|NCT04921046|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102175639|NCT04921046|Anesthetics, General|anesthetics, general|mesh-ancestor
102175640|NCT04921046|Anesthetics|anesthetics|mesh-ancestor
102175641|NCT04921046|GABA Modulators|gaba modulators|mesh-ancestor
102175642|NCT04921046|GABA Agents|gaba agents|mesh-ancestor
102175643|NCT04921046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102175644|NCT04921046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175645|NCT04921046|Anesthetics, Local|anesthetics, local|mesh-ancestor
102175646|NCT04921046|Sensory System Agents|sensory system agents|mesh-ancestor
102175647|NCT04921046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102175648|NCT04921046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102175649|NCT04921046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102175650|NCT04921046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102175651|NCT04921046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102175652|NCT02792231|Teriflunomide|teriflunomide|mesh-list
102175653|NCT02792231|Ofatumumab|ofatumumab|mesh-list
102175654|NCT02792231|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102175655|NCT02792231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102175656|NCT02792231|Immunologic Factors|immunologic factors|mesh-ancestor
102175657|NCT02792231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175658|NCT02792231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102175659|NCT02792231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102175660|NCT02792231|Analgesics|analgesics|mesh-ancestor
102175661|NCT02792231|Sensory System Agents|sensory system agents|mesh-ancestor
102175662|NCT02792231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102175663|NCT02792231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102175664|NCT02792231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102175665|NCT02792231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102175666|NCT04930952|Ethanol|ethanol|mesh-list
101884526|NCT05703191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102175667|NCT04930952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102175668|NCT04930952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102175669|NCT04930952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102175670|NCT04930952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175671|NCT04920968|Rituximab|rituximab|mesh-list
102175672|NCT04920968|Obinutuzumab|obinutuzumab|mesh-list
102175673|NCT04920968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102175674|NCT04920968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102175675|NCT04920968|Immunologic Factors|immunologic factors|mesh-ancestor
102175676|NCT04920968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175677|NCT04920968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102175678|NCT00700401|Ribavirin|ribavirin|mesh-list
102175679|NCT00700401|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102175680|NCT00700401|Antimetabolites|antimetabolites|mesh-ancestor
102175681|NCT00700401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175682|NCT00700401|Antiviral Agents|antiviral agents|mesh-ancestor
102175683|NCT00700401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102175684|NCT04931108|Atenolol|atenolol|mesh-list
102175685|NCT04931108|Nitrendipine|nitrendipine|mesh-list
102175686|NCT04931108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102175687|NCT04931108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102175688|NCT04931108|Sympatholytics|sympatholytics|mesh-ancestor
102175689|NCT04931108|Autonomic Agents|autonomic agents|mesh-ancestor
102175690|NCT04931108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102175691|NCT04931108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175692|NCT04931108|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102175693|NCT04931108|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102175694|NCT04931108|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102175695|NCT04931108|Adrenergic Agents|adrenergic agents|mesh-ancestor
102175696|NCT04931108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102175697|NCT04931108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175698|NCT04931108|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102175699|NCT04931108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102175700|NCT04931108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102175701|NCT04931108|Vasodilator Agents|vasodilator agents|mesh-ancestor
102175702|NCT04920500|Cytarabine|cytarabine|mesh-list
102175703|NCT04920500|Daunorubicin|daunorubicin|mesh-list
102175704|NCT04920500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102175705|NCT04920500|Antimetabolites|antimetabolites|mesh-ancestor
102175706|NCT04920500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175707|NCT04920500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102175708|NCT04920500|Antiviral Agents|antiviral agents|mesh-ancestor
102175709|NCT04920500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102175710|NCT04920500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102175711|NCT04920500|Immunologic Factors|immunologic factors|mesh-ancestor
102175712|NCT04920500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175713|NCT04920500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102175714|NCT04920500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102175715|NCT04920500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102175716|NCT04920500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102175717|NCT02084615|Aspirin|aspirin|mesh-list
102175718|NCT02084615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102175719|NCT02084615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102175720|NCT02084615|Analgesics|analgesics|mesh-ancestor
102175721|NCT02084615|Sensory System Agents|sensory system agents|mesh-ancestor
102175722|NCT02084615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102175723|NCT02084615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175724|NCT02084615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102175725|NCT02084615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102175726|NCT02084615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102175727|NCT02084615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102175728|NCT02084615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175729|NCT02084615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102175730|NCT02084615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102175731|NCT02084615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102175732|NCT02084615|Antipyretics|antipyretics|mesh-ancestor
102175733|NCT03559751|Nicotine|nicotine|mesh-list
102175734|NCT03559751|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102175735|NCT03559751|Autonomic Agents|autonomic agents|mesh-ancestor
102175736|NCT03559751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102175737|NCT03559751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175738|NCT03559751|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102175739|NCT03559751|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102175740|NCT03559751|Cholinergic Agents|cholinergic agents|mesh-ancestor
102175741|NCT03559751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102175742|NCT03559751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175743|NCT03234699|Midazolam|midazolam|mesh-list
102175744|NCT03234699|Cenobamate|cenobamate|mesh-list
102175745|NCT03234699|Bupropion|bupropion|mesh-list
102175746|NCT03234699|Omeprazole|omeprazole|mesh-list
102175747|NCT03234699|Warfarin|warfarin|mesh-list
102175748|NCT03234699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102175749|NCT03234699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102175750|NCT03234699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102175751|NCT03234699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175752|NCT03234699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102175753|NCT03234699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102175754|NCT03234699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102175755|NCT03234699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102175756|NCT03234699|Anesthetics, General|anesthetics, general|mesh-ancestor
102175757|NCT03234699|Anesthetics|anesthetics|mesh-ancestor
102175758|NCT03234699|GABA Modulators|gaba modulators|mesh-ancestor
102175759|NCT03234699|GABA Agents|gaba agents|mesh-ancestor
102175760|NCT03234699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102175761|NCT03234699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175763|NCT03234699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102175764|NCT03234699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102175765|NCT03234699|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102175766|NCT03234699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102175767|NCT03234699|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102175768|NCT03234699|Antidepressive Agents|antidepressive agents|mesh-ancestor
102175769|NCT03234699|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102175770|NCT03234699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102175771|NCT03234699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102175772|NCT03234699|Dopamine Agents|dopamine agents|mesh-ancestor
102175773|NCT03234699|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102175774|NCT03234699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102175775|NCT03234699|Anticonvulsants|anticonvulsants|mesh-ancestor
102175776|NCT03228771|Atorvastatin|atorvastatin|mesh-list
102175777|NCT03228771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102175778|NCT03228771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102175779|NCT03228771|Antimetabolites|antimetabolites|mesh-ancestor
102175780|NCT03228771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175781|NCT03228771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102175782|NCT03228771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102175783|NCT03228771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102175784|NCT02081339|Ranibizumab|ranibizumab|mesh-list
102175785|NCT02081339|Aflibercept|aflibercept|mesh-list
102175786|NCT02081339|Verteporfin|verteporfin|mesh-list
102175787|NCT02081339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102175788|NCT02081339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102175789|NCT02081339|Growth Substances|growth substances|mesh-ancestor
102175790|NCT02081339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175791|NCT02081339|Growth Inhibitors|growth inhibitors|mesh-ancestor
102175792|NCT02081339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102175793|NCT02081339|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102175794|NCT02081339|Dermatologic Agents|dermatologic agents|mesh-ancestor
102175795|NCT04939766|Insulin|insulin|mesh-list
102175796|NCT04939766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102175797|NCT04939766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175798|NCT02079545|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102175799|NCT02079545|Immunologic Factors|immunologic factors|mesh-ancestor
102175800|NCT02079545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175801|NCT03559673|Lacosamide|lacosamide|mesh-list
102175802|NCT03559673|Anticonvulsants|anticonvulsants|mesh-ancestor
102175803|NCT03559673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102175804|NCT03559673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102175805|NCT03559673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102175806|NCT03559673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175807|NCT03234387|Acetylcholine|acetylcholine|mesh-list
102175808|NCT03234387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175809|NCT03234387|Vasodilator Agents|vasodilator agents|mesh-ancestor
102175810|NCT03234387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102175811|NCT03234387|Cholinergic Agents|cholinergic agents|mesh-ancestor
102175812|NCT03234387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102175813|NCT03234387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175814|NCT03235947|Trimethoprim|trimethoprim|mesh-list
102175815|NCT03235947|Sulfamethoxazole|sulfamethoxazole|mesh-list
102175816|NCT03235947|Fosfomycin|fosfomycin|mesh-list
102175817|NCT03235947|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102175818|NCT03235947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102175819|NCT03235947|Antimalarials|antimalarials|mesh-ancestor
102175820|NCT03235947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102175821|NCT03235947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102175822|NCT03235947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102175823|NCT03235947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102175824|NCT03235947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175825|NCT03235947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102175826|NCT03235947|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102175827|NCT03235947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102175828|NCT03235947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102175829|NCT03057470|Insulin|insulin|mesh-list
102175830|NCT03057470|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102175831|NCT03057470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102175832|NCT03057470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175833|NCT02871401|Valganciclovir|valganciclovir|mesh-list
102175834|NCT02871401|Antiviral Agents|antiviral agents|mesh-ancestor
102175835|NCT02871401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102175836|NCT03228303|Imatinib Mesylate|imatinib mesylate|mesh-list
102175837|NCT03228303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102175838|NCT03228303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102175839|NCT03228303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102175840|NCT03228303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175841|NCT02085005|Capecitabine|capecitabine|mesh-list
102175842|NCT02085005|Oxaliplatin|oxaliplatin|mesh-list
102175843|NCT02085005|Aflibercept|aflibercept|mesh-list
102175844|NCT02085005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102175845|NCT02085005|Antimetabolites|antimetabolites|mesh-ancestor
102175846|NCT02085005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175847|NCT02085005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102175848|NCT02085005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102175849|NCT02085005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102175850|NCT02085005|Growth Substances|growth substances|mesh-ancestor
102175851|NCT02085005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175852|NCT02085005|Growth Inhibitors|growth inhibitors|mesh-ancestor
102175853|NCT03235869|Durvalumab|durvalumab|mesh-list
102175854|NCT03235869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102175855|NCT03235869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102175856|NCT02079701|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102175857|NCT02079701|Immunologic Factors|immunologic factors|mesh-ancestor
102175858|NCT02079701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175859|NCT03057314|Calcium Carbonate|calcium carbonate|mesh-list
102175860|NCT03057314|Calcium|calcium|mesh-list
102175861|NCT03057314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102175862|NCT03057314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175863|NCT03057314|Antacids|antacids|mesh-ancestor
102175864|NCT03057314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175865|NCT03057314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102175866|NCT02081495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102175867|NCT02081495|Doxorubicin|doxorubicin|mesh-list
102175868|NCT02081495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102175869|NCT02081495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102175870|NCT02081495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102175871|NCT02081495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102175872|NCT02081495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102175873|NCT02081495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175874|NCT03056846|Sulfalene|sulfalene|mesh-list
102175875|NCT03056846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102175876|NCT03056846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102175877|NCT03056846|Antimalarials|antimalarials|mesh-ancestor
102175878|NCT03056846|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102175879|NCT03056846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102175880|NCT03227679|Bupropion|bupropion|mesh-list
102175881|NCT03227679|Nicotine|nicotine|mesh-list
102175882|NCT03227679|Varenicline|varenicline|mesh-list
102175883|NCT03227679|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102175884|NCT03227679|Autonomic Agents|autonomic agents|mesh-ancestor
102175885|NCT03227679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102175886|NCT03227679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175887|NCT03227679|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102175888|NCT03227679|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102175889|NCT03227679|Cholinergic Agents|cholinergic agents|mesh-ancestor
102175890|NCT03227679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102175891|NCT03227679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175892|NCT03227679|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102175893|NCT03227679|Antidepressive Agents|antidepressive agents|mesh-ancestor
102175894|NCT03227679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102175895|NCT03227679|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102175896|NCT03227679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102175897|NCT03227679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102175898|NCT03227679|Dopamine Agents|dopamine agents|mesh-ancestor
102175899|NCT03227679|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102175900|NCT03227679|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102175901|NCT03227679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102175902|NCT04886167|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102175903|NCT04886167|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102175904|NCT04886167|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102175905|NCT04886167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102175906|NCT04886167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175907|NCT04886167|Cholinergic Agents|cholinergic agents|mesh-ancestor
102175908|NCT04886167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102175909|NCT04886167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175910|NCT04886167|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102175911|NCT04886167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102175912|NCT04937894|Tigecycline|tigecycline|mesh-list
102175913|NCT04937894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102175914|NCT04937894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102175915|NCT04937894|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102175916|NCT04937894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102175917|NCT04937894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175918|NCT04919252|Vedolizumab|vedolizumab|mesh-list
102175919|NCT04919252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102175920|NCT04919174|Dexmedetomidine|dexmedetomidine|mesh-list
102175921|NCT04919174|Remifentanil|remifentanil|mesh-list
102175922|NCT04919174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102175923|NCT04919174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102175924|NCT04919174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175925|NCT04919174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102175926|NCT04919174|Analgesics|analgesics|mesh-ancestor
102175927|NCT04919174|Sensory System Agents|sensory system agents|mesh-ancestor
102175928|NCT04919174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102175929|NCT04919174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102175930|NCT04919174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102175931|NCT04919174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102175932|NCT04919174|Adrenergic Agents|adrenergic agents|mesh-ancestor
102175933|NCT04919174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102175934|NCT04919174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175935|NCT04919174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102175936|NCT04919174|Narcotics|narcotics|mesh-ancestor
102175937|NCT02085239|Lidocaine|lidocaine|mesh-list
102175938|NCT02085239|Ropivacaine|ropivacaine|mesh-list
102175939|NCT02085239|Anesthetics, Local|anesthetics, local|mesh-ancestor
102175940|NCT02085239|Anesthetics|anesthetics|mesh-ancestor
102175941|NCT02085239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102175942|NCT02085239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175943|NCT02085239|Sensory System Agents|sensory system agents|mesh-ancestor
102175944|NCT02085239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102175945|NCT02085239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102175946|NCT02085239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102175947|NCT02085239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102175948|NCT02085239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102175949|NCT02085239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175950|NCT05143489|Lidocaine|lidocaine|mesh-list
102175951|NCT05143489|Anesthetics, Local|anesthetics, local|mesh-ancestor
102175952|NCT05143489|Anesthetics|anesthetics|mesh-ancestor
102175953|NCT05143489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102175954|NCT05143489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175955|NCT05143489|Sensory System Agents|sensory system agents|mesh-ancestor
102175956|NCT05143489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102175957|NCT05143489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102175958|NCT05143489|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102175959|NCT05143489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102175960|NCT05143489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102175961|NCT05143489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175962|NCT02085317|Nitroprusside|nitroprusside|mesh-list
102175963|NCT02085317|Acetylcholine|acetylcholine|mesh-list
102175964|NCT02085317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102175965|NCT02085317|Vasodilator Agents|vasodilator agents|mesh-ancestor
102175966|NCT02085317|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102175967|NCT02085317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175968|NCT02085317|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102175969|NCT02085317|Cholinergic Agents|cholinergic agents|mesh-ancestor
102175970|NCT02085317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102175971|NCT02085317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175973|NCT03234153|Tremelimumab|tremelimumab|mesh-list
102175974|NCT03234153|Immunomodulating Agents|immunomodulating agents|mesh-list
102175975|NCT03234153|Immunologic Factors|immunologic factors|mesh-list
102175976|NCT03234153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102175977|NCT03234153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102175978|NCT03234153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175979|NCT03056924|Vaccines|vaccines|mesh-list
102175980|NCT03056924|Immunologic Factors|immunologic factors|mesh-ancestor
102175981|NCT03056924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175982|NCT05523401|Psilocybin|psilocybin|mesh-list
102175983|NCT05523401|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
102175984|NCT05523401|2-(4-bromo-2,5-dimethoxyphenyl)ethylamine|2-(4-bromo-2,5-dimethoxyphenyl)ethylamine|mesh-list
102175985|NCT05523401|Hallucinogens|hallucinogens|mesh-ancestor
102175986|NCT05523401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102175987|NCT05523401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102175988|NCT05523401|Serotonin Agents|serotonin agents|mesh-ancestor
102175989|NCT05523401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102175990|NCT05523401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102175991|NCT05523401|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102175992|NCT05523401|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102175993|NCT05523401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102175994|NCT05523401|Adrenergic Agents|adrenergic agents|mesh-ancestor
102175995|NCT05523401|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102175996|NCT05523401|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102175997|NCT05523401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102175998|NCT05523401|Serotonin 5-HT2 Receptor Agonists|serotonin 5-ht2 receptor agonists|mesh-ancestor
102175999|NCT05523401|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102176000|NCT04918862|Granisetron|granisetron|mesh-list
102176001|NCT04918862|Antiemetics|antiemetics|mesh-ancestor
102176002|NCT04918862|Autonomic Agents|autonomic agents|mesh-ancestor
102176003|NCT04918862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102176004|NCT04918862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176005|NCT04918862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102176006|NCT04918862|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102176007|NCT04918862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102176008|NCT04918862|Serotonin Agents|serotonin agents|mesh-ancestor
102176009|NCT04918862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102176010|NCT04918862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176011|NCT02452905|Nitazoxanide|nitazoxanide|mesh-list
102176012|NCT02452905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102176013|NCT02452905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102176014|NCT02081885|Chitosan|chitosan|mesh-list
102176015|NCT02081885|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102176016|NCT02081885|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102176017|NCT02081885|Antimetabolites|antimetabolites|mesh-ancestor
102176018|NCT02081885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176019|NCT02081885|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102176020|NCT02081885|Chelating Agents|chelating agents|mesh-ancestor
102176021|NCT02081885|Sequestering Agents|sequestering agents|mesh-ancestor
102176022|NCT02081885|Hemostatics|hemostatics|mesh-ancestor
102176023|NCT02081885|Coagulants|coagulants|mesh-ancestor
102176024|NCT03235245|Nivolumab|nivolumab|mesh-list
102176025|NCT03235245|Ipilimumab|ipilimumab|mesh-list
102176026|NCT03235245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102176027|NCT03235245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102176028|NCT03235245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102176029|NCT03235245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176030|NCT02452281|Ipilimumab|ipilimumab|mesh-list
102176031|NCT02452281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102176032|NCT02452281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102176033|NCT02452281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102176034|NCT02452281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176035|NCT02452125|Nicotine|nicotine|mesh-list
102176036|NCT02452125|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102176037|NCT02452125|Autonomic Agents|autonomic agents|mesh-ancestor
102176038|NCT02452125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102176039|NCT02452125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176040|NCT02452125|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102176041|NCT02452125|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102176042|NCT02452125|Cholinergic Agents|cholinergic agents|mesh-ancestor
102176043|NCT02452125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102176044|NCT02452125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176045|NCT02619812|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
102176046|NCT02619812|Immunoglobulins|immunoglobulins|mesh-list
102176047|NCT02619812|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102176048|NCT02619812|Antibodies|antibodies|mesh-list
102176049|NCT02619812|Immunologic Factors|immunologic factors|mesh-ancestor
102176050|NCT02619812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176051|NCT02619812|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102176052|NCT02619812|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102176053|NCT02619812|Antimetabolites|antimetabolites|mesh-ancestor
102176054|NCT02619812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176055|NCT02619812|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102176056|NCT04928066|Prednisone|prednisone|mesh-list
102176057|NCT04928066|Tofacitinib|tofacitinib|mesh-list
102176058|NCT04928066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102176059|NCT04928066|Glucocorticoids|glucocorticoids|mesh-ancestor
102176060|NCT04928066|Hormones|hormones|mesh-ancestor
102176061|NCT04928066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102176062|NCT04928066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176063|NCT04928066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102176064|NCT04928066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102176065|NCT04928066|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102176066|NCT04928066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102176067|NCT04928066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102176068|NCT04928066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176069|NCT03222765|Metformin|metformin|mesh-list
102176070|NCT03222765|Linagliptin|linagliptin|mesh-list
102176071|NCT03222765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102176072|NCT03222765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176073|NCT03222765|Incretins|incretins|mesh-ancestor
102176074|NCT03222765|Hormones|hormones|mesh-ancestor
102176075|NCT03222765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102176076|NCT03222765|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102176077|NCT03222765|Protease Inhibitors|protease inhibitors|mesh-ancestor
102176078|NCT03222765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102176079|NCT03222765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176080|NCT04485585|Tamsulosin|tamsulosin|mesh-list
102176081|NCT04485585|Mirabegron|mirabegron|mesh-list
102176082|NCT04485585|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102176083|NCT04485585|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102176084|NCT04485585|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102176085|NCT04485585|Adrenergic Agents|adrenergic agents|mesh-ancestor
102176086|NCT04485585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102176087|NCT04485585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176088|NCT04485585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176089|NCT04485585|Urological Agents|urological agents|mesh-ancestor
102176090|NCT04485585|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102176091|NCT04485585|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102176092|NCT04485585|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102176093|NCT03222687|Prednisone|prednisone|mesh-list
102176094|NCT03222687|Tacrolimus|tacrolimus|mesh-list
102176095|NCT03222687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102176096|NCT03222687|Glucocorticoids|glucocorticoids|mesh-ancestor
102176097|NCT03222687|Hormones|hormones|mesh-ancestor
102176098|NCT03222687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102176099|NCT03222687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176100|NCT03222687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102176101|NCT03222687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102176102|NCT03222687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102176103|NCT03222687|Immunologic Factors|immunologic factors|mesh-ancestor
102176104|NCT03222687|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102176105|NCT03222687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102176106|NCT03222687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176107|NCT03055442|Inositol|inositol|mesh-list
102176108|NCT03055442|Vitamin B Complex|vitamin b complex|mesh-ancestor
102176109|NCT03055442|Vitamins|vitamins|mesh-ancestor
102176110|NCT03055442|Micronutrients|micronutrients|mesh-ancestor
102176111|NCT03055442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176112|NCT03226431|Ascorbic Acid|ascorbic acid|mesh-list
102176113|NCT03226431|Antioxidants|antioxidants|mesh-ancestor
102176114|NCT03226431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176115|NCT03226431|Protective Agents|protective agents|mesh-ancestor
102176116|NCT03226431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176117|NCT03226431|Vitamins|vitamins|mesh-ancestor
102176118|NCT03226431|Micronutrients|micronutrients|mesh-ancestor
102176119|NCT02451579|Cetirizine|cetirizine|mesh-list
102176120|NCT02451579|Histamine Antagonists|histamine antagonists|mesh-list
102176121|NCT02451579|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
102176122|NCT02451579|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102176123|NCT02451579|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102176124|NCT02451579|Histamine Agents|histamine agents|mesh-ancestor
102176125|NCT02451579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102176126|NCT02451579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176127|NCT02451579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176128|NCT04935788|Caseins|caseins|mesh-list
102176129|NCT04935788|Chelating Agents|chelating agents|mesh-ancestor
102176130|NCT04935788|Sequestering Agents|sequestering agents|mesh-ancestor
102176131|NCT04935788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176132|NCT03233295|Vitamin D|vitamin d|mesh-list
102176133|NCT03233295|Cholecalciferol|cholecalciferol|mesh-list
102176134|NCT03233295|Vitamins|vitamins|mesh-ancestor
102176135|NCT03233295|Micronutrients|micronutrients|mesh-ancestor
102176136|NCT03233295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176137|NCT03233295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102176138|NCT03233295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102176139|NCT04917458|Vitamin D|vitamin d|mesh-list
102176140|NCT04917458|Cholecalciferol|cholecalciferol|mesh-list
102176141|NCT04917458|Vitamins|vitamins|mesh-ancestor
102176142|NCT04917458|Micronutrients|micronutrients|mesh-ancestor
102176143|NCT04917458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176144|NCT04917458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102176145|NCT04917458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102176146|NCT03225963|Temozolomide|temozolomide|mesh-list
102176147|NCT03225963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102176148|NCT03225963|Alkylating Agents|alkylating agents|mesh-ancestor
102176149|NCT03225963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176150|NCT03225963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102176151|NCT03221907|Pregabalin|pregabalin|mesh-list
102176152|NCT03221907|Analgesics|analgesics|mesh-ancestor
102176153|NCT03221907|Sensory System Agents|sensory system agents|mesh-ancestor
102176154|NCT03221907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102176155|NCT03221907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176156|NCT03221907|Anticonvulsants|anticonvulsants|mesh-ancestor
102176157|NCT03221907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102176158|NCT03221907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102176159|NCT03221907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176160|NCT03221907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102176161|NCT03221907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102176162|NCT03221907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102176163|NCT03221907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102176164|NCT03221907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102176165|NCT04934930|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102176166|NCT04934930|Obinutuzumab|obinutuzumab|mesh-list
102176167|NCT04934930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102176168|NCT04934930|Alkylating Agents|alkylating agents|mesh-ancestor
102176169|NCT04934930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176170|NCT04934930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102176171|NCT04934930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102176172|NCT03107481|Acetaminophen|acetaminophen|mesh-list
102176173|NCT03107481|Hydromorphone|hydromorphone|mesh-list
102176174|NCT03107481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102176175|NCT03107481|Analgesics|analgesics|mesh-ancestor
102176176|NCT03107481|Sensory System Agents|sensory system agents|mesh-ancestor
102176177|NCT03107481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102176178|NCT03107481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176179|NCT03107481|Antipyretics|antipyretics|mesh-ancestor
102176180|NCT03107481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102176181|NCT03107481|Narcotics|narcotics|mesh-ancestor
102176182|NCT03107481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102176183|NCT04934852|Ephedrine|ephedrine|mesh-list
102176184|NCT04934852|Pseudoephedrine|pseudoephedrine|mesh-list
102176185|NCT04934852|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102176186|NCT04934852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176187|NCT04934852|Sympathomimetics|sympathomimetics|mesh-ancestor
101885053|NCT04377204|Lidocaine|lidocaine|mesh-list
102176188|NCT04934852|Autonomic Agents|autonomic agents|mesh-ancestor
102176189|NCT04934852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102176190|NCT04934852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102176191|NCT04934852|Adrenergic Agents|adrenergic agents|mesh-ancestor
102176192|NCT04934852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102176193|NCT04934852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176194|NCT04934852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102176195|NCT04934852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102176196|NCT04934852|Respiratory System Agents|respiratory system agents|mesh-ancestor
102176197|NCT04934852|Nasal Decongestants|nasal decongestants|mesh-ancestor
102176198|NCT04934618|Irinotecan|irinotecan|mesh-list
102176199|NCT04934618|Apatinib|apatinib|mesh-list
102176200|NCT04934618|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102176201|NCT04934618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102176202|NCT04934618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102176203|NCT04934618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176204|NCT04934618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102176205|NCT04934618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102176206|NCT03107325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102176207|NCT03107325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102176208|NCT03107325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176209|NCT04916522|Colchicine|colchicine|mesh-list
102176210|NCT04916522|Gout Suppressants|gout suppressants|mesh-ancestor
102176211|NCT04916522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102176212|NCT04916522|Tubulin Modulators|tubulin modulators|mesh-ancestor
102176213|NCT04916522|Antimitotic Agents|antimitotic agents|mesh-ancestor
102176214|NCT04916522|Mitosis Modulators|mitosis modulators|mesh-ancestor
102176215|NCT04916522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176216|NCT04916522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102176217|NCT04407650|Metformin|metformin|mesh-list
102176218|NCT04407650|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102176219|NCT04407650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102176220|NCT04407650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176221|NCT04407650|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102176222|NCT04407650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102176223|NCT00105157|Raltegravir Potassium|raltegravir potassium|mesh-list
102176224|NCT00105157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102176225|NCT00105157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102176226|NCT00105157|Antiviral Agents|antiviral agents|mesh-ancestor
102176227|NCT00105157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102176228|NCT00105157|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102176229|NCT00105157|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102176230|NCT00105157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102176231|NCT00105157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176232|NCT03220815|Methamphetamine|methamphetamine|mesh-list
102176233|NCT03220815|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102176234|NCT03220815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176235|NCT03220815|Sympathomimetics|sympathomimetics|mesh-ancestor
102176236|NCT03220815|Autonomic Agents|autonomic agents|mesh-ancestor
102176237|NCT03220815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102176238|NCT03220815|Dopamine Agents|dopamine agents|mesh-ancestor
102176239|NCT03220815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102176240|NCT03220815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176241|NCT03220815|Adrenergic Agents|adrenergic agents|mesh-ancestor
102176242|NCT03220815|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102176243|NCT03220815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102176244|NCT03220815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102176245|NCT03220815|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102176246|NCT04913402|Sufentanil|sufentanil|mesh-list
102176248|NCT04913402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101885127|NCT05934071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885128|NCT05933863|Antibodies|antibodies|mesh-list
101885129|NCT05933863|Immunologic Factors|immunologic factors|mesh-ancestor
101885130|NCT05933863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885131|NCT05933759|Insulin|insulin|mesh-list
101885132|NCT05933759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101885133|NCT05933759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885134|NCT05933486|Pregabalin|pregabalin|mesh-list
101885135|NCT05933486|Analgesics|analgesics|mesh-ancestor
101885136|NCT05933486|Sensory System Agents|sensory system agents|mesh-ancestor
101885137|NCT05933486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101885138|NCT05933486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885139|NCT05933486|Anticonvulsants|anticonvulsants|mesh-ancestor
101885140|NCT05933486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101885141|NCT05933486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102176249|NCT04913402|Narcotics|narcotics|mesh-ancestor
102176250|NCT04913402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102176251|NCT04913402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176252|NCT04913402|Analgesics|analgesics|mesh-ancestor
102176253|NCT04913402|Sensory System Agents|sensory system agents|mesh-ancestor
101447659|NCT00217191|Ibuprofen|ibuprofen|mesh-list
102176254|NCT04913402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102176255|NCT04913402|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102176256|NCT04913402|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102176257|NCT04913402|Anesthetics, General|anesthetics, general|mesh-ancestor
102176258|NCT04913402|Anesthetics|anesthetics|mesh-ancestor
102176259|NCT04912934|Insulin|insulin|mesh-list
102176260|NCT04912934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102176261|NCT04912934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176262|NCT04915586|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101900000|NCT03871322|Vitamins|vitamins|mesh-list
102176263|NCT04915586|Plasminogen|plasminogen|mesh-list
102176264|NCT04915586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102176265|NCT04915586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102176266|NCT04915586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176268|NCT03232125|Antiemetics|antiemetics|mesh-ancestor
102176269|NCT03232125|Autonomic Agents|autonomic agents|mesh-ancestor
102176270|NCT03232125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102176271|NCT03232125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176272|NCT03232125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102176273|NCT03232125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102176274|NCT03232125|Serotonin Agents|serotonin agents|mesh-ancestor
102176275|NCT03232125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102176276|NCT03232125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176277|NCT03224637|Acetaminophen|acetaminophen|mesh-list
102176278|NCT03224637|Ketorolac|ketorolac|mesh-list
102176279|NCT03224637|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102176280|NCT03224637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102176281|NCT03224637|Analgesics|analgesics|mesh-ancestor
102176282|NCT03224637|Sensory System Agents|sensory system agents|mesh-ancestor
102176283|NCT03224637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102176284|NCT03224637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176285|NCT03224637|Antipyretics|antipyretics|mesh-ancestor
102176286|NCT03224637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102176287|NCT03224637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102176288|NCT03224637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102176289|NCT03224637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102176290|NCT03224637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102176291|NCT03224637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176292|NCT04912700|Vaccines|vaccines|mesh-list
102176293|NCT04912700|Immunologic Factors|immunologic factors|mesh-ancestor
102176294|NCT04912700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176295|NCT03224871|Aldesleukin|aldesleukin|mesh-list
102176296|NCT03224871|Pembrolizumab|pembrolizumab|mesh-list
102176297|NCT03224871|Nivolumab|nivolumab|mesh-list
102176298|NCT03224871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102176299|NCT03224871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102176300|NCT03224871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102176301|NCT03224871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176302|NCT03224871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102176303|NCT03224871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102176304|NCT03224871|Antiviral Agents|antiviral agents|mesh-ancestor
102176305|NCT03224871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102176306|NCT03220425|Insulin|insulin|mesh-list
102176307|NCT03220425|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102176308|NCT03220425|Insulin Detemir|insulin detemir|mesh-list
102176309|NCT03220425|Insulin, Isophane|insulin, isophane|mesh-list
102176310|NCT03220425|Isophane Insulin, Human|isophane insulin, human|mesh-list
102176311|NCT03220425|Isophane insulin, beef|isophane insulin, beef|mesh-list
102176312|NCT03220425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102176313|NCT03220425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176314|NCT04924868|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102176315|NCT04924868|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102176316|NCT04924868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102176317|NCT04402346|Pancrelipase|pancrelipase|mesh-list
102176318|NCT04402346|Pancreatin|pancreatin|mesh-list
102176319|NCT04402346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102176320|NCT03220191|Palbociclib|palbociclib|mesh-list
102176321|NCT03220191|Rabeprazole|rabeprazole|mesh-list
101885201|NCT05932966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102176322|NCT03220191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102176323|NCT03220191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102176324|NCT03220191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102176325|NCT03220191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176326|NCT03220191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102176327|NCT03220191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102176328|NCT03220191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102176329|NCT03220113|Thiamine|thiamine|mesh-list
102176330|NCT03220113|Dexamethasone|dexamethasone|mesh-list
102176331|NCT03220113|Lidocaine|lidocaine|mesh-list
102176332|NCT03220113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102176333|NCT03220113|Antiemetics|antiemetics|mesh-ancestor
102176334|NCT03220113|Autonomic Agents|autonomic agents|mesh-ancestor
102176335|NCT03220113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102176336|NCT03220113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176337|NCT03220113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102176338|NCT03220113|Glucocorticoids|glucocorticoids|mesh-ancestor
102176339|NCT03220113|Hormones|hormones|mesh-ancestor
102176340|NCT03220113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102176341|NCT03220113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102176342|NCT03220113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102176343|NCT03220113|Anesthetics, Local|anesthetics, local|mesh-ancestor
102176344|NCT03220113|Anesthetics|anesthetics|mesh-ancestor
102176345|NCT03220113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102176346|NCT03220113|Sensory System Agents|sensory system agents|mesh-ancestor
102176347|NCT03220113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102176348|NCT03220113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102176349|NCT03220113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102176350|NCT03220113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102176351|NCT03220113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176352|NCT03220113|Vitamin B Complex|vitamin b complex|mesh-ancestor
102176354|NCT03220113|Micronutrients|micronutrients|mesh-ancestor
102176355|NCT02254525|Ibuprofen|ibuprofen|mesh-list
102176356|NCT02254525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102176357|NCT02254525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102176358|NCT02254525|Analgesics|analgesics|mesh-ancestor
102176359|NCT02254525|Sensory System Agents|sensory system agents|mesh-ancestor
102176360|NCT02254525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102176361|NCT02254525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176362|NCT02254525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102176363|NCT02254525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102176364|NCT02254525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102176365|NCT02254525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102176366|NCT02254525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176367|NCT03231813|Emollients|emollients|mesh-list
102176368|NCT03231813|Dermatologic Agents|dermatologic agents|mesh-ancestor
102176369|NCT04914962|Lithium Carbonate|lithium carbonate|mesh-list
102176370|NCT04914962|Antidepressive Agents|antidepressive agents|mesh-ancestor
102176371|NCT04914962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102176372|NCT04914962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102176373|NCT04914962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176374|NCT04914962|Antimanic Agents|antimanic agents|mesh-ancestor
102176375|NCT04914962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102176376|NCT04914962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102176377|NCT04914962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176378|NCT02143531|Haloperidol|haloperidol|mesh-list
102176379|NCT02143531|Ondansetron|ondansetron|mesh-list
102176380|NCT02143531|Haloperidol decanoate|haloperidol decanoate|mesh-list
102176381|NCT02143531|Antiemetics|antiemetics|mesh-ancestor
102176382|NCT02143531|Autonomic Agents|autonomic agents|mesh-ancestor
102176383|NCT02143531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102176384|NCT02143531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176385|NCT02143531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102176386|NCT02143531|Antipruritics|antipruritics|mesh-ancestor
102176387|NCT02143531|Dermatologic Agents|dermatologic agents|mesh-ancestor
102176388|NCT02143531|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102176389|NCT02143531|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102176390|NCT02143531|Serotonin Agents|serotonin agents|mesh-ancestor
102176391|NCT02143531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102176392|NCT02143531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176393|NCT02143531|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102176394|NCT02143531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102176395|NCT02143531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102176396|NCT02143531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102176397|NCT02143531|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102176398|NCT02143531|Dopamine Agents|dopamine agents|mesh-ancestor
102176399|NCT02143531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101885278|NCT05932316|Albuterol|albuterol|mesh-list
102176400|NCT04485117|Anesthetics|anesthetics|mesh-list
102176401|NCT04485117|Propofol|propofol|mesh-list
102176402|NCT04485117|Sevoflurane|sevoflurane|mesh-list
102176403|NCT04485117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102176404|NCT04485117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176405|NCT04485117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102176406|NCT04485117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102176407|NCT04485117|Anesthetics, General|anesthetics, general|mesh-ancestor
102176408|NCT04485117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102176409|NCT04485117|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102176410|NCT00803569|Sargramostim|sargramostim|mesh-list
102176411|NCT00803569|Immunologic Factors|immunologic factors|mesh-ancestor
102176412|NCT00803569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718184|NCT04905654|Cromakalim|cromakalim|mesh-list
102176413|NCT02143687|Sevoflurane|sevoflurane|mesh-list
102176414|NCT02143687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102176415|NCT02143687|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102176416|NCT02143687|Anesthetics, General|anesthetics, general|mesh-ancestor
102176417|NCT02143687|Anesthetics|anesthetics|mesh-ancestor
102176418|NCT02143687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102176419|NCT02143687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176420|NCT02143765|Acarbose|acarbose|mesh-list
102176421|NCT02143765|Mitiglinide|mitiglinide|mesh-list
102176422|NCT02143765|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102176423|NCT02143765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102176424|NCT02143765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176425|NCT02143765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102176426|NCT02143765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176427|NCT02148367|Epoetin Alfa|epoetin alfa|mesh-list
102176428|NCT02148367|Hematinics|hematinics|mesh-ancestor
102176429|NCT00482833|Methotrexate|methotrexate|mesh-list
102176430|NCT00482833|Mercaptopurine|mercaptopurine|mesh-list
102176431|NCT00482833|Idarubicin|idarubicin|mesh-list
102176432|NCT00482833|Tretinoin|tretinoin|mesh-list
102176433|NCT00482833|Arsenic Trioxide|arsenic trioxide|mesh-list
102176434|NCT00482833|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102176435|NCT00482833|Abortifacient Agents|abortifacient agents|mesh-ancestor
102176436|NCT00482833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102176437|NCT00482833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176438|NCT00482833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102176439|NCT00482833|Antimetabolites|antimetabolites|mesh-ancestor
102176440|NCT00482833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176441|NCT00482833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102176442|NCT00482833|Dermatologic Agents|dermatologic agents|mesh-ancestor
102176443|NCT00482833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102176444|NCT00482833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102176445|NCT00482833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102176446|NCT00482833|Immunologic Factors|immunologic factors|mesh-ancestor
102176447|NCT00482833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102176448|NCT00482833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102176449|NCT00482833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102176450|NCT00482833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102176451|NCT00482833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102176452|NCT00482833|Keratolytic Agents|keratolytic agents|mesh-ancestor
102176453|NCT02451033|Hormones|hormones|mesh-list
102176454|NCT02451033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102176455|NCT02451033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176456|NCT04485429|Methylprednisolone|methylprednisolone|mesh-list
102176457|NCT04485429|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102176458|NCT04485429|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102176459|NCT04485429|Prednisolone|prednisolone|mesh-list
102176460|NCT04485429|Prednisolone acetate|prednisolone acetate|mesh-list
102176461|NCT04485429|Heparin|heparin|mesh-list
102176462|NCT04485429|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102176463|NCT04485429|Prednisolone phosphate|prednisolone phosphate|mesh-list
102176464|NCT04485429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102176465|NCT04485429|Antiemetics|antiemetics|mesh-ancestor
102176466|NCT04485429|Autonomic Agents|autonomic agents|mesh-ancestor
102176467|NCT04485429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101447673|NCT00476008|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102176468|NCT04485429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176469|NCT04485429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102176470|NCT04485429|Glucocorticoids|glucocorticoids|mesh-ancestor
102176471|NCT04485429|Hormones|hormones|mesh-ancestor
102176472|NCT04485429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102176473|NCT04485429|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102176474|NCT04485429|Protective Agents|protective agents|mesh-ancestor
102176475|NCT04485429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102176476|NCT04485429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102176477|NCT04485429|Anticoagulants|anticoagulants|mesh-ancestor
102176478|NCT04485429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102176479|NCT04485429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102176480|NCT04485429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176482|NCT00112957|Immunologic Factors|immunologic factors|mesh-ancestor
102176483|NCT00112957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176484|NCT02140801|Clopidogrel|clopidogrel|mesh-list
102176485|NCT02140801|Ticagrelor|ticagrelor|mesh-list
102176486|NCT02140801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102176487|NCT02140801|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102176488|NCT02140801|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102176489|NCT02140801|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102176490|NCT02140801|Purinergic Agents|purinergic agents|mesh-ancestor
102176491|NCT02140801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102176492|NCT02140801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176493|NCT02140801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176494|NCT02148601|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102176495|NCT02148601|Vancomycin|vancomycin|mesh-list
102176496|NCT02148601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102176497|NCT02141035|Acetylcarnitine|acetylcarnitine|mesh-list
102176498|NCT02141035|Vitamin B Complex|vitamin b complex|mesh-ancestor
102176499|NCT02141035|Vitamins|vitamins|mesh-ancestor
102176500|NCT02141035|Micronutrients|micronutrients|mesh-ancestor
102176501|NCT02141035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176502|NCT02141035|Nootropic Agents|nootropic agents|mesh-ancestor
102176503|NCT03214653|Propofol|propofol|mesh-list
102176504|NCT03214653|Sevoflurane|sevoflurane|mesh-list
102176505|NCT03214653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102176506|NCT03214653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102176507|NCT03214653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176508|NCT03214653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102176509|NCT03214653|Anesthetics, General|anesthetics, general|mesh-ancestor
102176510|NCT03214653|Anesthetics|anesthetics|mesh-ancestor
102176511|NCT03214653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102176512|NCT03214653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102176513|NCT02450877|Azacitidine|azacitidine|mesh-list
102176514|NCT02450877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102176515|NCT02450877|Antimetabolites|antimetabolites|mesh-ancestor
102176516|NCT02450877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176517|NCT02450877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102176518|NCT02450877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102176519|NCT02141113|Guanfacine|guanfacine|mesh-list
102176520|NCT02141113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102176521|NCT02141113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102176522|NCT02141113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102176523|NCT02141113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102176524|NCT02141113|Adrenergic Agents|adrenergic agents|mesh-ancestor
102176525|NCT02141113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102176526|NCT02141113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176527|NCT02141113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176528|NCT03213639|Esomeprazole|esomeprazole|mesh-list
102176529|NCT03213639|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102176530|NCT03213639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102176531|NCT03213639|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102176532|NCT03213639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102176533|NCT03213639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176534|NCT03231033|Pioglitazone|pioglitazone|mesh-list
102176535|NCT03231033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102176536|NCT03231033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176537|NCT02141347|Durvalumab|durvalumab|mesh-list
102176538|NCT02141347|Tremelimumab|tremelimumab|mesh-list
102176539|NCT02141347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102176540|NCT02141347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102176541|NCT02254759|Midazolam|midazolam|mesh-list
102176542|NCT02254759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102176543|NCT02254759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102176544|NCT02254759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102176545|NCT02254759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176546|NCT02254759|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102176547|NCT02254759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102176548|NCT02254759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102176549|NCT02254759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102176550|NCT02254759|Anesthetics, General|anesthetics, general|mesh-ancestor
102176551|NCT02254759|Anesthetics|anesthetics|mesh-ancestor
102176552|NCT02254759|GABA Modulators|gaba modulators|mesh-ancestor
102176553|NCT02254759|GABA Agents|gaba agents|mesh-ancestor
102176554|NCT02254759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102176555|NCT02254759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176556|NCT03208257|Esmolol|esmolol|mesh-list
102176557|NCT03208257|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102176558|NCT03208257|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102176559|NCT03208257|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102176560|NCT03208257|Adrenergic Agents|adrenergic agents|mesh-ancestor
102176561|NCT03208257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102176562|NCT03208257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176563|NCT03208257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176564|NCT02141425|Peficitinib|peficitinib|mesh-list
102176565|NCT02141425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102176566|NCT02141425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176567|NCT02141425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102176568|NCT02141425|Immunologic Factors|immunologic factors|mesh-ancestor
102176569|NCT02141425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176571|NCT02148913|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102176572|NCT02148913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102176573|NCT02148913|Alkylating Agents|alkylating agents|mesh-ancestor
102176574|NCT02148913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176575|NCT02148913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102176576|NCT02148913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102176577|NCT02148913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102176578|NCT02148913|Immunologic Factors|immunologic factors|mesh-ancestor
102176579|NCT02148913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176580|NCT03208101|Vaccines|vaccines|mesh-list
102176581|NCT03208101|Immunologic Factors|immunologic factors|mesh-ancestor
102176582|NCT03208101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176583|NCT02149225|Poly I-C|poly i-c|mesh-list
102176584|NCT02149225|Molgramostim|molgramostim|mesh-list
102176585|NCT02149225|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102176586|NCT02149225|Vaccines|vaccines|mesh-list
102176587|NCT02149225|Sargramostim|sargramostim|mesh-list
102176588|NCT02149225|Poly ICLC|poly iclc|mesh-list
102176589|NCT02149225|Immunologic Factors|immunologic factors|mesh-ancestor
102176590|NCT02149225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176591|NCT02149225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102176592|NCT02149225|Interferon Inducers|interferon inducers|mesh-ancestor
102176593|NCT02149225|Laxatives|laxatives|mesh-ancestor
102176594|NCT02149225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102176595|NCT02149225|Antiviral Agents|antiviral agents|mesh-ancestor
102176596|NCT02149225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102176597|NCT03208335|Endostatins|endostatins|mesh-list
102176598|NCT03208335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102176599|NCT03208335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102176600|NCT03208335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102176601|NCT03208335|Growth Substances|growth substances|mesh-ancestor
102176602|NCT03208335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176603|NCT03208335|Growth Inhibitors|growth inhibitors|mesh-ancestor
102176604|NCT03211065|Immunoglobulins|immunoglobulins|mesh-list
102176605|NCT03211065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102176606|NCT03211065|Antibodies|antibodies|mesh-list
102176607|NCT03211065|Immunologic Factors|immunologic factors|mesh-ancestor
102176608|NCT03211065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176609|NCT02149459|Metformin|metformin|mesh-list
102176610|NCT02149459|Biguanides|biguanides|mesh-list
102176611|NCT02149459|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102176612|NCT02149459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176613|NCT02376790|Etanercept|etanercept|mesh-list
102176614|NCT02376790|Methotrexate|methotrexate|mesh-list
102176615|NCT02376790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102176616|NCT02376790|Abortifacient Agents|abortifacient agents|mesh-ancestor
102176617|NCT02376790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102176618|NCT02376790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176619|NCT02376790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102176620|NCT02376790|Antimetabolites|antimetabolites|mesh-ancestor
102176621|NCT02376790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176622|NCT02376790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102176623|NCT02376790|Dermatologic Agents|dermatologic agents|mesh-ancestor
102176624|NCT02376790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102176625|NCT02376790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102176626|NCT02376790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102176627|NCT02376790|Immunologic Factors|immunologic factors|mesh-ancestor
101885505|NCT05931263|Cytarabine|cytarabine|mesh-list
102176628|NCT02376790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102176629|NCT02376790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102176630|NCT02376790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102176631|NCT02376790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102176632|NCT02376790|Analgesics|analgesics|mesh-ancestor
102176633|NCT02376790|Sensory System Agents|sensory system agents|mesh-ancestor
102176634|NCT02376790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102176635|NCT02376790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102176636|NCT02376790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102176637|NCT02141737|Lidocaine|lidocaine|mesh-list
102176638|NCT02141737|Fentanyl|fentanyl|mesh-list
102176639|NCT02141737|Midazolam|midazolam|mesh-list
102176640|NCT02141737|Etomidate|etomidate|mesh-list
102176641|NCT02141737|Rocuronium|rocuronium|mesh-list
102176642|NCT02141737|Anesthetics, Local|anesthetics, local|mesh-ancestor
102176643|NCT02141737|Anesthetics|anesthetics|mesh-ancestor
102176644|NCT02141737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102176645|NCT02141737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176646|NCT02141737|Sensory System Agents|sensory system agents|mesh-ancestor
102176647|NCT02141737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102176648|NCT02141737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102176649|NCT02141737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102176650|NCT02141737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102176651|NCT02141737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102176652|NCT02141737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176653|NCT02141737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102176654|NCT02141737|Narcotics|narcotics|mesh-ancestor
102176655|NCT02141737|Analgesics|analgesics|mesh-ancestor
102176656|NCT02141737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102176657|NCT02141737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102176658|NCT02141737|Anesthetics, General|anesthetics, general|mesh-ancestor
102176659|NCT02141737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102176660|NCT02141737|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102176661|NCT02141737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102176662|NCT02141737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102176663|NCT02141737|GABA Modulators|gaba modulators|mesh-ancestor
102176664|NCT02141737|GABA Agents|gaba agents|mesh-ancestor
102176665|NCT02141737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102176666|NCT02141737|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102176667|NCT02141737|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102176668|NCT02141737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102176669|NCT02254447|Candesartan|candesartan|mesh-list
102176670|NCT02254447|Candesartan cilexetil|candesartan cilexetil|mesh-list
102176671|NCT02254447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102176672|NCT02254447|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102176673|NCT02254447|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102176674|NCT02254447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176675|NCT02376166|Metformin|metformin|mesh-list
102176676|NCT02376166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102176677|NCT02376166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176678|NCT03207165|Dobutamine|dobutamine|mesh-list
102176679|NCT03207165|Milrinone|milrinone|mesh-list
102176680|NCT03207165|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-list
102176681|NCT03207165|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102176682|NCT03207165|Sympathomimetics|sympathomimetics|mesh-ancestor
102176683|NCT03207165|Autonomic Agents|autonomic agents|mesh-ancestor
102176684|NCT03207165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102176685|NCT03207165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176686|NCT03207165|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102176687|NCT03207165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102176688|NCT03207165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102176689|NCT03207165|Adrenergic Agents|adrenergic agents|mesh-ancestor
102176690|NCT03207165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102176691|NCT03207165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176692|NCT03207165|Protective Agents|protective agents|mesh-ancestor
102176693|NCT03207165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102176694|NCT03207165|Vasodilator Agents|vasodilator agents|mesh-ancestor
102176695|NCT03207165|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102176696|NCT03207165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102176697|NCT02142205|Natalizumab|natalizumab|mesh-list
102176698|NCT02142205|Immunologic Factors|immunologic factors|mesh-ancestor
102176699|NCT02142205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176700|NCT03209427|Morphine|morphine|mesh-list
102176701|NCT03209427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102176702|NCT03209427|Narcotics|narcotics|mesh-ancestor
102176703|NCT03209427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101885572|NCT05930665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102176704|NCT03209427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176706|NCT03209427|Sensory System Agents|sensory system agents|mesh-ancestor
102176707|NCT03209427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102176708|NCT03544723|Pembrolizumab|pembrolizumab|mesh-list
102176709|NCT03544723|Nivolumab|nivolumab|mesh-list
102176710|NCT03544723|Atezolizumab|atezolizumab|mesh-list
102176711|NCT03544723|Durvalumab|durvalumab|mesh-list
102176712|NCT03544723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102176713|NCT03544723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102176714|NCT03544723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101900002|NCT03871322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176715|NCT03544723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176716|NCT03209661|Menthol|menthol|mesh-list
102176717|NCT03209661|Nicotine|nicotine|mesh-list
102176718|NCT03209661|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102176719|NCT03209661|Autonomic Agents|autonomic agents|mesh-ancestor
102176720|NCT03209661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102176721|NCT03209661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176722|NCT03209661|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102176723|NCT03209661|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102176724|NCT03209661|Cholinergic Agents|cholinergic agents|mesh-ancestor
102176725|NCT03209661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102176726|NCT03209661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176727|NCT03209661|Antipruritics|antipruritics|mesh-ancestor
102176728|NCT03209661|Dermatologic Agents|dermatologic agents|mesh-ancestor
102176729|NCT03209037|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102176730|NCT03209037|Antiviral Agents|antiviral agents|mesh-ancestor
102176731|NCT03209037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102176732|NCT03209115|Calcium, Dietary|calcium, dietary|mesh-list
102176733|NCT03209115|Chlorhexidine|chlorhexidine|mesh-list
102176734|NCT03209115|Calcium|calcium|mesh-list
102176735|NCT03209115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102176736|NCT03209115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176737|NCT03209115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102176738|NCT03209115|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102176739|NCT03209115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102176740|NCT03209115|Disinfectants|disinfectants|mesh-ancestor
102176741|NCT03209193|Sevoflurane|sevoflurane|mesh-list
102176742|NCT03209193|Desflurane|desflurane|mesh-list
102176743|NCT03209193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102176744|NCT03209193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102176745|NCT03209193|Anesthetics, General|anesthetics, general|mesh-ancestor
102176746|NCT03209193|Anesthetics|anesthetics|mesh-ancestor
102176747|NCT03209193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102176748|NCT03209193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176749|NCT02142595|Midazolam|midazolam|mesh-list
102176750|NCT02142595|Dexmedetomidine|dexmedetomidine|mesh-list
102176751|NCT02142595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102176752|NCT02142595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102176753|NCT02142595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176754|NCT02142595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102176755|NCT02142595|Analgesics|analgesics|mesh-ancestor
102176756|NCT02142595|Sensory System Agents|sensory system agents|mesh-ancestor
102176757|NCT02142595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102176758|NCT02142595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102176759|NCT02142595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102176760|NCT02142595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102176761|NCT02142595|Adrenergic Agents|adrenergic agents|mesh-ancestor
102176762|NCT02142595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102176763|NCT02142595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176764|NCT02142595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102176765|NCT02142595|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102176766|NCT02142595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102176767|NCT02142595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102176768|NCT02142595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102176769|NCT02142595|Anesthetics, General|anesthetics, general|mesh-ancestor
102176770|NCT02142595|Anesthetics|anesthetics|mesh-ancestor
102176771|NCT02142595|GABA Modulators|gaba modulators|mesh-ancestor
102176772|NCT02142595|GABA Agents|gaba agents|mesh-ancestor
102176773|NCT04898374|Cisplatin|cisplatin|mesh-list
102176774|NCT04898374|Gemcitabine|gemcitabine|mesh-list
102176775|NCT04898374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102176776|NCT04898374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102176777|NCT04898374|Antimetabolites|antimetabolites|mesh-ancestor
102176778|NCT04898374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176779|NCT03207477|Mydriatics|mydriatics|mesh-list
102176780|NCT03207477|Autonomic Agents|autonomic agents|mesh-ancestor
102176781|NCT03207477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102176782|NCT03207477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176783|NCT02452515|Fulacimstat|fulacimstat|mesh-list
102176784|NCT02452515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102176785|NCT02452515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176786|NCT03206931|Selitrectinib|selitrectinib|mesh-list
102176787|NCT03206931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102176788|NCT03206931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176789|NCT02344342|Diuretics|diuretics|mesh-list
102176790|NCT02344342|Natriuretic Agents|natriuretic agents|mesh-ancestor
102176791|NCT02344342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176793|NCT02452437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102176794|NCT02452437|Narcotics|narcotics|mesh-ancestor
102176795|NCT02452437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102176796|NCT02452437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176797|NCT02452437|Analgesics|analgesics|mesh-ancestor
102176798|NCT02452437|Sensory System Agents|sensory system agents|mesh-ancestor
102176799|NCT02452437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102176800|NCT03208413|Thalidomide|thalidomide|mesh-list
102176801|NCT03208413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102176802|NCT03208413|Immunologic Factors|immunologic factors|mesh-ancestor
102176803|NCT03208413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176804|NCT03208413|Leprostatic Agents|leprostatic agents|mesh-ancestor
102176805|NCT03208413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102176806|NCT03208413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102176807|NCT03208413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102176808|NCT03208413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102176809|NCT03208413|Growth Substances|growth substances|mesh-ancestor
102176810|NCT03208413|Growth Inhibitors|growth inhibitors|mesh-ancestor
102176811|NCT03208413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102176812|NCT03201159|Pentamidine|pentamidine|mesh-list
102176813|NCT03201159|Antifungal Agents|antifungal agents|mesh-ancestor
102176814|NCT03201159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102176815|NCT03201159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102176816|NCT03201159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102176817|NCT03201159|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102176818|NCT02149927|Sevoflurane|sevoflurane|mesh-list
102176819|NCT02149927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102176820|NCT02149927|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102176821|NCT02149927|Anesthetics, General|anesthetics, general|mesh-ancestor
102176822|NCT02149927|Anesthetics|anesthetics|mesh-ancestor
102176823|NCT02149927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102176824|NCT02149927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176825|NCT02142751|Meropenem|meropenem|mesh-list
102176826|NCT02142751|Ceftriaxone|ceftriaxone|mesh-list
102176827|NCT02142751|Fosfomycin|fosfomycin|mesh-list
102176828|NCT02142751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102176829|NCT02142751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102176830|NCT02142751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102176831|NCT02343952|Pembrolizumab|pembrolizumab|mesh-list
102176832|NCT02343952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102176833|NCT02343952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102176834|NCT02343952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102176835|NCT02343952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176836|NCT02142829|Bupivacaine|bupivacaine|mesh-list
102176837|NCT02142829|Anesthetics, Local|anesthetics, local|mesh-ancestor
102176838|NCT02142829|Anesthetics|anesthetics|mesh-ancestor
102176839|NCT02142829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102176840|NCT02142829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176841|NCT02142829|Sensory System Agents|sensory system agents|mesh-ancestor
102176842|NCT02142829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102176843|NCT03200691|Antibodies|antibodies|mesh-list
102176844|NCT03200691|Immunologic Factors|immunologic factors|mesh-ancestor
102176845|NCT03200691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176846|NCT02150161|Lidocaine|lidocaine|mesh-list
102176847|NCT02150161|Fentanyl|fentanyl|mesh-list
102176848|NCT02150161|Ketamine|ketamine|mesh-list
102176849|NCT02150161|Anesthetics, Local|anesthetics, local|mesh-ancestor
102176850|NCT02150161|Anesthetics|anesthetics|mesh-ancestor
102176851|NCT02150161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102176852|NCT02150161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176853|NCT02150161|Sensory System Agents|sensory system agents|mesh-ancestor
102176854|NCT02150161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102176855|NCT02150161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102176856|NCT02150161|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102176857|NCT02150161|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102176858|NCT02150161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102176859|NCT02150161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176860|NCT02150161|Analgesics|analgesics|mesh-ancestor
102176861|NCT02150161|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102176862|NCT02150161|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102176863|NCT02150161|Anesthetics, General|anesthetics, general|mesh-ancestor
102176864|NCT02150161|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102176865|NCT02150161|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102176866|NCT02150161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102176867|NCT02150161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102176868|NCT02150161|Narcotics|narcotics|mesh-ancestor
102176869|NCT02150161|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102176870|NCT03200613|Heparin|heparin|mesh-list
102176871|NCT03200613|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102176872|NCT03200613|Tinzaparin|tinzaparin|mesh-list
102176873|NCT03200613|Dalteparin|dalteparin|mesh-list
102176874|NCT03200613|Apixaban|apixaban|mesh-list
102176875|NCT03200613|Anticoagulants|anticoagulants|mesh-ancestor
102176876|NCT03200613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102176877|NCT03200613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102176878|NCT03200613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176879|NCT03200613|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102176880|NCT03200613|Antithrombins|antithrombins|mesh-ancestor
102176881|NCT03200613|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102176882|NCT03200613|Protease Inhibitors|protease inhibitors|mesh-ancestor
102176883|NCT03200613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102176884|NCT02150317|Sorafenib|sorafenib|mesh-list
102176885|NCT02150317|Chlorotrianisene|chlorotrianisene|mesh-list
102176886|NCT02150317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102176887|NCT02150317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102176888|NCT02150317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101447706|NCT00183911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102176889|NCT02150317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176890|NCT02150317|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102176891|NCT02150317|Estrogens|estrogens|mesh-ancestor
102176892|NCT02150317|Hormones|hormones|mesh-ancestor
102176893|NCT02150317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102176894|NCT02150317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176895|NCT02150317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102176896|NCT02310568|PF-06372865|pf-06372865|mesh-list
102176897|NCT02310568|GABA Modulators|gaba modulators|mesh-ancestor
102176898|NCT02310568|GABA Agents|gaba agents|mesh-ancestor
102176899|NCT02310568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102176900|NCT02310568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176901|NCT02310568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176902|NCT02448069|Argatroban|argatroban|mesh-list
102176903|NCT02448069|Antithrombins|antithrombins|mesh-ancestor
102176904|NCT02448069|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102176905|NCT02448069|Protease Inhibitors|protease inhibitors|mesh-ancestor
102176906|NCT02448069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102176907|NCT02448069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176908|NCT02448069|Anticoagulants|anticoagulants|mesh-ancestor
102176909|NCT02448069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102176910|NCT02449941|Rabeprazole|rabeprazole|mesh-list
102176911|NCT02449941|Pantoprazole|pantoprazole|mesh-list
102176912|NCT02449941|Lansoprazole|lansoprazole|mesh-list
102176913|NCT02449941|Dexlansoprazole|dexlansoprazole|mesh-list
102176914|NCT02449941|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
102176915|NCT02449941|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102176916|NCT02449941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102176917|NCT02449941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102176918|NCT02449941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176919|NCT04484493|Mometasone Furoate|mometasone furoate|mesh-list
102176920|NCT04484493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102176921|NCT04484493|Dermatologic Agents|dermatologic agents|mesh-ancestor
102176922|NCT04484493|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102176923|NCT03199989|Capecitabine|capecitabine|mesh-list
102176924|NCT03199989|Oxaliplatin|oxaliplatin|mesh-list
102176925|NCT03199989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102176926|NCT03199989|Antimetabolites|antimetabolites|mesh-ancestor
102176927|NCT03199989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176928|NCT03199989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102176929|NCT03195933|Hydrocortisone|hydrocortisone|mesh-list
102176930|NCT03195933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102176931|NCT03195543|Thrombin|thrombin|mesh-list
102176932|NCT03195543|Hemostatics|hemostatics|mesh-ancestor
102176933|NCT03195543|Coagulants|coagulants|mesh-ancestor
101885797|NCT05872542|Listerine|listerine|mesh-list
102176934|NCT03204669|Trace Elements|trace elements|mesh-list
102176936|NCT03204669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176937|NCT03199677|Apatinib|apatinib|mesh-list
102176938|NCT03199677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102176939|NCT03199677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102176940|NCT03199677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102176941|NCT03199677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176942|NCT02780167|Abrocitinib|abrocitinib|mesh-list
102176943|NCT02780167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102176944|NCT02780167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102176945|NCT02780167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176946|NCT02447757|Remifentanil|remifentanil|mesh-list
102176947|NCT02447757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102176948|NCT02447757|Narcotics|narcotics|mesh-ancestor
102176949|NCT02447757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102176950|NCT02447757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176951|NCT02447757|Analgesics|analgesics|mesh-ancestor
102176952|NCT02447757|Sensory System Agents|sensory system agents|mesh-ancestor
102176953|NCT02447757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102176954|NCT02447835|Olanzapine|olanzapine|mesh-list
102176955|NCT02447835|Antiemetics|antiemetics|mesh-ancestor
102176956|NCT02447835|Autonomic Agents|autonomic agents|mesh-ancestor
102176957|NCT02447835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102176958|NCT02447835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176959|NCT02447835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102176960|NCT02447835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102176961|NCT02447835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102176962|NCT02447835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102176963|NCT02447835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102176964|NCT02447835|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102176965|NCT02447835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102176966|NCT02447835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102176967|NCT02447835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176968|NCT02447835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102176969|NCT02447835|Serotonin Agents|serotonin agents|mesh-ancestor
102176970|NCT02447679|Tegafur|tegafur|mesh-list
102176971|NCT02447679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102176972|NCT02447679|Antimetabolites|antimetabolites|mesh-ancestor
102176973|NCT02447679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102176974|NCT02447679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102176975|NCT03203967|Morphine|morphine|mesh-list
102176976|NCT03203967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102176977|NCT03203967|Narcotics|narcotics|mesh-ancestor
102176978|NCT03203967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102176979|NCT03203967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176980|NCT03203967|Analgesics|analgesics|mesh-ancestor
102176981|NCT03203967|Sensory System Agents|sensory system agents|mesh-ancestor
102176982|NCT03203967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102176983|NCT03204045|Fentanyl|fentanyl|mesh-list
102176984|NCT03204045|Oxycodone|oxycodone|mesh-list
102176985|NCT03204045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102176986|NCT03204045|Narcotics|narcotics|mesh-ancestor
102176987|NCT03204045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102176988|NCT03204045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102176989|NCT03204045|Analgesics|analgesics|mesh-ancestor
102176990|NCT03204045|Sensory System Agents|sensory system agents|mesh-ancestor
102176991|NCT03204045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102176992|NCT03204045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102176993|NCT03204045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102176994|NCT03204045|Anesthetics, General|anesthetics, general|mesh-ancestor
102176995|NCT03204045|Anesthetics|anesthetics|mesh-ancestor
102176996|NCT03199521|Thrombin|thrombin|mesh-list
102176997|NCT03199521|Hemostatics|hemostatics|mesh-ancestor
102176998|NCT03199521|Coagulants|coagulants|mesh-ancestor
102176999|NCT03195153|Allopurinol|allopurinol|mesh-list
102177000|NCT03195153|Atorvastatin|atorvastatin|mesh-list
102177001|NCT03195153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102177002|NCT03195153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102177003|NCT03195153|Antimetabolites|antimetabolites|mesh-ancestor
102177004|NCT03195153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177005|NCT03195153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102177006|NCT03195153|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102177007|NCT03195153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102177008|NCT03195153|Gout Suppressants|gout suppressants|mesh-ancestor
102177009|NCT03195153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101885873|NCT05804123|Antidotes|antidotes|mesh-ancestor
102177010|NCT03195153|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102177011|NCT03195153|Antioxidants|antioxidants|mesh-ancestor
102177012|NCT03195153|Protective Agents|protective agents|mesh-ancestor
102177013|NCT03195153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177014|NCT03195309|Fentanyl|fentanyl|mesh-list
102177015|NCT03195309|Ropivacaine|ropivacaine|mesh-list
102177016|NCT03195309|Anesthetics, Local|anesthetics, local|mesh-ancestor
102177017|NCT03195309|Anesthetics|anesthetics|mesh-ancestor
102177018|NCT03195309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102177019|NCT03195309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177020|NCT03195309|Sensory System Agents|sensory system agents|mesh-ancestor
102177021|NCT03195309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102177022|NCT03195309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102177023|NCT03195309|Narcotics|narcotics|mesh-ancestor
102177024|NCT03195309|Analgesics|analgesics|mesh-ancestor
102177025|NCT03195309|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102177026|NCT03195309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102177027|NCT03195309|Anesthetics, General|anesthetics, general|mesh-ancestor
102177028|NCT03198819|Cefotaxime|cefotaxime|mesh-list
102177029|NCT03198819|Cefoxitin|cefoxitin|mesh-list
102177030|NCT03198819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102177031|NCT03198819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102177032|NCT02447601|Simvastatin|simvastatin|mesh-list
102177033|NCT02447601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102177034|NCT02447601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102177035|NCT02447601|Antimetabolites|antimetabolites|mesh-ancestor
102177036|NCT02447601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177037|NCT02447601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102177038|NCT02447601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102177039|NCT02447601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102177040|NCT03118713|Metformin|metformin|mesh-list
102177041|NCT03118713|Glimepiride|glimepiride|mesh-list
102177042|NCT03118713|Ipragliflozin|ipragliflozin|mesh-list
102177043|NCT03118713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102177044|NCT03118713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177045|NCT03118713|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102177046|NCT03118713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102177047|NCT03118713|Immunologic Factors|immunologic factors|mesh-ancestor
102177048|NCT03118713|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102177049|NCT03118713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177050|NCT03198585|Empagliflozin|empagliflozin|mesh-list
102177051|NCT03198585|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102177052|NCT03198585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177053|NCT03198585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102177054|NCT03198585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177055|NCT02447289|Midazolam|midazolam|mesh-list
102177056|NCT02447289|Ketamine|ketamine|mesh-list
102177057|NCT02447289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102177058|NCT02447289|Analgesics|analgesics|mesh-ancestor
102177059|NCT02447289|Sensory System Agents|sensory system agents|mesh-ancestor
102177060|NCT02447289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102177061|NCT02447289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177062|NCT02447289|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102177063|NCT02447289|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102177064|NCT02447289|Anesthetics, General|anesthetics, general|mesh-ancestor
102177065|NCT02447289|Anesthetics|anesthetics|mesh-ancestor
102177066|NCT02447289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102177067|NCT02447289|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102177068|NCT02447289|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102177069|NCT02447289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102177070|NCT02447289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177071|NCT02447289|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102177072|NCT02447289|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102177073|NCT02447289|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102177074|NCT02447289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102177075|NCT02447289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102177076|NCT02447289|GABA Modulators|gaba modulators|mesh-ancestor
102177077|NCT02447289|GABA Agents|gaba agents|mesh-ancestor
102177078|NCT02447211|Doxepin|doxepin|mesh-list
102177079|NCT02447211|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102177080|NCT02447211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102177081|NCT02447211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102177082|NCT02447211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177083|NCT02447211|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102177084|NCT02447211|Antidepressive Agents|antidepressive agents|mesh-ancestor
102177085|NCT02447211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102177086|NCT02447211|Histamine Antagonists|histamine antagonists|mesh-ancestor
102177087|NCT02447211|Histamine Agents|histamine agents|mesh-ancestor
102177088|NCT02447211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102177089|NCT02447211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177090|NCT03198195|Cyclophosphamide|cyclophosphamide|mesh-list
102177091|NCT03198195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102177092|NCT03198195|Immunologic Factors|immunologic factors|mesh-ancestor
102177093|NCT03198195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177094|NCT03198195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102177095|NCT03198195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102177096|NCT03198195|Alkylating Agents|alkylating agents|mesh-ancestor
102177097|NCT03198195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177098|NCT03198195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102177099|NCT03198195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102177100|NCT03203421|Heparin Cofactor II|heparin cofactor ii|mesh-list
102177101|NCT03203421|Antithrombins|antithrombins|mesh-ancestor
102177102|NCT03203421|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102177103|NCT03203421|Protease Inhibitors|protease inhibitors|mesh-ancestor
102177104|NCT03203421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102177105|NCT03203421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177106|NCT03203421|Anticoagulants|anticoagulants|mesh-ancestor
102177107|NCT03203031|Anesthetics|anesthetics|mesh-list
102177108|NCT03203031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102177109|NCT03203031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177110|NCT03118479|Anastrozole|anastrozole|mesh-list
102177111|NCT03118479|Testosterone|testosterone|mesh-list
102177112|NCT03118479|Androgens|androgens|mesh-ancestor
102177113|NCT03118479|Hormones|hormones|mesh-ancestor
102177114|NCT03118479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102177115|NCT03118479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177116|NCT03118479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102177117|NCT03118479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102177118|NCT03118479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102177119|NCT03118479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102177120|NCT03118479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102177121|NCT03118479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177122|NCT03118479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102177123|NCT03118479|Hormone Antagonists|hormone antagonists|mesh-ancestor
102177124|NCT03197961|Tenofovir|tenofovir|mesh-list
102177125|NCT03197961|Emtricitabine|emtricitabine|mesh-list
102177126|NCT03197961|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102177127|NCT03197961|Medroxyprogesterone|medroxyprogesterone|mesh-list
102177128|NCT03197961|Antiviral Agents|antiviral agents|mesh-ancestor
102177129|NCT03197961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102177130|NCT03197961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102177131|NCT03197961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102177132|NCT03197961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102177133|NCT03197961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177134|NCT03197961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102177135|NCT03197961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102177136|NCT03197961|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102177137|NCT03197961|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102177138|NCT03197961|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102177139|NCT03197961|Contraceptive Agents|contraceptive agents|mesh-ancestor
102177140|NCT03197961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102177141|NCT03197961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177142|NCT03197961|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102177143|NCT03197961|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102177144|NCT03197961|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102177145|NCT03197961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102177146|NCT03197961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102177147|NCT03202875|Insulin|insulin|mesh-list
102177148|NCT03202875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102177149|NCT03202875|Insulin Aspart|insulin aspart|mesh-list
102177150|NCT03202875|Insulin, Long-Acting|insulin, long-acting|mesh-list
102177151|NCT03202875|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102177152|NCT03202875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102177153|NCT03202875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177154|NCT03197571|Leucovorin|leucovorin|mesh-list
102177155|NCT03197571|Paclitaxel|paclitaxel|mesh-list
102177156|NCT03197571|Cyclophosphamide|cyclophosphamide|mesh-list
102177157|NCT03197571|Bevacizumab|bevacizumab|mesh-list
102177158|NCT03197571|Fluorouracil|fluorouracil|mesh-list
102177159|NCT03197571|Capecitabine|capecitabine|mesh-list
102177160|NCT03197571|Fulvestrant|fulvestrant|mesh-list
102177162|NCT03197571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102177163|NCT03197571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102177164|NCT03197571|Tubulin Modulators|tubulin modulators|mesh-ancestor
102177165|NCT03197571|Antimitotic Agents|antimitotic agents|mesh-ancestor
102177166|NCT03197571|Mitosis Modulators|mitosis modulators|mesh-ancestor
102177167|NCT03197571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177168|NCT03197571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101447729|NCT00425516|Docetaxel|docetaxel|mesh-list
102177169|NCT03197571|Immunologic Factors|immunologic factors|mesh-ancestor
102177170|NCT03197571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177171|NCT03197571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102177172|NCT03197571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102177173|NCT03197571|Alkylating Agents|alkylating agents|mesh-ancestor
102177174|NCT03197571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102177175|NCT03197571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102177176|NCT03197571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102177177|NCT03197571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102177178|NCT03197571|Growth Substances|growth substances|mesh-ancestor
102177179|NCT03197571|Growth Inhibitors|growth inhibitors|mesh-ancestor
102177180|NCT03197571|Antimetabolites|antimetabolites|mesh-ancestor
102177181|NCT03197571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102177182|NCT03197571|Antidotes|antidotes|mesh-ancestor
102177183|NCT03197571|Protective Agents|protective agents|mesh-ancestor
102177184|NCT03197571|Vitamin B Complex|vitamin b complex|mesh-ancestor
102177185|NCT03197571|Vitamins|vitamins|mesh-ancestor
102177186|NCT03197571|Micronutrients|micronutrients|mesh-ancestor
102177187|NCT03197571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102177188|NCT03197571|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102177189|NCT03197571|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102177190|NCT03197571|Hormone Antagonists|hormone antagonists|mesh-ancestor
102177191|NCT03197571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102177192|NCT02446977|Riboflavin|riboflavin|mesh-list
102177193|NCT02446977|Vitamins|vitamins|mesh-ancestor
102177194|NCT02446977|Micronutrients|micronutrients|mesh-ancestor
102177195|NCT02446977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177196|NCT02446977|Vitamin B Complex|vitamin b complex|mesh-ancestor
102177197|NCT02446977|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102177198|NCT02446977|Dermatologic Agents|dermatologic agents|mesh-ancestor
102177199|NCT02447055|Mycophenolic Acid|mycophenolic acid|mesh-list
102177200|NCT02447055|Cyclophosphamide|cyclophosphamide|mesh-list
102177201|NCT02447055|Melphalan|melphalan|mesh-list
102177202|NCT02447055|Fludarabine|fludarabine|mesh-list
102177203|NCT02447055|Fludarabine phosphate|fludarabine phosphate|mesh-list
102177204|NCT02447055|Tacrolimus|tacrolimus|mesh-list
102177205|NCT02447055|Lenograstim|lenograstim|mesh-list
102177206|NCT02447055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102177207|NCT02447055|Immunologic Factors|immunologic factors|mesh-ancestor
102177208|NCT02447055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177209|NCT02447055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102177210|NCT02447055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102177211|NCT02447055|Alkylating Agents|alkylating agents|mesh-ancestor
102177212|NCT02447055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177213|NCT02447055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102177214|NCT02447055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102177215|NCT02447055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102177216|NCT02447055|Antimetabolites|antimetabolites|mesh-ancestor
102177217|NCT02447055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102177218|NCT02447055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102177219|NCT02447055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102177220|NCT02447055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102177221|NCT02447055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102177222|NCT02447055|Antitubercular Agents|antitubercular agents|mesh-ancestor
102177223|NCT02447055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102177224|NCT02447055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102177225|NCT03202563|Metformin|metformin|mesh-list
102177226|NCT03202563|Dapagliflozin|dapagliflozin|mesh-list
102177227|NCT03202563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102177228|NCT03202563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177229|NCT03202563|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102177230|NCT03202563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177231|NCT03197493|Levodopa|levodopa|mesh-list
102177232|NCT03197493|Carbidopa|carbidopa|mesh-list
102177233|NCT03197493|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102177234|NCT03197493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102177235|NCT03197493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102177236|NCT03197493|Dopamine Agents|dopamine agents|mesh-ancestor
102177237|NCT03197493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102177238|NCT03197493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177239|NCT03197493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447756|NCT00412191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177240|NCT03197493|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102177241|NCT03197493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102177243|NCT03197493|Immunologic Factors|immunologic factors|mesh-ancestor
102177244|NCT03197493|Dopamine Agonists|dopamine agonists|mesh-ancestor
102177245|NCT02450175|Everolimus|everolimus|mesh-list
102177246|NCT02450175|Letrozole|letrozole|mesh-list
102177247|NCT02450175|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102177248|NCT02450175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102177249|NCT02450175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102177250|NCT02450175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177251|NCT02450175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102177252|NCT02450175|Immunologic Factors|immunologic factors|mesh-ancestor
102177253|NCT02450175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177254|NCT02450175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102177255|NCT02450175|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102177256|NCT02450175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102177257|NCT02450175|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102177258|NCT02450175|Hormone Antagonists|hormone antagonists|mesh-ancestor
102177259|NCT02450175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102177260|NCT03202719|Vaccines|vaccines|mesh-list
102177261|NCT03202719|Immunologic Factors|immunologic factors|mesh-ancestor
102177262|NCT03202719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177263|NCT03202407|Calcium|calcium|mesh-list
102177264|NCT03202407|Sevelamer|sevelamer|mesh-list
102177265|NCT03202407|Calcium acetate|calcium acetate|mesh-list
102177266|NCT03202407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102177267|NCT03202407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177268|NCT03202407|Chelating Agents|chelating agents|mesh-ancestor
102177269|NCT03202407|Sequestering Agents|sequestering agents|mesh-ancestor
102177270|NCT03202407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177271|NCT02261077|Scopolamine|scopolamine|mesh-list
102177272|NCT02261077|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102177273|NCT02261077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102177274|NCT02261077|Antiemetics|antiemetics|mesh-ancestor
102177275|NCT02261077|Autonomic Agents|autonomic agents|mesh-ancestor
102177276|NCT02261077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102177277|NCT02261077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177278|NCT02261077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102177279|NCT02261077|Mydriatics|mydriatics|mesh-ancestor
102177280|NCT02261077|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102177281|NCT02261077|Cholinergic Agents|cholinergic agents|mesh-ancestor
102177282|NCT02261077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102177283|NCT02261077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177284|NCT02261077|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102177285|NCT02261077|Parasympatholytics|parasympatholytics|mesh-ancestor
102177286|NCT03196869|Cisplatin|cisplatin|mesh-list
102177287|NCT03196869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102177288|NCT02150473|Adalimumab|adalimumab|mesh-list
102177289|NCT02150473|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102177290|NCT02150473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102177291|NCT02150473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102177292|NCT02446431|Sirolimus|sirolimus|mesh-list
102177293|NCT02446431|Cyclophosphamide|cyclophosphamide|mesh-list
102177294|NCT02446431|Bevacizumab|bevacizumab|mesh-list
102177295|NCT02446431|Temsirolimus|temsirolimus|mesh-list
102177296|NCT02446431|MTOR Inhibitors|mtor inhibitors|mesh-list
102177297|NCT02446431|Valproic Acid|valproic acid|mesh-list
102177298|NCT02446431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102177299|NCT02446431|Immunologic Factors|immunologic factors|mesh-ancestor
102177300|NCT02446431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177301|NCT02446431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102177302|NCT02446431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102177303|NCT02446431|Alkylating Agents|alkylating agents|mesh-ancestor
102177304|NCT02446431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177305|NCT02446431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102177306|NCT02446431|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102177307|NCT02446431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102177308|NCT02446431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101886170|NCT05571319|Metformin|metformin|mesh-list
101886171|NCT05571319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101886172|NCT05571319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177309|NCT02446431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102177310|NCT02446431|Growth Substances|growth substances|mesh-ancestor
102177311|NCT02446431|Growth Inhibitors|growth inhibitors|mesh-ancestor
102177312|NCT02446431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102177313|NCT02446431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102177314|NCT02446431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102177315|NCT02446431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102177316|NCT02446431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102177317|NCT02446431|Antifungal Agents|antifungal agents|mesh-ancestor
102177318|NCT02446431|Anticonvulsants|anticonvulsants|mesh-ancestor
102177320|NCT02446431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102177321|NCT02446431|Antimanic Agents|antimanic agents|mesh-ancestor
102177322|NCT02446431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102177323|NCT02446431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102177324|NCT02446431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102177325|NCT02446353|Megestrol Acetate|megestrol acetate|mesh-list
102177326|NCT02446353|Megestrol|megestrol|mesh-list
102177327|NCT02446353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102177328|NCT02446353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102177329|NCT02446353|Appetite Stimulants|appetite stimulants|mesh-ancestor
102177330|NCT02446353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102177331|NCT02446353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177332|NCT02446353|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102177333|NCT02446353|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102177334|NCT02446353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102177335|NCT02446353|Contraceptive Agents|contraceptive agents|mesh-ancestor
102177336|NCT02446353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102177337|NCT02446353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102177338|NCT02446353|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102177339|NCT02144389|Praziquantel|praziquantel|mesh-list
102177340|NCT02144389|Anthelmintics|anthelmintics|mesh-ancestor
102177341|NCT02144389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102177342|NCT02144389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102177343|NCT03197103|Acetylcysteine|acetylcysteine|mesh-list
102177344|NCT03197103|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102177345|NCT03197103|Antiviral Agents|antiviral agents|mesh-ancestor
102177346|NCT03197103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102177347|NCT03197103|Expectorants|expectorants|mesh-ancestor
102177348|NCT03197103|Respiratory System Agents|respiratory system agents|mesh-ancestor
102177349|NCT03197103|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102177350|NCT03197103|Antioxidants|antioxidants|mesh-ancestor
102177351|NCT03197103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177352|NCT03197103|Protective Agents|protective agents|mesh-ancestor
102177353|NCT03197103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177354|NCT03197103|Antidotes|antidotes|mesh-ancestor
102177355|NCT02144623|Valproic Acid|valproic acid|mesh-list
102177356|NCT02144623|Anticonvulsants|anticonvulsants|mesh-ancestor
102177357|NCT02144623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102177358|NCT02144623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177359|NCT02144623|GABA Agents|gaba agents|mesh-ancestor
102177360|NCT02144623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102177361|NCT02144623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177362|NCT02144623|Antimanic Agents|antimanic agents|mesh-ancestor
102177363|NCT02144623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102177364|NCT02144623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102177365|NCT02144623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102177366|NCT03201861|Paclitaxel|paclitaxel|mesh-list
102177367|NCT03201861|Docetaxel|docetaxel|mesh-list
102177368|NCT03201861|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102177369|NCT03201861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102177370|NCT03201861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102177371|NCT03201861|Tubulin Modulators|tubulin modulators|mesh-ancestor
102177372|NCT03201861|Antimitotic Agents|antimitotic agents|mesh-ancestor
102177373|NCT03201861|Mitosis Modulators|mitosis modulators|mesh-ancestor
102177374|NCT03201861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177375|NCT03194685|FF-10101|ff-10101|mesh-list
102177376|NCT03194685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102177377|NCT03194685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102177378|NCT03194685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177379|NCT00105079|Ritonavir|ritonavir|mesh-list
102177380|NCT00105079|Lopinavir|lopinavir|mesh-list
102177381|NCT00105079|Saquinavir|saquinavir|mesh-list
102177382|NCT00105079|Tenofovir|tenofovir|mesh-list
102177383|NCT00105079|Emtricitabine|emtricitabine|mesh-list
101886244|NCT05501548|Ascorbic Acid|ascorbic acid|mesh-list
102177384|NCT00105079|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102177385|NCT00105079|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102177386|NCT00105079|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102177387|NCT00105079|Protease Inhibitors|protease inhibitors|mesh-ancestor
102177388|NCT00105079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102177389|NCT00105079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177390|NCT00105079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102177391|NCT00105079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102177392|NCT00105079|Antiviral Agents|antiviral agents|mesh-ancestor
102177393|NCT00105079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102177394|NCT00105079|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102177395|NCT00105079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102177396|NCT00105079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102177397|NCT00105079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102177398|NCT03196401|Durvalumab|durvalumab|mesh-list
102177399|NCT03196401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102177400|NCT03196401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102177401|NCT02150707|Liraglutide|liraglutide|mesh-list
102177402|NCT02150707|Exenatide|exenatide|mesh-list
102177403|NCT02150707|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
102177404|NCT02150707|Glucagon|glucagon|mesh-list
102177405|NCT02150707|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102177406|NCT02150707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102177407|NCT02150707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177408|NCT02150707|Incretins|incretins|mesh-ancestor
102177409|NCT02150707|Hormones|hormones|mesh-ancestor
102177410|NCT02150707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102177411|NCT02150707|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102177412|NCT02150707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102177413|NCT02150707|Protease Inhibitors|protease inhibitors|mesh-ancestor
102177414|NCT02150707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102177415|NCT02150707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177416|NCT03196479|Ketamine|ketamine|mesh-list
102177417|NCT03196479|Propofol|propofol|mesh-list
102177418|NCT03196479|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102177419|NCT03196479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102177420|NCT03196479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177421|NCT03196479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102177422|NCT03196479|Anesthetics, General|anesthetics, general|mesh-ancestor
102177423|NCT03196479|Anesthetics|anesthetics|mesh-ancestor
102177424|NCT03196479|Analgesics|analgesics|mesh-ancestor
102177425|NCT03196479|Sensory System Agents|sensory system agents|mesh-ancestor
102177426|NCT03196479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102177427|NCT03196479|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102177428|NCT03196479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102177429|NCT03196479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102177430|NCT03196479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102177431|NCT03196479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177432|NCT03201627|Lithium Carbonate|lithium carbonate|mesh-list
102177433|NCT03201627|Antidepressive Agents|antidepressive agents|mesh-ancestor
102177434|NCT03201627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102177435|NCT03201627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102177436|NCT03201627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177437|NCT03201627|Antimanic Agents|antimanic agents|mesh-ancestor
102177438|NCT03201627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102177439|NCT03201627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102177440|NCT03201627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177441|NCT02151721|Gefitinib|gefitinib|mesh-list
102177442|NCT02151721|Vorinostat|vorinostat|mesh-list
102177443|NCT02151721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102177444|NCT02151721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102177445|NCT02151721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102177446|NCT02151721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177447|NCT02151721|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102177448|NCT03201393|Acetaminophen|acetaminophen|mesh-list
102177449|NCT03201393|Naltrexone|naltrexone|mesh-list
102177450|NCT03201393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102177451|NCT03201393|Analgesics|analgesics|mesh-ancestor
102177452|NCT03201393|Sensory System Agents|sensory system agents|mesh-ancestor
102177453|NCT03201393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102177454|NCT03201393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177455|NCT03201393|Antipyretics|antipyretics|mesh-ancestor
102177456|NCT03201393|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102177457|NCT03201393|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102177458|NCT03192969|Abatacept|abatacept|mesh-list
102177459|NCT03192969|Glucocorticoids|glucocorticoids|mesh-list
101886320|NCT05437575|Narcotics|narcotics|mesh-ancestor
102177460|NCT03192969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102177461|NCT03192969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177462|NCT03192969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102177463|NCT03192969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102177464|NCT03192969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102177465|NCT03192969|Immunologic Factors|immunologic factors|mesh-ancestor
102177466|NCT03192969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177467|NCT03192969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102177468|NCT03192969|Hormones|hormones|mesh-ancestor
102177469|NCT03192969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102177470|NCT03194139|Avasopasem manganese|avasopasem manganese|mesh-list
102177471|NCT03194139|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102177472|NCT03194139|Antioxidants|antioxidants|mesh-ancestor
102177473|NCT03194139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177474|NCT03194139|Protective Agents|protective agents|mesh-ancestor
102177475|NCT03194139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177476|NCT03118167|Antioxidants|antioxidants|mesh-list
102177477|NCT03118167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177478|NCT03118167|Protective Agents|protective agents|mesh-ancestor
102177479|NCT03118167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177480|NCT00189267|Imiquimod|imiquimod|mesh-list
102177481|NCT00189267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102177482|NCT00189267|Immunologic Factors|immunologic factors|mesh-ancestor
102177483|NCT00189267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177484|NCT00189267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102177485|NCT00189267|Interferon Inducers|interferon inducers|mesh-ancestor
102177486|NCT02444949|Cisplatin|cisplatin|mesh-list
102177487|NCT02444949|Endostar protein|endostar protein|mesh-list
102177488|NCT02444949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102177489|NCT02444949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102177490|NCT02444949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102177491|NCT02444949|Growth Substances|growth substances|mesh-ancestor
102177492|NCT02444949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177493|NCT02444949|Growth Inhibitors|growth inhibitors|mesh-ancestor
102177494|NCT03192579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102177495|NCT03192579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102177496|NCT03192579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102177497|NCT03192579|Antimetabolites|antimetabolites|mesh-ancestor
102177498|NCT03192579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177499|NCT03192579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102177500|NCT03192579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102177501|NCT03192579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102177502|NCT03192657|Basiliximab|basiliximab|mesh-list
102177503|NCT03192657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
102177504|NCT03192657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102177505|NCT03192657|Immunologic Factors|immunologic factors|mesh-ancestor
102177506|NCT03192657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177507|NCT03192657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102177508|NCT03192657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177509|NCT02444169|Hyaluronic Acid|hyaluronic acid|mesh-list
102177510|NCT02444169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102177511|NCT02444169|Immunologic Factors|immunologic factors|mesh-ancestor
102177512|NCT02444169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177513|NCT02444169|Viscosupplements|viscosupplements|mesh-ancestor
102177514|NCT02444169|Protective Agents|protective agents|mesh-ancestor
102177515|NCT03194061|Cisplatin|cisplatin|mesh-list
102177516|NCT03194061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102177517|NCT02343406|Temozolomide|temozolomide|mesh-list
102177518|NCT02343406|Lomustine|lomustine|mesh-list
102177519|NCT02343406|ABT-414|abt-414|mesh-list
102177520|NCT02343406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102177521|NCT02343406|Alkylating Agents|alkylating agents|mesh-ancestor
102177522|NCT02343406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177523|NCT02343406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102177524|NCT02343406|Immunoconjugates|immunoconjugates|mesh-ancestor
102177525|NCT02343406|Immunologic Factors|immunologic factors|mesh-ancestor
102177526|NCT02343406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177527|NCT02444091|Cyclophosphamide|cyclophosphamide|mesh-list
102177528|NCT02444091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102177529|NCT02444091|Immunologic Factors|immunologic factors|mesh-ancestor
102177530|NCT02444091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177531|NCT02444091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102177532|NCT02444091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102177533|NCT02444091|Alkylating Agents|alkylating agents|mesh-ancestor
102177534|NCT02444091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177535|NCT02444091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102177536|NCT02444091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102177537|NCT02443935|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
102177538|NCT02443935|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102177539|NCT02443935|Immunologic Factors|immunologic factors|mesh-ancestor
102177540|NCT02443935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177542|NCT03193749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102177543|NCT03193749|Vasodilator Agents|vasodilator agents|mesh-ancestor
102177544|NCT03193749|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102177545|NCT03193749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102177546|NCT03193749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177547|NCT03193749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102177548|NCT03193749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102177549|NCT03193749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102177550|NCT03193749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102177551|NCT03193749|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102177552|NCT03193749|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102177553|NCT03193749|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102177555|NCT02444013|Uric Acid|uric acid|mesh-list
102177556|NCT02444013|Hematinics|hematinics|mesh-ancestor
102177557|NCT02444013|Vitamin B Complex|vitamin b complex|mesh-ancestor
102177558|NCT02444013|Vitamins|vitamins|mesh-ancestor
102177559|NCT02444013|Micronutrients|micronutrients|mesh-ancestor
102177560|NCT02444013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177561|NCT02444013|Antioxidants|antioxidants|mesh-ancestor
102177562|NCT02444013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177563|NCT02444013|Protective Agents|protective agents|mesh-ancestor
102177564|NCT02444637|Rivastigmine|rivastigmine|mesh-list
102177565|NCT02444637|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102177566|NCT02444637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102177567|NCT02444637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177568|NCT02444637|Cholinergic Agents|cholinergic agents|mesh-ancestor
102177569|NCT02444637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102177570|NCT02444637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177571|NCT02444637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102177572|NCT02444637|Protective Agents|protective agents|mesh-ancestor
102177573|NCT05172999|Levonorgestrel|levonorgestrel|mesh-list
102177574|NCT05172999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102177575|NCT05172999|Contraceptive Agents|contraceptive agents|mesh-ancestor
102177576|NCT05172999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102177577|NCT05172999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177578|NCT05172999|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102177579|NCT05172999|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102177580|NCT05172999|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102177581|NCT02710071|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102177582|NCT02710071|Nebivolol|nebivolol|mesh-list
102177583|NCT02710071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102177584|NCT02710071|Diuretics|diuretics|mesh-ancestor
102177585|NCT02710071|Natriuretic Agents|natriuretic agents|mesh-ancestor
102177586|NCT02710071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177587|NCT02710071|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102177588|NCT02710071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102177589|NCT02710071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177590|NCT02710071|Vasodilator Agents|vasodilator agents|mesh-ancestor
102177591|NCT02710071|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102177592|NCT02710071|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102177593|NCT02710071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102177594|NCT02710071|Adrenergic Agents|adrenergic agents|mesh-ancestor
102177595|NCT02710071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102177596|NCT02443545|Deferiprone|deferiprone|mesh-list
102177597|NCT02443545|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102177598|NCT02443545|Chelating Agents|chelating agents|mesh-ancestor
102177599|NCT02443545|Sequestering Agents|sequestering agents|mesh-ancestor
102177600|NCT02443545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177601|NCT02439489|Carboplatin|carboplatin|mesh-list
102177602|NCT02439489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102177603|NCT02444481|Polymyxins|polymyxins|mesh-list
102177604|NCT02444481|Neomycin|neomycin|mesh-list
102177605|NCT02444481|Nystatin|nystatin|mesh-list
102177606|NCT02444481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102177607|NCT02444481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102177608|NCT02444481|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102177609|NCT02444481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102177610|NCT02444481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177611|NCT02444481|Antifungal Agents|antifungal agents|mesh-ancestor
102177612|NCT02444481|Ionophores|ionophores|mesh-ancestor
102177613|NCT02444481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102177615|NCT02444559|Ropivacaine|ropivacaine|mesh-list
102177616|NCT02444559|Anesthetics, Local|anesthetics, local|mesh-ancestor
102177617|NCT02444559|Anesthetics|anesthetics|mesh-ancestor
102177618|NCT02444559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102177619|NCT02444559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177620|NCT02444559|Sensory System Agents|sensory system agents|mesh-ancestor
102177621|NCT02444559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102177622|NCT02444559|Analgesics|analgesics|mesh-ancestor
102177623|NCT02444559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102177624|NCT02444559|Sympatholytics|sympatholytics|mesh-ancestor
102177625|NCT02444559|Autonomic Agents|autonomic agents|mesh-ancestor
102177626|NCT02444559|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102177627|NCT02444559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102177628|NCT02444559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102177629|NCT02444559|Adrenergic Agents|adrenergic agents|mesh-ancestor
102177630|NCT02444559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101447824|NCT00210444|Cholinergic Agents|cholinergic agents|mesh-ancestor
102177631|NCT02444559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177632|NCT03190239|Pemetrexed|pemetrexed|mesh-list
102177633|NCT03190239|Apatinib|apatinib|mesh-list
102177634|NCT03190239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102177635|NCT03190239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102177636|NCT03190239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177637|NCT03190239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102177638|NCT03190239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102177639|NCT03190239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102177640|NCT02439411|Trametinib|trametinib|mesh-list
102177641|NCT02439411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102177642|NCT02439411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102177643|NCT02439411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102177644|NCT02439411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177645|NCT03192735|Oxaliplatin|oxaliplatin|mesh-list
102177646|NCT03192735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102177647|NCT02443311|Betamethasone|betamethasone|mesh-list
102177648|NCT02443311|Betamethasone Valerate|betamethasone valerate|mesh-list
102177649|NCT02443311|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102177650|NCT02443311|Betamethasone benzoate|betamethasone benzoate|mesh-list
102177651|NCT02443311|Pimecrolimus|pimecrolimus|mesh-list
102177652|NCT02443311|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102177653|NCT02443311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102177654|NCT02443311|Glucocorticoids|glucocorticoids|mesh-ancestor
102177655|NCT02443311|Hormones|hormones|mesh-ancestor
102177656|NCT02443311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102177657|NCT02443311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177658|NCT02443311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102177659|NCT02443311|Respiratory System Agents|respiratory system agents|mesh-ancestor
102177660|NCT02443311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102177661|NCT02443311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102177662|NCT02443311|Analgesics|analgesics|mesh-ancestor
102177663|NCT02443311|Sensory System Agents|sensory system agents|mesh-ancestor
102177664|NCT02443311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102177665|NCT02443311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102177666|NCT02443311|Dermatologic Agents|dermatologic agents|mesh-ancestor
102177667|NCT02443311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102177668|NCT02443311|Immunologic Factors|immunologic factors|mesh-ancestor
102177669|NCT02443311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102177670|NCT02443311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102177671|NCT02443311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177672|NCT02373202|Sulfasalazine|sulfasalazine|mesh-list
102177673|NCT02373202|Mizoribine|mizoribine|mesh-list
102177674|NCT02373202|Bucillamine|bucillamine|mesh-list
102177675|NCT02373202|Tacrolimus|tacrolimus|mesh-list
102177676|NCT02373202|Leflunomide|leflunomide|mesh-list
102177677|NCT02373202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102177678|NCT02373202|Immunologic Factors|immunologic factors|mesh-ancestor
102177679|NCT02373202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177680|NCT02373202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102177681|NCT02373202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102177682|NCT02373202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177683|NCT02373202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102177684|NCT02373202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102177685|NCT02373202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102177687|NCT02373202|Sensory System Agents|sensory system agents|mesh-ancestor
102177688|NCT02373202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102177689|NCT02373202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102177690|NCT02373202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102177691|NCT02373202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102177692|NCT02373202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102177693|NCT02373202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102177694|NCT02373202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102177695|NCT02373202|Antimalarials|antimalarials|mesh-ancestor
102177696|NCT02373202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102177697|NCT02373202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102177699|NCT02373202|Protective Agents|protective agents|mesh-ancestor
102177700|NCT03192111|Entinostat|entinostat|mesh-list
102177701|NCT03192111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102177702|NCT03192111|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102177703|NCT03192111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102177704|NCT03192111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177705|NCT02622074|Paclitaxel|paclitaxel|mesh-list
102177706|NCT02622074|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102177707|NCT02622074|Cyclophosphamide|cyclophosphamide|mesh-list
102177708|NCT02622074|Carboplatin|carboplatin|mesh-list
102177709|NCT02622074|Doxorubicin|doxorubicin|mesh-list
102177710|NCT02622074|Pembrolizumab|pembrolizumab|mesh-list
102177711|NCT02622074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102177712|NCT02622074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102177713|NCT02622074|Tubulin Modulators|tubulin modulators|mesh-ancestor
102177714|NCT02622074|Antimitotic Agents|antimitotic agents|mesh-ancestor
102177715|NCT02622074|Mitosis Modulators|mitosis modulators|mesh-ancestor
102177716|NCT02622074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177717|NCT02622074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102177718|NCT02622074|Immunologic Factors|immunologic factors|mesh-ancestor
102177719|NCT02622074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177720|NCT02622074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102177721|NCT02622074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102177722|NCT02622074|Alkylating Agents|alkylating agents|mesh-ancestor
102177723|NCT02622074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102177724|NCT02622074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102177725|NCT02622074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102177726|NCT02622074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102177727|NCT02622074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102177728|NCT02622074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102177729|NCT02622074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102177730|NCT02438709|Etoricoxib|etoricoxib|mesh-list
102177731|NCT02438709|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
102177732|NCT02438709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102177733|NCT02438709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102177734|NCT02438709|Analgesics|analgesics|mesh-ancestor
102177735|NCT02438709|Sensory System Agents|sensory system agents|mesh-ancestor
102177736|NCT02438709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102177737|NCT02438709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177738|NCT02438709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102177739|NCT02438709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102177740|NCT02438709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102177741|NCT02438709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102177742|NCT02438709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177743|NCT05438758|Ketamine|ketamine|mesh-list
102177744|NCT05438758|Esketamine|esketamine|mesh-list
102177745|NCT05438758|Analgesics|analgesics|mesh-ancestor
102177746|NCT05438758|Sensory System Agents|sensory system agents|mesh-ancestor
102177747|NCT05438758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102177748|NCT05438758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177749|NCT05438758|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102177750|NCT05438758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102177751|NCT05438758|Anesthetics, General|anesthetics, general|mesh-ancestor
102177752|NCT05438758|Anesthetics|anesthetics|mesh-ancestor
102177753|NCT05438758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102177754|NCT05438758|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102177755|NCT05438758|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102177756|NCT05438758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102177757|NCT05438758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177758|NCT05438758|Antidepressive Agents|antidepressive agents|mesh-ancestor
101886626|NCT05117710|Ebselen|ebselen|mesh-list
102177759|NCT05438758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102177761|NCT02442921|Gout Suppressants|gout suppressants|mesh-ancestor
102177762|NCT02442921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102177764|NCT02442921|Antimitotic Agents|antimitotic agents|mesh-ancestor
102177765|NCT02442921|Mitosis Modulators|mitosis modulators|mesh-ancestor
102177766|NCT02442921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177767|NCT02442921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102177768|NCT02438865|Epirubicin|epirubicin|mesh-list
102177769|NCT02438865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102177770|NCT02438865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102177771|NCT02438865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102177772|NCT02438865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102177773|NCT02438865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102177774|NCT02438865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177775|NCT04924946|Antihypertensive Agents|antihypertensive agents|mesh-list
102177776|NCT03189771|Salicylic Acid|salicylic acid|mesh-list
102177777|NCT03189771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102177778|NCT03189771|Antifungal Agents|antifungal agents|mesh-ancestor
102177779|NCT03189771|Keratolytic Agents|keratolytic agents|mesh-ancestor
102177780|NCT03189771|Dermatologic Agents|dermatologic agents|mesh-ancestor
102177781|NCT02342704|Natalizumab|natalizumab|mesh-list
102177782|NCT02342704|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102177783|NCT02342704|Immunologic Factors|immunologic factors|mesh-ancestor
102177784|NCT02342704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177785|NCT02342704|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102177786|NCT02342704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177787|NCT02342704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102177788|NCT02442453|Turmeric extract|turmeric extract|mesh-list
102177789|NCT02442453|Antioxidants|antioxidants|mesh-ancestor
102177790|NCT02442453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177791|NCT02442453|Protective Agents|protective agents|mesh-ancestor
102177792|NCT02442453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177793|NCT02438397|Insulin|insulin|mesh-list
102177794|NCT02438397|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102177795|NCT02438397|Metformin|metformin|mesh-list
102177796|NCT02438397|Acarbose|acarbose|mesh-list
102177797|NCT02438397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102177798|NCT02438397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177799|NCT02438397|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102177800|NCT02438397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102177801|NCT02438397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177802|NCT03193359|Botulinum Toxins|botulinum toxins|mesh-list
102177803|NCT03193359|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102177804|NCT03193359|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102177805|NCT03193359|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102177806|NCT03193359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102177807|NCT03193359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177808|NCT03193359|Cholinergic Agents|cholinergic agents|mesh-ancestor
102177809|NCT03193359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102177810|NCT03193359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177811|NCT03193359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102177812|NCT03193359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102177813|NCT02442531|Docetaxel|docetaxel|mesh-list
102177814|NCT02442531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102177815|NCT02442531|Tubulin Modulators|tubulin modulators|mesh-ancestor
102177816|NCT02442531|Antimitotic Agents|antimitotic agents|mesh-ancestor
102177817|NCT02442531|Mitosis Modulators|mitosis modulators|mesh-ancestor
102177818|NCT02442531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177819|NCT03193203|Etanercept|etanercept|mesh-list
102177820|NCT03193203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102177821|NCT03193203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102177822|NCT03193203|Analgesics|analgesics|mesh-ancestor
102177823|NCT03193203|Sensory System Agents|sensory system agents|mesh-ancestor
102177824|NCT03193203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102177825|NCT03193203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177826|NCT03193203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102177827|NCT03193203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102177828|NCT03193203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102177829|NCT03193203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102177830|NCT03193203|Immunologic Factors|immunologic factors|mesh-ancestor
102177831|NCT02442063|Paclitaxel|paclitaxel|mesh-list
101886693|NCT05096468|Pregabalin|pregabalin|mesh-list
102177832|NCT02442063|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
102177833|NCT02442063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102177834|NCT02442063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102177835|NCT02442063|Tubulin Modulators|tubulin modulators|mesh-ancestor
102177836|NCT02442063|Antimitotic Agents|antimitotic agents|mesh-ancestor
102177837|NCT02442063|Mitosis Modulators|mitosis modulators|mesh-ancestor
102177838|NCT02442063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177839|NCT04923152|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
102177840|NCT04923152|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102177841|NCT04923152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102177843|NCT04923152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177844|NCT04923152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102177845|NCT04923152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102177846|NCT03369717|Clavulanic Acid|clavulanic acid|mesh-list
102177847|NCT03369717|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102177848|NCT03369717|Clavulanic Acids|clavulanic acids|mesh-list
102177849|NCT03369717|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102177850|NCT03369717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102177851|NCT03369717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177852|NCT03369717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102177853|NCT03369717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102177854|NCT03054662|Hemostatics|hemostatics|mesh-list
102177855|NCT03054662|Coagulants|coagulants|mesh-ancestor
102177856|NCT04922996|Calcium Dobesilate|calcium dobesilate|mesh-list
102177857|NCT04922996|Calcium|calcium|mesh-list
102177858|NCT04922996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102177859|NCT04922996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177860|NCT04922996|Hemostatics|hemostatics|mesh-ancestor
102177861|NCT04922996|Coagulants|coagulants|mesh-ancestor
102177862|NCT04913480|Durvalumab|durvalumab|mesh-list
102177863|NCT04913480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102177864|NCT04913480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102177865|NCT02441907|Aflibercept|aflibercept|mesh-list
102177866|NCT02441907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102177867|NCT02441907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102177868|NCT02441907|Growth Substances|growth substances|mesh-ancestor
102177869|NCT02441907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177870|NCT02441907|Growth Inhibitors|growth inhibitors|mesh-ancestor
102177871|NCT02441907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102177872|NCT02437461|Triamcinolone|triamcinolone|mesh-list
102177873|NCT02437461|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102177874|NCT02437461|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102177875|NCT02437461|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102177876|NCT02437461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102177877|NCT02437461|Glucocorticoids|glucocorticoids|mesh-ancestor
102177878|NCT02437461|Hormones|hormones|mesh-ancestor
102177879|NCT02437461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102177880|NCT02437461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177881|NCT02437461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102177882|NCT02437461|Immunologic Factors|immunologic factors|mesh-ancestor
102177883|NCT02437461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102177884|NCT02437461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177885|NCT04910594|Epoetin Alfa|epoetin alfa|mesh-list
102177886|NCT04910594|Hematinics|hematinics|mesh-ancestor
102177887|NCT02441673|Ephedrine|ephedrine|mesh-list
102177888|NCT02441673|Meperidine|meperidine|mesh-list
102177889|NCT02441673|Tramadol|tramadol|mesh-list
102177890|NCT02441673|Nefopam|nefopam|mesh-list
102177891|NCT02441673|Metoclopramide|metoclopramide|mesh-list
102177892|NCT02441673|Ranitidine|ranitidine|mesh-list
102177893|NCT02441673|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
102177894|NCT02441673|Oxytocin|oxytocin|mesh-list
102177895|NCT02441673|Oxytocics|oxytocics|mesh-ancestor
102177896|NCT02441673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101447852|NCT00475306|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102177897|NCT02441673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177898|NCT02441673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102177899|NCT02441673|Narcotics|narcotics|mesh-ancestor
102177900|NCT02441673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102177901|NCT02441673|Analgesics|analgesics|mesh-ancestor
102177902|NCT02441673|Sensory System Agents|sensory system agents|mesh-ancestor
102177903|NCT02441673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102177904|NCT02441673|Antiemetics|antiemetics|mesh-ancestor
102177905|NCT02441673|Autonomic Agents|autonomic agents|mesh-ancestor
102177906|NCT02441673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102177907|NCT02441673|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102177908|NCT02441673|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102177909|NCT02441673|Dopamine Agents|dopamine agents|mesh-ancestor
102177910|NCT02441673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102177911|NCT02441673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177912|NCT02441673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102177914|NCT02441673|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102177915|NCT02441673|Adrenergic Agents|adrenergic agents|mesh-ancestor
102177916|NCT02441673|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102177917|NCT02441673|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102177918|NCT02441673|Histamine Antagonists|histamine antagonists|mesh-ancestor
102177919|NCT02441673|Histamine Agents|histamine agents|mesh-ancestor
102177920|NCT02441673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102177921|NCT02441673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102177922|NCT04910126|Doxorubicin|doxorubicin|mesh-list
102177923|NCT04910126|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102177924|NCT04910126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102177925|NCT04910126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102177926|NCT04910126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102177927|NCT04910126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102177928|NCT04910126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102177929|NCT04910126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177930|NCT04922450|Paclitaxel|paclitaxel|mesh-list
102177931|NCT04922450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102177932|NCT04922450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102177933|NCT04922450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102177934|NCT04922450|Tubulin Modulators|tubulin modulators|mesh-ancestor
102177935|NCT04922450|Antimitotic Agents|antimitotic agents|mesh-ancestor
102177936|NCT04922450|Mitosis Modulators|mitosis modulators|mesh-ancestor
102177937|NCT04922450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177938|NCT04922450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102177939|NCT04903808|Allyl sulfide|allyl sulfide|mesh-list
102177940|NCT04903808|Antioxidants|antioxidants|mesh-ancestor
102177941|NCT04903808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177942|NCT04903808|Protective Agents|protective agents|mesh-ancestor
102177943|NCT04903808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177944|NCT04903808|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102177945|NCT04903808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102177946|NCT04903808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102177947|NCT04903808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102177948|NCT03189537|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
102177949|NCT03189537|Antiviral Agents|antiviral agents|mesh-ancestor
102177950|NCT03189537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102177951|NCT04893980|Aldesleukin|aldesleukin|mesh-list
102177952|NCT04893980|Interleukin-2|interleukin-2|mesh-list
102177953|NCT04893980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102177954|NCT04893980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102177955|NCT04893980|Analgesics|analgesics|mesh-ancestor
102177956|NCT04893980|Sensory System Agents|sensory system agents|mesh-ancestor
102177957|NCT04893980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102177958|NCT04893980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177959|NCT04893980|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102177960|NCT04893980|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102177961|NCT04893980|Antiviral Agents|antiviral agents|mesh-ancestor
102177962|NCT04893980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102177963|NCT04149470|Omeprazole|omeprazole|mesh-list
102177964|NCT04149470|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102177965|NCT04149470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102177966|NCT04149470|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102177967|NCT04149470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102177968|NCT04149470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102177969|NCT04902638|Dexamethasone|dexamethasone|mesh-list
102177970|NCT04902638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102177971|NCT04902638|Antiemetics|antiemetics|mesh-ancestor
102177972|NCT04902638|Autonomic Agents|autonomic agents|mesh-ancestor
102177973|NCT04902638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102177974|NCT04902638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177975|NCT04902638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102177976|NCT04902638|Glucocorticoids|glucocorticoids|mesh-ancestor
102177977|NCT04902638|Hormones|hormones|mesh-ancestor
102177978|NCT04902638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102177979|NCT04902638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102177980|NCT04902638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102177981|NCT02617628|Naltrexone|naltrexone|mesh-list
102177982|NCT02617628|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102177983|NCT02617628|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102177984|NCT02617628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177985|NCT02617628|Sensory System Agents|sensory system agents|mesh-ancestor
102177986|NCT02617628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102177988|NCT03053414|Cholecalciferol|cholecalciferol|mesh-list
102177989|NCT03053414|Ergocalciferols|ergocalciferols|mesh-list
102177990|NCT03053414|Vitamins|vitamins|mesh-ancestor
102177991|NCT03053414|Micronutrients|micronutrients|mesh-ancestor
102177992|NCT03053414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177993|NCT03053414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102177994|NCT03053414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102177995|NCT02308540|Vaccines|vaccines|mesh-list
102177996|NCT02308540|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102177997|NCT02308540|Immunologic Factors|immunologic factors|mesh-ancestor
102177998|NCT02308540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102177999|NCT02308228|Metformin|metformin|mesh-list
102178000|NCT02308228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102178001|NCT02308228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178002|NCT03051932|Acetaminophen|acetaminophen|mesh-list
102178003|NCT03051932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102178004|NCT03051932|Analgesics|analgesics|mesh-ancestor
102178005|NCT03051932|Sensory System Agents|sensory system agents|mesh-ancestor
102178006|NCT03051932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102178007|NCT03051932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178008|NCT03051932|Antipyretics|antipyretics|mesh-ancestor
102178009|NCT04900766|Mitoxantrone|mitoxantrone|mesh-list
102178010|NCT04900766|Analgesics|analgesics|mesh-ancestor
102178011|NCT04900766|Sensory System Agents|sensory system agents|mesh-ancestor
102178012|NCT04900766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102178013|NCT04900766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178014|NCT04900766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102178015|NCT04900766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102178016|NCT04900766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102178017|NCT04900766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102178018|NCT04900766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178019|NCT04908566|Folfirinox|folfirinox|mesh-list
102178020|NCT04908566|Antibodies|antibodies|mesh-list
102178021|NCT04908566|Immunoglobulins|immunoglobulins|mesh-list
102178022|NCT04908566|Immunologic Factors|immunologic factors|mesh-ancestor
102178023|NCT04908566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178024|NCT04908566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102178025|NCT04892654|Dolutegravir|dolutegravir|mesh-list
102178026|NCT04892654|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102178027|NCT04892654|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102178028|NCT04892654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102178029|NCT04892654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178030|NCT04892654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102178031|NCT04892654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102178032|NCT04892654|Antiviral Agents|antiviral agents|mesh-ancestor
102178033|NCT04892654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102178034|NCT04899674|Bupropion|bupropion|mesh-list
102178035|NCT04899674|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102178036|NCT04899674|Antidepressive Agents|antidepressive agents|mesh-ancestor
102178037|NCT04899674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102178038|NCT04899674|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102178039|NCT04899674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102178040|NCT04899674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102178041|NCT04899674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178042|NCT04899674|Dopamine Agents|dopamine agents|mesh-ancestor
102178043|NCT04899674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102178044|NCT04899674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178045|NCT04899674|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102178046|NCT04899674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102178047|NCT04899674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102178048|NCT04907708|Metformin|metformin|mesh-list
102178049|NCT04907708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102178050|NCT04907708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178051|NCT04890626|Tenofovir|tenofovir|mesh-list
102178052|NCT04890626|Emtricitabine|emtricitabine|mesh-list
102178053|NCT04890626|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102178054|NCT04890626|Dexamethasone|dexamethasone|mesh-list
102178055|NCT04890626|Dexamethasone acetate|dexamethasone acetate|mesh-list
102178056|NCT04890626|BB 1101|bb 1101|mesh-list
102178057|NCT04890626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102178058|NCT04890626|Antiemetics|antiemetics|mesh-ancestor
102178059|NCT04890626|Autonomic Agents|autonomic agents|mesh-ancestor
102178060|NCT04890626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102178062|NCT04890626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102178063|NCT04890626|Glucocorticoids|glucocorticoids|mesh-ancestor
102178064|NCT04890626|Hormones|hormones|mesh-ancestor
102178065|NCT04890626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102178066|NCT04890626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102178068|NCT04890626|Protease Inhibitors|protease inhibitors|mesh-ancestor
102178069|NCT04890626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102178070|NCT04890626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178071|NCT04890626|Antiviral Agents|antiviral agents|mesh-ancestor
102178072|NCT04890626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102178073|NCT04890626|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102178074|NCT04890626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102178075|NCT04890626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102178076|NCT04890626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102178077|NCT04907864|Ibuprofen|ibuprofen|mesh-list
102178078|NCT04907864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102178079|NCT04907864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102178080|NCT04907864|Analgesics|analgesics|mesh-ancestor
102178081|NCT04907864|Sensory System Agents|sensory system agents|mesh-ancestor
102178082|NCT04907864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102178083|NCT04907864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178084|NCT04907864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102178085|NCT04907864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102178086|NCT04907864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102178087|NCT04907864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102178088|NCT04907864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178089|NCT03051542|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102178090|NCT03051542|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102178091|NCT03051542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178092|NCT04907474|Phenylephrine|phenylephrine|mesh-list
102178093|NCT04907474|Oxymetazoline|oxymetazoline|mesh-list
102178094|NCT04907474|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102178095|NCT04907474|Tropicamide|tropicamide|mesh-list
102178096|NCT04907474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102178097|NCT04907474|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102178098|NCT04907474|Mydriatics|mydriatics|mesh-ancestor
102178099|NCT04907474|Autonomic Agents|autonomic agents|mesh-ancestor
102178100|NCT04907474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102178101|NCT04907474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178102|NCT04907474|Sympathomimetics|sympathomimetics|mesh-ancestor
102178103|NCT04907474|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102178104|NCT04907474|Nasal Decongestants|nasal decongestants|mesh-ancestor
102178105|NCT04907474|Respiratory System Agents|respiratory system agents|mesh-ancestor
102178106|NCT04907474|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102178107|NCT04907474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102178108|NCT04907474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102178109|NCT04907474|Adrenergic Agents|adrenergic agents|mesh-ancestor
102178110|NCT04907474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102178111|NCT04907474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178112|NCT04907474|Protective Agents|protective agents|mesh-ancestor
102178113|NCT04907474|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102178114|NCT04907474|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102178115|NCT04907474|Cholinergic Agents|cholinergic agents|mesh-ancestor
102178116|NCT04898738|Hand Sanitizers|hand sanitizers|mesh-list
102178117|NCT04898738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102178118|NCT04898738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102178119|NCT04898738|Disinfectants|disinfectants|mesh-ancestor
102178120|NCT04890392|Oxaliplatin|oxaliplatin|mesh-list
102178121|NCT04890392|Tislelizumab|tislelizumab|mesh-list
102178122|NCT04890392|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102178123|NCT04890392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101886988|NCT04753970|Respiratory System Agents|respiratory system agents|mesh-ancestor
101886989|NCT04753970|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101886990|NCT04753970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101886991|NCT04753970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886992|NCT04753970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101886993|NCT04753970|Vasodilator Agents|vasodilator agents|mesh-ancestor
101886994|NCT04753970|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101886995|NCT04753970|Protective Agents|protective agents|mesh-ancestor
101886996|NCT04753970|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101886997|NCT04753970|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102178124|NCT04890392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102178125|NCT04890392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178126|NCT04900532|Tocotrienols|tocotrienols|mesh-list
102178127|NCT04900532|Vitamin E|vitamin e|mesh-list
102178134|NCT04900532|Micronutrients|micronutrients|mesh-ancestor
102178135|NCT02616614|Clindamycin|clindamycin|mesh-list
102178136|NCT02616614|Clindamycin palmitate|clindamycin palmitate|mesh-list
102178137|NCT02616614|Clindamycin phosphate|clindamycin phosphate|mesh-list
102178138|NCT02616614|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102178139|NCT02616614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102178140|NCT02616614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102178141|NCT02616614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102178142|NCT02616614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102178143|NCT02616614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178144|NCT02616614|Dermatologic Agents|dermatologic agents|mesh-ancestor
102178145|NCT04906772|Dexmedetomidine|dexmedetomidine|mesh-list
102178146|NCT04906772|Ketamine|ketamine|mesh-list
102178147|NCT04906772|Propofol|propofol|mesh-list
102178148|NCT04906772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102178149|NCT04906772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102178150|NCT04906772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178151|NCT04906772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102178152|NCT04906772|Analgesics|analgesics|mesh-ancestor
102178153|NCT04906772|Sensory System Agents|sensory system agents|mesh-ancestor
102178154|NCT04906772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102178155|NCT04906772|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102178156|NCT04906772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102178157|NCT04906772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102178158|NCT04906772|Adrenergic Agents|adrenergic agents|mesh-ancestor
102178159|NCT04906772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102178160|NCT04906772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178161|NCT04906772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102178162|NCT04906772|Anesthetics, General|anesthetics, general|mesh-ancestor
102178163|NCT04906772|Anesthetics|anesthetics|mesh-ancestor
102178164|NCT04906772|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102178165|NCT04906772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102178166|NCT04906772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102178167|NCT04404140|Docetaxel|docetaxel|mesh-list
102178168|NCT04404140|Atezolizumab|atezolizumab|mesh-list
102178169|NCT04404140|Ipatasertib|ipatasertib|mesh-list
102178170|NCT04404140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102178171|NCT04404140|Tubulin Modulators|tubulin modulators|mesh-ancestor
102178172|NCT04404140|Antimitotic Agents|antimitotic agents|mesh-ancestor
102178173|NCT04404140|Mitosis Modulators|mitosis modulators|mesh-ancestor
102178174|NCT04404140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178175|NCT04404140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102178176|NCT04404140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102178177|NCT04404140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102178178|NCT04404140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102178184|NCT04890470|Vasopressins|vasopressins|mesh-list
102178185|NCT04890470|Arginine Vasopressin|arginine vasopressin|mesh-list
102178186|NCT04890470|Oxytocin|oxytocin|mesh-list
102178187|NCT04890470|Oxytocics|oxytocics|mesh-ancestor
102178188|NCT04890470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102178189|NCT04890470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178190|NCT04890470|Hemostatics|hemostatics|mesh-ancestor
102178191|NCT04890470|Coagulants|coagulants|mesh-ancestor
102178192|NCT04890470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102178193|NCT04890470|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102178194|NCT04890470|Natriuretic Agents|natriuretic agents|mesh-ancestor
102178195|NCT04889768|Antibodies|antibodies|mesh-list
102178196|NCT04889768|Immunologic Factors|immunologic factors|mesh-ancestor
102178197|NCT04889768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178198|NCT04898270|Antipsychotic Agents|antipsychotic agents|mesh-list
102178199|NCT04898270|Flupenthixol|flupenthixol|mesh-list
102178200|NCT04898270|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
102178201|NCT04898270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102178202|NCT04898270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102178203|NCT04898270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178205|NCT04898270|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102178206|NCT04898270|Dopamine Agents|dopamine agents|mesh-ancestor
102178207|NCT04898270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102178208|NCT04898270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178209|NCT04906304|Mycophenolic Acid|mycophenolic acid|mesh-list
102178211|NCT04906304|Everolimus|everolimus|mesh-list
102178212|NCT04906304|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102178213|NCT04906304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102178214|NCT04906304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102178215|NCT04906304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178216|NCT04906304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102178217|NCT04906304|Immunologic Factors|immunologic factors|mesh-ancestor
102178218|NCT04906304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178219|NCT04906304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102178220|NCT04906304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102178221|NCT04906304|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102178222|NCT04906304|Antitubercular Agents|antitubercular agents|mesh-ancestor
102178223|NCT04906304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102178224|NCT04906304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102178225|NCT04906304|Antifungal Agents|antifungal agents|mesh-ancestor
102178226|NCT04906304|Dermatologic Agents|dermatologic agents|mesh-ancestor
102178227|NCT04906304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102178228|NCT04906304|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102178229|NCT03051698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102178230|NCT03051698|Metronidazole|metronidazole|mesh-list
102178231|NCT03051698|Vancomycin|vancomycin|mesh-list
102178232|NCT03051698|Ciprofloxacin|ciprofloxacin|mesh-list
102178233|NCT03051698|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
102178234|NCT03051698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102178235|NCT03051698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102178236|NCT03051698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102178237|NCT03051698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102178238|NCT03051698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102178239|NCT03051698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102178240|NCT03051698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178241|NCT03051698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102178242|NCT03051698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102178243|NCT03051698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102178244|NCT03051698|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102178245|NCT03051698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102178246|NCT03051698|Immunologic Factors|immunologic factors|mesh-ancestor
101447895|NCT00210483|Almotriptan|almotriptan|mesh-list
102178247|NCT03051698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178248|NCT04896164|Curcumin|curcumin|mesh-list
102178249|NCT04896164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102178250|NCT04896164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102178251|NCT04896164|Analgesics|analgesics|mesh-ancestor
102178252|NCT04896164|Sensory System Agents|sensory system agents|mesh-ancestor
102178253|NCT04896164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102178254|NCT04896164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178255|NCT04896164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102178256|NCT04896164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102178257|NCT04896164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102178258|NCT04896164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102178259|NCT04896164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178260|NCT04887818|Lidocaine|lidocaine|mesh-list
102178261|NCT04887818|Diltiazem|diltiazem|mesh-list
102178262|NCT04887818|Nifedipine|nifedipine|mesh-list
102178263|NCT04887818|Anesthetics, Local|anesthetics, local|mesh-ancestor
102178264|NCT04887818|Anesthetics|anesthetics|mesh-ancestor
102178265|NCT04887818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102178266|NCT04887818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178267|NCT04887818|Sensory System Agents|sensory system agents|mesh-ancestor
102178268|NCT04887818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102178269|NCT04887818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102178270|NCT04887818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102178271|NCT04887818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102178272|NCT04887818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102178273|NCT04887818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887137|NCT04533880|Calcium|calcium|mesh-list
102178274|NCT04887818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102178275|NCT04887818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102178276|NCT04887818|Vasodilator Agents|vasodilator agents|mesh-ancestor
102178277|NCT04887818|Tocolytic Agents|tocolytic agents|mesh-ancestor
102178278|NCT04887818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102178279|NCT04887818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102178280|NCT04883996|Pilocarpine|pilocarpine|mesh-list
102178281|NCT04883996|Miotics|miotics|mesh-ancestor
102178282|NCT04883996|Autonomic Agents|autonomic agents|mesh-ancestor
102178283|NCT04883996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102178284|NCT04883996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178285|NCT04883996|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102178286|NCT04883996|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102178287|NCT04883996|Cholinergic Agents|cholinergic agents|mesh-ancestor
102178288|NCT04883996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102178289|NCT04883996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178290|NCT04884464|Chlorhexidine|chlorhexidine|mesh-list
102178291|NCT04884464|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102178292|NCT04884464|Hyaluronic Acid|hyaluronic acid|mesh-list
102178293|NCT04884464|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102178294|NCT04884464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102178295|NCT04884464|Disinfectants|disinfectants|mesh-ancestor
102178296|NCT04884464|Dermatologic Agents|dermatologic agents|mesh-ancestor
102178297|NCT04884464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102178298|NCT04884464|Immunologic Factors|immunologic factors|mesh-ancestor
102178299|NCT04884464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178300|NCT04884464|Viscosupplements|viscosupplements|mesh-ancestor
102178301|NCT04884464|Protective Agents|protective agents|mesh-ancestor
102178302|NCT05028608|Carbamazepine|carbamazepine|mesh-list
102178303|NCT05028608|Midazolam|midazolam|mesh-list
102178304|NCT05028608|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102178305|NCT05028608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102178306|NCT05028608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102178307|NCT05028608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178308|NCT05028608|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102178309|NCT05028608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102178310|NCT05028608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102178311|NCT05028608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102178312|NCT05028608|Anesthetics, General|anesthetics, general|mesh-ancestor
102178313|NCT05028608|Anesthetics|anesthetics|mesh-ancestor
102178314|NCT05028608|GABA Modulators|gaba modulators|mesh-ancestor
102178315|NCT05028608|GABA Agents|gaba agents|mesh-ancestor
102178316|NCT05028608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102178317|NCT05028608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178318|NCT05028608|Anticonvulsants|anticonvulsants|mesh-ancestor
102178319|NCT05028608|Antimanic Agents|antimanic agents|mesh-ancestor
102178320|NCT05028608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102178321|NCT05028608|Analgesics|analgesics|mesh-ancestor
102178322|NCT05028608|Sensory System Agents|sensory system agents|mesh-ancestor
102178323|NCT05028608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102178324|NCT05028608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102178325|NCT05028608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102178326|NCT05028608|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102178327|NCT05028608|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102178328|NCT04882826|Sildenafil Citrate|sildenafil citrate|mesh-list
102178329|NCT04882826|Vasodilator Agents|vasodilator agents|mesh-ancestor
102178330|NCT04882826|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102178331|NCT04882826|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102178332|NCT04882826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102178333|NCT04882826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178334|NCT04882826|Urological Agents|urological agents|mesh-ancestor
102178335|NCT04309916|Esomeprazole|esomeprazole|mesh-list
102178336|NCT04309916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102178337|NCT04309916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102178338|NCT04309916|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102178339|NCT04309916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102178340|NCT04309916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178341|NCT01596062|Cyclosporine|cyclosporine|mesh-list
102178342|NCT01596062|Mycophenolic Acid|mycophenolic acid|mesh-list
102178343|NCT01596062|Everolimus|everolimus|mesh-list
102178344|NCT01596062|Cyclosporins|cyclosporins|mesh-list
102178345|NCT01596062|Basiliximab|basiliximab|mesh-list
102178346|NCT01596062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102178347|NCT01596062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178348|NCT01596062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102178349|NCT01596062|Immunologic Factors|immunologic factors|mesh-ancestor
102178350|NCT01596062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178351|NCT01596062|Antifungal Agents|antifungal agents|mesh-ancestor
102178352|NCT01596062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102178353|NCT01596062|Dermatologic Agents|dermatologic agents|mesh-ancestor
102178354|NCT01596062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102178356|NCT01596062|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102178357|NCT01596062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102178358|NCT01596062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102178359|NCT01596062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102178360|NCT01596062|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102178361|NCT01596062|Antitubercular Agents|antitubercular agents|mesh-ancestor
102178362|NCT01596062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102178363|NCT02614898|Eculizumab|eculizumab|mesh-list
102178364|NCT02614898|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102178365|NCT02614898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102178366|NCT02614898|Immunologic Factors|immunologic factors|mesh-ancestor
102178367|NCT02614898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178368|NCT02145091|Psilocybin|psilocybin|mesh-list
102178369|NCT02145091|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
102178370|NCT02145091|Hallucinogens|hallucinogens|mesh-ancestor
102178371|NCT02145091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178372|NCT02145091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101447908|NCT00210561|Antipyretics|antipyretics|mesh-ancestor
102178373|NCT02145091|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102178374|NCT02145091|Serotonin Agents|serotonin agents|mesh-ancestor
102178375|NCT02145091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102178376|NCT02145091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178377|NCT02145091|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102178378|NCT03352934|Avelumab|avelumab|mesh-list
102178379|NCT03352934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102178380|NCT03352934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102178381|NCT04871828|Leukotriene Antagonists|leukotriene antagonists|mesh-list
102178382|NCT04871828|Hormone Antagonists|hormone antagonists|mesh-ancestor
102178383|NCT04871828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102178384|NCT04871828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178385|NCT04871828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102178386|NCT04871828|Respiratory System Agents|respiratory system agents|mesh-ancestor
102178387|NCT04881110|Liraglutide|liraglutide|mesh-list
102178388|NCT04881110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102178389|NCT04881110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178390|NCT04881110|Incretins|incretins|mesh-ancestor
102178391|NCT04881110|Hormones|hormones|mesh-ancestor
102178392|NCT04881110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102178393|NCT02152423|Enoxaparin|enoxaparin|mesh-list
102178394|NCT02152423|Anticoagulants|anticoagulants|mesh-ancestor
102178395|NCT02152423|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102178396|NCT02152423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102178397|NCT02152423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178398|NCT02145559|Metformin|metformin|mesh-list
102178399|NCT02145559|Sirolimus|sirolimus|mesh-list
102178400|NCT02145559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102178401|NCT02145559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178402|NCT02145559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102178403|NCT02145559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102178404|NCT02145559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102178405|NCT02145559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102178406|NCT02145559|Antifungal Agents|antifungal agents|mesh-ancestor
102178407|NCT02145559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102178408|NCT02145559|Immunologic Factors|immunologic factors|mesh-ancestor
102178409|NCT02145637|Afatinib|afatinib|mesh-list
102178410|NCT02145637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102178411|NCT02145637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102178412|NCT02145637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102178413|NCT02145637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178414|NCT03154580|Acetylcysteine|acetylcysteine|mesh-list
102178415|NCT03154580|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102178416|NCT03154580|Antiviral Agents|antiviral agents|mesh-ancestor
102178417|NCT03154580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102178418|NCT03154580|Expectorants|expectorants|mesh-ancestor
102178419|NCT03154580|Respiratory System Agents|respiratory system agents|mesh-ancestor
102178420|NCT03154580|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102178421|NCT03154580|Antioxidants|antioxidants|mesh-ancestor
102178422|NCT03154580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178423|NCT03154580|Protective Agents|protective agents|mesh-ancestor
102178424|NCT03154580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178425|NCT03154580|Antidotes|antidotes|mesh-ancestor
101887289|NCT04311502|Pyridoxine|pyridoxine|mesh-list
102178426|NCT02145715|Thalidomide|thalidomide|mesh-list
102178427|NCT02145715|Dexamethasone|dexamethasone|mesh-list
102178428|NCT02145715|Bortezomib|bortezomib|mesh-list
102178429|NCT02145715|Panobinostat|panobinostat|mesh-list
102178430|NCT02145715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102178432|NCT02145715|Autonomic Agents|autonomic agents|mesh-ancestor
102178433|NCT02145715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102178434|NCT02145715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178435|NCT02145715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102178436|NCT02145715|Glucocorticoids|glucocorticoids|mesh-ancestor
102178437|NCT02145715|Hormones|hormones|mesh-ancestor
102178438|NCT02145715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102178439|NCT02145715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102178440|NCT02145715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102178441|NCT02145715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102178442|NCT02145715|Immunologic Factors|immunologic factors|mesh-ancestor
102178443|NCT02145715|Leprostatic Agents|leprostatic agents|mesh-ancestor
102178444|NCT02145715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102178445|NCT02145715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102178446|NCT02145715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102178447|NCT02145715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102178448|NCT02145715|Growth Substances|growth substances|mesh-ancestor
102178449|NCT02145715|Growth Inhibitors|growth inhibitors|mesh-ancestor
102178450|NCT02145715|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102178451|NCT02145715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102178452|NCT02145715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178453|NCT04871750|Caseins|caseins|mesh-list
102178454|NCT04871750|Chelating Agents|chelating agents|mesh-ancestor
102178455|NCT04871750|Sequestering Agents|sequestering agents|mesh-ancestor
102178456|NCT04871750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178457|NCT02152579|Isosorbide|isosorbide|mesh-list
102178458|NCT02152579|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
102178459|NCT02152579|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
102178460|NCT02152579|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102178461|NCT02152579|Diuretics|diuretics|mesh-ancestor
102178462|NCT02152579|Natriuretic Agents|natriuretic agents|mesh-ancestor
102178463|NCT02152579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178464|NCT02152579|Vasodilator Agents|vasodilator agents|mesh-ancestor
102178465|NCT02152579|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102178466|NCT02152579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178467|NCT02155777|Norinyl|norinyl|mesh-list
102178468|NCT02155777|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102178469|NCT02155777|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102178470|NCT02155777|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102178471|NCT02155777|Contraceptive Agents|contraceptive agents|mesh-ancestor
102178472|NCT02155777|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102178473|NCT02155777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178474|NCT02155777|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102178475|NCT02155777|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102178476|NCT02145949|Tryptophan|tryptophan|mesh-list
102178477|NCT02145949|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102178478|NCT02145949|Antidepressive Agents|antidepressive agents|mesh-ancestor
102178479|NCT02145949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102178480|NCT00806390|Metoprolol|metoprolol|mesh-list
102178481|NCT00806390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102178482|NCT00806390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102178483|NCT00806390|Sympatholytics|sympatholytics|mesh-ancestor
102178484|NCT00806390|Autonomic Agents|autonomic agents|mesh-ancestor
102178485|NCT00806390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102178486|NCT00806390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178487|NCT00806390|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102178488|NCT00806390|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102178489|NCT00806390|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102178490|NCT00806390|Adrenergic Agents|adrenergic agents|mesh-ancestor
102178491|NCT00806390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102178492|NCT00806390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178493|NCT00566618|Zoledronic Acid|zoledronic acid|mesh-list
102178494|NCT00566618|Dasatinib|dasatinib|mesh-list
102178495|NCT00566618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102178496|NCT00566618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102178497|NCT00566618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102178498|NCT00566618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178499|NCT00566618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102178500|NCT00566618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178501|NCT02769481|Glimepiride|glimepiride|mesh-list
102178502|NCT02769481|Bexagliflozin|bexagliflozin|mesh-list
101720249|NCT00705120|Dermatologic Agents|dermatologic agents|mesh-ancestor
102178503|NCT02769481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102178504|NCT02769481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102178505|NCT02769481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178506|NCT02769481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102178507|NCT02769481|Immunologic Factors|immunologic factors|mesh-ancestor
102178508|NCT04877210|Insulin|insulin|mesh-list
102178509|NCT04877210|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102178510|NCT04877210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102178511|NCT04877210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178512|NCT02152969|Amlodipine|amlodipine|mesh-list
102178513|NCT02152969|Telmisartan|telmisartan|mesh-list
102178514|NCT02152969|Chlorthalidone|chlorthalidone|mesh-list
102178515|NCT02152969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102178516|NCT02152969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102178517|NCT02152969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102178518|NCT02152969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178519|NCT02152969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102178520|NCT02152969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178521|NCT02152969|Vasodilator Agents|vasodilator agents|mesh-ancestor
102178522|NCT02152969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102178523|NCT02152969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102178524|NCT02152969|Diuretics|diuretics|mesh-ancestor
102178525|NCT02152969|Natriuretic Agents|natriuretic agents|mesh-ancestor
102178526|NCT02152969|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102178527|NCT04879004|Ropivacaine|ropivacaine|mesh-list
102178528|NCT04879004|Anesthetics, Local|anesthetics, local|mesh-ancestor
102178529|NCT04879004|Anesthetics|anesthetics|mesh-ancestor
102178530|NCT04879004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102178531|NCT04879004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178532|NCT04879004|Sensory System Agents|sensory system agents|mesh-ancestor
102178533|NCT04879004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102178534|NCT02153125|Eplerenone|eplerenone|mesh-list
102178535|NCT02153125|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102178536|NCT02153125|Hormone Antagonists|hormone antagonists|mesh-ancestor
102178537|NCT02153125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102178538|NCT02153125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178539|NCT02153125|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102178540|NCT02153125|Diuretics|diuretics|mesh-ancestor
102178541|NCT02153125|Natriuretic Agents|natriuretic agents|mesh-ancestor
102178542|NCT02153125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102178543|NCT04878926|Midazolam|midazolam|mesh-list
102178544|NCT04878926|Propofol|propofol|mesh-list
102178545|NCT04878926|Anesthetics|anesthetics|mesh-list
102178546|NCT04878926|Anesthetics, Local|anesthetics, local|mesh-list
102178547|NCT04878926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102178548|NCT04878926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102178549|NCT04878926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178550|NCT04878926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102178551|NCT04878926|Anesthetics, General|anesthetics, general|mesh-ancestor
102178552|NCT04878926|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102178553|NCT04878926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102178554|NCT04878926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102178555|NCT04878926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102178556|NCT04878926|GABA Modulators|gaba modulators|mesh-ancestor
102178557|NCT04878926|GABA Agents|gaba agents|mesh-ancestor
102178558|NCT04878926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102178559|NCT04878926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178560|NCT04878926|Sensory System Agents|sensory system agents|mesh-ancestor
102178561|NCT04878926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102178562|NCT04862767|Aldesleukin|aldesleukin|mesh-list
102178563|NCT04862767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102178564|NCT04862767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102178565|NCT04862767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102178566|NCT04862767|Antiviral Agents|antiviral agents|mesh-ancestor
102178567|NCT04862767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102178568|NCT02146261|Quetmolimab|quetmolimab|mesh-list
102178569|NCT02146261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102178570|NCT02153281|Phenelzine|phenelzine|mesh-list
102178571|NCT02153281|Antidepressive Agents|antidepressive agents|mesh-ancestor
102178572|NCT02153281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102178573|NCT02153281|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102178574|NCT02153281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102178575|NCT02153281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178576|NCT03542851|Pentylenetetrazole|pentylenetetrazole|mesh-list
101887445|NCT04235959|Hormones|hormones|mesh-ancestor
102178577|NCT03542851|Convulsants|convulsants|mesh-ancestor
102178578|NCT03542851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102178579|NCT03542851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178580|NCT03542851|GABA Antagonists|gaba antagonists|mesh-ancestor
102178581|NCT03542851|GABA Agents|gaba agents|mesh-ancestor
102178582|NCT03542851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102178583|NCT03542851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178584|NCT02769247|Naproxen|naproxen|mesh-list
102178585|NCT02769247|Lidocaine|lidocaine|mesh-list
102178586|NCT02769247|Anesthetics, Local|anesthetics, local|mesh-ancestor
102178587|NCT02769247|Anesthetics|anesthetics|mesh-ancestor
102178588|NCT02769247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102178589|NCT02769247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178590|NCT02769247|Sensory System Agents|sensory system agents|mesh-ancestor
102178591|NCT02769247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102178592|NCT02769247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102178593|NCT02769247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102178594|NCT02769247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102178595|NCT02769247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102178596|NCT02769247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178597|NCT02769247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102178598|NCT02769247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102178599|NCT02769247|Analgesics|analgesics|mesh-ancestor
102178600|NCT02769247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102178601|NCT02769247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102178602|NCT02769247|Gout Suppressants|gout suppressants|mesh-ancestor
102178603|NCT02769247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102178604|NCT02769247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102178605|NCT02153437|Sotalol|sotalol|mesh-list
102178606|NCT02153437|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102178607|NCT02153437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102178608|NCT02153437|Adrenergic Agents|adrenergic agents|mesh-ancestor
102178609|NCT02153437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102178610|NCT02153437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178611|NCT02153437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178612|NCT02153437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102178613|NCT02153437|Sympatholytics|sympatholytics|mesh-ancestor
102178614|NCT02153437|Autonomic Agents|autonomic agents|mesh-ancestor
102178615|NCT02153437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102178616|NCT02146651|Insulin|insulin|mesh-list
102178617|NCT02146651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102178618|NCT02146651|Insulin Lispro|insulin lispro|mesh-list
102178619|NCT02146651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102178620|NCT02146651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178621|NCT03542149|Tocopherols|tocopherols|mesh-list
102178622|NCT03542149|Vitamin E|vitamin e|mesh-list
102178623|NCT03542149|Tocotrienols|tocotrienols|mesh-list
102178624|NCT03542149|alpha-Tocopherol|alpha-tocopherol|mesh-list
102178625|NCT03542149|Piperaquine|piperaquine|mesh-list
102178626|NCT03542149|Antimalarials|antimalarials|mesh-ancestor
102178627|NCT03542149|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102178628|NCT03542149|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102178629|NCT03542149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102178630|NCT03542149|Antioxidants|antioxidants|mesh-ancestor
102178631|NCT03542149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178632|NCT03542149|Protective Agents|protective agents|mesh-ancestor
102178633|NCT03542149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178634|NCT03542149|Vitamins|vitamins|mesh-ancestor
102178635|NCT03542149|Micronutrients|micronutrients|mesh-ancestor
102178636|NCT02153593|Tranexamic Acid|tranexamic acid|mesh-list
102178637|NCT02153593|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102178638|NCT02153593|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102178639|NCT02153593|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102178640|NCT02153593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178641|NCT02153593|Hemostatics|hemostatics|mesh-ancestor
102178642|NCT02153593|Coagulants|coagulants|mesh-ancestor
102178643|NCT02154217|Timolol|timolol|mesh-list
102178644|NCT02154217|Bimatoprost|bimatoprost|mesh-list
102178645|NCT02154217|Latanoprost|latanoprost|mesh-list
102178646|NCT02154217|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102178647|NCT02154217|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102178648|NCT02154217|Adrenergic Agents|adrenergic agents|mesh-ancestor
102178649|NCT02154217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102178650|NCT02154217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178651|NCT02154217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178652|NCT02154217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102178653|NCT02154217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102178654|NCT02154217|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102178655|NCT02154217|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102178656|NCT02147041|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
102178657|NCT02147041|Antioxidants|antioxidants|mesh-ancestor
102178658|NCT02147041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178659|NCT02147041|Protective Agents|protective agents|mesh-ancestor
102178660|NCT02147041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178661|NCT02147041|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
102178662|NCT02147041|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102178663|NCT02147041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102178664|NCT02147041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102178665|NCT02767765|Epoetin Alfa|epoetin alfa|mesh-list
102178666|NCT02767765|Hematinics|hematinics|mesh-ancestor
102178667|NCT00103207|Cetuximab|cetuximab|mesh-list
102178668|NCT00103207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102178669|NCT00103207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102178670|NCT02254915|BCG Vaccine|bcg vaccine|mesh-list
102178671|NCT02254915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102178672|NCT02254915|Immunologic Factors|immunologic factors|mesh-ancestor
102178673|NCT02254915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178674|NCT02157181|Rituximab|rituximab|mesh-list
102178675|NCT02157181|Cladribine|cladribine|mesh-list
102178676|NCT02157181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102178677|NCT02157181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102178678|NCT02157181|Immunologic Factors|immunologic factors|mesh-ancestor
102178679|NCT02157181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178680|NCT02157181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102178681|NCT02157181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102178682|NCT02159287|Heparin|heparin|mesh-list
102178683|NCT02159287|Calcium heparin|calcium heparin|mesh-list
102178684|NCT02159287|Enoxaparin|enoxaparin|mesh-list
102178685|NCT02159287|Enoxaparin sodium|enoxaparin sodium|mesh-list
102178686|NCT02159287|Anticoagulants|anticoagulants|mesh-ancestor
102178687|NCT02159287|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102178688|NCT02159287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102178689|NCT02159287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178690|NCT05005273|Nivolumab|nivolumab|mesh-list
102178691|NCT05005273|Ipilimumab|ipilimumab|mesh-list
102178692|NCT05005273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102178693|NCT05005273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102178694|NCT05005273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102178695|NCT05005273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178696|NCT02157337|Atorvastatin|atorvastatin|mesh-list
102178697|NCT02157337|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102178698|NCT02157337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102178699|NCT02157337|Antimetabolites|antimetabolites|mesh-ancestor
102178700|NCT02157337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178701|NCT02157337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102178702|NCT02157337|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102178703|NCT02157337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102178704|NCT02159599|Ritonavir|ritonavir|mesh-list
102178705|NCT02159599|Darunavir|darunavir|mesh-list
102178706|NCT02159599|Tenofovir|tenofovir|mesh-list
102178707|NCT02159599|Lamivudine|lamivudine|mesh-list
102178708|NCT02159599|Emtricitabine|emtricitabine|mesh-list
102178709|NCT02159599|Abacavir|abacavir|mesh-list
102178710|NCT02159599|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102178711|NCT02159599|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102178712|NCT02159599|Protease Inhibitors|protease inhibitors|mesh-ancestor
102178713|NCT02159599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102178714|NCT02159599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178715|NCT02159599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102178716|NCT02159599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102178717|NCT02159599|Antiviral Agents|antiviral agents|mesh-ancestor
102178718|NCT02159599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102178719|NCT02159599|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102178720|NCT02159599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102178721|NCT02159599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102178722|NCT02159599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102178723|NCT03541681|Anesthetics|anesthetics|mesh-list
102178724|NCT03541681|Glucocorticoids|glucocorticoids|mesh-list
102178725|NCT03541681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102178726|NCT03541681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178727|NCT03541681|Hormones|hormones|mesh-ancestor
102178728|NCT03541681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102178729|NCT02157415|Polihexanide|polihexanide|mesh-list
102178730|NCT02157415|Disinfectants|disinfectants|mesh-ancestor
102178731|NCT02157415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102178732|NCT02157571|Levofloxacin|levofloxacin|mesh-list
102178733|NCT02157571|Ofloxacin|ofloxacin|mesh-list
102178734|NCT02157571|Prulifloxacin|prulifloxacin|mesh-list
102178735|NCT02157571|Fluoroquinolones|fluoroquinolones|mesh-list
102178736|NCT02157571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102178737|NCT02157571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102178738|NCT02157571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102178739|NCT02157571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102178740|NCT02157571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102178741|NCT02157571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102178742|NCT02157571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178743|NCT02157571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102178744|NCT02157571|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102178745|NCT02157571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102178746|NCT02157571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102178747|NCT01369355|Ustekinumab|ustekinumab|mesh-list
102178748|NCT01369355|Dermatologic Agents|dermatologic agents|mesh-ancestor
102178749|NCT03541993|Resveratrol|resveratrol|mesh-list
102178750|NCT03541993|Antioxidants|antioxidants|mesh-ancestor
102178751|NCT03541993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178752|NCT03541993|Protective Agents|protective agents|mesh-ancestor
102178753|NCT03541993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178754|NCT03541993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102178755|NCT03541993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102178756|NCT02157649|Phenylpropanolamine|phenylpropanolamine|mesh-list
102178757|NCT02157649|Codeine|codeine|mesh-list
102178758|NCT02157649|Guaifenesin|guaifenesin|mesh-list
102178759|NCT02157649|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
102178760|NCT02157649|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102178761|NCT02157649|Narcotics|narcotics|mesh-ancestor
102178762|NCT02157649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102178763|NCT02157649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178764|NCT02157649|Analgesics|analgesics|mesh-ancestor
102178765|NCT02157649|Sensory System Agents|sensory system agents|mesh-ancestor
102178766|NCT02157649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102178767|NCT02157649|Antitussive Agents|antitussive agents|mesh-ancestor
102178768|NCT02157649|Respiratory System Agents|respiratory system agents|mesh-ancestor
102178769|NCT02157649|Expectorants|expectorants|mesh-ancestor
102178770|NCT02157649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102178771|NCT02157649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102178772|NCT02157649|Adrenergic Agents|adrenergic agents|mesh-ancestor
102178773|NCT02157649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102178774|NCT02157649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178775|NCT02157649|Appetite Depressants|appetite depressants|mesh-ancestor
102178776|NCT02157649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102178777|NCT02157649|Sympathomimetics|sympathomimetics|mesh-ancestor
102178778|NCT02157649|Autonomic Agents|autonomic agents|mesh-ancestor
102178779|NCT02157649|Nasal Decongestants|nasal decongestants|mesh-ancestor
102178780|NCT02157649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102178781|NCT02159911|Misoprostol|misoprostol|mesh-list
102178782|NCT02159911|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102178783|NCT02159911|Abortifacient Agents|abortifacient agents|mesh-ancestor
102178784|NCT02159911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102178785|NCT02159911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178786|NCT02159911|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102178787|NCT02159911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102178788|NCT02159911|Oxytocics|oxytocics|mesh-ancestor
102178789|NCT03542617|Dexamethasone|dexamethasone|mesh-list
102178790|NCT03542617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102178791|NCT03542617|Antiemetics|antiemetics|mesh-ancestor
102178792|NCT03542617|Autonomic Agents|autonomic agents|mesh-ancestor
102178793|NCT03542617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102178794|NCT03542617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178795|NCT03542617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102178796|NCT03542617|Glucocorticoids|glucocorticoids|mesh-ancestor
102178797|NCT03542617|Hormones|hormones|mesh-ancestor
102178798|NCT03542617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102178799|NCT03542617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102178800|NCT03542617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102178801|NCT04878770|Cyclosporine|cyclosporine|mesh-list
102178802|NCT04878770|Cyclosporins|cyclosporins|mesh-list
102178803|NCT04878770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102178804|NCT04878770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887674|NCT03890289|Idelalisib|idelalisib|mesh-list
102178805|NCT04878770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102178806|NCT04878770|Immunologic Factors|immunologic factors|mesh-ancestor
102178807|NCT04878770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178808|NCT04878770|Antifungal Agents|antifungal agents|mesh-ancestor
102178809|NCT04878770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102178810|NCT04878770|Dermatologic Agents|dermatologic agents|mesh-ancestor
102178811|NCT04878770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102178812|NCT04878770|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102178814|NCT02086019|Bisoprolol|bisoprolol|mesh-list
102178815|NCT02086019|Heparin|heparin|mesh-list
102178816|NCT02086019|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102178817|NCT02086019|Tinzaparin|tinzaparin|mesh-list
102178818|NCT02086019|Dalteparin|dalteparin|mesh-list
102178819|NCT02086019|Clopidogrel|clopidogrel|mesh-list
102178820|NCT02086019|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102178821|NCT02086019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102178822|NCT02086019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178823|NCT02086019|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102178824|NCT02086019|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102178825|NCT02086019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178826|NCT02086019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102178827|NCT02086019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102178828|NCT02086019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102178829|NCT02086019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102178830|NCT02086019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102178831|NCT02086019|Purinergic Agents|purinergic agents|mesh-ancestor
102178832|NCT02086019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102178833|NCT02086019|Anticoagulants|anticoagulants|mesh-ancestor
102178834|NCT02086019|Protease Inhibitors|protease inhibitors|mesh-ancestor
102178835|NCT02086019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102178836|NCT02086019|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102178837|NCT02086019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102178838|NCT02086019|Adrenergic Agents|adrenergic agents|mesh-ancestor
102178839|NCT02086019|Sympatholytics|sympatholytics|mesh-ancestor
102178840|NCT02086019|Autonomic Agents|autonomic agents|mesh-ancestor
102178841|NCT02086019|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102178842|NCT02086097|Ibuprofen|ibuprofen|mesh-list
102178843|NCT02086097|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
102178844|NCT02086097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102178845|NCT02086097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102178846|NCT02086097|Analgesics|analgesics|mesh-ancestor
102178847|NCT02086097|Sensory System Agents|sensory system agents|mesh-ancestor
102178848|NCT02086097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102178849|NCT02086097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178850|NCT02086097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102178851|NCT02086097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102178852|NCT02086097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102178853|NCT02086097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102178854|NCT02086097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178855|NCT02307682|Aflibercept|aflibercept|mesh-list
102178856|NCT02307682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102178857|NCT02307682|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102178858|NCT02307682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102178859|NCT02307682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102178860|NCT02307682|Growth Substances|growth substances|mesh-ancestor
102178861|NCT02307682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178862|NCT02307682|Growth Inhibitors|growth inhibitors|mesh-ancestor
102178863|NCT02307682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102178864|NCT02088515|Docetaxel|docetaxel|mesh-list
102178865|NCT02088515|Nedaplatin|nedaplatin|mesh-list
102178866|NCT02088515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102178867|NCT02088515|Tubulin Modulators|tubulin modulators|mesh-ancestor
102178868|NCT02088515|Antimitotic Agents|antimitotic agents|mesh-ancestor
102178869|NCT02088515|Mitosis Modulators|mitosis modulators|mesh-ancestor
102178870|NCT02088515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178871|NCT02086253|BQ 788|bq 788|mesh-list
102178872|NCT02086253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102178873|NCT02086253|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102178874|NCT02086253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178875|NCT02086253|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
102178876|NCT04870502|Clomiphene|clomiphene|mesh-list
102178877|NCT04870502|Enclomiphene|enclomiphene|mesh-list
102178878|NCT04870502|Zuclomiphene|zuclomiphene|mesh-list
102178879|NCT04870502|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102178880|NCT04870502|Hormone Antagonists|hormone antagonists|mesh-ancestor
102178881|NCT04870502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102178882|NCT04870502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178883|NCT04870502|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102178885|NCT04870502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102178886|NCT04870502|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102178887|NCT04870502|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102178888|NCT02088671|Propofol|propofol|mesh-list
102178889|NCT02088671|Desflurane|desflurane|mesh-list
102178890|NCT02088671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102178891|NCT02088671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102178892|NCT02088671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178893|NCT02088671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102178894|NCT02088671|Anesthetics, General|anesthetics, general|mesh-ancestor
102178895|NCT02088671|Anesthetics|anesthetics|mesh-ancestor
102178896|NCT02088671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102178897|NCT04870190|Osimertinib|osimertinib|mesh-list
102178898|NCT04870190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102178899|NCT04870190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102178900|NCT04870190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102178901|NCT04870190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178902|NCT03049046|Caffeic acid|caffeic acid|mesh-list
102178903|NCT03049046|Antioxidants|antioxidants|mesh-ancestor
102178904|NCT03049046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178905|NCT03049046|Protective Agents|protective agents|mesh-ancestor
102178906|NCT03049046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178907|NCT04385966|Levobupivacaine|levobupivacaine|mesh-list
102178908|NCT04385966|Anesthetics, Local|anesthetics, local|mesh-ancestor
102178909|NCT04385966|Anesthetics|anesthetics|mesh-ancestor
102178910|NCT04385966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102178911|NCT04385966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178912|NCT04385966|Sensory System Agents|sensory system agents|mesh-ancestor
102178913|NCT04385966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102178914|NCT03046082|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102178915|NCT03046082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102178916|NCT03048110|Itraconazole|itraconazole|mesh-list
102178917|NCT03048110|Rifampin|rifampin|mesh-list
102178918|NCT03048110|Antifungal Agents|antifungal agents|mesh-ancestor
102178919|NCT03048110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102178920|NCT03048110|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102178921|NCT03048110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102178922|NCT03048110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102178923|NCT03048110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178924|NCT03048110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102178925|NCT03048110|Hormone Antagonists|hormone antagonists|mesh-ancestor
102178926|NCT03048110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102178927|NCT03048110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178928|NCT03048110|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102178929|NCT03048110|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102178930|NCT03048110|Antitubercular Agents|antitubercular agents|mesh-ancestor
102178931|NCT03048110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102178932|NCT03048110|Leprostatic Agents|leprostatic agents|mesh-ancestor
102178933|NCT03048110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102178934|NCT03048110|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102178935|NCT03048110|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102178936|NCT03048110|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102178937|NCT03048110|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102178938|NCT03048110|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101448007|NCT00217659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102178939|NCT03048110|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102178940|NCT05256758|Fenofibrate|fenofibrate|mesh-list
102178941|NCT05256758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102178942|NCT05256758|Antimetabolites|antimetabolites|mesh-ancestor
102178943|NCT05256758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178944|NCT05256758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102178945|NCT02791763|Glycine|glycine|mesh-list
102178946|NCT02791763|Glycine Agents|glycine agents|mesh-ancestor
102178947|NCT02791763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102178948|NCT02791763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178949|NCT02791763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178950|NCT02086409|Calcium, Dietary|calcium, dietary|mesh-list
102178951|NCT02086409|Vitamin D|vitamin d|mesh-list
102178953|NCT02086409|Cholecalciferol|cholecalciferol|mesh-list
102178954|NCT02086409|Vitamins|vitamins|mesh-list
102178955|NCT02086409|Calcium|calcium|mesh-list
102178956|NCT02086409|Micronutrients|micronutrients|mesh-ancestor
102178957|NCT02086409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178958|NCT02086409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102178959|NCT02086409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102178960|NCT02613572|Thioctic Acid|thioctic acid|mesh-list
102178961|NCT02613572|Antioxidants|antioxidants|mesh-ancestor
102178962|NCT02613572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178963|NCT02613572|Protective Agents|protective agents|mesh-ancestor
102178964|NCT02613572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178965|NCT02613572|Vitamin B Complex|vitamin b complex|mesh-ancestor
102178966|NCT02613572|Vitamins|vitamins|mesh-ancestor
102178967|NCT02613572|Micronutrients|micronutrients|mesh-ancestor
102178968|NCT02088983|Choline|choline|mesh-list
102178969|NCT02088983|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
102178970|NCT02088983|Lipotropic Agents|lipotropic agents|mesh-ancestor
102178971|NCT02088983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102178972|NCT02088983|Antimetabolites|antimetabolites|mesh-ancestor
102178973|NCT02088983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178974|NCT02088983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102178975|NCT02088983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102178976|NCT02088983|Nootropic Agents|nootropic agents|mesh-ancestor
102178977|NCT02089061|Atorvastatin|atorvastatin|mesh-list
102178978|NCT02089061|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102178979|NCT02089061|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102178980|NCT02089061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102178981|NCT02089061|Antimetabolites|antimetabolites|mesh-ancestor
102178982|NCT02089061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102178983|NCT02089061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102178984|NCT02089061|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102178985|NCT02089061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102178986|NCT02082665|Dabrafenib|dabrafenib|mesh-list
102178987|NCT02082665|Midazolam|midazolam|mesh-list
102178988|NCT02082665|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102178989|NCT02082665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102178990|NCT02082665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102178991|NCT02082665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102178992|NCT02082665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102178993|NCT02082665|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102178994|NCT02082665|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102178995|NCT02082665|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102178996|NCT02082665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102178997|NCT02082665|Anesthetics, General|anesthetics, general|mesh-ancestor
102178998|NCT02082665|Anesthetics|anesthetics|mesh-ancestor
102178999|NCT02082665|GABA Modulators|gaba modulators|mesh-ancestor
102179000|NCT02082665|GABA Agents|gaba agents|mesh-ancestor
102179001|NCT02082665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102179002|NCT02082665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179003|NCT02082665|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102179004|NCT02082665|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102179005|NCT02082665|Antimetabolites|antimetabolites|mesh-ancestor
102179006|NCT02082665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102179007|NCT02082665|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102179008|NCT02082665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101448021|NCT00210795|Epoetin Alfa|epoetin alfa|mesh-list
102179009|NCT02082665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102179010|NCT02082665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102179011|NCT03047954|Broncho-Vaxom|broncho-vaxom|mesh-list
102179012|NCT03047954|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102179013|NCT03047954|Immunologic Factors|immunologic factors|mesh-ancestor
102179014|NCT03047954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179015|NCT03558971|Hydrocortisone|hydrocortisone|mesh-list
102179016|NCT03558971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102179017|NCT02341456|Paclitaxel|paclitaxel|mesh-list
102179018|NCT02341456|Carboplatin|carboplatin|mesh-list
102179019|NCT02341456|Adavosertib|adavosertib|mesh-list
102179020|NCT02341456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102179021|NCT02341456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102179022|NCT02341456|Tubulin Modulators|tubulin modulators|mesh-ancestor
102179023|NCT02341456|Antimitotic Agents|antimitotic agents|mesh-ancestor
102179024|NCT02341456|Mitosis Modulators|mitosis modulators|mesh-ancestor
102179025|NCT02341456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179026|NCT02341456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102179027|NCT02083055|Nitroglycerin|nitroglycerin|mesh-list
102179028|NCT02083055|Dexmedetomidine|dexmedetomidine|mesh-list
102179030|NCT02083055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102179031|NCT02083055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179032|NCT02083055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102179033|NCT02083055|Analgesics|analgesics|mesh-ancestor
102179034|NCT02083055|Sensory System Agents|sensory system agents|mesh-ancestor
102179035|NCT02083055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102179036|NCT02083055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102179037|NCT02083055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102179038|NCT02083055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102179039|NCT02083055|Adrenergic Agents|adrenergic agents|mesh-ancestor
102179040|NCT02083055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102179041|NCT02083055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179042|NCT02083055|Vasodilator Agents|vasodilator agents|mesh-ancestor
102179043|NCT02089295|Oxycodone|oxycodone|mesh-list
102179044|NCT02089295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102179045|NCT02089295|Narcotics|narcotics|mesh-ancestor
102179046|NCT02089295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102179047|NCT02089295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179048|NCT02089295|Analgesics|analgesics|mesh-ancestor
102179049|NCT02089295|Sensory System Agents|sensory system agents|mesh-ancestor
102179050|NCT02089295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102179051|NCT02370784|Atorvastatin|atorvastatin|mesh-list
102179052|NCT02370784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102179053|NCT02370784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102179054|NCT02370784|Antimetabolites|antimetabolites|mesh-ancestor
102179055|NCT02370784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179056|NCT02370784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102179057|NCT02370784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102179058|NCT02370784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102179059|NCT02083211|Nimotuzumab|nimotuzumab|mesh-list
102179060|NCT02083211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102179061|NCT02083211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102179062|NCT01595438|Ciprofloxacin|ciprofloxacin|mesh-list
102179063|NCT01595438|Ceftazidime|ceftazidime|mesh-list
102179064|NCT01595438|Avibactam|avibactam|mesh-list
102179065|NCT01595438|Doripenem|doripenem|mesh-list
102179066|NCT01595438|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102179067|NCT01595438|Trimethoprim|trimethoprim|mesh-list
102179068|NCT01595438|Sulfamethoxazole|sulfamethoxazole|mesh-list
102179069|NCT01595438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102179070|NCT01595438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102179071|NCT01595438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102179072|NCT01595438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102179073|NCT01595438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102179074|NCT01595438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179075|NCT01595438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102179076|NCT01595438|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102179077|NCT01595438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102179078|NCT01595438|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102179079|NCT01595438|Antimalarials|antimalarials|mesh-ancestor
102179080|NCT01595438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102179081|NCT01595438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102179082|NCT01595438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102179083|NCT01595438|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102179084|NCT01595438|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102179085|NCT01595438|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102179086|NCT02089451|Insulin Aspart|insulin aspart|mesh-list
102179087|NCT02089451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102179088|NCT02089451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179089|NCT02340520|Theophylline|theophylline|mesh-list
102179090|NCT02340520|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102179091|NCT02340520|Autonomic Agents|autonomic agents|mesh-ancestor
102179092|NCT02340520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102179093|NCT02340520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179094|NCT02340520|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102179095|NCT02340520|Respiratory System Agents|respiratory system agents|mesh-ancestor
102179096|NCT02340520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102179097|NCT02340520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102179098|NCT02340520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179099|NCT02340520|Vasodilator Agents|vasodilator agents|mesh-ancestor
102179100|NCT02340520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102179101|NCT02340520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102179102|NCT02340520|Purinergic Agents|purinergic agents|mesh-ancestor
102179103|NCT02340520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102179104|NCT02087579|Olanzapine|olanzapine|mesh-list
102179105|NCT02087579|Risperidone|risperidone|mesh-list
102179107|NCT02087579|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102179108|NCT02087579|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102179109|NCT02087579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102179110|NCT02087579|Serotonin Agents|serotonin agents|mesh-ancestor
102179111|NCT02087579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102179112|NCT02087579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179113|NCT02087579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179114|NCT02087579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102179115|NCT02087579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102179116|NCT02087579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102179117|NCT02087579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102179118|NCT02087579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102179119|NCT02087579|Dopamine Agents|dopamine agents|mesh-ancestor
102179120|NCT02087579|Antiemetics|antiemetics|mesh-ancestor
102179121|NCT02087579|Autonomic Agents|autonomic agents|mesh-ancestor
102179122|NCT02087579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102179123|NCT02087579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102179124|NCT02087579|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102179125|NCT02087579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102179126|NCT02087579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102179127|NCT02087579|Antidepressive Agents|antidepressive agents|mesh-ancestor
102179128|NCT02087579|Dopamine Agonists|dopamine agonists|mesh-ancestor
102179129|NCT02087579|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102179130|NCT02087579|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102179131|NCT02087579|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102179132|NCT02087579|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102179133|NCT02339584|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102179134|NCT02339584|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102179135|NCT02339584|Brinzolamide|brinzolamide|mesh-list
102179136|NCT02339584|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102179137|NCT02339584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102179138|NCT02339584|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102179139|NCT02339584|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102179140|NCT02339584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102179141|NCT02339584|Adrenergic Agents|adrenergic agents|mesh-ancestor
102179142|NCT02339584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102179143|NCT02339584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179144|NCT02339584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179145|NCT02339584|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102179146|NCT02339584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102179147|NCT02339506|Cosyntropin|cosyntropin|mesh-list
102179148|NCT02339506|Hormones|hormones|mesh-ancestor
102179149|NCT02339506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102179150|NCT02339506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179151|NCT02087813|Methylprednisolone|methylprednisolone|mesh-list
102179152|NCT02087813|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102179153|NCT02087813|Protease Inhibitors|protease inhibitors|mesh-list
102179154|NCT02087813|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
102179155|NCT02087813|Protein C Inhibitor|protein c inhibitor|mesh-list
102179156|NCT02087813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102179157|NCT02087813|Antiemetics|antiemetics|mesh-ancestor
102179158|NCT02087813|Autonomic Agents|autonomic agents|mesh-ancestor
102179159|NCT02087813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102179160|NCT02087813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179161|NCT02087813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102179162|NCT02087813|Glucocorticoids|glucocorticoids|mesh-ancestor
102179163|NCT02087813|Hormones|hormones|mesh-ancestor
102179164|NCT02087813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102179165|NCT02087813|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102179166|NCT02087813|Protective Agents|protective agents|mesh-ancestor
102179167|NCT02087813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102179168|NCT02087813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102179169|NCT02087813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102179170|NCT02087813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179171|NCT02087813|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102179172|NCT02087813|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102179173|NCT02089529|Ibuprofen|ibuprofen|mesh-list
102179174|NCT02089529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102179175|NCT02089529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102179176|NCT02089529|Analgesics|analgesics|mesh-ancestor
102179177|NCT02089529|Sensory System Agents|sensory system agents|mesh-ancestor
101888037|NCT03132532|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102179178|NCT02089529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102179179|NCT02089529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179180|NCT02089529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102179181|NCT02089529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102179182|NCT02089529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102179183|NCT02089529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102179184|NCT02089529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179185|NCT02090933|Celecoxib|celecoxib|mesh-list
102179186|NCT02090933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102179187|NCT02090933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102179188|NCT02090933|Analgesics|analgesics|mesh-ancestor
102179189|NCT02090933|Sensory System Agents|sensory system agents|mesh-ancestor
102179190|NCT02090933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102179191|NCT02090933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179192|NCT02090933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102179193|NCT02090933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102179194|NCT02090933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102179195|NCT02090933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102179196|NCT02090933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102179197|NCT02090933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179198|NCT03046238|Dexmedetomidine|dexmedetomidine|mesh-list
102179199|NCT03046238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102179200|NCT03046238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102179201|NCT03046238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179202|NCT03046238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102179203|NCT03046238|Analgesics|analgesics|mesh-ancestor
102179204|NCT03046238|Sensory System Agents|sensory system agents|mesh-ancestor
102179205|NCT03046238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102179206|NCT03046238|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102179207|NCT03046238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102179208|NCT03046238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102179209|NCT03046238|Adrenergic Agents|adrenergic agents|mesh-ancestor
102179210|NCT03046238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102179211|NCT03046238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179212|NCT02089763|BCT-100|bct-100|mesh-list
102179213|NCT02089763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102179214|NCT02089841|Lumefantrine|lumefantrine|mesh-list
102179215|NCT02089841|Artemether|artemether|mesh-list
102179216|NCT02089841|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102179217|NCT02089841|Antimalarials|antimalarials|mesh-ancestor
102179218|NCT02089841|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102179219|NCT02089841|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102179220|NCT02089841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102179221|NCT03045770|Leucovorin|leucovorin|mesh-list
102179222|NCT03045770|Paclitaxel|paclitaxel|mesh-list
102179223|NCT03045770|Fluorouracil|fluorouracil|mesh-list
102179224|NCT03045770|Oxaliplatin|oxaliplatin|mesh-list
102179225|NCT03045770|Irinotecan|irinotecan|mesh-list
102179226|NCT03045770|Calcium|calcium|mesh-list
102179227|NCT03045770|Levoleucovorin|levoleucovorin|mesh-list
102179228|NCT03045770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102179229|NCT03045770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102179230|NCT03045770|Tubulin Modulators|tubulin modulators|mesh-ancestor
102179231|NCT03045770|Antimitotic Agents|antimitotic agents|mesh-ancestor
102179232|NCT03045770|Mitosis Modulators|mitosis modulators|mesh-ancestor
102179233|NCT03045770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179234|NCT03045770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102179235|NCT03045770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179236|NCT03045770|Antimetabolites|antimetabolites|mesh-ancestor
102179237|NCT03045770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102179238|NCT03045770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102179239|NCT03045770|Immunologic Factors|immunologic factors|mesh-ancestor
102179240|NCT03045770|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102179241|NCT03045770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102179242|NCT03045770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102179243|NCT03045770|Antidotes|antidotes|mesh-ancestor
102179244|NCT03045770|Protective Agents|protective agents|mesh-ancestor
102179245|NCT03045770|Vitamin B Complex|vitamin b complex|mesh-ancestor
102179246|NCT03045770|Vitamins|vitamins|mesh-ancestor
102179247|NCT03045770|Micronutrients|micronutrients|mesh-ancestor
102179248|NCT02260505|Imatinib Mesylate|imatinib mesylate|mesh-list
102179249|NCT02260505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102179250|NCT02260505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102179251|NCT02260505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102179252|NCT02260505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179254|NCT02095847|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102179255|NCT02095847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102179256|NCT02091401|Magnesium Sulfate|magnesium sulfate|mesh-list
102179257|NCT02091401|Analgesics|analgesics|mesh-ancestor
102179258|NCT02091401|Sensory System Agents|sensory system agents|mesh-ancestor
102179259|NCT02091401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102179260|NCT02091401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179261|NCT02091401|Anesthetics|anesthetics|mesh-ancestor
102179262|NCT02091401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102179263|NCT02091401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102179264|NCT02091401|Anticonvulsants|anticonvulsants|mesh-ancestor
102179265|NCT02091401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102179266|NCT02091401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102179267|NCT02091401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179268|NCT02091401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102179269|NCT02091401|Tocolytic Agents|tocolytic agents|mesh-ancestor
102179270|NCT02091401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102179271|NCT01594970|Bimatoprost|bimatoprost|mesh-list
102179272|NCT01594970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102179273|NCT04869176|Caffeine|caffeine|mesh-list
102179274|NCT04869176|Caffeine citrate|caffeine citrate|mesh-list
102179275|NCT04869176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179276|NCT04869176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102179277|NCT04869176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179278|NCT04869176|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102179279|NCT04869176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102179280|NCT04869176|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102179281|NCT04869176|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102179282|NCT04869176|Purinergic Agents|purinergic agents|mesh-ancestor
102179283|NCT04869176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102179284|NCT03557255|Simendan|simendan|mesh-list
102179285|NCT03557255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102179286|NCT03557255|Vasodilator Agents|vasodilator agents|mesh-ancestor
102179287|NCT03557255|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102179288|NCT03557255|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102179289|NCT03557255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102179290|NCT03557255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179291|NCT03557255|Protective Agents|protective agents|mesh-ancestor
102179292|NCT03557255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179293|NCT04868552|Naloxone|naloxone|mesh-list
102179294|NCT04868552|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102179295|NCT04868552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179296|NCT04868552|Sensory System Agents|sensory system agents|mesh-ancestor
102179297|NCT04868552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102179298|NCT02090153|Leucovorin|leucovorin|mesh-list
102179299|NCT02090153|Tegafur|tegafur|mesh-list
102179300|NCT02090153|Antidotes|antidotes|mesh-ancestor
102179301|NCT02090153|Protective Agents|protective agents|mesh-ancestor
102179302|NCT02090153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179303|NCT02090153|Vitamin B Complex|vitamin b complex|mesh-ancestor
102179304|NCT02090153|Vitamins|vitamins|mesh-ancestor
102179305|NCT02090153|Micronutrients|micronutrients|mesh-ancestor
102179306|NCT02090153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102179307|NCT02090153|Antimetabolites|antimetabolites|mesh-ancestor
102179308|NCT02090153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179309|NCT02090153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102179310|NCT00358163|Paclitaxel|paclitaxel|mesh-list
102179311|NCT00358163|Vatalanib|vatalanib|mesh-list
102179312|NCT00358163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102179313|NCT00358163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102179314|NCT00358163|Tubulin Modulators|tubulin modulators|mesh-ancestor
102179315|NCT00358163|Antimitotic Agents|antimitotic agents|mesh-ancestor
102179316|NCT00358163|Mitosis Modulators|mitosis modulators|mesh-ancestor
102179317|NCT00358163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179318|NCT00358163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102179319|NCT00358163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102179320|NCT02096315|Murepavadin|murepavadin|mesh-list
102179321|NCT02096315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102179322|NCT02096315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102179323|NCT02337946|Calcium, Dietary|calcium, dietary|mesh-list
102179324|NCT02337946|Leucovorin|leucovorin|mesh-list
102179325|NCT02337946|Oxaliplatin|oxaliplatin|mesh-list
102179326|NCT02337946|Fluorouracil|fluorouracil|mesh-list
102179327|NCT02337946|Panitumumab|panitumumab|mesh-list
102179328|NCT02337946|Calcium|calcium|mesh-list
102179329|NCT02337946|Levoleucovorin|levoleucovorin|mesh-list
102179330|NCT02337946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102179331|NCT02337946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179332|NCT02337946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102179333|NCT02337946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102179334|NCT02337946|Antimetabolites|antimetabolites|mesh-ancestor
102179335|NCT02337946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179336|NCT02337946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102179337|NCT02337946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102179338|NCT02337946|Immunologic Factors|immunologic factors|mesh-ancestor
102179339|NCT02337946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102179340|NCT02337946|Antidotes|antidotes|mesh-ancestor
102179341|NCT02337946|Protective Agents|protective agents|mesh-ancestor
102179342|NCT02337946|Vitamin B Complex|vitamin b complex|mesh-ancestor
102179343|NCT02337946|Vitamins|vitamins|mesh-ancestor
102179344|NCT02337946|Micronutrients|micronutrients|mesh-ancestor
102179345|NCT04865510|Heparin|heparin|mesh-list
102179346|NCT04865510|Anticoagulants|anticoagulants|mesh-ancestor
102179347|NCT04865510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179348|NCT04865510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102179349|NCT04865510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102179350|NCT02090309|Hydrocortisone|hydrocortisone|mesh-list
102179351|NCT02090309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102179352|NCT03047096|Hyaluronic Acid|hyaluronic acid|mesh-list
102179353|NCT03047096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102179354|NCT03047096|Immunologic Factors|immunologic factors|mesh-ancestor
102179355|NCT03047096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179356|NCT03047096|Viscosupplements|viscosupplements|mesh-ancestor
102179357|NCT03047096|Protective Agents|protective agents|mesh-ancestor
102179358|NCT02090543|Rivaroxaban|rivaroxaban|mesh-list
102179359|NCT02090543|Phenprocoumon|phenprocoumon|mesh-list
102179360|NCT02090543|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102179361|NCT02090543|Antithrombins|antithrombins|mesh-ancestor
102179362|NCT02090543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102179363|NCT02090543|Protease Inhibitors|protease inhibitors|mesh-ancestor
102179364|NCT02090543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102179365|NCT02090543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179366|NCT02090543|Anticoagulants|anticoagulants|mesh-ancestor
102179367|NCT02093195|Bosentan|bosentan|mesh-list
102179368|NCT02093195|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
102179369|NCT02093195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102179370|NCT02093195|Respiratory System Agents|respiratory system agents|mesh-ancestor
102179371|NCT02093195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102179372|NCT02093195|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102179373|NCT02093195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179374|NCT02096939|Antihypertensive Agents|antihypertensive agents|mesh-list
102179375|NCT03555617|Itraconazole|itraconazole|mesh-list
102179376|NCT03555617|Antifungal Agents|antifungal agents|mesh-ancestor
102179377|NCT03555617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102179378|NCT03555617|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102179379|NCT03555617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102179380|NCT03555617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102179381|NCT03555617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179382|NCT03555617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102179383|NCT03555617|Hormone Antagonists|hormone antagonists|mesh-ancestor
102179384|NCT03555617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102179385|NCT03555617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179386|NCT03555617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102179387|NCT02098889|Scopolamine|scopolamine|mesh-list
102179388|NCT02098889|Bromides|bromides|mesh-list
102179389|NCT02098889|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102179390|NCT02098889|Anticonvulsants|anticonvulsants|mesh-ancestor
102179391|NCT02098889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102179392|NCT02098889|Antiemetics|antiemetics|mesh-ancestor
102179393|NCT02098889|Autonomic Agents|autonomic agents|mesh-ancestor
102179394|NCT02098889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102179395|NCT02098889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179396|NCT02098889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102179397|NCT02098889|Mydriatics|mydriatics|mesh-ancestor
102179398|NCT02098889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102179399|NCT02098889|Cholinergic Agents|cholinergic agents|mesh-ancestor
102179400|NCT02098889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102179401|NCT02098889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179402|NCT02098889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102179403|NCT02098889|Parasympatholytics|parasympatholytics|mesh-ancestor
102179404|NCT01369199|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102179405|NCT01369199|Entecavir|entecavir|mesh-list
102179406|NCT01369199|Antiviral Agents|antiviral agents|mesh-ancestor
102179407|NCT01369199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102179408|NCT02097173|Methotrexate|methotrexate|mesh-list
102179409|NCT02097173|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102179410|NCT02097173|Abortifacient Agents|abortifacient agents|mesh-ancestor
102179411|NCT02097173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102179412|NCT02097173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179413|NCT02097173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102179414|NCT02097173|Antimetabolites|antimetabolites|mesh-ancestor
102179415|NCT02097173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179416|NCT02097173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102179417|NCT02097173|Dermatologic Agents|dermatologic agents|mesh-ancestor
102179418|NCT02097173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102179419|NCT02097173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102179420|NCT02097173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102179421|NCT02097173|Immunologic Factors|immunologic factors|mesh-ancestor
102179422|NCT02097173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102179423|NCT02097173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102179424|NCT02097329|Palbociclib|palbociclib|mesh-list
102179425|NCT02097329|Rabeprazole|rabeprazole|mesh-list
102179426|NCT02097329|Famotidine|famotidine|mesh-list
102179427|NCT02097329|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
102179428|NCT02097329|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
102179429|NCT02097329|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102179430|NCT02097329|Magnesium Hydroxide|magnesium hydroxide|mesh-list
102179431|NCT02097329|Antacids|antacids|mesh-list
102179432|NCT02097329|TEMPO|tempo|mesh-list
102179433|NCT02097329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102179434|NCT02097329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102179435|NCT02097329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102179436|NCT02097329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179437|NCT02097329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102179438|NCT02097329|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102179439|NCT02097329|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102179440|NCT02097329|Histamine Antagonists|histamine antagonists|mesh-ancestor
102179441|NCT02097329|Histamine Agents|histamine agents|mesh-ancestor
102179442|NCT02097329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102179443|NCT02097329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179444|NCT02097329|Antioxidants|antioxidants|mesh-ancestor
102179445|NCT02097329|Protective Agents|protective agents|mesh-ancestor
102179446|NCT02097329|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102179447|NCT02097329|Immunologic Factors|immunologic factors|mesh-ancestor
102179448|NCT02093585|Tenofovir|tenofovir|mesh-list
102179449|NCT02093585|Abacavir|abacavir|mesh-list
102179450|NCT02093585|Antiviral Agents|antiviral agents|mesh-ancestor
102179451|NCT02093585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102179452|NCT02093585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102179453|NCT02093585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102179454|NCT02093585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102179455|NCT02093585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179456|NCT02093585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102179457|NCT02093585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102179458|NCT02099357|Vitamin D|vitamin d|mesh-list
102179459|NCT02099357|Vitamins|vitamins|mesh-ancestor
102179460|NCT02099357|Micronutrients|micronutrients|mesh-ancestor
102179461|NCT02099357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179462|NCT02099357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102179463|NCT02093741|Factor VIII|factor viii|mesh-list
102179464|NCT02093741|Coagulants|coagulants|mesh-ancestor
102179465|NCT02097407|Dexmedetomidine|dexmedetomidine|mesh-list
102179466|NCT02097407|Propofol|propofol|mesh-list
102179467|NCT02097407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102179468|NCT02097407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102179469|NCT02097407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179470|NCT02097407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102179471|NCT02097407|Analgesics|analgesics|mesh-ancestor
102179472|NCT02097407|Sensory System Agents|sensory system agents|mesh-ancestor
102179473|NCT02097407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102179474|NCT02097407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102179475|NCT02097407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102179477|NCT02097407|Adrenergic Agents|adrenergic agents|mesh-ancestor
102179478|NCT02097407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102179479|NCT02097407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179480|NCT02097407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102179481|NCT02097407|Anesthetics, General|anesthetics, general|mesh-ancestor
102179482|NCT02097407|Anesthetics|anesthetics|mesh-ancestor
102179484|NCT02250599|Bevacizumab|bevacizumab|mesh-list
102179485|NCT02250599|Carboplatin|carboplatin|mesh-list
102179486|NCT02250599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102179487|NCT02250599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102179488|NCT02250599|Tubulin Modulators|tubulin modulators|mesh-ancestor
102179489|NCT02250599|Antimitotic Agents|antimitotic agents|mesh-ancestor
102179490|NCT02250599|Mitosis Modulators|mitosis modulators|mesh-ancestor
102179491|NCT02250599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179492|NCT02250599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102179493|NCT02250599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102179494|NCT02250599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102179495|NCT02250599|Growth Substances|growth substances|mesh-ancestor
102179496|NCT02250599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179497|NCT02250599|Growth Inhibitors|growth inhibitors|mesh-ancestor
102179498|NCT02094053|Donepezil|donepezil|mesh-list
102179499|NCT02094053|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102179500|NCT02094053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102179501|NCT02094053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179502|NCT02094053|Cholinergic Agents|cholinergic agents|mesh-ancestor
102179503|NCT02094053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102179504|NCT02094053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179505|NCT02094053|Nootropic Agents|nootropic agents|mesh-ancestor
102179506|NCT03555929|Dexamethasone|dexamethasone|mesh-list
102179507|NCT03555929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102179508|NCT03555929|Antiemetics|antiemetics|mesh-ancestor
102179509|NCT03555929|Autonomic Agents|autonomic agents|mesh-ancestor
102179510|NCT03555929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102179511|NCT03555929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179512|NCT03555929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102179513|NCT03555929|Glucocorticoids|glucocorticoids|mesh-ancestor
102179514|NCT03555929|Hormones|hormones|mesh-ancestor
102179515|NCT03555929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102179516|NCT03555929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102179517|NCT03555929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102179518|NCT02099981|Pimagedine|pimagedine|mesh-list
102179519|NCT02099981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102179520|NCT02099981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179521|NCT02250209|Capecitabine|capecitabine|mesh-list
102179522|NCT02250209|Oxaliplatin|oxaliplatin|mesh-list
102179523|NCT02250209|Trastuzumab|trastuzumab|mesh-list
102179524|NCT02250209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102179525|NCT02250209|Antimetabolites|antimetabolites|mesh-ancestor
102179526|NCT02250209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179527|NCT02250209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102179528|NCT02250209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102179529|NCT02097953|Rifampin|rifampin|mesh-list
102179530|NCT02097953|Daptomycin|daptomycin|mesh-list
102179531|NCT02097953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102179532|NCT02097953|Antitubercular Agents|antitubercular agents|mesh-ancestor
102179533|NCT02097953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102179534|NCT02097953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102179535|NCT02097953|Leprostatic Agents|leprostatic agents|mesh-ancestor
102179536|NCT02097953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102179537|NCT02097953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102179538|NCT02097953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179539|NCT02097953|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102179540|NCT02097953|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102179541|NCT02097953|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102179542|NCT02097953|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102179543|NCT02097953|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102179544|NCT02097953|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102179545|NCT02094287|Dimethindene|dimethindene|mesh-list
102179546|NCT02094287|Antipruritics|antipruritics|mesh-ancestor
102179547|NCT02094287|Dermatologic Agents|dermatologic agents|mesh-ancestor
102179548|NCT02094287|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102179549|NCT02094287|Histamine Antagonists|histamine antagonists|mesh-ancestor
102179550|NCT02094287|Histamine Agents|histamine agents|mesh-ancestor
102179551|NCT02094287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102179552|NCT02094287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179553|NCT02094287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448088|NCT00184886|Antimetabolites|antimetabolites|mesh-ancestor
102179554|NCT02094287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102179555|NCT02100293|Magnesium Sulfate|magnesium sulfate|mesh-list
102179556|NCT02100293|Analgesics|analgesics|mesh-ancestor
102179557|NCT02100293|Sensory System Agents|sensory system agents|mesh-ancestor
102179558|NCT02100293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102179559|NCT02100293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179560|NCT02100293|Anesthetics|anesthetics|mesh-ancestor
102179561|NCT02100293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102179562|NCT02100293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102179563|NCT02100293|Anticonvulsants|anticonvulsants|mesh-ancestor
102179564|NCT02100293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102179565|NCT02100293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102179566|NCT02100293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179567|NCT02100293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102179568|NCT02100293|Tocolytic Agents|tocolytic agents|mesh-ancestor
102179569|NCT02100293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102179571|NCT02094599|Hallucinogens|hallucinogens|mesh-ancestor
102179572|NCT02094599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179573|NCT02094599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102179574|NCT02094599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102179575|NCT02094599|Analgesics|analgesics|mesh-ancestor
102179576|NCT02094599|Sensory System Agents|sensory system agents|mesh-ancestor
102179577|NCT02094599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102179578|NCT02094599|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102179579|NCT02094599|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102179580|NCT02094599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102179581|NCT02094599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179582|NCT02094599|Hormones|hormones|mesh-ancestor
102179583|NCT02094599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102179584|NCT02094833|Vaccines|vaccines|mesh-list
102179585|NCT02094833|Immunologic Factors|immunologic factors|mesh-ancestor
102179586|NCT02094833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179587|NCT02100605|Nasal Decongestants|nasal decongestants|mesh-list
102179588|NCT02100605|Pseudoephedrine|pseudoephedrine|mesh-list
102179589|NCT02100605|Ephedrine|ephedrine|mesh-list
102179590|NCT02100605|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102179591|NCT02100605|Respiratory System Agents|respiratory system agents|mesh-ancestor
102179592|NCT02100605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102179593|NCT02100605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179594|NCT02100605|Sympathomimetics|sympathomimetics|mesh-ancestor
102179595|NCT02100605|Autonomic Agents|autonomic agents|mesh-ancestor
102179596|NCT02100605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102179597|NCT02100605|Adrenergic Agents|adrenergic agents|mesh-ancestor
102179598|NCT02100605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102179599|NCT02100605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179600|NCT02100605|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102179601|NCT02100605|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102179602|NCT02100761|Voriconazole|voriconazole|mesh-list
102179603|NCT02100761|Antifungal Agents|antifungal agents|mesh-ancestor
102179604|NCT02100761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102179605|NCT02100761|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102179606|NCT02100761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102179607|NCT02100761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102179608|NCT02100761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179609|NCT02100761|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102179610|NCT02100761|Hormone Antagonists|hormone antagonists|mesh-ancestor
102179611|NCT02100761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102179612|NCT02100761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179613|NCT02100761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102179614|NCT02100917|Trastuzumab|trastuzumab|mesh-list
102179615|NCT02100917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102179616|NCT02100917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102179617|NCT02098421|Oxytocin|oxytocin|mesh-list
102179618|NCT02098421|Oxytocics|oxytocics|mesh-ancestor
102179619|NCT02098421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102179620|NCT02098421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179621|NCT02098499|Diphenhydramine|diphenhydramine|mesh-list
102179622|NCT02098499|Promethazine|promethazine|mesh-list
102179623|NCT02098499|Haloperidol|haloperidol|mesh-list
102179624|NCT02098499|Metoclopramide|metoclopramide|mesh-list
102179625|NCT02098499|Haloperidol decanoate|haloperidol decanoate|mesh-list
102179626|NCT02098499|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102179627|NCT02098499|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102179628|NCT02098499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101888496|NCT02037048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102179629|NCT02098499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179630|NCT02098499|Anesthetics, Local|anesthetics, local|mesh-ancestor
102179631|NCT02098499|Anesthetics|anesthetics|mesh-ancestor
102179632|NCT02098499|Sensory System Agents|sensory system agents|mesh-ancestor
102179633|NCT02098499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102179634|NCT02098499|Antiemetics|antiemetics|mesh-ancestor
102179635|NCT02098499|Autonomic Agents|autonomic agents|mesh-ancestor
102179636|NCT02098499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102179637|NCT02098499|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102179638|NCT02098499|Histamine Antagonists|histamine antagonists|mesh-ancestor
102179639|NCT02098499|Histamine Agents|histamine agents|mesh-ancestor
102179640|NCT02098499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102179641|NCT02098499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179642|NCT02098499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102179643|NCT02098499|Antipruritics|antipruritics|mesh-ancestor
102179644|NCT02098499|Dermatologic Agents|dermatologic agents|mesh-ancestor
102179645|NCT02098499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102179646|NCT02098499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102179647|NCT02098499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102179648|NCT02098499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102179649|NCT02098499|Dopamine Agents|dopamine agents|mesh-ancestor
102179650|NCT02098499|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102179651|NCT02098499|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102179652|NCT02097017|Lidocaine|lidocaine|mesh-list
102179653|NCT02097017|Anesthetics, Local|anesthetics, local|mesh-ancestor
102179654|NCT02097017|Anesthetics|anesthetics|mesh-ancestor
102179655|NCT02097017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102179656|NCT02097017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179657|NCT02097017|Sensory System Agents|sensory system agents|mesh-ancestor
102179658|NCT02097017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102179659|NCT02097017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102179660|NCT02097017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102179661|NCT02097017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102179662|NCT02097017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102179663|NCT02097017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179664|NCT03555383|Hemostatics|hemostatics|mesh-list
102179665|NCT03555383|Coagulants|coagulants|mesh-ancestor
102179666|NCT02101151|Vitamin D|vitamin d|mesh-list
102179667|NCT02101151|Cholecalciferol|cholecalciferol|mesh-list
102179668|NCT02101151|Vitamins|vitamins|mesh-ancestor
102179669|NCT02101151|Micronutrients|micronutrients|mesh-ancestor
102179670|NCT02101151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179671|NCT02101151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102179672|NCT02101151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102179673|NCT02101229|Insulin|insulin|mesh-list
102179674|NCT02101229|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102179675|NCT02101229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102179676|NCT02101229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179677|NCT02102555|Acetaminophen|acetaminophen|mesh-list
102179678|NCT02102555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102179679|NCT02102555|Analgesics|analgesics|mesh-ancestor
102179680|NCT02102555|Sensory System Agents|sensory system agents|mesh-ancestor
102179681|NCT02102555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102179682|NCT02102555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179683|NCT02102555|Antipyretics|antipyretics|mesh-ancestor
102179684|NCT02102633|Dabigatran|dabigatran|mesh-list
102179685|NCT02102633|Antithrombins|antithrombins|mesh-ancestor
102179686|NCT02102633|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102179687|NCT02102633|Protease Inhibitors|protease inhibitors|mesh-ancestor
102179688|NCT02102633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102179689|NCT02102633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179690|NCT02102633|Anticoagulants|anticoagulants|mesh-ancestor
102179691|NCT02102711|Vitamin A|vitamin a|mesh-list
102179692|NCT02102711|Vitamins|vitamins|mesh-ancestor
102179693|NCT02102711|Micronutrients|micronutrients|mesh-ancestor
102179694|NCT02102711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179695|NCT02106767|Rifampin|rifampin|mesh-list
102179696|NCT02106767|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102179697|NCT02106767|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102179698|NCT02106767|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102179699|NCT02106767|Antimetabolites|antimetabolites|mesh-ancestor
101448091|NCT00184886|Dermatologic Agents|dermatologic agents|mesh-ancestor
102179700|NCT02106767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179701|NCT02106767|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102179702|NCT02106767|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102179703|NCT02106767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102179704|NCT02106767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102179705|NCT02106767|Antitubercular Agents|antitubercular agents|mesh-ancestor
102179706|NCT02106767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102179707|NCT02106767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102179708|NCT02106767|Leprostatic Agents|leprostatic agents|mesh-ancestor
102179709|NCT02106767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102179710|NCT02106767|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102179711|NCT02106767|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102179712|NCT02106767|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102179713|NCT02106767|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102179714|NCT02106767|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102179715|NCT02106767|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102179716|NCT02103023|Imiquimod|imiquimod|mesh-list
102179717|NCT02103023|Vaccines|vaccines|mesh-list
102179718|NCT02103023|Immunologic Factors|immunologic factors|mesh-ancestor
102179719|NCT02103023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179720|NCT02103023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102179721|NCT02103023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102179722|NCT02103023|Interferon Inducers|interferon inducers|mesh-ancestor
102179723|NCT02101931|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102179724|NCT02101931|Levulinic acid|levulinic acid|mesh-list
102179725|NCT02101931|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102179726|NCT02101931|Dermatologic Agents|dermatologic agents|mesh-ancestor
102179727|NCT02101931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102179728|NCT02101931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179729|NCT02106845|Digoxin|digoxin|mesh-list
102179730|NCT02106845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102179731|NCT02106845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102179732|NCT02106845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102179733|NCT02106845|Antimetabolites|antimetabolites|mesh-ancestor
102179734|NCT02106845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179735|NCT02106845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102179736|NCT02106845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102179737|NCT02106845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102179738|NCT02106845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102179739|NCT02106845|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102179740|NCT02106845|Protective Agents|protective agents|mesh-ancestor
102179741|NCT02106845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179742|NCT03554447|Pentoxifylline|pentoxifylline|mesh-list
102179743|NCT03554447|Dexetimide|dexetimide|mesh-list
102179744|NCT03554447|Citalopram|citalopram|mesh-list
102179745|NCT03554447|Escitalopram|escitalopram|mesh-list
102179746|NCT03554447|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102179747|NCT03554447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102179748|NCT03554447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102179749|NCT03554447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179750|NCT03554447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102179751|NCT03554447|Serotonin Agents|serotonin agents|mesh-ancestor
102179752|NCT03554447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179753|NCT03554447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102179754|NCT03554447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102179755|NCT03554447|Parasympatholytics|parasympatholytics|mesh-ancestor
102179756|NCT03554447|Autonomic Agents|autonomic agents|mesh-ancestor
102179757|NCT03554447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102179758|NCT03554447|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102179759|NCT03554447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102179760|NCT03554447|Cholinergic Agents|cholinergic agents|mesh-ancestor
102179761|NCT03554447|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102179762|NCT03554447|Antidepressive Agents|antidepressive agents|mesh-ancestor
102179763|NCT03554447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102179764|NCT03554447|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102179765|NCT03554447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102179766|NCT03554447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102179767|NCT03554447|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102179768|NCT03554447|Protective Agents|protective agents|mesh-ancestor
102179769|NCT03554447|Vasodilator Agents|vasodilator agents|mesh-ancestor
102179770|NCT03554447|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102179771|NCT03554447|Antioxidants|antioxidants|mesh-ancestor
102179772|NCT02103335|Dexamethasone|dexamethasone|mesh-list
102179773|NCT02103335|Pomalidomide|pomalidomide|mesh-list
102179774|NCT02103335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102179775|NCT02103335|Antiemetics|antiemetics|mesh-ancestor
102179776|NCT02103335|Autonomic Agents|autonomic agents|mesh-ancestor
102179777|NCT02103335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102179778|NCT02103335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179779|NCT02103335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102179780|NCT02103335|Glucocorticoids|glucocorticoids|mesh-ancestor
102179782|NCT02103335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102179783|NCT02103335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102179784|NCT02103335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102179785|NCT02103335|Immunologic Factors|immunologic factors|mesh-ancestor
102179786|NCT02103335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102179787|NCT02103335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102179788|NCT02103335|Growth Substances|growth substances|mesh-ancestor
102179789|NCT02103335|Growth Inhibitors|growth inhibitors|mesh-ancestor
102179790|NCT02610140|Vinorelbine|vinorelbine|mesh-list
102179791|NCT02610140|Maytansine|maytansine|mesh-list
102179792|NCT02610140|Anetumab ravtansine|anetumab ravtansine|mesh-list
102179793|NCT02610140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102179794|NCT02610140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102179795|NCT02610140|Tubulin Modulators|tubulin modulators|mesh-ancestor
102179796|NCT02610140|Antimitotic Agents|antimitotic agents|mesh-ancestor
102179797|NCT02610140|Mitosis Modulators|mitosis modulators|mesh-ancestor
102179798|NCT02610140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179799|NCT02610140|Immunoconjugates|immunoconjugates|mesh-ancestor
102179800|NCT02610140|Immunologic Factors|immunologic factors|mesh-ancestor
102179801|NCT02610140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179802|NCT02102321|Albendazole|albendazole|mesh-list
102179803|NCT02102321|Anthelmintics|anthelmintics|mesh-ancestor
102179804|NCT02102321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102179805|NCT02102321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102179806|NCT02102321|Anticestodal Agents|anticestodal agents|mesh-ancestor
102179807|NCT02102321|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102179808|NCT02102321|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102179809|NCT02102321|Tubulin Modulators|tubulin modulators|mesh-ancestor
102179810|NCT02102321|Antimitotic Agents|antimitotic agents|mesh-ancestor
102179811|NCT02102321|Mitosis Modulators|mitosis modulators|mesh-ancestor
102179812|NCT02102321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179813|NCT02102321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102179814|NCT02103569|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102179815|NCT02103569|Norethindrone|norethindrone|mesh-list
102179816|NCT02103569|Norethindrone Acetate|norethindrone acetate|mesh-list
102179817|NCT02103569|Estradiol|estradiol|mesh-list
102179818|NCT02103569|Asunaprevir|asunaprevir|mesh-list
102179819|NCT02103569|Estrogens|estrogens|mesh-ancestor
102179820|NCT02103569|Hormones|hormones|mesh-ancestor
102179821|NCT02103569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102179822|NCT02103569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179823|NCT02103569|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102179824|NCT02103569|Contraceptive Agents|contraceptive agents|mesh-ancestor
102179825|NCT02103569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102179826|NCT02103569|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102179827|NCT02103569|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102179828|NCT02103569|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102179829|NCT02103569|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102179830|NCT02103569|Protease Inhibitors|protease inhibitors|mesh-ancestor
102179831|NCT02103569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102179832|NCT02103569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179833|NCT02103647|Pregabalin|pregabalin|mesh-list
102179834|NCT02103647|Analgesics|analgesics|mesh-ancestor
102179835|NCT02103647|Sensory System Agents|sensory system agents|mesh-ancestor
102179836|NCT02103647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102179837|NCT02103647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179838|NCT02103647|Anticonvulsants|anticonvulsants|mesh-ancestor
102179839|NCT02103647|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102179840|NCT02103647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102179841|NCT02103647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179842|NCT02103647|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102179843|NCT02103647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102179844|NCT02103647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102179845|NCT02103647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102179846|NCT02103647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102179847|NCT02109965|Midazolam|midazolam|mesh-list
102179848|NCT02109965|Dexmedetomidine|dexmedetomidine|mesh-list
102179849|NCT02109965|Propofol|propofol|mesh-list
102179850|NCT02109965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102179851|NCT02109965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102179852|NCT02109965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179853|NCT02109965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102179854|NCT02109965|Analgesics|analgesics|mesh-ancestor
102179855|NCT02109965|Sensory System Agents|sensory system agents|mesh-ancestor
102179856|NCT02109965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102179857|NCT02109965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102179858|NCT02109965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102179859|NCT02109965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102179860|NCT02109965|Adrenergic Agents|adrenergic agents|mesh-ancestor
102179861|NCT02109965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102179862|NCT02109965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179863|NCT02109965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102179864|NCT02109965|Anesthetics, General|anesthetics, general|mesh-ancestor
102179865|NCT02109965|Anesthetics|anesthetics|mesh-ancestor
102179866|NCT02109965|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102179867|NCT02109965|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102179868|NCT02109965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102179869|NCT02109965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102179870|NCT02109965|GABA Modulators|gaba modulators|mesh-ancestor
102179871|NCT02109965|GABA Agents|gaba agents|mesh-ancestor
102179872|NCT02789657|Paclitaxel|paclitaxel|mesh-list
102179873|NCT02789657|Carboplatin|carboplatin|mesh-list
102179874|NCT02789657|Trastuzumab|trastuzumab|mesh-list
102179875|NCT02789657|Pertuzumab|pertuzumab|mesh-list
102179876|NCT02789657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102179877|NCT02789657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102179878|NCT02789657|Tubulin Modulators|tubulin modulators|mesh-ancestor
102179879|NCT02789657|Antimitotic Agents|antimitotic agents|mesh-ancestor
102179880|NCT02789657|Mitosis Modulators|mitosis modulators|mesh-ancestor
102179881|NCT02789657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179882|NCT02789657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102179883|NCT03555071|Vaccines|vaccines|mesh-list
102179884|NCT03555071|Immunologic Factors|immunologic factors|mesh-ancestor
102179885|NCT03555071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179886|NCT02609984|Atezolizumab|atezolizumab|mesh-list
102179887|NCT02609984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102179888|NCT02609984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179889|NCT02609984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102179890|NCT02609984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102179891|NCT02107079|Melatonin|melatonin|mesh-list
102179892|NCT02107079|Antioxidants|antioxidants|mesh-ancestor
102179893|NCT02107079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179894|NCT02107079|Protective Agents|protective agents|mesh-ancestor
102179895|NCT02107079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179896|NCT02107079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102179897|NCT02107235|ON 01910|on 01910|mesh-list
102179898|NCT02107235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102179899|NCT02107235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102179900|NCT02107235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102179901|NCT02107235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179902|NCT02103725|Pimecrolimus|pimecrolimus|mesh-list
102179903|NCT02103725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102179904|NCT02103725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102179905|NCT02103725|Analgesics|analgesics|mesh-ancestor
102179906|NCT02103725|Sensory System Agents|sensory system agents|mesh-ancestor
102179907|NCT02103725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102179908|NCT02103725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179909|NCT02103725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102179910|NCT02103725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102179911|NCT02103725|Dermatologic Agents|dermatologic agents|mesh-ancestor
102179912|NCT02103725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102179913|NCT02103725|Immunologic Factors|immunologic factors|mesh-ancestor
102179914|NCT02103725|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102179915|NCT02103725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102179916|NCT02103725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179917|NCT03042260|Trimethoprim|trimethoprim|mesh-list
102179918|NCT03042260|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102179919|NCT03042260|Sulfamethoxazole|sulfamethoxazole|mesh-list
102179920|NCT03042260|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102179921|NCT03042260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102179922|NCT03042260|Antimalarials|antimalarials|mesh-ancestor
102179923|NCT03042260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102179924|NCT03042260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102179925|NCT03042260|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102179926|NCT03042260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102179927|NCT03042260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179928|NCT03042260|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102179929|NCT03042260|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102179930|NCT03042260|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102179931|NCT03042260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102179932|NCT02110355|Trametinib|trametinib|mesh-list
102179933|NCT02110355|Dabrafenib|dabrafenib|mesh-list
102179934|NCT02110355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102179935|NCT02110355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102179936|NCT02110355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102179937|NCT02110355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179938|NCT02107391|Leuprolide|leuprolide|mesh-list
102179939|NCT02107391|Goserelin|goserelin|mesh-list
102179940|NCT02107391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102179941|NCT02107391|Fertility Agents|fertility agents|mesh-ancestor
102179942|NCT02107391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102179943|NCT02107391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179944|NCT02107391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102179945|NCT02107391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102179946|NCT02103881|Ketamine|ketamine|mesh-list
102179947|NCT02103881|Haloperidol|haloperidol|mesh-list
102179948|NCT02103881|Haloperidol decanoate|haloperidol decanoate|mesh-list
102179949|NCT02103881|Analgesics|analgesics|mesh-ancestor
102179950|NCT02103881|Sensory System Agents|sensory system agents|mesh-ancestor
102179951|NCT02103881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102179952|NCT02103881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179953|NCT02103881|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102179954|NCT02103881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102179955|NCT02103881|Anesthetics, General|anesthetics, general|mesh-ancestor
102179956|NCT02103881|Anesthetics|anesthetics|mesh-ancestor
102179957|NCT02103881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102179958|NCT02103881|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102179959|NCT02103881|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102179960|NCT02103881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102179961|NCT02103881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179962|NCT02103881|Antiemetics|antiemetics|mesh-ancestor
102179963|NCT02103881|Autonomic Agents|autonomic agents|mesh-ancestor
102179964|NCT02103881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102179965|NCT02103881|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102179966|NCT02103881|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102179967|NCT02103881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102179968|NCT02103881|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102179969|NCT02103881|Dopamine Agents|dopamine agents|mesh-ancestor
102179970|NCT02103881|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102179971|NCT03554915|Midazolam|midazolam|mesh-list
102179972|NCT03554915|Ketamine|ketamine|mesh-list
102179973|NCT03554915|Analgesics|analgesics|mesh-ancestor
102179974|NCT03554915|Sensory System Agents|sensory system agents|mesh-ancestor
102179975|NCT03554915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102179976|NCT03554915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179977|NCT03554915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101448112|NCT00185003|Tolbutamide|tolbutamide|mesh-list
102179978|NCT03554915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102179979|NCT03554915|Anesthetics, General|anesthetics, general|mesh-ancestor
102179980|NCT03554915|Anesthetics|anesthetics|mesh-ancestor
102179981|NCT03554915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102179982|NCT03554915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102179983|NCT03554915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102179984|NCT03554915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102179985|NCT03554915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102179986|NCT03554915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102179987|NCT03554915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102179988|NCT03554915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102179989|NCT03554915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102179990|NCT03554915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102179991|NCT03554915|GABA Modulators|gaba modulators|mesh-ancestor
102179992|NCT03554915|GABA Agents|gaba agents|mesh-ancestor
102179993|NCT03044522|Analgesics, Opioid|analgesics, opioid|mesh-list
102179994|NCT03044522|Narcotics|narcotics|mesh-ancestor
102179995|NCT03044522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102179996|NCT03044522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102179997|NCT03044522|Analgesics|analgesics|mesh-ancestor
102179998|NCT03044522|Sensory System Agents|sensory system agents|mesh-ancestor
102179999|NCT03044522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102180000|NCT03044366|Anesthetics|anesthetics|mesh-list
102180001|NCT03044366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102180002|NCT03044366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180003|NCT02250833|Amlodipine|amlodipine|mesh-list
102180004|NCT02250833|Telmisartan|telmisartan|mesh-list
102180005|NCT02250833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101888876|NCT00059930|Vitamins|vitamins|mesh-ancestor
102180007|NCT02250833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102180008|NCT02250833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180009|NCT02250833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102180010|NCT02250833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180011|NCT02250833|Vasodilator Agents|vasodilator agents|mesh-ancestor
102180012|NCT02250833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102180013|NCT02250833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102180014|NCT02110745|Propofol|propofol|mesh-list
102180015|NCT02110745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102180016|NCT02110745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102180017|NCT02110745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180018|NCT02110745|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102180019|NCT02110745|Anesthetics, General|anesthetics, general|mesh-ancestor
102180020|NCT02110745|Anesthetics|anesthetics|mesh-ancestor
102180021|NCT04857320|Insulin|insulin|mesh-list
102180022|NCT04857320|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102180023|NCT04857320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102180024|NCT04857320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180025|NCT03041948|Acetaminophen|acetaminophen|mesh-list
102180026|NCT03041948|Dexamethasone|dexamethasone|mesh-list
102180027|NCT03041948|Ketorolac|ketorolac|mesh-list
102180028|NCT03041948|Morphine|morphine|mesh-list
102180029|NCT03041948|Remifentanil|remifentanil|mesh-list
102180030|NCT03041948|Ondansetron|ondansetron|mesh-list
102180031|NCT03041948|Propofol|propofol|mesh-list
102180032|NCT03041948|Sevoflurane|sevoflurane|mesh-list
102180033|NCT03041948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102180034|NCT03041948|Antiemetics|antiemetics|mesh-ancestor
102180035|NCT03041948|Autonomic Agents|autonomic agents|mesh-ancestor
102180036|NCT03041948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102180037|NCT03041948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180038|NCT03041948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102180039|NCT03041948|Glucocorticoids|glucocorticoids|mesh-ancestor
102180040|NCT03041948|Hormones|hormones|mesh-ancestor
102180041|NCT03041948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102180042|NCT03041948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102180043|NCT03041948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102180044|NCT03041948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101448118|NCT00185120|Amlodipine|amlodipine|mesh-list
102180045|NCT03041948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102180046|NCT03041948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102180047|NCT03041948|Anesthetics, General|anesthetics, general|mesh-ancestor
102180048|NCT03041948|Anesthetics|anesthetics|mesh-ancestor
102180049|NCT03041948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102180050|NCT03041948|Narcotics|narcotics|mesh-ancestor
102180051|NCT03041948|Analgesics|analgesics|mesh-ancestor
102180052|NCT03041948|Sensory System Agents|sensory system agents|mesh-ancestor
102180053|NCT03041948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102180054|NCT03041948|Antipyretics|antipyretics|mesh-ancestor
102180055|NCT03041948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102180056|NCT03041948|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102180057|NCT03041948|Antipruritics|antipruritics|mesh-ancestor
102180058|NCT03041948|Dermatologic Agents|dermatologic agents|mesh-ancestor
102180059|NCT03041948|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102180060|NCT03041948|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102180061|NCT03041948|Serotonin Agents|serotonin agents|mesh-ancestor
102180062|NCT03041948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102180063|NCT03041948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180064|NCT03041948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102180065|NCT03041948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102180066|NCT03041948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102180067|NCT03041948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102180068|NCT02104193|Simvastatin|simvastatin|mesh-list
102180069|NCT02104193|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102180070|NCT02104193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102180071|NCT02104193|Antimetabolites|antimetabolites|mesh-ancestor
102180072|NCT02104193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180073|NCT02104193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102180074|NCT02104193|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102180075|NCT02104193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102180076|NCT03042182|Vaccines|vaccines|mesh-list
102180077|NCT03042182|Immunologic Factors|immunologic factors|mesh-ancestor
102180078|NCT03042182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180079|NCT02104661|Oxcarbazepine|oxcarbazepine|mesh-list
102180080|NCT02104661|Anticonvulsants|anticonvulsants|mesh-ancestor
101888968|NCT00003910|Prednisone|prednisone|mesh-list
102180081|NCT02104661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102180082|NCT02104661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102180083|NCT02104661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102180084|NCT02104661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180085|NCT02104661|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102180086|NCT02104661|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102180088|NCT02611778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102180089|NCT02611778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102180090|NCT02611778|Growth Substances|growth substances|mesh-ancestor
102180091|NCT02611778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180092|NCT02611778|Growth Inhibitors|growth inhibitors|mesh-ancestor
102180093|NCT02611778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102180094|NCT04867226|Colchicine|colchicine|mesh-list
102180095|NCT04867226|Gout Suppressants|gout suppressants|mesh-ancestor
102180096|NCT04867226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102180097|NCT04867226|Tubulin Modulators|tubulin modulators|mesh-ancestor
102180098|NCT04867226|Antimitotic Agents|antimitotic agents|mesh-ancestor
102180099|NCT04867226|Mitosis Modulators|mitosis modulators|mesh-ancestor
102180100|NCT04867226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180101|NCT04867226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102180102|NCT04856852|Iodine|iodine|mesh-list
102180103|NCT04856852|Temozolomide|temozolomide|mesh-list
102180104|NCT04856852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102180105|NCT04856852|Alkylating Agents|alkylating agents|mesh-ancestor
102180106|NCT04856852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180107|NCT04856852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102180108|NCT04856852|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102180109|NCT04856852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102180110|NCT04856852|Trace Elements|trace elements|mesh-ancestor
102180111|NCT04856852|Micronutrients|micronutrients|mesh-ancestor
102180112|NCT04856852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180113|NCT02711553|Gemcitabine|gemcitabine|mesh-list
102180114|NCT02711553|Ramucirumab|ramucirumab|mesh-list
102180115|NCT02711553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102180116|NCT02711553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102180117|NCT02711553|Antimetabolites|antimetabolites|mesh-ancestor
102180118|NCT02711553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180119|NCT01453179|Diclofenac|diclofenac|mesh-list
102180120|NCT01453179|Imiquimod|imiquimod|mesh-list
102180121|NCT01453179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102180122|NCT01453179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102180123|NCT01453179|Analgesics|analgesics|mesh-ancestor
102180124|NCT01453179|Sensory System Agents|sensory system agents|mesh-ancestor
102180125|NCT01453179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102180126|NCT01453179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180127|NCT01453179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102180128|NCT01453179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102180129|NCT01453179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102180130|NCT01453179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102180131|NCT01453179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180132|NCT01453179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102180133|NCT01453179|Immunologic Factors|immunologic factors|mesh-ancestor
102180134|NCT01453179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102180135|NCT01453179|Interferon Inducers|interferon inducers|mesh-ancestor
102180136|NCT03192033|Hemostatics|hemostatics|mesh-list
102180137|NCT03192033|Coagulants|coagulants|mesh-ancestor
102180138|NCT03188445|Ascorbic Acid|ascorbic acid|mesh-list
102180139|NCT03188445|Ferrous fumarate|ferrous fumarate|mesh-list
102180140|NCT03188445|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
102180141|NCT03188445|Antioxidants|antioxidants|mesh-ancestor
102180142|NCT03188445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180143|NCT03188445|Protective Agents|protective agents|mesh-ancestor
102180144|NCT03188445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180145|NCT03188445|Vitamins|vitamins|mesh-ancestor
102180146|NCT03188445|Micronutrients|micronutrients|mesh-ancestor
102180147|NCT03188445|Trace Elements|trace elements|mesh-ancestor
102180148|NCT03188445|Hematinics|hematinics|mesh-ancestor
102180149|NCT04483635|Vitamin D|vitamin d|mesh-list
102180150|NCT04483635|Cholecalciferol|cholecalciferol|mesh-list
102180151|NCT04483635|Vitamins|vitamins|mesh-ancestor
102180152|NCT04483635|Micronutrients|micronutrients|mesh-ancestor
102180153|NCT04483635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180154|NCT04483635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102180155|NCT04483635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102180156|NCT04865900|Antibodies|antibodies|mesh-list
102180158|NCT04865900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180159|NCT03191721|Triclosan|triclosan|mesh-list
102180160|NCT03191721|Anti-Infective Agents|anti-infective agents|mesh-list
102180161|NCT03191721|Fluorides|fluorides|mesh-list
102180162|NCT03191721|Cariostatic Agents|cariostatic agents|mesh-ancestor
102180163|NCT03191721|Protective Agents|protective agents|mesh-ancestor
102180164|NCT03191721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180165|NCT03191721|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102180166|NCT03191721|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102180167|NCT03191721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102180168|NCT03191721|Antimetabolites|antimetabolites|mesh-ancestor
102180169|NCT03191721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180170|NCT03191721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102180171|NCT04864496|Acetylcysteine|acetylcysteine|mesh-list
102180172|NCT04864496|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102180173|NCT04864496|Antiviral Agents|antiviral agents|mesh-ancestor
102180174|NCT04864496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102180175|NCT04864496|Expectorants|expectorants|mesh-ancestor
102180176|NCT04864496|Respiratory System Agents|respiratory system agents|mesh-ancestor
102180177|NCT04864496|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102180178|NCT04864496|Antioxidants|antioxidants|mesh-ancestor
102180179|NCT04864496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180180|NCT04864496|Protective Agents|protective agents|mesh-ancestor
102180181|NCT04864496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180182|NCT04864496|Antidotes|antidotes|mesh-ancestor
102180183|NCT03188289|Chitosan|chitosan|mesh-list
102180184|NCT03188289|Hyaluronic Acid|hyaluronic acid|mesh-list
102180185|NCT03188289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102180186|NCT03188289|Immunologic Factors|immunologic factors|mesh-ancestor
102180187|NCT03188289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180188|NCT03188289|Viscosupplements|viscosupplements|mesh-ancestor
102180190|NCT03188289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102180191|NCT03188289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102180192|NCT03188289|Antimetabolites|antimetabolites|mesh-ancestor
102180193|NCT03188289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180194|NCT03188289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102180195|NCT03188289|Chelating Agents|chelating agents|mesh-ancestor
102180196|NCT03188289|Sequestering Agents|sequestering agents|mesh-ancestor
102180197|NCT03188289|Hemostatics|hemostatics|mesh-ancestor
102180198|NCT03188289|Coagulants|coagulants|mesh-ancestor
102180199|NCT03044912|Mirabegron|mirabegron|mesh-list
102180200|NCT03044912|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102180201|NCT03044912|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102180202|NCT03044912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102180203|NCT03044912|Adrenergic Agents|adrenergic agents|mesh-ancestor
102180204|NCT03044912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102180205|NCT03044912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180206|NCT03044912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180207|NCT03044912|Urological Agents|urological agents|mesh-ancestor
102180208|NCT03041012|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102180209|NCT03041012|Romidepsin|romidepsin|mesh-list
102180210|NCT03041012|Antibodies, Blocking|antibodies, blocking|mesh-list
102180211|NCT03041012|Antiviral Agents|antiviral agents|mesh-ancestor
102180212|NCT03041012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102180213|NCT03041012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102180214|NCT03041012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102180215|NCT03041012|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102180216|NCT03041012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102180217|NCT03041012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180218|NCT03041012|Immunologic Factors|immunologic factors|mesh-ancestor
102180219|NCT03041012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180220|NCT03187899|Ropivacaine|ropivacaine|mesh-list
102180221|NCT03187899|Anesthetics, Local|anesthetics, local|mesh-ancestor
102180222|NCT03187899|Anesthetics|anesthetics|mesh-ancestor
102180223|NCT03187899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102180224|NCT03187899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180225|NCT03187899|Sensory System Agents|sensory system agents|mesh-ancestor
102180226|NCT03187899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102180227|NCT01648582|Metformin|metformin|mesh-list
102180228|NCT01648582|Insulin Glargine|insulin glargine|mesh-list
102180229|NCT01648582|Dulaglutide|dulaglutide|mesh-list
101889107|NCT04140513|Deoxyglucose|deoxyglucose|mesh-list
102180230|NCT01648582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102180231|NCT01648582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180232|NCT02440347|Anesthetics|anesthetics|mesh-list
102180233|NCT02440347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102180234|NCT02440347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180235|NCT03043820|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
102180236|NCT03043820|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102180237|NCT03043820|Hormone Antagonists|hormone antagonists|mesh-ancestor
102180238|NCT03043820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102180239|NCT03043820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180240|NCT03043820|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102180241|NCT03043820|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102180242|NCT03043820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102180243|NCT03191097|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
102180244|NCT03191097|Antiviral Agents|antiviral agents|mesh-ancestor
102180245|NCT03191097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102180246|NCT04854668|Bevacizumab|bevacizumab|mesh-list
102180247|NCT04854668|Capecitabine|capecitabine|mesh-list
102180248|NCT04854668|Oxaliplatin|oxaliplatin|mesh-list
102180249|NCT04854668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102180250|NCT04854668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102180251|NCT04854668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102180252|NCT04854668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102180253|NCT04854668|Growth Substances|growth substances|mesh-ancestor
102180254|NCT04854668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180255|NCT04854668|Growth Inhibitors|growth inhibitors|mesh-ancestor
102180256|NCT04854668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102180257|NCT04854668|Antimetabolites|antimetabolites|mesh-ancestor
102180258|NCT04854668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180260|NCT03189069|Rivaroxaban|rivaroxaban|mesh-list
102180261|NCT03189069|Dabigatran|dabigatran|mesh-list
102180262|NCT03189069|Apixaban|apixaban|mesh-list
102180263|NCT03189069|Anticoagulants|anticoagulants|mesh-ancestor
102180264|NCT03189069|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102180265|NCT03189069|Antithrombins|antithrombins|mesh-ancestor
102180266|NCT03189069|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102180267|NCT03189069|Protease Inhibitors|protease inhibitors|mesh-ancestor
102180268|NCT03189069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102180269|NCT03189069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180270|NCT03040934|Sirolimus|sirolimus|mesh-list
102180271|NCT03040934|Everolimus|everolimus|mesh-list
102180272|NCT03040934|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102180273|NCT03040934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102180274|NCT03040934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102180275|NCT03040934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180276|NCT03040934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102180277|NCT03040934|Immunologic Factors|immunologic factors|mesh-ancestor
102180278|NCT03040934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180279|NCT03040934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102180280|NCT03040934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102180281|NCT03040934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102180282|NCT03040934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102180283|NCT03040934|Antifungal Agents|antifungal agents|mesh-ancestor
102180284|NCT04861142|Denosumab|denosumab|mesh-list
102180285|NCT04861142|Alendronate|alendronate|mesh-list
102180286|NCT04861142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102180287|NCT04861142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180288|NCT03117855|Capecitabine|capecitabine|mesh-list
102180289|NCT03117855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102180290|NCT03117855|Antimetabolites|antimetabolites|mesh-ancestor
102180291|NCT03117855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180292|NCT03117855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102180293|NCT02607800|Sofosbuvir|sofosbuvir|mesh-list
102180294|NCT02607800|Velpatasvir|velpatasvir|mesh-list
102180295|NCT02607800|Antiviral Agents|antiviral agents|mesh-ancestor
102180296|NCT02607800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102180297|NCT02304484|Evolocumab|evolocumab|mesh-list
102180298|NCT02304484|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102180299|NCT02304484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102180300|NCT02304484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102180301|NCT02304484|Antimetabolites|antimetabolites|mesh-ancestor
102180302|NCT02304484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180303|NCT02304484|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102180304|NCT02304484|Protease Inhibitors|protease inhibitors|mesh-ancestor
102180305|NCT02304484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102180306|NCT02304484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101889181|NCT03914443|Cisplatin|cisplatin|mesh-list
102180307|NCT02434029|Budesonide|budesonide|mesh-list
102180309|NCT02434029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102180310|NCT02434029|Autonomic Agents|autonomic agents|mesh-ancestor
102180311|NCT02434029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102180312|NCT02434029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180313|NCT02434029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102180314|NCT02434029|Respiratory System Agents|respiratory system agents|mesh-ancestor
102180315|NCT02434029|Glucocorticoids|glucocorticoids|mesh-ancestor
102180316|NCT02434029|Hormones|hormones|mesh-ancestor
102180317|NCT02434029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102180318|NCT02708355|Esomeprazole|esomeprazole|mesh-list
102180319|NCT02708355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102180320|NCT02708355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102180321|NCT02708355|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102180322|NCT02708355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102180323|NCT02708355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180324|NCT04854044|TIC10 compound|tic10 compound|mesh-list
102180325|NCT04854044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102180326|NCT02708277|Contraceptive Agents|contraceptive agents|mesh-list
102180327|NCT02708277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102180328|NCT02708277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180329|NCT02337478|Vincristine|vincristine|mesh-list
102180330|NCT02337478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102180331|NCT02337478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102180332|NCT02337478|Tubulin Modulators|tubulin modulators|mesh-ancestor
102180333|NCT02337478|Antimitotic Agents|antimitotic agents|mesh-ancestor
102180334|NCT02337478|Mitosis Modulators|mitosis modulators|mesh-ancestor
101448139|NCT00218049|Dopamine Agents|dopamine agents|mesh-ancestor
102180335|NCT02337478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180336|NCT02434653|Chrysarobin|chrysarobin|mesh-list
102180337|NCT02434653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102180338|NCT02434653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102180339|NCT02434653|Analgesics|analgesics|mesh-ancestor
102180340|NCT02434653|Sensory System Agents|sensory system agents|mesh-ancestor
102180341|NCT02434653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102180342|NCT02434653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180343|NCT02434653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102180344|NCT02434653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102180345|NCT03043196|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102180346|NCT03043196|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102180347|NCT03043196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102180348|NCT03043196|Antimetabolites|antimetabolites|mesh-ancestor
102180349|NCT03043196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180350|NCT03043196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102180351|NCT03043196|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102180352|NCT03043196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102180353|NCT03188835|Glycerol|glycerol|mesh-list
102180354|NCT03188835|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102180355|NCT03188835|Protective Agents|protective agents|mesh-ancestor
102180356|NCT03188835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180357|NCT04847024|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
102180358|NCT04847024|Parecoxib|parecoxib|mesh-list
102180359|NCT04847024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102180360|NCT04847024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102180361|NCT04847024|Analgesics|analgesics|mesh-ancestor
102180362|NCT04847024|Sensory System Agents|sensory system agents|mesh-ancestor
102180363|NCT04847024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102180364|NCT04847024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180365|NCT04847024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102180366|NCT04847024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102180367|NCT04847024|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102180368|NCT04847024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102180369|NCT04847024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102180370|NCT04847024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180371|NCT04860674|Carboplatin|carboplatin|mesh-list
102180372|NCT04860674|Etoposide|etoposide|mesh-list
102180373|NCT04860674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102180374|NCT04860674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102180375|NCT04860674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102180376|NCT04860674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102180377|NCT04860674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102180378|NCT04860674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102180379|NCT04860674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889266|NCT03322631|Hormones|hormones|mesh-ancestor
102180380|NCT04860674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102180382|NCT04853342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102180383|NCT04853342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102180384|NCT04853342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180385|NCT04853030|Insulin Aspart|insulin aspart|mesh-list
102180386|NCT04853030|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102180387|NCT04853030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180388|NCT02430363|Pembrolizumab|pembrolizumab|mesh-list
102180389|NCT02430363|Ipatasertib|ipatasertib|mesh-list
102180390|NCT02430363|Dactolisib|dactolisib|mesh-list
102180391|NCT02430363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102180392|NCT02430363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102180393|NCT02430363|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102180394|NCT02430363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180395|NCT02430363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102180396|NCT02430363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102180397|NCT02429973|Sirolimus|sirolimus|mesh-list
102180398|NCT02429973|Gemcitabine|gemcitabine|mesh-list
102180399|NCT02429973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102180400|NCT02429973|Antimetabolites|antimetabolites|mesh-ancestor
102180401|NCT02429973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180402|NCT02429973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102180403|NCT02429973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102180404|NCT02429973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102180405|NCT02429973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102180406|NCT02429973|Antifungal Agents|antifungal agents|mesh-ancestor
102180407|NCT02429973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102180408|NCT02429973|Immunologic Factors|immunologic factors|mesh-ancestor
102180409|NCT02429973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180410|NCT04860284|Hydroxychloroquine|hydroxychloroquine|mesh-list
102180411|NCT04860284|Antimalarials|antimalarials|mesh-ancestor
102180412|NCT04860284|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102180413|NCT04860284|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102180414|NCT04860284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102180415|NCT04860284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102180416|NCT04860284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180417|NCT04860284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102180418|NCT04846634|Paclitaxel|paclitaxel|mesh-list
102180419|NCT04846634|Docetaxel|docetaxel|mesh-list
102180420|NCT04846634|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102180421|NCT04846634|Cisplatin|cisplatin|mesh-list
102180422|NCT04846634|Carboplatin|carboplatin|mesh-list
102180423|NCT04846634|Gemcitabine|gemcitabine|mesh-list
102180424|NCT04846634|Pemetrexed|pemetrexed|mesh-list
102180425|NCT04846634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102180426|NCT04846634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102180427|NCT04846634|Tubulin Modulators|tubulin modulators|mesh-ancestor
102180428|NCT04846634|Antimitotic Agents|antimitotic agents|mesh-ancestor
102180429|NCT04846634|Mitosis Modulators|mitosis modulators|mesh-ancestor
102180430|NCT04846634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180431|NCT04846634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102180432|NCT04846634|Antimetabolites|antimetabolites|mesh-ancestor
102180433|NCT04846634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102180434|NCT04846634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102180435|NCT04846634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102180436|NCT02433717|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102180437|NCT02433717|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102180438|NCT02433717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102180439|NCT02433717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102180440|NCT02433717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180441|NCT02433717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102180442|NCT02433717|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102180443|NCT02433717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102180444|NCT02433717|Serotonin Agents|serotonin agents|mesh-ancestor
102180445|NCT02433717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102180446|NCT02433717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180447|NCT02433717|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102180448|NCT02433717|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102180449|NCT02433717|Dopamine Agents|dopamine agents|mesh-ancestor
102180450|NCT02429817|Edetic Acid|edetic acid|mesh-list
102180451|NCT02429817|Pentetic Acid|pentetic acid|mesh-list
102180452|NCT02429817|Antidotes|antidotes|mesh-ancestor
102180453|NCT02429817|Protective Agents|protective agents|mesh-ancestor
102180454|NCT02429817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180455|NCT02429817|Chelating Agents|chelating agents|mesh-ancestor
102180456|NCT02429817|Sequestering Agents|sequestering agents|mesh-ancestor
102180457|NCT02429817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180458|NCT02429817|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102180459|NCT02429817|Anticoagulants|anticoagulants|mesh-ancestor
102180460|NCT02429817|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102180461|NCT04851860|Immunomodulating Agents|immunomodulating agents|mesh-list
102180462|NCT04851860|Immunologic Factors|immunologic factors|mesh-ancestor
102180463|NCT04851860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180464|NCT04851548|Hyaluronic Acid|hyaluronic acid|mesh-list
102180465|NCT04851548|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102180466|NCT04851548|Immunologic Factors|immunologic factors|mesh-ancestor
102180467|NCT04851548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180468|NCT04851548|Viscosupplements|viscosupplements|mesh-ancestor
102180469|NCT04851548|Protective Agents|protective agents|mesh-ancestor
102180470|NCT02706951|Methotrexate|methotrexate|mesh-list
102180471|NCT02706951|Upadacitinib|upadacitinib|mesh-list
102180472|NCT02706951|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102180473|NCT02706951|Abortifacient Agents|abortifacient agents|mesh-ancestor
102180474|NCT02706951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102180475|NCT02706951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180476|NCT02706951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102180477|NCT02706951|Antimetabolites|antimetabolites|mesh-ancestor
102180478|NCT02706951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180479|NCT02706951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102180480|NCT02706951|Dermatologic Agents|dermatologic agents|mesh-ancestor
102180481|NCT02706951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102180482|NCT02706951|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102180483|NCT02706951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102180484|NCT02706951|Immunologic Factors|immunologic factors|mesh-ancestor
102180485|NCT02706951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102180486|NCT02706951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102180487|NCT02706951|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102180488|NCT02706951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102180489|NCT04851626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
102180490|NCT04851626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102180491|NCT04851626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180492|NCT04851392|Dronabinol|dronabinol|mesh-list
102180493|NCT04851392|Cannabidiol|cannabidiol|mesh-list
102180494|NCT04851392|Anticonvulsants|anticonvulsants|mesh-ancestor
102180495|NCT04851392|Hallucinogens|hallucinogens|mesh-ancestor
102180496|NCT04851392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180497|NCT04851392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102180498|NCT04851392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102180499|NCT04851392|Analgesics|analgesics|mesh-ancestor
102180500|NCT04851392|Sensory System Agents|sensory system agents|mesh-ancestor
102180501|NCT04851392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102180502|NCT04851392|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102180503|NCT04851392|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102180504|NCT04851392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102180505|NCT04851392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180506|NCT04851392|Hormones|hormones|mesh-ancestor
102180507|NCT04851392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102180508|NCT02429193|Prednisone|prednisone|mesh-list
102180509|NCT02429193|Abiraterone Acetate|abiraterone acetate|mesh-list
102180510|NCT02429193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102180511|NCT02429193|Glucocorticoids|glucocorticoids|mesh-ancestor
102180512|NCT02429193|Hormones|hormones|mesh-ancestor
102180513|NCT02429193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102180514|NCT02429193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180515|NCT02429193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102180516|NCT02429193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102180517|NCT02429193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102180518|NCT02429193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102180519|NCT02429193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180520|NCT02429193|Hormone Antagonists|hormone antagonists|mesh-ancestor
102180521|NCT02429193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102180522|NCT04859738|Lidocaine|lidocaine|mesh-list
102180523|NCT04859738|Anesthetics, Local|anesthetics, local|mesh-ancestor
102180524|NCT04859738|Anesthetics|anesthetics|mesh-ancestor
102180525|NCT04859738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102180526|NCT04859738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180527|NCT04859738|Sensory System Agents|sensory system agents|mesh-ancestor
102180528|NCT04859738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102180529|NCT04859738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102180530|NCT04859738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102180531|NCT04859738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102180532|NCT04859738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102180533|NCT04859738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180535|NCT02429271|Ticagrelor|ticagrelor|mesh-list
102180536|NCT02429271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102180537|NCT02429271|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102180538|NCT02429271|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102180539|NCT02429271|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102180540|NCT02429271|Purinergic Agents|purinergic agents|mesh-ancestor
102180541|NCT02429271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102180542|NCT02429271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180543|NCT02429271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180544|NCT02429505|Miltefosine|miltefosine|mesh-list
102180545|NCT02429505|Antifungal Agents|antifungal agents|mesh-ancestor
102180546|NCT02429505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102180547|NCT02429505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102180548|NCT02429505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102180549|NCT02429505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102180550|NCT04851002|Mitogens|mitogens|mesh-list
102180551|NCT04851002|Mitosis Modulators|mitosis modulators|mesh-ancestor
102180552|NCT04851002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180553|NCT04844996|Ezetimibe|ezetimibe|mesh-list
101900039|NCT00368537|Ampicillin|ampicillin|mesh-list
102180554|NCT04844996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102180555|NCT04844996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102180556|NCT04844996|Antimetabolites|antimetabolites|mesh-ancestor
102180557|NCT04844996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180558|NCT04844996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102180559|NCT02425137|Gemcitabine|gemcitabine|mesh-list
102180560|NCT02425137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102180561|NCT02425137|Antimetabolites|antimetabolites|mesh-ancestor
102180562|NCT02425137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180563|NCT02425137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102180564|NCT04841018|Dexamethasone|dexamethasone|mesh-list
102180565|NCT04841018|Dexamethasone acetate|dexamethasone acetate|mesh-list
102180566|NCT04841018|BB 1101|bb 1101|mesh-list
102180567|NCT04841018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102180568|NCT04841018|Antiemetics|antiemetics|mesh-ancestor
102180569|NCT04841018|Autonomic Agents|autonomic agents|mesh-ancestor
102180570|NCT04841018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102180571|NCT04841018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180572|NCT04841018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102180573|NCT04841018|Glucocorticoids|glucocorticoids|mesh-ancestor
102180574|NCT04841018|Hormones|hormones|mesh-ancestor
102180575|NCT04841018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102180576|NCT04841018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102180577|NCT04841018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102180578|NCT04841018|Protease Inhibitors|protease inhibitors|mesh-ancestor
102180579|NCT04841018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102180580|NCT04841018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180581|NCT03182595|Acetaminophen|acetaminophen|mesh-list
102180582|NCT03182595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102180583|NCT03182595|Analgesics|analgesics|mesh-ancestor
102180584|NCT03182595|Sensory System Agents|sensory system agents|mesh-ancestor
102180585|NCT03182595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102180586|NCT03182595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180587|NCT03182595|Antipyretics|antipyretics|mesh-ancestor
102180588|NCT02428959|Amyl Nitrite|amyl nitrite|mesh-list
102180589|NCT02428959|Vasodilator Agents|vasodilator agents|mesh-ancestor
102180590|NCT02429037|Cisplatin|cisplatin|mesh-list
102180591|NCT02429037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102180592|NCT04833608|Carbon Fiber|carbon fiber|mesh-list
102180593|NCT04833608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102180594|NCT04833608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102180595|NCT02428881|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102180596|NCT02428881|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102180597|NCT02428881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102180598|NCT02428881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102180599|NCT02428881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180600|NCT02428881|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102180601|NCT02428881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102180602|NCT02428881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180603|NCT02428881|Cholinergic Agents|cholinergic agents|mesh-ancestor
102180604|NCT02428881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102180605|NCT04833218|Propranolol|propranolol|mesh-list
102180606|NCT04833218|Clonidine|clonidine|mesh-list
102180607|NCT04833218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102180608|NCT04833218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102180609|NCT04833218|Adrenergic Agents|adrenergic agents|mesh-ancestor
102180610|NCT04833218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102180611|NCT04833218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180612|NCT04833218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180613|NCT04833218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102180614|NCT04833218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102180615|NCT04833218|Vasodilator Agents|vasodilator agents|mesh-ancestor
102180616|NCT04833218|Analgesics|analgesics|mesh-ancestor
102180617|NCT04833218|Sensory System Agents|sensory system agents|mesh-ancestor
102180618|NCT04833218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102180619|NCT04833218|Sympatholytics|sympatholytics|mesh-ancestor
102180620|NCT04833218|Autonomic Agents|autonomic agents|mesh-ancestor
102180621|NCT04833218|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102180622|NCT04833218|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102180623|NCT04833218|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102180624|NCT04833374|Prednisone|prednisone|mesh-list
102180625|NCT04833374|Methylprednisolone|methylprednisolone|mesh-list
102180626|NCT04833374|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102180627|NCT04833374|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102180628|NCT04833374|Prednisolone|prednisolone|mesh-list
102180629|NCT04833374|Prednisolone acetate|prednisolone acetate|mesh-list
102180630|NCT04833374|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102180631|NCT04833374|Prednisolone phosphate|prednisolone phosphate|mesh-list
102180632|NCT04833374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102180633|NCT04833374|Glucocorticoids|glucocorticoids|mesh-ancestor
102180634|NCT04833374|Hormones|hormones|mesh-ancestor
102180635|NCT04833374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102180636|NCT04833374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180637|NCT04833374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102180638|NCT04833374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102180639|NCT04833374|Antiemetics|antiemetics|mesh-ancestor
102180640|NCT04833374|Autonomic Agents|autonomic agents|mesh-ancestor
102180641|NCT04833374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102180642|NCT04833374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102180643|NCT04833374|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102180644|NCT04833374|Protective Agents|protective agents|mesh-ancestor
102180645|NCT02707965|Topiramate|topiramate|mesh-list
102180646|NCT02707965|Lamotrigine|lamotrigine|mesh-list
102180647|NCT02707965|Zonisamide|zonisamide|mesh-list
102180648|NCT02707965|Carbamazepine|carbamazepine|mesh-list
102180649|NCT02707965|Phenytoin|phenytoin|mesh-list
102180650|NCT02707965|Oxcarbazepine|oxcarbazepine|mesh-list
102180651|NCT02707965|Levetiracetam|levetiracetam|mesh-list
102180652|NCT02707965|Valproic Acid|valproic acid|mesh-list
102180653|NCT02707965|Anticonvulsants|anticonvulsants|mesh-ancestor
102180654|NCT02707965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102180655|NCT02707965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180656|NCT02707965|Nootropic Agents|nootropic agents|mesh-ancestor
102180657|NCT02707965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102180658|NCT02707965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102180659|NCT02707965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180660|NCT02707965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102180661|NCT02707965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102180662|NCT02707965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102180663|NCT02707965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102180664|NCT02707965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102180665|NCT02707965|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102180666|NCT02707965|Antimanic Agents|antimanic agents|mesh-ancestor
102180667|NCT02707965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102180668|NCT02707965|Analgesics|analgesics|mesh-ancestor
102180669|NCT02707965|Sensory System Agents|sensory system agents|mesh-ancestor
102180670|NCT02707965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102180671|NCT02707965|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102180672|NCT02707965|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102180673|NCT02707965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102180674|NCT02707965|GABA Agents|gaba agents|mesh-ancestor
102180675|NCT02707965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102180676|NCT02707965|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102180677|NCT02707965|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102180678|NCT04839536|Sevoflurane|sevoflurane|mesh-list
102180679|NCT04839536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102180680|NCT04839536|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102180681|NCT04839536|Anesthetics, General|anesthetics, general|mesh-ancestor
102180682|NCT04839536|Anesthetics|anesthetics|mesh-ancestor
102180683|NCT04839536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102180684|NCT04839536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180685|NCT02428257|Ephedrine|ephedrine|mesh-list
102180686|NCT02428257|Bupivacaine|bupivacaine|mesh-list
102180687|NCT02428257|Anesthetics, Local|anesthetics, local|mesh-ancestor
102180688|NCT02428257|Anesthetics|anesthetics|mesh-ancestor
102180689|NCT02428257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102180690|NCT02428257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180691|NCT02428257|Sensory System Agents|sensory system agents|mesh-ancestor
102180692|NCT02428257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102180693|NCT02428257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102180694|NCT02428257|Sympathomimetics|sympathomimetics|mesh-ancestor
102180695|NCT02428257|Autonomic Agents|autonomic agents|mesh-ancestor
102180696|NCT02428257|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102180697|NCT02428257|Adrenergic Agents|adrenergic agents|mesh-ancestor
102180698|NCT02428257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102180699|NCT02428257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180700|NCT04839224|Phenylephrine|phenylephrine|mesh-list
102180701|NCT04839224|Oxymetazoline|oxymetazoline|mesh-list
102180702|NCT04839224|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102180703|NCT04839224|Mydriatics|mydriatics|mesh-ancestor
102180704|NCT04839224|Autonomic Agents|autonomic agents|mesh-ancestor
102180705|NCT04839224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102180706|NCT04839224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180707|NCT04839224|Sympathomimetics|sympathomimetics|mesh-ancestor
102180708|NCT04839224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102180709|NCT04839224|Nasal Decongestants|nasal decongestants|mesh-ancestor
102180710|NCT04839224|Respiratory System Agents|respiratory system agents|mesh-ancestor
102180711|NCT04839224|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102180712|NCT04839224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102180713|NCT04839224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102180714|NCT04839224|Adrenergic Agents|adrenergic agents|mesh-ancestor
102180715|NCT04839224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102180716|NCT04839224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180717|NCT04839224|Protective Agents|protective agents|mesh-ancestor
102180718|NCT03036644|Nicotine|nicotine|mesh-list
102180719|NCT03036644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102180720|NCT03036644|Autonomic Agents|autonomic agents|mesh-ancestor
102180721|NCT03036644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102180722|NCT03036644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180723|NCT03036644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102180724|NCT03036644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102180725|NCT03036644|Cholinergic Agents|cholinergic agents|mesh-ancestor
102180726|NCT03036644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102180727|NCT03036644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180728|NCT02424201|Ascorbic Acid|ascorbic acid|mesh-list
102180729|NCT02424201|Misoprostol|misoprostol|mesh-list
102180730|NCT02424201|Vitamins|vitamins|mesh-ancestor
102180731|NCT02424201|Micronutrients|micronutrients|mesh-ancestor
102180732|NCT02424201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180733|NCT02424201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102180734|NCT02424201|Abortifacient Agents|abortifacient agents|mesh-ancestor
102180735|NCT02424201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102180736|NCT02424201|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102180737|NCT02424201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102180738|NCT02424201|Oxytocics|oxytocics|mesh-ancestor
102180739|NCT02424201|Antioxidants|antioxidants|mesh-ancestor
102180740|NCT02424201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180741|NCT02424201|Protective Agents|protective agents|mesh-ancestor
102180742|NCT02432781|Insulin|insulin|mesh-list
102180743|NCT02432781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102180744|NCT02432781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180745|NCT01667900|Dulaglutide|dulaglutide|mesh-list
102180746|NCT01667900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102180747|NCT01667900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180748|NCT04843280|Coal Tar|coal tar|mesh-list
102180749|NCT04843280|Keratolytic Agents|keratolytic agents|mesh-ancestor
102180750|NCT04843280|Dermatologic Agents|dermatologic agents|mesh-ancestor
102180751|NCT04833296|Ropivacaine|ropivacaine|mesh-list
102180752|NCT04833296|Anesthetics, Local|anesthetics, local|mesh-ancestor
102180753|NCT04833296|Anesthetics|anesthetics|mesh-ancestor
102180754|NCT04833296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102180755|NCT04833296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180756|NCT04833296|Sensory System Agents|sensory system agents|mesh-ancestor
102180757|NCT04833296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102180758|NCT04832906|Ulipristal acetate|ulipristal acetate|mesh-list
102180759|NCT04832906|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102180760|NCT04832906|Contraceptive Agents|contraceptive agents|mesh-ancestor
102180761|NCT04832906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102180762|NCT04832906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180763|NCT04832906|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102180764|NCT00702273|Progesterone|progesterone|mesh-list
102180765|NCT00702273|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102180766|NCT00702273|Ganirelix|ganirelix|mesh-list
102180767|NCT00702273|Progestins|progestins|mesh-ancestor
102180768|NCT00702273|Hormones|hormones|mesh-ancestor
102180769|NCT00702273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102180770|NCT00702273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180771|NCT00702273|Hormone Antagonists|hormone antagonists|mesh-ancestor
102180772|NCT02433795|Rituximab|rituximab|mesh-list
102180773|NCT02433795|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102180774|NCT02433795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102180775|NCT02433795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102180776|NCT02433795|Immunologic Factors|immunologic factors|mesh-ancestor
101900046|NCT00368537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102180777|NCT02433795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180778|NCT02433795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102180779|NCT02433795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102180780|NCT02433795|Alkylating Agents|alkylating agents|mesh-ancestor
102180781|NCT02433795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180782|NCT03038516|Cholecalciferol|cholecalciferol|mesh-list
102180783|NCT03038516|Vitamin D|vitamin d|mesh-list
102180784|NCT03038516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102180785|NCT03038516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180786|NCT03038516|Vitamins|vitamins|mesh-ancestor
102180787|NCT03038516|Micronutrients|micronutrients|mesh-ancestor
102180788|NCT03038516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102180789|NCT02424435|Methylprednisolone|methylprednisolone|mesh-list
102180790|NCT02424435|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102180791|NCT02424435|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102180792|NCT02424435|Prednisolone|prednisolone|mesh-list
102180793|NCT02424435|Prednisolone acetate|prednisolone acetate|mesh-list
102180794|NCT02424435|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102180795|NCT02424435|Prednisolone phosphate|prednisolone phosphate|mesh-list
102180796|NCT02424435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102180797|NCT02424435|Antiemetics|antiemetics|mesh-ancestor
102180798|NCT02424435|Autonomic Agents|autonomic agents|mesh-ancestor
102180799|NCT02424435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102180800|NCT02424435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180801|NCT02424435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102180802|NCT02424435|Glucocorticoids|glucocorticoids|mesh-ancestor
102180803|NCT02424435|Hormones|hormones|mesh-ancestor
102180804|NCT02424435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102180805|NCT02424435|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102180806|NCT02424435|Protective Agents|protective agents|mesh-ancestor
102180807|NCT02424435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102180808|NCT02424435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102180809|NCT04842968|Methylene Blue|methylene blue|mesh-list
102180810|NCT04842968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102180811|NCT04842968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180812|NCT04832204|Apatinib|apatinib|mesh-list
102180813|NCT04832204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102180814|NCT04832204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102180815|NCT04832204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102180816|NCT04832204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180817|NCT03038282|Chromium|chromium|mesh-list
102180818|NCT03038282|Chromous chloride|chromous chloride|mesh-list
102180819|NCT03038282|Trace Elements|trace elements|mesh-ancestor
102180820|NCT03038282|Micronutrients|micronutrients|mesh-ancestor
102180821|NCT03038282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180822|NCT03038282|Antioxidants|antioxidants|mesh-ancestor
102180823|NCT03038282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180824|NCT03038282|Protective Agents|protective agents|mesh-ancestor
102180825|NCT02424045|Dexamethasone|dexamethasone|mesh-list
102180826|NCT02424045|Carboplatin|carboplatin|mesh-list
102180827|NCT02424045|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102180828|NCT02424045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102180829|NCT02424045|Antiemetics|antiemetics|mesh-ancestor
102180830|NCT02424045|Autonomic Agents|autonomic agents|mesh-ancestor
102180831|NCT02424045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101889699|NCT03725020|Fluorides, Topical|fluorides, topical|mesh-list
102180832|NCT02424045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180833|NCT02424045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102180834|NCT02424045|Glucocorticoids|glucocorticoids|mesh-ancestor
102180835|NCT02424045|Hormones|hormones|mesh-ancestor
102180836|NCT02424045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102180837|NCT02424045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102180838|NCT02424045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102180839|NCT02424045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102180840|NCT02424045|Alkylating Agents|alkylating agents|mesh-ancestor
102180841|NCT02424045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180842|NCT03037970|Becaplermin|becaplermin|mesh-list
102180843|NCT03037970|Anticoagulants|anticoagulants|mesh-ancestor
102180844|NCT03037970|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
102180845|NCT03037970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102180846|NCT03037970|Growth Substances|growth substances|mesh-ancestor
102180847|NCT03037970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180848|NCT04841720|Metformin|metformin|mesh-list
102180849|NCT04841720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101722623|NCT03168256|Analgesics|analgesics|mesh-ancestor
102180850|NCT04841720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180851|NCT05117931|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
102180852|NCT05117931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102180853|NCT05117931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102180854|NCT03039842|Valproic Acid|valproic acid|mesh-list
102180855|NCT03039842|Memantine|memantine|mesh-list
102180856|NCT03039842|Dextromethorphan|dextromethorphan|mesh-list
102180857|NCT03039842|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102180858|NCT03039842|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102180859|NCT03039842|Dopamine Agents|dopamine agents|mesh-ancestor
102180860|NCT03039842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102180861|NCT03039842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180862|NCT03039842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180863|NCT03039842|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102180864|NCT03039842|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102180865|NCT03039842|Antitussive Agents|antitussive agents|mesh-ancestor
102180866|NCT03039842|Respiratory System Agents|respiratory system agents|mesh-ancestor
102180867|NCT03039842|Anticonvulsants|anticonvulsants|mesh-ancestor
102180868|NCT03039842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102180869|NCT03039842|GABA Agents|gaba agents|mesh-ancestor
102180870|NCT03039842|Antimanic Agents|antimanic agents|mesh-ancestor
102180871|NCT03039842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102180872|NCT03039842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102180873|NCT03039842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102180874|NCT03181815|Cytarabine|cytarabine|mesh-list
102180875|NCT03181815|Cladribine|cladribine|mesh-list
102180876|NCT03181815|Aclarubicin|aclarubicin|mesh-list
102180877|NCT03181815|Aclacinomycins|aclacinomycins|mesh-list
102180878|NCT03181815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102180879|NCT03181815|Antimetabolites|antimetabolites|mesh-ancestor
102180880|NCT03181815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180881|NCT03181815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102180882|NCT03181815|Antiviral Agents|antiviral agents|mesh-ancestor
102180883|NCT03181815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102180884|NCT03181815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102180885|NCT03181815|Immunologic Factors|immunologic factors|mesh-ancestor
102180886|NCT03181815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180887|NCT03181815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102180888|NCT03181815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102180889|NCT03181815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102180890|NCT03181815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102180891|NCT03181815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102180892|NCT03038048|Ranibizumab|ranibizumab|mesh-list
102180893|NCT03038048|Aflibercept|aflibercept|mesh-list
102180894|NCT03038048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102180895|NCT03038048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102180896|NCT03038048|Growth Substances|growth substances|mesh-ancestor
102180897|NCT03038048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180898|NCT03038048|Growth Inhibitors|growth inhibitors|mesh-ancestor
102180899|NCT03038048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102180900|NCT03185871|Celecoxib|celecoxib|mesh-list
102180901|NCT03185871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102180902|NCT03185871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102180903|NCT03185871|Analgesics|analgesics|mesh-ancestor
102180904|NCT03185871|Sensory System Agents|sensory system agents|mesh-ancestor
102180905|NCT03185871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102180906|NCT03185871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180907|NCT03185871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101889779|NCT00071006|Axitinib|axitinib|mesh-list
102180908|NCT03185871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102180909|NCT03185871|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102180910|NCT03185871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102180911|NCT03185871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102180912|NCT03185871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180913|NCT03181113|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102180914|NCT03181113|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102180915|NCT03181113|Antiviral Agents|antiviral agents|mesh-ancestor
102180916|NCT03181113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102180917|NCT03180957|Adalimumab|adalimumab|mesh-list
102180918|NCT03180957|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102180919|NCT03180957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102180920|NCT03180957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102180921|NCT02427165|Albuterol|albuterol|mesh-list
102180922|NCT02427165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102180923|NCT02427165|Autonomic Agents|autonomic agents|mesh-ancestor
102180924|NCT02427165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102180925|NCT02427165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180926|NCT02427165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102180927|NCT02427165|Respiratory System Agents|respiratory system agents|mesh-ancestor
102180928|NCT02427165|Tocolytic Agents|tocolytic agents|mesh-ancestor
102180929|NCT02427165|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102180930|NCT02427165|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102180931|NCT02427165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102180932|NCT02427165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102180933|NCT02427165|Adrenergic Agents|adrenergic agents|mesh-ancestor
102180934|NCT02427165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102180935|NCT02427165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180936|NCT03037736|Bevacizumab|bevacizumab|mesh-list
102180937|NCT03037736|Fluorouracil|fluorouracil|mesh-list
102180938|NCT03037736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102180939|NCT03037736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102180940|NCT03037736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102180941|NCT03037736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102180942|NCT03037736|Growth Substances|growth substances|mesh-ancestor
102180943|NCT03037736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180944|NCT03037736|Growth Inhibitors|growth inhibitors|mesh-ancestor
102180945|NCT03037736|Antimetabolites|antimetabolites|mesh-ancestor
102180946|NCT03037736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180947|NCT03037736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102180948|NCT03037736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102180949|NCT03037736|Immunologic Factors|immunologic factors|mesh-ancestor
102180950|NCT04838132|Ropivacaine|ropivacaine|mesh-list
102180951|NCT04838132|Anesthetics, Local|anesthetics, local|mesh-ancestor
102180952|NCT04838132|Anesthetics|anesthetics|mesh-ancestor
102180953|NCT04838132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102180954|NCT04838132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180955|NCT04838132|Sensory System Agents|sensory system agents|mesh-ancestor
102180956|NCT04838132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102180957|NCT03037892|Fentanyl|fentanyl|mesh-list
102180958|NCT03037892|Midazolam|midazolam|mesh-list
102180959|NCT03037892|Remifentanil|remifentanil|mesh-list
102180960|NCT03037892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102180961|NCT03037892|Narcotics|narcotics|mesh-ancestor
102180962|NCT03037892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102180963|NCT03037892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180964|NCT03037892|Analgesics|analgesics|mesh-ancestor
102180965|NCT03037892|Sensory System Agents|sensory system agents|mesh-ancestor
102180966|NCT03037892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102180967|NCT03037892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102180968|NCT03037892|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102180969|NCT03037892|Anesthetics, General|anesthetics, general|mesh-ancestor
102180970|NCT03037892|Anesthetics|anesthetics|mesh-ancestor
102180971|NCT03037892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102180972|NCT03037892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102180973|NCT03037892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102180974|NCT03037892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102180975|NCT03037892|GABA Modulators|gaba modulators|mesh-ancestor
102180976|NCT03037892|GABA Agents|gaba agents|mesh-ancestor
102180977|NCT03037892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102180978|NCT03037892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180979|NCT03183843|Warfarin|warfarin|mesh-list
102180980|NCT03183843|Dabigatran|dabigatran|mesh-list
102180981|NCT03183843|Anticoagulants|anticoagulants|mesh-ancestor
102180982|NCT03183843|Antithrombins|antithrombins|mesh-ancestor
102180983|NCT03183843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102180984|NCT03183843|Protease Inhibitors|protease inhibitors|mesh-ancestor
102180986|NCT03183843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180987|NCT03180879|Ibuprofen|ibuprofen|mesh-list
102180988|NCT03180879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102180989|NCT03180879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102180990|NCT03180879|Analgesics|analgesics|mesh-ancestor
102180991|NCT03180879|Sensory System Agents|sensory system agents|mesh-ancestor
102180992|NCT03180879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102180993|NCT03180879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102180994|NCT03180879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102180995|NCT03180879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102180996|NCT03180879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102180997|NCT03180879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102180998|NCT03180879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102180999|NCT03180723|Cyclosporine|cyclosporine|mesh-list
102181000|NCT03180723|Rituximab|rituximab|mesh-list
102181001|NCT03180723|Cyclosporins|cyclosporins|mesh-list
102181002|NCT03180723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102181003|NCT03180723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102181004|NCT03180723|Immunologic Factors|immunologic factors|mesh-ancestor
102181005|NCT03180723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181006|NCT03180723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102181007|NCT03180723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102181008|NCT03180723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181009|NCT03180723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102181010|NCT03180723|Antifungal Agents|antifungal agents|mesh-ancestor
102181011|NCT03180723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102181012|NCT03180723|Dermatologic Agents|dermatologic agents|mesh-ancestor
102181013|NCT03180723|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102181014|NCT04841096|Metformin|metformin|mesh-list
102181015|NCT04841096|Glimepiride|glimepiride|mesh-list
102181016|NCT04841096|Vildagliptin|vildagliptin|mesh-list
102181017|NCT04841096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102181018|NCT04841096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181019|NCT04841096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102181020|NCT04841096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102181021|NCT04841096|Immunologic Factors|immunologic factors|mesh-ancestor
102181022|NCT04841096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102181023|NCT04841096|Protease Inhibitors|protease inhibitors|mesh-ancestor
102181024|NCT04841096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102181025|NCT04841096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181026|NCT02427243|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102181027|NCT02427243|Immunologic Factors|immunologic factors|mesh-ancestor
102181028|NCT02427243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181029|NCT02426697|Fentanyl|fentanyl|mesh-list
102181030|NCT02426697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102181031|NCT02426697|Narcotics|narcotics|mesh-ancestor
102181032|NCT02426697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102181033|NCT02426697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181034|NCT02426697|Analgesics|analgesics|mesh-ancestor
102181035|NCT02426697|Sensory System Agents|sensory system agents|mesh-ancestor
102181036|NCT02426697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102181037|NCT02426697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102181038|NCT02426697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102181039|NCT02426697|Anesthetics, General|anesthetics, general|mesh-ancestor
102181040|NCT02426697|Anesthetics|anesthetics|mesh-ancestor
102181041|NCT03039608|Prednisone|prednisone|mesh-list
102181042|NCT03039608|Triamcinolone|triamcinolone|mesh-list
102181043|NCT03039608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102181044|NCT03039608|Glucocorticoids|glucocorticoids|mesh-ancestor
102181045|NCT03039608|Hormones|hormones|mesh-ancestor
102181046|NCT03039608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102181047|NCT03039608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181048|NCT03039608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102181049|NCT03039608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102181050|NCT02423811|Fursultiamin|fursultiamin|mesh-list
102181051|NCT02423811|Vitamin B Complex|vitamin b complex|mesh-ancestor
102181052|NCT02423811|Vitamins|vitamins|mesh-ancestor
102181053|NCT02423811|Micronutrients|micronutrients|mesh-ancestor
102181054|NCT02423811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181055|NCT04837664|Nystatin|nystatin|mesh-list
102181056|NCT04837664|Curcumin|curcumin|mesh-list
102181057|NCT04837664|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102181058|NCT04837664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102181059|NCT04837664|Analgesics|analgesics|mesh-ancestor
102181060|NCT04837664|Sensory System Agents|sensory system agents|mesh-ancestor
102181061|NCT04837664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102181062|NCT04837664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181063|NCT04837664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102181064|NCT04837664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102181065|NCT04837664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102181066|NCT04837664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102181067|NCT04837664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181068|NCT04837664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102181069|NCT04837664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102181070|NCT04837664|Antifungal Agents|antifungal agents|mesh-ancestor
102181071|NCT04837664|Ionophores|ionophores|mesh-ancestor
102181072|NCT04837664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102181073|NCT01331837|Etanercept|etanercept|mesh-list
102181074|NCT01331837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102181075|NCT01331837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102181076|NCT01331837|Analgesics|analgesics|mesh-ancestor
102181077|NCT01331837|Sensory System Agents|sensory system agents|mesh-ancestor
102181078|NCT01331837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102181079|NCT01331837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181080|NCT01331837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102181081|NCT01331837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102181082|NCT01331837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102181083|NCT01331837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102181084|NCT01331837|Immunologic Factors|immunologic factors|mesh-ancestor
102181085|NCT02706483|Plecanatide|plecanatide|mesh-list
102181086|NCT02706483|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102181087|NCT02706483|Enzyme Activators|enzyme activators|mesh-ancestor
102181088|NCT02706483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181089|NCT02706483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102181090|NCT03183375|Hydroxyurea|hydroxyurea|mesh-list
102181091|NCT03183375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102181092|NCT03183375|Antisickling Agents|antisickling agents|mesh-ancestor
102181093|NCT03183375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102181094|NCT03183375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181095|NCT03183375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102181096|NCT03183297|Fexofenadine|fexofenadine|mesh-list
102181097|NCT03183297|Naproxen|naproxen|mesh-list
102181098|NCT03183297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102181099|NCT03183297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102181100|NCT03183297|Analgesics|analgesics|mesh-ancestor
102181101|NCT03183297|Sensory System Agents|sensory system agents|mesh-ancestor
102181102|NCT03183297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102181103|NCT03183297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181104|NCT03183297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102181105|NCT03183297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102181106|NCT03183297|Gout Suppressants|gout suppressants|mesh-ancestor
102181107|NCT03183297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102181108|NCT03183297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102181109|NCT03183297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181110|NCT03183297|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102181111|NCT03183297|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102181112|NCT03183297|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102181113|NCT03183297|Histamine Antagonists|histamine antagonists|mesh-ancestor
102181114|NCT03183297|Histamine Agents|histamine agents|mesh-ancestor
102181115|NCT03183297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102181116|NCT02426619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102181117|NCT02426619|Fluorides|fluorides|mesh-list
102181118|NCT02426619|Sodium Fluoride|sodium fluoride|mesh-list
102181119|NCT02426619|Fluorides, Topical|fluorides, topical|mesh-list
102181120|NCT02426619|Cariostatic Agents|cariostatic agents|mesh-ancestor
102181121|NCT02426619|Protective Agents|protective agents|mesh-ancestor
102181122|NCT02426619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181123|NCT02108483|Dapsone|dapsone|mesh-list
102181124|NCT02108483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102181125|NCT02108483|Antimalarials|antimalarials|mesh-ancestor
102181126|NCT02108483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102181127|NCT02108483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102181128|NCT02108483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102181129|NCT02108483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102181130|NCT02108483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181131|NCT02108483|Leprostatic Agents|leprostatic agents|mesh-ancestor
102181132|NCT02108483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102181133|NCT01648348|Bevacizumab|bevacizumab|mesh-list
102181134|NCT01648348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102181135|NCT01648348|Endothelial Growth Factors|endothelial growth factors|mesh-list
102181137|NCT01648348|Immunoglobulins|immunoglobulins|mesh-list
102181138|NCT01648348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102181139|NCT01648348|Immunoglobulin G|immunoglobulin g|mesh-list
102181140|NCT01648348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102181141|NCT01648348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102181142|NCT01648348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102181143|NCT01648348|Growth Substances|growth substances|mesh-ancestor
102181144|NCT01648348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181145|NCT01648348|Growth Inhibitors|growth inhibitors|mesh-ancestor
102181146|NCT01648348|Immunologic Factors|immunologic factors|mesh-ancestor
102181147|NCT03180255|Dexamethasone|dexamethasone|mesh-list
102181148|NCT03180255|Sodium Citrate|sodium citrate|mesh-list
102181149|NCT03180255|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102181150|NCT03180255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102181151|NCT03180255|Antiemetics|antiemetics|mesh-ancestor
102181152|NCT03180255|Autonomic Agents|autonomic agents|mesh-ancestor
102181153|NCT03180255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102181154|NCT03180255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181155|NCT03180255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102181156|NCT03180255|Glucocorticoids|glucocorticoids|mesh-ancestor
102181157|NCT03180255|Hormones|hormones|mesh-ancestor
102181158|NCT03180255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102181159|NCT03180255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102181160|NCT03180255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102181161|NCT03180255|Anticoagulants|anticoagulants|mesh-ancestor
102181162|NCT02431221|Perhexiline|perhexiline|mesh-list
102181163|NCT02431221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102181164|NCT02431221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102181165|NCT02431221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181166|NCT02431221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102181167|NCT02431221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181168|NCT02431221|Vasodilator Agents|vasodilator agents|mesh-ancestor
102181169|NCT02108639|Asunaprevir|asunaprevir|mesh-list
102181170|NCT02108639|Protease Inhibitors|protease inhibitors|mesh-ancestor
102181171|NCT02108639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102181172|NCT02108639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181173|NCT03180099|Bupivacaine|bupivacaine|mesh-list
102181174|NCT03180099|Anesthetics, Local|anesthetics, local|mesh-ancestor
102181175|NCT03180099|Anesthetics|anesthetics|mesh-ancestor
102181176|NCT03180099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102181177|NCT03180099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181178|NCT03180099|Sensory System Agents|sensory system agents|mesh-ancestor
102181179|NCT03180099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102181180|NCT04770272|Paclitaxel|paclitaxel|mesh-list
102181181|NCT04770272|Cyclophosphamide|cyclophosphamide|mesh-list
102181182|NCT04770272|Carboplatin|carboplatin|mesh-list
102181183|NCT04770272|Atezolizumab|atezolizumab|mesh-list
102181184|NCT04770272|Epirubicin|epirubicin|mesh-list
102181185|NCT04770272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102181186|NCT04770272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102181187|NCT04770272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102181188|NCT04770272|Tubulin Modulators|tubulin modulators|mesh-ancestor
102181189|NCT04770272|Antimitotic Agents|antimitotic agents|mesh-ancestor
102181190|NCT04770272|Mitosis Modulators|mitosis modulators|mesh-ancestor
102181191|NCT04770272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181192|NCT04770272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102181193|NCT04770272|Immunologic Factors|immunologic factors|mesh-ancestor
102181194|NCT04770272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181195|NCT04770272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102181196|NCT04770272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102181197|NCT04770272|Alkylating Agents|alkylating agents|mesh-ancestor
102181198|NCT04770272|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102181199|NCT04770272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102181200|NCT04770272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102181201|NCT04770272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102181202|NCT04770272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102181203|NCT04770272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102181204|NCT04770272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102181205|NCT02251145|Ritonavir|ritonavir|mesh-list
102181206|NCT02251145|Tenofovir|tenofovir|mesh-list
102181207|NCT02251145|Tipranavir|tipranavir|mesh-list
102181208|NCT02251145|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102181209|NCT02251145|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102181210|NCT02251145|Protease Inhibitors|protease inhibitors|mesh-ancestor
102181211|NCT02251145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102181212|NCT02251145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181213|NCT02251145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102181214|NCT02251145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102181215|NCT02251145|Antiviral Agents|antiviral agents|mesh-ancestor
102181216|NCT02251145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102181217|NCT02251145|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102181218|NCT02251145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102181219|NCT02251145|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102181220|NCT02251145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102181221|NCT04792424|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102181222|NCT04792424|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
102181223|NCT04792424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102181224|NCT00709371|Zonisamide|zonisamide|mesh-list
102181225|NCT00709371|Bupropion|bupropion|mesh-list
102181226|NCT00709371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102181227|NCT00709371|Antidepressive Agents|antidepressive agents|mesh-ancestor
102181228|NCT00709371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102181229|NCT00709371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102181230|NCT00709371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102181231|NCT00709371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102181232|NCT00709371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181233|NCT00709371|Dopamine Agents|dopamine agents|mesh-ancestor
102181234|NCT00709371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102181235|NCT00709371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181236|NCT00709371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102181237|NCT00709371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102181238|NCT00709371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102181239|NCT00709371|Anticonvulsants|anticonvulsants|mesh-ancestor
102181240|NCT00709371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102181241|NCT00709371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102181242|NCT02426463|Oxycodone|oxycodone|mesh-list
102181243|NCT02426463|Propofol|propofol|mesh-list
102181244|NCT02426463|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102181245|NCT02426463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102181246|NCT02426463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181247|NCT02426463|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102181248|NCT02426463|Anesthetics, General|anesthetics, general|mesh-ancestor
102181249|NCT02426463|Anesthetics|anesthetics|mesh-ancestor
102181250|NCT02426463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102181251|NCT02426463|Narcotics|narcotics|mesh-ancestor
102181252|NCT02426463|Analgesics|analgesics|mesh-ancestor
102181253|NCT02426463|Sensory System Agents|sensory system agents|mesh-ancestor
102181254|NCT02426463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102181255|NCT02426229|Dabigatran|dabigatran|mesh-list
102181256|NCT02426229|Antithrombins|antithrombins|mesh-ancestor
102181257|NCT02426229|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102181258|NCT02426229|Protease Inhibitors|protease inhibitors|mesh-ancestor
102181259|NCT02426229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102181260|NCT02426229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181261|NCT02426229|Anticoagulants|anticoagulants|mesh-ancestor
102181262|NCT01648270|Buprenorphine|buprenorphine|mesh-list
102181263|NCT01648270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102181264|NCT01648270|Narcotics|narcotics|mesh-ancestor
102181265|NCT01648270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102181266|NCT01648270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181267|NCT01648270|Analgesics|analgesics|mesh-ancestor
102181268|NCT01648270|Sensory System Agents|sensory system agents|mesh-ancestor
102181269|NCT01648270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102181270|NCT01648270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102181271|NCT02108795|Remifentanil|remifentanil|mesh-list
102181272|NCT02108795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102181273|NCT02108795|Narcotics|narcotics|mesh-ancestor
102181274|NCT02108795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102181275|NCT02108795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181276|NCT02108795|Analgesics|analgesics|mesh-ancestor
102181277|NCT02108795|Sensory System Agents|sensory system agents|mesh-ancestor
102181278|NCT02108795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102181279|NCT02431143|Miltefosine|miltefosine|mesh-list
102181280|NCT02431143|Antifungal Agents|antifungal agents|mesh-ancestor
102181281|NCT02431143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102181282|NCT02431143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102181283|NCT02431143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102181284|NCT02431143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102181285|NCT02302846|Ixazomib|ixazomib|mesh-list
102181286|NCT02302846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102181287|NCT02302846|Protease Inhibitors|protease inhibitors|mesh-ancestor
102181288|NCT02302846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102181289|NCT02302846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181290|NCT02431065|Ropivacaine|ropivacaine|mesh-list
102181291|NCT02431065|Anesthetics, Local|anesthetics, local|mesh-ancestor
102181292|NCT02431065|Anesthetics|anesthetics|mesh-ancestor
102181293|NCT02431065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102181294|NCT02431065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181295|NCT02431065|Sensory System Agents|sensory system agents|mesh-ancestor
102181296|NCT02431065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102181297|NCT04836806|Cetirizine|cetirizine|mesh-list
102181298|NCT04836806|Famotidine|famotidine|mesh-list
102181299|NCT04836806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102181300|NCT04836806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101308247|NCT02046538|Fluorouracil|fluorouracil|mesh-list
102181301|NCT04836806|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102181302|NCT04836806|Histamine Antagonists|histamine antagonists|mesh-ancestor
102181303|NCT04836806|Histamine Agents|histamine agents|mesh-ancestor
102181304|NCT04836806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102181305|NCT04836806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181306|NCT04836806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181307|NCT04836806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102181308|NCT04836806|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102181309|NCT04836806|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102181310|NCT04836728|Paclitaxel|paclitaxel|mesh-list
102181311|NCT04836728|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102181312|NCT04836728|Carboplatin|carboplatin|mesh-list
102181313|NCT04836728|Pemetrexed|pemetrexed|mesh-list
102181314|NCT04836728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102181315|NCT04836728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102181316|NCT04836728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102181317|NCT04836728|Tubulin Modulators|tubulin modulators|mesh-ancestor
102181318|NCT04836728|Antimitotic Agents|antimitotic agents|mesh-ancestor
102181319|NCT04836728|Mitosis Modulators|mitosis modulators|mesh-ancestor
102181320|NCT04836728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181321|NCT04836728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102181322|NCT04836728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102181323|NCT04836728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102181324|NCT04836728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102181325|NCT02109185|Mometasone Furoate|mometasone furoate|mesh-list
102181326|NCT02109185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102181327|NCT02109185|Dermatologic Agents|dermatologic agents|mesh-ancestor
102181328|NCT02109185|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102181329|NCT02430909|Certolizumab Pegol|certolizumab pegol|mesh-list
102181330|NCT02430909|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102181331|NCT02430909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102181332|NCT02430909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102181333|NCT02430909|Immunologic Factors|immunologic factors|mesh-ancestor
102181334|NCT02430909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181335|NCT02430909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102181336|NCT02105675|Docetaxel|docetaxel|mesh-list
102181337|NCT02105675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102181338|NCT02105675|Tubulin Modulators|tubulin modulators|mesh-ancestor
102181339|NCT02105675|Antimitotic Agents|antimitotic agents|mesh-ancestor
102181340|NCT02105675|Mitosis Modulators|mitosis modulators|mesh-ancestor
102181341|NCT02105675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181342|NCT02336230|Remestemcel-l|remestemcel-l|mesh-list
102181343|NCT02336230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102181344|NCT02336230|Antiviral Agents|antiviral agents|mesh-ancestor
102181345|NCT02336230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102181346|NCT04835948|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102181347|NCT04835948|Immunologic Factors|immunologic factors|mesh-ancestor
102181348|NCT04835948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181349|NCT04835948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102181350|NCT04824404|Buprenorphine|buprenorphine|mesh-list
102181351|NCT04824404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102181352|NCT04824404|Narcotics|narcotics|mesh-ancestor
102181353|NCT04824404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102181354|NCT04824404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181355|NCT04824404|Analgesics|analgesics|mesh-ancestor
102181356|NCT04824404|Sensory System Agents|sensory system agents|mesh-ancestor
102181357|NCT04824404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102181358|NCT04824404|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102181359|NCT02109341|Paclitaxel|paclitaxel|mesh-list
102181360|NCT02109341|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102181361|NCT02109341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102181362|NCT02109341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101890221|NCT03956732|Chelating Agents|chelating agents|mesh-ancestor
102181363|NCT02109341|Tubulin Modulators|tubulin modulators|mesh-ancestor
102181364|NCT02109341|Antimitotic Agents|antimitotic agents|mesh-ancestor
102181365|NCT02109341|Mitosis Modulators|mitosis modulators|mesh-ancestor
102181366|NCT02109341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181367|NCT02336074|Raltegravir Potassium|raltegravir potassium|mesh-list
102181368|NCT02336074|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102181369|NCT02336074|Vorinostat|vorinostat|mesh-list
102181370|NCT02336074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102181371|NCT02336074|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102181372|NCT02336074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102181373|NCT02336074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181374|NCT02336074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102181375|NCT02336074|Antiviral Agents|antiviral agents|mesh-ancestor
102181376|NCT02336074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102181377|NCT02336074|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102181378|NCT02336074|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102181379|NCT04367168|Colchicine|colchicine|mesh-list
102181380|NCT04367168|Gout Suppressants|gout suppressants|mesh-ancestor
102181381|NCT04367168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102181382|NCT04367168|Tubulin Modulators|tubulin modulators|mesh-ancestor
102181383|NCT04367168|Antimitotic Agents|antimitotic agents|mesh-ancestor
102181384|NCT04367168|Mitosis Modulators|mitosis modulators|mesh-ancestor
102181385|NCT04367168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181386|NCT04367168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102181387|NCT02113943|Citalopram|citalopram|mesh-list
102181388|NCT02113943|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102181389|NCT02113943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102181390|NCT02113943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102181391|NCT02113943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181392|NCT02113943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102181393|NCT02113943|Serotonin Agents|serotonin agents|mesh-ancestor
102181394|NCT02113943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181395|NCT02113943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102181396|NCT02113943|Antidepressive Agents|antidepressive agents|mesh-ancestor
102181397|NCT02113943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102181398|NCT02114021|Betamethasone|betamethasone|mesh-list
102181399|NCT02114021|Lidocaine|lidocaine|mesh-list
102181400|NCT02114021|Anesthetics, Local|anesthetics, local|mesh-ancestor
102181401|NCT02114021|Anesthetics|anesthetics|mesh-ancestor
102181402|NCT02114021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102181403|NCT02114021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181404|NCT02114021|Sensory System Agents|sensory system agents|mesh-ancestor
102181405|NCT02114021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102181406|NCT02114021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102181407|NCT02114021|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102181408|NCT02114021|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102181409|NCT02114021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102181410|NCT02114021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181411|NCT02114021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102181412|NCT02114021|Glucocorticoids|glucocorticoids|mesh-ancestor
102181413|NCT02114021|Hormones|hormones|mesh-ancestor
102181414|NCT02114021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102181415|NCT02114021|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102181416|NCT02114021|Respiratory System Agents|respiratory system agents|mesh-ancestor
102181417|NCT04826822|Dexamethasone|dexamethasone|mesh-list
102181418|NCT04826822|Spironolactone|spironolactone|mesh-list
102181419|NCT04826822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102181420|NCT04826822|Antiemetics|antiemetics|mesh-ancestor
102181421|NCT04826822|Autonomic Agents|autonomic agents|mesh-ancestor
102181422|NCT04826822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102181423|NCT04826822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181424|NCT04826822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102181425|NCT04826822|Glucocorticoids|glucocorticoids|mesh-ancestor
102181426|NCT04826822|Hormones|hormones|mesh-ancestor
102181427|NCT04826822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102181428|NCT04826822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102181429|NCT04826822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102181430|NCT04826822|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102181431|NCT04826822|Hormone Antagonists|hormone antagonists|mesh-ancestor
102181432|NCT04826822|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102181433|NCT04826822|Diuretics|diuretics|mesh-ancestor
102181434|NCT04826822|Natriuretic Agents|natriuretic agents|mesh-ancestor
102181435|NCT02251457|Ranolazine|ranolazine|mesh-list
102181436|NCT02251457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102181437|NCT02251457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102181438|NCT02251457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181439|NCT02112305|Magnesium Sulfate|magnesium sulfate|mesh-list
102181440|NCT02112305|Analgesics|analgesics|mesh-ancestor
102181441|NCT02112305|Sensory System Agents|sensory system agents|mesh-ancestor
102181442|NCT02112305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102181443|NCT02112305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181444|NCT02112305|Anesthetics|anesthetics|mesh-ancestor
102181445|NCT02112305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102181446|NCT02112305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102181447|NCT02112305|Anticonvulsants|anticonvulsants|mesh-ancestor
102181448|NCT02112305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102181449|NCT02112305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102181450|NCT02112305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181451|NCT02112305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102181452|NCT02112305|Tocolytic Agents|tocolytic agents|mesh-ancestor
102181453|NCT02112305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102181454|NCT02114099|Atorvastatin|atorvastatin|mesh-list
102181455|NCT02114099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102181456|NCT02114099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102181457|NCT02114099|Antimetabolites|antimetabolites|mesh-ancestor
102181458|NCT02114099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181459|NCT02114099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102181460|NCT02114099|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102181461|NCT02114099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102181462|NCT02251223|Ritonavir|ritonavir|mesh-list
102181463|NCT02251223|Tipranavir|tipranavir|mesh-list
102181464|NCT02251223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102181465|NCT02251223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102181466|NCT02251223|Protease Inhibitors|protease inhibitors|mesh-ancestor
102181467|NCT02251223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102181468|NCT02251223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181469|NCT02251223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102181470|NCT02251223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102181471|NCT02251223|Antiviral Agents|antiviral agents|mesh-ancestor
102181472|NCT02251223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102181473|NCT02251223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102181474|NCT02251223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102181475|NCT02114333|Vaccines|vaccines|mesh-list
102181476|NCT02114333|Immunologic Factors|immunologic factors|mesh-ancestor
102181477|NCT02114333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181478|NCT02114489|Ibandronic Acid|ibandronic acid|mesh-list
102181479|NCT02114489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102181480|NCT02114489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181481|NCT02114645|Leuprolide|leuprolide|mesh-list
102181482|NCT02114645|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102181483|NCT02114645|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102181484|NCT02114645|Estradiol|estradiol|mesh-list
102181485|NCT02114645|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102181486|NCT02114645|Progesterone|progesterone|mesh-list
102181487|NCT02114645|Estrogens|estrogens|mesh-ancestor
102181488|NCT02114645|Hormones|hormones|mesh-ancestor
102181489|NCT02114645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102181490|NCT02114645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181491|NCT02114645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102181492|NCT02114645|Contraceptive Agents|contraceptive agents|mesh-ancestor
102181493|NCT02114645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102181494|NCT02114645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102181495|NCT02114645|Progestins|progestins|mesh-ancestor
102181496|NCT02114645|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102181497|NCT02114645|Fertility Agents|fertility agents|mesh-ancestor
102181498|NCT02114645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102181499|NCT02114645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102181500|NCT02112695|Diprenorphine|diprenorphine|mesh-list
102181501|NCT02112695|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102181502|NCT02112695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181503|NCT02112695|Sensory System Agents|sensory system agents|mesh-ancestor
101448291|NCT00218283|Autonomic Agents|autonomic agents|mesh-ancestor
102181504|NCT02112695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102181505|NCT04826900|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102181506|NCT04826900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102181507|NCT04826900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102181508|NCT04826900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181509|NCT04826900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102181510|NCT04826900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102181511|NCT04826900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181512|NCT04826900|Cholinergic Agents|cholinergic agents|mesh-ancestor
102181513|NCT04826900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102181514|NCT04361162|Nivolumab|nivolumab|mesh-list
102181515|NCT04361162|Ipilimumab|ipilimumab|mesh-list
102181516|NCT04361162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102181517|NCT04361162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102181518|NCT04361162|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102181519|NCT04361162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181520|NCT04823390|Fentanyl|fentanyl|mesh-list
102181521|NCT04823390|Midazolam|midazolam|mesh-list
102181522|NCT04823390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102181523|NCT04823390|Narcotics|narcotics|mesh-ancestor
102181524|NCT04823390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102181525|NCT04823390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181526|NCT04823390|Analgesics|analgesics|mesh-ancestor
102181527|NCT04823390|Sensory System Agents|sensory system agents|mesh-ancestor
102181528|NCT04823390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102181529|NCT04823390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102181530|NCT04823390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102181531|NCT04823390|Anesthetics, General|anesthetics, general|mesh-ancestor
102181532|NCT04823390|Anesthetics|anesthetics|mesh-ancestor
102181533|NCT04823390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102181534|NCT04823390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102181535|NCT04823390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102181536|NCT04823390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102181537|NCT04823390|GABA Modulators|gaba modulators|mesh-ancestor
102181538|NCT04823390|GABA Agents|gaba agents|mesh-ancestor
102181539|NCT04823390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102181540|NCT04823390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181541|NCT05618912|Petrolatum|petrolatum|mesh-list
102181542|NCT05618912|Emollients|emollients|mesh-ancestor
102181543|NCT05618912|Dermatologic Agents|dermatologic agents|mesh-ancestor
102181544|NCT04826510|Lithium Carbonate|lithium carbonate|mesh-list
102181545|NCT04826510|Perospirone|perospirone|mesh-list
102181546|NCT04826510|Antidepressive Agents|antidepressive agents|mesh-ancestor
102181547|NCT04826510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102181548|NCT04826510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102181549|NCT04826510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181550|NCT04826510|Antimanic Agents|antimanic agents|mesh-ancestor
102181551|NCT04826510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102181552|NCT04826510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102181553|NCT04826510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181554|NCT04826510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102181555|NCT03036800|Liraglutide|liraglutide|mesh-list
102181556|NCT03036800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102181557|NCT03036800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181558|NCT03036800|Incretins|incretins|mesh-ancestor
102181559|NCT03036800|Hormones|hormones|mesh-ancestor
102181560|NCT03036800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102181561|NCT02301988|Paclitaxel|paclitaxel|mesh-list
102181562|NCT02301988|Ipatasertib|ipatasertib|mesh-list
102181563|NCT02301988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102181564|NCT02301988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102181565|NCT02301988|Tubulin Modulators|tubulin modulators|mesh-ancestor
102181566|NCT02301988|Antimitotic Agents|antimitotic agents|mesh-ancestor
102181567|NCT02301988|Mitosis Modulators|mitosis modulators|mesh-ancestor
102181568|NCT02301988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181569|NCT02301988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101448299|NCT00185705|Telmisartan|telmisartan|mesh-list
102181570|NCT02301988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102181571|NCT04326920|Sargramostim|sargramostim|mesh-list
102181572|NCT04326920|Immunologic Factors|immunologic factors|mesh-ancestor
102181573|NCT04326920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181574|NCT02112929|Xenon|xenon|mesh-list
102181575|NCT02112929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102181576|NCT02112929|Anesthetics, General|anesthetics, general|mesh-ancestor
102181577|NCT02112929|Anesthetics|anesthetics|mesh-ancestor
102181578|NCT02112929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102181579|NCT02112929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181580|NCT02119091|Moxifloxacin|moxifloxacin|mesh-list
102181581|NCT02119091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102181582|NCT02119091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102181583|NCT02119091|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102181584|NCT02119091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102181585|NCT02119091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102181586|NCT02119091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181587|NCT02119091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101900062|NCT03982121|Nivolumab|nivolumab|mesh-list
102181589|NCT02115035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102181590|NCT02115035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102181591|NCT02115035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102181592|NCT02115035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181593|NCT02113319|Dasatinib|dasatinib|mesh-list
102181594|NCT02113319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102181595|NCT02113319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102181596|NCT02113319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102181597|NCT02113319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181598|NCT02113397|Tobramycin|tobramycin|mesh-list
102181599|NCT02113397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102181600|NCT02113397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102181601|NCT04822064|Dexmedetomidine|dexmedetomidine|mesh-list
102181602|NCT04822064|Ketamine|ketamine|mesh-list
102181603|NCT04822064|Chloral Hydrate|chloral hydrate|mesh-list
102181604|NCT04822064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102181605|NCT04822064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102181606|NCT04822064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181607|NCT04822064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102181608|NCT04822064|Analgesics|analgesics|mesh-ancestor
102181609|NCT04822064|Sensory System Agents|sensory system agents|mesh-ancestor
102181610|NCT04822064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102181611|NCT04822064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102181612|NCT04822064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102181613|NCT04822064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102181614|NCT04822064|Adrenergic Agents|adrenergic agents|mesh-ancestor
102181615|NCT04822064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102181616|NCT04822064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181617|NCT04822064|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102181618|NCT04822064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102181619|NCT04822064|Anesthetics, General|anesthetics, general|mesh-ancestor
102181620|NCT04822064|Anesthetics|anesthetics|mesh-ancestor
102181621|NCT04822064|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102181622|NCT04822064|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102181623|NCT03553433|Apremilast|apremilast|mesh-list
102181624|NCT03553433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102181625|NCT03553433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102181626|NCT03553433|Analgesics|analgesics|mesh-ancestor
102181627|NCT03553433|Sensory System Agents|sensory system agents|mesh-ancestor
102181628|NCT03553433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102181629|NCT03553433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181630|NCT03553433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102181631|NCT03553433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102181632|NCT03553433|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102181633|NCT03553433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102181634|NCT03553433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102181635|NCT03553433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181636|NCT02604212|Tenofovir|tenofovir|mesh-list
102181637|NCT02604212|Entecavir|entecavir|mesh-list
102181638|NCT02604212|Histamine Antagonists|histamine antagonists|mesh-list
102181639|NCT02604212|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
102181640|NCT02604212|Antiviral Agents|antiviral agents|mesh-ancestor
102181641|NCT02604212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102181642|NCT02604212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102181643|NCT02604212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102181644|NCT02604212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102181645|NCT02604212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181646|NCT02604212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102181647|NCT02604212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102181648|NCT02604212|Histamine Agents|histamine agents|mesh-ancestor
102181649|NCT02604212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102181650|NCT02604212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181651|NCT02115659|Triptolide|triptolide|mesh-list
102181652|NCT02115659|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
102181653|NCT02115659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181654|NCT02115659|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102181655|NCT02115659|Contraceptive Agents|contraceptive agents|mesh-ancestor
102181656|NCT02115659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102181657|NCT02115659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102181658|NCT02115659|Immunologic Factors|immunologic factors|mesh-ancestor
102181659|NCT02115659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101890526|NCT03449758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102181660|NCT02115659|Alkylating Agents|alkylating agents|mesh-ancestor
102181661|NCT02115659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181662|NCT02115659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102181664|NCT02113631|Ribavirin|ribavirin|mesh-list
102181665|NCT02113631|Interferon-alpha|interferon-alpha|mesh-list
102181666|NCT02113631|Interferon alpha-2|interferon alpha-2|mesh-list
102181667|NCT02113631|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102181668|NCT02113631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102181669|NCT02113631|Antiviral Agents|antiviral agents|mesh-ancestor
102181670|NCT02113631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102181671|NCT02113631|Antimetabolites|antimetabolites|mesh-ancestor
102181672|NCT02113631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181673|NCT02113631|Immunologic Factors|immunologic factors|mesh-ancestor
102181674|NCT02113631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181675|NCT02123069|Nitroprusside|nitroprusside|mesh-list
102181676|NCT02123069|Phenylephrine|phenylephrine|mesh-list
102181677|NCT02123069|Oxymetazoline|oxymetazoline|mesh-list
102181678|NCT02123069|Norepinephrine|norepinephrine|mesh-list
102181679|NCT02123069|Acetylcholine|acetylcholine|mesh-list
102181680|NCT02123069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102181681|NCT02123069|Mydriatics|mydriatics|mesh-ancestor
102181682|NCT02123069|Autonomic Agents|autonomic agents|mesh-ancestor
102181683|NCT02123069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102181684|NCT02123069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181685|NCT02123069|Sympathomimetics|sympathomimetics|mesh-ancestor
102181686|NCT02123069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102181687|NCT02123069|Nasal Decongestants|nasal decongestants|mesh-ancestor
102181688|NCT02123069|Respiratory System Agents|respiratory system agents|mesh-ancestor
102181689|NCT02123069|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102181690|NCT02123069|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102181691|NCT02123069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102181692|NCT02123069|Adrenergic Agents|adrenergic agents|mesh-ancestor
102181693|NCT02123069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102181694|NCT02123069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181695|NCT02123069|Protective Agents|protective agents|mesh-ancestor
102181696|NCT02123069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102181697|NCT02123069|Vasodilator Agents|vasodilator agents|mesh-ancestor
102181698|NCT02123069|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102181699|NCT02123069|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102181700|NCT02123069|Cholinergic Agents|cholinergic agents|mesh-ancestor
102181701|NCT04428632|Berotralstat|berotralstat|mesh-list
102181702|NCT04428632|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102181703|NCT04428632|Protease Inhibitors|protease inhibitors|mesh-ancestor
102181704|NCT04428632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102181705|NCT04428632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181706|NCT05618210|Anesthetics|anesthetics|mesh-list
102181707|NCT05618210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102181708|NCT05618210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181709|NCT04807634|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102181710|NCT04807634|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
102181711|NCT04807634|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102181712|NCT04807634|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102181713|NCT02789111|Alvimopan|alvimopan|mesh-list
102181714|NCT02789111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102181715|NCT04807166|Paclitaxel|paclitaxel|mesh-list
102181716|NCT04807166|Carboplatin|carboplatin|mesh-list
102181717|NCT04807166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102181718|NCT04807166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102181719|NCT04807166|Tubulin Modulators|tubulin modulators|mesh-ancestor
102181720|NCT04807166|Antimitotic Agents|antimitotic agents|mesh-ancestor
102181721|NCT04807166|Mitosis Modulators|mitosis modulators|mesh-ancestor
102181722|NCT04807166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181723|NCT02251925|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102181724|NCT02251925|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102181725|NCT02251925|Estradiol|estradiol|mesh-list
102181726|NCT02251925|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102181727|NCT02251925|Estrogens|estrogens|mesh-ancestor
102181728|NCT02251925|Hormones|hormones|mesh-ancestor
102181729|NCT02251925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102181730|NCT02251925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181731|NCT02251925|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102181732|NCT02251925|Contraceptive Agents|contraceptive agents|mesh-ancestor
102181733|NCT02251925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102181734|NCT02251925|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102181736|NCT03552653|Ergocalciferols|ergocalciferols|mesh-list
102181737|NCT03552653|Cholecalciferol|cholecalciferol|mesh-list
102181738|NCT03552653|Vitamins|vitamins|mesh-list
102181739|NCT03552653|Micronutrients|micronutrients|mesh-ancestor
102181740|NCT03552653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181741|NCT03552653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102181742|NCT03552653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102181743|NCT01359644|Ribavirin|ribavirin|mesh-list
102181744|NCT01359644|Sofosbuvir|sofosbuvir|mesh-list
102181745|NCT01359644|Antimetabolites|antimetabolites|mesh-ancestor
102181746|NCT01359644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181747|NCT01359644|Antiviral Agents|antiviral agents|mesh-ancestor
102181748|NCT01359644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102181749|NCT04821206|Antirheumatic Agents|antirheumatic agents|mesh-list
102181750|NCT04821206|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
102181751|NCT04821206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102181752|NCT04821206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102181753|NCT04821206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181754|NCT04806230|Mirtazapine|mirtazapine|mesh-list
102181755|NCT04806230|Citalopram|citalopram|mesh-list
102181756|NCT04806230|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102181757|NCT04806230|Sertraline|sertraline|mesh-list
102181758|NCT04806230|Escitalopram|escitalopram|mesh-list
102181759|NCT04806230|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102181760|NCT04806230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102181761|NCT04806230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102181762|NCT04806230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181763|NCT04806230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102181764|NCT04806230|Serotonin Agents|serotonin agents|mesh-ancestor
102181765|NCT04806230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181766|NCT04806230|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102181767|NCT04806230|Antidepressive Agents|antidepressive agents|mesh-ancestor
102181768|NCT04806230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102181769|NCT04806230|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102181770|NCT04806230|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102181771|NCT04806230|Histamine Antagonists|histamine antagonists|mesh-ancestor
102181772|NCT04806230|Histamine Agents|histamine agents|mesh-ancestor
102181773|NCT04806230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102181774|NCT04806230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102181775|NCT04806230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102181776|NCT04806230|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102181777|NCT04806230|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102181778|NCT04806230|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102181779|NCT04806230|Adrenergic Agents|adrenergic agents|mesh-ancestor
102181780|NCT04806230|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102181781|NCT04806230|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102181782|NCT04806230|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102181783|NCT02603120|Tenofovir|tenofovir|mesh-list
102181784|NCT02603120|Emtricitabine|emtricitabine|mesh-list
102181785|NCT02603120|Lamivudine|lamivudine|mesh-list
102181786|NCT02603120|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
102181787|NCT02603120|Antiviral Agents|antiviral agents|mesh-ancestor
102181788|NCT02603120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102181789|NCT02603120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102181790|NCT02603120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102181791|NCT02603120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102181792|NCT02603120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181793|NCT02603120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102181794|NCT02603120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102181795|NCT04815200|Copper|copper|mesh-list
102181796|NCT04815200|Nickel|nickel|mesh-list
102181797|NCT04815200|Trace Elements|trace elements|mesh-ancestor
102181798|NCT04815200|Micronutrients|micronutrients|mesh-ancestor
102181799|NCT04815200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181800|NCT04426994|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
102181801|NCT04426994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102181802|NCT04426994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181803|NCT04814030|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102181804|NCT04814030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181805|NCT04814030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102181806|NCT04814030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102181807|NCT04412252|Tofacitinib|tofacitinib|mesh-list
102181808|NCT04412252|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102181809|NCT04412252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102181810|NCT04412252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102181811|NCT04412252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181812|NCT04813952|Sevoflurane|sevoflurane|mesh-list
102181813|NCT04813952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102181814|NCT04813952|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102181815|NCT04813952|Anesthetics, General|anesthetics, general|mesh-ancestor
102181816|NCT04813952|Anesthetics|anesthetics|mesh-ancestor
102181817|NCT04813952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102181818|NCT04813952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181819|NCT04813874|Nitrous Oxide|nitrous oxide|mesh-list
102181820|NCT04813874|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102181821|NCT04813874|Anesthetics, General|anesthetics, general|mesh-ancestor
102181822|NCT04813874|Anesthetics|anesthetics|mesh-ancestor
102181823|NCT04813874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102181824|NCT04813874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181825|NCT04813874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102181826|NCT04813874|Analgesics|analgesics|mesh-ancestor
102181827|NCT04813874|Sensory System Agents|sensory system agents|mesh-ancestor
102181828|NCT04813874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102181829|NCT04803500|Simvastatin|simvastatin|mesh-list
102181830|NCT04803500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102181831|NCT04803500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102181832|NCT04803500|Antimetabolites|antimetabolites|mesh-ancestor
102181833|NCT04803500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181834|NCT04803500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102181835|NCT04803500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102181836|NCT04803500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102181837|NCT01331681|Aflibercept|aflibercept|mesh-list
102181838|NCT01331681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102181839|NCT01331681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102181840|NCT01331681|Growth Substances|growth substances|mesh-ancestor
102181841|NCT01331681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181842|NCT01331681|Growth Inhibitors|growth inhibitors|mesh-ancestor
102181843|NCT01331681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102181844|NCT02120339|Carvedilol|carvedilol|mesh-list
102181845|NCT02120339|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102181846|NCT02120339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102181847|NCT02120339|Adrenergic Agents|adrenergic agents|mesh-ancestor
102181848|NCT02120339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102181849|NCT02120339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181850|NCT02120339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181851|NCT02120339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102181852|NCT02120339|Antioxidants|antioxidants|mesh-ancestor
102181853|NCT02120339|Protective Agents|protective agents|mesh-ancestor
102181854|NCT02120339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102181855|NCT02120339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102181856|NCT02120339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102181857|NCT02120339|Vasodilator Agents|vasodilator agents|mesh-ancestor
102181858|NCT02120339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102181859|NCT02120339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102181860|NCT02123381|Cetuximab|cetuximab|mesh-list
102181861|NCT02123381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102181862|NCT02123381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102181863|NCT02123615|Immunoglobulins|immunoglobulins|mesh-list
102181864|NCT02123615|Antibodies|antibodies|mesh-list
102181865|NCT02123615|gamma-Globulins|gamma-globulins|mesh-list
102181866|NCT02123615|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102181867|NCT02123615|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102181868|NCT02123615|Immunoglobulin G|immunoglobulin g|mesh-list
102181869|NCT02123615|Immunologic Factors|immunologic factors|mesh-ancestor
102181870|NCT02123615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181871|NCT02120651|Hemostatics|hemostatics|mesh-list
102181872|NCT02120651|Coagulants|coagulants|mesh-ancestor
102181873|NCT02117219|Azacitidine|azacitidine|mesh-list
102181874|NCT02117219|Durvalumab|durvalumab|mesh-list
102181875|NCT02117219|Tremelimumab|tremelimumab|mesh-list
102181876|NCT02117219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102181877|NCT02117219|Antimetabolites|antimetabolites|mesh-ancestor
102181878|NCT02117219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181879|NCT02117219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102181880|NCT02117219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102181881|NCT02117219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102181882|NCT02117453|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102181883|NCT02117453|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102181884|NCT02117453|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102181885|NCT02117453|Antimetabolites|antimetabolites|mesh-ancestor
101890747|NCT00006164|Antiviral Agents|antiviral agents|mesh-ancestor
102181886|NCT02117453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181887|NCT02117453|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102181888|NCT02117453|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102181889|NCT02117453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102181890|NCT02124005|Bupivacaine|bupivacaine|mesh-list
102181891|NCT02124005|Anesthetics, Local|anesthetics, local|mesh-ancestor
102181892|NCT02124005|Anesthetics|anesthetics|mesh-ancestor
102181893|NCT02124005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102181894|NCT02124005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181895|NCT02124005|Sensory System Agents|sensory system agents|mesh-ancestor
102181896|NCT02124005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102181897|NCT03551873|Plecanatide|plecanatide|mesh-list
102181898|NCT03551873|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102181899|NCT03551873|Enzyme Activators|enzyme activators|mesh-ancestor
102181900|NCT03551873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181901|NCT03551873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102181902|NCT02117765|Ustekinumab|ustekinumab|mesh-list
102181903|NCT02117765|Dermatologic Agents|dermatologic agents|mesh-ancestor
102181904|NCT02121119|Lidocaine|lidocaine|mesh-list
102181905|NCT02121119|Bupivacaine|bupivacaine|mesh-list
102181906|NCT02121119|Anesthetics, Local|anesthetics, local|mesh-ancestor
102181907|NCT02121119|Anesthetics|anesthetics|mesh-ancestor
102181908|NCT02121119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102181909|NCT02121119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181910|NCT02121119|Sensory System Agents|sensory system agents|mesh-ancestor
102181911|NCT02121119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102181912|NCT02121119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102181913|NCT02121119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102181914|NCT02121119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102181915|NCT02121119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102181916|NCT02121119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181917|NCT02121197|Dexamethasone|dexamethasone|mesh-list
102181918|NCT02121197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102181919|NCT02121197|Antiemetics|antiemetics|mesh-ancestor
102181920|NCT02121197|Autonomic Agents|autonomic agents|mesh-ancestor
102181921|NCT02121197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102181922|NCT02121197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181923|NCT02121197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102181924|NCT02121197|Glucocorticoids|glucocorticoids|mesh-ancestor
102181925|NCT02121197|Hormones|hormones|mesh-ancestor
102181926|NCT02121197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102181927|NCT02121197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102181928|NCT02121197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102181929|NCT02124317|Paclitaxel|paclitaxel|mesh-list
102181930|NCT02124317|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102181931|NCT02124317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102181932|NCT02124317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102181933|NCT02124317|Tubulin Modulators|tubulin modulators|mesh-ancestor
102181934|NCT02124317|Antimitotic Agents|antimitotic agents|mesh-ancestor
102181935|NCT02124317|Mitosis Modulators|mitosis modulators|mesh-ancestor
102181936|NCT02124317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181937|NCT02117843|Arsenic Trioxide|arsenic trioxide|mesh-list
102181938|NCT02117843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102181939|NCT02121353|Ranibizumab|ranibizumab|mesh-list
102181940|NCT02121353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101448371|NCT00211419|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102181941|NCT02121353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102181942|NCT02121353|Growth Substances|growth substances|mesh-ancestor
102181943|NCT02121353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181944|NCT02121353|Growth Inhibitors|growth inhibitors|mesh-ancestor
102181945|NCT02121353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102181946|NCT05617430|Leucovorin|leucovorin|mesh-list
102181947|NCT05617430|Bevacizumab|bevacizumab|mesh-list
102181948|NCT05617430|Fluorouracil|fluorouracil|mesh-list
102181949|NCT05617430|Oxaliplatin|oxaliplatin|mesh-list
102181950|NCT05617430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102181951|NCT05617430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102181952|NCT05617430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101900068|NCT01167530|Everolimus|everolimus|mesh-list
102181953|NCT05617430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102181954|NCT05617430|Growth Substances|growth substances|mesh-ancestor
102181955|NCT05617430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181956|NCT05617430|Growth Inhibitors|growth inhibitors|mesh-ancestor
102181957|NCT05617430|Antimetabolites|antimetabolites|mesh-ancestor
102181958|NCT05617430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181959|NCT05617430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102181960|NCT05617430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102181961|NCT05617430|Immunologic Factors|immunologic factors|mesh-ancestor
102181962|NCT05617430|Antidotes|antidotes|mesh-ancestor
102181963|NCT05617430|Protective Agents|protective agents|mesh-ancestor
102181964|NCT05617430|Vitamin B Complex|vitamin b complex|mesh-ancestor
102181965|NCT05617430|Vitamins|vitamins|mesh-ancestor
102181966|NCT05617430|Micronutrients|micronutrients|mesh-ancestor
102181967|NCT02251691|Tacrolimus|tacrolimus|mesh-list
102181968|NCT02251691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102181969|NCT02251691|Immunologic Factors|immunologic factors|mesh-ancestor
102181970|NCT02251691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181971|NCT02251691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102181972|NCT02251691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102181973|NCT02251691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181974|NCT02595398|Triamcinolone|triamcinolone|mesh-list
102181975|NCT02595398|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102181976|NCT02595398|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102181977|NCT02595398|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102181978|NCT02595398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102181979|NCT02595398|Glucocorticoids|glucocorticoids|mesh-ancestor
102181980|NCT02595398|Hormones|hormones|mesh-ancestor
102181981|NCT02595398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102181982|NCT02595398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102181983|NCT02595398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102181984|NCT02595398|Immunologic Factors|immunologic factors|mesh-ancestor
102181985|NCT02595398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102181986|NCT02595398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181987|NCT02251769|Ritonavir|ritonavir|mesh-list
102181988|NCT02251769|Tipranavir|tipranavir|mesh-list
102181989|NCT02251769|Clarithromycin|clarithromycin|mesh-list
102181990|NCT02251769|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102181991|NCT02251769|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102181992|NCT02251769|Protease Inhibitors|protease inhibitors|mesh-ancestor
102181993|NCT02251769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102181994|NCT02251769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102181995|NCT02251769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102181996|NCT02251769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102181997|NCT02251769|Antiviral Agents|antiviral agents|mesh-ancestor
102181998|NCT02251769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102181999|NCT02251769|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102182000|NCT02251769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102182001|NCT02251769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102182002|NCT02251769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102182003|NCT02118311|Cyclophosphamide|cyclophosphamide|mesh-list
102182004|NCT02118311|Fludarabine|fludarabine|mesh-list
102182005|NCT02118311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102182006|NCT02118311|Immunologic Factors|immunologic factors|mesh-ancestor
102182007|NCT02118311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182008|NCT02118311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102182009|NCT02118311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102182010|NCT02118311|Alkylating Agents|alkylating agents|mesh-ancestor
102182011|NCT02118311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182012|NCT02118311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102182013|NCT02118311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102182014|NCT01368497|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102182015|NCT01368497|Entecavir|entecavir|mesh-list
102182016|NCT01368497|Antiviral Agents|antiviral agents|mesh-ancestor
102182017|NCT01368497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102182018|NCT04812860|Tramadol|tramadol|mesh-list
102182019|NCT04812860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102182020|NCT04812860|Narcotics|narcotics|mesh-ancestor
102182021|NCT04812860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102182022|NCT04812860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182023|NCT04812860|Analgesics|analgesics|mesh-ancestor
102182024|NCT04812860|Sensory System Agents|sensory system agents|mesh-ancestor
102182025|NCT04812860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102182026|NCT03551561|Chlorhexidine|chlorhexidine|mesh-list
102182027|NCT03551561|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102182028|NCT03551561|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102182029|NCT03551561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102182030|NCT03551561|Disinfectants|disinfectants|mesh-ancestor
102182031|NCT03551561|Dermatologic Agents|dermatologic agents|mesh-ancestor
102182032|NCT04427540|Oxytocin|oxytocin|mesh-list
102182033|NCT04427540|Oxytocics|oxytocics|mesh-ancestor
102182034|NCT04427540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102182035|NCT04427540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182036|NCT04801940|Apixaban|apixaban|mesh-list
102182037|NCT04801940|Atorvastatin|atorvastatin|mesh-list
102182038|NCT04801940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102182039|NCT04801940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102182040|NCT04801940|Antimetabolites|antimetabolites|mesh-ancestor
102182041|NCT04801940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182042|NCT04801940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102182043|NCT04801940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102182044|NCT04801940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102182045|NCT04801940|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102182046|NCT04801940|Antithrombins|antithrombins|mesh-ancestor
102182047|NCT04801940|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102182048|NCT04801940|Protease Inhibitors|protease inhibitors|mesh-ancestor
102182049|NCT04801940|Anticoagulants|anticoagulants|mesh-ancestor
102182050|NCT02251847|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102182052|NCT02251847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102182053|NCT02251847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102182054|NCT02251847|Antimetabolites|antimetabolites|mesh-ancestor
102182055|NCT02251847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182056|NCT02251847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102182057|NCT02251847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102182058|NCT02251847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102182059|NCT02127047|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102182060|NCT02127047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102182061|NCT02127047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182062|NCT02127047|Incretins|incretins|mesh-ancestor
102182063|NCT02127047|Hormones|hormones|mesh-ancestor
102182064|NCT02127047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102182065|NCT02127047|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102182066|NCT02127047|Protease Inhibitors|protease inhibitors|mesh-ancestor
102182067|NCT02127047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102182068|NCT02127047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182069|NCT02122055|Fentanyl|fentanyl|mesh-list
102182070|NCT02122055|Midazolam|midazolam|mesh-list
102182071|NCT02122055|Dexmedetomidine|dexmedetomidine|mesh-list
102182072|NCT02122055|Propofol|propofol|mesh-list
102182073|NCT02122055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102182074|NCT02122055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102182075|NCT02122055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182076|NCT02122055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102182077|NCT02122055|Analgesics|analgesics|mesh-ancestor
102182078|NCT02122055|Sensory System Agents|sensory system agents|mesh-ancestor
102182079|NCT02122055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102182080|NCT02122055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102182081|NCT02122055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102182082|NCT02122055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102182083|NCT02122055|Adrenergic Agents|adrenergic agents|mesh-ancestor
102182084|NCT02122055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102182085|NCT02122055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182086|NCT02122055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102182087|NCT02122055|Anesthetics, General|anesthetics, general|mesh-ancestor
102182088|NCT02122055|Anesthetics|anesthetics|mesh-ancestor
102182089|NCT02122055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102182090|NCT02122055|Narcotics|narcotics|mesh-ancestor
102182091|NCT02122055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102182092|NCT02122055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102182093|NCT02122055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102182094|NCT02122055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102182095|NCT02122055|GABA Modulators|gaba modulators|mesh-ancestor
102182096|NCT02122055|GABA Agents|gaba agents|mesh-ancestor
102182097|NCT02125409|Aspirin|aspirin|mesh-list
102182098|NCT02125409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102182099|NCT02125409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102182100|NCT02125409|Analgesics|analgesics|mesh-ancestor
102182101|NCT02125409|Sensory System Agents|sensory system agents|mesh-ancestor
102182102|NCT02125409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102182103|NCT02125409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182104|NCT02125409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102182105|NCT02125409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102182106|NCT02125409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102182107|NCT02125409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102182108|NCT02125409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182109|NCT02125409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102182110|NCT02125409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102182111|NCT02125409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102182113|NCT04816838|Osimertinib|osimertinib|mesh-list
102182114|NCT04816838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102182115|NCT04816838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102182116|NCT04816838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102182117|NCT04816838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182118|NCT02788175|Vedolizumab|vedolizumab|mesh-list
102182119|NCT02788175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102182120|NCT03551171|Niraparib|niraparib|mesh-list
102182121|NCT03551171|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102182122|NCT03551171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102182123|NCT03551171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182124|NCT03551171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102182125|NCT02787083|Mirabegron|mirabegron|mesh-list
102182126|NCT02787083|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102182127|NCT02787083|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102182128|NCT02787083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102182129|NCT02787083|Adrenergic Agents|adrenergic agents|mesh-ancestor
102182130|NCT02787083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102182131|NCT02787083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182132|NCT02787083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182133|NCT02787083|Urological Agents|urological agents|mesh-ancestor
102182134|NCT02122211|Betaine|betaine|mesh-list
102182135|NCT02122211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102182136|NCT02122211|Lipotropic Agents|lipotropic agents|mesh-ancestor
102182137|NCT02122211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102182138|NCT02122211|Antimetabolites|antimetabolites|mesh-ancestor
102182139|NCT02122211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182140|NCT02122211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102182141|NCT02125565|Lidocaine|lidocaine|mesh-list
102182142|NCT02125565|Anesthetics, Local|anesthetics, local|mesh-ancestor
102182143|NCT02125565|Anesthetics|anesthetics|mesh-ancestor
102182144|NCT02125565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102182145|NCT02125565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182146|NCT02125565|Sensory System Agents|sensory system agents|mesh-ancestor
102182147|NCT02125565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102182148|NCT02125565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102182149|NCT02125565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102182150|NCT02125565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101448401|NCT00186797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102182151|NCT02125565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102182152|NCT02125565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182153|NCT02125643|Caffeine|caffeine|mesh-list
102182154|NCT02125643|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102182155|NCT02125643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182156|NCT02125643|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102182157|NCT02125643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102182158|NCT02125643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182159|NCT02125643|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102182160|NCT02125643|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102182161|NCT02125643|Purinergic Agents|purinergic agents|mesh-ancestor
102182162|NCT02125643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102182163|NCT02127437|Lanreotide|lanreotide|mesh-list
102182164|NCT02127437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102182165|NCT02122601|Hyaluronic Acid|hyaluronic acid|mesh-list
102182166|NCT02122601|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102182167|NCT02122601|Immunologic Factors|immunologic factors|mesh-ancestor
102182168|NCT02122601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182169|NCT02122601|Viscosupplements|viscosupplements|mesh-ancestor
102182170|NCT02122601|Protective Agents|protective agents|mesh-ancestor
102182171|NCT02127593|Moxifloxacin|moxifloxacin|mesh-list
102182172|NCT02127593|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102182173|NCT02127593|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102182174|NCT02127593|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102182175|NCT02127593|Norgestimate|norgestimate|mesh-list
102182176|NCT02127593|Norgestrel|norgestrel|mesh-list
102182177|NCT02127593|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102182178|NCT02127593|Estradiol|estradiol|mesh-list
102182179|NCT02127593|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102182180|NCT02127593|Estrogens|estrogens|mesh-ancestor
102182181|NCT02127593|Hormones|hormones|mesh-ancestor
102182182|NCT02127593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102182183|NCT02127593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182184|NCT02127593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102182185|NCT02127593|Contraceptive Agents|contraceptive agents|mesh-ancestor
102182186|NCT02127593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102182187|NCT02127593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102182188|NCT02127593|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102182189|NCT02127593|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102182190|NCT02127593|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102182191|NCT02127593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102182192|NCT02127593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102182193|NCT02127593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102182194|NCT02127593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102182195|NCT02127593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102182196|NCT02127593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182197|NCT02127593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102182198|NCT02127593|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102182199|NCT02122679|Tranexamic Acid|tranexamic acid|mesh-list
102182200|NCT02122679|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102182201|NCT02122679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102182202|NCT02122679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182203|NCT02122679|Hemostatics|hemostatics|mesh-ancestor
102182204|NCT02122679|Coagulants|coagulants|mesh-ancestor
102182205|NCT04810754|Daratumumab|daratumumab|mesh-list
102182206|NCT04810754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102182207|NCT02127749|Metronidazole|metronidazole|mesh-list
102182208|NCT02127749|Vancomycin|vancomycin|mesh-list
102182209|NCT02127749|Ciprofloxacin|ciprofloxacin|mesh-list
102182210|NCT02127749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102182211|NCT02127749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102182212|NCT02127749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102182213|NCT02127749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102182214|NCT02127749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102182215|NCT02127749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102182216|NCT02127749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102182217|NCT02127749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182218|NCT02127749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102182219|NCT02127749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102182220|NCT02127749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102182221|NCT04797338|Nafarelin|nafarelin|mesh-list
102182222|NCT04797338|Progesterone|progesterone|mesh-list
102182223|NCT04797338|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
102182224|NCT04797338|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
102182225|NCT04797338|Estradiol|estradiol|mesh-list
102182226|NCT04797338|Progestins|progestins|mesh-ancestor
102182227|NCT04797338|Hormones|hormones|mesh-ancestor
102182228|NCT04797338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102182229|NCT04797338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182230|NCT04797338|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102182231|NCT04797338|Hormone Antagonists|hormone antagonists|mesh-ancestor
102182232|NCT04797338|Estrogens|estrogens|mesh-ancestor
102182233|NCT04797338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102182234|NCT04797338|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102182235|NCT04797338|Fertility Agents|fertility agents|mesh-ancestor
102182236|NCT05272865|Dronabinol|dronabinol|mesh-list
102182237|NCT05272865|Hallucinogens|hallucinogens|mesh-ancestor
102182238|NCT05272865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182239|NCT05272865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102182240|NCT05272865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102182241|NCT05272865|Analgesics|analgesics|mesh-ancestor
102182242|NCT05272865|Sensory System Agents|sensory system agents|mesh-ancestor
102182243|NCT05272865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102182244|NCT05272865|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102182245|NCT05272865|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102182246|NCT05272865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102182247|NCT05272865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182248|NCT05272865|Hormones|hormones|mesh-ancestor
102182249|NCT05272865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102182250|NCT02787863|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102182251|NCT02787863|Immunologic Factors|immunologic factors|mesh-ancestor
102182252|NCT02787863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182253|NCT04809818|Aspirin|aspirin|mesh-list
102182254|NCT04809818|Dabigatran|dabigatran|mesh-list
102182255|NCT04809818|Apixaban|apixaban|mesh-list
102182256|NCT04809818|Clopidogrel|clopidogrel|mesh-list
102182257|NCT04809818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102182258|NCT04809818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102182259|NCT04809818|Analgesics|analgesics|mesh-ancestor
102182260|NCT04809818|Sensory System Agents|sensory system agents|mesh-ancestor
102182261|NCT04809818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102182262|NCT04809818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182263|NCT04809818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102182264|NCT04809818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102182265|NCT04809818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102182266|NCT04809818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102182267|NCT04809818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182268|NCT04809818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102182269|NCT04809818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102182270|NCT04809818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102182271|NCT04809818|Antipyretics|antipyretics|mesh-ancestor
102182272|NCT04809818|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102182273|NCT04809818|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102182274|NCT04809818|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102182275|NCT04809818|Purinergic Agents|purinergic agents|mesh-ancestor
102182276|NCT04809818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102182277|NCT04809818|Antithrombins|antithrombins|mesh-ancestor
102182278|NCT04809818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102182279|NCT04809818|Protease Inhibitors|protease inhibitors|mesh-ancestor
102182280|NCT04809818|Anticoagulants|anticoagulants|mesh-ancestor
102182281|NCT04809818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102182282|NCT04796402|Bamlanivimab|bamlanivimab|mesh-list
102182283|NCT04796402|Antiviral Agents|antiviral agents|mesh-ancestor
102182284|NCT04796402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102182285|NCT04809584|Motexafin gadolinium|motexafin gadolinium|mesh-list
102182286|NCT04809584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102182287|NCT04809584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102182288|NCT04809584|Dermatologic Agents|dermatologic agents|mesh-ancestor
102182289|NCT02126267|Chlorhexidine|chlorhexidine|mesh-list
102182290|NCT02126267|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102182291|NCT02126267|Azithromycin|azithromycin|mesh-list
102182292|NCT02126267|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102182293|NCT02126267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102182294|NCT02126267|Disinfectants|disinfectants|mesh-ancestor
102182295|NCT02126267|Dermatologic Agents|dermatologic agents|mesh-ancestor
102182296|NCT02126267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102182297|NCT02128061|Rituximab|rituximab|mesh-list
102182298|NCT02128061|Lenalidomide|lenalidomide|mesh-list
102182299|NCT02128061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102182300|NCT02128061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102182301|NCT02128061|Immunologic Factors|immunologic factors|mesh-ancestor
102182302|NCT02128061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182303|NCT02128061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102182304|NCT02128061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102182305|NCT02128061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102182306|NCT02128061|Growth Substances|growth substances|mesh-ancestor
102182307|NCT02128061|Growth Inhibitors|growth inhibitors|mesh-ancestor
102182308|NCT02596958|Bevacizumab|bevacizumab|mesh-list
102182309|NCT02596958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102182310|NCT02596958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102182311|NCT02596958|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102182312|NCT02596958|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102182313|NCT02596958|Growth Substances|growth substances|mesh-ancestor
102182314|NCT02596958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182315|NCT02596958|Growth Inhibitors|growth inhibitors|mesh-ancestor
102182316|NCT02126579|Poly ICLC|poly iclc|mesh-list
102182317|NCT02126579|Interferon Inducers|interferon inducers|mesh-ancestor
102182318|NCT02126579|Immunologic Factors|immunologic factors|mesh-ancestor
102182319|NCT02126579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182320|NCT04808648|Itraconazole|itraconazole|mesh-list
102182321|NCT04808648|Rifampin|rifampin|mesh-list
102182322|NCT04808648|Antifungal Agents|antifungal agents|mesh-ancestor
102182323|NCT04808648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102182324|NCT04808648|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102182325|NCT04808648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102182326|NCT04808648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724090|NCT02556814|Protective Agents|protective agents|mesh-ancestor
102182327|NCT04808648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182328|NCT04808648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102182329|NCT04808648|Hormone Antagonists|hormone antagonists|mesh-ancestor
102182330|NCT04808648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102182331|NCT04808648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182332|NCT04808648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102182333|NCT04808648|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102182334|NCT04808648|Antitubercular Agents|antitubercular agents|mesh-ancestor
102182335|NCT04808648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102182336|NCT04808648|Leprostatic Agents|leprostatic agents|mesh-ancestor
102182337|NCT04808648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102182338|NCT04808648|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102182339|NCT04808648|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102182340|NCT04808648|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102182341|NCT04808648|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102182342|NCT04808648|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102182343|NCT04808648|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102182344|NCT02126657|Glycolic acid|glycolic acid|mesh-list
101448430|NCT00187070|Dexamethasone|dexamethasone|mesh-list
102182345|NCT02126657|Keratolytic Agents|keratolytic agents|mesh-ancestor
102182346|NCT02126657|Dermatologic Agents|dermatologic agents|mesh-ancestor
102182347|NCT02128451|Fentanyl|fentanyl|mesh-list
102182348|NCT02128451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102182349|NCT02128451|Narcotics|narcotics|mesh-ancestor
102182350|NCT02128451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102182351|NCT02128451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182352|NCT02128451|Analgesics|analgesics|mesh-ancestor
102182353|NCT02128451|Sensory System Agents|sensory system agents|mesh-ancestor
102182354|NCT02128451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102182355|NCT02128451|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102182356|NCT02128451|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102182357|NCT02128451|Anesthetics, General|anesthetics, general|mesh-ancestor
102182358|NCT02128451|Anesthetics|anesthetics|mesh-ancestor
102182359|NCT04785716|Niraparib|niraparib|mesh-list
102182360|NCT04785716|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102182361|NCT04785716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102182362|NCT04785716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182363|NCT04785716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102182364|NCT01367249|Bromfenac|bromfenac|mesh-list
102182365|NCT01367249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102182366|NCT01367249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102182367|NCT01367249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102182368|NCT01367249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102182369|NCT01367249|Analgesics|analgesics|mesh-ancestor
102182370|NCT01367249|Sensory System Agents|sensory system agents|mesh-ancestor
102182371|NCT01367249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102182372|NCT01367249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182373|NCT01367249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102182374|NCT01367249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102182375|NCT02128685|Dydrogesterone|dydrogesterone|mesh-list
102182376|NCT02128685|Progestins|progestins|mesh-ancestor
102182377|NCT02128685|Hormones|hormones|mesh-ancestor
102182378|NCT02128685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102182379|NCT02128685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182380|NCT02252627|Phenylephrine|phenylephrine|mesh-list
102182381|NCT02252627|Oxymetazoline|oxymetazoline|mesh-list
102182382|NCT02252627|Ephedrine|ephedrine|mesh-list
102182383|NCT02252627|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102182384|NCT02252627|Mydriatics|mydriatics|mesh-ancestor
102182385|NCT02252627|Autonomic Agents|autonomic agents|mesh-ancestor
102182386|NCT02252627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102182387|NCT02252627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182388|NCT02252627|Sympathomimetics|sympathomimetics|mesh-ancestor
102182389|NCT02252627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102182390|NCT02252627|Nasal Decongestants|nasal decongestants|mesh-ancestor
102182391|NCT02252627|Respiratory System Agents|respiratory system agents|mesh-ancestor
102182392|NCT02252627|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102182393|NCT02252627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102182394|NCT02252627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102182395|NCT02252627|Adrenergic Agents|adrenergic agents|mesh-ancestor
102182396|NCT02252627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102182397|NCT02252627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182398|NCT02252627|Protective Agents|protective agents|mesh-ancestor
102182399|NCT02252627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102182400|NCT02128841|Rivaroxaban|rivaroxaban|mesh-list
102182401|NCT02128841|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102182402|NCT02128841|Antithrombins|antithrombins|mesh-ancestor
102182403|NCT02128841|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102182404|NCT02128841|Protease Inhibitors|protease inhibitors|mesh-ancestor
102182405|NCT02128841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102182406|NCT02128841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182407|NCT02128841|Anticoagulants|anticoagulants|mesh-ancestor
102182408|NCT03550859|Telmisartan|telmisartan|mesh-list
102182409|NCT03550859|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102182410|NCT03550859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101891271|NCT01101620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102182411|NCT03550859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102182412|NCT03550859|Antimetabolites|antimetabolites|mesh-ancestor
102182413|NCT03550859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182414|NCT03550859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101448433|NCT00187070|Ifosfamide|ifosfamide|mesh-list
102182415|NCT03550859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102182416|NCT03550859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102182417|NCT03550859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102182418|NCT03550859|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102182419|NCT03550859|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102182421|NCT03550781|Cyclophosphamide|cyclophosphamide|mesh-list
102182422|NCT03550781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102182423|NCT03550781|Immunologic Factors|immunologic factors|mesh-ancestor
102182424|NCT03550781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182425|NCT03550781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102182426|NCT03550781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102182427|NCT03550781|Alkylating Agents|alkylating agents|mesh-ancestor
102182428|NCT03550781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182429|NCT03550781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102182430|NCT03550781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102182431|NCT03550781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102182432|NCT03550781|Glucocorticoids|glucocorticoids|mesh-ancestor
102182433|NCT03550781|Hormones|hormones|mesh-ancestor
102182434|NCT03550781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102182435|NCT03550781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102182436|NCT02260661|Fulvestrant|fulvestrant|mesh-list
102182437|NCT02260661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102182438|NCT02260661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102182439|NCT02260661|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102182440|NCT02260661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102182441|NCT02260661|Hormone Antagonists|hormone antagonists|mesh-ancestor
102182442|NCT02260661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102182443|NCT02260661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182444|NCT02136329|Sildenafil Citrate|sildenafil citrate|mesh-list
102182445|NCT02136329|Vasodilator Agents|vasodilator agents|mesh-ancestor
102182446|NCT02136329|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102182447|NCT02136329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102182448|NCT02136329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102182449|NCT02136329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182450|NCT02136329|Urological Agents|urological agents|mesh-ancestor
102182451|NCT02129231|Magnesium Oxide|magnesium oxide|mesh-list
102182452|NCT02129231|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102182453|NCT02129231|Simvastatin|simvastatin|mesh-list
102182454|NCT02129231|Ezetimibe|ezetimibe|mesh-list
102182455|NCT02129231|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
102182456|NCT02129231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102182457|NCT02129231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102182458|NCT02129231|Antimetabolites|antimetabolites|mesh-ancestor
102182459|NCT02129231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182460|NCT02129231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102182461|NCT02129231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102182462|NCT02129231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102182463|NCT02129231|Antacids|antacids|mesh-ancestor
102182464|NCT02129231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102182465|NCT02136641|Fentanyl|fentanyl|mesh-list
102182466|NCT02136641|Midazolam|midazolam|mesh-list
102182467|NCT02136641|Ketamine|ketamine|mesh-list
102182468|NCT02136641|Analgesics|analgesics|mesh-ancestor
102182469|NCT02136641|Sensory System Agents|sensory system agents|mesh-ancestor
102182470|NCT02136641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102182471|NCT02136641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182472|NCT02136641|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102182473|NCT02136641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102182474|NCT02136641|Anesthetics, General|anesthetics, general|mesh-ancestor
102182475|NCT02136641|Anesthetics|anesthetics|mesh-ancestor
102182476|NCT02136641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102182477|NCT02136641|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102182478|NCT02136641|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102182479|NCT02136641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102182480|NCT02136641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182481|NCT02136641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102182482|NCT02136641|Narcotics|narcotics|mesh-ancestor
102182483|NCT02136641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102182484|NCT02136641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102182485|NCT02136641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102182486|NCT02136641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102182487|NCT02136641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102182488|NCT02136641|GABA Modulators|gaba modulators|mesh-ancestor
102182489|NCT02136641|GABA Agents|gaba agents|mesh-ancestor
102182490|NCT03549689|Tenofovir|tenofovir|mesh-list
102182491|NCT03549689|Lamivudine|lamivudine|mesh-list
102182492|NCT03549689|Dolutegravir|dolutegravir|mesh-list
102182493|NCT03549689|Antiviral Agents|antiviral agents|mesh-ancestor
102182494|NCT03549689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102182495|NCT03549689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102182496|NCT03549689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102182497|NCT03549689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102182498|NCT03549689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182499|NCT03549689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102182500|NCT03549689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102182501|NCT03549689|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102182502|NCT03549689|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102182503|NCT02129621|Spironolactone|spironolactone|mesh-list
102182504|NCT02129621|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102182505|NCT02129621|Hormone Antagonists|hormone antagonists|mesh-ancestor
102182506|NCT02129621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102182507|NCT02129621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182508|NCT02129621|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102182509|NCT02129621|Diuretics|diuretics|mesh-ancestor
102182510|NCT02129621|Natriuretic Agents|natriuretic agents|mesh-ancestor
102182511|NCT02129699|Denosumab|denosumab|mesh-list
102182512|NCT02129699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102182513|NCT02129699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182514|NCT03549923|Esmolol|esmolol|mesh-list
102182515|NCT03549923|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102182516|NCT03549923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102182517|NCT03549923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102182518|NCT03549923|Adrenergic Agents|adrenergic agents|mesh-ancestor
102182519|NCT03549923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102182520|NCT03549923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182521|NCT03549923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182522|NCT02136875|Fluticasone|fluticasone|mesh-list
102182523|NCT02136875|Xhance|xhance|mesh-list
102182524|NCT02136875|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102182525|NCT02136875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102182526|NCT02136875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102182527|NCT02136875|Autonomic Agents|autonomic agents|mesh-ancestor
102182528|NCT02136875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102182529|NCT02136875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182530|NCT02136875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102182531|NCT02136875|Respiratory System Agents|respiratory system agents|mesh-ancestor
102182532|NCT02136875|Dermatologic Agents|dermatologic agents|mesh-ancestor
102182533|NCT02136875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102182534|NCT02136875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102182535|NCT02136875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102182536|NCT02136875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102182537|NCT02136875|Adrenergic Agents|adrenergic agents|mesh-ancestor
102182538|NCT02136875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102182539|NCT02136875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182540|NCT02129933|Bevacizumab|bevacizumab|mesh-list
102182541|NCT02129933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102182542|NCT02129933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102182543|NCT02129933|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102182544|NCT02129933|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102182545|NCT02129933|Growth Substances|growth substances|mesh-ancestor
102182546|NCT02129933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182547|NCT02129933|Growth Inhibitors|growth inhibitors|mesh-ancestor
102182548|NCT02132897|Carbamazepine|carbamazepine|mesh-list
102182549|NCT02132897|Anticonvulsants|anticonvulsants|mesh-ancestor
102182550|NCT02132897|Antimanic Agents|antimanic agents|mesh-ancestor
102182551|NCT02132897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102182552|NCT02132897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102182553|NCT02132897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182554|NCT02132897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102182555|NCT02132897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102182556|NCT02132897|Analgesics|analgesics|mesh-ancestor
102182557|NCT02132897|Sensory System Agents|sensory system agents|mesh-ancestor
101891423|NCT01583439|Antimetabolites|antimetabolites|mesh-ancestor
102182558|NCT02132897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102182559|NCT02132897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102182560|NCT02132897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102182561|NCT02132897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182562|NCT02132897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102182563|NCT02132897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102182564|NCT02133053|Beclomethasone|beclomethasone|mesh-list
102182565|NCT02133053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102182566|NCT02133053|Glucocorticoids|glucocorticoids|mesh-ancestor
102182567|NCT02133053|Hormones|hormones|mesh-ancestor
102182568|NCT02133053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102182569|NCT02133053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182570|NCT02133053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102182571|NCT02133053|Respiratory System Agents|respiratory system agents|mesh-ancestor
102182572|NCT02137109|Natalizumab|natalizumab|mesh-list
102182573|NCT02137109|Immunologic Factors|immunologic factors|mesh-ancestor
102182574|NCT02137109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182575|NCT02130167|Atropine|atropine|mesh-list
102182576|NCT02130167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102182577|NCT02130167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102182578|NCT02130167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102182579|NCT02130167|Autonomic Agents|autonomic agents|mesh-ancestor
102182580|NCT02130167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102182581|NCT02130167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182582|NCT02130167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102182583|NCT02130167|Respiratory System Agents|respiratory system agents|mesh-ancestor
102182584|NCT02130167|Mydriatics|mydriatics|mesh-ancestor
102182585|NCT02130167|Parasympatholytics|parasympatholytics|mesh-ancestor
102182586|NCT02130167|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102182587|NCT02130167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102182588|NCT02130167|Cholinergic Agents|cholinergic agents|mesh-ancestor
102182589|NCT02130167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102182590|NCT02130167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182591|NCT02130323|Imiquimod|imiquimod|mesh-list
102182592|NCT02130323|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102182593|NCT02130323|Immunologic Factors|immunologic factors|mesh-ancestor
102182594|NCT02130323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182595|NCT02130323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102182596|NCT02130323|Interferon Inducers|interferon inducers|mesh-ancestor
102182597|NCT03549611|Acetaminophen|acetaminophen|mesh-list
102182598|NCT03549611|Celecoxib|celecoxib|mesh-list
102182599|NCT03549611|Oxycodone|oxycodone|mesh-list
102182600|NCT03549611|Gabapentin|gabapentin|mesh-list
102182601|NCT03549611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102182602|NCT03549611|Analgesics|analgesics|mesh-ancestor
102182603|NCT03549611|Sensory System Agents|sensory system agents|mesh-ancestor
102182604|NCT03549611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102182605|NCT03549611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182606|NCT03549611|Antipyretics|antipyretics|mesh-ancestor
102182607|NCT03549611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102182608|NCT03549611|Narcotics|narcotics|mesh-ancestor
102182609|NCT03549611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102182610|NCT03549611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102182611|NCT03549611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102182612|NCT03549611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102182613|NCT03549611|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102182614|NCT03549611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102182615|NCT03549611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102182616|NCT03549611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182617|NCT03549611|Anticonvulsants|anticonvulsants|mesh-ancestor
102182618|NCT03549611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102182619|NCT03549611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102182620|NCT03549611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102182621|NCT03549611|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102182622|NCT03549611|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102182623|NCT03549611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102182624|NCT03549611|Antimanic Agents|antimanic agents|mesh-ancestor
102182625|NCT02133287|Sirolimus|sirolimus|mesh-list
102182626|NCT02133287|Arsenic Trioxide|arsenic trioxide|mesh-list
102182627|NCT02133287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102182628|NCT02133287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102182629|NCT02133287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102182630|NCT02133287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102182631|NCT02133287|Antifungal Agents|antifungal agents|mesh-ancestor
102182632|NCT02133287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102182633|NCT02133287|Immunologic Factors|immunologic factors|mesh-ancestor
102182634|NCT02133287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182635|NCT02137265|Clomiphene|clomiphene|mesh-list
102182636|NCT02137265|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102182637|NCT02137265|Hormone Antagonists|hormone antagonists|mesh-ancestor
102182638|NCT02137265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102182639|NCT02137265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182640|NCT02137265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102182641|NCT02137265|Fertility Agents|fertility agents|mesh-ancestor
102182642|NCT02137265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102182643|NCT02137265|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102182644|NCT02137265|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102182645|NCT02592434|Tofacitinib|tofacitinib|mesh-list
102182646|NCT02592434|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102182647|NCT02592434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102182648|NCT02592434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102182649|NCT02592434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182650|NCT02130713|Fluoroquinolones|fluoroquinolones|mesh-list
102182651|NCT02130713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102182652|NCT02130713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102182653|NCT02130713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102182654|NCT02130713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102182655|NCT02130713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182656|NCT02137421|Resveratrol|resveratrol|mesh-list
102182657|NCT02137421|Antioxidants|antioxidants|mesh-ancestor
102182658|NCT02137421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182659|NCT02137421|Protective Agents|protective agents|mesh-ancestor
102182660|NCT02137421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182661|NCT02137421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102182662|NCT02137421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102182663|NCT02133677|Temozolomide|temozolomide|mesh-list
102182664|NCT02133677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102182665|NCT02133677|Alkylating Agents|alkylating agents|mesh-ancestor
102182666|NCT02133677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182667|NCT02133677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102182668|NCT02137733|Carvedilol|carvedilol|mesh-list
102182669|NCT02137733|Bisoprolol|bisoprolol|mesh-list
102182670|NCT02137733|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102182671|NCT02137733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102182672|NCT02137733|Adrenergic Agents|adrenergic agents|mesh-ancestor
102182673|NCT02137733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102182674|NCT02137733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182675|NCT02137733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182676|NCT02137733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102182677|NCT02137733|Antioxidants|antioxidants|mesh-ancestor
102182678|NCT02137733|Protective Agents|protective agents|mesh-ancestor
102182679|NCT02137733|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102182680|NCT02137733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102182681|NCT02137733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102182682|NCT02137733|Vasodilator Agents|vasodilator agents|mesh-ancestor
102182683|NCT02137733|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102182684|NCT02137733|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102182685|NCT02137733|Sympatholytics|sympatholytics|mesh-ancestor
102182686|NCT02137733|Autonomic Agents|autonomic agents|mesh-ancestor
102182687|NCT02137733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102182688|NCT02137733|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102182689|NCT02133755|Bromocriptine|bromocriptine|mesh-list
102182690|NCT02133755|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102182691|NCT02133755|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102182692|NCT02133755|Hormone Antagonists|hormone antagonists|mesh-ancestor
102182693|NCT02133755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102182694|NCT02133755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182695|NCT02133755|Dopamine Agonists|dopamine agonists|mesh-ancestor
102182696|NCT02133755|Dopamine Agents|dopamine agents|mesh-ancestor
102182697|NCT02133755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102182698|NCT02133755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182699|NCT02130869|Cytarabine|cytarabine|mesh-list
102182700|NCT02130869|Aldesleukin|aldesleukin|mesh-list
102182701|NCT02130869|Carboplatin|carboplatin|mesh-list
102182702|NCT02130869|Etoposide|etoposide|mesh-list
102182703|NCT02130869|Etoposide phosphate|etoposide phosphate|mesh-list
102182704|NCT02130869|Melphalan|melphalan|mesh-list
102182705|NCT02130869|Busulfan|busulfan|mesh-list
102182706|NCT02130869|Interleukin-2|interleukin-2|mesh-list
102182707|NCT02130869|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102182708|NCT02130869|Mechlorethamine|mechlorethamine|mesh-list
102182709|NCT02130869|Sargramostim|sargramostim|mesh-list
102182710|NCT02130869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102182711|NCT02130869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102182712|NCT02130869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102182713|NCT02130869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102182714|NCT02130869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102182715|NCT02130869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182716|NCT02130869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102182717|NCT02130869|Antimetabolites|antimetabolites|mesh-ancestor
102182718|NCT02130869|Antiviral Agents|antiviral agents|mesh-ancestor
102182719|NCT02130869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102182720|NCT02130869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102182721|NCT02130869|Immunologic Factors|immunologic factors|mesh-ancestor
102182722|NCT02130869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182723|NCT02130869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102182724|NCT02130869|Alkylating Agents|alkylating agents|mesh-ancestor
102182725|NCT02130869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102182726|NCT02130869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102182727|NCT02130869|Analgesics|analgesics|mesh-ancestor
102182728|NCT02130869|Sensory System Agents|sensory system agents|mesh-ancestor
102182729|NCT02130869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102182730|NCT02130869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102182731|NCT02130869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102182732|NCT02133911|Ranolazine|ranolazine|mesh-list
102182733|NCT02133911|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102182734|NCT02133911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102182735|NCT02133911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182736|NCT02133989|Ticlopidine|ticlopidine|mesh-list
102182737|NCT02133989|Clopidogrel|clopidogrel|mesh-list
102182738|NCT02133989|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102182739|NCT02133989|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102182740|NCT02133989|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102182741|NCT02133989|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102182742|NCT02133989|Purinergic Agents|purinergic agents|mesh-ancestor
102182743|NCT02133989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102182744|NCT02133989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182745|NCT02133989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182746|NCT02133989|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102182747|NCT02133989|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102182748|NCT02133989|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102182749|NCT02133989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102182750|NCT02133989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102182751|NCT02138045|Liraglutide|liraglutide|mesh-list
102182752|NCT02138045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102182753|NCT02138045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182754|NCT02138045|Incretins|incretins|mesh-ancestor
102182755|NCT02138045|Hormones|hormones|mesh-ancestor
102182756|NCT02138045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102182757|NCT02134067|Paclitaxel|paclitaxel|mesh-list
102182758|NCT02134067|TAS-119|tas-119|mesh-list
102182759|NCT02134067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102182760|NCT02134067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102182761|NCT02134067|Tubulin Modulators|tubulin modulators|mesh-ancestor
102182762|NCT02134067|Antimitotic Agents|antimitotic agents|mesh-ancestor
102182763|NCT02134067|Mitosis Modulators|mitosis modulators|mesh-ancestor
102182764|NCT02134067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182765|NCT02134067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102182766|NCT02134067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102182767|NCT04091126|Dexamethasone|dexamethasone|mesh-list
102182768|NCT04091126|Lenalidomide|lenalidomide|mesh-list
102182769|NCT04091126|Bortezomib|bortezomib|mesh-list
102182770|NCT04091126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102182771|NCT04091126|Antiemetics|antiemetics|mesh-ancestor
102182772|NCT04091126|Autonomic Agents|autonomic agents|mesh-ancestor
102182773|NCT04091126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102182774|NCT04091126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182775|NCT04091126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102182776|NCT04091126|Glucocorticoids|glucocorticoids|mesh-ancestor
102182777|NCT04091126|Hormones|hormones|mesh-ancestor
102182778|NCT04091126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102182779|NCT04091126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102182780|NCT04091126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102182781|NCT04091126|Immunologic Factors|immunologic factors|mesh-ancestor
102182782|NCT04091126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102182783|NCT04091126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102182784|NCT04091126|Growth Substances|growth substances|mesh-ancestor
102182785|NCT04091126|Growth Inhibitors|growth inhibitors|mesh-ancestor
102182787|NCT03962114|Niacin|niacin|mesh-list
102182788|NCT03962114|Nicotinic Acids|nicotinic acids|mesh-list
102182789|NCT03962114|Vitamins|vitamins|mesh-ancestor
102182790|NCT03962114|Micronutrients|micronutrients|mesh-ancestor
102182791|NCT03962114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182792|NCT03962114|Vitamin B Complex|vitamin b complex|mesh-ancestor
102182793|NCT03962114|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102182794|NCT03962114|Antimetabolites|antimetabolites|mesh-ancestor
102182795|NCT03962114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182796|NCT03962114|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102182797|NCT03962114|Vasodilator Agents|vasodilator agents|mesh-ancestor
102182798|NCT04346186|Immunoglobulin G|immunoglobulin g|mesh-list
102182799|NCT04346186|Immunoglobulin M|immunoglobulin m|mesh-list
102182800|NCT04346186|Immunologic Factors|immunologic factors|mesh-ancestor
102182801|NCT04346186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182802|NCT05472896|Epirubicin|epirubicin|mesh-list
102182803|NCT05472896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102182804|NCT05472896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102182805|NCT05472896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102182806|NCT05472896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102182807|NCT05472896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102182808|NCT05472896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182809|NCT02138357|Buprenorphine|buprenorphine|mesh-list
102182810|NCT02138357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102182811|NCT02138357|Narcotics|narcotics|mesh-ancestor
102182812|NCT02138357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102182813|NCT02138357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182814|NCT02138357|Analgesics|analgesics|mesh-ancestor
102182815|NCT02138357|Sensory System Agents|sensory system agents|mesh-ancestor
102182816|NCT02138357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102182817|NCT02138357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102182818|NCT03596918|Vincristine|vincristine|mesh-list
102182819|NCT03596918|Bleomycin|bleomycin|mesh-list
102182820|NCT03596918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102182821|NCT03596918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102182822|NCT03596918|Tubulin Modulators|tubulin modulators|mesh-ancestor
102182823|NCT03596918|Antimitotic Agents|antimitotic agents|mesh-ancestor
102182824|NCT03596918|Mitosis Modulators|mitosis modulators|mesh-ancestor
102182825|NCT03596918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182826|NCT03596918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102182827|NCT02134379|Clotrimazole|clotrimazole|mesh-list
102182828|NCT02134379|Miconazole|miconazole|mesh-list
102182829|NCT02134379|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102182830|NCT02134379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102182831|NCT02134379|Antifungal Agents|antifungal agents|mesh-ancestor
102182832|NCT02134379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102182833|NCT02134379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102182834|NCT02134379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102182835|NCT02134379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182836|NCT02134379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102182837|NCT02134379|Hormone Antagonists|hormone antagonists|mesh-ancestor
102182838|NCT02134379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102182839|NCT02134379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182840|NCT02134379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102182841|NCT02134379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102182842|NCT02134457|Ranibizumab|ranibizumab|mesh-list
102182843|NCT02134457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102182844|NCT02134457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102182845|NCT02134457|Growth Substances|growth substances|mesh-ancestor
102182846|NCT02134457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182847|NCT02134457|Growth Inhibitors|growth inhibitors|mesh-ancestor
102182848|NCT02134457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102182849|NCT04090190|Solifenacin Succinate|solifenacin succinate|mesh-list
102182850|NCT04090190|Tolterodine Tartrate|tolterodine tartrate|mesh-list
102182851|NCT04090190|Fesoterodine|fesoterodine|mesh-list
102182852|NCT04090190|Oxybutynin|oxybutynin|mesh-list
102182853|NCT04090190|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102182854|NCT04090190|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102182855|NCT04090190|Cholinergic Agents|cholinergic agents|mesh-ancestor
102182856|NCT04090190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102182857|NCT04090190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182858|NCT04090190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182859|NCT04090190|Urological Agents|urological agents|mesh-ancestor
102182860|NCT04090190|Parasympatholytics|parasympatholytics|mesh-ancestor
102182861|NCT04090190|Autonomic Agents|autonomic agents|mesh-ancestor
102182862|NCT04090190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102182863|NCT04792034|Cocaine|cocaine|mesh-list
102182864|NCT04792034|Anesthetics, Local|anesthetics, local|mesh-ancestor
102182865|NCT04792034|Anesthetics|anesthetics|mesh-ancestor
102182866|NCT04792034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102182867|NCT04792034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182868|NCT04792034|Sensory System Agents|sensory system agents|mesh-ancestor
102182869|NCT04792034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102182870|NCT04792034|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102182871|NCT04792034|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102182872|NCT04792034|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102182873|NCT04792034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102182874|NCT04792034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182875|NCT04792034|Dopamine Agents|dopamine agents|mesh-ancestor
102182876|NCT04792034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102182877|NCT02253095|Micronutrients|micronutrients|mesh-list
102182878|NCT02253095|Trace Elements|trace elements|mesh-list
102182879|NCT02253095|Albendazole|albendazole|mesh-list
102182880|NCT02253095|Anthelmintics|anthelmintics|mesh-ancestor
102182881|NCT02253095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102182882|NCT02253095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102182883|NCT02253095|Anticestodal Agents|anticestodal agents|mesh-ancestor
102182884|NCT02253095|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101448488|NCT00412347|Insulin|insulin|mesh-list
102182885|NCT02253095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102182886|NCT02253095|Tubulin Modulators|tubulin modulators|mesh-ancestor
102182887|NCT02253095|Antimitotic Agents|antimitotic agents|mesh-ancestor
102182888|NCT02253095|Mitosis Modulators|mitosis modulators|mesh-ancestor
102182889|NCT02253095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182890|NCT02253095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102182891|NCT02253095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182892|NCT04791332|Aticaprant|aticaprant|mesh-list
102182893|NCT04791332|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102182894|NCT04791332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182895|NCT04791332|Sensory System Agents|sensory system agents|mesh-ancestor
102182896|NCT04791332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102182897|NCT05461820|Methimazole|methimazole|mesh-list
102182898|NCT05461820|Antithyroid Agents|antithyroid agents|mesh-ancestor
102182899|NCT05461820|Hormone Antagonists|hormone antagonists|mesh-ancestor
102182900|NCT05461820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102182901|NCT05461820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182902|NCT04791020|Lidocaine|lidocaine|mesh-list
102182903|NCT04791020|Anesthetics, Local|anesthetics, local|mesh-ancestor
102182904|NCT04791020|Anesthetics|anesthetics|mesh-ancestor
102182905|NCT04791020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102182906|NCT04791020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182907|NCT04791020|Sensory System Agents|sensory system agents|mesh-ancestor
102182908|NCT04791020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102182909|NCT04791020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102182910|NCT04791020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102182911|NCT04791020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102182912|NCT04791020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102182913|NCT04791020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182914|NCT02531906|Oxycodone|oxycodone|mesh-list
102182915|NCT02531906|Methadone|methadone|mesh-list
102182916|NCT02531906|Gabapentin|gabapentin|mesh-list
102182917|NCT02531906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102182918|NCT02531906|Narcotics|narcotics|mesh-ancestor
102182919|NCT02531906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102182920|NCT02531906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182921|NCT02531906|Analgesics|analgesics|mesh-ancestor
102182922|NCT02531906|Sensory System Agents|sensory system agents|mesh-ancestor
102182923|NCT02531906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102182924|NCT02531906|Anticonvulsants|anticonvulsants|mesh-ancestor
102182925|NCT02531906|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102182926|NCT02531906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102182927|NCT02531906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102182928|NCT02531906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102182929|NCT02531906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102182930|NCT02531906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102182931|NCT02531906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182932|NCT02531906|Antimanic Agents|antimanic agents|mesh-ancestor
102182933|NCT02531906|Antitussive Agents|antitussive agents|mesh-ancestor
102182934|NCT02531906|Respiratory System Agents|respiratory system agents|mesh-ancestor
102182935|NCT02783729|Zolpidem|zolpidem|mesh-list
102182936|NCT02783729|Lemborexant|lemborexant|mesh-list
102182937|NCT02783729|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102182938|NCT02783729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102182939|NCT02783729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102182940|NCT02783729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182941|NCT02783729|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102182942|NCT02783729|GABA Agonists|gaba agonists|mesh-ancestor
102182943|NCT02783729|GABA Agents|gaba agents|mesh-ancestor
102182944|NCT02783729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102182945|NCT02783729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182946|NCT02783729|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102182947|NCT02227940|Paclitaxel|paclitaxel|mesh-list
102182948|NCT02227940|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102182949|NCT02227940|Cisplatin|cisplatin|mesh-list
102182950|NCT02227940|Gemcitabine|gemcitabine|mesh-list
102182951|NCT02227940|Ceritinib|ceritinib|mesh-list
102182952|NCT02227940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102182953|NCT02227940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102182954|NCT02227940|Tubulin Modulators|tubulin modulators|mesh-ancestor
102182955|NCT02227940|Antimitotic Agents|antimitotic agents|mesh-ancestor
102182956|NCT02227940|Mitosis Modulators|mitosis modulators|mesh-ancestor
102182957|NCT02227940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182958|NCT02227940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102182959|NCT02227940|Antimetabolites|antimetabolites|mesh-ancestor
102182960|NCT02227940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102182961|NCT02227940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102182962|NCT02072486|Sorafenib|sorafenib|mesh-list
102182963|NCT02072486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102182964|NCT02072486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102182965|NCT02072486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102182966|NCT02072486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182967|NCT00988364|Simvastatin|simvastatin|mesh-list
102182968|NCT00988364|Ezetimibe|ezetimibe|mesh-list
102182969|NCT00988364|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
102182970|NCT00988364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102182971|NCT00988364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102182972|NCT00988364|Antimetabolites|antimetabolites|mesh-ancestor
102182973|NCT00988364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182974|NCT00988364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102182975|NCT00988364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102182976|NCT00988364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102182977|NCT05578001|Pilocarpine|pilocarpine|mesh-list
102182978|NCT05578001|Miotics|miotics|mesh-ancestor
102182979|NCT05578001|Autonomic Agents|autonomic agents|mesh-ancestor
102182980|NCT05578001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102182981|NCT05578001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182982|NCT05578001|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102182983|NCT05578001|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102182984|NCT05578001|Cholinergic Agents|cholinergic agents|mesh-ancestor
102182985|NCT05578001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102182986|NCT05578001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102182987|NCT05577923|Trastuzumab|trastuzumab|mesh-list
102182988|NCT05577923|Fulvestrant|fulvestrant|mesh-list
102182989|NCT05577923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102182990|NCT05577923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102182991|NCT05577923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102182992|NCT05577923|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102182993|NCT05577923|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102182994|NCT05577923|Hormone Antagonists|hormone antagonists|mesh-ancestor
102182995|NCT05577923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102182996|NCT05577923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102182997|NCT04790708|Octreotide|octreotide|mesh-list
102182998|NCT04790708|Edotreotide|edotreotide|mesh-list
102182999|NCT04790708|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
102183000|NCT04790708|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102183001|NCT04790708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183002|NCT04790708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102183003|NCT04790708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102183004|NCT04790708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102183005|NCT05615012|Metformin|metformin|mesh-list
102183006|NCT05615012|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102183007|NCT05615012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102183008|NCT05615012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183009|NCT05615012|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102183010|NCT05615012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102183011|NCT05615012|Antimetabolites|antimetabolites|mesh-ancestor
102183012|NCT05615012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183013|NCT05615012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102183014|NCT05615012|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102183015|NCT05615012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102183016|NCT05614934|Clarithromycin|clarithromycin|mesh-list
102183017|NCT05614934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102183018|NCT05614934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102183019|NCT05614934|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102183020|NCT05614934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102183021|NCT05614934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183022|NCT05614934|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102183023|NCT05614934|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102183024|NCT02135393|Folic Acid|folic acid|mesh-list
102183025|NCT02135393|Hematinics|hematinics|mesh-ancestor
102183026|NCT02135393|Vitamin B Complex|vitamin b complex|mesh-ancestor
102183027|NCT02135393|Vitamins|vitamins|mesh-ancestor
102183028|NCT02135393|Micronutrients|micronutrients|mesh-ancestor
102183029|NCT02135393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183030|NCT02139761|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
102183031|NCT02139761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102183032|NCT02139761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102183033|NCT02139761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102183034|NCT02139761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101900105|NCT01167920|Angiotensin II|angiotensin ii|mesh-list
102183035|NCT02139761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183036|NCT02139761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102183037|NCT02139761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183038|NCT02139761|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102183039|NCT02139761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102183040|NCT02139761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102183041|NCT02139761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102183042|NCT02139761|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102183043|NCT02139761|Dopamine Agents|dopamine agents|mesh-ancestor
102183044|NCT02139761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102183045|NCT02139761|Adrenergic Agents|adrenergic agents|mesh-ancestor
102183046|NCT02139761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102183047|NCT02139761|Analgesics|analgesics|mesh-ancestor
102183048|NCT02139761|Sensory System Agents|sensory system agents|mesh-ancestor
102183049|NCT02139761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102183050|NCT05614778|Zoledronic Acid|zoledronic acid|mesh-list
102183051|NCT05614778|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102183052|NCT05614778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183053|NCT05474924|Prednisolone|prednisolone|mesh-list
102183054|NCT05474924|Budesonide|budesonide|mesh-list
102183055|NCT05474924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102183056|NCT05474924|Glucocorticoids|glucocorticoids|mesh-ancestor
102183057|NCT05474924|Hormones|hormones|mesh-ancestor
102183058|NCT05474924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102183059|NCT05474924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183060|NCT05474924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102183061|NCT05474924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102183062|NCT05474924|Autonomic Agents|autonomic agents|mesh-ancestor
102183063|NCT05474924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102183064|NCT05474924|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102183065|NCT05474924|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102183066|NCT05474924|Respiratory System Agents|respiratory system agents|mesh-ancestor
102183067|NCT02135627|Epinephrine|epinephrine|mesh-list
102183068|NCT02135627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102183069|NCT02135627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102183070|NCT02135627|Adrenergic Agents|adrenergic agents|mesh-ancestor
102183071|NCT02135627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102183072|NCT02135627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183073|NCT02135627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183074|NCT02135627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102183075|NCT02135627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102183076|NCT02135627|Autonomic Agents|autonomic agents|mesh-ancestor
102183077|NCT02135627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102183078|NCT02135627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102183079|NCT02135627|Respiratory System Agents|respiratory system agents|mesh-ancestor
102183080|NCT02135627|Mydriatics|mydriatics|mesh-ancestor
101891944|NCT05009082|Growth Substances|growth substances|mesh-ancestor
102183081|NCT02135627|Sympathomimetics|sympathomimetics|mesh-ancestor
102183082|NCT02135627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102183083|NCT05614622|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102183084|NCT05614622|Cyclopentolate|cyclopentolate|mesh-list
102183085|NCT05614622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102183086|NCT05614622|Mydriatics|mydriatics|mesh-ancestor
102183087|NCT05614622|Autonomic Agents|autonomic agents|mesh-ancestor
102183088|NCT05614622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102183089|NCT05614622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183090|NCT05614622|Parasympatholytics|parasympatholytics|mesh-ancestor
102183091|NCT05614622|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102183092|NCT05614622|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102183093|NCT05614622|Cholinergic Agents|cholinergic agents|mesh-ancestor
102183094|NCT05614622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101334529|NCT00044629|Zolpidem|zolpidem|mesh-list
102183095|NCT05614622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183096|NCT03548129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102183097|NCT03548129|Fosfomycin|fosfomycin|mesh-list
102183098|NCT03548129|Anti-Infective Agents|anti-infective agents|mesh-list
102183099|NCT02140073|Domperidone|domperidone|mesh-list
102183100|NCT02140073|Omeprazole|omeprazole|mesh-list
102183101|NCT02140073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102183102|NCT02140073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102183103|NCT02140073|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102183104|NCT02140073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102183105|NCT02140073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183106|NCT02140073|Antiemetics|antiemetics|mesh-ancestor
102183107|NCT02140073|Autonomic Agents|autonomic agents|mesh-ancestor
102183108|NCT02140073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102183109|NCT02140073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183110|NCT02140073|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102183111|NCT02140073|Dopamine Agents|dopamine agents|mesh-ancestor
102183112|NCT02140073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102183113|NCT05474690|Cyclophosphamide|cyclophosphamide|mesh-list
102183114|NCT05474690|Carboplatin|carboplatin|mesh-list
102183115|NCT05474690|Docetaxel|docetaxel|mesh-list
102183116|NCT05474690|Trastuzumab|trastuzumab|mesh-list
102183117|NCT05474690|Epirubicin|epirubicin|mesh-list
102183118|NCT05474690|Pertuzumab|pertuzumab|mesh-list
102183119|NCT05474690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102183120|NCT05474690|Immunologic Factors|immunologic factors|mesh-ancestor
102183121|NCT05474690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183122|NCT05474690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102183123|NCT05474690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102183124|NCT05474690|Alkylating Agents|alkylating agents|mesh-ancestor
102183125|NCT05474690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183126|NCT05474690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102183127|NCT05474690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102183128|NCT05474690|Tubulin Modulators|tubulin modulators|mesh-ancestor
102183129|NCT05474690|Antimitotic Agents|antimitotic agents|mesh-ancestor
102183130|NCT05474690|Mitosis Modulators|mitosis modulators|mesh-ancestor
102183131|NCT05474690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102183132|NCT05474690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102183133|NCT05474690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102183134|NCT05474690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102183135|NCT05474690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102183136|NCT05575973|Rituximab|rituximab|mesh-list
102183137|NCT05575973|Lenalidomide|lenalidomide|mesh-list
102183138|NCT05575973|Mitoxantrone|mitoxantrone|mesh-list
102183139|NCT05575973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102183140|NCT05575973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102183141|NCT05575973|Immunologic Factors|immunologic factors|mesh-ancestor
102183142|NCT05575973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183143|NCT05575973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102183144|NCT05575973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102183145|NCT05575973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102183146|NCT05575973|Growth Substances|growth substances|mesh-ancestor
102183147|NCT05575973|Growth Inhibitors|growth inhibitors|mesh-ancestor
102183148|NCT05575973|Analgesics|analgesics|mesh-ancestor
102183149|NCT05575973|Sensory System Agents|sensory system agents|mesh-ancestor
102183150|NCT05575973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102183151|NCT05575973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102183152|NCT05575973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102183153|NCT05575973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102183154|NCT05575973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183155|NCT03547895|Vitamin K|vitamin k|mesh-list
102183156|NCT03547895|Vitamin K 1|vitamin k 1|mesh-list
102183157|NCT03547895|Ribavirin|ribavirin|mesh-list
102183158|NCT03547895|Sofosbuvir|sofosbuvir|mesh-list
102183159|NCT03547895|Furosemide|furosemide|mesh-list
102183161|NCT03547895|Silymarin|silymarin|mesh-list
102183162|NCT03547895|Vitamins|vitamins|mesh-ancestor
102183163|NCT03547895|Micronutrients|micronutrients|mesh-ancestor
102183164|NCT03547895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183165|NCT03547895|Antimetabolites|antimetabolites|mesh-ancestor
102183166|NCT03547895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183167|NCT03547895|Antiviral Agents|antiviral agents|mesh-ancestor
102183168|NCT03547895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102183169|NCT03547895|Diuretics|diuretics|mesh-ancestor
102183170|NCT03547895|Natriuretic Agents|natriuretic agents|mesh-ancestor
102183171|NCT03547895|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102183172|NCT03547895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102183173|NCT03547895|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102183174|NCT03547895|Hormone Antagonists|hormone antagonists|mesh-ancestor
102183175|NCT03547895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102183176|NCT03547895|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102183177|NCT03547895|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102183178|NCT03547895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102183179|NCT03547895|Hemostatics|hemostatics|mesh-ancestor
102183180|NCT03547895|Coagulants|coagulants|mesh-ancestor
102183181|NCT03547895|Antioxidants|antioxidants|mesh-ancestor
102183182|NCT03547895|Protective Agents|protective agents|mesh-ancestor
102183183|NCT01359254|Fludarabine|fludarabine|mesh-list
102183184|NCT01359254|Fludarabine phosphate|fludarabine phosphate|mesh-list
102183185|NCT01359254|Melphalan|melphalan|mesh-list
102183186|NCT01359254|Busulfan|busulfan|mesh-list
102183187|NCT01359254|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102183188|NCT01359254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102183189|NCT01359254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102183190|NCT01359254|Antimetabolites|antimetabolites|mesh-ancestor
102183191|NCT01359254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183192|NCT01359254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102183193|NCT01359254|Immunologic Factors|immunologic factors|mesh-ancestor
102183194|NCT01359254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183195|NCT01359254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102183196|NCT01359254|Alkylating Agents|alkylating agents|mesh-ancestor
102183197|NCT01359254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102183198|NCT05575739|Antioxidants|antioxidants|mesh-list
102183199|NCT05575739|Superoxide Dismutase|superoxide dismutase|mesh-list
102183200|NCT05575739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183201|NCT05575739|Protective Agents|protective agents|mesh-ancestor
102183202|NCT05575739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183203|NCT05575739|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102183204|NCT05035862|Interferons|interferons|mesh-list
102183205|NCT05035862|Interferon-gamma|interferon-gamma|mesh-list
102183206|NCT05035862|Prednisone|prednisone|mesh-list
102183207|NCT05035862|Albuterol|albuterol|mesh-list
102183208|NCT05035862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102183209|NCT05035862|Glucocorticoids|glucocorticoids|mesh-ancestor
102183210|NCT05035862|Hormones|hormones|mesh-ancestor
102183211|NCT05035862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102183212|NCT05035862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183213|NCT05035862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102183214|NCT05035862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102183215|NCT05035862|Antiviral Agents|antiviral agents|mesh-ancestor
102183216|NCT05035862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102183217|NCT05035862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102183218|NCT05035862|Autonomic Agents|autonomic agents|mesh-ancestor
102183219|NCT05035862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102183220|NCT05035862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102183221|NCT05035862|Respiratory System Agents|respiratory system agents|mesh-ancestor
102183222|NCT05035862|Tocolytic Agents|tocolytic agents|mesh-ancestor
102183223|NCT05035862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102183224|NCT05035862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102183225|NCT05035862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102183226|NCT05035862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102183227|NCT05035862|Adrenergic Agents|adrenergic agents|mesh-ancestor
102183228|NCT05035862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102183229|NCT05035862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183230|NCT03549221|Ketorolac|ketorolac|mesh-list
102183231|NCT03549221|Epinephrine|epinephrine|mesh-list
102183232|NCT03549221|Levobupivacaine|levobupivacaine|mesh-list
102183233|NCT03549221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102183234|NCT03549221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102183235|NCT03549221|Adrenergic Agents|adrenergic agents|mesh-ancestor
102183236|NCT03549221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102183237|NCT03549221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183238|NCT03549221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183239|NCT03549221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102183240|NCT03549221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102183241|NCT03549221|Autonomic Agents|autonomic agents|mesh-ancestor
102183242|NCT03549221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102183243|NCT03549221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102183244|NCT03549221|Respiratory System Agents|respiratory system agents|mesh-ancestor
102183245|NCT03549221|Mydriatics|mydriatics|mesh-ancestor
102183246|NCT03549221|Sympathomimetics|sympathomimetics|mesh-ancestor
102183247|NCT03549221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102183248|NCT03549221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102183249|NCT03549221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102183250|NCT03549221|Analgesics|analgesics|mesh-ancestor
102183251|NCT03549221|Sensory System Agents|sensory system agents|mesh-ancestor
102183252|NCT03549221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102183253|NCT03549221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102183254|NCT03549221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102183255|NCT03549221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102183256|NCT03549221|Anesthetics, Local|anesthetics, local|mesh-ancestor
102183257|NCT03549221|Anesthetics|anesthetics|mesh-ancestor
102183258|NCT03549221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102183259|NCT05013632|Antiviral Agents|antiviral agents|mesh-list
102183260|NCT05013632|Remdesivir|remdesivir|mesh-list
102183261|NCT05013632|Sotrovimab|sotrovimab|mesh-list
102183262|NCT05013632|Molnupiravir|molnupiravir|mesh-list
102183263|NCT05013632|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
102183264|NCT05013632|Antibodies|antibodies|mesh-list
102183265|NCT05013632|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102183266|NCT05013632|Immunologic Factors|immunologic factors|mesh-ancestor
102183267|NCT05013632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183268|NCT05013632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102183269|NCT05013632|Antimetabolites|antimetabolites|mesh-ancestor
102183270|NCT05013632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183271|NCT05614544|Propofol|propofol|mesh-list
102183272|NCT05614544|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102183273|NCT05614544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102183274|NCT05614544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183275|NCT05614544|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102183276|NCT05614544|Anesthetics, General|anesthetics, general|mesh-ancestor
102183277|NCT05614544|Anesthetics|anesthetics|mesh-ancestor
102183278|NCT05185505|Bevacizumab|bevacizumab|mesh-list
102183279|NCT05185505|Atezolizumab|atezolizumab|mesh-list
102183280|NCT05185505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102183281|NCT05185505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102183282|NCT05185505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102183283|NCT05185505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102183284|NCT05185505|Growth Substances|growth substances|mesh-ancestor
102183285|NCT05185505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183286|NCT05185505|Growth Inhibitors|growth inhibitors|mesh-ancestor
102183287|NCT05185505|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102183288|NCT05185505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183289|NCT01667432|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102183290|NCT01667432|Antiviral Agents|antiviral agents|mesh-ancestor
102183291|NCT01667432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102183292|NCT05575271|Norepinephrine|norepinephrine|mesh-list
102183293|NCT05575271|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102183294|NCT05575271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102183295|NCT05575271|Adrenergic Agents|adrenergic agents|mesh-ancestor
102183296|NCT05575271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102183297|NCT05575271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183298|NCT05575271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183299|NCT05575271|Sympathomimetics|sympathomimetics|mesh-ancestor
102183300|NCT05575271|Autonomic Agents|autonomic agents|mesh-ancestor
102183301|NCT05575271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102183302|NCT05575271|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102183303|NCT04750460|Teriparatide|teriparatide|mesh-list
102183304|NCT04750460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102183305|NCT04750460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183306|NCT04750460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102183307|NCT05575037|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102183308|NCT05575037|Immunologic Factors|immunologic factors|mesh-ancestor
102183309|NCT05575037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183310|NCT05574881|Trastuzumab|trastuzumab|mesh-list
102183311|NCT05574881|Pertuzumab|pertuzumab|mesh-list
102183312|NCT05574881|Fulvestrant|fulvestrant|mesh-list
102183313|NCT05574881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102183314|NCT05574881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102183315|NCT05574881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102183316|NCT05574881|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102183317|NCT05574881|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102183318|NCT05574881|Hormone Antagonists|hormone antagonists|mesh-ancestor
102183319|NCT05574881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102183320|NCT05574881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183322|NCT05612984|Folic Acid|folic acid|mesh-list
102183323|NCT05612984|Micronutrients|micronutrients|mesh-list
102183324|NCT05612984|Trace Elements|trace elements|mesh-list
102183325|NCT05612984|Calcium|calcium|mesh-list
102183326|NCT05612984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102183327|NCT05612984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183328|NCT05612984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102183329|NCT05612984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102183330|NCT05612984|Analgesics|analgesics|mesh-ancestor
102183332|NCT05612984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102183333|NCT05612984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102183334|NCT05612984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102183335|NCT05612984|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102183336|NCT05612984|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102183337|NCT05612984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183338|NCT05612984|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102183339|NCT05612984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102183340|NCT05612984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102183341|NCT05612984|Antipyretics|antipyretics|mesh-ancestor
102183342|NCT05612984|Hematinics|hematinics|mesh-ancestor
102183343|NCT05612984|Vitamin B Complex|vitamin b complex|mesh-ancestor
102183344|NCT05612984|Vitamins|vitamins|mesh-ancestor
102183345|NCT04787510|Heparin|heparin|mesh-list
102183346|NCT04787510|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102183347|NCT04787510|Tinzaparin|tinzaparin|mesh-list
102183348|NCT04787510|Dalteparin|dalteparin|mesh-list
102183349|NCT04787510|Anticoagulants|anticoagulants|mesh-ancestor
102183350|NCT04787510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102183351|NCT04787510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102183352|NCT04787510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183353|NCT05424263|Calcium, Dietary|calcium, dietary|mesh-list
102183354|NCT05424263|Calcium Carbonate|calcium carbonate|mesh-list
102183355|NCT05424263|Calcium|calcium|mesh-list
102183356|NCT05424263|Calcium acetate|calcium acetate|mesh-list
102183357|NCT05424263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102183358|NCT05424263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183359|NCT05424263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102183360|NCT05424263|Antacids|antacids|mesh-ancestor
102183361|NCT05424263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183362|NCT05424263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102183363|NCT05424263|Chelating Agents|chelating agents|mesh-ancestor
102183364|NCT05424263|Sequestering Agents|sequestering agents|mesh-ancestor
102183365|NCT04787276|Rifaximin|rifaximin|mesh-list
102183366|NCT04787276|Lactulose|lactulose|mesh-list
102183367|NCT04787276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102183368|NCT04787276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102183369|NCT04787276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102183370|NCT01564979|Botulinum Toxins|botulinum toxins|mesh-list
102183371|NCT01564979|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102183372|NCT01564979|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102183373|NCT01564979|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102183374|NCT01564979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102183375|NCT01564979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183376|NCT01564979|Cholinergic Agents|cholinergic agents|mesh-ancestor
102183377|NCT01564979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102183378|NCT01564979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183379|NCT01564979|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102183380|NCT01564979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102183381|NCT05613140|Valsartan|valsartan|mesh-list
101892249|NCT03694002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892250|NCT03694002|Tubulin Modulators|tubulin modulators|mesh-ancestor
101892251|NCT03694002|Antimitotic Agents|antimitotic agents|mesh-ancestor
101892252|NCT03694002|Mitosis Modulators|mitosis modulators|mesh-ancestor
101892253|NCT03694002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892256|NCT03623321|Pimavanserin|pimavanserin|mesh-list
102183382|NCT05613140|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102183383|NCT05613140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102183384|NCT05613140|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102183385|NCT05613140|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102183386|NCT05613140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183387|NCT03547505|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
102183388|NCT03547505|Vasodilator Agents|vasodilator agents|mesh-ancestor
102183389|NCT03547505|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
102183390|NCT03547505|Protective Agents|protective agents|mesh-ancestor
102183391|NCT03547505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183392|NCT05279183|Erythritol|erythritol|mesh-list
102183393|NCT05279183|Vasodilator Agents|vasodilator agents|mesh-ancestor
102183394|NCT04462952|Adavosertib|adavosertib|mesh-list
102183395|NCT04462952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102183396|NCT04462952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183397|NCT02253485|Telbivudine|telbivudine|mesh-list
102183398|NCT02253485|Antiviral Agents|antiviral agents|mesh-ancestor
102183399|NCT02253485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102183400|NCT02253485|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102183401|NCT02253485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102183402|NCT02253485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183403|NCT05612516|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102183404|NCT05612516|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102183405|NCT05612516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102183406|NCT02589626|Empagliflozin|empagliflozin|mesh-list
102183407|NCT02589626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102183408|NCT02589626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183409|NCT02589626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102183410|NCT02589626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183411|NCT04976036|Nintedanib|nintedanib|mesh-list
102183412|NCT04976036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102183413|NCT04976036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102183414|NCT04976036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102183415|NCT04976036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183416|NCT05557604|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102183417|NCT05557604|Luteolytic Agents|luteolytic agents|mesh-ancestor
102183418|NCT05557604|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102183419|NCT05557604|Contraceptive Agents|contraceptive agents|mesh-ancestor
102183420|NCT05557604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102183421|NCT05557604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183422|NCT05557604|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102183423|NCT05557604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102183424|NCT05557604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102183425|NCT05556122|Betamethasone|betamethasone|mesh-list
102183426|NCT05556122|Ropivacaine|ropivacaine|mesh-list
102183427|NCT05556122|Anesthetics, Local|anesthetics, local|mesh-ancestor
102183428|NCT05556122|Anesthetics|anesthetics|mesh-ancestor
102183429|NCT05556122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102183430|NCT05556122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183431|NCT05556122|Sensory System Agents|sensory system agents|mesh-ancestor
102183432|NCT05556122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102183433|NCT05556122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102183434|NCT05556122|Glucocorticoids|glucocorticoids|mesh-ancestor
102183435|NCT05556122|Hormones|hormones|mesh-ancestor
102183436|NCT05556122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102183437|NCT05556122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102183438|NCT05556122|Respiratory System Agents|respiratory system agents|mesh-ancestor
102183439|NCT05611268|Pentoxifylline|pentoxifylline|mesh-list
102183440|NCT05611268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102183441|NCT05611268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102183442|NCT05611268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183443|NCT05611268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102183444|NCT05611268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102183445|NCT05611268|Protective Agents|protective agents|mesh-ancestor
102183446|NCT05611268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183447|NCT05611268|Vasodilator Agents|vasodilator agents|mesh-ancestor
102183448|NCT05611268|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102183449|NCT05611268|Antioxidants|antioxidants|mesh-ancestor
102183450|NCT05549570|Metformin|metformin|mesh-list
102183451|NCT05549570|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102183452|NCT05549570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102183453|NCT05549570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183454|NCT05549570|Incretins|incretins|mesh-ancestor
102183455|NCT05549570|Hormones|hormones|mesh-ancestor
102183456|NCT05549570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102183457|NCT05549570|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102183458|NCT05549570|Protease Inhibitors|protease inhibitors|mesh-ancestor
102183459|NCT05549570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102183460|NCT05549570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183461|NCT05549492|Buprenorphine|buprenorphine|mesh-list
102183462|NCT05549492|Ropivacaine|ropivacaine|mesh-list
102183463|NCT05549492|Anesthetics, Local|anesthetics, local|mesh-ancestor
102183464|NCT05549492|Anesthetics|anesthetics|mesh-ancestor
102183465|NCT05549492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102183466|NCT05549492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183467|NCT05549492|Sensory System Agents|sensory system agents|mesh-ancestor
101900117|NCT03873974|Immunoglobulin G|immunoglobulin g|mesh-list
102183468|NCT05549492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102183469|NCT05549492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102183471|NCT05549492|Analgesics|analgesics|mesh-ancestor
102183472|NCT05549492|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102183473|NCT04331132|Tolvaptan|tolvaptan|mesh-list
102183474|NCT04331132|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102183475|NCT04331132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183476|NCT04331132|Natriuretic Agents|natriuretic agents|mesh-ancestor
102183477|NCT04331132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183478|NCT05549336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102183479|NCT05549336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183480|NCT05549336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102183481|NCT05549336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102183482|NCT04759274|Diuretics|diuretics|mesh-list
102183483|NCT04759274|Natriuretic Agents|natriuretic agents|mesh-ancestor
102183484|NCT04759274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183485|NCT05549024|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102183486|NCT05549024|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102183487|NCT05549024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183488|NCT01666730|Leucovorin|leucovorin|mesh-list
102183489|NCT01666730|Metformin|metformin|mesh-list
102183490|NCT01666730|Fluorouracil|fluorouracil|mesh-list
102183491|NCT01666730|Oxaliplatin|oxaliplatin|mesh-list
102183492|NCT01666730|Calcium|calcium|mesh-list
102183493|NCT01666730|Levoleucovorin|levoleucovorin|mesh-list
102183494|NCT01666730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102183495|NCT01666730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183496|NCT01666730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102183497|NCT01666730|Antimetabolites|antimetabolites|mesh-ancestor
102183498|NCT01666730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183499|NCT01666730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102183500|NCT01666730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102183501|NCT01666730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102183502|NCT01666730|Immunologic Factors|immunologic factors|mesh-ancestor
102183503|NCT01666730|Antidotes|antidotes|mesh-ancestor
102183504|NCT01666730|Protective Agents|protective agents|mesh-ancestor
102183505|NCT01666730|Vitamin B Complex|vitamin b complex|mesh-ancestor
102183506|NCT01666730|Vitamins|vitamins|mesh-ancestor
102183507|NCT01666730|Micronutrients|micronutrients|mesh-ancestor
102183508|NCT05554094|Psilocybin|psilocybin|mesh-list
102183509|NCT05554094|Hallucinogens|hallucinogens|mesh-ancestor
102183510|NCT05554094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183511|NCT05554094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102183512|NCT04434560|Nivolumab|nivolumab|mesh-list
102183513|NCT04434560|Ipilimumab|ipilimumab|mesh-list
101448603|NCT00219570|Clindamycin|clindamycin|mesh-list
102183514|NCT04434560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102183515|NCT04434560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102183516|NCT04434560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102183517|NCT04434560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183518|NCT05700656|Capecitabine|capecitabine|mesh-list
102183519|NCT05700656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102183520|NCT05700656|Antimetabolites|antimetabolites|mesh-ancestor
102183521|NCT05700656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183522|NCT05700656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102183523|NCT00103285|Calcium, Dietary|calcium, dietary|mesh-list
102183524|NCT00103285|Leucovorin|leucovorin|mesh-list
102183525|NCT00103285|Folic Acid|folic acid|mesh-list
102183526|NCT00103285|Cytarabine|cytarabine|mesh-list
102183527|NCT00103285|Dexamethasone|dexamethasone|mesh-list
102183528|NCT00103285|Dexamethasone acetate|dexamethasone acetate|mesh-list
102183529|NCT00103285|Cyclophosphamide|cyclophosphamide|mesh-list
102183530|NCT00103285|Doxorubicin|doxorubicin|mesh-list
102183531|NCT00103285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102183532|NCT00103285|Methotrexate|methotrexate|mesh-list
102183533|NCT00103285|Vincristine|vincristine|mesh-list
102183534|NCT00103285|Asparaginase|asparaginase|mesh-list
102183535|NCT00103285|Mercaptopurine|mercaptopurine|mesh-list
102183536|NCT00103285|Pegaspargase|pegaspargase|mesh-list
102183537|NCT00103285|Thioguanine|thioguanine|mesh-list
102183538|NCT00103285|BB 1101|bb 1101|mesh-list
102183539|NCT00103285|Calcium|calcium|mesh-list
102183540|NCT00103285|2-Aminopurine|2-aminopurine|mesh-list
102183541|NCT00103285|Levoleucovorin|levoleucovorin|mesh-list
102183542|NCT00103285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102183543|NCT00103285|Immunologic Factors|immunologic factors|mesh-ancestor
102183544|NCT00103285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183545|NCT00103285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102183546|NCT00103285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102183548|NCT00103285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183549|NCT00103285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102183550|NCT00103285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102183551|NCT00103285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102183552|NCT00103285|Antiemetics|antiemetics|mesh-ancestor
102183553|NCT00103285|Autonomic Agents|autonomic agents|mesh-ancestor
102183554|NCT00103285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102183555|NCT00103285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102183556|NCT00103285|Glucocorticoids|glucocorticoids|mesh-ancestor
102183557|NCT00103285|Hormones|hormones|mesh-ancestor
102183558|NCT00103285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102183559|NCT00103285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102183560|NCT00103285|Protease Inhibitors|protease inhibitors|mesh-ancestor
102183561|NCT00103285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102183562|NCT00103285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102183563|NCT00103285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102183564|NCT00103285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102183565|NCT00103285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102183566|NCT00103285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102183567|NCT00103285|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102183568|NCT00103285|Abortifacient Agents|abortifacient agents|mesh-ancestor
102183569|NCT00103285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102183570|NCT00103285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102183571|NCT00103285|Antimetabolites|antimetabolites|mesh-ancestor
102183572|NCT00103285|Dermatologic Agents|dermatologic agents|mesh-ancestor
102183573|NCT00103285|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102183574|NCT00103285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102183575|NCT00103285|Antiviral Agents|antiviral agents|mesh-ancestor
102183576|NCT00103285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102183577|NCT00103285|Antidotes|antidotes|mesh-ancestor
102183578|NCT00103285|Protective Agents|protective agents|mesh-ancestor
102183579|NCT00103285|Vitamin B Complex|vitamin b complex|mesh-ancestor
102183580|NCT00103285|Vitamins|vitamins|mesh-ancestor
102183581|NCT00103285|Micronutrients|micronutrients|mesh-ancestor
102183582|NCT00103285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102183583|NCT00103285|Tubulin Modulators|tubulin modulators|mesh-ancestor
102183584|NCT00103285|Antimitotic Agents|antimitotic agents|mesh-ancestor
102183585|NCT00103285|Mitosis Modulators|mitosis modulators|mesh-ancestor
102183586|NCT00103285|Hematinics|hematinics|mesh-ancestor
102183587|NCT03541915|Magnesium Sulfate|magnesium sulfate|mesh-list
102183588|NCT03541915|Analgesics|analgesics|mesh-ancestor
102183589|NCT03541915|Sensory System Agents|sensory system agents|mesh-ancestor
102183590|NCT03541915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102183591|NCT03541915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183592|NCT03541915|Anesthetics|anesthetics|mesh-ancestor
102183593|NCT03541915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102183594|NCT03541915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102183595|NCT03541915|Anticonvulsants|anticonvulsants|mesh-ancestor
102183596|NCT03541915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102183597|NCT03541915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102183598|NCT03541915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183599|NCT03541915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102183600|NCT03541915|Tocolytic Agents|tocolytic agents|mesh-ancestor
102183601|NCT03541915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102183602|NCT03541837|Ropivacaine|ropivacaine|mesh-list
102183603|NCT03541837|Anesthetics, Local|anesthetics, local|mesh-ancestor
102183604|NCT03541837|Anesthetics|anesthetics|mesh-ancestor
102183605|NCT03541837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102183606|NCT03541837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183607|NCT03541837|Sensory System Agents|sensory system agents|mesh-ancestor
102183608|NCT03541837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102183609|NCT02158117|Naloxone|naloxone|mesh-list
102183610|NCT02158117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102183611|NCT02158117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183612|NCT02158117|Sensory System Agents|sensory system agents|mesh-ancestor
102183613|NCT02158117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102183614|NCT03541603|Simendan|simendan|mesh-list
102183615|NCT03541603|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102183616|NCT03541603|Vasodilator Agents|vasodilator agents|mesh-ancestor
102183617|NCT03541603|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102183618|NCT03541603|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102183619|NCT03541603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102183620|NCT03541603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183622|NCT03541603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183623|NCT02160223|Neostigmine|neostigmine|mesh-list
102183624|NCT02160223|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102183625|NCT02160223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102183626|NCT02160223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183627|NCT02160223|Cholinergic Agents|cholinergic agents|mesh-ancestor
102183628|NCT02160223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102183629|NCT02160223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183630|NCT02160223|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102183631|NCT02160223|Autonomic Agents|autonomic agents|mesh-ancestor
102183632|NCT02160223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102183633|NCT02160301|Acetaminophen|acetaminophen|mesh-list
102183634|NCT02160301|Dexamethasone|dexamethasone|mesh-list
102183635|NCT02160301|Celecoxib|celecoxib|mesh-list
102183636|NCT02160301|Oxycodone|oxycodone|mesh-list
102183637|NCT02160301|Gabapentin|gabapentin|mesh-list
102183638|NCT02160301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102183639|NCT02160301|Antiemetics|antiemetics|mesh-ancestor
102183640|NCT02160301|Autonomic Agents|autonomic agents|mesh-ancestor
102183641|NCT02160301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102183642|NCT02160301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183643|NCT02160301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102183644|NCT02160301|Glucocorticoids|glucocorticoids|mesh-ancestor
102183645|NCT02160301|Hormones|hormones|mesh-ancestor
102183646|NCT02160301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102183647|NCT02160301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102183648|NCT02160301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102183649|NCT02160301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102183650|NCT02160301|Analgesics|analgesics|mesh-ancestor
101448616|NCT00212472|Coagulants|coagulants|mesh-ancestor
102183651|NCT02160301|Sensory System Agents|sensory system agents|mesh-ancestor
102183652|NCT02160301|Antipyretics|antipyretics|mesh-ancestor
102183653|NCT02160301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102183654|NCT02160301|Narcotics|narcotics|mesh-ancestor
102183655|NCT02160301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102183656|NCT02160301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102183657|NCT02160301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102183658|NCT02160301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102183659|NCT02160301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102183660|NCT02160301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102183661|NCT02160301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183662|NCT02160301|Anticonvulsants|anticonvulsants|mesh-ancestor
102183663|NCT02160301|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102183664|NCT02160301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102183665|NCT02160301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102183666|NCT02160301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102183667|NCT02160301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102183668|NCT02160301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102183669|NCT02160301|Antimanic Agents|antimanic agents|mesh-ancestor
102183670|NCT03541759|Hydromorphone|hydromorphone|mesh-list
102183671|NCT03541759|Pirinitramide|pirinitramide|mesh-list
102183672|NCT03541759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102183673|NCT03541759|Narcotics|narcotics|mesh-ancestor
102183674|NCT03541759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102183675|NCT03541759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183676|NCT03541759|Analgesics|analgesics|mesh-ancestor
102183677|NCT03541759|Sensory System Agents|sensory system agents|mesh-ancestor
102183678|NCT03541759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102183679|NCT05206955|Tadalafil|tadalafil|mesh-list
102183680|NCT05206955|Vasodilator Agents|vasodilator agents|mesh-ancestor
102183681|NCT05206955|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102183682|NCT05206955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102183683|NCT05206955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102183684|NCT05206955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183685|NCT05206955|Urological Agents|urological agents|mesh-ancestor
102183686|NCT01666652|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102183687|NCT01666652|Aluminum sulfate|aluminum sulfate|mesh-list
102183688|NCT01666652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102183689|NCT01666652|Immunologic Factors|immunologic factors|mesh-ancestor
102183690|NCT01666652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183691|NCT01666652|Antacids|antacids|mesh-ancestor
102183692|NCT01666652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183693|NCT01666652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102183694|NCT05174585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102183695|NCT05174585|Pembrolizumab|pembrolizumab|mesh-list
102183696|NCT05174585|Antibodies|antibodies|mesh-list
102183697|NCT05174585|Immunoglobulins|immunoglobulins|mesh-list
102183698|NCT05174585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102183699|NCT05174585|Immunologic Factors|immunologic factors|mesh-ancestor
102183700|NCT05174585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183701|NCT05174585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102183702|NCT05174585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102183703|NCT05174585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183704|NCT04428086|Metformin|metformin|mesh-list
102183705|NCT04428086|Apatinib|apatinib|mesh-list
102183706|NCT04428086|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102183707|NCT04428086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102183708|NCT04428086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183709|NCT04428086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102183710|NCT04428086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102183711|NCT04428086|Antimetabolites|antimetabolites|mesh-ancestor
102183712|NCT04428086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183713|NCT04428086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102183714|NCT04428086|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102183715|NCT04428086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102183716|NCT04428086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102183717|NCT04428086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102183718|NCT05125055|Paclitaxel|paclitaxel|mesh-list
102183719|NCT05125055|Docetaxel|docetaxel|mesh-list
102183720|NCT05125055|Fluorouracil|fluorouracil|mesh-list
101308268|NCT02046551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102183721|NCT05125055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102183722|NCT05125055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102183723|NCT05125055|Tubulin Modulators|tubulin modulators|mesh-ancestor
102183724|NCT05125055|Antimitotic Agents|antimitotic agents|mesh-ancestor
102183725|NCT05125055|Mitosis Modulators|mitosis modulators|mesh-ancestor
102183726|NCT05125055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183727|NCT05125055|Antimetabolites|antimetabolites|mesh-ancestor
102183728|NCT05125055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102183729|NCT05125055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102183730|NCT05125055|Immunologic Factors|immunologic factors|mesh-ancestor
102183731|NCT05125055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183732|NCT04355858|Paclitaxel|paclitaxel|mesh-list
102183733|NCT04355858|Capecitabine|capecitabine|mesh-list
102183734|NCT04355858|Everolimus|everolimus|mesh-list
102183735|NCT04355858|Fluzoparib|fluzoparib|mesh-list
102183736|NCT04355858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102183737|NCT04355858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102183738|NCT04355858|Tubulin Modulators|tubulin modulators|mesh-ancestor
102183739|NCT04355858|Antimitotic Agents|antimitotic agents|mesh-ancestor
102183740|NCT04355858|Mitosis Modulators|mitosis modulators|mesh-ancestor
102183741|NCT04355858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183742|NCT04355858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102183743|NCT04355858|Antimetabolites|antimetabolites|mesh-ancestor
102183744|NCT04355858|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102183745|NCT04355858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102183746|NCT04355858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102183747|NCT04355858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102183748|NCT04355858|Immunologic Factors|immunologic factors|mesh-ancestor
102183749|NCT04355858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183750|NCT04355858|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102183751|NCT05610956|Empagliflozin|empagliflozin|mesh-list
102183752|NCT05610956|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102183753|NCT05610956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183754|NCT05610956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102183755|NCT05610956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183756|NCT00109733|Hormones|hormones|mesh-list
102183757|NCT00109733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101892627|NCT01088724|Cyclophosphamide|cyclophosphamide|mesh-list
102183758|NCT00109733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183759|NCT05699876|Gabapentin|gabapentin|mesh-list
102183760|NCT05699876|Melatonin|melatonin|mesh-list
102183761|NCT05699876|Analgesics|analgesics|mesh-ancestor
102183762|NCT05699876|Sensory System Agents|sensory system agents|mesh-ancestor
102183763|NCT05699876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102183764|NCT05699876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183765|NCT05699876|Anticonvulsants|anticonvulsants|mesh-ancestor
102183766|NCT05699876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102183767|NCT05699876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102183768|NCT05699876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102183769|NCT05699876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102183770|NCT05699876|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102183771|NCT05699876|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102183772|NCT05699876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102183773|NCT05699876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183774|NCT05699876|Antimanic Agents|antimanic agents|mesh-ancestor
102183775|NCT05699876|Antioxidants|antioxidants|mesh-ancestor
102183776|NCT05699876|Protective Agents|protective agents|mesh-ancestor
102183777|NCT05610878|Curcumin|curcumin|mesh-list
102183778|NCT05610878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102183779|NCT05610878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102183780|NCT05610878|Analgesics|analgesics|mesh-ancestor
102183781|NCT05610878|Sensory System Agents|sensory system agents|mesh-ancestor
102183782|NCT05610878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102183783|NCT05610878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183784|NCT05610878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102183785|NCT05610878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102183786|NCT05610878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102183787|NCT05610878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102183788|NCT05610878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183789|NCT02706405|Cyclophosphamide|cyclophosphamide|mesh-list
102183790|NCT02706405|Fludarabine|fludarabine|mesh-list
102183791|NCT02706405|Durvalumab|durvalumab|mesh-list
102183792|NCT02706405|Immunoglobulins|immunoglobulins|mesh-list
102183793|NCT02706405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102183794|NCT02706405|Immunoglobulin G|immunoglobulin g|mesh-list
102183795|NCT02706405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102183796|NCT02706405|Immunologic Factors|immunologic factors|mesh-ancestor
102183797|NCT02706405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183798|NCT02706405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102183799|NCT02706405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102183800|NCT02706405|Alkylating Agents|alkylating agents|mesh-ancestor
102183801|NCT02706405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183802|NCT02706405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102183803|NCT02706405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102183804|NCT02706405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102183805|NCT02254031|Maytansine|maytansine|mesh-list
102183806|NCT02254031|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
102183807|NCT02254031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102183808|NCT02254031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102183809|NCT02254031|Tubulin Modulators|tubulin modulators|mesh-ancestor
102183810|NCT02254031|Antimitotic Agents|antimitotic agents|mesh-ancestor
102183811|NCT02254031|Mitosis Modulators|mitosis modulators|mesh-ancestor
102183812|NCT02254031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183813|NCT02254031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102183814|NCT02254031|Immunotoxins|immunotoxins|mesh-ancestor
102183815|NCT02254031|Immunoconjugates|immunoconjugates|mesh-ancestor
102183816|NCT02254031|Immunologic Factors|immunologic factors|mesh-ancestor
102183817|NCT02254031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183818|NCT03545711|Irinotecan|irinotecan|mesh-list
102183819|NCT03545711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102183820|NCT03545711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102183821|NCT03545711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102183822|NCT03545711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183823|NCT03545711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102183824|NCT03546959|Botulinum Toxins|botulinum toxins|mesh-list
102183825|NCT03546959|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102183826|NCT03546959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102183827|NCT03546959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183828|NCT03546959|Cholinergic Agents|cholinergic agents|mesh-ancestor
102183829|NCT03546959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102183830|NCT03546959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183831|NCT03998813|Ropivacaine|ropivacaine|mesh-list
102183832|NCT03998813|Anesthetics, Local|anesthetics, local|mesh-ancestor
102183833|NCT03998813|Anesthetics|anesthetics|mesh-ancestor
102183834|NCT03998813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102183835|NCT03998813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183836|NCT03998813|Sensory System Agents|sensory system agents|mesh-ancestor
102183837|NCT03998813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102183838|NCT01569659|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102183839|NCT01569659|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102183840|NCT01569659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102183841|NCT01569659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102183842|NCT01569659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183843|NCT01569659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102183844|NCT01569659|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102183845|NCT01569659|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102183846|NCT01569659|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102183847|NCT01569659|Adrenergic Agents|adrenergic agents|mesh-ancestor
102183848|NCT01569659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102183849|NCT01569659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183850|NCT01569659|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101448656|NCT00188669|Protective Agents|protective agents|mesh-ancestor
102183851|NCT01569659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102183852|NCT01569659|Serotonin Agents|serotonin agents|mesh-ancestor
102183853|NCT01569659|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102183854|NCT01569659|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102183855|NCT01569659|Dopamine Agents|dopamine agents|mesh-ancestor
102183857|NCT02253953|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102183858|NCT02253953|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102183859|NCT02253953|Protease Inhibitors|protease inhibitors|mesh-ancestor
102183860|NCT02253953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102183861|NCT02253953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183862|NCT02253953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102183863|NCT02253953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102183864|NCT02253953|Antiviral Agents|antiviral agents|mesh-ancestor
102183865|NCT02253953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102183866|NCT02253953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102183867|NCT02253953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102183868|NCT03546803|Protective Agents|protective agents|mesh-list
102183869|NCT03546803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183870|NCT02422953|Micronutrients|micronutrients|mesh-list
102183871|NCT02422953|Trace Elements|trace elements|mesh-list
102183872|NCT02422953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183873|NCT04053140|Penicillins|penicillins|mesh-list
102183874|NCT04053140|Penicillin G|penicillin g|mesh-list
102183875|NCT04053140|Penicillin G Benzathine|penicillin g benzathine|mesh-list
102183876|NCT04053140|Penicillin G Procaine|penicillin g procaine|mesh-list
102183877|NCT04053140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102183878|NCT04053140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102183879|NCT03713879|Indomethacin|indomethacin|mesh-list
102183880|NCT03713879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102183881|NCT03713879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102183882|NCT03713879|Analgesics|analgesics|mesh-ancestor
102183883|NCT03713879|Sensory System Agents|sensory system agents|mesh-ancestor
102183884|NCT03713879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102183885|NCT03713879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183886|NCT03713879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102183887|NCT03713879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102183888|NCT03713879|Gout Suppressants|gout suppressants|mesh-ancestor
102183889|NCT03713879|Tocolytic Agents|tocolytic agents|mesh-ancestor
102183890|NCT03713879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102183891|NCT03713879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102183892|NCT03713879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102183893|NCT03713879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183894|NCT03107169|Vancomycin|vancomycin|mesh-list
102183895|NCT03107169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102183896|NCT03107169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102183897|NCT05552300|Antihypertensive Agents|antihypertensive agents|mesh-list
102183898|NCT05064059|Pembrolizumab|pembrolizumab|mesh-list
102183899|NCT05064059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102183900|NCT05064059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102183901|NCT05064059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102183902|NCT05064059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183903|NCT02425605|Sorafenib|sorafenib|mesh-list
102183904|NCT02425605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102183905|NCT02425605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102183906|NCT02425605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101892775|NCT03404206|Analgesics|analgesics|mesh-ancestor
102183907|NCT02425605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183908|NCT02422563|Paclitaxel|paclitaxel|mesh-list
102183909|NCT02422563|Carboplatin|carboplatin|mesh-list
102183910|NCT02422563|Ifosfamide|ifosfamide|mesh-list
101900130|NCT02526758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183911|NCT02422563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102183912|NCT02422563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102183913|NCT02422563|Tubulin Modulators|tubulin modulators|mesh-ancestor
102183914|NCT02422563|Antimitotic Agents|antimitotic agents|mesh-ancestor
102183915|NCT02422563|Mitosis Modulators|mitosis modulators|mesh-ancestor
102183916|NCT02422563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183917|NCT02422563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102183918|NCT02422563|Alkylating Agents|alkylating agents|mesh-ancestor
101448667|NCT02963051|Copper|copper|mesh-list
102183920|NCT03185403|Ropivacaine|ropivacaine|mesh-list
102183921|NCT03185403|Anesthetics, Local|anesthetics, local|mesh-ancestor
102183922|NCT03185403|Anesthetics|anesthetics|mesh-ancestor
102183923|NCT03185403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102183924|NCT03185403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183925|NCT03185403|Sensory System Agents|sensory system agents|mesh-ancestor
102183926|NCT03185403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102183927|NCT03185403|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102183928|NCT03185403|Narcotics|narcotics|mesh-ancestor
102183929|NCT03185403|Analgesics|analgesics|mesh-ancestor
102183930|NCT03185403|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102183931|NCT03185403|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102183932|NCT03185403|Anesthetics, General|anesthetics, general|mesh-ancestor
102183933|NCT04329806|Amlodipine|amlodipine|mesh-list
102183934|NCT04329806|Moxonidine|moxonidine|mesh-list
102183935|NCT04329806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102183936|NCT04329806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102183937|NCT04329806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102183938|NCT04329806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183939|NCT04329806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102183940|NCT04329806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183941|NCT04329806|Vasodilator Agents|vasodilator agents|mesh-ancestor
102183942|NCT02422485|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
102183943|NCT02422485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102183944|NCT02422485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102183945|NCT02422485|Analgesics|analgesics|mesh-ancestor
102183946|NCT02422485|Sensory System Agents|sensory system agents|mesh-ancestor
102183947|NCT02422485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102183948|NCT02422485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183949|NCT02422485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102183950|NCT02422485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102183951|NCT05551910|Remifentanil|remifentanil|mesh-list
102183952|NCT05551910|Propofol|propofol|mesh-list
102183953|NCT05551910|Esketamine|esketamine|mesh-list
102183954|NCT05551910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102183955|NCT05551910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102183956|NCT05551910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183957|NCT05551910|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102183958|NCT05551910|Anesthetics, General|anesthetics, general|mesh-ancestor
102183959|NCT05551910|Anesthetics|anesthetics|mesh-ancestor
102183960|NCT05551910|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102183961|NCT05551910|Narcotics|narcotics|mesh-ancestor
102183962|NCT05551910|Analgesics|analgesics|mesh-ancestor
102183963|NCT05551910|Sensory System Agents|sensory system agents|mesh-ancestor
102183964|NCT05551910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102183965|NCT05551910|Antidepressive Agents|antidepressive agents|mesh-ancestor
102183966|NCT05551910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102183967|NCT05699720|Magnesium Sulfate|magnesium sulfate|mesh-list
102183968|NCT05699720|Analgesics|analgesics|mesh-ancestor
102183969|NCT05699720|Sensory System Agents|sensory system agents|mesh-ancestor
102183970|NCT05699720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102183971|NCT05699720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183972|NCT05699720|Anesthetics|anesthetics|mesh-ancestor
102183973|NCT05699720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102183974|NCT05699720|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102183975|NCT05699720|Anticonvulsants|anticonvulsants|mesh-ancestor
102183976|NCT05699720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102183977|NCT05699720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102183978|NCT05699720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102183979|NCT05699720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102183980|NCT05699720|Tocolytic Agents|tocolytic agents|mesh-ancestor
102183981|NCT05699720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102183982|NCT05546762|Povidone-Iodine|povidone-iodine|mesh-list
102183984|NCT05546762|Plasma Substitutes|plasma substitutes|mesh-ancestor
102183985|NCT05546762|Blood Substitutes|blood substitutes|mesh-ancestor
102183986|NCT05546762|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102183987|NCT05546762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102183988|NCT03535883|Anticoagulants|anticoagulants|mesh-list
102183989|NCT03535883|Coagulants|coagulants|mesh-list
102183990|NCT05551598|Mitoxantrone|mitoxantrone|mesh-list
102183991|NCT05551598|Analgesics|analgesics|mesh-ancestor
102183992|NCT05551598|Sensory System Agents|sensory system agents|mesh-ancestor
102183993|NCT05551598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102183994|NCT05551598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102183995|NCT05551598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102183996|NCT05551598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102183997|NCT05551598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102183998|NCT05551598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102183999|NCT05551598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184000|NCT03810794|Donepezil|donepezil|mesh-list
102184001|NCT03810794|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102184002|NCT03810794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102184003|NCT03810794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184004|NCT03810794|Cholinergic Agents|cholinergic agents|mesh-ancestor
102184005|NCT03810794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102184006|NCT03810794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184007|NCT03810794|Nootropic Agents|nootropic agents|mesh-ancestor
102184008|NCT03185793|Benzbromarone|benzbromarone|mesh-list
102184009|NCT03185793|Uricosuric Agents|uricosuric agents|mesh-ancestor
102184010|NCT03185793|Gout Suppressants|gout suppressants|mesh-ancestor
102184011|NCT03185793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102184012|NCT03660488|Penicillins|penicillins|mesh-list
102184013|NCT03660488|Cefixime|cefixime|mesh-list
102184014|NCT03660488|Penicillin G|penicillin g|mesh-list
102184015|NCT03660488|Penicillin G Benzathine|penicillin g benzathine|mesh-list
102184016|NCT03660488|Penicillin G Procaine|penicillin g procaine|mesh-list
102184017|NCT03660488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102184018|NCT03660488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102184019|NCT02422017|Timolol|timolol|mesh-list
102184020|NCT02422017|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102184021|NCT02422017|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102184022|NCT02422017|Adrenergic Agents|adrenergic agents|mesh-ancestor
102184023|NCT02422017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102184024|NCT02422017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184025|NCT02422017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184026|NCT02422017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102184027|NCT02422017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102184028|NCT02761915|Cyclophosphamide|cyclophosphamide|mesh-list
102184029|NCT02761915|Fludarabine|fludarabine|mesh-list
102184030|NCT02761915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102184031|NCT02761915|Immunologic Factors|immunologic factors|mesh-ancestor
102184032|NCT02761915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184033|NCT02761915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102184034|NCT02761915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102184035|NCT02761915|Alkylating Agents|alkylating agents|mesh-ancestor
102184036|NCT02761915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184037|NCT02761915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102184038|NCT02761915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102184039|NCT03464084|Melatonin|melatonin|mesh-list
102184040|NCT03464084|Antioxidants|antioxidants|mesh-ancestor
102184041|NCT03464084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184042|NCT03464084|Protective Agents|protective agents|mesh-ancestor
102184043|NCT03464084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184044|NCT03464084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102184045|NCT05551208|Bevacizumab|bevacizumab|mesh-list
102184046|NCT05551208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102184047|NCT05551208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102184048|NCT05551208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102184049|NCT05551208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102184050|NCT05551208|Growth Substances|growth substances|mesh-ancestor
102184051|NCT05551208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184052|NCT05551208|Growth Inhibitors|growth inhibitors|mesh-ancestor
102184053|NCT02764333|Durvalumab|durvalumab|mesh-list
101448677|NCT00219726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102184054|NCT02764333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102184055|NCT02764333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102184056|NCT02161159|Botulinum Toxins|botulinum toxins|mesh-list
102184057|NCT02161159|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102184058|NCT02161159|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101900133|NCT02526758|Glucocorticoids|glucocorticoids|mesh-ancestor
102184059|NCT02161159|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102184060|NCT02161159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102184061|NCT02161159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184062|NCT02161159|Cholinergic Agents|cholinergic agents|mesh-ancestor
102184063|NCT02161159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102184064|NCT02161159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184065|NCT02161159|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102184066|NCT02161159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102184067|NCT02160925|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
102184068|NCT02160925|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102184069|NCT02160925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184071|NCT02161237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102184072|NCT02161237|Immunologic Factors|immunologic factors|mesh-ancestor
102184073|NCT02161237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184074|NCT02161237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102184075|NCT02161237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102184076|NCT02161237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184077|NCT03173066|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102184078|NCT03173066|Hematinics|hematinics|mesh-ancestor
102184079|NCT03173066|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102184080|NCT03173066|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102184081|NCT05546060|Dexamethasone|dexamethasone|mesh-list
102184082|NCT05546060|Etoposide|etoposide|mesh-list
102184083|NCT05546060|Venetoclax|venetoclax|mesh-list
102184084|NCT05546060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102184085|NCT05546060|Antiemetics|antiemetics|mesh-ancestor
102184086|NCT05546060|Autonomic Agents|autonomic agents|mesh-ancestor
102184087|NCT05546060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102184088|NCT05546060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184089|NCT05546060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102184090|NCT05546060|Glucocorticoids|glucocorticoids|mesh-ancestor
102184091|NCT05546060|Hormones|hormones|mesh-ancestor
102184092|NCT05546060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102184093|NCT05546060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102184094|NCT05546060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102184095|NCT05546060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102184096|NCT05546060|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102184097|NCT05546060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102184098|NCT05546060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102184099|NCT05546060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184100|NCT02416869|Dexamethasone|dexamethasone|mesh-list
102184101|NCT02416869|Dexamethasone acetate|dexamethasone acetate|mesh-list
102184102|NCT02416869|BB 1101|bb 1101|mesh-list
102184103|NCT02416869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102184104|NCT02416869|Antiemetics|antiemetics|mesh-ancestor
102184105|NCT02416869|Autonomic Agents|autonomic agents|mesh-ancestor
102184106|NCT02416869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102184107|NCT02416869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184108|NCT02416869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102184109|NCT02416869|Glucocorticoids|glucocorticoids|mesh-ancestor
102184110|NCT02416869|Hormones|hormones|mesh-ancestor
102184111|NCT02416869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102184112|NCT02416869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102184113|NCT02416869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102184114|NCT02416869|Protease Inhibitors|protease inhibitors|mesh-ancestor
102184115|NCT02416869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102184116|NCT02416869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184117|NCT02588612|Cyclophosphamide|cyclophosphamide|mesh-list
102184118|NCT02588612|Fludarabine|fludarabine|mesh-list
102184119|NCT02588612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102184120|NCT02588612|Immunologic Factors|immunologic factors|mesh-ancestor
102184121|NCT02588612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184122|NCT02588612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102184123|NCT02588612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102184124|NCT02588612|Alkylating Agents|alkylating agents|mesh-ancestor
102184125|NCT02588612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184126|NCT02588612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102184127|NCT02588612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102184128|NCT02161939|Sofosbuvir|sofosbuvir|mesh-list
102184129|NCT02161939|Antiviral Agents|antiviral agents|mesh-ancestor
102184130|NCT02161939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102184131|NCT03540979|Letrozole|letrozole|mesh-list
102184132|NCT03540979|Progesterone|progesterone|mesh-list
102184133|NCT03540979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102184134|NCT03540979|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102184135|NCT03540979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102184136|NCT03540979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102184137|NCT03540979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184138|NCT03540979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102184139|NCT03540979|Hormone Antagonists|hormone antagonists|mesh-ancestor
102184140|NCT03540979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102184141|NCT03540979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184142|NCT03540979|Progestins|progestins|mesh-ancestor
102184143|NCT03540979|Hormones|hormones|mesh-ancestor
102184144|NCT02946788|Minocycline|minocycline|mesh-list
102184145|NCT02946788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102184146|NCT02946788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102184147|NCT02159131|Cabotegravir|cabotegravir|mesh-list
102184148|NCT02159131|Levonorgestrel|levonorgestrel|mesh-list
102184149|NCT02159131|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102184150|NCT02159131|Contraceptive Agents|contraceptive agents|mesh-ancestor
102184151|NCT02159131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102184152|NCT02159131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184153|NCT02159131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102184154|NCT02159131|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102184155|NCT02159131|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102184156|NCT02159131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102184157|NCT02159131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102184158|NCT02159131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102184159|NCT02159131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184160|NCT02159131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102184161|NCT02159131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102184162|NCT02159131|Antiviral Agents|antiviral agents|mesh-ancestor
102184163|NCT02159131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102184164|NCT05550506|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102184165|NCT05550506|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102184166|NCT05550506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102184167|NCT05550506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102184168|NCT05550506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184169|NCT05550506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102184170|NCT05550506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184171|NCT05550506|Analgesics|analgesics|mesh-ancestor
102184172|NCT05550506|Sensory System Agents|sensory system agents|mesh-ancestor
102184173|NCT05550506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102184174|NCT05550506|Antidepressive Agents|antidepressive agents|mesh-ancestor
102184175|NCT05550506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102184176|NCT05550506|Dopamine Agents|dopamine agents|mesh-ancestor
102184177|NCT03174795|Meropenem|meropenem|mesh-list
102184178|NCT03174795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102184179|NCT03174795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102184180|NCT02163655|Furosemide|furosemide|mesh-list
102184181|NCT02163655|Diuretics|diuretics|mesh-ancestor
102184182|NCT02163655|Natriuretic Agents|natriuretic agents|mesh-ancestor
102184183|NCT02163655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184184|NCT02163655|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102184185|NCT02163655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102184186|NCT02163655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184187|NCT02410083|Aspirin|aspirin|mesh-list
102184188|NCT02410083|Clopidogrel|clopidogrel|mesh-list
102184189|NCT02410083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102184190|NCT02410083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102184191|NCT02410083|Analgesics|analgesics|mesh-ancestor
102184192|NCT02410083|Sensory System Agents|sensory system agents|mesh-ancestor
102184193|NCT02410083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102184194|NCT02410083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184195|NCT02410083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102184196|NCT02410083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102184197|NCT02410083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102184198|NCT02410083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102184199|NCT02410083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184200|NCT02410083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102184201|NCT02410083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102184202|NCT02410083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102184204|NCT02410083|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102184205|NCT02410083|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102184206|NCT02410083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102184207|NCT02410083|Purinergic Agents|purinergic agents|mesh-ancestor
102184208|NCT02410083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102184209|NCT02416245|Micronutrients|micronutrients|mesh-list
102184210|NCT02416245|Trace Elements|trace elements|mesh-list
102184211|NCT02416245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184212|NCT02416167|Dotinurad|dotinurad|mesh-list
102184213|NCT02416167|Uricosuric Agents|uricosuric agents|mesh-ancestor
102184214|NCT02416167|Gout Suppressants|gout suppressants|mesh-ancestor
102184215|NCT02416167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102184216|NCT02166853|Midazolam|midazolam|mesh-list
102184217|NCT02166853|Sevoflurane|sevoflurane|mesh-list
102184218|NCT02166853|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102184219|NCT02166853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102184220|NCT02166853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102184221|NCT02166853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184222|NCT02166853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102184223|NCT02166853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102184224|NCT02166853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102184225|NCT02166853|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102184226|NCT02166853|Anesthetics, General|anesthetics, general|mesh-ancestor
102184227|NCT02166853|Anesthetics|anesthetics|mesh-ancestor
102184228|NCT02166853|GABA Modulators|gaba modulators|mesh-ancestor
102184229|NCT02166853|GABA Agents|gaba agents|mesh-ancestor
102184230|NCT02166853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102184231|NCT02166853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184232|NCT02166853|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102184233|NCT02166853|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102184234|NCT02162251|Donepezil|donepezil|mesh-list
102184235|NCT02162251|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102184236|NCT02162251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102184237|NCT02162251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184238|NCT02162251|Cholinergic Agents|cholinergic agents|mesh-ancestor
102184239|NCT02162251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102184240|NCT02162251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184241|NCT02162251|Nootropic Agents|nootropic agents|mesh-ancestor
102184242|NCT02164045|Fostemsavir|fostemsavir|mesh-list
102184243|NCT02164045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102184244|NCT02164045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102184245|NCT02164045|Antiviral Agents|antiviral agents|mesh-ancestor
102184246|NCT02164045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102184247|NCT02164045|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102184248|NCT02164045|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102184249|NCT02164045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184250|NCT02410005|Calcitriol|calcitriol|mesh-list
102184251|NCT02410005|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
102184252|NCT02410005|Losartan|losartan|mesh-list
102184253|NCT02410005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101448714|NCT00212589|Leucovorin|leucovorin|mesh-list
102184254|NCT02410005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102184255|NCT02410005|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102184256|NCT02410005|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102184257|NCT02410005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184258|NCT02410005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102184259|NCT02410005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184260|NCT02410005|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102184261|NCT02410005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102184262|NCT02410005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102184263|NCT02410005|Vitamins|vitamins|mesh-ancestor
102184264|NCT02410005|Micronutrients|micronutrients|mesh-ancestor
102184265|NCT02410005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102184266|NCT05543330|Cisplatin|cisplatin|mesh-list
102184267|NCT05543330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102184268|NCT03174561|Choline|choline|mesh-list
102184269|NCT03174561|Silymarin|silymarin|mesh-list
102184270|NCT03174561|Lipotropic Agents|lipotropic agents|mesh-ancestor
102184271|NCT03174561|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102184272|NCT03174561|Antimetabolites|antimetabolites|mesh-ancestor
102184273|NCT03174561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184274|NCT03174561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102184275|NCT03174561|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102184276|NCT03174561|Nootropic Agents|nootropic agents|mesh-ancestor
102184277|NCT03174561|Antioxidants|antioxidants|mesh-ancestor
102184278|NCT03174561|Protective Agents|protective agents|mesh-ancestor
102184279|NCT03174561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184280|NCT05545592|Estrogens|estrogens|mesh-list
102184281|NCT05545592|Hormones|hormones|mesh-ancestor
102184282|NCT05545592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102184283|NCT05545592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184284|NCT05545436|Capecitabine|capecitabine|mesh-list
102184285|NCT05545436|Oxaliplatin|oxaliplatin|mesh-list
102184286|NCT05545436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102184287|NCT05545436|Antimetabolites|antimetabolites|mesh-ancestor
102184288|NCT05545436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184289|NCT05545436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102184290|NCT02167165|Digoxin|digoxin|mesh-list
102184291|NCT02167165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102184292|NCT02167165|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102184293|NCT02167165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102184294|NCT02167165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184295|NCT02167165|Protective Agents|protective agents|mesh-ancestor
102184296|NCT02167165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184297|NCT05545124|Tislelizumab|tislelizumab|mesh-list
102184298|NCT05545124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102184299|NCT05545124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102184300|NCT02409849|Octreotide|octreotide|mesh-list
102184301|NCT02409849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102184302|NCT02409849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102184303|NCT02409849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102184304|NCT00664040|Aspirin|aspirin|mesh-list
102184305|NCT00664040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102184306|NCT00664040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102184307|NCT00664040|Analgesics|analgesics|mesh-ancestor
102184308|NCT00664040|Sensory System Agents|sensory system agents|mesh-ancestor
102184309|NCT00664040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102184310|NCT00664040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184311|NCT00664040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102184312|NCT00664040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102184313|NCT00664040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102184314|NCT00664040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102184315|NCT00664040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184316|NCT00664040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102184317|NCT00664040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102184318|NCT00664040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102184319|NCT00664040|Antipyretics|antipyretics|mesh-ancestor
102184320|NCT02162407|Insulin|insulin|mesh-list
102184321|NCT02162407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102184322|NCT02162407|Insulin Detemir|insulin detemir|mesh-list
102184323|NCT02162407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102184324|NCT02162407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184325|NCT02162485|Fluticasone|fluticasone|mesh-list
102184326|NCT02162485|Xhance|xhance|mesh-list
102184327|NCT02162485|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102184328|NCT02162485|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102184329|NCT02162485|Charcoal|charcoal|mesh-list
102184330|NCT02162485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102184331|NCT02162485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102184332|NCT02162485|Autonomic Agents|autonomic agents|mesh-ancestor
102184333|NCT02162485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102184334|NCT02162485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184335|NCT02162485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102184336|NCT02162485|Respiratory System Agents|respiratory system agents|mesh-ancestor
102184337|NCT02162485|Dermatologic Agents|dermatologic agents|mesh-ancestor
102184338|NCT02162485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102184339|NCT02162485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102184340|NCT02162485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102184341|NCT02162485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102184342|NCT02162485|Adrenergic Agents|adrenergic agents|mesh-ancestor
102184343|NCT02162485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102184344|NCT02162485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184345|NCT02162485|Glucocorticoids|glucocorticoids|mesh-ancestor
102184346|NCT02162485|Hormones|hormones|mesh-ancestor
102184347|NCT02162485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102184348|NCT02162485|Sympathomimetics|sympathomimetics|mesh-ancestor
102184349|NCT02162485|Antidotes|antidotes|mesh-ancestor
102184350|NCT02162485|Protective Agents|protective agents|mesh-ancestor
102184351|NCT02415777|Riboflavin|riboflavin|mesh-list
102184353|NCT02415777|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102184354|NCT02415777|Vitamin B Complex|vitamin b complex|mesh-ancestor
102184355|NCT02415777|Vitamins|vitamins|mesh-ancestor
102184356|NCT02415777|Micronutrients|micronutrients|mesh-ancestor
102184357|NCT02415777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184358|NCT02415777|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102184359|NCT02415777|Dermatologic Agents|dermatologic agents|mesh-ancestor
101893223|NCT00041132|Antiemetics|antiemetics|mesh-ancestor
102184360|NCT02415777|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102184361|NCT02415777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102184362|NCT05544968|Antibodies|antibodies|mesh-list
102184363|NCT05544968|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102184364|NCT05544968|Immunologic Factors|immunologic factors|mesh-ancestor
102184365|NCT05544968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184366|NCT03178539|Diclofenac|diclofenac|mesh-list
102184367|NCT03178539|Ketorolac|ketorolac|mesh-list
102184368|NCT03178539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102184369|NCT03178539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102184370|NCT03178539|Analgesics|analgesics|mesh-ancestor
102184371|NCT03178539|Sensory System Agents|sensory system agents|mesh-ancestor
102184372|NCT03178539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102184373|NCT03178539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184374|NCT03178539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102184375|NCT03178539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102184376|NCT03178539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102184377|NCT03178539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102184378|NCT03178539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184379|NCT03174483|Fluticasone|fluticasone|mesh-list
102184380|NCT03174483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102184381|NCT03174483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102184382|NCT03174483|Autonomic Agents|autonomic agents|mesh-ancestor
102184383|NCT03174483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102184384|NCT03174483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184385|NCT03174483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102184386|NCT03174483|Respiratory System Agents|respiratory system agents|mesh-ancestor
102184387|NCT03174483|Dermatologic Agents|dermatologic agents|mesh-ancestor
102184388|NCT03174483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102184389|NCT05699174|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102184390|NCT05699174|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102184391|NCT05699174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102184392|NCT05699174|Antitubercular Agents|antitubercular agents|mesh-ancestor
102184393|NCT04320914|Ibuprofen|ibuprofen|mesh-list
102184394|NCT04320914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102184395|NCT04320914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102184396|NCT04320914|Analgesics|analgesics|mesh-ancestor
102184397|NCT04320914|Sensory System Agents|sensory system agents|mesh-ancestor
102184398|NCT04320914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102184399|NCT04320914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184400|NCT04320914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102184401|NCT04320914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102184402|NCT04320914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102184403|NCT04320914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102184404|NCT04320914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184405|NCT05544812|Cetuximab|cetuximab|mesh-list
102184406|NCT05544812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102184407|NCT05544812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102184408|NCT02415699|Leucovorin|leucovorin|mesh-list
102184409|NCT02415699|Fluorouracil|fluorouracil|mesh-list
102184410|NCT02415699|Oxaliplatin|oxaliplatin|mesh-list
102184411|NCT02415699|Antimetabolites|antimetabolites|mesh-ancestor
102184412|NCT02415699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184413|NCT02415699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102184414|NCT02415699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102184415|NCT02415699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102184416|NCT02415699|Immunologic Factors|immunologic factors|mesh-ancestor
102184417|NCT02415699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184418|NCT02415699|Antidotes|antidotes|mesh-ancestor
102184419|NCT02415699|Protective Agents|protective agents|mesh-ancestor
102184420|NCT02415699|Vitamin B Complex|vitamin b complex|mesh-ancestor
102184421|NCT02415699|Vitamins|vitamins|mesh-ancestor
102184422|NCT02415699|Micronutrients|micronutrients|mesh-ancestor
102184423|NCT05544656|Tolperisone|tolperisone|mesh-list
102184424|NCT05544656|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102184425|NCT05544656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184426|NCT05544656|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102184427|NCT05544656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102184428|NCT02409537|Resveratrol|resveratrol|mesh-list
102184429|NCT02409537|Antioxidants|antioxidants|mesh-ancestor
102184430|NCT02409537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893306|NCT01096706|Antipyretics|antipyretics|mesh-ancestor
102184431|NCT02409537|Protective Agents|protective agents|mesh-ancestor
102184432|NCT02409537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184433|NCT02409537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102184434|NCT02409537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102184435|NCT03177993|Ivermectin|ivermectin|mesh-list
102184436|NCT03177993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102184437|NCT03177993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102184438|NCT04425590|Aspirin|aspirin|mesh-list
102184439|NCT04425590|Atorvastatin|atorvastatin|mesh-list
102184440|NCT04425590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102184441|NCT04425590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102184442|NCT04425590|Analgesics|analgesics|mesh-ancestor
102184443|NCT04425590|Sensory System Agents|sensory system agents|mesh-ancestor
102184444|NCT04425590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102184445|NCT04425590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184446|NCT04425590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102184447|NCT04425590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102184448|NCT04425590|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102184449|NCT04425590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102184450|NCT04425590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184451|NCT04425590|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102184452|NCT04425590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102184453|NCT04425590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102184454|NCT04425590|Antipyretics|antipyretics|mesh-ancestor
102184455|NCT04425590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102184456|NCT04425590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102184457|NCT04425590|Antimetabolites|antimetabolites|mesh-ancestor
102184458|NCT04425590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102184459|NCT04425590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102184460|NCT00707889|Leucovorin|leucovorin|mesh-list
102184461|NCT00707889|Folic Acid|folic acid|mesh-list
102184462|NCT00707889|Bevacizumab|bevacizumab|mesh-list
102184463|NCT00707889|Fluorouracil|fluorouracil|mesh-list
102184464|NCT00707889|Oxaliplatin|oxaliplatin|mesh-list
102184465|NCT00707889|Levoleucovorin|levoleucovorin|mesh-list
102184466|NCT00707889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102184467|NCT00707889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102184468|NCT00707889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102184469|NCT00707889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102184470|NCT00707889|Growth Substances|growth substances|mesh-ancestor
102184471|NCT00707889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184472|NCT00707889|Growth Inhibitors|growth inhibitors|mesh-ancestor
102184473|NCT00707889|Antimetabolites|antimetabolites|mesh-ancestor
102184474|NCT00707889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184475|NCT00707889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102184476|NCT00707889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102184477|NCT00707889|Immunologic Factors|immunologic factors|mesh-ancestor
102184478|NCT00707889|Antidotes|antidotes|mesh-ancestor
102184479|NCT00707889|Protective Agents|protective agents|mesh-ancestor
102184480|NCT00707889|Vitamin B Complex|vitamin b complex|mesh-ancestor
102184481|NCT00707889|Vitamins|vitamins|mesh-ancestor
102184482|NCT00707889|Micronutrients|micronutrients|mesh-ancestor
102184483|NCT00707889|Hematinics|hematinics|mesh-ancestor
102184484|NCT00109031|Cyclophosphamide|cyclophosphamide|mesh-list
102184485|NCT00109031|Etoposide|etoposide|mesh-list
102184486|NCT00109031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102184487|NCT00109031|Immunologic Factors|immunologic factors|mesh-ancestor
102184488|NCT00109031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184489|NCT00109031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102184490|NCT00109031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102184491|NCT00109031|Alkylating Agents|alkylating agents|mesh-ancestor
102184492|NCT00109031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184493|NCT00109031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102184494|NCT00109031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102184495|NCT00109031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102184496|NCT00109031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102184497|NCT00109031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102184498|NCT00109031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102184499|NCT02419443|Gabapentin|gabapentin|mesh-list
102184500|NCT02419443|Analgesics|analgesics|mesh-ancestor
102184501|NCT02419443|Sensory System Agents|sensory system agents|mesh-ancestor
102184502|NCT02419443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102184503|NCT02419443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184504|NCT02419443|Anticonvulsants|anticonvulsants|mesh-ancestor
102184505|NCT02419443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102184506|NCT02419443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102184507|NCT02419443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102184508|NCT02419443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102184509|NCT02419443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102184510|NCT02419443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102184511|NCT02419443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102184512|NCT02419443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184513|NCT02419443|Antimanic Agents|antimanic agents|mesh-ancestor
102184514|NCT05017103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102184515|NCT05017103|Antibodies|antibodies|mesh-list
102184516|NCT05017103|Immunoglobulins|immunoglobulins|mesh-list
102184517|NCT05017103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102184518|NCT05017103|Immunologic Factors|immunologic factors|mesh-ancestor
102184519|NCT05017103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184520|NCT05017103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102184521|NCT02414919|Levonorgestrel|levonorgestrel|mesh-list
102184522|NCT02414919|Etonogestrel|etonogestrel|mesh-list
102184523|NCT02414919|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102184524|NCT02414919|Contraceptive Agents|contraceptive agents|mesh-ancestor
102184525|NCT02414919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102184526|NCT02414919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184527|NCT02414919|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102184528|NCT02414919|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102184529|NCT02414919|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102184530|NCT05005559|Myeloma Proteins|myeloma proteins|mesh-list
102184531|NCT05005559|Paraproteins|paraproteins|mesh-list
102184532|NCT05005559|Immunologic Factors|immunologic factors|mesh-ancestor
101448729|NCT00212589|Vitamins|vitamins|mesh-ancestor
102184533|NCT05005559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184534|NCT05543954|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102184535|NCT05543954|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102184536|NCT05543954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184537|NCT02408679|Vitamin D|vitamin d|mesh-list
102184538|NCT02408679|Vitamins|vitamins|mesh-ancestor
102184539|NCT02408679|Micronutrients|micronutrients|mesh-ancestor
102184540|NCT02408679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184541|NCT02408679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102184542|NCT04486781|Pembrolizumab|pembrolizumab|mesh-list
102184543|NCT04486781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102184544|NCT04486781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102184545|NCT04486781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102184546|NCT04486781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184547|NCT05089565|Interferons|interferons|mesh-list
102184548|NCT05089565|Interferon-gamma|interferon-gamma|mesh-list
102184549|NCT05089565|Antibodies|antibodies|mesh-list
102184550|NCT05089565|Immunoglobulin G|immunoglobulin g|mesh-list
102184551|NCT05089565|Immunologic Factors|immunologic factors|mesh-ancestor
102184552|NCT05089565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184553|NCT05089565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102184554|NCT05089565|Antiviral Agents|antiviral agents|mesh-ancestor
102184555|NCT05089565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102184556|NCT03174171|Everolimus|everolimus|mesh-list
102184557|NCT03174171|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102184558|NCT03174171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102184559|NCT03174171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102184560|NCT03174171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184561|NCT03174171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102184562|NCT03174171|Immunologic Factors|immunologic factors|mesh-ancestor
102184563|NCT03174171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184564|NCT03174171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102184565|NCT02414529|Vitamin D|vitamin d|mesh-list
102184566|NCT02414529|Ergocalciferols|ergocalciferols|mesh-list
102184567|NCT02414529|Cholecalciferol|cholecalciferol|mesh-list
102184568|NCT02414529|Vitamins|vitamins|mesh-list
102184569|NCT02414529|Micronutrients|micronutrients|mesh-ancestor
102184570|NCT02414529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184571|NCT02414529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102184572|NCT02414529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102184573|NCT02418273|Denosumab|denosumab|mesh-list
102184574|NCT02418273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102184575|NCT02418273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184576|NCT02414685|Paclitaxel|paclitaxel|mesh-list
102184577|NCT02414685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102184578|NCT02414685|Cisplatin|cisplatin|mesh-list
102184579|NCT02414685|Ifosfamide|ifosfamide|mesh-list
102184580|NCT02414685|Isophosphamide mustard|isophosphamide mustard|mesh-list
102184581|NCT02414685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102184582|NCT02414685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102184583|NCT02414685|Tubulin Modulators|tubulin modulators|mesh-ancestor
102184584|NCT02414685|Antimitotic Agents|antimitotic agents|mesh-ancestor
102184585|NCT02414685|Mitosis Modulators|mitosis modulators|mesh-ancestor
102184586|NCT02414685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184587|NCT02414685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101893443|NCT01053611|Anesthetics|anesthetics|mesh-ancestor
102184588|NCT02414685|Alkylating Agents|alkylating agents|mesh-ancestor
102184589|NCT04425824|Rituximab|rituximab|mesh-list
102184590|NCT04425824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102184591|NCT04425824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102184592|NCT04425824|Immunologic Factors|immunologic factors|mesh-ancestor
102184593|NCT04425824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184594|NCT04425824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102184595|NCT02414451|Propranolol|propranolol|mesh-list
102184596|NCT02414451|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102184597|NCT02414451|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102184598|NCT02414451|Adrenergic Agents|adrenergic agents|mesh-ancestor
102184599|NCT02414451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102184600|NCT02414451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184601|NCT02414451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184602|NCT02414451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102184603|NCT02414451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102184604|NCT02414451|Vasodilator Agents|vasodilator agents|mesh-ancestor
102184605|NCT02408289|Proanthocyanidin|proanthocyanidin|mesh-list
102184606|NCT02408289|Procyanidin|procyanidin|mesh-list
102184607|NCT02408289|Antioxidants|antioxidants|mesh-ancestor
102184608|NCT02408289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184609|NCT02408289|Protective Agents|protective agents|mesh-ancestor
102184610|NCT02408289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184611|NCT02408289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102184612|NCT02408289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102184613|NCT02408289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102184614|NCT02417883|Furosemide|furosemide|mesh-list
102184615|NCT02417883|Diuretics|diuretics|mesh-ancestor
102184616|NCT02417883|Natriuretic Agents|natriuretic agents|mesh-ancestor
102184617|NCT02417883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184618|NCT02417883|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102184619|NCT02417883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102184620|NCT02417883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184621|NCT01664624|Exenatide|exenatide|mesh-list
102184622|NCT01664624|Alogliptin|alogliptin|mesh-list
102184623|NCT01664624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102184624|NCT01664624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184625|NCT01664624|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102184626|NCT01664624|Incretins|incretins|mesh-ancestor
102184627|NCT01664624|Hormones|hormones|mesh-ancestor
102184628|NCT01664624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102184629|NCT01664624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102184630|NCT01664624|Protease Inhibitors|protease inhibitors|mesh-ancestor
102184631|NCT01664624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102184632|NCT01664624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184633|NCT03173781|Droxidopa|droxidopa|mesh-list
102184634|NCT03173781|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102184635|NCT03173781|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102184636|NCT05540834|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102184637|NCT05540834|Plasminogen|plasminogen|mesh-list
102184638|NCT05540834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102184639|NCT05540834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102184640|NCT05540834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184641|NCT05696132|Povidone-Iodine|povidone-iodine|mesh-list
102184642|NCT05696132|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102184643|NCT05696132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102184644|NCT02407899|Vitamin D|vitamin d|mesh-list
102184645|NCT02407899|Cholecalciferol|cholecalciferol|mesh-list
102184646|NCT02407899|Insulin|insulin|mesh-list
102184647|NCT02407899|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102184648|NCT02407899|Metformin|metformin|mesh-list
102184649|NCT02407899|Saxagliptin|saxagliptin|mesh-list
102184650|NCT02407899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
102184651|NCT02407899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102184652|NCT02407899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184653|NCT02407899|Vitamins|vitamins|mesh-ancestor
102184654|NCT02407899|Micronutrients|micronutrients|mesh-ancestor
102184655|NCT02407899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102184656|NCT02407899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102184657|NCT02407899|Incretins|incretins|mesh-ancestor
102184658|NCT02407899|Hormones|hormones|mesh-ancestor
102184659|NCT02407899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102184660|NCT02407899|Protease Inhibitors|protease inhibitors|mesh-ancestor
102184661|NCT02407899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102184662|NCT02407899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184663|NCT02417493|Epinephrine|epinephrine|mesh-list
102184664|NCT02417493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102184665|NCT02417493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102184666|NCT02417493|Adrenergic Agents|adrenergic agents|mesh-ancestor
102184667|NCT02417493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102184668|NCT02417493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184669|NCT02417493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184670|NCT02417493|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102184671|NCT02417493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102184672|NCT02417493|Autonomic Agents|autonomic agents|mesh-ancestor
102184673|NCT02417493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102184674|NCT02417493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102184675|NCT02417493|Respiratory System Agents|respiratory system agents|mesh-ancestor
102184676|NCT02417493|Mydriatics|mydriatics|mesh-ancestor
102184677|NCT02417493|Sympathomimetics|sympathomimetics|mesh-ancestor
102184678|NCT02417493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102184679|NCT05540600|Digoxin|digoxin|mesh-list
102184680|NCT05540600|Bisoprolol|bisoprolol|mesh-list
102184681|NCT05540600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102184682|NCT05540600|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102184683|NCT05540600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102184684|NCT05540600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184685|NCT05540600|Protective Agents|protective agents|mesh-ancestor
102184686|NCT05540600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184687|NCT05540600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102184688|NCT05540600|Sympatholytics|sympatholytics|mesh-ancestor
102184689|NCT05540600|Autonomic Agents|autonomic agents|mesh-ancestor
102184690|NCT05540600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102184691|NCT05540600|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102184692|NCT05540600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102184693|NCT05540600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102184694|NCT05540600|Adrenergic Agents|adrenergic agents|mesh-ancestor
102184695|NCT05540600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102184696|NCT02417649|Broncho-Vaxom|broncho-vaxom|mesh-list
102184697|NCT02417649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102184698|NCT02417649|Immunologic Factors|immunologic factors|mesh-ancestor
102184699|NCT02417649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184700|NCT03265574|Enalapril|enalapril|mesh-list
102184701|NCT03265574|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102184702|NCT03265574|Protease Inhibitors|protease inhibitors|mesh-ancestor
102184703|NCT03265574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102184704|NCT03265574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184705|NCT03265574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102184706|NCT03177837|Acetazolamide|acetazolamide|mesh-list
102184707|NCT03177837|Anticonvulsants|anticonvulsants|mesh-ancestor
102184708|NCT03177837|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102184709|NCT03177837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102184710|NCT03177837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184711|NCT03177837|Diuretics|diuretics|mesh-ancestor
102184712|NCT03177837|Natriuretic Agents|natriuretic agents|mesh-ancestor
102184713|NCT03177837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184714|NCT02414373|Bupivacaine|bupivacaine|mesh-list
102184715|NCT02414373|Ropivacaine|ropivacaine|mesh-list
102184716|NCT02414373|Anesthetics, Local|anesthetics, local|mesh-ancestor
102184717|NCT02414373|Anesthetics|anesthetics|mesh-ancestor
102184718|NCT02414373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102184719|NCT02414373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184720|NCT02414373|Sensory System Agents|sensory system agents|mesh-ancestor
102184721|NCT02414373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102184722|NCT04320290|Antiviral Agents|antiviral agents|mesh-list
102184723|NCT04320290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102184725|NCT03173235|Vitamins|vitamins|mesh-ancestor
102184726|NCT03173235|Micronutrients|micronutrients|mesh-ancestor
102184727|NCT03173235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184728|NCT03173235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102184729|NCT05697692|Heparin|heparin|mesh-list
102184730|NCT05697692|Calcium heparin|calcium heparin|mesh-list
102184731|NCT05697692|Anticoagulants|anticoagulants|mesh-ancestor
102184732|NCT05697692|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102184733|NCT05697692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102184734|NCT05697692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184735|NCT02761057|Sunitinib|sunitinib|mesh-list
102184736|NCT02761057|Crizotinib|crizotinib|mesh-list
102184737|NCT02761057|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101893594|NCT01109264|Chlorambucil|chlorambucil|mesh-list
102184738|NCT02761057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102184739|NCT02761057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102184740|NCT02761057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102184741|NCT02761057|Growth Substances|growth substances|mesh-ancestor
102184742|NCT02761057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184743|NCT02761057|Growth Inhibitors|growth inhibitors|mesh-ancestor
102184744|NCT02761057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102184745|NCT02761057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102184746|NCT02761057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184747|NCT02407821|Escitalopram|escitalopram|mesh-list
102184748|NCT02407821|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102184749|NCT02407821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102184750|NCT02407821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102184751|NCT02407821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184752|NCT02407821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102184753|NCT02407821|Serotonin Agents|serotonin agents|mesh-ancestor
102184754|NCT02407821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184755|NCT02164357|Fibrinolytic Agents|fibrinolytic agents|mesh-list
102184756|NCT02164357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102184757|NCT02164357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184758|NCT02417337|Acetaminophen|acetaminophen|mesh-list
102184759|NCT02417337|Ibuprofen|ibuprofen|mesh-list
102184760|NCT02417337|Diclofenac|diclofenac|mesh-list
102184761|NCT02417337|Mefenamic Acid|mefenamic acid|mesh-list
102184762|NCT02417337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102184763|NCT02417337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102184764|NCT02417337|Analgesics|analgesics|mesh-ancestor
102184765|NCT02417337|Sensory System Agents|sensory system agents|mesh-ancestor
102184766|NCT02417337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102184767|NCT02417337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184768|NCT02417337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102184769|NCT02417337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102184770|NCT02417337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102184771|NCT02417337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102184772|NCT02417337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184773|NCT02417337|Antipyretics|antipyretics|mesh-ancestor
102184774|NCT02167321|Leucovorin|leucovorin|mesh-list
102184775|NCT02167321|Fluorouracil|fluorouracil|mesh-list
102184776|NCT02167321|Oxaliplatin|oxaliplatin|mesh-list
102184777|NCT02167321|Antimetabolites|antimetabolites|mesh-ancestor
102184778|NCT02167321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184779|NCT02167321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102184780|NCT02167321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102184781|NCT02167321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102184782|NCT02167321|Immunologic Factors|immunologic factors|mesh-ancestor
102184783|NCT02167321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184784|NCT02167321|Antidotes|antidotes|mesh-ancestor
102184785|NCT02167321|Protective Agents|protective agents|mesh-ancestor
102184786|NCT02167321|Vitamin B Complex|vitamin b complex|mesh-ancestor
102184787|NCT02167321|Vitamins|vitamins|mesh-ancestor
102184788|NCT02167321|Micronutrients|micronutrients|mesh-ancestor
102184789|NCT02162797|Zinc|zinc|mesh-list
102184790|NCT02162797|Trace Elements|trace elements|mesh-ancestor
102184791|NCT02162797|Micronutrients|micronutrients|mesh-ancestor
102184792|NCT02162797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184793|NCT02162875|Praziquantel|praziquantel|mesh-list
102184794|NCT02162875|Anthelmintics|anthelmintics|mesh-ancestor
102184795|NCT02162875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102184796|NCT02162875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102184797|NCT02167633|Pantoprazole|pantoprazole|mesh-list
102184798|NCT02167633|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
102184799|NCT02167633|Glucocorticoids|glucocorticoids|mesh-list
102184800|NCT02167633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102184801|NCT02167633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102184802|NCT02167633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102184803|NCT02167633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184804|NCT02167633|Hormones|hormones|mesh-ancestor
102184805|NCT02167633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102184806|NCT02167633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184807|NCT02413281|Buprenorphine|buprenorphine|mesh-list
102184808|NCT02413281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102184809|NCT02413281|Narcotics|narcotics|mesh-ancestor
102184810|NCT02413281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102184811|NCT02413281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184812|NCT02413281|Analgesics|analgesics|mesh-ancestor
102184813|NCT02413281|Sensory System Agents|sensory system agents|mesh-ancestor
102184814|NCT02413281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102184815|NCT02413281|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102184817|NCT02170909|Antithrombins|antithrombins|mesh-ancestor
102184818|NCT02170909|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102184819|NCT02170909|Protease Inhibitors|protease inhibitors|mesh-ancestor
102184820|NCT02170909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102184821|NCT02170909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184822|NCT02170909|Anticoagulants|anticoagulants|mesh-ancestor
102184823|NCT02164825|Morphine|morphine|mesh-list
102184824|NCT02164825|Ropivacaine|ropivacaine|mesh-list
102184825|NCT02164825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102184826|NCT02164825|Narcotics|narcotics|mesh-ancestor
102184827|NCT02164825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102184828|NCT02164825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184829|NCT02164825|Analgesics|analgesics|mesh-ancestor
102184830|NCT02164825|Sensory System Agents|sensory system agents|mesh-ancestor
102184831|NCT02164825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102184832|NCT02164825|Anesthetics, Local|anesthetics, local|mesh-ancestor
102184833|NCT02164825|Anesthetics|anesthetics|mesh-ancestor
102184834|NCT02170987|Moxifloxacin|moxifloxacin|mesh-list
102184835|NCT02170987|Dabigatran|dabigatran|mesh-list
102184836|NCT02170987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102184837|NCT02170987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102184838|NCT02170987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102184839|NCT02170987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102184840|NCT02170987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102184841|NCT02170987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184842|NCT02170987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102184843|NCT02170987|Antithrombins|antithrombins|mesh-ancestor
102184844|NCT02170987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102184845|NCT02170987|Protease Inhibitors|protease inhibitors|mesh-ancestor
102184846|NCT02170987|Anticoagulants|anticoagulants|mesh-ancestor
102184847|NCT03176121|Oxycodone|oxycodone|mesh-list
102184848|NCT03176121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102184849|NCT03176121|Narcotics|narcotics|mesh-ancestor
102184850|NCT03176121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102184851|NCT03176121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184852|NCT03176121|Analgesics|analgesics|mesh-ancestor
102184853|NCT03176121|Sensory System Agents|sensory system agents|mesh-ancestor
102184854|NCT03176121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102184855|NCT02261155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
102184856|NCT02261155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102184857|NCT02261155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184858|NCT02171143|ASP2409|asp2409|mesh-list
102184859|NCT02171143|Immunoconjugates|immunoconjugates|mesh-ancestor
102184860|NCT02171143|Immunologic Factors|immunologic factors|mesh-ancestor
102184861|NCT02171143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184862|NCT03176199|Oxycodone|oxycodone|mesh-list
102184863|NCT03176199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102184864|NCT03176199|Narcotics|narcotics|mesh-ancestor
102184865|NCT03176199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102184866|NCT03176199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184867|NCT03176199|Analgesics|analgesics|mesh-ancestor
102184868|NCT03176199|Sensory System Agents|sensory system agents|mesh-ancestor
102184869|NCT03176199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102184870|NCT05697614|Lamotrigine|lamotrigine|mesh-list
102184871|NCT05697614|Carbamazepine|carbamazepine|mesh-list
102184872|NCT05697614|Phenytoin|phenytoin|mesh-list
102184874|NCT05697614|Valproic Acid|valproic acid|mesh-list
102184875|NCT05697614|Clobazam|clobazam|mesh-list
102184876|NCT05697614|Anticonvulsants|anticonvulsants|mesh-ancestor
102184877|NCT05697614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102184878|NCT05697614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102184879|NCT05697614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184880|NCT05697614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102184881|NCT05697614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184882|NCT05697614|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102184883|NCT05697614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102184884|NCT05697614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102184885|NCT05697614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102184886|NCT05697614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102184887|NCT05697614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102184888|NCT05697614|GABA Agents|gaba agents|mesh-ancestor
102184889|NCT05697614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102184890|NCT05697614|Antimanic Agents|antimanic agents|mesh-ancestor
102184891|NCT05697614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102184892|NCT05697614|Analgesics|analgesics|mesh-ancestor
102184893|NCT05697614|Sensory System Agents|sensory system agents|mesh-ancestor
102184894|NCT05697614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102184895|NCT05697614|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102184896|NCT05697614|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102184897|NCT05697614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102184898|NCT05697614|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102184899|NCT05697614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102184900|NCT05697614|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102184901|NCT05697614|GABA Agonists|gaba agonists|mesh-ancestor
102184902|NCT02171221|DFP-11207|dfp-11207|mesh-list
102184903|NCT02171221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102184904|NCT02171221|Antimetabolites|antimetabolites|mesh-ancestor
102184905|NCT02171221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184906|NCT02171221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102184907|NCT02413515|Nifedipine|nifedipine|mesh-list
102184908|NCT02413515|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102184909|NCT02413515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102184910|NCT02413515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184911|NCT02413515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102184912|NCT02413515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184913|NCT02413515|Vasodilator Agents|vasodilator agents|mesh-ancestor
102184914|NCT02413515|Tocolytic Agents|tocolytic agents|mesh-ancestor
102184915|NCT02413515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102184916|NCT03194906|Memantine|memantine|mesh-list
102184917|NCT03194906|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102184918|NCT03194906|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102184919|NCT03194906|Dopamine Agents|dopamine agents|mesh-ancestor
102184920|NCT03194906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102184921|NCT03194906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184922|NCT03194906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184923|NCT03194906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102184924|NCT03194906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102184925|NCT03171987|Flurbiprofen|flurbiprofen|mesh-list
102184926|NCT03171987|Lidocaine|lidocaine|mesh-list
102184927|NCT03171987|Anesthetics, Local|anesthetics, local|mesh-ancestor
102184928|NCT03171987|Anesthetics|anesthetics|mesh-ancestor
102184929|NCT03171987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102184930|NCT03171987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184931|NCT03171987|Sensory System Agents|sensory system agents|mesh-ancestor
102184932|NCT03171987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102184933|NCT03171987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102184934|NCT03171987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102184935|NCT03171987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102184936|NCT03171987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102184937|NCT03171987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184938|NCT03171987|Analgesics|analgesics|mesh-ancestor
102184939|NCT03171987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102184940|NCT03171987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102184941|NCT03171987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102184942|NCT03171987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102184943|NCT03171987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102184944|NCT03171987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102184945|NCT05540288|Nalmefene|nalmefene|mesh-list
102184946|NCT05540288|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102184947|NCT05540288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184948|NCT05540288|Sensory System Agents|sensory system agents|mesh-ancestor
102184949|NCT05540288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102184950|NCT03172065|Dexmedetomidine|dexmedetomidine|mesh-list
102184951|NCT03172065|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102184952|NCT03172065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102184953|NCT03172065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184954|NCT03172065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102184955|NCT03172065|Analgesics|analgesics|mesh-ancestor
102184956|NCT03172065|Sensory System Agents|sensory system agents|mesh-ancestor
102184957|NCT03172065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102184958|NCT03172065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102184959|NCT03172065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102184960|NCT03172065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102184961|NCT03172065|Adrenergic Agents|adrenergic agents|mesh-ancestor
102184962|NCT03172065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102184963|NCT03172065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184964|NCT02171299|Ropivacaine|ropivacaine|mesh-list
102184965|NCT02171299|Anesthetics, Local|anesthetics, local|mesh-list
102184966|NCT02171299|Anesthetics|anesthetics|mesh-list
102184967|NCT02171299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102184968|NCT02171299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184969|NCT02171299|Sensory System Agents|sensory system agents|mesh-ancestor
102184970|NCT02171299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102184971|NCT03171831|Mycophenolic Acid|mycophenolic acid|mesh-list
102184972|NCT03171831|Cyclophosphamide|cyclophosphamide|mesh-list
102184974|NCT03171831|Methotrexate|methotrexate|mesh-list
102184975|NCT03171831|Fludarabine|fludarabine|mesh-list
102184976|NCT03171831|Tacrolimus|tacrolimus|mesh-list
102184977|NCT03171831|Thymoglobulin|thymoglobulin|mesh-list
102184978|NCT03171831|Basiliximab|basiliximab|mesh-list
102184979|NCT03171831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102184980|NCT03171831|Immunologic Factors|immunologic factors|mesh-ancestor
102184981|NCT03171831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102184982|NCT03171831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102184983|NCT03171831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102184984|NCT03171831|Alkylating Agents|alkylating agents|mesh-ancestor
102184985|NCT03171831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102184986|NCT03171831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102184987|NCT03171831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102184988|NCT03171831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102184989|NCT03171831|Abortifacient Agents|abortifacient agents|mesh-ancestor
102184990|NCT03171831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102184991|NCT03171831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102184992|NCT03171831|Antimetabolites|antimetabolites|mesh-ancestor
102184993|NCT03171831|Dermatologic Agents|dermatologic agents|mesh-ancestor
102184994|NCT03171831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102184995|NCT03171831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102184996|NCT03171831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102184997|NCT03171831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102184998|NCT03171831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102184999|NCT03171831|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102185000|NCT03171831|Antitubercular Agents|antitubercular agents|mesh-ancestor
102185001|NCT03171831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102185002|NCT03171831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102185003|NCT02171455|Dabigatran|dabigatran|mesh-list
102185004|NCT02171455|Antithrombins|antithrombins|mesh-ancestor
102185005|NCT02171455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102185006|NCT02171455|Protease Inhibitors|protease inhibitors|mesh-ancestor
102185007|NCT02171455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102185008|NCT02171455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185009|NCT02171455|Anticoagulants|anticoagulants|mesh-ancestor
102185010|NCT02171533|Verapamil|verapamil|mesh-list
102185011|NCT02171533|Dabigatran|dabigatran|mesh-list
102185012|NCT02171533|Antithrombins|antithrombins|mesh-ancestor
102185013|NCT02171533|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102185014|NCT02171533|Protease Inhibitors|protease inhibitors|mesh-ancestor
102185015|NCT02171533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101448763|NCT00188942|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102185016|NCT02171533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185017|NCT02171533|Anticoagulants|anticoagulants|mesh-ancestor
102185018|NCT02171533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102185019|NCT02171533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102185020|NCT02171533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102185021|NCT02171533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102185022|NCT02171533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185023|NCT02171533|Vasodilator Agents|vasodilator agents|mesh-ancestor
102185024|NCT04482543|Methotrexate|methotrexate|mesh-list
102185025|NCT04482543|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102185026|NCT04482543|Abortifacient Agents|abortifacient agents|mesh-ancestor
102185027|NCT04482543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102185028|NCT04482543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185029|NCT04482543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102185030|NCT04482543|Antimetabolites|antimetabolites|mesh-ancestor
102185031|NCT04482543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185032|NCT04482543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102185033|NCT04482543|Dermatologic Agents|dermatologic agents|mesh-ancestor
102185034|NCT04482543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102185035|NCT04482543|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102185036|NCT04482543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102185037|NCT04482543|Immunologic Factors|immunologic factors|mesh-ancestor
102185038|NCT04482543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102185039|NCT04482543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102185040|NCT02406183|Ipilimumab|ipilimumab|mesh-list
101893882|NCT00130286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185041|NCT02406183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102185042|NCT02406183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102185043|NCT02406183|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102185044|NCT02406183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185046|NCT04723472|Cefuroxime axetil|cefuroxime axetil|mesh-list
102185047|NCT04723472|Bismuth|bismuth|mesh-list
102185048|NCT04723472|Antacids|antacids|mesh-ancestor
102185049|NCT04723472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185050|NCT04723472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102185051|NCT04723472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102185052|NCT04723472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102185054|NCT02412813|Trace Elements|trace elements|mesh-ancestor
102185055|NCT02412813|Micronutrients|micronutrients|mesh-ancestor
102185056|NCT02412813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185057|NCT03116295|Opicapone|opicapone|mesh-list
102185058|NCT03116295|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102185059|NCT03116295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102185060|NCT03116295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185061|NCT03116295|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102185062|NCT03116295|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102185063|NCT02405715|Oxytocin|oxytocin|mesh-list
102185064|NCT02405715|Oxytocics|oxytocics|mesh-ancestor
102185065|NCT02405715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102185066|NCT02405715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185067|NCT02412423|Cyclophosphamide|cyclophosphamide|mesh-list
102185068|NCT02412423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102185069|NCT02412423|Immunologic Factors|immunologic factors|mesh-ancestor
102185070|NCT02412423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185071|NCT02412423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102185072|NCT02412423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102185073|NCT02412423|Alkylating Agents|alkylating agents|mesh-ancestor
102185074|NCT02412423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185075|NCT02412423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102185076|NCT02412423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102185077|NCT02412345|Alprostadil|alprostadil|mesh-list
102185078|NCT02412345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102185079|NCT02412345|Vasodilator Agents|vasodilator agents|mesh-ancestor
102185080|NCT02412345|Urological Agents|urological agents|mesh-ancestor
102185081|NCT05679050|Folfirinox|folfirinox|mesh-list
102185082|NCT05679050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102185083|NCT02412267|Carboplatin|carboplatin|mesh-list
102185084|NCT02412267|Etoposide|etoposide|mesh-list
102185085|NCT02412267|Ifosfamide|ifosfamide|mesh-list
102185086|NCT02412267|Ofatumumab|ofatumumab|mesh-list
102185087|NCT02412267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102185088|NCT02412267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102185089|NCT02412267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102185090|NCT02412267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102185091|NCT02412267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102185092|NCT02412267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185093|NCT02412267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102185094|NCT02412267|Alkylating Agents|alkylating agents|mesh-ancestor
102185095|NCT03172455|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
102185096|NCT03172455|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102185097|NCT03172455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102185098|NCT03172455|Protease Inhibitors|protease inhibitors|mesh-ancestor
102185099|NCT03172455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102185100|NCT03172455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185101|NCT03171597|Vasodilator Agents|vasodilator agents|mesh-list
102185102|NCT03171597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
102185103|NCT03171597|Lipid Regulating Agents|lipid regulating agents|mesh-list
102185104|NCT05698394|Esketamine|esketamine|mesh-list
102185105|NCT05698394|Antidepressive Agents|antidepressive agents|mesh-ancestor
102185106|NCT05698394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102185107|NCT05539118|Interferons|interferons|mesh-list
102185108|NCT05539118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102185109|NCT05539118|Antiviral Agents|antiviral agents|mesh-ancestor
102185110|NCT05539118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102185111|NCT02405793|Meloxicam|meloxicam|mesh-list
102185112|NCT02405793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102185113|NCT02405793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102185114|NCT02405793|Analgesics|analgesics|mesh-ancestor
102185115|NCT02405793|Sensory System Agents|sensory system agents|mesh-ancestor
102185116|NCT02405793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102185117|NCT02405793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185118|NCT02405793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102185119|NCT02405793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102185120|NCT02405793|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102185121|NCT02405793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102185122|NCT02405793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102185123|NCT02405793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185124|NCT05695664|Ibuprofen|ibuprofen|mesh-list
102185125|NCT05695664|Ketorolac|ketorolac|mesh-list
102185126|NCT05695664|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102185127|NCT05695664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102185128|NCT05695664|Analgesics|analgesics|mesh-ancestor
102185129|NCT05695664|Sensory System Agents|sensory system agents|mesh-ancestor
102185130|NCT05695664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102185131|NCT05695664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185132|NCT05695664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102185133|NCT05695664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102185134|NCT05695664|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102185135|NCT05695664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102185136|NCT05695664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185137|NCT02412189|Norepinephrine|norepinephrine|mesh-list
102185138|NCT02412189|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102185139|NCT02412189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102185140|NCT02412189|Adrenergic Agents|adrenergic agents|mesh-ancestor
102185141|NCT02412189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102185142|NCT02412189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185143|NCT02412189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185144|NCT02412189|Sympathomimetics|sympathomimetics|mesh-ancestor
102185145|NCT02412189|Autonomic Agents|autonomic agents|mesh-ancestor
102185146|NCT02412189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102185147|NCT02412189|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102185148|NCT02411955|Nicotinic Acids|nicotinic acids|mesh-list
102185149|NCT02411955|Tazarotene|tazarotene|mesh-list
102185150|NCT02411955|Dermatologic Agents|dermatologic agents|mesh-ancestor
102185151|NCT02411955|Keratolytic Agents|keratolytic agents|mesh-ancestor
102185152|NCT02411955|Vitamin B Complex|vitamin b complex|mesh-ancestor
102185153|NCT02411955|Vitamins|vitamins|mesh-ancestor
102185154|NCT02411955|Micronutrients|micronutrients|mesh-ancestor
102185155|NCT02411955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185156|NCT03172533|Dienogest|dienogest|mesh-list
102185157|NCT03172533|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102185158|NCT03172533|Estradiol|estradiol|mesh-list
102185159|NCT03172533|Estrogens|estrogens|mesh-ancestor
102185160|NCT03172533|Hormones|hormones|mesh-ancestor
102185161|NCT03172533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102185162|NCT03172533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185163|NCT03172533|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102185164|NCT03172533|Contraceptive Agents|contraceptive agents|mesh-ancestor
102185165|NCT03172533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102185166|NCT03172533|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102185167|NCT03172533|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102185168|NCT03172533|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102185169|NCT03172533|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102185170|NCT03172533|Hormone Antagonists|hormone antagonists|mesh-ancestor
102185171|NCT03172533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102185172|NCT03172533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102185173|NCT02412033|Misoprostol|misoprostol|mesh-list
102185174|NCT02412033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102185175|NCT02412033|Abortifacient Agents|abortifacient agents|mesh-ancestor
102185176|NCT02412033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102185177|NCT02412033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185178|NCT02412033|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102185179|NCT02412033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102185180|NCT02412033|Oxytocics|oxytocics|mesh-ancestor
102185181|NCT02401971|Thalidomide|thalidomide|mesh-list
102185182|NCT02401971|Irinotecan|irinotecan|mesh-list
102185183|NCT02401971|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102185184|NCT02401971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102185185|NCT02401971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102185186|NCT02401971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185187|NCT02401971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102185188|NCT02401971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102185189|NCT02401971|Immunologic Factors|immunologic factors|mesh-ancestor
102185190|NCT02401971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185191|NCT02401971|Leprostatic Agents|leprostatic agents|mesh-ancestor
102185192|NCT02401971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102185193|NCT02401971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102185194|NCT02401971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102185195|NCT02401971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102185196|NCT02401971|Growth Substances|growth substances|mesh-ancestor
102185197|NCT02401971|Growth Inhibitors|growth inhibitors|mesh-ancestor
102185198|NCT00701883|Atorvastatin|atorvastatin|mesh-list
102185199|NCT00701883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102185200|NCT00701883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102185201|NCT00701883|Antimetabolites|antimetabolites|mesh-ancestor
102185202|NCT00701883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185203|NCT00701883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102185204|NCT00701883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102185205|NCT00701883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102185206|NCT05678738|Antioxidants|antioxidants|mesh-list
102185207|NCT05678738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185208|NCT05678738|Protective Agents|protective agents|mesh-ancestor
102185209|NCT05678738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185210|NCT03175653|Oxycodone|oxycodone|mesh-list
102185211|NCT03175653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102185212|NCT03175653|Narcotics|narcotics|mesh-ancestor
102185213|NCT03175653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102185214|NCT03175653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185215|NCT03175653|Analgesics|analgesics|mesh-ancestor
102185216|NCT03175653|Sensory System Agents|sensory system agents|mesh-ancestor
102185217|NCT03175653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102185218|NCT02401737|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102185219|NCT02401737|Antiviral Agents|antiviral agents|mesh-ancestor
102185220|NCT02401737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102185221|NCT03175341|Ascorbic Acid|ascorbic acid|mesh-list
102185222|NCT03175341|Vitamins|vitamins|mesh-ancestor
102185223|NCT03175341|Micronutrients|micronutrients|mesh-ancestor
102185224|NCT03175341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185225|NCT03175341|Antioxidants|antioxidants|mesh-ancestor
102185226|NCT03175341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185227|NCT03175341|Protective Agents|protective agents|mesh-ancestor
102185228|NCT05538026|Mesalamine|mesalamine|mesh-list
102185229|NCT05538026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102185230|NCT05538026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102185231|NCT05538026|Analgesics|analgesics|mesh-ancestor
102185232|NCT05538026|Sensory System Agents|sensory system agents|mesh-ancestor
102185233|NCT05538026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102185234|NCT05538026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185235|NCT05538026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102185236|NCT05538026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102185237|NCT02401425|Letrozole|letrozole|mesh-list
102185238|NCT02401425|Misoprostol|misoprostol|mesh-list
102185239|NCT02401425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102185240|NCT02401425|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102185241|NCT02401425|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102185242|NCT02401425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102185243|NCT02401425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185244|NCT02401425|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102185245|NCT02401425|Hormone Antagonists|hormone antagonists|mesh-ancestor
102185246|NCT02401425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102185247|NCT02401425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185248|NCT02401425|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102185249|NCT02401425|Abortifacient Agents|abortifacient agents|mesh-ancestor
102185250|NCT02401425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102185251|NCT02401425|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102185252|NCT02401425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102185253|NCT02401425|Oxytocics|oxytocics|mesh-ancestor
102185254|NCT05537948|Pitavastatin|pitavastatin|mesh-list
102185255|NCT05537948|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
102185256|NCT05537948|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102185257|NCT05537948|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102185258|NCT05537948|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102185259|NCT05537948|Antimetabolites|antimetabolites|mesh-ancestor
102185260|NCT05537948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185261|NCT05537948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102185262|NCT05537948|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102185263|NCT05537948|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102185264|NCT05537948|Protease Inhibitors|protease inhibitors|mesh-ancestor
102185265|NCT02401269|Aspirin|aspirin|mesh-list
102185266|NCT02401269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101894105|NCT01115504|Thiamine|thiamine|mesh-list
102185267|NCT02401269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102185268|NCT02401269|Analgesics|analgesics|mesh-ancestor
102185269|NCT02401269|Sensory System Agents|sensory system agents|mesh-ancestor
102185270|NCT02401269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102185271|NCT02401269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185272|NCT02401269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102185273|NCT02401269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102185274|NCT02401269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102185275|NCT02401269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102185276|NCT02401269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185277|NCT02401269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102185278|NCT02401269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102185279|NCT02401269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102185280|NCT02401269|Antipyretics|antipyretics|mesh-ancestor
102185281|NCT04480827|Cholic Acids|cholic acids|mesh-list
102185282|NCT04480827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102185283|NCT02582684|Lamivudine|lamivudine|mesh-list
102185284|NCT02582684|Dolutegravir|dolutegravir|mesh-list
102185285|NCT02582684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102185286|NCT02582684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102185287|NCT02582684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102185288|NCT02582684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185289|NCT02582684|Antiviral Agents|antiviral agents|mesh-ancestor
102185290|NCT02582684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102185291|NCT02582684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102185292|NCT02582684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102185293|NCT02582684|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102185294|NCT02582684|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102185295|NCT02411877|Clotrimazole|clotrimazole|mesh-list
102185296|NCT02411877|Miconazole|miconazole|mesh-list
102185297|NCT02411877|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102185298|NCT02411877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102185299|NCT02411877|Antifungal Agents|antifungal agents|mesh-ancestor
102185300|NCT02411877|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102185301|NCT02411877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102185302|NCT02411877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102185303|NCT02411877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185304|NCT02411877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102185305|NCT02411877|Hormone Antagonists|hormone antagonists|mesh-ancestor
102185306|NCT02411877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102185307|NCT02411877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185308|NCT02411877|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102185309|NCT02411877|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102185310|NCT03169569|Hemostatics|hemostatics|mesh-list
102185311|NCT03169569|Coagulants|coagulants|mesh-ancestor
102185312|NCT02585960|Factor VIII|factor viii|mesh-list
102185313|NCT02585960|BAX 855|bax 855|mesh-list
102185314|NCT02585960|Coagulants|coagulants|mesh-ancestor
102185315|NCT03169413|Adenosine|adenosine|mesh-list
102185316|NCT03169413|Analgesics|analgesics|mesh-ancestor
102185317|NCT03169413|Sensory System Agents|sensory system agents|mesh-ancestor
102185318|NCT03169413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102185319|NCT03169413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185320|NCT03169413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102185321|NCT03169413|Vasodilator Agents|vasodilator agents|mesh-ancestor
102185322|NCT03169413|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102185323|NCT03169413|Purinergic Agonists|purinergic agonists|mesh-ancestor
102185324|NCT03169413|Purinergic Agents|purinergic agents|mesh-ancestor
102185325|NCT03169413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102185326|NCT03169413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185327|NCT03169335|Paclitaxel|paclitaxel|mesh-list
102185328|NCT03169335|Bevacizumab|bevacizumab|mesh-list
102185329|NCT03169335|Carboplatin|carboplatin|mesh-list
102185330|NCT03169335|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102185331|NCT03169335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102185332|NCT03169335|Tubulin Modulators|tubulin modulators|mesh-ancestor
102185333|NCT03169335|Antimitotic Agents|antimitotic agents|mesh-ancestor
102185334|NCT03169335|Mitosis Modulators|mitosis modulators|mesh-ancestor
102185335|NCT03169335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185336|NCT03169335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102185337|NCT03169335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102185338|NCT03169335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102185339|NCT03169335|Growth Substances|growth substances|mesh-ancestor
102185340|NCT03169335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185341|NCT03169335|Growth Inhibitors|growth inhibitors|mesh-ancestor
102185342|NCT03106623|Solifenacin Succinate|solifenacin succinate|mesh-list
102185343|NCT03106623|Mirabegron|mirabegron|mesh-list
102185344|NCT03106623|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102185345|NCT03106623|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102185346|NCT03106623|Cholinergic Agents|cholinergic agents|mesh-ancestor
102185347|NCT03106623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102185348|NCT03106623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185349|NCT03106623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185350|NCT03106623|Urological Agents|urological agents|mesh-ancestor
102185351|NCT03106623|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102185352|NCT03106623|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102185353|NCT03106623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102185354|NCT03106623|Adrenergic Agents|adrenergic agents|mesh-ancestor
102185355|NCT02411175|Ethanol|ethanol|mesh-list
102185356|NCT02411175|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102185357|NCT02411175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102185358|NCT02411175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102185359|NCT02411175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185360|NCT05537558|Antidepressive Agents|antidepressive agents|mesh-list
102185361|NCT05537558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102185362|NCT02411331|Ethanol|ethanol|mesh-list
102185363|NCT02411331|Enoxaparin|enoxaparin|mesh-list
102185364|NCT02411331|Anticoagulants|anticoagulants|mesh-ancestor
102185365|NCT02411331|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102185366|NCT02411331|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102185367|NCT02411331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185368|NCT02411331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102185369|NCT02411331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102185370|NCT02411331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102185371|NCT02411331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185372|NCT00100789|Paclitaxel|paclitaxel|mesh-list
102185373|NCT00100789|Gemcitabine|gemcitabine|mesh-list
102185374|NCT00100789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102185375|NCT00100789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102185376|NCT00100789|Tubulin Modulators|tubulin modulators|mesh-ancestor
102185377|NCT00100789|Antimitotic Agents|antimitotic agents|mesh-ancestor
102185378|NCT00100789|Mitosis Modulators|mitosis modulators|mesh-ancestor
102185379|NCT00100789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185380|NCT00100789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102185381|NCT00100789|Antimetabolites|antimetabolites|mesh-ancestor
102185382|NCT02410863|Trametinib|trametinib|mesh-list
102185384|NCT02410863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102185385|NCT02410863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102185386|NCT02410863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102185387|NCT02410863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185388|NCT05678192|Hormones|hormones|mesh-list
102185389|NCT05678192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102185390|NCT05678192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185391|NCT00708123|Listerine|listerine|mesh-list
102185392|NCT00708123|Fluorides|fluorides|mesh-list
102185393|NCT00708123|Sodium Fluoride|sodium fluoride|mesh-list
102185394|NCT00708123|Cariostatic Agents|cariostatic agents|mesh-ancestor
102185395|NCT00708123|Protective Agents|protective agents|mesh-ancestor
102185396|NCT00708123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185397|NCT00708123|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102185398|NCT00708123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102185399|NCT05678036|Analgesics, Opioid|analgesics, opioid|mesh-list
102185400|NCT05678036|Narcotics|narcotics|mesh-ancestor
102185401|NCT05678036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102185402|NCT05678036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185403|NCT05678036|Analgesics|analgesics|mesh-ancestor
102185404|NCT05678036|Sensory System Agents|sensory system agents|mesh-ancestor
102185405|NCT05678036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102185406|NCT05537090|Midazolam|midazolam|mesh-list
102185407|NCT05537090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102185408|NCT05537090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102185409|NCT05537090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102185410|NCT05537090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185411|NCT05537090|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102185412|NCT05537090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102185413|NCT05537090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102185414|NCT05537090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102185415|NCT05537090|Anesthetics, General|anesthetics, general|mesh-ancestor
102185416|NCT05537090|Anesthetics|anesthetics|mesh-ancestor
102185417|NCT05537090|GABA Modulators|gaba modulators|mesh-ancestor
102185418|NCT05537090|GABA Agents|gaba agents|mesh-ancestor
102185419|NCT05537090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102185420|NCT05537090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185421|NCT02400879|Sufentanil|sufentanil|mesh-list
102185422|NCT02400879|Remifentanil|remifentanil|mesh-list
102185423|NCT02400879|Sevoflurane|sevoflurane|mesh-list
102185424|NCT02400879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102185425|NCT02400879|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102185426|NCT02400879|Anesthetics, General|anesthetics, general|mesh-ancestor
102185427|NCT02400879|Anesthetics|anesthetics|mesh-ancestor
102185428|NCT02400879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102185429|NCT02400879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185430|NCT02400879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102185431|NCT02400879|Narcotics|narcotics|mesh-ancestor
102185432|NCT02400879|Analgesics|analgesics|mesh-ancestor
102185433|NCT02400879|Sensory System Agents|sensory system agents|mesh-ancestor
102185434|NCT02400879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102185435|NCT02400879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102185436|NCT02400879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102185437|NCT04133480|Cannabidiol|cannabidiol|mesh-list
102185438|NCT04133480|Anticonvulsants|anticonvulsants|mesh-ancestor
102185439|NCT02400645|Ketorolac|ketorolac|mesh-list
102185440|NCT02400645|Bupivacaine|bupivacaine|mesh-list
102185441|NCT02400645|Anesthetics, Local|anesthetics, local|mesh-ancestor
102185442|NCT02400645|Anesthetics|anesthetics|mesh-ancestor
102185443|NCT02400645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102185444|NCT02400645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185445|NCT02400645|Sensory System Agents|sensory system agents|mesh-ancestor
102185446|NCT02400645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102185447|NCT02400645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102185448|NCT02400645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102185449|NCT02400645|Analgesics|analgesics|mesh-ancestor
102185450|NCT02400645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102185451|NCT02400645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102185452|NCT02400645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102185453|NCT02400645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102185454|NCT02400645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185455|NCT02165215|Etrolizumab|etrolizumab|mesh-list
102185456|NCT02165215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102185457|NCT02165215|Immunologic Factors|immunologic factors|mesh-ancestor
102185458|NCT02165215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185460|NCT02400801|Dienogest|dienogest|mesh-list
102185461|NCT02400801|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102185462|NCT02400801|Luteolytic Agents|luteolytic agents|mesh-ancestor
102185463|NCT02400801|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102185464|NCT02400801|Contraceptive Agents|contraceptive agents|mesh-ancestor
102185465|NCT02400801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102185466|NCT02400801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185467|NCT02400801|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102185468|NCT02400801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102185469|NCT02400801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102185470|NCT02400801|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102185471|NCT02400801|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102185472|NCT02400801|Estrogens|estrogens|mesh-ancestor
102185473|NCT02400801|Hormones|hormones|mesh-ancestor
102185474|NCT02400801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102185475|NCT02400801|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102185476|NCT02400801|Hormone Antagonists|hormone antagonists|mesh-ancestor
102185477|NCT02168569|Artesunate|artesunate|mesh-list
102185478|NCT02168569|Lumefantrine|lumefantrine|mesh-list
102185479|NCT02168569|Artemether|artemether|mesh-list
102185480|NCT02168569|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102185481|NCT02168569|Amodiaquine|amodiaquine|mesh-list
102185482|NCT02168569|Antimalarials|antimalarials|mesh-ancestor
102185483|NCT02168569|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102185484|NCT02168569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102185485|NCT02168569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102185486|NCT02168569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102185487|NCT02168569|Antiviral Agents|antiviral agents|mesh-ancestor
102185488|NCT02168569|Schistosomicides|schistosomicides|mesh-ancestor
102185489|NCT02168569|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102185490|NCT02168569|Anthelmintics|anthelmintics|mesh-ancestor
102185491|NCT02400255|Crenolanib|crenolanib|mesh-list
102185492|NCT02400255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102185493|NCT02171689|Afatinib|afatinib|mesh-list
102185494|NCT02171689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102185495|NCT02171689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102185496|NCT02171689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102185497|NCT02171689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185498|NCT02171767|Afatinib|afatinib|mesh-list
102185499|NCT02171767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102185500|NCT02171767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102185501|NCT02171767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102185502|NCT02171767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185503|NCT02400021|Progesterone|progesterone|mesh-list
102185504|NCT02400021|Progestins|progestins|mesh-ancestor
102185505|NCT02400021|Hormones|hormones|mesh-ancestor
101448813|NCT00189059|Adrenergic Agents|adrenergic agents|mesh-ancestor
102185506|NCT02400021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102185507|NCT02400021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185508|NCT02165449|Ketamine|ketamine|mesh-list
102185509|NCT02165449|Analgesics|analgesics|mesh-ancestor
102185510|NCT02165449|Sensory System Agents|sensory system agents|mesh-ancestor
102185511|NCT02165449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102185512|NCT02165449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185513|NCT02165449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102185514|NCT02165449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102185515|NCT02165449|Anesthetics, General|anesthetics, general|mesh-ancestor
102185516|NCT02165449|Anesthetics|anesthetics|mesh-ancestor
102185517|NCT02165449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102185518|NCT02165449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102185519|NCT02165449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102185520|NCT02165449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102185521|NCT02165449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185522|NCT02172001|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
102185523|NCT02172001|Hematinics|hematinics|mesh-ancestor
102185524|NCT05535998|Chlorotrianisene|chlorotrianisene|mesh-list
102185525|NCT05535998|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102185526|NCT05535998|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102185527|NCT05535998|Estrogens|estrogens|mesh-ancestor
102185528|NCT05535998|Hormones|hormones|mesh-ancestor
102185529|NCT05535998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102185530|NCT05535998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185531|NCT05535998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102185532|NCT05535998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101900170|NCT00312845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102185533|NCT05535998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185534|NCT05535998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102185536|NCT03540199|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102185537|NCT03540199|Immunologic Factors|immunologic factors|mesh-ancestor
102185538|NCT03540199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185539|NCT02165917|Hyaluronic Acid|hyaluronic acid|mesh-list
102185540|NCT02165917|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102185541|NCT02165917|Immunologic Factors|immunologic factors|mesh-ancestor
102185542|NCT02165917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185543|NCT02165917|Viscosupplements|viscosupplements|mesh-ancestor
102185544|NCT02165917|Protective Agents|protective agents|mesh-ancestor
102185545|NCT02168881|Misoprostol|misoprostol|mesh-list
102185546|NCT02168881|Dinoprostone|dinoprostone|mesh-list
102185547|NCT02168881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102185548|NCT02168881|Abortifacient Agents|abortifacient agents|mesh-ancestor
102185549|NCT02168881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102185550|NCT02168881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185551|NCT02168881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102185552|NCT02168881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102185553|NCT02168881|Oxytocics|oxytocics|mesh-ancestor
102185554|NCT02168959|Bupivacaine|bupivacaine|mesh-list
102185555|NCT02168959|Anesthetics, Local|anesthetics, local|mesh-ancestor
102185556|NCT02168959|Anesthetics|anesthetics|mesh-ancestor
102185557|NCT02168959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102185558|NCT02168959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185559|NCT02168959|Sensory System Agents|sensory system agents|mesh-ancestor
102185560|NCT02168959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102185561|NCT05696678|Morphine|morphine|mesh-list
102185562|NCT05696678|Ropivacaine|ropivacaine|mesh-list
102185563|NCT05696678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102185564|NCT05696678|Narcotics|narcotics|mesh-ancestor
102185565|NCT05696678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102185566|NCT05696678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185567|NCT05696678|Analgesics|analgesics|mesh-ancestor
102185568|NCT05696678|Sensory System Agents|sensory system agents|mesh-ancestor
102185569|NCT05696678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102185570|NCT05696678|Anesthetics, Local|anesthetics, local|mesh-ancestor
102185572|NCT05450822|Lamotrigine|lamotrigine|mesh-list
102185573|NCT05450822|Levetiracetam|levetiracetam|mesh-list
102185574|NCT05450822|Anticonvulsants|anticonvulsants|mesh-list
102185575|NCT05450822|Nootropic Agents|nootropic agents|mesh-ancestor
102185576|NCT05450822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102185577|NCT05450822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102185578|NCT05450822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185579|NCT05450822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102185580|NCT05450822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185581|NCT05450822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102185582|NCT05450822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102185583|NCT05450822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102185584|NCT05450822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102185585|NCT05450822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102185586|NCT02172157|Olodaterol|olodaterol|mesh-list
102185587|NCT02172157|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102185588|NCT02172157|Autonomic Agents|autonomic agents|mesh-ancestor
102185589|NCT02172157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102185590|NCT02172157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185591|NCT02172157|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102185592|NCT02172157|Respiratory System Agents|respiratory system agents|mesh-ancestor
102185593|NCT02172235|Pioglitazone|pioglitazone|mesh-list
102185594|NCT02172235|Empagliflozin|empagliflozin|mesh-list
102185595|NCT02172235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102185596|NCT02172235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185597|NCT02172235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102185598|NCT02172235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185599|NCT02166229|Valproic Acid|valproic acid|mesh-list
102185600|NCT02166229|Anticonvulsants|anticonvulsants|mesh-ancestor
102185601|NCT02166229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102185602|NCT02166229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185603|NCT02166229|GABA Agents|gaba agents|mesh-ancestor
102185604|NCT02166229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102185605|NCT02166229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185606|NCT02166229|Antimanic Agents|antimanic agents|mesh-ancestor
102185607|NCT02166229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102185608|NCT02166229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102185609|NCT02166229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102185610|NCT05297864|Niraparib|niraparib|mesh-list
102185611|NCT05297864|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102185612|NCT05297864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102185613|NCT05297864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185614|NCT05297864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102185615|NCT02757625|Dexmedetomidine|dexmedetomidine|mesh-list
102185616|NCT02757625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102185617|NCT02757625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102185618|NCT02757625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185619|NCT02757625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102185620|NCT02757625|Analgesics|analgesics|mesh-ancestor
102185621|NCT02757625|Sensory System Agents|sensory system agents|mesh-ancestor
102185622|NCT02757625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102185623|NCT02757625|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102185624|NCT02757625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102185625|NCT02757625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102185626|NCT02757625|Adrenergic Agents|adrenergic agents|mesh-ancestor
102185627|NCT02757625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102185628|NCT02757625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185629|NCT05691920|Fentanyl|fentanyl|mesh-list
102185630|NCT05691920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102185631|NCT05691920|Narcotics|narcotics|mesh-ancestor
102185632|NCT05691920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102185633|NCT05691920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185634|NCT05691920|Analgesics|analgesics|mesh-ancestor
102185635|NCT05691920|Sensory System Agents|sensory system agents|mesh-ancestor
102185636|NCT05691920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102185637|NCT05691920|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102185638|NCT05691920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102185639|NCT05691920|Anesthetics, General|anesthetics, general|mesh-ancestor
102185640|NCT05691920|Anesthetics|anesthetics|mesh-ancestor
102185641|NCT05696366|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
102185642|NCT05696366|Volagidemab|volagidemab|mesh-list
101894487|NCT01211210|Fluorouracil|fluorouracil|mesh-list
102185643|NCT05696366|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102185644|NCT05696366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185645|NCT05696366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102185646|NCT05696366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185647|NCT02169583|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102185648|NCT05613842|Copper|copper|mesh-list
102185649|NCT05613842|Bombesin|bombesin|mesh-list
102185650|NCT05613842|Trace Elements|trace elements|mesh-ancestor
102185651|NCT05613842|Micronutrients|micronutrients|mesh-ancestor
102185652|NCT05613842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185653|NCT05613842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102185654|NCT05613842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185655|NCT02172391|Tiotropium Bromide|tiotropium bromide|mesh-list
102185656|NCT02172391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102185657|NCT02172391|Autonomic Agents|autonomic agents|mesh-ancestor
102185658|NCT02172391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102185659|NCT02172391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185660|NCT02172391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102185661|NCT02172391|Respiratory System Agents|respiratory system agents|mesh-ancestor
102185662|NCT02172391|Parasympatholytics|parasympatholytics|mesh-ancestor
102185663|NCT02172391|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102185664|NCT02172391|Cholinergic Agents|cholinergic agents|mesh-ancestor
102185665|NCT02172391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102185666|NCT02172391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185667|NCT00109681|Iloprost|iloprost|mesh-list
102185668|NCT00109681|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102185669|NCT00109681|Vasodilator Agents|vasodilator agents|mesh-ancestor
102185670|NCT02172469|Bromides|bromides|mesh-list
102185671|NCT02172469|Tiotropium Bromide|tiotropium bromide|mesh-list
102185672|NCT02172469|Ipratropium|ipratropium|mesh-list
102185673|NCT02172469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102185674|NCT02172469|Autonomic Agents|autonomic agents|mesh-ancestor
102185675|NCT02172469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102185676|NCT02172469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185677|NCT02172469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102185678|NCT02172469|Respiratory System Agents|respiratory system agents|mesh-ancestor
102185679|NCT02172469|Parasympatholytics|parasympatholytics|mesh-ancestor
102185680|NCT02172469|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102185681|NCT02172469|Cholinergic Agents|cholinergic agents|mesh-ancestor
102185682|NCT02172469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102185683|NCT02172469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185684|NCT02172469|Anticonvulsants|anticonvulsants|mesh-ancestor
102185685|NCT02172547|Tiotropium Bromide|tiotropium bromide|mesh-list
102185686|NCT02172547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102185687|NCT02172547|Autonomic Agents|autonomic agents|mesh-ancestor
102185688|NCT02172547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102185689|NCT02172547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185690|NCT02172547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102185691|NCT02172547|Respiratory System Agents|respiratory system agents|mesh-ancestor
102185692|NCT02172547|Parasympatholytics|parasympatholytics|mesh-ancestor
102185693|NCT02172547|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102185694|NCT02172547|Cholinergic Agents|cholinergic agents|mesh-ancestor
102185695|NCT02172547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102185696|NCT02172547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185697|NCT02174887|Paclitaxel|paclitaxel|mesh-list
102185698|NCT02174887|Gemcitabine|gemcitabine|mesh-list
102185699|NCT02174887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102185700|NCT02174887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102185701|NCT02174887|Tubulin Modulators|tubulin modulators|mesh-ancestor
102185702|NCT02174887|Antimitotic Agents|antimitotic agents|mesh-ancestor
102185703|NCT02174887|Mitosis Modulators|mitosis modulators|mesh-ancestor
102185704|NCT02174887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185705|NCT02174887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102185706|NCT02174887|Antimetabolites|antimetabolites|mesh-ancestor
102185707|NCT04373564|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
102185708|NCT04373564|Chelating Agents|chelating agents|mesh-ancestor
102185709|NCT04373564|Sequestering Agents|sequestering agents|mesh-ancestor
102185710|NCT04373564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185711|NCT05142319|Vaccines|vaccines|mesh-list
102185712|NCT05142319|Immunologic Factors|immunologic factors|mesh-ancestor
102185713|NCT05142319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894556|NCT01208480|Tubulin Modulators|tubulin modulators|mesh-ancestor
102185714|NCT02169973|JNJ-42165279|jnj-42165279|mesh-list
102185715|NCT02169973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102185716|NCT02169973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185717|NCT04298528|Dronabinol|dronabinol|mesh-list
102185718|NCT04298528|Hallucinogens|hallucinogens|mesh-ancestor
102185719|NCT04298528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185720|NCT04298528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102185721|NCT04298528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102185722|NCT04298528|Analgesics|analgesics|mesh-ancestor
102185723|NCT04298528|Sensory System Agents|sensory system agents|mesh-ancestor
102185724|NCT04298528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102185725|NCT04298528|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102185726|NCT04298528|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102185727|NCT04298528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102185728|NCT04298528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185729|NCT04298528|Hormones|hormones|mesh-ancestor
102185730|NCT04298528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102185731|NCT00100711|Motexafin gadolinium|motexafin gadolinium|mesh-list
102185732|NCT00100711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102185733|NCT00100711|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102185734|NCT00100711|Dermatologic Agents|dermatologic agents|mesh-ancestor
102185735|NCT02581202|Ritonavir|ritonavir|mesh-list
102185736|NCT02581202|Lopinavir|lopinavir|mesh-list
102185737|NCT02581202|Lamivudine|lamivudine|mesh-list
102185738|NCT02581202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102185739|NCT02581202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102185740|NCT02581202|Protease Inhibitors|protease inhibitors|mesh-ancestor
102185741|NCT02581202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102185742|NCT02581202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185743|NCT02581202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102185744|NCT02581202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102185745|NCT02581202|Antiviral Agents|antiviral agents|mesh-ancestor
102185746|NCT02581202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102185747|NCT02581202|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102185748|NCT02581202|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102185749|NCT02581202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102185750|NCT02581202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102185751|NCT02758171|Empagliflozin|empagliflozin|mesh-list
102185752|NCT02758171|Linagliptin|linagliptin|mesh-list
102185753|NCT02758171|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102185754|NCT02758171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185755|NCT02758171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102185756|NCT02758171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185757|NCT02758171|Incretins|incretins|mesh-ancestor
102185758|NCT02758171|Hormones|hormones|mesh-ancestor
102185759|NCT02758171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102185760|NCT02758171|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102185761|NCT02758171|Protease Inhibitors|protease inhibitors|mesh-ancestor
102185762|NCT02758171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102185763|NCT02172781|Tiotropium Bromide|tiotropium bromide|mesh-list
102185764|NCT02172781|Ipratropium|ipratropium|mesh-list
102185765|NCT02172781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102185766|NCT02172781|Autonomic Agents|autonomic agents|mesh-ancestor
102185767|NCT02172781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102185768|NCT02172781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185769|NCT02172781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102185770|NCT02172781|Respiratory System Agents|respiratory system agents|mesh-ancestor
102185771|NCT02172781|Parasympatholytics|parasympatholytics|mesh-ancestor
102185772|NCT02172781|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102185773|NCT02172781|Cholinergic Agents|cholinergic agents|mesh-ancestor
102185774|NCT02172781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102185775|NCT02172781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185776|NCT02173093|Aldesleukin|aldesleukin|mesh-list
102185777|NCT02173093|Interleukin-2|interleukin-2|mesh-list
102185778|NCT02173093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102185779|NCT02173093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102185780|NCT02173093|Analgesics|analgesics|mesh-ancestor
101448835|NCT00189371|Hematinics|hematinics|mesh-ancestor
102185781|NCT02173093|Sensory System Agents|sensory system agents|mesh-ancestor
102185782|NCT02173093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102185783|NCT02173093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185784|NCT02173093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102185785|NCT02173093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102185786|NCT02173093|Antiviral Agents|antiviral agents|mesh-ancestor
102185787|NCT02173093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102185788|NCT05142085|Mineral Oil|mineral oil|mesh-list
101894630|NCT01213238|Bevacizumab|bevacizumab|mesh-list
102185789|NCT05142085|Emollients|emollients|mesh-ancestor
102185790|NCT05142085|Dermatologic Agents|dermatologic agents|mesh-ancestor
102185791|NCT00103831|Taxane|taxane|mesh-list
102185792|NCT00103831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102185793|NCT03538483|Bupivacaine|bupivacaine|mesh-list
102185794|NCT03538483|Anesthetics, Local|anesthetics, local|mesh-ancestor
102185795|NCT03538483|Anesthetics|anesthetics|mesh-ancestor
102185796|NCT03538483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102185797|NCT03538483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185798|NCT03538483|Sensory System Agents|sensory system agents|mesh-ancestor
102185799|NCT03538483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102185800|NCT05033054|Dapagliflozin|dapagliflozin|mesh-list
102185801|NCT05033054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102185802|NCT05033054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185803|NCT05033054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102185804|NCT05033054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185805|NCT02175355|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102185806|NCT02175355|Telmisartan|telmisartan|mesh-list
102185807|NCT02175355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102185808|NCT02175355|Diuretics|diuretics|mesh-ancestor
102185809|NCT02175355|Natriuretic Agents|natriuretic agents|mesh-ancestor
102185810|NCT02175355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185811|NCT02175355|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102185812|NCT02175355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102185813|NCT02175355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185814|NCT02175355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102185815|NCT02175355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102185816|NCT03538327|Silybin|silybin|mesh-list
102185817|NCT03538327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102185818|NCT03538327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102185819|NCT03538327|Protective Agents|protective agents|mesh-ancestor
102185820|NCT03538327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185821|NCT02170597|Dabigatran|dabigatran|mesh-list
101900175|NCT01168544|Vitamin D|vitamin d|mesh-list
102185823|NCT02170597|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102185824|NCT02170597|Protease Inhibitors|protease inhibitors|mesh-ancestor
102185825|NCT02170597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102185826|NCT02170597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185827|NCT02170597|Anticoagulants|anticoagulants|mesh-ancestor
102185828|NCT02170675|Ketoconazole|ketoconazole|mesh-list
102185829|NCT02170675|Dabigatran|dabigatran|mesh-list
102185830|NCT02170675|Antithrombins|antithrombins|mesh-ancestor
102185831|NCT02170675|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102185832|NCT02170675|Protease Inhibitors|protease inhibitors|mesh-ancestor
102185833|NCT02170675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102185834|NCT02170675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185835|NCT02170675|Anticoagulants|anticoagulants|mesh-ancestor
102185836|NCT02170675|Antifungal Agents|antifungal agents|mesh-ancestor
102185837|NCT02170675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102185838|NCT02170675|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102185839|NCT02170675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102185840|NCT02170675|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102185841|NCT02170675|Hormone Antagonists|hormone antagonists|mesh-ancestor
102185842|NCT02170675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102185843|NCT02170675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185844|NCT02170675|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102185845|NCT02175433|AGS67E|ags67e|mesh-list
102185846|NCT02175433|Immunoconjugates|immunoconjugates|mesh-ancestor
102185847|NCT02175433|Immunologic Factors|immunologic factors|mesh-ancestor
101448837|NCT00189410|Doxorubicin|doxorubicin|mesh-list
102185848|NCT02175433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185849|NCT04154150|Ketamine|ketamine|mesh-list
102185850|NCT04154150|Analgesics|analgesics|mesh-ancestor
102185851|NCT04154150|Sensory System Agents|sensory system agents|mesh-ancestor
102185852|NCT04154150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102185853|NCT04154150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185854|NCT04154150|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102185855|NCT04154150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102185856|NCT04154150|Anesthetics, General|anesthetics, general|mesh-ancestor
102185857|NCT04154150|Anesthetics|anesthetics|mesh-ancestor
102185858|NCT04154150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102185859|NCT04154150|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102185860|NCT04154150|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102185861|NCT04154150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102185862|NCT04154150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185863|NCT00521846|Cimetidine|cimetidine|mesh-list
102185864|NCT00521846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102185865|NCT00521846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102185866|NCT00521846|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102185867|NCT00521846|Histamine Antagonists|histamine antagonists|mesh-ancestor
102185868|NCT00521846|Histamine Agents|histamine agents|mesh-ancestor
102185869|NCT00521846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102185870|NCT00521846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185871|NCT00521846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185872|NCT00521846|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102185873|NCT00521846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102185874|NCT00521846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102185875|NCT02170831|Dabigatran|dabigatran|mesh-list
102185876|NCT02170831|Antithrombins|antithrombins|mesh-ancestor
102185877|NCT02170831|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102185878|NCT02170831|Protease Inhibitors|protease inhibitors|mesh-ancestor
102185879|NCT02170831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102185880|NCT02170831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185881|NCT02170831|Anticoagulants|anticoagulants|mesh-ancestor
102185882|NCT02175589|Colchicine|colchicine|mesh-list
102185883|NCT02175589|Gout Suppressants|gout suppressants|mesh-ancestor
102185884|NCT02175589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102185885|NCT02175589|Tubulin Modulators|tubulin modulators|mesh-ancestor
102185886|NCT02175589|Antimitotic Agents|antimitotic agents|mesh-ancestor
102185887|NCT02175589|Mitosis Modulators|mitosis modulators|mesh-ancestor
102185888|NCT02175589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185889|NCT02175589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102185890|NCT05438186|Liraglutide|liraglutide|mesh-list
102185891|NCT05438186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102185892|NCT05438186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185893|NCT05438186|Incretins|incretins|mesh-ancestor
102185894|NCT05438186|Hormones|hormones|mesh-ancestor
101900178|NCT01168544|Vitamins|vitamins|mesh-list
102185895|NCT05438186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102185896|NCT02178397|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102185897|NCT02178397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102185898|NCT02178397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102185899|NCT02178397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102185900|NCT02178397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185901|NCT02173639|Metformin|metformin|mesh-list
102185902|NCT02173639|Linagliptin|linagliptin|mesh-list
102185903|NCT02173639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102185904|NCT02173639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185905|NCT02173639|Incretins|incretins|mesh-ancestor
102185906|NCT02173639|Hormones|hormones|mesh-ancestor
102185907|NCT02173639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102185908|NCT02173639|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102185909|NCT02173639|Protease Inhibitors|protease inhibitors|mesh-ancestor
102185910|NCT02173639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102185911|NCT02173639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185912|NCT02173717|Rifampin|rifampin|mesh-list
102185913|NCT02173717|Dabigatran|dabigatran|mesh-list
102185914|NCT02173717|Antithrombins|antithrombins|mesh-ancestor
102185915|NCT02173717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102185916|NCT02173717|Protease Inhibitors|protease inhibitors|mesh-ancestor
102185917|NCT02173717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102185918|NCT02173717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185919|NCT02173717|Anticoagulants|anticoagulants|mesh-ancestor
102185920|NCT02173717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102185921|NCT02173717|Antitubercular Agents|antitubercular agents|mesh-ancestor
102185922|NCT02173717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102185923|NCT02173717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102185924|NCT02173717|Leprostatic Agents|leprostatic agents|mesh-ancestor
102185925|NCT02173717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102185926|NCT02173717|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102185927|NCT02173717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102185928|NCT02173717|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102185929|NCT02173717|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102185930|NCT02173717|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102185931|NCT02173717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102185932|NCT04067648|Sufentanil|sufentanil|mesh-list
102185933|NCT04067648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102185934|NCT04067648|Narcotics|narcotics|mesh-ancestor
102185935|NCT04067648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101894778|NCT01122134|Antiviral Agents|antiviral agents|mesh-ancestor
102185936|NCT04067648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185937|NCT04067648|Analgesics|analgesics|mesh-ancestor
102185938|NCT04067648|Sensory System Agents|sensory system agents|mesh-ancestor
102185939|NCT04067648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102185940|NCT04067648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102185941|NCT04067648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102185942|NCT04067648|Anesthetics, General|anesthetics, general|mesh-ancestor
102185943|NCT04067648|Anesthetics|anesthetics|mesh-ancestor
102185944|NCT02173795|Fenoterol|fenoterol|mesh-list
102185945|NCT02173795|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
102185946|NCT02173795|Ipratropium|ipratropium|mesh-list
102185947|NCT02173795|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102185948|NCT02173795|Autonomic Agents|autonomic agents|mesh-ancestor
102185949|NCT02173795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102185950|NCT02173795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185951|NCT02173795|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102185952|NCT02173795|Respiratory System Agents|respiratory system agents|mesh-ancestor
102185953|NCT02173795|Sympathomimetics|sympathomimetics|mesh-ancestor
102185954|NCT02173795|Tocolytic Agents|tocolytic agents|mesh-ancestor
102185955|NCT02173795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102185956|NCT02173795|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102185957|NCT02173795|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102185958|NCT02173795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102185959|NCT02173795|Adrenergic Agents|adrenergic agents|mesh-ancestor
102185960|NCT02173795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102185961|NCT02173795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185962|NCT02173795|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102185963|NCT02173795|Cholinergic Agents|cholinergic agents|mesh-ancestor
102185964|NCT02175901|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102185965|NCT02175901|Amoxicillin|amoxicillin|mesh-list
102185966|NCT02175901|Metronidazole|metronidazole|mesh-list
102185967|NCT02175901|Clarithromycin|clarithromycin|mesh-list
102185968|NCT02175901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102185969|NCT02175901|Potassium Citrate|potassium citrate|mesh-list
102185970|NCT02175901|Lansoprazole|lansoprazole|mesh-list
102185971|NCT02175901|Bismuth|bismuth|mesh-list
102185972|NCT02175901|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
102185973|NCT02175901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185974|NCT02175901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102185975|NCT02175901|Antitubercular Agents|antitubercular agents|mesh-ancestor
102185976|NCT02175901|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102185977|NCT02175901|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102185978|NCT02175901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102185979|NCT02175901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102185980|NCT02175901|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102185981|NCT02175901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102185982|NCT02175901|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102185983|NCT02175901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102185984|NCT02175901|Antacids|antacids|mesh-ancestor
102185985|NCT02175901|Diuretics|diuretics|mesh-ancestor
102185986|NCT02175901|Natriuretic Agents|natriuretic agents|mesh-ancestor
102185987|NCT02175901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102185988|NCT02175901|Expectorants|expectorants|mesh-ancestor
101448846|NCT00189566|Carboplatin|carboplatin|mesh-list
102185989|NCT02175901|Respiratory System Agents|respiratory system agents|mesh-ancestor
102185990|NCT05534750|Linezolid|linezolid|mesh-list
102185991|NCT05534750|Tedizolid|tedizolid|mesh-list
102185992|NCT05534750|Tedizolid phosphate|tedizolid phosphate|mesh-list
102185993|NCT05534750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102185994|NCT05534750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102185995|NCT05534750|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102185996|NCT05534750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102185997|NCT05534750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102185998|NCT02173873|Aflibercept|aflibercept|mesh-list
102185999|NCT02173873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102186000|NCT02173873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102186001|NCT02173873|Growth Substances|growth substances|mesh-ancestor
102186002|NCT02173873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186003|NCT02173873|Growth Inhibitors|growth inhibitors|mesh-ancestor
102186004|NCT02173873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102186005|NCT02176057|Azithromycin|azithromycin|mesh-list
102186006|NCT02176057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102186007|NCT02176057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102186008|NCT02173951|Deferiprone|deferiprone|mesh-list
102186009|NCT02173951|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102186010|NCT02173951|Chelating Agents|chelating agents|mesh-ancestor
102186011|NCT02173951|Sequestering Agents|sequestering agents|mesh-ancestor
102186012|NCT02173951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186013|NCT02176135|Auranofin|auranofin|mesh-list
102186014|NCT02176135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102186015|NCT02176213|Dexamethasone|dexamethasone|mesh-list
102186016|NCT02176213|Cyclophosphamide|cyclophosphamide|mesh-list
102186017|NCT02176213|Pomalidomide|pomalidomide|mesh-list
102186018|NCT02176213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102186019|NCT02176213|Immunologic Factors|immunologic factors|mesh-ancestor
102186020|NCT02176213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186021|NCT02176213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102186022|NCT02176213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102186023|NCT02176213|Alkylating Agents|alkylating agents|mesh-ancestor
102186024|NCT02176213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186025|NCT02176213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102186026|NCT02176213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102186027|NCT02176213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102186028|NCT02176213|Antiemetics|antiemetics|mesh-ancestor
102186029|NCT02176213|Autonomic Agents|autonomic agents|mesh-ancestor
102186030|NCT02176213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102186031|NCT02176213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102186032|NCT02176213|Glucocorticoids|glucocorticoids|mesh-ancestor
102186033|NCT02176213|Hormones|hormones|mesh-ancestor
102186034|NCT02176213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102186035|NCT02176213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102186036|NCT02176213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102186037|NCT02176213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102186038|NCT02176213|Growth Substances|growth substances|mesh-ancestor
102186039|NCT02176213|Growth Inhibitors|growth inhibitors|mesh-ancestor
102186040|NCT03537547|Antipsychotic Agents|antipsychotic agents|mesh-list
102186041|NCT03537547|Antidepressive Agents|antidepressive agents|mesh-list
102186042|NCT03537547|Psychotropic Drugs|psychotropic drugs|mesh-list
102186043|NCT03537547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102186044|NCT03537547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102186045|NCT03537547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186046|NCT04305002|Exenatide|exenatide|mesh-list
102186047|NCT04305002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101448851|NCT00189566|Antimitotic Agents|antimitotic agents|mesh-ancestor
102186048|NCT04305002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186049|NCT04305002|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102186050|NCT04305002|Incretins|incretins|mesh-ancestor
102186051|NCT04305002|Hormones|hormones|mesh-ancestor
102186052|NCT04305002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102186053|NCT02253797|Ritonavir|ritonavir|mesh-list
102186054|NCT02253797|Tipranavir|tipranavir|mesh-list
102186055|NCT02253797|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102186056|NCT02253797|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102186057|NCT02253797|Protease Inhibitors|protease inhibitors|mesh-ancestor
102186058|NCT02253797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102186059|NCT02253797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186060|NCT02253797|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102186061|NCT02253797|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102186062|NCT02253797|Antiviral Agents|antiviral agents|mesh-ancestor
102186063|NCT02253797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102186064|NCT02253797|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102186065|NCT02253797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102186066|NCT04620746|Penicillins|penicillins|mesh-list
102186067|NCT04620746|Penicillin G|penicillin g|mesh-list
102186068|NCT04620746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102186069|NCT04620746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102186070|NCT02253875|Ritonavir|ritonavir|mesh-list
102186071|NCT02253875|Tipranavir|tipranavir|mesh-list
102186072|NCT02253875|Omeprazole|omeprazole|mesh-list
102186073|NCT02253875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102186074|NCT02253875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102186075|NCT02253875|Protease Inhibitors|protease inhibitors|mesh-ancestor
102186076|NCT02253875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102186077|NCT02253875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186078|NCT02253875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102186079|NCT02253875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102186080|NCT02253875|Antiviral Agents|antiviral agents|mesh-ancestor
102186081|NCT02253875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102186082|NCT02253875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102186083|NCT02253875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102186084|NCT02253875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102186085|NCT02253875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102186086|NCT02253875|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102186087|NCT03819140|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
102186088|NCT03819140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102186089|NCT03819140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186090|NCT04597268|Midazolam|midazolam|mesh-list
102186092|NCT04597268|Ketamine|ketamine|mesh-list
102186093|NCT04597268|Propofol|propofol|mesh-list
102186094|NCT04597268|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102186095|NCT04597268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102186096|NCT04597268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186097|NCT04597268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102186098|NCT04597268|Analgesics|analgesics|mesh-ancestor
102186099|NCT04597268|Sensory System Agents|sensory system agents|mesh-ancestor
102186100|NCT04597268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102186101|NCT04597268|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102186102|NCT04597268|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102186103|NCT04597268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102186104|NCT04597268|Adrenergic Agents|adrenergic agents|mesh-ancestor
102186105|NCT04597268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102186106|NCT04597268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186107|NCT04597268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102186108|NCT04597268|Anesthetics, General|anesthetics, general|mesh-ancestor
102186109|NCT04597268|Anesthetics|anesthetics|mesh-ancestor
102186110|NCT04597268|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102186111|NCT04597268|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102186112|NCT04597268|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102186113|NCT04597268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102186114|NCT04597268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102186115|NCT04597268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102186116|NCT04597268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102186117|NCT04597268|GABA Modulators|gaba modulators|mesh-ancestor
102186119|NCT04976543|Nadroparin|nadroparin|mesh-list
102186120|NCT04976543|Warfarin|warfarin|mesh-list
102186121|NCT04976543|Calcium|calcium|mesh-list
102186122|NCT04976543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102186123|NCT04976543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186124|NCT04976543|Anticoagulants|anticoagulants|mesh-ancestor
102186125|NCT04976543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102186126|NCT04976543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102186127|NCT04976543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186128|NCT05533892|Lenvatinib|lenvatinib|mesh-list
102186129|NCT05533892|Tislelizumab|tislelizumab|mesh-list
102186130|NCT05533892|Cell Wall Skeleton|cell wall skeleton|mesh-list
102186131|NCT05533892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102186132|NCT05533892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102186133|NCT05533892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102186134|NCT05533892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186135|NCT05533892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102186136|NCT05533892|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102186137|NCT05533892|Immunologic Factors|immunologic factors|mesh-ancestor
102186138|NCT05533892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186139|NCT02924441|Lidocaine|lidocaine|mesh-list
102186140|NCT02924441|Anesthetics, Local|anesthetics, local|mesh-ancestor
102186141|NCT02924441|Anesthetics|anesthetics|mesh-ancestor
102186142|NCT02924441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102186143|NCT02924441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186144|NCT02924441|Sensory System Agents|sensory system agents|mesh-ancestor
102186145|NCT02924441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102186146|NCT02924441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102186147|NCT02924441|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102186148|NCT02924441|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102186149|NCT02924441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102186150|NCT02924441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186151|NCT00109967|Sirolimus|sirolimus|mesh-list
102186152|NCT00109967|Rituximab|rituximab|mesh-list
102186153|NCT00109967|Temsirolimus|temsirolimus|mesh-list
102186154|NCT00109967|MTOR Inhibitors|mtor inhibitors|mesh-list
102186155|NCT00109967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102186156|NCT00109967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102186157|NCT00109967|Immunologic Factors|immunologic factors|mesh-ancestor
102186158|NCT00109967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186159|NCT00109967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102186160|NCT00109967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102186161|NCT00109967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102186162|NCT00109967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186163|NCT00109967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102186164|NCT00109967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101895005|NCT01217294|Morphine|morphine|mesh-list
102186165|NCT00109967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102186166|NCT00109967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102186167|NCT00109967|Antifungal Agents|antifungal agents|mesh-ancestor
102186168|NCT02579096|Allopurinol|allopurinol|mesh-list
102186169|NCT02579096|Febuxostat|febuxostat|mesh-list
102186170|NCT02579096|Antimetabolites|antimetabolites|mesh-ancestor
102186171|NCT02579096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186172|NCT02579096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102186173|NCT02579096|Gout Suppressants|gout suppressants|mesh-ancestor
102186174|NCT02579096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102186175|NCT02579096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102186176|NCT02579096|Antioxidants|antioxidants|mesh-ancestor
102186177|NCT02579096|Protective Agents|protective agents|mesh-ancestor
102186178|NCT02579096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186179|NCT02578862|Propofol|propofol|mesh-list
102186180|NCT02578862|Sevoflurane|sevoflurane|mesh-list
102186181|NCT02578862|Isoflurane|isoflurane|mesh-list
102186182|NCT02578862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101448874|NCT00189644|Cyclophosphamide|cyclophosphamide|mesh-list
102186183|NCT02578862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102186184|NCT02578862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186185|NCT02578862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102186186|NCT02578862|Anesthetics, General|anesthetics, general|mesh-ancestor
102186187|NCT02578862|Anesthetics|anesthetics|mesh-ancestor
102186188|NCT02578862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102186189|NCT02578862|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102186190|NCT02578706|Aspirin|aspirin|mesh-list
102186191|NCT02578706|Clopidogrel|clopidogrel|mesh-list
102186192|NCT02578706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102186193|NCT02578706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102186194|NCT02578706|Analgesics|analgesics|mesh-ancestor
102186195|NCT02578706|Sensory System Agents|sensory system agents|mesh-ancestor
102186196|NCT02578706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102186197|NCT02578706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186198|NCT02578706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102186199|NCT02578706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102186200|NCT02578706|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102186201|NCT02578706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102186202|NCT02578706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186203|NCT02578706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102186204|NCT02578706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102186205|NCT02578706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102186206|NCT02578706|Antipyretics|antipyretics|mesh-ancestor
102186207|NCT02578706|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102186208|NCT02578706|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102186209|NCT02578706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102186210|NCT02578706|Purinergic Agents|purinergic agents|mesh-ancestor
102186211|NCT02578706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102186212|NCT03455504|Venetoclax|venetoclax|mesh-list
102186213|NCT03455504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102186214|NCT00108953|Doxorubicin|doxorubicin|mesh-list
102186215|NCT00108953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102186216|NCT00108953|Sorafenib|sorafenib|mesh-list
102186217|NCT00108953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102186218|NCT00108953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102186219|NCT00108953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102186220|NCT00108953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102186221|NCT00108953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102186222|NCT00108953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186223|NCT00108953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102186224|NCT02741531|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102186225|NCT02578316|Lenvatinib|lenvatinib|mesh-list
102186226|NCT02578316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102186227|NCT02578316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102186228|NCT02578316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102186229|NCT02578316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186230|NCT05532878|Apixaban|apixaban|mesh-list
102186231|NCT05532878|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102186232|NCT05532878|Antithrombins|antithrombins|mesh-ancestor
102186233|NCT05532878|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102186234|NCT05532878|Protease Inhibitors|protease inhibitors|mesh-ancestor
102186235|NCT05532878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102186236|NCT05532878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186237|NCT05532878|Anticoagulants|anticoagulants|mesh-ancestor
102186238|NCT02576678|Apremilast|apremilast|mesh-list
101895077|NCT01125410|Dequalinium|dequalinium|mesh-list
102186239|NCT02576678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102186240|NCT02576678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102186241|NCT02576678|Analgesics|analgesics|mesh-ancestor
102186242|NCT02576678|Sensory System Agents|sensory system agents|mesh-ancestor
102186243|NCT02576678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102186244|NCT02576678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186245|NCT02576678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102186246|NCT02576678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102186247|NCT02576678|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102186248|NCT02576678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102186249|NCT02576678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102186250|NCT02576678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186251|NCT05532332|Fluoxetine|fluoxetine|mesh-list
102186252|NCT05532332|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102186253|NCT05532332|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102186254|NCT05532332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102186255|NCT05532332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186256|NCT05532332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102186257|NCT05532332|Serotonin Agents|serotonin agents|mesh-ancestor
102186258|NCT05532332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186259|NCT05532332|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102186260|NCT05532332|Antidepressive Agents|antidepressive agents|mesh-ancestor
102186261|NCT05532332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102186262|NCT05532332|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101728043|NCT01227876|Hormones|hormones|mesh-ancestor
102186263|NCT05532332|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102186264|NCT05532332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102186265|NCT05532254|Aripiprazole|aripiprazole|mesh-list
102186266|NCT05532254|Antidepressive Agents|antidepressive agents|mesh-ancestor
102186267|NCT05532254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102186268|NCT05532254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102186269|NCT05532254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102186270|NCT05532254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102186271|NCT05532254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186272|NCT05532254|Dopamine Agonists|dopamine agonists|mesh-ancestor
102186273|NCT05532254|Dopamine Agents|dopamine agents|mesh-ancestor
102186274|NCT05532254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102186275|NCT05532254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186276|NCT05532254|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102186277|NCT05532254|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102186278|NCT05532254|Serotonin Agents|serotonin agents|mesh-ancestor
102186279|NCT05532254|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102186280|NCT05532254|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102186281|NCT05532254|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102186282|NCT05532254|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102186283|NCT05471648|Pertuzumab|pertuzumab|mesh-list
102186284|NCT05471648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102186285|NCT05471648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102186286|NCT00108745|Paclitaxel|paclitaxel|mesh-list
102186287|NCT00108745|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102186288|NCT00108745|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
102186289|NCT00108745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102186290|NCT00108745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102186291|NCT00108745|Tubulin Modulators|tubulin modulators|mesh-ancestor
102186292|NCT00108745|Antimitotic Agents|antimitotic agents|mesh-ancestor
102186293|NCT00108745|Mitosis Modulators|mitosis modulators|mesh-ancestor
102186294|NCT00108745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186295|NCT05532020|Diazoxide|diazoxide|mesh-list
102186296|NCT05532020|Choline|choline|mesh-list
102186297|NCT05532020|Lipotropic Agents|lipotropic agents|mesh-ancestor
102186298|NCT05532020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102186299|NCT05532020|Antimetabolites|antimetabolites|mesh-ancestor
102186300|NCT05532020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186301|NCT05532020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102186302|NCT05532020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102186303|NCT05532020|Nootropic Agents|nootropic agents|mesh-ancestor
102186304|NCT05532020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102186305|NCT05532020|Vasodilator Agents|vasodilator agents|mesh-ancestor
102186306|NCT02098343|Carboplatin|carboplatin|mesh-list
102186307|NCT02098343|Doxorubicin|doxorubicin|mesh-list
102186308|NCT02098343|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102186309|NCT02098343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102186310|NCT02098343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102186311|NCT02098343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102186312|NCT02098343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102186313|NCT02098343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895156|NCT01215578|Sunitinib|sunitinib|mesh-list
102186314|NCT02098343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186315|NCT02176369|Vinorelbine|vinorelbine|mesh-list
102186316|NCT02176369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102186317|NCT02176369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102186318|NCT02176369|Tubulin Modulators|tubulin modulators|mesh-ancestor
102186319|NCT02176369|Antimitotic Agents|antimitotic agents|mesh-ancestor
102186320|NCT02176369|Mitosis Modulators|mitosis modulators|mesh-ancestor
102186321|NCT02176369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186322|NCT02716805|Melphalan|melphalan|mesh-list
102186323|NCT02716805|Durvalumab|durvalumab|mesh-list
102186324|NCT02716805|Tremelimumab|tremelimumab|mesh-list
102186325|NCT02716805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102186326|NCT02716805|Alkylating Agents|alkylating agents|mesh-ancestor
102186327|NCT02716805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186328|NCT02716805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102186329|NCT02716805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102186330|NCT02716805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102186331|NCT02716805|Immunologic Factors|immunologic factors|mesh-ancestor
102186332|NCT02716805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186333|NCT02716805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102186334|NCT02174263|Immunoglobulins|immunoglobulins|mesh-list
101385617|NCT00304993|Niacin|niacin|mesh-list
102186335|NCT02174263|Immunoglobulin G|immunoglobulin g|mesh-list
102186336|NCT02174263|Immunologic Factors|immunologic factors|mesh-ancestor
102186337|NCT02174263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186338|NCT04152473|Proglumide|proglumide|mesh-list
102186339|NCT04152473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102186340|NCT04152473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102186341|NCT04099355|Dronabinol|dronabinol|mesh-list
102186342|NCT04099355|Hallucinogens|hallucinogens|mesh-ancestor
102186343|NCT04099355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186344|NCT04099355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102186345|NCT04099355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102186346|NCT04099355|Analgesics|analgesics|mesh-ancestor
102186347|NCT04099355|Sensory System Agents|sensory system agents|mesh-ancestor
102186348|NCT04099355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102186349|NCT04099355|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102186350|NCT04099355|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102186351|NCT04099355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102186352|NCT04099355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186353|NCT04099355|Hormones|hormones|mesh-ancestor
102186354|NCT04099355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102186355|NCT02581982|Paclitaxel|paclitaxel|mesh-list
102186356|NCT02581982|Pembrolizumab|pembrolizumab|mesh-list
102186357|NCT02581982|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102186358|NCT02581982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102186359|NCT02581982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102186360|NCT02581982|Tubulin Modulators|tubulin modulators|mesh-ancestor
102186361|NCT02581982|Antimitotic Agents|antimitotic agents|mesh-ancestor
102186362|NCT02581982|Mitosis Modulators|mitosis modulators|mesh-ancestor
102186363|NCT02581982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186364|NCT02581982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102186365|NCT02581982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102186366|NCT03751397|Cystatins|cystatins|mesh-list
102186367|NCT03751397|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
102186368|NCT03751397|Protease Inhibitors|protease inhibitors|mesh-ancestor
102186369|NCT03751397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102186370|NCT03751397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186371|NCT02176681|Vildagliptin|vildagliptin|mesh-list
102186372|NCT02176681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102186373|NCT02176681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186374|NCT02176681|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102186375|NCT02176681|Protease Inhibitors|protease inhibitors|mesh-ancestor
102186376|NCT02176681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102186377|NCT02176681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186378|NCT02179099|Botulinum Toxins|botulinum toxins|mesh-list
102186379|NCT02179099|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102186380|NCT02179099|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102186381|NCT02179099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102186382|NCT02179099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186383|NCT02179099|Cholinergic Agents|cholinergic agents|mesh-ancestor
102186384|NCT02179099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102186385|NCT02179099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186386|NCT02179099|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102186387|NCT02179099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102186388|NCT02254577|Progesterone|progesterone|mesh-list
102186389|NCT02254577|Progestins|progestins|mesh-ancestor
102186390|NCT02254577|Hormones|hormones|mesh-ancestor
102186391|NCT02254577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102186392|NCT02254577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186393|NCT02176759|Citric Acid|citric acid|mesh-list
102186394|NCT02176759|Sodium Citrate|sodium citrate|mesh-list
102186395|NCT02176759|Anticoagulants|anticoagulants|mesh-ancestor
102186396|NCT02176759|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102186397|NCT02176759|Chelating Agents|chelating agents|mesh-ancestor
102186398|NCT02176759|Sequestering Agents|sequestering agents|mesh-ancestor
102186399|NCT02176759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186400|NCT06010602|Analgesics|analgesics|mesh-list
102186401|NCT06010602|Sensory System Agents|sensory system agents|mesh-ancestor
102186402|NCT06010602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102186403|NCT06010602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186404|NCT06010329|Maleic acid|maleic acid|mesh-list
102186405|NCT06010329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102186406|NCT06010329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186407|NCT06010303|Tislelizumab|tislelizumab|mesh-list
102186408|NCT06010303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102186409|NCT06010303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102186410|NCT06010290|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102186411|NCT06010290|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102186412|NCT06010290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186413|NCT06010277|Leucovorin|leucovorin|mesh-list
102186414|NCT06010277|Folic Acid|folic acid|mesh-list
102186415|NCT06010277|Levoleucovorin|levoleucovorin|mesh-list
102186416|NCT06010277|Antidotes|antidotes|mesh-ancestor
102186417|NCT06010277|Protective Agents|protective agents|mesh-ancestor
102186418|NCT06010277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186419|NCT06010277|Vitamin B Complex|vitamin b complex|mesh-ancestor
102186420|NCT06010277|Vitamins|vitamins|mesh-ancestor
102186421|NCT06010277|Micronutrients|micronutrients|mesh-ancestor
102186422|NCT06010277|Hematinics|hematinics|mesh-ancestor
102186423|NCT06010212|Paclitaxel|paclitaxel|mesh-list
102186424|NCT06010212|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102186425|NCT06010212|Nedaplatin|nedaplatin|mesh-list
102186426|NCT06010212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102186427|NCT06010212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102186428|NCT06010212|Tubulin Modulators|tubulin modulators|mesh-ancestor
102186429|NCT06010212|Antimitotic Agents|antimitotic agents|mesh-ancestor
102186430|NCT06010212|Mitosis Modulators|mitosis modulators|mesh-ancestor
102186431|NCT06010212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186432|NCT06010095|Nivolumab|nivolumab|mesh-list
102186433|NCT06010095|Ipilimumab|ipilimumab|mesh-list
102186434|NCT06010095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102186435|NCT06010095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102186436|NCT06010095|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102186437|NCT06010095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186438|NCT06010056|Ketamine|ketamine|mesh-list
102186439|NCT06010056|Morphine|morphine|mesh-list
102186440|NCT06010056|Analgesics|analgesics|mesh-ancestor
102186441|NCT06010056|Sensory System Agents|sensory system agents|mesh-ancestor
102186442|NCT06010056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102186443|NCT06010056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186444|NCT06010056|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102186445|NCT06010056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102186446|NCT06010056|Anesthetics, General|anesthetics, general|mesh-ancestor
102186447|NCT06010056|Anesthetics|anesthetics|mesh-ancestor
102186448|NCT06010056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102186449|NCT06010056|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102186450|NCT06010056|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102186451|NCT06010056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102186452|NCT06010056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186453|NCT06010056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102186454|NCT06010056|Narcotics|narcotics|mesh-ancestor
102186455|NCT06009991|Propofol|propofol|mesh-list
102186456|NCT06009991|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102186457|NCT06009991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102186458|NCT06009991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186459|NCT06009991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102186460|NCT06009991|Anesthetics, General|anesthetics, general|mesh-ancestor
102186461|NCT06009991|Anesthetics|anesthetics|mesh-ancestor
102186462|NCT06009900|Celecoxib|celecoxib|mesh-list
102186463|NCT06009900|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102186464|NCT06009900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102186465|NCT06009900|Analgesics|analgesics|mesh-ancestor
102186466|NCT06009900|Sensory System Agents|sensory system agents|mesh-ancestor
102186467|NCT06009900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102186468|NCT06009900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186469|NCT06009900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102186470|NCT06009900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102186471|NCT06009900|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102186472|NCT06009900|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102186473|NCT06009900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102186474|NCT06009900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186475|NCT06009874|Dapagliflozin|dapagliflozin|mesh-list
102186476|NCT06009874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102186477|NCT06009874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186478|NCT06009874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102186479|NCT06009874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186480|NCT06009861|Paclitaxel|paclitaxel|mesh-list
102186481|NCT06009861|Tislelizumab|tislelizumab|mesh-list
102186482|NCT06009861|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102186483|NCT06009861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102186484|NCT06009861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102186485|NCT06009861|Tubulin Modulators|tubulin modulators|mesh-ancestor
102186486|NCT06009861|Antimitotic Agents|antimitotic agents|mesh-ancestor
102186487|NCT06009861|Mitosis Modulators|mitosis modulators|mesh-ancestor
102186488|NCT06009861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186489|NCT06009861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102186490|NCT06009744|Vitamins|vitamins|mesh-list
102186491|NCT06009744|Ascorbic Acid|ascorbic acid|mesh-list
102186492|NCT06009744|Zinc|zinc|mesh-list
102186493|NCT06009744|Micronutrients|micronutrients|mesh-ancestor
102186494|NCT06009744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186495|NCT06009744|Trace Elements|trace elements|mesh-ancestor
102186496|NCT06009744|Antioxidants|antioxidants|mesh-ancestor
102186497|NCT06009744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186498|NCT06009744|Protective Agents|protective agents|mesh-ancestor
102186499|NCT06009679|Misoprostol|misoprostol|mesh-list
102186500|NCT06009679|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102186501|NCT06009679|Abortifacient Agents|abortifacient agents|mesh-ancestor
102186502|NCT06009679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102186503|NCT06009679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186504|NCT06009679|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102186505|NCT06009679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102186506|NCT06009679|Oxytocics|oxytocics|mesh-ancestor
102186507|NCT06009653|Tirzepatide|tirzepatide|mesh-list
102186508|NCT06009653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102186509|NCT06009653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186510|NCT06009653|Incretins|incretins|mesh-ancestor
102186511|NCT06009653|Hormones|hormones|mesh-ancestor
102186512|NCT06009653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102186513|NCT06009627|Cyclophosphamide|cyclophosphamide|mesh-list
102186514|NCT06009627|Docetaxel|docetaxel|mesh-list
102186515|NCT06009627|Epirubicin|epirubicin|mesh-list
102186516|NCT06009627|Exemestane|exemestane|mesh-list
102186517|NCT06009627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102186518|NCT06009627|Immunologic Factors|immunologic factors|mesh-ancestor
102186519|NCT06009627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186520|NCT06009627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102186521|NCT06009627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102186522|NCT06009627|Alkylating Agents|alkylating agents|mesh-ancestor
102186523|NCT06009627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186524|NCT06009627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102186525|NCT06009627|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102186526|NCT06009627|Tubulin Modulators|tubulin modulators|mesh-ancestor
102186527|NCT06009627|Antimitotic Agents|antimitotic agents|mesh-ancestor
102186528|NCT06009627|Mitosis Modulators|mitosis modulators|mesh-ancestor
102186529|NCT06009627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102186530|NCT06009627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102186531|NCT06009627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101448906|NCT00220194|Fertility Agents|fertility agents|mesh-ancestor
102186532|NCT06009627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102186533|NCT06009627|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102186534|NCT06009627|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102186535|NCT06009627|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102186536|NCT06009627|Hormone Antagonists|hormone antagonists|mesh-ancestor
102186537|NCT06009627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102186538|NCT06009497|Cyclosporine|cyclosporine|mesh-list
102186539|NCT06009497|Cyclosporins|cyclosporins|mesh-list
102186540|NCT06009497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102186541|NCT06009497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186542|NCT06009497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102186543|NCT06009497|Immunologic Factors|immunologic factors|mesh-ancestor
102186544|NCT06009497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186545|NCT06009497|Antifungal Agents|antifungal agents|mesh-ancestor
102186546|NCT06009497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102186547|NCT06009497|Dermatologic Agents|dermatologic agents|mesh-ancestor
102186548|NCT06009497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102186549|NCT06009497|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102186550|NCT06009185|Zamicastat|zamicastat|mesh-list
102186551|NCT06009185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102186552|NCT06009185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186553|NCT06009107|Cyclophosphamide|cyclophosphamide|mesh-list
102186554|NCT06009107|Fludarabine|fludarabine|mesh-list
102186555|NCT06009107|Fludarabine phosphate|fludarabine phosphate|mesh-list
102186556|NCT06009107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102186557|NCT06009107|Immunologic Factors|immunologic factors|mesh-ancestor
102186558|NCT06009107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186559|NCT06009107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102186560|NCT06009107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102186561|NCT06009107|Alkylating Agents|alkylating agents|mesh-ancestor
102186562|NCT06009107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186563|NCT06009107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102186564|NCT06009107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102186565|NCT06009107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102186566|NCT06009107|Antimetabolites|antimetabolites|mesh-ancestor
102186567|NCT06009055|Propofol|propofol|mesh-list
102186568|NCT06009055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102186569|NCT06009055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102186570|NCT06009055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186571|NCT06009055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102186572|NCT06009055|Anesthetics, General|anesthetics, general|mesh-ancestor
102186573|NCT06009055|Anesthetics|anesthetics|mesh-ancestor
102186574|NCT06009042|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102186575|NCT06009042|gamma-Globulins|gamma-globulins|mesh-list
102186576|NCT06009042|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102186577|NCT06009042|Immunologic Factors|immunologic factors|mesh-ancestor
102186578|NCT06009042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186579|NCT06009029|Immunomodulating Agents|immunomodulating agents|mesh-list
102186580|NCT06009029|Immunologic Factors|immunologic factors|mesh-ancestor
102186581|NCT06009029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186582|NCT06008925|Nivolumab|nivolumab|mesh-list
102186583|NCT06008925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102186584|NCT06008925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102186585|NCT06008925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102186586|NCT06008925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186587|NCT06008821|Epinephrine|epinephrine|mesh-list
102186588|NCT06008821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102186589|NCT06008821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102186590|NCT06008821|Adrenergic Agents|adrenergic agents|mesh-ancestor
102186591|NCT06008821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102186592|NCT06008821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186593|NCT06008821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186594|NCT06008821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102186595|NCT06008821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102186596|NCT06008821|Autonomic Agents|autonomic agents|mesh-ancestor
102186597|NCT06008821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102186598|NCT06008821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102186599|NCT06008821|Respiratory System Agents|respiratory system agents|mesh-ancestor
102186600|NCT06008821|Mydriatics|mydriatics|mesh-ancestor
102186601|NCT06008821|Sympathomimetics|sympathomimetics|mesh-ancestor
102186602|NCT06008821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102186603|NCT06008795|Dexamethasone|dexamethasone|mesh-list
102186604|NCT06008795|Ropivacaine|ropivacaine|mesh-list
102186605|NCT06008795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102186606|NCT06008795|Antiemetics|antiemetics|mesh-ancestor
102186607|NCT06008795|Autonomic Agents|autonomic agents|mesh-ancestor
102186608|NCT06008795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102186609|NCT06008795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186610|NCT06008795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102186611|NCT06008795|Glucocorticoids|glucocorticoids|mesh-ancestor
102186612|NCT06008795|Hormones|hormones|mesh-ancestor
102186613|NCT06008795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102186614|NCT06008795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102186615|NCT06008795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102186616|NCT06008795|Anesthetics, Local|anesthetics, local|mesh-ancestor
102186617|NCT06008795|Anesthetics|anesthetics|mesh-ancestor
102186618|NCT06008795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102186619|NCT06008795|Sensory System Agents|sensory system agents|mesh-ancestor
102186621|NCT06007378|Ketamine|ketamine|mesh-list
102186622|NCT06007378|Bupivacaine|bupivacaine|mesh-list
102186623|NCT06007378|Anesthetics, Local|anesthetics, local|mesh-ancestor
102186624|NCT06007378|Anesthetics|anesthetics|mesh-ancestor
102186625|NCT06007378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102186626|NCT06007378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186627|NCT06007378|Sensory System Agents|sensory system agents|mesh-ancestor
102186628|NCT06007378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102186629|NCT06007378|Analgesics|analgesics|mesh-ancestor
102186630|NCT06007378|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102186631|NCT06007378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102186632|NCT06007378|Anesthetics, General|anesthetics, general|mesh-ancestor
102186633|NCT06007378|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102186634|NCT06007378|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102186635|NCT06007378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102186636|NCT06007378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186637|NCT06007378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102186638|NCT06007378|Narcotics|narcotics|mesh-ancestor
102186639|NCT06007378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102186640|NCT06006273|Irinotecan|irinotecan|mesh-list
102186641|NCT06006273|Temozolomide|temozolomide|mesh-list
102186642|NCT06006273|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102186643|NCT06006273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102186644|NCT06006273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102186645|NCT06006273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186646|NCT06006273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102186647|NCT06006273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102186648|NCT06006273|Alkylating Agents|alkylating agents|mesh-ancestor
102186649|NCT06005597|Ezetimibe|ezetimibe|mesh-list
102186650|NCT06005597|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102186651|NCT06005597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102186652|NCT06005597|Antimetabolites|antimetabolites|mesh-ancestor
102186653|NCT06005597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186654|NCT06005597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102186655|NCT06003621|Atezolizumab|atezolizumab|mesh-list
102186656|NCT06003621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102186657|NCT06003621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186658|NCT06003621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102186659|NCT06003621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102186660|NCT05999604|Ocrelizumab|ocrelizumab|mesh-list
102186661|NCT05999604|Immunologic Factors|immunologic factors|mesh-ancestor
102186662|NCT05999604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186663|NCT05997732|Propranolol|propranolol|mesh-list
102186664|NCT05997732|Phentolamine|phentolamine|mesh-list
102186665|NCT05997732|Phenylephrine|phenylephrine|mesh-list
102186666|NCT05997732|Isoproterenol|isoproterenol|mesh-list
102186667|NCT05997732|Oxymetazoline|oxymetazoline|mesh-list
102186668|NCT05997732|Norepinephrine|norepinephrine|mesh-list
102186669|NCT05997732|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102186670|NCT05997732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102186671|NCT05997732|Adrenergic Agents|adrenergic agents|mesh-ancestor
102186672|NCT05997732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102186673|NCT05997732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186674|NCT05997732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186675|NCT05997732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102186676|NCT05997732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102186677|NCT05997732|Vasodilator Agents|vasodilator agents|mesh-ancestor
102186678|NCT05997732|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102186679|NCT05997732|Mydriatics|mydriatics|mesh-ancestor
102186680|NCT05997732|Autonomic Agents|autonomic agents|mesh-ancestor
102186681|NCT05997732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102186682|NCT05997732|Sympathomimetics|sympathomimetics|mesh-ancestor
102186683|NCT05997732|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102186684|NCT05997732|Nasal Decongestants|nasal decongestants|mesh-ancestor
102186685|NCT05997732|Respiratory System Agents|respiratory system agents|mesh-ancestor
102186686|NCT05997732|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102186687|NCT05997732|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102186688|NCT05997732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102186689|NCT05997732|Protective Agents|protective agents|mesh-ancestor
102186690|NCT05997732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102186691|NCT05997732|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102186692|NCT05997732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102186693|NCT05997732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102186694|NCT05992428|Paroxetine|paroxetine|mesh-list
102186695|NCT05992428|Mirabegron|mirabegron|mesh-list
102186696|NCT05992428|DA-8010|da-8010|mesh-list
102186697|NCT05992428|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102186698|NCT05992428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102186699|NCT05992428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102186700|NCT05992428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186701|NCT05992428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102186702|NCT05992428|Serotonin Agents|serotonin agents|mesh-ancestor
102186703|NCT05992428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186704|NCT05992428|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102186705|NCT05992428|Antidepressive Agents|antidepressive agents|mesh-ancestor
102186706|NCT05992428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102186707|NCT05992428|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102186708|NCT05992428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102186709|NCT05992428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102186710|NCT05992428|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102186711|NCT05992428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102186712|NCT05992428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102186713|NCT05992428|Adrenergic Agents|adrenergic agents|mesh-ancestor
102186714|NCT05992428|Urological Agents|urological agents|mesh-ancestor
102186715|NCT05992428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102186716|NCT05992428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102186717|NCT05992428|Cholinergic Agents|cholinergic agents|mesh-ancestor
102186718|NCT05981352|Hyaluronic Acid|hyaluronic acid|mesh-list
102186719|NCT05981352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102186720|NCT05981352|Immunologic Factors|immunologic factors|mesh-ancestor
102186721|NCT05981352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186722|NCT05981352|Viscosupplements|viscosupplements|mesh-ancestor
102186723|NCT05981352|Protective Agents|protective agents|mesh-ancestor
102186724|NCT05973851|Ketamine|ketamine|mesh-list
102186725|NCT05973851|Antidepressive Agents|antidepressive agents|mesh-list
102186726|NCT05973851|Esketamine|esketamine|mesh-list
102186727|NCT05973851|Analgesics|analgesics|mesh-ancestor
102186728|NCT05973851|Sensory System Agents|sensory system agents|mesh-ancestor
102186729|NCT05973851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102186730|NCT05973851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186731|NCT05973851|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102186732|NCT05973851|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102186733|NCT05973851|Anesthetics, General|anesthetics, general|mesh-ancestor
102186734|NCT05973851|Anesthetics|anesthetics|mesh-ancestor
102186735|NCT05973851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102186736|NCT05973851|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102186737|NCT05973851|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102186738|NCT05973851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102186739|NCT05973851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186740|NCT05973851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102186741|NCT05973786|Lamotrigine|lamotrigine|mesh-list
102186742|NCT05973786|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102186743|NCT05973786|Valproic Acid|valproic acid|mesh-list
102186744|NCT05973786|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102186745|NCT05973786|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102186746|NCT05973786|Sertraline|sertraline|mesh-list
102186747|NCT05973786|Escitalopram|escitalopram|mesh-list
102186748|NCT05973786|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102186749|NCT05973786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102186750|NCT05973786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102186751|NCT05973786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186752|NCT05973786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102186753|NCT05973786|Serotonin Agents|serotonin agents|mesh-ancestor
102186754|NCT05973786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186755|NCT05973786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102186756|NCT05973786|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102186757|NCT05973786|Antidepressive Agents|antidepressive agents|mesh-ancestor
102186758|NCT05973786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102186759|NCT05973786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102186760|NCT05973786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102186761|NCT05973786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102186762|NCT05973786|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102186763|NCT05973786|Analgesics|analgesics|mesh-ancestor
102186764|NCT05973786|Sensory System Agents|sensory system agents|mesh-ancestor
102186765|NCT05973786|Dopamine Agents|dopamine agents|mesh-ancestor
102186766|NCT05973786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102186767|NCT05973786|Antimanic Agents|antimanic agents|mesh-ancestor
102186768|NCT05973786|Anticonvulsants|anticonvulsants|mesh-ancestor
102186769|NCT05973786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102186770|NCT05973786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102186771|NCT05973786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102186772|NCT05973786|GABA Agents|gaba agents|mesh-ancestor
102186774|NCT05969327|Vitamins|vitamins|mesh-ancestor
102186775|NCT05969327|Micronutrients|micronutrients|mesh-ancestor
102186776|NCT05969327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186777|NCT05969327|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102186798|NCT05963022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102186799|NCT05955261|Cytarabine|cytarabine|mesh-list
102186800|NCT05955261|Fludarabine|fludarabine|mesh-list
102186801|NCT05955261|Fludarabine phosphate|fludarabine phosphate|mesh-list
102186802|NCT05955261|Etoposide|etoposide|mesh-list
102186803|NCT05955261|Azacitidine|azacitidine|mesh-list
102186804|NCT05955261|Daunorubicin|daunorubicin|mesh-list
102186805|NCT05955261|Venetoclax|venetoclax|mesh-list
102186806|NCT05955261|Mitoxantrone|mitoxantrone|mesh-list
102186807|NCT05955261|Idarubicin|idarubicin|mesh-list
102186808|NCT05955261|Gemtuzumab|gemtuzumab|mesh-list
102186809|NCT05955261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102186810|NCT05955261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102186811|NCT05955261|Antimetabolites|antimetabolites|mesh-ancestor
102186812|NCT05955261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186813|NCT05955261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102186814|NCT05955261|Immunologic Factors|immunologic factors|mesh-ancestor
102186815|NCT05955261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186816|NCT05955261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102186817|NCT05955261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102186818|NCT05955261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102186819|NCT05955261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102186820|NCT05955261|Antiviral Agents|antiviral agents|mesh-ancestor
102186821|NCT05955261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102186822|NCT05955261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102186823|NCT05955261|Analgesics|analgesics|mesh-ancestor
102186824|NCT05955261|Sensory System Agents|sensory system agents|mesh-ancestor
102186825|NCT05955261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102186826|NCT05955261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102186827|NCT05955261|Immunotoxins|immunotoxins|mesh-ancestor
102186828|NCT05955261|Immunoconjugates|immunoconjugates|mesh-ancestor
102186829|NCT05945901|Bevacizumab|bevacizumab|mesh-list
102186830|NCT05945901|Oxaliplatin|oxaliplatin|mesh-list
102186831|NCT05945901|Fluorouracil|fluorouracil|mesh-list
102186832|NCT05945901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102186833|NCT05945901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102186834|NCT05945901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102186835|NCT05945901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102186836|NCT05945901|Growth Substances|growth substances|mesh-ancestor
102186837|NCT05945901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186838|NCT05945901|Growth Inhibitors|growth inhibitors|mesh-ancestor
101895670|NCT01218698|Losartan|losartan|mesh-list
102186839|NCT05945901|Antimetabolites|antimetabolites|mesh-ancestor
102186840|NCT05945901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186841|NCT05945901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102186842|NCT05945901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102186843|NCT05945901|Immunologic Factors|immunologic factors|mesh-ancestor
102186844|NCT05943106|Durvalumab|durvalumab|mesh-list
102186845|NCT05943106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102186846|NCT05943106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102186847|NCT05938075|Vaccines|vaccines|mesh-list
102186848|NCT05938075|Immunologic Factors|immunologic factors|mesh-ancestor
102186849|NCT05938075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186856|NCT05920863|Tislelizumab|tislelizumab|mesh-list
102186857|NCT05920863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102186858|NCT05920863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102186859|NCT05920863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102186860|NCT05920863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186861|NCT05920863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102186862|NCT05920642|Morphine|morphine|mesh-list
102186863|NCT05920642|Analgesics|analgesics|mesh-list
102186864|NCT05920642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102186865|NCT05920642|Narcotics|narcotics|mesh-ancestor
102186866|NCT05920642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102186867|NCT05920642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186868|NCT05920642|Sensory System Agents|sensory system agents|mesh-ancestor
102186869|NCT05920642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102186870|NCT05920005|Amlodipine|amlodipine|mesh-list
102186871|NCT05920005|Valsartan|valsartan|mesh-list
102186872|NCT05920005|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102186873|NCT05920005|Candesartan|candesartan|mesh-list
102186874|NCT05920005|Candesartan cilexetil|candesartan cilexetil|mesh-list
102186875|NCT05920005|Chlorthalidone|chlorthalidone|mesh-list
102186876|NCT05920005|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
102186877|NCT05920005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102186878|NCT05920005|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102186879|NCT05920005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102186880|NCT05920005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186881|NCT05920005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102186882|NCT05920005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186883|NCT05920005|Vasodilator Agents|vasodilator agents|mesh-ancestor
102186884|NCT05920005|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102186885|NCT05920005|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102186886|NCT05920005|Diuretics|diuretics|mesh-ancestor
102186887|NCT05920005|Natriuretic Agents|natriuretic agents|mesh-ancestor
102186888|NCT05920005|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102186889|NCT05918796|Dexamethasone|dexamethasone|mesh-list
102186890|NCT05918796|Bupivacaine|bupivacaine|mesh-list
102186891|NCT05918796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102186892|NCT05918796|Antiemetics|antiemetics|mesh-ancestor
102186893|NCT05918796|Autonomic Agents|autonomic agents|mesh-ancestor
102186894|NCT05918796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102186895|NCT05918796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186896|NCT05918796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102186897|NCT05918796|Glucocorticoids|glucocorticoids|mesh-ancestor
102186898|NCT05918796|Hormones|hormones|mesh-ancestor
102186899|NCT05918796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102186900|NCT05918796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102186901|NCT05918796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102186902|NCT05918796|Anesthetics, Local|anesthetics, local|mesh-ancestor
102186903|NCT05918796|Anesthetics|anesthetics|mesh-ancestor
102186904|NCT05918796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102186905|NCT05918796|Sensory System Agents|sensory system agents|mesh-ancestor
102186908|NCT05846698|Tibolone|tibolone|mesh-list
102186909|NCT05846698|Androgen Antagonists|androgen antagonists|mesh-ancestor
102186910|NCT05846698|Hormone Antagonists|hormone antagonists|mesh-ancestor
102186911|NCT05846698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102186912|NCT05846698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186913|NCT05846698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102186914|NCT05846698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102186915|NCT05846698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101895742|NCT03929744|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102186916|NCT05846698|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102186918|NCT05846698|Hormones|hormones|mesh-ancestor
102186919|NCT05842044|Acetaminophen|acetaminophen|mesh-list
102186920|NCT05842044|Ibuprofen|ibuprofen|mesh-list
102186921|NCT05842044|Ketorolac|ketorolac|mesh-list
102186922|NCT05842044|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102186923|NCT05842044|Oxycodone|oxycodone|mesh-list
102186924|NCT05842044|Hydromorphone|hydromorphone|mesh-list
102186925|NCT05842044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102186926|NCT05842044|Analgesics|analgesics|mesh-ancestor
102186927|NCT05842044|Sensory System Agents|sensory system agents|mesh-ancestor
102186928|NCT05842044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102186929|NCT05842044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186930|NCT05842044|Antipyretics|antipyretics|mesh-ancestor
102186931|NCT05842044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102186932|NCT05842044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102186933|NCT05842044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102186934|NCT05842044|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102186935|NCT05842044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102186936|NCT05842044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186937|NCT05842044|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102186938|NCT05842044|Narcotics|narcotics|mesh-ancestor
102186939|NCT05842044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102186940|NCT05815199|Nicotine|nicotine|mesh-list
102186941|NCT05815199|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102186942|NCT05815199|Autonomic Agents|autonomic agents|mesh-ancestor
102186943|NCT05815199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102186944|NCT05815199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186945|NCT05815199|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102186946|NCT05815199|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102186947|NCT05815199|Cholinergic Agents|cholinergic agents|mesh-ancestor
102186948|NCT05815199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102186949|NCT05815199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186950|NCT05800600|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102186951|NCT05800600|Hematinics|hematinics|mesh-ancestor
102186952|NCT05774704|Curcumin|curcumin|mesh-list
102186953|NCT05774704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102186954|NCT05774704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102186955|NCT05774704|Analgesics|analgesics|mesh-ancestor
102186956|NCT05774704|Sensory System Agents|sensory system agents|mesh-ancestor
102186957|NCT05774704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102186958|NCT05774704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186959|NCT05774704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102186960|NCT05774704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102186961|NCT05774704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102186962|NCT05774704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102186963|NCT05774704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186964|NCT05768854|Diphosphonates|diphosphonates|mesh-list
102186965|NCT05768854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102186966|NCT05768854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186967|NCT05745233|Pembrolizumab|pembrolizumab|mesh-list
102186968|NCT05745233|Nivolumab|nivolumab|mesh-list
102186969|NCT05745233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102186970|NCT05745233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102186971|NCT05745233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102186972|NCT05745233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186981|NCT05736224|Sunscreening Agents|sunscreening agents|mesh-list
102186982|NCT05736224|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102186983|NCT05736224|Protective Agents|protective agents|mesh-ancestor
102186984|NCT05736224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186985|NCT05736224|Dermatologic Agents|dermatologic agents|mesh-ancestor
102186986|NCT05735184|Cytarabine|cytarabine|mesh-list
102186987|NCT05735184|Azacitidine|azacitidine|mesh-list
102186988|NCT05735184|Daunorubicin|daunorubicin|mesh-list
102186989|NCT05735184|Venetoclax|venetoclax|mesh-list
101895818|NCT01225874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102186990|NCT05735184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102186991|NCT05735184|Antimetabolites|antimetabolites|mesh-ancestor
102186992|NCT05735184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102186993|NCT05735184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102186994|NCT05735184|Antiviral Agents|antiviral agents|mesh-ancestor
102186995|NCT05735184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102186996|NCT05735184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102186997|NCT05735184|Immunologic Factors|immunologic factors|mesh-ancestor
102186998|NCT05735184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102186999|NCT05735184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102187000|NCT05735184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102187001|NCT05735184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102187002|NCT05735184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102187003|NCT05733611|Bevacizumab|bevacizumab|mesh-list
102187004|NCT05733611|Atezolizumab|atezolizumab|mesh-list
102187005|NCT05733611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102187006|NCT05733611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187007|NCT05733611|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102187008|NCT05733611|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102187009|NCT05733611|Growth Substances|growth substances|mesh-ancestor
102187010|NCT05733611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187011|NCT05733611|Growth Inhibitors|growth inhibitors|mesh-ancestor
102187012|NCT05733611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102187013|NCT05733611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187014|NCT05729568|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102187015|NCT05729568|Antiviral Agents|antiviral agents|mesh-ancestor
102187016|NCT05729568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102187017|NCT05727904|Pembrolizumab|pembrolizumab|mesh-list
102187018|NCT05727904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102187019|NCT05727904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187020|NCT05727904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102187021|NCT05727904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187022|NCT05725382|Remifentanil|remifentanil|mesh-list
102187023|NCT05725382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102187024|NCT05725382|Narcotics|narcotics|mesh-ancestor
102187025|NCT05725382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102187026|NCT05725382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187027|NCT05725382|Analgesics|analgesics|mesh-ancestor
102187028|NCT05725382|Sensory System Agents|sensory system agents|mesh-ancestor
102187029|NCT05725382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102187030|NCT05721404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102187031|NCT05721404|Icodextrin|icodextrin|mesh-list
102187032|NCT05721404|Dialysis Solutions|dialysis solutions|mesh-list
102187033|NCT05710874|Fluorides|fluorides|mesh-list
102187034|NCT05710874|Cariostatic Agents|cariostatic agents|mesh-ancestor
102187035|NCT05710874|Protective Agents|protective agents|mesh-ancestor
102187036|NCT05710874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187037|NCT05710237|Risperidone|risperidone|mesh-list
102187038|NCT05710237|Psilocybin|psilocybin|mesh-list
102187039|NCT05710237|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102187040|NCT05710237|Serotonin Agents|serotonin agents|mesh-ancestor
102187041|NCT05710237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102187042|NCT05710237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187043|NCT05710237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187044|NCT05710237|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102187045|NCT05710237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102187046|NCT05710237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102187047|NCT05710237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102187048|NCT05710237|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102187049|NCT05710237|Dopamine Agents|dopamine agents|mesh-ancestor
102187050|NCT05710237|Hallucinogens|hallucinogens|mesh-ancestor
102187051|NCT05696080|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102187052|NCT05696080|Immunologic Factors|immunologic factors|mesh-ancestor
102187053|NCT05696080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187054|NCT05691699|Itraconazole|itraconazole|mesh-list
102187055|NCT05691699|Antifungal Agents|antifungal agents|mesh-ancestor
102187056|NCT05691699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102187057|NCT05691699|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102187058|NCT05691699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102187059|NCT05691699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102187060|NCT05691699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187061|NCT05691699|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102187062|NCT05691699|Hormone Antagonists|hormone antagonists|mesh-ancestor
102187063|NCT05691699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102187064|NCT05691699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895892|NCT00321737|Dexlansoprazole|dexlansoprazole|mesh-list
102187065|NCT05691699|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102187066|NCT05684289|Sildenafil Citrate|sildenafil citrate|mesh-list
102187067|NCT05684289|Vasodilator Agents|vasodilator agents|mesh-ancestor
102187068|NCT05684289|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102187069|NCT05684289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101728856|NCT00448435|Hormones|hormones|mesh-ancestor
102187070|NCT05684289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102187071|NCT05684289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187072|NCT05684289|Urological Agents|urological agents|mesh-ancestor
102187073|NCT05683691|Acetaminophen, aspirin, caffeine drug combination|acetaminophen, aspirin, caffeine drug combination|mesh-list
102187074|NCT05683691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102187075|NCT05683691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102187076|NCT05683691|Analgesics|analgesics|mesh-ancestor
102187077|NCT05683691|Sensory System Agents|sensory system agents|mesh-ancestor
102187078|NCT05683691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102187079|NCT05683691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187080|NCT05683691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102187081|NCT05683691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102187083|NCT05677126|Trace Elements|trace elements|mesh-list
102187084|NCT05677126|Selenious Acid|selenious acid|mesh-list
102187085|NCT05677126|Micronutrients|micronutrients|mesh-list
102187086|NCT05677126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187087|NCT05673187|Adagrasib|adagrasib|mesh-list
102187088|NCT05673187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187089|NCT05661682|Zinc|zinc|mesh-list
102187090|NCT05661682|Copper|copper|mesh-list
102187091|NCT05661682|Manganese|manganese|mesh-list
102187092|NCT05661682|Trace Elements|trace elements|mesh-list
102187093|NCT05661682|Selenious Acid|selenious acid|mesh-list
102187094|NCT05661682|Micronutrients|micronutrients|mesh-list
102187095|NCT05661682|Copper Sulfate|copper sulfate|mesh-list
102187096|NCT05661682|Zinc Sulfate|zinc sulfate|mesh-list
102187097|NCT05661682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187098|NCT05661682|Astringents|astringents|mesh-ancestor
102187099|NCT05661682|Dermatologic Agents|dermatologic agents|mesh-ancestor
102187100|NCT05661682|Antidotes|antidotes|mesh-ancestor
102187101|NCT05661682|Protective Agents|protective agents|mesh-ancestor
102187102|NCT05661682|Emetics|emetics|mesh-ancestor
102187103|NCT05661682|Autonomic Agents|autonomic agents|mesh-ancestor
102187104|NCT05661682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102187105|NCT05661682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102187106|NCT05639647|Aztreonam|aztreonam|mesh-list
102187107|NCT05639647|Avibactam|avibactam|mesh-list
102187108|NCT05639647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102187109|NCT05639647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102187110|NCT05639647|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102187111|NCT05639647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102187112|NCT05639647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187113|NCT05626322|Lenalidomide|lenalidomide|mesh-list
102187114|NCT05626322|Immunologic Factors|immunologic factors|mesh-ancestor
102187115|NCT05626322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187116|NCT05626322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102187117|NCT05626322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102187118|NCT05626322|Growth Substances|growth substances|mesh-ancestor
102187119|NCT05626322|Growth Inhibitors|growth inhibitors|mesh-ancestor
102187120|NCT05626322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187135|NCT05617820|Estradiol|estradiol|mesh-list
102187136|NCT05617820|Estrogens|estrogens|mesh-ancestor
102187137|NCT05617820|Hormones|hormones|mesh-ancestor
102187138|NCT05617820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102187139|NCT05617820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187140|NCT05614739|Pembrolizumab|pembrolizumab|mesh-list
102187141|NCT05614739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102187142|NCT05614739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187143|NCT05614739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102187144|NCT05614739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187145|NCT05609578|Carboplatin|carboplatin|mesh-list
102187146|NCT05609578|Pembrolizumab|pembrolizumab|mesh-list
102187148|NCT05609578|Adagrasib|adagrasib|mesh-list
102187149|NCT05609578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187150|NCT05609578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102187151|NCT05609578|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102187152|NCT05609578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187153|NCT05609578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102187154|NCT05609578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102187155|NCT05609578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102187156|NCT05607147|Antibodies|antibodies|mesh-list
102187157|NCT05607147|Immunologic Factors|immunologic factors|mesh-ancestor
102187158|NCT05607147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187159|NCT05581004|Atezolizumab|atezolizumab|mesh-list
102187160|NCT05581004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102187161|NCT05581004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187162|NCT05581004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102187163|NCT05581004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187164|NCT05579964|Dexmedetomidine|dexmedetomidine|mesh-list
102187165|NCT05579964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102187166|NCT05579964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102187167|NCT05579964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187168|NCT05579964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102187169|NCT05579964|Analgesics|analgesics|mesh-ancestor
102187170|NCT05579964|Sensory System Agents|sensory system agents|mesh-ancestor
102187171|NCT05579964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102187172|NCT05579964|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102187173|NCT05579964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102187174|NCT05579964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102187175|NCT05579964|Adrenergic Agents|adrenergic agents|mesh-ancestor
102187176|NCT05579964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102187177|NCT05579964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187178|NCT05567770|Androgens|androgens|mesh-list
102187179|NCT05567770|Hormones|hormones|mesh-ancestor
102187180|NCT05567770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102187181|NCT05567770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187182|NCT05554380|Paclitaxel|paclitaxel|mesh-list
102187183|NCT05554380|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102187184|NCT05554380|Ipatasertib|ipatasertib|mesh-list
102187185|NCT05554380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102187186|NCT05554380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187187|NCT05554380|Tubulin Modulators|tubulin modulators|mesh-ancestor
102187188|NCT05554380|Antimitotic Agents|antimitotic agents|mesh-ancestor
102187189|NCT05554380|Mitosis Modulators|mitosis modulators|mesh-ancestor
102187190|NCT05554380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187191|NCT05554380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102187192|NCT05554380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102187193|NCT05550337|Trifarotene|trifarotene|mesh-list
102187194|NCT05550337|Dermatologic Agents|dermatologic agents|mesh-ancestor
102187195|NCT05549180|Emtricitabine|emtricitabine|mesh-list
102187196|NCT05549180|Antiviral Agents|antiviral agents|mesh-ancestor
102187197|NCT05549180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102187198|NCT05549180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102187199|NCT05549180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102187200|NCT05549180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102187201|NCT05549180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187202|NCT05549180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102187203|NCT05549180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102187204|NCT05519085|Dexamethasone|dexamethasone|mesh-list
102187205|NCT05519085|Bortezomib|bortezomib|mesh-list
102187206|NCT05519085|Pomalidomide|pomalidomide|mesh-list
102187207|NCT05519085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102187208|NCT05519085|Antiemetics|antiemetics|mesh-ancestor
102187209|NCT05519085|Autonomic Agents|autonomic agents|mesh-ancestor
102187210|NCT05519085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102187211|NCT05519085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187212|NCT05519085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102187213|NCT05519085|Glucocorticoids|glucocorticoids|mesh-ancestor
102187214|NCT05519085|Hormones|hormones|mesh-ancestor
102187215|NCT05519085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102187216|NCT05519085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102187217|NCT05519085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187218|NCT05519085|Immunologic Factors|immunologic factors|mesh-ancestor
102187219|NCT05519085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102187220|NCT05519085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102187221|NCT05519085|Growth Substances|growth substances|mesh-ancestor
102187222|NCT05519085|Growth Inhibitors|growth inhibitors|mesh-ancestor
102187223|NCT05514912|Paclitaxel|paclitaxel|mesh-list
102187224|NCT05514912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102187225|NCT05514912|Cisplatin|cisplatin|mesh-list
102187226|NCT05514912|Gemcitabine|gemcitabine|mesh-list
102187227|NCT05514912|Infigratinib|infigratinib|mesh-list
102187228|NCT05514912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102187229|NCT05514912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187230|NCT05514912|Tubulin Modulators|tubulin modulators|mesh-ancestor
102187231|NCT05514912|Antimitotic Agents|antimitotic agents|mesh-ancestor
102187232|NCT05514912|Mitosis Modulators|mitosis modulators|mesh-ancestor
102187233|NCT05514912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187234|NCT05514912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102187235|NCT05514912|Antimetabolites|antimetabolites|mesh-ancestor
102187236|NCT05514119|Fenofibrate|fenofibrate|mesh-list
102187237|NCT05514119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102187238|NCT05514119|Antimetabolites|antimetabolites|mesh-ancestor
102187239|NCT05514119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187240|NCT05514119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102187241|NCT05439616|Cariprazine|cariprazine|mesh-list
102187242|NCT05439616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102187243|NCT05439616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102187244|NCT05439616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102187245|NCT05439616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187246|NCT05439616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102187247|NCT05425862|Talazoparib|talazoparib|mesh-list
102187248|NCT05425862|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102187249|NCT05425862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102187250|NCT05425862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187251|NCT05425862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187252|NCT05416229|Psilocybin|psilocybin|mesh-list
102187253|NCT05416229|Hallucinogens|hallucinogens|mesh-ancestor
102187254|NCT05416229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187255|NCT05416229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102187256|NCT05414877|Phenylephrine|phenylephrine|mesh-list
102187257|NCT05414877|Oxymetazoline|oxymetazoline|mesh-list
102187258|NCT05414877|Norepinephrine|norepinephrine|mesh-list
102187259|NCT05414877|Ephedrine|ephedrine|mesh-list
102187260|NCT05414877|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102187261|NCT05414877|Mydriatics|mydriatics|mesh-ancestor
102187262|NCT05414877|Autonomic Agents|autonomic agents|mesh-ancestor
102187263|NCT05414877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102187264|NCT05414877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187265|NCT05414877|Sympathomimetics|sympathomimetics|mesh-ancestor
102187266|NCT05414877|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102187267|NCT05414877|Nasal Decongestants|nasal decongestants|mesh-ancestor
102187268|NCT05414877|Respiratory System Agents|respiratory system agents|mesh-ancestor
102187269|NCT05414877|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102187270|NCT05414877|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102187271|NCT05414877|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102187272|NCT05414877|Adrenergic Agents|adrenergic agents|mesh-ancestor
102187273|NCT05414877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102187274|NCT05414877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187275|NCT05414877|Protective Agents|protective agents|mesh-ancestor
102187276|NCT05414877|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102187277|NCT05406713|Pembrolizumab|pembrolizumab|mesh-list
102187278|NCT05406713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102187279|NCT05406713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187280|NCT05406713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102187281|NCT05406713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187282|NCT05345327|Metformin|metformin|mesh-list
102187283|NCT05345327|Dapagliflozin|dapagliflozin|mesh-list
102187284|NCT05345327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102187285|NCT05345327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187286|NCT05345327|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102187287|NCT05345327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187288|NCT05305287|Pioglitazone|pioglitazone|mesh-list
102187289|NCT05305287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102187290|NCT05305287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187291|NCT05237947|Vaccines|vaccines|mesh-list
102187292|NCT05237947|Immunologic Factors|immunologic factors|mesh-ancestor
102187293|NCT05237947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187294|NCT05218499|Doxorubicin|doxorubicin|mesh-list
102187295|NCT05218499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102187296|NCT05218499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187297|NCT05218499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102187298|NCT05218499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102187299|NCT05218499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102187300|NCT05218499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187301|NCT05211895|Durvalumab|durvalumab|mesh-list
102187302|NCT05211895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102187303|NCT05211895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187304|NCT05188677|Vaccines|vaccines|mesh-list
102187305|NCT05188677|Immunologic Factors|immunologic factors|mesh-ancestor
102187306|NCT05188677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187307|NCT05177055|Methamphetamine|methamphetamine|mesh-list
102187308|NCT05177055|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102187309|NCT05177055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187310|NCT05177055|Sympathomimetics|sympathomimetics|mesh-ancestor
102187311|NCT05177055|Autonomic Agents|autonomic agents|mesh-ancestor
102187312|NCT05177055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102187313|NCT05177055|Dopamine Agents|dopamine agents|mesh-ancestor
102187314|NCT05177055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102187315|NCT05177055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187316|NCT05177055|Adrenergic Agents|adrenergic agents|mesh-ancestor
102187317|NCT05177055|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102187318|NCT05177055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102187319|NCT05177055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102187320|NCT05177055|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102187321|NCT05174065|Apremilast|apremilast|mesh-list
102187322|NCT05174065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102187323|NCT05174065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102187324|NCT05174065|Analgesics|analgesics|mesh-ancestor
102187325|NCT05174065|Sensory System Agents|sensory system agents|mesh-ancestor
102187326|NCT05174065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102187327|NCT05174065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187328|NCT05174065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102187329|NCT05174065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102187330|NCT05174065|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102187331|NCT05174065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102187332|NCT05174065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102187333|NCT05174065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187334|NCT05170009|Oseltamivir|oseltamivir|mesh-list
102187335|NCT05170009|Baloxavir|baloxavir|mesh-list
102187336|NCT05170009|Antiviral Agents|antiviral agents|mesh-ancestor
102187337|NCT05170009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102187338|NCT05170009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102187339|NCT05170009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187340|NCT05159427|Glipizide|glipizide|mesh-list
102187341|NCT05159427|Rifaximin|rifaximin|mesh-list
102187342|NCT05159427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102187343|NCT05159427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102187344|NCT05159427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102187345|NCT05159427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102187346|NCT05159427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187347|NCT05132699|Cannabidiol|cannabidiol|mesh-list
102187348|NCT05132699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102187349|NCT05132699|Anticonvulsants|anticonvulsants|mesh-ancestor
102187350|NCT05126784|Denosumab|denosumab|mesh-list
102187351|NCT05126784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102187352|NCT05126784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187353|NCT05117476|Pembrolizumab|pembrolizumab|mesh-list
102187354|NCT05117476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102187355|NCT05117476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187356|NCT05117476|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102187357|NCT05117476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187358|NCT05052801|Bemarituzumab|bemarituzumab|mesh-list
102187359|NCT05052801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102187360|NCT05052801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187361|NCT05033665|Benzocaine|benzocaine|mesh-list
102187362|NCT05033665|Anesthetics, Local|anesthetics, local|mesh-ancestor
102187363|NCT05033665|Anesthetics|anesthetics|mesh-ancestor
102187364|NCT05033665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102187365|NCT05033665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187366|NCT05033665|Sensory System Agents|sensory system agents|mesh-ancestor
101896195|NCT01227200|Tramadol|tramadol|mesh-list
102187367|NCT05033665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102187369|NCT05020236|Daratumumab|daratumumab|mesh-list
102187370|NCT05020236|Pomalidomide|pomalidomide|mesh-list
102187371|NCT05020236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102187372|NCT05020236|Antiemetics|antiemetics|mesh-ancestor
102187373|NCT05020236|Autonomic Agents|autonomic agents|mesh-ancestor
102187374|NCT05020236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102187375|NCT05020236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187376|NCT05020236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102187377|NCT05020236|Glucocorticoids|glucocorticoids|mesh-ancestor
102187378|NCT05020236|Hormones|hormones|mesh-ancestor
102187379|NCT05020236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102187380|NCT05020236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102187381|NCT05020236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187382|NCT05020236|Immunologic Factors|immunologic factors|mesh-ancestor
102187383|NCT05020236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102187384|NCT05020236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102187385|NCT05020236|Growth Substances|growth substances|mesh-ancestor
102187386|NCT05020236|Growth Inhibitors|growth inhibitors|mesh-ancestor
102187387|NCT05011188|Antibodies|antibodies|mesh-list
102187388|NCT05011188|Immunoglobulins|immunoglobulins|mesh-list
102187389|NCT05011188|Immunoconjugates|immunoconjugates|mesh-list
102187390|NCT05011188|Immunologic Factors|immunologic factors|mesh-ancestor
102187391|NCT05011188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187392|NCT05009979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102187393|NCT05009979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102187394|NCT05009979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187403|NCT04956640|Carboplatin|carboplatin|mesh-list
102187404|NCT04956640|Pembrolizumab|pembrolizumab|mesh-list
102187405|NCT04956640|Pemetrexed|pemetrexed|mesh-list
102187406|NCT04956640|Cetuximab|cetuximab|mesh-list
102187407|NCT04956640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187408|NCT04956640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102187409|NCT04956640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102187410|NCT04956640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187411|NCT04956640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102187412|NCT04956640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102187413|NCT04956640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102187414|NCT04934683|Propofol|propofol|mesh-list
102187415|NCT04934683|Etomidate|etomidate|mesh-list
102187416|NCT04934683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102187417|NCT04934683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102187418|NCT04934683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187419|NCT04934683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102187420|NCT04934683|Anesthetics, General|anesthetics, general|mesh-ancestor
102187421|NCT04934683|Anesthetics|anesthetics|mesh-ancestor
102187422|NCT04933539|Dexamethasone|dexamethasone|mesh-list
102187423|NCT04933539|Daratumumab|daratumumab|mesh-list
102187424|NCT04933539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102187425|NCT04933539|Antiemetics|antiemetics|mesh-ancestor
102187426|NCT04933539|Autonomic Agents|autonomic agents|mesh-ancestor
102187427|NCT04933539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102187428|NCT04933539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187429|NCT04933539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102187430|NCT04933539|Glucocorticoids|glucocorticoids|mesh-ancestor
102187431|NCT04933539|Hormones|hormones|mesh-ancestor
102187432|NCT04933539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102187433|NCT04933539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102187434|NCT04933539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187435|NCT04919629|Bevacizumab|bevacizumab|mesh-list
102187436|NCT04919629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102187437|NCT04919629|Pembrolizumab|pembrolizumab|mesh-list
102187438|NCT04919629|Endothelial Growth Factors|endothelial growth factors|mesh-list
102187439|NCT04919629|Antibodies|antibodies|mesh-list
102187440|NCT04919629|Immunoglobulins|immunoglobulins|mesh-list
102187441|NCT04919629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102187442|NCT04919629|Immunoglobulin G|immunoglobulin g|mesh-list
102187443|NCT04919629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187444|NCT04919629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102187445|NCT04919629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102187446|NCT04919629|Growth Substances|growth substances|mesh-ancestor
102187447|NCT04919629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187448|NCT04919629|Growth Inhibitors|growth inhibitors|mesh-ancestor
102187449|NCT04919629|Immunologic Factors|immunologic factors|mesh-ancestor
102187450|NCT04919629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102187451|NCT04919629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187452|NCT04902040|Pembrolizumab|pembrolizumab|mesh-list
102187453|NCT04902040|Nivolumab|nivolumab|mesh-list
102187454|NCT04902040|Atezolizumab|atezolizumab|mesh-list
102187455|NCT04902040|Durvalumab|durvalumab|mesh-list
102187456|NCT04902040|Avelumab|avelumab|mesh-list
102187457|NCT04902040|Immunoglobulins|immunoglobulins|mesh-list
102187458|NCT04902040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102187459|NCT04902040|Immunoglobulin G|immunoglobulin g|mesh-list
102187460|NCT04902040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102187461|NCT04902040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187462|NCT04902040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102187463|NCT04902040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187464|NCT04902040|Immunologic Factors|immunologic factors|mesh-ancestor
102187465|NCT04902040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187466|NCT04901208|Nicotine|nicotine|mesh-list
102187467|NCT04901208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102187468|NCT04901208|Autonomic Agents|autonomic agents|mesh-ancestor
102187469|NCT04901208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102187470|NCT04901208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187471|NCT04901208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102187472|NCT04901208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102187473|NCT04901208|Cholinergic Agents|cholinergic agents|mesh-ancestor
102187474|NCT04901208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102187475|NCT04901208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187481|NCT04891757|Cytarabine|cytarabine|mesh-list
102187482|NCT04891757|Decitabine|decitabine|mesh-list
102187483|NCT04891757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102187484|NCT04891757|Antimetabolites|antimetabolites|mesh-ancestor
102187485|NCT04891757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187486|NCT04891757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187487|NCT04891757|Antiviral Agents|antiviral agents|mesh-ancestor
102187488|NCT04891757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102187489|NCT04891757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102187490|NCT04891757|Immunologic Factors|immunologic factors|mesh-ancestor
102187491|NCT04891757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187492|NCT04891757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102187493|NCT04837716|Bevacizumab|bevacizumab|mesh-list
102187494|NCT04837716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102187495|NCT04837716|Carboplatin|carboplatin|mesh-list
102187496|NCT04837716|Pemetrexed|pemetrexed|mesh-list
102187497|NCT04837716|Ensartinib|ensartinib|mesh-list
102187498|NCT04837716|Endothelial Growth Factors|endothelial growth factors|mesh-list
102187499|NCT04837716|Antibodies|antibodies|mesh-list
102187500|NCT04837716|Immunoglobulins|immunoglobulins|mesh-list
102187501|NCT04837716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102187502|NCT04837716|Immunoglobulin G|immunoglobulin g|mesh-list
102187503|NCT04837716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187504|NCT04837716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102187505|NCT04837716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102187506|NCT04837716|Growth Substances|growth substances|mesh-ancestor
102187507|NCT04837716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187508|NCT04837716|Growth Inhibitors|growth inhibitors|mesh-ancestor
102187509|NCT04837716|Immunologic Factors|immunologic factors|mesh-ancestor
102187510|NCT04837716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102187511|NCT04837716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187512|NCT04837716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102187513|NCT04837716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102187514|NCT04837716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102187515|NCT04826341|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
102187516|NCT04826341|Immunoconjugates|immunoconjugates|mesh-ancestor
102187517|NCT04826341|Immunologic Factors|immunologic factors|mesh-ancestor
102187518|NCT04826341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187519|NCT04821141|Bazedoxifene|bazedoxifene|mesh-list
102187520|NCT04821141|Estrogens|estrogens|mesh-list
102187521|NCT04821141|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
102187522|NCT04821141|Hormones|hormones|mesh-ancestor
102187523|NCT04821141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102187524|NCT04821141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187525|NCT04821141|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102187526|NCT04821141|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102187527|NCT04821141|Hormone Antagonists|hormone antagonists|mesh-ancestor
102187528|NCT04821141|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102187529|NCT04781855|Nivolumab|nivolumab|mesh-list
102187530|NCT04781855|Ipilimumab|ipilimumab|mesh-list
102187531|NCT04781855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102187532|NCT04781855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187533|NCT04781855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102187534|NCT04781855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187535|NCT04774393|Decitabine|decitabine|mesh-list
102187536|NCT04774393|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
102187537|NCT04774393|Venetoclax|venetoclax|mesh-list
102187538|NCT04774393|Ivosidenib|ivosidenib|mesh-list
102187539|NCT04774393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102187540|NCT04774393|Antimetabolites|antimetabolites|mesh-ancestor
102187541|NCT04774393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187542|NCT04774393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187543|NCT04774393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102187544|NCT04768023|Vitamin D|vitamin d|mesh-list
102187545|NCT04768023|Vitamins|vitamins|mesh-ancestor
102187546|NCT04768023|Micronutrients|micronutrients|mesh-ancestor
102187547|NCT04768023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187548|NCT04768023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102187549|NCT04701307|Niraparib|niraparib|mesh-list
102187550|NCT04701307|Dostarlimab|dostarlimab|mesh-list
102187551|NCT04701307|Immunoglobulins|immunoglobulins|mesh-list
102187552|NCT04701307|Immunoglobulin G|immunoglobulin g|mesh-list
102187553|NCT04701307|Immunologic Factors|immunologic factors|mesh-ancestor
102187554|NCT04701307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187555|NCT04701307|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102187556|NCT04701307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102187557|NCT04701307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187558|NCT04701307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187559|NCT04673461|Xylometazoline|xylometazoline|mesh-list
102187560|NCT04673461|Nasal Decongestants|nasal decongestants|mesh-ancestor
102187561|NCT04673461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102187562|NCT04673461|Respiratory System Agents|respiratory system agents|mesh-ancestor
102187563|NCT04673175|Tazobactam|tazobactam|mesh-list
102187564|NCT04673175|Ceftolozane|ceftolozane|mesh-list
102187565|NCT04673175|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
102187566|NCT04673175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102187567|NCT04673175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102187568|NCT04673175|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102187569|NCT04673175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102187570|NCT04673175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187571|NCT04673175|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102187572|NCT04666649|Venetoclax|venetoclax|mesh-list
102187573|NCT04666649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187574|NCT04634604|Bevacizumab|bevacizumab|mesh-list
102187575|NCT04634604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102187576|NCT04634604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187577|NCT04634604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102187578|NCT04634604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102187579|NCT04634604|Growth Substances|growth substances|mesh-ancestor
102187580|NCT04634604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187581|NCT04634604|Growth Inhibitors|growth inhibitors|mesh-ancestor
102187582|NCT04624204|Pembrolizumab|pembrolizumab|mesh-list
102187583|NCT04624204|Etoposide|etoposide|mesh-list
102187584|NCT04624204|Olaparib|olaparib|mesh-list
102187585|NCT04624204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102187586|NCT04624204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187587|NCT04624204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102187588|NCT04624204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187589|NCT04624204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102187590|NCT04624204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102187591|NCT04624204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102187592|NCT04624204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102187593|NCT04624204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102187594|NCT04606901|Glycopyrrolate|glycopyrrolate|mesh-list
102187595|NCT04606901|Neostigmine|neostigmine|mesh-list
102187596|NCT04606901|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102187597|NCT04606901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102187598|NCT04606901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187599|NCT04606901|Cholinergic Agents|cholinergic agents|mesh-ancestor
102187600|NCT04606901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102187601|NCT04606901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187602|NCT04606901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102187603|NCT04606901|Autonomic Agents|autonomic agents|mesh-ancestor
102187604|NCT04606901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102187605|NCT04606901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102187606|NCT04606901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102187607|NCT04606901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102187609|NCT04599634|Obinutuzumab|obinutuzumab|mesh-list
102187610|NCT04599634|Magrolimab|magrolimab|mesh-list
102187611|NCT04599634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187612|NCT04599634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102187613|NCT04595825|Antibodies|antibodies|mesh-list
102187614|NCT04595825|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102187615|NCT04595825|Immunologic Factors|immunologic factors|mesh-ancestor
102187616|NCT04595825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187617|NCT04578756|Cariprazine|cariprazine|mesh-list
102187618|NCT04578756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102187619|NCT04578756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102187620|NCT04578756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102187621|NCT04578756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187622|NCT04578756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102187623|NCT04576117|Vinblastine|vinblastine|mesh-list
102187624|NCT04576117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102187625|NCT04576117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187626|NCT04576117|Tubulin Modulators|tubulin modulators|mesh-ancestor
102187627|NCT04576117|Antimitotic Agents|antimitotic agents|mesh-ancestor
102187628|NCT04576117|Mitosis Modulators|mitosis modulators|mesh-ancestor
102187629|NCT04576117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187630|NCT04560673|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102187631|NCT04560673|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102187632|NCT04560673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102187633|NCT04560673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101448996|NCT00189956|Antiviral Agents|antiviral agents|mesh-ancestor
102187634|NCT04560673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187635|NCT04560673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102187636|NCT04560673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187637|NCT04560673|Analgesics|analgesics|mesh-ancestor
102187638|NCT04560673|Sensory System Agents|sensory system agents|mesh-ancestor
102187639|NCT04560673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102187640|NCT04560673|Antidepressive Agents|antidepressive agents|mesh-ancestor
102187641|NCT04560673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102187642|NCT04560673|Dopamine Agents|dopamine agents|mesh-ancestor
102187643|NCT04553536|Sufentanil|sufentanil|mesh-list
102187644|NCT04553536|Remifentanil|remifentanil|mesh-list
102187645|NCT04553536|Dsuvia|dsuvia|mesh-list
102187646|NCT04553536|Bromides|bromides|mesh-list
102187647|NCT04553536|Propofol|propofol|mesh-list
102187648|NCT04553536|Esketamine|esketamine|mesh-list
102187649|NCT04553536|Rocuronium|rocuronium|mesh-list
102187650|NCT04553536|Cisatracurium|cisatracurium|mesh-list
102187651|NCT04553536|Atracurium|atracurium|mesh-list
102187652|NCT04553536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102187653|NCT04553536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102187654|NCT04553536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187655|NCT04553536|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102187656|NCT04553536|Anesthetics, General|anesthetics, general|mesh-ancestor
102187657|NCT04553536|Anesthetics|anesthetics|mesh-ancestor
102187658|NCT04553536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102187659|NCT04553536|Narcotics|narcotics|mesh-ancestor
102187660|NCT04553536|Analgesics|analgesics|mesh-ancestor
102187661|NCT04553536|Sensory System Agents|sensory system agents|mesh-ancestor
102187662|NCT04553536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102187663|NCT04553536|Anticonvulsants|anticonvulsants|mesh-ancestor
102187664|NCT04553536|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102187665|NCT04553536|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102187666|NCT04553536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102187667|NCT04553536|Antidepressive Agents|antidepressive agents|mesh-ancestor
102187668|NCT04553536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102187669|NCT04553536|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102187670|NCT04553536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102187671|NCT04553536|Cholinergic Agents|cholinergic agents|mesh-ancestor
102187672|NCT04553536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102187673|NCT04553536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187674|NCT04553536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102187676|NCT04545736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102187677|NCT04545736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187678|NCT04534725|Interferons|interferons|mesh-list
102187679|NCT04534725|Interferon-alpha|interferon-alpha|mesh-list
102187680|NCT04534725|Lenzilumab|lenzilumab|mesh-list
102187681|NCT04534725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187682|NCT04534725|Antiviral Agents|antiviral agents|mesh-ancestor
102187683|NCT04534725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102187684|NCT04534725|Immunologic Factors|immunologic factors|mesh-ancestor
102187685|NCT04534725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187686|NCT04534725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102187687|NCT04517851|Elotuzumab|elotuzumab|mesh-list
102187688|NCT04517851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187705|NCT04493138|Azacitidine|azacitidine|mesh-list
102187706|NCT04493138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102187707|NCT04493138|Antimetabolites|antimetabolites|mesh-ancestor
102187708|NCT04493138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187709|NCT04493138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187710|NCT04493138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102187711|NCT04489719|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
102187712|NCT04489719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187713|NCT04485559|Everolimus|everolimus|mesh-list
102187714|NCT04485559|Trametinib|trametinib|mesh-list
102187715|NCT04485559|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102187716|NCT04485559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102187717|NCT04485559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102187718|NCT04485559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187719|NCT04485559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102187720|NCT04485559|Immunologic Factors|immunologic factors|mesh-ancestor
102187721|NCT04485559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187722|NCT04485559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187723|NCT04463498|Methamphetamine|methamphetamine|mesh-list
102187724|NCT04463498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102187725|NCT04463498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187726|NCT04463498|Sympathomimetics|sympathomimetics|mesh-ancestor
102187727|NCT04463498|Autonomic Agents|autonomic agents|mesh-ancestor
102187728|NCT04463498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102187729|NCT04463498|Dopamine Agents|dopamine agents|mesh-ancestor
102187730|NCT04463498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102187731|NCT04463498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187732|NCT04463498|Adrenergic Agents|adrenergic agents|mesh-ancestor
102187733|NCT04463498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102187734|NCT04463498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102187735|NCT04463498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102187736|NCT04463498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102187737|NCT04454658|Navitoclax|navitoclax|mesh-list
102187738|NCT04454658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187739|NCT04439201|Palbociclib|palbociclib|mesh-list
102187740|NCT04439201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187741|NCT04439201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102187742|NCT04439201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102187743|NCT04439201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187744|NCT04428151|Paclitaxel|paclitaxel|mesh-list
102187745|NCT04428151|Docetaxel|docetaxel|mesh-list
102187746|NCT04428151|Pembrolizumab|pembrolizumab|mesh-list
102187747|NCT04428151|Capecitabine|capecitabine|mesh-list
102187748|NCT04428151|Cetuximab|cetuximab|mesh-list
102187749|NCT04428151|Lenvatinib|lenvatinib|mesh-list
102187750|NCT04428151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102187751|NCT04428151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187752|NCT04428151|Tubulin Modulators|tubulin modulators|mesh-ancestor
102187753|NCT04428151|Antimitotic Agents|antimitotic agents|mesh-ancestor
102187754|NCT04428151|Mitosis Modulators|mitosis modulators|mesh-ancestor
102187755|NCT04428151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187756|NCT04428151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102187757|NCT04428151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102187758|NCT04428151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102187759|NCT04428151|Antimetabolites|antimetabolites|mesh-ancestor
102187760|NCT04428151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102187761|NCT04428151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102187762|NCT04385433|Pravastatin|pravastatin|mesh-list
102187763|NCT04385433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102187764|NCT04385433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102187765|NCT04385433|Antimetabolites|antimetabolites|mesh-ancestor
102187766|NCT04385433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187767|NCT04385433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102187768|NCT04385433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102187769|NCT04385433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102187791|NCT04362839|Nivolumab|nivolumab|mesh-list
102187792|NCT04362839|Ipilimumab|ipilimumab|mesh-list
102187793|NCT04362839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102187794|NCT04362839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187795|NCT04362839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102187796|NCT04362839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187797|NCT04362111|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102187798|NCT04362111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102187799|NCT04331288|Ethanol|ethanol|mesh-list
102187800|NCT04331288|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102187801|NCT04331288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102187802|NCT04331288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102187803|NCT04331288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187804|NCT04284761|Bicalutamide|bicalutamide|mesh-list
102187805|NCT04284761|Androgen Antagonists|androgen antagonists|mesh-ancestor
102187806|NCT04284761|Hormone Antagonists|hormone antagonists|mesh-ancestor
102187807|NCT04284761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102187808|NCT04284761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187809|NCT04284761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187810|NCT04283669|Crizotinib|crizotinib|mesh-list
102187811|NCT04283669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187812|NCT04283669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102187813|NCT04283669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102187814|NCT04283669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187815|NCT04275024|Calcipotriene|calcipotriene|mesh-list
102187816|NCT04275024|Dermatologic Agents|dermatologic agents|mesh-ancestor
102187817|NCT04269902|Venetoclax|venetoclax|mesh-list
101681888|NCT04215432|Propolis|propolis|mesh-list
102187818|NCT04269902|Obinutuzumab|obinutuzumab|mesh-list
102187819|NCT04269902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187820|NCT04269902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102187821|NCT04259255|Edaravone|edaravone|mesh-list
102187822|NCT04259255|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102187823|NCT04259255|Antioxidants|antioxidants|mesh-ancestor
102187844|NCT04169763|Nelfinavir|nelfinavir|mesh-list
102187845|NCT04169763|Cisplatin|cisplatin|mesh-list
102187846|NCT04169763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187847|NCT04169763|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102187848|NCT04169763|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102187849|NCT04169763|Protease Inhibitors|protease inhibitors|mesh-ancestor
102187850|NCT04169763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102187851|NCT04169763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187852|NCT04169763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102187853|NCT04169763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102187854|NCT04169763|Antiviral Agents|antiviral agents|mesh-ancestor
102187855|NCT04169763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102187856|NCT04166409|Carboplatin|carboplatin|mesh-list
102187857|NCT04166409|Vincristine|vincristine|mesh-list
102187858|NCT04166409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187859|NCT04166409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102187860|NCT04166409|Tubulin Modulators|tubulin modulators|mesh-ancestor
102187861|NCT04166409|Antimitotic Agents|antimitotic agents|mesh-ancestor
102187862|NCT04166409|Mitosis Modulators|mitosis modulators|mesh-ancestor
102187863|NCT04166409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187864|NCT04151082|Prednisone|prednisone|mesh-list
102187865|NCT04151082|Methylprednisolone|methylprednisolone|mesh-list
102187866|NCT04151082|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102187867|NCT04151082|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102187868|NCT04151082|Prednisolone|prednisolone|mesh-list
102187869|NCT04151082|Prednisolone acetate|prednisolone acetate|mesh-list
102187870|NCT04151082|Cortisone|cortisone|mesh-list
102187871|NCT04151082|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102187872|NCT04151082|Prednisolone phosphate|prednisolone phosphate|mesh-list
102187873|NCT04151082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102187874|NCT04151082|Glucocorticoids|glucocorticoids|mesh-ancestor
102187875|NCT04151082|Hormones|hormones|mesh-ancestor
102187876|NCT04151082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102187877|NCT04151082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187878|NCT04151082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102187879|NCT04151082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187880|NCT04151082|Antiemetics|antiemetics|mesh-ancestor
102187881|NCT04151082|Autonomic Agents|autonomic agents|mesh-ancestor
102187882|NCT04151082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102187883|NCT04151082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102187884|NCT04151082|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102187885|NCT04151082|Protective Agents|protective agents|mesh-ancestor
102187886|NCT04146935|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102187887|NCT04146935|Immunologic Factors|immunologic factors|mesh-ancestor
102187888|NCT04146935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187889|NCT04128748|Cytarabine|cytarabine|mesh-list
102187890|NCT04128748|Daunorubicin|daunorubicin|mesh-list
102187891|NCT04128748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102187892|NCT04128748|Antimetabolites|antimetabolites|mesh-ancestor
102187893|NCT04128748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187894|NCT04128748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187895|NCT04128748|Antiviral Agents|antiviral agents|mesh-ancestor
102187896|NCT04128748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102187897|NCT04128748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102187898|NCT04128748|Immunologic Factors|immunologic factors|mesh-ancestor
102187899|NCT04128748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187900|NCT04128748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102187901|NCT04128748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102187903|NCT04128748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102187910|NCT04069156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102187911|NCT04069156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102187912|NCT04069156|Analgesics|analgesics|mesh-ancestor
102187913|NCT04069156|Sensory System Agents|sensory system agents|mesh-ancestor
102187914|NCT04069156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102187915|NCT04069156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187916|NCT04069156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102187917|NCT04069156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102187918|NCT04069156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102187919|NCT04069156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102187920|NCT04069156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187921|NCT04069156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102187922|NCT04069156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102187923|NCT04069156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102187924|NCT04069156|Antipyretics|antipyretics|mesh-ancestor
102187925|NCT04030455|Cisplatin|cisplatin|mesh-list
102187926|NCT04030455|Carboplatin|carboplatin|mesh-list
102187927|NCT04030455|Docetaxel|docetaxel|mesh-list
102187928|NCT04030455|Pembrolizumab|pembrolizumab|mesh-list
102187929|NCT04030455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187930|NCT04030455|Tubulin Modulators|tubulin modulators|mesh-ancestor
102187931|NCT04030455|Antimitotic Agents|antimitotic agents|mesh-ancestor
102187932|NCT04030455|Mitosis Modulators|mitosis modulators|mesh-ancestor
102187933|NCT04030455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187934|NCT04030455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102187935|NCT04030455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102187936|NCT04011345|Folic Acid|folic acid|mesh-list
102187937|NCT04011345|Hematinics|hematinics|mesh-ancestor
102187938|NCT04011345|Vitamin B Complex|vitamin b complex|mesh-ancestor
102187939|NCT04011345|Vitamins|vitamins|mesh-ancestor
102187940|NCT04011345|Micronutrients|micronutrients|mesh-ancestor
102187941|NCT04011345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187942|NCT04002297|Rituximab|rituximab|mesh-list
102187943|NCT04002297|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102187944|NCT04002297|Zanubrutinib|zanubrutinib|mesh-list
102187945|NCT04002297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102187946|NCT04002297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187947|NCT04002297|Immunologic Factors|immunologic factors|mesh-ancestor
102187948|NCT04002297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187949|NCT04002297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102187950|NCT04002297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102187951|NCT04002297|Alkylating Agents|alkylating agents|mesh-ancestor
102187952|NCT04002297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187953|NCT04002297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102187954|NCT04002297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102187955|NCT03993353|Pembrolizumab|pembrolizumab|mesh-list
102187956|NCT03993353|Tadalafil|tadalafil|mesh-list
102187957|NCT03993353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102187958|NCT03993353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187959|NCT03993353|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102187960|NCT03993353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187961|NCT03993353|Vasodilator Agents|vasodilator agents|mesh-ancestor
102187962|NCT03993353|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102187963|NCT03993353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102187964|NCT03993353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102187965|NCT03993353|Urological Agents|urological agents|mesh-ancestor
102187966|NCT03970837|Tofacitinib|tofacitinib|mesh-list
102187967|NCT03970837|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102187968|NCT03970837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102187969|NCT03970837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102187970|NCT03970837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187971|NCT03945357|Clindamycin|clindamycin|mesh-list
102187972|NCT03945357|Clindamycin palmitate|clindamycin palmitate|mesh-list
102187973|NCT03945357|Clindamycin phosphate|clindamycin phosphate|mesh-list
102187974|NCT03945357|Gemcitabine|gemcitabine|mesh-list
102187975|NCT03945357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102187976|NCT03945357|Antimetabolites|antimetabolites|mesh-ancestor
102187977|NCT03945357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187978|NCT03945357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187979|NCT03945357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102187980|NCT03945357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102187981|NCT03945357|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102187982|NCT03945357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102187983|NCT03909334|Osimertinib|osimertinib|mesh-list
102187984|NCT03909334|Ramucirumab|ramucirumab|mesh-list
102187985|NCT03909334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102187986|NCT03909334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102187987|NCT03909334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102187988|NCT03909334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102187989|NCT03896009|Meloxicam|meloxicam|mesh-list
102187990|NCT03896009|Rizatriptan|rizatriptan|mesh-list
102187991|NCT03896009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102187992|NCT03896009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102187993|NCT03896009|Analgesics|analgesics|mesh-ancestor
102187994|NCT03896009|Sensory System Agents|sensory system agents|mesh-ancestor
102187995|NCT03896009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102187996|NCT03896009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102187997|NCT03896009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102187998|NCT03896009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102187999|NCT03896009|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102188000|NCT03896009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102188001|NCT03896009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102188002|NCT03896009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188003|NCT03896009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102188004|NCT03896009|Serotonin Agents|serotonin agents|mesh-ancestor
102188005|NCT03896009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102188006|NCT03841617|Hormones|hormones|mesh-list
102188007|NCT03841617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102188008|NCT03841617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188009|NCT03744975|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102188010|NCT03744975|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102188011|NCT03744975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188012|NCT03606174|Pembrolizumab|pembrolizumab|mesh-list
102188013|NCT03606174|Nivolumab|nivolumab|mesh-list
102188014|NCT03606174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102188015|NCT03606174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188016|NCT03606174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102188017|NCT03606174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188018|NCT03450707|Thiamine|thiamine|mesh-list
102188019|NCT03450707|Vitamins|vitamins|mesh-ancestor
102188020|NCT03450707|Micronutrients|micronutrients|mesh-ancestor
102188021|NCT03450707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188022|NCT03450707|Vitamin B Complex|vitamin b complex|mesh-ancestor
102188023|NCT03392311|Calcipotriene|calcipotriene|mesh-list
102188024|NCT03392311|Dermatologic Agents|dermatologic agents|mesh-ancestor
102188025|NCT03337009|Naloxone|naloxone|mesh-list
102188026|NCT03337009|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102188027|NCT03337009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188028|NCT03337009|Sensory System Agents|sensory system agents|mesh-ancestor
102188029|NCT03337009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102188030|NCT03324373|Everolimus|everolimus|mesh-list
102188031|NCT03324373|Lenvatinib|lenvatinib|mesh-list
102188032|NCT03324373|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102188033|NCT03324373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102188034|NCT03324373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102188035|NCT03324373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188036|NCT03324373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102188037|NCT03324373|Immunologic Factors|immunologic factors|mesh-ancestor
102188038|NCT03324373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188039|NCT03324373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188040|NCT03322865|Obinutuzumab|obinutuzumab|mesh-list
102188041|NCT03322865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102188042|NCT03322865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188043|NCT03296527|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102188044|NCT03296527|Hormones|hormones|mesh-ancestor
102188045|NCT03296527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102188046|NCT03296527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188047|NCT03269669|Prednisone|prednisone|mesh-list
102188048|NCT03269669|Cortisone|cortisone|mesh-list
102188049|NCT03269669|Cyclophosphamide|cyclophosphamide|mesh-list
102188050|NCT03269669|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102188051|NCT03269669|Doxorubicin|doxorubicin|mesh-list
102188052|NCT03269669|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102188054|NCT03269669|Lenalidomide|lenalidomide|mesh-list
102188055|NCT03269669|Obinutuzumab|obinutuzumab|mesh-list
102188056|NCT03269669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102188057|NCT03269669|Immunologic Factors|immunologic factors|mesh-ancestor
102188058|NCT03269669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188059|NCT03269669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102188060|NCT03269669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102188061|NCT03269669|Alkylating Agents|alkylating agents|mesh-ancestor
102188062|NCT03269669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188063|NCT03269669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188064|NCT03269669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102188065|NCT03269669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102188066|NCT03269669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102188067|NCT03269669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102188068|NCT03269669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102188069|NCT03269669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102188070|NCT03269669|Glucocorticoids|glucocorticoids|mesh-ancestor
102188071|NCT03269669|Hormones|hormones|mesh-ancestor
102188072|NCT03269669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102188073|NCT03269669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102188074|NCT03269669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102188075|NCT03269669|Tubulin Modulators|tubulin modulators|mesh-ancestor
102188076|NCT03269669|Antimitotic Agents|antimitotic agents|mesh-ancestor
102188077|NCT03269669|Mitosis Modulators|mitosis modulators|mesh-ancestor
102188078|NCT03269669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102188079|NCT03269669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102188080|NCT03269669|Growth Substances|growth substances|mesh-ancestor
102188081|NCT03269669|Growth Inhibitors|growth inhibitors|mesh-ancestor
102188082|NCT03269669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102188083|NCT03267498|Nivolumab|nivolumab|mesh-list
102188084|NCT03267498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188085|NCT03267498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102188086|NCT03267498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102188087|NCT03267498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188088|NCT03258567|Nivolumab|nivolumab|mesh-list
102188089|NCT03258567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102188090|NCT03258567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188091|NCT03258567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102188092|NCT03258567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188093|NCT03241771|Naloxone|naloxone|mesh-list
102188094|NCT03241771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102188095|NCT03241771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188096|NCT03241771|Sensory System Agents|sensory system agents|mesh-ancestor
102188097|NCT03241771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102188098|NCT03228680|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102188099|NCT03228680|Hormones|hormones|mesh-ancestor
102188100|NCT03228680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102188101|NCT03228680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188102|NCT03194542|Luspatercept|luspatercept|mesh-list
102188103|NCT03194542|Hematinics|hematinics|mesh-ancestor
102188104|NCT03160079|Pembrolizumab|pembrolizumab|mesh-list
102188105|NCT03160079|Blinatumomab|blinatumomab|mesh-list
102188106|NCT03160079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102188107|NCT03160079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188108|NCT03160079|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102188109|NCT03160079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188110|NCT03083808|Pembrolizumab|pembrolizumab|mesh-list
102188111|NCT03083808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102188112|NCT03083808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188113|NCT03083808|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102188114|NCT03083808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188115|NCT03076554|Avelumab|avelumab|mesh-list
102188116|NCT03076554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102188117|NCT03076554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188118|NCT03065335|Ketamine|ketamine|mesh-list
102188119|NCT03065335|Analgesics|analgesics|mesh-ancestor
102188120|NCT03065335|Sensory System Agents|sensory system agents|mesh-ancestor
102188121|NCT03065335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101896954|NCT05152940|Ertugliflozin|ertugliflozin|mesh-list
102188122|NCT03065335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188123|NCT03065335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102188124|NCT03065335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102188125|NCT03065335|Anesthetics, General|anesthetics, general|mesh-ancestor
102188126|NCT03065335|Anesthetics|anesthetics|mesh-ancestor
102188127|NCT03065335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102188128|NCT03065335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102188129|NCT03065335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102188130|NCT03065335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102188131|NCT03065335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188132|NCT03047330|Leuprolide|leuprolide|mesh-list
102188133|NCT03047330|Estradiol|estradiol|mesh-list
102188134|NCT03047330|Estrogens|estrogens|mesh-ancestor
102188135|NCT03047330|Hormones|hormones|mesh-ancestor
102188136|NCT03047330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102188137|NCT03047330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188138|NCT03047330|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102188139|NCT03047330|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102188140|NCT03047330|Fertility Agents|fertility agents|mesh-ancestor
102188141|NCT03047330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102188142|NCT03047330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188152|NCT02911142|Prednisone|prednisone|mesh-list
102188153|NCT02911142|Cyclophosphamide|cyclophosphamide|mesh-list
102188154|NCT02911142|Rituximab|rituximab|mesh-list
102188155|NCT02911142|Doxorubicin|doxorubicin|mesh-list
102188156|NCT02911142|Vincristine|vincristine|mesh-list
102188157|NCT02911142|Lenalidomide|lenalidomide|mesh-list
102188158|NCT02911142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102188159|NCT02911142|Immunologic Factors|immunologic factors|mesh-ancestor
102188160|NCT02911142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188161|NCT02911142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102188162|NCT02911142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102188163|NCT02911142|Alkylating Agents|alkylating agents|mesh-ancestor
102188164|NCT02911142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188165|NCT02911142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188166|NCT02911142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102188167|NCT02911142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102188168|NCT02911142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102188169|NCT02911142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102188170|NCT02911142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102188171|NCT02911142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102188172|NCT02911142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102188173|NCT02911142|Glucocorticoids|glucocorticoids|mesh-ancestor
102188174|NCT02911142|Hormones|hormones|mesh-ancestor
102188175|NCT02911142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102188176|NCT02911142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102188177|NCT02911142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102188178|NCT02911142|Tubulin Modulators|tubulin modulators|mesh-ancestor
102188179|NCT02911142|Antimitotic Agents|antimitotic agents|mesh-ancestor
102188180|NCT02911142|Mitosis Modulators|mitosis modulators|mesh-ancestor
102188181|NCT02911142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102188182|NCT02911142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102188183|NCT02911142|Growth Substances|growth substances|mesh-ancestor
102188184|NCT02911142|Growth Inhibitors|growth inhibitors|mesh-ancestor
102188185|NCT02762266|Ethiodized Oil|ethiodized oil|mesh-list
102188186|NCT02762266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188187|NCT02717611|Acalabrutinib|acalabrutinib|mesh-list
102188188|NCT02717611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188189|NCT02707926|Anti-HIV Agents|anti-hiv agents|mesh-list
102188190|NCT02707926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102188191|NCT02707926|Antiviral Agents|antiviral agents|mesh-ancestor
102188192|NCT02707926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102188193|NCT02608216|Paclitaxel|paclitaxel|mesh-list
102188194|NCT02608216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102188195|NCT02608216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188196|NCT02608216|Tubulin Modulators|tubulin modulators|mesh-ancestor
102188197|NCT02608216|Antimitotic Agents|antimitotic agents|mesh-ancestor
102188198|NCT02608216|Mitosis Modulators|mitosis modulators|mesh-ancestor
102188199|NCT02608216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188200|NCT02511028|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102188201|NCT02511028|Hematinics|hematinics|mesh-ancestor
102188202|NCT02511028|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102188203|NCT02511028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102188204|NCT02362035|Pembrolizumab|pembrolizumab|mesh-list
102188205|NCT02362035|Acalabrutinib|acalabrutinib|mesh-list
102188206|NCT02362035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102188207|NCT02362035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188208|NCT02362035|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102188209|NCT02362035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188210|NCT02328014|Acalabrutinib|acalabrutinib|mesh-list
102188211|NCT02328014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188212|NCT02213926|Acalabrutinib|acalabrutinib|mesh-list
102188213|NCT02213926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188214|NCT02180724|Acalabrutinib|acalabrutinib|mesh-list
102188215|NCT02180724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188216|NCT02133196|Aldesleukin|aldesleukin|mesh-list
102188217|NCT02133196|Cyclophosphamide|cyclophosphamide|mesh-list
102188218|NCT02133196|Fludarabine|fludarabine|mesh-list
102188219|NCT02133196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102188220|NCT02133196|Immunologic Factors|immunologic factors|mesh-ancestor
102188221|NCT02133196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188222|NCT02133196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102188223|NCT02133196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102188224|NCT02133196|Alkylating Agents|alkylating agents|mesh-ancestor
102188225|NCT02133196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188226|NCT02133196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188227|NCT02133196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102188228|NCT02133196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102188229|NCT02133196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102188230|NCT02133196|Antiviral Agents|antiviral agents|mesh-ancestor
102188231|NCT02133196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102188232|NCT02125786|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102188233|NCT02125786|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102188234|NCT02125786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188235|NCT02107963|Cyclophosphamide|cyclophosphamide|mesh-list
102188236|NCT02107963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102188237|NCT02107963|Immunologic Factors|immunologic factors|mesh-ancestor
102188238|NCT02107963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188239|NCT02107963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102188240|NCT02107963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102188241|NCT02107963|Alkylating Agents|alkylating agents|mesh-ancestor
102188242|NCT02107963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188243|NCT02107963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188244|NCT02107963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102188245|NCT02016924|Cobicistat|cobicistat|mesh-list
102188246|NCT02016924|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
102188247|NCT02016924|Emtricitabine|emtricitabine|mesh-list
102188248|NCT02016924|Tenofovir|tenofovir|mesh-list
102188249|NCT02016924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102188250|NCT02016924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188251|NCT02016924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102188252|NCT02016924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102188253|NCT02016924|Antiviral Agents|antiviral agents|mesh-ancestor
102188254|NCT02016924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102188255|NCT02016924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102188256|NCT02016924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102188257|NCT02016924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102188258|NCT02016924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102188259|NCT01799538|Albuterol|albuterol|mesh-list
102188260|NCT01799538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102188261|NCT01799538|Autonomic Agents|autonomic agents|mesh-ancestor
102188262|NCT01799538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102188263|NCT01799538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188264|NCT01799538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102188265|NCT01799538|Respiratory System Agents|respiratory system agents|mesh-ancestor
102188266|NCT01799538|Tocolytic Agents|tocolytic agents|mesh-ancestor
102188267|NCT01799538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102188268|NCT01799538|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102188269|NCT01799538|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102188270|NCT01799538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101897100|NCT01144910|Miotics|miotics|mesh-ancestor
102188271|NCT01799538|Adrenergic Agents|adrenergic agents|mesh-ancestor
102188272|NCT01799538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102188273|NCT01799538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188274|NCT01631617|Doxycycline|doxycycline|mesh-list
102188276|NCT01631617|Trimethoprim|trimethoprim|mesh-list
102188277|NCT01631617|Sulfamethoxazole|sulfamethoxazole|mesh-list
102188278|NCT01631617|Sodium Hypochlorite|sodium hypochlorite|mesh-list
102188279|NCT01631617|Eusol|eusol|mesh-list
102188280|NCT01631617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102188281|NCT01631617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102188282|NCT01631617|Antimalarials|antimalarials|mesh-ancestor
102188283|NCT01631617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102188284|NCT01631617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102188285|NCT01631617|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102188286|NCT01631617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102188287|NCT01631617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102188288|NCT01631617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188289|NCT01631617|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102188290|NCT01631617|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102188291|NCT01631617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102188292|NCT01631617|Disinfectants|disinfectants|mesh-ancestor
102188293|NCT01553214|Dexamethasone|dexamethasone|mesh-list
102188294|NCT01553214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102188295|NCT01553214|Antiemetics|antiemetics|mesh-ancestor
102188296|NCT01553214|Autonomic Agents|autonomic agents|mesh-ancestor
102188297|NCT01553214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102188298|NCT01553214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188299|NCT01553214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102188300|NCT01553214|Glucocorticoids|glucocorticoids|mesh-ancestor
102188301|NCT01553214|Hormones|hormones|mesh-ancestor
102188302|NCT01553214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102188303|NCT01553214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102188304|NCT01553214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188305|NCT01419561|Zidovudine|zidovudine|mesh-list
102188306|NCT01419561|Rituximab|rituximab|mesh-list
102188307|NCT01419561|Doxorubicin|doxorubicin|mesh-list
102188308|NCT01419561|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102188309|NCT01419561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102188310|NCT01419561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188311|NCT01419561|Immunologic Factors|immunologic factors|mesh-ancestor
102188312|NCT01419561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188313|NCT01419561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102188314|NCT01419561|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102188315|NCT01419561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102188316|NCT01419561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102188317|NCT01419561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102188318|NCT01419561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188319|NCT01419561|Antimetabolites|antimetabolites|mesh-ancestor
102188320|NCT01419561|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102188321|NCT01419561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102188322|NCT01419561|Antiviral Agents|antiviral agents|mesh-ancestor
102188323|NCT01419561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102188324|NCT01419561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102188325|NCT01419561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102188326|NCT01311713|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102188327|NCT01311713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102188328|NCT01311713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188329|NCT01311713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101897175|NCT01234454|Olanzapine|olanzapine|mesh-list
102188354|NCT00588991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102188355|NCT00588991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102188356|NCT00588991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188357|NCT00588991|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102188358|NCT00390325|Sorafenib|sorafenib|mesh-list
102188359|NCT00390325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188360|NCT00390325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102188361|NCT00390325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102188362|NCT00390325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188363|NCT00381641|Sunitinib|sunitinib|mesh-list
102188364|NCT00381641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188365|NCT00381641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102188366|NCT00381641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102188367|NCT00381641|Growth Substances|growth substances|mesh-ancestor
102188368|NCT00381641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188369|NCT00381641|Growth Inhibitors|growth inhibitors|mesh-ancestor
102188370|NCT00381641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102188371|NCT00381641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102188372|NCT00381641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188373|NCT00365157|Halichondrin B|halichondrin b|mesh-list
102188374|NCT00365157|Tubulin Modulators|tubulin modulators|mesh-ancestor
102188375|NCT00365157|Antimitotic Agents|antimitotic agents|mesh-ancestor
102188376|NCT00365157|Mitosis Modulators|mitosis modulators|mesh-ancestor
102188377|NCT00365157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188378|NCT00365157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188379|NCT00353158|Doxycycline|doxycycline|mesh-list
102188380|NCT00353158|Voriconazole|voriconazole|mesh-list
102188381|NCT00353158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102188382|NCT00353158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102188383|NCT00353158|Antimalarials|antimalarials|mesh-ancestor
102188384|NCT00353158|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102188385|NCT00353158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102188386|NCT00353158|Antifungal Agents|antifungal agents|mesh-ancestor
102188387|NCT00353158|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102188388|NCT00353158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102188389|NCT00353158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102188390|NCT00353158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188391|NCT00353158|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102188392|NCT00353158|Hormone Antagonists|hormone antagonists|mesh-ancestor
102188393|NCT00353158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102188394|NCT00353158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188395|NCT00353158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102188396|NCT00265798|Sorafenib|sorafenib|mesh-list
102188397|NCT00265798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188398|NCT00265798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102188399|NCT00265798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102188400|NCT00265798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188401|NCT00114101|Lenalidomide|lenalidomide|mesh-list
102188402|NCT00114101|Melphalan|melphalan|mesh-list
102188403|NCT00114101|Mechlorethamine|mechlorethamine|mesh-list
102188404|NCT00114101|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102188405|NCT00114101|Immunologic Factors|immunologic factors|mesh-ancestor
102188406|NCT00114101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188407|NCT00114101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102188408|NCT00114101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102188409|NCT00114101|Growth Substances|growth substances|mesh-ancestor
102188410|NCT00114101|Growth Inhibitors|growth inhibitors|mesh-ancestor
102188411|NCT00114101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188412|NCT00114101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102188413|NCT00114101|Alkylating Agents|alkylating agents|mesh-ancestor
102188414|NCT00114101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188415|NCT00114101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102188416|NCT00114101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102188417|NCT00045201|Irinotecan|irinotecan|mesh-list
102188418|NCT00045201|Camptothecin|camptothecin|mesh-list
102188419|NCT00045201|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101730161|NCT00818194|Tacrolimus|tacrolimus|mesh-list
102188425|NCT00045201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102188426|NCT00045201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102188432|NCT00001379|Interferons|interferons|mesh-list
102188434|NCT00001379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188435|NCT00001379|Antiviral Agents|antiviral agents|mesh-ancestor
102188436|NCT00001379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102188437|NCT00001379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102188438|NCT00001379|Immunologic Factors|immunologic factors|mesh-ancestor
102188439|NCT00001379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188440|NCT00001379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102188441|NCT00001247|Sirolimus|sirolimus|mesh-list
102188442|NCT00001247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102188443|NCT00001247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102188444|NCT00001247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102188445|NCT00001247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188446|NCT00001247|Antifungal Agents|antifungal agents|mesh-ancestor
102188447|NCT00001247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102188448|NCT00001247|Immunologic Factors|immunologic factors|mesh-ancestor
102188449|NCT00001247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188450|NCT03538171|Exemestane|exemestane|mesh-list
102188451|NCT03538171|Entinostat|entinostat|mesh-list
102188452|NCT03538171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188453|NCT03538171|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102188454|NCT03538171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102188455|NCT03538171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102188456|NCT03538171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188457|NCT03538171|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102188458|NCT03538171|Hormone Antagonists|hormone antagonists|mesh-ancestor
102188459|NCT03538171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102188460|NCT03538171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188461|NCT03538171|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102188462|NCT05312216|Durvalumab|durvalumab|mesh-list
102188463|NCT05312216|Lenvatinib|lenvatinib|mesh-list
102188464|NCT05312216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102188465|NCT05312216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188466|NCT05312216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102188467|NCT05312216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102188468|NCT05312216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188469|NCT02256319|Dexmedetomidine|dexmedetomidine|mesh-list
102188470|NCT02256319|Propofol|propofol|mesh-list
102188471|NCT02256319|Imidazole|imidazole|mesh-list
102188472|NCT02256319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102188473|NCT02256319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102188474|NCT02256319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188475|NCT02256319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102188476|NCT02256319|Analgesics|analgesics|mesh-ancestor
102188477|NCT02256319|Sensory System Agents|sensory system agents|mesh-ancestor
102188478|NCT02256319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102188479|NCT02256319|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102188480|NCT02256319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102188481|NCT02256319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102188482|NCT02256319|Adrenergic Agents|adrenergic agents|mesh-ancestor
102188483|NCT02256319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102188484|NCT02256319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188485|NCT02256319|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102188486|NCT02256319|Anesthetics, General|anesthetics, general|mesh-ancestor
102188487|NCT02256319|Anesthetics|anesthetics|mesh-ancestor
102188488|NCT02256319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102188489|NCT04510285|Pembrolizumab|pembrolizumab|mesh-list
102188490|NCT04510285|Trastuzumab|trastuzumab|mesh-list
102188491|NCT04510285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102188492|NCT04510285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188493|NCT04510285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101897326|NCT01312792|Ampicillin|ampicillin|mesh-list
102188494|NCT04510285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188496|NCT05450432|Esketamine|esketamine|mesh-list
102188497|NCT05450432|Analgesics|analgesics|mesh-ancestor
102188498|NCT05450432|Sensory System Agents|sensory system agents|mesh-ancestor
102188499|NCT05450432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102188500|NCT05450432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188501|NCT05450432|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102188502|NCT05450432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102188503|NCT05450432|Anesthetics, General|anesthetics, general|mesh-ancestor
102188504|NCT05450432|Anesthetics|anesthetics|mesh-ancestor
102188505|NCT05450432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102188506|NCT05450432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102188507|NCT05450432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102188508|NCT05450432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101308294|NCT02046629|Antimetabolites|antimetabolites|mesh-ancestor
102188509|NCT05450432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188510|NCT05450432|Antidepressive Agents|antidepressive agents|mesh-ancestor
102188511|NCT05450432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102188512|NCT02179255|Hormones|hormones|mesh-list
102188513|NCT02179255|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102188514|NCT02179255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102188515|NCT02179255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188516|NCT02182063|Nintedanib|nintedanib|mesh-list
102188517|NCT02182063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188518|NCT02182063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102188519|NCT02182063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102188520|NCT02182063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188521|NCT02182141|Nintedanib|nintedanib|mesh-list
102188522|NCT02182141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188523|NCT02182141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102188524|NCT02182141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102188525|NCT02182141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188526|NCT02182219|Nintedanib|nintedanib|mesh-list
102188527|NCT02182219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188528|NCT02182219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102188529|NCT02182219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102188530|NCT02182219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188531|NCT05303480|Mechlorethamine|mechlorethamine|mesh-list
102188532|NCT05303480|Alkylating Agents|alkylating agents|mesh-ancestor
102188533|NCT05303480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188534|NCT05303480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102188535|NCT05303480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188536|NCT02182375|Raltegravir Potassium|raltegravir potassium|mesh-list
102188537|NCT02182375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102188538|NCT02182375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102188539|NCT02182375|Antiviral Agents|antiviral agents|mesh-ancestor
102188540|NCT02182375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102188541|NCT02182375|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102188542|NCT02182375|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102188543|NCT02182375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102188544|NCT02182375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188545|NCT02179567|Bevacizumab|bevacizumab|mesh-list
102188546|NCT02179567|Docetaxel|docetaxel|mesh-list
102188547|NCT02179567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102188548|NCT02179567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188549|NCT02179567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102188550|NCT02179567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102188551|NCT02179567|Growth Substances|growth substances|mesh-ancestor
102188552|NCT02179567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188553|NCT02179567|Growth Inhibitors|growth inhibitors|mesh-ancestor
102188554|NCT02179567|Tubulin Modulators|tubulin modulators|mesh-ancestor
102188555|NCT02179567|Antimitotic Agents|antimitotic agents|mesh-ancestor
102188556|NCT02179567|Mitosis Modulators|mitosis modulators|mesh-ancestor
102188557|NCT02179567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188558|NCT02182453|Empagliflozin|empagliflozin|mesh-list
102188559|NCT02182453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102188560|NCT02182453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188561|NCT02182453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102188562|NCT02182453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188563|NCT02182531|Pseudoephedrine|pseudoephedrine|mesh-list
102188564|NCT02182531|Ephedrine|ephedrine|mesh-list
102188566|NCT02182531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102188567|NCT02182531|Autonomic Agents|autonomic agents|mesh-ancestor
102188568|NCT02182531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102188569|NCT02182531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188570|NCT02182531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102188571|NCT02182531|Respiratory System Agents|respiratory system agents|mesh-ancestor
102188572|NCT02182531|Nasal Decongestants|nasal decongestants|mesh-ancestor
102188573|NCT02182531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102188574|NCT02182531|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102188575|NCT02182531|Sympathomimetics|sympathomimetics|mesh-ancestor
102188576|NCT02182531|Adrenergic Agents|adrenergic agents|mesh-ancestor
102188577|NCT02182531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102188578|NCT02182531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188579|NCT02182531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102188580|NCT02182531|Histamine Antagonists|histamine antagonists|mesh-ancestor
102188581|NCT02182531|Histamine Agents|histamine agents|mesh-ancestor
102188582|NCT02177305|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102188583|NCT02177305|Tiotropium Bromide|tiotropium bromide|mesh-list
102188584|NCT02177305|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102188585|NCT02177305|Autonomic Agents|autonomic agents|mesh-ancestor
102188586|NCT02177305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102188587|NCT02177305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188588|NCT02177305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102188589|NCT02177305|Respiratory System Agents|respiratory system agents|mesh-ancestor
102188590|NCT02177305|Parasympatholytics|parasympatholytics|mesh-ancestor
102188591|NCT02177305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102188592|NCT02177305|Cholinergic Agents|cholinergic agents|mesh-ancestor
102188593|NCT02177305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102188594|NCT02177305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188596|NCT02182765|Abacavir|abacavir|mesh-list
102188597|NCT02182765|Amprenavir|amprenavir|mesh-list
102188598|NCT02182765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102188599|NCT02182765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102188600|NCT02182765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102188601|NCT02182765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188602|NCT02182765|Antiviral Agents|antiviral agents|mesh-ancestor
102188603|NCT02182765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102188604|NCT02182765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102188605|NCT02182765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102188606|NCT02182765|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102188607|NCT02182765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102188608|NCT02182765|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102188609|NCT02182765|Antitubercular Agents|antitubercular agents|mesh-ancestor
102188610|NCT02182765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102188611|NCT02182765|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102188612|NCT02182765|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102188613|NCT02182765|Protease Inhibitors|protease inhibitors|mesh-ancestor
102188614|NCT02179645|Celecoxib|celecoxib|mesh-list
102188615|NCT02179645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102188616|NCT02179645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102188617|NCT02179645|Analgesics|analgesics|mesh-ancestor
102188618|NCT02179645|Sensory System Agents|sensory system agents|mesh-ancestor
102188619|NCT02179645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102188620|NCT02179645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188621|NCT02179645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102188622|NCT02179645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102188623|NCT02179645|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102188624|NCT02179645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102188625|NCT02179645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102188626|NCT02179645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188627|NCT03537157|Rifaximin|rifaximin|mesh-list
102188628|NCT03537157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102188629|NCT03537157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102188630|NCT03537157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102188631|NCT01606202|Nabiximols|nabiximols|mesh-list
102188632|NCT01606202|Analgesics|analgesics|mesh-ancestor
102188633|NCT01606202|Sensory System Agents|sensory system agents|mesh-ancestor
102188634|NCT01606202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102188635|NCT01606202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188636|NCT03536611|Warfarin|warfarin|mesh-list
102188637|NCT03536611|Dabigatran|dabigatran|mesh-list
102188638|NCT03536611|Anticoagulants|anticoagulants|mesh-ancestor
102188639|NCT03536611|Antithrombins|antithrombins|mesh-ancestor
102188640|NCT03536611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102188641|NCT03536611|Protease Inhibitors|protease inhibitors|mesh-ancestor
102188642|NCT03536611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102188643|NCT03536611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188644|NCT02630459|Erenumab|erenumab|mesh-list
102188645|NCT02630459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102188646|NCT02630459|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
102188647|NCT02630459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188648|NCT02630459|Analgesics|analgesics|mesh-ancestor
102188649|NCT02630459|Sensory System Agents|sensory system agents|mesh-ancestor
102188650|NCT02630459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102188651|NCT02630459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188652|NCT02630459|Immunologic Factors|immunologic factors|mesh-ancestor
102188653|NCT02183077|Meloxicam|meloxicam|mesh-list
102188654|NCT02183077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102188655|NCT02183077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102188656|NCT02183077|Analgesics|analgesics|mesh-ancestor
102188657|NCT02183077|Sensory System Agents|sensory system agents|mesh-ancestor
102188658|NCT02183077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102188659|NCT02183077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188660|NCT02183077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102188661|NCT02183077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102188662|NCT02183077|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102188663|NCT02183077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102188664|NCT02183077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102188665|NCT02183077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188666|NCT02183155|Indomethacin|indomethacin|mesh-list
102188667|NCT02183155|Meloxicam|meloxicam|mesh-list
102188668|NCT02183155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102188669|NCT02183155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102188670|NCT02183155|Analgesics|analgesics|mesh-ancestor
102188671|NCT02183155|Sensory System Agents|sensory system agents|mesh-ancestor
102188672|NCT02183155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102188673|NCT02183155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188674|NCT02183155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102188675|NCT02183155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102188676|NCT02183155|Gout Suppressants|gout suppressants|mesh-ancestor
102188677|NCT02183155|Tocolytic Agents|tocolytic agents|mesh-ancestor
102188678|NCT02183155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102188679|NCT02183155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102188680|NCT02183155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102188681|NCT02183155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188682|NCT02183155|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102188683|NCT02177461|Telmisartan|telmisartan|mesh-list
102188684|NCT02177461|Clonidine|clonidine|mesh-list
102188685|NCT02177461|Enalapril|enalapril|mesh-list
102188686|NCT02177461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102188687|NCT02177461|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102188688|NCT02177461|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102188689|NCT02177461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188690|NCT02177461|Analgesics|analgesics|mesh-ancestor
102188691|NCT02177461|Sensory System Agents|sensory system agents|mesh-ancestor
102188692|NCT02177461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102188693|NCT02177461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188694|NCT02177461|Sympatholytics|sympatholytics|mesh-ancestor
102188695|NCT02177461|Autonomic Agents|autonomic agents|mesh-ancestor
102188696|NCT02177461|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102188697|NCT02177461|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102188698|NCT02177461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102188699|NCT02177461|Adrenergic Agents|adrenergic agents|mesh-ancestor
102188700|NCT02177461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102188701|NCT02177461|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102188702|NCT02177461|Protease Inhibitors|protease inhibitors|mesh-ancestor
102188703|NCT02177461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102188704|NCT03545243|Pantoprazole|pantoprazole|mesh-list
102188705|NCT03545243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102188706|NCT03545243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102188707|NCT03545243|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102188708|NCT03545243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102188709|NCT03545243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188710|NCT02183311|Linagliptin|linagliptin|mesh-list
102188711|NCT02183311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102188712|NCT02183311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188713|NCT02183311|Incretins|incretins|mesh-ancestor
102188714|NCT02183311|Hormones|hormones|mesh-ancestor
102188715|NCT02183311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102188716|NCT02183311|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102188717|NCT02183311|Protease Inhibitors|protease inhibitors|mesh-ancestor
102188718|NCT02183311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102188719|NCT02183311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188720|NCT05518526|Annamycin|annamycin|mesh-list
102188721|NCT05518526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102188722|NCT05518526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188723|NCT01464593|Doxorubicin|doxorubicin|mesh-list
102188724|NCT01464593|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102188725|NCT01464593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102188726|NCT01464593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188727|NCT01464593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102188728|NCT01464593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102188729|NCT01464593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102188730|NCT01464593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188731|NCT02183389|Linagliptin|linagliptin|mesh-list
102188732|NCT02183389|Warfarin|warfarin|mesh-list
102188733|NCT02183389|Anticoagulants|anticoagulants|mesh-ancestor
102188734|NCT02183389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102188735|NCT02183389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188736|NCT02183389|Incretins|incretins|mesh-ancestor
102188737|NCT02183389|Hormones|hormones|mesh-ancestor
102188738|NCT02183389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102188739|NCT02183389|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102188740|NCT02183389|Protease Inhibitors|protease inhibitors|mesh-ancestor
102188741|NCT02183389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102188742|NCT02183389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188743|NCT02177539|Phenylephrine|phenylephrine|mesh-list
102188744|NCT02177539|Oxymetazoline|oxymetazoline|mesh-list
102188745|NCT02177539|Tropicamide|tropicamide|mesh-list
102188746|NCT02177539|Cyclopentolate|cyclopentolate|mesh-list
102188747|NCT02177539|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102188748|NCT02177539|Mydriatics|mydriatics|mesh-ancestor
102188749|NCT02177539|Autonomic Agents|autonomic agents|mesh-ancestor
102188750|NCT02177539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102188751|NCT02177539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188752|NCT02177539|Sympathomimetics|sympathomimetics|mesh-ancestor
102188753|NCT02177539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102188754|NCT02177539|Nasal Decongestants|nasal decongestants|mesh-ancestor
102188755|NCT02177539|Respiratory System Agents|respiratory system agents|mesh-ancestor
102188756|NCT02177539|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102188757|NCT02177539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102188758|NCT02177539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102188759|NCT02177539|Adrenergic Agents|adrenergic agents|mesh-ancestor
102188760|NCT02177539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102188761|NCT02177539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188762|NCT02177539|Protective Agents|protective agents|mesh-ancestor
102188763|NCT02177539|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102188764|NCT02177539|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102188765|NCT02177539|Cholinergic Agents|cholinergic agents|mesh-ancestor
102188766|NCT02177539|Parasympatholytics|parasympatholytics|mesh-ancestor
102188767|NCT04141904|Tofacitinib|tofacitinib|mesh-list
102188768|NCT04141904|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102188769|NCT04141904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102188770|NCT04141904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102188771|NCT04141904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188772|NCT05523986|Vitamin D|vitamin d|mesh-list
102188773|NCT05523986|Vitamins|vitamins|mesh-ancestor
102188774|NCT05523986|Micronutrients|micronutrients|mesh-ancestor
102188775|NCT05523986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188776|NCT05523986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102188777|NCT01361711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102188778|NCT01361711|Alemtuzumab|alemtuzumab|mesh-list
102188779|NCT01361711|Ofatumumab|ofatumumab|mesh-list
102188780|NCT01361711|Antibodies|antibodies|mesh-list
102188781|NCT01361711|Immunoglobulins|immunoglobulins|mesh-list
102188782|NCT01361711|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102188783|NCT01361711|Immunologic Factors|immunologic factors|mesh-ancestor
101900222|NCT03874832|Analgesics|analgesics|mesh-ancestor
102188784|NCT01361711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188785|NCT01361711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188786|NCT05517746|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101897618|NCT01240850|Methotrexate|methotrexate|mesh-list
102188788|NCT05527340|Daratumumab|daratumumab|mesh-list
102188789|NCT05527340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102188790|NCT05527340|Antiemetics|antiemetics|mesh-ancestor
102188791|NCT05527340|Autonomic Agents|autonomic agents|mesh-ancestor
102188792|NCT05527340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102188793|NCT05527340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188794|NCT05527340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102188795|NCT05527340|Glucocorticoids|glucocorticoids|mesh-ancestor
102188796|NCT05527340|Hormones|hormones|mesh-ancestor
102188797|NCT05527340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102188798|NCT05527340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102188799|NCT05527340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188800|NCT05527106|Ascorbic Acid|ascorbic acid|mesh-list
102188801|NCT05527106|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
102188802|NCT05527106|Vitamins|vitamins|mesh-ancestor
102188803|NCT05527106|Micronutrients|micronutrients|mesh-ancestor
102188804|NCT05527106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188805|NCT05527106|Antioxidants|antioxidants|mesh-ancestor
102188806|NCT05527106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188807|NCT05527106|Protective Agents|protective agents|mesh-ancestor
102188808|NCT05527106|Nootropic Agents|nootropic agents|mesh-ancestor
102188809|NCT05526794|Analgesics|analgesics|mesh-list
102188810|NCT05526794|Sensory System Agents|sensory system agents|mesh-ancestor
102188811|NCT05526794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102188812|NCT05526794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188813|NCT05522894|Paclitaxel|paclitaxel|mesh-list
102188814|NCT05522894|Cisplatin|cisplatin|mesh-list
102188815|NCT05522894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102188816|NCT05522894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188817|NCT05522894|Tubulin Modulators|tubulin modulators|mesh-ancestor
102188818|NCT05522894|Antimitotic Agents|antimitotic agents|mesh-ancestor
102188819|NCT05522894|Mitosis Modulators|mitosis modulators|mesh-ancestor
102188820|NCT05522894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188821|NCT05522816|Tirbanibulin|tirbanibulin|mesh-list
102188822|NCT05522816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102188823|NCT05522816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188824|NCT02573870|Fluticasone|fluticasone|mesh-list
102188825|NCT02573870|Xhance|xhance|mesh-list
102188826|NCT02573870|Albuterol|albuterol|mesh-list
102188827|NCT02573870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102188828|NCT02573870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102188829|NCT02573870|Autonomic Agents|autonomic agents|mesh-ancestor
102188830|NCT02573870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102188831|NCT02573870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188832|NCT02573870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102188833|NCT02573870|Respiratory System Agents|respiratory system agents|mesh-ancestor
102188834|NCT02573870|Dermatologic Agents|dermatologic agents|mesh-ancestor
102188835|NCT02573870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102188836|NCT02573870|Tocolytic Agents|tocolytic agents|mesh-ancestor
102188837|NCT02573870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102188838|NCT02573870|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102188839|NCT02573870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102188840|NCT02573870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102188841|NCT02573870|Adrenergic Agents|adrenergic agents|mesh-ancestor
102188842|NCT02573870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102188843|NCT02573870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188844|NCT05149898|Cannabidiol|cannabidiol|mesh-list
102188845|NCT05149898|Anticonvulsants|anticonvulsants|mesh-ancestor
102188846|NCT05148026|Heparin|heparin|mesh-list
102188847|NCT05148026|Calcium heparin|calcium heparin|mesh-list
102188848|NCT05148026|Dialysis Solutions|dialysis solutions|mesh-list
102188849|NCT05148026|Anticoagulants|anticoagulants|mesh-ancestor
102188850|NCT05148026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102188851|NCT05148026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102188852|NCT05148026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188853|NCT05148026|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102188854|NCT05522270|Mitogens|mitogens|mesh-list
102188855|NCT05522270|Mitosis Modulators|mitosis modulators|mesh-ancestor
102188856|NCT05522270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188857|NCT05522192|Venetoclax|venetoclax|mesh-list
102188858|NCT05522192|Mitoxantrone|mitoxantrone|mesh-list
102188859|NCT05522192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188861|NCT05522192|Sensory System Agents|sensory system agents|mesh-ancestor
102188862|NCT05522192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102188863|NCT05522192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188864|NCT05522192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102188865|NCT05522192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102188866|NCT05522192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102188867|NCT05522192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188868|NCT05522036|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
102188869|NCT05522036|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102188870|NCT05522036|Dermatologic Agents|dermatologic agents|mesh-ancestor
102188871|NCT05515874|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102188872|NCT05515874|Hematinics|hematinics|mesh-ancestor
102188873|NCT05515874|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102188874|NCT05515874|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102188875|NCT05525234|Thalidomide|thalidomide|mesh-list
102188876|NCT05525234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102188877|NCT05525234|Immunologic Factors|immunologic factors|mesh-ancestor
102188878|NCT05525234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188879|NCT05525234|Leprostatic Agents|leprostatic agents|mesh-ancestor
102188880|NCT05525234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102188881|NCT05525234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102188882|NCT05525234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102188883|NCT05525234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102188884|NCT05525234|Growth Substances|growth substances|mesh-ancestor
102188885|NCT05525234|Growth Inhibitors|growth inhibitors|mesh-ancestor
102188886|NCT05525234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188887|NCT02574260|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
102188888|NCT02574260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102188889|NCT02574260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188890|NCT04300790|Metformin|metformin|mesh-list
102188891|NCT04300790|Letrozole|letrozole|mesh-list
102188892|NCT04300790|Fulvestrant|fulvestrant|mesh-list
102188893|NCT04300790|Exemestane|exemestane|mesh-list
102188894|NCT04300790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102188895|NCT04300790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188896|NCT04300790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188897|NCT04300790|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102188898|NCT04300790|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102188899|NCT04300790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102188900|NCT04300790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188901|NCT04300790|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102188902|NCT04300790|Hormone Antagonists|hormone antagonists|mesh-ancestor
102188903|NCT04300790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102188904|NCT04300790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102188905|NCT04300790|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102188906|NCT04295330|Lidocaine|lidocaine|mesh-list
102188907|NCT04295330|Anesthetics, Local|anesthetics, local|mesh-ancestor
102188908|NCT04295330|Anesthetics|anesthetics|mesh-ancestor
102188909|NCT04295330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102188910|NCT04295330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188911|NCT04295330|Sensory System Agents|sensory system agents|mesh-ancestor
102188912|NCT04295330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102188913|NCT04295330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102188914|NCT04295330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102188915|NCT04295330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102188916|NCT04295330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102188917|NCT04295330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188918|NCT05525156|Aspirin|aspirin|mesh-list
102188919|NCT05525156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102188920|NCT05525156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102188921|NCT05525156|Analgesics|analgesics|mesh-ancestor
102188922|NCT05525156|Sensory System Agents|sensory system agents|mesh-ancestor
102188923|NCT05525156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102188924|NCT05525156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188925|NCT05525156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102188926|NCT05525156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102188927|NCT05525156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102188928|NCT05525156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102188929|NCT05525156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188930|NCT05525156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102188931|NCT05525156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102188932|NCT05525156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102188933|NCT05525156|Antipyretics|antipyretics|mesh-ancestor
102188934|NCT05512364|Tamoxifen|tamoxifen|mesh-list
102188935|NCT05512364|Letrozole|letrozole|mesh-list
102188936|NCT05512364|Anastrozole|anastrozole|mesh-list
102188937|NCT05512364|Exemestane|exemestane|mesh-list
102188938|NCT05512364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188939|NCT05512364|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102188940|NCT05512364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102188941|NCT05512364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102188942|NCT05512364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188943|NCT05512364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102188944|NCT05512364|Hormone Antagonists|hormone antagonists|mesh-ancestor
102188945|NCT05512364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102188946|NCT05512364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188947|NCT05512364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102188948|NCT05512364|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102188949|NCT05512364|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102188950|NCT05512364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102188951|NCT05512130|Empagliflozin|empagliflozin|mesh-list
102188952|NCT05512130|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102188953|NCT05512130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188954|NCT05512130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102188955|NCT05512130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188956|NCT02180425|Adapalene|adapalene|mesh-list
102188957|NCT02180425|Tretinoin|tretinoin|mesh-list
102188958|NCT02180425|Isotretinoin|isotretinoin|mesh-list
102188959|NCT02180425|Dermatologic Agents|dermatologic agents|mesh-ancestor
102188960|NCT02180425|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102188961|NCT02180425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102188962|NCT02180425|Analgesics|analgesics|mesh-ancestor
102188963|NCT02180425|Sensory System Agents|sensory system agents|mesh-ancestor
102188964|NCT02180425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102188965|NCT02180425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188966|NCT02180425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102188967|NCT02180425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102188968|NCT02180425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188969|NCT02180425|Keratolytic Agents|keratolytic agents|mesh-ancestor
102188970|NCT02183467|Linagliptin|linagliptin|mesh-list
102188971|NCT02183467|Moxifloxacin|moxifloxacin|mesh-list
102188972|NCT02183467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102188973|NCT02183467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102188974|NCT02183467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102188975|NCT02183467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102188976|NCT02183467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102188977|NCT02183467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188978|NCT02183467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102188979|NCT02183467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188980|NCT02183467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102188981|NCT02183467|Incretins|incretins|mesh-ancestor
102188982|NCT02183467|Hormones|hormones|mesh-ancestor
102188983|NCT02183467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102188984|NCT02183467|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102188985|NCT02183467|Protease Inhibitors|protease inhibitors|mesh-ancestor
102188986|NCT02180503|Linagliptin|linagliptin|mesh-list
102188987|NCT02180503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102188988|NCT02180503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102188989|NCT02180503|Incretins|incretins|mesh-ancestor
102188990|NCT02180503|Hormones|hormones|mesh-ancestor
102188991|NCT02180503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102188992|NCT02180503|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102188993|NCT02180503|Protease Inhibitors|protease inhibitors|mesh-ancestor
102188994|NCT02180503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102188995|NCT02180503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102188996|NCT02177851|Iron|iron|mesh-list
102188997|NCT02177851|Trace Elements|trace elements|mesh-ancestor
102188998|NCT02177851|Micronutrients|micronutrients|mesh-ancestor
102188999|NCT02177851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189000|NCT05075876|Granisetron|granisetron|mesh-list
102189001|NCT05075876|Antiemetics|antiemetics|mesh-ancestor
102189002|NCT05075876|Autonomic Agents|autonomic agents|mesh-ancestor
102189003|NCT05075876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101730754|NCT00847145|Vaccines|vaccines|mesh-list
102189004|NCT05075876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189005|NCT05075876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102189006|NCT05075876|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102189007|NCT05075876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102189008|NCT05075876|Serotonin Agents|serotonin agents|mesh-ancestor
102189009|NCT05075876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102189010|NCT05075876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189011|NCT02180737|Dexmedetomidine|dexmedetomidine|mesh-list
102189012|NCT02180737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102189013|NCT02180737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102189014|NCT02180737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189015|NCT02180737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102189016|NCT02180737|Analgesics|analgesics|mesh-ancestor
102189017|NCT02180737|Sensory System Agents|sensory system agents|mesh-ancestor
102189018|NCT02180737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102189019|NCT02180737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102189020|NCT02180737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102189021|NCT02180737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102189022|NCT02180737|Adrenergic Agents|adrenergic agents|mesh-ancestor
102189023|NCT02180737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102189024|NCT02180737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189025|NCT05520944|Chlorpheniramine|chlorpheniramine|mesh-list
102189026|NCT05520944|Antipruritics|antipruritics|mesh-ancestor
102189027|NCT05520944|Dermatologic Agents|dermatologic agents|mesh-ancestor
102189028|NCT05520944|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102189029|NCT05520944|Histamine Antagonists|histamine antagonists|mesh-ancestor
102189030|NCT05520944|Histamine Agents|histamine agents|mesh-ancestor
102189031|NCT05520944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102189032|NCT05520944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189033|NCT05520944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189034|NCT05520944|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102189035|NCT02183623|Linagliptin|linagliptin|mesh-list
102189036|NCT02183623|Simvastatin|simvastatin|mesh-list
102189037|NCT02183623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102189038|NCT02183623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102189039|NCT02183623|Antimetabolites|antimetabolites|mesh-ancestor
102189040|NCT02183623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189041|NCT02183623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102189042|NCT02183623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102189043|NCT02183623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102189044|NCT02183623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102189045|NCT02183623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189046|NCT02183623|Incretins|incretins|mesh-ancestor
102189047|NCT02183623|Hormones|hormones|mesh-ancestor
102189048|NCT02183623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102189049|NCT02183623|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102189050|NCT02183623|Protease Inhibitors|protease inhibitors|mesh-ancestor
102189051|NCT02183701|Losartan|losartan|mesh-list
102189052|NCT02183701|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102189053|NCT02183701|Telmisartan|telmisartan|mesh-list
102189054|NCT02183701|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102189055|NCT02183701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102189056|NCT02183701|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102189057|NCT02183701|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102189058|NCT02183701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189059|NCT02183701|Diuretics|diuretics|mesh-ancestor
102189060|NCT02183701|Natriuretic Agents|natriuretic agents|mesh-ancestor
102189061|NCT02183701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189062|NCT02183701|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102189063|NCT02183701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102189064|NCT02183779|Fluconazole|fluconazole|mesh-list
102189065|NCT02183779|Antifungal Agents|antifungal agents|mesh-ancestor
102189066|NCT02183779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102189067|NCT02183779|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102189068|NCT02183779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102189069|NCT02183779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102189070|NCT02183779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189071|NCT02183779|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102189072|NCT02183779|Hormone Antagonists|hormone antagonists|mesh-ancestor
102189073|NCT02183779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102189074|NCT02183779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189075|NCT02183779|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102189076|NCT02183779|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102189078|NCT02184091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102189079|NCT02184091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102189080|NCT02184091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102189081|NCT02184091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189082|NCT02184091|Antiviral Agents|antiviral agents|mesh-ancestor
102189083|NCT02184091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102189084|NCT02184091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102189085|NCT02184091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101897897|NCT01251926|Growth Inhibitors|growth inhibitors|mesh-ancestor
102189086|NCT02184091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102189087|NCT02184091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102189089|NCT02184247|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102189090|NCT02184247|Autonomic Agents|autonomic agents|mesh-ancestor
102189091|NCT02184247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102189092|NCT02184247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189093|NCT02184247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102189094|NCT02184247|Respiratory System Agents|respiratory system agents|mesh-ancestor
102189095|NCT02184247|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102189096|NCT02184247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102189097|NCT02184247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189098|NCT02184247|Vasodilator Agents|vasodilator agents|mesh-ancestor
102189099|NCT02184247|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102189100|NCT02184247|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102189101|NCT02184247|Purinergic Agents|purinergic agents|mesh-ancestor
102189102|NCT02184247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102189103|NCT04292756|Triamcinolone|triamcinolone|mesh-list
102189104|NCT04292756|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102189105|NCT04292756|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102189106|NCT04292756|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102189107|NCT04292756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102189108|NCT04292756|Glucocorticoids|glucocorticoids|mesh-ancestor
102189109|NCT04292756|Hormones|hormones|mesh-ancestor
102189110|NCT04292756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102189111|NCT04292756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189112|NCT04292756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102189113|NCT04292756|Immunologic Factors|immunologic factors|mesh-ancestor
102189114|NCT04292756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102189115|NCT04292756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189116|NCT05074706|Antibodies|antibodies|mesh-list
102189117|NCT05074706|Immunoglobulin G|immunoglobulin g|mesh-list
102189118|NCT05074706|Immunologic Factors|immunologic factors|mesh-ancestor
102189119|NCT05074706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189120|NCT02181205|Bupivacaine|bupivacaine|mesh-list
102189121|NCT02181205|Anesthetics, Local|anesthetics, local|mesh-ancestor
102189122|NCT02181205|Anesthetics|anesthetics|mesh-ancestor
102189123|NCT02181205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102189124|NCT02181205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189125|NCT02181205|Sensory System Agents|sensory system agents|mesh-ancestor
102189126|NCT02181205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102189127|NCT02184559|Ropivacaine|ropivacaine|mesh-list
102189128|NCT02184559|Anesthetics, Local|anesthetics, local|mesh-ancestor
102189129|NCT02184559|Anesthetics|anesthetics|mesh-ancestor
102189130|NCT02184559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102189131|NCT02184559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189132|NCT02184559|Sensory System Agents|sensory system agents|mesh-ancestor
102189133|NCT02184559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102189134|NCT02185651|Miglustat|miglustat|mesh-list
101449150|NCT00213486|Irinotecan|irinotecan|mesh-list
102189135|NCT02185651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102189136|NCT02185651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189137|NCT02185651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102189138|NCT02185651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102189139|NCT02185651|Antiviral Agents|antiviral agents|mesh-ancestor
102189140|NCT02185651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102189141|NCT02185651|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102189142|NCT02185651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102189143|NCT02185651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189144|NCT02181361|Aspirin|aspirin|mesh-list
102189145|NCT02181361|Hirudins|hirudins|mesh-list
102189146|NCT02181361|Warfarin|warfarin|mesh-list
102189147|NCT02181361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102189148|NCT02181361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102189149|NCT02181361|Analgesics|analgesics|mesh-ancestor
102189150|NCT02181361|Sensory System Agents|sensory system agents|mesh-ancestor
102189151|NCT02181361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102189152|NCT02181361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189153|NCT02181361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102189154|NCT02181361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102189155|NCT02181361|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102189156|NCT02181361|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102189157|NCT02181361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189158|NCT02181361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102189159|NCT02181361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102189160|NCT02181361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102189161|NCT02181361|Antipyretics|antipyretics|mesh-ancestor
102189162|NCT02181361|Anticoagulants|anticoagulants|mesh-ancestor
102189163|NCT02181361|Antithrombins|antithrombins|mesh-ancestor
102189164|NCT02181361|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102189165|NCT02181361|Protease Inhibitors|protease inhibitors|mesh-ancestor
102189166|NCT05060276|Immunoconjugates|immunoconjugates|mesh-list
102189167|NCT05060276|Immunologic Factors|immunologic factors|mesh-ancestor
102189168|NCT05060276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189169|NCT02184637|Lumefantrine|lumefantrine|mesh-list
102189170|NCT02184637|Artemether|artemether|mesh-list
102189171|NCT02184637|Piperaquine|piperaquine|mesh-list
102189172|NCT02184637|Artenimol|artenimol|mesh-list
102189173|NCT02184637|Tafenoquine|tafenoquine|mesh-list
102189174|NCT02184637|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102189175|NCT02184637|Antimalarials|antimalarials|mesh-ancestor
102189176|NCT02184637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102189177|NCT02184637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102189178|NCT02184637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102189179|NCT04870424|Colchicine|colchicine|mesh-list
102189180|NCT04870424|Gout Suppressants|gout suppressants|mesh-ancestor
102189181|NCT04870424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102189182|NCT04870424|Tubulin Modulators|tubulin modulators|mesh-ancestor
102189183|NCT04870424|Antimitotic Agents|antimitotic agents|mesh-ancestor
102189184|NCT04870424|Mitosis Modulators|mitosis modulators|mesh-ancestor
102189185|NCT04870424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189186|NCT04870424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102189187|NCT03536845|Vitamin D|vitamin d|mesh-list
102189188|NCT03536845|Cholecalciferol|cholecalciferol|mesh-list
102189189|NCT03536845|Vitamins|vitamins|mesh-ancestor
102189190|NCT03536845|Micronutrients|micronutrients|mesh-ancestor
102189191|NCT03536845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189192|NCT03536845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102189193|NCT03536845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102189194|NCT02256709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102189195|NCT02181985|Heparin|heparin|mesh-list
102189196|NCT02181985|Enoxaparin|enoxaparin|mesh-list
102189197|NCT02181985|Tenecteplase|tenecteplase|mesh-list
102189198|NCT02181985|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102189199|NCT02181985|Abciximab|abciximab|mesh-list
102189200|NCT02181985|Anticoagulants|anticoagulants|mesh-ancestor
102189201|NCT02181985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102189202|NCT02181985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102189203|NCT02181985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189204|NCT02181985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102189205|NCT05514080|Insulin|insulin|mesh-list
102189206|NCT05514080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102189207|NCT05514080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189208|NCT02185963|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102189209|NCT02185963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101683210|NCT02716766|Oxaliplatin|oxaliplatin|mesh-list
102189210|NCT02185963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102189211|NCT02185963|Antimetabolites|antimetabolites|mesh-ancestor
102189212|NCT02185963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189213|NCT02185963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102189214|NCT02185963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102189215|NCT02185963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102189216|NCT02186119|Ranibizumab|ranibizumab|mesh-list
102189217|NCT02186119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102189218|NCT02186119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102189219|NCT02186119|Growth Substances|growth substances|mesh-ancestor
102189220|NCT02186119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189221|NCT02186119|Growth Inhibitors|growth inhibitors|mesh-ancestor
102189222|NCT02186119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102189224|NCT02185261|Interferon-alpha|interferon-alpha|mesh-list
102189225|NCT02185261|Interferon alpha-2|interferon alpha-2|mesh-list
102189226|NCT02185261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102189227|NCT02185261|Antiviral Agents|antiviral agents|mesh-ancestor
102189228|NCT02185261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102189229|NCT02185261|Immunologic Factors|immunologic factors|mesh-ancestor
102189230|NCT02185261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189231|NCT02573012|Prednisone|prednisone|mesh-list
102189232|NCT02573012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102189233|NCT02573012|Glucocorticoids|glucocorticoids|mesh-ancestor
102189234|NCT02573012|Hormones|hormones|mesh-ancestor
101898048|NCT03914534|Antimanic Agents|antimanic agents|mesh-ancestor
102189235|NCT02573012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102189236|NCT02573012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189237|NCT02573012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102189238|NCT02573012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102189239|NCT04128176|Omalizumab|omalizumab|mesh-list
102189240|NCT04128176|Rituximab|rituximab|mesh-list
102189241|NCT04128176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102189242|NCT04128176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102189243|NCT04128176|Immunologic Factors|immunologic factors|mesh-ancestor
102189244|NCT04128176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189245|NCT04128176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102189246|NCT04128176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102189247|NCT04128176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102189248|NCT04128176|Respiratory System Agents|respiratory system agents|mesh-ancestor
102189249|NCT02186275|Vitamin D|vitamin d|mesh-list
102189250|NCT02186275|Ergocalciferols|ergocalciferols|mesh-list
102189251|NCT02186275|Cholecalciferol|cholecalciferol|mesh-list
102189252|NCT02186275|Vitamins|vitamins|mesh-list
102189253|NCT02186275|Micronutrients|micronutrients|mesh-ancestor
102189254|NCT02186275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189255|NCT02186275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102189256|NCT02186275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102189257|NCT05117281|Levobupivacaine|levobupivacaine|mesh-list
102189258|NCT05117281|Anesthetics, Local|anesthetics, local|mesh-ancestor
102189259|NCT05117281|Anesthetics|anesthetics|mesh-ancestor
102189260|NCT05117281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102189261|NCT05117281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189262|NCT05117281|Sensory System Agents|sensory system agents|mesh-ancestor
102189263|NCT05117281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102189264|NCT05519072|Ciprofloxacin|ciprofloxacin|mesh-list
102189265|NCT05519072|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102189266|NCT05519072|Cephalexin|cephalexin|mesh-list
102189267|NCT05519072|Fosfomycin|fosfomycin|mesh-list
102189268|NCT05519072|Nitrofurantoin|nitrofurantoin|mesh-list
102189269|NCT05519072|Trimethoprim|trimethoprim|mesh-list
102189270|NCT05519072|Sulfamethoxazole|sulfamethoxazole|mesh-list
102189271|NCT05519072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102189272|NCT05519072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102189273|NCT05519072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102189274|NCT05519072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102189275|NCT05519072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102189276|NCT05519072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189277|NCT05519072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101449156|NCT00190502|Antibodies|antibodies|mesh-list
102189278|NCT05519072|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102189279|NCT05519072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102189280|NCT05519072|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102189281|NCT05519072|Antimalarials|antimalarials|mesh-ancestor
102189282|NCT05519072|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102189283|NCT05519072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102189284|NCT05519072|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102189285|NCT05519072|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102189286|NCT05519072|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102189287|NCT05519072|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102189288|NCT04411706|Capecitabine|capecitabine|mesh-list
102189289|NCT04411706|Apatinib|apatinib|mesh-list
102189290|NCT04411706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102189291|NCT04411706|Antimetabolites|antimetabolites|mesh-ancestor
102189292|NCT04411706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189293|NCT04411706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102189294|NCT04411706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102189295|NCT04411706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102189296|NCT05518994|Bevacizumab|bevacizumab|mesh-list
102189297|NCT05518994|Tislelizumab|tislelizumab|mesh-list
102189298|NCT05518994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102189299|NCT05518994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102189300|NCT05518994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102189301|NCT05518994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102189302|NCT05518994|Growth Substances|growth substances|mesh-ancestor
102189303|NCT05518994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189304|NCT05518994|Growth Inhibitors|growth inhibitors|mesh-ancestor
102189305|NCT02256943|Amitriptyline|amitriptyline|mesh-list
102189306|NCT02256943|Tolterodine Tartrate|tolterodine tartrate|mesh-list
102189307|NCT02256943|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102189308|NCT02256943|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102189309|NCT02256943|Cholinergic Agents|cholinergic agents|mesh-ancestor
102189310|NCT02256943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102189311|NCT02256943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189312|NCT02256943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189313|NCT02256943|Urological Agents|urological agents|mesh-ancestor
102189314|NCT02256943|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102189315|NCT02256943|Antidepressive Agents|antidepressive agents|mesh-ancestor
102189316|NCT02256943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102189317|NCT02256943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102189318|NCT02256943|Analgesics|analgesics|mesh-ancestor
102189319|NCT02256943|Sensory System Agents|sensory system agents|mesh-ancestor
102189320|NCT02256943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102189321|NCT02256943|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102189322|NCT02256943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102189323|NCT02256943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102189324|NCT02256943|Adrenergic Agents|adrenergic agents|mesh-ancestor
102189325|NCT05059951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102189326|NCT05059951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189327|NCT05059951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102189328|NCT05059951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102189329|NCT02186899|Anesthetics|anesthetics|mesh-list
102189330|NCT02186899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102189331|NCT02186899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189332|NCT05510024|Immunomodulating Agents|immunomodulating agents|mesh-list
102189333|NCT05510024|Immunologic Factors|immunologic factors|mesh-ancestor
102189334|NCT05510024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189335|NCT02752633|Allopurinol|allopurinol|mesh-list
102189336|NCT02752633|Febuxostat|febuxostat|mesh-list
102189337|NCT02752633|Antimetabolites|antimetabolites|mesh-ancestor
102189338|NCT02752633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189339|NCT02752633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102189340|NCT02752633|Gout Suppressants|gout suppressants|mesh-ancestor
102189341|NCT02752633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102189342|NCT02752633|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102189343|NCT02752633|Antioxidants|antioxidants|mesh-ancestor
102189344|NCT02752633|Protective Agents|protective agents|mesh-ancestor
102189345|NCT02752633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189346|NCT02191189|Nevirapine|nevirapine|mesh-list
102189347|NCT02191189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102189348|NCT02191189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102189349|NCT02191189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102189350|NCT02191189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189351|NCT02191189|Antiviral Agents|antiviral agents|mesh-ancestor
102189352|NCT02191189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102189353|NCT02191189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102189354|NCT02191189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102189355|NCT02191189|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102189356|NCT02191189|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102189357|NCT05512520|Capecitabine|capecitabine|mesh-list
102189358|NCT05512520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102189359|NCT05512520|Antimetabolites|antimetabolites|mesh-ancestor
102189360|NCT05512520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189361|NCT05512520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102189362|NCT02187133|Rituximab|rituximab|mesh-list
102189363|NCT02187133|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102189364|NCT02187133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102189365|NCT02187133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102189366|NCT02187133|Immunologic Factors|immunologic factors|mesh-ancestor
102189367|NCT02187133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189369|NCT02187133|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102189370|NCT02187133|Alkylating Agents|alkylating agents|mesh-ancestor
102189371|NCT02187133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189372|NCT04411862|Choline|choline|mesh-list
102189373|NCT04411862|Lipotropic Agents|lipotropic agents|mesh-ancestor
102189374|NCT04411862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102189375|NCT04411862|Antimetabolites|antimetabolites|mesh-ancestor
102189376|NCT04411862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189377|NCT04411862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102189378|NCT04411862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102189379|NCT04411862|Nootropic Agents|nootropic agents|mesh-ancestor
102189380|NCT02187211|Minocycline|minocycline|mesh-list
102189381|NCT02187211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102189382|NCT02187211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102189383|NCT04766996|Aspirin|aspirin|mesh-list
102189384|NCT04766996|Acetaminophen|acetaminophen|mesh-list
102189385|NCT04766996|Prednisone|prednisone|mesh-list
102189386|NCT04766996|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102189387|NCT04766996|Meloxicam|meloxicam|mesh-list
102189388|NCT04766996|Diclofenac|diclofenac|mesh-list
102189389|NCT04766996|Lidocaine|lidocaine|mesh-list
102189390|NCT04766996|Pregabalin|pregabalin|mesh-list
102189391|NCT04766996|Tramadol|tramadol|mesh-list
102189392|NCT04766996|Bupivacaine|bupivacaine|mesh-list
102189393|NCT04766996|Propofol|propofol|mesh-list
102189394|NCT04766996|Omeprazole|omeprazole|mesh-list
102189395|NCT04766996|Tranexamic Acid|tranexamic acid|mesh-list
102189396|NCT04766996|Anesthetics, Local|anesthetics, local|mesh-ancestor
102189397|NCT04766996|Anesthetics|anesthetics|mesh-ancestor
102189398|NCT04766996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102189399|NCT04766996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189400|NCT04766996|Sensory System Agents|sensory system agents|mesh-ancestor
102189401|NCT04766996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102189402|NCT04766996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102189403|NCT04766996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102189404|NCT04766996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102189405|NCT04766996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102189406|NCT04766996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189407|NCT04766996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102189408|NCT04766996|Glucocorticoids|glucocorticoids|mesh-ancestor
102189409|NCT04766996|Hormones|hormones|mesh-ancestor
102189410|NCT04766996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102189411|NCT04766996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102189412|NCT04766996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102189413|NCT04766996|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102189414|NCT04766996|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102189415|NCT04766996|Anesthetics, General|anesthetics, general|mesh-ancestor
102189416|NCT04766996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101487418|NCT00428025|Diclofenac|diclofenac|mesh-list
102189417|NCT04766996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102189418|NCT04766996|Analgesics|analgesics|mesh-ancestor
102189419|NCT04766996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102189420|NCT04766996|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102189421|NCT04766996|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102189422|NCT04766996|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102189423|NCT04766996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102189424|NCT04766996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102189425|NCT04766996|Antipyretics|antipyretics|mesh-ancestor
102189426|NCT04766996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102189427|NCT04766996|Anticonvulsants|anticonvulsants|mesh-ancestor
102189428|NCT04766996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102189429|NCT04766996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102189430|NCT04766996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102189431|NCT04766996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102189432|NCT04766996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102189433|NCT04766996|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102189434|NCT04766996|Hemostatics|hemostatics|mesh-ancestor
102189435|NCT04766996|Coagulants|coagulants|mesh-ancestor
102189436|NCT04766996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102189437|NCT04766996|Narcotics|narcotics|mesh-ancestor
102189438|NCT04766996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102189439|NCT04766996|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102189440|NCT04766996|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102189441|NCT02191423|Oxytocin|oxytocin|mesh-list
102189442|NCT02191423|Oxytocics|oxytocics|mesh-ancestor
102189443|NCT02191423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102189444|NCT02191423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189445|NCT05509946|Celecoxib|celecoxib|mesh-list
102189446|NCT05509946|Pregabalin|pregabalin|mesh-list
102189447|NCT05509946|Analgesics|analgesics|mesh-ancestor
102189448|NCT05509946|Sensory System Agents|sensory system agents|mesh-ancestor
102189449|NCT05509946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102189450|NCT05509946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189451|NCT05509946|Anticonvulsants|anticonvulsants|mesh-ancestor
102189452|NCT05509946|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102189453|NCT05509946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102189454|NCT05509946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189455|NCT05509946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102189456|NCT05509946|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102189457|NCT05509946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102189458|NCT05509946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102189459|NCT05509946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102189460|NCT05509946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102189461|NCT05509946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102189462|NCT05509946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102189463|NCT05509946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102189464|NCT05509946|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102189465|NCT05509946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102189466|NCT05509946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102189468|NCT04304209|Oxaliplatin|oxaliplatin|mesh-list
102189469|NCT04304209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102189470|NCT04304209|Antimetabolites|antimetabolites|mesh-ancestor
102189471|NCT04304209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189472|NCT04304209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102189473|NCT02187367|Cyclophosphamide|cyclophosphamide|mesh-list
102189474|NCT02187367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102189475|NCT02187367|Immunologic Factors|immunologic factors|mesh-ancestor
102189476|NCT02187367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189477|NCT02187367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102189478|NCT02187367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102189479|NCT02187367|Alkylating Agents|alkylating agents|mesh-ancestor
102189480|NCT02187367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189481|NCT02187367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102189482|NCT02187367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102189483|NCT02187445|Budesonide|budesonide|mesh-list
102189484|NCT02187445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102189485|NCT02187445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102189486|NCT02187445|Autonomic Agents|autonomic agents|mesh-ancestor
102189487|NCT02187445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102189488|NCT02187445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189489|NCT02187445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102189490|NCT02187445|Respiratory System Agents|respiratory system agents|mesh-ancestor
102189491|NCT02187445|Glucocorticoids|glucocorticoids|mesh-ancestor
102189492|NCT02187445|Hormones|hormones|mesh-ancestor
102189493|NCT02187445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102189494|NCT02187523|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102189495|NCT02187523|Telmisartan|telmisartan|mesh-list
102189496|NCT02187523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102189497|NCT02187523|Diuretics|diuretics|mesh-ancestor
102189498|NCT02187523|Natriuretic Agents|natriuretic agents|mesh-ancestor
102189499|NCT02187523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189500|NCT02187523|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102189501|NCT02187523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102189502|NCT02187523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189503|NCT02187523|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102189504|NCT02187523|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102189505|NCT02187679|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102189506|NCT02187679|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102189507|NCT02187679|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102189508|NCT02187679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102189509|NCT02187679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189510|NCT02187679|Cholinergic Agents|cholinergic agents|mesh-ancestor
102189511|NCT02187679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102189512|NCT02187679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189513|NCT02187679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102189514|NCT02187679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102189515|NCT05507606|Bevacizumab|bevacizumab|mesh-list
102189516|NCT05507606|Carboplatin|carboplatin|mesh-list
102189517|NCT05507606|Pemetrexed|pemetrexed|mesh-list
102189518|NCT05507606|Osimertinib|osimertinib|mesh-list
102189519|NCT05507606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102189520|NCT05507606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102189521|NCT05507606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102189522|NCT05507606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102189523|NCT05507606|Growth Substances|growth substances|mesh-ancestor
102189524|NCT05507606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189525|NCT05507606|Growth Inhibitors|growth inhibitors|mesh-ancestor
102189526|NCT05507606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102189527|NCT05507606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189528|NCT05507606|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102189529|NCT05507606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102189530|NCT05507606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102189531|NCT02191657|Deferiprone|deferiprone|mesh-list
102189532|NCT02191657|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102189533|NCT02191657|Chelating Agents|chelating agents|mesh-ancestor
102189534|NCT02191657|Sequestering Agents|sequestering agents|mesh-ancestor
102189535|NCT02191657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189536|NCT02191891|Afatinib|afatinib|mesh-list
102189537|NCT02191891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101898351|NCT04597918|Growth Substances|growth substances|mesh-ancestor
102189538|NCT02191891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102189539|NCT02191891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102189540|NCT02191891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189542|NCT05507372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102189543|NCT05507372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102189544|NCT05507372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102189545|NCT05507372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189546|NCT05507372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102189547|NCT05507372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102189548|NCT05507372|Dopamine Agents|dopamine agents|mesh-ancestor
102189549|NCT05507372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102189550|NCT05507372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189551|NCT05507372|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102189552|NCT02192203|Diclofenac|diclofenac|mesh-list
102189553|NCT02192203|Menthol|menthol|mesh-list
102189554|NCT02192203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102189555|NCT02192203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102189556|NCT02192203|Analgesics|analgesics|mesh-ancestor
102189557|NCT02192203|Sensory System Agents|sensory system agents|mesh-ancestor
102189558|NCT02192203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102189559|NCT02192203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189560|NCT02192203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102189561|NCT02192203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102189562|NCT02192203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102189563|NCT02192203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102189564|NCT02192203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189565|NCT02192203|Antipruritics|antipruritics|mesh-ancestor
102189566|NCT02192203|Dermatologic Agents|dermatologic agents|mesh-ancestor
102189567|NCT02257021|Ritonavir|ritonavir|mesh-list
102189568|NCT02257021|Tipranavir|tipranavir|mesh-list
102189569|NCT02257021|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102189570|NCT02257021|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102189571|NCT02257021|Protease Inhibitors|protease inhibitors|mesh-ancestor
102189572|NCT02257021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102189573|NCT02257021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189574|NCT02257021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102189575|NCT02257021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102189576|NCT02257021|Antiviral Agents|antiviral agents|mesh-ancestor
102189577|NCT02257021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102189578|NCT02257021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102189579|NCT02257021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102189580|NCT03536065|Analgesics, Opioid|analgesics, opioid|mesh-list
102189581|NCT03536065|Narcotics|narcotics|mesh-ancestor
102189582|NCT03536065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102189583|NCT03536065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189584|NCT03536065|Analgesics|analgesics|mesh-ancestor
102189585|NCT03536065|Sensory System Agents|sensory system agents|mesh-ancestor
102189586|NCT03536065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102189587|NCT02192827|Dexamethasone|dexamethasone|mesh-list
102189588|NCT02192827|Dexamethasone acetate|dexamethasone acetate|mesh-list
102189589|NCT02192827|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102189590|NCT02192827|BB 1101|bb 1101|mesh-list
102189591|NCT02192827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102189592|NCT02192827|Antiemetics|antiemetics|mesh-ancestor
102189593|NCT02192827|Autonomic Agents|autonomic agents|mesh-ancestor
102189594|NCT02192827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102189595|NCT02192827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189596|NCT02192827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102189597|NCT02192827|Glucocorticoids|glucocorticoids|mesh-ancestor
102189599|NCT02192827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102189600|NCT02192827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102189601|NCT02192827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102189602|NCT02192827|Protease Inhibitors|protease inhibitors|mesh-ancestor
102189603|NCT02192827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102189604|NCT02192827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189605|NCT02188225|Fluoxetine|fluoxetine|mesh-list
102189606|NCT02188225|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102189607|NCT02188225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102189608|NCT02188225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102189609|NCT02188225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189610|NCT02188225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102189611|NCT02188225|Serotonin Agents|serotonin agents|mesh-ancestor
102189612|NCT02188225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189613|NCT02188225|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102189614|NCT02188225|Antidepressive Agents|antidepressive agents|mesh-ancestor
102189615|NCT02188225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102189616|NCT02188225|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102189617|NCT02188225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102189618|NCT02188225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102189620|NCT04535089|Dexmedetomidine|dexmedetomidine|mesh-list
102189621|NCT04535089|Anesthetics, Local|anesthetics, local|mesh-ancestor
102189622|NCT04535089|Anesthetics|anesthetics|mesh-ancestor
102189623|NCT04535089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102189624|NCT04535089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189625|NCT04535089|Sensory System Agents|sensory system agents|mesh-ancestor
102189626|NCT04535089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102189627|NCT04535089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102189628|NCT04535089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102189629|NCT04535089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102189630|NCT04535089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102189631|NCT04535089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189632|NCT04535089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102189633|NCT04535089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102189634|NCT04535089|Analgesics|analgesics|mesh-ancestor
102189635|NCT04535089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102189636|NCT04535089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102189637|NCT04535089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102189638|NCT04535089|Adrenergic Agents|adrenergic agents|mesh-ancestor
102189639|NCT04535089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102189640|NCT02188537|Nelfinavir|nelfinavir|mesh-list
102189641|NCT02188537|Dexamethasone|dexamethasone|mesh-list
102189642|NCT02188537|Bortezomib|bortezomib|mesh-list
102189643|NCT02188537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102189644|NCT02188537|Antiemetics|antiemetics|mesh-ancestor
102189645|NCT02188537|Autonomic Agents|autonomic agents|mesh-ancestor
102189646|NCT02188537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102189647|NCT02188537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189648|NCT02188537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102189649|NCT02188537|Glucocorticoids|glucocorticoids|mesh-ancestor
102189650|NCT02188537|Hormones|hormones|mesh-ancestor
102189651|NCT02188537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102189652|NCT02188537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102189653|NCT02188537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102189654|NCT02188537|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102189655|NCT02188537|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102189656|NCT02188537|Protease Inhibitors|protease inhibitors|mesh-ancestor
102189657|NCT02188537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102189658|NCT02188537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189659|NCT02188537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102189660|NCT02188537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102189661|NCT02188537|Antiviral Agents|antiviral agents|mesh-ancestor
102189662|NCT02188537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102189663|NCT03535051|Tacrolimus|tacrolimus|mesh-list
102189664|NCT03535051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102189665|NCT03535051|Immunologic Factors|immunologic factors|mesh-ancestor
102189666|NCT03535051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189667|NCT03535051|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102189668|NCT03535051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102189669|NCT03535051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189670|NCT02188615|Vinorelbine|vinorelbine|mesh-list
102189671|NCT02188615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102189672|NCT02188615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102189673|NCT02188615|Tubulin Modulators|tubulin modulators|mesh-ancestor
102189674|NCT02188615|Antimitotic Agents|antimitotic agents|mesh-ancestor
102189675|NCT02188615|Mitosis Modulators|mitosis modulators|mesh-ancestor
102189676|NCT02188615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189677|NCT02188771|Hyaluronic Acid|hyaluronic acid|mesh-list
102189678|NCT02188771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102189679|NCT02188771|Immunologic Factors|immunologic factors|mesh-ancestor
102189680|NCT02188771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189681|NCT02188771|Viscosupplements|viscosupplements|mesh-ancestor
102189682|NCT02188771|Protective Agents|protective agents|mesh-ancestor
102189683|NCT02194075|Fluvoxamine|fluvoxamine|mesh-list
102189684|NCT02194075|Methylphenidate|methylphenidate|mesh-list
102189685|NCT02194075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102189686|NCT02194075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189687|NCT02194075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102189688|NCT02194075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102189689|NCT02194075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102189690|NCT02194075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189691|NCT02194075|Dopamine Agents|dopamine agents|mesh-ancestor
102189692|NCT02194075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102189693|NCT02194075|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102189694|NCT02194075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102189695|NCT02194075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102189696|NCT02194075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102189697|NCT02194075|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102189698|NCT02194075|Serotonin Agents|serotonin agents|mesh-ancestor
102189699|NCT02194075|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102189700|NCT02194075|Antidepressive Agents|antidepressive agents|mesh-ancestor
102189701|NCT02194075|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102189702|NCT02194075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102189703|NCT02194075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102189704|NCT02194075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102189705|NCT02193217|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102189706|NCT02193217|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102189707|NCT02193217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189708|NCT02193217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102189709|NCT02193217|Immunologic Factors|immunologic factors|mesh-ancestor
102189710|NCT02193217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189712|NCT03534973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102189713|NCT03534973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189714|NCT03534973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102189715|NCT03534973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102189716|NCT03534973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189717|NCT03534973|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102189718|NCT03534973|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102189719|NCT03534973|Purinergic Agents|purinergic agents|mesh-ancestor
102189720|NCT03534973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102189721|NCT03534895|Midazolam|midazolam|mesh-list
102189722|NCT03534895|Anesthetics|anesthetics|mesh-ancestor
102189723|NCT03534895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102189724|NCT03534895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189725|NCT03534895|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102189726|NCT03534895|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102189727|NCT03534895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102189728|NCT03534895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102189729|NCT03534895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102189730|NCT03534895|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102189731|NCT03534895|Anesthetics, General|anesthetics, general|mesh-ancestor
102189732|NCT03534895|GABA Modulators|gaba modulators|mesh-ancestor
102189733|NCT03534895|GABA Agents|gaba agents|mesh-ancestor
102189734|NCT03534895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102189735|NCT03534895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189737|NCT03535753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102189738|NCT03535753|Antimetabolites|antimetabolites|mesh-ancestor
102189739|NCT03535753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189740|NCT03535753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102189741|NCT03535753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102189742|NCT02189395|Insulin|insulin|mesh-list
102189743|NCT02189395|Insulin Lispro|insulin lispro|mesh-list
102189744|NCT02189395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102189745|NCT02189395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102189746|NCT02189395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189747|NCT03535519|Methotrexate|methotrexate|mesh-list
102189748|NCT03535519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102189749|NCT03535519|Abortifacient Agents|abortifacient agents|mesh-ancestor
102189750|NCT03535519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102189751|NCT03535519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189752|NCT03535519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102189753|NCT03535519|Antimetabolites|antimetabolites|mesh-ancestor
102189754|NCT03535519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449209|NCT00213564|Dermatologic Agents|dermatologic agents|mesh-ancestor
102189755|NCT03535519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102189756|NCT03535519|Dermatologic Agents|dermatologic agents|mesh-ancestor
102189757|NCT03535519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102189758|NCT03535519|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102189759|NCT03535519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102189760|NCT03535519|Immunologic Factors|immunologic factors|mesh-ancestor
102189761|NCT03535519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102189762|NCT03535519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102189763|NCT02194153|Tenecteplase|tenecteplase|mesh-list
102189764|NCT02194153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102189765|NCT02194153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102189766|NCT02194153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189767|NCT02194231|Trabectedin|trabectedin|mesh-list
102189768|NCT02194231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102189769|NCT02194231|Alkylating Agents|alkylating agents|mesh-ancestor
102189770|NCT02194231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189771|NCT02194231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102189772|NCT04292054|Cefazolin|cefazolin|mesh-list
102189773|NCT04292054|Tazobactam|tazobactam|mesh-list
102189774|NCT04292054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102189775|NCT04292054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102189776|NCT04292054|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102189777|NCT04292054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102189778|NCT04292054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189779|NCT04291508|Acetaminophen|acetaminophen|mesh-list
102189780|NCT04291508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189781|NCT04291508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102189782|NCT04291508|Analgesics|analgesics|mesh-ancestor
102189783|NCT04291508|Sensory System Agents|sensory system agents|mesh-ancestor
102189784|NCT04291508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102189785|NCT04291508|Antipyretics|antipyretics|mesh-ancestor
102189786|NCT02933671|Ropivacaine|ropivacaine|mesh-list
102189787|NCT02933671|Anesthetics, Local|anesthetics, local|mesh-ancestor
102189788|NCT02933671|Anesthetics|anesthetics|mesh-ancestor
102189789|NCT02933671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102189790|NCT02933671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189791|NCT02933671|Sensory System Agents|sensory system agents|mesh-ancestor
102189792|NCT02933671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102189793|NCT05509478|Lenvatinib|lenvatinib|mesh-list
102189794|NCT05509478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102189795|NCT05509478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102189796|NCT05509478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102189797|NCT05509478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102189798|NCT05509478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189799|NCT05509478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102189800|NCT02194309|Amlodipine|amlodipine|mesh-list
102189801|NCT02194309|Telmisartan|telmisartan|mesh-list
102189802|NCT02194309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102189803|NCT02194309|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102189804|NCT02194309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102189805|NCT02194309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189806|NCT02194309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102189807|NCT02194309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189808|NCT02194309|Vasodilator Agents|vasodilator agents|mesh-ancestor
102189809|NCT02194309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102189810|NCT02194309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102189811|NCT04392505|Durvalumab|durvalumab|mesh-list
102189812|NCT04392505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102189813|NCT04392505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102189814|NCT05502458|Propofol|propofol|mesh-list
102189815|NCT05502458|Desflurane|desflurane|mesh-list
102189816|NCT05502458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102189817|NCT05502458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102189818|NCT05502458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189819|NCT05502458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102189820|NCT05502458|Anesthetics, General|anesthetics, general|mesh-ancestor
102189821|NCT05502458|Anesthetics|anesthetics|mesh-ancestor
102189822|NCT05502458|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102189823|NCT03534037|Febuxostat|febuxostat|mesh-list
102189824|NCT03534037|Benzbromarone|benzbromarone|mesh-list
102189825|NCT03534037|Gout Suppressants|gout suppressants|mesh-ancestor
102189826|NCT03534037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102189827|NCT03534037|Uricosuric Agents|uricosuric agents|mesh-ancestor
102189828|NCT03533959|Alirocumab|alirocumab|mesh-list
102189829|NCT03533959|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102189830|NCT03533959|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102189831|NCT03533959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102189832|NCT03533959|Antimetabolites|antimetabolites|mesh-ancestor
102189833|NCT03533959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189834|NCT03533959|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102189835|NCT03533959|Protease Inhibitors|protease inhibitors|mesh-ancestor
102189836|NCT03533959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102189837|NCT03533959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102189838|NCT05502380|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102189839|NCT05502380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102189841|NCT02567708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102189842|NCT02567708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102189843|NCT02567708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189844|NCT05509244|Acetaminophen|acetaminophen|mesh-list
102189845|NCT05509244|Ibuprofen|ibuprofen|mesh-list
102189846|NCT05509244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102189847|NCT05509244|Analgesics|analgesics|mesh-ancestor
102189848|NCT05509244|Sensory System Agents|sensory system agents|mesh-ancestor
102189849|NCT05509244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102189850|NCT05509244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189851|NCT05509244|Antipyretics|antipyretics|mesh-ancestor
102189852|NCT05509244|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102189853|NCT05509244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102189854|NCT05509244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102189855|NCT05509244|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102189856|NCT05509244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102189857|NCT05509244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189858|NCT05502068|Vitamin D|vitamin d|mesh-list
102189859|NCT05502068|Vitamins|vitamins|mesh-ancestor
102189860|NCT05502068|Micronutrients|micronutrients|mesh-ancestor
102189861|NCT05502068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189862|NCT05502068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102189863|NCT02194777|Olcegepant|olcegepant|mesh-list
102189864|NCT02194777|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
102189865|NCT02194777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189866|NCT02194777|Analgesics|analgesics|mesh-ancestor
102189867|NCT02194777|Sensory System Agents|sensory system agents|mesh-ancestor
102189868|NCT02194777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102189869|NCT02194777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189870|NCT02030977|Resveratrol|resveratrol|mesh-list
102189871|NCT02030977|Antioxidants|antioxidants|mesh-ancestor
102189872|NCT02030977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189873|NCT02030977|Protective Agents|protective agents|mesh-ancestor
102189874|NCT02030977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189875|NCT02030977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102189876|NCT02030977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102189877|NCT02194855|Rocuronium|rocuronium|mesh-list
102189878|NCT02194855|Cisatracurium|cisatracurium|mesh-list
102189879|NCT02194855|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102189880|NCT02194855|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102189881|NCT02194855|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102189882|NCT02194855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102189883|NCT02194855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189884|NCT03534661|Teduglutide|teduglutide|mesh-list
102189885|NCT03534661|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
102189886|NCT03534661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102189887|NCT03534661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189888|NCT03534661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102189889|NCT03534661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102189890|NCT03534661|Protective Agents|protective agents|mesh-ancestor
102189891|NCT03534661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189892|NCT02562716|Paclitaxel|paclitaxel|mesh-list
102189893|NCT02562716|Camptothecin|camptothecin|mesh-list
102189894|NCT02562716|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102189895|NCT02562716|Gemcitabine|gemcitabine|mesh-list
102189896|NCT02562716|Fluorouracil|fluorouracil|mesh-list
102189897|NCT02562716|Oxaliplatin|oxaliplatin|mesh-list
102189898|NCT02562716|Irinotecan|irinotecan|mesh-list
102189899|NCT02562716|Pancrelipase|pancrelipase|mesh-list
102189900|NCT02562716|Pancreatin|pancreatin|mesh-list
102189901|NCT02562716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102189902|NCT02562716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102189903|NCT02562716|Tubulin Modulators|tubulin modulators|mesh-ancestor
102189904|NCT02562716|Antimitotic Agents|antimitotic agents|mesh-ancestor
102189905|NCT02562716|Mitosis Modulators|mitosis modulators|mesh-ancestor
102189906|NCT02562716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189907|NCT02562716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102189909|NCT02562716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102189910|NCT02562716|Immunologic Factors|immunologic factors|mesh-ancestor
102189911|NCT02562716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189912|NCT02562716|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102189913|NCT02562716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102189914|NCT02562716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102189915|NCT02562716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102189916|NCT02031211|Etanercept|etanercept|mesh-list
102189917|NCT02031211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102189918|NCT02031211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102189919|NCT02031211|Analgesics|analgesics|mesh-ancestor
102189920|NCT02031211|Sensory System Agents|sensory system agents|mesh-ancestor
102189921|NCT02031211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102189922|NCT02031211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189923|NCT02031211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102189924|NCT02031211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102189925|NCT02031211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102189926|NCT02031211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102189927|NCT02031211|Immunologic Factors|immunologic factors|mesh-ancestor
102189928|NCT02195089|Vaccines|vaccines|mesh-list
102189929|NCT02195089|Immunologic Factors|immunologic factors|mesh-ancestor
102189930|NCT02195089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189931|NCT02031289|Folic Acid|folic acid|mesh-list
102189932|NCT02031289|Vitamin B 12|vitamin b 12|mesh-list
102189933|NCT02031289|Hydroxocobalamin|hydroxocobalamin|mesh-list
102189934|NCT02031289|Epoetin Alfa|epoetin alfa|mesh-list
102189935|NCT02031289|Vitamins|vitamins|mesh-ancestor
102189936|NCT02031289|Micronutrients|micronutrients|mesh-ancestor
102189937|NCT02031289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189938|NCT02031289|Hematinics|hematinics|mesh-ancestor
102189939|NCT02031289|Vitamin B Complex|vitamin b complex|mesh-ancestor
102189940|NCT02197741|Opiate Alkaloids|opiate alkaloids|mesh-list
102189941|NCT02197741|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102189942|NCT02197741|Narcotics|narcotics|mesh-ancestor
102189943|NCT02197741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102189944|NCT02197741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189945|NCT02197741|Analgesics|analgesics|mesh-ancestor
102189946|NCT02197741|Sensory System Agents|sensory system agents|mesh-ancestor
102189947|NCT02197741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102189948|NCT02196493|Azithromycin|azithromycin|mesh-list
102189949|NCT02196493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102189950|NCT02196493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102189951|NCT05506592|Dermatologic Agents|dermatologic agents|mesh-list
102189953|NCT03533803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102189954|NCT03533803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102189955|NCT03533803|Analgesics|analgesics|mesh-ancestor
102189956|NCT03533803|Sensory System Agents|sensory system agents|mesh-ancestor
102189957|NCT03533803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102189958|NCT03533803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189959|NCT03533803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102189960|NCT03533803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102189961|NCT03533803|Gout Suppressants|gout suppressants|mesh-ancestor
102189962|NCT03533803|Tocolytic Agents|tocolytic agents|mesh-ancestor
102189963|NCT03533803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102189964|NCT03533803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102189965|NCT03533803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102189966|NCT03533803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189967|NCT02198209|Liraglutide|liraglutide|mesh-list
102189968|NCT02198209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102189969|NCT02198209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189970|NCT02198209|Incretins|incretins|mesh-ancestor
102189971|NCT02198209|Hormones|hormones|mesh-ancestor
102189972|NCT02198209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102189973|NCT02031055|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102189974|NCT02195557|Hylan|hylan|mesh-list
102189975|NCT02195557|Viscosupplements|viscosupplements|mesh-ancestor
102189976|NCT02195557|Protective Agents|protective agents|mesh-ancestor
102189977|NCT02195557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189978|NCT02195635|Octreotide|octreotide|mesh-list
102189979|NCT02195635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102189980|NCT02195635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102189981|NCT02195635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102189982|NCT03534505|Ketorolac|ketorolac|mesh-list
102189983|NCT03534505|Bupivacaine|bupivacaine|mesh-list
102189984|NCT03534505|Anesthetics, Local|anesthetics, local|mesh-ancestor
102189985|NCT03534505|Anesthetics|anesthetics|mesh-ancestor
102189986|NCT03534505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102189987|NCT03534505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102189988|NCT03534505|Sensory System Agents|sensory system agents|mesh-ancestor
102189989|NCT03534505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102189990|NCT03534505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102189991|NCT03534505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102189993|NCT03534505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102189994|NCT03534505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102189995|NCT03534505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102189996|NCT03534505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102189997|NCT03534505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102189998|NCT02195791|Pioglitazone|pioglitazone|mesh-list
102189999|NCT02195791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102190000|NCT02195791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190001|NCT02196805|Probucol|probucol|mesh-list
102190002|NCT02196805|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102190003|NCT02196805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102190004|NCT02196805|Antimetabolites|antimetabolites|mesh-ancestor
102190005|NCT02196805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190006|NCT02196805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102190007|NCT02196805|Antioxidants|antioxidants|mesh-ancestor
102190008|NCT02196805|Protective Agents|protective agents|mesh-ancestor
102190009|NCT02196805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190010|NCT02198443|Ritonavir|ritonavir|mesh-list
102190011|NCT02198443|Lopinavir|lopinavir|mesh-list
102190012|NCT02198443|Tenofovir|tenofovir|mesh-list
102190013|NCT02198443|Emtricitabine|emtricitabine|mesh-list
102190014|NCT02198443|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102190015|NCT02198443|Cobicistat|cobicistat|mesh-list
102190016|NCT02198443|Elvitegravir|elvitegravir|mesh-list
102190017|NCT02198443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102190018|NCT02198443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102190019|NCT02198443|Protease Inhibitors|protease inhibitors|mesh-ancestor
102190020|NCT02198443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102190021|NCT02198443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190022|NCT02198443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102190023|NCT02198443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102190024|NCT02198443|Antiviral Agents|antiviral agents|mesh-ancestor
102190025|NCT02198443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102190026|NCT02198443|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102190027|NCT02198443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102190028|NCT02198443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102190029|NCT02198443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102190030|NCT02198443|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102190032|NCT03533179|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102190033|NCT03533179|Esmolol|esmolol|mesh-list
102190034|NCT03533179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102190035|NCT03533179|Hormones|hormones|mesh-ancestor
102190036|NCT03533179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102190037|NCT03533179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190038|NCT03533179|Incretins|incretins|mesh-ancestor
102190039|NCT03533179|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102190040|NCT03533179|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102190041|NCT03533179|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102190042|NCT03533179|Adrenergic Agents|adrenergic agents|mesh-ancestor
102190043|NCT03533179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102190044|NCT03533179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190045|NCT02201407|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102190046|NCT02201407|Antiviral Agents|antiviral agents|mesh-ancestor
102190047|NCT02201407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102190048|NCT05261971|Etodolac|etodolac|mesh-list
102190049|NCT05261971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102190050|NCT05261971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102190051|NCT05261971|Analgesics|analgesics|mesh-ancestor
102190052|NCT05261971|Sensory System Agents|sensory system agents|mesh-ancestor
102190053|NCT05261971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102190054|NCT05261971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190055|NCT05261971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102190056|NCT05261971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102190057|NCT05261971|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102190058|NCT05261971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102190059|NCT05261971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102190060|NCT05261971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190061|NCT02201563|Minocycline|minocycline|mesh-list
102190062|NCT02201563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102190063|NCT02201563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102190064|NCT02206477|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
102190065|NCT02206477|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102190066|NCT02206477|Protective Agents|protective agents|mesh-ancestor
102190067|NCT02206477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190068|NCT02206477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102190069|NCT02206477|Antioxidants|antioxidants|mesh-ancestor
102190070|NCT02206477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190071|NCT02201641|Calcium|calcium|mesh-list
102190072|NCT02201641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102190073|NCT02201641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190074|NCT02206555|Tenofovir|tenofovir|mesh-list
102190075|NCT02206555|Emtricitabine|emtricitabine|mesh-list
102190076|NCT02206555|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102190077|NCT02206555|Antiviral Agents|antiviral agents|mesh-ancestor
102190078|NCT02206555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102190079|NCT02206555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102190080|NCT02206555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102190081|NCT02206555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102190082|NCT02206555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190083|NCT02206555|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102190084|NCT02206555|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102190085|NCT02206711|BMS-955176|bms-955176|mesh-list
102190086|NCT02206711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102190087|NCT02206711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102190088|NCT02206711|Antiviral Agents|antiviral agents|mesh-ancestor
102190089|NCT02206711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102190090|NCT02202187|Gepotidacin|gepotidacin|mesh-list
102190091|NCT02202187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102190092|NCT02202187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102190093|NCT02202187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190094|NCT02202187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102190095|NCT02206789|Cyclosporine|cyclosporine|mesh-list
102190096|NCT02206789|Prednisolone|prednisolone|mesh-list
102190097|NCT02206789|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101900256|NCT01169792|Tamoxifen|tamoxifen|mesh-list
102190098|NCT02206789|Methylprednisolone|methylprednisolone|mesh-list
102190099|NCT02206789|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102190100|NCT02206789|Prednisolone acetate|prednisolone acetate|mesh-list
102190101|NCT02206789|Cyclosporins|cyclosporins|mesh-list
102190102|NCT02206789|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102190103|NCT02206789|Prednisolone phosphate|prednisolone phosphate|mesh-list
102190104|NCT02206789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102190105|NCT02206789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190106|NCT02206789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102190107|NCT02206789|Immunologic Factors|immunologic factors|mesh-ancestor
102190108|NCT02206789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190109|NCT02206789|Antifungal Agents|antifungal agents|mesh-ancestor
102190110|NCT02206789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102190111|NCT02206789|Dermatologic Agents|dermatologic agents|mesh-ancestor
102190112|NCT02206789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102190113|NCT02206789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102190114|NCT02206789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102190115|NCT02206789|Glucocorticoids|glucocorticoids|mesh-ancestor
102190117|NCT02206789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102190118|NCT02206789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102190119|NCT02206789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102190120|NCT02206789|Antiemetics|antiemetics|mesh-ancestor
102190121|NCT02206789|Autonomic Agents|autonomic agents|mesh-ancestor
102190122|NCT02206789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102190123|NCT02206789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102190124|NCT02206789|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102190125|NCT02206789|Protective Agents|protective agents|mesh-ancestor
102190126|NCT03892369|Ethanol|ethanol|mesh-list
102190127|NCT03892369|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102190128|NCT03892369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102190129|NCT03892369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102190130|NCT03892369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190131|NCT02206867|Adalimumab|adalimumab|mesh-list
102190132|NCT02206867|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102190133|NCT02206867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102190134|NCT02206867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102190135|NCT02751931|Mirabegron|mirabegron|mesh-list
102190136|NCT02751931|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102190137|NCT02751931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102190138|NCT02751931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102190139|NCT02751931|Adrenergic Agents|adrenergic agents|mesh-ancestor
102190140|NCT02751931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102190141|NCT02751931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190142|NCT02751931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190143|NCT02751931|Urological Agents|urological agents|mesh-ancestor
102190144|NCT05261581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102190145|NCT05261581|Analgesics|analgesics|mesh-list
102190146|NCT05261581|Sensory System Agents|sensory system agents|mesh-ancestor
102190147|NCT05261581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102190148|NCT05261581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190149|NCT02199223|Panitumumab|panitumumab|mesh-list
102190150|NCT02199223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102190151|NCT02199223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102190152|NCT02207335|Carboplatin|carboplatin|mesh-list
102190153|NCT02207335|Gemcitabine|gemcitabine|mesh-list
102190154|NCT02207335|Capecitabine|capecitabine|mesh-list
102190155|NCT02207335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102190156|NCT02207335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102190157|NCT02207335|Antimetabolites|antimetabolites|mesh-ancestor
102190158|NCT02207335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190159|NCT02561078|Insulin|insulin|mesh-list
102190160|NCT02561078|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102190161|NCT02561078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102190162|NCT02561078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190163|NCT02202889|Calcium|calcium|mesh-list
102190164|NCT02202889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101900257|NCT01169792|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102190165|NCT02202889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190167|NCT04058197|Siderophores|siderophores|mesh-ancestor
102190168|NCT04058197|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102190169|NCT04058197|Chelating Agents|chelating agents|mesh-ancestor
102190170|NCT04058197|Sequestering Agents|sequestering agents|mesh-ancestor
102190171|NCT04058197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190172|NCT02202967|Misoprostol|misoprostol|mesh-list
102190173|NCT02202967|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102190174|NCT02202967|Abortifacient Agents|abortifacient agents|mesh-ancestor
102190175|NCT02202967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102190176|NCT02202967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190177|NCT02202967|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102190178|NCT02202967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102190179|NCT02202967|Oxytocics|oxytocics|mesh-ancestor
102190180|NCT05977738|Pitavastatin|pitavastatin|mesh-list
102190181|NCT05977738|Calcium|calcium|mesh-list
102190182|NCT05977738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102190183|NCT05977738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190184|NCT05977738|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102190185|NCT05977738|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102190186|NCT05977738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102190187|NCT05977738|Antimetabolites|antimetabolites|mesh-ancestor
102190188|NCT05977738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190189|NCT05977738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102190190|NCT05977738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102190191|NCT05977699|Albuterol|albuterol|mesh-list
102190192|NCT05977699|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102190193|NCT05977699|Autonomic Agents|autonomic agents|mesh-ancestor
102190194|NCT05977699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102190195|NCT05977699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190196|NCT05977699|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102190197|NCT05977699|Respiratory System Agents|respiratory system agents|mesh-ancestor
102190198|NCT05977699|Tocolytic Agents|tocolytic agents|mesh-ancestor
102190199|NCT05977699|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102190200|NCT05977699|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102190201|NCT05977699|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102190202|NCT05977699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102190203|NCT05977699|Adrenergic Agents|adrenergic agents|mesh-ancestor
102190204|NCT05977699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102190205|NCT05977699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190206|NCT05977647|Tamsulosin|tamsulosin|mesh-list
102190207|NCT05977647|Silodosin|silodosin|mesh-list
102190208|NCT05977647|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102190209|NCT05977647|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102190211|NCT05977647|Adrenergic Agents|adrenergic agents|mesh-ancestor
102190212|NCT05977647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102190213|NCT05977647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190214|NCT05977647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190215|NCT05977647|Urological Agents|urological agents|mesh-ancestor
102190216|NCT05977465|Empagliflozin|empagliflozin|mesh-list
102190217|NCT05977465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102190218|NCT05977465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190219|NCT05977465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102190220|NCT05977465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190221|NCT05977400|Gentamicins|gentamicins|mesh-list
102190222|NCT05977400|Ampicillin|ampicillin|mesh-list
102190223|NCT05977400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102190224|NCT05977400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102190225|NCT05977400|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102190226|NCT05977400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102190227|NCT05977400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190228|NCT05977101|Antibodies|antibodies|mesh-list
102190229|NCT05977101|Immunoglobulins|immunoglobulins|mesh-list
102190230|NCT05977101|Antibodies, Blocking|antibodies, blocking|mesh-list
102190231|NCT05977101|Immunologic Factors|immunologic factors|mesh-ancestor
102190232|NCT05977101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190233|NCT05976932|Doxorubicin|doxorubicin|mesh-list
102190234|NCT05976932|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102190235|NCT05976932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102190236|NCT05976932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102190237|NCT05976932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102190238|NCT05976932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102190239|NCT05976932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102190240|NCT05976932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190241|NCT05976893|Evolocumab|evolocumab|mesh-list
102190242|NCT05976893|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102190243|NCT05976893|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102190244|NCT05976893|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102190245|NCT05976893|Antimetabolites|antimetabolites|mesh-ancestor
102190246|NCT05976893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190247|NCT05976893|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102190248|NCT05976893|Protease Inhibitors|protease inhibitors|mesh-ancestor
102190249|NCT05976893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102190250|NCT05976893|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102190251|NCT05976828|Vaccines|vaccines|mesh-list
102190252|NCT05976828|Immunologic Factors|immunologic factors|mesh-ancestor
102190253|NCT05976828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190254|NCT05976802|Budesonide|budesonide|mesh-list
102190255|NCT05976802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102190256|NCT05976802|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102190257|NCT05976802|Autonomic Agents|autonomic agents|mesh-ancestor
102190258|NCT05976802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102190259|NCT05976802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190260|NCT05976802|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102190261|NCT05976802|Respiratory System Agents|respiratory system agents|mesh-ancestor
102190262|NCT05976802|Glucocorticoids|glucocorticoids|mesh-ancestor
102190263|NCT05976802|Hormones|hormones|mesh-ancestor
102190264|NCT05976802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102190277|NCT05976737|Levodopa|levodopa|mesh-list
102190278|NCT05976737|Carbidopa|carbidopa|mesh-list
102190279|NCT05976737|Entacapone|entacapone|mesh-list
102190280|NCT05976737|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102190281|NCT05976737|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102190282|NCT05976737|Dopamine Agents|dopamine agents|mesh-ancestor
102190283|NCT05976737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102190284|NCT05976737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190285|NCT05976737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190286|NCT05976737|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102190287|NCT05976737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102190288|NCT05976737|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102190289|NCT05976698|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
102190290|NCT05976698|Hallucinogens|hallucinogens|mesh-ancestor
102190291|NCT05976698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190292|NCT05976698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102190293|NCT05976698|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102190294|NCT05976698|Serotonin Agents|serotonin agents|mesh-ancestor
102190295|NCT05976698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102190296|NCT05976698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190297|NCT05976698|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102190298|NCT05976685|Clopidogrel|clopidogrel|mesh-list
102190299|NCT05976685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102190300|NCT05976685|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102190301|NCT05976685|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102190302|NCT05976685|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102190303|NCT05976685|Purinergic Agents|purinergic agents|mesh-ancestor
102190304|NCT05976685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102190305|NCT05976685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190306|NCT05976685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190307|NCT05976568|Bevacizumab|bevacizumab|mesh-list
102190308|NCT05976568|Capecitabine|capecitabine|mesh-list
102190309|NCT05976568|Oxaliplatin|oxaliplatin|mesh-list
102190310|NCT05976568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102190311|NCT05976568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102190312|NCT05976568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102190313|NCT05976568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102190314|NCT05976568|Growth Substances|growth substances|mesh-ancestor
102190315|NCT05976568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190316|NCT05976568|Growth Inhibitors|growth inhibitors|mesh-ancestor
102190317|NCT05976568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102190318|NCT05976568|Antimetabolites|antimetabolites|mesh-ancestor
102190319|NCT05976568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190320|NCT05976464|Magnesium Sulfate|magnesium sulfate|mesh-list
102190321|NCT05976464|Analgesics|analgesics|mesh-ancestor
102190322|NCT05976464|Sensory System Agents|sensory system agents|mesh-ancestor
102190323|NCT05976464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102190324|NCT05976464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190325|NCT05976464|Anesthetics|anesthetics|mesh-ancestor
102190326|NCT05976464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102190327|NCT05976464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102190328|NCT05976464|Anticonvulsants|anticonvulsants|mesh-ancestor
102190329|NCT05976464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102190330|NCT05976464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101449254|NCT00220818|Lansoprazole|lansoprazole|mesh-list
102190331|NCT05976464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190332|NCT05976464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102190333|NCT05976464|Tocolytic Agents|tocolytic agents|mesh-ancestor
102190334|NCT05976464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102190335|NCT05976451|Melatonin|melatonin|mesh-list
102190336|NCT05976451|Antioxidants|antioxidants|mesh-ancestor
102190337|NCT05976451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190338|NCT05976451|Protective Agents|protective agents|mesh-ancestor
102190339|NCT05976451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190340|NCT05976451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102190341|NCT05976438|Amlodipine|amlodipine|mesh-list
102190342|NCT05976438|Chlorthalidone|chlorthalidone|mesh-list
102190343|NCT05976438|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102190344|NCT05976438|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102190345|NCT05976438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102190346|NCT05976438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190347|NCT05976438|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102190348|NCT05976438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190349|NCT05976438|Vasodilator Agents|vasodilator agents|mesh-ancestor
102190350|NCT05976438|Diuretics|diuretics|mesh-ancestor
102190351|NCT05976438|Natriuretic Agents|natriuretic agents|mesh-ancestor
102190352|NCT05976438|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102190353|NCT05976360|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102190354|NCT05976360|Immunologic Factors|immunologic factors|mesh-ancestor
102190355|NCT05976360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190360|NCT05976230|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102190361|NCT05976230|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102190362|NCT05976230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190363|NCT05976217|Venetoclax|venetoclax|mesh-list
102190364|NCT05976217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102190365|NCT05976152|3-n-butylphthalide|3-n-butylphthalide|mesh-list
102190366|NCT05976152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102190367|NCT05976152|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102190368|NCT05976152|Protective Agents|protective agents|mesh-ancestor
102190369|NCT05976152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190370|NCT05976126|Trace Elements|trace elements|mesh-list
102190371|NCT05976126|Micronutrients|micronutrients|mesh-list
102190372|NCT05976126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190373|NCT05975996|Cyclophosphamide|cyclophosphamide|mesh-list
102190374|NCT05975996|Immunosuppressive Agents|immunosuppressive agents|mesh-list
102190375|NCT05975996|Immunologic Factors|immunologic factors|mesh-ancestor
102190376|NCT05975996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190377|NCT05975996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102190378|NCT05975996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102190379|NCT05975996|Alkylating Agents|alkylating agents|mesh-ancestor
101900266|NCT01169402|Fluconazole|fluconazole|mesh-list
102190380|NCT05975996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190381|NCT05975996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102190382|NCT05975996|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102190383|NCT05975944|Olaparib|olaparib|mesh-list
102190384|NCT05975944|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102190385|NCT05975944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102190386|NCT05975944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190387|NCT05975944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102190388|NCT05975879|Vitamin D|vitamin d|mesh-list
102190389|NCT05975879|Cholecalciferol|cholecalciferol|mesh-list
102190390|NCT05975879|Vitamins|vitamins|mesh-list
102190391|NCT05975879|Dimethyl sulfone|dimethyl sulfone|mesh-list
102190392|NCT05975879|Micronutrients|micronutrients|mesh-ancestor
102190393|NCT05975879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190394|NCT05975879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102190395|NCT05975879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102190396|NCT05975879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102190397|NCT05975866|Curcumin|curcumin|mesh-list
102190398|NCT05975866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102190399|NCT05975866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102190400|NCT05975866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102190401|NCT05975866|Analgesics|analgesics|mesh-ancestor
101449261|NCT00213759|Lenograstim|lenograstim|mesh-list
102190402|NCT05975866|Sensory System Agents|sensory system agents|mesh-ancestor
102190403|NCT05975866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102190404|NCT05975866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190405|NCT05975866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102190406|NCT05975866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102190407|NCT05975866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102190408|NCT05975866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190409|NCT05975684|Baclofen|baclofen|mesh-list
102190410|NCT05975684|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102190411|NCT05975684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190412|NCT05975684|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102190413|NCT05975684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102190414|NCT05975684|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102190415|NCT05975684|GABA Agonists|gaba agonists|mesh-ancestor
102190416|NCT05975684|GABA Agents|gaba agents|mesh-ancestor
102190417|NCT05975684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102190418|NCT05975684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190419|NCT05975671|Vancomycin|vancomycin|mesh-list
102190420|NCT05975671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102190421|NCT05975671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102190422|NCT05975580|Topiramate|topiramate|mesh-list
102190423|NCT05975580|Phentermine|phentermine|mesh-list
102190424|NCT05975580|Anticonvulsants|anticonvulsants|mesh-ancestor
102190425|NCT05975580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102190426|NCT05975580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190427|NCT05975580|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102190428|NCT05975580|Appetite Depressants|appetite depressants|mesh-ancestor
102190429|NCT05975580|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102190430|NCT05975580|Sympathomimetics|sympathomimetics|mesh-ancestor
102190431|NCT05975580|Autonomic Agents|autonomic agents|mesh-ancestor
102190432|NCT05975580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102190433|NCT05975580|Adrenergic Agents|adrenergic agents|mesh-ancestor
102190434|NCT05975580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102190435|NCT05975580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190437|NCT05975554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102190438|NCT05975554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102190439|NCT05975554|Analgesics|analgesics|mesh-ancestor
102190440|NCT05975554|Sensory System Agents|sensory system agents|mesh-ancestor
102190441|NCT05975554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102190442|NCT05975554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190443|NCT05975528|Glimepiride|glimepiride|mesh-list
102190444|NCT05975528|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102190445|NCT05975528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102190446|NCT05975528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102190447|NCT05975528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190448|NCT05975528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102190449|NCT05975528|Immunologic Factors|immunologic factors|mesh-ancestor
102190450|NCT05975528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190451|NCT05974124|Chlorhexidine|chlorhexidine|mesh-list
102190452|NCT05974124|Povidone-Iodine|povidone-iodine|mesh-list
102190453|NCT05974124|Povidone|povidone|mesh-list
102190454|NCT05974124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102190455|NCT05974124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102190456|NCT05974124|Disinfectants|disinfectants|mesh-ancestor
102190457|NCT05974124|Plasma Substitutes|plasma substitutes|mesh-ancestor
102190458|NCT05974124|Blood Substitutes|blood substitutes|mesh-ancestor
102190460|NCT05969054|Levetiracetam|levetiracetam|mesh-list
102190461|NCT05969054|Anticonvulsants|anticonvulsants|mesh-ancestor
102190462|NCT05969054|Nootropic Agents|nootropic agents|mesh-ancestor
102190463|NCT05969054|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102190464|NCT05969054|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102190465|NCT05969054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102190466|NCT05969054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190467|NCT05957107|Antibodies|antibodies|mesh-list
102190468|NCT05957107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102190469|NCT05957107|Immunologic Factors|immunologic factors|mesh-ancestor
102190470|NCT05957107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190471|NCT05924880|Durvalumab|durvalumab|mesh-list
102190472|NCT05924880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102190473|NCT05924880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101449265|NCT00190853|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102190474|NCT05924594|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
102190475|NCT05924594|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102190476|NCT05924594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190477|NCT05924594|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102190478|NCT05924594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102190479|NCT05924594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102190480|NCT05924594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190481|NCT05924594|Dopamine Agents|dopamine agents|mesh-ancestor
102190482|NCT05924594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102190483|NCT05900388|Rivaroxaban|rivaroxaban|mesh-list
102190484|NCT05900388|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102190485|NCT05900388|Antithrombins|antithrombins|mesh-ancestor
102190486|NCT05900388|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102190487|NCT05900388|Protease Inhibitors|protease inhibitors|mesh-ancestor
102190488|NCT05900388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102190489|NCT05900388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190490|NCT05900388|Anticoagulants|anticoagulants|mesh-ancestor
102190491|NCT05892341|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102190492|NCT05892341|Laxatives|laxatives|mesh-ancestor
102190493|NCT05892341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102190494|NCT05876351|Eculizumab|eculizumab|mesh-list
102190495|NCT05876351|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102190496|NCT05876351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102190497|NCT05876351|Immunologic Factors|immunologic factors|mesh-ancestor
102190498|NCT05876351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190499|NCT05866536|BCG Vaccine|bcg vaccine|mesh-list
102190500|NCT05866536|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102190501|NCT05866536|Immunologic Factors|immunologic factors|mesh-ancestor
102190502|NCT05866536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190503|NCT05849298|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102190504|NCT05849298|177Lu-PSMA-617|177lu-psma-617|mesh-list
101899320|NCT03879746|Antidepressive Agents|antidepressive agents|mesh-ancestor
102190505|NCT05849298|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102190506|NCT05849298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190507|NCT05848128|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102190508|NCT05848128|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102190509|NCT05799755|Nintedanib|nintedanib|mesh-list
102190510|NCT05799755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102190511|NCT05799755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102190512|NCT05799755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102190513|NCT05799755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190514|NCT05796661|Citric Acid|citric acid|mesh-list
102190515|NCT05796661|Sodium Citrate|sodium citrate|mesh-list
102190516|NCT05796661|Anticoagulants|anticoagulants|mesh-ancestor
102190517|NCT05796661|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102190518|NCT05796661|Chelating Agents|chelating agents|mesh-ancestor
102190519|NCT05796661|Sequestering Agents|sequestering agents|mesh-ancestor
102190520|NCT05796661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190521|NCT05790525|Bismuth|bismuth|mesh-list
102190522|NCT05790525|Antacids|antacids|mesh-ancestor
102190523|NCT05790525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190524|NCT05790525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102190525|NCT05757310|Vidarabine|vidarabine|mesh-list
102190526|NCT05757310|Cyclophosphamide|cyclophosphamide|mesh-list
102190527|NCT05757310|Pentostatin|pentostatin|mesh-list
102190528|NCT05757310|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102190529|NCT05757310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102190530|NCT05757310|Immunologic Factors|immunologic factors|mesh-ancestor
102190531|NCT05757310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190532|NCT05757310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102190533|NCT05757310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102190534|NCT05757310|Alkylating Agents|alkylating agents|mesh-ancestor
102190535|NCT05757310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190536|NCT05757310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102190537|NCT05757310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102190538|NCT05757310|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
102190539|NCT05757310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102190540|NCT05757310|Antimetabolites|antimetabolites|mesh-ancestor
102190541|NCT05757310|Antiviral Agents|antiviral agents|mesh-ancestor
102190542|NCT05757310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102190543|NCT05751668|Paclitaxel|paclitaxel|mesh-list
102190544|NCT05751668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102190545|NCT05751668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102190546|NCT05751668|Tubulin Modulators|tubulin modulators|mesh-ancestor
102190547|NCT05751668|Antimitotic Agents|antimitotic agents|mesh-ancestor
102190548|NCT05751668|Mitosis Modulators|mitosis modulators|mesh-ancestor
102190549|NCT05751668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190550|NCT05737628|Rituximab|rituximab|mesh-list
102190551|NCT05737628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102190552|NCT05737628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102190553|NCT05737628|Immunologic Factors|immunologic factors|mesh-ancestor
102190554|NCT05737628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190555|NCT05737628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102190556|NCT05710406|Cetuximab|cetuximab|mesh-list
102190557|NCT05710406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102190558|NCT05710406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102190559|NCT05685277|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102190560|NCT05685277|Ramipril|ramipril|mesh-list
102190561|NCT05685277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102190562|NCT05685277|Diuretics|diuretics|mesh-ancestor
102190563|NCT05685277|Natriuretic Agents|natriuretic agents|mesh-ancestor
102190564|NCT05685277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190565|NCT05685277|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102190566|NCT05685277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102190567|NCT05685277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190568|NCT05685277|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102190569|NCT05685277|Protease Inhibitors|protease inhibitors|mesh-ancestor
102190570|NCT05685277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102190571|NCT05678348|Pyrimethamine|pyrimethamine|mesh-list
102190572|NCT05678348|Antimalarials|antimalarials|mesh-ancestor
102190573|NCT05678348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102190574|NCT05678348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102190575|NCT05678348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102190576|NCT05678348|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102190577|NCT05678348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102190578|NCT05678348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190579|NCT05668585|Trametinib|trametinib|mesh-list
102190580|NCT05668585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102190581|NCT05668585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102190582|NCT05668585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102190583|NCT05668585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190584|NCT05667285|Sirolimus|sirolimus|mesh-list
102190585|NCT05667285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102190586|NCT05667285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102190587|NCT05667285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102190588|NCT05667285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102190589|NCT05667285|Antifungal Agents|antifungal agents|mesh-ancestor
102190590|NCT05667285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102190591|NCT05667285|Immunologic Factors|immunologic factors|mesh-ancestor
102190592|NCT05667285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190593|NCT05642780|Pembrolizumab|pembrolizumab|mesh-list
102190594|NCT05642780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102190595|NCT05642780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102190596|NCT05642780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102190597|NCT05642780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190598|NCT05627635|Calcium, Dietary|calcium, dietary|mesh-list
102190599|NCT05627635|Leucovorin|leucovorin|mesh-list
102190600|NCT05627635|Folic Acid|folic acid|mesh-list
102190601|NCT05627635|Bevacizumab|bevacizumab|mesh-list
102190602|NCT05627635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102190603|NCT05627635|Fluorouracil|fluorouracil|mesh-list
102190604|NCT05627635|Oxaliplatin|oxaliplatin|mesh-list
102190605|NCT05627635|Endothelial Growth Factors|endothelial growth factors|mesh-list
102190606|NCT05627635|Antibodies|antibodies|mesh-list
102190607|NCT05627635|Immunoglobulins|immunoglobulins|mesh-list
102190608|NCT05627635|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102190609|NCT05627635|Immunoglobulin G|immunoglobulin g|mesh-list
102190610|NCT05627635|Calcium|calcium|mesh-list
102190611|NCT05627635|Levoleucovorin|levoleucovorin|mesh-list
102190612|NCT05627635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102190613|NCT05627635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102190614|NCT05627635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102190615|NCT05627635|Growth Substances|growth substances|mesh-ancestor
102190616|NCT05627635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190617|NCT05627635|Growth Inhibitors|growth inhibitors|mesh-ancestor
102190618|NCT05627635|Immunologic Factors|immunologic factors|mesh-ancestor
102190619|NCT05627635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102190620|NCT05627635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102190621|NCT05627635|Antimetabolites|antimetabolites|mesh-ancestor
102190622|NCT05627635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190623|NCT05627635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102190624|NCT05627635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102190625|NCT05627635|Antidotes|antidotes|mesh-ancestor
102190626|NCT05627635|Protective Agents|protective agents|mesh-ancestor
102190627|NCT05627635|Vitamin B Complex|vitamin b complex|mesh-ancestor
102190628|NCT05627635|Vitamins|vitamins|mesh-ancestor
102190629|NCT05627635|Micronutrients|micronutrients|mesh-ancestor
102190630|NCT05627635|Hematinics|hematinics|mesh-ancestor
102190631|NCT05603702|Lacosamide|lacosamide|mesh-list
102190632|NCT05603702|Anticonvulsants|anticonvulsants|mesh-ancestor
102190633|NCT05603702|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102190634|NCT05603702|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102190635|NCT05603702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102190636|NCT05603702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190637|NCT05601440|Gemcitabine|gemcitabine|mesh-list
102190638|NCT05601440|Fulvestrant|fulvestrant|mesh-list
102190639|NCT05601440|Niraparib|niraparib|mesh-list
102190640|NCT05601440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102190641|NCT05601440|Antimetabolites|antimetabolites|mesh-ancestor
102190642|NCT05601440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190643|NCT05601440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102190644|NCT05601440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102190645|NCT05601440|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102190646|NCT05601440|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102190647|NCT05601440|Hormone Antagonists|hormone antagonists|mesh-ancestor
102190648|NCT05601440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102190649|NCT05601440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190650|NCT05601440|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102190651|NCT05601440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102190652|NCT05590598|Azelastine|azelastine|mesh-list
102190653|NCT05590598|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102190654|NCT05590598|Autonomic Agents|autonomic agents|mesh-ancestor
102190655|NCT05590598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102190656|NCT05590598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190657|NCT05590598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102190658|NCT05590598|Respiratory System Agents|respiratory system agents|mesh-ancestor
102190659|NCT05590598|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
102190661|NCT05590598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190662|NCT05590598|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102190663|NCT05590598|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102190664|NCT05590598|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102190665|NCT05590598|Histamine Antagonists|histamine antagonists|mesh-ancestor
102190666|NCT05590598|Histamine Agents|histamine agents|mesh-ancestor
102190667|NCT05590598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102190676|NCT05546866|Osimertinib|osimertinib|mesh-list
102190677|NCT05546866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102190678|NCT05546866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102190679|NCT05546866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102190680|NCT05546866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190681|NCT05524935|Pembrolizumab|pembrolizumab|mesh-list
102190682|NCT05524935|Olaparib|olaparib|mesh-list
102190683|NCT05524935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102190684|NCT05524935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102190685|NCT05524935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102190686|NCT05524935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190687|NCT05524935|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102190688|NCT05524935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102190689|NCT05507775|Digoxin|digoxin|mesh-list
102190690|NCT05507775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102190691|NCT05507775|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102190692|NCT05507775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102190693|NCT05507775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190694|NCT05507775|Protective Agents|protective agents|mesh-ancestor
102190695|NCT05507775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190696|NCT05503797|Cobicistat|cobicistat|mesh-list
102190697|NCT05503797|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102190698|NCT05503797|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102190699|NCT05503797|Antiviral Agents|antiviral agents|mesh-ancestor
102190700|NCT05503797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102190701|NCT05503797|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102190702|NCT05503797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102190703|NCT05503797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102190704|NCT05503797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190705|NCT05495945|Propofol|propofol|mesh-list
102190706|NCT05495945|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102190707|NCT05495945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102190708|NCT05495945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190709|NCT05495945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102190710|NCT05495945|Anesthetics, General|anesthetics, general|mesh-ancestor
102190711|NCT05495945|Anesthetics|anesthetics|mesh-ancestor
102190712|NCT05450692|Docetaxel|docetaxel|mesh-list
102190713|NCT05450692|Durvalumab|durvalumab|mesh-list
102190714|NCT05450692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102190715|NCT05450692|Tubulin Modulators|tubulin modulators|mesh-ancestor
102190716|NCT05450692|Antimitotic Agents|antimitotic agents|mesh-ancestor
102190717|NCT05450692|Mitosis Modulators|mitosis modulators|mesh-ancestor
102190718|NCT05450692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190719|NCT05450692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102190720|NCT05441592|Tranexamic Acid|tranexamic acid|mesh-list
102190721|NCT05441592|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102190722|NCT05441592|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102190723|NCT05441592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190724|NCT05441592|Hemostatics|hemostatics|mesh-ancestor
102190725|NCT05441592|Coagulants|coagulants|mesh-ancestor
102190726|NCT05430152|Naltrexone|naltrexone|mesh-list
102190727|NCT05430152|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102190728|NCT05430152|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102190729|NCT05430152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190730|NCT05430152|Sensory System Agents|sensory system agents|mesh-ancestor
102190731|NCT05430152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102190732|NCT05406505|Dapagliflozin|dapagliflozin|mesh-list
102190733|NCT05406505|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102190734|NCT05406505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190735|NCT05406505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102190736|NCT05406505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190738|NCT05398094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102190739|NCT05398094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190740|NCT05398094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102190741|NCT05398094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102190742|NCT05354778|Hydrocortisone|hydrocortisone|mesh-list
102190743|NCT05354778|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102190744|NCT05354778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102190745|NCT05331183|Ivacaftor|ivacaftor|mesh-list
102190746|NCT05331183|Elexacaftor|elexacaftor|mesh-list
102190747|NCT05331183|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102190748|NCT05331183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102190749|NCT05331183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190750|NCT05325632|Paclitaxel|paclitaxel|mesh-list
102190751|NCT05325632|Trastuzumab|trastuzumab|mesh-list
102190752|NCT05325632|Pertuzumab|pertuzumab|mesh-list
102190753|NCT05325632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101449298|NCT00190892|Analgesics|analgesics|mesh-ancestor
102190754|NCT05325632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102190755|NCT05325632|Tubulin Modulators|tubulin modulators|mesh-ancestor
102190756|NCT05325632|Antimitotic Agents|antimitotic agents|mesh-ancestor
102190757|NCT05325632|Mitosis Modulators|mitosis modulators|mesh-ancestor
102190758|NCT05325632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190759|NCT05325632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102190760|NCT05309928|Amoxicillin|amoxicillin|mesh-list
102190761|NCT05309928|Probenecid|probenecid|mesh-list
102190762|NCT05309928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102190763|NCT05309928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102190764|NCT05309928|Uricosuric Agents|uricosuric agents|mesh-ancestor
102190765|NCT05309928|Gout Suppressants|gout suppressants|mesh-ancestor
102190766|NCT05309928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102190767|NCT05298592|Paclitaxel|paclitaxel|mesh-list
102190768|NCT05298592|Carboplatin|carboplatin|mesh-list
102190769|NCT05298592|Nivolumab|nivolumab|mesh-list
102190770|NCT05298592|Pemetrexed|pemetrexed|mesh-list
102190771|NCT05298592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102190772|NCT05298592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102190773|NCT05298592|Tubulin Modulators|tubulin modulators|mesh-ancestor
102190774|NCT05298592|Antimitotic Agents|antimitotic agents|mesh-ancestor
102190775|NCT05298592|Mitosis Modulators|mitosis modulators|mesh-ancestor
102190776|NCT05298592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190777|NCT05298592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102190778|NCT05298592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102190779|NCT05298592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102190780|NCT05298592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102190781|NCT05298592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102190782|NCT05286814|Leucovorin|leucovorin|mesh-list
102190783|NCT05286814|Dexamethasone|dexamethasone|mesh-list
102190784|NCT05286814|Gemcitabine|gemcitabine|mesh-list
102190785|NCT05286814|Fluorouracil|fluorouracil|mesh-list
102190786|NCT05286814|Oxaliplatin|oxaliplatin|mesh-list
102190787|NCT05286814|Irinotecan|irinotecan|mesh-list
102190788|NCT05286814|Floxuridine|floxuridine|mesh-list
102190789|NCT05286814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102190790|NCT05286814|Antiemetics|antiemetics|mesh-ancestor
102190791|NCT05286814|Autonomic Agents|autonomic agents|mesh-ancestor
102190792|NCT05286814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102190793|NCT05286814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190794|NCT05286814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102190795|NCT05286814|Glucocorticoids|glucocorticoids|mesh-ancestor
102190796|NCT05286814|Hormones|hormones|mesh-ancestor
102190797|NCT05286814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102190798|NCT05286814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102190799|NCT05286814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102190800|NCT05286814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102190801|NCT05286814|Antimetabolites|antimetabolites|mesh-ancestor
102190802|NCT05286814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190803|NCT05286814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102190804|NCT05286814|Immunologic Factors|immunologic factors|mesh-ancestor
102190805|NCT05286814|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101899618|NCT03878654|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
102190807|NCT05286814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102190808|NCT05286814|Antidotes|antidotes|mesh-ancestor
102190809|NCT05286814|Protective Agents|protective agents|mesh-ancestor
102190810|NCT05286814|Vitamin B Complex|vitamin b complex|mesh-ancestor
102190811|NCT05286814|Vitamins|vitamins|mesh-ancestor
102190812|NCT05286814|Micronutrients|micronutrients|mesh-ancestor
102190827|NCT05259800|Peppermint oil|peppermint oil|mesh-list
102190828|NCT05259800|Mineral Oil|mineral oil|mesh-list
102190829|NCT05259800|Antiemetics|antiemetics|mesh-ancestor
102190830|NCT05259800|Autonomic Agents|autonomic agents|mesh-ancestor
102190831|NCT05259800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102190832|NCT05259800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190833|NCT05259800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102190834|NCT05259800|Parasympatholytics|parasympatholytics|mesh-ancestor
102190835|NCT05259800|Emollients|emollients|mesh-ancestor
102190836|NCT05259800|Dermatologic Agents|dermatologic agents|mesh-ancestor
102190837|NCT05254002|Empagliflozin|empagliflozin|mesh-list
102190838|NCT05254002|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102190839|NCT05254002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190840|NCT05254002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102190841|NCT05254002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190842|NCT05215236|Opiate Alkaloids|opiate alkaloids|mesh-list
102190843|NCT05215236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102190844|NCT05215236|Narcotics|narcotics|mesh-ancestor
102190845|NCT05215236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102190846|NCT05215236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190847|NCT05215236|Analgesics|analgesics|mesh-ancestor
102190848|NCT05215236|Sensory System Agents|sensory system agents|mesh-ancestor
102190849|NCT05215236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102190850|NCT05209295|Azacitidine|azacitidine|mesh-list
102190851|NCT05209295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102190852|NCT05209295|Antimetabolites|antimetabolites|mesh-ancestor
102190853|NCT05209295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190854|NCT05209295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102190855|NCT05209295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102190856|NCT05202262|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
102190857|NCT05202262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102190858|NCT05202262|Respiratory System Agents|respiratory system agents|mesh-ancestor
102190859|NCT05180591|BCG Vaccine|bcg vaccine|mesh-list
102190860|NCT05180591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102190861|NCT05180591|Immunologic Factors|immunologic factors|mesh-ancestor
102190862|NCT05180591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190863|NCT05169567|Fulvestrant|fulvestrant|mesh-list
102190864|NCT05169567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102190865|NCT05169567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102190866|NCT05169567|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102190867|NCT05169567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102190868|NCT05169567|Hormone Antagonists|hormone antagonists|mesh-ancestor
102190869|NCT05169567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102190870|NCT05169567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190871|NCT05157971|Cytarabine|cytarabine|mesh-list
102190872|NCT05157971|Prednisone|prednisone|mesh-list
102190873|NCT05157971|Cortisone|cortisone|mesh-list
102190874|NCT05157971|Cyclophosphamide|cyclophosphamide|mesh-list
102190875|NCT05157971|Methotrexate|methotrexate|mesh-list
102190876|NCT05157971|Vincristine|vincristine|mesh-list
102190877|NCT05157971|Daunorubicin|daunorubicin|mesh-list
102190878|NCT05157971|Venetoclax|venetoclax|mesh-list
102190879|NCT05157971|Asparaginase|asparaginase|mesh-list
102190880|NCT05157971|Mercaptopurine|mercaptopurine|mesh-list
102190881|NCT05157971|Pegaspargase|pegaspargase|mesh-list
102190882|NCT05157971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102190883|NCT05157971|Immunologic Factors|immunologic factors|mesh-ancestor
102190885|NCT05157971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102190886|NCT05157971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102190887|NCT05157971|Alkylating Agents|alkylating agents|mesh-ancestor
102190888|NCT05157971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190889|NCT05157971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102190890|NCT05157971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102190891|NCT05157971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102190892|NCT05157971|Glucocorticoids|glucocorticoids|mesh-ancestor
102190893|NCT05157971|Hormones|hormones|mesh-ancestor
102190894|NCT05157971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102190895|NCT05157971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102190896|NCT05157971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102190897|NCT05157971|Abortifacient Agents|abortifacient agents|mesh-ancestor
102190898|NCT05157971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102190899|NCT05157971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102190900|NCT05157971|Antimetabolites|antimetabolites|mesh-ancestor
102190901|NCT05157971|Dermatologic Agents|dermatologic agents|mesh-ancestor
102190902|NCT05157971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102190903|NCT05157971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102190904|NCT05157971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102190905|NCT05157971|Antiviral Agents|antiviral agents|mesh-ancestor
102190906|NCT05157971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102190907|NCT05157971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102190908|NCT05157971|Tubulin Modulators|tubulin modulators|mesh-ancestor
102190909|NCT05157971|Antimitotic Agents|antimitotic agents|mesh-ancestor
102190910|NCT05157971|Mitosis Modulators|mitosis modulators|mesh-ancestor
101449304|NCT00220857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102190911|NCT05157971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102190912|NCT05157971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102190913|NCT05157971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102190914|NCT05070260|Glenzocimab|glenzocimab|mesh-list
102190915|NCT05070260|Anticoagulants|anticoagulants|mesh-ancestor
102190916|NCT05061550|Paclitaxel|paclitaxel|mesh-list
102190917|NCT05061550|Cisplatin|cisplatin|mesh-list
102190918|NCT05061550|Carboplatin|carboplatin|mesh-list
102190919|NCT05061550|Pemetrexed|pemetrexed|mesh-list
102190920|NCT05061550|Durvalumab|durvalumab|mesh-list
102190921|NCT05061550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102190922|NCT05061550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102190923|NCT05061550|Tubulin Modulators|tubulin modulators|mesh-ancestor
102190924|NCT05061550|Antimitotic Agents|antimitotic agents|mesh-ancestor
102190925|NCT05061550|Mitosis Modulators|mitosis modulators|mesh-ancestor
102190926|NCT05061550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190927|NCT05061550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102190928|NCT05061550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102190929|NCT05061550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102190930|NCT05061550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102190944|NCT04995653|Vancomycin|vancomycin|mesh-list
102190945|NCT04995653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102190946|NCT04995653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102190947|NCT04972968|Glucocorticoids|glucocorticoids|mesh-list
102190948|NCT04972968|Hormones|hormones|mesh-ancestor
102190949|NCT04972968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102190950|NCT04972968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190951|NCT04972123|Phenylephrine|phenylephrine|mesh-list
102190952|NCT04972123|Oxymetazoline|oxymetazoline|mesh-list
102190953|NCT04972123|Caffeine|caffeine|mesh-list
102190954|NCT04972123|Capsaicin|capsaicin|mesh-list
102190955|NCT04972123|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102190956|NCT04972123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190957|NCT04972123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102190958|NCT04972123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102190959|NCT04972123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190960|NCT04972123|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102190961|NCT04972123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102190962|NCT04972123|Purinergic Agents|purinergic agents|mesh-ancestor
102190963|NCT04972123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102190964|NCT04972123|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102190965|NCT04972123|Mydriatics|mydriatics|mesh-ancestor
102190966|NCT04972123|Autonomic Agents|autonomic agents|mesh-ancestor
102190967|NCT04972123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102190968|NCT04972123|Sympathomimetics|sympathomimetics|mesh-ancestor
102190969|NCT04972123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102190970|NCT04972123|Nasal Decongestants|nasal decongestants|mesh-ancestor
102190971|NCT04972123|Respiratory System Agents|respiratory system agents|mesh-ancestor
102190972|NCT04972123|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102190973|NCT04972123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102190974|NCT04972123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102190975|NCT04972123|Adrenergic Agents|adrenergic agents|mesh-ancestor
102190976|NCT04972123|Protective Agents|protective agents|mesh-ancestor
102190977|NCT04972123|Antipruritics|antipruritics|mesh-ancestor
102190978|NCT04972123|Dermatologic Agents|dermatologic agents|mesh-ancestor
102190979|NCT04972123|Sensory System Agents|sensory system agents|mesh-ancestor
102190980|NCT04939701|Pembrolizumab|pembrolizumab|mesh-list
102190981|NCT04939701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102190982|NCT04939701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102190983|NCT04939701|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102190984|NCT04939701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190985|NCT04928651|Clonidine|clonidine|mesh-list
102190986|NCT04928651|Analgesics|analgesics|mesh-ancestor
102190987|NCT04928651|Sensory System Agents|sensory system agents|mesh-ancestor
102190988|NCT04928651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102190989|NCT04928651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102190990|NCT04928651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102190991|NCT04928651|Sympatholytics|sympatholytics|mesh-ancestor
102190992|NCT04928651|Autonomic Agents|autonomic agents|mesh-ancestor
102190993|NCT04928651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102190994|NCT04928651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102190995|NCT04928651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102190996|NCT04928651|Adrenergic Agents|adrenergic agents|mesh-ancestor
102190997|NCT04928651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102190998|NCT04928651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102190999|NCT04916327|Antioxidants|antioxidants|mesh-list
102191000|NCT04916327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191001|NCT04916327|Protective Agents|protective agents|mesh-ancestor
102191002|NCT04916327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191003|NCT04907227|Dexamethasone|dexamethasone|mesh-list
102191004|NCT04907227|Prednisone|prednisone|mesh-list
102191005|NCT04907227|Docetaxel|docetaxel|mesh-list
102191006|NCT04907227|Pembrolizumab|pembrolizumab|mesh-list
102191007|NCT04907227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102191008|NCT04907227|Antiemetics|antiemetics|mesh-ancestor
102191009|NCT04907227|Autonomic Agents|autonomic agents|mesh-ancestor
102191010|NCT04907227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102191011|NCT04907227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191012|NCT04907227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102191013|NCT04907227|Glucocorticoids|glucocorticoids|mesh-ancestor
102191014|NCT04907227|Hormones|hormones|mesh-ancestor
102191015|NCT04907227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102191016|NCT04907227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102191017|NCT04907227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191018|NCT04907227|Tubulin Modulators|tubulin modulators|mesh-ancestor
102191019|NCT04907227|Antimitotic Agents|antimitotic agents|mesh-ancestor
102191020|NCT04907227|Mitosis Modulators|mitosis modulators|mesh-ancestor
102191021|NCT04907227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191022|NCT04907227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102191023|NCT04907227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102191024|NCT04875364|Eszopiclone|eszopiclone|mesh-list
102191025|NCT04875364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102191026|NCT04875364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102191027|NCT04875364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191028|NCT04848116|Nivolumab|nivolumab|mesh-list
102191029|NCT04848116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102191030|NCT04848116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191031|NCT04848116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102191032|NCT04848116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191033|NCT04846829|Citalopram|citalopram|mesh-list
102191034|NCT04846829|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102191035|NCT04846829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102191036|NCT04846829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102191037|NCT04846829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191038|NCT04846829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102191039|NCT04846829|Serotonin Agents|serotonin agents|mesh-ancestor
102191040|NCT04846829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191041|NCT04846829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102191042|NCT04846829|Antidepressive Agents|antidepressive agents|mesh-ancestor
102191043|NCT04846829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102191044|NCT04838301|Pregnanolone|pregnanolone|mesh-list
102191045|NCT04838301|Anesthetics|anesthetics|mesh-ancestor
102191046|NCT04838301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102191047|NCT04838301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191048|NCT04835805|Nivolumab|nivolumab|mesh-list
102191049|NCT04835805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102191050|NCT04835805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191051|NCT04835805|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102191052|NCT04835805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191053|NCT04825704|Bupivacaine|bupivacaine|mesh-list
102191054|NCT04825704|Anesthetics, Local|anesthetics, local|mesh-ancestor
102191055|NCT04825704|Anesthetics|anesthetics|mesh-ancestor
102191056|NCT04825704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102191057|NCT04825704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191058|NCT04825704|Sensory System Agents|sensory system agents|mesh-ancestor
102191059|NCT04825704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102191060|NCT04815083|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102191061|NCT04815083|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102191062|NCT04815083|Dermatologic Agents|dermatologic agents|mesh-ancestor
102191063|NCT04798469|Methyltestosterone|methyltestosterone|mesh-list
102191064|NCT04798469|Testosterone|testosterone|mesh-list
102191065|NCT04798469|Testosterone undecanoate|testosterone undecanoate|mesh-list
102191066|NCT04798469|Testosterone enanthate|testosterone enanthate|mesh-list
102191067|NCT04798469|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102191068|NCT04798469|Androgens|androgens|mesh-ancestor
102191069|NCT04798469|Hormones|hormones|mesh-ancestor
102191070|NCT04798469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102191071|NCT04798469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191072|NCT04798469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102191073|NCT04798469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191074|NCT04798469|Anabolic Agents|anabolic agents|mesh-ancestor
102191075|NCT04787991|Hydroxychloroquine|hydroxychloroquine|mesh-list
102191076|NCT04787991|Paclitaxel|paclitaxel|mesh-list
102191077|NCT04787991|Gemcitabine|gemcitabine|mesh-list
102191078|NCT04787991|Nivolumab|nivolumab|mesh-list
102191079|NCT04787991|Ipilimumab|ipilimumab|mesh-list
102191080|NCT04787991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102191081|NCT04787991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191082|NCT04787991|Tubulin Modulators|tubulin modulators|mesh-ancestor
102191083|NCT04787991|Antimitotic Agents|antimitotic agents|mesh-ancestor
102191084|NCT04787991|Mitosis Modulators|mitosis modulators|mesh-ancestor
102191085|NCT04787991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191086|NCT04787991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102191087|NCT04787991|Antimetabolites|antimetabolites|mesh-ancestor
102191088|NCT04787991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102191089|NCT04787991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102191090|NCT04787991|Antimalarials|antimalarials|mesh-ancestor
102191091|NCT04787991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102191092|NCT04787991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102191093|NCT04787991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102191094|NCT04787991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102191095|NCT04787991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102191096|NCT04777201|Faricimab|faricimab|mesh-list
102191097|NCT04777201|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102191098|NCT04777201|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102191099|NCT04777201|Growth Substances|growth substances|mesh-ancestor
102191100|NCT04777201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191101|NCT04777201|Growth Inhibitors|growth inhibitors|mesh-ancestor
102191102|NCT04777201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191103|NCT04758000|Metformin|metformin|mesh-list
102191104|NCT04758000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102191105|NCT04758000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191106|NCT04728087|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
102191107|NCT04728087|Hemostatics|hemostatics|mesh-ancestor
102191108|NCT04728087|Coagulants|coagulants|mesh-ancestor
102191109|NCT04688320|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102191111|NCT04688320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102191112|NCT04688320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191113|NCT04663997|Docetaxel|docetaxel|mesh-list
102191114|NCT04663997|177Lu-PSMA-617|177lu-psma-617|mesh-list
102191115|NCT04663997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191116|NCT04663997|Tubulin Modulators|tubulin modulators|mesh-ancestor
102191117|NCT04663997|Antimitotic Agents|antimitotic agents|mesh-ancestor
102191118|NCT04663997|Mitosis Modulators|mitosis modulators|mesh-ancestor
102191119|NCT04663997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191120|NCT04663997|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102191121|NCT04659616|Cytarabine|cytarabine|mesh-list
102191122|NCT04659616|Daunorubicin|daunorubicin|mesh-list
102191123|NCT04659616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102191124|NCT04659616|Antimetabolites|antimetabolites|mesh-ancestor
102191125|NCT04659616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191126|NCT04659616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191127|NCT04659616|Antiviral Agents|antiviral agents|mesh-ancestor
102191128|NCT04659616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102191129|NCT04659616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102191130|NCT04659616|Immunologic Factors|immunologic factors|mesh-ancestor
102191131|NCT04659616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191132|NCT04659616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102191133|NCT04659616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102191134|NCT04659616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102191135|NCT04659616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102191136|NCT04657081|Decitabine|decitabine|mesh-list
102191137|NCT04657081|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
102191138|NCT04657081|Venetoclax|venetoclax|mesh-list
102191139|NCT04657081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102191140|NCT04657081|Antimetabolites|antimetabolites|mesh-ancestor
102191141|NCT04657081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191142|NCT04657081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191143|NCT04657081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102191144|NCT04637763|Cyclophosphamide|cyclophosphamide|mesh-list
102191145|NCT04637763|Fludarabine|fludarabine|mesh-list
102191146|NCT04637763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102191147|NCT04637763|Immunologic Factors|immunologic factors|mesh-ancestor
102191148|NCT04637763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191149|NCT04637763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102191150|NCT04637763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102191151|NCT04637763|Alkylating Agents|alkylating agents|mesh-ancestor
102191152|NCT04637763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191153|NCT04637763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191154|NCT04637763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102191155|NCT04627870|Paclitaxel|paclitaxel|mesh-list
102191156|NCT04627870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102191157|NCT04627870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191158|NCT04627870|Tubulin Modulators|tubulin modulators|mesh-ancestor
102191159|NCT04627870|Antimitotic Agents|antimitotic agents|mesh-ancestor
102191160|NCT04627870|Mitosis Modulators|mitosis modulators|mesh-ancestor
102191161|NCT04627870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191162|NCT04610671|Nivolumab|nivolumab|mesh-list
102191163|NCT04610671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102191164|NCT04610671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191165|NCT04610671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102191166|NCT04610671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191167|NCT04595617|Antibodies|antibodies|mesh-list
102191168|NCT04595617|Immunologic Factors|immunologic factors|mesh-ancestor
102191169|NCT04595617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191170|NCT04564742|Dapagliflozin|dapagliflozin|mesh-list
102191171|NCT04564742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102191172|NCT04564742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191173|NCT04564742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102191174|NCT04564742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191175|NCT04508790|Dexamethasone|dexamethasone|mesh-list
102191176|NCT04508790|Dexamethasone acetate|dexamethasone acetate|mesh-list
102191177|NCT04508790|Pomalidomide|pomalidomide|mesh-list
102191178|NCT04508790|Ichthammol|ichthammol|mesh-list
102191179|NCT04508790|BB 1101|bb 1101|mesh-list
102191180|NCT04508790|Leflunomide|leflunomide|mesh-list
102191181|NCT04508790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102191182|NCT04508790|Antiemetics|antiemetics|mesh-ancestor
102191183|NCT04508790|Autonomic Agents|autonomic agents|mesh-ancestor
102191184|NCT04508790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102191185|NCT04508790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191186|NCT04508790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102191187|NCT04508790|Glucocorticoids|glucocorticoids|mesh-ancestor
102191188|NCT04508790|Hormones|hormones|mesh-ancestor
102191189|NCT04508790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102191190|NCT04508790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102191191|NCT04508790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191192|NCT04508790|Protease Inhibitors|protease inhibitors|mesh-ancestor
102191193|NCT04508790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102191194|NCT04508790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191195|NCT04508790|Immunologic Factors|immunologic factors|mesh-ancestor
102191196|NCT04508790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102191197|NCT04508790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102191198|NCT04508790|Growth Substances|growth substances|mesh-ancestor
102191199|NCT04508790|Growth Inhibitors|growth inhibitors|mesh-ancestor
102191200|NCT04508790|Dermatologic Agents|dermatologic agents|mesh-ancestor
102191201|NCT04508790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102191202|NCT04492566|Pancrelipase|pancrelipase|mesh-list
102191203|NCT04492566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102191204|NCT04421963|Olaparib|olaparib|mesh-list
102191205|NCT04421963|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102191206|NCT04421963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102191207|NCT04421963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191208|NCT04421963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191209|NCT04393389|Paclitaxel|paclitaxel|mesh-list
102191210|NCT04393389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102191211|NCT04393389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191212|NCT04393389|Tubulin Modulators|tubulin modulators|mesh-ancestor
102191213|NCT04393389|Antimitotic Agents|antimitotic agents|mesh-ancestor
102191214|NCT04393389|Mitosis Modulators|mitosis modulators|mesh-ancestor
102191215|NCT04393389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191216|NCT04273061|Atezolizumab|atezolizumab|mesh-list
102191217|NCT04273061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102191218|NCT04273061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191219|NCT04273061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102191220|NCT04273061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191221|NCT04256317|Azacitidine|azacitidine|mesh-list
102191222|NCT04256317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102191223|NCT04256317|Antimetabolites|antimetabolites|mesh-ancestor
102191224|NCT04256317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191225|NCT04256317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191226|NCT04256317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102191227|NCT04161248|Dexamethasone|dexamethasone|mesh-list
102191228|NCT04161248|Rituximab|rituximab|mesh-list
102191229|NCT04161248|Gemcitabine|gemcitabine|mesh-list
102191230|NCT04161248|Venetoclax|venetoclax|mesh-list
102191231|NCT04161248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102191232|NCT04161248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191233|NCT04161248|Immunologic Factors|immunologic factors|mesh-ancestor
102191234|NCT04161248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191235|NCT04161248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102191236|NCT04161248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102191237|NCT04161248|Antiemetics|antiemetics|mesh-ancestor
102191238|NCT04161248|Autonomic Agents|autonomic agents|mesh-ancestor
102191239|NCT04161248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102191240|NCT04161248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102191241|NCT04161248|Glucocorticoids|glucocorticoids|mesh-ancestor
102191242|NCT04161248|Hormones|hormones|mesh-ancestor
102191243|NCT04161248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102191244|NCT04161248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102191245|NCT04161248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102191246|NCT04161248|Antimetabolites|antimetabolites|mesh-ancestor
102191247|NCT04161248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191248|NCT04151667|Dexamethasone|dexamethasone|mesh-list
102191249|NCT04151667|Lenalidomide|lenalidomide|mesh-list
102191250|NCT04151667|Bortezomib|bortezomib|mesh-list
102191251|NCT04151667|Daratumumab|daratumumab|mesh-list
102191252|NCT04151667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102191253|NCT04151667|Antiemetics|antiemetics|mesh-ancestor
102191254|NCT04151667|Autonomic Agents|autonomic agents|mesh-ancestor
102191255|NCT04151667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102191256|NCT04151667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191257|NCT04151667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102191258|NCT04151667|Glucocorticoids|glucocorticoids|mesh-ancestor
102191259|NCT04151667|Hormones|hormones|mesh-ancestor
102191260|NCT04151667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102191261|NCT04151667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102191262|NCT04151667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191263|NCT04151667|Immunologic Factors|immunologic factors|mesh-ancestor
102191264|NCT04151667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102191265|NCT04151667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102191266|NCT04151667|Growth Substances|growth substances|mesh-ancestor
102191267|NCT04151667|Growth Inhibitors|growth inhibitors|mesh-ancestor
102191268|NCT04140266|Tenofovir|tenofovir|mesh-list
102191269|NCT04140266|Emtricitabine|emtricitabine|mesh-list
102191270|NCT04140266|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102191271|NCT04140266|Dapivirine|dapivirine|mesh-list
102191272|NCT04140266|Antiviral Agents|antiviral agents|mesh-ancestor
102191273|NCT04140266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102191274|NCT04140266|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102191275|NCT04140266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102191276|NCT04140266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102191277|NCT04140266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191278|NCT04140266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102191279|NCT04140266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102191280|NCT04123795|Certolizumab Pegol|certolizumab pegol|mesh-list
102191281|NCT04123795|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102191282|NCT04123795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102191283|NCT04123795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102191284|NCT04123795|Immunologic Factors|immunologic factors|mesh-ancestor
102191285|NCT04123795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191286|NCT04123795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102191287|NCT04120415|Vedolizumab|vedolizumab|mesh-list
102191288|NCT04120415|Vaccines|vaccines|mesh-list
102191289|NCT04120415|Immunologic Factors|immunologic factors|mesh-ancestor
102191290|NCT04120415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191291|NCT04120415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102191292|NCT04102098|Bevacizumab|bevacizumab|mesh-list
102191293|NCT04102098|Atezolizumab|atezolizumab|mesh-list
102191294|NCT04102098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102191295|NCT04102098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191296|NCT04102098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102191297|NCT04102098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102191298|NCT04102098|Growth Substances|growth substances|mesh-ancestor
102191299|NCT04102098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191300|NCT04102098|Growth Inhibitors|growth inhibitors|mesh-ancestor
102191301|NCT04102098|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102191302|NCT04102098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191303|NCT04093570|Decitabine|decitabine|mesh-list
102191304|NCT04093570|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
102191305|NCT04093570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102191306|NCT04093570|Antimetabolites|antimetabolites|mesh-ancestor
102191307|NCT04093570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191308|NCT04093570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191309|NCT04093570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102191310|NCT04093167|Pembrolizumab|pembrolizumab|mesh-list
102191311|NCT04093167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102191312|NCT04093167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191313|NCT04093167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102191314|NCT04093167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191325|NCT04034004|Naloxone|naloxone|mesh-list
102191326|NCT04034004|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102191327|NCT04034004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191328|NCT04034004|Sensory System Agents|sensory system agents|mesh-ancestor
102191329|NCT04034004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102191330|NCT04008030|Leucovorin|leucovorin|mesh-list
102191331|NCT04008030|Bevacizumab|bevacizumab|mesh-list
102191332|NCT04008030|Nivolumab|nivolumab|mesh-list
101900144|NCT01281878|Pyridoxine|pyridoxine|mesh-list
102191333|NCT04008030|Cetuximab|cetuximab|mesh-list
102191334|NCT04008030|Ipilimumab|ipilimumab|mesh-list
102191335|NCT04008030|Fluorouracil|fluorouracil|mesh-list
102191336|NCT04008030|Oxaliplatin|oxaliplatin|mesh-list
102191337|NCT04008030|Irinotecan|irinotecan|mesh-list
102191338|NCT04008030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102191339|NCT04008030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191340|NCT04008030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102191341|NCT04008030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102191342|NCT04008030|Growth Substances|growth substances|mesh-ancestor
102191343|NCT04008030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191344|NCT04008030|Growth Inhibitors|growth inhibitors|mesh-ancestor
102191345|NCT04008030|Antimetabolites|antimetabolites|mesh-ancestor
102191346|NCT04008030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191347|NCT04008030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102191348|NCT04008030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102191349|NCT04008030|Immunologic Factors|immunologic factors|mesh-ancestor
102191350|NCT04008030|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102191351|NCT04008030|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102191352|NCT04008030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102191353|NCT04008030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102191354|NCT04008030|Antidotes|antidotes|mesh-ancestor
102191355|NCT04008030|Protective Agents|protective agents|mesh-ancestor
102191356|NCT04008030|Vitamin B Complex|vitamin b complex|mesh-ancestor
102191357|NCT04008030|Vitamins|vitamins|mesh-ancestor
102191358|NCT04008030|Micronutrients|micronutrients|mesh-ancestor
102191359|NCT03971461|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102191360|NCT03971461|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102191361|NCT03971461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191362|NCT03960008|Doxorubicin|doxorubicin|mesh-list
102191363|NCT03960008|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102191364|NCT03960008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102191365|NCT03960008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191366|NCT03960008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102191367|NCT03960008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102191368|NCT03960008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102191369|NCT03960008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191370|NCT03954067|Pembrolizumab|pembrolizumab|mesh-list
102191371|NCT03954067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102191372|NCT03954067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191373|NCT03954067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102191374|NCT03954067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191375|NCT03939520|Pirfenidone|pirfenidone|mesh-list
102191376|NCT03939520|Nintedanib|nintedanib|mesh-list
102191377|NCT03939520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191378|NCT03939520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102191379|NCT03939520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102191380|NCT03939520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191381|NCT03939520|Analgesics|analgesics|mesh-ancestor
102191382|NCT03939520|Sensory System Agents|sensory system agents|mesh-ancestor
102191383|NCT03939520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102191384|NCT03939520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191385|NCT03939520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102191386|NCT03939520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102191387|NCT03939520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102191388|NCT03939520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102191389|NCT03926143|Maytansine|maytansine|mesh-list
102191390|NCT03926143|Tubulin Modulators|tubulin modulators|mesh-list
102191391|NCT03926143|Anetumab ravtansine|anetumab ravtansine|mesh-list
102191392|NCT03926143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102191393|NCT03926143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191394|NCT03926143|Antimitotic Agents|antimitotic agents|mesh-ancestor
102191395|NCT03926143|Mitosis Modulators|mitosis modulators|mesh-ancestor
102191396|NCT03926143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191397|NCT03926143|Immunoconjugates|immunoconjugates|mesh-ancestor
102191398|NCT03926143|Immunologic Factors|immunologic factors|mesh-ancestor
102191399|NCT03926143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191400|NCT03878459|Pioglitazone|pioglitazone|mesh-list
102191401|NCT03878459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102191402|NCT03878459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191403|NCT03876262|Ivermectin|ivermectin|mesh-list
102191404|NCT03876262|Moxidectin|moxidectin|mesh-list
102191405|NCT03876262|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102191406|NCT03876262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102191407|NCT03876262|Anthelmintics|anthelmintics|mesh-ancestor
102191408|NCT03876262|Antinematodal Agents|antinematodal agents|mesh-ancestor
102191409|NCT03867682|Venetoclax|venetoclax|mesh-list
102191410|NCT03867682|Lintuzumab|lintuzumab|mesh-list
102191411|NCT03867682|Spironolactone|spironolactone|mesh-list
102191412|NCT03867682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191413|NCT03867682|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102191414|NCT03867682|Hormone Antagonists|hormone antagonists|mesh-ancestor
102191415|NCT03867682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102191416|NCT03867682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191417|NCT03867682|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102191418|NCT03867682|Diuretics|diuretics|mesh-ancestor
102191419|NCT03867682|Natriuretic Agents|natriuretic agents|mesh-ancestor
102191420|NCT03867682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102191421|NCT03846505|Oxytocin|oxytocin|mesh-list
102191422|NCT03846505|Oxytocics|oxytocics|mesh-ancestor
102191423|NCT03846505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102191424|NCT03846505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191425|NCT03822897|Cisplatin|cisplatin|mesh-list
102191426|NCT03822897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191427|NCT03815643|Avelumab|avelumab|mesh-list
102191428|NCT03815643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102191429|NCT03815643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191430|NCT03799003|Pembrolizumab|pembrolizumab|mesh-list
102191431|NCT03799003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102191432|NCT03799003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191433|NCT03799003|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102191434|NCT03799003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191435|NCT03768570|Durvalumab|durvalumab|mesh-list
102191436|NCT03768570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102191437|NCT03768570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191438|NCT03683251|Ranibizumab|ranibizumab|mesh-list
102191439|NCT03683251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102191440|NCT03683251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102191441|NCT03683251|Growth Substances|growth substances|mesh-ancestor
102191442|NCT03683251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191443|NCT03683251|Growth Inhibitors|growth inhibitors|mesh-ancestor
102191444|NCT03683251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191445|NCT03630211|Cyclophosphamide|cyclophosphamide|mesh-list
102191446|NCT03630211|Thiotepa|thiotepa|mesh-list
102191447|NCT03630211|Rituximab|rituximab|mesh-list
102191448|NCT03630211|Alemtuzumab|alemtuzumab|mesh-list
102191449|NCT03630211|Thymoglobulin|thymoglobulin|mesh-list
102191450|NCT03630211|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102191451|NCT03630211|Immunoglobulins|immunoglobulins|mesh-list
102191452|NCT03630211|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102191453|NCT03630211|gamma-Globulins|gamma-globulins|mesh-list
102191454|NCT03630211|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102191455|NCT03630211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102191456|NCT03630211|Immunologic Factors|immunologic factors|mesh-ancestor
102191457|NCT03630211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191458|NCT03630211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102191459|NCT03630211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102191460|NCT03630211|Alkylating Agents|alkylating agents|mesh-ancestor
102191461|NCT03630211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191462|NCT03630211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191463|NCT03630211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102191464|NCT03630211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102191465|NCT03617445|Vancomycin|vancomycin|mesh-list
102191466|NCT03617445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102191467|NCT03617445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102191468|NCT03593317|Spironolactone|spironolactone|mesh-list
102191469|NCT03593317|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102191470|NCT03593317|Hormone Antagonists|hormone antagonists|mesh-ancestor
102191471|NCT03593317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102191472|NCT03593317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191473|NCT03593317|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102191474|NCT03593317|Diuretics|diuretics|mesh-ancestor
102191475|NCT03593317|Natriuretic Agents|natriuretic agents|mesh-ancestor
102191476|NCT03574571|Docetaxel|docetaxel|mesh-list
102191477|NCT03574571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191478|NCT03574571|Tubulin Modulators|tubulin modulators|mesh-ancestor
102191479|NCT03574571|Antimitotic Agents|antimitotic agents|mesh-ancestor
102191480|NCT03574571|Mitosis Modulators|mitosis modulators|mesh-ancestor
102191481|NCT03574571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191482|NCT03550391|Memantine|memantine|mesh-list
102191483|NCT03550391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102191484|NCT03550391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102191485|NCT03550391|Dopamine Agents|dopamine agents|mesh-ancestor
102191486|NCT03550391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102191487|NCT03550391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191488|NCT03550391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191489|NCT03550391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102191490|NCT03550391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102191492|NCT03480776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102191493|NCT03480776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102191494|NCT03480776|Analgesics|analgesics|mesh-ancestor
102191495|NCT03480776|Sensory System Agents|sensory system agents|mesh-ancestor
102191496|NCT03480776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102191497|NCT03480776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191498|NCT03480776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102191499|NCT03480776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102191500|NCT03480776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102191501|NCT03480776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102191502|NCT03480776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191503|NCT03480776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102191504|NCT03480776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102191505|NCT03480776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102191506|NCT03480776|Antipyretics|antipyretics|mesh-ancestor
102191507|NCT03456063|Paclitaxel|paclitaxel|mesh-list
102191508|NCT03456063|Carboplatin|carboplatin|mesh-list
102191509|NCT03456063|Gemcitabine|gemcitabine|mesh-list
102191510|NCT03456063|Pemetrexed|pemetrexed|mesh-list
102191511|NCT03456063|Atezolizumab|atezolizumab|mesh-list
102191512|NCT03456063|Antibodies|antibodies|mesh-list
102191513|NCT03456063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102191514|NCT03456063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191515|NCT03456063|Tubulin Modulators|tubulin modulators|mesh-ancestor
102191516|NCT03456063|Antimitotic Agents|antimitotic agents|mesh-ancestor
102191517|NCT03456063|Mitosis Modulators|mitosis modulators|mesh-ancestor
102191518|NCT03456063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191519|NCT03456063|Immunologic Factors|immunologic factors|mesh-ancestor
102191520|NCT03456063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191521|NCT03456063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102191522|NCT03456063|Antimetabolites|antimetabolites|mesh-ancestor
102191523|NCT03456063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102191524|NCT03456063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102191525|NCT03456063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102191526|NCT03456063|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102191527|NCT03456063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102191528|NCT03450018|Gemcitabine|gemcitabine|mesh-list
102191529|NCT03450018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102191530|NCT03450018|Antimetabolites|antimetabolites|mesh-ancestor
102191531|NCT03450018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191532|NCT03450018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191533|NCT03421652|Nivolumab|nivolumab|mesh-list
102191534|NCT03421652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102191535|NCT03421652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191536|NCT03421652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102191537|NCT03421652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191538|NCT03410615|Durvalumab|durvalumab|mesh-list
102191539|NCT03410615|Tremelimumab|tremelimumab|mesh-list
102191540|NCT03410615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191541|NCT03410615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102191542|NCT03385655|Carboplatin|carboplatin|mesh-list
102191543|NCT03385655|Durvalumab|durvalumab|mesh-list
102191544|NCT03385655|Tremelimumab|tremelimumab|mesh-list
102191545|NCT03385655|Ipatasertib|ipatasertib|mesh-list
102191546|NCT03385655|Adavosertib|adavosertib|mesh-list
102191547|NCT03385655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191548|NCT03385655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102191549|NCT03385655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102191550|NCT03385655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102191551|NCT03385655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191552|NCT03366155|Oxaliplatin|oxaliplatin|mesh-list
102191553|NCT03366155|Irinotecan|irinotecan|mesh-list
102191554|NCT03366155|Cetuximab|cetuximab|mesh-list
102191555|NCT03366155|Panitumumab|panitumumab|mesh-list
102191556|NCT03366155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191557|NCT03366155|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102191558|NCT03366155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102191559|NCT03366155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102191560|NCT03366155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191561|NCT03366155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102191562|NCT03297606|Nivolumab|nivolumab|mesh-list
102191563|NCT03297606|Trastuzumab|trastuzumab|mesh-list
102191564|NCT03297606|Ipilimumab|ipilimumab|mesh-list
102191565|NCT03297606|Pertuzumab|pertuzumab|mesh-list
102191566|NCT03297606|Sunitinib|sunitinib|mesh-list
102191567|NCT03297606|Dasatinib|dasatinib|mesh-list
102191568|NCT03297606|Olaparib|olaparib|mesh-list
102191569|NCT03297606|Palbociclib|palbociclib|mesh-list
102191570|NCT03297606|Temsirolimus|temsirolimus|mesh-list
102191571|NCT03297606|Axitinib|axitinib|mesh-list
102191572|NCT03297606|Vemurafenib|vemurafenib|mesh-list
102191573|NCT03297606|Crizotinib|crizotinib|mesh-list
102191574|NCT03297606|Tucatinib|tucatinib|mesh-list
102191575|NCT03297606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102191576|NCT03297606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191577|NCT03297606|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102191578|NCT03297606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191579|NCT03297606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102191580|NCT03297606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102191581|NCT03297606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102191582|NCT03297606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102191583|NCT03297606|Growth Substances|growth substances|mesh-ancestor
102191584|NCT03297606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191585|NCT03297606|Growth Inhibitors|growth inhibitors|mesh-ancestor
102191586|NCT03297606|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102191587|NCT03297606|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102191588|NCT03297606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102191589|NCT03297606|Immunologic Factors|immunologic factors|mesh-ancestor
102191590|NCT03215524|Thalidomide|thalidomide|mesh-list
102191591|NCT03215524|Dexamethasone|dexamethasone|mesh-list
102191592|NCT03215524|Dexamethasone acetate|dexamethasone acetate|mesh-list
102191593|NCT03215524|Cyclophosphamide|cyclophosphamide|mesh-list
102191594|NCT03215524|Daratumumab|daratumumab|mesh-list
102191595|NCT03215524|Pomalidomide|pomalidomide|mesh-list
102191596|NCT03215524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102191597|NCT03215524|BB 1101|bb 1101|mesh-list
102191598|NCT03215524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102191599|NCT03215524|Immunologic Factors|immunologic factors|mesh-ancestor
102191600|NCT03215524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191601|NCT03215524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102191602|NCT03215524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102191603|NCT03215524|Alkylating Agents|alkylating agents|mesh-ancestor
102191604|NCT03215524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191605|NCT03215524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191606|NCT03215524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102191607|NCT03215524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102191608|NCT03215524|Antiemetics|antiemetics|mesh-ancestor
102191609|NCT03215524|Autonomic Agents|autonomic agents|mesh-ancestor
102191610|NCT03215524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102191611|NCT03215524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102191612|NCT03215524|Glucocorticoids|glucocorticoids|mesh-ancestor
102191613|NCT03215524|Hormones|hormones|mesh-ancestor
102191614|NCT03215524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102191615|NCT03215524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102191616|NCT03215524|Protease Inhibitors|protease inhibitors|mesh-ancestor
102191617|NCT03215524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102191618|NCT03215524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102191619|NCT03215524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102191620|NCT03215524|Growth Substances|growth substances|mesh-ancestor
102191621|NCT03215524|Growth Inhibitors|growth inhibitors|mesh-ancestor
102191622|NCT03215524|Leprostatic Agents|leprostatic agents|mesh-ancestor
102191623|NCT03215524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102191624|NCT03215524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102191625|NCT03045029|Treprostinil|treprostinil|mesh-list
102191626|NCT03045029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102191627|NCT03018080|Paclitaxel|paclitaxel|mesh-list
102191628|NCT03018080|Pembrolizumab|pembrolizumab|mesh-list
102191629|NCT03018080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102191630|NCT03018080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191631|NCT03018080|Tubulin Modulators|tubulin modulators|mesh-ancestor
102191632|NCT03018080|Antimitotic Agents|antimitotic agents|mesh-ancestor
102191633|NCT03018080|Mitosis Modulators|mitosis modulators|mesh-ancestor
102191634|NCT03018080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191635|NCT03018080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101900440|NCT00312377|Antimitotic Agents|antimitotic agents|mesh-ancestor
102191636|NCT03018080|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102191637|NCT02907983|Bupivacaine|bupivacaine|mesh-list
102191638|NCT02907983|Anesthetics, Local|anesthetics, local|mesh-ancestor
102191639|NCT02907983|Anesthetics|anesthetics|mesh-ancestor
102191640|NCT02907983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102191641|NCT02907983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191642|NCT02907983|Sensory System Agents|sensory system agents|mesh-ancestor
102191643|NCT02907983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102191644|NCT02905318|Palbociclib|palbociclib|mesh-list
102191645|NCT02905318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191646|NCT02905318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102191647|NCT02905318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102191648|NCT02905318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191649|NCT02821013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102191650|NCT02821013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191651|NCT02821013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102191652|NCT02821013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191654|NCT02811133|Vitamin B Complex|vitamin b complex|mesh-ancestor
102191655|NCT02811133|Vitamins|vitamins|mesh-ancestor
102191656|NCT02811133|Micronutrients|micronutrients|mesh-ancestor
102191657|NCT02811133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191658|NCT02799641|Lidocaine|lidocaine|mesh-list
102191659|NCT02799641|Diazepam|diazepam|mesh-list
102191660|NCT02799641|Anesthetics, Local|anesthetics, local|mesh-ancestor
102191661|NCT02799641|Anesthetics|anesthetics|mesh-ancestor
102191662|NCT02799641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102191663|NCT02799641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191664|NCT02799641|Sensory System Agents|sensory system agents|mesh-ancestor
102191665|NCT02799641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102191666|NCT02799641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102191667|NCT02799641|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102191668|NCT02799641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102191669|NCT02799641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102191670|NCT02799641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191671|NCT02799641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102191672|NCT02799641|Anticonvulsants|anticonvulsants|mesh-ancestor
102191673|NCT02799641|Antiemetics|antiemetics|mesh-ancestor
102191674|NCT02799641|Autonomic Agents|autonomic agents|mesh-ancestor
102191675|NCT02799641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102191676|NCT02799641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102191677|NCT02799641|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102191678|NCT02799641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102191679|NCT02799641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102191680|NCT02799641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102191681|NCT02799641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102191682|NCT02799641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102191683|NCT02799641|Anesthetics, General|anesthetics, general|mesh-ancestor
102191684|NCT02799641|GABA Modulators|gaba modulators|mesh-ancestor
102191685|NCT02799641|GABA Agents|gaba agents|mesh-ancestor
102191686|NCT02799641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102191687|NCT02784171|Pembrolizumab|pembrolizumab|mesh-list
102191688|NCT02784171|Pemetrexed|pemetrexed|mesh-list
102191689|NCT02784171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191690|NCT02784171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102191691|NCT02784171|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102191692|NCT02784171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191693|NCT02784171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102191694|NCT02784171|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102191695|NCT02784171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102191696|NCT02782546|Mycophenolic Acid|mycophenolic acid|mesh-list
102191697|NCT02782546|Tacrolimus|tacrolimus|mesh-list
102191698|NCT02782546|Lenograstim|lenograstim|mesh-list
102191699|NCT02782546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102191700|NCT02782546|Immunologic Factors|immunologic factors|mesh-ancestor
102191701|NCT02782546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191702|NCT02782546|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102191703|NCT02782546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102191704|NCT02782546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191705|NCT02782546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102191706|NCT02782546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191707|NCT02782546|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102191708|NCT02782546|Antitubercular Agents|antitubercular agents|mesh-ancestor
102191709|NCT02782546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102191710|NCT02782546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102191711|NCT02782546|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102191712|NCT02781090|Nicotine|nicotine|mesh-list
102191713|NCT02781090|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102191715|NCT02781090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102191716|NCT02781090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191718|NCT02781090|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102191719|NCT02781090|Cholinergic Agents|cholinergic agents|mesh-ancestor
102191720|NCT02781090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102191721|NCT02781090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191722|NCT02774291|Aldesleukin|aldesleukin|mesh-list
102191723|NCT02774291|Cyclophosphamide|cyclophosphamide|mesh-list
102191724|NCT02774291|Fludarabine|fludarabine|mesh-list
102191725|NCT02774291|Fludarabine phosphate|fludarabine phosphate|mesh-list
102191726|NCT02774291|Interleukin-2|interleukin-2|mesh-list
102191727|NCT02774291|Lenograstim|lenograstim|mesh-list
102191728|NCT02774291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102191729|NCT02774291|Immunologic Factors|immunologic factors|mesh-ancestor
102191730|NCT02774291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191731|NCT02774291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102191732|NCT02774291|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102191733|NCT02774291|Alkylating Agents|alkylating agents|mesh-ancestor
102191734|NCT02774291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191735|NCT02774291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191736|NCT02774291|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102191737|NCT02774291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102191738|NCT02774291|Antimetabolites|antimetabolites|mesh-ancestor
102191739|NCT02774291|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102191740|NCT02774291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102191741|NCT02774291|Analgesics|analgesics|mesh-ancestor
102191742|NCT02774291|Sensory System Agents|sensory system agents|mesh-ancestor
102191743|NCT02774291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102191744|NCT02774291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102191745|NCT02774291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102191746|NCT02774291|Antiviral Agents|antiviral agents|mesh-ancestor
102191747|NCT02774291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102191748|NCT02734771|Prednisone|prednisone|mesh-list
102191749|NCT02734771|Cyclophosphamide|cyclophosphamide|mesh-list
102191750|NCT02734771|Rituximab|rituximab|mesh-list
102191751|NCT02734771|Doxorubicin|doxorubicin|mesh-list
102191752|NCT02734771|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102191753|NCT02734771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102191754|NCT02734771|Immunologic Factors|immunologic factors|mesh-ancestor
102191755|NCT02734771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191756|NCT02734771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102191757|NCT02734771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102191758|NCT02734771|Alkylating Agents|alkylating agents|mesh-ancestor
102191759|NCT02734771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191760|NCT02734771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191761|NCT02734771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102191762|NCT02734771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102191763|NCT02734771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102191764|NCT02734771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102191765|NCT02734771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102191766|NCT02734771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102191767|NCT02734771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102191768|NCT02734771|Glucocorticoids|glucocorticoids|mesh-ancestor
102191769|NCT02734771|Hormones|hormones|mesh-ancestor
102191770|NCT02734771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102191771|NCT02734771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102191772|NCT02734771|Immunotoxins|immunotoxins|mesh-ancestor
102191773|NCT02734771|Immunoconjugates|immunoconjugates|mesh-ancestor
102191774|NCT02704858|Perillyl alcohol|perillyl alcohol|mesh-list
102191775|NCT02704858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191776|NCT02704858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102191777|NCT02704858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191778|NCT02689024|Acetaminophen|acetaminophen|mesh-list
102191779|NCT02689024|Dipyrone|dipyrone|mesh-list
102191780|NCT02689024|Ibuprofen|ibuprofen|mesh-list
102191781|NCT02689024|Diclofenac|diclofenac|mesh-list
102191782|NCT02689024|Naproxen|naproxen|mesh-list
102191783|NCT02689024|Fentanyl|fentanyl|mesh-list
102191784|NCT02689024|Morphine|morphine|mesh-list
102191785|NCT02689024|Bupivacaine|bupivacaine|mesh-list
101900599|NCT01285388|Beta-lapachone|beta-lapachone|mesh-list
102191786|NCT02689024|Ropivacaine|ropivacaine|mesh-list
102191787|NCT02689024|Levobupivacaine|levobupivacaine|mesh-list
102191788|NCT02689024|Anesthetics, Local|anesthetics, local|mesh-ancestor
102191789|NCT02689024|Anesthetics|anesthetics|mesh-ancestor
102191790|NCT02689024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102191791|NCT02689024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191793|NCT02689024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102191794|NCT02689024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102191795|NCT02689024|Narcotics|narcotics|mesh-ancestor
102191796|NCT02689024|Analgesics|analgesics|mesh-ancestor
102191797|NCT02689024|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102191798|NCT02689024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102191799|NCT02689024|Anesthetics, General|anesthetics, general|mesh-ancestor
102191800|NCT02689024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102191801|NCT02689024|Antipyretics|antipyretics|mesh-ancestor
102191802|NCT02689024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102191803|NCT02689024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102191804|NCT02689024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102191805|NCT02689024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102191806|NCT02689024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102191807|NCT02689024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191808|NCT02689024|Gout Suppressants|gout suppressants|mesh-ancestor
102191809|NCT02658279|Pembrolizumab|pembrolizumab|mesh-list
102191810|NCT02658279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102191811|NCT02658279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191812|NCT02658279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102191813|NCT02658279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191814|NCT02649686|Trastuzumab|trastuzumab|mesh-list
102191815|NCT02649686|Durvalumab|durvalumab|mesh-list
102191816|NCT02649686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102191817|NCT02649686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191818|NCT02486718|Gemcitabine|gemcitabine|mesh-list
102191819|NCT02486718|Docetaxel|docetaxel|mesh-list
102191820|NCT02486718|Pemetrexed|pemetrexed|mesh-list
102191821|NCT02486718|Atezolizumab|atezolizumab|mesh-list
102191822|NCT02486718|Vinorelbine|vinorelbine|mesh-list
102191823|NCT02486718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191824|NCT02486718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102191825|NCT02486718|Antimetabolites|antimetabolites|mesh-ancestor
102191826|NCT02486718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191827|NCT02486718|Tubulin Modulators|tubulin modulators|mesh-ancestor
102191828|NCT02486718|Antimitotic Agents|antimitotic agents|mesh-ancestor
102191829|NCT02486718|Mitosis Modulators|mitosis modulators|mesh-ancestor
102191830|NCT02486718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102191831|NCT02486718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102191832|NCT02486718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102191833|NCT02486718|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102191834|NCT02486718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102191835|NCT02486718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102191836|NCT02436707|Dexamethasone|dexamethasone|mesh-list
102191837|NCT02436707|Cyclophosphamide|cyclophosphamide|mesh-list
102191838|NCT02436707|Rituximab|rituximab|mesh-list
102191839|NCT02436707|Gemcitabine|gemcitabine|mesh-list
102191840|NCT02436707|Etoposide|etoposide|mesh-list
102191841|NCT02436707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102191842|NCT02436707|Immunologic Factors|immunologic factors|mesh-ancestor
102191843|NCT02436707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191844|NCT02436707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102191845|NCT02436707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102191846|NCT02436707|Alkylating Agents|alkylating agents|mesh-ancestor
102191847|NCT02436707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191848|NCT02436707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191849|NCT02436707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102191850|NCT02436707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102191851|NCT02436707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102191852|NCT02436707|Antiemetics|antiemetics|mesh-ancestor
102191853|NCT02436707|Autonomic Agents|autonomic agents|mesh-ancestor
102191854|NCT02436707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102191855|NCT02436707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102191856|NCT02436707|Glucocorticoids|glucocorticoids|mesh-ancestor
102191857|NCT02436707|Hormones|hormones|mesh-ancestor
102191858|NCT02436707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102191859|NCT02436707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102191860|NCT02436707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102191861|NCT02436707|Antimetabolites|antimetabolites|mesh-ancestor
102191862|NCT02436707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102191863|NCT02436707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102191864|NCT02436707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102191865|NCT02436707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102191866|NCT02356159|Rituximab|rituximab|mesh-list
102191867|NCT02356159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102191868|NCT02356159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191869|NCT02356159|Immunologic Factors|immunologic factors|mesh-ancestor
102191870|NCT02356159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191871|NCT02356159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102191873|NCT02337985|Cyclophosphamide|cyclophosphamide|mesh-list
102191874|NCT02337985|Rituximab|rituximab|mesh-list
102191875|NCT02337985|Doxorubicin|doxorubicin|mesh-list
102191876|NCT02337985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102191877|NCT02337985|Etoposide|etoposide|mesh-list
102191878|NCT02337985|Vincristine|vincristine|mesh-list
102191879|NCT02337985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102191880|NCT02337985|Immunologic Factors|immunologic factors|mesh-ancestor
102191881|NCT02337985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191882|NCT02337985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102191883|NCT02337985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102191884|NCT02337985|Alkylating Agents|alkylating agents|mesh-ancestor
102191885|NCT02337985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191886|NCT02337985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191887|NCT02337985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102191888|NCT02337985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102191889|NCT02337985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102191890|NCT02337985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102191891|NCT02337985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102191892|NCT02337985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102191893|NCT02337985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102191894|NCT02337985|Glucocorticoids|glucocorticoids|mesh-ancestor
102191895|NCT02337985|Hormones|hormones|mesh-ancestor
102191896|NCT02337985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102191897|NCT02337985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102191898|NCT02337985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102191899|NCT02337985|Tubulin Modulators|tubulin modulators|mesh-ancestor
102191900|NCT02337985|Antimitotic Agents|antimitotic agents|mesh-ancestor
102191901|NCT02337985|Mitosis Modulators|mitosis modulators|mesh-ancestor
102191902|NCT02273375|Durvalumab|durvalumab|mesh-list
102191903|NCT02273375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102191904|NCT02273375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191905|NCT02264678|Carboplatin|carboplatin|mesh-list
102191906|NCT02264678|Durvalumab|durvalumab|mesh-list
102191907|NCT02264678|Olaparib|olaparib|mesh-list
102191908|NCT02264678|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102191909|NCT02264678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191910|NCT02264678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102191911|NCT02264678|Immunologic Factors|immunologic factors|mesh-ancestor
102191912|NCT02264678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191913|NCT02264678|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102191914|NCT02264678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102191915|NCT02264678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191916|NCT02153580|Cyclophosphamide|cyclophosphamide|mesh-list
102191917|NCT02153580|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102191918|NCT02153580|Fludarabine|fludarabine|mesh-list
102191919|NCT02153580|Fludarabine phosphate|fludarabine phosphate|mesh-list
102191920|NCT02153580|Etoposide|etoposide|mesh-list
102191921|NCT02153580|Etoposide phosphate|etoposide phosphate|mesh-list
102191922|NCT02153580|Podophyllotoxin|podophyllotoxin|mesh-list
102191923|NCT02153580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102191924|NCT02153580|Immunologic Factors|immunologic factors|mesh-ancestor
102191925|NCT02153580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191926|NCT02153580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102191927|NCT02153580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102191928|NCT02153580|Alkylating Agents|alkylating agents|mesh-ancestor
102191929|NCT02153580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191930|NCT02153580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191931|NCT02153580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102191932|NCT02153580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102191933|NCT02153580|Antimetabolites|antimetabolites|mesh-ancestor
102191934|NCT02153580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102191935|NCT02153580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102191936|NCT02153580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102191937|NCT02153580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102191938|NCT02153580|Keratolytic Agents|keratolytic agents|mesh-ancestor
102191939|NCT02153580|Dermatologic Agents|dermatologic agents|mesh-ancestor
102191940|NCT02153580|Tubulin Modulators|tubulin modulators|mesh-ancestor
102191941|NCT02153580|Antimitotic Agents|antimitotic agents|mesh-ancestor
102191942|NCT02153580|Mitosis Modulators|mitosis modulators|mesh-ancestor
102191943|NCT02144584|Memantine|memantine|mesh-list
102191944|NCT02144584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102191945|NCT02144584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102191946|NCT02144584|Dopamine Agents|dopamine agents|mesh-ancestor
102191947|NCT02144584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102191948|NCT02144584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191949|NCT02144584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191950|NCT02144584|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102191951|NCT02144584|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102191952|NCT02124421|Paclitaxel|paclitaxel|mesh-list
102191953|NCT02124421|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102191954|NCT02124421|Carboplatin|carboplatin|mesh-list
102191955|NCT02124421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102191956|NCT02124421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191957|NCT02124421|Tubulin Modulators|tubulin modulators|mesh-ancestor
102191958|NCT02124421|Antimitotic Agents|antimitotic agents|mesh-ancestor
102191959|NCT02124421|Mitosis Modulators|mitosis modulators|mesh-ancestor
102191960|NCT02124421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191961|NCT01897571|Prednisolone|prednisolone|mesh-list
102191962|NCT01897571|Prednisolone acetate|prednisolone acetate|mesh-list
102191963|NCT01897571|Prednisolone phosphate|prednisolone phosphate|mesh-list
102191964|NCT01897571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102191965|NCT01897571|Glucocorticoids|glucocorticoids|mesh-ancestor
102191966|NCT01897571|Hormones|hormones|mesh-ancestor
102191967|NCT01897571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102191968|NCT01897571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191969|NCT01897571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102191970|NCT01897571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191971|NCT01846390|Dexamethasone|dexamethasone|mesh-list
102191972|NCT01846390|Gemcitabine|gemcitabine|mesh-list
102191973|NCT01846390|Romidepsin|romidepsin|mesh-list
102191974|NCT01846390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102191975|NCT01846390|Antiemetics|antiemetics|mesh-ancestor
102191976|NCT01846390|Autonomic Agents|autonomic agents|mesh-ancestor
102191977|NCT01846390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102191978|NCT01846390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102191979|NCT01846390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102191980|NCT01846390|Glucocorticoids|glucocorticoids|mesh-ancestor
102191981|NCT01846390|Hormones|hormones|mesh-ancestor
102191982|NCT01846390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102191983|NCT01846390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102191984|NCT01846390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191985|NCT01846390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102191986|NCT01846390|Antimetabolites|antimetabolites|mesh-ancestor
102191987|NCT01846390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102191988|NCT01846390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102191989|NCT01846390|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102191990|NCT01846390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102191991|NCT01783197|Paclitaxel|paclitaxel|mesh-list
102191992|NCT01783197|Carboplatin|carboplatin|mesh-list
102191993|NCT01783197|Pemetrexed|pemetrexed|mesh-list
102191994|NCT01783197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102191995|NCT01783197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102191996|NCT01783197|Tubulin Modulators|tubulin modulators|mesh-ancestor
102191997|NCT01783197|Antimitotic Agents|antimitotic agents|mesh-ancestor
102191998|NCT01783197|Mitosis Modulators|mitosis modulators|mesh-ancestor
102191999|NCT01783197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192000|NCT01783197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102192001|NCT01783197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102192002|NCT01783197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102192003|NCT01765855|Betrixaban|betrixaban|mesh-list
102192004|NCT01765855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102192005|NCT01765855|Antithrombins|antithrombins|mesh-ancestor
102192006|NCT01765855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102192007|NCT01765855|Protease Inhibitors|protease inhibitors|mesh-ancestor
102192008|NCT01765855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102192009|NCT01765855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192010|NCT01765855|Anticoagulants|anticoagulants|mesh-ancestor
102192011|NCT01708993|Docetaxel|docetaxel|mesh-list
102192012|NCT01708993|Pemetrexed|pemetrexed|mesh-list
102192013|NCT01708993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192014|NCT01708993|Tubulin Modulators|tubulin modulators|mesh-ancestor
102192015|NCT01708993|Antimitotic Agents|antimitotic agents|mesh-ancestor
102192017|NCT01708993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192018|NCT01708993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102192019|NCT01708993|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102192020|NCT01708993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102192022|NCT01656538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102192023|NCT01656538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192024|NCT01656538|Tubulin Modulators|tubulin modulators|mesh-ancestor
102192025|NCT01656538|Antimitotic Agents|antimitotic agents|mesh-ancestor
102192026|NCT01656538|Mitosis Modulators|mitosis modulators|mesh-ancestor
102192027|NCT01656538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192028|NCT01651403|Tenofovir|tenofovir|mesh-list
102192029|NCT01651403|Antiviral Agents|antiviral agents|mesh-ancestor
102192030|NCT01651403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102192031|NCT01651403|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102192032|NCT01651403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102192033|NCT01651403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102192034|NCT01651403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192035|NCT01651403|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102192036|NCT01651403|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102192037|NCT01619813|Prednisone|prednisone|mesh-list
102192038|NCT01619813|Docetaxel|docetaxel|mesh-list
102192039|NCT01619813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192040|NCT01619813|Tubulin Modulators|tubulin modulators|mesh-ancestor
102192041|NCT01619813|Antimitotic Agents|antimitotic agents|mesh-ancestor
102192042|NCT01619813|Mitosis Modulators|mitosis modulators|mesh-ancestor
102192043|NCT01619813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192044|NCT01619813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102192045|NCT01619813|Glucocorticoids|glucocorticoids|mesh-ancestor
102192046|NCT01619813|Hormones|hormones|mesh-ancestor
102192047|NCT01619813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102192048|NCT01619813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192049|NCT01619813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102192050|NCT01591421|Panitumumab|panitumumab|mesh-list
102192051|NCT01591421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102192052|NCT01591421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192058|NCT01419834|Antibodies|antibodies|mesh-list
102192059|NCT01419834|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102192060|NCT01419834|Immunologic Factors|immunologic factors|mesh-ancestor
102192061|NCT01419834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192062|NCT01138384|Lapatinib|lapatinib|mesh-list
102192063|NCT01138384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192064|NCT01138384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102192065|NCT01138384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102192066|NCT01138384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192067|NCT01075308|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
102192068|NCT01075308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102192069|NCT01075308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192070|NCT01068587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102192071|NCT01068587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192072|NCT01068587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102192073|NCT01068587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102192074|NCT01068587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192075|NCT00953771|Danazol|danazol|mesh-list
102192076|NCT00953771|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102192077|NCT00953771|Hormone Antagonists|hormone antagonists|mesh-ancestor
102192078|NCT00953771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102192079|NCT00953771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192080|NCT00930332|Methadone|methadone|mesh-list
102192081|NCT00930332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102192082|NCT00930332|Narcotics|narcotics|mesh-ancestor
102192083|NCT00930332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102192084|NCT00930332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192085|NCT00930332|Analgesics|analgesics|mesh-ancestor
101900297|NCT01169870|Paclitaxel|paclitaxel|mesh-list
102192086|NCT00930332|Sensory System Agents|sensory system agents|mesh-ancestor
102192087|NCT00930332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102192088|NCT00930332|Antitussive Agents|antitussive agents|mesh-ancestor
102192089|NCT00930332|Respiratory System Agents|respiratory system agents|mesh-ancestor
102192090|NCT00869752|Etoposide|etoposide|mesh-list
102192091|NCT00869752|Antibodies|antibodies|mesh-list
102192092|NCT00869752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102192093|NCT00869752|Immunologic Factors|immunologic factors|mesh-ancestor
102192094|NCT00869752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192095|NCT00869752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192096|NCT00869752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102192097|NCT00869752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102192098|NCT00869752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102192099|NCT00869752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102192100|NCT00869752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192101|NCT00836485|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
102192102|NCT00836485|Ketotifen|ketotifen|mesh-list
102192103|NCT00836485|Lubricant Eye Drops|lubricant eye drops|mesh-list
102192104|NCT00836485|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102192105|NCT00836485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102192106|NCT00836485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102192107|NCT00836485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102192108|NCT00836485|Analgesics|analgesics|mesh-ancestor
102192109|NCT00836485|Sensory System Agents|sensory system agents|mesh-ancestor
102192110|NCT00836485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102192111|NCT00836485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192112|NCT00836485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102192113|NCT00836485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102192114|NCT00836485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102192115|NCT00836485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102192116|NCT00836485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102192117|NCT00836485|Histamine Antagonists|histamine antagonists|mesh-ancestor
102192118|NCT00836485|Histamine Agents|histamine agents|mesh-ancestor
102192119|NCT00836485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102192120|NCT00836485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192121|NCT00836485|Antipruritics|antipruritics|mesh-ancestor
102192122|NCT00836485|Dermatologic Agents|dermatologic agents|mesh-ancestor
102192123|NCT00720785|Bortezomib|bortezomib|mesh-list
102192124|NCT00720785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192125|NCT00658593|Gemcitabine|gemcitabine|mesh-list
102192126|NCT00658593|Capecitabine|capecitabine|mesh-list
102192127|NCT00658593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102192128|NCT00658593|Antimetabolites|antimetabolites|mesh-ancestor
102192129|NCT00658593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192130|NCT00658593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192131|NCT00651326|Docetaxel|docetaxel|mesh-list
102192132|NCT00651326|Leuprolide|leuprolide|mesh-list
102192133|NCT00651326|Goserelin|goserelin|mesh-list
102192134|NCT00651326|Bicalutamide|bicalutamide|mesh-list
102192135|NCT00651326|Flutamide|flutamide|mesh-list
102192136|NCT00651326|Buserelin|buserelin|mesh-list
102192137|NCT00651326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192138|NCT00651326|Tubulin Modulators|tubulin modulators|mesh-ancestor
102192139|NCT00651326|Antimitotic Agents|antimitotic agents|mesh-ancestor
102192140|NCT00651326|Mitosis Modulators|mitosis modulators|mesh-ancestor
101686034|NCT00903617|Vitamins|vitamins|mesh-ancestor
102192141|NCT00651326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192142|NCT00651326|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102192143|NCT00651326|Fertility Agents|fertility agents|mesh-ancestor
102192144|NCT00651326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102192145|NCT00651326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192146|NCT00651326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102192147|NCT00651326|Androgen Antagonists|androgen antagonists|mesh-ancestor
102192148|NCT00651326|Hormone Antagonists|hormone antagonists|mesh-ancestor
102192149|NCT00651326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102192150|NCT00640471|Cetuximab|cetuximab|mesh-list
102192151|NCT00640471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102192152|NCT00640471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192153|NCT00535353|Irinotecan|irinotecan|mesh-list
102192154|NCT00535353|Olaparib|olaparib|mesh-list
102192155|NCT00535353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102192156|NCT00535353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102192157|NCT00535353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102192158|NCT00535353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192159|NCT00535353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192160|NCT00535353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102192161|NCT00516828|Cytarabine|cytarabine|mesh-list
102192162|NCT00516828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102192163|NCT00516828|Antimetabolites|antimetabolites|mesh-ancestor
102192164|NCT00516828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192165|NCT00516828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192166|NCT00516828|Antiviral Agents|antiviral agents|mesh-ancestor
101900962|NCT00074490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102192167|NCT00516828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102192168|NCT00516828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102192169|NCT00516828|Immunologic Factors|immunologic factors|mesh-ancestor
102192170|NCT00516828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192171|NCT00504296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
102192172|NCT00504296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102192173|NCT00504296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192175|NCT00482755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192176|NCT00482755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102192177|NCT00482755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102192178|NCT00482755|Growth Substances|growth substances|mesh-ancestor
102192179|NCT00482755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192180|NCT00482755|Growth Inhibitors|growth inhibitors|mesh-ancestor
102192181|NCT00482755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102192182|NCT00482755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102192183|NCT00482755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192184|NCT00471432|Docetaxel|docetaxel|mesh-list
102192185|NCT00471432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192186|NCT00471432|Tubulin Modulators|tubulin modulators|mesh-ancestor
102192187|NCT00471432|Antimitotic Agents|antimitotic agents|mesh-ancestor
102192188|NCT00471432|Mitosis Modulators|mitosis modulators|mesh-ancestor
102192189|NCT00471432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192190|NCT00470353|Cholecalciferol|cholecalciferol|mesh-list
102192191|NCT00470353|Vitamin D|vitamin d|mesh-list
102192192|NCT00470353|Calcium Carbonate|calcium carbonate|mesh-list
102192193|NCT00470353|Calcium|calcium|mesh-list
102192194|NCT00470353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102192195|NCT00470353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192196|NCT00470353|Vitamins|vitamins|mesh-ancestor
102192197|NCT00470353|Micronutrients|micronutrients|mesh-ancestor
102192198|NCT00470353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102192199|NCT00470353|Antacids|antacids|mesh-ancestor
102192200|NCT00470353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192201|NCT00470353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102192202|NCT00428142|Prednisone|prednisone|mesh-list
102192203|NCT00428142|Cyclophosphamide|cyclophosphamide|mesh-list
102192204|NCT00428142|Rituximab|rituximab|mesh-list
102192205|NCT00428142|Vincristine|vincristine|mesh-list
102192206|NCT00428142|Bortezomib|bortezomib|mesh-list
102192207|NCT00428142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102192208|NCT00428142|Immunologic Factors|immunologic factors|mesh-ancestor
102192209|NCT00428142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192210|NCT00428142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102192211|NCT00428142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102192212|NCT00428142|Alkylating Agents|alkylating agents|mesh-ancestor
102192213|NCT00428142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192214|NCT00428142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192215|NCT00428142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102192216|NCT00428142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102192217|NCT00428142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102192218|NCT00428142|Glucocorticoids|glucocorticoids|mesh-ancestor
102192219|NCT00428142|Hormones|hormones|mesh-ancestor
102192220|NCT00428142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102192221|NCT00428142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102192222|NCT00428142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102192223|NCT00428142|Tubulin Modulators|tubulin modulators|mesh-ancestor
102192224|NCT00428142|Antimitotic Agents|antimitotic agents|mesh-ancestor
102192225|NCT00428142|Mitosis Modulators|mitosis modulators|mesh-ancestor
102192226|NCT00387400|Everolimus|everolimus|mesh-list
102192227|NCT00387400|Temozolomide|temozolomide|mesh-list
102192228|NCT00387400|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102192229|NCT00387400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102192231|NCT00387400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192232|NCT00387400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102192233|NCT00387400|Immunologic Factors|immunologic factors|mesh-ancestor
102192234|NCT00387400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192235|NCT00387400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192236|NCT00387400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102192237|NCT00387400|Alkylating Agents|alkylating agents|mesh-ancestor
102192238|NCT00377052|Gemcitabine|gemcitabine|mesh-list
102192239|NCT00377052|Bortezomib|bortezomib|mesh-list
102192240|NCT00377052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102192241|NCT00377052|Antimetabolites|antimetabolites|mesh-ancestor
102192242|NCT00377052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192243|NCT00377052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192244|NCT00372736|Docetaxel|docetaxel|mesh-list
102192245|NCT00372736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192246|NCT00372736|Tubulin Modulators|tubulin modulators|mesh-ancestor
102192247|NCT00372736|Antimitotic Agents|antimitotic agents|mesh-ancestor
102192248|NCT00372736|Mitosis Modulators|mitosis modulators|mesh-ancestor
102192249|NCT00372736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192250|NCT00357747|Docetaxel|docetaxel|mesh-list
102192251|NCT00357747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192252|NCT00357747|Tubulin Modulators|tubulin modulators|mesh-ancestor
102192253|NCT00357747|Antimitotic Agents|antimitotic agents|mesh-ancestor
102192254|NCT00357747|Mitosis Modulators|mitosis modulators|mesh-ancestor
102192255|NCT00357747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192256|NCT00352079|Gefitinib|gefitinib|mesh-list
102192257|NCT00352079|BCG Vaccine|bcg vaccine|mesh-list
102192258|NCT00352079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192259|NCT00352079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102192260|NCT00352079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102192261|NCT00352079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192262|NCT00352079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102192263|NCT00352079|Immunologic Factors|immunologic factors|mesh-ancestor
102192264|NCT00352079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192265|NCT00343408|Leucovorin|leucovorin|mesh-list
102192266|NCT00343408|Gemcitabine|gemcitabine|mesh-list
102192267|NCT00343408|Fluorouracil|fluorouracil|mesh-list
102192268|NCT00343408|Oxaliplatin|oxaliplatin|mesh-list
102192269|NCT00343408|Cediranib|cediranib|mesh-list
102192270|NCT00343408|Calcium|calcium|mesh-list
102192271|NCT00343408|Levoleucovorin|levoleucovorin|mesh-list
102192272|NCT00343408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192273|NCT00343408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102192274|NCT00343408|Antimetabolites|antimetabolites|mesh-ancestor
102192275|NCT00343408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192276|NCT00343408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102192277|NCT00343408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192278|NCT00343408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102192279|NCT00343408|Immunologic Factors|immunologic factors|mesh-ancestor
102192280|NCT00343408|Antidotes|antidotes|mesh-ancestor
102192281|NCT00343408|Protective Agents|protective agents|mesh-ancestor
102192282|NCT00343408|Vitamin B Complex|vitamin b complex|mesh-ancestor
102192283|NCT00343408|Vitamins|vitamins|mesh-ancestor
102192284|NCT00343408|Micronutrients|micronutrients|mesh-ancestor
102192285|NCT00343408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102192286|NCT00343408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102192287|NCT00305812|Dexamethasone|dexamethasone|mesh-list
102192288|NCT00305812|Lenalidomide|lenalidomide|mesh-list
102192289|NCT00305812|Melphalan|melphalan|mesh-list
102192290|NCT00305812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102192291|NCT00305812|Antiemetics|antiemetics|mesh-ancestor
102192292|NCT00305812|Autonomic Agents|autonomic agents|mesh-ancestor
102192293|NCT00305812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102192294|NCT00305812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192295|NCT00305812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102192296|NCT00305812|Glucocorticoids|glucocorticoids|mesh-ancestor
102192297|NCT00305812|Hormones|hormones|mesh-ancestor
102192298|NCT00305812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102192299|NCT00305812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102192300|NCT00305812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192301|NCT00305812|Immunologic Factors|immunologic factors|mesh-ancestor
102192302|NCT00305812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102192303|NCT00305812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102192304|NCT00305812|Growth Substances|growth substances|mesh-ancestor
101900306|NCT01165970|Laxatives|laxatives|mesh-ancestor
102192305|NCT00305812|Growth Inhibitors|growth inhibitors|mesh-ancestor
102192306|NCT00305812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102192307|NCT00305812|Alkylating Agents|alkylating agents|mesh-ancestor
102192308|NCT00305812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192309|NCT00305812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102192310|NCT00305812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102192311|NCT00265876|Gemcitabine|gemcitabine|mesh-list
102192312|NCT00265876|Saracatinib|saracatinib|mesh-list
102192313|NCT00265876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102192314|NCT00265876|Antimetabolites|antimetabolites|mesh-ancestor
102192315|NCT00265876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192316|NCT00265876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192317|NCT00265876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102192318|NCT00258388|Prednisone|prednisone|mesh-list
102192319|NCT00258388|Docetaxel|docetaxel|mesh-list
102192320|NCT00258388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192321|NCT00258388|Tubulin Modulators|tubulin modulators|mesh-ancestor
102192322|NCT00258388|Antimitotic Agents|antimitotic agents|mesh-ancestor
102192323|NCT00258388|Mitosis Modulators|mitosis modulators|mesh-ancestor
102192324|NCT00258388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192325|NCT00258388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102192326|NCT00258388|Glucocorticoids|glucocorticoids|mesh-ancestor
102192328|NCT00258388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102192329|NCT00258388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192330|NCT00258388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102192331|NCT00258375|Docetaxel|docetaxel|mesh-list
102192332|NCT00258375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192333|NCT00258375|Tubulin Modulators|tubulin modulators|mesh-ancestor
102192334|NCT00258375|Antimitotic Agents|antimitotic agents|mesh-ancestor
102192335|NCT00258375|Mitosis Modulators|mitosis modulators|mesh-ancestor
102192336|NCT00258375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192337|NCT00255788|Everolimus|everolimus|mesh-list
102192338|NCT00255788|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102192339|NCT00255788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102192340|NCT00255788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102192341|NCT00255788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192342|NCT00255788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102192343|NCT00255788|Immunologic Factors|immunologic factors|mesh-ancestor
102192344|NCT00255788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192345|NCT00255788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192346|NCT00245154|Paclitaxel|paclitaxel|mesh-list
102192347|NCT00245154|Carboplatin|carboplatin|mesh-list
102192348|NCT00245154|Cediranib|cediranib|mesh-list
102192349|NCT00245154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101686231|NCT00619944|Antiviral Agents|antiviral agents|mesh-ancestor
102192350|NCT00245154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192351|NCT00245154|Tubulin Modulators|tubulin modulators|mesh-ancestor
102192352|NCT00245154|Antimitotic Agents|antimitotic agents|mesh-ancestor
102192353|NCT00245154|Mitosis Modulators|mitosis modulators|mesh-ancestor
102192354|NCT00245154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192355|NCT00245154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102192356|NCT00245154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102192357|NCT00093457|Sorafenib|sorafenib|mesh-list
102192358|NCT00093457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192359|NCT00093457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102192360|NCT00093457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102192361|NCT00093457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192362|NCT00084734|Docetaxel|docetaxel|mesh-list
102192363|NCT00084734|Capecitabine|capecitabine|mesh-list
102192364|NCT00084734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192365|NCT00084734|Tubulin Modulators|tubulin modulators|mesh-ancestor
102192366|NCT00084734|Antimitotic Agents|antimitotic agents|mesh-ancestor
102192367|NCT00084734|Mitosis Modulators|mitosis modulators|mesh-ancestor
102192368|NCT00084734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192369|NCT00084734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102192370|NCT00084734|Antimetabolites|antimetabolites|mesh-ancestor
102192371|NCT00080756|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102192372|NCT00080756|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102192373|NCT00080756|Estradiol|estradiol|mesh-list
102192374|NCT00080756|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102192375|NCT00080756|Testosterone|testosterone|mesh-list
102192376|NCT00080756|Deslorelin|deslorelin|mesh-list
102192377|NCT00080756|Estrogens|estrogens|mesh-ancestor
102192378|NCT00080756|Hormones|hormones|mesh-ancestor
102192379|NCT00080756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102192380|NCT00080756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192381|NCT00080756|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102192382|NCT00080756|Contraceptive Agents|contraceptive agents|mesh-ancestor
102192383|NCT00080756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102192384|NCT00080756|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102192385|NCT00080756|Androgens|androgens|mesh-ancestor
102192386|NCT00080756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102192387|NCT00080756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192388|NCT00079079|Carboplatin|carboplatin|mesh-list
102192389|NCT00079079|Gemcitabine|gemcitabine|mesh-list
102192390|NCT00079079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192391|NCT00079079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102192392|NCT00079079|Antimetabolites|antimetabolites|mesh-ancestor
102192393|NCT00079079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192394|NCT00079066|Cetuximab|cetuximab|mesh-list
102192395|NCT00079066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102192396|NCT00079066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192397|NCT00079053|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102192398|NCT00079053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192399|NCT00079053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102192400|NCT00079053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102192401|NCT00079053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192402|NCT00066443|Docetaxel|docetaxel|mesh-list
102192403|NCT00066443|Epirubicin|epirubicin|mesh-list
102192404|NCT00066443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192405|NCT00066443|Tubulin Modulators|tubulin modulators|mesh-ancestor
102192406|NCT00066443|Antimitotic Agents|antimitotic agents|mesh-ancestor
102192407|NCT00066443|Mitosis Modulators|mitosis modulators|mesh-ancestor
102192408|NCT00066443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192409|NCT00066443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102192410|NCT00066443|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102192411|NCT00066443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102192412|NCT00066443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102192413|NCT00054106|Flutamide|flutamide|mesh-list
102192414|NCT00054106|Buserelin|buserelin|mesh-list
102192415|NCT00054106|Androgen Antagonists|androgen antagonists|mesh-ancestor
102192416|NCT00054106|Hormone Antagonists|hormone antagonists|mesh-ancestor
102192417|NCT00054106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102192418|NCT00054106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192419|NCT00054106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102192420|NCT00054106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192421|NCT00054106|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102192422|NCT00054106|Fertility Agents|fertility agents|mesh-ancestor
102192423|NCT00054106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102192424|NCT00030875|Bortezomib|bortezomib|mesh-list
102192425|NCT00030875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192426|NCT00025935|Lithium Carbonate|lithium carbonate|mesh-list
102192427|NCT00025935|Antidepressive Agents|antidepressive agents|mesh-ancestor
102192428|NCT00025935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102192429|NCT00025935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102192430|NCT00025935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192431|NCT00025935|Antimanic Agents|antimanic agents|mesh-ancestor
102192432|NCT00025935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102192433|NCT00025935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102192434|NCT00025935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192435|NCT03532867|Tin Fluorides|tin fluorides|mesh-list
102192436|NCT03532867|Cariostatic Agents|cariostatic agents|mesh-ancestor
102192437|NCT03532867|Protective Agents|protective agents|mesh-ancestor
102192438|NCT03532867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192439|NCT02207959|Proflavine|proflavine|mesh-list
102192440|NCT02207959|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102192441|NCT02207959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102192442|NCT02567552|Progesterone|progesterone|mesh-list
102192443|NCT02567552|Progestins|progestins|mesh-ancestor
102192444|NCT02567552|Hormones|hormones|mesh-ancestor
102192445|NCT02567552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102192446|NCT02567552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192447|NCT02208427|Isoniazid|isoniazid|mesh-list
102192448|NCT02208427|Rifapentine|rifapentine|mesh-list
102192449|NCT02208427|Antitubercular Agents|antitubercular agents|mesh-ancestor
102192450|NCT02208427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102192451|NCT02208427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102192452|NCT02208427|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102192453|NCT02208427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102192454|NCT02208427|Antimetabolites|antimetabolites|mesh-ancestor
102192455|NCT02208427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192456|NCT02208427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102192457|NCT02208427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102192458|NCT02208427|Leprostatic Agents|leprostatic agents|mesh-ancestor
102192459|NCT05508620|Sirolimus|sirolimus|mesh-list
102192460|NCT05508620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102192461|NCT05508620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102192462|NCT05508620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102192463|NCT05508620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192464|NCT05508620|Antifungal Agents|antifungal agents|mesh-ancestor
102192465|NCT05508620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102192466|NCT05508620|Immunologic Factors|immunologic factors|mesh-ancestor
102192467|NCT05508620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192468|NCT03803605|Vorinostat|vorinostat|mesh-list
102192469|NCT03803605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192470|NCT03803605|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102192471|NCT03803605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102192472|NCT03803605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192473|NCT02208505|Dexmedetomidine|dexmedetomidine|mesh-list
102192474|NCT02208505|Remifentanil|remifentanil|mesh-list
102192475|NCT02208505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102192476|NCT02208505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102192477|NCT02208505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192478|NCT02208505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102192479|NCT02208505|Analgesics|analgesics|mesh-ancestor
102192480|NCT02208505|Sensory System Agents|sensory system agents|mesh-ancestor
102192481|NCT02208505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102192482|NCT02208505|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102192483|NCT02208505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102192484|NCT02208505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102192485|NCT02208505|Adrenergic Agents|adrenergic agents|mesh-ancestor
102192486|NCT02208505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102192487|NCT02208505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192488|NCT02208505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102192489|NCT02208505|Narcotics|narcotics|mesh-ancestor
102192490|NCT02208583|Prednisone|prednisone|mesh-list
102192491|NCT02208583|Cisplatin|cisplatin|mesh-list
102192492|NCT02208583|Docetaxel|docetaxel|mesh-list
102192493|NCT02208583|Etoposide|etoposide|mesh-list
102192494|NCT02208583|Etoposide phosphate|etoposide phosphate|mesh-list
102192495|NCT02208583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192496|NCT02208583|Tubulin Modulators|tubulin modulators|mesh-ancestor
102192497|NCT02208583|Antimitotic Agents|antimitotic agents|mesh-ancestor
102192498|NCT02208583|Mitosis Modulators|mitosis modulators|mesh-ancestor
102192499|NCT02208583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192500|NCT02208583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102192501|NCT02208583|Glucocorticoids|glucocorticoids|mesh-ancestor
102192502|NCT02208583|Hormones|hormones|mesh-ancestor
102192503|NCT02208583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102192504|NCT02208583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192505|NCT02208583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102192506|NCT02208583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102192507|NCT02208583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102192508|NCT02208583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102192509|NCT02208583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102192510|NCT05501288|Pholcodine|pholcodine|mesh-list
102192511|NCT05501288|Analgesics|analgesics|mesh-ancestor
102192512|NCT05501288|Sensory System Agents|sensory system agents|mesh-ancestor
102192513|NCT05501288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102192514|NCT05501288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192515|NCT05501288|Antitussive Agents|antitussive agents|mesh-ancestor
102192516|NCT05501288|Respiratory System Agents|respiratory system agents|mesh-ancestor
102192517|NCT04738292|Fulvestrant|fulvestrant|mesh-list
102192518|NCT04738292|Onapristone|onapristone|mesh-list
102192519|NCT04738292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102192520|NCT04738292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192521|NCT04738292|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102192522|NCT04738292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102192523|NCT04738292|Hormone Antagonists|hormone antagonists|mesh-ancestor
102192524|NCT04738292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102192525|NCT04738292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192526|NCT04738292|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102192527|NCT04738292|Fertility Agents|fertility agents|mesh-ancestor
102192528|NCT04738292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102192529|NCT02199379|Lenvatinib|lenvatinib|mesh-list
102192530|NCT02199379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192531|NCT02199379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102192532|NCT02199379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102192533|NCT02199379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192534|NCT03532711|Leucovorin|leucovorin|mesh-list
102192535|NCT03532711|Fluorouracil|fluorouracil|mesh-list
102192536|NCT03532711|Capecitabine|capecitabine|mesh-list
102192537|NCT03532711|Oxaliplatin|oxaliplatin|mesh-list
102192538|NCT03532711|Irinotecan|irinotecan|mesh-list
102192539|NCT03532711|Levoleucovorin|levoleucovorin|mesh-list
102192540|NCT03532711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192541|NCT03532711|Antimetabolites|antimetabolites|mesh-ancestor
102192542|NCT03532711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192543|NCT03532711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102192544|NCT03532711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192545|NCT03532711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101901333|NCT01180166|Nimotuzumab|nimotuzumab|mesh-list
102192546|NCT03532711|Immunologic Factors|immunologic factors|mesh-ancestor
102192547|NCT03532711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102192548|NCT03532711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102192549|NCT03532711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102192550|NCT03532711|Antidotes|antidotes|mesh-ancestor
102192551|NCT03532711|Protective Agents|protective agents|mesh-ancestor
102192552|NCT03532711|Vitamin B Complex|vitamin b complex|mesh-ancestor
102192553|NCT03532711|Vitamins|vitamins|mesh-ancestor
102192554|NCT03532711|Micronutrients|micronutrients|mesh-ancestor
102192555|NCT04714112|Dexamethasone|dexamethasone|mesh-list
102192556|NCT04714112|Dexamethasone acetate|dexamethasone acetate|mesh-list
102192557|NCT04714112|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102192558|NCT04714112|BB 1101|bb 1101|mesh-list
102192559|NCT04714112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102192560|NCT04714112|Antiemetics|antiemetics|mesh-ancestor
102192561|NCT04714112|Autonomic Agents|autonomic agents|mesh-ancestor
102192562|NCT04714112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102192563|NCT04714112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192564|NCT04714112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102192566|NCT04714112|Hormones|hormones|mesh-ancestor
102192567|NCT04714112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102192568|NCT04714112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102192569|NCT04714112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192570|NCT04714112|Protease Inhibitors|protease inhibitors|mesh-ancestor
102192571|NCT04714112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102192572|NCT04714112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192573|NCT02199613|Darunavir|darunavir|mesh-list
102192574|NCT02199613|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102192575|NCT02199613|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102192576|NCT02199613|Protease Inhibitors|protease inhibitors|mesh-ancestor
102192577|NCT02199613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102192578|NCT02199613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192579|NCT02199613|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102192580|NCT02199613|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102192581|NCT02199613|Antiviral Agents|antiviral agents|mesh-ancestor
102192582|NCT02199613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102192583|NCT02209441|Sorafenib|sorafenib|mesh-list
102192584|NCT02209441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192585|NCT02209441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102192586|NCT02209441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102192587|NCT02209441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192588|NCT02199925|gamma-Globulins|gamma-globulins|mesh-list
102192589|NCT02199925|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102192590|NCT02199925|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102192591|NCT02199925|Immunologic Factors|immunologic factors|mesh-ancestor
102192592|NCT02199925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192593|NCT03338647|Doxorubicin|doxorubicin|mesh-list
102192594|NCT03338647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102192595|NCT03338647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192596|NCT03338647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102192597|NCT03338647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102192598|NCT03338647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102192599|NCT03338647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192600|NCT05500742|Selenium|selenium|mesh-list
102192601|NCT05500742|Ubiquinone|ubiquinone|mesh-list
102192602|NCT05500742|Coenzyme Q10|coenzyme q10|mesh-list
102192603|NCT05500742|Resveratrol|resveratrol|mesh-list
102192604|NCT05500742|Antioxidants|antioxidants|mesh-ancestor
102192605|NCT05500742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192606|NCT05500742|Protective Agents|protective agents|mesh-ancestor
102192607|NCT05500742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192608|NCT05500742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102192609|NCT05500742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102192610|NCT05500742|Trace Elements|trace elements|mesh-ancestor
102192611|NCT05500742|Micronutrients|micronutrients|mesh-ancestor
102192612|NCT05500742|Vitamins|vitamins|mesh-ancestor
102192613|NCT03533335|Chlorhexidine|chlorhexidine|mesh-list
102192614|NCT03533335|Chlorine dioxide|chlorine dioxide|mesh-list
102192615|NCT03533335|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102192616|NCT03533335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102192617|NCT03533335|Disinfectants|disinfectants|mesh-ancestor
102192618|NCT03533335|Dental Disinfectants|dental disinfectants|mesh-ancestor
102192619|NCT02200159|Dexmedetomidine|dexmedetomidine|mesh-list
101901407|NCT01287494|Serotonin Agents|serotonin agents|mesh-ancestor
102192620|NCT02200159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102192621|NCT02200159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102192622|NCT02200159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192623|NCT02200159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102192624|NCT02200159|Analgesics|analgesics|mesh-ancestor
102192625|NCT02200159|Sensory System Agents|sensory system agents|mesh-ancestor
102192626|NCT02200159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102192627|NCT02200159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101449409|NCT00123266|Plasminogen|plasminogen|mesh-list
102192628|NCT02200159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102192629|NCT02200159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102192630|NCT02200159|Adrenergic Agents|adrenergic agents|mesh-ancestor
102192631|NCT02200159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102192632|NCT02200159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192633|NCT02204527|Vitamin D|vitamin d|mesh-list
102192634|NCT02204527|Ergocalciferols|ergocalciferols|mesh-list
102192635|NCT02204527|Cholecalciferol|cholecalciferol|mesh-list
102192636|NCT02204527|Vitamins|vitamins|mesh-list
102192637|NCT02204527|Micronutrients|micronutrients|mesh-ancestor
102192638|NCT02204527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192639|NCT02204527|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102192640|NCT02204527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102192642|NCT02200237|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102192643|NCT02200237|Immunologic Factors|immunologic factors|mesh-ancestor
102192644|NCT02200237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192645|NCT02200237|Antacids|antacids|mesh-ancestor
102192646|NCT02200237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192647|NCT02200237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102192648|NCT02209831|Pantoprazole|pantoprazole|mesh-list
102192649|NCT02209831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102192650|NCT02209831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102192651|NCT02209831|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102192652|NCT02209831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102192653|NCT02209831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192654|NCT01663532|Aripiprazole|aripiprazole|mesh-list
102192655|NCT01663532|Antidepressive Agents|antidepressive agents|mesh-ancestor
102192656|NCT01663532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102192657|NCT01663532|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102192658|NCT01663532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102192659|NCT01663532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102192660|NCT01663532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192661|NCT01663532|Dopamine Agonists|dopamine agonists|mesh-ancestor
102192662|NCT01663532|Dopamine Agents|dopamine agents|mesh-ancestor
102192663|NCT01663532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102192664|NCT01663532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192665|NCT01663532|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102192666|NCT01663532|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102192667|NCT01663532|Serotonin Agents|serotonin agents|mesh-ancestor
102192668|NCT01663532|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102192669|NCT01663532|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102192670|NCT01663532|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102192671|NCT01663532|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102192672|NCT02200315|Anti-Infective Agents|anti-infective agents|mesh-list
102192673|NCT02200315|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102192674|NCT02204683|Aflibercept|aflibercept|mesh-list
102192675|NCT02204683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102192676|NCT02204683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102192677|NCT02204683|Growth Substances|growth substances|mesh-ancestor
102192678|NCT02204683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192679|NCT02204683|Growth Inhibitors|growth inhibitors|mesh-ancestor
102192680|NCT02204683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192681|NCT02204839|Insulin|insulin|mesh-list
102192682|NCT02204839|Insulin Glargine|insulin glargine|mesh-list
102192683|NCT02204839|Insulin Detemir|insulin detemir|mesh-list
102192684|NCT02204839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102192685|NCT02204839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192686|NCT02209909|Aspirin|aspirin|mesh-list
102192687|NCT02209909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102192688|NCT02209909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102192689|NCT02209909|Analgesics|analgesics|mesh-ancestor
102192690|NCT02209909|Sensory System Agents|sensory system agents|mesh-ancestor
102192691|NCT02209909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102192692|NCT02209909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192693|NCT02209909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102192694|NCT02209909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102192695|NCT02209909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102192696|NCT02209909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102192697|NCT02209909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192698|NCT02209909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102192699|NCT02209909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102192700|NCT02209909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102192701|NCT02209909|Antipyretics|antipyretics|mesh-ancestor
102192702|NCT02209987|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102192703|NCT02209987|Immunologic Factors|immunologic factors|mesh-ancestor
102192704|NCT02209987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192705|NCT02205151|Amlodipine|amlodipine|mesh-list
102192706|NCT02205151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102192707|NCT02205151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102192708|NCT02205151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102192709|NCT02205151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192710|NCT02205151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102192711|NCT02205151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192713|NCT05262985|Durvalumab|durvalumab|mesh-list
102192714|NCT05262985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102192715|NCT05262985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192716|NCT05504720|Pembrolizumab|pembrolizumab|mesh-list
102192717|NCT05504720|Trastuzumab|trastuzumab|mesh-list
102192718|NCT05504720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102192719|NCT05504720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192720|NCT05504720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102192721|NCT05504720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192722|NCT04476992|Nitric Oxide|nitric oxide|mesh-list
102192723|NCT04476992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102192724|NCT04476992|Autonomic Agents|autonomic agents|mesh-ancestor
102192725|NCT04476992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102192726|NCT04476992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192727|NCT04476992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102192728|NCT04476992|Respiratory System Agents|respiratory system agents|mesh-ancestor
102192729|NCT04476992|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102192730|NCT04476992|Antioxidants|antioxidants|mesh-ancestor
102192731|NCT04476992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192732|NCT04476992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102192733|NCT04476992|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102192734|NCT04476992|Vasodilator Agents|vasodilator agents|mesh-ancestor
102192735|NCT04476992|Gasotransmitters|gasotransmitters|mesh-ancestor
102192736|NCT04476992|Protective Agents|protective agents|mesh-ancestor
102192737|NCT02220673|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
102192738|NCT02220673|Antioxidants|antioxidants|mesh-ancestor
102192739|NCT02220673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192740|NCT02220673|Protective Agents|protective agents|mesh-ancestor
102192741|NCT02220673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192742|NCT05499572|Minocycline|minocycline|mesh-list
102192743|NCT05499572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102192744|NCT05499572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102192745|NCT02220751|Doxycycline|doxycycline|mesh-list
101686627|NCT02689362|Hormones|hormones|mesh-ancestor
102192746|NCT02220751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102192747|NCT02220751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102192748|NCT02220751|Antimalarials|antimalarials|mesh-ancestor
102192749|NCT02220751|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102192750|NCT02220751|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102192751|NCT02205541|Eculizumab|eculizumab|mesh-list
102192752|NCT02205541|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102192753|NCT02205541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102192754|NCT02205541|Immunologic Factors|immunologic factors|mesh-ancestor
102192755|NCT02205541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192756|NCT02205619|Glycine|glycine|mesh-list
102192757|NCT02205619|Glycine Agents|glycine agents|mesh-ancestor
102192758|NCT02205619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102192759|NCT02205619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192760|NCT02205619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192761|NCT05504330|Aspirin|aspirin|mesh-list
102192762|NCT05504330|Clopidogrel|clopidogrel|mesh-list
102192763|NCT05504330|Atorvastatin|atorvastatin|mesh-list
102192764|NCT05504330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102192765|NCT05504330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102192766|NCT05504330|Analgesics|analgesics|mesh-ancestor
102192767|NCT05504330|Sensory System Agents|sensory system agents|mesh-ancestor
102192768|NCT05504330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102192769|NCT05504330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192770|NCT05504330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102192771|NCT05504330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102192772|NCT05504330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102192773|NCT05504330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102192774|NCT05504330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192775|NCT05504330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102192776|NCT05504330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102192777|NCT05504330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102192778|NCT05504330|Antipyretics|antipyretics|mesh-ancestor
102192779|NCT05504330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102192780|NCT05504330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102192781|NCT05504330|Antimetabolites|antimetabolites|mesh-ancestor
102192782|NCT05504330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102192783|NCT05504330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102192784|NCT05504330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102192785|NCT05504330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102192786|NCT05504330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102192787|NCT05504330|Purinergic Agents|purinergic agents|mesh-ancestor
102192788|NCT05504330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102192790|NCT02220829|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102192791|NCT02220829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102192792|NCT02220829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102192793|NCT02220829|Adrenergic Agents|adrenergic agents|mesh-ancestor
102192794|NCT02220829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102192795|NCT02220829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192796|NCT02220829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192797|NCT02220829|Urological Agents|urological agents|mesh-ancestor
102192799|NCT02525939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102192800|NCT02525939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102192801|NCT02525939|Antimetabolites|antimetabolites|mesh-ancestor
102192802|NCT02525939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192803|NCT02525939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102192804|NCT02215213|Vitamin D|vitamin d|mesh-list
102192805|NCT02215213|Ergocalciferols|ergocalciferols|mesh-list
102192806|NCT02215213|Cholecalciferol|cholecalciferol|mesh-list
102192807|NCT02215213|Vitamins|vitamins|mesh-list
102192808|NCT02215213|Micronutrients|micronutrients|mesh-ancestor
102192809|NCT02215213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192810|NCT02215213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102192811|NCT02215213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102192812|NCT02205775|Atorvastatin|atorvastatin|mesh-list
102192813|NCT02205775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102192814|NCT02205775|Ezetimibe|ezetimibe|mesh-list
102192815|NCT02205775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102192816|NCT02205775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102192817|NCT02205775|Antimetabolites|antimetabolites|mesh-ancestor
102192818|NCT02205775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192819|NCT02205775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102192820|NCT02205775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102192821|NCT02205775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102192822|NCT02217787|PF-06372865|pf-06372865|mesh-list
102192823|NCT02217787|GABA Modulators|gaba modulators|mesh-ancestor
102192824|NCT02217787|GABA Agents|gaba agents|mesh-ancestor
102192825|NCT02217787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102192826|NCT02217787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192827|NCT02217787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192828|NCT02205931|Topiramate|topiramate|mesh-list
102192829|NCT02205931|Lamotrigine|lamotrigine|mesh-list
102192830|NCT02205931|Zonisamide|zonisamide|mesh-list
102192831|NCT02205931|Carbamazepine|carbamazepine|mesh-list
102192832|NCT02205931|Phenytoin|phenytoin|mesh-list
102192833|NCT02205931|Rufinamide|rufinamide|mesh-list
102192834|NCT02205931|Levetiracetam|levetiracetam|mesh-list
102192835|NCT02205931|Valproic Acid|valproic acid|mesh-list
102192836|NCT02205931|Clonazepam|clonazepam|mesh-list
102192837|NCT02205931|Vigabatrin|vigabatrin|mesh-list
102192838|NCT02205931|Anticonvulsants|anticonvulsants|mesh-list
102192839|NCT02205931|Clobazam|clobazam|mesh-list
102192840|NCT02205931|Ethosuximide|ethosuximide|mesh-list
102192841|NCT02205931|Stiripentol|stiripentol|mesh-list
102192842|NCT02205931|Nitrazepam|nitrazepam|mesh-list
102192843|NCT02205931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102192844|NCT02205931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192845|NCT02205931|Nootropic Agents|nootropic agents|mesh-ancestor
102192846|NCT02205931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102192847|NCT02205931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102192848|NCT02205931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192849|NCT02205931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102192850|NCT02205931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102192851|NCT02205931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102192852|NCT02205931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102192853|NCT02205931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102192854|NCT02205931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102192855|NCT02205931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102192856|NCT02205931|GABA Agents|gaba agents|mesh-ancestor
102192857|NCT02205931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102192858|NCT02205931|Antimanic Agents|antimanic agents|mesh-ancestor
102192859|NCT02205931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102192860|NCT02205931|Analgesics|analgesics|mesh-ancestor
102192861|NCT02205931|Sensory System Agents|sensory system agents|mesh-ancestor
102192862|NCT02205931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101734570|NCT02605460|Busulfan|busulfan|mesh-list
102192863|NCT02205931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102192864|NCT02205931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102192865|NCT02205931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102192866|NCT02205931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102192867|NCT02205931|GABA Modulators|gaba modulators|mesh-ancestor
102192868|NCT02205931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102192869|NCT02205931|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102192870|NCT02205931|GABA Agonists|gaba agonists|mesh-ancestor
102192871|NCT02205931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102192872|NCT02221063|Thiamine|thiamine|mesh-list
102192873|NCT02221063|Vitamin B Complex|vitamin b complex|mesh-ancestor
102192874|NCT02221063|Vitamins|vitamins|mesh-ancestor
102192875|NCT02221063|Micronutrients|micronutrients|mesh-ancestor
102192876|NCT02221063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192877|NCT02220049|Bortezomib|bortezomib|mesh-list
102192878|NCT02220049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192879|NCT01351805|Vitamin D|vitamin d|mesh-list
102192880|NCT01351805|Ergocalciferols|ergocalciferols|mesh-list
102192881|NCT01351805|Cholecalciferol|cholecalciferol|mesh-list
102192882|NCT01351805|Vitamins|vitamins|mesh-list
102192883|NCT01351805|Micronutrients|micronutrients|mesh-ancestor
102192884|NCT01351805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192885|NCT01351805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102192886|NCT01351805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102192887|NCT02206165|Amlodipine|amlodipine|mesh-list
102192888|NCT02206165|Candesartan|candesartan|mesh-list
102192889|NCT02206165|Candesartan cilexetil|candesartan cilexetil|mesh-list
102192890|NCT02206165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102192891|NCT02206165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102192892|NCT02206165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102192893|NCT02206165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192894|NCT02206165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102192895|NCT02206165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192896|NCT02206165|Vasodilator Agents|vasodilator agents|mesh-ancestor
102192897|NCT02206165|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102192898|NCT02206165|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102192899|NCT04356950|Thrombin|thrombin|mesh-list
102192900|NCT04356950|Hemostatics|hemostatics|mesh-ancestor
102192901|NCT04356950|Coagulants|coagulants|mesh-ancestor
102192902|NCT02254187|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102192903|NCT02254187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102192904|NCT02254187|Autonomic Agents|autonomic agents|mesh-ancestor
102192905|NCT02254187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102192906|NCT02254187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192907|NCT02254187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102192908|NCT02254187|Respiratory System Agents|respiratory system agents|mesh-ancestor
102192909|NCT02254187|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102192910|NCT02254187|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102192911|NCT02254187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102192912|NCT02254187|Adrenergic Agents|adrenergic agents|mesh-ancestor
102192913|NCT02254187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102192914|NCT02254187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192915|NCT05563610|Amoxicillin|amoxicillin|mesh-list
102192916|NCT05563610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102192917|NCT05563610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102192918|NCT05503706|Selenium|selenium|mesh-list
102192919|NCT05503706|Salicylic Acid|salicylic acid|mesh-list
102192920|NCT05503706|Salicylates|salicylates|mesh-list
102192921|NCT05503706|Selenium disulfide|selenium disulfide|mesh-list
102192922|NCT05503706|Antioxidants|antioxidants|mesh-ancestor
102192923|NCT05503706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192924|NCT05503706|Protective Agents|protective agents|mesh-ancestor
101901709|NCT00060840|Antioxidants|antioxidants|mesh-ancestor
102192925|NCT05503706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192926|NCT05503706|Trace Elements|trace elements|mesh-ancestor
102192927|NCT05503706|Micronutrients|micronutrients|mesh-ancestor
102192928|NCT05503706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102192929|NCT05503706|Antifungal Agents|antifungal agents|mesh-ancestor
102192930|NCT05503706|Keratolytic Agents|keratolytic agents|mesh-ancestor
102192931|NCT05503706|Dermatologic Agents|dermatologic agents|mesh-ancestor
102192932|NCT05503706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102192933|NCT05503706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102192934|NCT05503706|Analgesics|analgesics|mesh-ancestor
102192935|NCT05503706|Sensory System Agents|sensory system agents|mesh-ancestor
101734655|NCT04025840|Hormones|hormones|mesh-ancestor
102192936|NCT05503706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102192937|NCT05503706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102192938|NCT05503706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102192939|NCT05503706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102192940|NCT05503706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102192941|NCT02174861|Erenumab|erenumab|mesh-list
102192942|NCT02174861|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
102192943|NCT02174861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192944|NCT02174861|Analgesics|analgesics|mesh-ancestor
102192945|NCT02174861|Sensory System Agents|sensory system agents|mesh-ancestor
102192946|NCT02174861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102192947|NCT02174861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192948|NCT02221375|Ciclesonide|ciclesonide|mesh-list
102192949|NCT02221375|Glucocorticoids|glucocorticoids|mesh-ancestor
102192950|NCT02221375|Hormones|hormones|mesh-ancestor
102192951|NCT02221375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102192952|NCT02221375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192953|NCT02221375|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102192954|NCT02399709|Simvastatin|simvastatin|mesh-list
102192955|NCT02399709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102192956|NCT02399709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102192957|NCT02399709|Antimetabolites|antimetabolites|mesh-ancestor
102192958|NCT02399709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192959|NCT02399709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102192960|NCT02399709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102192961|NCT02399709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102192962|NCT02220361|Dexmedetomidine|dexmedetomidine|mesh-list
102192963|NCT02220361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102192964|NCT02220361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102192965|NCT02220361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192966|NCT02220361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102192967|NCT02220361|Analgesics|analgesics|mesh-ancestor
102192968|NCT02220361|Sensory System Agents|sensory system agents|mesh-ancestor
102192969|NCT02220361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102192970|NCT02220361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102192971|NCT02220361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102192972|NCT02220361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102192973|NCT02220361|Adrenergic Agents|adrenergic agents|mesh-ancestor
102192974|NCT02220361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102192975|NCT02220361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102192976|NCT05175001|Betamethasone|betamethasone|mesh-list
102192977|NCT05175001|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
102192978|NCT05175001|Ropivacaine|ropivacaine|mesh-list
102192979|NCT05175001|Anesthetics, Local|anesthetics, local|mesh-ancestor
102192980|NCT05175001|Anesthetics|anesthetics|mesh-ancestor
102192981|NCT05175001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102192982|NCT05175001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192983|NCT05175001|Sensory System Agents|sensory system agents|mesh-ancestor
102192984|NCT05175001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102192985|NCT05175001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102192986|NCT05175001|Glucocorticoids|glucocorticoids|mesh-ancestor
102192987|NCT05175001|Hormones|hormones|mesh-ancestor
102192988|NCT05175001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102192989|NCT05175001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102192990|NCT05175001|Respiratory System Agents|respiratory system agents|mesh-ancestor
102192991|NCT00140855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102192992|NCT00140855|Ipilimumab|ipilimumab|mesh-list
102192993|NCT00140855|Antibodies|antibodies|mesh-list
102192994|NCT00140855|Immunoglobulins|immunoglobulins|mesh-list
102192995|NCT00140855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102192996|NCT00140855|Immunologic Factors|immunologic factors|mesh-ancestor
102192997|NCT00140855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102192998|NCT00140855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102192999|NCT00140855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102193000|NCT00140855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193001|NCT02399397|Fentanyl|fentanyl|mesh-list
102193002|NCT02399397|Midazolam|midazolam|mesh-list
102193003|NCT02399397|Anesthetics|anesthetics|mesh-list
102193004|NCT02399397|Propofol|propofol|mesh-list
102193005|NCT02399397|Rocuronium|rocuronium|mesh-list
102193006|NCT02399397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102193007|NCT02399397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193008|NCT02399397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102193009|NCT02399397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102193010|NCT02399397|Anesthetics, General|anesthetics, general|mesh-ancestor
102193011|NCT02399397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102193012|NCT02399397|Narcotics|narcotics|mesh-ancestor
102193013|NCT02399397|Analgesics|analgesics|mesh-ancestor
102193014|NCT02399397|Sensory System Agents|sensory system agents|mesh-ancestor
102193015|NCT02399397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102193016|NCT02399397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102193017|NCT02399397|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102193018|NCT02399397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102193019|NCT02399397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102193020|NCT02399397|GABA Modulators|gaba modulators|mesh-ancestor
102193021|NCT02399397|GABA Agents|gaba agents|mesh-ancestor
102193022|NCT02399397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102193023|NCT02399397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193024|NCT02399397|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102193025|NCT02399397|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102193026|NCT02399397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102193027|NCT02221453|Triamcinolone|triamcinolone|mesh-list
102193028|NCT02221453|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102193029|NCT02221453|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102193030|NCT02221453|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102193031|NCT02221453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102193032|NCT02221453|Glucocorticoids|glucocorticoids|mesh-ancestor
102193033|NCT02221453|Hormones|hormones|mesh-ancestor
102193034|NCT02221453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102193035|NCT02221453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193036|NCT02221453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102193037|NCT02221453|Immunologic Factors|immunologic factors|mesh-ancestor
102193038|NCT02221453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102193039|NCT02221453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193040|NCT03106545|Bupivacaine|bupivacaine|mesh-list
102193041|NCT03106545|Anesthetics, Local|anesthetics, local|mesh-ancestor
102193042|NCT03106545|Anesthetics|anesthetics|mesh-ancestor
102193043|NCT03106545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102193044|NCT03106545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193045|NCT03106545|Sensory System Agents|sensory system agents|mesh-ancestor
102193046|NCT03106545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102193047|NCT02221531|Carbetocin|carbetocin|mesh-list
102193048|NCT02221531|Oxytocin|oxytocin|mesh-list
102193049|NCT02221531|Oxytocics|oxytocics|mesh-ancestor
102193050|NCT02221531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102193051|NCT02221531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193052|NCT02231125|Losartan|losartan|mesh-list
102193053|NCT02231125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102193054|NCT02231125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102193055|NCT02231125|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102193056|NCT02231125|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102193057|NCT02231125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193058|NCT02396433|Carboplatin|carboplatin|mesh-list
102193059|NCT02396433|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102193060|NCT02396433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102193061|NCT02396433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102193062|NCT02396433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193063|NCT02231203|Tocopherols|tocopherols|mesh-list
102193064|NCT02231203|Antioxidants|antioxidants|mesh-list
102193065|NCT02231203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193066|NCT02231203|Protective Agents|protective agents|mesh-ancestor
102193067|NCT02231203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193068|NCT02231203|Vitamins|vitamins|mesh-ancestor
102193069|NCT02231203|Micronutrients|micronutrients|mesh-ancestor
102193070|NCT02231281|Ritonavir|ritonavir|mesh-list
102193071|NCT02231281|Lopinavir|lopinavir|mesh-list
102193072|NCT02231281|Tenofovir|tenofovir|mesh-list
102193073|NCT02231281|Lamivudine|lamivudine|mesh-list
102193074|NCT02231281|Zidovudine|zidovudine|mesh-list
102193075|NCT02231281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102193076|NCT02231281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102193077|NCT02231281|Protease Inhibitors|protease inhibitors|mesh-ancestor
102193078|NCT02231281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102193079|NCT02231281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193080|NCT02231281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102193081|NCT02231281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102193083|NCT02231281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102193084|NCT02231281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102193085|NCT02231281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102193086|NCT02231281|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102193087|NCT02231281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102193088|NCT02231281|Antimetabolites|antimetabolites|mesh-ancestor
102193089|NCT02231359|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
102193090|NCT02231359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102193091|NCT02231359|Autonomic Agents|autonomic agents|mesh-ancestor
102193092|NCT02231359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102193093|NCT02231359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449471|NCT00221286|Antiviral Agents|antiviral agents|mesh-ancestor
102193094|NCT02231359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102193095|NCT02231359|Respiratory System Agents|respiratory system agents|mesh-ancestor
102193096|NCT02780687|Afatinib|afatinib|mesh-list
102193097|NCT02780687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102193098|NCT02780687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102193099|NCT02780687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102193100|NCT02780687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193101|NCT02231437|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
102193102|NCT02231437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102193103|NCT02231437|Autonomic Agents|autonomic agents|mesh-ancestor
102193104|NCT02231437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102193105|NCT02231437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193106|NCT02231437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102193107|NCT02231437|Respiratory System Agents|respiratory system agents|mesh-ancestor
102193108|NCT02147873|Azacitidine|azacitidine|mesh-list
102193109|NCT02147873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102193110|NCT02147873|Antimetabolites|antimetabolites|mesh-ancestor
102193111|NCT02147873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193112|NCT02147873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102193113|NCT02147873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102193114|NCT02398929|Bisoprolol|bisoprolol|mesh-list
102193115|NCT02398929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102193116|NCT02398929|Sympatholytics|sympatholytics|mesh-ancestor
102193117|NCT02398929|Autonomic Agents|autonomic agents|mesh-ancestor
102193118|NCT02398929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102193119|NCT02398929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193120|NCT02398929|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102193121|NCT02398929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102193122|NCT02398929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102193123|NCT02398929|Adrenergic Agents|adrenergic agents|mesh-ancestor
102193124|NCT02398929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102193125|NCT02398929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193126|NCT02221765|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
102193127|NCT02221765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102193128|NCT02221765|Hormones|hormones|mesh-ancestor
102193129|NCT02221765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102193130|NCT02221765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193131|NCT05069129|Vaccines|vaccines|mesh-list
102193132|NCT05069129|Immunologic Factors|immunologic factors|mesh-ancestor
102193133|NCT05069129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193134|NCT02147951|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
102193135|NCT02147951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102193136|NCT02147951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102193137|NCT03544073|Leuprolide|leuprolide|mesh-list
102193138|NCT03544073|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102193139|NCT03544073|Fertility Agents|fertility agents|mesh-ancestor
102193140|NCT03544073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102193141|NCT03544073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193142|NCT03544073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102193143|NCT03544073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102193144|NCT02398383|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102193145|NCT02398383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193146|NCT03168087|Plasma-lyte 148|plasma-lyte 148|mesh-list
102193147|NCT03168087|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102193148|NCT03168087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101901931|NCT01094964|Epirubicin|epirubicin|mesh-list
102193149|NCT02781311|Finasteride|finasteride|mesh-list
102193150|NCT02781311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102193151|NCT02781311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102193152|NCT02781311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102193153|NCT02781311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193154|NCT02781311|Hormone Antagonists|hormone antagonists|mesh-ancestor
102193155|NCT02781311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102193156|NCT02781311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193157|NCT02781311|Urological Agents|urological agents|mesh-ancestor
102193158|NCT02144441|Insulin Glargine|insulin glargine|mesh-list
102193159|NCT02144441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102193160|NCT02144441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193161|NCT02225977|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102193162|NCT02225977|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102193163|NCT02225977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193164|NCT02225977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102193165|NCT02225977|Immunologic Factors|immunologic factors|mesh-ancestor
102193166|NCT02225977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193167|NCT02141009|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102193168|NCT02141009|Immunologic Factors|immunologic factors|mesh-ancestor
102193169|NCT02141009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193170|NCT02564198|Ramucirumab|ramucirumab|mesh-list
102193171|NCT02564198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102193172|NCT02398539|Silver Nitrate|silver nitrate|mesh-list
102193173|NCT02398539|Triamcinolone|triamcinolone|mesh-list
102193174|NCT02398539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102193175|NCT02398539|Glucocorticoids|glucocorticoids|mesh-ancestor
102193176|NCT02398539|Hormones|hormones|mesh-ancestor
102193177|NCT02398539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102193178|NCT02398539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193179|NCT02398539|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102193180|NCT02398539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102193181|NCT02144753|Psyllium|psyllium|mesh-list
102193182|NCT02144753|Calcium polycarbophil|calcium polycarbophil|mesh-list
102193183|NCT02144753|Cathartics|cathartics|mesh-ancestor
102193184|NCT02144753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102193185|NCT02144753|Antidiarrheals|antidiarrheals|mesh-ancestor
102193186|NCT02231905|Pramipexole|pramipexole|mesh-list
102193187|NCT02231905|Antioxidants|antioxidants|mesh-ancestor
102193188|NCT02231905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193189|NCT02231905|Protective Agents|protective agents|mesh-ancestor
102193190|NCT02231905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193191|NCT02231905|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102193192|NCT02231905|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102193193|NCT02231905|Dopamine Agonists|dopamine agonists|mesh-ancestor
102193194|NCT02231905|Dopamine Agents|dopamine agents|mesh-ancestor
102193195|NCT02231905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102193196|NCT02141087|Pirfenidone|pirfenidone|mesh-list
102193197|NCT02141087|Analgesics|analgesics|mesh-ancestor
102193198|NCT02141087|Sensory System Agents|sensory system agents|mesh-ancestor
102193199|NCT02141087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102193200|NCT02141087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193201|NCT02141087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102193202|NCT02141087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102193203|NCT02141087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102193204|NCT02141087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102193205|NCT02141087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102193206|NCT02698293|Vitamin D|vitamin d|mesh-list
102193207|NCT02698293|Ergocalciferols|ergocalciferols|mesh-list
102193208|NCT02698293|Cholecalciferol|cholecalciferol|mesh-list
102193209|NCT02698293|Vitamins|vitamins|mesh-list
102193210|NCT02698293|Micronutrients|micronutrients|mesh-ancestor
102193211|NCT02698293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193212|NCT02698293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102193213|NCT02698293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102193214|NCT02226289|Bevacizumab|bevacizumab|mesh-list
102193215|NCT02226289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102193216|NCT02226289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102193217|NCT02226289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102193218|NCT02226289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102193219|NCT02226289|Growth Substances|growth substances|mesh-ancestor
102193220|NCT02226289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193221|NCT02226289|Growth Inhibitors|growth inhibitors|mesh-ancestor
102193222|NCT04480593|Propolis|propolis|mesh-list
101902006|NCT01187108|Protective Agents|protective agents|mesh-ancestor
102193224|NCT05079217|Vaccines|vaccines|mesh-list
102193225|NCT05079217|Immunologic Factors|immunologic factors|mesh-ancestor
102193226|NCT05079217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193227|NCT02141321|Alprostadil|alprostadil|mesh-list
102193228|NCT02141321|Misoprostol|misoprostol|mesh-list
102193229|NCT02141321|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102193230|NCT02141321|Abortifacient Agents|abortifacient agents|mesh-ancestor
101308346|NCT02046915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102193231|NCT02141321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102193232|NCT02141321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193233|NCT02141321|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102193234|NCT02141321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102193235|NCT02141321|Oxytocics|oxytocics|mesh-ancestor
102193236|NCT02141321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102193237|NCT02141321|Vasodilator Agents|vasodilator agents|mesh-ancestor
102193238|NCT02141321|Urological Agents|urological agents|mesh-ancestor
102193239|NCT03965078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102193240|NCT03965078|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102193241|NCT03965078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102193242|NCT02141477|Decitabine|decitabine|mesh-list
102193243|NCT02141477|Homoharringtonine|homoharringtonine|mesh-list
102193244|NCT02141477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102193245|NCT02141477|Antimetabolites|antimetabolites|mesh-ancestor
102193246|NCT02141477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193247|NCT02141477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102193248|NCT02141477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102193249|NCT02141477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102193250|NCT02141477|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102193251|NCT02232139|Midazolam|midazolam|mesh-list
102193252|NCT02232139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102193253|NCT02232139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102193254|NCT02232139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102193255|NCT02232139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193256|NCT02232139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102193257|NCT02232139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102193258|NCT02232139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102193259|NCT02232139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102193260|NCT02232139|Anesthetics, General|anesthetics, general|mesh-ancestor
102193261|NCT02232139|Anesthetics|anesthetics|mesh-ancestor
102193262|NCT02232139|GABA Modulators|gaba modulators|mesh-ancestor
102193263|NCT02232139|GABA Agents|gaba agents|mesh-ancestor
102193264|NCT02232139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102193265|NCT02232139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193266|NCT02226601|Aprepitant|aprepitant|mesh-list
102193267|NCT02226601|Antiemetics|antiemetics|mesh-ancestor
102193268|NCT02226601|Autonomic Agents|autonomic agents|mesh-ancestor
102193269|NCT02226601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102193270|NCT02226601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193271|NCT02226601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102193272|NCT02226601|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102193273|NCT02226601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102193274|NCT02226601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193275|NCT02397603|Dexmedetomidine|dexmedetomidine|mesh-list
102193276|NCT02397603|Bupivacaine|bupivacaine|mesh-list
102193277|NCT02397603|Anesthetics, Local|anesthetics, local|mesh-ancestor
102193278|NCT02397603|Anesthetics|anesthetics|mesh-ancestor
102193279|NCT02397603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102193280|NCT02397603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193281|NCT02397603|Sensory System Agents|sensory system agents|mesh-ancestor
102193282|NCT02397603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102193283|NCT02397603|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102193284|NCT02397603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102193285|NCT02397603|Analgesics|analgesics|mesh-ancestor
102193286|NCT02397603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102193287|NCT02397603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102193288|NCT02397603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102193289|NCT02397603|Adrenergic Agents|adrenergic agents|mesh-ancestor
102193290|NCT02397603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102193291|NCT02397603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193292|NCT02145065|Paclitaxel|paclitaxel|mesh-list
102193293|NCT02145065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102193294|NCT02145065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102193295|NCT02145065|Tubulin Modulators|tubulin modulators|mesh-ancestor
102193296|NCT02145065|Antimitotic Agents|antimitotic agents|mesh-ancestor
102193297|NCT02145065|Mitosis Modulators|mitosis modulators|mesh-ancestor
102193298|NCT02145065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193299|NCT02226757|Paclitaxel|paclitaxel|mesh-list
102193300|NCT02226757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102193301|NCT02226757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102193302|NCT02226757|Tubulin Modulators|tubulin modulators|mesh-ancestor
102193303|NCT02226757|Antimitotic Agents|antimitotic agents|mesh-ancestor
102193304|NCT02226757|Mitosis Modulators|mitosis modulators|mesh-ancestor
102193305|NCT02226757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193306|NCT04616924|Clarithromycin|clarithromycin|mesh-list
102193307|NCT04616924|Rifabutin|rifabutin|mesh-list
102193308|NCT04616924|Clofazimine|clofazimine|mesh-list
102193309|NCT04616924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102193310|NCT04616924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102193311|NCT04616924|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102193312|NCT04616924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102193313|NCT04616924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193314|NCT04616924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102193315|NCT04616924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102193316|NCT04616924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102193317|NCT04616924|Antitubercular Agents|antitubercular agents|mesh-ancestor
102193318|NCT04616924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102193319|NCT04616924|Leprostatic Agents|leprostatic agents|mesh-ancestor
102193320|NCT02226913|Lidocaine|lidocaine|mesh-list
102193321|NCT02226913|Epinephrine|epinephrine|mesh-list
102193322|NCT02226913|Anesthetics, Local|anesthetics, local|mesh-ancestor
102193323|NCT02226913|Anesthetics|anesthetics|mesh-ancestor
102193324|NCT02226913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102193325|NCT02226913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193326|NCT02226913|Sensory System Agents|sensory system agents|mesh-ancestor
102193327|NCT02226913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102193328|NCT02226913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102193329|NCT02226913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102193330|NCT02226913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102193331|NCT02226913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102193332|NCT02226913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193333|NCT02226913|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102193334|NCT02226913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102193335|NCT02226913|Adrenergic Agents|adrenergic agents|mesh-ancestor
102193336|NCT02226913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102193337|NCT02226913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102193338|NCT02226913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102193339|NCT02226913|Autonomic Agents|autonomic agents|mesh-ancestor
102193340|NCT02226913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102193341|NCT02226913|Respiratory System Agents|respiratory system agents|mesh-ancestor
102193342|NCT02226913|Mydriatics|mydriatics|mesh-ancestor
102193343|NCT02226913|Sympathomimetics|sympathomimetics|mesh-ancestor
102193344|NCT02226913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102193345|NCT05491616|Nivolumab|nivolumab|mesh-list
102193346|NCT05491616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102193347|NCT05491616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102193348|NCT05491616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102193349|NCT05491616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193350|NCT02254655|Antirheumatic Agents|antirheumatic agents|mesh-list
102193351|NCT02254655|Puerarin|puerarin|mesh-list
102193352|NCT02254655|Vasodilator Agents|vasodilator agents|mesh-ancestor
102193353|NCT02226991|Ritonavir|ritonavir|mesh-list
102193354|NCT02226991|Tipranavir|tipranavir|mesh-list
102193355|NCT02226991|Efavirenz|efavirenz|mesh-list
102193356|NCT02226991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102193357|NCT02226991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102193358|NCT02226991|Protease Inhibitors|protease inhibitors|mesh-ancestor
102193359|NCT02226991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102193360|NCT02226991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193361|NCT02226991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102193362|NCT02226991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102193363|NCT02226991|Antiviral Agents|antiviral agents|mesh-ancestor
102193364|NCT02226991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102193365|NCT02226991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102193366|NCT02226991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102193367|NCT02226991|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102193368|NCT02226991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101449492|NCT00214266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102193369|NCT02226991|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102193370|NCT02226991|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102193371|NCT02226991|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102193372|NCT02226991|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102193373|NCT02226991|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102193375|NCT05042791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102193377|NCT05042791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193378|NCT05042791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102193379|NCT00705783|Aripiprazole|aripiprazole|mesh-list
102193380|NCT00705783|Antidepressive Agents|antidepressive agents|mesh-ancestor
102193381|NCT00705783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102193382|NCT00705783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102193383|NCT00705783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102193384|NCT00705783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102193385|NCT00705783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193386|NCT00705783|Dopamine Agonists|dopamine agonists|mesh-ancestor
102193387|NCT00705783|Dopamine Agents|dopamine agents|mesh-ancestor
102193388|NCT00705783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102193389|NCT00705783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193390|NCT00705783|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102193391|NCT00705783|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102193392|NCT00705783|Serotonin Agents|serotonin agents|mesh-ancestor
102193393|NCT00705783|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102193394|NCT00705783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102193395|NCT00705783|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102193396|NCT00705783|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102193397|NCT02145611|Vildagliptin|vildagliptin|mesh-list
102193398|NCT02145611|Glyburide|glyburide|mesh-list
102193399|NCT02145611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102193400|NCT02145611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193401|NCT02145611|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102193402|NCT02145611|Protease Inhibitors|protease inhibitors|mesh-ancestor
102193403|NCT02145611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102193404|NCT02145611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193405|NCT02222623|Isophane Insulin, Human|isophane insulin, human|mesh-list
102193406|NCT02222623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102193407|NCT02222623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193408|NCT03543683|Aspirin|aspirin|mesh-list
102193409|NCT03543683|Osimertinib|osimertinib|mesh-list
102193410|NCT03543683|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102193411|NCT03543683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102193412|NCT03543683|Analgesics|analgesics|mesh-ancestor
102193413|NCT03543683|Sensory System Agents|sensory system agents|mesh-ancestor
102193414|NCT03543683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102193415|NCT03543683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193416|NCT03543683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102193417|NCT03543683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102193418|NCT03543683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102193419|NCT03543683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102193420|NCT03543683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193421|NCT03543683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102193422|NCT03543683|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102193423|NCT03543683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102193424|NCT03543683|Antipyretics|antipyretics|mesh-ancestor
102193425|NCT03543683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102193426|NCT03543683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102193427|NCT02145689|Botulinum Toxins|botulinum toxins|mesh-list
102193428|NCT02145689|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102193429|NCT02145689|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102193430|NCT02145689|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102193431|NCT02145689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102193432|NCT02145689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193433|NCT02145689|Cholinergic Agents|cholinergic agents|mesh-ancestor
102193434|NCT02145689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102193435|NCT02145689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193436|NCT02145689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102193437|NCT02145689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102193438|NCT02396979|Methadone|methadone|mesh-list
102193439|NCT02396979|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102193440|NCT02396979|Narcotics|narcotics|mesh-ancestor
102193441|NCT02396979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102193442|NCT02396979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193443|NCT02396979|Analgesics|analgesics|mesh-ancestor
102193444|NCT02396979|Sensory System Agents|sensory system agents|mesh-ancestor
102193445|NCT02396979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102193446|NCT02396979|Antitussive Agents|antitussive agents|mesh-ancestor
102193447|NCT02396979|Respiratory System Agents|respiratory system agents|mesh-ancestor
102193449|NCT02145767|Progestins|progestins|mesh-ancestor
102193450|NCT02145767|Hormones|hormones|mesh-ancestor
102193451|NCT02145767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102193452|NCT02145767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193453|NCT02031523|Analgesics|analgesics|mesh-list
102193454|NCT02031523|Sensory System Agents|sensory system agents|mesh-ancestor
102193455|NCT02031523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102193456|NCT02031523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193457|NCT02397213|Cyclosporine|cyclosporine|mesh-list
102193458|NCT02397213|Cyclosporins|cyclosporins|mesh-list
102193459|NCT02397213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102193460|NCT02397213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193461|NCT02397213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102193462|NCT02397213|Immunologic Factors|immunologic factors|mesh-ancestor
102193463|NCT02397213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193464|NCT02397213|Antifungal Agents|antifungal agents|mesh-ancestor
102193465|NCT02397213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102193466|NCT02397213|Dermatologic Agents|dermatologic agents|mesh-ancestor
102193467|NCT02397213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102193468|NCT02397213|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102193469|NCT04480281|Lidocaine|lidocaine|mesh-list
102193470|NCT04480281|Anesthetics, Local|anesthetics, local|mesh-ancestor
102193471|NCT04480281|Anesthetics|anesthetics|mesh-ancestor
102193472|NCT04480281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102193473|NCT04480281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193474|NCT04480281|Sensory System Agents|sensory system agents|mesh-ancestor
102193475|NCT04480281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102193476|NCT04480281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102193477|NCT04480281|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102193478|NCT04480281|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102193479|NCT04480281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102193480|NCT04480281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193481|NCT03544775|Anesthetics|anesthetics|mesh-list
102193482|NCT03544775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102193483|NCT03544775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193484|NCT02258815|Dinutuximab|dinutuximab|mesh-list
102193485|NCT02258815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102193486|NCT02149433|Prednisone|prednisone|mesh-list
102193487|NCT02149433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102193488|NCT02149433|Glucocorticoids|glucocorticoids|mesh-ancestor
102193489|NCT02149433|Hormones|hormones|mesh-ancestor
102193490|NCT02149433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102193491|NCT02149433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193492|NCT02149433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102193493|NCT02149433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102193494|NCT02228005|Sertraline|sertraline|mesh-list
102193495|NCT02228005|Antidepressive Agents|antidepressive agents|mesh-ancestor
102193496|NCT02228005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102193497|NCT02228005|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102193498|NCT02228005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102193499|NCT02228005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102193500|NCT02228005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193501|NCT02228005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102193502|NCT02228005|Serotonin Agents|serotonin agents|mesh-ancestor
102193503|NCT02228005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193504|NCT02228083|Lidocaine|lidocaine|mesh-list
102193505|NCT02228083|Epinephrine|epinephrine|mesh-list
102193506|NCT02228083|Anesthetics, Local|anesthetics, local|mesh-ancestor
102193507|NCT02228083|Anesthetics|anesthetics|mesh-ancestor
102193508|NCT02228083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101449501|NCT00214266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102193509|NCT02228083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193510|NCT02228083|Sensory System Agents|sensory system agents|mesh-ancestor
102193511|NCT02228083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102193512|NCT02228083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102193513|NCT02228083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102193514|NCT02228083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102193515|NCT02228083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102193516|NCT02228083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902315|NCT01291940|Petrolatum|petrolatum|mesh-list
102193517|NCT02228083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102193518|NCT02228083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102193519|NCT02228083|Adrenergic Agents|adrenergic agents|mesh-ancestor
102193520|NCT02228083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102193521|NCT02228083|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102193522|NCT02228083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102193523|NCT02228083|Autonomic Agents|autonomic agents|mesh-ancestor
102193524|NCT02228083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102193525|NCT02228083|Respiratory System Agents|respiratory system agents|mesh-ancestor
102193526|NCT02228083|Mydriatics|mydriatics|mesh-ancestor
102193527|NCT02228083|Sympathomimetics|sympathomimetics|mesh-ancestor
102193528|NCT02228083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102193529|NCT02394483|Olorofim|olorofim|mesh-list
102193530|NCT02394483|Antifungal Agents|antifungal agents|mesh-ancestor
102193531|NCT02394483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102193532|NCT02142335|Rituximab|rituximab|mesh-list
102193533|NCT02142335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102193534|NCT02142335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102193535|NCT02142335|Immunologic Factors|immunologic factors|mesh-ancestor
102193536|NCT02142335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193537|NCT02142335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102193538|NCT02228239|Mirtazapine|mirtazapine|mesh-list
102193539|NCT02228239|Esketamine|esketamine|mesh-list
102193540|NCT02228239|Antidepressive Agents|antidepressive agents|mesh-ancestor
102193541|NCT02228239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102193542|NCT02228239|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102193543|NCT02228239|Histamine Antagonists|histamine antagonists|mesh-ancestor
102193544|NCT02228239|Histamine Agents|histamine agents|mesh-ancestor
102193545|NCT02228239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102193546|NCT02228239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193547|NCT02228239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193548|NCT02228239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102193549|NCT02228239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102193550|NCT02228239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102193551|NCT02228239|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102193552|NCT02228239|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102193553|NCT02228239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102193554|NCT02228239|Adrenergic Agents|adrenergic agents|mesh-ancestor
102193555|NCT02228239|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102193556|NCT02228239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102193557|NCT02228239|Serotonin Agents|serotonin agents|mesh-ancestor
102193558|NCT02228239|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102193559|NCT03167385|Apatinib|apatinib|mesh-list
102193560|NCT03167385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102193561|NCT03167385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102193562|NCT03167385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102193563|NCT03167385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193564|NCT02142569|Tocotrienols|tocotrienols|mesh-list
102193565|NCT02142569|Vitamin E|vitamin e|mesh-list
102193566|NCT02142569|Tocopherols|tocopherols|mesh-list
102193567|NCT02142569|Red yeast rice|red yeast rice|mesh-list
102193568|NCT02142569|Antioxidants|antioxidants|mesh-ancestor
102193569|NCT02142569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193570|NCT02142569|Protective Agents|protective agents|mesh-ancestor
102193571|NCT02142569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193572|NCT02142569|Vitamins|vitamins|mesh-ancestor
102193573|NCT02142569|Micronutrients|micronutrients|mesh-ancestor
102193574|NCT02142569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102193575|NCT02142569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102193576|NCT02142569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102193577|NCT02142569|Antimetabolites|antimetabolites|mesh-ancestor
102193578|NCT02142569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102193579|NCT02142569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102193580|NCT02228473|Atropine|atropine|mesh-list
102193581|NCT02228473|Glycopyrrolate|glycopyrrolate|mesh-list
102193582|NCT02228473|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102193583|NCT02228473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102193584|NCT02228473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102193585|NCT02228473|Autonomic Agents|autonomic agents|mesh-ancestor
102193586|NCT02228473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102193587|NCT02228473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193588|NCT02228473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102193589|NCT02228473|Respiratory System Agents|respiratory system agents|mesh-ancestor
102193590|NCT02228473|Mydriatics|mydriatics|mesh-ancestor
102193591|NCT02228473|Parasympatholytics|parasympatholytics|mesh-ancestor
102193592|NCT02228473|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102193593|NCT02228473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102193594|NCT02228473|Cholinergic Agents|cholinergic agents|mesh-ancestor
102193595|NCT02228473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102193596|NCT02228473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193597|NCT02394093|Aspirin|aspirin|mesh-list
102193598|NCT02394093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102193599|NCT02394093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102193600|NCT02394093|Analgesics|analgesics|mesh-ancestor
102193601|NCT02394093|Sensory System Agents|sensory system agents|mesh-ancestor
102193602|NCT02394093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102193603|NCT02394093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193604|NCT02394093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102193605|NCT02394093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102193606|NCT02394093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102193607|NCT02394093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102193608|NCT02394093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193609|NCT02394093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102193610|NCT02394093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102193611|NCT02394093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102193612|NCT02394093|Antipyretics|antipyretics|mesh-ancestor
102193613|NCT02146391|Enclomiphene|enclomiphene|mesh-list
102193614|NCT02146391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102193615|NCT02146391|Hormone Antagonists|hormone antagonists|mesh-ancestor
102193616|NCT02146391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102193617|NCT02146391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193618|NCT02146391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102193619|NCT02146391|Fertility Agents|fertility agents|mesh-ancestor
102193620|NCT02146391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102193621|NCT02146391|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102193622|NCT02146391|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102193623|NCT04225273|Lidocaine|lidocaine|mesh-list
102193624|NCT04225273|Anesthetics, Local|anesthetics, local|mesh-ancestor
102193625|NCT04225273|Anesthetics|anesthetics|mesh-ancestor
102193626|NCT04225273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102193627|NCT04225273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193628|NCT04225273|Sensory System Agents|sensory system agents|mesh-ancestor
102193629|NCT04225273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102193630|NCT04225273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102193631|NCT04225273|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102193632|NCT04225273|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102193633|NCT04225273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102193634|NCT04225273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193635|NCT02146547|Aripiprazole|aripiprazole|mesh-list
102193636|NCT02146547|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102193637|NCT02146547|Antidepressive Agents|antidepressive agents|mesh-ancestor
102193638|NCT02146547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102193639|NCT02146547|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102193640|NCT02146547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102193641|NCT02146547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102193642|NCT02146547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193643|NCT02146547|Dopamine Agonists|dopamine agonists|mesh-ancestor
102193644|NCT02146547|Dopamine Agents|dopamine agents|mesh-ancestor
102193645|NCT02146547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102193646|NCT02146547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193647|NCT02146547|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102193648|NCT02146547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102193649|NCT02146547|Serotonin Agents|serotonin agents|mesh-ancestor
102193650|NCT02146547|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102193651|NCT02146547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102193652|NCT02146547|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102193653|NCT02146547|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102193654|NCT02394015|Doxorubicin|doxorubicin|mesh-list
102193655|NCT02394015|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102193656|NCT02394015|Trabectedin|trabectedin|mesh-list
102193657|NCT02394015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102193658|NCT02394015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102193659|NCT02394015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102193660|NCT02394015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102193661|NCT02394015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102193662|NCT02394015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193663|NCT02394015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102193664|NCT02394015|Alkylating Agents|alkylating agents|mesh-ancestor
102193665|NCT02142881|Antihypertensive Agents|antihypertensive agents|mesh-list
102193666|NCT02146703|Gemcitabine|gemcitabine|mesh-list
102193667|NCT02146703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102193668|NCT02146703|Antimetabolites|antimetabolites|mesh-ancestor
102193669|NCT02146703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193670|NCT02146703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102193671|NCT02228863|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102193672|NCT02228863|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102193673|NCT02228863|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102193674|NCT02228863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102193675|NCT02228863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193676|NCT02228863|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102193677|NCT02228863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102193678|NCT02228863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193679|NCT02228863|Cholinergic Agents|cholinergic agents|mesh-ancestor
102193680|NCT02228863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102193681|NCT02782169|Pregabalin|pregabalin|mesh-list
102193682|NCT02782169|Analgesics|analgesics|mesh-ancestor
102193683|NCT02782169|Sensory System Agents|sensory system agents|mesh-ancestor
102193684|NCT02782169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102193685|NCT02782169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193686|NCT02782169|Anticonvulsants|anticonvulsants|mesh-ancestor
102193687|NCT02782169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102193688|NCT02782169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102193689|NCT02782169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193690|NCT02782169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102193691|NCT02782169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102193692|NCT02782169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102193693|NCT02782169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102193694|NCT02782169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102193695|NCT04163185|Meloxicam|meloxicam|mesh-list
102193696|NCT04163185|Rizatriptan|rizatriptan|mesh-list
102193697|NCT04163185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102193698|NCT04163185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102193699|NCT04163185|Analgesics|analgesics|mesh-ancestor
102193700|NCT04163185|Sensory System Agents|sensory system agents|mesh-ancestor
102193701|NCT04163185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102193702|NCT04163185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193703|NCT04163185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102193704|NCT04163185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102193705|NCT04163185|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102193706|NCT04163185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102193707|NCT04163185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102193708|NCT04163185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193709|NCT04163185|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102193710|NCT04163185|Serotonin Agents|serotonin agents|mesh-ancestor
102193711|NCT04163185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102193712|NCT02149901|Pseudoephedrine|pseudoephedrine|mesh-list
102193713|NCT02149901|Ephedrine|ephedrine|mesh-list
102193714|NCT02149901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102193715|NCT02149901|Autonomic Agents|autonomic agents|mesh-ancestor
102193716|NCT02149901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102193717|NCT02149901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193718|NCT02149901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102193719|NCT02149901|Respiratory System Agents|respiratory system agents|mesh-ancestor
102193720|NCT02149901|Nasal Decongestants|nasal decongestants|mesh-ancestor
102193721|NCT02149901|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102193722|NCT02149901|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102193723|NCT02149901|Sympathomimetics|sympathomimetics|mesh-ancestor
102193724|NCT02149901|Adrenergic Agents|adrenergic agents|mesh-ancestor
102193725|NCT02149901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102193726|NCT02149901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193727|NCT04440267|Dexamethasone|dexamethasone|mesh-list
102193728|NCT04440267|Prednisone|prednisone|mesh-list
102193729|NCT04440267|Cyclophosphamide|cyclophosphamide|mesh-list
102193730|NCT04440267|Methotrexate|methotrexate|mesh-list
102193731|NCT04440267|Vincristine|vincristine|mesh-list
102193732|NCT04440267|Daunorubicin|daunorubicin|mesh-list
102193733|NCT04440267|Asparaginase|asparaginase|mesh-list
102193734|NCT04440267|Mercaptopurine|mercaptopurine|mesh-list
102193735|NCT04440267|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101900367|NCT01283204|Docetaxel|docetaxel|mesh-list
102193736|NCT04440267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102193737|NCT04440267|Immunologic Factors|immunologic factors|mesh-ancestor
102193738|NCT04440267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193739|NCT04440267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102193740|NCT04440267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102193741|NCT04440267|Alkylating Agents|alkylating agents|mesh-ancestor
102193742|NCT04440267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193743|NCT04440267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102193744|NCT04440267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102193745|NCT04440267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102193747|NCT04440267|Autonomic Agents|autonomic agents|mesh-ancestor
102193748|NCT04440267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102193749|NCT04440267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102193750|NCT04440267|Glucocorticoids|glucocorticoids|mesh-ancestor
102193752|NCT04440267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102193753|NCT04440267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102193754|NCT04440267|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102193755|NCT04440267|Abortifacient Agents|abortifacient agents|mesh-ancestor
102193756|NCT04440267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102193757|NCT04440267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102193758|NCT04440267|Antimetabolites|antimetabolites|mesh-ancestor
102193759|NCT04440267|Dermatologic Agents|dermatologic agents|mesh-ancestor
102193760|NCT04440267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102193761|NCT04440267|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102193762|NCT04440267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102193763|NCT04440267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102193764|NCT04440267|Tubulin Modulators|tubulin modulators|mesh-ancestor
102193765|NCT04440267|Antimitotic Agents|antimitotic agents|mesh-ancestor
102193766|NCT04440267|Mitosis Modulators|mitosis modulators|mesh-ancestor
102193767|NCT04440267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102193768|NCT04440267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102193769|NCT04440267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102193770|NCT04440267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102193771|NCT02043847|Melphalan|melphalan|mesh-list
102193772|NCT02043847|Lenograstim|lenograstim|mesh-list
102193773|NCT02043847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102193774|NCT02043847|Immunologic Factors|immunologic factors|mesh-ancestor
102193775|NCT02043847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193776|NCT02043847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102193777|NCT02043847|Alkylating Agents|alkylating agents|mesh-ancestor
102193778|NCT02043847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193779|NCT02043847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102193780|NCT02043847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102193781|NCT02043847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102193782|NCT02146937|Bicalutamide|bicalutamide|mesh-list
102193783|NCT02146937|Finasteride|finasteride|mesh-list
102193784|NCT02146937|Androgen Antagonists|androgen antagonists|mesh-ancestor
102193785|NCT02146937|Hormone Antagonists|hormone antagonists|mesh-ancestor
102193786|NCT02146937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102193787|NCT02146937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193788|NCT02146937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102193789|NCT02146937|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102193790|NCT02146937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102193791|NCT02146937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102193792|NCT02146937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193793|NCT02146937|Urological Agents|urological agents|mesh-ancestor
102193794|NCT02147015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102193795|NCT02147015|Methylprednisolone|methylprednisolone|mesh-list
102193796|NCT02147015|Glucocorticoids|glucocorticoids|mesh-list
102193797|NCT02147015|Cholinergic Agents|cholinergic agents|mesh-list
102193798|NCT02147015|Muscarinic Antagonists|muscarinic antagonists|mesh-list
102193799|NCT02147015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102193800|NCT02147015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102193801|NCT02147015|Antiemetics|antiemetics|mesh-ancestor
102193802|NCT02147015|Autonomic Agents|autonomic agents|mesh-ancestor
102193803|NCT02147015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102193804|NCT02147015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193805|NCT02147015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102193806|NCT02147015|Hormones|hormones|mesh-ancestor
101573986|NCT02199184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193807|NCT02147015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102193808|NCT02147015|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102193809|NCT02147015|Protective Agents|protective agents|mesh-ancestor
102193810|NCT02147015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102193811|NCT02147015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193812|NCT02147015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102193813|NCT02229175|Bevacizumab|bevacizumab|mesh-list
102193814|NCT02229175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102193815|NCT02229175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102193816|NCT02229175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102193817|NCT02229175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102193818|NCT02229175|Growth Substances|growth substances|mesh-ancestor
102193819|NCT02229175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193820|NCT02229175|Growth Inhibitors|growth inhibitors|mesh-ancestor
102193821|NCT05744739|Azacitidine|azacitidine|mesh-list
102193822|NCT05744739|Venetoclax|venetoclax|mesh-list
102193823|NCT05744739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102193824|NCT05744739|Antimetabolites|antimetabolites|mesh-ancestor
102193825|NCT05744739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193826|NCT05744739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102193827|NCT05744739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102193828|NCT04947007|Bupivacaine|bupivacaine|mesh-list
102193829|NCT04947007|Anesthetics, Local|anesthetics, local|mesh-ancestor
102193830|NCT04947007|Anesthetics|anesthetics|mesh-ancestor
102193831|NCT04947007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102193832|NCT04947007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193833|NCT04947007|Sensory System Agents|sensory system agents|mesh-ancestor
102193834|NCT04947007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102193835|NCT04104685|Minocycline|minocycline|mesh-list
102193836|NCT04104685|Adapalene|adapalene|mesh-list
102193837|NCT04104685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102193838|NCT04104685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102193839|NCT04104685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102193840|NCT04104685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102193841|NCT04104685|Analgesics|analgesics|mesh-ancestor
102193842|NCT04104685|Sensory System Agents|sensory system agents|mesh-ancestor
102193843|NCT04104685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102193844|NCT04104685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193845|NCT04104685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102193846|NCT04104685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102193847|NCT04104685|Dermatologic Agents|dermatologic agents|mesh-ancestor
102193848|NCT02147249|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102193849|NCT02147249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102193850|NCT02392845|Docetaxel|docetaxel|mesh-list
102193851|NCT02392845|Epirubicin|epirubicin|mesh-list
102193852|NCT02392845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102193853|NCT02392845|Tubulin Modulators|tubulin modulators|mesh-ancestor
102193854|NCT02392845|Antimitotic Agents|antimitotic agents|mesh-ancestor
102193855|NCT02392845|Mitosis Modulators|mitosis modulators|mesh-ancestor
102193856|NCT02392845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224334|NCT01523327|Uric Acid|uric acid|mesh-list
102193857|NCT02392845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102193858|NCT02392845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102193859|NCT02392845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102193860|NCT02392845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102193861|NCT04093765|Antimalarials|antimalarials|mesh-list
102193862|NCT04093765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102193863|NCT04093765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102193864|NCT04093765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102193865|NCT03166605|Simethicone|simethicone|mesh-list
102193866|NCT03166605|Antifoaming Agents|antifoaming agents|mesh-ancestor
102193867|NCT03166605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193868|NCT03166605|Emollients|emollients|mesh-ancestor
102193869|NCT03166605|Dermatologic Agents|dermatologic agents|mesh-ancestor
102193870|NCT03699956|Carboplatin|carboplatin|mesh-list
102193871|NCT03699956|Etoposide|etoposide|mesh-list
102193872|NCT03699956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102193873|NCT03699956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102193874|NCT03699956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102193875|NCT03699956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102193876|NCT03699956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102193877|NCT03699956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193878|NCT03166527|Immunoglobulins|immunoglobulins|mesh-list
102193879|NCT03166527|Antibodies|antibodies|mesh-list
102193880|NCT03166527|gamma-Globulins|gamma-globulins|mesh-list
102193881|NCT03166527|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102193882|NCT03166527|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102193883|NCT03166527|Immunologic Factors|immunologic factors|mesh-ancestor
102193884|NCT03166527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193885|NCT02695719|Lubiprostone|lubiprostone|mesh-list
102193886|NCT02695719|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102193887|NCT02695719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102193888|NCT02695719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193889|NCT05498012|Cannabidiol|cannabidiol|mesh-list
102193890|NCT05498012|Anticonvulsants|anticonvulsants|mesh-ancestor
102193891|NCT02150291|Folic Acid|folic acid|mesh-list
102193892|NCT02150291|Vitamin B Complex|vitamin b complex|mesh-list
102193893|NCT02150291|Hematinics|hematinics|mesh-ancestor
102193895|NCT02150291|Micronutrients|micronutrients|mesh-ancestor
102193896|NCT02150291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193897|NCT04907071|Coal Tar|coal tar|mesh-list
102193898|NCT04907071|Keratolytic Agents|keratolytic agents|mesh-ancestor
102193899|NCT04907071|Dermatologic Agents|dermatologic agents|mesh-ancestor
102193900|NCT02155517|Propofol|propofol|mesh-list
102193901|NCT02155517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102193902|NCT02155517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102193903|NCT02155517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193904|NCT02155517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102193905|NCT02155517|Anesthetics, General|anesthetics, general|mesh-ancestor
102193906|NCT02155517|Anesthetics|anesthetics|mesh-ancestor
102193907|NCT05497934|Glycerol|glycerol|mesh-list
102193908|NCT05497934|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102193909|NCT05497934|Protective Agents|protective agents|mesh-ancestor
102193910|NCT05497934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193911|NCT02229721|Oxytocin|oxytocin|mesh-list
102193912|NCT02229721|Oxytocics|oxytocics|mesh-ancestor
102193913|NCT02229721|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102193914|NCT02229721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193915|NCT05497700|Norepinephrine|norepinephrine|mesh-list
102193916|NCT05497700|Ephedrine|ephedrine|mesh-list
102193917|NCT05497700|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102193918|NCT05497700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102193919|NCT05497700|Adrenergic Agents|adrenergic agents|mesh-ancestor
102193920|NCT05497700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102193921|NCT05497700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193922|NCT05497700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193923|NCT05497700|Sympathomimetics|sympathomimetics|mesh-ancestor
102193924|NCT05497700|Autonomic Agents|autonomic agents|mesh-ancestor
102193925|NCT05497700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102193926|NCT05497700|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102193927|NCT05497700|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102193928|NCT03106389|Misoprostol|misoprostol|mesh-list
102193929|NCT03106389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102193930|NCT03106389|Abortifacient Agents|abortifacient agents|mesh-ancestor
102193931|NCT03106389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102193932|NCT03106389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193933|NCT03106389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102193934|NCT03106389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102193935|NCT03106389|Oxytocics|oxytocics|mesh-ancestor
102193936|NCT03106311|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102193937|NCT03106311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102193938|NCT03106311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193939|NCT02255045|Diclofenac|diclofenac|mesh-list
102193940|NCT02255045|Meloxicam|meloxicam|mesh-list
102193941|NCT02255045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102193942|NCT02255045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102193943|NCT02255045|Analgesics|analgesics|mesh-ancestor
102193944|NCT02255045|Sensory System Agents|sensory system agents|mesh-ancestor
102193945|NCT02255045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102193946|NCT02255045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193947|NCT02255045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102193948|NCT02255045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102193949|NCT02255045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102193950|NCT02255045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102193951|NCT02255045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193952|NCT02255045|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102193953|NCT02229799|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102193954|NCT02229799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102193955|NCT02229799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102193956|NCT02229799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193957|NCT02150447|Lansoprazole|lansoprazole|mesh-list
102193958|NCT02150447|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
102193959|NCT02150447|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102193960|NCT02150447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102193961|NCT02150447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102193962|NCT02150447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193963|NCT02254889|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
102193964|NCT02254889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102193965|NCT02254889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193966|NCT02229955|Cyclosporine|cyclosporine|mesh-list
102193967|NCT02229955|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102193968|NCT02229955|Cyclosporins|cyclosporins|mesh-list
102193969|NCT02229955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102193970|NCT02229955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193971|NCT02229955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102193972|NCT02229955|Immunologic Factors|immunologic factors|mesh-ancestor
102193973|NCT02229955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193974|NCT02229955|Antifungal Agents|antifungal agents|mesh-ancestor
102193975|NCT02229955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102193976|NCT02229955|Dermatologic Agents|dermatologic agents|mesh-ancestor
102193977|NCT02229955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102193978|NCT02229955|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102193979|NCT02229955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102193980|NCT02230033|Itraconazole|itraconazole|mesh-list
102193981|NCT02230033|Gemfibrozil|gemfibrozil|mesh-list
102193982|NCT02230033|Antifungal Agents|antifungal agents|mesh-ancestor
102193983|NCT02230033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102193984|NCT02230033|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102193985|NCT02230033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102193986|NCT02230033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102193987|NCT02230033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102193988|NCT02230033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102193989|NCT02230033|Hormone Antagonists|hormone antagonists|mesh-ancestor
102193990|NCT02230033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102193991|NCT02230033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102193992|NCT02230033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102193993|NCT02230033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102193994|NCT02230033|Antimetabolites|antimetabolites|mesh-ancestor
102193995|NCT02230033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102193996|NCT02230033|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102193997|NCT05740371|Argatroban|argatroban|mesh-list
102193998|NCT05740371|Antithrombins|antithrombins|mesh-ancestor
102193999|NCT05740371|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102194000|NCT05740371|Protease Inhibitors|protease inhibitors|mesh-ancestor
102194001|NCT05740371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102194002|NCT05740371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194003|NCT05740371|Anticoagulants|anticoagulants|mesh-ancestor
102194004|NCT05740371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102194005|NCT02223949|Alprostadil|alprostadil|mesh-list
102194006|NCT02223949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102194007|NCT02223949|Vasodilator Agents|vasodilator agents|mesh-ancestor
102194008|NCT02223949|Urological Agents|urological agents|mesh-ancestor
102194009|NCT02691507|Decanoic acid|decanoic acid|mesh-list
102194010|NCT02691507|Antifungal Agents|antifungal agents|mesh-ancestor
102194011|NCT02691507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102194012|NCT02259361|4-Aminopyridine|4-aminopyridine|mesh-list
102194014|NCT02259361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102194015|NCT02259361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194016|NCT02151695|Aflibercept|aflibercept|mesh-list
102194017|NCT02151695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102194018|NCT02151695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102194019|NCT02151695|Growth Substances|growth substances|mesh-ancestor
102194020|NCT02151695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194021|NCT02151695|Growth Inhibitors|growth inhibitors|mesh-ancestor
102194022|NCT02151695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102194023|NCT02151929|Everolimus|everolimus|mesh-list
102194024|NCT02151929|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102194025|NCT02151929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102194026|NCT02151929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102194027|NCT02151929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194028|NCT02151929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102194029|NCT02151929|Immunologic Factors|immunologic factors|mesh-ancestor
102194030|NCT02151929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194031|NCT02151929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102194032|NCT03542357|Calcitonin|calcitonin|mesh-list
102194033|NCT03542357|Salmon calcitonin|salmon calcitonin|mesh-list
102194034|NCT03542357|Sumatriptan|sumatriptan|mesh-list
102194035|NCT03542357|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
102194036|NCT03542357|Katacalcin|katacalcin|mesh-list
102194037|NCT03542357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102194038|NCT03542357|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102194039|NCT03542357|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102194040|NCT03542357|Serotonin Agents|serotonin agents|mesh-ancestor
102194041|NCT03542357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101902856|NCT05516966|Dulaglutide|dulaglutide|mesh-list
102194042|NCT03542357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194043|NCT03542357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194044|NCT03542357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102194045|NCT03542357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102194046|NCT03542357|Vasodilator Agents|vasodilator agents|mesh-ancestor
102194047|NCT04811001|Osimertinib|osimertinib|mesh-list
102194048|NCT04811001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102194049|NCT04811001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102194050|NCT04811001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102194051|NCT04811001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194053|NCT02150993|Lopinavir|lopinavir|mesh-list
102194054|NCT02150993|Tenofovir|tenofovir|mesh-list
102194055|NCT02150993|Lamivudine|lamivudine|mesh-list
102194056|NCT02150993|Emtricitabine|emtricitabine|mesh-list
102194057|NCT02150993|Zidovudine|zidovudine|mesh-list
102194058|NCT02150993|Raltegravir Potassium|raltegravir potassium|mesh-list
102194059|NCT02150993|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
102194060|NCT02150993|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102194061|NCT02150993|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102194062|NCT02150993|Protease Inhibitors|protease inhibitors|mesh-ancestor
102194063|NCT02150993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102194064|NCT02150993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194065|NCT02150993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102194066|NCT02150993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102194067|NCT02150993|Antiviral Agents|antiviral agents|mesh-ancestor
102194068|NCT02150993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102194069|NCT02150993|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102194070|NCT02150993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102194071|NCT02150993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102194072|NCT02150993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102194073|NCT02150993|Antimetabolites|antimetabolites|mesh-ancestor
102194074|NCT02150993|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102194075|NCT02150993|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102194076|NCT02690727|Tenalisib|tenalisib|mesh-list
102194077|NCT02690727|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
102194078|NCT02690727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102194079|NCT02690727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194080|NCT02224105|Prednisolone|prednisolone|mesh-list
102194081|NCT02224105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102194082|NCT02224105|Methylprednisolone|methylprednisolone|mesh-list
102194083|NCT02224105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102194084|NCT02224105|Prednisolone acetate|prednisolone acetate|mesh-list
102194085|NCT02224105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102194086|NCT02224105|Prednisolone phosphate|prednisolone phosphate|mesh-list
102194087|NCT02224105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102194088|NCT02224105|Glucocorticoids|glucocorticoids|mesh-ancestor
102194090|NCT02224105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102194091|NCT02224105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194092|NCT02224105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102194093|NCT02224105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102194094|NCT02224105|Antiemetics|antiemetics|mesh-ancestor
102194095|NCT02224105|Autonomic Agents|autonomic agents|mesh-ancestor
102194096|NCT02224105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102194097|NCT02224105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102194098|NCT02224105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102194099|NCT02224105|Protective Agents|protective agents|mesh-ancestor
102194100|NCT02156375|Ustekinumab|ustekinumab|mesh-list
102194101|NCT02156375|Dermatologic Agents|dermatologic agents|mesh-ancestor
102194102|NCT04057131|Icatibant|icatibant|mesh-list
102194103|NCT04057131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102194104|NCT04057131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102194105|NCT04057131|Analgesics|analgesics|mesh-ancestor
102194106|NCT04057131|Sensory System Agents|sensory system agents|mesh-ancestor
102194107|NCT04057131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102194108|NCT04057131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194109|NCT04057131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102194110|NCT04057131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102194111|NCT04057131|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
102194112|NCT04057131|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
102194113|NCT04057131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194114|NCT04057131|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101902923|NCT03238924|Oxytocin|oxytocin|mesh-list
102194115|NCT04057131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102194116|NCT04057131|Immunologic Factors|immunologic factors|mesh-ancestor
102194117|NCT03542279|Glucocorticoids|glucocorticoids|mesh-list
102194118|NCT03542279|Hormones|hormones|mesh-ancestor
102194119|NCT03542279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102194120|NCT03542279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194121|NCT02230735|Epinephrine|epinephrine|mesh-list
102194122|NCT02230735|Racepinephrine|racepinephrine|mesh-list
102194123|NCT02230735|Epinephryl borate|epinephryl borate|mesh-list
102194124|NCT02230735|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102194125|NCT02230735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102194126|NCT02230735|Adrenergic Agents|adrenergic agents|mesh-ancestor
102194127|NCT02230735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102194128|NCT02230735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194129|NCT02230735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194130|NCT02230735|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102194131|NCT02230735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102194132|NCT02230735|Autonomic Agents|autonomic agents|mesh-ancestor
102194133|NCT02230735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102194134|NCT02230735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102194135|NCT02230735|Respiratory System Agents|respiratory system agents|mesh-ancestor
102194136|NCT02230735|Mydriatics|mydriatics|mesh-ancestor
102194137|NCT02230735|Sympathomimetics|sympathomimetics|mesh-ancestor
102194138|NCT02230735|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102194139|NCT02258581|Tenofovir|tenofovir|mesh-list
102194140|NCT02258581|Vesatolimod|vesatolimod|mesh-list
102194141|NCT02258581|Antiviral Agents|antiviral agents|mesh-ancestor
102194142|NCT02258581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102194143|NCT02258581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102194144|NCT02258581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102194145|NCT02258581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102194146|NCT02258581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194147|NCT02258581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102194148|NCT02258581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102194149|NCT03165825|Dexamethasone|dexamethasone|mesh-list
102194150|NCT03165825|Betamethasone|betamethasone|mesh-list
102194151|NCT03165825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102194152|NCT03165825|Antiemetics|antiemetics|mesh-ancestor
102194153|NCT03165825|Autonomic Agents|autonomic agents|mesh-ancestor
102194154|NCT03165825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102194155|NCT03165825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194156|NCT03165825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102194157|NCT03165825|Glucocorticoids|glucocorticoids|mesh-ancestor
102194158|NCT03165825|Hormones|hormones|mesh-ancestor
102194159|NCT03165825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102194160|NCT03165825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102194161|NCT03165825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102194162|NCT03165825|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102194163|NCT03165825|Respiratory System Agents|respiratory system agents|mesh-ancestor
102194164|NCT03167853|Antibodies|antibodies|mesh-list
102194165|NCT03167853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102194166|NCT03167853|Immunologic Factors|immunologic factors|mesh-ancestor
102194167|NCT03167853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194168|NCT05746143|Zolpidem|zolpidem|mesh-list
102194169|NCT05746143|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102194170|NCT05746143|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102194171|NCT05746143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102194172|NCT05746143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194173|NCT05746143|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102194174|NCT05746143|GABA Agonists|gaba agonists|mesh-ancestor
102194175|NCT05746143|GABA Agents|gaba agents|mesh-ancestor
102194176|NCT05746143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102194177|NCT05746143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194178|NCT03165591|Vaccines|vaccines|mesh-list
102194179|NCT03165591|Immunologic Factors|immunologic factors|mesh-ancestor
102194180|NCT03165591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194181|NCT03114813|Carvedilol|carvedilol|mesh-list
102194182|NCT03114813|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102194183|NCT03114813|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102194184|NCT03114813|Adrenergic Agents|adrenergic agents|mesh-ancestor
102194185|NCT03114813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102194186|NCT03114813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194187|NCT03114813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194188|NCT03114813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102194189|NCT03114813|Antioxidants|antioxidants|mesh-ancestor
102194190|NCT03114813|Protective Agents|protective agents|mesh-ancestor
102194191|NCT03114813|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102194192|NCT03114813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102194193|NCT03114813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102194194|NCT03114813|Vasodilator Agents|vasodilator agents|mesh-ancestor
102194195|NCT03114813|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102194196|NCT03114813|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102194197|NCT01358864|Interferons|interferons|mesh-list
102194198|NCT01358864|Ribavirin|ribavirin|mesh-list
102194199|NCT01358864|Interferon-alpha|interferon-alpha|mesh-list
102194200|NCT01358864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102194201|NCT01358864|Antiviral Agents|antiviral agents|mesh-ancestor
102194202|NCT01358864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102194203|NCT01358864|Antimetabolites|antimetabolites|mesh-ancestor
102194204|NCT01358864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194205|NCT01358864|Immunologic Factors|immunologic factors|mesh-ancestor
102194206|NCT01358864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194207|NCT02750761|Tedizolid|tedizolid|mesh-list
102194208|NCT02750761|Tedizolid phosphate|tedizolid phosphate|mesh-list
102194209|NCT02750761|Oxazolidinones|oxazolidinones|mesh-list
102194210|NCT02750761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102194211|NCT02750761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102194212|NCT02750761|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102194213|NCT02750761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102194214|NCT02750761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194215|NCT05746065|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102194216|NCT05746065|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102194217|NCT05746065|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102194218|NCT05746065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102194219|NCT05746065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194220|NCT05746065|Antiviral Agents|antiviral agents|mesh-ancestor
102194221|NCT05746065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102194222|NCT05746065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102194223|NCT05746065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102194224|NCT02814019|Idebenone|idebenone|mesh-list
102194225|NCT02814019|Antioxidants|antioxidants|mesh-ancestor
102194226|NCT02814019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194227|NCT02814019|Protective Agents|protective agents|mesh-ancestor
102194228|NCT02814019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194229|NCT03364244|Sildenafil Citrate|sildenafil citrate|mesh-list
102194230|NCT03364244|Vasodilator Agents|vasodilator agents|mesh-ancestor
102194231|NCT03364244|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102194232|NCT03364244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102194233|NCT03364244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102194234|NCT03364244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194235|NCT03364244|Urological Agents|urological agents|mesh-ancestor
102194236|NCT03165123|Azithromycin|azithromycin|mesh-list
102194237|NCT03165123|Dexamethasone|dexamethasone|mesh-list
102194238|NCT03165123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102194239|NCT03165123|Antiemetics|antiemetics|mesh-ancestor
102194240|NCT03165123|Autonomic Agents|autonomic agents|mesh-ancestor
102194241|NCT03165123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102194242|NCT03165123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194243|NCT03165123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102194244|NCT03165123|Glucocorticoids|glucocorticoids|mesh-ancestor
102194245|NCT03165123|Hormones|hormones|mesh-ancestor
102194246|NCT03165123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102194247|NCT03165123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102194248|NCT03165123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102194249|NCT03165123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102194250|NCT03165123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102194251|NCT01131169|Vidarabine|vidarabine|mesh-list
102194252|NCT01131169|Fludarabine|fludarabine|mesh-list
102194253|NCT01131169|Fludarabine phosphate|fludarabine phosphate|mesh-list
102194254|NCT01131169|Melphalan|melphalan|mesh-list
102194255|NCT01131169|Busulfan|busulfan|mesh-list
102194256|NCT01131169|Lenograstim|lenograstim|mesh-list
102194257|NCT01131169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102194258|NCT01131169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102194259|NCT01131169|Antimetabolites|antimetabolites|mesh-ancestor
102194260|NCT01131169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194261|NCT01131169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102194262|NCT01131169|Immunologic Factors|immunologic factors|mesh-ancestor
102194263|NCT01131169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194264|NCT01131169|Antiviral Agents|antiviral agents|mesh-ancestor
102194265|NCT01131169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102194266|NCT01131169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102194267|NCT01131169|Alkylating Agents|alkylating agents|mesh-ancestor
102194268|NCT01131169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102194269|NCT01131169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102194270|NCT02688933|Insulin|insulin|mesh-list
102194271|NCT02688933|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102194272|NCT02688933|Insulin Glargine|insulin glargine|mesh-list
102194273|NCT02688933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102194274|NCT02688933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194275|NCT04372628|Ritonavir|ritonavir|mesh-list
102194276|NCT04372628|Lopinavir|lopinavir|mesh-list
102194277|NCT04372628|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102194278|NCT04372628|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102194279|NCT04372628|Protease Inhibitors|protease inhibitors|mesh-ancestor
102194280|NCT04372628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102194281|NCT04372628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194282|NCT04372628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102194283|NCT04372628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102194284|NCT04372628|Antiviral Agents|antiviral agents|mesh-ancestor
102194285|NCT04372628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102194286|NCT04372628|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102194287|NCT04372628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102194288|NCT04230980|Gabapentin|gabapentin|mesh-list
102194289|NCT04230980|Analgesics|analgesics|mesh-ancestor
102194290|NCT04230980|Sensory System Agents|sensory system agents|mesh-ancestor
102194291|NCT04230980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102194292|NCT04230980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194293|NCT04230980|Anticonvulsants|anticonvulsants|mesh-ancestor
102194294|NCT04230980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102194295|NCT04230980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102194296|NCT04230980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102194297|NCT04230980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102194298|NCT04230980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102194299|NCT04230980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102194300|NCT04230980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102194301|NCT04230980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194302|NCT04230980|Antimanic Agents|antimanic agents|mesh-ancestor
102194303|NCT00882505|Vitamin D|vitamin d|mesh-list
102194304|NCT00882505|Vitamins|vitamins|mesh-ancestor
102194305|NCT00882505|Micronutrients|micronutrients|mesh-ancestor
102194306|NCT00882505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194307|NCT00882505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102194308|NCT04480359|Meloxicam|meloxicam|mesh-list
102194309|NCT04480359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102194310|NCT04480359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102194311|NCT04480359|Analgesics|analgesics|mesh-ancestor
102194312|NCT04480359|Sensory System Agents|sensory system agents|mesh-ancestor
102194313|NCT04480359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102194314|NCT04480359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194315|NCT04480359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102194316|NCT04480359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102194317|NCT04480359|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102194318|NCT04480359|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102194319|NCT04480359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102194320|NCT04480359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194321|NCT03724825|Testosterone|testosterone|mesh-list
102194322|NCT03724825|Androgens|androgens|mesh-ancestor
102194323|NCT03724825|Hormones|hormones|mesh-ancestor
102194324|NCT03724825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102194325|NCT03724825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194326|NCT04227704|Ketamine|ketamine|mesh-list
102194327|NCT04227704|Analgesics|analgesics|mesh-ancestor
102194328|NCT04227704|Sensory System Agents|sensory system agents|mesh-ancestor
102194329|NCT04227704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102194330|NCT04227704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194331|NCT04227704|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102194332|NCT04227704|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102194333|NCT04227704|Anesthetics, General|anesthetics, general|mesh-ancestor
102194334|NCT04227704|Anesthetics|anesthetics|mesh-ancestor
102194335|NCT04227704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102194336|NCT04227704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102194337|NCT04227704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102194338|NCT04227704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102194339|NCT04227704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194340|NCT03720613|Naloxegol|naloxegol|mesh-list
102194341|NCT03720613|Lubiprostone|lubiprostone|mesh-list
102194342|NCT03720613|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102194343|NCT03720613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102194344|NCT03720613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194345|NCT03720613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102194346|NCT03720613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194347|NCT03720613|Sensory System Agents|sensory system agents|mesh-ancestor
102194348|NCT03720613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102194349|NCT02709512|Cisplatin|cisplatin|mesh-list
102194350|NCT02709512|Pemetrexed|pemetrexed|mesh-list
102194351|NCT02709512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102194352|NCT02709512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102194353|NCT02709512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194354|NCT02709512|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102194355|NCT02709512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102194356|NCT03699475|Cyclophosphamide|cyclophosphamide|mesh-list
102194357|NCT03699475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102194358|NCT03699475|Immunologic Factors|immunologic factors|mesh-ancestor
102194359|NCT03699475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194360|NCT03699475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102194361|NCT03699475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102194362|NCT03699475|Alkylating Agents|alkylating agents|mesh-ancestor
102194363|NCT03699475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194364|NCT03699475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102194365|NCT03699475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102194366|NCT03659929|Amphetamine|amphetamine|mesh-list
102194367|NCT03659929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102194368|NCT03659929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194369|NCT03659929|Sympathomimetics|sympathomimetics|mesh-ancestor
102194370|NCT03659929|Autonomic Agents|autonomic agents|mesh-ancestor
102194371|NCT03659929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102194372|NCT03659929|Dopamine Agents|dopamine agents|mesh-ancestor
102194373|NCT03659929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102194374|NCT03659929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194375|NCT03659929|Adrenergic Agents|adrenergic agents|mesh-ancestor
102194376|NCT03659929|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102194377|NCT03659929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102194378|NCT03659929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102194379|NCT03659929|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102194380|NCT02811679|Blinatumomab|blinatumomab|mesh-list
102194381|NCT02811679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102194382|NCT03448081|Calcipotriene|calcipotriene|mesh-list
102194383|NCT03448081|Dermatologic Agents|dermatologic agents|mesh-ancestor
102194384|NCT02232607|Lacidipine|lacidipine|mesh-list
102194385|NCT02232607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102194386|NCT02232607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102194387|NCT02232607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102194388|NCT02232607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194389|NCT02232607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102194390|NCT02232607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194391|NCT02232685|Choline|choline|mesh-list
102194392|NCT02232685|Lipotropic Agents|lipotropic agents|mesh-ancestor
102194393|NCT02232685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102194394|NCT02232685|Antimetabolites|antimetabolites|mesh-ancestor
102194395|NCT02232685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194396|NCT02232685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102194397|NCT02232685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102194398|NCT02232685|Nootropic Agents|nootropic agents|mesh-ancestor
102194399|NCT02232763|Losartan|losartan|mesh-list
102194400|NCT02232763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102194401|NCT02232763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102194402|NCT02232763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102194403|NCT02232763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102194404|NCT02232763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194405|NCT04294784|Paclitaxel|paclitaxel|mesh-list
102194406|NCT04294784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102194407|NCT04294784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102194408|NCT04294784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102194409|NCT04294784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102194410|NCT04294784|Tubulin Modulators|tubulin modulators|mesh-ancestor
102194411|NCT04294784|Antimitotic Agents|antimitotic agents|mesh-ancestor
102194412|NCT04294784|Mitosis Modulators|mitosis modulators|mesh-ancestor
102194413|NCT04294784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194414|NCT04294784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102194415|NCT02262559|Telmisartan|telmisartan|mesh-list
102194416|NCT02262559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102194417|NCT02262559|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101449573|NCT00123578|Antiemetics|antiemetics|mesh-ancestor
102194418|NCT02262559|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102194419|NCT02262559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194420|NCT05491460|Rivaroxaban|rivaroxaban|mesh-list
102194421|NCT05491460|Apixaban|apixaban|mesh-list
102194422|NCT05491460|Edoxaban|edoxaban|mesh-list
102194423|NCT05491460|Dabigatran|dabigatran|mesh-list
102194424|NCT05491460|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102194425|NCT05491460|Antithrombins|antithrombins|mesh-ancestor
102194426|NCT05491460|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102194427|NCT05491460|Protease Inhibitors|protease inhibitors|mesh-ancestor
102194428|NCT05491460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102194429|NCT05491460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194430|NCT05491460|Anticoagulants|anticoagulants|mesh-ancestor
102194431|NCT03311269|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
102194432|NCT03311269|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102194433|NCT03311269|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102194434|NCT02762929|Bupivacaine|bupivacaine|mesh-list
102194435|NCT02762929|Anesthetics, Local|anesthetics, local|mesh-ancestor
102194436|NCT02762929|Anesthetics|anesthetics|mesh-ancestor
102194437|NCT02762929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102194438|NCT02762929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194439|NCT02762929|Sensory System Agents|sensory system agents|mesh-ancestor
102194440|NCT02762929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102194441|NCT02262637|Telmisartan|telmisartan|mesh-list
102194442|NCT02262637|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
102194443|NCT02262637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102194444|NCT02262637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102194445|NCT02262637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102194446|NCT02262637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194447|NCT02262637|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102194448|NCT02262637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102194449|NCT02262637|Diuretics|diuretics|mesh-ancestor
102194450|NCT02262637|Natriuretic Agents|natriuretic agents|mesh-ancestor
102194451|NCT02262637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194452|NCT02606305|Bevacizumab|bevacizumab|mesh-list
102194453|NCT02606305|Pembrolizumab|pembrolizumab|mesh-list
102194454|NCT02606305|Carboplatin|carboplatin|mesh-list
102194455|NCT02606305|Doxorubicin|doxorubicin|mesh-list
102194456|NCT02606305|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102194457|NCT02606305|Maytansine|maytansine|mesh-list
102194458|NCT02606305|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
102194459|NCT02606305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102194460|NCT02606305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102194461|NCT02606305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102194462|NCT02606305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102194463|NCT02606305|Growth Substances|growth substances|mesh-ancestor
102194464|NCT02606305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194465|NCT02606305|Growth Inhibitors|growth inhibitors|mesh-ancestor
102194466|NCT02606305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102194467|NCT02606305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102194468|NCT02606305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102194469|NCT02606305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102194470|NCT02606305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194471|NCT02606305|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102194472|NCT02606305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102194473|NCT02606305|Tubulin Modulators|tubulin modulators|mesh-ancestor
102194474|NCT02606305|Antimitotic Agents|antimitotic agents|mesh-ancestor
102194475|NCT02606305|Mitosis Modulators|mitosis modulators|mesh-ancestor
102194476|NCT02606305|Immunoconjugates|immunoconjugates|mesh-ancestor
102194477|NCT02606305|Immunologic Factors|immunologic factors|mesh-ancestor
102194478|NCT01662986|Bromides|bromides|mesh-list
102194479|NCT01662986|Tiotropium Bromide|tiotropium bromide|mesh-list
102194480|NCT01662986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102194481|NCT01662986|Autonomic Agents|autonomic agents|mesh-ancestor
102194482|NCT01662986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102194483|NCT01662986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194484|NCT01662986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102194485|NCT01662986|Respiratory System Agents|respiratory system agents|mesh-ancestor
102194486|NCT01662986|Parasympatholytics|parasympatholytics|mesh-ancestor
102194487|NCT01662986|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102194488|NCT01662986|Cholinergic Agents|cholinergic agents|mesh-ancestor
102194489|NCT01662986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102194490|NCT01662986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194491|NCT01662986|Anticonvulsants|anticonvulsants|mesh-ancestor
102194493|NCT05497232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102194494|NCT00054158|Thalidomide|thalidomide|mesh-list
102194495|NCT00054158|Dexamethasone|dexamethasone|mesh-list
102194496|NCT00054158|Doxorubicin|doxorubicin|mesh-list
102194497|NCT00054158|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102194498|NCT00054158|Vincristine|vincristine|mesh-list
102194499|NCT00054158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102194500|NCT00054158|Antiemetics|antiemetics|mesh-ancestor
102194501|NCT00054158|Autonomic Agents|autonomic agents|mesh-ancestor
102194502|NCT00054158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102194503|NCT00054158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194504|NCT00054158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102194505|NCT00054158|Glucocorticoids|glucocorticoids|mesh-ancestor
102194506|NCT00054158|Hormones|hormones|mesh-ancestor
102194507|NCT00054158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102194508|NCT00054158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102194509|NCT00054158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102194510|NCT00054158|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102194511|NCT00054158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102194512|NCT00054158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102194513|NCT00054158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102194514|NCT00054158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194515|NCT00054158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102194516|NCT00054158|Tubulin Modulators|tubulin modulators|mesh-ancestor
102194517|NCT00054158|Antimitotic Agents|antimitotic agents|mesh-ancestor
102194518|NCT00054158|Mitosis Modulators|mitosis modulators|mesh-ancestor
102194519|NCT00054158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102194520|NCT00054158|Immunologic Factors|immunologic factors|mesh-ancestor
102194521|NCT00054158|Leprostatic Agents|leprostatic agents|mesh-ancestor
102194522|NCT00054158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102194523|NCT00054158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102194524|NCT00054158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102194525|NCT00054158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102194526|NCT00054158|Growth Substances|growth substances|mesh-ancestor
102194527|NCT00054158|Growth Inhibitors|growth inhibitors|mesh-ancestor
102194528|NCT01337167|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102194529|NCT01337167|Immunologic Factors|immunologic factors|mesh-ancestor
102194530|NCT01337167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194531|NCT05496764|Dexamethasone|dexamethasone|mesh-list
102194532|NCT05496764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102194533|NCT05496764|Antiemetics|antiemetics|mesh-ancestor
102194534|NCT05496764|Autonomic Agents|autonomic agents|mesh-ancestor
102194535|NCT05496764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102194536|NCT05496764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194537|NCT05496764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102194538|NCT05496764|Glucocorticoids|glucocorticoids|mesh-ancestor
102194539|NCT05496764|Hormones|hormones|mesh-ancestor
102194540|NCT05496764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102194541|NCT05496764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102194542|NCT05496764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102194543|NCT05496530|Triamcinolone|triamcinolone|mesh-list
102194544|NCT05496530|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102194545|NCT05496530|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102194546|NCT05496530|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102194547|NCT05496530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102194548|NCT05496530|Glucocorticoids|glucocorticoids|mesh-ancestor
102194549|NCT05496530|Hormones|hormones|mesh-ancestor
102194550|NCT05496530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102194551|NCT05496530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194552|NCT05496530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102194553|NCT05496530|Immunologic Factors|immunologic factors|mesh-ancestor
102194554|NCT05496530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102194555|NCT05496530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194556|NCT02744833|Enoxaparin|enoxaparin|mesh-list
102194557|NCT02744833|Enoxaparin sodium|enoxaparin sodium|mesh-list
102194558|NCT02744833|Anticoagulants|anticoagulants|mesh-ancestor
102194559|NCT02744833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102194560|NCT02744833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102194561|NCT02744833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194562|NCT02234869|Interferons|interferons|mesh-list
102194563|NCT02234869|Interferon-beta|interferon-beta|mesh-list
102194565|NCT02234869|Interferon beta-1b|interferon beta-1b|mesh-list
102194566|NCT02234869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102194567|NCT02234869|Antiviral Agents|antiviral agents|mesh-ancestor
102194568|NCT02234869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102194569|NCT02234869|Immunologic Factors|immunologic factors|mesh-ancestor
102194570|NCT02234869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194571|NCT02234869|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102194572|NCT05499026|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
102194573|NCT05499026|Cathartics|cathartics|mesh-ancestor
102194574|NCT05499026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102194575|NCT05498714|Lactulose|lactulose|mesh-list
102194576|NCT05498714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102194577|NCT05490836|Interferon-alpha|interferon-alpha|mesh-list
102194578|NCT05490836|Interferon alpha-2|interferon alpha-2|mesh-list
102194579|NCT05490836|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
102194580|NCT05490836|Antiviral Agents|antiviral agents|mesh-ancestor
102194581|NCT05490836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102194582|NCT05490836|Immunologic Factors|immunologic factors|mesh-ancestor
102194583|NCT05490836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194584|NCT05490836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102194585|NCT01338025|Lamivudine|lamivudine|mesh-list
102194586|NCT01338025|Emtricitabine|emtricitabine|mesh-list
102194587|NCT01338025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102194588|NCT01338025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102194589|NCT01338025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102194590|NCT01338025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194591|NCT01338025|Antiviral Agents|antiviral agents|mesh-ancestor
102194592|NCT01338025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102194593|NCT01338025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102194594|NCT01338025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102194595|NCT05498636|Prednisone|prednisone|mesh-list
102194596|NCT05498636|Etoposide|etoposide|mesh-list
102194597|NCT05498636|Lenalidomide|lenalidomide|mesh-list
102194598|NCT05498636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102194599|NCT05498636|Glucocorticoids|glucocorticoids|mesh-ancestor
102194600|NCT05498636|Hormones|hormones|mesh-ancestor
102194601|NCT05498636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102194602|NCT05498636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194603|NCT05498636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102194604|NCT05498636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102194605|NCT05498636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102194606|NCT05498636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102194607|NCT05498636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102194608|NCT05498636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102194609|NCT05498636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194610|NCT05498636|Immunologic Factors|immunologic factors|mesh-ancestor
102194611|NCT05498636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102194612|NCT05498636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102194613|NCT05498636|Growth Substances|growth substances|mesh-ancestor
102194614|NCT05498636|Growth Inhibitors|growth inhibitors|mesh-ancestor
102194615|NCT02262715|Oseltamivir|oseltamivir|mesh-list
102194616|NCT02262715|Antiviral Agents|antiviral agents|mesh-ancestor
102194617|NCT02262715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102194618|NCT02262715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102194619|NCT02262715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194620|NCT02588677|Riluzole|riluzole|mesh-list
102194621|NCT02588677|Anticonvulsants|anticonvulsants|mesh-ancestor
102194622|NCT02588677|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102194623|NCT02588677|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102194624|NCT02588677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102194625|NCT02588677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449584|NCT00123578|GABA Agents|gaba agents|mesh-ancestor
102194626|NCT02588677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194627|NCT02588677|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102194628|NCT02588677|Protective Agents|protective agents|mesh-ancestor
102194629|NCT04424420|Acetaminophen|acetaminophen|mesh-list
102194630|NCT04424420|Ibuprofen|ibuprofen|mesh-list
102194631|NCT04424420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102194632|NCT04424420|Analgesics|analgesics|mesh-ancestor
102194633|NCT04424420|Sensory System Agents|sensory system agents|mesh-ancestor
102194634|NCT04424420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102194635|NCT04424420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194636|NCT04424420|Antipyretics|antipyretics|mesh-ancestor
102194637|NCT04424420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102194638|NCT04424420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102194639|NCT04424420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102194640|NCT04424420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102194641|NCT04424420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102194642|NCT04424420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194643|NCT05495750|Bupivacaine|bupivacaine|mesh-list
102194644|NCT05495750|Anesthetics, Local|anesthetics, local|mesh-ancestor
102194645|NCT05495750|Anesthetics|anesthetics|mesh-ancestor
102194646|NCT05495750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102194647|NCT05495750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194648|NCT05495750|Sensory System Agents|sensory system agents|mesh-ancestor
102194649|NCT05495750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102194650|NCT02233075|Interferons|interferons|mesh-list
102194651|NCT02233075|Interferon-alpha|interferon-alpha|mesh-list
102194652|NCT02233075|Interferon alpha-2|interferon alpha-2|mesh-list
102194653|NCT02233075|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102194654|NCT02233075|REP 2139|rep 2139|mesh-list
102194655|NCT02233075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102194656|NCT02233075|Antiviral Agents|antiviral agents|mesh-ancestor
102194657|NCT02233075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102194658|NCT02233075|Immunologic Factors|immunologic factors|mesh-ancestor
102194659|NCT02233075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194660|NCT04300244|Nivolumab|nivolumab|mesh-list
102194661|NCT04300244|Ipilimumab|ipilimumab|mesh-list
102194662|NCT04300244|Sargramostim|sargramostim|mesh-list
102194663|NCT04300244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102194664|NCT04300244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102194665|NCT04300244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102194666|NCT04300244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194667|NCT04300244|Immunologic Factors|immunologic factors|mesh-ancestor
102194668|NCT04300244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194669|NCT02578771|Methylene Blue|methylene blue|mesh-list
102194670|NCT02578771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102194671|NCT02578771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194672|NCT02259595|Acetylcysteine|acetylcysteine|mesh-list
102194673|NCT02259595|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102194674|NCT02259595|Disufenton sodium|disufenton sodium|mesh-list
102194675|NCT02259595|Antiviral Agents|antiviral agents|mesh-ancestor
102194676|NCT02259595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102194677|NCT02259595|Expectorants|expectorants|mesh-ancestor
102194678|NCT02259595|Respiratory System Agents|respiratory system agents|mesh-ancestor
102194679|NCT02259595|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102194680|NCT02259595|Antioxidants|antioxidants|mesh-ancestor
102194681|NCT02259595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194682|NCT02259595|Protective Agents|protective agents|mesh-ancestor
102194683|NCT02259595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194684|NCT02259595|Antidotes|antidotes|mesh-ancestor
102194685|NCT02804035|Furosemide|furosemide|mesh-list
102194686|NCT02804035|Diuretics|diuretics|mesh-ancestor
102194687|NCT02804035|Natriuretic Agents|natriuretic agents|mesh-ancestor
102194688|NCT02804035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194689|NCT02804035|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102194690|NCT02804035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102194691|NCT02804035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194692|NCT02262793|Telmisartan|telmisartan|mesh-list
102194693|NCT02262793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102194694|NCT02262793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102194695|NCT02262793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102194696|NCT02262793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194697|NCT02559206|Linaclotide|linaclotide|mesh-list
102194698|NCT02559206|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102194699|NCT02559206|Enzyme Activators|enzyme activators|mesh-ancestor
102194700|NCT02559206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194701|NCT02559206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102194702|NCT05485766|Paclitaxel|paclitaxel|mesh-list
102194703|NCT05485766|Carboplatin|carboplatin|mesh-list
102194704|NCT05485766|Pembrolizumab|pembrolizumab|mesh-list
102194705|NCT05485766|Olaparib|olaparib|mesh-list
102194706|NCT05485766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102194707|NCT05485766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102194708|NCT05485766|Tubulin Modulators|tubulin modulators|mesh-ancestor
102194709|NCT05485766|Antimitotic Agents|antimitotic agents|mesh-ancestor
102194710|NCT05485766|Mitosis Modulators|mitosis modulators|mesh-ancestor
102194711|NCT05485766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194712|NCT05485766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102194713|NCT05485766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102194714|NCT05485766|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102194715|NCT05485766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102194716|NCT04402723|Cytarabine|cytarabine|mesh-list
102194717|NCT04402723|Daunorubicin|daunorubicin|mesh-list
102194718|NCT04402723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102194719|NCT04402723|Antimetabolites|antimetabolites|mesh-ancestor
102194720|NCT04402723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194721|NCT04402723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102194722|NCT04402723|Antiviral Agents|antiviral agents|mesh-ancestor
102194723|NCT04402723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102194724|NCT04402723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102194725|NCT04402723|Immunologic Factors|immunologic factors|mesh-ancestor
102194726|NCT04402723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194727|NCT04402723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102194728|NCT04402723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102194729|NCT04402723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102194730|NCT04402723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102194731|NCT02235337|Riboflavin|riboflavin|mesh-list
102194732|NCT02235337|Vitamins|vitamins|mesh-ancestor
102194733|NCT02235337|Micronutrients|micronutrients|mesh-ancestor
102194734|NCT02235337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194735|NCT02235337|Vitamin B Complex|vitamin b complex|mesh-ancestor
102194736|NCT02235337|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102194737|NCT02235337|Dermatologic Agents|dermatologic agents|mesh-ancestor
102194738|NCT02233231|Varenicline|varenicline|mesh-list
102194739|NCT02233231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102194740|NCT02233231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102194741|NCT02233231|Cholinergic Agents|cholinergic agents|mesh-ancestor
102194742|NCT02233231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102194743|NCT02233231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194744|NCT02233231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194745|NCT02263027|Vaccines|vaccines|mesh-list
102194746|NCT02263027|Immunologic Factors|immunologic factors|mesh-ancestor
102194747|NCT02263027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194748|NCT02263105|Temozolomide|temozolomide|mesh-list
102194749|NCT02263105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102194750|NCT02263105|Alkylating Agents|alkylating agents|mesh-ancestor
102194751|NCT02263105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194752|NCT02263105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102194753|NCT05485064|Fentanyl|fentanyl|mesh-list
102194754|NCT05485064|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102194755|NCT05485064|Narcotics|narcotics|mesh-ancestor
102194756|NCT05485064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102194757|NCT05485064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194758|NCT05485064|Analgesics|analgesics|mesh-ancestor
102194759|NCT05485064|Sensory System Agents|sensory system agents|mesh-ancestor
102194760|NCT05485064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102194761|NCT05485064|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102194762|NCT05485064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102194763|NCT05485064|Anesthetics, General|anesthetics, general|mesh-ancestor
102194764|NCT05485064|Anesthetics|anesthetics|mesh-ancestor
102194765|NCT05626153|Anesthetics|anesthetics|mesh-list
102194766|NCT05626153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102194767|NCT05626153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194768|NCT02553343|Vaccines|vaccines|mesh-list
102194769|NCT02553343|Immunologic Factors|immunologic factors|mesh-ancestor
102194770|NCT02553343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194771|NCT02235415|Lacidipine|lacidipine|mesh-list
102194772|NCT02235415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102194773|NCT02235415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102194774|NCT02235415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102194775|NCT02235415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194776|NCT02235415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102194777|NCT02235415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194778|NCT03995017|Nivolumab|nivolumab|mesh-list
102194779|NCT03995017|Ramucirumab|ramucirumab|mesh-list
102194780|NCT03995017|Rucaparib|rucaparib|mesh-list
102194781|NCT03995017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102194782|NCT03995017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102194783|NCT03995017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102194784|NCT03995017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194785|NCT03995017|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102194786|NCT03995017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102194787|NCT02558894|Durvalumab|durvalumab|mesh-list
102194788|NCT02558894|Tremelimumab|tremelimumab|mesh-list
102194789|NCT02558894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102194790|NCT02558894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102194791|NCT02558894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102194792|NCT02558894|Immunologic Factors|immunologic factors|mesh-ancestor
102194793|NCT02558894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194795|NCT02233387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102194796|NCT02233387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194797|NCT02510599|Solithromycin|solithromycin|mesh-list
102194798|NCT02510599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102194799|NCT02510599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102194800|NCT02235805|Magnesium citrate|magnesium citrate|mesh-list
102194801|NCT02235805|Cathartics|cathartics|mesh-ancestor
102194802|NCT02235805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102194803|NCT04227769|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102194804|NCT04227769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102194805|NCT02688387|Ambrisentan|ambrisentan|mesh-list
102194806|NCT02688387|Tadalafil|tadalafil|mesh-list
102194807|NCT02688387|Vasodilator Agents|vasodilator agents|mesh-ancestor
102194808|NCT02688387|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102194809|NCT02688387|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102194810|NCT02688387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102194811|NCT02688387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194812|NCT02688387|Urological Agents|urological agents|mesh-ancestor
102194813|NCT02688387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102194814|NCT05489900|Dexmedetomidine|dexmedetomidine|mesh-list
102194815|NCT05489900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102194816|NCT05489900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102194817|NCT05489900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194818|NCT05489900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102194819|NCT05489900|Analgesics|analgesics|mesh-ancestor
102194820|NCT05489900|Sensory System Agents|sensory system agents|mesh-ancestor
102194821|NCT05489900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102194822|NCT05489900|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102194823|NCT05489900|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102194824|NCT05489900|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102194825|NCT05489900|Adrenergic Agents|adrenergic agents|mesh-ancestor
102194826|NCT05489900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101573987|NCT02199184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102194827|NCT05489900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194828|NCT05489666|Vitamin D|vitamin d|mesh-list
102194829|NCT05489666|Cholecalciferol|cholecalciferol|mesh-list
102194830|NCT05489666|Vitamins|vitamins|mesh-ancestor
102194831|NCT05489666|Micronutrients|micronutrients|mesh-ancestor
102194832|NCT05489666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194833|NCT05489666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102194834|NCT05489666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102194835|NCT05484284|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102194836|NCT05484284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102194837|NCT05483894|Atorvastatin|atorvastatin|mesh-list
102194838|NCT05483894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102194839|NCT05483894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102194840|NCT05483894|Antimetabolites|antimetabolites|mesh-ancestor
102194841|NCT05483894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194842|NCT05483894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102194843|NCT05483894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102194844|NCT05483894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102194845|NCT01621243|Paclitaxel|paclitaxel|mesh-list
102194846|NCT01621243|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102194847|NCT01621243|Gemcitabine|gemcitabine|mesh-list
102194848|NCT01621243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102194849|NCT01621243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102194850|NCT01621243|Tubulin Modulators|tubulin modulators|mesh-ancestor
102194851|NCT01621243|Antimitotic Agents|antimitotic agents|mesh-ancestor
102194852|NCT01621243|Mitosis Modulators|mitosis modulators|mesh-ancestor
102194853|NCT01621243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194854|NCT01621243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102194855|NCT01621243|Antimetabolites|antimetabolites|mesh-ancestor
102194856|NCT04076761|Trifluridine|trifluridine|mesh-list
102194857|NCT04076761|Antimetabolites|antimetabolites|mesh-ancestor
102194858|NCT04076761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194859|NCT04076761|Antiviral Agents|antiviral agents|mesh-ancestor
102194860|NCT04076761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102194861|NCT04046887|Paclitaxel|paclitaxel|mesh-list
102194862|NCT04046887|Gemcitabine|gemcitabine|mesh-list
102194863|NCT04046887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102194864|NCT04046887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102194865|NCT04046887|Tubulin Modulators|tubulin modulators|mesh-ancestor
102194866|NCT04046887|Antimitotic Agents|antimitotic agents|mesh-ancestor
102194867|NCT04046887|Mitosis Modulators|mitosis modulators|mesh-ancestor
102194868|NCT04046887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194869|NCT04046887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102194870|NCT04046887|Antimetabolites|antimetabolites|mesh-ancestor
102194871|NCT02235961|Liraglutide|liraglutide|mesh-list
102194872|NCT02235961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102194873|NCT02235961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194874|NCT02235961|Incretins|incretins|mesh-ancestor
102194875|NCT02235961|Hormones|hormones|mesh-ancestor
102194876|NCT02235961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102194877|NCT01610245|Oseltamivir|oseltamivir|mesh-list
102194878|NCT01610245|Nitazoxanide|nitazoxanide|mesh-list
102194879|NCT01610245|Antiviral Agents|antiviral agents|mesh-ancestor
102194880|NCT01610245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102194881|NCT01610245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102194882|NCT01610245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194883|NCT01610245|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102194884|NCT04138628|Atezolizumab|atezolizumab|mesh-list
102194885|NCT04138628|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102194886|NCT04138628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194887|NCT04138628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102194888|NCT04138628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102194889|NCT02741791|Bupropion|bupropion|mesh-list
102194890|NCT02741791|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102194891|NCT02741791|Antidepressive Agents|antidepressive agents|mesh-ancestor
102194892|NCT02741791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102194893|NCT02741791|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102194894|NCT02741791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102194895|NCT02741791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102194896|NCT02741791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194897|NCT02741791|Dopamine Agents|dopamine agents|mesh-ancestor
102194898|NCT02741791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102194899|NCT02741791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194900|NCT02741791|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102194901|NCT02741791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102194902|NCT02741791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102194903|NCT04275518|Cytarabine|cytarabine|mesh-list
102194904|NCT04275518|Azacitidine|azacitidine|mesh-list
102194905|NCT04275518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102194906|NCT04275518|Antimetabolites|antimetabolites|mesh-ancestor
102194907|NCT04275518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194908|NCT04275518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102194909|NCT04275518|Antiviral Agents|antiviral agents|mesh-ancestor
102194910|NCT04275518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102194911|NCT04275518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102194912|NCT04275518|Immunologic Factors|immunologic factors|mesh-ancestor
102194913|NCT04275518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194914|NCT04275518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102194915|NCT02263495|Paclitaxel|paclitaxel|mesh-list
102194916|NCT02263495|Gemcitabine|gemcitabine|mesh-list
101836479|NCT01063816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101836480|NCT01063816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101836481|NCT00501852|Glycopyrrolate|glycopyrrolate|mesh-list
101836482|NCT00501852|Tiotropium Bromide|tiotropium bromide|mesh-list
101836483|NCT00501852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101836484|NCT00501852|Autonomic Agents|autonomic agents|mesh-ancestor
101836485|NCT00501852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101836486|NCT00501852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836487|NCT00501852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101836488|NCT00501852|Respiratory System Agents|respiratory system agents|mesh-ancestor
101836489|NCT00501852|Parasympatholytics|parasympatholytics|mesh-ancestor
101836490|NCT00501852|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101836491|NCT00501852|Cholinergic Agents|cholinergic agents|mesh-ancestor
101836492|NCT00501852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101556260|NCT01187901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101836493|NCT00501852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836495|NCT00501852|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101836496|NCT00482274|Docetaxel|docetaxel|mesh-list
101836497|NCT00482274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101836498|NCT00482274|Tubulin Modulators|tubulin modulators|mesh-ancestor
101836499|NCT00482274|Antimitotic Agents|antimitotic agents|mesh-ancestor
101836500|NCT00482274|Mitosis Modulators|mitosis modulators|mesh-ancestor
101836501|NCT00482274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194917|NCT02263495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102194918|NCT02263495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102194919|NCT02263495|Tubulin Modulators|tubulin modulators|mesh-ancestor
102194920|NCT02263495|Antimitotic Agents|antimitotic agents|mesh-ancestor
102194921|NCT02263495|Mitosis Modulators|mitosis modulators|mesh-ancestor
102194922|NCT02263495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194923|NCT02263495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102194924|NCT02263495|Antimetabolites|antimetabolites|mesh-ancestor
102194925|NCT02687451|Oxymorphone|oxymorphone|mesh-list
102194926|NCT02687451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102194927|NCT02687451|Narcotics|narcotics|mesh-ancestor
102194928|NCT02687451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102194929|NCT02687451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194930|NCT02687451|Analgesics|analgesics|mesh-ancestor
102194931|NCT02687451|Sensory System Agents|sensory system agents|mesh-ancestor
102194932|NCT02687451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102194933|NCT02687451|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102194934|NCT02557646|Ribavirin|ribavirin|mesh-list
102194935|NCT02557646|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102194936|NCT02557646|Antimetabolites|antimetabolites|mesh-ancestor
102194937|NCT02557646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194938|NCT02557646|Antiviral Agents|antiviral agents|mesh-ancestor
102194939|NCT02557646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102194940|NCT03859687|Vitamins|vitamins|mesh-list
102194941|NCT03859687|Vitamin A|vitamin a|mesh-list
102194942|NCT03859687|Retinol palmitate|retinol palmitate|mesh-list
102194943|NCT03859687|Micronutrients|micronutrients|mesh-ancestor
102194944|NCT03859687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194945|NCT03859687|Antioxidants|antioxidants|mesh-ancestor
102194946|NCT03859687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194947|NCT03859687|Protective Agents|protective agents|mesh-ancestor
102194948|NCT03859687|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102194949|NCT03859687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102194950|NCT02679573|Moxifloxacin|moxifloxacin|mesh-list
102194951|NCT02679573|Linezolid|linezolid|mesh-list
102194952|NCT02679573|Delafloxacin|delafloxacin|mesh-list
102194953|NCT02679573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102194954|NCT02679573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102194955|NCT02679573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102194956|NCT02679573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102194957|NCT02679573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102194958|NCT02679573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194959|NCT02679573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102194960|NCT02679573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102194961|NCT05493332|Leucovorin|leucovorin|mesh-list
102194962|NCT05493332|Fluorouracil|fluorouracil|mesh-list
102194963|NCT05493332|Oxaliplatin|oxaliplatin|mesh-list
102194964|NCT05493332|Antimetabolites|antimetabolites|mesh-ancestor
102194965|NCT05493332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102194966|NCT05493332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102194967|NCT05493332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102194968|NCT05493332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102194969|NCT05493332|Immunologic Factors|immunologic factors|mesh-ancestor
102194970|NCT05493332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194971|NCT05493332|Antidotes|antidotes|mesh-ancestor
102194972|NCT05493332|Protective Agents|protective agents|mesh-ancestor
102194973|NCT05493332|Vitamin B Complex|vitamin b complex|mesh-ancestor
102194974|NCT05493332|Vitamins|vitamins|mesh-ancestor
102194975|NCT05493332|Micronutrients|micronutrients|mesh-ancestor
102194976|NCT01591447|Solithromycin|solithromycin|mesh-list
102194977|NCT01591447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102194978|NCT01591447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102194979|NCT01578655|Prednisone|prednisone|mesh-list
102194980|NCT01578655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102194981|NCT01578655|Glucocorticoids|glucocorticoids|mesh-ancestor
102194982|NCT01578655|Hormones|hormones|mesh-ancestor
102194983|NCT01578655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102194984|NCT01578655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194985|NCT01578655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102194986|NCT01578655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102194987|NCT05361447|Diazepam|diazepam|mesh-list
102194988|NCT05361447|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102194989|NCT05361447|Anticonvulsants|anticonvulsants|mesh-ancestor
102194990|NCT05361447|Antiemetics|antiemetics|mesh-ancestor
102194991|NCT05361447|Autonomic Agents|autonomic agents|mesh-ancestor
102194992|NCT05361447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102194993|NCT05361447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102194994|NCT05361447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102194995|NCT05361447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102194996|NCT05361447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102194997|NCT05361447|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102194998|NCT05361447|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102194999|NCT05361447|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102195000|NCT05361447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102195001|NCT05361447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102195002|NCT05361447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102195003|NCT05361447|Anesthetics, General|anesthetics, general|mesh-ancestor
102195004|NCT05361447|Anesthetics|anesthetics|mesh-ancestor
102195005|NCT05361447|GABA Modulators|gaba modulators|mesh-ancestor
102195006|NCT05361447|GABA Agents|gaba agents|mesh-ancestor
102195007|NCT05361447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102195008|NCT05361447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195009|NCT01577173|Cetuximab|cetuximab|mesh-list
102195010|NCT01577173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102195011|NCT01577173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195012|NCT01573351|Interferons|interferons|mesh-list
102195013|NCT01573351|Ribavirin|ribavirin|mesh-list
102195014|NCT01573351|Interferon-alpha|interferon-alpha|mesh-list
102195015|NCT01573351|Interferon alpha-2|interferon alpha-2|mesh-list
102195016|NCT01573351|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102195017|NCT01573351|Asunaprevir|asunaprevir|mesh-list
102195018|NCT01573351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195019|NCT01573351|Antiviral Agents|antiviral agents|mesh-ancestor
102195020|NCT01573351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102195021|NCT01573351|Antimetabolites|antimetabolites|mesh-ancestor
102195022|NCT01573351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688918|NCT00649038|Benazepril|benazepril|mesh-list
102195023|NCT01573351|Immunologic Factors|immunologic factors|mesh-ancestor
102195024|NCT01573351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195025|NCT01573351|Protease Inhibitors|protease inhibitors|mesh-ancestor
102195026|NCT01573351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102195027|NCT02685033|Dalbavancin|dalbavancin|mesh-list
102195028|NCT02685033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102195029|NCT02685033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102195030|NCT05579223|Hydromorphone|hydromorphone|mesh-list
102195031|NCT05579223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102195032|NCT05579223|Narcotics|narcotics|mesh-ancestor
102195033|NCT05579223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102195034|NCT05579223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195035|NCT05579223|Analgesics|analgesics|mesh-ancestor
102195036|NCT05579223|Sensory System Agents|sensory system agents|mesh-ancestor
102195037|NCT05579223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102195038|NCT00258427|Methylprednisolone|methylprednisolone|mesh-list
102195039|NCT00258427|Cyclophosphamide|cyclophosphamide|mesh-list
102195040|NCT00258427|Busulfan|busulfan|mesh-list
102195041|NCT00258427|Fludarabine|fludarabine|mesh-list
102195042|NCT00258427|Fludarabine phosphate|fludarabine phosphate|mesh-list
102195043|NCT00258427|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102195044|NCT00258427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102195045|NCT00258427|Immunologic Factors|immunologic factors|mesh-ancestor
102195046|NCT00258427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195047|NCT00258427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102195048|NCT00258427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102195049|NCT00258427|Alkylating Agents|alkylating agents|mesh-ancestor
102195050|NCT00258427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195051|NCT00258427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195052|NCT00258427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102195053|NCT00258427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102195054|NCT00258427|Antimetabolites|antimetabolites|mesh-ancestor
102195055|NCT00258427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102195056|NCT00258427|Antiemetics|antiemetics|mesh-ancestor
102195057|NCT00258427|Autonomic Agents|autonomic agents|mesh-ancestor
102195058|NCT00258427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102195059|NCT00258427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102195060|NCT00258427|Glucocorticoids|glucocorticoids|mesh-ancestor
102195061|NCT00258427|Hormones|hormones|mesh-ancestor
102195062|NCT00258427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102195063|NCT00258427|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102195064|NCT00258427|Protective Agents|protective agents|mesh-ancestor
102195065|NCT01531699|Povidone-Iodine|povidone-iodine|mesh-list
102195066|NCT01531699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102195067|NCT01531699|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102195068|NCT01531699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102195069|NCT02233621|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102195070|NCT02233621|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102195071|NCT02233621|Estradiol|estradiol|mesh-list
102195072|NCT02233621|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102195073|NCT02233621|Estrogens|estrogens|mesh-ancestor
102195075|NCT02233621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102195076|NCT02233621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195077|NCT02233621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102195078|NCT02233621|Contraceptive Agents|contraceptive agents|mesh-ancestor
102195079|NCT02233621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102195080|NCT02233621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102195081|NCT02557100|Adalimumab|adalimumab|mesh-list
102195082|NCT02557100|Methotrexate|methotrexate|mesh-list
102195083|NCT02557100|Abatacept|abatacept|mesh-list
102195084|NCT02557100|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102195085|NCT02557100|Abortifacient Agents|abortifacient agents|mesh-ancestor
102195086|NCT02557100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102195087|NCT02557100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195088|NCT02557100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102195089|NCT02557100|Antimetabolites|antimetabolites|mesh-ancestor
102195090|NCT02557100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195091|NCT02557100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195092|NCT02557100|Dermatologic Agents|dermatologic agents|mesh-ancestor
102195093|NCT02557100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102195094|NCT02557100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102195095|NCT02557100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102195096|NCT02557100|Immunologic Factors|immunologic factors|mesh-ancestor
102195097|NCT02557100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102195098|NCT02557100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102195099|NCT02557100|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102195100|NCT02557100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102195101|NCT02557100|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102195102|NCT02557100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102195104|NCT02233777|Analgesics|analgesics|mesh-ancestor
102195105|NCT02233777|Sensory System Agents|sensory system agents|mesh-ancestor
102195106|NCT02233777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102195107|NCT02233777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195108|NCT02233777|Anticonvulsants|anticonvulsants|mesh-ancestor
102195109|NCT02233777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102195110|NCT02233777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102195111|NCT02233777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195112|NCT02233777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102195113|NCT02233777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102195114|NCT02233777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102195115|NCT02233777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102195116|NCT02233777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102195117|NCT02634853|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102195118|NCT02634853|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102195119|NCT01520545|Baclofen|baclofen|mesh-list
102195120|NCT01520545|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102195121|NCT01520545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195122|NCT01520545|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102195123|NCT01520545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102195124|NCT01520545|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102195125|NCT01520545|GABA Agonists|gaba agonists|mesh-ancestor
102195126|NCT01520545|GABA Agents|gaba agents|mesh-ancestor
102195127|NCT01520545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102195128|NCT01520545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195129|NCT05488106|Riboflavin|riboflavin|mesh-list
102195130|NCT05488106|Vitamin B Complex|vitamin b complex|mesh-ancestor
102195131|NCT05488106|Vitamins|vitamins|mesh-ancestor
102195132|NCT05488106|Micronutrients|micronutrients|mesh-ancestor
102195133|NCT05488106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195134|NCT05488106|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102195135|NCT05488106|Dermatologic Agents|dermatologic agents|mesh-ancestor
102195136|NCT05492318|Clarithromycin|clarithromycin|mesh-list
102195137|NCT05492318|Midazolam|midazolam|mesh-list
102195138|NCT05492318|Dabigatran|dabigatran|mesh-list
102195139|NCT05492318|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
102195140|NCT05492318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102195141|NCT05492318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102195142|NCT05492318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102195143|NCT05492318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195144|NCT05492318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102195145|NCT05492318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102195146|NCT05492318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102195147|NCT05492318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102195148|NCT05492318|Anesthetics, General|anesthetics, general|mesh-ancestor
102195149|NCT05492318|Anesthetics|anesthetics|mesh-ancestor
102195150|NCT05492318|GABA Modulators|gaba modulators|mesh-ancestor
102195151|NCT05492318|GABA Agents|gaba agents|mesh-ancestor
102195152|NCT05492318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102195153|NCT05492318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195154|NCT05492318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102195155|NCT05492318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102195156|NCT05492318|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102195157|NCT05492318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102195158|NCT05492318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102195159|NCT05492318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102195160|NCT05492318|Antithrombins|antithrombins|mesh-ancestor
102195161|NCT05492318|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102195162|NCT05492318|Protease Inhibitors|protease inhibitors|mesh-ancestor
102195163|NCT05492318|Anticoagulants|anticoagulants|mesh-ancestor
102195164|NCT05492318|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102195165|NCT01337635|Vitamin D|vitamin d|mesh-list
102195166|NCT01337635|Vitamins|vitamins|mesh-ancestor
102195167|NCT01337635|Micronutrients|micronutrients|mesh-ancestor
102195168|NCT01337635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195169|NCT01337635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102195170|NCT02264041|Itraconazole|itraconazole|mesh-list
102195171|NCT02264041|Antifungal Agents|antifungal agents|mesh-ancestor
102195172|NCT02264041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102195173|NCT02264041|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102195174|NCT02264041|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102195175|NCT02264041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102195176|NCT02264041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195177|NCT02264041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102195178|NCT02264041|Hormone Antagonists|hormone antagonists|mesh-ancestor
102195179|NCT02264041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102195180|NCT02264041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195181|NCT02264041|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102195182|NCT02261779|Tretinoin|tretinoin|mesh-list
102195183|NCT02261779|Tranylcypromine|tranylcypromine|mesh-list
102195184|NCT02261779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195185|NCT02261779|Keratolytic Agents|keratolytic agents|mesh-ancestor
102195186|NCT02261779|Dermatologic Agents|dermatologic agents|mesh-ancestor
102195187|NCT02261779|Antidepressive Agents|antidepressive agents|mesh-ancestor
102195188|NCT02261779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102195189|NCT02261779|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102195190|NCT02261779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102195191|NCT02261779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195192|NCT02261779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102195193|NCT02261779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102195194|NCT02261779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102195195|NCT02261779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195196|NCT05157685|Azithromycin|azithromycin|mesh-list
102195197|NCT05157685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102195198|NCT05157685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102195199|NCT02556632|Curcumin|curcumin|mesh-list
102195200|NCT02556632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102195201|NCT02556632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102195202|NCT02556632|Analgesics|analgesics|mesh-ancestor
102195203|NCT02556632|Sensory System Agents|sensory system agents|mesh-ancestor
102195204|NCT02556632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102195205|NCT02556632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195206|NCT02556632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102195207|NCT02556632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102195208|NCT02556632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195209|NCT02556632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102195210|NCT02556632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195212|NCT05491928|Antioxidants|antioxidants|mesh-ancestor
102195213|NCT05491928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195214|NCT05491928|Protective Agents|protective agents|mesh-ancestor
102195215|NCT05491928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195216|NCT05491928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102195217|NCT05491928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102195218|NCT05491928|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102195219|NCT05491928|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102195220|NCT01515007|Ciprofloxacin|ciprofloxacin|mesh-list
102195221|NCT01515007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102195222|NCT01515007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102195223|NCT01515007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102195224|NCT01515007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102195225|NCT01515007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102195226|NCT01515007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195227|NCT01515007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195228|NCT01515007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102195229|NCT01515007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102195230|NCT02262169|Omeprazole|omeprazole|mesh-list
102195231|NCT02262169|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102195232|NCT02262169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102195233|NCT02262169|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102195234|NCT02262169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102195235|NCT02262169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195236|NCT05491694|Paclitaxel|paclitaxel|mesh-list
102195237|NCT05491694|Cyclophosphamide|cyclophosphamide|mesh-list
102195238|NCT05491694|Carboplatin|carboplatin|mesh-list
102195239|NCT05491694|Epirubicin|epirubicin|mesh-list
102195240|NCT05491694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102195241|NCT05491694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195242|NCT05491694|Tubulin Modulators|tubulin modulators|mesh-ancestor
102195243|NCT05491694|Antimitotic Agents|antimitotic agents|mesh-ancestor
102195244|NCT05491694|Mitosis Modulators|mitosis modulators|mesh-ancestor
102195245|NCT05491694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195246|NCT05491694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102195247|NCT05491694|Immunologic Factors|immunologic factors|mesh-ancestor
102195248|NCT05491694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195249|NCT05491694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102195250|NCT05491694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102195251|NCT05491694|Alkylating Agents|alkylating agents|mesh-ancestor
102195252|NCT05491694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102195253|NCT05491694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102195254|NCT05491694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102195255|NCT05491694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102195256|NCT05491694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102195257|NCT01501513|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
102195258|NCT01501513|Laxatives|laxatives|mesh-ancestor
102195259|NCT01501513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102195260|NCT05480072|Palmidrol|palmidrol|mesh-list
102195261|NCT05480072|Analgesics|analgesics|mesh-ancestor
102195262|NCT05480072|Sensory System Agents|sensory system agents|mesh-ancestor
102195263|NCT05480072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102195264|NCT05480072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195265|NCT05480072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102195266|NCT05480072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102195267|NCT05480072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102195268|NCT05480072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102195269|NCT05480072|Antiviral Agents|antiviral agents|mesh-ancestor
102195270|NCT05480072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102195271|NCT05480072|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102195272|NCT05480072|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102195273|NCT05480072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102195274|NCT05480072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195275|NCT05480072|Hormones|hormones|mesh-ancestor
102195276|NCT05480072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102195277|NCT01499563|Risperidone|risperidone|mesh-list
102195278|NCT01499563|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102195279|NCT01499563|Serotonin Agents|serotonin agents|mesh-ancestor
102195280|NCT01499563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102195281|NCT01499563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195282|NCT01499563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195283|NCT01499563|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102195284|NCT01499563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102195285|NCT01499563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102195286|NCT01499563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102195287|NCT01499563|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102195288|NCT01499563|Dopamine Agents|dopamine agents|mesh-ancestor
102195289|NCT03922880|Nivolumab|nivolumab|mesh-list
102195290|NCT03922880|Ipilimumab|ipilimumab|mesh-list
102195291|NCT03922880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102195292|NCT03922880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195293|NCT03922880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102195294|NCT03922880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195295|NCT02264119|Pantoprazole|pantoprazole|mesh-list
102195297|NCT02264119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102195298|NCT02264119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102195299|NCT02264119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102195300|NCT02264119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195301|NCT02262481|Dydrogesterone|dydrogesterone|mesh-list
102195302|NCT02262481|Progestins|progestins|mesh-ancestor
102195303|NCT02262481|Hormones|hormones|mesh-ancestor
102195304|NCT02262481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102195305|NCT02262481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195306|NCT01435369|Pidilizumab|pidilizumab|mesh-list
102195307|NCT01435369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102195308|NCT01435369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195309|NCT01257607|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102195310|NCT01257607|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102195311|NCT01252693|Goserelin|goserelin|mesh-list
102195312|NCT01252693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102195313|NCT01252693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195314|NCT01486849|Riluzole|riluzole|mesh-list
102195315|NCT01486849|Anticonvulsants|anticonvulsants|mesh-ancestor
102195316|NCT01486849|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102195317|NCT01486849|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102195318|NCT01486849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102195319|NCT01486849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195320|NCT01486849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195321|NCT01486849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102195322|NCT01486849|Protective Agents|protective agents|mesh-ancestor
102195323|NCT01484119|Cetirizine|cetirizine|mesh-list
102195324|NCT01484119|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102195325|NCT01484119|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102195326|NCT01484119|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102195327|NCT01484119|Histamine Antagonists|histamine antagonists|mesh-ancestor
102195328|NCT01484119|Histamine Agents|histamine agents|mesh-ancestor
102195329|NCT01484119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102195330|NCT01484119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195331|NCT01484119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195332|NCT01482403|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102195333|NCT01482403|Interferon-alpha|interferon-alpha|mesh-list
102195334|NCT01482403|Ribavirin|ribavirin|mesh-list
102195335|NCT01482403|Antiviral Agents|antiviral agents|mesh-ancestor
102195336|NCT01482403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102195337|NCT01482403|Immunologic Factors|immunologic factors|mesh-ancestor
102195338|NCT01482403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195339|NCT01482403|Antimetabolites|antimetabolites|mesh-ancestor
102195340|NCT01482403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195341|NCT01481077|Latanoprost|latanoprost|mesh-list
102195342|NCT01481077|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102195343|NCT01481077|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102195344|NCT02268409|Luspatercept|luspatercept|mesh-list
102195345|NCT02268409|Hematinics|hematinics|mesh-ancestor
102195346|NCT02268487|Sertraline|sertraline|mesh-list
102195347|NCT02268487|Antidepressive Agents|antidepressive agents|mesh-ancestor
102195348|NCT02268487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102195349|NCT02268487|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102195350|NCT02268487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102195351|NCT02268487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102195352|NCT02268487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195353|NCT02268487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102195354|NCT02268487|Serotonin Agents|serotonin agents|mesh-ancestor
102195355|NCT02268487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195356|NCT02265289|Clopidogrel|clopidogrel|mesh-list
102195357|NCT02265289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102195358|NCT02265289|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102195359|NCT02265289|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102195360|NCT02265289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102195361|NCT02265289|Purinergic Agents|purinergic agents|mesh-ancestor
102195362|NCT02265289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102195363|NCT02265289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195364|NCT02265289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195365|NCT02265445|beta-Lactams|beta-lactams|mesh-list
102195366|NCT02265445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102195367|NCT02265445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102195368|NCT04476121|Aspirin|aspirin|mesh-list
101836502|NCT00490542|Ziprasidone|ziprasidone|mesh-list
102195369|NCT04476121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102195370|NCT04476121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102195371|NCT04476121|Analgesics|analgesics|mesh-ancestor
102195372|NCT04476121|Sensory System Agents|sensory system agents|mesh-ancestor
102195373|NCT04476121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102195374|NCT04476121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195375|NCT04476121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102195376|NCT04476121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102195377|NCT04476121|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102195378|NCT04476121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102195379|NCT04476121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195380|NCT04476121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102195381|NCT04476121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102195382|NCT04476121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102195383|NCT04476121|Antipyretics|antipyretics|mesh-ancestor
102195384|NCT01234519|Doxorubicin|doxorubicin|mesh-list
102195385|NCT01234519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102195386|NCT01234519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195387|NCT01234519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102195388|NCT01234519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102195389|NCT01234519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102195390|NCT01234519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195391|NCT01474135|Travoprost|travoprost|mesh-list
102195392|NCT01474135|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102195393|NCT02268565|Aspirin|aspirin|mesh-list
102195394|NCT02268565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
102195395|NCT02268565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102195396|NCT02268565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102195397|NCT02268565|Analgesics|analgesics|mesh-ancestor
102195398|NCT02268565|Sensory System Agents|sensory system agents|mesh-ancestor
102195399|NCT02268565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102195400|NCT02268565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195401|NCT02268565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102195402|NCT02268565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102195403|NCT02268565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102195404|NCT02268565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195405|NCT02268565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102195406|NCT02268565|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102195407|NCT02268565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102195408|NCT02268565|Antipyretics|antipyretics|mesh-ancestor
102195409|NCT05479448|Prednisone|prednisone|mesh-list
102195410|NCT05479448|Hormones|hormones|mesh-list
102195411|NCT05479448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102195412|NCT05479448|Glucocorticoids|glucocorticoids|mesh-ancestor
102195413|NCT05479448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102195414|NCT05479448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195415|NCT05479448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102195416|NCT05479448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195417|NCT02264587|Domperidone|domperidone|mesh-list
102195418|NCT02264587|Mosapride|mosapride|mesh-list
102195419|NCT02264587|Antiemetics|antiemetics|mesh-ancestor
102195420|NCT02264587|Autonomic Agents|autonomic agents|mesh-ancestor
102195421|NCT02264587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102195422|NCT02264587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195423|NCT02264587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102195424|NCT02264587|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102195425|NCT02264587|Dopamine Agents|dopamine agents|mesh-ancestor
102195426|NCT02264587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102195427|NCT02264587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195428|NCT02264587|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102195429|NCT02264587|Serotonin Agents|serotonin agents|mesh-ancestor
102195430|NCT05475080|Anticoagulants|anticoagulants|mesh-list
102195431|NCT05475080|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
102195432|NCT02264665|Everolimus|everolimus|mesh-list
102195433|NCT02264665|Sunitinib|sunitinib|mesh-list
102195434|NCT02264665|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102195435|NCT02264665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102195436|NCT02264665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102195437|NCT02264665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195438|NCT02264665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102195439|NCT02264665|Immunologic Factors|immunologic factors|mesh-ancestor
102195440|NCT02264665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195441|NCT02264665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195442|NCT02264665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101449650|NCT00191711|Gemcitabine|gemcitabine|mesh-list
102195443|NCT02264665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102195444|NCT02264665|Growth Substances|growth substances|mesh-ancestor
102195445|NCT02264665|Growth Inhibitors|growth inhibitors|mesh-ancestor
102195446|NCT02683941|Lanreotide|lanreotide|mesh-list
102195447|NCT02683941|Somatostatin|somatostatin|mesh-list
102195448|NCT02683941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195449|NCT02683941|Hormones|hormones|mesh-ancestor
102195450|NCT02683941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102195451|NCT02683941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195452|NCT01225393|Adalimumab|adalimumab|mesh-list
102195453|NCT01225393|Methotrexate|methotrexate|mesh-list
102195454|NCT01225393|Leflunomide|leflunomide|mesh-list
102195455|NCT01225393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102195456|NCT01225393|Abortifacient Agents|abortifacient agents|mesh-ancestor
102195457|NCT01225393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102195458|NCT01225393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195459|NCT01225393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102195460|NCT01225393|Antimetabolites|antimetabolites|mesh-ancestor
102195461|NCT01225393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195462|NCT01225393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195463|NCT01225393|Dermatologic Agents|dermatologic agents|mesh-ancestor
102195464|NCT01225393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102195465|NCT01225393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102195466|NCT01225393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102195467|NCT01225393|Immunologic Factors|immunologic factors|mesh-ancestor
102195468|NCT01225393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102195469|NCT01225393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102195470|NCT01225393|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102195471|NCT01225393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102195472|NCT02264743|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102195473|NCT02264743|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102195475|NCT02264743|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102195476|NCT02264743|Estrogens|estrogens|mesh-ancestor
102195477|NCT02264743|Hormones|hormones|mesh-ancestor
102195478|NCT02264743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102195479|NCT02264743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195480|NCT02264743|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102195481|NCT02264743|Contraceptive Agents|contraceptive agents|mesh-ancestor
102195482|NCT02264743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102195483|NCT02264743|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102195484|NCT01220947|Ritonavir|ritonavir|mesh-list
102195485|NCT01220947|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102195486|NCT01220947|Lactams|lactams|mesh-list
102195487|NCT01220947|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102195488|NCT01220947|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102195489|NCT01220947|Protease Inhibitors|protease inhibitors|mesh-ancestor
102195490|NCT01220947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102195491|NCT01220947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195492|NCT01220947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102195493|NCT01220947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102195494|NCT01220947|Antiviral Agents|antiviral agents|mesh-ancestor
102195495|NCT01220947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102195496|NCT01220947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102195497|NCT01220947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102195498|NCT01220947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102195499|NCT03953833|Antibodies|antibodies|mesh-list
102195500|NCT03953833|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102195501|NCT03953833|Immunologic Factors|immunologic factors|mesh-ancestor
102195502|NCT03953833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195503|NCT01393639|Prednisone|prednisone|mesh-list
102195504|NCT01393639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102195505|NCT01393639|Glucocorticoids|glucocorticoids|mesh-ancestor
102195506|NCT01393639|Hormones|hormones|mesh-ancestor
102195507|NCT01393639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101449655|NCT00221637|Valproic Acid|valproic acid|mesh-list
102195508|NCT01393639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195509|NCT01393639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102195510|NCT01393639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195511|NCT01379209|Mycophenolic Acid|mycophenolic acid|mesh-list
102195512|NCT01379209|Sirolimus|sirolimus|mesh-list
102195513|NCT01379209|Methotrexate|methotrexate|mesh-list
102195514|NCT01379209|KRN 7000|krn 7000|mesh-list
102195515|NCT01379209|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
102195516|NCT01379209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102195517|NCT01379209|Abortifacient Agents|abortifacient agents|mesh-ancestor
102195518|NCT01379209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102195519|NCT01379209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195520|NCT01379209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102195521|NCT01379209|Antimetabolites|antimetabolites|mesh-ancestor
102195522|NCT01379209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195523|NCT01379209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195524|NCT01379209|Dermatologic Agents|dermatologic agents|mesh-ancestor
102195525|NCT01379209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102195526|NCT01379209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102195527|NCT01379209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102195528|NCT01379209|Immunologic Factors|immunologic factors|mesh-ancestor
102195529|NCT01379209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102195530|NCT01379209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102195531|NCT01379209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102195532|NCT01379209|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102195533|NCT01379209|Antitubercular Agents|antitubercular agents|mesh-ancestor
102195534|NCT01379209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101737299|NCT00920283|Cobalt|cobalt|mesh-list
102195535|NCT01379209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102195536|NCT01379209|Antifungal Agents|antifungal agents|mesh-ancestor
102195537|NCT01379209|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102195538|NCT01204099|Docetaxel|docetaxel|mesh-list
102195539|NCT01204099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195540|NCT01204099|Tubulin Modulators|tubulin modulators|mesh-ancestor
102195541|NCT01204099|Antimitotic Agents|antimitotic agents|mesh-ancestor
102195542|NCT01204099|Mitosis Modulators|mitosis modulators|mesh-ancestor
102195543|NCT01204099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195544|NCT02853500|Doxorubicin|doxorubicin|mesh-list
102195545|NCT02853500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102195546|NCT02853500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195547|NCT02853500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102195548|NCT02853500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102195549|NCT02853500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102195550|NCT02853500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195551|NCT01188187|Dexamethasone|dexamethasone|mesh-list
102195552|NCT01188187|Prednisone|prednisone|mesh-list
102195553|NCT01188187|Docetaxel|docetaxel|mesh-list
102195554|NCT01188187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102195555|NCT01188187|Antiemetics|antiemetics|mesh-ancestor
102195556|NCT01188187|Autonomic Agents|autonomic agents|mesh-ancestor
102195557|NCT01188187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102195558|NCT01188187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195559|NCT01188187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102195560|NCT01188187|Glucocorticoids|glucocorticoids|mesh-ancestor
102195561|NCT01188187|Hormones|hormones|mesh-ancestor
102195562|NCT01188187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102195563|NCT01188187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102195564|NCT01188187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195565|NCT01188187|Tubulin Modulators|tubulin modulators|mesh-ancestor
102195566|NCT01188187|Antimitotic Agents|antimitotic agents|mesh-ancestor
102195567|NCT01188187|Mitosis Modulators|mitosis modulators|mesh-ancestor
102195568|NCT01188187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195569|NCT05478356|Atropine|atropine|mesh-list
102195570|NCT05478356|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102195571|NCT05478356|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101449667|NCT00123656|Esomeprazole|esomeprazole|mesh-list
102195572|NCT05478356|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102195573|NCT05478356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102195574|NCT05478356|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102195575|NCT05478356|Autonomic Agents|autonomic agents|mesh-ancestor
102195576|NCT05478356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102195577|NCT05478356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195578|NCT05478356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102195579|NCT05478356|Respiratory System Agents|respiratory system agents|mesh-ancestor
102195580|NCT05478356|Mydriatics|mydriatics|mesh-ancestor
102195581|NCT05478356|Parasympatholytics|parasympatholytics|mesh-ancestor
102195582|NCT05478356|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102195583|NCT05478356|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102195584|NCT05478356|Cholinergic Agents|cholinergic agents|mesh-ancestor
102195585|NCT05478356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102195586|NCT05478356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195587|NCT01186861|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102195588|NCT01186861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195589|NCT01186861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102195590|NCT01186861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102195591|NCT01186861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195592|NCT01175785|Cyclosporine|cyclosporine|mesh-list
102195593|NCT01175785|Mycophenolic Acid|mycophenolic acid|mesh-list
101904367|NCT03814616|Artesunate|artesunate|mesh-list
102195595|NCT01175785|Fludarabine|fludarabine|mesh-list
102195596|NCT01175785|Fludarabine phosphate|fludarabine phosphate|mesh-list
102195597|NCT01175785|Cyclosporins|cyclosporins|mesh-list
102195598|NCT01175785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102195599|NCT01175785|Immunologic Factors|immunologic factors|mesh-ancestor
102195600|NCT01175785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195601|NCT01175785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102195602|NCT01175785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102195603|NCT01175785|Alkylating Agents|alkylating agents|mesh-ancestor
102195604|NCT01175785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195605|NCT01175785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195606|NCT01175785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102195607|NCT01175785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102195608|NCT01175785|Antimetabolites|antimetabolites|mesh-ancestor
102195609|NCT01175785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102195610|NCT01175785|Antifungal Agents|antifungal agents|mesh-ancestor
102195611|NCT01175785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102195612|NCT01175785|Dermatologic Agents|dermatologic agents|mesh-ancestor
102195613|NCT01175785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102195614|NCT01175785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102195615|NCT01175785|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102195616|NCT01175785|Antitubercular Agents|antitubercular agents|mesh-ancestor
102195617|NCT01175785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102195618|NCT05478044|Ascorbic Acid|ascorbic acid|mesh-list
102195619|NCT05478044|Vitamins|vitamins|mesh-ancestor
102195620|NCT05478044|Micronutrients|micronutrients|mesh-ancestor
102195621|NCT05478044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195622|NCT05478044|Antioxidants|antioxidants|mesh-ancestor
102195623|NCT05478044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195624|NCT05478044|Protective Agents|protective agents|mesh-ancestor
102195625|NCT05472506|Nivolumab|nivolumab|mesh-list
102195626|NCT05472506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102195627|NCT05472506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195628|NCT05472506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102195629|NCT05472506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195630|NCT01445899|Ranibizumab|ranibizumab|mesh-list
102195631|NCT01445899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102195632|NCT01445899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102195633|NCT01445899|Growth Substances|growth substances|mesh-ancestor
102195634|NCT01445899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195635|NCT01445899|Growth Inhibitors|growth inhibitors|mesh-ancestor
102195636|NCT01445899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195637|NCT03649724|Leuprolide|leuprolide|mesh-list
102195638|NCT03649724|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102195639|NCT03649724|Fertility Agents|fertility agents|mesh-ancestor
102195640|NCT03649724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102195641|NCT03649724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195642|NCT03649724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102195643|NCT03649724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195644|NCT01358695|Botulinum Toxins|botulinum toxins|mesh-list
102195645|NCT01358695|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102195646|NCT01358695|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102195647|NCT01358695|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102195648|NCT01358695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102195649|NCT01358695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195650|NCT01358695|Cholinergic Agents|cholinergic agents|mesh-ancestor
102195651|NCT01358695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102195652|NCT01358695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195653|NCT01358695|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102195654|NCT01358695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102195655|NCT02266303|Insulin|insulin|mesh-list
102195656|NCT02266303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102195657|NCT02266303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195658|NCT02551874|Metformin|metformin|mesh-list
102195659|NCT02551874|Insulin Glargine|insulin glargine|mesh-list
102195660|NCT02551874|Dapagliflozin|dapagliflozin|mesh-list
102195661|NCT02551874|Saxagliptin|saxagliptin|mesh-list
102195662|NCT02551874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102195663|NCT02551874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195664|NCT02551874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102195665|NCT02551874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195666|NCT02551874|Incretins|incretins|mesh-ancestor
102195667|NCT02551874|Hormones|hormones|mesh-ancestor
101904449|NCT00036270|Tamoxifen|tamoxifen|mesh-list
102195668|NCT02551874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102195669|NCT02551874|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102195670|NCT02551874|Protease Inhibitors|protease inhibitors|mesh-ancestor
102195671|NCT02551874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102195672|NCT03646604|Upadacitinib|upadacitinib|mesh-list
102195673|NCT03646604|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102195674|NCT03646604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102195675|NCT03646604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102195676|NCT03646604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195677|NCT03646604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102195678|NCT01354717|Fluorouracil|fluorouracil|mesh-list
102195679|NCT01354717|Antimetabolites|antimetabolites|mesh-ancestor
102195680|NCT01354717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195681|NCT01354717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102195682|NCT01354717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195683|NCT01354717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102195684|NCT01354717|Immunologic Factors|immunologic factors|mesh-ancestor
102195685|NCT01354717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195686|NCT01072981|Gemcitabine|gemcitabine|mesh-list
102195687|NCT01072981|Fluorouracil|fluorouracil|mesh-list
102195688|NCT01072981|Pancrelipase|pancrelipase|mesh-list
102195689|NCT01072981|Immunologic Factors|immunologic factors|mesh-list
102195690|NCT01072981|Immunomodulating Agents|immunomodulating agents|mesh-list
102195691|NCT01072981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102195692|NCT01072981|Antimetabolites|antimetabolites|mesh-ancestor
102195693|NCT01072981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195694|NCT01072981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195695|NCT01072981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102195696|NCT01072981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195697|NCT01072981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102195698|NCT03347708|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102195699|NCT03347708|Hyaluronic Acid|hyaluronic acid|mesh-list
102195700|NCT03347708|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102195701|NCT03347708|Immunologic Factors|immunologic factors|mesh-ancestor
102195702|NCT03347708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195703|NCT03347708|Viscosupplements|viscosupplements|mesh-ancestor
102195704|NCT03347708|Protective Agents|protective agents|mesh-ancestor
102195705|NCT01159249|Vildagliptin|vildagliptin|mesh-list
102195706|NCT01159249|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102195707|NCT01159249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195708|NCT01159249|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102195709|NCT01159249|Protease Inhibitors|protease inhibitors|mesh-ancestor
102195710|NCT01159249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102195711|NCT01159249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195712|NCT01156753|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
102195713|NCT01156753|Immunoconjugates|immunoconjugates|mesh-ancestor
102195714|NCT01156753|Immunologic Factors|immunologic factors|mesh-ancestor
102195715|NCT01156753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195716|NCT01156753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102195717|NCT01156753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195718|NCT01345045|Pregabalin|pregabalin|mesh-list
102195719|NCT01345045|Analgesics|analgesics|mesh-ancestor
102195720|NCT01345045|Sensory System Agents|sensory system agents|mesh-ancestor
102195721|NCT01345045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102195722|NCT01345045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195723|NCT01345045|Anticonvulsants|anticonvulsants|mesh-ancestor
102195724|NCT01345045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102195725|NCT01345045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102195726|NCT01345045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195727|NCT01345045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102195728|NCT01345045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102195729|NCT01345045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102195730|NCT01345045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102195731|NCT01345045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102195732|NCT01344187|Riboflavin|riboflavin|mesh-list
102195733|NCT01344187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102195734|NCT01344187|Vitamin B Complex|vitamin b complex|mesh-ancestor
102195735|NCT01344187|Vitamins|vitamins|mesh-ancestor
102195736|NCT01344187|Micronutrients|micronutrients|mesh-ancestor
102195737|NCT01344187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195738|NCT01344187|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102195739|NCT01344187|Dermatologic Agents|dermatologic agents|mesh-ancestor
102195740|NCT01338883|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102195741|NCT01338883|Efavirenz|efavirenz|mesh-list
102195742|NCT01338883|Cenicriviroc|cenicriviroc|mesh-list
102195743|NCT01338883|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102195744|NCT01338883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102195745|NCT01338883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102195746|NCT01338883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195747|NCT01338883|Antiviral Agents|antiviral agents|mesh-ancestor
102195748|NCT01338883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102195749|NCT01338883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102195750|NCT01338883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102195751|NCT01338883|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102195752|NCT01338883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102195753|NCT01338883|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102195754|NCT01338883|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102195755|NCT01338883|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102195756|NCT01338883|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102195757|NCT01338883|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102195758|NCT05625919|Sirolimus|sirolimus|mesh-list
102195759|NCT05625919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102195760|NCT05625919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102195761|NCT05625919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102195762|NCT05625919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195763|NCT05625919|Antifungal Agents|antifungal agents|mesh-ancestor
102195764|NCT05625919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102195765|NCT05625919|Immunologic Factors|immunologic factors|mesh-ancestor
102195766|NCT05625919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195767|NCT02682927|Fenfluramine|fenfluramine|mesh-list
102195768|NCT02682927|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102195769|NCT02682927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102195770|NCT02682927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102195771|NCT02682927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195772|NCT02682927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102195773|NCT02682927|Serotonin Agents|serotonin agents|mesh-ancestor
102195774|NCT02682927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195775|NCT02266537|Doxazosin|doxazosin|mesh-list
102195776|NCT02266537|Tamsulosin|tamsulosin|mesh-list
102195777|NCT02266537|Alfuzosin|alfuzosin|mesh-list
102195778|NCT02266537|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102195779|NCT02266537|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102195780|NCT02266537|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102195781|NCT02266537|Adrenergic Agents|adrenergic agents|mesh-ancestor
102195782|NCT02266537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102195783|NCT02266537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195784|NCT02266537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195785|NCT02266537|Urological Agents|urological agents|mesh-ancestor
102195786|NCT02266537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102195787|NCT02269735|Insulin|insulin|mesh-list
102195788|NCT02269735|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102195789|NCT02269735|Insulin Aspart|insulin aspart|mesh-list
102195790|NCT02269735|MK-2640|mk-2640|mesh-list
102195791|NCT02269735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102195792|NCT02269735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195793|NCT05625373|Vancomycin|vancomycin|mesh-list
102195794|NCT05625373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102195795|NCT05625373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102195796|NCT01038739|Mesalamine|mesalamine|mesh-list
102195797|NCT01038739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102195798|NCT01038739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102195799|NCT01038739|Analgesics|analgesics|mesh-ancestor
102195800|NCT01038739|Sensory System Agents|sensory system agents|mesh-ancestor
102195801|NCT01038739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102195802|NCT01038739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195803|NCT01038739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102195804|NCT01038739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102195805|NCT01336465|Etrolizumab|etrolizumab|mesh-list
102195806|NCT01336465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102195807|NCT01336465|Immunologic Factors|immunologic factors|mesh-ancestor
102195808|NCT01336465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195809|NCT03315026|Siltuximab|siltuximab|mesh-list
102195810|NCT03315026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195811|NCT02769065|Donepezil|donepezil|mesh-list
102195812|NCT02769065|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102195813|NCT02769065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102195814|NCT02769065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195815|NCT02769065|Cholinergic Agents|cholinergic agents|mesh-ancestor
102195816|NCT02769065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102195817|NCT02769065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195818|NCT02769065|Nootropic Agents|nootropic agents|mesh-ancestor
102195819|NCT02540954|Aflibercept|aflibercept|mesh-list
102195820|NCT02540954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102195821|NCT02540954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102195822|NCT02540954|Growth Substances|growth substances|mesh-ancestor
102195823|NCT02540954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195824|NCT02540954|Growth Inhibitors|growth inhibitors|mesh-ancestor
102195825|NCT02540954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195826|NCT05265975|Rituximab|rituximab|mesh-list
102195827|NCT05265975|Lenalidomide|lenalidomide|mesh-list
102195828|NCT05265975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102195829|NCT05265975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195830|NCT05265975|Immunologic Factors|immunologic factors|mesh-ancestor
102195831|NCT05265975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195832|NCT05265975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102195833|NCT05265975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102195834|NCT05265975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102195835|NCT05265975|Growth Substances|growth substances|mesh-ancestor
102195836|NCT05265975|Growth Inhibitors|growth inhibitors|mesh-ancestor
102195837|NCT02151305|Remifentanil|remifentanil|mesh-list
102195839|NCT02151305|Sevoflurane|sevoflurane|mesh-list
102195840|NCT02151305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101449706|NCT00191828|Olanzapine|olanzapine|mesh-list
102195841|NCT02151305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102195842|NCT02151305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195843|NCT02151305|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102195844|NCT02151305|Anesthetics, General|anesthetics, general|mesh-ancestor
102195845|NCT02151305|Anesthetics|anesthetics|mesh-ancestor
102195846|NCT02151305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102195847|NCT02151305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102195848|NCT02151305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102195849|NCT02151305|Narcotics|narcotics|mesh-ancestor
102195850|NCT02151305|Analgesics|analgesics|mesh-ancestor
102195851|NCT02151305|Sensory System Agents|sensory system agents|mesh-ancestor
102195852|NCT02151305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102195853|NCT03164421|Acetylcysteine|acetylcysteine|mesh-list
102195854|NCT03164421|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102195855|NCT03164421|Antiviral Agents|antiviral agents|mesh-ancestor
102195856|NCT03164421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102195857|NCT03164421|Expectorants|expectorants|mesh-ancestor
102195858|NCT03164421|Respiratory System Agents|respiratory system agents|mesh-ancestor
102195859|NCT03164421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102195860|NCT03164421|Antioxidants|antioxidants|mesh-ancestor
102195861|NCT03164421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195862|NCT03164421|Protective Agents|protective agents|mesh-ancestor
102195863|NCT03164421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195864|NCT03164421|Antidotes|antidotes|mesh-ancestor
102195865|NCT05476952|Rocuronium|rocuronium|mesh-list
102195866|NCT05476952|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102195867|NCT05476952|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102195868|NCT05476952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102195869|NCT05476952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102195870|NCT05476952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195871|NCT05228613|Vaccines|vaccines|mesh-list
102195872|NCT05228613|Immunologic Factors|immunologic factors|mesh-ancestor
102195873|NCT05228613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195874|NCT02658812|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
102195875|NCT02658812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102195876|NCT02658812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195877|NCT02628704|Dexamethasone|dexamethasone|mesh-list
102195878|NCT02628704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102195879|NCT02628704|Antiemetics|antiemetics|mesh-ancestor
102195880|NCT02628704|Autonomic Agents|autonomic agents|mesh-ancestor
102195881|NCT02628704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102195882|NCT02628704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195883|NCT02628704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102195884|NCT02628704|Glucocorticoids|glucocorticoids|mesh-ancestor
102195885|NCT02628704|Hormones|hormones|mesh-ancestor
102195886|NCT02628704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102195887|NCT02628704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102195888|NCT02628704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195889|NCT02152475|Curcumin|curcumin|mesh-list
102195890|NCT02152475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101904663|NCT03979469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102195891|NCT02152475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102195892|NCT02152475|Analgesics|analgesics|mesh-ancestor
102195894|NCT02152475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102195895|NCT02152475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195896|NCT02152475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102195897|NCT02152475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102195898|NCT02152475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195899|NCT02152475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102195900|NCT02152475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195901|NCT02152553|Hydrocortisone|hydrocortisone|mesh-list
102195902|NCT02152553|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102195903|NCT02152553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102195904|NCT03161457|Rituximab|rituximab|mesh-list
102195905|NCT03161457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102195906|NCT03161457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195907|NCT03161457|Immunologic Factors|immunologic factors|mesh-ancestor
102195908|NCT03161457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195909|NCT03161457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102195910|NCT02159573|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102195911|NCT02159573|Natalizumab|natalizumab|mesh-list
102195912|NCT02159573|Immunologic Factors|immunologic factors|mesh-ancestor
102195913|NCT02159573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195914|NCT02159573|Dermatologic Agents|dermatologic agents|mesh-ancestor
102195915|NCT02159573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102195916|NCT02152709|Vaccines|vaccines|mesh-list
102195917|NCT02152709|Immunologic Factors|immunologic factors|mesh-ancestor
102195918|NCT02152709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195919|NCT03164109|Moxifloxacin|moxifloxacin|mesh-list
102195920|NCT03164109|Avasopasem manganese|avasopasem manganese|mesh-list
102195921|NCT03164109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102195922|NCT03164109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102195923|NCT03164109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102195924|NCT03164109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102195925|NCT03164109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102195926|NCT03164109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195927|NCT03164109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195928|NCT03164109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195929|NCT03164109|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102195930|NCT03164109|Antioxidants|antioxidants|mesh-ancestor
102195931|NCT03164109|Protective Agents|protective agents|mesh-ancestor
102195932|NCT02152787|Propofol|propofol|mesh-list
102195933|NCT02152787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102195934|NCT02152787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102195935|NCT02152787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195936|NCT02152787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102195937|NCT02152787|Anesthetics, General|anesthetics, general|mesh-ancestor
102195938|NCT02152787|Anesthetics|anesthetics|mesh-ancestor
102195939|NCT00154375|Imatinib Mesylate|imatinib mesylate|mesh-list
102195940|NCT00154375|Hydroxyurea|hydroxyurea|mesh-list
102195941|NCT00154375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195942|NCT00154375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102195943|NCT00154375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102195944|NCT00154375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195945|NCT00154375|Antisickling Agents|antisickling agents|mesh-ancestor
102195946|NCT00154375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102195947|NCT02765399|Liraglutide|liraglutide|mesh-list
102195948|NCT02765399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102195949|NCT02765399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195950|NCT02765399|Incretins|incretins|mesh-ancestor
102195951|NCT02765399|Hormones|hormones|mesh-ancestor
102195952|NCT02765399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102195953|NCT03970304|Vaccines|vaccines|mesh-list
102195954|NCT03970304|Immunologic Factors|immunologic factors|mesh-ancestor
102195955|NCT03970304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195956|NCT01037179|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
102195957|NCT01037179|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102195958|NCT01037179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102195959|NCT01037179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102195960|NCT01037179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102195961|NCT01037179|Analgesics|analgesics|mesh-ancestor
102195962|NCT01037179|Sensory System Agents|sensory system agents|mesh-ancestor
102195963|NCT01037179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102195964|NCT01037179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195965|NCT01037179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102195966|NCT01037179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102195967|NCT01037179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102195968|NCT01037179|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102195970|NCT01037179|Histamine Antagonists|histamine antagonists|mesh-ancestor
102195971|NCT01037179|Histamine Agents|histamine agents|mesh-ancestor
102195972|NCT01037179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102195973|NCT01037179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195974|NCT02269969|Tobramycin|tobramycin|mesh-list
102195975|NCT02269969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102195976|NCT02269969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102195977|NCT03555578|Leuprolide|leuprolide|mesh-list
102195978|NCT03555578|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102195979|NCT03555578|Fertility Agents|fertility agents|mesh-ancestor
102195980|NCT03555578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102195981|NCT03555578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195982|NCT03555578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102195983|NCT03555578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195984|NCT03232424|Temozolomide|temozolomide|mesh-list
102195985|NCT03232424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102195986|NCT03232424|Alkylating Agents|alkylating agents|mesh-ancestor
102195987|NCT03232424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195988|NCT03232424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102195989|NCT03163407|Norepinephrine|norepinephrine|mesh-list
102195990|NCT03163407|Ephedrine|ephedrine|mesh-list
102195991|NCT03163407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102195992|NCT03163407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102195993|NCT03163407|Adrenergic Agents|adrenergic agents|mesh-ancestor
102195994|NCT03163407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102195995|NCT03163407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102195996|NCT03163407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102195997|NCT03163407|Sympathomimetics|sympathomimetics|mesh-ancestor
102195998|NCT03163407|Autonomic Agents|autonomic agents|mesh-ancestor
102195999|NCT03163407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102196000|NCT03163407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102196001|NCT03163407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102196002|NCT02547974|Vaccines|vaccines|mesh-list
102196003|NCT02547974|Immunologic Factors|immunologic factors|mesh-ancestor
102196004|NCT02547974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196005|NCT00154297|Everolimus|everolimus|mesh-list
102196006|NCT00154297|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102196007|NCT00154297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102196008|NCT00154297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102196009|NCT00154297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196010|NCT00154297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102196011|NCT00154297|Immunologic Factors|immunologic factors|mesh-ancestor
102196012|NCT00154297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196013|NCT00154297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102196014|NCT02270281|Dexmedetomidine|dexmedetomidine|mesh-list
102196015|NCT02270281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102196016|NCT02270281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102196017|NCT02270281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196018|NCT02270281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102196019|NCT02270281|Analgesics|analgesics|mesh-ancestor
102196020|NCT02270281|Sensory System Agents|sensory system agents|mesh-ancestor
102196021|NCT02270281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102196022|NCT02270281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102196023|NCT02270281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102196024|NCT02270281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102196025|NCT02270281|Adrenergic Agents|adrenergic agents|mesh-ancestor
102196026|NCT02270281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102196027|NCT02270281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196028|NCT01033123|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102196029|NCT01033123|Iniparib|iniparib|mesh-list
102196030|NCT01033123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102196031|NCT01033123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196032|NCT01033123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102196033|NCT03163173|Avasopasem manganese|avasopasem manganese|mesh-list
102196034|NCT03163173|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102196035|NCT03163173|Antioxidants|antioxidants|mesh-ancestor
102196036|NCT03163173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196037|NCT03163173|Protective Agents|protective agents|mesh-ancestor
102196038|NCT03163173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196039|NCT01323205|Antipsychotic Agents|antipsychotic agents|mesh-list
102196040|NCT01323205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102196041|NCT01323205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102196042|NCT01323205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196043|NCT01323205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102196044|NCT03162861|Anesthetics|anesthetics|mesh-list
102196045|NCT03162861|Propofol|propofol|mesh-list
102196046|NCT03162861|Sevoflurane|sevoflurane|mesh-list
102196047|NCT03162861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102196048|NCT03162861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196049|NCT03162861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102196050|NCT03162861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102196051|NCT03162861|Anesthetics, General|anesthetics, general|mesh-ancestor
102196052|NCT03162861|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102196053|NCT03162861|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102196054|NCT04506554|Nivolumab|nivolumab|mesh-list
102196055|NCT04506554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102196056|NCT04506554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102196057|NCT04506554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102196058|NCT04506554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196059|NCT02765165|Lomustine|lomustine|mesh-list
102196060|NCT02765165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102196061|NCT02765165|Alkylating Agents|alkylating agents|mesh-ancestor
102196062|NCT02765165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196063|NCT02765165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102196064|NCT02156843|Pyridoxamine|pyridoxamine|mesh-list
102196065|NCT02156843|Vitamin B Complex|vitamin b complex|mesh-ancestor
102196066|NCT02156843|Vitamins|vitamins|mesh-ancestor
102196067|NCT02156843|Micronutrients|micronutrients|mesh-ancestor
102196068|NCT02156843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196069|NCT02675907|Meloxicam|meloxicam|mesh-list
102196070|NCT02675907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102196071|NCT02675907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102196072|NCT02675907|Analgesics|analgesics|mesh-ancestor
102196073|NCT02675907|Sensory System Agents|sensory system agents|mesh-ancestor
102196074|NCT02675907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102196075|NCT02675907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196076|NCT02675907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102196077|NCT02675907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102196078|NCT02675907|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102196079|NCT02675907|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102196080|NCT02675907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102196081|NCT02675907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196082|NCT02152865|Lupeol|lupeol|mesh-list
102196083|NCT02152865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102196084|NCT02152943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102196085|NCT02152943|Trastuzumab|trastuzumab|mesh-list
102196086|NCT02152943|Everolimus|everolimus|mesh-list
102196087|NCT02152943|Letrozole|letrozole|mesh-list
102196088|NCT02152943|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
102196089|NCT02152943|Antibodies|antibodies|mesh-list
102196090|NCT02152943|Immunoglobulins|immunoglobulins|mesh-list
102196091|NCT02152943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102196092|NCT02152943|Immunologic Factors|immunologic factors|mesh-ancestor
102196093|NCT02152943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196094|NCT02152943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102196095|NCT02152943|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102196096|NCT02152943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102196097|NCT02152943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102196098|NCT02152943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196099|NCT02152943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102196100|NCT02152943|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102196101|NCT02152943|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102196102|NCT02152943|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102196103|NCT02152943|Hormone Antagonists|hormone antagonists|mesh-ancestor
102196104|NCT02152943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102196105|NCT02156999|Vitamin D|vitamin d|mesh-list
102196106|NCT02156999|Ibandronic Acid|ibandronic acid|mesh-list
102196107|NCT02156999|Vitamins|vitamins|mesh-ancestor
102196108|NCT02156999|Micronutrients|micronutrients|mesh-ancestor
102196109|NCT02156999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196110|NCT02156999|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102196111|NCT05014581|Norepinephrine|norepinephrine|mesh-list
102196112|NCT05014581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102196113|NCT05014581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102196114|NCT05014581|Adrenergic Agents|adrenergic agents|mesh-ancestor
102196115|NCT05014581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102196116|NCT05014581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196117|NCT05014581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196118|NCT05014581|Sympathomimetics|sympathomimetics|mesh-ancestor
102196119|NCT05014581|Autonomic Agents|autonomic agents|mesh-ancestor
102196120|NCT05014581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102196121|NCT05014581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102196122|NCT02159651|Tacrolimus|tacrolimus|mesh-list
102196123|NCT02159651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102196124|NCT02159651|Immunologic Factors|immunologic factors|mesh-ancestor
102196125|NCT02159651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196126|NCT02159651|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102196127|NCT02159651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102196128|NCT02159651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196129|NCT02774681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102196131|NCT02774681|Palbociclib|palbociclib|mesh-list
102196132|NCT02774681|Antibodies|antibodies|mesh-list
102196133|NCT02774681|Immunoglobulins|immunoglobulins|mesh-list
102196134|NCT02774681|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102196135|NCT02774681|Immunologic Factors|immunologic factors|mesh-ancestor
102196136|NCT02774681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196137|NCT02774681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102196138|NCT02774681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102196139|NCT02774681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102196140|NCT02774681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196141|NCT02157311|Tenofovir|tenofovir|mesh-list
102196142|NCT02157311|Lamivudine|lamivudine|mesh-list
102196143|NCT02157311|Emtricitabine|emtricitabine|mesh-list
102196144|NCT02157311|Efavirenz|efavirenz|mesh-list
102196145|NCT02157311|Lopinavir|lopinavir|mesh-list
102196146|NCT02157311|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102196147|NCT02157311|Darunavir|darunavir|mesh-list
102196148|NCT02157311|Abacavir|abacavir|mesh-list
102196149|NCT02157311|Rilpivirine|rilpivirine|mesh-list
102196150|NCT02157311|Etravirine|etravirine|mesh-list
102196151|NCT02157311|Antiviral Agents|antiviral agents|mesh-ancestor
102196152|NCT02157311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102196153|NCT02157311|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102196154|NCT02157311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102196155|NCT02157311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102196156|NCT02157311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196157|NCT02157311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102196158|NCT02157311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102196159|NCT02157311|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102196160|NCT02157311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102196161|NCT02157311|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102196162|NCT02157311|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102196163|NCT02157311|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102196164|NCT02157311|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102196165|NCT02157311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102196166|NCT02157311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102196167|NCT02157311|Protease Inhibitors|protease inhibitors|mesh-ancestor
102196168|NCT02157311|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102196169|NCT04784039|Fibrin fragment D|fibrin fragment d|mesh-list
102196170|NCT04784039|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102196171|NCT04784039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102196172|NCT04784039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196173|NCT04784039|Hemostatics|hemostatics|mesh-ancestor
102196174|NCT04784039|Coagulants|coagulants|mesh-ancestor
102196175|NCT02157467|Moxifloxacin|moxifloxacin|mesh-list
102196176|NCT02157467|BMS-955176|bms-955176|mesh-list
102196177|NCT02157467|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102196178|NCT02157467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102196179|NCT02157467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102196180|NCT02157467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102196181|NCT02157467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102196182|NCT02157467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102196183|NCT02157467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196184|NCT02157467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102196185|NCT02157467|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102196186|NCT02157467|Contraceptive Agents|contraceptive agents|mesh-ancestor
102196187|NCT02157467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102196188|NCT02157467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196189|NCT02157467|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102196190|NCT02157467|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102196191|NCT02157467|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102196192|NCT02157467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102196193|NCT02157467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102196194|NCT02157467|Antiviral Agents|antiviral agents|mesh-ancestor
102196195|NCT01374087|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102196196|NCT01374087|Luteolytic Agents|luteolytic agents|mesh-ancestor
102196197|NCT01374087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102196198|NCT01374087|Contraceptive Agents|contraceptive agents|mesh-ancestor
102196199|NCT01374087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102196200|NCT01374087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196201|NCT01374087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102196202|NCT01374087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102196203|NCT01374087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102196204|NCT00152971|Enoxaparin|enoxaparin|mesh-list
102196205|NCT00152971|Dabigatran|dabigatran|mesh-list
102196206|NCT00152971|Anticoagulants|anticoagulants|mesh-ancestor
102196207|NCT00152971|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102196208|NCT00152971|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102196209|NCT00152971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196210|NCT00152971|Antithrombins|antithrombins|mesh-ancestor
102196211|NCT00152971|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102196212|NCT00152971|Protease Inhibitors|protease inhibitors|mesh-ancestor
102196213|NCT00152971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102196214|NCT02538614|Idelalisib|idelalisib|mesh-list
102196215|NCT02538614|BI 836826|bi 836826|mesh-list
102196216|NCT02538614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102196217|NCT02538614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102196218|NCT02538614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196219|NCT02538614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102196220|NCT03504644|Vincristine|vincristine|mesh-list
102196221|NCT03504644|Venetoclax|venetoclax|mesh-list
102196222|NCT03504644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102196223|NCT03504644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102196224|NCT03504644|Tubulin Modulators|tubulin modulators|mesh-ancestor
102196225|NCT03504644|Antimitotic Agents|antimitotic agents|mesh-ancestor
102196226|NCT03504644|Mitosis Modulators|mitosis modulators|mesh-ancestor
102196227|NCT03504644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196228|NCT04620135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102196229|NCT04620135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102196230|NCT02160275|Insulin|insulin|mesh-list
102196231|NCT02160275|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102196232|NCT02160275|Pancrelipase|pancrelipase|mesh-list
102196233|NCT02160275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102196234|NCT02160275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196235|NCT02160275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102196236|NCT03126968|Epinephrine|epinephrine|mesh-list
102196237|NCT03126968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102196238|NCT03126968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102196239|NCT03126968|Adrenergic Agents|adrenergic agents|mesh-ancestor
102196240|NCT03126968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102196241|NCT03126968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196242|NCT03126968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196243|NCT03126968|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102196244|NCT03126968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102196245|NCT03126968|Autonomic Agents|autonomic agents|mesh-ancestor
102196246|NCT03126968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102196247|NCT03126968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102196248|NCT03126968|Respiratory System Agents|respiratory system agents|mesh-ancestor
102196249|NCT03126968|Mydriatics|mydriatics|mesh-ancestor
102196250|NCT03126968|Sympathomimetics|sympathomimetics|mesh-ancestor
102196251|NCT03126968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102196252|NCT02266849|Loperamide|loperamide|mesh-list
102196253|NCT02266849|Antidiarrheals|antidiarrheals|mesh-list
102196254|NCT02266849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102196255|NCT01309945|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102196256|NCT01309945|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102196257|NCT01309945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102196258|NCT01309945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102196259|NCT01309945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449735|NCT00123890|Aplaviroc|aplaviroc|mesh-list
102196260|NCT01309945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102196261|NCT01309945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196262|NCT01309945|Analgesics|analgesics|mesh-ancestor
102196263|NCT01309945|Sensory System Agents|sensory system agents|mesh-ancestor
102196264|NCT01309945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101905047|NCT01333696|Pemetrexed|pemetrexed|mesh-list
102196265|NCT01309945|Antidepressive Agents|antidepressive agents|mesh-ancestor
102196266|NCT01309945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102196267|NCT01309945|Dopamine Agents|dopamine agents|mesh-ancestor
102196268|NCT02153567|Escitalopram|escitalopram|mesh-list
102196269|NCT02153567|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102196270|NCT02153567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102196271|NCT02153567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102196272|NCT02153567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196273|NCT02153567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102196274|NCT02153567|Serotonin Agents|serotonin agents|mesh-ancestor
101738037|NCT00802529|Hormones|hormones|mesh-ancestor
102196275|NCT02153567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196277|NCT02441660|Antipruritics|antipruritics|mesh-ancestor
102196278|NCT02441660|Dermatologic Agents|dermatologic agents|mesh-ancestor
102196279|NCT02441660|Sensory System Agents|sensory system agents|mesh-ancestor
102196280|NCT02441660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102196281|NCT02441660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196282|NCT01303783|Candesartan|candesartan|mesh-list
102196283|NCT01303783|Candesartan cilexetil|candesartan cilexetil|mesh-list
102196284|NCT01303783|Nifedipine|nifedipine|mesh-list
102196285|NCT01303783|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102196286|NCT01303783|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102196287|NCT01303783|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102196288|NCT01303783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196289|NCT01303783|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102196290|NCT01303783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102196291|NCT01303783|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102196292|NCT01303783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196293|NCT01303783|Vasodilator Agents|vasodilator agents|mesh-ancestor
102196294|NCT01303783|Tocolytic Agents|tocolytic agents|mesh-ancestor
102196295|NCT01303783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102196296|NCT02160587|Chlorhexidine|chlorhexidine|mesh-list
102196297|NCT02160587|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102196298|NCT02160587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102196299|NCT02160587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102196300|NCT02160587|Disinfectants|disinfectants|mesh-ancestor
102196301|NCT02160587|Dermatologic Agents|dermatologic agents|mesh-ancestor
102196302|NCT02153879|Niacin|niacin|mesh-list
102196303|NCT02153879|Fenofibrate|fenofibrate|mesh-list
102196304|NCT02153879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102196305|NCT02153879|Antimetabolites|antimetabolites|mesh-ancestor
102196306|NCT02153879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196307|NCT02153879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102196308|NCT02153879|Vasodilator Agents|vasodilator agents|mesh-ancestor
102196309|NCT02153879|Vitamin B Complex|vitamin b complex|mesh-ancestor
102196310|NCT02153879|Vitamins|vitamins|mesh-ancestor
102196311|NCT02153879|Micronutrients|micronutrients|mesh-ancestor
102196312|NCT02153879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196313|NCT01373931|Moxifloxacin|moxifloxacin|mesh-list
102196314|NCT01373931|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102196315|NCT01373931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102196316|NCT01373931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102196317|NCT01373931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102196318|NCT01373931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102196319|NCT01373931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102196320|NCT01373931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196321|NCT01373931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102196322|NCT01373931|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102196323|NCT01373931|Contraceptive Agents|contraceptive agents|mesh-ancestor
102196324|NCT01373931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102196325|NCT01373931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196326|NCT01373931|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102196327|NCT01373931|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102196328|NCT01373931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102196329|NCT02160743|Metformin|metformin|mesh-list
102196330|NCT02160743|Atorvastatin|atorvastatin|mesh-list
102196331|NCT02160743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102196332|NCT02160743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196333|NCT02160743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102196334|NCT02160743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102196335|NCT02160743|Antimetabolites|antimetabolites|mesh-ancestor
102196336|NCT02160743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196337|NCT02160743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102196338|NCT02160743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102196339|NCT02160743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102196340|NCT02158013|Diltiazem|diltiazem|mesh-list
101905108|NCT03201562|Miotics|miotics|mesh-ancestor
102196341|NCT02158013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102196342|NCT02158013|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102196343|NCT02158013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102196344|NCT02158013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196345|NCT02158013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102196346|NCT02158013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196349|NCT01023295|Combretastatin|combretastatin|mesh-list
102196350|NCT01023295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102196351|NCT01023295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102196352|NCT01023295|Tubulin Modulators|tubulin modulators|mesh-ancestor
102196353|NCT01023295|Antimitotic Agents|antimitotic agents|mesh-ancestor
102196354|NCT01023295|Mitosis Modulators|mitosis modulators|mesh-ancestor
102196355|NCT01023295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196356|NCT05468138|Antibodies|antibodies|mesh-list
102196357|NCT05468138|Immunologic Factors|immunologic factors|mesh-ancestor
102196358|NCT05468138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196359|NCT01140217|Norethindrone|norethindrone|mesh-list
102196360|NCT01140217|Norethindrone Acetate|norethindrone acetate|mesh-list
102196361|NCT01140217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102196362|NCT01140217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102196363|NCT01140217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102196364|NCT01140217|Contraceptive Agents|contraceptive agents|mesh-ancestor
102196365|NCT01140217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102196366|NCT01140217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196367|NCT01140217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102196368|NCT01140217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102196369|NCT01297543|Lenograstim|lenograstim|mesh-list
102196370|NCT01297543|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102196371|NCT01297543|Immunologic Factors|immunologic factors|mesh-ancestor
102196372|NCT01297543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196373|NCT03541265|Bupivacaine|bupivacaine|mesh-list
102196374|NCT03541265|Anesthetics, Local|anesthetics, local|mesh-ancestor
102196375|NCT03541265|Anesthetics|anesthetics|mesh-ancestor
102196376|NCT03541265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102196377|NCT03541265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196378|NCT03541265|Sensory System Agents|sensory system agents|mesh-ancestor
102196379|NCT03541265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102196380|NCT02547038|Amoxicillin|amoxicillin|mesh-list
102196381|NCT02547038|Metronidazole|metronidazole|mesh-list
102196382|NCT02547038|Clarithromycin|clarithromycin|mesh-list
102196383|NCT02547038|Tetracycline|tetracycline|mesh-list
102196384|NCT02547038|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
102196385|NCT02547038|Pantoprazole|pantoprazole|mesh-list
102196386|NCT02547038|Bismuth|bismuth|mesh-list
102196387|NCT02547038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102196388|NCT02547038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102196389|NCT02547038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102196390|NCT02547038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102196391|NCT02547038|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102196392|NCT02547038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102196393|NCT02547038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196394|NCT02547038|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102196395|NCT02547038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102196396|NCT02547038|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102196397|NCT02547038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102196398|NCT02547038|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102196399|NCT02547038|Antacids|antacids|mesh-ancestor
102196400|NCT02161055|Insulin|insulin|mesh-list
102196401|NCT02161055|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101690234|NCT00652782|Rolofylline|rolofylline|mesh-list
102196402|NCT02161055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102196403|NCT02161055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196404|NCT02764697|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102196405|NCT02764697|Hormones|hormones|mesh-ancestor
102196406|NCT02764697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102196407|NCT02764697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196408|NCT02266927|Fluticasone|fluticasone|mesh-list
102196409|NCT02266927|Xhance|xhance|mesh-list
102196410|NCT02266927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102196411|NCT02266927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102196412|NCT02266927|Autonomic Agents|autonomic agents|mesh-ancestor
102196413|NCT02266927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102196414|NCT02266927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196415|NCT02266927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102196416|NCT02266927|Respiratory System Agents|respiratory system agents|mesh-ancestor
102196417|NCT02266927|Dermatologic Agents|dermatologic agents|mesh-ancestor
102196418|NCT02266927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102196419|NCT02158481|Carotenoids|carotenoids|mesh-list
102196420|NCT02158481|Antioxidants|antioxidants|mesh-ancestor
102196421|NCT02158481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196422|NCT02158481|Protective Agents|protective agents|mesh-ancestor
102196423|NCT02158481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196424|NCT05445362|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102196425|NCT05445362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102196426|NCT01020565|Entecavir|entecavir|mesh-list
102196427|NCT01020565|Antiviral Agents|antiviral agents|mesh-ancestor
102196428|NCT01020565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102196429|NCT01020097|Fluorides|fluorides|mesh-list
102196430|NCT01020097|Cariostatic Agents|cariostatic agents|mesh-ancestor
102196431|NCT01020097|Protective Agents|protective agents|mesh-ancestor
102196432|NCT01020097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196433|NCT02154269|Lenograstim|lenograstim|mesh-list
102196434|NCT02154269|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102196435|NCT02154269|Immunologic Factors|immunologic factors|mesh-ancestor
102196436|NCT02154269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196437|NCT03738683|Tazobactam|tazobactam|mesh-list
102196438|NCT03738683|Piperacillin|piperacillin|mesh-list
102196439|NCT03738683|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102196440|NCT03738683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102196441|NCT03738683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102196442|NCT03738683|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102196443|NCT03738683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102196444|NCT03738683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196445|NCT04475887|Iron|iron|mesh-list
102196446|NCT04475887|Trace Elements|trace elements|mesh-ancestor
102196447|NCT04475887|Micronutrients|micronutrients|mesh-ancestor
102196448|NCT04475887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196449|NCT02267239|Chlorhexidine|chlorhexidine|mesh-list
102196450|NCT02267239|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102196451|NCT02267239|Listerine|listerine|mesh-list
102196452|NCT02267239|Hexetidine|hexetidine|mesh-list
102196453|NCT02267239|Menthol|menthol|mesh-list
102196454|NCT02267239|Sodium Fluoride|sodium fluoride|mesh-list
102196455|NCT02267239|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102196456|NCT02267239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102196457|NCT02267239|Disinfectants|disinfectants|mesh-ancestor
102196458|NCT02267239|Dermatologic Agents|dermatologic agents|mesh-ancestor
102196459|NCT02267239|Cariostatic Agents|cariostatic agents|mesh-ancestor
102196460|NCT02267239|Protective Agents|protective agents|mesh-ancestor
101449749|NCT00412698|Hormones|hormones|mesh-ancestor
102196461|NCT02267239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196462|NCT02267239|Antipruritics|antipruritics|mesh-ancestor
102196463|NCT02267239|Antifungal Agents|antifungal agents|mesh-ancestor
102196464|NCT02766023|Metronidazole|metronidazole|mesh-list
102196465|NCT02766023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102196466|NCT02766023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102196467|NCT02766023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102196468|NCT02766023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102196469|NCT05466500|Dexamethasone|dexamethasone|mesh-list
102196470|NCT05466500|Dexamethasone acetate|dexamethasone acetate|mesh-list
102196471|NCT05466500|Bupivacaine|bupivacaine|mesh-list
102196472|NCT05466500|BB 1101|bb 1101|mesh-list
102196473|NCT05466500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102196474|NCT05466500|Antiemetics|antiemetics|mesh-ancestor
102196475|NCT05466500|Autonomic Agents|autonomic agents|mesh-ancestor
102196476|NCT05466500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102196477|NCT05466500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196478|NCT05466500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102196479|NCT05466500|Glucocorticoids|glucocorticoids|mesh-ancestor
102196480|NCT05466500|Hormones|hormones|mesh-ancestor
102196481|NCT05466500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102196482|NCT05466500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102196483|NCT05466500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102196484|NCT05466500|Protease Inhibitors|protease inhibitors|mesh-ancestor
102196485|NCT05466500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102196486|NCT05466500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196487|NCT05466500|Anesthetics, Local|anesthetics, local|mesh-ancestor
102196488|NCT05466500|Anesthetics|anesthetics|mesh-ancestor
101836503|NCT00490542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102196489|NCT05466500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102196490|NCT05466500|Sensory System Agents|sensory system agents|mesh-ancestor
102196491|NCT04475107|Artesunate|artesunate|mesh-list
102196492|NCT04475107|Pyronaridine|pyronaridine|mesh-list
102196493|NCT04475107|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
102196494|NCT04475107|Antimalarials|antimalarials|mesh-ancestor
102196495|NCT04475107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102196496|NCT04475107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102196497|NCT04475107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101900414|NCT01170104|Sorafenib|sorafenib|mesh-list
102196498|NCT04475107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102196499|NCT04475107|Antiviral Agents|antiviral agents|mesh-ancestor
102196500|NCT04475107|Schistosomicides|schistosomicides|mesh-ancestor
102196501|NCT04475107|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102196502|NCT04475107|Anthelmintics|anthelmintics|mesh-ancestor
102196503|NCT02254967|Vancomycin|vancomycin|mesh-list
102196504|NCT02254967|Fidaxomicin|fidaxomicin|mesh-list
102196505|NCT02254967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102196506|NCT02254967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102196507|NCT05444036|Ketamine|ketamine|mesh-list
102196508|NCT05444036|Analgesics|analgesics|mesh-ancestor
102196509|NCT05444036|Sensory System Agents|sensory system agents|mesh-ancestor
102196510|NCT05444036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102196511|NCT05444036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196512|NCT05444036|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102196513|NCT05444036|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102196514|NCT05444036|Anesthetics, General|anesthetics, general|mesh-ancestor
102196515|NCT05444036|Anesthetics|anesthetics|mesh-ancestor
102196516|NCT05444036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102196517|NCT05444036|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102196518|NCT05444036|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102196519|NCT05444036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102196520|NCT05444036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196521|NCT03923959|Tranexamic Acid|tranexamic acid|mesh-list
102196522|NCT03923959|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102196523|NCT03923959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102196524|NCT03923959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196525|NCT03923959|Hemostatics|hemostatics|mesh-ancestor
102196526|NCT03923959|Coagulants|coagulants|mesh-ancestor
102196527|NCT02161367|Simethicone|simethicone|mesh-list
102196528|NCT02161367|Antifoaming Agents|antifoaming agents|mesh-ancestor
102196529|NCT02161367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196530|NCT02161367|Emollients|emollients|mesh-ancestor
102196531|NCT02161367|Dermatologic Agents|dermatologic agents|mesh-ancestor
102196532|NCT03542825|Iron|iron|mesh-list
102196533|NCT03542825|Lactoferrin|lactoferrin|mesh-list
102196534|NCT03542825|Iron Chelating Agents|iron chelating agents|mesh-list
102196535|NCT03542825|Trace Elements|trace elements|mesh-ancestor
102196536|NCT03542825|Micronutrients|micronutrients|mesh-ancestor
102196537|NCT03542825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196538|NCT03542825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102196539|NCT03542825|Chelating Agents|chelating agents|mesh-ancestor
102196540|NCT03542825|Sequestering Agents|sequestering agents|mesh-ancestor
102196541|NCT03542825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196542|NCT01001923|Fasinumab|fasinumab|mesh-list
102196543|NCT01001923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102196544|NCT01001923|Analgesics|analgesics|mesh-ancestor
102196545|NCT01001923|Sensory System Agents|sensory system agents|mesh-ancestor
102196546|NCT01001923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102196547|NCT01001923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196548|NCT02154503|Minoxidil|minoxidil|mesh-list
102196549|NCT02154503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102196550|NCT02154503|Vasodilator Agents|vasodilator agents|mesh-ancestor
102196551|NCT02536976|Mirabegron|mirabegron|mesh-list
102196552|NCT02536976|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102196553|NCT02536976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102196554|NCT02536976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102196555|NCT02536976|Adrenergic Agents|adrenergic agents|mesh-ancestor
102196556|NCT02536976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102196557|NCT02536976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196558|NCT02536976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196559|NCT02536976|Urological Agents|urological agents|mesh-ancestor
102196560|NCT05526703|Antihypertensive Agents|antihypertensive agents|mesh-list
102196561|NCT00992563|Ranibizumab|ranibizumab|mesh-list
102196562|NCT00992563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102196563|NCT00992563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102196564|NCT00992563|Growth Substances|growth substances|mesh-ancestor
102196565|NCT00992563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196566|NCT00992563|Growth Inhibitors|growth inhibitors|mesh-ancestor
101836504|NCT00490542|Serotonin Agents|serotonin agents|mesh-ancestor
102196567|NCT00992563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102196568|NCT02267707|Paclitaxel|paclitaxel|mesh-list
102196570|NCT02267707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102196571|NCT02267707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102196572|NCT02267707|Tubulin Modulators|tubulin modulators|mesh-ancestor
102196573|NCT02267707|Antimitotic Agents|antimitotic agents|mesh-ancestor
102196574|NCT02267707|Mitosis Modulators|mitosis modulators|mesh-ancestor
102196575|NCT02267707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196576|NCT02267707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102196577|NCT02267707|Antimetabolites|antimetabolites|mesh-ancestor
102196578|NCT01373229|Plerixafor|plerixafor|mesh-list
102196579|NCT01373229|Rituximab|rituximab|mesh-list
102196580|NCT01373229|Lenalidomide|lenalidomide|mesh-list
102196581|NCT01373229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102196582|NCT01373229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102196583|NCT01373229|Immunologic Factors|immunologic factors|mesh-ancestor
102196584|NCT01373229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196585|NCT01373229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102196586|NCT01373229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102196587|NCT01373229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102196588|NCT01373229|Growth Substances|growth substances|mesh-ancestor
102196589|NCT01373229|Growth Inhibitors|growth inhibitors|mesh-ancestor
102196590|NCT01373229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102196591|NCT01373229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102196592|NCT01373229|Antiviral Agents|antiviral agents|mesh-ancestor
102196593|NCT01373229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102196594|NCT02671461|Aspirin|aspirin|mesh-list
102196595|NCT02671461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102196596|NCT02671461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102196597|NCT02671461|Analgesics|analgesics|mesh-ancestor
102196598|NCT02671461|Sensory System Agents|sensory system agents|mesh-ancestor
102196599|NCT02671461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102196600|NCT02671461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196601|NCT02671461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102196602|NCT02671461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102196603|NCT02671461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102196604|NCT02671461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102196605|NCT02671461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196606|NCT02671461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102196607|NCT02671461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102196608|NCT02671461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102196609|NCT02671461|Antipyretics|antipyretics|mesh-ancestor
102196610|NCT05467033|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
102196611|NCT05467033|Hemostatics|hemostatics|mesh-ancestor
102196612|NCT05467033|Coagulants|coagulants|mesh-ancestor
102196613|NCT05467033|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102196614|NCT05467033|Natriuretic Agents|natriuretic agents|mesh-ancestor
102196615|NCT05467033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196616|NCT04196283|Paclitaxel|paclitaxel|mesh-list
102196617|NCT04196283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102196618|NCT04196283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102196619|NCT04196283|Tubulin Modulators|tubulin modulators|mesh-ancestor
102196620|NCT04196283|Antimitotic Agents|antimitotic agents|mesh-ancestor
102196621|NCT04196283|Mitosis Modulators|mitosis modulators|mesh-ancestor
102196622|NCT04196283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196623|NCT02268019|Epinephrine|epinephrine|mesh-list
102196624|NCT02268019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102196625|NCT02268019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102196626|NCT02268019|Adrenergic Agents|adrenergic agents|mesh-ancestor
102196627|NCT02268019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102196628|NCT02268019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196629|NCT02268019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196630|NCT02268019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102196631|NCT02268019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102196632|NCT02268019|Autonomic Agents|autonomic agents|mesh-ancestor
102196633|NCT02268019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102196634|NCT02268019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102196635|NCT02268019|Respiratory System Agents|respiratory system agents|mesh-ancestor
102196636|NCT02268019|Mydriatics|mydriatics|mesh-ancestor
102196637|NCT02268019|Sympathomimetics|sympathomimetics|mesh-ancestor
102196638|NCT02268019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102196639|NCT03114111|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102196640|NCT03114111|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102196641|NCT03114111|Dermatologic Agents|dermatologic agents|mesh-ancestor
102196642|NCT01110889|Agomelatine|agomelatine|mesh-list
102196643|NCT01110889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102196644|NCT01110889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102196645|NCT01110889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196647|NCT01106989|Tetracaine|tetracaine|mesh-list
102196648|NCT01106989|Anesthetics, Local|anesthetics, local|mesh-ancestor
102196649|NCT01106989|Anesthetics|anesthetics|mesh-ancestor
102196650|NCT01106989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102196651|NCT01106989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196652|NCT01106989|Sensory System Agents|sensory system agents|mesh-ancestor
102196653|NCT01106989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102196654|NCT01106989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102196655|NCT01106989|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102196656|NCT01106989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102196657|NCT01106989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102196658|NCT01106989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196659|NCT00975091|Entecavir|entecavir|mesh-list
102196660|NCT00975091|Antiviral Agents|antiviral agents|mesh-ancestor
102196661|NCT00975091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102196662|NCT02535416|Diphenhydramine|diphenhydramine|mesh-list
102196663|NCT02535416|Promethazine|promethazine|mesh-list
102196664|NCT02535416|Cetirizine|cetirizine|mesh-list
102196665|NCT02535416|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102196666|NCT02535416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102196667|NCT02535416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102196668|NCT02535416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196669|NCT02535416|Anesthetics, Local|anesthetics, local|mesh-ancestor
102196670|NCT02535416|Anesthetics|anesthetics|mesh-ancestor
102196671|NCT02535416|Sensory System Agents|sensory system agents|mesh-ancestor
102196672|NCT02535416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102196673|NCT02535416|Antiemetics|antiemetics|mesh-ancestor
102196674|NCT02535416|Autonomic Agents|autonomic agents|mesh-ancestor
102196675|NCT02535416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102196676|NCT02535416|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102196677|NCT02535416|Histamine Antagonists|histamine antagonists|mesh-ancestor
102196678|NCT02535416|Histamine Agents|histamine agents|mesh-ancestor
102196679|NCT02535416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102196680|NCT02535416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196681|NCT02535416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102196682|NCT02535416|Antipruritics|antipruritics|mesh-ancestor
102196683|NCT02535416|Dermatologic Agents|dermatologic agents|mesh-ancestor
102196684|NCT02535416|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102196685|NCT00911443|Interferons|interferons|mesh-list
102196686|NCT00911443|Interferon-alpha|interferon-alpha|mesh-list
102196687|NCT00911443|Interferon alpha-2|interferon alpha-2|mesh-list
102196688|NCT00911443|Dacarbazine|dacarbazine|mesh-list
102196689|NCT00911443|Thymalfasin|thymalfasin|mesh-list
102196690|NCT00911443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102196691|NCT00911443|Antiviral Agents|antiviral agents|mesh-ancestor
102196692|NCT00911443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102196693|NCT00911443|Immunologic Factors|immunologic factors|mesh-ancestor
102196694|NCT00911443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196695|NCT00911443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102196696|NCT00911443|Alkylating Agents|alkylating agents|mesh-ancestor
102196697|NCT00911443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196698|NCT00911443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102196699|NCT03949478|Ibuprofen|ibuprofen|mesh-list
102196700|NCT03949478|Nifedipine|nifedipine|mesh-list
102196701|NCT03949478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102196702|NCT03949478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102196703|NCT03949478|Analgesics|analgesics|mesh-ancestor
102196704|NCT03949478|Sensory System Agents|sensory system agents|mesh-ancestor
102196705|NCT03949478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102196706|NCT03949478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196707|NCT03949478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102196708|NCT03949478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102196709|NCT03949478|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102196710|NCT03949478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102196711|NCT03949478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196712|NCT03949478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102196713|NCT03949478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102196714|NCT03949478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102196715|NCT03949478|Vasodilator Agents|vasodilator agents|mesh-ancestor
102196716|NCT03949478|Tocolytic Agents|tocolytic agents|mesh-ancestor
101900422|NCT01284764|Serotonin Agents|serotonin agents|mesh-ancestor
102196717|NCT03949478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102196718|NCT00909649|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102196720|NCT00909649|Coagulants|coagulants|mesh-ancestor
102196721|NCT00971035|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102196722|NCT00971035|Immunologic Factors|immunologic factors|mesh-ancestor
102196723|NCT00971035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196724|NCT04787965|Opicapone|opicapone|mesh-list
102196725|NCT04787965|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102196726|NCT04787965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101449788|NCT00215007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102196727|NCT04787965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196728|NCT04787965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102196729|NCT04787965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102196730|NCT02670915|Insulin|insulin|mesh-list
102196731|NCT02670915|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102196732|NCT02670915|Insulin Aspart|insulin aspart|mesh-list
102196733|NCT02670915|Insulin, Long-Acting|insulin, long-acting|mesh-list
102196734|NCT02670915|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102196735|NCT02670915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102196736|NCT02670915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196737|NCT02545868|Vaccines|vaccines|mesh-list
102196738|NCT02545868|Immunologic Factors|immunologic factors|mesh-ancestor
102196739|NCT02545868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196740|NCT00821977|Vildagliptin|vildagliptin|mesh-list
102196741|NCT00821977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102196742|NCT00821977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196743|NCT00821977|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102196744|NCT00821977|Protease Inhibitors|protease inhibitors|mesh-ancestor
102196745|NCT00821977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102196746|NCT00821977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196747|NCT04474327|Montelukast|montelukast|mesh-list
102196748|NCT04474327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102196749|NCT04474327|Respiratory System Agents|respiratory system agents|mesh-ancestor
102196750|NCT04474327|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102196751|NCT04474327|Hormone Antagonists|hormone antagonists|mesh-ancestor
102196752|NCT04474327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102196753|NCT04474327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196754|NCT04474327|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102196755|NCT04474327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102196756|NCT04474327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196791|NCT00961675|Ciprofloxacin|ciprofloxacin|mesh-list
102196792|NCT00961675|Povidone-Iodine|povidone-iodine|mesh-list
102196793|NCT00961675|Dexamethasone|dexamethasone|mesh-list
102196794|NCT00961675|Dexamethasone acetate|dexamethasone acetate|mesh-list
102196795|NCT00961675|Povidone|povidone|mesh-list
102196796|NCT00961675|BB 1101|bb 1101|mesh-list
102196797|NCT00961675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102196798|NCT00961675|Antiemetics|antiemetics|mesh-ancestor
102196799|NCT00961675|Autonomic Agents|autonomic agents|mesh-ancestor
102196800|NCT00961675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102196801|NCT00961675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196802|NCT00961675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102196803|NCT00961675|Glucocorticoids|glucocorticoids|mesh-ancestor
102196804|NCT00961675|Hormones|hormones|mesh-ancestor
102196805|NCT00961675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102196806|NCT00961675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102196807|NCT00961675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102196808|NCT00961675|Protease Inhibitors|protease inhibitors|mesh-ancestor
102196809|NCT00961675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102196810|NCT00961675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196811|NCT00961675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102196812|NCT00961675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102196813|NCT00961675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102196814|NCT00961675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102196815|NCT00961675|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102196816|NCT00961675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102196817|NCT00961675|Plasma Substitutes|plasma substitutes|mesh-ancestor
102196818|NCT00961675|Blood Substitutes|blood substitutes|mesh-ancestor
102196819|NCT00961675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102196820|NCT00819169|Conatumumab|conatumumab|mesh-list
102196821|NCT00819169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102196822|NCT00819169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102196823|NCT02161679|Carboplatin|carboplatin|mesh-list
102196824|NCT02161679|Camptothecin|camptothecin|mesh-list
102196825|NCT02161679|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
102196826|NCT02161679|Immunoconjugates|immunoconjugates|mesh-list
102196827|NCT02161679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102196828|NCT02161679|Immunologic Factors|immunologic factors|mesh-ancestor
102196829|NCT02161679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196830|NCT02161679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102196831|NCT02161679|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102196832|NCT02161679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102196833|NCT02161679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102196834|NCT02161679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196835|NCT04262492|Rivaroxaban|rivaroxaban|mesh-list
102196836|NCT04262492|Apixaban|apixaban|mesh-list
102196837|NCT04262492|Edoxaban|edoxaban|mesh-list
102196838|NCT04262492|Dabigatran|dabigatran|mesh-list
102196839|NCT04262492|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102196840|NCT04262492|Antithrombins|antithrombins|mesh-ancestor
102196841|NCT04262492|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102196842|NCT04262492|Protease Inhibitors|protease inhibitors|mesh-ancestor
102196843|NCT04262492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102196844|NCT04262492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196845|NCT04262492|Anticoagulants|anticoagulants|mesh-ancestor
102196846|NCT00955981|Lesinurad|lesinurad|mesh-list
102196847|NCT00955981|Gout Suppressants|gout suppressants|mesh-ancestor
102196848|NCT00955981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102196849|NCT00955981|Uricosuric Agents|uricosuric agents|mesh-ancestor
102196850|NCT03541031|Micronutrients|micronutrients|mesh-list
102196851|NCT03541031|Trace Elements|trace elements|mesh-list
102196852|NCT03541031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196853|NCT05454709|Glucagon|glucagon|mesh-list
102196854|NCT05454709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102196855|NCT05454709|Hormones|hormones|mesh-ancestor
102196856|NCT05454709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102196857|NCT05454709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196858|NCT02154737|Gemcitabine|gemcitabine|mesh-list
102196859|NCT02154737|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102196860|NCT02154737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102196861|NCT02154737|Antimetabolites|antimetabolites|mesh-ancestor
102196862|NCT02154737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196863|NCT02154737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102196864|NCT02154737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102196865|NCT02154737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102196866|NCT00813163|Irinotecan|irinotecan|mesh-list
102196867|NCT00813163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102196868|NCT00813163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102196869|NCT00813163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102196870|NCT00813163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196871|NCT00813163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102196872|NCT05440916|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102196873|NCT05440916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905629|NCT01341496|Celecoxib|celecoxib|mesh-list
102196874|NCT05440916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102196875|NCT05440916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102196876|NCT00901693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102196877|NCT00901693|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102196878|NCT04474093|Lithium Carbonate|lithium carbonate|mesh-list
102196879|NCT04474093|Antidepressive Agents|antidepressive agents|mesh-ancestor
102196880|NCT04474093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102196881|NCT04474093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102196882|NCT04474093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196883|NCT04474093|Antimanic Agents|antimanic agents|mesh-ancestor
102196884|NCT04474093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102196885|NCT04474093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102196886|NCT04474093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196887|NCT02159027|Maraviroc|maraviroc|mesh-list
102196888|NCT02159027|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102196889|NCT02159027|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102196890|NCT02159027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196891|NCT02159027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102196892|NCT02159027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102196893|NCT02159027|Antiviral Agents|antiviral agents|mesh-ancestor
102196894|NCT02159027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102196895|NCT02159027|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102196896|NCT02161991|Aprepitant|aprepitant|mesh-list
102196897|NCT02161991|Antiemetics|antiemetics|mesh-ancestor
102196898|NCT02161991|Autonomic Agents|autonomic agents|mesh-ancestor
102196899|NCT02161991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102196900|NCT02161991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196901|NCT02161991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102196902|NCT02161991|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102196903|NCT02161991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102196904|NCT02161991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196905|NCT00948961|Poly I-C|poly i-c|mesh-list
102196906|NCT00948961|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102196907|NCT00948961|Poly ICLC|poly iclc|mesh-list
102196908|NCT00948961|Interferon Inducers|interferon inducers|mesh-ancestor
102196909|NCT00948961|Immunologic Factors|immunologic factors|mesh-ancestor
102196910|NCT00948961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196911|NCT00948961|Laxatives|laxatives|mesh-ancestor
102196912|NCT00948961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102196913|NCT00948961|Antiviral Agents|antiviral agents|mesh-ancestor
102196914|NCT00948961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102196915|NCT02159105|Chrysarobin|chrysarobin|mesh-list
102196916|NCT02159105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102196917|NCT02159105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102196918|NCT02159105|Analgesics|analgesics|mesh-ancestor
102196919|NCT02159105|Sensory System Agents|sensory system agents|mesh-ancestor
102196920|NCT02159105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102196921|NCT02159105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196922|NCT02159105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102196923|NCT02159105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102196924|NCT00890305|Pidilizumab|pidilizumab|mesh-list
102196925|NCT00890305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102196926|NCT00890305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102196927|NCT01661972|Capecitabine|capecitabine|mesh-list
102196928|NCT01661972|Aflibercept|aflibercept|mesh-list
102196929|NCT01661972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102196930|NCT01661972|Antimetabolites|antimetabolites|mesh-ancestor
102196931|NCT01661972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196932|NCT01661972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102196933|NCT01661972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102196934|NCT01661972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102196935|NCT01661972|Growth Substances|growth substances|mesh-ancestor
101308361|NCT02047006|Antithrombins|antithrombins|mesh-ancestor
102196936|NCT01661972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196937|NCT01661972|Growth Inhibitors|growth inhibitors|mesh-ancestor
102196938|NCT02155049|Bimatoprost|bimatoprost|mesh-list
102196939|NCT02155049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102196940|NCT03540953|Mitomycins|mitomycins|mesh-list
102196941|NCT03540953|Mitomycin|mitomycin|mesh-list
102196942|NCT03540953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102196943|NCT03540953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102196944|NCT03540953|Alkylating Agents|alkylating agents|mesh-ancestor
102196945|NCT03540953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196946|NCT03540953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102196947|NCT03540953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102196948|NCT00888355|Losartan|losartan|mesh-list
101905712|NCT01342744|Metformin|metformin|mesh-list
102196949|NCT00888355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102196950|NCT00888355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102196951|NCT00888355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102196952|NCT00888355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102196953|NCT00888355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196955|NCT00794677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102196956|NCT00794677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102196957|NCT00794677|Antimetabolites|antimetabolites|mesh-ancestor
102196958|NCT00794677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196959|NCT00794677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102196960|NCT00792727|Ketoprofen|ketoprofen|mesh-list
102196961|NCT00792727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102196962|NCT00792727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102196963|NCT00792727|Analgesics|analgesics|mesh-ancestor
102196964|NCT00792727|Sensory System Agents|sensory system agents|mesh-ancestor
102196965|NCT00792727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102196966|NCT00792727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196967|NCT00792727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102196968|NCT00792727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102196969|NCT00792727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102196970|NCT00792727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102196971|NCT00792727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196972|NCT00945763|Ibuprofen|ibuprofen|mesh-list
102196973|NCT00945763|Meloxicam|meloxicam|mesh-list
102196974|NCT00945763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102196975|NCT00945763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102196976|NCT00945763|Analgesics|analgesics|mesh-ancestor
102196977|NCT00945763|Sensory System Agents|sensory system agents|mesh-ancestor
102196978|NCT00945763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102196979|NCT00945763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196980|NCT00945763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102196981|NCT00945763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102196982|NCT00945763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102196983|NCT00945763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102196984|NCT00945763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102196985|NCT00945763|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102196986|NCT02770391|Leuprolide|leuprolide|mesh-list
102196987|NCT02770391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102196988|NCT02770391|Fertility Agents|fertility agents|mesh-ancestor
102196989|NCT02770391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102196990|NCT02770391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102196991|NCT02770391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102196992|NCT02770391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102196993|NCT02155205|Moxifloxacin|moxifloxacin|mesh-list
102196994|NCT02155205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102196995|NCT02155205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102196996|NCT02155205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102196997|NCT02155205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102196998|NCT02155205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102196999|NCT02155205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197000|NCT02155205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102197001|NCT00938587|Prednisone|prednisone|mesh-list
102197002|NCT00938587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102197003|NCT00938587|Glucocorticoids|glucocorticoids|mesh-ancestor
102197004|NCT00938587|Hormones|hormones|mesh-ancestor
101449856|NCT00474058|Rotigotine|rotigotine|mesh-list
102197005|NCT00938587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102197006|NCT00938587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197007|NCT00938587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102197008|NCT00938587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102197009|NCT02162303|Colchicine|colchicine|mesh-list
102197010|NCT02162303|Gout Suppressants|gout suppressants|mesh-ancestor
102197011|NCT02162303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102197012|NCT02162303|Tubulin Modulators|tubulin modulators|mesh-ancestor
102197013|NCT02162303|Antimitotic Agents|antimitotic agents|mesh-ancestor
102197014|NCT02162303|Mitosis Modulators|mitosis modulators|mesh-ancestor
102197015|NCT02162303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197016|NCT02162303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102197017|NCT05430308|Chlorhexidine|chlorhexidine|mesh-list
102197018|NCT05430308|Povidone-Iodine|povidone-iodine|mesh-list
102197020|NCT05430308|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102197021|NCT05430308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102197022|NCT05430308|Disinfectants|disinfectants|mesh-ancestor
102197023|NCT05430308|Plasma Substitutes|plasma substitutes|mesh-ancestor
102197024|NCT05430308|Blood Substitutes|blood substitutes|mesh-ancestor
102197025|NCT00877903|Remestemcel-l|remestemcel-l|mesh-list
102197026|NCT00877903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102197027|NCT00877903|Antiviral Agents|antiviral agents|mesh-ancestor
102197028|NCT00877903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102197029|NCT04707703|Isavuconazole|isavuconazole|mesh-list
102197030|NCT04707703|Antifungal Agents|antifungal agents|mesh-ancestor
102197031|NCT04707703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102197032|NCT04681105|Acetaminophen|acetaminophen|mesh-list
102197033|NCT04681105|Diphenhydramine|diphenhydramine|mesh-list
102197034|NCT04681105|Promethazine|promethazine|mesh-list
102197035|NCT04681105|Dexamethasone|dexamethasone|mesh-list
102197036|NCT04681105|Dexamethasone acetate|dexamethasone acetate|mesh-list
102197037|NCT04681105|Ibuprofen|ibuprofen|mesh-list
102197038|NCT04681105|Ranitidine|ranitidine|mesh-list
102197039|NCT04681105|Antibodies|antibodies|mesh-list
102197040|NCT04681105|Immunoglobulins|immunoglobulins|mesh-list
102197041|NCT04681105|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102197042|NCT04681105|BB 1101|bb 1101|mesh-list
102197043|NCT04681105|Immunologic Factors|immunologic factors|mesh-ancestor
102197044|NCT04681105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197045|NCT04681105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102197046|NCT04681105|Antiemetics|antiemetics|mesh-ancestor
102197047|NCT04681105|Autonomic Agents|autonomic agents|mesh-ancestor
102197048|NCT04681105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102197049|NCT04681105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102197050|NCT04681105|Glucocorticoids|glucocorticoids|mesh-ancestor
102197051|NCT04681105|Hormones|hormones|mesh-ancestor
102197052|NCT04681105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102197053|NCT04681105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102197054|NCT04681105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102197055|NCT04681105|Protease Inhibitors|protease inhibitors|mesh-ancestor
102197056|NCT04681105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102197057|NCT04681105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197058|NCT04681105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102197059|NCT04681105|Analgesics|analgesics|mesh-ancestor
102197060|NCT04681105|Sensory System Agents|sensory system agents|mesh-ancestor
102197061|NCT04681105|Antipyretics|antipyretics|mesh-ancestor
102197062|NCT04681105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102197063|NCT04681105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102197064|NCT04681105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102197065|NCT04681105|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102197066|NCT04681105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102197067|NCT04681105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102197068|NCT04681105|Anesthetics, Local|anesthetics, local|mesh-ancestor
102197069|NCT04681105|Anesthetics|anesthetics|mesh-ancestor
102197070|NCT04681105|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102197071|NCT04681105|Histamine Antagonists|histamine antagonists|mesh-ancestor
102197072|NCT04681105|Histamine Agents|histamine agents|mesh-ancestor
102197073|NCT04681105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102197074|NCT04681105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102197075|NCT04681105|Antipruritics|antipruritics|mesh-ancestor
102197076|NCT04681105|Dermatologic Agents|dermatologic agents|mesh-ancestor
102197077|NCT04681105|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102197078|NCT04681105|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102197079|NCT00936871|Moxifloxacin|moxifloxacin|mesh-list
102197080|NCT00936871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102197081|NCT00936871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102197082|NCT00936871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102197083|NCT00936871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102197084|NCT00936871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102197085|NCT00936871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197086|NCT00936871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102197087|NCT00934921|Ondansetron|ondansetron|mesh-list
102197088|NCT00934921|Antiemetics|antiemetics|mesh-ancestor
102197089|NCT00934921|Autonomic Agents|autonomic agents|mesh-ancestor
102197090|NCT00934921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102197091|NCT00934921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197092|NCT00934921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102197093|NCT00934921|Antipruritics|antipruritics|mesh-ancestor
102197094|NCT00934921|Dermatologic Agents|dermatologic agents|mesh-ancestor
102197095|NCT00934921|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102197096|NCT00934921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102197097|NCT00934921|Serotonin Agents|serotonin agents|mesh-ancestor
102197098|NCT00934921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101905854|NCT04473508|Anesthetics|anesthetics|mesh-ancestor
102197099|NCT00934921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197100|NCT05429450|Triamcinolone|triamcinolone|mesh-list
102197101|NCT05429450|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102197102|NCT05429450|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102197103|NCT05429450|Methotrexate|methotrexate|mesh-list
102197104|NCT05429450|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102197105|NCT05429450|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102197106|NCT05429450|Abortifacient Agents|abortifacient agents|mesh-ancestor
102197107|NCT05429450|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102197108|NCT05429450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197109|NCT05429450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102197110|NCT05429450|Antimetabolites|antimetabolites|mesh-ancestor
102197111|NCT05429450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197112|NCT05429450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102197113|NCT05429450|Dermatologic Agents|dermatologic agents|mesh-ancestor
102197114|NCT05429450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102197115|NCT05429450|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102197116|NCT05429450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102197117|NCT05429450|Immunologic Factors|immunologic factors|mesh-ancestor
102197118|NCT05429450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102197119|NCT05429450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102197120|NCT05429450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102197121|NCT05429450|Glucocorticoids|glucocorticoids|mesh-ancestor
102197122|NCT05429450|Hormones|hormones|mesh-ancestor
102197123|NCT05429450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102197124|NCT00103259|Irinotecan|irinotecan|mesh-list
102197125|NCT00103259|Bortezomib|bortezomib|mesh-list
102197126|NCT00103259|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102197127|NCT00103259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102197128|NCT00103259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102197129|NCT00103259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197130|NCT00103259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102197131|NCT02162381|Methylphenidate|methylphenidate|mesh-list
102197132|NCT02162381|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102197133|NCT02162381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197134|NCT02162381|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102197135|NCT02162381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102197136|NCT02162381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102197137|NCT02162381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197138|NCT02162381|Dopamine Agents|dopamine agents|mesh-ancestor
102197139|NCT02162381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102197140|NCT00782431|Vaccines|vaccines|mesh-list
102197141|NCT00782431|Immunologic Factors|immunologic factors|mesh-ancestor
102197142|NCT00782431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197143|NCT02155439|Triamcinolone|triamcinolone|mesh-list
102197144|NCT02155439|Fluorouracil|fluorouracil|mesh-list
102197145|NCT02155439|Antimetabolites|antimetabolites|mesh-ancestor
101449866|NCT02277730|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102197146|NCT02155439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197147|NCT02155439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102197148|NCT02155439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102197149|NCT02155439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102197150|NCT02155439|Immunologic Factors|immunologic factors|mesh-ancestor
102197151|NCT02155439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197152|NCT02155439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102197153|NCT02155439|Glucocorticoids|glucocorticoids|mesh-ancestor
102197154|NCT02155439|Hormones|hormones|mesh-ancestor
102197155|NCT02155439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102197156|NCT04627285|Lacosamide|lacosamide|mesh-list
102197157|NCT04627285|Anticonvulsants|anticonvulsants|mesh-ancestor
102197158|NCT04627285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102197159|NCT04627285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102197160|NCT04627285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102197161|NCT04627285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197162|NCT02544152|Lubiprostone|lubiprostone|mesh-list
102197163|NCT02544152|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102197164|NCT02544152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102197165|NCT02544152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197166|NCT02162537|Bevacizumab|bevacizumab|mesh-list
102197168|NCT02162537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102197169|NCT02162537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102197170|NCT02162537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102197171|NCT02162537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102197172|NCT02162537|Growth Substances|growth substances|mesh-ancestor
101905949|NCT01343680|Heparin|heparin|mesh-list
102197173|NCT02162537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197174|NCT02162537|Growth Inhibitors|growth inhibitors|mesh-ancestor
102197175|NCT02162537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102197176|NCT02162537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197177|NCT02162537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102197178|NCT02162537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102197179|NCT02534324|Antihypertensive Agents|antihypertensive agents|mesh-list
102197180|NCT00864175|Docetaxel|docetaxel|mesh-list
102197181|NCT00864175|Trastuzumab|trastuzumab|mesh-list
102197182|NCT00864175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102197183|NCT00864175|Tubulin Modulators|tubulin modulators|mesh-ancestor
102197184|NCT00864175|Antimitotic Agents|antimitotic agents|mesh-ancestor
102197185|NCT00864175|Mitosis Modulators|mitosis modulators|mesh-ancestor
102197186|NCT00864175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197187|NCT00864175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102197188|NCT02166593|Atorvastatin|atorvastatin|mesh-list
102197189|NCT02166593|Pravastatin|pravastatin|mesh-list
102197190|NCT02166593|Fenofibrate|fenofibrate|mesh-list
102197191|NCT02166593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102197192|NCT02166593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102197193|NCT02166593|Antimetabolites|antimetabolites|mesh-ancestor
102197194|NCT02166593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197195|NCT02166593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102197196|NCT02166593|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102197197|NCT02166593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102197198|NCT00858871|Sorafenib|sorafenib|mesh-list
102197199|NCT00858871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102197200|NCT00858871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102197201|NCT00858871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102197202|NCT00858871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197203|NCT02162693|Hyaluronic Acid|hyaluronic acid|mesh-list
102197204|NCT02162693|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102197205|NCT02162693|Immunologic Factors|immunologic factors|mesh-ancestor
102197206|NCT02162693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197207|NCT02162693|Viscosupplements|viscosupplements|mesh-ancestor
102197208|NCT02162693|Protective Agents|protective agents|mesh-ancestor
102197209|NCT02163161|Abrocitinib|abrocitinib|mesh-list
102197210|NCT02163161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102197211|NCT02163161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102197212|NCT02163161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197213|NCT00917293|Pyridoxal|pyridoxal|mesh-list
102197214|NCT00917293|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
102197215|NCT00917293|Vitamin B Complex|vitamin b complex|mesh-ancestor
102197216|NCT00917293|Vitamins|vitamins|mesh-ancestor
102197217|NCT00917293|Micronutrients|micronutrients|mesh-ancestor
102197218|NCT00917293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197219|NCT00845299|Benzalkonium Compounds|benzalkonium compounds|mesh-list
102197220|NCT00845299|Latanoprost|latanoprost|mesh-list
102197221|NCT00845299|Lubricant Eye Drops|lubricant eye drops|mesh-list
102197222|NCT00845299|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102197223|NCT00845299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102197224|NCT00845299|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102197225|NCT00845299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102197226|NCT02255591|Lidocaine|lidocaine|mesh-list
102197227|NCT02255591|Epinephrine|epinephrine|mesh-list
102197228|NCT02255591|Racepinephrine|racepinephrine|mesh-list
102197229|NCT02255591|Epinephryl borate|epinephryl borate|mesh-list
102197230|NCT02255591|Anesthetics, Local|anesthetics, local|mesh-ancestor
102197231|NCT02255591|Anesthetics|anesthetics|mesh-ancestor
102197232|NCT02255591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102197233|NCT02255591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197234|NCT02255591|Sensory System Agents|sensory system agents|mesh-ancestor
102197235|NCT02255591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102197236|NCT02255591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102197237|NCT02255591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102197238|NCT02255591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102197239|NCT02255591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102197240|NCT02255591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197241|NCT02255591|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102197242|NCT02255591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102197243|NCT02255591|Adrenergic Agents|adrenergic agents|mesh-ancestor
102197244|NCT02255591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102197245|NCT02255591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102197246|NCT02255591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102197247|NCT02255591|Autonomic Agents|autonomic agents|mesh-ancestor
101836505|NCT00490542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102197248|NCT02255591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102197249|NCT02255591|Respiratory System Agents|respiratory system agents|mesh-ancestor
102197250|NCT02255591|Mydriatics|mydriatics|mesh-ancestor
102197251|NCT02255591|Sympathomimetics|sympathomimetics|mesh-ancestor
102197252|NCT02255591|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102197253|NCT00913393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102197254|NCT00913393|Immunologic Factors|immunologic factors|mesh-ancestor
102197255|NCT00913393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197256|NCT02167061|Metformin|metformin|mesh-list
102197257|NCT02167061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102197258|NCT02167061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197259|NCT03715465|Melatonin|melatonin|mesh-list
102197260|NCT03715465|Antioxidants|antioxidants|mesh-ancestor
102197261|NCT03715465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197262|NCT03715465|Protective Agents|protective agents|mesh-ancestor
102197263|NCT03715465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197264|NCT03715465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102197265|NCT02171039|Dabigatran|dabigatran|mesh-list
102197266|NCT02171039|Atorvastatin|atorvastatin|mesh-list
102197267|NCT02171039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102197268|NCT02171039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102197269|NCT02171039|Antimetabolites|antimetabolites|mesh-ancestor
102197270|NCT02171039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197271|NCT02171039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102197272|NCT02171039|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102197273|NCT02171039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102197274|NCT02171039|Antithrombins|antithrombins|mesh-ancestor
102197275|NCT02171039|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102197276|NCT02171039|Protease Inhibitors|protease inhibitors|mesh-ancestor
102197277|NCT02171039|Anticoagulants|anticoagulants|mesh-ancestor
102197278|NCT00840073|Trandolapril|trandolapril|mesh-list
102197279|NCT00840073|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102197280|NCT00840073|Protease Inhibitors|protease inhibitors|mesh-ancestor
102197281|NCT00840073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102197282|NCT00840073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197283|NCT00840073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102197284|NCT02261207|Axitinib|axitinib|mesh-list
102197285|NCT02261207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102197286|NCT02261207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102197287|NCT02261207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102197288|NCT02261207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197289|NCT00838279|Lamotrigine|lamotrigine|mesh-list
102197290|NCT00838279|Anticonvulsants|anticonvulsants|mesh-ancestor
102197291|NCT00838279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102197292|NCT00838279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102197293|NCT00838279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197294|NCT00838279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102197295|NCT00838279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197296|NCT00838279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102197297|NCT00838279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102197298|NCT00838279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102197299|NCT00838279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102197300|NCT00838279|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102197301|NCT02163707|Psilocybin|psilocybin|mesh-list
102197302|NCT02163707|Hallucinogens|hallucinogens|mesh-ancestor
102197303|NCT02163707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197304|NCT02163707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102197305|NCT00769795|Goserelin|goserelin|mesh-list
102197306|NCT00769795|Bicalutamide|bicalutamide|mesh-list
102197307|NCT00769795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102197308|NCT00769795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102197309|NCT00769795|Androgen Antagonists|androgen antagonists|mesh-ancestor
102197310|NCT00769795|Hormone Antagonists|hormone antagonists|mesh-ancestor
102197311|NCT00769795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102197312|NCT00769795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197313|NCT03134677|Bupivacaine|bupivacaine|mesh-list
102197314|NCT03134677|Sevoflurane|sevoflurane|mesh-list
102197315|NCT03134677|Anesthetics, Local|anesthetics, local|mesh-ancestor
102197316|NCT03134677|Anesthetics|anesthetics|mesh-ancestor
102197317|NCT03134677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102197318|NCT03134677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197319|NCT03134677|Sensory System Agents|sensory system agents|mesh-ancestor
102197320|NCT03134677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102197321|NCT03134677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102197322|NCT03134677|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102197323|NCT03134677|Anesthetics, General|anesthetics, general|mesh-ancestor
102197324|NCT00722917|Pioglitazone|pioglitazone|mesh-list
102197325|NCT00722917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102197326|NCT00722917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197327|NCT02164097|Heparin|heparin|mesh-list
102197328|NCT02164097|Anticoagulants|anticoagulants|mesh-ancestor
102197329|NCT02164097|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102197330|NCT02164097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102197331|NCT02164097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197332|NCT00717457|Exenatide|exenatide|mesh-list
102197333|NCT00717457|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102197334|NCT00717457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102197335|NCT00717457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197336|NCT00717457|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102197337|NCT00717457|Incretins|incretins|mesh-ancestor
102197338|NCT00717457|Hormones|hormones|mesh-ancestor
102197339|NCT00717457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102197340|NCT02171507|Diclofenac|diclofenac|mesh-list
102197341|NCT02171507|Dabigatran|dabigatran|mesh-list
102197342|NCT02171507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102197343|NCT02171507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102197344|NCT02171507|Analgesics|analgesics|mesh-ancestor
102197345|NCT02171507|Sensory System Agents|sensory system agents|mesh-ancestor
102197346|NCT02171507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102197347|NCT02171507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197348|NCT02171507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102197349|NCT02171507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102197350|NCT02171507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102197351|NCT02171507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102197352|NCT02171507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197353|NCT02171507|Antithrombins|antithrombins|mesh-ancestor
102197354|NCT02171507|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102197355|NCT02171507|Protease Inhibitors|protease inhibitors|mesh-ancestor
102197356|NCT02171507|Anticoagulants|anticoagulants|mesh-ancestor
102197357|NCT03539159|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102197358|NCT03539159|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102197359|NCT00758953|Danazol|danazol|mesh-list
102197360|NCT00758953|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102197361|NCT00758953|Hormone Antagonists|hormone antagonists|mesh-ancestor
102197362|NCT00758953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102197363|NCT00758953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197364|NCT02167685|Brincidofovir|brincidofovir|mesh-list
102197365|NCT02167685|Antiviral Agents|antiviral agents|mesh-ancestor
102197366|NCT02167685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102197367|NCT00758563|Triclosan|triclosan|mesh-list
102197368|NCT00758563|Fluorides|fluorides|mesh-list
102197369|NCT00758563|Cariostatic Agents|cariostatic agents|mesh-ancestor
102197370|NCT00758563|Protective Agents|protective agents|mesh-ancestor
102197371|NCT00758563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197372|NCT00758563|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102197373|NCT00758563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102197374|NCT00758563|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102197375|NCT00758563|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102197376|NCT00758563|Antimetabolites|antimetabolites|mesh-ancestor
102197377|NCT00758563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197378|NCT00758563|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102197379|NCT02171585|Clarithromycin|clarithromycin|mesh-list
102197380|NCT02171585|Dabigatran|dabigatran|mesh-list
102197381|NCT02171585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102197382|NCT02171585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102197383|NCT02171585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102197384|NCT02171585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102197385|NCT02171585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197386|NCT02171585|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102197387|NCT02171585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102197388|NCT02171585|Antithrombins|antithrombins|mesh-ancestor
102197389|NCT02171585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102197390|NCT02171585|Protease Inhibitors|protease inhibitors|mesh-ancestor
102197391|NCT02171585|Anticoagulants|anticoagulants|mesh-ancestor
102197392|NCT03134443|Andrographolide|andrographolide|mesh-list
102197393|NCT03134443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102197394|NCT03134443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102197395|NCT03134443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102197396|NCT03134443|Analgesics|analgesics|mesh-ancestor
102197397|NCT03134443|Sensory System Agents|sensory system agents|mesh-ancestor
102197398|NCT03134443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102197399|NCT03134443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197400|NCT03134443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102197401|NCT03134443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102197402|NCT03134443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102197403|NCT03134443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102197404|NCT03134443|Antiviral Agents|antiviral agents|mesh-ancestor
102197405|NCT03134443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102197406|NCT02171663|Afatinib|afatinib|mesh-list
102197407|NCT02171663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102197408|NCT02171663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102197409|NCT02171663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102197410|NCT02171663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197411|NCT02171741|Docetaxel|docetaxel|mesh-list
102197412|NCT02171741|Afatinib|afatinib|mesh-list
102197413|NCT02171741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102197414|NCT02171741|Tubulin Modulators|tubulin modulators|mesh-ancestor
102197415|NCT02171741|Antimitotic Agents|antimitotic agents|mesh-ancestor
102197416|NCT02171741|Mitosis Modulators|mitosis modulators|mesh-ancestor
102197417|NCT02171741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197418|NCT02171741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102197419|NCT02171741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102197420|NCT00835705|Amoxicillin|amoxicillin|mesh-list
102197421|NCT00835705|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102197422|NCT00835705|Clavulanic Acids|clavulanic acids|mesh-list
102197423|NCT00835705|Clavulanic Acid|clavulanic acid|mesh-list
102197424|NCT00835705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102197425|NCT00835705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102197426|NCT00835705|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102197427|NCT00835705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102197428|NCT00835705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197441|NCT00713401|Esmolol|esmolol|mesh-list
102197442|NCT00713401|Tecadenoson|tecadenoson|mesh-list
102197443|NCT00713401|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102197444|NCT00713401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102197445|NCT00713401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102197446|NCT00713401|Adrenergic Agents|adrenergic agents|mesh-ancestor
102197447|NCT00713401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102197448|NCT00713401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197449|NCT00713401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197450|NCT00713401|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102197451|NCT00713401|Purinergic Agonists|purinergic agonists|mesh-ancestor
102197452|NCT00713401|Purinergic Agents|purinergic agents|mesh-ancestor
102197453|NCT02171975|Anesthetics|anesthetics|mesh-list
102197454|NCT02171975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102197455|NCT02171975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197456|NCT00835549|Cefdinir|cefdinir|mesh-list
102197457|NCT00835549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102197458|NCT00835549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102197459|NCT02164253|Deferiprone|deferiprone|mesh-list
102197460|NCT02164253|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102197461|NCT02164253|Chelating Agents|chelating agents|mesh-ancestor
102197462|NCT02164253|Sequestering Agents|sequestering agents|mesh-ancestor
102197463|NCT02164253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197464|NCT00755287|Metformin|metformin|mesh-list
102197465|NCT00755287|Insulin Glargine|insulin glargine|mesh-list
102197466|NCT00755287|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102197467|NCT00755287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102197468|NCT00755287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197469|NCT00755287|Incretins|incretins|mesh-ancestor
102197470|NCT00755287|Hormones|hormones|mesh-ancestor
102197471|NCT00755287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102197472|NCT02168075|Mannitol|mannitol|mesh-list
102197473|NCT02168075|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102197474|NCT02168075|Diuretics|diuretics|mesh-ancestor
102197475|NCT02168075|Natriuretic Agents|natriuretic agents|mesh-ancestor
102197476|NCT02168075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197477|NCT00712699|Adderall|adderall|mesh-list
102197478|NCT00712699|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102197479|NCT00712699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197480|NCT03945825|Vaccines|vaccines|mesh-list
102197481|NCT03945825|Immunologic Factors|immunologic factors|mesh-ancestor
102197482|NCT03945825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197483|NCT03819517|Resveratrol|resveratrol|mesh-list
102197484|NCT03819517|Antioxidants|antioxidants|mesh-ancestor
102197485|NCT03819517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197486|NCT03819517|Protective Agents|protective agents|mesh-ancestor
102197487|NCT03819517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197488|NCT03819517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102197489|NCT03819517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102197490|NCT02759315|Ruzasvir|ruzasvir|mesh-list
102197491|NCT02759315|Uprifosbuvir|uprifosbuvir|mesh-list
102197492|NCT02759315|Antiviral Agents|antiviral agents|mesh-ancestor
102197493|NCT02759315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102197494|NCT00697099|Enoxaparin|enoxaparin|mesh-list
102197495|NCT00697099|Semuloparin|semuloparin|mesh-list
102197496|NCT00697099|Enoxaparin sodium|enoxaparin sodium|mesh-list
102197497|NCT00697099|Anticoagulants|anticoagulants|mesh-ancestor
102197498|NCT00697099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102197499|NCT00697099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102197500|NCT00697099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197501|NCT02172131|Olodaterol|olodaterol|mesh-list
102197502|NCT02172131|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102197503|NCT02172131|Autonomic Agents|autonomic agents|mesh-ancestor
102197504|NCT02172131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102197505|NCT02172131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197506|NCT02172131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102197507|NCT02172131|Respiratory System Agents|respiratory system agents|mesh-ancestor
102197508|NCT05435768|Denosumab|denosumab|mesh-list
102197509|NCT05435768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102197510|NCT05435768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197511|NCT00835081|Cefadroxil|cefadroxil|mesh-list
102197512|NCT00835081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102197513|NCT00835081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102197514|NCT02543918|Ixekizumab|ixekizumab|mesh-list
102197515|NCT02543918|Vaccines|vaccines|mesh-list
102197516|NCT02543918|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102197517|NCT02543918|Immunologic Factors|immunologic factors|mesh-ancestor
102197518|NCT02543918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197519|NCT02543918|Dermatologic Agents|dermatologic agents|mesh-ancestor
102197520|NCT03539003|Remifentanil|remifentanil|mesh-list
102197521|NCT03539003|Propofol|propofol|mesh-list
102197522|NCT03539003|Sevoflurane|sevoflurane|mesh-list
102197523|NCT03539003|Desflurane|desflurane|mesh-list
102197524|NCT03539003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102197525|NCT03539003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102197526|NCT03539003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197527|NCT03539003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102197528|NCT03539003|Anesthetics, General|anesthetics, general|mesh-ancestor
102197529|NCT03539003|Anesthetics|anesthetics|mesh-ancestor
102197530|NCT03539003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102197531|NCT03539003|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102197532|NCT03539003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101900432|NCT01170260|Ethanol|ethanol|mesh-list
102197534|NCT03539003|Analgesics|analgesics|mesh-ancestor
102197535|NCT03539003|Sensory System Agents|sensory system agents|mesh-ancestor
102197536|NCT03539003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102197537|NCT02164565|Tranexamic Acid|tranexamic acid|mesh-list
102197538|NCT02164565|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102197539|NCT02164565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102197540|NCT02164565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197541|NCT02164565|Hemostatics|hemostatics|mesh-ancestor
102197542|NCT02164565|Coagulants|coagulants|mesh-ancestor
102197543|NCT04265534|Folic Acid|folic acid|mesh-list
102197544|NCT04265534|Vitamin B 12|vitamin b 12|mesh-list
102197545|NCT04265534|Dexamethasone|dexamethasone|mesh-list
102197546|NCT04265534|Carboplatin|carboplatin|mesh-list
102197547|NCT04265534|Pembrolizumab|pembrolizumab|mesh-list
102197548|NCT04265534|Pemetrexed|pemetrexed|mesh-list
101906305|NCT01302236|Eplerenone|eplerenone|mesh-list
102197549|NCT04265534|Vitamins|vitamins|mesh-ancestor
102197550|NCT04265534|Micronutrients|micronutrients|mesh-ancestor
102197551|NCT04265534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197552|NCT04265534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102197553|NCT04265534|Antiemetics|antiemetics|mesh-ancestor
102197554|NCT04265534|Autonomic Agents|autonomic agents|mesh-ancestor
102197555|NCT04265534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102197556|NCT04265534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102197558|NCT04265534|Hormones|hormones|mesh-ancestor
102197559|NCT04265534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102197560|NCT04265534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102197561|NCT04265534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102197562|NCT04265534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102197563|NCT04265534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102197564|NCT04265534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197565|NCT04265534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102197566|NCT04265534|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102197567|NCT04265534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102197568|NCT04265534|Hematinics|hematinics|mesh-ancestor
102197569|NCT04265534|Vitamin B Complex|vitamin b complex|mesh-ancestor
102197570|NCT00750295|Ferric Compounds|ferric compounds|mesh-list
102197571|NCT00750295|Hematinics|hematinics|mesh-ancestor
102197572|NCT02172209|Empagliflozin|empagliflozin|mesh-list
102197573|NCT02172209|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102197574|NCT02172209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197575|NCT02172209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102197576|NCT02172209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197577|NCT02168543|Alendronate|alendronate|mesh-list
102197578|NCT02168543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102197579|NCT02168543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197580|NCT01372995|Vitamin D|vitamin d|mesh-list
102197581|NCT01372995|Ergocalciferols|ergocalciferols|mesh-list
102197582|NCT01372995|Cholecalciferol|cholecalciferol|mesh-list
102197583|NCT01372995|Vitamins|vitamins|mesh-list
102197584|NCT01372995|Micronutrients|micronutrients|mesh-ancestor
102197585|NCT01372995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449890|NCT04571437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102197586|NCT01372995|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102197587|NCT01372995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102197588|NCT04239859|Cyclosporine|cyclosporine|mesh-list
102197589|NCT04239859|Methotrexate|methotrexate|mesh-list
102197590|NCT04239859|Acitretin|acitretin|mesh-list
102197591|NCT04239859|Cyclosporins|cyclosporins|mesh-list
102197592|NCT04239859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102197593|NCT04239859|Abortifacient Agents|abortifacient agents|mesh-ancestor
102197594|NCT04239859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102197595|NCT04239859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197596|NCT04239859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102197597|NCT04239859|Antimetabolites|antimetabolites|mesh-ancestor
102197598|NCT04239859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197599|NCT04239859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102197600|NCT04239859|Dermatologic Agents|dermatologic agents|mesh-ancestor
102197601|NCT04239859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102197602|NCT04239859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102197603|NCT04239859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102197604|NCT04239859|Immunologic Factors|immunologic factors|mesh-ancestor
102197605|NCT04239859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102197606|NCT04239859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102197607|NCT04239859|Antifungal Agents|antifungal agents|mesh-ancestor
102197608|NCT04239859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102197609|NCT04239859|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102197610|NCT04239859|Keratolytic Agents|keratolytic agents|mesh-ancestor
102197611|NCT02938923|Testosterone|testosterone|mesh-list
102197612|NCT02938923|Androgens|androgens|mesh-ancestor
102197613|NCT02938923|Hormones|hormones|mesh-ancestor
102197614|NCT02938923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102197615|NCT02938923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197616|NCT02757521|Nitrous Oxide|nitrous oxide|mesh-list
102197617|NCT02757521|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102197618|NCT02757521|Anesthetics, General|anesthetics, general|mesh-ancestor
102197619|NCT02757521|Anesthetics|anesthetics|mesh-ancestor
102197620|NCT02757521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102197621|NCT02757521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197622|NCT02757521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102197623|NCT02757521|Analgesics|analgesics|mesh-ancestor
102197624|NCT02757521|Sensory System Agents|sensory system agents|mesh-ancestor
102197625|NCT02757521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102197626|NCT00744367|Metformin|metformin|mesh-list
102197627|NCT00744367|Pioglitazone|pioglitazone|mesh-list
102197628|NCT00744367|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102197629|NCT00744367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102197630|NCT00744367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197631|NCT00744367|Incretins|incretins|mesh-ancestor
102197632|NCT00744367|Hormones|hormones|mesh-ancestor
102197633|NCT00744367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102197634|NCT02172287|Tiotropium Bromide|tiotropium bromide|mesh-list
102197635|NCT02172287|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102197636|NCT02172287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102197637|NCT02172287|Autonomic Agents|autonomic agents|mesh-ancestor
102197638|NCT02172287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102197639|NCT02172287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197640|NCT02172287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102197641|NCT02172287|Respiratory System Agents|respiratory system agents|mesh-ancestor
102197642|NCT02172287|Parasympatholytics|parasympatholytics|mesh-ancestor
102197643|NCT02172287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102197644|NCT02172287|Cholinergic Agents|cholinergic agents|mesh-ancestor
102197645|NCT02172287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102197646|NCT02172287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197647|NCT02172287|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102197648|NCT02172287|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102197649|NCT02172287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102197650|NCT02172287|Adrenergic Agents|adrenergic agents|mesh-ancestor
102197651|NCT02261129|Telmisartan|telmisartan|mesh-list
102197652|NCT02261129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102197653|NCT02261129|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101449900|NCT00473824|Antibodies|antibodies|mesh-list
102197654|NCT02261129|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102197655|NCT02261129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197656|NCT00694135|Dexamethasone|dexamethasone|mesh-list
102197657|NCT00694135|Dexamethasone acetate|dexamethasone acetate|mesh-list
102197658|NCT00694135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102197659|NCT00694135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102197660|NCT00694135|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102197661|NCT00694135|BB 1101|bb 1101|mesh-list
102197662|NCT00694135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102197663|NCT00694135|Antiemetics|antiemetics|mesh-ancestor
102197664|NCT00694135|Autonomic Agents|autonomic agents|mesh-ancestor
102197665|NCT00694135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102197666|NCT00694135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197667|NCT00694135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102197668|NCT00694135|Glucocorticoids|glucocorticoids|mesh-ancestor
102197669|NCT00694135|Hormones|hormones|mesh-ancestor
102197670|NCT00694135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102197671|NCT00694135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102197672|NCT00694135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102197673|NCT00694135|Protease Inhibitors|protease inhibitors|mesh-ancestor
102197674|NCT00694135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102197675|NCT00694135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197676|NCT03540095|Bupivacaine|bupivacaine|mesh-list
102197677|NCT03540095|Anesthetics, Local|anesthetics, local|mesh-ancestor
102197678|NCT03540095|Anesthetics|anesthetics|mesh-ancestor
102197679|NCT03540095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102197680|NCT03540095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197681|NCT03540095|Sensory System Agents|sensory system agents|mesh-ancestor
102197682|NCT03540095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102197683|NCT03071185|Dexmedetomidine|dexmedetomidine|mesh-list
102197684|NCT03071185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102197685|NCT03071185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102197686|NCT03071185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197687|NCT03071185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102197688|NCT03071185|Analgesics|analgesics|mesh-ancestor
102197689|NCT03071185|Sensory System Agents|sensory system agents|mesh-ancestor
102197690|NCT03071185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102197691|NCT03071185|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102197692|NCT03071185|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102197693|NCT03071185|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102197694|NCT03071185|Adrenergic Agents|adrenergic agents|mesh-ancestor
102197695|NCT03071185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102197696|NCT03071185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197697|NCT00741715|Atorvastatin|atorvastatin|mesh-list
102197698|NCT00741715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102197699|NCT00741715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102197700|NCT00741715|Antimetabolites|antimetabolites|mesh-ancestor
102197701|NCT00741715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906452|NCT00262067|Growth Inhibitors|growth inhibitors|mesh-ancestor
102197702|NCT00741715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102197703|NCT00741715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102197704|NCT00741715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102197705|NCT02169167|Octenidine|octenidine|mesh-list
102197706|NCT02169167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102197707|NCT02169167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102197708|NCT02172443|Tiotropium Bromide|tiotropium bromide|mesh-list
102197709|NCT02172443|Ipratropium|ipratropium|mesh-list
102197710|NCT02172443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102197711|NCT02172443|Autonomic Agents|autonomic agents|mesh-ancestor
102197712|NCT02172443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102197713|NCT02172443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197714|NCT02172443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102197715|NCT02172443|Respiratory System Agents|respiratory system agents|mesh-ancestor
102197716|NCT02172443|Parasympatholytics|parasympatholytics|mesh-ancestor
102197717|NCT02172443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102197718|NCT02172443|Cholinergic Agents|cholinergic agents|mesh-ancestor
102197719|NCT02172443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102197720|NCT02172443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197721|NCT00834613|Metformin|metformin|mesh-list
102197722|NCT00834613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102197723|NCT00834613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197724|NCT02172521|Bromides|bromides|mesh-list
102197725|NCT02172521|Tiotropium Bromide|tiotropium bromide|mesh-list
102197726|NCT02172521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102197727|NCT02172521|Autonomic Agents|autonomic agents|mesh-ancestor
102197728|NCT02172521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102197729|NCT02172521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197730|NCT02172521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102197731|NCT02172521|Respiratory System Agents|respiratory system agents|mesh-ancestor
102197732|NCT02172521|Parasympatholytics|parasympatholytics|mesh-ancestor
102197733|NCT02172521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102197734|NCT02172521|Cholinergic Agents|cholinergic agents|mesh-ancestor
102197735|NCT02172521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102197736|NCT02172521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197737|NCT02172521|Anticonvulsants|anticonvulsants|mesh-ancestor
102197738|NCT00834535|Cefdinir|cefdinir|mesh-list
102197739|NCT00834535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102197740|NCT00834535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102197741|NCT00691717|Hydrocortisone|hydrocortisone|mesh-list
102197742|NCT00691717|Anecortave|anecortave|mesh-list
102197743|NCT00691717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102197744|NCT00691717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102197745|NCT00691717|Growth Substances|growth substances|mesh-ancestor
102197746|NCT00691717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197747|NCT00691717|Growth Inhibitors|growth inhibitors|mesh-ancestor
102197748|NCT00691717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102197749|NCT00691717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102197750|NCT00834067|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102197751|NCT00834067|Moexipril|moexipril|mesh-list
102197752|NCT00834067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102197753|NCT00834067|Diuretics|diuretics|mesh-ancestor
102197754|NCT00834067|Natriuretic Agents|natriuretic agents|mesh-ancestor
102197755|NCT00834067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197756|NCT00834067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102197757|NCT00834067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102197758|NCT00834067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197759|NCT00834067|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102197760|NCT00834067|Protease Inhibitors|protease inhibitors|mesh-ancestor
102197761|NCT00834067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102197762|NCT00682981|Carboplatin|carboplatin|mesh-list
102197763|NCT00682981|Etoposide|etoposide|mesh-list
102197764|NCT00682981|Obatoclax|obatoclax|mesh-list
102197765|NCT00682981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102197766|NCT00682981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102197767|NCT00682981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102197768|NCT00682981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102197769|NCT00682981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102197770|NCT00682981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197771|NCT00833521|Zolpidem|zolpidem|mesh-list
102197772|NCT00833521|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102197773|NCT00833521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102197774|NCT00833521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102197775|NCT00833521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197776|NCT00833521|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102197777|NCT00833521|GABA Agonists|gaba agonists|mesh-ancestor
102197778|NCT00833521|GABA Agents|gaba agents|mesh-ancestor
102197779|NCT00833521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102197780|NCT00833521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197781|NCT00832507|Cicletanine|cicletanine|mesh-list
102197782|NCT00832507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102197783|NCT00832507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102197784|NCT00832507|Diuretics|diuretics|mesh-ancestor
102197785|NCT00832507|Natriuretic Agents|natriuretic agents|mesh-ancestor
102197786|NCT00832507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197787|NCT04862143|Fulvestrant|fulvestrant|mesh-list
102197788|NCT04862143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102197789|NCT04862143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101691567|NCT02684708|Prednisone|prednisone|mesh-list
102197790|NCT04862143|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102197791|NCT04862143|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102197792|NCT04862143|Hormone Antagonists|hormone antagonists|mesh-ancestor
102197793|NCT04862143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102197794|NCT04862143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197795|NCT02802943|Imiquimod|imiquimod|mesh-list
102197796|NCT02802943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102197797|NCT02802943|Immunologic Factors|immunologic factors|mesh-ancestor
102197798|NCT02802943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197799|NCT02802943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102197800|NCT02802943|Interferon Inducers|interferon inducers|mesh-ancestor
102197801|NCT02165033|Budesonide|budesonide|mesh-list
102197802|NCT02165033|Procaterol|procaterol|mesh-list
102197803|NCT02165033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102197804|NCT02165033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102197805|NCT02165033|Autonomic Agents|autonomic agents|mesh-ancestor
102197806|NCT02165033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102197807|NCT02165033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197808|NCT02165033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102197809|NCT02165033|Respiratory System Agents|respiratory system agents|mesh-ancestor
102197810|NCT02165033|Glucocorticoids|glucocorticoids|mesh-ancestor
102197811|NCT02165033|Hormones|hormones|mesh-ancestor
102197812|NCT02165033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102197813|NCT02165033|Sympathomimetics|sympathomimetics|mesh-ancestor
102197814|NCT02165033|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102197815|NCT02165033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102197816|NCT02165033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102197817|NCT02165033|Adrenergic Agents|adrenergic agents|mesh-ancestor
102197818|NCT02165033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102197819|NCT02165033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197820|NCT00734461|Naltrexone|naltrexone|mesh-list
102197821|NCT00734461|Oxycodone|oxycodone|mesh-list
102197822|NCT00734461|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102197823|NCT00734461|Narcotics|narcotics|mesh-ancestor
102197824|NCT00734461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102197825|NCT00734461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197826|NCT00734461|Analgesics|analgesics|mesh-ancestor
102197827|NCT00734461|Sensory System Agents|sensory system agents|mesh-ancestor
102197828|NCT00734461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102197829|NCT00734461|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102197830|NCT00734461|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102197831|NCT02169713|Tamsulosin|tamsulosin|mesh-list
102197832|NCT02169713|Solifenacin Succinate|solifenacin succinate|mesh-list
102197833|NCT02169713|Mirabegron|mirabegron|mesh-list
102197834|NCT02169713|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102197835|NCT02169713|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102197836|NCT02169713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102197837|NCT02169713|Adrenergic Agents|adrenergic agents|mesh-ancestor
102197838|NCT02169713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102197839|NCT02169713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197840|NCT02169713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197841|NCT02169713|Urological Agents|urological agents|mesh-ancestor
102197842|NCT02169713|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102197843|NCT02169713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102197844|NCT02169713|Cholinergic Agents|cholinergic agents|mesh-ancestor
102197845|NCT02169713|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102197846|NCT02169713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102197847|NCT02169713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102197848|NCT03980041|Nivolumab|nivolumab|mesh-list
102197849|NCT03980041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102197850|NCT03980041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102197851|NCT03980041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102197852|NCT03980041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197853|NCT02756819|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
102197854|NCT02756819|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102197855|NCT02756819|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102197856|NCT02756819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197857|NCT00829309|Pravastatin|pravastatin|mesh-list
102197858|NCT00829309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102197859|NCT00829309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102197860|NCT00829309|Antimetabolites|antimetabolites|mesh-ancestor
102197861|NCT00829309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197862|NCT00829309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102197863|NCT00829309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102197864|NCT00829309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102197865|NCT02165189|Ribavirin|ribavirin|mesh-list
102197866|NCT02165189|Sofosbuvir|sofosbuvir|mesh-list
102197867|NCT02165189|Simeprevir|simeprevir|mesh-list
102197868|NCT02165189|Antimetabolites|antimetabolites|mesh-ancestor
102197869|NCT02165189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197870|NCT02165189|Antiviral Agents|antiviral agents|mesh-ancestor
102197871|NCT02165189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102197872|NCT02165189|Protease Inhibitors|protease inhibitors|mesh-ancestor
102197873|NCT02165189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102197874|NCT00725881|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
102197875|NCT00725881|Antioxidants|antioxidants|mesh-ancestor
102197876|NCT00725881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197877|NCT00725881|Protective Agents|protective agents|mesh-ancestor
102197878|NCT00725881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197879|NCT00725881|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102197880|NCT00725881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102197881|NCT02292225|Obinutuzumab|obinutuzumab|mesh-list
102197882|NCT02292225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102197883|NCT02292225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102197884|NCT00677053|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1H)-one|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1h)-one|mesh-list
102197885|NCT00677053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102197886|NCT00677053|Antithrombins|antithrombins|mesh-ancestor
102197887|NCT00677053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102197888|NCT00677053|Protease Inhibitors|protease inhibitors|mesh-ancestor
102197889|NCT00677053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102197890|NCT00677053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197891|NCT00677053|Anticoagulants|anticoagulants|mesh-ancestor
102197892|NCT01950403|Linaclotide|linaclotide|mesh-list
102197893|NCT01950403|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102197894|NCT01950403|Enzyme Activators|enzyme activators|mesh-ancestor
102197895|NCT01950403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197896|NCT01950403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102197897|NCT03607539|Pemetrexed|pemetrexed|mesh-list
102197898|NCT03607539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102197899|NCT03607539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102197900|NCT03607539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197901|NCT03607539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102197902|NCT03607539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102197903|NCT00629941|Azithromycin|azithromycin|mesh-list
102197904|NCT00629941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102197905|NCT00629941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102197906|NCT02404779|Cisatracurium|cisatracurium|mesh-list
102197907|NCT02404779|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102197908|NCT02404779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102197909|NCT02404779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102197910|NCT02404779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197911|NCT00629551|Paroxetine|paroxetine|mesh-list
102197912|NCT00629551|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102197913|NCT00629551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102197914|NCT00629551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102197915|NCT00629551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197916|NCT00629551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102197917|NCT00629551|Serotonin Agents|serotonin agents|mesh-ancestor
102197918|NCT00629551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197919|NCT00629551|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102197920|NCT00629551|Antidepressive Agents|antidepressive agents|mesh-ancestor
102197921|NCT00629551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102197922|NCT00629551|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102197923|NCT00629551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102197924|NCT00629551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102197925|NCT00625651|Bevacizumab|bevacizumab|mesh-list
102197926|NCT00625651|Conatumumab|conatumumab|mesh-list
102197927|NCT00625651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102197928|NCT00625651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102197929|NCT00625651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102197930|NCT00625651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102197931|NCT00625651|Growth Substances|growth substances|mesh-ancestor
102197932|NCT00625651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197933|NCT00625651|Growth Inhibitors|growth inhibitors|mesh-ancestor
102197934|NCT00672997|Timolol|timolol|mesh-list
102197935|NCT00672997|Travoprost|travoprost|mesh-list
102197936|NCT00672997|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102197937|NCT00672997|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102197938|NCT00672997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102197939|NCT00672997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102197940|NCT00672997|Adrenergic Agents|adrenergic agents|mesh-ancestor
102197941|NCT00672997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102197942|NCT00672997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197943|NCT00672997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197944|NCT00672997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102197945|NCT00672997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102197946|NCT02669043|Ketamine|ketamine|mesh-list
102197947|NCT02669043|Analgesics|analgesics|mesh-ancestor
102197948|NCT02669043|Sensory System Agents|sensory system agents|mesh-ancestor
102197949|NCT02669043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102197950|NCT02669043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197951|NCT02669043|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102197952|NCT02669043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102197953|NCT02669043|Anesthetics, General|anesthetics, general|mesh-ancestor
102197954|NCT02669043|Anesthetics|anesthetics|mesh-ancestor
102197955|NCT02669043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102197956|NCT02669043|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102197957|NCT02669043|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102197958|NCT02669043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102197959|NCT02669043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197960|NCT02760407|Adalimumab|adalimumab|mesh-list
102197961|NCT02760407|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102197962|NCT02760407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102197963|NCT02760407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102197964|NCT02281045|Citric Acid|citric acid|mesh-list
102197965|NCT02281045|Sodium Citrate|sodium citrate|mesh-list
102197966|NCT02281045|Anticoagulants|anticoagulants|mesh-ancestor
102197967|NCT02281045|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102197968|NCT02281045|Chelating Agents|chelating agents|mesh-ancestor
102197969|NCT02281045|Sequestering Agents|sequestering agents|mesh-ancestor
102197970|NCT02281045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197971|NCT04472689|Lidocaine|lidocaine|mesh-list
102197972|NCT04472689|Anesthetics, Local|anesthetics, local|mesh-ancestor
102197973|NCT04472689|Anesthetics|anesthetics|mesh-ancestor
102197974|NCT04472689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102197975|NCT04472689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102197976|NCT04472689|Sensory System Agents|sensory system agents|mesh-ancestor
102197977|NCT04472689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102197978|NCT04472689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102197979|NCT04472689|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102197980|NCT04472689|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102197981|NCT04472689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102197982|NCT04472689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197983|NCT02405013|Ribavirin|ribavirin|mesh-list
102197984|NCT02405013|Sofosbuvir|sofosbuvir|mesh-list
102197985|NCT02405013|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102197986|NCT02405013|Ledipasvir|ledipasvir|mesh-list
102197987|NCT02405013|Antimetabolites|antimetabolites|mesh-ancestor
102197988|NCT02405013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102197989|NCT02405013|Antiviral Agents|antiviral agents|mesh-ancestor
102197990|NCT02405013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102197991|NCT02173145|Azithromycin|azithromycin|mesh-list
102197992|NCT02173145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102197993|NCT02173145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102197994|NCT00670033|Travoprost|travoprost|mesh-list
102197995|NCT00670033|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102197996|NCT00670033|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102197997|NCT00670033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102197998|NCT02283775|Dexamethasone|dexamethasone|mesh-list
102197999|NCT02283775|Pomalidomide|pomalidomide|mesh-list
102198000|NCT02283775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102198001|NCT02283775|Antiemetics|antiemetics|mesh-ancestor
102198002|NCT02283775|Autonomic Agents|autonomic agents|mesh-ancestor
102198003|NCT02283775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102198004|NCT02283775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198005|NCT02283775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102198006|NCT02283775|Glucocorticoids|glucocorticoids|mesh-ancestor
102198007|NCT02283775|Hormones|hormones|mesh-ancestor
102198008|NCT02283775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102198009|NCT02283775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102198010|NCT02283775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102198011|NCT02283775|Immunologic Factors|immunologic factors|mesh-ancestor
102198012|NCT02283775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102198013|NCT02283775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102198014|NCT02283775|Growth Substances|growth substances|mesh-ancestor
102198015|NCT02283775|Growth Inhibitors|growth inhibitors|mesh-ancestor
102198016|NCT04479891|Itraconazole|itraconazole|mesh-list
102198017|NCT04479891|Antifungal Agents|antifungal agents|mesh-ancestor
102198018|NCT04479891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102198019|NCT04479891|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102198020|NCT04479891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102198021|NCT04479891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102198022|NCT04479891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198023|NCT04479891|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102198024|NCT04479891|Hormone Antagonists|hormone antagonists|mesh-ancestor
102198025|NCT04479891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102198026|NCT04479891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198027|NCT04479891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102198028|NCT02281201|Thrombin|thrombin|mesh-list
102198029|NCT02281201|Hemostatics|hemostatics|mesh-ancestor
102198030|NCT02281201|Coagulants|coagulants|mesh-ancestor
102198031|NCT02281279|Rituximab|rituximab|mesh-list
102198032|NCT02281279|Lenalidomide|lenalidomide|mesh-list
102198033|NCT02281279|Romidepsin|romidepsin|mesh-list
102198034|NCT02281279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102198035|NCT02281279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102198036|NCT02281279|Immunologic Factors|immunologic factors|mesh-ancestor
102198037|NCT02281279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198038|NCT02281279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102198039|NCT02281279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102198040|NCT02281279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102198041|NCT02281279|Growth Substances|growth substances|mesh-ancestor
102198042|NCT02281279|Growth Inhibitors|growth inhibitors|mesh-ancestor
102198043|NCT02281279|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102198044|NCT02281279|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102198045|NCT02281279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102198046|NCT02281279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198047|NCT02173457|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102198048|NCT02173457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102198049|NCT02173457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198050|NCT02173457|Incretins|incretins|mesh-ancestor
102198051|NCT02173457|Hormones|hormones|mesh-ancestor
102198052|NCT02173457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102198053|NCT02173457|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102198054|NCT02173457|Protease Inhibitors|protease inhibitors|mesh-ancestor
102198055|NCT02173457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102198056|NCT02173457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198057|NCT00805129|Everolimus|everolimus|mesh-list
102198058|NCT00805129|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102198059|NCT00805129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102198060|NCT00805129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102198061|NCT00805129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198062|NCT00805129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102198063|NCT00805129|Immunologic Factors|immunologic factors|mesh-ancestor
102198064|NCT00805129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198065|NCT00805129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102198066|NCT02165813|Nitazoxanide|nitazoxanide|mesh-list
102198067|NCT02165813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102198068|NCT02165813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102198069|NCT00501709|Abatacept|abatacept|mesh-list
102198070|NCT00501709|Immunosuppressive Agents|immunosuppressive agents|mesh-list
102198071|NCT00501709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102198072|NCT00501709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906826|NCT01308086|Micronutrients|micronutrients|mesh-ancestor
102198073|NCT00501709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102198074|NCT00501709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102198075|NCT00501709|Immunologic Factors|immunologic factors|mesh-ancestor
102198076|NCT00501709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198077|NCT00501709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102198078|NCT02273635|Andrographolide|andrographolide|mesh-list
102198079|NCT02273635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102198080|NCT02273635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102198081|NCT02273635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102198082|NCT02273635|Analgesics|analgesics|mesh-ancestor
102198083|NCT02273635|Sensory System Agents|sensory system agents|mesh-ancestor
102198084|NCT02273635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102198085|NCT02273635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198086|NCT02273635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102198087|NCT02273635|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102198088|NCT02273635|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102198089|NCT02273635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102198090|NCT02273635|Antiviral Agents|antiviral agents|mesh-ancestor
102198091|NCT02273635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102198092|NCT02170415|Pregabalin|pregabalin|mesh-list
102198093|NCT02170415|Anesthetics|anesthetics|mesh-list
102198094|NCT02170415|Anesthetics, Local|anesthetics, local|mesh-list
102198095|NCT02170415|Analgesics|analgesics|mesh-ancestor
102198096|NCT02170415|Sensory System Agents|sensory system agents|mesh-ancestor
102198097|NCT02170415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102198098|NCT02170415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198099|NCT02170415|Anticonvulsants|anticonvulsants|mesh-ancestor
102198100|NCT02170415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102198101|NCT02170415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102198102|NCT02170415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198103|NCT02170415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102198104|NCT02170415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102198105|NCT02170415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102198106|NCT02170415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102198107|NCT02170415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102198108|NCT00622063|Beta-lapachone|beta-lapachone|mesh-list
102198109|NCT00622063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102198110|NCT00622063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102198111|NCT00622063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102198112|NCT00622063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102198113|NCT00622063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198114|NCT00622063|Antiviral Agents|antiviral agents|mesh-ancestor
102198115|NCT02173691|Tiotropium Bromide|tiotropium bromide|mesh-list
102198116|NCT02173691|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102198117|NCT02173691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102198118|NCT02173691|Autonomic Agents|autonomic agents|mesh-ancestor
102198119|NCT02173691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102198120|NCT02173691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198121|NCT02173691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102198122|NCT02173691|Respiratory System Agents|respiratory system agents|mesh-ancestor
102198123|NCT02173691|Parasympatholytics|parasympatholytics|mesh-ancestor
102198124|NCT02173691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102198125|NCT02173691|Cholinergic Agents|cholinergic agents|mesh-ancestor
102198126|NCT02173691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102198127|NCT02173691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198128|NCT02173691|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101449932|NCT00215241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102198129|NCT02173691|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102198130|NCT02173691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102198131|NCT02173691|Adrenergic Agents|adrenergic agents|mesh-ancestor
102198132|NCT02274259|Ranibizumab|ranibizumab|mesh-list
102198133|NCT02274259|Aflibercept|aflibercept|mesh-list
102198134|NCT02274259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102198135|NCT02274259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102198136|NCT02274259|Growth Substances|growth substances|mesh-ancestor
102198137|NCT02274259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198138|NCT02274259|Growth Inhibitors|growth inhibitors|mesh-ancestor
102198139|NCT02274259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102198140|NCT05571111|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102198141|NCT05571111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102198142|NCT05571111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198143|NCT02404623|Vitamin D|vitamin d|mesh-list
102198144|NCT02404623|Vitamins|vitamins|mesh-ancestor
102198145|NCT02404623|Micronutrients|micronutrients|mesh-ancestor
102198146|NCT02404623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198147|NCT02404623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102198149|NCT02170571|Antithrombins|antithrombins|mesh-ancestor
102198150|NCT02170571|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102198151|NCT02170571|Protease Inhibitors|protease inhibitors|mesh-ancestor
102198152|NCT02170571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102198153|NCT02170571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198154|NCT02170571|Anticoagulants|anticoagulants|mesh-ancestor
102198155|NCT04481841|Vitamins|vitamins|mesh-list
102198156|NCT04481841|Vitamin E|vitamin e|mesh-list
102198157|NCT04481841|Riboflavin|riboflavin|mesh-list
102198158|NCT04481841|Micronutrients|micronutrients|mesh-ancestor
102198159|NCT04481841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198160|NCT04481841|Vitamin B Complex|vitamin b complex|mesh-ancestor
102198161|NCT04481841|Antioxidants|antioxidants|mesh-ancestor
102198162|NCT04481841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198163|NCT04481841|Protective Agents|protective agents|mesh-ancestor
102198164|NCT04481841|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102198165|NCT04481841|Dermatologic Agents|dermatologic agents|mesh-ancestor
102198166|NCT02388477|Doxycycline|doxycycline|mesh-list
102198167|NCT02388477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102198168|NCT02388477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102198169|NCT02388477|Antimalarials|antimalarials|mesh-ancestor
102198170|NCT02388477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102198171|NCT02388477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102198172|NCT02166359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102198173|NCT02166359|Icodextrin|icodextrin|mesh-list
102198174|NCT02166359|Dialysis Solutions|dialysis solutions|mesh-ancestor
102198175|NCT00488839|Baclofen|baclofen|mesh-list
102198176|NCT00488839|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102198177|NCT00488839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198178|NCT00488839|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102198179|NCT00488839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102198180|NCT00488839|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102198181|NCT00488839|GABA Agonists|gaba agonists|mesh-ancestor
102198182|NCT00488839|GABA Agents|gaba agents|mesh-ancestor
102198183|NCT00488839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102198184|NCT00488839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198185|NCT02255747|Lactulose|lactulose|mesh-list
102198186|NCT02255747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102198187|NCT01654731|Bezafibrate|bezafibrate|mesh-list
102198188|NCT01654731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102198189|NCT01654731|Antimetabolites|antimetabolites|mesh-ancestor
101449942|NCT00124241|Lamivudine|lamivudine|mesh-list
102198190|NCT01654731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198191|NCT01654731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102198192|NCT00485563|Folic Acid|folic acid|mesh-list
102198193|NCT00485563|Vitamin B Complex|vitamin b complex|mesh-list
102198194|NCT00485563|Interferons|interferons|mesh-list
102198195|NCT00485563|Interferon-alpha|interferon-alpha|mesh-list
102198196|NCT00485563|Interleukin-2|interleukin-2|mesh-list
102198197|NCT00485563|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
102198198|NCT00485563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102198199|NCT00485563|Antiviral Agents|antiviral agents|mesh-ancestor
102198200|NCT00485563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102198201|NCT00485563|Immunologic Factors|immunologic factors|mesh-ancestor
102198202|NCT00485563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198203|NCT00485563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102198204|NCT00485563|Analgesics|analgesics|mesh-ancestor
102198205|NCT00485563|Sensory System Agents|sensory system agents|mesh-ancestor
102198206|NCT00485563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102198207|NCT00485563|Hematinics|hematinics|mesh-ancestor
102198208|NCT00485563|Vitamins|vitamins|mesh-ancestor
102198209|NCT00485563|Micronutrients|micronutrients|mesh-ancestor
102198210|NCT00485563|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102198211|NCT02170805|Pantoprazole|pantoprazole|mesh-list
102198212|NCT02170805|Dabigatran|dabigatran|mesh-list
102198213|NCT02170805|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102198214|NCT02170805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102198215|NCT02170805|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102198216|NCT02170805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102198217|NCT02170805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198218|NCT02170805|Antithrombins|antithrombins|mesh-ancestor
102198219|NCT02170805|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102198220|NCT02170805|Protease Inhibitors|protease inhibitors|mesh-ancestor
102198221|NCT02170805|Anticoagulants|anticoagulants|mesh-ancestor
102198222|NCT00606697|Vofopitant|vofopitant|mesh-list
102198223|NCT00606697|Vestipitant|vestipitant|mesh-list
102198224|NCT00606697|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102198225|NCT00606697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102198226|NCT00606697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198227|NCT00606697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198229|NCT00606697|Autonomic Agents|autonomic agents|mesh-ancestor
102198230|NCT00606697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102198231|NCT00606697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102198232|NCT02404077|Clonidine|clonidine|mesh-list
102198233|NCT02404077|Analgesics|analgesics|mesh-ancestor
102198234|NCT02404077|Sensory System Agents|sensory system agents|mesh-ancestor
102198235|NCT02404077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102198236|NCT02404077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198237|NCT02404077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102198238|NCT02404077|Sympatholytics|sympatholytics|mesh-ancestor
102198239|NCT02404077|Autonomic Agents|autonomic agents|mesh-ancestor
102198240|NCT02404077|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102198241|NCT02404077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102198242|NCT02404077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102198243|NCT02404077|Adrenergic Agents|adrenergic agents|mesh-ancestor
102198244|NCT02404077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102198245|NCT02404077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198246|NCT02174939|Cilostazol|cilostazol|mesh-list
102198247|NCT02174939|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102198248|NCT02174939|Autonomic Agents|autonomic agents|mesh-ancestor
102198249|NCT02174939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102198250|NCT02174939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198251|NCT02174939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102198252|NCT02174939|Respiratory System Agents|respiratory system agents|mesh-ancestor
102198253|NCT02174939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102198254|NCT02174939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102198255|NCT02174939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198256|NCT02174939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102198257|NCT02174939|Vasodilator Agents|vasodilator agents|mesh-ancestor
102198258|NCT02174939|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102198259|NCT02174939|Protective Agents|protective agents|mesh-ancestor
102198260|NCT02174939|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102198261|NCT02174939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102198262|NCT02174939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102198263|NCT02404233|Darunavir|darunavir|mesh-list
102198264|NCT02404233|Cobicistat|cobicistat|mesh-list
102198265|NCT02404233|Rilpivirine|rilpivirine|mesh-list
102198266|NCT02404233|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
102198267|NCT02404233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102198268|NCT02404233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102198269|NCT02404233|Protease Inhibitors|protease inhibitors|mesh-ancestor
102198270|NCT02404233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102198271|NCT02404233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198272|NCT02404233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102198273|NCT02404233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102198274|NCT02404233|Antiviral Agents|antiviral agents|mesh-ancestor
102198275|NCT02404233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102198276|NCT02404233|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102198277|NCT02404233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102198278|NCT02404233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102198279|NCT02404233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102198280|NCT00603577|Xaliproden|xaliproden|mesh-list
102198281|NCT00603577|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102198282|NCT00603577|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102198283|NCT00603577|Serotonin Agents|serotonin agents|mesh-ancestor
102198284|NCT00603577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102198285|NCT00603577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198286|NCT00603577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198287|NCT02178293|Ketoprofen|ketoprofen|mesh-list
102198288|NCT02178293|Ketoprofen lysine|ketoprofen lysine|mesh-list
102198289|NCT02178293|Benzydamine|benzydamine|mesh-list
102198290|NCT02178293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102198291|NCT02178293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102198292|NCT02178293|Analgesics|analgesics|mesh-ancestor
102198293|NCT02178293|Sensory System Agents|sensory system agents|mesh-ancestor
102198294|NCT02178293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102198295|NCT02178293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198296|NCT02178293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102198297|NCT02178293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102198298|NCT02178293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102198299|NCT02178293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101907055|NCT03775928|Capecitabine|capecitabine|mesh-list
102198300|NCT02178293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198302|NCT03170895|Homoharringtonine|homoharringtonine|mesh-list
102198303|NCT03170895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102198304|NCT03170895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102198305|NCT03170895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102198306|NCT03170895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198307|NCT03170895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102198308|NCT03170895|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102198309|NCT02277847|Cytarabine|cytarabine|mesh-list
102198310|NCT02277847|Idarubicin|idarubicin|mesh-list
102198311|NCT02277847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102198312|NCT02277847|Antimetabolites|antimetabolites|mesh-ancestor
102198313|NCT02277847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198314|NCT02277847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102198315|NCT02277847|Antiviral Agents|antiviral agents|mesh-ancestor
102198316|NCT02277847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102198317|NCT02277847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102198318|NCT02277847|Immunologic Factors|immunologic factors|mesh-ancestor
102198319|NCT02277847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198320|NCT02277847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102198321|NCT02277847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102198322|NCT02277847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102198323|NCT02277847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102198324|NCT01457781|Nitric Oxide|nitric oxide|mesh-list
102198325|NCT01457781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102198326|NCT01457781|Autonomic Agents|autonomic agents|mesh-ancestor
101449962|NCT00215280|Albendazole|albendazole|mesh-list
102198327|NCT01457781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102198328|NCT01457781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198329|NCT01457781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102198330|NCT01457781|Respiratory System Agents|respiratory system agents|mesh-ancestor
102198331|NCT01457781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102198332|NCT01457781|Antioxidants|antioxidants|mesh-ancestor
102198333|NCT01457781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198334|NCT01457781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102198335|NCT01457781|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102198336|NCT01457781|Vasodilator Agents|vasodilator agents|mesh-ancestor
102198338|NCT01457781|Protective Agents|protective agents|mesh-ancestor
102198339|NCT00468403|Mycophenolic Acid|mycophenolic acid|mesh-list
102198340|NCT00468403|Abatacept|abatacept|mesh-list
102198341|NCT00468403|Tacrolimus|tacrolimus|mesh-list
102198342|NCT00468403|Basiliximab|basiliximab|mesh-list
102198343|NCT00468403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102198344|NCT00468403|Immunologic Factors|immunologic factors|mesh-ancestor
102198345|NCT00468403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198346|NCT00468403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102198347|NCT00468403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102198348|NCT00468403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198349|NCT00468403|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102198350|NCT00468403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102198351|NCT00468403|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102198352|NCT00468403|Antitubercular Agents|antitubercular agents|mesh-ancestor
102198353|NCT00468403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102198354|NCT00468403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102198355|NCT00468403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102198356|NCT00468403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102198357|NCT00468403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102198358|NCT02175017|Nivolumab|nivolumab|mesh-list
102198359|NCT02175017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102198360|NCT02175017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102198361|NCT02175017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102198362|NCT02175017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198363|NCT02178449|Dexamethasone|dexamethasone|mesh-list
102198364|NCT02178449|Dexamethasone acetate|dexamethasone acetate|mesh-list
102198365|NCT02178449|Ropivacaine|ropivacaine|mesh-list
102198366|NCT02178449|BB 1101|bb 1101|mesh-list
102198367|NCT02178449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102198368|NCT02178449|Antiemetics|antiemetics|mesh-ancestor
102198369|NCT02178449|Autonomic Agents|autonomic agents|mesh-ancestor
102198370|NCT02178449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102198371|NCT02178449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198372|NCT02178449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102198373|NCT02178449|Glucocorticoids|glucocorticoids|mesh-ancestor
102198374|NCT02178449|Hormones|hormones|mesh-ancestor
102198375|NCT02178449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102198376|NCT02178449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102198377|NCT02178449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102198378|NCT02178449|Anesthetics, Local|anesthetics, local|mesh-ancestor
102198379|NCT02178449|Anesthetics|anesthetics|mesh-ancestor
102198380|NCT02178449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102198381|NCT02178449|Sensory System Agents|sensory system agents|mesh-ancestor
102198382|NCT02178449|Protease Inhibitors|protease inhibitors|mesh-ancestor
102198383|NCT02178449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102198384|NCT02178449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198385|NCT02387931|Vitamin D|vitamin d|mesh-list
102198386|NCT02387931|Ergocalciferols|ergocalciferols|mesh-list
102198387|NCT02387931|Cholecalciferol|cholecalciferol|mesh-list
102198388|NCT02387931|Vitamins|vitamins|mesh-list
102198389|NCT02387931|Micronutrients|micronutrients|mesh-ancestor
102198390|NCT02387931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198391|NCT02387931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102198392|NCT02387931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102198393|NCT02281669|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
102198394|NCT02281669|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102198395|NCT02281669|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102198396|NCT02281669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102198397|NCT02281669|Schistosomicides|schistosomicides|mesh-ancestor
102198398|NCT02281669|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102198399|NCT02281669|Anthelmintics|anthelmintics|mesh-ancestor
102198400|NCT02178683|Mycophenolic Acid|mycophenolic acid|mesh-list
102198401|NCT02178683|Tacrolimus|tacrolimus|mesh-list
102198402|NCT02178683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102198403|NCT02178683|Immunologic Factors|immunologic factors|mesh-ancestor
102198404|NCT02178683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198405|NCT02178683|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102198406|NCT02178683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102198407|NCT02178683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198408|NCT02178683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102198409|NCT02178683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102198410|NCT02178683|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102198411|NCT02178683|Antitubercular Agents|antitubercular agents|mesh-ancestor
102198412|NCT02178683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102198413|NCT02178683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102198414|NCT03170739|Dopamine|dopamine|mesh-list
102198415|NCT03170739|Dexmedetomidine|dexmedetomidine|mesh-list
102198416|NCT03170739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102198417|NCT03170739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102198418|NCT03170739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198419|NCT03170739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102198420|NCT03170739|Analgesics|analgesics|mesh-ancestor
102198421|NCT03170739|Sensory System Agents|sensory system agents|mesh-ancestor
102198422|NCT03170739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102198423|NCT03170739|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102198424|NCT03170739|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102198425|NCT03170739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102198426|NCT03170739|Adrenergic Agents|adrenergic agents|mesh-ancestor
102198427|NCT03170739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102198428|NCT03170739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198429|NCT03170739|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102198430|NCT03170739|Sympathomimetics|sympathomimetics|mesh-ancestor
102198431|NCT03170739|Autonomic Agents|autonomic agents|mesh-ancestor
102198432|NCT03170739|Dopamine Agents|dopamine agents|mesh-ancestor
102198433|NCT03170739|Protective Agents|protective agents|mesh-ancestor
102198434|NCT05309421|Pembrolizumab|pembrolizumab|mesh-list
102198435|NCT05309421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102198436|NCT05309421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102198437|NCT05309421|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102198438|NCT05309421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198439|NCT00459745|Fenofibrate|fenofibrate|mesh-list
102198440|NCT00459745|Pravastatin|pravastatin|mesh-list
102198441|NCT00459745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102198442|NCT00459745|Antimetabolites|antimetabolites|mesh-ancestor
102198443|NCT00459745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198444|NCT00459745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102198445|NCT00459745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102198446|NCT00459745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101907206|NCT03774524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102198447|NCT00459745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102198448|NCT02178761|Chromium|chromium|mesh-list
102198450|NCT02178761|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102198451|NCT02178761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102198452|NCT02178761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102198453|NCT02178761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198454|NCT02178761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102198455|NCT02178761|Immunologic Factors|immunologic factors|mesh-ancestor
102198456|NCT02178761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198457|NCT02178761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102198458|NCT02178761|Trace Elements|trace elements|mesh-ancestor
102198459|NCT02178761|Micronutrients|micronutrients|mesh-ancestor
102198460|NCT02742181|Alvimopan|alvimopan|mesh-list
102198461|NCT02742181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102198462|NCT02175407|Itraconazole|itraconazole|mesh-list
102198463|NCT02175407|Antifungal Agents|antifungal agents|mesh-ancestor
102198464|NCT02175407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102198465|NCT02175407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102198466|NCT02175407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102198467|NCT02175407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101449980|NCT00215358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102198468|NCT02175407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198469|NCT02175407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102198470|NCT02175407|Hormone Antagonists|hormone antagonists|mesh-ancestor
102198471|NCT02175407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102198472|NCT02175407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198473|NCT02175407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102198474|NCT02182193|Nintedanib|nintedanib|mesh-list
102198475|NCT02182193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102198476|NCT02182193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102198477|NCT02182193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102198478|NCT02182193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198479|NCT02175485|Fexofenadine|fexofenadine|mesh-list
102198480|NCT02175485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102198481|NCT02175485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102198482|NCT02175485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102198483|NCT02175485|Histamine Antagonists|histamine antagonists|mesh-ancestor
102198484|NCT02175485|Histamine Agents|histamine agents|mesh-ancestor
102198485|NCT02175485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102198486|NCT02175485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198487|NCT02175485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198488|NCT04575779|Cyclosporine|cyclosporine|mesh-list
102198489|NCT04575779|Cyclosporins|cyclosporins|mesh-list
102198490|NCT04575779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102198491|NCT04575779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198492|NCT04575779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102198493|NCT04575779|Immunologic Factors|immunologic factors|mesh-ancestor
102198494|NCT04575779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198495|NCT04575779|Antifungal Agents|antifungal agents|mesh-ancestor
102198496|NCT04575779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102198497|NCT04575779|Dermatologic Agents|dermatologic agents|mesh-ancestor
102198498|NCT04575779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102198499|NCT04575779|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102198500|NCT02741713|Lidocaine|lidocaine|mesh-list
102198501|NCT02741713|Clonidine|clonidine|mesh-list
102198502|NCT02741713|Epinephrine|epinephrine|mesh-list
102198503|NCT02741713|Racepinephrine|racepinephrine|mesh-list
102198504|NCT02741713|Bupivacaine|bupivacaine|mesh-list
102198505|NCT02741713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102198506|NCT02741713|Epinephryl borate|epinephryl borate|mesh-list
102198507|NCT02741713|Anesthetics, Local|anesthetics, local|mesh-ancestor
102198508|NCT02741713|Anesthetics|anesthetics|mesh-ancestor
102198509|NCT02741713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102198510|NCT02741713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198511|NCT02741713|Sensory System Agents|sensory system agents|mesh-ancestor
102198512|NCT02741713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102198513|NCT02741713|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102198514|NCT02741713|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102198515|NCT02741713|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102198516|NCT02741713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102198517|NCT02741713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198518|NCT02741713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102198519|NCT02741713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102198520|NCT02741713|Adrenergic Agents|adrenergic agents|mesh-ancestor
102198521|NCT02741713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102198522|NCT02741713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102198523|NCT02741713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102198524|NCT02741713|Autonomic Agents|autonomic agents|mesh-ancestor
102198525|NCT02741713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102198526|NCT02741713|Respiratory System Agents|respiratory system agents|mesh-ancestor
102198527|NCT02741713|Mydriatics|mydriatics|mesh-ancestor
102198528|NCT02741713|Sympathomimetics|sympathomimetics|mesh-ancestor
102198529|NCT02741713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102198530|NCT02741713|Analgesics|analgesics|mesh-ancestor
102198531|NCT02741713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102198532|NCT02741713|Sympatholytics|sympatholytics|mesh-ancestor
102198533|NCT02741713|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102198534|NCT00459277|Fentanyl|fentanyl|mesh-list
102198535|NCT00459277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102198536|NCT00459277|Narcotics|narcotics|mesh-ancestor
102198537|NCT00459277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102198538|NCT00459277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198539|NCT00459277|Analgesics|analgesics|mesh-ancestor
102198540|NCT00459277|Sensory System Agents|sensory system agents|mesh-ancestor
102198541|NCT00459277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102198542|NCT00459277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102198543|NCT00459277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102198544|NCT00459277|Anesthetics, General|anesthetics, general|mesh-ancestor
102198545|NCT00459277|Anesthetics|anesthetics|mesh-ancestor
102198546|NCT00602329|Leucovorin|leucovorin|mesh-list
102198547|NCT00602329|Bevacizumab|bevacizumab|mesh-list
102198548|NCT00602329|Fluorouracil|fluorouracil|mesh-list
102198549|NCT00602329|Oxaliplatin|oxaliplatin|mesh-list
102198550|NCT00602329|Calcium|calcium|mesh-list
102198551|NCT00602329|Levoleucovorin|levoleucovorin|mesh-list
102198552|NCT00602329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102198553|NCT00602329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102198554|NCT00602329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102198555|NCT00602329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102198556|NCT00602329|Growth Substances|growth substances|mesh-ancestor
102198557|NCT00602329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198558|NCT00602329|Growth Inhibitors|growth inhibitors|mesh-ancestor
101900453|NCT01580891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102198559|NCT00602329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102198560|NCT00602329|Antimetabolites|antimetabolites|mesh-ancestor
102198561|NCT00602329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198562|NCT00602329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102198563|NCT00602329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102198564|NCT00602329|Immunologic Factors|immunologic factors|mesh-ancestor
102198565|NCT00602329|Antidotes|antidotes|mesh-ancestor
102198566|NCT00602329|Protective Agents|protective agents|mesh-ancestor
102198567|NCT00602329|Vitamin B Complex|vitamin b complex|mesh-ancestor
102198568|NCT00602329|Vitamins|vitamins|mesh-ancestor
102198569|NCT00602329|Micronutrients|micronutrients|mesh-ancestor
102198570|NCT02182505|Fenoterol|fenoterol|mesh-list
102198571|NCT02182505|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
102198572|NCT02182505|Ipratropium|ipratropium|mesh-list
102198573|NCT02182505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102198574|NCT02182505|Autonomic Agents|autonomic agents|mesh-ancestor
102198575|NCT02182505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102198576|NCT02182505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198577|NCT02182505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102198578|NCT02182505|Respiratory System Agents|respiratory system agents|mesh-ancestor
102198579|NCT02182505|Sympathomimetics|sympathomimetics|mesh-ancestor
102198580|NCT02182505|Tocolytic Agents|tocolytic agents|mesh-ancestor
102198581|NCT02182505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102198582|NCT02182505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102198583|NCT02182505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102198584|NCT02182505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102198585|NCT02182505|Adrenergic Agents|adrenergic agents|mesh-ancestor
102198586|NCT02182505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102198587|NCT02182505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198588|NCT02182505|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102198589|NCT02182505|Cholinergic Agents|cholinergic agents|mesh-ancestor
102198590|NCT02387619|Amlodipine|amlodipine|mesh-list
102198591|NCT02387619|Telmisartan|telmisartan|mesh-list
102198592|NCT02387619|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
102198593|NCT02387619|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102198594|NCT02387619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102198595|NCT02387619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102198596|NCT02387619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102198597|NCT02387619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198598|NCT02387619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102198599|NCT02387619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198600|NCT02387619|Vasodilator Agents|vasodilator agents|mesh-ancestor
102198601|NCT02387619|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102198602|NCT02387619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102198603|NCT02387619|Antimetabolites|antimetabolites|mesh-ancestor
102198604|NCT02387619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101308366|NCT02047006|Anticoagulants|anticoagulants|mesh-ancestor
102198605|NCT02387619|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102198606|NCT02387619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102198607|NCT02387619|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102198608|NCT02387619|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102198609|NCT03537443|Vitamin D|vitamin d|mesh-list
102198610|NCT03537443|Cholecalciferol|cholecalciferol|mesh-list
102198611|NCT03537443|Vitamins|vitamins|mesh-ancestor
102198612|NCT03537443|Micronutrients|micronutrients|mesh-ancestor
102198613|NCT03537443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198614|NCT03537443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102198615|NCT03537443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102198616|NCT00595699|Escitalopram|escitalopram|mesh-list
102198617|NCT00595699|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102198618|NCT00595699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102198619|NCT00595699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102198620|NCT00595699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198621|NCT00595699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102198622|NCT00595699|Serotonin Agents|serotonin agents|mesh-ancestor
102198623|NCT00595699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198624|NCT02256215|Vitamin D|vitamin d|mesh-list
102198625|NCT02256215|Vitamins|vitamins|mesh-ancestor
102198626|NCT02256215|Micronutrients|micronutrients|mesh-ancestor
102198627|NCT02256215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198628|NCT02256215|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102198629|NCT02182583|Oxitropium|oxitropium|mesh-list
102198630|NCT02182583|Parasympatholytics|parasympatholytics|mesh-ancestor
102198631|NCT02182583|Autonomic Agents|autonomic agents|mesh-ancestor
101740408|NCT05136846|Durvalumab|durvalumab|mesh-list
102198632|NCT02182583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102198633|NCT02182583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198634|NCT03133975|Vitamin D|vitamin d|mesh-list
102198635|NCT03133975|Cholecalciferol|cholecalciferol|mesh-list
102198636|NCT03133975|Vitamins|vitamins|mesh-ancestor
102198637|NCT03133975|Micronutrients|micronutrients|mesh-ancestor
102198638|NCT03133975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198639|NCT03133975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102198640|NCT03133975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102198641|NCT02282137|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102198642|NCT02282137|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102198643|NCT02282137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198644|NCT02182661|Oxitropium|oxitropium|mesh-list
102198645|NCT02182661|Parasympatholytics|parasympatholytics|mesh-ancestor
102198646|NCT02182661|Autonomic Agents|autonomic agents|mesh-ancestor
102198647|NCT02182661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102198648|NCT02182661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198649|NCT02663271|Bevacizumab|bevacizumab|mesh-list
102198650|NCT02663271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102198651|NCT02663271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102198652|NCT02663271|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102198653|NCT02663271|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102198654|NCT02663271|Growth Substances|growth substances|mesh-ancestor
102198655|NCT02663271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198656|NCT02663271|Growth Inhibitors|growth inhibitors|mesh-ancestor
102198657|NCT00659191|Cabotegravir|cabotegravir|mesh-list
102198658|NCT00659191|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102198659|NCT00659191|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102198660|NCT00659191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102198661|NCT00659191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198662|NCT00659191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102198663|NCT00659191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102198664|NCT00659191|Antiviral Agents|antiviral agents|mesh-ancestor
102198665|NCT00659191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102198666|NCT02182739|Meloxicam|meloxicam|mesh-list
102198667|NCT02182739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102198668|NCT02182739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102198669|NCT02182739|Analgesics|analgesics|mesh-ancestor
102198670|NCT02182739|Sensory System Agents|sensory system agents|mesh-ancestor
102198671|NCT02182739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102198672|NCT02182739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198673|NCT02182739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102198674|NCT02182739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102198675|NCT02182739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102198676|NCT02182739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102198677|NCT02182739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102198678|NCT02182739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198679|NCT00583609|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
102198680|NCT00583609|Laxatives|laxatives|mesh-ancestor
102198681|NCT00583609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102198682|NCT03170115|Aspirin|aspirin|mesh-list
102198683|NCT03170115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102198684|NCT03170115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102198685|NCT03170115|Analgesics|analgesics|mesh-ancestor
102198686|NCT03170115|Sensory System Agents|sensory system agents|mesh-ancestor
102198687|NCT03170115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102198688|NCT03170115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198689|NCT03170115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102198690|NCT03170115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102198691|NCT03170115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102198692|NCT03170115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102198693|NCT03170115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198694|NCT03170115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102198695|NCT03170115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102198696|NCT03170115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102198697|NCT03170115|Antipyretics|antipyretics|mesh-ancestor
102198698|NCT03169959|Metformin|metformin|mesh-list
102198699|NCT03169959|Dapagliflozin|dapagliflozin|mesh-list
102198700|NCT03169959|Saxagliptin|saxagliptin|mesh-list
102198701|NCT03169959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102198702|NCT03169959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198703|NCT03169959|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102198704|NCT03169959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198705|NCT03169959|Incretins|incretins|mesh-ancestor
102198706|NCT03169959|Hormones|hormones|mesh-ancestor
102198707|NCT03169959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102198708|NCT03169959|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102198709|NCT03169959|Protease Inhibitors|protease inhibitors|mesh-ancestor
102198710|NCT03169959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102198712|NCT02176187|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
102198713|NCT02176187|Ipratropium|ipratropium|mesh-list
102198714|NCT02176187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102198715|NCT02176187|Autonomic Agents|autonomic agents|mesh-ancestor
102198716|NCT02176187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102198717|NCT02176187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198718|NCT02176187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102198719|NCT02176187|Respiratory System Agents|respiratory system agents|mesh-ancestor
102198720|NCT02176187|Sympathomimetics|sympathomimetics|mesh-ancestor
102198721|NCT02176187|Tocolytic Agents|tocolytic agents|mesh-ancestor
102198722|NCT02176187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102198723|NCT02176187|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102198724|NCT02176187|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102198725|NCT02176187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102198726|NCT02176187|Adrenergic Agents|adrenergic agents|mesh-ancestor
102198727|NCT02176187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102198728|NCT02176187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198729|NCT02176187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102198730|NCT02176187|Cholinergic Agents|cholinergic agents|mesh-ancestor
102198731|NCT02176499|Telmisartan|telmisartan|mesh-list
102198732|NCT02176499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102198733|NCT02176499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102198734|NCT02176499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102198735|NCT02176499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198736|NCT02176733|Cyclosporine|cyclosporine|mesh-list
102198737|NCT02176733|Cyclosporins|cyclosporins|mesh-list
102198738|NCT02176733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102198739|NCT02176733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198740|NCT02176733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102198741|NCT02176733|Immunologic Factors|immunologic factors|mesh-ancestor
102198742|NCT02176733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198743|NCT02176733|Antifungal Agents|antifungal agents|mesh-ancestor
102198744|NCT02176733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102198745|NCT02176733|Dermatologic Agents|dermatologic agents|mesh-ancestor
102198746|NCT02176733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102198747|NCT02176733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102198748|NCT03536741|Anesthetics|anesthetics|mesh-list
102198749|NCT03536741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
102198750|NCT03536741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102198751|NCT03536741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198752|NCT03536741|Anesthetics, General|anesthetics, general|mesh-ancestor
102198754|NCT02403687|Diclofenac|diclofenac|mesh-list
102198755|NCT02403687|Meloxicam|meloxicam|mesh-list
102198756|NCT02403687|Flurbiprofen|flurbiprofen|mesh-list
102198757|NCT02403687|Lidocaine|lidocaine|mesh-list
102198758|NCT02403687|Clonidine|clonidine|mesh-list
102198759|NCT02403687|Sumatriptan|sumatriptan|mesh-list
102198760|NCT02403687|Ketamine|ketamine|mesh-list
102198761|NCT02403687|Gabapentin|gabapentin|mesh-list
102198762|NCT02403687|Amitriptyline|amitriptyline|mesh-list
102198763|NCT02403687|Tizanidine|tizanidine|mesh-list
102198764|NCT02403687|Bupivacaine|bupivacaine|mesh-list
102198765|NCT02403687|Prilocaine|prilocaine|mesh-list
102198766|NCT02403687|Cyclobenzaprine|cyclobenzaprine|mesh-list
102198767|NCT02403687|Baclofen|baclofen|mesh-list
102198768|NCT02403687|Capsaicin|capsaicin|mesh-list
102198769|NCT02403687|Menthol|menthol|mesh-list
102198770|NCT02403687|Anesthetics, Local|anesthetics, local|mesh-ancestor
102198771|NCT02403687|Anesthetics|anesthetics|mesh-ancestor
102198772|NCT02403687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102198773|NCT02403687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198774|NCT02403687|Sensory System Agents|sensory system agents|mesh-ancestor
102198775|NCT02403687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102198776|NCT02403687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102198777|NCT02403687|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102198778|NCT02403687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102198779|NCT02403687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102198780|NCT02403687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198781|NCT02403687|Analgesics|analgesics|mesh-ancestor
102198782|NCT02403687|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102198783|NCT02403687|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101900454|NCT01059383|Esomeprazole|esomeprazole|mesh-list
102198784|NCT02403687|Anesthetics, General|anesthetics, general|mesh-ancestor
102198785|NCT02403687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102198786|NCT02403687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102198787|NCT02403687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102198788|NCT02403687|Anticonvulsants|anticonvulsants|mesh-ancestor
102198789|NCT02403687|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102198790|NCT02403687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102198791|NCT02403687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102198792|NCT02403687|Antimanic Agents|antimanic agents|mesh-ancestor
102198793|NCT02403687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102198794|NCT02403687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102198795|NCT02403687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102198796|NCT02403687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102198797|NCT02403687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102198798|NCT02403687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102198799|NCT02403687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102198800|NCT02403687|Antipruritics|antipruritics|mesh-ancestor
102198801|NCT02403687|Dermatologic Agents|dermatologic agents|mesh-ancestor
102198802|NCT02403687|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102198803|NCT02403687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102198804|NCT02403687|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102198805|NCT02403687|GABA Agonists|gaba agonists|mesh-ancestor
102198806|NCT02403687|GABA Agents|gaba agents|mesh-ancestor
102198807|NCT02403687|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102198808|NCT02403687|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102198809|NCT02403687|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102198810|NCT02403687|Serotonin Agents|serotonin agents|mesh-ancestor
102198811|NCT02403687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102198812|NCT02403687|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102198813|NCT02403687|Antidepressive Agents|antidepressive agents|mesh-ancestor
102198814|NCT02403687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102198815|NCT02403687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102198816|NCT02403687|Adrenergic Agents|adrenergic agents|mesh-ancestor
102198817|NCT02403687|Parasympatholytics|parasympatholytics|mesh-ancestor
102198818|NCT02403687|Autonomic Agents|autonomic agents|mesh-ancestor
102198819|NCT02403687|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102198820|NCT02403687|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102198821|NCT02403687|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102198822|NCT02403687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102198823|NCT02403687|Sympatholytics|sympatholytics|mesh-ancestor
102198825|NCT02742649|Bimatoprost|bimatoprost|mesh-list
102198826|NCT02742649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102198827|NCT02742649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102198828|NCT02742649|Adrenergic Agents|adrenergic agents|mesh-ancestor
102198829|NCT02742649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102198830|NCT02742649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198831|NCT02742649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198832|NCT02742649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102198833|NCT02742649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102198835|NCT02183051|Meloxicam|meloxicam|mesh-list
102198836|NCT02183051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102198837|NCT02183051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102198838|NCT02183051|Analgesics|analgesics|mesh-ancestor
102198839|NCT02183051|Sensory System Agents|sensory system agents|mesh-ancestor
102198840|NCT02183051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102198841|NCT02183051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198842|NCT02183051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102198843|NCT02183051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102198844|NCT02183051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102198845|NCT02183051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102198846|NCT02183051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198847|NCT02183051|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102198848|NCT03169725|Vaccines|vaccines|mesh-list
102198849|NCT03169725|Immunologic Factors|immunologic factors|mesh-ancestor
102198850|NCT03169725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198851|NCT02403531|Docetaxel|docetaxel|mesh-list
102198852|NCT02403531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102198853|NCT02403531|Tubulin Modulators|tubulin modulators|mesh-ancestor
102198854|NCT02403531|Antimitotic Agents|antimitotic agents|mesh-ancestor
102198855|NCT02403531|Mitosis Modulators|mitosis modulators|mesh-ancestor
102198856|NCT02403531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198857|NCT02183129|Diclofenac|diclofenac|mesh-list
102198858|NCT02183129|Meloxicam|meloxicam|mesh-list
102198859|NCT02183129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102198860|NCT02183129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102198861|NCT02183129|Analgesics|analgesics|mesh-ancestor
102198862|NCT02183129|Sensory System Agents|sensory system agents|mesh-ancestor
102198863|NCT02183129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102198864|NCT02183129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198865|NCT02183129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102198866|NCT02183129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102198867|NCT02183129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102198868|NCT02183129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102198869|NCT02183129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198870|NCT02183129|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102198871|NCT02279953|Vortioxetine|vortioxetine|mesh-list
102198872|NCT02279953|Antidepressive Agents|antidepressive agents|mesh-ancestor
102198873|NCT02279953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102198874|NCT02279953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102198875|NCT02279953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102198876|NCT02279953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102198877|NCT02279953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198878|NCT02279953|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102198879|NCT02279953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102198880|NCT02279953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102198881|NCT02279953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198882|NCT02279953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102198883|NCT02279953|Serotonin Agents|serotonin agents|mesh-ancestor
102198884|NCT02279953|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102198885|NCT02279953|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102198886|NCT02279953|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102198887|NCT02279953|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102198888|NCT00578773|Moxifloxacin|moxifloxacin|mesh-list
102198889|NCT00578773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102198890|NCT00578773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102198891|NCT00578773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102198892|NCT00578773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102198893|NCT00578773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102198894|NCT00578773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102198895|NCT00578773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198896|NCT00578773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102198897|NCT02387307|Interferons|interferons|mesh-list
102198898|NCT02387307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102198899|NCT02387307|Antiviral Agents|antiviral agents|mesh-ancestor
102198900|NCT02387307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102198901|NCT02183363|Linagliptin|linagliptin|mesh-list
102198902|NCT02183363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102198903|NCT02183363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198904|NCT02183363|Incretins|incretins|mesh-ancestor
102198906|NCT02183363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102198907|NCT02183363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102198908|NCT02183363|Protease Inhibitors|protease inhibitors|mesh-ancestor
102198909|NCT02183363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102198910|NCT02183363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198911|NCT02183441|Linagliptin|linagliptin|mesh-list
102198912|NCT02183441|Ritonavir|ritonavir|mesh-list
102198913|NCT02183441|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102198914|NCT02183441|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102198915|NCT02183441|Protease Inhibitors|protease inhibitors|mesh-ancestor
102198916|NCT02183441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102198917|NCT02183441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198918|NCT02183441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102198919|NCT02183441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102198920|NCT02183441|Antiviral Agents|antiviral agents|mesh-ancestor
102198921|NCT02183441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102198922|NCT02183441|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102198923|NCT02183441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102198924|NCT02183441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102198925|NCT02183441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198926|NCT02183441|Incretins|incretins|mesh-ancestor
102198927|NCT02183441|Hormones|hormones|mesh-ancestor
102198928|NCT02183441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102198929|NCT02183441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102198930|NCT02403219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102198931|NCT02403219|Botulinum Toxins|botulinum toxins|mesh-list
102198932|NCT02403219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102198933|NCT02403219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102198934|NCT02403219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102198935|NCT02403219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102198936|NCT02403219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198937|NCT02403219|Cholinergic Agents|cholinergic agents|mesh-ancestor
102198938|NCT02403219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102198939|NCT02403219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198940|NCT02403219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102198941|NCT02403219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102198942|NCT03537287|Progesterone|progesterone|mesh-list
102198943|NCT03537287|Dydrogesterone|dydrogesterone|mesh-list
102198944|NCT03537287|Progestins|progestins|mesh-ancestor
102198946|NCT03537287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102198947|NCT03537287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198948|NCT02280031|Aspirin|aspirin|mesh-list
102198949|NCT02280031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102198950|NCT02280031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102198951|NCT02280031|Analgesics|analgesics|mesh-ancestor
102198952|NCT02280031|Sensory System Agents|sensory system agents|mesh-ancestor
102198953|NCT02280031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102198954|NCT02280031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450015|NCT00192608|Saquinavir|saquinavir|mesh-list
102198955|NCT02280031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102198956|NCT02280031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102198957|NCT02280031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102198958|NCT02280031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102198959|NCT02280031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198960|NCT02280031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102198961|NCT02280031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102198962|NCT02280031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102198963|NCT02280031|Antipyretics|antipyretics|mesh-ancestor
102198964|NCT00449605|Metformin|metformin|mesh-list
102198965|NCT00449605|Glimepiride|glimepiride|mesh-list
102198966|NCT00449605|Rimonabant|rimonabant|mesh-list
102198967|NCT00449605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102198968|NCT00449605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198969|NCT00449605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102198970|NCT00449605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102198971|NCT00449605|Immunologic Factors|immunologic factors|mesh-ancestor
102198972|NCT00449605|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102198973|NCT00449605|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
102198974|NCT00449605|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102198976|NCT00449605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198977|NCT00449605|Hormones|hormones|mesh-ancestor
102198978|NCT00449605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102198979|NCT02774239|Immunoglobulins|immunoglobulins|mesh-list
102198980|NCT02774239|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102198981|NCT02774239|Antibodies|antibodies|mesh-list
102198982|NCT02774239|Immunoglobulin G|immunoglobulin g|mesh-list
102198983|NCT02774239|Immunologic Factors|immunologic factors|mesh-ancestor
102198984|NCT02774239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102198985|NCT02280109|Tenofovir|tenofovir|mesh-list
102198986|NCT02280109|Antiviral Agents|antiviral agents|mesh-ancestor
102198987|NCT02280109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102198988|NCT02280109|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102198989|NCT02280109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102198990|NCT02280109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102198991|NCT02280109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102198992|NCT02280109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102198993|NCT02280109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102198994|NCT00576667|Rimonabant|rimonabant|mesh-list
102198995|NCT00576667|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102198996|NCT00576667|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
102198997|NCT00576667|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102198998|NCT00576667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102198999|NCT00576667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199000|NCT00576667|Hormones|hormones|mesh-ancestor
102199001|NCT00576667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102199002|NCT00576667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199003|NCT02403063|Neostigmine|neostigmine|mesh-list
102199004|NCT02403063|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102199005|NCT02403063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102199006|NCT02403063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199007|NCT02403063|Cholinergic Agents|cholinergic agents|mesh-ancestor
102199008|NCT02403063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102199009|NCT02403063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199010|NCT02403063|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102199011|NCT02403063|Autonomic Agents|autonomic agents|mesh-ancestor
102199012|NCT02403063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102199013|NCT02177357|Pramipexole|pramipexole|mesh-list
102199014|NCT02177357|Antioxidants|antioxidants|mesh-ancestor
102199015|NCT02177357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199016|NCT02177357|Protective Agents|protective agents|mesh-ancestor
102199017|NCT02177357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199018|NCT02177357|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102199019|NCT02177357|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102199020|NCT02177357|Dopamine Agonists|dopamine agonists|mesh-ancestor
102199021|NCT02177357|Dopamine Agents|dopamine agents|mesh-ancestor
102199022|NCT02177357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102199023|NCT02386449|Mannitol|mannitol|mesh-list
102199024|NCT02386449|Bisacodyl|bisacodyl|mesh-list
102199025|NCT02386449|Picosulfate sodium|picosulfate sodium|mesh-list
102199026|NCT02386449|Magnesium Oxide|magnesium oxide|mesh-list
102199027|NCT02386449|Citric Acid|citric acid|mesh-list
102199028|NCT02386449|Sodium Citrate|sodium citrate|mesh-list
102199029|NCT02386449|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102199030|NCT02386449|Diuretics|diuretics|mesh-ancestor
102199031|NCT02386449|Natriuretic Agents|natriuretic agents|mesh-ancestor
102199032|NCT02386449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199033|NCT02386449|Cathartics|cathartics|mesh-ancestor
102199034|NCT02386449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102199035|NCT02386449|Laxatives|laxatives|mesh-ancestor
102199036|NCT02386449|Anticoagulants|anticoagulants|mesh-ancestor
102199037|NCT02386449|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102199038|NCT02386449|Chelating Agents|chelating agents|mesh-ancestor
102199039|NCT02386449|Sequestering Agents|sequestering agents|mesh-ancestor
102199040|NCT02386449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199041|NCT02386449|Antacids|antacids|mesh-ancestor
102199042|NCT00656539|Azithromycin|azithromycin|mesh-list
102199043|NCT00656539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102199044|NCT00656539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102199045|NCT02179775|Propranolol|propranolol|mesh-list
102199046|NCT02179775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102199047|NCT02179775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102199048|NCT02179775|Adrenergic Agents|adrenergic agents|mesh-ancestor
102199049|NCT02179775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101907811|NCT00536380|Loratadine|loratadine|mesh-list
102199050|NCT02179775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199051|NCT02179775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199052|NCT02179775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102199053|NCT02179775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102199054|NCT02179775|Vasodilator Agents|vasodilator agents|mesh-ancestor
102199055|NCT02177435|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102199056|NCT02177435|Telmisartan|telmisartan|mesh-list
102199057|NCT02177435|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
102199058|NCT02177435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102199059|NCT02177435|Diuretics|diuretics|mesh-ancestor
102199060|NCT02177435|Natriuretic Agents|natriuretic agents|mesh-ancestor
102199061|NCT02177435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199062|NCT02177435|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102199063|NCT02177435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102199064|NCT02177435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900469|NCT00312221|Oxycodone|oxycodone|mesh-list
102199065|NCT02177435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102199066|NCT02177435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102199068|NCT02280265|Coagulants|coagulants|mesh-ancestor
102199069|NCT02179931|Flupenthixol|flupenthixol|mesh-list
102199070|NCT02179931|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
102199071|NCT02179931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102199072|NCT02179931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102199073|NCT02179931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102199074|NCT02179931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199075|NCT02179931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102199076|NCT02179931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102199077|NCT02179931|Dopamine Agents|dopamine agents|mesh-ancestor
102199078|NCT02179931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102199079|NCT02179931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199080|NCT02184065|Meloxicam|meloxicam|mesh-list
102199081|NCT02184065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102199082|NCT02184065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102199083|NCT02184065|Analgesics|analgesics|mesh-ancestor
102199084|NCT02184065|Sensory System Agents|sensory system agents|mesh-ancestor
102199085|NCT02184065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102199086|NCT02184065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199087|NCT02184065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102199088|NCT02184065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102199089|NCT02184065|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102199090|NCT02184065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102199091|NCT02184065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102199092|NCT02184065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199093|NCT00564421|Epinastine|epinastine|mesh-list
102199094|NCT00564421|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102199095|NCT00564421|Histamine Antagonists|histamine antagonists|mesh-ancestor
102199096|NCT00564421|Histamine Agents|histamine agents|mesh-ancestor
102199097|NCT00564421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102199098|NCT00564421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199099|NCT00564421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199100|NCT02665689|Ranibizumab|ranibizumab|mesh-list
102199101|NCT02665689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102199102|NCT02665689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102199103|NCT02665689|Growth Substances|growth substances|mesh-ancestor
102199104|NCT02665689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199105|NCT02665689|Growth Inhibitors|growth inhibitors|mesh-ancestor
102199106|NCT02665689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102199107|NCT02386293|Irbesartan|irbesartan|mesh-list
102199108|NCT02386293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102199109|NCT02386293|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102199110|NCT02386293|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102199111|NCT02386293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199112|NCT00563563|Naltrexone|naltrexone|mesh-list
102199113|NCT00563563|Bupropion|bupropion|mesh-list
102199114|NCT00563563|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102199115|NCT00563563|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102199116|NCT00563563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199117|NCT00563563|Sensory System Agents|sensory system agents|mesh-ancestor
102199118|NCT00563563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102199119|NCT00563563|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102199120|NCT00563563|Antidepressive Agents|antidepressive agents|mesh-ancestor
102199121|NCT00563563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102199122|NCT00563563|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102199123|NCT00563563|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102199124|NCT00563563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102199125|NCT00563563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199126|NCT00563563|Dopamine Agents|dopamine agents|mesh-ancestor
102199127|NCT00563563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102199128|NCT00563563|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102199129|NCT00563563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102199130|NCT00563563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102199131|NCT05149365|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102199133|NCT05149365|Methotrexate|methotrexate|mesh-list
102199134|NCT05149365|Cyclosporins|cyclosporins|mesh-list
102199135|NCT05149365|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102199136|NCT05149365|Abortifacient Agents|abortifacient agents|mesh-ancestor
102199137|NCT05149365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102199138|NCT05149365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199139|NCT05149365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102199140|NCT05149365|Antimetabolites|antimetabolites|mesh-ancestor
102199141|NCT05149365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199142|NCT05149365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102199143|NCT05149365|Dermatologic Agents|dermatologic agents|mesh-ancestor
102199144|NCT05149365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102199145|NCT05149365|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102199146|NCT05149365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102199147|NCT05149365|Immunologic Factors|immunologic factors|mesh-ancestor
102199148|NCT05149365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102199149|NCT05149365|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102199150|NCT05149365|Antifungal Agents|antifungal agents|mesh-ancestor
102199151|NCT05149365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102199152|NCT05149365|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102199153|NCT05149365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102199154|NCT05149365|Incretins|incretins|mesh-ancestor
102199155|NCT05149365|Hormones|hormones|mesh-ancestor
102199156|NCT05149365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102199157|NCT05149365|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102199158|NCT05149365|Protease Inhibitors|protease inhibitors|mesh-ancestor
102199159|NCT02180087|Ketoprofen|ketoprofen|mesh-list
102199160|NCT02180087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102199161|NCT02180087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102199162|NCT02180087|Analgesics|analgesics|mesh-ancestor
102199163|NCT02180087|Sensory System Agents|sensory system agents|mesh-ancestor
102199164|NCT02180087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102199165|NCT02180087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199166|NCT02180087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102199167|NCT02180087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102199168|NCT02180087|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102199169|NCT02180087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102199170|NCT02180087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199171|NCT02184299|Nevirapine|nevirapine|mesh-list
102199172|NCT02184299|Prednisone|prednisone|mesh-list
102199173|NCT02184299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102199174|NCT02184299|Glucocorticoids|glucocorticoids|mesh-ancestor
102199175|NCT02184299|Hormones|hormones|mesh-ancestor
102199176|NCT02184299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102199177|NCT02184299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199178|NCT02184299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102199179|NCT02184299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102199180|NCT02184299|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102199181|NCT02184299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102199182|NCT02184299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102199183|NCT02184299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199184|NCT02184299|Antiviral Agents|antiviral agents|mesh-ancestor
102199185|NCT02184299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102199186|NCT02184299|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102199187|NCT02184299|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102199188|NCT02184299|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102199189|NCT02184299|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102199190|NCT00549679|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
102199191|NCT00549679|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102199192|NCT00549679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102199193|NCT00549679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102199194|NCT00549679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199196|NCT02282371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102199197|NCT02282371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102199198|NCT02402595|Itraconazole|itraconazole|mesh-list
102199199|NCT02402595|Antifungal Agents|antifungal agents|mesh-ancestor
102199200|NCT02402595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102199201|NCT02402595|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102199202|NCT02402595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102199203|NCT02402595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102199204|NCT02402595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900475|NCT00312221|Analgesics|analgesics|mesh-ancestor
102199205|NCT02402595|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102199206|NCT02402595|Hormone Antagonists|hormone antagonists|mesh-ancestor
102199207|NCT02402595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102199208|NCT02402595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199209|NCT02402595|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102199210|NCT02180321|Tranexamic Acid|tranexamic acid|mesh-list
102199211|NCT02180321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102199212|NCT02180321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102199213|NCT02180321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199214|NCT02180321|Hemostatics|hemostatics|mesh-ancestor
102199215|NCT02180321|Coagulants|coagulants|mesh-ancestor
102199216|NCT00547651|Topotecan|topotecan|mesh-list
102199217|NCT00547651|Amrubicin|amrubicin|mesh-list
102199218|NCT00547651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102199219|NCT00547651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102199220|NCT00547651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102199221|NCT00547651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199222|NCT00547651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102199223|NCT00546793|Veltuzumab|veltuzumab|mesh-list
102199224|NCT00546793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102199225|NCT02402283|Metronidazole|metronidazole|mesh-list
102199226|NCT02402283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102199227|NCT02402283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102199228|NCT02402283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102199229|NCT02402283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102199230|NCT02184533|Selenious Acid|selenious acid|mesh-list
102199231|NCT02184533|Sodium Selenite|sodium selenite|mesh-list
102199232|NCT02184533|Trace Elements|trace elements|mesh-ancestor
102199233|NCT02184533|Micronutrients|micronutrients|mesh-ancestor
102199234|NCT02184533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199235|NCT02386059|Dexamethasone|dexamethasone|mesh-list
102199236|NCT02386059|Dexamethasone acetate|dexamethasone acetate|mesh-list
102199237|NCT02386059|Ondansetron|ondansetron|mesh-list
102199238|NCT02386059|BB 1101|bb 1101|mesh-list
102199239|NCT02386059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102199240|NCT02386059|Antiemetics|antiemetics|mesh-ancestor
102199241|NCT02386059|Autonomic Agents|autonomic agents|mesh-ancestor
102199242|NCT02386059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102199243|NCT02386059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199244|NCT02386059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102199245|NCT02386059|Glucocorticoids|glucocorticoids|mesh-ancestor
102199246|NCT02386059|Hormones|hormones|mesh-ancestor
102199247|NCT02386059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102199248|NCT02386059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102199249|NCT02386059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102199250|NCT02386059|Protease Inhibitors|protease inhibitors|mesh-ancestor
102199251|NCT02386059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102199252|NCT02386059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199253|NCT02386059|Antipruritics|antipruritics|mesh-ancestor
102199254|NCT02386059|Dermatologic Agents|dermatologic agents|mesh-ancestor
102199255|NCT02386059|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102199256|NCT02386059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102199257|NCT02386059|Serotonin Agents|serotonin agents|mesh-ancestor
102199258|NCT02386059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102199259|NCT00443287|Cilostazol|cilostazol|mesh-list
102199260|NCT00443287|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
102199261|NCT00443287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102199262|NCT00443287|Autonomic Agents|autonomic agents|mesh-ancestor
102199263|NCT00443287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102199264|NCT00443287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199265|NCT00443287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102199266|NCT00443287|Respiratory System Agents|respiratory system agents|mesh-ancestor
101908039|NCT03767036|Ketorolac|ketorolac|mesh-list
102199267|NCT00443287|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102199268|NCT00443287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102199269|NCT00443287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199270|NCT00443287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102199271|NCT00443287|Vasodilator Agents|vasodilator agents|mesh-ancestor
102199272|NCT00443287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102199273|NCT00443287|Protective Agents|protective agents|mesh-ancestor
102199274|NCT00443287|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102199275|NCT00443287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102199276|NCT00443287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102199277|NCT00443287|Enzyme Activators|enzyme activators|mesh-ancestor
102199278|NCT00442039|Lithium Carbonate|lithium carbonate|mesh-list
102199279|NCT00442039|Antidepressive Agents|antidepressive agents|mesh-ancestor
102199280|NCT00442039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102199281|NCT00442039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102199282|NCT00442039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199283|NCT00442039|Antimanic Agents|antimanic agents|mesh-ancestor
102199284|NCT00442039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102199285|NCT00442039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102199286|NCT00442039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199287|NCT02390739|Aldesleukin|aldesleukin|mesh-list
102199288|NCT02390739|Cyclophosphamide|cyclophosphamide|mesh-list
102199289|NCT02390739|Fludarabine|fludarabine|mesh-list
102199290|NCT02390739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102199291|NCT02390739|Immunologic Factors|immunologic factors|mesh-ancestor
102199292|NCT02390739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199293|NCT02390739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102199294|NCT02390739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102199295|NCT02390739|Alkylating Agents|alkylating agents|mesh-ancestor
102199296|NCT02390739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199297|NCT02390739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102199298|NCT02390739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102199299|NCT02390739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102199300|NCT02390739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102199301|NCT02390739|Antiviral Agents|antiviral agents|mesh-ancestor
102199302|NCT02390739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102199303|NCT02385825|Vaccines|vaccines|mesh-list
102199304|NCT02385825|Immunologic Factors|immunologic factors|mesh-ancestor
102199305|NCT02385825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199306|NCT02177825|Imatinib Mesylate|imatinib mesylate|mesh-list
102199307|NCT02177825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102199308|NCT02177825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102199309|NCT02177825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102199310|NCT02177825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199311|NCT02390817|Neostigmine|neostigmine|mesh-list
102199312|NCT02390817|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102199313|NCT02390817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102199314|NCT02390817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199315|NCT02390817|Cholinergic Agents|cholinergic agents|mesh-ancestor
102199316|NCT02390817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102199317|NCT02390817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199318|NCT02390817|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102199319|NCT02390817|Autonomic Agents|autonomic agents|mesh-ancestor
102199320|NCT02390817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102199321|NCT00537043|Carvedilol|carvedilol|mesh-list
102199322|NCT00537043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102199323|NCT00537043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102199324|NCT00537043|Adrenergic Agents|adrenergic agents|mesh-ancestor
102199325|NCT00537043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102199326|NCT00537043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199327|NCT00537043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199328|NCT00537043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102199329|NCT00537043|Antioxidants|antioxidants|mesh-ancestor
102199330|NCT00537043|Protective Agents|protective agents|mesh-ancestor
102199331|NCT00537043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102199332|NCT00537043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102199333|NCT00537043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102199334|NCT00537043|Vasodilator Agents|vasodilator agents|mesh-ancestor
102199335|NCT00537043|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102199336|NCT00537043|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102199337|NCT00387907|Trastuzumab|trastuzumab|mesh-list
102199338|NCT00387907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102199339|NCT00387907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101908105|NCT03766490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102199340|NCT02180789|Tamsulosin|tamsulosin|mesh-list
102199341|NCT02180789|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102199342|NCT02180789|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102199343|NCT02180789|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102199344|NCT02180789|Adrenergic Agents|adrenergic agents|mesh-ancestor
102199345|NCT02180789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102199346|NCT02180789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199347|NCT02180789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199348|NCT02180789|Urological Agents|urological agents|mesh-ancestor
102199349|NCT02282683|Prednisone|prednisone|mesh-list
102199350|NCT02282683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102199351|NCT02282683|Glucocorticoids|glucocorticoids|mesh-ancestor
102199352|NCT02282683|Hormones|hormones|mesh-ancestor
102199353|NCT02282683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102199354|NCT02282683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199355|NCT02282683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102199356|NCT02282683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102199357|NCT02183909|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102199358|NCT02183909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102199359|NCT02183909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102199360|NCT02183909|Antiviral Agents|antiviral agents|mesh-ancestor
102199361|NCT02183909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102199362|NCT00375193|Amrubicin|amrubicin|mesh-list
102199363|NCT00375193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102199364|NCT00151411|Metformin|metformin|mesh-list
102199365|NCT00151411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102199366|NCT00151411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199367|NCT04471441|Mycophenolic Acid|mycophenolic acid|mesh-list
102199368|NCT04471441|Everolimus|everolimus|mesh-list
102199369|NCT04471441|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102199370|NCT04471441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102199371|NCT04471441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102199372|NCT04471441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199373|NCT04471441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102199374|NCT04471441|Immunologic Factors|immunologic factors|mesh-ancestor
102199375|NCT04471441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199376|NCT04471441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102199377|NCT04471441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102199378|NCT04471441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102199379|NCT04471441|Antitubercular Agents|antitubercular agents|mesh-ancestor
102199380|NCT04471441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102199381|NCT04471441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102199382|NCT02662569|Atorvastatin|atorvastatin|mesh-list
102199383|NCT02662569|Evolocumab|evolocumab|mesh-list
102199384|NCT02662569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102199385|NCT02662569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102199386|NCT02662569|Antimetabolites|antimetabolites|mesh-ancestor
102199387|NCT02662569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199388|NCT02662569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102199389|NCT02662569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102199390|NCT02662569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102199391|NCT02662569|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102199392|NCT02662569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102199393|NCT02662569|Protease Inhibitors|protease inhibitors|mesh-ancestor
102199394|NCT02178137|Zinc Sulfate|zinc sulfate|mesh-list
102199395|NCT02178137|Astringents|astringents|mesh-ancestor
102199396|NCT02178137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199397|NCT02178137|Dermatologic Agents|dermatologic agents|mesh-ancestor
102199398|NCT02181023|Glycopyrrolate|glycopyrrolate|mesh-list
102199399|NCT02181023|Bromides|bromides|mesh-list
102199400|NCT02181023|Anticonvulsants|anticonvulsants|mesh-ancestor
102199401|NCT02181023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102199402|NCT02181023|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102199403|NCT02181023|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102199404|NCT02181023|Cholinergic Agents|cholinergic agents|mesh-ancestor
102199405|NCT02181023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102199406|NCT02181023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199407|NCT02181023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199408|NCT02286973|Tranexamic Acid|tranexamic acid|mesh-list
102199409|NCT02286973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102199410|NCT02286973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102199411|NCT02286973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199412|NCT02286973|Hemostatics|hemostatics|mesh-ancestor
102199413|NCT02286973|Coagulants|coagulants|mesh-ancestor
101908181|NCT04737278|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102199414|NCT02181101|Zoledronic Acid|zoledronic acid|mesh-list
102199415|NCT02181101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102199416|NCT02181101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199417|NCT02287129|Paclitaxel|paclitaxel|mesh-list
102199418|NCT02287129|Carboplatin|carboplatin|mesh-list
102199419|NCT02287129|Capecitabine|capecitabine|mesh-list
102199420|NCT02287129|Oxaliplatin|oxaliplatin|mesh-list
102199421|NCT02287129|Epirubicin|epirubicin|mesh-list
102199422|NCT02287129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102199423|NCT02287129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102199424|NCT02287129|Tubulin Modulators|tubulin modulators|mesh-ancestor
102199425|NCT02287129|Antimitotic Agents|antimitotic agents|mesh-ancestor
102199426|NCT02287129|Mitosis Modulators|mitosis modulators|mesh-ancestor
102199427|NCT02287129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199428|NCT02287129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102199429|NCT02287129|Antimetabolites|antimetabolites|mesh-ancestor
102199430|NCT02287129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102199431|NCT02287129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102199432|NCT02287129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102199433|NCT02287129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102199434|NCT02256683|Dabigatran|dabigatran|mesh-list
102199435|NCT02256683|Phenprocoumon|phenprocoumon|mesh-list
102199436|NCT02256683|Antithrombins|antithrombins|mesh-ancestor
102199437|NCT02256683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102199438|NCT02256683|Protease Inhibitors|protease inhibitors|mesh-ancestor
102199439|NCT02256683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102199440|NCT02256683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199441|NCT02256683|Anticoagulants|anticoagulants|mesh-ancestor
102199442|NCT00411385|Interferons|interferons|mesh-list
102199443|NCT00411385|Ribavirin|ribavirin|mesh-list
102199444|NCT00411385|Interferon-alpha|interferon-alpha|mesh-list
102199445|NCT00411385|Interferon alpha-2|interferon alpha-2|mesh-list
102199446|NCT00411385|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102199447|NCT00411385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102199448|NCT00411385|Antiviral Agents|antiviral agents|mesh-ancestor
102199449|NCT00411385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102199450|NCT00411385|Antimetabolites|antimetabolites|mesh-ancestor
102199451|NCT00411385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199452|NCT00411385|Immunologic Factors|immunologic factors|mesh-ancestor
102199453|NCT00411385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199454|NCT02385513|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102199455|NCT02385513|Immunologic Factors|immunologic factors|mesh-ancestor
102199456|NCT02385513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199457|NCT02185547|Sertraline|sertraline|mesh-list
102199458|NCT02185547|Antidepressive Agents|antidepressive agents|mesh-ancestor
102199459|NCT02185547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102199460|NCT02185547|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102199461|NCT02185547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102199462|NCT02185547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102199463|NCT02185547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199464|NCT02185547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102199465|NCT02185547|Serotonin Agents|serotonin agents|mesh-ancestor
102199466|NCT02185547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199467|NCT02030483|Dexamethasone|dexamethasone|mesh-list
102199468|NCT02030483|Lenalidomide|lenalidomide|mesh-list
102199469|NCT02030483|Palbociclib|palbociclib|mesh-list
102199470|NCT02030483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102199471|NCT02030483|Antiemetics|antiemetics|mesh-ancestor
102199472|NCT02030483|Autonomic Agents|autonomic agents|mesh-ancestor
102199473|NCT02030483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102199474|NCT02030483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199475|NCT02030483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102199476|NCT02030483|Glucocorticoids|glucocorticoids|mesh-ancestor
102199477|NCT02030483|Hormones|hormones|mesh-ancestor
102199478|NCT02030483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102199479|NCT02030483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102199480|NCT02030483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102199481|NCT02030483|Immunologic Factors|immunologic factors|mesh-ancestor
102199482|NCT02030483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102199483|NCT02030483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102199484|NCT02030483|Growth Substances|growth substances|mesh-ancestor
102199485|NCT02030483|Growth Inhibitors|growth inhibitors|mesh-ancestor
102199486|NCT02030483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102199487|NCT02030483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102199488|NCT02030483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199489|NCT00528697|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102199490|NCT00528697|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102199491|NCT00528697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102199492|NCT00528697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102199493|NCT00528697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199494|NCT00528697|Adrenergic Agents|adrenergic agents|mesh-ancestor
102199495|NCT00528697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102199496|NCT00528697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199497|NCT02385435|Dexmedetomidine|dexmedetomidine|mesh-list
102199498|NCT02385435|Bupivacaine|bupivacaine|mesh-list
102199499|NCT02385435|Anesthetics, Local|anesthetics, local|mesh-ancestor
102199500|NCT02385435|Anesthetics|anesthetics|mesh-ancestor
101450055|NCT00192725|Antidepressive Agents|antidepressive agents|mesh-ancestor
102199501|NCT02385435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102199502|NCT02385435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199503|NCT02385435|Sensory System Agents|sensory system agents|mesh-ancestor
102199504|NCT02385435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102199505|NCT02385435|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102199506|NCT02385435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102199507|NCT02385435|Analgesics|analgesics|mesh-ancestor
102199508|NCT02385435|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102199509|NCT02385435|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102199510|NCT02385435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102199511|NCT02385435|Adrenergic Agents|adrenergic agents|mesh-ancestor
102199512|NCT02385435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102199513|NCT02385435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199514|NCT02753075|Fluorides|fluorides|mesh-list
102199515|NCT02753075|Cariostatic Agents|cariostatic agents|mesh-ancestor
102199516|NCT02753075|Protective Agents|protective agents|mesh-ancestor
102199517|NCT02753075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199518|NCT03133897|Dexamethasone|dexamethasone|mesh-list
102199519|NCT03133897|Prednisone|prednisone|mesh-list
102199520|NCT03133897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102199521|NCT03133897|Antiemetics|antiemetics|mesh-ancestor
102199522|NCT03133897|Autonomic Agents|autonomic agents|mesh-ancestor
102199523|NCT03133897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102199524|NCT03133897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199525|NCT03133897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102199526|NCT03133897|Glucocorticoids|glucocorticoids|mesh-ancestor
102199527|NCT03133897|Hormones|hormones|mesh-ancestor
102199528|NCT03133897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102199529|NCT03133897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102199530|NCT03133897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102199531|NCT05443425|Cholestyramine Resin|cholestyramine resin|mesh-list
102199532|NCT05443425|Leflunomide|leflunomide|mesh-list
102199533|NCT05443425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102199534|NCT05443425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199535|NCT05443425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102199536|NCT05443425|Immunologic Factors|immunologic factors|mesh-ancestor
102199537|NCT05443425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199538|NCT05443425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102199539|NCT05443425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102199540|NCT05443425|Antimetabolites|antimetabolites|mesh-ancestor
102199541|NCT05443425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102199542|NCT02190149|Factor VIII|factor viii|mesh-list
102199543|NCT02190149|Coagulants|coagulants|mesh-ancestor
102199544|NCT00366145|Remestemcel-l|remestemcel-l|mesh-list
102199545|NCT00366145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102199546|NCT00366145|Antiviral Agents|antiviral agents|mesh-ancestor
102199547|NCT00366145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102199548|NCT02185859|Lidocaine|lidocaine|mesh-list
102199549|NCT02185859|Magnesium Sulfate|magnesium sulfate|mesh-list
102199550|NCT02185859|Anesthetics, Local|anesthetics, local|mesh-ancestor
102199551|NCT02185859|Anesthetics|anesthetics|mesh-ancestor
102199552|NCT02185859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102199553|NCT02185859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199554|NCT02185859|Sensory System Agents|sensory system agents|mesh-ancestor
102199555|NCT02185859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102199556|NCT02185859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102199557|NCT02185859|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102199558|NCT02185859|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102199559|NCT02185859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102199560|NCT02185859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199561|NCT02185859|Analgesics|analgesics|mesh-ancestor
102199562|NCT02185859|Anticonvulsants|anticonvulsants|mesh-ancestor
102199563|NCT02185859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102199564|NCT02185859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102199565|NCT02185859|Tocolytic Agents|tocolytic agents|mesh-ancestor
102199566|NCT02185859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102199567|NCT02332720|Ribavirin|ribavirin|mesh-list
102199568|NCT02332720|Grazoprevir|grazoprevir|mesh-list
102199569|NCT02332720|Ruzasvir|ruzasvir|mesh-list
102199570|NCT02332720|Uprifosbuvir|uprifosbuvir|mesh-list
102199571|NCT02332720|Antimetabolites|antimetabolites|mesh-ancestor
102199572|NCT02332720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199573|NCT02332720|Antiviral Agents|antiviral agents|mesh-ancestor
102199574|NCT02332720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102199575|NCT05089175|Aspirin|aspirin|mesh-list
102199576|NCT05089175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102199577|NCT05089175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102199578|NCT05089175|Analgesics|analgesics|mesh-ancestor
102199579|NCT05089175|Sensory System Agents|sensory system agents|mesh-ancestor
102199580|NCT05089175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102199581|NCT05089175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199582|NCT05089175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102199583|NCT05089175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102199584|NCT05089175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102199585|NCT05089175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102199586|NCT05089175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199587|NCT05089175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102199588|NCT05089175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102199589|NCT05089175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102199590|NCT05089175|Antipyretics|antipyretics|mesh-ancestor
102199591|NCT02181335|Budesonide|budesonide|mesh-list
102199592|NCT02181335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102199593|NCT02181335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102199594|NCT02181335|Autonomic Agents|autonomic agents|mesh-ancestor
102199595|NCT02181335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102199596|NCT02181335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199597|NCT02181335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102199598|NCT02181335|Respiratory System Agents|respiratory system agents|mesh-ancestor
102199599|NCT02181335|Glucocorticoids|glucocorticoids|mesh-ancestor
102199600|NCT02181335|Hormones|hormones|mesh-ancestor
102199601|NCT02181335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102199602|NCT00517153|Miglustat|miglustat|mesh-list
102199603|NCT00517153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102199604|NCT00517153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199605|NCT00517153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102199606|NCT00517153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102199607|NCT00517153|Antiviral Agents|antiviral agents|mesh-ancestor
102199608|NCT00517153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102199609|NCT00517153|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102199610|NCT00517153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102199611|NCT00517153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199612|NCT02285101|BCT-100|bct-100|mesh-list
102199613|NCT02285101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102199614|NCT00359437|Satavaptan|satavaptan|mesh-list
102199615|NCT00359437|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102199616|NCT00359437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199617|NCT00359437|Natriuretic Agents|natriuretic agents|mesh-ancestor
102199618|NCT00359437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199619|NCT05064449|Itraconazole|itraconazole|mesh-list
102199620|NCT05064449|Mefenamic Acid|mefenamic acid|mesh-list
102199621|NCT05064449|Antifungal Agents|antifungal agents|mesh-ancestor
102199622|NCT05064449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102199623|NCT05064449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102199624|NCT05064449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102199625|NCT05064449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102199626|NCT05064449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199627|NCT05064449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102199628|NCT05064449|Hormone Antagonists|hormone antagonists|mesh-ancestor
102199629|NCT05064449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102199630|NCT05064449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199631|NCT05064449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102199632|NCT05064449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102199633|NCT05064449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102199634|NCT05064449|Analgesics|analgesics|mesh-ancestor
102199635|NCT05064449|Sensory System Agents|sensory system agents|mesh-ancestor
102199636|NCT05064449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102199637|NCT05064449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102199638|NCT05064449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102199639|NCT05064449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102199640|NCT00401011|Dexamethasone|dexamethasone|mesh-list
102199641|NCT00401011|Bortezomib|bortezomib|mesh-list
102199642|NCT00401011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102199643|NCT00401011|Antiemetics|antiemetics|mesh-ancestor
102199644|NCT00401011|Autonomic Agents|autonomic agents|mesh-ancestor
102199645|NCT00401011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102199646|NCT00401011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199647|NCT00401011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102199648|NCT00401011|Glucocorticoids|glucocorticoids|mesh-ancestor
102199650|NCT00401011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102199651|NCT00401011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102199652|NCT00401011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102199653|NCT01645930|Dexamethasone|dexamethasone|mesh-list
102199654|NCT01645930|Lenalidomide|lenalidomide|mesh-list
102199655|NCT01645930|Ixazomib|ixazomib|mesh-list
102199656|NCT01645930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102199657|NCT01645930|Antiemetics|antiemetics|mesh-ancestor
102199658|NCT01645930|Autonomic Agents|autonomic agents|mesh-ancestor
102199659|NCT01645930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102199660|NCT01645930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199661|NCT01645930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102199662|NCT01645930|Glucocorticoids|glucocorticoids|mesh-ancestor
102199663|NCT01645930|Hormones|hormones|mesh-ancestor
102199664|NCT01645930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102199665|NCT01645930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102199666|NCT01645930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102199667|NCT01645930|Immunologic Factors|immunologic factors|mesh-ancestor
102199668|NCT01645930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102199669|NCT01645930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102199670|NCT01645930|Growth Substances|growth substances|mesh-ancestor
102199671|NCT01645930|Growth Inhibitors|growth inhibitors|mesh-ancestor
102199672|NCT01645930|Protease Inhibitors|protease inhibitors|mesh-ancestor
102199673|NCT01645930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102199674|NCT01645930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199675|NCT02190695|Carboplatin|carboplatin|mesh-list
102199676|NCT02190695|Decitabine|decitabine|mesh-list
102199677|NCT02190695|Arsenic Trioxide|arsenic trioxide|mesh-list
102199678|NCT02190695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102199679|NCT02190695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102199680|NCT02190695|Antimetabolites|antimetabolites|mesh-ancestor
102199681|NCT02190695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199682|NCT02190695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102199683|NCT00514267|Prednisone|prednisone|mesh-list
102199684|NCT00514267|Docetaxel|docetaxel|mesh-list
102199685|NCT00514267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102199686|NCT00514267|Tubulin Modulators|tubulin modulators|mesh-ancestor
102199687|NCT00514267|Antimitotic Agents|antimitotic agents|mesh-ancestor
102199688|NCT00514267|Mitosis Modulators|mitosis modulators|mesh-ancestor
102199689|NCT00514267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199690|NCT00514267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102199691|NCT00514267|Glucocorticoids|glucocorticoids|mesh-ancestor
102199692|NCT00514267|Hormones|hormones|mesh-ancestor
102199693|NCT00514267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102199694|NCT00514267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199695|NCT00514267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102199696|NCT04199104|Pembrolizumab|pembrolizumab|mesh-list
102199697|NCT04199104|Lenvatinib|lenvatinib|mesh-list
102199698|NCT04199104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102199699|NCT04199104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102199700|NCT04199104|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102199701|NCT04199104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199702|NCT04199104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102199703|NCT04199104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102199704|NCT02384967|Darunavir|darunavir|mesh-list
102199705|NCT02384967|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102199706|NCT02384967|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102199707|NCT02384967|Protease Inhibitors|protease inhibitors|mesh-ancestor
101450073|NCT00222183|Pimecrolimus|pimecrolimus|mesh-list
102199708|NCT02384967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102199709|NCT02384967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199710|NCT02384967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102199711|NCT02384967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102199712|NCT02384967|Antiviral Agents|antiviral agents|mesh-ancestor
102199713|NCT02384967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102199714|NCT02186249|Nivolumab|nivolumab|mesh-list
102199715|NCT02186249|Ipilimumab|ipilimumab|mesh-list
102199716|NCT02186249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102199717|NCT02186249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102199718|NCT02186249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102199719|NCT02186249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199720|NCT00511459|Paclitaxel|paclitaxel|mesh-list
102199721|NCT00511459|Bevacizumab|bevacizumab|mesh-list
102199722|NCT00511459|Trebananib|trebananib|mesh-list
102199723|NCT00511459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102199724|NCT00511459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102199725|NCT00511459|Tubulin Modulators|tubulin modulators|mesh-ancestor
102199726|NCT00511459|Antimitotic Agents|antimitotic agents|mesh-ancestor
102199727|NCT00511459|Mitosis Modulators|mitosis modulators|mesh-ancestor
102199728|NCT00511459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199729|NCT00511459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102199730|NCT00511459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102199731|NCT00511459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102199732|NCT00511459|Growth Substances|growth substances|mesh-ancestor
102199733|NCT00511459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199734|NCT00511459|Growth Inhibitors|growth inhibitors|mesh-ancestor
102199735|NCT02384889|Eflornithine|eflornithine|mesh-list
102199736|NCT02384889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102199737|NCT02384889|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102199738|NCT02384889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102199739|NCT02384889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102199740|NCT02384889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102199741|NCT02384889|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
102199742|NCT02384889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102199743|NCT02384889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199744|NCT02299336|Aflibercept|aflibercept|mesh-list
102199745|NCT02299336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102199746|NCT02299336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102199747|NCT02299336|Growth Substances|growth substances|mesh-ancestor
102199748|NCT02299336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199749|NCT02299336|Growth Inhibitors|growth inhibitors|mesh-ancestor
102199750|NCT02299336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102199751|NCT02384655|Fenugreek seed meal|fenugreek seed meal|mesh-list
102199752|NCT02384655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102199753|NCT02384655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199754|NCT02186483|Metformin|metformin|mesh-list
102199755|NCT02186483|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102199756|NCT02186483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102199757|NCT02186483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199758|NCT02186483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102199759|NCT02186483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102199760|NCT02186483|Antimetabolites|antimetabolites|mesh-ancestor
102199761|NCT02186483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199762|NCT02186483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102199763|NCT02186483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102199764|NCT02186483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102199765|NCT02256605|Vitamin D|vitamin d|mesh-list
102199766|NCT02256605|Cholecalciferol|cholecalciferol|mesh-list
102199767|NCT02256605|Vitamins|vitamins|mesh-ancestor
102199768|NCT02256605|Micronutrients|micronutrients|mesh-ancestor
102199769|NCT02256605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199770|NCT02256605|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102199771|NCT02256605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102199772|NCT00393991|Fluticasone|fluticasone|mesh-list
102199773|NCT00393991|Xhance|xhance|mesh-list
102199774|NCT00393991|Formoterol Fumarate|formoterol fumarate|mesh-list
102199775|NCT00393991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102199776|NCT00393991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102199777|NCT00393991|Autonomic Agents|autonomic agents|mesh-ancestor
102199778|NCT00393991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101693564|NCT02637726|Anesthetics|anesthetics|mesh-ancestor
102199779|NCT00393991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199780|NCT00393991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102199781|NCT00393991|Respiratory System Agents|respiratory system agents|mesh-ancestor
102199782|NCT00393991|Dermatologic Agents|dermatologic agents|mesh-ancestor
102199783|NCT00393991|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102199784|NCT00393991|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102199785|NCT00393991|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102199786|NCT00393991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102199787|NCT00393991|Adrenergic Agents|adrenergic agents|mesh-ancestor
102199788|NCT00393991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102199789|NCT00393991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199790|NCT02664441|Exenatide|exenatide|mesh-list
102199791|NCT02664441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102199792|NCT02664441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199793|NCT02664441|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102199794|NCT02664441|Incretins|incretins|mesh-ancestor
102199795|NCT02664441|Hormones|hormones|mesh-ancestor
102199796|NCT02664441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102199797|NCT02191007|Calcitriol|calcitriol|mesh-list
102199798|NCT02191007|Betamethasone|betamethasone|mesh-list
102199799|NCT02191007|Betamethasone Valerate|betamethasone valerate|mesh-list
102199800|NCT02191007|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102199801|NCT02191007|Betamethasone benzoate|betamethasone benzoate|mesh-list
102199802|NCT02191007|Calcipotriene|calcipotriene|mesh-list
102199803|NCT02191007|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102199804|NCT02191007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102199805|NCT02191007|Glucocorticoids|glucocorticoids|mesh-ancestor
102199806|NCT02191007|Hormones|hormones|mesh-ancestor
102199807|NCT02191007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102199808|NCT02191007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199809|NCT02191007|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102199810|NCT02191007|Respiratory System Agents|respiratory system agents|mesh-ancestor
102199811|NCT02191007|Dermatologic Agents|dermatologic agents|mesh-ancestor
102199812|NCT02191007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102199813|NCT02191007|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102199814|NCT02191007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102199815|NCT02191007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199816|NCT02191007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102199817|NCT02191007|Vitamins|vitamins|mesh-ancestor
102199818|NCT02191007|Micronutrients|micronutrients|mesh-ancestor
102199819|NCT02191007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102199820|NCT02298946|Cyclophosphamide|cyclophosphamide|mesh-list
102199821|NCT02298946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102199822|NCT02298946|Immunologic Factors|immunologic factors|mesh-ancestor
102199823|NCT02298946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199824|NCT02298946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102199825|NCT02298946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102199826|NCT02298946|Alkylating Agents|alkylating agents|mesh-ancestor
102199827|NCT02298946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199828|NCT02298946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102199829|NCT02298946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102199830|NCT04470115|Anesthetics|anesthetics|mesh-list
102199831|NCT04470115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102199832|NCT04470115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199833|NCT02384343|Dexmedetomidine|dexmedetomidine|mesh-list
102199834|NCT02384343|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102199835|NCT02384343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102199836|NCT02384343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199837|NCT02384343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102199838|NCT02384343|Analgesics|analgesics|mesh-ancestor
102199839|NCT02384343|Sensory System Agents|sensory system agents|mesh-ancestor
102199840|NCT02384343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102199841|NCT02384343|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102199842|NCT02384343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102199843|NCT02384343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102199844|NCT02384343|Adrenergic Agents|adrenergic agents|mesh-ancestor
102199845|NCT02384343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102199846|NCT02384343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199847|NCT05033639|Melatonin|melatonin|mesh-list
102199848|NCT05033639|Antioxidants|antioxidants|mesh-ancestor
102199849|NCT05033639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199850|NCT05033639|Protective Agents|protective agents|mesh-ancestor
102199851|NCT05033639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199852|NCT05033639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102199853|NCT02328040|Insulin|insulin|mesh-list
102199854|NCT02328040|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102199855|NCT02328040|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102199856|NCT02328040|Insulin Aspart|insulin aspart|mesh-list
102199857|NCT02328040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102199858|NCT02328040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199859|NCT02328040|Incretins|incretins|mesh-ancestor
102199860|NCT02328040|Hormones|hormones|mesh-ancestor
102199861|NCT02328040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102199862|NCT02328040|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101908628|NCT01357486|Pravastatin|pravastatin|mesh-list
102199863|NCT02328040|Protease Inhibitors|protease inhibitors|mesh-ancestor
102199864|NCT02328040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102199865|NCT02328040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199866|NCT00355849|Insulin|insulin|mesh-list
102199867|NCT00355849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102199868|NCT00355849|Insulin Glargine|insulin glargine|mesh-list
102199869|NCT00355849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102199870|NCT00355849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199871|NCT02384499|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102199872|NCT02384499|Hemostatics|hemostatics|mesh-ancestor
102199873|NCT02384499|Coagulants|coagulants|mesh-ancestor
102199874|NCT02186951|Amoxicillin|amoxicillin|mesh-list
102199875|NCT02186951|Clavulanic Acids|clavulanic acids|mesh-list
102199876|NCT02186951|Clavulanic Acid|clavulanic acid|mesh-list
102199877|NCT02186951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102199878|NCT02186951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102199879|NCT02186951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102199880|NCT02186951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199881|NCT02186951|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102199882|NCT02285413|Cisplatin|cisplatin|mesh-list
102199883|NCT02285413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102199884|NCT02381379|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102199885|NCT02381379|Antiviral Agents|antiviral agents|mesh-ancestor
102199886|NCT02381379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102199887|NCT02187107|Darunavir|darunavir|mesh-list
102199888|NCT02187107|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102199889|NCT02187107|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102199890|NCT02187107|Protease Inhibitors|protease inhibitors|mesh-ancestor
102199891|NCT02187107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102199892|NCT02187107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199893|NCT02187107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102199894|NCT02187107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102199895|NCT02187107|Antiviral Agents|antiviral agents|mesh-ancestor
102199896|NCT02187107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102199897|NCT02285491|Bupivacaine|bupivacaine|mesh-list
102199898|NCT02285491|Anesthetics, Local|anesthetics, local|mesh-ancestor
102199899|NCT02285491|Anesthetics|anesthetics|mesh-ancestor
102199900|NCT02285491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102199901|NCT02285491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199902|NCT02285491|Sensory System Agents|sensory system agents|mesh-ancestor
102199903|NCT02285491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102199904|NCT02298868|Baclofen|baclofen|mesh-list
102199905|NCT02298868|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102199906|NCT02298868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199907|NCT02298868|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102199908|NCT02298868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102199909|NCT02298868|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102199910|NCT02298868|GABA Agonists|gaba agonists|mesh-ancestor
102199911|NCT02298868|GABA Agents|gaba agents|mesh-ancestor
102199912|NCT02298868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102199913|NCT02298868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199914|NCT02389179|Vitamin D|vitamin d|mesh-list
102199915|NCT02389179|Cholecalciferol|cholecalciferol|mesh-list
102199916|NCT02389179|Vitamins|vitamins|mesh-ancestor
102199917|NCT02389179|Micronutrients|micronutrients|mesh-ancestor
102199918|NCT02389179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199919|NCT02389179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101450082|NCT00222183|Dermatologic Agents|dermatologic agents|mesh-ancestor
102199920|NCT02389179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102199921|NCT02285647|Rolapitant|rolapitant|mesh-list
102199922|NCT02285647|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102199923|NCT02285647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102199924|NCT02285647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199925|NCT02285647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199926|NCT02187419|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
102199927|NCT02187419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102199928|NCT02187419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199930|NCT02187497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102199931|NCT02187497|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102199932|NCT02187497|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102199933|NCT02187497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199934|NCT04195750|Everolimus|everolimus|mesh-list
102199935|NCT04195750|Belzutifan|belzutifan|mesh-list
102199936|NCT04195750|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102199937|NCT04195750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101908704|NCT03950700|Sensory System Agents|sensory system agents|mesh-ancestor
102199939|NCT04195750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199940|NCT04195750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102199941|NCT04195750|Immunologic Factors|immunologic factors|mesh-ancestor
102199942|NCT04195750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199943|NCT04195750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102199944|NCT00099853|Pioglitazone|pioglitazone|mesh-list
102199945|NCT00099853|Vildagliptin|vildagliptin|mesh-list
102199946|NCT00099853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102199947|NCT00099853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199948|NCT00099853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102199949|NCT00099853|Protease Inhibitors|protease inhibitors|mesh-ancestor
102199950|NCT00099853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102199951|NCT00099853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199952|NCT02381145|Resveratrol|resveratrol|mesh-list
102199953|NCT02381145|Antioxidants|antioxidants|mesh-ancestor
102199954|NCT02381145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199955|NCT02381145|Protective Agents|protective agents|mesh-ancestor
102199956|NCT02381145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199957|NCT02381145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102199958|NCT02381145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102199959|NCT00097357|Enoxaparin|enoxaparin|mesh-list
102199960|NCT00097357|Warfarin|warfarin|mesh-list
102199961|NCT00097357|Enoxaparin sodium|enoxaparin sodium|mesh-list
102199962|NCT00097357|Apixaban|apixaban|mesh-list
102199963|NCT00097357|Anticoagulants|anticoagulants|mesh-ancestor
102199964|NCT00097357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102199965|NCT00097357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102199966|NCT00097357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199967|NCT00097357|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102199968|NCT00097357|Antithrombins|antithrombins|mesh-ancestor
102199969|NCT00097357|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102199970|NCT00097357|Protease Inhibitors|protease inhibitors|mesh-ancestor
102199971|NCT00097357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102199972|NCT02296840|Acetaminophen|acetaminophen|mesh-list
102199973|NCT02296840|Ibuprofen|ibuprofen|mesh-list
102199974|NCT02296840|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
102199975|NCT02296840|Hydrocodone|hydrocodone|mesh-list
102199976|NCT02296840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102199977|NCT02296840|Analgesics|analgesics|mesh-ancestor
102199978|NCT02296840|Sensory System Agents|sensory system agents|mesh-ancestor
102199979|NCT02296840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102199980|NCT02296840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102199981|NCT02296840|Antipyretics|antipyretics|mesh-ancestor
102199982|NCT02296840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102199983|NCT02296840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102199984|NCT02296840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102199985|NCT02296840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102199986|NCT02296840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102199987|NCT02296840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199988|NCT02296840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102199989|NCT02296840|Narcotics|narcotics|mesh-ancestor
102199990|NCT02296840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102199991|NCT02296840|Antitussive Agents|antitussive agents|mesh-ancestor
102199992|NCT02296840|Respiratory System Agents|respiratory system agents|mesh-ancestor
102199993|NCT02191319|Nevirapine|nevirapine|mesh-list
102199994|NCT02191319|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101741803|NCT02582892|Vitamin D|vitamin d|mesh-list
102199995|NCT02191319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102199996|NCT02191319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102199997|NCT02191319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102199998|NCT02191319|Antiviral Agents|antiviral agents|mesh-ancestor
102199999|NCT02191319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102200000|NCT02191319|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102200001|NCT02191319|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102200002|NCT02191319|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102200003|NCT02191319|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102200004|NCT02191475|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102200005|NCT02191475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102200006|NCT02191475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102200007|NCT02191475|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102200008|NCT02191475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102200009|NCT02191475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200010|NCT02191709|Dextromethorphan|dextromethorphan|mesh-list
102200011|NCT02191709|Antitussive Agents|antitussive agents|mesh-ancestor
102200012|NCT02191709|Respiratory System Agents|respiratory system agents|mesh-ancestor
102200013|NCT02191709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102200014|NCT02191709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102200015|NCT02191709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102200016|NCT02191709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200017|NCT02191709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200018|NCT00326287|Ceftriaxone|ceftriaxone|mesh-list
102200020|NCT00326287|Ceftobiprole|ceftobiprole|mesh-list
102200021|NCT00326287|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
102200022|NCT00326287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102200023|NCT00326287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102200024|NCT00326287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102200025|NCT00326287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102200026|NCT00326287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200027|NCT02191943|Fluorides|fluorides|mesh-list
102200028|NCT02191943|Fluorides, Topical|fluorides, topical|mesh-list
102200029|NCT02191943|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
102200030|NCT02191943|Cariostatic Agents|cariostatic agents|mesh-ancestor
102200031|NCT02191943|Protective Agents|protective agents|mesh-ancestor
102200032|NCT02191943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200033|NCT02663895|Treprostinil|treprostinil|mesh-list
102200034|NCT02663895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102200035|NCT00320203|Hydrocortisone|hydrocortisone|mesh-list
102200036|NCT00320203|Anecortave|anecortave|mesh-list
102200037|NCT00320203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102200038|NCT00320203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102200039|NCT00320203|Growth Substances|growth substances|mesh-ancestor
102200040|NCT00320203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200041|NCT00320203|Growth Inhibitors|growth inhibitors|mesh-ancestor
102200042|NCT00320203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102200043|NCT00320203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102200044|NCT00071461|Bosentan|bosentan|mesh-list
102200045|NCT00071461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102200046|NCT00071461|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102200047|NCT00071461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200048|NCT00069745|Prednisone|prednisone|mesh-list
102200049|NCT00069745|Satraplatin|satraplatin|mesh-list
102200050|NCT00069745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102200051|NCT00069745|Glucocorticoids|glucocorticoids|mesh-ancestor
102200052|NCT00069745|Hormones|hormones|mesh-ancestor
102200053|NCT00069745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102200054|NCT00069745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450098|NCT00411957|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102200055|NCT00069745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102200056|NCT00069745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102200057|NCT02192411|Lidocaine|lidocaine|mesh-list
102200058|NCT02192411|Anesthetics, Local|anesthetics, local|mesh-ancestor
102200059|NCT02192411|Anesthetics|anesthetics|mesh-ancestor
102200060|NCT02192411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102200061|NCT02192411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200062|NCT02192411|Sensory System Agents|sensory system agents|mesh-ancestor
102200063|NCT02192411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102200064|NCT02192411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102200065|NCT02192411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102200066|NCT02192411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102200067|NCT02192411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102200068|NCT02192411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200069|NCT02193893|Coal Tar|coal tar|mesh-list
102200070|NCT02193893|Keratolytic Agents|keratolytic agents|mesh-ancestor
102200071|NCT02193893|Dermatologic Agents|dermatologic agents|mesh-ancestor
102200072|NCT02384187|Gabapentin|gabapentin|mesh-list
102200073|NCT02384187|Analgesics|analgesics|mesh-ancestor
102200074|NCT02384187|Sensory System Agents|sensory system agents|mesh-ancestor
102200075|NCT02384187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102200076|NCT02384187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200077|NCT02384187|Anticonvulsants|anticonvulsants|mesh-ancestor
102200078|NCT02384187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102200079|NCT02384187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102200080|NCT02384187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102200081|NCT02384187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102200082|NCT02384187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102200083|NCT02384187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102200084|NCT02384187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102200085|NCT02384187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200086|NCT02384187|Antimanic Agents|antimanic agents|mesh-ancestor
102200087|NCT02192723|Olanzapine|olanzapine|mesh-list
102200088|NCT02192723|Risperidone|risperidone|mesh-list
102200089|NCT02192723|Aripiprazole|aripiprazole|mesh-list
102200090|NCT02192723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102200091|NCT02192723|Ziprasidone|ziprasidone|mesh-list
102200092|NCT02192723|Antipsychotic Agents|antipsychotic agents|mesh-list
102200093|NCT02192723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102200094|NCT02192723|Serotonin Agents|serotonin agents|mesh-ancestor
102200095|NCT02192723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102200096|NCT02192723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200097|NCT02192723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200098|NCT02192723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102200099|NCT02192723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102200100|NCT02192723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102200101|NCT02192723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102200102|NCT02192723|Dopamine Agents|dopamine agents|mesh-ancestor
102200103|NCT02192723|Antiemetics|antiemetics|mesh-ancestor
102200104|NCT02192723|Autonomic Agents|autonomic agents|mesh-ancestor
102200105|NCT02192723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102200106|NCT02192723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102200107|NCT02192723|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102200108|NCT02192723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102200109|NCT02192723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102200110|NCT02192723|Antidepressive Agents|antidepressive agents|mesh-ancestor
102200111|NCT02192723|Dopamine Agonists|dopamine agonists|mesh-ancestor
102200112|NCT02192723|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102200113|NCT02192723|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102200114|NCT02192723|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102200115|NCT02192723|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102200116|NCT00319969|Topotecan|topotecan|mesh-list
102200117|NCT00319969|Amrubicin|amrubicin|mesh-list
102200118|NCT00319969|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102200119|NCT00319969|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102200120|NCT00319969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102200121|NCT00319969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200122|NCT00319969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102200123|NCT00317395|Heparin|heparin|mesh-list
102200124|NCT00317395|Calcium heparin|calcium heparin|mesh-list
102200125|NCT00317395|Otamixaban|otamixaban|mesh-list
102200126|NCT00317395|Eptifibatide|eptifibatide|mesh-list
102200127|NCT00317395|Anticoagulants|anticoagulants|mesh-ancestor
102200128|NCT00317395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102200129|NCT00317395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102200130|NCT00317395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200131|NCT00317395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102200132|NCT00317395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102200133|NCT00317395|Antithrombins|antithrombins|mesh-ancestor
102200134|NCT00317395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102200135|NCT00317395|Protease Inhibitors|protease inhibitors|mesh-ancestor
102200136|NCT00317395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102200137|NCT02383563|Metformin|metformin|mesh-list
102200138|NCT02383563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102200139|NCT02383563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200140|NCT03535961|Etoposide|etoposide|mesh-list
102200141|NCT03535961|Apatinib|apatinib|mesh-list
102200142|NCT03535961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102200143|NCT03535961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102200144|NCT03535961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102200145|NCT03535961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102200146|NCT03535961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102200147|NCT03535961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200148|NCT03535961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102200149|NCT02380755|Clomiphene|clomiphene|mesh-list
102200150|NCT02380755|Enclomiphene|enclomiphene|mesh-list
102200151|NCT02380755|Zuclomiphene|zuclomiphene|mesh-list
102200152|NCT02380755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102200153|NCT02380755|Hormone Antagonists|hormone antagonists|mesh-ancestor
102200154|NCT02380755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102200155|NCT02380755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200156|NCT02380755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102200157|NCT02380755|Fertility Agents|fertility agents|mesh-ancestor
102200158|NCT02380755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102200159|NCT02380755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102200160|NCT02380755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102200161|NCT02188277|Botulinum Toxins|botulinum toxins|mesh-list
102200162|NCT02188277|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102200164|NCT02188277|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102200165|NCT02188277|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102200166|NCT02188277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102200167|NCT02188277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200168|NCT02188277|Cholinergic Agents|cholinergic agents|mesh-ancestor
102200169|NCT02188277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102200170|NCT02188277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200171|NCT02188277|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102200172|NCT02188277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102200173|NCT02380521|Exenatide|exenatide|mesh-list
102200174|NCT02380521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102200175|NCT02380521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200176|NCT02380521|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102200177|NCT02380521|Incretins|incretins|mesh-ancestor
102200178|NCT02380521|Hormones|hormones|mesh-ancestor
102200179|NCT02380521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102200180|NCT00315757|Bortezomib|bortezomib|mesh-list
102200181|NCT00315757|Mapatumumab|mapatumumab|mesh-list
102200182|NCT00315757|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102200183|NCT00315757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102200184|NCT00315757|Immunologic Factors|immunologic factors|mesh-ancestor
102200185|NCT00315757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200186|NCT02377401|Zanamivir|zanamivir|mesh-list
102200187|NCT02377401|Antiviral Agents|antiviral agents|mesh-ancestor
102200188|NCT02377401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102200189|NCT02377401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102200190|NCT02377401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200191|NCT00312091|Lamivudine|lamivudine|mesh-list
102200192|NCT00312091|Nevirapine|nevirapine|mesh-list
102200193|NCT00312091|Stavudine|stavudine|mesh-list
102200194|NCT00312091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102200195|NCT00312091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102200196|NCT00312091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102200197|NCT00312091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200198|NCT00312091|Antiviral Agents|antiviral agents|mesh-ancestor
102200199|NCT00312091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102200200|NCT00312091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102200201|NCT00312091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102200202|NCT00312091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102200203|NCT00312091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102200204|NCT00312091|Antimetabolites|antimetabolites|mesh-ancestor
102200205|NCT00389779|Guanfacine|guanfacine|mesh-list
102200206|NCT00389779|Darusentan|darusentan|mesh-list
102200207|NCT00389779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102200208|NCT00389779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102200209|NCT00389779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102200210|NCT00389779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102200211|NCT00389779|Adrenergic Agents|adrenergic agents|mesh-ancestor
102200212|NCT00389779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102200213|NCT00389779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200214|NCT00389779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200215|NCT00389779|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102200216|NCT00389155|Gemcitabine|gemcitabine|mesh-list
102200217|NCT00389155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102200218|NCT00389155|Antimetabolites|antimetabolites|mesh-ancestor
102200219|NCT00389155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200220|NCT00389155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102200221|NCT02188511|Nicotine|nicotine|mesh-list
102200222|NCT02188511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102200223|NCT02188511|Autonomic Agents|autonomic agents|mesh-ancestor
102200224|NCT02188511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102200225|NCT02188511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200226|NCT02188511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102200227|NCT02188511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102200228|NCT02188511|Cholinergic Agents|cholinergic agents|mesh-ancestor
102200229|NCT02188511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102200230|NCT02188511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200231|NCT02380131|Capecitabine|capecitabine|mesh-list
102200232|NCT02380131|Oxaliplatin|oxaliplatin|mesh-list
102200233|NCT02380131|Trastuzumab|trastuzumab|mesh-list
102200234|NCT02380131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102200235|NCT02380131|Antimetabolites|antimetabolites|mesh-ancestor
102200236|NCT02380131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909005|NCT00027846|Vincristine|vincristine|mesh-list
102200238|NCT02380131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102200239|NCT03535103|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102200240|NCT03535103|Hormones|hormones|mesh-ancestor
102200241|NCT03535103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102200242|NCT03535103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200243|NCT04360941|Palbociclib|palbociclib|mesh-list
102200244|NCT04360941|Avelumab|avelumab|mesh-list
102200245|NCT04360941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102200246|NCT04360941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102200247|NCT04360941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102200248|NCT04360941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200249|NCT04360941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102200250|NCT04551365|Chitosan|chitosan|mesh-list
102200251|NCT04551365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102200252|NCT04551365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102200253|NCT04551365|Antimetabolites|antimetabolites|mesh-ancestor
102200254|NCT04551365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200255|NCT04551365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102200256|NCT04551365|Chelating Agents|chelating agents|mesh-ancestor
102200257|NCT04551365|Sequestering Agents|sequestering agents|mesh-ancestor
102200258|NCT04551365|Hemostatics|hemostatics|mesh-ancestor
102200259|NCT04551365|Coagulants|coagulants|mesh-ancestor
102200260|NCT00028639|Bortezomib|bortezomib|mesh-list
102200261|NCT00028639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102200262|NCT02371941|Cromolyn Sodium|cromolyn sodium|mesh-list
102200263|NCT02371941|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
102200264|NCT02371941|Immunologic Factors|immunologic factors|mesh-ancestor
102200265|NCT02371941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200266|NCT02371941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102200267|NCT02371941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102200268|NCT02371941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102200269|NCT02371941|Respiratory System Agents|respiratory system agents|mesh-ancestor
102200270|NCT00298987|Dasatinib|dasatinib|mesh-list
102200271|NCT00298987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102200272|NCT00298987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102200273|NCT00298987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102200274|NCT00298987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200275|NCT02380053|Celiprolol|celiprolol|mesh-list
102200276|NCT02380053|Bisoprolol|bisoprolol|mesh-list
102200277|NCT02380053|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102200278|NCT02380053|Sympatholytics|sympatholytics|mesh-ancestor
102200279|NCT02380053|Autonomic Agents|autonomic agents|mesh-ancestor
102200280|NCT02380053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102200281|NCT02380053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200282|NCT02380053|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102200283|NCT02380053|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102200284|NCT02380053|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102200285|NCT02380053|Adrenergic Agents|adrenergic agents|mesh-ancestor
102200286|NCT02380053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102200287|NCT02380053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200288|NCT02380053|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102200289|NCT02380053|Sympathomimetics|sympathomimetics|mesh-ancestor
102200290|NCT02380053|Vasodilator Agents|vasodilator agents|mesh-ancestor
102200291|NCT02371707|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
102200292|NCT02371707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102200293|NCT02371707|Serotonin Agents|serotonin agents|mesh-ancestor
102200294|NCT02371707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102200295|NCT02371707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200296|NCT02371707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200297|NCT02193971|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102200298|NCT02193971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102200299|NCT00004915|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
102200300|NCT00004915|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102200301|NCT00004915|Hormone Antagonists|hormone antagonists|mesh-ancestor
102200302|NCT00004915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102200303|NCT00004915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200304|NCT00004915|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102200305|NCT00004915|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102200306|NCT00004915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101909080|NCT00026208|Immunologic Factors|immunologic factors|mesh-ancestor
102200308|NCT03535415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102200309|NCT03535415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200310|NCT02030717|Clonidine|clonidine|mesh-list
102200311|NCT02030717|Anesthetics|anesthetics|mesh-list
102200312|NCT02030717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102200313|NCT02030717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200314|NCT02030717|Analgesics|analgesics|mesh-ancestor
102200315|NCT02030717|Sensory System Agents|sensory system agents|mesh-ancestor
102200316|NCT02030717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102200317|NCT02030717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102200318|NCT02030717|Sympatholytics|sympatholytics|mesh-ancestor
102200319|NCT02030717|Autonomic Agents|autonomic agents|mesh-ancestor
102200320|NCT02030717|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102200321|NCT02030717|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102200322|NCT02030717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102200323|NCT02030717|Adrenergic Agents|adrenergic agents|mesh-ancestor
102200324|NCT02030717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102200325|NCT02030717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200326|NCT02371473|Acetazolamide|acetazolamide|mesh-list
102200327|NCT02371473|Anticonvulsants|anticonvulsants|mesh-ancestor
102200328|NCT02371473|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102200329|NCT02371473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102200330|NCT02371473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200331|NCT02371473|Diuretics|diuretics|mesh-ancestor
102200332|NCT02371473|Natriuretic Agents|natriuretic agents|mesh-ancestor
102200333|NCT02371473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200334|NCT04301661|Tenofovir|tenofovir|mesh-list
102200335|NCT04301661|Lamivudine|lamivudine|mesh-list
102200336|NCT04301661|Emtricitabine|emtricitabine|mesh-list
102200337|NCT04301661|Abacavir|abacavir|mesh-list
102200338|NCT04301661|Antiviral Agents|antiviral agents|mesh-ancestor
102200339|NCT04301661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102200340|NCT04301661|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102200341|NCT04301661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102200342|NCT04301661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102200343|NCT04301661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200344|NCT04301661|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102200345|NCT04301661|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102200346|NCT02194049|Etoposide|etoposide|mesh-list
102200347|NCT02194049|Etoposide phosphate|etoposide phosphate|mesh-list
102200348|NCT02194049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102200349|NCT02194049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102200350|NCT02194049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102200351|NCT02194049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102200352|NCT02194049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102200353|NCT02194049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200354|NCT02379663|Enoxaparin|enoxaparin|mesh-list
102200355|NCT02379663|Rivaroxaban|rivaroxaban|mesh-list
102200356|NCT02379663|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102200357|NCT02379663|Antithrombins|antithrombins|mesh-ancestor
102200358|NCT02379663|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102200359|NCT02379663|Protease Inhibitors|protease inhibitors|mesh-ancestor
102200360|NCT02379663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101742167|NCT00732693|Progestins|progestins|mesh-ancestor
102200361|NCT02379663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200362|NCT02379663|Anticoagulants|anticoagulants|mesh-ancestor
102200363|NCT02379663|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102200364|NCT02379663|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102200365|NCT02030639|ON 01910|on 01910|mesh-list
102200366|NCT02030639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102200367|NCT02030639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102200368|NCT02030639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102200369|NCT02030639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200370|NCT00004897|Leucovorin|leucovorin|mesh-list
102200371|NCT00004897|Interferons|interferons|mesh-list
102200372|NCT00004897|Interferon-alpha|interferon-alpha|mesh-list
102200373|NCT00004897|Fluorouracil|fluorouracil|mesh-list
102200374|NCT00004897|Hydroxyurea|hydroxyurea|mesh-list
102200375|NCT00004897|Calcium|calcium|mesh-list
102200376|NCT00004897|Levoleucovorin|levoleucovorin|mesh-list
102200377|NCT00004897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102200378|NCT00004897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102200379|NCT00004897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200380|NCT00004897|Antimetabolites|antimetabolites|mesh-ancestor
102200381|NCT00004897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200382|NCT00004897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102200383|NCT00004897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102200384|NCT00004897|Immunologic Factors|immunologic factors|mesh-ancestor
102200385|NCT00004897|Antiviral Agents|antiviral agents|mesh-ancestor
102200386|NCT00004897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102200388|NCT00004897|Protective Agents|protective agents|mesh-ancestor
102200389|NCT00004897|Vitamin B Complex|vitamin b complex|mesh-ancestor
102200390|NCT00004897|Vitamins|vitamins|mesh-ancestor
102200391|NCT00004897|Micronutrients|micronutrients|mesh-ancestor
102200392|NCT00004897|Antisickling Agents|antisickling agents|mesh-ancestor
102200393|NCT00004897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102200394|NCT00004897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102200395|NCT00004231|Leucovorin|leucovorin|mesh-list
102200396|NCT00004231|Interferons|interferons|mesh-list
102200397|NCT00004231|Cytarabine|cytarabine|mesh-list
102200398|NCT00004231|Interferon-alpha|interferon-alpha|mesh-list
102200399|NCT00004231|Aldesleukin|aldesleukin|mesh-list
102200400|NCT00004231|Prednisone|prednisone|mesh-list
102200401|NCT00004231|Cyclophosphamide|cyclophosphamide|mesh-list
102200402|NCT00004231|Busulfan|busulfan|mesh-list
102200403|NCT00004231|Doxorubicin|doxorubicin|mesh-list
102200404|NCT00004231|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102200405|NCT00004231|Methotrexate|methotrexate|mesh-list
102200406|NCT00004231|Vincristine|vincristine|mesh-list
102200407|NCT00004231|Teniposide|teniposide|mesh-list
102200408|NCT00004231|Levoleucovorin|levoleucovorin|mesh-list
102200409|NCT00004231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102200410|NCT00004231|Immunologic Factors|immunologic factors|mesh-ancestor
102200411|NCT00004231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200412|NCT00004231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102200413|NCT00004231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102200414|NCT00004231|Alkylating Agents|alkylating agents|mesh-ancestor
102200415|NCT00004231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200416|NCT00004231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102200417|NCT00004231|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102200418|NCT00004231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102200419|NCT00004231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102200420|NCT00004231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102200421|NCT00004231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102200422|NCT00004231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102200423|NCT00004231|Glucocorticoids|glucocorticoids|mesh-ancestor
102200424|NCT00004231|Hormones|hormones|mesh-ancestor
102200425|NCT00004231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102200426|NCT00004231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102200427|NCT00004231|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102200428|NCT00004231|Abortifacient Agents|abortifacient agents|mesh-ancestor
102200429|NCT00004231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102200430|NCT00004231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102200431|NCT00004231|Antimetabolites|antimetabolites|mesh-ancestor
102200432|NCT00004231|Dermatologic Agents|dermatologic agents|mesh-ancestor
102200433|NCT00004231|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102200434|NCT00004231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102200435|NCT00004231|Antiviral Agents|antiviral agents|mesh-ancestor
102200436|NCT00004231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102200437|NCT00004231|Antidotes|antidotes|mesh-ancestor
102200438|NCT00004231|Protective Agents|protective agents|mesh-ancestor
102200439|NCT00004231|Vitamin B Complex|vitamin b complex|mesh-ancestor
102200440|NCT00004231|Vitamins|vitamins|mesh-ancestor
102200441|NCT00004231|Micronutrients|micronutrients|mesh-ancestor
102200442|NCT00004231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102200443|NCT00004231|Tubulin Modulators|tubulin modulators|mesh-ancestor
102200444|NCT00004231|Antimitotic Agents|antimitotic agents|mesh-ancestor
102200445|NCT00004231|Mitosis Modulators|mitosis modulators|mesh-ancestor
102200446|NCT00004231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102200447|NCT00004231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102200448|NCT00004171|Cyclophosphamide|cyclophosphamide|mesh-list
102200449|NCT00004171|Busulfan|busulfan|mesh-list
102200450|NCT00004171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102200451|NCT00004171|Immunologic Factors|immunologic factors|mesh-ancestor
102200452|NCT00004171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200453|NCT00004171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102200454|NCT00004171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102200455|NCT00004171|Alkylating Agents|alkylating agents|mesh-ancestor
102200456|NCT00004171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200457|NCT00004171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102200458|NCT00004171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101909230|NCT01584726|Anesthetics|anesthetics|mesh-ancestor
102200459|NCT00004165|Melphalan|melphalan|mesh-list
102200460|NCT00004165|Immunologic Factors|immunologic factors|mesh-ancestor
102200461|NCT00004165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200462|NCT00004165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102200463|NCT00004165|Alkylating Agents|alkylating agents|mesh-ancestor
102200464|NCT00004165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200465|NCT00004165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102200466|NCT00004165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102200467|NCT00004165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102200468|NCT00004093|Paclitaxel|paclitaxel|mesh-list
102200469|NCT00004093|Vinorelbine|vinorelbine|mesh-list
102200470|NCT00004093|Carboplatin|carboplatin|mesh-list
102200471|NCT00004093|Gemcitabine|gemcitabine|mesh-list
102200472|NCT00004093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102200473|NCT00004093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102200474|NCT00004093|Tubulin Modulators|tubulin modulators|mesh-ancestor
102200475|NCT00004093|Antimitotic Agents|antimitotic agents|mesh-ancestor
102200476|NCT00004093|Mitosis Modulators|mitosis modulators|mesh-ancestor
102200477|NCT00004093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200478|NCT00004093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102200479|NCT00004093|Antimetabolites|antimetabolites|mesh-ancestor
102200480|NCT02193269|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102200481|NCT02193269|Minocycline|minocycline|mesh-list
102200482|NCT02193269|Tetracycline|tetracycline|mesh-list
102200483|NCT02193269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102200484|NCT02193269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102200485|NCT02193269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102200486|NCT02193269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200487|NCT00002479|Tretinoin|tretinoin|mesh-list
102200488|NCT00002479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102200489|NCT00002479|Keratolytic Agents|keratolytic agents|mesh-ancestor
102200490|NCT00002479|Dermatologic Agents|dermatologic agents|mesh-ancestor
102200491|NCT00002371|Lamivudine|lamivudine|mesh-list
102200492|NCT00002371|Zidovudine|zidovudine|mesh-list
102200493|NCT00002371|Stavudine|stavudine|mesh-list
102200494|NCT00002371|Indinavir|indinavir|mesh-list
102200495|NCT00002371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102200496|NCT00002371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102200497|NCT00002371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102200498|NCT00002371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200499|NCT00002371|Antiviral Agents|antiviral agents|mesh-ancestor
102200500|NCT00002371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102200501|NCT00002371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102200502|NCT00002371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102200503|NCT00002371|Antimetabolites|antimetabolites|mesh-ancestor
102200504|NCT00002371|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102200505|NCT00002371|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102200506|NCT00002371|Protease Inhibitors|protease inhibitors|mesh-ancestor
102200507|NCT02189681|Anesthetics|anesthetics|mesh-list
102200508|NCT02189681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102200509|NCT02189681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200510|NCT05715385|Bromfenac|bromfenac|mesh-list
102200511|NCT05715385|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102200512|NCT05715385|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102200513|NCT05715385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102200514|NCT05715385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102200515|NCT05715385|Analgesics|analgesics|mesh-ancestor
102200516|NCT05715385|Sensory System Agents|sensory system agents|mesh-ancestor
102200517|NCT05715385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102200518|NCT05715385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200519|NCT05715385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102200520|NCT05715385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102200521|NCT04182633|Vancomycin|vancomycin|mesh-list
102200522|NCT04182633|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
102200523|NCT04182633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102200524|NCT04182633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102200525|NCT04182633|Laxatives|laxatives|mesh-ancestor
102200526|NCT04182633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102200527|NCT02194283|Ambroxol|ambroxol|mesh-list
102200528|NCT02194283|Expectorants|expectorants|mesh-ancestor
102200529|NCT02194283|Respiratory System Agents|respiratory system agents|mesh-ancestor
102200530|NCT00263341|Contraceptive Agents|contraceptive agents|mesh-list
102200531|NCT00263341|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102200532|NCT00263341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102200533|NCT00263341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200534|NCT00263341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102200535|NCT00263341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102200536|NCT00263341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102200537|NCT00263341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102200538|NCT00263341|Estrogens|estrogens|mesh-ancestor
102200539|NCT00263341|Hormones|hormones|mesh-ancestor
102200540|NCT00263341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102200541|NCT03534869|Analgesics|analgesics|mesh-list
102200542|NCT03534869|Sensory System Agents|sensory system agents|mesh-ancestor
102200543|NCT03534869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102200544|NCT03534869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200545|NCT02370849|Nimotuzumab|nimotuzumab|mesh-list
102200546|NCT02370849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102200547|NCT02370849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102200548|NCT02378649|Sildenafil Citrate|sildenafil citrate|mesh-list
102200549|NCT02378649|Vasodilator Agents|vasodilator agents|mesh-ancestor
102200550|NCT02378649|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102200551|NCT02378649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102200552|NCT02378649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102200553|NCT02378649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200554|NCT02378649|Urological Agents|urological agents|mesh-ancestor
102200555|NCT02197169|Interferons|interferons|mesh-list
102200556|NCT02197169|Interferon-gamma|interferon-gamma|mesh-list
102200557|NCT02197169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102200558|NCT02197169|Antiviral Agents|antiviral agents|mesh-ancestor
102200559|NCT02197169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102200560|NCT02376309|Nandrolone|nandrolone|mesh-list
102200561|NCT02376309|Androgens|androgens|mesh-ancestor
102200562|NCT02376309|Hormones|hormones|mesh-ancestor
102200563|NCT02376309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102200564|NCT02376309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200565|NCT02376309|Anabolic Agents|anabolic agents|mesh-ancestor
102200566|NCT00232141|Pregabalin|pregabalin|mesh-list
102200567|NCT00232141|Analgesics|analgesics|mesh-ancestor
102200568|NCT00232141|Sensory System Agents|sensory system agents|mesh-ancestor
102200569|NCT00232141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102200570|NCT00232141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200571|NCT00232141|Anticonvulsants|anticonvulsants|mesh-ancestor
102200572|NCT00232141|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102200573|NCT00232141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102200574|NCT00232141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200575|NCT00232141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102200576|NCT00232141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102200577|NCT00232141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102200578|NCT00232141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102200579|NCT00232141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102200580|NCT02378415|Ketamine|ketamine|mesh-list
102200581|NCT02378415|Analgesics|analgesics|mesh-ancestor
102200582|NCT02378415|Sensory System Agents|sensory system agents|mesh-ancestor
102200583|NCT02378415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102200584|NCT02378415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200585|NCT02378415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102200586|NCT02378415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102200587|NCT02378415|Anesthetics, General|anesthetics, general|mesh-ancestor
102200588|NCT02378415|Anesthetics|anesthetics|mesh-ancestor
102200589|NCT02378415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102200590|NCT02378415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102200591|NCT02378415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102200592|NCT02378415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102200593|NCT02378415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200594|NCT02197403|Dexmedetomidine|dexmedetomidine|mesh-list
102200595|NCT02197403|Propofol|propofol|mesh-list
102200596|NCT02197403|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102200597|NCT02197403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102200598|NCT02197403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200599|NCT02197403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102200600|NCT02197403|Analgesics|analgesics|mesh-ancestor
102200601|NCT02197403|Sensory System Agents|sensory system agents|mesh-ancestor
102200602|NCT02197403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102200603|NCT02197403|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102200604|NCT02197403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102200605|NCT02197403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102200606|NCT02197403|Adrenergic Agents|adrenergic agents|mesh-ancestor
102200607|NCT02197403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102200608|NCT02197403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200609|NCT02197403|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102200610|NCT02197403|Anesthetics, General|anesthetics, general|mesh-ancestor
102200611|NCT02197403|Anesthetics|anesthetics|mesh-ancestor
102200612|NCT02370069|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101909378|NCT00233987|Melphalan|melphalan|mesh-list
102200613|NCT02370069|Immunologic Factors|immunologic factors|mesh-ancestor
102200614|NCT02370069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200615|NCT03534713|Paclitaxel|paclitaxel|mesh-list
102200616|NCT03534713|Carboplatin|carboplatin|mesh-list
102200617|NCT03534713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102200618|NCT03534713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102200619|NCT03534713|Tubulin Modulators|tubulin modulators|mesh-ancestor
102200620|NCT03534713|Antimitotic Agents|antimitotic agents|mesh-ancestor
102200621|NCT03534713|Mitosis Modulators|mitosis modulators|mesh-ancestor
102200622|NCT03534713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200623|NCT02376075|Linagliptin|linagliptin|mesh-list
102200624|NCT02376075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102200625|NCT02376075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200626|NCT02376075|Incretins|incretins|mesh-ancestor
102200627|NCT02376075|Hormones|hormones|mesh-ancestor
102200628|NCT02376075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102200629|NCT02376075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102200630|NCT02376075|Protease Inhibitors|protease inhibitors|mesh-ancestor
102200631|NCT02376075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102200632|NCT02376075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200633|NCT02197637|Vinorelbine|vinorelbine|mesh-list
102200634|NCT02197637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102200635|NCT02197637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102200636|NCT02197637|Tubulin Modulators|tubulin modulators|mesh-ancestor
102200637|NCT02197637|Antimitotic Agents|antimitotic agents|mesh-ancestor
102200638|NCT02197637|Mitosis Modulators|mitosis modulators|mesh-ancestor
102200639|NCT02197637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200640|NCT04469413|Acetaminophen|acetaminophen|mesh-list
102200641|NCT04469413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102200642|NCT04469413|Analgesics|analgesics|mesh-ancestor
102200643|NCT04469413|Sensory System Agents|sensory system agents|mesh-ancestor
102200644|NCT04469413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102200645|NCT04469413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200646|NCT04469413|Antipyretics|antipyretics|mesh-ancestor
102200647|NCT03532087|Denosumab|denosumab|mesh-list
102200648|NCT03532087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102200649|NCT03532087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200650|NCT02288923|Acetaminophen|acetaminophen|mesh-list
102200651|NCT02288923|Ibuprofen|ibuprofen|mesh-list
102200652|NCT02288923|Morphine|morphine|mesh-list
102200653|NCT02288923|Antiemetics|antiemetics|mesh-list
102200654|NCT02288923|Anesthetics|anesthetics|mesh-list
102200655|NCT02288923|Emetics|emetics|mesh-list
102200656|NCT02288923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102200657|NCT02288923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200658|NCT02288923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102200659|NCT02288923|Narcotics|narcotics|mesh-ancestor
102200660|NCT02288923|Analgesics|analgesics|mesh-ancestor
102200661|NCT02288923|Sensory System Agents|sensory system agents|mesh-ancestor
102200662|NCT02288923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102200663|NCT02288923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102200664|NCT02288923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102200665|NCT02288923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102200666|NCT02288923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102200667|NCT02288923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102200668|NCT02288923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102200669|NCT02288923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200670|NCT02288923|Antipyretics|antipyretics|mesh-ancestor
102200671|NCT02288923|Autonomic Agents|autonomic agents|mesh-ancestor
102200672|NCT02288923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102200673|NCT02195375|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102200674|NCT02195375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102200675|NCT02195375|Autonomic Agents|autonomic agents|mesh-ancestor
102200676|NCT02195375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102200677|NCT02195375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200678|NCT02195375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102200679|NCT02195375|Respiratory System Agents|respiratory system agents|mesh-ancestor
102200680|NCT02195375|Glucocorticoids|glucocorticoids|mesh-ancestor
102200681|NCT02195375|Hormones|hormones|mesh-ancestor
102200682|NCT02195375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102200683|NCT02195375|Sympathomimetics|sympathomimetics|mesh-ancestor
102200684|NCT03531931|Apatinib|apatinib|mesh-list
102200685|NCT03531931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102200686|NCT03531931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101909453|NCT05321394|Protease Inhibitors|protease inhibitors|mesh-ancestor
102200687|NCT03531931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102200688|NCT03531931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200689|NCT03601455|Durvalumab|durvalumab|mesh-list
102200690|NCT03601455|Ipilimumab|ipilimumab|mesh-list
102200691|NCT03601455|Tremelimumab|tremelimumab|mesh-list
102200692|NCT03601455|Immunoglobulins|immunoglobulins|mesh-list
102200693|NCT03601455|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102200694|NCT03601455|Immunoglobulin G|immunoglobulin g|mesh-list
102200695|NCT03601455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102200696|NCT03601455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102200697|NCT03601455|Immunologic Factors|immunologic factors|mesh-ancestor
102200698|NCT03601455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200699|NCT03601455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102200700|NCT03601455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200701|NCT03531697|Loteprednol Etabonate|loteprednol etabonate|mesh-list
102200702|NCT03531697|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102200703|NCT02369133|Acetaminophen|acetaminophen|mesh-list
102200704|NCT02369133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102200705|NCT02369133|Analgesics|analgesics|mesh-ancestor
102200706|NCT02369133|Sensory System Agents|sensory system agents|mesh-ancestor
102200707|NCT02369133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102200708|NCT02369133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200709|NCT02369133|Antipyretics|antipyretics|mesh-ancestor
102200710|NCT02377635|Selenious Acid|selenious acid|mesh-list
102200711|NCT02377635|Sodium Selenite|sodium selenite|mesh-list
102200712|NCT02377635|Trace Elements|trace elements|mesh-ancestor
102200713|NCT02377635|Micronutrients|micronutrients|mesh-ancestor
102200714|NCT02377635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200715|NCT03534479|Immunoglobulins|immunoglobulins|mesh-list
102200716|NCT03534479|Immunologic Factors|immunologic factors|mesh-ancestor
102200717|NCT03534479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200718|NCT02198027|Bupivacaine|bupivacaine|mesh-list
102200719|NCT02198027|Anesthetics, Local|anesthetics, local|mesh-ancestor
102200720|NCT02198027|Anesthetics|anesthetics|mesh-ancestor
102200721|NCT02198027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102200722|NCT02198027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200723|NCT02198027|Sensory System Agents|sensory system agents|mesh-ancestor
102200724|NCT02198027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102200725|NCT02257463|Theophylline|theophylline|mesh-list
102200726|NCT02257463|Bronchodilator Agents|bronchodilator agents|mesh-list
102200727|NCT02257463|Autonomic Agents|autonomic agents|mesh-ancestor
102200728|NCT02257463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102200729|NCT02257463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200730|NCT02257463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102200731|NCT02257463|Respiratory System Agents|respiratory system agents|mesh-ancestor
102200732|NCT02257463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102200733|NCT02257463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200734|NCT02257463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102200735|NCT02257463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102200736|NCT02257463|Vasodilator Agents|vasodilator agents|mesh-ancestor
102200737|NCT02257463|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102200738|NCT02257463|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102200739|NCT02257463|Purinergic Agents|purinergic agents|mesh-ancestor
102200741|NCT02198261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102200742|NCT02198261|Vasodilator Agents|vasodilator agents|mesh-ancestor
102200743|NCT03533699|Propranolol|propranolol|mesh-list
102200744|NCT03533699|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102200745|NCT03533699|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102200746|NCT03533699|Adrenergic Agents|adrenergic agents|mesh-ancestor
102200747|NCT03533699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102200748|NCT03533699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200749|NCT03533699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200750|NCT03533699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102200751|NCT03533699|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102200752|NCT03533699|Vasodilator Agents|vasodilator agents|mesh-ancestor
102200753|NCT00135421|Escitalopram|escitalopram|mesh-list
102200754|NCT00135421|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102200755|NCT00135421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102200756|NCT00135421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102200757|NCT00135421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200758|NCT00135421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102200759|NCT00135421|Serotonin Agents|serotonin agents|mesh-ancestor
102200760|NCT00135421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200761|NCT02200991|Insulin Glargine|insulin glargine|mesh-list
101909570|NCT03764462|AD 101|ad 101|mesh-list
102200762|NCT02200991|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102200764|NCT02200991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102200765|NCT02200991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200766|NCT02200991|Incretins|incretins|mesh-ancestor
102200767|NCT02200991|Hormones|hormones|mesh-ancestor
102200768|NCT02200991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102200769|NCT02200991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102200770|NCT02200991|Protease Inhibitors|protease inhibitors|mesh-ancestor
102200771|NCT02200991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102200772|NCT02200991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200773|NCT01979367|Analgesics|analgesics|mesh-list
102200774|NCT01979367|Sensory System Agents|sensory system agents|mesh-ancestor
102200775|NCT01979367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102200776|NCT01979367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200777|NCT02368743|Mesalamine|mesalamine|mesh-list
102200778|NCT02368743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102200779|NCT02368743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102200780|NCT02368743|Analgesics|analgesics|mesh-ancestor
102200781|NCT02368743|Sensory System Agents|sensory system agents|mesh-ancestor
102200782|NCT02368743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102200783|NCT02368743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200784|NCT02368743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102200785|NCT02368743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102200786|NCT00135343|Ritonavir|ritonavir|mesh-list
102200787|NCT00135343|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102200788|NCT00135343|Efavirenz|efavirenz|mesh-list
102200789|NCT00135343|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102200790|NCT00135343|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102200791|NCT00135343|Protease Inhibitors|protease inhibitors|mesh-ancestor
102200792|NCT00135343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102200793|NCT00135343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200794|NCT00135343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102200795|NCT00135343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102200796|NCT00135343|Antiviral Agents|antiviral agents|mesh-ancestor
102200797|NCT00135343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102200798|NCT00135343|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102200799|NCT00135343|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102200800|NCT00135343|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102200801|NCT00135343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102200802|NCT00135343|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102200803|NCT00135343|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102200804|NCT00135343|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102200805|NCT00135343|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102200806|NCT00135343|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102200807|NCT02201225|Micronutrients|micronutrients|mesh-list
102200808|NCT02201225|Trace Elements|trace elements|mesh-list
102200809|NCT02201225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200810|NCT02365155|Vitamin D|vitamin d|mesh-list
102200811|NCT02365155|Vitamins|vitamins|mesh-ancestor
102200812|NCT02365155|Micronutrients|micronutrients|mesh-ancestor
102200813|NCT02365155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200814|NCT02365155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102200815|NCT05724745|Albuterol|albuterol|mesh-list
102200816|NCT05724745|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102200817|NCT05724745|Autonomic Agents|autonomic agents|mesh-ancestor
102200818|NCT05724745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102200819|NCT05724745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200820|NCT05724745|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102200821|NCT05724745|Respiratory System Agents|respiratory system agents|mesh-ancestor
102200822|NCT05724745|Tocolytic Agents|tocolytic agents|mesh-ancestor
102200823|NCT05724745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102200824|NCT05724745|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102200825|NCT05724745|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102200826|NCT05724745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102200827|NCT05724745|Adrenergic Agents|adrenergic agents|mesh-ancestor
102200828|NCT05724745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102200829|NCT05724745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200830|NCT02198339|Olcegepant|olcegepant|mesh-list
102200831|NCT02198339|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
102200832|NCT02198339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200833|NCT02198339|Analgesics|analgesics|mesh-ancestor
102200834|NCT02198339|Sensory System Agents|sensory system agents|mesh-ancestor
102200835|NCT02198339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102200836|NCT02198339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200837|NCT02198807|Piperaquine|piperaquine|mesh-list
102200838|NCT02198807|Fosmidomycin|fosmidomycin|mesh-list
102200839|NCT02198807|Antimalarials|antimalarials|mesh-ancestor
102200840|NCT02198807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102200841|NCT02198807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102200842|NCT02198807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102200843|NCT02198807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102200844|NCT02198417|Metformin|metformin|mesh-list
102200845|NCT02198417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102200846|NCT02198417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200847|NCT02201459|Interferons|interferons|mesh-list
102200848|NCT02201459|Interferon-alpha|interferon-alpha|mesh-list
102200849|NCT02201459|Interferon alpha-2|interferon alpha-2|mesh-list
102200850|NCT02201459|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102200851|NCT02201459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102200852|NCT02201459|Antiviral Agents|antiviral agents|mesh-ancestor
102200853|NCT02201459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102200854|NCT02201459|Immunologic Factors|immunologic factors|mesh-ancestor
102200855|NCT02201459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200856|NCT05724589|Mitogens|mitogens|mesh-list
102200857|NCT05724589|Mitosis Modulators|mitosis modulators|mesh-ancestor
102200858|NCT05724589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200859|NCT02198495|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102200860|NCT02198495|Hematinics|hematinics|mesh-ancestor
102200861|NCT02201849|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102200862|NCT02201849|Dermatologic Agents|dermatologic agents|mesh-ancestor
102200863|NCT02201849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102200864|NCT02201849|Immunologic Factors|immunologic factors|mesh-ancestor
102200865|NCT02201849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200866|NCT02375217|Glycopyrrolate|glycopyrrolate|mesh-list
102200867|NCT02375217|Neostigmine|neostigmine|mesh-list
102200868|NCT02375217|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102200869|NCT02375217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102200870|NCT02375217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200871|NCT02375217|Cholinergic Agents|cholinergic agents|mesh-ancestor
102200872|NCT02375217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102200873|NCT02375217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200874|NCT02375217|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102200875|NCT02375217|Autonomic Agents|autonomic agents|mesh-ancestor
102200876|NCT02375217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102200877|NCT02375217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102200878|NCT02375217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102200879|NCT02375217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102200880|NCT02206295|Selexipag|selexipag|mesh-list
102200881|NCT02206295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102200883|NCT02375139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102200884|NCT02375139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200885|NCT02202005|Nevirapine|nevirapine|mesh-list
102200886|NCT02202005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102200887|NCT02202005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102200888|NCT02202005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102200889|NCT02202005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200890|NCT02202005|Antiviral Agents|antiviral agents|mesh-ancestor
102200891|NCT02202005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102200892|NCT02202005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102200893|NCT02202005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102200894|NCT02202005|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102200895|NCT02202005|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102200896|NCT02741245|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102200897|NCT02741245|Ezetimibe|ezetimibe|mesh-list
102200898|NCT02741245|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102200899|NCT02741245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102200900|NCT02741245|Antimetabolites|antimetabolites|mesh-ancestor
102200901|NCT02741245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200902|NCT02741245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102200903|NCT02741245|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102200904|NCT02741245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102200905|NCT02202239|Fentanyl|fentanyl|mesh-list
102200906|NCT02202239|Midazolam|midazolam|mesh-list
102200907|NCT02202239|Remifentanil|remifentanil|mesh-list
102200908|NCT02202239|Propofol|propofol|mesh-list
102200909|NCT02202239|Etomidate|etomidate|mesh-list
102200910|NCT02202239|Sevoflurane|sevoflurane|mesh-list
101909676|NCT01356862|Hormones|hormones|mesh-ancestor
102200911|NCT02202239|Cisatracurium|cisatracurium|mesh-list
102200912|NCT02202239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102200913|NCT02202239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102200914|NCT02202239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200915|NCT02202239|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102200916|NCT02202239|Anesthetics, General|anesthetics, general|mesh-ancestor
102200917|NCT02202239|Anesthetics|anesthetics|mesh-ancestor
102200918|NCT02202239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102200919|NCT02202239|Narcotics|narcotics|mesh-ancestor
102200920|NCT02202239|Analgesics|analgesics|mesh-ancestor
102200921|NCT02202239|Sensory System Agents|sensory system agents|mesh-ancestor
102200922|NCT02202239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102200923|NCT02202239|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102200924|NCT02202239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102200925|NCT02202239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102200926|NCT02202239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102200927|NCT02202239|GABA Modulators|gaba modulators|mesh-ancestor
102200928|NCT02202239|GABA Agents|gaba agents|mesh-ancestor
102200929|NCT02202239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102200930|NCT02202239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200931|NCT02202239|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102200932|NCT02202239|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102200933|NCT02202239|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102200934|NCT02202239|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102200935|NCT02368197|Paclitaxel|paclitaxel|mesh-list
102200936|NCT02368197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102200937|NCT02368197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102200938|NCT02368197|Tubulin Modulators|tubulin modulators|mesh-ancestor
102200939|NCT02368197|Antimitotic Agents|antimitotic agents|mesh-ancestor
102200940|NCT02368197|Mitosis Modulators|mitosis modulators|mesh-ancestor
102200941|NCT02368197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200942|NCT02364765|Remifentanil|remifentanil|mesh-list
102200943|NCT02364765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102200944|NCT02364765|Narcotics|narcotics|mesh-ancestor
102200945|NCT02364765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102200946|NCT02364765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200947|NCT02364765|Analgesics|analgesics|mesh-ancestor
102200948|NCT02364765|Sensory System Agents|sensory system agents|mesh-ancestor
102200949|NCT02364765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102200950|NCT03529201|Fentanyl|fentanyl|mesh-list
102200951|NCT03529201|Oxycodone|oxycodone|mesh-list
102200952|NCT03529201|Sevoflurane|sevoflurane|mesh-list
102200953|NCT03529201|Rocuronium|rocuronium|mesh-list
102200954|NCT03529201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102200955|NCT03529201|Narcotics|narcotics|mesh-ancestor
102200956|NCT03529201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102200957|NCT03529201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200958|NCT03529201|Analgesics|analgesics|mesh-ancestor
102200959|NCT03529201|Sensory System Agents|sensory system agents|mesh-ancestor
102200960|NCT03529201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102200961|NCT03529201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102200962|NCT03529201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102200963|NCT03529201|Anesthetics, General|anesthetics, general|mesh-ancestor
102200964|NCT03529201|Anesthetics|anesthetics|mesh-ancestor
102200965|NCT03529201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102200966|NCT03529201|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102200967|NCT03529201|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102200968|NCT03529201|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102200969|NCT03529201|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102200970|NCT04547049|Cytarabine|cytarabine|mesh-list
102200971|NCT04547049|Cyclosporine|cyclosporine|mesh-list
102200972|NCT04547049|Mycophenolic Acid|mycophenolic acid|mesh-list
102200973|NCT04547049|Cyclophosphamide|cyclophosphamide|mesh-list
102200974|NCT04547049|Busulfan|busulfan|mesh-list
102200975|NCT04547049|Cyclosporins|cyclosporins|mesh-list
102200976|NCT04547049|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102200977|NCT04547049|Thymoglobulin|thymoglobulin|mesh-list
102200978|NCT04547049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102200979|NCT04547049|Immunologic Factors|immunologic factors|mesh-ancestor
102200980|NCT04547049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102200981|NCT04547049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102200982|NCT04547049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102200983|NCT04547049|Alkylating Agents|alkylating agents|mesh-ancestor
102200984|NCT04547049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102200985|NCT04547049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101909752|NCT00070018|Alkylating Agents|alkylating agents|mesh-ancestor
102200986|NCT04547049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102200987|NCT04547049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102200988|NCT04547049|Antimetabolites|antimetabolites|mesh-ancestor
102200989|NCT04547049|Antiviral Agents|antiviral agents|mesh-ancestor
102200990|NCT04547049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102200991|NCT04547049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102200992|NCT04547049|Antifungal Agents|antifungal agents|mesh-ancestor
102200993|NCT04547049|Dermatologic Agents|dermatologic agents|mesh-ancestor
102200994|NCT04547049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102200995|NCT04547049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102200996|NCT04547049|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102200997|NCT04547049|Antitubercular Agents|antitubercular agents|mesh-ancestor
102200998|NCT04547049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102201000|NCT05647291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102201001|NCT05647291|Antiemetics|antiemetics|mesh-ancestor
102201002|NCT05647291|Autonomic Agents|autonomic agents|mesh-ancestor
102201003|NCT05647291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102201004|NCT05647291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201005|NCT05647291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102201006|NCT05647291|Glucocorticoids|glucocorticoids|mesh-ancestor
102201007|NCT05647291|Hormones|hormones|mesh-ancestor
102201008|NCT05647291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102201009|NCT05647291|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102201010|NCT05647291|Protective Agents|protective agents|mesh-ancestor
102201011|NCT03105765|Ketamine|ketamine|mesh-list
102201012|NCT03105765|Analgesics|analgesics|mesh-ancestor
102201013|NCT03105765|Sensory System Agents|sensory system agents|mesh-ancestor
102201014|NCT03105765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102201015|NCT03105765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201016|NCT03105765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102201017|NCT03105765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102201018|NCT03105765|Anesthetics, General|anesthetics, general|mesh-ancestor
102201019|NCT03105765|Anesthetics|anesthetics|mesh-ancestor
102201020|NCT03105765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102201021|NCT03105765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102201022|NCT03105765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102201023|NCT03105765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102201024|NCT03105765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201025|NCT02202473|Lamivudine|lamivudine|mesh-list
102201026|NCT02202473|Oxymatrine|oxymatrine|mesh-list
102201027|NCT02202473|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102201028|NCT02202473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102201029|NCT02202473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102201030|NCT02202473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201031|NCT02202473|Antiviral Agents|antiviral agents|mesh-ancestor
102201032|NCT02202473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102201033|NCT02202473|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102201034|NCT02202473|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102201035|NCT02202473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102201036|NCT02364531|Abiraterone Acetate|abiraterone acetate|mesh-list
102201037|NCT02364531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201038|NCT02364531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102201039|NCT02364531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102201040|NCT02364531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201041|NCT02364531|Hormone Antagonists|hormone antagonists|mesh-ancestor
102201042|NCT02364531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102201043|NCT02364531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201044|NCT02364531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102201045|NCT02206763|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102201046|NCT02206763|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
102201047|NCT02206763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201048|NCT02206763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102201049|NCT02206763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102201050|NCT02206763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201051|NCT02202707|Gabapentin|gabapentin|mesh-list
102201052|NCT02202707|Analgesics|analgesics|mesh-ancestor
102201053|NCT02202707|Sensory System Agents|sensory system agents|mesh-ancestor
102201054|NCT02202707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102201055|NCT02202707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201056|NCT02202707|Anticonvulsants|anticonvulsants|mesh-ancestor
102201057|NCT02202707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102201058|NCT02202707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102201059|NCT02202707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102201060|NCT02202707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102201061|NCT02202707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102201062|NCT02202707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102201064|NCT02202707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201065|NCT02202707|Antimanic Agents|antimanic agents|mesh-ancestor
102201066|NCT02367807|Tenofovir|tenofovir|mesh-list
102201067|NCT02367807|Emtricitabine|emtricitabine|mesh-list
102201068|NCT02367807|Antiviral Agents|antiviral agents|mesh-ancestor
102201069|NCT02367807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102201070|NCT02367807|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102201071|NCT02367807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102201072|NCT02367807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102201073|NCT02367807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201074|NCT02367807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102201075|NCT02367807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102201076|NCT02364609|Pembrolizumab|pembrolizumab|mesh-list
102201077|NCT02364609|Afatinib|afatinib|mesh-list
102201078|NCT02364609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102201079|NCT02364609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201080|NCT02364609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102201081|NCT02364609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201082|NCT02364609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102201083|NCT02364609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102201084|NCT02364453|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
102201085|NCT02364453|Growth Substances|growth substances|mesh-ancestor
102201086|NCT02364453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201087|NCT02364453|Vasodilator Agents|vasodilator agents|mesh-ancestor
102201088|NCT02364453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102201089|NCT02364453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201090|NCT02258009|Ranibizumab|ranibizumab|mesh-list
102201091|NCT02258009|Aflibercept|aflibercept|mesh-list
102201092|NCT02258009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102201093|NCT02258009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102201094|NCT02258009|Growth Substances|growth substances|mesh-ancestor
102201095|NCT02258009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201096|NCT02258009|Growth Inhibitors|growth inhibitors|mesh-ancestor
102201097|NCT02258009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201098|NCT02203097|Propofol|propofol|mesh-list
102201099|NCT02203097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102201100|NCT02203097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102201101|NCT02203097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201102|NCT02203097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102201103|NCT02203097|Anesthetics, General|anesthetics, general|mesh-ancestor
102201104|NCT02203097|Anesthetics|anesthetics|mesh-ancestor
102201105|NCT04439487|Anesthetics|anesthetics|mesh-list
102201106|NCT04439487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102201107|NCT04439487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201108|NCT03528967|Aspirin|aspirin|mesh-list
102201109|NCT03528967|Enoxaparin|enoxaparin|mesh-list
102201110|NCT03528967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102201111|NCT03528967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102201112|NCT03528967|Analgesics|analgesics|mesh-ancestor
102201113|NCT03528967|Sensory System Agents|sensory system agents|mesh-ancestor
102201114|NCT03528967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102201115|NCT03528967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201116|NCT03528967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102201117|NCT03528967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102201118|NCT03528967|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102201119|NCT03528967|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102201120|NCT03528967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201121|NCT03528967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102201122|NCT03528967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102201123|NCT03528967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102201124|NCT03528967|Antipyretics|antipyretics|mesh-ancestor
102201125|NCT03528967|Anticoagulants|anticoagulants|mesh-ancestor
102201126|NCT02363985|Vitamin A|vitamin a|mesh-list
102201127|NCT02363985|Vitamins|vitamins|mesh-ancestor
102201128|NCT02363985|Micronutrients|micronutrients|mesh-ancestor
102201129|NCT02363985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201130|NCT05723731|Laxatives|laxatives|mesh-list
102201131|NCT05723731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102201132|NCT02363829|Nelfinavir|nelfinavir|mesh-list
102201133|NCT02363829|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102201134|NCT02363829|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102201135|NCT02363829|Protease Inhibitors|protease inhibitors|mesh-ancestor
102201136|NCT02363829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101909900|NCT05190952|Analgesics|analgesics|mesh-ancestor
102201137|NCT02363829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201139|NCT02363829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102201140|NCT02363829|Antiviral Agents|antiviral agents|mesh-ancestor
102201141|NCT02363829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102201142|NCT03113019|Immunomodulating Agents|immunomodulating agents|mesh-list
102201143|NCT03113019|Immunologic Factors|immunologic factors|mesh-ancestor
102201144|NCT03113019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201145|NCT02363751|Bevacizumab|bevacizumab|mesh-list
102201146|NCT02363751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102201147|NCT02363751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201148|NCT02363751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102201149|NCT02363751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102201150|NCT02363751|Growth Substances|growth substances|mesh-ancestor
102201151|NCT02363751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201152|NCT02363751|Growth Inhibitors|growth inhibitors|mesh-ancestor
102201153|NCT03240861|Aldesleukin|aldesleukin|mesh-list
102201154|NCT03240861|Plerixafor|plerixafor|mesh-list
102201155|NCT03240861|Fludarabine|fludarabine|mesh-list
102201156|NCT03240861|Busulfan|busulfan|mesh-list
102201157|NCT03240861|Interleukin-2|interleukin-2|mesh-list
102201158|NCT03240861|Lenograstim|lenograstim|mesh-list
102201159|NCT03240861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201160|NCT03240861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201161|NCT03240861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102201162|NCT03240861|Immunologic Factors|immunologic factors|mesh-ancestor
102201163|NCT03240861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201164|NCT03240861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102201165|NCT03240861|Alkylating Agents|alkylating agents|mesh-ancestor
102201166|NCT03240861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102201167|NCT03240861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102201168|NCT03240861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102201169|NCT03240861|Analgesics|analgesics|mesh-ancestor
102201170|NCT03240861|Sensory System Agents|sensory system agents|mesh-ancestor
102201171|NCT03240861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102201172|NCT03240861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102201173|NCT03240861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102201174|NCT03240861|Antiviral Agents|antiviral agents|mesh-ancestor
102201175|NCT03240861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102201176|NCT03527251|Ipilimumab|ipilimumab|mesh-list
102201177|NCT03527251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102201178|NCT03527251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201179|NCT03527251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102201180|NCT03527251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201181|NCT02363517|Sofosbuvir|sofosbuvir|mesh-list
102201182|NCT02363517|Antiviral Agents|antiviral agents|mesh-ancestor
102201183|NCT02363517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102201184|NCT04467463|Levobupivacaine|levobupivacaine|mesh-list
102201185|NCT04467463|Anesthetics, Local|anesthetics, local|mesh-ancestor
102201186|NCT04467463|Anesthetics|anesthetics|mesh-ancestor
102201187|NCT04467463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102201188|NCT04467463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201189|NCT04467463|Sensory System Agents|sensory system agents|mesh-ancestor
102201190|NCT04467463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102201191|NCT02363361|Imatinib Mesylate|imatinib mesylate|mesh-list
102201192|NCT02363361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201193|NCT02363361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102201194|NCT02363361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102201195|NCT02363361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201196|NCT04594915|Edoxaban|edoxaban|mesh-list
102201197|NCT04594915|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102201198|NCT04594915|Antithrombins|antithrombins|mesh-ancestor
102201199|NCT04594915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102201200|NCT04594915|Protease Inhibitors|protease inhibitors|mesh-ancestor
102201201|NCT04594915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102201202|NCT04594915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201203|NCT04594915|Anticoagulants|anticoagulants|mesh-ancestor
102201204|NCT02367027|Rivaroxaban|rivaroxaban|mesh-list
102201205|NCT02367027|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102201206|NCT02367027|Antithrombins|antithrombins|mesh-ancestor
102201207|NCT02367027|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102201208|NCT02367027|Protease Inhibitors|protease inhibitors|mesh-ancestor
102201209|NCT02367027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102201210|NCT02367027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201211|NCT02367027|Anticoagulants|anticoagulants|mesh-ancestor
102201212|NCT02366949|Paclitaxel|paclitaxel|mesh-list
102201213|NCT02366949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102201214|NCT02366949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201215|NCT02366949|Tubulin Modulators|tubulin modulators|mesh-ancestor
102201216|NCT02366949|Antimitotic Agents|antimitotic agents|mesh-ancestor
102201217|NCT02366949|Mitosis Modulators|mitosis modulators|mesh-ancestor
102201218|NCT02366949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201220|NCT03532919|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
102201221|NCT03532919|Protease Inhibitors|protease inhibitors|mesh-ancestor
102201222|NCT03532919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102201223|NCT03532919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201224|NCT05503225|Colchicine|colchicine|mesh-list
102201225|NCT05503225|Gout Suppressants|gout suppressants|mesh-ancestor
102201226|NCT05503225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102201227|NCT05503225|Tubulin Modulators|tubulin modulators|mesh-ancestor
102201228|NCT05503225|Antimitotic Agents|antimitotic agents|mesh-ancestor
102201229|NCT05503225|Mitosis Modulators|mitosis modulators|mesh-ancestor
102201230|NCT05503225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201231|NCT05503225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201232|NCT02203175|Fentanyl|fentanyl|mesh-list
102201233|NCT02203175|Propofol|propofol|mesh-list
102201234|NCT02203175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102201235|NCT02203175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102201236|NCT02203175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201237|NCT02203175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102201238|NCT02203175|Anesthetics, General|anesthetics, general|mesh-ancestor
102201239|NCT02203175|Anesthetics|anesthetics|mesh-ancestor
102201240|NCT02203175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102201241|NCT02203175|Narcotics|narcotics|mesh-ancestor
102201242|NCT02203175|Analgesics|analgesics|mesh-ancestor
102201243|NCT02203175|Sensory System Agents|sensory system agents|mesh-ancestor
102201244|NCT02203175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102201245|NCT02203175|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102201246|NCT05791799|Etonogestrel|etonogestrel|mesh-list
102201247|NCT05791799|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102201248|NCT05791799|Contraceptive Agents|contraceptive agents|mesh-ancestor
102201249|NCT05791799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102201250|NCT05791799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201251|NCT05791799|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102201252|NCT05791721|Dexamethasone|dexamethasone|mesh-list
102201253|NCT05791721|Etoricoxib|etoricoxib|mesh-list
102201254|NCT05791721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102201255|NCT05791721|Antiemetics|antiemetics|mesh-ancestor
102201256|NCT05791721|Autonomic Agents|autonomic agents|mesh-ancestor
101743068|NCT02567799|Paclitaxel|paclitaxel|mesh-list
102201257|NCT05791721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102201258|NCT05791721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201259|NCT05791721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102201260|NCT05791721|Glucocorticoids|glucocorticoids|mesh-ancestor
102201261|NCT05791721|Hormones|hormones|mesh-ancestor
102201262|NCT05791721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102201263|NCT05791721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102201264|NCT05791721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201265|NCT05791721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102201266|NCT05791721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102201267|NCT05791721|Analgesics|analgesics|mesh-ancestor
102201268|NCT05791721|Sensory System Agents|sensory system agents|mesh-ancestor
102201269|NCT05791721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102201270|NCT05791721|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102201271|NCT05791721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102201272|NCT05791721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102201273|NCT05791721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201274|NCT05791669|Listerine|listerine|mesh-list
102201275|NCT05791669|Fluorides|fluorides|mesh-list
102201276|NCT05791669|Sodium Fluoride|sodium fluoride|mesh-list
102201277|NCT05791669|Fluorides, Topical|fluorides, topical|mesh-list
102201278|NCT05791669|Cariostatic Agents|cariostatic agents|mesh-ancestor
102201279|NCT05791669|Protective Agents|protective agents|mesh-ancestor
102201280|NCT05791669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201281|NCT05791669|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102201282|NCT05791669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102201283|NCT05791487|Budesonide|budesonide|mesh-list
102201284|NCT05791487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102201285|NCT05791487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102201286|NCT05791487|Autonomic Agents|autonomic agents|mesh-ancestor
102201287|NCT05791487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102201288|NCT05791487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201289|NCT05791487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102201290|NCT05791487|Respiratory System Agents|respiratory system agents|mesh-ancestor
102201291|NCT05791487|Glucocorticoids|glucocorticoids|mesh-ancestor
102201292|NCT05791487|Hormones|hormones|mesh-ancestor
102201293|NCT05791487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102201294|NCT05791409|Venetoclax|venetoclax|mesh-list
102201295|NCT05791409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201296|NCT05791331|Pulmonary Surfactants|pulmonary surfactants|mesh-list
102201297|NCT05791331|Respiratory System Agents|respiratory system agents|mesh-ancestor
102201298|NCT05791136|Immunomodulating Agents|immunomodulating agents|mesh-list
102201299|NCT05791136|Immunologic Factors|immunologic factors|mesh-ancestor
102201300|NCT05791136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201301|NCT05791058|Anesthetics|anesthetics|mesh-list
102201302|NCT05791058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102201303|NCT05791058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201304|NCT05790941|Minoxidil|minoxidil|mesh-list
102201305|NCT05790941|Latanoprost|latanoprost|mesh-list
102201306|NCT05790941|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102201307|NCT05790941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102201308|NCT05790941|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102201309|NCT05790941|Vasodilator Agents|vasodilator agents|mesh-ancestor
102201310|NCT05790902|Tamsulosin|tamsulosin|mesh-list
102201311|NCT05790902|Silodosin|silodosin|mesh-list
102201312|NCT05790902|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102201313|NCT05790902|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102201314|NCT05790902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102201315|NCT05790902|Adrenergic Agents|adrenergic agents|mesh-ancestor
102201316|NCT05790902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102201317|NCT05790902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201318|NCT05790902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201319|NCT05790902|Urological Agents|urological agents|mesh-ancestor
102201320|NCT05790720|Propofol|propofol|mesh-list
102201321|NCT05790720|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102201322|NCT05790720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102201323|NCT05790720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201324|NCT05790720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102201325|NCT05790720|Anesthetics, General|anesthetics, general|mesh-ancestor
102201326|NCT05790720|Anesthetics|anesthetics|mesh-ancestor
102201327|NCT05790629|Calcium, Dietary|calcium, dietary|mesh-list
102201328|NCT05790629|Calcium|calcium|mesh-list
102201329|NCT05790629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102201330|NCT05790629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900524|NCT01587326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102201331|NCT05790629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102201332|NCT05790603|Hemostatics|hemostatics|mesh-list
102201333|NCT05790603|Coagulants|coagulants|mesh-ancestor
102201334|NCT05790447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102201335|NCT05790447|Thymalfasin|thymalfasin|mesh-list
102201336|NCT05790447|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102201337|NCT05790447|Immunologic Factors|immunologic factors|mesh-ancestor
102201338|NCT05790447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201339|NCT05790447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201340|NCT05790447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102201341|NCT05790447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201342|NCT05790330|Methotrexate|methotrexate|mesh-list
102201343|NCT05790330|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102201344|NCT05790330|Abortifacient Agents|abortifacient agents|mesh-ancestor
102201345|NCT05790330|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102201346|NCT05790330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201347|NCT05790330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102201348|NCT05790330|Antimetabolites|antimetabolites|mesh-ancestor
102201349|NCT05790330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201350|NCT05790330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201351|NCT05790330|Dermatologic Agents|dermatologic agents|mesh-ancestor
102201352|NCT05790330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102201353|NCT05790330|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102201354|NCT05790330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102201355|NCT05790330|Immunologic Factors|immunologic factors|mesh-ancestor
102201356|NCT05790330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102201357|NCT05790330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102201358|NCT05790239|Amphetamine|amphetamine|mesh-list
102201359|NCT05790239|Dextroamphetamine|dextroamphetamine|mesh-list
102201360|NCT05790239|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
102201361|NCT05790239|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102201362|NCT05790239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201363|NCT05790239|Sympathomimetics|sympathomimetics|mesh-ancestor
102201364|NCT05790239|Autonomic Agents|autonomic agents|mesh-ancestor
102201365|NCT05790239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102201366|NCT05790239|Dopamine Agents|dopamine agents|mesh-ancestor
102201367|NCT05790239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102201368|NCT05790239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201369|NCT05790239|Adrenergic Agents|adrenergic agents|mesh-ancestor
102201370|NCT05790239|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102201371|NCT05790239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102201372|NCT05790239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102201373|NCT05790239|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102201374|NCT05790239|Hallucinogens|hallucinogens|mesh-ancestor
102201375|NCT05790239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102201376|NCT05790239|Serotonin Agents|serotonin agents|mesh-ancestor
102201377|NCT05786716|Trastuzumab|trastuzumab|mesh-list
102201378|NCT05786716|Pertuzumab|pertuzumab|mesh-list
102201379|NCT05786716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102201380|NCT05786716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201381|NCT05786599|Methadone|methadone|mesh-list
102201382|NCT05786599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102201383|NCT05786599|Narcotics|narcotics|mesh-ancestor
102201384|NCT05786599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102201385|NCT05786599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201386|NCT05786599|Analgesics|analgesics|mesh-ancestor
102201387|NCT05786599|Sensory System Agents|sensory system agents|mesh-ancestor
102201388|NCT05786599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102201389|NCT05786599|Antitussive Agents|antitussive agents|mesh-ancestor
102201390|NCT05786599|Respiratory System Agents|respiratory system agents|mesh-ancestor
102201391|NCT05768178|Vemurafenib|vemurafenib|mesh-list
102201392|NCT05768178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201393|NCT05768178|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102201394|NCT05768178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102201395|NCT05768178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201396|NCT05704725|Aflibercept|aflibercept|mesh-list
102201397|NCT05704725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102201398|NCT05704725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102201399|NCT05704725|Growth Substances|growth substances|mesh-ancestor
102201400|NCT05704725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201401|NCT05704725|Growth Inhibitors|growth inhibitors|mesh-ancestor
102201402|NCT05704725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201403|NCT05683444|Octreotide|octreotide|mesh-list
102201404|NCT05683444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102201405|NCT05683444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102201406|NCT05683444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201407|NCT05669274|Caseins|caseins|mesh-list
102201408|NCT05669274|Chelating Agents|chelating agents|mesh-ancestor
102201409|NCT05669274|Sequestering Agents|sequestering agents|mesh-ancestor
102201410|NCT05669274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201411|NCT05667090|Vitamin D|vitamin d|mesh-list
102201412|NCT05667090|Vitamins|vitamins|mesh-ancestor
102201413|NCT05667090|Micronutrients|micronutrients|mesh-ancestor
102201414|NCT05667090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201415|NCT05667090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102201416|NCT05647343|Ciclopirox|ciclopirox|mesh-list
102201417|NCT05647343|Antifungal Agents|antifungal agents|mesh-ancestor
102201418|NCT05647343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102201419|NCT05553392|Petrolatum|petrolatum|mesh-list
102201420|NCT05553392|Emollients|emollients|mesh-ancestor
102201421|NCT05553392|Dermatologic Agents|dermatologic agents|mesh-ancestor
102201422|NCT05530421|Dexamethasone|dexamethasone|mesh-list
102201423|NCT05530421|Venetoclax|venetoclax|mesh-list
102201424|NCT05530421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102201425|NCT05530421|Antiemetics|antiemetics|mesh-ancestor
102201426|NCT05530421|Autonomic Agents|autonomic agents|mesh-ancestor
102201427|NCT05530421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102201428|NCT05530421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201429|NCT05530421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102201430|NCT05530421|Glucocorticoids|glucocorticoids|mesh-ancestor
102201431|NCT05530421|Hormones|hormones|mesh-ancestor
102201432|NCT05530421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102201433|NCT05530421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102201434|NCT05530421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201435|NCT05523596|Benzonidazole|benzonidazole|mesh-list
102201436|NCT05523596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102201437|NCT05523596|Immunologic Factors|immunologic factors|mesh-ancestor
101910202|NCT03127384|Lidocaine|lidocaine|mesh-list
102201438|NCT05523596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201439|NCT05523596|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102201440|NCT05523596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102201441|NCT05523596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102201442|NCT05523596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102201443|NCT05518734|Itraconazole|itraconazole|mesh-list
102201444|NCT05518734|Midazolam|midazolam|mesh-list
102201445|NCT05518734|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102201446|NCT05518734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102201447|NCT05518734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102201448|NCT05518734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201449|NCT05518734|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102201450|NCT05518734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102201451|NCT05518734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102201452|NCT05518734|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102201453|NCT05518734|Anesthetics, General|anesthetics, general|mesh-ancestor
102201454|NCT05518734|Anesthetics|anesthetics|mesh-ancestor
102201455|NCT05518734|GABA Modulators|gaba modulators|mesh-ancestor
102201456|NCT05518734|GABA Agents|gaba agents|mesh-ancestor
102201457|NCT05518734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102201458|NCT05518734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201459|NCT05518734|Antifungal Agents|antifungal agents|mesh-ancestor
102201460|NCT05518734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102201461|NCT05518734|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102201462|NCT05518734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102201463|NCT05518734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102201464|NCT05518734|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102201465|NCT05518734|Hormone Antagonists|hormone antagonists|mesh-ancestor
102201466|NCT05518734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102201467|NCT05518734|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102201468|NCT05513365|Goserelin|goserelin|mesh-list
102201469|NCT05513365|Bicalutamide|bicalutamide|mesh-list
102201470|NCT05513365|Dutasteride|dutasteride|mesh-list
102201471|NCT05513365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102201472|NCT05513365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201473|NCT05513365|Androgen Antagonists|androgen antagonists|mesh-ancestor
102201474|NCT05513365|Hormone Antagonists|hormone antagonists|mesh-ancestor
102201475|NCT05513365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102201476|NCT05513365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201477|NCT05513365|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102201478|NCT05513365|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102201479|NCT05513365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102201480|NCT05513365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201482|NCT05442749|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102201483|NCT05442749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102201484|NCT05442749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201485|NCT05442749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201486|NCT05361655|Palbociclib|palbociclib|mesh-list
102201487|NCT05361655|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102201488|NCT05361655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201489|NCT05361655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102201490|NCT05361655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102201491|NCT05361655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201492|NCT05361655|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102201493|NCT05361655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102201494|NCT05361655|Hormone Antagonists|hormone antagonists|mesh-ancestor
102201495|NCT05361655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102201496|NCT05361655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201497|NCT05355740|Chlorhexidine|chlorhexidine|mesh-list
102201498|NCT05355740|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102201499|NCT05355740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102201500|NCT05355740|Disinfectants|disinfectants|mesh-ancestor
102201501|NCT05316831|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102201502|NCT05316831|Immunologic Factors|immunologic factors|mesh-ancestor
102201503|NCT05316831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201504|NCT05308056|Anesthetics|anesthetics|mesh-list
102201505|NCT05308056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102201506|NCT05308056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201507|NCT05276284|Atezolizumab|atezolizumab|mesh-list
102201508|NCT05276284|Mercaptopurine|mercaptopurine|mesh-list
102201509|NCT05276284|Thioguanine|thioguanine|mesh-list
102201510|NCT05276284|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102201511|NCT05276284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201512|NCT05276284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102201513|NCT05276284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201514|NCT05276284|Antimetabolites|antimetabolites|mesh-ancestor
102201515|NCT05276284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102201516|NCT05276284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102201517|NCT05276284|Immunologic Factors|immunologic factors|mesh-ancestor
102201518|NCT05276284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201519|NCT05276284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102201520|NCT05276284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102201521|NCT05237960|Metformin|metformin|mesh-list
102201522|NCT05237960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102201523|NCT05237960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201524|NCT05144698|Sirolimus|sirolimus|mesh-list
102201525|NCT05144698|Temsirolimus|temsirolimus|mesh-list
102201526|NCT05144698|MTOR Inhibitors|mtor inhibitors|mesh-list
102201527|NCT05144698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102201528|NCT05144698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102201529|NCT05144698|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102201530|NCT05144698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201531|NCT05144698|Antifungal Agents|antifungal agents|mesh-ancestor
102201532|NCT05144698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102201533|NCT05144698|Immunologic Factors|immunologic factors|mesh-ancestor
102201534|NCT05144698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201535|NCT05144698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102201536|NCT05144698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102201537|NCT05144698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201538|NCT05122182|Propagermanium|propagermanium|mesh-list
102201539|NCT05122182|Candesartan|candesartan|mesh-list
102201540|NCT05122182|Candesartan cilexetil|candesartan cilexetil|mesh-list
102201541|NCT05122182|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102201542|NCT05122182|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102201543|NCT05122182|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102201544|NCT05122182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201545|NCT05122182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201546|NCT05122182|Interferon Inducers|interferon inducers|mesh-ancestor
102201547|NCT05122182|Immunologic Factors|immunologic factors|mesh-ancestor
102201548|NCT05122182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201549|NCT05065801|Folfirinox|folfirinox|mesh-list
102201550|NCT05065801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201551|NCT04979442|Trabectedin|trabectedin|mesh-list
102201552|NCT04979442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102201553|NCT04979442|Alkylating Agents|alkylating agents|mesh-ancestor
102201554|NCT04979442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201555|NCT04979442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201556|NCT04969133|Levobupivacaine|levobupivacaine|mesh-list
102201557|NCT04969133|Anesthetics, Local|anesthetics, local|mesh-ancestor
102201558|NCT04969133|Anesthetics|anesthetics|mesh-ancestor
102201559|NCT04969133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102201560|NCT04969133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201561|NCT04969133|Sensory System Agents|sensory system agents|mesh-ancestor
102201562|NCT04969133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102201563|NCT04910061|Niacinamide|niacinamide|mesh-list
102201564|NCT04910061|Niacin|niacin|mesh-list
102201565|NCT04910061|Nicotinic Acids|nicotinic acids|mesh-list
102201566|NCT04910061|Vitamin B Complex|vitamin b complex|mesh-ancestor
102201567|NCT04910061|Vitamins|vitamins|mesh-ancestor
102201568|NCT04910061|Micronutrients|micronutrients|mesh-ancestor
102201569|NCT04910061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201570|NCT04910061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102201571|NCT04910061|Antimetabolites|antimetabolites|mesh-ancestor
102201572|NCT04910061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201573|NCT04910061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102201574|NCT04910061|Vasodilator Agents|vasodilator agents|mesh-ancestor
102201575|NCT04887467|Apomorphine|apomorphine|mesh-list
102201576|NCT04887467|Emetics|emetics|mesh-ancestor
102201577|NCT04887467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201578|NCT04887467|Autonomic Agents|autonomic agents|mesh-ancestor
102201579|NCT04887467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102201580|NCT04887467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102201581|NCT04887467|Dopamine Agonists|dopamine agonists|mesh-ancestor
102201582|NCT04887467|Dopamine Agents|dopamine agents|mesh-ancestor
102201583|NCT04887467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102201584|NCT04887467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201585|NCT04868409|Rocuronium|rocuronium|mesh-list
102201586|NCT04868409|Succinylcholine|succinylcholine|mesh-list
102201587|NCT04868409|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102201588|NCT04868409|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102201589|NCT04868409|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102201590|NCT04868409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102201591|NCT04868409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201592|NCT04868409|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
102201593|NCT04861064|Sirolimus|sirolimus|mesh-list
102201594|NCT04861064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102201595|NCT04861064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102201596|NCT04861064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102201597|NCT04861064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201598|NCT04861064|Antifungal Agents|antifungal agents|mesh-ancestor
102201599|NCT04861064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102201600|NCT04861064|Immunologic Factors|immunologic factors|mesh-ancestor
102201601|NCT04861064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201602|NCT04846335|Doxycycline|doxycycline|mesh-list
102201603|NCT04846335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102201604|NCT04846335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102201605|NCT04846335|Antimalarials|antimalarials|mesh-ancestor
102201606|NCT04846335|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102201607|NCT04846335|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102201608|NCT04796220|Gemcitabine|gemcitabine|mesh-list
102201609|NCT04796220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102201610|NCT04796220|Antimetabolites|antimetabolites|mesh-ancestor
102201611|NCT04796220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201612|NCT04796220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201613|NCT04777045|Diltiazem|diltiazem|mesh-list
102201614|NCT04777045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102201615|NCT04777045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102201616|NCT04777045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102201617|NCT04777045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201618|NCT04777045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102201619|NCT04777045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201620|NCT04777045|Vasodilator Agents|vasodilator agents|mesh-ancestor
102201621|NCT04632238|Metronidazole|metronidazole|mesh-list
102201622|NCT04632238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101900529|NCT03294538|Estradiol|estradiol|mesh-list
102201623|NCT04632238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102201624|NCT04632238|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102201625|NCT04632238|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102201626|NCT04597190|Norepinephrine|norepinephrine|mesh-list
102201627|NCT04597190|Serotonin|serotonin|mesh-list
102201628|NCT04597190|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
102201629|NCT04597190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102201630|NCT04597190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102201631|NCT04597190|Adrenergic Agents|adrenergic agents|mesh-ancestor
102201632|NCT04597190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102201633|NCT04597190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201634|NCT04597190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201635|NCT04597190|Sympathomimetics|sympathomimetics|mesh-ancestor
102201636|NCT04597190|Autonomic Agents|autonomic agents|mesh-ancestor
102201637|NCT04597190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102201638|NCT04597190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102201639|NCT04597190|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102201640|NCT04597190|Serotonin Agents|serotonin agents|mesh-ancestor
102201641|NCT04597190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102201642|NCT04597190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102201643|NCT04577638|Nivolumab|nivolumab|mesh-list
102201644|NCT04577638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102201645|NCT04577638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201646|NCT04577638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102201647|NCT04577638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201648|NCT04517799|Cannabidiol|cannabidiol|mesh-list
102201649|NCT04517799|Anticonvulsants|anticonvulsants|mesh-ancestor
102201650|NCT04495296|Paclitaxel|paclitaxel|mesh-list
102201651|NCT04495296|Gemcitabine|gemcitabine|mesh-list
102201652|NCT04495296|Capecitabine|capecitabine|mesh-list
102201653|NCT04495296|Oxaliplatin|oxaliplatin|mesh-list
102201654|NCT04495296|Nivolumab|nivolumab|mesh-list
102201655|NCT04495296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102201656|NCT04495296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101450229|NCT00193232|Docetaxel|docetaxel|mesh-list
102201657|NCT04495296|Tubulin Modulators|tubulin modulators|mesh-ancestor
102201658|NCT04495296|Antimitotic Agents|antimitotic agents|mesh-ancestor
102201659|NCT04495296|Mitosis Modulators|mitosis modulators|mesh-ancestor
102201660|NCT04495296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201661|NCT04495296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102201662|NCT04495296|Antimetabolites|antimetabolites|mesh-ancestor
102201663|NCT04495296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102201664|NCT04495296|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102201666|NCT04404062|Immunoglobulins|immunoglobulins|mesh-list
102201667|NCT04404062|Immunologic Factors|immunologic factors|mesh-ancestor
102201668|NCT04404062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201669|NCT04352777|Fulvestrant|fulvestrant|mesh-list
102201670|NCT04352777|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102201671|NCT04352777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102201672|NCT04352777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201673|NCT04352777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102201674|NCT04352777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102201675|NCT04352777|Hormone Antagonists|hormone antagonists|mesh-ancestor
102201676|NCT04352777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102201677|NCT04352777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201678|NCT04352777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102201679|NCT04352777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102201680|NCT04352777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201681|NCT04276363|Nicotine|nicotine|mesh-list
102201682|NCT04276363|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102201683|NCT04276363|Autonomic Agents|autonomic agents|mesh-ancestor
102201684|NCT04276363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102201685|NCT04276363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201686|NCT04276363|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102201687|NCT04276363|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102201688|NCT04276363|Cholinergic Agents|cholinergic agents|mesh-ancestor
102201689|NCT04276363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102201690|NCT04276363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201691|NCT04260854|Bupivacaine|bupivacaine|mesh-list
102201692|NCT04260854|Anesthetics, Local|anesthetics, local|mesh-ancestor
102201693|NCT04260854|Anesthetics|anesthetics|mesh-ancestor
102201694|NCT04260854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102201695|NCT04260854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201696|NCT04260854|Sensory System Agents|sensory system agents|mesh-ancestor
102201697|NCT04260854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102201698|NCT04147546|Artenimol|artenimol|mesh-list
102201700|NCT04147546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102201701|NCT04147546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102201702|NCT04147546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102201703|NCT04141579|Evolocumab|evolocumab|mesh-list
102201704|NCT04141579|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102201705|NCT04141579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102201706|NCT04141579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102201707|NCT04141579|Antimetabolites|antimetabolites|mesh-ancestor
102201708|NCT04141579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201709|NCT04141579|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102201710|NCT04141579|Protease Inhibitors|protease inhibitors|mesh-ancestor
102201711|NCT04141579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102201712|NCT04141579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102201713|NCT04095689|Docetaxel|docetaxel|mesh-list
102201714|NCT04095689|Pembrolizumab|pembrolizumab|mesh-list
102201715|NCT04095689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201716|NCT04095689|Tubulin Modulators|tubulin modulators|mesh-ancestor
102201717|NCT04095689|Antimitotic Agents|antimitotic agents|mesh-ancestor
102201718|NCT04095689|Mitosis Modulators|mitosis modulators|mesh-ancestor
102201719|NCT04095689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201720|NCT04095689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102201721|NCT04095689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102201722|NCT04038502|Carboplatin|carboplatin|mesh-list
102201723|NCT04038502|Olaparib|olaparib|mesh-list
102201724|NCT04038502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201725|NCT04038502|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102201726|NCT04038502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102201727|NCT04038502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201728|NCT03977493|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102201729|NCT03977493|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102201730|NCT03977493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102201731|NCT03977493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201732|NCT03977493|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102201733|NCT03977493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102201734|NCT03977493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201735|NCT03977493|Cholinergic Agents|cholinergic agents|mesh-ancestor
102201736|NCT03977493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102201737|NCT03867175|Pembrolizumab|pembrolizumab|mesh-list
102201738|NCT03867175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102201739|NCT03867175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201740|NCT03867175|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102201741|NCT03867175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201742|NCT03852433|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102201743|NCT03852433|Antiviral Agents|antiviral agents|mesh-ancestor
102201744|NCT03852433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102201745|NCT03849469|Pembrolizumab|pembrolizumab|mesh-list
102201746|NCT03849469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102201747|NCT03849469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201748|NCT03849469|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102201749|NCT03849469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201750|NCT03805607|Ketorolac|ketorolac|mesh-list
102201751|NCT03805607|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102201752|NCT03805607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102201753|NCT03805607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102201754|NCT03805607|Analgesics|analgesics|mesh-ancestor
102201755|NCT03805607|Sensory System Agents|sensory system agents|mesh-ancestor
102201756|NCT03805607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102201757|NCT03805607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201758|NCT03805607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102201759|NCT03805607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102201760|NCT03805607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102201761|NCT03805607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102201762|NCT03805607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201763|NCT03678545|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102201764|NCT03678545|Immunologic Factors|immunologic factors|mesh-ancestor
102201765|NCT03678545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201766|NCT03671018|Rituximab|rituximab|mesh-list
102201767|NCT03671018|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
102201768|NCT03671018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102201769|NCT03671018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201770|NCT03671018|Immunologic Factors|immunologic factors|mesh-ancestor
102201771|NCT03671018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201772|NCT03671018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102201773|NCT03671018|Immunoconjugates|immunoconjugates|mesh-ancestor
102201774|NCT03514368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102201775|NCT03514368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201776|NCT03514368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102201777|NCT03514368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201778|NCT03496766|Tipifarnib|tipifarnib|mesh-list
102201779|NCT03496766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201780|NCT03467789|Vitamin D|vitamin d|mesh-list
102201781|NCT03467789|Ergocalciferols|ergocalciferols|mesh-list
102201782|NCT03467789|Cholecalciferol|cholecalciferol|mesh-list
102201783|NCT03467789|Vitamins|vitamins|mesh-list
102201784|NCT03467789|Micronutrients|micronutrients|mesh-ancestor
102201785|NCT03467789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201786|NCT03467789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102201787|NCT03467789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102201788|NCT03406715|Nivolumab|nivolumab|mesh-list
102201789|NCT03406715|Ipilimumab|ipilimumab|mesh-list
102201790|NCT03406715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102201791|NCT03406715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201792|NCT03406715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102201793|NCT03406715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201794|NCT03363763|Sirolimus|sirolimus|mesh-list
102201795|NCT03363763|Temsirolimus|temsirolimus|mesh-list
102201796|NCT03363763|MTOR Inhibitors|mtor inhibitors|mesh-list
102201797|NCT03363763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102201798|NCT03363763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102201799|NCT03363763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102201800|NCT03363763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201801|NCT03363763|Antifungal Agents|antifungal agents|mesh-ancestor
102201802|NCT03363763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102201803|NCT03363763|Immunologic Factors|immunologic factors|mesh-ancestor
102201804|NCT03363763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201805|NCT03363763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102201806|NCT03363763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102201807|NCT03363763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201808|NCT03224507|Dexamethasone|dexamethasone|mesh-list
101910576|NCT01112748|Lidocaine|lidocaine|mesh-list
102201809|NCT03224507|Dexamethasone acetate|dexamethasone acetate|mesh-list
102201810|NCT03224507|Lenalidomide|lenalidomide|mesh-list
102201811|NCT03224507|Daratumumab|daratumumab|mesh-list
102201812|NCT03224507|BB 1101|bb 1101|mesh-list
102201813|NCT03224507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102201814|NCT03224507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102201815|NCT03224507|Antiemetics|antiemetics|mesh-ancestor
102201816|NCT03224507|Autonomic Agents|autonomic agents|mesh-ancestor
102201817|NCT03224507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102201818|NCT03224507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201819|NCT03224507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102201820|NCT03224507|Glucocorticoids|glucocorticoids|mesh-ancestor
102201821|NCT03224507|Hormones|hormones|mesh-ancestor
102201822|NCT03224507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102201823|NCT03224507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102201824|NCT03224507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201825|NCT03224507|Protease Inhibitors|protease inhibitors|mesh-ancestor
102201826|NCT03224507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102201827|NCT03224507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201828|NCT03224507|Immunologic Factors|immunologic factors|mesh-ancestor
102201829|NCT03224507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102201830|NCT03224507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102201831|NCT03224507|Growth Substances|growth substances|mesh-ancestor
102201832|NCT03224507|Growth Inhibitors|growth inhibitors|mesh-ancestor
102201833|NCT03182751|Tranexamic Acid|tranexamic acid|mesh-list
102201834|NCT03182751|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102201835|NCT03182751|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102201836|NCT03182751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201837|NCT03182751|Hemostatics|hemostatics|mesh-ancestor
102201838|NCT03182751|Coagulants|coagulants|mesh-ancestor
102201839|NCT03105245|Thiopental|thiopental|mesh-list
102201840|NCT03105245|Anesthetics|anesthetics|mesh-list
102201841|NCT03105245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102201842|NCT03105245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201843|NCT03105245|Anticonvulsants|anticonvulsants|mesh-ancestor
102201844|NCT03105245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102201845|NCT03105245|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102201846|NCT03105245|Anesthetics, General|anesthetics, general|mesh-ancestor
102201848|NCT03105245|GABA Agents|gaba agents|mesh-ancestor
102201849|NCT03105245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102201850|NCT03105245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201851|NCT03020199|Betamethasone|betamethasone|mesh-list
102201852|NCT03020199|Calcipotriene|calcipotriene|mesh-list
102201853|NCT03020199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102201854|NCT03020199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102201855|NCT03020199|Glucocorticoids|glucocorticoids|mesh-ancestor
102201856|NCT03020199|Hormones|hormones|mesh-ancestor
102201857|NCT03020199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102201858|NCT03020199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201859|NCT03020199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102201860|NCT03020199|Respiratory System Agents|respiratory system agents|mesh-ancestor
102201861|NCT03020199|Immunologic Factors|immunologic factors|mesh-ancestor
102201862|NCT03020199|Dermatologic Agents|dermatologic agents|mesh-ancestor
102201863|NCT03019588|Paclitaxel|paclitaxel|mesh-list
102201864|NCT03019588|Pembrolizumab|pembrolizumab|mesh-list
102201865|NCT03019588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102201866|NCT03019588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201867|NCT03019588|Tubulin Modulators|tubulin modulators|mesh-ancestor
102201868|NCT03019588|Antimitotic Agents|antimitotic agents|mesh-ancestor
102201869|NCT03019588|Mitosis Modulators|mitosis modulators|mesh-ancestor
102201870|NCT03019588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201871|NCT03019588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102201872|NCT03019588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102201873|NCT02959944|Prednisone|prednisone|mesh-list
102201874|NCT02959944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102201875|NCT02959944|Glucocorticoids|glucocorticoids|mesh-ancestor
102201876|NCT02959944|Hormones|hormones|mesh-ancestor
102201877|NCT02959944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102201878|NCT02959944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201879|NCT02959944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102201880|NCT02959944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201881|NCT02823002|Lidocaine|lidocaine|mesh-list
102201882|NCT02823002|Anesthetics, Local|anesthetics, local|mesh-ancestor
102201883|NCT02823002|Anesthetics|anesthetics|mesh-ancestor
102201884|NCT02823002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102201885|NCT02823002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201886|NCT02823002|Sensory System Agents|sensory system agents|mesh-ancestor
102201887|NCT02823002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102201888|NCT02823002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102201889|NCT02823002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102201890|NCT02823002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102201891|NCT02823002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102201892|NCT02823002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201893|NCT02806687|Gemcitabine|gemcitabine|mesh-list
102201894|NCT02806687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102201895|NCT02806687|Antimetabolites|antimetabolites|mesh-ancestor
102201896|NCT02806687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201897|NCT02806687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201898|NCT02581137|Metformin|metformin|mesh-list
102201899|NCT02581137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102201900|NCT02581137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201901|NCT02559180|Aflibercept|aflibercept|mesh-list
102201902|NCT02559180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102201903|NCT02559180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102201904|NCT02559180|Growth Substances|growth substances|mesh-ancestor
102201905|NCT02559180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201906|NCT02559180|Growth Inhibitors|growth inhibitors|mesh-ancestor
102201907|NCT02559180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201908|NCT02539966|Sirolimus|sirolimus|mesh-list
102201909|NCT02539966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102201910|NCT02539966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102201911|NCT02539966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102201912|NCT02539966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201913|NCT02539966|Antifungal Agents|antifungal agents|mesh-ancestor
102201914|NCT02539966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102201915|NCT02539966|Immunologic Factors|immunologic factors|mesh-ancestor
102201916|NCT02539966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201917|NCT02525029|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102201918|NCT02525029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101900530|NCT03294538|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102201919|NCT02525029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201920|NCT02455557|Temozolomide|temozolomide|mesh-list
102201921|NCT02455557|Sargramostim|sargramostim|mesh-list
102201922|NCT02455557|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
102201923|NCT02455557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102201924|NCT02455557|Alkylating Agents|alkylating agents|mesh-ancestor
102201925|NCT02455557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201926|NCT02455557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201927|NCT02455557|Immunologic Factors|immunologic factors|mesh-ancestor
102201928|NCT02455557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201929|NCT02455557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102201930|NCT02401139|Ketamine|ketamine|mesh-list
102201931|NCT02401139|Analgesics|analgesics|mesh-ancestor
102201932|NCT02401139|Sensory System Agents|sensory system agents|mesh-ancestor
102201933|NCT02401139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102201934|NCT02401139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201935|NCT02401139|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102201936|NCT02401139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102201937|NCT02401139|Anesthetics, General|anesthetics, general|mesh-ancestor
102201938|NCT02401139|Anesthetics|anesthetics|mesh-ancestor
102201939|NCT02401139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102201940|NCT02401139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102201941|NCT02401139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102201942|NCT02401139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102201943|NCT02401139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201944|NCT02390635|Deoxyglucose|deoxyglucose|mesh-list
102201945|NCT02390635|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102201946|NCT02390635|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102201947|NCT02390635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201948|NCT02390635|Antimetabolites|antimetabolites|mesh-ancestor
102201949|NCT02390635|Antiviral Agents|antiviral agents|mesh-ancestor
102201950|NCT02390635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102201951|NCT02367846|Contraceptive Agents|contraceptive agents|mesh-list
102201952|NCT02367846|NuvaRing|nuvaring|mesh-list
102201953|NCT02367846|Contraceptives, Oral|contraceptives, oral|mesh-list
102201954|NCT02367846|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
102201955|NCT02367846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102201956|NCT02367846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201957|NCT02367846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102201958|NCT02367846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102201959|NCT02195895|Calcium, Dietary|calcium, dietary|mesh-list
102201960|NCT02195895|Vitamin D|vitamin d|mesh-list
102201961|NCT02195895|Ergocalciferols|ergocalciferols|mesh-list
102201962|NCT02195895|Cholecalciferol|cholecalciferol|mesh-list
102201963|NCT02195895|Alendronate|alendronate|mesh-list
102201964|NCT02195895|Vitamins|vitamins|mesh-list
102201965|NCT02195895|Calcium Carbonate|calcium carbonate|mesh-list
102201966|NCT02195895|Antacids|antacids|mesh-list
102201967|NCT02195895|Calcium|calcium|mesh-list
102201968|NCT02195895|Micronutrients|micronutrients|mesh-ancestor
102201969|NCT02195895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201970|NCT02195895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102201971|NCT02195895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102201972|NCT02195895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201973|NCT02195895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102201974|NCT01970722|Paclitaxel|paclitaxel|mesh-list
102201975|NCT01970722|Cisplatin|cisplatin|mesh-list
102201976|NCT01970722|Carboplatin|carboplatin|mesh-list
102201977|NCT01970722|Gemcitabine|gemcitabine|mesh-list
102201978|NCT01970722|Doxorubicin|doxorubicin|mesh-list
102201979|NCT01970722|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102201980|NCT01970722|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102201981|NCT01970722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102201982|NCT01970722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102201983|NCT01970722|Tubulin Modulators|tubulin modulators|mesh-ancestor
102201984|NCT01970722|Antimitotic Agents|antimitotic agents|mesh-ancestor
102201985|NCT01970722|Mitosis Modulators|mitosis modulators|mesh-ancestor
101900532|NCT03294538|Hormones|hormones|mesh-ancestor
102201986|NCT01970722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102201987|NCT01970722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102201988|NCT01970722|Antimetabolites|antimetabolites|mesh-ancestor
102201989|NCT01970722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102201990|NCT01970722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102201991|NCT01970722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102201992|NCT01970722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102201993|NCT01953900|Cyclophosphamide|cyclophosphamide|mesh-list
102201994|NCT01953900|Fludarabine|fludarabine|mesh-list
102201995|NCT01953900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102201996|NCT01953900|Immunologic Factors|immunologic factors|mesh-ancestor
102201997|NCT01953900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102201998|NCT01953900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102201999|NCT01953900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102202000|NCT01953900|Alkylating Agents|alkylating agents|mesh-ancestor
102202001|NCT01953900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202002|NCT01953900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102202003|NCT01953900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102202004|NCT01913951|Azacitidine|azacitidine|mesh-list
102202005|NCT01913951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102202006|NCT01913951|Antimetabolites|antimetabolites|mesh-ancestor
102202007|NCT01913951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202008|NCT01913951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102202009|NCT01913951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102202010|NCT01867320|Raltegravir Potassium|raltegravir potassium|mesh-list
102202011|NCT01867320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102202012|NCT01867320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102202013|NCT01867320|Antiviral Agents|antiviral agents|mesh-ancestor
102202014|NCT01867320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102202015|NCT01867320|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102202016|NCT01867320|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102202017|NCT01867320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102202018|NCT01867320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202019|NCT01709136|Sirolimus|sirolimus|mesh-list
102202020|NCT01709136|Temsirolimus|temsirolimus|mesh-list
102202021|NCT01709136|MTOR Inhibitors|mtor inhibitors|mesh-list
102202022|NCT01709136|Tacrolimus|tacrolimus|mesh-list
102202023|NCT01709136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102202024|NCT01709136|Immunologic Factors|immunologic factors|mesh-ancestor
102202025|NCT01709136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202026|NCT01709136|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102202027|NCT01709136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102202028|NCT01709136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202029|NCT01709136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102202030|NCT01709136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102202031|NCT01709136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102202032|NCT01709136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102202033|NCT01709136|Antifungal Agents|antifungal agents|mesh-ancestor
102202034|NCT01709136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102202035|NCT01570868|Ponatinib|ponatinib|mesh-list
101450285|NCT00193349|Irinotecan|irinotecan|mesh-list
102202036|NCT01570868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102202037|NCT01570868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102202038|NCT01570868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102202039|NCT01570868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202041|NCT01565499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102202042|NCT01565499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102202043|NCT01565499|Tubulin Modulators|tubulin modulators|mesh-ancestor
102202044|NCT01565499|Antimitotic Agents|antimitotic agents|mesh-ancestor
102202045|NCT01565499|Mitosis Modulators|mitosis modulators|mesh-ancestor
102202046|NCT01565499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202047|NCT01371630|Cytarabine|cytarabine|mesh-list
102202048|NCT01371630|Dexamethasone|dexamethasone|mesh-list
102202049|NCT01371630|Prednisone|prednisone|mesh-list
102202050|NCT01371630|Cyclophosphamide|cyclophosphamide|mesh-list
102202051|NCT01371630|Rituximab|rituximab|mesh-list
102202052|NCT01371630|Methotrexate|methotrexate|mesh-list
102202053|NCT01371630|Vincristine|vincristine|mesh-list
102202054|NCT01371630|Mercaptopurine|mercaptopurine|mesh-list
102202055|NCT01371630|Blinatumomab|blinatumomab|mesh-list
102202056|NCT01371630|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
102202057|NCT01371630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102202058|NCT01371630|Immunologic Factors|immunologic factors|mesh-ancestor
102202059|NCT01371630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202060|NCT01371630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102202061|NCT01371630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102202063|NCT01371630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202064|NCT01371630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102202065|NCT01371630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102202066|NCT01371630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102202067|NCT01371630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102202068|NCT01371630|Antiemetics|antiemetics|mesh-ancestor
102202069|NCT01371630|Autonomic Agents|autonomic agents|mesh-ancestor
102202070|NCT01371630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102202071|NCT01371630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102202072|NCT01371630|Glucocorticoids|glucocorticoids|mesh-ancestor
102202073|NCT01371630|Hormones|hormones|mesh-ancestor
102202074|NCT01371630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102202075|NCT01371630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102202076|NCT01371630|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102202077|NCT01371630|Abortifacient Agents|abortifacient agents|mesh-ancestor
102202078|NCT01371630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102202079|NCT01371630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102202080|NCT01371630|Antimetabolites|antimetabolites|mesh-ancestor
102202081|NCT01371630|Dermatologic Agents|dermatologic agents|mesh-ancestor
102202082|NCT01371630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102202083|NCT01371630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102202084|NCT01371630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102202085|NCT01371630|Antiviral Agents|antiviral agents|mesh-ancestor
102202086|NCT01371630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102202087|NCT01371630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102202088|NCT01371630|Tubulin Modulators|tubulin modulators|mesh-ancestor
102202089|NCT01371630|Antimitotic Agents|antimitotic agents|mesh-ancestor
102202090|NCT01371630|Mitosis Modulators|mitosis modulators|mesh-ancestor
102202091|NCT01371630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102202092|NCT01371630|Immunotoxins|immunotoxins|mesh-ancestor
102202093|NCT01371630|Immunoconjugates|immunoconjugates|mesh-ancestor
102202094|NCT01036087|Paclitaxel|paclitaxel|mesh-list
102202095|NCT01036087|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102202096|NCT01036087|Cyclophosphamide|cyclophosphamide|mesh-list
102202097|NCT01036087|Carboplatin|carboplatin|mesh-list
102202098|NCT01036087|Fluorouracil|fluorouracil|mesh-list
102202099|NCT01036087|Epirubicin|epirubicin|mesh-list
102202100|NCT01036087|Panitumumab|panitumumab|mesh-list
102202101|NCT01036087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102202102|NCT01036087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102202103|NCT01036087|Tubulin Modulators|tubulin modulators|mesh-ancestor
102202104|NCT01036087|Antimitotic Agents|antimitotic agents|mesh-ancestor
102202105|NCT01036087|Mitosis Modulators|mitosis modulators|mesh-ancestor
102202106|NCT01036087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202107|NCT01036087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102202108|NCT01036087|Immunologic Factors|immunologic factors|mesh-ancestor
102202109|NCT01036087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202110|NCT01036087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102202111|NCT01036087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102202112|NCT01036087|Alkylating Agents|alkylating agents|mesh-ancestor
102202113|NCT01036087|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102202114|NCT01036087|Antimetabolites|antimetabolites|mesh-ancestor
102202115|NCT01036087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101910868|NCT01210638|Oxymorphone|oxymorphone|mesh-list
102202116|NCT01036087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102202117|NCT01036087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102202118|NCT01036087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102202119|NCT01036087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102202120|NCT01036087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102202121|NCT00783367|Dexamethasone|dexamethasone|mesh-list
102202122|NCT00783367|Dexamethasone acetate|dexamethasone acetate|mesh-list
102202123|NCT00783367|Rituximab|rituximab|mesh-list
102202124|NCT00783367|Lenalidomide|lenalidomide|mesh-list
102202125|NCT00783367|BB 1101|bb 1101|mesh-list
102202126|NCT00783367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102202127|NCT00783367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102202128|NCT00783367|Immunologic Factors|immunologic factors|mesh-ancestor
102202129|NCT00783367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202130|NCT00783367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102202131|NCT00783367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102202132|NCT00783367|Antiemetics|antiemetics|mesh-ancestor
102202133|NCT00783367|Autonomic Agents|autonomic agents|mesh-ancestor
102202134|NCT00783367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102202135|NCT00783367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102202136|NCT00783367|Glucocorticoids|glucocorticoids|mesh-ancestor
102202138|NCT00783367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102202139|NCT00783367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102202140|NCT00783367|Protease Inhibitors|protease inhibitors|mesh-ancestor
102202141|NCT00783367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102202142|NCT00783367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202143|NCT00783367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102202144|NCT00783367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102202145|NCT00783367|Growth Substances|growth substances|mesh-ancestor
102202146|NCT00783367|Growth Inhibitors|growth inhibitors|mesh-ancestor
102202147|NCT00572156|Mecasermin|mecasermin|mesh-list
102202148|NCT00572156|Growth Substances|growth substances|mesh-ancestor
102202149|NCT00572156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202150|NCT00447772|Botulinum Toxins|botulinum toxins|mesh-list
102202151|NCT00447772|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102202152|NCT00447772|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102202153|NCT00447772|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102202154|NCT00447772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102202155|NCT00447772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202156|NCT00447772|Cholinergic Agents|cholinergic agents|mesh-ancestor
102202157|NCT00447772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102202158|NCT00447772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202159|NCT00447772|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102202160|NCT00447772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102202161|NCT00255216|Policosanol|policosanol|mesh-list
102202162|NCT00255216|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102202163|NCT00255216|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102202164|NCT00255216|Antimetabolites|antimetabolites|mesh-ancestor
102202165|NCT00255216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202166|NCT00255216|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102202167|NCT00255216|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102202168|NCT03525223|Dialysis Solutions|dialysis solutions|mesh-list
102202169|NCT03525223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102202170|NCT02257697|Mizoribine|mizoribine|mesh-list
102202171|NCT02257697|Cyclophosphamide|cyclophosphamide|mesh-list
102202172|NCT02257697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102202173|NCT02257697|Immunologic Factors|immunologic factors|mesh-ancestor
102202174|NCT02257697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202175|NCT02257697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102202176|NCT02257697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102202177|NCT02257697|Alkylating Agents|alkylating agents|mesh-ancestor
102202178|NCT02257697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202179|NCT02257697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102202180|NCT02257697|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102202181|NCT02257697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102202182|NCT02257697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102202183|NCT02257697|Analgesics|analgesics|mesh-ancestor
102202184|NCT02257697|Sensory System Agents|sensory system agents|mesh-ancestor
102202185|NCT02257697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102202186|NCT02257697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102202187|NCT02257697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102202188|NCT02257697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102202189|NCT02257697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102202190|NCT02257697|Antimalarials|antimalarials|mesh-ancestor
102202191|NCT02257697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102202192|NCT02257697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102202193|NCT02257697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102202194|NCT04468711|Vitamin D|vitamin d|mesh-list
102202195|NCT04468711|Hydrocortisone|hydrocortisone|mesh-list
102202196|NCT04468711|Vitamins|vitamins|mesh-ancestor
102202197|NCT04468711|Micronutrients|micronutrients|mesh-ancestor
102202198|NCT04468711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202199|NCT04468711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102202200|NCT04468711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102202201|NCT02207387|Rasagiline|rasagiline|mesh-list
102202202|NCT02207387|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102202203|NCT02207387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102202204|NCT02207387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202205|NCT02207387|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102202206|NCT02207387|Protective Agents|protective agents|mesh-ancestor
102202207|NCT02207387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202208|NCT03528421|Cyclophosphamide|cyclophosphamide|mesh-list
102202209|NCT03528421|Fludarabine|fludarabine|mesh-list
102202210|NCT03528421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102202211|NCT03528421|Immunologic Factors|immunologic factors|mesh-ancestor
102202212|NCT03528421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202213|NCT03528421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102202214|NCT03528421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102202215|NCT03528421|Alkylating Agents|alkylating agents|mesh-ancestor
102202216|NCT03528421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202217|NCT03528421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102202218|NCT03528421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102202219|NCT02374047|Atorvastatin|atorvastatin|mesh-list
102202220|NCT02374047|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102202221|NCT02374047|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102202222|NCT02374047|Antimetabolites|antimetabolites|mesh-ancestor
102202223|NCT02374047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202224|NCT02374047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102202225|NCT02374047|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102202226|NCT02374047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102202227|NCT02203253|Thalidomide|thalidomide|mesh-list
102202228|NCT02203253|Dexamethasone|dexamethasone|mesh-list
102202229|NCT02203253|Palonosetron|palonosetron|mesh-list
102202230|NCT02203253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102202231|NCT02203253|Antiemetics|antiemetics|mesh-ancestor
102202232|NCT02203253|Autonomic Agents|autonomic agents|mesh-ancestor
102202233|NCT02203253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102202234|NCT02203253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202235|NCT02203253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102202236|NCT02203253|Glucocorticoids|glucocorticoids|mesh-ancestor
102202237|NCT02203253|Hormones|hormones|mesh-ancestor
102202238|NCT02203253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102202239|NCT02203253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102202240|NCT02203253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102202241|NCT02203253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102202242|NCT02203253|Immunologic Factors|immunologic factors|mesh-ancestor
102202243|NCT02203253|Leprostatic Agents|leprostatic agents|mesh-ancestor
102202244|NCT02203253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102202245|NCT02203253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102202246|NCT02203253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102202247|NCT02203253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102202248|NCT02203253|Growth Substances|growth substances|mesh-ancestor
102202249|NCT02203253|Growth Inhibitors|growth inhibitors|mesh-ancestor
102202250|NCT02203253|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102202251|NCT02203253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102202252|NCT02203253|Serotonin Agents|serotonin agents|mesh-ancestor
102202253|NCT02203253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102202254|NCT02203253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202255|NCT02207699|Moxifloxacin|moxifloxacin|mesh-list
102202256|NCT02207699|Benzonatate|benzonatate|mesh-list
102202257|NCT02207699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102202258|NCT02207699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102202259|NCT02207699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102202260|NCT02207699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102202261|NCT02207699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102202262|NCT02207699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202263|NCT02207699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101911017|NCT01369576|Zopiclone|zopiclone|mesh-list
102202264|NCT02207699|Antitussive Agents|antitussive agents|mesh-ancestor
102202265|NCT02207699|Respiratory System Agents|respiratory system agents|mesh-ancestor
102202266|NCT02296138|Tiotropium Bromide|tiotropium bromide|mesh-list
102202267|NCT02296138|Olodaterol|olodaterol|mesh-list
102202268|NCT02296138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102202269|NCT02296138|Autonomic Agents|autonomic agents|mesh-ancestor
102202270|NCT02296138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102202271|NCT02296138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202272|NCT02296138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102202273|NCT02296138|Respiratory System Agents|respiratory system agents|mesh-ancestor
102202274|NCT02296138|Parasympatholytics|parasympatholytics|mesh-ancestor
102202275|NCT02296138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102202276|NCT02296138|Cholinergic Agents|cholinergic agents|mesh-ancestor
102202277|NCT02296138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102202278|NCT02296138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202279|NCT01306942|Paclitaxel|paclitaxel|mesh-list
102202280|NCT01306942|Trastuzumab|trastuzumab|mesh-list
102202281|NCT01306942|Dasatinib|dasatinib|mesh-list
102202282|NCT01306942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102202283|NCT01306942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102202285|NCT01306942|Antimitotic Agents|antimitotic agents|mesh-ancestor
102202286|NCT01306942|Mitosis Modulators|mitosis modulators|mesh-ancestor
102202287|NCT01306942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202288|NCT01306942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102202289|NCT01306942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102202290|NCT01306942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102202291|NCT02207855|Chloroprocaine|chloroprocaine|mesh-list
102202292|NCT02207855|Anesthetics, Local|anesthetics, local|mesh-ancestor
102202293|NCT02207855|Anesthetics|anesthetics|mesh-ancestor
102202294|NCT02207855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102202295|NCT02207855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202296|NCT02207855|Sensory System Agents|sensory system agents|mesh-ancestor
102202297|NCT02207855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102202298|NCT01345851|Paclitaxel|paclitaxel|mesh-list
102202299|NCT01345851|Carboplatin|carboplatin|mesh-list
102202300|NCT01345851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102202301|NCT01345851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102202302|NCT01345851|Tubulin Modulators|tubulin modulators|mesh-ancestor
102202303|NCT01345851|Antimitotic Agents|antimitotic agents|mesh-ancestor
102202304|NCT01345851|Mitosis Modulators|mitosis modulators|mesh-ancestor
102202305|NCT01345851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202306|NCT03532841|Tramadol|tramadol|mesh-list
102202307|NCT03532841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102202308|NCT03532841|Narcotics|narcotics|mesh-ancestor
102202309|NCT03532841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102202310|NCT03532841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202311|NCT03532841|Analgesics|analgesics|mesh-ancestor
102202312|NCT03532841|Sensory System Agents|sensory system agents|mesh-ancestor
102202313|NCT03532841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102202314|NCT02199431|Itraconazole|itraconazole|mesh-list
102202315|NCT02199431|Antifungal Agents|antifungal agents|mesh-ancestor
102202316|NCT02199431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102202317|NCT02199431|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102202318|NCT02199431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102202319|NCT02199431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102202320|NCT02199431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202321|NCT02199431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102202322|NCT02199431|Hormone Antagonists|hormone antagonists|mesh-ancestor
102202323|NCT02199431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102202324|NCT02199431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202325|NCT02199431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102202326|NCT02203799|Immunomodulating Agents|immunomodulating agents|mesh-list
102202327|NCT02203799|Immunologic Factors|immunologic factors|mesh-list
102202328|NCT02203799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202329|NCT03532763|Tocotrienols|tocotrienols|mesh-list
102202330|NCT03532763|Vitamin E|vitamin e|mesh-list
102202331|NCT03532763|Tocopherols|tocopherols|mesh-list
102202332|NCT03532763|Tocovid|tocovid|mesh-list
102202333|NCT03532763|Antioxidants|antioxidants|mesh-ancestor
102202334|NCT03532763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202335|NCT03532763|Protective Agents|protective agents|mesh-ancestor
102202336|NCT03532763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202337|NCT03532763|Vitamins|vitamins|mesh-ancestor
102202338|NCT03532763|Micronutrients|micronutrients|mesh-ancestor
102202339|NCT02208245|Ropivacaine|ropivacaine|mesh-list
102202340|NCT02208245|Anesthetics, Local|anesthetics, local|mesh-ancestor
102202341|NCT02208245|Anesthetics|anesthetics|mesh-ancestor
102202342|NCT02208245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102202343|NCT02208245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202344|NCT02208245|Sensory System Agents|sensory system agents|mesh-ancestor
102202345|NCT02208245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102202346|NCT03514901|Pembrolizumab|pembrolizumab|mesh-list
102202347|NCT03514901|Nivolumab|nivolumab|mesh-list
102202348|NCT03514901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102202349|NCT03514901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102202350|NCT03514901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102202351|NCT03514901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202352|NCT04441021|Penicillins|penicillins|mesh-list
102202353|NCT04441021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102202354|NCT04441021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102202355|NCT03533387|Ibudilast|ibudilast|mesh-list
102202356|NCT03533387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102202357|NCT03533387|Autonomic Agents|autonomic agents|mesh-ancestor
102202358|NCT03533387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102202359|NCT03533387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202360|NCT03533387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102202361|NCT03533387|Respiratory System Agents|respiratory system agents|mesh-ancestor
102202362|NCT03533387|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102202363|NCT03533387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102202364|NCT03533387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202365|NCT03533387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102202366|NCT03533387|Vasodilator Agents|vasodilator agents|mesh-ancestor
102202367|NCT02324842|Liraglutide|liraglutide|mesh-list
102202368|NCT02324842|Canagliflozin|canagliflozin|mesh-list
102202369|NCT02324842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102202370|NCT02324842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202371|NCT02324842|Incretins|incretins|mesh-ancestor
102202372|NCT02324842|Hormones|hormones|mesh-ancestor
102202373|NCT02324842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102202374|NCT02324842|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102202375|NCT02324842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202376|NCT02295280|Diphenhydramine|diphenhydramine|mesh-list
102202377|NCT02295280|Promethazine|promethazine|mesh-list
102202378|NCT02295280|Codeine|codeine|mesh-list
102202379|NCT02295280|Metoclopramide|metoclopramide|mesh-list
102202380|NCT02295280|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102202381|NCT02295280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102202382|NCT02295280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102202383|NCT02295280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202384|NCT02295280|Anesthetics, Local|anesthetics, local|mesh-ancestor
102202385|NCT02295280|Anesthetics|anesthetics|mesh-ancestor
102202386|NCT02295280|Sensory System Agents|sensory system agents|mesh-ancestor
102202387|NCT02295280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102202388|NCT02295280|Antiemetics|antiemetics|mesh-ancestor
102202389|NCT02295280|Autonomic Agents|autonomic agents|mesh-ancestor
102202390|NCT02295280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102202391|NCT02295280|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102202392|NCT02295280|Histamine Antagonists|histamine antagonists|mesh-ancestor
102202393|NCT02295280|Histamine Agents|histamine agents|mesh-ancestor
102202394|NCT02295280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102202395|NCT02295280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202396|NCT02295280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102202397|NCT02295280|Antipruritics|antipruritics|mesh-ancestor
102202398|NCT02295280|Dermatologic Agents|dermatologic agents|mesh-ancestor
102202399|NCT02295280|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102202400|NCT02295280|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102202401|NCT02295280|Dopamine Agents|dopamine agents|mesh-ancestor
102202402|NCT02295280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102202403|NCT02295280|Narcotics|narcotics|mesh-ancestor
102202404|NCT02295280|Analgesics|analgesics|mesh-ancestor
102202405|NCT02295280|Antitussive Agents|antitussive agents|mesh-ancestor
102202406|NCT02295280|Respiratory System Agents|respiratory system agents|mesh-ancestor
102202407|NCT05263505|Methotrexate|methotrexate|mesh-list
102202408|NCT05263505|Azathioprine|azathioprine|mesh-list
102202409|NCT05263505|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102202410|NCT05263505|Abortifacient Agents|abortifacient agents|mesh-ancestor
102202411|NCT05263505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102202412|NCT05263505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202413|NCT05263505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102202414|NCT05263505|Antimetabolites|antimetabolites|mesh-ancestor
102202415|NCT05263505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202416|NCT05263505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102202417|NCT05263505|Dermatologic Agents|dermatologic agents|mesh-ancestor
102202418|NCT05263505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102202419|NCT05263505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102202420|NCT05263505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102202421|NCT05263505|Immunologic Factors|immunologic factors|mesh-ancestor
102202422|NCT05263505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102202423|NCT05263505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102202424|NCT02204501|Midazolam|midazolam|mesh-list
102202425|NCT02204501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102202426|NCT02204501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102202427|NCT02204501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102202428|NCT02204501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202429|NCT02204501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102202430|NCT02204501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102202431|NCT02204501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102202432|NCT02204501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102202433|NCT02204501|Anesthetics, General|anesthetics, general|mesh-ancestor
102202434|NCT02204501|Anesthetics|anesthetics|mesh-ancestor
102202435|NCT02204501|GABA Modulators|gaba modulators|mesh-ancestor
102202436|NCT02204501|GABA Agents|gaba agents|mesh-ancestor
102202437|NCT02204501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102202438|NCT02204501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202439|NCT02294734|Nemiralisib|nemiralisib|mesh-list
102202440|NCT02294734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102202441|NCT02294734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102202442|NCT02294734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202443|NCT03533231|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102202444|NCT03533231|Metronidazole|metronidazole|mesh-list
102202445|NCT03533231|Ciprofloxacin|ciprofloxacin|mesh-list
102202446|NCT03533231|Propolis|propolis|mesh-list
102202447|NCT03533231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102202448|NCT03533231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102202449|NCT03533231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102202450|NCT03533231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102202451|NCT03533231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102202452|NCT03533231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102202453|NCT03533231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202454|NCT03533231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102202455|NCT03533231|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102202456|NCT03533231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102202457|NCT02200757|Topotecan|topotecan|mesh-list
102202458|NCT02200757|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102202459|NCT02200757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102202460|NCT02200757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102202461|NCT02200757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202462|NCT02200757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102202463|NCT02208791|Sirolimus|sirolimus|mesh-list
102202464|NCT02208791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102202465|NCT02208791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102202466|NCT02208791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102202467|NCT02208791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102202468|NCT02208791|Antifungal Agents|antifungal agents|mesh-ancestor
102202469|NCT02208791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102202470|NCT02208791|Immunologic Factors|immunologic factors|mesh-ancestor
102202471|NCT02208791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202472|NCT05223101|Telmisartan|telmisartan|mesh-list
102202473|NCT05223101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102202474|NCT05223101|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102202475|NCT05223101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102202476|NCT05223101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202477|NCT05438953|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
102202478|NCT05438953|Antiviral Agents|antiviral agents|mesh-ancestor
102202479|NCT05438953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102202480|NCT02852057|Timolol|timolol|mesh-list
102202481|NCT02852057|Dorzolamide|dorzolamide|mesh-list
102202482|NCT02852057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102202483|NCT02852057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202484|NCT02852057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102202485|NCT02852057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102202486|NCT02852057|Adrenergic Agents|adrenergic agents|mesh-ancestor
102202487|NCT02852057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102202488|NCT02852057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202489|NCT02852057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102202490|NCT02852057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102202491|NCT02852057|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102202492|NCT04020445|Insulin|insulin|mesh-list
102202493|NCT04020445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102202494|NCT04020445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202495|NCT03524833|Amoxicillin|amoxicillin|mesh-list
102202496|NCT03524833|Metronidazole|metronidazole|mesh-list
102202497|NCT03524833|Lansoprazole|lansoprazole|mesh-list
102202498|NCT03524833|Dexlansoprazole|dexlansoprazole|mesh-list
102202499|NCT03524833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102202500|NCT03524833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102202501|NCT03524833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102202503|NCT03524833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102202504|NCT03524833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102202505|NCT03524833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102202506|NCT03524833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102202507|NCT03524833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202508|NCT02220647|Metformin|metformin|mesh-list
102202509|NCT02220647|Linagliptin|linagliptin|mesh-list
102202510|NCT02220647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102202511|NCT02220647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202512|NCT02220647|Incretins|incretins|mesh-ancestor
102202513|NCT02220647|Hormones|hormones|mesh-ancestor
102202514|NCT02220647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102202515|NCT02220647|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102202516|NCT02220647|Protease Inhibitors|protease inhibitors|mesh-ancestor
102202517|NCT02220647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102202518|NCT02220647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202519|NCT05426395|Vitamins|vitamins|mesh-list
102202520|NCT05426395|Hydroxocobalamin|hydroxocobalamin|mesh-list
102202521|NCT05426395|Vitamin B 12|vitamin b 12|mesh-list
102202522|NCT05426395|Vitamin B Complex|vitamin b complex|mesh-list
102202523|NCT05426395|Micronutrients|micronutrients|mesh-ancestor
102202524|NCT05426395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202525|NCT05426395|Hematinics|hematinics|mesh-ancestor
102202526|NCT03544567|Paclitaxel|paclitaxel|mesh-list
102202527|NCT03544567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102202528|NCT03544567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102202529|NCT03544567|Tubulin Modulators|tubulin modulators|mesh-ancestor
102202530|NCT03544567|Antimitotic Agents|antimitotic agents|mesh-ancestor
102202531|NCT03544567|Mitosis Modulators|mitosis modulators|mesh-ancestor
102202532|NCT03544567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202533|NCT02209025|Theobromine|theobromine|mesh-list
102202534|NCT02209025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102202535|NCT02209025|Autonomic Agents|autonomic agents|mesh-ancestor
102202536|NCT02209025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102202537|NCT02209025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202538|NCT02209025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102202539|NCT02209025|Respiratory System Agents|respiratory system agents|mesh-ancestor
102202540|NCT02209025|Vasodilator Agents|vasodilator agents|mesh-ancestor
102202541|NCT02220803|Acetazolamide|acetazolamide|mesh-list
102202542|NCT02220803|Anticonvulsants|anticonvulsants|mesh-ancestor
102202543|NCT02220803|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102202544|NCT02220803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102202545|NCT02220803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202546|NCT02220803|Diuretics|diuretics|mesh-ancestor
102202547|NCT02220803|Natriuretic Agents|natriuretic agents|mesh-ancestor
102202548|NCT02220803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202549|NCT02322892|Thiamine|thiamine|mesh-list
102202550|NCT02322892|Vitamins|vitamins|mesh-ancestor
102202551|NCT02322892|Micronutrients|micronutrients|mesh-ancestor
102202552|NCT02322892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202553|NCT02322892|Vitamin B Complex|vitamin b complex|mesh-ancestor
102202554|NCT03274375|Rituximab|rituximab|mesh-list
102202555|NCT03274375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102202556|NCT03274375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102202557|NCT03274375|Immunologic Factors|immunologic factors|mesh-ancestor
102202558|NCT03274375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202559|NCT03274375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102202560|NCT02739997|Metronidazole|metronidazole|mesh-list
102202561|NCT02739997|Tazobactam|tazobactam|mesh-list
102202562|NCT02739997|Ceftolozane|ceftolozane|mesh-list
102202563|NCT02739997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102202564|NCT02739997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101911347|NCT01216956|Niacin|niacin|mesh-list
102202565|NCT02739997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102202566|NCT02739997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102202567|NCT02739997|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102202568|NCT02739997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102202569|NCT02739997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202570|NCT04467931|Losartan|losartan|mesh-list
102202571|NCT04467931|Timolol|timolol|mesh-list
102202572|NCT04467931|Propranolol|propranolol|mesh-list
102202573|NCT04467931|Metoprolol|metoprolol|mesh-list
102202574|NCT04467931|Atenolol|atenolol|mesh-list
102202575|NCT04467931|Verapamil|verapamil|mesh-list
102202576|NCT04467931|Felodipine|felodipine|mesh-list
102202577|NCT04467931|Nadolol|nadolol|mesh-list
102202578|NCT04467931|Acebutolol|acebutolol|mesh-list
102202579|NCT04467931|Amlodipine|amlodipine|mesh-list
102202580|NCT04467931|Valsartan|valsartan|mesh-list
102202581|NCT04467931|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102202582|NCT04467931|Telmisartan|telmisartan|mesh-list
102202583|NCT04467931|Clonidine|clonidine|mesh-list
102202584|NCT04467931|Carvedilol|carvedilol|mesh-list
102202585|NCT04467931|Candesartan|candesartan|mesh-list
102202586|NCT04467931|Candesartan cilexetil|candesartan cilexetil|mesh-list
102202587|NCT04467931|Ramipril|ramipril|mesh-list
102202588|NCT04467931|Olmesartan|olmesartan|mesh-list
102202589|NCT04467931|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
102202590|NCT04467931|Enalapril|enalapril|mesh-list
102202591|NCT04467931|Enalaprilat|enalaprilat|mesh-list
102202592|NCT04467931|Lisinopril|lisinopril|mesh-list
102202593|NCT04467931|Irbesartan|irbesartan|mesh-list
102202594|NCT04467931|Eplerenone|eplerenone|mesh-list
102202595|NCT04467931|Nebivolol|nebivolol|mesh-list
102202596|NCT04467931|Chlorthalidone|chlorthalidone|mesh-list
102202597|NCT04467931|Bisoprolol|bisoprolol|mesh-list
102202598|NCT04467931|Perindopril|perindopril|mesh-list
102202599|NCT04467931|Diltiazem|diltiazem|mesh-list
102202600|NCT04467931|Minoxidil|minoxidil|mesh-list
102202601|NCT04467931|Guanfacine|guanfacine|mesh-list
102202602|NCT04467931|Prazosin|prazosin|mesh-list
102202603|NCT04467931|Doxazosin|doxazosin|mesh-list
102202604|NCT04467931|Benazepril|benazepril|mesh-list
102202605|NCT04467931|Labetalol|labetalol|mesh-list
102202606|NCT04467931|Hydralazine|hydralazine|mesh-list
102202607|NCT04467931|Captopril|captopril|mesh-list
102202608|NCT04467931|Indapamide|indapamide|mesh-list
102202609|NCT04467931|Nicardipine|nicardipine|mesh-list
102202610|NCT04467931|Quinapril|quinapril|mesh-list
102202611|NCT04467931|Metolazone|metolazone|mesh-list
102202612|NCT04467931|Trandolapril|trandolapril|mesh-list
102202613|NCT04467931|Torsemide|torsemide|mesh-list
102202614|NCT04467931|Methyldopa|methyldopa|mesh-list
102202615|NCT04467931|Fosinopril|fosinopril|mesh-list
102202616|NCT04467931|Isradipine|isradipine|mesh-list
102202617|NCT04467931|Eprosartan|eprosartan|mesh-list
102202618|NCT04467931|Pindolol|pindolol|mesh-list
102202619|NCT04467931|Moexipril|moexipril|mesh-list
102202620|NCT04467931|Betaxolol|betaxolol|mesh-list
102202621|NCT04467931|Bendroflumethiazide|bendroflumethiazide|mesh-list
102202622|NCT04467931|Reserpine|reserpine|mesh-list
102202623|NCT04467931|Chlorothiazide|chlorothiazide|mesh-list
102202624|NCT04467931|Guanabenz|guanabenz|mesh-list
102202625|NCT04467931|Nisoldipine|nisoldipine|mesh-list
102202626|NCT04467931|Penbutolol|penbutolol|mesh-list
102202627|NCT04467931|Nifedipine|nifedipine|mesh-list
102202628|NCT04467931|Amiloride|amiloride|mesh-list
102202629|NCT04467931|Triamterene|triamterene|mesh-list
102202630|NCT04467931|Furosemide|furosemide|mesh-list
102202631|NCT04467931|Spironolactone|spironolactone|mesh-list
102202632|NCT04467931|Bumetanide|bumetanide|mesh-list
102202633|NCT04467931|Ethacrynic Acid|ethacrynic acid|mesh-list
102202634|NCT04467931|Terazosin|terazosin|mesh-list
102202635|NCT04467931|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
102202636|NCT04467931|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102202637|NCT04467931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102202638|NCT04467931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102202639|NCT04467931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102202640|NCT04467931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202641|NCT04467931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102202642|NCT04467931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202643|NCT04467931|Vasodilator Agents|vasodilator agents|mesh-ancestor
102202644|NCT04467931|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102202645|NCT04467931|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102202646|NCT04467931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102202647|NCT04467931|Diuretics|diuretics|mesh-ancestor
102202648|NCT04467931|Natriuretic Agents|natriuretic agents|mesh-ancestor
102202649|NCT04467931|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102202650|NCT04467931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102202651|NCT04467931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102202652|NCT04467931|Adrenergic Agents|adrenergic agents|mesh-ancestor
102202653|NCT04467931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102202654|NCT04467931|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102202655|NCT04467931|Sympatholytics|sympatholytics|mesh-ancestor
102202656|NCT04467931|Autonomic Agents|autonomic agents|mesh-ancestor
102202657|NCT04467931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102202658|NCT04467931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102202660|NCT04467931|Sensory System Agents|sensory system agents|mesh-ancestor
102202661|NCT04467931|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102202662|NCT04467931|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102202663|NCT04467931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102202664|NCT04467931|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102202665|NCT04467931|Hormone Antagonists|hormone antagonists|mesh-ancestor
102202666|NCT04467931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102202667|NCT04467931|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102202669|NCT04467931|Protective Agents|protective agents|mesh-ancestor
102202670|NCT04467931|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102202671|NCT04467931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102202672|NCT04467931|Protease Inhibitors|protease inhibitors|mesh-ancestor
102202673|NCT04467931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102202674|NCT04467931|Tocolytic Agents|tocolytic agents|mesh-ancestor
102202675|NCT04467931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102202676|NCT04467931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102202677|NCT04467931|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102202678|NCT04467931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102202679|NCT04467931|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
102202680|NCT04467931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102202681|NCT04467931|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
102202682|NCT04467931|Sympathomimetics|sympathomimetics|mesh-ancestor
102202683|NCT04467931|Urological Agents|urological agents|mesh-ancestor
102202684|NCT04467931|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
102202685|NCT04467931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102202686|NCT04467931|Serotonin Agents|serotonin agents|mesh-ancestor
102202687|NCT04467931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102202688|NCT04467931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102202689|NCT04467931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102202690|NCT04467931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102202691|NCT04467931|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102202692|NCT04467931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102202693|NCT03705559|Analgesics, Opioid|analgesics, opioid|mesh-list
102202694|NCT03705559|Narcotics|narcotics|mesh-ancestor
102202695|NCT03705559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102202696|NCT03705559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202697|NCT03705559|Analgesics|analgesics|mesh-ancestor
102202698|NCT03705559|Sensory System Agents|sensory system agents|mesh-ancestor
102202699|NCT03705559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102202700|NCT03522649|Leucovorin|leucovorin|mesh-list
102202701|NCT03522649|Fluorouracil|fluorouracil|mesh-list
102202702|NCT03522649|Irinotecan|irinotecan|mesh-list
102202703|NCT03522649|Antimetabolites|antimetabolites|mesh-ancestor
102202704|NCT03522649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202705|NCT03522649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102202706|NCT03522649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102202707|NCT03522649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102202708|NCT03522649|Immunologic Factors|immunologic factors|mesh-ancestor
102202709|NCT03522649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202710|NCT03522649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102202711|NCT03522649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102202712|NCT03522649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102202713|NCT03522649|Antidotes|antidotes|mesh-ancestor
102202714|NCT03522649|Protective Agents|protective agents|mesh-ancestor
102202715|NCT03522649|Vitamin B Complex|vitamin b complex|mesh-ancestor
102202716|NCT03522649|Vitamins|vitamins|mesh-ancestor
102202717|NCT03522649|Micronutrients|micronutrients|mesh-ancestor
102202718|NCT02366481|Vitamins|vitamins|mesh-list
102202719|NCT02366481|Vitamin K|vitamin k|mesh-list
102202720|NCT02366481|Vitamin K 2|vitamin k 2|mesh-list
102202721|NCT02366481|Menaquinone 7|menaquinone 7|mesh-list
102202722|NCT02366481|Micronutrients|micronutrients|mesh-ancestor
102202723|NCT02366481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202724|NCT02366481|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102202725|NCT02366481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102202726|NCT02366481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202727|NCT02366481|Hemostatics|hemostatics|mesh-ancestor
102202728|NCT02366481|Coagulants|coagulants|mesh-ancestor
102202729|NCT02366247|Adefovir|adefovir|mesh-list
102202730|NCT02366247|Thymalfasin|thymalfasin|mesh-list
102202731|NCT02366247|Antiviral Agents|antiviral agents|mesh-ancestor
102202732|NCT02366247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101911479|NCT03575572|Colchicine|colchicine|mesh-list
102202733|NCT02366247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102202734|NCT02366247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102202736|NCT02366247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202737|NCT02366247|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102202738|NCT02366247|Immunologic Factors|immunologic factors|mesh-ancestor
102202739|NCT02366247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202740|NCT02373735|Mannitol|mannitol|mesh-list
102202741|NCT02373735|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102202742|NCT02373735|Diuretics|diuretics|mesh-ancestor
102202743|NCT02373735|Natriuretic Agents|natriuretic agents|mesh-ancestor
102202744|NCT02373735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202745|NCT03526315|Fluorides|fluorides|mesh-list
102202746|NCT03526315|Cariostatic Agents|cariostatic agents|mesh-ancestor
102202747|NCT03526315|Protective Agents|protective agents|mesh-ancestor
102202748|NCT03526315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202749|NCT03112551|Magnesium Sulfate|magnesium sulfate|mesh-list
102202750|NCT03112551|Analgesics|analgesics|mesh-ancestor
102202751|NCT03112551|Sensory System Agents|sensory system agents|mesh-ancestor
102202752|NCT03112551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102202753|NCT03112551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202754|NCT03112551|Anesthetics|anesthetics|mesh-ancestor
102202755|NCT03112551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102202756|NCT03112551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102202757|NCT03112551|Anticonvulsants|anticonvulsants|mesh-ancestor
102202758|NCT03112551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102202759|NCT03112551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102202760|NCT03112551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202761|NCT03112551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102202762|NCT03112551|Tocolytic Agents|tocolytic agents|mesh-ancestor
102202763|NCT03112551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102202764|NCT05373433|Ritonavir|ritonavir|mesh-list
102202765|NCT05373433|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102202766|NCT05373433|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102202767|NCT05373433|Protease Inhibitors|protease inhibitors|mesh-ancestor
102202768|NCT05373433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102202769|NCT05373433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202770|NCT05373433|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102202771|NCT05373433|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102202772|NCT05373433|Antiviral Agents|antiviral agents|mesh-ancestor
102202773|NCT05373433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102202774|NCT05373433|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102202775|NCT05373433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102202776|NCT02363127|Progesterone|progesterone|mesh-list
102202777|NCT02363127|Progestins|progestins|mesh-ancestor
102202778|NCT02363127|Hormones|hormones|mesh-ancestor
102202779|NCT02363127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102202780|NCT02363127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202781|NCT03526159|Gentamicins|gentamicins|mesh-list
102202782|NCT03526159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102202783|NCT03526159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102202784|NCT03526159|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102202785|NCT03526159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102202786|NCT03526159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202787|NCT03523741|Clozapine|clozapine|mesh-list
102202788|NCT03523741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102202789|NCT03523741|Serotonin Agents|serotonin agents|mesh-ancestor
102202790|NCT03523741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102202791|NCT03523741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202792|NCT03523741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202793|NCT03523741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102202794|NCT03523741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102202795|NCT03523741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102202796|NCT03523741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102202797|NCT03523741|GABA Antagonists|gaba antagonists|mesh-ancestor
102202798|NCT03523741|GABA Agents|gaba agents|mesh-ancestor
102202799|NCT02362581|Factor VIII|factor viii|mesh-list
102202800|NCT02362581|Coagulants|coagulants|mesh-ancestor
102202801|NCT03525925|Nivolumab|nivolumab|mesh-list
102202802|NCT03525925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102202803|NCT03525925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101450382|NCT00216021|Capecitabine|capecitabine|mesh-list
102202804|NCT03525925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102202805|NCT03525925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202806|NCT02373579|Methotrexate|methotrexate|mesh-list
101911544|NCT01219764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102202807|NCT02373579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102202808|NCT02373579|Abortifacient Agents|abortifacient agents|mesh-ancestor
102202809|NCT02373579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102202810|NCT02373579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202811|NCT02373579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102202812|NCT02373579|Antimetabolites|antimetabolites|mesh-ancestor
102202813|NCT02373579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202814|NCT02373579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101900552|NCT02987530|Tenofovir|tenofovir|mesh-list
102202815|NCT02373579|Dermatologic Agents|dermatologic agents|mesh-ancestor
102202816|NCT02373579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102202817|NCT02373579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102202818|NCT02373579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102202819|NCT02373579|Immunologic Factors|immunologic factors|mesh-ancestor
102202820|NCT02373579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102202821|NCT02373579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102202822|NCT02365857|Dexmedetomidine|dexmedetomidine|mesh-list
102202823|NCT02365857|Bupivacaine|bupivacaine|mesh-list
102202824|NCT02365857|Anesthetics, Local|anesthetics, local|mesh-ancestor
102202825|NCT02365857|Anesthetics|anesthetics|mesh-ancestor
102202826|NCT02365857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102202827|NCT02365857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202828|NCT02365857|Sensory System Agents|sensory system agents|mesh-ancestor
102202829|NCT02365857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102202830|NCT02365857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102202831|NCT02365857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102202832|NCT02365857|Analgesics|analgesics|mesh-ancestor
102202833|NCT02365857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102202834|NCT02365857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102202835|NCT02365857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102202836|NCT02365857|Adrenergic Agents|adrenergic agents|mesh-ancestor
102202837|NCT02365857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102202838|NCT02365857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202839|NCT02365935|Paclitaxel|paclitaxel|mesh-list
102202840|NCT02365935|Cisplatin|cisplatin|mesh-list
102202841|NCT02365935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102202842|NCT02365935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102202843|NCT02365935|Tubulin Modulators|tubulin modulators|mesh-ancestor
102202844|NCT02365935|Antimitotic Agents|antimitotic agents|mesh-ancestor
102202845|NCT02365935|Mitosis Modulators|mitosis modulators|mesh-ancestor
102202846|NCT02365935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202847|NCT02365623|Bedaquiline|bedaquiline|mesh-list
102202848|NCT02365623|Diarylquinolines|diarylquinolines|mesh-list
102202849|NCT02365623|Antitubercular Agents|antitubercular agents|mesh-ancestor
102202850|NCT02365623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102202851|NCT02365623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102202852|NCT03112707|Aspirin|aspirin|mesh-list
102202853|NCT03112707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102202854|NCT03112707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102202855|NCT03112707|Analgesics|analgesics|mesh-ancestor
102202856|NCT03112707|Sensory System Agents|sensory system agents|mesh-ancestor
102202857|NCT03112707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102202858|NCT03112707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202859|NCT03112707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102202860|NCT03112707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102202861|NCT03112707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102202862|NCT03112707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102202863|NCT03112707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202864|NCT03112707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102202865|NCT03112707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102202866|NCT03112707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102202867|NCT03112707|Antipyretics|antipyretics|mesh-ancestor
102202868|NCT05262413|Lenvatinib|lenvatinib|mesh-list
102202869|NCT05262413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102202870|NCT05262413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102202871|NCT05262413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102202872|NCT05262413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202873|NCT02209649|Telmisartan|telmisartan|mesh-list
102202874|NCT02209649|Lacidipine|lacidipine|mesh-list
102202875|NCT02209649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102202876|NCT02209649|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102202877|NCT02209649|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102202878|NCT02209649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202879|NCT02209649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102202880|NCT02209649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102202881|NCT02209649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102202882|NCT02209649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202883|NCT02361567|Acetaminophen|acetaminophen|mesh-list
102202884|NCT02361567|Oxycodone|oxycodone|mesh-list
102202885|NCT02361567|Tramadol|tramadol|mesh-list
102202886|NCT02361567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102202887|NCT02361567|Narcotics|narcotics|mesh-ancestor
102202888|NCT02361567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102202889|NCT02361567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202890|NCT02361567|Analgesics|analgesics|mesh-ancestor
102202891|NCT02361567|Sensory System Agents|sensory system agents|mesh-ancestor
102202892|NCT02361567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102202893|NCT02361567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102202894|NCT02361567|Antipyretics|antipyretics|mesh-ancestor
102202895|NCT03112785|Cimetidine|cimetidine|mesh-list
102202896|NCT03112785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102202897|NCT03112785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102202898|NCT03112785|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102202899|NCT03112785|Histamine Antagonists|histamine antagonists|mesh-ancestor
102202900|NCT03112785|Histamine Agents|histamine agents|mesh-ancestor
102202901|NCT03112785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102202902|NCT03112785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202903|NCT03112785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202904|NCT03112785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102202905|NCT03112785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102202906|NCT03112785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102202907|NCT02361879|Leuprolide|leuprolide|mesh-list
102202908|NCT02361879|Ulipristal acetate|ulipristal acetate|mesh-list
102202909|NCT02361879|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102202910|NCT02361879|Fertility Agents|fertility agents|mesh-ancestor
102202911|NCT02361879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102202912|NCT02361879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202913|NCT02361879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102202914|NCT02361879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102202915|NCT02361879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102202916|NCT02361879|Contraceptive Agents|contraceptive agents|mesh-ancestor
102202917|NCT02361879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102202918|NCT05262335|Paclitaxel|paclitaxel|mesh-list
102202919|NCT05262335|Docetaxel|docetaxel|mesh-list
102202920|NCT05262335|Capecitabine|capecitabine|mesh-list
102202921|NCT05262335|Oxaliplatin|oxaliplatin|mesh-list
102202922|NCT05262335|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102202923|NCT05262335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102202924|NCT05262335|Tubulin Modulators|tubulin modulators|mesh-ancestor
102202925|NCT05262335|Antimitotic Agents|antimitotic agents|mesh-ancestor
102202926|NCT05262335|Mitosis Modulators|mitosis modulators|mesh-ancestor
102202927|NCT05262335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202928|NCT05262335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102202929|NCT05262335|Antimetabolites|antimetabolites|mesh-ancestor
102202930|NCT02361645|Ketorolac|ketorolac|mesh-list
102202931|NCT02361645|Indomethacin|indomethacin|mesh-list
102202932|NCT02361645|Nepafenac|nepafenac|mesh-list
102202933|NCT02361645|Bromfenac|bromfenac|mesh-list
102202934|NCT02361645|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102202935|NCT02361645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102202936|NCT02361645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102202937|NCT02361645|Analgesics|analgesics|mesh-ancestor
102202938|NCT02361645|Sensory System Agents|sensory system agents|mesh-ancestor
102202939|NCT02361645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101450392|NCT00216138|Capecitabine|capecitabine|mesh-list
102202940|NCT02361645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202941|NCT02361645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102202942|NCT02361645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102202943|NCT02361645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102202944|NCT02361645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102202945|NCT02361645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202946|NCT02361645|Gout Suppressants|gout suppressants|mesh-ancestor
102202947|NCT02361645|Tocolytic Agents|tocolytic agents|mesh-ancestor
102202948|NCT02361645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102202949|NCT02361645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102202950|NCT03522181|Insulin|insulin|mesh-list
102202951|NCT03522181|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102202952|NCT03522181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102202953|NCT03522181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202954|NCT02373033|Folic Acid|folic acid|mesh-list
102202955|NCT02373033|Vitamin B Complex|vitamin b complex|mesh-list
102202956|NCT02373033|Hematinics|hematinics|mesh-ancestor
102202957|NCT02373033|Vitamins|vitamins|mesh-ancestor
102202958|NCT02373033|Micronutrients|micronutrients|mesh-ancestor
102202959|NCT02373033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202960|NCT05186129|Clopidogrel|clopidogrel|mesh-list
102202961|NCT05186129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102202962|NCT05186129|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102202963|NCT05186129|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102202964|NCT05186129|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102202965|NCT05186129|Purinergic Agents|purinergic agents|mesh-ancestor
102202966|NCT05186129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102202967|NCT05186129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202968|NCT05186129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202969|NCT02361723|Pamiparib|pamiparib|mesh-list
102202970|NCT02361723|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102202971|NCT02361723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102202972|NCT02361723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202973|NCT02361723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102202974|NCT03596281|Bevacizumab|bevacizumab|mesh-list
102202975|NCT03596281|Pembrolizumab|pembrolizumab|mesh-list
102202976|NCT03596281|Doxorubicin|doxorubicin|mesh-list
102202977|NCT03596281|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102202978|NCT03596281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102202979|NCT03596281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102202980|NCT03596281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102202981|NCT03596281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102202982|NCT03596281|Growth Substances|growth substances|mesh-ancestor
102202983|NCT03596281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202984|NCT03596281|Growth Inhibitors|growth inhibitors|mesh-ancestor
102202985|NCT03596281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102202986|NCT03596281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102202987|NCT03596281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102202988|NCT03596281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102202989|NCT03596281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102202990|NCT03596281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102202991|NCT05172167|Antibodies|antibodies|mesh-list
102202992|NCT05172167|Immunologic Factors|immunologic factors|mesh-ancestor
102202993|NCT05172167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202994|NCT02359149|Endothelial Growth Factors|endothelial growth factors|mesh-list
102202995|NCT02359149|Growth Substances|growth substances|mesh-ancestor
102202996|NCT02359149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102202997|NCT02221583|Mycophenolic Acid|mycophenolic acid|mesh-list
102202998|NCT02221583|Tacrolimus|tacrolimus|mesh-list
102202999|NCT02221583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102203000|NCT02221583|Immunologic Factors|immunologic factors|mesh-ancestor
102203001|NCT02221583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203002|NCT02221583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102203003|NCT02221583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102203004|NCT02221583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203005|NCT02221583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102203006|NCT02221583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102203007|NCT02221583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102203008|NCT02221583|Antitubercular Agents|antitubercular agents|mesh-ancestor
102203009|NCT02221583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102203010|NCT02221583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102203011|NCT03500731|Rituximab|rituximab|mesh-list
102203012|NCT03500731|Alemtuzumab|alemtuzumab|mesh-list
102203013|NCT03500731|Fludarabine|fludarabine|mesh-list
102203014|NCT03500731|Thiotepa|thiotepa|mesh-list
102203015|NCT03500731|Hydroxyurea|hydroxyurea|mesh-list
102203016|NCT03500731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102203017|NCT03500731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102203018|NCT03500731|Immunologic Factors|immunologic factors|mesh-ancestor
102203019|NCT03500731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203020|NCT03500731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102203021|NCT03500731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203022|NCT03500731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102203023|NCT03500731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102203024|NCT03500731|Alkylating Agents|alkylating agents|mesh-ancestor
102203025|NCT03500731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102203026|NCT03500731|Antisickling Agents|antisickling agents|mesh-ancestor
102203027|NCT03500731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102203028|NCT03500731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102203029|NCT02751359|Cannabidiol|cannabidiol|mesh-list
101911771|NCT05123170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102203030|NCT02751359|Anticonvulsants|anticonvulsants|mesh-ancestor
102203031|NCT02358993|Ciprofloxacin|ciprofloxacin|mesh-list
102203032|NCT02358993|Methenamine hippurate|methenamine hippurate|mesh-list
102203034|NCT02358993|Methenamine|methenamine|mesh-list
102203035|NCT02358993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102203036|NCT02358993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102203037|NCT02358993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102203038|NCT02358993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102203039|NCT02358993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102203040|NCT02358993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203041|NCT02358993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102203042|NCT02358993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102203043|NCT02358993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102203044|NCT02358993|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102203045|NCT04059445|Calcium, Dietary|calcium, dietary|mesh-list
102203046|NCT04059445|Calcium|calcium|mesh-list
102203047|NCT04059445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102203048|NCT04059445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203049|NCT04059445|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102203050|NCT05092841|Naltrexone|naltrexone|mesh-list
102203051|NCT05092841|Baclofen|baclofen|mesh-list
102203052|NCT05092841|Sorbitol|sorbitol|mesh-list
102203053|NCT05092841|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102203054|NCT05092841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102203055|NCT05092841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203056|NCT05092841|Sensory System Agents|sensory system agents|mesh-ancestor
102203057|NCT05092841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102203058|NCT05092841|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102203059|NCT05092841|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102203060|NCT05092841|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102203061|NCT05092841|GABA Agonists|gaba agonists|mesh-ancestor
102203062|NCT05092841|GABA Agents|gaba agents|mesh-ancestor
102203063|NCT05092841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102203064|NCT05092841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203065|NCT05092841|Cathartics|cathartics|mesh-ancestor
102203066|NCT05092841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102203067|NCT02224937|Melatonin|melatonin|mesh-list
102203068|NCT02224937|Antioxidants|antioxidants|mesh-ancestor
102203069|NCT02224937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203070|NCT02224937|Protective Agents|protective agents|mesh-ancestor
102203071|NCT02224937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203072|NCT02224937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102203073|NCT02290327|Pantoprazole|pantoprazole|mesh-list
102203074|NCT02290327|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102203075|NCT02290327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102203076|NCT02290327|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102203077|NCT02290327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102203078|NCT02290327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203079|NCT02372955|Dapagliflozin|dapagliflozin|mesh-list
102203080|NCT02372955|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102203081|NCT02372955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203082|NCT02372955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102203083|NCT02372955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203084|NCT02358057|Dexmedetomidine|dexmedetomidine|mesh-list
102203085|NCT02358057|Alfentanil|alfentanil|mesh-list
102203086|NCT02358057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102203087|NCT02358057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102203088|NCT02358057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203089|NCT02358057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102203090|NCT02358057|Analgesics|analgesics|mesh-ancestor
102203091|NCT02358057|Sensory System Agents|sensory system agents|mesh-ancestor
102203092|NCT02358057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102203093|NCT02358057|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102203094|NCT02358057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102203095|NCT02358057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102203096|NCT02358057|Adrenergic Agents|adrenergic agents|mesh-ancestor
102203097|NCT02358057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102203098|NCT02358057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203099|NCT02358057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102203100|NCT02358057|Narcotics|narcotics|mesh-ancestor
102203101|NCT02358057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102203102|NCT02358057|Anesthetics, General|anesthetics, general|mesh-ancestor
102203103|NCT02358057|Anesthetics|anesthetics|mesh-ancestor
102203104|NCT02225093|Dextromethorphan|dextromethorphan|mesh-list
102203105|NCT02225093|Caffeine|caffeine|mesh-list
102203106|NCT02225093|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102203107|NCT02225093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203108|NCT02225093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102203110|NCT02225093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203111|NCT02225093|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102203112|NCT02225093|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102203113|NCT02225093|Purinergic Agents|purinergic agents|mesh-ancestor
102203114|NCT02225093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102203115|NCT02225093|Antitussive Agents|antitussive agents|mesh-ancestor
102203116|NCT02225093|Respiratory System Agents|respiratory system agents|mesh-ancestor
102203117|NCT02225093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102203118|NCT02225093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102203120|NCT02212535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102203121|NCT02212535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102203122|NCT02212535|Antiviral Agents|antiviral agents|mesh-ancestor
102203123|NCT02212535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102203124|NCT02372487|Sildenafil Citrate|sildenafil citrate|mesh-list
101450422|NCT00473746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102203125|NCT02372487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203126|NCT02372487|Vasodilator Agents|vasodilator agents|mesh-ancestor
102203127|NCT02372487|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102203128|NCT02372487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102203129|NCT02372487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102203130|NCT02372487|Urological Agents|urological agents|mesh-ancestor
102203131|NCT02361177|Oxytocin|oxytocin|mesh-list
102203132|NCT02361177|Oxytocics|oxytocics|mesh-ancestor
102203133|NCT02361177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102203134|NCT02361177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203135|NCT05055713|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102203136|NCT05055713|Somatostatin|somatostatin|mesh-list
102203137|NCT05055713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102203138|NCT05055713|Adrenergic Agents|adrenergic agents|mesh-ancestor
102203139|NCT05055713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102203140|NCT05055713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203141|NCT05055713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203142|NCT05055713|Hormones|hormones|mesh-ancestor
102203143|NCT05055713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102203144|NCT02360709|Sirolimus|sirolimus|mesh-list
102203145|NCT02360709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102203146|NCT02360709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102203147|NCT02360709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102203148|NCT02360709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102203149|NCT02360709|Antifungal Agents|antifungal agents|mesh-ancestor
102203150|NCT02360709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102203151|NCT02360709|Immunologic Factors|immunologic factors|mesh-ancestor
102203152|NCT02360709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203153|NCT04624113|Pembrolizumab|pembrolizumab|mesh-list
102203154|NCT04624113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102203155|NCT04624113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102203156|NCT04624113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102203157|NCT04624113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203158|NCT05030519|Trastuzumab|trastuzumab|mesh-list
102203159|NCT05030519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102203160|NCT05030519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102203161|NCT02357277|Budesonide|budesonide|mesh-list
102203162|NCT02357277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102203163|NCT02357277|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102203164|NCT02357277|Autonomic Agents|autonomic agents|mesh-ancestor
102203165|NCT02357277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102203166|NCT02357277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203167|NCT02357277|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102203168|NCT02357277|Respiratory System Agents|respiratory system agents|mesh-ancestor
102203169|NCT02357277|Glucocorticoids|glucocorticoids|mesh-ancestor
102203170|NCT02357277|Hormones|hormones|mesh-ancestor
102203171|NCT02357277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102203172|NCT02222441|Pioglitazone|pioglitazone|mesh-list
102203173|NCT02222441|Palbociclib|palbociclib|mesh-list
102203174|NCT02222441|Modafinil|modafinil|mesh-list
102203175|NCT02222441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102203176|NCT02222441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203177|NCT02222441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102203178|NCT02222441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102203179|NCT02222441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101911913|NCT01222650|Urological Agents|urological agents|mesh-ancestor
102203180|NCT02222441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203181|NCT02222441|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102203182|NCT02222441|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102203183|NCT02222441|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102203184|NCT02222441|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102203185|NCT02290717|Fluticasone|fluticasone|mesh-list
102203186|NCT02290717|Xhance|xhance|mesh-list
102203187|NCT02290717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102203188|NCT02290717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102203189|NCT02290717|Autonomic Agents|autonomic agents|mesh-ancestor
102203190|NCT02290717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101450446|NCT00216294|Hormones|hormones|mesh-ancestor
102203191|NCT02290717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203192|NCT02290717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102203193|NCT02290717|Respiratory System Agents|respiratory system agents|mesh-ancestor
102203194|NCT02290717|Dermatologic Agents|dermatologic agents|mesh-ancestor
102203195|NCT02290717|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102203196|NCT02225795|Cyclophosphamide|cyclophosphamide|mesh-list
102203197|NCT02225795|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102203198|NCT02225795|Thymoglobulin|thymoglobulin|mesh-list
102203199|NCT02225795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102203200|NCT02225795|Immunologic Factors|immunologic factors|mesh-ancestor
102203201|NCT02225795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203202|NCT02225795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102203203|NCT02225795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102203204|NCT02225795|Alkylating Agents|alkylating agents|mesh-ancestor
102203205|NCT02225795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203206|NCT02225795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102203207|NCT02225795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102203208|NCT02360007|Buprenorphine|buprenorphine|mesh-list
102203209|NCT02360007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102203210|NCT02360007|Narcotics|narcotics|mesh-ancestor
102203211|NCT02360007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102203212|NCT02360007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203213|NCT02360007|Analgesics|analgesics|mesh-ancestor
102203214|NCT02360007|Sensory System Agents|sensory system agents|mesh-ancestor
102203215|NCT02360007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102203216|NCT02360007|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102203217|NCT02294305|Vortioxetine|vortioxetine|mesh-list
102203218|NCT02294305|Antidepressive Agents|antidepressive agents|mesh-ancestor
102203219|NCT02294305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102203220|NCT02294305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102203221|NCT02294305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102203222|NCT02294305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102203223|NCT02294305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203224|NCT02294305|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102203225|NCT02294305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102203226|NCT02294305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102203227|NCT02294305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203228|NCT02294305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102203229|NCT02294305|Serotonin Agents|serotonin agents|mesh-ancestor
102203230|NCT02294305|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102203231|NCT02294305|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102203232|NCT02294305|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102203233|NCT02294305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102203234|NCT01672255|Fluoxetine|fluoxetine|mesh-list
102203235|NCT01672255|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102203236|NCT01672255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102203237|NCT01672255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102203238|NCT01672255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203239|NCT01672255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102203240|NCT01672255|Serotonin Agents|serotonin agents|mesh-ancestor
102203241|NCT01672255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203242|NCT01672255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102203243|NCT01672255|Antidepressive Agents|antidepressive agents|mesh-ancestor
102203244|NCT01672255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102203245|NCT01672255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102203246|NCT01672255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102203247|NCT01672255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102203248|NCT02222519|Bromides|bromides|mesh-list
102203249|NCT02222519|Rocuronium|rocuronium|mesh-list
102203250|NCT02222519|Anticonvulsants|anticonvulsants|mesh-ancestor
102203251|NCT02222519|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101911994|NCT01127490|Analgesics|analgesics|mesh-ancestor
102203252|NCT02222519|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102203254|NCT02222519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102203255|NCT02222519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203256|NCT02220023|Nitric Oxide|nitric oxide|mesh-list
102203257|NCT02220023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102203258|NCT02220023|Autonomic Agents|autonomic agents|mesh-ancestor
102203259|NCT02220023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102203260|NCT02220023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203261|NCT02220023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102203262|NCT02220023|Respiratory System Agents|respiratory system agents|mesh-ancestor
102203263|NCT02220023|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102203264|NCT02220023|Antioxidants|antioxidants|mesh-ancestor
102203265|NCT02220023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203266|NCT02220023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102203267|NCT02220023|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102203268|NCT02220023|Vasodilator Agents|vasodilator agents|mesh-ancestor
102203269|NCT02220023|Gasotransmitters|gasotransmitters|mesh-ancestor
102203270|NCT02220023|Protective Agents|protective agents|mesh-ancestor
102203271|NCT02356965|Ketamine|ketamine|mesh-list
102203272|NCT02356965|Analgesics|analgesics|mesh-ancestor
102203273|NCT02356965|Sensory System Agents|sensory system agents|mesh-ancestor
102203274|NCT02356965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102203275|NCT02356965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203276|NCT02356965|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102203277|NCT02356965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102203278|NCT02356965|Anesthetics, General|anesthetics, general|mesh-ancestor
102203279|NCT02356965|Anesthetics|anesthetics|mesh-ancestor
102203280|NCT02356965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102203281|NCT02356965|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102203282|NCT02356965|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102203283|NCT02356965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102203284|NCT02356965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203285|NCT02359695|Hormones|hormones|mesh-list
102203286|NCT02359695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102203287|NCT02359695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203288|NCT02294539|Losartan|losartan|mesh-list
102203289|NCT02294539|Amlodipine|amlodipine|mesh-list
102203290|NCT02294539|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102203291|NCT02294539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102203292|NCT02294539|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102203293|NCT02294539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102203294|NCT02294539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203295|NCT02294539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102203296|NCT02294539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203297|NCT02294539|Vasodilator Agents|vasodilator agents|mesh-ancestor
102203298|NCT02294539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102203299|NCT02294539|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102203300|NCT02294539|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102203301|NCT02294539|Diuretics|diuretics|mesh-ancestor
102203302|NCT02294539|Natriuretic Agents|natriuretic agents|mesh-ancestor
102203303|NCT02294539|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102203304|NCT02359617|Insulin|insulin|mesh-list
102203305|NCT02359617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102203306|NCT02359617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203307|NCT03154125|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102203308|NCT03154125|Medroxyprogesterone|medroxyprogesterone|mesh-list
102203309|NCT03154125|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102203310|NCT03154125|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102203311|NCT03154125|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102203312|NCT03154125|Contraceptive Agents|contraceptive agents|mesh-ancestor
102203313|NCT03154125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102203314|NCT03154125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203315|NCT03154125|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102203316|NCT03154125|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102203317|NCT03154125|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102203318|NCT03154125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102203319|NCT03154125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102203320|NCT02294617|Nicotine|nicotine|mesh-list
102203321|NCT02294617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102203322|NCT02294617|Autonomic Agents|autonomic agents|mesh-ancestor
102203323|NCT02294617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102203324|NCT02294617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203325|NCT02294617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102203326|NCT02294617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102203327|NCT02294617|Cholinergic Agents|cholinergic agents|mesh-ancestor
102203328|NCT02294617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102203329|NCT02294617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203330|NCT02291341|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102203331|NCT02291341|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102203332|NCT02291341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102203333|NCT02291341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102203334|NCT02291341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203335|NCT02291341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102203336|NCT02291341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203337|NCT02291341|Analgesics|analgesics|mesh-ancestor
102203338|NCT02291341|Sensory System Agents|sensory system agents|mesh-ancestor
102203339|NCT02291341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102203340|NCT02291341|Antidepressive Agents|antidepressive agents|mesh-ancestor
102203341|NCT02291341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102203342|NCT02291341|Dopamine Agents|dopamine agents|mesh-ancestor
102203343|NCT02352987|Salicylic Acid|salicylic acid|mesh-list
102203344|NCT02352987|Salicylates|salicylates|mesh-list
102203345|NCT02352987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102203346|NCT02352987|Antifungal Agents|antifungal agents|mesh-ancestor
102203347|NCT02352987|Keratolytic Agents|keratolytic agents|mesh-ancestor
102203348|NCT02352987|Dermatologic Agents|dermatologic agents|mesh-ancestor
102203349|NCT02352987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102203350|NCT02352987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102203351|NCT02352987|Analgesics|analgesics|mesh-ancestor
102203352|NCT02352987|Sensory System Agents|sensory system agents|mesh-ancestor
102203353|NCT02352987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102203354|NCT02352987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203355|NCT02352987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102203356|NCT02352987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102203357|NCT02352987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102203358|NCT02352987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102203359|NCT02352987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203360|NCT02226341|Mycophenolic Acid|mycophenolic acid|mesh-list
102203361|NCT02226341|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102203362|NCT02226341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102203363|NCT02226341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102203364|NCT02226341|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102203365|NCT02226341|Antitubercular Agents|antitubercular agents|mesh-ancestor
102203366|NCT02226341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102203367|NCT02226341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102203368|NCT02226341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102203369|NCT02226341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203370|NCT02226341|Hormones|hormones|mesh-ancestor
102203371|NCT02226341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102203372|NCT02226341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203373|NCT02222987|Clopidogrel|clopidogrel|mesh-list
102203374|NCT02222987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102203375|NCT02222987|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102203376|NCT02222987|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102203377|NCT02222987|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102203378|NCT02222987|Purinergic Agents|purinergic agents|mesh-ancestor
102203379|NCT02222987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102203380|NCT02222987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203381|NCT02222987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203382|NCT03521245|Trastuzumab|trastuzumab|mesh-list
102203383|NCT03521245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102203384|NCT03521245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102203385|NCT02481245|Bezafibrate|bezafibrate|mesh-list
102203386|NCT02481245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102203387|NCT02481245|Antimetabolites|antimetabolites|mesh-ancestor
102203388|NCT02481245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203389|NCT02481245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102203390|NCT02352597|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102203391|NCT02352597|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102203392|NCT02352597|Clomiphene|clomiphene|mesh-list
102203393|NCT02352597|Enclomiphene|enclomiphene|mesh-list
102203394|NCT02352597|Zuclomiphene|zuclomiphene|mesh-list
102203395|NCT02352597|Estradiol|estradiol|mesh-list
101912136|NCT01127724|Micronutrients|micronutrients|mesh-ancestor
102203396|NCT02352597|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102203397|NCT02352597|Phytoestrogens|phytoestrogens|mesh-list
102203398|NCT02352597|Estrogens|estrogens|mesh-ancestor
102203399|NCT02352597|Hormones|hormones|mesh-ancestor
102203400|NCT02352597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102203401|NCT02352597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203402|NCT02352597|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102203403|NCT02352597|Contraceptive Agents|contraceptive agents|mesh-ancestor
102203404|NCT02352597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102203405|NCT02352597|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102203406|NCT02352597|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102203407|NCT02352597|Hormone Antagonists|hormone antagonists|mesh-ancestor
102203408|NCT02352597|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102203409|NCT02352597|Fertility Agents|fertility agents|mesh-ancestor
102203410|NCT02352597|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102203411|NCT02352597|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102203412|NCT02352597|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102203413|NCT03521167|Acetaminophen|acetaminophen|mesh-list
102203414|NCT03521167|Lidocaine|lidocaine|mesh-list
102203415|NCT03521167|Dexmedetomidine|dexmedetomidine|mesh-list
102203416|NCT03521167|Ketamine|ketamine|mesh-list
102203417|NCT03521167|Gabapentin|gabapentin|mesh-list
102203418|NCT03521167|Anesthetics, Local|anesthetics, local|mesh-ancestor
102203419|NCT03521167|Anesthetics|anesthetics|mesh-ancestor
102203420|NCT03521167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102203421|NCT03521167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203422|NCT03521167|Sensory System Agents|sensory system agents|mesh-ancestor
102203423|NCT03521167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102203424|NCT03521167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102203425|NCT03521167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102203426|NCT03521167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102203427|NCT03521167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102203428|NCT03521167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203429|NCT03521167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102203430|NCT03521167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102203431|NCT03521167|Analgesics|analgesics|mesh-ancestor
102203432|NCT03521167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102203433|NCT03521167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102203434|NCT03521167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102203435|NCT03521167|Adrenergic Agents|adrenergic agents|mesh-ancestor
102203436|NCT03521167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102203437|NCT03521167|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102203438|NCT03521167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102203439|NCT03521167|Anesthetics, General|anesthetics, general|mesh-ancestor
102203440|NCT03521167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102203441|NCT03521167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102203442|NCT03521167|Anticonvulsants|anticonvulsants|mesh-ancestor
102203443|NCT03521167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102203444|NCT03521167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102203445|NCT03521167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102203446|NCT03521167|Antimanic Agents|antimanic agents|mesh-ancestor
102203447|NCT03521167|Antipyretics|antipyretics|mesh-ancestor
102203448|NCT02352519|Anesthetics|anesthetics|mesh-list
102203449|NCT02352519|Anesthetics, Local|anesthetics, local|mesh-list
102203450|NCT02352519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102203451|NCT02352519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203452|NCT02352519|Sensory System Agents|sensory system agents|mesh-ancestor
102203453|NCT02352519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102203454|NCT02356419|Epoetin Alfa|epoetin alfa|mesh-list
102203455|NCT02356419|Hematinics|hematinics|mesh-ancestor
102203456|NCT02220335|Digoxin|digoxin|mesh-list
102203457|NCT02220335|Diuretics|diuretics|mesh-list
102203458|NCT02220335|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102203459|NCT02220335|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
102203460|NCT02220335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102203461|NCT02220335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102203462|NCT02220335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102203463|NCT02220335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203464|NCT02220335|Protective Agents|protective agents|mesh-ancestor
102203465|NCT02220335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203466|NCT02220335|Natriuretic Agents|natriuretic agents|mesh-ancestor
102203467|NCT02220335|Protease Inhibitors|protease inhibitors|mesh-ancestor
102203468|NCT02220335|Hormone Antagonists|hormone antagonists|mesh-ancestor
102203469|NCT02220335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102203470|NCT02220335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102203471|NCT02291731|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102203472|NCT02291731|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102203474|NCT02223299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102203475|NCT02223299|Antidepressive Agents|antidepressive agents|mesh-ancestor
102203476|NCT02223299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102203477|NCT02356341|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102203478|NCT02356341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102203479|NCT02223377|Morphine|morphine|mesh-list
102203480|NCT02223377|Hydromorphone|hydromorphone|mesh-list
102203481|NCT02223377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102203482|NCT02223377|Narcotics|narcotics|mesh-ancestor
102203483|NCT02223377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102203484|NCT02223377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203485|NCT02223377|Analgesics|analgesics|mesh-ancestor
102203486|NCT02223377|Sensory System Agents|sensory system agents|mesh-ancestor
102203487|NCT02223377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102203488|NCT02291887|Ranibizumab|ranibizumab|mesh-list
102203489|NCT02291887|Aflibercept|aflibercept|mesh-list
102203490|NCT02291887|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102203491|NCT02291887|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102203492|NCT02291887|Growth Substances|growth substances|mesh-ancestor
102203493|NCT02291887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203494|NCT02291887|Growth Inhibitors|growth inhibitors|mesh-ancestor
102203495|NCT02291887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102203496|NCT02352285|Tolvaptan|tolvaptan|mesh-list
102203497|NCT02352285|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102203498|NCT02352285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203499|NCT02352285|Natriuretic Agents|natriuretic agents|mesh-ancestor
102203500|NCT02352285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203501|NCT03521713|Epoetin Alfa|epoetin alfa|mesh-list
102203502|NCT03521713|Hematinics|hematinics|mesh-ancestor
102203503|NCT02223533|Morphine|morphine|mesh-list
102203504|NCT02223533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102203505|NCT02223533|Narcotics|narcotics|mesh-ancestor
102203506|NCT02223533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102203507|NCT02223533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203508|NCT02223533|Analgesics|analgesics|mesh-ancestor
102203509|NCT02223533|Sensory System Agents|sensory system agents|mesh-ancestor
102203510|NCT02223533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102203511|NCT02231021|Pioglitazone|pioglitazone|mesh-list
102203512|NCT02231021|Alogliptin|alogliptin|mesh-list
102203513|NCT02231021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102203514|NCT02231021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203515|NCT02231021|Incretins|incretins|mesh-ancestor
102203516|NCT02231021|Hormones|hormones|mesh-ancestor
102203517|NCT02231021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102203518|NCT02231021|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102203519|NCT02231021|Protease Inhibitors|protease inhibitors|mesh-ancestor
102203520|NCT02231021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102203521|NCT02231021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203522|NCT04465123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102203523|NCT04465123|Spironolactone|spironolactone|mesh-list
102203524|NCT04465123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102203525|NCT04465123|Diuretics|diuretics|mesh-ancestor
102203526|NCT04465123|Natriuretic Agents|natriuretic agents|mesh-ancestor
102203527|NCT04465123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203528|NCT04465123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102203529|NCT04465123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102203530|NCT04465123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203531|NCT04465123|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102203532|NCT04465123|Hormone Antagonists|hormone antagonists|mesh-ancestor
102203533|NCT04465123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102203534|NCT04465123|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102203535|NCT02401347|Talazoparib|talazoparib|mesh-list
102203536|NCT02401347|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102203537|NCT02401347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102203538|NCT02401347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203539|NCT02401347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102203540|NCT02231255|Pramipexole|pramipexole|mesh-list
102203541|NCT02231255|Antioxidants|antioxidants|mesh-ancestor
102203542|NCT02231255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203543|NCT02231255|Protective Agents|protective agents|mesh-ancestor
102203544|NCT02231255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203545|NCT02231255|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102203546|NCT02231255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102203547|NCT02231255|Dopamine Agonists|dopamine agonists|mesh-ancestor
102203548|NCT02231255|Dopamine Agents|dopamine agents|mesh-ancestor
102203549|NCT02231255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102203550|NCT02352051|Methylphenidate|methylphenidate|mesh-list
102203551|NCT02352051|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102203552|NCT02352051|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102203553|NCT02352051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203554|NCT02352051|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102203555|NCT02352051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102203556|NCT02352051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102203557|NCT02352051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203558|NCT02352051|Dopamine Agents|dopamine agents|mesh-ancestor
102203559|NCT02352051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102203560|NCT02352051|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102203561|NCT02352051|Adrenergic Agents|adrenergic agents|mesh-ancestor
102203562|NCT02227277|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102203563|NCT02227277|Interferon alpha-2|interferon alpha-2|mesh-list
102203564|NCT02227277|Antiviral Agents|antiviral agents|mesh-ancestor
102203565|NCT02227277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102203566|NCT02227277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102203567|NCT03147183|Thymoglobulin|thymoglobulin|mesh-list
102203568|NCT03147183|Immunologic Factors|immunologic factors|mesh-ancestor
102203569|NCT03147183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203570|NCT03147183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102203571|NCT02292121|Mannitol|mannitol|mesh-list
102203572|NCT02292121|Lactitol|lactitol|mesh-list
102203573|NCT02292121|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102203574|NCT02292121|Diuretics|diuretics|mesh-ancestor
102203575|NCT02292121|Natriuretic Agents|natriuretic agents|mesh-ancestor
102203576|NCT02292121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203577|NCT02292121|Cathartics|cathartics|mesh-ancestor
102203578|NCT02292121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102203579|NCT02223611|Cisplatin|cisplatin|mesh-list
102203580|NCT02223611|Vinorelbine|vinorelbine|mesh-list
102203581|NCT02223611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102203582|NCT02223611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102203583|NCT02223611|Tubulin Modulators|tubulin modulators|mesh-ancestor
102203584|NCT02223611|Antimitotic Agents|antimitotic agents|mesh-ancestor
102203585|NCT02223611|Mitosis Modulators|mitosis modulators|mesh-ancestor
102203586|NCT02223611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203587|NCT02231333|Pentoxifylline|pentoxifylline|mesh-list
102203588|NCT02231333|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102203589|NCT02231333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102203590|NCT02231333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203591|NCT02231333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102203592|NCT02231333|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102203593|NCT02231333|Protective Agents|protective agents|mesh-ancestor
102203594|NCT02231333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203595|NCT02231333|Vasodilator Agents|vasodilator agents|mesh-ancestor
102203596|NCT02231333|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102203597|NCT02231333|Antioxidants|antioxidants|mesh-ancestor
102203598|NCT02227433|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102203599|NCT02227433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102203600|NCT02227433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102203601|NCT02227433|Immunotoxins|immunotoxins|mesh-ancestor
102203602|NCT02227433|Immunoconjugates|immunoconjugates|mesh-ancestor
102203603|NCT02227433|Immunologic Factors|immunologic factors|mesh-ancestor
102203604|NCT02227433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203605|NCT02351973|Amiloride|amiloride|mesh-list
102203606|NCT02351973|Diuretics|diuretics|mesh-ancestor
102203607|NCT02351973|Natriuretic Agents|natriuretic agents|mesh-ancestor
102203608|NCT02351973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203609|NCT02351973|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
102203610|NCT02351973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102203611|NCT02351973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102203612|NCT02351973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203613|NCT02351973|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
102203614|NCT02351973|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102203616|NCT04831619|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102203617|NCT04831619|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102203618|NCT04831619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203619|NCT04831619|Antimetabolites|antimetabolites|mesh-ancestor
102203620|NCT04831619|Antiviral Agents|antiviral agents|mesh-ancestor
102203621|NCT04831619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102203622|NCT03520543|Clonidine|clonidine|mesh-list
102203623|NCT03520543|Yohimbine|yohimbine|mesh-list
102203624|NCT03520543|Analgesics|analgesics|mesh-ancestor
102203625|NCT03520543|Sensory System Agents|sensory system agents|mesh-ancestor
102203626|NCT03520543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102203627|NCT03520543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203628|NCT03520543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102203629|NCT03520543|Sympatholytics|sympatholytics|mesh-ancestor
102203630|NCT03520543|Autonomic Agents|autonomic agents|mesh-ancestor
102203631|NCT03520543|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102203632|NCT03520543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102203633|NCT03520543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102203634|NCT03520543|Adrenergic Agents|adrenergic agents|mesh-ancestor
102203635|NCT03520543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102203636|NCT03520543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203637|NCT03520543|Mydriatics|mydriatics|mesh-ancestor
102203638|NCT03520543|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102203639|NCT03520543|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102203640|NCT03520543|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102203641|NCT03520543|Urological Agents|urological agents|mesh-ancestor
102203642|NCT02355639|Betamethasone|betamethasone|mesh-list
102203643|NCT02355639|Betamethasone Valerate|betamethasone valerate|mesh-list
102203644|NCT02355639|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102203645|NCT02355639|Betamethasone benzoate|betamethasone benzoate|mesh-list
102203646|NCT02355639|Clobetasol|clobetasol|mesh-list
102203647|NCT02355639|Petrolatum|petrolatum|mesh-list
102203648|NCT02355639|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102203649|NCT02355639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102203650|NCT02355639|Glucocorticoids|glucocorticoids|mesh-ancestor
102203651|NCT02355639|Hormones|hormones|mesh-ancestor
102203652|NCT02355639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102203653|NCT02355639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203654|NCT02355639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102203655|NCT02355639|Respiratory System Agents|respiratory system agents|mesh-ancestor
102203656|NCT02355639|Emollients|emollients|mesh-ancestor
102203657|NCT02355639|Dermatologic Agents|dermatologic agents|mesh-ancestor
102203658|NCT02351895|Copper|copper|mesh-list
102203659|NCT02351895|Trace Elements|trace elements|mesh-ancestor
102203660|NCT02351895|Micronutrients|micronutrients|mesh-ancestor
102203661|NCT02351895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203662|NCT00503035|Celecoxib|celecoxib|mesh-list
102203663|NCT00503035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102203664|NCT00503035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102203665|NCT00503035|Analgesics|analgesics|mesh-ancestor
102203666|NCT00503035|Sensory System Agents|sensory system agents|mesh-ancestor
102203667|NCT00503035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102203668|NCT00503035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203669|NCT00503035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102203670|NCT00503035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102203671|NCT00503035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102203672|NCT00503035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102203673|NCT00503035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102203674|NCT00503035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203675|NCT02227745|Dorzolamide|dorzolamide|mesh-list
102203676|NCT02227745|Hyaluronic Acid|hyaluronic acid|mesh-list
102203677|NCT02227745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102203678|NCT02227745|Immunologic Factors|immunologic factors|mesh-ancestor
102203679|NCT02227745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203680|NCT02227745|Viscosupplements|viscosupplements|mesh-ancestor
102203681|NCT02227745|Protective Agents|protective agents|mesh-ancestor
102203682|NCT02227745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102203683|NCT02227745|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102203684|NCT02227745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102203685|NCT02227745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203686|NCT03517033|Nebivolol|nebivolol|mesh-list
102203687|NCT03517033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101745505|NCT00919022|Cyproterone|cyproterone|mesh-list
102203689|NCT03517033|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102203690|NCT03517033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102203691|NCT03517033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102203692|NCT03517033|Adrenergic Agents|adrenergic agents|mesh-ancestor
102203693|NCT03517033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102203694|NCT03517033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203695|NCT03517033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203696|NCT03516955|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102203698|NCT03516955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102203699|NCT03516955|Antimetabolites|antimetabolites|mesh-ancestor
102203700|NCT03516955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203701|NCT03516955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102203702|NCT03516955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102203703|NCT03516955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102203704|NCT02259179|Naltrexone|naltrexone|mesh-list
102203705|NCT02259179|Bupropion|bupropion|mesh-list
102203706|NCT02259179|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102203707|NCT02259179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102203708|NCT02259179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203709|NCT02259179|Sensory System Agents|sensory system agents|mesh-ancestor
102203710|NCT02259179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102203711|NCT02259179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102203712|NCT02259179|Antidepressive Agents|antidepressive agents|mesh-ancestor
102203713|NCT02259179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102203714|NCT02259179|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102203715|NCT02259179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102203716|NCT02259179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102203717|NCT02259179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203718|NCT02259179|Dopamine Agents|dopamine agents|mesh-ancestor
102203719|NCT02259179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102203720|NCT02259179|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102203721|NCT02259179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102203722|NCT02259179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102203723|NCT02355093|Ropivacaine|ropivacaine|mesh-list
102203724|NCT02355093|Anesthetics, Local|anesthetics, local|mesh-ancestor
102203725|NCT02355093|Anesthetics|anesthetics|mesh-ancestor
102203726|NCT02355093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102203727|NCT02355093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203728|NCT02355093|Sensory System Agents|sensory system agents|mesh-ancestor
102203729|NCT02355093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102203730|NCT02227823|Bromides|bromides|mesh-list
102203731|NCT02227823|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
102203732|NCT02227823|Anticonvulsants|anticonvulsants|mesh-ancestor
102203733|NCT02227823|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102203734|NCT02227823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101450497|NCT00193661|Androgens|androgens|mesh-ancestor
102203735|NCT02227823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203736|NCT02227823|Cholinergic Agents|cholinergic agents|mesh-ancestor
102203737|NCT02227823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102203738|NCT02227823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203739|NCT02295475|Warfarin|warfarin|mesh-list
102203740|NCT02295475|Apixaban|apixaban|mesh-list
102203741|NCT02295475|Anticoagulants|anticoagulants|mesh-ancestor
102203742|NCT02295475|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102203743|NCT02295475|Antithrombins|antithrombins|mesh-ancestor
102203744|NCT02295475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102203745|NCT02295475|Protease Inhibitors|protease inhibitors|mesh-ancestor
102203746|NCT02295475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102203747|NCT02295475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203748|NCT02227901|Temozolomide|temozolomide|mesh-list
102203749|NCT02227901|Tipifarnib|tipifarnib|mesh-list
102203750|NCT02227901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102203751|NCT02227901|Alkylating Agents|alkylating agents|mesh-ancestor
102203752|NCT02227901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203753|NCT02227901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102203754|NCT03146793|Sodium thiosulfate|sodium thiosulfate|mesh-list
102203755|NCT03146793|Antidotes|antidotes|mesh-ancestor
102203756|NCT03146793|Protective Agents|protective agents|mesh-ancestor
102203757|NCT03146793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203758|NCT03146793|Antioxidants|antioxidants|mesh-ancestor
102203759|NCT03146793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203760|NCT03146793|Antitubercular Agents|antitubercular agents|mesh-ancestor
102203761|NCT03146793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102203762|NCT03146793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102203763|NCT03146793|Chelating Agents|chelating agents|mesh-ancestor
102203764|NCT03146793|Sequestering Agents|sequestering agents|mesh-ancestor
102203765|NCT03133195|Vitamin D|vitamin d|mesh-list
102203766|NCT03133195|Teriparatide|teriparatide|mesh-list
102203767|NCT03133195|Calcium|calcium|mesh-list
102203768|NCT03133195|Parathyroid Hormone|parathyroid hormone|mesh-list
102203769|NCT03133195|Vitamins|vitamins|mesh-ancestor
102203770|NCT03133195|Micronutrients|micronutrients|mesh-ancestor
102203771|NCT03133195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203772|NCT03133195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102203773|NCT03133195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102203775|NCT03159741|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102203776|NCT03159741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102203777|NCT03159741|Hormones|hormones|mesh-ancestor
102203778|NCT03159741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102203779|NCT03159741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203780|NCT03159741|Incretins|incretins|mesh-ancestor
102203781|NCT02292277|Ticagrelor|ticagrelor|mesh-list
102203782|NCT02292277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102203783|NCT02292277|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102203784|NCT02292277|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102203785|NCT02292277|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102203786|NCT02292277|Purinergic Agents|purinergic agents|mesh-ancestor
102203787|NCT02292277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102203788|NCT02292277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203789|NCT02292277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203790|NCT02228135|Dexamethasone|dexamethasone|mesh-list
102203791|NCT02228135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102203792|NCT02228135|Antiemetics|antiemetics|mesh-ancestor
102203793|NCT02228135|Autonomic Agents|autonomic agents|mesh-ancestor
102203794|NCT02228135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102203795|NCT02228135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203796|NCT02228135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102203797|NCT02228135|Glucocorticoids|glucocorticoids|mesh-ancestor
102203798|NCT02228135|Hormones|hormones|mesh-ancestor
102203799|NCT02228135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102203800|NCT02228135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102203801|NCT02228135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102203802|NCT03152877|Bupivacaine|bupivacaine|mesh-list
102203803|NCT03152877|Anesthetics, Local|anesthetics, local|mesh-ancestor
102203804|NCT03152877|Anesthetics|anesthetics|mesh-ancestor
102203805|NCT03152877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101450503|NCT00206232|Hormone Antagonists|hormone antagonists|mesh-ancestor
102203806|NCT03152877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203807|NCT03152877|Sensory System Agents|sensory system agents|mesh-ancestor
102203808|NCT03152877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102203809|NCT02295709|Dexamethasone|dexamethasone|mesh-list
102203810|NCT02295709|Dexamethasone acetate|dexamethasone acetate|mesh-list
102203811|NCT02295709|BB 1101|bb 1101|mesh-list
102203812|NCT02295709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102203813|NCT02295709|Antiemetics|antiemetics|mesh-ancestor
102203814|NCT02295709|Autonomic Agents|autonomic agents|mesh-ancestor
102203815|NCT02295709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102203816|NCT02295709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203817|NCT02295709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102203818|NCT02295709|Glucocorticoids|glucocorticoids|mesh-ancestor
102203819|NCT02295709|Hormones|hormones|mesh-ancestor
102203820|NCT02295709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102203821|NCT02295709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102203822|NCT02295709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102203823|NCT02295709|Protease Inhibitors|protease inhibitors|mesh-ancestor
102203824|NCT02295709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102203825|NCT02295709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203826|NCT02354937|Cabotegravir|cabotegravir|mesh-list
102203827|NCT02354937|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102203828|NCT02354937|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102203829|NCT02354937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102203830|NCT02354937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203831|NCT02354937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102203832|NCT02354937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102203833|NCT02354937|Antiviral Agents|antiviral agents|mesh-ancestor
102203834|NCT02354937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102203835|NCT02295787|Ketamine|ketamine|mesh-list
102203836|NCT02295787|Analgesics|analgesics|mesh-ancestor
102203837|NCT02295787|Sensory System Agents|sensory system agents|mesh-ancestor
102203838|NCT02295787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102203839|NCT02295787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203840|NCT02295787|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102203841|NCT02295787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102203842|NCT02295787|Anesthetics, General|anesthetics, general|mesh-ancestor
102203844|NCT02295787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102203845|NCT02295787|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102203846|NCT02295787|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102203847|NCT02295787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102203848|NCT02295787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203849|NCT04464967|Trastuzumab|trastuzumab|mesh-list
102203850|NCT04464967|Cetuximab|cetuximab|mesh-list
102203851|NCT04464967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102203852|NCT04464967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102203853|NCT02228369|Osimertinib|osimertinib|mesh-list
102203854|NCT02228369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102203855|NCT02228369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102203856|NCT02228369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102203857|NCT02228369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203858|NCT03146871|Azacitidine|azacitidine|mesh-list
102203859|NCT03146871|Decitabine|decitabine|mesh-list
102203860|NCT03146871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102203861|NCT03146871|Antimetabolites|antimetabolites|mesh-ancestor
102203862|NCT03146871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203863|NCT03146871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102203864|NCT03146871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102203865|NCT02231957|Vaccines|vaccines|mesh-list
102203866|NCT02231957|Immunologic Factors|immunologic factors|mesh-ancestor
102203867|NCT02231957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203868|NCT02354547|Cyclophosphamide|cyclophosphamide|mesh-list
102203869|NCT02354547|Topotecan|topotecan|mesh-list
102203870|NCT02354547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102203871|NCT02354547|Immunologic Factors|immunologic factors|mesh-ancestor
102203872|NCT02354547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203873|NCT02354547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102203874|NCT02354547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102203875|NCT02354547|Alkylating Agents|alkylating agents|mesh-ancestor
102203876|NCT02354547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450507|NCT00206232|Diuretics|diuretics|mesh-ancestor
102203877|NCT02354547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102203878|NCT02354547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102203879|NCT02354547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102203880|NCT02354547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102203881|NCT02354547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102203882|NCT02232035|Diazepam|diazepam|mesh-list
102203883|NCT02232035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102203884|NCT02232035|Anticonvulsants|anticonvulsants|mesh-ancestor
102203885|NCT02232035|Antiemetics|antiemetics|mesh-ancestor
102203886|NCT02232035|Autonomic Agents|autonomic agents|mesh-ancestor
102203887|NCT02232035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102203888|NCT02232035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203889|NCT02232035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102203890|NCT02232035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102203891|NCT02232035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102203892|NCT02232035|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102203893|NCT02232035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102203894|NCT02232035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102203895|NCT02232035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102203896|NCT02232035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102203897|NCT02232035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102203898|NCT02232035|Anesthetics, General|anesthetics, general|mesh-ancestor
102203899|NCT02232035|Anesthetics|anesthetics|mesh-ancestor
102203900|NCT02232035|GABA Modulators|gaba modulators|mesh-ancestor
102203901|NCT02232035|GABA Agents|gaba agents|mesh-ancestor
102203902|NCT02232035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102203903|NCT02232035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203904|NCT02296021|Amoxicillin|amoxicillin|mesh-list
102203905|NCT02296021|Clarithromycin|clarithromycin|mesh-list
102203906|NCT02296021|Esomeprazole|esomeprazole|mesh-list
102203907|NCT02296021|Bismuth|bismuth|mesh-list
102203908|NCT02296021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102203909|NCT02296021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102203910|NCT02296021|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102203911|NCT02296021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102203912|NCT02296021|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102203913|NCT02296021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102203914|NCT02296021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203915|NCT02296021|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102203916|NCT02296021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102203917|NCT02296021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102203918|NCT02296021|Antacids|antacids|mesh-ancestor
102203919|NCT02289391|Anesthetics|anesthetics|mesh-list
102203920|NCT02289391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102203921|NCT02289391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203922|NCT02354313|Lenalidomide|lenalidomide|mesh-list
102203923|NCT02354313|Immunologic Factors|immunologic factors|mesh-ancestor
102203924|NCT02354313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203925|NCT02354313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102203926|NCT02354313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102203927|NCT02354313|Growth Substances|growth substances|mesh-ancestor
102203928|NCT02354313|Growth Inhibitors|growth inhibitors|mesh-ancestor
102203929|NCT02354313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102203930|NCT02292667|Acetaminophen|acetaminophen|mesh-list
102203931|NCT02292667|Morphine|morphine|mesh-list
102203932|NCT02292667|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102203933|NCT02292667|Narcotics|narcotics|mesh-ancestor
102203934|NCT02292667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102203935|NCT02292667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203936|NCT02292667|Analgesics|analgesics|mesh-ancestor
102203937|NCT02292667|Sensory System Agents|sensory system agents|mesh-ancestor
102203938|NCT02292667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102203939|NCT02292667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102203940|NCT02292667|Antipyretics|antipyretics|mesh-ancestor
102203941|NCT02232269|Felodipine|felodipine|mesh-list
102203942|NCT02232269|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102203943|NCT02232269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102203944|NCT02232269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102203945|NCT02232269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102203946|NCT02232269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203947|NCT02232269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102203948|NCT02232269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203949|NCT02232269|Vasodilator Agents|vasodilator agents|mesh-ancestor
102203950|NCT04486313|Nitazoxanide|nitazoxanide|mesh-list
102203951|NCT04486313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102203952|NCT04486313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102203953|NCT02354001|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
102203954|NCT02354001|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102203955|NCT02354001|Hormone Antagonists|hormone antagonists|mesh-ancestor
102203956|NCT02354001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102203957|NCT02354001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203958|NCT02354001|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102203959|NCT02354001|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102203960|NCT02354001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102203961|NCT02347839|Gefitinib|gefitinib|mesh-list
102203962|NCT02347839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102203963|NCT02347839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102203964|NCT02347839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102203965|NCT02347839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203966|NCT02289547|Capecitabine|capecitabine|mesh-list
102203967|NCT02289547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102203968|NCT02289547|Antimetabolites|antimetabolites|mesh-ancestor
102203969|NCT02289547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203970|NCT02289547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102203971|NCT02351427|Bortezomib|bortezomib|mesh-list
102203972|NCT02351427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102203973|NCT02232971|Glucagon|glucagon|mesh-list
102203974|NCT02232971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102203975|NCT02232971|Hormones|hormones|mesh-ancestor
102203976|NCT02232971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102203977|NCT02232971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203978|NCT02296333|Ondansetron|ondansetron|mesh-list
102203979|NCT02296333|Antiemetics|antiemetics|mesh-ancestor
102203980|NCT02296333|Autonomic Agents|autonomic agents|mesh-ancestor
102203981|NCT02296333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102203982|NCT02296333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102203983|NCT02296333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102203984|NCT02296333|Antipruritics|antipruritics|mesh-ancestor
102203985|NCT02296333|Dermatologic Agents|dermatologic agents|mesh-ancestor
102203986|NCT02296333|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102203987|NCT02296333|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102203988|NCT02296333|Serotonin Agents|serotonin agents|mesh-ancestor
102203989|NCT02296333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102203990|NCT02296333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203991|NCT03149913|Paclitaxel|paclitaxel|mesh-list
102203992|NCT03149913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102203993|NCT03149913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102203994|NCT03149913|Tubulin Modulators|tubulin modulators|mesh-ancestor
102203995|NCT03149913|Antimitotic Agents|antimitotic agents|mesh-ancestor
102203996|NCT03149913|Mitosis Modulators|mitosis modulators|mesh-ancestor
102203997|NCT03149913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102203998|NCT02289703|Rivaroxaban|rivaroxaban|mesh-list
102203999|NCT02289703|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102204000|NCT02289703|Antithrombins|antithrombins|mesh-ancestor
102204001|NCT02289703|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102204002|NCT02289703|Protease Inhibitors|protease inhibitors|mesh-ancestor
102204003|NCT02289703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102204004|NCT02289703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204005|NCT02289703|Anticoagulants|anticoagulants|mesh-ancestor
102204006|NCT02232347|Sufentanil|sufentanil|mesh-list
102204007|NCT02232347|Ketamine|ketamine|mesh-list
102204008|NCT02232347|Analgesics|analgesics|mesh-ancestor
102204009|NCT02232347|Sensory System Agents|sensory system agents|mesh-ancestor
102204010|NCT02232347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102204011|NCT02232347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204012|NCT02232347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102204013|NCT02232347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102204014|NCT02232347|Anesthetics, General|anesthetics, general|mesh-ancestor
102204015|NCT02232347|Anesthetics|anesthetics|mesh-ancestor
102204016|NCT02232347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102204017|NCT02232347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102204018|NCT02232347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102204019|NCT02232347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102204020|NCT02232347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204021|NCT02232347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102204022|NCT02232347|Narcotics|narcotics|mesh-ancestor
102204023|NCT02232347|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102204024|NCT03542669|Doxorubicin|doxorubicin|mesh-list
102204025|NCT03542669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102204026|NCT03542669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102204027|NCT03542669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102204028|NCT03542669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102204029|NCT03542669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102204030|NCT03542669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204031|NCT03146481|Aceclofenac|aceclofenac|mesh-list
102204032|NCT03146481|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102204033|NCT03146481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102204034|NCT03146481|Analgesics|analgesics|mesh-ancestor
102204035|NCT03146481|Sensory System Agents|sensory system agents|mesh-ancestor
102204036|NCT03146481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102204037|NCT03146481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204038|NCT03146481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102204039|NCT03146481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102204040|NCT03541655|Celecoxib|celecoxib|mesh-list
102204041|NCT03541655|Bupivacaine|bupivacaine|mesh-list
102204042|NCT03541655|Anesthetics, Local|anesthetics, local|mesh-ancestor
102204043|NCT03541655|Anesthetics|anesthetics|mesh-ancestor
102204044|NCT03541655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102204045|NCT03541655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204046|NCT03541655|Sensory System Agents|sensory system agents|mesh-ancestor
102204047|NCT03541655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102204048|NCT03541655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102204049|NCT03541655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102204050|NCT03541655|Analgesics|analgesics|mesh-ancestor
102204051|NCT03541655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102204052|NCT03541655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102204053|NCT03541655|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102204054|NCT03541655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102204055|NCT03541655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101573988|NCT02199184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102204056|NCT03541655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204057|NCT02296411|Glycopyrrolate|glycopyrrolate|mesh-list
102204058|NCT02296411|Bromides|bromides|mesh-list
102204059|NCT02296411|Anticonvulsants|anticonvulsants|mesh-ancestor
102204060|NCT02296411|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102204061|NCT02296411|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102204062|NCT02296411|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102204063|NCT02296411|Cholinergic Agents|cholinergic agents|mesh-ancestor
102204064|NCT02296411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102204065|NCT02296411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204066|NCT02296411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204067|NCT04581473|Paclitaxel|paclitaxel|mesh-list
102204068|NCT04581473|Irinotecan|irinotecan|mesh-list
102204069|NCT04581473|Apatinib|apatinib|mesh-list
101912808|NCT03765138|Pramipexole|pramipexole|mesh-list
102204070|NCT04581473|Antibodies|antibodies|mesh-list
102204071|NCT04581473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102204072|NCT04581473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102204073|NCT04581473|Tubulin Modulators|tubulin modulators|mesh-ancestor
102204074|NCT04581473|Antimitotic Agents|antimitotic agents|mesh-ancestor
102204075|NCT04581473|Mitosis Modulators|mitosis modulators|mesh-ancestor
102204076|NCT04581473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204077|NCT04581473|Immunologic Factors|immunologic factors|mesh-ancestor
102204078|NCT04581473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204079|NCT04581473|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102204080|NCT04581473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102204081|NCT04581473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102204082|NCT04581473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102204083|NCT02229617|Methyltestosterone|methyltestosterone|mesh-list
102204084|NCT02229617|Testosterone|testosterone|mesh-list
102204085|NCT02229617|Testosterone undecanoate|testosterone undecanoate|mesh-list
102204086|NCT02229617|Testosterone enanthate|testosterone enanthate|mesh-list
102204087|NCT02229617|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102204088|NCT02229617|Androgens|androgens|mesh-ancestor
102204089|NCT02229617|Hormones|hormones|mesh-ancestor
102204090|NCT02229617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102204091|NCT02229617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204092|NCT02229617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102204093|NCT02229617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102204094|NCT02229617|Anabolic Agents|anabolic agents|mesh-ancestor
102204095|NCT02347059|Dopamine|dopamine|mesh-list
102204096|NCT02347059|Levodopa|levodopa|mesh-list
102204097|NCT02347059|Pramipexole|pramipexole|mesh-list
102204098|NCT02347059|Dopamine Agonists|dopamine agonists|mesh-list
102204099|NCT02347059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102204100|NCT02347059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102204101|NCT02347059|Dopamine Agents|dopamine agents|mesh-ancestor
102204102|NCT02347059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102204103|NCT02347059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204104|NCT02347059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204105|NCT02347059|Antioxidants|antioxidants|mesh-ancestor
102204106|NCT02347059|Protective Agents|protective agents|mesh-ancestor
102204107|NCT02347059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102204108|NCT02347059|Sympathomimetics|sympathomimetics|mesh-ancestor
102204109|NCT02347059|Autonomic Agents|autonomic agents|mesh-ancestor
102204110|NCT02347059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102204111|NCT02353611|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102204112|NCT02353611|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102204113|NCT02353611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102204114|NCT02296567|Bevacizumab|bevacizumab|mesh-list
102204115|NCT02296567|Ranibizumab|ranibizumab|mesh-list
102204116|NCT02296567|Aflibercept|aflibercept|mesh-list
102204117|NCT02296567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102204118|NCT02296567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102204119|NCT02296567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102204120|NCT02296567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102204121|NCT02296567|Growth Substances|growth substances|mesh-ancestor
102204122|NCT02296567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204123|NCT02296567|Growth Inhibitors|growth inhibitors|mesh-ancestor
102204124|NCT02296723|Valganciclovir|valganciclovir|mesh-list
102204125|NCT02296723|Antiviral Agents|antiviral agents|mesh-ancestor
102204126|NCT02296723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102204127|NCT02289937|Ropivacaine|ropivacaine|mesh-list
102204128|NCT02289937|Anesthetics, Local|anesthetics, local|mesh-ancestor
102204129|NCT02289937|Anesthetics|anesthetics|mesh-ancestor
102204130|NCT02289937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102204131|NCT02289937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204132|NCT02289937|Sensory System Agents|sensory system agents|mesh-ancestor
102204133|NCT02289937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102204134|NCT03446807|Droxidopa|droxidopa|mesh-list
102204135|NCT03446807|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102204136|NCT03446807|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102204137|NCT03519061|Budesonide|budesonide|mesh-list
102204138|NCT03519061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102204139|NCT03519061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102204140|NCT03519061|Autonomic Agents|autonomic agents|mesh-ancestor
102204141|NCT03519061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102204142|NCT03519061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204143|NCT03519061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102204144|NCT03519061|Respiratory System Agents|respiratory system agents|mesh-ancestor
102204145|NCT03519061|Glucocorticoids|glucocorticoids|mesh-ancestor
102204146|NCT03519061|Hormones|hormones|mesh-ancestor
101912883|NCT01135602|Topiramate|topiramate|mesh-list
102204147|NCT03519061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102204148|NCT02229773|Pravastatin|pravastatin|mesh-list
102204150|NCT02229773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102204151|NCT02229773|Antimetabolites|antimetabolites|mesh-ancestor
102204152|NCT02229773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204153|NCT02229773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102204154|NCT02229773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102204155|NCT02229773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102204156|NCT02293291|Lithium Carbonate|lithium carbonate|mesh-list
102204157|NCT02293291|Antidepressive Agents|antidepressive agents|mesh-ancestor
102204158|NCT02293291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102204159|NCT02293291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102204160|NCT02293291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450518|NCT00193739|Carboplatin|carboplatin|mesh-list
102204161|NCT02293291|Antimanic Agents|antimanic agents|mesh-ancestor
102204162|NCT02293291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102204163|NCT02293291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102204164|NCT02293291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204165|NCT03515707|Etoposide|etoposide|mesh-list
102204166|NCT03515707|Podophyllotoxin|podophyllotoxin|mesh-list
102204167|NCT03515707|Etoposide phosphate|etoposide phosphate|mesh-list
102204168|NCT03515707|Busulfan|busulfan|mesh-list
102204169|NCT03515707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102204170|NCT03515707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102204171|NCT03515707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102204172|NCT03515707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102204173|NCT03515707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102204174|NCT03515707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204175|NCT03515707|Alkylating Agents|alkylating agents|mesh-ancestor
102204176|NCT03515707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102204177|NCT03515707|Immunologic Factors|immunologic factors|mesh-ancestor
102204178|NCT03515707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204179|NCT03515707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102204180|NCT03515707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102204181|NCT03515707|Keratolytic Agents|keratolytic agents|mesh-ancestor
102204182|NCT03515707|Dermatologic Agents|dermatologic agents|mesh-ancestor
102204183|NCT03515707|Tubulin Modulators|tubulin modulators|mesh-ancestor
102204184|NCT03515707|Antimitotic Agents|antimitotic agents|mesh-ancestor
102204185|NCT03515707|Mitosis Modulators|mitosis modulators|mesh-ancestor
102204186|NCT02298205|Beclomethasone|beclomethasone|mesh-list
102204187|NCT02298205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102204188|NCT02298205|Glucocorticoids|glucocorticoids|mesh-ancestor
102204189|NCT02298205|Hormones|hormones|mesh-ancestor
102204190|NCT02298205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102204191|NCT02298205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204192|NCT02298205|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102204193|NCT02298205|Respiratory System Agents|respiratory system agents|mesh-ancestor
102204194|NCT03514771|Valacyclovir|valacyclovir|mesh-list
102204195|NCT03514771|Isotretinoin|isotretinoin|mesh-list
102204196|NCT03514771|Antiviral Agents|antiviral agents|mesh-ancestor
102204197|NCT03514771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102204198|NCT03514771|Dermatologic Agents|dermatologic agents|mesh-ancestor
102204199|NCT02298283|Prednisone|prednisone|mesh-list
102204200|NCT02298283|Cyclophosphamide|cyclophosphamide|mesh-list
102204201|NCT02298283|Doxorubicin|doxorubicin|mesh-list
102204202|NCT02298283|Etoposide|etoposide|mesh-list
102204203|NCT02298283|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102204204|NCT02298283|Vincristine|vincristine|mesh-list
102204205|NCT02298283|Bleomycin|bleomycin|mesh-list
102204206|NCT02298283|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102204207|NCT02298283|Procarbazine|procarbazine|mesh-list
102204208|NCT02298283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102204209|NCT02298283|Immunologic Factors|immunologic factors|mesh-ancestor
102204210|NCT02298283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204211|NCT02298283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102204212|NCT02298283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102204213|NCT02298283|Alkylating Agents|alkylating agents|mesh-ancestor
102204214|NCT02298283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204215|NCT02298283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102204216|NCT02298283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102204217|NCT02298283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102204218|NCT02298283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102204219|NCT02298283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102204220|NCT02298283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102204221|NCT02298283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102204222|NCT02298283|Glucocorticoids|glucocorticoids|mesh-ancestor
101912962|NCT01232244|Glucagon|glucagon|mesh-list
102204224|NCT02298283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102204225|NCT02298283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102204226|NCT02298283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102204227|NCT02298283|Tubulin Modulators|tubulin modulators|mesh-ancestor
102204228|NCT02298283|Antimitotic Agents|antimitotic agents|mesh-ancestor
102204229|NCT02298283|Mitosis Modulators|mitosis modulators|mesh-ancestor
102204230|NCT02298283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102204231|NCT02298283|Immunotoxins|immunotoxins|mesh-ancestor
102204232|NCT02298283|Immunoconjugates|immunoconjugates|mesh-ancestor
102204233|NCT02346357|Ropivacaine|ropivacaine|mesh-list
102204234|NCT02346357|Anesthetics, Local|anesthetics, local|mesh-ancestor
102204235|NCT02346357|Anesthetics|anesthetics|mesh-ancestor
102204236|NCT02346357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102204237|NCT02346357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204238|NCT02346357|Sensory System Agents|sensory system agents|mesh-ancestor
102204239|NCT02346357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102204240|NCT03146247|Apremilast|apremilast|mesh-list
102204241|NCT03146247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102204242|NCT03146247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102204243|NCT03146247|Analgesics|analgesics|mesh-ancestor
102204244|NCT03146247|Sensory System Agents|sensory system agents|mesh-ancestor
102204245|NCT03146247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102204246|NCT03146247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204247|NCT03146247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102204248|NCT03146247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102204249|NCT03146247|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102204250|NCT03146247|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102204251|NCT03146247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102204252|NCT03146247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204253|NCT03263273|Minocycline|minocycline|mesh-list
102204254|NCT03263273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102204255|NCT03263273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102204256|NCT03146325|Metronidazole|metronidazole|mesh-list
102204257|NCT03146325|Tetracycline|tetracycline|mesh-list
102204258|NCT03146325|Omeprazole|omeprazole|mesh-list
102204259|NCT03146325|Bismuth|bismuth|mesh-list
102204260|NCT03146325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102204261|NCT03146325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102204262|NCT03146325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102204263|NCT03146325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102204264|NCT03146325|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102204265|NCT03146325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102204266|NCT03146325|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102204267|NCT03146325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102204268|NCT03146325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204269|NCT03146325|Antacids|antacids|mesh-ancestor
102204270|NCT03146325|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102204271|NCT02233049|Everolimus|everolimus|mesh-list
102204272|NCT02233049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102204273|NCT02233049|Dasatinib|dasatinib|mesh-list
102204274|NCT02233049|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102204275|NCT02233049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102204276|NCT02233049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102204277|NCT02233049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204278|NCT02233049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102204279|NCT02233049|Immunologic Factors|immunologic factors|mesh-ancestor
102204280|NCT02233049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204281|NCT02233049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102204282|NCT02350725|Furosemide|furosemide|mesh-list
102204283|NCT02350725|Diuretics|diuretics|mesh-ancestor
102204284|NCT02350725|Natriuretic Agents|natriuretic agents|mesh-ancestor
102204285|NCT02350725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204286|NCT02350725|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102204287|NCT02350725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102204288|NCT02350725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204289|NCT02350959|Atorvastatin|atorvastatin|mesh-list
102204290|NCT02350959|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102204291|NCT02350959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102204292|NCT02350959|Antimetabolites|antimetabolites|mesh-ancestor
102204293|NCT02350959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204294|NCT02350959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102204295|NCT02350959|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102204296|NCT02350959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102204297|NCT02350335|Nicotine|nicotine|mesh-list
101913033|NCT01136850|Amebicides|amebicides|mesh-ancestor
102204298|NCT02350335|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102204299|NCT02350335|Autonomic Agents|autonomic agents|mesh-ancestor
102204300|NCT02350335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102204301|NCT02350335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204302|NCT02350335|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102204303|NCT02350335|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102204304|NCT02350335|Cholinergic Agents|cholinergic agents|mesh-ancestor
102204305|NCT02350335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102204306|NCT02350335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204307|NCT02293447|Lidocaine|lidocaine|mesh-list
102204308|NCT02293447|Anesthetics, Local|anesthetics, local|mesh-list
102204309|NCT02293447|Anesthetics|anesthetics|mesh-list
102204310|NCT02293447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102204311|NCT02293447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204312|NCT02293447|Sensory System Agents|sensory system agents|mesh-ancestor
102204313|NCT02293447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102204314|NCT02293447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102204315|NCT02293447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102204316|NCT02293447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102204317|NCT02293447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102204318|NCT02293447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204319|NCT04464811|Furosemide|furosemide|mesh-list
102204320|NCT04464811|Diuretics|diuretics|mesh-ancestor
102204321|NCT04464811|Natriuretic Agents|natriuretic agents|mesh-ancestor
102204322|NCT04464811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204323|NCT04464811|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102204324|NCT04464811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102204325|NCT04464811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204326|NCT02293525|Morphine|morphine|mesh-list
102204327|NCT02293525|Oxycodone|oxycodone|mesh-list
102204328|NCT02293525|Ropivacaine|ropivacaine|mesh-list
102204329|NCT02293525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102204330|NCT02293525|Narcotics|narcotics|mesh-ancestor
102204331|NCT02293525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102204332|NCT02293525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204333|NCT02293525|Analgesics|analgesics|mesh-ancestor
102204334|NCT02293525|Sensory System Agents|sensory system agents|mesh-ancestor
102204335|NCT02293525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102204336|NCT02293525|Anesthetics, Local|anesthetics, local|mesh-ancestor
102204337|NCT02293525|Anesthetics|anesthetics|mesh-ancestor
102204338|NCT02298595|Cetuximab|cetuximab|mesh-list
102204339|NCT02298595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102204340|NCT02298595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102204341|NCT02345343|Apixaban|apixaban|mesh-list
102204342|NCT02345343|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102204343|NCT02345343|Antithrombins|antithrombins|mesh-ancestor
102204344|NCT02345343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102204345|NCT02345343|Protease Inhibitors|protease inhibitors|mesh-ancestor
102204346|NCT02345343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102204347|NCT02345343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204348|NCT02345343|Anticoagulants|anticoagulants|mesh-ancestor
102204349|NCT03949673|Celecoxib|celecoxib|mesh-list
102204350|NCT03949673|Diclofenac|diclofenac|mesh-list
102204351|NCT03949673|Naproxen|naproxen|mesh-list
102204352|NCT03949673|Fasinumab|fasinumab|mesh-list
102204353|NCT03949673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102204354|NCT03949673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102204356|NCT03949673|Sensory System Agents|sensory system agents|mesh-ancestor
102204357|NCT03949673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102204358|NCT03949673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204359|NCT03949673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102204360|NCT03949673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102204361|NCT03949673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102204362|NCT03949673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102204363|NCT03949673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102204364|NCT03949673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204365|NCT03949673|Gout Suppressants|gout suppressants|mesh-ancestor
102204366|NCT02350179|Tranexamic Acid|tranexamic acid|mesh-list
102204367|NCT02350179|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102204368|NCT02350179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102204369|NCT02350179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204370|NCT02350179|Hemostatics|hemostatics|mesh-ancestor
102204371|NCT02350179|Coagulants|coagulants|mesh-ancestor
102204372|NCT02233205|Gemcitabine|gemcitabine|mesh-list
102204373|NCT02233205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102204375|NCT02233205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204376|NCT02233205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102204377|NCT02843633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
102204378|NCT02293681|Infliximab|infliximab|mesh-list
102204379|NCT02293681|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102204380|NCT02293681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102204381|NCT02293681|Dermatologic Agents|dermatologic agents|mesh-ancestor
102204382|NCT02293681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102204383|NCT02293681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102204384|NCT02259491|Calcium|calcium|mesh-list
102204385|NCT02259491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102204386|NCT02259491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204387|NCT05255523|Capecitabine|capecitabine|mesh-list
102204388|NCT05255523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102204389|NCT05255523|Antimetabolites|antimetabolites|mesh-ancestor
102204390|NCT05255523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204391|NCT05255523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102204392|NCT03149679|Cyclophosphamide|cyclophosphamide|mesh-list
102204393|NCT03149679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102204394|NCT03149679|Immunologic Factors|immunologic factors|mesh-ancestor
102204395|NCT03149679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204396|NCT03149679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102204397|NCT03149679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102204398|NCT03149679|Alkylating Agents|alkylating agents|mesh-ancestor
102204399|NCT03149679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204400|NCT03149679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102204401|NCT03149679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102204402|NCT02298985|Curcumin|curcumin|mesh-list
102204403|NCT02298985|Antipsychotic Agents|antipsychotic agents|mesh-list
101308390|NCT02047149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102204404|NCT02298985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102204405|NCT02298985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102204406|NCT02298985|Analgesics|analgesics|mesh-ancestor
102204407|NCT02298985|Sensory System Agents|sensory system agents|mesh-ancestor
102204408|NCT02298985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102204409|NCT02298985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204410|NCT02298985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102204411|NCT02298985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102204412|NCT02298985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102204413|NCT02298985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102204414|NCT02298985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204415|NCT02298985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102204416|NCT02298985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102204417|NCT02298985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102204418|NCT03149445|Metoprolol|metoprolol|mesh-list
102204419|NCT03149445|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102204420|NCT03149445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102204421|NCT03149445|Sympatholytics|sympatholytics|mesh-ancestor
102204422|NCT03149445|Autonomic Agents|autonomic agents|mesh-ancestor
102204423|NCT03149445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102204424|NCT03149445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204425|NCT03149445|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102204426|NCT03149445|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102204428|NCT03149445|Adrenergic Agents|adrenergic agents|mesh-ancestor
102204429|NCT03149445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102204430|NCT03149445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204431|NCT02345187|Micronutrients|micronutrients|mesh-list
102204432|NCT02345187|Trace Elements|trace elements|mesh-list
102204433|NCT02345187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204434|NCT02299063|Dexmedetomidine|dexmedetomidine|mesh-list
102204435|NCT02299063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102204436|NCT02299063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102204437|NCT02299063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204438|NCT02299063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102204439|NCT02299063|Analgesics|analgesics|mesh-ancestor
102204440|NCT02299063|Sensory System Agents|sensory system agents|mesh-ancestor
102204441|NCT02299063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102204442|NCT02299063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102204443|NCT02299063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102204444|NCT02299063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102204445|NCT02299063|Adrenergic Agents|adrenergic agents|mesh-ancestor
102204446|NCT02299063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102204447|NCT02299063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204448|NCT03149289|Antiviral Agents|antiviral agents|mesh-list
102204449|NCT03149289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102204450|NCT05624801|Vitamin D|vitamin d|mesh-list
102204451|NCT05624801|Vitamins|vitamins|mesh-ancestor
102204452|NCT05624801|Micronutrients|micronutrients|mesh-ancestor
102204453|NCT05624801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204454|NCT05624801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102204455|NCT05255211|Propofol|propofol|mesh-list
102204456|NCT05255211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102204457|NCT05255211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102204458|NCT05255211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204459|NCT05255211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102204460|NCT05255211|Anesthetics, General|anesthetics, general|mesh-ancestor
102204461|NCT05255211|Anesthetics|anesthetics|mesh-ancestor
102204462|NCT03514381|Doxorubicin|doxorubicin|mesh-list
102204463|NCT03514381|Ifosfamide|ifosfamide|mesh-list
102204464|NCT03514381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102204465|NCT03514381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102204466|NCT03514381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102204467|NCT03514381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102204468|NCT03514381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102204469|NCT03514381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204470|NCT03514381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102204471|NCT03514381|Alkylating Agents|alkylating agents|mesh-ancestor
102204472|NCT02343393|Hydralazine|hydralazine|mesh-list
102204473|NCT02343393|Isosorbide|isosorbide|mesh-list
102204474|NCT02343393|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
102204475|NCT02343393|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
102204476|NCT02343393|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102204477|NCT02343393|Diuretics|diuretics|mesh-ancestor
102204478|NCT02343393|Natriuretic Agents|natriuretic agents|mesh-ancestor
102204479|NCT02343393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204480|NCT02343393|Vasodilator Agents|vasodilator agents|mesh-ancestor
102204481|NCT02343393|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102204482|NCT02343393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204483|NCT02343393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102204484|NCT02344875|Dotinurad|dotinurad|mesh-list
102204485|NCT02344875|Uricosuric Agents|uricosuric agents|mesh-ancestor
102204486|NCT02344875|Gout Suppressants|gout suppressants|mesh-ancestor
102204487|NCT02344875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102204488|NCT03145623|Grazoprevir|grazoprevir|mesh-list
102204489|NCT03145623|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
102204490|NCT03145623|Antiviral Agents|antiviral agents|mesh-ancestor
102204491|NCT03145623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102204492|NCT02294071|Acetaminophen|acetaminophen|mesh-list
102204493|NCT02294071|Ibuprofen|ibuprofen|mesh-list
102204494|NCT02294071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102204495|NCT02294071|Analgesics|analgesics|mesh-ancestor
102204496|NCT02294071|Sensory System Agents|sensory system agents|mesh-ancestor
102204497|NCT02294071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102204498|NCT02294071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204499|NCT02294071|Antipyretics|antipyretics|mesh-ancestor
102204500|NCT02294071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102204501|NCT02294071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102204502|NCT02294071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102204503|NCT02294071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102204505|NCT02294071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204506|NCT02233439|Galactogogues|galactogogues|mesh-list
102204507|NCT02233439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204508|NCT02350023|Betamethasone|betamethasone|mesh-list
102204509|NCT02350023|Latanoprost|latanoprost|mesh-list
102204510|NCT02350023|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102204511|NCT02350023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102204512|NCT02350023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102204513|NCT02350023|Glucocorticoids|glucocorticoids|mesh-ancestor
102204514|NCT02350023|Hormones|hormones|mesh-ancestor
102204515|NCT02350023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102204516|NCT02350023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204517|NCT02350023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102204518|NCT02350023|Respiratory System Agents|respiratory system agents|mesh-ancestor
102204519|NCT02342925|Metformin|metformin|mesh-list
101913259|NCT01140828|Rabeprazole|rabeprazole|mesh-list
102204520|NCT02342925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102204521|NCT02342925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204522|NCT03879863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102204523|NCT03879863|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102204524|NCT02344641|Exenatide|exenatide|mesh-list
102204525|NCT02344641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102204526|NCT02344641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204527|NCT02344641|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102204528|NCT02344641|Incretins|incretins|mesh-ancestor
102204529|NCT02344641|Hormones|hormones|mesh-ancestor
102204530|NCT02344641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102204531|NCT03798743|Docetaxel|docetaxel|mesh-list
102204532|NCT03798743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102204533|NCT03798743|Tubulin Modulators|tubulin modulators|mesh-ancestor
102204534|NCT03798743|Antimitotic Agents|antimitotic agents|mesh-ancestor
102204535|NCT03798743|Mitosis Modulators|mitosis modulators|mesh-ancestor
102204536|NCT03798743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204537|NCT04083183|Mycophenolic Acid|mycophenolic acid|mesh-list
102204538|NCT04083183|Sirolimus|sirolimus|mesh-list
102204539|NCT04083183|Vidarabine|vidarabine|mesh-list
102204540|NCT04083183|Cyclophosphamide|cyclophosphamide|mesh-list
102204541|NCT04083183|Fludarabine|fludarabine|mesh-list
102204542|NCT04083183|Fludarabine phosphate|fludarabine phosphate|mesh-list
102204543|NCT04083183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102204544|NCT04083183|Thymoglobulin|thymoglobulin|mesh-list
102204545|NCT04083183|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102204546|NCT04083183|Antibodies|antibodies|mesh-list
102204547|NCT04083183|Immunoglobulins|immunoglobulins|mesh-list
102204548|NCT04083183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102204549|NCT04083183|gamma-Globulins|gamma-globulins|mesh-list
102204550|NCT04083183|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102204551|NCT04083183|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102204552|NCT04083183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102204553|NCT04083183|Immunologic Factors|immunologic factors|mesh-ancestor
102204554|NCT04083183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204555|NCT04083183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102204556|NCT04083183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102204557|NCT04083183|Alkylating Agents|alkylating agents|mesh-ancestor
102204558|NCT04083183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204559|NCT04083183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102204560|NCT04083183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102204561|NCT04083183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102204562|NCT04083183|Antimetabolites|antimetabolites|mesh-ancestor
102204563|NCT04083183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102204564|NCT04083183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102204565|NCT04083183|Antitubercular Agents|antitubercular agents|mesh-ancestor
102204566|NCT04083183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102204567|NCT04083183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102204568|NCT04083183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102204569|NCT04083183|Antifungal Agents|antifungal agents|mesh-ancestor
102204570|NCT04083183|Antiviral Agents|antiviral agents|mesh-ancestor
102204571|NCT02342769|Dolutegravir|dolutegravir|mesh-list
102204572|NCT02342769|Abacavir|abacavir|mesh-list
102204573|NCT02342769|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102204574|NCT02342769|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102204575|NCT02342769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102204576|NCT02342769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204577|NCT02342769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102204578|NCT02342769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102204580|NCT02342769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102204581|NCT02342769|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102204582|NCT02342769|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102204583|NCT03766295|Gemcitabine|gemcitabine|mesh-list
102204584|NCT03766295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102204585|NCT03766295|Antimetabolites|antimetabolites|mesh-ancestor
102204586|NCT03766295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204587|NCT03766295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102204588|NCT03761225|Prednisone|prednisone|mesh-list
102204589|NCT03761225|Docetaxel|docetaxel|mesh-list
102204590|NCT03761225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102204591|NCT03761225|Tubulin Modulators|tubulin modulators|mesh-ancestor
102204592|NCT03761225|Antimitotic Agents|antimitotic agents|mesh-ancestor
102204593|NCT03761225|Mitosis Modulators|mitosis modulators|mesh-ancestor
102204594|NCT03761225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204595|NCT03761225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102204596|NCT03761225|Glucocorticoids|glucocorticoids|mesh-ancestor
102204597|NCT03761225|Hormones|hormones|mesh-ancestor
102204598|NCT03761225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102204599|NCT03761225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204600|NCT03761225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102204601|NCT02349945|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102204602|NCT02349945|Hormones|hormones|mesh-ancestor
102204603|NCT02349945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102204604|NCT02349945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204605|NCT02302495|Prednisone|prednisone|mesh-list
102204606|NCT02302495|Melphalan|melphalan|mesh-list
102204607|NCT02302495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102204608|NCT02302495|Glucocorticoids|glucocorticoids|mesh-ancestor
102204609|NCT02302495|Hormones|hormones|mesh-ancestor
102204610|NCT02302495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102204611|NCT02302495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204612|NCT02302495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102204613|NCT02302495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102204614|NCT02302495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102204615|NCT02302495|Alkylating Agents|alkylating agents|mesh-ancestor
102204616|NCT02302495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204617|NCT02302495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102204618|NCT02302495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102204619|NCT02302495|Immunologic Factors|immunologic factors|mesh-ancestor
102204620|NCT02813447|Sertraline|sertraline|mesh-list
102204621|NCT02813447|Antidepressive Agents|antidepressive agents|mesh-ancestor
102204622|NCT02813447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102204623|NCT02813447|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102204624|NCT02813447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102204625|NCT02813447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102204626|NCT02813447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204627|NCT02813447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102204628|NCT02813447|Serotonin Agents|serotonin agents|mesh-ancestor
102204629|NCT02813447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204630|NCT02342145|Cyclosporine|cyclosporine|mesh-list
102204631|NCT02342145|Mycophenolic Acid|mycophenolic acid|mesh-list
102204632|NCT02342145|Methotrexate|methotrexate|mesh-list
102204633|NCT02342145|Cyclosporins|cyclosporins|mesh-list
102204634|NCT02342145|Basiliximab|basiliximab|mesh-list
102204635|NCT02342145|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102204636|NCT02342145|Abortifacient Agents|abortifacient agents|mesh-ancestor
102204637|NCT02342145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102204638|NCT02342145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204639|NCT02342145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102204640|NCT02342145|Antimetabolites|antimetabolites|mesh-ancestor
102204641|NCT02342145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204642|NCT02342145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102204643|NCT02342145|Dermatologic Agents|dermatologic agents|mesh-ancestor
102204644|NCT02342145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102204645|NCT02342145|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102204646|NCT02342145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102204647|NCT02342145|Immunologic Factors|immunologic factors|mesh-ancestor
101450657|NCT00223860|Hormones|hormones|mesh-list
102204648|NCT02342145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102204649|NCT02342145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102204650|NCT02342145|Antifungal Agents|antifungal agents|mesh-ancestor
101900580|NCT03865550|Anesthetics, General|anesthetics, general|mesh-ancestor
102204651|NCT02342145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102204652|NCT02342145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102204653|NCT02342145|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102204654|NCT02342145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102204655|NCT02342145|Antitubercular Agents|antitubercular agents|mesh-ancestor
102204656|NCT02342145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102204657|NCT02349399|Cyproterone Acetate|cyproterone acetate|mesh-list
102204658|NCT02349399|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102204659|NCT02349399|Cyproterone|cyproterone|mesh-list
102204660|NCT02349399|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
102204661|NCT02349399|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102204662|NCT02349399|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102204663|NCT02349399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102204664|NCT02349399|Contraceptive Agents|contraceptive agents|mesh-ancestor
102204665|NCT02349399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102204666|NCT02349399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204667|NCT02349399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102204668|NCT02349399|Estrogens|estrogens|mesh-ancestor
102204669|NCT02349399|Hormones|hormones|mesh-ancestor
102204670|NCT02349399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102204671|NCT02349399|Androgen Antagonists|androgen antagonists|mesh-ancestor
102204672|NCT02349399|Hormone Antagonists|hormone antagonists|mesh-ancestor
102204673|NCT02349399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102204674|NCT02349399|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102204676|NCT02306473|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102204677|NCT02306473|Diuretics|diuretics|mesh-ancestor
102204678|NCT02306473|Natriuretic Agents|natriuretic agents|mesh-ancestor
102204679|NCT02306473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204680|NCT03737123|Carboplatin|carboplatin|mesh-list
102204681|NCT03737123|Gemcitabine|gemcitabine|mesh-list
102204682|NCT03737123|Docetaxel|docetaxel|mesh-list
102204683|NCT03737123|Atezolizumab|atezolizumab|mesh-list
102204684|NCT03737123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102204685|NCT03737123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102204686|NCT03737123|Antimetabolites|antimetabolites|mesh-ancestor
102204687|NCT03737123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204688|NCT03737123|Tubulin Modulators|tubulin modulators|mesh-ancestor
102204689|NCT03737123|Antimitotic Agents|antimitotic agents|mesh-ancestor
102204690|NCT03737123|Mitosis Modulators|mitosis modulators|mesh-ancestor
102204691|NCT03737123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102204692|NCT03737123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102204693|NCT03709121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102204694|NCT03709121|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102204695|NCT02344095|Paclitaxel|paclitaxel|mesh-list
102204696|NCT02344095|Cisplatin|cisplatin|mesh-list
102204697|NCT02344095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102204698|NCT02344095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102204699|NCT02344095|Tubulin Modulators|tubulin modulators|mesh-ancestor
102204700|NCT02344095|Antimitotic Agents|antimitotic agents|mesh-ancestor
102204701|NCT02344095|Mitosis Modulators|mitosis modulators|mesh-ancestor
102204702|NCT02344095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204703|NCT00157339|Insulin|insulin|mesh-list
102204704|NCT00157339|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102204705|NCT00157339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102204706|NCT00157339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204707|NCT02342067|Pioglitazone|pioglitazone|mesh-list
102204708|NCT02342067|Cenicriviroc|cenicriviroc|mesh-list
102204709|NCT02342067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102204710|NCT02342067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204711|NCT02342067|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102204712|NCT02342067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204713|NCT02342067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102204714|NCT02342067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102204715|NCT02342067|Antiviral Agents|antiviral agents|mesh-ancestor
102204716|NCT02342067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102204717|NCT02344017|Prednisone|prednisone|mesh-list
102204718|NCT02344017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102204719|NCT02344017|Glucocorticoids|glucocorticoids|mesh-ancestor
102204720|NCT02344017|Hormones|hormones|mesh-ancestor
102204721|NCT02344017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102204722|NCT02344017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204723|NCT02344017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102204724|NCT02344017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102204725|NCT02343861|Emollients|emollients|mesh-list
102204726|NCT02343861|Dermatologic Agents|dermatologic agents|mesh-ancestor
102204727|NCT03676751|Azithromycin|azithromycin|mesh-list
102204728|NCT03676751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102204729|NCT03676751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102204730|NCT02302729|Micronutrients|micronutrients|mesh-list
102204731|NCT02302729|Trace Elements|trace elements|mesh-list
102204732|NCT02302729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204733|NCT03513601|Rituximab|rituximab|mesh-list
102204734|NCT03513601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102204735|NCT03513601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102204736|NCT03513601|Immunologic Factors|immunologic factors|mesh-ancestor
102204737|NCT03513601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204738|NCT03513601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102204739|NCT03647111|Crizotinib|crizotinib|mesh-list
102204740|NCT03647111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102204741|NCT03647111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102204742|NCT03647111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102204743|NCT03647111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204744|NCT03507829|Insulin|insulin|mesh-list
102204745|NCT03507829|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102204746|NCT03507829|Insulin Lispro|insulin lispro|mesh-list
102204747|NCT03507829|Isophane Insulin, Human|isophane insulin, human|mesh-list
102204748|NCT03507829|Insulin, Isophane|insulin, isophane|mesh-list
102204749|NCT03507829|Isophane insulin, beef|isophane insulin, beef|mesh-list
102204750|NCT03507829|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102204751|NCT03507829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204753|NCT02232581|Dideoxynucleosides|dideoxynucleosides|mesh-list
102204754|NCT02232581|Antiviral Agents|antiviral agents|mesh-ancestor
102204755|NCT02232581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102204756|NCT02232581|Antimetabolites|antimetabolites|mesh-ancestor
102204757|NCT02232581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204758|NCT02232581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102204759|NCT02232581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102204760|NCT02232581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102204761|NCT02341833|Sevoflurane|sevoflurane|mesh-list
102204762|NCT02341833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102204763|NCT02341833|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102204764|NCT02341833|Anesthetics, General|anesthetics, general|mesh-ancestor
102204765|NCT02341833|Anesthetics|anesthetics|mesh-ancestor
102204766|NCT02341833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102204767|NCT02341833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204768|NCT02337231|Borage oil|borage oil|mesh-list
102204769|NCT02337231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102204770|NCT03507751|Meropenem|meropenem|mesh-list
102204771|NCT03507751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102204772|NCT03507751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102204773|NCT02306629|Epratuzumab|epratuzumab|mesh-list
102204774|NCT02306629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102204775|NCT02306629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102204776|NCT03510793|Anesthetics|anesthetics|mesh-list
102204777|NCT03510793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102204778|NCT03510793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204779|NCT05230797|Zinc|zinc|mesh-list
102204780|NCT05230797|Propolis|propolis|mesh-list
102204781|NCT05230797|Eugenol|eugenol|mesh-list
102204782|NCT05230797|Zinc Oxide|zinc oxide|mesh-list
102204783|NCT05230797|Trace Elements|trace elements|mesh-ancestor
102204784|NCT05230797|Micronutrients|micronutrients|mesh-ancestor
102204785|NCT05230797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204786|NCT05230797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102204787|NCT05230797|Dermatologic Agents|dermatologic agents|mesh-ancestor
102204788|NCT05230797|Sunscreening Agents|sunscreening agents|mesh-ancestor
102204789|NCT05230797|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102204790|NCT05230797|Protective Agents|protective agents|mesh-ancestor
102204791|NCT02341365|Vitamin D|vitamin d|mesh-list
102204792|NCT02341365|Vitamins|vitamins|mesh-ancestor
102204793|NCT02341365|Micronutrients|micronutrients|mesh-ancestor
102204794|NCT02341365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204795|NCT02341365|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102204796|NCT02299687|Omeprazole|omeprazole|mesh-list
102204797|NCT02299687|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102204798|NCT02299687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102204799|NCT02299687|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102204800|NCT02299687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102204801|NCT02299687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204802|NCT02349243|Entacapone|entacapone|mesh-list
102204803|NCT02349243|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102204804|NCT02349243|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102204805|NCT02349243|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102204807|NCT02349243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204808|NCT02341209|Doxycycline|doxycycline|mesh-list
102204809|NCT02341209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102204810|NCT02341209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102204811|NCT02341209|Antimalarials|antimalarials|mesh-ancestor
102204812|NCT02341209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102204813|NCT02341209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102204814|NCT02349165|Riboflavin|riboflavin|mesh-list
102204815|NCT02349165|Vitamin B Complex|vitamin b complex|mesh-ancestor
102204816|NCT02349165|Vitamins|vitamins|mesh-ancestor
102204817|NCT02349165|Micronutrients|micronutrients|mesh-ancestor
102204818|NCT02349165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204819|NCT02349165|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102204820|NCT02349165|Dermatologic Agents|dermatologic agents|mesh-ancestor
102204821|NCT03112005|Mydriatics|mydriatics|mesh-list
102204822|NCT03112005|Autonomic Agents|autonomic agents|mesh-ancestor
102204823|NCT03112005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102204824|NCT03112005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204825|NCT02306785|Mesalamine|mesalamine|mesh-list
102204826|NCT02306785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101913610|NCT05846373|Niacin|niacin|mesh-list
102204827|NCT02306785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102204828|NCT02306785|Analgesics|analgesics|mesh-ancestor
102204829|NCT02306785|Sensory System Agents|sensory system agents|mesh-ancestor
102204830|NCT02306785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102204831|NCT02306785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204832|NCT02306785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102204833|NCT02306785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102204834|NCT02299765|Carboplatin|carboplatin|mesh-list
102204835|NCT02299765|Gemcitabine|gemcitabine|mesh-list
102204836|NCT02299765|Gefitinib|gefitinib|mesh-list
102204837|NCT02299765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102204838|NCT02299765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102204839|NCT02299765|Antimetabolites|antimetabolites|mesh-ancestor
102204840|NCT02299765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204841|NCT02299765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102204842|NCT02299765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102204843|NCT04771923|Epinephrine|epinephrine|mesh-list
102204844|NCT04771923|Racepinephrine|racepinephrine|mesh-list
102204845|NCT04771923|Tranexamic Acid|tranexamic acid|mesh-list
102204846|NCT04771923|Epinephryl borate|epinephryl borate|mesh-list
102204847|NCT04771923|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102204848|NCT04771923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102204849|NCT04771923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204850|NCT04771923|Hemostatics|hemostatics|mesh-ancestor
102204851|NCT04771923|Coagulants|coagulants|mesh-ancestor
102204852|NCT04771923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102204853|NCT04771923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102204854|NCT04771923|Adrenergic Agents|adrenergic agents|mesh-ancestor
102204855|NCT04771923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102204856|NCT04771923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204857|NCT04771923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102204858|NCT04771923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102204859|NCT04771923|Autonomic Agents|autonomic agents|mesh-ancestor
102204860|NCT04771923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102204861|NCT04771923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102204862|NCT04771923|Respiratory System Agents|respiratory system agents|mesh-ancestor
102204863|NCT04771923|Mydriatics|mydriatics|mesh-ancestor
102204864|NCT04771923|Sympathomimetics|sympathomimetics|mesh-ancestor
102204865|NCT04771923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102204866|NCT04718415|Paclitaxel|paclitaxel|mesh-list
102204867|NCT04718415|Carboplatin|carboplatin|mesh-list
102204868|NCT04718415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102204869|NCT04718415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102204870|NCT04718415|Tubulin Modulators|tubulin modulators|mesh-ancestor
102204871|NCT04718415|Antimitotic Agents|antimitotic agents|mesh-ancestor
102204872|NCT04718415|Mitosis Modulators|mitosis modulators|mesh-ancestor
102204873|NCT04718415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204874|NCT04598321|Talazoparib|talazoparib|mesh-list
102204875|NCT04598321|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102204876|NCT04598321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102204877|NCT04598321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204878|NCT04598321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102204879|NCT05254899|Gemcitabine|gemcitabine|mesh-list
102204880|NCT05254899|Oxaliplatin|oxaliplatin|mesh-list
102204882|NCT05254899|Pegaspargase|pegaspargase|mesh-list
102204883|NCT05254899|Antibodies|antibodies|mesh-list
102204884|NCT05254899|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102204885|NCT05254899|Immunologic Factors|immunologic factors|mesh-ancestor
102204886|NCT05254899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204887|NCT05254899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102204888|NCT05254899|Antimetabolites|antimetabolites|mesh-ancestor
102204889|NCT05254899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204890|NCT05254899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102204891|NCT05254899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102204892|NCT03148509|Risperidone|risperidone|mesh-list
102204893|NCT03148509|Aripiprazole|aripiprazole|mesh-list
102204894|NCT03148509|Bupropion|bupropion|mesh-list
102204895|NCT03148509|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102204896|NCT03148509|Serotonin Agents|serotonin agents|mesh-ancestor
102204897|NCT03148509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102204898|NCT03148509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204899|NCT03148509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204900|NCT03148509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102204901|NCT03148509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101913638|NCT05845723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102204902|NCT03148509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102204903|NCT03148509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102204904|NCT03148509|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102204905|NCT03148509|Dopamine Agents|dopamine agents|mesh-ancestor
102204906|NCT03148509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102204907|NCT03148509|Antidepressive Agents|antidepressive agents|mesh-ancestor
102204908|NCT03148509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102204909|NCT03148509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102204910|NCT03148509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102204911|NCT03148509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102204912|NCT03148509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102204913|NCT03148509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102204914|NCT03148509|Dopamine Agonists|dopamine agonists|mesh-ancestor
102204915|NCT03148509|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102204916|NCT03148509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102204917|NCT03148509|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102204918|NCT03148509|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102204919|NCT05254665|Docetaxel|docetaxel|mesh-list
102204920|NCT05254665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102204921|NCT05254665|Tubulin Modulators|tubulin modulators|mesh-ancestor
102204922|NCT05254665|Antimitotic Agents|antimitotic agents|mesh-ancestor
102204923|NCT05254665|Mitosis Modulators|mitosis modulators|mesh-ancestor
102204924|NCT05254665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204925|NCT03513055|Insulin|insulin|mesh-list
102204926|NCT03513055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102204927|NCT03513055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204928|NCT03510325|Olanzapine|olanzapine|mesh-list
102204929|NCT03510325|Risperidone|risperidone|mesh-list
102204930|NCT03510325|Aripiprazole|aripiprazole|mesh-list
102204931|NCT03510325|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102204932|NCT03510325|Amisulpride|amisulpride|mesh-list
101450688|NCT00206466|Docetaxel|docetaxel|mesh-list
102204933|NCT03510325|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102204934|NCT03510325|Serotonin Agents|serotonin agents|mesh-ancestor
102204935|NCT03510325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102204936|NCT03510325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204937|NCT03510325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204938|NCT03510325|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102204939|NCT03510325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102204940|NCT03510325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102204941|NCT03510325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102204942|NCT03510325|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102204943|NCT03510325|Dopamine Agents|dopamine agents|mesh-ancestor
102204944|NCT03510325|Antiemetics|antiemetics|mesh-ancestor
102204945|NCT03510325|Autonomic Agents|autonomic agents|mesh-ancestor
102204946|NCT03510325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102204947|NCT03510325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102204948|NCT03510325|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102204949|NCT03510325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102204950|NCT03510325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102204951|NCT03510325|Antidepressive Agents|antidepressive agents|mesh-ancestor
102204952|NCT03510325|Dopamine Agonists|dopamine agonists|mesh-ancestor
102204953|NCT03510325|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102204954|NCT03510325|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102204955|NCT03510325|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102204956|NCT03510325|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102204957|NCT03510325|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102204958|NCT03507127|Varenicline|varenicline|mesh-list
102204959|NCT03507127|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102204960|NCT03507127|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102204961|NCT03507127|Cholinergic Agents|cholinergic agents|mesh-ancestor
102204962|NCT03507127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102204963|NCT03507127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204964|NCT03507127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204965|NCT03512821|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102204966|NCT03512821|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102204967|NCT03512821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102204968|NCT02336529|Bupivacaine|bupivacaine|mesh-list
102204969|NCT02336529|Anesthetics, Local|anesthetics, local|mesh-ancestor
102204970|NCT02336529|Anesthetics|anesthetics|mesh-ancestor
102204971|NCT02336529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102204972|NCT02336529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204973|NCT02336529|Sensory System Agents|sensory system agents|mesh-ancestor
102204974|NCT02336529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102204975|NCT02307487|Mitomycins|mitomycins|mesh-list
102204976|NCT02307487|Mitomycin|mitomycin|mesh-list
102204977|NCT02307487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102204978|NCT02307487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102204979|NCT02307487|Alkylating Agents|alkylating agents|mesh-ancestor
102204980|NCT02307487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204981|NCT02307487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102204982|NCT02307487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102204983|NCT02307565|Midodrine|midodrine|mesh-list
102204984|NCT02307565|Sympathomimetics|sympathomimetics|mesh-ancestor
102204985|NCT02307565|Autonomic Agents|autonomic agents|mesh-ancestor
102204986|NCT02307565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102204987|NCT02307565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102204988|NCT02307565|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102204989|NCT02307565|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102204990|NCT02307565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102204991|NCT02307565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102204992|NCT02307565|Adrenergic Agents|adrenergic agents|mesh-ancestor
102204993|NCT02307565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102204994|NCT02307565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102204995|NCT03510013|Anesthetics|anesthetics|mesh-list
102204996|NCT03510013|Sevoflurane|sevoflurane|mesh-list
102204997|NCT03510013|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
102204998|NCT03510013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102204999|NCT03510013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205000|NCT03510013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102205001|NCT03510013|Anesthetics, General|anesthetics, general|mesh-ancestor
102205002|NCT02307721|Remifentanil|remifentanil|mesh-list
102205003|NCT02307721|Naloxone|naloxone|mesh-list
102205004|NCT02307721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102205005|NCT02307721|Narcotics|narcotics|mesh-ancestor
102205006|NCT02307721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102205007|NCT02307721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205008|NCT02307721|Analgesics|analgesics|mesh-ancestor
102205009|NCT02307721|Sensory System Agents|sensory system agents|mesh-ancestor
102205010|NCT02307721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102205011|NCT02307721|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102205012|NCT03506815|Rivaroxaban|rivaroxaban|mesh-list
102205013|NCT03506815|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102205014|NCT03506815|Antithrombins|antithrombins|mesh-ancestor
102205015|NCT03506815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102205016|NCT03506815|Protease Inhibitors|protease inhibitors|mesh-ancestor
102205017|NCT03506815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102205018|NCT03506815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205019|NCT03506815|Anticoagulants|anticoagulants|mesh-ancestor
102205020|NCT05227677|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102205021|NCT05227677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205022|NCT02348463|Clindamycin|clindamycin|mesh-list
102205023|NCT02348463|Clindamycin palmitate|clindamycin palmitate|mesh-list
102205024|NCT02348463|Clindamycin phosphate|clindamycin phosphate|mesh-list
102205025|NCT02348463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102205026|NCT02348463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102205027|NCT02348463|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102205028|NCT02348463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102205029|NCT02348463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205030|NCT02340273|Oxymetazoline|oxymetazoline|mesh-list
102205031|NCT02340273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102205032|NCT02340273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102205033|NCT02340273|Adrenergic Agents|adrenergic agents|mesh-ancestor
102205034|NCT02340273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102205035|NCT02340273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205036|NCT02340273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205037|NCT02340273|Sympathomimetics|sympathomimetics|mesh-ancestor
102205038|NCT02340273|Autonomic Agents|autonomic agents|mesh-ancestor
102205039|NCT02340273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102205040|NCT02340273|Nasal Decongestants|nasal decongestants|mesh-ancestor
102205041|NCT02340273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102205042|NCT02340273|Respiratory System Agents|respiratory system agents|mesh-ancestor
102205043|NCT02300623|Lamivudine|lamivudine|mesh-list
102205044|NCT02300623|Stavudine|stavudine|mesh-list
102205045|NCT02300623|Indinavir|indinavir|mesh-list
102205046|NCT02300623|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102205047|NCT02300623|Interleukin-2|interleukin-2|mesh-list
102205048|NCT02300623|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102205049|NCT02300623|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102205050|NCT02300623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102205051|NCT02300623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205052|NCT02300623|Antiviral Agents|antiviral agents|mesh-ancestor
102205053|NCT02300623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101913831|NCT05843292|Taxane|taxane|mesh-list
102205054|NCT02300623|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102205055|NCT02300623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205056|NCT02300623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102205057|NCT02300623|Analgesics|analgesics|mesh-ancestor
102205058|NCT02300623|Sensory System Agents|sensory system agents|mesh-ancestor
102205059|NCT02300623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102205060|NCT02300623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205061|NCT02300623|Antimetabolites|antimetabolites|mesh-ancestor
102205062|NCT02300623|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102205063|NCT02300623|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102205064|NCT02300623|Protease Inhibitors|protease inhibitors|mesh-ancestor
102205065|NCT04463953|Dexamethasone|dexamethasone|mesh-list
102205066|NCT04463953|Ixazomib|ixazomib|mesh-list
102205067|NCT04463953|Zanubrutinib|zanubrutinib|mesh-list
102205068|NCT04463953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102205069|NCT04463953|Antiemetics|antiemetics|mesh-ancestor
102205070|NCT04463953|Autonomic Agents|autonomic agents|mesh-ancestor
102205071|NCT04463953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102205072|NCT04463953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205073|NCT04463953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102205074|NCT04463953|Glucocorticoids|glucocorticoids|mesh-ancestor
102205075|NCT04463953|Hormones|hormones|mesh-ancestor
102205076|NCT04463953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102205077|NCT04463953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102205078|NCT04463953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205079|NCT04463953|Protease Inhibitors|protease inhibitors|mesh-ancestor
102205080|NCT04463953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102205081|NCT04463953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205082|NCT04463953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102205083|NCT02307955|Fluorophosphate|fluorophosphate|mesh-list
102205084|NCT02307955|Cariostatic Agents|cariostatic agents|mesh-ancestor
102205085|NCT02307955|Protective Agents|protective agents|mesh-ancestor
102205086|NCT02307955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205087|NCT03147963|Docetaxel|docetaxel|mesh-list
102205088|NCT03147963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205089|NCT03147963|Tubulin Modulators|tubulin modulators|mesh-ancestor
102205090|NCT03147963|Antimitotic Agents|antimitotic agents|mesh-ancestor
102205091|NCT03147963|Mitosis Modulators|mitosis modulators|mesh-ancestor
102205092|NCT03147963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205093|NCT02348307|Dotinurad|dotinurad|mesh-list
102205094|NCT02348307|Uricosuric Agents|uricosuric agents|mesh-ancestor
102205095|NCT02348307|Gout Suppressants|gout suppressants|mesh-ancestor
102205096|NCT02348307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102205097|NCT02340117|Paclitaxel|paclitaxel|mesh-list
102205098|NCT02340117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102205099|NCT02340117|Gemcitabine|gemcitabine|mesh-list
102205100|NCT02340117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102205101|NCT02340117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205102|NCT02340117|Tubulin Modulators|tubulin modulators|mesh-ancestor
102205103|NCT02340117|Antimitotic Agents|antimitotic agents|mesh-ancestor
102205104|NCT02340117|Mitosis Modulators|mitosis modulators|mesh-ancestor
102205105|NCT02340117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205106|NCT02340117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102205107|NCT02340117|Antimetabolites|antimetabolites|mesh-ancestor
102205109|NCT02300701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102205110|NCT02300701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102205111|NCT02300701|Respiratory System Agents|respiratory system agents|mesh-ancestor
102205112|NCT02336139|Sofosbuvir|sofosbuvir|mesh-list
102205113|NCT02336139|Velpatasvir|velpatasvir|mesh-list
102205114|NCT02336139|Antiviral Agents|antiviral agents|mesh-ancestor
102205115|NCT02336139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102205116|NCT02340195|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
102205117|NCT02340195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102205118|NCT02340195|Serotonin Agents|serotonin agents|mesh-ancestor
102205119|NCT02340195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102205120|NCT02340195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205121|NCT02340195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205122|NCT02300935|Paclitaxel|paclitaxel|mesh-list
102205123|NCT02300935|Trametinib|trametinib|mesh-list
102205124|NCT02300935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102205125|NCT02300935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205126|NCT02300935|Tubulin Modulators|tubulin modulators|mesh-ancestor
102205127|NCT02300935|Antimitotic Agents|antimitotic agents|mesh-ancestor
102205128|NCT02300935|Mitosis Modulators|mitosis modulators|mesh-ancestor
102205129|NCT02300935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205130|NCT02300935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102205131|NCT02300935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102205132|NCT02339805|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102205133|NCT02339805|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102205134|NCT02339805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205135|NCT02301091|Mitomycins|mitomycins|mesh-list
102205136|NCT02301091|Mitomycin|mitomycin|mesh-list
102205137|NCT02301091|Pirarubicin|pirarubicin|mesh-list
102205138|NCT02301091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102205139|NCT02301091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205140|NCT02301091|Alkylating Agents|alkylating agents|mesh-ancestor
102205141|NCT02301091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205142|NCT02301091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102205143|NCT02301091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102205144|NCT02335593|Zinc Sulfate|zinc sulfate|mesh-list
102205145|NCT02335593|Epoetin Alfa|epoetin alfa|mesh-list
102205146|NCT02335593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102205147|NCT02335593|Hematinics|hematinics|mesh-ancestor
102205148|NCT02335593|Astringents|astringents|mesh-ancestor
102205149|NCT02335593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205150|NCT02335593|Dermatologic Agents|dermatologic agents|mesh-ancestor
102205151|NCT02308891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102205152|NCT02308969|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
102205153|NCT02308969|Hallucinogens|hallucinogens|mesh-ancestor
102205154|NCT02308969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205155|NCT02308969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102205156|NCT02308969|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102205157|NCT02308969|Serotonin Agents|serotonin agents|mesh-ancestor
102205158|NCT02308969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102205159|NCT02308969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205160|NCT02308969|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102205161|NCT02309281|Aflibercept|aflibercept|mesh-list
102205162|NCT02309281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102205163|NCT02309281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102205164|NCT02309281|Growth Substances|growth substances|mesh-ancestor
102205165|NCT02309281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205166|NCT02309281|Growth Inhibitors|growth inhibitors|mesh-ancestor
102205167|NCT02309281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205168|NCT02335281|Mesalamine|mesalamine|mesh-list
102205169|NCT02335281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102205170|NCT02335281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102205171|NCT02335281|Analgesics|analgesics|mesh-ancestor
102205172|NCT02335281|Sensory System Agents|sensory system agents|mesh-ancestor
102205173|NCT02335281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102205174|NCT02335281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205175|NCT02335281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102205176|NCT02335281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102205178|NCT02309437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102205179|NCT02309437|Narcotics|narcotics|mesh-ancestor
102205180|NCT02309437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102205181|NCT02309437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205182|NCT02309437|Analgesics|analgesics|mesh-ancestor
102205183|NCT02309437|Sensory System Agents|sensory system agents|mesh-ancestor
102205184|NCT02309437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102205185|NCT02335359|Tranexamic Acid|tranexamic acid|mesh-list
102205186|NCT02335359|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102205187|NCT02335359|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102205188|NCT02335359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205189|NCT02335359|Hemostatics|hemostatics|mesh-ancestor
102205190|NCT02335359|Coagulants|coagulants|mesh-ancestor
102205191|NCT03511261|Curcumin|curcumin|mesh-list
102205192|NCT03511261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102205193|NCT03511261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102205194|NCT03511261|Analgesics|analgesics|mesh-ancestor
101913934|NCT05840562|Sensory System Agents|sensory system agents|mesh-ancestor
101913935|NCT05840562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101913936|NCT05840562|Antidepressive Agents|antidepressive agents|mesh-ancestor
101913937|NCT05840562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101913938|NCT05840562|Dopamine Agents|dopamine agents|mesh-ancestor
101913939|NCT05840562|Antipruritics|antipruritics|mesh-ancestor
101913940|NCT05840562|Dermatologic Agents|dermatologic agents|mesh-ancestor
101913941|NCT05840471|Tranexamic Acid|tranexamic acid|mesh-list
101913942|NCT05840471|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101913943|NCT05840471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101913944|NCT05840471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205195|NCT03511261|Sensory System Agents|sensory system agents|mesh-ancestor
102205196|NCT03511261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102205197|NCT03511261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205198|NCT03511261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102205199|NCT03511261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102205200|NCT03511261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101450709|NCT00224094|Estrogens|estrogens|mesh-ancestor
102205201|NCT03511261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102205202|NCT03511261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205203|NCT03509701|Antibodies|antibodies|mesh-list
102205204|NCT03509701|Immunologic Factors|immunologic factors|mesh-ancestor
102205205|NCT03509701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205206|NCT03511183|Bevacizumab|bevacizumab|mesh-list
102205207|NCT03511183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102205208|NCT03511183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205209|NCT03511183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102205210|NCT03511183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102205211|NCT03511183|Growth Substances|growth substances|mesh-ancestor
102205212|NCT03511183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205213|NCT03511183|Growth Inhibitors|growth inhibitors|mesh-ancestor
102205214|NCT02303587|Methylprednisolone|methylprednisolone|mesh-list
102205215|NCT02303587|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102205216|NCT02303587|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102205217|NCT02303587|Prednisolone|prednisolone|mesh-list
102205218|NCT02303587|Prednisolone acetate|prednisolone acetate|mesh-list
102205219|NCT02303587|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102205220|NCT02303587|Prednisolone phosphate|prednisolone phosphate|mesh-list
102205221|NCT02303587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102205222|NCT02303587|Antiemetics|antiemetics|mesh-ancestor
102205223|NCT02303587|Autonomic Agents|autonomic agents|mesh-ancestor
102205224|NCT02303587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102205225|NCT02303587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205226|NCT02303587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102205227|NCT02303587|Glucocorticoids|glucocorticoids|mesh-ancestor
102205228|NCT02303587|Hormones|hormones|mesh-ancestor
102205229|NCT02303587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102205230|NCT02303587|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102205231|NCT02303587|Protective Agents|protective agents|mesh-ancestor
102205232|NCT02303587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102205233|NCT02303587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205234|NCT03916419|Paclitaxel|paclitaxel|mesh-list
102205235|NCT03916419|Carboplatin|carboplatin|mesh-list
102205236|NCT03916419|Durvalumab|durvalumab|mesh-list
102205237|NCT03916419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102205238|NCT03916419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205240|NCT03916419|Antimitotic Agents|antimitotic agents|mesh-ancestor
102205241|NCT03916419|Mitosis Modulators|mitosis modulators|mesh-ancestor
102205242|NCT03916419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205243|NCT03916419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102205244|NCT02301481|Oxaliplatin|oxaliplatin|mesh-list
102205245|NCT02301481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205246|NCT03107871|Valganciclovir|valganciclovir|mesh-list
102205247|NCT03107871|Antiviral Agents|antiviral agents|mesh-ancestor
102205248|NCT03107871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102205249|NCT03064113|Ipratropium|ipratropium|mesh-list
102205250|NCT03064113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102205251|NCT03064113|Autonomic Agents|autonomic agents|mesh-ancestor
102205252|NCT03064113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102205253|NCT03064113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205254|NCT03064113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102205255|NCT03064113|Respiratory System Agents|respiratory system agents|mesh-ancestor
102205256|NCT03064113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102205257|NCT03064113|Cholinergic Agents|cholinergic agents|mesh-ancestor
102205258|NCT03064113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102205259|NCT03064113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205260|NCT02301715|Oxytocin|oxytocin|mesh-list
102205261|NCT02301715|Oxytocics|oxytocics|mesh-ancestor
102205262|NCT02301715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102205263|NCT02301715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205264|NCT03509545|Torsemide|torsemide|mesh-list
102205265|NCT03509545|Furosemide|furosemide|mesh-list
102205266|NCT03509545|Diuretics|diuretics|mesh-ancestor
102205267|NCT03509545|Natriuretic Agents|natriuretic agents|mesh-ancestor
102205268|NCT03509545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205269|NCT03509545|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102205270|NCT03509545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102205271|NCT03509545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205272|NCT03509545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102205273|NCT02301949|Thalidomide|thalidomide|mesh-list
102205274|NCT02301949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102205275|NCT02301949|Immunologic Factors|immunologic factors|mesh-ancestor
102205276|NCT02301949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205277|NCT02301949|Leprostatic Agents|leprostatic agents|mesh-ancestor
102205278|NCT02301949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102205279|NCT02301949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102205280|NCT02301949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102205281|NCT02301949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102205282|NCT02301949|Growth Substances|growth substances|mesh-ancestor
102205283|NCT02301949|Growth Inhibitors|growth inhibitors|mesh-ancestor
102205284|NCT02301949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205285|NCT02335203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102205286|NCT02335203|Medroxyprogesterone|medroxyprogesterone|mesh-list
102205287|NCT02335203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102205288|NCT02335203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102205289|NCT02335203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102205290|NCT02335203|Contraceptive Agents|contraceptive agents|mesh-ancestor
102205291|NCT02335203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102205292|NCT02335203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205293|NCT02335203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102205294|NCT02335203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102205295|NCT02335203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102205296|NCT02335203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102205297|NCT02335203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205298|NCT02303899|Gemcitabine|gemcitabine|mesh-list
102205299|NCT02303899|Imatinib Mesylate|imatinib mesylate|mesh-list
102205300|NCT02303899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102205301|NCT02303899|Antimetabolites|antimetabolites|mesh-ancestor
102205302|NCT02303899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205303|NCT02303899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205304|NCT02303899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102205305|NCT02303899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102205306|NCT02338635|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102205307|NCT02338635|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102205308|NCT02338635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102205309|NCT03510871|Nivolumab|nivolumab|mesh-list
102205310|NCT03510871|Ipilimumab|ipilimumab|mesh-list
102205311|NCT03510871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102205312|NCT03510871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205313|NCT03510871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102205314|NCT03510871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205316|NCT02331771|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102205317|NCT02331771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102205318|NCT02331771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205319|NCT02331771|Cholinergic Agents|cholinergic agents|mesh-ancestor
102205320|NCT02331771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102205321|NCT02331771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205322|NCT02331771|Nootropic Agents|nootropic agents|mesh-ancestor
102205323|NCT02334501|Lansoprazole|lansoprazole|mesh-list
102205324|NCT02334501|Dexlansoprazole|dexlansoprazole|mesh-list
102205325|NCT02334501|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102205326|NCT02334501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102205327|NCT02334501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102205328|NCT02334501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102205329|NCT02334501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205330|NCT02331927|Aflibercept|aflibercept|mesh-list
102205331|NCT02331927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102205332|NCT02331927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102205333|NCT02331927|Growth Substances|growth substances|mesh-ancestor
102205334|NCT02331927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205335|NCT02331927|Growth Inhibitors|growth inhibitors|mesh-ancestor
102205336|NCT02331927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205337|NCT02322190|Methoxsalen|methoxsalen|mesh-list
102205338|NCT02322190|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102205339|NCT02322190|Dermatologic Agents|dermatologic agents|mesh-ancestor
102205340|NCT02304055|Oxytocin|oxytocin|mesh-list
102205341|NCT02304055|Carbetocin|carbetocin|mesh-list
102205342|NCT02304055|Oxytocics|oxytocics|mesh-ancestor
102205343|NCT02304055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101450722|NCT00206505|Tubulin Modulators|tubulin modulators|mesh-ancestor
102205344|NCT02304055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205345|NCT05012865|Avelumab|avelumab|mesh-list
102205346|NCT05012865|Axitinib|axitinib|mesh-list
102205347|NCT05012865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102205348|NCT05012865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205349|NCT05012865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102205350|NCT05012865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102205351|NCT05012865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205352|NCT03505489|Mannitol|mannitol|mesh-list
102205353|NCT03505489|Methacholine Chloride|methacholine chloride|mesh-list
102205354|NCT03505489|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102205355|NCT03505489|Diuretics|diuretics|mesh-ancestor
102205356|NCT03505489|Natriuretic Agents|natriuretic agents|mesh-ancestor
102205357|NCT03505489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205358|NCT03505489|Miotics|miotics|mesh-ancestor
102205359|NCT03505489|Autonomic Agents|autonomic agents|mesh-ancestor
102205360|NCT03505489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102205361|NCT03505489|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102205362|NCT03505489|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
102205363|NCT03505489|Respiratory System Agents|respiratory system agents|mesh-ancestor
102205364|NCT03505489|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102205365|NCT03505489|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102205366|NCT03505489|Cholinergic Agents|cholinergic agents|mesh-ancestor
102205367|NCT03505489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102205368|NCT03505489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205369|NCT02310373|Nicotine|nicotine|mesh-list
102205370|NCT02310373|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102205371|NCT02310373|Autonomic Agents|autonomic agents|mesh-ancestor
102205372|NCT02310373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102205373|NCT02310373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205374|NCT02310373|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102205375|NCT02310373|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102205376|NCT02310373|Cholinergic Agents|cholinergic agents|mesh-ancestor
102205377|NCT02310373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102205378|NCT02310373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205379|NCT02338323|Febuxostat|febuxostat|mesh-list
102205380|NCT02338323|Benzbromarone|benzbromarone|mesh-list
102205381|NCT02338323|Gout Suppressants|gout suppressants|mesh-ancestor
102205382|NCT02338323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102205383|NCT02338323|Uricosuric Agents|uricosuric agents|mesh-ancestor
102205384|NCT02321800|Imipenem|imipenem|mesh-list
102205385|NCT02321800|Cilastatin|cilastatin|mesh-list
102205386|NCT02321800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102205387|NCT02321800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102205388|NCT02321800|Protease Inhibitors|protease inhibitors|mesh-ancestor
102205389|NCT02321800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102205390|NCT02321800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205391|NCT02310295|Triamcinolone|triamcinolone|mesh-list
102205392|NCT02310295|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102205393|NCT02310295|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102205394|NCT02310295|Bevacizumab|bevacizumab|mesh-list
102205395|NCT02310295|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102205396|NCT02310295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102205397|NCT02310295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205398|NCT02310295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102205399|NCT02310295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102205400|NCT02310295|Growth Substances|growth substances|mesh-ancestor
102205401|NCT02310295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205402|NCT02310295|Growth Inhibitors|growth inhibitors|mesh-ancestor
102205403|NCT02310295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102205404|NCT02310295|Glucocorticoids|glucocorticoids|mesh-ancestor
102205405|NCT02310295|Hormones|hormones|mesh-ancestor
102205406|NCT02310295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102205407|NCT02310295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102205408|NCT02310295|Immunologic Factors|immunologic factors|mesh-ancestor
102205409|NCT02310295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102205410|NCT02310295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205411|NCT02338089|Oxytocin|oxytocin|mesh-list
102205412|NCT02338089|Oxytocics|oxytocics|mesh-ancestor
102205413|NCT02338089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102205414|NCT02338089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205415|NCT02338245|Capecitabine|capecitabine|mesh-list
101914164|NCT05804032|Growth Substances|growth substances|mesh-ancestor
101914165|NCT05804032|Growth Inhibitors|growth inhibitors|mesh-ancestor
101914166|NCT05801913|Vaccines|vaccines|mesh-list
101914167|NCT05801913|Immunologic Factors|immunologic factors|mesh-ancestor
101914168|NCT05801913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914169|NCT05797090|Cardioplegic Solutions|cardioplegic solutions|mesh-list
101914170|NCT05797090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102205416|NCT02338245|Lapatinib|lapatinib|mesh-list
102205417|NCT02338245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102205418|NCT02338245|Antimetabolites|antimetabolites|mesh-ancestor
102205419|NCT02338245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205420|NCT02338245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205421|NCT02338245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102205422|NCT02338245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102205423|NCT02332005|Choline|choline|mesh-list
102205424|NCT02332005|Lipotropic Agents|lipotropic agents|mesh-ancestor
102205425|NCT02332005|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102205426|NCT02332005|Antimetabolites|antimetabolites|mesh-ancestor
102205427|NCT02332005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205428|NCT02332005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102205429|NCT02332005|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102205430|NCT02332005|Nootropic Agents|nootropic agents|mesh-ancestor
102205431|NCT02304211|Insulin|insulin|mesh-list
102205432|NCT02304211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102205433|NCT02304211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205434|NCT02311777|Pregabalin|pregabalin|mesh-list
102205435|NCT02311777|Ketamine|ketamine|mesh-list
102205436|NCT02311777|Analgesics|analgesics|mesh-ancestor
102205437|NCT02311777|Sensory System Agents|sensory system agents|mesh-ancestor
102205438|NCT02311777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102205439|NCT02311777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205440|NCT02311777|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102205441|NCT02311777|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102205442|NCT02311777|Anesthetics, General|anesthetics, general|mesh-ancestor
102205443|NCT02311777|Anesthetics|anesthetics|mesh-ancestor
102205444|NCT02311777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102205445|NCT02311777|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102205446|NCT02311777|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102205447|NCT02311777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102205448|NCT02311777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205449|NCT02311777|Anticonvulsants|anticonvulsants|mesh-ancestor
102205450|NCT02311777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102205451|NCT02311777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102205452|NCT02311777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102205453|NCT02311777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102205454|NCT02311777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102205455|NCT02311777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102205456|NCT03504865|Bupivacaine|bupivacaine|mesh-list
102205457|NCT03504865|Anesthetics, Local|anesthetics, local|mesh-ancestor
102205458|NCT03504865|Anesthetics|anesthetics|mesh-ancestor
102205459|NCT03504865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102205460|NCT03504865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205461|NCT03504865|Sensory System Agents|sensory system agents|mesh-ancestor
102205462|NCT03504865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102205463|NCT02304289|Artesunate|artesunate|mesh-list
102205464|NCT02304289|Antimalarials|antimalarials|mesh-ancestor
102205465|NCT02304289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102205466|NCT02304289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102205467|NCT02304289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102205468|NCT02304289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205469|NCT02304289|Antiviral Agents|antiviral agents|mesh-ancestor
102205470|NCT02304289|Schistosomicides|schistosomicides|mesh-ancestor
102205471|NCT02304289|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102205472|NCT02304289|Anthelmintics|anthelmintics|mesh-ancestor
102205473|NCT02292784|Atosiban|atosiban|mesh-list
102205474|NCT02292784|Hormone Antagonists|hormone antagonists|mesh-ancestor
102205475|NCT02292784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102205476|NCT02292784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205477|NCT02292784|Tocolytic Agents|tocolytic agents|mesh-ancestor
102205478|NCT02292784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102205479|NCT02338011|Gefitinib|gefitinib|mesh-list
102205480|NCT02338011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205481|NCT02338011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102205482|NCT02338011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102205483|NCT02338011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205484|NCT02337855|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102205485|NCT02337855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102205486|NCT02337855|Immunologic Factors|immunologic factors|mesh-ancestor
102205487|NCT02337855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205488|NCT02337855|Antacids|antacids|mesh-ancestor
102205489|NCT02337855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205490|NCT02337855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102205491|NCT02320396|Desloratadine|desloratadine|mesh-list
102205492|NCT02320396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102205493|NCT02320396|Cholinergic Agents|cholinergic agents|mesh-ancestor
102205494|NCT02320396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102205495|NCT02320396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205496|NCT02320396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205497|NCT02320396|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102205498|NCT02320396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102205499|NCT02320396|Histamine Antagonists|histamine antagonists|mesh-ancestor
102205500|NCT02320396|Histamine Agents|histamine agents|mesh-ancestor
102205501|NCT02312089|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102205502|NCT02312089|Luteolytic Agents|luteolytic agents|mesh-ancestor
102205503|NCT02312089|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102205504|NCT02312089|Contraceptive Agents|contraceptive agents|mesh-ancestor
102205505|NCT02312089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102205506|NCT02312089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205507|NCT02312089|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102205508|NCT02312089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102205509|NCT02312089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205510|NCT02310997|Cyclophosphamide|cyclophosphamide|mesh-list
102205511|NCT02310997|Melphalan|melphalan|mesh-list
102205512|NCT02310997|Busulfan|busulfan|mesh-list
102205513|NCT02310997|Fludarabine|fludarabine|mesh-list
102205514|NCT02310997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102205515|NCT02310997|Immunologic Factors|immunologic factors|mesh-ancestor
102205516|NCT02310997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205517|NCT02310997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102205518|NCT02310997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102205519|NCT02310997|Alkylating Agents|alkylating agents|mesh-ancestor
102205520|NCT02310997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205521|NCT02310997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205522|NCT02310997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102205523|NCT03505411|Melatonin|melatonin|mesh-list
102205524|NCT03505411|Antioxidants|antioxidants|mesh-ancestor
102205525|NCT03505411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205526|NCT03505411|Protective Agents|protective agents|mesh-ancestor
102205527|NCT03505411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205528|NCT03505411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102205530|NCT02292238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102205531|NCT02292238|Immunologic Factors|immunologic factors|mesh-ancestor
102205532|NCT02292238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205533|NCT02292238|Chelating Agents|chelating agents|mesh-ancestor
102205534|NCT02292238|Sequestering Agents|sequestering agents|mesh-ancestor
102205535|NCT02292238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205536|NCT02631447|Nivolumab|nivolumab|mesh-list
102205537|NCT02631447|Ipilimumab|ipilimumab|mesh-list
102205538|NCT02631447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102205539|NCT02631447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205540|NCT02631447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102205541|NCT02631447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205542|NCT03867123|Temozolomide|temozolomide|mesh-list
102205543|NCT03867123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102205544|NCT03867123|Alkylating Agents|alkylating agents|mesh-ancestor
102205545|NCT03867123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205546|NCT03867123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205547|NCT03504475|Paroxetine|paroxetine|mesh-list
102205548|NCT03504475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102205549|NCT03504475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102205550|NCT03504475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102205551|NCT03504475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205552|NCT03504475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102205553|NCT03504475|Serotonin Agents|serotonin agents|mesh-ancestor
102205554|NCT03504475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205555|NCT03504475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102205556|NCT03504475|Antidepressive Agents|antidepressive agents|mesh-ancestor
102205557|NCT03504475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102205558|NCT03504475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102205559|NCT03504475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102205560|NCT03504475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102205561|NCT02327247|Felodipine|felodipine|mesh-list
102205562|NCT02327247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102205563|NCT02327247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101914324|NCT05681780|Analgesics|analgesics|mesh-ancestor
102205564|NCT02327247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102205565|NCT02327247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102205566|NCT02327247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205567|NCT02327247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102205568|NCT02327247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205569|NCT02327247|Vasodilator Agents|vasodilator agents|mesh-ancestor
102205570|NCT03505255|Neostigmine|neostigmine|mesh-list
102205571|NCT03505255|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102205572|NCT03505255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102205573|NCT03505255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205574|NCT03505255|Cholinergic Agents|cholinergic agents|mesh-ancestor
102205575|NCT03505255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102205576|NCT03505255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205577|NCT03505255|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102205578|NCT03505255|Autonomic Agents|autonomic agents|mesh-ancestor
102205579|NCT03505255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102205581|NCT02333799|Bedaquiline|bedaquiline|mesh-list
102205582|NCT02333799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102205583|NCT02333799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102205584|NCT02333799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102205585|NCT02333799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102205586|NCT02333799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205587|NCT02333799|Antitubercular Agents|antitubercular agents|mesh-ancestor
102205588|NCT02311231|Heparin|heparin|mesh-list
102205589|NCT02311231|Calcium heparin|calcium heparin|mesh-list
102205590|NCT02311231|Bivalirudin|bivalirudin|mesh-list
102205591|NCT02311231|Anticoagulants|anticoagulants|mesh-ancestor
102205592|NCT02311231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102205593|NCT02311231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102205594|NCT02311231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205595|NCT02311231|Antithrombins|antithrombins|mesh-ancestor
102205596|NCT02311231|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102205597|NCT02311231|Protease Inhibitors|protease inhibitors|mesh-ancestor
102205598|NCT02311231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102205599|NCT03508999|Metronidazole|metronidazole|mesh-list
102205600|NCT03508999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102205601|NCT03508999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102205602|NCT03508999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102205603|NCT03508999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102205604|NCT03105375|Omeprazole|omeprazole|mesh-list
102205605|NCT03105375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102205606|NCT03105375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102205607|NCT03105375|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102205608|NCT03105375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102205609|NCT03105375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205610|NCT02304445|Chlorotrianisene|chlorotrianisene|mesh-list
102205611|NCT02304445|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102205612|NCT02304445|Estrogens|estrogens|mesh-ancestor
102205613|NCT02304445|Hormones|hormones|mesh-ancestor
102205614|NCT02304445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102205615|NCT02304445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205616|NCT02304445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102205617|NCT02304445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205618|NCT02316301|Misoprostol|misoprostol|mesh-list
102205619|NCT02316301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102205620|NCT02316301|Abortifacient Agents|abortifacient agents|mesh-ancestor
102205621|NCT02316301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102205622|NCT02316301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205623|NCT02316301|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102205624|NCT02316301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102205625|NCT02316301|Oxytocics|oxytocics|mesh-ancestor
102205626|NCT02327091|Alfacalcidol|alfacalcidol|mesh-list
102205627|NCT02327091|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
102205628|NCT02327091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102205629|NCT02327091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205630|NCT02327091|Vitamins|vitamins|mesh-ancestor
102205631|NCT02327091|Micronutrients|micronutrients|mesh-ancestor
102205632|NCT02316535|Capecitabine|capecitabine|mesh-list
102205633|NCT02316535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102205634|NCT02316535|Antimetabolites|antimetabolites|mesh-ancestor
102205635|NCT02316535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205636|NCT02316535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101914392|NCT05613205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205637|NCT02333253|Cetrorelix|cetrorelix|mesh-list
102205638|NCT02333253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102205639|NCT02333253|Fertility Agents|fertility agents|mesh-ancestor
102205640|NCT02333253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102205641|NCT02333253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205642|NCT02333253|Hormone Antagonists|hormone antagonists|mesh-ancestor
102205643|NCT02333253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102205645|NCT02039661|Anesthetics, Local|anesthetics, local|mesh-ancestor
102205646|NCT02039661|Anesthetics|anesthetics|mesh-ancestor
102205647|NCT02039661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102205648|NCT02039661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205649|NCT02039661|Sensory System Agents|sensory system agents|mesh-ancestor
102205650|NCT02039661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102205651|NCT02039661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102205652|NCT02039661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102205653|NCT02039661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102205654|NCT02039661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102205655|NCT02039661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205656|NCT02326779|Aspirin|aspirin|mesh-list
102205657|NCT02326779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102205658|NCT02326779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102205659|NCT02326779|Analgesics|analgesics|mesh-ancestor
102205660|NCT02326779|Sensory System Agents|sensory system agents|mesh-ancestor
102205661|NCT02326779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102205662|NCT02326779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205663|NCT02326779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102205664|NCT02326779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102205665|NCT02326779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102205666|NCT02326779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102205667|NCT02326779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205668|NCT02326779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102205669|NCT02326779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102205670|NCT02326779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102205672|NCT02331303|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
102205673|NCT02331303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205674|NCT02312635|Cycloserine|cycloserine|mesh-list
102205675|NCT02312635|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102205676|NCT02312635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102205677|NCT02312635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102205678|NCT02312635|Antitubercular Agents|antitubercular agents|mesh-ancestor
102205679|NCT02312635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102205680|NCT02312635|Antimetabolites|antimetabolites|mesh-ancestor
102205681|NCT02312635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205682|NCT03144453|Atropine|atropine|mesh-list
102205683|NCT03144453|Neostigmine|neostigmine|mesh-list
102205684|NCT03144453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102205685|NCT03144453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102205686|NCT03144453|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102205687|NCT03144453|Autonomic Agents|autonomic agents|mesh-ancestor
102205688|NCT03144453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102205689|NCT03144453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205690|NCT03144453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102205691|NCT03144453|Respiratory System Agents|respiratory system agents|mesh-ancestor
102205692|NCT03144453|Mydriatics|mydriatics|mesh-ancestor
102205693|NCT03144453|Parasympatholytics|parasympatholytics|mesh-ancestor
102205694|NCT03144453|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102205695|NCT03144453|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102205696|NCT03144453|Cholinergic Agents|cholinergic agents|mesh-ancestor
102205697|NCT03144453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102205698|NCT03144453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205699|NCT03144453|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102205700|NCT03144453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102205701|NCT03144453|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102205702|NCT02317159|Imatinib Mesylate|imatinib mesylate|mesh-list
102205703|NCT02317159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205704|NCT02317159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102205705|NCT02317159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102205706|NCT02317159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205707|NCT02332941|Rituximab|rituximab|mesh-list
102205708|NCT02332941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102205709|NCT02332941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205710|NCT02332941|Immunologic Factors|immunologic factors|mesh-ancestor
102205711|NCT02332941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205712|NCT02332941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102205713|NCT03503227|Aspirin|aspirin|mesh-list
102205714|NCT03503227|Salicylic Acid|salicylic acid|mesh-list
102205715|NCT03503227|Prednisolone|prednisolone|mesh-list
102205716|NCT03503227|Salicylates|salicylates|mesh-list
102205717|NCT03503227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102205718|NCT03503227|Glucocorticoids|glucocorticoids|mesh-ancestor
102205719|NCT03503227|Hormones|hormones|mesh-ancestor
102205720|NCT03503227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102205721|NCT03503227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205722|NCT03503227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102205723|NCT03503227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205724|NCT03503227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102205725|NCT03503227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102205726|NCT03503227|Antifungal Agents|antifungal agents|mesh-ancestor
102205727|NCT03503227|Keratolytic Agents|keratolytic agents|mesh-ancestor
102205728|NCT03503227|Dermatologic Agents|dermatologic agents|mesh-ancestor
102205729|NCT03503227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102205730|NCT03503227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102205731|NCT03503227|Analgesics|analgesics|mesh-ancestor
102205732|NCT03503227|Sensory System Agents|sensory system agents|mesh-ancestor
102205733|NCT03503227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102205734|NCT03503227|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102205735|NCT03503227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102205736|NCT03503227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205737|NCT03503227|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102205738|NCT03503227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102205739|NCT03503227|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102205740|NCT03503227|Antipyretics|antipyretics|mesh-ancestor
102205741|NCT02305069|Pioglitazone|pioglitazone|mesh-list
102205742|NCT02305069|Octreotide|octreotide|mesh-list
102205743|NCT02305069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102205745|NCT02305069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102205746|NCT02305069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102205747|NCT02305069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205748|NCT02317237|Anesthetics|anesthetics|mesh-list
102205749|NCT02317237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102205750|NCT02317237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205751|NCT02332473|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102205752|NCT02332473|Molgramostim|molgramostim|mesh-list
102205753|NCT02332473|Sargramostim|sargramostim|mesh-list
102205754|NCT02332473|Antiviral Agents|antiviral agents|mesh-ancestor
102205755|NCT02332473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102205756|NCT02332473|Immunologic Factors|immunologic factors|mesh-ancestor
102205757|NCT02332473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205758|NCT02332473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205759|NCT03501433|Niacinamide|niacinamide|mesh-list
102205760|NCT03501433|Niacin|niacin|mesh-list
102205761|NCT03501433|Nicotinic Acids|nicotinic acids|mesh-list
102205762|NCT03501433|Vitamin B Complex|vitamin b complex|mesh-ancestor
102205763|NCT03501433|Vitamins|vitamins|mesh-ancestor
102205764|NCT03501433|Micronutrients|micronutrients|mesh-ancestor
102205765|NCT03501433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205766|NCT03501433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102205767|NCT03501433|Antimetabolites|antimetabolites|mesh-ancestor
102205768|NCT03501433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205769|NCT03501433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102205770|NCT03501433|Vasodilator Agents|vasodilator agents|mesh-ancestor
102205771|NCT02383251|Paclitaxel|paclitaxel|mesh-list
102205772|NCT02383251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102205773|NCT02383251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205774|NCT02383251|Tubulin Modulators|tubulin modulators|mesh-ancestor
102205775|NCT02383251|Antimitotic Agents|antimitotic agents|mesh-ancestor
102205776|NCT02383251|Mitosis Modulators|mitosis modulators|mesh-ancestor
102205777|NCT02383251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205778|NCT02313103|Lofexidine|lofexidine|mesh-list
102205779|NCT02313103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102205780|NCT02313103|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102205781|NCT02313103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205782|NCT02313103|Sensory System Agents|sensory system agents|mesh-ancestor
102205783|NCT02313103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102205784|NCT02313103|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102205785|NCT02313103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102205786|NCT02313103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102205787|NCT02313103|Adrenergic Agents|adrenergic agents|mesh-ancestor
102205789|NCT02313103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205790|NCT01959633|Interferons|interferons|mesh-list
102205791|NCT01959633|Vemurafenib|vemurafenib|mesh-list
102205792|NCT01959633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205793|NCT01959633|Antiviral Agents|antiviral agents|mesh-ancestor
101450782|NCT00194402|Vitamins|vitamins|mesh-ancestor
102205794|NCT01959633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102205795|NCT01959633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102205796|NCT01959633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102205797|NCT01959633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205798|NCT02326623|Anesthetics|anesthetics|mesh-list
102205799|NCT02326623|Anesthetics, Local|anesthetics, local|mesh-list
102205800|NCT02326623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102205801|NCT02326623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205802|NCT02326623|Sensory System Agents|sensory system agents|mesh-ancestor
102205803|NCT02326623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102205804|NCT02317471|Oxaliplatin|oxaliplatin|mesh-list
102205805|NCT02317471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205806|NCT02332629|Methylprednisolone|methylprednisolone|mesh-list
102205807|NCT02332629|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102205808|NCT02332629|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102205809|NCT02332629|Prednisolone|prednisolone|mesh-list
102205810|NCT02332629|Prednisolone acetate|prednisolone acetate|mesh-list
102205811|NCT02332629|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102205812|NCT02332629|Prednisolone phosphate|prednisolone phosphate|mesh-list
102205813|NCT02332629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102205814|NCT02332629|Antiemetics|antiemetics|mesh-ancestor
102205815|NCT02332629|Autonomic Agents|autonomic agents|mesh-ancestor
102205816|NCT02332629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102205817|NCT02332629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205818|NCT02332629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102205819|NCT02332629|Glucocorticoids|glucocorticoids|mesh-ancestor
102205820|NCT02332629|Hormones|hormones|mesh-ancestor
102205821|NCT02332629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102205822|NCT02332629|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102205823|NCT02332629|Protective Agents|protective agents|mesh-ancestor
102205824|NCT02332629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102205825|NCT02332629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205826|NCT02313337|Fentanyl|fentanyl|mesh-list
102205827|NCT02313337|Midazolam|midazolam|mesh-list
102205828|NCT02313337|Anesthetics|anesthetics|mesh-list
102205829|NCT02313337|Propofol|propofol|mesh-list
102205830|NCT02313337|Atracurium|atracurium|mesh-list
102205831|NCT02313337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102205832|NCT02313337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205833|NCT02313337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102205834|NCT02313337|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102205835|NCT02313337|Anesthetics, General|anesthetics, general|mesh-ancestor
102205836|NCT02313337|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102205837|NCT02313337|Narcotics|narcotics|mesh-ancestor
102205838|NCT02313337|Analgesics|analgesics|mesh-ancestor
102205839|NCT02313337|Sensory System Agents|sensory system agents|mesh-ancestor
102205840|NCT02313337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102205841|NCT02313337|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102205842|NCT02313337|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102205843|NCT02313337|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102205844|NCT02313337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102205845|NCT02313337|GABA Modulators|gaba modulators|mesh-ancestor
102205846|NCT02313337|GABA Agents|gaba agents|mesh-ancestor
102205847|NCT02313337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102205848|NCT02313337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205849|NCT02313337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102205850|NCT02313337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102205851|NCT02313337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102205852|NCT02313337|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102205853|NCT02313337|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102205854|NCT02313337|Cholinergic Agents|cholinergic agents|mesh-ancestor
102205855|NCT02330757|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102205856|NCT02330757|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102205857|NCT02330757|Clomiphene|clomiphene|mesh-list
102205858|NCT02330757|Enclomiphene|enclomiphene|mesh-list
102205859|NCT02330757|Zuclomiphene|zuclomiphene|mesh-list
102205860|NCT02330757|Estradiol|estradiol|mesh-list
102205861|NCT02330757|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102205862|NCT02330757|Estrogens|estrogens|mesh-ancestor
102205863|NCT02330757|Hormones|hormones|mesh-ancestor
102205864|NCT02330757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102205865|NCT02330757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205866|NCT02330757|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102205867|NCT02330757|Contraceptive Agents|contraceptive agents|mesh-ancestor
102205868|NCT02330757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102205869|NCT02330757|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102205870|NCT02330757|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102205871|NCT02330757|Hormone Antagonists|hormone antagonists|mesh-ancestor
102205872|NCT02330757|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102205873|NCT02330757|Fertility Agents|fertility agents|mesh-ancestor
102205874|NCT02330757|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102205875|NCT02330757|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102205876|NCT03502993|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102205877|NCT03502993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102205878|NCT02305615|Bevacizumab|bevacizumab|mesh-list
102205879|NCT02305615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102205880|NCT02305615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205881|NCT02305615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102205882|NCT02305615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102205883|NCT02305615|Growth Substances|growth substances|mesh-ancestor
102205884|NCT02305615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205885|NCT02305615|Growth Inhibitors|growth inhibitors|mesh-ancestor
102205886|NCT02305693|Letrozole|letrozole|mesh-list
102205887|NCT02305693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205888|NCT02305693|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102205889|NCT02305693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102205890|NCT02305693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102205891|NCT02305693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205892|NCT02305693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102205893|NCT02305693|Hormone Antagonists|hormone antagonists|mesh-ancestor
102205894|NCT02305693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102205895|NCT02305693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205897|NCT02317861|Verinurad|verinurad|mesh-list
102205898|NCT02317861|Benzbromarone|benzbromarone|mesh-list
102205899|NCT02317861|Gout Suppressants|gout suppressants|mesh-ancestor
102205900|NCT02317861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102205901|NCT02317861|Uricosuric Agents|uricosuric agents|mesh-ancestor
102205902|NCT02318017|Methylphenidate|methylphenidate|mesh-list
102205903|NCT02318017|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102205904|NCT02318017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205905|NCT02318017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102205906|NCT02318017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102205907|NCT02318017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102205908|NCT02318017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205909|NCT02318017|Dopamine Agents|dopamine agents|mesh-ancestor
102205910|NCT02318017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102205911|NCT02313727|Pamidronate|pamidronate|mesh-list
102205912|NCT02313727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102205913|NCT02313727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205914|NCT02313805|Insulin|insulin|mesh-list
102205915|NCT02313805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102205916|NCT02313805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205917|NCT03132493|Nivolumab|nivolumab|mesh-list
102205918|NCT03132493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102205919|NCT03132493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205920|NCT03132493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102205921|NCT03132493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205922|NCT02313883|Taurolidine|taurolidine|mesh-list
102205923|NCT02313883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102205924|NCT02313883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102205925|NCT02313883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205926|NCT03500653|Curcumin|curcumin|mesh-list
102205927|NCT03500653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102205928|NCT03500653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102205929|NCT03500653|Analgesics|analgesics|mesh-ancestor
102205930|NCT03500653|Sensory System Agents|sensory system agents|mesh-ancestor
102205931|NCT03500653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102205932|NCT03500653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205933|NCT03500653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102205934|NCT03500653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102205935|NCT03500653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205936|NCT03500653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102205937|NCT03500653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205938|NCT02305927|Vitamin D|vitamin d|mesh-list
102205939|NCT02305927|Cholecalciferol|cholecalciferol|mesh-list
102205941|NCT02305927|Micronutrients|micronutrients|mesh-ancestor
102205942|NCT02305927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205943|NCT02305927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102205944|NCT02305927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102205945|NCT02440009|Itraconazole|itraconazole|mesh-list
102205946|NCT02440009|Glucocorticoids|glucocorticoids|mesh-list
102205947|NCT02440009|Antifungal Agents|antifungal agents|mesh-ancestor
102205948|NCT02440009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102205949|NCT02440009|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102205950|NCT02440009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102205951|NCT02440009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102205952|NCT02440009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205953|NCT02440009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102205954|NCT02440009|Hormone Antagonists|hormone antagonists|mesh-ancestor
102205955|NCT02440009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102205956|NCT02440009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205957|NCT02440009|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102205958|NCT02440009|Hormones|hormones|mesh-ancestor
102205959|NCT02318563|Cannabidiol|cannabidiol|mesh-list
102205960|NCT02318563|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102205961|NCT02318563|Anticonvulsants|anticonvulsants|mesh-ancestor
102205962|NCT02314195|Serotonin|serotonin|mesh-list
102205963|NCT02314195|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
102205964|NCT02314195|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102205965|NCT02314195|Serotonin Agents|serotonin agents|mesh-ancestor
102205966|NCT02314195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101747787|NCT00427999|Etoricoxib|etoricoxib|mesh-list
102205968|NCT02314195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205969|NCT02314195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102205970|NCT02314195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102205971|NCT02314273|Oprelvekin|oprelvekin|mesh-list
102205972|NCT02314273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102205973|NCT02314351|Fentanyl|fentanyl|mesh-list
102205974|NCT02314351|Metoclopramide|metoclopramide|mesh-list
102205975|NCT02314351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102205976|NCT02314351|Narcotics|narcotics|mesh-ancestor
102205977|NCT02314351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102205978|NCT02314351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102205979|NCT02314351|Analgesics|analgesics|mesh-ancestor
102205980|NCT02314351|Sensory System Agents|sensory system agents|mesh-ancestor
102205981|NCT02314351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102205982|NCT02314351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102205983|NCT02314351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102205984|NCT02314351|Anesthetics, General|anesthetics, general|mesh-ancestor
102205985|NCT02314351|Anesthetics|anesthetics|mesh-ancestor
102205986|NCT02314351|Antiemetics|antiemetics|mesh-ancestor
102205987|NCT02314351|Autonomic Agents|autonomic agents|mesh-ancestor
102205988|NCT02314351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102205989|NCT02314351|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102205990|NCT02314351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102205991|NCT02314351|Dopamine Agents|dopamine agents|mesh-ancestor
102205992|NCT02314351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102205993|NCT02314351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102205994|NCT04463875|Coenzyme Q10|coenzyme q10|mesh-list
102205995|NCT04463875|Riboflavin|riboflavin|mesh-list
102205996|NCT04463875|Ubiquinone|ubiquinone|mesh-list
102205997|NCT04463875|Andrographolide|andrographolide|mesh-list
102205998|NCT04463875|Vitamins|vitamins|mesh-ancestor
102205999|NCT04463875|Micronutrients|micronutrients|mesh-ancestor
102206000|NCT04463875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206001|NCT04463875|Vitamin B Complex|vitamin b complex|mesh-ancestor
102206002|NCT04463875|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102206003|NCT04463875|Dermatologic Agents|dermatologic agents|mesh-ancestor
102206004|NCT04463875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102206005|NCT04463875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102206006|NCT04463875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102206007|NCT04463875|Analgesics|analgesics|mesh-ancestor
102206008|NCT04463875|Sensory System Agents|sensory system agents|mesh-ancestor
102206009|NCT04463875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102206010|NCT04463875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102206011|NCT04463875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102206012|NCT04463875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102206013|NCT04463875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102206014|NCT04463875|Antiviral Agents|antiviral agents|mesh-ancestor
102206015|NCT04463875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102206016|NCT03500029|Antidepressive Agents|antidepressive agents|mesh-list
102206017|NCT03500029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102206018|NCT04462939|Micronutrients|micronutrients|mesh-list
102206019|NCT04462939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206020|NCT02306239|Terlipressin|terlipressin|mesh-list
102206021|NCT02306239|Norepinephrine|norepinephrine|mesh-list
102206022|NCT02306239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102206023|NCT02306239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102206024|NCT02306239|Adrenergic Agents|adrenergic agents|mesh-ancestor
102206025|NCT02306239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102206026|NCT02306239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206027|NCT02306239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206028|NCT02306239|Sympathomimetics|sympathomimetics|mesh-ancestor
102206029|NCT02306239|Autonomic Agents|autonomic agents|mesh-ancestor
102206030|NCT02306239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102206031|NCT02306239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102206032|NCT02306239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102206033|NCT02319187|Irinotecan|irinotecan|mesh-list
102206034|NCT02319187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102206035|NCT02319187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102206036|NCT02319187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102206037|NCT02319187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206038|NCT02319187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102206039|NCT02319265|Melatonin|melatonin|mesh-list
102206040|NCT02319265|Antioxidants|antioxidants|mesh-ancestor
102206041|NCT02319265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206042|NCT02319265|Protective Agents|protective agents|mesh-ancestor
102206043|NCT02319265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206044|NCT02319265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102206045|NCT02319343|Methylprednisolone|methylprednisolone|mesh-list
102206046|NCT02319343|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102206047|NCT02319343|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102206048|NCT02319343|Prednisolone|prednisolone|mesh-list
102206049|NCT02319343|Prednisolone acetate|prednisolone acetate|mesh-list
102206050|NCT02319343|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102206051|NCT02319343|Prednisolone phosphate|prednisolone phosphate|mesh-list
102206052|NCT02319343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102206053|NCT02319343|Antiemetics|antiemetics|mesh-ancestor
102206054|NCT02319343|Autonomic Agents|autonomic agents|mesh-ancestor
102206055|NCT02319343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102206056|NCT02319343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206057|NCT02319343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102206058|NCT02319343|Glucocorticoids|glucocorticoids|mesh-ancestor
102206059|NCT02319343|Hormones|hormones|mesh-ancestor
102206060|NCT02319343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102206061|NCT02319343|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102206062|NCT02319343|Protective Agents|protective agents|mesh-ancestor
102206063|NCT02319343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102206064|NCT02319343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102206065|NCT02319499|Vitamin A|vitamin a|mesh-list
102206066|NCT02319499|Iron|iron|mesh-list
102206067|NCT02319499|Zinc|zinc|mesh-list
102206068|NCT02319499|Vitamins|vitamins|mesh-ancestor
102206069|NCT02319499|Micronutrients|micronutrients|mesh-ancestor
102206070|NCT02319499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206071|NCT02319499|Trace Elements|trace elements|mesh-ancestor
102206072|NCT03499639|Ritonavir|ritonavir|mesh-list
102206073|NCT03499639|Ribavirin|ribavirin|mesh-list
102206074|NCT03499639|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102206075|NCT03499639|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102206076|NCT03499639|Protease Inhibitors|protease inhibitors|mesh-ancestor
102206077|NCT03499639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102206078|NCT03499639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206079|NCT03499639|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102206080|NCT03499639|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102206081|NCT03499639|Antiviral Agents|antiviral agents|mesh-ancestor
102206082|NCT03499639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102206083|NCT03499639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102206084|NCT03499639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102206085|NCT03499639|Antimetabolites|antimetabolites|mesh-ancestor
102206086|NCT03502135|Phenylephrine|phenylephrine|mesh-list
102206087|NCT03502135|Oxymetazoline|oxymetazoline|mesh-list
102206088|NCT03502135|Tetracaine|tetracaine|mesh-list
102206089|NCT03502135|Anesthetics, Local|anesthetics, local|mesh-ancestor
101914840|NCT05118672|Histamine Agents|histamine agents|mesh-ancestor
102206090|NCT03502135|Anesthetics|anesthetics|mesh-ancestor
102206091|NCT03502135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102206092|NCT03502135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206093|NCT03502135|Sensory System Agents|sensory system agents|mesh-ancestor
102206094|NCT03502135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102206095|NCT03502135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102206096|NCT03502135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102206097|NCT03502135|Adrenergic Agents|adrenergic agents|mesh-ancestor
102206098|NCT03502135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102206099|NCT03502135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206100|NCT03502135|Sympathomimetics|sympathomimetics|mesh-ancestor
102206101|NCT03502135|Autonomic Agents|autonomic agents|mesh-ancestor
102206102|NCT03502135|Nasal Decongestants|nasal decongestants|mesh-ancestor
102206103|NCT03502135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102206104|NCT03502135|Respiratory System Agents|respiratory system agents|mesh-ancestor
102206105|NCT03502135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102206106|NCT03502135|Mydriatics|mydriatics|mesh-ancestor
102206107|NCT03502135|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102206108|NCT03502135|Protective Agents|protective agents|mesh-ancestor
102206109|NCT02315287|Pioglitazone|pioglitazone|mesh-list
102206110|NCT02315287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102206111|NCT02315287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206112|NCT02319577|Vinorelbine|vinorelbine|mesh-list
102206113|NCT02319577|Gefitinib|gefitinib|mesh-list
102206114|NCT02319577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102206115|NCT02319577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102206116|NCT02319577|Tubulin Modulators|tubulin modulators|mesh-ancestor
102206117|NCT02319577|Antimitotic Agents|antimitotic agents|mesh-ancestor
102206118|NCT02319577|Mitosis Modulators|mitosis modulators|mesh-ancestor
102206119|NCT02319577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206121|NCT02319577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102206122|NCT03501901|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102206123|NCT03501901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102206124|NCT03132259|Dexmedetomidine|dexmedetomidine|mesh-list
102206125|NCT03132259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102206126|NCT03132259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102206127|NCT03132259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206128|NCT03132259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102206129|NCT03132259|Analgesics|analgesics|mesh-ancestor
102206130|NCT03132259|Sensory System Agents|sensory system agents|mesh-ancestor
102206131|NCT03132259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102206132|NCT03132259|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102206133|NCT03132259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101699925|NCT02647424|Clomiphene|clomiphene|mesh-list
102206134|NCT03132259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102206135|NCT03132259|Adrenergic Agents|adrenergic agents|mesh-ancestor
102206136|NCT03132259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102206137|NCT03132259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206138|NCT03499171|Citalopram|citalopram|mesh-list
102206139|NCT03499171|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102206140|NCT03499171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102206141|NCT03499171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102206142|NCT03499171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206143|NCT03499171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102206144|NCT03499171|Serotonin Agents|serotonin agents|mesh-ancestor
102206145|NCT03499171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206146|NCT03499171|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102206147|NCT03499171|Antidepressive Agents|antidepressive agents|mesh-ancestor
102206148|NCT03499171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102206149|NCT02447419|Gefitinib|gefitinib|mesh-list
102206150|NCT02447419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102206151|NCT02447419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102206152|NCT02447419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102206153|NCT02447419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206154|NCT02319889|Paclitaxel|paclitaxel|mesh-list
102206155|NCT02319889|Carboplatin|carboplatin|mesh-list
102206156|NCT02319889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102206157|NCT02319889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102206158|NCT02319889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102206159|NCT02319889|Tubulin Modulators|tubulin modulators|mesh-ancestor
102206160|NCT02319889|Antimitotic Agents|antimitotic agents|mesh-ancestor
102206161|NCT02319889|Mitosis Modulators|mitosis modulators|mesh-ancestor
102206162|NCT02319889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206163|NCT02324413|Clonidine|clonidine|mesh-list
102206164|NCT02324413|Analgesics|analgesics|mesh-ancestor
102206165|NCT02324413|Sensory System Agents|sensory system agents|mesh-ancestor
102206166|NCT02324413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102206167|NCT02324413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206168|NCT02324413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102206169|NCT02324413|Sympatholytics|sympatholytics|mesh-ancestor
102206170|NCT02324413|Autonomic Agents|autonomic agents|mesh-ancestor
102206171|NCT02324413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102206172|NCT02324413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102206173|NCT02324413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102206174|NCT02324413|Adrenergic Agents|adrenergic agents|mesh-ancestor
102206175|NCT02324413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102206176|NCT02324413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206178|NCT03498703|Antimetabolites|antimetabolites|mesh-ancestor
102206179|NCT03498703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206180|NCT03498703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102206181|NCT03498703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102206182|NCT03498703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102206183|NCT03498703|Immunologic Factors|immunologic factors|mesh-ancestor
102206184|NCT03498703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206185|NCT03498703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102206186|NCT02324491|CKD732|ckd732|mesh-list
102206187|NCT02324491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102206188|NCT02324491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102206189|NCT02324491|Growth Substances|growth substances|mesh-ancestor
102206190|NCT02324491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206191|NCT02324491|Growth Inhibitors|growth inhibitors|mesh-ancestor
102206192|NCT02324491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102206194|NCT03494257|Brinzolamide|brinzolamide|mesh-list
102206195|NCT03494257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102206196|NCT03494257|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102206197|NCT03494257|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102206198|NCT03494257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102206199|NCT03494257|Adrenergic Agents|adrenergic agents|mesh-ancestor
102206200|NCT03494257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102206201|NCT03494257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206202|NCT03494257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206203|NCT03494257|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102206204|NCT03494257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102206205|NCT03132181|Empagliflozin|empagliflozin|mesh-list
102206206|NCT03132181|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102206207|NCT03132181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206208|NCT03132181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102206209|NCT03132181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206210|NCT02320045|Exenatide|exenatide|mesh-list
102206211|NCT02320045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102206212|NCT02320045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206213|NCT02320045|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102206214|NCT02320045|Incretins|incretins|mesh-ancestor
102206215|NCT02320045|Hormones|hormones|mesh-ancestor
102206216|NCT02320045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102206217|NCT02320357|Clopidogrel|clopidogrel|mesh-list
102206218|NCT02320357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102206219|NCT02320357|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102206220|NCT02320357|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102206221|NCT02320357|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102206222|NCT02320357|Purinergic Agents|purinergic agents|mesh-ancestor
102206223|NCT02320357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102206224|NCT02320357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206225|NCT02320357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206226|NCT03498235|Propofol|propofol|mesh-list
102206227|NCT03498235|Sevoflurane|sevoflurane|mesh-list
102206228|NCT03498235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102206229|NCT03498235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102206230|NCT03498235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206231|NCT03498235|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102206232|NCT03498235|Anesthetics, General|anesthetics, general|mesh-ancestor
102206233|NCT03498235|Anesthetics|anesthetics|mesh-ancestor
102206234|NCT03498235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102206235|NCT03498235|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102206236|NCT03491761|Hyaluronic Acid|hyaluronic acid|mesh-list
102206237|NCT03491761|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102206238|NCT03491761|Immunologic Factors|immunologic factors|mesh-ancestor
102206239|NCT03491761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206240|NCT03491761|Viscosupplements|viscosupplements|mesh-ancestor
102206241|NCT03491761|Protective Agents|protective agents|mesh-ancestor
102206242|NCT03132103|Vitamin D|vitamin d|mesh-list
102206243|NCT03132103|Ergocalciferols|ergocalciferols|mesh-list
102206244|NCT03132103|Cholecalciferol|cholecalciferol|mesh-list
102206245|NCT03132103|Vitamins|vitamins|mesh-list
102206246|NCT03132103|Micronutrients|micronutrients|mesh-ancestor
102206247|NCT03132103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206248|NCT03132103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102206249|NCT03132103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102206250|NCT04635943|Ivermectin|ivermectin|mesh-list
102206251|NCT04635943|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102206252|NCT04635943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102206253|NCT04461925|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102206254|NCT04461925|Azithromycin|azithromycin|mesh-list
102206255|NCT04461925|Ceftriaxone|ceftriaxone|mesh-list
102206256|NCT04461925|Dexamethasone|dexamethasone|mesh-list
102206257|NCT04461925|Enoxaparin|enoxaparin|mesh-list
102206258|NCT04461925|Anticoagulants|anticoagulants|mesh-list
102206259|NCT04461925|Hormones|hormones|mesh-list
102206260|NCT04461925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102206261|NCT04461925|Antiemetics|antiemetics|mesh-ancestor
102206262|NCT04461925|Autonomic Agents|autonomic agents|mesh-ancestor
102206263|NCT04461925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102206264|NCT04461925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206265|NCT04461925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102206266|NCT04461925|Glucocorticoids|glucocorticoids|mesh-ancestor
101573989|NCT02199184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102206267|NCT04461925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102206268|NCT04461925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102206269|NCT04461925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102206270|NCT04461925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206271|NCT04461925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102206272|NCT04461925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102206273|NCT04461925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102206275|NCT02325583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102206276|NCT02325583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102206277|NCT02325583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102206278|NCT02325583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206279|NCT02325583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102206280|NCT02325583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102206281|NCT02325583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102206282|NCT02325583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102206283|NCT02325583|Anesthetics, General|anesthetics, general|mesh-ancestor
102206284|NCT02325583|Anesthetics|anesthetics|mesh-ancestor
102206285|NCT02325583|GABA Modulators|gaba modulators|mesh-ancestor
102206286|NCT02325583|GABA Agents|gaba agents|mesh-ancestor
102206287|NCT02325583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102206288|NCT02325583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206289|NCT02321293|Curcumin|curcumin|mesh-list
102206290|NCT02321293|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102206291|NCT02321293|Gefitinib|gefitinib|mesh-list
102206292|NCT02321293|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102206293|NCT02321293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102206294|NCT02321293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102206295|NCT02321293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102206296|NCT02321293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206297|NCT02321293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102206298|NCT02321293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102206299|NCT02321293|Analgesics|analgesics|mesh-ancestor
102206300|NCT02321293|Sensory System Agents|sensory system agents|mesh-ancestor
101308396|NCT02047149|Analgesics|analgesics|mesh-ancestor
102206301|NCT02321293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102206302|NCT02321293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206303|NCT02321293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102206304|NCT02321293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102206305|NCT02321371|Rifaximin|rifaximin|mesh-list
102206306|NCT02321371|Lactulose|lactulose|mesh-list
102206307|NCT02321371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102206308|NCT02321371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102206309|NCT02321371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102206310|NCT04002037|Dexamethasone|dexamethasone|mesh-list
102206311|NCT04002037|Triamcinolone|triamcinolone|mesh-list
101915083|NCT04937699|Aspirin|aspirin|mesh-list
102206312|NCT04002037|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102206313|NCT04002037|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102206314|NCT04002037|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102206315|NCT04002037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102206316|NCT04002037|Antiemetics|antiemetics|mesh-ancestor
102206317|NCT04002037|Autonomic Agents|autonomic agents|mesh-ancestor
102206318|NCT04002037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102206319|NCT04002037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206320|NCT04002037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102206321|NCT04002037|Glucocorticoids|glucocorticoids|mesh-ancestor
102206322|NCT04002037|Hormones|hormones|mesh-ancestor
102206323|NCT04002037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102206324|NCT04002037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102206325|NCT04002037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102206326|NCT04002037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102206327|NCT04002037|Immunologic Factors|immunologic factors|mesh-ancestor
102206328|NCT04002037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102206329|NCT04002037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206330|NCT03491371|Apatinib|apatinib|mesh-list
102206331|NCT03491371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102206332|NCT03491371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102206333|NCT03491371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102206334|NCT03491371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206335|NCT03546829|Vancomycin|vancomycin|mesh-list
102206336|NCT03546829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102206337|NCT03546829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102206338|NCT03284047|Botulinum Toxins|botulinum toxins|mesh-list
102206339|NCT03284047|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102206340|NCT03284047|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102206341|NCT03284047|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102206342|NCT03284047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102206343|NCT03284047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206344|NCT03284047|Cholinergic Agents|cholinergic agents|mesh-ancestor
102206345|NCT03284047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102206346|NCT03284047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206347|NCT03284047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102206348|NCT03284047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102206349|NCT03493087|Vitamin K|vitamin k|mesh-list
102206350|NCT03493087|Vitamins|vitamins|mesh-ancestor
102206351|NCT03493087|Micronutrients|micronutrients|mesh-ancestor
102206352|NCT03493087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206353|NCT03493087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102206354|NCT03493087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102206355|NCT03493087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206356|NCT03493087|Hemostatics|hemostatics|mesh-ancestor
102206357|NCT03493087|Coagulants|coagulants|mesh-ancestor
102206358|NCT03136627|Nivolumab|nivolumab|mesh-list
102206359|NCT03136627|Tivozanib|tivozanib|mesh-list
102206360|NCT03136627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102206361|NCT03136627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102206362|NCT03136627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102206363|NCT03136627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206364|NCT03136627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102206365|NCT03136627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102206366|NCT02922985|Acetaminophen|acetaminophen|mesh-list
102206367|NCT02922985|Ketorolac|ketorolac|mesh-list
102206368|NCT02922985|Bupivacaine|bupivacaine|mesh-list
102206369|NCT02922985|Anesthetics, Local|anesthetics, local|mesh-ancestor
102206370|NCT02922985|Anesthetics|anesthetics|mesh-ancestor
102206371|NCT02922985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102206372|NCT02922985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206373|NCT02922985|Sensory System Agents|sensory system agents|mesh-ancestor
102206374|NCT02922985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102206375|NCT02922985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102206376|NCT02922985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102206377|NCT02922985|Analgesics|analgesics|mesh-ancestor
102206378|NCT02922985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102206379|NCT02922985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102206380|NCT02922985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102206381|NCT02922985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102206382|NCT02922985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206383|NCT02922985|Antipyretics|antipyretics|mesh-ancestor
102206384|NCT04881955|Ecopipam|ecopipam|mesh-list
102206385|NCT04881955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102206386|NCT04881955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102206387|NCT04881955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102206388|NCT04881955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206389|NCT04881955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102206390|NCT04881955|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102206391|NCT04881955|Dopamine Agents|dopamine agents|mesh-ancestor
102206392|NCT04881955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102206393|NCT04881955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206394|NCT02234843|Rivaroxaban|rivaroxaban|mesh-list
102206395|NCT02234843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102206396|NCT02234843|Antithrombins|antithrombins|mesh-ancestor
102206397|NCT02234843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102206398|NCT02234843|Protease Inhibitors|protease inhibitors|mesh-ancestor
102206399|NCT02234843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102206400|NCT02234843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206401|NCT02234843|Anticoagulants|anticoagulants|mesh-ancestor
102206402|NCT03492931|Ticagrelor|ticagrelor|mesh-list
102206403|NCT03492931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102206404|NCT03492931|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102206405|NCT03492931|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102206406|NCT03492931|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102206407|NCT03492931|Purinergic Agents|purinergic agents|mesh-ancestor
102206408|NCT03492931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102206409|NCT03492931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206410|NCT03492931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206411|NCT02234921|Cyclophosphamide|cyclophosphamide|mesh-list
102206412|NCT02234921|Imiquimod|imiquimod|mesh-list
102206413|NCT02234921|Vaccines|vaccines|mesh-list
102206414|NCT02234921|Immunologic Factors|immunologic factors|mesh-ancestor
102206415|NCT02234921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206416|NCT02234921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102206417|NCT02234921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102206418|NCT02234921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102206419|NCT02234921|Alkylating Agents|alkylating agents|mesh-ancestor
102206420|NCT02234921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206421|NCT02234921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102206422|NCT02234921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102206423|NCT02234921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102206424|NCT02234921|Interferon Inducers|interferon inducers|mesh-ancestor
102206425|NCT02321761|Amantadine|amantadine|mesh-list
102206426|NCT02321761|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102206427|NCT02321761|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102206428|NCT02321761|Antiviral Agents|antiviral agents|mesh-ancestor
102206429|NCT02321761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102206430|NCT02321761|Dopamine Agents|dopamine agents|mesh-ancestor
102206431|NCT02321761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102206432|NCT02321761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206433|NCT02321761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206434|NCT02321761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102206435|NCT02321761|Analgesics|analgesics|mesh-ancestor
102206436|NCT02321761|Sensory System Agents|sensory system agents|mesh-ancestor
102206437|NCT02321761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102206438|NCT04674241|Dexmedetomidine|dexmedetomidine|mesh-list
102206439|NCT04674241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102206440|NCT04674241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102206441|NCT04674241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206442|NCT04674241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102206443|NCT04674241|Analgesics|analgesics|mesh-ancestor
102206444|NCT04674241|Sensory System Agents|sensory system agents|mesh-ancestor
102206445|NCT04674241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102206446|NCT04674241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102206447|NCT04674241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102206448|NCT04674241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102206449|NCT04674241|Adrenergic Agents|adrenergic agents|mesh-ancestor
102206450|NCT04674241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102206451|NCT04674241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206452|NCT02259647|Sorafenib|sorafenib|mesh-list
102206453|NCT02259647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102206454|NCT02259647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102206455|NCT02259647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102206456|NCT02259647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206457|NCT02321839|Ranibizumab|ranibizumab|mesh-list
102206458|NCT02321839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102206459|NCT02321839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102206460|NCT02321839|Growth Substances|growth substances|mesh-ancestor
102206461|NCT02321839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206462|NCT02321839|Growth Inhibitors|growth inhibitors|mesh-ancestor
102206463|NCT02321839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102206464|NCT03490279|Lactoferrin|lactoferrin|mesh-list
102206465|NCT03490279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102206466|NCT02750345|Nitisinone|nitisinone|mesh-list
102206467|NCT02750345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102206468|NCT02750345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206469|NCT01329263|Menthol|menthol|mesh-list
102206470|NCT01329263|Antipruritics|antipruritics|mesh-ancestor
102206471|NCT01329263|Dermatologic Agents|dermatologic agents|mesh-ancestor
102206472|NCT03490123|Azithromycin|azithromycin|mesh-list
102206473|NCT03490123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102206474|NCT03490123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102206475|NCT02235233|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
102206476|NCT02235233|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102206477|NCT02235233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206478|NCT02182687|Doxorubicin|doxorubicin|mesh-list
102206479|NCT02182687|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102206480|NCT02182687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102206481|NCT02182687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102206482|NCT02182687|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102206483|NCT02182687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102206484|NCT02182687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101900611|NCT01285466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102206485|NCT02182687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206487|NCT02235389|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102206488|NCT02235389|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102206489|NCT02235389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206490|NCT03489889|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102206491|NCT03489889|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102206492|NCT03489889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102206493|NCT01388491|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102206494|NCT01388491|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102206495|NCT01388491|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102206496|NCT01388491|Desogestrel|desogestrel|mesh-list
102206497|NCT01388491|Estradiol|estradiol|mesh-list
102206498|NCT01388491|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102206499|NCT01388491|Estrogens|estrogens|mesh-ancestor
102206500|NCT01388491|Hormones|hormones|mesh-ancestor
102206501|NCT01388491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102206502|NCT01388491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206503|NCT01388491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102206504|NCT01388491|Contraceptive Agents|contraceptive agents|mesh-ancestor
102206505|NCT01388491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102206506|NCT01388491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102206507|NCT01388491|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102206508|NCT01388491|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102206509|NCT01388491|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102206510|NCT01388491|Progestins|progestins|mesh-ancestor
102206511|NCT02236169|Bromides|bromides|mesh-list
102206512|NCT02236169|Norflurane|norflurane|mesh-list
102206513|NCT02236169|Ipratropium|ipratropium|mesh-list
102206514|NCT02236169|Anticonvulsants|anticonvulsants|mesh-ancestor
102206515|NCT02236169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102206516|NCT02236169|Autonomic Agents|autonomic agents|mesh-ancestor
102206517|NCT02236169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102206518|NCT02236169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206519|NCT02236169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102206520|NCT02236169|Respiratory System Agents|respiratory system agents|mesh-ancestor
102206521|NCT02236169|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102206522|NCT02236169|Cholinergic Agents|cholinergic agents|mesh-ancestor
102206523|NCT02236169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102206524|NCT02236169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206525|NCT02236169|Anesthetics|anesthetics|mesh-ancestor
102206526|NCT02236169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102206527|NCT02749799|Betamethasone|betamethasone|mesh-list
102206528|NCT02749799|Betamethasone Valerate|betamethasone valerate|mesh-list
102206529|NCT02749799|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102206530|NCT02749799|Betamethasone benzoate|betamethasone benzoate|mesh-list
102206531|NCT02749799|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102206532|NCT02749799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102206533|NCT02749799|Glucocorticoids|glucocorticoids|mesh-ancestor
102206534|NCT02749799|Hormones|hormones|mesh-ancestor
102206535|NCT02749799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102206536|NCT02749799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206537|NCT02749799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102206538|NCT02749799|Respiratory System Agents|respiratory system agents|mesh-ancestor
102206539|NCT03492541|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102206540|NCT03492541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102206541|NCT03492385|Ticagrelor|ticagrelor|mesh-list
102206542|NCT03492385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102206543|NCT03492385|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102206544|NCT03492385|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102206545|NCT03492385|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102206546|NCT03492385|Purinergic Agents|purinergic agents|mesh-ancestor
102206547|NCT03492385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102206548|NCT03492385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206549|NCT03492385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206550|NCT03736265|Carvedilol|carvedilol|mesh-list
102206551|NCT03736265|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102206552|NCT03736265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102206553|NCT03736265|Adrenergic Agents|adrenergic agents|mesh-ancestor
102206554|NCT03736265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102206555|NCT03736265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206556|NCT03736265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206557|NCT03736265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102206559|NCT03736265|Protective Agents|protective agents|mesh-ancestor
102206560|NCT03736265|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102206561|NCT03736265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102206562|NCT03736265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102206563|NCT03736265|Vasodilator Agents|vasodilator agents|mesh-ancestor
102206564|NCT03736265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102206565|NCT03736265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102206566|NCT04939363|Venetoclax|venetoclax|mesh-list
102206567|NCT04939363|Obinutuzumab|obinutuzumab|mesh-list
102206568|NCT04939363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102206569|NCT04939363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102206570|NCT02236403|Metronidazole|metronidazole|mesh-list
102206571|NCT02236403|Ivermectin|ivermectin|mesh-list
102206572|NCT02236403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102206573|NCT02236403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102206574|NCT02236403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102206575|NCT02236403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102206576|NCT02236481|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102206577|NCT02236481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102206578|NCT03491527|Salicylic Acid|salicylic acid|mesh-list
102206579|NCT03491527|Pemetrexed|pemetrexed|mesh-list
102206580|NCT03491527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102206581|NCT03491527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102206582|NCT03491527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206583|NCT03491527|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102206584|NCT03491527|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102206585|NCT03491527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102206586|NCT03491527|Antifungal Agents|antifungal agents|mesh-ancestor
102206587|NCT03491527|Keratolytic Agents|keratolytic agents|mesh-ancestor
102206588|NCT03491527|Dermatologic Agents|dermatologic agents|mesh-ancestor
102206589|NCT02934529|Leucovorin|leucovorin|mesh-list
102206590|NCT02934529|Folic Acid|folic acid|mesh-list
102206591|NCT02934529|Bevacizumab|bevacizumab|mesh-list
102206592|NCT02934529|Cetuximab|cetuximab|mesh-list
102206593|NCT02934529|Fluorouracil|fluorouracil|mesh-list
102206594|NCT02934529|Capecitabine|capecitabine|mesh-list
102206595|NCT02934529|Irinotecan|irinotecan|mesh-list
102206596|NCT02934529|Levoleucovorin|levoleucovorin|mesh-list
102206597|NCT02934529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102206598|NCT02934529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102206599|NCT02934529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102206600|NCT02934529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102206601|NCT02934529|Growth Substances|growth substances|mesh-ancestor
102206602|NCT02934529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206603|NCT02934529|Growth Inhibitors|growth inhibitors|mesh-ancestor
102206604|NCT02934529|Antimetabolites|antimetabolites|mesh-ancestor
102206605|NCT02934529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206606|NCT02934529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102206607|NCT02934529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102206608|NCT02934529|Immunologic Factors|immunologic factors|mesh-ancestor
102206609|NCT02934529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102206610|NCT02934529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102206611|NCT02934529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102206612|NCT02934529|Antidotes|antidotes|mesh-ancestor
102206613|NCT02934529|Protective Agents|protective agents|mesh-ancestor
102206614|NCT02934529|Vitamin B Complex|vitamin b complex|mesh-ancestor
102206615|NCT02934529|Vitamins|vitamins|mesh-ancestor
102206616|NCT02934529|Micronutrients|micronutrients|mesh-ancestor
102206617|NCT02934529|Hematinics|hematinics|mesh-ancestor
102206618|NCT02638805|Metformin|metformin|mesh-list
102206619|NCT02638805|Liraglutide|liraglutide|mesh-list
102206620|NCT02638805|Exenatide|exenatide|mesh-list
102206621|NCT02638805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102206622|NCT02638805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206623|NCT02638805|Incretins|incretins|mesh-ancestor
102206624|NCT02638805|Hormones|hormones|mesh-ancestor
102206625|NCT02638805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102206626|NCT02638805|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102206627|NCT02261675|Dexmedetomidine|dexmedetomidine|mesh-list
102206628|NCT02261675|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102206629|NCT02261675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102206630|NCT02261675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206631|NCT02261675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102206632|NCT02261675|Analgesics|analgesics|mesh-ancestor
102206633|NCT02261675|Sensory System Agents|sensory system agents|mesh-ancestor
102206634|NCT02261675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101748455|NCT00710216|Antiviral Agents|antiviral agents|mesh-ancestor
102206635|NCT02261675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102206636|NCT02261675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102206637|NCT02261675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102206638|NCT02261675|Adrenergic Agents|adrenergic agents|mesh-ancestor
102206639|NCT02261675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102206640|NCT02261675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206641|NCT02262143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102206642|NCT02262143|Fenofibrate|fenofibrate|mesh-list
102206643|NCT02262143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102206644|NCT02262143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102206645|NCT02262143|Antimetabolites|antimetabolites|mesh-ancestor
102206646|NCT02262143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206647|NCT02262143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102206648|NCT02262143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102206649|NCT02262143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102206650|NCT02620553|Insulin|insulin|mesh-list
102206651|NCT02620553|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102206652|NCT02620553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102206653|NCT02620553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206654|NCT04588727|Aspirin|aspirin|mesh-list
102206655|NCT04588727|Ticagrelor|ticagrelor|mesh-list
102206656|NCT04588727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102206657|NCT04588727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102206658|NCT04588727|Analgesics|analgesics|mesh-ancestor
102206659|NCT04588727|Sensory System Agents|sensory system agents|mesh-ancestor
102206660|NCT04588727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102206661|NCT04588727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206662|NCT04588727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102206663|NCT04588727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102206664|NCT04588727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102206665|NCT04588727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102206666|NCT04588727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206667|NCT04588727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102206668|NCT04588727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102206669|NCT04588727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102206670|NCT04588727|Antipyretics|antipyretics|mesh-ancestor
102206671|NCT04588727|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102206672|NCT04588727|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102206673|NCT04588727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102206674|NCT04588727|Purinergic Agents|purinergic agents|mesh-ancestor
102206675|NCT04588727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102206676|NCT02262299|Pirfenidone|pirfenidone|mesh-list
102206677|NCT02262299|Analgesics|analgesics|mesh-ancestor
102206678|NCT02262299|Sensory System Agents|sensory system agents|mesh-ancestor
102206679|NCT02262299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102206680|NCT02262299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206681|NCT02262299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102206682|NCT02262299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102206683|NCT02262299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102206684|NCT02262299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102206685|NCT02262299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102206686|NCT02608697|Atorvastatin|atorvastatin|mesh-list
102206687|NCT02608697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102206688|NCT02608697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102206689|NCT02608697|Antimetabolites|antimetabolites|mesh-ancestor
102206690|NCT02608697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206691|NCT02608697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102206692|NCT02608697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102206693|NCT02608697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102206694|NCT02262455|Doxorubicin|doxorubicin|mesh-list
102206695|NCT02262455|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102206696|NCT02262455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102206697|NCT02262455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102206698|NCT02262455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102206699|NCT02262455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102206700|NCT02262455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102206701|NCT02262455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206702|NCT02262533|Atenolol|atenolol|mesh-list
102206703|NCT02262533|Apixaban|apixaban|mesh-list
102206704|NCT02262533|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102206705|NCT02262533|Antithrombins|antithrombins|mesh-ancestor
102206706|NCT02262533|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102206707|NCT02262533|Protease Inhibitors|protease inhibitors|mesh-ancestor
102206709|NCT02262533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206710|NCT02262533|Anticoagulants|anticoagulants|mesh-ancestor
101450961|NCT00224445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102206711|NCT02262533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102206712|NCT02262533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102206713|NCT02262533|Sympatholytics|sympatholytics|mesh-ancestor
102206714|NCT02262533|Autonomic Agents|autonomic agents|mesh-ancestor
102206715|NCT02262533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102206716|NCT02262533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206717|NCT02262533|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102206718|NCT02262533|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102206719|NCT02262533|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102206720|NCT02262533|Adrenergic Agents|adrenergic agents|mesh-ancestor
102206721|NCT02262533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102206722|NCT02262611|Telmisartan|telmisartan|mesh-list
102206723|NCT02262611|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
102206724|NCT02262611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102206725|NCT02262611|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102206726|NCT02262611|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102206727|NCT02262611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206728|NCT02262611|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102206729|NCT02262611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102206730|NCT02262611|Diuretics|diuretics|mesh-ancestor
102206731|NCT02262611|Natriuretic Agents|natriuretic agents|mesh-ancestor
102206732|NCT02262611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206733|NCT02262767|Trimethobenzamide|trimethobenzamide|mesh-list
102206734|NCT02262767|Antiemetics|antiemetics|mesh-ancestor
102206735|NCT02262767|Autonomic Agents|autonomic agents|mesh-ancestor
102206736|NCT02262767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102206737|NCT02262767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206738|NCT02262767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102206739|NCT02589275|Cyclobenzaprine|cyclobenzaprine|mesh-list
102206740|NCT02589275|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102206741|NCT02589275|Antidepressive Agents|antidepressive agents|mesh-ancestor
102206742|NCT02589275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102206743|NCT02589275|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102206744|NCT02589275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206745|NCT02589275|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102206746|NCT02589275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102206747|NCT02589275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102206748|NCT02589275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102206749|NCT02543567|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
102206750|NCT02543567|Antiviral Agents|antiviral agents|mesh-ancestor
102206751|NCT02543567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102206752|NCT02515175|Vaccines|vaccines|mesh-list
102206753|NCT02515175|Immunologic Factors|immunologic factors|mesh-ancestor
102206754|NCT02515175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206755|NCT02513303|Sirolimus|sirolimus|mesh-list
102206756|NCT02513303|Temsirolimus|temsirolimus|mesh-list
102206757|NCT02513303|MTOR Inhibitors|mtor inhibitors|mesh-list
102206758|NCT02513303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102206759|NCT02513303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102206760|NCT02513303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101450971|NCT00194753|Paclitaxel|paclitaxel|mesh-list
102206761|NCT02513303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102206762|NCT02513303|Antifungal Agents|antifungal agents|mesh-ancestor
102206763|NCT02513303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102206764|NCT02513303|Immunologic Factors|immunologic factors|mesh-ancestor
101915519|NCT04550442|Azacitidine|azacitidine|mesh-list
102206765|NCT02513303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206766|NCT02513303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102206767|NCT02513303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102206768|NCT02513303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206769|NCT01616303|Paclitaxel|paclitaxel|mesh-list
102206770|NCT01616303|Carboplatin|carboplatin|mesh-list
102206771|NCT01616303|Oregovomab|oregovomab|mesh-list
102206772|NCT01616303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102206773|NCT01616303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102206774|NCT01616303|Tubulin Modulators|tubulin modulators|mesh-ancestor
102206775|NCT01616303|Antimitotic Agents|antimitotic agents|mesh-ancestor
102206776|NCT01616303|Mitosis Modulators|mitosis modulators|mesh-ancestor
102206777|NCT01616303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206778|NCT01616303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102206779|NCT01590719|Leucovorin|leucovorin|mesh-list
102206780|NCT01590719|Folic Acid|folic acid|mesh-list
102206781|NCT01590719|Fluorouracil|fluorouracil|mesh-list
102206782|NCT01590719|Oxaliplatin|oxaliplatin|mesh-list
102206783|NCT01590719|Levoleucovorin|levoleucovorin|mesh-list
102206784|NCT01590719|Antimetabolites|antimetabolites|mesh-ancestor
102206785|NCT01590719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206786|NCT01590719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102206787|NCT01590719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102206788|NCT01590719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102206789|NCT01590719|Immunologic Factors|immunologic factors|mesh-ancestor
102206790|NCT01590719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206791|NCT01590719|Antidotes|antidotes|mesh-ancestor
102206792|NCT01590719|Protective Agents|protective agents|mesh-ancestor
102206793|NCT01590719|Vitamin B Complex|vitamin b complex|mesh-ancestor
102206794|NCT01590719|Vitamins|vitamins|mesh-ancestor
102206795|NCT01590719|Micronutrients|micronutrients|mesh-ancestor
102206796|NCT01590719|Hematinics|hematinics|mesh-ancestor
102206797|NCT01536041|Montelukast|montelukast|mesh-list
102206798|NCT01536041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102206799|NCT01536041|Respiratory System Agents|respiratory system agents|mesh-ancestor
102206800|NCT01536041|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102206801|NCT01536041|Hormone Antagonists|hormone antagonists|mesh-ancestor
102206802|NCT01536041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102206803|NCT01536041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206804|NCT01536041|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102206805|NCT01536041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102206806|NCT01536041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206807|NCT01534403|Epratuzumab|epratuzumab|mesh-list
102206808|NCT01534403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102206809|NCT01534403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102206810|NCT01522469|Crenolanib|crenolanib|mesh-list
102206811|NCT01522469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102206812|NCT02264015|Moxifloxacin|moxifloxacin|mesh-list
102206813|NCT02264015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102206814|NCT02264015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102206815|NCT02264015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102206816|NCT02264015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102206817|NCT02264015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102206818|NCT02264015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206819|NCT02264015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102206820|NCT02264093|Propranolol|propranolol|mesh-list
102206821|NCT02264093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102206822|NCT02264093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102206823|NCT02264093|Adrenergic Agents|adrenergic agents|mesh-ancestor
102206824|NCT02264093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102206825|NCT02264093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206826|NCT02264093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206827|NCT02264093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102206828|NCT02264093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101451008|NCT00472303|Narcotics|narcotics|mesh-ancestor
102206829|NCT02264093|Vasodilator Agents|vasodilator agents|mesh-ancestor
102206830|NCT01516541|Dalcetrapib|dalcetrapib|mesh-list
102206831|NCT01516541|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102206832|NCT01516541|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102206833|NCT01516541|Antimetabolites|antimetabolites|mesh-ancestor
102206834|NCT01516541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206835|NCT01516541|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102206836|NCT01516307|Cyclophosphamide|cyclophosphamide|mesh-list
102206837|NCT01516307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102206838|NCT01516307|Immunologic Factors|immunologic factors|mesh-ancestor
102206839|NCT01516307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206840|NCT01516307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102206841|NCT01516307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102206842|NCT01516307|Alkylating Agents|alkylating agents|mesh-ancestor
102206843|NCT01516307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206844|NCT01516307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102206845|NCT01516307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102206846|NCT01516073|Fluticasone|fluticasone|mesh-list
102206847|NCT01516073|Xhance|xhance|mesh-list
102206848|NCT01516073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102206849|NCT01516073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102206850|NCT01516073|Autonomic Agents|autonomic agents|mesh-ancestor
102206851|NCT01516073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102206852|NCT01516073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206853|NCT01516073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102206854|NCT01516073|Respiratory System Agents|respiratory system agents|mesh-ancestor
102206855|NCT01516073|Dermatologic Agents|dermatologic agents|mesh-ancestor
102206856|NCT01516073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102206857|NCT01495247|Paclitaxel|paclitaxel|mesh-list
102206858|NCT01495247|Dactolisib|dactolisib|mesh-list
102206859|NCT01495247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102206860|NCT01495247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102206861|NCT01495247|Tubulin Modulators|tubulin modulators|mesh-ancestor
102206862|NCT01495247|Antimitotic Agents|antimitotic agents|mesh-ancestor
102206863|NCT01495247|Mitosis Modulators|mitosis modulators|mesh-ancestor
102206864|NCT01495247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206865|NCT01495013|Glimepiride|glimepiride|mesh-list
102206866|NCT01495013|Atorvastatin|atorvastatin|mesh-list
102206867|NCT01495013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102206868|NCT01495013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102206869|NCT01495013|Antimetabolites|antimetabolites|mesh-ancestor
102206870|NCT01495013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206871|NCT01495013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102206872|NCT01495013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102206873|NCT01495013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102206874|NCT01495013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102206875|NCT01495013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102206876|NCT01495013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206877|NCT01495013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102206878|NCT01495013|Immunologic Factors|immunologic factors|mesh-ancestor
101915669|NCT04384367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101915670|NCT04378933|Methamphetamine|methamphetamine|mesh-list
101915671|NCT04378933|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101915672|NCT04378933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915673|NCT04378933|Sympathomimetics|sympathomimetics|mesh-ancestor
101915674|NCT04378933|Autonomic Agents|autonomic agents|mesh-ancestor
101915675|NCT04378933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101915676|NCT04378933|Dopamine Agents|dopamine agents|mesh-ancestor
101915677|NCT04378933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101915678|NCT04378933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915679|NCT04378933|Adrenergic Agents|adrenergic agents|mesh-ancestor
101915680|NCT04378933|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101915681|NCT04378933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101915682|NCT04378933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101915683|NCT04378933|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101915684|NCT04341259|Ipatasertib|ipatasertib|mesh-list
101915685|NCT04341259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101915686|NCT04341259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101915687|NCT04341259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101915688|NCT04341259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915689|NCT04341116|Plonmarlimab|plonmarlimab|mesh-list
101915690|NCT04341116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101915691|NCT04341116|Antiviral Agents|antiviral agents|mesh-ancestor
101915692|NCT04341116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101915693|NCT04335006|Paclitaxel|paclitaxel|mesh-list
101915694|NCT04335006|Apatinib|apatinib|mesh-list
101915695|NCT04335006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101915696|NCT04335006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101915697|NCT04335006|Tubulin Modulators|tubulin modulators|mesh-ancestor
101915698|NCT04335006|Antimitotic Agents|antimitotic agents|mesh-ancestor
101915699|NCT04335006|Mitosis Modulators|mitosis modulators|mesh-ancestor
101915700|NCT04335006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915701|NCT04335006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101915702|NCT04335006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101915740|NCT04318548|Vaccines|vaccines|mesh-list
102206880|NCT02264171|Tamsulosin|tamsulosin|mesh-list
102206881|NCT02264171|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102206882|NCT02264171|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102206883|NCT02264171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102206884|NCT02264171|Adrenergic Agents|adrenergic agents|mesh-ancestor
102206885|NCT02264171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102206886|NCT02264171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206887|NCT02264171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206888|NCT02264171|Urological Agents|urological agents|mesh-ancestor
102206889|NCT02264171|Antifungal Agents|antifungal agents|mesh-ancestor
102206890|NCT02264171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102206891|NCT02264171|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102206892|NCT02264171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102206893|NCT02264171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102206894|NCT02264171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102206895|NCT02264171|Hormone Antagonists|hormone antagonists|mesh-ancestor
102206896|NCT02264171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102206897|NCT02264171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102206898|NCT01481051|Latanoprost|latanoprost|mesh-list
102206899|NCT01481051|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102206900|NCT01481051|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102206901|NCT01480583|Alovudine|alovudine|mesh-list
102206902|NCT01480583|Trastuzumab|trastuzumab|mesh-list
102206903|NCT01480583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102206904|NCT01480583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102206905|NCT01480583|Antiviral Agents|antiviral agents|mesh-ancestor
102206906|NCT01480583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102206907|NCT01470131|Dexamethasone|dexamethasone|mesh-list
102206908|NCT01470131|Bortezomib|bortezomib|mesh-list
102206909|NCT01470131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102206910|NCT01470131|Antiemetics|antiemetics|mesh-ancestor
102206911|NCT01470131|Autonomic Agents|autonomic agents|mesh-ancestor
102206912|NCT01470131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102206913|NCT01470131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206914|NCT01470131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102206915|NCT01470131|Glucocorticoids|glucocorticoids|mesh-ancestor
102206916|NCT01470131|Hormones|hormones|mesh-ancestor
102206917|NCT01470131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102206918|NCT01470131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102206919|NCT01470131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102206920|NCT02264561|Caffeine|caffeine|mesh-list
102206921|NCT02264561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102206922|NCT02264561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206923|NCT02264561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102206924|NCT02264561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102206925|NCT02264561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206926|NCT02264561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102206927|NCT02264561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102206928|NCT02264561|Purinergic Agents|purinergic agents|mesh-ancestor
102206929|NCT02264561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102206930|NCT01464437|Metformin|metformin|mesh-list
102206931|NCT01464437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102206932|NCT01464437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206933|NCT01461317|Etrolizumab|etrolizumab|mesh-list
102206934|NCT01461317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102206935|NCT01461317|Immunologic Factors|immunologic factors|mesh-ancestor
102206936|NCT01461317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206937|NCT01449071|Epratuzumab|epratuzumab|mesh-list
102206938|NCT01449071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102206939|NCT01449071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102206940|NCT01445795|Ribavirin|ribavirin|mesh-list
102206941|NCT01445795|Antimetabolites|antimetabolites|mesh-ancestor
102206942|NCT01445795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206943|NCT01445795|Antiviral Agents|antiviral agents|mesh-ancestor
102206944|NCT01445795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102206945|NCT02264795|Lidocaine|lidocaine|mesh-list
102206946|NCT02264795|Anesthetics, Local|anesthetics, local|mesh-ancestor
102206947|NCT02264795|Anesthetics|anesthetics|mesh-ancestor
102206948|NCT02264795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102206949|NCT02264795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206950|NCT02264795|Sensory System Agents|sensory system agents|mesh-ancestor
102206951|NCT02264795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102206952|NCT02264795|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102206953|NCT02264795|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102206954|NCT02264795|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102206955|NCT02264795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102206956|NCT02264795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206958|NCT02264873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102206959|NCT02264873|Antimetabolites|antimetabolites|mesh-ancestor
102206960|NCT02264873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206961|NCT02264873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102206962|NCT02264873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102206963|NCT00156533|Zolpidem|zolpidem|mesh-list
102206964|NCT00156533|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101900617|NCT01285544|Atorvastatin|atorvastatin|mesh-list
102206965|NCT00156533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102206966|NCT00156533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102206967|NCT00156533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206968|NCT00156533|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102206969|NCT00156533|GABA Agonists|gaba agonists|mesh-ancestor
102206971|NCT00156533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102206972|NCT00156533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206973|NCT01410695|Methotrexate|methotrexate|mesh-list
102206974|NCT01410695|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102206975|NCT01410695|Abortifacient Agents|abortifacient agents|mesh-ancestor
102206976|NCT01410695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102206977|NCT01410695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206978|NCT01410695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102206979|NCT01410695|Antimetabolites|antimetabolites|mesh-ancestor
102206980|NCT01410695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102206981|NCT01410695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102206982|NCT01410695|Dermatologic Agents|dermatologic agents|mesh-ancestor
102206983|NCT01410695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102206984|NCT01410695|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102206985|NCT01410695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102206986|NCT01410695|Immunologic Factors|immunologic factors|mesh-ancestor
102206987|NCT01410695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102206988|NCT01410695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102206989|NCT01660022|Piperaquine|piperaquine|mesh-list
102206990|NCT01660022|Artefenomel|artefenomel|mesh-list
102206991|NCT01660022|Antimalarials|antimalarials|mesh-ancestor
102206992|NCT01660022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102206993|NCT01660022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102206994|NCT01660022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102206995|NCT02265575|Hyaluronic Acid|hyaluronic acid|mesh-list
102206996|NCT02265575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102206997|NCT02265575|Immunologic Factors|immunologic factors|mesh-ancestor
102206998|NCT02265575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102206999|NCT02265575|Viscosupplements|viscosupplements|mesh-ancestor
102207000|NCT02265575|Protective Agents|protective agents|mesh-ancestor
102207001|NCT02265731|Rituximab|rituximab|mesh-list
102207002|NCT02265731|Venetoclax|venetoclax|mesh-list
102207003|NCT02265731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102207004|NCT02265731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102207005|NCT02265731|Immunologic Factors|immunologic factors|mesh-ancestor
102207006|NCT02265731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207007|NCT02265731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102207008|NCT02265809|Aldesleukin|aldesleukin|mesh-list
102207009|NCT02265809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102207010|NCT02265809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102207011|NCT02265809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102207012|NCT02265809|Antiviral Agents|antiviral agents|mesh-ancestor
102207013|NCT02265809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102207014|NCT01372475|Hyaluronic Acid|hyaluronic acid|mesh-list
102207015|NCT01372475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102207016|NCT01372475|Immunologic Factors|immunologic factors|mesh-ancestor
102207017|NCT01372475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207018|NCT01372475|Viscosupplements|viscosupplements|mesh-ancestor
102207019|NCT01372475|Protective Agents|protective agents|mesh-ancestor
102207020|NCT00156065|Haloperidol|haloperidol|mesh-list
102207021|NCT00156065|Haloperidol decanoate|haloperidol decanoate|mesh-list
102207022|NCT00156065|Asenapine|asenapine|mesh-list
102207023|NCT00156065|Antiemetics|antiemetics|mesh-ancestor
102207024|NCT00156065|Autonomic Agents|autonomic agents|mesh-ancestor
102207025|NCT00156065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102207026|NCT00156065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207027|NCT00156065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102207028|NCT00156065|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102207029|NCT00156065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102207030|NCT00156065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102207031|NCT00156065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102207032|NCT00156065|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102207033|NCT00156065|Dopamine Agents|dopamine agents|mesh-ancestor
102207034|NCT00156065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102207035|NCT00156065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207036|NCT00156065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102207037|NCT04476173|Morphine|morphine|mesh-list
102207038|NCT04476173|Methoxyflurane|methoxyflurane|mesh-list
102207039|NCT04476173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102207041|NCT04476173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102207042|NCT04476173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207043|NCT04476173|Analgesics|analgesics|mesh-ancestor
102207044|NCT04476173|Sensory System Agents|sensory system agents|mesh-ancestor
102207045|NCT04476173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102207046|NCT04476173|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102207047|NCT04476173|Anesthetics, General|anesthetics, general|mesh-ancestor
102207048|NCT04476173|Anesthetics|anesthetics|mesh-ancestor
102207049|NCT01554956|Plasminogen|plasminogen|mesh-list
102207050|NCT01554956|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102207051|NCT01554956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102207052|NCT01554956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207053|NCT01360853|Gemcitabine|gemcitabine|mesh-list
102207054|NCT01360853|ON 01910|on 01910|mesh-list
102207055|NCT01360853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102207056|NCT01360853|Antimetabolites|antimetabolites|mesh-ancestor
102207057|NCT01360853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207058|NCT01360853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102207059|NCT01360853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102207060|NCT01360853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102207061|NCT01355393|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
102207062|NCT01355393|Sargramostim|sargramostim|mesh-list
102207063|NCT01355393|Immunologic Factors|immunologic factors|mesh-ancestor
102207064|NCT01355393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207065|NCT01355393|Antiviral Agents|antiviral agents|mesh-ancestor
102207066|NCT01355393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102207067|NCT02266355|Omalizumab|omalizumab|mesh-list
102207068|NCT02266355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102207069|NCT02266355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102207070|NCT02266355|Respiratory System Agents|respiratory system agents|mesh-ancestor
102207071|NCT02266511|Tamsulosin|tamsulosin|mesh-list
102207072|NCT02266511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102207073|NCT02266511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102207074|NCT02266511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102207075|NCT02266511|Adrenergic Agents|adrenergic agents|mesh-ancestor
102207076|NCT02266511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102207077|NCT02266511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207078|NCT02266511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207079|NCT02266511|Urological Agents|urological agents|mesh-ancestor
102207080|NCT02266589|Hydrocortisone|hydrocortisone|mesh-list
102207081|NCT02266589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102207082|NCT01330979|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102207083|NCT01330979|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102207084|NCT01298687|Travoprost|travoprost|mesh-list
102207085|NCT01298687|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102207086|NCT01298687|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102207087|NCT01298687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102207088|NCT02267057|Acetaminophen|acetaminophen|mesh-list
102207089|NCT02267057|Buprenorphine|buprenorphine|mesh-list
102207090|NCT02267057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102207091|NCT02267057|Analgesics|analgesics|mesh-ancestor
102207092|NCT02267057|Sensory System Agents|sensory system agents|mesh-ancestor
102207093|NCT02267057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102207094|NCT02267057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207095|NCT02267057|Antipyretics|antipyretics|mesh-ancestor
102207096|NCT02267057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102207097|NCT02267057|Narcotics|narcotics|mesh-ancestor
102207098|NCT02267057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102207099|NCT02267057|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102207100|NCT05260541|Pramoxine|pramoxine|mesh-list
102207101|NCT05260541|Anesthetics, Local|anesthetics, local|mesh-ancestor
102207102|NCT05260541|Anesthetics|anesthetics|mesh-ancestor
102207103|NCT05260541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102207104|NCT05260541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915902|NCT04016714|Vaccines|vaccines|mesh-list
102207105|NCT05260541|Sensory System Agents|sensory system agents|mesh-ancestor
102207106|NCT05260541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102207107|NCT01262261|Buprenorphine|buprenorphine|mesh-list
102207108|NCT01262261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102207109|NCT01262261|Narcotics|narcotics|mesh-ancestor
102207110|NCT01262261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102207111|NCT01262261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207112|NCT01262261|Analgesics|analgesics|mesh-ancestor
102207113|NCT01262261|Sensory System Agents|sensory system agents|mesh-ancestor
102207114|NCT01262261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102207115|NCT01262261|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102207116|NCT02267681|Fentanyl|fentanyl|mesh-list
102207117|NCT02267681|Alfentanil|alfentanil|mesh-list
102207118|NCT02267681|Propofol|propofol|mesh-list
102207119|NCT02267681|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102207120|NCT02267681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102207121|NCT02267681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207122|NCT02267681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102207123|NCT02267681|Anesthetics, General|anesthetics, general|mesh-ancestor
102207124|NCT02267681|Anesthetics|anesthetics|mesh-ancestor
102207125|NCT02267681|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102207126|NCT02267681|Narcotics|narcotics|mesh-ancestor
102207127|NCT02267681|Analgesics|analgesics|mesh-ancestor
102207128|NCT02267681|Sensory System Agents|sensory system agents|mesh-ancestor
102207129|NCT02267681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102207130|NCT02267681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102207131|NCT05177939|Methylprednisolone|methylprednisolone|mesh-list
102207132|NCT05177939|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102207133|NCT05177939|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102207134|NCT05177939|Prednisolone|prednisolone|mesh-list
102207135|NCT05177939|Prednisolone acetate|prednisolone acetate|mesh-list
102207136|NCT05177939|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102207137|NCT05177939|Prednisolone phosphate|prednisolone phosphate|mesh-list
102207138|NCT05177939|Immunoglobulins|immunoglobulins|mesh-list
102207139|NCT05177939|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102207140|NCT05177939|gamma-Globulins|gamma-globulins|mesh-list
102207141|NCT05177939|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102207142|NCT05177939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102207143|NCT05177939|Antiemetics|antiemetics|mesh-ancestor
102207144|NCT05177939|Autonomic Agents|autonomic agents|mesh-ancestor
102207145|NCT05177939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102207146|NCT05177939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207147|NCT05177939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102207148|NCT05177939|Glucocorticoids|glucocorticoids|mesh-ancestor
102207149|NCT05177939|Hormones|hormones|mesh-ancestor
102207150|NCT05177939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102207151|NCT05177939|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102207152|NCT05177939|Protective Agents|protective agents|mesh-ancestor
102207153|NCT05177939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102207154|NCT05177939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102207155|NCT05177939|Immunologic Factors|immunologic factors|mesh-ancestor
102207156|NCT05174507|Empagliflozin|empagliflozin|mesh-list
102207157|NCT05174507|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102207158|NCT05174507|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102207159|NCT05174507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207160|NCT05174507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102207161|NCT05174507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207162|NCT05174507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102207163|NCT01480154|Hydroxychloroquine|hydroxychloroquine|mesh-list
102207164|NCT01480154|Antimalarials|antimalarials|mesh-ancestor
102207165|NCT01480154|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102207166|NCT01480154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102207167|NCT01480154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102207168|NCT01480154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102207169|NCT01480154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207170|NCT01480154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102207171|NCT02267915|Rituximab|rituximab|mesh-list
102207172|NCT02267915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102207173|NCT02267915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102207174|NCT02267915|Immunologic Factors|immunologic factors|mesh-ancestor
102207175|NCT02267915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207176|NCT02267915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102207177|NCT02268071|Antihypertensive Agents|antihypertensive agents|mesh-list
102207178|NCT02268149|Prednisone|prednisone|mesh-list
102207179|NCT02268149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102207180|NCT02268149|Glucocorticoids|glucocorticoids|mesh-ancestor
102207181|NCT02268149|Hormones|hormones|mesh-ancestor
102207182|NCT02268149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102207183|NCT02268149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207184|NCT02268149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102207185|NCT02268149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102207186|NCT01258907|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102207187|NCT01258907|Immunologic Factors|immunologic factors|mesh-ancestor
102207188|NCT01258907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207190|NCT01255709|Racepinephrine|racepinephrine|mesh-list
102207191|NCT01255709|Epinephryl borate|epinephryl borate|mesh-list
102207192|NCT01255709|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102207193|NCT01255709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102207194|NCT01255709|Adrenergic Agents|adrenergic agents|mesh-ancestor
102207195|NCT01255709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102207196|NCT01255709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207197|NCT01255709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207198|NCT01255709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102207199|NCT01255709|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102207200|NCT01255709|Autonomic Agents|autonomic agents|mesh-ancestor
102207201|NCT01255709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102207202|NCT01255709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102207203|NCT01255709|Respiratory System Agents|respiratory system agents|mesh-ancestor
102207204|NCT01255709|Mydriatics|mydriatics|mesh-ancestor
102207205|NCT01255709|Sympathomimetics|sympathomimetics|mesh-ancestor
102207206|NCT01255709|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102207207|NCT02233907|Oxitropium|oxitropium|mesh-list
102207208|NCT02233907|Parasympatholytics|parasympatholytics|mesh-ancestor
102207209|NCT02233907|Autonomic Agents|autonomic agents|mesh-ancestor
102207210|NCT02233907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102207211|NCT02233907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207212|NCT01253603|Fluticasone|fluticasone|mesh-list
102207213|NCT01253603|Xhance|xhance|mesh-list
102207214|NCT01253603|Indoleacetic Acids|indoleacetic acids|mesh-list
102207215|NCT01253603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102207216|NCT01253603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102207217|NCT01253603|Autonomic Agents|autonomic agents|mesh-ancestor
102207218|NCT01253603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102207219|NCT01253603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207220|NCT01253603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102207221|NCT01253603|Respiratory System Agents|respiratory system agents|mesh-ancestor
102207222|NCT01253603|Dermatologic Agents|dermatologic agents|mesh-ancestor
102207223|NCT01253603|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102207224|NCT01253603|Plant Growth Regulators|plant growth regulators|mesh-ancestor
102207225|NCT01253603|Growth Substances|growth substances|mesh-ancestor
102207226|NCT02268305|Dimethyl sulfone|dimethyl sulfone|mesh-list
102207227|NCT02268305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102207228|NCT02268383|Luspatercept|luspatercept|mesh-list
102207229|NCT02268383|Hematinics|hematinics|mesh-ancestor
102207230|NCT01329419|Adefovir|adefovir|mesh-list
102207231|NCT01329419|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
102207232|NCT01329419|Antiviral Agents|antiviral agents|mesh-ancestor
102207233|NCT01329419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102207234|NCT01329419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102207235|NCT01329419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102207236|NCT01329419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102207237|NCT01329419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207238|NCT01235039|Insulin|insulin|mesh-list
102207239|NCT01235039|Insulin Lispro|insulin lispro|mesh-list
102207240|NCT01235039|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102207241|NCT01235039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102207242|NCT01235039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207243|NCT01234025|Prednisone|prednisone|mesh-list
102207244|NCT01234025|Docetaxel|docetaxel|mesh-list
102207245|NCT01234025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102207246|NCT01234025|Tubulin Modulators|tubulin modulators|mesh-ancestor
102207247|NCT01234025|Antimitotic Agents|antimitotic agents|mesh-ancestor
102207248|NCT01234025|Mitosis Modulators|mitosis modulators|mesh-ancestor
102207249|NCT01234025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207250|NCT01234025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102207251|NCT01234025|Glucocorticoids|glucocorticoids|mesh-ancestor
102207252|NCT01234025|Hormones|hormones|mesh-ancestor
102207253|NCT01234025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102207254|NCT01234025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207255|NCT01234025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102207256|NCT01221077|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102207257|NCT01221077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916054|NCT03895099|Hormones|hormones|mesh-ancestor
102207258|NCT01221077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102207259|NCT01221077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102207260|NCT01221077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207262|NCT01207115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102207263|NCT01207115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102207264|NCT01207115|Analgesics|analgesics|mesh-ancestor
102207265|NCT01207115|Sensory System Agents|sensory system agents|mesh-ancestor
102207266|NCT01207115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102207267|NCT01207115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207268|NCT01207115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102207269|NCT01207115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102207270|NCT01207115|Gout Suppressants|gout suppressants|mesh-ancestor
102207271|NCT01207115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102207272|NCT01207115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102207273|NCT01207115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207274|NCT01186991|Paclitaxel|paclitaxel|mesh-list
102207275|NCT01186991|Bevacizumab|bevacizumab|mesh-list
102207276|NCT01186991|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102207277|NCT01186991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102207278|NCT01186991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102207279|NCT01186991|Tubulin Modulators|tubulin modulators|mesh-ancestor
102207280|NCT01186991|Antimitotic Agents|antimitotic agents|mesh-ancestor
102207281|NCT01186991|Mitosis Modulators|mitosis modulators|mesh-ancestor
102207282|NCT01186991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207283|NCT01186991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102207284|NCT01186991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102207285|NCT01186991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102207286|NCT01186991|Growth Substances|growth substances|mesh-ancestor
102207287|NCT01186991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207288|NCT01186991|Growth Inhibitors|growth inhibitors|mesh-ancestor
102207289|NCT01186991|Immunologic Factors|immunologic factors|mesh-ancestor
102207290|NCT02268773|Aspirin|aspirin|mesh-list
102207291|NCT02268773|Dipyridamole|dipyridamole|mesh-list
102207292|NCT02268773|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
102207293|NCT02268773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102207294|NCT02268773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102207295|NCT02268773|Analgesics|analgesics|mesh-ancestor
102207296|NCT02268773|Sensory System Agents|sensory system agents|mesh-ancestor
102207297|NCT02268773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102207298|NCT02268773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207299|NCT02268773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102207300|NCT02268773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102207301|NCT02268773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102207302|NCT02268773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102207303|NCT02268773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207304|NCT02268773|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102207305|NCT02268773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102207306|NCT02268773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102207307|NCT02268773|Antipyretics|antipyretics|mesh-ancestor
102207308|NCT02268773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102207309|NCT02268773|Vasodilator Agents|vasodilator agents|mesh-ancestor
102207310|NCT01183949|Bortezomib|bortezomib|mesh-list
102207311|NCT01183949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102207312|NCT01092065|Levodopa|levodopa|mesh-list
102207313|NCT01092065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102207314|NCT01092065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102207315|NCT01092065|Dopamine Agents|dopamine agents|mesh-ancestor
102207316|NCT01092065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102207317|NCT01092065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207318|NCT01092065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207319|NCT05626829|Tranilast|tranilast|mesh-list
102207320|NCT05626829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102207321|NCT05626829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102207322|NCT05626829|Analgesics|analgesics|mesh-ancestor
102207323|NCT05626829|Sensory System Agents|sensory system agents|mesh-ancestor
102207324|NCT05626829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102207325|NCT05626829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207326|NCT05626829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102207327|NCT05626829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102207328|NCT05626829|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102207329|NCT05626829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102207330|NCT05626829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207331|NCT05626829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102207332|NCT05626829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102207333|NCT05626829|Histamine Antagonists|histamine antagonists|mesh-ancestor
102207334|NCT05626829|Histamine Agents|histamine agents|mesh-ancestor
102207335|NCT05626829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102207336|NCT05626829|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102207337|NCT05626829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102207338|NCT01173497|Irinotecan|irinotecan|mesh-list
102207339|NCT01173497|Iniparib|iniparib|mesh-list
102207340|NCT01173497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102207341|NCT01173497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102207342|NCT01173497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102207343|NCT01173497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207344|NCT01173497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102207345|NCT01173497|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102207346|NCT01171313|Carbidopa|carbidopa|mesh-list
102207347|NCT01171313|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102207348|NCT01171313|Levodopa|levodopa|mesh-list
102207349|NCT01171313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102207350|NCT01171313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102207351|NCT01171313|Dopamine Agents|dopamine agents|mesh-ancestor
102207352|NCT01171313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102207353|NCT01171313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207354|NCT01171313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207355|NCT01171313|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102207356|NCT01171313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102207357|NCT01171313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102207358|NCT01171313|Immunologic Factors|immunologic factors|mesh-ancestor
102207359|NCT01171313|Dopamine Agonists|dopamine agonists|mesh-ancestor
102207366|NCT01071239|Cyclophosphamide|cyclophosphamide|mesh-list
102207367|NCT01071239|Busulfan|busulfan|mesh-list
102207368|NCT01071239|Fludarabine|fludarabine|mesh-list
102207369|NCT01071239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102207370|NCT01071239|Immunologic Factors|immunologic factors|mesh-ancestor
102207371|NCT01071239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207372|NCT01071239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102207373|NCT01071239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102207374|NCT01071239|Alkylating Agents|alkylating agents|mesh-ancestor
102207375|NCT01071239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207376|NCT01071239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102207377|NCT01071239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102207378|NCT01156415|Agomelatine|agomelatine|mesh-list
102207379|NCT01156415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102207380|NCT01156415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102207381|NCT01156415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207382|NCT01057667|Ribavirin|ribavirin|mesh-list
102207383|NCT01057667|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102207384|NCT01057667|Antimetabolites|antimetabolites|mesh-ancestor
102207385|NCT01057667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207386|NCT01057667|Antiviral Agents|antiviral agents|mesh-ancestor
102207387|NCT01057667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102207388|NCT01027013|Rebamipide|rebamipide|mesh-list
102207389|NCT01027013|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102207390|NCT01027013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102207391|NCT01027013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102207392|NCT01027013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102207393|NCT01027013|Antioxidants|antioxidants|mesh-ancestor
102207394|NCT01027013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207395|NCT01027013|Protective Agents|protective agents|mesh-ancestor
102207396|NCT01027013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207397|NCT01027013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102207398|NCT04197076|Immunomodulating Agents|immunomodulating agents|mesh-list
102207399|NCT04197076|Immunologic Factors|immunologic factors|mesh-ancestor
102207400|NCT04197076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207401|NCT01138163|Docetaxel|docetaxel|mesh-list
102207402|NCT01138163|Bavituximab|bavituximab|mesh-list
102207403|NCT01138163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102207404|NCT01138163|Tubulin Modulators|tubulin modulators|mesh-ancestor
102207405|NCT01138163|Antimitotic Agents|antimitotic agents|mesh-ancestor
102207406|NCT01138163|Mitosis Modulators|mitosis modulators|mesh-ancestor
101916198|NCT03631706|Pembrolizumab|pembrolizumab|mesh-list
102207407|NCT01138163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749271|NCT00795015|Insulin|insulin|mesh-list
102207408|NCT01138163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102207409|NCT01022801|Entecavir|entecavir|mesh-list
102207410|NCT01022801|Antiviral Agents|antiviral agents|mesh-ancestor
102207411|NCT01022801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102207412|NCT05628467|Antidepressive Agents|antidepressive agents|mesh-list
102207413|NCT05628467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102207414|NCT05628389|Nicotine|nicotine|mesh-list
102207415|NCT05628389|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102207416|NCT05628389|Autonomic Agents|autonomic agents|mesh-ancestor
102207417|NCT05628389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102207418|NCT05628389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207419|NCT05628389|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102207420|NCT05628389|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102207421|NCT05628389|Cholinergic Agents|cholinergic agents|mesh-ancestor
102207422|NCT05628389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102207423|NCT05628389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207424|NCT01128335|Tacrolimus|tacrolimus|mesh-list
102207425|NCT01128335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102207426|NCT01128335|Immunologic Factors|immunologic factors|mesh-ancestor
102207427|NCT01128335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207428|NCT01128335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102207429|NCT01128335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102207430|NCT01128335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207431|NCT01012895|Interferons|interferons|mesh-list
102207432|NCT01012895|Ribavirin|ribavirin|mesh-list
102207433|NCT01012895|Interferon-alpha|interferon-alpha|mesh-list
102207434|NCT01012895|Interferon alpha-2|interferon alpha-2|mesh-list
102207435|NCT01012895|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102207436|NCT01012895|Asunaprevir|asunaprevir|mesh-list
102207437|NCT01012895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102207438|NCT01012895|Antiviral Agents|antiviral agents|mesh-ancestor
102207439|NCT01012895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102207440|NCT01012895|Antimetabolites|antimetabolites|mesh-ancestor
102207441|NCT01012895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207442|NCT01012895|Immunologic Factors|immunologic factors|mesh-ancestor
102207443|NCT01012895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207444|NCT01012895|Protease Inhibitors|protease inhibitors|mesh-ancestor
102207445|NCT01012895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102207446|NCT01009775|Docetaxel|docetaxel|mesh-list
102207447|NCT01009775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102207448|NCT01009775|Tubulin Modulators|tubulin modulators|mesh-ancestor
102207449|NCT01009775|Antimitotic Agents|antimitotic agents|mesh-ancestor
102207450|NCT01009775|Mitosis Modulators|mitosis modulators|mesh-ancestor
102207451|NCT01009775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207452|NCT02319148|Itraconazole|itraconazole|mesh-list
102207453|NCT02319148|Verapamil|verapamil|mesh-list
102207454|NCT02319148|Diltiazem|diltiazem|mesh-list
102207455|NCT02319148|Antifungal Agents|antifungal agents|mesh-ancestor
102207456|NCT02319148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102207457|NCT02319148|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102207458|NCT02319148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102207459|NCT02319148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102207460|NCT02319148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207461|NCT02319148|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102207462|NCT02319148|Hormone Antagonists|hormone antagonists|mesh-ancestor
102207463|NCT02319148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102207464|NCT02319148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207465|NCT02319148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102207466|NCT02319148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102207467|NCT02319148|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102207468|NCT02319148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102207469|NCT02319148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102207470|NCT02319148|Vasodilator Agents|vasodilator agents|mesh-ancestor
102207471|NCT02319148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102207472|NCT02526212|Buprenorphine|buprenorphine|mesh-list
102207473|NCT02526212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102207474|NCT02526212|Narcotics|narcotics|mesh-ancestor
102207475|NCT02526212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102207476|NCT02526212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207477|NCT02526212|Analgesics|analgesics|mesh-ancestor
102207478|NCT02526212|Sensory System Agents|sensory system agents|mesh-ancestor
102207479|NCT02526212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102207480|NCT02526212|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101916276|NCT03578081|Serotonin Agents|serotonin agents|mesh-ancestor
102207481|NCT05627843|Curcumin|curcumin|mesh-list
101749335|NCT00718484|Ifosfamide|ifosfamide|mesh-list
102207482|NCT05627843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102207483|NCT05627843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102207484|NCT05627843|Analgesics|analgesics|mesh-ancestor
102207485|NCT05627843|Sensory System Agents|sensory system agents|mesh-ancestor
102207486|NCT05627843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102207487|NCT05627843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207488|NCT05627843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102207489|NCT05627843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102207490|NCT05627843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102207491|NCT05627843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102207492|NCT05627843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207493|NCT01004081|Exemestane|exemestane|mesh-list
102207494|NCT01004081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102207495|NCT01004081|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102207496|NCT01004081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102207497|NCT01004081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102207498|NCT01004081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207499|NCT01004081|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102207500|NCT01004081|Hormone Antagonists|hormone antagonists|mesh-ancestor
102207501|NCT01004081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102207502|NCT01004081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207503|NCT01113593|Formoterol Fumarate|formoterol fumarate|mesh-list
102207504|NCT01113593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102207505|NCT01113593|Autonomic Agents|autonomic agents|mesh-ancestor
102207506|NCT01113593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102207507|NCT01113593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207508|NCT01113593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102207509|NCT01113593|Respiratory System Agents|respiratory system agents|mesh-ancestor
102207510|NCT01113593|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102207511|NCT01113593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102207512|NCT01113593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102207513|NCT01113593|Adrenergic Agents|adrenergic agents|mesh-ancestor
102207514|NCT01113593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102207515|NCT01113593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207516|NCT04137224|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102207517|NCT04137224|Immunologic Factors|immunologic factors|mesh-ancestor
102207518|NCT04137224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207519|NCT05401214|Prednisone|prednisone|mesh-list
102207520|NCT05401214|Prednisolone|prednisolone|mesh-list
102207521|NCT05401214|Abiraterone Acetate|abiraterone acetate|mesh-list
102207522|NCT05401214|Niraparib|niraparib|mesh-list
102207523|NCT05401214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102207524|NCT05401214|Glucocorticoids|glucocorticoids|mesh-ancestor
102207525|NCT05401214|Hormones|hormones|mesh-ancestor
102207526|NCT05401214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102207527|NCT05401214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207528|NCT05401214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102207529|NCT05401214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102207530|NCT05401214|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102207531|NCT05401214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102207532|NCT05401214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207533|NCT05401214|Hormone Antagonists|hormone antagonists|mesh-ancestor
102207534|NCT05401214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102207535|NCT05401214|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102207536|NCT02532374|Nicotine|nicotine|mesh-list
102207537|NCT02532374|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102207538|NCT02532374|Autonomic Agents|autonomic agents|mesh-ancestor
102207539|NCT02532374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102207540|NCT02532374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207541|NCT02532374|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102207542|NCT02532374|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102207543|NCT02532374|Cholinergic Agents|cholinergic agents|mesh-ancestor
102207544|NCT02532374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102207545|NCT02532374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207546|NCT05398874|Acetaminophen|acetaminophen|mesh-list
102207547|NCT05398874|Diclofenac|diclofenac|mesh-list
102207548|NCT05398874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102207549|NCT05398874|Analgesics|analgesics|mesh-ancestor
102207550|NCT05398874|Sensory System Agents|sensory system agents|mesh-ancestor
102207551|NCT05398874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102207552|NCT05398874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207553|NCT05398874|Antipyretics|antipyretics|mesh-ancestor
102207554|NCT05398874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102207555|NCT05398874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102207556|NCT05398874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102207557|NCT05398874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102207558|NCT05398874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102207559|NCT05398874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207560|NCT01281176|Paclitaxel|paclitaxel|mesh-list
102207561|NCT01281176|Carboplatin|carboplatin|mesh-list
102207562|NCT01281176|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102207563|NCT01281176|Vorinostat|vorinostat|mesh-list
102207564|NCT01281176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102207565|NCT01281176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102207566|NCT01281176|Tubulin Modulators|tubulin modulators|mesh-ancestor
102207567|NCT01281176|Antimitotic Agents|antimitotic agents|mesh-ancestor
102207568|NCT01281176|Mitosis Modulators|mitosis modulators|mesh-ancestor
102207569|NCT01281176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207570|NCT01281176|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102207571|NCT01281176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102207572|NCT02525744|Insulin Lispro|insulin lispro|mesh-list
102207573|NCT02525744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102207574|NCT02525744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207575|NCT05360732|Folfirinox|folfirinox|mesh-list
102207576|NCT05360732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102207577|NCT00152477|Paclitaxel|paclitaxel|mesh-list
102207578|NCT00152477|Carboplatin|carboplatin|mesh-list
102207579|NCT00152477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102207580|NCT00152477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102207581|NCT00152477|Tubulin Modulators|tubulin modulators|mesh-ancestor
102207582|NCT00152477|Antimitotic Agents|antimitotic agents|mesh-ancestor
102207583|NCT00152477|Mitosis Modulators|mitosis modulators|mesh-ancestor
102207584|NCT00152477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207585|NCT01111955|Metformin|metformin|mesh-list
102207586|NCT01111955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102207587|NCT01111955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207588|NCT01106807|Adapalene|adapalene|mesh-list
102207589|NCT01106807|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
102207590|NCT01106807|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102207591|NCT01106807|Dermatologic Agents|dermatologic agents|mesh-ancestor
102207592|NCT01106807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102207593|NCT01106807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102207594|NCT01106807|Analgesics|analgesics|mesh-ancestor
102207595|NCT01106807|Sensory System Agents|sensory system agents|mesh-ancestor
102207596|NCT01106807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102207597|NCT01106807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207598|NCT01106807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102207599|NCT01106807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102207600|NCT05533229|Fentanyl|fentanyl|mesh-list
102207601|NCT05533229|Morphine|morphine|mesh-list
102207602|NCT05533229|Bupivacaine|bupivacaine|mesh-list
102207603|NCT05533229|Anesthetics, Local|anesthetics, local|mesh-ancestor
102207604|NCT05533229|Anesthetics|anesthetics|mesh-ancestor
102207605|NCT05533229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102207606|NCT05533229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207607|NCT05533229|Sensory System Agents|sensory system agents|mesh-ancestor
102207608|NCT05533229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102207609|NCT05533229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102207610|NCT05533229|Narcotics|narcotics|mesh-ancestor
102207611|NCT05533229|Analgesics|analgesics|mesh-ancestor
102207612|NCT05533229|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102207613|NCT05533229|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102207614|NCT05533229|Anesthetics, General|anesthetics, general|mesh-ancestor
102207615|NCT00153179|Acipimox|acipimox|mesh-list
102207616|NCT00153179|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102207617|NCT00153179|Antimetabolites|antimetabolites|mesh-ancestor
102207618|NCT00153179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207619|NCT00153179|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102207620|NCT02743949|Esomeprazole|esomeprazole|mesh-list
102207621|NCT02743949|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102207622|NCT02743949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102207623|NCT02743949|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102207624|NCT02743949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102207625|NCT02743949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207626|NCT02531438|Moxifloxacin|moxifloxacin|mesh-list
101916427|NCT03429244|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102207627|NCT02531438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102207628|NCT02531438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102207629|NCT02531438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102207630|NCT02531438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102207631|NCT02531438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102207632|NCT02531438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207633|NCT02531438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102207634|NCT02289898|Gemcitabine|gemcitabine|mesh-list
102207635|NCT02289898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102207636|NCT02289898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102207637|NCT02289898|Antimetabolites|antimetabolites|mesh-ancestor
102207638|NCT02289898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207639|NCT02289898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102207640|NCT01659554|Cisplatin|cisplatin|mesh-list
102207641|NCT01659554|Doxorubicin|doxorubicin|mesh-list
102207642|NCT01659554|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102207643|NCT01659554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102207644|NCT01659554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102207645|NCT01659554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102207646|NCT01659554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102207647|NCT01659554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102207648|NCT01659554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207649|NCT05355350|Meropenem|meropenem|mesh-list
102207650|NCT05355350|Tazobactam|tazobactam|mesh-list
102207651|NCT05355350|Piperacillin|piperacillin|mesh-list
102207652|NCT05355350|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102207653|NCT05355350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102207654|NCT05355350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102207655|NCT05355350|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102207656|NCT05355350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102207657|NCT05355350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207658|NCT01054196|Lenalidomide|lenalidomide|mesh-list
102207659|NCT01054196|Melphalan|melphalan|mesh-list
102207660|NCT01054196|Immunologic Factors|immunologic factors|mesh-ancestor
102207661|NCT01054196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207662|NCT01054196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102207663|NCT01054196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102207664|NCT01054196|Growth Substances|growth substances|mesh-ancestor
102207665|NCT01054196|Growth Inhibitors|growth inhibitors|mesh-ancestor
102207666|NCT01054196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102207667|NCT01054196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102207668|NCT01054196|Alkylating Agents|alkylating agents|mesh-ancestor
102207669|NCT01054196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207670|NCT01054196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102207671|NCT01054196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102207672|NCT01659320|Minocycline|minocycline|mesh-list
102207673|NCT01659320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102207674|NCT01659320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102207675|NCT05414084|Phenol|phenol|mesh-list
102207676|NCT05414084|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102207677|NCT05414084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102207678|NCT05414084|Disinfectants|disinfectants|mesh-ancestor
102207679|NCT05414084|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102207680|NCT05414084|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102207681|NCT01660334|Voriconazole|voriconazole|mesh-list
102207682|NCT01660334|Antifungal Agents|antifungal agents|mesh-ancestor
102207683|NCT01660334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102207684|NCT01660334|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102207685|NCT01660334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102207686|NCT01660334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102207687|NCT01660334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207688|NCT01660334|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102207689|NCT01660334|Hormone Antagonists|hormone antagonists|mesh-ancestor
102207690|NCT01660334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102207691|NCT01660334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207692|NCT01660334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102207693|NCT01660256|Rebamipide|rebamipide|mesh-list
102207694|NCT01660256|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102207695|NCT01660256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102207696|NCT01660256|Antioxidants|antioxidants|mesh-ancestor
101573990|NCT02199184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102207697|NCT01660256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207698|NCT01660256|Protective Agents|protective agents|mesh-ancestor
102207699|NCT01660256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207700|NCT01660256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102207701|NCT04968938|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
102207703|NCT04968938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207704|NCT04968938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102207705|NCT04968938|Serotonin Agents|serotonin agents|mesh-ancestor
102207706|NCT04968938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102207707|NCT04968938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207708|NCT04968938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102207709|NCT04968938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102207710|NCT04968938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102207711|NCT04968938|Adrenergic Agents|adrenergic agents|mesh-ancestor
102207712|NCT05412758|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
102207713|NCT05412758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207714|NCT02330367|Abivertinib|abivertinib|mesh-list
102207715|NCT02330367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102207716|NCT02330367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102207717|NCT02330367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207718|NCT02318602|Cannabidiol|cannabidiol|mesh-list
102207719|NCT02318602|Anticonvulsants|anticonvulsants|mesh-ancestor
102207720|NCT02330679|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
102207721|NCT02330679|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102207722|NCT02330679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102207723|NCT02330679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102207724|NCT02330679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207725|NCT02330679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102207726|NCT02330679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207727|NCT02330679|Antidepressive Agents|antidepressive agents|mesh-ancestor
102207728|NCT02330679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102207729|NCT05559008|Azacitidine|azacitidine|mesh-list
102207730|NCT05559008|Apatinib|apatinib|mesh-list
102207731|NCT05559008|Dasatinib|dasatinib|mesh-list
102207732|NCT05559008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102207733|NCT05559008|Antimetabolites|antimetabolites|mesh-ancestor
102207734|NCT05559008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207735|NCT05559008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102207736|NCT05559008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102207737|NCT05559008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102207738|NCT02318368|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102207739|NCT02318368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102207740|NCT02318368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102207741|NCT02318368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102207742|NCT02318368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207743|NCT05053425|Cytarabine|cytarabine|mesh-list
102207744|NCT05053425|Azacitidine|azacitidine|mesh-list
102207745|NCT05053425|Venetoclax|venetoclax|mesh-list
102207746|NCT05053425|Idarubicin|idarubicin|mesh-list
102207747|NCT05053425|Cladribine|cladribine|mesh-list
102207748|NCT05053425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102207749|NCT05053425|Antimetabolites|antimetabolites|mesh-ancestor
102207750|NCT05053425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207751|NCT05053425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102207752|NCT05053425|Antiviral Agents|antiviral agents|mesh-ancestor
102207753|NCT05053425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102207754|NCT05053425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102207755|NCT05053425|Immunologic Factors|immunologic factors|mesh-ancestor
102207756|NCT05053425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207757|NCT05053425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102207758|NCT05053425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102207759|NCT05053425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102207760|NCT05053425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102207761|NCT02317510|Anesthetics|anesthetics|mesh-list
102207762|NCT02317510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102207763|NCT02317510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207764|NCT05350124|Vitamins|vitamins|mesh-list
102207765|NCT05350124|Ascorbic Acid|ascorbic acid|mesh-list
102207766|NCT05350124|Vitamin E|vitamin e|mesh-list
102207767|NCT05350124|Tocopherols|tocopherols|mesh-list
102207768|NCT05350124|Micronutrients|micronutrients|mesh-ancestor
102207769|NCT05350124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207771|NCT05350124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207772|NCT05350124|Protective Agents|protective agents|mesh-ancestor
102207773|NCT04925427|Naloxone|naloxone|mesh-list
102207774|NCT04925427|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102207775|NCT04925427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207776|NCT04925427|Sensory System Agents|sensory system agents|mesh-ancestor
102207777|NCT04925427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101916571|NCT03179761|Vaccines|vaccines|mesh-list
102207778|NCT00494234|Olaparib|olaparib|mesh-list
102207779|NCT00494234|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102207780|NCT00494234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102207781|NCT00494234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207782|NCT00494234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102207783|NCT05556746|Rifampin|rifampin|mesh-list
102207784|NCT05556746|Clofazimine|clofazimine|mesh-list
102207785|NCT05556746|Isoniazid|isoniazid|mesh-list
102207786|NCT05556746|Pyrazinamide|pyrazinamide|mesh-list
102207787|NCT05556746|Ethambutol|ethambutol|mesh-list
102207788|NCT05556746|Bedaquiline|bedaquiline|mesh-list
102207789|NCT05556746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102207790|NCT05556746|Antitubercular Agents|antitubercular agents|mesh-ancestor
102207791|NCT05556746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102207792|NCT05556746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102207793|NCT05556746|Leprostatic Agents|leprostatic agents|mesh-ancestor
102207794|NCT05556746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102207795|NCT05556746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102207796|NCT05556746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207797|NCT05556746|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102207798|NCT05556746|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102207799|NCT05556746|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102207800|NCT05556746|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102207801|NCT05556746|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102207802|NCT05556746|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102207803|NCT05556746|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102207804|NCT05556746|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102207805|NCT05556746|Antimetabolites|antimetabolites|mesh-ancestor
102207806|NCT05556746|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102207807|NCT05556746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102207808|NCT05554406|Cytarabine|cytarabine|mesh-list
102207809|NCT05554406|Azacitidine|azacitidine|mesh-list
102207810|NCT05554406|Daunorubicin|daunorubicin|mesh-list
102207811|NCT05554406|Venetoclax|venetoclax|mesh-list
102207812|NCT05554406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102207813|NCT05554406|Antimetabolites|antimetabolites|mesh-ancestor
102207814|NCT05554406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207815|NCT05554406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102207816|NCT05554406|Antiviral Agents|antiviral agents|mesh-ancestor
102207817|NCT05554406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102207818|NCT05554406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102207819|NCT05554406|Immunologic Factors|immunologic factors|mesh-ancestor
102207820|NCT05554406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207821|NCT05554406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102207822|NCT05554406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102207823|NCT05554406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102207824|NCT05554406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102207825|NCT04803591|Tranexamic Acid|tranexamic acid|mesh-list
102207826|NCT04803591|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102207827|NCT04803591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102207828|NCT04803591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207829|NCT04803591|Hemostatics|hemostatics|mesh-ancestor
102207830|NCT04803591|Coagulants|coagulants|mesh-ancestor
102207831|NCT04735263|Atorvastatin|atorvastatin|mesh-list
102207832|NCT04735263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102207833|NCT04735263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102207834|NCT04735263|Antimetabolites|antimetabolites|mesh-ancestor
102207835|NCT04735263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207836|NCT04735263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102207837|NCT04735263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102207838|NCT04735263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102207839|NCT00493298|Natalizumab|natalizumab|mesh-list
102207840|NCT00493298|Immunologic Factors|immunologic factors|mesh-ancestor
102207841|NCT00493298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207842|NCT02329197|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102207843|NCT02329197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102207844|NCT02329197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207845|NCT04662723|Dapagliflozin|dapagliflozin|mesh-list
102207846|NCT04662723|Empagliflozin|empagliflozin|mesh-list
102207847|NCT04662723|Canagliflozin|canagliflozin|mesh-list
102207848|NCT04662723|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102207849|NCT04662723|Methylprednisolone|methylprednisolone|mesh-list
102207850|NCT04662723|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102207851|NCT04662723|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102207852|NCT04662723|Prednisolone|prednisolone|mesh-list
102207853|NCT04662723|Prednisolone acetate|prednisolone acetate|mesh-list
102207855|NCT04662723|Ramipril|ramipril|mesh-list
102207856|NCT04662723|Lisinopril|lisinopril|mesh-list
102207857|NCT04662723|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102207858|NCT04662723|Prednisolone phosphate|prednisolone phosphate|mesh-list
102207859|NCT04662723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102207860|NCT04662723|Antiemetics|antiemetics|mesh-ancestor
102207861|NCT04662723|Autonomic Agents|autonomic agents|mesh-ancestor
102207862|NCT04662723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102207863|NCT04662723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207864|NCT04662723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102207865|NCT04662723|Glucocorticoids|glucocorticoids|mesh-ancestor
102207866|NCT04662723|Hormones|hormones|mesh-ancestor
102207867|NCT04662723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102207868|NCT04662723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102207869|NCT04662723|Protective Agents|protective agents|mesh-ancestor
102207870|NCT04662723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102207871|NCT04662723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102207872|NCT04662723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207873|NCT04662723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102207874|NCT04662723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102207875|NCT04662723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102207876|NCT04662723|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102207877|NCT04662723|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102207878|NCT04662723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102207879|NCT04662723|Protease Inhibitors|protease inhibitors|mesh-ancestor
102207880|NCT04662723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102207881|NCT04662723|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102207882|NCT05307926|Lenvatinib|lenvatinib|mesh-list
102207883|NCT05307926|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102207884|NCT05307926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102207885|NCT05307926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102207886|NCT05307926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102207887|NCT05307926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207888|NCT05307926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102207889|NCT04026945|Lidocaine|lidocaine|mesh-list
102207890|NCT04026945|Anesthetics, Local|anesthetics, local|mesh-ancestor
102207891|NCT04026945|Anesthetics|anesthetics|mesh-ancestor
102207892|NCT04026945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102207893|NCT04026945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207894|NCT04026945|Sensory System Agents|sensory system agents|mesh-ancestor
102207895|NCT04026945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102207896|NCT04026945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102207897|NCT04026945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102207898|NCT04026945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102207899|NCT04026945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102207900|NCT04026945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207901|NCT02328729|Epinephrine|epinephrine|mesh-list
102207902|NCT02328729|Racepinephrine|racepinephrine|mesh-list
102207903|NCT02328729|Epinephryl borate|epinephryl borate|mesh-list
102207904|NCT02328729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102207905|NCT02328729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102207906|NCT02328729|Adrenergic Agents|adrenergic agents|mesh-ancestor
102207907|NCT02328729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102207908|NCT02328729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207909|NCT02328729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207910|NCT02328729|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102207911|NCT02328729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102207912|NCT02328729|Autonomic Agents|autonomic agents|mesh-ancestor
102207913|NCT02328729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102207914|NCT02328729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102207915|NCT02328729|Respiratory System Agents|respiratory system agents|mesh-ancestor
102207916|NCT02328729|Mydriatics|mydriatics|mesh-ancestor
102207917|NCT02328729|Sympathomimetics|sympathomimetics|mesh-ancestor
102207918|NCT02328729|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102207919|NCT02328963|Mycophenolic Acid|mycophenolic acid|mesh-list
102207921|NCT02328963|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102207922|NCT02328963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102207923|NCT02328963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102207924|NCT02328963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207925|NCT02328963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102207926|NCT02328963|Immunologic Factors|immunologic factors|mesh-ancestor
102207927|NCT02328963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207929|NCT02328963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102207930|NCT02328963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102207931|NCT02328963|Antitubercular Agents|antitubercular agents|mesh-ancestor
102207932|NCT02328963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102207933|NCT02328963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102207934|NCT03353259|Tranexamic Acid|tranexamic acid|mesh-list
102207935|NCT03353259|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102207936|NCT03353259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102207937|NCT03353259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207938|NCT03353259|Hemostatics|hemostatics|mesh-ancestor
102207939|NCT03353259|Coagulants|coagulants|mesh-ancestor
102207940|NCT02328651|Ribavirin|ribavirin|mesh-list
102207941|NCT02328651|Antimetabolites|antimetabolites|mesh-ancestor
102207942|NCT02328651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207943|NCT02328651|Antiviral Agents|antiviral agents|mesh-ancestor
102207944|NCT02328651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102207945|NCT02289352|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102207946|NCT02289352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102207947|NCT02289352|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102207948|NCT02289352|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102207949|NCT02289352|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102207950|NCT02289352|Adrenergic Agents|adrenergic agents|mesh-ancestor
102207951|NCT02289352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102207952|NCT02289352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207953|NCT02289352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207954|NCT05337566|Azithromycin|azithromycin|mesh-list
102207955|NCT05337566|Cefuroxime|cefuroxime|mesh-list
102207956|NCT05337566|Cefuroxime axetil|cefuroxime axetil|mesh-list
102207957|NCT05337566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102207958|NCT05337566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102207959|NCT02328495|Misoprostol|misoprostol|mesh-list
102207960|NCT02328495|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102207961|NCT02328495|Abortifacient Agents|abortifacient agents|mesh-ancestor
102207962|NCT02328495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102207963|NCT02328495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207964|NCT02328495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102207965|NCT02328495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102207966|NCT02328495|Oxytocics|oxytocics|mesh-ancestor
102207967|NCT02287402|Voglibose|voglibose|mesh-list
102207968|NCT02287402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102207969|NCT02287402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207970|NCT02287402|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102207971|NCT02287402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102207972|NCT02287402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207973|NCT02913495|Progesterone|progesterone|mesh-list
102207974|NCT02913495|Progestins|progestins|mesh-ancestor
102207975|NCT02913495|Hormones|hormones|mesh-ancestor
102207976|NCT02913495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102207977|NCT02913495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207978|NCT03111069|Doxorubicin|doxorubicin|mesh-list
102207979|NCT03111069|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102207980|NCT03111069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102207981|NCT03111069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102207982|NCT03111069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102207983|NCT03111069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102207984|NCT03111069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102207985|NCT03111069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207986|NCT03110757|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102207987|NCT03110757|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102207988|NCT03110757|Immunologic Factors|immunologic factors|mesh-ancestor
102207989|NCT03110757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207990|NCT03110757|Antacids|antacids|mesh-ancestor
102207991|NCT03110757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102207992|NCT03110757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102207993|NCT05080569|Progesterone|progesterone|mesh-list
102207994|NCT05080569|Progestins|progestins|mesh-ancestor
102207995|NCT05080569|Hormones|hormones|mesh-ancestor
102207996|NCT05080569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102207997|NCT05080569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102207998|NCT03145467|Acetaminophen|acetaminophen|mesh-list
102207999|NCT03145467|Zolmitriptan|zolmitriptan|mesh-list
102208000|NCT03145467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102208001|NCT03145467|Analgesics|analgesics|mesh-ancestor
102208002|NCT03145467|Sensory System Agents|sensory system agents|mesh-ancestor
102208003|NCT03145467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102208004|NCT03145467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208005|NCT03145467|Antipyretics|antipyretics|mesh-ancestor
102208006|NCT03145467|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102208007|NCT03145467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102208008|NCT03145467|Serotonin Agents|serotonin agents|mesh-ancestor
102208009|NCT03145467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102208010|NCT03145467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208011|NCT05302856|Antibodies|antibodies|mesh-list
102208012|NCT05302856|Testosterone|testosterone|mesh-list
102208013|NCT05302856|Immunologic Factors|immunologic factors|mesh-ancestor
102208014|NCT05302856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208015|NCT05302856|Androgens|androgens|mesh-ancestor
102208016|NCT05302856|Hormones|hormones|mesh-ancestor
102208017|NCT05302856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102208018|NCT02328183|Polymyxins|polymyxins|mesh-list
102208019|NCT02328183|Polymyxin B|polymyxin b|mesh-list
102208020|NCT02328183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102208021|NCT02328183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102208022|NCT05610488|Faricimab|faricimab|mesh-list
102208023|NCT05610488|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102208024|NCT05610488|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102208025|NCT05610488|Growth Substances|growth substances|mesh-ancestor
102208026|NCT05610488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208027|NCT05610488|Growth Inhibitors|growth inhibitors|mesh-ancestor
102208028|NCT05610488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102208029|NCT01646398|Vaccines|vaccines|mesh-list
102208030|NCT01646398|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102208031|NCT01646398|Immunologic Factors|immunologic factors|mesh-ancestor
102208032|NCT01646398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208033|NCT05382104|Maribavir|maribavir|mesh-list
102208034|NCT05382104|Antiviral Agents|antiviral agents|mesh-ancestor
102208035|NCT05382104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102208036|NCT01646320|Metformin|metformin|mesh-list
102208037|NCT01646320|Dapagliflozin|dapagliflozin|mesh-list
102208038|NCT01646320|Saxagliptin|saxagliptin|mesh-list
102208039|NCT01646320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102208040|NCT01646320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208041|NCT01646320|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102208042|NCT01646320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208043|NCT01646320|Incretins|incretins|mesh-ancestor
102208044|NCT01646320|Hormones|hormones|mesh-ancestor
101451112|NCT00224679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102208045|NCT01646320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102208046|NCT01646320|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102208047|NCT01646320|Protease Inhibitors|protease inhibitors|mesh-ancestor
102208048|NCT01646320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102208049|NCT03141645|Ondansetron|ondansetron|mesh-list
102208050|NCT03141645|Antiemetics|antiemetics|mesh-ancestor
102208051|NCT03141645|Autonomic Agents|autonomic agents|mesh-ancestor
102208052|NCT03141645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102208053|NCT03141645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208054|NCT03141645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102208055|NCT03141645|Antipruritics|antipruritics|mesh-ancestor
102208056|NCT03141645|Dermatologic Agents|dermatologic agents|mesh-ancestor
102208057|NCT03141645|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102208058|NCT03141645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102208059|NCT03141645|Serotonin Agents|serotonin agents|mesh-ancestor
102208060|NCT03141645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102208061|NCT03141645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208062|NCT05327426|Vaccines|vaccines|mesh-list
102208063|NCT05327426|Immunologic Factors|immunologic factors|mesh-ancestor
102208064|NCT05327426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208065|NCT05327270|Nivolumab|nivolumab|mesh-list
102208066|NCT05327270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102208067|NCT05327270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102208068|NCT05327270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102208069|NCT05327270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208070|NCT05297396|Analgesics, Opioid|analgesics, opioid|mesh-list
102208071|NCT05297396|Narcotics|narcotics|mesh-ancestor
102208072|NCT05297396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102208073|NCT05297396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208074|NCT05297396|Analgesics|analgesics|mesh-ancestor
102208075|NCT05297396|Sensory System Agents|sensory system agents|mesh-ancestor
102208076|NCT05297396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102208077|NCT01658150|Isradipine|isradipine|mesh-list
102208078|NCT01658150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102208079|NCT01658150|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102208080|NCT01658150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102208081|NCT01658150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208082|NCT01658150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102208083|NCT01658150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208084|NCT01658150|Vasodilator Agents|vasodilator agents|mesh-ancestor
102208085|NCT02285998|Vaccines|vaccines|mesh-list
102208086|NCT02285998|Immunologic Factors|immunologic factors|mesh-ancestor
102208087|NCT02285998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208088|NCT02285920|Spironolactone|spironolactone|mesh-list
102208089|NCT02285920|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102208090|NCT02285920|Hormone Antagonists|hormone antagonists|mesh-ancestor
102208091|NCT02285920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102208092|NCT02285920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208093|NCT02285920|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102208094|NCT02285920|Diuretics|diuretics|mesh-ancestor
102208095|NCT02285920|Natriuretic Agents|natriuretic agents|mesh-ancestor
102208096|NCT05292872|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
102208097|NCT05292872|Cathartics|cathartics|mesh-ancestor
102208098|NCT05292872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102208099|NCT02035137|Irinotecan|irinotecan|mesh-list
102208100|NCT02035137|Vincristine|vincristine|mesh-list
102208101|NCT02035137|Vorinostat|vorinostat|mesh-list
102208102|NCT02035137|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
102208103|NCT02035137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102208104|NCT02035137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102208105|NCT02035137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102208106|NCT02035137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208107|NCT02035137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102208108|NCT02035137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102208109|NCT02035137|Tubulin Modulators|tubulin modulators|mesh-ancestor
102208110|NCT02035137|Antimitotic Agents|antimitotic agents|mesh-ancestor
102208111|NCT02035137|Mitosis Modulators|mitosis modulators|mesh-ancestor
102208112|NCT02035137|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102208113|NCT02035137|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102208114|NCT05321810|Warfarin|warfarin|mesh-list
102208115|NCT05321810|Apixaban|apixaban|mesh-list
102208116|NCT05321810|Anticoagulants|anticoagulants|mesh-ancestor
102208117|NCT05321810|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102208118|NCT05321810|Antithrombins|antithrombins|mesh-ancestor
102208119|NCT05321810|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102208120|NCT05321810|Protease Inhibitors|protease inhibitors|mesh-ancestor
102208121|NCT05321810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102208122|NCT05321810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208123|NCT05264870|Norepinephrine|norepinephrine|mesh-list
102208124|NCT05264870|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102208125|NCT05264870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102208126|NCT05264870|Adrenergic Agents|adrenergic agents|mesh-ancestor
102208127|NCT05264870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102208128|NCT05264870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208129|NCT05264870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208130|NCT05264870|Sympathomimetics|sympathomimetics|mesh-ancestor
102208131|NCT05264870|Autonomic Agents|autonomic agents|mesh-ancestor
102208132|NCT05264870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102208133|NCT05264870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102208134|NCT04249232|Abaloparatide|abaloparatide|mesh-list
102208135|NCT04249232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102208136|NCT04249232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208137|NCT05079087|Midazolam|midazolam|mesh-list
102208138|NCT05079087|Ketamine|ketamine|mesh-list
102208139|NCT05079087|Analgesics|analgesics|mesh-ancestor
102208140|NCT05079087|Sensory System Agents|sensory system agents|mesh-ancestor
102208141|NCT05079087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102208142|NCT05079087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208143|NCT05079087|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102208144|NCT05079087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102208145|NCT05079087|Anesthetics, General|anesthetics, general|mesh-ancestor
102208146|NCT05079087|Anesthetics|anesthetics|mesh-ancestor
102208147|NCT05079087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102208148|NCT05079087|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102208149|NCT05079087|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102208150|NCT05079087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102208151|NCT05079087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208152|NCT05079087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101916953|NCT02403323|Etrolizumab|etrolizumab|mesh-list
102208153|NCT05079087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102208154|NCT05079087|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102208155|NCT05079087|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102208156|NCT05079087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102208157|NCT05079087|GABA Modulators|gaba modulators|mesh-ancestor
102208158|NCT05079087|GABA Agents|gaba agents|mesh-ancestor
102208159|NCT02522780|Mesalamine|mesalamine|mesh-list
102208160|NCT02522780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102208161|NCT02522780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102208162|NCT02522780|Analgesics|analgesics|mesh-ancestor
102208163|NCT02522780|Sensory System Agents|sensory system agents|mesh-ancestor
102208164|NCT02522780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102208165|NCT02522780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208166|NCT02522780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102208167|NCT02522780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102208168|NCT03618225|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102208169|NCT03618225|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102208170|NCT03618225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102208171|NCT03618225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102208172|NCT03618225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208173|NCT03618225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102208174|NCT03618225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208175|NCT03618225|Analgesics|analgesics|mesh-ancestor
102208176|NCT03618225|Sensory System Agents|sensory system agents|mesh-ancestor
102208177|NCT03618225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102208178|NCT03618225|Antidepressive Agents|antidepressive agents|mesh-ancestor
102208179|NCT03618225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102208180|NCT03618225|Dopamine Agents|dopamine agents|mesh-ancestor
102208181|NCT03566199|Panobinostat|panobinostat|mesh-list
102208182|NCT03566199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102208183|NCT03566199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102208184|NCT03566199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102208185|NCT03566199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208186|NCT03561831|Propofol|propofol|mesh-list
102208187|NCT03561831|Sevoflurane|sevoflurane|mesh-list
102208188|NCT03561831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102208189|NCT03561831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102208190|NCT03561831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208191|NCT03561831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102208192|NCT03561831|Anesthetics, General|anesthetics, general|mesh-ancestor
102208193|NCT03561831|Anesthetics|anesthetics|mesh-ancestor
102208194|NCT03561831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102208195|NCT03561831|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102208196|NCT03144843|Apatinib|apatinib|mesh-list
102208197|NCT03144843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102208198|NCT03144843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102208199|NCT03144843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102208200|NCT03144843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208201|NCT05288348|Sufentanil|sufentanil|mesh-list
102208202|NCT05288348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102208203|NCT05288348|Narcotics|narcotics|mesh-ancestor
102208204|NCT05288348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102208205|NCT05288348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208206|NCT05288348|Analgesics|analgesics|mesh-ancestor
102208207|NCT05288348|Sensory System Agents|sensory system agents|mesh-ancestor
102208208|NCT05288348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102208209|NCT05288348|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102208210|NCT05288348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102208211|NCT05288348|Anesthetics, General|anesthetics, general|mesh-ancestor
102208212|NCT05288348|Anesthetics|anesthetics|mesh-ancestor
102208213|NCT03111615|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102208214|NCT03111615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102208215|NCT03111615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102208216|NCT03111615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208217|NCT03111615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102208218|NCT03111615|Hormone Antagonists|hormone antagonists|mesh-ancestor
102208219|NCT03111615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102208220|NCT03111615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208221|NCT03199755|Lumefantrine|lumefantrine|mesh-list
102208222|NCT03199755|Artemether|artemether|mesh-list
102208223|NCT03199755|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102208224|NCT03199755|Antimalarials|antimalarials|mesh-ancestor
102208225|NCT03199755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101917029|NCT02312245|Antimitotic Agents|antimitotic agents|mesh-ancestor
102208226|NCT03199755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102208227|NCT03199755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102208229|NCT05318066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102208230|NCT05318066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102208231|NCT05318066|Adrenergic Agents|adrenergic agents|mesh-ancestor
102208232|NCT05318066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102208233|NCT05318066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208234|NCT05318066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208235|NCT05318066|Sympathomimetics|sympathomimetics|mesh-ancestor
102208236|NCT05318066|Autonomic Agents|autonomic agents|mesh-ancestor
102208237|NCT05318066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102208238|NCT05318066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102208239|NCT02327793|Labetalol|labetalol|mesh-list
102208240|NCT02327793|Nitroglycerin|nitroglycerin|mesh-list
102208241|NCT02327793|Vasodilator Agents|vasodilator agents|mesh-ancestor
102208242|NCT02327793|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102208243|NCT02327793|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102208244|NCT02327793|Adrenergic Agents|adrenergic agents|mesh-ancestor
102208245|NCT02327793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102208246|NCT02327793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208247|NCT02327793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208248|NCT02327793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102208249|NCT02327793|Sympathomimetics|sympathomimetics|mesh-ancestor
101451175|NCT00413127|Lidocaine|lidocaine|mesh-list
102208250|NCT02327793|Autonomic Agents|autonomic agents|mesh-ancestor
102208251|NCT02327793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102208252|NCT02327793|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102208253|NCT02327793|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102208254|NCT02327715|Emtricitabine|emtricitabine|mesh-list
102208255|NCT02327715|Antiviral Agents|antiviral agents|mesh-ancestor
102208256|NCT02327715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102208257|NCT02327715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102208258|NCT02327715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102208259|NCT02327715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102208260|NCT02327715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208261|NCT02327715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102208262|NCT02327715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102208263|NCT02951013|Chrysarobin|chrysarobin|mesh-list
102208264|NCT02951013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102208265|NCT02951013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102208266|NCT02951013|Analgesics|analgesics|mesh-ancestor
102208267|NCT02951013|Sensory System Agents|sensory system agents|mesh-ancestor
102208268|NCT02951013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102208269|NCT02951013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208270|NCT02951013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102208271|NCT02951013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102208272|NCT05080803|Bevacizumab|bevacizumab|mesh-list
102208273|NCT05080803|Ranibizumab|ranibizumab|mesh-list
102208274|NCT05080803|Aflibercept|aflibercept|mesh-list
102208275|NCT05080803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102208276|NCT05080803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102208277|NCT05080803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102208278|NCT05080803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102208279|NCT05080803|Growth Substances|growth substances|mesh-ancestor
102208280|NCT05080803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208281|NCT05080803|Growth Inhibitors|growth inhibitors|mesh-ancestor
102208282|NCT02285062|Prednisone|prednisone|mesh-list
102208283|NCT02285062|Cyclophosphamide|cyclophosphamide|mesh-list
102208284|NCT02285062|Rituximab|rituximab|mesh-list
102208285|NCT02285062|Doxorubicin|doxorubicin|mesh-list
102208286|NCT02285062|Vincristine|vincristine|mesh-list
102208287|NCT02285062|Lenalidomide|lenalidomide|mesh-list
102208288|NCT02285062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102208289|NCT02285062|Immunologic Factors|immunologic factors|mesh-ancestor
102208290|NCT02285062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208291|NCT02285062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102208292|NCT02285062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102208293|NCT02285062|Alkylating Agents|alkylating agents|mesh-ancestor
102208294|NCT02285062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208295|NCT02285062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102208296|NCT02285062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102208297|NCT02285062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102208298|NCT02285062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102208299|NCT02285062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102208300|NCT02285062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102208301|NCT02285062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102208302|NCT02285062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102208303|NCT02285062|Glucocorticoids|glucocorticoids|mesh-ancestor
102208304|NCT02285062|Hormones|hormones|mesh-ancestor
102208305|NCT02285062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102208306|NCT02285062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102208307|NCT02285062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102208308|NCT02285062|Tubulin Modulators|tubulin modulators|mesh-ancestor
102208309|NCT02285062|Antimitotic Agents|antimitotic agents|mesh-ancestor
102208310|NCT02285062|Mitosis Modulators|mitosis modulators|mesh-ancestor
102208311|NCT02285062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102208312|NCT02285062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102208313|NCT02285062|Growth Substances|growth substances|mesh-ancestor
102208314|NCT02285062|Growth Inhibitors|growth inhibitors|mesh-ancestor
102208315|NCT02431767|Interleukin-12|interleukin-12|mesh-list
102208316|NCT02431767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102208317|NCT02431767|Immunologic Factors|immunologic factors|mesh-ancestor
102208318|NCT02431767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208319|NCT02431767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101451180|NCT00413127|Sensory System Agents|sensory system agents|mesh-ancestor
102208320|NCT02431767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102208321|NCT02431767|Growth Substances|growth substances|mesh-ancestor
102208322|NCT02431767|Growth Inhibitors|growth inhibitors|mesh-ancestor
102208323|NCT02431767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102208324|NCT05313620|Adalimumab|adalimumab|mesh-list
102208325|NCT05313620|Infliximab|infliximab|mesh-list
102208326|NCT05313620|Golimumab|golimumab|mesh-list
102208327|NCT05313620|Tofacitinib|tofacitinib|mesh-list
102208328|NCT05313620|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102208329|NCT05313620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102208330|NCT05313620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102208331|NCT05313620|Dermatologic Agents|dermatologic agents|mesh-ancestor
102208332|NCT05313620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102208333|NCT05313620|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102208334|NCT05313620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102208335|NCT05313620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102208336|NCT05313620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208337|NCT05313620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102208338|NCT05313620|Immunologic Factors|immunologic factors|mesh-ancestor
102208339|NCT05313620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208340|NCT04571697|Methotrexate|methotrexate|mesh-list
102208341|NCT04571697|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102208342|NCT04571697|Abortifacient Agents|abortifacient agents|mesh-ancestor
102208343|NCT04571697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102208344|NCT04571697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208345|NCT04571697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102208346|NCT04571697|Antimetabolites|antimetabolites|mesh-ancestor
102208347|NCT04571697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208348|NCT04571697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102208349|NCT04571697|Dermatologic Agents|dermatologic agents|mesh-ancestor
102208350|NCT04571697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102208351|NCT04571697|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102208352|NCT04571697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102208353|NCT04571697|Immunologic Factors|immunologic factors|mesh-ancestor
102208354|NCT04571697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102208355|NCT04571697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102208356|NCT05482334|Molgramostim|molgramostim|mesh-list
102208357|NCT05482334|Sargramostim|sargramostim|mesh-list
102208358|NCT05482334|Immunologic Factors|immunologic factors|mesh-ancestor
102208359|NCT05482334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208360|NCT05482334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102208361|NCT05253794|Colchicine|colchicine|mesh-list
102208363|NCT05253794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102208364|NCT05253794|Tubulin Modulators|tubulin modulators|mesh-ancestor
102208365|NCT05253794|Antimitotic Agents|antimitotic agents|mesh-ancestor
102208366|NCT05253794|Mitosis Modulators|mitosis modulators|mesh-ancestor
102208367|NCT05253794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208368|NCT05253794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102208369|NCT03140943|Thalidomide|thalidomide|mesh-list
102208370|NCT03140943|Dexamethasone|dexamethasone|mesh-list
102208371|NCT03140943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102208372|NCT03140943|Antiemetics|antiemetics|mesh-ancestor
102208373|NCT03140943|Autonomic Agents|autonomic agents|mesh-ancestor
102208374|NCT03140943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102208375|NCT03140943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208376|NCT03140943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102208377|NCT03140943|Glucocorticoids|glucocorticoids|mesh-ancestor
102208378|NCT03140943|Hormones|hormones|mesh-ancestor
102208393|NCT02038257|Dermatologic Agents|dermatologic agents|mesh-ancestor
102208395|NCT05311436|Folic Acid|folic acid|mesh-list
102208396|NCT05311436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208397|NCT05311436|Trace Elements|trace elements|mesh-ancestor
102208398|NCT05311436|Micronutrients|micronutrients|mesh-ancestor
102208399|NCT05311436|Hematinics|hematinics|mesh-ancestor
102208400|NCT05311436|Vitamin B Complex|vitamin b complex|mesh-ancestor
102208401|NCT05311436|Vitamins|vitamins|mesh-ancestor
102208402|NCT05199753|Antibodies|antibodies|mesh-list
102208403|NCT05199753|Immunologic Factors|immunologic factors|mesh-ancestor
102208404|NCT05199753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208405|NCT01352741|Pregabalin|pregabalin|mesh-list
102208406|NCT01352741|Tapentadol|tapentadol|mesh-list
102208407|NCT01352741|Analgesics|analgesics|mesh-ancestor
102208408|NCT01352741|Sensory System Agents|sensory system agents|mesh-ancestor
102208409|NCT01352741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102208410|NCT01352741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208411|NCT01352741|Anticonvulsants|anticonvulsants|mesh-ancestor
102208412|NCT01352741|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102208413|NCT01352741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102208414|NCT01352741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208415|NCT01352741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102208416|NCT01352741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102208417|NCT01352741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102208418|NCT01352741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102208419|NCT01352741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102208420|NCT01352741|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102208421|NCT01352741|Narcotics|narcotics|mesh-ancestor
102208422|NCT01352741|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102208423|NCT01352741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102208424|NCT01352741|Adrenergic Agents|adrenergic agents|mesh-ancestor
102208425|NCT01352741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102208441|NCT03973593|Contraceptive Agents|contraceptive agents|mesh-list
102208442|NCT03973593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102208443|NCT03973593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208444|NCT00911963|Ribavirin|ribavirin|mesh-list
102208445|NCT00911963|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102208446|NCT00911963|Antimetabolites|antimetabolites|mesh-ancestor
102208447|NCT00911963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208448|NCT00911963|Antiviral Agents|antiviral agents|mesh-ancestor
102208449|NCT00911963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102208450|NCT01657292|Octenidine|octenidine|mesh-list
102208451|NCT01657292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102208452|NCT01657292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102208453|NCT04167033|Hormones|hormones|mesh-list
101917257|NCT01489813|Phytoestrogens|phytoestrogens|mesh-ancestor
102208454|NCT04167033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102208455|NCT04167033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208456|NCT00907907|Mycophenolic Acid|mycophenolic acid|mesh-list
102208457|NCT00907907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102208458|NCT00907907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102208459|NCT00907907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102208460|NCT00907907|Antitubercular Agents|antitubercular agents|mesh-ancestor
102208461|NCT00907907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102208462|NCT00907907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102208463|NCT00907907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102208464|NCT00907907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208465|NCT03140553|Cyclophosphamide|cyclophosphamide|mesh-list
102208466|NCT03140553|Carboplatin|carboplatin|mesh-list
102208467|NCT03140553|Docetaxel|docetaxel|mesh-list
102208468|NCT03140553|Trastuzumab|trastuzumab|mesh-list
102208469|NCT03140553|Epirubicin|epirubicin|mesh-list
102208470|NCT03140553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102208471|NCT03140553|Immunologic Factors|immunologic factors|mesh-ancestor
102208472|NCT03140553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208473|NCT03140553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102208474|NCT03140553|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102208475|NCT03140553|Alkylating Agents|alkylating agents|mesh-ancestor
102208476|NCT03140553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208477|NCT03140553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102208478|NCT03140553|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102208479|NCT03140553|Tubulin Modulators|tubulin modulators|mesh-ancestor
102208480|NCT03140553|Antimitotic Agents|antimitotic agents|mesh-ancestor
102208481|NCT03140553|Mitosis Modulators|mitosis modulators|mesh-ancestor
102208482|NCT03140553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102208483|NCT03140553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102208484|NCT03140553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102208485|NCT03140553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102208486|NCT03140553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102208487|NCT00905567|Topiramate|topiramate|mesh-list
102208488|NCT00905567|Anticonvulsants|anticonvulsants|mesh-ancestor
102208489|NCT00905567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102208490|NCT00905567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208491|NCT05277896|Ketamine|ketamine|mesh-list
102208492|NCT05277896|Etomidate|etomidate|mesh-list
102208493|NCT05277896|Analgesics|analgesics|mesh-ancestor
102208494|NCT05277896|Sensory System Agents|sensory system agents|mesh-ancestor
102208495|NCT05277896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102208496|NCT05277896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208497|NCT05277896|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102208498|NCT05277896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102208499|NCT05277896|Anesthetics, General|anesthetics, general|mesh-ancestor
102208500|NCT05277896|Anesthetics|anesthetics|mesh-ancestor
102208501|NCT05277896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102208502|NCT05277896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102208503|NCT05277896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102208504|NCT05277896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102208505|NCT05277896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208506|NCT05277896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102208507|NCT02282020|Olaparib|olaparib|mesh-list
102208508|NCT02282020|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102208509|NCT02282020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102208510|NCT02282020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208511|NCT02282020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102208512|NCT05249972|Calcitriol|calcitriol|mesh-list
102208513|NCT05249972|Betamethasone|betamethasone|mesh-list
102208514|NCT05249972|Betamethasone Valerate|betamethasone valerate|mesh-list
102208515|NCT05249972|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102208516|NCT05249972|Betamethasone benzoate|betamethasone benzoate|mesh-list
102208517|NCT05249972|Calcipotriene|calcipotriene|mesh-list
102208518|NCT05249972|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102208519|NCT05249972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102208520|NCT05249972|Glucocorticoids|glucocorticoids|mesh-ancestor
102208521|NCT05249972|Hormones|hormones|mesh-ancestor
102208522|NCT05249972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102208523|NCT05249972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208524|NCT05249972|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102208525|NCT05249972|Respiratory System Agents|respiratory system agents|mesh-ancestor
102208526|NCT05249972|Dermatologic Agents|dermatologic agents|mesh-ancestor
102208527|NCT05249972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102208528|NCT05249972|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102208529|NCT05249972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102208530|NCT05249972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208531|NCT05249972|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102208532|NCT05249972|Vitamins|vitamins|mesh-ancestor
102208533|NCT05249972|Micronutrients|micronutrients|mesh-ancestor
102208534|NCT05249972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102208535|NCT00904943|Topiramate|topiramate|mesh-list
102208536|NCT00904943|Anticonvulsants|anticonvulsants|mesh-ancestor
102208537|NCT00904943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102208538|NCT00904943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208539|NCT00902291|Gemcitabine|gemcitabine|mesh-list
102208540|NCT00902291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102208541|NCT00902291|Antimetabolites|antimetabolites|mesh-ancestor
102208542|NCT00902291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208543|NCT00902291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102208544|NCT05217680|Bevacizumab|bevacizumab|mesh-list
102208545|NCT05217680|Ranibizumab|ranibizumab|mesh-list
102208546|NCT05217680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102208547|NCT05217680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102208548|NCT05217680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102208549|NCT05217680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102208550|NCT05217680|Growth Substances|growth substances|mesh-ancestor
102208551|NCT05217680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208552|NCT05217680|Growth Inhibitors|growth inhibitors|mesh-ancestor
102208553|NCT02281552|Tofacitinib|tofacitinib|mesh-list
102208554|NCT02281552|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102208555|NCT02281552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102208556|NCT02281552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102208557|NCT02281552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208558|NCT03832647|Salicylic Acid|salicylic acid|mesh-list
102208559|NCT03832647|Salicylates|salicylates|mesh-list
102208560|NCT03832647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102208561|NCT03832647|Antifungal Agents|antifungal agents|mesh-ancestor
102208562|NCT03832647|Keratolytic Agents|keratolytic agents|mesh-ancestor
102208563|NCT03832647|Dermatologic Agents|dermatologic agents|mesh-ancestor
101451193|NCT00207363|Interferons|interferons|mesh-list
102208564|NCT03832647|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102208565|NCT03832647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102208566|NCT03832647|Analgesics|analgesics|mesh-ancestor
102208567|NCT03832647|Sensory System Agents|sensory system agents|mesh-ancestor
102208568|NCT03832647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102208569|NCT03832647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208570|NCT03832647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102208571|NCT03832647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102208572|NCT03832647|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102208573|NCT03832647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102208574|NCT03832647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208575|NCT00901979|Metformin|metformin|mesh-list
102208576|NCT00901979|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102208577|NCT00901979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102208578|NCT00901979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208579|NCT00901979|Incretins|incretins|mesh-ancestor
102208580|NCT00901979|Hormones|hormones|mesh-ancestor
102208581|NCT00901979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102208582|NCT00901979|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102208583|NCT00901979|Protease Inhibitors|protease inhibitors|mesh-ancestor
102208584|NCT00901979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102208585|NCT00901979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208586|NCT03778671|Fentanyl|fentanyl|mesh-list
102208587|NCT03778671|Dexmedetomidine|dexmedetomidine|mesh-list
102208588|NCT03778671|Levobupivacaine|levobupivacaine|mesh-list
102208589|NCT03778671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102208590|NCT03778671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102208591|NCT03778671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208592|NCT03778671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102208593|NCT03778671|Analgesics|analgesics|mesh-ancestor
102208594|NCT03778671|Sensory System Agents|sensory system agents|mesh-ancestor
102208595|NCT03778671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102208596|NCT03778671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102208597|NCT03778671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102208598|NCT03778671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102208599|NCT03778671|Adrenergic Agents|adrenergic agents|mesh-ancestor
102208600|NCT03778671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102208601|NCT03778671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208602|NCT03778671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102208603|NCT03778671|Narcotics|narcotics|mesh-ancestor
102208604|NCT03778671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102208605|NCT03778671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102208606|NCT03778671|Anesthetics, General|anesthetics, general|mesh-ancestor
102208607|NCT03778671|Anesthetics|anesthetics|mesh-ancestor
102208608|NCT03778671|Anesthetics, Local|anesthetics, local|mesh-ancestor
102208609|NCT00978497|Ribavirin|ribavirin|mesh-list
102208610|NCT00978497|Antimetabolites|antimetabolites|mesh-ancestor
102208611|NCT00978497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208612|NCT00978497|Antiviral Agents|antiviral agents|mesh-ancestor
102208613|NCT00978497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102208614|NCT03692715|Ciprofloxacin|ciprofloxacin|mesh-list
102208615|NCT03692715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102208616|NCT03692715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102208617|NCT03692715|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102208618|NCT03692715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102208619|NCT03692715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102208620|NCT03692715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208621|NCT03692715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102208622|NCT03692715|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102208623|NCT03692715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102208624|NCT03558789|Lactoferrin|lactoferrin|mesh-list
102208625|NCT03558789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102208626|NCT00890591|Amlodipine|amlodipine|mesh-list
102208627|NCT00890591|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102208628|NCT00890591|Olmesartan|olmesartan|mesh-list
102208629|NCT00890591|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
102208630|NCT00890591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102208631|NCT00890591|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102208632|NCT00890591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102208633|NCT00890591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208634|NCT00890591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102208635|NCT00890591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208636|NCT00890591|Vasodilator Agents|vasodilator agents|mesh-ancestor
102208637|NCT00890591|Diuretics|diuretics|mesh-ancestor
102208638|NCT00890591|Natriuretic Agents|natriuretic agents|mesh-ancestor
102208639|NCT00890591|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102208640|NCT00890591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102208641|NCT00890591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102208642|NCT05248334|Ranibizumab|ranibizumab|mesh-list
102208643|NCT05248334|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102208644|NCT05248334|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102208645|NCT05248334|Growth Substances|growth substances|mesh-ancestor
102208646|NCT05248334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208647|NCT05248334|Growth Inhibitors|growth inhibitors|mesh-ancestor
102208648|NCT05248334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102208649|NCT03140787|Lidocaine|lidocaine|mesh-list
102208650|NCT03140787|Anesthetics, Local|anesthetics, local|mesh-ancestor
102208651|NCT03140787|Anesthetics|anesthetics|mesh-ancestor
102208652|NCT03140787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102208653|NCT03140787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208654|NCT03140787|Sensory System Agents|sensory system agents|mesh-ancestor
102208655|NCT03140787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102208656|NCT03140787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102208657|NCT03140787|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102208658|NCT03140787|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102208659|NCT03140787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102208660|NCT03140787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208661|NCT00889967|Ciprofloxacin|ciprofloxacin|mesh-list
102208662|NCT00889967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102208663|NCT00889967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102208664|NCT00889967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102208665|NCT00889967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102208666|NCT00889967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102208667|NCT00889967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208668|NCT00889967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102208669|NCT00889967|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102208670|NCT00889967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102208671|NCT03317223|Amoxicillin|amoxicillin|mesh-list
102208672|NCT03317223|Clarithromycin|clarithromycin|mesh-list
102208673|NCT03317223|Lansoprazole|lansoprazole|mesh-list
102208674|NCT03317223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102208675|NCT03317223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102208676|NCT03317223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102208677|NCT03317223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102208678|NCT03317223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208679|NCT03317223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102208680|NCT03317223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102208681|NCT03317223|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102208682|NCT03317223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102208683|NCT03317223|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102208684|NCT02284906|Pioglitazone|pioglitazone|mesh-list
102208685|NCT02284906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102208686|NCT02284906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208688|NCT02566863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102208689|NCT02566863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102208690|NCT02566863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208691|NCT02566863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102208692|NCT02566863|Analgesics|analgesics|mesh-ancestor
102208693|NCT02566863|Sensory System Agents|sensory system agents|mesh-ancestor
102208694|NCT02566863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102208695|NCT02566863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102208696|NCT02566863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102208697|NCT02566863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102208698|NCT02566863|Adrenergic Agents|adrenergic agents|mesh-ancestor
102208699|NCT02566863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102208700|NCT02566863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208701|NCT05137847|Denileukin diftitox|denileukin diftitox|mesh-list
102208702|NCT05137847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102208703|NCT00968825|Botulinum Toxins|botulinum toxins|mesh-list
102208704|NCT00968825|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102208705|NCT00968825|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102208706|NCT00968825|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102208707|NCT00968825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102208708|NCT00968825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208709|NCT00968825|Cholinergic Agents|cholinergic agents|mesh-ancestor
102208710|NCT00968825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102208711|NCT00968825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208712|NCT00968825|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102208713|NCT00968825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102208714|NCT04474457|Favipiravir|favipiravir|mesh-list
102208715|NCT04474457|Antiviral Agents|antiviral agents|mesh-ancestor
102208716|NCT04474457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102208717|NCT03139383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102208718|NCT00880217|Methylphenidate|methylphenidate|mesh-list
102208719|NCT00880217|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102208720|NCT00880217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102208721|NCT00880217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208722|NCT00880217|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102208723|NCT00880217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102208724|NCT00880217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102208725|NCT00880217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208726|NCT00880217|Dopamine Agents|dopamine agents|mesh-ancestor
102208727|NCT00880217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102208728|NCT00880217|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102208729|NCT00880217|Adrenergic Agents|adrenergic agents|mesh-ancestor
102208730|NCT01657760|Citalopram|citalopram|mesh-list
102208731|NCT01657760|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102208732|NCT01657760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102208733|NCT01657760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102208734|NCT01657760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208735|NCT01657760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102208736|NCT01657760|Serotonin Agents|serotonin agents|mesh-ancestor
102208737|NCT01657760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208738|NCT01657760|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102208739|NCT01657760|Antidepressive Agents|antidepressive agents|mesh-ancestor
102208740|NCT01657760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102208741|NCT00966953|Honokiol|honokiol|mesh-list
102208742|NCT00966953|Triclosan|triclosan|mesh-list
102208743|NCT00966953|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102208744|NCT00966953|Fluorides|fluorides|mesh-list
102208745|NCT00966953|Cariostatic Agents|cariostatic agents|mesh-ancestor
102208746|NCT00966953|Protective Agents|protective agents|mesh-ancestor
102208747|NCT00966953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208748|NCT00966953|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102208749|NCT00966953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101917560|NCT05663515|Hormones|hormones|mesh-ancestor
102208750|NCT00966953|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102208751|NCT00966953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102208752|NCT00966953|Antimetabolites|antimetabolites|mesh-ancestor
102208753|NCT00966953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208754|NCT00966953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102208755|NCT00966953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102208756|NCT00966953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102208757|NCT00966953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102208758|NCT00966953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102208759|NCT00966953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102208760|NCT00966953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102208761|NCT00966953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102208762|NCT00966953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102208763|NCT00966953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102208764|NCT00966953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102208765|NCT05247320|Sotalol|sotalol|mesh-list
102208766|NCT05247320|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102208767|NCT05247320|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102208768|NCT05247320|Adrenergic Agents|adrenergic agents|mesh-ancestor
102208769|NCT05247320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102208770|NCT05247320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208771|NCT05247320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208772|NCT05247320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102208773|NCT05247320|Sympatholytics|sympatholytics|mesh-ancestor
102208774|NCT05247320|Autonomic Agents|autonomic agents|mesh-ancestor
102208775|NCT05247320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102208776|NCT05084079|Insulin|insulin|mesh-list
102208777|NCT05084079|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102208778|NCT05084079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102208779|NCT05084079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208780|NCT05084001|Listerine|listerine|mesh-list
102208781|NCT05084001|Fluorides|fluorides|mesh-list
102208782|NCT05084001|Sodium Fluoride|sodium fluoride|mesh-list
102208783|NCT05084001|Fluorides, Topical|fluorides, topical|mesh-list
102208784|NCT05084001|Cariostatic Agents|cariostatic agents|mesh-ancestor
102208785|NCT05084001|Protective Agents|protective agents|mesh-ancestor
102208786|NCT05084001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208787|NCT05084001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102208788|NCT05084001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102208789|NCT05245916|Rituximab|rituximab|mesh-list
102208790|NCT05245916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102208791|NCT05245916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102208792|NCT05245916|Immunologic Factors|immunologic factors|mesh-ancestor
102208793|NCT05245916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208794|NCT05245916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102208795|NCT00875459|Insulin|insulin|mesh-list
102208796|NCT00875459|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102208797|NCT00875459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102208798|NCT00875459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208799|NCT03837353|Docetaxel|docetaxel|mesh-list
102208800|NCT03837353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102208801|NCT03837353|Tubulin Modulators|tubulin modulators|mesh-ancestor
102208802|NCT03837353|Antimitotic Agents|antimitotic agents|mesh-ancestor
102208803|NCT03837353|Mitosis Modulators|mitosis modulators|mesh-ancestor
102208804|NCT03837353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208805|NCT03140709|Oxytocin|oxytocin|mesh-list
102208806|NCT03140709|Oxytocics|oxytocics|mesh-ancestor
102208807|NCT03140709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102208808|NCT03140709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208809|NCT02283658|Everolimus|everolimus|mesh-list
102208810|NCT02283658|Letrozole|letrozole|mesh-list
102208811|NCT02283658|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102208812|NCT02283658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102208813|NCT02283658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102208814|NCT02283658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208815|NCT02283658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102208816|NCT02283658|Immunologic Factors|immunologic factors|mesh-ancestor
102208817|NCT02283658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208818|NCT02283658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102208819|NCT02283658|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102208820|NCT02283658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102208821|NCT02283658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101917636|NCT05352828|Nivolumab|nivolumab|mesh-list
102208822|NCT02283658|Hormone Antagonists|hormone antagonists|mesh-ancestor
102208823|NCT02283658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102208824|NCT00872885|Morphine|morphine|mesh-list
102208825|NCT00872885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102208826|NCT00872885|Narcotics|narcotics|mesh-ancestor
102208827|NCT00872885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102208828|NCT00872885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208829|NCT00872885|Analgesics|analgesics|mesh-ancestor
102208830|NCT00872885|Sensory System Agents|sensory system agents|mesh-ancestor
102208831|NCT00872885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102208832|NCT00871481|Aldesleukin|aldesleukin|mesh-list
102208833|NCT00871481|Cyclophosphamide|cyclophosphamide|mesh-list
102208834|NCT00871481|Ipilimumab|ipilimumab|mesh-list
102208835|NCT00871481|Interleukin-2|interleukin-2|mesh-list
102208836|NCT00871481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102208837|NCT00871481|Antibodies|antibodies|mesh-list
102208838|NCT00871481|Immunoglobulins|immunoglobulins|mesh-list
102208839|NCT00871481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102208840|NCT00871481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102208841|NCT00871481|Immunologic Factors|immunologic factors|mesh-ancestor
102208842|NCT00871481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208843|NCT00871481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102208844|NCT00871481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102208845|NCT00871481|Alkylating Agents|alkylating agents|mesh-ancestor
102208846|NCT00871481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208847|NCT00871481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102208848|NCT00871481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102208849|NCT00871481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102208850|NCT00871481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102208851|NCT00871481|Analgesics|analgesics|mesh-ancestor
102208852|NCT00871481|Sensory System Agents|sensory system agents|mesh-ancestor
102208853|NCT00871481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102208854|NCT00871481|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102208855|NCT00871481|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102208856|NCT00871481|Antiviral Agents|antiviral agents|mesh-ancestor
102208857|NCT00871481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102208858|NCT05456165|Ipilimumab|ipilimumab|mesh-list
102208859|NCT05456165|Atezolizumab|atezolizumab|mesh-list
102208860|NCT05456165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102208861|NCT05456165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102208862|NCT05456165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102208863|NCT05456165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208864|NCT05083689|Bevacizumab|bevacizumab|mesh-list
102208865|NCT05083689|Timolol|timolol|mesh-list
102208866|NCT05083689|Dorzolamide|dorzolamide|mesh-list
102208867|NCT05083689|Lubricant Eye Drops|lubricant eye drops|mesh-list
102208868|NCT05083689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102208869|NCT05083689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102208870|NCT05083689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102208871|NCT05083689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102208872|NCT05083689|Growth Substances|growth substances|mesh-ancestor
102208873|NCT05083689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208874|NCT05083689|Growth Inhibitors|growth inhibitors|mesh-ancestor
102208875|NCT05083689|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102208876|NCT05083689|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102208877|NCT05083689|Adrenergic Agents|adrenergic agents|mesh-ancestor
102208878|NCT05083689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102208879|NCT05083689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208880|NCT05083689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102208881|NCT05083689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102208882|NCT05083689|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102208883|NCT05083689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102208884|NCT05083689|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102208885|NCT05083689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102208886|NCT05165966|Vaccines|vaccines|mesh-list
102208887|NCT05165966|Immunologic Factors|immunologic factors|mesh-ancestor
102208888|NCT05165966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208889|NCT05165732|Vaccines|vaccines|mesh-list
102208890|NCT05165732|Immunologic Factors|immunologic factors|mesh-ancestor
102208891|NCT05165732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208892|NCT04477083|Hydroxychloroquine|hydroxychloroquine|mesh-list
102208893|NCT04477083|Antimalarials|antimalarials|mesh-ancestor
101917706|NCT05193318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917707|NCT05163041|Nivolumab|nivolumab|mesh-list
101917708|NCT05163041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102208894|NCT04477083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101917709|NCT05163041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101917710|NCT05163041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102208895|NCT04477083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102208896|NCT04477083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102208897|NCT04477083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101573991|NCT02199184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102208898|NCT04477083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208899|NCT04477083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102208900|NCT03138759|Probenecid|probenecid|mesh-list
102208901|NCT03138759|Uricosuric Agents|uricosuric agents|mesh-ancestor
102208902|NCT03138759|Gout Suppressants|gout suppressants|mesh-ancestor
102208903|NCT03138759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102208904|NCT03079921|Propranolol|propranolol|mesh-list
102208905|NCT03079921|Phentolamine|phentolamine|mesh-list
102208906|NCT03079921|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102208907|NCT03079921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102208908|NCT03079921|Adrenergic Agents|adrenergic agents|mesh-ancestor
102208909|NCT03079921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102208910|NCT03079921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208911|NCT03079921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208912|NCT03079921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102208913|NCT03079921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102208914|NCT03079921|Vasodilator Agents|vasodilator agents|mesh-ancestor
102208915|NCT03079921|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102208916|NCT04473989|Teriparatide|teriparatide|mesh-list
102208917|NCT04473989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102208918|NCT04473989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208919|NCT04473989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102208921|NCT05209490|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102208922|NCT05209490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102208923|NCT05209490|Trace Elements|trace elements|mesh-ancestor
102208924|NCT05209490|Micronutrients|micronutrients|mesh-ancestor
102208925|NCT05209490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208926|NCT04473911|Mycophenolic Acid|mycophenolic acid|mesh-list
102208927|NCT04473911|Sirolimus|sirolimus|mesh-list
102208928|NCT04473911|Cyclophosphamide|cyclophosphamide|mesh-list
102208929|NCT04473911|Melphalan|melphalan|mesh-list
102208930|NCT04473911|Fludarabine|fludarabine|mesh-list
102208931|NCT04473911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102208932|NCT04473911|Immunologic Factors|immunologic factors|mesh-ancestor
102208933|NCT04473911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208934|NCT04473911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102208935|NCT04473911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102208936|NCT04473911|Alkylating Agents|alkylating agents|mesh-ancestor
102208937|NCT04473911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208938|NCT04473911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102208939|NCT04473911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102208940|NCT04473911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102208941|NCT04473911|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102208942|NCT04473911|Antitubercular Agents|antitubercular agents|mesh-ancestor
102208943|NCT04473911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102208944|NCT04473911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102208945|NCT04473911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102208946|NCT04473911|Antifungal Agents|antifungal agents|mesh-ancestor
102208947|NCT05162222|Itraconazole|itraconazole|mesh-list
102208948|NCT05162222|Diltiazem|diltiazem|mesh-list
102208949|NCT05162222|Antifungal Agents|antifungal agents|mesh-ancestor
102208950|NCT05162222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102208951|NCT05162222|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102208952|NCT05162222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102208953|NCT05162222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102208954|NCT05162222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208955|NCT05162222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102208956|NCT05162222|Hormone Antagonists|hormone antagonists|mesh-ancestor
102208957|NCT05162222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102208958|NCT05162222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102208959|NCT05162222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102208960|NCT05162222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102208961|NCT05162222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102208962|NCT05162222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102208963|NCT05162222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102208964|NCT05162222|Vasodilator Agents|vasodilator agents|mesh-ancestor
102208965|NCT05088057|Cyclophosphamide|cyclophosphamide|mesh-list
102208966|NCT05088057|Docetaxel|docetaxel|mesh-list
102208967|NCT05088057|Doxorubicin|doxorubicin|mesh-list
102208968|NCT05088057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102208969|NCT05088057|Immunologic Factors|immunologic factors|mesh-ancestor
102208970|NCT05088057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917779|NCT04897971|Antibodies|antibodies|mesh-list
102208971|NCT05088057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102208972|NCT05088057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102208973|NCT05088057|Alkylating Agents|alkylating agents|mesh-ancestor
102208974|NCT05088057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208975|NCT05088057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102208976|NCT05088057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102208977|NCT05088057|Tubulin Modulators|tubulin modulators|mesh-ancestor
102208978|NCT05088057|Antimitotic Agents|antimitotic agents|mesh-ancestor
102208979|NCT05088057|Mitosis Modulators|mitosis modulators|mesh-ancestor
102208980|NCT05088057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102208981|NCT05088057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102208982|NCT05088057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102208983|NCT05088057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102208984|NCT03132025|Capecitabine|capecitabine|mesh-list
102208985|NCT03132025|Apatinib|apatinib|mesh-list
102208986|NCT03132025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102208987|NCT03132025|Antimetabolites|antimetabolites|mesh-ancestor
102208988|NCT03132025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102208989|NCT03132025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102208990|NCT03132025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102208991|NCT03132025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102208992|NCT00857285|Losartan|losartan|mesh-list
102208993|NCT00857285|Olmesartan|olmesartan|mesh-list
102208994|NCT00857285|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
102208995|NCT00857285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102208996|NCT00857285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102208997|NCT00857285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102208998|NCT00857285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102208999|NCT00857285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209000|NCT04461379|Vaccines|vaccines|mesh-list
102209001|NCT04461379|BCG Vaccine|bcg vaccine|mesh-list
102209002|NCT04461379|Immunologic Factors|immunologic factors|mesh-ancestor
102209003|NCT04461379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209004|NCT04461379|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102209005|NCT00854945|ON 01910|on 01910|mesh-list
102209006|NCT00854945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102209007|NCT00854945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102209008|NCT00854945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102209009|NCT00854945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209010|NCT04876534|Methylprednisolone|methylprednisolone|mesh-list
102209011|NCT04876534|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102209012|NCT04876534|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102209013|NCT04876534|Prednisolone|prednisolone|mesh-list
102209014|NCT04876534|Prednisolone acetate|prednisolone acetate|mesh-list
102209015|NCT04876534|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102209016|NCT04876534|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102209017|NCT04876534|Prednisolone phosphate|prednisolone phosphate|mesh-list
102209018|NCT04876534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102209019|NCT04876534|Antiemetics|antiemetics|mesh-ancestor
102209020|NCT04876534|Autonomic Agents|autonomic agents|mesh-ancestor
102209021|NCT04876534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102209022|NCT04876534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209023|NCT04876534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102209024|NCT04876534|Glucocorticoids|glucocorticoids|mesh-ancestor
102209025|NCT04876534|Hormones|hormones|mesh-ancestor
102209026|NCT04876534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102209027|NCT04876534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102209028|NCT04876534|Protective Agents|protective agents|mesh-ancestor
102209029|NCT04876534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102209030|NCT04876534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102209031|NCT05082753|Ivermectin|ivermectin|mesh-list
102209032|NCT05082753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102209033|NCT05082753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102209034|NCT02443831|Cyclophosphamide|cyclophosphamide|mesh-list
102209035|NCT02443831|Fludarabine|fludarabine|mesh-list
102209036|NCT02443831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102209037|NCT02443831|Immunologic Factors|immunologic factors|mesh-ancestor
102209038|NCT02443831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209039|NCT02443831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102209040|NCT02443831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102209041|NCT02443831|Alkylating Agents|alkylating agents|mesh-ancestor
102209042|NCT02443831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209043|NCT02443831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102209044|NCT02443831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102209045|NCT00851045|Leucovorin|leucovorin|mesh-list
101917856|NCT04457232|FAPI-46|fapi-46|mesh-list
102209046|NCT00851045|Bevacizumab|bevacizumab|mesh-list
102209047|NCT00851045|Fluorouracil|fluorouracil|mesh-list
102209048|NCT00851045|Irinotecan|irinotecan|mesh-list
102209049|NCT00851045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102209050|NCT00851045|Calcium|calcium|mesh-list
102209051|NCT00851045|Levoleucovorin|levoleucovorin|mesh-list
102209052|NCT00851045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102209053|NCT00851045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102209054|NCT00851045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102209055|NCT00851045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102209056|NCT00851045|Growth Substances|growth substances|mesh-ancestor
102209057|NCT00851045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209058|NCT00851045|Growth Inhibitors|growth inhibitors|mesh-ancestor
102209059|NCT00851045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102209060|NCT00851045|Antimetabolites|antimetabolites|mesh-ancestor
102209061|NCT00851045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209062|NCT00851045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102209063|NCT00851045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102209064|NCT00851045|Immunologic Factors|immunologic factors|mesh-ancestor
102209065|NCT00851045|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102209066|NCT00851045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102209067|NCT00851045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102209068|NCT00851045|Antidotes|antidotes|mesh-ancestor
102209069|NCT00851045|Protective Agents|protective agents|mesh-ancestor
102209070|NCT00851045|Vitamin B Complex|vitamin b complex|mesh-ancestor
102209071|NCT00851045|Vitamins|vitamins|mesh-ancestor
102209072|NCT00851045|Micronutrients|micronutrients|mesh-ancestor
102209073|NCT00850577|Paclitaxel|paclitaxel|mesh-list
102209074|NCT00850577|Bevacizumab|bevacizumab|mesh-list
102209075|NCT00850577|Carboplatin|carboplatin|mesh-list
102209076|NCT00850577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102209077|NCT00850577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102209078|NCT00850577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102209079|NCT00850577|Tubulin Modulators|tubulin modulators|mesh-ancestor
102209080|NCT00850577|Antimitotic Agents|antimitotic agents|mesh-ancestor
102209081|NCT00850577|Mitosis Modulators|mitosis modulators|mesh-ancestor
102209082|NCT00850577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209083|NCT00850577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102209084|NCT00850577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102209085|NCT00850577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102209086|NCT00850577|Growth Substances|growth substances|mesh-ancestor
102209087|NCT00850577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209088|NCT00850577|Growth Inhibitors|growth inhibitors|mesh-ancestor
102209089|NCT00838981|Methadone|methadone|mesh-list
102209090|NCT00838981|Modafinil|modafinil|mesh-list
102209091|NCT00838981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102209092|NCT00838981|Narcotics|narcotics|mesh-ancestor
102209093|NCT00838981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102209094|NCT00838981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209095|NCT00838981|Analgesics|analgesics|mesh-ancestor
102209096|NCT00838981|Sensory System Agents|sensory system agents|mesh-ancestor
102209097|NCT00838981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102209098|NCT00838981|Antitussive Agents|antitussive agents|mesh-ancestor
102209099|NCT00838981|Respiratory System Agents|respiratory system agents|mesh-ancestor
102209100|NCT00838981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102209101|NCT00838981|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102209102|NCT00838981|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102209103|NCT00838981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102209104|NCT00838981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209105|NCT00849797|Oxcarbazepine|oxcarbazepine|mesh-list
102209106|NCT00849797|Anticonvulsants|anticonvulsants|mesh-ancestor
102209107|NCT00849797|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102209108|NCT00849797|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102209109|NCT00849797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101451239|NCT00471328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102209110|NCT00849797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209111|NCT00849797|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102209112|NCT00849797|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102209113|NCT05082441|Bupivacaine|bupivacaine|mesh-list
102209114|NCT05082441|Anesthetics, Local|anesthetics, local|mesh-ancestor
102209115|NCT05082441|Anesthetics|anesthetics|mesh-ancestor
102209116|NCT05082441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102209117|NCT05082441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209118|NCT05082441|Sensory System Agents|sensory system agents|mesh-ancestor
102209119|NCT05082441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102209120|NCT00950885|Melatonin|melatonin|mesh-list
102209122|NCT00950885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209123|NCT00950885|Protective Agents|protective agents|mesh-ancestor
102209124|NCT00950885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209125|NCT00950885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102209126|NCT00849485|Levetiracetam|levetiracetam|mesh-list
102209127|NCT00849485|Anticonvulsants|anticonvulsants|mesh-ancestor
102209128|NCT00849485|Nootropic Agents|nootropic agents|mesh-ancestor
102209129|NCT03140397|8-prenylnaringenin|8-prenylnaringenin|mesh-list
102209130|NCT03140397|Phytoestrogens|phytoestrogens|mesh-ancestor
102209131|NCT03140397|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102209132|NCT03140397|Estrogens|estrogens|mesh-ancestor
102209133|NCT03140397|Hormones|hormones|mesh-ancestor
102209134|NCT03140397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102209135|NCT03140397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209136|NCT05047445|Vaccines|vaccines|mesh-list
102209137|NCT05047445|Immunologic Factors|immunologic factors|mesh-ancestor
102209138|NCT05047445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209139|NCT05235542|Paclitaxel|paclitaxel|mesh-list
102209140|NCT05235542|Docetaxel|docetaxel|mesh-list
102209141|NCT05235542|Capecitabine|capecitabine|mesh-list
102209142|NCT05235542|Oxaliplatin|oxaliplatin|mesh-list
102209143|NCT05235542|Irinotecan|irinotecan|mesh-list
102209144|NCT05235542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102209145|NCT05235542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102209146|NCT05235542|Tubulin Modulators|tubulin modulators|mesh-ancestor
102209147|NCT05235542|Antimitotic Agents|antimitotic agents|mesh-ancestor
102209148|NCT05235542|Mitosis Modulators|mitosis modulators|mesh-ancestor
102209149|NCT05235542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209150|NCT05235542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102209151|NCT05235542|Antimetabolites|antimetabolites|mesh-ancestor
102209152|NCT05235542|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102209153|NCT05235542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102209154|NCT05235542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102209155|NCT00840281|Cefprozil|cefprozil|mesh-list
102209156|NCT00840281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102209157|NCT00840281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102209158|NCT00840203|Mesalamine|mesalamine|mesh-list
102209159|NCT00840203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102209160|NCT00840203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102209161|NCT00840203|Analgesics|analgesics|mesh-ancestor
102209162|NCT00840203|Sensory System Agents|sensory system agents|mesh-ancestor
102209163|NCT00840203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102209164|NCT00840203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209165|NCT00840203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102209166|NCT00840203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102209167|NCT00838799|Pregabalin|pregabalin|mesh-list
102209168|NCT00838799|Analgesics|analgesics|mesh-ancestor
102209169|NCT00838799|Sensory System Agents|sensory system agents|mesh-ancestor
102209170|NCT00838799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102209171|NCT00838799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209172|NCT00838799|Anticonvulsants|anticonvulsants|mesh-ancestor
102209173|NCT00838799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102209174|NCT00838799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102209175|NCT00838799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209176|NCT00838799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102209177|NCT00838799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102209178|NCT00838799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101451244|NCT00471328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102209179|NCT00838799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102209180|NCT00838799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102209181|NCT05025735|Dapagliflozin|dapagliflozin|mesh-list
102209182|NCT05025735|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102209183|NCT05025735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209184|NCT05025735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102209185|NCT05025735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209186|NCT00836069|Paroxetine|paroxetine|mesh-list
102209187|NCT00836069|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102209188|NCT00836069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102209189|NCT00836069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102209190|NCT00836069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209191|NCT00836069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102209192|NCT00836069|Serotonin Agents|serotonin agents|mesh-ancestor
102209193|NCT00836069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209194|NCT00836069|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102209195|NCT00836069|Antidepressive Agents|antidepressive agents|mesh-ancestor
102209196|NCT00836069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102209197|NCT00836069|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102209198|NCT00836069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102209199|NCT00836069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102209200|NCT03134729|Ropivacaine|ropivacaine|mesh-list
102209201|NCT03134729|Anesthetics, Local|anesthetics, local|mesh-ancestor
102209202|NCT03134729|Anesthetics|anesthetics|mesh-ancestor
102209203|NCT03134729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102209204|NCT03134729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209205|NCT03134729|Sensory System Agents|sensory system agents|mesh-ancestor
102209206|NCT03134729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102209208|NCT03134651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102209209|NCT03134651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102209210|NCT03134651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209211|NCT03134651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102209212|NCT03134651|Anesthetics, General|anesthetics, general|mesh-ancestor
102209213|NCT03134651|Anesthetics|anesthetics|mesh-ancestor
102209214|NCT05202860|Vaccines|vaccines|mesh-list
102209215|NCT05202860|Immunologic Factors|immunologic factors|mesh-ancestor
102209216|NCT05202860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209217|NCT05202782|Zanubrutinib|zanubrutinib|mesh-list
102209218|NCT05202782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102209219|NCT05202782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102209220|NCT05202782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102209221|NCT05202782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209222|NCT05202080|Analgesics, Opioid|analgesics, opioid|mesh-list
102209223|NCT05202080|Narcotics|narcotics|mesh-ancestor
102209224|NCT05202080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102209225|NCT05202080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209226|NCT05202080|Analgesics|analgesics|mesh-ancestor
102209227|NCT05202080|Sensory System Agents|sensory system agents|mesh-ancestor
102209228|NCT05202080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102209229|NCT00935987|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
102209230|NCT00935987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102209231|NCT00935987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102209232|NCT00935987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209233|NCT05155124|Cetuximab|cetuximab|mesh-list
102209234|NCT05155124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102209235|NCT05155124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102209236|NCT00927641|Ketoprofen|ketoprofen|mesh-list
102209237|NCT00927641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102209238|NCT00927641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102209239|NCT00927641|Analgesics|analgesics|mesh-ancestor
102209240|NCT00927641|Sensory System Agents|sensory system agents|mesh-ancestor
102209241|NCT00927641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102209242|NCT00927641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209243|NCT00927641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102209244|NCT00927641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101308401|NCT02047149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102209245|NCT00927641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102209246|NCT00927641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102209247|NCT00927641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209248|NCT05200364|Bevacizumab|bevacizumab|mesh-list
102209249|NCT05200364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102209250|NCT05200364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102209251|NCT05200364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102209252|NCT05200364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102209253|NCT05200364|Growth Substances|growth substances|mesh-ancestor
102209254|NCT05200364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209255|NCT05200364|Growth Inhibitors|growth inhibitors|mesh-ancestor
102209256|NCT00835991|Metformin|metformin|mesh-list
102209257|NCT00835991|Glyburide|glyburide|mesh-list
102209258|NCT00835991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102209259|NCT00835991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209260|NCT05200052|Colchicine|colchicine|mesh-list
102209261|NCT05200052|Gout Suppressants|gout suppressants|mesh-ancestor
102209262|NCT05200052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102209263|NCT05200052|Tubulin Modulators|tubulin modulators|mesh-ancestor
102209264|NCT05200052|Antimitotic Agents|antimitotic agents|mesh-ancestor
102209265|NCT05200052|Mitosis Modulators|mitosis modulators|mesh-ancestor
102209266|NCT05200052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209267|NCT05200052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102209268|NCT00925535|Rifabutin|rifabutin|mesh-list
102209269|NCT00925535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102209270|NCT00925535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102209271|NCT00925535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102209272|NCT00925535|Antitubercular Agents|antitubercular agents|mesh-ancestor
102209273|NCT02276872|Treprostinil|treprostinil|mesh-list
102209274|NCT02276872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102209275|NCT00835367|Amlodipine|amlodipine|mesh-list
102209276|NCT00835367|Benazepril|benazepril|mesh-list
102209277|NCT00835367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102209278|NCT00835367|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102209279|NCT00835367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102209280|NCT00835367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209281|NCT00835367|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102209282|NCT00835367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209283|NCT00835367|Vasodilator Agents|vasodilator agents|mesh-ancestor
102209284|NCT00835367|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102209285|NCT00835367|Protease Inhibitors|protease inhibitors|mesh-ancestor
102209286|NCT00835367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102209287|NCT02276560|Paclitaxel|paclitaxel|mesh-list
102209288|NCT02276560|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102209289|NCT02276560|Cisplatin|cisplatin|mesh-list
102209290|NCT02276560|Gemcitabine|gemcitabine|mesh-list
102209291|NCT02276560|Pemetrexed|pemetrexed|mesh-list
102209292|NCT02276560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102209293|NCT02276560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102209294|NCT02276560|Tubulin Modulators|tubulin modulators|mesh-ancestor
102209295|NCT02276560|Antimitotic Agents|antimitotic agents|mesh-ancestor
102209296|NCT02276560|Mitosis Modulators|mitosis modulators|mesh-ancestor
102209297|NCT02276560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209298|NCT02276560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102209299|NCT02276560|Antimetabolites|antimetabolites|mesh-ancestor
102209300|NCT02276560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102209301|NCT02276560|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102209302|NCT02276560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102209303|NCT02276482|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102209304|NCT02276482|Metronidazole|metronidazole|mesh-list
102209305|NCT02276482|Vancomycin|vancomycin|mesh-list
102209306|NCT02276482|Clindamycin|clindamycin|mesh-list
102209307|NCT02276482|Cefazolin|cefazolin|mesh-list
102209308|NCT02276482|Linezolid|linezolid|mesh-list
102209309|NCT02276482|Cephalexin|cephalexin|mesh-list
102209310|NCT02276482|Aztreonam|aztreonam|mesh-list
102209311|NCT02276482|Tedizolid|tedizolid|mesh-list
102209312|NCT02276482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102209313|NCT02276482|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102209314|NCT02276482|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102209315|NCT02276482|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102209316|NCT02276482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101451255|NCT00195377|Analgesics|analgesics|mesh-ancestor
102209317|NCT02276482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209318|NCT00924833|Carvedilol|carvedilol|mesh-list
102209319|NCT00924833|Nebivolol|nebivolol|mesh-list
102209320|NCT00924833|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102209321|NCT00924833|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102209322|NCT00924833|Adrenergic Agents|adrenergic agents|mesh-ancestor
102209323|NCT00924833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102209324|NCT00924833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209325|NCT00924833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209326|NCT00924833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102209327|NCT00924833|Antioxidants|antioxidants|mesh-ancestor
102209328|NCT00924833|Protective Agents|protective agents|mesh-ancestor
102209329|NCT00924833|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102209330|NCT00924833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102209331|NCT00924833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102209332|NCT00924833|Vasodilator Agents|vasodilator agents|mesh-ancestor
102209333|NCT00924833|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102209334|NCT00924833|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102209335|NCT00924833|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102209336|NCT00924833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102209337|NCT00924833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102209338|NCT05142254|Hydroxyurea|hydroxyurea|mesh-list
102209339|NCT05142254|Tadalafil|tadalafil|mesh-list
102209340|NCT05142254|Vasodilator Agents|vasodilator agents|mesh-ancestor
102209341|NCT05142254|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102209342|NCT05142254|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102209343|NCT05142254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102209344|NCT05142254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209345|NCT05142254|Urological Agents|urological agents|mesh-ancestor
102209347|NCT05142254|Antisickling Agents|antisickling agents|mesh-ancestor
102209348|NCT05142254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102209349|NCT00835211|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
102209350|NCT00835211|Hemostatics|hemostatics|mesh-ancestor
102209351|NCT00835211|Coagulants|coagulants|mesh-ancestor
102209352|NCT00835211|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102209353|NCT00835211|Natriuretic Agents|natriuretic agents|mesh-ancestor
102209354|NCT00835211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209355|NCT00834977|Amlodipine|amlodipine|mesh-list
102209356|NCT00834977|Benazepril|benazepril|mesh-list
102209357|NCT00834977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102209358|NCT00834977|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102209359|NCT00834977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102209360|NCT00834977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209361|NCT00834977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102209362|NCT00834977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209363|NCT00834977|Vasodilator Agents|vasodilator agents|mesh-ancestor
102209364|NCT00834977|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102209365|NCT00834977|Protease Inhibitors|protease inhibitors|mesh-ancestor
102209366|NCT00834977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102209367|NCT05227664|Paclitaxel|paclitaxel|mesh-list
102209368|NCT05227664|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102209369|NCT05227664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102209370|NCT05227664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102209371|NCT05227664|Tubulin Modulators|tubulin modulators|mesh-ancestor
102209372|NCT05227664|Antimitotic Agents|antimitotic agents|mesh-ancestor
102209373|NCT05227664|Mitosis Modulators|mitosis modulators|mesh-ancestor
102209374|NCT05227664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209375|NCT00834743|Metformin|metformin|mesh-list
102209376|NCT00834743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102209377|NCT00834743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209378|NCT00834587|Metformin|metformin|mesh-list
102209379|NCT00834587|Glipizide|glipizide|mesh-list
102209380|NCT00834587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102209381|NCT00834587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209382|NCT00834431|Famciclovir|famciclovir|mesh-list
102209383|NCT00834431|Antiviral Agents|antiviral agents|mesh-ancestor
102209384|NCT00834431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102209385|NCT00834431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102209386|NCT00834431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102209387|NCT00834431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209388|NCT04875767|Coal Tar|coal tar|mesh-list
102209389|NCT04875767|Keratolytic Agents|keratolytic agents|mesh-ancestor
102209390|NCT04875767|Dermatologic Agents|dermatologic agents|mesh-ancestor
102209391|NCT05191940|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102209392|NCT05191940|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102209393|NCT05191940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209394|NCT00834275|Cefadroxil|cefadroxil|mesh-list
102209395|NCT00834275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102209396|NCT00834275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102209397|NCT05191472|Pembrolizumab|pembrolizumab|mesh-list
102209398|NCT05191472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102209399|NCT05191472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102209400|NCT05191472|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102209401|NCT05191472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209402|NCT00834197|Mirtazapine|mirtazapine|mesh-list
102209403|NCT00834197|Antidepressive Agents|antidepressive agents|mesh-ancestor
102209404|NCT00834197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102209405|NCT00834197|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102209406|NCT00834197|Histamine Antagonists|histamine antagonists|mesh-ancestor
102209407|NCT00834197|Histamine Agents|histamine agents|mesh-ancestor
102209408|NCT00834197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102209409|NCT00834197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209410|NCT00834197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209411|NCT00834197|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102209412|NCT00834197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102209413|NCT00834197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102209414|NCT00834197|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102209415|NCT00834197|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102209416|NCT00834197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102209417|NCT00834197|Adrenergic Agents|adrenergic agents|mesh-ancestor
102209418|NCT00834197|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102209419|NCT00834197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102209420|NCT00834197|Serotonin Agents|serotonin agents|mesh-ancestor
102209421|NCT00834197|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102209422|NCT00833495|Prednisolone|prednisolone|mesh-list
102209423|NCT00833495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102209424|NCT00833495|Methylprednisolone|methylprednisolone|mesh-list
102209425|NCT00833495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102209426|NCT00833495|Prednisolone acetate|prednisolone acetate|mesh-list
102209427|NCT00833495|Prednisone|prednisone|mesh-list
102209428|NCT00833495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102209429|NCT00833495|Prednisolone phosphate|prednisolone phosphate|mesh-list
102209430|NCT00833495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102209431|NCT00833495|Glucocorticoids|glucocorticoids|mesh-ancestor
102209432|NCT00833495|Hormones|hormones|mesh-ancestor
102209433|NCT00833495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102209434|NCT00833495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209435|NCT00833495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102209436|NCT00833495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102209437|NCT00833495|Antiemetics|antiemetics|mesh-ancestor
102209438|NCT00833495|Autonomic Agents|autonomic agents|mesh-ancestor
102209439|NCT00833495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102209440|NCT00833495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102209441|NCT00833495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102209442|NCT00833495|Protective Agents|protective agents|mesh-ancestor
102209443|NCT00830219|Ropinirole|ropinirole|mesh-list
102209444|NCT00830219|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102209445|NCT00830219|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102209446|NCT00830219|Dopamine Agonists|dopamine agonists|mesh-ancestor
102209447|NCT00830219|Dopamine Agents|dopamine agents|mesh-ancestor
102209448|NCT00830219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102209449|NCT00830219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209450|NCT00830219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209451|NCT02274766|Amantadine|amantadine|mesh-list
102209452|NCT02274766|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102209453|NCT02274766|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102209454|NCT02274766|Antiviral Agents|antiviral agents|mesh-ancestor
102209455|NCT02274766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102209456|NCT02274766|Dopamine Agents|dopamine agents|mesh-ancestor
102209457|NCT02274766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102209458|NCT02274766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209459|NCT02274766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209460|NCT02274766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102209461|NCT02274766|Analgesics|analgesics|mesh-ancestor
102209462|NCT02274766|Sensory System Agents|sensory system agents|mesh-ancestor
102209463|NCT02274766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102209464|NCT04757363|Oxaliplatin|oxaliplatin|mesh-list
102209465|NCT04757363|Nivolumab|nivolumab|mesh-list
102209466|NCT04757363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102209467|NCT04757363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102209468|NCT04757363|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102209469|NCT04757363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209470|NCT00829673|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
102209471|NCT00829673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102209472|NCT00829673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209473|NCT00829673|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102209474|NCT00829673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102209475|NCT00829673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102209476|NCT00829673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209477|NCT00829673|Dopamine Agents|dopamine agents|mesh-ancestor
102209478|NCT00829673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102209479|NCT05221658|Cisplatin|cisplatin|mesh-list
102209480|NCT05221658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102209481|NCT05132114|Lugol's solution|lugol's solution|mesh-list
102209482|NCT05132114|Hemostatics|hemostatics|mesh-ancestor
102209483|NCT05132114|Coagulants|coagulants|mesh-ancestor
102209484|NCT02370238|Paclitaxel|paclitaxel|mesh-list
102209485|NCT02370238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102209486|NCT02370238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102209487|NCT02370238|Tubulin Modulators|tubulin modulators|mesh-ancestor
102209488|NCT02370238|Antimitotic Agents|antimitotic agents|mesh-ancestor
102209489|NCT02370238|Mitosis Modulators|mitosis modulators|mesh-ancestor
102209490|NCT02370238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209491|NCT05109104|Sunscreening Agents|sunscreening agents|mesh-list
102209492|NCT05109104|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102209493|NCT05109104|Protective Agents|protective agents|mesh-ancestor
102209494|NCT05109104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209495|NCT05109104|Dermatologic Agents|dermatologic agents|mesh-ancestor
102209497|NCT05126342|Dostarlimab|dostarlimab|mesh-list
102209498|NCT05126342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102209499|NCT05126342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102209500|NCT05126342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209501|NCT05126342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102209502|NCT05126108|Parathyroid Hormone|parathyroid hormone|mesh-list
102209503|NCT05126108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102209504|NCT05126108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209505|NCT05473910|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
102209506|NCT05473910|Antioxidants|antioxidants|mesh-ancestor
102209507|NCT05473910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209508|NCT05473910|Protective Agents|protective agents|mesh-ancestor
102209509|NCT05473910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209510|NCT05473910|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102209511|NCT05473910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102209512|NCT05180708|Sirolimus|sirolimus|mesh-list
102209513|NCT05180708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102209514|NCT05180708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102209515|NCT05180708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102209516|NCT05180708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102209517|NCT05180708|Antifungal Agents|antifungal agents|mesh-ancestor
102209518|NCT05180708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102209519|NCT05180708|Immunologic Factors|immunologic factors|mesh-ancestor
102209520|NCT05180708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209521|NCT02273752|Everolimus|everolimus|mesh-list
102209522|NCT02273752|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102209523|NCT02273752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102209524|NCT02273752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102209525|NCT02273752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209526|NCT02273752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102209527|NCT02273752|Immunologic Factors|immunologic factors|mesh-ancestor
102209528|NCT02273752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209529|NCT02273752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102209530|NCT05102552|Huperzine A|huperzine a|mesh-list
102209531|NCT05102552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102209532|NCT05102552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102209533|NCT05102552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209534|NCT05102552|Cholinergic Agents|cholinergic agents|mesh-ancestor
102209535|NCT05102552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102209536|NCT05102552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209537|NCT05102552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102209538|NCT05102552|Protective Agents|protective agents|mesh-ancestor
102209539|NCT05096390|Pembrolizumab|pembrolizumab|mesh-list
102209540|NCT05096390|Axitinib|axitinib|mesh-list
102209541|NCT05096390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102209542|NCT05096390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102209543|NCT05096390|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102209544|NCT05096390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209545|NCT05096390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102209546|NCT05096390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102209547|NCT02273050|Metformin|metformin|mesh-list
102209548|NCT02273050|Saxagliptin|saxagliptin|mesh-list
102209549|NCT02273050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102209550|NCT02273050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209551|NCT02273050|Incretins|incretins|mesh-ancestor
102209552|NCT02273050|Hormones|hormones|mesh-ancestor
102209553|NCT02273050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102209554|NCT02273050|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102209555|NCT02273050|Protease Inhibitors|protease inhibitors|mesh-ancestor
102209556|NCT02273050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102209557|NCT02273050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209558|NCT02272816|Carboplatin|carboplatin|mesh-list
102209559|NCT02272816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102209560|NCT04869436|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102209561|NCT04869436|Immunologic Factors|immunologic factors|mesh-ancestor
102209562|NCT04869436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209563|NCT05170256|Trastuzumab|trastuzumab|mesh-list
102209564|NCT05170256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102209565|NCT05170256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102209566|NCT05386979|Analgesics, Opioid|analgesics, opioid|mesh-list
102209567|NCT05386979|Anesthetics|anesthetics|mesh-list
102209568|NCT05386979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101918404|NCT05158998|Propofol|propofol|mesh-list
102209569|NCT05386979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209570|NCT05386979|Narcotics|narcotics|mesh-ancestor
102209571|NCT05386979|Analgesics|analgesics|mesh-ancestor
102209572|NCT05386979|Sensory System Agents|sensory system agents|mesh-ancestor
102209573|NCT05386979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102209574|NCT02367352|Paclitaxel|paclitaxel|mesh-list
102209575|NCT02367352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102209576|NCT02367352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102209577|NCT02367352|Tubulin Modulators|tubulin modulators|mesh-ancestor
102209578|NCT02367352|Antimitotic Agents|antimitotic agents|mesh-ancestor
102209579|NCT02367352|Mitosis Modulators|mitosis modulators|mesh-ancestor
102209580|NCT02367352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209581|NCT02270944|Vaccines|vaccines|mesh-list
102209582|NCT02270944|Immunologic Factors|immunologic factors|mesh-ancestor
102209583|NCT02270944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209584|NCT05648734|Pirfenidone|pirfenidone|mesh-list
102209585|NCT05648734|Colchicine|colchicine|mesh-list
102209586|NCT05648734|Gout Suppressants|gout suppressants|mesh-ancestor
102209587|NCT05648734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102209588|NCT05648734|Tubulin Modulators|tubulin modulators|mesh-ancestor
102209589|NCT05648734|Antimitotic Agents|antimitotic agents|mesh-ancestor
102209590|NCT05648734|Mitosis Modulators|mitosis modulators|mesh-ancestor
102209591|NCT05648734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209592|NCT05648734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102209593|NCT05648734|Analgesics|analgesics|mesh-ancestor
102209594|NCT05648734|Sensory System Agents|sensory system agents|mesh-ancestor
102209595|NCT05648734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102209596|NCT05648734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209597|NCT05648734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102209598|NCT05648734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102209599|NCT05648734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102209600|NCT02365558|Omeprazole|omeprazole|mesh-list
102209601|NCT02365558|Evacetrapib|evacetrapib|mesh-list
102209602|NCT02365558|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102209603|NCT02365558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102209604|NCT02365558|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102209605|NCT02365558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102209606|NCT02365558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209607|NCT02365558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102209608|NCT02365558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102209609|NCT02365558|Antimetabolites|antimetabolites|mesh-ancestor
102209610|NCT02365558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102209611|NCT05050214|Obinutuzumab|obinutuzumab|mesh-list
102209612|NCT05050214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102209613|NCT05050214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102209614|NCT02270242|Aspirin|aspirin|mesh-list
102209615|NCT02270242|Ticagrelor|ticagrelor|mesh-list
102209616|NCT02270242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102209617|NCT02270242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102209618|NCT02270242|Analgesics|analgesics|mesh-ancestor
101451307|NCT00225264|Pioglitazone|pioglitazone|mesh-list
102209619|NCT02270242|Sensory System Agents|sensory system agents|mesh-ancestor
102209620|NCT02270242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102209621|NCT02270242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209622|NCT02270242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102209623|NCT02270242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102209624|NCT02270242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102209625|NCT02270242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102209626|NCT02270242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209627|NCT02270242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102209628|NCT02270242|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102209629|NCT02270242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102209630|NCT02270242|Antipyretics|antipyretics|mesh-ancestor
102209631|NCT02270242|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102209632|NCT02270242|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102209633|NCT02270242|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102209634|NCT02270242|Purinergic Agents|purinergic agents|mesh-ancestor
102209635|NCT02270242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102209636|NCT04869124|Dapagliflozin|dapagliflozin|mesh-list
102209637|NCT04869124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102209638|NCT04869124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209639|NCT04869124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102209640|NCT04869124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209641|NCT05648266|Analgesics|analgesics|mesh-list
102209642|NCT05648266|Sensory System Agents|sensory system agents|mesh-ancestor
102209643|NCT05648266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102209644|NCT05648266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209646|NCT05047094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102209647|NCT05047094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102209648|NCT05047094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102209649|NCT05047094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209650|NCT04993352|Antibodies|antibodies|mesh-list
102209651|NCT04993352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102209652|NCT04993352|Mitogens|mitogens|mesh-list
102209653|NCT04993352|Endothelial Growth Factors|endothelial growth factors|mesh-list
102209654|NCT04993352|Immunologic Factors|immunologic factors|mesh-ancestor
102209655|NCT04993352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209656|NCT04993352|Mitosis Modulators|mitosis modulators|mesh-ancestor
102209657|NCT04993352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209658|NCT04993352|Growth Substances|growth substances|mesh-ancestor
102209659|NCT04992026|Prednisone|prednisone|mesh-list
102209660|NCT04992026|Abiraterone Acetate|abiraterone acetate|mesh-list
102209661|NCT04992026|Hormones|hormones|mesh-list
102209662|NCT04992026|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
102209663|NCT04992026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102209664|NCT04992026|Glucocorticoids|glucocorticoids|mesh-ancestor
102209665|NCT04992026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102209666|NCT04992026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209667|NCT04992026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102209668|NCT04992026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102209669|NCT04992026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102209670|NCT04992026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102209671|NCT04992026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209672|NCT04992026|Hormone Antagonists|hormone antagonists|mesh-ancestor
102209673|NCT04992026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102209674|NCT04991402|Dolutegravir|dolutegravir|mesh-list
102209675|NCT04991402|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102209676|NCT04991402|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102209677|NCT04991402|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102209678|NCT04991402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102209679|NCT04991402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209680|NCT04991402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102209681|NCT04991402|Antiviral Agents|antiviral agents|mesh-ancestor
102209682|NCT04991402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102209683|NCT05042102|Donepezil|donepezil|mesh-list
102209684|NCT05042102|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102209685|NCT05042102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102209686|NCT05042102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451340|NCT00195572|Leucovorin|leucovorin|mesh-list
102209687|NCT05042102|Cholinergic Agents|cholinergic agents|mesh-ancestor
102209688|NCT05042102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102209689|NCT05042102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209690|NCT05042102|Nootropic Agents|nootropic agents|mesh-ancestor
102209691|NCT05074940|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
102209692|NCT05074940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102209693|NCT05074940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102209694|NCT05036798|Lenvatinib|lenvatinib|mesh-list
102209695|NCT05036798|Tislelizumab|tislelizumab|mesh-list
102209696|NCT05036798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102209697|NCT05036798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102209698|NCT05036798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102209699|NCT05036798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209700|NCT05036798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102209701|NCT04209218|Dexamethasone|dexamethasone|mesh-list
102209702|NCT04209218|Glucocorticoids|glucocorticoids|mesh-list
102209703|NCT04209218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102209704|NCT04209218|Antiemetics|antiemetics|mesh-ancestor
102209705|NCT04209218|Autonomic Agents|autonomic agents|mesh-ancestor
102209706|NCT04209218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102209707|NCT04209218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209708|NCT04209218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102209709|NCT04209218|Hormones|hormones|mesh-ancestor
102209710|NCT04209218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102209711|NCT04209218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102209712|NCT04209218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102209713|NCT04218968|Carvedilol|carvedilol|mesh-list
101573992|NCT02199184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102209714|NCT04218968|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102209715|NCT04218968|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101918548|NCT01075529|Serotonin Agents|serotonin agents|mesh-ancestor
102209716|NCT04218968|Adrenergic Agents|adrenergic agents|mesh-ancestor
102209717|NCT04218968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102209718|NCT04218968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209719|NCT04218968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209720|NCT04218968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102209721|NCT04218968|Antioxidants|antioxidants|mesh-ancestor
102209722|NCT04218968|Protective Agents|protective agents|mesh-ancestor
102209723|NCT04218968|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102209724|NCT04218968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102209725|NCT04218968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102209726|NCT04218968|Vasodilator Agents|vasodilator agents|mesh-ancestor
102209727|NCT04218968|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102209728|NCT04218968|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102209729|NCT02268214|Dapagliflozin|dapagliflozin|mesh-list
102209730|NCT02268214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102209731|NCT02268214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209732|NCT02268214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102209733|NCT02268214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209734|NCT04421300|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102209735|NCT04421300|Hyaluronic Acid|hyaluronic acid|mesh-list
102209736|NCT04421300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102209737|NCT04421300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102209738|NCT04421300|Immunologic Factors|immunologic factors|mesh-ancestor
102209739|NCT04421300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209740|NCT04421300|Viscosupplements|viscosupplements|mesh-ancestor
102209741|NCT04421300|Protective Agents|protective agents|mesh-ancestor
102209742|NCT05026736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102209744|NCT05026736|Immunoglobulins|immunoglobulins|mesh-list
102209745|NCT05026736|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102209746|NCT05026736|Immunologic Factors|immunologic factors|mesh-ancestor
102209747|NCT05026736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209748|NCT05026736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102209749|NCT02268058|Acetaminophen|acetaminophen|mesh-list
102209750|NCT02268058|Ibuprofen|ibuprofen|mesh-list
102209751|NCT02268058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102209752|NCT02268058|Analgesics|analgesics|mesh-ancestor
102209753|NCT02268058|Sensory System Agents|sensory system agents|mesh-ancestor
102209754|NCT02268058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102209755|NCT02268058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209756|NCT02268058|Antipyretics|antipyretics|mesh-ancestor
102209757|NCT02268058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102209758|NCT02268058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102209759|NCT02268058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102209760|NCT02268058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102209761|NCT02268058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102209762|NCT02268058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209763|NCT02267746|Nicotinic Acids|nicotinic acids|mesh-list
102209764|NCT02267746|Tazarotene|tazarotene|mesh-list
102209765|NCT02267746|Dermatologic Agents|dermatologic agents|mesh-ancestor
102209766|NCT02267746|Keratolytic Agents|keratolytic agents|mesh-ancestor
102209767|NCT02267746|Vitamin B Complex|vitamin b complex|mesh-ancestor
102209768|NCT02267746|Vitamins|vitamins|mesh-ancestor
102209769|NCT02267746|Micronutrients|micronutrients|mesh-ancestor
102209770|NCT02267746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209771|NCT04970108|Empagliflozin|empagliflozin|mesh-list
102209772|NCT04970108|Telmisartan|telmisartan|mesh-list
102209773|NCT04970108|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102209774|NCT04970108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209775|NCT04970108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102209776|NCT04970108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209777|NCT04970108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102209778|NCT04970108|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102209779|NCT04970108|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102209780|NCT04421534|Lactoferrin|lactoferrin|mesh-list
102209781|NCT04421534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102209782|NCT05059028|Oxytocin|oxytocin|mesh-list
102209783|NCT05059028|Oxytocics|oxytocics|mesh-ancestor
102209784|NCT05059028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102209785|NCT05059028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209786|NCT02517866|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
101751641|NCT03579784|Paclitaxel|paclitaxel|mesh-list
102209787|NCT02517866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102209788|NCT02517866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102209789|NCT02517866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918617|NCT00203021|Immunologic Factors|immunologic factors|mesh-ancestor
102209791|NCT04215848|Formoterol Fumarate|formoterol fumarate|mesh-list
102209792|NCT04215848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102209793|NCT04215848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102209794|NCT04215848|Autonomic Agents|autonomic agents|mesh-ancestor
102209795|NCT04215848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102209796|NCT04215848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209797|NCT04215848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102209798|NCT04215848|Respiratory System Agents|respiratory system agents|mesh-ancestor
102209799|NCT04215848|Glucocorticoids|glucocorticoids|mesh-ancestor
102209800|NCT04215848|Hormones|hormones|mesh-ancestor
102209801|NCT04215848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102209802|NCT04215848|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102209803|NCT04215848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102209804|NCT04215848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102209805|NCT04215848|Adrenergic Agents|adrenergic agents|mesh-ancestor
102209806|NCT04215848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102209807|NCT04215848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209808|NCT04215146|Paclitaxel|paclitaxel|mesh-list
102209809|NCT04215146|Avelumab|avelumab|mesh-list
102209810|NCT04215146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102209811|NCT04215146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102209812|NCT04215146|Tubulin Modulators|tubulin modulators|mesh-ancestor
102209813|NCT04215146|Antimitotic Agents|antimitotic agents|mesh-ancestor
102209814|NCT04215146|Mitosis Modulators|mitosis modulators|mesh-ancestor
102209815|NCT04215146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209816|NCT04215146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102209817|NCT05010200|Poly ICLC|poly iclc|mesh-list
102209818|NCT05010200|Interferon Inducers|interferon inducers|mesh-ancestor
102209819|NCT05010200|Immunologic Factors|immunologic factors|mesh-ancestor
102209820|NCT05010200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209821|NCT04959266|Itraconazole|itraconazole|mesh-list
102209822|NCT04959266|Rifampin|rifampin|mesh-list
102209823|NCT04959266|Omeprazole|omeprazole|mesh-list
102209824|NCT04959266|Adavosertib|adavosertib|mesh-list
102209825|NCT04959266|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102209826|NCT04959266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102209827|NCT04959266|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102209828|NCT04959266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102209829|NCT04959266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209830|NCT04959266|Antifungal Agents|antifungal agents|mesh-ancestor
102209831|NCT04959266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102209832|NCT04959266|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102209833|NCT04959266|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102209834|NCT04959266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102209835|NCT04959266|Hormone Antagonists|hormone antagonists|mesh-ancestor
102209836|NCT04959266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102209837|NCT04959266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209838|NCT04959266|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102209839|NCT04959266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102209840|NCT04959266|Antitubercular Agents|antitubercular agents|mesh-ancestor
102209841|NCT04959266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102209842|NCT04959266|Leprostatic Agents|leprostatic agents|mesh-ancestor
102209843|NCT04959266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102209844|NCT04959266|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102209845|NCT04959266|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102209846|NCT04959266|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102209847|NCT04959266|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102209848|NCT04959266|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102209849|NCT04959266|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102209850|NCT05008484|Vitamin D|vitamin d|mesh-list
102209851|NCT05008484|Vitamins|vitamins|mesh-ancestor
102209852|NCT05008484|Micronutrients|micronutrients|mesh-ancestor
102209853|NCT05008484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209854|NCT05008484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102209855|NCT04212416|Leflunomide|leflunomide|mesh-list
102209856|NCT04212416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102209857|NCT04212416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209858|NCT04212416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102209859|NCT04212416|Immunologic Factors|immunologic factors|mesh-ancestor
102209860|NCT04212416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209861|NCT04947254|Ascorbic Acid|ascorbic acid|mesh-list
102209862|NCT04947254|Prednisone|prednisone|mesh-list
102209863|NCT04947254|Cortisone|cortisone|mesh-list
102209864|NCT04947254|Methyltestosterone|methyltestosterone|mesh-list
102209865|NCT04947254|Abiraterone Acetate|abiraterone acetate|mesh-list
102209866|NCT04947254|Niraparib|niraparib|mesh-list
102209867|NCT04947254|Hormones|hormones|mesh-list
102209868|NCT04947254|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
102209869|NCT04947254|Androgens|androgens|mesh-list
102209870|NCT04947254|Androgen Antagonists|androgen antagonists|mesh-list
102209871|NCT04947254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102209872|NCT04947254|Glucocorticoids|glucocorticoids|mesh-ancestor
102209873|NCT04947254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102209874|NCT04947254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209875|NCT04947254|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102209876|NCT04947254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102209877|NCT04947254|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102209878|NCT04947254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102209879|NCT04947254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209880|NCT04947254|Hormone Antagonists|hormone antagonists|mesh-ancestor
102209881|NCT04947254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102209882|NCT04947254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102209883|NCT04947254|Antioxidants|antioxidants|mesh-ancestor
102209884|NCT04947254|Protective Agents|protective agents|mesh-ancestor
102209885|NCT04947254|Vitamins|vitamins|mesh-ancestor
102209886|NCT04947254|Micronutrients|micronutrients|mesh-ancestor
102209887|NCT04947254|Estrogens|estrogens|mesh-ancestor
102209888|NCT04947254|Anabolic Agents|anabolic agents|mesh-ancestor
102209889|NCT04946864|Palbociclib|palbociclib|mesh-list
102209890|NCT04946864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102209891|NCT04946864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102209892|NCT04946864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102209893|NCT04946864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209894|NCT04945148|Metformin|metformin|mesh-list
102209895|NCT04945148|Temozolomide|temozolomide|mesh-list
102209896|NCT04945148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102209897|NCT04945148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209898|NCT04945148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102209899|NCT04945148|Alkylating Agents|alkylating agents|mesh-ancestor
102209900|NCT04945148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209901|NCT04945148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102209902|NCT02516306|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102209903|NCT02516306|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102209904|NCT05003570|Fentanyl|fentanyl|mesh-list
102209905|NCT05003570|Remifentanil|remifentanil|mesh-list
102209906|NCT05003570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102209907|NCT05003570|Narcotics|narcotics|mesh-ancestor
102209908|NCT05003570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102209909|NCT05003570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209910|NCT05003570|Analgesics|analgesics|mesh-ancestor
102209911|NCT05003570|Sensory System Agents|sensory system agents|mesh-ancestor
102209912|NCT05003570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102209913|NCT05003570|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102209914|NCT05003570|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102209915|NCT05003570|Anesthetics, General|anesthetics, general|mesh-ancestor
102209916|NCT05003570|Anesthetics|anesthetics|mesh-ancestor
102209917|NCT04999592|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102209918|NCT04999592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102209919|NCT02483078|Leronlimab|leronlimab|mesh-list
102209920|NCT02483078|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102209921|NCT02483078|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102209922|NCT02483078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209923|NCT02483078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102209924|NCT02483078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102209925|NCT02483078|Antiviral Agents|antiviral agents|mesh-ancestor
102209926|NCT02483078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102209927|NCT02452190|Reslizumab|reslizumab|mesh-list
102209928|NCT02452190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102209929|NCT02452190|Respiratory System Agents|respiratory system agents|mesh-ancestor
102209930|NCT02514122|Ketamine|ketamine|mesh-list
102209931|NCT02514122|Analgesics|analgesics|mesh-ancestor
102209932|NCT02514122|Sensory System Agents|sensory system agents|mesh-ancestor
102209933|NCT02514122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102209934|NCT02514122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209935|NCT02514122|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102209936|NCT02514122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101918765|NCT01239810|Viscosupplements|viscosupplements|mesh-ancestor
102209937|NCT02514122|Anesthetics, General|anesthetics, general|mesh-ancestor
102209938|NCT02514122|Anesthetics|anesthetics|mesh-ancestor
102209939|NCT02514122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102209940|NCT02514122|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102209941|NCT02514122|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102209942|NCT02514122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102209943|NCT02514122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209945|NCT00730639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102209946|NCT00730639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102209947|NCT00730639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102209948|NCT00730639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209949|NCT03964207|Tiotropium Bromide|tiotropium bromide|mesh-list
102209950|NCT03964207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102209951|NCT03964207|Autonomic Agents|autonomic agents|mesh-ancestor
102209952|NCT03964207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102209953|NCT03964207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451370|NCT00470470|Imatinib Mesylate|imatinib mesylate|mesh-list
102209954|NCT03964207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102209955|NCT03964207|Respiratory System Agents|respiratory system agents|mesh-ancestor
102209956|NCT03964207|Parasympatholytics|parasympatholytics|mesh-ancestor
102209957|NCT03964207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102209958|NCT03964207|Cholinergic Agents|cholinergic agents|mesh-ancestor
102209959|NCT03964207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102209960|NCT03964207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209961|NCT04462003|Enoxaparin|enoxaparin|mesh-list
102209962|NCT04462003|Apixaban|apixaban|mesh-list
102209963|NCT04462003|Anticoagulants|anticoagulants|mesh-ancestor
102209964|NCT04462003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102209965|NCT04462003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102209966|NCT04462003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209967|NCT04462003|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102209968|NCT04462003|Antithrombins|antithrombins|mesh-ancestor
102209969|NCT04462003|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102209970|NCT04462003|Protease Inhibitors|protease inhibitors|mesh-ancestor
102209971|NCT04462003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102209972|NCT03489265|Eluxadoline|eluxadoline|mesh-list
102209973|NCT03489265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102209974|NCT03344341|Dapagliflozin|dapagliflozin|mesh-list
102209975|NCT03344341|Acarbose|acarbose|mesh-list
102209976|NCT03344341|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102209977|NCT03344341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102209978|NCT03344341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102209979|NCT03344341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209980|NCT03344341|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102209981|NCT03344341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102209982|NCT03260881|Liraglutide|liraglutide|mesh-list
102209983|NCT03260881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102209984|NCT03260881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209985|NCT03260881|Incretins|incretins|mesh-ancestor
102209986|NCT03260881|Hormones|hormones|mesh-ancestor
102209987|NCT03260881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102209988|NCT03238495|Metformin|metformin|mesh-list
102209989|NCT03238495|Carboplatin|carboplatin|mesh-list
102209990|NCT03238495|Docetaxel|docetaxel|mesh-list
102209991|NCT03238495|Trastuzumab|trastuzumab|mesh-list
102209992|NCT03238495|Pertuzumab|pertuzumab|mesh-list
102209993|NCT03238495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102209994|NCT03238495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102209995|NCT03238495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102209996|NCT03238495|Tubulin Modulators|tubulin modulators|mesh-ancestor
102209997|NCT03238495|Antimitotic Agents|antimitotic agents|mesh-ancestor
102209998|NCT03238495|Mitosis Modulators|mitosis modulators|mesh-ancestor
102209999|NCT03238495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210000|NCT03238495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102210001|NCT02536339|Trastuzumab|trastuzumab|mesh-list
102210002|NCT02536339|Pertuzumab|pertuzumab|mesh-list
102210003|NCT02536339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102210004|NCT02536339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102210005|NCT01869361|Indomethacin|indomethacin|mesh-list
102210006|NCT01869361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102210007|NCT01869361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102210008|NCT01869361|Analgesics|analgesics|mesh-ancestor
102210009|NCT01869361|Sensory System Agents|sensory system agents|mesh-ancestor
102210010|NCT01869361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102210011|NCT01869361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210012|NCT01869361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102210013|NCT01869361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102210014|NCT01869361|Gout Suppressants|gout suppressants|mesh-ancestor
102210015|NCT01869361|Tocolytic Agents|tocolytic agents|mesh-ancestor
102210016|NCT01869361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102210017|NCT01869361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102210018|NCT01869361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102210019|NCT01869361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210020|NCT02322619|Moxifloxacin|moxifloxacin|mesh-list
102210021|NCT02322619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102210022|NCT02322619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102210023|NCT02322619|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102210024|NCT02322619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102210025|NCT02322619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101451381|NCT00195689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102210026|NCT02322619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210027|NCT02322619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102210028|NCT01578967|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102210029|NCT01578967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102210030|NCT01578967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102210031|NCT01578967|Immunotoxins|immunotoxins|mesh-ancestor
102210032|NCT01578967|Immunoconjugates|immunoconjugates|mesh-ancestor
102210033|NCT01578967|Immunologic Factors|immunologic factors|mesh-ancestor
102210034|NCT01578967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210035|NCT01186003|Insulin Detemir|insulin detemir|mesh-list
102210036|NCT01186003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102210037|NCT01186003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210038|NCT02322853|Tamoxifen|tamoxifen|mesh-list
102210039|NCT02322853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102210040|NCT02322853|Hormone Antagonists|hormone antagonists|mesh-ancestor
102210041|NCT02322853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102210042|NCT02322853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210043|NCT02322853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102210044|NCT02322853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102210045|NCT02322853|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102210046|NCT02322853|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102210047|NCT02322853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102210048|NCT03488719|Metoprolol|metoprolol|mesh-list
102210049|NCT03488719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102210050|NCT03488719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102210051|NCT03488719|Sympatholytics|sympatholytics|mesh-ancestor
102210052|NCT03488719|Autonomic Agents|autonomic agents|mesh-ancestor
102210053|NCT03488719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102210054|NCT03488719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210055|NCT03488719|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102210056|NCT03488719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102210057|NCT03488719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102210058|NCT03488719|Adrenergic Agents|adrenergic agents|mesh-ancestor
102210059|NCT03488719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102210060|NCT03488719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210061|NCT03496831|Adalimumab|adalimumab|mesh-list
102210062|NCT03496831|Infliximab|infliximab|mesh-list
102210063|NCT03496831|Golimumab|golimumab|mesh-list
102210064|NCT03496831|Etanercept|etanercept|mesh-list
102210065|NCT03496831|Abatacept|abatacept|mesh-list
102210066|NCT03496831|Ustekinumab|ustekinumab|mesh-list
102210067|NCT03496831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102210068|NCT03496831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102210069|NCT03496831|Immunologic Factors|immunologic factors|mesh-ancestor
102210070|NCT03496831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210071|NCT03496831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102210072|NCT03496831|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102210073|NCT03496831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102210074|NCT03496831|Dermatologic Agents|dermatologic agents|mesh-ancestor
102210075|NCT03496831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102210076|NCT03496831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102210077|NCT03496831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102210078|NCT03496831|Analgesics|analgesics|mesh-ancestor
102210079|NCT03496831|Sensory System Agents|sensory system agents|mesh-ancestor
102210080|NCT03496831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102210081|NCT03496831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102210082|NCT03496831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102210083|NCT03496831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210084|NCT03488485|Sofosbuvir|sofosbuvir|mesh-list
102210085|NCT03488485|Antiviral Agents|antiviral agents|mesh-list
102210086|NCT03488485|Ledipasvir|ledipasvir|mesh-list
102210087|NCT03488485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102210088|NCT00821249|Dexamethasone|dexamethasone|mesh-list
101918917|NCT01375816|Antimetabolites|antimetabolites|mesh-ancestor
102210089|NCT00821249|Filanesib|filanesib|mesh-list
102210090|NCT00821249|Lenograstim|lenograstim|mesh-list
102210091|NCT00821249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102210092|NCT00821249|Antiemetics|antiemetics|mesh-ancestor
102210093|NCT00821249|Autonomic Agents|autonomic agents|mesh-ancestor
102210094|NCT00821249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102210095|NCT00821249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210096|NCT00821249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102210097|NCT00821249|Glucocorticoids|glucocorticoids|mesh-ancestor
102210098|NCT00821249|Hormones|hormones|mesh-ancestor
102210099|NCT00821249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102210100|NCT00821249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102210101|NCT00821249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102210102|NCT00821249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102210103|NCT00821249|Immunologic Factors|immunologic factors|mesh-ancestor
102210104|NCT00821249|Antimitotic Agents|antimitotic agents|mesh-ancestor
102210105|NCT00821249|Mitosis Modulators|mitosis modulators|mesh-ancestor
102210106|NCT00821249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210107|NCT03752723|Cyclophosphamide|cyclophosphamide|mesh-list
102210108|NCT03752723|Pembrolizumab|pembrolizumab|mesh-list
102210109|NCT03752723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102210110|NCT03752723|Immunologic Factors|immunologic factors|mesh-ancestor
102210111|NCT03752723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210112|NCT03752723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102210113|NCT03752723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102210114|NCT03752723|Alkylating Agents|alkylating agents|mesh-ancestor
102210115|NCT03752723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210116|NCT03752723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102210117|NCT03752723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102210118|NCT03752723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102210119|NCT03752723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102210120|NCT04472585|Ivermectin|ivermectin|mesh-list
102210121|NCT04472585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102210122|NCT04472585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102210123|NCT03496519|Durvalumab|durvalumab|mesh-list
102210124|NCT03496519|Trabectedin|trabectedin|mesh-list
102210125|NCT03496519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102210126|NCT03496519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102210127|NCT03496519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102210128|NCT03496519|Immunologic Factors|immunologic factors|mesh-ancestor
102210129|NCT03496519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210130|NCT03496519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102210131|NCT03496519|Alkylating Agents|alkylating agents|mesh-ancestor
102210132|NCT03496519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210133|NCT00813605|Conatumumab|conatumumab|mesh-list
102210134|NCT00813605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102210135|NCT00813605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102210136|NCT00724841|Temozolomide|temozolomide|mesh-list
102210137|NCT00724841|Obatoclax|obatoclax|mesh-list
102210138|NCT00724841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102210139|NCT00724841|Alkylating Agents|alkylating agents|mesh-ancestor
102210140|NCT00724841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210141|NCT00724841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102210142|NCT00724841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102210143|NCT03131791|Botulinum Toxins|botulinum toxins|mesh-list
102210144|NCT03131791|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102210145|NCT03131791|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102210146|NCT03131791|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102210147|NCT03131791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102210148|NCT03131791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210149|NCT03131791|Cholinergic Agents|cholinergic agents|mesh-ancestor
102210150|NCT03131791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102210151|NCT03131791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210152|NCT03131791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102210153|NCT03131791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102210154|NCT00805805|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
102210155|NCT00805805|Chelating Agents|chelating agents|mesh-ancestor
102210156|NCT00805805|Sequestering Agents|sequestering agents|mesh-ancestor
102210157|NCT00805805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210158|NCT00805805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102210159|NCT00805805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102210160|NCT00805805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102210161|NCT00805805|Growth Substances|growth substances|mesh-ancestor
102210162|NCT00805805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210164|NCT00805805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102210165|NCT03488173|Lansoprazole|lansoprazole|mesh-list
102210166|NCT03488173|Dexlansoprazole|dexlansoprazole|mesh-list
102210167|NCT03488173|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102210168|NCT03488173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102210169|NCT03488173|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102210170|NCT03488173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102210171|NCT03488173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210172|NCT03420521|Nivolumab|nivolumab|mesh-list
102210173|NCT03420521|Ipilimumab|ipilimumab|mesh-list
102210174|NCT03420521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102210175|NCT03420521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102210176|NCT03420521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102210177|NCT03420521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210178|NCT04750759|Niclosamide|niclosamide|mesh-list
102210179|NCT04750759|Camostat|camostat|mesh-list
102210180|NCT04750759|Protease Inhibitors|protease inhibitors|mesh-ancestor
102210181|NCT04750759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102210182|NCT04750759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210183|NCT04750759|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102210184|NCT04750759|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102210185|NCT04750759|Anticestodal Agents|anticestodal agents|mesh-ancestor
102210186|NCT04750759|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102210187|NCT04750759|Anthelmintics|anthelmintics|mesh-ancestor
102210188|NCT04750759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102210189|NCT04750759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102210190|NCT04750759|Antinematodal Agents|antinematodal agents|mesh-ancestor
102210191|NCT03382925|Triamcinolone|triamcinolone|mesh-list
102210192|NCT03382925|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102210193|NCT03382925|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102210194|NCT03382925|Lidocaine|lidocaine|mesh-list
102210195|NCT03382925|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102210196|NCT03382925|Anesthetics, Local|anesthetics, local|mesh-ancestor
102210197|NCT03382925|Anesthetics|anesthetics|mesh-ancestor
102210198|NCT03382925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102210199|NCT03382925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210200|NCT03382925|Sensory System Agents|sensory system agents|mesh-ancestor
102210201|NCT03382925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102210202|NCT03382925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102210203|NCT03382925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102210204|NCT03382925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102210205|NCT03382925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102210206|NCT03382925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210207|NCT03382925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102210208|NCT03382925|Glucocorticoids|glucocorticoids|mesh-ancestor
102210209|NCT03382925|Hormones|hormones|mesh-ancestor
102210210|NCT03382925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102210211|NCT03382925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102210212|NCT03382925|Immunologic Factors|immunologic factors|mesh-ancestor
102210213|NCT03382925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102210214|NCT03487939|Fluorouracil|fluorouracil|mesh-list
102210215|NCT03487939|Oxaliplatin|oxaliplatin|mesh-list
102210216|NCT03487939|Irinotecan|irinotecan|mesh-list
102210217|NCT03487939|Antimetabolites|antimetabolites|mesh-ancestor
102210218|NCT03487939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210219|NCT03487939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102210220|NCT03487939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102210221|NCT03487939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102210222|NCT03487939|Immunologic Factors|immunologic factors|mesh-ancestor
102210223|NCT03487939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210224|NCT03487939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102210225|NCT03487939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102210226|NCT03487939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102210227|NCT00796289|Citric Acid|citric acid|mesh-list
102210228|NCT00796289|Sodium Citrate|sodium citrate|mesh-list
102210229|NCT00796289|Clomiphene|clomiphene|mesh-list
102210230|NCT00796289|Enclomiphene|enclomiphene|mesh-list
102210231|NCT00796289|Zuclomiphene|zuclomiphene|mesh-list
102210232|NCT00796289|Hormones|hormones|mesh-list
102210233|NCT00796289|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
102210234|NCT00796289|Anticoagulants|anticoagulants|mesh-ancestor
102210235|NCT00796289|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102210236|NCT00796289|Chelating Agents|chelating agents|mesh-ancestor
101451393|NCT00225381|Anesthetics|anesthetics|mesh-list
102210237|NCT00796289|Sequestering Agents|sequestering agents|mesh-ancestor
102210238|NCT00796289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210239|NCT00796289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102210240|NCT00796289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210241|NCT00796289|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102210242|NCT00796289|Hormone Antagonists|hormone antagonists|mesh-ancestor
102210243|NCT00796289|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102210244|NCT00796289|Fertility Agents|fertility agents|mesh-ancestor
102210245|NCT00796289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102210246|NCT00796289|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102210247|NCT00796289|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102210248|NCT04460443|Sofosbuvir|sofosbuvir|mesh-list
102210249|NCT04460443|Antiviral Agents|antiviral agents|mesh-ancestor
102210250|NCT04460443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102210251|NCT04460521|Acetylcysteine|acetylcysteine|mesh-list
102210252|NCT04460521|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102210253|NCT04460521|Antiviral Agents|antiviral agents|mesh-ancestor
102210254|NCT04460521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102210255|NCT04460521|Expectorants|expectorants|mesh-ancestor
102210256|NCT04460521|Respiratory System Agents|respiratory system agents|mesh-ancestor
102210257|NCT04460521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102210258|NCT04460521|Antioxidants|antioxidants|mesh-ancestor
102210259|NCT04460521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210260|NCT04460521|Protective Agents|protective agents|mesh-ancestor
102210261|NCT04460521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210262|NCT04460521|Antidotes|antidotes|mesh-ancestor
102210263|NCT00698789|Metformin|metformin|mesh-list
102210264|NCT00698789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102210265|NCT00698789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210266|NCT03487783|Aripiprazole|aripiprazole|mesh-list
102210267|NCT03487783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102210268|NCT03487783|Antidepressive Agents|antidepressive agents|mesh-ancestor
102210269|NCT03487783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102210270|NCT03487783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102210271|NCT03487783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102210272|NCT03487783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102210273|NCT03487783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210274|NCT03487783|Dopamine Agonists|dopamine agonists|mesh-ancestor
102210275|NCT03487783|Dopamine Agents|dopamine agents|mesh-ancestor
102210276|NCT03487783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102210277|NCT03487783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210278|NCT03487783|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102210279|NCT03487783|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102210280|NCT03487783|Serotonin Agents|serotonin agents|mesh-ancestor
102210281|NCT03487783|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102210282|NCT03487783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102210283|NCT03487783|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102210284|NCT03487783|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102210285|NCT03495739|Dabigatran|dabigatran|mesh-list
102210286|NCT03495739|Antithrombins|antithrombins|mesh-ancestor
102210287|NCT03495739|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102210288|NCT03495739|Protease Inhibitors|protease inhibitors|mesh-ancestor
102210289|NCT03495739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102210290|NCT03495739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210291|NCT03495739|Anticoagulants|anticoagulants|mesh-ancestor
102210292|NCT03298061|Prednisolone|prednisolone|mesh-list
102210293|NCT03298061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102210294|NCT03298061|Glucocorticoids|glucocorticoids|mesh-ancestor
102210295|NCT03298061|Hormones|hormones|mesh-ancestor
102210296|NCT03298061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101451396|NCT00195728|Acetaminophen|acetaminophen|mesh-list
102210297|NCT03298061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210298|NCT03298061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102210299|NCT03298061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102210300|NCT04071613|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102210301|NCT04071613|Plasminogen|plasminogen|mesh-list
102210302|NCT04071613|Tenecteplase|tenecteplase|mesh-list
102210303|NCT04071613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102210304|NCT04071613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102210305|NCT04071613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210306|NCT00678119|Sunitinib|sunitinib|mesh-list
102210307|NCT00678119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102210308|NCT00678119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102210309|NCT00678119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102210310|NCT00678119|Growth Substances|growth substances|mesh-ancestor
102210311|NCT00678119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210312|NCT00678119|Growth Inhibitors|growth inhibitors|mesh-ancestor
102210313|NCT00678119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102210314|NCT00678119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102210315|NCT00678119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210317|NCT02812667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102210318|NCT02812667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102210319|NCT02812667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102210320|NCT02812667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210321|NCT02799095|Pembrolizumab|pembrolizumab|mesh-list
102210322|NCT02799095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102210323|NCT02799095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102210324|NCT02799095|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102210325|NCT02799095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210326|NCT02011321|Clevidipine|clevidipine|mesh-list
102210327|NCT02011321|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102210328|NCT02011321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102210329|NCT02011321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210330|NCT02011321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102210331|NCT02011321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210332|NCT01352585|Anagrelide|anagrelide|mesh-list
102210333|NCT01352585|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102210334|NCT01352585|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102210335|NCT01352585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210336|NCT01352585|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102210337|NCT03484507|Chlorhexidine|chlorhexidine|mesh-list
102210338|NCT03484507|Povidone-Iodine|povidone-iodine|mesh-list
102210339|NCT03484507|Prednisolone|prednisolone|mesh-list
102210340|NCT03484507|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102210341|NCT03484507|Methylprednisolone|methylprednisolone|mesh-list
102210342|NCT03484507|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102210343|NCT03484507|Prednisolone acetate|prednisolone acetate|mesh-list
102210344|NCT03484507|Povidone|povidone|mesh-list
102210345|NCT03484507|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102210346|NCT03484507|Prednisolone phosphate|prednisolone phosphate|mesh-list
102210347|NCT03484507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102210348|NCT03484507|Glucocorticoids|glucocorticoids|mesh-ancestor
102210349|NCT03484507|Hormones|hormones|mesh-ancestor
102210350|NCT03484507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102210351|NCT03484507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210352|NCT03484507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102210353|NCT03484507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102210354|NCT03484507|Antiemetics|antiemetics|mesh-ancestor
102210355|NCT03484507|Autonomic Agents|autonomic agents|mesh-ancestor
102210356|NCT03484507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102210357|NCT03484507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102210358|NCT03484507|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102210359|NCT03484507|Protective Agents|protective agents|mesh-ancestor
102210360|NCT03484507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102210361|NCT03484507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102210362|NCT03484507|Disinfectants|disinfectants|mesh-ancestor
102210363|NCT03484507|Plasma Substitutes|plasma substitutes|mesh-ancestor
102210364|NCT03484507|Blood Substitutes|blood substitutes|mesh-ancestor
102210365|NCT02773355|Liraglutide|liraglutide|mesh-list
102210366|NCT02773355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102210367|NCT02773355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210368|NCT02773355|Incretins|incretins|mesh-ancestor
102210369|NCT02773355|Hormones|hormones|mesh-ancestor
102210370|NCT02773355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102210371|NCT02744183|Benzocaine|benzocaine|mesh-list
102210372|NCT02744183|Anesthetics, Local|anesthetics, local|mesh-ancestor
102210373|NCT02744183|Anesthetics|anesthetics|mesh-ancestor
102210374|NCT02744183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102210375|NCT02744183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210376|NCT02744183|Sensory System Agents|sensory system agents|mesh-ancestor
102210377|NCT02744183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102210378|NCT03484195|Fluorouracil|fluorouracil|mesh-list
102210379|NCT03484195|Oxaliplatin|oxaliplatin|mesh-list
102210380|NCT03484195|Irinotecan|irinotecan|mesh-list
102210381|NCT03484195|Antimetabolites|antimetabolites|mesh-ancestor
102210382|NCT03484195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210383|NCT03484195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102210384|NCT03484195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102210385|NCT03484195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102210386|NCT03484195|Immunologic Factors|immunologic factors|mesh-ancestor
102210387|NCT03484195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210388|NCT03484195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102210389|NCT03484195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102210390|NCT03484195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102210391|NCT02713607|Doxycycline|doxycycline|mesh-list
102210392|NCT02713607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102210393|NCT02713607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102210394|NCT02713607|Antimalarials|antimalarials|mesh-ancestor
102210395|NCT02713607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102210396|NCT02713607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102210397|NCT04526821|Lactoferrin|lactoferrin|mesh-list
102210398|NCT04526821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102210399|NCT02681549|Bevacizumab|bevacizumab|mesh-list
102210400|NCT02681549|Pembrolizumab|pembrolizumab|mesh-list
102210401|NCT02681549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102210402|NCT02681549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102210403|NCT02681549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102210404|NCT02681549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102210405|NCT02681549|Growth Substances|growth substances|mesh-ancestor
102210406|NCT02681549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210407|NCT02681549|Growth Inhibitors|growth inhibitors|mesh-ancestor
102210408|NCT02681549|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102210409|NCT02681549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210410|NCT02323399|Phenylephrine|phenylephrine|mesh-list
102210411|NCT02323399|Oxymetazoline|oxymetazoline|mesh-list
102210412|NCT02323399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102210413|NCT02323399|Mydriatics|mydriatics|mesh-ancestor
102210414|NCT02323399|Autonomic Agents|autonomic agents|mesh-ancestor
102210415|NCT02323399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102210416|NCT02323399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210417|NCT02323399|Sympathomimetics|sympathomimetics|mesh-ancestor
102210418|NCT02323399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102210419|NCT02323399|Nasal Decongestants|nasal decongestants|mesh-ancestor
102210420|NCT02323399|Respiratory System Agents|respiratory system agents|mesh-ancestor
102210421|NCT02323399|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102210422|NCT02323399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102210423|NCT02323399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102210424|NCT02323399|Adrenergic Agents|adrenergic agents|mesh-ancestor
102210425|NCT02323399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102210426|NCT02323399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210427|NCT02323399|Protective Agents|protective agents|mesh-ancestor
102210428|NCT01352507|Sildenafil Citrate|sildenafil citrate|mesh-list
102210429|NCT01352507|Tadalafil|tadalafil|mesh-list
102210431|NCT01352507|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102210432|NCT01352507|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102210433|NCT01352507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102210434|NCT01352507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210435|NCT01352507|Urological Agents|urological agents|mesh-ancestor
102210436|NCT04460963|Adrenomedullin|adrenomedullin|mesh-list
102210437|NCT04460963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102210438|NCT04460963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102210439|NCT04460963|Autonomic Agents|autonomic agents|mesh-ancestor
102210440|NCT04460963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102210441|NCT04460963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210442|NCT04460963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102210443|NCT04460963|Respiratory System Agents|respiratory system agents|mesh-ancestor
102210444|NCT04460963|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102210445|NCT04460963|Vasodilator Agents|vasodilator agents|mesh-ancestor
102210446|NCT04460963|Protective Agents|protective agents|mesh-ancestor
102210447|NCT00873275|Leucovorin|leucovorin|mesh-list
102210448|NCT00873275|Bevacizumab|bevacizumab|mesh-list
102210449|NCT00873275|Fluorouracil|fluorouracil|mesh-list
102210450|NCT00873275|Oxaliplatin|oxaliplatin|mesh-list
102210451|NCT00873275|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102210452|NCT00873275|Calcium|calcium|mesh-list
102210453|NCT00873275|Levoleucovorin|levoleucovorin|mesh-list
102210454|NCT00873275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102210455|NCT00873275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102210456|NCT00873275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102210457|NCT00873275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102210458|NCT00873275|Growth Substances|growth substances|mesh-ancestor
102210459|NCT00873275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210460|NCT00873275|Growth Inhibitors|growth inhibitors|mesh-ancestor
102210461|NCT00873275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102210462|NCT00873275|Antimetabolites|antimetabolites|mesh-ancestor
102210463|NCT00873275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919298|NCT01147146|Fentanyl|fentanyl|mesh-list
102210464|NCT00873275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102210465|NCT00873275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102210466|NCT00873275|Immunologic Factors|immunologic factors|mesh-ancestor
102210467|NCT00873275|Antidotes|antidotes|mesh-ancestor
102210468|NCT00873275|Protective Agents|protective agents|mesh-ancestor
102210469|NCT00873275|Vitamin B Complex|vitamin b complex|mesh-ancestor
102210471|NCT00873275|Micronutrients|micronutrients|mesh-ancestor
102210472|NCT00873275|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102210473|NCT00873275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102210474|NCT04403243|Colchicine|colchicine|mesh-list
102210475|NCT04403243|Gout Suppressants|gout suppressants|mesh-ancestor
102210476|NCT04403243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102210477|NCT04403243|Tubulin Modulators|tubulin modulators|mesh-ancestor
102210478|NCT04403243|Antimitotic Agents|antimitotic agents|mesh-ancestor
102210479|NCT04403243|Mitosis Modulators|mitosis modulators|mesh-ancestor
102210480|NCT04403243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210481|NCT04403243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102210482|NCT05648032|Triamcinolone|triamcinolone|mesh-list
102210483|NCT05648032|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102210484|NCT05648032|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102210485|NCT05648032|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102210486|NCT05648032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102210487|NCT05648032|Glucocorticoids|glucocorticoids|mesh-ancestor
102210488|NCT05648032|Hormones|hormones|mesh-ancestor
102210489|NCT05648032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102210490|NCT05648032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210491|NCT05648032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102210492|NCT05648032|Immunologic Factors|immunologic factors|mesh-ancestor
102210493|NCT05648032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102210494|NCT05648032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210495|NCT00774761|Fluticasone|fluticasone|mesh-list
102210496|NCT00774761|Xhance|xhance|mesh-list
102210497|NCT00774761|Formoterol Fumarate|formoterol fumarate|mesh-list
102210498|NCT00774761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102210499|NCT00774761|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102210500|NCT00774761|Autonomic Agents|autonomic agents|mesh-ancestor
102210501|NCT00774761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102210502|NCT00774761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210503|NCT00774761|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102210504|NCT00774761|Respiratory System Agents|respiratory system agents|mesh-ancestor
102210505|NCT00774761|Dermatologic Agents|dermatologic agents|mesh-ancestor
102210507|NCT00774761|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102210508|NCT00774761|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102210509|NCT00774761|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102210510|NCT00774761|Adrenergic Agents|adrenergic agents|mesh-ancestor
102210511|NCT00774761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102210512|NCT00774761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210513|NCT00772343|Vaccines|vaccines|mesh-list
102210514|NCT00772343|Immunologic Factors|immunologic factors|mesh-ancestor
102210515|NCT00772343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210516|NCT05647954|Pembrolizumab|pembrolizumab|mesh-list
102210517|NCT05647954|Temozolomide|temozolomide|mesh-list
102210518|NCT05647954|Chlorotrianisene|chlorotrianisene|mesh-list
102210519|NCT05647954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102210520|NCT05647954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102210521|NCT05647954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102210522|NCT05647954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210523|NCT05647954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102210524|NCT05647954|Alkylating Agents|alkylating agents|mesh-ancestor
102210525|NCT05647954|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102210526|NCT05647954|Estrogens|estrogens|mesh-ancestor
102210527|NCT05647954|Hormones|hormones|mesh-ancestor
102210528|NCT05647954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102210529|NCT05647954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210530|NCT05647954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102210531|NCT00770081|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102210532|NCT00770081|Vildagliptin|vildagliptin|mesh-list
102210533|NCT00770081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102210534|NCT00770081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210535|NCT00770081|Incretins|incretins|mesh-ancestor
102210536|NCT00770081|Hormones|hormones|mesh-ancestor
102210537|NCT00770081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102210538|NCT00770081|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102210539|NCT00770081|Protease Inhibitors|protease inhibitors|mesh-ancestor
102210540|NCT00770081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102210541|NCT00770081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210542|NCT02360098|Anesthetics|anesthetics|mesh-list
102210543|NCT02360098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102210544|NCT02360098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210545|NCT02273609|Vitamin K|vitamin k|mesh-list
102210546|NCT02273609|Warfarin|warfarin|mesh-list
102210547|NCT02273609|Acenocoumarol|acenocoumarol|mesh-list
102210548|NCT02273609|Vitamins|vitamins|mesh-ancestor
102210549|NCT02273609|Micronutrients|micronutrients|mesh-ancestor
102210550|NCT02273609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210551|NCT02273609|Anticoagulants|anticoagulants|mesh-ancestor
102210552|NCT02273609|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102210553|NCT02273609|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102210554|NCT02273609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210555|NCT02273609|Hemostatics|hemostatics|mesh-ancestor
102210556|NCT02273609|Coagulants|coagulants|mesh-ancestor
102210557|NCT02273843|Vitamin D|vitamin d|mesh-list
102210558|NCT02273843|Ergocalciferols|ergocalciferols|mesh-list
102210559|NCT02273843|Cholecalciferol|cholecalciferol|mesh-list
102210560|NCT02273843|Vitamins|vitamins|mesh-list
102210561|NCT02273843|Micronutrients|micronutrients|mesh-ancestor
102210562|NCT02273843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210563|NCT02273843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102210564|NCT02273843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102210565|NCT00666497|Azacitidine|azacitidine|mesh-list
102210566|NCT00666497|Mocetinostat|mocetinostat|mesh-list
102210567|NCT00666497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102210568|NCT00666497|Antimetabolites|antimetabolites|mesh-ancestor
102210569|NCT00666497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210570|NCT00666497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102210571|NCT00666497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102210572|NCT00666497|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102210573|NCT02274077|Bupivacaine|bupivacaine|mesh-list
102210574|NCT02274077|Anesthetics, Local|anesthetics, local|mesh-ancestor
102210575|NCT02274077|Anesthetics|anesthetics|mesh-ancestor
102210576|NCT02274077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102210577|NCT02274077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210578|NCT02274077|Sensory System Agents|sensory system agents|mesh-ancestor
102210579|NCT02274077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102210580|NCT00765323|Octreotide|octreotide|mesh-list
102210581|NCT00765323|Somatostatin|somatostatin|mesh-list
102210582|NCT00765323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102210583|NCT00765323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102210584|NCT00765323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102210586|NCT00765323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102210587|NCT00765323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210621|NCT02277587|Hydrocortisone|hydrocortisone|mesh-list
102210622|NCT02277587|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102210623|NCT02277587|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102210624|NCT02277587|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102210625|NCT02277587|Cortisone|cortisone|mesh-list
102210626|NCT02277587|Glucocorticoids|glucocorticoids|mesh-list
102210627|NCT02277587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102210628|NCT02277587|Hormones|hormones|mesh-ancestor
102210629|NCT02277587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102210630|NCT02277587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210631|NCT00663767|Celecoxib|celecoxib|mesh-list
102210632|NCT00663767|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
102210633|NCT00663767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102210634|NCT00663767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102210635|NCT00663767|Analgesics|analgesics|mesh-ancestor
102210636|NCT00663767|Sensory System Agents|sensory system agents|mesh-ancestor
102210637|NCT00663767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102210638|NCT00663767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210639|NCT00663767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102210640|NCT00663767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102210641|NCT00663767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102210642|NCT00663767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102210643|NCT00663767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210644|NCT00662597|Paclitaxel|paclitaxel|mesh-list
102210645|NCT00662597|Carboplatin|carboplatin|mesh-list
102210646|NCT00662597|Vadimezan|vadimezan|mesh-list
102210647|NCT00662597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102210648|NCT00662597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102210649|NCT00662597|Tubulin Modulators|tubulin modulators|mesh-ancestor
102210650|NCT00662597|Antimitotic Agents|antimitotic agents|mesh-ancestor
102210651|NCT00662597|Mitosis Modulators|mitosis modulators|mesh-ancestor
102210652|NCT00662597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210653|NCT02266888|Rituximab|rituximab|mesh-list
102210654|NCT02266888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101752540|NCT04018768|Narcotics|narcotics|mesh-ancestor
102210655|NCT02266888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102210656|NCT02266888|Immunologic Factors|immunologic factors|mesh-ancestor
102210657|NCT02266888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210658|NCT02266888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102210660|NCT01641952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102210661|NCT01641952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102210662|NCT01641952|Immunologic Factors|immunologic factors|mesh-ancestor
102210663|NCT01641952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210664|NCT01641952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102210665|NCT00660881|Epratuzumab|epratuzumab|mesh-list
102210666|NCT00660881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102210667|NCT00660881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102210668|NCT02359552|Rasagiline|rasagiline|mesh-list
102210669|NCT02359552|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102210670|NCT02359552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102210671|NCT02359552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210672|NCT02359552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102210673|NCT02359552|Protective Agents|protective agents|mesh-ancestor
102210674|NCT02359552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210675|NCT02279537|Aflibercept|aflibercept|mesh-list
102210676|NCT02279537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102210677|NCT02279537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102210678|NCT02279537|Growth Substances|growth substances|mesh-ancestor
102210679|NCT02279537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210680|NCT02279537|Growth Inhibitors|growth inhibitors|mesh-ancestor
102210681|NCT02279537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102210682|NCT02280083|Botulinum Toxins|botulinum toxins|mesh-list
102210683|NCT02280083|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102210684|NCT02280083|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101451432|NCT00195767|Antimanic Agents|antimanic agents|mesh-ancestor
102210685|NCT02280083|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102210686|NCT02280083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102210687|NCT02280083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210688|NCT02280083|Cholinergic Agents|cholinergic agents|mesh-ancestor
102210689|NCT02280083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102210690|NCT02280083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210691|NCT02280083|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102210692|NCT02280083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102210693|NCT00752297|Botulinum Toxins|botulinum toxins|mesh-list
102210694|NCT00752297|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102210695|NCT00752297|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102210696|NCT00752297|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102210697|NCT00752297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102210698|NCT00752297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210699|NCT00752297|Cholinergic Agents|cholinergic agents|mesh-ancestor
102210700|NCT00752297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102210701|NCT00752297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210702|NCT00752297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102210703|NCT00752297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102210704|NCT00656357|Cocaine|cocaine|mesh-list
102210705|NCT00656357|Anesthetics, Local|anesthetics, local|mesh-ancestor
102210706|NCT00656357|Anesthetics|anesthetics|mesh-ancestor
102210707|NCT00656357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102210708|NCT00656357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210709|NCT00656357|Sensory System Agents|sensory system agents|mesh-ancestor
102210710|NCT00656357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102210711|NCT00656357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102210712|NCT00656357|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102210713|NCT00656357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102210714|NCT00656357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102210715|NCT00656357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210716|NCT00656357|Dopamine Agents|dopamine agents|mesh-ancestor
102210717|NCT00656357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102210718|NCT02280629|Mesalamine|mesalamine|mesh-list
102210719|NCT02280629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102210720|NCT02280629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102210721|NCT02280629|Analgesics|analgesics|mesh-ancestor
102210722|NCT02280629|Sensory System Agents|sensory system agents|mesh-ancestor
102210723|NCT02280629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102210724|NCT02280629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210725|NCT02280629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102210726|NCT02280629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102210727|NCT03134573|Interferons|interferons|mesh-list
102210728|NCT03134573|Interferon-beta|interferon-beta|mesh-list
102210729|NCT03134573|Interferon beta-1b|interferon beta-1b|mesh-list
102210730|NCT03134573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102210731|NCT03134573|Antiviral Agents|antiviral agents|mesh-ancestor
102210732|NCT03134573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102210733|NCT03134573|Immunologic Factors|immunologic factors|mesh-ancestor
102210734|NCT03134573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210735|NCT03134573|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102210736|NCT00743795|Ribavirin|ribavirin|mesh-list
102210737|NCT00743795|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102210738|NCT00743795|Antimetabolites|antimetabolites|mesh-ancestor
102210739|NCT00743795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210740|NCT00743795|Antiviral Agents|antiviral agents|mesh-ancestor
102210741|NCT00743795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102210742|NCT04232033|Mitogens|mitogens|mesh-list
102210743|NCT04232033|Mitosis Modulators|mitosis modulators|mesh-ancestor
102210744|NCT04232033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210745|NCT03134417|Vitamin D|vitamin d|mesh-list
102210746|NCT03134417|Ergocalciferols|ergocalciferols|mesh-list
102210747|NCT03134417|Cholecalciferol|cholecalciferol|mesh-list
102210748|NCT03134417|Vitamins|vitamins|mesh-list
102210749|NCT03134417|Micronutrients|micronutrients|mesh-ancestor
102210750|NCT03134417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210751|NCT03134417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102210752|NCT03134417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102210753|NCT00649025|Fluticasone|fluticasone|mesh-list
102210754|NCT00649025|Xhance|xhance|mesh-list
102210755|NCT00649025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102210756|NCT00649025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102210757|NCT00649025|Autonomic Agents|autonomic agents|mesh-ancestor
102210758|NCT00649025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102210759|NCT00649025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210760|NCT00649025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102210761|NCT00649025|Respiratory System Agents|respiratory system agents|mesh-ancestor
102210762|NCT00649025|Dermatologic Agents|dermatologic agents|mesh-ancestor
102210763|NCT00649025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102210764|NCT00647231|Ketoprofen|ketoprofen|mesh-list
101919607|NCT01256580|Hormones|hormones|mesh-ancestor
102210765|NCT00647231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102210766|NCT00647231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102210767|NCT00647231|Analgesics|analgesics|mesh-ancestor
102210768|NCT00647231|Sensory System Agents|sensory system agents|mesh-ancestor
102210769|NCT00647231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102210770|NCT00647231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210771|NCT00647231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102210772|NCT00647231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102210773|NCT00647231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102210774|NCT00647231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102210775|NCT00647231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210776|NCT00739349|Cyclosporine|cyclosporine|mesh-list
102210777|NCT00739349|Cyclosporins|cyclosporins|mesh-list
102210778|NCT00739349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102210779|NCT00739349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210780|NCT00739349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102210781|NCT00739349|Immunologic Factors|immunologic factors|mesh-ancestor
102210782|NCT00739349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210783|NCT00739349|Antifungal Agents|antifungal agents|mesh-ancestor
102210784|NCT00739349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102210785|NCT00739349|Dermatologic Agents|dermatologic agents|mesh-ancestor
102210786|NCT00739349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102210787|NCT00739349|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102210788|NCT00152009|Guanfacine|guanfacine|mesh-list
102210789|NCT00152009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102210790|NCT00152009|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102210791|NCT00152009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102210792|NCT00152009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102210793|NCT00152009|Adrenergic Agents|adrenergic agents|mesh-ancestor
102210794|NCT00152009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102210795|NCT00152009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210796|NCT00152009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210797|NCT02280785|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102210798|NCT02280785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102210799|NCT02280785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102210800|NCT02280785|Immunotoxins|immunotoxins|mesh-ancestor
102210801|NCT02280785|Immunoconjugates|immunoconjugates|mesh-ancestor
102210803|NCT02280785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210804|NCT04158635|Paclitaxel|paclitaxel|mesh-list
102210805|NCT04158635|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102210806|NCT04158635|Gemcitabine|gemcitabine|mesh-list
102210807|NCT04158635|Bosentan|bosentan|mesh-list
102210808|NCT04158635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102210809|NCT04158635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102210810|NCT04158635|Tubulin Modulators|tubulin modulators|mesh-ancestor
102210811|NCT04158635|Antimitotic Agents|antimitotic agents|mesh-ancestor
102210812|NCT04158635|Mitosis Modulators|mitosis modulators|mesh-ancestor
102210813|NCT04158635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210814|NCT04158635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102210815|NCT04158635|Antimetabolites|antimetabolites|mesh-ancestor
102210816|NCT04158635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102210817|NCT04158635|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102210818|NCT00734435|Zonisamide|zonisamide|mesh-list
102210819|NCT00734435|Olanzapine|olanzapine|mesh-list
102210820|NCT00734435|Antiemetics|antiemetics|mesh-ancestor
102210821|NCT00734435|Autonomic Agents|autonomic agents|mesh-ancestor
102210822|NCT00734435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102210823|NCT00734435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210824|NCT00734435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102210825|NCT00734435|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102210826|NCT00734435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102210827|NCT00734435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102210828|NCT00734435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102210829|NCT00734435|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102210830|NCT00734435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102210831|NCT00734435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102210832|NCT00734435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210833|NCT00734435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102210834|NCT00734435|Serotonin Agents|serotonin agents|mesh-ancestor
102210835|NCT00734435|Anticonvulsants|anticonvulsants|mesh-ancestor
102210836|NCT00734435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102210837|NCT00734435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102210838|NCT00728351|Metformin|metformin|mesh-list
102210839|NCT00728351|Vildagliptin|vildagliptin|mesh-list
102210841|NCT00728351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210842|NCT00728351|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102210843|NCT00728351|Protease Inhibitors|protease inhibitors|mesh-ancestor
102210844|NCT00728351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102210845|NCT00728351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210846|NCT00616811|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102210847|NCT00616811|Vildagliptin|vildagliptin|mesh-list
102210848|NCT00616811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102210849|NCT00616811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210850|NCT00616811|Incretins|incretins|mesh-ancestor
102210851|NCT00616811|Hormones|hormones|mesh-ancestor
102210852|NCT00616811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102210853|NCT00616811|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102210854|NCT00616811|Protease Inhibitors|protease inhibitors|mesh-ancestor
102210855|NCT00616811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102210856|NCT00616811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210857|NCT00615251|Progesterone|progesterone|mesh-list
102210858|NCT00615251|Progestins|progestins|mesh-ancestor
102210859|NCT00615251|Hormones|hormones|mesh-ancestor
102210860|NCT00615251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102210861|NCT00615251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210862|NCT02265796|Ranolazine|ranolazine|mesh-list
102210863|NCT02265796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102210864|NCT02265796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102210865|NCT02265796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210866|NCT05647642|Midazolam|midazolam|mesh-list
102210867|NCT05647642|Dexmedetomidine|dexmedetomidine|mesh-list
102210868|NCT05647642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102210869|NCT05647642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102210870|NCT05647642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210871|NCT05647642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102210872|NCT05647642|Analgesics|analgesics|mesh-ancestor
102210873|NCT05647642|Sensory System Agents|sensory system agents|mesh-ancestor
102210874|NCT05647642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101900689|NCT03265132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102210875|NCT05647642|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102210876|NCT05647642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102210877|NCT05647642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102210878|NCT05647642|Adrenergic Agents|adrenergic agents|mesh-ancestor
102210879|NCT05647642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102210880|NCT05647642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210881|NCT05647642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102210882|NCT05647642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102210883|NCT05647642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102210884|NCT05647642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102210885|NCT05647642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102210886|NCT05647642|Anesthetics, General|anesthetics, general|mesh-ancestor
102210888|NCT05647642|GABA Modulators|gaba modulators|mesh-ancestor
102210889|NCT05647642|GABA Agents|gaba agents|mesh-ancestor
102210890|NCT02357368|Copper|copper|mesh-list
102210891|NCT02357368|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102210892|NCT02357368|Contraceptive Agents|contraceptive agents|mesh-list
102210893|NCT02357368|Levonorgestrel|levonorgestrel|mesh-list
102210894|NCT02357368|Medroxyprogesterone|medroxyprogesterone|mesh-list
102210895|NCT02357368|Etonogestrel|etonogestrel|mesh-list
102210896|NCT02357368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102210897|NCT02357368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210898|NCT02357368|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102210899|NCT02357368|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102210900|NCT02357368|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102210901|NCT02357368|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102210902|NCT02357368|Trace Elements|trace elements|mesh-ancestor
102210903|NCT02357368|Micronutrients|micronutrients|mesh-ancestor
102210904|NCT02357368|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102210905|NCT02357368|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102210906|NCT02357368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102210907|NCT02357368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102210908|NCT04873570|Moxifloxacin|moxifloxacin|mesh-list
102210909|NCT04873570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102210910|NCT04873570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102210911|NCT04873570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102210912|NCT04873570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102210913|NCT04873570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102210914|NCT04873570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210915|NCT04873570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102210916|NCT05647408|Dexamethasone|dexamethasone|mesh-list
102210917|NCT05647408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102210918|NCT05647408|Antiemetics|antiemetics|mesh-ancestor
102210919|NCT05647408|Autonomic Agents|autonomic agents|mesh-ancestor
102210920|NCT05647408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102210921|NCT05647408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210922|NCT05647408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102210923|NCT05647408|Glucocorticoids|glucocorticoids|mesh-ancestor
102210924|NCT05647408|Hormones|hormones|mesh-ancestor
102210925|NCT05647408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102210926|NCT05647408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102210927|NCT05647408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102210928|NCT05984953|Evolocumab|evolocumab|mesh-list
102210929|NCT05984953|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102210930|NCT05984953|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102210931|NCT05984953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102210932|NCT05984953|Antimetabolites|antimetabolites|mesh-ancestor
102210933|NCT05984953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210934|NCT05984953|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102210935|NCT05984953|Protease Inhibitors|protease inhibitors|mesh-ancestor
102210936|NCT05984953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102210937|NCT05984953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102210938|NCT05984745|Ubiquinone|ubiquinone|mesh-list
102210939|NCT05984745|Coenzyme Q10|coenzyme q10|mesh-list
102210940|NCT05984745|Micronutrients|micronutrients|mesh-ancestor
102210941|NCT05984745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102210942|NCT05984745|Vitamins|vitamins|mesh-ancestor
102210943|NCT05984602|Paclitaxel|paclitaxel|mesh-list
102210944|NCT05984602|Gemcitabine|gemcitabine|mesh-list
102210945|NCT05984602|Tislelizumab|tislelizumab|mesh-list
102210946|NCT05984602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102210947|NCT05984602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102210948|NCT05984602|Tubulin Modulators|tubulin modulators|mesh-ancestor
102210949|NCT05984602|Antimitotic Agents|antimitotic agents|mesh-ancestor
102210950|NCT05984602|Mitosis Modulators|mitosis modulators|mesh-ancestor
101900691|NCT03865160|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102210951|NCT05984602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210952|NCT05984602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102210954|NCT05984602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102210955|NCT05984537|Heparin|heparin|mesh-list
102210956|NCT05984537|Calcium heparin|calcium heparin|mesh-list
102210957|NCT05984537|Hirudins|hirudins|mesh-list
102210958|NCT05984537|Bivalirudin|bivalirudin|mesh-list
102210959|NCT05984537|Anticoagulants|anticoagulants|mesh-ancestor
102210960|NCT05984537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102210961|NCT05984537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102210962|NCT05984537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210963|NCT05984537|Antithrombins|antithrombins|mesh-ancestor
102210964|NCT05984537|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102210965|NCT05984537|Protease Inhibitors|protease inhibitors|mesh-ancestor
102210966|NCT05984537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102210967|NCT05984420|Emollients|emollients|mesh-list
102210968|NCT05984420|Dermatologic Agents|dermatologic agents|mesh-ancestor
102210969|NCT05984342|Paclitaxel|paclitaxel|mesh-list
102210970|NCT05984342|Cisplatin|cisplatin|mesh-list
102210971|NCT05984342|Tislelizumab|tislelizumab|mesh-list
102210972|NCT05984342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102210973|NCT05984342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102210974|NCT05984342|Tubulin Modulators|tubulin modulators|mesh-ancestor
102210975|NCT05984342|Antimitotic Agents|antimitotic agents|mesh-ancestor
102210976|NCT05984342|Mitosis Modulators|mitosis modulators|mesh-ancestor
102210977|NCT05984342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210978|NCT05984342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102210979|NCT05984277|Paclitaxel|paclitaxel|mesh-list
102210980|NCT05984277|Carboplatin|carboplatin|mesh-list
102210981|NCT05984277|Pembrolizumab|pembrolizumab|mesh-list
102210982|NCT05984277|Pemetrexed|pemetrexed|mesh-list
102210983|NCT05984277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102210984|NCT05984277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102210985|NCT05984277|Tubulin Modulators|tubulin modulators|mesh-ancestor
102210986|NCT05984277|Antimitotic Agents|antimitotic agents|mesh-ancestor
102210987|NCT05984277|Mitosis Modulators|mitosis modulators|mesh-ancestor
102210988|NCT05984277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102210989|NCT05984277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102210990|NCT05984277|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102210991|NCT05984277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102210992|NCT05984277|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102210993|NCT05984277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102210994|NCT05984264|Lidocaine|lidocaine|mesh-list
102210995|NCT05984264|Prilocaine|prilocaine|mesh-list
102210996|NCT05984264|Anesthetics, Local|anesthetics, local|mesh-ancestor
102210997|NCT05984264|Anesthetics|anesthetics|mesh-ancestor
102210998|NCT05984264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102210999|NCT05984264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211000|NCT05984264|Sensory System Agents|sensory system agents|mesh-ancestor
102211001|NCT05984264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102211002|NCT05984264|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102211003|NCT05984264|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102211004|NCT05984264|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102211005|NCT05984264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102211006|NCT05984264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211007|NCT05984212|Dexmedetomidine|dexmedetomidine|mesh-list
102211008|NCT05984212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102211009|NCT05984212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102211010|NCT05984212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211011|NCT05984212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102211012|NCT05984212|Analgesics|analgesics|mesh-ancestor
102211013|NCT05984212|Sensory System Agents|sensory system agents|mesh-ancestor
102211014|NCT05984212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102211015|NCT05984212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102211016|NCT05984212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102211017|NCT05984212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102211018|NCT05984212|Adrenergic Agents|adrenergic agents|mesh-ancestor
102211019|NCT05984212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102211020|NCT05984212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211021|NCT05984173|Vitamin E|vitamin e|mesh-list
102211022|NCT05984173|Tocopherols|tocopherols|mesh-list
102211023|NCT05984173|Vitamins|vitamins|mesh-ancestor
102211024|NCT05984173|Micronutrients|micronutrients|mesh-ancestor
102211025|NCT05984173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211027|NCT05984173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211028|NCT05984173|Protective Agents|protective agents|mesh-ancestor
102211029|NCT05983874|MEDI9197|medi9197|mesh-list
102211030|NCT05983874|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102211031|NCT05983874|Immunologic Factors|immunologic factors|mesh-ancestor
102211032|NCT05983874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211033|NCT05983783|Docetaxel|docetaxel|mesh-list
102211034|NCT05983783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211035|NCT05983783|Tubulin Modulators|tubulin modulators|mesh-ancestor
102211036|NCT05983783|Antimitotic Agents|antimitotic agents|mesh-ancestor
102211037|NCT05983783|Mitosis Modulators|mitosis modulators|mesh-ancestor
102211038|NCT05983783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211039|NCT05983770|Tacrolimus|tacrolimus|mesh-list
102211040|NCT05983770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102211041|NCT05983770|Immunologic Factors|immunologic factors|mesh-ancestor
102211042|NCT05983770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211043|NCT05983770|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102211044|NCT05983770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211045|NCT05983770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211046|NCT05983588|Glycerol|glycerol|mesh-list
102211047|NCT05983588|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102211048|NCT05983588|Protective Agents|protective agents|mesh-ancestor
102211049|NCT05983588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211050|NCT05983471|Suplatast tosilate|suplatast tosilate|mesh-list
102211051|NCT05983471|Histamine Antagonists|histamine antagonists|mesh-ancestor
102211052|NCT05983471|Histamine Agents|histamine agents|mesh-ancestor
102211053|NCT05983471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102211054|NCT05983471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211055|NCT05983471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211056|NCT05983471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102211057|NCT05983445|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
102211058|NCT05983445|Betamethasone|betamethasone|mesh-list
102211059|NCT05983445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102211060|NCT05983445|Glucocorticoids|glucocorticoids|mesh-ancestor
102211061|NCT05983445|Hormones|hormones|mesh-ancestor
102211062|NCT05983445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102211063|NCT05983445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211064|NCT05983445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101919893|NCT05942573|Paclitaxel|paclitaxel|mesh-list
102211065|NCT05983445|Respiratory System Agents|respiratory system agents|mesh-ancestor
102211066|NCT05983367|Bevacizumab|bevacizumab|mesh-list
102211067|NCT05983367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102211068|NCT05983367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211069|NCT05983367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102211070|NCT05983367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102211071|NCT05983367|Growth Substances|growth substances|mesh-ancestor
102211072|NCT05983367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211073|NCT05983367|Growth Inhibitors|growth inhibitors|mesh-ancestor
102211074|NCT05983354|Ibuprofen|ibuprofen|mesh-list
102211075|NCT05983354|Ketorolac|ketorolac|mesh-list
102211076|NCT05983354|Metoclopramide|metoclopramide|mesh-list
102211077|NCT05983354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102211078|NCT05983354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102211079|NCT05983354|Analgesics|analgesics|mesh-ancestor
102211080|NCT05983354|Sensory System Agents|sensory system agents|mesh-ancestor
102211081|NCT05983354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102211082|NCT05983354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211083|NCT05983354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102211084|NCT05983354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102211085|NCT05983354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102211086|NCT05983354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211087|NCT05983354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211088|NCT05983354|Antiemetics|antiemetics|mesh-ancestor
102211089|NCT05983354|Autonomic Agents|autonomic agents|mesh-ancestor
102211090|NCT05983354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102211091|NCT05983354|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102211092|NCT05983354|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102211093|NCT05983354|Dopamine Agents|dopamine agents|mesh-ancestor
102211094|NCT05983354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102211095|NCT05983302|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102211096|NCT05983302|Hemostatics|hemostatics|mesh-ancestor
102211097|NCT05983302|Coagulants|coagulants|mesh-ancestor
102211098|NCT05983276|Paclitaxel|paclitaxel|mesh-list
102211122|NCT05983107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211123|NCT05983107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211124|NCT05983107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102211125|NCT05983107|Immunologic Factors|immunologic factors|mesh-ancestor
102211126|NCT05983107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211127|NCT05983107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211128|NCT05983094|Carboplatin|carboplatin|mesh-list
102211129|NCT05983094|Trastuzumab|trastuzumab|mesh-list
102211130|NCT05983094|Epirubicin|epirubicin|mesh-list
102211131|NCT05983094|Pertuzumab|pertuzumab|mesh-list
102211132|NCT05983094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211133|NCT05983094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102211134|NCT05983094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102211135|NCT05983094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102211136|NCT05983094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102211137|NCT05983094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211138|NCT05983094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211139|NCT05983042|Ibuprofen|ibuprofen|mesh-list
102211140|NCT05983042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102211141|NCT05983042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102211142|NCT05983042|Analgesics|analgesics|mesh-ancestor
102211143|NCT05983042|Sensory System Agents|sensory system agents|mesh-ancestor
102211144|NCT05983042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102211145|NCT05983042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211146|NCT05983042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102211147|NCT05983042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102211148|NCT05983042|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102211149|NCT05983042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211150|NCT05983042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211174|NCT05982834|Tislelizumab|tislelizumab|mesh-list
102211175|NCT05982834|Disitamab vedotin|disitamab vedotin|mesh-list
102211176|NCT05982834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102211177|NCT05982834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211178|NCT05982834|Immunoconjugates|immunoconjugates|mesh-ancestor
102211179|NCT05982834|Immunologic Factors|immunologic factors|mesh-ancestor
102211180|NCT05982834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211181|NCT05982756|Bortezomib|bortezomib|mesh-list
102211182|NCT05982756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211183|NCT05981703|Tislelizumab|tislelizumab|mesh-list
102211184|NCT05981703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102211185|NCT05981703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211186|NCT05980091|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102211187|NCT05980091|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102211188|NCT05980091|Estradiol|estradiol|mesh-list
102211189|NCT05980091|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102211190|NCT05980091|Progesterone|progesterone|mesh-list
102211191|NCT05980091|Estrogens|estrogens|mesh-ancestor
102211192|NCT05980091|Hormones|hormones|mesh-ancestor
102211193|NCT05980091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102211194|NCT05980091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211195|NCT05980091|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102211196|NCT05980091|Contraceptive Agents|contraceptive agents|mesh-ancestor
102211197|NCT05980091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102211198|NCT05980091|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102211199|NCT05980091|Progestins|progestins|mesh-ancestor
102211200|NCT05969626|Vaccines|vaccines|mesh-list
102211201|NCT05969626|Immunologic Factors|immunologic factors|mesh-ancestor
102211202|NCT05969626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211203|NCT05961124|Niraparib|niraparib|mesh-list
102211204|NCT05961124|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102211205|NCT05961124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211206|NCT05961124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211207|NCT05961124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211208|NCT05959720|Cytarabine|cytarabine|mesh-list
102211209|NCT05959720|Prednisone|prednisone|mesh-list
102211210|NCT05959720|Cyclophosphamide|cyclophosphamide|mesh-list
102211211|NCT05959720|Doxorubicin|doxorubicin|mesh-list
102211212|NCT05959720|Methotrexate|methotrexate|mesh-list
102211213|NCT05959720|Daunorubicin|daunorubicin|mesh-list
102211214|NCT05959720|Asparaginase|asparaginase|mesh-list
102211215|NCT05959720|Mercaptopurine|mercaptopurine|mesh-list
101920044|NCT05941494|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102211216|NCT05959720|Pegaspargase|pegaspargase|mesh-list
102211217|NCT05959720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102211218|NCT05959720|Immunologic Factors|immunologic factors|mesh-ancestor
102211219|NCT05959720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211220|NCT05959720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102211221|NCT05959720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102211222|NCT05959720|Alkylating Agents|alkylating agents|mesh-ancestor
102211223|NCT05959720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211224|NCT05959720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211225|NCT05959720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102211226|NCT05959720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102211227|NCT05959720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102211228|NCT05959720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102211229|NCT05959720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211230|NCT05959720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102211231|NCT05959720|Glucocorticoids|glucocorticoids|mesh-ancestor
102211232|NCT05959720|Hormones|hormones|mesh-ancestor
102211233|NCT05959720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102211234|NCT05959720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102211235|NCT05959720|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102211236|NCT05959720|Abortifacient Agents|abortifacient agents|mesh-ancestor
102211237|NCT05959720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102211238|NCT05959720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102211239|NCT05959720|Antimetabolites|antimetabolites|mesh-ancestor
102211240|NCT05959720|Dermatologic Agents|dermatologic agents|mesh-ancestor
102211241|NCT05959720|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102211242|NCT05959720|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102211243|NCT05959720|Antiviral Agents|antiviral agents|mesh-ancestor
102211244|NCT05959720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102211245|NCT05953584|Hydroxyurea|hydroxyurea|mesh-list
102211246|NCT05953584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211247|NCT05953584|Antisickling Agents|antisickling agents|mesh-ancestor
102211248|NCT05953584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211249|NCT05953584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211250|NCT05953584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102211252|NCT05929716|Magrolimab|magrolimab|mesh-list
102211253|NCT05929716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102211254|NCT05929716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211255|NCT05929716|Immunologic Factors|immunologic factors|mesh-ancestor
102211256|NCT05929716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211257|NCT05929716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102211258|NCT05913284|Morphine|morphine|mesh-list
102211259|NCT05913284|Methadone|methadone|mesh-list
102211260|NCT05913284|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102211261|NCT05913284|Narcotics|narcotics|mesh-ancestor
102211262|NCT05913284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102211263|NCT05913284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211264|NCT05913284|Analgesics|analgesics|mesh-ancestor
102211265|NCT05913284|Sensory System Agents|sensory system agents|mesh-ancestor
102211266|NCT05913284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102211267|NCT05913284|Antitussive Agents|antitussive agents|mesh-ancestor
102211268|NCT05913284|Respiratory System Agents|respiratory system agents|mesh-ancestor
102211269|NCT05904106|Azacitidine|azacitidine|mesh-list
102211270|NCT05904106|Venetoclax|venetoclax|mesh-list
102211271|NCT05904106|Gemtuzumab|gemtuzumab|mesh-list
102211272|NCT05904106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102211273|NCT05904106|Antimetabolites|antimetabolites|mesh-ancestor
102211274|NCT05904106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211275|NCT05904106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211276|NCT05904106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211277|NCT05904106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102211278|NCT05904106|Immunotoxins|immunotoxins|mesh-ancestor
102211279|NCT05904106|Immunoconjugates|immunoconjugates|mesh-ancestor
102211280|NCT05904106|Immunologic Factors|immunologic factors|mesh-ancestor
102211281|NCT05904106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211282|NCT05901545|Panitumumab|panitumumab|mesh-list
102211283|NCT05901545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102211284|NCT05901545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211285|NCT05859269|Methylprednisolone|methylprednisolone|mesh-list
102211286|NCT05859269|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102211287|NCT05859269|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102211288|NCT05859269|Prednisolone|prednisolone|mesh-list
102211289|NCT05859269|Prednisolone acetate|prednisolone acetate|mesh-list
102211290|NCT05859269|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102211291|NCT05859269|Prednisolone phosphate|prednisolone phosphate|mesh-list
102211292|NCT05859269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102211293|NCT05859269|Antiemetics|antiemetics|mesh-ancestor
102211296|NCT05859269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211298|NCT05859269|Glucocorticoids|glucocorticoids|mesh-ancestor
102211299|NCT05859269|Hormones|hormones|mesh-ancestor
102211300|NCT05859269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102211301|NCT05859269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102211302|NCT05859269|Protective Agents|protective agents|mesh-ancestor
102211303|NCT05859269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102211304|NCT05859269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211305|NCT05854966|Metformin|metformin|mesh-list
102211306|NCT05854966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102211307|NCT05854966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211308|NCT05847686|Psilocybin|psilocybin|mesh-list
102211309|NCT05847686|Hallucinogens|hallucinogens|mesh-ancestor
102211310|NCT05847686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211311|NCT05847686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102211312|NCT05831774|Vancomycin|vancomycin|mesh-list
102211313|NCT05831774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102211314|NCT05831774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102211318|NCT05824299|Anesthetics|anesthetics|mesh-list
102211319|NCT05824299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102211320|NCT05824299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211321|NCT05817461|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102211322|NCT05815173|Sotorasib|sotorasib|mesh-list
102211323|NCT05815173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102211324|NCT05815173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211325|NCT05815173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102211326|NCT05815173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211327|NCT05784753|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
102211328|NCT05784753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101753204|NCT00723060|Serotonin Agents|serotonin agents|mesh-ancestor
102211330|NCT05784753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211331|NCT05782972|Dapagliflozin|dapagliflozin|mesh-list
102211332|NCT05782972|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102211333|NCT05782972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211334|NCT05782972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102211335|NCT05782972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211336|NCT05738148|Vasopressins|vasopressins|mesh-list
102211337|NCT05738148|Arginine Vasopressin|arginine vasopressin|mesh-list
102211338|NCT05738148|Epinephrine|epinephrine|mesh-list
102211339|NCT05738148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102211340|NCT05738148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102211341|NCT05738148|Adrenergic Agents|adrenergic agents|mesh-ancestor
102211342|NCT05738148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102211343|NCT05738148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211344|NCT05738148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211345|NCT05738148|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102211346|NCT05738148|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102211347|NCT05738148|Autonomic Agents|autonomic agents|mesh-ancestor
102211348|NCT05738148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102211349|NCT05738148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102211350|NCT05738148|Respiratory System Agents|respiratory system agents|mesh-ancestor
102211351|NCT05738148|Mydriatics|mydriatics|mesh-ancestor
102211352|NCT05738148|Sympathomimetics|sympathomimetics|mesh-ancestor
102211353|NCT05738148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102211354|NCT05738148|Hemostatics|hemostatics|mesh-ancestor
102211355|NCT05738148|Coagulants|coagulants|mesh-ancestor
102211356|NCT05738148|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102211357|NCT05738148|Natriuretic Agents|natriuretic agents|mesh-ancestor
102211358|NCT05736419|Mycophenolic Acid|mycophenolic acid|mesh-list
102211359|NCT05736419|Dexamethasone|dexamethasone|mesh-list
102211360|NCT05736419|Cyclophosphamide|cyclophosphamide|mesh-list
102211361|NCT05736419|Rituximab|rituximab|mesh-list
102211362|NCT05736419|Fludarabine|fludarabine|mesh-list
102211363|NCT05736419|Bortezomib|bortezomib|mesh-list
102211364|NCT05736419|Tacrolimus|tacrolimus|mesh-list
102211365|NCT05736419|Thymoglobulin|thymoglobulin|mesh-list
102211366|NCT05736419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102211367|NCT05736419|Immunologic Factors|immunologic factors|mesh-ancestor
102211368|NCT05736419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211369|NCT05736419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102211370|NCT05736419|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102211371|NCT05736419|Alkylating Agents|alkylating agents|mesh-ancestor
102211372|NCT05736419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211373|NCT05736419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211374|NCT05736419|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102211375|NCT05736419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102211376|NCT05736419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102211378|NCT05736419|Autonomic Agents|autonomic agents|mesh-ancestor
102211379|NCT05736419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102211380|NCT05736419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102211381|NCT05736419|Glucocorticoids|glucocorticoids|mesh-ancestor
102211382|NCT05736419|Hormones|hormones|mesh-ancestor
102211383|NCT05736419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102211384|NCT05736419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102211385|NCT05736419|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102211386|NCT05736419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211387|NCT05736419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102211388|NCT05736419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102211389|NCT05736419|Antitubercular Agents|antitubercular agents|mesh-ancestor
102211390|NCT05736419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102211391|NCT05736419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102211392|NCT05729139|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102211393|NCT05729139|Interferon alpha-2|interferon alpha-2|mesh-list
102211394|NCT05729139|Cemiplimab|cemiplimab|mesh-list
102211395|NCT05729139|Antiviral Agents|antiviral agents|mesh-ancestor
102211396|NCT05729139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102211397|NCT05729139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102211398|NCT05729139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211399|NCT05726344|Lactulose|lactulose|mesh-list
102211407|NCT05694260|Antimetabolites|antimetabolites|mesh-ancestor
102211408|NCT05694260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211409|NCT05694260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102211410|NCT05694260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211411|NCT05694260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102211412|NCT05694260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211413|NCT05688020|Epinephrine|epinephrine|mesh-list
102211414|NCT05688020|Tranexamic Acid|tranexamic acid|mesh-list
102211415|NCT05688020|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102211416|NCT05688020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102211417|NCT05688020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211418|NCT05688020|Hemostatics|hemostatics|mesh-ancestor
102211419|NCT05688020|Coagulants|coagulants|mesh-ancestor
102211420|NCT05688020|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102211421|NCT05688020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102211422|NCT05688020|Adrenergic Agents|adrenergic agents|mesh-ancestor
102211423|NCT05688020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102211424|NCT05688020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211425|NCT05688020|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102211426|NCT05688020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102211427|NCT05688020|Autonomic Agents|autonomic agents|mesh-ancestor
102211428|NCT05688020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102211429|NCT05688020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102211430|NCT05688020|Respiratory System Agents|respiratory system agents|mesh-ancestor
102211431|NCT05688020|Mydriatics|mydriatics|mesh-ancestor
102211432|NCT05688020|Sympathomimetics|sympathomimetics|mesh-ancestor
102211433|NCT05688020|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102211434|NCT05687266|Paclitaxel|paclitaxel|mesh-list
102211435|NCT05687266|Carboplatin|carboplatin|mesh-list
102211436|NCT05687266|Pembrolizumab|pembrolizumab|mesh-list
102211437|NCT05687266|Pemetrexed|pemetrexed|mesh-list
102211438|NCT05687266|Durvalumab|durvalumab|mesh-list
102211439|NCT05687266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102211440|NCT05687266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211441|NCT05687266|Tubulin Modulators|tubulin modulators|mesh-ancestor
102211442|NCT05687266|Antimitotic Agents|antimitotic agents|mesh-ancestor
102211443|NCT05687266|Mitosis Modulators|mitosis modulators|mesh-ancestor
102211444|NCT05687266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211445|NCT05687266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102211446|NCT05687266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102211484|NCT05668455|Dexamethasone|dexamethasone|mesh-list
102211485|NCT05668455|Hydrocortisone|hydrocortisone|mesh-list
102211487|NCT05668455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102211489|NCT05668455|Autonomic Agents|autonomic agents|mesh-ancestor
102211490|NCT05668455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102211491|NCT05668455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211492|NCT05668455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102211493|NCT05668455|Glucocorticoids|glucocorticoids|mesh-ancestor
102211494|NCT05668455|Hormones|hormones|mesh-ancestor
102211495|NCT05668455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102211496|NCT05668455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102211497|NCT05668455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211498|NCT05668455|Plasma Substitutes|plasma substitutes|mesh-ancestor
102211499|NCT05668455|Blood Substitutes|blood substitutes|mesh-ancestor
102211500|NCT05653492|Sulforaphane|sulforaphane|mesh-list
102211501|NCT05653492|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102211502|NCT05653492|Protective Agents|protective agents|mesh-ancestor
102211503|NCT05653492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211504|NCT05653492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211505|NCT05630872|Lamivudine|lamivudine|mesh-list
101308414|NCT02047175|Niacin|niacin|mesh-list
102211506|NCT05630872|Dolutegravir|dolutegravir|mesh-list
102211507|NCT05630872|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102211508|NCT05630872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102211509|NCT05630872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211510|NCT05630872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211511|NCT05630872|Antiviral Agents|antiviral agents|mesh-ancestor
102211512|NCT05630872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102211513|NCT05630872|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102211514|NCT05630872|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102211515|NCT05630872|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102211516|NCT05630872|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101920346|NCT05698979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920347|NCT05698979|Cholinergic Agents|cholinergic agents|mesh-ancestor
101920348|NCT05698979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101920349|NCT05698979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211523|NCT05623319|Pembrolizumab|pembrolizumab|mesh-list
102211524|NCT05623319|Olaparib|olaparib|mesh-list
102211525|NCT05623319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102211526|NCT05623319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211527|NCT05623319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102211528|NCT05623319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211529|NCT05623319|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102211530|NCT05623319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211531|NCT05592418|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
102211532|NCT05592418|Poly I-C|poly i-c|mesh-list
102211533|NCT05592418|Antiviral Agents|antiviral agents|mesh-ancestor
102211534|NCT05592418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102211535|NCT05592418|Interferon Inducers|interferon inducers|mesh-ancestor
102211536|NCT05592418|Immunologic Factors|immunologic factors|mesh-ancestor
102211537|NCT05592418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211538|NCT05590793|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102211539|NCT05590793|Luteolytic Agents|luteolytic agents|mesh-ancestor
102211540|NCT05590793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102211541|NCT05590793|Contraceptive Agents|contraceptive agents|mesh-ancestor
102211542|NCT05590793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102211543|NCT05590793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211544|NCT05590793|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102211545|NCT05590793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102211546|NCT05590793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211547|NCT05571059|Ifetroban|ifetroban|mesh-list
102211548|NCT05571059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102211549|NCT05548062|Hydroxyurea|hydroxyurea|mesh-list
102211550|NCT05548062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211551|NCT05548062|Antisickling Agents|antisickling agents|mesh-ancestor
102211552|NCT05548062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211553|NCT05548062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211554|NCT05548062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102211555|NCT05546242|Dolutegravir|dolutegravir|mesh-list
102211556|NCT05546242|Cabotegravir|cabotegravir|mesh-list
102211557|NCT05546242|Rilpivirine|rilpivirine|mesh-list
102211558|NCT05546242|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102211559|NCT05546242|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102211560|NCT05546242|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102211561|NCT05546242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211562|NCT05546242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211564|NCT05546242|Antiviral Agents|antiviral agents|mesh-ancestor
102211565|NCT05546242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102211566|NCT05546242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102211567|NCT05546242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102211568|NCT05517668|Acetylcysteine|acetylcysteine|mesh-list
102211569|NCT05517668|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102211570|NCT05517668|Fomepizole|fomepizole|mesh-list
102211571|NCT05517668|Antiviral Agents|antiviral agents|mesh-ancestor
102211572|NCT05517668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102211573|NCT05517668|Expectorants|expectorants|mesh-ancestor
102211574|NCT05517668|Respiratory System Agents|respiratory system agents|mesh-ancestor
102211575|NCT05517668|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102211576|NCT05517668|Antioxidants|antioxidants|mesh-ancestor
102211577|NCT05517668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211578|NCT05517668|Protective Agents|protective agents|mesh-ancestor
102211579|NCT05517668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211580|NCT05517668|Antidotes|antidotes|mesh-ancestor
102211581|NCT05517668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211582|NCT05494697|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
102211583|NCT05494697|Antiviral Agents|antiviral agents|mesh-ancestor
102211584|NCT05494697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102211585|NCT05457257|Prednisone|prednisone|mesh-list
102211586|NCT05457257|Olaparib|olaparib|mesh-list
102211587|NCT05457257|Abiraterone Acetate|abiraterone acetate|mesh-list
102211588|NCT05457257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102211589|NCT05457257|Glucocorticoids|glucocorticoids|mesh-ancestor
102211590|NCT05457257|Hormones|hormones|mesh-ancestor
102211591|NCT05457257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102211592|NCT05457257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211593|NCT05457257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102211594|NCT05457257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211595|NCT05457257|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102211596|NCT05457257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211597|NCT05457257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211598|NCT05457257|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102211599|NCT05457257|Hormone Antagonists|hormone antagonists|mesh-ancestor
102211600|NCT05457257|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102211601|NCT05445804|Cannabidiol|cannabidiol|mesh-list
102211602|NCT05445804|Anticonvulsants|anticonvulsants|mesh-ancestor
102211603|NCT05435729|Levodopa|levodopa|mesh-list
102211604|NCT05435729|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102211605|NCT05435729|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102211606|NCT05435729|Dopamine Agents|dopamine agents|mesh-ancestor
102211607|NCT05435729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102211608|NCT05435729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211609|NCT05435729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211610|NCT05430750|Nitrous Oxide|nitrous oxide|mesh-list
102211611|NCT05430750|Sevoflurane|sevoflurane|mesh-list
102211612|NCT05430750|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102211613|NCT05430750|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102211614|NCT05430750|Anesthetics, General|anesthetics, general|mesh-ancestor
102211615|NCT05430750|Anesthetics|anesthetics|mesh-ancestor
102211616|NCT05430750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102211617|NCT05430750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211618|NCT05430750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102211619|NCT05430750|Analgesics|analgesics|mesh-ancestor
102211620|NCT05430750|Sensory System Agents|sensory system agents|mesh-ancestor
102211621|NCT05430750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102211622|NCT05429593|Dapagliflozin|dapagliflozin|mesh-list
102211623|NCT05429593|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102211624|NCT05429593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211625|NCT05429593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102211626|NCT05429593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211627|NCT05422794|Paclitaxel|paclitaxel|mesh-list
102211628|NCT05422794|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102211629|NCT05422794|Pembrolizumab|pembrolizumab|mesh-list
102211630|NCT05422794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102211631|NCT05422794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211633|NCT05422794|Antimitotic Agents|antimitotic agents|mesh-ancestor
102211634|NCT05422794|Mitosis Modulators|mitosis modulators|mesh-ancestor
102211635|NCT05422794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211636|NCT05422794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102211637|NCT05422794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102211638|NCT05403476|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102211639|NCT05403476|Hormones|hormones|mesh-ancestor
102211640|NCT05403476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102211641|NCT05403476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211642|NCT05394350|Pembrolizumab|pembrolizumab|mesh-list
102211643|NCT05394350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102211644|NCT05394350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211645|NCT05394350|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101308425|NCT02047175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102211646|NCT05394350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211647|NCT05383352|Leucovorin|leucovorin|mesh-list
102211648|NCT05383352|Folic Acid|folic acid|mesh-list
102211649|NCT05383352|Fluorouracil|fluorouracil|mesh-list
102211650|NCT05383352|Irinotecan|irinotecan|mesh-list
102211651|NCT05383352|Camptothecin|camptothecin|mesh-list
102211652|NCT05383352|Levoleucovorin|levoleucovorin|mesh-list
102211653|NCT05383352|Antimetabolites|antimetabolites|mesh-ancestor
102211654|NCT05383352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211655|NCT05383352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102211656|NCT05383352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211657|NCT05383352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102211658|NCT05383352|Immunologic Factors|immunologic factors|mesh-ancestor
102211659|NCT05383352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211660|NCT05383352|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101920496|NCT05433584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920497|NCT05433584|Incretins|incretins|mesh-ancestor
101920498|NCT05433584|Hormones|hormones|mesh-ancestor
101920499|NCT05433584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101920500|NCT05377424|Istradefylline|istradefylline|mesh-list
101920501|NCT05377424|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
101920502|NCT05377424|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102211661|NCT05383352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102211662|NCT05383352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211663|NCT05383352|Antidotes|antidotes|mesh-ancestor
102211664|NCT05383352|Protective Agents|protective agents|mesh-ancestor
102211665|NCT05383352|Vitamin B Complex|vitamin b complex|mesh-ancestor
102211666|NCT05383352|Vitamins|vitamins|mesh-ancestor
102211667|NCT05383352|Micronutrients|micronutrients|mesh-ancestor
102211668|NCT05383352|Hematinics|hematinics|mesh-ancestor
102211669|NCT05383352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102211670|NCT05374603|Durvalumab|durvalumab|mesh-list
102211671|NCT05374603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102211672|NCT05374603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211673|NCT05353439|Pembrolizumab|pembrolizumab|mesh-list
102211674|NCT05353439|Topotecan|topotecan|mesh-list
102211675|NCT05353439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102211676|NCT05353439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211677|NCT05353439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102211678|NCT05353439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211679|NCT05353439|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102211680|NCT05353439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102211681|NCT05353439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211682|NCT05346224|Pertuzumab|pertuzumab|mesh-list
102211683|NCT05346224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102211684|NCT05346224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211685|NCT05335941|Pemetrexed|pemetrexed|mesh-list
102211686|NCT05335941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211687|NCT05335941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211688|NCT05335941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211689|NCT05335941|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102211690|NCT05335941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102211691|NCT05326776|Oxytocin|oxytocin|mesh-list
102211692|NCT05326776|Oxytocics|oxytocics|mesh-ancestor
102211693|NCT05326776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102211694|NCT05326776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211695|NCT05302804|Menthol|menthol|mesh-list
102211696|NCT05302804|Antipruritics|antipruritics|mesh-ancestor
102211697|NCT05302804|Dermatologic Agents|dermatologic agents|mesh-ancestor
102211699|NCT05298202|Antipruritics|antipruritics|mesh-ancestor
102211700|NCT05298202|Dermatologic Agents|dermatologic agents|mesh-ancestor
102211701|NCT05298202|Sensory System Agents|sensory system agents|mesh-ancestor
102211702|NCT05298202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102211703|NCT05298202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211704|NCT05285644|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102211705|NCT05285644|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102211706|NCT05283304|Buprenorphine|buprenorphine|mesh-list
102211707|NCT05283304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102211708|NCT05283304|Narcotics|narcotics|mesh-ancestor
102211709|NCT05283304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101451588|NCT00411333|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102211710|NCT05283304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211711|NCT05283304|Analgesics|analgesics|mesh-ancestor
102211712|NCT05283304|Sensory System Agents|sensory system agents|mesh-ancestor
102211713|NCT05283304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102211714|NCT05283304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102211715|NCT05263388|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102211716|NCT05263388|Hormones|hormones|mesh-ancestor
102211717|NCT05263388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102211718|NCT05263388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211719|NCT05232071|Empagliflozin|empagliflozin|mesh-list
102211720|NCT05232071|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102211721|NCT05232071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211722|NCT05232071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102211723|NCT05232071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211724|NCT05221580|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102211725|NCT05221580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102211726|NCT05221580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211727|NCT05208307|Dexamethasone|dexamethasone|mesh-list
102211728|NCT05208307|Dexamethasone acetate|dexamethasone acetate|mesh-list
102211729|NCT05208307|Pomalidomide|pomalidomide|mesh-list
102211730|NCT05208307|Ichthammol|ichthammol|mesh-list
102211731|NCT05208307|BB 1101|bb 1101|mesh-list
102211732|NCT05208307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102211733|NCT05208307|Antiemetics|antiemetics|mesh-ancestor
102211734|NCT05208307|Autonomic Agents|autonomic agents|mesh-ancestor
102211735|NCT05208307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102211736|NCT05208307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211737|NCT05208307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102211738|NCT05208307|Glucocorticoids|glucocorticoids|mesh-ancestor
102211739|NCT05208307|Hormones|hormones|mesh-ancestor
102211740|NCT05208307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102211741|NCT05208307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102211742|NCT05208307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211743|NCT05208307|Protease Inhibitors|protease inhibitors|mesh-ancestor
102211744|NCT05208307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211745|NCT05208307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211746|NCT05208307|Immunologic Factors|immunologic factors|mesh-ancestor
102211747|NCT05208307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102211748|NCT05208307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102211749|NCT05208307|Growth Substances|growth substances|mesh-ancestor
102211750|NCT05208307|Growth Inhibitors|growth inhibitors|mesh-ancestor
102211751|NCT05208307|Dermatologic Agents|dermatologic agents|mesh-ancestor
102211752|NCT05201248|Prednisone|prednisone|mesh-list
102211753|NCT05201248|Cyclophosphamide|cyclophosphamide|mesh-list
102211754|NCT05201248|Rituximab|rituximab|mesh-list
102211755|NCT05201248|Doxorubicin|doxorubicin|mesh-list
102211756|NCT05201248|Vincristine|vincristine|mesh-list
102211757|NCT05201248|Lenalidomide|lenalidomide|mesh-list
102211758|NCT05201248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102211759|NCT05201248|Immunologic Factors|immunologic factors|mesh-ancestor
102211760|NCT05201248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211761|NCT05201248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102211762|NCT05201248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102211763|NCT05201248|Alkylating Agents|alkylating agents|mesh-ancestor
102211764|NCT05201248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211765|NCT05201248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211766|NCT05201248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102211767|NCT05201248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102211768|NCT05201248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102211769|NCT05201248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102211770|NCT05201248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102211772|NCT05201248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102211773|NCT05201248|Glucocorticoids|glucocorticoids|mesh-ancestor
102211774|NCT05201248|Hormones|hormones|mesh-ancestor
102211775|NCT05201248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102211776|NCT05201248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102211777|NCT05201248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102211778|NCT05201248|Tubulin Modulators|tubulin modulators|mesh-ancestor
102211779|NCT05201248|Antimitotic Agents|antimitotic agents|mesh-ancestor
102211780|NCT05201248|Mitosis Modulators|mitosis modulators|mesh-ancestor
102211781|NCT05201248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102211782|NCT05201248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102211783|NCT05201248|Growth Substances|growth substances|mesh-ancestor
102211784|NCT05201248|Growth Inhibitors|growth inhibitors|mesh-ancestor
102211785|NCT05198830|Cisplatin|cisplatin|mesh-list
102211786|NCT05198830|Pemetrexed|pemetrexed|mesh-list
102211787|NCT05198830|Durvalumab|durvalumab|mesh-list
102211788|NCT05198830|Immunoglobulins|immunoglobulins|mesh-list
102211789|NCT05198830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102211790|NCT05198830|Immunoglobulin G|immunoglobulin g|mesh-list
102211791|NCT05198830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211792|NCT05198830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211793|NCT05198830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211794|NCT05198830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102211795|NCT05198830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102211796|NCT05198830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102211797|NCT05198830|Immunologic Factors|immunologic factors|mesh-ancestor
102211798|NCT05198830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211799|NCT05172258|Pembrolizumab|pembrolizumab|mesh-list
102211800|NCT05172258|Ipatasertib|ipatasertib|mesh-list
102211801|NCT05172258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102211802|NCT05172258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211803|NCT05172258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102211804|NCT05172258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211805|NCT05172258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102211806|NCT05172258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211807|NCT05172245|Cisplatin|cisplatin|mesh-list
102211808|NCT05172245|Ipatasertib|ipatasertib|mesh-list
102211809|NCT05172245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211810|NCT05172245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102211811|NCT05172245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211812|NCT05172245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211813|NCT05171816|Olaparib|olaparib|mesh-list
102211814|NCT05171816|Abiraterone Acetate|abiraterone acetate|mesh-list
102211815|NCT05171816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102211816|NCT05171816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211817|NCT05171816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211818|NCT05171816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211819|NCT05171816|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102211820|NCT05171816|Hormone Antagonists|hormone antagonists|mesh-ancestor
102211821|NCT05171816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102211822|NCT05171816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211823|NCT05171816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102211824|NCT05169866|Amiodarone|amiodarone|mesh-list
102211825|NCT05169866|Nifekalant|nifekalant|mesh-list
102211826|NCT05169866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102211827|NCT05169866|Vasodilator Agents|vasodilator agents|mesh-ancestor
102211828|NCT05169866|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102211829|NCT05169866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102211830|NCT05169866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211831|NCT05169866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102211832|NCT05169866|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102211833|NCT05169866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102211834|NCT05169866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211835|NCT05169866|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102211836|NCT05169866|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102211837|NCT05169866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102211838|NCT05168202|Azacitidine|azacitidine|mesh-list
102211839|NCT05168202|Venetoclax|venetoclax|mesh-list
102211840|NCT05168202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102211841|NCT05168202|Antimetabolites|antimetabolites|mesh-ancestor
102211842|NCT05168202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211843|NCT05168202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211844|NCT05168202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211846|NCT05156658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102211847|NCT05156658|Contraceptive Agents|contraceptive agents|mesh-ancestor
102211848|NCT05156658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102211849|NCT05156658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211850|NCT05156658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102211851|NCT05095961|Prednisone|prednisone|mesh-list
102211852|NCT05095961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102211853|NCT05095961|Glucocorticoids|glucocorticoids|mesh-ancestor
102211854|NCT05095961|Hormones|hormones|mesh-ancestor
102211855|NCT05095961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102211856|NCT05095961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211857|NCT05095961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102211858|NCT05095961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211859|NCT05052957|Temozolomide|temozolomide|mesh-list
102211860|NCT05052957|Carmustine|carmustine|mesh-list
102211861|NCT05052957|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
102211862|NCT05052957|Lenograstim|lenograstim|mesh-list
102211863|NCT05052957|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102211864|NCT05052957|Immunologic Factors|immunologic factors|mesh-ancestor
102211865|NCT05052957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211866|NCT05052957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102211867|NCT05052957|Alkylating Agents|alkylating agents|mesh-ancestor
102211868|NCT05052957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211869|NCT05052957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211870|NCT05052957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211871|NCT04999020|Ravulizumab|ravulizumab|mesh-list
102211872|NCT04999020|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102211873|NCT04999020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102211874|NCT04999020|Immunologic Factors|immunologic factors|mesh-ancestor
102211875|NCT04999020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211876|NCT04998617|Curcumin|curcumin|mesh-list
102211877|NCT04998617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102211878|NCT04998617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102211879|NCT04998617|Analgesics|analgesics|mesh-ancestor
102211880|NCT04998617|Sensory System Agents|sensory system agents|mesh-ancestor
102211881|NCT04998617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102211882|NCT04998617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211883|NCT04998617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102211884|NCT04998617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102211885|NCT04998617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211886|NCT04998617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211887|NCT04998617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211889|NCT04952597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102211890|NCT04952597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211891|NCT04933266|Levobupivacaine|levobupivacaine|mesh-list
102211892|NCT04933266|Anesthetics, Local|anesthetics, local|mesh-ancestor
102211893|NCT04933266|Anesthetics|anesthetics|mesh-ancestor
102211894|NCT04933266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102211895|NCT04933266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211896|NCT04933266|Sensory System Agents|sensory system agents|mesh-ancestor
102211897|NCT04933266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102211898|NCT04914247|Selexipag|selexipag|mesh-list
102211899|NCT04914247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102211900|NCT04908449|Bupivacaine|bupivacaine|mesh-list
102211901|NCT04908449|Anesthetics, Local|anesthetics, local|mesh-ancestor
102211902|NCT04908449|Anesthetics|anesthetics|mesh-ancestor
102211903|NCT04908449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102211904|NCT04908449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211905|NCT04908449|Sensory System Agents|sensory system agents|mesh-ancestor
102211906|NCT04908449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102211907|NCT04889287|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102211908|NCT04889287|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102211909|NCT04889287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102211910|NCT04889287|Antimetabolites|antimetabolites|mesh-ancestor
102211911|NCT04889287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211912|NCT04889287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102211913|NCT04889287|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102211914|NCT04889287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211915|NCT04883281|Paclitaxel|paclitaxel|mesh-list
102211916|NCT04883281|Carboplatin|carboplatin|mesh-list
102211917|NCT04883281|Cetuximab|cetuximab|mesh-list
101753774|NCT00578136|Bupivacaine|bupivacaine|mesh-list
102211918|NCT04883281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102211919|NCT04883281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211920|NCT04883281|Tubulin Modulators|tubulin modulators|mesh-ancestor
102211921|NCT04883281|Antimitotic Agents|antimitotic agents|mesh-ancestor
102211922|NCT04883281|Mitosis Modulators|mitosis modulators|mesh-ancestor
102211923|NCT04883281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211924|NCT04883281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102211925|NCT04877522|Niacinamide|niacinamide|mesh-list
102211926|NCT04877522|Imatinib Mesylate|imatinib mesylate|mesh-list
102211927|NCT04877522|Dasatinib|dasatinib|mesh-list
102211928|NCT04877522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211929|NCT04877522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102211930|NCT04877522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211931|NCT04877522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211932|NCT04877522|Vitamin B Complex|vitamin b complex|mesh-ancestor
102211933|NCT04877522|Vitamins|vitamins|mesh-ancestor
102211934|NCT04877522|Micronutrients|micronutrients|mesh-ancestor
102211935|NCT04877522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211936|NCT04862663|Fulvestrant|fulvestrant|mesh-list
102211937|NCT04862663|Palbociclib|palbociclib|mesh-list
102211938|NCT04862663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102211939|NCT04862663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211940|NCT04862663|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102211941|NCT04862663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102211942|NCT04862663|Hormone Antagonists|hormone antagonists|mesh-ancestor
102211943|NCT04862663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102211944|NCT04862663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211945|NCT04862663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102211946|NCT04862663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211947|NCT04862663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211948|NCT04835441|ALPN-101|alpn-101|mesh-list
102211949|NCT04835441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102211950|NCT04835441|Immunologic Factors|immunologic factors|mesh-ancestor
102211951|NCT04835441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211952|NCT04821089|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101920797|NCT04670679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101920798|NCT04670679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920799|NCT04670679|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101920800|NCT04670679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920808|NCT04631510|Gabapentin|gabapentin|mesh-list
101920809|NCT04631510|Analgesics|analgesics|mesh-ancestor
101920813|NCT04631510|Anticonvulsants|anticonvulsants|mesh-ancestor
102211953|NCT04821089|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102211954|NCT04821089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102211955|NCT04821089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211956|NCT04821089|Cholinergic Agents|cholinergic agents|mesh-ancestor
102211957|NCT04821089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102211958|NCT04821089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211959|NCT04797780|Azacitidine|azacitidine|mesh-list
102211960|NCT04797780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102211961|NCT04797780|Antimetabolites|antimetabolites|mesh-ancestor
102211962|NCT04797780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211963|NCT04797780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211964|NCT04797780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211965|NCT04791176|Lenvatinib|lenvatinib|mesh-list
102211966|NCT04791176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211967|NCT04791176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102211968|NCT04791176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211969|NCT04791176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211970|NCT04751370|Nivolumab|nivolumab|mesh-list
102211971|NCT04751370|Ipilimumab|ipilimumab|mesh-list
102211972|NCT04751370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102211973|NCT04751370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211974|NCT04751370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102211975|NCT04751370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211976|NCT04748419|Durvalumab|durvalumab|mesh-list
102211977|NCT04748419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102211978|NCT04748419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211979|NCT04731363|Erythritol|erythritol|mesh-list
102211980|NCT04731363|Vasodilator Agents|vasodilator agents|mesh-ancestor
102211981|NCT04709380|Sorafenib|sorafenib|mesh-list
102211982|NCT04709380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101900727|NCT01063127|Insulin|insulin|mesh-list
102211983|NCT04709380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102211984|NCT04709380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102211985|NCT04709380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211986|NCT04673617|Cyclophosphamide|cyclophosphamide|mesh-list
102211987|NCT04673617|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102211988|NCT04673617|Rituximab|rituximab|mesh-list
102211989|NCT04673617|Fludarabine|fludarabine|mesh-list
102211990|NCT04673617|Interleukin-2|interleukin-2|mesh-list
102211991|NCT04673617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102211992|NCT04673617|Immunologic Factors|immunologic factors|mesh-ancestor
102211993|NCT04673617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102211994|NCT04673617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102211995|NCT04673617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102211996|NCT04673617|Alkylating Agents|alkylating agents|mesh-ancestor
102211997|NCT04673617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102211998|NCT04673617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102211999|NCT04673617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102212000|NCT04673617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102212001|NCT04673617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102212002|NCT04673617|Analgesics|analgesics|mesh-ancestor
102212003|NCT04673617|Sensory System Agents|sensory system agents|mesh-ancestor
102212004|NCT04673617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102212005|NCT04657068|Gemcitabine|gemcitabine|mesh-list
102212006|NCT04657068|Irinotecan|irinotecan|mesh-list
102212007|NCT04657068|Camptothecin|camptothecin|mesh-list
102212008|NCT04657068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102212009|NCT04657068|Antimetabolites|antimetabolites|mesh-ancestor
102212010|NCT04657068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212011|NCT04657068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212012|NCT04657068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102212013|NCT04657068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102212014|NCT04657068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102212015|NCT04657068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102212016|NCT04640636|Midazolam|midazolam|mesh-list
102212017|NCT04640636|Ketamine|ketamine|mesh-list
102212018|NCT04640636|Analgesics|analgesics|mesh-ancestor
102212019|NCT04640636|Sensory System Agents|sensory system agents|mesh-ancestor
102212020|NCT04640636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102212021|NCT04640636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212022|NCT04640636|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102212023|NCT04640636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102212024|NCT04640636|Anesthetics, General|anesthetics, general|mesh-ancestor
102212025|NCT04640636|Anesthetics|anesthetics|mesh-ancestor
102212026|NCT04640636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102212027|NCT04640636|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102212028|NCT04640636|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102212029|NCT04640636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102212030|NCT04640636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212031|NCT04640636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102212032|NCT04640636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102212033|NCT04640636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102212034|NCT04640636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102212035|NCT04640636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102212036|NCT04640636|GABA Modulators|gaba modulators|mesh-ancestor
102212037|NCT04640636|GABA Agents|gaba agents|mesh-ancestor
102212038|NCT04638660|Phentolamine|phentolamine|mesh-list
102212039|NCT04638660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102212040|NCT04638660|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102212041|NCT04638660|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102212042|NCT04638660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102212043|NCT04638660|Adrenergic Agents|adrenergic agents|mesh-ancestor
102212044|NCT04638660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102212045|NCT04638660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212046|NCT04638660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212047|NCT04638660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102212048|NCT04603651|Bamlanivimab|bamlanivimab|mesh-list
102212049|NCT04603651|Antiviral Agents|antiviral agents|mesh-ancestor
102212050|NCT04603651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102212051|NCT04577326|Cyclophosphamide|cyclophosphamide|mesh-list
102212052|NCT04577326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102212053|NCT04577326|Immunologic Factors|immunologic factors|mesh-ancestor
102212054|NCT04577326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212055|NCT04577326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102212056|NCT04577326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102212057|NCT04577326|Alkylating Agents|alkylating agents|mesh-ancestor
102212058|NCT04577326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212059|NCT04577326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212060|NCT04577326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102212061|NCT04576091|Pembrolizumab|pembrolizumab|mesh-list
102212062|NCT04576091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102212063|NCT04576091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212064|NCT04576091|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102212065|NCT04576091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212067|NCT04573946|Ergocalciferols|ergocalciferols|mesh-list
102212068|NCT04573946|Cholecalciferol|cholecalciferol|mesh-list
102212069|NCT04573946|Vitamins|vitamins|mesh-list
102212070|NCT04573946|Micronutrients|micronutrients|mesh-ancestor
102212071|NCT04573946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212072|NCT04573946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102212073|NCT04573946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102212074|NCT04558359|Angiotensin II|angiotensin ii|mesh-list
102212075|NCT04558359|Giapreza|giapreza|mesh-list
102212076|NCT04558359|Angiotensinogen|angiotensinogen|mesh-list
102212077|NCT04558359|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102212078|NCT04558359|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102212079|NCT04558359|Protease Inhibitors|protease inhibitors|mesh-ancestor
102212080|NCT04558359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102212081|NCT04558359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212082|NCT04538053|Cefazolin|cefazolin|mesh-list
102212083|NCT04538053|Cephalexin|cephalexin|mesh-list
102212084|NCT04538053|Floxacillin|floxacillin|mesh-list
102212085|NCT04538053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102212086|NCT04538053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102212087|NCT04495179|Durvalumab|durvalumab|mesh-list
102212088|NCT04495179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102212089|NCT04495179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212090|NCT04491942|Cisplatin|cisplatin|mesh-list
102212091|NCT04491942|Gemcitabine|gemcitabine|mesh-list
102212092|NCT04491942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212093|NCT04491942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102212094|NCT04491942|Antimetabolites|antimetabolites|mesh-ancestor
102212095|NCT04491942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212096|NCT04460937|Adavosertib|adavosertib|mesh-list
101920948|NCT04325217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101920949|NCT04325217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920950|NCT04269408|Nicardipine|nicardipine|mesh-list
102212097|NCT04460937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102212098|NCT04460937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212099|NCT04413123|Nivolumab|nivolumab|mesh-list
102212100|NCT04413123|Ipilimumab|ipilimumab|mesh-list
102212101|NCT04413123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102212102|NCT04413123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212103|NCT04413123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102212104|NCT04413123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212105|NCT04397484|Lidocaine|lidocaine|mesh-list
102212106|NCT04397484|Epinephrine|epinephrine|mesh-list
102212107|NCT04397484|Racepinephrine|racepinephrine|mesh-list
102212108|NCT04397484|Levobupivacaine|levobupivacaine|mesh-list
102212109|NCT04397484|Epinephryl borate|epinephryl borate|mesh-list
102212110|NCT04397484|Anesthetics, Local|anesthetics, local|mesh-ancestor
102212111|NCT04397484|Anesthetics|anesthetics|mesh-ancestor
102212112|NCT04397484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102212113|NCT04397484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212114|NCT04397484|Sensory System Agents|sensory system agents|mesh-ancestor
102212115|NCT04397484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102212116|NCT04397484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102212117|NCT04397484|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102212118|NCT04397484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102212119|NCT04397484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102212120|NCT04397484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212121|NCT04397484|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102212122|NCT04397484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102212123|NCT04397484|Adrenergic Agents|adrenergic agents|mesh-ancestor
102212124|NCT04397484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102212125|NCT04397484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102212126|NCT04397484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102212127|NCT04397484|Autonomic Agents|autonomic agents|mesh-ancestor
102212128|NCT04397484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102212129|NCT04397484|Respiratory System Agents|respiratory system agents|mesh-ancestor
102212130|NCT04397484|Mydriatics|mydriatics|mesh-ancestor
102212131|NCT04397484|Sympathomimetics|sympathomimetics|mesh-ancestor
102212132|NCT04397484|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102212133|NCT04391049|Paclitaxel|paclitaxel|mesh-list
102212134|NCT04391049|Carboplatin|carboplatin|mesh-list
102212135|NCT04391049|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102212136|NCT04391049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102212137|NCT04391049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212138|NCT04391049|Tubulin Modulators|tubulin modulators|mesh-ancestor
102212139|NCT04391049|Antimitotic Agents|antimitotic agents|mesh-ancestor
102212140|NCT04391049|Mitosis Modulators|mitosis modulators|mesh-ancestor
102212141|NCT04391049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212147|NCT04385290|Cytarabine|cytarabine|mesh-list
102212148|NCT04385290|Daunorubicin|daunorubicin|mesh-list
102212149|NCT04385290|Gemtuzumab|gemtuzumab|mesh-list
102212150|NCT04385290|Midostaurin|midostaurin|mesh-list
102212151|NCT04385290|Staurosporine|staurosporine|mesh-list
102212152|NCT04385290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102212153|NCT04385290|Antimetabolites|antimetabolites|mesh-ancestor
102212154|NCT04385290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212155|NCT04385290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212156|NCT04385290|Antiviral Agents|antiviral agents|mesh-ancestor
102212157|NCT04385290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102212158|NCT04385290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102212159|NCT04385290|Immunologic Factors|immunologic factors|mesh-ancestor
102212160|NCT04385290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212161|NCT04385290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102212162|NCT04385290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102212163|NCT04385290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101921034|NCT04073433|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
101921035|NCT04073433|Hallucinogens|hallucinogens|mesh-ancestor
101921036|NCT04073433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921037|NCT04073433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101921038|NCT04073433|Serotonin Agents|serotonin agents|mesh-ancestor
101921039|NCT04073433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101921040|NCT04073433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921041|NCT04073433|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101921042|NCT04073433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101921043|NCT04073433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101921045|NCT04038515|Menthol|menthol|mesh-list
102212164|NCT04385290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102212165|NCT04385290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102212166|NCT04385290|Immunotoxins|immunotoxins|mesh-ancestor
102212167|NCT04385290|Immunoconjugates|immunoconjugates|mesh-ancestor
102212168|NCT04385290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102212169|NCT04336241|Nivolumab|nivolumab|mesh-list
102212170|NCT04336241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102212171|NCT04336241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212172|NCT04336241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102212173|NCT04336241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212174|NCT04313712|Ibogaine|ibogaine|mesh-list
102212175|NCT04313712|Hallucinogens|hallucinogens|mesh-ancestor
102212176|NCT04313712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212177|NCT04313712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102212178|NCT04313712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102212179|NCT04313712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102212180|NCT04313712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102212181|NCT04313712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212182|NCT04284787|Pembrolizumab|pembrolizumab|mesh-list
102212183|NCT04284787|Azacitidine|azacitidine|mesh-list
102212184|NCT04284787|Venetoclax|venetoclax|mesh-list
102212185|NCT04284787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102212186|NCT04284787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212187|NCT04284787|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102212188|NCT04284787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212189|NCT04284787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102212190|NCT04284787|Antimetabolites|antimetabolites|mesh-ancestor
102212191|NCT04284787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102212193|NCT04272242|Pyridoxal|pyridoxal|mesh-list
102212194|NCT04272242|Vitamin B 6|vitamin b 6|mesh-list
102212195|NCT04272242|Isoniazid|isoniazid|mesh-list
102212196|NCT04272242|Rifapentine|rifapentine|mesh-list
102212197|NCT04272242|Dolutegravir|dolutegravir|mesh-list
102212198|NCT04272242|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102212199|NCT04272242|Vitamins|vitamins|mesh-ancestor
102212200|NCT04272242|Micronutrients|micronutrients|mesh-ancestor
102212201|NCT04272242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212202|NCT04272242|Vitamin B Complex|vitamin b complex|mesh-ancestor
102212203|NCT04272242|Antitubercular Agents|antitubercular agents|mesh-ancestor
102212204|NCT04272242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102212205|NCT04272242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102212206|NCT04272242|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102212207|NCT04272242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102212208|NCT04272242|Antimetabolites|antimetabolites|mesh-ancestor
102212209|NCT04272242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212210|NCT04272242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102212211|NCT04272242|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102212212|NCT04272242|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102212213|NCT04272242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102212214|NCT04272242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102212215|NCT04272242|Antiviral Agents|antiviral agents|mesh-ancestor
102212216|NCT04272242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102212217|NCT04272242|Leprostatic Agents|leprostatic agents|mesh-ancestor
102212218|NCT04241549|Azacitidine|azacitidine|mesh-list
102212219|NCT04241549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102212220|NCT04241549|Antimetabolites|antimetabolites|mesh-ancestor
102212221|NCT04241549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212222|NCT04241549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212223|NCT04241549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102212224|NCT04240626|Acetaminophen|acetaminophen|mesh-list
102212225|NCT04240626|Scopolamine|scopolamine|mesh-list
102212226|NCT04240626|Oxycodone|oxycodone|mesh-list
102212227|NCT04240626|Gabapentin|gabapentin|mesh-list
102212228|NCT04240626|Hydromorphone|hydromorphone|mesh-list
102212229|NCT04240626|Hydrocodone|hydrocodone|mesh-list
102212230|NCT04240626|Bupivacaine|bupivacaine|mesh-list
102212231|NCT04240626|Cyclobenzaprine|cyclobenzaprine|mesh-list
102212232|NCT04240626|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102212233|NCT04240626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102212234|NCT04240626|Analgesics|analgesics|mesh-ancestor
102212235|NCT04240626|Sensory System Agents|sensory system agents|mesh-ancestor
102212236|NCT04240626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102212237|NCT04240626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212238|NCT04240626|Antipyretics|antipyretics|mesh-ancestor
102212239|NCT04240626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102212240|NCT04240626|Narcotics|narcotics|mesh-ancestor
102212241|NCT04240626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102212242|NCT04240626|Anticonvulsants|anticonvulsants|mesh-ancestor
102212243|NCT04240626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102212244|NCT04240626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102212245|NCT04240626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102212246|NCT04240626|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102212247|NCT04240626|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102212248|NCT04240626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102212249|NCT04240626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212250|NCT04240626|Antimanic Agents|antimanic agents|mesh-ancestor
102212251|NCT04240626|Anesthetics, Local|anesthetics, local|mesh-ancestor
102212252|NCT04240626|Anesthetics|anesthetics|mesh-ancestor
102212253|NCT04240626|Antiemetics|antiemetics|mesh-ancestor
102212254|NCT04240626|Autonomic Agents|autonomic agents|mesh-ancestor
102212255|NCT04240626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102212256|NCT04240626|Antitussive Agents|antitussive agents|mesh-ancestor
102212257|NCT04240626|Respiratory System Agents|respiratory system agents|mesh-ancestor
102212258|NCT04240626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102212259|NCT04240626|Mydriatics|mydriatics|mesh-ancestor
102212260|NCT04240626|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102212261|NCT04240626|Cholinergic Agents|cholinergic agents|mesh-ancestor
102212262|NCT04240626|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102212263|NCT04240626|Parasympatholytics|parasympatholytics|mesh-ancestor
102212264|NCT04240626|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102212265|NCT04240626|Antidepressive Agents|antidepressive agents|mesh-ancestor
102212266|NCT04240626|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102212267|NCT04240626|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102212268|NCT04231318|Triamcinolone|triamcinolone|mesh-list
101900732|NCT03865004|Morphine|morphine|mesh-list
102212269|NCT04231318|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102212270|NCT04231318|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102212271|NCT04231318|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102212272|NCT04231318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102212274|NCT04231318|Hormones|hormones|mesh-ancestor
102212275|NCT04231318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102212276|NCT04231318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212277|NCT04231318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102212278|NCT04231318|Immunologic Factors|immunologic factors|mesh-ancestor
102212279|NCT04231318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102212280|NCT04231318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212281|NCT04214249|Cytarabine|cytarabine|mesh-list
102212282|NCT04214249|Pembrolizumab|pembrolizumab|mesh-list
102212283|NCT04214249|Daunorubicin|daunorubicin|mesh-list
102212284|NCT04214249|Idarubicin|idarubicin|mesh-list
102212285|NCT04214249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102212286|NCT04214249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212287|NCT04214249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102212288|NCT04214249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212289|NCT04214249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102212290|NCT04214249|Antimetabolites|antimetabolites|mesh-ancestor
102212291|NCT04214249|Antiviral Agents|antiviral agents|mesh-ancestor
102212292|NCT04214249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102212293|NCT04214249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102212294|NCT04214249|Immunologic Factors|immunologic factors|mesh-ancestor
102212295|NCT04214249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212296|NCT04214249|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102212297|NCT04214249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102212298|NCT04214249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102212299|NCT04214249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102212300|NCT04214067|Pembrolizumab|pembrolizumab|mesh-list
102212301|NCT04214067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102212302|NCT04214067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212303|NCT04214067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102212304|NCT04214067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212305|NCT04201262|Ravulizumab|ravulizumab|mesh-list
102212306|NCT04201262|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102212307|NCT04201262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102212308|NCT04201262|Immunologic Factors|immunologic factors|mesh-ancestor
102212309|NCT04201262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212310|NCT04150887|Azacitidine|azacitidine|mesh-list
102212311|NCT04150887|Venetoclax|venetoclax|mesh-list
102212312|NCT04150887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102212313|NCT04150887|Antimetabolites|antimetabolites|mesh-ancestor
102212314|NCT04150887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212315|NCT04150887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212316|NCT04150887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102212317|NCT04072445|Trifluridine|trifluridine|mesh-list
102212318|NCT04072445|Irinotecan|irinotecan|mesh-list
102212319|NCT04072445|Camptothecin|camptothecin|mesh-list
102212320|NCT04072445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102212321|NCT04072445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102212322|NCT04072445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102212323|NCT04072445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212324|NCT04072445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212325|NCT04072445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102212326|NCT04072445|Antimetabolites|antimetabolites|mesh-ancestor
102212327|NCT04072445|Antiviral Agents|antiviral agents|mesh-ancestor
102212328|NCT04072445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102212332|NCT04050540|Doxycycline|doxycycline|mesh-list
102212333|NCT04050540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102212334|NCT04050540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102212335|NCT04050540|Antimalarials|antimalarials|mesh-ancestor
102212336|NCT04050540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102212337|NCT04050540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102212338|NCT04046107|Cemiplimab|cemiplimab|mesh-list
102212339|NCT04046107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102212340|NCT04046107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212341|NCT04023526|Azacitidine|azacitidine|mesh-list
102212342|NCT04023526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102212343|NCT04023526|Antimetabolites|antimetabolites|mesh-ancestor
102212344|NCT04023526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212345|NCT04023526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212346|NCT04023526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102212347|NCT04020913|Hormones|hormones|mesh-list
102212348|NCT04020913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102212349|NCT04020913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212350|NCT04004442|Avelumab|avelumab|mesh-list
102212351|NCT04004442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102212352|NCT04004442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212353|NCT03957551|Pembrolizumab|pembrolizumab|mesh-list
102212354|NCT03957551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102212355|NCT03957551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212356|NCT03957551|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102212357|NCT03957551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212358|NCT03945513|Dienogest|dienogest|mesh-list
102212359|NCT03945513|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102212360|NCT03945513|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102212361|NCT03945513|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102212362|NCT03945513|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102212363|NCT03945513|Contraceptive Agents|contraceptive agents|mesh-ancestor
102212364|NCT03945513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102212365|NCT03945513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212366|NCT03945513|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102212367|NCT03945513|Estrogens|estrogens|mesh-ancestor
102212368|NCT03945513|Hormones|hormones|mesh-ancestor
102212369|NCT03945513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102212370|NCT03945513|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102212371|NCT03945513|Hormone Antagonists|hormone antagonists|mesh-ancestor
102212372|NCT03945513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102212373|NCT03945513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212374|NCT03932643|TIC10 compound|tic10 compound|mesh-list
102212375|NCT03932643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212376|NCT03907488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102212377|NCT03907488|Nivolumab|nivolumab|mesh-list
102212378|NCT03907488|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102212379|NCT03907488|Doxorubicin|doxorubicin|mesh-list
102212380|NCT03907488|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102212381|NCT03907488|Dacarbazine|dacarbazine|mesh-list
102212382|NCT03907488|Vinblastine|vinblastine|mesh-list
102212383|NCT03907488|Antibodies|antibodies|mesh-list
102212384|NCT03907488|Immunoglobulins|immunoglobulins|mesh-list
102212385|NCT03907488|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102212386|NCT03907488|Lenograstim|lenograstim|mesh-list
102212387|NCT03907488|Imidazole|imidazole|mesh-list
102212388|NCT03907488|Immunoconjugates|immunoconjugates|mesh-list
102212389|NCT03907488|Immunologic Factors|immunologic factors|mesh-ancestor
102212390|NCT03907488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212391|NCT03907488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212392|NCT03907488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102212393|NCT03907488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102212394|NCT03907488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102212396|NCT03907488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212397|NCT03907488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102212398|NCT03907488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102212399|NCT03907488|Immunotoxins|immunotoxins|mesh-ancestor
102212400|NCT03907488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102212401|NCT03907488|Alkylating Agents|alkylating agents|mesh-ancestor
102212402|NCT03907488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102212403|NCT03907488|Tubulin Modulators|tubulin modulators|mesh-ancestor
102212404|NCT03907488|Antimitotic Agents|antimitotic agents|mesh-ancestor
102212405|NCT03907488|Mitosis Modulators|mitosis modulators|mesh-ancestor
102212406|NCT03907475|Paclitaxel|paclitaxel|mesh-list
102212407|NCT03907475|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102212408|NCT03907475|Carboplatin|carboplatin|mesh-list
102212409|NCT03907475|Gemcitabine|gemcitabine|mesh-list
102212410|NCT03907475|Doxorubicin|doxorubicin|mesh-list
102212411|NCT03907475|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102212412|NCT03907475|Capecitabine|capecitabine|mesh-list
102212413|NCT03907475|Durvalumab|durvalumab|mesh-list
102212414|NCT03907475|Immunoglobulins|immunoglobulins|mesh-list
102212415|NCT03907475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102212416|NCT03907475|Immunoglobulin G|immunoglobulin g|mesh-list
102212417|NCT03907475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102212418|NCT03907475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212419|NCT03907475|Tubulin Modulators|tubulin modulators|mesh-ancestor
102212420|NCT03907475|Antimitotic Agents|antimitotic agents|mesh-ancestor
102212421|NCT03907475|Mitosis Modulators|mitosis modulators|mesh-ancestor
102212422|NCT03907475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212423|NCT03907475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102212424|NCT03907475|Antimetabolites|antimetabolites|mesh-ancestor
102212425|NCT03907475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102212426|NCT03907475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102212427|NCT03907475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102212428|NCT03907475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102212429|NCT03907475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102212430|NCT03907475|Immunologic Factors|immunologic factors|mesh-ancestor
102212431|NCT03907475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212432|NCT03897127|Cytarabine|cytarabine|mesh-list
102212433|NCT03897127|Daunorubicin|daunorubicin|mesh-list
102212434|NCT03897127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102212435|NCT03897127|Antimetabolites|antimetabolites|mesh-ancestor
102212436|NCT03897127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212437|NCT03897127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212438|NCT03897127|Antiviral Agents|antiviral agents|mesh-ancestor
102212439|NCT03897127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102212440|NCT03897127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102212441|NCT03897127|Immunologic Factors|immunologic factors|mesh-ancestor
102212442|NCT03897127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212443|NCT03897127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102212444|NCT03897127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102212445|NCT03897127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102212446|NCT03897127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102212447|NCT03863288|Oxytocin|oxytocin|mesh-list
102212448|NCT03863288|Oxytocics|oxytocics|mesh-ancestor
102212449|NCT03863288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102212450|NCT03863288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212451|NCT03862495|Azithromycin|azithromycin|mesh-list
102212452|NCT03862495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102212453|NCT03862495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102212454|NCT03854474|Pembrolizumab|pembrolizumab|mesh-list
101451666|NCT00202982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102212455|NCT03854474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102212456|NCT03854474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212457|NCT03854474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102212458|NCT03854474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212459|NCT03831932|Osimertinib|osimertinib|mesh-list
102212460|NCT03831932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212461|NCT03831932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102212462|NCT03831932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102212463|NCT03831932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212464|NCT03816358|Gemcitabine|gemcitabine|mesh-list
102212465|NCT03816358|Nivolumab|nivolumab|mesh-list
102212466|NCT03816358|Ipilimumab|ipilimumab|mesh-list
102212467|NCT03816358|Maytansine|maytansine|mesh-list
102212468|NCT03816358|Anetumab ravtansine|anetumab ravtansine|mesh-list
102212469|NCT03816358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102212470|NCT03816358|Antimetabolites|antimetabolites|mesh-ancestor
102212471|NCT03816358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212472|NCT03816358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212473|NCT03816358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102212474|NCT03816358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102212475|NCT03816358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102212476|NCT03816358|Tubulin Modulators|tubulin modulators|mesh-ancestor
102212477|NCT03816358|Antimitotic Agents|antimitotic agents|mesh-ancestor
102212478|NCT03816358|Mitosis Modulators|mitosis modulators|mesh-ancestor
102212479|NCT03816358|Immunoconjugates|immunoconjugates|mesh-ancestor
102212480|NCT03816358|Immunologic Factors|immunologic factors|mesh-ancestor
102212481|NCT03816358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212482|NCT03801902|Durvalumab|durvalumab|mesh-list
102212483|NCT03801902|Immunoglobulins|immunoglobulins|mesh-list
102212484|NCT03801902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102212485|NCT03801902|Immunoglobulin G|immunoglobulin g|mesh-list
102212486|NCT03801902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102212487|NCT03801902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212488|NCT03801902|Immunologic Factors|immunologic factors|mesh-ancestor
102212489|NCT03801902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212490|NCT03793478|Cytarabine|cytarabine|mesh-list
102212491|NCT03793478|Fludarabine|fludarabine|mesh-list
102212492|NCT03793478|Etoposide|etoposide|mesh-list
102212493|NCT03793478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212494|NCT03793478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102212495|NCT03793478|Antimetabolites|antimetabolites|mesh-ancestor
102212496|NCT03793478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212497|NCT03793478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102212498|NCT03793478|Immunologic Factors|immunologic factors|mesh-ancestor
102212499|NCT03793478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212500|NCT03793478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102212501|NCT03793478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102212502|NCT03793478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102212503|NCT03793478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102212504|NCT03793478|Antiviral Agents|antiviral agents|mesh-ancestor
102212505|NCT03793478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102212506|NCT03785405|Valsartan|valsartan|mesh-list
102212507|NCT03785405|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102212508|NCT03785405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102212509|NCT03785405|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102212510|NCT03785405|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102212511|NCT03785405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212512|NCT03728673|Dexetimide|dexetimide|mesh-list
102212513|NCT03728673|Citalopram|citalopram|mesh-list
102212514|NCT03728673|Escitalopram|escitalopram|mesh-list
102212515|NCT03728673|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102212516|NCT03728673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102212517|NCT03728673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102212518|NCT03728673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212519|NCT03728673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102212520|NCT03728673|Serotonin Agents|serotonin agents|mesh-ancestor
102212521|NCT03728673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212522|NCT03728673|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102212523|NCT03728673|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102212524|NCT03728673|Parasympatholytics|parasympatholytics|mesh-ancestor
102212525|NCT03728673|Autonomic Agents|autonomic agents|mesh-ancestor
102212526|NCT03728673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102212527|NCT03728673|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102212528|NCT03728673|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102212529|NCT03728673|Cholinergic Agents|cholinergic agents|mesh-ancestor
102212530|NCT03728673|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102212531|NCT03728673|Antidepressive Agents|antidepressive agents|mesh-ancestor
102212532|NCT03728673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102212533|NCT03691662|Timolol|timolol|mesh-list
102212534|NCT03691662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102212535|NCT03691662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102212536|NCT03691662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212537|NCT03691662|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102212538|NCT03691662|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102212539|NCT03691662|Adrenergic Agents|adrenergic agents|mesh-ancestor
102212540|NCT03691662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102212541|NCT03691662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212542|NCT03691662|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102212543|NCT03691662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101921391|NCT02759185|Hormones|hormones|mesh-ancestor
102212545|NCT03689244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102212546|NCT03646617|Nivolumab|nivolumab|mesh-list
102212547|NCT03646617|Ipilimumab|ipilimumab|mesh-list
102212548|NCT03646617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102212549|NCT03646617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212550|NCT03646617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102212551|NCT03646617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212552|NCT03606967|Poly I-C|poly i-c|mesh-list
102212553|NCT03606967|Paclitaxel|paclitaxel|mesh-list
102212554|NCT03606967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102212555|NCT03606967|Carboplatin|carboplatin|mesh-list
102212556|NCT03606967|Gemcitabine|gemcitabine|mesh-list
102212557|NCT03606967|Durvalumab|durvalumab|mesh-list
102212558|NCT03606967|Tremelimumab|tremelimumab|mesh-list
102212559|NCT03606967|Ipilimumab|ipilimumab|mesh-list
102212560|NCT03606967|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102212561|NCT03606967|Vaccines|vaccines|mesh-list
102212562|NCT03606967|Immunoglobulins|immunoglobulins|mesh-list
102212563|NCT03606967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102212564|NCT03606967|Immunoglobulin G|immunoglobulin g|mesh-list
102212565|NCT03606967|Poly ICLC|poly iclc|mesh-list
102212566|NCT03606967|Immunologic Factors|immunologic factors|mesh-ancestor
102212567|NCT03606967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212568|NCT03606967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102212569|NCT03606967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212570|NCT03606967|Tubulin Modulators|tubulin modulators|mesh-ancestor
102212571|NCT03606967|Antimitotic Agents|antimitotic agents|mesh-ancestor
102212572|NCT03606967|Mitosis Modulators|mitosis modulators|mesh-ancestor
102212573|NCT03606967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212574|NCT03606967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102212575|NCT03606967|Antimetabolites|antimetabolites|mesh-ancestor
102212576|NCT03606967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102212577|NCT03606967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102212578|NCT03606967|Interferon Inducers|interferon inducers|mesh-ancestor
102212579|NCT03606967|Laxatives|laxatives|mesh-ancestor
102212580|NCT03606967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102212581|NCT03606967|Antiviral Agents|antiviral agents|mesh-ancestor
102212582|NCT03606967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102212583|NCT03604991|Paclitaxel|paclitaxel|mesh-list
102212584|NCT03604991|Carboplatin|carboplatin|mesh-list
102212585|NCT03604991|Nivolumab|nivolumab|mesh-list
102212586|NCT03604991|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102212587|NCT03604991|Ipilimumab|ipilimumab|mesh-list
102212588|NCT03604991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102212589|NCT03604991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212590|NCT03604991|Tubulin Modulators|tubulin modulators|mesh-ancestor
102212591|NCT03604991|Antimitotic Agents|antimitotic agents|mesh-ancestor
102212592|NCT03604991|Mitosis Modulators|mitosis modulators|mesh-ancestor
102212593|NCT03604991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451675|NCT00207948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102212594|NCT03604991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102212595|NCT03604991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102212596|NCT03594175|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102212597|NCT03594175|Reteplase|reteplase|mesh-list
102212598|NCT03594175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102212599|NCT03594175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102212600|NCT03594175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212601|NCT03587038|Temozolomide|temozolomide|mesh-list
102212602|NCT03587038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102212603|NCT03587038|Alkylating Agents|alkylating agents|mesh-ancestor
102212604|NCT03587038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212605|NCT03587038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212606|NCT03581292|Temozolomide|temozolomide|mesh-list
102212607|NCT03581292|Veliparib|veliparib|mesh-list
102212608|NCT03581292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102212609|NCT03581292|Alkylating Agents|alkylating agents|mesh-ancestor
102212610|NCT03581292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212611|NCT03581292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212612|NCT03581292|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102212613|NCT03581292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102212614|NCT03568630|Chrysarobin|chrysarobin|mesh-list
102212615|NCT03568630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102212616|NCT03568630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102212617|NCT03568630|Analgesics|analgesics|mesh-ancestor
102212618|NCT03568630|Sensory System Agents|sensory system agents|mesh-ancestor
102212619|NCT03568630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102212620|NCT03568630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212621|NCT03568630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102212622|NCT03568630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102212623|NCT03528642|Temozolomide|temozolomide|mesh-list
102212624|NCT03528642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102212625|NCT03528642|Alkylating Agents|alkylating agents|mesh-ancestor
102212626|NCT03528642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212627|NCT03528642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212628|NCT03425279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102212629|NCT03425279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212630|NCT03425279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102212631|NCT03425279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212632|NCT03414229|Pembrolizumab|pembrolizumab|mesh-list
102212633|NCT03414229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102212634|NCT03414229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212635|NCT03414229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102212636|NCT03414229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212637|NCT03338959|Pembrolizumab|pembrolizumab|mesh-list
102212638|NCT03338959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102212639|NCT03338959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212640|NCT03338959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102212641|NCT03338959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212643|NCT03288545|Gemcitabine|gemcitabine|mesh-list
102212644|NCT03288545|Pembrolizumab|pembrolizumab|mesh-list
102212645|NCT03288545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212646|NCT03288545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102212647|NCT03288545|Antimetabolites|antimetabolites|mesh-ancestor
102212648|NCT03288545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212649|NCT03288545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102212650|NCT03288545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102212651|NCT03278782|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102212652|NCT03278782|Pembrolizumab|pembrolizumab|mesh-list
102212653|NCT03278782|Romidepsin|romidepsin|mesh-list
102212654|NCT03278782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102212655|NCT03278782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212656|NCT03278782|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102212657|NCT03278782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212658|NCT03278782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102212659|NCT03278782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102212660|NCT03278782|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102212661|NCT03278782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102212688|NCT03228537|Cisplatin|cisplatin|mesh-list
102212689|NCT03228537|Pemetrexed|pemetrexed|mesh-list
102212690|NCT03228537|Atezolizumab|atezolizumab|mesh-list
102212691|NCT03228537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102212692|NCT03228537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212693|NCT03228537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101921547|NCT01853826|Afatinib|afatinib|mesh-list
102212694|NCT03228537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212695|NCT03228537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102212696|NCT03228537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102212697|NCT03228537|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102212698|NCT03228537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102212699|NCT03228537|Immunologic Factors|immunologic factors|mesh-ancestor
102212700|NCT03228537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212701|NCT03141684|Bevacizumab|bevacizumab|mesh-list
102212702|NCT03141684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102212703|NCT03141684|Atezolizumab|atezolizumab|mesh-list
102212704|NCT03141684|Endothelial Growth Factors|endothelial growth factors|mesh-list
102212705|NCT03141684|Antibodies|antibodies|mesh-list
102212706|NCT03141684|Immunoglobulins|immunoglobulins|mesh-list
102212707|NCT03141684|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102212708|NCT03141684|Immunoglobulin G|immunoglobulin g|mesh-list
102212709|NCT03141684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212710|NCT03141684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102212711|NCT03141684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102212712|NCT03141684|Growth Substances|growth substances|mesh-ancestor
102212713|NCT03141684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212714|NCT03141684|Growth Inhibitors|growth inhibitors|mesh-ancestor
102212715|NCT03141684|Immunologic Factors|immunologic factors|mesh-ancestor
102212716|NCT03141684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102212717|NCT03141684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212718|NCT03126630|Pembrolizumab|pembrolizumab|mesh-list
102212719|NCT03126630|Maytansine|maytansine|mesh-list
102212720|NCT03126630|Anetumab ravtansine|anetumab ravtansine|mesh-list
102212721|NCT03126630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102212722|NCT03126630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212723|NCT03126630|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102212724|NCT03126630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212725|NCT03126630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102212726|NCT03126630|Tubulin Modulators|tubulin modulators|mesh-ancestor
102212727|NCT03126630|Antimitotic Agents|antimitotic agents|mesh-ancestor
102212728|NCT03126630|Mitosis Modulators|mitosis modulators|mesh-ancestor
102212729|NCT03126630|Immunoconjugates|immunoconjugates|mesh-ancestor
102212730|NCT03126630|Immunologic Factors|immunologic factors|mesh-ancestor
102212731|NCT03126630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212732|NCT03113968|Ketamine|ketamine|mesh-list
102212733|NCT03113968|Analgesics|analgesics|mesh-ancestor
102212734|NCT03113968|Sensory System Agents|sensory system agents|mesh-ancestor
102212735|NCT03113968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102212736|NCT03113968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212737|NCT03113968|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102212738|NCT03113968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102212739|NCT03113968|Anesthetics, General|anesthetics, general|mesh-ancestor
102212740|NCT03113968|Anesthetics|anesthetics|mesh-ancestor
102212741|NCT03113968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102212742|NCT03113968|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102212743|NCT03113968|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102212744|NCT03113968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102212745|NCT03113968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212746|NCT03104491|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
102212747|NCT03104491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102212748|NCT03104491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212749|NCT03104491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102212750|NCT03104491|Immunotoxins|immunotoxins|mesh-ancestor
102212751|NCT03104491|Immunoconjugates|immunoconjugates|mesh-ancestor
102212752|NCT03104491|Immunologic Factors|immunologic factors|mesh-ancestor
102212753|NCT03104491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212754|NCT03030378|Pembrolizumab|pembrolizumab|mesh-list
102212755|NCT03030378|Interleukin-12|interleukin-12|mesh-list
102212756|NCT03030378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102212757|NCT03030378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212758|NCT03030378|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102212759|NCT03030378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212760|NCT03030378|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102212761|NCT03030378|Immunologic Factors|immunologic factors|mesh-ancestor
102212762|NCT03030378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212763|NCT03030378|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102212764|NCT03030378|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102212765|NCT03030378|Growth Substances|growth substances|mesh-ancestor
102212766|NCT03030378|Growth Inhibitors|growth inhibitors|mesh-ancestor
102212767|NCT02977780|Temozolomide|temozolomide|mesh-list
102212768|NCT02977780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102212769|NCT02977780|Alkylating Agents|alkylating agents|mesh-ancestor
102212770|NCT02977780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212771|NCT02977780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212772|NCT02971501|Bevacizumab|bevacizumab|mesh-list
102212773|NCT02971501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102212774|NCT02971501|Osimertinib|osimertinib|mesh-list
102212775|NCT02971501|Endothelial Growth Factors|endothelial growth factors|mesh-list
102212776|NCT02971501|Antibodies|antibodies|mesh-list
102212777|NCT02971501|Immunoglobulins|immunoglobulins|mesh-list
102212778|NCT02971501|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102212779|NCT02971501|Immunoglobulin G|immunoglobulin g|mesh-list
102212780|NCT02971501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212781|NCT02971501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102212782|NCT02971501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102212783|NCT02971501|Growth Substances|growth substances|mesh-ancestor
102212784|NCT02971501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212785|NCT02971501|Growth Inhibitors|growth inhibitors|mesh-ancestor
102212786|NCT02971501|Immunologic Factors|immunologic factors|mesh-ancestor
102212787|NCT02971501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212788|NCT02971501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102212789|NCT02971501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102212790|NCT02954874|Pembrolizumab|pembrolizumab|mesh-list
102212791|NCT02954874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102212792|NCT02954874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212793|NCT02954874|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102212794|NCT02954874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212795|NCT02897063|Midodrine|midodrine|mesh-list
102212796|NCT02897063|Droxidopa|droxidopa|mesh-list
102212797|NCT02897063|Sympathomimetics|sympathomimetics|mesh-ancestor
102212798|NCT02897063|Autonomic Agents|autonomic agents|mesh-ancestor
102212799|NCT02897063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102212800|NCT02897063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212801|NCT02897063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102212802|NCT02897063|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102212803|NCT02897063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102212804|NCT02897063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102212805|NCT02897063|Adrenergic Agents|adrenergic agents|mesh-ancestor
102212806|NCT02897063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102212807|NCT02897063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212808|NCT02897063|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102212809|NCT02897063|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102212810|NCT02890329|Ipilimumab|ipilimumab|mesh-list
102212811|NCT02890329|Decitabine|decitabine|mesh-list
102212812|NCT02890329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102212813|NCT02890329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212814|NCT02890329|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102212815|NCT02890329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212816|NCT02890329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102212817|NCT02890329|Antimetabolites|antimetabolites|mesh-ancestor
102212818|NCT02890329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102212819|NCT02888743|Durvalumab|durvalumab|mesh-list
102212820|NCT02888743|Ipilimumab|ipilimumab|mesh-list
102212821|NCT02888743|Tremelimumab|tremelimumab|mesh-list
102212822|NCT02888743|Immunoglobulins|immunoglobulins|mesh-list
102212823|NCT02888743|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101308434|NCT02047175|Vitamins|vitamins|mesh-ancestor
102212824|NCT02888743|Immunoglobulin G|immunoglobulin g|mesh-list
102212825|NCT02888743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102212826|NCT02888743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212827|NCT02888743|Immunologic Factors|immunologic factors|mesh-ancestor
102212828|NCT02888743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212829|NCT02888743|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102212830|NCT02888743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212831|NCT02883049|Calcium, Dietary|calcium, dietary|mesh-list
102212832|NCT02883049|Leucovorin|leucovorin|mesh-list
102212833|NCT02883049|Folic Acid|folic acid|mesh-list
102212834|NCT02883049|Cytarabine|cytarabine|mesh-list
102212835|NCT02883049|Dexamethasone|dexamethasone|mesh-list
102212836|NCT02883049|Dexamethasone acetate|dexamethasone acetate|mesh-list
102212837|NCT02883049|Prednisone|prednisone|mesh-list
102212838|NCT02883049|Hydrocortisone|hydrocortisone|mesh-list
102212839|NCT02883049|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102212840|NCT02883049|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102212841|NCT02883049|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102212842|NCT02883049|Cortisone|cortisone|mesh-list
102212843|NCT02883049|Cyclophosphamide|cyclophosphamide|mesh-list
102212844|NCT02883049|Doxorubicin|doxorubicin|mesh-list
102212845|NCT02883049|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102212846|NCT02883049|Methotrexate|methotrexate|mesh-list
102212847|NCT02883049|Etoposide|etoposide|mesh-list
102212848|NCT02883049|Vincristine|vincristine|mesh-list
102212849|NCT02883049|Etoposide phosphate|etoposide phosphate|mesh-list
102212850|NCT02883049|Daunorubicin|daunorubicin|mesh-list
102212851|NCT02883049|Asparaginase|asparaginase|mesh-list
102212852|NCT02883049|Dasatinib|dasatinib|mesh-list
102212853|NCT02883049|Mercaptopurine|mercaptopurine|mesh-list
102212854|NCT02883049|Clofarabine|clofarabine|mesh-list
102212855|NCT02883049|Podophyllotoxin|podophyllotoxin|mesh-list
102212856|NCT02883049|Pegaspargase|pegaspargase|mesh-list
102212857|NCT02883049|Thioguanine|thioguanine|mesh-list
102212858|NCT02883049|BB 1101|bb 1101|mesh-list
102212859|NCT02883049|Calcium|calcium|mesh-list
102212860|NCT02883049|2-Aminopurine|2-aminopurine|mesh-list
102212861|NCT02883049|Levoleucovorin|levoleucovorin|mesh-list
102212862|NCT02883049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102212863|NCT02883049|Immunologic Factors|immunologic factors|mesh-ancestor
102212864|NCT02883049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212865|NCT02883049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102212866|NCT02883049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102212867|NCT02883049|Alkylating Agents|alkylating agents|mesh-ancestor
102212868|NCT02883049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212869|NCT02883049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212870|NCT02883049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102212871|NCT02883049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102212872|NCT02883049|Antiemetics|antiemetics|mesh-ancestor
102212873|NCT02883049|Autonomic Agents|autonomic agents|mesh-ancestor
102212874|NCT02883049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102212875|NCT02883049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102212876|NCT02883049|Glucocorticoids|glucocorticoids|mesh-ancestor
102212877|NCT02883049|Hormones|hormones|mesh-ancestor
102212878|NCT02883049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102212879|NCT02883049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102212880|NCT02883049|Protease Inhibitors|protease inhibitors|mesh-ancestor
102212881|NCT02883049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102212882|NCT02883049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102212883|NCT02883049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102212884|NCT02883049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102212885|NCT02883049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102212886|NCT02883049|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102212887|NCT02883049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102212888|NCT02883049|Abortifacient Agents|abortifacient agents|mesh-ancestor
102212889|NCT02883049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102212890|NCT02883049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102212891|NCT02883049|Antimetabolites|antimetabolites|mesh-ancestor
102212892|NCT02883049|Dermatologic Agents|dermatologic agents|mesh-ancestor
102212893|NCT02883049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102212894|NCT02883049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102212895|NCT02883049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102212896|NCT02883049|Antiviral Agents|antiviral agents|mesh-ancestor
102212897|NCT02883049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102212898|NCT02883049|Antidotes|antidotes|mesh-ancestor
102212899|NCT02883049|Protective Agents|protective agents|mesh-ancestor
102212900|NCT02883049|Vitamin B Complex|vitamin b complex|mesh-ancestor
102212901|NCT02883049|Vitamins|vitamins|mesh-ancestor
102212902|NCT02883049|Micronutrients|micronutrients|mesh-ancestor
102212903|NCT02883049|Tubulin Modulators|tubulin modulators|mesh-ancestor
102212904|NCT02883049|Antimitotic Agents|antimitotic agents|mesh-ancestor
102212905|NCT02883049|Mitosis Modulators|mitosis modulators|mesh-ancestor
102212906|NCT02883049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102212907|NCT02883049|Hematinics|hematinics|mesh-ancestor
102212908|NCT02883049|Keratolytic Agents|keratolytic agents|mesh-ancestor
102212909|NCT02839707|Bevacizumab|bevacizumab|mesh-list
102212910|NCT02839707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102212911|NCT02839707|Atezolizumab|atezolizumab|mesh-list
102212912|NCT02839707|Doxorubicin|doxorubicin|mesh-list
102212913|NCT02839707|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102212914|NCT02839707|Endothelial Growth Factors|endothelial growth factors|mesh-list
102212915|NCT02839707|Antibodies|antibodies|mesh-list
102212916|NCT02839707|Immunoglobulins|immunoglobulins|mesh-list
102212917|NCT02839707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102212918|NCT02839707|Immunoglobulin G|immunoglobulin g|mesh-list
102212919|NCT02839707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212920|NCT02839707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101921769|NCT01255410|Vaccines|vaccines|mesh-list
102212921|NCT02839707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102212922|NCT02839707|Growth Substances|growth substances|mesh-ancestor
102212923|NCT02839707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212924|NCT02839707|Growth Inhibitors|growth inhibitors|mesh-ancestor
102212925|NCT02839707|Immunologic Factors|immunologic factors|mesh-ancestor
102212926|NCT02839707|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102212927|NCT02839707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102212928|NCT02839707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102212929|NCT02839707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102212930|NCT02839707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212931|NCT02839707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102212932|NCT02804022|Morphine|morphine|mesh-list
102212933|NCT02804022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102212934|NCT02804022|Narcotics|narcotics|mesh-ancestor
102212935|NCT02804022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102212936|NCT02804022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212937|NCT02804022|Analgesics|analgesics|mesh-ancestor
102212938|NCT02804022|Sensory System Agents|sensory system agents|mesh-ancestor
102212939|NCT02804022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102212940|NCT02792413|Denosumab|denosumab|mesh-list
102212941|NCT02792413|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102212942|NCT02792413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212943|NCT02775851|Pembrolizumab|pembrolizumab|mesh-list
102212944|NCT02775851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102212945|NCT02775851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212946|NCT02775851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102212947|NCT02775851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212948|NCT02754596|Timolol|timolol|mesh-list
102212949|NCT02754596|Travoprost|travoprost|mesh-list
102212950|NCT02754596|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102212951|NCT02754596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102212952|NCT02754596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212953|NCT02754596|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102212954|NCT02754596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102212955|NCT02754596|Adrenergic Agents|adrenergic agents|mesh-ancestor
102212956|NCT02754596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102212957|NCT02754596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212958|NCT02754596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102212959|NCT02754596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102212960|NCT02719574|Cytarabine|cytarabine|mesh-list
102212961|NCT02719574|Azacitidine|azacitidine|mesh-list
102212962|NCT02719574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102212963|NCT02719574|Antimetabolites|antimetabolites|mesh-ancestor
102212964|NCT02719574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212965|NCT02719574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212966|NCT02719574|Antiviral Agents|antiviral agents|mesh-ancestor
102212967|NCT02719574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102212968|NCT02719574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102212969|NCT02719574|Immunologic Factors|immunologic factors|mesh-ancestor
102212970|NCT02719574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212971|NCT02719574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102212972|NCT02717624|Acalabrutinib|acalabrutinib|mesh-list
102212973|NCT02717624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212974|NCT02714439|Proflavine|proflavine|mesh-list
102212975|NCT02714439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102212976|NCT02714439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102212977|NCT02654119|Paclitaxel|paclitaxel|mesh-list
102212978|NCT02654119|Cyclophosphamide|cyclophosphamide|mesh-list
102212979|NCT02654119|Trastuzumab|trastuzumab|mesh-list
102212980|NCT02654119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102212981|NCT02654119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102212982|NCT02654119|Antibodies|antibodies|mesh-list
102212983|NCT02654119|Immunoglobulins|immunoglobulins|mesh-list
102212984|NCT02654119|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102212985|NCT02654119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102212986|NCT02654119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102212987|NCT02654119|Tubulin Modulators|tubulin modulators|mesh-ancestor
102212988|NCT02654119|Antimitotic Agents|antimitotic agents|mesh-ancestor
102212989|NCT02654119|Mitosis Modulators|mitosis modulators|mesh-ancestor
102212990|NCT02654119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102212991|NCT02654119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102212992|NCT02654119|Immunologic Factors|immunologic factors|mesh-ancestor
102212993|NCT02654119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102212994|NCT02654119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102212995|NCT02654119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102212996|NCT02654119|Alkylating Agents|alkylating agents|mesh-ancestor
102212997|NCT02654119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102212998|NCT02631733|Irinotecan|irinotecan|mesh-list
101921843|NCT03892668|Hemostatics|hemostatics|mesh-ancestor
102212999|NCT02631733|Veliparib|veliparib|mesh-list
102213000|NCT02631733|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102213001|NCT02631733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102213002|NCT02631733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102213003|NCT02631733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102213004|NCT02631733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213005|NCT02631733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102213006|NCT02631733|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102213007|NCT02631733|Hematinics|hematinics|mesh-ancestor
102213008|NCT02631733|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102213009|NCT02631733|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102213010|NCT02627443|Carboplatin|carboplatin|mesh-list
102213011|NCT02627443|Gemcitabine|gemcitabine|mesh-list
102213012|NCT02627443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102213013|NCT02627443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102213014|NCT02627443|Antimetabolites|antimetabolites|mesh-ancestor
102213015|NCT02627443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213016|NCT02567435|Sirolimus|sirolimus|mesh-list
102213017|NCT02567435|Dactinomycin|dactinomycin|mesh-list
102213018|NCT02567435|Cyclophosphamide|cyclophosphamide|mesh-list
102213019|NCT02567435|Irinotecan|irinotecan|mesh-list
102213020|NCT02567435|Vincristine|vincristine|mesh-list
102213021|NCT02567435|Temsirolimus|temsirolimus|mesh-list
102213022|NCT02567435|Vinorelbine|vinorelbine|mesh-list
102213023|NCT02567435|Camptothecin|camptothecin|mesh-list
102213024|NCT02567435|MTOR Inhibitors|mtor inhibitors|mesh-list
102213025|NCT02567435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102213026|NCT02567435|Immunologic Factors|immunologic factors|mesh-ancestor
102213027|NCT02567435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213028|NCT02567435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102213029|NCT02567435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102213030|NCT02567435|Alkylating Agents|alkylating agents|mesh-ancestor
102213031|NCT02567435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213032|NCT02567435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102213033|NCT02567435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102213034|NCT02567435|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102213035|NCT02567435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102213036|NCT02567435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102213037|NCT02567435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102213038|NCT02567435|Tubulin Modulators|tubulin modulators|mesh-ancestor
102213039|NCT02567435|Antimitotic Agents|antimitotic agents|mesh-ancestor
102213040|NCT02567435|Mitosis Modulators|mitosis modulators|mesh-ancestor
102213041|NCT02567435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102213042|NCT02567435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102213043|NCT02567435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102213044|NCT02567435|Antifungal Agents|antifungal agents|mesh-ancestor
102213045|NCT02567435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102213046|NCT02567435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102213047|NCT02567435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102213048|NCT02567422|Cisplatin|cisplatin|mesh-list
102213049|NCT02567422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102213050|NCT02543879|Azacitidine|azacitidine|mesh-list
102213051|NCT02543879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102213052|NCT02543879|Antimetabolites|antimetabolites|mesh-ancestor
102213053|NCT02543879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213054|NCT02543879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102213055|NCT02543879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102213056|NCT02506153|Interferons|interferons|mesh-list
102213057|NCT02506153|Interferon-alpha|interferon-alpha|mesh-list
102213058|NCT02506153|Interferon alpha-2|interferon alpha-2|mesh-list
102213059|NCT02506153|Pembrolizumab|pembrolizumab|mesh-list
102213060|NCT02506153|Ipilimumab|ipilimumab|mesh-list
102213061|NCT02506153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102213062|NCT02506153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102213063|NCT02506153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102213064|NCT02506153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213065|NCT02506153|Antiviral Agents|antiviral agents|mesh-ancestor
102213066|NCT02506153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102213067|NCT02506153|Immunologic Factors|immunologic factors|mesh-ancestor
102213068|NCT02506153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213069|NCT02466971|Cisplatin|cisplatin|mesh-list
102213070|NCT02466971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102213071|NCT02307812|Paclitaxel|paclitaxel|mesh-list
102213072|NCT02307812|Ramucirumab|ramucirumab|mesh-list
102213073|NCT02307812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102213074|NCT02307812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102213075|NCT02307812|Tubulin Modulators|tubulin modulators|mesh-ancestor
102213076|NCT02307812|Antimitotic Agents|antimitotic agents|mesh-ancestor
102213077|NCT02307812|Mitosis Modulators|mitosis modulators|mesh-ancestor
102213078|NCT02307812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213080|NCT02298959|Aflibercept|aflibercept|mesh-list
102213081|NCT02298959|Endothelial Growth Factors|endothelial growth factors|mesh-list
102213082|NCT02298959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102213083|NCT02298959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102213084|NCT02298959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102213085|NCT02298959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900745|NCT00334295|Fulvestrant|fulvestrant|mesh-list
102213086|NCT02298959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102213087|NCT02298959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102213088|NCT02298959|Growth Substances|growth substances|mesh-ancestor
102213089|NCT02298959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213090|NCT02298959|Growth Inhibitors|growth inhibitors|mesh-ancestor
102213091|NCT02220985|Mycophenolic Acid|mycophenolic acid|mesh-list
102213092|NCT02220985|Cyclophosphamide|cyclophosphamide|mesh-list
102213093|NCT02220985|Thiotepa|thiotepa|mesh-list
102213094|NCT02220985|Methotrexate|methotrexate|mesh-list
102213095|NCT02220985|Fludarabine|fludarabine|mesh-list
102213096|NCT02220985|Fludarabine phosphate|fludarabine phosphate|mesh-list
102213097|NCT02220985|Tacrolimus|tacrolimus|mesh-list
102213098|NCT02220985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102213099|NCT02220985|Immunologic Factors|immunologic factors|mesh-ancestor
102213100|NCT02220985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213101|NCT02220985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102213102|NCT02220985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102213103|NCT02220985|Alkylating Agents|alkylating agents|mesh-ancestor
102213104|NCT02220985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213105|NCT02220985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102213106|NCT02220985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102213107|NCT02220985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102213108|NCT02220985|Abortifacient Agents|abortifacient agents|mesh-ancestor
102213109|NCT02220985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102213110|NCT02220985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102213111|NCT02220985|Antimetabolites|antimetabolites|mesh-ancestor
102213112|NCT02220985|Dermatologic Agents|dermatologic agents|mesh-ancestor
102213113|NCT02220985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102213114|NCT02220985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102213115|NCT02220985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102213116|NCT02220985|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102213117|NCT02220985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102213118|NCT02220985|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102213119|NCT02220985|Antitubercular Agents|antitubercular agents|mesh-ancestor
102213120|NCT02220985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102213121|NCT02220985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102213122|NCT02193191|Plerixafor|plerixafor|mesh-list
102213123|NCT02193191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102213124|NCT02193191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102213125|NCT02193191|Antiviral Agents|antiviral agents|mesh-ancestor
102213126|NCT02193191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102213127|NCT02133573|Progesterone|progesterone|mesh-list
102213128|NCT02133573|Progestins|progestins|mesh-ancestor
102213129|NCT02133573|Hormones|hormones|mesh-ancestor
102213130|NCT02133573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102213131|NCT02133573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213132|NCT02073994|Ivosidenib|ivosidenib|mesh-list
102213133|NCT02073994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102213134|NCT02073994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102213135|NCT02073994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213136|NCT02065765|Ramucirumab|ramucirumab|mesh-list
102213137|NCT02065765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102213138|NCT01950390|Bevacizumab|bevacizumab|mesh-list
102213139|NCT01950390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102213140|NCT01950390|Ipilimumab|ipilimumab|mesh-list
102213141|NCT01950390|Endothelial Growth Factors|endothelial growth factors|mesh-list
102213142|NCT01950390|Antibodies|antibodies|mesh-list
102213143|NCT01950390|Immunoglobulins|immunoglobulins|mesh-list
102213144|NCT01950390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102213145|NCT01950390|Immunoglobulin G|immunoglobulin g|mesh-list
102213146|NCT01950390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102213147|NCT01950390|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102213148|NCT01950390|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102213149|NCT01950390|Growth Substances|growth substances|mesh-ancestor
102213150|NCT01950390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921990|NCT01259934|Interferons|interferons|mesh-list
102213151|NCT01950390|Growth Inhibitors|growth inhibitors|mesh-ancestor
102213152|NCT01950390|Immunologic Factors|immunologic factors|mesh-ancestor
102213153|NCT01950390|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102213154|NCT01950390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213156|NCT01932697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102213157|NCT01932697|Tubulin Modulators|tubulin modulators|mesh-ancestor
102213158|NCT01932697|Antimitotic Agents|antimitotic agents|mesh-ancestor
102213159|NCT01932697|Mitosis Modulators|mitosis modulators|mesh-ancestor
102213160|NCT01932697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213161|NCT01878669|Acetylcysteine|acetylcysteine|mesh-list
102213162|NCT01878669|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102213163|NCT01878669|Antiviral Agents|antiviral agents|mesh-ancestor
102213164|NCT01878669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102213165|NCT01878669|Expectorants|expectorants|mesh-ancestor
102213166|NCT01878669|Respiratory System Agents|respiratory system agents|mesh-ancestor
102213167|NCT01878669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102213168|NCT01878669|Antioxidants|antioxidants|mesh-ancestor
102213169|NCT01878669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213170|NCT01878669|Protective Agents|protective agents|mesh-ancestor
102213171|NCT01878669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213172|NCT01878669|Antidotes|antidotes|mesh-ancestor
102213173|NCT01861314|Bortezomib|bortezomib|mesh-list
102213174|NCT01861314|Sorafenib|sorafenib|mesh-list
102213175|NCT01861314|Decitabine|decitabine|mesh-list
102213176|NCT01861314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102213177|NCT01861314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102213178|NCT01861314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102213179|NCT01861314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213180|NCT01861314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102213181|NCT01861314|Antimetabolites|antimetabolites|mesh-ancestor
102213182|NCT01849146|Temozolomide|temozolomide|mesh-list
102213183|NCT01849146|Adavosertib|adavosertib|mesh-list
102213184|NCT01849146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102213185|NCT01849146|Alkylating Agents|alkylating agents|mesh-ancestor
102213186|NCT01849146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213187|NCT01849146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102213188|NCT01849146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102213189|NCT01704859|Vitamin D|vitamin d|mesh-list
102213190|NCT01704859|Ergocalciferols|ergocalciferols|mesh-list
102213191|NCT01704859|Cholecalciferol|cholecalciferol|mesh-list
102213192|NCT01704859|Vitamins|vitamins|mesh-list
102213193|NCT01704859|Micronutrients|micronutrients|mesh-ancestor
102213194|NCT01704859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213195|NCT01704859|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102213196|NCT01704859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102213197|NCT01660971|Gemcitabine|gemcitabine|mesh-list
102213198|NCT01660971|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102213199|NCT01660971|Dasatinib|dasatinib|mesh-list
102213200|NCT01660971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102213201|NCT01660971|Antimetabolites|antimetabolites|mesh-ancestor
102213202|NCT01660971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213203|NCT01660971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102213204|NCT01660971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102213205|NCT01660971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102213206|NCT01585805|Cisplatin|cisplatin|mesh-list
102213207|NCT01585805|Gemcitabine|gemcitabine|mesh-list
102213208|NCT01585805|Veliparib|veliparib|mesh-list
102213209|NCT01585805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102213210|NCT01585805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102213211|NCT01585805|Antimetabolites|antimetabolites|mesh-ancestor
102213212|NCT01585805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213213|NCT01585805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102213214|NCT01585805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102213215|NCT00878163|Gemcitabine|gemcitabine|mesh-list
102213216|NCT00878163|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102213217|NCT00878163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102213218|NCT00878163|Antimetabolites|antimetabolites|mesh-ancestor
102213219|NCT00878163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213220|NCT00878163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102213221|NCT00878163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102213222|NCT00878163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102213223|NCT00869232|Thalidomide|thalidomide|mesh-list
102213224|NCT00869232|Dexamethasone|dexamethasone|mesh-list
101922067|NCT03885804|Dexmedetomidine|dexmedetomidine|mesh-list
102213225|NCT00869232|Cyclophosphamide|cyclophosphamide|mesh-list
102213226|NCT00869232|Melphalan|melphalan|mesh-list
102213228|NCT00869232|Etoposide|etoposide|mesh-list
102213229|NCT00869232|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102213230|NCT00869232|Bortezomib|bortezomib|mesh-list
102213231|NCT00869232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102213232|NCT00869232|Immunologic Factors|immunologic factors|mesh-ancestor
102213233|NCT00869232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213234|NCT00869232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102213235|NCT00869232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102213236|NCT00869232|Alkylating Agents|alkylating agents|mesh-ancestor
102213237|NCT00869232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213238|NCT00869232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102213239|NCT00869232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102213240|NCT00869232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102213241|NCT00869232|Antiemetics|antiemetics|mesh-ancestor
102213242|NCT00869232|Autonomic Agents|autonomic agents|mesh-ancestor
102213243|NCT00869232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102213244|NCT00869232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102213245|NCT00869232|Glucocorticoids|glucocorticoids|mesh-ancestor
102213246|NCT00869232|Hormones|hormones|mesh-ancestor
102213247|NCT00869232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102213248|NCT00869232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102213249|NCT00869232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102213250|NCT00869232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102213251|NCT00869232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102213252|NCT00869232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102213253|NCT00869232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102213254|NCT00869232|Leprostatic Agents|leprostatic agents|mesh-ancestor
102213255|NCT00869232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102213256|NCT00869232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102213257|NCT00869232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102213258|NCT00869232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102213259|NCT00869232|Growth Substances|growth substances|mesh-ancestor
102213260|NCT00869232|Growth Inhibitors|growth inhibitors|mesh-ancestor
102213261|NCT00765765|Hydroxychloroquine|hydroxychloroquine|mesh-list
102213262|NCT00765765|Antimalarials|antimalarials|mesh-ancestor
102213263|NCT00765765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102213264|NCT00765765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102213265|NCT00765765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102213266|NCT00765765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102213267|NCT00765765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213268|NCT00765765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102213269|NCT00734877|Thalidomide|thalidomide|mesh-list
102213270|NCT00734877|Dexamethasone|dexamethasone|mesh-list
102213271|NCT00734877|Dexamethasone acetate|dexamethasone acetate|mesh-list
102213272|NCT00734877|Cyclophosphamide|cyclophosphamide|mesh-list
102213273|NCT00734877|Melphalan|melphalan|mesh-list
102213274|NCT00734877|Cisplatin|cisplatin|mesh-list
102213275|NCT00734877|Etoposide|etoposide|mesh-list
102213276|NCT00734877|Etoposide phosphate|etoposide phosphate|mesh-list
102213277|NCT00734877|Doxorubicin|doxorubicin|mesh-list
102213278|NCT00734877|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102213279|NCT00734877|Bortezomib|bortezomib|mesh-list
102213280|NCT00734877|BB 1101|bb 1101|mesh-list
102213281|NCT00734877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102213282|NCT00734877|Immunologic Factors|immunologic factors|mesh-ancestor
102213283|NCT00734877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213284|NCT00734877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102213285|NCT00734877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102213286|NCT00734877|Alkylating Agents|alkylating agents|mesh-ancestor
102213287|NCT00734877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213288|NCT00734877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102213289|NCT00734877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102213290|NCT00734877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102213291|NCT00734877|Antiemetics|antiemetics|mesh-ancestor
102213292|NCT00734877|Autonomic Agents|autonomic agents|mesh-ancestor
102213293|NCT00734877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102213294|NCT00734877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102213295|NCT00734877|Glucocorticoids|glucocorticoids|mesh-ancestor
102213296|NCT00734877|Hormones|hormones|mesh-ancestor
102213297|NCT00734877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102213298|NCT00734877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102213299|NCT00734877|Protease Inhibitors|protease inhibitors|mesh-ancestor
102213300|NCT00734877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102213301|NCT00734877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102213302|NCT00734877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101922147|NCT01260558|Sirolimus|sirolimus|mesh-list
102213303|NCT00734877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102213304|NCT00734877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102213305|NCT00734877|Leprostatic Agents|leprostatic agents|mesh-ancestor
102213306|NCT00734877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102213307|NCT00734877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102213308|NCT00734877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102213309|NCT00734877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102213310|NCT00734877|Growth Substances|growth substances|mesh-ancestor
102213311|NCT00734877|Growth Inhibitors|growth inhibitors|mesh-ancestor
102213312|NCT00716066|Cytarabine|cytarabine|mesh-list
102213313|NCT00716066|Prednisone|prednisone|mesh-list
102213314|NCT00716066|Cortisone|cortisone|mesh-list
102213315|NCT00716066|Etoposide|etoposide|mesh-list
102213316|NCT00716066|Etoposide phosphate|etoposide phosphate|mesh-list
102213317|NCT00716066|Melphalan|melphalan|mesh-list
102213318|NCT00716066|Mechlorethamine|mechlorethamine|mesh-list
102213319|NCT00716066|Carmustine|carmustine|mesh-list
102213320|NCT00716066|Podophyllotoxin|podophyllotoxin|mesh-list
102213321|NCT00716066|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102213322|NCT00716066|Thymoglobulin|thymoglobulin|mesh-list
102213323|NCT00716066|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102213324|NCT00716066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102213325|NCT00716066|Glucocorticoids|glucocorticoids|mesh-ancestor
102213326|NCT00716066|Hormones|hormones|mesh-ancestor
102213327|NCT00716066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102213328|NCT00716066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628348|NCT00720109|BB 1101|bb 1101|mesh-list
102213329|NCT00716066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102213330|NCT00716066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102213331|NCT00716066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102213332|NCT00716066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102213333|NCT00716066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102213334|NCT00716066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102213335|NCT00716066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213336|NCT00716066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102213337|NCT00716066|Antimetabolites|antimetabolites|mesh-ancestor
102213338|NCT00716066|Antiviral Agents|antiviral agents|mesh-ancestor
102213339|NCT00716066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102213340|NCT00716066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102213341|NCT00716066|Immunologic Factors|immunologic factors|mesh-ancestor
102213342|NCT00716066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102213343|NCT00716066|Alkylating Agents|alkylating agents|mesh-ancestor
102213344|NCT00716066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102213345|NCT00716066|Keratolytic Agents|keratolytic agents|mesh-ancestor
102213346|NCT00716066|Dermatologic Agents|dermatologic agents|mesh-ancestor
102213347|NCT00716066|Tubulin Modulators|tubulin modulators|mesh-ancestor
102213348|NCT00716066|Antimitotic Agents|antimitotic agents|mesh-ancestor
102213349|NCT00716066|Mitosis Modulators|mitosis modulators|mesh-ancestor
102213350|NCT00686595|Infliximab|infliximab|mesh-list
102213351|NCT00686595|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102213352|NCT00686595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102213353|NCT00686595|Dermatologic Agents|dermatologic agents|mesh-ancestor
102213354|NCT00686595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102213355|NCT00686595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102213356|NCT00640159|Selegiline|selegiline|mesh-list
102213357|NCT00640159|Antidepressive Agents|antidepressive agents|mesh-ancestor
102213358|NCT00640159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102213359|NCT00640159|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102213360|NCT00640159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102213361|NCT00640159|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102213362|NCT00640159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102213363|NCT00640159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213364|NCT00640159|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102213365|NCT00640159|Protective Agents|protective agents|mesh-ancestor
102213366|NCT00640159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213367|NCT00071708|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102213368|NCT00071708|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102213369|NCT00071708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102213370|NCT00071708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102213371|NCT00071708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213372|NCT00071708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102213373|NCT00071708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213374|NCT00071708|Analgesics|analgesics|mesh-ancestor
102213375|NCT00071708|Sensory System Agents|sensory system agents|mesh-ancestor
102213376|NCT00071708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102213377|NCT00071708|Antidepressive Agents|antidepressive agents|mesh-ancestor
102213378|NCT00071708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102213379|NCT00071708|Dopamine Agents|dopamine agents|mesh-ancestor
102213380|NCT00001337|Rituximab|rituximab|mesh-list
102213381|NCT00001337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102213382|NCT00001337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102213383|NCT00001337|Immunologic Factors|immunologic factors|mesh-ancestor
102213384|NCT00001337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213385|NCT00001337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102213386|NCT03483415|Morphine|morphine|mesh-list
102213387|NCT03483415|Bupivacaine|bupivacaine|mesh-list
102213388|NCT03483415|Anesthetics, Local|anesthetics, local|mesh-ancestor
102213389|NCT03483415|Anesthetics|anesthetics|mesh-ancestor
102213390|NCT03483415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102213391|NCT03483415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213392|NCT03483415|Sensory System Agents|sensory system agents|mesh-ancestor
102213393|NCT03483415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102213394|NCT03483415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102213395|NCT03483415|Narcotics|narcotics|mesh-ancestor
102213396|NCT03483415|Analgesics|analgesics|mesh-ancestor
102213397|NCT03487003|Bromides|bromides|mesh-list
102213398|NCT03487003|Rocuronium|rocuronium|mesh-list
102213399|NCT03487003|Anticonvulsants|anticonvulsants|mesh-ancestor
102213400|NCT03487003|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102213401|NCT03487003|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102213402|NCT03487003|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102213403|NCT03487003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102213404|NCT03487003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213405|NCT03486925|Oxytocin|oxytocin|mesh-list
102213406|NCT03486925|Oxytocics|oxytocics|mesh-ancestor
102213407|NCT03486925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102213408|NCT03486925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213409|NCT02262754|Naproxen|naproxen|mesh-list
102213410|NCT02262754|PF-06372865|pf-06372865|mesh-list
102213411|NCT02262754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102213412|NCT02262754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102213413|NCT02262754|Analgesics|analgesics|mesh-ancestor
102213414|NCT02262754|Sensory System Agents|sensory system agents|mesh-ancestor
102213415|NCT02262754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102213416|NCT02262754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213417|NCT02262754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102213418|NCT02262754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102213419|NCT02262754|Gout Suppressants|gout suppressants|mesh-ancestor
102213420|NCT02262754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102213421|NCT02262754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102213422|NCT02262754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213423|NCT02262754|GABA Modulators|gaba modulators|mesh-ancestor
102213424|NCT02262754|GABA Agents|gaba agents|mesh-ancestor
102213425|NCT02262754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102213426|NCT03483181|Enoxaparin|enoxaparin|mesh-list
102213427|NCT03483181|Rivaroxaban|rivaroxaban|mesh-list
102213428|NCT03483181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102213429|NCT03483181|Antithrombins|antithrombins|mesh-ancestor
102213430|NCT03483181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102213431|NCT03483181|Protease Inhibitors|protease inhibitors|mesh-ancestor
102213432|NCT03483181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102213433|NCT03483181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213434|NCT03483181|Anticoagulants|anticoagulants|mesh-ancestor
102213435|NCT03483181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102213436|NCT03483181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102213438|NCT02356588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102213439|NCT02356588|Narcotics|narcotics|mesh-ancestor
102213440|NCT02356588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102213441|NCT02356588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213442|NCT02356588|Analgesics|analgesics|mesh-ancestor
102213443|NCT02356588|Sensory System Agents|sensory system agents|mesh-ancestor
102213444|NCT02356588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102213445|NCT02356588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102213446|NCT02356588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102213447|NCT02356588|Anesthetics, General|anesthetics, general|mesh-ancestor
102213448|NCT02356588|Anesthetics|anesthetics|mesh-ancestor
102213449|NCT04445389|Vaccines|vaccines|mesh-list
102213450|NCT04445389|Immunologic Factors|immunologic factors|mesh-ancestor
102213451|NCT04445389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213452|NCT02355028|Ranibizumab|ranibizumab|mesh-list
102213453|NCT02355028|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102213454|NCT02355028|Acrizanib|acrizanib|mesh-list
102213455|NCT02355028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102213456|NCT02355028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102213457|NCT02355028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102213458|NCT02355028|Growth Substances|growth substances|mesh-ancestor
102213459|NCT02355028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213460|NCT02355028|Growth Inhibitors|growth inhibitors|mesh-ancestor
102213461|NCT02355028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102213462|NCT02355028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102213463|NCT02355028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102213464|NCT02355028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213465|NCT05647330|Hydroxychloroquine|hydroxychloroquine|mesh-list
102213466|NCT05647330|Chloroquine|chloroquine|mesh-list
102213467|NCT05647330|Gemcitabine|gemcitabine|mesh-list
102213468|NCT05647330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102213469|NCT05647330|Antimetabolites|antimetabolites|mesh-ancestor
102213470|NCT05647330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213471|NCT05647330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102213472|NCT05647330|Antimalarials|antimalarials|mesh-ancestor
102213473|NCT05647330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102213474|NCT05647330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102213475|NCT05647330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102213476|NCT05647330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102213477|NCT05647330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102213478|NCT05647330|Amebicides|amebicides|mesh-ancestor
102213479|NCT01643668|Busulfan|busulfan|mesh-list
102213480|NCT01643668|Clofarabine|clofarabine|mesh-list
102213481|NCT01643668|Alkylating Agents|alkylating agents|mesh-ancestor
102213482|NCT01643668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213483|NCT01643668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102213484|NCT01643668|Immunologic Factors|immunologic factors|mesh-ancestor
102213485|NCT01643668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213486|NCT01643668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102213487|NCT01643668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102213488|NCT01643668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102213489|NCT01643668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102213490|NCT01643668|Antimetabolites|antimetabolites|mesh-ancestor
102213491|NCT02260882|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102213492|NCT02260882|Immunologic Factors|immunologic factors|mesh-ancestor
102213493|NCT02260882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213494|NCT00112411|Bronchodilator Agents|bronchodilator agents|mesh-list
102213495|NCT00112411|Autonomic Agents|autonomic agents|mesh-ancestor
102213496|NCT00112411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102213497|NCT00112411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213498|NCT00112411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102213499|NCT00112411|Respiratory System Agents|respiratory system agents|mesh-ancestor
102213500|NCT02260804|Rituximab|rituximab|mesh-list
102213501|NCT02260804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102213502|NCT02260804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102213503|NCT02260804|Immunologic Factors|immunologic factors|mesh-ancestor
102213504|NCT02260804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213505|NCT02260804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102213506|NCT03486457|Tofacitinib|tofacitinib|mesh-list
102213507|NCT03486457|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102213508|NCT03486457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102213509|NCT03486457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102213510|NCT03486457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213511|NCT02260648|Atorvastatin|atorvastatin|mesh-list
102213512|NCT02260648|Ezetimibe|ezetimibe|mesh-list
102213513|NCT02260648|Evacetrapib|evacetrapib|mesh-list
102213514|NCT02260648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102213515|NCT02260648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102213516|NCT02260648|Antimetabolites|antimetabolites|mesh-ancestor
102213517|NCT02260648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213518|NCT02260648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102213519|NCT02260648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102213520|NCT02260648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102213521|NCT04179019|Amlodipine|amlodipine|mesh-list
102213522|NCT04179019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102213523|NCT04179019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102213524|NCT04179019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102213525|NCT04179019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213526|NCT04179019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101628366|NCT00720109|Hormones|hormones|mesh-ancestor
102213527|NCT04179019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213528|NCT04179019|Vasodilator Agents|vasodilator agents|mesh-ancestor
102213529|NCT02260492|Fluticasone|fluticasone|mesh-list
102213530|NCT02260492|Xhance|xhance|mesh-list
102213531|NCT02260492|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102213532|NCT02260492|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102213539|NCT02260492|Respiratory System Agents|respiratory system agents|mesh-ancestor
102213540|NCT02260492|Dermatologic Agents|dermatologic agents|mesh-ancestor
102213541|NCT02260492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102213542|NCT02260492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102213543|NCT02260492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102213544|NCT02260492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102213545|NCT02260492|Adrenergic Agents|adrenergic agents|mesh-ancestor
102213546|NCT02260492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102213547|NCT02260492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213548|NCT02260492|Glucocorticoids|glucocorticoids|mesh-ancestor
102213549|NCT02260492|Hormones|hormones|mesh-ancestor
102213550|NCT02260492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102213551|NCT02260492|Sympathomimetics|sympathomimetics|mesh-ancestor
102213552|NCT03966625|Autoantibodies|autoantibodies|mesh-list
102213553|NCT03966625|Immunologic Factors|immunologic factors|mesh-ancestor
102213554|NCT03966625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213555|NCT02260258|Rocuronium|rocuronium|mesh-list
102213556|NCT02260258|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102213557|NCT02260258|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102213558|NCT02260258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102213559|NCT02260258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102213560|NCT02260258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213562|NCT05151679|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102213563|NCT05151679|Iron Chelating Agents|iron chelating agents|mesh-list
102213564|NCT05151679|Trace Elements|trace elements|mesh-ancestor
102213565|NCT05151679|Micronutrients|micronutrients|mesh-ancestor
102213566|NCT05151679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213567|NCT05151679|Hematinics|hematinics|mesh-ancestor
102213568|NCT05151679|Chelating Agents|chelating agents|mesh-ancestor
102213569|NCT05151679|Sequestering Agents|sequestering agents|mesh-ancestor
102213570|NCT05151679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213571|NCT02324257|Obinutuzumab|obinutuzumab|mesh-list
102213572|NCT02324257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102213573|NCT02324257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102213574|NCT02353468|Dexamethasone|dexamethasone|mesh-list
102213575|NCT02353468|Lenalidomide|lenalidomide|mesh-list
102213576|NCT02353468|Bortezomib|bortezomib|mesh-list
102213577|NCT02353468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102213578|NCT02353468|Antiemetics|antiemetics|mesh-ancestor
102213579|NCT02353468|Autonomic Agents|autonomic agents|mesh-ancestor
102213580|NCT02353468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102213581|NCT02353468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213582|NCT02353468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102213583|NCT02353468|Glucocorticoids|glucocorticoids|mesh-ancestor
102213584|NCT02353468|Hormones|hormones|mesh-ancestor
102213585|NCT02353468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102213586|NCT02353468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102213587|NCT02353468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102213588|NCT02353468|Immunologic Factors|immunologic factors|mesh-ancestor
102213590|NCT02353468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102213591|NCT02353468|Growth Substances|growth substances|mesh-ancestor
102213592|NCT02353468|Growth Inhibitors|growth inhibitors|mesh-ancestor
102213600|NCT04459663|Axitinib|axitinib|mesh-list
102213601|NCT04459663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102213602|NCT04459663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102213603|NCT04459663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102213604|NCT04459663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213605|NCT05150899|Fexofenadine|fexofenadine|mesh-list
102213606|NCT05150899|Tamsulosin|tamsulosin|mesh-list
101628382|NCT00720109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102213607|NCT05150899|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102213608|NCT05150899|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102213609|NCT05150899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102213610|NCT05150899|Adrenergic Agents|adrenergic agents|mesh-ancestor
102213611|NCT05150899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102213612|NCT05150899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213613|NCT05150899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213614|NCT05150899|Urological Agents|urological agents|mesh-ancestor
102213615|NCT05150899|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102213616|NCT05150899|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102213617|NCT05150899|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102213618|NCT05150899|Histamine Antagonists|histamine antagonists|mesh-ancestor
102213619|NCT05150899|Histamine Agents|histamine agents|mesh-ancestor
102213620|NCT01530997|Cisplatin|cisplatin|mesh-list
102213621|NCT01530997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102213622|NCT00593905|Bosentan|bosentan|mesh-list
102213623|NCT00593905|Ambrisentan|ambrisentan|mesh-list
102213624|NCT00593905|Sitaxsentan|sitaxsentan|mesh-list
102213625|NCT00593905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102213626|NCT00593905|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102213627|NCT00593905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213628|NCT02259088|Ranibizumab|ranibizumab|mesh-list
102213629|NCT02259088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102213630|NCT02259088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102213631|NCT02259088|Growth Substances|growth substances|mesh-ancestor
102213632|NCT02259088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213633|NCT02259088|Growth Inhibitors|growth inhibitors|mesh-ancestor
102213634|NCT02259088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102213635|NCT02830477|Factor VIII|factor viii|mesh-list
102213636|NCT02830477|Coagulants|coagulants|mesh-ancestor
102213637|NCT02259010|Itraconazole|itraconazole|mesh-list
102213638|NCT02259010|Antifungal Agents|antifungal agents|mesh-ancestor
102213639|NCT02259010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102213640|NCT02259010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102213641|NCT02259010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102213642|NCT02259010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102213643|NCT02259010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213644|NCT02259010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102213645|NCT02259010|Hormone Antagonists|hormone antagonists|mesh-ancestor
102213646|NCT02259010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102213647|NCT02259010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213648|NCT02259010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102213649|NCT02021773|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102213650|NCT02021773|Immunologic Factors|immunologic factors|mesh-ancestor
102213651|NCT02021773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213652|NCT05153785|Lidocaine|lidocaine|mesh-list
102213653|NCT05153785|Anesthetics, Local|anesthetics, local|mesh-ancestor
102213654|NCT05153785|Anesthetics|anesthetics|mesh-ancestor
102213655|NCT05153785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102213656|NCT05153785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213657|NCT05153785|Sensory System Agents|sensory system agents|mesh-ancestor
102213658|NCT05153785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102213659|NCT05153785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102213660|NCT05153785|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102213661|NCT05153785|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102213662|NCT05153785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102213663|NCT05153785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213664|NCT00151775|Olmesartan|olmesartan|mesh-list
102213665|NCT00151775|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
102213666|NCT00151775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102213667|NCT00151775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101900784|NCT01060163|Hemostatics|hemostatics|mesh-ancestor
102213668|NCT00151775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102213669|NCT00151775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213670|NCT02258464|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
102213671|NCT02258464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102213673|NCT03476941|Clindamycin palmitate|clindamycin palmitate|mesh-list
102213674|NCT03476941|Clindamycin phosphate|clindamycin phosphate|mesh-list
102213675|NCT03476941|Gentamicins|gentamicins|mesh-list
102213676|NCT03476941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102213677|NCT03476941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102213678|NCT03476941|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102213679|NCT03476941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102213680|NCT03476941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922511|NCT01266252|Analgesics|analgesics|mesh-ancestor
102213681|NCT00609323|Lidocaine|lidocaine|mesh-list
102213682|NCT00609323|Tetracaine|tetracaine|mesh-list
102213683|NCT00609323|Anesthetics, Local|anesthetics, local|mesh-ancestor
102213684|NCT00609323|Anesthetics|anesthetics|mesh-ancestor
102213685|NCT00609323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102213686|NCT00609323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213687|NCT00609323|Sensory System Agents|sensory system agents|mesh-ancestor
102213688|NCT00609323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102213689|NCT00609323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102213690|NCT00609323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102213691|NCT00609323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102213692|NCT00609323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102213693|NCT00609323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213694|NCT02682901|Bromocriptine|bromocriptine|mesh-list
102213695|NCT02682901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102213696|NCT02682901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102213697|NCT02682901|Hormone Antagonists|hormone antagonists|mesh-ancestor
102213698|NCT02682901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102213699|NCT02682901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213700|NCT02682901|Dopamine Agonists|dopamine agonists|mesh-ancestor
102213701|NCT02682901|Dopamine Agents|dopamine agents|mesh-ancestor
102213702|NCT02682901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102213703|NCT02682901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213704|NCT02258074|Niacinamide|niacinamide|mesh-list
102213705|NCT02258074|Niacin|niacin|mesh-list
102213706|NCT02258074|Nicotinic Acids|nicotinic acids|mesh-list
102213707|NCT02258074|Vitamin B Complex|vitamin b complex|mesh-ancestor
102213708|NCT02258074|Vitamins|vitamins|mesh-ancestor
102213709|NCT02258074|Micronutrients|micronutrients|mesh-ancestor
102213710|NCT02258074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213711|NCT02258074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102213712|NCT02258074|Antimetabolites|antimetabolites|mesh-ancestor
102213713|NCT02258074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213714|NCT02258074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102213715|NCT02258074|Vasodilator Agents|vasodilator agents|mesh-ancestor
102213716|NCT04473053|Nafamostat|nafamostat|mesh-list
102213717|NCT04473053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102213718|NCT04473053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102213719|NCT04473053|Analgesics|analgesics|mesh-ancestor
102213720|NCT04473053|Sensory System Agents|sensory system agents|mesh-ancestor
102213721|NCT04473053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102213722|NCT04473053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213723|NCT04473053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102213724|NCT04473053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102213725|NCT04473053|Anticoagulants|anticoagulants|mesh-ancestor
102213726|NCT04473053|Protease Inhibitors|protease inhibitors|mesh-ancestor
102213727|NCT04473053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102213728|NCT04473053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213729|NCT04473053|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102213730|NCT04473053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102213731|NCT04473053|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102213732|NCT04473053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102213733|NCT04473053|Immunologic Factors|immunologic factors|mesh-ancestor
102213734|NCT02281643|Doxycycline|doxycycline|mesh-list
102213735|NCT02281643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102213736|NCT02281643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102213737|NCT02281643|Antimalarials|antimalarials|mesh-ancestor
102213738|NCT02281643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102213739|NCT02281643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102213740|NCT02281721|Calcium Carbonate|calcium carbonate|mesh-list
102213741|NCT02281721|Antacids|antacids|mesh-ancestor
102213742|NCT02281721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213743|NCT02281721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102213744|NCT01642732|Everolimus|everolimus|mesh-list
102213745|NCT01642732|Leuprolide|leuprolide|mesh-list
101628397|NCT00720109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101628398|NCT00720109|Hematinics|hematinics|mesh-ancestor
102213746|NCT01642732|Bicalutamide|bicalutamide|mesh-list
102213747|NCT01642732|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102213748|NCT01642732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102213749|NCT01642732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102213750|NCT01642732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213751|NCT01642732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102213752|NCT01642732|Immunologic Factors|immunologic factors|mesh-ancestor
102213753|NCT01642732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213754|NCT01642732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102213755|NCT01642732|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102213756|NCT01642732|Fertility Agents|fertility agents|mesh-ancestor
102213757|NCT01642732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102213758|NCT01642732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102213759|NCT01642732|Androgen Antagonists|androgen antagonists|mesh-ancestor
102213760|NCT01642732|Hormone Antagonists|hormone antagonists|mesh-ancestor
102213761|NCT01642732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102213762|NCT02281799|Mercaptopurine|mercaptopurine|mesh-list
102213763|NCT02281799|Azathioprine|azathioprine|mesh-list
102213764|NCT02281799|Antimetabolites|antimetabolites|mesh-ancestor
102213765|NCT02281799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213766|NCT02281799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102213767|NCT02281799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102213768|NCT02281799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102213769|NCT02281799|Immunologic Factors|immunologic factors|mesh-ancestor
102213770|NCT02281799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213771|NCT02281799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102213772|NCT02281799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102213773|NCT02281799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102213774|NCT02283515|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102213775|NCT02283515|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102213776|NCT02283515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102213777|NCT02283515|Antimetabolites|antimetabolites|mesh-ancestor
102213778|NCT02283515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213779|NCT02283515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102213780|NCT02283515|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102213781|NCT02283515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102213782|NCT00589823|Fentanyl|fentanyl|mesh-list
102213783|NCT00589823|Morphine|morphine|mesh-list
102213784|NCT00589823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102213785|NCT00589823|Narcotics|narcotics|mesh-ancestor
102213786|NCT00589823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102213787|NCT00589823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213788|NCT00589823|Analgesics|analgesics|mesh-ancestor
102213789|NCT00589823|Sensory System Agents|sensory system agents|mesh-ancestor
102213790|NCT00589823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102213791|NCT00589823|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102213792|NCT00589823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102213793|NCT00589823|Anesthetics, General|anesthetics, general|mesh-ancestor
102213794|NCT00589823|Anesthetics|anesthetics|mesh-ancestor
102213795|NCT02190721|Lenograstim|lenograstim|mesh-list
102213796|NCT02190721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102213797|NCT02190721|Immunologic Factors|immunologic factors|mesh-ancestor
102213798|NCT02190721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213799|NCT00581477|Droxidopa|droxidopa|mesh-list
102213800|NCT00581477|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102213801|NCT00581477|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102213802|NCT03134339|Nicotine|nicotine|mesh-list
102213803|NCT03134339|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102213804|NCT03134339|Autonomic Agents|autonomic agents|mesh-ancestor
102213805|NCT03134339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102213806|NCT03134339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213807|NCT03134339|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102213808|NCT03134339|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102213809|NCT03134339|Cholinergic Agents|cholinergic agents|mesh-ancestor
102213810|NCT03134339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102213811|NCT03134339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213812|NCT02282267|Gefitinib|gefitinib|mesh-list
102213813|NCT02282267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102213814|NCT02282267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102213815|NCT02282267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102213816|NCT02282267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213817|NCT02283905|Voriconazole|voriconazole|mesh-list
102213818|NCT02283905|Amphotericin B|amphotericin b|mesh-list
101628404|NCT02590627|Lumefantrine|lumefantrine|mesh-list
102213819|NCT02283905|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102213820|NCT02283905|Antifungal Agents|antifungal agents|mesh-ancestor
102213821|NCT02283905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102213822|NCT02283905|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102213823|NCT02283905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102213824|NCT02283905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102213825|NCT02283905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213826|NCT02283905|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102213827|NCT02283905|Hormone Antagonists|hormone antagonists|mesh-ancestor
102213828|NCT02283905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102213829|NCT02283905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213830|NCT02283905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102213831|NCT02283905|Amebicides|amebicides|mesh-ancestor
102213832|NCT02283905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102213833|NCT02283905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102213834|NCT02283905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102213835|NCT03480997|Bromides|bromides|mesh-list
102213836|NCT03480997|Albuterol|albuterol|mesh-list
102213837|NCT03480997|Ipratropium|ipratropium|mesh-list
102213838|NCT03480997|Anticonvulsants|anticonvulsants|mesh-ancestor
102213839|NCT03480997|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102213840|NCT03480997|Autonomic Agents|autonomic agents|mesh-ancestor
102213841|NCT03480997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102213842|NCT03480997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213843|NCT03480997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102213844|NCT03480997|Respiratory System Agents|respiratory system agents|mesh-ancestor
102213845|NCT03480997|Tocolytic Agents|tocolytic agents|mesh-ancestor
102213846|NCT03480997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102213847|NCT03480997|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102213848|NCT03480997|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102213849|NCT03480997|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102213850|NCT03480997|Adrenergic Agents|adrenergic agents|mesh-ancestor
102213851|NCT03480997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102213852|NCT03480997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213853|NCT03480997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102213854|NCT03480997|Cholinergic Agents|cholinergic agents|mesh-ancestor
102213855|NCT04660747|Anticoagulants|anticoagulants|mesh-list
102213856|NCT02348008|Bevacizumab|bevacizumab|mesh-list
102213857|NCT02348008|Pembrolizumab|pembrolizumab|mesh-list
102213858|NCT02348008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102213859|NCT02348008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102213860|NCT02348008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102213861|NCT02348008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102213862|NCT02348008|Growth Substances|growth substances|mesh-ancestor
102213863|NCT02348008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213864|NCT02348008|Growth Inhibitors|growth inhibitors|mesh-ancestor
102213865|NCT02348008|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102213866|NCT02348008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213867|NCT00569387|Vaccines|vaccines|mesh-list
102213868|NCT00569387|Immunologic Factors|immunologic factors|mesh-ancestor
102213869|NCT00569387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213870|NCT04468087|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102213871|NCT04468087|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102213872|NCT04468087|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102213873|NCT04468087|Protease Inhibitors|protease inhibitors|mesh-ancestor
102213874|NCT04468087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102213875|NCT04468087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213876|NCT04468087|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102213877|NCT04468087|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102213878|NCT04468087|Antiviral Agents|antiviral agents|mesh-ancestor
102213879|NCT04468087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102213880|NCT05944887|Lidocaine|lidocaine|mesh-list
102213881|NCT05944887|Propofol|propofol|mesh-list
101628405|NCT02590627|Artemether|artemether|mesh-list
102213882|NCT05944887|Anesthetics, Local|anesthetics, local|mesh-ancestor
102213883|NCT05944887|Anesthetics|anesthetics|mesh-ancestor
102213884|NCT05944887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102213885|NCT05944887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213886|NCT05944887|Sensory System Agents|sensory system agents|mesh-ancestor
102213887|NCT05944887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102213888|NCT05944887|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102213889|NCT05944887|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102213890|NCT05944887|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102213891|NCT05944887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102213892|NCT05944887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213893|NCT05944887|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102213894|NCT05944887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102213895|NCT05944887|Anesthetics, General|anesthetics, general|mesh-ancestor
102213896|NCT05944783|Dasatinib|dasatinib|mesh-list
102213897|NCT05944783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102213898|NCT05944783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102213899|NCT05944783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102213900|NCT05944783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213901|NCT05944458|Acetylcysteine|acetylcysteine|mesh-list
102213902|NCT05944458|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102213903|NCT05944458|Antiviral Agents|antiviral agents|mesh-ancestor
102213904|NCT05944458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102213905|NCT05944458|Expectorants|expectorants|mesh-ancestor
102213906|NCT05944458|Respiratory System Agents|respiratory system agents|mesh-ancestor
102213908|NCT05944458|Antioxidants|antioxidants|mesh-ancestor
102213909|NCT05944458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213910|NCT05944458|Protective Agents|protective agents|mesh-ancestor
102213911|NCT05944458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213912|NCT05944458|Antidotes|antidotes|mesh-ancestor
102213913|NCT05944393|Ropivacaine|ropivacaine|mesh-list
102213914|NCT05944393|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102213915|NCT05944393|Anesthetics, Local|anesthetics, local|mesh-ancestor
102213916|NCT05944393|Anesthetics|anesthetics|mesh-ancestor
102213917|NCT05944393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102213918|NCT05944393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213919|NCT05944393|Sensory System Agents|sensory system agents|mesh-ancestor
102213920|NCT05944393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102213921|NCT05944380|Ropivacaine|ropivacaine|mesh-list
102213922|NCT05944380|Anesthetics, Local|anesthetics, local|mesh-ancestor
102213923|NCT05944380|Anesthetics|anesthetics|mesh-ancestor
102213924|NCT05944380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102213925|NCT05944380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213926|NCT05944380|Sensory System Agents|sensory system agents|mesh-ancestor
102213927|NCT05944380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102213928|NCT05944341|Lidocaine|lidocaine|mesh-list
102213929|NCT05944341|Epinephrine|epinephrine|mesh-list
102213930|NCT05944341|Racepinephrine|racepinephrine|mesh-list
102213931|NCT05944341|Carticaine|carticaine|mesh-list
102213932|NCT05944341|Epinephryl borate|epinephryl borate|mesh-list
102213933|NCT05944341|Anesthetics, Local|anesthetics, local|mesh-ancestor
102213934|NCT05944341|Anesthetics|anesthetics|mesh-ancestor
102213935|NCT05944341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102213936|NCT05944341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213937|NCT05944341|Sensory System Agents|sensory system agents|mesh-ancestor
102213938|NCT05944341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102213939|NCT05944341|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102213940|NCT05944341|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102213941|NCT05944341|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102213942|NCT05944341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102213943|NCT05944341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213944|NCT05944341|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102213945|NCT05944341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102213946|NCT05944341|Adrenergic Agents|adrenergic agents|mesh-ancestor
102213947|NCT05944341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102213948|NCT05944341|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102213949|NCT05944341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102213950|NCT05944341|Autonomic Agents|autonomic agents|mesh-ancestor
102213951|NCT05944341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102213952|NCT05944341|Respiratory System Agents|respiratory system agents|mesh-ancestor
102213953|NCT05944341|Mydriatics|mydriatics|mesh-ancestor
102213954|NCT05944341|Sympathomimetics|sympathomimetics|mesh-ancestor
102213955|NCT05944341|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102213956|NCT05944146|Dobutamine|dobutamine|mesh-list
102213957|NCT05944146|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102213958|NCT05944146|Sympathomimetics|sympathomimetics|mesh-ancestor
102213959|NCT05944146|Autonomic Agents|autonomic agents|mesh-ancestor
102213960|NCT05944146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102213961|NCT05944146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213962|NCT05944146|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102213963|NCT05944146|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102213964|NCT05944146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102213965|NCT05944146|Adrenergic Agents|adrenergic agents|mesh-ancestor
101900787|NCT01063439|Etoposide|etoposide|mesh-list
102213966|NCT05944146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102213967|NCT05944146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213968|NCT05944146|Protective Agents|protective agents|mesh-ancestor
102213969|NCT05943990|Cyclophosphamide|cyclophosphamide|mesh-list
102213970|NCT05943990|Fludarabine|fludarabine|mesh-list
102213971|NCT05943990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102213972|NCT05943990|Immunologic Factors|immunologic factors|mesh-ancestor
102213973|NCT05943990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213974|NCT05943990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102213975|NCT05943990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102213976|NCT05943990|Alkylating Agents|alkylating agents|mesh-ancestor
102213977|NCT05943990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213978|NCT05943990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102213979|NCT05943990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102213980|NCT05943821|Allopurinol|allopurinol|mesh-list
102213981|NCT05943821|Antimetabolites|antimetabolites|mesh-ancestor
102213982|NCT05943821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102213983|NCT05943821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102213984|NCT05943821|Gout Suppressants|gout suppressants|mesh-ancestor
102213985|NCT05943821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102213986|NCT05943821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102213987|NCT05943821|Antioxidants|antioxidants|mesh-ancestor
102213988|NCT05943821|Protective Agents|protective agents|mesh-ancestor
102213989|NCT05943821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213990|NCT05943691|Dexamethasone|dexamethasone|mesh-list
102213991|NCT05943691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102213992|NCT05943691|Antiemetics|antiemetics|mesh-ancestor
102213993|NCT05943691|Autonomic Agents|autonomic agents|mesh-ancestor
102213994|NCT05943691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102213995|NCT05943691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102213996|NCT05943691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102213997|NCT05943691|Glucocorticoids|glucocorticoids|mesh-ancestor
102213998|NCT05943691|Hormones|hormones|mesh-ancestor
102213999|NCT05943691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102214000|NCT05943691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102214001|NCT05943691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214002|NCT05943613|Clonidine|clonidine|mesh-list
102214003|NCT05943613|Analgesics|analgesics|mesh-ancestor
102214004|NCT05943613|Sensory System Agents|sensory system agents|mesh-ancestor
102214005|NCT05943613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102214006|NCT05943613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214007|NCT05943613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102214008|NCT05943613|Sympatholytics|sympatholytics|mesh-ancestor
102214009|NCT05943613|Autonomic Agents|autonomic agents|mesh-ancestor
102214010|NCT05943613|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102214011|NCT05943613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102214012|NCT05943613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102214013|NCT05943613|Adrenergic Agents|adrenergic agents|mesh-ancestor
102214014|NCT05943613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102214015|NCT05943613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214016|NCT05943470|Icodextrin|icodextrin|mesh-list
102214017|NCT05943470|Dialysis Solutions|dialysis solutions|mesh-list
102214018|NCT05943470|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102214019|NCT05943457|Vitamin K|vitamin k|mesh-list
102214020|NCT05943457|Vitamin K 2|vitamin k 2|mesh-list
102214021|NCT05943457|Menaquinone 7|menaquinone 7|mesh-list
102214022|NCT05943457|Vitamins|vitamins|mesh-ancestor
102214023|NCT05943457|Micronutrients|micronutrients|mesh-ancestor
102214024|NCT05943457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214025|NCT05943457|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102214026|NCT05943457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102214027|NCT05943457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214028|NCT05943457|Hemostatics|hemostatics|mesh-ancestor
102214029|NCT05943457|Coagulants|coagulants|mesh-ancestor
102214030|NCT05943379|Gemcitabine|gemcitabine|mesh-list
102214031|NCT05943379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102214032|NCT05943379|Antimetabolites|antimetabolites|mesh-ancestor
102214033|NCT05943379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214034|NCT05943379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214035|NCT05943353|Pentoxifylline|pentoxifylline|mesh-list
102214036|NCT05943353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102214037|NCT05943353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102214038|NCT05943353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214039|NCT05943353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101900789|NCT01063439|Busulfan|busulfan|mesh-list
102214040|NCT05943353|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102214041|NCT05943353|Protective Agents|protective agents|mesh-ancestor
102214042|NCT05943353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214043|NCT05943353|Vasodilator Agents|vasodilator agents|mesh-ancestor
102214044|NCT05943353|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102214045|NCT05943353|Antioxidants|antioxidants|mesh-ancestor
102214046|NCT05943223|Metronidazole|metronidazole|mesh-list
102214047|NCT05943223|Ceftriaxone|ceftriaxone|mesh-list
102214049|NCT05943223|Piperacillin|piperacillin|mesh-list
102214050|NCT05943223|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102214051|NCT05943223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102214052|NCT05943223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102214053|NCT05943223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102214054|NCT05943223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102214055|NCT05943223|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102214056|NCT05943223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102214057|NCT05943223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214058|NCT05943158|Folic Acid|folic acid|mesh-list
102214059|NCT05943158|Vitamin B Complex|vitamin b complex|mesh-list
102214061|NCT05943158|Hematinics|hematinics|mesh-ancestor
102214062|NCT05943158|Vitamins|vitamins|mesh-ancestor
102214063|NCT05943158|Micronutrients|micronutrients|mesh-ancestor
102214064|NCT05943158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214065|NCT05941949|Vitamins|vitamins|mesh-list
102214066|NCT05941949|Vitamin E|vitamin e|mesh-list
102214067|NCT05941949|Tocopherols|tocopherols|mesh-list
102214068|NCT05941949|Tocotrienols|tocotrienols|mesh-list
102214069|NCT05941949|alpha-Tocopherol|alpha-tocopherol|mesh-list
102214070|NCT05941949|Micronutrients|micronutrients|mesh-ancestor
102214071|NCT05941949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214072|NCT05941949|Antioxidants|antioxidants|mesh-ancestor
102214073|NCT05941949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214074|NCT05941949|Protective Agents|protective agents|mesh-ancestor
102214075|NCT05939674|Flumazenil|flumazenil|mesh-list
102214076|NCT05939674|Antidotes|antidotes|mesh-ancestor
102214077|NCT05939674|Protective Agents|protective agents|mesh-ancestor
102214078|NCT05939674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214079|NCT05939674|GABA Modulators|gaba modulators|mesh-ancestor
102214080|NCT05939674|GABA Agents|gaba agents|mesh-ancestor
102214081|NCT05939674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102214082|NCT05939674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214083|NCT05939635|Morphine|morphine|mesh-list
102214084|NCT05939635|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102214085|NCT05939635|Narcotics|narcotics|mesh-ancestor
102214086|NCT05939635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102214087|NCT05939635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214088|NCT05939635|Analgesics|analgesics|mesh-ancestor
102214089|NCT05939635|Sensory System Agents|sensory system agents|mesh-ancestor
102214090|NCT05939635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102214091|NCT05939622|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
102214092|NCT05939622|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102214093|NCT05939622|Immunologic Factors|immunologic factors|mesh-ancestor
102214094|NCT05939622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214095|NCT05939544|Milk fat globule|milk fat globule|mesh-list
102214096|NCT05939544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102214097|NCT05939193|Furosemide|furosemide|mesh-list
102214098|NCT05939193|Diuretics|diuretics|mesh-ancestor
102214099|NCT05939193|Natriuretic Agents|natriuretic agents|mesh-ancestor
102214100|NCT05939193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214101|NCT05939193|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102214102|NCT05939193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102214103|NCT05939193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214104|NCT05920213|Lactulose|lactulose|mesh-list
102214105|NCT05920213|N-Methylaspartate|n-methylaspartate|mesh-list
102214106|NCT05920213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102214107|NCT05920213|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
102214108|NCT05920213|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102214109|NCT05920213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102214110|NCT05920213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214111|NCT05920213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214112|NCT05901714|Phenytoin|phenytoin|mesh-list
102214113|NCT05901714|Midazolam|midazolam|mesh-list
102214114|NCT05901714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102214115|NCT05901714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102214116|NCT05901714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102214117|NCT05901714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214119|NCT05901714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102214120|NCT05901714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102214121|NCT05901714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102214122|NCT05901714|Anesthetics, General|anesthetics, general|mesh-ancestor
102214123|NCT05901714|Anesthetics|anesthetics|mesh-ancestor
102214124|NCT05901714|GABA Modulators|gaba modulators|mesh-ancestor
102214125|NCT05901714|GABA Agents|gaba agents|mesh-ancestor
102214126|NCT05901714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102214127|NCT05901714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214128|NCT05901714|Anticonvulsants|anticonvulsants|mesh-ancestor
102214129|NCT05901714|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102214130|NCT05901714|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102214131|NCT05901714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102214132|NCT05901714|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102214133|NCT05901714|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102214134|NCT05898399|Olaparib|olaparib|mesh-list
102214135|NCT05898399|Talazoparib|talazoparib|mesh-list
102214136|NCT05898399|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102214138|NCT05898399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214139|NCT05898399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214140|NCT05866627|Famotidine|famotidine|mesh-list
102214141|NCT05866627|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102214142|NCT05866627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102214143|NCT05866627|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102214144|NCT05866627|Histamine Antagonists|histamine antagonists|mesh-ancestor
102214145|NCT05866627|Histamine Agents|histamine agents|mesh-ancestor
102214146|NCT05866627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102214147|NCT05866627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214148|NCT05866627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214149|NCT05838391|Fluorouracil|fluorouracil|mesh-list
102214150|NCT05838391|Capecitabine|capecitabine|mesh-list
102214151|NCT05838391|Mitomycins|mitomycins|mesh-list
102214152|NCT05838391|Mitomycin|mitomycin|mesh-list
102214153|NCT05838391|Antimetabolites|antimetabolites|mesh-ancestor
102214154|NCT05838391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214155|NCT05838391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102214156|NCT05838391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214157|NCT05838391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102214158|NCT05838391|Immunologic Factors|immunologic factors|mesh-ancestor
102214159|NCT05838391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214160|NCT05838391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102214161|NCT05838391|Alkylating Agents|alkylating agents|mesh-ancestor
102214162|NCT05838391|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102214163|NCT05838391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102214164|NCT05813327|Ifosfamide|ifosfamide|mesh-list
102214165|NCT05813327|Mesna|mesna|mesh-list
102214166|NCT05813327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102214167|NCT05813327|Alkylating Agents|alkylating agents|mesh-ancestor
102214168|NCT05813327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214169|NCT05813327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214170|NCT05813327|Protective Agents|protective agents|mesh-ancestor
102214171|NCT05813327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214172|NCT05797506|Sulforaphane|sulforaphane|mesh-list
102214173|NCT05797506|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102214174|NCT05797506|Protective Agents|protective agents|mesh-ancestor
102214175|NCT05797506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214176|NCT05797506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214177|NCT05768360|Metformin|metformin|mesh-list
102214178|NCT05768360|Digoxin|digoxin|mesh-list
102214179|NCT05768360|Furosemide|furosemide|mesh-list
102214180|NCT05768360|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102214181|NCT05768360|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102214182|NCT05768360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214183|NCT05768360|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102214184|NCT05768360|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102214185|NCT05768360|Antimetabolites|antimetabolites|mesh-ancestor
102214186|NCT05768360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214187|NCT05768360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102214188|NCT05768360|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102214189|NCT05768360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102214190|NCT05768360|Diuretics|diuretics|mesh-ancestor
102214191|NCT05768360|Natriuretic Agents|natriuretic agents|mesh-ancestor
101900791|NCT01063439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214192|NCT05768360|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102214194|NCT05768360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102214195|NCT05768360|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102214196|NCT05768360|Protective Agents|protective agents|mesh-ancestor
102214197|NCT05756972|Carboplatin|carboplatin|mesh-list
102214198|NCT05756972|Pemetrexed|pemetrexed|mesh-list
102214199|NCT05756972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214200|NCT05756972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102214201|NCT05756972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214202|NCT05756972|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102214203|NCT05756972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102214204|NCT05737693|Midazolam|midazolam|mesh-list
102214205|NCT05737693|Ketamine|ketamine|mesh-list
102214206|NCT05737693|Analgesics|analgesics|mesh-ancestor
102214207|NCT05737693|Sensory System Agents|sensory system agents|mesh-ancestor
102214208|NCT05737693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102214209|NCT05737693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214210|NCT05737693|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102214212|NCT05737693|Anesthetics, General|anesthetics, general|mesh-ancestor
102214213|NCT05737693|Anesthetics|anesthetics|mesh-ancestor
102214214|NCT05737693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102214215|NCT05737693|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102214216|NCT05737693|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102214217|NCT05737693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102214218|NCT05737693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214219|NCT05737693|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102214220|NCT05737693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102214221|NCT05737693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102214222|NCT05737693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102214223|NCT05737693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102214224|NCT05737693|GABA Modulators|gaba modulators|mesh-ancestor
102214225|NCT05737693|GABA Agents|gaba agents|mesh-ancestor
102214226|NCT05708950|Pembrolizumab|pembrolizumab|mesh-list
102214227|NCT05708950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102214228|NCT05708950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214229|NCT05708950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102214230|NCT05708950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214231|NCT05689827|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
102214232|NCT05689827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102214233|NCT05689827|Immunologic Factors|immunologic factors|mesh-ancestor
102214234|NCT05689827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214235|NCT05682443|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
102214236|NCT05682443|Chelating Agents|chelating agents|mesh-ancestor
102214237|NCT05682443|Sequestering Agents|sequestering agents|mesh-ancestor
102214238|NCT05682443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214239|NCT05653050|Insulin|insulin|mesh-list
102214240|NCT05653050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102214241|NCT05653050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214242|NCT05651607|Cannabidiol|cannabidiol|mesh-list
102214243|NCT05651607|Anticonvulsants|anticonvulsants|mesh-ancestor
102214244|NCT05650736|Abrocitinib|abrocitinib|mesh-list
102214245|NCT05650736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102214246|NCT05650736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102214247|NCT05650736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214248|NCT05648006|Bevacizumab|bevacizumab|mesh-list
102214249|NCT05648006|Capecitabine|capecitabine|mesh-list
102214250|NCT05648006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102214251|NCT05648006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214252|NCT05648006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102214253|NCT05648006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102214254|NCT05648006|Growth Substances|growth substances|mesh-ancestor
102214255|NCT05648006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214256|NCT05648006|Growth Inhibitors|growth inhibitors|mesh-ancestor
102214257|NCT05648006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102214258|NCT05648006|Antimetabolites|antimetabolites|mesh-ancestor
102214259|NCT05648006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214260|NCT05644626|Tislelizumab|tislelizumab|mesh-list
102214261|NCT05644626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102214262|NCT05644626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214263|NCT05624528|Tolcapone|tolcapone|mesh-list
102214264|NCT05624528|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102214265|NCT05624528|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102214266|NCT05624528|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102214268|NCT05624528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214269|NCT05602818|Alprazolam|alprazolam|mesh-list
102214270|NCT05602818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102214271|NCT05602818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102214272|NCT05602818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214273|NCT05602818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102214274|NCT05602818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102214275|NCT05602818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102214276|NCT05602818|GABA Modulators|gaba modulators|mesh-ancestor
102214277|NCT05602818|GABA Agents|gaba agents|mesh-ancestor
102214278|NCT05602818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102214279|NCT05602818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214280|NCT05592379|Psilocybin|psilocybin|mesh-list
102214281|NCT05592379|Hallucinogens|hallucinogens|mesh-ancestor
102214282|NCT05592379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214283|NCT05592379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102214284|NCT05569954|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102214285|NCT05569954|Immunologic Factors|immunologic factors|mesh-ancestor
102214286|NCT05569954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214287|NCT05568407|Avelumab|avelumab|mesh-list
102214288|NCT05568407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102214289|NCT05568407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214290|NCT05567094|Dexamethasone|dexamethasone|mesh-list
102214291|NCT05567094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102214292|NCT05567094|Antiemetics|antiemetics|mesh-ancestor
102214293|NCT05567094|Autonomic Agents|autonomic agents|mesh-ancestor
102214294|NCT05567094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102214295|NCT05567094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214296|NCT05567094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102214297|NCT05567094|Glucocorticoids|glucocorticoids|mesh-ancestor
102214298|NCT05567094|Hormones|hormones|mesh-ancestor
102214299|NCT05567094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102214300|NCT05567094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102214301|NCT05567094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214302|NCT05550246|Oxybutynin|oxybutynin|mesh-list
102214303|NCT05550246|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102214304|NCT05550246|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102214305|NCT05550246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102214306|NCT05550246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102214307|NCT05550246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214308|NCT05550246|Adrenergic Agents|adrenergic agents|mesh-ancestor
102214309|NCT05550246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102214310|NCT05550246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214311|NCT05550246|Parasympatholytics|parasympatholytics|mesh-ancestor
102214312|NCT05550246|Autonomic Agents|autonomic agents|mesh-ancestor
102214313|NCT05550246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102214314|NCT05550246|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102214315|NCT05550246|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102214316|NCT05550246|Cholinergic Agents|cholinergic agents|mesh-ancestor
102214317|NCT05550246|Urological Agents|urological agents|mesh-ancestor
102214318|NCT05463744|Insulin|insulin|mesh-list
102214319|NCT05463744|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102214320|NCT05463744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102214321|NCT05463744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214322|NCT05446129|Pembrolizumab|pembrolizumab|mesh-list
102214323|NCT05446129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102214324|NCT05446129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214325|NCT05446129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102214326|NCT05446129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214327|NCT05430399|Docetaxel|docetaxel|mesh-list
102214328|NCT05430399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214329|NCT05430399|Tubulin Modulators|tubulin modulators|mesh-ancestor
102214330|NCT05430399|Antimitotic Agents|antimitotic agents|mesh-ancestor
102214331|NCT05430399|Mitosis Modulators|mitosis modulators|mesh-ancestor
102214332|NCT05430399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214333|NCT05399329|Palbociclib|palbociclib|mesh-list
102214334|NCT05399329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214335|NCT05399329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102214336|NCT05399329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102214337|NCT05399329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214344|NCT05386888|Antimitotic Agents|antimitotic agents|mesh-ancestor
102214345|NCT05386888|Mitosis Modulators|mitosis modulators|mesh-ancestor
102214346|NCT05386888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214347|NCT05386888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102214348|NCT05386888|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102214349|NCT05386888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102214350|NCT05374291|Dapagliflozin|dapagliflozin|mesh-list
102214351|NCT05374291|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102214352|NCT05374291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214353|NCT05374291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102214354|NCT05374291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214355|NCT05362058|Insulin|insulin|mesh-list
102214356|NCT05362058|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102214357|NCT05362058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102214358|NCT05362058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214359|NCT05354674|Bevacizumab|bevacizumab|mesh-list
102214360|NCT05354674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102214361|NCT05354674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214362|NCT05354674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102214363|NCT05354674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102214364|NCT05354674|Growth Substances|growth substances|mesh-ancestor
102214365|NCT05354674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214366|NCT05354674|Growth Inhibitors|growth inhibitors|mesh-ancestor
102214367|NCT05334329|Cyclophosphamide|cyclophosphamide|mesh-list
102214368|NCT05334329|Fludarabine|fludarabine|mesh-list
102214369|NCT05334329|Atezolizumab|atezolizumab|mesh-list
102214370|NCT05334329|Antineoplastic Agents|antineoplastic agents|mesh-list
102214371|NCT05334329|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102214372|NCT05334329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102214373|NCT05334329|Immunologic Factors|immunologic factors|mesh-ancestor
102214374|NCT05334329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708048|NCT00660920|Ponatinib|ponatinib|mesh-list
102214375|NCT05334329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102214376|NCT05334329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102214377|NCT05334329|Alkylating Agents|alkylating agents|mesh-ancestor
102214378|NCT05334329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214379|NCT05334329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102214380|NCT05334329|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102214381|NCT05334329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102214382|NCT05293041|Arginine Vasopressin|arginine vasopressin|mesh-list
102214383|NCT05293041|Hemostatics|hemostatics|mesh-ancestor
102214384|NCT05293041|Coagulants|coagulants|mesh-ancestor
102214385|NCT05293041|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102214386|NCT05293041|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102214387|NCT05293041|Natriuretic Agents|natriuretic agents|mesh-ancestor
102214388|NCT05293041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214389|NCT05288166|Prednisone|prednisone|mesh-list
102214390|NCT05288166|Prednisolone|prednisolone|mesh-list
102214391|NCT05288166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102214392|NCT05288166|Glucocorticoids|glucocorticoids|mesh-ancestor
102214393|NCT05288166|Hormones|hormones|mesh-ancestor
102214394|NCT05288166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102214395|NCT05288166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214396|NCT05288166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102214397|NCT05288166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214414|NCT05255653|Cisplatin|cisplatin|mesh-list
102214415|NCT05255653|Carboplatin|carboplatin|mesh-list
102214416|NCT05255653|Durvalumab|durvalumab|mesh-list
102214417|NCT05255653|Olaparib|olaparib|mesh-list
102214418|NCT05255653|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102214419|NCT05255653|Megestrol|megestrol|mesh-list
102214420|NCT05255653|Megestrol Acetate|megestrol acetate|mesh-list
102214421|NCT05255653|Medroxyprogesterone|medroxyprogesterone|mesh-list
102214422|NCT05255653|Progestins|progestins|mesh-list
102214423|NCT05255653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214424|NCT05255653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214425|NCT05255653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102214426|NCT05255653|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102214427|NCT05255653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102214428|NCT05255653|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102214429|NCT05255653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102214430|NCT05255653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102214431|NCT05255653|Contraceptive Agents|contraceptive agents|mesh-ancestor
102214432|NCT05255653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101923259|NCT05834517|Hyaluronic Acid|hyaluronic acid|mesh-list
102214433|NCT05255653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214434|NCT05255653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102214435|NCT05255653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102214436|NCT05255653|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102214437|NCT05255653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102214438|NCT05255653|Appetite Stimulants|appetite stimulants|mesh-ancestor
102214439|NCT05255653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102214440|NCT05255653|Hormones|hormones|mesh-ancestor
102214441|NCT05255653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102214442|NCT05239182|Gemcitabine|gemcitabine|mesh-list
102214443|NCT05239182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102214444|NCT05239182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102214445|NCT05239182|Antimetabolites|antimetabolites|mesh-ancestor
102214446|NCT05239182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214447|NCT05239182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214448|NCT05236894|Nicotine|nicotine|mesh-list
102214449|NCT05236894|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102214450|NCT05236894|Autonomic Agents|autonomic agents|mesh-ancestor
102214451|NCT05236894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102214452|NCT05236894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214453|NCT05236894|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102214454|NCT05236894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102214455|NCT05236894|Cholinergic Agents|cholinergic agents|mesh-ancestor
102214456|NCT05236894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102214457|NCT05236894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214458|NCT05153226|Cyclophosphamide|cyclophosphamide|mesh-list
102214459|NCT05153226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102214460|NCT05153226|Immunologic Factors|immunologic factors|mesh-ancestor
102214461|NCT05153226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214462|NCT05153226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102214463|NCT05153226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102214464|NCT05153226|Alkylating Agents|alkylating agents|mesh-ancestor
102214465|NCT05153226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214466|NCT05153226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214467|NCT05153226|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102214468|NCT05109052|Bevacizumab|bevacizumab|mesh-list
102214469|NCT05109052|Atezolizumab|atezolizumab|mesh-list
102214470|NCT05109052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102214471|NCT05109052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214472|NCT05109052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102214473|NCT05109052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102214474|NCT05109052|Growth Substances|growth substances|mesh-ancestor
102214475|NCT05109052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214476|NCT05109052|Growth Inhibitors|growth inhibitors|mesh-ancestor
102214477|NCT05109052|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102214478|NCT05109052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214479|NCT05104866|Gemcitabine|gemcitabine|mesh-list
102214480|NCT05104866|Capecitabine|capecitabine|mesh-list
102214481|NCT05104866|Vinorelbine|vinorelbine|mesh-list
102214482|NCT05104866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102214483|NCT05104866|Antimetabolites|antimetabolites|mesh-ancestor
102214484|NCT05104866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214485|NCT05104866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214486|NCT05104866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102214487|NCT05104866|Tubulin Modulators|tubulin modulators|mesh-ancestor
102214488|NCT05104866|Antimitotic Agents|antimitotic agents|mesh-ancestor
102214489|NCT05104866|Mitosis Modulators|mitosis modulators|mesh-ancestor
102214490|NCT05103358|Sirolimus|sirolimus|mesh-list
102214491|NCT05103358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102214492|NCT05103358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102214493|NCT05103358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102214494|NCT05103358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214495|NCT05103358|Antifungal Agents|antifungal agents|mesh-ancestor
102214496|NCT05103358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102214497|NCT05103358|Immunologic Factors|immunologic factors|mesh-ancestor
102214498|NCT05103358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214499|NCT05072314|Lidocaine|lidocaine|mesh-list
102214500|NCT05072314|Anesthetics, Local|anesthetics, local|mesh-ancestor
102214501|NCT05072314|Anesthetics|anesthetics|mesh-ancestor
102214502|NCT05072314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102214503|NCT05072314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214504|NCT05072314|Sensory System Agents|sensory system agents|mesh-ancestor
102214505|NCT05072314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101923336|NCT05833958|Hormones|hormones|mesh-ancestor
102214506|NCT05072314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102214507|NCT05072314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102214508|NCT05072314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102214509|NCT05072314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102214510|NCT05072314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214511|NCT05060315|Treprostinil|treprostinil|mesh-list
102214512|NCT05060315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102214513|NCT05006079|Morphine|morphine|mesh-list
102214514|NCT05006079|Alprazolam|alprazolam|mesh-list
102214515|NCT05006079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102214516|NCT05006079|Narcotics|narcotics|mesh-ancestor
102214517|NCT05006079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102214518|NCT05006079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214519|NCT05006079|Analgesics|analgesics|mesh-ancestor
102214520|NCT05006079|Sensory System Agents|sensory system agents|mesh-ancestor
102214521|NCT05006079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102214522|NCT05006079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102214523|NCT05006079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102214524|NCT05006079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102214525|NCT05006079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102214526|NCT05006079|GABA Modulators|gaba modulators|mesh-ancestor
102214527|NCT05006079|GABA Agents|gaba agents|mesh-ancestor
102214528|NCT05006079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102214529|NCT05006079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214530|NCT04975308|Fulvestrant|fulvestrant|mesh-list
102214531|NCT04975308|Exemestane|exemestane|mesh-list
102214532|NCT04975308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101628467|NCT00614835|Gemcitabine|gemcitabine|mesh-list
102214533|NCT04975308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214534|NCT04975308|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102214535|NCT04975308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102214536|NCT04975308|Hormone Antagonists|hormone antagonists|mesh-ancestor
102214537|NCT04975308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102214538|NCT04975308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214539|NCT04975308|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102214540|NCT04975308|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102214541|NCT04975308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102214542|NCT04975308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214543|NCT04962022|Ritonavir|ritonavir|mesh-list
102214544|NCT04962022|Itraconazole|itraconazole|mesh-list
102214545|NCT04962022|Nirmatrelvir|nirmatrelvir|mesh-list
102214547|NCT04962022|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102214548|NCT04962022|Protease Inhibitors|protease inhibitors|mesh-ancestor
102214549|NCT04962022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102214550|NCT04962022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214551|NCT04962022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102214552|NCT04962022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102214553|NCT04962022|Antiviral Agents|antiviral agents|mesh-ancestor
102214554|NCT04962022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102214555|NCT04962022|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102214556|NCT04962022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102214557|NCT04962022|Antifungal Agents|antifungal agents|mesh-ancestor
102214558|NCT04962022|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102214559|NCT04962022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102214560|NCT04962022|Hormone Antagonists|hormone antagonists|mesh-ancestor
102214561|NCT04962022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102214562|NCT04962022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214563|NCT04959175|Mycophenolic Acid|mycophenolic acid|mesh-list
102214564|NCT04959175|Sirolimus|sirolimus|mesh-list
102214565|NCT04959175|Cyclophosphamide|cyclophosphamide|mesh-list
102214566|NCT04959175|Fludarabine|fludarabine|mesh-list
102214567|NCT04959175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102214568|NCT04959175|Immunologic Factors|immunologic factors|mesh-ancestor
102214569|NCT04959175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214570|NCT04959175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102214571|NCT04959175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102214572|NCT04959175|Alkylating Agents|alkylating agents|mesh-ancestor
102214573|NCT04959175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214574|NCT04959175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214575|NCT04959175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102214576|NCT04959175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102214577|NCT04959175|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102214578|NCT04959175|Antitubercular Agents|antitubercular agents|mesh-ancestor
102214579|NCT04959175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102214580|NCT04959175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102214581|NCT04959175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102214582|NCT04959175|Antifungal Agents|antifungal agents|mesh-ancestor
102214584|NCT04929808|Dermatologic Agents|dermatologic agents|mesh-ancestor
102214585|NCT04910386|Cisplatin|cisplatin|mesh-list
102214586|NCT04910386|Gemcitabine|gemcitabine|mesh-list
102214587|NCT04910386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214588|NCT04910386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102214589|NCT04910386|Antimetabolites|antimetabolites|mesh-ancestor
102214590|NCT04910386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214591|NCT04903223|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102214592|NCT04903223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102214593|NCT04903223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102214594|NCT04903223|Antimetabolites|antimetabolites|mesh-ancestor
102214595|NCT04903223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214596|NCT04903223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102214597|NCT04903223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102214598|NCT04903223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102214599|NCT04895748|Everolimus|everolimus|mesh-list
102214600|NCT04895748|Spartalizumab|spartalizumab|mesh-list
102214601|NCT04895748|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102214602|NCT04895748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102214603|NCT04895748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102214604|NCT04895748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214605|NCT04895748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102214606|NCT04895748|Immunologic Factors|immunologic factors|mesh-ancestor
102214607|NCT04895748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214608|NCT04895748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214609|NCT04895748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102214610|NCT04895748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102214611|NCT04895137|Bevacizumab|bevacizumab|mesh-list
102214612|NCT04895137|Antibodies|antibodies|mesh-list
102214613|NCT04895137|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102214614|NCT04895137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102214615|NCT04895137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214616|NCT04895137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102214617|NCT04895137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102214618|NCT04895137|Growth Substances|growth substances|mesh-ancestor
102214619|NCT04895137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214620|NCT04895137|Growth Inhibitors|growth inhibitors|mesh-ancestor
102214621|NCT04895137|Immunologic Factors|immunologic factors|mesh-ancestor
102214623|NCT04852224|Goserelin|goserelin|mesh-list
102214624|NCT04852224|Androgens|androgens|mesh-list
102214625|NCT04852224|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102214626|NCT04852224|Fertility Agents|fertility agents|mesh-ancestor
102214627|NCT04852224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102214628|NCT04852224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214629|NCT04852224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102214630|NCT04852224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214631|NCT04852224|Hormones|hormones|mesh-ancestor
102214632|NCT04852224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102214633|NCT04827953|Paclitaxel|paclitaxel|mesh-list
102214634|NCT04827953|Gemcitabine|gemcitabine|mesh-list
102214635|NCT04827953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102214636|NCT04827953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214637|NCT04827953|Tubulin Modulators|tubulin modulators|mesh-ancestor
102214638|NCT04827953|Antimitotic Agents|antimitotic agents|mesh-ancestor
102214639|NCT04827953|Mitosis Modulators|mitosis modulators|mesh-ancestor
102214640|NCT04827953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214641|NCT04827953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102214642|NCT04827953|Antimetabolites|antimetabolites|mesh-ancestor
102214643|NCT04752774|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102214644|NCT04752774|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102214645|NCT04752774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102214646|NCT04752774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214647|NCT04752774|Cholinergic Agents|cholinergic agents|mesh-ancestor
102214648|NCT04752774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102214649|NCT04752774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214650|NCT04744545|Curcumin|curcumin|mesh-list
102214651|NCT04744545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102214652|NCT04744545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102214653|NCT04744545|Analgesics|analgesics|mesh-ancestor
102214654|NCT04744545|Sensory System Agents|sensory system agents|mesh-ancestor
102214655|NCT04744545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102214656|NCT04744545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214657|NCT04744545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102214658|NCT04744545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102214659|NCT04744545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214660|NCT04744545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102214661|NCT04744545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214662|NCT04742751|Metformin|metformin|mesh-list
102214663|NCT04742751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102214664|NCT04742751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214665|NCT04740905|Aflibercept|aflibercept|mesh-list
102214666|NCT04740905|Faricimab|faricimab|mesh-list
102214667|NCT04740905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102214668|NCT04740905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102214669|NCT04740905|Growth Substances|growth substances|mesh-ancestor
102214670|NCT04740905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214671|NCT04740905|Growth Inhibitors|growth inhibitors|mesh-ancestor
102214672|NCT04740905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214673|NCT04667949|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102214674|NCT04667949|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102214675|NCT04667949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214676|NCT04667949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102214677|NCT04667949|Immunologic Factors|immunologic factors|mesh-ancestor
102214678|NCT04667949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214679|NCT04667117|Ofatumumab|ofatumumab|mesh-list
102214680|NCT04667117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214681|NCT04650893|Dexamethasone|dexamethasone|mesh-list
102214682|NCT04650893|Ketorolac|ketorolac|mesh-list
102214683|NCT04650893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102214684|NCT04650893|Antiemetics|antiemetics|mesh-ancestor
102214685|NCT04650893|Autonomic Agents|autonomic agents|mesh-ancestor
102214686|NCT04650893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102214687|NCT04650893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214688|NCT04650893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102214689|NCT04650893|Glucocorticoids|glucocorticoids|mesh-ancestor
102214690|NCT04650893|Hormones|hormones|mesh-ancestor
102214691|NCT04650893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102214692|NCT04650893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102214693|NCT04650893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214694|NCT04650893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102214695|NCT04650893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102214696|NCT04650893|Analgesics|analgesics|mesh-ancestor
102214697|NCT04650893|Sensory System Agents|sensory system agents|mesh-ancestor
102214698|NCT04650893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102214699|NCT04650893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102214700|NCT04650893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102214701|NCT04650893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214702|NCT04632927|Ustekinumab|ustekinumab|mesh-list
102214703|NCT04632927|Dermatologic Agents|dermatologic agents|mesh-ancestor
102214704|NCT04594551|Vaccines|vaccines|mesh-list
102214705|NCT04594551|Immunoglobulins|immunoglobulins|mesh-list
102214706|NCT04594551|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102214707|NCT04594551|Antibodies|antibodies|mesh-list
102214708|NCT04594551|Immunologic Factors|immunologic factors|mesh-ancestor
102214709|NCT04594551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214710|NCT04548349|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102214711|NCT04548349|Dermatologic Agents|dermatologic agents|mesh-ancestor
102214712|NCT04544449|Ocrelizumab|ocrelizumab|mesh-list
102214713|NCT04544449|Immunologic Factors|immunologic factors|mesh-ancestor
102214714|NCT04544449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214715|NCT04510194|Metformin|metformin|mesh-list
102214716|NCT04510194|Ivermectin|ivermectin|mesh-list
102214717|NCT04510194|Fluvoxamine|fluvoxamine|mesh-list
102214718|NCT04510194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102214719|NCT04510194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214720|NCT04510194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102214721|NCT04510194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102214722|NCT04510194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102214723|NCT04510194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102214724|NCT04510194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102214725|NCT04510194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102214726|NCT04510194|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102214727|NCT04510194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102214728|NCT04510194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101923558|NCT05594563|Eflornithine|eflornithine|mesh-list
102214729|NCT04510194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214730|NCT04510194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102214731|NCT04510194|Serotonin Agents|serotonin agents|mesh-ancestor
102214732|NCT04510194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102214733|NCT04510194|Antidepressive Agents|antidepressive agents|mesh-ancestor
102214734|NCT04510194|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102214735|NCT04510194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102214736|NCT04510194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102214737|NCT04510194|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102214738|NCT04502966|Immunomodulating Agents|immunomodulating agents|mesh-list
102214739|NCT04502966|Immunologic Factors|immunologic factors|mesh-list
102214740|NCT04502966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102214741|NCT04502966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214742|NCT04482803|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102214743|NCT04482803|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
102214744|NCT04482803|beta-Endorphin|beta-endorphin|mesh-list
102214745|NCT04482803|Hormones|hormones|mesh-ancestor
102214746|NCT04482803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102214747|NCT04482803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214748|NCT04482803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102214749|NCT04482803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214750|NCT04462328|Durvalumab|durvalumab|mesh-list
102214751|NCT04462328|Acalabrutinib|acalabrutinib|mesh-list
102214752|NCT04462328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102214753|NCT04462328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214754|NCT04419519|Venetoclax|venetoclax|mesh-list
102214755|NCT04419519|Antibodies|antibodies|mesh-list
102214756|NCT04419519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102214757|NCT04419519|Immunologic Factors|immunologic factors|mesh-ancestor
102214758|NCT04419519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214759|NCT04419519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214760|NCT04406272|Bevacizumab|bevacizumab|mesh-list
102214761|NCT04406272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102214762|NCT04406272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214763|NCT04406272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102214764|NCT04406272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102214765|NCT04406272|Growth Substances|growth substances|mesh-ancestor
102214766|NCT04406272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214768|NCT04398706|Vaccines|vaccines|mesh-list
102214769|NCT04398706|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102214770|NCT04398706|Immunologic Factors|immunologic factors|mesh-ancestor
102214771|NCT04398706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214772|NCT04396535|Docetaxel|docetaxel|mesh-list
102214773|NCT04396535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214774|NCT04396535|Tubulin Modulators|tubulin modulators|mesh-ancestor
102214775|NCT04396535|Antimitotic Agents|antimitotic agents|mesh-ancestor
102214776|NCT04396535|Mitosis Modulators|mitosis modulators|mesh-ancestor
102214777|NCT04396535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214778|NCT04390009|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
102214779|NCT04390009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214780|NCT04357366|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102214781|NCT04357366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102214782|NCT04335461|Anesthetics|anesthetics|mesh-list
102214783|NCT04335461|Anesthetics, Local|anesthetics, local|mesh-list
102214784|NCT04335461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102214785|NCT04335461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214786|NCT04335461|Sensory System Agents|sensory system agents|mesh-ancestor
102214787|NCT04335461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102214788|NCT04332211|Pseudoephedrine|pseudoephedrine|mesh-list
102214789|NCT04332211|Ephedrine|ephedrine|mesh-list
102214790|NCT04332211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102214791|NCT04332211|Autonomic Agents|autonomic agents|mesh-ancestor
102214792|NCT04332211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102214793|NCT04332211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214794|NCT04332211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102214795|NCT04332211|Respiratory System Agents|respiratory system agents|mesh-ancestor
102214796|NCT04332211|Nasal Decongestants|nasal decongestants|mesh-ancestor
102214797|NCT04332211|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102214798|NCT04332211|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102214799|NCT04332211|Sympathomimetics|sympathomimetics|mesh-ancestor
102214800|NCT04332211|Adrenergic Agents|adrenergic agents|mesh-ancestor
102214801|NCT04332211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102214802|NCT04332211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214803|NCT04300192|Vaccines|vaccines|mesh-list
102214804|NCT04300192|Immunologic Factors|immunologic factors|mesh-ancestor
102214805|NCT04300192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214806|NCT04278898|Acetylcysteine|acetylcysteine|mesh-list
102214807|NCT04278898|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102214808|NCT04278898|Antiviral Agents|antiviral agents|mesh-ancestor
102214809|NCT04278898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102214810|NCT04278898|Expectorants|expectorants|mesh-ancestor
102214811|NCT04278898|Respiratory System Agents|respiratory system agents|mesh-ancestor
102214812|NCT04278898|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102214813|NCT04278898|Antioxidants|antioxidants|mesh-ancestor
101628484|NCT02606032|Doxycycline|doxycycline|mesh-list
102214814|NCT04278898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214815|NCT04278898|Protective Agents|protective agents|mesh-ancestor
102214816|NCT04278898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214817|NCT04278898|Antidotes|antidotes|mesh-ancestor
102214818|NCT04256421|Carboplatin|carboplatin|mesh-list
102214819|NCT04256421|Etoposide|etoposide|mesh-list
102214820|NCT04256421|Atezolizumab|atezolizumab|mesh-list
102214821|NCT04256421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214822|NCT04256421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102214823|NCT04256421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102214824|NCT04256421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102214825|NCT04256421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102214826|NCT04256421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214827|NCT04256421|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102214828|NCT04256421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102214829|NCT04255433|Dulaglutide|dulaglutide|mesh-list
102214830|NCT04255433|Tirzepatide|tirzepatide|mesh-list
102214831|NCT04255433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102214832|NCT04255433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214833|NCT04255433|Incretins|incretins|mesh-ancestor
102214834|NCT04255433|Hormones|hormones|mesh-ancestor
102214835|NCT04255433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102214836|NCT04188665|Lectins|lectins|mesh-list
102214837|NCT04188665|Agglutinins|agglutinins|mesh-ancestor
102214838|NCT04188665|Immunologic Factors|immunologic factors|mesh-ancestor
102214839|NCT04188665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214841|NCT04141995|Leucovorin|leucovorin|mesh-list
102214842|NCT04141995|Fluorouracil|fluorouracil|mesh-list
102214843|NCT04141995|Oxaliplatin|oxaliplatin|mesh-list
102214844|NCT04141995|Irinotecan|irinotecan|mesh-list
102214845|NCT04141995|Camptothecin|camptothecin|mesh-list
102214846|NCT04141995|Digoxin|digoxin|mesh-list
102214847|NCT04141995|Calcium|calcium|mesh-list
102214848|NCT04141995|Levoleucovorin|levoleucovorin|mesh-list
102214849|NCT04141995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102214850|NCT04141995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214851|NCT04141995|Antimetabolites|antimetabolites|mesh-ancestor
102214852|NCT04141995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214853|NCT04141995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102214854|NCT04141995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214855|NCT04141995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102214856|NCT04141995|Immunologic Factors|immunologic factors|mesh-ancestor
102214857|NCT04141995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102214858|NCT04141995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102214859|NCT04141995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102214860|NCT04141995|Antidotes|antidotes|mesh-ancestor
102214861|NCT04141995|Protective Agents|protective agents|mesh-ancestor
102214862|NCT04141995|Vitamin B Complex|vitamin b complex|mesh-ancestor
102214863|NCT04141995|Vitamins|vitamins|mesh-ancestor
102214864|NCT04141995|Micronutrients|micronutrients|mesh-ancestor
102214865|NCT04141995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102214866|NCT04141995|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102214867|NCT04141995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102214868|NCT04127578|Sirolimus|sirolimus|mesh-list
102214869|NCT04127578|Methylprednisolone|methylprednisolone|mesh-list
102214870|NCT04127578|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102214871|NCT04127578|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102214872|NCT04127578|Prednisolone|prednisolone|mesh-list
102214873|NCT04127578|Prednisolone acetate|prednisolone acetate|mesh-list
102214874|NCT04127578|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102214875|NCT04127578|Prednisolone phosphate|prednisolone phosphate|mesh-list
102214876|NCT04127578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102214877|NCT04127578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102214878|NCT04127578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102214879|NCT04127578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214880|NCT04127578|Antifungal Agents|antifungal agents|mesh-ancestor
102214881|NCT04127578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102214882|NCT04127578|Immunologic Factors|immunologic factors|mesh-ancestor
102214883|NCT04127578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214884|NCT04127578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102214885|NCT04127578|Antiemetics|antiemetics|mesh-ancestor
102214886|NCT04127578|Autonomic Agents|autonomic agents|mesh-ancestor
102214887|NCT04127578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102214888|NCT04127578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102214889|NCT04127578|Glucocorticoids|glucocorticoids|mesh-ancestor
102214890|NCT04127578|Hormones|hormones|mesh-ancestor
102214891|NCT04127578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102214892|NCT04127578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102214893|NCT04127578|Protective Agents|protective agents|mesh-ancestor
102214894|NCT04127578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102214895|NCT04068597|Dexamethasone|dexamethasone|mesh-list
102214896|NCT04068597|Azacitidine|azacitidine|mesh-list
102214897|NCT04068597|Venetoclax|venetoclax|mesh-list
102214898|NCT04068597|Pomalidomide|pomalidomide|mesh-list
102214899|NCT04068597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102214900|NCT04068597|Antiemetics|antiemetics|mesh-ancestor
102214901|NCT04068597|Autonomic Agents|autonomic agents|mesh-ancestor
102214902|NCT04068597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102214903|NCT04068597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214904|NCT04068597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102214905|NCT04068597|Glucocorticoids|glucocorticoids|mesh-ancestor
102214906|NCT04068597|Hormones|hormones|mesh-ancestor
102214907|NCT04068597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102214908|NCT04068597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102214909|NCT04068597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214910|NCT04068597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102214911|NCT04068597|Antimetabolites|antimetabolites|mesh-ancestor
102214912|NCT04068597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214913|NCT04068597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102214914|NCT04068597|Immunologic Factors|immunologic factors|mesh-ancestor
102214915|NCT04068597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101756760|NCT02567838|Lidocaine|lidocaine|mesh-list
102214916|NCT04068597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102214917|NCT04068597|Growth Substances|growth substances|mesh-ancestor
102214918|NCT04068597|Growth Inhibitors|growth inhibitors|mesh-ancestor
102214919|NCT04064294|Levodopa|levodopa|mesh-list
102214920|NCT04064294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102214921|NCT04064294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102214922|NCT04064294|Dopamine Agents|dopamine agents|mesh-ancestor
102214923|NCT04064294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102214924|NCT04064294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214925|NCT04064294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214926|NCT04029688|Cytarabine|cytarabine|mesh-list
102214927|NCT04029688|Cyclophosphamide|cyclophosphamide|mesh-list
102214928|NCT04029688|Fludarabine|fludarabine|mesh-list
102214929|NCT04029688|Venetoclax|venetoclax|mesh-list
102214930|NCT04029688|Topotecan|topotecan|mesh-list
102214931|NCT04029688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102214932|NCT04029688|Immunologic Factors|immunologic factors|mesh-ancestor
102214933|NCT04029688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214934|NCT04029688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102214935|NCT04029688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102214936|NCT04029688|Alkylating Agents|alkylating agents|mesh-ancestor
102214937|NCT04029688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214938|NCT04029688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214939|NCT04029688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102214940|NCT04029688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102214941|NCT04029688|Antimetabolites|antimetabolites|mesh-ancestor
102214942|NCT04029688|Antiviral Agents|antiviral agents|mesh-ancestor
102214943|NCT04029688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102214944|NCT04029688|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102214945|NCT04029688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102214946|NCT04029688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102214947|NCT04009044|Tamoxifen|tamoxifen|mesh-list
102214948|NCT04009044|Afimoxifene|afimoxifene|mesh-list
102214949|NCT04009044|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102214950|NCT04009044|Hormone Antagonists|hormone antagonists|mesh-ancestor
102214951|NCT04009044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102214952|NCT04009044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214953|NCT04009044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102214954|NCT04009044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101628500|NCT01743651|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102214955|NCT04009044|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102214956|NCT04009044|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102214957|NCT04009044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102214958|NCT03928210|Digoxin|digoxin|mesh-list
102214959|NCT03928210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102214960|NCT03928210|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102214961|NCT03928210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102214962|NCT03928210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214963|NCT03928210|Protective Agents|protective agents|mesh-ancestor
102214964|NCT03928210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214966|NCT03867201|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
102214967|NCT03867201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214968|NCT03867201|Analgesics|analgesics|mesh-ancestor
102214969|NCT03867201|Sensory System Agents|sensory system agents|mesh-ancestor
102214970|NCT03867201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102214971|NCT03867201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214972|NCT03805932|Rituximab|rituximab|mesh-list
102214973|NCT03805932|Immunotoxin HA22|immunotoxin ha22|mesh-list
102214974|NCT03805932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102214975|NCT03805932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214976|NCT03805932|Immunologic Factors|immunologic factors|mesh-ancestor
102214977|NCT03805932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214978|NCT03805932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102214979|NCT03805932|Immunotoxins|immunotoxins|mesh-ancestor
102214980|NCT03805932|Immunoconjugates|immunoconjugates|mesh-ancestor
102214981|NCT03790670|Sargramostim|sargramostim|mesh-list
102214982|NCT03790670|Immunologic Factors|immunologic factors|mesh-ancestor
102214983|NCT03790670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214984|NCT03720990|Cholic Acids|cholic acids|mesh-list
102214985|NCT03720990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102214986|NCT03699319|Leucovorin|leucovorin|mesh-list
102214987|NCT03699319|Folic Acid|folic acid|mesh-list
102214988|NCT03699319|Oxaliplatin|oxaliplatin|mesh-list
102214989|NCT03699319|Irinotecan|irinotecan|mesh-list
102214990|NCT03699319|Levoleucovorin|levoleucovorin|mesh-list
102214991|NCT03699319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102214992|NCT03699319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102214993|NCT03699319|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102214994|NCT03699319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102214995|NCT03699319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102214996|NCT03699319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102214997|NCT03699319|Antidotes|antidotes|mesh-ancestor
102214998|NCT03699319|Protective Agents|protective agents|mesh-ancestor
102214999|NCT03699319|Vitamin B Complex|vitamin b complex|mesh-ancestor
102215000|NCT03699319|Vitamins|vitamins|mesh-ancestor
102215001|NCT03699319|Micronutrients|micronutrients|mesh-ancestor
102215002|NCT03699319|Hematinics|hematinics|mesh-ancestor
102215003|NCT03677141|Prednisone|prednisone|mesh-list
102215004|NCT03677141|Cyclophosphamide|cyclophosphamide|mesh-list
102215005|NCT03677141|Doxorubicin|doxorubicin|mesh-list
102215006|NCT03677141|Vincristine|vincristine|mesh-list
102215007|NCT03677141|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
102215008|NCT03677141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102215009|NCT03677141|Immunologic Factors|immunologic factors|mesh-ancestor
102215010|NCT03677141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215011|NCT03677141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102215012|NCT03677141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102215013|NCT03677141|Alkylating Agents|alkylating agents|mesh-ancestor
102215014|NCT03677141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215015|NCT03677141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102215016|NCT03677141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102215017|NCT03677141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102215018|NCT03677141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102215019|NCT03677141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102215020|NCT03677141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102215021|NCT03677141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102215022|NCT03677141|Glucocorticoids|glucocorticoids|mesh-ancestor
102215023|NCT03677141|Hormones|hormones|mesh-ancestor
102215024|NCT03677141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102215025|NCT03677141|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102215026|NCT03677141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102215027|NCT03677141|Tubulin Modulators|tubulin modulators|mesh-ancestor
101628505|NCT00715117|Naltrexone|naltrexone|mesh-list
102215028|NCT03677141|Antimitotic Agents|antimitotic agents|mesh-ancestor
102215029|NCT03677141|Mitosis Modulators|mitosis modulators|mesh-ancestor
102215030|NCT03677141|Immunoconjugates|immunoconjugates|mesh-ancestor
102215031|NCT03651271|Nivolumab|nivolumab|mesh-list
102215032|NCT03651271|Ipilimumab|ipilimumab|mesh-list
102215033|NCT03651271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102215034|NCT03651271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102215035|NCT03651271|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102215036|NCT03651271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215037|NCT03635892|Nivolumab|nivolumab|mesh-list
102215038|NCT03635892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102215039|NCT03635892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102215040|NCT03635892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102215041|NCT03635892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215042|NCT03594435|Ibudilast|ibudilast|mesh-list
102215043|NCT03594435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102215044|NCT03594435|Autonomic Agents|autonomic agents|mesh-ancestor
102215045|NCT03594435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102215046|NCT03594435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215047|NCT03594435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102215048|NCT03594435|Respiratory System Agents|respiratory system agents|mesh-ancestor
102215049|NCT03594435|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102215050|NCT03594435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102215051|NCT03594435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215052|NCT03594435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102215053|NCT03594435|Vasodilator Agents|vasodilator agents|mesh-ancestor
102215054|NCT03563729|Pembrolizumab|pembrolizumab|mesh-list
102215055|NCT03563729|Nivolumab|nivolumab|mesh-list
102215056|NCT03563729|Ipilimumab|ipilimumab|mesh-list
102215057|NCT03563729|Trametinib|trametinib|mesh-list
102215058|NCT03563729|Dabrafenib|dabrafenib|mesh-list
102215059|NCT03563729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102215060|NCT03563729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102215061|NCT03563729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102215062|NCT03563729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215063|NCT03563729|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102215064|NCT03563729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102215065|NCT03539822|Durvalumab|durvalumab|mesh-list
102215066|NCT03539822|Tremelimumab|tremelimumab|mesh-list
102215068|NCT03539822|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102215069|NCT03539822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102215070|NCT03539822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102215071|NCT03539822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102215072|NCT03539822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102215073|NCT03539822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215074|NCT03325101|Pembrolizumab|pembrolizumab|mesh-list
102215075|NCT03325101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102215076|NCT03325101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102215077|NCT03325101|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102215078|NCT03325101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215079|NCT03323463|Carboplatin|carboplatin|mesh-list
102215080|NCT03323463|Fluorouracil|fluorouracil|mesh-list
102215081|NCT03323463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102215082|NCT03323463|Antimetabolites|antimetabolites|mesh-ancestor
102215083|NCT03323463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215084|NCT03323463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102215085|NCT03323463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102215086|NCT03323463|Immunologic Factors|immunologic factors|mesh-ancestor
102215087|NCT03323463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215088|NCT03291028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102215089|NCT03291028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215090|NCT03291028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102215091|NCT03291028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102215092|NCT03287908|Dexamethasone|dexamethasone|mesh-list
102215093|NCT03287908|Pomalidomide|pomalidomide|mesh-list
102215094|NCT03287908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102215095|NCT03287908|Antiemetics|antiemetics|mesh-ancestor
102215096|NCT03287908|Autonomic Agents|autonomic agents|mesh-ancestor
102215097|NCT03287908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102215098|NCT03287908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215099|NCT03287908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102215100|NCT03287908|Glucocorticoids|glucocorticoids|mesh-ancestor
102215101|NCT03287908|Hormones|hormones|mesh-ancestor
102215102|NCT03287908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102215103|NCT03287908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102215104|NCT03287908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102215105|NCT03287908|Immunologic Factors|immunologic factors|mesh-ancestor
102215106|NCT03287908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102215107|NCT03287908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102215108|NCT03287908|Growth Substances|growth substances|mesh-ancestor
102215109|NCT03287908|Growth Inhibitors|growth inhibitors|mesh-ancestor
102215110|NCT03257163|Pembrolizumab|pembrolizumab|mesh-list
102215111|NCT03257163|Capecitabine|capecitabine|mesh-list
102215112|NCT03257163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102215113|NCT03257163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102215114|NCT03257163|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102215115|NCT03257163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215116|NCT03257163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102215117|NCT03257163|Antimetabolites|antimetabolites|mesh-ancestor
102215118|NCT03091192|Sunitinib|sunitinib|mesh-list
102215119|NCT03091192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102215120|NCT03091192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102215121|NCT03091192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102215122|NCT03091192|Growth Substances|growth substances|mesh-ancestor
102215123|NCT03091192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215124|NCT03091192|Growth Inhibitors|growth inhibitors|mesh-ancestor
102215125|NCT03091192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102215126|NCT03091192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102215127|NCT03091192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215128|NCT03027388|LB100|lb100|mesh-list
102215129|NCT03027388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102215130|NCT03027388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102215131|NCT03027388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215132|NCT03004287|Thalidomide|thalidomide|mesh-list
102215133|NCT03004287|Dexamethasone|dexamethasone|mesh-list
102215134|NCT03004287|Cyclophosphamide|cyclophosphamide|mesh-list
102215135|NCT03004287|Melphalan|melphalan|mesh-list
102215136|NCT03004287|Doxorubicin|doxorubicin|mesh-list
102215137|NCT03004287|Etoposide|etoposide|mesh-list
102215138|NCT03004287|Lenalidomide|lenalidomide|mesh-list
102215139|NCT03004287|Bortezomib|bortezomib|mesh-list
102215140|NCT03004287|Daratumumab|daratumumab|mesh-list
102215141|NCT03004287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102215142|NCT03004287|Immunologic Factors|immunologic factors|mesh-ancestor
102215143|NCT03004287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215144|NCT03004287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102215145|NCT03004287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102215146|NCT03004287|Alkylating Agents|alkylating agents|mesh-ancestor
102215147|NCT03004287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215148|NCT03004287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102215149|NCT03004287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102215150|NCT03004287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102215151|NCT03004287|Antiemetics|antiemetics|mesh-ancestor
102215152|NCT03004287|Autonomic Agents|autonomic agents|mesh-ancestor
102215153|NCT03004287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102215154|NCT03004287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102215155|NCT03004287|Glucocorticoids|glucocorticoids|mesh-ancestor
102215156|NCT03004287|Hormones|hormones|mesh-ancestor
102215157|NCT03004287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102215158|NCT03004287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102215159|NCT03004287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102215160|NCT03004287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102215161|NCT03004287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102215162|NCT03004287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102215163|NCT03004287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102215164|NCT03004287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102215165|NCT03004287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102215166|NCT03004287|Growth Substances|growth substances|mesh-ancestor
102215167|NCT03004287|Growth Inhibitors|growth inhibitors|mesh-ancestor
102215168|NCT03004287|Leprostatic Agents|leprostatic agents|mesh-ancestor
102215169|NCT03004287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102215170|NCT03004287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102215171|NCT02885974|Celecoxib|celecoxib|mesh-list
102215172|NCT02885974|Gemcitabine|gemcitabine|mesh-list
102215173|NCT02885974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102215174|NCT02885974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102215175|NCT02885974|Antimetabolites|antimetabolites|mesh-ancestor
102215176|NCT02885974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215177|NCT02885974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102215178|NCT02885974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102215179|NCT02885974|Analgesics|analgesics|mesh-ancestor
102215180|NCT02885974|Sensory System Agents|sensory system agents|mesh-ancestor
102215181|NCT02885974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102215182|NCT02885974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215183|NCT02885974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102215184|NCT02885974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102215185|NCT02885974|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102215186|NCT02885974|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102215187|NCT02885974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102215188|NCT02861300|Capecitabine|capecitabine|mesh-list
102215189|NCT02861300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102215190|NCT02861300|Antimetabolites|antimetabolites|mesh-ancestor
102215191|NCT02861300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215192|NCT02861300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102215193|NCT02838420|Crizotinib|crizotinib|mesh-list
102215194|NCT02838420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102215195|NCT02838420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102215196|NCT02838420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102215197|NCT02838420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215198|NCT02611960|Gemcitabine|gemcitabine|mesh-list
102215199|NCT02611960|Capecitabine|capecitabine|mesh-list
102215200|NCT02611960|Docetaxel|docetaxel|mesh-list
102215201|NCT02611960|Pembrolizumab|pembrolizumab|mesh-list
102215202|NCT02611960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102215203|NCT02611960|Antimetabolites|antimetabolites|mesh-ancestor
102215204|NCT02611960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215205|NCT02611960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102215206|NCT02611960|Tubulin Modulators|tubulin modulators|mesh-ancestor
102215207|NCT02611960|Antimitotic Agents|antimitotic agents|mesh-ancestor
102215208|NCT02611960|Mitosis Modulators|mitosis modulators|mesh-ancestor
102215209|NCT02611960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102215210|NCT02611960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102215211|NCT02603146|Hydroxychloroquine|hydroxychloroquine|mesh-list
102215212|NCT02603146|Antimalarials|antimalarials|mesh-ancestor
102215213|NCT02603146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102215214|NCT02603146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102215215|NCT02603146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102215216|NCT02603146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102215217|NCT02603146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215218|NCT02603146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102215219|NCT02358850|Acetaminophen|acetaminophen|mesh-list
102215220|NCT02358850|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
102215221|NCT02358850|Oxycodone|oxycodone|mesh-list
102215222|NCT02358850|Hydromorphone|hydromorphone|mesh-list
102215223|NCT02358850|Hydrocodone|hydrocodone|mesh-list
102215224|NCT02358850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102215225|NCT02358850|Analgesics|analgesics|mesh-ancestor
102215226|NCT02358850|Sensory System Agents|sensory system agents|mesh-ancestor
102215227|NCT02358850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102215228|NCT02358850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215229|NCT02358850|Antipyretics|antipyretics|mesh-ancestor
102215230|NCT02358850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102215231|NCT02358850|Narcotics|narcotics|mesh-ancestor
102215232|NCT02358850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102215233|NCT02358850|Antitussive Agents|antitussive agents|mesh-ancestor
102215234|NCT02358850|Respiratory System Agents|respiratory system agents|mesh-ancestor
102215235|NCT02358850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102215236|NCT02358850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102215237|NCT02358850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102215238|NCT01909453|Vemurafenib|vemurafenib|mesh-list
102215239|NCT01909453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102215240|NCT01909453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102215241|NCT01909453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102215242|NCT01909453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215243|NCT01784159|Aspirin|aspirin|mesh-list
102215244|NCT01784159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102215245|NCT01784159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102215246|NCT01784159|Analgesics|analgesics|mesh-ancestor
102215247|NCT01784159|Sensory System Agents|sensory system agents|mesh-ancestor
102215248|NCT01784159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102215249|NCT01784159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215250|NCT01784159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102215251|NCT01784159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102215252|NCT01784159|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102215253|NCT01784159|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102215254|NCT01784159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215255|NCT01784159|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102215256|NCT01784159|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102215257|NCT01784159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102215258|NCT01784159|Antipyretics|antipyretics|mesh-ancestor
102215259|NCT01749969|Dexamethasone|dexamethasone|mesh-list
101924082|NCT02668770|Ipilimumab|ipilimumab|mesh-list
102215260|NCT01749969|Lenalidomide|lenalidomide|mesh-list
102215261|NCT01749969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102215262|NCT01749969|Antiemetics|antiemetics|mesh-ancestor
102215263|NCT01749969|Autonomic Agents|autonomic agents|mesh-ancestor
102215264|NCT01749969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102215265|NCT01749969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215266|NCT01749969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102215267|NCT01749969|Glucocorticoids|glucocorticoids|mesh-ancestor
102215268|NCT01749969|Hormones|hormones|mesh-ancestor
102215269|NCT01749969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102215270|NCT01749969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101628557|NCT01019486|Regadenoson|regadenoson|mesh-list
102215271|NCT01749969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102215272|NCT01749969|Immunologic Factors|immunologic factors|mesh-ancestor
102215273|NCT01749969|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102215274|NCT01749969|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102215275|NCT01749969|Growth Substances|growth substances|mesh-ancestor
102215276|NCT01749969|Growth Inhibitors|growth inhibitors|mesh-ancestor
102215277|NCT01458327|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
102215278|NCT01458327|Hallucinogens|hallucinogens|mesh-ancestor
102215279|NCT01458327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215280|NCT01458327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102215281|NCT01458327|Serotonin Agents|serotonin agents|mesh-ancestor
102215282|NCT01458327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102215283|NCT01458327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215284|NCT01458327|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102215285|NCT01458327|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102215286|NCT01458327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102215287|NCT01458327|Adrenergic Agents|adrenergic agents|mesh-ancestor
102215288|NCT01275677|Paclitaxel|paclitaxel|mesh-list
102215289|NCT01275677|Docetaxel|docetaxel|mesh-list
102215290|NCT01275677|Cyclophosphamide|cyclophosphamide|mesh-list
102215291|NCT01275677|Doxorubicin|doxorubicin|mesh-list
102215292|NCT01275677|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102215293|NCT01275677|Trastuzumab|trastuzumab|mesh-list
102215294|NCT01275677|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102215295|NCT01275677|Daunorubicin|daunorubicin|mesh-list
102215296|NCT01275677|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
102215297|NCT01275677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102215298|NCT01275677|Antibodies|antibodies|mesh-list
102215299|NCT01275677|Immunoglobulins|immunoglobulins|mesh-list
102215300|NCT01275677|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102215301|NCT01275677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102215302|NCT01275677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102215303|NCT01275677|Tubulin Modulators|tubulin modulators|mesh-ancestor
102215304|NCT01275677|Antimitotic Agents|antimitotic agents|mesh-ancestor
102215305|NCT01275677|Mitosis Modulators|mitosis modulators|mesh-ancestor
102215306|NCT01275677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215307|NCT01275677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102215308|NCT01275677|Immunologic Factors|immunologic factors|mesh-ancestor
102215309|NCT01275677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215310|NCT01275677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102215311|NCT01275677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102215312|NCT01275677|Alkylating Agents|alkylating agents|mesh-ancestor
102215313|NCT01275677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102215314|NCT01275677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102215315|NCT01275677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102215316|NCT01275677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102215317|NCT01275677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102215318|NCT01203020|Fludarabine|fludarabine|mesh-list
102215319|NCT01203020|Fludarabine phosphate|fludarabine phosphate|mesh-list
102215320|NCT01203020|Busulfan|busulfan|mesh-list
102215321|NCT01203020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102215322|NCT01203020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102215323|NCT01203020|Antimetabolites|antimetabolites|mesh-ancestor
102215324|NCT01203020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215325|NCT01203020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102215326|NCT01203020|Immunologic Factors|immunologic factors|mesh-ancestor
102215327|NCT01203020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215328|NCT01203020|Alkylating Agents|alkylating agents|mesh-ancestor
102215329|NCT01203020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102215330|NCT01203020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102215331|NCT00644228|Dexamethasone|dexamethasone|mesh-list
102215332|NCT00644228|Dexamethasone acetate|dexamethasone acetate|mesh-list
102215333|NCT00644228|Lenalidomide|lenalidomide|mesh-list
102215334|NCT00644228|Bortezomib|bortezomib|mesh-list
102215335|NCT00644228|Ichthammol|ichthammol|mesh-list
102215336|NCT00644228|BB 1101|bb 1101|mesh-list
102215337|NCT00644228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102215339|NCT00644228|Autonomic Agents|autonomic agents|mesh-ancestor
102215340|NCT00644228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102215341|NCT00644228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215342|NCT00644228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102215343|NCT00644228|Glucocorticoids|glucocorticoids|mesh-ancestor
102215344|NCT00644228|Hormones|hormones|mesh-ancestor
101628562|NCT01019486|Purinergic Agents|purinergic agents|mesh-ancestor
102215345|NCT00644228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102215346|NCT00644228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102215347|NCT00644228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102215348|NCT00644228|Protease Inhibitors|protease inhibitors|mesh-ancestor
102215349|NCT00644228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102215350|NCT00644228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215351|NCT00644228|Immunologic Factors|immunologic factors|mesh-ancestor
102215352|NCT00644228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102215353|NCT00644228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102215354|NCT00644228|Growth Substances|growth substances|mesh-ancestor
102215355|NCT00644228|Growth Inhibitors|growth inhibitors|mesh-ancestor
102215356|NCT00644228|Dermatologic Agents|dermatologic agents|mesh-ancestor
102215357|NCT00501826|Cytarabine|cytarabine|mesh-list
102215358|NCT00501826|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
102215359|NCT00501826|Dexamethasone|dexamethasone|mesh-list
102215360|NCT00501826|Dexamethasone acetate|dexamethasone acetate|mesh-list
102215361|NCT00501826|Prednisone|prednisone|mesh-list
102215362|NCT00501826|Cortisone|cortisone|mesh-list
102215363|NCT00501826|Cyclophosphamide|cyclophosphamide|mesh-list
102215364|NCT00501826|Doxorubicin|doxorubicin|mesh-list
102215365|NCT00501826|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102215366|NCT00501826|Methotrexate|methotrexate|mesh-list
102215367|NCT00501826|Vincristine|vincristine|mesh-list
102215368|NCT00501826|Venetoclax|venetoclax|mesh-list
102215369|NCT00501826|Asparaginase|asparaginase|mesh-list
102215370|NCT00501826|Mercaptopurine|mercaptopurine|mesh-list
102215371|NCT00501826|Pegaspargase|pegaspargase|mesh-list
102215372|NCT00501826|BB 1101|bb 1101|mesh-list
102215373|NCT00501826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102215374|NCT00501826|Immunologic Factors|immunologic factors|mesh-ancestor
102215375|NCT00501826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215376|NCT00501826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102215377|NCT00501826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102215378|NCT00501826|Alkylating Agents|alkylating agents|mesh-ancestor
102215379|NCT00501826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215380|NCT00501826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102215381|NCT00501826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102215382|NCT00501826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102215383|NCT00501826|Antiemetics|antiemetics|mesh-ancestor
102215384|NCT00501826|Autonomic Agents|autonomic agents|mesh-ancestor
102215385|NCT00501826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102215386|NCT00501826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102215387|NCT00501826|Glucocorticoids|glucocorticoids|mesh-ancestor
102215388|NCT00501826|Hormones|hormones|mesh-ancestor
102215389|NCT00501826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102215390|NCT00501826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102215391|NCT00501826|Protease Inhibitors|protease inhibitors|mesh-ancestor
102215392|NCT00501826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102215393|NCT00501826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102215394|NCT00501826|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102215395|NCT00501826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102215396|NCT00501826|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102215397|NCT00501826|Abortifacient Agents|abortifacient agents|mesh-ancestor
102215398|NCT00501826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102215399|NCT00501826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102215400|NCT00501826|Antimetabolites|antimetabolites|mesh-ancestor
102215401|NCT00501826|Dermatologic Agents|dermatologic agents|mesh-ancestor
102215402|NCT00501826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102215403|NCT00501826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102215404|NCT00501826|Antiviral Agents|antiviral agents|mesh-ancestor
102215405|NCT00501826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102215406|NCT00501826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102215407|NCT00501826|Tubulin Modulators|tubulin modulators|mesh-ancestor
102215408|NCT00501826|Antimitotic Agents|antimitotic agents|mesh-ancestor
102215409|NCT00501826|Mitosis Modulators|mitosis modulators|mesh-ancestor
102215410|NCT00006256|Paclitaxel|paclitaxel|mesh-list
102215411|NCT00006256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102215412|NCT00006256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102215413|NCT00006256|Tubulin Modulators|tubulin modulators|mesh-ancestor
102215414|NCT00006256|Antimitotic Agents|antimitotic agents|mesh-ancestor
102215415|NCT00006256|Mitosis Modulators|mitosis modulators|mesh-ancestor
102215416|NCT00006256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215417|NCT00495131|Interferons|interferons|mesh-list
102215418|NCT00495131|Ribavirin|ribavirin|mesh-list
102215419|NCT00495131|Interferon-alpha|interferon-alpha|mesh-list
102215420|NCT00495131|Interferon alpha-2|interferon alpha-2|mesh-list
102215421|NCT00495131|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102215422|NCT00495131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102215423|NCT00495131|Antiviral Agents|antiviral agents|mesh-ancestor
102215424|NCT00495131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102215425|NCT00495131|Antimetabolites|antimetabolites|mesh-ancestor
102215426|NCT00495131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215427|NCT00495131|Immunologic Factors|immunologic factors|mesh-ancestor
102215428|NCT00495131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215429|NCT02257372|Albuterol|albuterol|mesh-list
102215430|NCT02257372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102215431|NCT02257372|Autonomic Agents|autonomic agents|mesh-ancestor
102215432|NCT02257372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102215433|NCT02257372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215434|NCT02257372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102215435|NCT02257372|Respiratory System Agents|respiratory system agents|mesh-ancestor
102215436|NCT02257372|Tocolytic Agents|tocolytic agents|mesh-ancestor
102215437|NCT02257372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102215438|NCT02257372|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102215439|NCT02257372|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102215440|NCT02257372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102215441|NCT02257372|Adrenergic Agents|adrenergic agents|mesh-ancestor
102215442|NCT02257372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102215443|NCT02257372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215444|NCT02256982|Cisplatin|cisplatin|mesh-list
102215445|NCT02256982|Gemcitabine|gemcitabine|mesh-list
102215446|NCT02256982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102215447|NCT02256982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102215448|NCT02256982|Antimetabolites|antimetabolites|mesh-ancestor
102215449|NCT02256982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215450|NCT04860154|Hematoporphyrins|hematoporphyrins|mesh-list
102215451|NCT04860154|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102215452|NCT04860154|Dermatologic Agents|dermatologic agents|mesh-ancestor
102215453|NCT03480607|Dexamethasone|dexamethasone|mesh-list
102215454|NCT03480607|Dexmedetomidine|dexmedetomidine|mesh-list
102215455|NCT03480607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102215456|NCT03480607|Antiemetics|antiemetics|mesh-ancestor
102215457|NCT03480607|Autonomic Agents|autonomic agents|mesh-ancestor
102215458|NCT03480607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102215459|NCT03480607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215460|NCT03480607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102215461|NCT03480607|Glucocorticoids|glucocorticoids|mesh-ancestor
102215462|NCT03480607|Hormones|hormones|mesh-ancestor
102215463|NCT03480607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102215464|NCT03480607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102215465|NCT03480607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102215466|NCT03480607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102215467|NCT03480607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102215468|NCT03480607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102215469|NCT03480607|Analgesics|analgesics|mesh-ancestor
102215470|NCT03480607|Sensory System Agents|sensory system agents|mesh-ancestor
102215471|NCT03480607|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102215472|NCT03480607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102215473|NCT03480607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102215474|NCT03480607|Adrenergic Agents|adrenergic agents|mesh-ancestor
102215475|NCT03480607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102215476|NCT03480607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215477|NCT00489203|Beclomethasone|beclomethasone|mesh-list
102215478|NCT00489203|Methotrexate|methotrexate|mesh-list
102215479|NCT00489203|Tacrolimus|tacrolimus|mesh-list
102215480|NCT00489203|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102215481|NCT00489203|Abortifacient Agents|abortifacient agents|mesh-ancestor
102215482|NCT00489203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102215483|NCT00489203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215484|NCT00489203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102215485|NCT00489203|Antimetabolites|antimetabolites|mesh-ancestor
102215486|NCT00489203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215487|NCT00489203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924312|NCT02213913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102215488|NCT00489203|Dermatologic Agents|dermatologic agents|mesh-ancestor
102215489|NCT00489203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102215490|NCT00489203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102215491|NCT00489203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102215492|NCT00489203|Immunologic Factors|immunologic factors|mesh-ancestor
102215493|NCT00489203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102215494|NCT00489203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102215495|NCT00489203|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102215496|NCT00489203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102215497|NCT00489203|Glucocorticoids|glucocorticoids|mesh-ancestor
102215499|NCT00489203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102215500|NCT00489203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102215501|NCT00489203|Respiratory System Agents|respiratory system agents|mesh-ancestor
102215502|NCT05646394|Aspirin|aspirin|mesh-list
102215503|NCT05646394|Vitamins|vitamins|mesh-list
102215504|NCT05646394|Vitamin K|vitamin k|mesh-list
102215505|NCT05646394|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
102215506|NCT05646394|Micronutrients|micronutrients|mesh-ancestor
102215507|NCT05646394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215508|NCT05646394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102215509|NCT05646394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102215510|NCT05646394|Analgesics|analgesics|mesh-ancestor
102215511|NCT05646394|Sensory System Agents|sensory system agents|mesh-ancestor
102215512|NCT05646394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102215513|NCT05646394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102215514|NCT05646394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102215515|NCT05646394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102215516|NCT05646394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102215517|NCT05646394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215518|NCT05646394|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102215519|NCT05646394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102215520|NCT05646394|Antipyretics|antipyretics|mesh-ancestor
102215521|NCT05646394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102215522|NCT05646394|Hemostatics|hemostatics|mesh-ancestor
102215523|NCT05646394|Coagulants|coagulants|mesh-ancestor
102215525|NCT00563459|Levetiracetam|levetiracetam|mesh-list
102215526|NCT00563459|Anticonvulsants|anticonvulsants|mesh-ancestor
102215527|NCT00563459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102215528|NCT00563459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215529|NCT00563459|Nootropic Agents|nootropic agents|mesh-ancestor
102215530|NCT04947631|Tadalafil|tadalafil|mesh-list
102215531|NCT04947631|Dutasteride|dutasteride|mesh-list
102215532|NCT04947631|Vasodilator Agents|vasodilator agents|mesh-ancestor
102215533|NCT04947631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102215534|NCT04947631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102215535|NCT04947631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102215536|NCT04947631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215537|NCT04947631|Urological Agents|urological agents|mesh-ancestor
102215538|NCT04947631|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102215539|NCT04947631|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102215540|NCT04947631|Hormone Antagonists|hormone antagonists|mesh-ancestor
102215541|NCT04947631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102215542|NCT04947631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215543|NCT00561743|Dexamethasone|dexamethasone|mesh-list
102215544|NCT00561743|Doxorubicin|doxorubicin|mesh-list
102215545|NCT00561743|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102215546|NCT00561743|Bortezomib|bortezomib|mesh-list
102215547|NCT00561743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102215548|NCT00561743|Antiemetics|antiemetics|mesh-ancestor
102215549|NCT00561743|Autonomic Agents|autonomic agents|mesh-ancestor
102215550|NCT00561743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102215551|NCT00561743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215552|NCT00561743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102215553|NCT00561743|Glucocorticoids|glucocorticoids|mesh-ancestor
102215554|NCT00561743|Hormones|hormones|mesh-ancestor
102215555|NCT00561743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102215556|NCT00561743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102215557|NCT00561743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102215558|NCT00561743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102215559|NCT00561743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102215560|NCT00561743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102215561|NCT00561743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102215562|NCT00561743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215563|NCT00488267|Ketoprofen|ketoprofen|mesh-list
102215564|NCT00488267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102215565|NCT00488267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102215566|NCT00488267|Analgesics|analgesics|mesh-ancestor
102215567|NCT00488267|Sensory System Agents|sensory system agents|mesh-ancestor
102215568|NCT00488267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102215569|NCT00488267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215570|NCT00488267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102215571|NCT00488267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102215572|NCT00488267|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102215573|NCT00488267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102215574|NCT00488267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215575|NCT00560183|Morphine|morphine|mesh-list
102215576|NCT00560183|Oxycodone|oxycodone|mesh-list
102215577|NCT00560183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102215578|NCT00560183|Narcotics|narcotics|mesh-ancestor
102215579|NCT00560183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102215580|NCT00560183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215581|NCT00560183|Analgesics|analgesics|mesh-ancestor
102215582|NCT00560183|Sensory System Agents|sensory system agents|mesh-ancestor
102215583|NCT00560183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102215584|NCT02736721|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102215585|NCT02736721|Antiviral Agents|antiviral agents|mesh-ancestor
101414917|NCT00495781|Iron|iron|mesh-list
102215586|NCT02736721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102215587|NCT00542633|Insulin|insulin|mesh-list
102215588|NCT00542633|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102215589|NCT00542633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102215590|NCT00542633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215591|NCT02523547|Entecavir|entecavir|mesh-list
102215592|NCT02523547|Antiviral Agents|antiviral agents|mesh-ancestor
102215593|NCT02523547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102215594|NCT00483977|Oxycodone|oxycodone|mesh-list
102215595|NCT00483977|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102215596|NCT00483977|Narcotics|narcotics|mesh-ancestor
102215597|NCT00483977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102215598|NCT00483977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215599|NCT00483977|Analgesics|analgesics|mesh-ancestor
102215600|NCT00483977|Sensory System Agents|sensory system agents|mesh-ancestor
102215601|NCT00483977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102215602|NCT00481325|Escitalopram|escitalopram|mesh-list
102215603|NCT00481325|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102215604|NCT00481325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102215605|NCT00481325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102215606|NCT00481325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215607|NCT00481325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102215608|NCT00481325|Serotonin Agents|serotonin agents|mesh-ancestor
102215609|NCT00481325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215610|NCT02523703|N-Methylaspartate|n-methylaspartate|mesh-list
102215611|NCT02523703|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
102215612|NCT02523703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102215613|NCT02523703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102215614|NCT02523703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215615|NCT02523703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215616|NCT03480295|Hyaluronic Acid|hyaluronic acid|mesh-list
102215617|NCT03480295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102215618|NCT03480295|Immunologic Factors|immunologic factors|mesh-ancestor
102215619|NCT03480295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215620|NCT03480295|Viscosupplements|viscosupplements|mesh-ancestor
102215621|NCT03480295|Protective Agents|protective agents|mesh-ancestor
102215622|NCT03472963|Darunavir|darunavir|mesh-list
102215623|NCT03472963|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102215624|NCT03472963|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102215625|NCT03472963|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102215626|NCT03472963|Protease Inhibitors|protease inhibitors|mesh-ancestor
102215627|NCT03472963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102215628|NCT03472963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215629|NCT03472963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102215630|NCT03472963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102215631|NCT03472963|Antiviral Agents|antiviral agents|mesh-ancestor
102215632|NCT03472963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102215633|NCT02282657|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
102215634|NCT02282657|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102215635|NCT02282657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102215636|NCT02282657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924459|NCT01586442|Hormone Antagonists|hormone antagonists|mesh-ancestor
102215637|NCT00465959|Trospium chloride|trospium chloride|mesh-list
102215638|NCT00465959|Parasympatholytics|parasympatholytics|mesh-ancestor
102215639|NCT00465959|Autonomic Agents|autonomic agents|mesh-ancestor
102215640|NCT00465959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102215641|NCT00465959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215642|NCT00465959|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102215643|NCT00465959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102215644|NCT00465959|Cholinergic Agents|cholinergic agents|mesh-ancestor
102215645|NCT00465959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102215646|NCT00465959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215647|NCT00465959|Urological Agents|urological agents|mesh-ancestor
102215648|NCT00465803|Timolol|timolol|mesh-list
102215649|NCT00465803|Travoprost|travoprost|mesh-list
102215650|NCT00465803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102215651|NCT00465803|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102215652|NCT00465803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215653|NCT00465803|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102215654|NCT00465803|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102215655|NCT00465803|Adrenergic Agents|adrenergic agents|mesh-ancestor
102215656|NCT00465803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102215657|NCT00465803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215659|NCT00465803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102215660|NCT02282891|Ketamine|ketamine|mesh-list
102215661|NCT02282891|Propofol|propofol|mesh-list
102215662|NCT02282891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102215663|NCT02282891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102215664|NCT02282891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215665|NCT02282891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102215666|NCT02282891|Anesthetics, General|anesthetics, general|mesh-ancestor
102215667|NCT02282891|Anesthetics|anesthetics|mesh-ancestor
102215668|NCT02282891|Analgesics|analgesics|mesh-ancestor
102215669|NCT02282891|Sensory System Agents|sensory system agents|mesh-ancestor
102215670|NCT02282891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102215671|NCT02282891|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102215672|NCT02282891|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102215673|NCT02282891|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102215674|NCT02282891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102215675|NCT02282891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215676|NCT00464633|Alvocidib|alvocidib|mesh-list
102215677|NCT00464633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102215678|NCT00464633|Growth Inhibitors|growth inhibitors|mesh-ancestor
102215679|NCT00464633|Growth Substances|growth substances|mesh-ancestor
102215680|NCT00464633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215681|NCT00464633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102215682|NCT00464633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102215683|NCT00464633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215684|NCT00464555|Sirolimus|sirolimus|mesh-list
102215685|NCT00464555|Lisofylline|lisofylline|mesh-list
102215686|NCT00464555|Tacrolimus|tacrolimus|mesh-list
102215687|NCT00464555|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102215688|NCT00464555|Basiliximab|basiliximab|mesh-list
102215689|NCT00464555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102215690|NCT00464555|Immunologic Factors|immunologic factors|mesh-ancestor
102215691|NCT00464555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215692|NCT00464555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102215693|NCT00464555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102215694|NCT00464555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215695|NCT00464555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102215696|NCT00464555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102215697|NCT00464555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102215698|NCT00464555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102215699|NCT00464555|Antifungal Agents|antifungal agents|mesh-ancestor
102215700|NCT00464555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102215701|NCT00464555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102215702|NCT00464555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102215703|NCT00464555|Analgesics|analgesics|mesh-ancestor
102215704|NCT00464555|Sensory System Agents|sensory system agents|mesh-ancestor
102215705|NCT00464555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102215706|NCT00464555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102215707|NCT00464555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102215708|NCT00464243|Volinanserin|volinanserin|mesh-list
102215709|NCT00464243|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102215710|NCT00464243|Serotonin Agents|serotonin agents|mesh-ancestor
102215711|NCT00464243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101924534|NCT01167894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102215712|NCT00464243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215713|NCT00464243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215714|NCT03336541|Ketamine|ketamine|mesh-list
102215715|NCT03336541|Analgesics|analgesics|mesh-ancestor
102215716|NCT03336541|Sensory System Agents|sensory system agents|mesh-ancestor
102215717|NCT03336541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102215718|NCT03336541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215719|NCT03336541|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102215720|NCT03336541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102215721|NCT03336541|Anesthetics, General|anesthetics, general|mesh-ancestor
102215722|NCT03336541|Anesthetics|anesthetics|mesh-ancestor
102215723|NCT03336541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102215724|NCT03336541|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102215725|NCT03336541|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102215726|NCT03336541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102215727|NCT03336541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215728|NCT00525941|Indiplon|indiplon|mesh-list
102215729|NCT00525941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102215730|NCT00525941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102215731|NCT00525941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215732|NCT00525941|GABA Modulators|gaba modulators|mesh-ancestor
102215733|NCT00525941|GABA Agents|gaba agents|mesh-ancestor
102215734|NCT00525941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102215735|NCT00525941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215736|NCT03476083|Tenofovir|tenofovir|mesh-list
102215737|NCT03476083|Antiviral Agents|antiviral agents|mesh-ancestor
102215738|NCT03476083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102215739|NCT03476083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102215740|NCT03476083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102215741|NCT03476083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628612|NCT00628316|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102215742|NCT03476083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215743|NCT03476083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102215744|NCT03476083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102215745|NCT02738203|Lidocaine|lidocaine|mesh-list
102215746|NCT02738203|Anesthetics, Local|anesthetics, local|mesh-ancestor
102215747|NCT02738203|Anesthetics|anesthetics|mesh-ancestor
102215748|NCT02738203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102215749|NCT02738203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215750|NCT02738203|Sensory System Agents|sensory system agents|mesh-ancestor
102215751|NCT02738203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102215752|NCT02738203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102215753|NCT02738203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102215754|NCT02738203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102215755|NCT02738203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102215756|NCT02738203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215757|NCT00457457|Tamsulosin|tamsulosin|mesh-list
102215758|NCT00457457|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102215759|NCT00457457|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102215760|NCT00457457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102215761|NCT00457457|Adrenergic Agents|adrenergic agents|mesh-ancestor
102215762|NCT00457457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102215763|NCT00457457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215764|NCT00457457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215765|NCT00457457|Urological Agents|urological agents|mesh-ancestor
102215766|NCT00517439|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102215767|NCT00517439|Interferon-alpha|interferon-alpha|mesh-list
102215768|NCT00517439|Antiviral Agents|antiviral agents|mesh-ancestor
102215769|NCT00517439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102215770|NCT00517439|Immunologic Factors|immunologic factors|mesh-ancestor
102215771|NCT00517439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215772|NCT03472651|Flupenthixol|flupenthixol|mesh-list
102215773|NCT03472651|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
102215774|NCT03472651|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102215775|NCT03472651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102215776|NCT03472651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102215777|NCT03472651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215778|NCT03472651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102215779|NCT03472651|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102215780|NCT03472651|Dopamine Agents|dopamine agents|mesh-ancestor
102215781|NCT03472651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102215782|NCT03472651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215783|NCT00517049|Rituximab|rituximab|mesh-list
102215784|NCT00517049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102215785|NCT00517049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102215786|NCT00517049|Immunologic Factors|immunologic factors|mesh-ancestor
102215787|NCT00517049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215788|NCT00517049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102215789|NCT02283203|Acetaminophen|acetaminophen|mesh-list
102215790|NCT02283203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102215791|NCT02283203|Analgesics|analgesics|mesh-ancestor
102215792|NCT02283203|Sensory System Agents|sensory system agents|mesh-ancestor
102215793|NCT02283203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102215794|NCT02283203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215795|NCT02283203|Antipyretics|antipyretics|mesh-ancestor
102215796|NCT02523313|Nivolumab|nivolumab|mesh-list
102215797|NCT02523313|Ipilimumab|ipilimumab|mesh-list
102215798|NCT02523313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102215799|NCT02523313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102215800|NCT02523313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102215801|NCT02523313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215802|NCT02452034|Posaconazole|posaconazole|mesh-list
102215803|NCT02452034|Antifungal Agents|antifungal agents|mesh-ancestor
102215804|NCT02452034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102215805|NCT02452034|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102215806|NCT02452034|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102215807|NCT02452034|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102215808|NCT02452034|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102215809|NCT02452034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102215810|NCT02452034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102215811|NCT02452034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215812|NCT02452034|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102215813|NCT02452034|Hormone Antagonists|hormone antagonists|mesh-ancestor
102215814|NCT02452034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102215815|NCT02452034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215816|NCT02283359|Irinotecan|irinotecan|mesh-list
102215817|NCT02283359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102215818|NCT02283359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102215819|NCT02283359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102215820|NCT02283359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215821|NCT02283359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102215822|NCT00511043|Vatalanib|vatalanib|mesh-list
102215823|NCT00511043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102215824|NCT00511043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102215825|NCT00511043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215826|NCT00508625|Paclitaxel|paclitaxel|mesh-list
102215827|NCT00508625|Bevacizumab|bevacizumab|mesh-list
102215828|NCT00508625|Carboplatin|carboplatin|mesh-list
102215829|NCT00508625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102215830|NCT00508625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102215831|NCT00508625|Tubulin Modulators|tubulin modulators|mesh-ancestor
102215832|NCT00508625|Antimitotic Agents|antimitotic agents|mesh-ancestor
102215833|NCT00508625|Mitosis Modulators|mitosis modulators|mesh-ancestor
102215834|NCT00508625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215835|NCT00508625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102215836|NCT00508625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102215837|NCT00508625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102215838|NCT00508625|Growth Substances|growth substances|mesh-ancestor
102215839|NCT00508625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215840|NCT00508625|Growth Inhibitors|growth inhibitors|mesh-ancestor
102215841|NCT02284529|Leucovorin|leucovorin|mesh-list
102215842|NCT02284529|Fluorouracil|fluorouracil|mesh-list
102215843|NCT02284529|Antimetabolites|antimetabolites|mesh-ancestor
102215844|NCT02284529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215845|NCT02284529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102215846|NCT02284529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102215847|NCT02284529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102215848|NCT02284529|Immunologic Factors|immunologic factors|mesh-ancestor
102215849|NCT02284529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215850|NCT02284529|Antidotes|antidotes|mesh-ancestor
102215851|NCT02284529|Protective Agents|protective agents|mesh-ancestor
102215852|NCT02284529|Vitamin B Complex|vitamin b complex|mesh-ancestor
102215853|NCT02284529|Vitamins|vitamins|mesh-ancestor
102215854|NCT02284529|Micronutrients|micronutrients|mesh-ancestor
102215855|NCT02482298|Ticagrelor|ticagrelor|mesh-list
102215856|NCT02482298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102215857|NCT02482298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102215858|NCT02482298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102215859|NCT02482298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102215860|NCT02482298|Purinergic Agents|purinergic agents|mesh-ancestor
102215861|NCT02482298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102215862|NCT02482298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215863|NCT02482298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215864|NCT04470479|Pilocarpine|pilocarpine|mesh-list
102215866|NCT04470479|Autonomic Agents|autonomic agents|mesh-ancestor
102215867|NCT04470479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102215868|NCT04470479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215869|NCT04470479|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102215870|NCT04470479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102215871|NCT04470479|Cholinergic Agents|cholinergic agents|mesh-ancestor
102215872|NCT04470479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102215873|NCT04470479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215875|NCT00383513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102215876|NCT00383513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102215877|NCT00382811|Carboplatin|carboplatin|mesh-list
102215878|NCT00382811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102215879|NCT02286635|Clarithromycin|clarithromycin|mesh-list
102215880|NCT02286635|Rifampin|rifampin|mesh-list
102215881|NCT02286635|Deflazacort|deflazacort|mesh-list
102215882|NCT02286635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102215883|NCT02286635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102215884|NCT02286635|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102215885|NCT02286635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102215886|NCT02286635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215887|NCT02286635|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102215888|NCT02286635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102215889|NCT02286635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102215890|NCT02286635|Antitubercular Agents|antitubercular agents|mesh-ancestor
102215891|NCT02286635|Leprostatic Agents|leprostatic agents|mesh-ancestor
102215892|NCT02286635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102215893|NCT02286635|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102215894|NCT02286635|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102215895|NCT02286635|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102215896|NCT02286635|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102215897|NCT02286635|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102215898|NCT02286635|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102215899|NCT02286635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102215900|NCT02286635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102215901|NCT02286635|Immunologic Factors|immunologic factors|mesh-ancestor
102215902|NCT02286635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215903|NCT00440531|Vaccines|vaccines|mesh-list
102215904|NCT00440531|Immunologic Factors|immunologic factors|mesh-ancestor
102215905|NCT00440531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215906|NCT00437021|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
102215907|NCT00437021|Antiviral Agents|antiviral agents|mesh-ancestor
102215908|NCT00437021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102215909|NCT00375791|Dexamethasone|dexamethasone|mesh-list
102215910|NCT00375791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102215911|NCT00375791|Antiemetics|antiemetics|mesh-ancestor
102215912|NCT00375791|Autonomic Agents|autonomic agents|mesh-ancestor
102215913|NCT00375791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102215914|NCT00375791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215915|NCT00375791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102215916|NCT00375791|Glucocorticoids|glucocorticoids|mesh-ancestor
102215917|NCT00375791|Hormones|hormones|mesh-ancestor
102215918|NCT00375791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102215919|NCT00375791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102215920|NCT00375791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102215921|NCT00431873|Mocetinostat|mocetinostat|mesh-list
102215922|NCT00431873|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102215923|NCT00431873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102215924|NCT00431873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215925|NCT02287181|Remifentanil|remifentanil|mesh-list
102215926|NCT02287181|Propofol|propofol|mesh-list
102215927|NCT02287181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102215928|NCT02287181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102215929|NCT02287181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215930|NCT02287181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102215931|NCT02287181|Anesthetics, General|anesthetics, general|mesh-ancestor
102215932|NCT02287181|Anesthetics|anesthetics|mesh-ancestor
102215933|NCT02287181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102215934|NCT02287181|Narcotics|narcotics|mesh-ancestor
102215935|NCT02287181|Analgesics|analgesics|mesh-ancestor
102215936|NCT02287181|Sensory System Agents|sensory system agents|mesh-ancestor
102215937|NCT02287181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102215938|NCT02287259|Olanzapine|olanzapine|mesh-list
102215939|NCT02287259|Antiemetics|antiemetics|mesh-ancestor
102215940|NCT02287259|Autonomic Agents|autonomic agents|mesh-ancestor
102215941|NCT02287259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102215942|NCT02287259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215943|NCT02287259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102215944|NCT02287259|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102215945|NCT02287259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102215946|NCT02287259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101900831|NCT00311363|Antimanic Agents|antimanic agents|mesh-ancestor
102215947|NCT02287259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102215948|NCT02287259|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102215949|NCT02287259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101367057|NCT00160537|Levocetirizine|levocetirizine|mesh-list
102215950|NCT02287259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102215951|NCT02287259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215952|NCT02287259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102215953|NCT02287259|Serotonin Agents|serotonin agents|mesh-ancestor
102215954|NCT00429923|Fluprednisolone|fluprednisolone|mesh-list
102215955|NCT00429923|Difluprednate|difluprednate|mesh-list
102215956|NCT00429923|Glucocorticoids|glucocorticoids|mesh-ancestor
102215957|NCT00429923|Hormones|hormones|mesh-ancestor
102215958|NCT00429923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102215959|NCT00429923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215960|NCT00429923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102215961|NCT04470557|Fibrin fragment D|fibrin fragment d|mesh-list
102215962|NCT04470557|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102215963|NCT04470557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102215964|NCT04470557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215965|NCT04470557|Hemostatics|hemostatics|mesh-ancestor
102215966|NCT04470557|Coagulants|coagulants|mesh-ancestor
102215967|NCT00372437|Gemcitabine|gemcitabine|mesh-list
102215968|NCT00372437|Mocetinostat|mocetinostat|mesh-list
102215969|NCT00372437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102215970|NCT00372437|Antimetabolites|antimetabolites|mesh-ancestor
102215971|NCT00372437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215972|NCT00372437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102215973|NCT00372437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102215974|NCT00372437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102215975|NCT00369473|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102215976|NCT00369473|Immunologic Factors|immunologic factors|mesh-ancestor
102215977|NCT00369473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215978|NCT04470791|Antivenins|antivenins|mesh-list
102215979|NCT04470791|Immunologic Factors|immunologic factors|mesh-ancestor
102215980|NCT04470791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215981|NCT00364247|Tapentadol|tapentadol|mesh-list
102215982|NCT00364247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102215983|NCT00364247|Narcotics|narcotics|mesh-ancestor
102215984|NCT00364247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102215985|NCT00364247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102215986|NCT00364247|Analgesics|analgesics|mesh-ancestor
102215987|NCT00364247|Sensory System Agents|sensory system agents|mesh-ancestor
102215988|NCT00364247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102215989|NCT00364247|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102215990|NCT00364247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102215991|NCT00364247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102215992|NCT00364247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102215993|NCT00364247|Adrenergic Agents|adrenergic agents|mesh-ancestor
102215994|NCT00364247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102215995|NCT00424697|Lorazepam|lorazepam|mesh-list
102215996|NCT00424697|Anticonvulsants|anticonvulsants|mesh-ancestor
102215997|NCT00424697|Antiemetics|antiemetics|mesh-ancestor
102215998|NCT00424697|Autonomic Agents|autonomic agents|mesh-ancestor
102215999|NCT00424697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102216000|NCT00424697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216001|NCT00424697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102216002|NCT00424697|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102216003|NCT00424697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102216004|NCT00424697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102216005|NCT00424697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102216006|NCT00424697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102216007|NCT00424697|GABA Modulators|gaba modulators|mesh-ancestor
102216008|NCT00424697|GABA Agents|gaba agents|mesh-ancestor
102216009|NCT00424697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102216010|NCT00424697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216012|NCT00360035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102216013|NCT00360035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216014|NCT00356681|Niacinamide|niacinamide|mesh-list
102216015|NCT00356681|Paclitaxel|paclitaxel|mesh-list
102216016|NCT00356681|Bevacizumab|bevacizumab|mesh-list
102216017|NCT00356681|Motesanib diphosphate|motesanib diphosphate|mesh-list
102216018|NCT00356681|Imetelstat|imetelstat|mesh-list
101628631|NCT01018394|Nicotine|nicotine|mesh-list
102216019|NCT00356681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102216020|NCT00356681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102216021|NCT00356681|Tubulin Modulators|tubulin modulators|mesh-ancestor
102216022|NCT00356681|Antimitotic Agents|antimitotic agents|mesh-ancestor
102216023|NCT00356681|Mitosis Modulators|mitosis modulators|mesh-ancestor
102216024|NCT00356681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216025|NCT00356681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102216026|NCT00356681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102216027|NCT00356681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102216028|NCT00356681|Growth Substances|growth substances|mesh-ancestor
102216029|NCT00356681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216030|NCT00356681|Growth Inhibitors|growth inhibitors|mesh-ancestor
102216031|NCT00356681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102216032|NCT00356681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102216033|NCT00356681|Vitamin B Complex|vitamin b complex|mesh-ancestor
102216034|NCT00356681|Vitamins|vitamins|mesh-ancestor
102216035|NCT00356681|Micronutrients|micronutrients|mesh-ancestor
102216036|NCT00417209|Fluorouracil|fluorouracil|mesh-list
102216037|NCT00417209|Capecitabine|capecitabine|mesh-list
102216038|NCT00417209|Antimetabolites|antimetabolites|mesh-ancestor
102216039|NCT00417209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216040|NCT00417209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102216041|NCT00417209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102216042|NCT00417209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102216043|NCT00417209|Immunologic Factors|immunologic factors|mesh-ancestor
102216044|NCT00417209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216045|NCT04470401|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102216046|NCT04470401|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102216047|NCT04470401|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102216048|NCT04470401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102216049|NCT04470401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216050|NCT04470401|Cholinergic Agents|cholinergic agents|mesh-ancestor
102216051|NCT04470401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102216052|NCT04470401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216053|NCT04470401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102216054|NCT04470401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102216055|NCT00355355|Talaporfin|talaporfin|mesh-list
102216056|NCT00355355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102216057|NCT00355355|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102216058|NCT00355355|Dermatologic Agents|dermatologic agents|mesh-ancestor
102216059|NCT00407303|Bortezomib|bortezomib|mesh-list
102216060|NCT00407303|Obatoclax|obatoclax|mesh-list
102216061|NCT00407303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102216062|NCT00407303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102216063|NCT00407303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216064|NCT00344045|Acetaminophen|acetaminophen|mesh-list
102216065|NCT00344045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102216066|NCT00344045|Analgesics|analgesics|mesh-ancestor
102216067|NCT00344045|Sensory System Agents|sensory system agents|mesh-ancestor
102216068|NCT00344045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102216069|NCT00344045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216070|NCT00344045|Antipyretics|antipyretics|mesh-ancestor
102216071|NCT02256436|Paclitaxel|paclitaxel|mesh-list
102216072|NCT02256436|Docetaxel|docetaxel|mesh-list
102216073|NCT02256436|Pembrolizumab|pembrolizumab|mesh-list
102216074|NCT02256436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102216075|NCT02256436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102216076|NCT02256436|Tubulin Modulators|tubulin modulators|mesh-ancestor
102216077|NCT02256436|Antimitotic Agents|antimitotic agents|mesh-ancestor
102216078|NCT02256436|Mitosis Modulators|mitosis modulators|mesh-ancestor
102216079|NCT02256436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216080|NCT02256436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102216081|NCT02256436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102216082|NCT00343109|Sargramostim|sargramostim|mesh-list
102216083|NCT00343109|Vaccines|vaccines|mesh-list
102216084|NCT00343109|Immunologic Factors|immunologic factors|mesh-ancestor
102216085|NCT00343109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216087|NCT00405743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102216088|NCT00405743|Antimetabolites|antimetabolites|mesh-ancestor
102216089|NCT00405743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216090|NCT00405743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102216091|NCT00405743|Antiviral Agents|antiviral agents|mesh-ancestor
102216092|NCT00405743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102216093|NCT00405743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102216094|NCT00405743|Immunologic Factors|immunologic factors|mesh-ancestor
102216095|NCT00405743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216096|NCT00403169|Lenalidomide|lenalidomide|mesh-list
102216097|NCT00403169|Immunologic Factors|immunologic factors|mesh-ancestor
102216098|NCT00403169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216099|NCT00403169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102216100|NCT00403169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102216101|NCT00403169|Growth Substances|growth substances|mesh-ancestor
102216102|NCT00403169|Growth Inhibitors|growth inhibitors|mesh-ancestor
102216103|NCT00403169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102216104|NCT00332657|Hydrocortisone|hydrocortisone|mesh-list
102216105|NCT00332657|Anecortave|anecortave|mesh-list
102216106|NCT00332657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102216107|NCT00332657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102216108|NCT00332657|Growth Substances|growth substances|mesh-ancestor
102216109|NCT00332657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216110|NCT00332657|Growth Inhibitors|growth inhibitors|mesh-ancestor
102216111|NCT00332657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102216112|NCT00332657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102216113|NCT00330473|Insulin|insulin|mesh-list
102216114|NCT00330473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102216115|NCT00330473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102216116|NCT00330473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216117|NCT00327743|Capecitabine|capecitabine|mesh-list
102216118|NCT00327743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102216119|NCT00327743|Antimetabolites|antimetabolites|mesh-ancestor
102216120|NCT00327743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216121|NCT00327743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102216122|NCT02285075|Temocillin|temocillin|mesh-list
102216123|NCT02285075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102216124|NCT02285075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102216125|NCT00321815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102216126|NCT00321815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102216127|NCT00321815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102216128|NCT00321815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102216129|NCT00321815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216130|NCT00398879|Capecitabine|capecitabine|mesh-list
102216131|NCT00398879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102216132|NCT00398879|Antimetabolites|antimetabolites|mesh-ancestor
102216133|NCT00398879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216134|NCT00398879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102216135|NCT00309179|Cetuximab|cetuximab|mesh-list
102216136|NCT00309179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102216137|NCT00309179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102216138|NCT00394199|Fluticasone|fluticasone|mesh-list
102216139|NCT00394199|Xhance|xhance|mesh-list
102216140|NCT00394199|Formoterol Fumarate|formoterol fumarate|mesh-list
102216141|NCT00394199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102216142|NCT00394199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102216143|NCT00394199|Autonomic Agents|autonomic agents|mesh-ancestor
102216144|NCT00394199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102216145|NCT00394199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216146|NCT00394199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102216147|NCT00394199|Respiratory System Agents|respiratory system agents|mesh-ancestor
102216148|NCT00394199|Dermatologic Agents|dermatologic agents|mesh-ancestor
102216149|NCT00394199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102216150|NCT00394199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102216151|NCT00394199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102216152|NCT00394199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102216153|NCT00394199|Adrenergic Agents|adrenergic agents|mesh-ancestor
102216154|NCT00394199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102216155|NCT00394199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216156|NCT00394121|Fluticasone|fluticasone|mesh-list
102216157|NCT00394121|Xhance|xhance|mesh-list
101924981|NCT01173978|Hormones|hormones|mesh-list
102216158|NCT00394121|Formoterol Fumarate|formoterol fumarate|mesh-list
102216159|NCT00394121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102216160|NCT00394121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102216161|NCT00394121|Autonomic Agents|autonomic agents|mesh-ancestor
102216162|NCT00394121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102216163|NCT00394121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216164|NCT00394121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102216165|NCT00394121|Respiratory System Agents|respiratory system agents|mesh-ancestor
102216166|NCT00394121|Dermatologic Agents|dermatologic agents|mesh-ancestor
102216167|NCT00394121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102216168|NCT00394121|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102216169|NCT00394121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102216170|NCT00394121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102216171|NCT00394121|Adrenergic Agents|adrenergic agents|mesh-ancestor
102216173|NCT00394121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216174|NCT02480114|Acetaminophen|acetaminophen|mesh-list
102216175|NCT02480114|Ibuprofen|ibuprofen|mesh-list
102216176|NCT02480114|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
102216177|NCT02480114|Fentanyl|fentanyl|mesh-list
102216178|NCT02480114|Oxycodone|oxycodone|mesh-list
102216179|NCT02480114|Hydrocodone|hydrocodone|mesh-list
102216180|NCT02480114|Gabapentin|gabapentin|mesh-list
102216181|NCT02480114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102216182|NCT02480114|Narcotics|narcotics|mesh-ancestor
102216183|NCT02480114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102216184|NCT02480114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216185|NCT02480114|Analgesics|analgesics|mesh-ancestor
102216186|NCT02480114|Sensory System Agents|sensory system agents|mesh-ancestor
102216187|NCT02480114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102216188|NCT02480114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102216189|NCT02480114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102216190|NCT02480114|Anesthetics, General|anesthetics, general|mesh-ancestor
102216191|NCT02480114|Anesthetics|anesthetics|mesh-ancestor
102216192|NCT02480114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102216193|NCT02480114|Antipyretics|antipyretics|mesh-ancestor
102216194|NCT02480114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102216195|NCT02480114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102216196|NCT02480114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102216197|NCT02480114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102216198|NCT02480114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102216199|NCT02480114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216200|NCT02480114|Anticonvulsants|anticonvulsants|mesh-ancestor
102216201|NCT02480114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102216202|NCT02480114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102216203|NCT02480114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102216204|NCT02480114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102216205|NCT02480114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102216206|NCT02480114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102216207|NCT02480114|Antimanic Agents|antimanic agents|mesh-ancestor
102216208|NCT02480114|Antitussive Agents|antitussive agents|mesh-ancestor
102216209|NCT02480114|Respiratory System Agents|respiratory system agents|mesh-ancestor
102216210|NCT00299507|Hydrocortisone|hydrocortisone|mesh-list
102216211|NCT00299507|Anecortave|anecortave|mesh-list
102216212|NCT00299507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102216213|NCT00299507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102216214|NCT00299507|Growth Substances|growth substances|mesh-ancestor
102216215|NCT00299507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216216|NCT00299507|Growth Inhibitors|growth inhibitors|mesh-ancestor
102216217|NCT00299507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102216218|NCT00299507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102216219|NCT02285309|Enoximone|enoximone|mesh-list
102216220|NCT02285309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102216221|NCT02285309|Vasodilator Agents|vasodilator agents|mesh-ancestor
102216222|NCT02285309|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102216223|NCT02285309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102216224|NCT02285309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102216225|NCT02285309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216226|NCT02285309|Protective Agents|protective agents|mesh-ancestor
102216227|NCT02285309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216228|NCT02479880|Tenofovir|tenofovir|mesh-list
102216229|NCT02479880|Antiviral Agents|antiviral agents|mesh-ancestor
102216230|NCT02479880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102216231|NCT02479880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102216232|NCT02479880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102216233|NCT02479880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102216234|NCT02479880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925058|NCT01288716|Baclofen|baclofen|mesh-list
102216235|NCT02479880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102216236|NCT02479880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102216237|NCT00297401|Ruboxistaurin|ruboxistaurin|mesh-list
102216238|NCT00297401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102216239|NCT00297401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216240|NCT00297089|Pemetrexed|pemetrexed|mesh-list
102216241|NCT00297089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102216242|NCT00297089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102216243|NCT00297089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216244|NCT00297089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102216245|NCT00297089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102216246|NCT00286793|Gossypol acetic acid|gossypol acetic acid|mesh-list
102216247|NCT00286793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102216248|NCT00286793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102216249|NCT00286793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102216250|NCT00286793|Contraceptive Agents|contraceptive agents|mesh-ancestor
102216251|NCT00286793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102216252|NCT00286793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216253|NCT00286793|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
102216254|NCT00286793|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
102216255|NCT00286793|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102216256|NCT02285699|Fluvoxamine|fluvoxamine|mesh-list
102216257|NCT02285699|Citalopram|citalopram|mesh-list
102216258|NCT02285699|Fluoxetine|fluoxetine|mesh-list
102216259|NCT02285699|Paroxetine|paroxetine|mesh-list
102216260|NCT02285699|Sertraline|sertraline|mesh-list
102216261|NCT02285699|Escitalopram|escitalopram|mesh-list
102216262|NCT02285699|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102216263|NCT02285699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102216264|NCT02285699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102216265|NCT02285699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216266|NCT02285699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102216267|NCT02285699|Serotonin Agents|serotonin agents|mesh-ancestor
102216268|NCT02285699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216269|NCT02285699|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102216270|NCT02285699|Antidepressive Agents|antidepressive agents|mesh-ancestor
102216271|NCT02285699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102216272|NCT02285699|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102216273|NCT02285699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102216274|NCT02285699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102216275|NCT02285699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102216276|NCT02285699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102216277|NCT02285699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102216278|NCT02285699|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102216279|NCT02285699|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102216280|NCT02288429|Colistin|colistin|mesh-list
102216281|NCT02288429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102216282|NCT02288429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102216283|NCT03133637|Ceftriaxone|ceftriaxone|mesh-list
102216284|NCT03133637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102216285|NCT03133637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102216286|NCT00265655|Satraplatin|satraplatin|mesh-list
102216287|NCT00265655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102216288|NCT00254891|Paclitaxel|paclitaxel|mesh-list
102216289|NCT00254891|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102216290|NCT00254891|Carboplatin|carboplatin|mesh-list
102216291|NCT00254891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102216292|NCT00254891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102216293|NCT00254891|Tubulin Modulators|tubulin modulators|mesh-ancestor
102216294|NCT00254891|Antimitotic Agents|antimitotic agents|mesh-ancestor
102216295|NCT00254891|Mitosis Modulators|mitosis modulators|mesh-ancestor
102216296|NCT00254891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216297|NCT02479412|Albuterol|albuterol|mesh-list
102216298|NCT02479412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102216299|NCT02479412|Autonomic Agents|autonomic agents|mesh-ancestor
102216300|NCT02479412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102216301|NCT02479412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216302|NCT02479412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102216303|NCT02479412|Respiratory System Agents|respiratory system agents|mesh-ancestor
102216304|NCT02479412|Tocolytic Agents|tocolytic agents|mesh-ancestor
102216305|NCT02479412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102216306|NCT02479412|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102216307|NCT02479412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102216308|NCT02479412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102216309|NCT02479412|Adrenergic Agents|adrenergic agents|mesh-ancestor
102216310|NCT02479412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102216311|NCT02479412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216312|NCT00254579|Tremelimumab|tremelimumab|mesh-list
102216313|NCT00254579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102216314|NCT00252005|Apixaban|apixaban|mesh-list
102216315|NCT00252005|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102216316|NCT00252005|Antithrombins|antithrombins|mesh-ancestor
102216317|NCT00252005|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102216318|NCT00252005|Protease Inhibitors|protease inhibitors|mesh-ancestor
102216319|NCT00252005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102216320|NCT00252005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216321|NCT00252005|Anticoagulants|anticoagulants|mesh-ancestor
102216322|NCT02288507|Sorafenib|sorafenib|mesh-list
102216323|NCT02288507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102216324|NCT02288507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102216325|NCT02288507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102216326|NCT02288507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216327|NCT00231257|Sirolimus|sirolimus|mesh-list
102216328|NCT00231257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102216329|NCT00231257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102216330|NCT00231257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102216331|NCT00231257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102216332|NCT00231257|Antifungal Agents|antifungal agents|mesh-ancestor
102216333|NCT00231257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102216334|NCT00231257|Immunologic Factors|immunologic factors|mesh-ancestor
102216335|NCT00231257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216336|NCT00224003|Ferric gluconate|ferric gluconate|mesh-list
102216337|NCT00224003|Hematinics|hematinics|mesh-ancestor
102216338|NCT00216593|Galantamine|galantamine|mesh-list
102216339|NCT00216593|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102216340|NCT00216593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102216341|NCT00216593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216342|NCT00216593|Cholinergic Agents|cholinergic agents|mesh-ancestor
102216343|NCT00216593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102216344|NCT00216593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216345|NCT00216593|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102216346|NCT00216593|Autonomic Agents|autonomic agents|mesh-ancestor
102216347|NCT00216593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102216348|NCT00216593|Nootropic Agents|nootropic agents|mesh-ancestor
102216349|NCT00389675|Guanfacine|guanfacine|mesh-list
102216350|NCT00389675|Darusentan|darusentan|mesh-list
102216351|NCT00389675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102216352|NCT00389675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102216353|NCT00389675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102216354|NCT00389675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102216355|NCT00389675|Adrenergic Agents|adrenergic agents|mesh-ancestor
102216356|NCT00389675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102216357|NCT00389675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216358|NCT00389675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216359|NCT00389675|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102216360|NCT02288741|Dexamethasone|dexamethasone|mesh-list
102216361|NCT02288741|Dexamethasone acetate|dexamethasone acetate|mesh-list
102216362|NCT02288741|Melphalan|melphalan|mesh-list
102216363|NCT02288741|BB 1101|bb 1101|mesh-list
102216364|NCT02288741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102216365|NCT02288741|Antiemetics|antiemetics|mesh-ancestor
102216366|NCT02288741|Autonomic Agents|autonomic agents|mesh-ancestor
102216367|NCT02288741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102216368|NCT02288741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216369|NCT02288741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102216370|NCT02288741|Glucocorticoids|glucocorticoids|mesh-ancestor
102216371|NCT02288741|Hormones|hormones|mesh-ancestor
102216372|NCT02288741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102216373|NCT02288741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102216374|NCT02288741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102216375|NCT02288741|Protease Inhibitors|protease inhibitors|mesh-ancestor
102216376|NCT02288741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102216377|NCT02288741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216378|NCT02288741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102216379|NCT02288741|Alkylating Agents|alkylating agents|mesh-ancestor
102216380|NCT02288741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102216381|NCT02288741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102216382|NCT02288741|Immunologic Factors|immunologic factors|mesh-ancestor
102216383|NCT02450552|Ezogabine|ezogabine|mesh-list
102216384|NCT02450552|Anticonvulsants|anticonvulsants|mesh-ancestor
102216385|NCT02450552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102216386|NCT02450552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216387|NCT02508428|Methyclothiazide|methyclothiazide|mesh-list
102216388|NCT02508428|Diuretics|diuretics|mesh-ancestor
102216389|NCT02508428|Natriuretic Agents|natriuretic agents|mesh-ancestor
102216390|NCT02508428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216391|NCT02508428|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102216392|NCT02508428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102216393|NCT02508428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216394|NCT02448446|Ranibizumab|ranibizumab|mesh-list
102216395|NCT02448446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102216396|NCT02448446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102216397|NCT02448446|Growth Substances|growth substances|mesh-ancestor
102216398|NCT02448446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216399|NCT02448446|Growth Inhibitors|growth inhibitors|mesh-ancestor
102216400|NCT02448446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102216401|NCT02478398|Mometasone Furoate|mometasone furoate|mesh-list
102216402|NCT02478398|Loratadine|loratadine|mesh-list
102216403|NCT02478398|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
102216404|NCT02478398|Epinephrine|epinephrine|mesh-list
102216405|NCT02478398|Albuterol|albuterol|mesh-list
102216406|NCT02478398|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102216407|NCT02478398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102216408|NCT02478398|Adrenergic Agents|adrenergic agents|mesh-ancestor
102216409|NCT02478398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102216410|NCT02478398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216411|NCT02478398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216412|NCT02478398|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102216413|NCT02478398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102216414|NCT02478398|Autonomic Agents|autonomic agents|mesh-ancestor
102216415|NCT02478398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102216416|NCT02478398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102216417|NCT02478398|Respiratory System Agents|respiratory system agents|mesh-ancestor
102216418|NCT02478398|Mydriatics|mydriatics|mesh-ancestor
102216419|NCT02478398|Sympathomimetics|sympathomimetics|mesh-ancestor
102216420|NCT02478398|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102216421|NCT02478398|Tocolytic Agents|tocolytic agents|mesh-ancestor
102216422|NCT02478398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102216423|NCT02478398|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102216424|NCT02478398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102216425|NCT02478398|Dermatologic Agents|dermatologic agents|mesh-ancestor
102216426|NCT02478398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102216427|NCT02478398|Antipruritics|antipruritics|mesh-ancestor
102216428|NCT02478398|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102216429|NCT02478398|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102216430|NCT02478398|Histamine Antagonists|histamine antagonists|mesh-ancestor
102216431|NCT02478398|Histamine Agents|histamine agents|mesh-ancestor
102216432|NCT02478398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102216433|NCT02478398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102216434|NCT02478398|Analgesics|analgesics|mesh-ancestor
102216435|NCT02478398|Sensory System Agents|sensory system agents|mesh-ancestor
102216436|NCT02478398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102216437|NCT02478164|Ponatinib|ponatinib|mesh-list
102216438|NCT02478164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102216439|NCT02478164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102216440|NCT02478164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102216441|NCT02478164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628665|NCT04301336|Vitamins|vitamins|mesh-ancestor
102216442|NCT02476994|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102216443|NCT02476994|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102216444|NCT02476994|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102216445|NCT02476994|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102216446|NCT02318329|Bemarituzumab|bemarituzumab|mesh-list
102216447|NCT02318329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102216448|NCT02318329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102216449|NCT05259319|Atezolizumab|atezolizumab|mesh-list
102216450|NCT05259319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102216451|NCT05259319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216452|NCT05259319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102216453|NCT05259319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102216454|NCT05259007|Amoxicillin|amoxicillin|mesh-list
102216455|NCT05259007|Clarithromycin|clarithromycin|mesh-list
102216456|NCT05259007|Propolis|propolis|mesh-list
102216457|NCT05259007|Lansoprazole|lansoprazole|mesh-list
102216458|NCT05259007|Dexlansoprazole|dexlansoprazole|mesh-list
102216459|NCT05259007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102216460|NCT05259007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102216462|NCT05259007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102216463|NCT05259007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216464|NCT05259007|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102216465|NCT05259007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102216466|NCT05259007|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102216467|NCT05259007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102216468|NCT05259007|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102216469|NCT02255656|Alemtuzumab|alemtuzumab|mesh-list
102216470|NCT02255656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102216471|NCT02255656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102216472|NCT00380653|Sapacitabine|sapacitabine|mesh-list
102216473|NCT00380653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102216474|NCT03472339|Diclofenac|diclofenac|mesh-list
102216475|NCT03472339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102216476|NCT03472339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102216477|NCT03472339|Analgesics|analgesics|mesh-ancestor
102216478|NCT03472339|Sensory System Agents|sensory system agents|mesh-ancestor
102216479|NCT03472339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102216480|NCT03472339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216481|NCT03472339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102216482|NCT03472339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102216483|NCT03472339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102216484|NCT03472339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102216485|NCT03472339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216486|NCT03472261|Botulinum Toxins|botulinum toxins|mesh-list
102216487|NCT03472261|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102216488|NCT03472261|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102216489|NCT03472261|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102216490|NCT03472261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102216491|NCT03472261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216492|NCT03472261|Cholinergic Agents|cholinergic agents|mesh-ancestor
102216493|NCT03472261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102216494|NCT03472261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216495|NCT03472261|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102216496|NCT03472261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102216497|NCT03951025|Melatonin|melatonin|mesh-list
102216498|NCT03951025|Antioxidants|antioxidants|mesh-ancestor
102216499|NCT03951025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216500|NCT03951025|Protective Agents|protective agents|mesh-ancestor
102216501|NCT03951025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216502|NCT03951025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102216503|NCT02255500|Bupivacaine|bupivacaine|mesh-list
102216504|NCT02255500|Anesthetics, Local|anesthetics, local|mesh-ancestor
102216505|NCT02255500|Anesthetics|anesthetics|mesh-ancestor
102216506|NCT02255500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102216507|NCT02255500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216508|NCT02255500|Sensory System Agents|sensory system agents|mesh-ancestor
102216509|NCT02255500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102216510|NCT03475693|Acetaminophen|acetaminophen|mesh-list
102216511|NCT03475693|Ondansetron|ondansetron|mesh-list
102216512|NCT03475693|Magnesium Oxide|magnesium oxide|mesh-list
102216513|NCT03475693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102216514|NCT03475693|Analgesics|analgesics|mesh-ancestor
102216515|NCT03475693|Sensory System Agents|sensory system agents|mesh-ancestor
102216516|NCT03475693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102216517|NCT03475693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216518|NCT03475693|Antipyretics|antipyretics|mesh-ancestor
102216519|NCT03475693|Antiemetics|antiemetics|mesh-ancestor
102216520|NCT03475693|Autonomic Agents|autonomic agents|mesh-ancestor
102216521|NCT03475693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102216522|NCT03475693|Antipruritics|antipruritics|mesh-ancestor
102216523|NCT03475693|Dermatologic Agents|dermatologic agents|mesh-ancestor
102216524|NCT03475693|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102216525|NCT03475693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102216526|NCT03475693|Serotonin Agents|serotonin agents|mesh-ancestor
102216527|NCT03475693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102216528|NCT03475693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216529|NCT03475693|Antacids|antacids|mesh-ancestor
102216530|NCT05156749|Calpastatin|calpastatin|mesh-list
102216531|NCT05156749|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
102216532|NCT05156749|Protease Inhibitors|protease inhibitors|mesh-ancestor
102216533|NCT05156749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101925358|NCT01174914|Sensory System Agents|sensory system agents|mesh-ancestor
102216534|NCT05156749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216535|NCT03475615|Paclitaxel|paclitaxel|mesh-list
102216536|NCT03475615|Oxaliplatin|oxaliplatin|mesh-list
102216537|NCT03475615|Tegafur|tegafur|mesh-list
102216538|NCT03475615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102216539|NCT03475615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102216540|NCT03475615|Tubulin Modulators|tubulin modulators|mesh-ancestor
102216541|NCT03475615|Antimitotic Agents|antimitotic agents|mesh-ancestor
102216542|NCT03475615|Mitosis Modulators|mitosis modulators|mesh-ancestor
102216543|NCT03475615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216544|NCT03475615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102216545|NCT03475615|Antimetabolites|antimetabolites|mesh-ancestor
102216546|NCT03478423|Oxycodone|oxycodone|mesh-list
102216547|NCT03478423|Hydromorphone|hydromorphone|mesh-list
102216548|NCT03478423|Codeine|codeine|mesh-list
102216549|NCT03478423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102216550|NCT03478423|Narcotics|narcotics|mesh-ancestor
102216551|NCT03478423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102216552|NCT03478423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216553|NCT03478423|Analgesics|analgesics|mesh-ancestor
102216554|NCT03478423|Sensory System Agents|sensory system agents|mesh-ancestor
102216555|NCT03478423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102216556|NCT03478423|Antitussive Agents|antitussive agents|mesh-ancestor
102216557|NCT03478423|Respiratory System Agents|respiratory system agents|mesh-ancestor
102216558|NCT03478345|Endocrine Disruptors|endocrine disruptors|mesh-list
102216559|NCT03478345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216560|NCT03130933|Amoxicillin|amoxicillin|mesh-list
102216561|NCT03130933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102216562|NCT03130933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102216563|NCT05155969|Ketamine|ketamine|mesh-list
102216564|NCT05155969|Esketamine|esketamine|mesh-list
102216565|NCT05155969|Analgesics|analgesics|mesh-ancestor
102216566|NCT05155969|Sensory System Agents|sensory system agents|mesh-ancestor
102216567|NCT05155969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102216568|NCT05155969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216569|NCT05155969|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102216570|NCT05155969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102216571|NCT05155969|Anesthetics, General|anesthetics, general|mesh-ancestor
102216572|NCT05155969|Anesthetics|anesthetics|mesh-ancestor
102216573|NCT05155969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102216574|NCT05155969|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102216575|NCT05155969|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102216576|NCT05155969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102216577|NCT05155969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216578|NCT05155969|Antidepressive Agents|antidepressive agents|mesh-ancestor
102216579|NCT05155969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102216580|NCT05112913|Vaccines|vaccines|mesh-list
102216581|NCT05112913|Immunologic Factors|immunologic factors|mesh-ancestor
102216582|NCT05112913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216583|NCT03475459|Melatonin|melatonin|mesh-list
102216584|NCT03475459|Antioxidants|antioxidants|mesh-ancestor
102216585|NCT03475459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216586|NCT03475459|Protective Agents|protective agents|mesh-ancestor
102216587|NCT03475459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216588|NCT03475459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102216589|NCT03478111|Infliximab|infliximab|mesh-list
102216590|NCT03478111|Methotrexate|methotrexate|mesh-list
102216591|NCT03478111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102216592|NCT03478111|Abortifacient Agents|abortifacient agents|mesh-ancestor
102216593|NCT03478111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102216594|NCT03478111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216595|NCT03478111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102216596|NCT03478111|Antimetabolites|antimetabolites|mesh-ancestor
102216597|NCT03478111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216598|NCT03478111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102216599|NCT03478111|Dermatologic Agents|dermatologic agents|mesh-ancestor
102216600|NCT03478111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102216601|NCT03478111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102216602|NCT03478111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102216603|NCT03478111|Immunologic Factors|immunologic factors|mesh-ancestor
102216604|NCT03478111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102216605|NCT03478111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102216606|NCT03478111|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102216607|NCT03478111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102216608|NCT03478111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102216609|NCT03478033|Rifampin|rifampin|mesh-list
102216610|NCT03478033|Rifabutin|rifabutin|mesh-list
102216611|NCT03478033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102216612|NCT03478033|Antitubercular Agents|antitubercular agents|mesh-ancestor
102216613|NCT03478033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102216614|NCT03478033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102216615|NCT03478033|Leprostatic Agents|leprostatic agents|mesh-ancestor
102216616|NCT03478033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102216617|NCT03478033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102216618|NCT03478033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216619|NCT03478033|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102216620|NCT03478033|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102216621|NCT03478033|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102216622|NCT03478033|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102216623|NCT03478033|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102216624|NCT03478033|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102216625|NCT03477955|Silicon|silicon|mesh-list
102216626|NCT03477955|Trace Elements|trace elements|mesh-ancestor
102216627|NCT03477955|Micronutrients|micronutrients|mesh-ancestor
102216628|NCT03477955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216629|NCT05189197|Zanubrutinib|zanubrutinib|mesh-list
102216630|NCT05189197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102216631|NCT05189197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102216632|NCT05189197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102216633|NCT05189197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216634|NCT05084599|Metaraminol|metaraminol|mesh-list
102216635|NCT05084599|Sympathomimetics|sympathomimetics|mesh-ancestor
102216636|NCT05084599|Autonomic Agents|autonomic agents|mesh-ancestor
102216637|NCT05084599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102216638|NCT05084599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216639|NCT05084599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102216640|NCT05084599|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102216641|NCT05084599|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102216642|NCT05084599|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101628680|NCT04299854|Dinoprostone|dinoprostone|mesh-list
102216643|NCT05084599|Adrenergic Agents|adrenergic agents|mesh-ancestor
102216644|NCT05084599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102216645|NCT05084599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216646|NCT02505542|Certolizumab Pegol|certolizumab pegol|mesh-list
102216647|NCT02505542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102216648|NCT02505542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102216649|NCT02505542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102216650|NCT02505542|Immunologic Factors|immunologic factors|mesh-ancestor
102216651|NCT02505542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216652|NCT02505542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102216653|NCT00701623|Heparin|heparin|mesh-list
102216654|NCT00701623|Calcium heparin|calcium heparin|mesh-list
102216655|NCT00701623|Anticoagulants|anticoagulants|mesh-ancestor
102216656|NCT00701623|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102216657|NCT00701623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102216658|NCT00701623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216659|NCT04456153|Atovaquone|atovaquone|mesh-list
102216660|NCT04456153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102216661|NCT04456153|Antimalarials|antimalarials|mesh-ancestor
102216662|NCT04456153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102216663|NCT04456153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102216664|NCT04456153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102216665|NCT04456153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216666|NCT04403971|Chlorhexidine|chlorhexidine|mesh-list
102216667|NCT04403971|Listerine|listerine|mesh-list
102216668|NCT04403971|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102216669|NCT04403971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102216670|NCT04403971|Disinfectants|disinfectants|mesh-ancestor
102216671|NCT02447432|Vaccines|vaccines|mesh-list
102216672|NCT02447432|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102216673|NCT02447432|Immunologic Factors|immunologic factors|mesh-ancestor
102216674|NCT02447432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216675|NCT02446886|Hormones|hormones|mesh-list
102216676|NCT02446886|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102216677|NCT02446886|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
102216678|NCT02446886|beta-Endorphin|beta-endorphin|mesh-list
102216679|NCT02446886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102216680|NCT02446886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216681|NCT02446886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102216682|NCT02446886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925507|NCT01181310|Nootropic Agents|nootropic agents|mesh-ancestor
102216684|NCT04351243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102216685|NCT04351243|Antiviral Agents|antiviral agents|mesh-ancestor
102216686|NCT04351243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102216687|NCT05008003|Vitamin D|vitamin d|mesh-list
102216688|NCT05008003|Cholecalciferol|cholecalciferol|mesh-list
102216689|NCT05008003|Vitamins|vitamins|mesh-ancestor
102216690|NCT05008003|Micronutrients|micronutrients|mesh-ancestor
102216691|NCT05008003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216692|NCT05008003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102216693|NCT05008003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102216694|NCT03475225|Cholecalciferol|cholecalciferol|mesh-list
102216695|NCT03475225|Vitamin D|vitamin d|mesh-list
102216696|NCT03475225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102216697|NCT03475225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216698|NCT03475225|Vitamins|vitamins|mesh-ancestor
102216699|NCT03475225|Micronutrients|micronutrients|mesh-ancestor
102216700|NCT03475225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102216701|NCT03448939|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102216702|NCT03448939|Dermatologic Agents|dermatologic agents|mesh-ancestor
102216703|NCT02504294|Epoetin Alfa|epoetin alfa|mesh-list
102216704|NCT02504294|Hematinics|hematinics|mesh-ancestor
102216705|NCT02446418|Fluticasone|fluticasone|mesh-list
102216706|NCT02446418|Xhance|xhance|mesh-list
102216707|NCT02446418|Budesonide|budesonide|mesh-list
102216708|NCT02446418|Formoterol Fumarate|formoterol fumarate|mesh-list
102216709|NCT02446418|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102216710|NCT02446418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102216711|NCT02446418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102216712|NCT02446418|Autonomic Agents|autonomic agents|mesh-ancestor
102216713|NCT02446418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102216714|NCT02446418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628691|NCT04205240|Cyclophosphamide|cyclophosphamide|mesh-list
102216715|NCT02446418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102216716|NCT02446418|Respiratory System Agents|respiratory system agents|mesh-ancestor
102216717|NCT02446418|Dermatologic Agents|dermatologic agents|mesh-ancestor
102216718|NCT02446418|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102216719|NCT02446418|Glucocorticoids|glucocorticoids|mesh-ancestor
102216720|NCT02446418|Hormones|hormones|mesh-ancestor
102216721|NCT02446418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102216722|NCT02446418|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102216723|NCT02446418|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102216724|NCT02446418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102216725|NCT02446418|Adrenergic Agents|adrenergic agents|mesh-ancestor
102216726|NCT02446418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102216727|NCT02446418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216728|NCT04859062|Lidocaine|lidocaine|mesh-list
102216729|NCT04859062|Anesthetics, Local|anesthetics, local|mesh-ancestor
102216730|NCT04859062|Anesthetics|anesthetics|mesh-ancestor
102216731|NCT04859062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102216732|NCT04859062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216733|NCT04859062|Sensory System Agents|sensory system agents|mesh-ancestor
102216734|NCT04859062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102216735|NCT04859062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102216736|NCT04859062|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102216737|NCT04859062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102216738|NCT04859062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102216739|NCT04859062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216740|NCT04864210|Bupivacaine|bupivacaine|mesh-list
102216741|NCT04864210|Anesthetics, Local|anesthetics, local|mesh-ancestor
102216742|NCT04864210|Anesthetics|anesthetics|mesh-ancestor
102216743|NCT04864210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102216744|NCT04864210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216745|NCT04864210|Sensory System Agents|sensory system agents|mesh-ancestor
102216746|NCT04864210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102216747|NCT01641640|Sofosbuvir|sofosbuvir|mesh-list
102216748|NCT01641640|Ribavirin|ribavirin|mesh-list
102216749|NCT01641640|Antiviral Agents|antiviral agents|mesh-ancestor
102216750|NCT01641640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102216751|NCT01641640|Antimetabolites|antimetabolites|mesh-ancestor
102216752|NCT01641640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216753|NCT05650216|Paclitaxel|paclitaxel|mesh-list
102216754|NCT05650216|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102216755|NCT05650216|Carboplatin|carboplatin|mesh-list
102216756|NCT05650216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102216757|NCT05650216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102216758|NCT05650216|Tubulin Modulators|tubulin modulators|mesh-ancestor
102216759|NCT05650216|Antimitotic Agents|antimitotic agents|mesh-ancestor
102216761|NCT05650216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216762|NCT04848688|Ivermectin|ivermectin|mesh-list
102216763|NCT04848688|Moxidectin|moxidectin|mesh-list
102216764|NCT04848688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102216765|NCT04848688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102216766|NCT04848688|Anthelmintics|anthelmintics|mesh-ancestor
102216767|NCT04848688|Antinematodal Agents|antinematodal agents|mesh-ancestor
102216769|NCT05369650|Anesthetics, Local|anesthetics, local|mesh-ancestor
102216770|NCT05369650|Anesthetics|anesthetics|mesh-ancestor
102216771|NCT05369650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102216772|NCT05369650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216773|NCT05369650|Sensory System Agents|sensory system agents|mesh-ancestor
102216774|NCT05369650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102216775|NCT05369650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102216776|NCT05369650|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102216777|NCT05369650|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102216778|NCT05369650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102216779|NCT05369650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216780|NCT05071612|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102216781|NCT05071612|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102216782|NCT05071612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102216783|NCT05071612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102216784|NCT05071612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216785|NCT05071612|Adrenergic Agents|adrenergic agents|mesh-ancestor
102216786|NCT05071612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102216787|NCT05071612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216788|NCT05069740|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
102216789|NCT05069740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102216790|NCT05069740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102216791|NCT05069740|Analgesics|analgesics|mesh-ancestor
102216792|NCT05069740|Sensory System Agents|sensory system agents|mesh-ancestor
102216793|NCT05069740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102216794|NCT05069740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216795|NCT05069740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102216796|NCT05069740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102216797|NCT01601626|Pyridoxine|pyridoxine|mesh-list
102216798|NCT01601626|Vitamin B 6|vitamin b 6|mesh-list
102216799|NCT01601626|Ritonavir|ritonavir|mesh-list
102216800|NCT01601626|Lopinavir|lopinavir|mesh-list
102216801|NCT01601626|Raltegravir Potassium|raltegravir potassium|mesh-list
102216802|NCT01601626|Rifampin|rifampin|mesh-list
102216803|NCT01601626|Isoniazid|isoniazid|mesh-list
102216804|NCT01601626|Pyrazinamide|pyrazinamide|mesh-list
102216805|NCT01601626|Ethambutol|ethambutol|mesh-list
102216806|NCT01601626|Rifabutin|rifabutin|mesh-list
102216807|NCT01601626|Vitamins|vitamins|mesh-ancestor
102216808|NCT01601626|Micronutrients|micronutrients|mesh-ancestor
102216809|NCT01601626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216810|NCT01601626|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102216811|NCT01601626|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102216812|NCT01601626|Protease Inhibitors|protease inhibitors|mesh-ancestor
102216813|NCT01601626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102216814|NCT01601626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216815|NCT01601626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102216816|NCT01601626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102216817|NCT01601626|Antiviral Agents|antiviral agents|mesh-ancestor
102216818|NCT01601626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102216819|NCT01601626|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102216820|NCT01601626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102216821|NCT01601626|Vitamin B Complex|vitamin b complex|mesh-ancestor
102216822|NCT01601626|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102216823|NCT01601626|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102216824|NCT01601626|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102216825|NCT01601626|Antitubercular Agents|antitubercular agents|mesh-ancestor
102216826|NCT01601626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102216827|NCT01601626|Leprostatic Agents|leprostatic agents|mesh-ancestor
102216828|NCT01601626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102216829|NCT01601626|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102216830|NCT01601626|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102216831|NCT01601626|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102216832|NCT01601626|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102216833|NCT01601626|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101925675|NCT03857334|Cortivazol|cortivazol|mesh-list
102216834|NCT01601626|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102216835|NCT01601626|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102216836|NCT01601626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102216837|NCT01601626|Antimetabolites|antimetabolites|mesh-ancestor
102216838|NCT01601626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102216839|NCT05428150|Pirfenidone|pirfenidone|mesh-list
102216840|NCT05428150|Analgesics|analgesics|mesh-ancestor
102216841|NCT05428150|Sensory System Agents|sensory system agents|mesh-ancestor
102216842|NCT05428150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102216843|NCT05428150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216844|NCT05428150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102216845|NCT05428150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102216846|NCT05428150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102216847|NCT05428150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102216848|NCT05428150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102216849|NCT02737501|Crizotinib|crizotinib|mesh-list
102216850|NCT02737501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102216851|NCT02737501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102216852|NCT02737501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102216853|NCT02737501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216854|NCT04848220|APD791|apd791|mesh-list
102216855|NCT04848220|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102216856|NCT04848220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102216857|NCT04848220|Serotonin Agents|serotonin agents|mesh-ancestor
102216858|NCT04848220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102216859|NCT04848220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216860|NCT04848220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216861|NCT05642182|Vitamin D|vitamin d|mesh-list
102216862|NCT05642182|Ergocalciferols|ergocalciferols|mesh-list
102216863|NCT05642182|Cholecalciferol|cholecalciferol|mesh-list
102216864|NCT05642182|Vitamins|vitamins|mesh-list
102216865|NCT05642182|Micronutrients|micronutrients|mesh-ancestor
102216866|NCT05642182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216867|NCT05642182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102216868|NCT05642182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102216869|NCT03471559|Cannabidiol|cannabidiol|mesh-list
102216870|NCT03471559|Anticonvulsants|anticonvulsants|mesh-ancestor
102216871|NCT05641480|Donepezil|donepezil|mesh-list
102216872|NCT05641480|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102216873|NCT05641480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102216874|NCT05641480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216875|NCT05641480|Cholinergic Agents|cholinergic agents|mesh-ancestor
102216876|NCT05641480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102216877|NCT05641480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216878|NCT05641480|Nootropic Agents|nootropic agents|mesh-ancestor
102216879|NCT03377803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102216880|NCT03377803|Cantharidin|cantharidin|mesh-list
102216881|NCT03377803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102216882|NCT03377803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216883|NCT03471325|Methamphetamine|methamphetamine|mesh-list
102216884|NCT03471325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102216885|NCT03471325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216886|NCT03471325|Sympathomimetics|sympathomimetics|mesh-ancestor
102216887|NCT03471325|Autonomic Agents|autonomic agents|mesh-ancestor
102216888|NCT03471325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102216889|NCT03471325|Dopamine Agents|dopamine agents|mesh-ancestor
102216890|NCT03471325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102216891|NCT03471325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216892|NCT03471325|Adrenergic Agents|adrenergic agents|mesh-ancestor
102216893|NCT03471325|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102216894|NCT03471325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102216895|NCT03471325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102216896|NCT03471325|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102216897|NCT04844164|Cholecalciferol|cholecalciferol|mesh-list
102216898|NCT04844164|Vitamin D|vitamin d|mesh-list
102216899|NCT04844164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102216900|NCT04844164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216901|NCT04844164|Vitamins|vitamins|mesh-ancestor
102216902|NCT04844164|Micronutrients|micronutrients|mesh-ancestor
102216903|NCT04844164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102216904|NCT05392972|Anesthetics|anesthetics|mesh-list
101925733|NCT01182168|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102216905|NCT05392972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102216906|NCT05392972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216907|NCT03474601|Hormones|hormones|mesh-list
101573993|NCT02199184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102216908|NCT03474601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102216909|NCT03474601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216911|NCT04988308|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102216912|NCT04988308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102216913|NCT04988308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102216915|NCT04984798|Tocopherols|tocopherols|mesh-list
102216916|NCT04984798|alpha-Tocopherol|alpha-tocopherol|mesh-list
102216917|NCT04984798|Vitamins|vitamins|mesh-ancestor
102216918|NCT04984798|Micronutrients|micronutrients|mesh-ancestor
102216919|NCT04984798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216920|NCT04984798|Antioxidants|antioxidants|mesh-ancestor
102216921|NCT04984798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216922|NCT04984798|Protective Agents|protective agents|mesh-ancestor
102216923|NCT02230163|Immunoglobulins|immunoglobulins|mesh-list
102216924|NCT02230163|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102216925|NCT02230163|Antibodies|antibodies|mesh-list
102216926|NCT02230163|Immunologic Factors|immunologic factors|mesh-ancestor
102216927|NCT02230163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216928|NCT02230319|Paclitaxel|paclitaxel|mesh-list
102216929|NCT02230319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102216930|NCT02230319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102216931|NCT02230319|Tubulin Modulators|tubulin modulators|mesh-ancestor
102216932|NCT02230319|Antimitotic Agents|antimitotic agents|mesh-ancestor
102216933|NCT02230319|Mitosis Modulators|mitosis modulators|mesh-ancestor
102216934|NCT02230319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216935|NCT00135395|Ritonavir|ritonavir|mesh-list
102216936|NCT00135395|Lopinavir|lopinavir|mesh-list
102216937|NCT00135395|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102216938|NCT00135395|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102216939|NCT00135395|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102216940|NCT00135395|Protease Inhibitors|protease inhibitors|mesh-ancestor
102216941|NCT00135395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102216942|NCT00135395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216943|NCT00135395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102216944|NCT00135395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102216945|NCT00135395|Antiviral Agents|antiviral agents|mesh-ancestor
102216946|NCT00135395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102216947|NCT00135395|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102216948|NCT00135395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102216949|NCT02230553|Lapatinib|lapatinib|mesh-list
102216950|NCT02230553|Trametinib|trametinib|mesh-list
102216951|NCT02230553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102216952|NCT02230553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102216953|NCT02230553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102216954|NCT02230553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216955|NCT04261049|Triamcinolone|triamcinolone|mesh-list
102216956|NCT04261049|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102216957|NCT04261049|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102216958|NCT04261049|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102216959|NCT04261049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102216960|NCT04261049|Glucocorticoids|glucocorticoids|mesh-ancestor
102216961|NCT04261049|Hormones|hormones|mesh-ancestor
102216962|NCT04261049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102216963|NCT04261049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102216964|NCT04261049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102216965|NCT04261049|Immunologic Factors|immunologic factors|mesh-ancestor
102216966|NCT04261049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102216967|NCT04261049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216968|NCT00057473|Carboplatin|carboplatin|mesh-list
102216969|NCT00057473|Irinotecan|irinotecan|mesh-list
102216970|NCT00057473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102216971|NCT00057473|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102216972|NCT00057473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102216973|NCT00057473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102216974|NCT00057473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216975|NCT00035789|Entecavir|entecavir|mesh-list
102216976|NCT00035789|Antiviral Agents|antiviral agents|mesh-ancestor
102216977|NCT00035789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102216978|NCT00035633|Entecavir|entecavir|mesh-list
102216979|NCT00035633|Antiviral Agents|antiviral agents|mesh-ancestor
102216980|NCT00035633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102216981|NCT00028301|Ritonavir|ritonavir|mesh-list
102216982|NCT00028301|Lopinavir|lopinavir|mesh-list
102216983|NCT00028301|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102216984|NCT00028301|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102216986|NCT00028301|Protease Inhibitors|protease inhibitors|mesh-ancestor
102216987|NCT00028301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102216988|NCT00028301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102216989|NCT00028301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102216990|NCT00028301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102216991|NCT00028301|Antiviral Agents|antiviral agents|mesh-ancestor
102216992|NCT00028301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102216993|NCT00028301|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102216994|NCT00028301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102216995|NCT00028067|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102216996|NCT00028067|Nelfinavir|nelfinavir|mesh-list
102216997|NCT00028067|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102216998|NCT00028067|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102216999|NCT00028067|Protease Inhibitors|protease inhibitors|mesh-ancestor
102217000|NCT00028067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102217001|NCT00028067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217002|NCT00028067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102217003|NCT00028067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102217004|NCT00028067|Antiviral Agents|antiviral agents|mesh-ancestor
102217005|NCT00028067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102217006|NCT00005795|Arsenic Trioxide|arsenic trioxide|mesh-list
102217007|NCT00005795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102217008|NCT00004907|Cyclophosphamide|cyclophosphamide|mesh-list
102217009|NCT00004907|Busulfan|busulfan|mesh-list
102217010|NCT00004907|Etoposide|etoposide|mesh-list
102217011|NCT00004907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102217012|NCT00004907|Immunologic Factors|immunologic factors|mesh-ancestor
102217013|NCT00004907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217014|NCT00004907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102217015|NCT00004907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102217016|NCT00004907|Alkylating Agents|alkylating agents|mesh-ancestor
102217017|NCT00004907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217018|NCT00004907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102217019|NCT00004907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102217020|NCT00004907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102217021|NCT00004907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102217022|NCT00004907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102217023|NCT00004907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102217024|NCT04469777|Epoetin Alfa|epoetin alfa|mesh-list
102217025|NCT04469777|Hematinics|hematinics|mesh-ancestor
102217026|NCT00004895|Octreotide|octreotide|mesh-list
102217027|NCT00004895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102217028|NCT00004895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102217029|NCT00004895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102217030|NCT00004181|Cyclophosphamide|cyclophosphamide|mesh-list
102217031|NCT00004181|Busulfan|busulfan|mesh-list
102217032|NCT00004181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102217033|NCT00004181|Immunologic Factors|immunologic factors|mesh-ancestor
102217034|NCT00004181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217035|NCT00004181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102217036|NCT00004181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102217037|NCT00004181|Alkylating Agents|alkylating agents|mesh-ancestor
102217038|NCT00004181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217039|NCT00004181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102217040|NCT00004181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102217041|NCT00004175|Cyclophosphamide|cyclophosphamide|mesh-list
102217042|NCT00004175|Docetaxel|docetaxel|mesh-list
102217043|NCT00004175|Doxorubicin|doxorubicin|mesh-list
102217044|NCT00004175|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102217045|NCT00004175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102217046|NCT00004175|Immunologic Factors|immunologic factors|mesh-ancestor
102217047|NCT00004175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217048|NCT00004175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102217049|NCT00004175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102217050|NCT00004175|Alkylating Agents|alkylating agents|mesh-ancestor
102217051|NCT00004175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217052|NCT00004175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102217053|NCT00004175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102217054|NCT00004175|Tubulin Modulators|tubulin modulators|mesh-ancestor
102217055|NCT00004175|Antimitotic Agents|antimitotic agents|mesh-ancestor
102217056|NCT00004175|Mitosis Modulators|mitosis modulators|mesh-ancestor
102217057|NCT00004175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102217058|NCT00004175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102217059|NCT00004175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102217060|NCT00004175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102217061|NCT05708573|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102217062|NCT05708573|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102217063|NCT05708573|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102217064|NCT05708573|Antimetabolites|antimetabolites|mesh-ancestor
102217065|NCT05708573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217066|NCT05708573|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101628775|NCT00722137|Glucocorticoids|glucocorticoids|mesh-ancestor
102217067|NCT05708573|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102217068|NCT05708573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102217069|NCT00004169|Cyclophosphamide|cyclophosphamide|mesh-list
102217070|NCT00004169|Carboplatin|carboplatin|mesh-list
102217072|NCT00004169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102217073|NCT00004169|Immunologic Factors|immunologic factors|mesh-ancestor
102217074|NCT00004169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217075|NCT00004169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102217076|NCT00004169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102217077|NCT00004169|Alkylating Agents|alkylating agents|mesh-ancestor
102217078|NCT00004169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217079|NCT00004169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102217080|NCT00004169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102217081|NCT00004169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102217082|NCT00004169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102217083|NCT00004169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102217084|NCT00004169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102217085|NCT00002429|Lamivudine|lamivudine|mesh-list
102217086|NCT00002429|Zidovudine|zidovudine|mesh-list
102217087|NCT00002429|Stavudine|stavudine|mesh-list
102217088|NCT00002429|Didanosine|didanosine|mesh-list
102217089|NCT00002429|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
102217090|NCT00002429|Nelfinavir|nelfinavir|mesh-list
102217091|NCT00002429|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102217092|NCT00002429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102217093|NCT00002429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102217094|NCT00002429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217095|NCT00002429|Antiviral Agents|antiviral agents|mesh-ancestor
102217096|NCT00002429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102217097|NCT00002429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102217098|NCT00002429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102217099|NCT00002429|Antimetabolites|antimetabolites|mesh-ancestor
102217100|NCT00002429|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102217101|NCT00002429|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102217102|NCT00002429|Protease Inhibitors|protease inhibitors|mesh-ancestor
102217103|NCT00002411|Lamivudine|lamivudine|mesh-list
102217104|NCT00002411|Zidovudine|zidovudine|mesh-list
102217105|NCT00002411|Stavudine|stavudine|mesh-list
102217106|NCT00002411|Didanosine|didanosine|mesh-list
102217107|NCT00002411|Nelfinavir|nelfinavir|mesh-list
102217108|NCT00002411|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102217109|NCT00002411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102217110|NCT00002411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102217111|NCT00002411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217112|NCT00002411|Antiviral Agents|antiviral agents|mesh-ancestor
102217113|NCT00002411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102217114|NCT00002411|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102217115|NCT00002411|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102217116|NCT00002411|Antimetabolites|antimetabolites|mesh-ancestor
102217117|NCT00002411|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102217118|NCT00002411|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102217119|NCT00002411|Protease Inhibitors|protease inhibitors|mesh-ancestor
102217120|NCT03530033|Lidocaine|lidocaine|mesh-list
102217121|NCT03530033|Anesthetics, Local|anesthetics, local|mesh-ancestor
102217122|NCT03530033|Anesthetics|anesthetics|mesh-ancestor
102217123|NCT03530033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102217124|NCT03530033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217125|NCT03530033|Sensory System Agents|sensory system agents|mesh-ancestor
102217126|NCT03530033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102217127|NCT03530033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102217128|NCT03530033|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102217129|NCT03530033|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102217130|NCT03530033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102217131|NCT03530033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217132|NCT03529643|Dexmedetomidine|dexmedetomidine|mesh-list
102217133|NCT03529643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101900847|NCT00310817|Vaccines|vaccines|mesh-list
102217134|NCT03529643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102217135|NCT03529643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217136|NCT03529643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102217137|NCT03529643|Analgesics|analgesics|mesh-ancestor
102217138|NCT03529643|Sensory System Agents|sensory system agents|mesh-ancestor
102217139|NCT03529643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102217140|NCT03529643|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102217141|NCT03529643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102217142|NCT03529643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102217143|NCT03529643|Adrenergic Agents|adrenergic agents|mesh-ancestor
102217144|NCT03529643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102217145|NCT03529643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217146|NCT03529331|Acetaminophen|acetaminophen|mesh-list
102217147|NCT03529331|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
102217148|NCT03529331|Morphine|morphine|mesh-list
102217149|NCT03529331|Oxycodone|oxycodone|mesh-list
102217150|NCT03529331|Hydrocodone|hydrocodone|mesh-list
102217151|NCT03529331|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102217152|NCT03529331|Narcotics|narcotics|mesh-ancestor
102217153|NCT03529331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102217154|NCT03529331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217155|NCT03529331|Analgesics|analgesics|mesh-ancestor
102217156|NCT03529331|Sensory System Agents|sensory system agents|mesh-ancestor
102217157|NCT03529331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102217158|NCT03529331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102217159|NCT03529331|Antipyretics|antipyretics|mesh-ancestor
102217160|NCT03529331|Antitussive Agents|antitussive agents|mesh-ancestor
102217161|NCT03529331|Respiratory System Agents|respiratory system agents|mesh-ancestor
102217162|NCT03529331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102217163|NCT03529331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102217164|NCT03529331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102217165|NCT03529253|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102217166|NCT03529253|Alirocumab|alirocumab|mesh-list
102217167|NCT03529253|Calcium|calcium|mesh-list
102217168|NCT03529253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102217169|NCT03529253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217170|NCT03529253|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102217171|NCT03529253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102217172|NCT03529253|Antimetabolites|antimetabolites|mesh-ancestor
102217173|NCT03529253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217174|NCT03529253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102217175|NCT03529253|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102217176|NCT03529253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102217177|NCT03529253|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102217178|NCT03529253|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102217179|NCT03529253|Protease Inhibitors|protease inhibitors|mesh-ancestor
102217180|NCT03529175|Paclitaxel|paclitaxel|mesh-list
102217181|NCT03529175|Gemcitabine|gemcitabine|mesh-list
102217182|NCT03529175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102217183|NCT03529175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102217184|NCT03529175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102217185|NCT03529175|Tubulin Modulators|tubulin modulators|mesh-ancestor
102217186|NCT03529175|Antimitotic Agents|antimitotic agents|mesh-ancestor
102217187|NCT03529175|Mitosis Modulators|mitosis modulators|mesh-ancestor
102217188|NCT03529175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217189|NCT03529175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102217190|NCT03529175|Antimetabolites|antimetabolites|mesh-ancestor
102217191|NCT00002207|Stavudine|stavudine|mesh-list
102217192|NCT00002207|Didanosine|didanosine|mesh-list
102217193|NCT00002207|Antimetabolites|antimetabolites|mesh-ancestor
102217194|NCT00002207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217195|NCT00002207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102217196|NCT00002207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102217197|NCT00002207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102217198|NCT00002207|Antiviral Agents|antiviral agents|mesh-ancestor
102217199|NCT00002207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102217200|NCT00002207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102217201|NCT00002207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102217202|NCT03529097|Dipyrone|dipyrone|mesh-list
102217203|NCT03529097|Diclofenac|diclofenac|mesh-list
102217204|NCT03529097|Morphine|morphine|mesh-list
102217205|NCT03529097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102217206|NCT03529097|Narcotics|narcotics|mesh-ancestor
102217207|NCT03529097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102217208|NCT03529097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217209|NCT03529097|Analgesics|analgesics|mesh-ancestor
102217210|NCT03529097|Sensory System Agents|sensory system agents|mesh-ancestor
102217211|NCT03529097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102217212|NCT03529097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102217213|NCT03529097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102217214|NCT03529097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102217215|NCT03529097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102217216|NCT03529097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102217217|NCT03529097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102217218|NCT03529097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217219|NCT03529097|Antipyretics|antipyretics|mesh-ancestor
102217220|NCT03531749|Ascorbic Acid|ascorbic acid|mesh-list
102217221|NCT03531749|Antioxidants|antioxidants|mesh-ancestor
102217222|NCT03531749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217223|NCT03531749|Protective Agents|protective agents|mesh-ancestor
102217224|NCT03531749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217225|NCT03531749|Vitamins|vitamins|mesh-ancestor
102217226|NCT03531749|Micronutrients|micronutrients|mesh-ancestor
102217227|NCT03528785|Leucovorin|leucovorin|mesh-list
102217228|NCT03528785|Oxaliplatin|oxaliplatin|mesh-list
102217229|NCT03528785|Irinotecan|irinotecan|mesh-list
102217230|NCT03528785|Levoleucovorin|levoleucovorin|mesh-list
102217231|NCT03528785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102217232|NCT03528785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102217233|NCT03528785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102217234|NCT03528785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102217235|NCT03528785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217236|NCT03528785|Antidotes|antidotes|mesh-ancestor
102217237|NCT03528785|Protective Agents|protective agents|mesh-ancestor
102217238|NCT03528785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217239|NCT03528785|Vitamin B Complex|vitamin b complex|mesh-ancestor
102217240|NCT03528785|Vitamins|vitamins|mesh-ancestor
102217241|NCT03528785|Micronutrients|micronutrients|mesh-ancestor
102217242|NCT03531437|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102217243|NCT03531437|Gestodene|gestodene|mesh-list
102217244|NCT03531437|Estradiol|estradiol|mesh-list
102217245|NCT03531437|Estrogens|estrogens|mesh-ancestor
102217246|NCT03531437|Hormones|hormones|mesh-ancestor
102217247|NCT03531437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102217248|NCT03531437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217249|NCT03531437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102217250|NCT03531437|Contraceptive Agents|contraceptive agents|mesh-ancestor
102217251|NCT03531437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102217252|NCT03531437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102217253|NCT03531437|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102217254|NCT03531437|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102217255|NCT03531437|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102217256|NCT03531437|Progestins|progestins|mesh-ancestor
102217257|NCT03527381|Nitric Oxide|nitric oxide|mesh-list
102217258|NCT03527381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102217259|NCT03527381|Autonomic Agents|autonomic agents|mesh-ancestor
102217260|NCT03527381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102217261|NCT03527381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217262|NCT03527381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102217263|NCT03527381|Respiratory System Agents|respiratory system agents|mesh-ancestor
102217264|NCT03527381|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102217265|NCT03527381|Antioxidants|antioxidants|mesh-ancestor
102217266|NCT03527381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217267|NCT03527381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102217268|NCT03527381|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102217269|NCT03527381|Vasodilator Agents|vasodilator agents|mesh-ancestor
102217270|NCT03527381|Gasotransmitters|gasotransmitters|mesh-ancestor
102217271|NCT03527381|Protective Agents|protective agents|mesh-ancestor
102217272|NCT04441385|Maraviroc|maraviroc|mesh-list
102217273|NCT04441385|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102217274|NCT04441385|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102217275|NCT04441385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217276|NCT04441385|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102217277|NCT04441385|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102217278|NCT04441385|Antiviral Agents|antiviral agents|mesh-ancestor
102217279|NCT04441385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102217280|NCT04441385|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102217281|NCT03531359|Midazolam|midazolam|mesh-list
102217282|NCT03531359|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102217283|NCT03531359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102217284|NCT03531359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102217286|NCT03531359|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102217287|NCT03531359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102217288|NCT03531359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102217289|NCT03531359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102217290|NCT03531359|Anesthetics, General|anesthetics, general|mesh-ancestor
102217291|NCT03531359|Anesthetics|anesthetics|mesh-ancestor
102217292|NCT03531359|GABA Modulators|gaba modulators|mesh-ancestor
102217293|NCT03531359|GABA Agents|gaba agents|mesh-ancestor
102217294|NCT03531359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102217295|NCT03531359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217296|NCT03531281|Sirolimus|sirolimus|mesh-list
102217297|NCT03531281|Cyclophosphamide|cyclophosphamide|mesh-list
102217298|NCT03531281|Etoposide|etoposide|mesh-list
102217299|NCT03531281|Etoposide phosphate|etoposide phosphate|mesh-list
102217300|NCT03531281|Podophyllotoxin|podophyllotoxin|mesh-list
102217301|NCT03531281|Tacrolimus|tacrolimus|mesh-list
102217302|NCT03531281|Mitogens|mitogens|mesh-list
102217303|NCT03531281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102217304|NCT03531281|Immunologic Factors|immunologic factors|mesh-ancestor
102217305|NCT03531281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217306|NCT03531281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102217307|NCT03531281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102217308|NCT03531281|Alkylating Agents|alkylating agents|mesh-ancestor
102217309|NCT03531281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217310|NCT03531281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102217311|NCT03531281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102217312|NCT03531281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102217313|NCT03531281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102217314|NCT03531281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102217315|NCT03531281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102217316|NCT03531281|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102217317|NCT03531281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102217318|NCT03531281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102217319|NCT03531281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102217320|NCT03531281|Antifungal Agents|antifungal agents|mesh-ancestor
102217321|NCT03531281|Mitosis Modulators|mitosis modulators|mesh-ancestor
102217322|NCT03531281|Keratolytic Agents|keratolytic agents|mesh-ancestor
102217323|NCT03531281|Dermatologic Agents|dermatologic agents|mesh-ancestor
102217324|NCT03531281|Tubulin Modulators|tubulin modulators|mesh-ancestor
102217325|NCT03531281|Antimitotic Agents|antimitotic agents|mesh-ancestor
102217326|NCT04468685|Ondansetron|ondansetron|mesh-list
102217327|NCT04468685|Antiemetics|antiemetics|mesh-ancestor
102217328|NCT04468685|Autonomic Agents|autonomic agents|mesh-ancestor
102217329|NCT04468685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102217330|NCT04468685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217331|NCT04468685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102217332|NCT04468685|Antipruritics|antipruritics|mesh-ancestor
102217333|NCT04468685|Dermatologic Agents|dermatologic agents|mesh-ancestor
102217334|NCT04468685|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102217335|NCT04468685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102217336|NCT04468685|Serotonin Agents|serotonin agents|mesh-ancestor
102217337|NCT04468685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102217338|NCT04468685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217339|NCT03531047|Riboflavin|riboflavin|mesh-list
102217340|NCT03531047|Vitamin B Complex|vitamin b complex|mesh-ancestor
102217341|NCT03531047|Vitamins|vitamins|mesh-ancestor
102217342|NCT03531047|Micronutrients|micronutrients|mesh-ancestor
102217343|NCT03531047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217344|NCT03531047|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102217345|NCT03531047|Dermatologic Agents|dermatologic agents|mesh-ancestor
102217346|NCT04440917|Apatinib|apatinib|mesh-list
102217347|NCT04440917|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102217348|NCT04440917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102217349|NCT04440917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102217350|NCT04440917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102217351|NCT04440917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217352|NCT04440917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102217353|NCT04192019|Glucagon|glucagon|mesh-list
102217354|NCT04192019|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102217355|NCT04192019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102217356|NCT04192019|Hormones|hormones|mesh-ancestor
102217357|NCT04192019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102217358|NCT04192019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217359|NCT04192019|Incretins|incretins|mesh-ancestor
102217360|NCT05455931|Mogamulizumab|mogamulizumab|mesh-list
102217361|NCT05455931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102217362|NCT05062031|Atropine|atropine|mesh-list
102217363|NCT05062031|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102217364|NCT05062031|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102217365|NCT05062031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102217366|NCT05062031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102217367|NCT05062031|Autonomic Agents|autonomic agents|mesh-ancestor
102217368|NCT05062031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102217369|NCT05062031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217370|NCT05062031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102217371|NCT05062031|Respiratory System Agents|respiratory system agents|mesh-ancestor
102217372|NCT05062031|Mydriatics|mydriatics|mesh-ancestor
102217373|NCT05062031|Parasympatholytics|parasympatholytics|mesh-ancestor
102217374|NCT05062031|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102217375|NCT05062031|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102217376|NCT05062031|Cholinergic Agents|cholinergic agents|mesh-ancestor
102217377|NCT05062031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102217378|NCT05062031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217379|NCT05062031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102217380|NCT05446571|Valacyclovir|valacyclovir|mesh-list
102217381|NCT05446571|Letermovir|letermovir|mesh-list
102217382|NCT05446571|Antiviral Agents|antiviral agents|mesh-ancestor
102217383|NCT05446571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102217384|NCT05446571|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102217385|NCT05446571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102217386|NCT05446571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217387|NCT05446571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102217388|NCT05439005|Dexmedetomidine|dexmedetomidine|mesh-list
102217389|NCT05439005|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102217390|NCT05439005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102217391|NCT05439005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217392|NCT05439005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102217393|NCT05439005|Analgesics|analgesics|mesh-ancestor
102217394|NCT05439005|Sensory System Agents|sensory system agents|mesh-ancestor
102217395|NCT05439005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102217396|NCT05439005|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102217397|NCT05439005|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102217398|NCT05439005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102217399|NCT05439005|Adrenergic Agents|adrenergic agents|mesh-ancestor
102217400|NCT05439005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102217401|NCT05439005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217402|NCT04468139|Quercetin|quercetin|mesh-list
102217403|NCT04468139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217404|NCT04468139|Antioxidants|antioxidants|mesh-ancestor
102217405|NCT04468139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217406|NCT04468139|Protective Agents|protective agents|mesh-ancestor
102217407|NCT03526445|Glucagon|glucagon|mesh-list
102217408|NCT03526445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102217409|NCT03526445|Hormones|hormones|mesh-ancestor
102217410|NCT03526445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102217411|NCT03526445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217412|NCT04939649|Midazolam|midazolam|mesh-list
102217413|NCT04939649|Ketamine|ketamine|mesh-list
102217414|NCT04939649|Analgesics|analgesics|mesh-ancestor
102217415|NCT04939649|Sensory System Agents|sensory system agents|mesh-ancestor
102217416|NCT04939649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102217417|NCT04939649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217418|NCT04939649|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102217419|NCT04939649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102217420|NCT04939649|Anesthetics, General|anesthetics, general|mesh-ancestor
102217421|NCT04939649|Anesthetics|anesthetics|mesh-ancestor
102217422|NCT04939649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102217423|NCT04939649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102217424|NCT04939649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102217425|NCT04939649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102217426|NCT04939649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217427|NCT04939649|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102217428|NCT04939649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102217429|NCT04939649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102217430|NCT04939649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102217431|NCT04939649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102217432|NCT04939649|GABA Modulators|gaba modulators|mesh-ancestor
102217433|NCT04939649|GABA Agents|gaba agents|mesh-ancestor
102217434|NCT04927949|Cangrelor|cangrelor|mesh-list
102217435|NCT04927949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102217436|NCT04927949|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102217437|NCT04927949|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102217438|NCT04927949|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102217439|NCT04927949|Purinergic Agents|purinergic agents|mesh-ancestor
102217440|NCT04927949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101926264|NCT01097746|Mitosis Modulators|mitosis modulators|mesh-ancestor
102217441|NCT04927949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217442|NCT04927949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217444|NCT04589819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102217445|NCT04589819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217446|NCT04589819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102217447|NCT03526367|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102217448|NCT03526367|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102217449|NCT03526367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102217450|NCT03526367|Antimetabolites|antimetabolites|mesh-ancestor
102217451|NCT03526367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217452|NCT03526367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102217453|NCT03526367|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102217454|NCT03526367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102217455|NCT04467983|Denosumab|denosumab|mesh-list
102217456|NCT04467983|Abaloparatide|abaloparatide|mesh-list
102217457|NCT04467983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102217458|NCT04467983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217459|NCT04839731|Fluorouracil|fluorouracil|mesh-list
102217460|NCT04839731|Calcipotriene|calcipotriene|mesh-list
102217461|NCT04839731|Antimetabolites|antimetabolites|mesh-ancestor
102217462|NCT04839731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217463|NCT04839731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102217464|NCT04839731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102217465|NCT04839731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102217466|NCT04839731|Immunologic Factors|immunologic factors|mesh-ancestor
102217467|NCT04839731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217468|NCT04839731|Dermatologic Agents|dermatologic agents|mesh-ancestor
102217469|NCT03525509|Morphine|morphine|mesh-list
102217470|NCT03525509|Methadone|methadone|mesh-list
102217471|NCT03525509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102217472|NCT03525509|Narcotics|narcotics|mesh-ancestor
102217473|NCT03525509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102217474|NCT03525509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217475|NCT03525509|Analgesics|analgesics|mesh-ancestor
102217476|NCT03525509|Sensory System Agents|sensory system agents|mesh-ancestor
102217477|NCT03525509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102217478|NCT03525509|Antitussive Agents|antitussive agents|mesh-ancestor
102217479|NCT03525509|Respiratory System Agents|respiratory system agents|mesh-ancestor
102217480|NCT04699721|Paclitaxel|paclitaxel|mesh-list
102217481|NCT04699721|Carboplatin|carboplatin|mesh-list
102217482|NCT04699721|Nivolumab|nivolumab|mesh-list
102217483|NCT04699721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102217484|NCT04699721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102217485|NCT04699721|Tubulin Modulators|tubulin modulators|mesh-ancestor
102217486|NCT04699721|Antimitotic Agents|antimitotic agents|mesh-ancestor
102217487|NCT04699721|Mitosis Modulators|mitosis modulators|mesh-ancestor
102217488|NCT04699721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217489|NCT04699721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102217490|NCT04699721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102217491|NCT05179499|Norepinephrine|norepinephrine|mesh-list
102217492|NCT05179499|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102217493|NCT05179499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102217494|NCT05179499|Adrenergic Agents|adrenergic agents|mesh-ancestor
102217495|NCT05179499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102217496|NCT05179499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217497|NCT05179499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217498|NCT05179499|Sympathomimetics|sympathomimetics|mesh-ancestor
102217499|NCT05179499|Autonomic Agents|autonomic agents|mesh-ancestor
102217500|NCT05179499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102217501|NCT05179499|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102217502|NCT03525821|Ketamine|ketamine|mesh-list
102217503|NCT03525821|Analgesics|analgesics|mesh-ancestor
102217504|NCT03525821|Sensory System Agents|sensory system agents|mesh-ancestor
102217505|NCT03525821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102217506|NCT03525821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217507|NCT03525821|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102217508|NCT03525821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102217509|NCT03525821|Anesthetics, General|anesthetics, general|mesh-ancestor
102217510|NCT03525821|Anesthetics|anesthetics|mesh-ancestor
102217511|NCT03525821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102217512|NCT03525821|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102217513|NCT03525821|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102217514|NCT03525821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102217515|NCT03525821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217516|NCT04221035|Cyclophosphamide|cyclophosphamide|mesh-list
102217517|NCT04221035|Temozolomide|temozolomide|mesh-list
102217518|NCT04221035|Melphalan|melphalan|mesh-list
102217519|NCT04221035|Busulfan|busulfan|mesh-list
102217520|NCT04221035|Ifosfamide|ifosfamide|mesh-list
102217521|NCT04221035|Thiotepa|thiotepa|mesh-list
102217522|NCT04221035|Dacarbazine|dacarbazine|mesh-list
102217523|NCT04221035|Carboplatin|carboplatin|mesh-list
102217524|NCT04221035|Doxorubicin|doxorubicin|mesh-list
102217525|NCT04221035|Irinotecan|irinotecan|mesh-list
102217526|NCT04221035|Etoposide|etoposide|mesh-list
102217527|NCT04221035|Vincristine|vincristine|mesh-list
102217528|NCT04221035|Vindesine|vindesine|mesh-list
102217529|NCT04221035|Dinutuximab|dinutuximab|mesh-list
102217530|NCT04221035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102217531|NCT04221035|Immunologic Factors|immunologic factors|mesh-ancestor
102217532|NCT04221035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217533|NCT04221035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102217534|NCT04221035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102217535|NCT04221035|Alkylating Agents|alkylating agents|mesh-ancestor
102217536|NCT04221035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217537|NCT04221035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102217538|NCT04221035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102217539|NCT04221035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102217540|NCT04221035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102217541|NCT04221035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102217542|NCT04221035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102217543|NCT04221035|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102217544|NCT04221035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102217545|NCT04221035|Tubulin Modulators|tubulin modulators|mesh-ancestor
102217546|NCT04221035|Antimitotic Agents|antimitotic agents|mesh-ancestor
102217547|NCT04221035|Mitosis Modulators|mitosis modulators|mesh-ancestor
102217548|NCT01601704|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
102217549|NCT01601704|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102217550|NCT04842682|Diazepam|diazepam|mesh-list
102217551|NCT04842682|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102217552|NCT04842682|Anticonvulsants|anticonvulsants|mesh-ancestor
102217553|NCT04842682|Antiemetics|antiemetics|mesh-ancestor
102217554|NCT04842682|Autonomic Agents|autonomic agents|mesh-ancestor
102217555|NCT04842682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102217556|NCT04842682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217557|NCT04842682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102217558|NCT04842682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102217559|NCT04842682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102217560|NCT04842682|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102217561|NCT04842682|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102217562|NCT04842682|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102217563|NCT04842682|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102217564|NCT04842682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102217565|NCT04842682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102217566|NCT04842682|Anesthetics, General|anesthetics, general|mesh-ancestor
102217567|NCT04842682|Anesthetics|anesthetics|mesh-ancestor
102217568|NCT04842682|GABA Modulators|gaba modulators|mesh-ancestor
102217569|NCT04842682|GABA Agents|gaba agents|mesh-ancestor
102217570|NCT04842682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102217571|NCT04842682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217572|NCT04969276|Vaccines|vaccines|mesh-list
102217573|NCT04969276|Immunologic Factors|immunologic factors|mesh-ancestor
102217574|NCT04969276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217575|NCT04969198|Nicotine|nicotine|mesh-list
102217576|NCT04969198|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102217577|NCT04969198|Autonomic Agents|autonomic agents|mesh-ancestor
102217578|NCT04969198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102217579|NCT04969198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217580|NCT04969198|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102217581|NCT04969198|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102217582|NCT04969198|Cholinergic Agents|cholinergic agents|mesh-ancestor
102217583|NCT04969198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102217584|NCT04969198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217585|NCT04666636|Mirabegron|mirabegron|mesh-list
102217586|NCT04666636|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102217587|NCT04666636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102217588|NCT04666636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101926415|NCT01383148|Antimitotic Agents|antimitotic agents|mesh-ancestor
102217589|NCT04666636|Adrenergic Agents|adrenergic agents|mesh-ancestor
102217590|NCT04666636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102217591|NCT04666636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217592|NCT04666636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217593|NCT04666636|Urological Agents|urological agents|mesh-ancestor
102217594|NCT04890106|Bimatoprost|bimatoprost|mesh-list
102217595|NCT04890106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102217596|NCT04890106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102217597|NCT04890106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102217598|NCT04640194|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102217599|NCT04640194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102217600|NCT04640194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102217601|NCT04640194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217602|NCT05214664|Anesthetics|anesthetics|mesh-list
102217603|NCT05214664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102217604|NCT05214664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217605|NCT05206084|Sirolimus|sirolimus|mesh-list
102217606|NCT05206084|Everolimus|everolimus|mesh-list
102217607|NCT05206084|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102217608|NCT05206084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102217609|NCT05206084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102217610|NCT05206084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217611|NCT05206084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102217612|NCT05206084|Immunologic Factors|immunologic factors|mesh-ancestor
102217613|NCT05206084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217614|NCT05206084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102217615|NCT05206084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102217616|NCT05206084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102217617|NCT05206084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102217618|NCT05206084|Antifungal Agents|antifungal agents|mesh-ancestor
102217619|NCT05198362|Metoprolol|metoprolol|mesh-list
102217620|NCT05198362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102217621|NCT05198362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102217622|NCT05198362|Sympatholytics|sympatholytics|mesh-ancestor
102217623|NCT05198362|Autonomic Agents|autonomic agents|mesh-ancestor
102217624|NCT05198362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102217625|NCT05198362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217626|NCT05198362|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102217627|NCT05198362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102217628|NCT05198362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102217629|NCT05198362|Adrenergic Agents|adrenergic agents|mesh-ancestor
102217630|NCT05198362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102217631|NCT05198362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217632|NCT05188222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102217633|NCT04810156|Mycophenolic Acid|mycophenolic acid|mesh-list
102217634|NCT04810156|Prednisone|prednisone|mesh-list
102217635|NCT04810156|Methylprednisolone|methylprednisolone|mesh-list
102217636|NCT04810156|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102217637|NCT04810156|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102217638|NCT04810156|Prednisolone|prednisolone|mesh-list
102217639|NCT04810156|Prednisolone acetate|prednisolone acetate|mesh-list
102217640|NCT04810156|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102217641|NCT04810156|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102217642|NCT04810156|Prednisolone phosphate|prednisolone phosphate|mesh-list
102217643|NCT04810156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102217644|NCT04810156|Glucocorticoids|glucocorticoids|mesh-ancestor
102217645|NCT04810156|Hormones|hormones|mesh-ancestor
102217646|NCT04810156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102217647|NCT04810156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217648|NCT04810156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102217649|NCT04810156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102217650|NCT04810156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102217651|NCT04810156|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102217652|NCT04810156|Antitubercular Agents|antitubercular agents|mesh-ancestor
102217653|NCT04810156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102217654|NCT04810156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102217655|NCT04810156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102217656|NCT04810156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217657|NCT04810156|Antiemetics|antiemetics|mesh-ancestor
102217658|NCT04810156|Autonomic Agents|autonomic agents|mesh-ancestor
102217659|NCT04810156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102217660|NCT04810156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102217661|NCT04810156|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102217662|NCT04810156|Protective Agents|protective agents|mesh-ancestor
102217663|NCT04810156|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102217664|NCT04837924|Acetaminophen|acetaminophen|mesh-list
101926491|NCT01193400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102217665|NCT04837924|Tramadol|tramadol|mesh-list
102217666|NCT04837924|Analgesics|analgesics|mesh-list
102217667|NCT04837924|Levobupivacaine|levobupivacaine|mesh-list
102217668|NCT04837924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102217669|NCT04837924|Sensory System Agents|sensory system agents|mesh-ancestor
102217670|NCT04837924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102217671|NCT04837924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217672|NCT04837924|Antipyretics|antipyretics|mesh-ancestor
102217673|NCT04837924|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102217674|NCT04837924|Narcotics|narcotics|mesh-ancestor
102217675|NCT04837924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102217676|NCT04837924|Anesthetics, Local|anesthetics, local|mesh-ancestor
102217677|NCT04837924|Anesthetics|anesthetics|mesh-ancestor
102217678|NCT05406466|Lenvatinib|lenvatinib|mesh-list
102217679|NCT05406466|Tislelizumab|tislelizumab|mesh-list
102217680|NCT05406466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102217681|NCT05406466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102217682|NCT05406466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102217683|NCT05406466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628910|NCT02604784|Cisplatin|cisplatin|mesh-list
102217684|NCT05406466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102217685|NCT05152420|Rivaroxaban|rivaroxaban|mesh-list
102217686|NCT05152420|Apixaban|apixaban|mesh-list
102217687|NCT05152420|Edoxaban|edoxaban|mesh-list
102217688|NCT05152420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102217689|NCT05152420|Antithrombins|antithrombins|mesh-ancestor
102217690|NCT05152420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102217691|NCT05152420|Protease Inhibitors|protease inhibitors|mesh-ancestor
102217692|NCT05152420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102217693|NCT05152420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217694|NCT05152420|Anticoagulants|anticoagulants|mesh-ancestor
102217695|NCT01601470|Sildenafil Citrate|sildenafil citrate|mesh-list
102217696|NCT01601470|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102217697|NCT01601470|Vasodilator Agents|vasodilator agents|mesh-ancestor
102217698|NCT01601470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102217699|NCT01601470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102217700|NCT01601470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102217701|NCT01601470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217702|NCT01601470|Urological Agents|urological agents|mesh-ancestor
102217703|NCT01601470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102217704|NCT04418908|Cetrorelix|cetrorelix|mesh-list
102217705|NCT04418908|Estradiol|estradiol|mesh-list
102217706|NCT04418908|Estrogens|estrogens|mesh-ancestor
102217707|NCT04418908|Hormones|hormones|mesh-ancestor
102217708|NCT04418908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102217709|NCT04418908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217710|NCT04418908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102217711|NCT04418908|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102217712|NCT04418908|Fertility Agents|fertility agents|mesh-ancestor
102217713|NCT04418908|Hormone Antagonists|hormone antagonists|mesh-ancestor
102217714|NCT04546126|Dexamethasone|dexamethasone|mesh-list
102217715|NCT04546126|Cosyntropin|cosyntropin|mesh-list
102217716|NCT04546126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102217717|NCT04546126|Antiemetics|antiemetics|mesh-ancestor
102217718|NCT04546126|Autonomic Agents|autonomic agents|mesh-ancestor
102217719|NCT04546126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102217720|NCT04546126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217721|NCT04546126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102217722|NCT04546126|Glucocorticoids|glucocorticoids|mesh-ancestor
102217723|NCT04546126|Hormones|hormones|mesh-ancestor
102217724|NCT04546126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102217725|NCT04546126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102217726|NCT04546126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102217727|NCT04831450|Cemiplimab|cemiplimab|mesh-list
102217728|NCT04831450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102217729|NCT04831450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102217731|NCT04830982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102217732|NCT04830982|Vasodilator Agents|vasodilator agents|mesh-ancestor
102217733|NCT04466423|Sulfamethazine|sulfamethazine|mesh-list
102217734|NCT04466423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102217735|NCT04508140|Pembrolizumab|pembrolizumab|mesh-list
102217736|NCT04508140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102217737|NCT04508140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102217738|NCT04508140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102217739|NCT04508140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217740|NCT04820452|Aflibercept|aflibercept|mesh-list
102217741|NCT04820452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102217742|NCT04820452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102217743|NCT04820452|Growth Substances|growth substances|mesh-ancestor
102217744|NCT04820452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217745|NCT04820452|Growth Inhibitors|growth inhibitors|mesh-ancestor
102217746|NCT04820452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102217748|NCT01637272|Hormones|hormones|mesh-ancestor
102217749|NCT01637272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102217750|NCT01637272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217751|NCT04458922|Atezolizumab|atezolizumab|mesh-list
102217752|NCT04458922|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102217753|NCT04458922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102217754|NCT04458922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217755|NCT04458922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102217756|NCT04458922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102217757|NCT04458922|Immunologic Factors|immunologic factors|mesh-ancestor
102217758|NCT04458922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217759|NCT03178864|Heparin|heparin|mesh-list
102217760|NCT03178864|Rivaroxaban|rivaroxaban|mesh-list
102217761|NCT03178864|Anticoagulants|anticoagulants|mesh-ancestor
102217762|NCT03178864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102217763|NCT03178864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102217764|NCT03178864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217765|NCT03178864|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102217766|NCT03178864|Antithrombins|antithrombins|mesh-ancestor
102217767|NCT03178864|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102217768|NCT03178864|Protease Inhibitors|protease inhibitors|mesh-ancestor
102217769|NCT03178864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102217770|NCT01636960|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102217771|NCT01636960|Antiviral Agents|antiviral agents|mesh-ancestor
102217772|NCT01636960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102217773|NCT04009876|Oxaliplatin|oxaliplatin|mesh-list
102217774|NCT04009876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102217775|NCT05309902|Moxifloxacin|moxifloxacin|mesh-list
102217776|NCT05309902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102217777|NCT05309902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102217778|NCT05309902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102217779|NCT05309902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102217780|NCT05309902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102217781|NCT05309902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217782|NCT05309902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102217783|NCT02987686|Infliximab|infliximab|mesh-list
102217784|NCT02987686|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102217785|NCT02987686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102217786|NCT02987686|Dermatologic Agents|dermatologic agents|mesh-ancestor
102217787|NCT02987686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102217788|NCT02987686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102217789|NCT02504216|Rivaroxaban|rivaroxaban|mesh-list
102217790|NCT02504216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102217791|NCT02504216|Antithrombins|antithrombins|mesh-ancestor
102217792|NCT02504216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102217793|NCT02504216|Protease Inhibitors|protease inhibitors|mesh-ancestor
102217794|NCT02504216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102217795|NCT02504216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217796|NCT02504216|Anticoagulants|anticoagulants|mesh-ancestor
102217797|NCT05277922|Nitroprusside|nitroprusside|mesh-list
102217798|NCT05277922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102217799|NCT05277922|Vasodilator Agents|vasodilator agents|mesh-ancestor
102217800|NCT05277922|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102217801|NCT05277922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217802|NCT04354870|Hydroxychloroquine|hydroxychloroquine|mesh-list
102217803|NCT04354870|Antimalarials|antimalarials|mesh-ancestor
102217804|NCT04354870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102217805|NCT04354870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102217806|NCT04354870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102217807|NCT04354870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102217808|NCT04354870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217809|NCT04354870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102217811|NCT02917096|Sirolimus|sirolimus|mesh-list
102217812|NCT02917096|Fludarabine|fludarabine|mesh-list
102217813|NCT02917096|Fludarabine phosphate|fludarabine phosphate|mesh-list
102217814|NCT02917096|Melphalan|melphalan|mesh-list
102217815|NCT02917096|Mechlorethamine|mechlorethamine|mesh-list
102217816|NCT02917096|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102217817|NCT02917096|Tacrolimus|tacrolimus|mesh-list
102217818|NCT02917096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102217819|NCT02917096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102217820|NCT02917096|Antimetabolites|antimetabolites|mesh-ancestor
102217821|NCT02917096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217822|NCT02917096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102217823|NCT02917096|Immunologic Factors|immunologic factors|mesh-ancestor
102217824|NCT02917096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217825|NCT02917096|Antiviral Agents|antiviral agents|mesh-ancestor
102217826|NCT02917096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102217827|NCT02917096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102217828|NCT02917096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102217829|NCT02917096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102217830|NCT02917096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102217831|NCT02917096|Antifungal Agents|antifungal agents|mesh-ancestor
102217832|NCT02917096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102217833|NCT02917096|Alkylating Agents|alkylating agents|mesh-ancestor
102217834|NCT02917096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102217835|NCT04194424|Metformin|metformin|mesh-list
102217836|NCT04194424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102217837|NCT04194424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217838|NCT02473640|Ceftriaxone|ceftriaxone|mesh-list
102217839|NCT02473640|Esomeprazole|esomeprazole|mesh-list
102217840|NCT02473640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102217841|NCT02473640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102217842|NCT02473640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102217843|NCT02473640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102217844|NCT02473640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217845|NCT02473640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102217846|NCT02473640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102217847|NCT01637584|Prazosin|prazosin|mesh-list
102217848|NCT01637584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102217849|NCT01637584|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102217850|NCT01637584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102217851|NCT01637584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102217852|NCT01637584|Adrenergic Agents|adrenergic agents|mesh-ancestor
102217853|NCT01637584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102217854|NCT01637584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217855|NCT01637584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217856|NCT03875092|Paclitaxel|paclitaxel|mesh-list
102217857|NCT03875092|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102217858|NCT03875092|Carboplatin|carboplatin|mesh-list
102217859|NCT03875092|Pembrolizumab|pembrolizumab|mesh-list
102217860|NCT03875092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102217861|NCT03875092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102217862|NCT03875092|Tubulin Modulators|tubulin modulators|mesh-ancestor
102217863|NCT03875092|Antimitotic Agents|antimitotic agents|mesh-ancestor
102217864|NCT03875092|Mitosis Modulators|mitosis modulators|mesh-ancestor
102217865|NCT03875092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217866|NCT03875092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102217867|NCT03875092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102217868|NCT02728102|Lenalidomide|lenalidomide|mesh-list
102217869|NCT02728102|Melphalan|melphalan|mesh-list
102217870|NCT02728102|Molgramostim|molgramostim|mesh-list
102217871|NCT02728102|Vaccines|vaccines|mesh-list
102217872|NCT02728102|Sargramostim|sargramostim|mesh-list
102217873|NCT02728102|Immunologic Factors|immunologic factors|mesh-ancestor
102217874|NCT02728102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217875|NCT02728102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102217876|NCT02728102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102217877|NCT02728102|Growth Substances|growth substances|mesh-ancestor
102217878|NCT02728102|Growth Inhibitors|growth inhibitors|mesh-ancestor
102217879|NCT02728102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102217880|NCT02728102|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102217881|NCT02728102|Alkylating Agents|alkylating agents|mesh-ancestor
102217882|NCT02728102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217883|NCT02728102|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102217884|NCT02728102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102217885|NCT02502734|Fluticasone|fluticasone|mesh-list
102217886|NCT02502734|Xhance|xhance|mesh-list
102217887|NCT02502734|Albuterol|albuterol|mesh-list
102217888|NCT02502734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102217889|NCT02502734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102217890|NCT02502734|Autonomic Agents|autonomic agents|mesh-ancestor
102217891|NCT02502734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102217892|NCT02502734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217893|NCT02502734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102217894|NCT02502734|Respiratory System Agents|respiratory system agents|mesh-ancestor
102217895|NCT02502734|Dermatologic Agents|dermatologic agents|mesh-ancestor
102217896|NCT02502734|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102217897|NCT02502734|Tocolytic Agents|tocolytic agents|mesh-ancestor
102217898|NCT02502734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102217899|NCT02502734|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102217900|NCT02502734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102217901|NCT02502734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102217902|NCT02502734|Adrenergic Agents|adrenergic agents|mesh-ancestor
102217903|NCT02502734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102217904|NCT02502734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217905|NCT04193878|Budesonide|budesonide|mesh-list
102217906|NCT04193878|Formoterol Fumarate|formoterol fumarate|mesh-list
102217907|NCT04193878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102217908|NCT04193878|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102217909|NCT04193878|Autonomic Agents|autonomic agents|mesh-ancestor
102217910|NCT04193878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102217911|NCT04193878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217912|NCT04193878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102217913|NCT04193878|Respiratory System Agents|respiratory system agents|mesh-ancestor
102217914|NCT04193878|Glucocorticoids|glucocorticoids|mesh-ancestor
102217915|NCT04193878|Hormones|hormones|mesh-ancestor
102217916|NCT04193878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102217917|NCT04193878|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102217918|NCT04193878|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102217919|NCT04193878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102217920|NCT04193878|Adrenergic Agents|adrenergic agents|mesh-ancestor
102217921|NCT04193878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102217922|NCT04193878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217923|NCT02473250|Fluoxetine|fluoxetine|mesh-list
102217924|NCT02473250|Citalopram|citalopram|mesh-list
102217925|NCT02473250|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102217926|NCT02473250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102217927|NCT02473250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102217928|NCT02473250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217929|NCT02473250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102217930|NCT02473250|Serotonin Agents|serotonin agents|mesh-ancestor
102217931|NCT02473250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217932|NCT02473250|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102217933|NCT02473250|Antidepressive Agents|antidepressive agents|mesh-ancestor
102217934|NCT02473250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102217935|NCT02473250|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102217936|NCT02473250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102217937|NCT02473250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102217938|NCT04253626|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102217939|NCT04253626|Hematinics|hematinics|mesh-ancestor
102217940|NCT04253626|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102217941|NCT04253626|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102217942|NCT03840148|Meropenem|meropenem|mesh-list
102217943|NCT03840148|Cefepime|cefepime|mesh-list
102217944|NCT03840148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102217945|NCT03840148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102217946|NCT04821778|Paclitaxel|paclitaxel|mesh-list
102217947|NCT04821778|Nimotuzumab|nimotuzumab|mesh-list
102217948|NCT04821778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102217949|NCT04821778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102217950|NCT04821778|Tubulin Modulators|tubulin modulators|mesh-ancestor
102217951|NCT04821778|Antimitotic Agents|antimitotic agents|mesh-ancestor
102217952|NCT04821778|Mitosis Modulators|mitosis modulators|mesh-ancestor
102217953|NCT04821778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217954|NCT04821778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102217956|NCT02611024|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102217957|NCT02611024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102217958|NCT02611024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102217959|NCT02611024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217960|NCT02611024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102217961|NCT04222504|Tenofovir|tenofovir|mesh-list
102217962|NCT04222504|Emtricitabine|emtricitabine|mesh-list
102217963|NCT04222504|Antiviral Agents|antiviral agents|mesh-ancestor
102217964|NCT04222504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102217965|NCT04222504|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102217966|NCT04222504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102217967|NCT04222504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102217968|NCT04222504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217969|NCT04222504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102217970|NCT04222504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102217971|NCT02500706|Insulin|insulin|mesh-list
102217972|NCT02500706|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102217973|NCT02500706|Insulin Aspart|insulin aspart|mesh-list
102217974|NCT02500706|Insulin, Long-Acting|insulin, long-acting|mesh-list
102217975|NCT02500706|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102217976|NCT02500706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102217977|NCT02500706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217978|NCT04201496|Empagliflozin|empagliflozin|mesh-list
102217979|NCT04201496|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102217980|NCT04201496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217981|NCT04201496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102217982|NCT04201496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102217983|NCT02456974|Amoxicillin|amoxicillin|mesh-list
102217984|NCT02456974|Vancomycin|vancomycin|mesh-list
102217985|NCT02456974|Ciprofloxacin|ciprofloxacin|mesh-list
102217986|NCT02456974|Meropenem|meropenem|mesh-list
102217987|NCT02456974|Tazobactam|tazobactam|mesh-list
102217988|NCT02456974|Clavulanic Acid|clavulanic acid|mesh-list
102217989|NCT02456974|Amikacin|amikacin|mesh-list
102217990|NCT02456974|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102217991|NCT02456974|Teicoplanin|teicoplanin|mesh-list
102217992|NCT02456974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102217993|NCT02456974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102217994|NCT02456974|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102217995|NCT02456974|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102217996|NCT02456974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102217997|NCT02456974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102217998|NCT02456974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102217999|NCT02456974|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102218000|NCT02456974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102218001|NCT02456974|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102218002|NCT04797286|Sildenafil Citrate|sildenafil citrate|mesh-list
102218003|NCT04797286|Vasodilator Agents|vasodilator agents|mesh-ancestor
102218004|NCT04797286|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102218005|NCT04797286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102218006|NCT04797286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102218007|NCT04797286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218008|NCT04797286|Urological Agents|urological agents|mesh-ancestor
102218009|NCT03682276|Nivolumab|nivolumab|mesh-list
102218010|NCT03682276|Ipilimumab|ipilimumab|mesh-list
102218011|NCT03682276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102218012|NCT03682276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102218013|NCT03682276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102218014|NCT03682276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218015|NCT05653024|Albuterol|albuterol|mesh-list
102218016|NCT05653024|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102218017|NCT05653024|Autonomic Agents|autonomic agents|mesh-ancestor
102218018|NCT05653024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102218019|NCT05653024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218020|NCT05653024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102218021|NCT05653024|Respiratory System Agents|respiratory system agents|mesh-ancestor
102218022|NCT05653024|Tocolytic Agents|tocolytic agents|mesh-ancestor
102218023|NCT05653024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102218024|NCT05653024|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102218025|NCT05653024|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102218027|NCT05653024|Adrenergic Agents|adrenergic agents|mesh-ancestor
102218028|NCT05653024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102218029|NCT05653024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218030|NCT02499770|Carboplatin|carboplatin|mesh-list
102218031|NCT02499770|Etoposide|etoposide|mesh-list
102218032|NCT02499770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101628964|NCT04110028|Vitamins|vitamins|mesh-ancestor
102218033|NCT02499770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102218034|NCT02499770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102218035|NCT02499770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102218036|NCT02499770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102218037|NCT02499770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218038|NCT04418674|Fentanyl|fentanyl|mesh-list
102218039|NCT04418674|Ketamine|ketamine|mesh-list
102218040|NCT04418674|Analgesics|analgesics|mesh-ancestor
102218041|NCT04418674|Sensory System Agents|sensory system agents|mesh-ancestor
102218042|NCT04418674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102218043|NCT04418674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926864|NCT04427904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102218044|NCT04418674|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102218045|NCT04418674|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102218046|NCT04418674|Anesthetics, General|anesthetics, general|mesh-ancestor
102218047|NCT04418674|Anesthetics|anesthetics|mesh-ancestor
102218048|NCT04418674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102218049|NCT04418674|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102218050|NCT04418674|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102218051|NCT04418674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102218052|NCT04418674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218053|NCT04418674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102218054|NCT04418674|Narcotics|narcotics|mesh-ancestor
102218055|NCT04418674|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102218056|NCT02442284|Ritonavir|ritonavir|mesh-list
102218057|NCT02442284|Ribavirin|ribavirin|mesh-list
102218058|NCT02442284|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102218059|NCT02442284|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102218060|NCT02442284|Protease Inhibitors|protease inhibitors|mesh-ancestor
102218061|NCT02442284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102218062|NCT02442284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218063|NCT02442284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102218064|NCT02442284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102218065|NCT02442284|Antiviral Agents|antiviral agents|mesh-ancestor
102218066|NCT02442284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102218067|NCT02442284|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102218068|NCT02442284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102218069|NCT02442284|Antimetabolites|antimetabolites|mesh-ancestor
102218070|NCT03781960|Nivolumab|nivolumab|mesh-list
102218071|NCT03781960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102218072|NCT03781960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102218073|NCT03781960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102218074|NCT03781960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218075|NCT02499146|Letrozole|letrozole|mesh-list
102218076|NCT02499146|Palbociclib|palbociclib|mesh-list
102218077|NCT02499146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102218078|NCT02499146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102218079|NCT02499146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102218080|NCT02499146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102218081|NCT02499146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218082|NCT02499146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102218083|NCT02499146|Hormone Antagonists|hormone antagonists|mesh-ancestor
102218084|NCT02499146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102218085|NCT02499146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218086|NCT02499146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102218087|NCT01634854|Misoprostol|misoprostol|mesh-list
102218088|NCT01634854|Oxytocin|oxytocin|mesh-list
102218089|NCT01634854|Oxytocics|oxytocics|mesh-ancestor
102218090|NCT01634854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102218091|NCT01634854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218092|NCT01634854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102218093|NCT01634854|Abortifacient Agents|abortifacient agents|mesh-ancestor
102218094|NCT01634854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102218095|NCT01634854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102218096|NCT05651464|Vancomycin|vancomycin|mesh-list
102218097|NCT05651464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102218098|NCT05651464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102218099|NCT01897480|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102218100|NCT01897480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102218101|NCT01897480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102218102|NCT01897480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102218103|NCT01897480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218104|NCT02441114|Fluticasone|fluticasone|mesh-list
102218105|NCT02441114|Tiotropium Bromide|tiotropium bromide|mesh-list
102218106|NCT02441114|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102218107|NCT02441114|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102218108|NCT02441114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102218109|NCT02441114|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102218110|NCT02441114|Autonomic Agents|autonomic agents|mesh-ancestor
102218111|NCT02441114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102218112|NCT02441114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218113|NCT02441114|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102218114|NCT02441114|Respiratory System Agents|respiratory system agents|mesh-ancestor
102218115|NCT02441114|Dermatologic Agents|dermatologic agents|mesh-ancestor
101836506|NCT00490542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218116|NCT02441114|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102218117|NCT02441114|Parasympatholytics|parasympatholytics|mesh-ancestor
102218118|NCT02441114|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102218119|NCT02441114|Cholinergic Agents|cholinergic agents|mesh-ancestor
102218120|NCT02441114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102218121|NCT02441114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218122|NCT02441114|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102218123|NCT02441114|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102218124|NCT02441114|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102218125|NCT02441114|Adrenergic Agents|adrenergic agents|mesh-ancestor
102218126|NCT02441114|Glucocorticoids|glucocorticoids|mesh-ancestor
102218127|NCT02441114|Hormones|hormones|mesh-ancestor
102218128|NCT02441114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102218129|NCT02441114|Sympathomimetics|sympathomimetics|mesh-ancestor
102218130|NCT02498444|Treprostinil|treprostinil|mesh-list
102218131|NCT02498444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102218132|NCT05235256|Dexamethasone|dexamethasone|mesh-list
102218133|NCT05235256|Lidocaine|lidocaine|mesh-list
102218134|NCT05235256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102218135|NCT05235256|Antiemetics|antiemetics|mesh-ancestor
102218136|NCT05235256|Autonomic Agents|autonomic agents|mesh-ancestor
102218137|NCT05235256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102218138|NCT05235256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218139|NCT05235256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102218140|NCT05235256|Glucocorticoids|glucocorticoids|mesh-ancestor
102218141|NCT05235256|Hormones|hormones|mesh-ancestor
102218142|NCT05235256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102218143|NCT05235256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102218144|NCT05235256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102218145|NCT05235256|Anesthetics, Local|anesthetics, local|mesh-ancestor
102218146|NCT05235256|Anesthetics|anesthetics|mesh-ancestor
102218147|NCT05235256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102218148|NCT05235256|Sensory System Agents|sensory system agents|mesh-ancestor
102218149|NCT05235256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102218150|NCT05235256|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102218151|NCT05235256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102218152|NCT05235256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102218153|NCT05235256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218154|NCT02497976|Certolizumab Pegol|certolizumab pegol|mesh-list
102218155|NCT02497976|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102218156|NCT02497976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102218157|NCT02497976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102218158|NCT02497976|Immunologic Factors|immunologic factors|mesh-ancestor
102218159|NCT02497976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218160|NCT02497976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102218161|NCT04791514|Treprostinil|treprostinil|mesh-list
102218162|NCT04791514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102218163|NCT04810546|Lactoferrin|lactoferrin|mesh-list
102218164|NCT04810546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102218165|NCT04596826|Dronabinol|dronabinol|mesh-list
102218166|NCT04596826|Hallucinogens|hallucinogens|mesh-ancestor
102218167|NCT04596826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218168|NCT04596826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102218169|NCT04596826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102218171|NCT04596826|Sensory System Agents|sensory system agents|mesh-ancestor
102218172|NCT04596826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102218173|NCT04596826|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102218174|NCT04596826|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102218175|NCT04596826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102218176|NCT04596826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218177|NCT04596826|Hormones|hormones|mesh-ancestor
102218178|NCT04596826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102218179|NCT02440568|Cytarabine|cytarabine|mesh-list
102218180|NCT02440568|Idarubicin|idarubicin|mesh-list
102218181|NCT02440568|Homoharringtonine|homoharringtonine|mesh-list
102218182|NCT02440568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102218183|NCT02440568|Antimetabolites|antimetabolites|mesh-ancestor
102218184|NCT02440568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218185|NCT02440568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102218186|NCT02440568|Antiviral Agents|antiviral agents|mesh-ancestor
102218187|NCT02440568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102218188|NCT02440568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102218189|NCT02440568|Immunologic Factors|immunologic factors|mesh-ancestor
102218190|NCT02440568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218191|NCT02440568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102218192|NCT02440568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102218194|NCT02440568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102218195|NCT02440568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102218196|NCT02440568|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102218197|NCT00679120|Cimetidine|cimetidine|mesh-list
102218198|NCT00679120|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102218199|NCT00679120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102218200|NCT00679120|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102218201|NCT00679120|Histamine Antagonists|histamine antagonists|mesh-ancestor
102218202|NCT00679120|Histamine Agents|histamine agents|mesh-ancestor
102218203|NCT00679120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102218204|NCT00679120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218205|NCT00679120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218206|NCT00679120|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102218207|NCT00679120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102218208|NCT00679120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102218209|NCT04420624|Colchicine|colchicine|mesh-list
102218210|NCT04420624|Gout Suppressants|gout suppressants|mesh-ancestor
102218211|NCT04420624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102218212|NCT04420624|Tubulin Modulators|tubulin modulators|mesh-ancestor
102218213|NCT04420624|Antimitotic Agents|antimitotic agents|mesh-ancestor
102218214|NCT04420624|Mitosis Modulators|mitosis modulators|mesh-ancestor
102218215|NCT04420624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218216|NCT04420624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102218217|NCT04782778|Bupivacaine|bupivacaine|mesh-list
102218218|NCT04782778|Anesthetics, Local|anesthetics, local|mesh-ancestor
102218219|NCT04782778|Anesthetics|anesthetics|mesh-ancestor
102218220|NCT04782778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102218221|NCT04782778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218222|NCT04782778|Sensory System Agents|sensory system agents|mesh-ancestor
102218223|NCT04782778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102218224|NCT00434434|Omalizumab|omalizumab|mesh-list
102218225|NCT00434434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102218226|NCT00434434|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102218227|NCT00434434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102218228|NCT00434434|Respiratory System Agents|respiratory system agents|mesh-ancestor
102218229|NCT00434434|Immunologic Factors|immunologic factors|mesh-ancestor
102218230|NCT00434434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218231|NCT04002401|Cyclophosphamide|cyclophosphamide|mesh-list
102218232|NCT04002401|Rituximab|rituximab|mesh-list
102218233|NCT04002401|Fludarabine|fludarabine|mesh-list
102218234|NCT04002401|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
102218235|NCT04002401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102218236|NCT04002401|Immunologic Factors|immunologic factors|mesh-ancestor
102218237|NCT04002401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218238|NCT04002401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102218239|NCT04002401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102218240|NCT04002401|Alkylating Agents|alkylating agents|mesh-ancestor
102218241|NCT04002401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760061|NCT00907114|Analgesics|analgesics|mesh-ancestor
102218242|NCT04002401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102218243|NCT04002401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102218244|NCT04002401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102218245|NCT03046511|Cefazolin|cefazolin|mesh-list
102218246|NCT03046511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102218247|NCT03046511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102218248|NCT02439320|Lasmiditan|lasmiditan|mesh-list
102218249|NCT02439320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102218250|NCT02439320|Serotonin Agents|serotonin agents|mesh-ancestor
102218251|NCT02439320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102218252|NCT02439320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218253|NCT02439320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218254|NCT02468648|Sofosbuvir|sofosbuvir|mesh-list
102218255|NCT02468648|Velpatasvir|velpatasvir|mesh-list
102218256|NCT02468648|Antiviral Agents|antiviral agents|mesh-ancestor
102218257|NCT02468648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102218258|NCT02466386|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102218259|NCT02466386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102218260|NCT02466386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927085|NCT03722238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101927086|NCT03722238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927087|NCT03722238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101927088|NCT03722238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101927089|NCT03722238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102218261|NCT02466386|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102218262|NCT02466386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102218263|NCT02466386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102218264|NCT02466386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218265|NCT02466386|Dopamine Agents|dopamine agents|mesh-ancestor
102218266|NCT02466386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102218267|NCT01633060|Fulvestrant|fulvestrant|mesh-list
102218268|NCT01633060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102218269|NCT01633060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102218270|NCT01633060|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102218271|NCT01633060|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102218272|NCT01633060|Hormone Antagonists|hormone antagonists|mesh-ancestor
102218273|NCT01633060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102218274|NCT01633060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218275|NCT03906695|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
102218276|NCT03906695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102218277|NCT03906695|Antimetabolites|antimetabolites|mesh-ancestor
102218278|NCT03906695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218279|NCT03906695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102218280|NCT02819141|Dexmedetomidine|dexmedetomidine|mesh-list
102218281|NCT02819141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102218282|NCT02819141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102218283|NCT02819141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218284|NCT02819141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102218285|NCT02819141|Analgesics|analgesics|mesh-ancestor
102218286|NCT02819141|Sensory System Agents|sensory system agents|mesh-ancestor
102218287|NCT02819141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102218288|NCT02819141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102218289|NCT02819141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102218290|NCT02819141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102218291|NCT02819141|Adrenergic Agents|adrenergic agents|mesh-ancestor
102218292|NCT02819141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102218293|NCT02819141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218294|NCT01632904|Hydroxyurea|hydroxyurea|mesh-list
102218295|NCT01632904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102218296|NCT01632904|Antisickling Agents|antisickling agents|mesh-ancestor
102218297|NCT01632904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102218298|NCT01632904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218299|NCT01632904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102218300|NCT04240756|Amphetamine|amphetamine|mesh-list
102218301|NCT04240756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102218302|NCT04240756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218303|NCT04240756|Sympathomimetics|sympathomimetics|mesh-ancestor
102218304|NCT04240756|Autonomic Agents|autonomic agents|mesh-ancestor
102218305|NCT04240756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102218306|NCT04240756|Dopamine Agents|dopamine agents|mesh-ancestor
102218307|NCT04240756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101628979|NCT02589457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102218308|NCT04240756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218309|NCT04240756|Adrenergic Agents|adrenergic agents|mesh-ancestor
102218310|NCT04240756|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102218311|NCT04240756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102218312|NCT04240756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102218313|NCT04240756|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102218314|NCT04467125|Lidocaine|lidocaine|mesh-list
102218315|NCT04467125|Prilocaine|prilocaine|mesh-list
102218316|NCT04467125|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
102218317|NCT04467125|Anesthetics, Local|anesthetics, local|mesh-ancestor
102218318|NCT04467125|Anesthetics|anesthetics|mesh-ancestor
102218319|NCT04467125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102218320|NCT04467125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218321|NCT04467125|Sensory System Agents|sensory system agents|mesh-ancestor
102218322|NCT04467125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102218323|NCT04467125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102218324|NCT04467125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102218325|NCT04467125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102218326|NCT04467125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102218327|NCT04467125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218328|NCT04467125|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
102218329|NCT02692313|Epinephrine|epinephrine|mesh-list
102218330|NCT02692313|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102218331|NCT02692313|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102218332|NCT02692313|Adrenergic Agents|adrenergic agents|mesh-ancestor
102218333|NCT02692313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102218334|NCT02692313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218335|NCT02692313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218336|NCT02692313|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102218337|NCT02692313|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102218338|NCT02692313|Autonomic Agents|autonomic agents|mesh-ancestor
102218339|NCT02692313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102218340|NCT02692313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102218341|NCT02692313|Respiratory System Agents|respiratory system agents|mesh-ancestor
102218342|NCT02692313|Mydriatics|mydriatics|mesh-ancestor
102218343|NCT02692313|Sympathomimetics|sympathomimetics|mesh-ancestor
102218344|NCT02692313|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102218345|NCT02465528|Ceritinib|ceritinib|mesh-list
102218346|NCT02465528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102218347|NCT02465528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102218348|NCT02465528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102218349|NCT02465528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218350|NCT03524261|Antibodies|antibodies|mesh-list
102218351|NCT03524261|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102218352|NCT03524261|Immunologic Factors|immunologic factors|mesh-ancestor
102218353|NCT03524261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218354|NCT03386721|Gemcitabine|gemcitabine|mesh-list
102218355|NCT03386721|Atezolizumab|atezolizumab|mesh-list
102218356|NCT03386721|Vinorelbine|vinorelbine|mesh-list
102218357|NCT03386721|Antibodies|antibodies|mesh-list
102218358|NCT03386721|Immunologic Factors|immunologic factors|mesh-ancestor
102218359|NCT03386721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218360|NCT03386721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102218361|NCT03386721|Antimetabolites|antimetabolites|mesh-ancestor
102218362|NCT03386721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218363|NCT03386721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102218364|NCT03386721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102218365|NCT03386721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102218366|NCT03386721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102218367|NCT03386721|Tubulin Modulators|tubulin modulators|mesh-ancestor
102218368|NCT03386721|Antimitotic Agents|antimitotic agents|mesh-ancestor
102218369|NCT03386721|Mitosis Modulators|mitosis modulators|mesh-ancestor
102218370|NCT02462720|Polidocanol|polidocanol|mesh-list
102218371|NCT02462720|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102218372|NCT02462720|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102218373|NCT02246218|Glycerol|glycerol|mesh-list
102218374|NCT02246218|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102218375|NCT02246218|Protective Agents|protective agents|mesh-ancestor
102218376|NCT02246218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218377|NCT05073939|Oxytocin|oxytocin|mesh-list
102218378|NCT05073939|Oxytocics|oxytocics|mesh-ancestor
102218379|NCT05073939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101760211|NCT00932542|Lidocaine|lidocaine|mesh-list
102218380|NCT05073939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218381|NCT04192630|Hyaluronic Acid|hyaluronic acid|mesh-list
102218382|NCT04192630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102218383|NCT04192630|Immunologic Factors|immunologic factors|mesh-ancestor
102218384|NCT04192630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218385|NCT04192630|Viscosupplements|viscosupplements|mesh-ancestor
102218386|NCT04192630|Protective Agents|protective agents|mesh-ancestor
102218387|NCT00159783|Olanzapine|olanzapine|mesh-list
102218388|NCT00159783|Asenapine|asenapine|mesh-list
102218389|NCT00159783|Antiemetics|antiemetics|mesh-ancestor
102218390|NCT00159783|Autonomic Agents|autonomic agents|mesh-ancestor
102218391|NCT00159783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102218392|NCT00159783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218393|NCT00159783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102218394|NCT00159783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102218395|NCT00159783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102218396|NCT00159783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102218397|NCT00159783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102218398|NCT00159783|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102218399|NCT00159783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102218400|NCT00159783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102218401|NCT00159783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218402|NCT00159783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102218403|NCT00159783|Serotonin Agents|serotonin agents|mesh-ancestor
102218404|NCT01023737|Hydroxychloroquine|hydroxychloroquine|mesh-list
102218405|NCT01023737|Vorinostat|vorinostat|mesh-list
102218406|NCT01023737|Antimalarials|antimalarials|mesh-ancestor
102218407|NCT01023737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102218408|NCT01023737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102218409|NCT01023737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102218410|NCT01023737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102218411|NCT01023737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218412|NCT01023737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102218413|NCT01023737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102218414|NCT01023737|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102218415|NCT00646204|Memantine|memantine|mesh-list
102218416|NCT00646204|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102218417|NCT00646204|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102218418|NCT00646204|Dopamine Agents|dopamine agents|mesh-ancestor
102218419|NCT00646204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102218420|NCT00646204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218421|NCT00646204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218422|NCT00646204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102218423|NCT00646204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102218424|NCT04105270|Carboplatin|carboplatin|mesh-list
102218425|NCT04105270|Pemetrexed|pemetrexed|mesh-list
102218426|NCT04105270|Durvalumab|durvalumab|mesh-list
102218427|NCT04105270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102218428|NCT04105270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102218429|NCT04105270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218430|NCT04105270|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102218431|NCT04105270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102218432|NCT04105270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102218433|NCT02243176|Saxagliptin|saxagliptin|mesh-list
102218434|NCT02243176|Acarbose|acarbose|mesh-list
102218435|NCT02243176|Incretins|incretins|mesh-ancestor
102218436|NCT02243176|Hormones|hormones|mesh-ancestor
102218437|NCT02243176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102218438|NCT02243176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218439|NCT02243176|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102218440|NCT02243176|Protease Inhibitors|protease inhibitors|mesh-ancestor
102218441|NCT02243176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102218442|NCT02243176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218443|NCT02243176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102218444|NCT02243176|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102218445|NCT00692939|Cyclophosphamide|cyclophosphamide|mesh-list
102218446|NCT00692939|Melphalan|melphalan|mesh-list
102218447|NCT00692939|Thiotepa|thiotepa|mesh-list
102218448|NCT00692939|Rituximab|rituximab|mesh-list
102218449|NCT00692939|Alemtuzumab|alemtuzumab|mesh-list
102218450|NCT00692939|Thymoglobulin|thymoglobulin|mesh-list
102218451|NCT00692939|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102218452|NCT00692939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102218453|NCT00692939|Immunologic Factors|immunologic factors|mesh-ancestor
102218454|NCT00692939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218455|NCT00692939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102218456|NCT00692939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102218457|NCT00692939|Alkylating Agents|alkylating agents|mesh-ancestor
102218458|NCT00692939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218459|NCT00692939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102218460|NCT00692939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102218461|NCT00692939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102218462|NCT04551261|Ritonavir|ritonavir|mesh-list
102218463|NCT04551261|Tenofovir|tenofovir|mesh-list
102218464|NCT04551261|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102218465|NCT04551261|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102218466|NCT04551261|Protease Inhibitors|protease inhibitors|mesh-ancestor
102218467|NCT04551261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102218468|NCT04551261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218469|NCT04551261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102218470|NCT04551261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102218471|NCT04551261|Antiviral Agents|antiviral agents|mesh-ancestor
102218472|NCT04551261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102218473|NCT04551261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102218474|NCT04551261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102218475|NCT04551261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102218476|NCT04551261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102218477|NCT04534257|Sirolimus|sirolimus|mesh-list
102218478|NCT04534257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102218479|NCT04534257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102218480|NCT04534257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102218481|NCT04534257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102218482|NCT04534257|Antifungal Agents|antifungal agents|mesh-ancestor
102218483|NCT04534257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102218484|NCT04534257|Immunologic Factors|immunologic factors|mesh-ancestor
102218485|NCT04534257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218486|NCT03522935|Elafin|elafin|mesh-list
102218487|NCT03522935|Protease Inhibitors|protease inhibitors|mesh-ancestor
102218488|NCT03522935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102218489|NCT03522935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218490|NCT03138681|Phosphocreatine|phosphocreatine|mesh-list
102218491|NCT03138681|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102218492|NCT03138681|Protective Agents|protective agents|mesh-ancestor
102218493|NCT03138681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218494|NCT05392257|Rituximab|rituximab|mesh-list
102218495|NCT05392257|Lenalidomide|lenalidomide|mesh-list
102218496|NCT05392257|Zanubrutinib|zanubrutinib|mesh-list
102218497|NCT05392257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102218498|NCT05392257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102218499|NCT05392257|Immunologic Factors|immunologic factors|mesh-ancestor
102218500|NCT05392257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218501|NCT05392257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102218502|NCT05392257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102218503|NCT05392257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102218504|NCT05392257|Growth Substances|growth substances|mesh-ancestor
102218505|NCT05392257|Growth Inhibitors|growth inhibitors|mesh-ancestor
102218506|NCT05392257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102218507|NCT05392257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102218508|NCT05392257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218509|NCT02240680|Linagliptin|linagliptin|mesh-list
102218510|NCT02240680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102218511|NCT02240680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218512|NCT02240680|Incretins|incretins|mesh-ancestor
102218513|NCT02240680|Hormones|hormones|mesh-ancestor
102218514|NCT02240680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102218515|NCT02240680|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102218516|NCT02240680|Protease Inhibitors|protease inhibitors|mesh-ancestor
102218517|NCT02240680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102218518|NCT02240680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218519|NCT05391867|Sorafenib|sorafenib|mesh-list
102218520|NCT05391867|Lenvatinib|lenvatinib|mesh-list
102218521|NCT05391867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102218522|NCT05391867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102218523|NCT05391867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102218524|NCT05391867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218525|NCT03110679|Hyaluronic Acid|hyaluronic acid|mesh-list
102218526|NCT03110679|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102218527|NCT03110679|Immunologic Factors|immunologic factors|mesh-ancestor
102218528|NCT03110679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218529|NCT03110679|Viscosupplements|viscosupplements|mesh-ancestor
102218530|NCT03110679|Protective Agents|protective agents|mesh-ancestor
102218531|NCT05391789|Urinastatin|urinastatin|mesh-list
102218532|NCT05391789|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102218533|NCT05391789|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102218534|NCT05391789|Protease Inhibitors|protease inhibitors|mesh-ancestor
102218535|NCT05391789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102218536|NCT05391789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218537|NCT04699071|Pembrolizumab|pembrolizumab|mesh-list
102218539|NCT04699071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102218540|NCT04699071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102218541|NCT04699071|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102218542|NCT04699071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218543|NCT04699071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102218544|NCT04699071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102218545|NCT03139851|Cyclophosphamide|cyclophosphamide|mesh-list
102218546|NCT03139851|Pembrolizumab|pembrolizumab|mesh-list
102218547|NCT03139851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102218548|NCT03139851|Immunologic Factors|immunologic factors|mesh-ancestor
102218549|NCT03139851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218550|NCT03139851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102218551|NCT03139851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102218552|NCT03139851|Alkylating Agents|alkylating agents|mesh-ancestor
102218553|NCT03139851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218554|NCT03139851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102218555|NCT03139851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102218556|NCT03139851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102218557|NCT03139851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101927385|NCT01205022|Calcium|calcium|mesh-list
102218558|NCT03967288|Bupivacaine|bupivacaine|mesh-list
102218559|NCT03967288|Chloroprocaine|chloroprocaine|mesh-list
102218560|NCT03967288|Procaine|procaine|mesh-list
102218561|NCT03967288|Anesthetics, Local|anesthetics, local|mesh-ancestor
102218562|NCT03967288|Anesthetics|anesthetics|mesh-ancestor
102218563|NCT03967288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102218564|NCT03967288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218565|NCT03967288|Sensory System Agents|sensory system agents|mesh-ancestor
102218566|NCT03967288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102218567|NCT03962062|Moxidectin|moxidectin|mesh-list
102218568|NCT03962062|Anthelmintics|anthelmintics|mesh-ancestor
102218569|NCT03962062|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102218570|NCT03962062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102218571|NCT03962062|Antinematodal Agents|antinematodal agents|mesh-ancestor
102218572|NCT03140085|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102218573|NCT03140085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102218574|NCT02239510|Linaclotide|linaclotide|mesh-list
102218575|NCT02239510|Sennosides|sennosides|mesh-list
102218576|NCT02239510|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102218577|NCT02239510|Enzyme Activators|enzyme activators|mesh-ancestor
102218578|NCT02239510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218579|NCT02239510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102218580|NCT02239510|Laxatives|laxatives|mesh-ancestor
102218581|NCT04507581|Anesthetics|anesthetics|mesh-list
102218582|NCT04507581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102218583|NCT04507581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218584|NCT02291471|T0001|t0001|mesh-list
102218585|NCT02291471|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
102218586|NCT02291471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102218587|NCT02291471|Immunologic Factors|immunologic factors|mesh-ancestor
102218588|NCT02291471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218589|NCT03899961|Oxytocin|oxytocin|mesh-list
102218590|NCT03899961|Carbetocin|carbetocin|mesh-list
102218591|NCT03899961|Oxytocics|oxytocics|mesh-ancestor
102218592|NCT03899961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102218593|NCT03899961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218594|NCT02462486|Ranibizumab|ranibizumab|mesh-list
102218595|NCT02462486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102218596|NCT02462486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102218597|NCT02462486|Growth Substances|growth substances|mesh-ancestor
101573994|NCT02199184|Glucocorticoids|glucocorticoids|mesh-ancestor
102218598|NCT02462486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218599|NCT02462486|Growth Inhibitors|growth inhibitors|mesh-ancestor
102218600|NCT02462486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102218601|NCT03521219|Apatinib|apatinib|mesh-list
102218602|NCT03521219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102218603|NCT03521219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102218604|NCT03521219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102218605|NCT03521219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218606|NCT05318157|Emedastine|emedastine|mesh-list
102218607|NCT05318157|Budesonide|budesonide|mesh-list
102218608|NCT05318157|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102218609|NCT05318157|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102218610|NCT05318157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102218611|NCT05318157|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102218612|NCT05318157|Autonomic Agents|autonomic agents|mesh-ancestor
102218613|NCT05318157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102218614|NCT05318157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218615|NCT05318157|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102218616|NCT05318157|Respiratory System Agents|respiratory system agents|mesh-ancestor
102218617|NCT05318157|Glucocorticoids|glucocorticoids|mesh-ancestor
102218618|NCT05318157|Hormones|hormones|mesh-ancestor
102218619|NCT05318157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102218620|NCT05318157|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102218621|NCT05318157|Histamine Antagonists|histamine antagonists|mesh-ancestor
102218622|NCT05318157|Histamine Agents|histamine agents|mesh-ancestor
102218623|NCT05318157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102218624|NCT05318157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218625|NCT05318157|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102218626|NCT02294279|Beclomethasone|beclomethasone|mesh-list
102218627|NCT02294279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102218628|NCT02294279|Glucocorticoids|glucocorticoids|mesh-ancestor
102218629|NCT02294279|Hormones|hormones|mesh-ancestor
102218630|NCT02294279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102218631|NCT02294279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218632|NCT02294279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102218633|NCT02294279|Respiratory System Agents|respiratory system agents|mesh-ancestor
102218634|NCT02294357|Dexamethasone|dexamethasone|mesh-list
102218635|NCT02294357|Dexamethasone acetate|dexamethasone acetate|mesh-list
102218636|NCT02294357|Prednisone|prednisone|mesh-list
102218637|NCT02294357|Methylprednisolone|methylprednisolone|mesh-list
102218638|NCT02294357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102218639|NCT02294357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102218640|NCT02294357|Prednisolone|prednisolone|mesh-list
102218641|NCT02294357|Prednisolone acetate|prednisolone acetate|mesh-list
102218642|NCT02294357|Lenalidomide|lenalidomide|mesh-list
102218643|NCT02294357|Pomalidomide|pomalidomide|mesh-list
102218644|NCT02294357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102218645|NCT02294357|Prednisolone phosphate|prednisolone phosphate|mesh-list
102218646|NCT02294357|BB 1101|bb 1101|mesh-list
102218647|NCT02294357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102218648|NCT02294357|Antiemetics|antiemetics|mesh-ancestor
102218649|NCT02294357|Autonomic Agents|autonomic agents|mesh-ancestor
102218650|NCT02294357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102218651|NCT02294357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218652|NCT02294357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102218653|NCT02294357|Glucocorticoids|glucocorticoids|mesh-ancestor
102218654|NCT02294357|Hormones|hormones|mesh-ancestor
102218655|NCT02294357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102218656|NCT02294357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102218657|NCT02294357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102218658|NCT02294357|Protease Inhibitors|protease inhibitors|mesh-ancestor
102218659|NCT02294357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102218660|NCT02294357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628998|NCT01016600|Azacitidine|azacitidine|mesh-list
102218661|NCT02294357|Immunologic Factors|immunologic factors|mesh-ancestor
102218662|NCT02294357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102218663|NCT02294357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102218664|NCT02294357|Growth Substances|growth substances|mesh-ancestor
102218665|NCT02294357|Growth Inhibitors|growth inhibitors|mesh-ancestor
102218666|NCT02294357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102218667|NCT02294357|Protective Agents|protective agents|mesh-ancestor
102218668|NCT03880539|Vancomycin|vancomycin|mesh-list
102218669|NCT03880539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102218670|NCT03880539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102218671|NCT03518021|Naloxone|naloxone|mesh-list
102218672|NCT03518021|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102218673|NCT03518021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218674|NCT03518021|Sensory System Agents|sensory system agents|mesh-ancestor
102218675|NCT03518021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102218676|NCT02495948|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102218677|NCT02495948|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102218678|NCT02495948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102218679|NCT02495948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102218681|NCT02294591|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102218682|NCT02294591|Antiviral Agents|antiviral agents|mesh-ancestor
102218683|NCT02294591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102218684|NCT02294591|Expectorants|expectorants|mesh-ancestor
102218685|NCT02294591|Respiratory System Agents|respiratory system agents|mesh-ancestor
102218686|NCT02294591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102218687|NCT02294591|Antioxidants|antioxidants|mesh-ancestor
102218688|NCT02294591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218689|NCT02294591|Protective Agents|protective agents|mesh-ancestor
102218690|NCT02294591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218691|NCT02294591|Antidotes|antidotes|mesh-ancestor
102218692|NCT03521063|Budesonide|budesonide|mesh-list
102218693|NCT03521063|Poractant alfa|poractant alfa|mesh-list
102218694|NCT03521063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102218695|NCT03521063|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102218696|NCT03521063|Autonomic Agents|autonomic agents|mesh-ancestor
102218697|NCT03521063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102218698|NCT03521063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218699|NCT03521063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102218700|NCT03521063|Respiratory System Agents|respiratory system agents|mesh-ancestor
102218701|NCT03521063|Glucocorticoids|glucocorticoids|mesh-ancestor
102218702|NCT03521063|Hormones|hormones|mesh-ancestor
102218703|NCT03521063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102218704|NCT03521063|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
102218705|NCT03520985|Dexamethasone|dexamethasone|mesh-list
102218706|NCT03520985|Pomalidomide|pomalidomide|mesh-list
102218707|NCT03520985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102218708|NCT03520985|Antiemetics|antiemetics|mesh-ancestor
102218709|NCT03520985|Autonomic Agents|autonomic agents|mesh-ancestor
102218710|NCT03520985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102218711|NCT03520985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218712|NCT03520985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102218713|NCT03520985|Glucocorticoids|glucocorticoids|mesh-ancestor
102218715|NCT03520985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102218716|NCT03520985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102218717|NCT03520985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102218718|NCT03520985|Immunologic Factors|immunologic factors|mesh-ancestor
102218719|NCT03520985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102218720|NCT03520985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102218721|NCT03520985|Growth Substances|growth substances|mesh-ancestor
102218722|NCT03520985|Growth Inhibitors|growth inhibitors|mesh-ancestor
102218723|NCT03517943|Loratadine|loratadine|mesh-list
102218724|NCT03517943|Pseudoephedrine|pseudoephedrine|mesh-list
102218725|NCT03517943|Ephedrine|ephedrine|mesh-list
102218726|NCT03517943|Antipruritics|antipruritics|mesh-ancestor
102218727|NCT03517943|Dermatologic Agents|dermatologic agents|mesh-ancestor
102218728|NCT03517943|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102218729|NCT03517943|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102218730|NCT03517943|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102218731|NCT03517943|Histamine Antagonists|histamine antagonists|mesh-ancestor
102218732|NCT03517943|Histamine Agents|histamine agents|mesh-ancestor
102218733|NCT03517943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102218734|NCT03517943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218735|NCT03517943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218736|NCT03517943|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102218737|NCT03517943|Autonomic Agents|autonomic agents|mesh-ancestor
102218738|NCT03517943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102218739|NCT03517943|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102218740|NCT03517943|Respiratory System Agents|respiratory system agents|mesh-ancestor
102218741|NCT03517943|Nasal Decongestants|nasal decongestants|mesh-ancestor
102218742|NCT03517943|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102218743|NCT03517943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102218744|NCT03517943|Sympathomimetics|sympathomimetics|mesh-ancestor
102218745|NCT03517943|Adrenergic Agents|adrenergic agents|mesh-ancestor
102218746|NCT03823521|Cardioplegic Solutions|cardioplegic solutions|mesh-list
102218747|NCT03823521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102218748|NCT03136341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102218749|NCT03136341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102218750|NCT03136341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102218751|NCT03136341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102218752|NCT03136341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218753|NCT03136341|Cholinergic Agents|cholinergic agents|mesh-ancestor
102218754|NCT03136341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102218755|NCT03136341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218756|NCT03136341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102218757|NCT03136341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102218759|NCT04465175|Analgesics|analgesics|mesh-ancestor
102218760|NCT04465175|Sensory System Agents|sensory system agents|mesh-ancestor
102218761|NCT04465175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102218762|NCT04465175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218763|NCT04465175|Anesthetics|anesthetics|mesh-ancestor
102218764|NCT04465175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102218765|NCT04465175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102218766|NCT04465175|Anticonvulsants|anticonvulsants|mesh-ancestor
102218767|NCT04465175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102218768|NCT04465175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102218769|NCT04465175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218770|NCT04465175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102218771|NCT04465175|Tocolytic Agents|tocolytic agents|mesh-ancestor
102218772|NCT04465175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102218773|NCT03158883|Avelumab|avelumab|mesh-list
102218774|NCT03158883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102218775|NCT03158883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102218776|NCT03138447|Insulin|insulin|mesh-list
102218777|NCT03138447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102218778|NCT03138447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218779|NCT03109977|Pertuzumab|pertuzumab|mesh-list
102218780|NCT03109977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102218781|NCT03109977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102218782|NCT03520595|Diclofenac|diclofenac|mesh-list
102218783|NCT03520595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102218784|NCT03520595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102218785|NCT03520595|Analgesics|analgesics|mesh-ancestor
102218786|NCT03520595|Sensory System Agents|sensory system agents|mesh-ancestor
102218787|NCT03520595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102218788|NCT03520595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218789|NCT03520595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102218790|NCT03520595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102218791|NCT03520595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102218792|NCT03520595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102218793|NCT03520595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218794|NCT03520439|Mifepristone|mifepristone|mesh-list
102218795|NCT03520439|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102218796|NCT03520439|Abortifacient Agents|abortifacient agents|mesh-ancestor
102218797|NCT03520439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102218798|NCT03520439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218799|NCT03520439|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102218800|NCT03520439|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102218801|NCT03520439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102218802|NCT03520439|Contraceptive Agents|contraceptive agents|mesh-ancestor
101629010|NCT05175235|Pembrolizumab|pembrolizumab|mesh-list
102218803|NCT03520439|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102218804|NCT03520439|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102218805|NCT03520439|Hormone Antagonists|hormone antagonists|mesh-ancestor
102218806|NCT03520439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102218807|NCT03520439|Luteolytic Agents|luteolytic agents|mesh-ancestor
102218808|NCT03520439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102218809|NCT03520439|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102218810|NCT04543227|Analgesics, Opioid|analgesics, opioid|mesh-list
102218811|NCT04543227|Narcotics|narcotics|mesh-ancestor
102218812|NCT04543227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102218813|NCT04543227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218814|NCT04543227|Analgesics|analgesics|mesh-ancestor
102218815|NCT04543227|Sensory System Agents|sensory system agents|mesh-ancestor
102218816|NCT04543227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102218817|NCT04542993|Zinc|zinc|mesh-list
102218818|NCT04542993|Resveratrol|resveratrol|mesh-list
102218819|NCT04542993|Picolinic acid|picolinic acid|mesh-list
102218820|NCT04542993|Trace Elements|trace elements|mesh-ancestor
102218821|NCT04542993|Micronutrients|micronutrients|mesh-ancestor
102218822|NCT04542993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218823|NCT04542993|Antioxidants|antioxidants|mesh-ancestor
102218824|NCT04542993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218825|NCT04542993|Protective Agents|protective agents|mesh-ancestor
102218826|NCT04542993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102218827|NCT04542993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102218828|NCT04542993|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102218829|NCT04542993|Chelating Agents|chelating agents|mesh-ancestor
102218830|NCT04542993|Sequestering Agents|sequestering agents|mesh-ancestor
102218831|NCT03520361|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102218832|NCT02292173|Sorafenib|sorafenib|mesh-list
102218833|NCT02292173|Trametinib|trametinib|mesh-list
102218834|NCT02292173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102218835|NCT02292173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102218836|NCT02292173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102218837|NCT02292173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218838|NCT03517319|Botulinum Toxins|botulinum toxins|mesh-list
102218839|NCT03517319|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102218840|NCT03517319|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102218841|NCT03517319|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102218842|NCT03517319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102218843|NCT03517319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218844|NCT03517319|Cholinergic Agents|cholinergic agents|mesh-ancestor
102218845|NCT03517319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102218846|NCT03517319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218847|NCT03517319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102218848|NCT03517319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102218849|NCT03520049|Oseltamivir|oseltamivir|mesh-list
102218850|NCT03520049|Antiviral Agents|antiviral agents|mesh-ancestor
102218851|NCT03520049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102218852|NCT03520049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102218853|NCT03520049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218854|NCT03517631|Busulfan|busulfan|mesh-list
102218855|NCT03517631|Alkylating Agents|alkylating agents|mesh-ancestor
102218856|NCT03517631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218857|NCT03517631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102218858|NCT03517631|Immunologic Factors|immunologic factors|mesh-ancestor
102218859|NCT03517631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218860|NCT03517631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102218861|NCT03517631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102218862|NCT03517631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102218863|NCT03516773|Parathyroid Hormone|parathyroid hormone|mesh-list
102218864|NCT03516773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102218865|NCT03516773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218866|NCT02461160|Midazolam|midazolam|mesh-list
102218867|NCT02461160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102218868|NCT02461160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102218869|NCT02461160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102218870|NCT02461160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218871|NCT02461160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102218872|NCT02461160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102218873|NCT02461160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102218874|NCT02461160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102218875|NCT02461160|Anesthetics, General|anesthetics, general|mesh-ancestor
102218876|NCT02461160|Anesthetics|anesthetics|mesh-ancestor
102218877|NCT02461160|GABA Modulators|gaba modulators|mesh-ancestor
102218878|NCT02461160|GABA Agents|gaba agents|mesh-ancestor
102218879|NCT02461160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102218880|NCT02461160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218881|NCT02296073|Fentanyl|fentanyl|mesh-list
102218882|NCT02296073|Midazolam|midazolam|mesh-list
102218883|NCT02296073|Dexmedetomidine|dexmedetomidine|mesh-list
102218884|NCT02296073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102218885|NCT02296073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102218886|NCT02296073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218887|NCT02296073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102218888|NCT02296073|Analgesics|analgesics|mesh-ancestor
102218889|NCT02296073|Sensory System Agents|sensory system agents|mesh-ancestor
102218890|NCT02296073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102218891|NCT02296073|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102218892|NCT02296073|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102218893|NCT02296073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102218894|NCT02296073|Adrenergic Agents|adrenergic agents|mesh-ancestor
102218895|NCT02296073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102218896|NCT02296073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218897|NCT02296073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102218898|NCT02296073|Narcotics|narcotics|mesh-ancestor
102218899|NCT02296073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102218900|NCT02296073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102218901|NCT02296073|Anesthetics, General|anesthetics, general|mesh-ancestor
102218902|NCT02296073|Anesthetics|anesthetics|mesh-ancestor
102218903|NCT02296073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102218904|NCT02296073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102218905|NCT02296073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102218906|NCT02296073|GABA Modulators|gaba modulators|mesh-ancestor
102218907|NCT02296073|GABA Agents|gaba agents|mesh-ancestor
102218908|NCT03132779|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102218909|NCT03132779|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102218910|NCT03132779|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102218911|NCT03132779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102218912|NCT02293187|Vitamin D|vitamin d|mesh-list
102218913|NCT02293187|Cholecalciferol|cholecalciferol|mesh-list
102218914|NCT02293187|Vitamins|vitamins|mesh-ancestor
102218915|NCT02293187|Micronutrients|micronutrients|mesh-ancestor
102218916|NCT02293187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218917|NCT02293187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102218918|NCT02293187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102218919|NCT02296463|Vaccines|vaccines|mesh-list
102218920|NCT02296463|Immunologic Factors|immunologic factors|mesh-ancestor
102218921|NCT02296463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218922|NCT02495168|Budesonide|budesonide|mesh-list
102218923|NCT02495168|Formoterol Fumarate|formoterol fumarate|mesh-list
102218924|NCT02495168|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
102218925|NCT02495168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102218926|NCT02495168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102218927|NCT02495168|Autonomic Agents|autonomic agents|mesh-ancestor
102218928|NCT02495168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102218929|NCT02495168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218930|NCT02495168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102218931|NCT02495168|Respiratory System Agents|respiratory system agents|mesh-ancestor
102218932|NCT02495168|Glucocorticoids|glucocorticoids|mesh-ancestor
102218933|NCT02495168|Hormones|hormones|mesh-ancestor
102218934|NCT02495168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102218935|NCT02495168|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102218936|NCT02495168|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102218937|NCT02495168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102218938|NCT02495168|Adrenergic Agents|adrenergic agents|mesh-ancestor
102218939|NCT02495168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102218940|NCT02495168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218941|NCT04934072|Denosumab|denosumab|mesh-list
102218942|NCT04934072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102218943|NCT04934072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218944|NCT03518489|Lappaconitine|lappaconitine|mesh-list
102218945|NCT03518489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102218946|NCT03518489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102218947|NCT03518489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102218948|NCT03518489|Analgesics|analgesics|mesh-ancestor
102218949|NCT03518489|Sensory System Agents|sensory system agents|mesh-ancestor
102218950|NCT03518489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102218951|NCT03518489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218952|NCT04933526|Dasatinib|dasatinib|mesh-list
102218953|NCT04933526|Flumatinib|flumatinib|mesh-list
102218954|NCT04933526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102218955|NCT04933526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102218956|NCT04933526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102218957|NCT04933526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218958|NCT02293889|Vitamin D|vitamin d|mesh-list
102218959|NCT02293889|Ergocalciferols|ergocalciferols|mesh-list
102218960|NCT02293889|Cholecalciferol|cholecalciferol|mesh-list
102218961|NCT02293889|Vitamins|vitamins|mesh-list
102218962|NCT02293889|Micronutrients|micronutrients|mesh-ancestor
102218963|NCT02293889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218964|NCT02293889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102218965|NCT02293889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102218967|NCT02298335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102218968|NCT02298335|Glucocorticoids|glucocorticoids|mesh-ancestor
102218969|NCT02298335|Hormones|hormones|mesh-ancestor
102218970|NCT02298335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102218971|NCT02298335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218972|NCT02298335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102218973|NCT02298335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102218974|NCT03514667|Curcumin|curcumin|mesh-list
102218975|NCT03514667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102218976|NCT03514667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102218977|NCT03514667|Analgesics|analgesics|mesh-ancestor
102218978|NCT03514667|Sensory System Agents|sensory system agents|mesh-ancestor
102218979|NCT03514667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102218980|NCT03514667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218981|NCT03514667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102218982|NCT03514667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102218983|NCT03514667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102218984|NCT03514667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102218985|NCT03514667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218986|NCT04465097|Exemestane|exemestane|mesh-list
102218987|NCT04465097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102218988|NCT04465097|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102218989|NCT04465097|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102218990|NCT04465097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102218991|NCT04465097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102218992|NCT04465097|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102218993|NCT04465097|Hormone Antagonists|hormone antagonists|mesh-ancestor
102218994|NCT04465097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102218995|NCT04465097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102218996|NCT02493764|Tazobactam|tazobactam|mesh-list
102218997|NCT02493764|Linezolid|linezolid|mesh-list
102218998|NCT02493764|Piperacillin|piperacillin|mesh-list
102218999|NCT02493764|Imipenem|imipenem|mesh-list
102219000|NCT02493764|Relebactam|relebactam|mesh-list
102219001|NCT02493764|Cilastatin|cilastatin|mesh-list
102219002|NCT02493764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102219003|NCT02493764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102219004|NCT02493764|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102219005|NCT02493764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102219006|NCT02493764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219007|NCT02493764|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102219008|NCT02493764|Protease Inhibitors|protease inhibitors|mesh-ancestor
102219009|NCT02297477|Artesunate|artesunate|mesh-list
102219010|NCT02297477|Atovaquone|atovaquone|mesh-list
102219011|NCT02297477|Proguanil|proguanil|mesh-list
102219012|NCT02297477|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
102219013|NCT02297477|Antimalarials|antimalarials|mesh-ancestor
102219014|NCT02297477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102219015|NCT02297477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102219016|NCT02297477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102219017|NCT02297477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102219018|NCT02297477|Antiviral Agents|antiviral agents|mesh-ancestor
102219019|NCT02297477|Schistosomicides|schistosomicides|mesh-ancestor
102219020|NCT02297477|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102219021|NCT02297477|Anthelmintics|anthelmintics|mesh-ancestor
102219022|NCT02297477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102219023|NCT02297477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219024|NCT02297477|Antimetabolites|antimetabolites|mesh-ancestor
102219025|NCT02460380|Vitamin D|vitamin d|mesh-list
102219026|NCT02460380|Cholecalciferol|cholecalciferol|mesh-list
102219027|NCT02460380|Vitamins|vitamins|mesh-ancestor
102219028|NCT02460380|Micronutrients|micronutrients|mesh-ancestor
102219029|NCT02460380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219030|NCT02460380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102219031|NCT02460380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102219032|NCT02299115|Prednisolone|prednisolone|mesh-list
102219033|NCT02299115|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102219034|NCT02299115|Methylprednisolone|methylprednisolone|mesh-list
102219035|NCT02299115|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102219036|NCT02299115|Prednisolone acetate|prednisolone acetate|mesh-list
102219037|NCT02299115|Vigabatrin|vigabatrin|mesh-list
102219038|NCT02299115|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102219039|NCT02299115|Prednisolone phosphate|prednisolone phosphate|mesh-list
102219040|NCT02299115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102219041|NCT02299115|Glucocorticoids|glucocorticoids|mesh-ancestor
102219042|NCT02299115|Hormones|hormones|mesh-ancestor
102219043|NCT02299115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102219044|NCT02299115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219045|NCT02299115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102219046|NCT02299115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102219047|NCT02299115|Antiemetics|antiemetics|mesh-ancestor
102219048|NCT02299115|Autonomic Agents|autonomic agents|mesh-ancestor
102219049|NCT02299115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102219050|NCT02299115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102219051|NCT02299115|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102219052|NCT02299115|Protective Agents|protective agents|mesh-ancestor
102219053|NCT02299115|Anticonvulsants|anticonvulsants|mesh-ancestor
102219054|NCT02299115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102219055|NCT02299115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219056|NCT02299115|GABA Agents|gaba agents|mesh-ancestor
102219057|NCT02299115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102219058|NCT03515213|Fenofibrate|fenofibrate|mesh-list
102219059|NCT03515213|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101629043|NCT00718549|Rituximab|rituximab|mesh-list
102219060|NCT03515213|Antimetabolites|antimetabolites|mesh-ancestor
102219061|NCT03515213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219062|NCT03515213|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102219063|NCT02297945|Metyrapone|metyrapone|mesh-list
102219064|NCT02297945|Antimetabolites|antimetabolites|mesh-ancestor
102219065|NCT02297945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219066|NCT02297945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102219067|NCT02492984|Factor VIII|factor viii|mesh-list
102219068|NCT02492984|Coagulants|coagulants|mesh-ancestor
102219069|NCT03132623|Andrographolide|andrographolide|mesh-list
102219070|NCT03132623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102219071|NCT03132623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102219072|NCT03132623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102219073|NCT03132623|Analgesics|analgesics|mesh-ancestor
102219074|NCT03132623|Sensory System Agents|sensory system agents|mesh-ancestor
102219075|NCT03132623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102219076|NCT03132623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219077|NCT03132623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102219078|NCT03132623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102219079|NCT03132623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102219080|NCT03132623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102219081|NCT03132623|Antiviral Agents|antiviral agents|mesh-ancestor
102219082|NCT03132623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102219083|NCT03514979|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102219084|NCT03514979|Immunologic Factors|immunologic factors|mesh-ancestor
102219085|NCT03514979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219086|NCT02298101|Edetic Acid|edetic acid|mesh-list
101927909|NCT03798600|Antifungal Agents|antifungal agents|mesh-ancestor
102219087|NCT02298101|Pentetic Acid|pentetic acid|mesh-list
102219088|NCT02298101|Antidotes|antidotes|mesh-ancestor
102219089|NCT02298101|Protective Agents|protective agents|mesh-ancestor
102219090|NCT02298101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219091|NCT02298101|Chelating Agents|chelating agents|mesh-ancestor
102219092|NCT02298101|Sequestering Agents|sequestering agents|mesh-ancestor
102219093|NCT02298101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219094|NCT02298101|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102219095|NCT02298101|Anticoagulants|anticoagulants|mesh-ancestor
102219096|NCT02298101|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102219097|NCT02491892|Pertuzumab|pertuzumab|mesh-list
102219098|NCT02491892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102219099|NCT02491892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102219100|NCT03476811|Analgesics|analgesics|mesh-list
102219101|NCT03476811|Bupivacaine|bupivacaine|mesh-list
102219102|NCT03476811|Anesthetics, Local|anesthetics, local|mesh-ancestor
102219103|NCT03476811|Anesthetics|anesthetics|mesh-ancestor
102219104|NCT03476811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102219105|NCT03476811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219106|NCT03476811|Sensory System Agents|sensory system agents|mesh-ancestor
102219107|NCT03476811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102219108|NCT02834403|Aspirin|aspirin|mesh-list
102219109|NCT02834403|Docetaxel|docetaxel|mesh-list
102219110|NCT02834403|Amlodipine|amlodipine|mesh-list
102219111|NCT02834403|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
102219112|NCT02834403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102219113|NCT02834403|Tubulin Modulators|tubulin modulators|mesh-ancestor
102219114|NCT02834403|Antimitotic Agents|antimitotic agents|mesh-ancestor
102219115|NCT02834403|Mitosis Modulators|mitosis modulators|mesh-ancestor
102219116|NCT02834403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219117|NCT02834403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102219118|NCT02834403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102219119|NCT02834403|Analgesics|analgesics|mesh-ancestor
102219120|NCT02834403|Sensory System Agents|sensory system agents|mesh-ancestor
102219121|NCT02834403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102219122|NCT02834403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219123|NCT02834403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102219124|NCT02834403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102219125|NCT02834403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102219126|NCT02834403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102219127|NCT02834403|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102219128|NCT02834403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102219129|NCT02834403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102219130|NCT02834403|Antipyretics|antipyretics|mesh-ancestor
102219131|NCT02834403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102219132|NCT02834403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102219133|NCT02834403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102219134|NCT02834403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102219135|NCT02834403|Vasodilator Agents|vasodilator agents|mesh-ancestor
102219136|NCT02299271|Ropivacaine|ropivacaine|mesh-list
102219137|NCT02299271|Anesthetics, Local|anesthetics, local|mesh-ancestor
102219138|NCT02299271|Anesthetics|anesthetics|mesh-ancestor
102219139|NCT02299271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102219140|NCT02299271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219141|NCT02299271|Sensory System Agents|sensory system agents|mesh-ancestor
102219142|NCT02299271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102219143|NCT02302469|Lenalidomide|lenalidomide|mesh-list
102219144|NCT02302469|Immunologic Factors|immunologic factors|mesh-ancestor
102219145|NCT02302469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219146|NCT02302469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102219147|NCT02302469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102219148|NCT02302469|Growth Substances|growth substances|mesh-ancestor
102219149|NCT02302469|Growth Inhibitors|growth inhibitors|mesh-ancestor
102219150|NCT02302469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102219151|NCT02302547|Ritonavir|ritonavir|mesh-list
102219152|NCT02302547|Lopinavir|lopinavir|mesh-list
102219153|NCT02302547|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102219154|NCT02302547|Darunavir|darunavir|mesh-list
102219155|NCT02302547|Indinavir|indinavir|mesh-list
102219156|NCT02302547|Saquinavir|saquinavir|mesh-list
102219157|NCT02302547|Fosamprenavir|fosamprenavir|mesh-list
102219158|NCT02302547|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
102219159|NCT02302547|Tenofovir|tenofovir|mesh-list
102219160|NCT02302547|Emtricitabine|emtricitabine|mesh-list
102219161|NCT02302547|Raltegravir Potassium|raltegravir potassium|mesh-list
102219162|NCT02302547|Nevirapine|nevirapine|mesh-list
102219163|NCT02302547|Dolutegravir|dolutegravir|mesh-list
102219164|NCT02302547|Maraviroc|maraviroc|mesh-list
102219165|NCT02302547|Cobicistat|cobicistat|mesh-list
102219166|NCT02302547|Rilpivirine|rilpivirine|mesh-list
102219167|NCT02302547|Tipranavir|tipranavir|mesh-list
102219168|NCT02302547|Enfuvirtide|enfuvirtide|mesh-list
102219169|NCT02302547|Elvitegravir|elvitegravir|mesh-list
102219170|NCT02302547|Efavirenz|efavirenz|mesh-list
102219171|NCT02302547|Etravirine|etravirine|mesh-list
102219172|NCT02302547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
102219173|NCT02302547|Protease Inhibitors|protease inhibitors|mesh-list
102219174|NCT02302547|Integrase Inhibitors|integrase inhibitors|mesh-list
102219175|NCT02302547|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102219176|NCT02302547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102219177|NCT02302547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219178|NCT02302547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102219179|NCT02302547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102219180|NCT02302547|Antiviral Agents|antiviral agents|mesh-ancestor
102219181|NCT02302547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102219182|NCT02302547|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102219183|NCT02302547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102219184|NCT02302547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102219185|NCT02302547|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102219186|NCT02302547|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102219187|NCT02302547|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102219188|NCT02302547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102219189|NCT02302547|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102219190|NCT02302547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102219191|NCT02302547|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102219192|NCT02302547|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102219193|NCT02302547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102219194|NCT01190787|Prednisone|prednisone|mesh-list
102219195|NCT01190787|Cyclophosphamide|cyclophosphamide|mesh-list
102219196|NCT01190787|Melphalan|melphalan|mesh-list
102219197|NCT01190787|Bortezomib|bortezomib|mesh-list
102219198|NCT01190787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102219199|NCT01190787|Immunologic Factors|immunologic factors|mesh-ancestor
102219200|NCT01190787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219201|NCT01190787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102219202|NCT01190787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102219203|NCT01190787|Alkylating Agents|alkylating agents|mesh-ancestor
102219204|NCT01190787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219205|NCT01190787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102219206|NCT01190787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102219207|NCT01190787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102219208|NCT01190787|Glucocorticoids|glucocorticoids|mesh-ancestor
102219209|NCT01190787|Hormones|hormones|mesh-ancestor
102219210|NCT01190787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102219211|NCT01190787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102219212|NCT03515369|Liver Extracts|liver extracts|mesh-list
102219213|NCT03515369|Hematinics|hematinics|mesh-ancestor
102219214|NCT02634411|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102219215|NCT02634411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102219216|NCT02634411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102219217|NCT02634411|Antitubercular Agents|antitubercular agents|mesh-ancestor
102219218|NCT03513575|Chlorhexidine|chlorhexidine|mesh-list
102219219|NCT03513575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102219220|NCT03513575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102219221|NCT03513575|Disinfectants|disinfectants|mesh-ancestor
102219222|NCT03334461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
102219223|NCT03334461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102219224|NCT03252093|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
102219225|NCT03252093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102219226|NCT03252093|Vasodilator Agents|vasodilator agents|mesh-ancestor
102219227|NCT03510611|Ensartinib|ensartinib|mesh-list
102219228|NCT03510611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102219229|NCT03510611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102219230|NCT03510611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102219231|NCT03510611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219232|NCT02299817|Denosumab|denosumab|mesh-list
102219233|NCT02299817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102219234|NCT02299817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219235|NCT01679613|Ketoconazole|ketoconazole|mesh-list
102219236|NCT01679613|Nintedanib|nintedanib|mesh-list
102219237|NCT01679613|Antifungal Agents|antifungal agents|mesh-ancestor
102219238|NCT01679613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102219239|NCT01679613|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102219240|NCT01679613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102219241|NCT01679613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102219242|NCT01679613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219243|NCT01679613|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102219244|NCT01679613|Hormone Antagonists|hormone antagonists|mesh-ancestor
101928089|NCT01379326|Piperazine|piperazine|mesh-list
102219245|NCT01679613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102219246|NCT01679613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219247|NCT01679613|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102219248|NCT01679613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102219249|NCT01679613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102219250|NCT02489630|Ketamine|ketamine|mesh-list
102219251|NCT02489630|Analgesics|analgesics|mesh-list
102219252|NCT02489630|Sensory System Agents|sensory system agents|mesh-ancestor
102219253|NCT02489630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102219254|NCT02489630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219255|NCT02489630|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102219256|NCT02489630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102219257|NCT02489630|Anesthetics, General|anesthetics, general|mesh-ancestor
102219258|NCT02489630|Anesthetics|anesthetics|mesh-ancestor
102219259|NCT02489630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102219260|NCT02489630|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102219261|NCT02489630|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102219262|NCT02489630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102219263|NCT02489630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219264|NCT05089539|Valsartan|valsartan|mesh-list
102219265|NCT05089539|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102219266|NCT05089539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102219267|NCT05089539|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102219268|NCT05089539|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102219269|NCT05089539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219270|NCT05089383|Progesterone|progesterone|mesh-list
102219271|NCT05089383|Progestins|progestins|mesh-ancestor
102219272|NCT05089383|Hormones|hormones|mesh-ancestor
102219273|NCT05089383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102219274|NCT05089383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219275|NCT03510533|Autoantibodies|autoantibodies|mesh-list
102219276|NCT03510533|alpha-MSH|alpha-msh|mesh-list
102219277|NCT03510533|Immunologic Factors|immunologic factors|mesh-ancestor
102219278|NCT03510533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219279|NCT03510533|Hormones|hormones|mesh-ancestor
102219280|NCT03510533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102219281|NCT03512873|Tranilast|tranilast|mesh-list
102219282|NCT03512873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102219283|NCT03512873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102219284|NCT03512873|Analgesics|analgesics|mesh-ancestor
102219285|NCT03512873|Sensory System Agents|sensory system agents|mesh-ancestor
102219286|NCT03512873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102219287|NCT03512873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219288|NCT03512873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102219289|NCT03512873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102219290|NCT03512873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102219291|NCT03512873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102219292|NCT03512873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219293|NCT03512873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102219294|NCT03512873|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102219295|NCT03512873|Histamine Antagonists|histamine antagonists|mesh-ancestor
102219296|NCT03512873|Histamine Agents|histamine agents|mesh-ancestor
102219297|NCT03512873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102219298|NCT03512873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102219299|NCT03512873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102219300|NCT01678911|Gabapentin|gabapentin|mesh-list
102219301|NCT01678911|Analgesics|analgesics|mesh-ancestor
102219302|NCT01678911|Sensory System Agents|sensory system agents|mesh-ancestor
102219303|NCT01678911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102219304|NCT01678911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219305|NCT01678911|Anticonvulsants|anticonvulsants|mesh-ancestor
102219306|NCT01678911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102219307|NCT01678911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102219308|NCT01678911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102219309|NCT01678911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102219310|NCT01678911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102219311|NCT01678911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102219312|NCT01678911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102219313|NCT01678911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219314|NCT01678911|Antimanic Agents|antimanic agents|mesh-ancestor
102219315|NCT03132701|Magnesium Sulfate|magnesium sulfate|mesh-list
102219316|NCT03132701|Analgesics|analgesics|mesh-ancestor
102219317|NCT03132701|Sensory System Agents|sensory system agents|mesh-ancestor
102219318|NCT03132701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102219319|NCT03132701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219320|NCT03132701|Anesthetics|anesthetics|mesh-ancestor
102219321|NCT03132701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102219322|NCT03132701|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102219323|NCT03132701|Anticonvulsants|anticonvulsants|mesh-ancestor
102219324|NCT03132701|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102219325|NCT03132701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102219326|NCT03132701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219327|NCT03132701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102219328|NCT03132701|Tocolytic Agents|tocolytic agents|mesh-ancestor
102219329|NCT03132701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102219330|NCT02322099|Alendronate|alendronate|mesh-list
102219331|NCT02322099|Cholecalciferol|cholecalciferol|mesh-list
102219332|NCT02322099|Vitamin D|vitamin d|mesh-list
102219333|NCT02322099|Tenofovir|tenofovir|mesh-list
102219334|NCT02322099|Calcium Carbonate|calcium carbonate|mesh-list
102219336|NCT02322099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102219337|NCT02322099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219338|NCT02322099|Antiviral Agents|antiviral agents|mesh-ancestor
102219339|NCT02322099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102219340|NCT02322099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102219341|NCT02322099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102219342|NCT02322099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102219343|NCT02322099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219344|NCT02322099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102219345|NCT02322099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102219346|NCT02322099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102219347|NCT02322099|Antacids|antacids|mesh-ancestor
102219348|NCT02322099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102219349|NCT02322099|Vitamins|vitamins|mesh-ancestor
102219350|NCT02322099|Micronutrients|micronutrients|mesh-ancestor
102219351|NCT02487446|Glycopyrrolate|glycopyrrolate|mesh-list
102219352|NCT02487446|Bromides|bromides|mesh-list
102219353|NCT02487446|Anticonvulsants|anticonvulsants|mesh-ancestor
102219354|NCT02487446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219355|NCT02487446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102219356|NCT02487446|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102219357|NCT02487446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102219358|NCT02487446|Cholinergic Agents|cholinergic agents|mesh-ancestor
102219359|NCT02487446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102219360|NCT02487446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219361|NCT05081349|Hydroxyurea|hydroxyurea|mesh-list
102219362|NCT05081349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102219363|NCT05081349|Antisickling Agents|antisickling agents|mesh-ancestor
102219364|NCT05081349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102219365|NCT05081349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219366|NCT05081349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102219367|NCT04464005|Magnesium Sulfate|magnesium sulfate|mesh-list
102219368|NCT04464005|Analgesics|analgesics|mesh-ancestor
102219369|NCT04464005|Sensory System Agents|sensory system agents|mesh-ancestor
102219370|NCT04464005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102219371|NCT04464005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219372|NCT04464005|Anesthetics|anesthetics|mesh-ancestor
102219373|NCT04464005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102219374|NCT04464005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102219375|NCT04464005|Anticonvulsants|anticonvulsants|mesh-ancestor
102219376|NCT04464005|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102219377|NCT04464005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102219378|NCT04464005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219379|NCT04464005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102219380|NCT04464005|Tocolytic Agents|tocolytic agents|mesh-ancestor
102219381|NCT04464005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102219382|NCT02303327|Androgens|androgens|mesh-list
102219383|NCT02303327|Hormones|hormones|mesh-ancestor
102219384|NCT02303327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102219385|NCT02303327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219386|NCT03510221|Antioxidants|antioxidants|mesh-list
102219387|NCT03510221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219388|NCT03510221|Protective Agents|protective agents|mesh-ancestor
102219389|NCT03510221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219390|NCT03509831|Irsogladine|irsogladine|mesh-list
102219391|NCT03509831|Nizatidine|nizatidine|mesh-list
102219392|NCT03509831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219393|NCT03509831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102219394|NCT03509831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102219395|NCT03509831|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102219396|NCT03509831|Histamine Antagonists|histamine antagonists|mesh-ancestor
102219397|NCT03509831|Histamine Agents|histamine agents|mesh-ancestor
102219398|NCT03509831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102219399|NCT03509831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219400|NCT03509831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102219401|NCT03509831|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102219402|NCT03509831|Protective Agents|protective agents|mesh-ancestor
102219403|NCT03509831|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102219404|NCT02303483|Niacinamide|niacinamide|mesh-list
102219405|NCT02303483|Niacin|niacin|mesh-list
102219406|NCT02303483|Nicotinic Acids|nicotinic acids|mesh-list
102219407|NCT02303483|Vitamin B Complex|vitamin b complex|mesh-ancestor
102219408|NCT02303483|Vitamins|vitamins|mesh-ancestor
102219409|NCT02303483|Micronutrients|micronutrients|mesh-ancestor
102219410|NCT02303483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219411|NCT02303483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102219412|NCT02303483|Antimetabolites|antimetabolites|mesh-ancestor
102219413|NCT02303483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219414|NCT02303483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102219415|NCT02303483|Vasodilator Agents|vasodilator agents|mesh-ancestor
102219416|NCT05378061|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
102219417|NCT05378061|Growth Substances|growth substances|mesh-ancestor
102219418|NCT05378061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219419|NCT05378061|Vasodilator Agents|vasodilator agents|mesh-ancestor
102219420|NCT05378061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102219421|NCT05378061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219422|NCT02303639|Amiodarone|amiodarone|mesh-list
102219423|NCT02303639|Sotalol|sotalol|mesh-list
102219424|NCT02303639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
102219425|NCT02303639|Vasodilator Agents|vasodilator agents|mesh-ancestor
102219426|NCT02303639|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102219427|NCT02303639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102219428|NCT02303639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219429|NCT02303639|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102219430|NCT02303639|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102219431|NCT02303639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102219432|NCT02303639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102219433|NCT02303639|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102219434|NCT02303639|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102219435|NCT02303639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102219436|NCT02303639|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102219437|NCT02303639|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102219438|NCT02303639|Adrenergic Agents|adrenergic agents|mesh-ancestor
102219439|NCT02303639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102219440|NCT02303639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219441|NCT02303639|Sympatholytics|sympatholytics|mesh-ancestor
102219442|NCT02303639|Autonomic Agents|autonomic agents|mesh-ancestor
102219443|NCT02303639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102219444|NCT02303873|Alendronate|alendronate|mesh-list
102219445|NCT02303873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102219446|NCT02303873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219447|NCT04757493|Prucalopride|prucalopride|mesh-list
102219448|NCT04757493|Laxatives|laxatives|mesh-ancestor
102219449|NCT04757493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102219450|NCT04757493|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
102219451|NCT04757493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102219452|NCT04757493|Serotonin Agents|serotonin agents|mesh-ancestor
102219453|NCT04757493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102219454|NCT04757493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219455|NCT04757493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219456|NCT02303951|Atezolizumab|atezolizumab|mesh-list
102219457|NCT02303951|Vemurafenib|vemurafenib|mesh-list
102219458|NCT02303951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102219459|NCT02303951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219460|NCT02303951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102219461|NCT02303951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102219462|NCT02303951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102219463|NCT02303951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102219464|NCT04406415|Nafamostat|nafamostat|mesh-list
101928299|NCT05461690|Niraparib|niraparib|mesh-list
102219465|NCT04406415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102219466|NCT04406415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102219467|NCT04406415|Analgesics|analgesics|mesh-ancestor
102219468|NCT04406415|Sensory System Agents|sensory system agents|mesh-ancestor
102219469|NCT04406415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102219470|NCT04406415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219471|NCT04406415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102219472|NCT04406415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102219473|NCT04406415|Anticoagulants|anticoagulants|mesh-ancestor
102219474|NCT04406415|Protease Inhibitors|protease inhibitors|mesh-ancestor
102219475|NCT04406415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102219476|NCT04406415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219477|NCT04406415|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102219478|NCT04406415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102219479|NCT04406415|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102219480|NCT04406415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102219481|NCT04406415|Immunologic Factors|immunologic factors|mesh-ancestor
102219482|NCT02304107|Letrozole|letrozole|mesh-list
102219483|NCT02304107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102219484|NCT02304107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102219485|NCT02304107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102219486|NCT02304107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102219487|NCT02304107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219488|NCT02304107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102219489|NCT02304107|Hormone Antagonists|hormone antagonists|mesh-ancestor
102219490|NCT02304107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102219491|NCT02304107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219492|NCT03509285|Cenobamate|cenobamate|mesh-list
102219493|NCT03509285|Alprazolam|alprazolam|mesh-list
102219494|NCT03509285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102219495|NCT03509285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102219496|NCT03509285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219497|NCT03509285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102219498|NCT03509285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102219499|NCT03509285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102219500|NCT03509285|GABA Modulators|gaba modulators|mesh-ancestor
102219501|NCT03509285|GABA Agents|gaba agents|mesh-ancestor
102219502|NCT03509285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102219503|NCT03509285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219504|NCT03509285|Anticonvulsants|anticonvulsants|mesh-ancestor
102219505|NCT02300363|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
102219506|NCT02300363|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102219507|NCT02300363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102219508|NCT02300363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101629120|NCT00798694|Travoprost|travoprost|mesh-list
102219509|NCT02300363|Antimetabolites|antimetabolites|mesh-ancestor
102219510|NCT02300363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219511|NCT02300363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102219512|NCT02300363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102219513|NCT02300363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102219514|NCT02300363|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102219515|NCT02300363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102219516|NCT02300363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219517|NCT03135795|Parecoxib|parecoxib|mesh-list
102219518|NCT03135795|Sufentanil|sufentanil|mesh-list
102219519|NCT03135795|Dexmedetomidine|dexmedetomidine|mesh-list
102219520|NCT03135795|Remifentanil|remifentanil|mesh-list
102219521|NCT03135795|Dsuvia|dsuvia|mesh-list
102219522|NCT03135795|Bromides|bromides|mesh-list
102219523|NCT03135795|Propofol|propofol|mesh-list
102219524|NCT03135795|Sevoflurane|sevoflurane|mesh-list
102219525|NCT03135795|Citric Acid|citric acid|mesh-list
102219526|NCT03135795|Sodium Citrate|sodium citrate|mesh-list
102219527|NCT03135795|Rocuronium|rocuronium|mesh-list
102219528|NCT03135795|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102219529|NCT03135795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102219530|NCT03135795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219531|NCT03135795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102219532|NCT03135795|Analgesics|analgesics|mesh-ancestor
102219533|NCT03135795|Sensory System Agents|sensory system agents|mesh-ancestor
102219534|NCT03135795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102219535|NCT03135795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102219536|NCT03135795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102219537|NCT03135795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102219538|NCT03135795|Adrenergic Agents|adrenergic agents|mesh-ancestor
102219539|NCT03135795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102219540|NCT03135795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219541|NCT03135795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102219542|NCT03135795|Anesthetics, General|anesthetics, general|mesh-ancestor
102219543|NCT03135795|Anesthetics|anesthetics|mesh-ancestor
102219544|NCT03135795|Anticoagulants|anticoagulants|mesh-ancestor
102219545|NCT03135795|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102219546|NCT03135795|Chelating Agents|chelating agents|mesh-ancestor
102219547|NCT03135795|Sequestering Agents|sequestering agents|mesh-ancestor
102219548|NCT03135795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102219549|NCT03135795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102219550|NCT03135795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102219551|NCT03135795|Narcotics|narcotics|mesh-ancestor
102219552|NCT03135795|Anticonvulsants|anticonvulsants|mesh-ancestor
102219553|NCT03135795|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102219554|NCT03135795|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102219555|NCT03135795|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102219556|NCT03135795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102219557|NCT03135795|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102219558|NCT03135795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102219559|NCT03135795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102219560|NCT03135795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102219561|NCT03135795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102219562|NCT03135795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102219564|NCT04958967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102219565|NCT04958967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102219566|NCT04958967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219567|NCT03469531|Cisplatin|cisplatin|mesh-list
102219568|NCT03469531|Nimotuzumab|nimotuzumab|mesh-list
102219569|NCT03469531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102219570|NCT03469531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102219571|NCT03309007|Metformin|metformin|mesh-list
102219572|NCT03309007|Calcium Carbonate|calcium carbonate|mesh-list
102219573|NCT03309007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102219574|NCT03309007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219575|NCT03309007|Antacids|antacids|mesh-ancestor
102219576|NCT03309007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629129|NCT00718315|Fusidic Acid|fusidic acid|mesh-list
102219577|NCT03309007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102219578|NCT03508817|Atropine|atropine|mesh-list
102219579|NCT03508817|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102219580|NCT03508817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102219581|NCT03508817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102219582|NCT03508817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102219583|NCT03508817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102219584|NCT03508817|Autonomic Agents|autonomic agents|mesh-ancestor
102219585|NCT03508817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102219586|NCT03508817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219587|NCT03508817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102219588|NCT03508817|Respiratory System Agents|respiratory system agents|mesh-ancestor
102219589|NCT03508817|Mydriatics|mydriatics|mesh-ancestor
102219590|NCT03508817|Parasympatholytics|parasympatholytics|mesh-ancestor
102219591|NCT03508817|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102219592|NCT03508817|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102219593|NCT03508817|Cholinergic Agents|cholinergic agents|mesh-ancestor
102219594|NCT03508817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102219595|NCT03508817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219596|NCT05158777|Vaccines|vaccines|mesh-list
102219597|NCT05158777|Immunologic Factors|immunologic factors|mesh-ancestor
102219598|NCT05158777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219599|NCT01678209|Methylphenidate|methylphenidate|mesh-list
102219600|NCT01678209|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102219601|NCT01678209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102219602|NCT01678209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219603|NCT01678209|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102219604|NCT01678209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102219605|NCT01678209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102219606|NCT01678209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219607|NCT01678209|Dopamine Agents|dopamine agents|mesh-ancestor
102219608|NCT01678209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102219609|NCT01678209|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102219610|NCT01678209|Adrenergic Agents|adrenergic agents|mesh-ancestor
102219611|NCT02239120|Dabigatran|dabigatran|mesh-list
102219612|NCT02239120|Antithrombins|antithrombins|mesh-ancestor
102219613|NCT02239120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102219614|NCT02239120|Protease Inhibitors|protease inhibitors|mesh-ancestor
102219616|NCT02239120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219617|NCT02239120|Anticoagulants|anticoagulants|mesh-ancestor
102219618|NCT04464863|Metronidazole|metronidazole|mesh-list
102219619|NCT04464863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102219620|NCT04464863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102219621|NCT04464863|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102219622|NCT04464863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102219623|NCT05158699|Dexamethasone|dexamethasone|mesh-list
102219624|NCT05158699|Dexamethasone acetate|dexamethasone acetate|mesh-list
102219625|NCT05158699|Triamcinolone|triamcinolone|mesh-list
102219626|NCT05158699|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102219627|NCT05158699|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102219628|NCT05158699|Ketorolac|ketorolac|mesh-list
102219629|NCT05158699|Bromfenac|bromfenac|mesh-list
102219630|NCT05158699|Phenylephrine|phenylephrine|mesh-list
102219631|NCT05158699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102219632|NCT05158699|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102219633|NCT05158699|BB 1101|bb 1101|mesh-list
102219634|NCT05158699|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102219635|NCT05158699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102219636|NCT05158699|Antiemetics|antiemetics|mesh-ancestor
102219637|NCT05158699|Autonomic Agents|autonomic agents|mesh-ancestor
102219638|NCT05158699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102219639|NCT05158699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219640|NCT05158699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102219641|NCT05158699|Glucocorticoids|glucocorticoids|mesh-ancestor
102219642|NCT05158699|Hormones|hormones|mesh-ancestor
102219643|NCT05158699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102219644|NCT05158699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102219645|NCT05158699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102219646|NCT05158699|Protease Inhibitors|protease inhibitors|mesh-ancestor
102219647|NCT05158699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102219648|NCT05158699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219649|NCT05158699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102219650|NCT05158699|Immunologic Factors|immunologic factors|mesh-ancestor
102219651|NCT05158699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102219652|NCT05158699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102219653|NCT05158699|Analgesics|analgesics|mesh-ancestor
102219654|NCT05158699|Sensory System Agents|sensory system agents|mesh-ancestor
102219655|NCT05158699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102219656|NCT05158699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102219657|NCT05158699|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102219658|NCT05158699|Mydriatics|mydriatics|mesh-ancestor
102219659|NCT05158699|Sympathomimetics|sympathomimetics|mesh-ancestor
102219660|NCT05158699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102219661|NCT05158699|Nasal Decongestants|nasal decongestants|mesh-ancestor
102219662|NCT05158699|Respiratory System Agents|respiratory system agents|mesh-ancestor
102219663|NCT05158699|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102219664|NCT05158699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102219665|NCT05158699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102219666|NCT05158699|Adrenergic Agents|adrenergic agents|mesh-ancestor
102219667|NCT05158699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102219668|NCT05158699|Protective Agents|protective agents|mesh-ancestor
102219669|NCT02304887|Denosumab|denosumab|mesh-list
102219670|NCT02304887|Teriparatide|teriparatide|mesh-list
102219671|NCT02304887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102219672|NCT02304887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219673|NCT02304887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102219674|NCT03474133|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102219675|NCT03474133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102219676|NCT03474133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102219677|NCT03474133|Immunotoxins|immunotoxins|mesh-ancestor
102219678|NCT03474133|Immunoconjugates|immunoconjugates|mesh-ancestor
102219679|NCT03474133|Immunologic Factors|immunologic factors|mesh-ancestor
102219680|NCT03474133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219681|NCT03512171|Amphetamine|amphetamine|mesh-list
102219682|NCT03512171|Dextroamphetamine|dextroamphetamine|mesh-list
102219683|NCT03512171|Fallypride|fallypride|mesh-list
102219684|NCT03512171|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102219685|NCT03512171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219686|NCT03512171|Sympathomimetics|sympathomimetics|mesh-ancestor
102219687|NCT03512171|Autonomic Agents|autonomic agents|mesh-ancestor
102219688|NCT03512171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102219689|NCT03512171|Dopamine Agents|dopamine agents|mesh-ancestor
102219690|NCT03512171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101928509|NCT04436224|Anesthetics|anesthetics|mesh-ancestor
102219691|NCT03512171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219692|NCT03512171|Adrenergic Agents|adrenergic agents|mesh-ancestor
102219693|NCT03512171|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102219694|NCT03512171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102219695|NCT03512171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102219696|NCT03512171|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102219697|NCT03512171|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102219698|NCT03512171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102219700|NCT03739099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102219701|NCT02305199|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102219702|NCT03469375|Folfirinox|folfirinox|mesh-list
102219703|NCT03469375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102219704|NCT01603407|Prednisone|prednisone|mesh-list
102219705|NCT01603407|Deflazacort|deflazacort|mesh-list
102219706|NCT01603407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102219707|NCT01603407|Glucocorticoids|glucocorticoids|mesh-ancestor
102219708|NCT01603407|Hormones|hormones|mesh-ancestor
102219709|NCT01603407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102219710|NCT01603407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219711|NCT01603407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102219712|NCT01603407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102219713|NCT01603407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102219714|NCT01603407|Immunologic Factors|immunologic factors|mesh-ancestor
102219715|NCT02305355|Atorvastatin|atorvastatin|mesh-list
102219716|NCT02305355|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102219717|NCT02305355|Simvastatin|simvastatin|mesh-list
102219718|NCT02305355|Pravastatin|pravastatin|mesh-list
102219719|NCT02305355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102219720|NCT02305355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102219721|NCT02305355|Antimetabolites|antimetabolites|mesh-ancestor
102219722|NCT02305355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219723|NCT02305355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102219724|NCT02305355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102219725|NCT02305355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102219726|NCT03511703|Apatinib|apatinib|mesh-list
102219727|NCT03511703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102219728|NCT03511703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102219729|NCT03511703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102219730|NCT03511703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219731|NCT05157295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102219732|NCT05157295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102219733|NCT05157295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102219734|NCT05157295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102219735|NCT05157295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219736|NCT05157295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102219737|NCT05157295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102219738|NCT05157295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219739|NCT05157295|Cholinergic Agents|cholinergic agents|mesh-ancestor
102219740|NCT05157295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102219741|NCT02301221|Vancomycin|vancomycin|mesh-list
102219742|NCT02301221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102219743|NCT02301221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102219744|NCT03122431|Hydroxychloroquine|hydroxychloroquine|mesh-list
102219745|NCT03122431|Thalidomide|thalidomide|mesh-list
102219746|NCT03122431|Antimalarials|antimalarials|mesh-ancestor
102219747|NCT03122431|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102219748|NCT03122431|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102219749|NCT03122431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102219750|NCT03122431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102219751|NCT03122431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219752|NCT03122431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102219753|NCT03122431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102219754|NCT03122431|Immunologic Factors|immunologic factors|mesh-ancestor
102219755|NCT03122431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219756|NCT03122431|Leprostatic Agents|leprostatic agents|mesh-ancestor
102219757|NCT03122431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102219758|NCT03122431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102219759|NCT03122431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102219760|NCT03122431|Growth Substances|growth substances|mesh-ancestor
102219761|NCT03122431|Growth Inhibitors|growth inhibitors|mesh-ancestor
102219762|NCT03122431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102219763|NCT05248360|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102219764|NCT05248360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102219765|NCT05248360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102219766|NCT02305823|Aripiprazole|aripiprazole|mesh-list
102219767|NCT02305823|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102219768|NCT02305823|Ziprasidone|ziprasidone|mesh-list
102219769|NCT02305823|Antidepressive Agents|antidepressive agents|mesh-ancestor
102219770|NCT02305823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102219771|NCT02305823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102219772|NCT02305823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102219773|NCT02305823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101573995|NCT02199184|Hormones|hormones|mesh-ancestor
102219775|NCT02305823|Dopamine Agonists|dopamine agonists|mesh-ancestor
102219776|NCT02305823|Dopamine Agents|dopamine agents|mesh-ancestor
102219777|NCT02305823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102219778|NCT02305823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219779|NCT02305823|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102219780|NCT02305823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102219781|NCT02305823|Serotonin Agents|serotonin agents|mesh-ancestor
102219782|NCT02305823|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102219783|NCT02305823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102219784|NCT02305823|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102219785|NCT02305823|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102219786|NCT05376189|Vitamin D|vitamin d|mesh-list
102219787|NCT05376189|Ergocalciferols|ergocalciferols|mesh-list
102219788|NCT05376189|Cholecalciferol|cholecalciferol|mesh-list
102219789|NCT05376189|Vitamins|vitamins|mesh-list
102219790|NCT05376189|Micronutrients|micronutrients|mesh-ancestor
102219791|NCT05376189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219792|NCT05376189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102219793|NCT05376189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102219794|NCT02235298|Metformin|metformin|mesh-list
102219795|NCT02235298|Dapagliflozin|dapagliflozin|mesh-list
102219796|NCT02235298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102219797|NCT02235298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219798|NCT02235298|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102219799|NCT02235298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219800|NCT02305901|Repaglinide|repaglinide|mesh-list
102219801|NCT02305901|Bupropion|bupropion|mesh-list
102219802|NCT02305901|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102219803|NCT02305901|Antidepressive Agents|antidepressive agents|mesh-ancestor
102219804|NCT02305901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102219805|NCT02305901|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102219806|NCT02305901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102219807|NCT02305901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102219808|NCT02305901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219809|NCT02305901|Dopamine Agents|dopamine agents|mesh-ancestor
102219810|NCT02305901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102219811|NCT02305901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219812|NCT02305901|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102219813|NCT02305901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102219814|NCT02305901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102219815|NCT02305901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102219816|NCT03942887|Methylprednisolone|methylprednisolone|mesh-list
102219817|NCT03942887|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102219818|NCT03942887|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102219819|NCT03942887|Prednisolone|prednisolone|mesh-list
102219820|NCT03942887|Prednisolone acetate|prednisolone acetate|mesh-list
102219821|NCT03942887|Cyclophosphamide|cyclophosphamide|mesh-list
102219822|NCT03942887|Rituximab|rituximab|mesh-list
102219823|NCT03942887|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102219824|NCT03942887|Prednisolone phosphate|prednisolone phosphate|mesh-list
102219825|NCT03942887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102219826|NCT03942887|Immunologic Factors|immunologic factors|mesh-ancestor
102219827|NCT03942887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219828|NCT03942887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102219829|NCT03942887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102219830|NCT03942887|Alkylating Agents|alkylating agents|mesh-ancestor
102219831|NCT03942887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219832|NCT03942887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102219833|NCT03942887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102219834|NCT03942887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102219835|NCT03942887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102219836|NCT03942887|Antiemetics|antiemetics|mesh-ancestor
102219837|NCT03942887|Autonomic Agents|autonomic agents|mesh-ancestor
102219838|NCT03942887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101928663|NCT03786120|GABA Agents|gaba agents|mesh-ancestor
102219839|NCT03942887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102219840|NCT03942887|Glucocorticoids|glucocorticoids|mesh-ancestor
102219841|NCT03942887|Hormones|hormones|mesh-ancestor
102219842|NCT03942887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102219843|NCT03942887|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102219844|NCT03942887|Protective Agents|protective agents|mesh-ancestor
102219845|NCT03942887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102612400|NCT00002447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219847|NCT02234596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102219848|NCT02234596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102219849|NCT02234596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102219850|NCT02234596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219851|NCT02305979|Loratadine|loratadine|mesh-list
102219852|NCT02305979|Antipruritics|antipruritics|mesh-ancestor
102219853|NCT02305979|Dermatologic Agents|dermatologic agents|mesh-ancestor
102219854|NCT02305979|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102219855|NCT02305979|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102219856|NCT02305979|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102219857|NCT02305979|Histamine Antagonists|histamine antagonists|mesh-ancestor
102219858|NCT02305979|Histamine Agents|histamine agents|mesh-ancestor
102219859|NCT02305979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102219860|NCT02305979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219861|NCT02305979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219862|NCT04539951|Memantine|memantine|mesh-list
102219863|NCT04539951|Aripiprazole|aripiprazole|mesh-list
102219864|NCT04539951|Fluvoxamine|fluvoxamine|mesh-list
102219865|NCT04539951|Sertraline|sertraline|mesh-list
102219866|NCT04539951|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102219867|NCT04539951|Antidepressive Agents|antidepressive agents|mesh-ancestor
102219868|NCT04539951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102219869|NCT04539951|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102219870|NCT04539951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102219871|NCT04539951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102219872|NCT04539951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219873|NCT04539951|Dopamine Agonists|dopamine agonists|mesh-ancestor
102219874|NCT04539951|Dopamine Agents|dopamine agents|mesh-ancestor
102219875|NCT04539951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102219876|NCT04539951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219877|NCT04539951|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102219878|NCT04539951|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102219879|NCT04539951|Serotonin Agents|serotonin agents|mesh-ancestor
102219880|NCT04539951|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102219881|NCT04539951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102219882|NCT04539951|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102219883|NCT04539951|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102219884|NCT04539951|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102219885|NCT04539951|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102219886|NCT04539951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102219887|NCT04539951|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102219888|NCT04539951|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102219889|NCT04539951|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102219890|NCT04539951|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102219891|NCT04539951|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102219892|NCT04539951|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102219893|NCT04539951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102219894|NCT04539951|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102219895|NCT04539951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102219896|NCT04539951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102219897|NCT04539951|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102219898|NCT04539327|Rucaparib|rucaparib|mesh-list
102219899|NCT04539327|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102219900|NCT04539327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102219901|NCT04539327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219902|NCT04539327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102219903|NCT02234362|Vortioxetine|vortioxetine|mesh-list
102219904|NCT02234362|Antidepressive Agents|antidepressive agents|mesh-ancestor
102219905|NCT02234362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102219906|NCT02234362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102219907|NCT02234362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102219908|NCT02234362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102219909|NCT02234362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219910|NCT02234362|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102219911|NCT02234362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102219912|NCT02234362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102219913|NCT02234362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219914|NCT02234362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102219915|NCT02234362|Serotonin Agents|serotonin agents|mesh-ancestor
102612401|NCT00002447|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102219916|NCT02234362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102219917|NCT02234362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102219918|NCT02234362|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102219919|NCT02234362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102219920|NCT05091177|Acetylcholine|acetylcholine|mesh-list
102219921|NCT05091177|Antibodies|antibodies|mesh-list
102219922|NCT05091177|Neostigmine|neostigmine|mesh-list
102219923|NCT05091177|Immunologic Factors|immunologic factors|mesh-ancestor
102219924|NCT05091177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219925|NCT05091177|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102219926|NCT05091177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102219927|NCT05091177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219928|NCT05091177|Cholinergic Agents|cholinergic agents|mesh-ancestor
102219929|NCT05091177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102219930|NCT05091177|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102219931|NCT05091177|Autonomic Agents|autonomic agents|mesh-ancestor
102219932|NCT05091177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102219933|NCT05091177|Vasodilator Agents|vasodilator agents|mesh-ancestor
102219934|NCT05091177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102219935|NCT05091099|Zoledronic Acid|zoledronic acid|mesh-list
102219936|NCT05091099|Alendronate|alendronate|mesh-list
102219937|NCT05091099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102219938|NCT05091099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219939|NCT03505151|BI 409306|bi 409306|mesh-list
102219940|NCT03505151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102219941|NCT03505151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102219942|NCT03505151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219943|NCT02232880|Abatacept|abatacept|mesh-list
102219944|NCT02232880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102219945|NCT02232880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219946|NCT02232880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102219947|NCT02232880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102219948|NCT02232880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102219949|NCT02232880|Immunologic Factors|immunologic factors|mesh-ancestor
102219950|NCT02232880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219951|NCT02232880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102219952|NCT02896855|Docetaxel|docetaxel|mesh-list
102219953|NCT02896855|Trastuzumab|trastuzumab|mesh-list
102219954|NCT02896855|Pertuzumab|pertuzumab|mesh-list
102219955|NCT02896855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102219956|NCT02896855|Tubulin Modulators|tubulin modulators|mesh-ancestor
102219957|NCT02896855|Antimitotic Agents|antimitotic agents|mesh-ancestor
102219958|NCT02896855|Mitosis Modulators|mitosis modulators|mesh-ancestor
102219959|NCT02896855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219960|NCT02896855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102219961|NCT02311439|Folfirinox|folfirinox|mesh-list
102219962|NCT02311439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102219963|NCT02311517|Ropivacaine|ropivacaine|mesh-list
102219964|NCT02311517|Anesthetics, Local|anesthetics, local|mesh-ancestor
102219965|NCT02311517|Anesthetics|anesthetics|mesh-ancestor
102219966|NCT02311517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102219967|NCT02311517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219968|NCT02311517|Sensory System Agents|sensory system agents|mesh-ancestor
102219969|NCT02311517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102219970|NCT02232802|Enoxaparin|enoxaparin|mesh-list
102219971|NCT02232802|Enoxaparin sodium|enoxaparin sodium|mesh-list
102219972|NCT02232802|Anticoagulants|anticoagulants|mesh-ancestor
102219973|NCT02232802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102219974|NCT02232802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102219975|NCT02232802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219976|NCT04463459|Vitamins|vitamins|mesh-list
102219977|NCT04463459|Vitamin E|vitamin e|mesh-list
102219978|NCT04463459|Micronutrients|micronutrients|mesh-ancestor
102219979|NCT04463459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219980|NCT04463459|Antioxidants|antioxidants|mesh-ancestor
102219981|NCT04463459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102219982|NCT04463459|Protective Agents|protective agents|mesh-ancestor
102219983|NCT02434328|Aflibercept|aflibercept|mesh-list
102219984|NCT02434328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102219985|NCT02434328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102219986|NCT02434328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102219987|NCT02434328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102612402|NCT00002447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102219988|NCT02434328|Growth Substances|growth substances|mesh-ancestor
102219989|NCT02434328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219990|NCT02434328|Growth Inhibitors|growth inhibitors|mesh-ancestor
102219991|NCT02434328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102219992|NCT04785274|Chrysarobin|chrysarobin|mesh-list
102219993|NCT04785274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102219994|NCT04785274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102219995|NCT04785274|Analgesics|analgesics|mesh-ancestor
102219996|NCT04785274|Sensory System Agents|sensory system agents|mesh-ancestor
102219997|NCT04785274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102219998|NCT04785274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102219999|NCT04785274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102220000|NCT04785274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102220002|NCT04778176|Carbidopa|carbidopa|mesh-list
102220003|NCT04778176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102220004|NCT04778176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102220005|NCT04778176|Dopamine Agents|dopamine agents|mesh-ancestor
102220006|NCT04778176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102220007|NCT04778176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220008|NCT04778176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220009|NCT04778176|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102220010|NCT04778176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102220011|NCT05174026|Deoxyglucose|deoxyglucose|mesh-list
102220012|NCT05174026|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102220013|NCT05174026|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102220014|NCT05174026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220015|NCT05174026|Antimetabolites|antimetabolites|mesh-ancestor
102220016|NCT05174026|Antiviral Agents|antiviral agents|mesh-ancestor
102220017|NCT05174026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102220018|NCT05076253|Ivermectin|ivermectin|mesh-list
102220019|NCT05076253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102220020|NCT05076253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102220021|NCT05077839|Trifluridine|trifluridine|mesh-list
102220022|NCT05077839|Antimetabolites|antimetabolites|mesh-ancestor
102220023|NCT05077839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220024|NCT05077839|Antiviral Agents|antiviral agents|mesh-ancestor
102220025|NCT05077839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102220026|NCT03132233|Calcium|calcium|mesh-list
102220027|NCT03132233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102220028|NCT03132233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220029|NCT02307227|Paclitaxel|paclitaxel|mesh-list
102220030|NCT02307227|Docetaxel|docetaxel|mesh-list
102220031|NCT02307227|Trastuzumab|trastuzumab|mesh-list
102220032|NCT02307227|Epirubicin|epirubicin|mesh-list
102220033|NCT02307227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102220034|NCT02307227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102220035|NCT02307227|Tubulin Modulators|tubulin modulators|mesh-ancestor
102220036|NCT02307227|Antimitotic Agents|antimitotic agents|mesh-ancestor
102220037|NCT02307227|Mitosis Modulators|mitosis modulators|mesh-ancestor
102220038|NCT02307227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220039|NCT02307227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102220040|NCT02307227|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102220041|NCT02307227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102220042|NCT02307227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102220043|NCT02307227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102220044|NCT02307305|Acetaminophen|acetaminophen|mesh-list
102220045|NCT02307305|Celecoxib|celecoxib|mesh-list
102220046|NCT02307305|Naproxen|naproxen|mesh-list
102220047|NCT02307305|Oxycodone|oxycodone|mesh-list
102220048|NCT02307305|Tramadol|tramadol|mesh-list
102220049|NCT02307305|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102220050|NCT02307305|Naloxone|naloxone|mesh-list
102220051|NCT02307305|Esomeprazole|esomeprazole|mesh-list
102220052|NCT02307305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102220053|NCT02307305|Analgesics|analgesics|mesh-ancestor
102220054|NCT02307305|Sensory System Agents|sensory system agents|mesh-ancestor
102220055|NCT02307305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102220056|NCT02307305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220057|NCT02307305|Antipyretics|antipyretics|mesh-ancestor
102220058|NCT02307305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102220059|NCT02307305|Narcotics|narcotics|mesh-ancestor
102220060|NCT02307305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102220061|NCT02307305|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102220062|NCT02307305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102612403|NCT00002447|Antiviral Agents|antiviral agents|mesh-ancestor
102612404|NCT00002447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102220063|NCT02307305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102220064|NCT02307305|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101900902|NCT03860636|Estradiol|estradiol|mesh-list
102220065|NCT02307305|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102220067|NCT02307305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220068|NCT02307305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102220069|NCT02307305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102220070|NCT02307305|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102220071|NCT02307305|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102220072|NCT02307305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102220073|NCT02307305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102220074|NCT02307305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102220075|NCT02307305|Antidepressive Agents|antidepressive agents|mesh-ancestor
102220076|NCT02307305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102220077|NCT02307305|Dopamine Agents|dopamine agents|mesh-ancestor
102220078|NCT02307305|Gout Suppressants|gout suppressants|mesh-ancestor
102220079|NCT02307305|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102220080|NCT02660229|Morphine|morphine|mesh-list
102220081|NCT02660229|Oxycodone|oxycodone|mesh-list
102220082|NCT02660229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102220083|NCT02660229|Narcotics|narcotics|mesh-ancestor
102220084|NCT02660229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102220085|NCT02660229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220086|NCT02660229|Analgesics|analgesics|mesh-ancestor
102220087|NCT02660229|Sensory System Agents|sensory system agents|mesh-ancestor
102220088|NCT02660229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102220089|NCT02307383|Lactitol|lactitol|mesh-list
102220090|NCT02307383|Cathartics|cathartics|mesh-ancestor
102220091|NCT02307383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102220092|NCT02232178|Bupivacaine|bupivacaine|mesh-list
102220093|NCT02232178|Anesthetics, Local|anesthetics, local|mesh-ancestor
102220094|NCT02232178|Anesthetics|anesthetics|mesh-ancestor
102220095|NCT02232178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102220096|NCT02232178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220097|NCT02232178|Sensory System Agents|sensory system agents|mesh-ancestor
102220098|NCT02232178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102220099|NCT04457323|Metoprolol|metoprolol|mesh-list
102220100|NCT04457323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102220101|NCT04457323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102220102|NCT04457323|Sympatholytics|sympatholytics|mesh-ancestor
102220103|NCT04457323|Autonomic Agents|autonomic agents|mesh-ancestor
102220104|NCT04457323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102220105|NCT04457323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220106|NCT04457323|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102220107|NCT04457323|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102220108|NCT04457323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102220109|NCT04457323|Adrenergic Agents|adrenergic agents|mesh-ancestor
102220110|NCT04457323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102220111|NCT04457323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220112|NCT04448431|Vortioxetine|vortioxetine|mesh-list
102220113|NCT04448431|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
102220114|NCT04448431|Antidepressive Agents|antidepressive agents|mesh-ancestor
102220115|NCT04448431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102220116|NCT04448431|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102220117|NCT04448431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102220118|NCT04448431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102220119|NCT04448431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220120|NCT04448431|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102220121|NCT04448431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102220122|NCT04448431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102220123|NCT04448431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220124|NCT04448431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102220125|NCT04448431|Serotonin Agents|serotonin agents|mesh-ancestor
102220126|NCT04448431|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102220127|NCT04448431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102220128|NCT04448431|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102220129|NCT04448431|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102220130|NCT04448431|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102220131|NCT05713149|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102220132|NCT05713149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102220133|NCT02307695|Saxagliptin|saxagliptin|mesh-list
102220134|NCT02307695|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
102220135|NCT02307695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102220136|NCT02307695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220137|NCT02307695|Incretins|incretins|mesh-ancestor
102612405|NCT00002447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101928960|NCT01561404|Everolimus|everolimus|mesh-list
102220139|NCT02307695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102220141|NCT02307695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102220142|NCT02307695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220143|NCT05161975|Vitamin K|vitamin k|mesh-list
102220144|NCT05161975|Vitamin K 2|vitamin k 2|mesh-list
102220145|NCT05161975|Vitamins|vitamins|mesh-ancestor
102220146|NCT05161975|Micronutrients|micronutrients|mesh-ancestor
102220147|NCT05161975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220148|NCT05161975|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102220149|NCT05161975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102220150|NCT05161975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220151|NCT05161975|Hemostatics|hemostatics|mesh-ancestor
102220152|NCT05161975|Coagulants|coagulants|mesh-ancestor
102220153|NCT03504527|Budesonide|budesonide|mesh-list
102220154|NCT03504527|Bromides|bromides|mesh-list
102220155|NCT03504527|Tiotropium Bromide|tiotropium bromide|mesh-list
102220156|NCT03504527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102220157|NCT03504527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102220158|NCT03504527|Autonomic Agents|autonomic agents|mesh-ancestor
102220159|NCT03504527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102220160|NCT03504527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220161|NCT03504527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102220162|NCT03504527|Respiratory System Agents|respiratory system agents|mesh-ancestor
102220163|NCT03504527|Glucocorticoids|glucocorticoids|mesh-ancestor
102220164|NCT03504527|Hormones|hormones|mesh-ancestor
102220165|NCT03504527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102220166|NCT03504527|Parasympatholytics|parasympatholytics|mesh-ancestor
102220167|NCT03504527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102220168|NCT03504527|Cholinergic Agents|cholinergic agents|mesh-ancestor
102220169|NCT03504527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102220170|NCT03504527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220171|NCT03504527|Anticonvulsants|anticonvulsants|mesh-ancestor
102220172|NCT01678131|Ribavirin|ribavirin|mesh-list
102220173|NCT01678131|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102220174|NCT01678131|Interferon alpha-2|interferon alpha-2|mesh-list
102220175|NCT01678131|Liver Extracts|liver extracts|mesh-list
102220176|NCT01678131|Antimetabolites|antimetabolites|mesh-ancestor
102220177|NCT01678131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220178|NCT01678131|Antiviral Agents|antiviral agents|mesh-ancestor
102220179|NCT01678131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102220180|NCT01678131|Hematinics|hematinics|mesh-ancestor
102220181|NCT01678131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102220182|NCT04579783|Triamcinolone|triamcinolone|mesh-list
102220183|NCT04579783|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102220184|NCT04579783|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102220185|NCT04579783|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102220186|NCT04579783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102220187|NCT04579783|Glucocorticoids|glucocorticoids|mesh-ancestor
102220188|NCT04579783|Hormones|hormones|mesh-ancestor
102220189|NCT04579783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102220190|NCT04579783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220191|NCT04579783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102220192|NCT04579783|Immunologic Factors|immunologic factors|mesh-ancestor
102220193|NCT04579783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102220194|NCT04579783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220195|NCT02231164|Docetaxel|docetaxel|mesh-list
102220196|NCT02231164|Nintedanib|nintedanib|mesh-list
102220197|NCT02231164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102220198|NCT02231164|Tubulin Modulators|tubulin modulators|mesh-ancestor
102220199|NCT02231164|Antimitotic Agents|antimitotic agents|mesh-ancestor
102220200|NCT02231164|Mitosis Modulators|mitosis modulators|mesh-ancestor
102220201|NCT02231164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220202|NCT02231164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102220203|NCT02231164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102220204|NCT03506789|Dexamethasone|dexamethasone|mesh-list
102220205|NCT03506789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102220206|NCT03506789|Antiemetics|antiemetics|mesh-ancestor
102220207|NCT03506789|Autonomic Agents|autonomic agents|mesh-ancestor
102220208|NCT03506789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101629179|NCT02591017|Narcotics|narcotics|mesh-ancestor
102220209|NCT03506789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220210|NCT03506789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102220211|NCT03506789|Glucocorticoids|glucocorticoids|mesh-ancestor
102220212|NCT03506789|Hormones|hormones|mesh-ancestor
101900906|NCT03860636|Hormones|hormones|mesh-ancestor
102612406|NCT00002447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102612407|NCT00002447|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102220213|NCT03506789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101929044|NCT05211622|Vitamins|vitamins|mesh-ancestor
102220214|NCT03506789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102220215|NCT03506789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102220216|NCT02312297|Minocycline|minocycline|mesh-list
102220217|NCT02312297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102220218|NCT02312297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102220220|NCT05108974|Lipotropic Agents|lipotropic agents|mesh-ancestor
102220221|NCT05108974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102220222|NCT05108974|Antimetabolites|antimetabolites|mesh-ancestor
102220223|NCT05108974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220224|NCT05108974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102220225|NCT05108974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102220226|NCT05108974|Nootropic Agents|nootropic agents|mesh-ancestor
102220227|NCT03473431|Ketamine|ketamine|mesh-list
102220228|NCT03473431|Analgesics|analgesics|mesh-ancestor
102220229|NCT03473431|Sensory System Agents|sensory system agents|mesh-ancestor
102220230|NCT03473431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102220231|NCT03473431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220232|NCT03473431|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102220233|NCT03473431|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102220234|NCT03473431|Anesthetics, General|anesthetics, general|mesh-ancestor
102220235|NCT03473431|Anesthetics|anesthetics|mesh-ancestor
102220236|NCT03473431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102220237|NCT03473431|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102220238|NCT03473431|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102220239|NCT03473431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102220240|NCT03473431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220241|NCT02378805|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102220242|NCT02378805|Ramipril|ramipril|mesh-list
102220243|NCT02378805|Spironolactone|spironolactone|mesh-list
102220244|NCT02378805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102220245|NCT02378805|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102220246|NCT02378805|Hormone Antagonists|hormone antagonists|mesh-ancestor
102220247|NCT02378805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102220248|NCT02378805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220249|NCT02378805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102220250|NCT02378805|Diuretics|diuretics|mesh-ancestor
102220251|NCT02378805|Natriuretic Agents|natriuretic agents|mesh-ancestor
102220252|NCT02378805|Protease Inhibitors|protease inhibitors|mesh-ancestor
102220253|NCT02378805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102220254|NCT02378805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220255|NCT02378805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102220256|NCT02378805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102220257|NCT05094375|Misoprostol|misoprostol|mesh-list
102220258|NCT05094375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102220259|NCT05094375|Abortifacient Agents|abortifacient agents|mesh-ancestor
102220260|NCT05094375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102220261|NCT05094375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220262|NCT05094375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102220263|NCT05094375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102220264|NCT05094375|Oxytocics|oxytocics|mesh-ancestor
102220265|NCT04345861|Azithromycin|azithromycin|mesh-list
102220266|NCT04345861|Hydroxychloroquine|hydroxychloroquine|mesh-list
102220267|NCT04345861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102220268|NCT04345861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102220269|NCT04345861|Antimalarials|antimalarials|mesh-ancestor
102220270|NCT04345861|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102220271|NCT04345861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102220272|NCT04345861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102220273|NCT04345861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220274|NCT04345861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102220275|NCT02067819|Salicylic Acid|salicylic acid|mesh-list
102220276|NCT02067819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102220277|NCT02067819|Antifungal Agents|antifungal agents|mesh-ancestor
102220278|NCT02067819|Keratolytic Agents|keratolytic agents|mesh-ancestor
102220279|NCT02067819|Dermatologic Agents|dermatologic agents|mesh-ancestor
102220280|NCT02230306|Vemurafenib|vemurafenib|mesh-list
102220281|NCT02230306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102220282|NCT02230306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102220283|NCT02230306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102220284|NCT02230306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220285|NCT04266379|Insulin|insulin|mesh-list
102612408|NCT00002447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102220286|NCT04266379|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102220287|NCT04266379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101929112|NCT03777930|Growth Substances|growth substances|mesh-ancestor
102220288|NCT04266379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220289|NCT02308319|Tenofovir|tenofovir|mesh-list
102220290|NCT02308319|Antiviral Agents|antiviral agents|mesh-ancestor
102220291|NCT02308319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102220292|NCT02308319|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102220293|NCT02308319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102220294|NCT02308319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102220295|NCT02308319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220296|NCT02308319|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102220297|NCT02308319|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102220298|NCT02312375|Amlodipine|amlodipine|mesh-list
102220299|NCT02312375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102220300|NCT02312375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102220301|NCT02312375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102220302|NCT02312375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220303|NCT02312375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102220304|NCT02312375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220305|NCT02312375|Vasodilator Agents|vasodilator agents|mesh-ancestor
102220306|NCT05062174|Mifepristone|mifepristone|mesh-list
102220307|NCT05062174|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102220308|NCT05062174|Abortifacient Agents|abortifacient agents|mesh-ancestor
102220309|NCT05062174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102220310|NCT05062174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220311|NCT05062174|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102220312|NCT05062174|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102220313|NCT05062174|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102220314|NCT05062174|Contraceptive Agents|contraceptive agents|mesh-ancestor
102220315|NCT05062174|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102220316|NCT05062174|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102220317|NCT05062174|Hormone Antagonists|hormone antagonists|mesh-ancestor
102220318|NCT05062174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102220319|NCT05062174|Luteolytic Agents|luteolytic agents|mesh-ancestor
102220320|NCT05062174|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102220321|NCT05062174|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102220322|NCT05095467|Paclitaxel|paclitaxel|mesh-list
102220323|NCT05095467|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102220324|NCT05095467|Tegafur|tegafur|mesh-list
102220325|NCT05095467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102220326|NCT05095467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102220327|NCT05095467|Tubulin Modulators|tubulin modulators|mesh-ancestor
102220328|NCT05095467|Antimitotic Agents|antimitotic agents|mesh-ancestor
102220329|NCT05095467|Mitosis Modulators|mitosis modulators|mesh-ancestor
102220330|NCT05095467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220331|NCT05095467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102220332|NCT05095467|Antimetabolites|antimetabolites|mesh-ancestor
102220333|NCT02312531|Immunoglobulins|immunoglobulins|mesh-list
102220334|NCT02312531|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102220335|NCT02312531|Antibodies|antibodies|mesh-list
102220336|NCT02312531|Immunologic Factors|immunologic factors|mesh-ancestor
102220337|NCT02312531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220338|NCT04234477|Metoprolol|metoprolol|mesh-list
102220339|NCT04234477|Verapamil|verapamil|mesh-list
102220340|NCT04234477|Diltiazem|diltiazem|mesh-list
102220341|NCT04234477|Calcium Channel Blockers|calcium channel blockers|mesh-list
102220342|NCT04234477|Calcium|calcium|mesh-list
102220343|NCT04234477|Esmolol|esmolol|mesh-list
102220344|NCT04234477|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102220345|NCT04234477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102220346|NCT04234477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220347|NCT04234477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102220348|NCT04234477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102220349|NCT04234477|Sympatholytics|sympatholytics|mesh-ancestor
102220350|NCT04234477|Autonomic Agents|autonomic agents|mesh-ancestor
102220351|NCT04234477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102220352|NCT04234477|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102220353|NCT04234477|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102220354|NCT04234477|Adrenergic Agents|adrenergic agents|mesh-ancestor
102220355|NCT04234477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102220356|NCT04234477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612409|NCT00002447|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102220357|NCT04234477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102220358|NCT04234477|Vasodilator Agents|vasodilator agents|mesh-ancestor
102220359|NCT02449031|Tobramycin|tobramycin|mesh-list
102220360|NCT02449031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102220361|NCT02449031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102220362|NCT01680861|Mycophenolic Acid|mycophenolic acid|mesh-list
102220363|NCT01680861|Methylprednisolone|methylprednisolone|mesh-list
102220364|NCT01680861|Everolimus|everolimus|mesh-list
102220365|NCT01680861|Tacrolimus|tacrolimus|mesh-list
102220366|NCT01680861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102220367|NCT01680861|Immunologic Factors|immunologic factors|mesh-ancestor
102220368|NCT01680861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220369|NCT01680861|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102220370|NCT01680861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102220371|NCT01680861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220372|NCT01680861|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102220373|NCT01680861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102220374|NCT01680861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102220375|NCT01680861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102220376|NCT01680861|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102220377|NCT01680861|Antitubercular Agents|antitubercular agents|mesh-ancestor
102220378|NCT01680861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102220379|NCT01680861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102220380|NCT01680861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102220381|NCT01680861|Antiemetics|antiemetics|mesh-ancestor
102220382|NCT01680861|Autonomic Agents|autonomic agents|mesh-ancestor
102220383|NCT01680861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102220384|NCT01680861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102220385|NCT01680861|Glucocorticoids|glucocorticoids|mesh-ancestor
102220386|NCT01680861|Hormones|hormones|mesh-ancestor
102220387|NCT01680861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102220388|NCT01680861|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102220389|NCT01680861|Protective Agents|protective agents|mesh-ancestor
102220390|NCT02229214|Topiramate|topiramate|mesh-list
102220391|NCT02229214|Phentermine|phentermine|mesh-list
102220392|NCT02229214|Anticonvulsants|anticonvulsants|mesh-ancestor
102220393|NCT02229214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102220394|NCT02229214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220395|NCT02229214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102220396|NCT02229214|Appetite Depressants|appetite depressants|mesh-ancestor
102220397|NCT02229214|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102220398|NCT02229214|Sympathomimetics|sympathomimetics|mesh-ancestor
102220399|NCT02229214|Autonomic Agents|autonomic agents|mesh-ancestor
102220400|NCT02229214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102220401|NCT02229214|Adrenergic Agents|adrenergic agents|mesh-ancestor
102220402|NCT02229214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102220403|NCT02229214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220404|NCT02308553|Paclitaxel|paclitaxel|mesh-list
102220405|NCT02308553|Nintedanib|nintedanib|mesh-list
102220406|NCT02308553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102220407|NCT02308553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102220408|NCT02308553|Tubulin Modulators|tubulin modulators|mesh-ancestor
102220409|NCT02308553|Antimitotic Agents|antimitotic agents|mesh-ancestor
102220410|NCT02308553|Mitosis Modulators|mitosis modulators|mesh-ancestor
102220411|NCT02308553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220412|NCT02308553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102220413|NCT02308553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102220414|NCT05093907|Capecitabine|capecitabine|mesh-list
102220415|NCT05093907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102220416|NCT05093907|Antimetabolites|antimetabolites|mesh-ancestor
102220417|NCT05093907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220418|NCT05093907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102220419|NCT02228980|Vaccines|vaccines|mesh-list
102220420|NCT02228980|Immunologic Factors|immunologic factors|mesh-ancestor
102220421|NCT02228980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220422|NCT03783091|Hydroxocobalamin|hydroxocobalamin|mesh-list
102220423|NCT03783091|Vitamin B 12|vitamin b 12|mesh-list
102220424|NCT03783091|Hematinics|hematinics|mesh-ancestor
102220425|NCT03783091|Vitamin B Complex|vitamin b complex|mesh-ancestor
102612410|NCT00002447|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102612411|NCT00002447|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102220426|NCT03783091|Vitamins|vitamins|mesh-ancestor
102220427|NCT03783091|Micronutrients|micronutrients|mesh-ancestor
102220428|NCT03783091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220429|NCT05057481|Mycophenolic Acid|mycophenolic acid|mesh-list
102220430|NCT05057481|Rituximab|rituximab|mesh-list
102220431|NCT05057481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102220432|NCT05057481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102220433|NCT05057481|Immunologic Factors|immunologic factors|mesh-ancestor
102220434|NCT05057481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220435|NCT05057481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102220436|NCT05057481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102220437|NCT05057481|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102220438|NCT05057481|Antitubercular Agents|antitubercular agents|mesh-ancestor
102220439|NCT05057481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102220440|NCT05057481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102220441|NCT05057481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102220442|NCT05057481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220443|NCT02312609|Minocycline|minocycline|mesh-list
102220444|NCT02312609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102220445|NCT02312609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102220446|NCT03506399|Levonorgestrel|levonorgestrel|mesh-list
102220447|NCT03506399|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102220448|NCT03506399|Contraceptive Agents|contraceptive agents|mesh-list
102220449|NCT03506399|Contraceptives, Oral|contraceptives, oral|mesh-list
102220450|NCT03506399|Estradiol|estradiol|mesh-list
102220451|NCT03506399|Estrogens|estrogens|mesh-ancestor
102220452|NCT03506399|Hormones|hormones|mesh-ancestor
102220453|NCT03506399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102220454|NCT03506399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220455|NCT03506399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102220456|NCT03506399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102220457|NCT03506399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102220458|NCT03506399|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102220459|NCT03506399|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102220460|NCT02228590|Apomorphine|apomorphine|mesh-list
102220461|NCT02228590|Emetics|emetics|mesh-ancestor
102220462|NCT02228590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220463|NCT02228590|Autonomic Agents|autonomic agents|mesh-ancestor
102220464|NCT02228590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102220465|NCT02228590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102220466|NCT02228590|Dopamine Agonists|dopamine agonists|mesh-ancestor
102220467|NCT02228590|Dopamine Agents|dopamine agents|mesh-ancestor
102220468|NCT02228590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102220469|NCT02228590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220470|NCT03503201|Chromium|chromium|mesh-list
102220471|NCT03503201|Trace Elements|trace elements|mesh-ancestor
102220472|NCT03503201|Micronutrients|micronutrients|mesh-ancestor
102220473|NCT03503201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220474|NCT05095077|Tadalafil|tadalafil|mesh-list
102220475|NCT05095077|Vasodilator Agents|vasodilator agents|mesh-ancestor
102220476|NCT05095077|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102220477|NCT05095077|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102220478|NCT05095077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102220479|NCT05095077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220480|NCT05095077|Urological Agents|urological agents|mesh-ancestor
102220481|NCT02309177|Paclitaxel|paclitaxel|mesh-list
102220482|NCT02309177|Carboplatin|carboplatin|mesh-list
102220483|NCT02309177|Gemcitabine|gemcitabine|mesh-list
102220484|NCT02309177|Nivolumab|nivolumab|mesh-list
102220485|NCT02309177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102220486|NCT02309177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102220487|NCT02309177|Tubulin Modulators|tubulin modulators|mesh-ancestor
102220488|NCT02309177|Antimitotic Agents|antimitotic agents|mesh-ancestor
102220489|NCT02309177|Mitosis Modulators|mitosis modulators|mesh-ancestor
102220490|NCT02309177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220491|NCT02309177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102220492|NCT02309177|Antimetabolites|antimetabolites|mesh-ancestor
102220493|NCT02309177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102220494|NCT02309177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102220495|NCT02227108|Immunotoxin HA22|immunotoxin ha22|mesh-list
102220496|NCT02227108|Immunotoxins|immunotoxins|mesh-ancestor
102220497|NCT02227108|Immunoconjugates|immunoconjugates|mesh-ancestor
102220498|NCT02227108|Immunologic Factors|immunologic factors|mesh-ancestor
102220499|NCT02227108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220500|NCT02227108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102220501|NCT03564145|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102220502|NCT03564145|Dermatologic Agents|dermatologic agents|mesh-ancestor
102220503|NCT02312999|Plasma-lyte 148|plasma-lyte 148|mesh-list
102612412|NCT00002447|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102220504|NCT02312999|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102220505|NCT02312999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102612413|NCT00002447|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102220506|NCT04863261|Cabotegravir, rilpivirine drug combination|cabotegravir, rilpivirine drug combination|mesh-list
102220507|NCT04863261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102220508|NCT04863261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102220509|NCT04863261|Antiviral Agents|antiviral agents|mesh-ancestor
102220510|NCT04863261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102220511|NCT02313077|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
102220512|NCT02313077|Antiviral Agents|antiviral agents|mesh-ancestor
102220513|NCT02313077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102220514|NCT03423355|Dapagliflozin|dapagliflozin|mesh-list
102220515|NCT03423355|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102220516|NCT03423355|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102220517|NCT03423355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220518|NCT03423355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102220519|NCT03423355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220520|NCT03423355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102220521|NCT03423355|Diuretics|diuretics|mesh-ancestor
102220522|NCT03423355|Natriuretic Agents|natriuretic agents|mesh-ancestor
102220523|NCT03423355|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102220524|NCT03423355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102220525|NCT02226562|Listerine|listerine|mesh-list
102220526|NCT02226562|Fluorides|fluorides|mesh-list
102220527|NCT02226562|Sodium Fluoride|sodium fluoride|mesh-list
102220528|NCT02226562|Cariostatic Agents|cariostatic agents|mesh-ancestor
102220529|NCT02226562|Protective Agents|protective agents|mesh-ancestor
102220530|NCT02226562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220531|NCT02226562|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102220532|NCT02226562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102220533|NCT04430985|Leucovorin|leucovorin|mesh-list
102220534|NCT04430985|Fluorouracil|fluorouracil|mesh-list
102220535|NCT04430985|Oxaliplatin|oxaliplatin|mesh-list
102220536|NCT04430985|Nivolumab|nivolumab|mesh-list
102220537|NCT04430985|Ipilimumab|ipilimumab|mesh-list
102220538|NCT04430985|Antimetabolites|antimetabolites|mesh-ancestor
102220539|NCT04430985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220540|NCT04430985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102220541|NCT04430985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102220542|NCT04430985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102220543|NCT04430985|Immunologic Factors|immunologic factors|mesh-ancestor
101629207|NCT02643303|Poly ICLC|poly iclc|mesh-list
102220544|NCT04430985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220545|NCT04430985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102220546|NCT04430985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102220547|NCT04430985|Antidotes|antidotes|mesh-ancestor
102220548|NCT04430985|Protective Agents|protective agents|mesh-ancestor
102220549|NCT04430985|Vitamin B Complex|vitamin b complex|mesh-ancestor
102220550|NCT04430985|Vitamins|vitamins|mesh-ancestor
102220551|NCT04430985|Micronutrients|micronutrients|mesh-ancestor
102220552|NCT03365635|Ribavirin|ribavirin|mesh-list
102220553|NCT03365635|Grazoprevir|grazoprevir|mesh-list
102220554|NCT03365635|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
102220555|NCT03365635|Antimetabolites|antimetabolites|mesh-ancestor
102220556|NCT03365635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220557|NCT03365635|Antiviral Agents|antiviral agents|mesh-ancestor
102220558|NCT03365635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102220559|NCT04658277|Clarithromycin|clarithromycin|mesh-list
102220560|NCT04658277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102220561|NCT04658277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102220562|NCT04658277|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102220563|NCT04658277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102220564|NCT04658277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220565|NCT04658277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102220566|NCT04658277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102220567|NCT04456777|Vortioxetine|vortioxetine|mesh-list
102220568|NCT04456777|Antidepressive Agents|antidepressive agents|mesh-ancestor
102220569|NCT04456777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102220570|NCT04456777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102220571|NCT04456777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102220572|NCT04456777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102220573|NCT04456777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220574|NCT04456777|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102220575|NCT04456777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102220576|NCT04456777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102220577|NCT04456777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220578|NCT04456777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102220579|NCT04456777|Serotonin Agents|serotonin agents|mesh-ancestor
102220580|NCT04456777|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102220581|NCT04456777|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102220582|NCT04456777|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102220583|NCT04456777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102220584|NCT02874430|Metformin|metformin|mesh-list
102220585|NCT02874430|Doxycycline|doxycycline|mesh-list
102220586|NCT02874430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102220587|NCT02874430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220588|NCT02874430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102220589|NCT02874430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102220590|NCT02874430|Antimalarials|antimalarials|mesh-ancestor
102220591|NCT02874430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102220592|NCT02874430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102220593|NCT05160727|Irinotecan|irinotecan|mesh-list
102220594|NCT05160727|Tislelizumab|tislelizumab|mesh-list
102220595|NCT05160727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102220596|NCT05160727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102220597|NCT05160727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102220598|NCT05160727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220599|NCT05160727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102220600|NCT05160727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102220601|NCT03506009|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102220602|NCT03506009|Argatroban|argatroban|mesh-list
102220603|NCT03506009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102220604|NCT03506009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102220605|NCT03506009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220606|NCT03506009|Antithrombins|antithrombins|mesh-ancestor
102220607|NCT03506009|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102220608|NCT03506009|Protease Inhibitors|protease inhibitors|mesh-ancestor
102220609|NCT03506009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102220610|NCT03506009|Anticoagulants|anticoagulants|mesh-ancestor
102220611|NCT03506009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102220612|NCT03130855|Carticaine|carticaine|mesh-list
102220613|NCT03130855|Anesthetics, Local|anesthetics, local|mesh-ancestor
102220614|NCT03130855|Anesthetics|anesthetics|mesh-ancestor
102220615|NCT03130855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102220616|NCT03130855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220617|NCT03130855|Sensory System Agents|sensory system agents|mesh-ancestor
102220618|NCT03130855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102220619|NCT02309801|Daidzin|daidzin|mesh-list
102220620|NCT02309801|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102220621|NCT02309801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102220622|NCT02309801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220623|NCT02309879|Lidocaine|lidocaine|mesh-list
102220624|NCT02309879|Magnesium Sulfate|magnesium sulfate|mesh-list
102220625|NCT02309879|Remifentanil|remifentanil|mesh-list
102220626|NCT02309879|Anesthetics, Local|anesthetics, local|mesh-ancestor
102220627|NCT02309879|Anesthetics|anesthetics|mesh-ancestor
102220628|NCT02309879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102220629|NCT02309879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220630|NCT02309879|Sensory System Agents|sensory system agents|mesh-ancestor
102220631|NCT02309879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102220632|NCT02309879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102220633|NCT02309879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102220634|NCT02309879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102220635|NCT02309879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102220636|NCT02309879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220637|NCT02309879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102220638|NCT02309879|Narcotics|narcotics|mesh-ancestor
102220639|NCT02309879|Analgesics|analgesics|mesh-ancestor
102220640|NCT02309879|Anticonvulsants|anticonvulsants|mesh-ancestor
102220641|NCT02309879|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102220642|NCT02309879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102220643|NCT02309879|Tocolytic Agents|tocolytic agents|mesh-ancestor
102220644|NCT02309879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102220645|NCT02476786|Tamoxifen|tamoxifen|mesh-list
102220646|NCT02476786|Fulvestrant|fulvestrant|mesh-list
102220647|NCT02476786|Anastrozole|anastrozole|mesh-list
102220648|NCT02476786|Goserelin|goserelin|mesh-list
102220649|NCT02476786|Exemestane|exemestane|mesh-list
102220650|NCT02476786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102612414|NCT00002453|Tenofovir|tenofovir|mesh-list
102220651|NCT02476786|Hormone Antagonists|hormone antagonists|mesh-ancestor
102220652|NCT02476786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102220653|NCT02476786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102612415|NCT00002453|Antiviral Agents|antiviral agents|mesh-ancestor
102220654|NCT02476786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102612416|NCT00002453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102220655|NCT02476786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102220656|NCT02476786|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102220657|NCT02476786|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102220658|NCT02476786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102220659|NCT02476786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102220660|NCT02476786|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102220661|NCT02476786|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102220662|NCT02476786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102220663|NCT02476786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220665|NCT02820961|Entinostat|entinostat|mesh-list
102220666|NCT02820961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102220667|NCT02820961|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102220668|NCT02820961|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102220669|NCT02820961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102220670|NCT02820961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220671|NCT02820961|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102220672|NCT02820961|Hormone Antagonists|hormone antagonists|mesh-ancestor
102220673|NCT02820961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102220674|NCT02820961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220675|NCT02820961|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102220676|NCT04658173|Alfentanil|alfentanil|mesh-list
102220677|NCT04658173|Propofol|propofol|mesh-list
102220678|NCT04658173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102220679|NCT04658173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102220680|NCT04658173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220681|NCT04658173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102220682|NCT04658173|Anesthetics, General|anesthetics, general|mesh-ancestor
102220683|NCT04658173|Anesthetics|anesthetics|mesh-ancestor
102220684|NCT04658173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102220685|NCT04658173|Narcotics|narcotics|mesh-ancestor
102220686|NCT04658173|Analgesics|analgesics|mesh-ancestor
102220687|NCT04658173|Sensory System Agents|sensory system agents|mesh-ancestor
102220688|NCT04658173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102220689|NCT02399410|Bevacizumab|bevacizumab|mesh-list
102220690|NCT02399410|Oxaliplatin|oxaliplatin|mesh-list
102220691|NCT02399410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102220692|NCT02399410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102220693|NCT02399410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102220694|NCT02399410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102220695|NCT02399410|Growth Substances|growth substances|mesh-ancestor
102220696|NCT02399410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220697|NCT02399410|Growth Inhibitors|growth inhibitors|mesh-ancestor
102220698|NCT03636165|Methylprednisolone|methylprednisolone|mesh-list
102220699|NCT03636165|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102220700|NCT03636165|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102220701|NCT03636165|Prednisolone|prednisolone|mesh-list
102220702|NCT03636165|Prednisolone acetate|prednisolone acetate|mesh-list
102220703|NCT03636165|Ropivacaine|ropivacaine|mesh-list
102220704|NCT03636165|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102220705|NCT03636165|Prednisolone phosphate|prednisolone phosphate|mesh-list
102220706|NCT03636165|Anesthetics, Local|anesthetics, local|mesh-ancestor
102220707|NCT03636165|Anesthetics|anesthetics|mesh-ancestor
102220708|NCT03636165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102220709|NCT03636165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220710|NCT03636165|Sensory System Agents|sensory system agents|mesh-ancestor
102220711|NCT03636165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102220712|NCT03636165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102220713|NCT03636165|Antiemetics|antiemetics|mesh-ancestor
102220714|NCT03636165|Autonomic Agents|autonomic agents|mesh-ancestor
102220715|NCT03636165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102220716|NCT03636165|Glucocorticoids|glucocorticoids|mesh-ancestor
102220717|NCT03636165|Hormones|hormones|mesh-ancestor
102220718|NCT03636165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102220719|NCT03636165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102220720|NCT03636165|Protective Agents|protective agents|mesh-ancestor
102220721|NCT03636165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102220722|NCT03636165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102220723|NCT02310347|Dronabinol|dronabinol|mesh-list
102220724|NCT02310347|Hallucinogens|hallucinogens|mesh-ancestor
102220725|NCT02310347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220726|NCT02310347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102220727|NCT02310347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102220728|NCT02310347|Analgesics|analgesics|mesh-ancestor
102220729|NCT02310347|Sensory System Agents|sensory system agents|mesh-ancestor
102220730|NCT02310347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102220731|NCT02310347|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102220732|NCT02310347|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102220733|NCT02310347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102220734|NCT02310347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220735|NCT02310347|Hormones|hormones|mesh-ancestor
102220736|NCT02310347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102220737|NCT04429425|Anesthetics|anesthetics|mesh-list
102220738|NCT04429425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102220739|NCT04429425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220740|NCT03502889|Ropivacaine|ropivacaine|mesh-list
102220741|NCT03502889|Anesthetics, Local|anesthetics, local|mesh-ancestor
102220742|NCT03502889|Anesthetics|anesthetics|mesh-ancestor
102220743|NCT03502889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102220744|NCT03502889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220745|NCT03502889|Sensory System Agents|sensory system agents|mesh-ancestor
102220746|NCT03502889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102220747|NCT05098353|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102220748|NCT05098353|Antidepressive Agents|antidepressive agents|mesh-ancestor
102220749|NCT05098353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102220750|NCT05098353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102220751|NCT05098353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102220752|NCT05098353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102220753|NCT05098353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220754|NCT05098119|Paclitaxel|paclitaxel|mesh-list
102220755|NCT05098119|Carboplatin|carboplatin|mesh-list
102220756|NCT05098119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102220757|NCT05098119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102220758|NCT05098119|Tubulin Modulators|tubulin modulators|mesh-ancestor
102220759|NCT05098119|Antimitotic Agents|antimitotic agents|mesh-ancestor
102220760|NCT05098119|Mitosis Modulators|mitosis modulators|mesh-ancestor
102220761|NCT05098119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220762|NCT02738879|Metformin|metformin|mesh-list
102220763|NCT02738879|Insulin Glargine|insulin glargine|mesh-list
102220764|NCT02738879|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102220765|NCT02738879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102220766|NCT02738879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220767|NCT02738879|Incretins|incretins|mesh-ancestor
102220768|NCT02738879|Hormones|hormones|mesh-ancestor
102220769|NCT02738879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102220770|NCT02738879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102220771|NCT02738879|Protease Inhibitors|protease inhibitors|mesh-ancestor
102220772|NCT02738879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102220773|NCT02738879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220774|NCT03253913|Sirolimus|sirolimus|mesh-list
102220775|NCT03253913|Resveratrol|resveratrol|mesh-list
102220776|NCT03253913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102220777|NCT03253913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102220778|NCT03253913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102220779|NCT03253913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102220780|NCT03253913|Antifungal Agents|antifungal agents|mesh-ancestor
102220781|NCT03253913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102220782|NCT03253913|Immunologic Factors|immunologic factors|mesh-ancestor
102220783|NCT03253913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220784|NCT03253913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102220785|NCT03253913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220786|NCT03253913|Antioxidants|antioxidants|mesh-ancestor
102220787|NCT03253913|Protective Agents|protective agents|mesh-ancestor
102220788|NCT03253913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102220789|NCT03237819|Magnesium Sulfate|magnesium sulfate|mesh-list
102220790|NCT03237819|Analgesics|analgesics|mesh-ancestor
102220791|NCT03237819|Sensory System Agents|sensory system agents|mesh-ancestor
102220792|NCT03237819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102220793|NCT03237819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220794|NCT03237819|Anesthetics|anesthetics|mesh-ancestor
102220795|NCT03237819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102220796|NCT03237819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102220797|NCT03237819|Anticonvulsants|anticonvulsants|mesh-ancestor
102220798|NCT03237819|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102220799|NCT03237819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102220800|NCT03237819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612417|NCT00002453|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102220801|NCT03237819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102220802|NCT03237819|Tocolytic Agents|tocolytic agents|mesh-ancestor
102220803|NCT03237819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102220804|NCT03468907|Tenofovir|tenofovir|mesh-list
102220805|NCT03468907|Telbivudine|telbivudine|mesh-list
102220806|NCT03468907|Antiviral Agents|antiviral agents|mesh-ancestor
102220807|NCT03468907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102220808|NCT03468907|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102220809|NCT03468907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102220810|NCT03468907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102220811|NCT03468907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629239|NCT00790036|Everolimus|everolimus|mesh-list
102220812|NCT03468907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102220813|NCT03468907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102220814|NCT05089851|Sunscreening Agents|sunscreening agents|mesh-list
101929645|NCT05133804|Reboxetine|reboxetine|mesh-list
102220815|NCT05089851|Botulinum Toxins|botulinum toxins|mesh-list
102220816|NCT05089851|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102220817|NCT05089851|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102220818|NCT05089851|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102220819|NCT05089851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102220820|NCT05089851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220821|NCT05089851|Cholinergic Agents|cholinergic agents|mesh-ancestor
102220822|NCT05089851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102220823|NCT05089851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220824|NCT05089851|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102220825|NCT05089851|Protective Agents|protective agents|mesh-ancestor
102220826|NCT05089851|Dermatologic Agents|dermatologic agents|mesh-ancestor
102220827|NCT05089851|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102220828|NCT05089851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102220829|NCT04657809|Insulin|insulin|mesh-list
102220830|NCT04657809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102220831|NCT04657809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220832|NCT05350917|Tislelizumab|tislelizumab|mesh-list
102220833|NCT05350917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102220834|NCT05350917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102220835|NCT02311205|Sorafenib|sorafenib|mesh-list
102220836|NCT02311205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102220837|NCT02311205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102220838|NCT02311205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102220839|NCT02311205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220840|NCT05390749|Rituximab|rituximab|mesh-list
102220841|NCT05390749|Methotrexate|methotrexate|mesh-list
102220842|NCT05390749|Pomalidomide|pomalidomide|mesh-list
102220843|NCT05390749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102220844|NCT05390749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102220845|NCT05390749|Immunologic Factors|immunologic factors|mesh-ancestor
102220846|NCT05390749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220847|NCT05390749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102220848|NCT05390749|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102220849|NCT05390749|Abortifacient Agents|abortifacient agents|mesh-ancestor
102220850|NCT05390749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102220851|NCT05390749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102220852|NCT05390749|Antimetabolites|antimetabolites|mesh-ancestor
102220853|NCT05390749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220854|NCT05390749|Dermatologic Agents|dermatologic agents|mesh-ancestor
102220855|NCT05390749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102220856|NCT05390749|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102220857|NCT05390749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102220858|NCT05390749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102220859|NCT05390749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102220860|NCT05390749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102220861|NCT05390749|Growth Substances|growth substances|mesh-ancestor
102220862|NCT05390749|Growth Inhibitors|growth inhibitors|mesh-ancestor
102220863|NCT02813655|Cosyntropin|cosyntropin|mesh-list
102220864|NCT02813655|Hormones|hormones|mesh-ancestor
102220865|NCT02813655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102220866|NCT02813655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220867|NCT03468829|Gontivimab|gontivimab|mesh-list
102220868|NCT03468829|Antiviral Agents|antiviral agents|mesh-ancestor
102220869|NCT03468829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102220870|NCT04912791|Anesthetics|anesthetics|mesh-list
102220871|NCT04912791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102220872|NCT04912791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220873|NCT02316197|Peposertib|peposertib|mesh-list
102220874|NCT02316197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102220875|NCT02316197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102220876|NCT02316197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220877|NCT02314013|Metronidazole|metronidazole|mesh-list
102220878|NCT02314013|Cephalosporins|cephalosporins|mesh-list
102220879|NCT02314013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102220880|NCT02314013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102220881|NCT02314013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102220882|NCT02314013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102220883|NCT01677195|Calcium Carbonate|calcium carbonate|mesh-list
102220884|NCT01677195|Antacids|antacids|mesh-ancestor
102220885|NCT01677195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220886|NCT01677195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102220887|NCT05331807|Vitamin D|vitamin d|mesh-list
101929722|NCT04236258|Vasodilator Agents|vasodilator agents|mesh-ancestor
102220888|NCT05331807|Ergocalciferols|ergocalciferols|mesh-list
102220889|NCT05331807|Cholecalciferol|cholecalciferol|mesh-list
102220890|NCT05331807|Vitamins|vitamins|mesh-list
102220891|NCT05331807|Micronutrients|micronutrients|mesh-ancestor
102220892|NCT05331807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220893|NCT05331807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102220894|NCT05331807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102220895|NCT02314325|Factor VIII|factor viii|mesh-list
102220896|NCT02314325|Coagulants|coagulants|mesh-ancestor
102220897|NCT04707261|Dapagliflozin|dapagliflozin|mesh-list
102220898|NCT04707261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102220899|NCT04707261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220900|NCT04707261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102220901|NCT04707261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220902|NCT02314481|Trastuzumab|trastuzumab|mesh-list
102220903|NCT02314481|Atezolizumab|atezolizumab|mesh-list
102220904|NCT02314481|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102220905|NCT02314481|Vemurafenib|vemurafenib|mesh-list
102220906|NCT02314481|Maytansine|maytansine|mesh-list
102220907|NCT02314481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102220908|NCT02314481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102220909|NCT02314481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102220910|NCT02314481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220911|NCT02314481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102220912|NCT02314481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102220913|NCT02314481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102220914|NCT02314481|Tubulin Modulators|tubulin modulators|mesh-ancestor
102220915|NCT02314481|Antimitotic Agents|antimitotic agents|mesh-ancestor
102220916|NCT02314481|Mitosis Modulators|mitosis modulators|mesh-ancestor
102220917|NCT02314481|Immunotoxins|immunotoxins|mesh-ancestor
102220918|NCT02314481|Immunoconjugates|immunoconjugates|mesh-ancestor
102220919|NCT02314481|Immunologic Factors|immunologic factors|mesh-ancestor
102220920|NCT02314481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220921|NCT03502421|Ketamine|ketamine|mesh-list
102220922|NCT03502421|Analgesics|analgesics|mesh-ancestor
102220923|NCT03502421|Sensory System Agents|sensory system agents|mesh-ancestor
102220924|NCT03502421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102220925|NCT03502421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220926|NCT03502421|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102220927|NCT03502421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102220928|NCT03502421|Anesthetics, General|anesthetics, general|mesh-ancestor
102220929|NCT03502421|Anesthetics|anesthetics|mesh-ancestor
102220930|NCT03502421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102220931|NCT03502421|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102220932|NCT03502421|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102220933|NCT03502421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102220934|NCT03502421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220935|NCT03502343|Paclitaxel|paclitaxel|mesh-list
102220936|NCT03502343|Gemcitabine|gemcitabine|mesh-list
102220937|NCT03502343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102220938|NCT03502343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102220939|NCT03502343|Tubulin Modulators|tubulin modulators|mesh-ancestor
102220940|NCT03502343|Antimitotic Agents|antimitotic agents|mesh-ancestor
102220941|NCT03502343|Mitosis Modulators|mitosis modulators|mesh-ancestor
102220942|NCT03502343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220943|NCT03502343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102220944|NCT03502343|Antimetabolites|antimetabolites|mesh-ancestor
102220945|NCT04345887|Spironolactone|spironolactone|mesh-list
102220946|NCT04345887|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102220947|NCT04345887|Hormone Antagonists|hormone antagonists|mesh-ancestor
101900914|NCT03860480|Bupivacaine|bupivacaine|mesh-list
102612418|NCT00002453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102612419|NCT00002453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102220948|NCT04345887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102220949|NCT04345887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220950|NCT04345887|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102220952|NCT04345887|Natriuretic Agents|natriuretic agents|mesh-ancestor
102220953|NCT02316899|Linaclotide|linaclotide|mesh-list
102220954|NCT02316899|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102220955|NCT02316899|Enzyme Activators|enzyme activators|mesh-ancestor
102220956|NCT02316899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220957|NCT02316899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102220958|NCT02314871|Morphine|morphine|mesh-list
102220959|NCT02314871|Pirinitramide|pirinitramide|mesh-list
102220960|NCT02314871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102220961|NCT02314871|Narcotics|narcotics|mesh-ancestor
102220962|NCT02314871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102220963|NCT02314871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220964|NCT02314871|Analgesics|analgesics|mesh-ancestor
102220965|NCT02314871|Sensory System Agents|sensory system agents|mesh-ancestor
102220966|NCT02314871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102220967|NCT02224846|Tadalafil|tadalafil|mesh-list
102220968|NCT02224846|Vasodilator Agents|vasodilator agents|mesh-ancestor
102220969|NCT02224846|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102220970|NCT02224846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102220971|NCT02224846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102220972|NCT02224846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220973|NCT02224846|Urological Agents|urological agents|mesh-ancestor
102220974|NCT03470077|Nalbuphine|nalbuphine|mesh-list
102220975|NCT03470077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102220976|NCT03470077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102220977|NCT03470077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102220978|NCT03470077|Narcotics|narcotics|mesh-ancestor
102220979|NCT03470077|Analgesics|analgesics|mesh-ancestor
102220980|NCT03470077|Sensory System Agents|sensory system agents|mesh-ancestor
102220981|NCT03470077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102220982|NCT03519295|Atezolizumab|atezolizumab|mesh-list
102220983|NCT03519295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102220984|NCT03519295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102220985|NCT03519295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102220986|NCT03519295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102220987|NCT02224690|Cannabidiol|cannabidiol|mesh-list
102220988|NCT02224690|Anticonvulsants|anticonvulsants|mesh-ancestor
102220989|NCT03501251|Albendazole|albendazole|mesh-list
102220990|NCT03501251|Moxidectin|moxidectin|mesh-list
102220991|NCT03501251|Anthelmintics|anthelmintics|mesh-ancestor
102220992|NCT03501251|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102220993|NCT03501251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102220994|NCT03501251|Anticestodal Agents|anticestodal agents|mesh-ancestor
102220995|NCT03501251|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102220996|NCT03501251|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102220997|NCT03501251|Tubulin Modulators|tubulin modulators|mesh-ancestor
102220998|NCT03501251|Antimitotic Agents|antimitotic agents|mesh-ancestor
102220999|NCT03501251|Mitosis Modulators|mitosis modulators|mesh-ancestor
102221000|NCT03501251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221001|NCT03501251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102221002|NCT03501251|Antinematodal Agents|antinematodal agents|mesh-ancestor
102221003|NCT05163691|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
102221004|NCT05163691|Hallucinogens|hallucinogens|mesh-ancestor
102221005|NCT05163691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221006|NCT05163691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102221007|NCT05163691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102221008|NCT05163691|Serotonin Agents|serotonin agents|mesh-ancestor
102221009|NCT05163691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102221010|NCT05163691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221011|NCT05163691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102221012|NCT05390203|Testosterone|testosterone|mesh-list
102221013|NCT05390203|Androgens|androgens|mesh-ancestor
102221014|NCT05390203|Hormones|hormones|mesh-ancestor
102221015|NCT05390203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102221016|NCT05390203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221017|NCT01634152|Tiotropium Bromide|tiotropium bromide|mesh-list
102221018|NCT01634152|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102221019|NCT01634152|Autonomic Agents|autonomic agents|mesh-ancestor
102221020|NCT01634152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102221021|NCT01634152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102612420|NCT00002453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221022|NCT01634152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102221023|NCT01634152|Respiratory System Agents|respiratory system agents|mesh-ancestor
102221024|NCT01634152|Parasympatholytics|parasympatholytics|mesh-ancestor
102221025|NCT01634152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102221026|NCT01634152|Cholinergic Agents|cholinergic agents|mesh-ancestor
102221027|NCT01634152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102221028|NCT01634152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221029|NCT02315495|Saxagliptin|saxagliptin|mesh-list
102221030|NCT02315495|Acarbose|acarbose|mesh-list
102221031|NCT02315495|Incretins|incretins|mesh-ancestor
102221032|NCT02315495|Hormones|hormones|mesh-ancestor
102221033|NCT02315495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102221034|NCT02315495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221035|NCT02315495|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102221036|NCT02315495|Protease Inhibitors|protease inhibitors|mesh-ancestor
102221037|NCT02315495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102221038|NCT02315495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221039|NCT02315495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102221040|NCT02315495|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102221041|NCT02317601|Methylprednisolone|methylprednisolone|mesh-list
102221042|NCT02317601|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102221043|NCT02317601|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102221045|NCT02317601|Prednisolone acetate|prednisolone acetate|mesh-list
102221046|NCT02317601|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102221047|NCT02317601|Prednisolone phosphate|prednisolone phosphate|mesh-list
102221048|NCT02317601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102221049|NCT02317601|Antiemetics|antiemetics|mesh-ancestor
102221050|NCT02317601|Autonomic Agents|autonomic agents|mesh-ancestor
102221051|NCT02317601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102221052|NCT02317601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221053|NCT02317601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102221054|NCT02317601|Glucocorticoids|glucocorticoids|mesh-ancestor
102221055|NCT02317601|Hormones|hormones|mesh-ancestor
102221056|NCT02317601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102221057|NCT02317601|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102221058|NCT02317601|Protective Agents|protective agents|mesh-ancestor
102221059|NCT02317601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102221060|NCT02317601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102221061|NCT05101785|Lidocaine|lidocaine|mesh-list
102221062|NCT05101785|Epinephrine|epinephrine|mesh-list
102221063|NCT05101785|Racepinephrine|racepinephrine|mesh-list
102221064|NCT05101785|Carticaine|carticaine|mesh-list
102221065|NCT05101785|Epinephryl borate|epinephryl borate|mesh-list
102221066|NCT05101785|Anesthetics, Local|anesthetics, local|mesh-ancestor
102221067|NCT05101785|Anesthetics|anesthetics|mesh-ancestor
102221068|NCT05101785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102221069|NCT05101785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221070|NCT05101785|Sensory System Agents|sensory system agents|mesh-ancestor
102221071|NCT05101785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102221072|NCT05101785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102221073|NCT05101785|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102221074|NCT05101785|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102221075|NCT05101785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102221076|NCT05101785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221077|NCT05101785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102221078|NCT05101785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102221079|NCT05101785|Adrenergic Agents|adrenergic agents|mesh-ancestor
102221080|NCT05101785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102221081|NCT05101785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102221082|NCT05101785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102221083|NCT05101785|Autonomic Agents|autonomic agents|mesh-ancestor
102221084|NCT05101785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102221085|NCT05101785|Respiratory System Agents|respiratory system agents|mesh-ancestor
102221086|NCT05101785|Mydriatics|mydriatics|mesh-ancestor
102221087|NCT05101785|Sympathomimetics|sympathomimetics|mesh-ancestor
102221088|NCT05101785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102221089|NCT02315573|Lidocaine|lidocaine|mesh-list
102221090|NCT02315573|Epinephrine|epinephrine|mesh-list
102221091|NCT02315573|Racepinephrine|racepinephrine|mesh-list
102221092|NCT02315573|Bupivacaine|bupivacaine|mesh-list
102221093|NCT02315573|Epinephryl borate|epinephryl borate|mesh-list
102221094|NCT02315573|Anesthetics, Local|anesthetics, local|mesh-ancestor
102221095|NCT02315573|Anesthetics|anesthetics|mesh-ancestor
102221096|NCT02315573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102612421|NCT00002453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102612422|NCT00002453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102221097|NCT02315573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221098|NCT02315573|Sensory System Agents|sensory system agents|mesh-ancestor
102221099|NCT02315573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102221100|NCT02315573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102221101|NCT02315573|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102221102|NCT02315573|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102221103|NCT02315573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102221104|NCT02315573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221105|NCT02315573|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102221106|NCT02315573|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102221107|NCT02315573|Adrenergic Agents|adrenergic agents|mesh-ancestor
102221108|NCT02315573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102221109|NCT02315573|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102221110|NCT02315573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102221111|NCT02315573|Autonomic Agents|autonomic agents|mesh-ancestor
102221112|NCT02315573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102221113|NCT02315573|Respiratory System Agents|respiratory system agents|mesh-ancestor
102221114|NCT02315573|Mydriatics|mydriatics|mesh-ancestor
102221115|NCT02315573|Sympathomimetics|sympathomimetics|mesh-ancestor
102221116|NCT02315573|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102221117|NCT02724241|Nicotine|nicotine|mesh-list
102221118|NCT02724241|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102221119|NCT02724241|Autonomic Agents|autonomic agents|mesh-ancestor
102221120|NCT02724241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102221121|NCT02724241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221122|NCT02724241|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102221123|NCT02724241|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102221124|NCT02724241|Cholinergic Agents|cholinergic agents|mesh-ancestor
102221125|NCT02724241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102221126|NCT02724241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221127|NCT02315651|Ubiquinone|ubiquinone|mesh-list
102221128|NCT02315651|Coenzyme Q10|coenzyme q10|mesh-list
102221129|NCT02315651|Micronutrients|micronutrients|mesh-ancestor
102221130|NCT02315651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221131|NCT02315651|Vitamins|vitamins|mesh-ancestor
102221132|NCT05366725|Avelumab|avelumab|mesh-list
102221133|NCT05366725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102221134|NCT05366725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102221135|NCT04437693|Hydroxychloroquine|hydroxychloroquine|mesh-list
102221136|NCT04437693|Antimalarials|antimalarials|mesh-ancestor
102221137|NCT04437693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102221138|NCT04437693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102221139|NCT04437693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102221140|NCT04437693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102221141|NCT04437693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221142|NCT04437693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102221143|NCT02317679|Bosentan|bosentan|mesh-list
102221144|NCT02317679|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102221145|NCT02317679|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102221146|NCT02317679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221147|NCT03475381|Ivacaftor|ivacaftor|mesh-list
102221148|NCT03475381|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102221149|NCT03475381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102221150|NCT03475381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221151|NCT04462757|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102221152|NCT04462757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102221153|NCT04535505|Erythromycin|erythromycin|mesh-list
102221154|NCT04535505|Erythromycin Estolate|erythromycin estolate|mesh-list
102221155|NCT04535505|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
102221156|NCT04535505|Erythromycin stearate|erythromycin stearate|mesh-list
102221157|NCT04535505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102221158|NCT04535505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102221159|NCT04535505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102221160|NCT04535505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102221161|NCT04535505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102221162|NCT04535505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221163|NCT03500783|Nitric Oxide|nitric oxide|mesh-list
102221164|NCT03500783|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102221165|NCT03500783|Autonomic Agents|autonomic agents|mesh-ancestor
102221166|NCT03500783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102221167|NCT03500783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221168|NCT03500783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101762999|NCT00943930|Analgesics|analgesics|mesh-ancestor
102612423|NCT00002465|Megestrol|megestrol|mesh-list
102221169|NCT03500783|Respiratory System Agents|respiratory system agents|mesh-ancestor
102221170|NCT03500783|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102221171|NCT03500783|Antioxidants|antioxidants|mesh-ancestor
102221172|NCT03500783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221173|NCT03500783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102221174|NCT03500783|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102221175|NCT03500783|Vasodilator Agents|vasodilator agents|mesh-ancestor
102221176|NCT03500783|Gasotransmitters|gasotransmitters|mesh-ancestor
102221177|NCT03500783|Protective Agents|protective agents|mesh-ancestor
102221178|NCT03353233|Ropivacaine|ropivacaine|mesh-list
102221179|NCT03353233|Anesthetics, Local|anesthetics, local|mesh-ancestor
102221180|NCT03353233|Anesthetics|anesthetics|mesh-ancestor
102221181|NCT03353233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102221182|NCT03353233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221183|NCT03353233|Sensory System Agents|sensory system agents|mesh-ancestor
102221184|NCT03353233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102221185|NCT02320877|Methaqualone|methaqualone|mesh-list
102221186|NCT02320877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102221187|NCT02320877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102221188|NCT02320877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221189|NCT01322971|Metronidazole|metronidazole|mesh-list
102221190|NCT01322971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102221191|NCT01322971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102221192|NCT01322971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102221193|NCT01322971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102221195|NCT04454281|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102221196|NCT04454281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221197|NCT04454281|Sensory System Agents|sensory system agents|mesh-ancestor
102221198|NCT04454281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102221199|NCT02318225|Misoprostol|misoprostol|mesh-list
102221200|NCT02318225|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102221201|NCT02318225|Abortifacient Agents|abortifacient agents|mesh-ancestor
102221202|NCT02318225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102221203|NCT02318225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221204|NCT02318225|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102221205|NCT02318225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102221206|NCT02318225|Oxytocics|oxytocics|mesh-ancestor
102221207|NCT01378429|Ciclesonide|ciclesonide|mesh-list
102221208|NCT01378429|Glucocorticoids|glucocorticoids|mesh-ancestor
102221209|NCT01378429|Hormones|hormones|mesh-ancestor
102221210|NCT01378429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102221211|NCT01378429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221212|NCT01378429|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102221213|NCT01599754|Axitinib|axitinib|mesh-list
102221214|NCT01599754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102221215|NCT01599754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102221216|NCT01599754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102221217|NCT01599754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221218|NCT02321267|Ranibizumab|ranibizumab|mesh-list
102221219|NCT02321267|Aflibercept|aflibercept|mesh-list
102221220|NCT02321267|Verteporfin|verteporfin|mesh-list
101629270|NCT00915616|Melatonin|melatonin|mesh-list
102221221|NCT02321267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102221222|NCT02321267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102221223|NCT02321267|Growth Substances|growth substances|mesh-ancestor
102221224|NCT02321267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221225|NCT02321267|Growth Inhibitors|growth inhibitors|mesh-ancestor
102221226|NCT02321267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102221227|NCT02321267|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102221228|NCT02321267|Dermatologic Agents|dermatologic agents|mesh-ancestor
102221229|NCT02318537|Cannabidiol|cannabidiol|mesh-list
102221230|NCT02318537|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102221231|NCT02318537|Anticonvulsants|anticonvulsants|mesh-ancestor
102221232|NCT04642261|Empagliflozin|empagliflozin|mesh-list
102221233|NCT04642261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102221234|NCT04642261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221235|NCT04642261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102221236|NCT04642261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221237|NCT02318771|Pembrolizumab|pembrolizumab|mesh-list
102221238|NCT02318771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102221239|NCT02318771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102221240|NCT02318771|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102221241|NCT02318771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221242|NCT04936399|Nivolumab|nivolumab|mesh-list
102221243|NCT04936399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102612424|NCT00002465|Megestrol Acetate|megestrol acetate|mesh-list
102612425|NCT00002465|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102221244|NCT04936399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102221245|NCT04936399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102221246|NCT04936399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221247|NCT02319161|Calcium Channel Blockers|calcium channel blockers|mesh-list
102221248|NCT02319161|Calcium|calcium|mesh-list
102221249|NCT02319161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102221250|NCT02319161|Esmolol|esmolol|mesh-list
102221251|NCT02319161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102221252|NCT02319161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221253|NCT02319161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102221254|NCT02319161|Adrenergic Agents|adrenergic agents|mesh-ancestor
102221255|NCT02319161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102221256|NCT02319161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221257|NCT02319161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102221258|NCT02319161|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102221259|NCT02321579|Vitamin B 6|vitamin b 6|mesh-list
102221260|NCT02321579|Pyridoxal|pyridoxal|mesh-list
102221261|NCT02321579|Pyridoxine|pyridoxine|mesh-list
102221262|NCT02321579|Vitamins|vitamins|mesh-ancestor
102221263|NCT02321579|Micronutrients|micronutrients|mesh-ancestor
102221264|NCT02321579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221265|NCT02321579|Vitamin B Complex|vitamin b complex|mesh-ancestor
102221267|NCT01584934|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102221268|NCT01584934|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102221269|NCT01584934|Anesthetics, General|anesthetics, general|mesh-ancestor
102221270|NCT01584934|Anesthetics|anesthetics|mesh-ancestor
102221271|NCT01584934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102221272|NCT01584934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221273|NCT03109691|Dexamethasone|dexamethasone|mesh-list
102221274|NCT03109691|Bupivacaine|bupivacaine|mesh-list
102221275|NCT03109691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102221276|NCT03109691|Antiemetics|antiemetics|mesh-ancestor
102221277|NCT03109691|Autonomic Agents|autonomic agents|mesh-ancestor
102221278|NCT03109691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102221279|NCT03109691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221280|NCT03109691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102221281|NCT03109691|Glucocorticoids|glucocorticoids|mesh-ancestor
102221282|NCT03109691|Hormones|hormones|mesh-ancestor
102221283|NCT03109691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102221284|NCT03109691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102221285|NCT03109691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102221286|NCT03109691|Anesthetics, Local|anesthetics, local|mesh-ancestor
102221287|NCT03109691|Anesthetics|anesthetics|mesh-ancestor
102221288|NCT03109691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102221289|NCT03109691|Sensory System Agents|sensory system agents|mesh-ancestor
102221290|NCT03497351|Nicardipine|nicardipine|mesh-list
102221291|NCT03497351|Urapidil|urapidil|mesh-list
102221292|NCT03497351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102221293|NCT03497351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102221294|NCT03497351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102221295|NCT03497351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221296|NCT03497351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102221297|NCT03497351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221298|NCT03497351|Vasodilator Agents|vasodilator agents|mesh-ancestor
102221299|NCT03497351|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102221300|NCT03497351|Serotonin Agents|serotonin agents|mesh-ancestor
102221301|NCT03497351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102221302|NCT03497351|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102221303|NCT03497351|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102221304|NCT03497351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102221305|NCT03497351|Adrenergic Agents|adrenergic agents|mesh-ancestor
102221306|NCT02223364|Bupivacaine|bupivacaine|mesh-list
102221307|NCT02223364|Ropivacaine|ropivacaine|mesh-list
102221308|NCT02223364|Anesthetics, Local|anesthetics, local|mesh-ancestor
102221309|NCT02223364|Anesthetics|anesthetics|mesh-ancestor
102221310|NCT02223364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102221311|NCT02223364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221312|NCT02223364|Sensory System Agents|sensory system agents|mesh-ancestor
102221313|NCT02223364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102221314|NCT01378975|Vemurafenib|vemurafenib|mesh-list
102221315|NCT01378975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102221316|NCT01378975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102221317|NCT01378975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101900921|NCT03285646|Fasinumab|fasinumab|mesh-list
102612426|NCT00002465|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102221318|NCT01378975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221319|NCT02222896|Chlorhexidine|chlorhexidine|mesh-list
102221320|NCT02222896|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102221321|NCT02222896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102221322|NCT02222896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102221323|NCT02222896|Disinfectants|disinfectants|mesh-ancestor
102221324|NCT02222896|Dermatologic Agents|dermatologic agents|mesh-ancestor
102221325|NCT03499457|Amoxicillin|amoxicillin|mesh-list
102221326|NCT03499457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102221327|NCT03499457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102221328|NCT03499379|Levonorgestrel|levonorgestrel|mesh-list
102221329|NCT03499379|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102221330|NCT03499379|Contraceptive Agents|contraceptive agents|mesh-ancestor
102221331|NCT03499379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102221332|NCT03499379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221333|NCT03499379|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102221334|NCT03499379|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102221335|NCT03499379|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102221337|NCT02322203|Niacinamide|niacinamide|mesh-list
102221338|NCT02322203|Nicotinic Acids|nicotinic acids|mesh-list
102221339|NCT02322203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102221340|NCT02322203|Antimetabolites|antimetabolites|mesh-ancestor
101930173|NCT05154994|Durvalumab|durvalumab|mesh-list
102221341|NCT02322203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221342|NCT02322203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102221343|NCT02322203|Vasodilator Agents|vasodilator agents|mesh-ancestor
102221344|NCT02322203|Vitamin B Complex|vitamin b complex|mesh-ancestor
102221346|NCT02322203|Micronutrients|micronutrients|mesh-ancestor
102221347|NCT02322203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221348|NCT04638751|Immunomodulating Agents|immunomodulating agents|mesh-list
102221349|NCT04638751|Immunologic Factors|immunologic factors|mesh-ancestor
102221350|NCT04638751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221351|NCT02319629|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102221352|NCT02319629|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102221353|NCT02319629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102221354|NCT04691362|Tranexamic Acid|tranexamic acid|mesh-list
102221355|NCT04691362|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102221356|NCT04691362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102221357|NCT04691362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221358|NCT04691362|Hemostatics|hemostatics|mesh-ancestor
102221359|NCT04691362|Coagulants|coagulants|mesh-ancestor
102221360|NCT03499223|Ranibizumab|ranibizumab|mesh-list
102221361|NCT03499223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102221362|NCT03499223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102221363|NCT03499223|Growth Substances|growth substances|mesh-ancestor
102221364|NCT03499223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221365|NCT03499223|Growth Inhibitors|growth inhibitors|mesh-ancestor
102221366|NCT03499223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102221367|NCT02319707|Oxytocin|oxytocin|mesh-list
102221368|NCT02319707|Oxytocics|oxytocics|mesh-ancestor
102221369|NCT02319707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102221370|NCT02319707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221371|NCT05398861|Bevacizumab|bevacizumab|mesh-list
102221372|NCT05398861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102221373|NCT05398861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102221374|NCT05398861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102221375|NCT05398861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102221376|NCT05398861|Growth Substances|growth substances|mesh-ancestor
102221377|NCT05398861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221378|NCT05398861|Growth Inhibitors|growth inhibitors|mesh-ancestor
102221379|NCT02448329|Paclitaxel|paclitaxel|mesh-list
102221380|NCT02448329|Adavosertib|adavosertib|mesh-list
102221381|NCT02448329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102221382|NCT02448329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102221383|NCT02448329|Tubulin Modulators|tubulin modulators|mesh-ancestor
102221384|NCT02448329|Antimitotic Agents|antimitotic agents|mesh-ancestor
102221385|NCT02448329|Mitosis Modulators|mitosis modulators|mesh-ancestor
102221386|NCT02448329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221387|NCT02448329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102221388|NCT05398393|Tenofovir|tenofovir|mesh-list
102221389|NCT05398393|Amlodipine|amlodipine|mesh-list
102221390|NCT05398393|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
102221391|NCT05398393|Atorvastatin|atorvastatin|mesh-list
102221392|NCT05398393|Hypolipidemic Agents|hypolipidemic agents|mesh-list
102221393|NCT05398393|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102221394|NCT05398393|Antimetabolites|antimetabolites|mesh-ancestor
102221395|NCT05398393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221396|NCT05398393|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102221397|NCT05398393|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102221398|NCT05398393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102221399|NCT05398393|Antiviral Agents|antiviral agents|mesh-ancestor
102221400|NCT05398393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102221401|NCT05398393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102221402|NCT05398393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102221403|NCT05398393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102221404|NCT05398393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102221405|NCT05398393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102221406|NCT05398393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102221407|NCT05398393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102221408|NCT05398393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102221409|NCT05398393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221410|NCT05398393|Vasodilator Agents|vasodilator agents|mesh-ancestor
102221411|NCT01356628|Palbociclib|palbociclib|mesh-list
102221412|NCT01356628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102221413|NCT01356628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102221414|NCT01356628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101930250|NCT04497948|Acalabrutinib|acalabrutinib|mesh-list
102221415|NCT01356628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221416|NCT02319941|Clopidogrel|clopidogrel|mesh-list
102221417|NCT02319941|Ticagrelor|ticagrelor|mesh-list
102221418|NCT02319941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102221419|NCT02319941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102221420|NCT02319941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102221421|NCT02319941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102221422|NCT02319941|Purinergic Agents|purinergic agents|mesh-ancestor
102221423|NCT02319941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102221424|NCT02319941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221425|NCT02319941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221426|NCT05164627|Magnesium Sulfate|magnesium sulfate|mesh-list
102221427|NCT05164627|Dexmedetomidine|dexmedetomidine|mesh-list
102221428|NCT05164627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102221429|NCT05164627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102221430|NCT05164627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221431|NCT05164627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102221432|NCT05164627|Analgesics|analgesics|mesh-ancestor
102221433|NCT05164627|Sensory System Agents|sensory system agents|mesh-ancestor
102221434|NCT05164627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102221435|NCT05164627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102221436|NCT05164627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102221437|NCT05164627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102221438|NCT05164627|Adrenergic Agents|adrenergic agents|mesh-ancestor
102221439|NCT05164627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102221440|NCT05164627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221441|NCT05164627|Anesthetics|anesthetics|mesh-ancestor
102221442|NCT05164627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102221443|NCT05164627|Anticonvulsants|anticonvulsants|mesh-ancestor
102221444|NCT05164627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102221445|NCT05164627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102221446|NCT05164627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102221447|NCT05164627|Tocolytic Agents|tocolytic agents|mesh-ancestor
102221448|NCT05164627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102221449|NCT02322671|Montelukast|montelukast|mesh-list
102221450|NCT02322671|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102221451|NCT02322671|Respiratory System Agents|respiratory system agents|mesh-ancestor
102221452|NCT02322671|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102221453|NCT02322671|Hormone Antagonists|hormone antagonists|mesh-ancestor
102221454|NCT02322671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102221455|NCT02322671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221456|NCT02322671|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102221457|NCT02322671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102221458|NCT02322671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221459|NCT05096143|Valsartan|valsartan|mesh-list
102221460|NCT05096143|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102612427|NCT00002465|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102612428|NCT00002465|Contraceptive Agents|contraceptive agents|mesh-ancestor
102612429|NCT00002465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102221462|NCT05096143|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102221463|NCT05096143|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102221464|NCT05096143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221465|NCT03494387|Ascorbic Acid|ascorbic acid|mesh-list
102221466|NCT03494387|Acetylcysteine|acetylcysteine|mesh-list
102221467|NCT03494387|Antioxidants|antioxidants|mesh-list
102221468|NCT03494387|Antiviral Agents|antiviral agents|mesh-ancestor
102221469|NCT03494387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102221470|NCT03494387|Expectorants|expectorants|mesh-ancestor
102221471|NCT03494387|Respiratory System Agents|respiratory system agents|mesh-ancestor
102221472|NCT03494387|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102221473|NCT03494387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221474|NCT03494387|Protective Agents|protective agents|mesh-ancestor
102221475|NCT03494387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221476|NCT03494387|Vitamins|vitamins|mesh-ancestor
102221477|NCT03494387|Micronutrients|micronutrients|mesh-ancestor
102221478|NCT03496649|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102221479|NCT03496649|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102221480|NCT03496649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102221481|NCT03496649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221482|NCT03496649|Cholinergic Agents|cholinergic agents|mesh-ancestor
102221483|NCT03496649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102221484|NCT03496649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221485|NCT02324621|TIC10 compound|tic10 compound|mesh-list
102221486|NCT02324621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102221487|NCT03821545|Lidocaine|lidocaine|mesh-list
102221488|NCT03821545|Ketamine|ketamine|mesh-list
102221489|NCT03821545|Anesthetics, Local|anesthetics, local|mesh-ancestor
102221490|NCT03821545|Anesthetics|anesthetics|mesh-ancestor
102221491|NCT03821545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102221492|NCT03821545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221493|NCT03821545|Sensory System Agents|sensory system agents|mesh-ancestor
102221494|NCT03821545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102221495|NCT03821545|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102221496|NCT03821545|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102221497|NCT03821545|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102221498|NCT03821545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102221499|NCT03821545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221500|NCT03821545|Analgesics|analgesics|mesh-ancestor
102221501|NCT03821545|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102221502|NCT03821545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102221503|NCT03821545|Anesthetics, General|anesthetics, general|mesh-ancestor
102221504|NCT03821545|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102221505|NCT03821545|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102221506|NCT03821545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102221507|NCT02324933|Fentanyl|fentanyl|mesh-list
102221508|NCT02324933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102221509|NCT02324933|Narcotics|narcotics|mesh-ancestor
102221510|NCT02324933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102221511|NCT02324933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221512|NCT02324933|Analgesics|analgesics|mesh-ancestor
102221513|NCT02324933|Sensory System Agents|sensory system agents|mesh-ancestor
102221514|NCT02324933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102221515|NCT02324933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102221516|NCT02324933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102221517|NCT02324933|Anesthetics, General|anesthetics, general|mesh-ancestor
102221518|NCT02324933|Anesthetics|anesthetics|mesh-ancestor
102221519|NCT01378117|Insulin Glargine|insulin glargine|mesh-list
102221520|NCT01378117|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102221521|NCT01378117|Insulin Lispro|insulin lispro|mesh-list
102221522|NCT01378117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102221523|NCT01378117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221524|NCT01378117|Incretins|incretins|mesh-ancestor
102221525|NCT01378117|Hormones|hormones|mesh-ancestor
102221526|NCT01378117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102221527|NCT01378117|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102221528|NCT01378117|Protease Inhibitors|protease inhibitors|mesh-ancestor
102221529|NCT01378117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102221530|NCT01378117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221531|NCT02323139|Azacitidine|azacitidine|mesh-list
102221532|NCT02323139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102612430|NCT00002465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221533|NCT02323139|Antimetabolites|antimetabolites|mesh-ancestor
102612431|NCT00002465|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101629307|NCT04108468|Golimumab|golimumab|mesh-list
102221534|NCT02323139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221535|NCT02323139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102221536|NCT02323139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102221537|NCT02325245|Metformin|metformin|mesh-list
102221538|NCT02325245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102221539|NCT02325245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221540|NCT02323373|Tranexamic Acid|tranexamic acid|mesh-list
102221541|NCT02323373|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102221542|NCT02323373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102221543|NCT02323373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221544|NCT02323373|Hemostatics|hemostatics|mesh-ancestor
102221545|NCT02323373|Coagulants|coagulants|mesh-ancestor
102221546|NCT02325479|Enoxaparin|enoxaparin|mesh-list
102221547|NCT02325479|Anticoagulants|anticoagulants|mesh-ancestor
102221548|NCT02325479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102221549|NCT02325479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102221550|NCT02325479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221551|NCT05236231|Tadalafil|tadalafil|mesh-list
102221552|NCT05236231|Macitentan|macitentan|mesh-list
102221553|NCT05236231|Vasodilator Agents|vasodilator agents|mesh-ancestor
102221554|NCT05236231|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102221555|NCT05236231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102221556|NCT05236231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102221557|NCT05236231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221558|NCT05236231|Urological Agents|urological agents|mesh-ancestor
102221559|NCT05236231|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
102221560|NCT05236231|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102221561|NCT05236231|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
102221563|NCT02325557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102221564|NCT02325557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102221565|NCT02325557|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102221566|NCT02325557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221567|NCT03495323|Prexasertib|prexasertib|mesh-list
102221568|NCT03495323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102221569|NCT03495323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102221570|NCT03495323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221571|NCT02323451|Chitosan|chitosan|mesh-list
102221572|NCT02323451|Hyaluronic Acid|hyaluronic acid|mesh-list
102221573|NCT02323451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102221574|NCT02323451|Immunologic Factors|immunologic factors|mesh-ancestor
102221575|NCT02323451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221576|NCT02323451|Viscosupplements|viscosupplements|mesh-ancestor
102221577|NCT02323451|Protective Agents|protective agents|mesh-ancestor
102221578|NCT02323451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102221579|NCT02323451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102221580|NCT02323451|Antimetabolites|antimetabolites|mesh-ancestor
102221581|NCT02323451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221582|NCT02323451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102221583|NCT02323451|Chelating Agents|chelating agents|mesh-ancestor
102221584|NCT02323451|Sequestering Agents|sequestering agents|mesh-ancestor
102221585|NCT02323451|Hemostatics|hemostatics|mesh-ancestor
102221586|NCT02323451|Coagulants|coagulants|mesh-ancestor
102221587|NCT02323529|Nitisinone|nitisinone|mesh-list
102221588|NCT02323529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102221589|NCT02323529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221590|NCT02323607|Cytarabine|cytarabine|mesh-list
102221591|NCT02323607|Decitabine|decitabine|mesh-list
102221592|NCT02323607|Daunorubicin|daunorubicin|mesh-list
102221593|NCT02323607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102221594|NCT02323607|Antimetabolites|antimetabolites|mesh-ancestor
102221595|NCT02323607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221596|NCT02323607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102221597|NCT02323607|Antiviral Agents|antiviral agents|mesh-ancestor
102221598|NCT02323607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102221599|NCT02323607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102221600|NCT02323607|Immunologic Factors|immunologic factors|mesh-ancestor
102221601|NCT02323607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221602|NCT02323607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102221603|NCT02323607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102221604|NCT02323607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102221605|NCT02323607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102221606|NCT03493841|Thioctic Acid|thioctic acid|mesh-list
102221607|NCT03493841|Antioxidants|antioxidants|mesh-ancestor
102221608|NCT03493841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221609|NCT03493841|Protective Agents|protective agents|mesh-ancestor
102221610|NCT03493841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221611|NCT03493841|Vitamin B Complex|vitamin b complex|mesh-ancestor
102221612|NCT03493841|Vitamins|vitamins|mesh-ancestor
102221613|NCT03493841|Micronutrients|micronutrients|mesh-ancestor
102221614|NCT05118737|Colchicine|colchicine|mesh-list
102221615|NCT05118737|Gout Suppressants|gout suppressants|mesh-ancestor
102221616|NCT05118737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102221617|NCT05118737|Tubulin Modulators|tubulin modulators|mesh-ancestor
102221618|NCT05118737|Antimitotic Agents|antimitotic agents|mesh-ancestor
102221619|NCT05118737|Mitosis Modulators|mitosis modulators|mesh-ancestor
102221620|NCT05118737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221621|NCT05118737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102221622|NCT04987931|Talazoparib|talazoparib|mesh-list
102221623|NCT04987931|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102221624|NCT04987931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102221625|NCT04987931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221626|NCT04987931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102221627|NCT03492827|Chlorhexidine|chlorhexidine|mesh-list
102221628|NCT03492827|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102221629|NCT03492827|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102221630|NCT03492827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102221631|NCT03492827|Disinfectants|disinfectants|mesh-ancestor
102221632|NCT03492827|Dermatologic Agents|dermatologic agents|mesh-ancestor
102221633|NCT03491579|Cytarabine|cytarabine|mesh-list
102221634|NCT03491579|Cladribine|cladribine|mesh-list
102221635|NCT03491579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102221636|NCT03491579|Antimetabolites|antimetabolites|mesh-ancestor
102221637|NCT03491579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221638|NCT03491579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102221639|NCT03491579|Antiviral Agents|antiviral agents|mesh-ancestor
102221640|NCT03491579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102221641|NCT03491579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102221642|NCT03491579|Immunologic Factors|immunologic factors|mesh-ancestor
102221643|NCT03491579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221644|NCT04600895|Favipiravir|favipiravir|mesh-list
102221645|NCT04600895|Antiviral Agents|antiviral agents|mesh-ancestor
102221646|NCT04600895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102221647|NCT03492593|Beta Carotene|beta carotene|mesh-list
102221648|NCT03492593|Lycopene|lycopene|mesh-list
102221649|NCT03492593|Carotenoids|carotenoids|mesh-list
102221650|NCT03492593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102221651|NCT03492593|Antioxidants|antioxidants|mesh-ancestor
102221652|NCT03492593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221653|NCT03492593|Protective Agents|protective agents|mesh-ancestor
102221654|NCT03492593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221655|NCT03492593|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102221656|NCT03492593|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102221657|NCT03492593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102221658|NCT03492593|Provitamins|provitamins|mesh-ancestor
102221659|NCT03492593|Vitamins|vitamins|mesh-ancestor
102221660|NCT03492593|Micronutrients|micronutrients|mesh-ancestor
102221661|NCT04461353|Hydroxychloroquine|hydroxychloroquine|mesh-list
102221662|NCT04461353|Antimalarials|antimalarials|mesh-ancestor
102221663|NCT04461353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102221664|NCT04461353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102221665|NCT04461353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102221666|NCT04461353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102221667|NCT04461353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221668|NCT04461353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102221669|NCT04034459|Leucovorin|leucovorin|mesh-list
102221670|NCT04034459|Folic Acid|folic acid|mesh-list
102221671|NCT04034459|Bevacizumab|bevacizumab|mesh-list
102221672|NCT04034459|Cetuximab|cetuximab|mesh-list
102221673|NCT04034459|Oxaliplatin|oxaliplatin|mesh-list
102221674|NCT04034459|Irinotecan|irinotecan|mesh-list
102221675|NCT04034459|Levoleucovorin|levoleucovorin|mesh-list
102221676|NCT04034459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102221677|NCT04034459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102221678|NCT04034459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102221679|NCT04034459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102221680|NCT04034459|Growth Substances|growth substances|mesh-ancestor
102221681|NCT04034459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221682|NCT04034459|Growth Inhibitors|growth inhibitors|mesh-ancestor
102221683|NCT04034459|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102612432|NCT00002465|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102221684|NCT04034459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102221685|NCT04034459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101900927|NCT03860012|Folic Acid|folic acid|mesh-list
102221686|NCT04034459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221687|NCT04034459|Antidotes|antidotes|mesh-ancestor
102221688|NCT04034459|Protective Agents|protective agents|mesh-ancestor
102221689|NCT04034459|Vitamin B Complex|vitamin b complex|mesh-ancestor
102221690|NCT04034459|Vitamins|vitamins|mesh-ancestor
102221691|NCT04034459|Micronutrients|micronutrients|mesh-ancestor
102221692|NCT04034459|Hematinics|hematinics|mesh-ancestor
102221693|NCT03914885|Fludarabine|fludarabine|mesh-list
102221694|NCT03914885|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102221695|NCT03914885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102221696|NCT03914885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221697|NCT03914885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102221698|NCT03914885|Alkylating Agents|alkylating agents|mesh-ancestor
102221699|NCT03779243|Melatonin|melatonin|mesh-list
102221700|NCT03779243|Antioxidants|antioxidants|mesh-ancestor
102221701|NCT03779243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221702|NCT03779243|Protective Agents|protective agents|mesh-ancestor
102221703|NCT03779243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221704|NCT03779243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102221705|NCT03757013|Apremilast|apremilast|mesh-list
102221706|NCT03757013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102221707|NCT03757013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102221708|NCT03757013|Analgesics|analgesics|mesh-ancestor
102221709|NCT03757013|Sensory System Agents|sensory system agents|mesh-ancestor
102221710|NCT03757013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102221711|NCT03757013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221712|NCT03757013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102221713|NCT03757013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102221714|NCT03757013|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102221715|NCT03757013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102221716|NCT03757013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102221717|NCT03757013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221718|NCT02736409|Budesonide|budesonide|mesh-list
102221719|NCT02736409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102221720|NCT02736409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102221721|NCT02736409|Autonomic Agents|autonomic agents|mesh-ancestor
102221722|NCT02736409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102221723|NCT02736409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221724|NCT02736409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102221725|NCT02736409|Respiratory System Agents|respiratory system agents|mesh-ancestor
102221726|NCT02736409|Glucocorticoids|glucocorticoids|mesh-ancestor
102221727|NCT02736409|Hormones|hormones|mesh-ancestor
102221728|NCT02736409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102221729|NCT05396677|Acetaminophen|acetaminophen|mesh-list
102221730|NCT05396677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102221731|NCT05396677|Analgesics|analgesics|mesh-ancestor
102221732|NCT05396677|Sensory System Agents|sensory system agents|mesh-ancestor
102221733|NCT05396677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102221734|NCT05396677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221735|NCT05396677|Antipyretics|antipyretics|mesh-ancestor
102221736|NCT05131867|Nimodipine|nimodipine|mesh-list
102221737|NCT05131867|Milrinone|milrinone|mesh-list
102221738|NCT05131867|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102221739|NCT05131867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102221740|NCT05131867|Vasodilator Agents|vasodilator agents|mesh-ancestor
102221741|NCT05131867|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102221742|NCT05131867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102221743|NCT05131867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101629336|NCT00718081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102221744|NCT05131867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221745|NCT05131867|Protective Agents|protective agents|mesh-ancestor
102221746|NCT05131867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221747|NCT05131867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102221748|NCT05131867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102221749|NCT05131867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102221750|NCT05131867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102221751|NCT02837783|Linaclotide|linaclotide|mesh-list
102221752|NCT02837783|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102221753|NCT02837783|Enzyme Activators|enzyme activators|mesh-ancestor
102221754|NCT02837783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221755|NCT02837783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102221756|NCT02221648|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102221757|NCT02221648|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102612433|NCT00002465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101900929|NCT03860012|Vitamin B Complex|vitamin b complex|mesh-ancestor
102221758|NCT02221648|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102221759|NCT02221648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102221760|NCT02221648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221762|NCT02221648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102221763|NCT02221648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221764|NCT02221648|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102221765|NCT02221648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102221766|NCT05007145|Paclitaxel|paclitaxel|mesh-list
102221767|NCT05007145|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102221768|NCT05007145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102221769|NCT05007145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102221770|NCT05007145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102221771|NCT05007145|Tubulin Modulators|tubulin modulators|mesh-ancestor
102221772|NCT05007145|Antimitotic Agents|antimitotic agents|mesh-ancestor
102221773|NCT05007145|Mitosis Modulators|mitosis modulators|mesh-ancestor
102221774|NCT05007145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221775|NCT05007145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102221776|NCT04952857|Vitamin D|vitamin d|mesh-list
102221777|NCT04952857|Cholecalciferol|cholecalciferol|mesh-list
102221778|NCT04952857|Vitamins|vitamins|mesh-ancestor
102221779|NCT04952857|Micronutrients|micronutrients|mesh-ancestor
102221780|NCT04952857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221781|NCT04952857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102221782|NCT04952857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102221783|NCT02220712|Aripiprazole|aripiprazole|mesh-list
102221784|NCT02220712|Antidepressive Agents|antidepressive agents|mesh-ancestor
102221785|NCT02220712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102221786|NCT02220712|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102221787|NCT02220712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102221788|NCT02220712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102221789|NCT02220712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221790|NCT02220712|Dopamine Agonists|dopamine agonists|mesh-ancestor
102221791|NCT02220712|Dopamine Agents|dopamine agents|mesh-ancestor
102221792|NCT02220712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102221793|NCT02220712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221794|NCT02220712|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102221795|NCT02220712|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102221796|NCT02220712|Serotonin Agents|serotonin agents|mesh-ancestor
102221797|NCT02220712|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102221798|NCT02220712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102221799|NCT02220712|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102221800|NCT02220712|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102221802|NCT04923295|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101629343|NCT00788710|Analgesics|analgesics|mesh-ancestor
102221803|NCT04923295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221804|NCT04923295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102221805|NCT04923295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221806|NCT05396209|Dimenhydrinate|dimenhydrinate|mesh-list
102221807|NCT05396209|Antiemetics|antiemetics|mesh-ancestor
102221808|NCT05396209|Autonomic Agents|autonomic agents|mesh-ancestor
102221809|NCT05396209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102221810|NCT05396209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221811|NCT05396209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102221812|NCT05396209|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102221813|NCT05396209|Histamine Antagonists|histamine antagonists|mesh-ancestor
102221814|NCT05396209|Histamine Agents|histamine agents|mesh-ancestor
102221815|NCT05396209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102221816|NCT05396209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221817|NCT02219932|4-Aminopyridine|4-aminopyridine|mesh-list
102221818|NCT02219932|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102221819|NCT02219932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102221820|NCT02219932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221821|NCT00846430|Interferons|interferons|mesh-list
102221822|NCT00846430|Interferon-alpha|interferon-alpha|mesh-list
102221823|NCT00846430|Interferon alpha-2|interferon alpha-2|mesh-list
102221824|NCT00846430|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102221825|NCT00846430|Celecoxib|celecoxib|mesh-list
102221826|NCT00846430|Vincristine|vincristine|mesh-list
102221827|NCT00846430|Temozolomide|temozolomide|mesh-list
102221828|NCT00846430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102221829|NCT00846430|Antiviral Agents|antiviral agents|mesh-ancestor
102221830|NCT00846430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102221831|NCT00846430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102221832|NCT00846430|Tubulin Modulators|tubulin modulators|mesh-ancestor
102221833|NCT00846430|Antimitotic Agents|antimitotic agents|mesh-ancestor
102221834|NCT00846430|Mitosis Modulators|mitosis modulators|mesh-ancestor
102221835|NCT00846430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221836|NCT00846430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102221837|NCT00846430|Alkylating Agents|alkylating agents|mesh-ancestor
102221838|NCT00846430|Immunologic Factors|immunologic factors|mesh-ancestor
102221839|NCT00846430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629355|NCT04083625|Carbetocin|carbetocin|mesh-list
102221840|NCT00846430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102221841|NCT00846430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102221842|NCT00846430|Analgesics|analgesics|mesh-ancestor
102221843|NCT00846430|Sensory System Agents|sensory system agents|mesh-ancestor
102221844|NCT00846430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102221845|NCT00846430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102221846|NCT00846430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102221847|NCT00846430|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102221848|NCT00846430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102221849|NCT00846430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102221850|NCT05439577|Heparinoids|heparinoids|mesh-list
102221851|NCT05439577|Glucocorticoids|glucocorticoids|mesh-list
102221852|NCT05439577|Hormones|hormones|mesh-ancestor
102221853|NCT05439577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102221854|NCT05439577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221855|NCT05439577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102221856|NCT05439577|Anticoagulants|anticoagulants|mesh-ancestor
102221857|NCT05385523|Dexamethasone|dexamethasone|mesh-list
102221858|NCT05385523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102221859|NCT05385523|Antiemetics|antiemetics|mesh-ancestor
102221860|NCT05385523|Autonomic Agents|autonomic agents|mesh-ancestor
102221861|NCT05385523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102221862|NCT05385523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221863|NCT05385523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102221864|NCT05385523|Glucocorticoids|glucocorticoids|mesh-ancestor
102221865|NCT05385523|Hormones|hormones|mesh-ancestor
102221866|NCT05385523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102221867|NCT05385523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102221868|NCT05385523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102221869|NCT03910621|Miglustat|miglustat|mesh-list
102221870|NCT03910621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102221871|NCT03910621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221872|NCT03910621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102221873|NCT03910621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102221874|NCT03910621|Antiviral Agents|antiviral agents|mesh-ancestor
102221875|NCT03910621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102221876|NCT03910621|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102221877|NCT03910621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102221878|NCT03910621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221879|NCT02218372|Vancomycin|vancomycin|mesh-list
102221880|NCT02218372|Fidaxomicin|fidaxomicin|mesh-list
102221881|NCT02218372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102221882|NCT02218372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102221883|NCT02217982|Simethicone|simethicone|mesh-list
102221884|NCT02217982|Loperamide|loperamide|mesh-list
102221885|NCT02217982|Antidiarrheals|antidiarrheals|mesh-list
102221886|NCT02217982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102221887|NCT02217982|Antifoaming Agents|antifoaming agents|mesh-ancestor
102221888|NCT02217982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221889|NCT02217982|Emollients|emollients|mesh-ancestor
102221890|NCT02217982|Dermatologic Agents|dermatologic agents|mesh-ancestor
102221891|NCT02207608|Hyaluronic Acid|hyaluronic acid|mesh-list
102221892|NCT02207608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102221893|NCT02207608|Immunologic Factors|immunologic factors|mesh-ancestor
102221894|NCT02207608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221895|NCT02207608|Viscosupplements|viscosupplements|mesh-ancestor
102221896|NCT02207608|Protective Agents|protective agents|mesh-ancestor
102221897|NCT03530995|Itraconazole|itraconazole|mesh-list
102221898|NCT03530995|Rifampin|rifampin|mesh-list
102221899|NCT03530995|Omeprazole|omeprazole|mesh-list
102221900|NCT03530995|Rabeprazole|rabeprazole|mesh-list
102221901|NCT03530995|Belumosudil|belumosudil|mesh-list
102221902|NCT03530995|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102221903|NCT03530995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102221904|NCT03530995|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102221905|NCT03530995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102221906|NCT03530995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221907|NCT03530995|Antifungal Agents|antifungal agents|mesh-ancestor
102221908|NCT03530995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102221909|NCT03530995|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102221910|NCT03530995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102221911|NCT03530995|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102221912|NCT03530995|Hormone Antagonists|hormone antagonists|mesh-ancestor
102221913|NCT03530995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102221914|NCT03530995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221915|NCT03530995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102221916|NCT03530995|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102221917|NCT03530995|Antitubercular Agents|antitubercular agents|mesh-ancestor
102221918|NCT03530995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102221919|NCT03530995|Leprostatic Agents|leprostatic agents|mesh-ancestor
102221920|NCT03530995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102221921|NCT03530995|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102221922|NCT03530995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102221923|NCT03530995|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102221924|NCT03530995|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102221925|NCT03530995|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102221926|NCT03530995|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102221927|NCT03530995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102221929|NCT05438875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102221930|NCT05438875|Keratolytic Agents|keratolytic agents|mesh-ancestor
102221931|NCT05438875|Dermatologic Agents|dermatologic agents|mesh-ancestor
102221932|NCT04740307|Pembrolizumab|pembrolizumab|mesh-list
102221933|NCT04740307|Lenvatinib|lenvatinib|mesh-list
102221934|NCT04740307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102221935|NCT04740307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102221936|NCT04740307|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102221937|NCT04740307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836507|NCT00490542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221938|NCT04740307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102221939|NCT04740307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102221940|NCT02207530|Durvalumab|durvalumab|mesh-list
102221941|NCT02207530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102221942|NCT02207530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102221943|NCT05359315|Interferons|interferons|mesh-list
102221944|NCT05359315|Interferon-gamma|interferon-gamma|mesh-list
102221945|NCT05359315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102221946|NCT05359315|Antiviral Agents|antiviral agents|mesh-ancestor
102221947|NCT05359315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102221948|NCT02616055|XL647|xl647|mesh-list
102221949|NCT02616055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102221950|NCT02616055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102221951|NCT02616055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102221952|NCT02616055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221953|NCT02207374|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
102221954|NCT02207374|Protease Inhibitors|protease inhibitors|mesh-ancestor
102221955|NCT02207374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102221956|NCT02207374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221957|NCT02207374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102221958|NCT02207374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221959|NCT02786537|Ritonavir|ritonavir|mesh-list
102221960|NCT02786537|Ribavirin|ribavirin|mesh-list
102221961|NCT02786537|Sofosbuvir|sofosbuvir|mesh-list
102221962|NCT02786537|Grazoprevir|grazoprevir|mesh-list
102221963|NCT02786537|Ledipasvir|ledipasvir|mesh-list
102221964|NCT02786537|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
102221965|NCT02786537|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102221966|NCT02786537|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102221967|NCT02786537|Protease Inhibitors|protease inhibitors|mesh-ancestor
102221968|NCT02786537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102221969|NCT02786537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221970|NCT02786537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102221971|NCT02786537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102221972|NCT02786537|Antiviral Agents|antiviral agents|mesh-ancestor
102221973|NCT02786537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102221974|NCT02786537|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102221975|NCT02786537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102221976|NCT02786537|Antimetabolites|antimetabolites|mesh-ancestor
102221977|NCT03307759|Pembrolizumab|pembrolizumab|mesh-list
102612434|NCT00002465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102221978|NCT03307759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102221979|NCT03307759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102221980|NCT03307759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102221981|NCT03307759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102221982|NCT03466645|Vancomycin|vancomycin|mesh-list
102221983|NCT03466645|Cefazolin|cefazolin|mesh-list
102221984|NCT03466645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102221985|NCT03466645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102221986|NCT04461665|Vitamin D|vitamin d|mesh-list
102221987|NCT04461665|Ergocalciferols|ergocalciferols|mesh-list
102221988|NCT04461665|Cholecalciferol|cholecalciferol|mesh-list
102221989|NCT04461665|Vitamins|vitamins|mesh-list
102221990|NCT04461665|Micronutrients|micronutrients|mesh-ancestor
102221991|NCT04461665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221992|NCT04461665|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102221993|NCT04461665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102221994|NCT02252536|Gabapentin|gabapentin|mesh-list
102221995|NCT02252536|Analgesics|analgesics|mesh-ancestor
102221996|NCT02252536|Sensory System Agents|sensory system agents|mesh-ancestor
102221997|NCT02252536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102221998|NCT02252536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102221999|NCT02252536|Anticonvulsants|anticonvulsants|mesh-ancestor
102222000|NCT02252536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102222001|NCT02252536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102222002|NCT02252536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102222003|NCT02252536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102222004|NCT02252536|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102222005|NCT02252536|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102222006|NCT02252536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102222007|NCT02252536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222008|NCT02252536|Antimanic Agents|antimanic agents|mesh-ancestor
102222009|NCT03490487|Prednisolone|prednisolone|mesh-list
102222010|NCT03490487|Carbamazepine|carbamazepine|mesh-list
102222011|NCT03490487|Oxcarbazepine|oxcarbazepine|mesh-list
102222012|NCT03490487|Levetiracetam|levetiracetam|mesh-list
102222013|NCT03490487|Valproic Acid|valproic acid|mesh-list
102222014|NCT03490487|Anticonvulsants|anticonvulsants|mesh-list
102222015|NCT03490487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102222016|NCT03490487|Glucocorticoids|glucocorticoids|mesh-ancestor
102222017|NCT03490487|Hormones|hormones|mesh-ancestor
102222018|NCT03490487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102222019|NCT03490487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222020|NCT03490487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102222021|NCT03490487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102222022|NCT03490487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102222023|NCT03490487|Nootropic Agents|nootropic agents|mesh-ancestor
102222024|NCT03490487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102222025|NCT03490487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222026|NCT03490487|GABA Agents|gaba agents|mesh-ancestor
102222027|NCT03490487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102222028|NCT03490487|Antimanic Agents|antimanic agents|mesh-ancestor
102222029|NCT03490487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102222030|NCT03490487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102222031|NCT03490487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102222032|NCT03490487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102222033|NCT03490487|Analgesics|analgesics|mesh-ancestor
102222034|NCT03490487|Sensory System Agents|sensory system agents|mesh-ancestor
102222035|NCT03490487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102222036|NCT03490487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102222037|NCT03490487|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102222038|NCT03490487|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102222039|NCT03490487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102222040|NCT05271331|Anesthetics|anesthetics|mesh-list
102222041|NCT05271331|Anesthetics, Local|anesthetics, local|mesh-list
102222042|NCT05271331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102222043|NCT05271331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222044|NCT05271331|Sensory System Agents|sensory system agents|mesh-ancestor
102222045|NCT05271331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102222046|NCT03466567|Cyclosporine|cyclosporine|mesh-list
102222047|NCT03466567|Probenecid|probenecid|mesh-list
102222048|NCT03466567|Cyclosporins|cyclosporins|mesh-list
102222049|NCT03466567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102222050|NCT03466567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222051|NCT03466567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102222052|NCT03466567|Immunologic Factors|immunologic factors|mesh-ancestor
102222053|NCT03466567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222054|NCT03466567|Antifungal Agents|antifungal agents|mesh-ancestor
102612435|NCT00002465|Appetite Stimulants|appetite stimulants|mesh-ancestor
102222056|NCT03466567|Dermatologic Agents|dermatologic agents|mesh-ancestor
102222057|NCT03466567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102222058|NCT03466567|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102222059|NCT03466567|Uricosuric Agents|uricosuric agents|mesh-ancestor
102222060|NCT03466567|Gout Suppressants|gout suppressants|mesh-ancestor
102222061|NCT03130153|Aspirin|aspirin|mesh-list
102222062|NCT03130153|Salicylic Acid|salicylic acid|mesh-list
102222063|NCT03130153|Salicylates|salicylates|mesh-list
102222064|NCT03130153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102222065|NCT03130153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102222066|NCT03130153|Analgesics|analgesics|mesh-ancestor
102222067|NCT03130153|Sensory System Agents|sensory system agents|mesh-ancestor
102222068|NCT03130153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102222069|NCT03130153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222070|NCT03130153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102222071|NCT03130153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102222072|NCT03130153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102222073|NCT03130153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102222074|NCT03130153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222075|NCT03130153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102222076|NCT03130153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102222077|NCT03130153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102222078|NCT03130153|Antipyretics|antipyretics|mesh-ancestor
102222079|NCT03130153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102222080|NCT03130153|Antifungal Agents|antifungal agents|mesh-ancestor
102222081|NCT03130153|Keratolytic Agents|keratolytic agents|mesh-ancestor
102222082|NCT03130153|Dermatologic Agents|dermatologic agents|mesh-ancestor
102222083|NCT03466333|Enalapril|enalapril|mesh-list
102222084|NCT03466333|Enalaprilat|enalaprilat|mesh-list
102222085|NCT03466333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102222086|NCT03466333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222087|NCT03466333|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102222088|NCT03466333|Protease Inhibitors|protease inhibitors|mesh-ancestor
102222089|NCT03466333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101930939|NCT04357782|Vitamins|vitamins|mesh-ancestor
102222090|NCT05382715|Ozanimod|ozanimod|mesh-list
102222091|NCT05382715|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102222092|NCT05382715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222093|NCT05382715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102222094|NCT05382715|Immunologic Factors|immunologic factors|mesh-ancestor
102222095|NCT05382715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222096|NCT03492047|Acetylcysteine|acetylcysteine|mesh-list
102222097|NCT03492047|Paclitaxel|paclitaxel|mesh-list
102222098|NCT03492047|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102222099|NCT03492047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102222100|NCT03492047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102222101|NCT03492047|Tubulin Modulators|tubulin modulators|mesh-ancestor
102222102|NCT03492047|Antimitotic Agents|antimitotic agents|mesh-ancestor
102222103|NCT03492047|Mitosis Modulators|mitosis modulators|mesh-ancestor
102222104|NCT03492047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222105|NCT03492047|Antiviral Agents|antiviral agents|mesh-ancestor
102222106|NCT03492047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102222107|NCT03492047|Expectorants|expectorants|mesh-ancestor
102222108|NCT03492047|Respiratory System Agents|respiratory system agents|mesh-ancestor
102222109|NCT03492047|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102222110|NCT03492047|Antioxidants|antioxidants|mesh-ancestor
102222111|NCT03492047|Protective Agents|protective agents|mesh-ancestor
102222112|NCT03492047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222113|NCT03492047|Antidotes|antidotes|mesh-ancestor
102222114|NCT02251990|Grazoprevir|grazoprevir|mesh-list
102222115|NCT02251990|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
102222116|NCT02251990|Antiviral Agents|antiviral agents|mesh-ancestor
102222117|NCT02251990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102222118|NCT03490097|Sofosbuvir|sofosbuvir|mesh-list
102222119|NCT03490097|Simvastatin|simvastatin|mesh-list
102222120|NCT03490097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102222121|NCT03490097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102222122|NCT03490097|Antimetabolites|antimetabolites|mesh-ancestor
102222123|NCT03490097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222124|NCT03490097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102222125|NCT03490097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102222126|NCT03490097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102222127|NCT03490097|Antiviral Agents|antiviral agents|mesh-ancestor
102222128|NCT03490097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102222129|NCT04453735|Atorvastatin|atorvastatin|mesh-list
102222130|NCT04453735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102222131|NCT04453735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102222132|NCT04453735|Antimetabolites|antimetabolites|mesh-ancestor
102222133|NCT04453735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222134|NCT04453735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102222135|NCT04453735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102222136|NCT04453735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102222137|NCT03490019|Metformin|metformin|mesh-list
102222138|NCT03490019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102222139|NCT03490019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222140|NCT03491969|Thioctic Acid|thioctic acid|mesh-list
102222141|NCT03491969|Antioxidants|antioxidants|mesh-ancestor
102222142|NCT03491969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222143|NCT03491969|Protective Agents|protective agents|mesh-ancestor
102222144|NCT03491969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222145|NCT03491969|Vitamin B Complex|vitamin b complex|mesh-ancestor
102222146|NCT03491969|Vitamins|vitamins|mesh-ancestor
102222147|NCT03491969|Micronutrients|micronutrients|mesh-ancestor
102222148|NCT05349409|Fluzoparib|fluzoparib|mesh-list
102222149|NCT05349409|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102222150|NCT05349409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102222151|NCT05349409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222152|NCT05349409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102222153|NCT02251912|Oxytocin|oxytocin|mesh-list
102222154|NCT02251912|Oxytocics|oxytocics|mesh-ancestor
102222155|NCT02251912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102222156|NCT02251912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222157|NCT01976273|Glycolic acid|glycolic acid|mesh-list
102222158|NCT01976273|Keratolytic Agents|keratolytic agents|mesh-ancestor
102222159|NCT01976273|Dermatologic Agents|dermatologic agents|mesh-ancestor
102222160|NCT02206048|Proflavine|proflavine|mesh-list
102222161|NCT02206048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102222162|NCT02206048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102222163|NCT03466021|Liraglutide|liraglutide|mesh-list
102222164|NCT03466021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101931005|NCT03979820|Sympathomimetics|sympathomimetics|mesh-ancestor
102222165|NCT03466021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222166|NCT03466021|Incretins|incretins|mesh-ancestor
102222168|NCT03466021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102222169|NCT04112407|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102222170|NCT04112407|Dermatologic Agents|dermatologic agents|mesh-ancestor
102222171|NCT02205814|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2H-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2h-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|mesh-list
102222172|NCT02205814|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
102222173|NCT02205814|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
102222174|NCT02205814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222175|NCT02205814|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102222176|NCT02205814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102222177|NCT02205814|Immunologic Factors|immunologic factors|mesh-ancestor
102222178|NCT02205814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222179|NCT02662985|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102222180|NCT02662985|Immunologic Factors|immunologic factors|mesh-ancestor
102222181|NCT02662985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222182|NCT04080271|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102222183|NCT04080271|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102222184|NCT04080271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222185|NCT03489005|Moxifloxacin|moxifloxacin|mesh-list
102222186|NCT03489005|Zamicastat|zamicastat|mesh-list
102222187|NCT03489005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102222188|NCT03489005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102222189|NCT03489005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102222190|NCT03489005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102222191|NCT03489005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102222192|NCT03489005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222193|NCT03489005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102222194|NCT02215252|Pregabalin|pregabalin|mesh-list
102222195|NCT02215252|Analgesics|analgesics|mesh-ancestor
102222196|NCT02215252|Sensory System Agents|sensory system agents|mesh-ancestor
102222197|NCT02215252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102222198|NCT02215252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222199|NCT02215252|Anticonvulsants|anticonvulsants|mesh-ancestor
102612436|NCT00002465|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102612437|NCT00002471|Leucovorin|leucovorin|mesh-list
102612438|NCT00002471|Cytarabine|cytarabine|mesh-list
102222200|NCT02215252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102222201|NCT02215252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102222202|NCT02215252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222203|NCT02215252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102222204|NCT02215252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102222205|NCT02215252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102222206|NCT02215252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102222207|NCT02215252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102222208|NCT04894721|Ivermectin|ivermectin|mesh-list
102222209|NCT04894721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102222210|NCT04894721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102222211|NCT02204410|Methylphenidate|methylphenidate|mesh-list
102222212|NCT02204410|Amphetamine|amphetamine|mesh-list
102222213|NCT02204410|Adderall|adderall|mesh-list
102222214|NCT02204410|Dextroamphetamine|dextroamphetamine|mesh-list
102222215|NCT02204410|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102222216|NCT02204410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222217|NCT02204410|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102222218|NCT02204410|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102222219|NCT02204410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102222220|NCT02204410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222221|NCT02204410|Dopamine Agents|dopamine agents|mesh-ancestor
102222222|NCT02204410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102222223|NCT02204410|Sympathomimetics|sympathomimetics|mesh-ancestor
102222224|NCT02204410|Autonomic Agents|autonomic agents|mesh-ancestor
102222225|NCT02204410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102222226|NCT02204410|Adrenergic Agents|adrenergic agents|mesh-ancestor
102222227|NCT02204410|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102222228|NCT03465397|Immunosuppressive Agents|immunosuppressive agents|mesh-list
102222229|NCT03465397|Immunologic Factors|immunologic factors|mesh-ancestor
102222230|NCT03465397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222231|NCT03461575|Cyclosporine|cyclosporine|mesh-list
102222232|NCT03461575|Cyclosporins|cyclosporins|mesh-list
102222233|NCT03461575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102222234|NCT03461575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222235|NCT03461575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102222236|NCT03461575|Immunologic Factors|immunologic factors|mesh-ancestor
102222237|NCT03461575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222238|NCT03461575|Antifungal Agents|antifungal agents|mesh-ancestor
102222239|NCT03461575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102222240|NCT03461575|Dermatologic Agents|dermatologic agents|mesh-ancestor
102222241|NCT03461575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102222242|NCT03461575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102222243|NCT03131843|Ethanol|ethanol|mesh-list
102222244|NCT03131843|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102222245|NCT03131843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102222246|NCT03131843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102222247|NCT03131843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222248|NCT02213380|Anesthetics|anesthetics|mesh-list
102222249|NCT02213380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102222250|NCT02213380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222251|NCT03488147|Esomeprazole|esomeprazole|mesh-list
102222252|NCT03488147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102222253|NCT03488147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102222254|NCT03488147|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102222255|NCT03488147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102222256|NCT03488147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222257|NCT03797261|Venetoclax|venetoclax|mesh-list
102222258|NCT03797261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102222259|NCT02202850|Etanercept|etanercept|mesh-list
102222260|NCT02202850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102222261|NCT02202850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102222262|NCT02202850|Analgesics|analgesics|mesh-ancestor
102222263|NCT02202850|Sensory System Agents|sensory system agents|mesh-ancestor
102222264|NCT02202850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102222265|NCT02202850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222266|NCT02202850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102222267|NCT02202850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102222268|NCT02202850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102222269|NCT02202850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102222270|NCT02202850|Immunologic Factors|immunologic factors|mesh-ancestor
102222271|NCT03489395|Edoxaban|edoxaban|mesh-list
102222272|NCT03489395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102612439|NCT00002471|Dexamethasone|dexamethasone|mesh-list
102612440|NCT00002471|Methylprednisolone|methylprednisolone|mesh-list
102612441|NCT00002471|Hydrocortisone|hydrocortisone|mesh-list
102222273|NCT03489395|Antithrombins|antithrombins|mesh-ancestor
102222274|NCT03489395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102222275|NCT03489395|Protease Inhibitors|protease inhibitors|mesh-ancestor
102222276|NCT03489395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102222277|NCT03489395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222278|NCT03489395|Anticoagulants|anticoagulants|mesh-ancestor
102222280|NCT03489317|Amlodipine|amlodipine|mesh-list
102222281|NCT03489317|Simvastatin|simvastatin|mesh-list
102222282|NCT03489317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102222283|NCT03489317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222284|NCT03489317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102222285|NCT03489317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102222286|NCT03489317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102222287|NCT03489317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222288|NCT03489317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102222289|NCT03489317|Vasodilator Agents|vasodilator agents|mesh-ancestor
102222290|NCT03489317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102222291|NCT03489317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102222292|NCT03489317|Antimetabolites|antimetabolites|mesh-ancestor
102222293|NCT03489317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102222294|NCT03489317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102222295|NCT03489317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102222296|NCT02212678|Acetylcysteine|acetylcysteine|mesh-list
102222297|NCT02212678|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102222298|NCT02212678|Antiviral Agents|antiviral agents|mesh-ancestor
102222299|NCT02212678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102222300|NCT02212678|Expectorants|expectorants|mesh-ancestor
102222301|NCT02212678|Respiratory System Agents|respiratory system agents|mesh-ancestor
102222302|NCT02212678|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102222303|NCT02212678|Antioxidants|antioxidants|mesh-ancestor
102222304|NCT02212678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222305|NCT02212678|Protective Agents|protective agents|mesh-ancestor
102222306|NCT02212678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222307|NCT02212678|Antidotes|antidotes|mesh-ancestor
102222308|NCT03489239|Tenofovir|tenofovir|mesh-list
102222309|NCT03489239|Antiviral Agents|antiviral agents|mesh-ancestor
102222310|NCT03489239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102222311|NCT03489239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102222312|NCT03489239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102222313|NCT03489239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102222314|NCT03489239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222315|NCT03489239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102222316|NCT03489239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102222317|NCT03489161|Buprenorphine|buprenorphine|mesh-list
102222318|NCT03489161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102222319|NCT03489161|Narcotics|narcotics|mesh-ancestor
102222320|NCT03489161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102222321|NCT03489161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222322|NCT03489161|Analgesics|analgesics|mesh-ancestor
102222323|NCT03489161|Sensory System Agents|sensory system agents|mesh-ancestor
102222324|NCT03489161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102222325|NCT03489161|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102222326|NCT04804709|Panobinostat|panobinostat|mesh-list
102222327|NCT04804709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102222328|NCT04804709|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102222329|NCT04804709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102222330|NCT04804709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222331|NCT04690673|Acetaminophen|acetaminophen|mesh-list
102222332|NCT04690673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102222333|NCT04690673|Analgesics|analgesics|mesh-ancestor
102222334|NCT04690673|Sensory System Agents|sensory system agents|mesh-ancestor
102222335|NCT04690673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102222336|NCT04690673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222337|NCT04690673|Antipyretics|antipyretics|mesh-ancestor
102222338|NCT03104075|Vaccines|vaccines|mesh-list
102222339|NCT03104075|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102222340|NCT03104075|Immunologic Factors|immunologic factors|mesh-ancestor
102222341|NCT03104075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222342|NCT02841215|Ivermectin|ivermectin|mesh-list
102222343|NCT02841215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102222344|NCT02841215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102222345|NCT04388501|Atorvastatin|atorvastatin|mesh-list
102222346|NCT04388501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102222347|NCT04388501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102222348|NCT04388501|Antimetabolites|antimetabolites|mesh-ancestor
102612442|NCT00002471|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102222349|NCT04388501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222350|NCT04388501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102222351|NCT04388501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102222352|NCT04388501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102222353|NCT02249182|Ribavirin|ribavirin|mesh-list
102222354|NCT02249182|Sofosbuvir|sofosbuvir|mesh-list
102222355|NCT02249182|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102222356|NCT02249182|Ledipasvir|ledipasvir|mesh-list
102222357|NCT02249182|Antimetabolites|antimetabolites|mesh-ancestor
102222358|NCT02249182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222359|NCT02249182|Antiviral Agents|antiviral agents|mesh-ancestor
102222360|NCT02249182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102222361|NCT04006769|Imatinib Mesylate|imatinib mesylate|mesh-list
102222362|NCT04006769|Entacapone|entacapone|mesh-list
102222363|NCT04006769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102222364|NCT04006769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102222365|NCT04006769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102222366|NCT04006769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222367|NCT04006769|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102222368|NCT04006769|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102222369|NCT04006769|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102222370|NCT03487211|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102222371|NCT03487211|Escitalopram|escitalopram|mesh-list
102222372|NCT03487211|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102222373|NCT03487211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102222374|NCT03487211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102222375|NCT03487211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222376|NCT03487211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102222377|NCT03487211|Serotonin Agents|serotonin agents|mesh-ancestor
102222378|NCT03487211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222379|NCT03487211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102222380|NCT03487211|Antidepressive Agents|antidepressive agents|mesh-ancestor
102222381|NCT03487211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102222382|NCT03487211|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102222383|NCT03487211|Analgesics|analgesics|mesh-ancestor
102222384|NCT03487211|Sensory System Agents|sensory system agents|mesh-ancestor
102222385|NCT03487211|Dopamine Agents|dopamine agents|mesh-ancestor
102222386|NCT03487133|Dexamethasone|dexamethasone|mesh-list
101836508|NCT00490542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102222387|NCT03487133|Bortezomib|bortezomib|mesh-list
102222388|NCT03487133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102222389|NCT03487133|Antiemetics|antiemetics|mesh-ancestor
102222390|NCT03487133|Autonomic Agents|autonomic agents|mesh-ancestor
102222391|NCT03487133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102222392|NCT03487133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222393|NCT03487133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102222394|NCT03487133|Glucocorticoids|glucocorticoids|mesh-ancestor
102222395|NCT03487133|Hormones|hormones|mesh-ancestor
102222396|NCT03487133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102222397|NCT03487133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102222398|NCT03487133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102222399|NCT02248480|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102222400|NCT02248480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102222401|NCT02248480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102222402|NCT02248480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102222403|NCT02248480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222404|NCT02248480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102222405|NCT02248480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222406|NCT02248480|Analgesics|analgesics|mesh-ancestor
102222407|NCT02248480|Sensory System Agents|sensory system agents|mesh-ancestor
102222408|NCT02248480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102222409|NCT02248480|Antidepressive Agents|antidepressive agents|mesh-ancestor
102222410|NCT02248480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102222411|NCT02248480|Dopamine Agents|dopamine agents|mesh-ancestor
102222412|NCT01653158|Docetaxel|docetaxel|mesh-list
102222413|NCT01653158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102222414|NCT01653158|Tubulin Modulators|tubulin modulators|mesh-ancestor
102222415|NCT01653158|Antimitotic Agents|antimitotic agents|mesh-ancestor
102222416|NCT01653158|Mitosis Modulators|mitosis modulators|mesh-ancestor
102222417|NCT01653158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222418|NCT00701207|Nicotine|nicotine|mesh-list
101900941|NCT01178450|Cinacalcet|cinacalcet|mesh-list
102612443|NCT00002471|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102612444|NCT00002471|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102612445|NCT00002471|Cyclophosphamide|cyclophosphamide|mesh-list
102612446|NCT00002471|Thiotepa|thiotepa|mesh-list
102612447|NCT00002471|Methotrexate|methotrexate|mesh-list
102222419|NCT00701207|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102222420|NCT00701207|Autonomic Agents|autonomic agents|mesh-ancestor
102222421|NCT00701207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102222422|NCT00701207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222423|NCT00701207|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102222424|NCT00701207|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102222425|NCT00701207|Cholinergic Agents|cholinergic agents|mesh-ancestor
102222426|NCT00701207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102222427|NCT00701207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222428|NCT02247466|Rocuronium|rocuronium|mesh-list
102222429|NCT02247466|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102222430|NCT02247466|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102222431|NCT02247466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102222432|NCT02247466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102222433|NCT02247466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222434|NCT03417479|Gabapentin|gabapentin|mesh-list
102222435|NCT03417479|Analgesics|analgesics|mesh-ancestor
102222436|NCT03417479|Sensory System Agents|sensory system agents|mesh-ancestor
102222437|NCT03417479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102222438|NCT03417479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222439|NCT03417479|Anticonvulsants|anticonvulsants|mesh-ancestor
102222440|NCT03417479|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102222441|NCT03417479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102222442|NCT03417479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102222443|NCT03417479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102222444|NCT03417479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102222445|NCT03417479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102222446|NCT03417479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102222447|NCT03417479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222448|NCT03417479|Antimanic Agents|antimanic agents|mesh-ancestor
102222449|NCT03317795|Tranexamic Acid|tranexamic acid|mesh-list
102222450|NCT03317795|Levonorgestrel|levonorgestrel|mesh-list
102222451|NCT03317795|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102222452|NCT03317795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102222453|NCT03317795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222454|NCT03317795|Hemostatics|hemostatics|mesh-ancestor
102222455|NCT03317795|Coagulants|coagulants|mesh-ancestor
102222456|NCT03317795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102222457|NCT03317795|Contraceptive Agents|contraceptive agents|mesh-ancestor
102222458|NCT03317795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102222459|NCT03317795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222460|NCT03317795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102222461|NCT03317795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102222462|NCT03317795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102222463|NCT02202616|Glycopyrrolate|glycopyrrolate|mesh-list
102222464|NCT02202616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222465|NCT02202616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102222466|NCT02202616|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102222467|NCT02202616|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102222468|NCT02202616|Cholinergic Agents|cholinergic agents|mesh-ancestor
102222469|NCT02202616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102222470|NCT02202616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222471|NCT03876119|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102222472|NCT03876119|Plasminogen|plasminogen|mesh-list
102222473|NCT03876119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102222474|NCT03876119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102222475|NCT03876119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222476|NCT02455076|Exenatide|exenatide|mesh-list
102222477|NCT02455076|Insulin, Short-Acting|insulin, short-acting|mesh-list
102222478|NCT02455076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102222479|NCT02455076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222480|NCT02455076|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102222481|NCT02455076|Incretins|incretins|mesh-ancestor
102222482|NCT02455076|Hormones|hormones|mesh-ancestor
102222483|NCT02455076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102222484|NCT02432846|Sunitinib|sunitinib|mesh-list
102222485|NCT02432846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102222486|NCT02432846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102612448|NCT00002471|Etoposide|etoposide|mesh-list
102612449|NCT00002471|Vincristine|vincristine|mesh-list
102612450|NCT00002471|Daunorubicin|daunorubicin|mesh-list
102222487|NCT02432846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102222488|NCT02432846|Growth Substances|growth substances|mesh-ancestor
102222489|NCT02432846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222490|NCT02432846|Growth Inhibitors|growth inhibitors|mesh-ancestor
102222491|NCT02432846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102222492|NCT02432846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102222493|NCT02432846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222494|NCT03486509|Afatinib|afatinib|mesh-list
102222495|NCT03486509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102222496|NCT03486509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102222497|NCT03486509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102222498|NCT03486509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222499|NCT04460807|Exemestane|exemestane|mesh-list
102222500|NCT04460807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102222501|NCT04460807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102222502|NCT04460807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102222503|NCT04460807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102222504|NCT04460807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222505|NCT04460807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102222506|NCT04460807|Hormone Antagonists|hormone antagonists|mesh-ancestor
102222507|NCT04460807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102222508|NCT04460807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222509|NCT02246998|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102222510|NCT02246998|Antiviral Agents|antiviral agents|mesh-ancestor
102222511|NCT02246998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102222512|NCT02246998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102222513|NCT02246998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102222514|NCT04928222|Doxorubicin|doxorubicin|mesh-list
102222515|NCT04928222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102222516|NCT04928222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102222517|NCT04928222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102222518|NCT04928222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102222519|NCT04928222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102222520|NCT04928222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222521|NCT00805961|Bevacizumab|bevacizumab|mesh-list
102222522|NCT00805961|Everolimus|everolimus|mesh-list
102222523|NCT00805961|Temozolomide|temozolomide|mesh-list
102222524|NCT00805961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102222525|NCT00805961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102222526|NCT00805961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102222527|NCT00805961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102222528|NCT00805961|Growth Substances|growth substances|mesh-ancestor
102222529|NCT00805961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222530|NCT00805961|Growth Inhibitors|growth inhibitors|mesh-ancestor
102222531|NCT00805961|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102222532|NCT00805961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102222533|NCT00805961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102222534|NCT00805961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222535|NCT00805961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102222536|NCT00805961|Immunologic Factors|immunologic factors|mesh-ancestor
102222537|NCT00805961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102222538|NCT00805961|Alkylating Agents|alkylating agents|mesh-ancestor
102222539|NCT02454608|Verapamil|verapamil|mesh-list
102222540|NCT02454608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102222541|NCT02454608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102222542|NCT02454608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102222543|NCT02454608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222544|NCT02454608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102222545|NCT02454608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222546|NCT02454608|Vasodilator Agents|vasodilator agents|mesh-ancestor
102222547|NCT05152355|Budesonide|budesonide|mesh-list
102222548|NCT05152355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102222549|NCT05152355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102222550|NCT05152355|Autonomic Agents|autonomic agents|mesh-ancestor
101629480|NCT02707263|Heparin|heparin|mesh-list
102222551|NCT05152355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102222552|NCT05152355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222553|NCT05152355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102222554|NCT05152355|Respiratory System Agents|respiratory system agents|mesh-ancestor
102222555|NCT05152355|Glucocorticoids|glucocorticoids|mesh-ancestor
102222556|NCT05152355|Hormones|hormones|mesh-ancestor
102222557|NCT05152355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102612451|NCT00002471|Asparaginase|asparaginase|mesh-list
102612452|NCT00002471|Levoleucovorin|levoleucovorin|mesh-list
102222558|NCT02246764|Timolol|timolol|mesh-list
102222559|NCT02246764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102222560|NCT02246764|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102222561|NCT02246764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222562|NCT02246764|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102222563|NCT02246764|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102222564|NCT02246764|Adrenergic Agents|adrenergic agents|mesh-ancestor
102222565|NCT02246764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102222566|NCT02246764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222567|NCT02246764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102222568|NCT02246764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102222569|NCT03484091|Hylan|hylan|mesh-list
102222570|NCT03484091|Viscosupplements|viscosupplements|mesh-ancestor
102222571|NCT03484091|Protective Agents|protective agents|mesh-ancestor
102222572|NCT03484091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222573|NCT03486353|Azacitidine|azacitidine|mesh-list
102222574|NCT03486353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102222575|NCT03486353|Antimetabolites|antimetabolites|mesh-ancestor
102222576|NCT03486353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222577|NCT03486353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102222578|NCT03486353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102222579|NCT04460651|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
102222580|NCT04460651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102222581|NCT04460651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102222582|NCT04492241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102222583|NCT02431676|Metformin|metformin|mesh-list
102222584|NCT02431676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102222585|NCT02431676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222586|NCT03483545|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102222587|NCT03483545|Hormones|hormones|mesh-ancestor
102222588|NCT03483545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102222589|NCT03483545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222590|NCT03483389|Ethanol|ethanol|mesh-list
102222591|NCT03483389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102222592|NCT03483389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102222593|NCT03483389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102222594|NCT03483389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222595|NCT03486119|Nivolumab|nivolumab|mesh-list
102222596|NCT03486119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102222597|NCT03486119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102222598|NCT03486119|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102222599|NCT03486119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222600|NCT02523833|Albuterol|albuterol|mesh-list
102222601|NCT02523833|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102222602|NCT02523833|Autonomic Agents|autonomic agents|mesh-ancestor
102222603|NCT02523833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102222604|NCT02523833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222605|NCT02523833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101931448|NCT01971970|Adalimumab|adalimumab|mesh-list
102222606|NCT02523833|Respiratory System Agents|respiratory system agents|mesh-ancestor
102222607|NCT02523833|Tocolytic Agents|tocolytic agents|mesh-ancestor
102222608|NCT02523833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102222609|NCT02523833|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102222610|NCT02523833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102222611|NCT02523833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102222612|NCT02523833|Adrenergic Agents|adrenergic agents|mesh-ancestor
102222613|NCT02523833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102222614|NCT02523833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222615|NCT04234529|Caffeine|caffeine|mesh-list
102222616|NCT04234529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102222617|NCT04234529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629486|NCT02705547|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102222618|NCT04234529|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102222619|NCT04234529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102222620|NCT04234529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222621|NCT04234529|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102222622|NCT04234529|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102222623|NCT04234529|Purinergic Agents|purinergic agents|mesh-ancestor
102222624|NCT04234529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102222625|NCT01652690|Denosumab|denosumab|mesh-list
102222626|NCT01652690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102222627|NCT01652690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222628|NCT03481517|Bupivacaine|bupivacaine|mesh-list
102612453|NCT00002471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102612454|NCT00002471|Immunologic Factors|immunologic factors|mesh-ancestor
102222629|NCT03481517|Anesthetics, Local|anesthetics, local|mesh-ancestor
102222631|NCT03481517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102222632|NCT03481517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222633|NCT03481517|Sensory System Agents|sensory system agents|mesh-ancestor
102222634|NCT03481517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102222635|NCT02429258|Metformin|metformin|mesh-list
102222636|NCT02429258|Dapagliflozin|dapagliflozin|mesh-list
102222637|NCT02429258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102222638|NCT02429258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222639|NCT02429258|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102222640|NCT02429258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222641|NCT02201524|Abrocitinib|abrocitinib|mesh-list
102222642|NCT02201524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102222643|NCT02201524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102222644|NCT02201524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222645|NCT05153603|Olaparib|olaparib|mesh-list
102222646|NCT05153603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102222647|NCT05153603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102222648|NCT05153603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222649|NCT05153603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102222650|NCT02137252|Naltrexone|naltrexone|mesh-list
102222651|NCT02137252|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102222652|NCT02137252|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102222653|NCT02137252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222654|NCT02137252|Sensory System Agents|sensory system agents|mesh-ancestor
102222655|NCT02137252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102222656|NCT05152667|Dienogest|dienogest|mesh-list
102222657|NCT05152667|Levonorgestrel|levonorgestrel|mesh-list
102222658|NCT05152667|Progestins|progestins|mesh-list
102222659|NCT05152667|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102222660|NCT05152667|Contraceptive Agents|contraceptive agents|mesh-ancestor
102222661|NCT05152667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102222662|NCT05152667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222663|NCT05152667|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102222664|NCT05152667|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102222665|NCT05152667|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102222666|NCT05152667|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102222667|NCT05152667|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102222668|NCT05152667|Hormone Antagonists|hormone antagonists|mesh-ancestor
102222669|NCT05152667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102222670|NCT05152667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102222671|NCT05152667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102222672|NCT05152667|Hormones|hormones|mesh-ancestor
102222673|NCT05152511|Pentoxifylline|pentoxifylline|mesh-list
102222674|NCT05152511|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102222675|NCT05152511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102222676|NCT05152511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222677|NCT05152511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102222678|NCT05152511|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102222679|NCT05152511|Protective Agents|protective agents|mesh-ancestor
102222680|NCT05152511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222681|NCT05152511|Vasodilator Agents|vasodilator agents|mesh-ancestor
102222682|NCT05152511|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102222683|NCT05152511|Antioxidants|antioxidants|mesh-ancestor
102222684|NCT02568449|Nintedanib|nintedanib|mesh-list
101629488|NCT02705547|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102222685|NCT02568449|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102222686|NCT02568449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102222687|NCT02568449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102222688|NCT02568449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102222689|NCT02568449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222690|NCT02738333|Sofosbuvir|sofosbuvir|mesh-list
102222691|NCT02738333|Antiviral Agents|antiviral agents|mesh-ancestor
102222692|NCT02738333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102222693|NCT04884893|Nitrous Oxide|nitrous oxide|mesh-list
102222694|NCT04884893|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102222695|NCT04884893|Anesthetics, General|anesthetics, general|mesh-ancestor
102222696|NCT04884893|Anesthetics|anesthetics|mesh-ancestor
102222697|NCT04884893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102222698|NCT04884893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222699|NCT04884893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102222700|NCT04884893|Analgesics|analgesics|mesh-ancestor
102222701|NCT04884893|Sensory System Agents|sensory system agents|mesh-ancestor
102612455|NCT00002471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222702|NCT04884893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102222703|NCT03479879|Misoprostol|misoprostol|mesh-list
102222705|NCT03479879|Estrogens|estrogens|mesh-ancestor
102222706|NCT03479879|Hormones|hormones|mesh-ancestor
102222707|NCT03479879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102222708|NCT03479879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222709|NCT03479879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102222710|NCT03479879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102222711|NCT03479879|Abortifacient Agents|abortifacient agents|mesh-ancestor
102222712|NCT03479879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102222713|NCT03479879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102222714|NCT03479879|Oxytocics|oxytocics|mesh-ancestor
102222715|NCT03479411|Itraconazole|itraconazole|mesh-list
102222716|NCT03479411|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
102222717|NCT03479411|Antifungal Agents|antifungal agents|mesh-ancestor
102222718|NCT03479411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102222719|NCT03479411|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102222720|NCT03479411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102222721|NCT03479411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102222722|NCT03479411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222723|NCT03479411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102222724|NCT03479411|Hormone Antagonists|hormone antagonists|mesh-ancestor
102222725|NCT03479411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102222726|NCT03479411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222727|NCT03479411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102222728|NCT03131375|Dexmedetomidine|dexmedetomidine|mesh-list
102222729|NCT03131375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102222730|NCT03131375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102222731|NCT03131375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222732|NCT03131375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102222733|NCT03131375|Analgesics|analgesics|mesh-ancestor
102222734|NCT03131375|Sensory System Agents|sensory system agents|mesh-ancestor
102222735|NCT03131375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102222736|NCT03131375|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102222737|NCT03131375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102222738|NCT03131375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102222739|NCT03131375|Adrenergic Agents|adrenergic agents|mesh-ancestor
102222740|NCT03131375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102222741|NCT03131375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222742|NCT03475589|Apatinib|apatinib|mesh-list
102222743|NCT03475589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102222744|NCT03475589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102222745|NCT03475589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102222746|NCT03475589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222747|NCT03478709|Norepinephrine|norepinephrine|mesh-list
102222748|NCT03478709|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102222749|NCT03478709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102222750|NCT03478709|Adrenergic Agents|adrenergic agents|mesh-ancestor
102222751|NCT03478709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101836509|NCT00490542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102222752|NCT03478709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222753|NCT03478709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222755|NCT03478709|Autonomic Agents|autonomic agents|mesh-ancestor
102222756|NCT03478709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102222757|NCT03478709|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102222758|NCT03478475|Cholecalciferol|cholecalciferol|mesh-list
102222759|NCT03478475|Vitamin D|vitamin d|mesh-list
102222760|NCT03478475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102222761|NCT03478475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222762|NCT03478475|Vitamins|vitamins|mesh-ancestor
102222763|NCT03478475|Micronutrients|micronutrients|mesh-ancestor
102222764|NCT03478475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102222765|NCT03475121|Topotecan|topotecan|mesh-list
102222766|NCT03475121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102222767|NCT03475121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102222768|NCT03475121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102222769|NCT03475121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222770|NCT03475121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102222771|NCT03131063|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102222772|NCT03131063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102222773|NCT02523755|Ropivacaine|ropivacaine|mesh-list
102612456|NCT00002471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102222774|NCT02523755|Anesthetics, Local|anesthetics, local|mesh-ancestor
102222775|NCT02523755|Anesthetics|anesthetics|mesh-ancestor
102222776|NCT02523755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102222777|NCT02523755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222778|NCT02523755|Sensory System Agents|sensory system agents|mesh-ancestor
102222779|NCT02523755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102222780|NCT02168842|Isradipine|isradipine|mesh-list
102222781|NCT02168842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102222782|NCT02168842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102222783|NCT02168842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102222784|NCT02168842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222785|NCT02168842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102222786|NCT02168842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222787|NCT02168842|Vasodilator Agents|vasodilator agents|mesh-ancestor
102222788|NCT03347123|Nivolumab|nivolumab|mesh-list
102222789|NCT03347123|Ipilimumab|ipilimumab|mesh-list
102222790|NCT03347123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102222791|NCT03347123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102222792|NCT03347123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102222793|NCT03347123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222794|NCT03131141|Lefamulin|lefamulin|mesh-list
102222795|NCT03131141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102222796|NCT03131141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102222797|NCT05258045|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102222798|NCT05258045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102222799|NCT05258045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222800|NCT03477929|Cetrorelix|cetrorelix|mesh-list
102222801|NCT03477929|Ganirelix|ganirelix|mesh-list
102222802|NCT03477929|Hormone Antagonists|hormone antagonists|mesh-ancestor
102222803|NCT03477929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102222804|NCT03477929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222805|NCT03477929|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102222806|NCT03477929|Fertility Agents|fertility agents|mesh-ancestor
102222807|NCT03477929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102222808|NCT03474341|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102222809|NCT03474341|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102222810|NCT03474341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222811|NCT03474263|Antibodies|antibodies|mesh-list
102222812|NCT03474263|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102222813|NCT03474263|Immunologic Factors|immunologic factors|mesh-ancestor
102222814|NCT03474263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222815|NCT03477461|Terlipressin|terlipressin|mesh-list
102222816|NCT03477461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102222817|NCT03477461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102222818|NCT02553161|Escitalopram|escitalopram|mesh-list
102222819|NCT02553161|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102222820|NCT02553161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102222821|NCT02553161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102222822|NCT02553161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222823|NCT02553161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102222824|NCT02553161|Serotonin Agents|serotonin agents|mesh-ancestor
102222825|NCT02553161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222826|NCT03473093|Pregabalin|pregabalin|mesh-list
102222827|NCT03473093|Morphine|morphine|mesh-list
102222828|NCT03473093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102222829|NCT03473093|Narcotics|narcotics|mesh-ancestor
102222830|NCT03473093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102222831|NCT03473093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222832|NCT03473093|Analgesics|analgesics|mesh-ancestor
102222833|NCT03473093|Sensory System Agents|sensory system agents|mesh-ancestor
102222834|NCT03473093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102222835|NCT03473093|Anticonvulsants|anticonvulsants|mesh-ancestor
102222836|NCT03473093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102222837|NCT03473093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102222838|NCT03473093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222839|NCT03473093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102222840|NCT03473093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102222841|NCT03473093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102222842|NCT03473093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102222843|NCT02523131|Insulin|insulin|mesh-list
102222844|NCT02523131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102612457|NCT00002471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102222845|NCT02523131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222846|NCT04339049|Lidocaine|lidocaine|mesh-list
102222847|NCT04339049|Misoprostol|misoprostol|mesh-list
102222848|NCT04339049|Anesthetics, Local|anesthetics, local|mesh-ancestor
102222849|NCT04339049|Anesthetics|anesthetics|mesh-ancestor
102222850|NCT04339049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102222851|NCT04339049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222852|NCT04339049|Sensory System Agents|sensory system agents|mesh-ancestor
102222853|NCT04339049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102222854|NCT04339049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102222855|NCT04339049|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102222856|NCT04339049|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102222857|NCT04339049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102222858|NCT04339049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222859|NCT04339049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102222860|NCT04339049|Abortifacient Agents|abortifacient agents|mesh-ancestor
102222861|NCT04339049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102222862|NCT04339049|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102222863|NCT04339049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102222864|NCT04339049|Oxytocics|oxytocics|mesh-ancestor
102222865|NCT02133664|Thioctic Acid|thioctic acid|mesh-list
102222866|NCT02133664|Antioxidants|antioxidants|mesh-ancestor
102222867|NCT02133664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222868|NCT02133664|Protective Agents|protective agents|mesh-ancestor
102222869|NCT02133664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222870|NCT02133664|Vitamin B Complex|vitamin b complex|mesh-ancestor
102222871|NCT02133664|Vitamins|vitamins|mesh-ancestor
102222872|NCT02133664|Micronutrients|micronutrients|mesh-ancestor
102222873|NCT02133352|Ranolazine|ranolazine|mesh-list
102222874|NCT02133352|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102222875|NCT02133352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102222876|NCT02133352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222877|NCT04418128|Nafamostat|nafamostat|mesh-list
102222878|NCT04418128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102222879|NCT04418128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102222880|NCT04418128|Analgesics|analgesics|mesh-ancestor
102222881|NCT04418128|Sensory System Agents|sensory system agents|mesh-ancestor
102222882|NCT04418128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102222883|NCT04418128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222884|NCT04418128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102222885|NCT04418128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102222886|NCT04418128|Anticoagulants|anticoagulants|mesh-ancestor
102222887|NCT04418128|Protease Inhibitors|protease inhibitors|mesh-ancestor
102222888|NCT04418128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102222889|NCT04418128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222890|NCT04418128|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102222891|NCT04418128|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102222892|NCT04418128|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102222893|NCT04418128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102222894|NCT04418128|Immunologic Factors|immunologic factors|mesh-ancestor
102222895|NCT02555657|Gemcitabine|gemcitabine|mesh-list
102222896|NCT02555657|Capecitabine|capecitabine|mesh-list
102222897|NCT02555657|Pembrolizumab|pembrolizumab|mesh-list
102222898|NCT02555657|Vinorelbine|vinorelbine|mesh-list
102222899|NCT02555657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102222900|NCT02555657|Antimetabolites|antimetabolites|mesh-ancestor
102222901|NCT02555657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222902|NCT02555657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102222903|NCT02555657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102222904|NCT02555657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102222905|NCT02555657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102222906|NCT02555657|Tubulin Modulators|tubulin modulators|mesh-ancestor
102222907|NCT02555657|Antimitotic Agents|antimitotic agents|mesh-ancestor
102222908|NCT02555657|Mitosis Modulators|mitosis modulators|mesh-ancestor
102222909|NCT02195518|Tenofovir|tenofovir|mesh-list
102222910|NCT02195518|Antiviral Agents|antiviral agents|mesh-ancestor
102222911|NCT02195518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102222912|NCT02195518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102222913|NCT02195518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102222914|NCT02195518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102222915|NCT02195518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222916|NCT02195518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102222917|NCT02195518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102612458|NCT00002471|Alkylating Agents|alkylating agents|mesh-ancestor
102612459|NCT00002471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612460|NCT00002471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102222918|NCT03990077|Docetaxel|docetaxel|mesh-list
102222919|NCT03990077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102222920|NCT03990077|Tubulin Modulators|tubulin modulators|mesh-ancestor
102222921|NCT03990077|Antimitotic Agents|antimitotic agents|mesh-ancestor
102222922|NCT03990077|Mitosis Modulators|mitosis modulators|mesh-ancestor
102222923|NCT03990077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222924|NCT05134415|Menthol|menthol|mesh-list
102222925|NCT05134415|Antipruritics|antipruritics|mesh-ancestor
102222926|NCT05134415|Dermatologic Agents|dermatologic agents|mesh-ancestor
102222927|NCT03380507|Thiamine|thiamine|mesh-list
102222928|NCT03380507|Hydrocortisone|hydrocortisone|mesh-list
102222929|NCT03380507|Vitamins|vitamins|mesh-ancestor
102222930|NCT03380507|Micronutrients|micronutrients|mesh-ancestor
102222931|NCT03380507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222932|NCT03380507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102222933|NCT03380507|Vitamin B Complex|vitamin b complex|mesh-ancestor
102222934|NCT03471455|Itraconazole|itraconazole|mesh-list
102222935|NCT03471455|Terbinafine|terbinafine|mesh-list
102222936|NCT03471455|Isotretinoin|isotretinoin|mesh-list
102222937|NCT03471455|Antifungal Agents|antifungal agents|mesh-ancestor
102222938|NCT03471455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102222939|NCT03471455|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102222940|NCT03471455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102222941|NCT03471455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102222942|NCT03471455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222943|NCT03471455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102222944|NCT03471455|Hormone Antagonists|hormone antagonists|mesh-ancestor
102222945|NCT03471455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102222946|NCT03471455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222947|NCT03471455|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102222948|NCT03471455|Dermatologic Agents|dermatologic agents|mesh-ancestor
102222949|NCT02824679|Scopolamine|scopolamine|mesh-list
102222950|NCT02824679|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102222951|NCT02824679|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102222952|NCT02824679|Antiemetics|antiemetics|mesh-ancestor
102222953|NCT02824679|Autonomic Agents|autonomic agents|mesh-ancestor
102222954|NCT02824679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102222955|NCT02824679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222956|NCT02824679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102222957|NCT02824679|Mydriatics|mydriatics|mesh-ancestor
102222958|NCT02824679|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102222959|NCT02824679|Cholinergic Agents|cholinergic agents|mesh-ancestor
102222960|NCT02824679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102222961|NCT02824679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222962|NCT02824679|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102222963|NCT02824679|Parasympatholytics|parasympatholytics|mesh-ancestor
102222964|NCT03202667|Empagliflozin|empagliflozin|mesh-list
102222965|NCT03202667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102222966|NCT03202667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222967|NCT03202667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102222968|NCT03202667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222969|NCT02133742|Pembrolizumab|pembrolizumab|mesh-list
102222970|NCT02133742|Axitinib|axitinib|mesh-list
102222971|NCT02133742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102222972|NCT02133742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102222973|NCT02133742|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102222974|NCT02133742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222975|NCT02133742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102222976|NCT02133742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102222978|NCT05157893|Sensory System Agents|sensory system agents|mesh-ancestor
102222979|NCT05157893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102222980|NCT05157893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620771|NCT05802992|Hormones|hormones|mesh-ancestor
102612461|NCT00002471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102612462|NCT00002471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102612463|NCT00002471|Antiemetics|antiemetics|mesh-ancestor
102612464|NCT00002471|Autonomic Agents|autonomic agents|mesh-ancestor
102612465|NCT00002471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102612466|NCT00002471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102612467|NCT00002471|Glucocorticoids|glucocorticoids|mesh-ancestor
102612468|NCT00002471|Hormones|hormones|mesh-ancestor
102612469|NCT00002471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102612470|NCT00002471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102612471|NCT00002471|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102222982|NCT02523053|Antimetabolites|antimetabolites|mesh-ancestor
102222983|NCT02523053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222984|NCT02523053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102222985|NCT02523053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102222986|NCT02523053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102222987|NCT02523053|Immunologic Factors|immunologic factors|mesh-ancestor
102222988|NCT02523053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102222989|NCT04457609|Azithromycin|azithromycin|mesh-list
102222990|NCT04457609|Oseltamivir|oseltamivir|mesh-list
102222991|NCT04457609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102222992|NCT04457609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102222993|NCT04457609|Antiviral Agents|antiviral agents|mesh-ancestor
102222994|NCT04457609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102222995|NCT04457609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102222996|NCT05157269|Nitazoxanide|nitazoxanide|mesh-list
102222997|NCT05157269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102222998|NCT05157269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102222999|NCT04457765|Povidone-Iodine|povidone-iodine|mesh-list
102223000|NCT04457765|Povidone|povidone|mesh-list
102223001|NCT04457765|Plasma Substitutes|plasma substitutes|mesh-ancestor
102223002|NCT04457765|Blood Substitutes|blood substitutes|mesh-ancestor
102223003|NCT04457765|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102223004|NCT04457765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102223005|NCT03795233|Vancomycin|vancomycin|mesh-list
102223006|NCT03795233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102223007|NCT03795233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102223008|NCT03645863|Iron|iron|mesh-list
102223009|NCT03645863|Trace Elements|trace elements|mesh-ancestor
102223010|NCT03645863|Micronutrients|micronutrients|mesh-ancestor
102223011|NCT03645863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223012|NCT03564119|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102223013|NCT03564119|Dermatologic Agents|dermatologic agents|mesh-ancestor
102223014|NCT04503707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102223015|NCT04503707|Hormones|hormones|mesh-ancestor
102223016|NCT04503707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102223017|NCT04503707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223018|NCT03470597|Iodine|iodine|mesh-list
102223019|NCT03470597|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102223020|NCT03470597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102223021|NCT03470597|Trace Elements|trace elements|mesh-ancestor
102223022|NCT03470597|Micronutrients|micronutrients|mesh-ancestor
102223023|NCT03470597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223024|NCT02522897|Ranibizumab|ranibizumab|mesh-list
102223025|NCT02522897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102223026|NCT02522897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102223027|NCT02522897|Growth Substances|growth substances|mesh-ancestor
102223028|NCT02522897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223029|NCT02522897|Growth Inhibitors|growth inhibitors|mesh-ancestor
102223030|NCT02522897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102223031|NCT04351061|Acetazolamide|acetazolamide|mesh-list
102223032|NCT04351061|Anticonvulsants|anticonvulsants|mesh-ancestor
102223033|NCT04351061|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102223034|NCT04351061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102223035|NCT04351061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223036|NCT04351061|Diuretics|diuretics|mesh-ancestor
102223037|NCT04351061|Natriuretic Agents|natriuretic agents|mesh-ancestor
102223038|NCT04351061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223039|NCT03130829|Fucoidan|fucoidan|mesh-list
102223040|NCT03130829|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102223041|NCT03130829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102223042|NCT03130829|Anticoagulants|anticoagulants|mesh-ancestor
102223043|NCT03130829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102223044|NCT04318145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102223045|NCT04206761|Mometasone Furoate|mometasone furoate|mesh-list
102223046|NCT04206761|Glycopyrrolate|glycopyrrolate|mesh-list
102223047|NCT04206761|Bromides|bromides|mesh-list
102223048|NCT04206761|Anticonvulsants|anticonvulsants|mesh-ancestor
102223049|NCT04206761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102223050|NCT04206761|Dermatologic Agents|dermatologic agents|mesh-ancestor
102223051|NCT04206761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102223052|NCT04206761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102223054|NCT04206761|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102612472|NCT00002471|Abortifacient Agents|abortifacient agents|mesh-ancestor
102223055|NCT04206761|Cholinergic Agents|cholinergic agents|mesh-ancestor
102223056|NCT04206761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102223057|NCT04206761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900970|NCT00074490|Hormones|hormones|mesh-ancestor
102612473|NCT00002471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102223058|NCT04206761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223060|NCT03181529|Hallucinogens|hallucinogens|mesh-ancestor
102223061|NCT03181529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223062|NCT03181529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102223063|NCT03668639|Dexamethasone|dexamethasone|mesh-list
102223064|NCT03668639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102223065|NCT03668639|Antiemetics|antiemetics|mesh-ancestor
102223066|NCT03668639|Autonomic Agents|autonomic agents|mesh-ancestor
102223067|NCT03668639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102223068|NCT03668639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629534|NCT03354039|Tamoxifen|tamoxifen|mesh-list
102223069|NCT03668639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102223070|NCT03668639|Glucocorticoids|glucocorticoids|mesh-ancestor
102223071|NCT03668639|Hormones|hormones|mesh-ancestor
102223072|NCT03668639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102223073|NCT03668639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102223074|NCT03668639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102223075|NCT03470363|Sufentanil|sufentanil|mesh-list
102223076|NCT03470363|Bupivacaine|bupivacaine|mesh-list
102223077|NCT03470363|Sevoflurane|sevoflurane|mesh-list
102223078|NCT03470363|Anesthetics, Local|anesthetics, local|mesh-ancestor
102223079|NCT03470363|Anesthetics|anesthetics|mesh-ancestor
102223080|NCT03470363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102223081|NCT03470363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223082|NCT03470363|Sensory System Agents|sensory system agents|mesh-ancestor
102223083|NCT03470363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102223084|NCT03470363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102223085|NCT03470363|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102223086|NCT03470363|Anesthetics, General|anesthetics, general|mesh-ancestor
102223087|NCT03470363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102223088|NCT03470363|Narcotics|narcotics|mesh-ancestor
102223089|NCT03470363|Analgesics|analgesics|mesh-ancestor
102223090|NCT03470363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102223091|NCT03470363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102223092|NCT03469895|Idelalisib|idelalisib|mesh-list
102223093|NCT03469895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102223094|NCT03469895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102223095|NCT03469895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223096|NCT05160623|Povidone-Iodine|povidone-iodine|mesh-list
102223097|NCT05160623|Povidone|povidone|mesh-list
102223098|NCT05160623|Plasma Substitutes|plasma substitutes|mesh-ancestor
102223099|NCT05160623|Blood Substitutes|blood substitutes|mesh-ancestor
102223100|NCT05160623|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102223101|NCT05160623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102223102|NCT04713137|Erythritol|erythritol|mesh-list
102223103|NCT04713137|Vasodilator Agents|vasodilator agents|mesh-ancestor
102223104|NCT04456985|Folic Acid|folic acid|mesh-list
102223105|NCT04456985|Vitamin B 12|vitamin b 12|mesh-list
102223106|NCT04456985|Hydroxocobalamin|hydroxocobalamin|mesh-list
102223107|NCT04456985|Vitamins|vitamins|mesh-ancestor
102223108|NCT04456985|Micronutrients|micronutrients|mesh-ancestor
102223109|NCT04456985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223110|NCT04456985|Hematinics|hematinics|mesh-ancestor
102223111|NCT04456985|Vitamin B Complex|vitamin b complex|mesh-ancestor
102223112|NCT03469583|Entecavir|entecavir|mesh-list
102223113|NCT03469583|Antiviral Agents|antiviral agents|mesh-ancestor
102223114|NCT03469583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102223115|NCT05096039|Valsartan|valsartan|mesh-list
102223116|NCT05096039|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102223117|NCT05096039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102223118|NCT05096039|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102223119|NCT05096039|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102223120|NCT05096039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223121|NCT05604131|Deferiprone|deferiprone|mesh-list
102223122|NCT05604131|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102223123|NCT05604131|Chelating Agents|chelating agents|mesh-ancestor
102223124|NCT05604131|Sequestering Agents|sequestering agents|mesh-ancestor
102223125|NCT05604131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931979|NCT04175808|Moxifloxacin|moxifloxacin|mesh-list
102223126|NCT03469271|Calcitriol|calcitriol|mesh-list
102223127|NCT03469271|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
102223128|NCT03469271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102223129|NCT03469271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223130|NCT03469271|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102223131|NCT03469271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101764974|NCT00615459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102612474|NCT00002471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102223132|NCT03469271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223133|NCT03469271|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102223135|NCT03469271|Micronutrients|micronutrients|mesh-ancestor
102223136|NCT03469271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102223137|NCT03361865|Pembrolizumab|pembrolizumab|mesh-list
102223138|NCT03361865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102223139|NCT03361865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102223140|NCT03361865|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102223141|NCT03361865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223142|NCT02982083|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
102223143|NCT02982083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102223144|NCT02982083|Hormone Antagonists|hormone antagonists|mesh-ancestor
102223145|NCT02982083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102223146|NCT02982083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223147|NCT02982083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102223148|NCT02982083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102223149|NCT02982083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102223150|NCT02421341|Fentanyl|fentanyl|mesh-list
102223151|NCT02421341|Analgesics, Opioid|analgesics, opioid|mesh-list
102223152|NCT02421341|Analgesics|analgesics|mesh-list
102223153|NCT02421341|Narcotics|narcotics|mesh-ancestor
102223154|NCT02421341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102223155|NCT02421341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223156|NCT02421341|Sensory System Agents|sensory system agents|mesh-ancestor
102223157|NCT02421341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102223158|NCT02421341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102223159|NCT02421341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102223160|NCT02421341|Anesthetics, General|anesthetics, general|mesh-ancestor
102223161|NCT02421341|Anesthetics|anesthetics|mesh-ancestor
102223162|NCT02149121|Rituximab|rituximab|mesh-list
102223163|NCT02149121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102223164|NCT02149121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102223165|NCT02149121|Immunologic Factors|immunologic factors|mesh-ancestor
102223166|NCT02149121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223167|NCT02149121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102223168|NCT05162417|Tolonium Chloride|tolonium chloride|mesh-list
102223169|NCT05162417|Methylene Blue|methylene blue|mesh-list
102223170|NCT05162417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102223171|NCT05162417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223172|NCT05162417|Hemostatics|hemostatics|mesh-ancestor
102223173|NCT05162417|Coagulants|coagulants|mesh-ancestor
102223174|NCT05162417|Heparin Antagonists|heparin antagonists|mesh-ancestor
102223175|NCT05161403|Hyaluronic Acid|hyaluronic acid|mesh-list
102223176|NCT05161403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102223177|NCT05161403|Immunologic Factors|immunologic factors|mesh-ancestor
102223178|NCT05161403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223179|NCT05161403|Viscosupplements|viscosupplements|mesh-ancestor
102223180|NCT05161403|Protective Agents|protective agents|mesh-ancestor
102223181|NCT03205553|Dialysis Solutions|dialysis solutions|mesh-list
102223182|NCT03205553|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102223183|NCT03166085|Paclitaxel|paclitaxel|mesh-list
102223184|NCT03166085|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
102223185|NCT03166085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102223186|NCT03166085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102223187|NCT03166085|Tubulin Modulators|tubulin modulators|mesh-ancestor
102223188|NCT03166085|Antimitotic Agents|antimitotic agents|mesh-ancestor
102223189|NCT03166085|Mitosis Modulators|mitosis modulators|mesh-ancestor
102223190|NCT03166085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223191|NCT05390255|Mometasone Furoate|mometasone furoate|mesh-list
102223192|NCT05390255|Omalizumab|omalizumab|mesh-list
102223193|NCT05390255|Hormones|hormones|mesh-list
102223194|NCT05390255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102223195|NCT05390255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223196|NCT05390255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102223197|NCT05390255|Dermatologic Agents|dermatologic agents|mesh-ancestor
102223198|NCT05390255|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102223199|NCT05390255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102223200|NCT05390255|Respiratory System Agents|respiratory system agents|mesh-ancestor
102223201|NCT04456829|Resveratrol|resveratrol|mesh-list
101836510|NCT00490542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102223203|NCT04456829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223222|NCT02458313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102223223|NCT02458313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223224|NCT02458313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223226|NCT02522221|Anticoagulants|anticoagulants|mesh-ancestor
102223227|NCT05389943|Vitamin D|vitamin d|mesh-list
102223228|NCT05389943|Ergocalciferols|ergocalciferols|mesh-list
102223229|NCT05389943|Cholecalciferol|cholecalciferol|mesh-list
102223230|NCT05389943|Vitamins|vitamins|mesh-list
102223231|NCT05389943|Micronutrients|micronutrients|mesh-ancestor
102223232|NCT05389943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223233|NCT05389943|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102223234|NCT05389943|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102223235|NCT04575961|Pembrolizumab|pembrolizumab|mesh-list
102223236|NCT04575961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102223237|NCT04575961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102223238|NCT04575961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102223239|NCT04575961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223240|NCT02522975|Epoetin Alfa|epoetin alfa|mesh-list
102223241|NCT02522975|Hematinics|hematinics|mesh-ancestor
102223242|NCT04508803|Trastuzumab|trastuzumab|mesh-list
102223243|NCT04508803|Niraparib|niraparib|mesh-list
102223244|NCT04508803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102223245|NCT04508803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102223246|NCT04508803|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102223247|NCT04508803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102223248|NCT04508803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223249|NCT04492033|Paclitaxel|paclitaxel|mesh-list
102223250|NCT04492033|Irinotecan|irinotecan|mesh-list
102223251|NCT04492033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102223252|NCT04492033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102223253|NCT04492033|Tubulin Modulators|tubulin modulators|mesh-ancestor
102223254|NCT04492033|Antimitotic Agents|antimitotic agents|mesh-ancestor
102223255|NCT04492033|Mitosis Modulators|mitosis modulators|mesh-ancestor
102223256|NCT04492033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223257|NCT04492033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102223258|NCT04492033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102223259|NCT04492033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102223260|NCT03461185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
102223261|NCT03461185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102223262|NCT03461185|Growth Substances|growth substances|mesh-ancestor
102223263|NCT03461185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223264|NCT03461185|Growth Inhibitors|growth inhibitors|mesh-ancestor
102223265|NCT03461185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102223266|NCT04453423|Carboplatin|carboplatin|mesh-list
102223267|NCT04453423|Pemetrexed|pemetrexed|mesh-list
102223268|NCT04453423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102223269|NCT04453423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102223270|NCT04453423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223271|NCT04453423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102223272|NCT04453423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102223273|NCT04453189|Lansoprazole|lansoprazole|mesh-list
102223274|NCT04453189|Dexlansoprazole|dexlansoprazole|mesh-list
102223275|NCT04453189|Famotidine|famotidine|mesh-list
102223276|NCT04453189|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102223277|NCT04453189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102223278|NCT04453189|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102612476|NCT00002471|Dermatologic Agents|dermatologic agents|mesh-ancestor
102223279|NCT04453189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102223280|NCT04453189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223281|NCT04453189|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102223282|NCT04453189|Histamine Antagonists|histamine antagonists|mesh-ancestor
102223284|NCT04453189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102223285|NCT04453189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223287|NCT03465085|Calcium heparin|calcium heparin|mesh-list
102223288|NCT03465085|Streptokinase|streptokinase|mesh-list
102223289|NCT03465085|Anticoagulants|anticoagulants|mesh-ancestor
102223290|NCT03465085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102223291|NCT03465085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102223292|NCT03465085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223293|NCT03465007|Hydrocortisone|hydrocortisone|mesh-list
102223294|NCT03465007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102223295|NCT05030155|Cyclophosphamide|cyclophosphamide|mesh-list
102223296|NCT05030155|Azathioprine|azathioprine|mesh-list
102223297|NCT05030155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102223298|NCT05030155|Immunologic Factors|immunologic factors|mesh-ancestor
102223299|NCT05030155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223300|NCT05030155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102223301|NCT05030155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102223302|NCT05030155|Alkylating Agents|alkylating agents|mesh-ancestor
102223303|NCT05030155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223304|NCT05030155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102223305|NCT05030155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102223306|NCT05030155|Antimetabolites|antimetabolites|mesh-ancestor
102223307|NCT05030155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102223308|NCT04453111|Hyaluronic Acid|hyaluronic acid|mesh-list
102223309|NCT04453111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102223310|NCT04453111|Immunologic Factors|immunologic factors|mesh-ancestor
102223311|NCT04453111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223312|NCT04453111|Viscosupplements|viscosupplements|mesh-ancestor
102223313|NCT04453111|Protective Agents|protective agents|mesh-ancestor
102223314|NCT03468595|Listerine|listerine|mesh-list
102223315|NCT03468595|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102223316|NCT03468595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102223317|NCT04453345|Thalidomide|thalidomide|mesh-list
102223318|NCT04453345|Prednisone|prednisone|mesh-list
102223319|NCT04453345|Methotrexate|methotrexate|mesh-list
102223320|NCT04453345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102223321|NCT04453345|Glucocorticoids|glucocorticoids|mesh-ancestor
102223322|NCT04453345|Hormones|hormones|mesh-ancestor
102223323|NCT04453345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102223324|NCT04453345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223325|NCT04453345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102223326|NCT04453345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102223327|NCT04453345|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102223328|NCT04453345|Abortifacient Agents|abortifacient agents|mesh-ancestor
102223329|NCT04453345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102223330|NCT04453345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102223331|NCT04453345|Antimetabolites|antimetabolites|mesh-ancestor
102223332|NCT04453345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223333|NCT04453345|Dermatologic Agents|dermatologic agents|mesh-ancestor
102223334|NCT04453345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102223335|NCT04453345|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102223336|NCT04453345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102223337|NCT04453345|Immunologic Factors|immunologic factors|mesh-ancestor
102223338|NCT04453345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102223339|NCT04453345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102223340|NCT04453345|Leprostatic Agents|leprostatic agents|mesh-ancestor
102223341|NCT04453345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102223342|NCT04453345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102223343|NCT04453345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102223344|NCT04453345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102223345|NCT04453345|Growth Substances|growth substances|mesh-ancestor
102223346|NCT04453345|Growth Inhibitors|growth inhibitors|mesh-ancestor
102223347|NCT02322593|Oxaliplatin|oxaliplatin|mesh-list
102223348|NCT02322593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102223349|NCT03464539|Chitosan|chitosan|mesh-list
102223350|NCT03464539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102223351|NCT03464539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102612477|NCT00002471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101932200|NCT04047446|Hormones|hormones|mesh-ancestor
102223352|NCT03464539|Antimetabolites|antimetabolites|mesh-ancestor
102223353|NCT03464539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223355|NCT03464539|Chelating Agents|chelating agents|mesh-ancestor
102223356|NCT03464539|Sequestering Agents|sequestering agents|mesh-ancestor
102223357|NCT03464539|Hemostatics|hemostatics|mesh-ancestor
102223358|NCT03464539|Coagulants|coagulants|mesh-ancestor
102223359|NCT03460405|Vaccines|vaccines|mesh-list
102223360|NCT03460405|Immunologic Factors|immunologic factors|mesh-ancestor
102223361|NCT03460405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223362|NCT05166005|Vitamin D|vitamin d|mesh-list
102223363|NCT05166005|Vitamins|vitamins|mesh-ancestor
102223364|NCT05166005|Micronutrients|micronutrients|mesh-ancestor
102223365|NCT05166005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223366|NCT05166005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102223367|NCT03464305|Aspirin|aspirin|mesh-list
102223368|NCT03464305|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102223369|NCT03464305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102223370|NCT03464305|Analgesics|analgesics|mesh-ancestor
102223371|NCT03464305|Sensory System Agents|sensory system agents|mesh-ancestor
102223372|NCT03464305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102223373|NCT03464305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223374|NCT03464305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102223375|NCT03464305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102223376|NCT03464305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102223377|NCT03464305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102223378|NCT03464305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223379|NCT03464305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102223380|NCT03464305|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102223381|NCT03464305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102223382|NCT03464305|Antipyretics|antipyretics|mesh-ancestor
102223383|NCT05165615|Insulin|insulin|mesh-list
102223384|NCT05165615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102223385|NCT05165615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223386|NCT03468439|Phenol|phenol|mesh-list
102223387|NCT03468439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102223388|NCT03468439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102223389|NCT03468439|Disinfectants|disinfectants|mesh-ancestor
102223390|NCT03468439|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102223391|NCT03468439|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102223392|NCT05165303|Lidocaine|lidocaine|mesh-list
102223393|NCT05165303|Propofol|propofol|mesh-list
102223394|NCT05165303|Anesthetics, Local|anesthetics, local|mesh-ancestor
102223395|NCT05165303|Anesthetics|anesthetics|mesh-ancestor
102223396|NCT05165303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102223397|NCT05165303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223398|NCT05165303|Sensory System Agents|sensory system agents|mesh-ancestor
102223399|NCT05165303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102223400|NCT05165303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102223401|NCT05165303|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102223402|NCT05165303|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102223403|NCT05165303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102223404|NCT05165303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223405|NCT05165303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102223406|NCT05165303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102223407|NCT05165303|Anesthetics, General|anesthetics, general|mesh-ancestor
102223408|NCT03376763|Aripiprazole|aripiprazole|mesh-list
102223409|NCT03376763|Antidepressive Agents|antidepressive agents|mesh-ancestor
102223410|NCT03376763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102223411|NCT03376763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102223412|NCT03376763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102223413|NCT03376763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102223414|NCT03376763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223415|NCT03376763|Dopamine Agonists|dopamine agonists|mesh-ancestor
102223416|NCT03376763|Dopamine Agents|dopamine agents|mesh-ancestor
102223417|NCT03376763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102223418|NCT03376763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223419|NCT03376763|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102223420|NCT03376763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102223421|NCT03376763|Serotonin Agents|serotonin agents|mesh-ancestor
102223422|NCT03376763|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102223423|NCT03376763|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102223424|NCT03376763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102223425|NCT03376763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102223426|NCT05153135|Palbociclib|palbociclib|mesh-list
102223427|NCT05153135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102223429|NCT05153135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102223430|NCT05153135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223432|NCT02616185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102223433|NCT04857307|Alprazolam|alprazolam|mesh-list
102223434|NCT04857307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102223435|NCT04857307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102223436|NCT04857307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223437|NCT04857307|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102223438|NCT04857307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102223439|NCT04857307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102223440|NCT04857307|GABA Modulators|gaba modulators|mesh-ancestor
102223441|NCT04857307|GABA Agents|gaba agents|mesh-ancestor
102223442|NCT04857307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102223443|NCT04857307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223444|NCT03467893|Antacids|antacids|mesh-list
102223445|NCT03467893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223446|NCT03467893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102223447|NCT05170711|Antihypertensive Agents|antihypertensive agents|mesh-list
102223448|NCT05170711|Anesthetics|anesthetics|mesh-list
102223449|NCT05170711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102223450|NCT05170711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223451|NCT03454945|Doxycycline|doxycycline|mesh-list
102223452|NCT03454945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102223453|NCT03454945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102223454|NCT03454945|Antimalarials|antimalarials|mesh-ancestor
102223455|NCT03454945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102223456|NCT03454945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102223457|NCT01857115|Dexamethasone|dexamethasone|mesh-list
102223458|NCT01857115|Cyclophosphamide|cyclophosphamide|mesh-list
102223459|NCT01857115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102223460|NCT01857115|Immunologic Factors|immunologic factors|mesh-ancestor
102223461|NCT01857115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223462|NCT01857115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102223463|NCT01857115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102223464|NCT01857115|Alkylating Agents|alkylating agents|mesh-ancestor
102223465|NCT01857115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223466|NCT01857115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102223467|NCT01857115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102223468|NCT01857115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102223469|NCT01857115|Antiemetics|antiemetics|mesh-ancestor
102223470|NCT01857115|Autonomic Agents|autonomic agents|mesh-ancestor
102223471|NCT01857115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102223472|NCT01857115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102223473|NCT01857115|Glucocorticoids|glucocorticoids|mesh-ancestor
102223474|NCT01857115|Hormones|hormones|mesh-ancestor
102223475|NCT01857115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102223476|NCT01857115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102223477|NCT03453541|Ketorolac|ketorolac|mesh-list
102223478|NCT03453541|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102223479|NCT03453541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102223480|NCT03453541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102223481|NCT03453541|Analgesics|analgesics|mesh-ancestor
102223482|NCT03453541|Sensory System Agents|sensory system agents|mesh-ancestor
102223483|NCT03453541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102223484|NCT03453541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223485|NCT03453541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102223486|NCT03453541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102223487|NCT03453541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102223488|NCT03453541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102223489|NCT03453541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223490|NCT00893789|Modafinil|modafinil|mesh-list
102223491|NCT00893789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102223492|NCT00893789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223493|NCT00893789|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102223494|NCT00893789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102223495|NCT00893789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102223496|NCT00893789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223497|NCT03449251|Verapamil|verapamil|mesh-list
102223498|NCT03449251|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
102223499|NCT03449251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102612478|NCT00002471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102612479|NCT00002471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102223500|NCT03449251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101932352|NCT01085877|Estradiol|estradiol|mesh-list
101629566|NCT04815967|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
102223501|NCT03449251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102223502|NCT03449251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223503|NCT03449251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102223504|NCT03449251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223505|NCT03449251|Vasodilator Agents|vasodilator agents|mesh-ancestor
102223506|NCT03449251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102223507|NCT05322499|Paclitaxel|paclitaxel|mesh-list
102223508|NCT05322499|Docetaxel|docetaxel|mesh-list
102223509|NCT05322499|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102223510|NCT05322499|Irinotecan|irinotecan|mesh-list
102223511|NCT05322499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102223512|NCT05322499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102223513|NCT05322499|Tubulin Modulators|tubulin modulators|mesh-ancestor
102223514|NCT05322499|Antimitotic Agents|antimitotic agents|mesh-ancestor
102223515|NCT05322499|Mitosis Modulators|mitosis modulators|mesh-ancestor
102223516|NCT05322499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223517|NCT05322499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102223518|NCT05322499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102223519|NCT05322499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102223520|NCT03449173|Sunitinib|sunitinib|mesh-list
102223521|NCT03449173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102223522|NCT03449173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102223523|NCT03449173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102223524|NCT03449173|Growth Substances|growth substances|mesh-ancestor
102223525|NCT03449173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223526|NCT03449173|Growth Inhibitors|growth inhibitors|mesh-ancestor
102223527|NCT03449173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102223528|NCT03449173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102223529|NCT03449173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223530|NCT04760041|Midazolam|midazolam|mesh-list
102223531|NCT04760041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102223532|NCT04760041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102223533|NCT04760041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102223534|NCT04760041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223535|NCT04760041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102223536|NCT04760041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102223537|NCT04760041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102223538|NCT04760041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102223539|NCT04760041|Anesthetics, General|anesthetics, general|mesh-ancestor
102223540|NCT04760041|Anesthetics|anesthetics|mesh-ancestor
102223541|NCT04760041|GABA Modulators|gaba modulators|mesh-ancestor
102223542|NCT04760041|GABA Agents|gaba agents|mesh-ancestor
102223543|NCT04760041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102223544|NCT04760041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223545|NCT04754035|Venetoclax|venetoclax|mesh-list
102223546|NCT04754035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102223547|NCT05322265|Epinephrine|epinephrine|mesh-list
102223548|NCT05322265|Racepinephrine|racepinephrine|mesh-list
102223549|NCT05322265|Epinephryl borate|epinephryl borate|mesh-list
102223550|NCT05322265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102223551|NCT05322265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102223552|NCT05322265|Adrenergic Agents|adrenergic agents|mesh-ancestor
102223553|NCT05322265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102223554|NCT05322265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223555|NCT05322265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223556|NCT05322265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102223557|NCT05322265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102223558|NCT05322265|Autonomic Agents|autonomic agents|mesh-ancestor
102223559|NCT05322265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102223560|NCT05322265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102223561|NCT05322265|Respiratory System Agents|respiratory system agents|mesh-ancestor
102223562|NCT05322265|Mydriatics|mydriatics|mesh-ancestor
102223563|NCT05322265|Sympathomimetics|sympathomimetics|mesh-ancestor
102223564|NCT05322265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102223565|NCT02164864|Aspirin|aspirin|mesh-list
102223566|NCT02164864|Warfarin|warfarin|mesh-list
102223567|NCT02164864|Dabigatran|dabigatran|mesh-list
102223568|NCT02164864|Clopidogrel|clopidogrel|mesh-list
102223569|NCT02164864|Ticagrelor|ticagrelor|mesh-list
102223570|NCT02164864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102223571|NCT02164864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102612480|NCT00002471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102612481|NCT00002471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102223572|NCT02164864|Analgesics|analgesics|mesh-ancestor
102223573|NCT02164864|Sensory System Agents|sensory system agents|mesh-ancestor
102612482|NCT00002471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102223574|NCT02164864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102223575|NCT02164864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223576|NCT02164864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102223577|NCT02164864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102223578|NCT02164864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102223579|NCT02164864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102223580|NCT02164864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223581|NCT02164864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102223582|NCT02164864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102223583|NCT02164864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102223584|NCT02164864|Antipyretics|antipyretics|mesh-ancestor
102223585|NCT02164864|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102223586|NCT02164864|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102223587|NCT02164864|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102223588|NCT02164864|Purinergic Agents|purinergic agents|mesh-ancestor
102223589|NCT02164864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102223590|NCT02164864|Anticoagulants|anticoagulants|mesh-ancestor
102223591|NCT02164864|Antithrombins|antithrombins|mesh-ancestor
102223592|NCT02164864|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102223593|NCT02164864|Protease Inhibitors|protease inhibitors|mesh-ancestor
102223594|NCT05579249|Liraglutide|liraglutide|mesh-list
102223595|NCT05579249|Topiramate|topiramate|mesh-list
102223596|NCT05579249|Orlistat|orlistat|mesh-list
102223597|NCT05579249|Phentermine|phentermine|mesh-list
102223598|NCT05579249|Naltrexone|naltrexone|mesh-list
102223599|NCT05579249|Bupropion|bupropion|mesh-list
102223600|NCT05579249|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102223601|NCT05579249|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102223602|NCT05579249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223603|NCT05579249|Sensory System Agents|sensory system agents|mesh-ancestor
102223604|NCT05579249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102223605|NCT05579249|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102223606|NCT05579249|Incretins|incretins|mesh-ancestor
102223607|NCT05579249|Hormones|hormones|mesh-ancestor
102223608|NCT05579249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102223609|NCT05579249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102223610|NCT05579249|Antidepressive Agents|antidepressive agents|mesh-ancestor
102223611|NCT05579249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102223612|NCT05579249|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102223613|NCT05579249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102223614|NCT05579249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102223615|NCT05579249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223616|NCT05579249|Dopamine Agents|dopamine agents|mesh-ancestor
102223617|NCT05579249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102223618|NCT05579249|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102223619|NCT05579249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102223620|NCT05579249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102223621|NCT05579249|Anticonvulsants|anticonvulsants|mesh-ancestor
102223622|NCT05579249|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102223623|NCT05579249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102223624|NCT05579249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102223625|NCT05579249|Appetite Depressants|appetite depressants|mesh-ancestor
102223626|NCT05579249|Sympathomimetics|sympathomimetics|mesh-ancestor
102223627|NCT05579249|Autonomic Agents|autonomic agents|mesh-ancestor
102223628|NCT05579249|Adrenergic Agents|adrenergic agents|mesh-ancestor
102223629|NCT02419807|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102223630|NCT02419807|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
102223631|NCT02419807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102223632|NCT02419807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223633|NCT05386589|Molnupiravir|molnupiravir|mesh-list
102223634|NCT05386589|Antiviral Agents|antiviral agents|mesh-ancestor
102223635|NCT05386589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102223636|NCT01998529|Cisplatin|cisplatin|mesh-list
102223637|NCT01998529|Amifostine|amifostine|mesh-list
102223638|NCT01998529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102223639|NCT01998529|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102223640|NCT01998529|Protective Agents|protective agents|mesh-ancestor
102223641|NCT01998529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223642|NCT03448705|Vaccines|vaccines|mesh-list
102223643|NCT03448705|Immunologic Factors|immunologic factors|mesh-ancestor
102223644|NCT03448705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223645|NCT04637425|Broncho-Vaxom|broncho-vaxom|mesh-list
102612483|NCT00002471|Antiviral Agents|antiviral agents|mesh-ancestor
102223646|NCT04637425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102223647|NCT04637425|Immunologic Factors|immunologic factors|mesh-ancestor
102612484|NCT00002471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102223648|NCT04637425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223649|NCT03448549|Capecitabine|capecitabine|mesh-list
102223650|NCT03448549|Tegafur|tegafur|mesh-list
102223651|NCT03448549|Oxaliplatin|oxaliplatin|mesh-list
101932504|NCT03040024|Ketamine|ketamine|mesh-list
102223652|NCT03448549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102223653|NCT03448549|Antimetabolites|antimetabolites|mesh-ancestor
102223654|NCT03448549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223655|NCT03448549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102223656|NCT03679091|Clopidogrel|clopidogrel|mesh-list
102223658|NCT03679091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102223659|NCT03679091|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102223660|NCT03679091|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102223661|NCT03679091|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102223662|NCT03679091|Purinergic Agents|purinergic agents|mesh-ancestor
102223663|NCT03679091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102223664|NCT03679091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223665|NCT03679091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223666|NCT01628926|Ropinirole|ropinirole|mesh-list
102223667|NCT01628926|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102223668|NCT01628926|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102223669|NCT01628926|Dopamine Agonists|dopamine agonists|mesh-ancestor
102223670|NCT01628926|Dopamine Agents|dopamine agents|mesh-ancestor
102223671|NCT01628926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102223672|NCT01628926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223673|NCT01628926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223674|NCT05313659|Ketamine|ketamine|mesh-list
102223675|NCT05313659|Analgesics|analgesics|mesh-ancestor
102223676|NCT05313659|Sensory System Agents|sensory system agents|mesh-ancestor
102223677|NCT05313659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102223678|NCT05313659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223679|NCT05313659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102223680|NCT05313659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102223681|NCT05313659|Anesthetics, General|anesthetics, general|mesh-ancestor
102223682|NCT05313659|Anesthetics|anesthetics|mesh-ancestor
102223683|NCT05313659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102223684|NCT05313659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102223685|NCT05313659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102223686|NCT05313659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102223687|NCT05313659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223688|NCT05322187|Pembrolizumab|pembrolizumab|mesh-list
102223689|NCT05322187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102223690|NCT05322187|Lenvatinib|lenvatinib|mesh-list
102223691|NCT05322187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102223692|NCT05322187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102223693|NCT05322187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223694|NCT05322187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102223695|NCT05322187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102223696|NCT02164318|Nitroglycerin|nitroglycerin|mesh-list
102223697|NCT02164318|Vasodilator Agents|vasodilator agents|mesh-ancestor
102223698|NCT03436199|Amantadine|amantadine|mesh-list
102223699|NCT03436199|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102223700|NCT03436199|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102223701|NCT03436199|Antiviral Agents|antiviral agents|mesh-ancestor
102223702|NCT03436199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102223703|NCT03436199|Dopamine Agents|dopamine agents|mesh-ancestor
102223704|NCT03436199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102223705|NCT03436199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223706|NCT03436199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223707|NCT03436199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102223708|NCT03436199|Analgesics|analgesics|mesh-ancestor
102223709|NCT03436199|Sensory System Agents|sensory system agents|mesh-ancestor
101629576|NCT04815967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102223710|NCT03436199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102223711|NCT02131324|Clobetasol|clobetasol|mesh-list
102223712|NCT02131324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102223713|NCT02131324|Glucocorticoids|glucocorticoids|mesh-ancestor
102223714|NCT02131324|Hormones|hormones|mesh-ancestor
102223715|NCT02131324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102223716|NCT02131324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223717|NCT04749394|Apatinib|apatinib|mesh-list
102223718|NCT04749394|Antibodies|antibodies|mesh-list
102223719|NCT04749394|Immunoglobulins|immunoglobulins|mesh-list
102223720|NCT04749394|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102612485|NCT00002471|Antidotes|antidotes|mesh-ancestor
101900977|NCT03859856|Hormones|hormones|mesh-list
102223721|NCT04749394|Immunologic Factors|immunologic factors|mesh-ancestor
102223722|NCT04749394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223723|NCT04749394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102223724|NCT04749394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102223725|NCT04749394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102223726|NCT04749394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223727|NCT02193880|Cyclophosphamide|cyclophosphamide|mesh-list
102223729|NCT02193880|Immunologic Factors|immunologic factors|mesh-ancestor
102223730|NCT02193880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223731|NCT02193880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102223732|NCT02193880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102223733|NCT02193880|Alkylating Agents|alkylating agents|mesh-ancestor
102223734|NCT02193880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223735|NCT02193880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102223736|NCT02193880|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102223737|NCT05159219|Colchicine|colchicine|mesh-list
102223738|NCT05159219|Gout Suppressants|gout suppressants|mesh-ancestor
102223739|NCT05159219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102223740|NCT05159219|Tubulin Modulators|tubulin modulators|mesh-ancestor
102223741|NCT05159219|Antimitotic Agents|antimitotic agents|mesh-ancestor
102223742|NCT05159219|Mitosis Modulators|mitosis modulators|mesh-ancestor
102223743|NCT05159219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223744|NCT05159219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102223745|NCT05321329|Capecitabine|capecitabine|mesh-list
102223746|NCT05321329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102223747|NCT05321329|Antimetabolites|antimetabolites|mesh-ancestor
102223748|NCT05321329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223749|NCT05321329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102223750|NCT02521831|Bupivacaine|bupivacaine|mesh-list
102223751|NCT02521831|Anesthetics|anesthetics|mesh-list
102223752|NCT02521831|Isoflurane|isoflurane|mesh-list
102223753|NCT02521831|Anesthetics, Local|anesthetics, local|mesh-ancestor
102223754|NCT02521831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102223755|NCT02521831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223756|NCT02521831|Sensory System Agents|sensory system agents|mesh-ancestor
102223757|NCT02521831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102223758|NCT02521831|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102223759|NCT02521831|Anesthetics, General|anesthetics, general|mesh-ancestor
102223760|NCT01425541|Progesterone|progesterone|mesh-list
102223761|NCT01425541|Estradiol|estradiol|mesh-list
102223762|NCT01425541|Estrogens|estrogens|mesh-list
102223763|NCT01425541|Progestins|progestins|mesh-ancestor
102223764|NCT01425541|Hormones|hormones|mesh-ancestor
102223765|NCT01425541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102223766|NCT01425541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223767|NCT03447925|Salicylic Acid|salicylic acid|mesh-list
102223768|NCT03447925|Salicylates|salicylates|mesh-list
102223769|NCT03447925|Petrolatum|petrolatum|mesh-list
102223770|NCT03447925|Emollients|emollients|mesh-ancestor
102223771|NCT03447925|Dermatologic Agents|dermatologic agents|mesh-ancestor
102223772|NCT03447925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102223773|NCT03447925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102223774|NCT03447925|Analgesics|analgesics|mesh-ancestor
102223775|NCT03447925|Sensory System Agents|sensory system agents|mesh-ancestor
102223776|NCT03447925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102223777|NCT03447925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223778|NCT03447925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102223779|NCT03447925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102223780|NCT03447925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102223781|NCT03447925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101629581|NCT02704767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102223782|NCT03447925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223783|NCT03447925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102223784|NCT03447925|Antifungal Agents|antifungal agents|mesh-ancestor
102223785|NCT03447925|Keratolytic Agents|keratolytic agents|mesh-ancestor
102223786|NCT04928183|Nitroprusside|nitroprusside|mesh-list
102223787|NCT04928183|Phenylephrine|phenylephrine|mesh-list
102223788|NCT04928183|Oxymetazoline|oxymetazoline|mesh-list
102223789|NCT04928183|Carbon Monoxide|carbon monoxide|mesh-list
102223790|NCT04928183|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102223791|NCT04928183|Mydriatics|mydriatics|mesh-ancestor
102223792|NCT04928183|Autonomic Agents|autonomic agents|mesh-ancestor
102223793|NCT04928183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102223794|NCT04928183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102612486|NCT00002471|Protective Agents|protective agents|mesh-ancestor
102223795|NCT04928183|Sympathomimetics|sympathomimetics|mesh-ancestor
102223796|NCT04928183|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102612487|NCT00002471|Vitamin B Complex|vitamin b complex|mesh-ancestor
102223797|NCT04928183|Nasal Decongestants|nasal decongestants|mesh-ancestor
102223798|NCT04928183|Respiratory System Agents|respiratory system agents|mesh-ancestor
102223799|NCT04928183|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102223800|NCT04928183|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102223801|NCT04928183|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102223802|NCT04928183|Adrenergic Agents|adrenergic agents|mesh-ancestor
102223803|NCT04928183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102223804|NCT04928183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223805|NCT04928183|Protective Agents|protective agents|mesh-ancestor
102223806|NCT04928183|Antimetabolites|antimetabolites|mesh-ancestor
102223807|NCT04928183|Gasotransmitters|gasotransmitters|mesh-ancestor
102223808|NCT04928183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102223809|NCT04928183|Vasodilator Agents|vasodilator agents|mesh-ancestor
102223810|NCT04928183|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102223811|NCT04311073|Tranexamic Acid|tranexamic acid|mesh-list
102223812|NCT04311073|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102223813|NCT04311073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102223814|NCT04311073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223815|NCT04311073|Hemostatics|hemostatics|mesh-ancestor
102223816|NCT04311073|Coagulants|coagulants|mesh-ancestor
102223817|NCT03447691|Remifentanil|remifentanil|mesh-list
102223818|NCT03447691|Anesthetics|anesthetics|mesh-list
102223819|NCT03447691|Propofol|propofol|mesh-list
102223820|NCT03447691|Desflurane|desflurane|mesh-list
102223821|NCT03447691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102223822|NCT03447691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223823|NCT03447691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102223824|NCT03447691|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102223825|NCT03447691|Anesthetics, General|anesthetics, general|mesh-ancestor
102223826|NCT03447691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102223827|NCT03447691|Narcotics|narcotics|mesh-ancestor
102223828|NCT03447691|Analgesics|analgesics|mesh-ancestor
102223829|NCT03447691|Sensory System Agents|sensory system agents|mesh-ancestor
102223830|NCT03447691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102223831|NCT03447691|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102223832|NCT04923659|Nimodipine|nimodipine|mesh-list
102223833|NCT04923659|Carbamazepine|carbamazepine|mesh-list
102223834|NCT04923659|Lorazepam|lorazepam|mesh-list
102223835|NCT04923659|Dextromethorphan|dextromethorphan|mesh-list
102223836|NCT04923659|Antitussive Agents|antitussive agents|mesh-ancestor
102223837|NCT04923659|Respiratory System Agents|respiratory system agents|mesh-ancestor
102223838|NCT04923659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102223839|NCT04923659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102223840|NCT04923659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102223841|NCT04923659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223842|NCT04923659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223843|NCT04923659|Anticonvulsants|anticonvulsants|mesh-ancestor
102223844|NCT04923659|Antiemetics|antiemetics|mesh-ancestor
102223845|NCT04923659|Autonomic Agents|autonomic agents|mesh-ancestor
102223846|NCT04923659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102223847|NCT04923659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102223848|NCT04923659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102223849|NCT04923659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102223850|NCT04923659|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102223851|NCT04923659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102223852|NCT04923659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102223853|NCT04923659|GABA Modulators|gaba modulators|mesh-ancestor
102223854|NCT04923659|GABA Agents|gaba agents|mesh-ancestor
102223855|NCT04923659|Antimanic Agents|antimanic agents|mesh-ancestor
102223856|NCT04923659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102223857|NCT04923659|Analgesics|analgesics|mesh-ancestor
102223858|NCT04923659|Sensory System Agents|sensory system agents|mesh-ancestor
102223859|NCT04923659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102223860|NCT04923659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102223861|NCT04923659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102223862|NCT04923659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102223863|NCT04923659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102223864|NCT04923659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102223865|NCT04923659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102223866|NCT04923659|Vasodilator Agents|vasodilator agents|mesh-ancestor
102223867|NCT05398679|Amoxicillin|amoxicillin|mesh-list
102223868|NCT05398679|Moxifloxacin|moxifloxacin|mesh-list
102223869|NCT05398679|Ciprofloxacin|ciprofloxacin|mesh-list
102223870|NCT05398679|Levofloxacin|levofloxacin|mesh-list
102612488|NCT00002471|Vitamins|vitamins|mesh-ancestor
102612489|NCT00002471|Micronutrients|micronutrients|mesh-ancestor
102223871|NCT05398679|Ofloxacin|ofloxacin|mesh-list
102223872|NCT05398679|Clindamycin|clindamycin|mesh-list
101900980|NCT01094028|Oxytocin|oxytocin|mesh-list
102612490|NCT00002471|Tubulin Modulators|tubulin modulators|mesh-ancestor
102223873|NCT05398679|Clindamycin palmitate|clindamycin palmitate|mesh-list
102223874|NCT05398679|Clindamycin phosphate|clindamycin phosphate|mesh-list
102223876|NCT05398679|Linezolid|linezolid|mesh-list
102223877|NCT05398679|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102223878|NCT05398679|Tedizolid|tedizolid|mesh-list
102223879|NCT05398679|Fusidic Acid|fusidic acid|mesh-list
102223880|NCT05398679|Dicloxacillin|dicloxacillin|mesh-list
102223881|NCT05398679|Cefaclor|cefaclor|mesh-list
102223882|NCT05398679|Trimethoprim|trimethoprim|mesh-list
102223883|NCT05398679|Sulfamethoxazole|sulfamethoxazole|mesh-list
102223884|NCT05398679|Oxazolidinones|oxazolidinones|mesh-list
102223885|NCT05398679|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102223886|NCT05398679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102223887|NCT05398679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102223888|NCT05398679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102223889|NCT05398679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102223890|NCT05398679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102223891|NCT05398679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223892|NCT05398679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102223893|NCT05398679|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102223894|NCT05398679|Contraceptive Agents|contraceptive agents|mesh-ancestor
102223895|NCT05398679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102223896|NCT05398679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223897|NCT05398679|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102223898|NCT05398679|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102223899|NCT05398679|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102223900|NCT05398679|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102223901|NCT05398679|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102223902|NCT05398679|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102223903|NCT05398679|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102223904|NCT05398679|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102223905|NCT05398679|Antitubercular Agents|antitubercular agents|mesh-ancestor
102223906|NCT05398679|Leprostatic Agents|leprostatic agents|mesh-ancestor
102223907|NCT05398679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102223908|NCT05398679|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102223909|NCT05398679|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102223910|NCT05398679|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102223911|NCT05398679|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102223912|NCT05398679|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102223913|NCT05398679|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102223914|NCT05398679|Antimalarials|antimalarials|mesh-ancestor
102223915|NCT05398679|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102223916|NCT05398679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102223917|NCT05398679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102223918|NCT05398679|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102223919|NCT05398679|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102223920|NCT04817501|Edetic Acid|edetic acid|mesh-list
102223921|NCT04817501|Anticoagulants|anticoagulants|mesh-ancestor
102223922|NCT04817501|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102223923|NCT04817501|Chelating Agents|chelating agents|mesh-ancestor
102223924|NCT04817501|Sequestering Agents|sequestering agents|mesh-ancestor
102223925|NCT04817501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223926|NCT05398055|Azithromycin|azithromycin|mesh-list
102223927|NCT05398055|Doxycycline|doxycycline|mesh-list
102223928|NCT05398055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102223929|NCT05398055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102223930|NCT05398055|Antimalarials|antimalarials|mesh-ancestor
102223931|NCT05398055|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102223932|NCT05398055|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102223933|NCT01378325|Phenylephrine|phenylephrine|mesh-list
102223934|NCT01378325|Oxymetazoline|oxymetazoline|mesh-list
102223935|NCT01378325|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102223936|NCT01378325|Mydriatics|mydriatics|mesh-ancestor
102223937|NCT01378325|Autonomic Agents|autonomic agents|mesh-ancestor
102223938|NCT01378325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102223939|NCT01378325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223940|NCT01378325|Sympathomimetics|sympathomimetics|mesh-ancestor
102223941|NCT01378325|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102223942|NCT01378325|Nasal Decongestants|nasal decongestants|mesh-ancestor
102223943|NCT01378325|Respiratory System Agents|respiratory system agents|mesh-ancestor
102223944|NCT01378325|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102223945|NCT01378325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102223946|NCT01378325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102223947|NCT01378325|Adrenergic Agents|adrenergic agents|mesh-ancestor
102223948|NCT01378325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102223949|NCT01378325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223950|NCT01378325|Protective Agents|protective agents|mesh-ancestor
102223951|NCT03854903|Fulvestrant|fulvestrant|mesh-list
102223952|NCT03854903|Palbociclib|palbociclib|mesh-list
102223953|NCT03854903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102223954|NCT03854903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102223955|NCT03854903|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102223956|NCT03854903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102223957|NCT03854903|Hormone Antagonists|hormone antagonists|mesh-ancestor
102223958|NCT03854903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102223959|NCT03854903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223960|NCT03854903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102223961|NCT03854903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102223962|NCT03854903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223963|NCT01093573|Azacitidine|azacitidine|mesh-list
102223964|NCT01093573|Midostaurin|midostaurin|mesh-list
102223965|NCT01093573|Staurosporine|staurosporine|mesh-list
102223966|NCT01093573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102223967|NCT01093573|Antimetabolites|antimetabolites|mesh-ancestor
102223968|NCT01093573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223969|NCT01093573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102223970|NCT01093573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102223971|NCT01093573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102223972|NCT05174845|Ascorbic Acid|ascorbic acid|mesh-list
102223973|NCT05174845|Antioxidants|antioxidants|mesh-ancestor
102223974|NCT05174845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223975|NCT05174845|Protective Agents|protective agents|mesh-ancestor
102223976|NCT05174845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223977|NCT05174845|Vitamins|vitamins|mesh-ancestor
101629610|NCT02703363|Celecoxib|celecoxib|mesh-list
102223978|NCT05174845|Micronutrients|micronutrients|mesh-ancestor
102223979|NCT04155203|Calcium, Dietary|calcium, dietary|mesh-list
102223980|NCT04155203|Mupirocin|mupirocin|mesh-list
102223981|NCT04155203|Calcium|calcium|mesh-list
102223982|NCT04155203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102223983|NCT04155203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223984|NCT04155203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102223985|NCT04155203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102223986|NCT04155203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102223987|NCT04155203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102223988|NCT04155203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102223989|NCT04155203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102223990|NCT04238143|Complement Factor H|complement factor h|mesh-list
102223991|NCT04238143|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102223992|NCT04238143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102223993|NCT04238143|Immunologic Factors|immunologic factors|mesh-ancestor
102223994|NCT04238143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102223995|NCT03057613|Pembrolizumab|pembrolizumab|mesh-list
102223996|NCT03057613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102223997|NCT03057613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102223998|NCT03057613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102223999|NCT03057613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224000|NCT03446911|Pembrolizumab|pembrolizumab|mesh-list
102224001|NCT03446911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102224002|NCT03446911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102224003|NCT03446911|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102224004|NCT03446911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224005|NCT03446599|Hydroxocobalamin|hydroxocobalamin|mesh-list
102224006|NCT03446599|Vitamin B 12|vitamin b 12|mesh-list
102224007|NCT03446599|Methylene Blue|methylene blue|mesh-list
102224008|NCT03446599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102224009|NCT03446599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224010|NCT03446599|Hematinics|hematinics|mesh-ancestor
102224011|NCT03446599|Vitamin B Complex|vitamin b complex|mesh-ancestor
102224012|NCT03446599|Vitamins|vitamins|mesh-ancestor
102224013|NCT03446599|Micronutrients|micronutrients|mesh-ancestor
102224014|NCT03446599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224015|NCT02856451|Nivolumab|nivolumab|mesh-list
102224016|NCT02856451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102224017|NCT02856451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102224018|NCT02856451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102224019|NCT02856451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224020|NCT03446443|Metronidazole|metronidazole|mesh-list
102612491|NCT00002471|Antimitotic Agents|antimitotic agents|mesh-ancestor
102612492|NCT00002471|Mitosis Modulators|mitosis modulators|mesh-ancestor
102612493|NCT00002471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102224021|NCT03446443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102224022|NCT03446443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102224023|NCT03446443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102224024|NCT03446443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102224025|NCT05102071|Metformin|metformin|mesh-list
102224026|NCT05102071|Empagliflozin|empagliflozin|mesh-list
102224027|NCT05102071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102224028|NCT05102071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224029|NCT05102071|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102224030|NCT05102071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224031|NCT03130517|Immunoglobulins|immunoglobulins|mesh-list
102224032|NCT03130517|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102224033|NCT03130517|Antibodies|antibodies|mesh-list
102224034|NCT03130517|gamma-Globulins|gamma-globulins|mesh-list
102224035|NCT03130517|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102224036|NCT03130517|Immunologic Factors|immunologic factors|mesh-ancestor
102224037|NCT03130517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224038|NCT03445897|Miltefosine|miltefosine|mesh-list
102224039|NCT03445897|Pentamidine|pentamidine|mesh-list
102224040|NCT03445897|Antifungal Agents|antifungal agents|mesh-ancestor
102224041|NCT03445897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102224042|NCT03445897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102224043|NCT03445897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102224044|NCT03445897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102224045|NCT03445897|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102224046|NCT03237611|Dexamethasone|dexamethasone|mesh-list
102224047|NCT03237611|Ondansetron|ondansetron|mesh-list
102224048|NCT03237611|Aprepitant|aprepitant|mesh-list
102224049|NCT03237611|Fosaprepitant|fosaprepitant|mesh-list
102224050|NCT03237611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102224051|NCT03237611|Antiemetics|antiemetics|mesh-ancestor
102224052|NCT03237611|Autonomic Agents|autonomic agents|mesh-ancestor
102224053|NCT03237611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102224054|NCT03237611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224055|NCT03237611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102224056|NCT03237611|Glucocorticoids|glucocorticoids|mesh-ancestor
102224057|NCT03237611|Hormones|hormones|mesh-ancestor
102224058|NCT03237611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102224059|NCT03237611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102224060|NCT03237611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102224061|NCT03237611|Antipruritics|antipruritics|mesh-ancestor
102224062|NCT03237611|Dermatologic Agents|dermatologic agents|mesh-ancestor
102224063|NCT03237611|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102224064|NCT03237611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102224065|NCT03237611|Serotonin Agents|serotonin agents|mesh-ancestor
102224066|NCT03237611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102224067|NCT03237611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224068|NCT03237611|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102224069|NCT03234491|Insulin|insulin|mesh-list
102224070|NCT03234491|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102224071|NCT03234491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102224072|NCT03234491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224073|NCT01961063|Busulfan|busulfan|mesh-list
102224074|NCT01961063|Alkylating Agents|alkylating agents|mesh-ancestor
102224075|NCT01961063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224076|NCT01961063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102224077|NCT01961063|Immunologic Factors|immunologic factors|mesh-ancestor
102224078|NCT01961063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224079|NCT01961063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102224080|NCT01961063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102224081|NCT01961063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102224082|NCT02951377|Dexamethasone|dexamethasone|mesh-list
102224083|NCT02951377|Lidocaine|lidocaine|mesh-list
102224084|NCT02951377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102224085|NCT02951377|Antiemetics|antiemetics|mesh-ancestor
102224086|NCT02951377|Autonomic Agents|autonomic agents|mesh-ancestor
102224087|NCT02951377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102224088|NCT02951377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224089|NCT02951377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102224090|NCT02951377|Glucocorticoids|glucocorticoids|mesh-ancestor
102224091|NCT02951377|Hormones|hormones|mesh-ancestor
102224092|NCT02951377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102224093|NCT02951377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101900984|NCT01288508|Psyllium|psyllium|mesh-list
102224094|NCT02951377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102224095|NCT02951377|Anesthetics, Local|anesthetics, local|mesh-ancestor
102224096|NCT02951377|Anesthetics|anesthetics|mesh-ancestor
102224097|NCT02951377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102224098|NCT02951377|Sensory System Agents|sensory system agents|mesh-ancestor
102224099|NCT02951377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102224100|NCT02951377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102224101|NCT02951377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102224102|NCT02951377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102224103|NCT02951377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224104|NCT03109717|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-list
101932952|NCT03730766|Antacids|antacids|mesh-ancestor
102224105|NCT03109717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102224106|NCT03109717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224107|NCT03442621|Cortisone|cortisone|mesh-list
102224108|NCT03442621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102224109|NCT03444649|Cytarabine|cytarabine|mesh-list
102224110|NCT03444649|Daunorubicin|daunorubicin|mesh-list
102224111|NCT03444649|Idarubicin|idarubicin|mesh-list
102224112|NCT03444649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102224113|NCT03444649|Antimetabolites|antimetabolites|mesh-ancestor
102224114|NCT03444649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224115|NCT03444649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102224116|NCT03444649|Antiviral Agents|antiviral agents|mesh-ancestor
102224117|NCT03444649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102224118|NCT03444649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102224119|NCT03444649|Immunologic Factors|immunologic factors|mesh-ancestor
102224120|NCT03444649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224121|NCT03444649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102224122|NCT03444649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102224123|NCT03444649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102224124|NCT03444649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102224125|NCT01328951|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102224126|NCT01328951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102224127|NCT01328951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102224128|NCT01328951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102224129|NCT01328951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224130|NCT03466775|Angiotensin II|angiotensin ii|mesh-list
102224131|NCT03466775|Giapreza|giapreza|mesh-list
102224132|NCT03466775|Antibodies|antibodies|mesh-list
102224133|NCT03466775|Angiotensinogen|angiotensinogen|mesh-list
102224134|NCT03466775|Immunologic Factors|immunologic factors|mesh-ancestor
102224135|NCT03466775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224136|NCT03466775|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102224137|NCT03466775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102224138|NCT03466775|Protease Inhibitors|protease inhibitors|mesh-ancestor
102224139|NCT03466775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102224140|NCT03466775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224141|NCT02611817|Vedolizumab|vedolizumab|mesh-list
102224142|NCT02611817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102224143|NCT05430893|Botulinum Toxins|botulinum toxins|mesh-list
102224144|NCT05430893|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102224145|NCT05430893|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102224146|NCT05430893|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102224147|NCT05430893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102224148|NCT05430893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224149|NCT05430893|Cholinergic Agents|cholinergic agents|mesh-ancestor
102224150|NCT05430893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102224151|NCT05430893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224152|NCT05430893|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102224153|NCT05430893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102224154|NCT02557139|Belumosudil|belumosudil|mesh-list
102224155|NCT02557139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102224156|NCT02557139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102224157|NCT02557139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224158|NCT01677741|Dabrafenib|dabrafenib|mesh-list
102224159|NCT01677741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102224160|NCT01677741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102224161|NCT01677741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102224162|NCT01677741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224163|NCT02457221|Prednisone|prednisone|mesh-list
102224164|NCT02457221|Cyclophosphamide|cyclophosphamide|mesh-list
102224165|NCT02457221|Tacrolimus|tacrolimus|mesh-list
102612494|NCT00002471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102612495|NCT00002477|Cyclophosphamide|cyclophosphamide|mesh-list
102224166|NCT02457221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102224167|NCT02457221|Immunologic Factors|immunologic factors|mesh-ancestor
102224168|NCT02457221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224169|NCT02457221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102224170|NCT02457221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102224171|NCT02457221|Alkylating Agents|alkylating agents|mesh-ancestor
102224172|NCT02457221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224173|NCT02457221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102224174|NCT02457221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102224175|NCT02457221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102224176|NCT02457221|Glucocorticoids|glucocorticoids|mesh-ancestor
102224177|NCT02457221|Hormones|hormones|mesh-ancestor
102224178|NCT02457221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102224179|NCT02457221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102224180|NCT02457221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102224181|NCT02457221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102224182|NCT05263895|Ritonavir|ritonavir|mesh-list
102224183|NCT05263895|Nirmatrelvir|nirmatrelvir|mesh-list
102224184|NCT05263895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102224185|NCT05263895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102224186|NCT05263895|Protease Inhibitors|protease inhibitors|mesh-ancestor
102224187|NCT05263895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102224188|NCT05263895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224189|NCT05263895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102224190|NCT05263895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102224191|NCT05263895|Antiviral Agents|antiviral agents|mesh-ancestor
102224192|NCT05263895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102224193|NCT05263895|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102224194|NCT05263895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102224195|NCT01709981|Colchicine|colchicine|mesh-list
102224196|NCT01709981|Gout Suppressants|gout suppressants|mesh-ancestor
102224197|NCT01709981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102224198|NCT01709981|Tubulin Modulators|tubulin modulators|mesh-ancestor
102224199|NCT01709981|Antimitotic Agents|antimitotic agents|mesh-ancestor
102224200|NCT01709981|Mitosis Modulators|mitosis modulators|mesh-ancestor
102224201|NCT01709981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224202|NCT01709981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102224203|NCT03268083|Vaccines|vaccines|mesh-list
102224204|NCT03268083|Immunologic Factors|immunologic factors|mesh-ancestor
102224205|NCT03268083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224206|NCT03465059|Zanubrutinib|zanubrutinib|mesh-list
102224207|NCT03465059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102224208|NCT03465059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102224209|NCT03465059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102224210|NCT03465059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224211|NCT03170817|Regadenoson|regadenoson|mesh-list
102224212|NCT03170817|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
102224213|NCT03170817|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102224214|NCT03170817|Purinergic Agonists|purinergic agonists|mesh-ancestor
102224215|NCT03170817|Purinergic Agents|purinergic agents|mesh-ancestor
102224216|NCT03170817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102224217|NCT03170817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224218|NCT03170817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224219|NCT05101005|Sirolimus|sirolimus|mesh-list
102224220|NCT05101005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102224221|NCT05101005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102224222|NCT05101005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102224223|NCT05101005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102224224|NCT05101005|Antifungal Agents|antifungal agents|mesh-ancestor
102224225|NCT05101005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102224226|NCT05101005|Immunologic Factors|immunologic factors|mesh-ancestor
102224227|NCT05101005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224228|NCT03130205|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102224229|NCT03130205|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102224230|NCT03130205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224231|NCT05015387|Proanthocyanidin|proanthocyanidin|mesh-list
102224232|NCT05015387|Procyanidin|procyanidin|mesh-list
102612496|NCT00002477|Carboplatin|carboplatin|mesh-list
102612497|NCT00002477|Doxorubicin|doxorubicin|mesh-list
102612498|NCT00002477|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102612499|NCT00002477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102612500|NCT00002477|Immunologic Factors|immunologic factors|mesh-ancestor
102612501|NCT00002477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102612502|NCT00002477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102612503|NCT00002477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102224233|NCT05015387|Antioxidants|antioxidants|mesh-ancestor
102224234|NCT05015387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224235|NCT05015387|Protective Agents|protective agents|mesh-ancestor
102224236|NCT05015387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224237|NCT05015387|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102224238|NCT05015387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102224239|NCT05015387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102224240|NCT00003857|Tamoxifen|tamoxifen|mesh-list
102224241|NCT00003857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102224242|NCT00003857|Hormone Antagonists|hormone antagonists|mesh-ancestor
102224243|NCT00003857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102224244|NCT00003857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224245|NCT00003857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102224246|NCT00003857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102224247|NCT00003857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102224248|NCT00003857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102224249|NCT00003857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102224250|NCT03464435|Loteprednol Etabonate|loteprednol etabonate|mesh-list
102224251|NCT03464435|Tobramycin|tobramycin|mesh-list
102224252|NCT03464435|Tacrolimus|tacrolimus|mesh-list
102224253|NCT03464435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102224254|NCT03464435|Immunologic Factors|immunologic factors|mesh-ancestor
102224255|NCT03464435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224256|NCT03464435|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102224257|NCT03464435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102224258|NCT03464435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224259|NCT03464435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102224260|NCT03464435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102224261|NCT03464435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102224262|NCT03464279|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102224263|NCT03464279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102224265|NCT03463967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102224266|NCT03463967|Antioxidants|antioxidants|mesh-ancestor
102224267|NCT03463967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224268|NCT03463967|Protective Agents|protective agents|mesh-ancestor
102224269|NCT03463967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224270|NCT03463967|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102224271|NCT03463967|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102224272|NCT03463967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102224273|NCT03463733|Temozolomide|temozolomide|mesh-list
102224274|NCT03463733|Hydroxyurea|hydroxyurea|mesh-list
102224275|NCT03463733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102224276|NCT03463733|Alkylating Agents|alkylating agents|mesh-ancestor
102224277|NCT03463733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224278|NCT03463733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102224279|NCT03463733|Antisickling Agents|antisickling agents|mesh-ancestor
102224280|NCT03463733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102224281|NCT03463733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102224282|NCT04222595|Vaccines|vaccines|mesh-list
102224283|NCT04222595|Immunologic Factors|immunologic factors|mesh-ancestor
102224284|NCT04222595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224285|NCT03468023|Calpastatin|calpastatin|mesh-list
102224286|NCT03468023|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
102224287|NCT03468023|Protease Inhibitors|protease inhibitors|mesh-ancestor
102224288|NCT03468023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102224289|NCT03468023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224290|NCT04830215|Brexpiprazole|brexpiprazole|mesh-list
102224291|NCT04830215|Serotonin Agents|serotonin agents|mesh-ancestor
102224292|NCT04830215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102224293|NCT04830215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629647|NCT05018221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102224294|NCT04830215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224295|NCT04830215|Dopamine Agonists|dopamine agonists|mesh-ancestor
102224296|NCT04830215|Dopamine Agents|dopamine agents|mesh-ancestor
102224297|NCT05100303|Cytarabine|cytarabine|mesh-list
102224298|NCT05100303|Mitoxantrone|mitoxantrone|mesh-list
102224299|NCT05100303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102224300|NCT05100303|Antimetabolites|antimetabolites|mesh-ancestor
102224301|NCT05100303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224302|NCT05100303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102224303|NCT05100303|Antiviral Agents|antiviral agents|mesh-ancestor
102224304|NCT05100303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102224305|NCT05100303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102224306|NCT05100303|Immunologic Factors|immunologic factors|mesh-ancestor
102224307|NCT05100303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224309|NCT05100303|Sensory System Agents|sensory system agents|mesh-ancestor
102224310|NCT05100303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102224311|NCT05100303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102224312|NCT05100303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102224313|NCT05100303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102224314|NCT03462173|Yimitasvir|yimitasvir|mesh-list
102224315|NCT03462173|Antiviral Agents|antiviral agents|mesh-ancestor
102224316|NCT03462173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102224317|NCT05096715|Bevacizumab|bevacizumab|mesh-list
102224318|NCT05096715|Atezolizumab|atezolizumab|mesh-list
102224319|NCT05096715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102224320|NCT05096715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102224321|NCT05096715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102224322|NCT05096715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102224323|NCT05096715|Growth Substances|growth substances|mesh-ancestor
102224324|NCT05096715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224325|NCT05096715|Growth Inhibitors|growth inhibitors|mesh-ancestor
102224326|NCT05096715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102224327|NCT05096715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224328|NCT04984889|Protein C|protein c|mesh-list
102224329|NCT04984889|Anticoagulants|anticoagulants|mesh-ancestor
102224330|NCT04984889|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102224331|NCT04984889|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102224332|NCT04984889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224333|NCT05099601|Silymarin|silymarin|mesh-list
102224334|NCT05099601|Antioxidants|antioxidants|mesh-ancestor
102224335|NCT05099601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224336|NCT05099601|Protective Agents|protective agents|mesh-ancestor
102224337|NCT05099601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224338|NCT03461783|Charcoal|charcoal|mesh-list
102224339|NCT03461783|Antidotes|antidotes|mesh-ancestor
102224340|NCT03461783|Protective Agents|protective agents|mesh-ancestor
102224341|NCT03461783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224342|NCT01677507|Timolol|timolol|mesh-list
102224343|NCT01677507|Latanoprost|latanoprost|mesh-list
102224344|NCT01677507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102224345|NCT01677507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102224346|NCT01677507|Adrenergic Agents|adrenergic agents|mesh-ancestor
102224347|NCT01677507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102224348|NCT01677507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224349|NCT01677507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224350|NCT01677507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102224351|NCT01677507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102224352|NCT01677507|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102224353|NCT01677507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102224354|NCT04796363|Anesthetics|anesthetics|mesh-list
102224355|NCT04796363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102224356|NCT04796363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224357|NCT03593109|Immunomodulating Agents|immunomodulating agents|mesh-list
102224358|NCT03593109|Immunologic Factors|immunologic factors|mesh-ancestor
102224359|NCT03593109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224360|NCT03522753|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102224361|NCT03522753|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
102224362|NCT03522753|beta-Endorphin|beta-endorphin|mesh-list
102224363|NCT03522753|Hormones|hormones|mesh-ancestor
102224364|NCT03522753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102224365|NCT03522753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224366|NCT03522753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102224367|NCT03522753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224368|NCT05103813|Beraprost|beraprost|mesh-list
102224369|NCT05103813|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102224370|NCT05103813|Vasodilator Agents|vasodilator agents|mesh-ancestor
102224371|NCT03461627|Fluticasone|fluticasone|mesh-list
102224372|NCT03461627|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102224373|NCT03461627|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102224374|NCT03461627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102224375|NCT03461627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102224376|NCT03461627|Autonomic Agents|autonomic agents|mesh-ancestor
102224377|NCT03461627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102224378|NCT03461627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224379|NCT03461627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102612504|NCT00002477|Alkylating Agents|alkylating agents|mesh-ancestor
102612505|NCT00002477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224380|NCT03461627|Respiratory System Agents|respiratory system agents|mesh-ancestor
102224381|NCT03461627|Dermatologic Agents|dermatologic agents|mesh-ancestor
102224382|NCT03461627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102224383|NCT03461627|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102224384|NCT03461627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102224385|NCT03461627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102224386|NCT03461627|Adrenergic Agents|adrenergic agents|mesh-ancestor
102224387|NCT03461627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102224388|NCT03461627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224389|NCT03461627|Glucocorticoids|glucocorticoids|mesh-ancestor
102224390|NCT03461627|Hormones|hormones|mesh-ancestor
102224391|NCT03461627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102224392|NCT03461627|Sympathomimetics|sympathomimetics|mesh-ancestor
102224393|NCT04452929|Calcitonin|calcitonin|mesh-list
102224394|NCT04452929|Salmon calcitonin|salmon calcitonin|mesh-list
102224395|NCT04452929|Cilostazol|cilostazol|mesh-list
102224396|NCT04452929|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
102224397|NCT04452929|Erenumab|erenumab|mesh-list
102224398|NCT04452929|Katacalcin|katacalcin|mesh-list
102224399|NCT04452929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102224400|NCT04452929|Autonomic Agents|autonomic agents|mesh-ancestor
102224401|NCT04452929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102224402|NCT04452929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224403|NCT04452929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102224404|NCT04452929|Respiratory System Agents|respiratory system agents|mesh-ancestor
102224405|NCT04452929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102224406|NCT04452929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102224407|NCT04452929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224408|NCT04452929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102224409|NCT04452929|Vasodilator Agents|vasodilator agents|mesh-ancestor
102224410|NCT04452929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102224411|NCT04452929|Protective Agents|protective agents|mesh-ancestor
102224412|NCT04452929|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102224413|NCT04452929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102224414|NCT04452929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102224415|NCT04452929|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
102224416|NCT04452929|Analgesics|analgesics|mesh-ancestor
102224417|NCT04452929|Sensory System Agents|sensory system agents|mesh-ancestor
102224418|NCT04452929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102224419|NCT04452929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102224420|NCT05103501|Pembrolizumab|pembrolizumab|mesh-list
102224421|NCT05103501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102224422|NCT05103501|Fluorouracil|fluorouracil|mesh-list
102224424|NCT05103501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102224425|NCT05103501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102224426|NCT05103501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224427|NCT05103501|Antimetabolites|antimetabolites|mesh-ancestor
101629661|NCT00785980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102224428|NCT05103501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102224429|NCT05103501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102224430|NCT05103501|Immunologic Factors|immunologic factors|mesh-ancestor
102224431|NCT05103501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224432|NCT02522117|Atorvastatin|atorvastatin|mesh-list
102224433|NCT02522117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102224434|NCT02522117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102224435|NCT02522117|Antimetabolites|antimetabolites|mesh-ancestor
102224436|NCT02522117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224437|NCT02522117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102224438|NCT02522117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102224439|NCT02522117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102224440|NCT05087199|Fibrin fragment D|fibrin fragment d|mesh-list
102224441|NCT05087199|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102224442|NCT05087199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102224443|NCT05087199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224444|NCT05087199|Hemostatics|hemostatics|mesh-ancestor
102224445|NCT05087199|Coagulants|coagulants|mesh-ancestor
102224446|NCT04628429|Erenumab|erenumab|mesh-list
102224447|NCT04628429|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
102224448|NCT04628429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224449|NCT04628429|Analgesics|analgesics|mesh-ancestor
102224450|NCT04628429|Sensory System Agents|sensory system agents|mesh-ancestor
102224451|NCT04628429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102224452|NCT04628429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224453|NCT03461081|Amlodipine|amlodipine|mesh-list
102224454|NCT03461081|Telmisartan|telmisartan|mesh-list
102224455|NCT03461081|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
102224456|NCT03461081|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
102224457|NCT03461081|Atorvastatin|atorvastatin|mesh-list
102224458|NCT03461081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102224459|NCT03461081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102224460|NCT03461081|Antimetabolites|antimetabolites|mesh-ancestor
102224461|NCT03461081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224462|NCT03461081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102224463|NCT03461081|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102224464|NCT03461081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102224465|NCT03461081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102224466|NCT03461081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102224467|NCT03461081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102224468|NCT03461081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102224469|NCT03461081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224470|NCT03461081|Vasodilator Agents|vasodilator agents|mesh-ancestor
102224471|NCT03461081|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102224472|NCT03461081|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102224473|NCT02522039|Timolol|timolol|mesh-list
102224474|NCT02522039|Dorzolamide|dorzolamide|mesh-list
102224475|NCT02522039|Latanoprost|latanoprost|mesh-list
102224476|NCT02522039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102224477|NCT02522039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102224478|NCT02522039|Adrenergic Agents|adrenergic agents|mesh-ancestor
102224479|NCT02522039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102224480|NCT02522039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224481|NCT02522039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224482|NCT02522039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102224483|NCT02522039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102224484|NCT02522039|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102224485|NCT02522039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102224486|NCT02522039|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102224487|NCT02522039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102224488|NCT05107791|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102224489|NCT05107791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102224490|NCT04430699|Cisplatin|cisplatin|mesh-list
102224491|NCT04430699|Pembrolizumab|pembrolizumab|mesh-list
102224492|NCT04430699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102224493|NCT04430699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102224494|NCT04430699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102224495|NCT04430699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224496|NCT05111769|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
102224497|NCT05111769|Natriuretic Agents|natriuretic agents|mesh-ancestor
102224498|NCT05111769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224499|NCT04358003|Coal Tar|coal tar|mesh-list
102224500|NCT04358003|Keratolytic Agents|keratolytic agents|mesh-ancestor
102224501|NCT04358003|Dermatologic Agents|dermatologic agents|mesh-ancestor
102224502|NCT04519905|Paclitaxel|paclitaxel|mesh-list
102224503|NCT04519905|Carboplatin|carboplatin|mesh-list
102224504|NCT04519905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102224505|NCT04519905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102224506|NCT04519905|Tubulin Modulators|tubulin modulators|mesh-ancestor
102224507|NCT04519905|Antimitotic Agents|antimitotic agents|mesh-ancestor
102224508|NCT04519905|Mitosis Modulators|mitosis modulators|mesh-ancestor
102224509|NCT04519905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224510|NCT04423341|Cannabidiol|cannabidiol|mesh-list
102224511|NCT04423341|Anticonvulsants|anticonvulsants|mesh-ancestor
102224512|NCT03378479|Posaconazole|posaconazole|mesh-list
102224513|NCT03378479|Antifungal Agents|antifungal agents|mesh-ancestor
101900998|NCT01288664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612506|NCT00002477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102612507|NCT00002477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102612508|NCT00002477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102612509|NCT00002477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102612510|NCT00002477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102612511|NCT00002477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612512|NCT00002489|Leucovorin|leucovorin|mesh-list
102612513|NCT00002489|Dactinomycin|dactinomycin|mesh-list
102612514|NCT00002489|Cyclophosphamide|cyclophosphamide|mesh-list
102612515|NCT00002489|Carboplatin|carboplatin|mesh-list
102612516|NCT00002489|Doxorubicin|doxorubicin|mesh-list
102612517|NCT00002489|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102612518|NCT00002489|Methotrexate|methotrexate|mesh-list
102612519|NCT00002489|Etoposide|etoposide|mesh-list
102612520|NCT00002489|Vincristine|vincristine|mesh-list
102612521|NCT00002489|Levoleucovorin|levoleucovorin|mesh-list
102612522|NCT00002489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102224514|NCT03378479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102224515|NCT03378479|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102224516|NCT03378479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102224517|NCT03378479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102224518|NCT03378479|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102224519|NCT03378479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102224520|NCT03378479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102224521|NCT03378479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224522|NCT03378479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102224523|NCT03378479|Hormone Antagonists|hormone antagonists|mesh-ancestor
102224524|NCT03378479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102224525|NCT03378479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224526|NCT03460145|Propofol|propofol|mesh-list
102224527|NCT03460145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102224528|NCT03460145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102224529|NCT03460145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224530|NCT03460145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102224531|NCT03460145|Anesthetics, General|anesthetics, general|mesh-ancestor
102224532|NCT03460145|Anesthetics|anesthetics|mesh-ancestor
102224533|NCT04125771|Diclofenac|diclofenac|mesh-list
102224534|NCT04125771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102224535|NCT04125771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102224536|NCT04125771|Analgesics|analgesics|mesh-ancestor
102224537|NCT04125771|Sensory System Agents|sensory system agents|mesh-ancestor
102224538|NCT04125771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102224539|NCT04125771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224540|NCT04125771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102224541|NCT04125771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102224542|NCT04125771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102224543|NCT04125771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102224544|NCT04125771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224545|NCT05115123|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102224546|NCT05115123|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102224547|NCT05115123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102224548|NCT05115123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102224549|NCT05115123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224550|NCT05115123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101836511|NCT00490542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102224551|NCT05115123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224553|NCT05115123|Sensory System Agents|sensory system agents|mesh-ancestor
102224554|NCT05115123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102224555|NCT05115123|Antidepressive Agents|antidepressive agents|mesh-ancestor
102224556|NCT05115123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102224557|NCT05115123|Dopamine Agents|dopamine agents|mesh-ancestor
102224558|NCT04636671|Dexamethasone|dexamethasone|mesh-list
102224559|NCT04636671|Methylprednisolone|methylprednisolone|mesh-list
102224560|NCT04636671|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102224561|NCT04636671|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102224562|NCT04636671|Prednisolone|prednisolone|mesh-list
102224563|NCT04636671|Prednisolone acetate|prednisolone acetate|mesh-list
102224564|NCT04636671|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102224565|NCT04636671|Prednisolone phosphate|prednisolone phosphate|mesh-list
102224566|NCT04636671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102224567|NCT04636671|Antiemetics|antiemetics|mesh-ancestor
102224568|NCT04636671|Autonomic Agents|autonomic agents|mesh-ancestor
102224569|NCT04636671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102224570|NCT04636671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224571|NCT04636671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102224572|NCT04636671|Glucocorticoids|glucocorticoids|mesh-ancestor
102224573|NCT04636671|Hormones|hormones|mesh-ancestor
102224574|NCT04636671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102224575|NCT04636671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102224576|NCT04636671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102224577|NCT04636671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102224578|NCT04636671|Protective Agents|protective agents|mesh-ancestor
102224579|NCT03459599|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102224580|NCT03459599|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102224581|NCT03459599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102224582|NCT03459599|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102224583|NCT03459599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102224584|NCT03459599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612523|NCT00002489|Immunologic Factors|immunologic factors|mesh-ancestor
102612524|NCT00002489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102612525|NCT00002489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102612526|NCT00002489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102224585|NCT03645603|Dexmedetomidine|dexmedetomidine|mesh-list
102224586|NCT03645603|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102224587|NCT03645603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102224588|NCT03645603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224589|NCT03645603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102224590|NCT03645603|Analgesics|analgesics|mesh-ancestor
102224591|NCT03645603|Sensory System Agents|sensory system agents|mesh-ancestor
102224592|NCT03645603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102224593|NCT03645603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102224594|NCT03645603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102224595|NCT03645603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102224596|NCT03645603|Adrenergic Agents|adrenergic agents|mesh-ancestor
102224597|NCT03645603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102224598|NCT03645603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224599|NCT04019873|Lamivudine|lamivudine|mesh-list
102224600|NCT04019873|Rilpivirine|rilpivirine|mesh-list
102224601|NCT04019873|Dolutegravir|dolutegravir|mesh-list
102224602|NCT04019873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102224603|NCT04019873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102224604|NCT04019873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102224605|NCT04019873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224606|NCT04019873|Antiviral Agents|antiviral agents|mesh-ancestor
102224607|NCT04019873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102224608|NCT04019873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102224609|NCT04019873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102224610|NCT04019873|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102224611|NCT04019873|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102224612|NCT04771689|Buprenorphine|buprenorphine|mesh-list
102224613|NCT04771689|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102224614|NCT04771689|Naloxone|naloxone|mesh-list
102224615|NCT04771689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102224616|NCT04771689|Narcotics|narcotics|mesh-ancestor
102224617|NCT04771689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102224618|NCT04771689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224619|NCT04771689|Analgesics|analgesics|mesh-ancestor
102224620|NCT04771689|Sensory System Agents|sensory system agents|mesh-ancestor
102224621|NCT04771689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102224622|NCT04771689|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102224623|NCT04674345|Sorafenib|sorafenib|mesh-list
102224624|NCT04674345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101933486|NCT03727100|Clonidine|clonidine|mesh-list
102224625|NCT04674345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102224626|NCT04674345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102224627|NCT04674345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224628|NCT04165239|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
102224629|NCT04165239|Antioxidants|antioxidants|mesh-ancestor
102224630|NCT04165239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224631|NCT04165239|Protective Agents|protective agents|mesh-ancestor
102224632|NCT04165239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224634|NCT03756311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102224635|NCT03756311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102224636|NCT03756311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102224637|NCT03756311|Tubulin Modulators|tubulin modulators|mesh-ancestor
102224638|NCT03756311|Antimitotic Agents|antimitotic agents|mesh-ancestor
102224639|NCT03756311|Mitosis Modulators|mitosis modulators|mesh-ancestor
102224640|NCT03756311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224641|NCT04576767|Anesthetics|anesthetics|mesh-list
102224642|NCT04576767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102224643|NCT04576767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224644|NCT03248531|Adalimumab|adalimumab|mesh-list
102224645|NCT03248531|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102224646|NCT03248531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102224647|NCT03248531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102224648|NCT03866525|Irinotecan|irinotecan|mesh-list
102224649|NCT03866525|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102224650|NCT03866525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102224651|NCT03866525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102224652|NCT03866525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224653|NCT03866525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102224654|NCT03129347|Nalmefene|nalmefene|mesh-list
101766525|NCT05551104|Tocolytic Agents|tocolytic agents|mesh-ancestor
102224655|NCT03129347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102224656|NCT03129347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224657|NCT03129347|Sensory System Agents|sensory system agents|mesh-ancestor
102224658|NCT03129347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102224659|NCT02262923|Metoclopramide|metoclopramide|mesh-list
102224660|NCT02262923|Antiemetics|antiemetics|mesh-ancestor
102224661|NCT02262923|Autonomic Agents|autonomic agents|mesh-ancestor
102224662|NCT02262923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102224663|NCT02262923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224664|NCT02262923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102224665|NCT02262923|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102224666|NCT02262923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102224667|NCT02262923|Dopamine Agents|dopamine agents|mesh-ancestor
102224668|NCT02262923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102224669|NCT02262923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224670|NCT02194595|Insulin|insulin|mesh-list
102224671|NCT02194595|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102224672|NCT02194595|Insulin Glargine|insulin glargine|mesh-list
102224673|NCT02194595|Exenatide|exenatide|mesh-list
102224674|NCT02194595|Insulin Lispro|insulin lispro|mesh-list
102224675|NCT02194595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102224676|NCT02194595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224677|NCT02194595|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102224678|NCT02194595|Incretins|incretins|mesh-ancestor
102224679|NCT02194595|Hormones|hormones|mesh-ancestor
102224680|NCT02194595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102224681|NCT02656329|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
102224682|NCT02656329|Lugol's solution|lugol's solution|mesh-list
102224683|NCT02656329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102224684|NCT02656329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102224685|NCT02656329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224686|NCT02656329|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102224687|NCT02656329|Hemostatics|hemostatics|mesh-ancestor
102224688|NCT02656329|Coagulants|coagulants|mesh-ancestor
102224689|NCT02712905|Nivolumab|nivolumab|mesh-list
102224690|NCT02712905|Azacitidine|azacitidine|mesh-list
102224691|NCT02712905|Tretinoin|tretinoin|mesh-list
102224692|NCT02712905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102224693|NCT02712905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102224694|NCT02712905|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102224695|NCT02712905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224696|NCT02712905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102224697|NCT02712905|Antimetabolites|antimetabolites|mesh-ancestor
102224698|NCT02712905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102224699|NCT02712905|Keratolytic Agents|keratolytic agents|mesh-ancestor
102224700|NCT02712905|Dermatologic Agents|dermatologic agents|mesh-ancestor
102224701|NCT01166633|Atorvastatin|atorvastatin|mesh-list
102224702|NCT01166633|Pitavastatin|pitavastatin|mesh-list
102224703|NCT01166633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102224704|NCT01166633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102224705|NCT01166633|Antimetabolites|antimetabolites|mesh-ancestor
102224706|NCT01166633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224707|NCT01166633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102224708|NCT01166633|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102224709|NCT01166633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102224710|NCT04315311|Pancrelipase|pancrelipase|mesh-list
102224711|NCT04315311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102224712|NCT03596073|Calcipotriene|calcipotriene|mesh-list
102224713|NCT03596073|Petrolatum|petrolatum|mesh-list
102224714|NCT03596073|Dermatologic Agents|dermatologic agents|mesh-ancestor
102224715|NCT03596073|Emollients|emollients|mesh-ancestor
102224716|NCT05320757|Olaparib|olaparib|mesh-list
102224717|NCT05320757|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102224718|NCT05320757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102224719|NCT05320757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224720|NCT05320757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102224721|NCT03449693|Magnesium Oxide|magnesium oxide|mesh-list
102224722|NCT03449693|Antacids|antacids|mesh-ancestor
102224723|NCT03449693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224724|NCT03449693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102224725|NCT03449537|Caseins|caseins|mesh-list
102224726|NCT03449537|Chelating Agents|chelating agents|mesh-ancestor
102224727|NCT03449537|Sequestering Agents|sequestering agents|mesh-ancestor
102224728|NCT03449537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224729|NCT02237183|Iloprost|iloprost|mesh-list
102612527|NCT00002489|Alkylating Agents|alkylating agents|mesh-ancestor
102612528|NCT00002489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612529|NCT00002489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102224730|NCT02237183|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102224731|NCT02237183|Vasodilator Agents|vasodilator agents|mesh-ancestor
102224732|NCT03371979|Pembrolizumab|pembrolizumab|mesh-list
102224733|NCT03371979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102224734|NCT03371979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102224735|NCT03371979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102224736|NCT03371979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224737|NCT05104437|Vaccines|vaccines|mesh-list
102224738|NCT05104437|Immunologic Factors|immunologic factors|mesh-ancestor
102224739|NCT05104437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224740|NCT03179943|Atezolizumab|atezolizumab|mesh-list
102224741|NCT03179943|Guadecitabine|guadecitabine|mesh-list
102224742|NCT03179943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102224743|NCT03179943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224744|NCT03179943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102224745|NCT03179943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102224746|NCT05114499|Donepezil|donepezil|mesh-list
102224747|NCT05114499|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102224748|NCT05114499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102224749|NCT05114499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224750|NCT05114499|Cholinergic Agents|cholinergic agents|mesh-ancestor
102224751|NCT05114499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102224752|NCT05114499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224753|NCT05114499|Nootropic Agents|nootropic agents|mesh-ancestor
102224754|NCT04520997|Hyaluronic Acid|hyaluronic acid|mesh-list
102224755|NCT04520997|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102224756|NCT04520997|Immunologic Factors|immunologic factors|mesh-ancestor
102224757|NCT04520997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224758|NCT04520997|Viscosupplements|viscosupplements|mesh-ancestor
102224759|NCT04520997|Protective Agents|protective agents|mesh-ancestor
102224760|NCT05109585|Antibodies|antibodies|mesh-list
102224761|NCT05109585|Immunoglobulins|immunoglobulins|mesh-list
102224762|NCT05109585|Immunoglobulin G|immunoglobulin g|mesh-list
102224763|NCT05109585|Immunologic Factors|immunologic factors|mesh-ancestor
102224764|NCT05109585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224765|NCT02142803|Bevacizumab|bevacizumab|mesh-list
102224766|NCT02142803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102224767|NCT02142803|Endothelial Growth Factors|endothelial growth factors|mesh-list
102224768|NCT02142803|Antibodies|antibodies|mesh-list
102224769|NCT02142803|Immunoglobulins|immunoglobulins|mesh-list
102224770|NCT02142803|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102224771|NCT02142803|Immunoglobulin G|immunoglobulin g|mesh-list
102224772|NCT02142803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102224773|NCT02142803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102224774|NCT02142803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102224775|NCT02142803|Growth Substances|growth substances|mesh-ancestor
102224776|NCT02142803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224777|NCT02142803|Growth Inhibitors|growth inhibitors|mesh-ancestor
102224778|NCT02142803|Immunologic Factors|immunologic factors|mesh-ancestor
102224779|NCT05283161|Dronabinol|dronabinol|mesh-list
102224780|NCT05283161|Cannabidiol|cannabidiol|mesh-list
102224781|NCT05283161|Anticonvulsants|anticonvulsants|mesh-ancestor
102224782|NCT05283161|Hallucinogens|hallucinogens|mesh-ancestor
102224783|NCT05283161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224784|NCT05283161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102224785|NCT05283161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102224786|NCT05283161|Analgesics|analgesics|mesh-ancestor
102224787|NCT05283161|Sensory System Agents|sensory system agents|mesh-ancestor
102224788|NCT05283161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102224789|NCT05283161|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102224790|NCT05283161|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102224791|NCT05283161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102224792|NCT05283161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224793|NCT05283161|Hormones|hormones|mesh-ancestor
102224794|NCT05283161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102224795|NCT03691311|Denosumab|denosumab|mesh-list
102224796|NCT03691311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102224797|NCT03691311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224798|NCT03448835|Docetaxel|docetaxel|mesh-list
102224799|NCT03448835|Capecitabine|capecitabine|mesh-list
102224800|NCT03448835|Oxaliplatin|oxaliplatin|mesh-list
102612530|NCT00002489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102224801|NCT03448835|Atezolizumab|atezolizumab|mesh-list
102224802|NCT03448835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102224803|NCT03448835|Tubulin Modulators|tubulin modulators|mesh-ancestor
102224804|NCT03448835|Antimitotic Agents|antimitotic agents|mesh-ancestor
102224805|NCT03448835|Mitosis Modulators|mitosis modulators|mesh-ancestor
102224806|NCT03448835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224807|NCT03448835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102224808|NCT03448835|Antimetabolites|antimetabolites|mesh-ancestor
102224809|NCT03448835|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102224810|NCT03448835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102224812|NCT03690453|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102224813|NCT03690453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102224814|NCT05211635|Vitamin D|vitamin d|mesh-list
102224815|NCT05211635|Vitamins|vitamins|mesh-ancestor
102224816|NCT05211635|Micronutrients|micronutrients|mesh-ancestor
102224817|NCT05211635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224818|NCT05211635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102224819|NCT05184335|RP5063|rp5063|mesh-list
102224820|NCT05184335|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102224821|NCT05184335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102224822|NCT05184335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102224823|NCT05184335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224824|NCT05184335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102224825|NCT05184335|Serotonin Agents|serotonin agents|mesh-ancestor
102224826|NCT05184335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102224827|NCT05184335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224828|NCT03443609|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102224829|NCT03443609|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102224830|NCT03443609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224831|NCT01709123|Chromium|chromium|mesh-list
102224832|NCT01709123|Trace Elements|trace elements|mesh-ancestor
102224833|NCT01709123|Micronutrients|micronutrients|mesh-ancestor
102224834|NCT01709123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224835|NCT01301807|Panobinostat|panobinostat|mesh-list
102224836|NCT01301807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102224837|NCT01301807|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102224838|NCT01301807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102224839|NCT01301807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224840|NCT04962893|Vaccines|vaccines|mesh-list
102224841|NCT04962893|Immunologic Factors|immunologic factors|mesh-ancestor
102224842|NCT04962893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224843|NCT03443141|Vitamin E|vitamin e|mesh-list
102224844|NCT03443141|Vitamins|vitamins|mesh-ancestor
102224845|NCT03443141|Micronutrients|micronutrients|mesh-ancestor
102224846|NCT03443141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224847|NCT03443141|Antioxidants|antioxidants|mesh-ancestor
102224848|NCT03443141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224849|NCT03443141|Protective Agents|protective agents|mesh-ancestor
102224850|NCT04937543|Beclomethasone|beclomethasone|mesh-list
102224851|NCT04937543|Glycopyrrolate|glycopyrrolate|mesh-list
102224852|NCT04937543|Formoterol Fumarate|formoterol fumarate|mesh-list
102224853|NCT04937543|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102224854|NCT04937543|Autonomic Agents|autonomic agents|mesh-ancestor
102224855|NCT04937543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102224856|NCT04937543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224857|NCT04937543|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102224858|NCT04937543|Respiratory System Agents|respiratory system agents|mesh-ancestor
102224859|NCT04937543|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102224860|NCT04937543|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101629711|NCT02703051|Lenograstim|lenograstim|mesh-list
102224861|NCT04937543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102224862|NCT04937543|Adrenergic Agents|adrenergic agents|mesh-ancestor
102224863|NCT04937543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102224864|NCT04937543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224865|NCT04937543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102224866|NCT04937543|Glucocorticoids|glucocorticoids|mesh-ancestor
102224867|NCT04937543|Hormones|hormones|mesh-ancestor
102224868|NCT04937543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102224869|NCT04937543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102224870|NCT04937543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102224871|NCT04937543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102224872|NCT04937543|Cholinergic Agents|cholinergic agents|mesh-ancestor
102224873|NCT03442907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
102224874|NCT04923737|Dexmedetomidine|dexmedetomidine|mesh-list
102224875|NCT04923737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102224876|NCT04923737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102612531|NCT00002489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102224877|NCT04923737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224878|NCT04923737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102612532|NCT00002489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102612533|NCT00002489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102224879|NCT04923737|Analgesics|analgesics|mesh-ancestor
102224880|NCT04923737|Sensory System Agents|sensory system agents|mesh-ancestor
102224881|NCT04923737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102224882|NCT04923737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102224883|NCT04923737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102224884|NCT04923737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102224885|NCT04923737|Adrenergic Agents|adrenergic agents|mesh-ancestor
102224886|NCT04923737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102224887|NCT04923737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224888|NCT02452424|Pembrolizumab|pembrolizumab|mesh-list
102224889|NCT02452424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102224890|NCT02452424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102224891|NCT02452424|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102224892|NCT02452424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224893|NCT04921943|Azithromycin|azithromycin|mesh-list
102224894|NCT04921943|Rifampin|rifampin|mesh-list
102224895|NCT04921943|Ethambutol|ethambutol|mesh-list
102224896|NCT04921943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102224897|NCT04921943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102224898|NCT04921943|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102224899|NCT04921943|Antitubercular Agents|antitubercular agents|mesh-ancestor
102224900|NCT04921943|Leprostatic Agents|leprostatic agents|mesh-ancestor
102224901|NCT04921943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102224902|NCT04921943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102224903|NCT04921943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224904|NCT04921943|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102224905|NCT04921943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102224906|NCT04921943|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102224907|NCT04921943|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102224908|NCT04921943|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102224909|NCT04921943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102224910|NCT02419508|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102224911|NCT02419508|Bimatoprost|bimatoprost|mesh-list
102224912|NCT02419508|Travoprost|travoprost|mesh-list
102224913|NCT02419508|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102224914|NCT02419508|Latanoprost|latanoprost|mesh-list
102224915|NCT02419508|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102224916|NCT02419508|Brinzolamide|brinzolamide|mesh-list
102224917|NCT02419508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102224918|NCT02419508|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102224919|NCT02419508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102224920|NCT02419508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102224921|NCT02419508|Adrenergic Agents|adrenergic agents|mesh-ancestor
102224922|NCT02419508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102224923|NCT02419508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224924|NCT02419508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224925|NCT02419508|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102224926|NCT02419508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101933788|NCT00620464|Hormones|hormones|mesh-ancestor
102224927|NCT03442283|Vitamins|vitamins|mesh-list
102224928|NCT03442283|Micronutrients|micronutrients|mesh-ancestor
102224929|NCT03442283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224930|NCT03441815|Histamine|histamine|mesh-list
102224931|NCT03441815|Glutarimide|glutarimide|mesh-list
102224932|NCT03441815|Histamine Agonists|histamine agonists|mesh-ancestor
102224933|NCT03441815|Histamine Agents|histamine agents|mesh-ancestor
102224934|NCT03441815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102224935|NCT03441815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224936|NCT03441815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629768|NCT04104334|Anesthetics|anesthetics|mesh-ancestor
102224937|NCT03441815|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102224938|NCT03441815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102224939|NCT02426918|Vancomycin|vancomycin|mesh-list
102224940|NCT02426918|Linezolid|linezolid|mesh-list
102224941|NCT02426918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102224942|NCT02426918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102224943|NCT02426918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102224944|NCT02426918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102224945|NCT02426918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224946|NCT02387762|Methotrexate|methotrexate|mesh-list
102224947|NCT02387762|Acalabrutinib|acalabrutinib|mesh-list
102224948|NCT02387762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102224949|NCT02387762|Abortifacient Agents|abortifacient agents|mesh-ancestor
102224950|NCT02387762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102224951|NCT02387762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224952|NCT02387762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102224953|NCT02387762|Antimetabolites|antimetabolites|mesh-ancestor
102224954|NCT02387762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224955|NCT02387762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102224956|NCT02387762|Dermatologic Agents|dermatologic agents|mesh-ancestor
102224957|NCT02387762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102224958|NCT02387762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102224959|NCT02387762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102224960|NCT02387762|Immunologic Factors|immunologic factors|mesh-ancestor
102224961|NCT02387762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102224962|NCT02387762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102224963|NCT02418182|Acetaminophen|acetaminophen|mesh-list
102224964|NCT02418182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102224965|NCT02418182|Analgesics|analgesics|mesh-ancestor
102224966|NCT02418182|Sensory System Agents|sensory system agents|mesh-ancestor
102224967|NCT02418182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102224968|NCT02418182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224969|NCT02418182|Antipyretics|antipyretics|mesh-ancestor
102224970|NCT02387372|Tazobactam|tazobactam|mesh-list
102224971|NCT02387372|Ceftolozane|ceftolozane|mesh-list
102224972|NCT02387372|Cephalosporins|cephalosporins|mesh-list
102224973|NCT02387372|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
102224974|NCT02387372|Penicillanic Acid|penicillanic acid|mesh-list
102224975|NCT02387372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102224976|NCT02387372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102224977|NCT02387372|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102224978|NCT02387372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102224979|NCT02387372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224980|NCT02387372|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102224981|NCT03446495|Trabectedin|trabectedin|mesh-list
102224982|NCT03446495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102224983|NCT03446495|Alkylating Agents|alkylating agents|mesh-ancestor
102224984|NCT03446495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224985|NCT03446495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102224986|NCT03441035|Anesthetics|anesthetics|mesh-list
102224987|NCT03441035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102224988|NCT03441035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102224989|NCT05105633|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102224990|NCT05105633|Tenecteplase|tenecteplase|mesh-list
102224991|NCT05105633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102224992|NCT05105633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102224993|NCT05105633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102224994|NCT04807673|Paclitaxel|paclitaxel|mesh-list
102224995|NCT04807673|Pembrolizumab|pembrolizumab|mesh-list
102224996|NCT04807673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102224997|NCT04807673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102224998|NCT04807673|Tubulin Modulators|tubulin modulators|mesh-ancestor
102224999|NCT04807673|Antimitotic Agents|antimitotic agents|mesh-ancestor
102225000|NCT04807673|Mitosis Modulators|mitosis modulators|mesh-ancestor
102225001|NCT04807673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225002|NCT04807673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102225003|NCT04807673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102225005|NCT02656173|Mirabegron|mirabegron|mesh-list
102225006|NCT02656173|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102225007|NCT02656173|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102225008|NCT02656173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102225009|NCT02656173|Adrenergic Agents|adrenergic agents|mesh-ancestor
102225010|NCT02656173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102225011|NCT02656173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225012|NCT02656173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225013|NCT02656173|Urological Agents|urological agents|mesh-ancestor
102225014|NCT02656173|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102225015|NCT02656173|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102225016|NCT02656173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102225017|NCT03440333|Pulmonary Surfactants|pulmonary surfactants|mesh-list
102225018|NCT03440333|Respiratory System Agents|respiratory system agents|mesh-ancestor
102225019|NCT04418895|Leucovorin|leucovorin|mesh-list
102225020|NCT04418895|Fluorouracil|fluorouracil|mesh-list
102225021|NCT04418895|Capecitabine|capecitabine|mesh-list
102225022|NCT04418895|Oxaliplatin|oxaliplatin|mesh-list
102225023|NCT04418895|Levoleucovorin|levoleucovorin|mesh-list
102225024|NCT04418895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225025|NCT04418895|Antimetabolites|antimetabolites|mesh-ancestor
102612534|NCT00002489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102225026|NCT04418895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225027|NCT04418895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102225028|NCT04418895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102225029|NCT04418895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102225030|NCT04418895|Immunologic Factors|immunologic factors|mesh-ancestor
102225031|NCT04418895|Antidotes|antidotes|mesh-ancestor
102225032|NCT04418895|Protective Agents|protective agents|mesh-ancestor
102225033|NCT04418895|Vitamin B Complex|vitamin b complex|mesh-ancestor
102225034|NCT04418895|Vitamins|vitamins|mesh-ancestor
102225035|NCT04418895|Micronutrients|micronutrients|mesh-ancestor
102225036|NCT04715633|Apatinib|apatinib|mesh-list
102225037|NCT04715633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102225038|NCT04715633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102225039|NCT04715633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102225040|NCT04715633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102225041|NCT04715633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225042|NCT04715633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102225043|NCT03439943|Lixisenatide|lixisenatide|mesh-list
102225044|NCT03439943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102225045|NCT03439943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225046|NCT03439787|Epinephrine|epinephrine|mesh-list
102225047|NCT03439787|Bupivacaine|bupivacaine|mesh-list
102225048|NCT03439787|Anesthetics, Local|anesthetics, local|mesh-ancestor
102225049|NCT03439787|Anesthetics|anesthetics|mesh-ancestor
102225050|NCT03439787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102225051|NCT03439787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225052|NCT03439787|Sensory System Agents|sensory system agents|mesh-ancestor
102225053|NCT03439787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102225054|NCT03439787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102225055|NCT03439787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102225056|NCT03439787|Adrenergic Agents|adrenergic agents|mesh-ancestor
102225057|NCT03439787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102225058|NCT03439787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225059|NCT03439787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102225060|NCT03439787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102225061|NCT03439787|Autonomic Agents|autonomic agents|mesh-ancestor
102225062|NCT03439787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102225063|NCT03439787|Respiratory System Agents|respiratory system agents|mesh-ancestor
102225064|NCT03439787|Mydriatics|mydriatics|mesh-ancestor
102225065|NCT03439787|Sympathomimetics|sympathomimetics|mesh-ancestor
102225066|NCT03439787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102225067|NCT05082155|Bupivacaine|bupivacaine|mesh-list
102225068|NCT05082155|Anesthetics, Local|anesthetics, local|mesh-ancestor
102225069|NCT05082155|Anesthetics|anesthetics|mesh-ancestor
102225070|NCT05082155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102225071|NCT05082155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225072|NCT05082155|Sensory System Agents|sensory system agents|mesh-ancestor
102225073|NCT05082155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102225074|NCT02656017|Metformin|metformin|mesh-list
102225075|NCT02656017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102225076|NCT02656017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225077|NCT03439709|Lanreotide|lanreotide|mesh-list
102225078|NCT03439709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102225079|NCT04451447|SMOFlipid|smoflipid|mesh-list
102225080|NCT04451447|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102225081|NCT04451447|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102225082|NCT04451447|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102225083|NCT04516941|Colchicine|colchicine|mesh-list
102225084|NCT04516941|Edoxaban|edoxaban|mesh-list
102225085|NCT04516941|Gout Suppressants|gout suppressants|mesh-ancestor
102225086|NCT04516941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102225087|NCT04516941|Tubulin Modulators|tubulin modulators|mesh-ancestor
102225088|NCT04516941|Antimitotic Agents|antimitotic agents|mesh-ancestor
102225089|NCT04516941|Mitosis Modulators|mitosis modulators|mesh-ancestor
102225090|NCT04516941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225091|NCT04516941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102225092|NCT04516941|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102225093|NCT04516941|Antithrombins|antithrombins|mesh-ancestor
102225094|NCT04516941|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102225095|NCT04516941|Protease Inhibitors|protease inhibitors|mesh-ancestor
102225096|NCT04516941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102225097|NCT04516941|Anticoagulants|anticoagulants|mesh-ancestor
102225098|NCT03444467|Glucagon|glucagon|mesh-list
102225099|NCT03444467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102225100|NCT03444467|Hormones|hormones|mesh-ancestor
102225101|NCT03444467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102612535|NCT00002489|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102225102|NCT03444467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225103|NCT02657343|Trastuzumab|trastuzumab|mesh-list
102225104|NCT02657343|Fulvestrant|fulvestrant|mesh-list
102225105|NCT02657343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102225106|NCT02657343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102225107|NCT02657343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102225108|NCT02657343|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102225109|NCT02657343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102225110|NCT02657343|Hormone Antagonists|hormone antagonists|mesh-ancestor
102225111|NCT02657343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102225112|NCT02657343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225113|NCT03445169|Belzutifan|belzutifan|mesh-list
102225114|NCT03445169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102225115|NCT04542837|Lenvatinib|lenvatinib|mesh-list
102225116|NCT04542837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102225117|NCT04542837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102225118|NCT04542837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102225119|NCT04542837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225120|NCT02655237|Leuprolide|leuprolide|mesh-list
102225121|NCT02655237|Relugolix|relugolix|mesh-list
102225122|NCT02655237|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102225123|NCT02655237|Fertility Agents|fertility agents|mesh-ancestor
102225124|NCT02655237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102225125|NCT02655237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225126|NCT02655237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102225127|NCT02655237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102225128|NCT02655237|Androgen Antagonists|androgen antagonists|mesh-ancestor
102225129|NCT02655237|Hormone Antagonists|hormone antagonists|mesh-ancestor
102225130|NCT02655237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102225131|NCT03890133|Pregabalin|pregabalin|mesh-list
102225132|NCT03890133|Analgesics|analgesics|mesh-ancestor
102225133|NCT03890133|Sensory System Agents|sensory system agents|mesh-ancestor
102225134|NCT03890133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102225135|NCT03890133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225136|NCT03890133|Anticonvulsants|anticonvulsants|mesh-ancestor
102225137|NCT03890133|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102225138|NCT03890133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102225139|NCT03890133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225140|NCT03890133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102225141|NCT03890133|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102225142|NCT03890133|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102225143|NCT03890133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102225144|NCT03890133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102225145|NCT03871647|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102225146|NCT03871647|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102225147|NCT03871647|Adrenergic Agents|adrenergic agents|mesh-ancestor
102225148|NCT03871647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102225149|NCT03871647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225150|NCT03871647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225151|NCT03443921|Paclitaxel|paclitaxel|mesh-list
101934016|NCT03522506|Modafinil|modafinil|mesh-list
102225152|NCT03443921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102225153|NCT03443921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102225154|NCT03443921|Tubulin Modulators|tubulin modulators|mesh-ancestor
102225155|NCT03443921|Antimitotic Agents|antimitotic agents|mesh-ancestor
102225156|NCT03443921|Mitosis Modulators|mitosis modulators|mesh-ancestor
102225157|NCT03443921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225158|NCT03443843|Fluticasone|fluticasone|mesh-list
102225160|NCT03443843|Loratadine|loratadine|mesh-list
102225161|NCT03443843|Pseudoephedrine|pseudoephedrine|mesh-list
102225162|NCT03443843|Ephedrine|ephedrine|mesh-list
102225163|NCT03443843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102225164|NCT03443843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102225165|NCT03443843|Autonomic Agents|autonomic agents|mesh-ancestor
102225166|NCT03443843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102225167|NCT03443843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225168|NCT03443843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102225169|NCT03443843|Respiratory System Agents|respiratory system agents|mesh-ancestor
102225170|NCT03443843|Dermatologic Agents|dermatologic agents|mesh-ancestor
102225171|NCT03443843|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102225172|NCT03443843|Antipruritics|antipruritics|mesh-ancestor
102225173|NCT03443843|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102612536|NCT00002489|Abortifacient Agents|abortifacient agents|mesh-ancestor
102612537|NCT00002489|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102612538|NCT00002489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102612539|NCT00002489|Antimetabolites|antimetabolites|mesh-ancestor
102612540|NCT00002489|Dermatologic Agents|dermatologic agents|mesh-ancestor
102612541|NCT00002489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102225174|NCT03443843|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102225175|NCT03443843|Histamine Antagonists|histamine antagonists|mesh-ancestor
102225176|NCT03443843|Histamine Agents|histamine agents|mesh-ancestor
102225177|NCT03443843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102225178|NCT03443843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225179|NCT03443843|Nasal Decongestants|nasal decongestants|mesh-ancestor
102225180|NCT03443843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102225181|NCT03443843|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102225182|NCT03443843|Sympathomimetics|sympathomimetics|mesh-ancestor
102225183|NCT03443843|Adrenergic Agents|adrenergic agents|mesh-ancestor
102225184|NCT03438227|Dextrans|dextrans|mesh-list
102225185|NCT03438227|Iron-Dextran Complex|iron-dextran complex|mesh-list
102225186|NCT03438227|Anticoagulants|anticoagulants|mesh-ancestor
102225187|NCT03438227|Plasma Substitutes|plasma substitutes|mesh-ancestor
102225188|NCT03438227|Blood Substitutes|blood substitutes|mesh-ancestor
102225189|NCT03438227|Hematinics|hematinics|mesh-ancestor
102225190|NCT03433235|Edoxaban|edoxaban|mesh-list
102612542|NCT00002489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102612543|NCT00002489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102612544|NCT00002489|Antidotes|antidotes|mesh-ancestor
102612545|NCT00002489|Protective Agents|protective agents|mesh-ancestor
102612546|NCT00002489|Vitamin B Complex|vitamin b complex|mesh-ancestor
102612547|NCT00002489|Vitamins|vitamins|mesh-ancestor
102612548|NCT00002489|Micronutrients|micronutrients|mesh-ancestor
102612549|NCT00002489|Tubulin Modulators|tubulin modulators|mesh-ancestor
102612550|NCT00002489|Antimitotic Agents|antimitotic agents|mesh-ancestor
102612551|NCT00002489|Mitosis Modulators|mitosis modulators|mesh-ancestor
102612552|NCT00002489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102612553|NCT00002489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102225191|NCT03433235|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102225192|NCT03433235|Antithrombins|antithrombins|mesh-ancestor
102225193|NCT03433235|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102225194|NCT03433235|Protease Inhibitors|protease inhibitors|mesh-ancestor
102225195|NCT03433235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102225196|NCT03433235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225197|NCT03433235|Anticoagulants|anticoagulants|mesh-ancestor
102225198|NCT03783351|Clopidogrel|clopidogrel|mesh-list
102225199|NCT03783351|Ticagrelor|ticagrelor|mesh-list
102225200|NCT03783351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102225201|NCT03783351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102225202|NCT03783351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102225203|NCT03783351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102225204|NCT03783351|Purinergic Agents|purinergic agents|mesh-ancestor
102225205|NCT03783351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102225206|NCT03783351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225207|NCT03783351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225208|NCT03342417|Nivolumab|nivolumab|mesh-list
102225209|NCT03342417|Ipilimumab|ipilimumab|mesh-list
102225210|NCT03342417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102225211|NCT03342417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102225212|NCT03342417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102225213|NCT03342417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225214|NCT03234309|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102612554|NCT00002489|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102612555|NCT00002495|Doxorubicin|doxorubicin|mesh-list
101630009|NCT02586961|Hormones|hormones|mesh-ancestor
102612556|NCT00002495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102612557|NCT00002495|Vinblastine|vinblastine|mesh-list
102612558|NCT00002495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102612559|NCT00002495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102612560|NCT00002495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102612561|NCT00002495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102612562|NCT00002495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612563|NCT00002495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612564|NCT00002495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102612565|NCT00002495|Tubulin Modulators|tubulin modulators|mesh-ancestor
102612566|NCT00002495|Antimitotic Agents|antimitotic agents|mesh-ancestor
102612567|NCT00002495|Mitosis Modulators|mitosis modulators|mesh-ancestor
102612568|NCT00002501|Cyclophosphamide|cyclophosphamide|mesh-list
102612569|NCT00002501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102612570|NCT00002501|Immunologic Factors|immunologic factors|mesh-ancestor
102612571|NCT00002501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225215|NCT03234309|Hematinics|hematinics|mesh-ancestor
101901032|NCT01178996|Ribavirin|ribavirin|mesh-list
102225216|NCT03234309|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102225217|NCT03234309|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102225218|NCT02657031|Diphenhydramine|diphenhydramine|mesh-list
102225219|NCT02657031|Promethazine|promethazine|mesh-list
102225220|NCT02657031|Ketamine|ketamine|mesh-list
102225221|NCT02657031|Ondansetron|ondansetron|mesh-list
102225222|NCT02657031|Prochlorperazine|prochlorperazine|mesh-list
102225223|NCT02657031|Analgesics|analgesics|mesh-ancestor
102225224|NCT02657031|Sensory System Agents|sensory system agents|mesh-ancestor
102225225|NCT02657031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101934070|NCT03726242|Autonomic Agents|autonomic agents|mesh-ancestor
102225226|NCT02657031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225227|NCT02657031|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102225228|NCT02657031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102225229|NCT02657031|Anesthetics, General|anesthetics, general|mesh-ancestor
102225230|NCT02657031|Anesthetics|anesthetics|mesh-ancestor
102225231|NCT02657031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102225232|NCT02657031|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102225233|NCT02657031|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102225234|NCT02657031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102225235|NCT02657031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225236|NCT02657031|Antiemetics|antiemetics|mesh-ancestor
102225237|NCT02657031|Autonomic Agents|autonomic agents|mesh-ancestor
102225238|NCT02657031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102225239|NCT02657031|Antipruritics|antipruritics|mesh-ancestor
102225240|NCT02657031|Dermatologic Agents|dermatologic agents|mesh-ancestor
102225241|NCT02657031|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102225242|NCT02657031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102225243|NCT02657031|Serotonin Agents|serotonin agents|mesh-ancestor
102225244|NCT02657031|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102225245|NCT02657031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102225246|NCT02657031|Anesthetics, Local|anesthetics, local|mesh-ancestor
102225247|NCT02657031|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102225248|NCT02657031|Histamine Antagonists|histamine antagonists|mesh-ancestor
102225249|NCT02657031|Histamine Agents|histamine agents|mesh-ancestor
102225250|NCT02657031|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102225251|NCT02657031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102225252|NCT02657031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102225253|NCT02657031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102225254|NCT02657031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102225255|NCT02657031|Dopamine Agents|dopamine agents|mesh-ancestor
102225256|NCT04944953|Botulinum Toxins|botulinum toxins|mesh-list
102225257|NCT04944953|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102225258|NCT04944953|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102225259|NCT04944953|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102225260|NCT04944953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102225261|NCT04944953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225262|NCT04944953|Cholinergic Agents|cholinergic agents|mesh-ancestor
102225263|NCT04944953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102225264|NCT04944953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225265|NCT04944953|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102225266|NCT04944953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102225267|NCT03433001|Dexamethasone|dexamethasone|mesh-list
102225268|NCT03433001|Lenalidomide|lenalidomide|mesh-list
102225269|NCT03433001|Ixazomib|ixazomib|mesh-list
102225270|NCT03433001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102225271|NCT03433001|Antiemetics|antiemetics|mesh-ancestor
102225272|NCT03433001|Autonomic Agents|autonomic agents|mesh-ancestor
102225273|NCT03433001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102225274|NCT03433001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225275|NCT03433001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102225276|NCT03433001|Glucocorticoids|glucocorticoids|mesh-ancestor
102225277|NCT03433001|Hormones|hormones|mesh-ancestor
102225278|NCT03433001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102225279|NCT03433001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102225280|NCT03433001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102225281|NCT03433001|Immunologic Factors|immunologic factors|mesh-ancestor
102225282|NCT03433001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102225283|NCT03433001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102225284|NCT03433001|Growth Substances|growth substances|mesh-ancestor
102225285|NCT03433001|Growth Inhibitors|growth inhibitors|mesh-ancestor
102225286|NCT03433001|Protease Inhibitors|protease inhibitors|mesh-ancestor
102225287|NCT03433001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612572|NCT00002501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102225288|NCT03433001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225289|NCT03797469|Niacinamide|niacinamide|mesh-list
102225290|NCT03797469|Niacin|niacin|mesh-list
102225291|NCT03797469|Nicotinic Acids|nicotinic acids|mesh-list
102225293|NCT03797469|Micronutrients|micronutrients|mesh-ancestor
102225294|NCT03797469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225295|NCT03797469|Vitamin B Complex|vitamin b complex|mesh-ancestor
102225296|NCT03797469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102225297|NCT03797469|Antimetabolites|antimetabolites|mesh-ancestor
102225298|NCT03797469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225299|NCT03797469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102225300|NCT03797469|Vasodilator Agents|vasodilator agents|mesh-ancestor
102225301|NCT03432923|Benzocaine|benzocaine|mesh-list
102225302|NCT03432923|Anesthetics, Local|anesthetics, local|mesh-ancestor
102225303|NCT03432923|Anesthetics|anesthetics|mesh-ancestor
102225304|NCT03432923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102225305|NCT03432923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225306|NCT03432923|Sensory System Agents|sensory system agents|mesh-ancestor
102225307|NCT03432923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102225308|NCT02384577|Budesonide|budesonide|mesh-list
102225309|NCT02384577|Formoterol Fumarate|formoterol fumarate|mesh-list
102225310|NCT02384577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102225311|NCT02384577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102225312|NCT02384577|Autonomic Agents|autonomic agents|mesh-ancestor
102225313|NCT02384577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102225314|NCT02384577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225315|NCT02384577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102225316|NCT02384577|Respiratory System Agents|respiratory system agents|mesh-ancestor
102225317|NCT02384577|Glucocorticoids|glucocorticoids|mesh-ancestor
102225318|NCT02384577|Hormones|hormones|mesh-ancestor
102225319|NCT02384577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102225320|NCT02384577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102225321|NCT02384577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102225322|NCT02384577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102225323|NCT02384577|Adrenergic Agents|adrenergic agents|mesh-ancestor
102225324|NCT02384577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102225325|NCT02384577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225326|NCT03437213|Anesthetics|anesthetics|mesh-list
102225327|NCT03437213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102225328|NCT03437213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225329|NCT02030457|Beclomethasone|beclomethasone|mesh-list
102225330|NCT02030457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102225331|NCT02030457|Glucocorticoids|glucocorticoids|mesh-ancestor
102225332|NCT02030457|Hormones|hormones|mesh-ancestor
102225333|NCT02030457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102225334|NCT02030457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225335|NCT02030457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102225336|NCT02030457|Respiratory System Agents|respiratory system agents|mesh-ancestor
102225337|NCT03432767|Chrysarobin|chrysarobin|mesh-list
102225338|NCT03432767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102225339|NCT03432767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102225340|NCT03432767|Analgesics|analgesics|mesh-ancestor
102225341|NCT03432767|Sensory System Agents|sensory system agents|mesh-ancestor
102225342|NCT03432767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102225343|NCT03432767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225344|NCT03432767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102225345|NCT03432767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102225346|NCT03437057|Aspirin|aspirin|mesh-list
102225347|NCT03437057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102225348|NCT03437057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102225349|NCT03437057|Analgesics|analgesics|mesh-ancestor
102225350|NCT03437057|Sensory System Agents|sensory system agents|mesh-ancestor
102225351|NCT03437057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102225352|NCT03437057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225353|NCT03437057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102225354|NCT03437057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102225355|NCT03437057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102225356|NCT03437057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102225357|NCT03437057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225358|NCT03437057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102225359|NCT03437057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102225360|NCT03437057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102225361|NCT03437057|Antipyretics|antipyretics|mesh-ancestor
102225362|NCT03579693|Niacinamide|niacinamide|mesh-list
102225363|NCT03579693|Niacin|niacin|mesh-list
102225364|NCT03579693|Nicotinic Acids|nicotinic acids|mesh-list
102225365|NCT03579693|Coenzyme Q10|coenzyme q10|mesh-list
102225366|NCT03579693|Vitamin B Complex|vitamin b complex|mesh-ancestor
102225367|NCT03579693|Vitamins|vitamins|mesh-ancestor
102225368|NCT03579693|Micronutrients|micronutrients|mesh-ancestor
102225369|NCT03579693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225370|NCT03579693|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102225371|NCT03579693|Antimetabolites|antimetabolites|mesh-ancestor
102225372|NCT03579693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225373|NCT03579693|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102225374|NCT03579693|Vasodilator Agents|vasodilator agents|mesh-ancestor
102225375|NCT03432689|Cycloserine|cycloserine|mesh-list
102225376|NCT03432689|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102225377|NCT03432689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102225378|NCT03432689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102225379|NCT03432689|Antitubercular Agents|antitubercular agents|mesh-ancestor
102225380|NCT03432689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102225381|NCT03432689|Antimetabolites|antimetabolites|mesh-ancestor
102225382|NCT03432689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225383|NCT02991807|Everolimus|everolimus|mesh-list
102225384|NCT02991807|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102225385|NCT02991807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102225386|NCT02991807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102225387|NCT02991807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225388|NCT02991807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102225389|NCT02991807|Immunologic Factors|immunologic factors|mesh-ancestor
102225390|NCT02991807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225391|NCT02991807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102225392|NCT04380311|Tacrolimus|tacrolimus|mesh-list
102225393|NCT04380311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102225394|NCT04380311|Immunologic Factors|immunologic factors|mesh-ancestor
102225395|NCT04380311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225396|NCT04380311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102225397|NCT04380311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102225398|NCT04380311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225399|NCT05018013|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102225400|NCT05018013|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102225401|NCT05018013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102225402|NCT05018013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102225403|NCT05018013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225404|NCT05018013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102225405|NCT05018013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225406|NCT05018013|Analgesics|analgesics|mesh-ancestor
102225407|NCT05018013|Sensory System Agents|sensory system agents|mesh-ancestor
102225408|NCT05018013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102225409|NCT05018013|Antidepressive Agents|antidepressive agents|mesh-ancestor
102225410|NCT05018013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102225411|NCT05018013|Dopamine Agents|dopamine agents|mesh-ancestor
102225412|NCT03432221|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
102225413|NCT03432221|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102225414|NCT03432221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102225415|NCT03432221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102225416|NCT03432221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225417|NCT03432221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102225418|NCT03432221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225419|NCT03432221|Antidepressive Agents|antidepressive agents|mesh-ancestor
102225420|NCT03432221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102225421|NCT05112471|Erythritol|erythritol|mesh-list
102225422|NCT05112471|Vasodilator Agents|vasodilator agents|mesh-ancestor
102225423|NCT02387216|Docetaxel|docetaxel|mesh-list
102225424|NCT02387216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102225425|NCT02387216|Tubulin Modulators|tubulin modulators|mesh-ancestor
102225426|NCT02387216|Antimitotic Agents|antimitotic agents|mesh-ancestor
102225427|NCT02387216|Mitosis Modulators|mitosis modulators|mesh-ancestor
102225428|NCT02387216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225429|NCT03431909|Aspirin|aspirin|mesh-list
102225430|NCT03431909|Kallikreins|kallikreins|mesh-list
102225431|NCT03431909|Clopidogrel|clopidogrel|mesh-list
102225432|NCT03431909|Atorvastatin|atorvastatin|mesh-list
102225433|NCT03431909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102225434|NCT03431909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102225435|NCT03431909|Analgesics|analgesics|mesh-ancestor
102225436|NCT03431909|Sensory System Agents|sensory system agents|mesh-ancestor
101630142|NCT02698995|Narcotics|narcotics|mesh-ancestor
101901057|NCT01180946|Micronutrients|micronutrients|mesh-ancestor
102612573|NCT00002501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102612574|NCT00002501|Alkylating Agents|alkylating agents|mesh-ancestor
102612575|NCT00002501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225437|NCT03431909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102225438|NCT03431909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225439|NCT03431909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102225440|NCT03431909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102225441|NCT03431909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102225442|NCT03431909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102225443|NCT03431909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225444|NCT03431909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102225445|NCT03431909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102225446|NCT03431909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102225447|NCT03431909|Antipyretics|antipyretics|mesh-ancestor
102225448|NCT03431909|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102225449|NCT03431909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102225450|NCT03431909|Antimetabolites|antimetabolites|mesh-ancestor
102225451|NCT03431909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102225452|NCT03431909|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102225453|NCT03431909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102225454|NCT03431909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102225455|NCT03431909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102225456|NCT03431909|Purinergic Agents|purinergic agents|mesh-ancestor
102225457|NCT03431909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102225458|NCT03431909|Coagulants|coagulants|mesh-ancestor
102225459|NCT03431909|Fertility Agents, Male|fertility agents, male|mesh-ancestor
102225460|NCT03431909|Fertility Agents|fertility agents|mesh-ancestor
102225461|NCT03431909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102225462|NCT03436121|Midazolam|midazolam|mesh-list
102225463|NCT03436121|Ketamine|ketamine|mesh-list
102225464|NCT03436121|Analgesics|analgesics|mesh-ancestor
102225465|NCT03436121|Sensory System Agents|sensory system agents|mesh-ancestor
102225466|NCT03436121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102225467|NCT03436121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225468|NCT03436121|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102225469|NCT03436121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102225470|NCT03436121|Anesthetics, General|anesthetics, general|mesh-ancestor
102225471|NCT03436121|Anesthetics|anesthetics|mesh-ancestor
102225472|NCT03436121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102225473|NCT03436121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102225474|NCT03436121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102225475|NCT03436121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102225476|NCT03436121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225477|NCT03436121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102225478|NCT03436121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102225479|NCT03436121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102225480|NCT03436121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102225481|NCT03436121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102225482|NCT03436121|GABA Modulators|gaba modulators|mesh-ancestor
102225483|NCT03436121|GABA Agents|gaba agents|mesh-ancestor
102225484|NCT02417246|Metoprolol|metoprolol|mesh-list
102225485|NCT02417246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102225486|NCT02417246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102225487|NCT02417246|Sympatholytics|sympatholytics|mesh-ancestor
102225488|NCT02417246|Autonomic Agents|autonomic agents|mesh-ancestor
102225489|NCT02417246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102225490|NCT02417246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225491|NCT02417246|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102225492|NCT02417246|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102225493|NCT02417246|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102225494|NCT02417246|Adrenergic Agents|adrenergic agents|mesh-ancestor
102225495|NCT02417246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102225496|NCT02417246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225497|NCT03431675|Ciprofloxacin|ciprofloxacin|mesh-list
102225498|NCT03431675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102225499|NCT03431675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102225500|NCT03431675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102225501|NCT03431675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102225502|NCT03431675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102225503|NCT03431675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225504|NCT03431675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102225505|NCT03431675|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102225506|NCT03431675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102225507|NCT02424734|Ampicillin|ampicillin|mesh-list
102225508|NCT02424734|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
102612576|NCT00002501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102225509|NCT02424734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102225510|NCT02424734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102225511|NCT03431597|Micronutrients|micronutrients|mesh-list
102225512|NCT03431597|Trace Elements|trace elements|mesh-list
102225513|NCT03431597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225514|NCT02424578|Diclofenac|diclofenac|mesh-list
102225515|NCT02424578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102225516|NCT02424578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102225517|NCT02424578|Analgesics|analgesics|mesh-ancestor
102225518|NCT02424578|Sensory System Agents|sensory system agents|mesh-ancestor
102225519|NCT02424578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102225520|NCT02424578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225521|NCT02424578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102225522|NCT02424578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101630192|NCT02586649|Bromides|bromides|mesh-list
102225523|NCT02424578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102225524|NCT02424578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102225525|NCT02424578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225526|NCT03431285|Ketamine|ketamine|mesh-list
102225527|NCT03431285|Morphine|morphine|mesh-list
102225528|NCT03431285|Analgesics|analgesics|mesh-ancestor
102225529|NCT03431285|Sensory System Agents|sensory system agents|mesh-ancestor
102225530|NCT03431285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102225531|NCT03431285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225532|NCT03431285|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102225533|NCT03431285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102225534|NCT03431285|Anesthetics, General|anesthetics, general|mesh-ancestor
102225535|NCT03431285|Anesthetics|anesthetics|mesh-ancestor
102225536|NCT03431285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102225537|NCT03431285|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102225538|NCT03431285|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102225539|NCT03431285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102225540|NCT03431285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225541|NCT03431285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102225542|NCT03431285|Narcotics|narcotics|mesh-ancestor
102225543|NCT02416934|Dexamethasone|dexamethasone|mesh-list
102225544|NCT02416934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102225545|NCT02416934|Antiemetics|antiemetics|mesh-ancestor
102225546|NCT02416934|Autonomic Agents|autonomic agents|mesh-ancestor
102225547|NCT02416934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102225548|NCT02416934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225549|NCT02416934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102225550|NCT02416934|Glucocorticoids|glucocorticoids|mesh-ancestor
102225551|NCT02416934|Hormones|hormones|mesh-ancestor
102225552|NCT02416934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102225553|NCT02416934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102225554|NCT02416934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102225555|NCT02819635|Upadacitinib|upadacitinib|mesh-list
102225556|NCT02819635|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102225557|NCT02819635|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102225558|NCT02819635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102225559|NCT02819635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225560|NCT02819635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102225561|NCT03874325|Durvalumab|durvalumab|mesh-list
102225562|NCT03874325|Letrozole|letrozole|mesh-list
102225563|NCT03874325|Anastrozole|anastrozole|mesh-list
102225564|NCT03874325|Exemestane|exemestane|mesh-list
102225565|NCT03874325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102225566|NCT03874325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102225567|NCT03874325|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102225568|NCT03874325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102225569|NCT03874325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102225570|NCT03874325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225571|NCT03874325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102225572|NCT03874325|Hormone Antagonists|hormone antagonists|mesh-ancestor
102225573|NCT03874325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102225574|NCT03874325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225575|NCT03874325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102225576|NCT02424344|Formoterol Fumarate|formoterol fumarate|mesh-list
102225577|NCT02424344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102225578|NCT02424344|Autonomic Agents|autonomic agents|mesh-ancestor
102225579|NCT02424344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102225580|NCT02424344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225581|NCT02424344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102612577|NCT00002501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102612578|NCT00002147|Doxorubicin|doxorubicin|mesh-list
102225582|NCT02424344|Respiratory System Agents|respiratory system agents|mesh-ancestor
102225583|NCT02424344|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102225584|NCT02424344|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102225586|NCT02424344|Adrenergic Agents|adrenergic agents|mesh-ancestor
102225587|NCT02424344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102225588|NCT02424344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225589|NCT03861611|Ibuprofen|ibuprofen|mesh-list
102225590|NCT03861611|Diclofenac|diclofenac|mesh-list
102225591|NCT03861611|Ketorolac|ketorolac|mesh-list
102225592|NCT03861611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102225593|NCT03861611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102225594|NCT03861611|Analgesics|analgesics|mesh-ancestor
102225595|NCT03861611|Sensory System Agents|sensory system agents|mesh-ancestor
102225596|NCT03861611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102225597|NCT03861611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225598|NCT03861611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102225599|NCT03861611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102225600|NCT03861611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102225601|NCT03861611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102225602|NCT03861611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225603|NCT03430817|Amantadine|amantadine|mesh-list
102225604|NCT03430817|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
102225605|NCT03430817|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102225606|NCT03430817|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102225607|NCT03430817|Antiviral Agents|antiviral agents|mesh-ancestor
102225608|NCT03430817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102225609|NCT03430817|Dopamine Agents|dopamine agents|mesh-ancestor
102225610|NCT03430817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102225611|NCT03430817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225612|NCT03430817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225613|NCT03430817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102225614|NCT03430817|Analgesics|analgesics|mesh-ancestor
102225615|NCT03430817|Sensory System Agents|sensory system agents|mesh-ancestor
102225616|NCT03430817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102225617|NCT03430817|Nootropic Agents|nootropic agents|mesh-ancestor
102225618|NCT02383940|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
102225619|NCT02383940|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102225620|NCT02383940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225621|NCT02383940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102225622|NCT02383940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225623|NCT03799835|Atezolizumab|atezolizumab|mesh-list
102225624|NCT03799835|BCG Vaccine|bcg vaccine|mesh-list
102225625|NCT03799835|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102225626|NCT03799835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225627|NCT03799835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102225628|NCT03799835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102225629|NCT03799835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102225630|NCT03799835|Immunologic Factors|immunologic factors|mesh-ancestor
102225631|NCT03799835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225632|NCT03430505|Albuterol|albuterol|mesh-list
102225633|NCT03430505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102225634|NCT03430505|Autonomic Agents|autonomic agents|mesh-ancestor
102225635|NCT03430505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102225636|NCT03430505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225637|NCT03430505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102225638|NCT03430505|Respiratory System Agents|respiratory system agents|mesh-ancestor
102225639|NCT03430505|Tocolytic Agents|tocolytic agents|mesh-ancestor
102225640|NCT03430505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102225641|NCT03430505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102225642|NCT03430505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102225643|NCT03430505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102225644|NCT03430505|Adrenergic Agents|adrenergic agents|mesh-ancestor
102225645|NCT03430505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101630284|NCT00617253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102225646|NCT03430505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225647|NCT03434951|Morphine|morphine|mesh-list
102225648|NCT03434951|Bupivacaine|bupivacaine|mesh-list
102225649|NCT03434951|Anesthetics, Local|anesthetics, local|mesh-ancestor
102225650|NCT03434951|Anesthetics|anesthetics|mesh-ancestor
102225651|NCT03434951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102225652|NCT03434951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102612579|NCT00002147|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102225653|NCT03434951|Sensory System Agents|sensory system agents|mesh-ancestor
102225654|NCT03434951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102225655|NCT03434951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102225657|NCT03434951|Analgesics|analgesics|mesh-ancestor
102225658|NCT02234323|Factor VIII|factor viii|mesh-list
102225659|NCT02234323|Coagulants|coagulants|mesh-ancestor
102225660|NCT03434405|Psychotropic Drugs|psychotropic drugs|mesh-list
102225661|NCT02413346|Sarecycline|sarecycline|mesh-list
102225662|NCT02413346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102225663|NCT02413346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102225664|NCT02413346|Dermatologic Agents|dermatologic agents|mesh-ancestor
102225665|NCT03433859|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102225666|NCT03433859|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102225667|NCT03433859|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102225668|NCT03433859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102225669|NCT03433859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225670|NCT03433859|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102225671|NCT03433859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102225672|NCT03433859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225673|NCT03433859|Cholinergic Agents|cholinergic agents|mesh-ancestor
101836512|NCT00490542|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102225674|NCT03433859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102225675|NCT03429179|Butorphanol|butorphanol|mesh-list
102225676|NCT03429179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102225677|NCT03429179|Narcotics|narcotics|mesh-ancestor
102225678|NCT03429179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102225679|NCT03429179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225680|NCT03429179|Analgesics|analgesics|mesh-ancestor
102225681|NCT03429179|Sensory System Agents|sensory system agents|mesh-ancestor
102225682|NCT03429179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102225683|NCT03429179|Antitussive Agents|antitussive agents|mesh-ancestor
102225684|NCT03429179|Respiratory System Agents|respiratory system agents|mesh-ancestor
102225685|NCT03429179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102225686|NCT03429101|Trastuzumab|trastuzumab|mesh-list
102225687|NCT03429101|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102225688|NCT03429101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102225689|NCT03429101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102225690|NCT03429101|Tubulin Modulators|tubulin modulators|mesh-ancestor
102225691|NCT03429101|Antimitotic Agents|antimitotic agents|mesh-ancestor
102225692|NCT03429101|Mitosis Modulators|mitosis modulators|mesh-ancestor
102225693|NCT03429101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225694|NCT03429101|Immunotoxins|immunotoxins|mesh-ancestor
102225695|NCT03429101|Immunoconjugates|immunoconjugates|mesh-ancestor
102225696|NCT03429101|Immunologic Factors|immunologic factors|mesh-ancestor
102225697|NCT03429101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225698|NCT04048343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102225699|NCT04048343|Immunologic Factors|immunologic factors|mesh-ancestor
102225700|NCT04048343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225701|NCT04016753|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
102225702|NCT04016753|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102225703|NCT04016753|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102225704|NCT04016753|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102225705|NCT04016753|Contraceptive Agents|contraceptive agents|mesh-ancestor
102225706|NCT04016753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102225707|NCT04016753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225708|NCT04016753|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102225709|NCT04016753|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102225710|NCT04016753|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
102225711|NCT04016753|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102225712|NCT02732639|Interferons|interferons|mesh-list
102225713|NCT02732639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102225714|NCT02732639|Antiviral Agents|antiviral agents|mesh-ancestor
102225715|NCT02732639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102225716|NCT03428633|Morphine|morphine|mesh-list
102225717|NCT03428633|Ropivacaine|ropivacaine|mesh-list
102225718|NCT03428633|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102225719|NCT03428633|Narcotics|narcotics|mesh-ancestor
102225720|NCT03428633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102225721|NCT03428633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225722|NCT03428633|Analgesics|analgesics|mesh-ancestor
102225723|NCT03428633|Sensory System Agents|sensory system agents|mesh-ancestor
102225724|NCT03428633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102225725|NCT03428633|Anesthetics, Local|anesthetics, local|mesh-ancestor
102225726|NCT03428633|Anesthetics|anesthetics|mesh-ancestor
102612580|NCT00002147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102225727|NCT02412878|Dexamethasone|dexamethasone|mesh-list
102225728|NCT02412878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102225729|NCT02412878|Antiemetics|antiemetics|mesh-ancestor
102225730|NCT02412878|Autonomic Agents|autonomic agents|mesh-ancestor
102225731|NCT02412878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102225732|NCT02412878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225733|NCT02412878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102225734|NCT02412878|Glucocorticoids|glucocorticoids|mesh-ancestor
102225735|NCT02412878|Hormones|hormones|mesh-ancestor
102225736|NCT02412878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102225737|NCT02412878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102225738|NCT02412878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102225739|NCT03423329|Ibuprofen|ibuprofen|mesh-list
102225740|NCT03423329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102225741|NCT03423329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102225742|NCT03423329|Analgesics|analgesics|mesh-ancestor
102225743|NCT03423329|Sensory System Agents|sensory system agents|mesh-ancestor
102225744|NCT03423329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102225745|NCT03423329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225746|NCT03423329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102225747|NCT03423329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101934599|NCT03430856|Insulin|insulin|mesh-list
102225748|NCT03423329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102225749|NCT03423329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102225750|NCT03423329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225751|NCT02380742|Lidocaine|lidocaine|mesh-list
102225752|NCT02380742|Prilocaine|prilocaine|mesh-list
102225753|NCT02380742|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
102225754|NCT02380742|Anesthetics, Local|anesthetics, local|mesh-ancestor
102225755|NCT02380742|Anesthetics|anesthetics|mesh-ancestor
102225756|NCT02380742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102225757|NCT02380742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225758|NCT02380742|Sensory System Agents|sensory system agents|mesh-ancestor
102225759|NCT02380742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102225760|NCT02380742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102225761|NCT02380742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102225762|NCT02380742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102225763|NCT02380742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102225764|NCT02380742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225765|NCT02380742|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
102225766|NCT02944019|Edoxaban|edoxaban|mesh-list
102225767|NCT02944019|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102225768|NCT02944019|Antithrombins|antithrombins|mesh-ancestor
102225769|NCT02944019|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102225770|NCT02944019|Protease Inhibitors|protease inhibitors|mesh-ancestor
102225771|NCT02944019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102225772|NCT02944019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225773|NCT02944019|Anticoagulants|anticoagulants|mesh-ancestor
102225774|NCT02022059|Lidocaine|lidocaine|mesh-list
102225775|NCT02022059|Anesthetics, Local|anesthetics, local|mesh-ancestor
102225776|NCT02022059|Anesthetics|anesthetics|mesh-ancestor
102225777|NCT02022059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102225778|NCT02022059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225779|NCT02022059|Sensory System Agents|sensory system agents|mesh-ancestor
102225780|NCT02022059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102225781|NCT02022059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102225782|NCT02022059|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102225783|NCT02022059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102225784|NCT02022059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102225785|NCT02022059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225786|NCT02922725|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
102225787|NCT02922725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102225788|NCT02922725|Antidepressive Agents|antidepressive agents|mesh-ancestor
102225789|NCT02922725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102225790|NCT03422315|Propofol|propofol|mesh-list
102225791|NCT03422315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102225792|NCT03422315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102225793|NCT03422315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225794|NCT03422315|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102225795|NCT03422315|Anesthetics, General|anesthetics, general|mesh-ancestor
102225796|NCT03422315|Anesthetics|anesthetics|mesh-ancestor
102225797|NCT03427385|Ropivacaine|ropivacaine|mesh-list
102612581|NCT00002147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102612582|NCT00002147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102612583|NCT00002147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102225798|NCT03427385|Anesthetics, Local|anesthetics, local|mesh-ancestor
102225799|NCT03427385|Anesthetics|anesthetics|mesh-ancestor
102225800|NCT03427385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102225801|NCT03427385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225802|NCT03427385|Sensory System Agents|sensory system agents|mesh-ancestor
102225803|NCT03427385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102225804|NCT03427229|Vancomycin|vancomycin|mesh-list
102225805|NCT03427229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102225806|NCT03427229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102225807|NCT04449185|Amoxicillin|amoxicillin|mesh-list
102225808|NCT04449185|Clarithromycin|clarithromycin|mesh-list
102225809|NCT04449185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102225810|NCT04449185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102225811|NCT04449185|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102225812|NCT04449185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102225813|NCT04449185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225814|NCT04449185|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102225815|NCT04449185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102225816|NCT03426761|Vancomycin|vancomycin|mesh-list
102225817|NCT03426761|Cefazolin|cefazolin|mesh-list
102225818|NCT03426761|Daptomycin|daptomycin|mesh-list
102225819|NCT03426761|Dalbavancin|dalbavancin|mesh-list
102225820|NCT03426761|Nafcillin|nafcillin|mesh-list
102225821|NCT03426761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101836513|NCT00490542|Dopamine Agents|dopamine agents|mesh-ancestor
102225822|NCT03426761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102225824|NCT03426527|Levobupivacaine|levobupivacaine|mesh-list
102225825|NCT03426527|Anesthetics|anesthetics|mesh-ancestor
102225826|NCT03426527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102225827|NCT03426527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225828|NCT03426527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102225829|NCT03426527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102225830|NCT03426527|Analgesics|analgesics|mesh-ancestor
102225831|NCT03426527|Sensory System Agents|sensory system agents|mesh-ancestor
102225832|NCT03426527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102225833|NCT03426527|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102225834|NCT03426527|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102225835|NCT03426527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102225836|NCT03426527|Adrenergic Agents|adrenergic agents|mesh-ancestor
102225837|NCT03426527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102225838|NCT03426527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225839|NCT03426527|Anesthetics, Local|anesthetics, local|mesh-ancestor
102225840|NCT02805257|Mitomycins|mitomycins|mesh-list
102225841|NCT02805257|Mitomycin|mitomycin|mesh-list
102225842|NCT02805257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102225843|NCT02805257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102225844|NCT02805257|Alkylating Agents|alkylating agents|mesh-ancestor
102225845|NCT02805257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225846|NCT02805257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102225847|NCT02805257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102225848|NCT02636387|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
102225849|NCT02636387|Hemostatics|hemostatics|mesh-ancestor
102225850|NCT02636387|Coagulants|coagulants|mesh-ancestor
102225851|NCT02636387|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102225852|NCT02636387|Natriuretic Agents|natriuretic agents|mesh-ancestor
102225853|NCT02636387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225854|NCT03425747|Calcium, Dietary|calcium, dietary|mesh-list
102225855|NCT03425747|Calcium Carbonate|calcium carbonate|mesh-list
102225856|NCT03425747|Calcium|calcium|mesh-list
102225857|NCT03425747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101630442|NCT04080349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102225858|NCT03425747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225859|NCT03425747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102225860|NCT03425747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225861|NCT03425747|Antacids|antacids|mesh-ancestor
102225862|NCT03425747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102225863|NCT03425669|Methylphenidate|methylphenidate|mesh-list
102225864|NCT03425669|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102225865|NCT03425669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225866|NCT03425669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102225867|NCT03425669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102225868|NCT03425669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102225869|NCT03425669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225870|NCT03425669|Dopamine Agents|dopamine agents|mesh-ancestor
102225871|NCT03425669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102225872|NCT03424889|Xylometazoline|xylometazoline|mesh-list
102225873|NCT03424889|Nasal Decongestants|nasal decongestants|mesh-ancestor
102225874|NCT03424889|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102225875|NCT03424889|Respiratory System Agents|respiratory system agents|mesh-ancestor
102225876|NCT03424733|Acetaminophen|acetaminophen|mesh-list
102225877|NCT03424733|Interferons|interferons|mesh-list
102225878|NCT03424733|Interferon-beta|interferon-beta|mesh-list
102225879|NCT03424733|Interferon beta-1a|interferon beta-1a|mesh-list
102225881|NCT03424733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102225882|NCT03424733|Glucocorticoids|glucocorticoids|mesh-ancestor
102225883|NCT03424733|Hormones|hormones|mesh-ancestor
102225884|NCT03424733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102225885|NCT03424733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225886|NCT03424733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102225887|NCT03424733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102225888|NCT03424733|Antiviral Agents|antiviral agents|mesh-ancestor
102225889|NCT03424733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102225890|NCT03424733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102225891|NCT03424733|Analgesics|analgesics|mesh-ancestor
102225892|NCT03424733|Sensory System Agents|sensory system agents|mesh-ancestor
102225893|NCT03424733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102225894|NCT03424733|Antipyretics|antipyretics|mesh-ancestor
102225895|NCT03424733|Immunologic Factors|immunologic factors|mesh-ancestor
102225896|NCT03424733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102225898|NCT03441841|Lidocaine|lidocaine|mesh-list
102225899|NCT03441841|Prilocaine|prilocaine|mesh-list
102225900|NCT03441841|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
102225901|NCT03441841|Anesthetics, Local|anesthetics, local|mesh-ancestor
102225902|NCT03441841|Anesthetics|anesthetics|mesh-ancestor
102225903|NCT03441841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102225904|NCT03441841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225905|NCT03441841|Sensory System Agents|sensory system agents|mesh-ancestor
102225906|NCT03441841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102225907|NCT03441841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102225908|NCT03441841|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102225909|NCT03441841|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102225910|NCT03441841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102225911|NCT03441841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225912|NCT03441841|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
102225913|NCT02692339|Dexamethasone|dexamethasone|mesh-list
102225914|NCT02692339|Lenalidomide|lenalidomide|mesh-list
102225915|NCT02692339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102225916|NCT02692339|Antiemetics|antiemetics|mesh-ancestor
102225917|NCT02692339|Autonomic Agents|autonomic agents|mesh-ancestor
102225918|NCT02692339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102225919|NCT02692339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225920|NCT02692339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102225921|NCT02692339|Glucocorticoids|glucocorticoids|mesh-ancestor
102225922|NCT02692339|Hormones|hormones|mesh-ancestor
102225923|NCT02692339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102225924|NCT02692339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102225925|NCT02692339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102225926|NCT02692339|Immunologic Factors|immunologic factors|mesh-ancestor
102225927|NCT02692339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102225928|NCT02692339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102225929|NCT02692339|Growth Substances|growth substances|mesh-ancestor
102225930|NCT02692339|Growth Inhibitors|growth inhibitors|mesh-ancestor
102225931|NCT03444025|Goserelin|goserelin|mesh-list
102225932|NCT03444025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102225933|NCT03444025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102225934|NCT03438253|Anesthetics|anesthetics|mesh-list
102225935|NCT03438253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102225936|NCT03438253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225937|NCT02535325|Cisplatin|cisplatin|mesh-list
102225938|NCT02535325|Pemetrexed|pemetrexed|mesh-list
102225939|NCT02535325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102225940|NCT02535325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102225941|NCT02535325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225942|NCT02535325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102225943|NCT02535325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102225944|NCT03441529|Tazobactam|tazobactam|mesh-list
102225945|NCT03441529|Piperacillin|piperacillin|mesh-list
102225946|NCT03441529|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102225947|NCT03441529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102225948|NCT03441529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102225949|NCT03441529|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102225950|NCT03441529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102225951|NCT03441529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225952|NCT03441373|Histamine|histamine|mesh-list
102225953|NCT03441373|Histamine phosphate|histamine phosphate|mesh-list
102225954|NCT03441373|Glutarimide|glutarimide|mesh-list
102225955|NCT03441373|Histamine Agonists|histamine agonists|mesh-ancestor
102225956|NCT03441373|Histamine Agents|histamine agents|mesh-ancestor
102225957|NCT03441373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102225958|NCT03441373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225959|NCT03441373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225960|NCT03441373|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102225961|NCT03441373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102225962|NCT03449797|Hydrocortisone|hydrocortisone|mesh-list
102225963|NCT03449797|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102225964|NCT03449797|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102225965|NCT03449797|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102225966|NCT03449797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102225967|NCT03449719|Abiraterone Acetate|abiraterone acetate|mesh-list
102225968|NCT03449719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102225969|NCT03449719|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102225970|NCT03449719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102225971|NCT03449719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225972|NCT03449719|Hormone Antagonists|hormone antagonists|mesh-ancestor
101630500|NCT04472299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102225973|NCT03449719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102225974|NCT03449719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225975|NCT03449719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102225976|NCT03437785|Ethanol|ethanol|mesh-list
102225977|NCT03437785|Rebamipide|rebamipide|mesh-list
102225978|NCT03437785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102225979|NCT03437785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102225980|NCT03437785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102225981|NCT03437785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225982|NCT03437785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102225983|NCT03437785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102225984|NCT03437785|Antioxidants|antioxidants|mesh-ancestor
102225985|NCT03437785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102225986|NCT03437785|Protective Agents|protective agents|mesh-ancestor
102225987|NCT03437785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102225988|NCT03437707|Acetaminophen|acetaminophen|mesh-list
102225989|NCT03437707|Ibuprofen|ibuprofen|mesh-list
102225990|NCT03437707|Morphine|morphine|mesh-list
102225991|NCT03437707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102225992|NCT03437707|Narcotics|narcotics|mesh-ancestor
102225993|NCT03437707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102225994|NCT03437707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102225995|NCT03437707|Analgesics|analgesics|mesh-ancestor
102225996|NCT03437707|Sensory System Agents|sensory system agents|mesh-ancestor
102225997|NCT03437707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102225998|NCT03437707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102225999|NCT03437707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102226000|NCT03437707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102226001|NCT03437707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102226002|NCT03437707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102226003|NCT03437707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102226004|NCT03437707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226005|NCT03437707|Antipyretics|antipyretics|mesh-ancestor
102226006|NCT03437629|Calcium|calcium|mesh-list
102226007|NCT03437629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102226008|NCT03437629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226009|NCT03437473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102226010|NCT03437473|Cholinergic Agents|cholinergic agents|mesh-list
102226011|NCT03437473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102226012|NCT03437473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226013|NCT03437473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226014|NCT03441217|Scopolamine|scopolamine|mesh-list
102226015|NCT03441217|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102226016|NCT03441217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102226017|NCT03441217|Antiemetics|antiemetics|mesh-ancestor
102226018|NCT03441217|Autonomic Agents|autonomic agents|mesh-ancestor
102226019|NCT03441217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102612584|NCT00002147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102226020|NCT03441217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102612585|NCT00002147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226021|NCT03441217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102226022|NCT03441217|Mydriatics|mydriatics|mesh-ancestor
102226023|NCT03441217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102226024|NCT03441217|Cholinergic Agents|cholinergic agents|mesh-ancestor
102226025|NCT03441217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102226026|NCT03441217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226027|NCT03441217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102226028|NCT03441217|Parasympatholytics|parasympatholytics|mesh-ancestor
102226029|NCT03128515|Hydroxyurea|hydroxyurea|mesh-list
102226030|NCT03128515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102226031|NCT03128515|Antisickling Agents|antisickling agents|mesh-ancestor
102226032|NCT03128515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102226033|NCT03128515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226034|NCT03128515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102226035|NCT02521441|Lenograstim|lenograstim|mesh-list
102226036|NCT02521441|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102226037|NCT02521441|Immunologic Factors|immunologic factors|mesh-ancestor
102226038|NCT02521441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226039|NCT04451239|Cyclosporine|cyclosporine|mesh-list
102226040|NCT04451239|Cyclosporins|cyclosporins|mesh-list
102226041|NCT04451239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102226042|NCT04451239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226043|NCT04451239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102226044|NCT04451239|Immunologic Factors|immunologic factors|mesh-ancestor
102226046|NCT04451239|Antifungal Agents|antifungal agents|mesh-ancestor
102226047|NCT04451239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102226048|NCT04451239|Dermatologic Agents|dermatologic agents|mesh-ancestor
102226049|NCT04451239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102226050|NCT04451239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102226051|NCT03440515|Prednisone|prednisone|mesh-list
102226052|NCT03440515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102226053|NCT03440515|Glucocorticoids|glucocorticoids|mesh-ancestor
102226054|NCT03440515|Hormones|hormones|mesh-ancestor
102226055|NCT03440515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102226056|NCT03440515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226057|NCT03440515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101630557|NCT04501939|Venetoclax|venetoclax|mesh-list
102226058|NCT03440515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102226059|NCT03432793|Itraconazole|itraconazole|mesh-list
102226060|NCT03432793|Fluvoxamine|fluvoxamine|mesh-list
102226061|NCT03432793|Caffeine|caffeine|mesh-list
102226062|NCT03432793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102226063|NCT03432793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226064|NCT03432793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102226065|NCT03432793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102226066|NCT03432793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226067|NCT03432793|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102226068|NCT03432793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102226069|NCT03432793|Purinergic Agents|purinergic agents|mesh-ancestor
102226070|NCT03432793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102226071|NCT03432793|Antifungal Agents|antifungal agents|mesh-ancestor
102226072|NCT03432793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102226073|NCT03432793|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102226074|NCT03432793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102226075|NCT03432793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102226076|NCT03432793|Hormone Antagonists|hormone antagonists|mesh-ancestor
102226077|NCT03432793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102226078|NCT03432793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102226079|NCT03432793|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102226080|NCT03432793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102226081|NCT03432793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102226082|NCT03432793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102226083|NCT03432793|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102226084|NCT03432793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102226085|NCT03432793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102226086|NCT03432793|Serotonin Agents|serotonin agents|mesh-ancestor
102226087|NCT03432793|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102226088|NCT03432793|Antidepressive Agents|antidepressive agents|mesh-ancestor
102226089|NCT03432793|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102226090|NCT03432793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102226091|NCT03436693|Canagliflozin|canagliflozin|mesh-list
102226092|NCT03436693|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102226093|NCT03436693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226094|NCT03436693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102226095|NCT03436693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226096|NCT03432637|Anesthetics|anesthetics|mesh-list
102226097|NCT03432637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102226098|NCT03432637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226099|NCT03436303|Dydrogesterone|dydrogesterone|mesh-list
102226100|NCT03436303|Progestins|progestins|mesh-ancestor
102226102|NCT03436303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102226103|NCT03436303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226104|NCT03436225|Dexamethasone|dexamethasone|mesh-list
102226105|NCT03436225|Dexamethasone acetate|dexamethasone acetate|mesh-list
102226106|NCT03436225|Budesonide|budesonide|mesh-list
102226107|NCT03436225|Albuterol|albuterol|mesh-list
102226108|NCT03436225|BB 1101|bb 1101|mesh-list
102226109|NCT03436225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102226110|NCT03436225|Antiemetics|antiemetics|mesh-ancestor
102226111|NCT03436225|Autonomic Agents|autonomic agents|mesh-ancestor
102226112|NCT03436225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102226113|NCT03436225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226114|NCT03436225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102226115|NCT03436225|Glucocorticoids|glucocorticoids|mesh-ancestor
102226116|NCT03436225|Hormones|hormones|mesh-ancestor
101934967|NCT00054327|Cytarabine|cytarabine|mesh-list
102226117|NCT03436225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102226118|NCT03436225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102226119|NCT03436225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102226120|NCT03436225|Protease Inhibitors|protease inhibitors|mesh-ancestor
102226121|NCT03436225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102226122|NCT03436225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226123|NCT03436225|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102226124|NCT03436225|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102226125|NCT03436225|Respiratory System Agents|respiratory system agents|mesh-ancestor
102226126|NCT03436225|Tocolytic Agents|tocolytic agents|mesh-ancestor
102226127|NCT03436225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102226128|NCT03436225|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102226129|NCT03436225|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102226130|NCT03436225|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102226131|NCT03436225|Adrenergic Agents|adrenergic agents|mesh-ancestor
102226132|NCT03436225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102226133|NCT03440359|Letrozole|letrozole|mesh-list
102226134|NCT03440359|Progesterone|progesterone|mesh-list
102226135|NCT03440359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102226136|NCT03440359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102226137|NCT03440359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102226138|NCT03440359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102226139|NCT03440359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226140|NCT03440359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102226141|NCT03440359|Hormone Antagonists|hormone antagonists|mesh-ancestor
102226142|NCT03440359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102226143|NCT03440359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226144|NCT03440359|Progestins|progestins|mesh-ancestor
102226145|NCT03440359|Hormones|hormones|mesh-ancestor
102226146|NCT03431701|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102226147|NCT03431701|Chlorhexidine|chlorhexidine|mesh-list
102226148|NCT03431701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102226149|NCT03431701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102226150|NCT03431701|Disinfectants|disinfectants|mesh-ancestor
102226151|NCT03431623|Darbepoetin alfa|darbepoetin alfa|mesh-list
102226152|NCT03431623|Hematinics|hematinics|mesh-ancestor
102226153|NCT04451395|Micronutrients|micronutrients|mesh-list
102226154|NCT04451395|Trace Elements|trace elements|mesh-list
102226155|NCT04451395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226156|NCT04451083|Camostat|camostat|mesh-list
102226157|NCT04451083|Protease Inhibitors|protease inhibitors|mesh-ancestor
102226158|NCT04451083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101630603|NCT04426669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102226159|NCT04451083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226160|NCT04451083|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102226161|NCT04451083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102226162|NCT03435289|Paclitaxel|paclitaxel|mesh-list
102612586|NCT00002159|Itraconazole|itraconazole|mesh-list
102612587|NCT00002159|Amphotericin B|amphotericin b|mesh-list
102226163|NCT03435289|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102226164|NCT03435289|Gemcitabine|gemcitabine|mesh-list
102226165|NCT03435289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102226166|NCT03435289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102226167|NCT03435289|Tubulin Modulators|tubulin modulators|mesh-ancestor
102226168|NCT03435289|Antimitotic Agents|antimitotic agents|mesh-ancestor
102226169|NCT03435289|Mitosis Modulators|mitosis modulators|mesh-ancestor
102226170|NCT03435289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226171|NCT03435289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102226172|NCT03435289|Antimetabolites|antimetabolites|mesh-ancestor
102226173|NCT03435133|Ticagrelor|ticagrelor|mesh-list
102226174|NCT03435133|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102226175|NCT03435133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102226176|NCT03435133|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102226177|NCT03435133|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102226178|NCT03435133|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102226179|NCT03435133|Purinergic Agents|purinergic agents|mesh-ancestor
102226180|NCT03435133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102226181|NCT03435133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226182|NCT03435133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226183|NCT03431077|Angiotensin II|angiotensin ii|mesh-list
102226184|NCT03431077|Giapreza|giapreza|mesh-list
102226185|NCT03431077|Angiotensinogen|angiotensinogen|mesh-list
102226186|NCT03431077|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102226187|NCT03431077|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102226188|NCT03431077|Protease Inhibitors|protease inhibitors|mesh-ancestor
102226189|NCT03431077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102226190|NCT03431077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226191|NCT03439501|Avelumab|avelumab|mesh-list
102226192|NCT03439501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102226193|NCT03439501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102226194|NCT03430687|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
102226195|NCT03430687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102226196|NCT03430687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102226197|NCT04255381|Pancrelipase|pancrelipase|mesh-list
102226198|NCT04255381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102226199|NCT03757897|Dexmedetomidine|dexmedetomidine|mesh-list
102226200|NCT03757897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102226201|NCT03757897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102226202|NCT03757897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226203|NCT03757897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102226204|NCT03757897|Analgesics|analgesics|mesh-ancestor
102226205|NCT03757897|Sensory System Agents|sensory system agents|mesh-ancestor
102226206|NCT03757897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102226207|NCT03757897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102226208|NCT03757897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102226209|NCT03757897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102226210|NCT03757897|Adrenergic Agents|adrenergic agents|mesh-ancestor
102226211|NCT03757897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102226212|NCT03757897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226213|NCT03434197|Diclofenac|diclofenac|mesh-list
102226214|NCT03434197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102226215|NCT03434197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102226216|NCT03434197|Analgesics|analgesics|mesh-ancestor
102226217|NCT03434197|Sensory System Agents|sensory system agents|mesh-ancestor
102226218|NCT03434197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102226219|NCT03434197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226220|NCT03434197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102226221|NCT03434197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102226222|NCT03434197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102226223|NCT03434197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102226224|NCT03434197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226225|NCT03430609|Hormones|hormones|mesh-list
102226226|NCT03430609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102226227|NCT03430609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226228|NCT03438955|Telmisartan|telmisartan|mesh-list
102226229|NCT03438955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102226230|NCT03438955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102226231|NCT03438955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102226232|NCT03438955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226233|NCT04219735|Minocycline|minocycline|mesh-list
102226234|NCT04219735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102226235|NCT04219735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102226236|NCT04449757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102226237|NCT03621553|Vitamin D|vitamin d|mesh-list
102226238|NCT03621553|Ergocalciferols|ergocalciferols|mesh-list
102226239|NCT03621553|Cholecalciferol|cholecalciferol|mesh-list
102226241|NCT03621553|Micronutrients|micronutrients|mesh-ancestor
102226242|NCT03621553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226243|NCT03621553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102226244|NCT03621553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102226245|NCT01559363|XL647|xl647|mesh-list
102226246|NCT01559363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102226247|NCT01559363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102226248|NCT01559363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102226249|NCT01559363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226250|NCT03569839|Propofol|propofol|mesh-list
102226251|NCT03569839|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102226252|NCT03569839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102226253|NCT03569839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226254|NCT03569839|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102226255|NCT03569839|Anesthetics, General|anesthetics, general|mesh-ancestor
102226256|NCT03569839|Anesthetics|anesthetics|mesh-ancestor
102226257|NCT01504919|Nicotine|nicotine|mesh-list
102226258|NCT01504919|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102226259|NCT01504919|Autonomic Agents|autonomic agents|mesh-ancestor
102226260|NCT01504919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102226261|NCT01504919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226262|NCT01504919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102226263|NCT01504919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102226264|NCT01504919|Cholinergic Agents|cholinergic agents|mesh-ancestor
101935116|NCT01092039|Lactoferrin|lactoferrin|mesh-list
102226265|NCT01504919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102226266|NCT01504919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226267|NCT02732327|Vancomycin|vancomycin|mesh-list
102226268|NCT02732327|Meropenem|meropenem|mesh-list
102226269|NCT02732327|Tazobactam|tazobactam|mesh-list
102226270|NCT02732327|Linezolid|linezolid|mesh-list
102226271|NCT02732327|Piperacillin|piperacillin|mesh-list
102226272|NCT02732327|Cefepime|cefepime|mesh-list
102226273|NCT02732327|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102226274|NCT02732327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102226275|NCT02732327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102226276|NCT02732327|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102226277|NCT02732327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102226278|NCT02732327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226279|NCT02732327|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102226280|NCT03428503|Acetaminophen|acetaminophen|mesh-list
102226281|NCT03428503|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
102226282|NCT03428503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102226283|NCT03428503|Analgesics|analgesics|mesh-ancestor
102226284|NCT03428503|Sensory System Agents|sensory system agents|mesh-ancestor
102226285|NCT03428503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102226286|NCT03428503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226287|NCT03428503|Antipyretics|antipyretics|mesh-ancestor
102226288|NCT03428503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102226289|NCT03428503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102226290|NCT03428503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102226291|NCT03428425|Paclitaxel|paclitaxel|mesh-list
102226292|NCT03428425|Apatinib|apatinib|mesh-list
102226293|NCT03428425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102226294|NCT03428425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102226295|NCT03428425|Tubulin Modulators|tubulin modulators|mesh-ancestor
102226296|NCT03428425|Antimitotic Agents|antimitotic agents|mesh-ancestor
102226297|NCT03428425|Mitosis Modulators|mitosis modulators|mesh-ancestor
102226298|NCT03428425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226299|NCT03428425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102226300|NCT03428425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102226301|NCT03416777|Tocopherols|tocopherols|mesh-list
102226302|NCT03416777|Vitamin E|vitamin e|mesh-list
102226303|NCT03416777|Tocotrienols|tocotrienols|mesh-list
102226304|NCT03416777|alpha-Tocopherol|alpha-tocopherol|mesh-list
102226305|NCT03416777|Antioxidants|antioxidants|mesh-ancestor
102226306|NCT03416777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226307|NCT03416777|Protective Agents|protective agents|mesh-ancestor
102226308|NCT03416777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226309|NCT03416777|Vitamins|vitamins|mesh-ancestor
102226310|NCT03416777|Micronutrients|micronutrients|mesh-ancestor
102226311|NCT03429439|Antiviral Agents|antiviral agents|mesh-list
102226312|NCT03429439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102226313|NCT03422887|Flurbiprofen|flurbiprofen|mesh-list
102226314|NCT03422887|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
102226315|NCT03422887|Nalbuphine|nalbuphine|mesh-list
101901070|NCT01179152|Glucocorticoids|glucocorticoids|mesh-ancestor
102612588|NCT00002159|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102226316|NCT03422887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102226317|NCT03422887|Narcotics|narcotics|mesh-ancestor
102226318|NCT03422887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102226319|NCT03422887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226320|NCT03422887|Analgesics|analgesics|mesh-ancestor
102226321|NCT03422887|Sensory System Agents|sensory system agents|mesh-ancestor
102226322|NCT03422887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102226323|NCT03422887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102226324|NCT03422887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102226325|NCT03422887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102226326|NCT03422887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102226327|NCT03422887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102226328|NCT03422887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102226329|NCT03422887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226330|NCT02521207|Ibuprofen|ibuprofen|mesh-list
102226331|NCT02521207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102226332|NCT02521207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102226333|NCT02521207|Analgesics|analgesics|mesh-ancestor
102226334|NCT02521207|Sensory System Agents|sensory system agents|mesh-ancestor
102226335|NCT02521207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102226336|NCT02521207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226337|NCT02521207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102226338|NCT02521207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102226339|NCT02521207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102226340|NCT02521207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102226341|NCT02521207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226342|NCT03179605|Clobetasol|clobetasol|mesh-list
102226343|NCT03179605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102226344|NCT03179605|Glucocorticoids|glucocorticoids|mesh-ancestor
102226345|NCT03179605|Hormones|hormones|mesh-ancestor
102226346|NCT03179605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102226347|NCT03179605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226348|NCT03173053|Chlorhexidine|chlorhexidine|mesh-list
102226349|NCT03173053|Povidone-Iodine|povidone-iodine|mesh-list
102226350|NCT03173053|Clarithromycin|clarithromycin|mesh-list
102226351|NCT03173053|Doxycycline|doxycycline|mesh-list
102226352|NCT03173053|Ciprofloxacin|ciprofloxacin|mesh-list
102226353|NCT03173053|Rifampin|rifampin|mesh-list
102226354|NCT03173053|Clindamycin|clindamycin|mesh-list
102226355|NCT03173053|Trimethoprim|trimethoprim|mesh-list
102226356|NCT03173053|Sulfamethoxazole|sulfamethoxazole|mesh-list
102226357|NCT03173053|Mupirocin|mupirocin|mesh-list
102226358|NCT03173053|Fusidic Acid|fusidic acid|mesh-list
102226359|NCT03173053|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102226360|NCT03173053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102226361|NCT03173053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102226362|NCT03173053|Disinfectants|disinfectants|mesh-ancestor
102226363|NCT03173053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102226364|NCT03173053|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102226365|NCT03173053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102226366|NCT03173053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226367|NCT03173053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102226368|NCT03173053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102226369|NCT03173053|Antimalarials|antimalarials|mesh-ancestor
102226370|NCT03173053|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102226371|NCT03173053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102226372|NCT03173053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102226373|NCT03173053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102226374|NCT03173053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102226375|NCT03173053|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102226376|NCT03173053|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102226377|NCT03173053|Antitubercular Agents|antitubercular agents|mesh-ancestor
102226378|NCT03173053|Leprostatic Agents|leprostatic agents|mesh-ancestor
102226379|NCT03173053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102226380|NCT03173053|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102226381|NCT03173053|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102226382|NCT03173053|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102226383|NCT03173053|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102226384|NCT03173053|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102226385|NCT03173053|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102226386|NCT03173053|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102226387|NCT03173053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102612589|NCT00002159|Antifungal Agents|antifungal agents|mesh-ancestor
102226388|NCT03173053|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102226389|NCT03173053|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102226390|NCT03109795|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102226391|NCT03109795|Clonidine|clonidine|mesh-list
102226392|NCT03109795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102226393|NCT03109795|Diuretics|diuretics|mesh-ancestor
102226394|NCT03109795|Natriuretic Agents|natriuretic agents|mesh-ancestor
102226395|NCT03109795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226396|NCT03109795|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102226397|NCT03109795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102226398|NCT03109795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226399|NCT03109795|Analgesics|analgesics|mesh-ancestor
102226400|NCT03109795|Sensory System Agents|sensory system agents|mesh-ancestor
102226401|NCT03109795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102226402|NCT03109795|Sympatholytics|sympatholytics|mesh-ancestor
102226403|NCT03109795|Autonomic Agents|autonomic agents|mesh-ancestor
102226404|NCT03109795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102226405|NCT03109795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102226406|NCT03109795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102226407|NCT03109795|Adrenergic Agents|adrenergic agents|mesh-ancestor
102226408|NCT03109795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102226409|NCT03429127|Plasma-lyte 148|plasma-lyte 148|mesh-list
102226410|NCT03429127|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102226411|NCT03429127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102226412|NCT03428191|Dexmedetomidine|dexmedetomidine|mesh-list
102226413|NCT03428191|Remifentanil|remifentanil|mesh-list
102226414|NCT03428191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102226415|NCT03428191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102226416|NCT03428191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226417|NCT03428191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102226418|NCT03428191|Analgesics|analgesics|mesh-ancestor
102226419|NCT03428191|Sensory System Agents|sensory system agents|mesh-ancestor
101630787|NCT04076371|Dopamine Agents|dopamine agents|mesh-ancestor
102226420|NCT03428191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102226421|NCT03428191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102226422|NCT03428191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102226423|NCT03428191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102226424|NCT03428191|Adrenergic Agents|adrenergic agents|mesh-ancestor
102226425|NCT03428191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102226426|NCT03428191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226427|NCT03428191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102226428|NCT03428191|Narcotics|narcotics|mesh-ancestor
102226429|NCT03422575|Etoricoxib|etoricoxib|mesh-list
102226430|NCT03422575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102226431|NCT03422575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102226432|NCT03422575|Analgesics|analgesics|mesh-ancestor
102226433|NCT03422575|Sensory System Agents|sensory system agents|mesh-ancestor
102226434|NCT03422575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102226435|NCT03422575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226436|NCT03422575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102226437|NCT03422575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102226438|NCT03422575|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102226439|NCT03422575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102226440|NCT03422575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102226441|NCT03422575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226442|NCT02412722|Paclitaxel|paclitaxel|mesh-list
102226443|NCT02412722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102226444|NCT02412722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102226445|NCT02412722|Tubulin Modulators|tubulin modulators|mesh-ancestor
102226446|NCT02412722|Antimitotic Agents|antimitotic agents|mesh-ancestor
102226447|NCT02412722|Mitosis Modulators|mitosis modulators|mesh-ancestor
102226448|NCT02412722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226449|NCT03422419|Heparin|heparin|mesh-list
102226450|NCT03422419|Anticoagulants|anticoagulants|mesh-ancestor
102226451|NCT03422419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102226452|NCT03422419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102226453|NCT03422419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226454|NCT04449289|Lidocaine|lidocaine|mesh-list
102226455|NCT04449289|Ropivacaine|ropivacaine|mesh-list
102226456|NCT04449289|Anesthetics, Local|anesthetics, local|mesh-ancestor
102226457|NCT04449289|Anesthetics|anesthetics|mesh-ancestor
102612591|NCT00002159|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102226458|NCT04449289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102226459|NCT04449289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226460|NCT04449289|Sensory System Agents|sensory system agents|mesh-ancestor
102226461|NCT04449289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102226462|NCT04449289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101630818|NCT01071083|Protective Agents|protective agents|mesh-ancestor
102226463|NCT04449289|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102226464|NCT04449289|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102226465|NCT04449289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102226466|NCT04449289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226468|NCT03128203|Oxytocics|oxytocics|mesh-ancestor
102226469|NCT03128203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102226470|NCT03128203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226471|NCT03469999|Botulinum Toxins|botulinum toxins|mesh-list
102226472|NCT03469999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102226473|NCT03469999|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102226474|NCT03469999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102226475|NCT03469999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102226476|NCT03469999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226477|NCT03469999|Cholinergic Agents|cholinergic agents|mesh-ancestor
102226478|NCT03469999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102226479|NCT03469999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226480|NCT03469999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102226481|NCT03469999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102226482|NCT02935309|Capecitabine|capecitabine|mesh-list
102226483|NCT02935309|Lenvatinib|lenvatinib|mesh-list
102226484|NCT02935309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102226485|NCT02935309|Antimetabolites|antimetabolites|mesh-ancestor
102226486|NCT02935309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226487|NCT02935309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102226488|NCT02935309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102226489|NCT02935309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101935340|NCT03689998|Melatonin|melatonin|mesh-list
102226490|NCT03463993|Tranexamic Acid|tranexamic acid|mesh-list
102226491|NCT03463993|Oxytocin|oxytocin|mesh-list
102226492|NCT03463993|Oxytocics|oxytocics|mesh-ancestor
102226493|NCT03463993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102226494|NCT03463993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226495|NCT03463993|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102226496|NCT03463993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102226497|NCT03463993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226498|NCT03463993|Hemostatics|hemostatics|mesh-ancestor
102226499|NCT03463993|Coagulants|coagulants|mesh-ancestor
102226500|NCT03422029|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102226501|NCT03422029|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102226502|NCT03422029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226503|NCT03417037|Nivolumab|nivolumab|mesh-list
102226504|NCT03417037|Linrodostat|linrodostat|mesh-list
102226505|NCT03417037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102226506|NCT03417037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102226507|NCT03417037|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102226508|NCT03417037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226509|NCT03417037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102226510|NCT02378480|Linezolid|linezolid|mesh-list
102226511|NCT02378480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102226512|NCT02378480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102226513|NCT02378480|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102226514|NCT02378480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102226515|NCT02378480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226516|NCT03421717|Chitosan|chitosan|mesh-list
102226517|NCT03421717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102226518|NCT03421717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102226519|NCT03421717|Antimetabolites|antimetabolites|mesh-ancestor
102226520|NCT03421717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226521|NCT03421717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102226522|NCT03421717|Chelating Agents|chelating agents|mesh-ancestor
102226523|NCT03421717|Sequestering Agents|sequestering agents|mesh-ancestor
102226524|NCT03421717|Hemostatics|hemostatics|mesh-ancestor
102226525|NCT03421717|Coagulants|coagulants|mesh-ancestor
102226526|NCT03427801|Hematinics|hematinics|mesh-list
102226527|NCT03416569|Prazosin|prazosin|mesh-list
102226528|NCT03416569|Nicotine|nicotine|mesh-list
102226529|NCT03416569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102226530|NCT03416569|Autonomic Agents|autonomic agents|mesh-ancestor
102226531|NCT03416569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102226532|NCT03416569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226533|NCT03416569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102612592|NCT00002159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102612593|NCT00002159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102226534|NCT03416569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102226535|NCT03416569|Cholinergic Agents|cholinergic agents|mesh-ancestor
102226536|NCT03416569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102226537|NCT03416569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226538|NCT03416569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102226539|NCT03416569|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102226540|NCT03416569|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102226541|NCT03416569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102226542|NCT03416569|Adrenergic Agents|adrenergic agents|mesh-ancestor
102226543|NCT01004029|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
102226544|NCT01004029|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
102226545|NCT01004029|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102226546|NCT01004029|Hormone Antagonists|hormone antagonists|mesh-ancestor
102226547|NCT01004029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102226548|NCT01004029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226549|NCT01004029|Progestins|progestins|mesh-ancestor
102226551|NCT03416491|Sofosbuvir|sofosbuvir|mesh-list
102226552|NCT03416491|Antiviral Agents|antiviral agents|mesh-ancestor
102226553|NCT03416491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102226554|NCT03420937|Atropine|atropine|mesh-list
102226555|NCT03420937|Neostigmine|neostigmine|mesh-list
102226556|NCT03420937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102226557|NCT03420937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102226558|NCT03420937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102226559|NCT03420937|Autonomic Agents|autonomic agents|mesh-ancestor
102226560|NCT03420937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102226561|NCT03420937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226562|NCT03420937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101836514|NCT01059604|Naproxen|naproxen|mesh-list
102226563|NCT03420937|Respiratory System Agents|respiratory system agents|mesh-ancestor
102226564|NCT03420937|Mydriatics|mydriatics|mesh-ancestor
102226565|NCT03420937|Parasympatholytics|parasympatholytics|mesh-ancestor
102226566|NCT03420937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102226567|NCT03420937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102226568|NCT03420937|Cholinergic Agents|cholinergic agents|mesh-ancestor
102226569|NCT03420937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102226570|NCT03420937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226571|NCT03420937|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102226572|NCT03420937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102226573|NCT03420937|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102226574|NCT02900443|Mycophenolic Acid|mycophenolic acid|mesh-list
102226575|NCT02900443|Azathioprine|azathioprine|mesh-list
102226576|NCT02900443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102226577|NCT02900443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102226578|NCT02900443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102226579|NCT02900443|Antitubercular Agents|antitubercular agents|mesh-ancestor
102226580|NCT02900443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102226581|NCT02900443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102226582|NCT02900443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102226583|NCT02900443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226584|NCT02900443|Antimetabolites|antimetabolites|mesh-ancestor
102226585|NCT02900443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102226586|NCT02900443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102226587|NCT02900443|Immunologic Factors|immunologic factors|mesh-ancestor
102226588|NCT02900443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226589|NCT02900443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102226590|NCT04594213|Botulinum Toxins|botulinum toxins|mesh-list
102226591|NCT04594213|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102226592|NCT04594213|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102226593|NCT04594213|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102226594|NCT04594213|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101630907|NCT00617877|Losartan|losartan|mesh-list
102226595|NCT04594213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102226596|NCT04594213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226597|NCT04594213|Cholinergic Agents|cholinergic agents|mesh-ancestor
102226598|NCT04594213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102226599|NCT04594213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226600|NCT04594213|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102226601|NCT04594213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102226602|NCT03420703|Morphine|morphine|mesh-list
102226603|NCT03420703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102226604|NCT03420703|Narcotics|narcotics|mesh-ancestor
101768488|NCT00674154|Cholecalciferol|cholecalciferol|mesh-list
102612594|NCT00002159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226605|NCT03420703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102226606|NCT03420703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226608|NCT03420703|Sensory System Agents|sensory system agents|mesh-ancestor
102226609|NCT03420703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102226610|NCT03420469|Bupropion|bupropion|mesh-list
102226611|NCT03420469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102226612|NCT03420469|Antidepressive Agents|antidepressive agents|mesh-ancestor
102226613|NCT03420469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102226614|NCT03420469|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102226615|NCT03420469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102226616|NCT03420469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102226617|NCT03420469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226618|NCT03420469|Dopamine Agents|dopamine agents|mesh-ancestor
102226619|NCT03420469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102226620|NCT03420469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226621|NCT03420469|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102226622|NCT03420469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102226623|NCT03420469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102226624|NCT03427021|Oxaliplatin|oxaliplatin|mesh-list
102226625|NCT03427021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102226626|NCT03415711|Mesalamine|mesalamine|mesh-list
102226627|NCT03415711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102226628|NCT03415711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102226629|NCT03415711|Analgesics|analgesics|mesh-ancestor
102226630|NCT03415711|Sensory System Agents|sensory system agents|mesh-ancestor
102226631|NCT03415711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102226632|NCT03415711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226633|NCT03415711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102226634|NCT03415711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102226635|NCT03420313|Buprenorphine|buprenorphine|mesh-list
102226636|NCT03420313|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102226637|NCT03420313|Naloxone|naloxone|mesh-list
102226638|NCT03420313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101836515|NCT01059604|Sumatriptan|sumatriptan|mesh-list
102226639|NCT03420313|Narcotics|narcotics|mesh-ancestor
102226640|NCT03420313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102226641|NCT03420313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226642|NCT03420313|Analgesics|analgesics|mesh-ancestor
102226643|NCT03420313|Sensory System Agents|sensory system agents|mesh-ancestor
102226644|NCT03420313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102226645|NCT03420313|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102226646|NCT03415555|Acetaminophen|acetaminophen|mesh-list
102226647|NCT03415555|Oxycodone|oxycodone|mesh-list
102226648|NCT03415555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102226649|NCT03415555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226650|NCT03415555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102226651|NCT03415555|Analgesics|analgesics|mesh-ancestor
102226652|NCT03415555|Sensory System Agents|sensory system agents|mesh-ancestor
102226653|NCT03415555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102226654|NCT03415555|Antipyretics|antipyretics|mesh-ancestor
102226655|NCT03415555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102226656|NCT03415555|Narcotics|narcotics|mesh-ancestor
102226657|NCT03415477|Denosumab|denosumab|mesh-list
102226658|NCT03415477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102226659|NCT03415477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226660|NCT02345252|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
102226661|NCT02345252|Antiviral Agents|antiviral agents|mesh-ancestor
102226662|NCT02345252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102226663|NCT02345252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102226664|NCT02345252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102226665|NCT02345252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102226666|NCT02345252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630970|NCT01009814|Ritonavir|ritonavir|mesh-list
102226667|NCT02345252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102226668|NCT02345252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102226669|NCT03419923|Citric Acid|citric acid|mesh-list
102226670|NCT03419923|Sodium Citrate|sodium citrate|mesh-list
102226671|NCT03419923|Anticoagulants|anticoagulants|mesh-ancestor
102226672|NCT03419923|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102226673|NCT03419923|Chelating Agents|chelating agents|mesh-ancestor
102226674|NCT03419923|Sequestering Agents|sequestering agents|mesh-ancestor
102226675|NCT03419923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226676|NCT03426553|Riboflavin|riboflavin|mesh-list
102226678|NCT03426553|Vitamins|vitamins|mesh-ancestor
102226679|NCT03426553|Micronutrients|micronutrients|mesh-ancestor
102226680|NCT03426553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226681|NCT03426553|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102226682|NCT03426553|Dermatologic Agents|dermatologic agents|mesh-ancestor
102226683|NCT03415087|Fentanyl|fentanyl|mesh-list
102226684|NCT03415087|Bupivacaine|bupivacaine|mesh-list
102226685|NCT03415087|Anesthetics, Local|anesthetics, local|mesh-ancestor
102226686|NCT03415087|Anesthetics|anesthetics|mesh-ancestor
102226687|NCT03415087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102226688|NCT03415087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226689|NCT03415087|Sensory System Agents|sensory system agents|mesh-ancestor
102226690|NCT03415087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102226691|NCT03415087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102226692|NCT03415087|Narcotics|narcotics|mesh-ancestor
102226693|NCT03415087|Analgesics|analgesics|mesh-ancestor
102226694|NCT03415087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102226695|NCT03415087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102226696|NCT03415087|Anesthetics, General|anesthetics, general|mesh-ancestor
102226697|NCT02833753|Oxaliplatin|oxaliplatin|mesh-list
102226698|NCT02833753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102226699|NCT03419767|Melatonin|melatonin|mesh-list
102226700|NCT03419767|Antioxidants|antioxidants|mesh-ancestor
102226701|NCT03419767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226702|NCT03419767|Protective Agents|protective agents|mesh-ancestor
102226703|NCT03419767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226704|NCT03419767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102226705|NCT03414931|Sertraline|sertraline|mesh-list
102226706|NCT03414931|Antidepressive Agents|antidepressive agents|mesh-ancestor
102226707|NCT03414931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102226708|NCT03414931|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102226709|NCT03414931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102226710|NCT03414931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102226711|NCT03414931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226712|NCT03414931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102226713|NCT03414931|Serotonin Agents|serotonin agents|mesh-ancestor
102226714|NCT03414931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226716|NCT04448821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102226717|NCT04448821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226718|NCT02835157|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102226719|NCT04448977|Ocrelizumab|ocrelizumab|mesh-list
102226720|NCT04448977|Immunologic Factors|immunologic factors|mesh-ancestor
102226721|NCT04448977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226722|NCT03418831|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
102226723|NCT03418831|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102226724|NCT03418831|Hormone Antagonists|hormone antagonists|mesh-ancestor
102226725|NCT03418831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102226726|NCT03418831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226727|NCT03418831|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102226728|NCT03418831|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102226729|NCT03418831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102226730|NCT04448587|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102226731|NCT04448587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102226732|NCT04448587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226733|NCT04448587|Incretins|incretins|mesh-ancestor
102226734|NCT04448587|Hormones|hormones|mesh-ancestor
102226735|NCT04448587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102226736|NCT04448587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102226737|NCT04448587|Protease Inhibitors|protease inhibitors|mesh-ancestor
102226738|NCT04448587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101631040|NCT01009580|Biphasic Insulins|biphasic insulins|mesh-list
102226739|NCT04448587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226740|NCT03426085|Liraglutide|liraglutide|mesh-list
102226741|NCT03426085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102226742|NCT03426085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226743|NCT03426085|Incretins|incretins|mesh-ancestor
102226744|NCT03426085|Hormones|hormones|mesh-ancestor
102226745|NCT03426085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102226746|NCT03418597|Anesthetics|anesthetics|mesh-list
102226747|NCT03418597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102226748|NCT03418597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226749|NCT03425929|Oxytocin|oxytocin|mesh-list
102226750|NCT03425929|Oxytocics|oxytocics|mesh-ancestor
102226751|NCT03425929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102612595|NCT00002159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102226752|NCT03425929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226753|NCT03127189|Rilpivirine|rilpivirine|mesh-list
102226754|NCT03127189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102226755|NCT03127189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102226756|NCT03127189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102226757|NCT03127189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226758|NCT03127189|Antiviral Agents|antiviral agents|mesh-ancestor
102226759|NCT03127189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102226760|NCT03127189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102226761|NCT03127189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102226762|NCT02521051|Bevacizumab|bevacizumab|mesh-list
102226763|NCT02521051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102226764|NCT02521051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102226765|NCT02521051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102226766|NCT02521051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102226767|NCT02521051|Growth Substances|growth substances|mesh-ancestor
102226768|NCT02521051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226769|NCT02521051|Growth Inhibitors|growth inhibitors|mesh-ancestor
102226770|NCT01239797|Dexamethasone|dexamethasone|mesh-list
102226771|NCT01239797|Dexamethasone acetate|dexamethasone acetate|mesh-list
102226772|NCT01239797|Lenalidomide|lenalidomide|mesh-list
102226773|NCT01239797|Elotuzumab|elotuzumab|mesh-list
102226774|NCT01239797|BB 1101|bb 1101|mesh-list
102226775|NCT01239797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102226776|NCT01239797|Antiemetics|antiemetics|mesh-ancestor
102226777|NCT01239797|Autonomic Agents|autonomic agents|mesh-ancestor
102226778|NCT01239797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102226779|NCT01239797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226780|NCT01239797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102226781|NCT01239797|Glucocorticoids|glucocorticoids|mesh-ancestor
102226782|NCT01239797|Hormones|hormones|mesh-ancestor
102226783|NCT01239797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102226784|NCT01239797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102226785|NCT01239797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102226786|NCT01239797|Protease Inhibitors|protease inhibitors|mesh-ancestor
102226787|NCT01239797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102226788|NCT01239797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226789|NCT01239797|Immunologic Factors|immunologic factors|mesh-ancestor
102226790|NCT01239797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102226791|NCT01239797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102226792|NCT01239797|Growth Substances|growth substances|mesh-ancestor
102226793|NCT01239797|Growth Inhibitors|growth inhibitors|mesh-ancestor
102226794|NCT02639065|Durvalumab|durvalumab|mesh-list
102226795|NCT02639065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102226796|NCT02639065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102226797|NCT01092143|Fluticasone|fluticasone|mesh-list
102226798|NCT01092143|Xhance|xhance|mesh-list
102226799|NCT01092143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102226800|NCT01092143|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102226801|NCT01092143|Autonomic Agents|autonomic agents|mesh-ancestor
102226802|NCT01092143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102226803|NCT01092143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226804|NCT01092143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102226805|NCT01092143|Respiratory System Agents|respiratory system agents|mesh-ancestor
102226806|NCT01092143|Dermatologic Agents|dermatologic agents|mesh-ancestor
102226807|NCT01092143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102226808|NCT00950989|Folic Acid|folic acid|mesh-list
102226809|NCT00950989|Methotrexate|methotrexate|mesh-list
102226810|NCT00950989|Brodalumab|brodalumab|mesh-list
102226811|NCT00950989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102226812|NCT00950989|Abortifacient Agents|abortifacient agents|mesh-ancestor
102226813|NCT00950989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102226814|NCT00950989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226815|NCT00950989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102226816|NCT00950989|Antimetabolites|antimetabolites|mesh-ancestor
102226817|NCT00950989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226818|NCT00950989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102226819|NCT00950989|Dermatologic Agents|dermatologic agents|mesh-ancestor
102226820|NCT00950989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102226821|NCT00950989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102612596|NCT00002159|Hormone Antagonists|hormone antagonists|mesh-ancestor
102612597|NCT00002159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102226822|NCT00950989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102226823|NCT00950989|Immunologic Factors|immunologic factors|mesh-ancestor
102226824|NCT00950989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102226825|NCT00950989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102226827|NCT00950989|Vitamin B Complex|vitamin b complex|mesh-ancestor
102226828|NCT00950989|Vitamins|vitamins|mesh-ancestor
102226829|NCT00950989|Micronutrients|micronutrients|mesh-ancestor
102226830|NCT03420911|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
102226831|NCT03420911|Midazolam|midazolam|mesh-list
102226832|NCT03420911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102226833|NCT03420911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102226834|NCT03420911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102226835|NCT03420911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226836|NCT03420911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102226837|NCT03420911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102226838|NCT03420911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102226839|NCT03420911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102226840|NCT03420911|Anesthetics, General|anesthetics, general|mesh-ancestor
102226841|NCT03420911|Anesthetics|anesthetics|mesh-ancestor
102226842|NCT03420911|GABA Modulators|gaba modulators|mesh-ancestor
102226843|NCT03420911|GABA Agents|gaba agents|mesh-ancestor
102226844|NCT03420911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102226845|NCT03420911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226846|NCT03420911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102226847|NCT03420911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102226848|NCT03420911|Analgesics|analgesics|mesh-ancestor
102226849|NCT03420911|Sensory System Agents|sensory system agents|mesh-ancestor
102226850|NCT03420911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102226851|NCT03420911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102226852|NCT03420911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102226853|NCT03416231|Docetaxel|docetaxel|mesh-list
102226854|NCT03416231|Apatinib|apatinib|mesh-list
102226855|NCT03416231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102226856|NCT03416231|Tubulin Modulators|tubulin modulators|mesh-ancestor
102226857|NCT03416231|Antimitotic Agents|antimitotic agents|mesh-ancestor
102226858|NCT03416231|Mitosis Modulators|mitosis modulators|mesh-ancestor
102226859|NCT03416231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226860|NCT03416231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102226861|NCT03416231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102226862|NCT03415763|Leucovorin|leucovorin|mesh-list
102226863|NCT03415763|Capecitabine|capecitabine|mesh-list
102226864|NCT03415763|Oxaliplatin|oxaliplatin|mesh-list
102226865|NCT03415763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102226866|NCT03415763|Antimetabolites|antimetabolites|mesh-ancestor
102226867|NCT03415763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226868|NCT03415763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102226869|NCT03415763|Antidotes|antidotes|mesh-ancestor
102226870|NCT03415763|Protective Agents|protective agents|mesh-ancestor
102226871|NCT03415763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226872|NCT03415763|Vitamin B Complex|vitamin b complex|mesh-ancestor
102226873|NCT03415763|Vitamins|vitamins|mesh-ancestor
102226874|NCT03415763|Micronutrients|micronutrients|mesh-ancestor
102226875|NCT00593567|Levofloxacin|levofloxacin|mesh-list
102226876|NCT00593567|Gentamicins|gentamicins|mesh-list
102226877|NCT00593567|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102226878|NCT00593567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102226879|NCT00593567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102226880|NCT00593567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102226881|NCT00593567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102226882|NCT00593567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102226883|NCT00593567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226884|NCT00593567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102226885|NCT00593567|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102226886|NCT00593567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102226887|NCT00593567|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102226888|NCT03419975|Latanoprost|latanoprost|mesh-list
102226889|NCT03419975|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102226890|NCT03419975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102226891|NCT00006455|Leucovorin|leucovorin|mesh-list
102226892|NCT00006455|Cytarabine|cytarabine|mesh-list
102226893|NCT00006455|Dexamethasone|dexamethasone|mesh-list
102226894|NCT00006455|Hydrocortisone|hydrocortisone|mesh-list
102226895|NCT00006455|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102226896|NCT00006455|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102226897|NCT00006455|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102226898|NCT00006455|Cyclophosphamide|cyclophosphamide|mesh-list
102226899|NCT00006455|Ifosfamide|ifosfamide|mesh-list
102226900|NCT00006455|Doxorubicin|doxorubicin|mesh-list
102226901|NCT00006455|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102226902|NCT00006455|Methotrexate|methotrexate|mesh-list
102612598|NCT00002159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226903|NCT00006455|Etoposide|etoposide|mesh-list
102226904|NCT00006455|Vinblastine|vinblastine|mesh-list
102226905|NCT00006455|Levoleucovorin|levoleucovorin|mesh-list
102226906|NCT00006455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102226907|NCT00006455|Immunologic Factors|immunologic factors|mesh-ancestor
102226908|NCT00006455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226909|NCT00006455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102226910|NCT00006455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102226911|NCT00006455|Alkylating Agents|alkylating agents|mesh-ancestor
102226912|NCT00006455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226913|NCT00006455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102226914|NCT00006455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102226915|NCT00006455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102226916|NCT00006455|Antiemetics|antiemetics|mesh-ancestor
102226917|NCT00006455|Autonomic Agents|autonomic agents|mesh-ancestor
102226918|NCT00006455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102226919|NCT00006455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102226920|NCT00006455|Glucocorticoids|glucocorticoids|mesh-ancestor
102226921|NCT00006455|Hormones|hormones|mesh-ancestor
102226922|NCT00006455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102226923|NCT00006455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102226924|NCT00006455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102226925|NCT00006455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102226926|NCT00006455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102226927|NCT00006455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102226928|NCT00006455|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102226929|NCT00006455|Abortifacient Agents|abortifacient agents|mesh-ancestor
102226930|NCT00006455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102226931|NCT00006455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102226932|NCT00006455|Antimetabolites|antimetabolites|mesh-ancestor
102226933|NCT00006455|Dermatologic Agents|dermatologic agents|mesh-ancestor
102226934|NCT00006455|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102226935|NCT00006455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102226936|NCT00006455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102226937|NCT00006455|Antiviral Agents|antiviral agents|mesh-ancestor
102226938|NCT00006455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102226939|NCT00006455|Antidotes|antidotes|mesh-ancestor
102226940|NCT00006455|Protective Agents|protective agents|mesh-ancestor
102226941|NCT00006455|Vitamin B Complex|vitamin b complex|mesh-ancestor
102226942|NCT00006455|Vitamins|vitamins|mesh-ancestor
101836516|NCT01059604|Naratriptan|naratriptan|mesh-list
102226943|NCT00006455|Micronutrients|micronutrients|mesh-ancestor
102226944|NCT00006455|Tubulin Modulators|tubulin modulators|mesh-ancestor
102226945|NCT00006455|Antimitotic Agents|antimitotic agents|mesh-ancestor
102226946|NCT00006455|Mitosis Modulators|mitosis modulators|mesh-ancestor
102226947|NCT01602315|Cetuximab|cetuximab|mesh-list
102226948|NCT01602315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102226949|NCT01602315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102226950|NCT02537197|Naltrexone|naltrexone|mesh-list
102226951|NCT02537197|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102226952|NCT02537197|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102226953|NCT02537197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226954|NCT02537197|Sensory System Agents|sensory system agents|mesh-ancestor
102226955|NCT02537197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102226956|NCT03127345|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102226957|NCT03127345|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102226958|NCT03127345|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102226959|NCT03127345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102226960|NCT03413371|Acetaminophen|acetaminophen|mesh-list
102226961|NCT03413371|Lidocaine|lidocaine|mesh-list
102226962|NCT03413371|Bupivacaine|bupivacaine|mesh-list
102226963|NCT03413371|Ropivacaine|ropivacaine|mesh-list
102226964|NCT03413371|Anesthetics, Local|anesthetics, local|mesh-ancestor
102226965|NCT03413371|Anesthetics|anesthetics|mesh-ancestor
102226966|NCT03413371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102226967|NCT03413371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226968|NCT03413371|Sensory System Agents|sensory system agents|mesh-ancestor
102226969|NCT03413371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102226970|NCT03413371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102226971|NCT03413371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102226972|NCT03413371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102226973|NCT03413371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102226974|NCT03413371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226975|NCT03413371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102226976|NCT03413371|Analgesics|analgesics|mesh-ancestor
102612599|NCT00002159|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102226977|NCT03413371|Antipyretics|antipyretics|mesh-ancestor
102226978|NCT05116995|Rivaroxaban|rivaroxaban|mesh-list
102226979|NCT05116995|Ticagrelor|ticagrelor|mesh-list
102226980|NCT05116995|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102226981|NCT05116995|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102226982|NCT05116995|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102226983|NCT05116995|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102226984|NCT05116995|Purinergic Agents|purinergic agents|mesh-ancestor
102226985|NCT05116995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102226986|NCT05116995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102226987|NCT05116995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102226988|NCT05116995|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102226989|NCT05116995|Antithrombins|antithrombins|mesh-ancestor
102226990|NCT05116995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102226991|NCT05116995|Protease Inhibitors|protease inhibitors|mesh-ancestor
102226992|NCT05116995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102226993|NCT05116995|Anticoagulants|anticoagulants|mesh-ancestor
102226994|NCT02344004|Amikacin|amikacin|mesh-list
102226995|NCT02344004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102226996|NCT02344004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102226997|NCT03677115|Dexmedetomidine|dexmedetomidine|mesh-list
102226998|NCT03677115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102226999|NCT03677115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102227000|NCT03677115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227001|NCT03677115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102227002|NCT03677115|Analgesics|analgesics|mesh-ancestor
102227003|NCT03677115|Sensory System Agents|sensory system agents|mesh-ancestor
102227004|NCT03677115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102227005|NCT03677115|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102227006|NCT03677115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102227007|NCT03677115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102227008|NCT03677115|Adrenergic Agents|adrenergic agents|mesh-ancestor
102227009|NCT03677115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102227010|NCT03677115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227011|NCT05116371|Levonorgestrel|levonorgestrel|mesh-list
102227012|NCT05116371|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102227013|NCT05116371|Contraceptive Agents|contraceptive agents|mesh-list
102227014|NCT05116371|Contraceptives, Oral|contraceptives, oral|mesh-list
102227015|NCT05116371|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
101935871|NCT03684772|Digoxin|digoxin|mesh-list
102227016|NCT05116371|Estradiol|estradiol|mesh-list
102227017|NCT05116371|Estrogens|estrogens|mesh-ancestor
102227018|NCT05116371|Hormones|hormones|mesh-ancestor
102227019|NCT05116371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102227020|NCT05116371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227021|NCT05116371|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102227022|NCT05116371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102227023|NCT05116371|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102227024|NCT05116371|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102227025|NCT05116371|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102227027|NCT01328093|Antidepressive Agents|antidepressive agents|mesh-ancestor
102227028|NCT01328093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102227029|NCT01328093|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102227030|NCT01328093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102227031|NCT01328093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102227032|NCT01328093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227033|NCT01328093|Dopamine Agonists|dopamine agonists|mesh-ancestor
102227034|NCT01328093|Dopamine Agents|dopamine agents|mesh-ancestor
102227035|NCT01328093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102227036|NCT01328093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227037|NCT01328093|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102227038|NCT01328093|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102227039|NCT01328093|Serotonin Agents|serotonin agents|mesh-ancestor
102227040|NCT01328093|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102227041|NCT01328093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102227042|NCT01328093|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102227043|NCT01328093|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102227044|NCT03417427|Cytarabine|cytarabine|mesh-list
102227045|NCT03417427|Decitabine|decitabine|mesh-list
102227046|NCT03417427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102227047|NCT03417427|Antimetabolites|antimetabolites|mesh-ancestor
102227048|NCT03417427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227049|NCT03417427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102612600|NCT00002159|Amebicides|amebicides|mesh-ancestor
102227050|NCT03417427|Antiviral Agents|antiviral agents|mesh-ancestor
102227051|NCT03417427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102227052|NCT03417427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102227053|NCT03417427|Immunologic Factors|immunologic factors|mesh-ancestor
102227054|NCT03417427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227055|NCT03417427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102227056|NCT03425617|Tiotropium Bromide|tiotropium bromide|mesh-list
102227057|NCT03425617|Olodaterol|olodaterol|mesh-list
102227058|NCT03425617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102227059|NCT03425617|Autonomic Agents|autonomic agents|mesh-ancestor
102227060|NCT03425617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102227061|NCT03425617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227062|NCT03425617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102227063|NCT03425617|Respiratory System Agents|respiratory system agents|mesh-ancestor
102227064|NCT03425617|Parasympatholytics|parasympatholytics|mesh-ancestor
102227065|NCT03425617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102227066|NCT03425617|Cholinergic Agents|cholinergic agents|mesh-ancestor
102227067|NCT03425617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102227068|NCT03425617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227069|NCT03419429|Simvastatin|simvastatin|mesh-list
102227070|NCT03419429|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102227071|NCT03419429|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102227072|NCT03419429|Antimetabolites|antimetabolites|mesh-ancestor
102227073|NCT03419429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227074|NCT03419429|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102227075|NCT03419429|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102227076|NCT03419429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102227077|NCT02654145|Omalizumab|omalizumab|mesh-list
102227078|NCT02654145|Albuterol|albuterol|mesh-list
102227079|NCT02654145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102227080|NCT02654145|Autonomic Agents|autonomic agents|mesh-ancestor
102227081|NCT02654145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102227082|NCT02654145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227083|NCT02654145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102227084|NCT02654145|Respiratory System Agents|respiratory system agents|mesh-ancestor
102227085|NCT02654145|Tocolytic Agents|tocolytic agents|mesh-ancestor
102227086|NCT02654145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102227087|NCT02654145|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102227088|NCT02654145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102227089|NCT02654145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102227090|NCT02654145|Adrenergic Agents|adrenergic agents|mesh-ancestor
101935942|NCT03678532|Anesthetics|anesthetics|mesh-ancestor
102227091|NCT02654145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102227092|NCT02654145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227093|NCT02654145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102227095|NCT05122455|Clopidogrel|clopidogrel|mesh-list
102227096|NCT05122455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102227097|NCT05122455|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102227098|NCT05122455|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102227099|NCT05122455|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102227100|NCT05122455|Purinergic Agents|purinergic agents|mesh-ancestor
102227101|NCT05122455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102227102|NCT05122455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227103|NCT05122455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227104|NCT05122455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102227105|NCT05122455|Antithrombins|antithrombins|mesh-ancestor
102227106|NCT05122455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102227107|NCT05122455|Protease Inhibitors|protease inhibitors|mesh-ancestor
102227108|NCT05122455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102227109|NCT05122455|Anticoagulants|anticoagulants|mesh-ancestor
102227110|NCT03413059|Triamcinolone|triamcinolone|mesh-list
102227111|NCT03413059|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102227112|NCT03413059|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102227113|NCT03413059|Morphine|morphine|mesh-list
102227114|NCT03413059|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102227115|NCT03413059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102227116|NCT03413059|Narcotics|narcotics|mesh-ancestor
102227117|NCT03413059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102227118|NCT03413059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227119|NCT03413059|Analgesics|analgesics|mesh-ancestor
102227120|NCT03413059|Sensory System Agents|sensory system agents|mesh-ancestor
102227121|NCT03413059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102227122|NCT03413059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102227123|NCT03413059|Glucocorticoids|glucocorticoids|mesh-ancestor
102612601|NCT00002159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102227144|NCT03425461|Immunologic Factors|immunologic factors|mesh-ancestor
102227145|NCT03425461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227146|NCT03425461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102227147|NCT03425461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102227148|NCT03425461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227170|NCT03411109|Hydromorphone|hydromorphone|mesh-list
102227171|NCT03411109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102227172|NCT03411109|Narcotics|narcotics|mesh-ancestor
102227173|NCT03411109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102227174|NCT03411109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227175|NCT03411109|Analgesics|analgesics|mesh-ancestor
102227176|NCT03411109|Sensory System Agents|sensory system agents|mesh-ancestor
102227177|NCT03411109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102227178|NCT01111565|Aripiprazole|aripiprazole|mesh-list
102227179|NCT01111565|Escitalopram|escitalopram|mesh-list
102227180|NCT01111565|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102227181|NCT01111565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102227182|NCT01111565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102227183|NCT01111565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227184|NCT01111565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102227185|NCT01111565|Serotonin Agents|serotonin agents|mesh-ancestor
102227186|NCT01111565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227187|NCT01111565|Antidepressive Agents|antidepressive agents|mesh-ancestor
102227188|NCT01111565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102227189|NCT01111565|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102227190|NCT01111565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102227191|NCT01111565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102227192|NCT01111565|Dopamine Agonists|dopamine agonists|mesh-ancestor
102227193|NCT01111565|Dopamine Agents|dopamine agents|mesh-ancestor
102227194|NCT01111565|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102227195|NCT01111565|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102227196|NCT01111565|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102612602|NCT00002159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102612603|NCT00002159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102612604|NCT00002165|Nelfinavir|nelfinavir|mesh-list
102227197|NCT01111565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102227198|NCT01111565|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102227199|NCT01111565|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102227200|NCT04564365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102227201|NCT04564365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102227202|NCT04564365|Adrenergic Agents|adrenergic agents|mesh-ancestor
102227203|NCT04564365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102227204|NCT04564365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227205|NCT04564365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227207|NCT03412513|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102227208|NCT03412513|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102227209|NCT03412513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102227210|NCT03412513|Adrenergic Agents|adrenergic agents|mesh-ancestor
102227211|NCT03412513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102227212|NCT03412513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227213|NCT03412513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227214|NCT03412513|Urological Agents|urological agents|mesh-ancestor
102227215|NCT04370379|Aflibercept|aflibercept|mesh-list
102227216|NCT04370379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102227217|NCT04370379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102227218|NCT04370379|Growth Substances|growth substances|mesh-ancestor
102227219|NCT04370379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227220|NCT04370379|Growth Inhibitors|growth inhibitors|mesh-ancestor
102227221|NCT04370379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102227222|NCT03413891|Tranexamic Acid|tranexamic acid|mesh-list
102227223|NCT03413891|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102227224|NCT03413891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102227225|NCT03413891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227226|NCT03413891|Hemostatics|hemostatics|mesh-ancestor
102227227|NCT03413891|Coagulants|coagulants|mesh-ancestor
102227228|NCT03317613|Capsaicin|capsaicin|mesh-list
102227229|NCT03317613|Antipruritics|antipruritics|mesh-ancestor
102227230|NCT03317613|Dermatologic Agents|dermatologic agents|mesh-ancestor
102227231|NCT03317613|Sensory System Agents|sensory system agents|mesh-ancestor
102227232|NCT03317613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102227233|NCT03317613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227234|NCT03126877|Mitomycins|mitomycins|mesh-list
102227235|NCT03126877|Mitomycin|mitomycin|mesh-list
102227236|NCT03126877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102227237|NCT03126877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102227238|NCT03126877|Alkylating Agents|alkylating agents|mesh-ancestor
102227239|NCT03126877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227240|NCT03126877|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102227241|NCT03126877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102227242|NCT04260477|Rifampin|rifampin|mesh-list
102227243|NCT04260477|Isoniazid|isoniazid|mesh-list
102227244|NCT04260477|Pyrazinamide|pyrazinamide|mesh-list
102227245|NCT04260477|Ethambutol|ethambutol|mesh-list
102227246|NCT04260477|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102227247|NCT04260477|Antitubercular Agents|antitubercular agents|mesh-ancestor
102227248|NCT04260477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102227249|NCT04260477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102227250|NCT04260477|Leprostatic Agents|leprostatic agents|mesh-ancestor
102227251|NCT04260477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102227252|NCT04260477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102227253|NCT04260477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227254|NCT04260477|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102227255|NCT04260477|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102227256|NCT04260477|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102227257|NCT04260477|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102227258|NCT04260477|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102227259|NCT04260477|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102227260|NCT04260477|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102227261|NCT04260477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102227262|NCT04260477|Antimetabolites|antimetabolites|mesh-ancestor
102227263|NCT04260477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102227264|NCT02343458|Glycopyrrolate|glycopyrrolate|mesh-list
102227265|NCT02343458|Formoterol Fumarate|formoterol fumarate|mesh-list
102227266|NCT02343458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102227267|NCT02343458|Autonomic Agents|autonomic agents|mesh-ancestor
102227268|NCT02343458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102227269|NCT02343458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227270|NCT02343458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102612605|NCT00002165|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102227271|NCT02343458|Respiratory System Agents|respiratory system agents|mesh-ancestor
102227272|NCT02343458|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102227273|NCT02343458|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102227274|NCT02343458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101631463|NCT05035927|Psilocybin|psilocybin|mesh-list
102227275|NCT02343458|Adrenergic Agents|adrenergic agents|mesh-ancestor
102227276|NCT02343458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102227277|NCT02343458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227278|NCT02343458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102227279|NCT02343458|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102227280|NCT02343458|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102227281|NCT02343458|Cholinergic Agents|cholinergic agents|mesh-ancestor
102227282|NCT03424759|Osimertinib|osimertinib|mesh-list
102227283|NCT03424759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102227284|NCT03424759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102227285|NCT03424759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102227286|NCT03424759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227287|NCT03413579|Nimotuzumab|nimotuzumab|mesh-list
102227288|NCT03413579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102227289|NCT03413579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102227290|NCT04814745|Morphine|morphine|mesh-list
102227291|NCT04814745|Tramadol|tramadol|mesh-list
102227292|NCT04814745|Ropivacaine|ropivacaine|mesh-list
102227293|NCT04814745|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102227294|NCT04814745|Narcotics|narcotics|mesh-ancestor
102227295|NCT04814745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102227296|NCT04814745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227297|NCT04814745|Analgesics|analgesics|mesh-ancestor
102227298|NCT04814745|Sensory System Agents|sensory system agents|mesh-ancestor
102227299|NCT04814745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102227300|NCT04814745|Anesthetics, Local|anesthetics, local|mesh-ancestor
102227301|NCT04814745|Anesthetics|anesthetics|mesh-ancestor
102227302|NCT04640571|Metformin|metformin|mesh-list
102227303|NCT04640571|Valacyclovir|valacyclovir|mesh-list
102227304|NCT04640571|Enalaprilat|enalaprilat|mesh-list
102227305|NCT04640571|Enalapril|enalapril|mesh-list
102227306|NCT04640571|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
102227307|NCT04640571|Pravastatin|pravastatin|mesh-list
102227308|NCT04640571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102227309|NCT04640571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227310|NCT04640571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102227311|NCT04640571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102227312|NCT04640571|Antimetabolites|antimetabolites|mesh-ancestor
102227313|NCT04640571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227314|NCT04640571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102227315|NCT04640571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102227316|NCT04640571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102227317|NCT04640571|Antiviral Agents|antiviral agents|mesh-ancestor
102227318|NCT04640571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102227319|NCT04640571|Cathartics|cathartics|mesh-ancestor
102227320|NCT04640571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102227321|NCT04640571|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102227322|NCT04640571|Protease Inhibitors|protease inhibitors|mesh-ancestor
102227323|NCT04640571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102227324|NCT04431141|Empagliflozin|empagliflozin|mesh-list
102227325|NCT04431141|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102227326|NCT04431141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227327|NCT04431141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102227328|NCT04431141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227329|NCT05229627|Methylphenidate|methylphenidate|mesh-list
102227330|NCT05229627|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102227331|NCT05229627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102227332|NCT05229627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227333|NCT05229627|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102227334|NCT05229627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102227335|NCT05229627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102227336|NCT05229627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227337|NCT05229627|Dopamine Agents|dopamine agents|mesh-ancestor
102227338|NCT05229627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102227339|NCT05229627|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102227340|NCT05229627|Adrenergic Agents|adrenergic agents|mesh-ancestor
102227341|NCT01976169|Palbociclib|palbociclib|mesh-list
102227342|NCT01976169|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102227343|NCT01976169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102227344|NCT01976169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102227345|NCT01976169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102227346|NCT01976169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227347|NCT01976169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102227348|NCT01976169|Immunotoxins|immunotoxins|mesh-ancestor
102227349|NCT01976169|Immunoconjugates|immunoconjugates|mesh-ancestor
102227350|NCT01976169|Immunologic Factors|immunologic factors|mesh-ancestor
102227351|NCT01976169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227352|NCT01976169|Tubulin Modulators|tubulin modulators|mesh-ancestor
102227353|NCT01976169|Antimitotic Agents|antimitotic agents|mesh-ancestor
102227354|NCT01976169|Mitosis Modulators|mitosis modulators|mesh-ancestor
102227355|NCT00148629|Mebendazole|mebendazole|mesh-list
102227356|NCT00148629|Piperazine|piperazine|mesh-list
102227357|NCT00148629|Piperazine citrate|piperazine citrate|mesh-list
102227358|NCT00148629|DMP 777|dmp 777|mesh-list
102227359|NCT00148629|Antinematodal Agents|antinematodal agents|mesh-ancestor
102227360|NCT00148629|Anthelmintics|anthelmintics|mesh-ancestor
102227361|NCT00148629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102227362|NCT00148629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102227363|NCT00148629|Tubulin Modulators|tubulin modulators|mesh-ancestor
102227364|NCT00148629|Antimitotic Agents|antimitotic agents|mesh-ancestor
102227365|NCT00148629|Mitosis Modulators|mitosis modulators|mesh-ancestor
102227366|NCT00148629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227367|NCT00148629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102227368|NCT00148629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102227369|NCT04448015|Analgesics, Opioid|analgesics, opioid|mesh-list
102227370|NCT04448015|Narcotics|narcotics|mesh-ancestor
102227371|NCT04448015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102227372|NCT04448015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227373|NCT04448015|Analgesics|analgesics|mesh-ancestor
102227374|NCT04448015|Sensory System Agents|sensory system agents|mesh-ancestor
102227375|NCT04448015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102227376|NCT01328041|Dolutegravir|dolutegravir|mesh-list
101631530|NCT04074421|Rifaximin|rifaximin|mesh-list
102227377|NCT01328041|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102227378|NCT01328041|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102227379|NCT01328041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102227380|NCT01328041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227381|NCT01328041|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102227382|NCT01328041|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102227383|NCT01328041|Antiviral Agents|antiviral agents|mesh-ancestor
102227384|NCT01328041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102227385|NCT03412721|Analgesics|analgesics|mesh-list
102227386|NCT03412721|Sensory System Agents|sensory system agents|mesh-ancestor
102227387|NCT03412721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102227388|NCT03412721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227389|NCT03418337|Lansoprazole|lansoprazole|mesh-list
102227390|NCT03418337|Dexlansoprazole|dexlansoprazole|mesh-list
102227391|NCT03418337|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102227392|NCT03418337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102227393|NCT03418337|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102227395|NCT03418337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227396|NCT03411967|Docetaxel|docetaxel|mesh-list
102227397|NCT03411967|Apatinib|apatinib|mesh-list
102227398|NCT03411967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102227399|NCT03411967|Tubulin Modulators|tubulin modulators|mesh-ancestor
102227400|NCT03411967|Antimitotic Agents|antimitotic agents|mesh-ancestor
102227401|NCT03411967|Mitosis Modulators|mitosis modulators|mesh-ancestor
102227402|NCT03411967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227403|NCT03411967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102227404|NCT03411967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102227405|NCT05228925|Vitamin D|vitamin d|mesh-list
102227406|NCT05228925|Vitamins|vitamins|mesh-ancestor
102227407|NCT05228925|Micronutrients|micronutrients|mesh-ancestor
102227408|NCT05228925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227409|NCT05228925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102227410|NCT03412409|Cytarabine|cytarabine|mesh-list
102227411|NCT03412409|Cyclophosphamide|cyclophosphamide|mesh-list
102227412|NCT03412409|Busulfan|busulfan|mesh-list
102227413|NCT03412409|Semustine|semustine|mesh-list
102227414|NCT03412409|Fludarabine|fludarabine|mesh-list
102227415|NCT03412409|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102227416|NCT03412409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102227417|NCT03412409|Immunologic Factors|immunologic factors|mesh-ancestor
102612606|NCT00002165|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102227418|NCT03412409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227419|NCT03412409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102227420|NCT03412409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102227421|NCT03412409|Alkylating Agents|alkylating agents|mesh-ancestor
101901087|NCT01286948|Contraceptive Agents|contraceptive agents|mesh-ancestor
102612607|NCT00002165|Protease Inhibitors|protease inhibitors|mesh-ancestor
102227422|NCT03412409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227423|NCT03412409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102227424|NCT03412409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102227425|NCT03412409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102227426|NCT03412409|Antimetabolites|antimetabolites|mesh-ancestor
102227427|NCT03412409|Antiviral Agents|antiviral agents|mesh-ancestor
102227428|NCT03412409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102227429|NCT02410772|Moxifloxacin|moxifloxacin|mesh-list
102227430|NCT02410772|Rifapentine|rifapentine|mesh-list
102227431|NCT02410772|Rifampin|rifampin|mesh-list
102227432|NCT02410772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102227433|NCT02410772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102227434|NCT02410772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102227435|NCT02410772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102227436|NCT02410772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102227437|NCT02410772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227438|NCT02410772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102227439|NCT02410772|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102227440|NCT02410772|Antitubercular Agents|antitubercular agents|mesh-ancestor
102227441|NCT02410772|Leprostatic Agents|leprostatic agents|mesh-ancestor
102227442|NCT02410772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102227443|NCT02410772|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102227444|NCT02410772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102227445|NCT02410772|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102227446|NCT02410772|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102227447|NCT02410772|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102227448|NCT02410772|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102227449|NCT03814317|Treprostinil|treprostinil|mesh-list
102227450|NCT03814317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102227451|NCT03127319|Docetaxel|docetaxel|mesh-list
102227452|NCT03127319|Apatinib|apatinib|mesh-list
102227453|NCT03127319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102227454|NCT03127319|Tubulin Modulators|tubulin modulators|mesh-ancestor
102227455|NCT03127319|Antimitotic Agents|antimitotic agents|mesh-ancestor
102227456|NCT03127319|Mitosis Modulators|mitosis modulators|mesh-ancestor
102227457|NCT03127319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227458|NCT03127319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102227459|NCT03127319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102227460|NCT03417947|Vitamin D|vitamin d|mesh-list
102227461|NCT03417947|Cholecalciferol|cholecalciferol|mesh-list
102227462|NCT03417947|Vitamins|vitamins|mesh-ancestor
102227463|NCT03417947|Micronutrients|micronutrients|mesh-ancestor
102227464|NCT03417947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227465|NCT03417947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102227466|NCT03417947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102227467|NCT03905811|Terazosin|terazosin|mesh-list
102227468|NCT03905811|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102227469|NCT03905811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102227470|NCT03905811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102227471|NCT03905811|Adrenergic Agents|adrenergic agents|mesh-ancestor
102227472|NCT03905811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102227473|NCT03905811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227474|NCT03905811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227475|NCT03905811|Urological Agents|urological agents|mesh-ancestor
102227476|NCT01648790|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102227477|NCT01648790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102227478|NCT05171309|Apatinib|apatinib|mesh-list
102227479|NCT05171309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102227480|NCT05171309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102227481|NCT05171309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102227482|NCT05171309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227483|NCT03409237|Mannitol|mannitol|mesh-list
102227484|NCT03409237|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102227485|NCT03409237|Diuretics|diuretics|mesh-ancestor
102227486|NCT03409237|Natriuretic Agents|natriuretic agents|mesh-ancestor
102227487|NCT03409237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227488|NCT03408847|Beclomethasone|beclomethasone|mesh-list
102227489|NCT03408847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102227490|NCT03408847|Glucocorticoids|glucocorticoids|mesh-ancestor
102227491|NCT03408847|Hormones|hormones|mesh-ancestor
102227492|NCT03408847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102227493|NCT03408847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769378|NCT00970996|Interferons|interferons|mesh-list
102227495|NCT03408847|Respiratory System Agents|respiratory system agents|mesh-ancestor
102227496|NCT03424291|Apatinib|apatinib|mesh-list
102227497|NCT03424291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102227498|NCT03424291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102227499|NCT03424291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102227500|NCT03424291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227501|NCT04412889|Immunomodulating Agents|immunomodulating agents|mesh-list
102227502|NCT04412889|Immunologic Factors|immunologic factors|mesh-ancestor
102227503|NCT04412889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227504|NCT03407521|Isosorbide|isosorbide|mesh-list
102227505|NCT03407521|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
102227506|NCT03407521|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
102227507|NCT03407521|Misoprostol|misoprostol|mesh-list
102227508|NCT03407521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102227509|NCT03407521|Abortifacient Agents|abortifacient agents|mesh-ancestor
102227510|NCT03407521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102227511|NCT03407521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227512|NCT03407521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102227513|NCT03407521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102227514|NCT03407521|Oxytocics|oxytocics|mesh-ancestor
102227515|NCT03407521|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102227516|NCT03407521|Diuretics|diuretics|mesh-ancestor
102227517|NCT03407521|Natriuretic Agents|natriuretic agents|mesh-ancestor
102227518|NCT03407521|Vasodilator Agents|vasodilator agents|mesh-ancestor
102227519|NCT03407521|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102227520|NCT03407521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227521|NCT03424135|Diphenhydramine|diphenhydramine|mesh-list
102227522|NCT03424135|Promethazine|promethazine|mesh-list
102227523|NCT03424135|Naproxen|naproxen|mesh-list
102227524|NCT03424135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102227525|NCT03424135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102227526|NCT03424135|Analgesics|analgesics|mesh-ancestor
102227527|NCT03424135|Sensory System Agents|sensory system agents|mesh-ancestor
102227528|NCT03424135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102227529|NCT03424135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227530|NCT03424135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102227531|NCT03424135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102227532|NCT03424135|Gout Suppressants|gout suppressants|mesh-ancestor
102227533|NCT03424135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102227534|NCT03424135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102227535|NCT03424135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227536|NCT03424135|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102227537|NCT03424135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102227538|NCT03424135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102227539|NCT03424135|Anesthetics, Local|anesthetics, local|mesh-ancestor
102227540|NCT03424135|Anesthetics|anesthetics|mesh-ancestor
102227541|NCT03424135|Antiemetics|antiemetics|mesh-ancestor
102227542|NCT03424135|Autonomic Agents|autonomic agents|mesh-ancestor
101936399|NCT00049257|Paclitaxel|paclitaxel|mesh-list
102227543|NCT03424135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102227544|NCT03424135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102227545|NCT03424135|Histamine Antagonists|histamine antagonists|mesh-ancestor
102227546|NCT03424135|Histamine Agents|histamine agents|mesh-ancestor
102227547|NCT03424135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102227548|NCT03424135|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102227549|NCT03424135|Antipruritics|antipruritics|mesh-ancestor
102227550|NCT03424135|Dermatologic Agents|dermatologic agents|mesh-ancestor
102227551|NCT03411941|Aflibercept|aflibercept|mesh-list
102227552|NCT03411941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102227553|NCT03411941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102227554|NCT03411941|Growth Substances|growth substances|mesh-ancestor
102227555|NCT03411941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227556|NCT03411941|Growth Inhibitors|growth inhibitors|mesh-ancestor
102227557|NCT03411941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102227558|NCT05170555|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102227559|NCT05170555|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
102227560|NCT05170555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102227561|NCT05170555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227562|NCT03406819|Nitroprusside|nitroprusside|mesh-list
102227563|NCT03406819|Tirofiban|tirofiban|mesh-list
102227564|NCT03406819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102227565|NCT03406819|Vasodilator Agents|vasodilator agents|mesh-ancestor
102227566|NCT03406819|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102227567|NCT03406819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227568|NCT03406819|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102227570|NCT03406819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102227571|NCT05170217|Cannabidiol|cannabidiol|mesh-list
102227572|NCT05170217|Anticonvulsants|anticonvulsants|mesh-ancestor
102227573|NCT03411551|Anesthetics|anesthetics|mesh-list
102227574|NCT03411551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102227575|NCT03411551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227576|NCT05170061|Valsartan|valsartan|mesh-list
102227577|NCT05170061|Nebivolol|nebivolol|mesh-list
102227578|NCT05170061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102227579|NCT05170061|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102227580|NCT05170061|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102227581|NCT05170061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227582|NCT05170061|Vasodilator Agents|vasodilator agents|mesh-ancestor
102227583|NCT05170061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102227584|NCT05170061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102227585|NCT05170061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102227586|NCT05170061|Adrenergic Agents|adrenergic agents|mesh-ancestor
102227587|NCT05170061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102227588|NCT05170061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227589|NCT04235205|Cholestyramine Resin|cholestyramine resin|mesh-list
102227590|NCT04235205|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102227591|NCT04235205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102227592|NCT04235205|Antimetabolites|antimetabolites|mesh-ancestor
102227593|NCT04235205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227594|NCT04235205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102227595|NCT02520635|Temozolomide|temozolomide|mesh-list
102227596|NCT02520635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102227597|NCT02520635|Alkylating Agents|alkylating agents|mesh-ancestor
102227598|NCT02520635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227599|NCT02520635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102227600|NCT03404947|Ethanol|ethanol|mesh-list
102227601|NCT03404947|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102227602|NCT03404947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102227603|NCT03404947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102227604|NCT03404947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227605|NCT03411473|Pembrolizumab|pembrolizumab|mesh-list
102227606|NCT03411473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102227607|NCT03411473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102227608|NCT03411473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102227609|NCT03411473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227610|NCT03423823|Ranibizumab|ranibizumab|mesh-list
102227611|NCT03423823|Aflibercept|aflibercept|mesh-list
102227612|NCT03423823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102227613|NCT03423823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102227614|NCT03423823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102227615|NCT03423823|Growth Substances|growth substances|mesh-ancestor
102227616|NCT03423823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227617|NCT03423823|Growth Inhibitors|growth inhibitors|mesh-ancestor
102227618|NCT03411161|Paclitaxel|paclitaxel|mesh-list
102227619|NCT03411161|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102227620|NCT03411161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102227621|NCT03411161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102227622|NCT03411161|Tubulin Modulators|tubulin modulators|mesh-ancestor
102227623|NCT03411161|Antimitotic Agents|antimitotic agents|mesh-ancestor
102227624|NCT03411161|Mitosis Modulators|mitosis modulators|mesh-ancestor
102227625|NCT03411161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227626|NCT04737603|Buprenorphine|buprenorphine|mesh-list
102227627|NCT04737603|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102227628|NCT04737603|Naloxone|naloxone|mesh-list
102227629|NCT04737603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102227630|NCT04737603|Narcotics|narcotics|mesh-ancestor
102227631|NCT04737603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102227632|NCT04737603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227633|NCT04737603|Analgesics|analgesics|mesh-ancestor
102227634|NCT04737603|Sensory System Agents|sensory system agents|mesh-ancestor
102227635|NCT04737603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102227636|NCT04737603|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102227637|NCT05168137|Colchicine|colchicine|mesh-list
102227638|NCT05168137|Gout Suppressants|gout suppressants|mesh-ancestor
102227639|NCT05168137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102227640|NCT05168137|Tubulin Modulators|tubulin modulators|mesh-ancestor
102227641|NCT05168137|Antimitotic Agents|antimitotic agents|mesh-ancestor
102227642|NCT05168137|Mitosis Modulators|mitosis modulators|mesh-ancestor
102612609|NCT00002165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227643|NCT05168137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227644|NCT05168137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102227645|NCT03410771|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102227646|NCT03410771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102227647|NCT05168059|Clevidipine|clevidipine|mesh-list
102227648|NCT05168059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102227649|NCT05168059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102227650|NCT05168059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227651|NCT05168059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102227652|NCT05168059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227653|NCT02375295|Ciprofloxacin|ciprofloxacin|mesh-list
102227654|NCT02375295|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102227655|NCT02375295|Nitrofurantoin|nitrofurantoin|mesh-list
102227656|NCT02375295|Trimethoprim|trimethoprim|mesh-list
102227657|NCT02375295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102227658|NCT02375295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102227659|NCT02375295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101631687|NCT01000610|Immunologic Factors|immunologic factors|mesh-ancestor
102227660|NCT02375295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102227661|NCT02375295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102227662|NCT02375295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227663|NCT02375295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102227664|NCT02375295|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102227665|NCT02375295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102227666|NCT02375295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102227667|NCT02375295|Antimalarials|antimalarials|mesh-ancestor
102227668|NCT02375295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102227669|NCT02375295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102227670|NCT02375295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102227671|NCT02375295|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102227672|NCT02375295|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102227673|NCT03394105|Docetaxel|docetaxel|mesh-list
102227674|NCT03394105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102227675|NCT03394105|Tubulin Modulators|tubulin modulators|mesh-ancestor
102227676|NCT03394105|Antimitotic Agents|antimitotic agents|mesh-ancestor
102227677|NCT03394105|Mitosis Modulators|mitosis modulators|mesh-ancestor
102227678|NCT03394105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227679|NCT03393949|Methylprednisolone|methylprednisolone|mesh-list
102227680|NCT03393949|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102227681|NCT03393949|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102227682|NCT03393949|Prednisolone|prednisolone|mesh-list
102227683|NCT03393949|Prednisolone acetate|prednisolone acetate|mesh-list
102227684|NCT03393949|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102227685|NCT03393949|Prednisolone phosphate|prednisolone phosphate|mesh-list
102227686|NCT03393949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102227687|NCT03393949|Antiemetics|antiemetics|mesh-ancestor
102227688|NCT03393949|Autonomic Agents|autonomic agents|mesh-ancestor
102227689|NCT03393949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102227690|NCT03393949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227691|NCT03393949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102227692|NCT03393949|Glucocorticoids|glucocorticoids|mesh-ancestor
102227693|NCT03393949|Hormones|hormones|mesh-ancestor
102227694|NCT03393949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102227695|NCT03393949|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102227696|NCT03393949|Protective Agents|protective agents|mesh-ancestor
102227697|NCT03393949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102227698|NCT03393949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102227699|NCT05169125|Dialysis Solutions|dialysis solutions|mesh-list
102227700|NCT05169125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102227701|NCT03818061|Bevacizumab|bevacizumab|mesh-list
102227702|NCT03818061|Atezolizumab|atezolizumab|mesh-list
102227703|NCT03818061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102227704|NCT03818061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102227705|NCT03818061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102227706|NCT03818061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102227707|NCT03818061|Growth Substances|growth substances|mesh-ancestor
101631717|NCT00586924|Immunotoxin HA22|immunotoxin ha22|mesh-list
102227708|NCT03818061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227709|NCT03818061|Growth Inhibitors|growth inhibitors|mesh-ancestor
102227710|NCT03818061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102227711|NCT03818061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227712|NCT03397615|Povidone-Iodine|povidone-iodine|mesh-list
102227713|NCT03397615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101769592|NCT00894621|Norepinephrine|norepinephrine|mesh-list
102612610|NCT00002165|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102227714|NCT03397615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102227715|NCT04435743|Lenalidomide|lenalidomide|mesh-list
102227716|NCT04435743|Immunologic Factors|immunologic factors|mesh-ancestor
102227717|NCT04435743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227718|NCT04435743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102227719|NCT04435743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102227720|NCT04435743|Growth Substances|growth substances|mesh-ancestor
102227721|NCT04435743|Growth Inhibitors|growth inhibitors|mesh-ancestor
102227722|NCT04435743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102227723|NCT03393715|Perindopril|perindopril|mesh-list
102227724|NCT03393715|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102227725|NCT03393715|Protease Inhibitors|protease inhibitors|mesh-ancestor
102227726|NCT03393715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102227727|NCT03393715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227728|NCT03393715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102227729|NCT03397537|Letrozole|letrozole|mesh-list
102227730|NCT03397537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102227731|NCT03397537|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102227732|NCT03397537|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102227733|NCT03397537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102227734|NCT03397537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227735|NCT03397537|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102227736|NCT03397537|Hormone Antagonists|hormone antagonists|mesh-ancestor
102227737|NCT03397537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102227738|NCT03397537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227739|NCT03612921|Amantadine|amantadine|mesh-list
102227740|NCT03612921|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102227741|NCT03612921|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102227742|NCT03612921|Antiviral Agents|antiviral agents|mesh-ancestor
102227743|NCT03612921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102227744|NCT03612921|Dopamine Agents|dopamine agents|mesh-ancestor
102227745|NCT03612921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102227746|NCT03612921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227747|NCT03612921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227748|NCT03612921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102227749|NCT03612921|Analgesics|analgesics|mesh-ancestor
102227750|NCT03612921|Sensory System Agents|sensory system agents|mesh-ancestor
101631746|NCT01000376|Hormone Antagonists|hormone antagonists|mesh-ancestor
102227751|NCT03612921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102227752|NCT03393481|Enoxaparin|enoxaparin|mesh-list
102227753|NCT03393481|Anticoagulants|anticoagulants|mesh-ancestor
102227754|NCT03393481|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102227755|NCT03393481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102227756|NCT03393481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227757|NCT01936857|Buprenorphine|buprenorphine|mesh-list
102227758|NCT01936857|Methadone|methadone|mesh-list
102227759|NCT01936857|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102227760|NCT01936857|Naloxone|naloxone|mesh-list
102227761|NCT01936857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102227762|NCT01936857|Narcotics|narcotics|mesh-ancestor
102227763|NCT01936857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102227764|NCT01936857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227765|NCT01936857|Analgesics|analgesics|mesh-ancestor
102227766|NCT01936857|Sensory System Agents|sensory system agents|mesh-ancestor
102227767|NCT01936857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102227768|NCT01936857|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102227769|NCT01936857|Antitussive Agents|antitussive agents|mesh-ancestor
102227770|NCT01936857|Respiratory System Agents|respiratory system agents|mesh-ancestor
102227771|NCT03393403|Dexmedetomidine|dexmedetomidine|mesh-list
102227772|NCT03393403|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102227773|NCT03393403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102227774|NCT03393403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227775|NCT03393403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102227776|NCT03393403|Analgesics|analgesics|mesh-ancestor
102227777|NCT03393403|Sensory System Agents|sensory system agents|mesh-ancestor
102227778|NCT03393403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102227779|NCT03393403|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102227780|NCT03393403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102227781|NCT03393403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102227782|NCT03393403|Adrenergic Agents|adrenergic agents|mesh-ancestor
102227783|NCT03393403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102227784|NCT03393403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227785|NCT03399955|Amphotericin B|amphotericin b|mesh-list
102227786|NCT03399955|Paromomycin|paromomycin|mesh-list
102227787|NCT03399955|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102227788|NCT03399955|Miltefosine|miltefosine|mesh-list
102227789|NCT03399955|Amebicides|amebicides|mesh-ancestor
102227790|NCT03399955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102227791|NCT03399955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102227792|NCT03399955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102227793|NCT03399955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102227794|NCT03399955|Antifungal Agents|antifungal agents|mesh-ancestor
102227795|NCT03399955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102227797|NCT03397199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102227798|NCT03397199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102227799|NCT03397199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102227800|NCT03397199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227801|NCT05188053|Ketorolac|ketorolac|mesh-list
102227802|NCT05188053|Epinephrine|epinephrine|mesh-list
102227803|NCT05188053|Ropivacaine|ropivacaine|mesh-list
102227804|NCT05188053|Anesthetics, Local|anesthetics, local|mesh-ancestor
102227805|NCT05188053|Anesthetics|anesthetics|mesh-ancestor
102227806|NCT05188053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102227807|NCT05188053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227808|NCT05188053|Sensory System Agents|sensory system agents|mesh-ancestor
102227809|NCT05188053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102227810|NCT05188053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102227811|NCT05188053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102227812|NCT05188053|Adrenergic Agents|adrenergic agents|mesh-ancestor
102227813|NCT05188053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102227814|NCT05188053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227815|NCT05188053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102227816|NCT05188053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102227817|NCT05188053|Autonomic Agents|autonomic agents|mesh-ancestor
102227818|NCT05188053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102227819|NCT05188053|Respiratory System Agents|respiratory system agents|mesh-ancestor
102227820|NCT05188053|Mydriatics|mydriatics|mesh-ancestor
102227821|NCT05188053|Sympathomimetics|sympathomimetics|mesh-ancestor
102227822|NCT05188053|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102227823|NCT05188053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102227824|NCT05188053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102227825|NCT05188053|Analgesics|analgesics|mesh-ancestor
102227826|NCT05188053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102227827|NCT05188053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102227828|NCT05188053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102227829|NCT05188053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102227830|NCT03393325|Tadalafil|tadalafil|mesh-list
102227831|NCT03393325|Vasodilator Agents|vasodilator agents|mesh-ancestor
102227832|NCT03393325|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102227833|NCT03393325|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102227834|NCT03393325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102227835|NCT03393325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227836|NCT03393325|Urological Agents|urological agents|mesh-ancestor
102227837|NCT03399643|Atezolizumab|atezolizumab|mesh-list
102227838|NCT03399643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102227839|NCT03399643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227840|NCT03399643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102227841|NCT03399643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102227842|NCT03393247|Infliximab|infliximab|mesh-list
101936697|NCT03666208|Sirolimus|sirolimus|mesh-list
102227843|NCT03393247|Azathioprine|azathioprine|mesh-list
102227844|NCT03393247|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102227845|NCT03393247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102227846|NCT03393247|Dermatologic Agents|dermatologic agents|mesh-ancestor
102227847|NCT03393247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102227848|NCT03393247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102227849|NCT03393247|Antimetabolites|antimetabolites|mesh-ancestor
102227850|NCT03393247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227851|NCT03393247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102227852|NCT03393247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102227853|NCT03393247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102227854|NCT03393247|Immunologic Factors|immunologic factors|mesh-ancestor
102227855|NCT03393247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227856|NCT03407027|Triamcinolone|triamcinolone|mesh-list
102227857|NCT03407027|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102227858|NCT03407027|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102227859|NCT03407027|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102612611|NCT00002165|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102612612|NCT00002165|Antiviral Agents|antiviral agents|mesh-ancestor
102227860|NCT03407027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102227862|NCT03407027|Hormones|hormones|mesh-ancestor
102227863|NCT03407027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102227864|NCT03407027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227865|NCT03407027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102227866|NCT03407027|Immunologic Factors|immunologic factors|mesh-ancestor
102227867|NCT03407027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102227868|NCT03407027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227869|NCT03343197|Ivosidenib|ivosidenib|mesh-list
102227870|NCT03343197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102227871|NCT03343197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102227872|NCT03343197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227873|NCT01602224|Dexamethasone|dexamethasone|mesh-list
102227874|NCT01602224|Bortezomib|bortezomib|mesh-list
102227875|NCT01602224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102227876|NCT01602224|Antiemetics|antiemetics|mesh-ancestor
102227877|NCT01602224|Autonomic Agents|autonomic agents|mesh-ancestor
102227878|NCT01602224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102227879|NCT01602224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227880|NCT01602224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102227881|NCT01602224|Glucocorticoids|glucocorticoids|mesh-ancestor
102227882|NCT01602224|Hormones|hormones|mesh-ancestor
102227883|NCT01602224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102227884|NCT01602224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102227885|NCT01602224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102227886|NCT03399487|Ceritinib|ceritinib|mesh-list
102227887|NCT03399487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102227888|NCT03399487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102227889|NCT03399487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102227890|NCT03399487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227891|NCT05161429|Insulin|insulin|mesh-list
102227892|NCT05161429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102227893|NCT05161429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227894|NCT03984045|Lidocaine|lidocaine|mesh-list
102227895|NCT03984045|Prochlorperazine|prochlorperazine|mesh-list
102227896|NCT03984045|Anesthetics, Local|anesthetics, local|mesh-ancestor
102227897|NCT03984045|Anesthetics|anesthetics|mesh-ancestor
102227898|NCT03984045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102227899|NCT03984045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227900|NCT03984045|Sensory System Agents|sensory system agents|mesh-ancestor
102227901|NCT03984045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102227902|NCT03984045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102227903|NCT03984045|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102227904|NCT03984045|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102227905|NCT03984045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102227906|NCT03984045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227907|NCT03984045|Antiemetics|antiemetics|mesh-ancestor
102227908|NCT03984045|Autonomic Agents|autonomic agents|mesh-ancestor
102227909|NCT03984045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102227910|NCT03984045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102227911|NCT03984045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102227912|NCT03984045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102227913|NCT03984045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102227914|NCT03984045|Dopamine Agents|dopamine agents|mesh-ancestor
102227915|NCT03984045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102227916|NCT03661047|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
102227917|NCT03661047|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102227918|NCT03661047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102227920|NCT05060991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227921|NCT03399409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102227922|NCT03397069|Midazolam|midazolam|mesh-list
102227923|NCT03397069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102227924|NCT03397069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102227925|NCT03397069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102227926|NCT03397069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227927|NCT03397069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102227928|NCT03397069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102227929|NCT03397069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101631869|NCT02576119|Moxifloxacin|moxifloxacin|mesh-list
102227930|NCT03397069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102227931|NCT03397069|Anesthetics, General|anesthetics, general|mesh-ancestor
102227932|NCT03397069|Anesthetics|anesthetics|mesh-ancestor
102227933|NCT03397069|GABA Modulators|gaba modulators|mesh-ancestor
102227934|NCT03397069|GABA Agents|gaba agents|mesh-ancestor
102227935|NCT03397069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101769817|NCT00359281|Niacin|niacin|mesh-list
102227936|NCT03397069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227937|NCT03396497|Pembrolizumab|pembrolizumab|mesh-list
102227938|NCT03396497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102227939|NCT03396497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102227940|NCT03396497|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102227941|NCT03396497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227942|NCT03399019|Midazolam|midazolam|mesh-list
102227943|NCT03399019|Dexmedetomidine|dexmedetomidine|mesh-list
102227944|NCT03399019|Propofol|propofol|mesh-list
102227945|NCT03399019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102227946|NCT03399019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102227947|NCT03399019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227948|NCT03399019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102227949|NCT03399019|Analgesics|analgesics|mesh-ancestor
102227950|NCT03399019|Sensory System Agents|sensory system agents|mesh-ancestor
102227951|NCT03399019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102227952|NCT03399019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102227953|NCT03399019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102227954|NCT03399019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102227955|NCT03399019|Adrenergic Agents|adrenergic agents|mesh-ancestor
102227956|NCT03399019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102227957|NCT03399019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227958|NCT03399019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102227959|NCT03399019|Anesthetics, General|anesthetics, general|mesh-ancestor
102227960|NCT03399019|Anesthetics|anesthetics|mesh-ancestor
102227961|NCT03399019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102227962|NCT03399019|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102227963|NCT03399019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102227964|NCT03399019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102227965|NCT03399019|GABA Modulators|gaba modulators|mesh-ancestor
102227966|NCT03399019|GABA Agents|gaba agents|mesh-ancestor
102227967|NCT04452383|Ketamine|ketamine|mesh-list
102227968|NCT04452383|Propofol|propofol|mesh-list
102227969|NCT04452383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102227970|NCT04452383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102227971|NCT04452383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227972|NCT04452383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102227973|NCT04452383|Anesthetics, General|anesthetics, general|mesh-ancestor
102227974|NCT04452383|Anesthetics|anesthetics|mesh-ancestor
102227975|NCT04452383|Analgesics|analgesics|mesh-ancestor
102227976|NCT04452383|Sensory System Agents|sensory system agents|mesh-ancestor
102227977|NCT04452383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102227978|NCT04452383|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102227979|NCT04452383|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102227980|NCT04452383|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102227981|NCT04452383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102227982|NCT04452383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102227983|NCT02520479|Pegaspargase|pegaspargase|mesh-list
102227984|NCT02520479|Asparaginase|asparaginase|mesh-list
102227985|NCT02520479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102227986|NCT02520947|Desflurane|desflurane|mesh-list
102227987|NCT02520947|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102227988|NCT02520947|Anesthetics, General|anesthetics, general|mesh-ancestor
102227989|NCT02520947|Anesthetics|anesthetics|mesh-ancestor
102227990|NCT02520947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101936848|NCT03002038|Rituximab|rituximab|mesh-list
102227991|NCT02520947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102227992|NCT03398941|Octreotide|octreotide|mesh-list
102227993|NCT03398941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102227994|NCT03398941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102227995|NCT03398941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102227997|NCT03396601|Analgesics|analgesics|mesh-ancestor
102227998|NCT03396601|Sensory System Agents|sensory system agents|mesh-ancestor
102227999|NCT03396601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102228000|NCT03396601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228001|NCT03396601|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102228002|NCT03396601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102228003|NCT03396601|Anesthetics, General|anesthetics, general|mesh-ancestor
102228004|NCT03396601|Anesthetics|anesthetics|mesh-ancestor
102228005|NCT03396601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102228006|NCT03396601|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102228007|NCT03396601|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102228008|NCT03396601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102612613|NCT00002165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102228009|NCT03396601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228011|NCT03392623|Niacin|niacin|mesh-list
102228012|NCT03392623|Nicotinic Acids|nicotinic acids|mesh-list
102228013|NCT03392623|Tretinoin|tretinoin|mesh-list
102228014|NCT03392623|Sunscreening Agents|sunscreening agents|mesh-list
102228015|NCT03392623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102228016|NCT03392623|Keratolytic Agents|keratolytic agents|mesh-ancestor
102228017|NCT03392623|Dermatologic Agents|dermatologic agents|mesh-ancestor
102228018|NCT03392623|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102228019|NCT03392623|Protective Agents|protective agents|mesh-ancestor
102228020|NCT03392623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228021|NCT03392623|Vitamin B Complex|vitamin b complex|mesh-ancestor
102228022|NCT03392623|Vitamins|vitamins|mesh-ancestor
102228023|NCT03392623|Micronutrients|micronutrients|mesh-ancestor
102228024|NCT03392623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102228025|NCT03392623|Antimetabolites|antimetabolites|mesh-ancestor
102228026|NCT03392623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228027|NCT03392623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102228028|NCT03392623|Vasodilator Agents|vasodilator agents|mesh-ancestor
102228029|NCT03396107|Dexamethasone|dexamethasone|mesh-list
102228030|NCT03396107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102228031|NCT03396107|Antiemetics|antiemetics|mesh-ancestor
102228032|NCT03396107|Autonomic Agents|autonomic agents|mesh-ancestor
102228033|NCT03396107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102228034|NCT03396107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228035|NCT03396107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102228036|NCT03396107|Glucocorticoids|glucocorticoids|mesh-ancestor
102228037|NCT03396107|Hormones|hormones|mesh-ancestor
102228038|NCT03396107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102228039|NCT03396107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102228040|NCT03396107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102228041|NCT03398785|Epinephrine|epinephrine|mesh-list
102228042|NCT03398785|Racepinephrine|racepinephrine|mesh-list
102228043|NCT03398785|Epinephryl borate|epinephryl borate|mesh-list
102228044|NCT03398785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102228045|NCT03398785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102228046|NCT03398785|Adrenergic Agents|adrenergic agents|mesh-ancestor
102228047|NCT03398785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102228048|NCT03398785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228049|NCT03398785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228050|NCT03398785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102228051|NCT03398785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102228052|NCT03398785|Autonomic Agents|autonomic agents|mesh-ancestor
102228053|NCT03398785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102228054|NCT03398785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102228055|NCT03398785|Respiratory System Agents|respiratory system agents|mesh-ancestor
102228056|NCT03398785|Mydriatics|mydriatics|mesh-ancestor
102228057|NCT03398785|Sympathomimetics|sympathomimetics|mesh-ancestor
102228058|NCT03398785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102228059|NCT03392545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
102228060|NCT03392545|Immunologic Factors|immunologic factors|mesh-ancestor
102228061|NCT03392545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228062|NCT03126695|Ticagrelor|ticagrelor|mesh-list
102228063|NCT03126695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102228064|NCT03126695|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102228065|NCT03126695|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101936926|NCT03367312|Xenon|xenon|mesh-list
102228066|NCT03126695|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102228067|NCT03126695|Purinergic Agents|purinergic agents|mesh-ancestor
102228068|NCT03126695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102228069|NCT03126695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228070|NCT03126695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228071|NCT04647643|Paclitaxel|paclitaxel|mesh-list
102228072|NCT04647643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102228073|NCT04647643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102228074|NCT04647643|Tubulin Modulators|tubulin modulators|mesh-ancestor
102228075|NCT04647643|Antimitotic Agents|antimitotic agents|mesh-ancestor
102228076|NCT04647643|Mitosis Modulators|mitosis modulators|mesh-ancestor
102228077|NCT04647643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228078|NCT04167761|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102228079|NCT04167761|Ertugliflozin|ertugliflozin|mesh-list
102228080|NCT04167761|Glipizide|glipizide|mesh-list
102228081|NCT04167761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228082|NCT04167761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102228083|NCT04167761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228084|NCT03401177|Naproxen|naproxen|mesh-list
102612614|NCT00002171|Nelfinavir|nelfinavir|mesh-list
102228085|NCT03401177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102228086|NCT03401177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102228087|NCT03401177|Analgesics|analgesics|mesh-ancestor
102228088|NCT03401177|Sensory System Agents|sensory system agents|mesh-ancestor
102228089|NCT03401177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102228090|NCT03401177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228091|NCT03401177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102228092|NCT03401177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102228093|NCT03401177|Gout Suppressants|gout suppressants|mesh-ancestor
102228094|NCT03401177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102228095|NCT03401177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102228096|NCT03401177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228097|NCT04446715|Sufentanil|sufentanil|mesh-list
102228098|NCT04446715|Meperidine|meperidine|mesh-list
102228099|NCT04446715|Bupivacaine|bupivacaine|mesh-list
102228100|NCT04446715|Anesthetics, Local|anesthetics, local|mesh-ancestor
102228101|NCT04446715|Anesthetics|anesthetics|mesh-ancestor
102228102|NCT04446715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102228103|NCT04446715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228104|NCT04446715|Sensory System Agents|sensory system agents|mesh-ancestor
102228105|NCT04446715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102228106|NCT04446715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102228107|NCT04446715|Narcotics|narcotics|mesh-ancestor
102228108|NCT04446715|Analgesics|analgesics|mesh-ancestor
102228109|NCT04446715|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102228110|NCT04446715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102228111|NCT04446715|Anesthetics, General|anesthetics, general|mesh-ancestor
102228112|NCT03398473|Epoetin Alfa|epoetin alfa|mesh-list
102228113|NCT03398473|Hematinics|hematinics|mesh-ancestor
102228114|NCT03395951|Diuretics|diuretics|mesh-list
102228115|NCT03395951|Natriuretic Agents|natriuretic agents|mesh-ancestor
102228116|NCT03395951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228117|NCT04535791|Vitamin D|vitamin d|mesh-list
102228118|NCT04535791|Cholecalciferol|cholecalciferol|mesh-list
102228119|NCT04535791|Vitamins|vitamins|mesh-ancestor
102228120|NCT04535791|Micronutrients|micronutrients|mesh-ancestor
102228121|NCT04535791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228122|NCT04535791|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102228123|NCT04535791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102228124|NCT03395873|Decitabine|decitabine|mesh-list
102228125|NCT03395873|Avelumab|avelumab|mesh-list
102228126|NCT03395873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102228127|NCT03395873|Antimetabolites|antimetabolites|mesh-ancestor
102228128|NCT03395873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228129|NCT03395873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102228130|NCT03395873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102228131|NCT03395873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102228132|NCT04447625|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102228133|NCT04447625|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102228134|NCT04447625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102228135|NCT04447625|Antitubercular Agents|antitubercular agents|mesh-ancestor
102228136|NCT03396523|Losartan|losartan|mesh-list
102228137|NCT03396523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102228138|NCT03396523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102228139|NCT03396523|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102228140|NCT03396523|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102228141|NCT03396523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228142|NCT03126097|Drospirenone|drospirenone|mesh-list
102228143|NCT03126097|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102228144|NCT03126097|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
102228145|NCT03126097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102228146|NCT03126097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102228147|NCT03126097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102228148|NCT03126097|Contraceptive Agents|contraceptive agents|mesh-ancestor
102228149|NCT03126097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102228150|NCT03126097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228151|NCT03126097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102228152|NCT03126097|Estrogens|estrogens|mesh-ancestor
102228153|NCT03126097|Hormones|hormones|mesh-ancestor
102228154|NCT03126097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102228155|NCT03126097|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102228156|NCT03126097|Hormone Antagonists|hormone antagonists|mesh-ancestor
102228157|NCT03126097|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102228158|NCT03126097|Diuretics|diuretics|mesh-ancestor
102612615|NCT00002171|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102228160|NCT03398083|Alprazolam|alprazolam|mesh-list
102228161|NCT03398083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102228162|NCT03398083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102228163|NCT03398083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228164|NCT03398083|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102228165|NCT03398083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102228166|NCT03398083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102228167|NCT03398083|GABA Modulators|gaba modulators|mesh-ancestor
102228168|NCT03398083|GABA Agents|gaba agents|mesh-ancestor
102228169|NCT03398083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102228170|NCT03398083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228171|NCT03126721|Midazolam|midazolam|mesh-list
102228172|NCT03126721|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102228173|NCT03126721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102228174|NCT03126721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102228175|NCT03126721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228176|NCT03126721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102228177|NCT03126721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102228178|NCT03126721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102228179|NCT03126721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102228180|NCT03126721|Anesthetics, General|anesthetics, general|mesh-ancestor
102228181|NCT03126721|Anesthetics|anesthetics|mesh-ancestor
102228182|NCT03126721|GABA Modulators|gaba modulators|mesh-ancestor
102228183|NCT03126721|GABA Agents|gaba agents|mesh-ancestor
102228184|NCT03126721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102228185|NCT03126721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228186|NCT04928521|Bupivacaine|bupivacaine|mesh-list
102228187|NCT04928521|Anesthetics, Local|anesthetics, local|mesh-ancestor
102228188|NCT04928521|Anesthetics|anesthetics|mesh-ancestor
102228189|NCT04928521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102228190|NCT04928521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228191|NCT04928521|Sensory System Agents|sensory system agents|mesh-ancestor
102228192|NCT04928521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102228193|NCT02823847|Carbon Monoxide|carbon monoxide|mesh-list
102228194|NCT02823847|Antimetabolites|antimetabolites|mesh-ancestor
102228195|NCT02823847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228196|NCT02823847|Gasotransmitters|gasotransmitters|mesh-ancestor
102228197|NCT02823847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102228198|NCT02823847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228199|NCT03391843|Cetuximab|cetuximab|mesh-list
102228200|NCT03391843|Oxaliplatin|oxaliplatin|mesh-list
102228201|NCT03391843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102228202|NCT03391843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102228203|NCT03389659|Vitamin D|vitamin d|mesh-list
102228204|NCT03389659|Cholecalciferol|cholecalciferol|mesh-list
102228205|NCT03389659|Vitamins|vitamins|mesh-ancestor
102228206|NCT03389659|Micronutrients|micronutrients|mesh-ancestor
102228207|NCT03389659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228208|NCT03389659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102228209|NCT03389659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102228210|NCT04446637|Albuterol|albuterol|mesh-list
102228211|NCT04446637|Ipratropium|ipratropium|mesh-list
102228212|NCT04446637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102228213|NCT04446637|Autonomic Agents|autonomic agents|mesh-ancestor
102228214|NCT04446637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102228215|NCT04446637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228216|NCT04446637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102228217|NCT04446637|Respiratory System Agents|respiratory system agents|mesh-ancestor
102228218|NCT04446637|Tocolytic Agents|tocolytic agents|mesh-ancestor
102228219|NCT04446637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102228220|NCT04446637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102228221|NCT04446637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102228222|NCT04446637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102228223|NCT04446637|Adrenergic Agents|adrenergic agents|mesh-ancestor
102228224|NCT04446637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102228225|NCT04446637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228226|NCT04446637|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102228227|NCT04446637|Cholinergic Agents|cholinergic agents|mesh-ancestor
102228228|NCT03395171|Vitamin D|vitamin d|mesh-list
102228229|NCT03395171|Cholecalciferol|cholecalciferol|mesh-list
102228230|NCT03395171|Vitamins|vitamins|mesh-ancestor
102228231|NCT03395171|Micronutrients|micronutrients|mesh-ancestor
102228232|NCT03395171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228233|NCT03395171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101901099|NCT03088826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102228234|NCT03395171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102228236|NCT03395977|Rasburicase|rasburicase|mesh-list
102228237|NCT03395977|Gout Suppressants|gout suppressants|mesh-ancestor
102228238|NCT03395977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102228239|NCT02678143|Mycophenolic Acid|mycophenolic acid|mesh-list
102228240|NCT02678143|Sirolimus|sirolimus|mesh-list
102228241|NCT02678143|Cyclophosphamide|cyclophosphamide|mesh-list
102228242|NCT02678143|Fludarabine|fludarabine|mesh-list
102228243|NCT02678143|Alemtuzumab|alemtuzumab|mesh-list
102228244|NCT02678143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102228245|NCT02678143|Immunologic Factors|immunologic factors|mesh-ancestor
102228246|NCT02678143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228247|NCT02678143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102228248|NCT02678143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102228249|NCT02678143|Alkylating Agents|alkylating agents|mesh-ancestor
102228250|NCT02678143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228251|NCT02678143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102228252|NCT02678143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102228253|NCT02678143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102228254|NCT02678143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102228255|NCT02678143|Antitubercular Agents|antitubercular agents|mesh-ancestor
102228256|NCT02678143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102228257|NCT02678143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102228258|NCT02678143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102228259|NCT02678143|Antifungal Agents|antifungal agents|mesh-ancestor
102228260|NCT02678143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102228261|NCT03395093|Fentanyl|fentanyl|mesh-list
102228262|NCT03395093|Midazolam|midazolam|mesh-list
102228263|NCT03395093|Propofol|propofol|mesh-list
102228264|NCT03395093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102228265|NCT03395093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102228266|NCT03395093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228267|NCT03395093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102228268|NCT03395093|Anesthetics, General|anesthetics, general|mesh-ancestor
102228269|NCT03395093|Anesthetics|anesthetics|mesh-ancestor
102228270|NCT03395093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102228271|NCT03395093|Narcotics|narcotics|mesh-ancestor
102228272|NCT03395093|Analgesics|analgesics|mesh-ancestor
102228273|NCT03395093|Sensory System Agents|sensory system agents|mesh-ancestor
102228274|NCT03395093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102228275|NCT03395093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102228276|NCT03395093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102228277|NCT03395093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102228278|NCT03395093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102228279|NCT03395093|GABA Modulators|gaba modulators|mesh-ancestor
102228280|NCT03395093|GABA Agents|gaba agents|mesh-ancestor
102228281|NCT03395093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102228282|NCT03395093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228283|NCT03389191|Acyclovir|acyclovir|mesh-list
102228284|NCT03389191|Antiviral Agents|antiviral agents|mesh-ancestor
102228285|NCT03389191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102228286|NCT04330183|Ketamine|ketamine|mesh-list
102228287|NCT04330183|Analgesics|analgesics|mesh-ancestor
102228288|NCT04330183|Sensory System Agents|sensory system agents|mesh-ancestor
102228289|NCT04330183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102228290|NCT04330183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228291|NCT04330183|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102228292|NCT04330183|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102228293|NCT04330183|Anesthetics, General|anesthetics, general|mesh-ancestor
102228294|NCT04330183|Anesthetics|anesthetics|mesh-ancestor
102228295|NCT04330183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102228296|NCT04330183|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102228297|NCT04330183|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102228298|NCT04330183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102228299|NCT04330183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228300|NCT03398993|Clomiphene|clomiphene|mesh-list
102228301|NCT03398993|Enclomiphene|enclomiphene|mesh-list
102228302|NCT03398993|Zuclomiphene|zuclomiphene|mesh-list
102228303|NCT03398993|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102228304|NCT03398993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102228305|NCT03398993|Hormone Antagonists|hormone antagonists|mesh-ancestor
102228306|NCT03398993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102228307|NCT03398993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228308|NCT03398993|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102228309|NCT03398993|Fertility Agents|fertility agents|mesh-ancestor
102228310|NCT03398993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102228311|NCT03398993|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102228312|NCT03398993|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102228313|NCT04249297|Dydrogesterone|dydrogesterone|mesh-list
102228314|NCT04249297|Progestins|progestins|mesh-ancestor
102228315|NCT04249297|Hormones|hormones|mesh-ancestor
102228316|NCT04249297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102228317|NCT04249297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228318|NCT03391609|Dexmedetomidine|dexmedetomidine|mesh-list
102228319|NCT03391609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102228320|NCT03391609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102228321|NCT03391609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228322|NCT03391609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102228323|NCT03391609|Analgesics|analgesics|mesh-ancestor
102228324|NCT03391609|Sensory System Agents|sensory system agents|mesh-ancestor
102228325|NCT03391609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102228326|NCT03391609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102228327|NCT03391609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102228328|NCT03391609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102228329|NCT03391609|Adrenergic Agents|adrenergic agents|mesh-ancestor
102228330|NCT03391609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102228331|NCT03391609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228332|NCT03398837|Dronabinol|dronabinol|mesh-list
102228333|NCT03398837|Lenabasum|lenabasum|mesh-list
102228334|NCT03398837|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102228335|NCT03398837|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102228336|NCT03398837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102228337|NCT03398837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228338|NCT03398837|Hormones|hormones|mesh-ancestor
102228339|NCT03398837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102228340|NCT03398837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228341|NCT03398837|Hallucinogens|hallucinogens|mesh-ancestor
102228342|NCT03398837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102228343|NCT03398837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102228344|NCT03398837|Analgesics|analgesics|mesh-ancestor
102228345|NCT03398837|Sensory System Agents|sensory system agents|mesh-ancestor
102228346|NCT03398837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102228347|NCT03398759|Butorphanol|butorphanol|mesh-list
102228348|NCT03398759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102228349|NCT03398759|Narcotics|narcotics|mesh-ancestor
102228350|NCT03398759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102228351|NCT03398759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228352|NCT03398759|Analgesics|analgesics|mesh-ancestor
102228353|NCT03398759|Sensory System Agents|sensory system agents|mesh-ancestor
102228354|NCT03398759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102228355|NCT03398759|Antitussive Agents|antitussive agents|mesh-ancestor
102228356|NCT03398759|Respiratory System Agents|respiratory system agents|mesh-ancestor
102228357|NCT03398759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102228358|NCT03391219|Bevacizumab|bevacizumab|mesh-list
102228359|NCT03391219|Fasudil|fasudil|mesh-list
102228360|NCT03391219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102228361|NCT03391219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102228362|NCT03391219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102228363|NCT03391219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102228364|NCT03391219|Growth Substances|growth substances|mesh-ancestor
102228365|NCT03391219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228366|NCT03391219|Growth Inhibitors|growth inhibitors|mesh-ancestor
102228367|NCT03391219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102228368|NCT03391219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102228369|NCT03391219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228370|NCT03391219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102228371|NCT03391219|Vasodilator Agents|vasodilator agents|mesh-ancestor
102228372|NCT03391219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102228373|NCT03391219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102228374|NCT04446923|Propranolol|propranolol|mesh-list
102228375|NCT04446923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102228376|NCT04446923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102228377|NCT04446923|Adrenergic Agents|adrenergic agents|mesh-ancestor
102228378|NCT04446923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102228379|NCT04446923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228380|NCT04446923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228381|NCT04446923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102228382|NCT04446923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102612616|NCT00002171|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102228383|NCT04446923|Vasodilator Agents|vasodilator agents|mesh-ancestor
102612617|NCT00002171|Protease Inhibitors|protease inhibitors|mesh-ancestor
102612618|NCT00002171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612619|NCT00002171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612620|NCT00002171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102612621|NCT00002171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102612622|NCT00002171|Antiviral Agents|antiviral agents|mesh-ancestor
102612623|NCT00002171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102612624|NCT00002177|Nelfinavir|nelfinavir|mesh-list
102612625|NCT00002177|Stavudine|stavudine|mesh-list
102612626|NCT00002177|Didanosine|didanosine|mesh-list
102612627|NCT00002177|Hydroxyurea|hydroxyurea|mesh-list
102612628|NCT00002177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102612629|NCT00002177|Antisickling Agents|antisickling agents|mesh-ancestor
102612630|NCT00002177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102228384|NCT05237843|Hydroxychloroquine|hydroxychloroquine|mesh-list
102228385|NCT05237843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102228386|NCT05237843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228387|NCT05237843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102228388|NCT05237843|Antimalarials|antimalarials|mesh-ancestor
102228389|NCT05237843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102228390|NCT05237843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102228391|NCT05237843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102228392|NCT04447105|Anesthetics|anesthetics|mesh-list
102228393|NCT04447105|Propofol|propofol|mesh-list
102228394|NCT04447105|Desflurane|desflurane|mesh-list
102228395|NCT04447105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102228396|NCT04447105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228397|NCT04447105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102228398|NCT04447105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102228399|NCT04447105|Anesthetics, General|anesthetics, general|mesh-ancestor
102228400|NCT04447105|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102228401|NCT03126461|Nivolumab|nivolumab|mesh-list
102228402|NCT03126461|Ipilimumab|ipilimumab|mesh-list
102228403|NCT03126461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102228404|NCT03126461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102228405|NCT03126461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102228406|NCT03126461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228407|NCT03389789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102228408|NCT03394001|Ketorolac|ketorolac|mesh-list
102228409|NCT03394001|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102228410|NCT03394001|Lidocaine|lidocaine|mesh-list
102228411|NCT03394001|Anesthetics, Local|anesthetics, local|mesh-ancestor
102228412|NCT03394001|Anesthetics|anesthetics|mesh-ancestor
102228413|NCT03394001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102228414|NCT03394001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228415|NCT03394001|Sensory System Agents|sensory system agents|mesh-ancestor
102228416|NCT03394001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102228417|NCT03394001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102228418|NCT03394001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102228419|NCT03394001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102228420|NCT03394001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102228421|NCT03394001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228422|NCT03394001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102228423|NCT03394001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102228424|NCT03394001|Analgesics|analgesics|mesh-ancestor
102228425|NCT03394001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102228426|NCT03394001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102228427|NCT03394001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102228428|NCT03394001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102228429|NCT03393767|Ranibizumab|ranibizumab|mesh-list
102228430|NCT03393767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102228431|NCT03393767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102228432|NCT03393767|Growth Substances|growth substances|mesh-ancestor
102228433|NCT03393767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228434|NCT03393767|Growth Inhibitors|growth inhibitors|mesh-ancestor
102228435|NCT03393767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102228436|NCT03389321|Macitentan|macitentan|mesh-list
102228437|NCT03389321|Riociguat|riociguat|mesh-list
102228438|NCT03389321|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
102228439|NCT03389321|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102228440|NCT03389321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228441|NCT03389321|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
102612631|NCT00002177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612632|NCT00002177|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102612633|NCT00002177|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102228443|NCT03393377|Valsartan|valsartan|mesh-list
102228444|NCT03393377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102228445|NCT03393377|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102228446|NCT03393377|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102228447|NCT03393377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228448|NCT02421263|Psilocybin|psilocybin|mesh-list
102228449|NCT02421263|Hallucinogens|hallucinogens|mesh-ancestor
102228450|NCT02421263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228451|NCT02421263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102228452|NCT01889303|Docetaxel|docetaxel|mesh-list
102228453|NCT01889303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102228454|NCT01889303|Tubulin Modulators|tubulin modulators|mesh-ancestor
102228455|NCT01889303|Antimitotic Agents|antimitotic agents|mesh-ancestor
102228456|NCT01889303|Mitosis Modulators|mitosis modulators|mesh-ancestor
102228457|NCT01889303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228458|NCT00783263|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102228459|NCT00783263|Ezetimibe|ezetimibe|mesh-list
102228460|NCT00783263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102228461|NCT00783263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102228462|NCT00783263|Antimetabolites|antimetabolites|mesh-ancestor
102228463|NCT00783263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228464|NCT00783263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102228465|NCT00783263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102228466|NCT00783263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102228467|NCT00664937|Montelukast|montelukast|mesh-list
102228468|NCT00664937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102228469|NCT00664937|Respiratory System Agents|respiratory system agents|mesh-ancestor
102228470|NCT00664937|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102228471|NCT00664937|Hormone Antagonists|hormone antagonists|mesh-ancestor
102228472|NCT00664937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102228473|NCT00664937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228474|NCT00664937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102228475|NCT00664937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102228476|NCT00664937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228477|NCT00540839|Fluticasone|fluticasone|mesh-list
102228478|NCT00540839|Xhance|xhance|mesh-list
102228479|NCT00540839|Montelukast|montelukast|mesh-list
102228480|NCT00540839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102228481|NCT00540839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102228482|NCT00540839|Autonomic Agents|autonomic agents|mesh-ancestor
102228483|NCT00540839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102228484|NCT00540839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228485|NCT00540839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102228486|NCT00540839|Respiratory System Agents|respiratory system agents|mesh-ancestor
102228487|NCT00540839|Dermatologic Agents|dermatologic agents|mesh-ancestor
102228488|NCT00540839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102228489|NCT00540839|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102228490|NCT00540839|Hormone Antagonists|hormone antagonists|mesh-ancestor
102228491|NCT00540839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102228492|NCT00540839|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102228493|NCT00540839|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102228494|NCT00540839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228495|NCT03389087|Etoposide|etoposide|mesh-list
102228496|NCT03389087|Apatinib|apatinib|mesh-list
102228497|NCT03389087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102228498|NCT03389087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102228499|NCT03389087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102228500|NCT03389087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102228501|NCT03389087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102228502|NCT03389087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228503|NCT03389087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102228504|NCT03388853|Acetylcysteine|acetylcysteine|mesh-list
102228505|NCT03388853|Doxofylline|doxofylline|mesh-list
102228506|NCT03388853|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102228507|NCT03388853|Antiviral Agents|antiviral agents|mesh-ancestor
102228508|NCT03388853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102228509|NCT03388853|Expectorants|expectorants|mesh-ancestor
102228510|NCT03388853|Respiratory System Agents|respiratory system agents|mesh-ancestor
102228511|NCT03388853|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102228512|NCT03388853|Antioxidants|antioxidants|mesh-ancestor
102228513|NCT03388853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228514|NCT03388853|Protective Agents|protective agents|mesh-ancestor
102228516|NCT03388853|Antidotes|antidotes|mesh-ancestor
102228517|NCT03388853|Antitussive Agents|antitussive agents|mesh-ancestor
102228518|NCT03388853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102228519|NCT03388853|Autonomic Agents|autonomic agents|mesh-ancestor
102228520|NCT03388853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102228521|NCT03388853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102228522|NCT03388853|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102228523|NCT03388853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102228524|NCT00380705|Montelukast|montelukast|mesh-list
102228525|NCT00380705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102228526|NCT00380705|Respiratory System Agents|respiratory system agents|mesh-ancestor
102228527|NCT00380705|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102228528|NCT00380705|Hormone Antagonists|hormone antagonists|mesh-ancestor
102228529|NCT00380705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102228530|NCT00380705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228531|NCT00380705|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102228532|NCT00380705|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102228533|NCT00380705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228534|NCT03388697|Insulin|insulin|mesh-list
102228535|NCT03388697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102228536|NCT03388697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228537|NCT03987919|Tirzepatide|tirzepatide|mesh-list
102228538|NCT03987919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102228539|NCT03987919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228540|NCT03987919|Incretins|incretins|mesh-ancestor
102228541|NCT03987919|Hormones|hormones|mesh-ancestor
102228542|NCT03987919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102228543|NCT03388957|Propranolol|propranolol|mesh-list
102228544|NCT03388957|Midazolam|midazolam|mesh-list
102228545|NCT03388957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102228546|NCT03388957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102228547|NCT03388957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102228548|NCT03388957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228549|NCT03388957|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102228550|NCT03388957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102228551|NCT03388957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102228552|NCT03388957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102228553|NCT03388957|Anesthetics, General|anesthetics, general|mesh-ancestor
102228554|NCT03388957|Anesthetics|anesthetics|mesh-ancestor
102228555|NCT03388957|GABA Modulators|gaba modulators|mesh-ancestor
102228556|NCT03388957|GABA Agents|gaba agents|mesh-ancestor
102228557|NCT03388957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102228558|NCT03388957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228559|NCT03388957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102228560|NCT03388957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102228561|NCT03388957|Adrenergic Agents|adrenergic agents|mesh-ancestor
102228562|NCT03388957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102228563|NCT03388957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102228564|NCT03388957|Vasodilator Agents|vasodilator agents|mesh-ancestor
102228565|NCT03395665|Estradiol|estradiol|mesh-list
102228566|NCT03395665|Progesterone|progesterone|mesh-list
102228567|NCT03395665|Estrogens|estrogens|mesh-ancestor
102228568|NCT03395665|Hormones|hormones|mesh-ancestor
102228569|NCT03395665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102228570|NCT03395665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228571|NCT03395665|Progestins|progestins|mesh-ancestor
102228572|NCT00535405|Atorvastatin|atorvastatin|mesh-list
102228573|NCT00535405|Simvastatin|simvastatin|mesh-list
102228574|NCT00535405|Ezetimibe|ezetimibe|mesh-list
102228575|NCT00535405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102228576|NCT00535405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102228577|NCT00535405|Antimetabolites|antimetabolites|mesh-ancestor
102228578|NCT00535405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228579|NCT00535405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102228580|NCT00535405|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102228581|NCT00535405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102228582|NCT03390595|Carboplatin|carboplatin|mesh-list
102228583|NCT03390595|Gemcitabine|gemcitabine|mesh-list
102228584|NCT03390595|Avelumab|avelumab|mesh-list
102228585|NCT03390595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102228586|NCT03390595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102228587|NCT03390595|Antimetabolites|antimetabolites|mesh-ancestor
102228588|NCT03390595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228589|NCT03390595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102612634|NCT00002177|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102228590|NCT00271817|Niacin|niacin|mesh-list
102228591|NCT00271817|Niacinamide|niacinamide|mesh-list
102228592|NCT00271817|Nicotinic Acids|nicotinic acids|mesh-list
102228593|NCT00271817|Simvastatin|simvastatin|mesh-list
102228594|NCT00271817|Ezetimibe|ezetimibe|mesh-list
101937442|NCT05974423|Ibuprofen|ibuprofen|mesh-list
102228595|NCT00271817|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
102228596|NCT00271817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102228597|NCT00271817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102228598|NCT00271817|Antimetabolites|antimetabolites|mesh-ancestor
102228599|NCT00271817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228600|NCT00271817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102228601|NCT00271817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101289625|NCT05875519|Nordefrin|nordefrin|mesh-list
102228602|NCT00271817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102228603|NCT00271817|Vasodilator Agents|vasodilator agents|mesh-ancestor
102228604|NCT00271817|Vitamin B Complex|vitamin b complex|mesh-ancestor
102228605|NCT00271817|Vitamins|vitamins|mesh-ancestor
102228606|NCT00271817|Micronutrients|micronutrients|mesh-ancestor
102228607|NCT00271817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228608|NCT03388541|Dexmedetomidine|dexmedetomidine|mesh-list
102228609|NCT03388541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102228610|NCT03388541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102228611|NCT03388541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228612|NCT03388541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102228613|NCT03388541|Analgesics|analgesics|mesh-ancestor
102228614|NCT03388541|Sensory System Agents|sensory system agents|mesh-ancestor
102228615|NCT03388541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102228616|NCT03388541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102228617|NCT03388541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102228618|NCT03388541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102228619|NCT03388541|Adrenergic Agents|adrenergic agents|mesh-ancestor
102228620|NCT03388541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102228621|NCT03388541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228622|NCT00092989|Montelukast|montelukast|mesh-list
102228623|NCT00092989|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102228624|NCT00092989|Respiratory System Agents|respiratory system agents|mesh-ancestor
102228625|NCT00092989|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102228626|NCT00092989|Hormone Antagonists|hormone antagonists|mesh-ancestor
102228627|NCT00092989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102228628|NCT00092989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228629|NCT00092989|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102228630|NCT00092989|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102228631|NCT00092989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228632|NCT03388463|Omeprazole|omeprazole|mesh-list
102228633|NCT03388463|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102228634|NCT03388463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102228635|NCT03388463|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102228636|NCT03388463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102228637|NCT03388463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228638|NCT03858049|Dydrogesterone|dydrogesterone|mesh-list
102228639|NCT03858049|Progestins|progestins|mesh-ancestor
102228640|NCT03858049|Hormones|hormones|mesh-ancestor
102228641|NCT03858049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102228642|NCT03858049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228643|NCT03388151|Midazolam|midazolam|mesh-list
102228644|NCT03388151|Propofol|propofol|mesh-list
102228645|NCT03388151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102228646|NCT03388151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102228647|NCT03388151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228648|NCT03388151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102228649|NCT03388151|Anesthetics, General|anesthetics, general|mesh-ancestor
102228650|NCT03388151|Anesthetics|anesthetics|mesh-ancestor
102228651|NCT03388151|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102228652|NCT03388151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102228653|NCT03388151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102228654|NCT03388151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102228655|NCT03388151|GABA Modulators|gaba modulators|mesh-ancestor
102228656|NCT03388151|GABA Agents|gaba agents|mesh-ancestor
102228657|NCT03388151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102228658|NCT03388151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228659|NCT03392909|Gentamicins|gentamicins|mesh-list
102228660|NCT03392909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102228661|NCT03392909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102228662|NCT03392909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102612635|NCT00002177|Protease Inhibitors|protease inhibitors|mesh-ancestor
102612636|NCT00002177|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102228663|NCT03392909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102228664|NCT03392909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228665|NCT04501211|Granisetron|granisetron|mesh-list
102228666|NCT04501211|Antiemetics|antiemetics|mesh-ancestor
102228667|NCT04501211|Autonomic Agents|autonomic agents|mesh-ancestor
102228668|NCT04501211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102228669|NCT04501211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228671|NCT04501211|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102228672|NCT04501211|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102228673|NCT04501211|Serotonin Agents|serotonin agents|mesh-ancestor
102228674|NCT04501211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102228675|NCT04501211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228676|NCT03126071|Bevacizumab|bevacizumab|mesh-list
102228677|NCT03126071|Oxaliplatin|oxaliplatin|mesh-list
102228678|NCT03126071|Irinotecan|irinotecan|mesh-list
102228679|NCT03126071|Raltitrexed|raltitrexed|mesh-list
102228680|NCT03126071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102228681|NCT03126071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102228682|NCT03126071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102228683|NCT03126071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102228684|NCT03126071|Growth Substances|growth substances|mesh-ancestor
102228685|NCT03126071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228686|NCT03126071|Growth Inhibitors|growth inhibitors|mesh-ancestor
102228687|NCT03126071|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102228688|NCT03126071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102228689|NCT03126071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102228690|NCT03126071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228691|NCT03126071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102228692|NCT03126071|Antimetabolites|antimetabolites|mesh-ancestor
102228693|NCT03126071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102228694|NCT03392051|Clopidogrel|clopidogrel|mesh-list
102228695|NCT03392051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102228696|NCT03392051|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102228697|NCT03392051|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102228698|NCT03392051|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102228699|NCT03392051|Purinergic Agents|purinergic agents|mesh-ancestor
102228700|NCT03392051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102228701|NCT03392051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228702|NCT03392051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228703|NCT04446533|Chlorhexidine|chlorhexidine|mesh-list
102228704|NCT04446533|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102228705|NCT04446533|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102228706|NCT04446533|Hyaluronic Acid|hyaluronic acid|mesh-list
102228707|NCT04446533|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102228708|NCT04446533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102228709|NCT04446533|Disinfectants|disinfectants|mesh-ancestor
102228710|NCT04446533|Dermatologic Agents|dermatologic agents|mesh-ancestor
102228711|NCT04446533|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102228712|NCT04446533|Immunologic Factors|immunologic factors|mesh-ancestor
102228713|NCT04446533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228714|NCT04446533|Viscosupplements|viscosupplements|mesh-ancestor
102228715|NCT04446533|Protective Agents|protective agents|mesh-ancestor
102228716|NCT03386591|Naloxone|naloxone|mesh-list
102228717|NCT03386591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102228718|NCT03386591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228719|NCT03386591|Sensory System Agents|sensory system agents|mesh-ancestor
102228720|NCT03386591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102228721|NCT03386279|Moxifloxacin|moxifloxacin|mesh-list
102228722|NCT03386279|Abrocitinib|abrocitinib|mesh-list
102228723|NCT03386279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102228724|NCT03386279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102228725|NCT03386279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102228726|NCT03386279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102228727|NCT03386279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102228728|NCT03386279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228729|NCT03386279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102228730|NCT03386279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102228731|NCT03386201|Methylene Blue|methylene blue|mesh-list
102228732|NCT03386201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102228733|NCT03386201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228734|NCT03268811|Teduglutide|teduglutide|mesh-list
102228735|NCT03268811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102228737|NCT03268811|Protective Agents|protective agents|mesh-ancestor
102228738|NCT03268811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228739|NCT03385967|Dexmedetomidine|dexmedetomidine|mesh-list
102228740|NCT03385967|Ropivacaine|ropivacaine|mesh-list
102228741|NCT03385967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102228742|NCT03385967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102228743|NCT03385967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228744|NCT03385967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102228745|NCT03385967|Analgesics|analgesics|mesh-ancestor
102228746|NCT03385967|Sensory System Agents|sensory system agents|mesh-ancestor
102228747|NCT03385967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102228748|NCT03385967|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102228749|NCT03385967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102228750|NCT03385967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102228751|NCT03385967|Adrenergic Agents|adrenergic agents|mesh-ancestor
102228752|NCT03385967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102228753|NCT03385967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228754|NCT03385967|Anesthetics, Local|anesthetics, local|mesh-ancestor
102228755|NCT03385967|Anesthetics|anesthetics|mesh-ancestor
102228756|NCT02732015|Dexamethasone|dexamethasone|mesh-list
102228757|NCT02732015|Dexamethasone acetate|dexamethasone acetate|mesh-list
102228758|NCT02732015|Doxorubicin|doxorubicin|mesh-list
102228759|NCT02732015|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102228760|NCT02732015|Vincristine|vincristine|mesh-list
102228761|NCT02732015|Daunorubicin|daunorubicin|mesh-list
102228762|NCT02732015|Ifosfamide|ifosfamide|mesh-list
102228763|NCT02732015|Isophosphamide mustard|isophosphamide mustard|mesh-list
102228764|NCT02732015|Ondansetron|ondansetron|mesh-list
102228765|NCT02732015|Fosaprepitant|fosaprepitant|mesh-list
102228766|NCT02732015|Aprepitant|aprepitant|mesh-list
102228767|NCT02732015|BB 1101|bb 1101|mesh-list
102228768|NCT02732015|Rolapitant|rolapitant|mesh-list
102228769|NCT02732015|Mesna|mesna|mesh-list
102228770|NCT02732015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102228771|NCT02732015|Antiemetics|antiemetics|mesh-ancestor
102228772|NCT02732015|Autonomic Agents|autonomic agents|mesh-ancestor
102228773|NCT02732015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102228774|NCT02732015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228775|NCT02732015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102228776|NCT02732015|Glucocorticoids|glucocorticoids|mesh-ancestor
102228777|NCT02732015|Hormones|hormones|mesh-ancestor
102228778|NCT02732015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102228779|NCT02732015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102228780|NCT02732015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102228781|NCT02732015|Protease Inhibitors|protease inhibitors|mesh-ancestor
102228782|NCT02732015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102228783|NCT02732015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228784|NCT02732015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102228785|NCT02732015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102228786|NCT02732015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102228787|NCT02732015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102228788|NCT02732015|Tubulin Modulators|tubulin modulators|mesh-ancestor
102228789|NCT02732015|Antimitotic Agents|antimitotic agents|mesh-ancestor
102228790|NCT02732015|Mitosis Modulators|mitosis modulators|mesh-ancestor
102228791|NCT02732015|Antipruritics|antipruritics|mesh-ancestor
102228792|NCT02732015|Dermatologic Agents|dermatologic agents|mesh-ancestor
102228793|NCT02732015|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102228794|NCT02732015|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102228795|NCT02732015|Serotonin Agents|serotonin agents|mesh-ancestor
102228796|NCT02732015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102228797|NCT02732015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102228798|NCT02732015|Alkylating Agents|alkylating agents|mesh-ancestor
102228799|NCT02732015|Protective Agents|protective agents|mesh-ancestor
102228800|NCT02732015|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102228801|NCT02520245|Cemiplimab|cemiplimab|mesh-list
101632624|NCT04369664|Ezetimibe|ezetimibe|mesh-list
102228802|NCT02520245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102228803|NCT02520245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102228804|NCT03537833|Pemetrexed|pemetrexed|mesh-list
102228805|NCT03537833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102228806|NCT03537833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102228807|NCT03537833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228808|NCT03537833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102228809|NCT03537833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102228810|NCT03439085|Durvalumab|durvalumab|mesh-list
102228811|NCT03439085|Interleukin-12|interleukin-12|mesh-list
102228812|NCT03439085|Vaccines|vaccines|mesh-list
102228813|NCT03439085|Immunoglobulins|immunoglobulins|mesh-list
102612637|NCT00002177|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102228814|NCT03439085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102228815|NCT03439085|Immunoglobulin G|immunoglobulin g|mesh-list
102228816|NCT03439085|Immunologic Factors|immunologic factors|mesh-ancestor
102228817|NCT03439085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228818|NCT03439085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102228819|NCT03439085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102228820|NCT03439085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102228821|NCT03439085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102228822|NCT03439085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102228823|NCT03439085|Growth Substances|growth substances|mesh-ancestor
102228824|NCT03439085|Growth Inhibitors|growth inhibitors|mesh-ancestor
102228825|NCT01964807|Nicotine|nicotine|mesh-list
102228826|NCT01964807|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102228827|NCT01964807|Autonomic Agents|autonomic agents|mesh-ancestor
102228828|NCT01964807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102228829|NCT01964807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228830|NCT01964807|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102228831|NCT01964807|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102228832|NCT01964807|Cholinergic Agents|cholinergic agents|mesh-ancestor
102228833|NCT01964807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102228834|NCT01964807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228835|NCT01164995|Carboplatin|carboplatin|mesh-list
102228836|NCT01164995|Adavosertib|adavosertib|mesh-list
102228837|NCT01164995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102228838|NCT01164995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102228839|NCT01164995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228840|NCT00999401|Roscovitine|roscovitine|mesh-list
102228841|NCT00999401|Sapacitabine|sapacitabine|mesh-list
102228842|NCT00999401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102228843|NCT00999401|Antiviral Agents|antiviral agents|mesh-ancestor
102228844|NCT00999401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102228845|NCT00999401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102228846|NCT00999401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102228847|NCT00999401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228848|NCT04446065|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
102228849|NCT04446065|Antioxidants|antioxidants|mesh-ancestor
102228850|NCT04446065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228851|NCT04446065|Protective Agents|protective agents|mesh-ancestor
102228852|NCT04446065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228853|NCT04446065|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
102228854|NCT04446065|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102228855|NCT04446065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102228856|NCT04446065|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102228857|NCT00225095|Hyaluronic Acid|hyaluronic acid|mesh-list
102228858|NCT00225095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102228859|NCT00225095|Immunologic Factors|immunologic factors|mesh-ancestor
102228860|NCT00225095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228861|NCT00225095|Viscosupplements|viscosupplements|mesh-ancestor
102228862|NCT00225095|Protective Agents|protective agents|mesh-ancestor
102228863|NCT02732119|Everolimus|everolimus|mesh-list
102228864|NCT02732119|Exemestane|exemestane|mesh-list
102228865|NCT02732119|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102228866|NCT02732119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102228867|NCT02732119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102228868|NCT02732119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228869|NCT02732119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102228870|NCT02732119|Immunologic Factors|immunologic factors|mesh-ancestor
102228871|NCT02732119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228872|NCT02732119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102228873|NCT02732119|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102228874|NCT02732119|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102228875|NCT02732119|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102228876|NCT02732119|Hormone Antagonists|hormone antagonists|mesh-ancestor
102228877|NCT02732119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102228878|NCT04448717|Antibodies|antibodies|mesh-list
102228879|NCT04448717|Immunologic Factors|immunologic factors|mesh-ancestor
102228880|NCT04448717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228881|NCT05174195|Desogestrel|desogestrel|mesh-list
102228882|NCT05174195|Etonogestrel|etonogestrel|mesh-list
102612638|NCT00002177|Antiviral Agents|antiviral agents|mesh-ancestor
102228883|NCT05174195|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102228884|NCT05174195|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102228885|NCT05174195|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102228886|NCT05174195|Contraceptive Agents|contraceptive agents|mesh-ancestor
102612639|NCT00002177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102228887|NCT05174195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102228888|NCT05174195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228889|NCT05174195|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102228890|NCT05174195|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102228891|NCT05174195|Progestins|progestins|mesh-ancestor
102228892|NCT05174195|Hormones|hormones|mesh-ancestor
102228893|NCT05174195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102228894|NCT05238727|Mepivacaine|mepivacaine|mesh-list
102228895|NCT05238727|Carticaine|carticaine|mesh-list
102228896|NCT05238727|Anesthetics, Local|anesthetics, local|mesh-ancestor
102228897|NCT05238727|Anesthetics|anesthetics|mesh-ancestor
102228898|NCT05238727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102228899|NCT05238727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228900|NCT05238727|Sensory System Agents|sensory system agents|mesh-ancestor
102228901|NCT05238727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102228902|NCT03754153|Atropine|atropine|mesh-list
102228903|NCT03754153|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102228904|NCT03754153|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102228905|NCT03754153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102228906|NCT03754153|Autonomic Agents|autonomic agents|mesh-ancestor
102228907|NCT03754153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102228908|NCT03754153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228909|NCT03754153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102228910|NCT03754153|Respiratory System Agents|respiratory system agents|mesh-ancestor
102228911|NCT03754153|Mydriatics|mydriatics|mesh-ancestor
102228912|NCT03754153|Parasympatholytics|parasympatholytics|mesh-ancestor
102228913|NCT03754153|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102228914|NCT03754153|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102228915|NCT03754153|Cholinergic Agents|cholinergic agents|mesh-ancestor
102228916|NCT03754153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102228917|NCT03754153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228918|NCT03380039|Cyclophosphamide|cyclophosphamide|mesh-list
102228919|NCT03380039|Fludarabine|fludarabine|mesh-list
102228920|NCT03380039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102228921|NCT03380039|Immunologic Factors|immunologic factors|mesh-ancestor
102228922|NCT03380039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228923|NCT03380039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102228924|NCT03380039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102228925|NCT03380039|Alkylating Agents|alkylating agents|mesh-ancestor
102228926|NCT03380039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228927|NCT03380039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102228928|NCT03380039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102228929|NCT03125213|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102228930|NCT03125213|Antiviral Agents|antiviral agents|mesh-ancestor
102228931|NCT03125213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102228932|NCT02520817|Vitamins|vitamins|mesh-list
102228933|NCT02520817|Vitamin E|vitamin e|mesh-list
102228934|NCT02520817|Vitamin A|vitamin a|mesh-list
102228935|NCT02520817|Lactulose|lactulose|mesh-list
102228936|NCT02520817|Micronutrients|micronutrients|mesh-ancestor
102228937|NCT02520817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228938|NCT02520817|Antioxidants|antioxidants|mesh-ancestor
102228939|NCT02520817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228940|NCT02520817|Protective Agents|protective agents|mesh-ancestor
102228941|NCT02520817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102228942|NCT03387943|Cisplatin|cisplatin|mesh-list
102228943|NCT03387943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102228944|NCT03384095|Hyaluronic Acid|hyaluronic acid|mesh-list
102228945|NCT03384095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102228946|NCT03384095|Immunologic Factors|immunologic factors|mesh-ancestor
102228947|NCT03384095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228948|NCT03384095|Viscosupplements|viscosupplements|mesh-ancestor
102228949|NCT03384095|Protective Agents|protective agents|mesh-ancestor
102228950|NCT03379181|Propranolol|propranolol|mesh-list
102228951|NCT03379181|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102228952|NCT03379181|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102228953|NCT03379181|Adrenergic Agents|adrenergic agents|mesh-ancestor
102228954|NCT03379181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102228955|NCT03379181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228956|NCT03379181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228957|NCT03379181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102228958|NCT03379181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102228959|NCT03379181|Vasodilator Agents|vasodilator agents|mesh-ancestor
102228960|NCT03383939|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
102612641|NCT00002177|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102228961|NCT03383939|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102228962|NCT03383939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102228963|NCT03383939|Protease Inhibitors|protease inhibitors|mesh-ancestor
102228964|NCT03383939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102228965|NCT03383939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228966|NCT03379103|Propofol|propofol|mesh-list
102228967|NCT03379103|Sevoflurane|sevoflurane|mesh-list
102228968|NCT03379103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102228969|NCT03379103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102228970|NCT03379103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228971|NCT03379103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102228972|NCT03379103|Anesthetics, General|anesthetics, general|mesh-ancestor
102228973|NCT03379103|Anesthetics|anesthetics|mesh-ancestor
102228974|NCT03379103|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102228975|NCT03379103|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102228976|NCT03387631|Lumefantrine|lumefantrine|mesh-list
102228977|NCT03387631|Artemether|artemether|mesh-list
102228978|NCT03387631|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102228979|NCT03387631|Antimalarials|antimalarials|mesh-ancestor
102228980|NCT03387631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102228981|NCT03387631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102228982|NCT03387631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102228983|NCT03383393|Adenosine|adenosine|mesh-list
102228984|NCT03383393|Eptifibatide|eptifibatide|mesh-list
102228985|NCT03383393|Analgesics|analgesics|mesh-ancestor
102228986|NCT03383393|Sensory System Agents|sensory system agents|mesh-ancestor
102228987|NCT03383393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102228988|NCT03383393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102228989|NCT03383393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102228990|NCT03383393|Vasodilator Agents|vasodilator agents|mesh-ancestor
102228991|NCT03383393|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102228992|NCT03383393|Purinergic Agonists|purinergic agonists|mesh-ancestor
102228993|NCT03383393|Purinergic Agents|purinergic agents|mesh-ancestor
102228994|NCT03383393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102228995|NCT03383393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102228996|NCT03383393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102228997|NCT03394807|Levobupivacaine|levobupivacaine|mesh-list
102228998|NCT03394807|Anesthetics, Local|anesthetics, local|mesh-ancestor
102228999|NCT03394807|Anesthetics|anesthetics|mesh-ancestor
102229000|NCT03394807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102229001|NCT03394807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229002|NCT03394807|Sensory System Agents|sensory system agents|mesh-ancestor
102229003|NCT03394807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102229004|NCT03383315|Tramadol|tramadol|mesh-list
102229005|NCT03383315|Metoclopramide|metoclopramide|mesh-list
102229006|NCT03383315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102229007|NCT03383315|Narcotics|narcotics|mesh-ancestor
102229008|NCT03383315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102229009|NCT03383315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229010|NCT03383315|Analgesics|analgesics|mesh-ancestor
102229011|NCT03383315|Sensory System Agents|sensory system agents|mesh-ancestor
102229012|NCT03383315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102229013|NCT03383315|Antiemetics|antiemetics|mesh-ancestor
102229014|NCT03383315|Autonomic Agents|autonomic agents|mesh-ancestor
102229015|NCT03383315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102229016|NCT03383315|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102229017|NCT03383315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102229018|NCT03383315|Dopamine Agents|dopamine agents|mesh-ancestor
102229019|NCT03383315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102229020|NCT03383315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229021|NCT03394729|Propolis|propolis|mesh-list
102229022|NCT03394729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102229023|NCT03252925|Acetylcysteine|acetylcysteine|mesh-list
102229024|NCT03252925|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102229025|NCT03252925|Antiviral Agents|antiviral agents|mesh-ancestor
102229026|NCT03252925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102229027|NCT03252925|Expectorants|expectorants|mesh-ancestor
102229028|NCT03252925|Respiratory System Agents|respiratory system agents|mesh-ancestor
102229029|NCT03252925|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102229030|NCT03252925|Antioxidants|antioxidants|mesh-ancestor
102229031|NCT03252925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229032|NCT03252925|Protective Agents|protective agents|mesh-ancestor
102229033|NCT03252925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229034|NCT03252925|Antidotes|antidotes|mesh-ancestor
102229035|NCT03383237|Apatinib|apatinib|mesh-list
102229036|NCT03383237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102229037|NCT03383237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102229038|NCT03383237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102229039|NCT03383237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229040|NCT03387241|Fluticasone|fluticasone|mesh-list
102229041|NCT03387241|Xhance|xhance|mesh-list
102229042|NCT03387241|Formoterol Fumarate|formoterol fumarate|mesh-list
102229043|NCT03387241|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102229044|NCT03387241|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102229045|NCT03387241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102229046|NCT03387241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102229047|NCT03387241|Autonomic Agents|autonomic agents|mesh-ancestor
102229048|NCT03387241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102229049|NCT03387241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229050|NCT03387241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102229051|NCT03387241|Respiratory System Agents|respiratory system agents|mesh-ancestor
102229052|NCT03387241|Dermatologic Agents|dermatologic agents|mesh-ancestor
102229053|NCT03387241|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102229054|NCT03387241|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102229055|NCT03387241|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102229056|NCT03387241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102229057|NCT03387241|Adrenergic Agents|adrenergic agents|mesh-ancestor
102229058|NCT03387241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102229059|NCT03387241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229060|NCT03387241|Glucocorticoids|glucocorticoids|mesh-ancestor
102229061|NCT03387241|Hormones|hormones|mesh-ancestor
102229062|NCT03387241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102229063|NCT03387241|Sympathomimetics|sympathomimetics|mesh-ancestor
102229064|NCT03378791|Ferrous fumarate|ferrous fumarate|mesh-list
102229065|NCT03378791|Trace Elements|trace elements|mesh-ancestor
102229066|NCT03378791|Micronutrients|micronutrients|mesh-ancestor
102229067|NCT03378791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229068|NCT03383003|Amoxicillin|amoxicillin|mesh-list
102229069|NCT03383003|Metronidazole|metronidazole|mesh-list
102229070|NCT03383003|Clarithromycin|clarithromycin|mesh-list
102229071|NCT03383003|Esomeprazole|esomeprazole|mesh-list
102229072|NCT03383003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102229073|NCT03383003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102229074|NCT03383003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102229075|NCT03383003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102229076|NCT03383003|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102229077|NCT03383003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102229078|NCT03383003|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102229079|NCT03383003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102229080|NCT03383003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229081|NCT03383003|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102229082|NCT03383003|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102229083|NCT03383003|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102229084|NCT03378713|Methyltestosterone|methyltestosterone|mesh-list
102229085|NCT03378713|Testosterone|testosterone|mesh-list
102229086|NCT03378713|Testosterone undecanoate|testosterone undecanoate|mesh-list
102229087|NCT03378713|Testosterone enanthate|testosterone enanthate|mesh-list
102229088|NCT03378713|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102229089|NCT03378713|Androgens|androgens|mesh-ancestor
102229090|NCT03378713|Hormones|hormones|mesh-ancestor
102229091|NCT03378713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102229092|NCT03378713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229093|NCT03378713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102229094|NCT03378713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102229095|NCT03378713|Anabolic Agents|anabolic agents|mesh-ancestor
102229096|NCT03378401|Octenidine|octenidine|mesh-list
102229097|NCT03378401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102229098|NCT03378401|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102229099|NCT03378323|Anesthetics|anesthetics|mesh-list
102229100|NCT03378323|Anesthetics, Local|anesthetics, local|mesh-list
102229101|NCT03378323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102229102|NCT03378323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229103|NCT03378323|Sensory System Agents|sensory system agents|mesh-ancestor
102229104|NCT03378323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102229105|NCT01327885|Dacarbazine|dacarbazine|mesh-list
102229106|NCT01327885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102229107|NCT01327885|Alkylating Agents|alkylating agents|mesh-ancestor
102229108|NCT01327885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229109|NCT01327885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102612642|NCT00002183|Lamivudine|lamivudine|mesh-list
102612643|NCT00002183|Zidovudine|zidovudine|mesh-list
102612644|NCT00002183|Abacavir|abacavir|mesh-list
102229111|NCT03381833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102229112|NCT02976337|Naloxone|naloxone|mesh-list
102229113|NCT02976337|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102229114|NCT02976337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229115|NCT02976337|Sensory System Agents|sensory system agents|mesh-ancestor
102229116|NCT02976337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102229117|NCT03377465|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
102229118|NCT03377465|N,N-dimethylarginine|n,n-dimethylarginine|mesh-list
102229119|NCT03377465|Natriuretic Agents|natriuretic agents|mesh-ancestor
102229120|NCT03377465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229121|NCT03377465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102229122|NCT03377465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229123|NCT03381755|Ticagrelor|ticagrelor|mesh-list
101937966|NCT04826393|Cemiplimab|cemiplimab|mesh-list
101632824|NCT02269267|Imatinib Mesylate|imatinib mesylate|mesh-list
102229124|NCT03381755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102229125|NCT03381755|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102229126|NCT03381755|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102229127|NCT03381755|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102229128|NCT03381755|Purinergic Agents|purinergic agents|mesh-ancestor
102229129|NCT03381755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102229130|NCT03381755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229131|NCT03381755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229132|NCT03387163|Valsartan|valsartan|mesh-list
102229133|NCT03387163|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102229134|NCT03387163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102229135|NCT03387163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102229136|NCT03387163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102229137|NCT03387163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229138|NCT04446403|Anesthetics|anesthetics|mesh-list
102229139|NCT04446403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102229140|NCT04446403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229141|NCT05237791|Magnesium Sulfate|magnesium sulfate|mesh-list
102229142|NCT05237791|Analgesics|analgesics|mesh-ancestor
102229143|NCT05237791|Sensory System Agents|sensory system agents|mesh-ancestor
102229144|NCT05237791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102229145|NCT05237791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229146|NCT05237791|Anesthetics|anesthetics|mesh-ancestor
102229147|NCT05237791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102229148|NCT05237791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102229149|NCT05237791|Anticonvulsants|anticonvulsants|mesh-ancestor
102229150|NCT05237791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102229151|NCT05237791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102229152|NCT05237791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229153|NCT05237791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102229154|NCT05237791|Tocolytic Agents|tocolytic agents|mesh-ancestor
102229155|NCT05237791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102229156|NCT03381599|Lenograstim|lenograstim|mesh-list
102229157|NCT03381599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102229158|NCT03381599|Immunologic Factors|immunologic factors|mesh-ancestor
102229159|NCT03381599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229160|NCT03394573|Aflibercept|aflibercept|mesh-list
102229161|NCT03394573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102229162|NCT03394573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102229163|NCT03394573|Growth Substances|growth substances|mesh-ancestor
102229164|NCT03394573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229165|NCT03394573|Growth Inhibitors|growth inhibitors|mesh-ancestor
102229166|NCT03394573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102229167|NCT03381053|Imatinib Mesylate|imatinib mesylate|mesh-list
102229168|NCT03381053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102229169|NCT03381053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102229170|NCT03381053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101632837|NCT02575495|Antitubercular Agents|antitubercular agents|mesh-ancestor
102229171|NCT03381053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229172|NCT03380975|Montelukast|montelukast|mesh-list
102229173|NCT03380975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102229174|NCT03380975|Respiratory System Agents|respiratory system agents|mesh-ancestor
102229175|NCT03380975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102229176|NCT03380975|Hormone Antagonists|hormone antagonists|mesh-ancestor
102229177|NCT03380975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102229178|NCT03380975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229179|NCT03380975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102612645|NCT00002183|Amprenavir|amprenavir|mesh-list
102229180|NCT03380975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102229181|NCT03380975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229183|NCT03460015|Sevoflurane|sevoflurane|mesh-list
102229184|NCT03460015|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102229185|NCT03460015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102229186|NCT03460015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229187|NCT03460015|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102229188|NCT03460015|Anesthetics, General|anesthetics, general|mesh-ancestor
102229189|NCT03460015|Anesthetics|anesthetics|mesh-ancestor
102229190|NCT03460015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102229191|NCT03460015|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102229192|NCT03376841|Cenicriviroc|cenicriviroc|mesh-list
102229193|NCT03376841|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102229194|NCT03376841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229195|NCT03376841|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102229196|NCT03376841|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102229197|NCT03376841|Antiviral Agents|antiviral agents|mesh-ancestor
102229198|NCT03376841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102229200|NCT03375515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102229201|NCT03375515|Narcotics|narcotics|mesh-ancestor
102229202|NCT03375515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102229203|NCT03375515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229204|NCT03375515|Analgesics|analgesics|mesh-ancestor
102229205|NCT03375515|Sensory System Agents|sensory system agents|mesh-ancestor
102229206|NCT03375515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102229207|NCT03099863|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
102229208|NCT03099863|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102229209|NCT03099863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102229210|NCT03099863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102229211|NCT03374501|PAZ320|paz320|mesh-list
102229212|NCT03374501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102229213|NCT03374501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229214|NCT03374345|Juzentaihoto|juzentaihoto|mesh-list
102229215|NCT03374345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102229216|NCT03374345|Mitogens|mitogens|mesh-ancestor
102229217|NCT03374345|Mitosis Modulators|mitosis modulators|mesh-ancestor
102229218|NCT03374345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229219|NCT03373955|Pembrolizumab|pembrolizumab|mesh-list
102229220|NCT03373955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102229221|NCT03373955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102229222|NCT03373955|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102229223|NCT03373955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229224|NCT02814695|Ascorbic Acid|ascorbic acid|mesh-list
102229225|NCT02814695|Antioxidants|antioxidants|mesh-ancestor
102229226|NCT02814695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229227|NCT02814695|Protective Agents|protective agents|mesh-ancestor
102229228|NCT02814695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229229|NCT02814695|Vitamins|vitamins|mesh-ancestor
102229230|NCT02814695|Micronutrients|micronutrients|mesh-ancestor
102229231|NCT03386305|Tacrolimus|tacrolimus|mesh-list
102229232|NCT03386305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102229233|NCT03386305|Immunologic Factors|immunologic factors|mesh-ancestor
102229234|NCT03386305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229235|NCT03386305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102229236|NCT03386305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102229237|NCT03386305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632861|NCT01017731|Autonomic Agents|autonomic agents|mesh-ancestor
102229238|NCT03386227|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102229239|NCT03386227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102229240|NCT05237323|Mycophenolic Acid|mycophenolic acid|mesh-list
102229241|NCT05237323|Azathioprine|azathioprine|mesh-list
102229242|NCT05237323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102229243|NCT05237323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102229244|NCT05237323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102229245|NCT05237323|Antitubercular Agents|antitubercular agents|mesh-ancestor
102229246|NCT05237323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102229247|NCT05237323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102229248|NCT05237323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102229249|NCT05237323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229250|NCT05237323|Antimetabolites|antimetabolites|mesh-ancestor
102229251|NCT05237323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102229252|NCT05237323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102229253|NCT05237323|Immunologic Factors|immunologic factors|mesh-ancestor
101901129|NCT01179620|Certoparin|certoparin|mesh-list
102229254|NCT05237323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229255|NCT05237323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102229256|NCT02520505|Citric Acid|citric acid|mesh-list
102229257|NCT02520505|Sodium Citrate|sodium citrate|mesh-list
102229258|NCT02520505|Clomiphene|clomiphene|mesh-list
102229259|NCT02520505|Enclomiphene|enclomiphene|mesh-list
102229260|NCT02520505|Zuclomiphene|zuclomiphene|mesh-list
102229261|NCT02520505|Anticoagulants|anticoagulants|mesh-ancestor
102229262|NCT02520505|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102229263|NCT02520505|Chelating Agents|chelating agents|mesh-ancestor
102229264|NCT02520505|Sequestering Agents|sequestering agents|mesh-ancestor
102229265|NCT02520505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229266|NCT02520505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102229267|NCT02520505|Hormone Antagonists|hormone antagonists|mesh-ancestor
102229268|NCT02520505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102229269|NCT02520505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229270|NCT02520505|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102229272|NCT02520505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102229273|NCT02520505|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102229274|NCT02520505|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102229275|NCT03380689|Bevacizumab|bevacizumab|mesh-list
102229276|NCT03380689|Irinotecan|irinotecan|mesh-list
102229277|NCT03380689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102229278|NCT03380689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102229279|NCT03380689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102229280|NCT03380689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102229281|NCT03380689|Growth Substances|growth substances|mesh-ancestor
102229282|NCT03380689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229283|NCT03380689|Growth Inhibitors|growth inhibitors|mesh-ancestor
102229284|NCT03380689|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102229285|NCT03380689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102229286|NCT03380689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102229287|NCT03380689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229288|NCT03380533|Buprenorphine|buprenorphine|mesh-list
102229289|NCT03380533|Tramadol|tramadol|mesh-list
102229290|NCT03380533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102229291|NCT03380533|Narcotics|narcotics|mesh-ancestor
102229292|NCT03380533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102229293|NCT03380533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229294|NCT03380533|Analgesics|analgesics|mesh-ancestor
102229295|NCT03380533|Sensory System Agents|sensory system agents|mesh-ancestor
102229296|NCT03380533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102229297|NCT03380533|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102229298|NCT03386149|Loxoprofen|loxoprofen|mesh-list
102229299|NCT03386149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102229300|NCT03386149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102229301|NCT03386149|Analgesics|analgesics|mesh-ancestor
102229302|NCT03386149|Sensory System Agents|sensory system agents|mesh-ancestor
102229303|NCT03386149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102229304|NCT03386149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229305|NCT03386149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102229306|NCT03386149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102229307|NCT03386071|Trametinib|trametinib|mesh-list
102229308|NCT03386071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102229309|NCT03386071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102229310|NCT03386071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102229311|NCT03386071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229312|NCT03231085|Ferrous fumarate|ferrous fumarate|mesh-list
102229313|NCT03231085|Trace Elements|trace elements|mesh-ancestor
102229314|NCT03231085|Micronutrients|micronutrients|mesh-ancestor
102229315|NCT03231085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229316|NCT03385135|Allopurinol|allopurinol|mesh-list
102229317|NCT03385135|Antimetabolites|antimetabolites|mesh-ancestor
102229318|NCT03385135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229319|NCT03385135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102229320|NCT03385135|Gout Suppressants|gout suppressants|mesh-ancestor
102229321|NCT03385135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102229322|NCT03385135|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102229323|NCT03385135|Antioxidants|antioxidants|mesh-ancestor
102612646|NCT00002183|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102612647|NCT00002183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102612648|NCT00002183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612649|NCT00002183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229324|NCT03385135|Protective Agents|protective agents|mesh-ancestor
102229325|NCT03385135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102612650|NCT00002183|Antiviral Agents|antiviral agents|mesh-ancestor
102229326|NCT00462943|Homoharringtonine|homoharringtonine|mesh-list
102229327|NCT00462943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102229328|NCT00462943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102229329|NCT00462943|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102229330|NCT00462943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102229331|NCT00462943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229332|NCT04436965|Cisplatin|cisplatin|mesh-list
102229333|NCT04436965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102229334|NCT04420741|Iloprost|iloprost|mesh-list
102229335|NCT04420741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102229336|NCT04420741|Vasodilator Agents|vasodilator agents|mesh-ancestor
102229337|NCT04409041|Naltrexone|naltrexone|mesh-list
102229338|NCT04409041|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102229339|NCT04409041|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102229340|NCT04409041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229341|NCT04409041|Sensory System Agents|sensory system agents|mesh-ancestor
101632896|NCT00769132|Niacin|niacin|mesh-list
102229342|NCT04409041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102229343|NCT03090997|Vitamins|vitamins|mesh-list
102229344|NCT03090997|Ascorbic Acid|ascorbic acid|mesh-list
102229345|NCT03090997|Resveratrol|resveratrol|mesh-list
102229346|NCT03090997|Micronutrients|micronutrients|mesh-ancestor
102229347|NCT03090997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229348|NCT03090997|Antioxidants|antioxidants|mesh-ancestor
102229349|NCT03090997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229350|NCT03090997|Protective Agents|protective agents|mesh-ancestor
102229351|NCT03090997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102229352|NCT03090997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102229353|NCT04446091|Irinotecan|irinotecan|mesh-list
102229354|NCT04446091|Apatinib|apatinib|mesh-list
102229355|NCT04446091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
102229356|NCT04446091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102229357|NCT04446091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102229358|NCT04446091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102229359|NCT04446091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229360|NCT04446091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102229361|NCT04446091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102229362|NCT04446091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102229363|NCT04446091|Growth Substances|growth substances|mesh-ancestor
102229364|NCT04446091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229365|NCT04446091|Growth Inhibitors|growth inhibitors|mesh-ancestor
102229366|NCT04445935|Bivalirudin|bivalirudin|mesh-list
102229367|NCT04445935|Antithrombins|antithrombins|mesh-ancestor
102229368|NCT04445935|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102229369|NCT04445935|Protease Inhibitors|protease inhibitors|mesh-ancestor
102229370|NCT04445935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102229371|NCT04445935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229372|NCT04445935|Anticoagulants|anticoagulants|mesh-ancestor
102229373|NCT03385057|Acetaminophen|acetaminophen|mesh-list
102229374|NCT03385057|Ibuprofen|ibuprofen|mesh-list
102229375|NCT03385057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102229376|NCT03385057|Analgesics|analgesics|mesh-ancestor
102229377|NCT03385057|Sensory System Agents|sensory system agents|mesh-ancestor
102229378|NCT03385057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102229379|NCT03385057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229380|NCT03385057|Antipyretics|antipyretics|mesh-ancestor
102229381|NCT03385057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102229382|NCT03385057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102229383|NCT03385057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102229384|NCT03385057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102229385|NCT03385057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102229386|NCT03385057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229387|NCT02051309|Guanfacine|guanfacine|mesh-list
102229388|NCT02051309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102229389|NCT02051309|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102229390|NCT02051309|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102229391|NCT02051309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102229392|NCT02051309|Adrenergic Agents|adrenergic agents|mesh-ancestor
102229393|NCT02051309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102229394|NCT02051309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229395|NCT02051309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229396|NCT00372073|Roscovitine|roscovitine|mesh-list
102229397|NCT00372073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102229398|NCT00372073|Antiviral Agents|antiviral agents|mesh-ancestor
102229399|NCT00372073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102229400|NCT00372073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102229401|NCT00372073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102229402|NCT00372073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229403|NCT03373409|Albuterol|albuterol|mesh-list
102229404|NCT03373409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102229405|NCT03373409|Autonomic Agents|autonomic agents|mesh-ancestor
102229406|NCT03373409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102229407|NCT03373409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229408|NCT03373409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102229409|NCT03373409|Respiratory System Agents|respiratory system agents|mesh-ancestor
102229410|NCT03373409|Tocolytic Agents|tocolytic agents|mesh-ancestor
102229411|NCT03373409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102229412|NCT03373409|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102229413|NCT03373409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102229414|NCT03373409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102229415|NCT03373409|Adrenergic Agents|adrenergic agents|mesh-ancestor
102229416|NCT03373409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102229417|NCT03373409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229418|NCT03379987|Morphine|morphine|mesh-list
102229419|NCT03379987|Bupivacaine|bupivacaine|mesh-list
101938267|NCT04186559|Antioxidants|antioxidants|mesh-ancestor
102229420|NCT03379987|Anesthetics, Local|anesthetics, local|mesh-ancestor
102229421|NCT03379987|Anesthetics|anesthetics|mesh-ancestor
102229422|NCT03379987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102229423|NCT03379987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229424|NCT03379987|Sensory System Agents|sensory system agents|mesh-ancestor
102229425|NCT03379987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102229426|NCT03379987|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102229427|NCT03379987|Narcotics|narcotics|mesh-ancestor
102229428|NCT03379987|Analgesics|analgesics|mesh-ancestor
102229429|NCT02730793|Aztreonam|aztreonam|mesh-list
102229430|NCT02730793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102229431|NCT02730793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102229432|NCT03379909|Metformin|metformin|mesh-list
102229433|NCT03379909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102229434|NCT03379909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229435|NCT02678533|Plerixafor|plerixafor|mesh-list
102229436|NCT02678533|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102229437|NCT02678533|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102229438|NCT02678533|Antiviral Agents|antiviral agents|mesh-ancestor
102229439|NCT02678533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102229440|NCT03379441|Pembrolizumab|pembrolizumab|mesh-list
102229441|NCT03379441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102229442|NCT03379441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102229443|NCT03379441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102229444|NCT03379441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229445|NCT03384511|Apatinib|apatinib|mesh-list
102229446|NCT03384511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102229447|NCT03384511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102229448|NCT03384511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102229449|NCT03384511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229450|NCT03385525|Valproic Acid|valproic acid|mesh-list
102229451|NCT03385525|Anticonvulsants|anticonvulsants|mesh-ancestor
102229452|NCT03385525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102229453|NCT03385525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229454|NCT03385525|GABA Agents|gaba agents|mesh-ancestor
102229455|NCT03385525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102229456|NCT03385525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229457|NCT03385525|Antimanic Agents|antimanic agents|mesh-ancestor
102229458|NCT03385525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102229459|NCT03385525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102229460|NCT03385525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102229461|NCT05172739|Analgesics, Opioid|analgesics, opioid|mesh-list
102229462|NCT05172739|Anesthetics|anesthetics|mesh-list
102229463|NCT05172739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102229464|NCT05172739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229465|NCT05172739|Narcotics|narcotics|mesh-ancestor
102229466|NCT05172739|Analgesics|analgesics|mesh-ancestor
102229467|NCT05172739|Sensory System Agents|sensory system agents|mesh-ancestor
102229468|NCT05172739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102229469|NCT03375463|Tirzepatide|tirzepatide|mesh-list
102229470|NCT03375463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102229471|NCT03375463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229472|NCT03375463|Incretins|incretins|mesh-ancestor
102612651|NCT00002183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102229473|NCT03375463|Hormones|hormones|mesh-ancestor
101901138|NCT01288820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102612652|NCT00002183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102229474|NCT03375463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102229475|NCT04445623|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102229476|NCT04445623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102229477|NCT04445311|Ivermectin|ivermectin|mesh-list
102229478|NCT04445311|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102229479|NCT04445311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102229480|NCT03384121|Rifampin|rifampin|mesh-list
102229481|NCT03384121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102229482|NCT03384121|Antitubercular Agents|antitubercular agents|mesh-ancestor
102229483|NCT03384121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102229484|NCT03384121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102229485|NCT03384121|Leprostatic Agents|leprostatic agents|mesh-ancestor
102229486|NCT03384121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102229487|NCT03384121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102229488|NCT03384121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229489|NCT03384121|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102229490|NCT03384121|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102229491|NCT03384121|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102229492|NCT03384121|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102229493|NCT03384121|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102229494|NCT03384121|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102229495|NCT03378661|Benzonidazole|benzonidazole|mesh-list
102229496|NCT03378661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102229497|NCT03378661|Immunologic Factors|immunologic factors|mesh-ancestor
102229498|NCT03378661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229499|NCT03378661|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102229500|NCT03378661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102229501|NCT03378661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102229502|NCT03378661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102229503|NCT03378427|Doxycycline|doxycycline|mesh-list
102229504|NCT03378427|Ciprofloxacin|ciprofloxacin|mesh-list
102229505|NCT03378427|Levofloxacin|levofloxacin|mesh-list
102229506|NCT03378427|Ofloxacin|ofloxacin|mesh-list
102229507|NCT03378427|Minocycline|minocycline|mesh-list
102229508|NCT03378427|Rifampin|rifampin|mesh-list
102229509|NCT03378427|Clindamycin|clindamycin|mesh-list
102229510|NCT03378427|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102229511|NCT03378427|Tedizolid|tedizolid|mesh-list
102229512|NCT03378427|Teicoplanin|teicoplanin|mesh-list
102229513|NCT03378427|Fusidic Acid|fusidic acid|mesh-list
102229514|NCT03378427|Tedizolid phosphate|tedizolid phosphate|mesh-list
102229515|NCT03378427|Trimethoprim|trimethoprim|mesh-list
102229516|NCT03378427|Sulfamethoxazole|sulfamethoxazole|mesh-list
102229517|NCT03378427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102229518|NCT03378427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102229519|NCT03378427|Antimalarials|antimalarials|mesh-ancestor
102229520|NCT03378427|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102229521|NCT03378427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102229522|NCT03378427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102229523|NCT03378427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102229524|NCT03378427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102229525|NCT03378427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229526|NCT03378427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102229527|NCT03378427|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102229528|NCT03378427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102229529|NCT03378427|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102229530|NCT03378427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102229531|NCT03378427|Antitubercular Agents|antitubercular agents|mesh-ancestor
102229532|NCT03378427|Leprostatic Agents|leprostatic agents|mesh-ancestor
102229533|NCT03378427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102229534|NCT03378427|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102229535|NCT03378427|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102229536|NCT03378427|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102229537|NCT03378427|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102229538|NCT03378427|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102229539|NCT03378427|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102229540|NCT03378427|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102229541|NCT03378427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102229542|NCT03378427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102229543|NCT03378427|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102229544|NCT05172115|Heparin|heparin|mesh-list
102229545|NCT05172115|Enoxaparin|enoxaparin|mesh-list
102229546|NCT05172115|Plasminogen|plasminogen|mesh-list
102229547|NCT05172115|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102229548|NCT05172115|Tinzaparin|tinzaparin|mesh-list
102229550|NCT05172115|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102229551|NCT05172115|Anticoagulants|anticoagulants|mesh-ancestor
102229552|NCT05172115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102229553|NCT05172115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101633042|NCT02576353|Analgesics|analgesics|mesh-ancestor
102229554|NCT05172115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229555|NCT03383185|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102229556|NCT03383185|Contraceptive Agents|contraceptive agents|mesh-list
102229557|NCT03383185|Medroxyprogesterone|medroxyprogesterone|mesh-list
102229558|NCT03383185|Contraceptives, Oral|contraceptives, oral|mesh-list
102229559|NCT03383185|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
102229560|NCT03383185|Progestins|progestins|mesh-list
102229561|NCT03383185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102229562|NCT03383185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229563|NCT03383185|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102229564|NCT03383185|Hormones|hormones|mesh-ancestor
102229565|NCT03383185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102229566|NCT03383185|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102229567|NCT03383185|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102229568|NCT03383185|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102229569|NCT03383185|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102229570|NCT03383185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101938411|NCT03278925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102229571|NCT03383185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102229572|NCT03374293|Antibodies|antibodies|mesh-list
102229573|NCT03374293|Immunologic Factors|immunologic factors|mesh-ancestor
102229574|NCT03374293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229575|NCT02730871|Timolol|timolol|mesh-list
102229576|NCT02730871|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102229577|NCT02730871|Travoprost|travoprost|mesh-list
102229578|NCT02730871|Brinzolamide|brinzolamide|mesh-list
102229579|NCT02730871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102229580|NCT02730871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102229581|NCT02730871|Adrenergic Agents|adrenergic agents|mesh-ancestor
102229582|NCT02730871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102229583|NCT02730871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229584|NCT02730871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229585|NCT02730871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102229586|NCT02730871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102229587|NCT02730871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102229588|NCT02730871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102229589|NCT02730871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102229590|NCT02730871|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102229591|NCT02730871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102229592|NCT03377335|Metformin|metformin|mesh-list
102229593|NCT03377335|Dapagliflozin|dapagliflozin|mesh-list
102229594|NCT03377335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102229595|NCT03377335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229596|NCT03377335|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102229597|NCT03377335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229598|NCT03377257|Oxazolidinones|oxazolidinones|mesh-list
102229599|NCT03377257|Zolmitriptan|zolmitriptan|mesh-list
102229600|NCT03377257|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102229601|NCT03377257|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102229602|NCT03377257|Serotonin Agents|serotonin agents|mesh-ancestor
102229603|NCT03377257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102229604|NCT03377257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229605|NCT03377257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229606|NCT03377257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102229607|NCT03377257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102229608|NCT03377257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102229609|NCT03373903|Everolimus|everolimus|mesh-list
102229610|NCT03373903|Dactolisib|dactolisib|mesh-list
102229611|NCT03373903|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102229612|NCT03373903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102229613|NCT03373903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102229614|NCT03373903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229615|NCT03373903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102229616|NCT03373903|Immunologic Factors|immunologic factors|mesh-ancestor
102229617|NCT03373903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229618|NCT03373903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102229619|NCT04445857|Calcitonin|calcitonin|mesh-list
102229620|NCT04445857|Salmon calcitonin|salmon calcitonin|mesh-list
101771490|NCT01056679|Growth Substances|growth substances|mesh-ancestor
102229621|NCT04445857|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
102229623|NCT04445857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102229624|NCT04445857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229625|NCT04445857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102229626|NCT04445857|Vasodilator Agents|vasodilator agents|mesh-ancestor
102229627|NCT03373825|Fentanyl|fentanyl|mesh-list
102229628|NCT03373825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102229629|NCT03373825|Narcotics|narcotics|mesh-ancestor
102229630|NCT03373825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102229631|NCT03373825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229632|NCT03373825|Analgesics|analgesics|mesh-ancestor
102229633|NCT03373825|Sensory System Agents|sensory system agents|mesh-ancestor
102229634|NCT03373825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102229635|NCT03373825|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102229636|NCT03373825|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102229637|NCT03373825|Anesthetics, General|anesthetics, general|mesh-ancestor
102229638|NCT03373825|Anesthetics|anesthetics|mesh-ancestor
102229639|NCT04445779|Ubiquinone|ubiquinone|mesh-list
102229640|NCT04445779|Coenzyme Q10|coenzyme q10|mesh-list
102229641|NCT04445779|Micronutrients|micronutrients|mesh-ancestor
102229642|NCT04445779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229643|NCT04445779|Vitamins|vitamins|mesh-ancestor
102229644|NCT03377101|Fulvestrant|fulvestrant|mesh-list
102229645|NCT03377101|Palbociclib|palbociclib|mesh-list
102229646|NCT03377101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102229647|NCT03377101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102229648|NCT03377101|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102229649|NCT03377101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102229650|NCT03377101|Hormone Antagonists|hormone antagonists|mesh-ancestor
101633106|NCT02573701|Serotonin Agents|serotonin agents|mesh-ancestor
102229651|NCT03377101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102229652|NCT03377101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229653|NCT03377101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102229654|NCT03377101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102229655|NCT03377101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229656|NCT04445467|Favipiravir|favipiravir|mesh-list
102229657|NCT04445467|Antiviral Agents|antiviral agents|mesh-ancestor
102229658|NCT04445467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102229659|NCT03373669|Vaccines|vaccines|mesh-list
102229660|NCT03373669|Immunologic Factors|immunologic factors|mesh-ancestor
102229661|NCT03373669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229662|NCT03382717|Amorolfine|amorolfine|mesh-list
102229663|NCT03382717|Antifungal Agents|antifungal agents|mesh-ancestor
102229664|NCT03382717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102229665|NCT03125473|Vaccines|vaccines|mesh-list
102229666|NCT03125473|Immunologic Factors|immunologic factors|mesh-ancestor
102229667|NCT03125473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229668|NCT03376789|MYL-1501D|myl-1501d|mesh-list
102229669|NCT03376789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102229670|NCT03376789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229671|NCT03376555|Nitroglycerin|nitroglycerin|mesh-list
102229672|NCT03376555|Acetylcholine|acetylcholine|mesh-list
102229673|NCT03376555|Vasodilator Agents|vasodilator agents|mesh-ancestor
102229674|NCT03376555|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102229675|NCT03376555|Cholinergic Agents|cholinergic agents|mesh-ancestor
102229676|NCT03376555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102229677|NCT03376555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229678|NCT03376555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229679|NCT03376243|Emollients|emollients|mesh-list
102229680|NCT03376243|Dermatologic Agents|dermatologic agents|mesh-ancestor
102229681|NCT03700411|Morphine|morphine|mesh-list
102229682|NCT03700411|Pirinitramide|pirinitramide|mesh-list
102229683|NCT03700411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102229684|NCT03700411|Narcotics|narcotics|mesh-ancestor
102229685|NCT03700411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102229686|NCT03700411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229687|NCT03700411|Analgesics|analgesics|mesh-ancestor
102229688|NCT03700411|Sensory System Agents|sensory system agents|mesh-ancestor
102229689|NCT03700411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102229690|NCT03691051|Capecitabine|capecitabine|mesh-list
102229691|NCT03691051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102229692|NCT03691051|Antimetabolites|antimetabolites|mesh-ancestor
102229693|NCT03691051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229694|NCT03691051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102229695|NCT03381859|Grazoprevir|grazoprevir|mesh-list
102229696|NCT03381859|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
102229697|NCT03381859|Antiviral Agents|antiviral agents|mesh-ancestor
102612653|NCT00002183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102229698|NCT03381859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102229699|NCT03381781|Cytarabine|cytarabine|mesh-list
102229700|NCT03381781|Decitabine|decitabine|mesh-list
102229701|NCT03381781|Arsenic Trioxide|arsenic trioxide|mesh-list
102229702|NCT03381781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102229703|NCT03381781|Antimetabolites|antimetabolites|mesh-ancestor
102229704|NCT03381781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229705|NCT03381781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102229706|NCT03381781|Antiviral Agents|antiviral agents|mesh-ancestor
102229707|NCT03381781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102229708|NCT03381781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102229709|NCT03381781|Immunologic Factors|immunologic factors|mesh-ancestor
102229710|NCT03381781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229711|NCT03381781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102229712|NCT03381703|YH12852|yh12852|mesh-list
102229713|NCT03381703|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
102229714|NCT03381703|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102229715|NCT03381703|Serotonin Agents|serotonin agents|mesh-ancestor
102229716|NCT03381703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101938562|NCT02642965|Daunorubicin|daunorubicin|mesh-list
101938563|NCT02642965|Lenograstim|lenograstim|mesh-list
101938564|NCT02642965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938565|NCT02642965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101938566|NCT02642965|Antimetabolites|antimetabolites|mesh-ancestor
101938567|NCT02642965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938568|NCT02642965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101938569|NCT02642965|Immunologic Factors|immunologic factors|mesh-ancestor
101938571|NCT02642965|Antiviral Agents|antiviral agents|mesh-ancestor
102229717|NCT03381703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229718|NCT03381703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229719|NCT03372265|Ropivacaine|ropivacaine|mesh-list
102229720|NCT03372265|Anesthetics, Local|anesthetics, local|mesh-ancestor
102229721|NCT03372265|Anesthetics|anesthetics|mesh-ancestor
102229722|NCT03372265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102229723|NCT03372265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229724|NCT03372265|Sensory System Agents|sensory system agents|mesh-ancestor
102229725|NCT03372265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102229726|NCT03372109|Calcium|calcium|mesh-list
102229727|NCT03372109|Turmeric extract|turmeric extract|mesh-list
102229728|NCT03372109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102229729|NCT03372109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229730|NCT03372109|Antioxidants|antioxidants|mesh-ancestor
102229731|NCT03372109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229732|NCT03372109|Protective Agents|protective agents|mesh-ancestor
102229733|NCT03371953|Atracurium|atracurium|mesh-list
102229734|NCT03371953|Vecuronium Bromide|vecuronium bromide|mesh-list
102229735|NCT03371953|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102229736|NCT03371953|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102229737|NCT03371953|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102229738|NCT03371953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102229739|NCT03371953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229740|NCT03371953|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102229741|NCT03371953|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102229742|NCT03371953|Cholinergic Agents|cholinergic agents|mesh-ancestor
102229743|NCT03371953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102229744|NCT03371953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229745|NCT03371797|Amlodipine|amlodipine|mesh-list
102229746|NCT03371797|Valsartan|valsartan|mesh-list
102229747|NCT03371797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102229748|NCT03371797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102229749|NCT03371797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102229750|NCT03371797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229751|NCT03371797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102229752|NCT03371797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229753|NCT03371797|Vasodilator Agents|vasodilator agents|mesh-ancestor
102229754|NCT03371797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102229755|NCT03371797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102229756|NCT02520115|Dexamethasone|dexamethasone|mesh-list
102229757|NCT02520115|Dexamethasone acetate|dexamethasone acetate|mesh-list
102229758|NCT02520115|Valproic Acid|valproic acid|mesh-list
102229759|NCT02520115|Ichthammol|ichthammol|mesh-list
102229760|NCT02520115|BB 1101|bb 1101|mesh-list
102229761|NCT02520115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102229762|NCT02520115|Antiemetics|antiemetics|mesh-ancestor
102229763|NCT02520115|Autonomic Agents|autonomic agents|mesh-ancestor
102612654|NCT00002183|Antimetabolites|antimetabolites|mesh-ancestor
102229764|NCT02520115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102229765|NCT02520115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229766|NCT02520115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102229767|NCT02520115|Glucocorticoids|glucocorticoids|mesh-ancestor
102229768|NCT02520115|Hormones|hormones|mesh-ancestor
102229769|NCT02520115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102229770|NCT02520115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102229771|NCT02520115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102229772|NCT02520115|Protease Inhibitors|protease inhibitors|mesh-ancestor
102229773|NCT02520115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102229774|NCT02520115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229775|NCT02520115|Anticonvulsants|anticonvulsants|mesh-ancestor
102229776|NCT02520115|GABA Agents|gaba agents|mesh-ancestor
102229777|NCT02520115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102229778|NCT02520115|Antimanic Agents|antimanic agents|mesh-ancestor
102229779|NCT02520115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102229780|NCT02520115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102229781|NCT02520115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102229782|NCT02520115|Dermatologic Agents|dermatologic agents|mesh-ancestor
102229783|NCT03375775|Immunomodulating Agents|immunomodulating agents|mesh-list
102229784|NCT03375775|Immunologic Factors|immunologic factors|mesh-list
102229785|NCT03375775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229786|NCT04527133|Aprotinin|aprotinin|mesh-list
102229787|NCT04527133|Hemostatics|hemostatics|mesh-ancestor
102229788|NCT04527133|Coagulants|coagulants|mesh-ancestor
102229789|NCT04527133|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102229790|NCT04527133|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102229791|NCT04527133|Protease Inhibitors|protease inhibitors|mesh-ancestor
102229792|NCT04527133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102229793|NCT04527133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229794|NCT03371563|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102229795|NCT03371563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102229796|NCT03369925|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
102229797|NCT03369925|Nootropic Agents|nootropic agents|mesh-ancestor
102229799|NCT03369847|Beclomethasone|beclomethasone|mesh-list
102229800|NCT03369847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102229801|NCT03369847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102229802|NCT03369847|Autonomic Agents|autonomic agents|mesh-ancestor
102229803|NCT03369847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102229804|NCT03369847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229805|NCT03369847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102229806|NCT03369847|Respiratory System Agents|respiratory system agents|mesh-ancestor
102229807|NCT03369847|Glucocorticoids|glucocorticoids|mesh-ancestor
102229808|NCT03369847|Hormones|hormones|mesh-ancestor
102229809|NCT03369847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102229810|NCT04526353|Oxybutynin|oxybutynin|mesh-list
102229811|NCT04526353|Parasympatholytics|parasympatholytics|mesh-ancestor
102229812|NCT04526353|Autonomic Agents|autonomic agents|mesh-ancestor
102229813|NCT04526353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102229814|NCT04526353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229815|NCT04526353|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102229816|NCT04526353|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102229817|NCT04526353|Cholinergic Agents|cholinergic agents|mesh-ancestor
102229818|NCT04526353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102229819|NCT04526353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229820|NCT04526353|Urological Agents|urological agents|mesh-ancestor
102229821|NCT03371173|Ferric maltol|ferric maltol|mesh-list
102229822|NCT03371173|Hematinics|hematinics|mesh-ancestor
102229823|NCT03371095|Infliximab|infliximab|mesh-list
102229824|NCT03371095|Cyclophosphamide|cyclophosphamide|mesh-list
102229825|NCT03371095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102229826|NCT03371095|Immunologic Factors|immunologic factors|mesh-ancestor
102229827|NCT03371095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229828|NCT03371095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102229829|NCT03371095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102229830|NCT03371095|Alkylating Agents|alkylating agents|mesh-ancestor
102229831|NCT03371095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633227|NCT01014767|Antidotes|antidotes|mesh-ancestor
102229832|NCT03371095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102229833|NCT03371095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102229834|NCT03371095|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102229835|NCT03371095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102229836|NCT03371095|Dermatologic Agents|dermatologic agents|mesh-ancestor
102229837|NCT03371095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102229838|NCT03363451|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102229839|NCT03363451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102229840|NCT03363295|Moxifloxacin|moxifloxacin|mesh-list
102229841|NCT03363295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102229842|NCT03363295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102229843|NCT03363295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102229844|NCT03363295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102229845|NCT03363295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102229846|NCT03363295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229847|NCT03363295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102229848|NCT03370861|Immunomodulating Agents|immunomodulating agents|mesh-list
102229849|NCT03370861|Immunologic Factors|immunologic factors|mesh-ancestor
102229850|NCT03370861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229851|NCT03370705|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
102229852|NCT03370705|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
102229853|NCT03370705|Captopril|captopril|mesh-list
102229854|NCT03370705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
102229855|NCT03370705|Atorvastatin|atorvastatin|mesh-list
102229856|NCT03370705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102229857|NCT03370705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102229858|NCT03370705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102229859|NCT03370705|Antimetabolites|antimetabolites|mesh-ancestor
102229860|NCT03370705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229861|NCT03370705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102229862|NCT03370705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102229863|NCT03370705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102229864|NCT03370705|Protease Inhibitors|protease inhibitors|mesh-ancestor
102229865|NCT03370705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102229866|NCT03370705|Anticoagulants|anticoagulants|mesh-ancestor
102229867|NCT03370705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102229868|NCT03370705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102229869|NCT03370705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102229870|NCT03370705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229871|NCT03370705|Analgesics|analgesics|mesh-ancestor
102229872|NCT03370705|Sensory System Agents|sensory system agents|mesh-ancestor
102229873|NCT03370705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102229874|NCT03370705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102229875|NCT03370705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102229876|NCT03370705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102229877|NCT03370705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102229878|NCT03370705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102229879|NCT03369379|Cholecalciferol|cholecalciferol|mesh-list
102229881|NCT03369379|Micronutrients|micronutrients|mesh-ancestor
102229882|NCT03369379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229883|NCT03369379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102229884|NCT03369379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102229885|NCT03362905|Lidocaine|lidocaine|mesh-list
102229886|NCT03362905|Anesthetics, Local|anesthetics, local|mesh-ancestor
102229887|NCT03362905|Anesthetics|anesthetics|mesh-ancestor
102229888|NCT03362905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102229889|NCT03362905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229890|NCT03362905|Sensory System Agents|sensory system agents|mesh-ancestor
102229891|NCT03362905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102229892|NCT03362905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102229893|NCT03362905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102229894|NCT03362905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102229895|NCT03362905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102229896|NCT03362905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229897|NCT03370159|Thioctic Acid|thioctic acid|mesh-list
102229898|NCT03370159|Docetaxel|docetaxel|mesh-list
102229899|NCT03370159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102229900|NCT03370159|Tubulin Modulators|tubulin modulators|mesh-ancestor
102229901|NCT03370159|Antimitotic Agents|antimitotic agents|mesh-ancestor
102229902|NCT03370159|Mitosis Modulators|mitosis modulators|mesh-ancestor
102229903|NCT03370159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229904|NCT03370159|Antioxidants|antioxidants|mesh-ancestor
102229905|NCT03370159|Protective Agents|protective agents|mesh-ancestor
102229906|NCT03370159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229907|NCT03370159|Vitamin B Complex|vitamin b complex|mesh-ancestor
102229908|NCT03370159|Vitamins|vitamins|mesh-ancestor
102612655|NCT00002183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102612656|NCT00002183|Antitubercular Agents|antitubercular agents|mesh-ancestor
102229909|NCT03370159|Micronutrients|micronutrients|mesh-ancestor
102229910|NCT04522297|Octreotide|octreotide|mesh-list
102229911|NCT04522297|Epinephrine|epinephrine|mesh-list
102229912|NCT04522297|Midodrine|midodrine|mesh-list
102229914|NCT04522297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102229915|NCT04522297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102229916|NCT04522297|Adrenergic Agents|adrenergic agents|mesh-ancestor
102229917|NCT04522297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102229918|NCT04522297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229919|NCT04522297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229920|NCT04522297|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102229921|NCT04522297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102229922|NCT04522297|Autonomic Agents|autonomic agents|mesh-ancestor
102229923|NCT04522297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102229924|NCT04522297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102229925|NCT04522297|Respiratory System Agents|respiratory system agents|mesh-ancestor
102229926|NCT04522297|Mydriatics|mydriatics|mesh-ancestor
102229927|NCT04522297|Sympathomimetics|sympathomimetics|mesh-ancestor
102229928|NCT04522297|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102229929|NCT04522297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102229930|NCT04522297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102229931|NCT04522297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102229932|NCT04522297|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102229933|NCT03369067|Insulin|insulin|mesh-list
102229934|NCT03369067|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102229935|NCT03369067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102229936|NCT03369067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229937|NCT03368989|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
101938791|NCT00006734|Lenograstim|lenograstim|mesh-list
102229938|NCT03368989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102229939|NCT04525729|Rituximab|rituximab|mesh-list
102229940|NCT04525729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102229941|NCT04525729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102229942|NCT04525729|Immunologic Factors|immunologic factors|mesh-ancestor
102229943|NCT04525729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229944|NCT04525729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102229945|NCT04525495|Dopamine|dopamine|mesh-list
102229946|NCT04525495|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102229947|NCT04525495|Sympathomimetics|sympathomimetics|mesh-ancestor
102229948|NCT04525495|Autonomic Agents|autonomic agents|mesh-ancestor
102229949|NCT04525495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102229950|NCT04525495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229951|NCT04525495|Dopamine Agents|dopamine agents|mesh-ancestor
102229952|NCT04525495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102229953|NCT04525495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229954|NCT04525495|Protective Agents|protective agents|mesh-ancestor
102229955|NCT03362359|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102229956|NCT03362359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229957|NCT03362359|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102229958|NCT03362281|Amoxicillin|amoxicillin|mesh-list
102229959|NCT03362281|Clarithromycin|clarithromycin|mesh-list
102229960|NCT03362281|Omeprazole|omeprazole|mesh-list
102229961|NCT03362281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102229962|NCT03362281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102229963|NCT03362281|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102229964|NCT03362281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102229965|NCT03362281|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102229966|NCT03362281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102229967|NCT03362281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229968|NCT03362281|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102229969|NCT03362281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102229970|NCT03362281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102229971|NCT02518789|Fentanyl|fentanyl|mesh-list
102229972|NCT02518789|Midazolam|midazolam|mesh-list
102229973|NCT02518789|Dexmedetomidine|dexmedetomidine|mesh-list
102229974|NCT02518789|Remifentanil|remifentanil|mesh-list
102229975|NCT02518789|Propofol|propofol|mesh-list
102229976|NCT02518789|Etomidate|etomidate|mesh-list
102229977|NCT02518789|Atracurium|atracurium|mesh-list
102229978|NCT02518789|Rocuronium|rocuronium|mesh-list
102229979|NCT02518789|Cisatracurium|cisatracurium|mesh-list
102229980|NCT02518789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102229981|NCT02518789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102229982|NCT02518789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102229983|NCT02518789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102612657|NCT00002183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102229984|NCT02518789|Analgesics|analgesics|mesh-ancestor
102229985|NCT02518789|Sensory System Agents|sensory system agents|mesh-ancestor
102229986|NCT02518789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101901142|NCT01288820|Schistosomicides|schistosomicides|mesh-ancestor
102229987|NCT02518789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102229988|NCT02518789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102229989|NCT02518789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102229990|NCT02518789|Adrenergic Agents|adrenergic agents|mesh-ancestor
102229991|NCT02518789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102229992|NCT02518789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102229993|NCT02518789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102229994|NCT02518789|Anesthetics, General|anesthetics, general|mesh-ancestor
102229996|NCT02518789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102229997|NCT02518789|Narcotics|narcotics|mesh-ancestor
102229998|NCT02518789|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102229999|NCT02518789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102230000|NCT02518789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102230001|NCT02518789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102230002|NCT02518789|GABA Modulators|gaba modulators|mesh-ancestor
102230003|NCT02518789|GABA Agents|gaba agents|mesh-ancestor
102230004|NCT02518789|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102230005|NCT02518789|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102230006|NCT02518789|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102230007|NCT02518789|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102230008|NCT02518789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102230009|NCT02518789|Cholinergic Agents|cholinergic agents|mesh-ancestor
102230010|NCT03357757|Avelumab|avelumab|mesh-list
102230011|NCT03357757|Valproic Acid|valproic acid|mesh-list
102230012|NCT03357757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102230013|NCT03357757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102230014|NCT03357757|Anticonvulsants|anticonvulsants|mesh-ancestor
102230015|NCT03357757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102230016|NCT03357757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230017|NCT03357757|GABA Agents|gaba agents|mesh-ancestor
102230018|NCT03357757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102230019|NCT03357757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230021|NCT03357757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102230022|NCT03357757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102230023|NCT03357757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102230024|NCT02929485|Bromocriptine|bromocriptine|mesh-list
102230025|NCT02929485|Tolcapone|tolcapone|mesh-list
102230026|NCT02929485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102230027|NCT02929485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102230028|NCT02929485|Hormone Antagonists|hormone antagonists|mesh-ancestor
102230029|NCT02929485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101633327|NCT00715039|Lorazepam|lorazepam|mesh-list
102230030|NCT02929485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230031|NCT02929485|Dopamine Agonists|dopamine agonists|mesh-ancestor
102230032|NCT02929485|Dopamine Agents|dopamine agents|mesh-ancestor
102230033|NCT02929485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102230034|NCT02929485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230035|NCT02929485|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102230036|NCT02929485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102230037|NCT04523623|Ibuprofen|ibuprofen|mesh-list
102230038|NCT04523623|Oxycodone|oxycodone|mesh-list
102230039|NCT04523623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102230040|NCT04523623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102230041|NCT04523623|Analgesics|analgesics|mesh-ancestor
102230042|NCT04523623|Sensory System Agents|sensory system agents|mesh-ancestor
102230043|NCT04523623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102230044|NCT04523623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230045|NCT04523623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102230046|NCT04523623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102230047|NCT04523623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102230048|NCT04523623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102230049|NCT04523623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230050|NCT04523623|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102230051|NCT04523623|Narcotics|narcotics|mesh-ancestor
102230052|NCT04523623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102230053|NCT03357289|Immunomodulating Agents|immunomodulating agents|mesh-list
102230054|NCT03357289|Immunologic Factors|immunologic factors|mesh-ancestor
102230055|NCT03357289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230056|NCT03368131|Capecitabine|capecitabine|mesh-list
102230057|NCT03368131|Oxaliplatin|oxaliplatin|mesh-list
102230058|NCT03368131|Trastuzumab|trastuzumab|mesh-list
102230059|NCT03368131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102230060|NCT03368131|Antimetabolites|antimetabolites|mesh-ancestor
102230061|NCT03368131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771947|NCT00779376|Zidovudine|zidovudine|mesh-list
102612658|NCT00002183|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102230062|NCT03368131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102230063|NCT03368131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102230064|NCT04521751|Acarbose|acarbose|mesh-list
102230065|NCT04521751|Orlistat|orlistat|mesh-list
102230066|NCT04521751|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102230067|NCT04521751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102230068|NCT04521751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230069|NCT04521751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102230070|NCT04521751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230071|NCT04521751|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102230072|NCT04521751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102230073|NCT04521517|Imidacloprid|imidacloprid|mesh-list
102230074|NCT04521517|Cholinergic Agents|cholinergic agents|mesh-ancestor
102230075|NCT04521517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101633342|NCT00715039|Anticonvulsants|anticonvulsants|mesh-ancestor
102230076|NCT04521517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230077|NCT04521517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230078|NCT01675167|Buprenorphine|buprenorphine|mesh-list
102230079|NCT01675167|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102230080|NCT01675167|Narcotics|narcotics|mesh-ancestor
102230081|NCT01675167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102230082|NCT01675167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230083|NCT01675167|Analgesics|analgesics|mesh-ancestor
102230084|NCT01675167|Sensory System Agents|sensory system agents|mesh-ancestor
102230085|NCT01675167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102230086|NCT01675167|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102230087|NCT03370627|Antibodies|antibodies|mesh-list
102230088|NCT03370627|Immunologic Factors|immunologic factors|mesh-ancestor
102230089|NCT03370627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230090|NCT03367663|Prednisone|prednisone|mesh-list
102230091|NCT03367663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102230092|NCT03367663|Glucocorticoids|glucocorticoids|mesh-ancestor
102230093|NCT03367663|Hormones|hormones|mesh-ancestor
102230094|NCT03367663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102230095|NCT03367663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230096|NCT03367663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102230097|NCT03367663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102230098|NCT03123289|Gallium citrate|gallium citrate|mesh-list
102230099|NCT03123289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230100|NCT03123289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102230102|NCT04521049|Incretins|incretins|mesh-ancestor
102230103|NCT04521049|Hormones|hormones|mesh-ancestor
102230104|NCT04521049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102230105|NCT04521049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230106|NCT04521049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102230107|NCT04521049|Protease Inhibitors|protease inhibitors|mesh-ancestor
102230108|NCT04521049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102230109|NCT04521049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230110|NCT04521049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102230111|NCT02267343|Nivolumab|nivolumab|mesh-list
102230112|NCT02267343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102230113|NCT02267343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102230114|NCT02267343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102230115|NCT02267343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230116|NCT03123445|Gemcitabine|gemcitabine|mesh-list
102230117|NCT03123445|Endostar protein|endostar protein|mesh-list
102230118|NCT03123445|Endostatins|endostatins|mesh-list
102230119|NCT03123445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102230120|NCT03123445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102230121|NCT03123445|Antimetabolites|antimetabolites|mesh-ancestor
102230122|NCT03123445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230123|NCT03123445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102230124|NCT03123445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102230125|NCT03123445|Growth Substances|growth substances|mesh-ancestor
102230126|NCT03123445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230127|NCT03123445|Growth Inhibitors|growth inhibitors|mesh-ancestor
102230128|NCT03357133|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102230129|NCT03357133|Tirofiban|tirofiban|mesh-list
102230130|NCT03357133|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102230131|NCT03357133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102230132|NCT03357133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230133|NCT03357133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102230134|NCT03357055|Ketamine|ketamine|mesh-list
102230135|NCT03357055|Analgesics|analgesics|mesh-ancestor
102230136|NCT03357055|Sensory System Agents|sensory system agents|mesh-ancestor
102230137|NCT03357055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102230138|NCT03357055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230139|NCT03357055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102230140|NCT03357055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102230142|NCT03357055|Anesthetics|anesthetics|mesh-ancestor
102230143|NCT03357055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102230144|NCT03357055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102230145|NCT03357055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102230146|NCT03357055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102230147|NCT03357055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230148|NCT03367585|Vitamin D|vitamin d|mesh-list
102230149|NCT03367585|Cholecalciferol|cholecalciferol|mesh-list
102230150|NCT03367585|Vitamins|vitamins|mesh-ancestor
102230151|NCT03367585|Micronutrients|micronutrients|mesh-ancestor
102230152|NCT03367585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230153|NCT03367585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102230154|NCT03367585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102230155|NCT03360955|Anesthetics|anesthetics|mesh-list
102230156|NCT03360955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102230157|NCT03360955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230158|NCT00584025|Levetiracetam|levetiracetam|mesh-list
102230159|NCT00584025|Anticonvulsants|anticonvulsants|mesh-ancestor
102230160|NCT00584025|Nootropic Agents|nootropic agents|mesh-ancestor
102230161|NCT01735461|Calcium Carbonate|calcium carbonate|mesh-list
102230162|NCT01735461|Calcium|calcium|mesh-list
102230163|NCT01735461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102230164|NCT01735461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230165|NCT01735461|Antacids|antacids|mesh-ancestor
101939012|NCT04440358|Carboplatin|carboplatin|mesh-list
102230166|NCT01735461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230167|NCT01735461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102230168|NCT01595841|Sirolimus|sirolimus|mesh-list
102230169|NCT01595841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102230170|NCT01595841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102230171|NCT01595841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102230172|NCT01595841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102230173|NCT01595841|Antifungal Agents|antifungal agents|mesh-ancestor
102230174|NCT01595841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102230175|NCT01595841|Immunologic Factors|immunologic factors|mesh-ancestor
102230176|NCT01595841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230177|NCT05405049|Lidocaine|lidocaine|mesh-list
102230178|NCT05405049|Fentanyl|fentanyl|mesh-list
102230179|NCT05405049|Morphine|morphine|mesh-list
102230180|NCT05405049|Bupivacaine|bupivacaine|mesh-list
102230181|NCT05405049|Anesthetics, Local|anesthetics, local|mesh-ancestor
102230182|NCT05405049|Anesthetics|anesthetics|mesh-ancestor
102230183|NCT05405049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101633386|NCT01013597|Panobinostat|panobinostat|mesh-list
102230184|NCT05405049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230185|NCT05405049|Sensory System Agents|sensory system agents|mesh-ancestor
102230186|NCT05405049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102230187|NCT05405049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102230188|NCT05405049|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102230189|NCT05405049|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102230190|NCT05405049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102230191|NCT05405049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230192|NCT05405049|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102230193|NCT05405049|Narcotics|narcotics|mesh-ancestor
102230194|NCT05405049|Analgesics|analgesics|mesh-ancestor
102230195|NCT05405049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102230196|NCT05405049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102230197|NCT05405049|Anesthetics, General|anesthetics, general|mesh-ancestor
102230198|NCT04520503|Propofol|propofol|mesh-list
102230199|NCT04520503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102230200|NCT04520503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102230201|NCT04520503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230202|NCT04520503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102230203|NCT04520503|Anesthetics, General|anesthetics, general|mesh-ancestor
102230204|NCT04520503|Anesthetics|anesthetics|mesh-ancestor
102230205|NCT02871843|Temozolomide|temozolomide|mesh-list
102230206|NCT02871843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102230207|NCT02871843|Alkylating Agents|alkylating agents|mesh-ancestor
102230208|NCT02871843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230209|NCT02871843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102230210|NCT03356899|Bupivacaine|bupivacaine|mesh-list
102230211|NCT03356899|Anesthetics|anesthetics|mesh-list
102230212|NCT03356899|Anesthetics, Local|anesthetics, local|mesh-ancestor
102230213|NCT03356899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102230214|NCT03356899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230215|NCT03356899|Sensory System Agents|sensory system agents|mesh-ancestor
102230216|NCT03356899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102230217|NCT04523467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
102230218|NCT04523467|Ginsenoside Rg3|ginsenoside rg3|mesh-list
102230219|NCT04523467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102230220|NCT04523467|Growth Substances|growth substances|mesh-ancestor
102230221|NCT04523467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230222|NCT04523467|Growth Inhibitors|growth inhibitors|mesh-ancestor
102230223|NCT04523467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102230224|NCT04523467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102230225|NCT02801097|Irinotecan|irinotecan|mesh-list
102230226|NCT02801097|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102230227|NCT02801097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102230228|NCT02801097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102230229|NCT02801097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230230|NCT02801097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102230231|NCT03367195|Omeprazole|omeprazole|mesh-list
102230232|NCT03367195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102230233|NCT03367195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102230234|NCT03367195|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102230235|NCT03367195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102230236|NCT03367195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230237|NCT05123781|Metformin|metformin|mesh-list
102230238|NCT05123781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102230239|NCT05123781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230240|NCT04523233|Vitamins|vitamins|mesh-list
102230241|NCT04523233|Micronutrients|micronutrients|mesh-ancestor
102230242|NCT04523233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230244|NCT05127369|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102230245|NCT05127369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102230246|NCT05127369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102230247|NCT05127369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230248|NCT05127369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102230249|NCT05127369|Serotonin Agents|serotonin agents|mesh-ancestor
102230250|NCT05127369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230251|NCT05127369|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102230252|NCT05127369|Antidepressive Agents|antidepressive agents|mesh-ancestor
102230253|NCT05127369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102230254|NCT05127369|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102230255|NCT05127369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102230256|NCT05127369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102230257|NCT05126901|Ferric maltol|ferric maltol|mesh-list
102230258|NCT05126901|Hematinics|hematinics|mesh-ancestor
102230259|NCT03356353|Sildenafil Citrate|sildenafil citrate|mesh-list
102230260|NCT03356353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230261|NCT03356353|Vasodilator Agents|vasodilator agents|mesh-ancestor
102230262|NCT03356353|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102230263|NCT03356353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102230264|NCT03356353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102230265|NCT03356353|Urological Agents|urological agents|mesh-ancestor
102230266|NCT04520035|Paclitaxel|paclitaxel|mesh-list
102230267|NCT04520035|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102230268|NCT04520035|Cisplatin|cisplatin|mesh-list
102230269|NCT04520035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102230270|NCT04520035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102230271|NCT04520035|Tubulin Modulators|tubulin modulators|mesh-ancestor
102230272|NCT04520035|Antimitotic Agents|antimitotic agents|mesh-ancestor
102230273|NCT04520035|Mitosis Modulators|mitosis modulators|mesh-ancestor
102230274|NCT04520035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230275|NCT04208997|Amiodarone|amiodarone|mesh-list
102230276|NCT04208997|Sotalol|sotalol|mesh-list
102230277|NCT04208997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
102230278|NCT04208997|Vasodilator Agents|vasodilator agents|mesh-ancestor
102230279|NCT04208997|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102230280|NCT04208997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102230281|NCT04208997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230282|NCT04208997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101901146|NCT00367055|Rosiglitazone|rosiglitazone|mesh-list
102612659|NCT00002183|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102612660|NCT00002183|Protease Inhibitors|protease inhibitors|mesh-ancestor
102230283|NCT04208997|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102230284|NCT04208997|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102230285|NCT04208997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101633428|NCT04245085|Paclitaxel|paclitaxel|mesh-list
102230286|NCT04208997|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102230287|NCT04208997|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102230288|NCT04208997|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102230289|NCT04208997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102230290|NCT04208997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102230291|NCT04208997|Adrenergic Agents|adrenergic agents|mesh-ancestor
102230292|NCT04208997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102230293|NCT04208997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230294|NCT04208997|Sympatholytics|sympatholytics|mesh-ancestor
102230295|NCT04208997|Autonomic Agents|autonomic agents|mesh-ancestor
102230296|NCT04208997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102230297|NCT03355963|Botulinum Toxins|botulinum toxins|mesh-list
102230298|NCT03355963|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102230299|NCT03355963|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102230300|NCT03355963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102230301|NCT03355963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102230302|NCT03355963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230303|NCT03355963|Cholinergic Agents|cholinergic agents|mesh-ancestor
102230304|NCT03355963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102230305|NCT03355963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230306|NCT03355963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102230307|NCT03355963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102230308|NCT04518475|Rituximab|rituximab|mesh-list
102230309|NCT04518475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102230310|NCT04518475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102230311|NCT04518475|Immunologic Factors|immunologic factors|mesh-ancestor
102230312|NCT04518475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939167|NCT04297150|Apixaban|apixaban|mesh-list
102230313|NCT04518475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102230314|NCT04278651|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102230316|NCT04278651|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102230317|NCT04278651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102230318|NCT05125575|Metformin|metformin|mesh-list
102230319|NCT05125575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102230320|NCT05125575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230321|NCT03366883|Paclitaxel|paclitaxel|mesh-list
102230322|NCT03366883|Cisplatin|cisplatin|mesh-list
102230323|NCT03366883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102230324|NCT03366883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102230325|NCT03366883|Tubulin Modulators|tubulin modulators|mesh-ancestor
102230326|NCT03366883|Antimitotic Agents|antimitotic agents|mesh-ancestor
102230327|NCT03366883|Mitosis Modulators|mitosis modulators|mesh-ancestor
102230328|NCT03366883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230329|NCT03366571|Entecavir|entecavir|mesh-list
102230330|NCT03366571|Antiviral Agents|antiviral agents|mesh-ancestor
102230331|NCT03366571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102230332|NCT05124951|Carboplatin|carboplatin|mesh-list
102230333|NCT05124951|Etoposide|etoposide|mesh-list
102230334|NCT05124951|Etoposide phosphate|etoposide phosphate|mesh-list
102230335|NCT05124951|Ifosfamide|ifosfamide|mesh-list
102230336|NCT05124951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101633451|NCT00711841|BB 1101|bb 1101|mesh-list
102230337|NCT05124951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102230338|NCT05124951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102230339|NCT05124951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102230340|NCT05124951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102230341|NCT05124951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230342|NCT05124951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102230343|NCT05124951|Alkylating Agents|alkylating agents|mesh-ancestor
102230344|NCT04523077|Antibodies|antibodies|mesh-list
102230345|NCT04523077|Hormones|hormones|mesh-list
102230346|NCT04523077|Immunologic Factors|immunologic factors|mesh-ancestor
102230347|NCT04523077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230348|NCT04523077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102230349|NCT05124717|Metformin|metformin|mesh-list
102230350|NCT05124717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102230351|NCT05124717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230352|NCT04139655|Colchicine|colchicine|mesh-list
102230353|NCT04139655|Gout Suppressants|gout suppressants|mesh-ancestor
102230354|NCT04139655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102230355|NCT04139655|Tubulin Modulators|tubulin modulators|mesh-ancestor
102230356|NCT04139655|Antimitotic Agents|antimitotic agents|mesh-ancestor
102230357|NCT04139655|Mitosis Modulators|mitosis modulators|mesh-ancestor
102230358|NCT04139655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230359|NCT04139655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102230360|NCT03366259|Misoprostol|misoprostol|mesh-list
102230361|NCT03366259|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102230362|NCT03366259|Abortifacient Agents|abortifacient agents|mesh-ancestor
102230363|NCT03366259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102230364|NCT03366259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230365|NCT03366259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102230366|NCT03366259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102230367|NCT03366259|Oxytocics|oxytocics|mesh-ancestor
102230368|NCT03366025|Progesterone|progesterone|mesh-list
102230369|NCT03366025|Progestins|progestins|mesh-ancestor
102230370|NCT03366025|Hormones|hormones|mesh-ancestor
102230371|NCT03366025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102230372|NCT03366025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230373|NCT05115591|Anesthetics|anesthetics|mesh-list
102230374|NCT05115591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102230375|NCT05115591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230376|NCT05403099|Hyaluronic Acid|hyaluronic acid|mesh-list
102230377|NCT05403099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102230378|NCT05403099|Immunologic Factors|immunologic factors|mesh-ancestor
102230379|NCT05403099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230380|NCT05403099|Viscosupplements|viscosupplements|mesh-ancestor
102230381|NCT05403099|Protective Agents|protective agents|mesh-ancestor
102230382|NCT03365869|Sirolimus|sirolimus|mesh-list
102230383|NCT03365869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102230384|NCT03365869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102230385|NCT03365869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102230386|NCT03365869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102230387|NCT03365869|Antifungal Agents|antifungal agents|mesh-ancestor
101939239|NCT00004635|Leprostatic Agents|leprostatic agents|mesh-ancestor
102230388|NCT03365869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102230389|NCT03365869|Immunologic Factors|immunologic factors|mesh-ancestor
102230390|NCT03365869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230391|NCT04932213|Tropicamide|tropicamide|mesh-list
102230392|NCT04932213|Mydriatics|mydriatics|mesh-ancestor
102230393|NCT04932213|Autonomic Agents|autonomic agents|mesh-ancestor
102230394|NCT04932213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102230395|NCT04932213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230396|NCT04932213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102230397|NCT04932213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102230398|NCT04932213|Cholinergic Agents|cholinergic agents|mesh-ancestor
102230399|NCT04932213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102230400|NCT04932213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230401|NCT03684213|Ascorbic Acid|ascorbic acid|mesh-list
102230402|NCT03684213|Norepinephrine|norepinephrine|mesh-list
102230403|NCT03684213|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
102230404|NCT03684213|Antioxidants|antioxidants|mesh-ancestor
102230405|NCT03684213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230406|NCT03684213|Protective Agents|protective agents|mesh-ancestor
102230407|NCT03684213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230408|NCT03684213|Vitamins|vitamins|mesh-ancestor
102230409|NCT03684213|Micronutrients|micronutrients|mesh-ancestor
102230410|NCT03684213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102230411|NCT03684213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102230412|NCT03684213|Adrenergic Agents|adrenergic agents|mesh-ancestor
102230413|NCT03684213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102230414|NCT03684213|Sympathomimetics|sympathomimetics|mesh-ancestor
102230415|NCT03684213|Autonomic Agents|autonomic agents|mesh-ancestor
102230416|NCT03684213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102230417|NCT03684213|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102230418|NCT03684213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102230419|NCT03365479|Iloprost|iloprost|mesh-list
102230420|NCT03365479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102230421|NCT03365479|Vasodilator Agents|vasodilator agents|mesh-ancestor
102230422|NCT03355027|Atorvastatin|atorvastatin|mesh-list
102230423|NCT03355027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102230424|NCT03355027|Simvastatin|simvastatin|mesh-list
102230425|NCT03355027|Ezetimibe|ezetimibe|mesh-list
102230426|NCT03355027|Alirocumab|alirocumab|mesh-list
102230427|NCT03355027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102230428|NCT03355027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102230429|NCT03355027|Antimetabolites|antimetabolites|mesh-ancestor
102230430|NCT03355027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612661|NCT00002189|Paclitaxel|paclitaxel|mesh-list
102230431|NCT03355027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102230432|NCT03355027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102612662|NCT00002189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102230433|NCT03355027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102230434|NCT03355027|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102230435|NCT03355027|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102230436|NCT03355027|Protease Inhibitors|protease inhibitors|mesh-ancestor
102230437|NCT03828045|Apremilast|apremilast|mesh-list
102230438|NCT03828045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102230439|NCT03828045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102230440|NCT03828045|Analgesics|analgesics|mesh-ancestor
102230441|NCT03828045|Sensory System Agents|sensory system agents|mesh-ancestor
102230442|NCT03828045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102230443|NCT03828045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230444|NCT03828045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102230445|NCT03828045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102230446|NCT03828045|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102230447|NCT03828045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102230448|NCT03828045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102230449|NCT03828045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230450|NCT03123679|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
102230451|NCT03123679|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102230452|NCT03123679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230453|NCT02519413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102230454|NCT02519413|Dermatologic Agents|dermatologic agents|mesh-ancestor
102230455|NCT02519413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102230456|NCT02519413|Immunologic Factors|immunologic factors|mesh-ancestor
102230457|NCT02519413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230458|NCT02519335|Dexrazoxane|dexrazoxane|mesh-list
102230459|NCT02519335|Razoxane|razoxane|mesh-list
102230460|NCT02519335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102230461|NCT02519335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101939318|NCT00003645|Leuprolide|leuprolide|mesh-list
102230462|NCT02519335|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102230463|NCT02519335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102230464|NCT02519335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102230465|NCT02519335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230467|NCT02519335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230468|NCT02519335|Antimitotic Agents|antimitotic agents|mesh-ancestor
102230469|NCT02519335|Mitosis Modulators|mitosis modulators|mesh-ancestor
102230470|NCT04509583|Vitamin E|vitamin e|mesh-list
102230471|NCT04509583|Vitamins|vitamins|mesh-ancestor
102230472|NCT04509583|Micronutrients|micronutrients|mesh-ancestor
102230473|NCT04509583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230474|NCT04509583|Antioxidants|antioxidants|mesh-ancestor
102230475|NCT04509583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230476|NCT04509583|Protective Agents|protective agents|mesh-ancestor
102230477|NCT04509661|Bronchodilator Agents|bronchodilator agents|mesh-list
102230478|NCT04509661|Autonomic Agents|autonomic agents|mesh-ancestor
102230479|NCT04509661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102230480|NCT04509661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230481|NCT04509661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102230482|NCT04509661|Respiratory System Agents|respiratory system agents|mesh-ancestor
102230483|NCT03350737|Heparin|heparin|mesh-list
102230484|NCT03350737|Anticoagulants|anticoagulants|mesh-ancestor
102230485|NCT03350737|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102230486|NCT03350737|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102230487|NCT03350737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230488|NCT03350659|Midodrine|midodrine|mesh-list
102230489|NCT03350659|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102230490|NCT03350659|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102230491|NCT03350659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102230492|NCT03350659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102230493|NCT03350659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230494|NCT03350659|Adrenergic Agents|adrenergic agents|mesh-ancestor
102230495|NCT03350659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102230496|NCT03350659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230497|NCT03350659|Sympathomimetics|sympathomimetics|mesh-ancestor
102230498|NCT03350659|Autonomic Agents|autonomic agents|mesh-ancestor
102230499|NCT03350659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102230500|NCT03350659|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102230501|NCT03350659|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102230502|NCT03350659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102230503|NCT03350659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102230504|NCT04443517|Propofol|propofol|mesh-list
102230505|NCT04443517|Anesthetics|anesthetics|mesh-ancestor
101901150|NCT00057330|polysaccharide-K|polysaccharide-k|mesh-list
102230506|NCT04443517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102230507|NCT04443517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230508|NCT04443517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102230509|NCT04443517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102230510|NCT04443517|Anesthetics, General|anesthetics, general|mesh-ancestor
102230511|NCT03350347|Darbepoetin alfa|darbepoetin alfa|mesh-list
102230512|NCT03350347|Hematinics|hematinics|mesh-ancestor
102230513|NCT03350191|Exenatide|exenatide|mesh-list
102230514|NCT03350191|Glucagon|glucagon|mesh-list
102230515|NCT03350191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102230516|NCT03350191|Hormones|hormones|mesh-ancestor
102230517|NCT03350191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102230518|NCT03350191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230519|NCT03350191|Incretins|incretins|mesh-ancestor
102230520|NCT03350191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102230521|NCT03350191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102230522|NCT02649231|Ketamine|ketamine|mesh-list
102230523|NCT02649231|Analgesics|analgesics|mesh-ancestor
102230524|NCT02649231|Sensory System Agents|sensory system agents|mesh-ancestor
102230525|NCT02649231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102230526|NCT02649231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230527|NCT02649231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102230528|NCT02649231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102230529|NCT02649231|Anesthetics, General|anesthetics, general|mesh-ancestor
102230530|NCT02649231|Anesthetics|anesthetics|mesh-ancestor
102230531|NCT02649231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101633562|NCT02537925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102230532|NCT02649231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102230533|NCT02649231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102230534|NCT02649231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102230535|NCT02649231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230536|NCT03364075|Propranolol|propranolol|mesh-list
102230537|NCT03364075|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102230538|NCT03364075|Serotonin|serotonin|mesh-list
101939386|NCT02530047|Interferons|interferons|mesh-list
102230539|NCT03364075|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102230540|NCT03364075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102230541|NCT03364075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102230542|NCT03364075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230543|NCT03364075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102230544|NCT03364075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230546|NCT03364075|Sensory System Agents|sensory system agents|mesh-ancestor
102230547|NCT03364075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102230548|NCT03364075|Antidepressive Agents|antidepressive agents|mesh-ancestor
102230549|NCT03364075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102230550|NCT03364075|Dopamine Agents|dopamine agents|mesh-ancestor
102230551|NCT03364075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102230552|NCT03364075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102230553|NCT03364075|Adrenergic Agents|adrenergic agents|mesh-ancestor
102230554|NCT03364075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102230555|NCT03364075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102230556|NCT03364075|Vasodilator Agents|vasodilator agents|mesh-ancestor
102230557|NCT03364075|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102230558|NCT03364075|Serotonin Agents|serotonin agents|mesh-ancestor
102230559|NCT03349957|Idarubicin|idarubicin|mesh-list
102230560|NCT03349957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102230561|NCT03349957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102230562|NCT03349957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102230563|NCT03349957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102230564|NCT03349957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102230565|NCT03349957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230566|NCT04524169|Thymalfasin|thymalfasin|mesh-list
102230567|NCT04524169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102230568|NCT04524169|Immunologic Factors|immunologic factors|mesh-ancestor
102230569|NCT04524169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230570|NCT03568929|Idelalisib|idelalisib|mesh-list
102230571|NCT03568929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102230572|NCT03568929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102230573|NCT03568929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230574|NCT04503967|Nivolumab|nivolumab|mesh-list
102230575|NCT04503967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102230576|NCT04503967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102230577|NCT04503967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102612663|NCT00002189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101901152|NCT00057330|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
102612664|NCT00002189|Tubulin Modulators|tubulin modulators|mesh-ancestor
102612665|NCT00002189|Antimitotic Agents|antimitotic agents|mesh-ancestor
102612666|NCT00002189|Mitosis Modulators|mitosis modulators|mesh-ancestor
102230578|NCT04503967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230579|NCT04841499|Niacinamide|niacinamide|mesh-list
102230580|NCT04841499|Niacin|niacin|mesh-list
102230581|NCT04841499|Nicotinic Acids|nicotinic acids|mesh-list
102230582|NCT04841499|Vitamin B Complex|vitamin b complex|mesh-ancestor
102230583|NCT04841499|Vitamins|vitamins|mesh-ancestor
102230584|NCT04841499|Micronutrients|micronutrients|mesh-ancestor
102230585|NCT04841499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230586|NCT04841499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102230587|NCT04841499|Antimetabolites|antimetabolites|mesh-ancestor
102230588|NCT04841499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230589|NCT04841499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102230590|NCT04841499|Vasodilator Agents|vasodilator agents|mesh-ancestor
102230591|NCT04773405|Lidocaine|lidocaine|mesh-list
102230592|NCT04773405|Epinephrine|epinephrine|mesh-list
102230593|NCT04773405|Levobupivacaine|levobupivacaine|mesh-list
102230594|NCT04773405|Anesthetics, Local|anesthetics, local|mesh-ancestor
102230595|NCT04773405|Anesthetics|anesthetics|mesh-ancestor
102230596|NCT04773405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102230597|NCT04773405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230598|NCT04773405|Sensory System Agents|sensory system agents|mesh-ancestor
102230599|NCT04773405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102230600|NCT04773405|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102230601|NCT04773405|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102230602|NCT04773405|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102230603|NCT04773405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102230604|NCT04773405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230605|NCT04773405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102230606|NCT04773405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102230607|NCT04773405|Adrenergic Agents|adrenergic agents|mesh-ancestor
102230608|NCT04773405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102230609|NCT04773405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102230610|NCT04773405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102230611|NCT04773405|Autonomic Agents|autonomic agents|mesh-ancestor
102230612|NCT04773405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102230613|NCT04773405|Respiratory System Agents|respiratory system agents|mesh-ancestor
102230614|NCT04773405|Mydriatics|mydriatics|mesh-ancestor
102230615|NCT04773405|Sympathomimetics|sympathomimetics|mesh-ancestor
102230616|NCT04773405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102230617|NCT04991571|Dapagliflozin|dapagliflozin|mesh-list
102230618|NCT04991571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102230619|NCT04991571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230620|NCT04991571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102230621|NCT04991571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230622|NCT01376245|Fluticasone|fluticasone|mesh-list
102230623|NCT01376245|Xhance|xhance|mesh-list
102230624|NCT01376245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102230625|NCT01376245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102230626|NCT01376245|Autonomic Agents|autonomic agents|mesh-ancestor
102230627|NCT01376245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102230628|NCT01376245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230629|NCT01376245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102230630|NCT01376245|Respiratory System Agents|respiratory system agents|mesh-ancestor
102230631|NCT01376245|Dermatologic Agents|dermatologic agents|mesh-ancestor
102230632|NCT01376245|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102230633|NCT04754061|Psilocybin|psilocybin|mesh-list
102230634|NCT04754061|Hallucinogens|hallucinogens|mesh-ancestor
102230635|NCT04754061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230636|NCT04754061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102230637|NCT03349489|Insulin|insulin|mesh-list
102230638|NCT03349489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102230639|NCT03349489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102230640|NCT03349489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230641|NCT04584567|Doxycycline|doxycycline|mesh-list
102230642|NCT04584567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102230643|NCT04584567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102230644|NCT04584567|Antimalarials|antimalarials|mesh-ancestor
102230645|NCT04584567|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102230646|NCT04584567|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102230647|NCT03349177|Cyclophosphamide|cyclophosphamide|mesh-list
102230648|NCT03349177|Docetaxel|docetaxel|mesh-list
102230649|NCT03349177|Fluorouracil|fluorouracil|mesh-list
102230650|NCT03349177|Epirubicin|epirubicin|mesh-list
102230651|NCT03349177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102230652|NCT03349177|Immunologic Factors|immunologic factors|mesh-ancestor
102230653|NCT03349177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230654|NCT03349177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102230655|NCT03349177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102230656|NCT03349177|Alkylating Agents|alkylating agents|mesh-ancestor
102230657|NCT03349177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230658|NCT03349177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102230659|NCT03349177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102230660|NCT03349177|Tubulin Modulators|tubulin modulators|mesh-ancestor
102230661|NCT03349177|Antimitotic Agents|antimitotic agents|mesh-ancestor
102230662|NCT03349177|Mitosis Modulators|mitosis modulators|mesh-ancestor
102230663|NCT03349177|Antimetabolites|antimetabolites|mesh-ancestor
102230664|NCT03349177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102230665|NCT03349177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102230666|NCT03349177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102230667|NCT03349177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102230668|NCT03349177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102230669|NCT04691505|Hydroxychloroquine|hydroxychloroquine|mesh-list
102230670|NCT04691505|Methotrexate|methotrexate|mesh-list
102230671|NCT04691505|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102230672|NCT04691505|Abortifacient Agents|abortifacient agents|mesh-ancestor
102230673|NCT04691505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102230674|NCT04691505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230675|NCT04691505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102230676|NCT04691505|Antimetabolites|antimetabolites|mesh-ancestor
102230677|NCT04691505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230678|NCT04691505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102230679|NCT04691505|Dermatologic Agents|dermatologic agents|mesh-ancestor
102230680|NCT04691505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102230681|NCT04691505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102230682|NCT04691505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102230683|NCT04691505|Immunologic Factors|immunologic factors|mesh-ancestor
102230684|NCT04691505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102230685|NCT04691505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102230686|NCT04691505|Antimalarials|antimalarials|mesh-ancestor
102230687|NCT04691505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102230688|NCT04691505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102230689|NCT04691505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102230690|NCT05364619|Bismuth|bismuth|mesh-list
102230691|NCT05364619|Antacids|antacids|mesh-ancestor
102230692|NCT05364619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230693|NCT05364619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102230694|NCT03353857|Rifampin|rifampin|mesh-list
102230695|NCT03353857|Dienogest|dienogest|mesh-list
102230696|NCT03353857|Drospirenone|drospirenone|mesh-list
102230697|NCT03353857|Midazolam|midazolam|mesh-list
102230698|NCT03353857|Levonorgestrel|levonorgestrel|mesh-list
102230699|NCT03353857|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102230700|NCT03353857|Norethindrone|norethindrone|mesh-list
102230701|NCT03353857|Norethindrone Acetate|norethindrone acetate|mesh-list
102230702|NCT03353857|Desogestrel|desogestrel|mesh-list
102230703|NCT03353857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102230704|NCT03353857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102230705|NCT03353857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102230706|NCT03353857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230707|NCT03353857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102230708|NCT03353857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102230709|NCT03353857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102230710|NCT03353857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102230711|NCT03353857|Anesthetics, General|anesthetics, general|mesh-ancestor
102230712|NCT03353857|Anesthetics|anesthetics|mesh-ancestor
102230713|NCT03353857|GABA Modulators|gaba modulators|mesh-ancestor
102230714|NCT03353857|GABA Agents|gaba agents|mesh-ancestor
102230715|NCT03353857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102230716|NCT03353857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230717|NCT03353857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102230718|NCT03353857|Contraceptive Agents|contraceptive agents|mesh-ancestor
102230719|NCT03353857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102230720|NCT03353857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102230721|NCT03353857|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102230722|NCT03353857|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102230723|NCT03353857|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102230724|NCT03353857|Antitubercular Agents|antitubercular agents|mesh-ancestor
102230725|NCT03353857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102612667|NCT00002189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230726|NCT03353857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102230727|NCT03353857|Leprostatic Agents|leprostatic agents|mesh-ancestor
101901157|NCT00057330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102230728|NCT03353857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102230729|NCT03353857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102230730|NCT03353857|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102230731|NCT03353857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102230732|NCT03353857|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102230733|NCT03353857|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101633643|NCT02686905|Calcium, Dietary|calcium, dietary|mesh-list
102230734|NCT03353857|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102230735|NCT03353857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102230736|NCT03353857|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102230737|NCT03353857|Estrogens|estrogens|mesh-ancestor
102230738|NCT03353857|Hormones|hormones|mesh-ancestor
102230739|NCT03353857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102230740|NCT03353857|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102230741|NCT03353857|Hormone Antagonists|hormone antagonists|mesh-ancestor
102230742|NCT03353857|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102230743|NCT03353857|Diuretics|diuretics|mesh-ancestor
102230744|NCT03353857|Natriuretic Agents|natriuretic agents|mesh-ancestor
102230745|NCT03353857|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102230746|NCT03353857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102230747|NCT03353857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102230748|NCT03353857|Progestins|progestins|mesh-ancestor
102230749|NCT04499859|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102230750|NCT04499859|Ezetimibe|ezetimibe|mesh-list
102230751|NCT04499859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102230752|NCT04499859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102230753|NCT04499859|Antimetabolites|antimetabolites|mesh-ancestor
102230754|NCT04499859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230755|NCT04499859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102230756|NCT04499859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102230757|NCT04499859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102230758|NCT05306899|Ketamine|ketamine|mesh-list
102230759|NCT05306899|Analgesics|analgesics|mesh-ancestor
102230760|NCT05306899|Sensory System Agents|sensory system agents|mesh-ancestor
102230761|NCT05306899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102230762|NCT05306899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230763|NCT05306899|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102230764|NCT05306899|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102230765|NCT05306899|Anesthetics, General|anesthetics, general|mesh-ancestor
102230766|NCT05306899|Anesthetics|anesthetics|mesh-ancestor
102230767|NCT05306899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102230768|NCT05306899|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102230769|NCT05306899|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102230770|NCT05306899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102230771|NCT05306899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230772|NCT00807651|Insulin|insulin|mesh-list
102230773|NCT00807651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102230774|NCT00807651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102230775|NCT00807651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230776|NCT00700791|Vitamins|vitamins|mesh-list
102230777|NCT00700791|Vitamin E|vitamin e|mesh-list
102230778|NCT00700791|Tocopherols|tocopherols|mesh-list
102230779|NCT00700791|Tocotrienols|tocotrienols|mesh-list
102230780|NCT00700791|alpha-Tocopherol|alpha-tocopherol|mesh-list
102230781|NCT00700791|Micronutrients|micronutrients|mesh-ancestor
102230782|NCT00700791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230783|NCT00700791|Antioxidants|antioxidants|mesh-ancestor
102230784|NCT00700791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230785|NCT00700791|Protective Agents|protective agents|mesh-ancestor
102230786|NCT05344365|Iloperidone|iloperidone|mesh-list
102230787|NCT05344365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102230788|NCT05344365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102230789|NCT05344365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102230790|NCT05344365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230791|NCT05344365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102230792|NCT04373733|Favipiravir|favipiravir|mesh-list
102230793|NCT04373733|Antiviral Agents|antiviral agents|mesh-ancestor
102230794|NCT04373733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102230795|NCT05403489|Dimercaprol|dimercaprol|mesh-list
102230796|NCT05403489|Chelating Agents|chelating agents|mesh-ancestor
102230797|NCT05403489|Sequestering Agents|sequestering agents|mesh-ancestor
102230798|NCT05403489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230799|NCT04969731|Gemcitabine|gemcitabine|mesh-list
102230800|NCT04969731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102612668|NCT00002195|Lamivudine|lamivudine|mesh-list
102230801|NCT04969731|Antimetabolites|antimetabolites|mesh-ancestor
102612669|NCT00002195|Zidovudine|zidovudine|mesh-list
102612670|NCT00002195|Amprenavir|amprenavir|mesh-list
102230802|NCT04969731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230803|NCT04969731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102230804|NCT02045901|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
102230805|NCT02045901|Antiemetics|antiemetics|mesh-ancestor
102230806|NCT02045901|Autonomic Agents|autonomic agents|mesh-ancestor
102230807|NCT02045901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102230808|NCT02045901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230809|NCT02045901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102230810|NCT02045901|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102230811|NCT02045901|Histamine Antagonists|histamine antagonists|mesh-ancestor
102230812|NCT02045901|Histamine Agents|histamine agents|mesh-ancestor
101633711|NCT00778102|Leucovorin|leucovorin|mesh-list
102230813|NCT02045901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102230814|NCT02045901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230815|NCT01674621|Abaloparatide|abaloparatide|mesh-list
102230816|NCT01674621|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
102230817|NCT01674621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102230818|NCT01674621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230819|NCT01674621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102230820|NCT04644705|Niclosamide|niclosamide|mesh-list
102230821|NCT04644705|Anticestodal Agents|anticestodal agents|mesh-ancestor
102230822|NCT04644705|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102230823|NCT04644705|Anthelmintics|anthelmintics|mesh-ancestor
102230824|NCT04644705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102230825|NCT04644705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102230826|NCT04644705|Antinematodal Agents|antinematodal agents|mesh-ancestor
102230827|NCT04038489|Aspirin|aspirin|mesh-list
102230828|NCT04038489|Tamoxifen|tamoxifen|mesh-list
102230829|NCT04038489|Paclitaxel|paclitaxel|mesh-list
102230830|NCT04038489|Cyclophosphamide|cyclophosphamide|mesh-list
102230831|NCT04038489|Doxorubicin|doxorubicin|mesh-list
102230832|NCT04038489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102230833|NCT04038489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102230834|NCT04038489|Tubulin Modulators|tubulin modulators|mesh-ancestor
102230835|NCT04038489|Antimitotic Agents|antimitotic agents|mesh-ancestor
102230836|NCT04038489|Mitosis Modulators|mitosis modulators|mesh-ancestor
102230837|NCT04038489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230838|NCT04038489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102230839|NCT04038489|Immunologic Factors|immunologic factors|mesh-ancestor
102230840|NCT04038489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230841|NCT04038489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102230842|NCT04038489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102230843|NCT04038489|Alkylating Agents|alkylating agents|mesh-ancestor
102230844|NCT04038489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102230845|NCT04038489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102230846|NCT04038489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102230847|NCT04038489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102230848|NCT04038489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102230849|NCT04038489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102230850|NCT04038489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102230851|NCT04038489|Analgesics|analgesics|mesh-ancestor
102230852|NCT04038489|Sensory System Agents|sensory system agents|mesh-ancestor
102230853|NCT04038489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102230854|NCT04038489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102230855|NCT04038489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102230856|NCT04038489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102230857|NCT04038489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102230858|NCT04038489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102230859|NCT04038489|Antipyretics|antipyretics|mesh-ancestor
102230860|NCT04038489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102230861|NCT04038489|Hormone Antagonists|hormone antagonists|mesh-ancestor
102230862|NCT04038489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102230863|NCT04038489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102230864|NCT04038489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102230865|NCT04038489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102230866|NCT04038489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102230867|NCT04468425|Tofacitinib|tofacitinib|mesh-list
102230868|NCT04468425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230869|NCT04468425|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102230870|NCT04468425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102230871|NCT04468425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102230872|NCT04287855|Dexamethasone|dexamethasone|mesh-list
102230873|NCT04287855|Pomalidomide|pomalidomide|mesh-list
102612671|NCT00002195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102230874|NCT04287855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102230875|NCT04287855|Antiemetics|antiemetics|mesh-ancestor
102230876|NCT04287855|Autonomic Agents|autonomic agents|mesh-ancestor
102230877|NCT04287855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102230878|NCT04287855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230879|NCT04287855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102230880|NCT04287855|Glucocorticoids|glucocorticoids|mesh-ancestor
102230881|NCT04287855|Hormones|hormones|mesh-ancestor
102230882|NCT04287855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102230883|NCT04287855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102230884|NCT04287855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102230885|NCT04287855|Immunologic Factors|immunologic factors|mesh-ancestor
102230886|NCT04287855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102230887|NCT04287855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102230888|NCT04287855|Growth Substances|growth substances|mesh-ancestor
102230889|NCT04287855|Growth Inhibitors|growth inhibitors|mesh-ancestor
102230890|NCT04435587|Ritonavir|ritonavir|mesh-list
102230891|NCT04435587|Darunavir|darunavir|mesh-list
102230892|NCT04435587|Hydroxychloroquine|hydroxychloroquine|mesh-list
102230893|NCT04435587|Ivermectin|ivermectin|mesh-list
102230894|NCT04435587|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102230895|NCT04435587|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102230896|NCT04435587|Protease Inhibitors|protease inhibitors|mesh-ancestor
102230897|NCT04435587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102230898|NCT04435587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230899|NCT04435587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102230900|NCT04435587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102230901|NCT04435587|Antiviral Agents|antiviral agents|mesh-ancestor
102230902|NCT04435587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102230903|NCT04435587|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102230904|NCT04435587|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102230905|NCT04435587|Antimalarials|antimalarials|mesh-ancestor
102230906|NCT04435587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102230907|NCT04435587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102230908|NCT04435587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102230909|NCT05131893|Tamoxifen|tamoxifen|mesh-list
102230910|NCT05131893|Docetaxel|docetaxel|mesh-list
102230911|NCT05131893|Cyclophosphamide|cyclophosphamide|mesh-list
102230912|NCT05131893|Capecitabine|capecitabine|mesh-list
102230913|NCT05131893|Trastuzumab|trastuzumab|mesh-list
102230914|NCT05131893|Letrozole|letrozole|mesh-list
102230915|NCT05131893|Epirubicin|epirubicin|mesh-list
102230916|NCT05131893|Pertuzumab|pertuzumab|mesh-list
102230917|NCT05131893|Goserelin|goserelin|mesh-list
102230918|NCT05131893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102230919|NCT05131893|Tubulin Modulators|tubulin modulators|mesh-ancestor
102230920|NCT05131893|Antimitotic Agents|antimitotic agents|mesh-ancestor
102230921|NCT05131893|Mitosis Modulators|mitosis modulators|mesh-ancestor
102230922|NCT05131893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230923|NCT05131893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102230924|NCT05131893|Immunologic Factors|immunologic factors|mesh-ancestor
102230925|NCT05131893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230926|NCT05131893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102230927|NCT05131893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102230928|NCT05131893|Alkylating Agents|alkylating agents|mesh-ancestor
102230929|NCT05131893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102230930|NCT05131893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102230931|NCT05131893|Antimetabolites|antimetabolites|mesh-ancestor
102230932|NCT05131893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102230933|NCT05131893|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102230934|NCT05131893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102230935|NCT05131893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102230936|NCT05131893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102230937|NCT05131893|Hormone Antagonists|hormone antagonists|mesh-ancestor
102230938|NCT05131893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102230939|NCT05131893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102230940|NCT05131893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102230941|NCT05131893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102230942|NCT05131893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102230943|NCT05131893|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102230944|NCT05131893|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102230945|NCT05131893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102230946|NCT02889237|Calcium, Dietary|calcium, dietary|mesh-list
102230947|NCT02889237|Vitamin D|vitamin d|mesh-list
102230948|NCT02889237|Ergocalciferols|ergocalciferols|mesh-list
102230949|NCT02889237|Cholecalciferol|cholecalciferol|mesh-list
102230950|NCT02889237|Vitamins|vitamins|mesh-list
102230951|NCT02889237|Calcium|calcium|mesh-list
102230952|NCT02889237|Micronutrients|micronutrients|mesh-ancestor
102230953|NCT02889237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230954|NCT02889237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102230955|NCT02889237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102230956|NCT02689167|Sunitinib|sunitinib|mesh-list
102230957|NCT02689167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102230958|NCT02689167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102230959|NCT02689167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102230960|NCT02689167|Growth Substances|growth substances|mesh-ancestor
102230961|NCT02689167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230962|NCT02689167|Growth Inhibitors|growth inhibitors|mesh-ancestor
102230963|NCT02689167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102230964|NCT02689167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102230965|NCT02689167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230966|NCT02582697|Cisplatin|cisplatin|mesh-list
102230967|NCT02582697|Etoposide|etoposide|mesh-list
102230968|NCT02582697|Etoposide phosphate|etoposide phosphate|mesh-list
102230969|NCT02582697|Bleomycin|bleomycin|mesh-list
102230970|NCT02582697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102230971|NCT02582697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102230972|NCT02582697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102230973|NCT02582697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102230974|NCT02582697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102230975|NCT02582697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230976|NCT02582697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102230977|NCT01503489|Norepinephrine|norepinephrine|mesh-list
102230978|NCT01503489|Antidepressive Agents|antidepressive agents|mesh-list
102230979|NCT01503489|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
102230980|NCT01503489|Serotonin|serotonin|mesh-list
102230981|NCT01503489|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
102230982|NCT01503489|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102230983|NCT01503489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102230984|NCT01503489|Adrenergic Agents|adrenergic agents|mesh-ancestor
102230985|NCT01503489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102230986|NCT01503489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102230987|NCT01503489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102230988|NCT01503489|Sympathomimetics|sympathomimetics|mesh-ancestor
102230989|NCT01503489|Autonomic Agents|autonomic agents|mesh-ancestor
102230990|NCT01503489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102230991|NCT01503489|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102230992|NCT01503489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102230993|NCT01503489|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102230994|NCT01503489|Serotonin Agents|serotonin agents|mesh-ancestor
102230995|NCT01503489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102230996|NCT01503489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102230997|NCT05059587|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102230998|NCT05059587|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102230999|NCT05059587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102231000|NCT05059587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231001|NCT05059587|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102231002|NCT05059587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102231003|NCT05059587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231004|NCT05059587|Cholinergic Agents|cholinergic agents|mesh-ancestor
102231005|NCT05059587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102231006|NCT05137197|Antidepressive Agents|antidepressive agents|mesh-list
102231007|NCT05137197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102231008|NCT05135715|Trastuzumab|trastuzumab|mesh-list
102231009|NCT05135715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102231010|NCT05135715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102231011|NCT05185167|Propofol|propofol|mesh-list
102231012|NCT05185167|Anesthetics|anesthetics|mesh-list
102231013|NCT05185167|Desflurane|desflurane|mesh-list
102231014|NCT05185167|Anesthetics, General|anesthetics, general|mesh-list
102231015|NCT05185167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102231016|NCT05185167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102231017|NCT05185167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231018|NCT05185167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102231019|NCT05185167|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102231020|NCT05133453|Pirfenidone|pirfenidone|mesh-list
102231021|NCT05133453|Analgesics|analgesics|mesh-ancestor
102231022|NCT05133453|Sensory System Agents|sensory system agents|mesh-ancestor
102231023|NCT05133453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102612672|NCT00002195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102231024|NCT05133453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102612673|NCT00002195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102231025|NCT05133453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102231026|NCT05133453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102231027|NCT05133453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102231028|NCT05133453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102231029|NCT05133453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102231030|NCT05125185|Insulin|insulin|mesh-list
102231031|NCT05125185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102231032|NCT05125185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231033|NCT04244877|Rifaximin|rifaximin|mesh-list
102231034|NCT04244877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102231035|NCT04244877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102231036|NCT04244877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102231037|NCT05118945|Insulin|insulin|mesh-list
102231038|NCT05118945|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102231039|NCT05118945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102231040|NCT05118945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231041|NCT05305131|Bevacizumab|bevacizumab|mesh-list
102231042|NCT05305131|Pembrolizumab|pembrolizumab|mesh-list
102231043|NCT05305131|Cisplatin|cisplatin|mesh-list
102231044|NCT05305131|Gemcitabine|gemcitabine|mesh-list
102231045|NCT05305131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102231046|NCT05305131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102231047|NCT05305131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102231048|NCT05305131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102231049|NCT05305131|Growth Substances|growth substances|mesh-ancestor
102231050|NCT05305131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231051|NCT05305131|Growth Inhibitors|growth inhibitors|mesh-ancestor
102231052|NCT05305131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102231053|NCT05305131|Antimetabolites|antimetabolites|mesh-ancestor
102231054|NCT05305131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231055|NCT05305131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102231056|NCT03122665|Nefopam|nefopam|mesh-list
102231057|NCT03122665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102231058|NCT03122665|Analgesics|analgesics|mesh-ancestor
102231059|NCT03122665|Sensory System Agents|sensory system agents|mesh-ancestor
102231060|NCT03122665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102231061|NCT03122665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231062|NCT05099913|Flupenthixol|flupenthixol|mesh-list
102231063|NCT05099913|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102231064|NCT05099913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102231065|NCT05099913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102231066|NCT05099913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231067|NCT05099913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102231068|NCT05099913|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102231069|NCT05099913|Dopamine Agents|dopamine agents|mesh-ancestor
102231070|NCT05099913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102231071|NCT05099913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231072|NCT03346993|Bupivacaine|bupivacaine|mesh-list
102231073|NCT03346993|Anesthetics, Local|anesthetics, local|mesh-ancestor
102231074|NCT03346993|Anesthetics|anesthetics|mesh-ancestor
102231075|NCT03346993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102231076|NCT03346993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231077|NCT03346993|Sensory System Agents|sensory system agents|mesh-ancestor
102231078|NCT03346993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102231079|NCT03346837|Itraconazole|itraconazole|mesh-list
102231080|NCT03346837|Rifampin|rifampin|mesh-list
102231081|NCT03346837|Linrodostat|linrodostat|mesh-list
102231082|NCT03346837|Antifungal Agents|antifungal agents|mesh-ancestor
102231083|NCT03346837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102231084|NCT03346837|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102231085|NCT03346837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102231086|NCT03346837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102231087|NCT03346837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231088|NCT03346837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102231089|NCT03346837|Hormone Antagonists|hormone antagonists|mesh-ancestor
102231090|NCT03346837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102231091|NCT03346837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231092|NCT03346837|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102231093|NCT03346837|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102231094|NCT03346837|Antitubercular Agents|antitubercular agents|mesh-ancestor
102231095|NCT03346837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102231096|NCT03346837|Leprostatic Agents|leprostatic agents|mesh-ancestor
102231097|NCT03346837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102231098|NCT03346837|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102231100|NCT03346837|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102231101|NCT03346837|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102231102|NCT03346837|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102231103|NCT03346837|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102231104|NCT04564521|Nitroglycerin|nitroglycerin|mesh-list
101633883|NCT02686047|Hylan|hylan|mesh-list
102231105|NCT04564521|Vasodilator Agents|vasodilator agents|mesh-ancestor
102231106|NCT05303961|Rebamipide|rebamipide|mesh-list
102231107|NCT05303961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102231108|NCT05303961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102231109|NCT05303961|Antioxidants|antioxidants|mesh-ancestor
102231110|NCT05303961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231111|NCT05303961|Protective Agents|protective agents|mesh-ancestor
102231112|NCT05303961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231113|NCT05303961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102231114|NCT03122353|Calcitriol|calcitriol|mesh-list
102231115|NCT03122353|Betamethasone|betamethasone|mesh-list
102231116|NCT03122353|Betamethasone Valerate|betamethasone valerate|mesh-list
102231117|NCT03122353|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102231118|NCT03122353|Betamethasone benzoate|betamethasone benzoate|mesh-list
102231119|NCT03122353|Calcipotriene|calcipotriene|mesh-list
102231120|NCT03122353|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102231121|NCT03122353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102231122|NCT03122353|Glucocorticoids|glucocorticoids|mesh-ancestor
102231123|NCT03122353|Hormones|hormones|mesh-ancestor
102231124|NCT03122353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102231125|NCT03122353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231126|NCT03122353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102231127|NCT03122353|Respiratory System Agents|respiratory system agents|mesh-ancestor
102231128|NCT03122353|Dermatologic Agents|dermatologic agents|mesh-ancestor
102231129|NCT03122353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102231130|NCT03122353|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102231131|NCT03122353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102231132|NCT03122353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231133|NCT03122353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102231134|NCT03122353|Vitamins|vitamins|mesh-ancestor
102231135|NCT03122353|Micronutrients|micronutrients|mesh-ancestor
102231136|NCT03122353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102231137|NCT05303259|Bevacizumab|bevacizumab|mesh-list
102231138|NCT05303259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102231139|NCT05303259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102231140|NCT05303259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102231141|NCT05303259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102231142|NCT05303259|Growth Substances|growth substances|mesh-ancestor
102231143|NCT05303259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231144|NCT05303259|Growth Inhibitors|growth inhibitors|mesh-ancestor
102231145|NCT03121963|Acetaminophen|acetaminophen|mesh-list
102231146|NCT03121963|Celecoxib|celecoxib|mesh-list
102231147|NCT03121963|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
102231148|NCT03121963|Oxycodone|oxycodone|mesh-list
102231149|NCT03121963|Gabapentin|gabapentin|mesh-list
102231150|NCT03121963|Hydrocodone|hydrocodone|mesh-list
102231151|NCT03121963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102231152|NCT03121963|Analgesics|analgesics|mesh-ancestor
102231153|NCT03121963|Sensory System Agents|sensory system agents|mesh-ancestor
102231154|NCT03121963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102231155|NCT03121963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231156|NCT03121963|Antipyretics|antipyretics|mesh-ancestor
102231157|NCT03121963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102231158|NCT03121963|Narcotics|narcotics|mesh-ancestor
102231159|NCT03121963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102231160|NCT03121963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102231161|NCT03121963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102231162|NCT03121963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102231163|NCT03121963|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102231164|NCT03121963|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102231165|NCT03121963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102231166|NCT03121963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231167|NCT03121963|Anticonvulsants|anticonvulsants|mesh-ancestor
102231168|NCT03121963|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102231169|NCT03121963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102231170|NCT03121963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102231171|NCT03121963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102231172|NCT03121963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102231174|NCT03121963|Antimanic Agents|antimanic agents|mesh-ancestor
102231175|NCT03121963|Antitussive Agents|antitussive agents|mesh-ancestor
102231176|NCT03121963|Respiratory System Agents|respiratory system agents|mesh-ancestor
102231177|NCT04502251|Naltrexone|naltrexone|mesh-list
102231178|NCT04502251|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102231179|NCT04502251|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102231180|NCT04502251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231181|NCT04502251|Sensory System Agents|sensory system agents|mesh-ancestor
101633941|NCT00717379|Immunologic Factors|immunologic factors|mesh-ancestor
102231182|NCT04502251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102231183|NCT02648217|Insulin|insulin|mesh-list
102231184|NCT02648217|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102231185|NCT02648217|Insulin Aspart|insulin aspart|mesh-list
102231186|NCT02648217|Insulin, Long-Acting|insulin, long-acting|mesh-list
102231187|NCT02648217|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102231188|NCT02648217|Biphasic Insulins|biphasic insulins|mesh-list
102231189|NCT02648217|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102231190|NCT02648217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231191|NCT03122041|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102231192|NCT03122041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102231193|NCT03122041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231194|NCT03122041|Incretins|incretins|mesh-ancestor
102231195|NCT03122041|Hormones|hormones|mesh-ancestor
102231196|NCT03122041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102231197|NCT03122041|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102231198|NCT03122041|Protease Inhibitors|protease inhibitors|mesh-ancestor
102231199|NCT03122041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102231200|NCT03122041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231201|NCT04943679|Interferons|interferons|mesh-list
102231202|NCT04943679|Interferon-alpha|interferon-alpha|mesh-list
102231203|NCT04943679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102231204|NCT04943679|Antiviral Agents|antiviral agents|mesh-ancestor
102231205|NCT04943679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102231206|NCT04943679|Immunologic Factors|immunologic factors|mesh-ancestor
102231207|NCT04943679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231208|NCT04507165|Analgesics, Opioid|analgesics, opioid|mesh-list
102231209|NCT04507165|Anesthetics|anesthetics|mesh-list
102231210|NCT04507165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102231211|NCT04507165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231212|NCT04507165|Narcotics|narcotics|mesh-ancestor
102231213|NCT04507165|Analgesics|analgesics|mesh-ancestor
102231214|NCT04507165|Sensory System Agents|sensory system agents|mesh-ancestor
102231215|NCT04507165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102231216|NCT04475991|Maraviroc|maraviroc|mesh-list
101940064|NCT01209351|Teduglutide|teduglutide|mesh-list
102231217|NCT04475991|Favipiravir|favipiravir|mesh-list
102231218|NCT04475991|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102231219|NCT04475991|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102231220|NCT04475991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231222|NCT04475991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102231223|NCT04475991|Antiviral Agents|antiviral agents|mesh-ancestor
102231224|NCT04475991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102231225|NCT04475991|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102231226|NCT03387475|Deferasirox|deferasirox|mesh-list
102231227|NCT03387475|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102231228|NCT03387475|Chelating Agents|chelating agents|mesh-ancestor
102231229|NCT03387475|Sequestering Agents|sequestering agents|mesh-ancestor
102231230|NCT03387475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231231|NCT04502017|Clopidogrel|clopidogrel|mesh-list
102231232|NCT04502017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102231233|NCT04502017|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102231234|NCT04502017|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102231235|NCT04502017|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102231236|NCT04502017|Purinergic Agents|purinergic agents|mesh-ancestor
102231237|NCT04502017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102231238|NCT04502017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231239|NCT04502017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231240|NCT05302713|Calcium, Dietary|calcium, dietary|mesh-list
102231241|NCT05302713|Calcium Carbonate|calcium carbonate|mesh-list
102231242|NCT05302713|Calcium|calcium|mesh-list
102231243|NCT05302713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102231244|NCT05302713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231245|NCT05302713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102231246|NCT05302713|Antacids|antacids|mesh-ancestor
101901162|NCT00057330|Protective Agents|protective agents|mesh-ancestor
102231247|NCT05302713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231249|NCT04921033|Prednisolone|prednisolone|mesh-list
102231250|NCT04921033|Budesonide|budesonide|mesh-list
102231251|NCT04921033|Azathioprine|azathioprine|mesh-list
102231252|NCT04921033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102231253|NCT04921033|Glucocorticoids|glucocorticoids|mesh-ancestor
102231254|NCT04921033|Hormones|hormones|mesh-ancestor
102231255|NCT04921033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102231256|NCT04921033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231257|NCT04921033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102231258|NCT04921033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102231259|NCT04921033|Autonomic Agents|autonomic agents|mesh-ancestor
102231260|NCT04921033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102231261|NCT04921033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102231262|NCT04921033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102231263|NCT04921033|Respiratory System Agents|respiratory system agents|mesh-ancestor
102231264|NCT04921033|Antimetabolites|antimetabolites|mesh-ancestor
102231265|NCT04921033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231266|NCT04921033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102231267|NCT04921033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102231268|NCT04921033|Immunologic Factors|immunologic factors|mesh-ancestor
102231269|NCT04921033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102231270|NCT03346681|Acetylcysteine|acetylcysteine|mesh-list
102231271|NCT03346681|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102231272|NCT03346681|Antiviral Agents|antiviral agents|mesh-ancestor
102231273|NCT03346681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102231274|NCT03346681|Expectorants|expectorants|mesh-ancestor
102231275|NCT03346681|Respiratory System Agents|respiratory system agents|mesh-ancestor
102231276|NCT03346681|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102231277|NCT03346681|Antioxidants|antioxidants|mesh-ancestor
102231278|NCT03346681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231279|NCT03346681|Protective Agents|protective agents|mesh-ancestor
102231280|NCT03346681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231281|NCT03346681|Antidotes|antidotes|mesh-ancestor
102231282|NCT04488315|Dexamethasone|dexamethasone|mesh-list
102231283|NCT04488315|Ropivacaine|ropivacaine|mesh-list
102231284|NCT04488315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102231285|NCT04488315|Antiemetics|antiemetics|mesh-ancestor
102231286|NCT04488315|Autonomic Agents|autonomic agents|mesh-ancestor
102231287|NCT04488315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102231288|NCT04488315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231289|NCT04488315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102231290|NCT04488315|Glucocorticoids|glucocorticoids|mesh-ancestor
102231291|NCT04488315|Hormones|hormones|mesh-ancestor
101940143|NCT03941925|Levan|levan|mesh-list
102231292|NCT04488315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102231293|NCT04488315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102231294|NCT04488315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102231295|NCT04488315|Anesthetics, Local|anesthetics, local|mesh-ancestor
102231296|NCT04488315|Anesthetics|anesthetics|mesh-ancestor
102231297|NCT04488315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102231298|NCT04488315|Sensory System Agents|sensory system agents|mesh-ancestor
102231299|NCT00709735|Propranolol|propranolol|mesh-list
102231300|NCT00709735|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102231301|NCT00709735|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102231302|NCT00709735|Adrenergic Agents|adrenergic agents|mesh-ancestor
102231303|NCT00709735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102231304|NCT00709735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231305|NCT00709735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231306|NCT00709735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102231307|NCT00709735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102231308|NCT00709735|Vasodilator Agents|vasodilator agents|mesh-ancestor
102231309|NCT04505995|Azacitidine|azacitidine|mesh-list
102231310|NCT04505995|Homoharringtonine|homoharringtonine|mesh-list
102231311|NCT04505995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102231312|NCT04505995|Antimetabolites|antimetabolites|mesh-ancestor
102231313|NCT04505995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231314|NCT04505995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102231315|NCT04505995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102231316|NCT04505995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102231317|NCT04505995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102231318|NCT04486911|Letrozole|letrozole|mesh-list
102231319|NCT04486911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102231320|NCT04486911|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102231321|NCT04486911|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102231322|NCT04486911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102231323|NCT04486911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231324|NCT04486911|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102231325|NCT04486911|Hormone Antagonists|hormone antagonists|mesh-ancestor
102231326|NCT04486911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102231327|NCT04486911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231329|NCT05135013|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102231330|NCT05135013|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102231331|NCT05135013|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102231332|NCT05135013|Norethindrone|norethindrone|mesh-list
102231333|NCT05135013|Norethindrone Acetate|norethindrone acetate|mesh-list
102231334|NCT05135013|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
102231335|NCT05135013|Estradiol|estradiol|mesh-list
102231336|NCT05135013|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102231337|NCT05135013|Dydrogesterone|dydrogesterone|mesh-list
102231338|NCT05135013|Estrogens|estrogens|mesh-ancestor
102231339|NCT05135013|Hormones|hormones|mesh-ancestor
101634012|NCT00714025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102231340|NCT05135013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102231341|NCT05135013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231342|NCT05135013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102231343|NCT05135013|Contraceptive Agents|contraceptive agents|mesh-ancestor
102231344|NCT05135013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102231345|NCT05135013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102231346|NCT05135013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102231347|NCT05135013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102231348|NCT05135013|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102231349|NCT05135013|Hormone Antagonists|hormone antagonists|mesh-ancestor
102231350|NCT05135013|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102231351|NCT05135013|Diuretics|diuretics|mesh-ancestor
102231352|NCT05135013|Natriuretic Agents|natriuretic agents|mesh-ancestor
102231353|NCT05135013|Progestins|progestins|mesh-ancestor
102231354|NCT05135013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102231355|NCT04516161|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
102231356|NCT04516161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102231357|NCT04505917|Misoprostol|misoprostol|mesh-list
102231358|NCT04505917|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102231359|NCT04505917|Abortifacient Agents|abortifacient agents|mesh-ancestor
102231360|NCT04505917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102231361|NCT04505917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231362|NCT04505917|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102231363|NCT04505917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102231364|NCT04505917|Oxytocics|oxytocics|mesh-ancestor
102231365|NCT04505683|Ertapenem|ertapenem|mesh-list
102231366|NCT04505683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102231367|NCT04505683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102231368|NCT05576155|Compound 21|compound 21|mesh-list
102231369|NCT05576155|Losartan|losartan|mesh-list
102231370|NCT05576155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102231371|NCT05576155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102231372|NCT05576155|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102231373|NCT05576155|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102231374|NCT05576155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231375|NCT05576155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102231376|NCT04501783|Favipiravir|favipiravir|mesh-list
102231377|NCT04501783|Antiviral Agents|antiviral agents|mesh-ancestor
102231378|NCT04501783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102231379|NCT03351751|PF-06372865|pf-06372865|mesh-list
102231380|NCT03351751|GABA Modulators|gaba modulators|mesh-ancestor
102231381|NCT03351751|GABA Agents|gaba agents|mesh-ancestor
102231382|NCT03351751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102231383|NCT03351751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231384|NCT03351751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231385|NCT03347461|Ciprofloxacin|ciprofloxacin|mesh-list
102231386|NCT03347461|Dexamethasone|dexamethasone|mesh-list
102231387|NCT03347461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102231388|NCT03347461|Antiemetics|antiemetics|mesh-ancestor
102231389|NCT03347461|Autonomic Agents|autonomic agents|mesh-ancestor
102231390|NCT03347461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102231391|NCT03347461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231392|NCT03347461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102231393|NCT03347461|Glucocorticoids|glucocorticoids|mesh-ancestor
102612674|NCT00002195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612675|NCT00002195|Antiviral Agents|antiviral agents|mesh-ancestor
102231394|NCT03347461|Hormones|hormones|mesh-ancestor
102231395|NCT03347461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102231396|NCT03347461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102231397|NCT03347461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102231398|NCT03347461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102231399|NCT03347461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231400|NCT03347461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102231401|NCT03347461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102231402|NCT03347461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102231403|NCT03347461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102231404|NCT03347461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102231405|NCT03347461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102231406|NCT03351517|Tapentadol|tapentadol|mesh-list
102231407|NCT03351517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102231408|NCT03351517|Narcotics|narcotics|mesh-ancestor
102231409|NCT03351517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102231410|NCT03351517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231411|NCT03351517|Analgesics|analgesics|mesh-ancestor
102231412|NCT03351517|Sensory System Agents|sensory system agents|mesh-ancestor
102231413|NCT03351517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102231414|NCT03351517|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102231415|NCT03351517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102231416|NCT03351517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102231417|NCT03351517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231418|NCT03351517|Adrenergic Agents|adrenergic agents|mesh-ancestor
102231419|NCT03351517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102231420|NCT03346525|Penicillins|penicillins|mesh-list
102231421|NCT03346525|Penicillin G|penicillin g|mesh-list
102231422|NCT03346525|Penicillin G Benzathine|penicillin g benzathine|mesh-list
102231423|NCT03346525|Penicillin G Procaine|penicillin g procaine|mesh-list
102231424|NCT03346525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102231425|NCT03346525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102231426|NCT05060523|Tolvaptan|tolvaptan|mesh-list
102231427|NCT05060523|Midodrine|midodrine|mesh-list
102231428|NCT05060523|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102231429|NCT05060523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231430|NCT05060523|Natriuretic Agents|natriuretic agents|mesh-ancestor
102231431|NCT05060523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231432|NCT05060523|Sympathomimetics|sympathomimetics|mesh-ancestor
102231433|NCT05060523|Autonomic Agents|autonomic agents|mesh-ancestor
102231434|NCT05060523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102231435|NCT05060523|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102231436|NCT05060523|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102231437|NCT05060523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102231438|NCT05060523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102231439|NCT05060523|Adrenergic Agents|adrenergic agents|mesh-ancestor
102231440|NCT05060523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102231441|NCT04502641|Docetaxel|docetaxel|mesh-list
102231442|NCT04502641|Fluorouracil|fluorouracil|mesh-list
102231443|NCT04502641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102231444|NCT04502641|Tubulin Modulators|tubulin modulators|mesh-ancestor
102231445|NCT04502641|Antimitotic Agents|antimitotic agents|mesh-ancestor
102231446|NCT04502641|Mitosis Modulators|mitosis modulators|mesh-ancestor
102231447|NCT04502641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231448|NCT04502641|Antimetabolites|antimetabolites|mesh-ancestor
102231449|NCT04502641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102231450|NCT04502641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102231451|NCT04502641|Immunologic Factors|immunologic factors|mesh-ancestor
102231452|NCT04502641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231453|NCT05555797|Betamethasone|betamethasone|mesh-list
102231454|NCT05555797|Betamethasone Valerate|betamethasone valerate|mesh-list
102231455|NCT05555797|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102231456|NCT05555797|Betamethasone benzoate|betamethasone benzoate|mesh-list
102231457|NCT05555797|Tazarotene|tazarotene|mesh-list
102231458|NCT05555797|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102231459|NCT05555797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102231460|NCT05555797|Glucocorticoids|glucocorticoids|mesh-ancestor
102231461|NCT05555797|Hormones|hormones|mesh-ancestor
102231462|NCT05555797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102231463|NCT05555797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231464|NCT05555797|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101901166|NCT03283696|Doxorubicin|doxorubicin|mesh-list
102612676|NCT00002195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102612677|NCT00002195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102612678|NCT00002195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102231465|NCT05555797|Respiratory System Agents|respiratory system agents|mesh-ancestor
102231466|NCT05555797|Dermatologic Agents|dermatologic agents|mesh-ancestor
102231467|NCT05555797|Keratolytic Agents|keratolytic agents|mesh-ancestor
102231468|NCT03955575|Liraglutide|liraglutide|mesh-list
102231469|NCT03955575|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
102231470|NCT03955575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102231471|NCT03955575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231472|NCT03955575|Incretins|incretins|mesh-ancestor
102231473|NCT03955575|Hormones|hormones|mesh-ancestor
102231474|NCT03955575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102231475|NCT03955575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102231476|NCT03955575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102231477|NCT03955575|Antimetabolites|antimetabolites|mesh-ancestor
102231478|NCT03955575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231479|NCT03955575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102231480|NCT04163419|Tanezumab|tanezumab|mesh-list
102231481|NCT04163419|Analgesics|analgesics|mesh-ancestor
102231482|NCT04163419|Sensory System Agents|sensory system agents|mesh-ancestor
102231483|NCT04163419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102231484|NCT04163419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231485|NCT03351205|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102231486|NCT03351205|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102231487|NCT03351205|Estradiol|estradiol|mesh-list
102231488|NCT03351205|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102231489|NCT03351205|Dydrogesterone|dydrogesterone|mesh-list
102231490|NCT03351205|Estrogens|estrogens|mesh-ancestor
102231491|NCT03351205|Hormones|hormones|mesh-ancestor
102231492|NCT03351205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102231493|NCT03351205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231494|NCT03351205|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102231495|NCT03351205|Contraceptive Agents|contraceptive agents|mesh-ancestor
102231496|NCT03351205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102231497|NCT03351205|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102231498|NCT03351205|Progestins|progestins|mesh-ancestor
102231499|NCT04698057|Amoxicillin|amoxicillin|mesh-list
102231500|NCT04698057|Ciprofloxacin|ciprofloxacin|mesh-list
102231501|NCT04698057|Clavulanic Acid|clavulanic acid|mesh-list
102231502|NCT04698057|Clavulanic Acids|clavulanic acids|mesh-list
102231503|NCT04698057|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102231504|NCT04698057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102231505|NCT04698057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102231506|NCT04698057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102231507|NCT04698057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102231508|NCT04698057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102231509|NCT04698057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231510|NCT04698057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102231511|NCT04698057|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102231512|NCT04698057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102231513|NCT04698057|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102231514|NCT02449005|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101940366|NCT03938259|Fentanyl|fentanyl|mesh-list
102231515|NCT02449005|Hemostatics|hemostatics|mesh-ancestor
102231516|NCT02449005|Coagulants|coagulants|mesh-ancestor
102231517|NCT04132791|Aspirin|aspirin|mesh-list
102231518|NCT04132791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102231519|NCT04132791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102231520|NCT04132791|Analgesics|analgesics|mesh-ancestor
102231521|NCT04132791|Sensory System Agents|sensory system agents|mesh-ancestor
102231522|NCT04132791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102231523|NCT04132791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231524|NCT04132791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102231525|NCT04132791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102231526|NCT04132791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102231527|NCT04132791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102231528|NCT04132791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231529|NCT04132791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102231530|NCT04132791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102231531|NCT04132791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102231532|NCT04132791|Antipyretics|antipyretics|mesh-ancestor
102231533|NCT04065009|Ropivacaine|ropivacaine|mesh-list
102231534|NCT04065009|Anesthetics, Local|anesthetics, local|mesh-ancestor
102231535|NCT04065009|Anesthetics|anesthetics|mesh-ancestor
102231536|NCT04065009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102231537|NCT04065009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102612679|NCT00002195|Antimetabolites|antimetabolites|mesh-ancestor
102231538|NCT04065009|Sensory System Agents|sensory system agents|mesh-ancestor
102612680|NCT00002195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102612681|NCT00002195|Antitubercular Agents|antitubercular agents|mesh-ancestor
102612682|NCT00002195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102612683|NCT00002195|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102612684|NCT00002195|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102612685|NCT00002195|Protease Inhibitors|protease inhibitors|mesh-ancestor
102612686|NCT00002201|Ritonavir|ritonavir|mesh-list
102231539|NCT04065009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102231540|NCT04250493|Insulin|insulin|mesh-list
102231541|NCT04250493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102231542|NCT04250493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231543|NCT03833479|Dostarlimab|dostarlimab|mesh-list
102231544|NCT03833479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102231545|NCT04147221|Imipenem|imipenem|mesh-list
102231546|NCT04147221|Relebactam|relebactam|mesh-list
102231547|NCT04147221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102231548|NCT04147221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102231549|NCT04147221|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102231550|NCT04147221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102231551|NCT04147221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231552|NCT02517619|Dexamethasone|dexamethasone|mesh-list
102231553|NCT02517619|Prednisolone|prednisolone|mesh-list
102231554|NCT02517619|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102231555|NCT02517619|Methylprednisolone|methylprednisolone|mesh-list
102231556|NCT02517619|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102231557|NCT02517619|Prednisolone acetate|prednisolone acetate|mesh-list
102231558|NCT02517619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102231559|NCT02517619|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102231560|NCT02517619|Prednisolone phosphate|prednisolone phosphate|mesh-list
102231561|NCT02517619|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102231562|NCT02517619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102231563|NCT02517619|Antiemetics|antiemetics|mesh-ancestor
102231564|NCT02517619|Autonomic Agents|autonomic agents|mesh-ancestor
102231565|NCT02517619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102231566|NCT02517619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231567|NCT02517619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102231568|NCT02517619|Glucocorticoids|glucocorticoids|mesh-ancestor
102231569|NCT02517619|Hormones|hormones|mesh-ancestor
102231570|NCT02517619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101634152|NCT03292809|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101634153|NCT00722839|Vaccines|vaccines|mesh-list
101634154|NCT00722839|Immunologic Factors|immunologic factors|mesh-ancestor
101634155|NCT00722839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231571|NCT02517619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102231572|NCT02517619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102231573|NCT02517619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102231574|NCT02517619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102231575|NCT02517619|Protective Agents|protective agents|mesh-ancestor
102231576|NCT03968913|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102231577|NCT03968913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102231578|NCT03892395|Vitamin D|vitamin d|mesh-list
102231579|NCT03892395|Vitamins|vitamins|mesh-list
102231580|NCT03892395|Vitamin B Complex|vitamin b complex|mesh-list
102231581|NCT03892395|Micronutrients|micronutrients|mesh-ancestor
102231582|NCT03892395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231583|NCT03892395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102231584|NCT04481451|Ropivacaine|ropivacaine|mesh-list
102231585|NCT04481451|Anesthetics, Local|anesthetics, local|mesh-ancestor
102231586|NCT04481451|Anesthetics|anesthetics|mesh-ancestor
102231587|NCT04481451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102231588|NCT04481451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231589|NCT04481451|Sensory System Agents|sensory system agents|mesh-ancestor
102231590|NCT04481451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102231591|NCT03376659|Bevacizumab|bevacizumab|mesh-list
102231592|NCT03376659|Durvalumab|durvalumab|mesh-list
102231593|NCT03376659|Capecitabine|capecitabine|mesh-list
102231594|NCT03376659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102231595|NCT03376659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102231596|NCT03376659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102231597|NCT03376659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102231598|NCT03376659|Growth Substances|growth substances|mesh-ancestor
102231599|NCT03376659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231600|NCT03376659|Growth Inhibitors|growth inhibitors|mesh-ancestor
102231601|NCT03376659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102231602|NCT03376659|Antimetabolites|antimetabolites|mesh-ancestor
102231603|NCT03376659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612687|NCT00002201|Nelfinavir|nelfinavir|mesh-list
102231604|NCT04102371|Plasma-lyte 148|plasma-lyte 148|mesh-list
102231605|NCT04102371|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102612688|NCT00002201|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102231606|NCT04102371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102231607|NCT04086147|Tenecteplase|tenecteplase|mesh-list
102231608|NCT04086147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102231609|NCT04086147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102231610|NCT04086147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231611|NCT03161223|Azacitidine|azacitidine|mesh-list
102231612|NCT03161223|Durvalumab|durvalumab|mesh-list
102231613|NCT03161223|Romidepsin|romidepsin|mesh-list
102231614|NCT03161223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102231615|NCT03161223|Antimetabolites|antimetabolites|mesh-ancestor
102231616|NCT03161223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231617|NCT03161223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102612689|NCT00002201|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102612690|NCT00002201|Protease Inhibitors|protease inhibitors|mesh-ancestor
102612691|NCT00002201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612692|NCT00002201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612693|NCT00002201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102612694|NCT00002201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102612695|NCT00002201|Antiviral Agents|antiviral agents|mesh-ancestor
102231618|NCT03161223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102231619|NCT03161223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102231620|NCT03161223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102231621|NCT03161223|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102231622|NCT03660813|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102231623|NCT03660813|Luteolytic Agents|luteolytic agents|mesh-ancestor
102231624|NCT03660813|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102231625|NCT03660813|Contraceptive Agents|contraceptive agents|mesh-ancestor
102231626|NCT03660813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102231627|NCT03660813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231628|NCT03660813|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102231629|NCT03660813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102231630|NCT03660813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102231631|NCT01285557|Cisplatin|cisplatin|mesh-list
102231632|NCT01285557|Fluorouracil|fluorouracil|mesh-list
102231633|NCT01285557|Tegafur|tegafur|mesh-list
102231634|NCT01285557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102231635|NCT01285557|Antimetabolites|antimetabolites|mesh-ancestor
102231636|NCT01285557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231637|NCT01285557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102231638|NCT01285557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102231639|NCT01285557|Immunologic Factors|immunologic factors|mesh-ancestor
101634214|NCT00717925|Immunologic Factors|immunologic factors|mesh-ancestor
102231640|NCT01285557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231641|NCT03083067|Budesonide|budesonide|mesh-list
102231642|NCT03083067|Bromides|bromides|mesh-list
102231643|NCT03083067|Formoterol Fumarate|formoterol fumarate|mesh-list
102231644|NCT03083067|Tiotropium Bromide|tiotropium bromide|mesh-list
102231645|NCT03083067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102231646|NCT03083067|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102231647|NCT03083067|Autonomic Agents|autonomic agents|mesh-ancestor
102231648|NCT03083067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102231649|NCT03083067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231650|NCT03083067|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102231651|NCT03083067|Respiratory System Agents|respiratory system agents|mesh-ancestor
102231652|NCT03083067|Glucocorticoids|glucocorticoids|mesh-ancestor
102231653|NCT03083067|Hormones|hormones|mesh-ancestor
102231654|NCT03083067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102231655|NCT03083067|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102231656|NCT03083067|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102231657|NCT03083067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102231658|NCT03083067|Adrenergic Agents|adrenergic agents|mesh-ancestor
102231659|NCT03083067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102231660|NCT03083067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231661|NCT03083067|Parasympatholytics|parasympatholytics|mesh-ancestor
102231662|NCT03083067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102231663|NCT03083067|Cholinergic Agents|cholinergic agents|mesh-ancestor
102231664|NCT03083067|Anticonvulsants|anticonvulsants|mesh-ancestor
102231665|NCT03218137|Adenosine|adenosine|mesh-list
102231666|NCT03218137|Verapamil|verapamil|mesh-list
102231667|NCT03218137|Analgesics|analgesics|mesh-ancestor
102231668|NCT03218137|Sensory System Agents|sensory system agents|mesh-ancestor
101634253|NCT00992108|Lidocaine|lidocaine|mesh-list
102612696|NCT00002201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102612697|NCT00002201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102612698|NCT00002201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102231669|NCT03218137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102231670|NCT03218137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231671|NCT03218137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102231672|NCT03218137|Vasodilator Agents|vasodilator agents|mesh-ancestor
102231673|NCT03218137|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102231674|NCT03218137|Purinergic Agonists|purinergic agonists|mesh-ancestor
102231675|NCT03218137|Purinergic Agents|purinergic agents|mesh-ancestor
102231676|NCT03218137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102231677|NCT03218137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231678|NCT03218137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102231679|NCT03218137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102231680|NCT03218137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102231681|NCT05638399|Zoledronic Acid|zoledronic acid|mesh-list
102231682|NCT05638399|Denosumab|denosumab|mesh-list
102231683|NCT05638399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102231684|NCT05638399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231685|NCT02512471|Ropivacaine|ropivacaine|mesh-list
102231686|NCT02512471|Anesthetics, Local|anesthetics, local|mesh-ancestor
102231687|NCT02512471|Anesthetics|anesthetics|mesh-ancestor
102231688|NCT02512471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102231689|NCT02512471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231690|NCT02512471|Sensory System Agents|sensory system agents|mesh-ancestor
102231691|NCT02512471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102231692|NCT02507479|Thiotepa|thiotepa|mesh-list
102231693|NCT02507479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102231694|NCT02507479|Alkylating Agents|alkylating agents|mesh-ancestor
102231695|NCT02507479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231696|NCT02507479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102231697|NCT02507479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102231698|NCT02507479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102231699|NCT02507479|Immunologic Factors|immunologic factors|mesh-ancestor
102231700|NCT02507479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231701|NCT02512315|Cisplatin|cisplatin|mesh-list
102231702|NCT02512315|Docetaxel|docetaxel|mesh-list
102231703|NCT02512315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102231704|NCT02512315|Tubulin Modulators|tubulin modulators|mesh-ancestor
102231705|NCT02512315|Antimitotic Agents|antimitotic agents|mesh-ancestor
102231706|NCT02512315|Mitosis Modulators|mitosis modulators|mesh-ancestor
102231707|NCT02512315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231708|NCT02507323|Ticagrelor|ticagrelor|mesh-list
102231709|NCT02507323|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102231710|NCT02507323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102231711|NCT02507323|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102231712|NCT02507323|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102231713|NCT02507323|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102231714|NCT02507323|Purinergic Agents|purinergic agents|mesh-ancestor
102231715|NCT02507323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102231716|NCT02507323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231717|NCT02507323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231718|NCT05431413|Phosphocreatine|phosphocreatine|mesh-list
102231719|NCT05431413|Fluoxetine|fluoxetine|mesh-list
102231720|NCT05431413|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102231721|NCT05431413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102231722|NCT05431413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102231723|NCT05431413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231724|NCT05431413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102231725|NCT05431413|Serotonin Agents|serotonin agents|mesh-ancestor
102231726|NCT05431413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231727|NCT05431413|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102231728|NCT05431413|Antidepressive Agents|antidepressive agents|mesh-ancestor
102231729|NCT05431413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102231730|NCT05431413|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102231731|NCT05431413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102231732|NCT05431413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102231733|NCT05431413|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102231734|NCT05431413|Protective Agents|protective agents|mesh-ancestor
102231735|NCT02507245|Hormones|hormones|mesh-list
102231736|NCT02507245|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
102231737|NCT02507245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102231738|NCT02507245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231739|NCT02517307|Heparin|heparin|mesh-list
102231740|NCT02517307|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102231741|NCT02517307|Glycerol|glycerol|mesh-list
102612699|NCT00002213|Efavirenz|efavirenz|mesh-list
102612700|NCT00002213|Abacavir|abacavir|mesh-list
102231742|NCT02517307|Anticoagulants|anticoagulants|mesh-ancestor
102231743|NCT02517307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102231744|NCT02517307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102231745|NCT02517307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231746|NCT02517307|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102231747|NCT02517307|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102231748|NCT02517307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102231749|NCT02517307|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102231750|NCT02517307|Protective Agents|protective agents|mesh-ancestor
102231751|NCT02517307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231752|NCT05431257|Venetoclax|venetoclax|mesh-list
102231753|NCT05431257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102231754|NCT05431023|Lactoferrin|lactoferrin|mesh-list
102231755|NCT05431023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102231756|NCT02507167|Rifampin|rifampin|mesh-list
102231757|NCT02507167|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102231758|NCT02507167|Antitubercular Agents|antitubercular agents|mesh-ancestor
102231759|NCT02507167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102231760|NCT02507167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102231761|NCT02507167|Leprostatic Agents|leprostatic agents|mesh-ancestor
102231762|NCT02507167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102231763|NCT02507167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102231764|NCT02507167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231765|NCT02507167|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102231766|NCT02507167|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102231767|NCT02507167|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102231768|NCT02507167|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102231769|NCT02507167|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102231770|NCT02507167|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102231771|NCT01376167|Chloroquine|chloroquine|mesh-list
102231772|NCT01376167|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
102231773|NCT01376167|Primaquine|primaquine|mesh-list
102231774|NCT01376167|Tafenoquine|tafenoquine|mesh-list
102231775|NCT01376167|Amebicides|amebicides|mesh-ancestor
102231776|NCT01376167|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102231777|NCT01376167|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102231778|NCT01376167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102231779|NCT01376167|Antimalarials|antimalarials|mesh-ancestor
102231780|NCT01376167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102231781|NCT01376167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102231782|NCT01376167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102231783|NCT01376167|Analgesics|analgesics|mesh-ancestor
102231784|NCT01376167|Sensory System Agents|sensory system agents|mesh-ancestor
102231785|NCT01376167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102231786|NCT01376167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231787|NCT01376167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102231788|NCT01376167|Filaricides|filaricides|mesh-ancestor
102231789|NCT01376167|Antinematodal Agents|antinematodal agents|mesh-ancestor
102231790|NCT01376167|Anthelmintics|anthelmintics|mesh-ancestor
102231791|NCT02511613|Squalamine|squalamine|mesh-list
102231792|NCT02511613|Ranibizumab|ranibizumab|mesh-list
102231793|NCT02511613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102231794|NCT02511613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102231795|NCT02511613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102231796|NCT02511613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102231797|NCT02511613|Growth Substances|growth substances|mesh-ancestor
102231798|NCT02511613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231799|NCT02511613|Growth Inhibitors|growth inhibitors|mesh-ancestor
102231800|NCT02511613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102231801|NCT02511613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102231802|NCT02511613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102231803|NCT02511613|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102231804|NCT02511613|Protective Agents|protective agents|mesh-ancestor
102231805|NCT02506699|Analgesics|analgesics|mesh-list
102231806|NCT02506699|Sensory System Agents|sensory system agents|mesh-ancestor
102231807|NCT02506699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102231808|NCT02506699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231809|NCT02506777|Metformin|metformin|mesh-list
102231810|NCT02506777|Cyclophosphamide|cyclophosphamide|mesh-list
102231811|NCT02506777|Doxorubicin|doxorubicin|mesh-list
102231812|NCT02506777|Fluorouracil|fluorouracil|mesh-list
101940666|NCT01219023|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102612701|NCT00002213|Amprenavir|amprenavir|mesh-list
102612702|NCT00002213|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102231813|NCT02506777|Melatonin|melatonin|mesh-list
102231814|NCT02506777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102612703|NCT00002213|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102231815|NCT02506777|Immunologic Factors|immunologic factors|mesh-ancestor
102231816|NCT02506777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231817|NCT02506777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102231818|NCT02506777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102231819|NCT02506777|Alkylating Agents|alkylating agents|mesh-ancestor
102231820|NCT02506777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231821|NCT02506777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102231822|NCT02506777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102231823|NCT02506777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102231824|NCT02506777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102231825|NCT02506777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102231826|NCT02506777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102231827|NCT02506777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102231828|NCT02506777|Antioxidants|antioxidants|mesh-ancestor
102231829|NCT02506777|Protective Agents|protective agents|mesh-ancestor
102231830|NCT02506777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102231831|NCT02506777|Antimetabolites|antimetabolites|mesh-ancestor
102231832|NCT02506777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102231833|NCT02516527|Ipilimumab|ipilimumab|mesh-list
102231834|NCT02516527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102231835|NCT02516527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102231836|NCT02516527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102231837|NCT02516527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231838|NCT02511847|Afatinib|afatinib|mesh-list
102231839|NCT02511847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102231840|NCT02511847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102231841|NCT02511847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102231842|NCT02511847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231843|NCT02506855|Ropivacaine|ropivacaine|mesh-list
102231844|NCT02506855|Anesthetics, Local|anesthetics, local|mesh-ancestor
102231845|NCT02506855|Anesthetics|anesthetics|mesh-ancestor
102231846|NCT02506855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102231847|NCT02506855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231848|NCT02506855|Sensory System Agents|sensory system agents|mesh-ancestor
102231849|NCT02506855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102231850|NCT02511223|Olaparib|olaparib|mesh-list
102231851|NCT02511223|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102231852|NCT02511223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102231853|NCT02511223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231854|NCT02511223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102231855|NCT02516059|Oxycodone|oxycodone|mesh-list
102231856|NCT02516059|Naloxone|naloxone|mesh-list
102231857|NCT02516059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102231858|NCT02516059|Narcotics|narcotics|mesh-ancestor
102231859|NCT02516059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102231860|NCT02516059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634370|NCT03084471|Durvalumab|durvalumab|mesh-list
102231861|NCT02516059|Analgesics|analgesics|mesh-ancestor
102231862|NCT02516059|Sensory System Agents|sensory system agents|mesh-ancestor
102231863|NCT02516059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102231864|NCT02516059|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102231865|NCT02506231|Leucovorin|leucovorin|mesh-list
102231866|NCT02506231|Folic Acid|folic acid|mesh-list
102231867|NCT02506231|Levoleucovorin|levoleucovorin|mesh-list
102231868|NCT02506231|Antidotes|antidotes|mesh-ancestor
102231869|NCT02506231|Protective Agents|protective agents|mesh-ancestor
102231870|NCT02506231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231871|NCT02506231|Vitamin B Complex|vitamin b complex|mesh-ancestor
102231872|NCT02506231|Vitamins|vitamins|mesh-ancestor
102231873|NCT02506231|Micronutrients|micronutrients|mesh-ancestor
102231874|NCT02506231|Hematinics|hematinics|mesh-ancestor
102231875|NCT02511145|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
102231876|NCT02511145|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102231877|NCT02511145|Dermatologic Agents|dermatologic agents|mesh-ancestor
102231878|NCT02505997|Delafloxacin|delafloxacin|mesh-list
102231879|NCT02505997|Midazolam|midazolam|mesh-list
102231880|NCT02505997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102231881|NCT02505997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102231882|NCT02505997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102231883|NCT02505997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231884|NCT02505997|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102231885|NCT02505997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102231886|NCT02505997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102231887|NCT02505997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102231888|NCT02505997|Anesthetics, General|anesthetics, general|mesh-ancestor
102231889|NCT02505997|Anesthetics|anesthetics|mesh-ancestor
102231890|NCT02505997|GABA Modulators|gaba modulators|mesh-ancestor
102231891|NCT02505997|GABA Agents|gaba agents|mesh-ancestor
102231892|NCT02505997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102231893|NCT02505997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231894|NCT02505997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102231895|NCT02505841|Ropivacaine|ropivacaine|mesh-list
102231896|NCT02505841|Succinylcholine|succinylcholine|mesh-list
102231898|NCT02505841|Anesthetics, Local|anesthetics, local|mesh-ancestor
102231899|NCT02505841|Anesthetics|anesthetics|mesh-ancestor
102231900|NCT02505841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102231901|NCT02505841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231902|NCT02505841|Sensory System Agents|sensory system agents|mesh-ancestor
102231903|NCT02505841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102231904|NCT02505841|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
102231905|NCT02505841|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102231906|NCT02505841|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102231907|NCT02505841|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102231908|NCT02505841|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102231909|NCT02505841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102231910|NCT02505841|Cholinergic Agents|cholinergic agents|mesh-ancestor
102231911|NCT02505841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102231912|NCT02505841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231913|NCT03345667|Ranibizumab|ranibizumab|mesh-list
102231914|NCT03345667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102231915|NCT03345667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102231916|NCT03345667|Growth Substances|growth substances|mesh-ancestor
102231917|NCT03345667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231918|NCT03345667|Growth Inhibitors|growth inhibitors|mesh-ancestor
102231919|NCT03345667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102231920|NCT04499989|Isoniazid|isoniazid|mesh-list
102231921|NCT04499989|Antitubercular Agents|antitubercular agents|mesh-ancestor
102231922|NCT04499989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102231923|NCT04499989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102231924|NCT04499989|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102231925|NCT04499989|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102231926|NCT04499989|Antimetabolites|antimetabolites|mesh-ancestor
102231927|NCT04499989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231928|NCT04499989|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102231929|NCT04500067|Immunoglobulins|immunoglobulins|mesh-list
102231930|NCT04500067|Immunologic Factors|immunologic factors|mesh-ancestor
102231931|NCT04500067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231932|NCT04497649|Sofosbuvir|sofosbuvir|mesh-list
102231933|NCT04497649|Antiviral Agents|antiviral agents|mesh-ancestor
102231934|NCT04497649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102231935|NCT02505451|Dobutamine|dobutamine|mesh-list
102231936|NCT02505451|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102231937|NCT02505451|Sympathomimetics|sympathomimetics|mesh-ancestor
102231938|NCT02505451|Autonomic Agents|autonomic agents|mesh-ancestor
102231939|NCT02505451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102231940|NCT02505451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231941|NCT02505451|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102231942|NCT02505451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102231943|NCT02505451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102231944|NCT02505451|Adrenergic Agents|adrenergic agents|mesh-ancestor
102231945|NCT02505451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102231946|NCT02505451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231947|NCT02505451|Protective Agents|protective agents|mesh-ancestor
102231948|NCT02505295|Selenium|selenium|mesh-list
102231949|NCT02505295|Antioxidants|antioxidants|mesh-ancestor
102231950|NCT02505295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231951|NCT02505295|Protective Agents|protective agents|mesh-ancestor
102231952|NCT02505295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231953|NCT02505295|Trace Elements|trace elements|mesh-ancestor
102231954|NCT02505295|Micronutrients|micronutrients|mesh-ancestor
102231955|NCT02510911|Caffeine|caffeine|mesh-list
102231956|NCT02510911|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102231957|NCT02510911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231958|NCT02510911|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102231959|NCT02510911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102231960|NCT02510911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231961|NCT02510911|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102231962|NCT02510911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102231963|NCT02510911|Purinergic Agents|purinergic agents|mesh-ancestor
102231964|NCT02510911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102231965|NCT03121807|Leucovorin|leucovorin|mesh-list
102612705|NCT00002213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612706|NCT00002213|Antiviral Agents|antiviral agents|mesh-ancestor
102612707|NCT00002213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102612708|NCT00002213|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102612709|NCT00002213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102231966|NCT03121807|Fluorouracil|fluorouracil|mesh-list
102231967|NCT03121807|Oxaliplatin|oxaliplatin|mesh-list
102231968|NCT03121807|Antimetabolites|antimetabolites|mesh-ancestor
102231969|NCT03121807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231970|NCT03121807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102231971|NCT03121807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102231972|NCT03121807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102231973|NCT03121807|Immunologic Factors|immunologic factors|mesh-ancestor
102231974|NCT03121807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231975|NCT03121807|Antidotes|antidotes|mesh-ancestor
102231976|NCT03121807|Protective Agents|protective agents|mesh-ancestor
102231977|NCT03121807|Vitamin B Complex|vitamin b complex|mesh-ancestor
102231978|NCT03121807|Vitamins|vitamins|mesh-ancestor
102231979|NCT03121807|Micronutrients|micronutrients|mesh-ancestor
102231980|NCT03343873|Midazolam|midazolam|mesh-list
102231981|NCT03343873|Dexmedetomidine|dexmedetomidine|mesh-list
102231982|NCT03343873|Propofol|propofol|mesh-list
102231983|NCT03343873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102231984|NCT03343873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102231985|NCT03343873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102231986|NCT03343873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102231987|NCT03343873|Analgesics|analgesics|mesh-ancestor
102231988|NCT03343873|Sensory System Agents|sensory system agents|mesh-ancestor
102231989|NCT03343873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102231990|NCT03343873|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102231991|NCT03343873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102231992|NCT03343873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102231993|NCT03343873|Adrenergic Agents|adrenergic agents|mesh-ancestor
102231994|NCT03343873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102231995|NCT03343873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102231996|NCT03343873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102231997|NCT03343873|Anesthetics, General|anesthetics, general|mesh-ancestor
102231998|NCT03343873|Anesthetics|anesthetics|mesh-ancestor
102231999|NCT03343873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102232000|NCT03343873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102232001|NCT03343873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102232002|NCT03343873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102232003|NCT03343873|GABA Modulators|gaba modulators|mesh-ancestor
102232004|NCT03343873|GABA Agents|gaba agents|mesh-ancestor
102232005|NCT03343795|Progesterone|progesterone|mesh-list
102232006|NCT03343795|Progestins|progestins|mesh-ancestor
102232007|NCT03343795|Hormones|hormones|mesh-ancestor
102232008|NCT03343795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102232009|NCT03343795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232010|NCT02510287|Lidocaine|lidocaine|mesh-list
102232011|NCT02510287|Fentanyl|fentanyl|mesh-list
102232012|NCT02510287|Bupivacaine|bupivacaine|mesh-list
102232013|NCT02510287|Anesthetics, Local|anesthetics, local|mesh-ancestor
102232014|NCT02510287|Anesthetics|anesthetics|mesh-ancestor
102232015|NCT02510287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102232016|NCT02510287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232017|NCT02510287|Sensory System Agents|sensory system agents|mesh-ancestor
102232018|NCT02510287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102232019|NCT02510287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102232020|NCT02510287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102232021|NCT02510287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102232022|NCT02510287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101634496|NCT02570581|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102232023|NCT02510287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232024|NCT02510287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102232025|NCT02510287|Narcotics|narcotics|mesh-ancestor
102232026|NCT02510287|Analgesics|analgesics|mesh-ancestor
102232027|NCT02510287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102232028|NCT02510287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102232029|NCT02510287|Anesthetics, General|anesthetics, general|mesh-ancestor
102232030|NCT02515435|Apatinib|apatinib|mesh-list
102232031|NCT02515435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102232032|NCT02515435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102232033|NCT02515435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102232034|NCT02515435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232035|NCT02515201|Taurolidine|taurolidine|mesh-list
102232036|NCT02515201|Heparin|heparin|mesh-list
102232037|NCT02515201|Calcium heparin|calcium heparin|mesh-list
102612710|NCT00002213|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102612711|NCT00002213|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102612712|NCT00002213|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102232038|NCT02515201|Anticoagulants|anticoagulants|mesh-ancestor
102232039|NCT02515201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102232040|NCT02515201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102232041|NCT02515201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232042|NCT02515201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102232043|NCT02515201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102232044|NCT02515201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102232045|NCT02504983|Sorafenib|sorafenib|mesh-list
102232046|NCT02504983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102232047|NCT02504983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102232048|NCT02504983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102232049|NCT02504983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232050|NCT02510053|Caspofungin|caspofungin|mesh-list
102232051|NCT02510053|Antifungal Agents|antifungal agents|mesh-ancestor
102232052|NCT02510053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102232053|NCT02510053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102232054|NCT02510053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232055|NCT02504359|Cytarabine|cytarabine|mesh-list
102232056|NCT02504359|Methotrexate|methotrexate|mesh-list
102232057|NCT02504359|Etoposide|etoposide|mesh-list
102232058|NCT02504359|Etoposide phosphate|etoposide phosphate|mesh-list
102232059|NCT02504359|Melphalan|melphalan|mesh-list
102232060|NCT02504359|Mechlorethamine|mechlorethamine|mesh-list
102232061|NCT02504359|Carmustine|carmustine|mesh-list
102232062|NCT02504359|Ixazomib|ixazomib|mesh-list
102232063|NCT02504359|Podophyllotoxin|podophyllotoxin|mesh-list
102232064|NCT02504359|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102232065|NCT02504359|Tacrolimus|tacrolimus|mesh-list
102232066|NCT02504359|Glycine|glycine|mesh-list
102232067|NCT02504359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102232068|NCT02504359|Abortifacient Agents|abortifacient agents|mesh-ancestor
102232069|NCT02504359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102232070|NCT02504359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232071|NCT02504359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102232072|NCT02504359|Antimetabolites|antimetabolites|mesh-ancestor
102232073|NCT02504359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232074|NCT02504359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102232075|NCT02504359|Dermatologic Agents|dermatologic agents|mesh-ancestor
102232076|NCT02504359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102232077|NCT02504359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102232078|NCT02504359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102232079|NCT02504359|Immunologic Factors|immunologic factors|mesh-ancestor
102232080|NCT02504359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102232081|NCT02504359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102232082|NCT02504359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102232083|NCT02504359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102232084|NCT02504359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102232085|NCT02504359|Antiviral Agents|antiviral agents|mesh-ancestor
102232086|NCT02504359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102232087|NCT02504359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102232088|NCT02504359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102232089|NCT02504359|Alkylating Agents|alkylating agents|mesh-ancestor
102232090|NCT02504359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102232091|NCT02504359|Protease Inhibitors|protease inhibitors|mesh-ancestor
102232092|NCT02504359|Keratolytic Agents|keratolytic agents|mesh-ancestor
102232093|NCT02504359|Tubulin Modulators|tubulin modulators|mesh-ancestor
102232094|NCT02504359|Antimitotic Agents|antimitotic agents|mesh-ancestor
102232095|NCT02504359|Mitosis Modulators|mitosis modulators|mesh-ancestor
102232096|NCT02504359|Glycine Agents|glycine agents|mesh-ancestor
102232097|NCT02504359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102232098|NCT02729545|Cyproterone Acetate|cyproterone acetate|mesh-list
102232099|NCT02729545|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102232100|NCT02729545|Cyproterone|cyproterone|mesh-list
102232101|NCT02729545|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102232102|NCT02729545|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102232103|NCT02729545|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102232104|NCT02729545|Contraceptive Agents|contraceptive agents|mesh-ancestor
102232105|NCT02729545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102232106|NCT02729545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232107|NCT02729545|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102232108|NCT02729545|Estrogens|estrogens|mesh-ancestor
102232109|NCT02729545|Hormones|hormones|mesh-ancestor
102232110|NCT02729545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102612713|NCT00002213|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102232111|NCT02729545|Androgen Antagonists|androgen antagonists|mesh-ancestor
102232112|NCT02729545|Hormone Antagonists|hormone antagonists|mesh-ancestor
102232113|NCT02729545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102232114|NCT02729545|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102232115|NCT02504125|Tranexamic Acid|tranexamic acid|mesh-list
102232116|NCT02504125|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102232117|NCT02504125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102232118|NCT02504125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232119|NCT02504125|Hemostatics|hemostatics|mesh-ancestor
102232120|NCT02504125|Coagulants|coagulants|mesh-ancestor
102232121|NCT02509429|Insulin|insulin|mesh-list
102232123|NCT02509429|Insulin Aspart|insulin aspart|mesh-list
102232124|NCT02509429|Insulin, Long-Acting|insulin, long-acting|mesh-list
102232125|NCT02509429|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102232126|NCT02509429|Insulin Lispro|insulin lispro|mesh-list
102232127|NCT02509429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102232128|NCT02509429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232129|NCT02509273|Clonidine|clonidine|mesh-list
102232130|NCT02509273|Midazolam|midazolam|mesh-list
102232131|NCT02509273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102232132|NCT02509273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102232133|NCT02509273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102232134|NCT02509273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232135|NCT02509273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102232136|NCT02509273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102232137|NCT02509273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102232138|NCT02509273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102232139|NCT02509273|Anesthetics, General|anesthetics, general|mesh-ancestor
102232140|NCT02509273|Anesthetics|anesthetics|mesh-ancestor
102232141|NCT02509273|GABA Modulators|gaba modulators|mesh-ancestor
102232142|NCT02509273|GABA Agents|gaba agents|mesh-ancestor
102232143|NCT02509273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102232144|NCT02509273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232145|NCT02509273|Analgesics|analgesics|mesh-ancestor
102232146|NCT02509273|Sensory System Agents|sensory system agents|mesh-ancestor
102232147|NCT02509273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102232148|NCT02509273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102232149|NCT02509273|Sympatholytics|sympatholytics|mesh-ancestor
102232150|NCT02509273|Autonomic Agents|autonomic agents|mesh-ancestor
102232151|NCT02509273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102232152|NCT02509273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102232153|NCT02509273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102232154|NCT02509273|Adrenergic Agents|adrenergic agents|mesh-ancestor
102232155|NCT02514343|Magnesium Sulfate|magnesium sulfate|mesh-list
102232156|NCT02514343|Bupivacaine|bupivacaine|mesh-list
102232157|NCT02514343|Anesthetics, Local|anesthetics, local|mesh-ancestor
102232158|NCT02514343|Anesthetics|anesthetics|mesh-ancestor
102232159|NCT02514343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102232160|NCT02514343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232161|NCT02514343|Sensory System Agents|sensory system agents|mesh-ancestor
102232162|NCT02514343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102232163|NCT02514343|Analgesics|analgesics|mesh-ancestor
102232164|NCT02514343|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102232165|NCT02514343|Anticonvulsants|anticonvulsants|mesh-ancestor
102232166|NCT02514343|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102232167|NCT02514343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102232168|NCT02514343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634631|NCT05373277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102232169|NCT02514343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102232170|NCT02514343|Tocolytic Agents|tocolytic agents|mesh-ancestor
102232171|NCT02514343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102232172|NCT02514421|Paclitaxel|paclitaxel|mesh-list
102232173|NCT02514421|Gemcitabine|gemcitabine|mesh-list
102232174|NCT02514421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102232175|NCT02514421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102232176|NCT02514421|Tubulin Modulators|tubulin modulators|mesh-ancestor
102612714|NCT00002213|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102612715|NCT00002213|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102612716|NCT00002213|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102612717|NCT00002213|Antitubercular Agents|antitubercular agents|mesh-ancestor
102612718|NCT00002213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102612719|NCT00002213|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102612720|NCT00002213|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102612721|NCT00002213|Protease Inhibitors|protease inhibitors|mesh-ancestor
102232177|NCT02514421|Antimitotic Agents|antimitotic agents|mesh-ancestor
101901204|NCT01093092|Calcitriol|calcitriol|mesh-list
102612722|NCT00381251|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
102612723|NCT00381251|Estrogens|estrogens|mesh-ancestor
102612724|NCT00381251|Hormones|hormones|mesh-ancestor
102612725|NCT00381251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102612726|NCT00381251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102612727|NCT00002219|Nelfinavir|nelfinavir|mesh-list
102612728|NCT00002219|Adefovir|adefovir|mesh-list
102612729|NCT00002219|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
102612730|NCT00002219|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102612731|NCT00002219|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102612732|NCT00002219|Protease Inhibitors|protease inhibitors|mesh-ancestor
102612733|NCT00002219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612734|NCT00002219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612735|NCT00002219|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102612736|NCT00002219|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102232178|NCT02514421|Mitosis Modulators|mitosis modulators|mesh-ancestor
102232179|NCT02514421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232180|NCT02514421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102232181|NCT02514421|Antimetabolites|antimetabolites|mesh-ancestor
102232182|NCT04499209|Naproxen|naproxen|mesh-list
102232183|NCT04499209|Pregabalin|pregabalin|mesh-list
102232184|NCT04499209|Analgesics|analgesics|mesh-ancestor
102232185|NCT04499209|Sensory System Agents|sensory system agents|mesh-ancestor
102232186|NCT04499209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101634692|NCT00577993|Antiemetics|antiemetics|mesh-ancestor
102232187|NCT04499209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232188|NCT04499209|Anticonvulsants|anticonvulsants|mesh-ancestor
102232189|NCT04499209|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102232190|NCT04499209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102232191|NCT04499209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232192|NCT04499209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102232193|NCT04499209|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102232194|NCT04499209|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102232195|NCT04499209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102232196|NCT04499209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102232197|NCT04499209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102232198|NCT04499209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102232199|NCT04499209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102232200|NCT04499209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102232201|NCT04499209|Gout Suppressants|gout suppressants|mesh-ancestor
102232202|NCT04499209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102232203|NCT04499209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102232204|NCT02509351|Misoprostol|misoprostol|mesh-list
102232205|NCT02509351|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102232206|NCT02509351|Abortifacient Agents|abortifacient agents|mesh-ancestor
102232207|NCT02509351|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102232208|NCT02509351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232209|NCT02509351|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102232210|NCT02509351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102232211|NCT02509351|Oxytocics|oxytocics|mesh-ancestor
102232212|NCT02509195|Lamivudine|lamivudine|mesh-list
102232213|NCT02509195|Abacavir|abacavir|mesh-list
102232214|NCT02509195|Dolutegravir|dolutegravir|mesh-list
102232215|NCT02509195|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
102232216|NCT02509195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102232217|NCT02509195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102232218|NCT02509195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102232219|NCT02509195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232220|NCT02509195|Antiviral Agents|antiviral agents|mesh-ancestor
102232221|NCT02509195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102232222|NCT02509195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102232223|NCT02509195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102232224|NCT02509195|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102232225|NCT02509195|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102232226|NCT02508805|Diclofenac|diclofenac|mesh-list
102232227|NCT02508805|Tizanidine|tizanidine|mesh-list
102232228|NCT02508805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102232229|NCT02508805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102232230|NCT02508805|Analgesics|analgesics|mesh-ancestor
102232231|NCT02508805|Sensory System Agents|sensory system agents|mesh-ancestor
102232232|NCT02508805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101634726|NCT00721201|Mifepristone|mifepristone|mesh-list
102232233|NCT02508805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232234|NCT02508805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102232235|NCT02508805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102232236|NCT02508805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102232237|NCT02508805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612737|NCT00002219|Antiviral Agents|antiviral agents|mesh-ancestor
102232238|NCT02508805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232239|NCT02508805|Anticonvulsants|anticonvulsants|mesh-ancestor
102232240|NCT02508805|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102232241|NCT02508805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102232242|NCT02508805|Parasympatholytics|parasympatholytics|mesh-ancestor
102232243|NCT02508805|Autonomic Agents|autonomic agents|mesh-ancestor
102232244|NCT02508805|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102232245|NCT02508805|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102232246|NCT02508805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102232247|NCT02508805|Adrenergic Agents|adrenergic agents|mesh-ancestor
102612738|NCT00002219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102612739|NCT00002219|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102612740|NCT00002219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102612741|NCT00002225|Efavirenz|efavirenz|mesh-list
102612742|NCT00002225|Stavudine|stavudine|mesh-list
102612743|NCT00002225|Didanosine|didanosine|mesh-list
102612744|NCT00002225|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102612745|NCT00002225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102612746|NCT00002225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612747|NCT00002225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232248|NCT02508805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102232249|NCT03121573|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102232250|NCT03121573|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102232251|NCT03121573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102232252|NCT03121573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102232253|NCT03121573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232254|NCT03121573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102232255|NCT03121573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232256|NCT03121573|Analgesics|analgesics|mesh-ancestor
102232257|NCT03121573|Sensory System Agents|sensory system agents|mesh-ancestor
102232258|NCT03121573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102232259|NCT03121573|Antidepressive Agents|antidepressive agents|mesh-ancestor
102232260|NCT03121573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101634760|NCT00978068|Ritonavir|ritonavir|mesh-list
102232261|NCT03121573|Dopamine Agents|dopamine agents|mesh-ancestor
102232262|NCT03121417|Nivolumab|nivolumab|mesh-list
102232263|NCT03121417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102232264|NCT03121417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102232265|NCT03121417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102232266|NCT03121417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232267|NCT02503189|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102232268|NCT02503189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102232269|NCT02502643|Picibanil|picibanil|mesh-list
102232270|NCT02502643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102232271|NCT02502565|Uric Acid|uric acid|mesh-list
102232272|NCT02502565|Antioxidants|antioxidants|mesh-ancestor
102232273|NCT02502565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232274|NCT02502565|Protective Agents|protective agents|mesh-ancestor
102232275|NCT02502565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232276|NCT04498897|Acamprosate|acamprosate|mesh-list
102232277|NCT04498897|Vortioxetine|vortioxetine|mesh-list
102232278|NCT04498897|Antidepressive Agents|antidepressive agents|mesh-ancestor
102232279|NCT04498897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102232280|NCT04498897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102232281|NCT04498897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102232282|NCT04498897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102232283|NCT04498897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232284|NCT04498897|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102232285|NCT04498897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102232286|NCT04498897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102232287|NCT04498897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232288|NCT04498897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102232289|NCT04498897|Serotonin Agents|serotonin agents|mesh-ancestor
102232290|NCT04498897|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102232291|NCT04498897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102232292|NCT04498897|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102232293|NCT04498897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102232294|NCT04498897|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102232295|NCT02502877|Midazolam|midazolam|mesh-list
102232296|NCT02502877|Propofol|propofol|mesh-list
102232297|NCT02502877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102232298|NCT02502877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102232299|NCT02502877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232300|NCT02502877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102232301|NCT02502877|Anesthetics, General|anesthetics, general|mesh-ancestor
102232303|NCT02502877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102232304|NCT02502877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102232305|NCT02502877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101634794|NCT02865356|Cyclosporine|cyclosporine|mesh-list
102232306|NCT02502877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102232307|NCT02502877|GABA Modulators|gaba modulators|mesh-ancestor
102232308|NCT02502877|GABA Agents|gaba agents|mesh-ancestor
102232309|NCT02502877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102232310|NCT02502877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232311|NCT03121339|Vaccines|vaccines|mesh-list
102232312|NCT03121339|Immunologic Factors|immunologic factors|mesh-ancestor
102232313|NCT03121339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232314|NCT03343327|Hydrocortisone|hydrocortisone|mesh-list
102232315|NCT03343327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102232316|NCT02502175|Methadone|methadone|mesh-list
102232317|NCT02502175|Opium|opium|mesh-list
102232318|NCT02502175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102232319|NCT02502175|Narcotics|narcotics|mesh-ancestor
102232320|NCT02502175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102232321|NCT02502175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232322|NCT02502175|Analgesics|analgesics|mesh-ancestor
102232323|NCT02502175|Sensory System Agents|sensory system agents|mesh-ancestor
102232324|NCT02502175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102232325|NCT02502175|Antitussive Agents|antitussive agents|mesh-ancestor
102232326|NCT02502175|Respiratory System Agents|respiratory system agents|mesh-ancestor
102232327|NCT02502175|Antidiarrheals|antidiarrheals|mesh-ancestor
102232328|NCT02502175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102232329|NCT02501941|Ketamine|ketamine|mesh-list
102232330|NCT02501941|Analgesics|analgesics|mesh-ancestor
102232331|NCT02501941|Sensory System Agents|sensory system agents|mesh-ancestor
102232332|NCT02501941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102232333|NCT02501941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232334|NCT02501941|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102232335|NCT02501941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102232336|NCT02501941|Anesthetics, General|anesthetics, general|mesh-ancestor
102232337|NCT02501941|Anesthetics|anesthetics|mesh-ancestor
102232338|NCT02501941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102232339|NCT02501941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101634834|NCT00603525|Ofatumumab|ofatumumab|mesh-list
102232340|NCT02501941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102232341|NCT02501941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102232342|NCT02501941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232343|NCT02500927|Naquotinib|naquotinib|mesh-list
101941193|NCT02968576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102232344|NCT02500927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102232345|NCT02500927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102232346|NCT02500927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102232347|NCT02500927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232348|NCT02501863|Fentanyl|fentanyl|mesh-list
102232349|NCT02501863|Ropivacaine|ropivacaine|mesh-list
102232350|NCT02501863|Anesthetics, Local|anesthetics, local|mesh-ancestor
102232351|NCT02501863|Anesthetics|anesthetics|mesh-ancestor
102232352|NCT02501863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102232353|NCT02501863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232354|NCT02501863|Sensory System Agents|sensory system agents|mesh-ancestor
102232355|NCT02501863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102232356|NCT02501863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102232357|NCT02501863|Narcotics|narcotics|mesh-ancestor
102232358|NCT02501863|Analgesics|analgesics|mesh-ancestor
102232359|NCT02501863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102232360|NCT02501863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102232361|NCT02501863|Anesthetics, General|anesthetics, general|mesh-ancestor
102232362|NCT02500459|Topotecan|topotecan|mesh-list
102232363|NCT02500459|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102232364|NCT02500459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102232365|NCT02500459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102232366|NCT02500459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232367|NCT02500459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102232368|NCT02500225|Sevoflurane|sevoflurane|mesh-list
102232369|NCT02500225|Etomidate|etomidate|mesh-list
102232370|NCT02500225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102232371|NCT02500225|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102232372|NCT02500225|Anesthetics, General|anesthetics, general|mesh-ancestor
102232373|NCT02500225|Anesthetics|anesthetics|mesh-ancestor
102232374|NCT02500225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102232375|NCT02500225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102612748|NCT00002225|Antiviral Agents|antiviral agents|mesh-ancestor
102232376|NCT02500225|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102232377|NCT02500225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102232378|NCT02507635|Levocetirizine|levocetirizine|mesh-list
102232379|NCT02507635|Desloratadine|desloratadine|mesh-list
102232380|NCT02507635|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102232381|NCT02507635|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102232382|NCT02507635|Histamine Antagonists|histamine antagonists|mesh-ancestor
102232383|NCT02507635|Histamine Agents|histamine agents|mesh-ancestor
102232384|NCT02507635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102232385|NCT02507635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232386|NCT02507635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232387|NCT02507635|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102232388|NCT02507635|Cholinergic Agents|cholinergic agents|mesh-ancestor
102232389|NCT04495933|Vaccines|vaccines|mesh-list
102232390|NCT04495933|MF59 oil emulsion|mf59 oil emulsion|mesh-list
102232391|NCT04495933|Immunologic Factors|immunologic factors|mesh-ancestor
102232392|NCT04495933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232393|NCT04495933|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102232394|NCT02500069|Caseins|caseins|mesh-list
102232395|NCT02500069|Chelating Agents|chelating agents|mesh-ancestor
102232396|NCT02500069|Sequestering Agents|sequestering agents|mesh-ancestor
102232397|NCT02500069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232398|NCT03344029|Vaccines|vaccines|mesh-list
102232399|NCT03344029|Immunologic Factors|immunologic factors|mesh-ancestor
102232400|NCT03344029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232401|NCT03120637|Methylene Blue|methylene blue|mesh-list
102232402|NCT03120637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102232403|NCT03120637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232404|NCT02499757|Nicotine|nicotine|mesh-list
102232405|NCT02499757|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102232406|NCT02499757|Autonomic Agents|autonomic agents|mesh-ancestor
102232407|NCT02499757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102232408|NCT02499757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232409|NCT02499757|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102232410|NCT02499757|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102232411|NCT02499757|Cholinergic Agents|cholinergic agents|mesh-ancestor
102232412|NCT02499757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102232413|NCT02499757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232414|NCT00706849|Mipomersen|mipomersen|mesh-list
102232415|NCT00706849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102232416|NCT00706849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102232417|NCT00706849|Antimetabolites|antimetabolites|mesh-ancestor
102232418|NCT00706849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232419|NCT00706849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102232420|NCT02499445|Sufentanil|sufentanil|mesh-list
102232421|NCT02499445|Remifentanil|remifentanil|mesh-list
102232422|NCT02499445|Propofol|propofol|mesh-list
102232423|NCT02499445|Sevoflurane|sevoflurane|mesh-list
102232424|NCT02499445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102232425|NCT02499445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102232426|NCT02499445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232427|NCT02499445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102232428|NCT02499445|Anesthetics, General|anesthetics, general|mesh-ancestor
102232429|NCT02499445|Anesthetics|anesthetics|mesh-ancestor
102232430|NCT02499445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102232431|NCT02499445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102232432|NCT02499445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102232433|NCT02499445|Narcotics|narcotics|mesh-ancestor
102232434|NCT02499445|Analgesics|analgesics|mesh-ancestor
102232435|NCT02499445|Sensory System Agents|sensory system agents|mesh-ancestor
102232436|NCT02499445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102232437|NCT02499445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102232438|NCT04443049|Mebendazole|mebendazole|mesh-list
102232439|NCT04443049|Piperazine|piperazine|mesh-list
102232440|NCT04443049|Piperazine citrate|piperazine citrate|mesh-list
102232441|NCT04443049|Lenvatinib|lenvatinib|mesh-list
102232442|NCT04443049|DMP 777|dmp 777|mesh-list
102232443|NCT04443049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102232444|NCT04443049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102232445|NCT04443049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102232446|NCT04443049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612749|NCT00002225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102232447|NCT04443049|Antinematodal Agents|antinematodal agents|mesh-ancestor
102232448|NCT04443049|Anthelmintics|anthelmintics|mesh-ancestor
102232449|NCT04443049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102232450|NCT04443049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102232451|NCT04443049|Tubulin Modulators|tubulin modulators|mesh-ancestor
102612750|NCT00002225|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102232452|NCT04443049|Antimitotic Agents|antimitotic agents|mesh-ancestor
102232453|NCT04443049|Mitosis Modulators|mitosis modulators|mesh-ancestor
102232454|NCT02494999|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102232455|NCT02494999|Immunologic Factors|immunologic factors|mesh-ancestor
102232456|NCT02494999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232458|NCT03341845|Axitinib|axitinib|mesh-list
102232459|NCT03341845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102232460|NCT03341845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102232461|NCT03341845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102232462|NCT03341845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102232463|NCT03341845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232464|NCT02498977|Cyclosporine|cyclosporine|mesh-list
102232465|NCT02498977|Mycophenolic Acid|mycophenolic acid|mesh-list
102232466|NCT02498977|Azathioprine|azathioprine|mesh-list
102232467|NCT02498977|Tacrolimus|tacrolimus|mesh-list
102232468|NCT02498977|Cyclosporins|cyclosporins|mesh-list
102232469|NCT02498977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102232470|NCT02498977|Immunologic Factors|immunologic factors|mesh-ancestor
102232471|NCT02498977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232472|NCT02498977|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102232473|NCT02498977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102232474|NCT02498977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232475|NCT02498977|Antifungal Agents|antifungal agents|mesh-ancestor
102232476|NCT02498977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102232477|NCT02498977|Dermatologic Agents|dermatologic agents|mesh-ancestor
102232478|NCT02498977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102232479|NCT02498977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102232480|NCT02498977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102232481|NCT02498977|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102232482|NCT02498977|Antitubercular Agents|antitubercular agents|mesh-ancestor
102232483|NCT02498977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102232484|NCT02498977|Antimetabolites|antimetabolites|mesh-ancestor
102232485|NCT02498977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102232486|NCT02494687|Domperidone|domperidone|mesh-list
102232487|NCT02494687|Antiemetics|antiemetics|mesh-ancestor
102232488|NCT02494687|Autonomic Agents|autonomic agents|mesh-ancestor
102232489|NCT02494687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102232490|NCT02494687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232491|NCT02494687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102232492|NCT02494687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102232493|NCT02494687|Dopamine Agents|dopamine agents|mesh-ancestor
102232494|NCT02494687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102232495|NCT02494687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232496|NCT02494609|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
102232497|NCT02494609|Contraceptive Agents|contraceptive agents|mesh-list
102232498|NCT02494609|Contraceptives, Oral|contraceptives, oral|mesh-list
102232499|NCT02494609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102232500|NCT02494609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232501|NCT02494609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102232502|NCT02494609|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102232503|NCT02494609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232504|NCT02494609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102232505|NCT03341767|Clofazimine|clofazimine|mesh-list
102232506|NCT03341767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102232507|NCT03341767|Leprostatic Agents|leprostatic agents|mesh-ancestor
102232508|NCT03341767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102232509|NCT03341767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102232510|NCT02498509|Mometasone Furoate|mometasone furoate|mesh-list
102232511|NCT02498509|Levocabastine|levocabastine|mesh-list
102232512|NCT02498509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102232513|NCT02498509|Dermatologic Agents|dermatologic agents|mesh-ancestor
102232514|NCT02498509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102232515|NCT02498509|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102232516|NCT02498509|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102232517|NCT02498509|Histamine Antagonists|histamine antagonists|mesh-ancestor
102232518|NCT02498509|Histamine Agents|histamine agents|mesh-ancestor
102232519|NCT02498509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102232520|NCT02498509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232521|NCT02498509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232522|NCT03342859|Ulipristal acetate|ulipristal acetate|mesh-list
102232523|NCT03342859|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102612751|NCT00002225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102232524|NCT03342859|Contraceptive Agents|contraceptive agents|mesh-ancestor
102232525|NCT03342859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102232526|NCT03342859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232527|NCT03342859|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102232528|NCT02493283|Dapsone|dapsone|mesh-list
102232529|NCT02493283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102232530|NCT02493283|Antimalarials|antimalarials|mesh-ancestor
102232531|NCT02493283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102232532|NCT02493283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102232533|NCT02493283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102232534|NCT02493283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102232535|NCT02493283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232536|NCT02493283|Leprostatic Agents|leprostatic agents|mesh-ancestor
102232537|NCT02493283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102232538|NCT03335527|Dexmedetomidine|dexmedetomidine|mesh-list
102232539|NCT03335527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102232540|NCT03335527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102232541|NCT03335527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232542|NCT03335527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102232543|NCT03335527|Analgesics|analgesics|mesh-ancestor
102232544|NCT03335527|Sensory System Agents|sensory system agents|mesh-ancestor
102232545|NCT03335527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102232546|NCT03335527|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102232547|NCT03335527|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102232548|NCT03335527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102232549|NCT03335527|Adrenergic Agents|adrenergic agents|mesh-ancestor
102232550|NCT03335527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102232551|NCT03335527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232552|NCT02493049|Domperidone|domperidone|mesh-list
102232553|NCT02493049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232554|NCT02493049|Antiemetics|antiemetics|mesh-ancestor
102232555|NCT02493049|Autonomic Agents|autonomic agents|mesh-ancestor
102232556|NCT02493049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102232557|NCT02493049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232558|NCT02493049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102232559|NCT02493049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102232560|NCT02493049|Dopamine Agents|dopamine agents|mesh-ancestor
102232561|NCT02493049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102232562|NCT03120715|Heparin|heparin|mesh-list
102232563|NCT03120715|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102232564|NCT03120715|Tinzaparin|tinzaparin|mesh-list
102232565|NCT03120715|Dalteparin|dalteparin|mesh-list
102232566|NCT03120715|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102232567|NCT03120715|Progesterone|progesterone|mesh-list
102232568|NCT03120715|Estrogens|estrogens|mesh-list
102232569|NCT03120715|Anticoagulants|anticoagulants|mesh-ancestor
102232570|NCT03120715|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101635060|NCT02571517|Hormones|hormones|mesh-ancestor
102232571|NCT03120715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102232572|NCT03120715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232573|NCT03120715|Progestins|progestins|mesh-ancestor
102232574|NCT03120715|Hormones|hormones|mesh-ancestor
102232575|NCT03120715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102232576|NCT03120715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232577|NCT03120715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102232578|NCT03120403|Morphine|morphine|mesh-list
102232579|NCT03120403|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102232580|NCT03120403|Narcotics|narcotics|mesh-ancestor
102232581|NCT03120403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102232582|NCT03120403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232583|NCT03120403|Analgesics|analgesics|mesh-ancestor
102232584|NCT03120403|Sensory System Agents|sensory system agents|mesh-ancestor
102232585|NCT03120403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102232586|NCT03335293|Epinephrine|epinephrine|mesh-list
102232587|NCT03335293|Racepinephrine|racepinephrine|mesh-list
102232588|NCT03335293|Epinephryl borate|epinephryl borate|mesh-list
102232589|NCT03335293|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102232590|NCT03335293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102232591|NCT03335293|Adrenergic Agents|adrenergic agents|mesh-ancestor
102232592|NCT03335293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102232593|NCT03335293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232594|NCT03335293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232595|NCT03335293|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102232596|NCT03335293|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102232597|NCT03335293|Autonomic Agents|autonomic agents|mesh-ancestor
102232598|NCT03335293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102612752|NCT00002225|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102232599|NCT03335293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102232600|NCT03335293|Respiratory System Agents|respiratory system agents|mesh-ancestor
102232601|NCT03335293|Mydriatics|mydriatics|mesh-ancestor
102232602|NCT03335293|Sympathomimetics|sympathomimetics|mesh-ancestor
102232603|NCT03335293|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102232604|NCT03340753|Mineralocorticoids|mineralocorticoids|mesh-list
102232605|NCT03340753|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
102232606|NCT03340753|Hormones|hormones|mesh-ancestor
102232607|NCT03340753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102232608|NCT03340753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232609|NCT03340753|Hormone Antagonists|hormone antagonists|mesh-ancestor
102232610|NCT03340753|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102232611|NCT03340753|Diuretics|diuretics|mesh-ancestor
102232612|NCT03340753|Natriuretic Agents|natriuretic agents|mesh-ancestor
102232613|NCT02494531|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102232614|NCT02494531|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102232615|NCT02494531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232616|NCT03340597|Olorofim|olorofim|mesh-list
102232617|NCT03340597|Antifungal Agents|antifungal agents|mesh-ancestor
102232618|NCT03340597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102232619|NCT00707161|Cisplatin|cisplatin|mesh-list
101635087|NCT04144465|Oxymetazoline|oxymetazoline|mesh-list
102232620|NCT00707161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102232621|NCT03120247|Dexmedetomidine|dexmedetomidine|mesh-list
102232622|NCT03120247|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102232623|NCT03120247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102232624|NCT03120247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232625|NCT03120247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102232626|NCT03120247|Analgesics|analgesics|mesh-ancestor
102232627|NCT03120247|Sensory System Agents|sensory system agents|mesh-ancestor
102232628|NCT03120247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102232629|NCT03120247|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102232630|NCT03120247|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102232631|NCT03120247|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102232632|NCT03120247|Adrenergic Agents|adrenergic agents|mesh-ancestor
102232633|NCT03120247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102232634|NCT03120247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232635|NCT03335059|Mitomycins|mitomycins|mesh-list
102232636|NCT03335059|Mitomycin|mitomycin|mesh-list
102232637|NCT03335059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102232638|NCT03335059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102232639|NCT03335059|Alkylating Agents|alkylating agents|mesh-ancestor
102232640|NCT03335059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232641|NCT03335059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102232642|NCT03335059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102232643|NCT03334981|Buprenorphine|buprenorphine|mesh-list
102232644|NCT03334981|Methadone|methadone|mesh-list
102232645|NCT03334981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102232646|NCT03334981|Narcotics|narcotics|mesh-ancestor
102232647|NCT03334981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102232648|NCT03334981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232649|NCT03334981|Analgesics|analgesics|mesh-ancestor
102232650|NCT03334981|Sensory System Agents|sensory system agents|mesh-ancestor
102232651|NCT03334981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102232652|NCT03334981|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102232653|NCT03334981|Antitussive Agents|antitussive agents|mesh-ancestor
102232654|NCT03334981|Respiratory System Agents|respiratory system agents|mesh-ancestor
102232656|NCT02492503|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102232657|NCT02492503|Carboplatin|carboplatin|mesh-list
102232658|NCT02492503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102232659|NCT02492503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102232660|NCT02492503|Tubulin Modulators|tubulin modulators|mesh-ancestor
102232661|NCT02492503|Antimitotic Agents|antimitotic agents|mesh-ancestor
102232662|NCT02492503|Mitosis Modulators|mitosis modulators|mesh-ancestor
101635105|NCT00754390|Calcium, Dietary|calcium, dietary|mesh-list
102232663|NCT02492503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232664|NCT03334591|Apatinib|apatinib|mesh-list
102232665|NCT03334591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102232666|NCT03334591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102232667|NCT03334591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102232668|NCT03334591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232669|NCT03334513|Bevacizumab|bevacizumab|mesh-list
102232670|NCT03334513|Ranibizumab|ranibizumab|mesh-list
102232671|NCT03334513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102232672|NCT03334513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102232673|NCT03334513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102612753|NCT00002225|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102232674|NCT03334513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102232675|NCT03334513|Growth Substances|growth substances|mesh-ancestor
102232676|NCT03334513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232677|NCT03334513|Growth Inhibitors|growth inhibitors|mesh-ancestor
102232678|NCT02130466|Pembrolizumab|pembrolizumab|mesh-list
102232679|NCT02130466|Trametinib|trametinib|mesh-list
102232680|NCT02130466|Dabrafenib|dabrafenib|mesh-list
102232681|NCT02130466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102232682|NCT02130466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102232683|NCT02130466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102232684|NCT02130466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232685|NCT02130466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102232686|NCT02130466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102232687|NCT03339427|Vitamin D|vitamin d|mesh-list
102232688|NCT03339427|Vitamins|vitamins|mesh-ancestor
102232689|NCT03339427|Micronutrients|micronutrients|mesh-ancestor
102232690|NCT03339427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232691|NCT03339427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102232692|NCT03339349|Enoxaparin|enoxaparin|mesh-list
102232693|NCT03339349|Anticoagulants|anticoagulants|mesh-ancestor
102232694|NCT03339349|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102232695|NCT03339349|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102232696|NCT03339349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232697|NCT02496715|Fluticasone|fluticasone|mesh-list
102232698|NCT02496715|Xhance|xhance|mesh-list
102232699|NCT02496715|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102232700|NCT02496715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102232701|NCT02496715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102232702|NCT02496715|Autonomic Agents|autonomic agents|mesh-ancestor
102232703|NCT02496715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102232704|NCT02496715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232705|NCT02496715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102232706|NCT02496715|Respiratory System Agents|respiratory system agents|mesh-ancestor
102232707|NCT02496715|Dermatologic Agents|dermatologic agents|mesh-ancestor
102232708|NCT02496715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102232709|NCT02496715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102232710|NCT02496715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102232711|NCT02496715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102232712|NCT02496715|Adrenergic Agents|adrenergic agents|mesh-ancestor
102232713|NCT02496715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102232714|NCT02496715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232715|NCT02492581|Nalmefene|nalmefene|mesh-list
102232716|NCT02492581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102232717|NCT02492581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232718|NCT02492581|Sensory System Agents|sensory system agents|mesh-ancestor
102232719|NCT02492581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102232720|NCT03342079|Nitrous Oxide|nitrous oxide|mesh-list
102232721|NCT03342079|Anesthetics|anesthetics|mesh-list
102232722|NCT03342079|Anesthetics, Local|anesthetics, local|mesh-list
102232723|NCT03342079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102232724|NCT03342079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232725|NCT03342079|Sensory System Agents|sensory system agents|mesh-ancestor
102232726|NCT03342079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102232727|NCT03342079|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102232728|NCT03342079|Anesthetics, General|anesthetics, general|mesh-ancestor
102232729|NCT03342079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102232730|NCT03342079|Analgesics|analgesics|mesh-ancestor
102232731|NCT04494763|Propranolol|propranolol|mesh-list
102232732|NCT04494763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102232733|NCT04494763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102232734|NCT04494763|Adrenergic Agents|adrenergic agents|mesh-ancestor
102232735|NCT04494763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102232736|NCT04494763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232737|NCT04494763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232738|NCT04494763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102232739|NCT04494763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102232740|NCT04494763|Vasodilator Agents|vasodilator agents|mesh-ancestor
102232741|NCT02162758|Dexlansoprazole|dexlansoprazole|mesh-list
102232742|NCT02162758|Lansoprazole|lansoprazole|mesh-list
102232743|NCT02162758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102232744|NCT02162758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101635166|NCT02571361|Acetaminophen|acetaminophen|mesh-list
102232745|NCT02162758|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102232746|NCT02162758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102232747|NCT02162758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232748|NCT03333499|Trimetazidine|trimetazidine|mesh-list
102612754|NCT00002225|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102612755|NCT00002225|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102232749|NCT03333499|Vasodilator Agents|vasodilator agents|mesh-ancestor
102232750|NCT02491879|Ketoprofen|ketoprofen|mesh-list
102232751|NCT02491879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102232752|NCT02491879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102232753|NCT02491879|Analgesics|analgesics|mesh-ancestor
102232754|NCT02491879|Sensory System Agents|sensory system agents|mesh-ancestor
102232755|NCT02491879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102232756|NCT02491879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232757|NCT02491879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102232758|NCT02491879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102232759|NCT02491879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102232760|NCT02491879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102232761|NCT02491879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232762|NCT03332953|Nicotine|nicotine|mesh-list
102232763|NCT03332953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102232764|NCT03332953|Autonomic Agents|autonomic agents|mesh-ancestor
102232765|NCT03332953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102232766|NCT03332953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232767|NCT03332953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102232768|NCT03332953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102232769|NCT03332953|Cholinergic Agents|cholinergic agents|mesh-ancestor
102232770|NCT03332953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102232771|NCT03332953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232772|NCT02491723|Azithromycin|azithromycin|mesh-list
102232773|NCT02491723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102232774|NCT02491723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102232775|NCT03332719|Etanercept|etanercept|mesh-list
102232776|NCT03332719|Methotrexate|methotrexate|mesh-list
102232777|NCT03332719|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102232778|NCT03332719|Abortifacient Agents|abortifacient agents|mesh-ancestor
102232779|NCT03332719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102232780|NCT03332719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232781|NCT03332719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102232782|NCT03332719|Antimetabolites|antimetabolites|mesh-ancestor
102232783|NCT03332719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232784|NCT03332719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102232785|NCT03332719|Dermatologic Agents|dermatologic agents|mesh-ancestor
102232786|NCT03332719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102232787|NCT03332719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102232788|NCT03332719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102232789|NCT03332719|Immunologic Factors|immunologic factors|mesh-ancestor
102232790|NCT03332719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102232791|NCT03332719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102232792|NCT03332719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102232793|NCT03332719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102232794|NCT03332719|Analgesics|analgesics|mesh-ancestor
102232795|NCT03332719|Sensory System Agents|sensory system agents|mesh-ancestor
102232796|NCT03332719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102232797|NCT03332719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102232798|NCT03332719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102232799|NCT03330769|Antirheumatic Agents|antirheumatic agents|mesh-list
102232801|NCT03330613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102232802|NCT03330613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232803|NCT03332329|Entecavir|entecavir|mesh-list
102232804|NCT03332329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102232805|NCT03332329|Molgramostim|molgramostim|mesh-list
102232806|NCT03332329|Vaccines|vaccines|mesh-list
102232807|NCT03332329|Sargramostim|sargramostim|mesh-list
102232808|NCT03332329|Immunologic Factors|immunologic factors|mesh-ancestor
102232809|NCT03332329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232810|NCT03332329|Antiviral Agents|antiviral agents|mesh-ancestor
102232811|NCT03332329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102232812|NCT03332329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102232813|NCT03330223|Clopidogrel|clopidogrel|mesh-list
102232814|NCT03330223|Ticagrelor|ticagrelor|mesh-list
102232815|NCT03330223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102232816|NCT03330223|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102232817|NCT03330223|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102232818|NCT03330223|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102232819|NCT03330223|Purinergic Agents|purinergic agents|mesh-ancestor
102612756|NCT00002225|Antimetabolites|antimetabolites|mesh-ancestor
102232820|NCT03330223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102232821|NCT03330223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612757|NCT00002225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102232822|NCT03330223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232824|NCT03331861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102232825|NCT03331861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232826|NCT03329443|Spironolactone|spironolactone|mesh-list
102232827|NCT03329443|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102232828|NCT03329443|Hormone Antagonists|hormone antagonists|mesh-ancestor
102232829|NCT03329443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102232830|NCT03329443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232831|NCT03329443|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102232832|NCT03329443|Diuretics|diuretics|mesh-ancestor
102232833|NCT03329443|Natriuretic Agents|natriuretic agents|mesh-ancestor
102232834|NCT03328975|Dexamethasone|dexamethasone|mesh-list
102232835|NCT03328975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102232836|NCT03328975|Antiemetics|antiemetics|mesh-ancestor
102232837|NCT03328975|Autonomic Agents|autonomic agents|mesh-ancestor
102232838|NCT03328975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102232839|NCT03328975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232840|NCT03328975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102232841|NCT03328975|Glucocorticoids|glucocorticoids|mesh-ancestor
102232842|NCT03328975|Hormones|hormones|mesh-ancestor
102232843|NCT03328975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102232844|NCT03328975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102232845|NCT03328975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102232846|NCT05430711|Dinoprostone|dinoprostone|mesh-list
102232847|NCT05430711|Oxytocics|oxytocics|mesh-ancestor
102232848|NCT05430711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102232849|NCT05430711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232850|NCT03324685|Levonorgestrel|levonorgestrel|mesh-list
102232851|NCT03324685|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102232852|NCT03324685|Estradiol|estradiol|mesh-list
102232853|NCT03324685|Estrogens|estrogens|mesh-ancestor
102232854|NCT03324685|Hormones|hormones|mesh-ancestor
102232855|NCT03324685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102232856|NCT03324685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232857|NCT03324685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102232858|NCT03324685|Contraceptive Agents|contraceptive agents|mesh-ancestor
102232859|NCT03324685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102232860|NCT03324685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102232861|NCT03324685|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102232862|NCT03324685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102232863|NCT03324685|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102232864|NCT03324139|Heparin|heparin|mesh-list
102232865|NCT03324139|Calcium heparin|calcium heparin|mesh-list
102232866|NCT03324139|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102232867|NCT03324139|Tinzaparin|tinzaparin|mesh-list
102232868|NCT03324139|Dalteparin|dalteparin|mesh-list
102232869|NCT03324139|Anticoagulants|anticoagulants|mesh-ancestor
102232870|NCT03324139|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102232871|NCT03324139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102232872|NCT03324139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232873|NCT03324061|Fulvestrant|fulvestrant|mesh-list
102232874|NCT03324061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102232875|NCT03324061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102232876|NCT03324061|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102232877|NCT03324061|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102232878|NCT03324061|Hormone Antagonists|hormone antagonists|mesh-ancestor
102232879|NCT03324061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102232880|NCT03324061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232881|NCT02488603|Tamoxifen|tamoxifen|mesh-list
102232882|NCT02488603|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102232883|NCT02488603|Hormone Antagonists|hormone antagonists|mesh-ancestor
102232884|NCT02488603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102232885|NCT02488603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232886|NCT02488603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102232887|NCT02488603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102232888|NCT02488603|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102232889|NCT02488603|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102232890|NCT02488603|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102232891|NCT03328117|Imatinib Mesylate|imatinib mesylate|mesh-list
102232892|NCT03328117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102232893|NCT03328117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102232894|NCT03328117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612758|NCT00002225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102232895|NCT03328117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232896|NCT05430087|Vitamin D|vitamin d|mesh-list
102232897|NCT05430087|Cholecalciferol|cholecalciferol|mesh-list
102232898|NCT05430087|Curcumin|curcumin|mesh-list
102232899|NCT05430087|Piperine|piperine|mesh-list
102232900|NCT05430087|Vitamins|vitamins|mesh-ancestor
102232901|NCT05430087|Micronutrients|micronutrients|mesh-ancestor
102232902|NCT05430087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232903|NCT05430087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102232904|NCT05430087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102232905|NCT05430087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102232906|NCT05430087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102232907|NCT05430087|Analgesics|analgesics|mesh-ancestor
102232908|NCT05430087|Sensory System Agents|sensory system agents|mesh-ancestor
102232909|NCT05430087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102232910|NCT05430087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102232911|NCT05430087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102232912|NCT05430087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102232913|NCT05430087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102232914|NCT05430087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232915|NCT05430087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102232916|NCT03327727|Voriconazole|voriconazole|mesh-list
102232917|NCT03327727|Amphotericin B|amphotericin b|mesh-list
102232918|NCT03327727|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102232919|NCT03327727|Isavuconazole|isavuconazole|mesh-list
102232920|NCT03327727|VL-2397|vl-2397|mesh-list
102232921|NCT03327727|Antifungal Agents|antifungal agents|mesh-ancestor
102232922|NCT03327727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102232923|NCT03327727|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102232924|NCT03327727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102232925|NCT03327727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102232926|NCT03327727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232927|NCT03327727|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102232928|NCT03327727|Hormone Antagonists|hormone antagonists|mesh-ancestor
102232929|NCT03327727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102232930|NCT03327727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232931|NCT03327727|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102232932|NCT03327727|Amebicides|amebicides|mesh-ancestor
102232933|NCT03327727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102232934|NCT03327727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102232935|NCT03327727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102232936|NCT03323671|Mefenamic Acid|mefenamic acid|mesh-list
102232937|NCT03323671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102232938|NCT03323671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102232939|NCT03323671|Analgesics|analgesics|mesh-ancestor
102232940|NCT03323671|Sensory System Agents|sensory system agents|mesh-ancestor
102232941|NCT03323671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102232942|NCT03323671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232943|NCT03323671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102232944|NCT03323671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102232945|NCT03323671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102232946|NCT03323671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102232947|NCT03323671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232948|NCT03323593|Dexmedetomidine|dexmedetomidine|mesh-list
102232949|NCT03323593|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102232950|NCT03323593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102232951|NCT03323593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232952|NCT03323593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102232953|NCT03323593|Analgesics|analgesics|mesh-ancestor
102232954|NCT03323593|Sensory System Agents|sensory system agents|mesh-ancestor
102232955|NCT03323593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102232956|NCT03323593|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102232957|NCT03323593|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102232958|NCT03323593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102232959|NCT03323593|Adrenergic Agents|adrenergic agents|mesh-ancestor
102232960|NCT03323593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102232961|NCT03323593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232962|NCT02499003|Obinutuzumab|obinutuzumab|mesh-list
102232963|NCT02499003|Pixantrone|pixantrone|mesh-list
102232964|NCT02499003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102232965|NCT02499003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102232966|NCT02499003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102612759|NCT00002243|Calanolide A|calanolide a|mesh-list
102232967|NCT02499003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102232968|NCT02499003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102232969|NCT02499003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232971|NCT04492813|Propofol|propofol|mesh-list
102232972|NCT04492813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101635399|NCT00727987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102232973|NCT04492813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102232974|NCT04492813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232975|NCT04492813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102232976|NCT04492813|Anesthetics, General|anesthetics, general|mesh-ancestor
102232977|NCT04492813|Anesthetics|anesthetics|mesh-ancestor
102232978|NCT04492813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102232979|NCT04492813|Narcotics|narcotics|mesh-ancestor
102232980|NCT04492813|Analgesics|analgesics|mesh-ancestor
102232981|NCT04492813|Sensory System Agents|sensory system agents|mesh-ancestor
102232982|NCT04492813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102232983|NCT03102801|Insulin|insulin|mesh-list
102232984|NCT03102801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102232985|NCT03102801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102232986|NCT03102801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232987|NCT02488057|Liraglutide|liraglutide|mesh-list
102232988|NCT02488057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102232989|NCT02488057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102232990|NCT02488057|Incretins|incretins|mesh-ancestor
102232991|NCT02488057|Hormones|hormones|mesh-ancestor
102232992|NCT02488057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102232993|NCT04039347|Cyclosporine|cyclosporine|mesh-list
102232994|NCT04039347|Cyclosporins|cyclosporins|mesh-list
102232995|NCT04039347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102232996|NCT04039347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102232997|NCT04039347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102232998|NCT04039347|Immunologic Factors|immunologic factors|mesh-ancestor
102232999|NCT04039347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233000|NCT04039347|Antifungal Agents|antifungal agents|mesh-ancestor
102233001|NCT04039347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102233002|NCT04039347|Dermatologic Agents|dermatologic agents|mesh-ancestor
102233003|NCT04039347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102233004|NCT04039347|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102233005|NCT02488291|Sufentanil|sufentanil|mesh-list
102233006|NCT02488291|Dsuvia|dsuvia|mesh-list
102233007|NCT02488291|Ropivacaine|ropivacaine|mesh-list
102233008|NCT02488291|Anesthetics, Local|anesthetics, local|mesh-list
102233009|NCT02488291|Anesthetics|anesthetics|mesh-list
102233010|NCT02488291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102233011|NCT02488291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233012|NCT02488291|Sensory System Agents|sensory system agents|mesh-ancestor
102233013|NCT02488291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102233014|NCT02488291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102233015|NCT02488291|Narcotics|narcotics|mesh-ancestor
102233016|NCT02488291|Analgesics|analgesics|mesh-ancestor
102233017|NCT02488291|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102233018|NCT02488291|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102233019|NCT02488291|Anesthetics, General|anesthetics, general|mesh-ancestor
102233020|NCT03323047|Acetaminophen|acetaminophen|mesh-list
102233021|NCT03323047|Dexamethasone|dexamethasone|mesh-list
102233022|NCT03323047|Dexamethasone acetate|dexamethasone acetate|mesh-list
102233023|NCT03323047|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102233024|NCT03323047|BB 1101|bb 1101|mesh-list
102233025|NCT03323047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102233026|NCT03323047|Antiemetics|antiemetics|mesh-ancestor
102233027|NCT03323047|Autonomic Agents|autonomic agents|mesh-ancestor
102233028|NCT03323047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102233029|NCT03323047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233030|NCT03323047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102233031|NCT03323047|Glucocorticoids|glucocorticoids|mesh-ancestor
102233032|NCT03323047|Hormones|hormones|mesh-ancestor
102233033|NCT03323047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102233034|NCT03323047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102233035|NCT03323047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102233036|NCT03323047|Protease Inhibitors|protease inhibitors|mesh-ancestor
102233037|NCT03323047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102233038|NCT03323047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233039|NCT03323047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102233040|NCT03323047|Analgesics|analgesics|mesh-ancestor
102233041|NCT03323047|Sensory System Agents|sensory system agents|mesh-ancestor
102233042|NCT03323047|Antipyretics|antipyretics|mesh-ancestor
102233043|NCT03322969|Paclitaxel|paclitaxel|mesh-list
102233044|NCT03322969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102233045|NCT03322969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102233046|NCT03322969|Tubulin Modulators|tubulin modulators|mesh-ancestor
102233047|NCT03322969|Antimitotic Agents|antimitotic agents|mesh-ancestor
102233048|NCT03322969|Mitosis Modulators|mitosis modulators|mesh-ancestor
102233049|NCT03322969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233050|NCT05464303|Antibodies|antibodies|mesh-list
102233051|NCT05464303|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102233052|NCT05464303|gamma-Globulins|gamma-globulins|mesh-list
102233053|NCT05464303|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102233054|NCT05464303|Immunologic Factors|immunologic factors|mesh-ancestor
102233055|NCT05464303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233056|NCT03322735|Cyclophosphamide|cyclophosphamide|mesh-list
102233057|NCT03322735|Fludarabine|fludarabine|mesh-list
102233058|NCT03322735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102233059|NCT03322735|Immunologic Factors|immunologic factors|mesh-ancestor
102233060|NCT03322735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233061|NCT03322735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101635449|NCT00641589|Hematinics|hematinics|mesh-ancestor
102233062|NCT03322735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102233063|NCT03322735|Alkylating Agents|alkylating agents|mesh-ancestor
102233064|NCT03322735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233065|NCT03322735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102233066|NCT03322735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102233067|NCT02487823|Bicalutamide|bicalutamide|mesh-list
102233068|NCT02487823|Buserelin|buserelin|mesh-list
102233069|NCT02487823|Androgen Antagonists|androgen antagonists|mesh-ancestor
102233070|NCT02487823|Hormone Antagonists|hormone antagonists|mesh-ancestor
102233071|NCT02487823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102233072|NCT02487823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233073|NCT02487823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102233074|NCT02487823|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102233075|NCT02487823|Fertility Agents|fertility agents|mesh-ancestor
102233076|NCT02487823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102233077|NCT05463913|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102233078|NCT05463913|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102233079|NCT05463913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233080|NCT02487433|Tofacitinib|tofacitinib|mesh-list
102233081|NCT02487433|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102233082|NCT02487433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102233083|NCT02487433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102233084|NCT02487433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233085|NCT04493125|Mosapride|mosapride|mesh-list
102233086|NCT04493125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233087|NCT04493125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102233088|NCT04493125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102233089|NCT04493125|Serotonin Agents|serotonin agents|mesh-ancestor
102233090|NCT04493125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102233091|NCT04493125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233092|NCT03318835|Thalidomide|thalidomide|mesh-list
102233093|NCT03318835|Prednisone|prednisone|mesh-list
102233094|NCT03318835|Cyclophosphamide|cyclophosphamide|mesh-list
102233095|NCT03318835|Vincristine|vincristine|mesh-list
102233096|NCT03318835|Rituximab|rituximab|mesh-list
102233097|NCT03318835|Doxorubicin|doxorubicin|mesh-list
102233098|NCT03318835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102233099|NCT03318835|Immunologic Factors|immunologic factors|mesh-ancestor
102233100|NCT03318835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233101|NCT03318835|Leprostatic Agents|leprostatic agents|mesh-ancestor
102233102|NCT03318835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102233103|NCT03318835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102233104|NCT03318835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102233105|NCT03318835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102233106|NCT03318835|Growth Substances|growth substances|mesh-ancestor
102233107|NCT03318835|Growth Inhibitors|growth inhibitors|mesh-ancestor
102233108|NCT03318835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102233109|NCT03318835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102233110|NCT03318835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102233111|NCT03318835|Alkylating Agents|alkylating agents|mesh-ancestor
102233112|NCT03318835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233113|NCT03318835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102233114|NCT03318835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102233115|NCT03318835|Glucocorticoids|glucocorticoids|mesh-ancestor
102233116|NCT03318835|Hormones|hormones|mesh-ancestor
102612760|NCT00002243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102233117|NCT03318835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102233118|NCT03318835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102233119|NCT03318835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102233120|NCT03318835|Tubulin Modulators|tubulin modulators|mesh-ancestor
102233121|NCT03318835|Antimitotic Agents|antimitotic agents|mesh-ancestor
102233122|NCT03318835|Mitosis Modulators|mitosis modulators|mesh-ancestor
102233123|NCT03318835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102233124|NCT03318835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102233125|NCT03318835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102233126|NCT03318835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102233127|NCT03318835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102233128|NCT03318757|Bupivacaine|bupivacaine|mesh-list
102233129|NCT03318757|Anesthetics, Local|anesthetics, local|mesh-ancestor
102233130|NCT03318757|Anesthetics|anesthetics|mesh-ancestor
102233131|NCT03318757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102233132|NCT03318757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233133|NCT03318757|Sensory System Agents|sensory system agents|mesh-ancestor
102233134|NCT03318757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102233135|NCT02487355|Magnesium Sulfate|magnesium sulfate|mesh-list
102233136|NCT02487355|Dexmedetomidine|dexmedetomidine|mesh-list
102233137|NCT02487355|Bupivacaine|bupivacaine|mesh-list
102233138|NCT02487355|Anesthetics, Local|anesthetics, local|mesh-ancestor
102233139|NCT02487355|Anesthetics|anesthetics|mesh-ancestor
102233140|NCT02487355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102233141|NCT02487355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233142|NCT02487355|Sensory System Agents|sensory system agents|mesh-ancestor
102233143|NCT02487355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102233144|NCT02487355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102233145|NCT02487355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102233146|NCT02487355|Analgesics|analgesics|mesh-ancestor
102233147|NCT02487355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102233148|NCT02487355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102233149|NCT02487355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102233150|NCT02487355|Adrenergic Agents|adrenergic agents|mesh-ancestor
102233151|NCT02487355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102233152|NCT02487355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233153|NCT02487355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102233154|NCT02487355|Anticonvulsants|anticonvulsants|mesh-ancestor
102233155|NCT02487355|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102233156|NCT02487355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102233157|NCT02487355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102233158|NCT02487355|Tocolytic Agents|tocolytic agents|mesh-ancestor
101635509|NCT00909987|Antimetabolites|antimetabolites|mesh-ancestor
102233159|NCT02487355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102233160|NCT03325465|Pembrolizumab|pembrolizumab|mesh-list
102233161|NCT03325465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102233162|NCT03325465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102233163|NCT03325465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102233164|NCT03325465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233166|NCT01876953|Dasatinib|dasatinib|mesh-list
102233167|NCT01876953|Idarubicin|idarubicin|mesh-list
102233168|NCT01876953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102233169|NCT01876953|Antimetabolites|antimetabolites|mesh-ancestor
102233170|NCT01876953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233171|NCT01876953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102233172|NCT01876953|Antiviral Agents|antiviral agents|mesh-ancestor
102233173|NCT01876953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102233174|NCT01876953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102233175|NCT01876953|Immunologic Factors|immunologic factors|mesh-ancestor
102233176|NCT01876953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233177|NCT01876953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102233178|NCT01876953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102233179|NCT01876953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102233180|NCT01876953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102233181|NCT01876953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102233182|NCT03321955|Ziconotide|ziconotide|mesh-list
102233183|NCT03321955|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102233184|NCT03321955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102233185|NCT03321955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233186|NCT03321955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102233187|NCT03321955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233188|NCT03321955|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102233189|NCT03321955|Protective Agents|protective agents|mesh-ancestor
102233190|NCT03321955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102233191|NCT03321955|Analgesics|analgesics|mesh-ancestor
101775069|NCT00800358|Calcitriol|calcitriol|mesh-list
102612761|NCT00002243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102612762|NCT00002243|Antiviral Agents|antiviral agents|mesh-ancestor
102612763|NCT00002243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102233192|NCT03321955|Sensory System Agents|sensory system agents|mesh-ancestor
102233193|NCT03321955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102233195|NCT04493281|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102233196|NCT04493281|Antioxidants|antioxidants|mesh-ancestor
102233197|NCT04493281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233198|NCT04493281|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102233199|NCT04493281|Protective Agents|protective agents|mesh-ancestor
102233200|NCT04493281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233201|NCT01764711|Cosyntropin|cosyntropin|mesh-list
102233202|NCT01764711|Hormones|hormones|mesh-ancestor
102233203|NCT01764711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102233204|NCT01764711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233205|NCT04493515|Oxytocin|oxytocin|mesh-list
102233206|NCT04493515|Oxytocics|oxytocics|mesh-ancestor
102233207|NCT04493515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102233208|NCT04493515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233209|NCT03318445|Irinotecan|irinotecan|mesh-list
102233210|NCT03318445|Rucaparib|rucaparib|mesh-list
102233211|NCT03318445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102233212|NCT03318445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102233213|NCT03318445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102233214|NCT03318445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233215|NCT03318445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102233216|NCT03318445|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102233217|NCT02485015|Apatinib|apatinib|mesh-list
102233218|NCT02485015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102233219|NCT02485015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102233220|NCT02485015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102233221|NCT02485015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233222|NCT03316339|Dexmedetomidine|dexmedetomidine|mesh-list
102233223|NCT03316339|Remifentanil|remifentanil|mesh-list
102233224|NCT03316339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102233225|NCT03316339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102233226|NCT03316339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233227|NCT03316339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102233228|NCT03316339|Analgesics|analgesics|mesh-ancestor
102233229|NCT03316339|Sensory System Agents|sensory system agents|mesh-ancestor
102233230|NCT03316339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102233231|NCT03316339|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102233232|NCT03316339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102233233|NCT03316339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102233234|NCT03316339|Adrenergic Agents|adrenergic agents|mesh-ancestor
102233235|NCT03316339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102233236|NCT03316339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233237|NCT03316339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102233238|NCT03316339|Narcotics|narcotics|mesh-ancestor
102233239|NCT02490865|RNS60|rns60|mesh-list
102233240|NCT02490865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102233241|NCT02490865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102233242|NCT02490865|Analgesics|analgesics|mesh-ancestor
102233243|NCT02490865|Sensory System Agents|sensory system agents|mesh-ancestor
102233244|NCT02490865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102233245|NCT02490865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233246|NCT02490865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102233247|NCT02490865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102233248|NCT02490865|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102233249|NCT03318211|Magnesium Sulfate|magnesium sulfate|mesh-list
102233250|NCT03318211|Analgesics|analgesics|mesh-ancestor
101942108|NCT03919383|Lenvatinib|lenvatinib|mesh-list
102233251|NCT03318211|Sensory System Agents|sensory system agents|mesh-ancestor
102233252|NCT03318211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102233253|NCT03318211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233254|NCT03318211|Anesthetics|anesthetics|mesh-ancestor
102612764|NCT00002249|Levofloxacin|levofloxacin|mesh-list
102612765|NCT00002249|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102612766|NCT00002249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102612767|NCT00002249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102612768|NCT00002249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102233255|NCT03318211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102233256|NCT03318211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102233257|NCT03318211|Anticonvulsants|anticonvulsants|mesh-ancestor
102612769|NCT00002249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102612770|NCT00002249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102233258|NCT03318211|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102233259|NCT03318211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102233260|NCT03318211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233261|NCT03318211|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102233262|NCT03318211|Tocolytic Agents|tocolytic agents|mesh-ancestor
102233263|NCT03318211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102233264|NCT02483767|Goserelin|goserelin|mesh-list
102233265|NCT02483767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102233266|NCT02483767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102233267|NCT02483845|Natalizumab|natalizumab|mesh-list
102233268|NCT02483845|Immunologic Factors|immunologic factors|mesh-ancestor
102233269|NCT02483845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233270|NCT02486341|Insulin|insulin|mesh-list
102233271|NCT02486341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102233272|NCT02486341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233273|NCT02484001|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102233274|NCT02484001|Anticonvulsants|anticonvulsants|mesh-ancestor
102233275|NCT02484001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102233276|NCT02484001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102233277|NCT02484001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102233278|NCT02484001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233279|NCT02483923|Ropivacaine|ropivacaine|mesh-list
102233280|NCT02483923|Anesthetics, Local|anesthetics, local|mesh-ancestor
102233281|NCT02483923|Anesthetics|anesthetics|mesh-ancestor
102233282|NCT02483923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102233283|NCT02483923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233284|NCT02483923|Sensory System Agents|sensory system agents|mesh-ancestor
102233285|NCT02483923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102233286|NCT02483689|Bupivacaine|bupivacaine|mesh-list
102233287|NCT02483689|Anesthetics, Local|anesthetics, local|mesh-list
102233288|NCT02483689|Anesthetics|anesthetics|mesh-list
102233289|NCT02483689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102233290|NCT02483689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233291|NCT02483689|Sensory System Agents|sensory system agents|mesh-ancestor
102233292|NCT02483689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102233293|NCT02490085|Insulin|insulin|mesh-list
102233294|NCT02490085|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102233295|NCT02490085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102233296|NCT02490085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233297|NCT03102021|Epoetin Alfa|epoetin alfa|mesh-list
102233298|NCT03102021|Hematinics|hematinics|mesh-ancestor
102233299|NCT04916691|Ropivacaine|ropivacaine|mesh-list
102233300|NCT04916691|Anesthetics, Local|anesthetics, local|mesh-ancestor
102233301|NCT04916691|Anesthetics|anesthetics|mesh-ancestor
101635579|NCT00975416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233302|NCT04916691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102233303|NCT04916691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233304|NCT04916691|Sensory System Agents|sensory system agents|mesh-ancestor
102233305|NCT04916691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102233306|NCT05105139|Triclosan|triclosan|mesh-list
102233307|NCT05105139|Coal Tar|coal tar|mesh-list
102233308|NCT05105139|Allantoin|allantoin|mesh-list
102233309|NCT05105139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102233310|NCT05105139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102233311|NCT05105139|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102233312|NCT05105139|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102233313|NCT05105139|Antimetabolites|antimetabolites|mesh-ancestor
102233314|NCT05105139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233315|NCT05105139|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102233316|NCT05105139|Keratolytic Agents|keratolytic agents|mesh-ancestor
102233317|NCT05105139|Dermatologic Agents|dermatologic agents|mesh-ancestor
102233318|NCT03862833|Zoledronic Acid|zoledronic acid|mesh-list
102233319|NCT03862833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102233320|NCT03862833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233321|NCT03317275|Fluorides|fluorides|mesh-list
102233322|NCT03317275|Cariostatic Agents|cariostatic agents|mesh-ancestor
102233323|NCT03317275|Protective Agents|protective agents|mesh-ancestor
102233324|NCT03317275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233325|NCT03317197|Vasopressins|vasopressins|mesh-list
102233326|NCT03317197|Arginine Vasopressin|arginine vasopressin|mesh-list
102233327|NCT03317197|Epinephrine|epinephrine|mesh-list
102233328|NCT03317197|Racepinephrine|racepinephrine|mesh-list
102233329|NCT03317197|Epinephryl borate|epinephryl borate|mesh-list
102233330|NCT03317197|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102233331|NCT03317197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102233332|NCT03317197|Adrenergic Agents|adrenergic agents|mesh-ancestor
102612771|NCT00002249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233333|NCT03317197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102233334|NCT03317197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233335|NCT03317197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233336|NCT03317197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102233337|NCT03317197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102233339|NCT03317197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101635609|NCT00735241|Antidotes|antidotes|mesh-ancestor
102233340|NCT03317197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102233341|NCT03317197|Respiratory System Agents|respiratory system agents|mesh-ancestor
102233342|NCT03317197|Mydriatics|mydriatics|mesh-ancestor
102233343|NCT03317197|Sympathomimetics|sympathomimetics|mesh-ancestor
102233344|NCT03317197|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102233345|NCT03317197|Hemostatics|hemostatics|mesh-ancestor
102233346|NCT03317197|Coagulants|coagulants|mesh-ancestor
102233347|NCT03317197|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102233348|NCT03317197|Natriuretic Agents|natriuretic agents|mesh-ancestor
102233349|NCT02483299|Metformin|metformin|mesh-list
102233350|NCT02483299|Liraglutide|liraglutide|mesh-list
102233351|NCT02483299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102233352|NCT02483299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233353|NCT02483299|Incretins|incretins|mesh-ancestor
102233354|NCT02483299|Hormones|hormones|mesh-ancestor
102233355|NCT02483299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102233356|NCT01597479|Anesthetics|anesthetics|mesh-list
102233357|NCT01597479|Levobupivacaine|levobupivacaine|mesh-list
102233358|NCT01597479|Anesthetics, Local|anesthetics, local|mesh-list
102233359|NCT01597479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102233360|NCT01597479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233361|NCT01597479|Sensory System Agents|sensory system agents|mesh-ancestor
102233362|NCT01597479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102233363|NCT03316963|Neostigmine|neostigmine|mesh-list
102233364|NCT03316963|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102233365|NCT03316963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102233366|NCT03316963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233367|NCT03316963|Cholinergic Agents|cholinergic agents|mesh-ancestor
102233368|NCT03316963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102233369|NCT03316963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233370|NCT03316963|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102233371|NCT03316963|Autonomic Agents|autonomic agents|mesh-ancestor
102233372|NCT03316963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102233373|NCT02489929|Azacitidine|azacitidine|mesh-list
102233374|NCT02489929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102233375|NCT02489929|Antimetabolites|antimetabolites|mesh-ancestor
102233376|NCT02489929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233377|NCT02489929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102233378|NCT02489929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102233379|NCT05154903|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
102233380|NCT05154903|Nootropic Agents|nootropic agents|mesh-ancestor
102233381|NCT02483143|Acetylcysteine|acetylcysteine|mesh-list
102233382|NCT02483143|Antiviral Agents|antiviral agents|mesh-ancestor
102233383|NCT02483143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102233384|NCT02483143|Expectorants|expectorants|mesh-ancestor
102233385|NCT02483143|Respiratory System Agents|respiratory system agents|mesh-ancestor
102233386|NCT02483143|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102233387|NCT02483143|Antioxidants|antioxidants|mesh-ancestor
102233388|NCT02483143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233389|NCT02483143|Protective Agents|protective agents|mesh-ancestor
102233390|NCT02483143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233391|NCT02483221|Morphine|morphine|mesh-list
102233392|NCT02483221|Hydromorphone|hydromorphone|mesh-list
102233393|NCT02483221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102233394|NCT02483221|Narcotics|narcotics|mesh-ancestor
102233395|NCT02483221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102233396|NCT02483221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233397|NCT02483221|Analgesics|analgesics|mesh-ancestor
102233398|NCT02483221|Sensory System Agents|sensory system agents|mesh-ancestor
102233399|NCT02483221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102233400|NCT02489461|Efavirenz|efavirenz|mesh-list
102233401|NCT02489461|Elsulfavirine|elsulfavirine|mesh-list
101942264|NCT01132911|Bortezomib|bortezomib|mesh-list
102233402|NCT02489461|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102233403|NCT02489461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102612772|NCT00002249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102233404|NCT02489461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102233405|NCT02489461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102233406|NCT02489461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233407|NCT02489461|Antiviral Agents|antiviral agents|mesh-ancestor
102233408|NCT02489461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102233409|NCT02489461|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102233410|NCT02489461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102233411|NCT02489461|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102233412|NCT02489461|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102233413|NCT02489461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102233414|NCT02489461|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102233415|NCT02489461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102233418|NCT05129475|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102233419|NCT05129475|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102233420|NCT05129475|Protease Inhibitors|protease inhibitors|mesh-ancestor
102233421|NCT05129475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102233422|NCT05129475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233423|NCT05129475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102233424|NCT05129475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102233425|NCT05129475|Antiviral Agents|antiviral agents|mesh-ancestor
102233426|NCT05129475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102233427|NCT05129475|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102233428|NCT05129475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102233429|NCT02485873|Vitamin K|vitamin k|mesh-list
102233430|NCT02485873|Rivaroxaban|rivaroxaban|mesh-list
102233431|NCT02485873|Vitamins|vitamins|mesh-ancestor
102233432|NCT02485873|Micronutrients|micronutrients|mesh-ancestor
102233433|NCT02485873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233434|NCT02485873|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102233435|NCT02485873|Antithrombins|antithrombins|mesh-ancestor
102233436|NCT02485873|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102233437|NCT02485873|Protease Inhibitors|protease inhibitors|mesh-ancestor
102233438|NCT02485873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102233439|NCT02485873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233440|NCT02485873|Anticoagulants|anticoagulants|mesh-ancestor
102233441|NCT02485873|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102233442|NCT02485873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102233443|NCT02485873|Hemostatics|hemostatics|mesh-ancestor
102233444|NCT02485873|Coagulants|coagulants|mesh-ancestor
102233445|NCT04412421|Vitamins|vitamins|mesh-list
102233446|NCT04412421|Micronutrients|micronutrients|mesh-ancestor
102233447|NCT04412421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233448|NCT03315091|Adavosertib|adavosertib|mesh-list
102233449|NCT03315091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102233450|NCT03315091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233451|NCT02488993|Rifaximin|rifaximin|mesh-list
102233452|NCT02488993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102233453|NCT02488993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102233454|NCT02488993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102233455|NCT02485327|Insulin|insulin|mesh-list
102233456|NCT02485327|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102233457|NCT02485327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102233458|NCT02485327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233459|NCT02485249|Dexamethasone|dexamethasone|mesh-list
102233460|NCT02485249|Dexamethasone acetate|dexamethasone acetate|mesh-list
102233461|NCT02485249|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102233462|NCT02485249|BB 1101|bb 1101|mesh-list
102233463|NCT02485249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102233464|NCT02485249|Antiemetics|antiemetics|mesh-ancestor
102233465|NCT02485249|Autonomic Agents|autonomic agents|mesh-ancestor
102233466|NCT02485249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102233467|NCT02485249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233468|NCT02485249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102233469|NCT02485249|Glucocorticoids|glucocorticoids|mesh-ancestor
102233470|NCT02485249|Hormones|hormones|mesh-ancestor
102233471|NCT02485249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102233472|NCT02485249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102233473|NCT02485249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102233474|NCT02485249|Protease Inhibitors|protease inhibitors|mesh-ancestor
102233475|NCT02485249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102233476|NCT02485249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233477|NCT03320707|Daratumumab|daratumumab|mesh-list
102233478|NCT03320707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102233479|NCT03320629|Apatinib|apatinib|mesh-list
102233480|NCT03320629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102233481|NCT03320629|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101575136|NCT02760043|Dexamethasone|dexamethasone|mesh-list
102233482|NCT03320629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102233483|NCT03320629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233484|NCT03316417|Immunomodulating Agents|immunomodulating agents|mesh-list
102233485|NCT03316417|Immunologic Factors|immunologic factors|mesh-ancestor
102233486|NCT03316417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233487|NCT02482207|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102233488|NCT02482207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102233489|NCT02482207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102233490|NCT02482207|Antimetabolites|antimetabolites|mesh-ancestor
102233491|NCT02482207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233492|NCT02482207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102233493|NCT02482207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102233494|NCT02482207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102233495|NCT02476981|Ephedrine|ephedrine|mesh-list
102233496|NCT02476981|Midazolam|midazolam|mesh-list
102233497|NCT02476981|Dexmedetomidine|dexmedetomidine|mesh-list
102233498|NCT02476981|Remifentanil|remifentanil|mesh-list
102233499|NCT02476981|Propofol|propofol|mesh-list
102233500|NCT02476981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102233501|NCT02476981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102233502|NCT02476981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233503|NCT02476981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102233504|NCT02476981|Analgesics|analgesics|mesh-ancestor
102233505|NCT02476981|Sensory System Agents|sensory system agents|mesh-ancestor
102233506|NCT02476981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102233507|NCT02476981|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102233508|NCT02476981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102233509|NCT02476981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102233510|NCT02476981|Adrenergic Agents|adrenergic agents|mesh-ancestor
102233511|NCT02476981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102233512|NCT02476981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233513|NCT02476981|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102233514|NCT02476981|Anesthetics, General|anesthetics, general|mesh-ancestor
102233515|NCT02476981|Anesthetics|anesthetics|mesh-ancestor
102233516|NCT02476981|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102233517|NCT02476981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102233518|NCT02476981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102233519|NCT02476981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102233520|NCT02476981|GABA Modulators|gaba modulators|mesh-ancestor
102233521|NCT02476981|GABA Agents|gaba agents|mesh-ancestor
101635729|NCT02675205|Ticagrelor|ticagrelor|mesh-list
102233522|NCT02476981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102233523|NCT02476981|Narcotics|narcotics|mesh-ancestor
102233524|NCT02476981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102233525|NCT02476981|Sympathomimetics|sympathomimetics|mesh-ancestor
102233526|NCT02476981|Autonomic Agents|autonomic agents|mesh-ancestor
102233527|NCT02476981|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102233528|NCT04248465|Ravulizumab|ravulizumab|mesh-list
102233529|NCT04248465|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102233530|NCT04248465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102233531|NCT04248465|Immunologic Factors|immunologic factors|mesh-ancestor
102233532|NCT04248465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233533|NCT02480335|Bosentan|bosentan|mesh-list
102233534|NCT02480335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102233535|NCT02480335|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102233536|NCT02480335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233537|NCT05456269|Cytarabine|cytarabine|mesh-list
102233538|NCT05456269|Decitabine|decitabine|mesh-list
102233539|NCT05456269|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
102233540|NCT05456269|Bisantrene|bisantrene|mesh-list
102233541|NCT05456269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102233542|NCT05456269|Antimetabolites|antimetabolites|mesh-ancestor
102233543|NCT05456269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233544|NCT05456269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102233545|NCT05456269|Antiviral Agents|antiviral agents|mesh-ancestor
102233546|NCT05456269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102233547|NCT05456269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102233548|NCT05456269|Immunologic Factors|immunologic factors|mesh-ancestor
102233549|NCT05456269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233550|NCT05456269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102233551|NCT05456269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102612773|NCT00002249|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102612774|NCT00002249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102612775|NCT00002255|Zidovudine|zidovudine|mesh-list
102233552|NCT02476825|Fluticasone|fluticasone|mesh-list
102233554|NCT02476825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101621080|NCT05350085|Anesthetics|anesthetics|mesh-ancestor
102612776|NCT00002255|Epoetin Alfa|epoetin alfa|mesh-list
102233555|NCT02476825|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102233556|NCT02476825|Autonomic Agents|autonomic agents|mesh-ancestor
102233557|NCT02476825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102233558|NCT02476825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233559|NCT02476825|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102233560|NCT02476825|Respiratory System Agents|respiratory system agents|mesh-ancestor
102233561|NCT02476825|Dermatologic Agents|dermatologic agents|mesh-ancestor
102233562|NCT02476825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102233563|NCT05245227|Misoprostol|misoprostol|mesh-list
102233564|NCT05245227|Oxytocin|oxytocin|mesh-list
102233565|NCT05245227|Oxytocics|oxytocics|mesh-ancestor
102233566|NCT05245227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102233567|NCT05245227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233568|NCT05245227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102233569|NCT05245227|Abortifacient Agents|abortifacient agents|mesh-ancestor
102233570|NCT05245227|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102233571|NCT05245227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102233572|NCT02479867|Cefadroxil|cefadroxil|mesh-list
102233573|NCT02479867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102233574|NCT02479867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102233575|NCT05244837|Paclitaxel|paclitaxel|mesh-list
102233576|NCT05244837|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102233577|NCT05244837|Carboplatin|carboplatin|mesh-list
102233578|NCT05244837|Pemetrexed|pemetrexed|mesh-list
102233579|NCT05244837|Tislelizumab|tislelizumab|mesh-list
102233580|NCT05244837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102233581|NCT05244837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102233582|NCT05244837|Tubulin Modulators|tubulin modulators|mesh-ancestor
102233583|NCT05244837|Antimitotic Agents|antimitotic agents|mesh-ancestor
102233584|NCT05244837|Mitosis Modulators|mitosis modulators|mesh-ancestor
102233585|NCT05244837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233586|NCT05244837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102233587|NCT05244837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102233588|NCT05244837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102233589|NCT05244837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102233590|NCT03103893|Sirolimus|sirolimus|mesh-list
102233591|NCT03103893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102233592|NCT03103893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102233593|NCT03103893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102233594|NCT03103893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102233595|NCT03103893|Antifungal Agents|antifungal agents|mesh-ancestor
102233596|NCT03103893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102233597|NCT03103893|Immunologic Factors|immunologic factors|mesh-ancestor
102233598|NCT03103893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233599|NCT02479789|Lidocaine|lidocaine|mesh-list
102233600|NCT02479789|Anesthetics, Local|anesthetics, local|mesh-ancestor
102233601|NCT02479789|Anesthetics|anesthetics|mesh-ancestor
102233602|NCT02479789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102233603|NCT02479789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233604|NCT02479789|Sensory System Agents|sensory system agents|mesh-ancestor
102233605|NCT02479789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102233606|NCT02479789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101635790|NCT00910065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102233607|NCT02479789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102233608|NCT02479789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102233609|NCT02479789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102233610|NCT02479789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233611|NCT02726113|Vitamin D|vitamin d|mesh-list
102233612|NCT02726113|Cholecalciferol|cholecalciferol|mesh-list
102233613|NCT02726113|Vitamins|vitamins|mesh-ancestor
102233614|NCT02726113|Micronutrients|micronutrients|mesh-ancestor
102233615|NCT02726113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233616|NCT02726113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102233617|NCT02726113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102233618|NCT05243355|Endostatins|endostatins|mesh-list
102233619|NCT05243355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102233620|NCT05243355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102233621|NCT05243355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102233622|NCT05243355|Growth Substances|growth substances|mesh-ancestor
102233623|NCT05243355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233624|NCT05243355|Growth Inhibitors|growth inhibitors|mesh-ancestor
102233625|NCT02479711|Methamphetamine|methamphetamine|mesh-list
102233626|NCT02479711|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102233627|NCT02479711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102612777|NCT00002255|Antimetabolites|antimetabolites|mesh-ancestor
102233628|NCT02479711|Sympathomimetics|sympathomimetics|mesh-ancestor
102233630|NCT02479711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102233631|NCT02479711|Dopamine Agents|dopamine agents|mesh-ancestor
102233633|NCT02479711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233634|NCT02479711|Adrenergic Agents|adrenergic agents|mesh-ancestor
102233635|NCT02479711|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102233636|NCT02479711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102233637|NCT02479711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102233638|NCT02479711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102233639|NCT05196945|Amoxicillin|amoxicillin|mesh-list
102233640|NCT05196945|Clarithromycin|clarithromycin|mesh-list
102233641|NCT05196945|Potassium Citrate|potassium citrate|mesh-list
102233642|NCT05196945|Esomeprazole|esomeprazole|mesh-list
102233643|NCT05196945|Bismuth|bismuth|mesh-list
102233644|NCT05196945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233645|NCT05196945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102233646|NCT05196945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102233647|NCT05196945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102233648|NCT05196945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102233649|NCT05196945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102233650|NCT05196945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102233651|NCT05196945|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102233652|NCT05196945|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102233653|NCT05196945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102233654|NCT05196945|Antacids|antacids|mesh-ancestor
102233655|NCT05196945|Diuretics|diuretics|mesh-ancestor
102233656|NCT05196945|Natriuretic Agents|natriuretic agents|mesh-ancestor
102233657|NCT05196945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233658|NCT05196945|Expectorants|expectorants|mesh-ancestor
102233659|NCT05196945|Respiratory System Agents|respiratory system agents|mesh-ancestor
102233660|NCT03800979|Tofacitinib|tofacitinib|mesh-list
102233661|NCT03800979|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102233662|NCT03800979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102233663|NCT03800979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102233664|NCT03800979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233665|NCT02476123|Nivolumab|nivolumab|mesh-list
102233666|NCT02476123|Mogamulizumab|mogamulizumab|mesh-list
102233667|NCT02476123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102233668|NCT02476123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102233669|NCT02476123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102233670|NCT02476123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233671|NCT02481193|Cisatracurium|cisatracurium|mesh-list
102233672|NCT02481193|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102233673|NCT02481193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102233674|NCT02481193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102233675|NCT02481193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233676|NCT03101709|Cyclophosphamide|cyclophosphamide|mesh-list
102233677|NCT03101709|Fludarabine|fludarabine|mesh-list
102233678|NCT03101709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102233679|NCT03101709|Immunologic Factors|immunologic factors|mesh-ancestor
102233680|NCT03101709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233681|NCT03101709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102233682|NCT03101709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102233683|NCT03101709|Alkylating Agents|alkylating agents|mesh-ancestor
102233684|NCT03101709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233685|NCT03101709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102233686|NCT03101709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102233687|NCT03101319|Vitamin D|vitamin d|mesh-list
102233688|NCT03101319|Cholecalciferol|cholecalciferol|mesh-list
102233689|NCT03101319|Vitamins|vitamins|mesh-ancestor
102233690|NCT03101319|Micronutrients|micronutrients|mesh-ancestor
102233691|NCT03101319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233692|NCT03101319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102233693|NCT03101319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102233694|NCT02479555|Dexamethasone|dexamethasone|mesh-list
102233695|NCT02479555|Dexamethasone acetate|dexamethasone acetate|mesh-list
102233696|NCT02479555|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102233697|NCT02479555|BB 1101|bb 1101|mesh-list
101635858|NCT02717455|Panobinostat|panobinostat|mesh-list
102233698|NCT02479555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102233699|NCT02479555|Antiemetics|antiemetics|mesh-ancestor
102233700|NCT02479555|Autonomic Agents|autonomic agents|mesh-ancestor
102233701|NCT02479555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102233702|NCT02479555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233703|NCT02479555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102233704|NCT02479555|Glucocorticoids|glucocorticoids|mesh-ancestor
102233705|NCT02479555|Hormones|hormones|mesh-ancestor
101942544|NCT01232439|Aticaprant|aticaprant|mesh-list
102233706|NCT02479555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102233707|NCT02479555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102233708|NCT02479555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102233709|NCT02479555|Protease Inhibitors|protease inhibitors|mesh-ancestor
102233710|NCT02479555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102233711|NCT02479555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233712|NCT02476045|Leucovorin|leucovorin|mesh-list
102233713|NCT02476045|Fluorouracil|fluorouracil|mesh-list
102233714|NCT02476045|Oxaliplatin|oxaliplatin|mesh-list
102233715|NCT02476045|Panitumumab|panitumumab|mesh-list
102233716|NCT02476045|Levoleucovorin|levoleucovorin|mesh-list
102233717|NCT02476045|Antimetabolites|antimetabolites|mesh-ancestor
102233718|NCT02476045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233719|NCT02476045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102233720|NCT02476045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102233721|NCT02476045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102233722|NCT02476045|Immunologic Factors|immunologic factors|mesh-ancestor
102233723|NCT02476045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233724|NCT02476045|Antidotes|antidotes|mesh-ancestor
102233725|NCT02476045|Protective Agents|protective agents|mesh-ancestor
102233726|NCT02476045|Vitamin B Complex|vitamin b complex|mesh-ancestor
102233727|NCT02476045|Vitamins|vitamins|mesh-ancestor
102233728|NCT02476045|Micronutrients|micronutrients|mesh-ancestor
102233729|NCT02476045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102233730|NCT02479399|Ipragliflozin|ipragliflozin|mesh-list
102233731|NCT02479399|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102233732|NCT02479399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233733|NCT02479399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102233734|NCT02479399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233735|NCT03885921|Atorvastatin|atorvastatin|mesh-list
102233736|NCT03885921|Simvastatin|simvastatin|mesh-list
102233737|NCT03885921|Ezetimibe|ezetimibe|mesh-list
102233738|NCT03885921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102233739|NCT03885921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102233740|NCT03885921|Antimetabolites|antimetabolites|mesh-ancestor
102233741|NCT03885921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233742|NCT03885921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102233743|NCT03885921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102233744|NCT03885921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102233745|NCT02480881|Fostemsavir|fostemsavir|mesh-list
102233746|NCT02480881|Contraceptive Agents|contraceptive agents|mesh-list
102233747|NCT02480881|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
102233748|NCT02480881|Contraceptives, Oral|contraceptives, oral|mesh-list
102233749|NCT02480881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102233750|NCT02480881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233751|NCT02480881|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102233752|NCT02480881|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102233753|NCT02480881|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102233754|NCT02480881|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102233755|NCT02480881|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
102233756|NCT02480881|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102233757|NCT02480881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102233758|NCT02480881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102233759|NCT02480881|Antiviral Agents|antiviral agents|mesh-ancestor
102233760|NCT02480881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102233761|NCT02480881|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102233762|NCT02480881|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102233763|NCT02480881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233764|NCT02480647|Levonorgestrel|levonorgestrel|mesh-list
102233765|NCT02480647|Etonogestrel|etonogestrel|mesh-list
102233766|NCT02480647|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102233767|NCT02480647|Contraceptive Agents|contraceptive agents|mesh-ancestor
102233768|NCT02480647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102233769|NCT02480647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233770|NCT02480647|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102233771|NCT02480647|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102233772|NCT02480647|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102233773|NCT03100071|Apixaban|apixaban|mesh-list
102233774|NCT03100071|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102233775|NCT03100071|Antithrombins|antithrombins|mesh-ancestor
102612778|NCT00002255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612779|NCT00002255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101635939|NCT00731575|Hormones|hormones|mesh-ancestor
102233776|NCT03100071|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102612780|NCT00002255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102233777|NCT03100071|Protease Inhibitors|protease inhibitors|mesh-ancestor
102233778|NCT03100071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101942623|NCT01138605|Ritonavir|ritonavir|mesh-list
102233779|NCT03100071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233781|NCT02479165|Oxycodone|oxycodone|mesh-list
102233782|NCT02479165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102233783|NCT02479165|Narcotics|narcotics|mesh-ancestor
102233784|NCT02479165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102233785|NCT02479165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233786|NCT02479165|Analgesics|analgesics|mesh-ancestor
102233787|NCT02479165|Sensory System Agents|sensory system agents|mesh-ancestor
102233788|NCT02479165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102233789|NCT05072691|Immunoglobulins|immunoglobulins|mesh-list
102233790|NCT05072691|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102233791|NCT05072691|Antibodies|antibodies|mesh-list
102233792|NCT05072691|Immunologic Factors|immunologic factors|mesh-ancestor
102233793|NCT05072691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233794|NCT05714839|Dexamethasone|dexamethasone|mesh-list
102233795|NCT05714839|Lenalidomide|lenalidomide|mesh-list
102233796|NCT05714839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102233797|NCT05714839|Antiemetics|antiemetics|mesh-ancestor
102233798|NCT05714839|Autonomic Agents|autonomic agents|mesh-ancestor
102233799|NCT05714839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102233800|NCT05714839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233801|NCT05714839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102233802|NCT05714839|Glucocorticoids|glucocorticoids|mesh-ancestor
102233803|NCT05714839|Hormones|hormones|mesh-ancestor
102233804|NCT05714839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102233805|NCT05714839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102233806|NCT05714839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102233807|NCT05714839|Immunologic Factors|immunologic factors|mesh-ancestor
102233808|NCT05714839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102233809|NCT05714839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102233810|NCT05714839|Growth Substances|growth substances|mesh-ancestor
102233811|NCT05714839|Growth Inhibitors|growth inhibitors|mesh-ancestor
102233812|NCT05378425|Pembrolizumab|pembrolizumab|mesh-list
102233813|NCT05378425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102233814|NCT05378425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102233815|NCT05378425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102233816|NCT05378425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233817|NCT05377255|Naloxone|naloxone|mesh-list
102233818|NCT05377255|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102233819|NCT05377255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233820|NCT05377255|Sensory System Agents|sensory system agents|mesh-ancestor
102233821|NCT05377255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102233822|NCT02475499|Metformin|metformin|mesh-list
102233823|NCT02475499|Pioglitazone|pioglitazone|mesh-list
102233824|NCT02475499|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102233825|NCT02475499|Liraglutide|liraglutide|mesh-list
102233826|NCT02475499|Exenatide|exenatide|mesh-list
102233827|NCT02475499|Glimepiride|glimepiride|mesh-list
102233828|NCT02475499|Rosiglitazone|rosiglitazone|mesh-list
102233829|NCT02475499|Vildagliptin|vildagliptin|mesh-list
102233830|NCT02475499|Saxagliptin|saxagliptin|mesh-list
102233831|NCT02475499|Acarbose|acarbose|mesh-list
102233832|NCT02475499|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102233833|NCT02475499|Repaglinide|repaglinide|mesh-list
102233834|NCT02475499|Gliclazide|gliclazide|mesh-list
102233835|NCT02475499|Glipizide|glipizide|mesh-list
102233836|NCT02475499|Biguanides|biguanides|mesh-list
102233837|NCT02475499|Tolbutamide|tolbutamide|mesh-list
102233838|NCT02475499|Voglibose|voglibose|mesh-list
102233839|NCT02475499|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
102233840|NCT02475499|Nateglinide|nateglinide|mesh-list
102233841|NCT02475499|Miglitol|miglitol|mesh-list
102233842|NCT02475499|Meglitinide|meglitinide|mesh-list
102233843|NCT02475499|Troglitazone|troglitazone|mesh-list
102233844|NCT02475499|Acetohexamide|acetohexamide|mesh-list
102233845|NCT02475499|Phenformin|phenformin|mesh-list
102233846|NCT02475499|Chlorpropamide|chlorpropamide|mesh-list
102233847|NCT02475499|Buformin|buformin|mesh-list
102233848|NCT02475499|Glibornuride|glibornuride|mesh-list
102233849|NCT02475499|Tolazamide|tolazamide|mesh-list
102233850|NCT02475499|Carbutamide|carbutamide|mesh-list
102233851|NCT02475499|Gliquidone|gliquidone|mesh-list
102233852|NCT02475499|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
102233853|NCT02475499|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
101942702|NCT01234857|Sirolimus|sirolimus|mesh-list
102233854|NCT02475499|Incretins|incretins|mesh-list
102233855|NCT02475499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233856|NCT02475499|Hormones|hormones|mesh-ancestor
102233857|NCT02475499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102233858|NCT02475499|Protease Inhibitors|protease inhibitors|mesh-ancestor
102233859|NCT02475499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102233860|NCT02475499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233862|NCT02475499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102233863|NCT02475499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102233864|NCT02475499|Immunologic Factors|immunologic factors|mesh-ancestor
102233865|NCT03375645|Analgesics, Opioid|analgesics, opioid|mesh-list
102233866|NCT03375645|Narcotics|narcotics|mesh-ancestor
102233867|NCT03375645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102233868|NCT03375645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233869|NCT03375645|Analgesics|analgesics|mesh-ancestor
102233870|NCT03375645|Sensory System Agents|sensory system agents|mesh-ancestor
102233871|NCT03375645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102233872|NCT03136809|Copper|copper|mesh-list
102233873|NCT03136809|Trace Elements|trace elements|mesh-ancestor
102233874|NCT03136809|Micronutrients|micronutrients|mesh-ancestor
102233875|NCT03136809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233876|NCT02475421|Glucagon|glucagon|mesh-list
102233877|NCT02475421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102233878|NCT02475421|Hormones|hormones|mesh-ancestor
102233879|NCT02475421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102233880|NCT02475421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233881|NCT02475343|Riboflavin|riboflavin|mesh-list
102233882|NCT02475343|Vitamin B Complex|vitamin b complex|mesh-ancestor
102233883|NCT02475343|Vitamins|vitamins|mesh-ancestor
102233884|NCT02475343|Micronutrients|micronutrients|mesh-ancestor
102233885|NCT02475343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233886|NCT02475343|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102233887|NCT02475343|Dermatologic Agents|dermatologic agents|mesh-ancestor
102233888|NCT02475109|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102233889|NCT02475109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102233890|NCT04492501|Remdesivir|remdesivir|mesh-list
102233891|NCT04492501|Antimetabolites|antimetabolites|mesh-ancestor
102233892|NCT04492501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233893|NCT04492501|Antiviral Agents|antiviral agents|mesh-ancestor
102233894|NCT04492501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102233895|NCT03101085|Equol|equol|mesh-list
102233896|NCT03101085|Phytoestrogens|phytoestrogens|mesh-ancestor
102233897|NCT03101085|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102233898|NCT03101085|Estrogens|estrogens|mesh-ancestor
102233899|NCT03101085|Hormones|hormones|mesh-ancestor
102233900|NCT03101085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102233901|NCT03101085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233902|NCT05070195|Midazolam|midazolam|mesh-list
102233903|NCT05070195|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102233904|NCT05070195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102233905|NCT05070195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102233906|NCT05070195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233907|NCT05070195|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102233908|NCT05070195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102233909|NCT05070195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102233910|NCT05070195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102233911|NCT05070195|Anesthetics, General|anesthetics, general|mesh-ancestor
102233912|NCT05070195|Anesthetics|anesthetics|mesh-ancestor
102233913|NCT05070195|GABA Modulators|gaba modulators|mesh-ancestor
102233914|NCT05070195|GABA Agents|gaba agents|mesh-ancestor
102233915|NCT05070195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102233916|NCT05070195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233917|NCT02474953|Curcumin|curcumin|mesh-list
102233918|NCT02474953|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102233919|NCT02474953|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102233920|NCT02474953|Analgesics|analgesics|mesh-ancestor
102233921|NCT02474953|Sensory System Agents|sensory system agents|mesh-ancestor
102233922|NCT02474953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102233923|NCT02474953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233924|NCT02474953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102233925|NCT02474953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102233926|NCT02474953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102233927|NCT02474953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102233928|NCT02474953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233929|NCT05714371|Pembrolizumab|pembrolizumab|mesh-list
102233930|NCT05714371|Nivolumab|nivolumab|mesh-list
102233931|NCT05714371|Ipilimumab|ipilimumab|mesh-list
102233932|NCT05714371|Trametinib|trametinib|mesh-list
102233933|NCT05714371|Dabrafenib|dabrafenib|mesh-list
101901255|NCT01094340|Growth Inhibitors|growth inhibitors|mesh-ancestor
102612781|NCT00002255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612782|NCT00002255|Antiviral Agents|antiviral agents|mesh-ancestor
102233934|NCT05714371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102233935|NCT05714371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102233936|NCT05714371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102233937|NCT05714371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233938|NCT05714371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102233939|NCT05714371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102233940|NCT02472613|Fluoxetine|fluoxetine|mesh-list
102233941|NCT02472613|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102233942|NCT02472613|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102233943|NCT02472613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102233944|NCT02472613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233945|NCT02472613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102233946|NCT02472613|Serotonin Agents|serotonin agents|mesh-ancestor
102233947|NCT02472613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233948|NCT02472613|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102233949|NCT02472613|Antidepressive Agents|antidepressive agents|mesh-ancestor
102233950|NCT02472613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102233951|NCT02472613|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102233952|NCT02472613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102233953|NCT02472613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102233954|NCT00783237|Mometasone Furoate|mometasone furoate|mesh-list
102233955|NCT00783237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102233956|NCT00783237|Dermatologic Agents|dermatologic agents|mesh-ancestor
102233957|NCT00783237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102233958|NCT02478229|Sofosbuvir|sofosbuvir|mesh-list
102233959|NCT02478229|Ledipasvir|ledipasvir|mesh-list
102233960|NCT02478229|Antiviral Agents|antiviral agents|mesh-ancestor
102233961|NCT02478229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102233962|NCT04879615|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102233963|NCT04879615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102233964|NCT04879615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102233965|NCT04879615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233966|NCT05713045|Vitamin K 1|vitamin k 1|mesh-list
102233967|NCT05713045|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102233968|NCT05713045|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102233969|NCT05713045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233970|NCT05713045|Hemostatics|hemostatics|mesh-ancestor
102233971|NCT05713045|Coagulants|coagulants|mesh-ancestor
102233972|NCT05713045|Vitamins|vitamins|mesh-ancestor
102233973|NCT05713045|Micronutrients|micronutrients|mesh-ancestor
102233974|NCT05713045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233975|NCT00653835|Simvastatin|simvastatin|mesh-list
102233976|NCT00653835|Ezetimibe|ezetimibe|mesh-list
102233977|NCT00653835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102233978|NCT00653835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102233979|NCT00653835|Antimetabolites|antimetabolites|mesh-ancestor
102233980|NCT00653835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102233981|NCT00653835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102233982|NCT00653835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102233983|NCT00653835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102233984|NCT03099759|Vitamin D|vitamin d|mesh-list
102233985|NCT03099759|Cholecalciferol|cholecalciferol|mesh-list
102233986|NCT03099759|Ergocalciferols|ergocalciferols|mesh-list
102233987|NCT03099759|Vitamins|vitamins|mesh-ancestor
102233988|NCT03099759|Micronutrients|micronutrients|mesh-ancestor
102233989|NCT03099759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233990|NCT03099759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102233991|NCT03099759|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102233992|NCT05244577|Olanzapine|olanzapine|mesh-list
102233993|NCT05244577|Antiemetics|antiemetics|mesh-ancestor
102233994|NCT05244577|Autonomic Agents|autonomic agents|mesh-ancestor
102233995|NCT05244577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102233996|NCT05244577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102233997|NCT05244577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102233998|NCT05244577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102233999|NCT05244577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102234000|NCT05244577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102234001|NCT05244577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102234002|NCT05244577|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102234003|NCT05244577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102234004|NCT05244577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102234005|NCT05244577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612783|NCT00002255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102234006|NCT05244577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102234008|NCT05067699|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
102234009|NCT05067699|Calcifediol|calcifediol|mesh-list
102234010|NCT05067699|Vitamins|vitamins|mesh-ancestor
102234011|NCT05067699|Micronutrients|micronutrients|mesh-ancestor
102234012|NCT05067699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234013|NCT05067699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102234015|NCT05067153|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102234016|NCT05067153|Tinzaparin|tinzaparin|mesh-list
102234017|NCT05067153|Dalteparin|dalteparin|mesh-list
102234018|NCT05067153|Anticoagulants|anticoagulants|mesh-ancestor
102234019|NCT05067153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102234020|NCT05067153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102234021|NCT05067153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234022|NCT05067309|Letrozole|letrozole|mesh-list
102234023|NCT05067309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102234024|NCT05067309|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102234025|NCT05067309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102234026|NCT05067309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102234027|NCT05067309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234028|NCT05067309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102234029|NCT05067309|Hormone Antagonists|hormone antagonists|mesh-ancestor
102234030|NCT05067309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102234031|NCT05067309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234032|NCT02474563|Prednisone|prednisone|mesh-list
102234033|NCT02474563|Bortezomib|bortezomib|mesh-list
102234034|NCT02474563|Melphalan|melphalan|mesh-list
102234035|NCT02474563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102234036|NCT02474563|Glucocorticoids|glucocorticoids|mesh-ancestor
102234037|NCT02474563|Hormones|hormones|mesh-ancestor
102234038|NCT02474563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102234039|NCT02474563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234040|NCT02474563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101636112|NCT02671383|Lopinavir|lopinavir|mesh-list
102234041|NCT02474563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102234042|NCT02474563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102234043|NCT02474563|Alkylating Agents|alkylating agents|mesh-ancestor
102234044|NCT02474563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234045|NCT02474563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102234046|NCT02474563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102234047|NCT02474563|Immunologic Factors|immunologic factors|mesh-ancestor
102234048|NCT02477995|Vaccines|vaccines|mesh-list
102234049|NCT02477995|Immunologic Factors|immunologic factors|mesh-ancestor
102234050|NCT02477995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234051|NCT03098823|Prednisone|prednisone|mesh-list
102234052|NCT03098823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102234053|NCT03098823|Glucocorticoids|glucocorticoids|mesh-ancestor
102234054|NCT03098823|Hormones|hormones|mesh-ancestor
102234055|NCT03098823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102234056|NCT03098823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234057|NCT03098823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102234058|NCT03098823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102234059|NCT03108937|Dexmedetomidine|dexmedetomidine|mesh-list
102234060|NCT03108937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102234061|NCT03108937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102234062|NCT03108937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234063|NCT03108937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102234064|NCT03108937|Analgesics|analgesics|mesh-ancestor
102234065|NCT03108937|Sensory System Agents|sensory system agents|mesh-ancestor
102234066|NCT03108937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102234067|NCT03108937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102234068|NCT03108937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102234069|NCT03108937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102234070|NCT03108937|Adrenergic Agents|adrenergic agents|mesh-ancestor
102234071|NCT03108937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102234072|NCT03108937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234073|NCT03913845|Lidocaine|lidocaine|mesh-list
102234074|NCT03913845|Epinephrine|epinephrine|mesh-list
102234075|NCT03913845|Racepinephrine|racepinephrine|mesh-list
102234076|NCT03913845|Epinephryl borate|epinephryl borate|mesh-list
102234077|NCT03913845|Anesthetics, Local|anesthetics, local|mesh-ancestor
102234078|NCT03913845|Anesthetics|anesthetics|mesh-ancestor
102234079|NCT03913845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102612784|NCT00002255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102234080|NCT03913845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234081|NCT03913845|Sensory System Agents|sensory system agents|mesh-ancestor
102234082|NCT03913845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102234083|NCT03913845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102234084|NCT03913845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102234085|NCT03913845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102234086|NCT03913845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102234087|NCT03913845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234088|NCT03913845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102234089|NCT03913845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102234090|NCT03913845|Adrenergic Agents|adrenergic agents|mesh-ancestor
102234091|NCT03913845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102234092|NCT03913845|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102234093|NCT03913845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102234094|NCT03913845|Autonomic Agents|autonomic agents|mesh-ancestor
102234095|NCT03913845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102234096|NCT03913845|Respiratory System Agents|respiratory system agents|mesh-ancestor
102234098|NCT03913845|Sympathomimetics|sympathomimetics|mesh-ancestor
102234099|NCT03913845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102234100|NCT00705523|Varenicline|varenicline|mesh-list
102234101|NCT00705523|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102234102|NCT00705523|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102234103|NCT00705523|Cholinergic Agents|cholinergic agents|mesh-ancestor
102234104|NCT00705523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102234105|NCT00705523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234106|NCT00705523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234107|NCT03903939|Iloprost|iloprost|mesh-list
102234108|NCT03903939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102234109|NCT03903939|Vasodilator Agents|vasodilator agents|mesh-ancestor
102234110|NCT05065905|Interferons|interferons|mesh-list
102234111|NCT05065905|Interferon-gamma|interferon-gamma|mesh-list
102234112|NCT05065905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102234113|NCT05065905|Antiviral Agents|antiviral agents|mesh-ancestor
102234114|NCT05065905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102234115|NCT05010681|Lenvatinib|lenvatinib|mesh-list
102234116|NCT05010681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102234117|NCT05010681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102234118|NCT05010681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102234119|NCT05010681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234120|NCT02725411|Celecoxib|celecoxib|mesh-list
102234121|NCT02725411|Tanezumab|tanezumab|mesh-list
102234122|NCT02725411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102234123|NCT02725411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102234124|NCT02725411|Analgesics|analgesics|mesh-ancestor
102234125|NCT02725411|Sensory System Agents|sensory system agents|mesh-ancestor
102234126|NCT02725411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102234127|NCT02725411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234128|NCT02725411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102234129|NCT02725411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102234130|NCT02725411|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102234131|NCT02725411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102234132|NCT02725411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102234133|NCT02725411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234134|NCT05058105|Meropenem|meropenem|mesh-list
102234135|NCT05058105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102234136|NCT05058105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102234137|NCT05649943|Androgens|androgens|mesh-list
102234138|NCT05649943|Hormones|hormones|mesh-ancestor
102234139|NCT05649943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102234140|NCT05649943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234141|NCT05046015|Carbamide Peroxide|carbamide peroxide|mesh-list
102234142|NCT05046015|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102234143|NCT05046015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102234144|NCT04652557|4-Aminopyridine|4-aminopyridine|mesh-list
102234145|NCT04652557|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102234146|NCT04652557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102234147|NCT04652557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234148|NCT03099213|Ramipril|ramipril|mesh-list
102234149|NCT03099213|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102612785|NCT00002255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102234150|NCT03099213|Protease Inhibitors|protease inhibitors|mesh-ancestor
102234151|NCT03099213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101901260|NCT00056862|Antimetabolites|antimetabolites|mesh-ancestor
102612786|NCT00002255|Hematinics|hematinics|mesh-ancestor
102612787|NCT00002261|Vaccines|vaccines|mesh-list
102234152|NCT03099213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234153|NCT03099213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102234155|NCT05061147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102234156|NCT05061147|Antimetabolites|antimetabolites|mesh-ancestor
102234157|NCT05061147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942993|NCT02869438|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102234158|NCT05061147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102234159|NCT05061147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102234160|NCT02127970|Dalbavancin|dalbavancin|mesh-list
102234161|NCT02127970|Teicoplanin|teicoplanin|mesh-list
102234162|NCT02127970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102234163|NCT02127970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102234164|NCT05056389|Oxaliplatin|oxaliplatin|mesh-list
102234165|NCT05056389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102234166|NCT02471677|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102234167|NCT02471677|Hormones|hormones|mesh-ancestor
102234168|NCT02471677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102234169|NCT02471677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234170|NCT04755634|Hyaluronic Acid|hyaluronic acid|mesh-list
102234171|NCT04755634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102234172|NCT04755634|Immunologic Factors|immunologic factors|mesh-ancestor
102234173|NCT04755634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234174|NCT04755634|Viscosupplements|viscosupplements|mesh-ancestor
102234175|NCT04755634|Protective Agents|protective agents|mesh-ancestor
102234176|NCT05395507|Interferons|interferons|mesh-list
102234177|NCT05395507|Interferon-alpha|interferon-alpha|mesh-list
102234178|NCT05395507|Interferon alpha-2|interferon alpha-2|mesh-list
102234179|NCT05395507|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102234180|NCT05395507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102234181|NCT05395507|Antiviral Agents|antiviral agents|mesh-ancestor
102234182|NCT05395507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102234183|NCT05395507|Immunologic Factors|immunologic factors|mesh-ancestor
102234184|NCT05395507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234185|NCT04470843|Acetazolamide|acetazolamide|mesh-list
102234186|NCT04470843|Anticonvulsants|anticonvulsants|mesh-ancestor
102234187|NCT04470843|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102234188|NCT04470843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102234189|NCT04470843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234190|NCT04470843|Diuretics|diuretics|mesh-ancestor
102234191|NCT04470843|Natriuretic Agents|natriuretic agents|mesh-ancestor
102234192|NCT04470843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234193|NCT05161741|Insulin|insulin|mesh-list
102234194|NCT05161741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102234195|NCT05161741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234196|NCT02473627|Pioglitazone|pioglitazone|mesh-list
102234197|NCT02473627|Tolbutamide|tolbutamide|mesh-list
102234198|NCT02473627|DS-1971a|ds-1971a|mesh-list
102234199|NCT02473627|Midazolam|midazolam|mesh-list
102234200|NCT02473627|Omeprazole|omeprazole|mesh-list
102234201|NCT02473627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102234202|NCT02473627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102234203|NCT02473627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102234204|NCT02473627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234205|NCT02473627|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102234206|NCT02473627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102234207|NCT02473627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102234208|NCT02473627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102234209|NCT02473627|Anesthetics, General|anesthetics, general|mesh-ancestor
102234210|NCT02473627|Anesthetics|anesthetics|mesh-ancestor
102234211|NCT02473627|GABA Modulators|gaba modulators|mesh-ancestor
102234212|NCT02473627|GABA Agents|gaba agents|mesh-ancestor
102234213|NCT02473627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102234214|NCT02473627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234215|NCT02473627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102234216|NCT02473627|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102234217|NCT02473627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102234218|NCT02473627|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102234219|NCT02473627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102234220|NCT02473627|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102612788|NCT00002261|Immunologic Factors|immunologic factors|mesh-ancestor
102234221|NCT02473627|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102234222|NCT02473627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102234223|NCT03095703|Sirolimus|sirolimus|mesh-list
102234224|NCT03095703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102234225|NCT03095703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101901264|NCT00056862|Immunologic Factors|immunologic factors|mesh-ancestor
102234226|NCT03095703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102234227|NCT03095703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102234228|NCT03095703|Antifungal Agents|antifungal agents|mesh-ancestor
102234229|NCT03095703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102234230|NCT03095703|Immunologic Factors|immunologic factors|mesh-ancestor
102234231|NCT03095703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234233|NCT05035953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102234234|NCT05035953|Antioxidants|antioxidants|mesh-ancestor
102234235|NCT05035953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234236|NCT05035953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101943069|NCT05383534|Anesthetics, General|anesthetics, general|mesh-ancestor
102234237|NCT05035953|Protective Agents|protective agents|mesh-ancestor
102234238|NCT05035953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234239|NCT02471209|Sevoflurane|sevoflurane|mesh-list
102234240|NCT02471209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102234241|NCT02471209|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102234242|NCT02471209|Anesthetics, General|anesthetics, general|mesh-ancestor
102234243|NCT02471209|Anesthetics|anesthetics|mesh-ancestor
102234244|NCT02471209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102234245|NCT02471209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234246|NCT02476903|Hyaluronic Acid|hyaluronic acid|mesh-list
102234247|NCT02476903|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102234248|NCT02476903|Immunologic Factors|immunologic factors|mesh-ancestor
102234249|NCT02476903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234250|NCT02476903|Viscosupplements|viscosupplements|mesh-ancestor
102234251|NCT02476903|Protective Agents|protective agents|mesh-ancestor
102234252|NCT02473237|Tiotropium Bromide|tiotropium bromide|mesh-list
102234253|NCT02473237|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102234254|NCT02473237|Autonomic Agents|autonomic agents|mesh-ancestor
102234255|NCT02473237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101636328|NCT00739609|Tryptophan|tryptophan|mesh-list
102234256|NCT02473237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234257|NCT02473237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102234258|NCT02473237|Respiratory System Agents|respiratory system agents|mesh-ancestor
102234259|NCT02473237|Parasympatholytics|parasympatholytics|mesh-ancestor
102234260|NCT02473237|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102234261|NCT02473237|Cholinergic Agents|cholinergic agents|mesh-ancestor
102234262|NCT02473237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102234263|NCT02473237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234264|NCT03403621|Pentamidine|pentamidine|mesh-list
102234265|NCT03403621|Antifungal Agents|antifungal agents|mesh-ancestor
102234266|NCT03403621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102234267|NCT03403621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102234268|NCT03403621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102234269|NCT03403621|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102234270|NCT04220125|Midazolam|midazolam|mesh-list
102234271|NCT04220125|Ketamine|ketamine|mesh-list
102234272|NCT04220125|Analgesics|analgesics|mesh-ancestor
102234273|NCT04220125|Sensory System Agents|sensory system agents|mesh-ancestor
102234274|NCT04220125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102234275|NCT04220125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234276|NCT04220125|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102234277|NCT04220125|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102234278|NCT04220125|Anesthetics, General|anesthetics, general|mesh-ancestor
102234279|NCT04220125|Anesthetics|anesthetics|mesh-ancestor
102234280|NCT04220125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102234281|NCT04220125|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102234282|NCT04220125|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102234283|NCT04220125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102234284|NCT04220125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234285|NCT04220125|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102234286|NCT04220125|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102234287|NCT04220125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101636378|NCT02666703|Methylprednisolone|methylprednisolone|mesh-list
102234288|NCT04220125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102234289|NCT04220125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102234290|NCT04220125|GABA Modulators|gaba modulators|mesh-ancestor
102234291|NCT04220125|GABA Agents|gaba agents|mesh-ancestor
102234292|NCT02472691|Lenalidomide|lenalidomide|mesh-list
102234293|NCT02472691|Azacitidine|azacitidine|mesh-list
102234294|NCT02472691|Immunologic Factors|immunologic factors|mesh-ancestor
102234295|NCT02472691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234296|NCT02472691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102234297|NCT02472691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102234298|NCT02472691|Growth Substances|growth substances|mesh-ancestor
102234299|NCT02472691|Growth Inhibitors|growth inhibitors|mesh-ancestor
102234300|NCT02472691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102612789|NCT00002261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234301|NCT02472691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102234302|NCT02472691|Antimetabolites|antimetabolites|mesh-ancestor
102234303|NCT02472691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234304|NCT02472691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102234305|NCT02470663|Calcium Carbonate|calcium carbonate|mesh-list
102234306|NCT02470663|Calcium|calcium|mesh-list
102234307|NCT02470663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102234308|NCT02470663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234309|NCT02470663|Antacids|antacids|mesh-ancestor
102234310|NCT02470663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234311|NCT02470663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102234312|NCT00705367|Abatacept|abatacept|mesh-list
102234313|NCT00705367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102234314|NCT00705367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234315|NCT00705367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102234316|NCT00705367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102234317|NCT00705367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102234318|NCT00705367|Immunologic Factors|immunologic factors|mesh-ancestor
102234319|NCT00705367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234320|NCT00705367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102234321|NCT03043729|Leucovorin|leucovorin|mesh-list
102234322|NCT03043729|Oxaliplatin|oxaliplatin|mesh-list
102234323|NCT03043729|Aflibercept|aflibercept|mesh-list
102234324|NCT03043729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102234325|NCT03043729|Antidotes|antidotes|mesh-ancestor
102234326|NCT03043729|Protective Agents|protective agents|mesh-ancestor
102234327|NCT03043729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234328|NCT03043729|Vitamin B Complex|vitamin b complex|mesh-ancestor
102234329|NCT03043729|Vitamins|vitamins|mesh-ancestor
102234330|NCT03043729|Micronutrients|micronutrients|mesh-ancestor
102234331|NCT03043729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102234332|NCT03043729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102234333|NCT03043729|Growth Substances|growth substances|mesh-ancestor
102234334|NCT03043729|Growth Inhibitors|growth inhibitors|mesh-ancestor
102234335|NCT05306431|Biguanides|biguanides|mesh-list
102234336|NCT05306431|Sodium Hypochlorite|sodium hypochlorite|mesh-list
102234337|NCT05306431|Polihexanide|polihexanide|mesh-list
102234339|NCT05306431|Disinfectants|disinfectants|mesh-ancestor
102234340|NCT05306431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102234341|NCT05306431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102234342|NCT05306431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234343|NCT03108313|Fluorides|fluorides|mesh-list
102234344|NCT03108313|Cariostatic Agents|cariostatic agents|mesh-ancestor
102234345|NCT03108313|Protective Agents|protective agents|mesh-ancestor
102234346|NCT03108313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234347|NCT03108625|Vortioxetine|vortioxetine|mesh-list
102234348|NCT03108625|Antidepressive Agents|antidepressive agents|mesh-ancestor
102234349|NCT03108625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102234350|NCT03108625|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102234351|NCT03108625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102234352|NCT03108625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102234353|NCT03108625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234354|NCT03108625|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102234355|NCT03108625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102234356|NCT03108625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102234357|NCT03108625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234358|NCT03108625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102234359|NCT03108625|Serotonin Agents|serotonin agents|mesh-ancestor
102234360|NCT03108625|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102234361|NCT03108625|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102234362|NCT03108625|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102234363|NCT03108625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102234364|NCT03310567|Pembrolizumab|pembrolizumab|mesh-list
102234365|NCT03310567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102234366|NCT03310567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102234367|NCT03310567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102234368|NCT03310567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234369|NCT03900949|Cytarabine|cytarabine|mesh-list
102234370|NCT03900949|Daunorubicin|daunorubicin|mesh-list
102234371|NCT03900949|Gemtuzumab|gemtuzumab|mesh-list
102234372|NCT03900949|Midostaurin|midostaurin|mesh-list
102234373|NCT03900949|Calicheamicins|calicheamicins|mesh-list
102234374|NCT03900949|Staurosporine|staurosporine|mesh-list
102234375|NCT03900949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102612790|NCT00002507|Mitomycins|mitomycins|mesh-list
102234376|NCT03900949|Antimetabolites|antimetabolites|mesh-ancestor
102234377|NCT03900949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234378|NCT03900949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102234379|NCT03900949|Antiviral Agents|antiviral agents|mesh-ancestor
102234380|NCT03900949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102234381|NCT03900949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102234382|NCT03900949|Immunologic Factors|immunologic factors|mesh-ancestor
102234383|NCT03900949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234384|NCT03900949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102234385|NCT03900949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102234386|NCT03900949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102234387|NCT03900949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102234388|NCT03900949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102234389|NCT03900949|Immunotoxins|immunotoxins|mesh-ancestor
102234390|NCT03900949|Immunoconjugates|immunoconjugates|mesh-ancestor
102234391|NCT03900949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102234392|NCT02864251|Carboplatin|carboplatin|mesh-list
102234393|NCT02864251|Nivolumab|nivolumab|mesh-list
102234394|NCT02864251|Pemetrexed|pemetrexed|mesh-list
102234395|NCT02864251|Ipilimumab|ipilimumab|mesh-list
102234396|NCT02864251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102234397|NCT02864251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102234398|NCT02864251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102234399|NCT02864251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234400|NCT02864251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102234401|NCT02864251|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102234402|NCT02864251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102234403|NCT02468791|Rituximab|rituximab|mesh-list
102234404|NCT02468791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102234405|NCT02468791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102234406|NCT02468791|Immunologic Factors|immunologic factors|mesh-ancestor
102234407|NCT02468791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234408|NCT02468791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102234409|NCT02693821|Gabapentin|gabapentin|mesh-list
102234410|NCT02693821|Analgesics|analgesics|mesh-ancestor
102234411|NCT02693821|Sensory System Agents|sensory system agents|mesh-ancestor
102234412|NCT02693821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102234413|NCT02693821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234414|NCT02693821|Anticonvulsants|anticonvulsants|mesh-ancestor
102234415|NCT02693821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102234416|NCT02693821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102234417|NCT02693821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102234418|NCT02693821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102234419|NCT02693821|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102234420|NCT02693821|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102234421|NCT02693821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102234422|NCT02693821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234423|NCT02693821|Antimanic Agents|antimanic agents|mesh-ancestor
102234424|NCT02470117|Antacids|antacids|mesh-list
102234425|NCT02470117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234426|NCT02470117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102234427|NCT03310333|Dinoprostone|dinoprostone|mesh-list
102234428|NCT03310333|Oxytocics|oxytocics|mesh-ancestor
102234429|NCT03310333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102234430|NCT03310333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234431|NCT02299999|Vincristine|vincristine|mesh-list
102234432|NCT02299999|Vinorelbine|vinorelbine|mesh-list
102234433|NCT02299999|Vinblastine|vinblastine|mesh-list
102234434|NCT02299999|Docetaxel|docetaxel|mesh-list
102234435|NCT02299999|Vinca Alkaloids|vinca alkaloids|mesh-list
102234436|NCT02299999|Cyclophosphamide|cyclophosphamide|mesh-list
102234437|NCT02299999|Bevacizumab|bevacizumab|mesh-list
102234438|NCT02299999|Cisplatin|cisplatin|mesh-list
102234439|NCT02299999|Carboplatin|carboplatin|mesh-list
102234440|NCT02299999|Gemcitabine|gemcitabine|mesh-list
102234441|NCT02299999|Doxorubicin|doxorubicin|mesh-list
102234442|NCT02299999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102234443|NCT02299999|Capecitabine|capecitabine|mesh-list
102234444|NCT02299999|Methotrexate|methotrexate|mesh-list
102234445|NCT02299999|Durvalumab|durvalumab|mesh-list
102234446|NCT02299999|Epirubicin|epirubicin|mesh-list
102612791|NCT00002507|Mitomycin|mitomycin|mesh-list
102234447|NCT02299999|Olaparib|olaparib|mesh-list
102234448|NCT02299999|Mitomycins|mitomycins|mesh-list
102234449|NCT02299999|Mitomycin|mitomycin|mesh-list
102234450|NCT02299999|Bicalutamide|bicalutamide|mesh-list
102612792|NCT00002507|Porfiromycin|porfiromycin|mesh-list
102234451|NCT02299999|Taxane|taxane|mesh-list
102234452|NCT02299999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102612793|NCT00002507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102234453|NCT02299999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102234454|NCT02299999|Tubulin Modulators|tubulin modulators|mesh-ancestor
102234455|NCT02299999|Antimitotic Agents|antimitotic agents|mesh-ancestor
102234456|NCT02299999|Mitosis Modulators|mitosis modulators|mesh-ancestor
102234457|NCT02299999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234458|NCT02299999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102234459|NCT02299999|Immunologic Factors|immunologic factors|mesh-ancestor
102234460|NCT02299999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234461|NCT02299999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102234462|NCT02299999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102234463|NCT02299999|Alkylating Agents|alkylating agents|mesh-ancestor
102234464|NCT02299999|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102234465|NCT02299999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102234466|NCT02299999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102234467|NCT02299999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102234468|NCT02299999|Growth Substances|growth substances|mesh-ancestor
102234469|NCT02299999|Growth Inhibitors|growth inhibitors|mesh-ancestor
102234470|NCT02299999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102234471|NCT02299999|Antimetabolites|antimetabolites|mesh-ancestor
102234472|NCT02299999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102234473|NCT02299999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102234474|NCT02299999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102234475|NCT02299999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102234476|NCT02299999|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102234477|NCT02299999|Abortifacient Agents|abortifacient agents|mesh-ancestor
102234478|NCT02299999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102234479|NCT02299999|Dermatologic Agents|dermatologic agents|mesh-ancestor
102234480|NCT02299999|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102234481|NCT02299999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102234482|NCT02299999|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102234483|NCT02299999|Androgen Antagonists|androgen antagonists|mesh-ancestor
102234484|NCT02299999|Hormone Antagonists|hormone antagonists|mesh-ancestor
102234485|NCT02299999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102234486|NCT00705289|Infliximab|infliximab|mesh-list
102234487|NCT00705289|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102234488|NCT00705289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102234489|NCT00705289|Dermatologic Agents|dermatologic agents|mesh-ancestor
102234490|NCT00705289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102234491|NCT00705289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102234492|NCT02263729|Losartan|losartan|mesh-list
102234493|NCT02263729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102234494|NCT02263729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102234495|NCT02263729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102234496|NCT02263729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102234497|NCT02263729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234498|NCT03309865|Vedolizumab|vedolizumab|mesh-list
102234499|NCT03309865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102234500|NCT02038777|Cytarabine|cytarabine|mesh-list
102234501|NCT02038777|Azacitidine|azacitidine|mesh-list
102234502|NCT02038777|Daunorubicin|daunorubicin|mesh-list
101636541|NCT00648531|Analgesics|analgesics|mesh-ancestor
102234503|NCT02038777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102234504|NCT02038777|Antimetabolites|antimetabolites|mesh-ancestor
102234505|NCT02038777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234506|NCT02038777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102234507|NCT02038777|Antiviral Agents|antiviral agents|mesh-ancestor
102234508|NCT02038777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102234509|NCT02038777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102234510|NCT02038777|Immunologic Factors|immunologic factors|mesh-ancestor
102234511|NCT02038777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234512|NCT02038777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102234513|NCT02038777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102234514|NCT02038777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102234515|NCT02038777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102234516|NCT03309709|Progesterone|progesterone|mesh-list
102234517|NCT03309709|Progestins|progestins|mesh-ancestor
102234518|NCT03309709|Hormones|hormones|mesh-ancestor
102234519|NCT03309709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102234520|NCT03309709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234521|NCT01720147|Quercetin|quercetin|mesh-list
102234522|NCT01720147|Antioxidants|antioxidants|mesh-ancestor
102234523|NCT01720147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612795|NCT00002507|Alkylating Agents|alkylating agents|mesh-ancestor
102612796|NCT00002507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234524|NCT01720147|Protective Agents|protective agents|mesh-ancestor
102234525|NCT01720147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234527|NCT03309319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102234528|NCT03309319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234529|NCT03309163|Tramadol|tramadol|mesh-list
102234530|NCT03309163|Hydromorphone|hydromorphone|mesh-list
102234531|NCT03309163|Ropivacaine|ropivacaine|mesh-list
102234532|NCT03309163|Anesthetics, Local|anesthetics, local|mesh-ancestor
102234533|NCT03309163|Anesthetics|anesthetics|mesh-ancestor
102234534|NCT03309163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102234535|NCT03309163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234536|NCT03309163|Sensory System Agents|sensory system agents|mesh-ancestor
102234537|NCT03309163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102234538|NCT03309163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102234539|NCT03309163|Narcotics|narcotics|mesh-ancestor
102234540|NCT03309163|Analgesics|analgesics|mesh-ancestor
102234541|NCT03174847|Eplerenone|eplerenone|mesh-list
102234542|NCT03174847|Amiloride|amiloride|mesh-list
102234543|NCT03174847|Spironolactone|spironolactone|mesh-list
102234544|NCT03174847|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
102234546|NCT03174847|Hormone Antagonists|hormone antagonists|mesh-ancestor
102234547|NCT03174847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102234548|NCT03174847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234549|NCT03174847|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102234550|NCT03174847|Diuretics|diuretics|mesh-ancestor
102234551|NCT03174847|Natriuretic Agents|natriuretic agents|mesh-ancestor
102234552|NCT03174847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102234553|NCT03174847|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
102234554|NCT03174847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102234555|NCT03174847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102234556|NCT03174847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234557|NCT03174847|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
102234558|NCT03174847|Hormones|hormones|mesh-ancestor
102234559|NCT03313531|Thrombin|thrombin|mesh-list
102234560|NCT03313531|Hemostatics|hemostatics|mesh-ancestor
102234561|NCT03313531|Coagulants|coagulants|mesh-ancestor
102234562|NCT02468167|Polidocanol|polidocanol|mesh-list
102234563|NCT02468167|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102234564|NCT02468167|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102234565|NCT03308149|Triamcinolone|triamcinolone|mesh-list
102234566|NCT03308149|Bupivacaine|bupivacaine|mesh-list
102234567|NCT03308149|Anesthetics, Local|anesthetics, local|mesh-ancestor
102234568|NCT03308149|Anesthetics|anesthetics|mesh-ancestor
102234569|NCT03308149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102234570|NCT03308149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234571|NCT03308149|Sensory System Agents|sensory system agents|mesh-ancestor
102234572|NCT03308149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102234573|NCT03308149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102234574|NCT03308149|Glucocorticoids|glucocorticoids|mesh-ancestor
102234575|NCT03308149|Hormones|hormones|mesh-ancestor
102234576|NCT03308149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102234577|NCT03303235|Methylergonovine|methylergonovine|mesh-list
102234578|NCT03303235|Oxytocics|oxytocics|mesh-ancestor
102234579|NCT03303235|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102234580|NCT03303235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234581|NCT03307993|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
102234582|NCT03307993|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102234583|NCT03307993|Serotonin Agents|serotonin agents|mesh-ancestor
102234584|NCT03307993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102234585|NCT03307993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234586|NCT03307993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234587|NCT03302845|Omeprazole|omeprazole|mesh-list
102234588|NCT03302845|Famotidine|famotidine|mesh-list
102234589|NCT03302845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102234590|NCT03302845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102234591|NCT03302845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102234592|NCT03302845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102234593|NCT03302845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234594|NCT03302845|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102612797|NCT00002507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102234595|NCT03302845|Histamine Antagonists|histamine antagonists|mesh-ancestor
102234596|NCT03302845|Histamine Agents|histamine agents|mesh-ancestor
102234597|NCT03302845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102612798|NCT00002507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102234598|NCT03302845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234599|NCT03302689|Ropivacaine|ropivacaine|mesh-list
102234600|NCT03302689|Levobupivacaine|levobupivacaine|mesh-list
102234601|NCT03302689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102234602|NCT03302689|Anesthetics, Local|anesthetics, local|mesh-ancestor
102234603|NCT03302689|Anesthetics|anesthetics|mesh-ancestor
102234604|NCT03302689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102234605|NCT03302689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234606|NCT03302689|Sensory System Agents|sensory system agents|mesh-ancestor
102234607|NCT03302689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102234608|NCT03307603|Nivolumab|nivolumab|mesh-list
102234609|NCT03307603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102234610|NCT03307603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102234611|NCT03307603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102234612|NCT03307603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234613|NCT02468323|Ondansetron|ondansetron|mesh-list
102234614|NCT02468323|Palonosetron|palonosetron|mesh-list
102234615|NCT02468323|Antiemetics|antiemetics|mesh-ancestor
102234616|NCT02468323|Autonomic Agents|autonomic agents|mesh-ancestor
102234617|NCT02468323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102234618|NCT02468323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234619|NCT02468323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102234620|NCT02468323|Antipruritics|antipruritics|mesh-ancestor
102234621|NCT02468323|Dermatologic Agents|dermatologic agents|mesh-ancestor
102234622|NCT02468323|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102234623|NCT02468323|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102234624|NCT02468323|Serotonin Agents|serotonin agents|mesh-ancestor
102234625|NCT02468323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102234626|NCT02468323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234627|NCT02469259|Oxytocin|oxytocin|mesh-list
102234628|NCT02469259|Oxytocics|oxytocics|mesh-ancestor
102234629|NCT02469259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102234630|NCT02469259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234631|NCT03307213|Sirolimus|sirolimus|mesh-list
102234632|NCT03307213|Umirolimus|umirolimus|mesh-list
102234633|NCT03307213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102234634|NCT03307213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102234635|NCT03307213|Immunologic Factors|immunologic factors|mesh-ancestor
102234636|NCT03307213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234637|NCT03307213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102234638|NCT03307213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102234639|NCT03307213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102234640|NCT03307213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102234641|NCT03307213|Antifungal Agents|antifungal agents|mesh-ancestor
102234642|NCT03302299|Pyridoxine|pyridoxine|mesh-list
102234643|NCT03302299|Vitamin B 6|vitamin b 6|mesh-list
102234644|NCT03302299|Isoniazid|isoniazid|mesh-list
102234645|NCT03302299|Vitamins|vitamins|mesh-ancestor
102234646|NCT03302299|Micronutrients|micronutrients|mesh-ancestor
102234647|NCT03302299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234648|NCT03302299|Vitamin B Complex|vitamin b complex|mesh-ancestor
102234649|NCT03302299|Antitubercular Agents|antitubercular agents|mesh-ancestor
102234650|NCT03302299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102234651|NCT03302299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102234652|NCT03302299|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102234653|NCT03302299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102234654|NCT03302299|Antimetabolites|antimetabolites|mesh-ancestor
102234655|NCT03302299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234656|NCT03302299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102234657|NCT03302221|Ropivacaine|ropivacaine|mesh-list
102234658|NCT03302221|Anesthetics|anesthetics|mesh-ancestor
102234659|NCT03302221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102234660|NCT03302221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234661|NCT03302221|Anesthetics, Local|anesthetics, local|mesh-ancestor
102234662|NCT03302221|Sensory System Agents|sensory system agents|mesh-ancestor
102234663|NCT03302221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102234664|NCT03302065|Tiotropium Bromide|tiotropium bromide|mesh-list
102234665|NCT03302065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102234666|NCT03302065|Autonomic Agents|autonomic agents|mesh-ancestor
102234667|NCT03302065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102234668|NCT03302065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102612799|NCT00002519|Paclitaxel|paclitaxel|mesh-list
102612800|NCT00002519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102234669|NCT03302065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102234670|NCT03302065|Respiratory System Agents|respiratory system agents|mesh-ancestor
102234671|NCT03302065|Parasympatholytics|parasympatholytics|mesh-ancestor
102234672|NCT03302065|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102234673|NCT03302065|Cholinergic Agents|cholinergic agents|mesh-ancestor
102234674|NCT03302065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102234675|NCT03302065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234677|NCT03306745|Hematinics|hematinics|mesh-ancestor
102234678|NCT03306745|Vitamin B Complex|vitamin b complex|mesh-ancestor
102234679|NCT03306745|Vitamins|vitamins|mesh-ancestor
102234680|NCT03306745|Micronutrients|micronutrients|mesh-ancestor
102234681|NCT03306745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234682|NCT03306667|Dotinurad|dotinurad|mesh-list
102234683|NCT03306667|Uricosuric Agents|uricosuric agents|mesh-ancestor
102234684|NCT03306667|Gout Suppressants|gout suppressants|mesh-ancestor
102234685|NCT03306667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102234686|NCT03312283|Ranibizumab|ranibizumab|mesh-list
102234687|NCT03312283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102234688|NCT03312283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102234689|NCT03312283|Growth Substances|growth substances|mesh-ancestor
102234690|NCT03312283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234691|NCT03312283|Growth Inhibitors|growth inhibitors|mesh-ancestor
101943515|NCT03610282|Anesthetics|anesthetics|mesh-ancestor
102234692|NCT03312283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102234693|NCT03301285|Zoledronic Acid|zoledronic acid|mesh-list
102234694|NCT03301285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102234695|NCT03301285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234696|NCT03301207|Midazolam|midazolam|mesh-list
102234697|NCT03301207|Bupropion|bupropion|mesh-list
102234698|NCT03301207|Levonorgestrel|levonorgestrel|mesh-list
102234699|NCT03301207|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102234700|NCT03301207|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
102234701|NCT03301207|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102234702|NCT03301207|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102234703|NCT03301207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102234704|NCT03301207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234705|NCT03301207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102234706|NCT03301207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102234707|NCT03301207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102234708|NCT03301207|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102234709|NCT03301207|Anesthetics, General|anesthetics, general|mesh-ancestor
102234710|NCT03301207|Anesthetics|anesthetics|mesh-ancestor
102234711|NCT03301207|GABA Modulators|gaba modulators|mesh-ancestor
102234712|NCT03301207|GABA Agents|gaba agents|mesh-ancestor
102234713|NCT03301207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102234714|NCT03301207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234715|NCT03301207|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102234716|NCT03301207|Antidepressive Agents|antidepressive agents|mesh-ancestor
102234717|NCT03301207|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102234718|NCT03301207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102234719|NCT03301207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102234720|NCT03301207|Dopamine Agents|dopamine agents|mesh-ancestor
102234721|NCT03301207|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102234722|NCT03301207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102234723|NCT03301207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102234724|NCT03301207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102234725|NCT03301207|Contraceptive Agents|contraceptive agents|mesh-ancestor
102234726|NCT03301207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102234727|NCT03301207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101636704|NCT02655471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102234728|NCT03301207|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102234729|NCT03301207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102234730|NCT03301207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102234731|NCT03301207|Estrogens|estrogens|mesh-ancestor
102234732|NCT03301207|Hormones|hormones|mesh-ancestor
102234733|NCT03301207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102234734|NCT03301207|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102234735|NCT03311971|Methamphetamine|methamphetamine|mesh-list
102234736|NCT03311971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102234737|NCT03311971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234738|NCT03311971|Sympathomimetics|sympathomimetics|mesh-ancestor
102234739|NCT03311971|Autonomic Agents|autonomic agents|mesh-ancestor
102234740|NCT03311971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102234741|NCT03311971|Dopamine Agents|dopamine agents|mesh-ancestor
102234742|NCT03311971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102612801|NCT00002519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101901275|NCT01287260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102612802|NCT00002519|Tubulin Modulators|tubulin modulators|mesh-ancestor
102612803|NCT00002519|Antimitotic Agents|antimitotic agents|mesh-ancestor
102612804|NCT00002519|Mitosis Modulators|mitosis modulators|mesh-ancestor
102234743|NCT03311971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234744|NCT03311971|Adrenergic Agents|adrenergic agents|mesh-ancestor
102234745|NCT03311971|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102234746|NCT03311971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102234747|NCT03311971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102234748|NCT03311971|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102234749|NCT03311737|Anesthetics|anesthetics|mesh-list
102234750|NCT03311737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102234751|NCT03311737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234752|NCT02467543|Ethanol|ethanol|mesh-list
102234753|NCT02467543|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102234754|NCT02467543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102234755|NCT02467543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102234756|NCT02467543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234757|NCT03311581|Propofol|propofol|mesh-list
102234758|NCT03311581|Sevoflurane|sevoflurane|mesh-list
102234759|NCT03311581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102234760|NCT03311581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102234761|NCT03311581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234762|NCT03311581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102234763|NCT03311581|Anesthetics, General|anesthetics, general|mesh-ancestor
102234764|NCT03311581|Anesthetics|anesthetics|mesh-ancestor
102234765|NCT03311581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102234766|NCT03311581|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102234767|NCT03311425|Dexamethasone|dexamethasone|mesh-list
102234768|NCT03311425|Methylprednisolone|methylprednisolone|mesh-list
101943594|NCT03351608|Atropine|atropine|mesh-list
102234769|NCT03311425|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102234770|NCT03311425|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102234772|NCT03311425|Prednisolone acetate|prednisolone acetate|mesh-list
102234773|NCT03311425|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102234774|NCT03311425|Prednisolone phosphate|prednisolone phosphate|mesh-list
102234775|NCT03311425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102234776|NCT03311425|Antiemetics|antiemetics|mesh-ancestor
102234777|NCT03311425|Autonomic Agents|autonomic agents|mesh-ancestor
102234778|NCT03311425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102234779|NCT03311425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234780|NCT03311425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102234781|NCT03311425|Glucocorticoids|glucocorticoids|mesh-ancestor
102234782|NCT03311425|Hormones|hormones|mesh-ancestor
102234783|NCT03311425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102234784|NCT03311425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102234785|NCT03311425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102234786|NCT03311425|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102234787|NCT03311425|Protective Agents|protective agents|mesh-ancestor
102234788|NCT03305263|Hydroxychloroquine|hydroxychloroquine|mesh-list
102234789|NCT03305263|Antimalarials|antimalarials|mesh-ancestor
102234790|NCT03305263|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102234791|NCT03305263|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102234792|NCT03305263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102234793|NCT03305263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102234794|NCT03305263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234795|NCT03305263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102234796|NCT03300115|Abivertinib|abivertinib|mesh-list
102234797|NCT03300115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102234798|NCT03300115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102234799|NCT03300115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234800|NCT02916979|Methotrexate|methotrexate|mesh-list
102234801|NCT02916979|Fludarabine|fludarabine|mesh-list
102234802|NCT02916979|Busulfan|busulfan|mesh-list
102234803|NCT02916979|Thymoglobulin|thymoglobulin|mesh-list
102234804|NCT02916979|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102234805|NCT02916979|Abortifacient Agents|abortifacient agents|mesh-ancestor
102234806|NCT02916979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102234807|NCT02916979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234808|NCT02916979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102234809|NCT02916979|Antimetabolites|antimetabolites|mesh-ancestor
102234810|NCT02916979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234811|NCT02916979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102234812|NCT02916979|Dermatologic Agents|dermatologic agents|mesh-ancestor
102234813|NCT02916979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102234814|NCT02916979|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102234815|NCT02916979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102234817|NCT02916979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102234818|NCT02916979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102234819|NCT02916979|Alkylating Agents|alkylating agents|mesh-ancestor
102234820|NCT02916979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102234821|NCT02916979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102234822|NCT00702949|Pregabalin|pregabalin|mesh-list
102234823|NCT00702949|Analgesics|analgesics|mesh-ancestor
102234824|NCT00702949|Sensory System Agents|sensory system agents|mesh-ancestor
102234825|NCT00702949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102234826|NCT00702949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234827|NCT00702949|Anticonvulsants|anticonvulsants|mesh-ancestor
102234828|NCT00702949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102234829|NCT00702949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102234830|NCT00702949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234831|NCT00702949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102234832|NCT00702949|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102234833|NCT00702949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102234834|NCT00702949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102234835|NCT00702949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102234836|NCT04791475|Dexamethasone|dexamethasone|mesh-list
102234837|NCT04791475|Dexmedetomidine|dexmedetomidine|mesh-list
102234838|NCT04791475|Bupivacaine|bupivacaine|mesh-list
102234839|NCT04791475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102234840|NCT04791475|Antiemetics|antiemetics|mesh-ancestor
102234841|NCT04791475|Autonomic Agents|autonomic agents|mesh-ancestor
102234842|NCT04791475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102234843|NCT04791475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234844|NCT04791475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102234845|NCT04791475|Glucocorticoids|glucocorticoids|mesh-ancestor
102234846|NCT04791475|Hormones|hormones|mesh-ancestor
102234847|NCT04791475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102234848|NCT04791475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102234849|NCT04791475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102234850|NCT04791475|Anesthetics, Local|anesthetics, local|mesh-ancestor
102234851|NCT04791475|Anesthetics|anesthetics|mesh-ancestor
102234852|NCT04791475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102234853|NCT04791475|Sensory System Agents|sensory system agents|mesh-ancestor
102234854|NCT04791475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102234855|NCT04791475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102234856|NCT04791475|Analgesics|analgesics|mesh-ancestor
102234857|NCT04791475|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102234858|NCT04791475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102234859|NCT04791475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102234860|NCT04791475|Adrenergic Agents|adrenergic agents|mesh-ancestor
102234861|NCT04791475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102234862|NCT04791475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234863|NCT03299725|Bismuth|bismuth|mesh-list
102234864|NCT03299725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234865|NCT03299725|Antacids|antacids|mesh-ancestor
102234866|NCT03299725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102234867|NCT02466997|Tacrolimus|tacrolimus|mesh-list
102234868|NCT02466997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102234869|NCT02466997|Immunologic Factors|immunologic factors|mesh-ancestor
102234870|NCT02466997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234871|NCT02466997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102234872|NCT02466997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102234873|NCT02466997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234874|NCT04939909|Botulinum Toxins|botulinum toxins|mesh-list
102234875|NCT04939909|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102234876|NCT04939909|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102234877|NCT04939909|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102234878|NCT04939909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102234879|NCT04939909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234880|NCT04939909|Cholinergic Agents|cholinergic agents|mesh-ancestor
102234881|NCT04939909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102234882|NCT04939909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234883|NCT04939909|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102234884|NCT04939909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102234885|NCT03299257|Donepezil|donepezil|mesh-list
102234886|NCT03299257|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102234887|NCT03299257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102234888|NCT03299257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234896|NCT02466373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102234897|NCT02466373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234898|NCT02466373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102234899|NCT02466373|Sympatholytics|sympatholytics|mesh-ancestor
102234900|NCT02466373|Autonomic Agents|autonomic agents|mesh-ancestor
102234901|NCT02466373|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102234902|NCT02466373|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102234903|NCT02466373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102234904|NCT02466373|Adrenergic Agents|adrenergic agents|mesh-ancestor
102234905|NCT02466373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102234906|NCT02466373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234914|NCT02466919|Amoxicillin|amoxicillin|mesh-list
102234915|NCT02466919|Metronidazole|metronidazole|mesh-list
102234916|NCT02466919|Clarithromycin|clarithromycin|mesh-list
102234917|NCT02466919|Levofloxacin|levofloxacin|mesh-list
102234918|NCT02466919|Pantoprazole|pantoprazole|mesh-list
102234919|NCT02466919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102234920|NCT02466919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102234921|NCT02466919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102234922|NCT02466919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102234923|NCT02466919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102234924|NCT02466919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102234925|NCT02466919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234926|NCT02466919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102234927|NCT02466919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102234928|NCT02466919|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102234929|NCT02466919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102234930|NCT02466919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102234931|NCT02466919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102234932|NCT02466919|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102234933|NCT02466919|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102234934|NCT02466919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102234935|NCT02466919|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102234936|NCT05727163|Leucovorin|leucovorin|mesh-list
102234937|NCT05727163|Dexamethasone|dexamethasone|mesh-list
102234938|NCT05727163|Anisodamine|anisodamine|mesh-list
102234939|NCT05727163|Bevacizumab|bevacizumab|mesh-list
102234940|NCT05727163|Fluorouracil|fluorouracil|mesh-list
102234941|NCT05727163|Oxaliplatin|oxaliplatin|mesh-list
102234942|NCT05727163|Irinotecan|irinotecan|mesh-list
102234943|NCT05727163|Levoleucovorin|levoleucovorin|mesh-list
102234944|NCT05727163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102234945|NCT05727163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102234946|NCT05727163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102234947|NCT05727163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102234948|NCT05727163|Growth Substances|growth substances|mesh-ancestor
102234949|NCT05727163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102234950|NCT05727163|Growth Inhibitors|growth inhibitors|mesh-ancestor
102234951|NCT05727163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102234952|NCT05727163|Antiemetics|antiemetics|mesh-ancestor
102234953|NCT05727163|Autonomic Agents|autonomic agents|mesh-ancestor
102234954|NCT05727163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102234955|NCT05727163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102234956|NCT05727163|Glucocorticoids|glucocorticoids|mesh-ancestor
102234957|NCT05727163|Hormones|hormones|mesh-ancestor
102241629|NCT03070665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234958|NCT05727163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102234959|NCT05727163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102234960|NCT05727163|Antimetabolites|antimetabolites|mesh-ancestor
102234961|NCT05727163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234962|NCT05727163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102612805|NCT00002519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102234963|NCT05727163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102234964|NCT05727163|Immunologic Factors|immunologic factors|mesh-ancestor
102234965|NCT05727163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102234966|NCT05727163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102234967|NCT05727163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102234968|NCT05727163|Antidotes|antidotes|mesh-ancestor
102234969|NCT05727163|Protective Agents|protective agents|mesh-ancestor
102234970|NCT05727163|Vitamin B Complex|vitamin b complex|mesh-ancestor
102234971|NCT05727163|Vitamins|vitamins|mesh-ancestor
102234972|NCT05727163|Micronutrients|micronutrients|mesh-ancestor
102234973|NCT05727163|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102234974|NCT05727163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102234975|NCT05727163|Adrenergic Agents|adrenergic agents|mesh-ancestor
102234976|NCT05727163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102234977|NCT05727163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102234978|NCT05727163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102234979|NCT05727163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102234980|NCT05727163|Analgesics|analgesics|mesh-ancestor
102234981|NCT05727163|Sensory System Agents|sensory system agents|mesh-ancestor
102234982|NCT05727163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102234983|NCT05727163|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102234984|NCT05727163|Parasympatholytics|parasympatholytics|mesh-ancestor
102234985|NCT05727163|Vasodilator Agents|vasodilator agents|mesh-ancestor
102234986|NCT05727163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102234987|NCT05727163|Antioxidants|antioxidants|mesh-ancestor
102234988|NCT05259709|Cemiplimab|cemiplimab|mesh-list
102234989|NCT05259709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102234990|NCT05259709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102234991|NCT05302531|Amoxicillin|amoxicillin|mesh-list
102234992|NCT05302531|Levofloxacin|levofloxacin|mesh-list
102234993|NCT05302531|Ofloxacin|ofloxacin|mesh-list
102234994|NCT05302531|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102234995|NCT05302531|Trimethoprim|trimethoprim|mesh-list
102234996|NCT05302531|Sulfamethoxazole|sulfamethoxazole|mesh-list
102234997|NCT05302531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102234998|NCT05302531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102234999|NCT05302531|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102235000|NCT05302531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102235001|NCT05302531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102235002|NCT05302531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102235003|NCT05302531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235004|NCT05302531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102235005|NCT05302531|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102235006|NCT05302531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102235007|NCT05302531|Antimalarials|antimalarials|mesh-ancestor
102235008|NCT05302531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102235009|NCT05302531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102235010|NCT05302531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102235011|NCT05302531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102235012|NCT05302531|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102235013|NCT00702403|Imatinib Mesylate|imatinib mesylate|mesh-list
102235014|NCT00702403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102235015|NCT00702403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102235016|NCT00702403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102235017|NCT00702403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235018|NCT00702325|Budesonide|budesonide|mesh-list
102235019|NCT00702325|Formoterol Fumarate|formoterol fumarate|mesh-list
102235020|NCT00702325|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
102235021|NCT00702325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102235022|NCT00702325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102235023|NCT00702325|Autonomic Agents|autonomic agents|mesh-ancestor
102235024|NCT00702325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102235025|NCT00702325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235026|NCT00702325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102235027|NCT00702325|Respiratory System Agents|respiratory system agents|mesh-ancestor
102235028|NCT00702325|Glucocorticoids|glucocorticoids|mesh-ancestor
102235029|NCT00702325|Hormones|hormones|mesh-ancestor
102235030|NCT00702325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102235031|NCT00702325|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102235032|NCT00702325|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102235033|NCT00702325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102235034|NCT00702325|Adrenergic Agents|adrenergic agents|mesh-ancestor
102235035|NCT00702325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102235036|NCT00702325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235037|NCT02719171|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102235038|NCT02719171|Immunologic Factors|immunologic factors|mesh-ancestor
102235039|NCT02719171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235041|NCT02464813|Oxycodone|oxycodone|mesh-list
102235042|NCT02464813|Analgesics|analgesics|mesh-ancestor
102235043|NCT02464813|Sensory System Agents|sensory system agents|mesh-ancestor
102235044|NCT02464813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102235045|NCT02464813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235046|NCT02464813|Anticonvulsants|anticonvulsants|mesh-ancestor
102235047|NCT02464813|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102235048|NCT02464813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102235049|NCT02464813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235050|NCT02464813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102235051|NCT02464813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102235052|NCT02464813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102235053|NCT02464813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102235054|NCT02464813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102235055|NCT02464813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102235056|NCT02464813|Narcotics|narcotics|mesh-ancestor
102235057|NCT05726929|Capsaicin|capsaicin|mesh-list
102235058|NCT05726929|Antipruritics|antipruritics|mesh-ancestor
102235059|NCT05726929|Dermatologic Agents|dermatologic agents|mesh-ancestor
102235060|NCT05726929|Sensory System Agents|sensory system agents|mesh-ancestor
102235061|NCT05726929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102235062|NCT05726929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235063|NCT05122351|Acetaminophen|acetaminophen|mesh-list
102235064|NCT05122351|Bupivacaine|bupivacaine|mesh-list
102235065|NCT05122351|Anesthetics, Local|anesthetics, local|mesh-ancestor
102235066|NCT05122351|Anesthetics|anesthetics|mesh-ancestor
102235067|NCT05122351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102235068|NCT05122351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943894|NCT03604354|Narcotics|narcotics|mesh-ancestor
102235069|NCT05122351|Sensory System Agents|sensory system agents|mesh-ancestor
102235070|NCT05122351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102235071|NCT05122351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102235072|NCT05122351|Analgesics|analgesics|mesh-ancestor
102235073|NCT05122351|Antipyretics|antipyretics|mesh-ancestor
102235074|NCT02464501|Paclitaxel|paclitaxel|mesh-list
102235075|NCT02464501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102235076|NCT02464501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102235077|NCT02464501|Tubulin Modulators|tubulin modulators|mesh-ancestor
102235078|NCT02464501|Antimitotic Agents|antimitotic agents|mesh-ancestor
102235079|NCT02464501|Mitosis Modulators|mitosis modulators|mesh-ancestor
102235080|NCT02464501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235081|NCT02465827|Ropivacaine|ropivacaine|mesh-list
102235082|NCT02465827|Anesthetics, Local|anesthetics, local|mesh-ancestor
102235083|NCT02465827|Anesthetics|anesthetics|mesh-ancestor
102235084|NCT02465827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102235085|NCT02465827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235086|NCT02465827|Sensory System Agents|sensory system agents|mesh-ancestor
102235087|NCT02465827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102235088|NCT04368403|Brodalumab|brodalumab|mesh-list
102235089|NCT04368403|Dermatologic Agents|dermatologic agents|mesh-ancestor
102235090|NCT04298203|Topiramate|topiramate|mesh-list
102235091|NCT04298203|Phentermine|phentermine|mesh-list
102235092|NCT04298203|Anticonvulsants|anticonvulsants|mesh-ancestor
102235093|NCT04298203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102235094|NCT04298203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235095|NCT04298203|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102235096|NCT04298203|Appetite Depressants|appetite depressants|mesh-ancestor
102235097|NCT04298203|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102235098|NCT04298203|Sympathomimetics|sympathomimetics|mesh-ancestor
102235099|NCT04298203|Autonomic Agents|autonomic agents|mesh-ancestor
102235100|NCT04298203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102235101|NCT04298203|Adrenergic Agents|adrenergic agents|mesh-ancestor
102235102|NCT04298203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102235103|NCT04298203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235104|NCT05679661|Chlorhexidine|chlorhexidine|mesh-list
102235105|NCT05679661|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102235106|NCT05679661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102612807|NCT00002267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102235107|NCT05679661|Disinfectants|disinfectants|mesh-ancestor
102235108|NCT02465983|Cyclophosphamide|cyclophosphamide|mesh-list
102235109|NCT02465983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102235110|NCT02465983|Immunologic Factors|immunologic factors|mesh-ancestor
102235111|NCT02465983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901282|NCT01181570|Adalimumab|adalimumab|mesh-list
102235112|NCT02465983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102235113|NCT02465983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101637021|NCT00920803|Resveratrol|resveratrol|mesh-list
102235114|NCT02465983|Alkylating Agents|alkylating agents|mesh-ancestor
102235115|NCT02465983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235116|NCT02465983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102235117|NCT02465983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102235119|NCT02465749|Micronutrients|micronutrients|mesh-ancestor
102235120|NCT02465749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235121|NCT00701779|Tamsulosin|tamsulosin|mesh-list
102235122|NCT00701779|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102235123|NCT00701779|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102235124|NCT00701779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102235125|NCT00701779|Adrenergic Agents|adrenergic agents|mesh-ancestor
102235126|NCT00701779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102235127|NCT00701779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235128|NCT00701779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235129|NCT00701779|Urological Agents|urological agents|mesh-ancestor
102235130|NCT02463643|Rabeprazole|rabeprazole|mesh-list
102235131|NCT02463643|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102235132|NCT02463643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102235133|NCT02463643|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102235134|NCT02463643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102235135|NCT02463643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235136|NCT04927975|Upadacitinib|upadacitinib|mesh-list
102235137|NCT04927975|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102235138|NCT04927975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102235139|NCT04927975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102235140|NCT04927975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235141|NCT04927975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102235142|NCT04913467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102235143|NCT04150861|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101943971|NCT03602638|Acarbose|acarbose|mesh-list
102235144|NCT04150861|Hormones|hormones|mesh-ancestor
102235145|NCT04150861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102235146|NCT04150861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235147|NCT02465359|Immunoglobulins|immunoglobulins|mesh-list
102235148|NCT02465359|Antibodies|antibodies|mesh-list
102235149|NCT02465359|gamma-Globulins|gamma-globulins|mesh-list
102235150|NCT02465359|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102235151|NCT02465359|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102235152|NCT02465359|Immunologic Factors|immunologic factors|mesh-ancestor
102235153|NCT02465359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235154|NCT02463019|Tenofovir|tenofovir|mesh-list
102235155|NCT02463019|Antiviral Agents|antiviral agents|mesh-ancestor
102235156|NCT02463019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102235157|NCT02463019|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102235158|NCT02463019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102235159|NCT02463019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101637024|NCT00920803|Protective Agents|protective agents|mesh-ancestor
102235160|NCT02463019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235161|NCT02463019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102235162|NCT02463019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102235163|NCT02462941|Adenosine|adenosine|mesh-list
102235164|NCT02462941|Analgesics|analgesics|mesh-ancestor
102235165|NCT02462941|Sensory System Agents|sensory system agents|mesh-ancestor
102235166|NCT02462941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102235167|NCT02462941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235168|NCT02462941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102235169|NCT02462941|Vasodilator Agents|vasodilator agents|mesh-ancestor
102235170|NCT02462941|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102235171|NCT02462941|Purinergic Agonists|purinergic agonists|mesh-ancestor
102235172|NCT02462941|Purinergic Agents|purinergic agents|mesh-ancestor
102235173|NCT02462941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102235174|NCT02462941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235175|NCT02462707|Nirogacestat|nirogacestat|mesh-list
102235176|NCT02462707|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
102235177|NCT02462707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102235178|NCT02462707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235179|NCT02463175|Plasma-lyte 148|plasma-lyte 148|mesh-list
102235180|NCT02463175|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102235181|NCT02463175|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102235182|NCT03297073|Acetaminophen|acetaminophen|mesh-list
101901283|NCT01181570|Mannitol|mannitol|mesh-list
102612808|NCT00002267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102235183|NCT03297073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102235185|NCT03297073|Sensory System Agents|sensory system agents|mesh-ancestor
102235186|NCT03297073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102235187|NCT03297073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235188|NCT03297073|Antipyretics|antipyretics|mesh-ancestor
102235189|NCT02462317|Baclofen|baclofen|mesh-list
102235190|NCT02462317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102235191|NCT02462317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102235192|NCT02462317|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102235193|NCT02462317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235194|NCT02462317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102235195|NCT02462317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102235196|NCT02462317|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102235197|NCT02462317|GABA Agonists|gaba agonists|mesh-ancestor
102235198|NCT02462317|GABA Agents|gaba agents|mesh-ancestor
102235199|NCT02462317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102235200|NCT02462317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235201|NCT02462317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102235202|NCT02462317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102235203|NCT02462317|Cholinergic Agents|cholinergic agents|mesh-ancestor
102235204|NCT02461069|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102235205|NCT02461069|Dermatologic Agents|dermatologic agents|mesh-ancestor
102235206|NCT02461069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102235207|NCT02461069|Immunologic Factors|immunologic factors|mesh-ancestor
102235208|NCT02461069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235209|NCT03332095|Tenofovir|tenofovir|mesh-list
102235210|NCT03332095|Lamivudine|lamivudine|mesh-list
102235211|NCT03332095|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102235212|NCT03332095|Antiviral Agents|antiviral agents|mesh-ancestor
102235213|NCT03332095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102235214|NCT03332095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102235215|NCT03332095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102235216|NCT03332095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102235217|NCT03332095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944049|NCT03600766|Mirabegron|mirabegron|mesh-list
102235218|NCT03332095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102235219|NCT04489381|Nitazoxanide|nitazoxanide|mesh-list
102235220|NCT04489381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102235221|NCT04489381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102235222|NCT04489849|Apixaban|apixaban|mesh-list
102235223|NCT04489849|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102235224|NCT04489849|Antithrombins|antithrombins|mesh-ancestor
102235225|NCT04489849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102235226|NCT04489849|Protease Inhibitors|protease inhibitors|mesh-ancestor
102235227|NCT04489849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102235228|NCT04489849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235229|NCT04489849|Anticoagulants|anticoagulants|mesh-ancestor
102235230|NCT04488367|Tranexamic Acid|tranexamic acid|mesh-list
102235231|NCT04488367|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102235232|NCT04488367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102235233|NCT04488367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235234|NCT04488367|Hemostatics|hemostatics|mesh-ancestor
102235235|NCT04488367|Coagulants|coagulants|mesh-ancestor
102235236|NCT03734653|Testosterone|testosterone|mesh-list
102235237|NCT03734653|Androgens|androgens|mesh-ancestor
102235238|NCT03734653|Hormones|hormones|mesh-ancestor
102235239|NCT03734653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102235240|NCT03734653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235241|NCT04489459|Meropenem|meropenem|mesh-list
102235242|NCT04489459|Colistin|colistin|mesh-list
102235243|NCT04489459|Tigecycline|tigecycline|mesh-list
102235244|NCT04489459|Polymyxins|polymyxins|mesh-list
102235245|NCT04489459|Polymyxin B|polymyxin b|mesh-list
101637079|NCT04578613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102235246|NCT04489459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102235247|NCT04489459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102235248|NCT04489459|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102235249|NCT04489459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102235250|NCT04489459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235251|NCT03296137|Aldesleukin|aldesleukin|mesh-list
102235252|NCT03296137|Cyclophosphamide|cyclophosphamide|mesh-list
102235253|NCT03296137|Nivolumab|nivolumab|mesh-list
102235254|NCT03296137|Ipilimumab|ipilimumab|mesh-list
102235255|NCT03296137|Fludarabine phosphate|fludarabine phosphate|mesh-list
102235256|NCT03296137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102235257|NCT03296137|Immunologic Factors|immunologic factors|mesh-ancestor
102235258|NCT03296137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235259|NCT03296137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102612809|NCT00002267|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102612810|NCT00002267|Antitubercular Agents|antitubercular agents|mesh-ancestor
102235260|NCT03296137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102235261|NCT03296137|Alkylating Agents|alkylating agents|mesh-ancestor
102235262|NCT03296137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235263|NCT03296137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102235264|NCT03296137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102235265|NCT03296137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102235266|NCT03296137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102235267|NCT03296137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102235268|NCT03296137|Antimetabolites|antimetabolites|mesh-ancestor
102235269|NCT03296137|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102235270|NCT03296137|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102235271|NCT03296137|Antiviral Agents|antiviral agents|mesh-ancestor
102235272|NCT03296137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102235273|NCT03295903|Cannabidiol|cannabidiol|mesh-list
102235274|NCT03295903|Anticonvulsants|anticonvulsants|mesh-ancestor
102235276|NCT02460913|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102235277|NCT02460913|Narcotics|narcotics|mesh-ancestor
102235278|NCT02460913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102235279|NCT02460913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235280|NCT02460913|Analgesics|analgesics|mesh-ancestor
102235281|NCT02460913|Sensory System Agents|sensory system agents|mesh-ancestor
102235282|NCT02460913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102235283|NCT02973997|Pembrolizumab|pembrolizumab|mesh-list
102235284|NCT02973997|Lenvatinib|lenvatinib|mesh-list
102235285|NCT02973997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102235286|NCT02973997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102235287|NCT02973997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102235288|NCT02973997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235289|NCT02973997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102235290|NCT02973997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101944140|NCT03707678|Albuterol|albuterol|mesh-list
102235291|NCT03295825|Heparin|heparin|mesh-list
102235292|NCT03295825|Anticoagulants|anticoagulants|mesh-ancestor
102235293|NCT03295825|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102235294|NCT03295825|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102235295|NCT03295825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235297|NCT03290365|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102235298|NCT03290365|Immunologic Factors|immunologic factors|mesh-ancestor
102235299|NCT03290365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235300|NCT03290365|Viscosupplements|viscosupplements|mesh-ancestor
102235301|NCT03290365|Protective Agents|protective agents|mesh-ancestor
102235302|NCT02764489|Thrombin|thrombin|mesh-list
102235303|NCT02764489|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
102235304|NCT02764489|Coagulants|coagulants|mesh-list
102235305|NCT02764489|Hemostatics|hemostatics|mesh-ancestor
102235306|NCT02462161|Insulin|insulin|mesh-list
102235307|NCT02462161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102235308|NCT02462161|Insulin Aspart|insulin aspart|mesh-list
102235309|NCT02462161|Insulin, Long-Acting|insulin, long-acting|mesh-list
102235310|NCT02462161|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102235311|NCT02462161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102235312|NCT02462161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235313|NCT03289819|Paclitaxel|paclitaxel|mesh-list
102235314|NCT03289819|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102235315|NCT03289819|Cyclophosphamide|cyclophosphamide|mesh-list
102235316|NCT03289819|Pembrolizumab|pembrolizumab|mesh-list
102235317|NCT03289819|Epirubicin|epirubicin|mesh-list
102235318|NCT03289819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102235319|NCT03289819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102235320|NCT03289819|Tubulin Modulators|tubulin modulators|mesh-ancestor
102235321|NCT03289819|Antimitotic Agents|antimitotic agents|mesh-ancestor
102235322|NCT03289819|Mitosis Modulators|mitosis modulators|mesh-ancestor
102235323|NCT03289819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235324|NCT03289819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102235325|NCT03289819|Immunologic Factors|immunologic factors|mesh-ancestor
102235326|NCT03289819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235327|NCT03289819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102235328|NCT03289819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102235329|NCT03289819|Alkylating Agents|alkylating agents|mesh-ancestor
102235330|NCT03289819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102235331|NCT03289819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102235332|NCT03289819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102235333|NCT03289819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102235334|NCT03289819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102235335|NCT03289819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102235336|NCT03289819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102235337|NCT02001623|Tisotumab vedotin|tisotumab vedotin|mesh-list
102235338|NCT02001623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102235339|NCT02001623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102235340|NCT02713867|Nivolumab|nivolumab|mesh-list
102235341|NCT02713867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102235342|NCT02713867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102235343|NCT02713867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102235344|NCT02713867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235345|NCT03372785|Aspirin|aspirin|mesh-list
102235346|NCT03372785|Metoprolol|metoprolol|mesh-list
102235347|NCT03372785|Clopidogrel|clopidogrel|mesh-list
102235348|NCT03372785|Ticagrelor|ticagrelor|mesh-list
102235349|NCT03372785|Atorvastatin|atorvastatin|mesh-list
102235350|NCT03372785|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102235351|NCT03372785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102235352|NCT03372785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102235353|NCT03372785|Analgesics|analgesics|mesh-ancestor
102235354|NCT03372785|Sensory System Agents|sensory system agents|mesh-ancestor
102235355|NCT03372785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102235356|NCT03372785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235357|NCT03372785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102235358|NCT03372785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102235359|NCT03372785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102235360|NCT03372785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102235361|NCT03372785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235362|NCT03372785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102235363|NCT03372785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102235364|NCT03372785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102235365|NCT03372785|Antipyretics|antipyretics|mesh-ancestor
102235366|NCT03372785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102235367|NCT03372785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102235368|NCT03372785|Antimetabolites|antimetabolites|mesh-ancestor
102235369|NCT03372785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101944191|NCT03590626|Dulaglutide|dulaglutide|mesh-list
102235370|NCT03372785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102235371|NCT03372785|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102235372|NCT03372785|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102235373|NCT03372785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102235374|NCT03372785|Purinergic Agents|purinergic agents|mesh-ancestor
102235375|NCT03372785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102235376|NCT03372785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102235377|NCT03372785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102235378|NCT03372785|Sympatholytics|sympatholytics|mesh-ancestor
102235379|NCT03372785|Autonomic Agents|autonomic agents|mesh-ancestor
102235380|NCT03372785|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102235381|NCT03372785|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102235382|NCT03372785|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102235383|NCT03372785|Adrenergic Agents|adrenergic agents|mesh-ancestor
102235384|NCT03372473|Loratadine|loratadine|mesh-list
102235385|NCT03372473|Montelukast|montelukast|mesh-list
102235386|NCT03372473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102235387|NCT03372473|Respiratory System Agents|respiratory system agents|mesh-ancestor
102235388|NCT03372473|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102235389|NCT03372473|Hormone Antagonists|hormone antagonists|mesh-ancestor
102235390|NCT03372473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102235391|NCT03372473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235392|NCT03372473|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102235393|NCT03372473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102235394|NCT03372473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235395|NCT03372473|Antipruritics|antipruritics|mesh-ancestor
102235396|NCT03372473|Dermatologic Agents|dermatologic agents|mesh-ancestor
102235397|NCT03372473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102235398|NCT03372473|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102235399|NCT03372473|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102235400|NCT03372473|Histamine Antagonists|histamine antagonists|mesh-ancestor
102235401|NCT03372473|Histamine Agents|histamine agents|mesh-ancestor
102235402|NCT03372473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102235403|NCT03289429|Magnesium Sulfate|magnesium sulfate|mesh-list
102235404|NCT03289429|Atorvastatin|atorvastatin|mesh-list
102235405|NCT03289429|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102235406|NCT03289429|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102612811|NCT00002273|Ganciclovir|ganciclovir|mesh-list
102235407|NCT03289429|Antimetabolites|antimetabolites|mesh-ancestor
102235408|NCT03289429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235409|NCT03289429|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102235410|NCT03289429|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102235411|NCT03289429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102235413|NCT03289429|Sensory System Agents|sensory system agents|mesh-ancestor
102235414|NCT03289429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102235415|NCT03289429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235416|NCT03289429|Anesthetics|anesthetics|mesh-ancestor
102235417|NCT03289429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102235418|NCT03289429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102235419|NCT03289429|Anticonvulsants|anticonvulsants|mesh-ancestor
102235420|NCT03289429|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102235421|NCT03289429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102235422|NCT03289429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102235423|NCT03289429|Tocolytic Agents|tocolytic agents|mesh-ancestor
102235424|NCT03289429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102235425|NCT03372239|Tryptophan|tryptophan|mesh-list
102235426|NCT03372239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102235427|NCT03372239|Antidepressive Agents|antidepressive agents|mesh-ancestor
102235428|NCT03372239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102235429|NCT03294967|Vitamin E|vitamin e|mesh-list
102235430|NCT03294967|Caffeine|caffeine|mesh-list
102235431|NCT03294967|Vitamins|vitamins|mesh-ancestor
102235432|NCT03294967|Micronutrients|micronutrients|mesh-ancestor
102235433|NCT03294967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235434|NCT03294967|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102235435|NCT03294967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102235436|NCT03294967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102235437|NCT03294967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235438|NCT03294967|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102235439|NCT03294967|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102235440|NCT03294967|Purinergic Agents|purinergic agents|mesh-ancestor
102235441|NCT03294967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102235442|NCT03294967|Antioxidants|antioxidants|mesh-ancestor
102235443|NCT03294967|Protective Agents|protective agents|mesh-ancestor
102235444|NCT03371849|Montelukast|montelukast|mesh-list
102235445|NCT03371849|Levocetirizine|levocetirizine|mesh-list
102235446|NCT03371849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102235447|NCT03371849|Respiratory System Agents|respiratory system agents|mesh-ancestor
102235448|NCT03371849|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102235449|NCT03371849|Hormone Antagonists|hormone antagonists|mesh-ancestor
102235450|NCT03371849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102235451|NCT03371849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235452|NCT03371849|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102235453|NCT03371849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102235454|NCT03371849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235455|NCT03371849|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102235456|NCT03371849|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102235457|NCT03371849|Histamine Antagonists|histamine antagonists|mesh-ancestor
102235458|NCT03371849|Histamine Agents|histamine agents|mesh-ancestor
102235459|NCT03371849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102235460|NCT04307329|Trastuzumab|trastuzumab|mesh-list
102235461|NCT04307329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102235462|NCT04307329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102235463|NCT03371069|Methylphenidate|methylphenidate|mesh-list
102235464|NCT03371069|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102235465|NCT03371069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235466|NCT03371069|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102235467|NCT03371069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102235468|NCT03371069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102235469|NCT03371069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235470|NCT03371069|Dopamine Agents|dopamine agents|mesh-ancestor
102235471|NCT03371069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102235472|NCT03294577|Cyclophosphamide|cyclophosphamide|mesh-list
102235473|NCT03294577|Docetaxel|docetaxel|mesh-list
102235474|NCT03294577|Doxorubicin|doxorubicin|mesh-list
102235475|NCT03294577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102235476|NCT03294577|Immunologic Factors|immunologic factors|mesh-ancestor
102235477|NCT03294577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235478|NCT03294577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101577131|NCT05342857|Aflibercept|aflibercept|mesh-list
102612812|NCT00002273|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102235479|NCT03294577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102235480|NCT03294577|Alkylating Agents|alkylating agents|mesh-ancestor
102235481|NCT03294577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235482|NCT03294577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102235483|NCT03294577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102235484|NCT03294577|Tubulin Modulators|tubulin modulators|mesh-ancestor
102235485|NCT03294577|Antimitotic Agents|antimitotic agents|mesh-ancestor
102235486|NCT03294577|Mitosis Modulators|mitosis modulators|mesh-ancestor
102235487|NCT03294577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102235488|NCT03294577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102235489|NCT03294577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102235490|NCT03294577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102235492|NCT03370835|Carvedilol|carvedilol|mesh-list
102235493|NCT03370835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101637352|NCT00968708|Protease Inhibitors|protease inhibitors|mesh-ancestor
102235494|NCT03370835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102235495|NCT03370835|Sympatholytics|sympatholytics|mesh-ancestor
102235496|NCT03370835|Autonomic Agents|autonomic agents|mesh-ancestor
102235497|NCT03370835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102235498|NCT03370835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235499|NCT03370835|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102235500|NCT03370835|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102235501|NCT03370835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102235502|NCT03370835|Adrenergic Agents|adrenergic agents|mesh-ancestor
102235503|NCT03370835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102235504|NCT03370835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235505|NCT03370835|Antioxidants|antioxidants|mesh-ancestor
102235506|NCT03370835|Protective Agents|protective agents|mesh-ancestor
102235507|NCT03370835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102235508|NCT03370835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102235509|NCT03370835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102235510|NCT03370835|Vasodilator Agents|vasodilator agents|mesh-ancestor
102235511|NCT03370835|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102235512|NCT03370835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102235513|NCT02460367|Docetaxel|docetaxel|mesh-list
102235514|NCT02460367|Tryptophan|tryptophan|mesh-list
102235515|NCT02460367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102235516|NCT02460367|Tubulin Modulators|tubulin modulators|mesh-ancestor
102235517|NCT02460367|Antimitotic Agents|antimitotic agents|mesh-ancestor
102235519|NCT02460367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235520|NCT02460367|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102235521|NCT02460367|Antidepressive Agents|antidepressive agents|mesh-ancestor
102235522|NCT02460367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102235523|NCT03370601|Infliximab|infliximab|mesh-list
102235524|NCT03370601|Mercaptopurine|mercaptopurine|mesh-list
102235525|NCT03370601|Azathioprine|azathioprine|mesh-list
102235526|NCT03370601|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102235527|NCT03370601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102235528|NCT03370601|Dermatologic Agents|dermatologic agents|mesh-ancestor
102235529|NCT03370601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102235530|NCT03370601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102235531|NCT03370601|Antimetabolites|antimetabolites|mesh-ancestor
102235532|NCT03370601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235533|NCT03370601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102235534|NCT03370601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102235535|NCT03370601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102235536|NCT03370601|Immunologic Factors|immunologic factors|mesh-ancestor
102235537|NCT03370601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235538|NCT03370601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102235539|NCT03370601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102235540|NCT03376529|Tazobactam|tazobactam|mesh-list
102235541|NCT03376529|Piperacillin|piperacillin|mesh-list
102235542|NCT03376529|Ceftazidime|ceftazidime|mesh-list
102235543|NCT03376529|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102235544|NCT03376529|Aztreonam|aztreonam|mesh-list
102235545|NCT03376529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102235546|NCT03376529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102235547|NCT03376529|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102235548|NCT03376529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102235549|NCT03376529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235550|NCT04132661|Bisacodyl|bisacodyl|mesh-list
102235551|NCT04132661|Cathartics|cathartics|mesh-ancestor
102235552|NCT04132661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102235553|NCT04132661|Laxatives|laxatives|mesh-ancestor
102235554|NCT03700541|Morphine|morphine|mesh-list
102235555|NCT03700541|Pirinitramide|pirinitramide|mesh-list
102235556|NCT03700541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102235557|NCT03700541|Narcotics|narcotics|mesh-ancestor
102235558|NCT03700541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102235559|NCT03700541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235560|NCT03700541|Analgesics|analgesics|mesh-ancestor
102235561|NCT03700541|Sensory System Agents|sensory system agents|mesh-ancestor
102235562|NCT03700541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102235563|NCT02460211|Vitamin D|vitamin d|mesh-list
102235564|NCT02460211|Cholecalciferol|cholecalciferol|mesh-list
102235565|NCT02460211|Vitamins|vitamins|mesh-ancestor
102235566|NCT02460211|Micronutrients|micronutrients|mesh-ancestor
102235567|NCT02460211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235568|NCT02460211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102235569|NCT02460211|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102235570|NCT03288259|Anesthetics|anesthetics|mesh-list
102235571|NCT03288259|Anesthetics, Local|anesthetics, local|mesh-list
102235572|NCT03288259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102235573|NCT03288259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235574|NCT03288259|Sensory System Agents|sensory system agents|mesh-ancestor
102235575|NCT03288259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102235576|NCT01653925|Dutasteride|dutasteride|mesh-list
102235577|NCT01653925|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102235578|NCT01653925|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102235579|NCT01653925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102235580|NCT01653925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235581|NCT01653925|Hormone Antagonists|hormone antagonists|mesh-ancestor
102235582|NCT01653925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102235583|NCT01653925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235584|NCT02730455|Natalizumab|natalizumab|mesh-list
102235585|NCT02730455|Immunologic Factors|immunologic factors|mesh-ancestor
102235586|NCT02730455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235587|NCT03376139|Zonisamide|zonisamide|mesh-list
102235588|NCT03376139|Anticonvulsants|anticonvulsants|mesh-ancestor
102235589|NCT03376139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102235590|NCT03376139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102235591|NCT03376139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944416|NCT01874860|Doxycycline|doxycycline|mesh-list
102235592|NCT03376139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102235593|NCT03376139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235594|NCT03369119|Montelukast|montelukast|mesh-list
101637485|NCT02639091|Pemetrexed|pemetrexed|mesh-list
102235595|NCT03369119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102235596|NCT03369119|Respiratory System Agents|respiratory system agents|mesh-ancestor
102235597|NCT03369119|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102235598|NCT03369119|Hormone Antagonists|hormone antagonists|mesh-ancestor
102235599|NCT03369119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102235600|NCT03369119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235601|NCT03369119|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102235602|NCT03369119|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102235603|NCT03369119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235604|NCT03287011|Listerine|listerine|mesh-list
102235605|NCT03287011|Sodium Fluoride|sodium fluoride|mesh-list
102235606|NCT03287011|Cariostatic Agents|cariostatic agents|mesh-ancestor
102235607|NCT03287011|Protective Agents|protective agents|mesh-ancestor
102235608|NCT03287011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235609|NCT03287011|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102235610|NCT03287011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102235611|NCT03293641|Folic Acid|folic acid|mesh-list
102235612|NCT03293641|Penicillins|penicillins|mesh-list
102235613|NCT03293641|Penicillin V|penicillin v|mesh-list
102235614|NCT03293641|Proguanil|proguanil|mesh-list
102235615|NCT03293641|Hydroxyurea|hydroxyurea|mesh-list
102235616|NCT03293641|Zinc Sulfate|zinc sulfate|mesh-list
102235617|NCT03293641|Hematinics|hematinics|mesh-ancestor
102235618|NCT03293641|Vitamin B Complex|vitamin b complex|mesh-ancestor
102235619|NCT03293641|Vitamins|vitamins|mesh-ancestor
102235620|NCT03293641|Micronutrients|micronutrients|mesh-ancestor
102235621|NCT03293641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235622|NCT03293641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102235623|NCT03293641|Antisickling Agents|antisickling agents|mesh-ancestor
102235624|NCT03293641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102235625|NCT03293641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235626|NCT03293641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102612814|NCT00002273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102235627|NCT03293641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102235628|NCT03293641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102235629|NCT03293641|Astringents|astringents|mesh-ancestor
102235630|NCT03293641|Dermatologic Agents|dermatologic agents|mesh-ancestor
102235631|NCT03293641|Antimalarials|antimalarials|mesh-ancestor
102235632|NCT03293641|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102235633|NCT03293641|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102235634|NCT03293641|Antimetabolites|antimetabolites|mesh-ancestor
102235635|NCT02519543|Metformin|metformin|mesh-list
101637525|NCT02638545|Dexmedetomidine|dexmedetomidine|mesh-list
102235636|NCT02519543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102235637|NCT02519543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235638|NCT03293407|Iloprost|iloprost|mesh-list
102235639|NCT03293407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102235640|NCT03293407|Vasodilator Agents|vasodilator agents|mesh-ancestor
102235641|NCT02519699|Norepinephrine|norepinephrine|mesh-list
102235642|NCT02519699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102235643|NCT02519699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102235644|NCT02519699|Adrenergic Agents|adrenergic agents|mesh-ancestor
102235645|NCT02519699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102235646|NCT02519699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235647|NCT02519699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235648|NCT02519699|Sympathomimetics|sympathomimetics|mesh-ancestor
102235649|NCT02519699|Autonomic Agents|autonomic agents|mesh-ancestor
102235650|NCT02519699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102235651|NCT02519699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102235652|NCT00701311|Apremilast|apremilast|mesh-list
102235653|NCT00701311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102235654|NCT00701311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102235655|NCT00701311|Analgesics|analgesics|mesh-ancestor
102235656|NCT00701311|Sensory System Agents|sensory system agents|mesh-ancestor
102235657|NCT00701311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102235658|NCT00701311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235659|NCT00701311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102235660|NCT00701311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102235661|NCT00701311|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102235662|NCT00701311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102235663|NCT00701311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102235664|NCT00701311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235665|NCT03375671|Midazolam|midazolam|mesh-list
102235666|NCT03375671|Ketamine|ketamine|mesh-list
102235667|NCT03375671|Haloperidol|haloperidol|mesh-list
102235668|NCT03375671|Haloperidol decanoate|haloperidol decanoate|mesh-list
102235669|NCT03375671|Analgesics|analgesics|mesh-ancestor
102235670|NCT03375671|Sensory System Agents|sensory system agents|mesh-ancestor
102235671|NCT03375671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102235672|NCT03375671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235673|NCT03375671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102235674|NCT03375671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102235675|NCT03375671|Anesthetics, General|anesthetics, general|mesh-ancestor
102235676|NCT03375671|Anesthetics|anesthetics|mesh-ancestor
102235677|NCT03375671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102235678|NCT03375671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102235679|NCT03375671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102235680|NCT03375671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102235681|NCT03375671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637571|NCT00970502|Analgesics|analgesics|mesh-ancestor
102235682|NCT03375671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102235683|NCT03375671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102235684|NCT03375671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102235685|NCT03375671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102235686|NCT03375671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102235687|NCT03375671|GABA Modulators|gaba modulators|mesh-ancestor
102235688|NCT03375671|GABA Agents|gaba agents|mesh-ancestor
102235689|NCT03375671|Antiemetics|antiemetics|mesh-ancestor
102235690|NCT03375671|Autonomic Agents|autonomic agents|mesh-ancestor
102235691|NCT03375671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102235692|NCT03375671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102235693|NCT03375671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102235694|NCT03375671|Dopamine Agents|dopamine agents|mesh-ancestor
102235695|NCT03375671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102235696|NCT03375593|Acetaminophen|acetaminophen|mesh-list
102235697|NCT03375593|Ibuprofen|ibuprofen|mesh-list
102235698|NCT03375593|Oxycodone|oxycodone|mesh-list
102235699|NCT03375593|Hydrocodone|hydrocodone|mesh-list
102235700|NCT03375593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102235701|NCT03375593|Analgesics|analgesics|mesh-ancestor
102235702|NCT03375593|Sensory System Agents|sensory system agents|mesh-ancestor
102235703|NCT03375593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102235704|NCT03375593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235706|NCT03375593|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102235707|NCT03375593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102235708|NCT03375593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102235709|NCT03375593|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102235710|NCT03375593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102235711|NCT03375593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235712|NCT03375593|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102235713|NCT03375593|Narcotics|narcotics|mesh-ancestor
102235714|NCT03375593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102235715|NCT03375593|Antitussive Agents|antitussive agents|mesh-ancestor
102235716|NCT03375593|Respiratory System Agents|respiratory system agents|mesh-ancestor
102235717|NCT04525235|Tolbutamide|tolbutamide|mesh-list
102235718|NCT04525235|Rifampin|rifampin|mesh-list
102235719|NCT04525235|Digoxin|digoxin|mesh-list
102235720|NCT04525235|Midazolam|midazolam|mesh-list
102235721|NCT04525235|Dextromethorphan|dextromethorphan|mesh-list
102235722|NCT04525235|Caffeine|caffeine|mesh-list
102235723|NCT04525235|Omeprazole|omeprazole|mesh-list
102235724|NCT04525235|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102235725|NCT04525235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102235726|NCT04525235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102235727|NCT04525235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235728|NCT04525235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102235729|NCT04525235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102235730|NCT04525235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102235731|NCT04525235|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102235732|NCT04525235|Anesthetics, General|anesthetics, general|mesh-ancestor
102235733|NCT04525235|Anesthetics|anesthetics|mesh-ancestor
102235734|NCT04525235|GABA Modulators|gaba modulators|mesh-ancestor
102235735|NCT04525235|GABA Agents|gaba agents|mesh-ancestor
102235736|NCT04525235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102235737|NCT04525235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235738|NCT04525235|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102235739|NCT04525235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102235740|NCT04525235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102235741|NCT04525235|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102235742|NCT04525235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102235743|NCT04525235|Purinergic Agents|purinergic agents|mesh-ancestor
101944565|NCT03709082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102235744|NCT04525235|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102235745|NCT04525235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102235746|NCT04525235|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102235747|NCT04525235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102235748|NCT04525235|Antitubercular Agents|antitubercular agents|mesh-ancestor
102235749|NCT04525235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102235750|NCT04525235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102235751|NCT04525235|Leprostatic Agents|leprostatic agents|mesh-ancestor
102235752|NCT04525235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102235753|NCT04525235|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102235754|NCT04525235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102235755|NCT04525235|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102235756|NCT04525235|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102235757|NCT04525235|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102235758|NCT04525235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102235759|NCT04525235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102235760|NCT04525235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102235761|NCT04525235|Protective Agents|protective agents|mesh-ancestor
102235762|NCT04525235|Antitussive Agents|antitussive agents|mesh-ancestor
102235763|NCT04525235|Respiratory System Agents|respiratory system agents|mesh-ancestor
102235764|NCT04525235|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102235765|NCT04525235|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102235766|NCT04525235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102235767|NCT03363815|Vitamin K|vitamin k|mesh-list
102235768|NCT03363815|Metformin|metformin|mesh-list
102235769|NCT03363815|Nintedanib|nintedanib|mesh-list
102235770|NCT03363815|Digoxin|digoxin|mesh-list
102235771|NCT03363815|Midazolam|midazolam|mesh-list
102235772|NCT03363815|Omeprazole|omeprazole|mesh-list
102235773|NCT03363815|Warfarin|warfarin|mesh-list
102235774|NCT03363815|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102235775|NCT03363815|Vitamins|vitamins|mesh-ancestor
102612815|NCT00002273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102235776|NCT03363815|Micronutrients|micronutrients|mesh-ancestor
102235777|NCT03363815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102612816|NCT00002273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102235778|NCT03363815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102235779|NCT03363815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102235780|NCT03363815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102235781|NCT03363815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102235782|NCT03363815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102235783|NCT03363815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102235784|NCT03363815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102235785|NCT03363815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102235786|NCT03363815|Anesthetics, General|anesthetics, general|mesh-ancestor
102235787|NCT03363815|Anesthetics|anesthetics|mesh-ancestor
102235788|NCT03363815|GABA Modulators|gaba modulators|mesh-ancestor
102235789|NCT03363815|GABA Agents|gaba agents|mesh-ancestor
102235790|NCT03363815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102235791|NCT03363815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235792|NCT03363815|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102235793|NCT03363815|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102235794|NCT03363815|Antimetabolites|antimetabolites|mesh-ancestor
102235795|NCT03363815|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102235796|NCT03363815|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102235797|NCT03363815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102235798|NCT03363815|Anticoagulants|anticoagulants|mesh-ancestor
102235799|NCT03363815|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102235800|NCT03363815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102235801|NCT03363815|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102235802|NCT03363815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102235803|NCT03363815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102235804|NCT03363815|Protective Agents|protective agents|mesh-ancestor
102235805|NCT03363815|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102235806|NCT03363815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102235807|NCT03363815|Hemostatics|hemostatics|mesh-ancestor
102235808|NCT03363815|Coagulants|coagulants|mesh-ancestor
102235809|NCT03363815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101637659|NCT04062019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102235810|NCT03363815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102235811|NCT03363659|Copper|copper|mesh-list
102235812|NCT03363659|Temozolomide|temozolomide|mesh-list
102235813|NCT03363659|Disulfiram|disulfiram|mesh-list
102235814|NCT03363659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102235815|NCT03363659|Alkylating Agents|alkylating agents|mesh-ancestor
102235816|NCT03363659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235817|NCT03363659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102235818|NCT03363659|Trace Elements|trace elements|mesh-ancestor
102235819|NCT03363659|Micronutrients|micronutrients|mesh-ancestor
102235820|NCT03363659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235821|NCT03363659|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102235822|NCT03363659|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
102235823|NCT03363659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102235824|NCT03363425|Lidocaine|lidocaine|mesh-list
102235825|NCT03363425|Dexmedetomidine|dexmedetomidine|mesh-list
102235826|NCT03363425|Anesthetics, Local|anesthetics, local|mesh-ancestor
102235827|NCT03363425|Anesthetics|anesthetics|mesh-ancestor
102235828|NCT03363425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102235829|NCT03363425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235830|NCT03363425|Sensory System Agents|sensory system agents|mesh-ancestor
102235831|NCT03363425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102235832|NCT03363425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102235833|NCT03363425|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102235834|NCT03363425|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102235835|NCT03363425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102235836|NCT03363425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235837|NCT03363425|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102235838|NCT03363425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102235839|NCT03363425|Analgesics|analgesics|mesh-ancestor
102235840|NCT03363425|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102235841|NCT03363425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102235842|NCT03363425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102235843|NCT03363425|Adrenergic Agents|adrenergic agents|mesh-ancestor
102235844|NCT03363425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102235845|NCT02459977|Basiliximab|basiliximab|mesh-list
102235846|NCT02459977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102235847|NCT02459977|Immunologic Factors|immunologic factors|mesh-ancestor
102235848|NCT02459977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235849|NCT02519153|Sildenafil Citrate|sildenafil citrate|mesh-list
102612817|NCT00002273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612818|NCT00002279|Zalcitabine|zalcitabine|mesh-list
102235850|NCT02519153|Vasodilator Agents|vasodilator agents|mesh-ancestor
102235851|NCT02519153|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102235853|NCT02519153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102235854|NCT02519153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235855|NCT02519153|Urological Agents|urological agents|mesh-ancestor
102235856|NCT04523987|Ciprofloxacin|ciprofloxacin|mesh-list
102235857|NCT04523987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102235858|NCT04523987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102235859|NCT04523987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102235860|NCT04523987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102235861|NCT04523987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102235862|NCT04523987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235863|NCT04523987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102235864|NCT04523987|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102235865|NCT04523987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102235866|NCT03363191|Fluticasone|fluticasone|mesh-list
102235867|NCT03363191|Xhance|xhance|mesh-list
102235868|NCT03363191|Albuterol|albuterol|mesh-list
102235869|NCT03363191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102235870|NCT03363191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102235871|NCT03363191|Autonomic Agents|autonomic agents|mesh-ancestor
102235872|NCT03363191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102235873|NCT03363191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235874|NCT03363191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102235875|NCT03363191|Respiratory System Agents|respiratory system agents|mesh-ancestor
102235876|NCT03363191|Dermatologic Agents|dermatologic agents|mesh-ancestor
102235877|NCT03363191|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102235878|NCT03363191|Tocolytic Agents|tocolytic agents|mesh-ancestor
102235879|NCT03363191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102235880|NCT03363191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102235881|NCT03363191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102235882|NCT03363191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102235883|NCT03363191|Adrenergic Agents|adrenergic agents|mesh-ancestor
102235884|NCT03363191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102235885|NCT03363191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235886|NCT03363113|Botulinum Toxins|botulinum toxins|mesh-list
102235887|NCT03363113|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102235888|NCT03363113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102235889|NCT03363113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235890|NCT03363113|Cholinergic Agents|cholinergic agents|mesh-ancestor
102235891|NCT03363113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102235892|NCT03363113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235893|NCT03285607|Paclitaxel|paclitaxel|mesh-list
102235894|NCT03285607|Cyclophosphamide|cyclophosphamide|mesh-list
102235895|NCT03285607|Doxorubicin|doxorubicin|mesh-list
102235896|NCT03285607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102235897|NCT03285607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102235899|NCT03285607|Antimitotic Agents|antimitotic agents|mesh-ancestor
102235900|NCT03285607|Mitosis Modulators|mitosis modulators|mesh-ancestor
102235901|NCT03285607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235902|NCT03285607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102235903|NCT03285607|Immunologic Factors|immunologic factors|mesh-ancestor
102235904|NCT03285607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235905|NCT03285607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102235906|NCT03285607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102235907|NCT03285607|Alkylating Agents|alkylating agents|mesh-ancestor
102235908|NCT03285607|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102235909|NCT03285607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102235910|NCT03285607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102235911|NCT03285607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102235912|NCT03285607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102235913|NCT03298321|Azacitidine|azacitidine|mesh-list
102235914|NCT03298321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102235915|NCT03298321|Antimetabolites|antimetabolites|mesh-ancestor
102235916|NCT03298321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235917|NCT03298321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102235918|NCT03298321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102235919|NCT04527055|Metronidazole|metronidazole|mesh-list
102235920|NCT04527055|Tetracycline|tetracycline|mesh-list
102235921|NCT04527055|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
102235922|NCT04527055|Esomeprazole|esomeprazole|mesh-list
102612819|NCT00002279|Antimetabolites|antimetabolites|mesh-ancestor
102235923|NCT04527055|Bismuth|bismuth|mesh-list
102235924|NCT04527055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102235925|NCT04527055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102235926|NCT04527055|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102235927|NCT04527055|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102235928|NCT04527055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102235929|NCT04527055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102235930|NCT04527055|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102235931|NCT04527055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102235932|NCT04527055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235933|NCT04527055|Antacids|antacids|mesh-ancestor
102235934|NCT04527055|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102235935|NCT02518763|Vitamin D|vitamin d|mesh-list
102235936|NCT02518763|Ergocalciferols|ergocalciferols|mesh-list
102235937|NCT02518763|Cholecalciferol|cholecalciferol|mesh-list
102235938|NCT02518763|Vitamins|vitamins|mesh-list
102235939|NCT02518763|Micronutrients|micronutrients|mesh-ancestor
102235940|NCT02518763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235941|NCT02518763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102235942|NCT02518763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102235943|NCT03362411|Linrodostat|linrodostat|mesh-list
102235944|NCT03362411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102235945|NCT03362411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235946|NCT03291457|Glucocorticoids|glucocorticoids|mesh-list
102235947|NCT03291457|Hormones|hormones|mesh-ancestor
102235948|NCT03291457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102235949|NCT03291457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235950|NCT03361709|Dexamethasone|dexamethasone|mesh-list
102235951|NCT03361709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102235952|NCT03361709|Antiemetics|antiemetics|mesh-ancestor
102235953|NCT03361709|Autonomic Agents|autonomic agents|mesh-ancestor
102235954|NCT03361709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102235955|NCT03361709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235956|NCT03361709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102235957|NCT03361709|Glucocorticoids|glucocorticoids|mesh-ancestor
102235958|NCT03361709|Hormones|hormones|mesh-ancestor
102235959|NCT03361709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102235960|NCT03361709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102235961|NCT03361709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102235962|NCT03284749|Copper|copper|mesh-list
102235963|NCT03284749|Trace Elements|trace elements|mesh-ancestor
102235964|NCT03284749|Micronutrients|micronutrients|mesh-ancestor
102235965|NCT03284749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235966|NCT04523675|Acetylcysteine|acetylcysteine|mesh-list
102235967|NCT04523675|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102235968|NCT04523675|Antiviral Agents|antiviral agents|mesh-ancestor
101637855|NCT05973253|Contraceptive Agents|contraceptive agents|mesh-ancestor
102235969|NCT04523675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102235970|NCT04523675|Expectorants|expectorants|mesh-ancestor
102235971|NCT04523675|Respiratory System Agents|respiratory system agents|mesh-ancestor
102235972|NCT04523675|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102235973|NCT04523675|Antioxidants|antioxidants|mesh-ancestor
102235974|NCT04523675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235975|NCT04523675|Protective Agents|protective agents|mesh-ancestor
102235976|NCT04523675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235977|NCT04523675|Antidotes|antidotes|mesh-ancestor
102235978|NCT03298009|Canagliflozin|canagliflozin|mesh-list
102235979|NCT03298009|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102235980|NCT03298009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235981|NCT03298009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102235982|NCT03298009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235983|NCT03291145|Spironolactone|spironolactone|mesh-list
102235984|NCT03291145|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102235985|NCT03291145|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102235986|NCT03291145|Hormone Antagonists|hormone antagonists|mesh-ancestor
102235987|NCT03291145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102235988|NCT03291145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102235989|NCT03291145|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102235990|NCT03291145|Diuretics|diuretics|mesh-ancestor
102235991|NCT03291145|Natriuretic Agents|natriuretic agents|mesh-ancestor
102235992|NCT03291145|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102235993|NCT03291145|Adrenergic Agents|adrenergic agents|mesh-ancestor
102235994|NCT03291145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102235995|NCT03291145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102235996|NCT03297931|Iproplatin|iproplatin|mesh-list
102235997|NCT03297931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102235998|NCT03284593|Azacitidine|azacitidine|mesh-list
102612820|NCT00002279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612821|NCT00002279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102235999|NCT03284593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102236000|NCT03284593|Antimetabolites|antimetabolites|mesh-ancestor
102236001|NCT03284593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236002|NCT03284593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102236003|NCT03284593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102236005|NCT03361397|Anesthetics, Local|anesthetics, local|mesh-ancestor
102236006|NCT03361397|Anesthetics|anesthetics|mesh-ancestor
102236007|NCT03361397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102236008|NCT03361397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236009|NCT03361397|Sensory System Agents|sensory system agents|mesh-ancestor
102236010|NCT03361397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102236011|NCT03361397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102236012|NCT03361397|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102236013|NCT03361397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102236014|NCT03361397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102236015|NCT03361397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236016|NCT03109379|Trospium chloride|trospium chloride|mesh-list
102236017|NCT03109379|Parasympatholytics|parasympatholytics|mesh-ancestor
102236018|NCT03109379|Autonomic Agents|autonomic agents|mesh-ancestor
102236019|NCT03109379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102236020|NCT03109379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236021|NCT03109379|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102236022|NCT03109379|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102236023|NCT03109379|Cholinergic Agents|cholinergic agents|mesh-ancestor
102236024|NCT03109379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102236025|NCT03109379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236026|NCT03109379|Urological Agents|urological agents|mesh-ancestor
102236027|NCT03361319|Paclitaxel|paclitaxel|mesh-list
102236028|NCT03361319|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102236029|NCT03361319|Nintedanib|nintedanib|mesh-list
102236030|NCT03361319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102236031|NCT03361319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102236032|NCT03361319|Tubulin Modulators|tubulin modulators|mesh-ancestor
102236033|NCT03361319|Antimitotic Agents|antimitotic agents|mesh-ancestor
102236034|NCT03361319|Mitosis Modulators|mitosis modulators|mesh-ancestor
102236035|NCT03361319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236036|NCT03361319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102236037|NCT03361319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102236038|NCT04489147|Metformin|metformin|mesh-list
101637935|NCT05972720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101637936|NCT05972720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101637937|NCT05972681|Epinephrine|epinephrine|mesh-list
101637938|NCT05972681|Bupivacaine|bupivacaine|mesh-list
101637939|NCT05972681|Anesthetics, Local|anesthetics, local|mesh-ancestor
101637940|NCT05972681|Anesthetics|anesthetics|mesh-ancestor
101637941|NCT05972681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101637942|NCT05972681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637943|NCT05972681|Sensory System Agents|sensory system agents|mesh-ancestor
102236039|NCT04489147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102236040|NCT04489147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236041|NCT03365999|Tranexamic Acid|tranexamic acid|mesh-list
102236042|NCT03365999|Aminocaproic Acid|aminocaproic acid|mesh-list
102236043|NCT03365999|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102236044|NCT03365999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102236045|NCT03365999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236046|NCT03365999|Hemostatics|hemostatics|mesh-ancestor
102236048|NCT02460055|Dexamethasone|dexamethasone|mesh-list
102236049|NCT02460055|Fentanyl|fentanyl|mesh-list
102236050|NCT02460055|Nitrous Oxide|nitrous oxide|mesh-list
102236051|NCT02460055|Ondansetron|ondansetron|mesh-list
102236052|NCT02460055|Propofol|propofol|mesh-list
102236053|NCT02460055|Sevoflurane|sevoflurane|mesh-list
102236054|NCT02460055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102236055|NCT02460055|Antiemetics|antiemetics|mesh-ancestor
102236056|NCT02460055|Autonomic Agents|autonomic agents|mesh-ancestor
102236057|NCT02460055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102236058|NCT02460055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236059|NCT02460055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102236060|NCT02460055|Glucocorticoids|glucocorticoids|mesh-ancestor
102236061|NCT02460055|Hormones|hormones|mesh-ancestor
101637981|NCT05972551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101637982|NCT05972551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637983|NCT05972512|Biotin|biotin|mesh-list
101637984|NCT05972512|Vitamin B Complex|vitamin b complex|mesh-ancestor
102236062|NCT02460055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102236063|NCT02460055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102236064|NCT02460055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102236065|NCT02460055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102236066|NCT02460055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102236067|NCT02460055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102236068|NCT02460055|Anesthetics, General|anesthetics, general|mesh-ancestor
102236069|NCT02460055|Anesthetics|anesthetics|mesh-ancestor
102236070|NCT02460055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102236071|NCT02460055|Narcotics|narcotics|mesh-ancestor
102236072|NCT02460055|Analgesics|analgesics|mesh-ancestor
102236073|NCT02460055|Sensory System Agents|sensory system agents|mesh-ancestor
102236074|NCT02460055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101901298|NCT05200312|Prednisone|prednisone|mesh-list
102236075|NCT02460055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102236076|NCT02460055|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102236078|NCT02460055|Dermatologic Agents|dermatologic agents|mesh-ancestor
102236079|NCT02460055|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102236080|NCT02460055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102236081|NCT02460055|Serotonin Agents|serotonin agents|mesh-ancestor
102236082|NCT02460055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102236083|NCT02460055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236084|NCT02460055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102236085|NCT03361163|Bromoacetylalprenololmenthane|bromoacetylalprenololmenthane|mesh-list
102236086|NCT03361163|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102236087|NCT03361163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102236088|NCT03361163|Adrenergic Agents|adrenergic agents|mesh-ancestor
102236089|NCT03361163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102236090|NCT03361163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236091|NCT03361163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236092|NCT03361163|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102236093|NCT03361163|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102236094|NCT03365765|Fluorouracil|fluorouracil|mesh-list
102236095|NCT03365765|Oxaliplatin|oxaliplatin|mesh-list
102236096|NCT03365765|Apatinib|apatinib|mesh-list
102236097|NCT03365765|Antimetabolites|antimetabolites|mesh-ancestor
102236098|NCT03365765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236099|NCT03365765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102236100|NCT03365765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102236101|NCT03365765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102236102|NCT03365765|Immunologic Factors|immunologic factors|mesh-ancestor
102236103|NCT03365765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236104|NCT03365765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102236105|NCT03365765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102236106|NCT03297463|Ipilimumab|ipilimumab|mesh-list
102236107|NCT03297463|Interleukin-2|interleukin-2|mesh-list
102236108|NCT03297463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102236109|NCT03297463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102236110|NCT03297463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102236111|NCT03297463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236112|NCT03297463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102236113|NCT03297463|Analgesics|analgesics|mesh-ancestor
102236114|NCT03297463|Sensory System Agents|sensory system agents|mesh-ancestor
102236115|NCT03297463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102236116|NCT03297463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236117|NCT03282643|Heparin|heparin|mesh-list
102236118|NCT03282643|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102236119|NCT03282643|Tinzaparin|tinzaparin|mesh-list
102236120|NCT03282643|Dalteparin|dalteparin|mesh-list
102236121|NCT03282643|Rivaroxaban|rivaroxaban|mesh-list
102236122|NCT03282643|Anticoagulants|anticoagulants|mesh-ancestor
102236123|NCT03282643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102236124|NCT03282643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102236125|NCT03282643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236126|NCT03282643|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102236127|NCT03282643|Antithrombins|antithrombins|mesh-ancestor
102236128|NCT03282643|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102236129|NCT03282643|Protease Inhibitors|protease inhibitors|mesh-ancestor
102236130|NCT03282643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102236131|NCT03282487|Hydrocortisone|hydrocortisone|mesh-list
102236132|NCT03282487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102236133|NCT02458729|Tranylcypromine|tranylcypromine|mesh-list
102236134|NCT02458729|Rivaroxaban|rivaroxaban|mesh-list
102236135|NCT02458729|Tranexamic Acid|tranexamic acid|mesh-list
102236136|NCT02458729|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102236137|NCT02458729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102236138|NCT02458729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236139|NCT02458729|Hemostatics|hemostatics|mesh-ancestor
102236140|NCT02458729|Coagulants|coagulants|mesh-ancestor
102236141|NCT02458729|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102236142|NCT02458729|Antithrombins|antithrombins|mesh-ancestor
102236143|NCT02458729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102236144|NCT02458729|Protease Inhibitors|protease inhibitors|mesh-ancestor
102236145|NCT02458729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102236146|NCT02458729|Anticoagulants|anticoagulants|mesh-ancestor
102236147|NCT02458729|Antidepressive Agents|antidepressive agents|mesh-ancestor
102236148|NCT02458729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102236149|NCT02458729|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102236150|NCT02458729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102236151|NCT02458729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102236152|NCT02458729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102236153|NCT02458729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236154|NCT03920527|Itraconazole|itraconazole|mesh-list
102236155|NCT03920527|Antifungal Agents|antifungal agents|mesh-ancestor
102236156|NCT03920527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102236157|NCT03920527|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102236158|NCT03920527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102236159|NCT03920527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102236160|NCT03920527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236161|NCT03920527|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102236162|NCT03920527|Hormone Antagonists|hormone antagonists|mesh-ancestor
102236163|NCT03920527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102236164|NCT03920527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236165|NCT03920527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102236166|NCT03536455|Acetazolamide|acetazolamide|mesh-list
102236167|NCT03536455|Anticonvulsants|anticonvulsants|mesh-ancestor
102236168|NCT03536455|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102236169|NCT03536455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102236170|NCT03536455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236171|NCT03536455|Diuretics|diuretics|mesh-ancestor
102236172|NCT03536455|Natriuretic Agents|natriuretic agents|mesh-ancestor
102236173|NCT03536455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236174|NCT03529825|Rifaximin|rifaximin|mesh-list
102236175|NCT03529825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102236176|NCT03529825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102236177|NCT03529825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102236178|NCT03281941|Capsaicin|capsaicin|mesh-list
102236179|NCT03281941|Antipruritics|antipruritics|mesh-ancestor
102236180|NCT03281941|Dermatologic Agents|dermatologic agents|mesh-ancestor
102236181|NCT03281941|Sensory System Agents|sensory system agents|mesh-ancestor
102236182|NCT03281941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102236183|NCT03281941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236184|NCT02459509|Dexmedetomidine|dexmedetomidine|mesh-list
102236185|NCT02459509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102236186|NCT02459509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102236187|NCT02459509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236188|NCT02459509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102236189|NCT02459509|Analgesics|analgesics|mesh-ancestor
102236190|NCT02459509|Sensory System Agents|sensory system agents|mesh-ancestor
102236191|NCT02459509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102236192|NCT02459509|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102236193|NCT02459509|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102236194|NCT02459509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102236195|NCT02459509|Adrenergic Agents|adrenergic agents|mesh-ancestor
102236196|NCT02459509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102236197|NCT02459509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236198|NCT03264781|CycloProvera|cycloprovera|mesh-list
102236200|NCT03264781|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102236201|NCT03264781|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102236202|NCT03264781|Contraceptive Agents|contraceptive agents|mesh-ancestor
102236203|NCT03264781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102236204|NCT03264781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236205|NCT03264781|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102236206|NCT03264781|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102236207|NCT03281863|Antibodies|antibodies|mesh-list
102236208|NCT03281863|Antistreptolysin|antistreptolysin|mesh-list
102236209|NCT03281863|Immunologic Factors|immunologic factors|mesh-ancestor
102236210|NCT03281863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236211|NCT03264625|Vitamin D|vitamin d|mesh-list
102236212|NCT03264625|Cholecalciferol|cholecalciferol|mesh-list
102236213|NCT03264625|Vitamins|vitamins|mesh-ancestor
102236214|NCT03264625|Micronutrients|micronutrients|mesh-ancestor
102236215|NCT03264625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236216|NCT03264625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102236217|NCT03264625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102236218|NCT03269929|Midazolam|midazolam|mesh-list
102236219|NCT03269929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102236220|NCT03269929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102236221|NCT03269929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102236222|NCT03269929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236223|NCT03269929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101901300|NCT05200312|Rituximab|rituximab|mesh-list
102612822|NCT00002279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102236224|NCT03269929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102236225|NCT03269929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102236226|NCT03269929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102236227|NCT03269929|Anesthetics, General|anesthetics, general|mesh-ancestor
102236228|NCT03269929|Anesthetics|anesthetics|mesh-ancestor
102236229|NCT03269929|GABA Modulators|gaba modulators|mesh-ancestor
102236230|NCT03269929|GABA Agents|gaba agents|mesh-ancestor
102236231|NCT03269929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102236232|NCT03269929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236233|NCT02730377|Liraglutide|liraglutide|mesh-list
102236234|NCT02730377|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
102236235|NCT02730377|Meglitinide|meglitinide|mesh-list
102236236|NCT02730377|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102236237|NCT02730377|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
102236238|NCT02730377|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
102236239|NCT02730377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102236240|NCT02730377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236241|NCT02730377|Incretins|incretins|mesh-ancestor
102236242|NCT02730377|Hormones|hormones|mesh-ancestor
102236243|NCT02730377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102236244|NCT02730377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236245|NCT02730377|Protease Inhibitors|protease inhibitors|mesh-ancestor
102236246|NCT02730377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102236247|NCT03264547|Paclitaxel|paclitaxel|mesh-list
102236248|NCT03264547|Docetaxel|docetaxel|mesh-list
102236249|NCT03264547|Trastuzumab|trastuzumab|mesh-list
101638189|NCT05916352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101638215|NCT05904470|Ruzasvir|ruzasvir|mesh-list
101638216|NCT05904470|Antiviral Agents|antiviral agents|mesh-ancestor
101638217|NCT05904470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101638218|NCT05890586|Fluvoxamine|fluvoxamine|mesh-list
101638219|NCT05890586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101638220|NCT05890586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638221|NCT05890586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101638222|NCT05890586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101638223|NCT05890586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101638224|NCT05890586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236250|NCT03264547|Pertuzumab|pertuzumab|mesh-list
102236251|NCT03264547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102236252|NCT03264547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102236253|NCT03264547|Tubulin Modulators|tubulin modulators|mesh-ancestor
102236254|NCT03264547|Antimitotic Agents|antimitotic agents|mesh-ancestor
102236255|NCT03264547|Mitosis Modulators|mitosis modulators|mesh-ancestor
102236256|NCT03264547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236257|NCT03264547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102236258|NCT03365141|Triamcinolone|triamcinolone|mesh-list
102236259|NCT03365141|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102236260|NCT03365141|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102236261|NCT03365141|Tacrolimus|tacrolimus|mesh-list
102236262|NCT03365141|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102236263|NCT03365141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102236264|NCT03365141|Immunologic Factors|immunologic factors|mesh-ancestor
102236265|NCT03365141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236266|NCT03365141|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102236267|NCT03365141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102236268|NCT03365141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236269|NCT03365141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102236270|NCT03365141|Glucocorticoids|glucocorticoids|mesh-ancestor
102236271|NCT03365141|Hormones|hormones|mesh-ancestor
102236272|NCT03365141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102236273|NCT03364985|Dapagliflozin|dapagliflozin|mesh-list
102236274|NCT03364985|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102236275|NCT03364985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236276|NCT03364985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102236277|NCT03364985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236278|NCT03364829|Glycopyrrolate|glycopyrrolate|mesh-list
102236279|NCT03364829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102236280|NCT03364829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102236281|NCT03364829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102236282|NCT03364829|Cholinergic Agents|cholinergic agents|mesh-ancestor
102236283|NCT03364829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102236284|NCT03364829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236285|NCT03364829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236286|NCT03359837|Insulin|insulin|mesh-list
102236287|NCT03359837|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102236288|NCT03359837|Metformin|metformin|mesh-list
102236289|NCT03359837|Insulin Glargine|insulin glargine|mesh-list
102236290|NCT03359837|Insulin Aspart|insulin aspart|mesh-list
102236291|NCT03359837|Biphasic Insulins|biphasic insulins|mesh-list
102236292|NCT03359837|Acarbose|acarbose|mesh-list
101638225|NCT05890586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101638226|NCT05890586|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101638227|NCT05890586|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101638228|NCT05890586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101638229|NCT05890586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101638230|NCT05890586|Serotonin Agents|serotonin agents|mesh-ancestor
101638231|NCT05890586|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101638232|NCT05890586|Antidepressive Agents|antidepressive agents|mesh-ancestor
101638233|NCT05890586|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101638234|NCT05890586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102236293|NCT03359837|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
102236294|NCT03359837|Insulin glulisine|insulin glulisine|mesh-list
102236295|NCT03359837|Repaglinide|repaglinide|mesh-list
102236296|NCT03359837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102612823|NCT00002279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612824|NCT00002279|Antiviral Agents|antiviral agents|mesh-ancestor
102236297|NCT03359837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236298|NCT03359837|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102236300|NCT03359837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236301|NCT03359681|Metformin|metformin|mesh-list
102236302|NCT03359681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102236303|NCT03359681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236304|NCT03359525|Tranexamic Acid|tranexamic acid|mesh-list
102236305|NCT03359525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102236306|NCT03359525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102236307|NCT03359525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236308|NCT03359525|Hemostatics|hemostatics|mesh-ancestor
102236309|NCT03359525|Coagulants|coagulants|mesh-ancestor
102236310|NCT03358433|Antidepressive Agents|antidepressive agents|mesh-list
102236311|NCT03358433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102236312|NCT03359291|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102236313|NCT03359291|Macitentan|macitentan|mesh-list
102236314|NCT03359291|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102236315|NCT03359291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102236316|NCT03359291|Antimetabolites|antimetabolites|mesh-ancestor
102236317|NCT03359291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236318|NCT03359291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102236319|NCT03359291|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102236320|NCT03359291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102236321|NCT03359291|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
102236322|NCT03359291|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102236323|NCT03359291|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
102236324|NCT03358277|Methylphenidate|methylphenidate|mesh-list
102236325|NCT03358277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236326|NCT03358277|Dopamine Agents|dopamine agents|mesh-ancestor
102236327|NCT03358277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102236328|NCT03358277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236329|NCT03358277|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102236330|NCT03358277|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102236331|NCT03358277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102236332|NCT03358277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102236333|NCT03359057|Folic Acid|folic acid|mesh-list
102236334|NCT03359057|Vitamin B Complex|vitamin b complex|mesh-list
102236335|NCT03359057|Levonorgestrel|levonorgestrel|mesh-list
102236336|NCT03359057|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102236337|NCT03359057|Estradiol|estradiol|mesh-list
102236338|NCT03359057|Estrogens|estrogens|mesh-ancestor
102236339|NCT03359057|Hormones|hormones|mesh-ancestor
102236340|NCT03359057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102236341|NCT03359057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236342|NCT03359057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102236343|NCT03359057|Contraceptive Agents|contraceptive agents|mesh-ancestor
102236344|NCT03359057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102236345|NCT03359057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102236346|NCT03359057|Hematinics|hematinics|mesh-ancestor
102236347|NCT03359057|Vitamins|vitamins|mesh-ancestor
102236348|NCT03359057|Micronutrients|micronutrients|mesh-ancestor
102236349|NCT03359057|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102236351|NCT03359057|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102236352|NCT02714569|Atorvastatin|atorvastatin|mesh-list
102236353|NCT02714569|Simvastatin|simvastatin|mesh-list
102236354|NCT02714569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102236355|NCT02714569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102236356|NCT02714569|Antimetabolites|antimetabolites|mesh-ancestor
102236357|NCT02714569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236358|NCT02714569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102236359|NCT02714569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102236360|NCT02714569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102236361|NCT04522037|Morphine|morphine|mesh-list
102236362|NCT04522037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102236363|NCT04522037|Narcotics|narcotics|mesh-ancestor
102236364|NCT04522037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102236365|NCT04522037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236366|NCT04522037|Analgesics|analgesics|mesh-ancestor
102236367|NCT04522037|Sensory System Agents|sensory system agents|mesh-ancestor
102236368|NCT04522037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102236369|NCT03357653|Losartan|losartan|mesh-list
102236370|NCT03357653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102236371|NCT03357653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102236372|NCT03357653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102236373|NCT03357653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102236374|NCT03357653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236375|NCT04522661|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102236376|NCT04522661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102236377|NCT03357575|Hyaluronic Acid|hyaluronic acid|mesh-list
102236378|NCT03357575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102236379|NCT03357575|Immunologic Factors|immunologic factors|mesh-ancestor
102236380|NCT03357575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236381|NCT03357575|Viscosupplements|viscosupplements|mesh-ancestor
102236382|NCT03357575|Protective Agents|protective agents|mesh-ancestor
102236383|NCT03280927|Efinaconazole|efinaconazole|mesh-list
102236384|NCT03280927|Antifungal Agents|antifungal agents|mesh-ancestor
102236385|NCT03280927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102236386|NCT03269383|Bupivacaine|bupivacaine|mesh-list
102236387|NCT03269383|Anesthetics, Local|anesthetics, local|mesh-ancestor
102236388|NCT03269383|Anesthetics|anesthetics|mesh-ancestor
102236389|NCT03269383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102236390|NCT03269383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236391|NCT03269383|Sensory System Agents|sensory system agents|mesh-ancestor
102236392|NCT03269383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101638342|NCT05700630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638343|NCT05695027|Niacinamide|niacinamide|mesh-list
101638344|NCT05695027|Niacin|niacin|mesh-list
101638345|NCT05695027|Nicotinic Acids|nicotinic acids|mesh-list
101638346|NCT05695027|Vitamin B Complex|vitamin b complex|mesh-ancestor
101638347|NCT05695027|Vitamins|vitamins|mesh-ancestor
101638348|NCT05695027|Micronutrients|micronutrients|mesh-ancestor
101638349|NCT05695027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638350|NCT05695027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101638351|NCT05695027|Antimetabolites|antimetabolites|mesh-ancestor
101638352|NCT05695027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638353|NCT05695027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101638354|NCT05695027|Vasodilator Agents|vasodilator agents|mesh-ancestor
101638355|NCT05680857|Ubiquinone|ubiquinone|mesh-list
101638356|NCT05680857|Coenzyme Q10|coenzyme q10|mesh-list
101638357|NCT05680857|Micronutrients|micronutrients|mesh-ancestor
101638358|NCT05680857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638359|NCT05680857|Vitamins|vitamins|mesh-ancestor
101638396|NCT05630183|Tubulin Modulators|tubulin modulators|mesh-ancestor
101638397|NCT05630183|Antimitotic Agents|antimitotic agents|mesh-ancestor
101638398|NCT05630183|Mitosis Modulators|mitosis modulators|mesh-ancestor
101638399|NCT05630183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638400|NCT05630183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101638401|NCT05630183|Antimetabolites|antimetabolites|mesh-ancestor
102236393|NCT03280849|Chitosan|chitosan|mesh-list
102236394|NCT03280849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102236395|NCT03280849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102236396|NCT03280849|Antimetabolites|antimetabolites|mesh-ancestor
102236397|NCT03280849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236398|NCT03280849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102236399|NCT03280849|Chelating Agents|chelating agents|mesh-ancestor
102236400|NCT03280849|Sequestering Agents|sequestering agents|mesh-ancestor
102236401|NCT03280849|Hemostatics|hemostatics|mesh-ancestor
102236402|NCT03280849|Coagulants|coagulants|mesh-ancestor
102236403|NCT04521491|Leucovorin|leucovorin|mesh-list
102236404|NCT04521491|Fluorouracil|fluorouracil|mesh-list
102236405|NCT04521491|Oxaliplatin|oxaliplatin|mesh-list
102236406|NCT04521491|Antimetabolites|antimetabolites|mesh-ancestor
102236407|NCT04521491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236408|NCT04521491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102236409|NCT04521491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102236410|NCT04521491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102236411|NCT04521491|Immunologic Factors|immunologic factors|mesh-ancestor
102236412|NCT04521491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236413|NCT04521491|Antidotes|antidotes|mesh-ancestor
102236414|NCT04521491|Protective Agents|protective agents|mesh-ancestor
102236415|NCT04521491|Vitamin B Complex|vitamin b complex|mesh-ancestor
102236416|NCT04521491|Vitamins|vitamins|mesh-ancestor
102236417|NCT04521491|Micronutrients|micronutrients|mesh-ancestor
102236418|NCT04509635|Cetuximab|cetuximab|mesh-list
102236419|NCT04509635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102236420|NCT04509635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102236421|NCT04444817|Tacrolimus|tacrolimus|mesh-list
101638438|NCT05624996|Paclitaxel|paclitaxel|mesh-list
101638439|NCT05624996|Etoposide|etoposide|mesh-list
101638440|NCT05624996|Podophyllotoxin|podophyllotoxin|mesh-list
101638441|NCT05624996|Cisplatin|cisplatin|mesh-list
101638442|NCT05624996|Carboplatin|carboplatin|mesh-list
101638456|NCT05624996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101638457|NCT05624996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101638458|NCT05624996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101638459|NCT05624996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101638460|NCT05624996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101638461|NCT05624996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102236422|NCT04444817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101945244|NCT03902925|Anesthetics|anesthetics|mesh-ancestor
102236423|NCT04444817|Immunologic Factors|immunologic factors|mesh-ancestor
102236424|NCT04444817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236425|NCT04444817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102236426|NCT04444817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102236427|NCT04444817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236428|NCT03264079|Itraconazole|itraconazole|mesh-list
102236429|NCT03264079|Antifungal Agents|antifungal agents|mesh-ancestor
102236430|NCT03264079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102236431|NCT03264079|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102236432|NCT03264079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102236433|NCT03264079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102236434|NCT03264079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236435|NCT03264079|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102236436|NCT03264079|Hormone Antagonists|hormone antagonists|mesh-ancestor
102236437|NCT03264079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102236438|NCT03264079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236439|NCT03264079|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102236440|NCT04509323|Huperzine A|huperzine a|mesh-list
102236441|NCT04509323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102236442|NCT04509323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612825|NCT00002279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102612826|NCT00002279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102612827|NCT00002279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102236443|NCT04509323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236444|NCT04509323|Cholinergic Agents|cholinergic agents|mesh-ancestor
102236445|NCT04509323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102236446|NCT04509323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236447|NCT04509323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102236448|NCT04509323|Protective Agents|protective agents|mesh-ancestor
102236449|NCT04443647|Oxytocin|oxytocin|mesh-list
102236450|NCT04443647|Oxytocics|oxytocics|mesh-ancestor
102236451|NCT04443647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102236452|NCT04443647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236453|NCT04443881|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102236454|NCT04443881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102236455|NCT02458339|Methotrexate|methotrexate|mesh-list
102236456|NCT02458339|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102236457|NCT02458339|Abortifacient Agents|abortifacient agents|mesh-ancestor
102236458|NCT02458339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102236459|NCT02458339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236460|NCT02458339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102236461|NCT02458339|Antimetabolites|antimetabolites|mesh-ancestor
102236462|NCT02458339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236463|NCT02458339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102236464|NCT02458339|Dermatologic Agents|dermatologic agents|mesh-ancestor
102236465|NCT02458339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102236466|NCT02458339|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102236467|NCT02458339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102236468|NCT02458339|Immunologic Factors|immunologic factors|mesh-ancestor
102236469|NCT02458339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102236470|NCT02458339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102236471|NCT03268525|Bupivacaine|bupivacaine|mesh-list
102236472|NCT03268525|Anesthetics, Local|anesthetics, local|mesh-ancestor
102236473|NCT03268525|Anesthetics|anesthetics|mesh-ancestor
102236474|NCT03268525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102236475|NCT03268525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236476|NCT03268525|Sensory System Agents|sensory system agents|mesh-ancestor
102236477|NCT03268525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102236478|NCT02456935|Esomeprazole|esomeprazole|mesh-list
102236479|NCT02456935|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102236480|NCT02456935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102236481|NCT02456935|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102236482|NCT02456935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102236483|NCT02456935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236484|NCT03280147|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102236485|NCT03280147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102236486|NCT03280147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102236487|NCT03280147|Antitubercular Agents|antitubercular agents|mesh-ancestor
102236488|NCT03263689|Morphine|morphine|mesh-list
102236489|NCT03263689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102236490|NCT03263689|Narcotics|narcotics|mesh-ancestor
102236491|NCT03263689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102236492|NCT03263689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236493|NCT03263689|Analgesics|analgesics|mesh-ancestor
102236494|NCT03263689|Sensory System Agents|sensory system agents|mesh-ancestor
102236495|NCT03263689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101945317|NCT03905967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102236496|NCT03279679|Ropivacaine|ropivacaine|mesh-list
102236497|NCT03279679|Anesthetics, Local|anesthetics, local|mesh-ancestor
102236498|NCT03279679|Anesthetics|anesthetics|mesh-ancestor
102236499|NCT03279679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102236500|NCT03279679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236501|NCT03279679|Sensory System Agents|sensory system agents|mesh-ancestor
102236502|NCT03279679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102236503|NCT02518451|Valsartan|valsartan|mesh-list
102236504|NCT02518451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102236505|NCT02518451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102236506|NCT02518451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102236507|NCT02518451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236508|NCT03263299|Aspirin|aspirin|mesh-list
102236509|NCT03263299|Cabergoline|cabergoline|mesh-list
102236510|NCT03263299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102236511|NCT03263299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102236512|NCT03263299|Analgesics|analgesics|mesh-ancestor
102236513|NCT03263299|Sensory System Agents|sensory system agents|mesh-ancestor
102236514|NCT03263299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102236515|NCT03263299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236516|NCT03263299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102236517|NCT03263299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102612828|NCT00002285|Zidovudine|zidovudine|mesh-list
102236518|NCT03263299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102236519|NCT03263299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102236520|NCT03263299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236521|NCT03263299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102236522|NCT03263299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101638596|NCT05303324|Choline|choline|mesh-list
102236523|NCT03263299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102236524|NCT03263299|Antipyretics|antipyretics|mesh-ancestor
102236525|NCT03263299|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102236526|NCT03263299|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102236527|NCT03263299|Dopamine Agonists|dopamine agonists|mesh-ancestor
102236528|NCT03263299|Dopamine Agents|dopamine agents|mesh-ancestor
102236529|NCT03263299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102236530|NCT04444349|Ubiquinone|ubiquinone|mesh-list
102236531|NCT04444349|Coenzyme Q10|coenzyme q10|mesh-list
102236532|NCT04444349|Micronutrients|micronutrients|mesh-ancestor
102236533|NCT04444349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236534|NCT04444349|Vitamins|vitamins|mesh-ancestor
102236535|NCT03263533|Vorinostat|vorinostat|mesh-list
102236536|NCT03263533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102236537|NCT03263533|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102236538|NCT03263533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102236539|NCT03263533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236540|NCT03123107|Ascorbic Acid|ascorbic acid|mesh-list
102236541|NCT03123107|Vitamins|vitamins|mesh-ancestor
102236542|NCT03123107|Micronutrients|micronutrients|mesh-ancestor
102236543|NCT03123107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236544|NCT03123107|Antioxidants|antioxidants|mesh-ancestor
102236545|NCT03123107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236546|NCT03123107|Protective Agents|protective agents|mesh-ancestor
102236547|NCT04516655|Rituximab|rituximab|mesh-list
102236548|NCT04516655|Methotrexate|methotrexate|mesh-list
102236549|NCT04516655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102236550|NCT04516655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102236551|NCT04516655|Immunologic Factors|immunologic factors|mesh-ancestor
102236552|NCT04516655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236553|NCT04516655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102236554|NCT04516655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102236555|NCT04516655|Abortifacient Agents|abortifacient agents|mesh-ancestor
102236556|NCT04516655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102236557|NCT04516655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102236558|NCT04516655|Antimetabolites|antimetabolites|mesh-ancestor
102236559|NCT04516655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236560|NCT04516655|Dermatologic Agents|dermatologic agents|mesh-ancestor
102236561|NCT04516655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102236562|NCT04516655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102236563|NCT04516655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102236564|NCT04516655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102236565|NCT02458183|Vaccines|vaccines|mesh-list
102236566|NCT02458183|Immunologic Factors|immunologic factors|mesh-ancestor
102236567|NCT02458183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236568|NCT04444193|Durvalumab|durvalumab|mesh-list
102236569|NCT04444193|Lenvatinib|lenvatinib|mesh-list
102236570|NCT04444193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101945390|NCT01255215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102236571|NCT04444193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102236572|NCT04444193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102236573|NCT04444193|Immunologic Factors|immunologic factors|mesh-ancestor
102236574|NCT04444193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236575|NCT04444193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102236576|NCT04444193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102236577|NCT04444193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236579|NCT03984955|Hyaluronic Acid|hyaluronic acid|mesh-list
102236580|NCT03984955|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102236581|NCT03984955|Diuretics|diuretics|mesh-ancestor
102236582|NCT03984955|Natriuretic Agents|natriuretic agents|mesh-ancestor
102236583|NCT03984955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236584|NCT03984955|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102236585|NCT03984955|Immunologic Factors|immunologic factors|mesh-ancestor
102236586|NCT03984955|Viscosupplements|viscosupplements|mesh-ancestor
102236587|NCT03984955|Protective Agents|protective agents|mesh-ancestor
102236588|NCT03946969|Paclitaxel|paclitaxel|mesh-list
102236589|NCT03946969|Cisplatin|cisplatin|mesh-list
102612829|NCT00002285|Antimetabolites|antimetabolites|mesh-ancestor
102612830|NCT00002285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236590|NCT03946969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102236591|NCT03946969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102236592|NCT03946969|Tubulin Modulators|tubulin modulators|mesh-ancestor
102612831|NCT00002285|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102236593|NCT03946969|Antimitotic Agents|antimitotic agents|mesh-ancestor
102236594|NCT03946969|Mitosis Modulators|mitosis modulators|mesh-ancestor
102236595|NCT03946969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236596|NCT03277573|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
102236597|NCT03277573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102236598|NCT03277573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102236599|NCT03277573|Analgesics|analgesics|mesh-ancestor
102236600|NCT03277573|Sensory System Agents|sensory system agents|mesh-ancestor
102236601|NCT03277573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102236602|NCT03277573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236603|NCT03277573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102236604|NCT03277573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102236605|NCT03353909|Hyaluronic Acid|hyaluronic acid|mesh-list
102236606|NCT03353909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102236607|NCT03353909|Immunologic Factors|immunologic factors|mesh-ancestor
102236608|NCT03353909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638683|NCT05074810|Sotorasib|sotorasib|mesh-list
102236609|NCT03353909|Viscosupplements|viscosupplements|mesh-ancestor
102236610|NCT03353909|Protective Agents|protective agents|mesh-ancestor
102236611|NCT02459353|Dapagliflozin|dapagliflozin|mesh-list
102236612|NCT02459353|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102236613|NCT02459353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236614|NCT02459353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102236615|NCT02459353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236616|NCT04508231|Hormones|hormones|mesh-list
102236617|NCT04508231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102236618|NCT04508231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236619|NCT03263065|Psyllium|psyllium|mesh-list
102236620|NCT03263065|Cathartics|cathartics|mesh-ancestor
102236621|NCT03263065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102236622|NCT02518373|Omeprazole|omeprazole|mesh-list
102236623|NCT02518373|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102236624|NCT02518373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102236625|NCT02518373|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102236626|NCT02518373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102236627|NCT02518373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236628|NCT03266965|Carbidopa|carbidopa|mesh-list
102236629|NCT03266965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102236630|NCT03266965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102236631|NCT03266965|Dopamine Agents|dopamine agents|mesh-ancestor
102236632|NCT03266965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102236633|NCT03266965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236634|NCT03266965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236635|NCT03266965|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102236636|NCT03266965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101638697|NCT05050162|Cisplatin|cisplatin|mesh-list
101638698|NCT05050162|1,2-diaminocyclohexaneplatinum II citrate|1,2-diaminocyclohexaneplatinum ii citrate|mesh-list
101638699|NCT05050162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101638700|NCT05050136|Volixibat|volixibat|mesh-list
101638701|NCT05050136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101638702|NCT05050084|Leuprolide|leuprolide|mesh-list
101638703|NCT05050084|Goserelin|goserelin|mesh-list
101638704|NCT05050084|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101638705|NCT05050084|Flutamide|flutamide|mesh-list
101638706|NCT05050084|Bicalutamide|bicalutamide|mesh-list
101638707|NCT05050084|Tryptophan|tryptophan|mesh-list
101638708|NCT05050084|Buserelin|buserelin|mesh-list
101638709|NCT05050084|Hormones|hormones|mesh-list
101638710|NCT05050084|Relugolix|relugolix|mesh-list
102236637|NCT03266731|Aspirin|aspirin|mesh-list
102236638|NCT03266731|Clopidogrel|clopidogrel|mesh-list
102236639|NCT03266731|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102236640|NCT03266731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102236641|NCT03266731|Analgesics|analgesics|mesh-ancestor
102236642|NCT03266731|Sensory System Agents|sensory system agents|mesh-ancestor
102236643|NCT03266731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102236644|NCT03266731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236645|NCT03266731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101945469|NCT01149993|Thymoglobulin|thymoglobulin|mesh-list
102236646|NCT03266731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102236647|NCT03266731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102236648|NCT03266731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102236649|NCT03266731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236650|NCT03266731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102236651|NCT03266731|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102236652|NCT03266731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102236654|NCT03266731|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102236655|NCT03266731|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102236656|NCT03266731|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102236657|NCT03266731|Purinergic Agents|purinergic agents|mesh-ancestor
102236658|NCT03266731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102236659|NCT02458963|Menotropins|menotropins|mesh-list
102236660|NCT02458963|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102236661|NCT02458963|Fertility Agents|fertility agents|mesh-ancestor
102236662|NCT02458963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102236663|NCT02458963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102612832|NCT00002285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102236664|NCT04507607|Tenofovir|tenofovir|mesh-list
102236665|NCT04507607|Antiviral Agents|antiviral agents|mesh-ancestor
102612833|NCT00002285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101638755|NCT05013502|Empagliflozin|empagliflozin|mesh-list
101638756|NCT05013502|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101638757|NCT05013502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638758|NCT05013502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101638759|NCT05013502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638763|NCT05007392|Febuxostat|febuxostat|mesh-list
101638764|NCT05007392|Dotinurad|dotinurad|mesh-list
101638765|NCT05007392|Gout Suppressants|gout suppressants|mesh-ancestor
101638766|NCT05007392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101638767|NCT05007392|Uricosuric Agents|uricosuric agents|mesh-ancestor
101638778|NCT04948333|Niacinamide|niacinamide|mesh-list
101638779|NCT04948333|Vitamin B Complex|vitamin b complex|mesh-ancestor
101638780|NCT04948333|Vitamins|vitamins|mesh-ancestor
101638781|NCT04948333|Micronutrients|micronutrients|mesh-ancestor
101638782|NCT04948333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638783|NCT04947501|Cyclophosphamide|cyclophosphamide|mesh-list
101638784|NCT04947501|Ifosfamide|ifosfamide|mesh-list
101638785|NCT04947501|Carboplatin|carboplatin|mesh-list
101638786|NCT04947501|Doxorubicin|doxorubicin|mesh-list
101638787|NCT04947501|Etoposide|etoposide|mesh-list
101638788|NCT04947501|Vincristine|vincristine|mesh-list
101638789|NCT04947501|Topotecan|topotecan|mesh-list
101638790|NCT04947501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102236666|NCT04507607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102236667|NCT04507607|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102236668|NCT04507607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102236669|NCT04507607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102236670|NCT04507607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236671|NCT04507607|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102236672|NCT04507607|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102236673|NCT03353441|Glycine|glycine|mesh-list
102236674|NCT03353441|Glycine Agents|glycine agents|mesh-ancestor
102236675|NCT03353441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102236676|NCT03353441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236677|NCT03353441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236678|NCT03353363|Bupivacaine|bupivacaine|mesh-list
102236679|NCT03353363|Anesthetics, Local|anesthetics, local|mesh-ancestor
102236680|NCT03353363|Anesthetics|anesthetics|mesh-ancestor
102236681|NCT03353363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102236682|NCT03353363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236683|NCT03353363|Sensory System Agents|sensory system agents|mesh-ancestor
102236684|NCT03353363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102236685|NCT04511195|Diclofenac|diclofenac|mesh-list
102236686|NCT04511195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102236687|NCT04511195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102236688|NCT04511195|Analgesics|analgesics|mesh-ancestor
102236689|NCT04511195|Sensory System Agents|sensory system agents|mesh-ancestor
102236690|NCT04511195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102236691|NCT04511195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236692|NCT04511195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102236693|NCT04511195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102236694|NCT04511195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102236695|NCT04511195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102236696|NCT04511195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236697|NCT04443725|Hydroxychloroquine|hydroxychloroquine|mesh-list
102236698|NCT04443725|Sofosbuvir|sofosbuvir|mesh-list
102236699|NCT04443725|Antimalarials|antimalarials|mesh-ancestor
102236700|NCT04443725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102236701|NCT04443725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102236702|NCT04443725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102236703|NCT04443725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102236704|NCT04443725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236705|NCT04443725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102236706|NCT04443725|Antiviral Agents|antiviral agents|mesh-ancestor
102236707|NCT03262363|Curcumin|curcumin|mesh-list
102236708|NCT03262363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102236709|NCT03262363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102236710|NCT03262363|Analgesics|analgesics|mesh-ancestor
102236711|NCT03262363|Sensory System Agents|sensory system agents|mesh-ancestor
102236712|NCT03262363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101638793|NCT04947501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102236713|NCT03262363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236714|NCT03262363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102236715|NCT03262363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102236716|NCT03262363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102236717|NCT03262363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102236718|NCT03262363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236719|NCT04506827|Hyaluronic Acid|hyaluronic acid|mesh-list
102236720|NCT04506827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102236721|NCT04506827|Immunologic Factors|immunologic factors|mesh-ancestor
102236722|NCT04506827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236724|NCT04506827|Protective Agents|protective agents|mesh-ancestor
102236725|NCT03352895|Grape Seed Extract|grape seed extract|mesh-list
102236726|NCT03352895|Resveratrol|resveratrol|mesh-list
102236727|NCT03352895|Antioxidants|antioxidants|mesh-ancestor
102236728|NCT03352895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236729|NCT03352895|Protective Agents|protective agents|mesh-ancestor
102236730|NCT03352895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236731|NCT03352895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102236732|NCT03352895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102236733|NCT03352895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102236734|NCT03352895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102236735|NCT05074147|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102236736|NCT05074147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102236737|NCT03350633|Azathioprine|azathioprine|mesh-list
102236738|NCT03350633|Antimetabolites|antimetabolites|mesh-ancestor
102612834|NCT00002285|Antiviral Agents|antiviral agents|mesh-ancestor
102236739|NCT03350633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236740|NCT03350633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102236742|NCT03350633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102236743|NCT03350633|Immunologic Factors|immunologic factors|mesh-ancestor
102236744|NCT03350633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236745|NCT03350633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102236746|NCT03265795|Ether|ether|mesh-list
102236747|NCT03265795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102236748|NCT03265795|Anesthetics, General|anesthetics, general|mesh-ancestor
102236749|NCT03265795|Anesthetics|anesthetics|mesh-ancestor
102236750|NCT03265795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101638819|NCT04909853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101535396|NCT00586911|Betaine|betaine|mesh-list
101638820|NCT04909853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101638829|NCT04852887|Tamoxifen|tamoxifen|mesh-list
101638830|NCT04852887|Letrozole|letrozole|mesh-list
101638831|NCT04852887|Exemestane|exemestane|mesh-list
101638832|NCT04852887|Anastrozole|anastrozole|mesh-list
101295922|NCT01987310|Atorvastatin|atorvastatin|mesh-list
101638833|NCT04852887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101638834|NCT04852887|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101638835|NCT04852887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101638836|NCT04852887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101638837|NCT04852887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638838|NCT04852887|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101638851|NCT04804644|Memantine|memantine|mesh-list
102236751|NCT03265795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236752|NCT03350399|Mitogens|mitogens|mesh-list
102236753|NCT03350399|Mitosis Modulators|mitosis modulators|mesh-ancestor
102236754|NCT03350399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236755|NCT03350321|Darbepoetin alfa|darbepoetin alfa|mesh-list
102236756|NCT03350321|Hematinics|hematinics|mesh-ancestor
102236757|NCT03352349|Terlipressin|terlipressin|mesh-list
102236758|NCT03352349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102236759|NCT03352349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102236760|NCT03265171|Plasminogen|plasminogen|mesh-list
102236761|NCT03265171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102236762|NCT03265171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102236763|NCT03265171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236764|NCT04933669|Imatinib Mesylate|imatinib mesylate|mesh-list
102236765|NCT04933669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102236766|NCT04933669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102236767|NCT04933669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102236768|NCT04933669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236769|NCT04669561|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102236770|NCT04669561|Lifitegrast|lifitegrast|mesh-list
102236771|NCT04669561|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102236772|NCT02729909|Lubiprostone|lubiprostone|mesh-list
102236773|NCT02729909|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102236774|NCT02729909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102236775|NCT02729909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236776|NCT03352115|Prednisolone|prednisolone|mesh-list
102236777|NCT03352115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102236778|NCT03352115|Glucocorticoids|glucocorticoids|mesh-ancestor
102236779|NCT03352115|Hormones|hormones|mesh-ancestor
102236780|NCT03352115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102236781|NCT03352115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236782|NCT03352115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102236783|NCT03352115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102236784|NCT03252457|Dexamethasone|dexamethasone|mesh-list
102236785|NCT03252457|Hydrocortisone|hydrocortisone|mesh-list
102236786|NCT03252457|Decitabine|decitabine|mesh-list
102236787|NCT03252457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102236788|NCT03252457|Antiemetics|antiemetics|mesh-ancestor
102236789|NCT03252457|Autonomic Agents|autonomic agents|mesh-ancestor
102236790|NCT03252457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102236791|NCT03252457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236792|NCT03252457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102236793|NCT03252457|Glucocorticoids|glucocorticoids|mesh-ancestor
102236794|NCT03252457|Hormones|hormones|mesh-ancestor
101945613|NCT03893097|Mefloquine|mefloquine|mesh-list
102236795|NCT03252457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102236796|NCT03252457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102236797|NCT03252457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102236798|NCT03252457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102236799|NCT03252457|Antimetabolites|antimetabolites|mesh-ancestor
102236800|NCT03252457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236801|NCT03252457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102236802|NCT03258931|Cytarabine|cytarabine|mesh-list
102236803|NCT03258931|Midostaurin|midostaurin|mesh-list
102236804|NCT03258931|Crenolanib|crenolanib|mesh-list
102236805|NCT03258931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102236806|NCT03258931|Antimetabolites|antimetabolites|mesh-ancestor
102236807|NCT03258931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236808|NCT03258931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102236809|NCT03258931|Antiviral Agents|antiviral agents|mesh-ancestor
102236810|NCT03258931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102236811|NCT03258931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102236812|NCT03258931|Immunologic Factors|immunologic factors|mesh-ancestor
102236813|NCT03258931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236814|NCT03258931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102236815|NCT03258931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102236816|NCT03261349|Sofosbuvir|sofosbuvir|mesh-list
102236817|NCT03261349|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102236818|NCT03261349|Ledipasvir|ledipasvir|mesh-list
102236819|NCT03261349|Antiviral Agents|antiviral agents|mesh-ancestor
102236820|NCT03261349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102236821|NCT02455609|Dexmedetomidine|dexmedetomidine|mesh-list
102236822|NCT02455609|Ketamine|ketamine|mesh-list
102236823|NCT02455609|Bupivacaine|bupivacaine|mesh-list
102236824|NCT02455609|Anesthetics, Local|anesthetics, local|mesh-ancestor
102236825|NCT02455609|Anesthetics|anesthetics|mesh-ancestor
102236826|NCT02455609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102236827|NCT02455609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236828|NCT02455609|Sensory System Agents|sensory system agents|mesh-ancestor
102236829|NCT02455609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102236830|NCT02455609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102236831|NCT02455609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102236832|NCT02455609|Analgesics|analgesics|mesh-ancestor
102236833|NCT02455609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102236834|NCT02455609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102236835|NCT02455609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102236836|NCT02455609|Adrenergic Agents|adrenergic agents|mesh-ancestor
102236837|NCT02455609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102236838|NCT02455609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236839|NCT02455609|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102236840|NCT02455609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102236841|NCT02455609|Anesthetics, General|anesthetics, general|mesh-ancestor
102236842|NCT02455609|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102236843|NCT02455609|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102236844|NCT05723627|Propofol|propofol|mesh-list
102236845|NCT05723627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102236846|NCT05723627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102236847|NCT05723627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236848|NCT05723627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102236849|NCT05723627|Anesthetics, General|anesthetics, general|mesh-ancestor
102236850|NCT05723627|Anesthetics|anesthetics|mesh-ancestor
102236851|NCT03349619|Resveratrol|resveratrol|mesh-list
102236852|NCT03349619|Antioxidants|antioxidants|mesh-ancestor
102236853|NCT03349619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236854|NCT03349619|Protective Agents|protective agents|mesh-ancestor
102236855|NCT03349619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236856|NCT03349619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102236857|NCT03349619|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102236858|NCT04505657|Celecoxib|celecoxib|mesh-list
102236859|NCT04505657|Lidocaine|lidocaine|mesh-list
102236860|NCT04505657|Anesthetics, Local|anesthetics, local|mesh-ancestor
102236861|NCT04505657|Anesthetics|anesthetics|mesh-ancestor
102236862|NCT04505657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102236863|NCT04505657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236864|NCT04505657|Sensory System Agents|sensory system agents|mesh-ancestor
102236865|NCT04505657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102236866|NCT04505657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102236867|NCT04505657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102236868|NCT04505657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101945700|NCT01258569|Alvimopan|alvimopan|mesh-list
102236869|NCT04505657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102236870|NCT04505657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236871|NCT04505657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102236872|NCT04505657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102236874|NCT04505657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102236875|NCT04505657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102236876|NCT04505657|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102236877|NCT04505657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102236878|NCT04505657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102236879|NCT03259243|Bupivacaine|bupivacaine|mesh-list
102236880|NCT03259243|Anesthetics, Local|anesthetics, local|mesh-ancestor
102236881|NCT03259243|Anesthetics|anesthetics|mesh-ancestor
102236882|NCT03259243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102236883|NCT03259243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236884|NCT03259243|Sensory System Agents|sensory system agents|mesh-ancestor
101295999|NCT01988506|Analgesics|analgesics|mesh-ancestor
102236885|NCT03259243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102236886|NCT03258697|Levobupivacaine|levobupivacaine|mesh-list
102236887|NCT03258697|Anesthetics, Local|anesthetics, local|mesh-ancestor
102612835|NCT00002285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102236888|NCT03258697|Anesthetics|anesthetics|mesh-ancestor
102236889|NCT03258697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102236890|NCT03258697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236891|NCT03258697|Sensory System Agents|sensory system agents|mesh-ancestor
102236892|NCT03258697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102236893|NCT02456701|Vemurafenib|vemurafenib|mesh-list
102236894|NCT02456701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102236895|NCT02456701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102236896|NCT02456701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102236897|NCT02456701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236898|NCT03252067|Azithromycin|azithromycin|mesh-list
102236899|NCT03252067|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102236900|NCT03252067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102236901|NCT03252067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102236902|NCT03252067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102236903|NCT03252223|Hormones|hormones|mesh-list
102236904|NCT03252223|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102236905|NCT03252223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102236906|NCT03252223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236907|NCT05513807|Niacinamide|niacinamide|mesh-list
102236908|NCT05513807|Niacin|niacin|mesh-list
102236909|NCT05513807|Nicotinic Acids|nicotinic acids|mesh-list
102236910|NCT05513807|Vitamin B Complex|vitamin b complex|mesh-ancestor
102236911|NCT05513807|Vitamins|vitamins|mesh-ancestor
102236912|NCT05513807|Micronutrients|micronutrients|mesh-ancestor
102236913|NCT05513807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236914|NCT05513807|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102236915|NCT05513807|Antimetabolites|antimetabolites|mesh-ancestor
102236916|NCT05513807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236917|NCT05513807|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102236918|NCT05513807|Vasodilator Agents|vasodilator agents|mesh-ancestor
102236919|NCT04504877|Cannabidiol|cannabidiol|mesh-list
102236920|NCT04504877|Anticonvulsants|anticonvulsants|mesh-ancestor
102236921|NCT02518295|Sulfalene|sulfalene|mesh-list
102236922|NCT02518295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102236923|NCT02518295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102236924|NCT02518295|Antimalarials|antimalarials|mesh-ancestor
102236925|NCT02518295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102236926|NCT02518295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102236927|NCT03257683|Ranolazine|ranolazine|mesh-list
102236928|NCT03257683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102236929|NCT03257683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102236930|NCT03257683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236931|NCT03251521|Botulinum Toxins|botulinum toxins|mesh-list
102236932|NCT03251521|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102236933|NCT03251521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102236934|NCT03251521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236935|NCT03251521|Cholinergic Agents|cholinergic agents|mesh-ancestor
102236936|NCT03251521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102236937|NCT03251521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236938|NCT03351569|Immunoglobulins|immunoglobulins|mesh-list
102236939|NCT03351569|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102236940|NCT03351569|Antibodies|antibodies|mesh-list
102236941|NCT03351569|gamma-Globulins|gamma-globulins|mesh-list
102236942|NCT03351569|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102236943|NCT03351569|Immunologic Factors|immunologic factors|mesh-ancestor
102236944|NCT03351569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236945|NCT03348917|Chlorhexidine|chlorhexidine|mesh-list
102236946|NCT03348917|Povidone-Iodine|povidone-iodine|mesh-list
102236947|NCT03348917|Povidone|povidone|mesh-list
102236948|NCT03348917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102236949|NCT03348917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102236950|NCT03348917|Disinfectants|disinfectants|mesh-ancestor
102236951|NCT03348917|Plasma Substitutes|plasma substitutes|mesh-ancestor
102236952|NCT03348917|Blood Substitutes|blood substitutes|mesh-ancestor
102236953|NCT03251599|Nitroglycerin|nitroglycerin|mesh-list
102236954|NCT03251599|Vasodilator Agents|vasodilator agents|mesh-ancestor
102236955|NCT03251365|Gemcitabine|gemcitabine|mesh-list
102236956|NCT03251365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102236957|NCT03251365|Antimetabolites|antimetabolites|mesh-ancestor
102236958|NCT03251365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236959|NCT03251365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102236960|NCT03251443|Apatinib|apatinib|mesh-list
102236961|NCT03251443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102236962|NCT03251443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102236963|NCT03251443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102236964|NCT03251443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612836|NCT00002285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102612837|NCT00002285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102612838|NCT00002531|Leucovorin|leucovorin|mesh-list
102612839|NCT00002531|Cytarabine|cytarabine|mesh-list
102612840|NCT00002531|Dexamethasone|dexamethasone|mesh-list
102612841|NCT00002531|Prednisolone|prednisolone|mesh-list
102236965|NCT04502303|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102236966|NCT04502303|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102236967|NCT04502303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236968|NCT05350943|Gemcitabine|gemcitabine|mesh-list
102236969|NCT05350943|Oxaliplatin|oxaliplatin|mesh-list
102236970|NCT05350943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102236971|NCT05350943|Antimetabolites|antimetabolites|mesh-ancestor
102236972|NCT05350943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236973|NCT05350943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102236974|NCT03261427|Pregabalin|pregabalin|mesh-list
102236975|NCT03261427|Analgesics|analgesics|mesh-ancestor
102236976|NCT03261427|Sensory System Agents|sensory system agents|mesh-ancestor
102236977|NCT03261427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102236978|NCT03261427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236979|NCT03261427|Anticonvulsants|anticonvulsants|mesh-ancestor
102236980|NCT03261427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102236981|NCT03261427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102236982|NCT03261427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236983|NCT03261427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102236984|NCT03261427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102236985|NCT03261427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102236986|NCT03261427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102236987|NCT03261427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102236988|NCT03261115|Anesthetics|anesthetics|mesh-list
101639040|NCT04494425|Paclitaxel|paclitaxel|mesh-list
102236989|NCT03261115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102236990|NCT03261115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236991|NCT03348527|Hydroxyflutamide|hydroxyflutamide|mesh-list
102236992|NCT03348527|Androgen Antagonists|androgen antagonists|mesh-ancestor
102236993|NCT03348527|Hormone Antagonists|hormone antagonists|mesh-ancestor
102236994|NCT03348527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102236995|NCT03348527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102236996|NCT05320133|Bismuth|bismuth|mesh-list
102236997|NCT05320133|Antacids|antacids|mesh-ancestor
102236998|NCT05320133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102236999|NCT05320133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102237000|NCT03122561|Acetaminophen|acetaminophen|mesh-list
102237001|NCT03122561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102237002|NCT03122561|Analgesics|analgesics|mesh-ancestor
102237003|NCT03122561|Sensory System Agents|sensory system agents|mesh-ancestor
102237004|NCT03122561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102237005|NCT03122561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237006|NCT03122561|Antipyretics|antipyretics|mesh-ancestor
102237007|NCT04503629|Rabeprazole|rabeprazole|mesh-list
102237008|NCT04503629|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102237009|NCT04503629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102237010|NCT04503629|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102237011|NCT04503629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102237012|NCT04503629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237013|NCT03256981|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102237014|NCT03256981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102237015|NCT03256981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102237016|NCT03256981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237017|NCT03256903|Methoxyflurane|methoxyflurane|mesh-list
101945839|NCT02947022|Anticoagulants|anticoagulants|mesh-ancestor
102237018|NCT03256903|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102237019|NCT03256903|Anesthetics, General|anesthetics, general|mesh-ancestor
102237020|NCT03256903|Anesthetics|anesthetics|mesh-ancestor
102237021|NCT03256903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102237022|NCT03256903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237023|NCT03256825|Anti-Infective Agents|anti-infective agents|mesh-list
102237024|NCT03256825|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102237025|NCT03348371|Ethanol|ethanol|mesh-list
102237026|NCT03348371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102237027|NCT03348371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102612842|NCT00002531|Cyclophosphamide|cyclophosphamide|mesh-list
102237028|NCT03348371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102612843|NCT00002531|Ifosfamide|ifosfamide|mesh-list
102612844|NCT00002531|Doxorubicin|doxorubicin|mesh-list
102612845|NCT00002531|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102237029|NCT03348371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237030|NCT05231603|Ivermectin|ivermectin|mesh-list
102237031|NCT05231603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102237032|NCT05231603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102237033|NCT05196191|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102237034|NCT05196191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102237035|NCT05196191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102237036|NCT05196191|Dermatologic Agents|dermatologic agents|mesh-ancestor
102237037|NCT03467113|Cannabidiol|cannabidiol|mesh-list
102237038|NCT03467113|Anticonvulsants|anticonvulsants|mesh-ancestor
102237039|NCT03434041|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102237040|NCT03434041|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102237041|NCT03434041|Sertraline|sertraline|mesh-list
102237042|NCT03434041|Antidepressive Agents|antidepressive agents|mesh-list
102237043|NCT03434041|Esketamine|esketamine|mesh-list
102237044|NCT03434041|Escitalopram|escitalopram|mesh-list
102237045|NCT03434041|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102237046|NCT03434041|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102237047|NCT03434041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102237048|NCT03434041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237049|NCT03434041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102237050|NCT03434041|Serotonin Agents|serotonin agents|mesh-ancestor
102237051|NCT03434041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237052|NCT03434041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102237053|NCT03434041|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102237054|NCT03434041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102237055|NCT03434041|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102237056|NCT03434041|Analgesics|analgesics|mesh-ancestor
102237057|NCT03434041|Sensory System Agents|sensory system agents|mesh-ancestor
102237058|NCT03434041|Dopamine Agents|dopamine agents|mesh-ancestor
102237059|NCT03250741|Rotigotine|rotigotine|mesh-list
102237060|NCT03250741|Dopamine Agonists|dopamine agonists|mesh-ancestor
102237061|NCT03250741|Dopamine Agents|dopamine agents|mesh-ancestor
102237062|NCT03250741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102237063|NCT03250741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237064|NCT03250741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237065|NCT03255811|Apatinib|apatinib|mesh-list
102237066|NCT03255811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102237067|NCT03255811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102237068|NCT03255811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102237069|NCT03255811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237070|NCT01842035|Regadenoson|regadenoson|mesh-list
102237071|NCT01842035|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
102237072|NCT01842035|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102237073|NCT01842035|Purinergic Agonists|purinergic agonists|mesh-ancestor
102237074|NCT01842035|Purinergic Agents|purinergic agents|mesh-ancestor
102237075|NCT01842035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102237076|NCT01842035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237077|NCT01842035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237078|NCT03348059|Antiviral Agents|antiviral agents|mesh-list
102237079|NCT03348059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102237080|NCT05585177|Hormones|hormones|mesh-list
102237081|NCT05585177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102237082|NCT05585177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237083|NCT03250039|Abrocitinib|abrocitinib|mesh-list
102237084|NCT03250039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102237085|NCT03250039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102237086|NCT03250039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237087|NCT02517827|Paclitaxel|paclitaxel|mesh-list
102237088|NCT02517827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102237089|NCT02517827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102237090|NCT02517827|Tubulin Modulators|tubulin modulators|mesh-ancestor
102237091|NCT02517827|Antimitotic Agents|antimitotic agents|mesh-ancestor
102237092|NCT02517827|Mitosis Modulators|mitosis modulators|mesh-ancestor
102237093|NCT02517827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237094|NCT05045183|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102237095|NCT05045183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
102237096|NCT05045183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102237098|NCT03246451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102237099|NCT03246451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237100|NCT05013437|Acetaminophen|acetaminophen|mesh-list
102237101|NCT05013437|Diphenhydramine|diphenhydramine|mesh-list
102237102|NCT05013437|Promethazine|promethazine|mesh-list
101639243|NCT03880019|Olaparib|olaparib|mesh-list
102612846|NCT00002531|Methotrexate|methotrexate|mesh-list
102612847|NCT00002531|Etoposide|etoposide|mesh-list
102612848|NCT00002531|Vincristine|vincristine|mesh-list
102612849|NCT00002531|Daunorubicin|daunorubicin|mesh-list
102237103|NCT05013437|Melphalan|melphalan|mesh-list
102237104|NCT05013437|Prochlorperazine|prochlorperazine|mesh-list
102237105|NCT05013437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102237106|NCT05013437|Analgesics|analgesics|mesh-ancestor
102237107|NCT05013437|Sensory System Agents|sensory system agents|mesh-ancestor
102237108|NCT05013437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102237109|NCT05013437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237110|NCT05013437|Antipyretics|antipyretics|mesh-ancestor
102237111|NCT05013437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102237112|NCT05013437|Alkylating Agents|alkylating agents|mesh-ancestor
102237113|NCT05013437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237114|NCT05013437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102237115|NCT05013437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102237116|NCT05013437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102237117|NCT05013437|Immunologic Factors|immunologic factors|mesh-ancestor
102237118|NCT05013437|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102237119|NCT05013437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102237120|NCT05013437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102237121|NCT05013437|Anesthetics, Local|anesthetics, local|mesh-ancestor
102237122|NCT05013437|Anesthetics|anesthetics|mesh-ancestor
102237123|NCT05013437|Antiemetics|antiemetics|mesh-ancestor
102237124|NCT05013437|Autonomic Agents|autonomic agents|mesh-ancestor
102237125|NCT05013437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102237126|NCT05013437|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102237127|NCT05013437|Histamine Antagonists|histamine antagonists|mesh-ancestor
102237128|NCT05013437|Histamine Agents|histamine agents|mesh-ancestor
102237129|NCT05013437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102237130|NCT05013437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102237131|NCT05013437|Antipruritics|antipruritics|mesh-ancestor
102237132|NCT05013437|Dermatologic Agents|dermatologic agents|mesh-ancestor
102237133|NCT05013437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102237134|NCT05013437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102237135|NCT05013437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102237136|NCT05013437|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102237137|NCT05013437|Dopamine Agents|dopamine agents|mesh-ancestor
102237138|NCT03246295|Insulin|insulin|mesh-list
102237139|NCT03246295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102237140|NCT03246295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237141|NCT03346733|Psyllium|psyllium|mesh-list
102237142|NCT03346733|Cathartics|cathartics|mesh-ancestor
102237143|NCT03346733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102237144|NCT03249337|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102237145|NCT03249337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102237146|NCT03346187|Atorvastatin|atorvastatin|mesh-list
102237147|NCT03346187|Fenofibrate|fenofibrate|mesh-list
102237148|NCT03346187|Calcium|calcium|mesh-list
102237149|NCT03346187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102237150|NCT03346187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237151|NCT03346187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102237152|NCT03346187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102237153|NCT03346187|Antimetabolites|antimetabolites|mesh-ancestor
102237154|NCT03346187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237155|NCT03346187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102237156|NCT03346187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102237157|NCT03346187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102237158|NCT04487743|Liraglutide|liraglutide|mesh-list
102237159|NCT04487743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102237160|NCT04487743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237161|NCT04487743|Incretins|incretins|mesh-ancestor
102237162|NCT04487743|Hormones|hormones|mesh-ancestor
102237163|NCT04487743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102237164|NCT05010629|Carboplatin|carboplatin|mesh-list
102237165|NCT05010629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102237166|NCT05584631|Immunoglobulins|immunoglobulins|mesh-list
102237167|NCT05584631|Antibodies|antibodies|mesh-list
102237168|NCT05584631|gamma-Globulins|gamma-globulins|mesh-list
102237169|NCT05584631|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102237170|NCT05584631|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102237171|NCT05584631|Immunoglobulin G|immunoglobulin g|mesh-list
102237172|NCT05584631|Immunologic Factors|immunologic factors|mesh-ancestor
102237173|NCT05584631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102612850|NCT00002531|Asparaginase|asparaginase|mesh-list
102612851|NCT00002531|Mitoxantrone|mitoxantrone|mesh-list
102612852|NCT00002531|Mercaptopurine|mercaptopurine|mesh-list
102237175|NCT03249259|Lipotropic Agents|lipotropic agents|mesh-ancestor
102237176|NCT03249259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102237177|NCT03249259|Antimetabolites|antimetabolites|mesh-ancestor
101901321|NCT05200312|Hormones|hormones|mesh-ancestor
102612853|NCT00002531|Thioguanine|thioguanine|mesh-list
102237178|NCT03249259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237179|NCT03249259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102237180|NCT03249259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102237181|NCT03249259|Nootropic Agents|nootropic agents|mesh-ancestor
102237182|NCT04487587|Olaparib|olaparib|mesh-list
102237183|NCT04487587|Cediranib|cediranib|mesh-list
102237184|NCT04487587|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102237185|NCT04487587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102237186|NCT04487587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237187|NCT04487587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102237188|NCT04487587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102237189|NCT04833413|Insulin|insulin|mesh-list
102237190|NCT04833413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101639380|NCT03439046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101639381|NCT03439046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639382|NCT03439046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102237191|NCT04833413|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102237192|NCT04833413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237193|NCT02454751|Fentanyl|fentanyl|mesh-list
102237194|NCT02454751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102237195|NCT02454751|Narcotics|narcotics|mesh-ancestor
102237196|NCT02454751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102237197|NCT02454751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237198|NCT02454751|Analgesics|analgesics|mesh-ancestor
102237199|NCT02454751|Sensory System Agents|sensory system agents|mesh-ancestor
102237200|NCT02454751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102237201|NCT02454751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102237202|NCT02454751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102237203|NCT02454751|Anesthetics, General|anesthetics, general|mesh-ancestor
102237204|NCT02454751|Anesthetics|anesthetics|mesh-ancestor
102237205|NCT02455921|Atropine|atropine|mesh-list
102237206|NCT02455921|Neostigmine|neostigmine|mesh-list
102237207|NCT02455921|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102237208|NCT02455921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102237209|NCT02455921|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102237210|NCT02455921|Autonomic Agents|autonomic agents|mesh-ancestor
102237211|NCT02455921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102237212|NCT02455921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237213|NCT02455921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102237214|NCT02455921|Respiratory System Agents|respiratory system agents|mesh-ancestor
102237215|NCT02455921|Mydriatics|mydriatics|mesh-ancestor
102237216|NCT02455921|Parasympatholytics|parasympatholytics|mesh-ancestor
102237217|NCT02455921|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102237218|NCT02455921|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102237219|NCT02455921|Cholinergic Agents|cholinergic agents|mesh-ancestor
102237220|NCT02455921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102237221|NCT02455921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237222|NCT02455921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102237223|NCT02455921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102237224|NCT02455921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102237225|NCT04786613|Hyaluronic Acid|hyaluronic acid|mesh-list
102237226|NCT04786613|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102237227|NCT04786613|Immunologic Factors|immunologic factors|mesh-ancestor
102237228|NCT04786613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237229|NCT04786613|Viscosupplements|viscosupplements|mesh-ancestor
102237230|NCT04786613|Protective Agents|protective agents|mesh-ancestor
102237231|NCT04767191|Lumefantrine|lumefantrine|mesh-list
102237232|NCT04767191|Artemether|artemether|mesh-list
102237233|NCT04767191|Piperaquine|piperaquine|mesh-list
101639417|NCT03358472|Carboplatin|carboplatin|mesh-list
102237234|NCT04767191|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102237235|NCT04767191|Artenimol|artenimol|mesh-list
102237236|NCT04767191|Antimalarials|antimalarials|mesh-ancestor
102237237|NCT04767191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102237238|NCT04767191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102237239|NCT04767191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102237240|NCT00700999|Paroxetine|paroxetine|mesh-list
102237241|NCT00700999|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102237242|NCT00700999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102237243|NCT00700999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102237244|NCT00700999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237245|NCT00700999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102237246|NCT00700999|Serotonin Agents|serotonin agents|mesh-ancestor
102237247|NCT00700999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237248|NCT00700999|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102237249|NCT00700999|Antidepressive Agents|antidepressive agents|mesh-ancestor
102237250|NCT00700999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102237251|NCT00700999|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102237252|NCT00700999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102237253|NCT00700999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102237254|NCT04502771|Antifungal Agents|antifungal agents|mesh-list
102237255|NCT04502771|Clotrimazole|clotrimazole|mesh-list
102237256|NCT04502771|Miconazole|miconazole|mesh-list
102237257|NCT04502771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102237258|NCT04502771|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102237259|NCT04502771|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102237260|NCT04502771|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102237261|NCT04502771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102237262|NCT04502771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237263|NCT04502771|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102237264|NCT04502771|Hormone Antagonists|hormone antagonists|mesh-ancestor
102237265|NCT04502771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102237266|NCT04502771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237267|NCT04502771|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102237268|NCT04502771|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102237269|NCT04761887|Ropivacaine|ropivacaine|mesh-list
102237270|NCT04761887|Anesthetics, Local|anesthetics, local|mesh-ancestor
102237271|NCT04761887|Anesthetics|anesthetics|mesh-ancestor
101639451|NCT03220022|Cortisone|cortisone|mesh-list
102237272|NCT04761887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102237273|NCT04761887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237274|NCT04761887|Sensory System Agents|sensory system agents|mesh-ancestor
102237275|NCT04761887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102237276|NCT03249025|Lidocaine|lidocaine|mesh-list
102237277|NCT03249025|Ketamine|ketamine|mesh-list
102237278|NCT03249025|Anesthetics, Local|anesthetics, local|mesh-ancestor
102237279|NCT03249025|Anesthetics|anesthetics|mesh-ancestor
102237280|NCT03249025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102237281|NCT03249025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237282|NCT03249025|Sensory System Agents|sensory system agents|mesh-ancestor
102237283|NCT03249025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102237284|NCT03249025|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102237285|NCT03249025|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102237286|NCT03249025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102237287|NCT03249025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102237288|NCT03249025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237289|NCT03249025|Analgesics|analgesics|mesh-ancestor
102237290|NCT03249025|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102237291|NCT03249025|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102237292|NCT03249025|Anesthetics, General|anesthetics, general|mesh-ancestor
102237293|NCT03249025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102237294|NCT03249025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102237295|NCT03249025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102237296|NCT03248713|Mifepristone|mifepristone|mesh-list
102237297|NCT03248713|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102237298|NCT03248713|Abortifacient Agents|abortifacient agents|mesh-ancestor
102237299|NCT03248713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102237300|NCT03248713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237301|NCT03248713|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102237302|NCT03248713|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102237303|NCT03248713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102237304|NCT03248713|Contraceptive Agents|contraceptive agents|mesh-ancestor
102237305|NCT03248713|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102237306|NCT03248713|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102237307|NCT03248713|Hormone Antagonists|hormone antagonists|mesh-ancestor
102237308|NCT03248713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102237309|NCT03248713|Luteolytic Agents|luteolytic agents|mesh-ancestor
102237310|NCT03248713|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102237311|NCT03248713|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102237312|NCT03245671|Dexamethasone|dexamethasone|mesh-list
102237313|NCT03245671|Dexamethasone acetate|dexamethasone acetate|mesh-list
102237314|NCT03245671|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102237315|NCT03245671|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102237316|NCT03245671|BB 1101|bb 1101|mesh-list
102237317|NCT03245671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101946147|NCT01157559|Ziprasidone|ziprasidone|mesh-list
102237318|NCT03245671|Antiemetics|antiemetics|mesh-ancestor
102237319|NCT03245671|Autonomic Agents|autonomic agents|mesh-ancestor
102237320|NCT03245671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102237321|NCT03245671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237322|NCT03245671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102237323|NCT03245671|Glucocorticoids|glucocorticoids|mesh-ancestor
102612854|NCT00002531|Vindesine|vindesine|mesh-list
102612855|NCT00002531|Teniposide|teniposide|mesh-list
102237324|NCT03245671|Hormones|hormones|mesh-ancestor
102237325|NCT03245671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102237326|NCT03245671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102237327|NCT03245671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102237328|NCT03245671|Protease Inhibitors|protease inhibitors|mesh-ancestor
102237329|NCT03245671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102237330|NCT03245671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237331|NCT03245671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102237332|NCT03245671|Immunologic Factors|immunologic factors|mesh-ancestor
102237333|NCT03254641|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102237334|NCT03254641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102237335|NCT03254641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237336|NCT04627571|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102237337|NCT04627571|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102237338|NCT03245515|Branebrutinib|branebrutinib|mesh-list
102237339|NCT03245515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102237340|NCT03245515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102237341|NCT03245515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237342|NCT03363503|Fluticasone|fluticasone|mesh-list
102237343|NCT03363503|Xhance|xhance|mesh-list
102237344|NCT03363503|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102237345|NCT03363503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102237346|NCT03363503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102237347|NCT03363503|Autonomic Agents|autonomic agents|mesh-ancestor
102237348|NCT03363503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102237349|NCT03363503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237350|NCT03363503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102237351|NCT03363503|Respiratory System Agents|respiratory system agents|mesh-ancestor
102237352|NCT03363503|Dermatologic Agents|dermatologic agents|mesh-ancestor
102237353|NCT03363503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102237354|NCT03363503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102237355|NCT03363503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102237356|NCT03363503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101639547|NCT03017820|Iodine|iodine|mesh-list
102237357|NCT03363503|Adrenergic Agents|adrenergic agents|mesh-ancestor
102237358|NCT03363503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102237359|NCT03363503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237360|NCT03248791|Phenylephrine|phenylephrine|mesh-list
102237361|NCT03248791|Oxymetazoline|oxymetazoline|mesh-list
102237362|NCT03248791|Norepinephrine|norepinephrine|mesh-list
102237363|NCT03248791|Bupivacaine|bupivacaine|mesh-list
102237364|NCT03248791|Anesthetics, Local|anesthetics, local|mesh-ancestor
102237365|NCT03248791|Anesthetics|anesthetics|mesh-ancestor
102237366|NCT03248791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102237367|NCT03248791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237368|NCT03248791|Sensory System Agents|sensory system agents|mesh-ancestor
102237369|NCT03248791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102237370|NCT03248791|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102237371|NCT03248791|Mydriatics|mydriatics|mesh-ancestor
102237372|NCT03248791|Autonomic Agents|autonomic agents|mesh-ancestor
102237373|NCT03248791|Sympathomimetics|sympathomimetics|mesh-ancestor
102237374|NCT03248791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102237375|NCT03248791|Nasal Decongestants|nasal decongestants|mesh-ancestor
102237376|NCT03248791|Respiratory System Agents|respiratory system agents|mesh-ancestor
102237377|NCT03248791|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102237378|NCT03248791|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102237379|NCT03248791|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102237380|NCT03248791|Adrenergic Agents|adrenergic agents|mesh-ancestor
102237381|NCT03248791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102237382|NCT03248791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237383|NCT03248791|Protective Agents|protective agents|mesh-ancestor
102237384|NCT03254173|Mirtazapine|mirtazapine|mesh-list
102237385|NCT03254173|Antidepressive Agents|antidepressive agents|mesh-ancestor
102237386|NCT03254173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102237387|NCT03254173|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102237388|NCT03254173|Histamine Antagonists|histamine antagonists|mesh-ancestor
102237389|NCT03254173|Histamine Agents|histamine agents|mesh-ancestor
102237390|NCT03254173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102237391|NCT03254173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237392|NCT03254173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237393|NCT03254173|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102237394|NCT03254173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102237395|NCT03254173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102241630|NCT03070665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237396|NCT03254173|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101901325|NCT05200312|Tubulin Modulators|tubulin modulators|mesh-ancestor
102612856|NCT00002531|Levoleucovorin|levoleucovorin|mesh-list
102237397|NCT03254173|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102237398|NCT03254173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102237399|NCT03254173|Adrenergic Agents|adrenergic agents|mesh-ancestor
102237400|NCT03254173|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102237401|NCT03254173|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102237403|NCT03254173|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102237404|NCT03248401|Aspirin|aspirin|mesh-list
102237405|NCT03248401|Cilostazol|cilostazol|mesh-list
102237406|NCT03248401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102237407|NCT03248401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102237408|NCT03248401|Analgesics|analgesics|mesh-ancestor
102237409|NCT03248401|Sensory System Agents|sensory system agents|mesh-ancestor
102237410|NCT03248401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102237411|NCT03248401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237412|NCT03248401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102237413|NCT03248401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102237414|NCT03248401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102237415|NCT03248401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102237416|NCT03248401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237417|NCT03248401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102237418|NCT03248401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102237419|NCT03248401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102237420|NCT03248401|Antipyretics|antipyretics|mesh-ancestor
102237421|NCT03248401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102237422|NCT03248401|Autonomic Agents|autonomic agents|mesh-ancestor
102237423|NCT03248401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102237424|NCT03248401|Respiratory System Agents|respiratory system agents|mesh-ancestor
102237425|NCT03248401|Vasodilator Agents|vasodilator agents|mesh-ancestor
102237426|NCT03248401|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102237427|NCT03248401|Protective Agents|protective agents|mesh-ancestor
102237428|NCT03248401|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102237429|NCT03248401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102237430|NCT02516423|Zoledronic Acid|zoledronic acid|mesh-list
102237431|NCT02516423|Dexamethasone|dexamethasone|mesh-list
102237432|NCT02516423|Lenalidomide|lenalidomide|mesh-list
102237433|NCT02516423|Ixazomib|ixazomib|mesh-list
101639662|NCT02723955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101296737|NCT01994265|Dabigatran|dabigatran|mesh-list
101639663|NCT02723955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101639664|NCT02632175|Adalimumab|adalimumab|mesh-list
101639665|NCT02632175|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101639666|NCT02632175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101639667|NCT02632175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101639697|NCT02582905|Choline|choline|mesh-list
102237434|NCT02516423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102237435|NCT02516423|Antiemetics|antiemetics|mesh-ancestor
102237436|NCT02516423|Autonomic Agents|autonomic agents|mesh-ancestor
102237437|NCT02516423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102237438|NCT02516423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237439|NCT02516423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102237440|NCT02516423|Glucocorticoids|glucocorticoids|mesh-ancestor
102237441|NCT02516423|Hormones|hormones|mesh-ancestor
102237442|NCT02516423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102237443|NCT02516423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102237444|NCT02516423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102237445|NCT02516423|Immunologic Factors|immunologic factors|mesh-ancestor
102237446|NCT02516423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102237447|NCT02516423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102237448|NCT02516423|Growth Substances|growth substances|mesh-ancestor
102237449|NCT02516423|Growth Inhibitors|growth inhibitors|mesh-ancestor
102237450|NCT02516423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102237451|NCT02516423|Protease Inhibitors|protease inhibitors|mesh-ancestor
102237452|NCT02516423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102237453|NCT02516423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237454|NCT03245281|Diuretics|diuretics|mesh-list
101639698|NCT02582905|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
101639699|NCT02582905|Lipotropic Agents|lipotropic agents|mesh-ancestor
101639700|NCT02582905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101639701|NCT02582905|Antimetabolites|antimetabolites|mesh-ancestor
101639702|NCT02582905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639703|NCT02582905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101639705|NCT02582905|Nootropic Agents|nootropic agents|mesh-ancestor
102237455|NCT03245281|Natriuretic Agents|natriuretic agents|mesh-ancestor
102237456|NCT03245281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237457|NCT02515955|Minocycline|minocycline|mesh-list
102237458|NCT02515955|Amphetamine|amphetamine|mesh-list
102237459|NCT02515955|Dextroamphetamine|dextroamphetamine|mesh-list
102237460|NCT02515955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102237461|NCT02515955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102237462|NCT02515955|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102237463|NCT02515955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237464|NCT02515955|Sympathomimetics|sympathomimetics|mesh-ancestor
102237465|NCT02515955|Autonomic Agents|autonomic agents|mesh-ancestor
102237466|NCT02515955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102237467|NCT02515955|Dopamine Agents|dopamine agents|mesh-ancestor
102237468|NCT02515955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102237469|NCT02515955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237470|NCT02515955|Adrenergic Agents|adrenergic agents|mesh-ancestor
102237471|NCT02515955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102237472|NCT02515955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102237473|NCT02515955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102237474|NCT02515955|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102237475|NCT03345797|Testosterone|testosterone|mesh-list
102237476|NCT03345797|Androgens|androgens|mesh-ancestor
102237477|NCT03345797|Hormones|hormones|mesh-ancestor
102237478|NCT03345797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102237479|NCT03345797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237480|NCT04500743|Leuprolide|leuprolide|mesh-list
102237481|NCT04500743|Dienogest|dienogest|mesh-list
102237482|NCT04500743|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102237483|NCT04500743|Fertility Agents|fertility agents|mesh-ancestor
102237484|NCT04500743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102237485|NCT04500743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237486|NCT04500743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102237487|NCT04500743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102237488|NCT04500743|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102237489|NCT04500743|Contraceptive Agents|contraceptive agents|mesh-ancestor
102237490|NCT04500743|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102237491|NCT04500743|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102237492|NCT04500743|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102237493|NCT04500743|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102237494|NCT04500743|Hormone Antagonists|hormone antagonists|mesh-ancestor
102237495|NCT04500743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102237496|NCT04501991|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102237497|NCT04501991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237498|NCT03239353|Entecavir|entecavir|mesh-list
102237499|NCT03239353|Antiviral Agents|antiviral agents|mesh-ancestor
102237500|NCT03239353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102237501|NCT03347591|polysaccharide-K|polysaccharide-k|mesh-list
102237502|NCT03347591|Hemostatics|hemostatics|mesh-list
102237503|NCT03347591|Coagulants|coagulants|mesh-ancestor
102237504|NCT03347591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102237505|NCT03347591|Immunologic Factors|immunologic factors|mesh-ancestor
102241631|NCT03070665|Sympathomimetics|sympathomimetics|mesh-ancestor
102237506|NCT03347591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237507|NCT03347591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102237508|NCT03347591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102237509|NCT03347591|Antiviral Agents|antiviral agents|mesh-ancestor
102237510|NCT03347591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102237511|NCT03347591|Interferon Inducers|interferon inducers|mesh-ancestor
102237512|NCT03347591|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102237513|NCT03347591|Protective Agents|protective agents|mesh-ancestor
102237514|NCT04486651|Irinotecan|irinotecan|mesh-list
102237515|NCT04486651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102237516|NCT04486651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102237517|NCT04486651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102237518|NCT04486651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237519|NCT04486651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102237520|NCT03347513|Glycine|glycine|mesh-list
102237521|NCT03347513|Glycine Agents|glycine agents|mesh-ancestor
102237522|NCT03347513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102237523|NCT03347513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237524|NCT03347513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237525|NCT04088591|Ascorbic Acid|ascorbic acid|mesh-list
102237526|NCT04088591|Antioxidants|antioxidants|mesh-ancestor
102237527|NCT04088591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237528|NCT04088591|Protective Agents|protective agents|mesh-ancestor
102237529|NCT04088591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237530|NCT04088591|Vitamins|vitamins|mesh-ancestor
102237531|NCT04088591|Micronutrients|micronutrients|mesh-ancestor
102237532|NCT04501289|Magnesium Sulfate|magnesium sulfate|mesh-list
102237533|NCT04501289|Analgesics|analgesics|mesh-ancestor
102237534|NCT04501289|Sensory System Agents|sensory system agents|mesh-ancestor
102237535|NCT04501289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102237536|NCT04501289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237537|NCT04501289|Anesthetics|anesthetics|mesh-ancestor
102237538|NCT04501289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102237539|NCT04501289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102237540|NCT04501289|Anticonvulsants|anticonvulsants|mesh-ancestor
102237541|NCT04501289|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102237542|NCT04501289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102237543|NCT04501289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237544|NCT04501289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102612857|NCT00002531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102237545|NCT04501289|Tocolytic Agents|tocolytic agents|mesh-ancestor
102237546|NCT04501289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102237547|NCT03244423|Tranexamic Acid|tranexamic acid|mesh-list
102237548|NCT03244423|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102237549|NCT03244423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102237550|NCT03244423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237551|NCT03244423|Hemostatics|hemostatics|mesh-ancestor
102237552|NCT03244423|Coagulants|coagulants|mesh-ancestor
102237553|NCT03347357|Tacrolimus|tacrolimus|mesh-list
102237554|NCT03347357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102237555|NCT03347357|Immunologic Factors|immunologic factors|mesh-ancestor
102237556|NCT03347357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237557|NCT03347357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102237558|NCT03347357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102237559|NCT03347357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237560|NCT02325349|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
102237561|NCT02325349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237562|NCT02515877|Carboplatin|carboplatin|mesh-list
102237563|NCT02515877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102237564|NCT03952091|Dexamethasone|dexamethasone|mesh-list
101639818|NCT01386710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101639819|NCT01386710|Growth Substances|growth substances|mesh-ancestor
101639820|NCT01386710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639821|NCT01386710|Growth Inhibitors|growth inhibitors|mesh-ancestor
101639830|NCT00878254|Leucovorin|leucovorin|mesh-list
101639831|NCT00878254|Cytarabine|cytarabine|mesh-list
101639832|NCT00878254|Cyclophosphamide|cyclophosphamide|mesh-list
101639833|NCT00878254|Ifosfamide|ifosfamide|mesh-list
101639834|NCT00878254|Rituximab|rituximab|mesh-list
102237565|NCT03952091|Dexamethasone acetate|dexamethasone acetate|mesh-list
102237566|NCT03952091|Lenalidomide|lenalidomide|mesh-list
102237567|NCT03952091|BB 1101|bb 1101|mesh-list
102237568|NCT03952091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102237569|NCT03952091|Antiemetics|antiemetics|mesh-ancestor
102237570|NCT03952091|Autonomic Agents|autonomic agents|mesh-ancestor
102237571|NCT03952091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102237572|NCT03952091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237573|NCT03952091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102237574|NCT03952091|Glucocorticoids|glucocorticoids|mesh-ancestor
102237575|NCT03952091|Hormones|hormones|mesh-ancestor
102237576|NCT03952091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102237577|NCT03952091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102237578|NCT03952091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102237579|NCT03952091|Protease Inhibitors|protease inhibitors|mesh-ancestor
102237580|NCT03952091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102237581|NCT03952091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237582|NCT03952091|Immunologic Factors|immunologic factors|mesh-ancestor
102237583|NCT03952091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102237584|NCT03952091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102237585|NCT03952091|Growth Substances|growth substances|mesh-ancestor
102237586|NCT03952091|Growth Inhibitors|growth inhibitors|mesh-ancestor
102237587|NCT03246919|Oxytocin|oxytocin|mesh-list
102237588|NCT03246919|Oxytocics|oxytocics|mesh-ancestor
102237589|NCT03246919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102237590|NCT03246919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237591|NCT04502537|Epoetin Alfa|epoetin alfa|mesh-list
102237592|NCT04502537|Hematinics|hematinics|mesh-ancestor
102237593|NCT02453659|Nicotine|nicotine|mesh-list
101639870|NCT00878254|Antimitotic Agents|antimitotic agents|mesh-ancestor
101639871|NCT00878254|Mitosis Modulators|mitosis modulators|mesh-ancestor
101639872|NCT00813423|Hydroxychloroquine|hydroxychloroquine|mesh-list
102237594|NCT02453659|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102237595|NCT02453659|Autonomic Agents|autonomic agents|mesh-ancestor
102237596|NCT02453659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102237597|NCT02453659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237598|NCT02453659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102237599|NCT02453659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102237600|NCT02453659|Cholinergic Agents|cholinergic agents|mesh-ancestor
102237601|NCT02453659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102237602|NCT02453659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237603|NCT02513147|Lopinavir|lopinavir|mesh-list
102237604|NCT02513147|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102237605|NCT02513147|Darunavir|darunavir|mesh-list
102237606|NCT02513147|Fosamprenavir|fosamprenavir|mesh-list
102237607|NCT02513147|Dolutegravir|dolutegravir|mesh-list
102237608|NCT02513147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102237609|NCT02513147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102237610|NCT02513147|Protease Inhibitors|protease inhibitors|mesh-ancestor
102237611|NCT02513147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102237612|NCT02513147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237613|NCT02513147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102237614|NCT02513147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102237615|NCT02513147|Antiviral Agents|antiviral agents|mesh-ancestor
102237616|NCT02513147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102237617|NCT02513147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102237618|NCT02513147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102237619|NCT02513147|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102237620|NCT02513147|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101901328|NCT05200312|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102612858|NCT00002531|Immunologic Factors|immunologic factors|mesh-ancestor
102612859|NCT00002531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102612860|NCT00002531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102612861|NCT00002531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102612862|NCT00002531|Alkylating Agents|alkylating agents|mesh-ancestor
102612863|NCT00002531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612864|NCT00002531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102612865|NCT00002531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102612866|NCT00002531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102237622|NCT03246685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102237623|NCT03246685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102237624|NCT03246685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102237625|NCT03246685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237626|NCT02453893|Risperidone|risperidone|mesh-list
102237627|NCT02453893|Iloperidone|iloperidone|mesh-list
102237628|NCT02453893|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102237629|NCT02453893|Serotonin Agents|serotonin agents|mesh-ancestor
102237630|NCT02453893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102612867|NCT00002531|Antiemetics|antiemetics|mesh-ancestor
102237631|NCT02453893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237632|NCT02453893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237633|NCT02453893|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102237634|NCT02453893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102237635|NCT02453893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102237636|NCT02453893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102237637|NCT02453893|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102237638|NCT02453893|Dopamine Agents|dopamine agents|mesh-ancestor
102237639|NCT03664895|Goserelin|goserelin|mesh-list
102237640|NCT03664895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102237641|NCT03664895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102237642|NCT02513069|Nicotine|nicotine|mesh-list
102237643|NCT02513069|Carbon Monoxide|carbon monoxide|mesh-list
102237644|NCT02513069|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102237645|NCT02513069|Autonomic Agents|autonomic agents|mesh-ancestor
102237646|NCT02513069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102237647|NCT02513069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237648|NCT02513069|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102237649|NCT02513069|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102237650|NCT02513069|Cholinergic Agents|cholinergic agents|mesh-ancestor
102237651|NCT02513069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102237652|NCT02513069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237653|NCT02513069|Antimetabolites|antimetabolites|mesh-ancestor
102237654|NCT02513069|Gasotransmitters|gasotransmitters|mesh-ancestor
102237655|NCT02454205|Moxifloxacin|moxifloxacin|mesh-list
102237656|NCT02454205|Levofloxacin|levofloxacin|mesh-list
102237657|NCT02454205|Isoniazid|isoniazid|mesh-list
102237658|NCT02454205|Linezolid|linezolid|mesh-list
102237659|NCT02454205|Pyrazinamide|pyrazinamide|mesh-list
102237660|NCT02454205|Bedaquiline|bedaquiline|mesh-list
102237661|NCT02454205|Kanamycin|kanamycin|mesh-list
102237662|NCT02454205|Ethionamide|ethionamide|mesh-list
102237663|NCT02454205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102237664|NCT02454205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102237665|NCT02454205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101639954|NCT00744328|Estrogens|estrogens|mesh-ancestor
102237666|NCT02454205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102237667|NCT02454205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102237668|NCT02454205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237669|NCT02454205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102237670|NCT02454205|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102237671|NCT02454205|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102237672|NCT02454205|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102237673|NCT02454205|Antitubercular Agents|antitubercular agents|mesh-ancestor
102237674|NCT02454205|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102237675|NCT02454205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102237676|NCT02454205|Antimetabolites|antimetabolites|mesh-ancestor
102237677|NCT02454205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102237678|NCT02454205|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102237679|NCT03235141|Azithromycin|azithromycin|mesh-list
102237680|NCT03235141|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102237681|NCT03235141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102237682|NCT03235141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102237683|NCT03235141|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102237684|NCT03234751|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
102237685|NCT03234751|Natriuretic Agents|natriuretic agents|mesh-ancestor
102237686|NCT03234751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237687|NCT03107689|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
102612868|NCT00002531|Autonomic Agents|autonomic agents|mesh-ancestor
102612869|NCT00002531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102237688|NCT03107689|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102237689|NCT03107689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102237690|NCT03234673|Calcipotriene|calcipotriene|mesh-list
102237691|NCT03234673|Tacrolimus|tacrolimus|mesh-list
102237692|NCT03234673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102237693|NCT03234673|Immunologic Factors|immunologic factors|mesh-ancestor
102237694|NCT03234673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237695|NCT03234673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102237696|NCT03234673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102237697|NCT03234673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237699|NCT03148613|Carbon Monoxide|carbon monoxide|mesh-list
102237700|NCT03148613|Antimetabolites|antimetabolites|mesh-ancestor
102237701|NCT03148613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237702|NCT03148613|Gasotransmitters|gasotransmitters|mesh-ancestor
102237703|NCT03148613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102237704|NCT03148613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237705|NCT03243643|Apatinib|apatinib|mesh-list
102237706|NCT03243643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102237707|NCT03243643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102237708|NCT03243643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102237709|NCT03243643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237710|NCT03234517|Clindamycin|clindamycin|mesh-list
102237711|NCT03234517|Clindamycin palmitate|clindamycin palmitate|mesh-list
102237712|NCT03234517|Clindamycin phosphate|clindamycin phosphate|mesh-list
102237713|NCT03234517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102237714|NCT03234517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102237715|NCT03234517|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102237716|NCT03234517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102237717|NCT03234517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237718|NCT03238183|Hyaluronic Acid|hyaluronic acid|mesh-list
102237719|NCT03238183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102237720|NCT03238183|Immunologic Factors|immunologic factors|mesh-ancestor
102237721|NCT03238183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237722|NCT03238183|Viscosupplements|viscosupplements|mesh-ancestor
102237723|NCT03238183|Protective Agents|protective agents|mesh-ancestor
102237724|NCT02729051|Albuterol|albuterol|mesh-list
102237725|NCT02729051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102237726|NCT02729051|Autonomic Agents|autonomic agents|mesh-ancestor
102237727|NCT02729051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102237728|NCT02729051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237729|NCT02729051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102237730|NCT02729051|Respiratory System Agents|respiratory system agents|mesh-ancestor
102237731|NCT02729051|Tocolytic Agents|tocolytic agents|mesh-ancestor
102237732|NCT02729051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102237733|NCT02729051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102237734|NCT02729051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102237735|NCT02729051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102237736|NCT02729051|Adrenergic Agents|adrenergic agents|mesh-ancestor
102237737|NCT02729051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102237738|NCT02729051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237739|NCT03237637|Propranolol|propranolol|mesh-list
102237740|NCT03237637|Atenolol|atenolol|mesh-list
102237741|NCT03237637|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102237742|NCT03237637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102237743|NCT03237637|Adrenergic Agents|adrenergic agents|mesh-ancestor
102237744|NCT03237637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102237745|NCT03237637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237746|NCT03237637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237747|NCT03237637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102237748|NCT03237637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102237749|NCT03237637|Vasodilator Agents|vasodilator agents|mesh-ancestor
102237750|NCT03237637|Sympatholytics|sympatholytics|mesh-ancestor
102237751|NCT03237637|Autonomic Agents|autonomic agents|mesh-ancestor
102237752|NCT03237637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102237753|NCT03237637|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102237754|NCT03243331|Gedatolisib|gedatolisib|mesh-list
102237755|NCT03243331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102237756|NCT03243331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102237757|NCT03243331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237758|NCT03237715|Bilirubin|bilirubin|mesh-list
102237759|NCT03237715|Antioxidants|antioxidants|mesh-ancestor
102237760|NCT03237715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612870|NCT00002531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102237761|NCT03237715|Protective Agents|protective agents|mesh-ancestor
102612871|NCT00002531|Glucocorticoids|glucocorticoids|mesh-ancestor
102237762|NCT03237715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237763|NCT02515565|Erythromycin|erythromycin|mesh-list
102237764|NCT02515565|Erythromycin Estolate|erythromycin estolate|mesh-list
102237765|NCT02515565|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
102237766|NCT02515565|Erythromycin stearate|erythromycin stearate|mesh-list
102237767|NCT02515565|Cephalosporins|cephalosporins|mesh-list
102237768|NCT02515565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102237769|NCT02515565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102237770|NCT02515565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102237771|NCT02515565|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102237772|NCT02515565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102237773|NCT02515565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237774|NCT05600075|Insulin|insulin|mesh-list
102237775|NCT05600075|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102237776|NCT05600075|Glycolic acid|glycolic acid|mesh-list
102237777|NCT05600075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102237778|NCT05600075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237779|NCT05600075|Keratolytic Agents|keratolytic agents|mesh-ancestor
102237780|NCT05600075|Dermatologic Agents|dermatologic agents|mesh-ancestor
102237781|NCT02512601|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
102237782|NCT02512601|Anticoagulants|anticoagulants|mesh-ancestor
102237783|NCT02512601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102237784|NCT02512601|Antimetabolites|antimetabolites|mesh-ancestor
102237785|NCT02512601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237786|NCT02512601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102237787|NCT02512601|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102237788|NCT02512601|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102237789|NCT02512601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102237790|NCT02512601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237791|NCT03233815|Propofol|propofol|mesh-list
102237792|NCT03233815|Sevoflurane|sevoflurane|mesh-list
102237793|NCT03233815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102237794|NCT03233815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102237795|NCT03233815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237796|NCT03233815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102237797|NCT03233815|Anesthetics, General|anesthetics, general|mesh-ancestor
102237798|NCT03233815|Anesthetics|anesthetics|mesh-ancestor
102237799|NCT03233815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102237800|NCT03233815|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102237801|NCT02507609|Rocuronium|rocuronium|mesh-list
102237802|NCT02507609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237803|NCT02507609|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102237804|NCT02507609|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102237805|NCT02507609|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102237806|NCT02507609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102237807|NCT02512523|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102237808|NCT02512523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102237809|NCT02512523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237810|NCT02512523|Incretins|incretins|mesh-ancestor
102237811|NCT02512523|Hormones|hormones|mesh-ancestor
102237812|NCT02512523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102237813|NCT02512523|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102237814|NCT02512523|Protease Inhibitors|protease inhibitors|mesh-ancestor
102237815|NCT02512523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102237816|NCT02512523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237817|NCT03233893|Calcium, Dietary|calcium, dietary|mesh-list
102237818|NCT03233893|Calcium|calcium|mesh-list
102237819|NCT03233893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102237820|NCT03233893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237821|NCT03233893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102237822|NCT05597813|Timolol|timolol|mesh-list
102237823|NCT05597813|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102237824|NCT05597813|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102237825|NCT05597813|Adrenergic Agents|adrenergic agents|mesh-ancestor
102237826|NCT05597813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102237827|NCT05597813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237828|NCT05597813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237829|NCT05597813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102612872|NCT00002531|Hormones|hormones|mesh-ancestor
102237830|NCT05597813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102237831|NCT03242707|Hyaluronic Acid|hyaluronic acid|mesh-list
101579482|NCT02688361|Expectorants|expectorants|mesh-ancestor
102612873|NCT00002531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102237832|NCT03242707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102612874|NCT00002531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102612875|NCT00002531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102612876|NCT00002531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102612877|NCT00002531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102612878|NCT00002531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612879|NCT00002531|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102612880|NCT00002531|Abortifacient Agents|abortifacient agents|mesh-ancestor
102612881|NCT00002531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102612882|NCT00002531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102612883|NCT00002531|Antimetabolites|antimetabolites|mesh-ancestor
102612884|NCT00002531|Dermatologic Agents|dermatologic agents|mesh-ancestor
102612885|NCT00002531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102612886|NCT00002531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102612887|NCT00002531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102237833|NCT03242707|Immunologic Factors|immunologic factors|mesh-ancestor
102241632|NCT03070665|Autonomic Agents|autonomic agents|mesh-ancestor
102237834|NCT03242707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237835|NCT03242707|Viscosupplements|viscosupplements|mesh-ancestor
102237836|NCT03242707|Protective Agents|protective agents|mesh-ancestor
102237837|NCT03242629|Chloral Hydrate|chloral hydrate|mesh-list
102237838|NCT03242629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102237839|NCT03242629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102237840|NCT03242629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237841|NCT02512055|Atropine|atropine|mesh-list
102237842|NCT02512055|Ketamine|ketamine|mesh-list
102237843|NCT02512055|Analgesics|analgesics|mesh-ancestor
102237844|NCT02512055|Sensory System Agents|sensory system agents|mesh-ancestor
102237845|NCT02512055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102237846|NCT02512055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237847|NCT02512055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102237848|NCT02512055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102237849|NCT02512055|Anesthetics, General|anesthetics, general|mesh-ancestor
102237850|NCT02512055|Anesthetics|anesthetics|mesh-ancestor
102237851|NCT02512055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102237852|NCT02512055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102237853|NCT02512055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102237854|NCT02512055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102237855|NCT02512055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237856|NCT02512055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102237857|NCT02512055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102237858|NCT02512055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102237859|NCT02512055|Autonomic Agents|autonomic agents|mesh-ancestor
102237860|NCT02512055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102237861|NCT02512055|Respiratory System Agents|respiratory system agents|mesh-ancestor
102237862|NCT02512055|Mydriatics|mydriatics|mesh-ancestor
102237863|NCT02512055|Parasympatholytics|parasympatholytics|mesh-ancestor
102237864|NCT02512055|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102237865|NCT02512055|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102237866|NCT02512055|Cholinergic Agents|cholinergic agents|mesh-ancestor
102237867|NCT02514941|Acetaminophen|acetaminophen|mesh-list
102237868|NCT02514941|Amoxicillin|amoxicillin|mesh-list
102237869|NCT02514941|Talinolol|talinolol|mesh-list
102237870|NCT02514941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102237871|NCT02514941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102237872|NCT02514941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102237873|NCT02514941|Analgesics|analgesics|mesh-ancestor
102237874|NCT02514941|Sensory System Agents|sensory system agents|mesh-ancestor
102237875|NCT02514941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102237876|NCT02514941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237877|NCT02514941|Antipyretics|antipyretics|mesh-ancestor
102237878|NCT02514941|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102237879|NCT02514941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102237880|NCT02514941|Adrenergic Agents|adrenergic agents|mesh-ancestor
102237881|NCT02514941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102237882|NCT02514941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237883|NCT02514941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102237884|NCT02514941|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102237885|NCT02511665|Metformin|metformin|mesh-list
102237886|NCT02511665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102237887|NCT02511665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237888|NCT02514629|Metformin|metformin|mesh-list
102237889|NCT02514629|Methyltestosterone|methyltestosterone|mesh-list
102612888|NCT00002531|Antiviral Agents|antiviral agents|mesh-ancestor
102237890|NCT02514629|Testosterone|testosterone|mesh-list
102237891|NCT02514629|Testosterone undecanoate|testosterone undecanoate|mesh-list
102237892|NCT02514629|Testosterone enanthate|testosterone enanthate|mesh-list
102237893|NCT02514629|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102237894|NCT02514629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102237895|NCT02514629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237896|NCT02514629|Androgens|androgens|mesh-ancestor
102237897|NCT02514629|Hormones|hormones|mesh-ancestor
102237898|NCT02514629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102237899|NCT02514629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102237900|NCT02514629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102237901|NCT02514629|Anabolic Agents|anabolic agents|mesh-ancestor
102237902|NCT02511353|Ivermectin|ivermectin|mesh-list
102237903|NCT02511353|Piperaquine|piperaquine|mesh-list
102237904|NCT02511353|Artenimol|artenimol|mesh-list
102237905|NCT02511353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102612889|NCT00002531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102612890|NCT00002531|Antidotes|antidotes|mesh-ancestor
102612891|NCT00002531|Protective Agents|protective agents|mesh-ancestor
102612892|NCT00002531|Vitamin B Complex|vitamin b complex|mesh-ancestor
102612893|NCT00002531|Vitamins|vitamins|mesh-ancestor
102612894|NCT00002531|Micronutrients|micronutrients|mesh-ancestor
102612895|NCT00002531|Tubulin Modulators|tubulin modulators|mesh-ancestor
102612896|NCT00002531|Antimitotic Agents|antimitotic agents|mesh-ancestor
102612897|NCT00002531|Mitosis Modulators|mitosis modulators|mesh-ancestor
102612898|NCT00002531|Analgesics|analgesics|mesh-ancestor
102237906|NCT02511353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102237907|NCT02511353|Antimalarials|antimalarials|mesh-ancestor
102237908|NCT02511353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102237909|NCT03242317|Mitomycins|mitomycins|mesh-list
102237910|NCT03242317|Mitomycin|mitomycin|mesh-list
102237911|NCT03242317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102237912|NCT03242317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102237913|NCT03242317|Alkylating Agents|alkylating agents|mesh-ancestor
102237914|NCT03242317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237915|NCT03242317|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102237916|NCT03242317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102237917|NCT02453503|Triamcinolone|triamcinolone|mesh-list
102237918|NCT02453503|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102237919|NCT02453503|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102237920|NCT02453503|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102237921|NCT02453503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102237922|NCT02453503|Glucocorticoids|glucocorticoids|mesh-ancestor
102237923|NCT02453503|Hormones|hormones|mesh-ancestor
102237924|NCT02453503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102237925|NCT02453503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237926|NCT02453503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102237927|NCT02453503|Immunologic Factors|immunologic factors|mesh-ancestor
102237928|NCT02453503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102237929|NCT02453503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237930|NCT04499885|Mineral Oil|mineral oil|mesh-list
102237931|NCT04499885|Emollients|emollients|mesh-ancestor
102237932|NCT04499885|Dermatologic Agents|dermatologic agents|mesh-ancestor
102237933|NCT02453425|Norepinephrine|norepinephrine|mesh-list
102237934|NCT02453425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102237935|NCT02453425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102237936|NCT02453425|Adrenergic Agents|adrenergic agents|mesh-ancestor
102237937|NCT02453425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102237938|NCT02453425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237939|NCT02453425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237940|NCT02453425|Sympathomimetics|sympathomimetics|mesh-ancestor
102237941|NCT02453425|Autonomic Agents|autonomic agents|mesh-ancestor
102237942|NCT02453425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102237943|NCT02453425|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102237944|NCT03233035|Ketamine|ketamine|mesh-list
102237945|NCT03233035|Analgesics|analgesics|mesh-ancestor
102237946|NCT03233035|Sensory System Agents|sensory system agents|mesh-ancestor
102237947|NCT03233035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102237948|NCT03233035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237949|NCT03233035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102237950|NCT03233035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102237951|NCT03233035|Anesthetics, General|anesthetics, general|mesh-ancestor
102237952|NCT03233035|Anesthetics|anesthetics|mesh-ancestor
102612899|NCT00002531|Sensory System Agents|sensory system agents|mesh-ancestor
102237953|NCT03233035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102612900|NCT00002537|Topotecan|topotecan|mesh-list
102612901|NCT00002537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102237954|NCT03233035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102237955|NCT03233035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102612902|NCT00002537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102612903|NCT00002537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612904|NCT00002537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237956|NCT03233035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102237957|NCT03233035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237958|NCT03242239|Trastuzumab|trastuzumab|mesh-list
102237959|NCT03242239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102237960|NCT03242239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102237961|NCT03232957|Morphine|morphine|mesh-list
102237962|NCT03232957|Bupivacaine|bupivacaine|mesh-list
102237963|NCT03232957|Anesthetics, Local|anesthetics, local|mesh-ancestor
102237964|NCT03232957|Anesthetics|anesthetics|mesh-ancestor
102237965|NCT03232957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102237966|NCT03232957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237967|NCT03232957|Sensory System Agents|sensory system agents|mesh-ancestor
102237968|NCT03232957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102237969|NCT03232957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102237970|NCT03232957|Narcotics|narcotics|mesh-ancestor
102237971|NCT03232957|Analgesics|analgesics|mesh-ancestor
102237972|NCT02513849|Tamoxifen|tamoxifen|mesh-list
102237973|NCT02513849|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102237974|NCT02513849|Hormone Antagonists|hormone antagonists|mesh-ancestor
102237975|NCT02513849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102237976|NCT02513849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237977|NCT02513849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102237978|NCT02513849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102237979|NCT02513849|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102237980|NCT02513849|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102237981|NCT02513849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102237982|NCT02513927|Metoprolol|metoprolol|mesh-list
102237983|NCT02513927|Nifedipine|nifedipine|mesh-list
102237984|NCT02513927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102237985|NCT02513927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102237986|NCT02513927|Sympatholytics|sympatholytics|mesh-ancestor
102237987|NCT02513927|Autonomic Agents|autonomic agents|mesh-ancestor
102237988|NCT02513927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102237989|NCT02513927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102237990|NCT02513927|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102237991|NCT02513927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102237992|NCT02513927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102237993|NCT02513927|Adrenergic Agents|adrenergic agents|mesh-ancestor
102237994|NCT02513927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102237995|NCT02513927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102237996|NCT02513927|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102237997|NCT02513927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102237998|NCT02513927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102237999|NCT02513927|Vasodilator Agents|vasodilator agents|mesh-ancestor
102238000|NCT02513927|Tocolytic Agents|tocolytic agents|mesh-ancestor
102238001|NCT02513927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102238002|NCT03236623|Menthol|menthol|mesh-list
102238003|NCT03236623|Antipruritics|antipruritics|mesh-ancestor
102238004|NCT03236623|Dermatologic Agents|dermatologic agents|mesh-ancestor
102238005|NCT03121313|Tegafur|tegafur|mesh-list
102238006|NCT03121313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102238007|NCT03121313|Antimetabolites|antimetabolites|mesh-ancestor
102238008|NCT03121313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238009|NCT03121313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102238010|NCT03236233|PC-786|pc-786|mesh-list
102238011|NCT03236233|Antiviral Agents|antiviral agents|mesh-ancestor
102238012|NCT03236233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102238013|NCT03236233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102238014|NCT03236233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238015|NCT02513693|Rocuronium|rocuronium|mesh-list
102238016|NCT02513693|Neostigmine|neostigmine|mesh-list
102238017|NCT02513693|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102238018|NCT02513693|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102238019|NCT02513693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102238020|NCT02513693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102238021|NCT02513693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238022|NCT02513693|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102238023|NCT02513693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102238024|NCT02513693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238025|NCT02513693|Cholinergic Agents|cholinergic agents|mesh-ancestor
102238026|NCT02513693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102612905|NCT00002537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102612906|NCT00002543|Gallium nitrate|gallium nitrate|mesh-list
102612907|NCT00002543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102612908|NCT00002543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102612909|NCT00002543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102612910|NCT00002291|Pentamidine|pentamidine|mesh-list
102238027|NCT02513693|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102238028|NCT02513693|Autonomic Agents|autonomic agents|mesh-ancestor
102238029|NCT03121547|Tramadol|tramadol|mesh-list
102238030|NCT03121547|Tapentadol|tapentadol|mesh-list
102238031|NCT03121547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238032|NCT03121547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102238033|NCT03121547|Narcotics|narcotics|mesh-ancestor
102238034|NCT03121547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102238035|NCT03121547|Analgesics|analgesics|mesh-ancestor
102238036|NCT03121547|Sensory System Agents|sensory system agents|mesh-ancestor
102238037|NCT03121547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102238038|NCT03121547|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102238039|NCT03121547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102238040|NCT03121547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102238041|NCT03121547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238042|NCT03121547|Adrenergic Agents|adrenergic agents|mesh-ancestor
102238043|NCT03121547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102238044|NCT03241381|Vitamin D|vitamin d|mesh-list
102238045|NCT03241381|Vitamins|vitamins|mesh-ancestor
102238046|NCT03241381|Micronutrients|micronutrients|mesh-ancestor
102238047|NCT03241381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238048|NCT03241381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102238049|NCT03241303|Acarbose|acarbose|mesh-list
102238050|NCT03241303|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102238051|NCT03241303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102238052|NCT03241303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238053|NCT03241303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102238054|NCT03241303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238055|NCT02510963|Tenofovir|tenofovir|mesh-list
102238056|NCT02510963|Antiviral Agents|antiviral agents|mesh-ancestor
102238057|NCT02510963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102238058|NCT02510963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102238059|NCT02510963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102238060|NCT02510963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102238061|NCT02510963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238062|NCT02510963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102238063|NCT02510963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102238064|NCT02513381|Vitamin D|vitamin d|mesh-list
102238065|NCT02513381|Cholecalciferol|cholecalciferol|mesh-list
102238066|NCT02513381|Vitamins|vitamins|mesh-ancestor
101946896|NCT01156857|Hormones|hormones|mesh-ancestor
102238067|NCT02513381|Micronutrients|micronutrients|mesh-ancestor
102238068|NCT02513381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238069|NCT02513381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102238070|NCT02513381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102238071|NCT03235921|Nitroglycerin|nitroglycerin|mesh-list
102238072|NCT03235921|Vasodilator Agents|vasodilator agents|mesh-ancestor
102238073|NCT03232021|Pregabalin|pregabalin|mesh-list
102238074|NCT03232021|Analgesics|analgesics|mesh-ancestor
102238075|NCT03232021|Sensory System Agents|sensory system agents|mesh-ancestor
102238076|NCT03232021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102238077|NCT03232021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238078|NCT03232021|Anticonvulsants|anticonvulsants|mesh-ancestor
102238079|NCT03232021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102238080|NCT03232021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102238081|NCT03232021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238082|NCT03232021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102238083|NCT03232021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102238084|NCT03232021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102238085|NCT03232021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102238086|NCT03232021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102612911|NCT00002291|Antifungal Agents|antifungal agents|mesh-ancestor
102612912|NCT00002291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102612913|NCT00002291|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102612914|NCT00002291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102612915|NCT00002291|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102612916|NCT00002549|Cytarabine|cytarabine|mesh-list
102612917|NCT00002549|Cyclophosphamide|cyclophosphamide|mesh-list
102612918|NCT00002549|Busulfan|busulfan|mesh-list
102612919|NCT00002549|Etoposide|etoposide|mesh-list
102612920|NCT00002549|Daunorubicin|daunorubicin|mesh-list
102238087|NCT03235609|Fentanyl|fentanyl|mesh-list
102238088|NCT03235609|Ketamine|ketamine|mesh-list
102612921|NCT00002549|Mitoxantrone|mitoxantrone|mesh-list
102612922|NCT00002549|Idarubicin|idarubicin|mesh-list
102238090|NCT03235609|Sensory System Agents|sensory system agents|mesh-ancestor
102612923|NCT00002549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102238091|NCT03235609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102238092|NCT03235609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238093|NCT03235609|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102238094|NCT03235609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102238095|NCT03235609|Anesthetics, General|anesthetics, general|mesh-ancestor
102238096|NCT03235609|Anesthetics|anesthetics|mesh-ancestor
102238097|NCT03235609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102238098|NCT03235609|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102238099|NCT03235609|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102238100|NCT03235609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102238101|NCT03235609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238102|NCT03235609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102238103|NCT03235609|Narcotics|narcotics|mesh-ancestor
102238104|NCT03235609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102238105|NCT02509949|Dexmedetomidine|dexmedetomidine|mesh-list
102238106|NCT02509949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102238107|NCT02509949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102238108|NCT02509949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238109|NCT02509949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102238110|NCT02509949|Analgesics|analgesics|mesh-ancestor
102238111|NCT02509949|Sensory System Agents|sensory system agents|mesh-ancestor
102238112|NCT02509949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102238113|NCT02509949|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102238114|NCT02509949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102238115|NCT02509949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102238116|NCT02509949|Adrenergic Agents|adrenergic agents|mesh-ancestor
102238117|NCT02509949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102238118|NCT02509949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238119|NCT03344705|Cyclophosphamide|cyclophosphamide|mesh-list
102238120|NCT03344705|Fludarabine|fludarabine|mesh-list
102238121|NCT03344705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102238122|NCT03344705|Immunologic Factors|immunologic factors|mesh-ancestor
102238123|NCT03344705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238124|NCT03344705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102238125|NCT03344705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102238126|NCT03344705|Alkylating Agents|alkylating agents|mesh-ancestor
102238127|NCT03344705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238128|NCT03344705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102238129|NCT03344705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102238130|NCT02501603|Paclitaxel|paclitaxel|mesh-list
102238131|NCT02501603|Afatinib|afatinib|mesh-list
102238132|NCT02501603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102238133|NCT02501603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102238134|NCT02501603|Tubulin Modulators|tubulin modulators|mesh-ancestor
102238135|NCT02501603|Antimitotic Agents|antimitotic agents|mesh-ancestor
102238136|NCT02501603|Mitosis Modulators|mitosis modulators|mesh-ancestor
102238137|NCT02501603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238138|NCT02501603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102238139|NCT02501603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102238140|NCT03344627|Meropenem|meropenem|mesh-list
102238141|NCT03344627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102238142|NCT03344627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102238143|NCT02501213|Furosemide|furosemide|mesh-list
102238144|NCT02501213|Spironolactone|spironolactone|mesh-list
102238145|NCT02501213|Diuretics|diuretics|mesh-ancestor
102238146|NCT02501213|Natriuretic Agents|natriuretic agents|mesh-ancestor
102238147|NCT02501213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238148|NCT02501213|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102238149|NCT02501213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102238150|NCT02501213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238151|NCT02501213|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102238152|NCT02501213|Hormone Antagonists|hormone antagonists|mesh-ancestor
102238153|NCT02501213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102238154|NCT02501213|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102238155|NCT02501291|Thalidomide|thalidomide|mesh-list
102238156|NCT02501291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102238157|NCT02501291|Immunologic Factors|immunologic factors|mesh-ancestor
102238158|NCT02501291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102612924|NCT00002549|Immunologic Factors|immunologic factors|mesh-ancestor
102612925|NCT00002549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238159|NCT02501291|Leprostatic Agents|leprostatic agents|mesh-ancestor
102238160|NCT02501291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102238161|NCT02501291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102238162|NCT02501291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102238163|NCT02501291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102238164|NCT02501291|Growth Substances|growth substances|mesh-ancestor
102238165|NCT02501291|Growth Inhibitors|growth inhibitors|mesh-ancestor
102238166|NCT02501291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102238167|NCT02509559|Propranolol|propranolol|mesh-list
102238168|NCT02509559|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102238169|NCT02509559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102238170|NCT02509559|Adrenergic Agents|adrenergic agents|mesh-ancestor
102238171|NCT02509559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102238172|NCT02509559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238173|NCT02509559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238174|NCT02509559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102238175|NCT02509559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102238176|NCT02509559|Vasodilator Agents|vasodilator agents|mesh-ancestor
102238177|NCT00707993|Alogliptin|alogliptin|mesh-list
102238178|NCT00707993|Glipizide|glipizide|mesh-list
102238179|NCT00707993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102238180|NCT00707993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238181|NCT00707993|Incretins|incretins|mesh-ancestor
102238182|NCT00707993|Hormones|hormones|mesh-ancestor
102238183|NCT00707993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102238184|NCT00707993|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102238185|NCT00707993|Protease Inhibitors|protease inhibitors|mesh-ancestor
102238186|NCT00707993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102238187|NCT00707993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238188|NCT02509091|Amikacin|amikacin|mesh-list
102238189|NCT02509091|Dimercaprol|dimercaprol|mesh-list
102238190|NCT02509091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102238191|NCT02509091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102238192|NCT02509091|Chelating Agents|chelating agents|mesh-ancestor
102238193|NCT02509091|Sequestering Agents|sequestering agents|mesh-ancestor
102238194|NCT02509091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238195|NCT02508857|Ketorolac|ketorolac|mesh-list
102238196|NCT02508857|Magnesium Sulfate|magnesium sulfate|mesh-list
102238197|NCT02508857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102238198|NCT02508857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102238199|NCT02508857|Analgesics|analgesics|mesh-ancestor
102238200|NCT02508857|Sensory System Agents|sensory system agents|mesh-ancestor
102238201|NCT02508857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102238202|NCT02508857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238203|NCT02508857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102238204|NCT02508857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102238205|NCT02508857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102238206|NCT02508857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102238207|NCT02508857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238208|NCT02508857|Anesthetics|anesthetics|mesh-ancestor
102238209|NCT02508857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102238210|NCT02508857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102238211|NCT02508857|Anticonvulsants|anticonvulsants|mesh-ancestor
102238212|NCT02508857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102238213|NCT02508857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102238214|NCT02508857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102238215|NCT02508857|Tocolytic Agents|tocolytic agents|mesh-ancestor
102238216|NCT02508857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102238217|NCT02508623|Rifaximin|rifaximin|mesh-list
102238218|NCT02508623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102238219|NCT02508623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102238220|NCT02508623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102238222|NCT02500667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102238223|NCT02500667|Antitubercular Agents|antitubercular agents|mesh-ancestor
102238224|NCT02500667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102238225|NCT02500667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102238226|NCT02500667|Leprostatic Agents|leprostatic agents|mesh-ancestor
102238227|NCT02500667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102238228|NCT02500667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102238229|NCT02500667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238230|NCT02500667|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102238231|NCT02500667|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102238232|NCT02500667|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102612926|NCT00002549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102238233|NCT02500667|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102238234|NCT02500667|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102238235|NCT02500667|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102238236|NCT02500511|Vaccines|vaccines|mesh-list
102238237|NCT02500511|Immunologic Factors|immunologic factors|mesh-ancestor
102238238|NCT02500511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238239|NCT03344393|Ketamine|ketamine|mesh-list
102238240|NCT03344393|Analgesics|analgesics|mesh-ancestor
102238241|NCT03344393|Sensory System Agents|sensory system agents|mesh-ancestor
102238242|NCT03344393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102238243|NCT03344393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238244|NCT03344393|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102238245|NCT03344393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102238246|NCT03344393|Anesthetics, General|anesthetics, general|mesh-ancestor
102238247|NCT03344393|Anesthetics|anesthetics|mesh-ancestor
102238248|NCT03344393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102238249|NCT03344393|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102238250|NCT03344393|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102238251|NCT03344393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101640375|NCT04063189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102238252|NCT03344393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238253|NCT04498793|Paclitaxel|paclitaxel|mesh-list
102238254|NCT04498793|Cyclophosphamide|cyclophosphamide|mesh-list
102238255|NCT04498793|Doxorubicin|doxorubicin|mesh-list
102238256|NCT04498793|Epirubicin|epirubicin|mesh-list
102238257|NCT04498793|Tislelizumab|tislelizumab|mesh-list
102238258|NCT04498793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102238259|NCT04498793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102238260|NCT04498793|Tubulin Modulators|tubulin modulators|mesh-ancestor
102238261|NCT04498793|Antimitotic Agents|antimitotic agents|mesh-ancestor
102238262|NCT04498793|Mitosis Modulators|mitosis modulators|mesh-ancestor
102238263|NCT04498793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238264|NCT04498793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102238265|NCT04498793|Immunologic Factors|immunologic factors|mesh-ancestor
102238266|NCT04498793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238267|NCT04498793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102238268|NCT04498793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102238269|NCT04498793|Alkylating Agents|alkylating agents|mesh-ancestor
102238270|NCT04498793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102238271|NCT04498793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102238272|NCT04498793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102238273|NCT04498793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102238274|NCT04498793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102238275|NCT04498793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102238276|NCT04498325|Antibodies|antibodies|mesh-list
102238277|NCT04498325|Immunologic Factors|immunologic factors|mesh-ancestor
102238278|NCT04498325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238279|NCT02507843|Vitamin D|vitamin d|mesh-list
102238280|NCT02507843|Cholecalciferol|cholecalciferol|mesh-list
102238281|NCT02507843|Vitamins|vitamins|mesh-ancestor
102238282|NCT02507843|Micronutrients|micronutrients|mesh-ancestor
102238283|NCT02507843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238284|NCT02507843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102238285|NCT02507843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102238286|NCT02425891|Paclitaxel|paclitaxel|mesh-list
102238287|NCT02425891|Atezolizumab|atezolizumab|mesh-list
102238288|NCT02425891|Antibodies|antibodies|mesh-list
102238289|NCT02425891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102238290|NCT02425891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102238291|NCT02425891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102238292|NCT02425891|Tubulin Modulators|tubulin modulators|mesh-ancestor
102238293|NCT02425891|Antimitotic Agents|antimitotic agents|mesh-ancestor
101947134|NCT01583283|Hormones|hormones|mesh-ancestor
102238294|NCT02425891|Mitosis Modulators|mitosis modulators|mesh-ancestor
102238295|NCT02425891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238296|NCT02425891|Immunologic Factors|immunologic factors|mesh-ancestor
102238297|NCT02425891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238298|NCT02425891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102238299|NCT02425891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102238300|NCT02499965|Anesthetics|anesthetics|mesh-list
102238301|NCT02499965|Ethyl Chloride|ethyl chloride|mesh-list
102238302|NCT02499965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102238303|NCT02499965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238304|NCT02499965|Anesthetics, Local|anesthetics, local|mesh-ancestor
102238305|NCT02499965|Sensory System Agents|sensory system agents|mesh-ancestor
102238306|NCT02499965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102238307|NCT05504057|Amantadine|amantadine|mesh-list
102238308|NCT05504057|Histamine Antagonists|histamine antagonists|mesh-list
102238309|NCT05504057|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
102238310|NCT05504057|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102238311|NCT05504057|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102238312|NCT05504057|Antiviral Agents|antiviral agents|mesh-ancestor
102238313|NCT05504057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102238314|NCT05504057|Dopamine Agents|dopamine agents|mesh-ancestor
102238315|NCT05504057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102238316|NCT05504057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238317|NCT05504057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238318|NCT05504057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102238319|NCT05504057|Analgesics|analgesics|mesh-ancestor
102238320|NCT05504057|Sensory System Agents|sensory system agents|mesh-ancestor
102238321|NCT05504057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102238322|NCT05504057|Histamine Agents|histamine agents|mesh-ancestor
102238323|NCT03344003|Factor VIII|factor viii|mesh-list
102238324|NCT03344003|Coagulants|coagulants|mesh-ancestor
102238325|NCT03235531|Valproic Acid|valproic acid|mesh-list
102238326|NCT03235531|Lorazepam|lorazepam|mesh-list
102238327|NCT03235531|Anticonvulsants|anticonvulsants|mesh-ancestor
102238328|NCT03235531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102238329|NCT03235531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238330|NCT03235531|GABA Agents|gaba agents|mesh-ancestor
102238331|NCT03235531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102238332|NCT03235531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238333|NCT03235531|Antimanic Agents|antimanic agents|mesh-ancestor
102238334|NCT03235531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102238335|NCT03235531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102238336|NCT03235531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102238337|NCT03235531|Antiemetics|antiemetics|mesh-ancestor
102238338|NCT03235531|Autonomic Agents|autonomic agents|mesh-ancestor
102238339|NCT03235531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102238340|NCT03235531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102238341|NCT03235531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102238342|NCT03235531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102238343|NCT03235531|GABA Modulators|gaba modulators|mesh-ancestor
102238344|NCT02506829|Nicotine|nicotine|mesh-list
102238345|NCT02506829|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102238346|NCT02506829|Autonomic Agents|autonomic agents|mesh-ancestor
102238347|NCT02506829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102238348|NCT02506829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238349|NCT02506829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102238350|NCT02506829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102238351|NCT02506829|Cholinergic Agents|cholinergic agents|mesh-ancestor
102238352|NCT02506829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102238353|NCT02506829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238354|NCT02506439|Vitamin D|vitamin d|mesh-list
102238355|NCT02506439|Ergocalciferols|ergocalciferols|mesh-list
102238356|NCT02506439|Cholecalciferol|cholecalciferol|mesh-list
102238357|NCT02506439|Vitamins|vitamins|mesh-list
102238358|NCT02506439|Micronutrients|micronutrients|mesh-ancestor
102238359|NCT02506439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238360|NCT02506439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102238361|NCT02506439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102238362|NCT02495519|Imatinib Mesylate|imatinib mesylate|mesh-list
102238363|NCT02495519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102238364|NCT02495519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102238365|NCT02495519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102238366|NCT02495519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238367|NCT02499341|Ketamine|ketamine|mesh-list
102238368|NCT02499341|Tramadol|tramadol|mesh-list
102238369|NCT02499341|Analgesics|analgesics|mesh-ancestor
101947188|NCT01271361|Immunologic Factors|immunologic factors|mesh-ancestor
102238370|NCT02499341|Sensory System Agents|sensory system agents|mesh-ancestor
102238371|NCT02499341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102238372|NCT02499341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238373|NCT02499341|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102238374|NCT02499341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102238375|NCT02499341|Anesthetics, General|anesthetics, general|mesh-ancestor
102238376|NCT02499341|Anesthetics|anesthetics|mesh-ancestor
102612927|NCT00002549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102238377|NCT02499341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102238378|NCT02499341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102238379|NCT02499341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102238380|NCT02499341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101901392|NCT01180322|Antiviral Agents|antiviral agents|mesh-ancestor
102238381|NCT02499341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238382|NCT02499341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102238383|NCT02499341|Narcotics|narcotics|mesh-ancestor
102238384|NCT02495285|Polygeline|polygeline|mesh-list
102238385|NCT02495285|Plasma Substitutes|plasma substitutes|mesh-ancestor
102238386|NCT02495285|Blood Substitutes|blood substitutes|mesh-ancestor
102238387|NCT02495363|Bupivacaine|bupivacaine|mesh-list
102238388|NCT02495363|Anesthetics, Local|anesthetics, local|mesh-ancestor
102238389|NCT02495363|Anesthetics|anesthetics|mesh-ancestor
102238390|NCT02495363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102238391|NCT02495363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238392|NCT02495363|Sensory System Agents|sensory system agents|mesh-ancestor
102238393|NCT02495363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102238394|NCT03121079|Interferons|interferons|mesh-list
102238395|NCT03121079|Interferon-alpha|interferon-alpha|mesh-list
102238396|NCT03121079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102238397|NCT03121079|Antiviral Agents|antiviral agents|mesh-ancestor
102238398|NCT03121079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102238399|NCT03121079|Immunologic Factors|immunologic factors|mesh-ancestor
102238400|NCT03121079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238401|NCT02494895|Aspirin|aspirin|mesh-list
102238402|NCT02494895|Ticagrelor|ticagrelor|mesh-list
102238403|NCT02494895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102238404|NCT02494895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102238405|NCT02494895|Analgesics|analgesics|mesh-ancestor
102238406|NCT02494895|Sensory System Agents|sensory system agents|mesh-ancestor
102238407|NCT02494895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102238408|NCT02494895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238409|NCT02494895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102238410|NCT02494895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102238411|NCT02494895|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102238412|NCT02494895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102238413|NCT02494895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238414|NCT02494895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102238415|NCT02494895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102238416|NCT02494895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102238417|NCT02494895|Antipyretics|antipyretics|mesh-ancestor
102238418|NCT02494895|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102238419|NCT02494895|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102238420|NCT02494895|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102238421|NCT02494895|Purinergic Agents|purinergic agents|mesh-ancestor
102238422|NCT02494895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102238423|NCT03341741|Tobramycin|tobramycin|mesh-list
102238424|NCT03341741|Colistin|colistin|mesh-list
102238425|NCT03341741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102238426|NCT03341741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102238427|NCT01597245|Etanercept|etanercept|mesh-list
102238428|NCT01597245|Ixekizumab|ixekizumab|mesh-list
102238429|NCT01597245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102238430|NCT01597245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102238431|NCT01597245|Analgesics|analgesics|mesh-ancestor
102238432|NCT01597245|Sensory System Agents|sensory system agents|mesh-ancestor
102238433|NCT01597245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102238434|NCT01597245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238435|NCT01597245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102238436|NCT01597245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102238437|NCT01597245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102238438|NCT01597245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102238439|NCT01597245|Immunologic Factors|immunologic factors|mesh-ancestor
102238440|NCT01597245|Dermatologic Agents|dermatologic agents|mesh-ancestor
102238441|NCT03341429|Liraglutide|liraglutide|mesh-list
102238442|NCT03341429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102238443|NCT03341429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238444|NCT03341429|Incretins|incretins|mesh-ancestor
102238445|NCT03341429|Hormones|hormones|mesh-ancestor
102238446|NCT03341429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102238448|NCT04494659|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102238449|NCT04494659|Antitubercular Agents|antitubercular agents|mesh-ancestor
102238450|NCT04494659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102238451|NCT04494659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101640550|NCT00696787|Analgesics|analgesics|mesh-ancestor
102238452|NCT04494659|Leprostatic Agents|leprostatic agents|mesh-ancestor
102238453|NCT04494659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102238454|NCT04494659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102238455|NCT04494659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238456|NCT04494659|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102612928|NCT00002549|Alkylating Agents|alkylating agents|mesh-ancestor
102612929|NCT00002549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238457|NCT04494659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102238458|NCT04494659|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102238459|NCT04494659|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102238460|NCT04494659|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102238461|NCT04494659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102238463|NCT03342599|Antioxidants|antioxidants|mesh-ancestor
102238464|NCT03342599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238465|NCT03342599|Protective Agents|protective agents|mesh-ancestor
102238466|NCT03342599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238467|NCT03342599|Vitamin B Complex|vitamin b complex|mesh-ancestor
102238468|NCT03342599|Vitamins|vitamins|mesh-ancestor
102238469|NCT03342599|Micronutrients|micronutrients|mesh-ancestor
102238470|NCT03341117|Aspirin|aspirin|mesh-list
102238471|NCT03341117|Magnesium Oxide|magnesium oxide|mesh-list
102238472|NCT03341117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102238473|NCT03341117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102238474|NCT03341117|Analgesics|analgesics|mesh-ancestor
102238475|NCT03341117|Sensory System Agents|sensory system agents|mesh-ancestor
102238476|NCT03341117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102238477|NCT03341117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238478|NCT03341117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102238479|NCT03341117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102238480|NCT03341117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102238481|NCT03341117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102238482|NCT03341117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238483|NCT03341117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102238484|NCT03341117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102238485|NCT03341117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102238486|NCT03341117|Antipyretics|antipyretics|mesh-ancestor
102238487|NCT03341117|Antacids|antacids|mesh-ancestor
102238488|NCT03341117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102238489|NCT02498171|Fentanyl|fentanyl|mesh-list
102238490|NCT02498171|Morphine|morphine|mesh-list
102238491|NCT02498171|Bupivacaine|bupivacaine|mesh-list
102238492|NCT02498171|Anesthetics, Local|anesthetics, local|mesh-ancestor
102238493|NCT02498171|Anesthetics|anesthetics|mesh-ancestor
102238494|NCT02498171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102238495|NCT02498171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238496|NCT02498171|Sensory System Agents|sensory system agents|mesh-ancestor
102238497|NCT02498171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102238498|NCT02498171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102238499|NCT02498171|Narcotics|narcotics|mesh-ancestor
102238500|NCT02498171|Analgesics|analgesics|mesh-ancestor
102238501|NCT02498171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102238502|NCT02498171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102238503|NCT02498171|Anesthetics, General|anesthetics, general|mesh-ancestor
102238504|NCT03120533|Treprostinil|treprostinil|mesh-list
102238505|NCT03120533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102238506|NCT03342443|Memantine|memantine|mesh-list
102238507|NCT03342443|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102238508|NCT03342443|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102238509|NCT03342443|Dopamine Agents|dopamine agents|mesh-ancestor
102238510|NCT03342443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102238511|NCT03342443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238512|NCT03342443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238513|NCT03342443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102238514|NCT03342443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102238515|NCT05035485|Phenylephrine|phenylephrine|mesh-list
102238516|NCT05035485|Oxymetazoline|oxymetazoline|mesh-list
102238517|NCT05035485|Norepinephrine|norepinephrine|mesh-list
102238518|NCT05035485|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
102238519|NCT05035485|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102238520|NCT05035485|Mydriatics|mydriatics|mesh-ancestor
102238521|NCT05035485|Autonomic Agents|autonomic agents|mesh-ancestor
102238522|NCT05035485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101640685|NCT00733408|Antibodies|antibodies|mesh-list
102238523|NCT05035485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238524|NCT05035485|Sympathomimetics|sympathomimetics|mesh-ancestor
102238525|NCT05035485|Nasal Decongestants|nasal decongestants|mesh-ancestor
102238526|NCT05035485|Respiratory System Agents|respiratory system agents|mesh-ancestor
102238527|NCT05035485|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102612930|NCT00002549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102238528|NCT05035485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102238529|NCT05035485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102238530|NCT05035485|Adrenergic Agents|adrenergic agents|mesh-ancestor
102612931|NCT00002549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102238531|NCT05035485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102238532|NCT05035485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238533|NCT05035485|Protective Agents|protective agents|mesh-ancestor
102238534|NCT02498015|Ribavirin|ribavirin|mesh-list
102238535|NCT02498015|Antimetabolites|antimetabolites|mesh-ancestor
102238536|NCT02498015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238537|NCT02498015|Antiviral Agents|antiviral agents|mesh-ancestor
102238538|NCT02498015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102238539|NCT02494505|Mycophenolic Acid|mycophenolic acid|mesh-list
102238540|NCT02494505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102238541|NCT02494505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102238542|NCT02494505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102238543|NCT02494505|Antitubercular Agents|antitubercular agents|mesh-ancestor
102238544|NCT02494505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102238545|NCT02494505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102238546|NCT02494505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102238547|NCT02494505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238548|NCT03340493|Tenecteplase|tenecteplase|mesh-list
102238549|NCT03340493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102238550|NCT03340493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102238551|NCT03340493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238552|NCT03098199|Menotropins|menotropins|mesh-list
102238553|NCT03098199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238554|NCT03098199|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102238555|NCT03098199|Fertility Agents|fertility agents|mesh-ancestor
102238556|NCT03098199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102238557|NCT00707057|Ibuprofen|ibuprofen|mesh-list
102238558|NCT00707057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102238559|NCT00707057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102238560|NCT00707057|Analgesics|analgesics|mesh-ancestor
102238561|NCT00707057|Sensory System Agents|sensory system agents|mesh-ancestor
102238562|NCT00707057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102238563|NCT00707057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238564|NCT00707057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102238565|NCT00707057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102238566|NCT00707057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102238567|NCT00707057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102238568|NCT00707057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238569|NCT02494349|Tamsulosin|tamsulosin|mesh-list
102238570|NCT02494349|Solifenacin Succinate|solifenacin succinate|mesh-list
102238571|NCT02494349|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102238572|NCT02494349|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102238573|NCT02494349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102238574|NCT02494349|Adrenergic Agents|adrenergic agents|mesh-ancestor
102238575|NCT02494349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102238576|NCT02494349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238577|NCT02494349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238578|NCT02494349|Urological Agents|urological agents|mesh-ancestor
102238579|NCT02494349|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102238580|NCT02494349|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102238581|NCT02494349|Cholinergic Agents|cholinergic agents|mesh-ancestor
102238582|NCT03095469|Dexmedetomidine|dexmedetomidine|mesh-list
102238583|NCT03095469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102238584|NCT03095469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102238585|NCT03095469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238586|NCT03095469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102238587|NCT03095469|Analgesics|analgesics|mesh-ancestor
102238588|NCT03095469|Sensory System Agents|sensory system agents|mesh-ancestor
101640769|NCT00958880|Yohimbine|yohimbine|mesh-list
102238589|NCT03095469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102238590|NCT03095469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102238591|NCT03095469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102238592|NCT03095469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102238593|NCT03095469|Adrenergic Agents|adrenergic agents|mesh-ancestor
102238594|NCT03095469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102238595|NCT03095469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238596|NCT02497547|Oxytocin|oxytocin|mesh-list
102238597|NCT02497547|Oxytocics|oxytocics|mesh-ancestor
102238598|NCT02497547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102238599|NCT02497547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238600|NCT05043129|Vaccines|vaccines|mesh-list
102238601|NCT05043129|Immunologic Factors|immunologic factors|mesh-ancestor
102238602|NCT05043129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238603|NCT02497313|Metformin|metformin|mesh-list
102238605|NCT02497313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102238606|NCT02497313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238607|NCT02497313|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102238608|NCT02497313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102238609|NCT02497157|Leucovorin|leucovorin|mesh-list
102238610|NCT02497157|Bevacizumab|bevacizumab|mesh-list
102238611|NCT02497157|Fluorouracil|fluorouracil|mesh-list
102238612|NCT02497157|Oxaliplatin|oxaliplatin|mesh-list
102238613|NCT02497157|Irinotecan|irinotecan|mesh-list
102238614|NCT02497157|Calcium|calcium|mesh-list
102238615|NCT02497157|Levoleucovorin|levoleucovorin|mesh-list
102238616|NCT02497157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102238617|NCT02497157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102238618|NCT02497157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102238619|NCT02497157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102238620|NCT02497157|Growth Substances|growth substances|mesh-ancestor
102238621|NCT02497157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238622|NCT02497157|Growth Inhibitors|growth inhibitors|mesh-ancestor
102238623|NCT02497157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102238624|NCT02497157|Antimetabolites|antimetabolites|mesh-ancestor
102238625|NCT02497157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238626|NCT02497157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102238627|NCT02497157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102238628|NCT02497157|Immunologic Factors|immunologic factors|mesh-ancestor
102238629|NCT02497157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102238630|NCT02497157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102238631|NCT02497157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102238632|NCT02497157|Antidotes|antidotes|mesh-ancestor
102238633|NCT02497157|Protective Agents|protective agents|mesh-ancestor
102238634|NCT02497157|Vitamin B Complex|vitamin b complex|mesh-ancestor
102238635|NCT02497157|Vitamins|vitamins|mesh-ancestor
102238636|NCT02497157|Micronutrients|micronutrients|mesh-ancestor
102238637|NCT03095079|Endostatins|endostatins|mesh-list
102238638|NCT03095079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102238639|NCT03095079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102238640|NCT03095079|Growth Substances|growth substances|mesh-ancestor
102238641|NCT03095079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238642|NCT03095079|Growth Inhibitors|growth inhibitors|mesh-ancestor
102238643|NCT03095079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102238644|NCT03120923|Triamcinolone|triamcinolone|mesh-list
102238645|NCT03120923|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102238646|NCT03120923|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102238647|NCT03120923|Lidocaine|lidocaine|mesh-list
102238648|NCT03120923|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102238649|NCT03120923|Anesthetics, Local|anesthetics, local|mesh-ancestor
102238650|NCT03120923|Anesthetics|anesthetics|mesh-ancestor
102238651|NCT03120923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102238652|NCT03120923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238653|NCT03120923|Sensory System Agents|sensory system agents|mesh-ancestor
102238654|NCT03120923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102238655|NCT03120923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102238656|NCT03120923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102238657|NCT03120923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102238658|NCT03120923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102238659|NCT03120923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238660|NCT03120923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102238661|NCT03120923|Glucocorticoids|glucocorticoids|mesh-ancestor
102238662|NCT03120923|Hormones|hormones|mesh-ancestor
102238663|NCT03120923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102238664|NCT03120923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102238665|NCT03120923|Immunologic Factors|immunologic factors|mesh-ancestor
102238666|NCT03120923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102238667|NCT02497079|Formaldehyde|formaldehyde|mesh-list
102238668|NCT02497079|Disinfectants|disinfectants|mesh-ancestor
102238669|NCT02497079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102238670|NCT04135677|Rivaroxaban|rivaroxaban|mesh-list
102238671|NCT04135677|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102238672|NCT04135677|Antithrombins|antithrombins|mesh-ancestor
102238673|NCT04135677|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102238674|NCT04135677|Protease Inhibitors|protease inhibitors|mesh-ancestor
102612932|NCT00002549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102612933|NCT00002549|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102238675|NCT04135677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102238676|NCT04135677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238677|NCT04135677|Anticoagulants|anticoagulants|mesh-ancestor
102612934|NCT00002549|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102238678|NCT02639247|Sofosbuvir|sofosbuvir|mesh-list
102238679|NCT02639247|Velpatasvir|velpatasvir|mesh-list
102238680|NCT02639247|Antiviral Agents|antiviral agents|mesh-ancestor
102238681|NCT02639247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102238682|NCT05033535|Olmesartan|olmesartan|mesh-list
102238683|NCT05033535|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
102238684|NCT05033535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102238685|NCT05033535|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102238686|NCT05033535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102238687|NCT05033535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238688|NCT05053893|Valsartan|valsartan|mesh-list
102238689|NCT05053893|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102238690|NCT05053893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102238691|NCT05053893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102238692|NCT05053893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102238693|NCT05053893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238694|NCT03096327|Montelukast|montelukast|mesh-list
102238695|NCT03096327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102238696|NCT03096327|Respiratory System Agents|respiratory system agents|mesh-ancestor
102238697|NCT03096327|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102238698|NCT03096327|Hormone Antagonists|hormone antagonists|mesh-ancestor
102238699|NCT03096327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102238700|NCT03096327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238701|NCT03096327|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102238702|NCT03096327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102238703|NCT03096327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238704|NCT03098121|Grazoprevir|grazoprevir|mesh-list
102238705|NCT03098121|Antiviral Agents|antiviral agents|mesh-ancestor
102238706|NCT03098121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102238707|NCT03095001|Paclitaxel|paclitaxel|mesh-list
102238708|NCT03095001|Bevacizumab|bevacizumab|mesh-list
102238709|NCT03095001|Carboplatin|carboplatin|mesh-list
102238710|NCT03095001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102238711|NCT03095001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102238712|NCT03095001|Tubulin Modulators|tubulin modulators|mesh-ancestor
102238713|NCT03095001|Antimitotic Agents|antimitotic agents|mesh-ancestor
102238714|NCT03095001|Mitosis Modulators|mitosis modulators|mesh-ancestor
102238715|NCT03095001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238716|NCT03095001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102238717|NCT03095001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102238718|NCT03095001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102238719|NCT03095001|Growth Substances|growth substances|mesh-ancestor
102238720|NCT03095001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238721|NCT03095001|Growth Inhibitors|growth inhibitors|mesh-ancestor
102238722|NCT05042271|Meropenem|meropenem|mesh-list
102238723|NCT05042271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102238724|NCT05042271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102238725|NCT02138955|Curcumin|curcumin|mesh-list
102238726|NCT02138955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102238727|NCT02138955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102238728|NCT02138955|Analgesics|analgesics|mesh-ancestor
102238729|NCT02138955|Sensory System Agents|sensory system agents|mesh-ancestor
102238730|NCT02138955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102238731|NCT02138955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238732|NCT02138955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102238733|NCT02138955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102238734|NCT02138955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102238735|NCT02138955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102238736|NCT02138955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238737|NCT03096405|Methicillin|methicillin|mesh-list
102238738|NCT03096405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102238739|NCT03096405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102238740|NCT05032287|Tamsulosin|tamsulosin|mesh-list
102238741|NCT05032287|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102238742|NCT05032287|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102238743|NCT05032287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102238744|NCT05032287|Adrenergic Agents|adrenergic agents|mesh-ancestor
101640925|NCT02858258|Rituximab|rituximab|mesh-list
102238745|NCT05032287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102238746|NCT05032287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238747|NCT05032287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238748|NCT05032287|Urological Agents|urological agents|mesh-ancestor
102238749|NCT02493959|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102238750|NCT02493959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102238751|NCT02493959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238752|NCT02493959|Incretins|incretins|mesh-ancestor
102238753|NCT02493959|Hormones|hormones|mesh-ancestor
102238754|NCT02493959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102238755|NCT02493959|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102238756|NCT02493959|Protease Inhibitors|protease inhibitors|mesh-ancestor
102238757|NCT02493959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102238758|NCT02493959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238759|NCT02496377|Epoetin Alfa|epoetin alfa|mesh-list
102238760|NCT02496377|Glycine|glycine|mesh-list
102238761|NCT02496377|Hematinics|hematinics|mesh-ancestor
102238762|NCT02496377|Glycine Agents|glycine agents|mesh-ancestor
102238763|NCT02496377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102238764|NCT02496377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238765|NCT02496377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238766|NCT02496455|Tramadol|tramadol|mesh-list
102238767|NCT02496455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102238768|NCT02496455|Narcotics|narcotics|mesh-ancestor
102238769|NCT02496455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102238770|NCT02496455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238771|NCT02496455|Analgesics|analgesics|mesh-ancestor
102238772|NCT02496455|Sensory System Agents|sensory system agents|mesh-ancestor
102238773|NCT02496455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102238774|NCT02496299|Dexamethasone|dexamethasone|mesh-list
102238775|NCT02496299|Bupivacaine|bupivacaine|mesh-list
102238776|NCT02496299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102238777|NCT02496299|Antiemetics|antiemetics|mesh-ancestor
102238778|NCT02496299|Autonomic Agents|autonomic agents|mesh-ancestor
102238779|NCT02496299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102238780|NCT02496299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238781|NCT02496299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102238782|NCT02496299|Glucocorticoids|glucocorticoids|mesh-ancestor
102238783|NCT02496299|Hormones|hormones|mesh-ancestor
102238784|NCT02496299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102238785|NCT02496299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102238786|NCT02496299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102238787|NCT02496299|Anesthetics, Local|anesthetics, local|mesh-ancestor
102238788|NCT02496299|Anesthetics|anesthetics|mesh-ancestor
102238789|NCT02496299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102238790|NCT02496299|Sensory System Agents|sensory system agents|mesh-ancestor
102238791|NCT02493725|Eculizumab|eculizumab|mesh-list
102238792|NCT02493725|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102238793|NCT02493725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102238794|NCT02493725|Immunologic Factors|immunologic factors|mesh-ancestor
102238795|NCT02493725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238796|NCT04467957|Xenon|xenon|mesh-list
102238797|NCT04467957|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102238798|NCT04467957|Anesthetics, General|anesthetics, general|mesh-ancestor
102238799|NCT04467957|Anesthetics|anesthetics|mesh-ancestor
102238800|NCT04467957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102238801|NCT04467957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238802|NCT02121405|Capecitabine|capecitabine|mesh-list
102238803|NCT02121405|Oxaliplatin|oxaliplatin|mesh-list
102238804|NCT02121405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102238805|NCT02121405|Antimetabolites|antimetabolites|mesh-ancestor
102238806|NCT02121405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238807|NCT02121405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102238808|NCT03337841|Pembrolizumab|pembrolizumab|mesh-list
102238809|NCT03337841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102238810|NCT03337841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102238811|NCT03337841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102238812|NCT03337841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238813|NCT02493335|Budesonide|budesonide|mesh-list
102238814|NCT02493335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102238815|NCT02493335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102238816|NCT02493335|Autonomic Agents|autonomic agents|mesh-ancestor
102238817|NCT02493335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102238818|NCT02493335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238819|NCT02493335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102238820|NCT02493335|Respiratory System Agents|respiratory system agents|mesh-ancestor
102238821|NCT02493335|Glucocorticoids|glucocorticoids|mesh-ancestor
102238822|NCT02493335|Hormones|hormones|mesh-ancestor
102238823|NCT02493335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102238824|NCT03336593|Vaccines|vaccines|mesh-list
102238825|NCT03336593|Immunologic Factors|immunologic factors|mesh-ancestor
102238826|NCT03336593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102612935|NCT00002549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102238827|NCT03337607|Celecoxib|celecoxib|mesh-list
102238828|NCT03337607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
102238829|NCT03337607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102238830|NCT03337607|Eperisone|eperisone|mesh-list
102238831|NCT03337607|Parasympatholytics|parasympatholytics|mesh-list
102238832|NCT03337607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102238833|NCT03337607|Analgesics|analgesics|mesh-ancestor
102238834|NCT03337607|Sensory System Agents|sensory system agents|mesh-ancestor
102238835|NCT03337607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102238836|NCT03337607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238837|NCT03337607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102238838|NCT03337607|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102238839|NCT03337607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102238840|NCT03337607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102238841|NCT03337607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238842|NCT03337607|Anticonvulsants|anticonvulsants|mesh-ancestor
102238843|NCT03337607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102238844|NCT03337607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102238845|NCT03337607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102238846|NCT03337607|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102238847|NCT03337607|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102238848|NCT03337607|Autonomic Agents|autonomic agents|mesh-ancestor
102238849|NCT03337607|Vasodilator Agents|vasodilator agents|mesh-ancestor
102238850|NCT02493179|Serratiopeptidase|serratiopeptidase|mesh-list
102238851|NCT02493179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102238852|NCT02493179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102238853|NCT02493179|Analgesics|analgesics|mesh-ancestor
102238854|NCT02493179|Sensory System Agents|sensory system agents|mesh-ancestor
102238855|NCT02493179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102238856|NCT02493179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238857|NCT02493179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102238858|NCT02493179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102238859|NCT03336437|Estradiol|estradiol|mesh-list
102238860|NCT03336437|Estrogens|estrogens|mesh-ancestor
102238861|NCT03336437|Hormones|hormones|mesh-ancestor
102238862|NCT03336437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102238863|NCT03336437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238864|NCT03337373|Cisatracurium|cisatracurium|mesh-list
102238865|NCT03337373|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102238866|NCT03337373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102238867|NCT03337373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102238868|NCT03337373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238869|NCT03336281|Ustekinumab|ustekinumab|mesh-list
102238870|NCT03336281|Dermatologic Agents|dermatologic agents|mesh-ancestor
102238871|NCT03336125|Vitamin D|vitamin d|mesh-list
102238872|NCT03336125|Vitamins|vitamins|mesh-ancestor
102238873|NCT03336125|Micronutrients|micronutrients|mesh-ancestor
102238874|NCT03336125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238875|NCT03336125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102238876|NCT05051163|Gentamicins|gentamicins|mesh-list
102238877|NCT05051163|Ceftriaxone|ceftriaxone|mesh-list
102238878|NCT05051163|Ampicillin|ampicillin|mesh-list
102238879|NCT05051163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102238880|NCT05051163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102238881|NCT05051163|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102238882|NCT05051163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102238883|NCT05051163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238884|NCT03331211|Dasatinib|dasatinib|mesh-list
102238885|NCT03331211|Ponatinib|ponatinib|mesh-list
102238886|NCT03331211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102238887|NCT03331211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102238888|NCT03331211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102238889|NCT03331211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238890|NCT01929915|Fentanyl|fentanyl|mesh-list
102238891|NCT01929915|Morphine|morphine|mesh-list
102238892|NCT01929915|Bupivacaine|bupivacaine|mesh-list
102238893|NCT01929915|Anesthetics, Local|anesthetics, local|mesh-ancestor
102238894|NCT01929915|Anesthetics|anesthetics|mesh-ancestor
102238895|NCT01929915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102238896|NCT01929915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238897|NCT01929915|Sensory System Agents|sensory system agents|mesh-ancestor
102238898|NCT01929915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102238899|NCT01929915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102238900|NCT01929915|Narcotics|narcotics|mesh-ancestor
102238901|NCT01929915|Analgesics|analgesics|mesh-ancestor
102238902|NCT01929915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102238903|NCT01929915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102238904|NCT01929915|Anesthetics, General|anesthetics, general|mesh-ancestor
102238905|NCT05464745|Perindopril|perindopril|mesh-list
102238907|NCT05464745|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102238908|NCT05464745|Protease Inhibitors|protease inhibitors|mesh-ancestor
102238909|NCT05464745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102238910|NCT05464745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238911|NCT05464745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102238912|NCT05464745|Diuretics|diuretics|mesh-ancestor
102238913|NCT05464745|Natriuretic Agents|natriuretic agents|mesh-ancestor
102238914|NCT05464745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238915|NCT05464745|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102238916|NCT05464745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102238917|NCT03094533|Propofol|propofol|mesh-list
102238918|NCT03094533|Sevoflurane|sevoflurane|mesh-list
102238919|NCT03094533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102238920|NCT03094533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102238921|NCT03094533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238922|NCT03094533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102238923|NCT03094533|Anesthetics, General|anesthetics, general|mesh-ancestor
102238924|NCT03094533|Anesthetics|anesthetics|mesh-ancestor
102238925|NCT03094533|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102238926|NCT03094533|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102238927|NCT05028231|Immunomodulating Agents|immunomodulating agents|mesh-list
102238928|NCT05028231|Immunologic Factors|immunologic factors|mesh-ancestor
102238929|NCT05028231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238930|NCT03335579|Sufentanil|sufentanil|mesh-list
102238931|NCT03335579|Remifentanil|remifentanil|mesh-list
102238932|NCT03335579|Propofol|propofol|mesh-list
102238933|NCT03335579|Anesthetics|anesthetics|mesh-ancestor
102238934|NCT03335579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102238935|NCT03335579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238936|NCT03335579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102238937|NCT03335579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102238938|NCT03335579|Anesthetics, General|anesthetics, general|mesh-ancestor
102238939|NCT03335579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102238940|NCT03335579|Narcotics|narcotics|mesh-ancestor
102238941|NCT03335579|Analgesics|analgesics|mesh-ancestor
102238942|NCT03335579|Sensory System Agents|sensory system agents|mesh-ancestor
102238943|NCT03335579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102238944|NCT03335579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102238945|NCT05050071|Calcium, Dietary|calcium, dietary|mesh-list
102238946|NCT05050071|Calcium|calcium|mesh-list
102238947|NCT05050071|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102238948|NCT05050071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238949|NCT05050071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102238950|NCT03335501|Pancrelipase|pancrelipase|mesh-list
102238951|NCT03335501|Hormones|hormones|mesh-list
102238952|NCT03335501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238953|NCT03335501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102238954|NCT03335501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102238955|NCT02492945|Lidocaine|lidocaine|mesh-list
102238956|NCT02492945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102238957|NCT02492945|Anesthetics, Local|anesthetics, local|mesh-ancestor
102238958|NCT02492945|Anesthetics|anesthetics|mesh-ancestor
102238959|NCT02492945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102238960|NCT02492945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238961|NCT02492945|Sensory System Agents|sensory system agents|mesh-ancestor
102238962|NCT02492945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102238963|NCT02492945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102238964|NCT02492945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102238965|NCT02492945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102238966|NCT02492945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102238967|NCT02492945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238968|NCT03335423|Metformin|metformin|mesh-list
102238969|NCT03335423|Codeine|codeine|mesh-list
102238970|NCT03335423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102238971|NCT03335423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102238972|NCT03335423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102238973|NCT03335423|Narcotics|narcotics|mesh-ancestor
102238974|NCT03335423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102612936|NCT00002549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102612937|NCT00002549|Antimetabolites|antimetabolites|mesh-ancestor
102238975|NCT03335423|Analgesics|analgesics|mesh-ancestor
102238976|NCT03335423|Sensory System Agents|sensory system agents|mesh-ancestor
102612938|NCT00002549|Antiviral Agents|antiviral agents|mesh-ancestor
102612939|NCT00002549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102612940|NCT00002549|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102612941|NCT00002549|Analgesics|analgesics|mesh-ancestor
102612942|NCT00002549|Sensory System Agents|sensory system agents|mesh-ancestor
102612943|NCT00002549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102612944|NCT00002555|Cobalt|cobalt|mesh-list
102612945|NCT00002555|Trace Elements|trace elements|mesh-ancestor
102612946|NCT00002555|Micronutrients|micronutrients|mesh-ancestor
102238977|NCT03335423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102238978|NCT03335423|Antitussive Agents|antitussive agents|mesh-ancestor
102238979|NCT03335423|Respiratory System Agents|respiratory system agents|mesh-ancestor
102238980|NCT05038605|Metronidazole|metronidazole|mesh-list
102238981|NCT05038605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102238982|NCT05038605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102238983|NCT05038605|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102238984|NCT05038605|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102238985|NCT03329729|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102238986|NCT03329729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102238987|NCT03329729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102238988|NCT03329729|Antimetabolites|antimetabolites|mesh-ancestor
102238989|NCT03329729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238990|NCT03329729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102238991|NCT03329729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102238992|NCT03329729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102238993|NCT02492477|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102238994|NCT02492477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102238995|NCT02492477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102238996|NCT02492477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102238997|NCT03095547|Cyclosporine|cyclosporine|mesh-list
102238998|NCT03095547|Posaconazole|posaconazole|mesh-list
102238999|NCT03095547|Olorofim|olorofim|mesh-list
102239000|NCT03095547|Pantoprazole|pantoprazole|mesh-list
102239001|NCT03095547|Tacrolimus|tacrolimus|mesh-list
102239002|NCT03095547|Cyclosporins|cyclosporins|mesh-list
102239003|NCT03095547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102239004|NCT03095547|Immunologic Factors|immunologic factors|mesh-ancestor
102239005|NCT03095547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239006|NCT03095547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102239007|NCT03095547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102239008|NCT03095547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239009|NCT03095547|Antifungal Agents|antifungal agents|mesh-ancestor
102239010|NCT03095547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102239011|NCT03095547|Dermatologic Agents|dermatologic agents|mesh-ancestor
102239012|NCT03095547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102239013|NCT03095547|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102239014|NCT03095547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102239015|NCT03095547|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102239016|NCT03095547|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102239017|NCT03095547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102239018|NCT03095547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102239019|NCT03095547|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102239020|NCT03095547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102239021|NCT03095547|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102239022|NCT03095547|Hormone Antagonists|hormone antagonists|mesh-ancestor
102239023|NCT03095547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102239024|NCT03329651|Metformin|metformin|mesh-list
102239025|NCT03329651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102239026|NCT03329651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239027|NCT03334877|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102239028|NCT03334877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102239029|NCT03334877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239030|NCT05049681|Apatinib|apatinib|mesh-list
102239031|NCT05049681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102239032|NCT05049681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102239033|NCT05049681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102239034|NCT05049681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239035|NCT03334487|Dexamethasone|dexamethasone|mesh-list
102239036|NCT03334487|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
102239037|NCT03334487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102239038|NCT03334487|Antiemetics|antiemetics|mesh-ancestor
102239039|NCT03334487|Autonomic Agents|autonomic agents|mesh-ancestor
102239040|NCT03334487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102612947|NCT00002555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621227|NCT04952389|Budesonide|budesonide|mesh-list
102612948|NCT00002561|Doxorubicin|doxorubicin|mesh-list
102612949|NCT00002561|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102612950|NCT00002561|Bleomycin|bleomycin|mesh-list
102239041|NCT03334487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239042|NCT03334487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102239043|NCT03334487|Glucocorticoids|glucocorticoids|mesh-ancestor
102239044|NCT03334487|Hormones|hormones|mesh-ancestor
102239045|NCT03334487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102239046|NCT03334487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102239047|NCT03334487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102239048|NCT03334487|Immunoconjugates|immunoconjugates|mesh-ancestor
102239049|NCT03334487|Immunologic Factors|immunologic factors|mesh-ancestor
102239050|NCT05038449|Colchicine|colchicine|mesh-list
102239051|NCT05038449|Gout Suppressants|gout suppressants|mesh-ancestor
102239052|NCT05038449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102239053|NCT05038449|Tubulin Modulators|tubulin modulators|mesh-ancestor
102239054|NCT05038449|Antimitotic Agents|antimitotic agents|mesh-ancestor
102239055|NCT05038449|Mitosis Modulators|mitosis modulators|mesh-ancestor
102239056|NCT05038449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239057|NCT05038449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102239058|NCT05038059|Acetic Acid|acetic acid|mesh-list
102239059|NCT05038059|Retinol acetate|retinol acetate|mesh-list
102239060|NCT05038059|Ethylene|ethylene|mesh-list
102239061|NCT05038059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102239062|NCT05038059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102239063|NCT05038059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102239064|NCT05038059|Immunologic Factors|immunologic factors|mesh-ancestor
102239065|NCT05038059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239066|NCT05038059|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102239067|NCT05038059|Protective Agents|protective agents|mesh-ancestor
102239068|NCT05038059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102239069|NCT05038059|Plant Growth Regulators|plant growth regulators|mesh-ancestor
102239070|NCT05038059|Growth Substances|growth substances|mesh-ancestor
102239071|NCT01236547|Paclitaxel|paclitaxel|mesh-list
102239072|NCT01236547|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102239073|NCT01236547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101641169|NCT04296851|Anthelmintics|anthelmintics|mesh-ancestor
102239074|NCT01236547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102239075|NCT01236547|Tubulin Modulators|tubulin modulators|mesh-ancestor
102239076|NCT01236547|Antimitotic Agents|antimitotic agents|mesh-ancestor
102239077|NCT01236547|Mitosis Modulators|mitosis modulators|mesh-ancestor
102239078|NCT01236547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239079|NCT03329339|Ascorbic Acid|ascorbic acid|mesh-list
102239080|NCT03329339|Antioxidants|antioxidants|mesh-ancestor
102239081|NCT03329339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239082|NCT03329339|Protective Agents|protective agents|mesh-ancestor
102239083|NCT03329339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239084|NCT03329339|Vitamins|vitamins|mesh-ancestor
102239085|NCT03329339|Micronutrients|micronutrients|mesh-ancestor
102239086|NCT03329261|Clopidogrel|clopidogrel|mesh-list
102239087|NCT03329261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102239088|NCT03329261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102239089|NCT03329261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102239090|NCT03329261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102239091|NCT03329261|Purinergic Agents|purinergic agents|mesh-ancestor
102239092|NCT03329261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102239093|NCT03329261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239094|NCT03329261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239095|NCT03329183|Irinotecan|irinotecan|mesh-list
102239096|NCT03329183|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102239097|NCT03329183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102239098|NCT03329183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102239099|NCT03329183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239100|NCT03329183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102239101|NCT05048511|Vitamin D|vitamin d|mesh-list
102239102|NCT05048511|Vitamins|vitamins|mesh-ancestor
102239103|NCT05048511|Micronutrients|micronutrients|mesh-ancestor
102239104|NCT05048511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239105|NCT05048511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102239106|NCT02167945|Ritonavir|ritonavir|mesh-list
102239107|NCT02167945|Ribavirin|ribavirin|mesh-list
102239108|NCT02167945|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102239109|NCT02167945|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102239110|NCT02167945|Protease Inhibitors|protease inhibitors|mesh-ancestor
102239111|NCT02167945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612951|NCT00002561|Dacarbazine|dacarbazine|mesh-list
102612952|NCT00002561|Vinblastine|vinblastine|mesh-list
102612953|NCT00002561|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102239112|NCT02167945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901413|NCT02524964|Analgesics|analgesics|mesh-ancestor
102239113|NCT02167945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102239114|NCT02167945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102239115|NCT02167945|Antiviral Agents|antiviral agents|mesh-ancestor
102239116|NCT02167945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102239117|NCT02167945|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102239118|NCT02167945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102239119|NCT02167945|Antimetabolites|antimetabolites|mesh-ancestor
102239120|NCT03328481|Anesthetics|anesthetics|mesh-list
102239121|NCT03328481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102239122|NCT03328481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239123|NCT02452879|Solifenacin Succinate|solifenacin succinate|mesh-list
102239124|NCT02452879|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102239125|NCT02452879|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102239126|NCT02452879|Cholinergic Agents|cholinergic agents|mesh-ancestor
102239127|NCT02452879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102239128|NCT02452879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239129|NCT02452879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239130|NCT02452879|Urological Agents|urological agents|mesh-ancestor
102239131|NCT01191697|Bevacizumab|bevacizumab|mesh-list
102239132|NCT01191697|Trastuzumab|trastuzumab|mesh-list
102239133|NCT01191697|Capecitabine|capecitabine|mesh-list
102239134|NCT01191697|Oxaliplatin|oxaliplatin|mesh-list
102239135|NCT01191697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102239136|NCT01191697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102239137|NCT01191697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102239138|NCT01191697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102239139|NCT01191697|Growth Substances|growth substances|mesh-ancestor
102239140|NCT01191697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239141|NCT01191697|Growth Inhibitors|growth inhibitors|mesh-ancestor
102239142|NCT01191697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102239143|NCT01191697|Antimetabolites|antimetabolites|mesh-ancestor
102239144|NCT01191697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239145|NCT05024799|Fentanyl|fentanyl|mesh-list
102239146|NCT05024799|Butorphanol|butorphanol|mesh-list
102239147|NCT05024799|Propofol|propofol|mesh-list
102239148|NCT05024799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102239149|NCT05024799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102239150|NCT05024799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239151|NCT05024799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102239152|NCT05024799|Anesthetics, General|anesthetics, general|mesh-ancestor
102239153|NCT05024799|Anesthetics|anesthetics|mesh-ancestor
102239154|NCT05024799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102239155|NCT05024799|Narcotics|narcotics|mesh-ancestor
102239156|NCT05024799|Analgesics|analgesics|mesh-ancestor
101641234|NCT04281680|Octreotide|octreotide|mesh-list
102239157|NCT05024799|Sensory System Agents|sensory system agents|mesh-ancestor
102239158|NCT05024799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102239159|NCT05024799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102239160|NCT05024799|Antitussive Agents|antitussive agents|mesh-ancestor
102239161|NCT05024799|Respiratory System Agents|respiratory system agents|mesh-ancestor
102239162|NCT05024799|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102239163|NCT05018637|Teriparatide|teriparatide|mesh-list
102239164|NCT05018637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102239165|NCT05018637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239166|NCT05018637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102239167|NCT03327701|Benralizumab|benralizumab|mesh-list
102239168|NCT03327701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102239169|NCT03327701|Respiratory System Agents|respiratory system agents|mesh-ancestor
102239170|NCT03327389|Dexmedetomidine|dexmedetomidine|mesh-list
102239171|NCT03327389|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102239172|NCT03327389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102239173|NCT03327389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239174|NCT03327389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102239175|NCT03327389|Analgesics|analgesics|mesh-ancestor
102239176|NCT03327389|Sensory System Agents|sensory system agents|mesh-ancestor
102239177|NCT03327389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102239178|NCT03327389|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102239179|NCT03327389|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102239180|NCT03327389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102239181|NCT03327389|Adrenergic Agents|adrenergic agents|mesh-ancestor
102239182|NCT03327389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102239183|NCT03327389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239184|NCT03333083|Lamivudine|lamivudine|mesh-list
102239185|NCT03333083|Raltegravir Potassium|raltegravir potassium|mesh-list
102239186|NCT03333083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102612954|NCT00002561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102239187|NCT03333083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102239188|NCT03333083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102239189|NCT03333083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239190|NCT03333083|Antiviral Agents|antiviral agents|mesh-ancestor
102239191|NCT03333083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102239192|NCT03333083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102239193|NCT03333083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102239194|NCT03333083|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102239195|NCT03333083|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102239196|NCT03093597|Petrolatum|petrolatum|mesh-list
102239197|NCT03093597|Emollients|emollients|mesh-ancestor
102239198|NCT03093597|Dermatologic Agents|dermatologic agents|mesh-ancestor
102239199|NCT03327155|Tenofovir|tenofovir|mesh-list
102239200|NCT03327155|Emtricitabine|emtricitabine|mesh-list
102239202|NCT03327155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102239203|NCT03327155|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101641276|NCT01007435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102239204|NCT03327155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102239205|NCT03327155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102239206|NCT03327155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239207|NCT03327155|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102239208|NCT03327155|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102239209|NCT05024877|Stanozolol|stanozolol|mesh-list
102239210|NCT05024877|Androgens|androgens|mesh-ancestor
102239211|NCT05024877|Hormones|hormones|mesh-ancestor
102239212|NCT05024877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102239213|NCT05024877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239214|NCT05024877|Anabolic Agents|anabolic agents|mesh-ancestor
102239215|NCT03079557|Botulinum Toxins|botulinum toxins|mesh-list
102239216|NCT03079557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102239217|NCT03079557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102239218|NCT03079557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102239219|NCT03079557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102239220|NCT03079557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239221|NCT03079557|Cholinergic Agents|cholinergic agents|mesh-ancestor
102239222|NCT03079557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102239223|NCT03079557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239224|NCT03079557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102239225|NCT03079557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102239226|NCT03230851|Aspirin|aspirin|mesh-list
102239227|NCT03230851|Indobufen|indobufen|mesh-list
102239228|NCT03230851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102239229|NCT03230851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102239230|NCT03230851|Analgesics|analgesics|mesh-ancestor
102239231|NCT03230851|Sensory System Agents|sensory system agents|mesh-ancestor
102239232|NCT03230851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102239233|NCT03230851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239234|NCT03230851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102239235|NCT03230851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102239236|NCT03230851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102239237|NCT03230851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102239238|NCT03230851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239239|NCT03230851|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102239240|NCT03230851|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102239241|NCT03230851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102239242|NCT03230851|Antipyretics|antipyretics|mesh-ancestor
102239243|NCT05464433|Tislelizumab|tislelizumab|mesh-list
102239244|NCT05464433|Mitoxantrone|mitoxantrone|mesh-list
102239245|NCT05464433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102239246|NCT05464433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102239247|NCT05464433|Analgesics|analgesics|mesh-ancestor
102239248|NCT05464433|Sensory System Agents|sensory system agents|mesh-ancestor
102239249|NCT05464433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102239250|NCT05464433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239251|NCT05464433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102239252|NCT05464433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102239253|NCT05464433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102239254|NCT05464433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239255|NCT03229135|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102239256|NCT03229135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102239257|NCT05024565|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102239258|NCT05024565|Lactams|lactams|mesh-list
102239259|NCT05024565|beta-Lactams|beta-lactams|mesh-list
102239260|NCT05024565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102612955|NCT00002561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102239261|NCT03228901|Oxytocin|oxytocin|mesh-list
102239262|NCT03228901|Oxytocics|oxytocics|mesh-ancestor
102612956|NCT00002561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102612957|NCT00002561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102239263|NCT03228901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102239264|NCT03228901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239265|NCT03228823|Amiodarone|amiodarone|mesh-list
102239266|NCT03228823|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
102239267|NCT03228823|Vasodilator Agents|vasodilator agents|mesh-ancestor
102239268|NCT03228823|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102239269|NCT03228823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102239270|NCT03228823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239271|NCT03228823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102239272|NCT03228823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102239273|NCT03228823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102239274|NCT03228823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102239275|NCT03228823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102239276|NCT03228823|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102239277|NCT03228823|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102239278|NCT03332225|Interferons|interferons|mesh-list
102239279|NCT03332225|Interferon-gamma|interferon-gamma|mesh-list
102239280|NCT03332225|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102239281|NCT03332225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102239282|NCT03332225|Antiviral Agents|antiviral agents|mesh-ancestor
102239283|NCT03332225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102239284|NCT03332225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102239285|NCT05023941|Acetazolamide|acetazolamide|mesh-list
101641330|NCT04060771|Antiemetics|antiemetics|mesh-ancestor
102239286|NCT05023941|Anticonvulsants|anticonvulsants|mesh-ancestor
102239287|NCT05023941|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102239288|NCT05023941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102239289|NCT05023941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239290|NCT05023941|Diuretics|diuretics|mesh-ancestor
102239291|NCT05023941|Natriuretic Agents|natriuretic agents|mesh-ancestor
102239292|NCT05023941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239293|NCT03332069|Cisplatin|cisplatin|mesh-list
102239294|NCT03332069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102239295|NCT03090087|Regadenoson|regadenoson|mesh-list
102239296|NCT03090087|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
102239297|NCT03090087|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102239298|NCT03090087|Purinergic Agonists|purinergic agonists|mesh-ancestor
102239299|NCT03090087|Purinergic Agents|purinergic agents|mesh-ancestor
102239300|NCT03090087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102239301|NCT03090087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239302|NCT03090087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239303|NCT03326609|Ropivacaine|ropivacaine|mesh-list
102239304|NCT03326609|Anesthetics, Local|anesthetics, local|mesh-ancestor
102239305|NCT03326609|Anesthetics|anesthetics|mesh-ancestor
102239306|NCT03326609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102239307|NCT03326609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239308|NCT03326609|Sensory System Agents|sensory system agents|mesh-ancestor
102239309|NCT03326609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102239310|NCT03331913|Botulinum Toxins|botulinum toxins|mesh-list
102239311|NCT03331913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102239312|NCT03331913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102239313|NCT03331913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102239314|NCT03331913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102239315|NCT03331913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239316|NCT03331913|Cholinergic Agents|cholinergic agents|mesh-ancestor
102239317|NCT03331913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102239318|NCT03331913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239319|NCT03331913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102239320|NCT03331913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102239321|NCT03090009|Flurbiprofen|flurbiprofen|mesh-list
102239322|NCT03090009|Analgesics|analgesics|mesh-ancestor
102239323|NCT03090009|Sensory System Agents|sensory system agents|mesh-ancestor
102239324|NCT03090009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102239325|NCT03090009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239326|NCT03090009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102239327|NCT03090009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102239328|NCT03090009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102239329|NCT03090009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102239330|NCT03090009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102239331|NCT03090009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102239332|NCT03090009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239333|NCT02492087|Tranexamic Acid|tranexamic acid|mesh-list
102239334|NCT02492087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102239335|NCT02492087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102239336|NCT02492087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239337|NCT02492087|Hemostatics|hemostatics|mesh-ancestor
102239338|NCT02492087|Coagulants|coagulants|mesh-ancestor
102239339|NCT03093129|Artesunate|artesunate|mesh-list
102239340|NCT03093129|Antimalarials|antimalarials|mesh-ancestor
102239341|NCT03093129|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102239342|NCT03093129|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102239343|NCT03093129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102239344|NCT03093129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102239345|NCT03093129|Antiviral Agents|antiviral agents|mesh-ancestor
102239346|NCT03093129|Schistosomicides|schistosomicides|mesh-ancestor
102239347|NCT03093129|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102239348|NCT03093129|Anthelmintics|anthelmintics|mesh-ancestor
102239349|NCT02491697|Capecitabine|capecitabine|mesh-list
102239350|NCT02491697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102239352|NCT02491697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239353|NCT02491697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102239354|NCT05024019|Nimotuzumab|nimotuzumab|mesh-list
102239355|NCT05024019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102239356|NCT05024019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102239357|NCT05008731|Botulinum Toxins|botulinum toxins|mesh-list
102239358|NCT05008731|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102239359|NCT05008731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102239360|NCT05008731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239361|NCT05008731|Cholinergic Agents|cholinergic agents|mesh-ancestor
102239362|NCT05008731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102239363|NCT05008731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239364|NCT03331523|Betamethasone|betamethasone|mesh-list
102239365|NCT03331523|Betamethasone Valerate|betamethasone valerate|mesh-list
102239366|NCT03331523|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102239367|NCT03331523|Betamethasone benzoate|betamethasone benzoate|mesh-list
102239368|NCT03331523|Calcipotriene|calcipotriene|mesh-list
102239369|NCT03331523|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102239370|NCT03331523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102239371|NCT03331523|Glucocorticoids|glucocorticoids|mesh-ancestor
102239372|NCT03331523|Hormones|hormones|mesh-ancestor
102239373|NCT03331523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102239374|NCT03331523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239375|NCT03331523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102239376|NCT03331523|Respiratory System Agents|respiratory system agents|mesh-ancestor
102239377|NCT03331523|Dermatologic Agents|dermatologic agents|mesh-ancestor
102239378|NCT05023863|Thioctic Acid|thioctic acid|mesh-list
102239379|NCT05023863|Antioxidants|antioxidants|mesh-ancestor
102239380|NCT05023863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239381|NCT05023863|Protective Agents|protective agents|mesh-ancestor
102239382|NCT05023863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239383|NCT05023863|Vitamin B Complex|vitamin b complex|mesh-ancestor
102239384|NCT05023863|Vitamins|vitamins|mesh-ancestor
102239385|NCT05023863|Micronutrients|micronutrients|mesh-ancestor
102239386|NCT05463809|Oxycodone|oxycodone|mesh-list
102239387|NCT05463809|Analgesics|analgesics|mesh-list
102239388|NCT05463809|Ropivacaine|ropivacaine|mesh-list
102239389|NCT05463809|Anesthetics, Local|anesthetics, local|mesh-ancestor
102239390|NCT05463809|Anesthetics|anesthetics|mesh-ancestor
102239391|NCT05463809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102239392|NCT05463809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239393|NCT05463809|Sensory System Agents|sensory system agents|mesh-ancestor
102239394|NCT05463809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102239395|NCT05463809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102239396|NCT05463809|Narcotics|narcotics|mesh-ancestor
102239397|NCT03331445|Nitric Oxide|nitric oxide|mesh-list
102239398|NCT03331445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102239399|NCT03331445|Autonomic Agents|autonomic agents|mesh-ancestor
102239400|NCT03331445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102239401|NCT03331445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239402|NCT03331445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101641444|NCT00688753|Everolimus|everolimus|mesh-list
102239403|NCT03331445|Respiratory System Agents|respiratory system agents|mesh-ancestor
102239404|NCT03331445|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102612958|NCT00002561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612959|NCT00002561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102612960|NCT00002561|Alkylating Agents|alkylating agents|mesh-ancestor
102612961|NCT00002561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102612962|NCT00002561|Tubulin Modulators|tubulin modulators|mesh-ancestor
102612963|NCT00002561|Antimitotic Agents|antimitotic agents|mesh-ancestor
102239405|NCT03331445|Antioxidants|antioxidants|mesh-ancestor
102239406|NCT03331445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239407|NCT03331445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102239408|NCT03331445|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102239409|NCT03331445|Vasodilator Agents|vasodilator agents|mesh-ancestor
102239410|NCT03331445|Gasotransmitters|gasotransmitters|mesh-ancestor
102239411|NCT03331445|Protective Agents|protective agents|mesh-ancestor
102239412|NCT05008029|Anesthetics|anesthetics|mesh-list
102239413|NCT05008029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102239414|NCT05008029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239415|NCT05008263|Liver Extracts|liver extracts|mesh-list
102239416|NCT05008263|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
102239417|NCT05008263|Hematinics|hematinics|mesh-ancestor
102239418|NCT05008263|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102239419|NCT05008263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239420|NCT03325127|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
102239421|NCT03325127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102239422|NCT05016063|Fludarabine|fludarabine|mesh-list
102239423|NCT05016063|Cyclophosphamide|cyclophosphamide|mesh-list
102239424|NCT05016063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102239425|NCT05016063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239426|NCT05016063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102239427|NCT05016063|Immunologic Factors|immunologic factors|mesh-ancestor
102239428|NCT05016063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239429|NCT05016063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102239430|NCT05016063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102239431|NCT05016063|Alkylating Agents|alkylating agents|mesh-ancestor
102239432|NCT05016063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102239433|NCT03078933|Nitric Oxide|nitric oxide|mesh-list
102239434|NCT03078933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102239435|NCT03078933|Autonomic Agents|autonomic agents|mesh-ancestor
102239436|NCT03078933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102239437|NCT03078933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239438|NCT03078933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102239439|NCT03078933|Respiratory System Agents|respiratory system agents|mesh-ancestor
102239440|NCT03078933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102239441|NCT03078933|Antioxidants|antioxidants|mesh-ancestor
102239442|NCT03078933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239443|NCT03078933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102239444|NCT03078933|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102239445|NCT03078933|Vasodilator Agents|vasodilator agents|mesh-ancestor
102239446|NCT03078933|Gasotransmitters|gasotransmitters|mesh-ancestor
102239447|NCT03078933|Protective Agents|protective agents|mesh-ancestor
102239448|NCT03092193|Naproxen|naproxen|mesh-list
102239449|NCT03092193|Esomeprazole|esomeprazole|mesh-list
102239450|NCT03092193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102239451|NCT03092193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102239452|NCT03092193|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102239453|NCT03092193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102239454|NCT03092193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239455|NCT03092193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102239456|NCT03092193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102239457|NCT03092193|Analgesics|analgesics|mesh-ancestor
102239458|NCT03092193|Sensory System Agents|sensory system agents|mesh-ancestor
102239459|NCT03092193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102239460|NCT03092193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239461|NCT03092193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102239462|NCT03092193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102239463|NCT03092193|Gout Suppressants|gout suppressants|mesh-ancestor
102239464|NCT03092193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102239465|NCT05015907|Ropivacaine|ropivacaine|mesh-list
102239466|NCT05015907|Anesthetics, Local|anesthetics, local|mesh-ancestor
102239467|NCT05015907|Anesthetics|anesthetics|mesh-ancestor
102239468|NCT05015907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102239469|NCT05015907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239470|NCT05015907|Sensory System Agents|sensory system agents|mesh-ancestor
102239471|NCT05015907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102239472|NCT05015595|Memantine|memantine|mesh-list
102239473|NCT05015595|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102239474|NCT05015595|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102239475|NCT05015595|Dopamine Agents|dopamine agents|mesh-ancestor
102239476|NCT05015595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102239477|NCT05015595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239478|NCT05015595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102612964|NCT00002561|Mitosis Modulators|mitosis modulators|mesh-ancestor
102239479|NCT05015595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102239480|NCT05015595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102239481|NCT05015829|Dobutamine|dobutamine|mesh-list
102239482|NCT05015829|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102239483|NCT05015829|Sympathomimetics|sympathomimetics|mesh-ancestor
102239484|NCT05015829|Autonomic Agents|autonomic agents|mesh-ancestor
102239485|NCT05015829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102239486|NCT05015829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239487|NCT05015829|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102239488|NCT05015829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102239489|NCT05015829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102239490|NCT05015829|Adrenergic Agents|adrenergic agents|mesh-ancestor
102239491|NCT05015829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102239492|NCT05015829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239493|NCT05015829|Protective Agents|protective agents|mesh-ancestor
102239494|NCT05015361|Propofol|propofol|mesh-list
102239495|NCT05015361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102239496|NCT05015361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102239497|NCT05015361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239498|NCT05015361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102239499|NCT05015361|Anesthetics, General|anesthetics, general|mesh-ancestor
102239501|NCT01375075|Atorvastatin|atorvastatin|mesh-list
102239502|NCT01375075|Evacetrapib|evacetrapib|mesh-list
102239503|NCT01375075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102239504|NCT01375075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102239505|NCT01375075|Antimetabolites|antimetabolites|mesh-ancestor
102239506|NCT01375075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239507|NCT01375075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102239508|NCT01375075|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102239509|NCT01375075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102239510|NCT00706433|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102239511|NCT00706433|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102239512|NCT00706433|Dermatologic Agents|dermatologic agents|mesh-ancestor
102239513|NCT03240055|Etomidate|etomidate|mesh-list
102239514|NCT03240055|Anesthetics|anesthetics|mesh-ancestor
102239515|NCT03240055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102239516|NCT03240055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239517|NCT03240055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102239518|NCT03240055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102239519|NCT03240055|Anesthetics, General|anesthetics, general|mesh-ancestor
102239520|NCT03087201|Nabiximols|nabiximols|mesh-list
102239521|NCT03087201|Analgesics|analgesics|mesh-ancestor
102239522|NCT03087201|Sensory System Agents|sensory system agents|mesh-ancestor
102239523|NCT03087201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102239524|NCT03087201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239525|NCT03230539|Ulipristal acetate|ulipristal acetate|mesh-list
102239526|NCT03230539|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102239527|NCT03230539|Contraceptive Agents|contraceptive agents|mesh-ancestor
102239528|NCT03230539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102239529|NCT03230539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239530|NCT03230539|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102239531|NCT03239743|Midazolam|midazolam|mesh-list
102239532|NCT03239743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102239533|NCT03239743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102239534|NCT03239743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102239535|NCT03239743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239536|NCT03239743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102239537|NCT03239743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102239538|NCT03239743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102239539|NCT03239743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102239540|NCT03239743|Anesthetics, General|anesthetics, general|mesh-ancestor
102239541|NCT03239743|Anesthetics|anesthetics|mesh-ancestor
102239542|NCT03239743|GABA Modulators|gaba modulators|mesh-ancestor
102239543|NCT03239743|GABA Agents|gaba agents|mesh-ancestor
102239544|NCT03239743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102239545|NCT03239743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239546|NCT03239821|Codeine|codeine|mesh-list
102239547|NCT03239821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102239548|NCT03239821|Narcotics|narcotics|mesh-ancestor
102239549|NCT03239821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102239550|NCT03239821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239551|NCT03239821|Analgesics|analgesics|mesh-ancestor
102239552|NCT03239821|Sensory System Agents|sensory system agents|mesh-ancestor
102239553|NCT03239821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102239554|NCT03239821|Antitussive Agents|antitussive agents|mesh-ancestor
102239555|NCT03239821|Respiratory System Agents|respiratory system agents|mesh-ancestor
102239556|NCT03230227|Bupivacaine|bupivacaine|mesh-list
102239557|NCT03230227|Anesthetics, Local|anesthetics, local|mesh-ancestor
102239558|NCT03230227|Anesthetics|anesthetics|mesh-ancestor
102239559|NCT03230227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102239560|NCT03230227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239561|NCT03230227|Sensory System Agents|sensory system agents|mesh-ancestor
102239562|NCT03230227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102239563|NCT03078465|Clopidogrel|clopidogrel|mesh-list
102239564|NCT03078465|Ticagrelor|ticagrelor|mesh-list
102239565|NCT03078465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102239566|NCT03078465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102239567|NCT03078465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102239568|NCT03078465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102239569|NCT03078465|Purinergic Agents|purinergic agents|mesh-ancestor
102239570|NCT03078465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102239571|NCT03078465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239572|NCT03078465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239573|NCT03324815|Morphine|morphine|mesh-list
102239574|NCT03324815|Methadone|methadone|mesh-list
102239575|NCT03324815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102239576|NCT03324815|Narcotics|narcotics|mesh-ancestor
102239577|NCT03324815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102239578|NCT03324815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239579|NCT03324815|Analgesics|analgesics|mesh-ancestor
102239580|NCT03324815|Sensory System Agents|sensory system agents|mesh-ancestor
102239581|NCT03324815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102239582|NCT03324815|Antitussive Agents|antitussive agents|mesh-ancestor
102239583|NCT03324815|Respiratory System Agents|respiratory system agents|mesh-ancestor
102239584|NCT05006469|Dexamethasone|dexamethasone|mesh-list
102239585|NCT05006469|Doxorubicin|doxorubicin|mesh-list
102239586|NCT05006469|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102239587|NCT05006469|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102239588|NCT05006469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102239589|NCT05006469|Antiemetics|antiemetics|mesh-ancestor
102239590|NCT05006469|Autonomic Agents|autonomic agents|mesh-ancestor
102239591|NCT05006469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102239592|NCT05006469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239593|NCT05006469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102239594|NCT05006469|Glucocorticoids|glucocorticoids|mesh-ancestor
102239595|NCT05006469|Hormones|hormones|mesh-ancestor
102239596|NCT05006469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102239597|NCT05006469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102239598|NCT05006469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102239599|NCT05006469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102239600|NCT05006469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239601|NCT05006469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102239602|NCT05006469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102239603|NCT05006469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102239604|NCT05006469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102239605|NCT05006469|Alkylating Agents|alkylating agents|mesh-ancestor
102239606|NCT03084783|Dexamethasone|dexamethasone|mesh-list
101641616|NCT00954512|Antidotes|antidotes|mesh-ancestor
102239607|NCT03084783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102239608|NCT03084783|Antiemetics|antiemetics|mesh-ancestor
102239609|NCT03084783|Autonomic Agents|autonomic agents|mesh-ancestor
102239610|NCT03084783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102239611|NCT03084783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239612|NCT03084783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102239613|NCT03084783|Glucocorticoids|glucocorticoids|mesh-ancestor
102239614|NCT03084783|Hormones|hormones|mesh-ancestor
102239615|NCT03084783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102239616|NCT03084783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102239617|NCT03084783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102239618|NCT03228355|Cromakalim|cromakalim|mesh-list
102239619|NCT03228355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102239620|NCT03228355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102239621|NCT03228355|Autonomic Agents|autonomic agents|mesh-ancestor
102239622|NCT03228355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102239623|NCT03228355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239624|NCT03228355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102239625|NCT03228355|Respiratory System Agents|respiratory system agents|mesh-ancestor
102239626|NCT03228355|Parasympatholytics|parasympatholytics|mesh-ancestor
102239627|NCT03228355|Vasodilator Agents|vasodilator agents|mesh-ancestor
102239628|NCT03324503|Prednisone|prednisone|mesh-list
102239629|NCT03324503|Prednisolone|prednisolone|mesh-list
102612965|NCT00002567|Etoposide|etoposide|mesh-list
102612966|NCT00002567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102239630|NCT03324503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102239631|NCT03324503|Methylprednisolone|methylprednisolone|mesh-list
102239632|NCT03324503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102239633|NCT03324503|Prednisolone acetate|prednisolone acetate|mesh-list
102239634|NCT03324503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102239635|NCT03324503|Prednisolone phosphate|prednisolone phosphate|mesh-list
102239636|NCT03324503|Glucocorticoids|glucocorticoids|mesh-list
102239637|NCT03324503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102239639|NCT03324503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102239640|NCT03324503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239641|NCT03324503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102239642|NCT03324503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102239643|NCT03324503|Antiemetics|antiemetics|mesh-ancestor
102239644|NCT03324503|Autonomic Agents|autonomic agents|mesh-ancestor
102239645|NCT03324503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102239646|NCT03324503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102239647|NCT03324503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102239648|NCT03324503|Protective Agents|protective agents|mesh-ancestor
102239649|NCT05006001|Colchicine|colchicine|mesh-list
101948471|NCT01287741|Hormones|hormones|mesh-ancestor
102239650|NCT05006001|Gout Suppressants|gout suppressants|mesh-ancestor
102239651|NCT05006001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102239652|NCT05006001|Tubulin Modulators|tubulin modulators|mesh-ancestor
102239653|NCT05006001|Antimitotic Agents|antimitotic agents|mesh-ancestor
102239654|NCT05006001|Mitosis Modulators|mitosis modulators|mesh-ancestor
102239655|NCT05006001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239656|NCT05006001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102239657|NCT04493489|Propranolol|propranolol|mesh-list
102239658|NCT04493489|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102239659|NCT04493489|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102239660|NCT04493489|Adrenergic Agents|adrenergic agents|mesh-ancestor
102239661|NCT04493489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102239662|NCT04493489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239663|NCT04493489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239664|NCT04493489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102239665|NCT04493489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102239666|NCT04493489|Vasodilator Agents|vasodilator agents|mesh-ancestor
102239667|NCT03228043|Apatinib|apatinib|mesh-list
102239668|NCT03228043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102239669|NCT03228043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102239670|NCT03228043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102239671|NCT03228043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239672|NCT03119857|Docetaxel|docetaxel|mesh-list
102239673|NCT03119857|Androgen Antagonists|androgen antagonists|mesh-list
102239674|NCT03119857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102239675|NCT03119857|Tubulin Modulators|tubulin modulators|mesh-ancestor
102239676|NCT03119857|Antimitotic Agents|antimitotic agents|mesh-ancestor
102239677|NCT03119857|Mitosis Modulators|mitosis modulators|mesh-ancestor
102239678|NCT03119857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239679|NCT03119857|Hormone Antagonists|hormone antagonists|mesh-ancestor
102239680|NCT03119857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101298838|NCT05968846|Iodine|iodine|mesh-list
102239681|NCT03119857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239682|NCT03320603|Thrombin|thrombin|mesh-list
102239683|NCT03320603|Hemostatics|hemostatics|mesh-ancestor
102239684|NCT03320603|Coagulants|coagulants|mesh-ancestor
102239685|NCT03227653|Ritonavir|ritonavir|mesh-list
102239686|NCT03227653|Lopinavir|lopinavir|mesh-list
102239687|NCT03227653|Nevirapine|nevirapine|mesh-list
102239688|NCT03227653|Efavirenz|efavirenz|mesh-list
102239689|NCT03227653|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102239690|NCT03227653|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102239691|NCT03227653|Protease Inhibitors|protease inhibitors|mesh-ancestor
102239692|NCT03227653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102239693|NCT03227653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239694|NCT03227653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102239695|NCT03227653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102239696|NCT03227653|Antiviral Agents|antiviral agents|mesh-ancestor
102239697|NCT03227653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102239698|NCT03227653|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102239699|NCT03227653|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102239700|NCT03227653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102239701|NCT03227653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102239702|NCT03227653|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102612967|NCT00002567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102612968|NCT00002567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102239703|NCT03227653|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102239704|NCT03227653|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102239705|NCT03227653|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102239706|NCT03227653|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102239707|NCT03320447|Lidocaine|lidocaine|mesh-list
102239708|NCT03320447|Prilocaine|prilocaine|mesh-list
102239709|NCT03320447|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
102239710|NCT03320447|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102239711|NCT03320447|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
102239712|NCT03320447|Anesthetics, Local|anesthetics, local|mesh-ancestor
102239713|NCT03320447|Anesthetics|anesthetics|mesh-ancestor
102239714|NCT03320447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102239715|NCT03320447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239716|NCT03320447|Sensory System Agents|sensory system agents|mesh-ancestor
102239717|NCT03320447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102239718|NCT03320447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102239719|NCT03320447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102239720|NCT03320447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102239721|NCT03320447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102239722|NCT03320447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948547|NCT01181193|Vitamin D|vitamin d|mesh-list
101641717|NCT00730756|Xhance|xhance|mesh-list
102239723|NCT03320447|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102239724|NCT03320447|Dermatologic Agents|dermatologic agents|mesh-ancestor
102239725|NCT03320447|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
102239726|NCT04434105|Triamcinolone|triamcinolone|mesh-list
102239727|NCT04434105|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102239728|NCT04434105|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102239729|NCT04434105|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102239730|NCT04434105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102239731|NCT04434105|Glucocorticoids|glucocorticoids|mesh-ancestor
102239732|NCT04434105|Hormones|hormones|mesh-ancestor
102239733|NCT04434105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102239734|NCT04434105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239735|NCT04434105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102239736|NCT04434105|Immunologic Factors|immunologic factors|mesh-ancestor
102239737|NCT04434105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102239738|NCT04434105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239739|NCT03078777|Fexofenadine|fexofenadine|mesh-list
102239740|NCT03078777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102239741|NCT03078777|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102239742|NCT03078777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102239743|NCT03078777|Histamine Antagonists|histamine antagonists|mesh-ancestor
102239744|NCT03078777|Histamine Agents|histamine agents|mesh-ancestor
102239745|NCT03078777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102239746|NCT03078777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239747|NCT03078777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239748|NCT03078309|Cannabidiol|cannabidiol|mesh-list
102239749|NCT03078309|Anticonvulsants|anticonvulsants|mesh-ancestor
102239750|NCT03227419|Abatacept|abatacept|mesh-list
102239751|NCT03227419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102239752|NCT03227419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239753|NCT03227419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102239754|NCT03227419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102239755|NCT03227419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102239756|NCT03227419|Immunologic Factors|immunologic factors|mesh-ancestor
102239757|NCT03227419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239758|NCT03227419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102239759|NCT03208309|Diacerein|diacerein|mesh-list
102239760|NCT03208309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102239761|NCT03091803|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
102239762|NCT03091803|Chelating Agents|chelating agents|mesh-ancestor
102239763|NCT03091803|Sequestering Agents|sequestering agents|mesh-ancestor
102239764|NCT03091803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239765|NCT03323567|Lidocaine|lidocaine|mesh-list
102239766|NCT03323567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102239767|NCT03323567|Anesthetics, Local|anesthetics, local|mesh-ancestor
102239768|NCT03323567|Anesthetics|anesthetics|mesh-ancestor
102239769|NCT03323567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102239770|NCT03323567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239771|NCT03323567|Sensory System Agents|sensory system agents|mesh-ancestor
102612969|NCT00002567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102239772|NCT03323567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102239773|NCT03323567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102239774|NCT03323567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102239775|NCT03323567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102239776|NCT03323567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102239777|NCT03323567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239778|NCT04492709|Midazolam|midazolam|mesh-list
102239779|NCT04492709|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102239780|NCT04492709|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102239781|NCT04492709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102239782|NCT04492709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239783|NCT04492709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102239784|NCT04492709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102239785|NCT04492709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102239786|NCT04492709|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102239787|NCT04492709|Anesthetics, General|anesthetics, general|mesh-ancestor
102239788|NCT04492709|Anesthetics|anesthetics|mesh-ancestor
102239789|NCT04492709|GABA Modulators|gaba modulators|mesh-ancestor
102239790|NCT04492709|GABA Agents|gaba agents|mesh-ancestor
102239791|NCT04492709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102239792|NCT04492709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239793|NCT05006235|Epinephrine|epinephrine|mesh-list
102239794|NCT05006235|Albuterol|albuterol|mesh-list
102239795|NCT05006235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102239796|NCT05006235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102239797|NCT05006235|Adrenergic Agents|adrenergic agents|mesh-ancestor
102239798|NCT05006235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102239799|NCT05006235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239800|NCT05006235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239801|NCT05006235|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102239802|NCT05006235|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102239803|NCT05006235|Autonomic Agents|autonomic agents|mesh-ancestor
102239804|NCT05006235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102239805|NCT05006235|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102239806|NCT05006235|Respiratory System Agents|respiratory system agents|mesh-ancestor
102239807|NCT05006235|Mydriatics|mydriatics|mesh-ancestor
102239808|NCT05006235|Sympathomimetics|sympathomimetics|mesh-ancestor
102239809|NCT05006235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102239810|NCT05006235|Tocolytic Agents|tocolytic agents|mesh-ancestor
102239811|NCT05006235|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102239812|NCT05006235|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102239813|NCT03319823|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
102239814|NCT03319823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102239815|NCT03319823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239816|NCT03319823|Diuretics|diuretics|mesh-ancestor
102239817|NCT03319823|Natriuretic Agents|natriuretic agents|mesh-ancestor
102239818|NCT03319823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239820|NCT02487953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102239821|NCT02487953|Autonomic Agents|autonomic agents|mesh-ancestor
102239822|NCT02487953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102239823|NCT02487953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239824|NCT02487953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102239825|NCT02487953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102239826|NCT02487953|Cholinergic Agents|cholinergic agents|mesh-ancestor
102239827|NCT02487953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102239828|NCT02487953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239829|NCT03091569|Vitamin K|vitamin k|mesh-list
102239830|NCT03091569|Vitamins|vitamins|mesh-ancestor
102239831|NCT03091569|Micronutrients|micronutrients|mesh-ancestor
102239832|NCT03091569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239833|NCT03091569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102239834|NCT03091569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102239835|NCT03091569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239836|NCT03091569|Hemostatics|hemostatics|mesh-ancestor
102239837|NCT03091569|Coagulants|coagulants|mesh-ancestor
102239838|NCT04948749|Sirolimus|sirolimus|mesh-list
102239839|NCT04948749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102239840|NCT04948749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102612970|NCT00002567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241633|NCT03070665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102612971|NCT00002567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612972|NCT00002579|Tamoxifen|tamoxifen|mesh-list
102612973|NCT00002579|Cyclophosphamide|cyclophosphamide|mesh-list
102612974|NCT00002579|Fluorouracil|fluorouracil|mesh-list
102612975|NCT00002579|Methotrexate|methotrexate|mesh-list
102612976|NCT00002579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102239841|NCT04948749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102239842|NCT04948749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102239843|NCT04948749|Antifungal Agents|antifungal agents|mesh-ancestor
102239844|NCT04948749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102239845|NCT04948749|Immunologic Factors|immunologic factors|mesh-ancestor
102239846|NCT04948749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239847|NCT03226717|Antiviral Agents|antiviral agents|mesh-list
102239848|NCT03226717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102239849|NCT02487719|Teferrol|teferrol|mesh-list
102239850|NCT02487719|Hematinics|hematinics|mesh-ancestor
102239851|NCT03207295|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
102239852|NCT03207295|Natriuretic Agents|natriuretic agents|mesh-ancestor
102239853|NCT03207295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239854|NCT04940871|Favipiravir|favipiravir|mesh-list
102239855|NCT04940871|Antiviral Agents|antiviral agents|mesh-ancestor
102239856|NCT04940871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102239857|NCT03207139|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102239858|NCT03207139|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102239859|NCT03207139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239860|NCT03080415|Sofosbuvir|sofosbuvir|mesh-list
102239861|NCT03080415|Antiviral Agents|antiviral agents|mesh-ancestor
102239862|NCT03080415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102239863|NCT03221881|Docetaxel|docetaxel|mesh-list
102239864|NCT03221881|Doxorubicin|doxorubicin|mesh-list
102239865|NCT03221881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102239866|NCT03221881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102239867|NCT03221881|Tubulin Modulators|tubulin modulators|mesh-ancestor
102239868|NCT03221881|Antimitotic Agents|antimitotic agents|mesh-ancestor
102239869|NCT03221881|Mitosis Modulators|mitosis modulators|mesh-ancestor
102239870|NCT03221881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239871|NCT03221881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102239872|NCT03221881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102239873|NCT03221881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102239874|NCT03221881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102239875|NCT03091257|Trametinib|trametinib|mesh-list
102239876|NCT03091257|Dabrafenib|dabrafenib|mesh-list
102239877|NCT03091257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102239878|NCT03091257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102239879|NCT03091257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102239880|NCT03091257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239881|NCT03206671|Cytarabine|cytarabine|mesh-list
102239882|NCT03206671|Dexamethasone|dexamethasone|mesh-list
102239883|NCT03206671|Prednisolone|prednisolone|mesh-list
102239884|NCT03206671|Cyclophosphamide|cyclophosphamide|mesh-list
102239885|NCT03206671|Ifosfamide|ifosfamide|mesh-list
102239886|NCT03206671|Rituximab|rituximab|mesh-list
102239887|NCT03206671|Doxorubicin|doxorubicin|mesh-list
102239888|NCT03206671|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102239889|NCT03206671|Methotrexate|methotrexate|mesh-list
102239890|NCT03206671|Etoposide|etoposide|mesh-list
102239891|NCT03206671|Vincristine|vincristine|mesh-list
102239892|NCT03206671|Vindesine|vindesine|mesh-list
102239893|NCT03206671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102239894|NCT03206671|Immunologic Factors|immunologic factors|mesh-ancestor
102239895|NCT03206671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239896|NCT03206671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102239897|NCT03206671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102239898|NCT03206671|Alkylating Agents|alkylating agents|mesh-ancestor
102239899|NCT03206671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239900|NCT03206671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102239901|NCT03206671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102239902|NCT03206671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102239903|NCT03206671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102239904|NCT03206671|Antiemetics|antiemetics|mesh-ancestor
102239905|NCT03206671|Autonomic Agents|autonomic agents|mesh-ancestor
102239906|NCT03206671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102239907|NCT03206671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102239908|NCT03206671|Glucocorticoids|glucocorticoids|mesh-ancestor
102239909|NCT03206671|Hormones|hormones|mesh-ancestor
102239910|NCT03206671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102239911|NCT03206671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102239912|NCT03206671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102239913|NCT03206671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102239914|NCT03206671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102239915|NCT03206671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102239916|NCT03206671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102239917|NCT03206671|Abortifacient Agents|abortifacient agents|mesh-ancestor
102239918|NCT03206671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102239919|NCT03206671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102239920|NCT03206671|Antimetabolites|antimetabolites|mesh-ancestor
102239921|NCT03206671|Dermatologic Agents|dermatologic agents|mesh-ancestor
102239922|NCT03206671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102239923|NCT03206671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102239924|NCT03206671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102239925|NCT03206671|Antiviral Agents|antiviral agents|mesh-ancestor
102239926|NCT03206671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102239927|NCT03206671|Tubulin Modulators|tubulin modulators|mesh-ancestor
102239928|NCT03206671|Antimitotic Agents|antimitotic agents|mesh-ancestor
102239929|NCT03206671|Mitosis Modulators|mitosis modulators|mesh-ancestor
102239930|NCT03078231|Mydriatics|mydriatics|mesh-list
102239931|NCT03078231|Autonomic Agents|autonomic agents|mesh-ancestor
102239932|NCT03078231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102239933|NCT03078231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239934|NCT03319121|Theophylline|theophylline|mesh-list
102239935|NCT03319121|Dexlansoprazole|dexlansoprazole|mesh-list
102239936|NCT03319121|Lansoprazole|lansoprazole|mesh-list
102239937|NCT03319121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102239938|NCT03319121|Autonomic Agents|autonomic agents|mesh-ancestor
102239939|NCT03319121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102239940|NCT03319121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239941|NCT03319121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102239942|NCT03319121|Respiratory System Agents|respiratory system agents|mesh-ancestor
102239943|NCT03319121|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102239944|NCT03319121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102239945|NCT03319121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239946|NCT03319121|Vasodilator Agents|vasodilator agents|mesh-ancestor
101948768|NCT06006949|Luspatercept|luspatercept|mesh-list
102239947|NCT03319121|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102239948|NCT03319121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102239949|NCT03319121|Purinergic Agents|purinergic agents|mesh-ancestor
102239950|NCT03319121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102239951|NCT03319121|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102239952|NCT03319121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102239953|NCT03319121|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102239954|NCT02487407|Simendan|simendan|mesh-list
102239955|NCT02487407|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102239956|NCT02487407|Vasodilator Agents|vasodilator agents|mesh-ancestor
102239957|NCT02487407|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102239958|NCT02487407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102239959|NCT02487407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102239960|NCT02487407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239961|NCT02487407|Protective Agents|protective agents|mesh-ancestor
102239962|NCT02487407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239963|NCT03221569|Ketorolac|ketorolac|mesh-list
102239964|NCT03221569|Ketamine|ketamine|mesh-list
102239965|NCT03221569|Analgesics|analgesics|mesh-ancestor
102239966|NCT03221569|Sensory System Agents|sensory system agents|mesh-ancestor
102239967|NCT03221569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102239968|NCT03221569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641906|NCT02594410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102239969|NCT03221569|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102239970|NCT03221569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102239971|NCT03221569|Anesthetics, General|anesthetics, general|mesh-ancestor
102239972|NCT03221569|Anesthetics|anesthetics|mesh-ancestor
102239973|NCT03221569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102239974|NCT03221569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102239975|NCT03221569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102239976|NCT03221569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102239977|NCT03221569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102239978|NCT03221569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102239979|NCT03221569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102239980|NCT03221569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102239981|NCT03221569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102239982|NCT03221569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102239983|NCT03221569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102239984|NCT03319043|Budesonide|budesonide|mesh-list
102239985|NCT03319043|Formoterol Fumarate|formoterol fumarate|mesh-list
102239986|NCT03319043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102239987|NCT03319043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102239988|NCT03319043|Autonomic Agents|autonomic agents|mesh-ancestor
102239989|NCT03319043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101901439|NCT01289756|Enclomiphene|enclomiphene|mesh-list
102612978|NCT00002579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102612979|NCT00002579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102239990|NCT03319043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102239991|NCT03319043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102239992|NCT03319043|Respiratory System Agents|respiratory system agents|mesh-ancestor
102239993|NCT03319043|Glucocorticoids|glucocorticoids|mesh-ancestor
102239994|NCT03319043|Hormones|hormones|mesh-ancestor
102239995|NCT03319043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102239996|NCT03319043|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102239997|NCT03319043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102239998|NCT03319043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102239999|NCT03319043|Adrenergic Agents|adrenergic agents|mesh-ancestor
102240000|NCT03319043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102240001|NCT03319043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240002|NCT02451475|Amitriptyline|amitriptyline|mesh-list
102240003|NCT02451475|Paroxetine|paroxetine|mesh-list
102240004|NCT02451475|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102240005|NCT02451475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102240006|NCT02451475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102240007|NCT02451475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102240008|NCT02451475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240009|NCT02451475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102240010|NCT02451475|Serotonin Agents|serotonin agents|mesh-ancestor
102240011|NCT02451475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240012|NCT02451475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102240013|NCT02451475|Antidepressive Agents|antidepressive agents|mesh-ancestor
102240014|NCT02451475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102240015|NCT02451475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102240016|NCT02451475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102240017|NCT02451475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102240018|NCT02451475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102240019|NCT02451475|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102240020|NCT02451475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102240021|NCT02451475|Analgesics|analgesics|mesh-ancestor
102240022|NCT02451475|Sensory System Agents|sensory system agents|mesh-ancestor
102240023|NCT02451475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102240024|NCT02451475|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102240025|NCT02451475|Adrenergic Agents|adrenergic agents|mesh-ancestor
102240026|NCT05019417|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
102240027|NCT05019417|Glycerol|glycerol|mesh-list
102240028|NCT05019417|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102240029|NCT05019417|Protective Agents|protective agents|mesh-ancestor
102240030|NCT05019417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240031|NCT05019417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102240032|NCT03225937|Trastuzumab|trastuzumab|mesh-list
102240033|NCT03225937|Pertuzumab|pertuzumab|mesh-list
102240034|NCT03225937|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102240035|NCT03225937|Lapatinib|lapatinib|mesh-list
102240036|NCT03225937|Maytansine|maytansine|mesh-list
102240037|NCT03225937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102240038|NCT03225937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102240039|NCT03225937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102240040|NCT03225937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102240041|NCT03225937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240042|NCT03225937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102240043|NCT03225937|Tubulin Modulators|tubulin modulators|mesh-ancestor
102240044|NCT03225937|Antimitotic Agents|antimitotic agents|mesh-ancestor
102240045|NCT03225937|Mitosis Modulators|mitosis modulators|mesh-ancestor
102240046|NCT03225937|Immunotoxins|immunotoxins|mesh-ancestor
102240047|NCT03225937|Immunoconjugates|immunoconjugates|mesh-ancestor
102240048|NCT03225937|Immunologic Factors|immunologic factors|mesh-ancestor
102240049|NCT03225937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240050|NCT03318887|Ribavirin|ribavirin|mesh-list
102240051|NCT03318887|Sofosbuvir|sofosbuvir|mesh-list
102240052|NCT03318887|Antimetabolites|antimetabolites|mesh-ancestor
102240053|NCT03318887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240054|NCT03318887|Antiviral Agents|antiviral agents|mesh-ancestor
102240055|NCT03318887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102240056|NCT03119077|Itraconazole|itraconazole|mesh-list
102240057|NCT03119077|Antifungal Agents|antifungal agents|mesh-ancestor
102240058|NCT03119077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102240059|NCT03119077|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102240060|NCT03119077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102240061|NCT03119077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102240062|NCT03119077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612980|NCT00002579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102240063|NCT03119077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102240064|NCT03119077|Hormone Antagonists|hormone antagonists|mesh-ancestor
102240065|NCT03119077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102240066|NCT03119077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240067|NCT03119077|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102240068|NCT02487329|Calcium, Dietary|calcium, dietary|mesh-list
102240069|NCT02487329|Calcium|calcium|mesh-list
102240070|NCT02487329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102240071|NCT02487329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240072|NCT02487329|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102240073|NCT03318731|Fenugreek seed meal|fenugreek seed meal|mesh-list
102240074|NCT03318731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102240075|NCT03318731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240076|NCT03080103|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102240077|NCT03080103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102240078|NCT04493099|Decitabine|decitabine|mesh-list
102240079|NCT04493099|Venetoclax|venetoclax|mesh-list
102240080|NCT04493099|Alvocidib|alvocidib|mesh-list
102240081|NCT04493099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102240082|NCT04493099|Antimetabolites|antimetabolites|mesh-ancestor
102240083|NCT04493099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240084|NCT04493099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102240085|NCT04493099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102240086|NCT04493099|Growth Inhibitors|growth inhibitors|mesh-ancestor
102240087|NCT04493099|Growth Substances|growth substances|mesh-ancestor
102240088|NCT04493099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240089|NCT04493099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102240090|NCT05004909|Tretinoin|tretinoin|mesh-list
102240091|NCT05004909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102240092|NCT05004909|Keratolytic Agents|keratolytic agents|mesh-ancestor
102240093|NCT05004909|Dermatologic Agents|dermatologic agents|mesh-ancestor
102240094|NCT03119623|Valsartan|valsartan|mesh-list
102240095|NCT03119623|Enalapril|enalapril|mesh-list
102240096|NCT03119623|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102240097|NCT03119623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102240098|NCT03119623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102240099|NCT03119623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101642002|NCT00736450|Hormones|hormones|mesh-ancestor
102240100|NCT03119623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240101|NCT03119623|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102240102|NCT03119623|Protease Inhibitors|protease inhibitors|mesh-ancestor
102240103|NCT03119623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102240105|NCT03318419|Pegaspargase|pegaspargase|mesh-list
102240106|NCT03318419|Asparaginase|asparaginase|mesh-list
102240107|NCT03318419|Cladribine|cladribine|mesh-list
102240108|NCT03318419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102240109|NCT03318419|Antimetabolites|antimetabolites|mesh-ancestor
102240110|NCT03318419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240111|NCT03318419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102240112|NCT03318419|Antiviral Agents|antiviral agents|mesh-ancestor
102240113|NCT03318419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102240114|NCT03318419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102240115|NCT03318419|Immunologic Factors|immunologic factors|mesh-ancestor
102240116|NCT03318419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240117|NCT03321773|Amoxicillin|amoxicillin|mesh-list
102240118|NCT03321773|Metronidazole|metronidazole|mesh-list
102240119|NCT03321773|Clarithromycin|clarithromycin|mesh-list
102240120|NCT03321773|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
102240121|NCT03321773|Pantoprazole|pantoprazole|mesh-list
102240122|NCT03321773|Bismuth|bismuth|mesh-list
102240123|NCT03321773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102240124|NCT03321773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102240125|NCT03321773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102240126|NCT03321773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102240127|NCT03321773|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102240128|NCT03321773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102240129|NCT03321773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240130|NCT03321773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102240131|NCT03321773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102240132|NCT03321773|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102240133|NCT03321773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102240134|NCT03321773|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102240135|NCT03321773|Antacids|antacids|mesh-ancestor
102240136|NCT03077217|Rifaximin|rifaximin|mesh-list
102240137|NCT03077217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102240138|NCT03077217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102240139|NCT03077217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102240140|NCT05001243|Bromfenac|bromfenac|mesh-list
102240141|NCT05001243|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102240142|NCT05001243|Phenylephrine|phenylephrine|mesh-list
102240143|NCT05001243|Oxymetazoline|oxymetazoline|mesh-list
102240144|NCT05001243|Hyaluronic Acid|hyaluronic acid|mesh-list
102240145|NCT05001243|Pilocarpine|pilocarpine|mesh-list
102240146|NCT05001243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102240147|NCT05001243|Immunologic Factors|immunologic factors|mesh-ancestor
102240148|NCT05001243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240149|NCT05001243|Viscosupplements|viscosupplements|mesh-ancestor
102240150|NCT05001243|Protective Agents|protective agents|mesh-ancestor
102240151|NCT05001243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102240152|NCT05001243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102240153|NCT05001243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102240154|NCT05001243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102240155|NCT05001243|Adrenergic Agents|adrenergic agents|mesh-ancestor
102240156|NCT05001243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102240157|NCT05001243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240158|NCT05001243|Sympathomimetics|sympathomimetics|mesh-ancestor
102240159|NCT05001243|Autonomic Agents|autonomic agents|mesh-ancestor
102240160|NCT05001243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102240161|NCT05001243|Nasal Decongestants|nasal decongestants|mesh-ancestor
102240162|NCT05001243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102240163|NCT05001243|Respiratory System Agents|respiratory system agents|mesh-ancestor
102240164|NCT05001243|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102240165|NCT05001243|Mydriatics|mydriatics|mesh-ancestor
102240166|NCT05001243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102240167|NCT05001243|Miotics|miotics|mesh-ancestor
102240168|NCT05001243|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102240169|NCT05001243|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102240170|NCT05001243|Cholinergic Agents|cholinergic agents|mesh-ancestor
102240171|NCT05001243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102240172|NCT05001243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102240173|NCT05001243|Analgesics|analgesics|mesh-ancestor
102240174|NCT05001243|Sensory System Agents|sensory system agents|mesh-ancestor
102240175|NCT05001243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102240177|NCT03225781|Bleomycin|bleomycin|mesh-list
102240178|NCT03225781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102240179|NCT03225781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102240180|NCT03205891|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102240181|NCT03205891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102240182|NCT03205891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102240183|NCT03205891|Immunotoxins|immunotoxins|mesh-ancestor
102240184|NCT03205891|Immunoconjugates|immunoconjugates|mesh-ancestor
102240185|NCT03205891|Immunologic Factors|immunologic factors|mesh-ancestor
102240186|NCT03205891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240187|NCT03221023|Vancomycin|vancomycin|mesh-list
102240188|NCT03221023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102240189|NCT03221023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102240190|NCT02490839|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102240191|NCT02490839|Amoxicillin|amoxicillin|mesh-list
102240192|NCT02490839|Metronidazole|metronidazole|mesh-list
102240193|NCT02490839|Tetracycline|tetracycline|mesh-list
102240194|NCT02490839|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102240195|NCT02490839|Rabeprazole|rabeprazole|mesh-list
102240196|NCT02490839|Bismuth|bismuth|mesh-list
102240197|NCT02490839|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
102240198|NCT02490839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102240199|NCT02490839|Antitubercular Agents|antitubercular agents|mesh-ancestor
102240200|NCT02490839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102240201|NCT02490839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102240202|NCT02490839|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102240203|NCT02490839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101299140|NCT05917340|Aspirin|aspirin|mesh-list
102240204|NCT02490839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102240205|NCT02490839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240206|NCT02490839|Antacids|antacids|mesh-ancestor
102240207|NCT02490839|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102240208|NCT02490527|Simvastatin|simvastatin|mesh-list
102240209|NCT02490527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102240210|NCT02490527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102240211|NCT02490527|Antimetabolites|antimetabolites|mesh-ancestor
102240212|NCT02490527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102612981|NCT00002579|Alkylating Agents|alkylating agents|mesh-ancestor
102612982|NCT00002579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240213|NCT02490527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102240214|NCT02490527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102240216|NCT02490449|Dexlansoprazole|dexlansoprazole|mesh-list
102240217|NCT02490449|Lansoprazole|lansoprazole|mesh-list
102240218|NCT02490449|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102240219|NCT02490449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102240220|NCT02490449|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102240221|NCT02490449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102240222|NCT02490449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240223|NCT02452177|Vitamin D|vitamin d|mesh-list
102240224|NCT02452177|Vitamins|vitamins|mesh-ancestor
102240225|NCT02452177|Micronutrients|micronutrients|mesh-ancestor
102240226|NCT02452177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240227|NCT02452177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102240228|NCT05000697|Oxaliplatin|oxaliplatin|mesh-list
102240229|NCT05000697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102240230|NCT03224923|Aspirin|aspirin|mesh-list
102240231|NCT03224923|Clopidogrel|clopidogrel|mesh-list
102240232|NCT03224923|Ticagrelor|ticagrelor|mesh-list
102240233|NCT03224923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102240234|NCT03224923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102240235|NCT03224923|Analgesics|analgesics|mesh-ancestor
102240236|NCT03224923|Sensory System Agents|sensory system agents|mesh-ancestor
102240237|NCT03224923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102240238|NCT03224923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240239|NCT03224923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102240240|NCT03224923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102240241|NCT03224923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102240242|NCT03224923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102240243|NCT03224923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240244|NCT03224923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102240245|NCT03224923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102240246|NCT03224923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102240247|NCT03224923|Antipyretics|antipyretics|mesh-ancestor
102240248|NCT03224923|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102240249|NCT03224923|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102240250|NCT03224923|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102240251|NCT03224923|Purinergic Agents|purinergic agents|mesh-ancestor
102240252|NCT03224923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102240253|NCT05004753|Artemisinins|artemisinins|mesh-list
102240254|NCT05004753|Artemisinin|artemisinin|mesh-list
102240255|NCT05004753|Dexamethasone|dexamethasone|mesh-list
101642092|NCT00918190|Midazolam|midazolam|mesh-list
102240256|NCT05004753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102240257|NCT05004753|Antiemetics|antiemetics|mesh-ancestor
102240258|NCT05004753|Autonomic Agents|autonomic agents|mesh-ancestor
102240259|NCT05004753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102240260|NCT05004753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240261|NCT05004753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102240262|NCT05004753|Glucocorticoids|glucocorticoids|mesh-ancestor
102240264|NCT05004753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102240265|NCT05004753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102240266|NCT05004753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102240267|NCT05004753|Antimalarials|antimalarials|mesh-ancestor
102240268|NCT05004753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102240269|NCT05004753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102240270|NCT05004753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102240271|NCT05004519|Dexmedetomidine|dexmedetomidine|mesh-list
102240272|NCT05004519|Remifentanil|remifentanil|mesh-list
102240273|NCT05004519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102240274|NCT05004519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102240275|NCT05004519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240276|NCT05004519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102240277|NCT05004519|Analgesics|analgesics|mesh-ancestor
102240278|NCT05004519|Sensory System Agents|sensory system agents|mesh-ancestor
102240279|NCT05004519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102240280|NCT05004519|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102240281|NCT05004519|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102240282|NCT05004519|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102240283|NCT05004519|Adrenergic Agents|adrenergic agents|mesh-ancestor
102240284|NCT05004519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102240285|NCT05004519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240286|NCT05004519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102240287|NCT05004519|Narcotics|narcotics|mesh-ancestor
102240288|NCT02486549|Bupivacaine|bupivacaine|mesh-list
102240289|NCT02486549|Anesthetics, Local|anesthetics, local|mesh-ancestor
102240290|NCT02486549|Anesthetics|anesthetics|mesh-ancestor
101581947|NCT05290740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102612983|NCT00002579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102240291|NCT02486549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102240292|NCT02486549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240293|NCT02486549|Sensory System Agents|sensory system agents|mesh-ancestor
102240294|NCT02486549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102240295|NCT02490605|Salicylic Acid|salicylic acid|mesh-list
102240296|NCT02490605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102240297|NCT02490605|Antifungal Agents|antifungal agents|mesh-ancestor
102240298|NCT02490605|Keratolytic Agents|keratolytic agents|mesh-ancestor
102240299|NCT02490605|Dermatologic Agents|dermatologic agents|mesh-ancestor
102240301|NCT04485403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102240302|NCT04485403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102240303|NCT04485403|Analgesics|analgesics|mesh-ancestor
102240304|NCT04485403|Sensory System Agents|sensory system agents|mesh-ancestor
102240305|NCT04485403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102240306|NCT04485403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240307|NCT04485403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102240308|NCT04485403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102240309|NCT04485403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102240310|NCT04485403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102240311|NCT04485403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240312|NCT03220867|Risperidone|risperidone|mesh-list
102240313|NCT03220867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102240314|NCT03220867|Serotonin Agents|serotonin agents|mesh-ancestor
102240315|NCT03220867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102240316|NCT03220867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240317|NCT03220867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240318|NCT03220867|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102240319|NCT03220867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102240320|NCT03220867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102240321|NCT03220867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102240322|NCT03220867|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102240323|NCT03220867|Dopamine Agents|dopamine agents|mesh-ancestor
102240324|NCT03318029|Vitamin D|vitamin d|mesh-list
102240325|NCT03318029|Vitamins|vitamins|mesh-ancestor
102240326|NCT03318029|Micronutrients|micronutrients|mesh-ancestor
102240327|NCT03318029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240328|NCT03318029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102240329|NCT03076281|Metformin|metformin|mesh-list
102240330|NCT03076281|Doxycycline|doxycycline|mesh-list
102240331|NCT03076281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102240332|NCT03076281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240333|NCT03076281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102240334|NCT03076281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102240335|NCT03076281|Antimalarials|antimalarials|mesh-ancestor
102240336|NCT03076281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102240337|NCT03076281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102240338|NCT02452255|Propranolol|propranolol|mesh-list
102240339|NCT02452255|Metoprolol|metoprolol|mesh-list
102240340|NCT02452255|Fenofibrate|fenofibrate|mesh-list
102240341|NCT02452255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102240342|NCT02452255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102240343|NCT02452255|Adrenergic Agents|adrenergic agents|mesh-ancestor
102240344|NCT02452255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102240345|NCT02452255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240346|NCT02452255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240347|NCT02452255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102240348|NCT02452255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102240349|NCT02452255|Vasodilator Agents|vasodilator agents|mesh-ancestor
102240350|NCT02452255|Sympatholytics|sympatholytics|mesh-ancestor
102240351|NCT02452255|Autonomic Agents|autonomic agents|mesh-ancestor
102240352|NCT02452255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102240353|NCT02452255|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102240354|NCT02452255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102240355|NCT02452255|Antimetabolites|antimetabolites|mesh-ancestor
102240356|NCT02452255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102240357|NCT03205033|Melatonin|melatonin|mesh-list
102240358|NCT03205033|Antioxidants|antioxidants|mesh-ancestor
102240359|NCT03205033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240360|NCT03205033|Protective Agents|protective agents|mesh-ancestor
102240361|NCT03205033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240362|NCT03205033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102240363|NCT03076905|Olorofim|olorofim|mesh-list
102240364|NCT03076905|Antifungal Agents|antifungal agents|mesh-ancestor
102240365|NCT03076905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102240366|NCT02452099|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
102240367|NCT02452099|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102240368|NCT02452099|Protective Agents|protective agents|mesh-ancestor
102240369|NCT02452099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240370|NCT02452099|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102240371|NCT02452099|Antioxidants|antioxidants|mesh-ancestor
102240372|NCT02452099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240373|NCT03317717|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102240374|NCT03317717|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102240375|NCT03317717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102240376|NCT03317717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240377|NCT03317717|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102240378|NCT03317717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102240379|NCT03317717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240380|NCT03317717|Cholinergic Agents|cholinergic agents|mesh-ancestor
102240381|NCT03317717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102240382|NCT03220789|Methamphetamine|methamphetamine|mesh-list
102240383|NCT03220789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102240384|NCT03220789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240385|NCT03220789|Sympathomimetics|sympathomimetics|mesh-ancestor
102240386|NCT03220789|Autonomic Agents|autonomic agents|mesh-ancestor
102240387|NCT03220789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102240388|NCT03220789|Dopamine Agents|dopamine agents|mesh-ancestor
102240389|NCT03220789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102240390|NCT03220789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240391|NCT03220789|Adrenergic Agents|adrenergic agents|mesh-ancestor
102240392|NCT03220789|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102240393|NCT03220789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102240394|NCT03220789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102240395|NCT03220789|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102240396|NCT03220555|Lidocaine|lidocaine|mesh-list
102240397|NCT03220555|Prilocaine|prilocaine|mesh-list
102240398|NCT03220555|Anesthetics, Local|anesthetics, local|mesh-ancestor
102240399|NCT03220555|Anesthetics|anesthetics|mesh-ancestor
102240400|NCT03220555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102240401|NCT03220555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240402|NCT03220555|Sensory System Agents|sensory system agents|mesh-ancestor
102240403|NCT03220555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102240404|NCT03220555|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102240405|NCT03220555|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102240406|NCT03220555|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102240407|NCT03220555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102240408|NCT03220555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240409|NCT03204877|Melatonin|melatonin|mesh-list
102240410|NCT03204877|Antioxidants|antioxidants|mesh-ancestor
102240411|NCT03204877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240412|NCT03204877|Protective Agents|protective agents|mesh-ancestor
102240413|NCT03204877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240414|NCT03204877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102240415|NCT03204799|Metformin|metformin|mesh-list
102240416|NCT03204799|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102240417|NCT03204799|Ezetimibe|ezetimibe|mesh-list
102240418|NCT03204799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102240419|NCT03204799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240420|NCT03204799|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102240421|NCT03204799|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102240422|NCT03204799|Antimetabolites|antimetabolites|mesh-ancestor
102240423|NCT03204799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240424|NCT03204799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102240425|NCT03317327|Nivolumab|nivolumab|mesh-list
101901451|NCT01289756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102612984|NCT00002579|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102612985|NCT00002579|Antimetabolites|antimetabolites|mesh-ancestor
102612986|NCT00002579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102612987|NCT00002579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102612988|NCT00002579|Abortifacient Agents|abortifacient agents|mesh-ancestor
102612989|NCT00002579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102612990|NCT00002579|Dermatologic Agents|dermatologic agents|mesh-ancestor
102612991|NCT00002579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102612992|NCT00002579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102612993|NCT00002579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102612994|NCT00002579|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102612995|NCT00002579|Hormone Antagonists|hormone antagonists|mesh-ancestor
102240426|NCT03317327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102240427|NCT03317327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102240428|NCT03317327|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102240429|NCT03317327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240430|NCT03204331|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102240432|NCT03204331|Norethindrone|norethindrone|mesh-list
102240433|NCT03204331|Norethindrone Acetate|norethindrone acetate|mesh-list
102240434|NCT03204331|Estradiol|estradiol|mesh-list
102240435|NCT03204331|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102240436|NCT03204331|Relugolix|relugolix|mesh-list
102240437|NCT03204331|Estrogens|estrogens|mesh-ancestor
102240438|NCT03204331|Hormones|hormones|mesh-ancestor
102240439|NCT03204331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102240440|NCT03204331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240441|NCT03204331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102240442|NCT03204331|Contraceptive Agents|contraceptive agents|mesh-ancestor
102240443|NCT03204331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102240444|NCT03204331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102240445|NCT03204331|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102240446|NCT03204331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102240447|NCT03204331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102240448|NCT03204331|Androgen Antagonists|androgen antagonists|mesh-ancestor
102240449|NCT03204331|Hormone Antagonists|hormone antagonists|mesh-ancestor
102240450|NCT03072849|Fluticasone|fluticasone|mesh-list
102240451|NCT03072849|Azithromycin|azithromycin|mesh-list
102240452|NCT03072849|Montelukast|montelukast|mesh-list
102240453|NCT03072849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102240454|NCT03072849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102240455|NCT03072849|Autonomic Agents|autonomic agents|mesh-ancestor
101642244|NCT02561845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102240456|NCT03072849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102240457|NCT03072849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240458|NCT03072849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102240459|NCT03072849|Respiratory System Agents|respiratory system agents|mesh-ancestor
102240460|NCT03072849|Dermatologic Agents|dermatologic agents|mesh-ancestor
102240461|NCT03072849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102240462|NCT03072849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102240463|NCT03072849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102240464|NCT03072849|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102240465|NCT03072849|Hormone Antagonists|hormone antagonists|mesh-ancestor
102240466|NCT03072849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102240467|NCT03072849|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102240468|NCT03072849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102240469|NCT03072849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240470|NCT03220321|Lithium Carbonate|lithium carbonate|mesh-list
102240471|NCT03220321|Antidepressive Agents|antidepressive agents|mesh-ancestor
102240472|NCT03220321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102240473|NCT03220321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102240474|NCT03220321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240475|NCT03220321|Antimanic Agents|antimanic agents|mesh-ancestor
102240476|NCT03220321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102240477|NCT03220321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102240478|NCT03220321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240480|NCT03075657|Risperidone|risperidone|mesh-list
102240481|NCT03075657|Haloperidol decanoate|haloperidol decanoate|mesh-list
102240482|NCT03075657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102240483|NCT03075657|Serotonin Agents|serotonin agents|mesh-ancestor
102240484|NCT03075657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102240485|NCT03075657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240486|NCT03075657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240487|NCT03075657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102240488|NCT03075657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102240489|NCT03075657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102240490|NCT03075657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102240491|NCT03075657|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102240492|NCT03075657|Dopamine Agents|dopamine agents|mesh-ancestor
102240493|NCT03075657|Antiemetics|antiemetics|mesh-ancestor
102240494|NCT03075657|Autonomic Agents|autonomic agents|mesh-ancestor
102240495|NCT03075657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102240496|NCT03075657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102240497|NCT03075657|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102240498|NCT02451865|Docetaxel|docetaxel|mesh-list
102240499|NCT02451865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102240500|NCT02451865|Tubulin Modulators|tubulin modulators|mesh-ancestor
102240501|NCT02451865|Antimitotic Agents|antimitotic agents|mesh-ancestor
102240502|NCT02451865|Mitosis Modulators|mitosis modulators|mesh-ancestor
102240503|NCT02451865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240505|NCT05004207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102240506|NCT03317093|Ceftobiprole|ceftobiprole|mesh-list
102240507|NCT03317093|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
102240508|NCT03317093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102240509|NCT03317093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102240510|NCT02489513|Ivosidenib|ivosidenib|mesh-list
102240511|NCT02489513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102240512|NCT02489513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102240513|NCT02489513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240514|NCT03317015|Fluticasone|fluticasone|mesh-list
102240515|NCT03317015|Triamcinolone|triamcinolone|mesh-list
102240516|NCT03317015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102240517|NCT03317015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102240518|NCT03317015|Autonomic Agents|autonomic agents|mesh-ancestor
102240519|NCT03317015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102240520|NCT03317015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240521|NCT03317015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102240522|NCT03317015|Respiratory System Agents|respiratory system agents|mesh-ancestor
102240523|NCT03317015|Dermatologic Agents|dermatologic agents|mesh-ancestor
102240524|NCT03317015|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102240525|NCT03317015|Glucocorticoids|glucocorticoids|mesh-ancestor
102240526|NCT03317015|Hormones|hormones|mesh-ancestor
102240527|NCT03317015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102240528|NCT03204565|Hyaluronic Acid|hyaluronic acid|mesh-list
102240529|NCT03204565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102240530|NCT03204565|Immunologic Factors|immunologic factors|mesh-ancestor
102240531|NCT03204565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240532|NCT03204565|Viscosupplements|viscosupplements|mesh-ancestor
102240533|NCT03204565|Protective Agents|protective agents|mesh-ancestor
102240534|NCT03224377|Antibodies|antibodies|mesh-list
102240535|NCT03224377|Immunoglobulins|immunoglobulins|mesh-list
102240536|NCT03224377|Immunologic Factors|immunologic factors|mesh-ancestor
102240537|NCT03224377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240538|NCT02451787|Vitamin D|vitamin d|mesh-list
102240539|NCT02451787|Cholecalciferol|cholecalciferol|mesh-list
102240540|NCT02451787|Vitamins|vitamins|mesh-ancestor
102240541|NCT02451787|Micronutrients|micronutrients|mesh-ancestor
102240542|NCT02451787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240543|NCT02451787|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102240544|NCT02451787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102240545|NCT03224221|Fluorouracil|fluorouracil|mesh-list
102240546|NCT03224221|Apatinib|apatinib|mesh-list
102240547|NCT03224221|Antimetabolites|antimetabolites|mesh-ancestor
102240548|NCT03224221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240549|NCT03224221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102240550|NCT03224221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102240551|NCT03224221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102240552|NCT03224221|Immunologic Factors|immunologic factors|mesh-ancestor
102240553|NCT03224221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240554|NCT03224221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102240555|NCT03224221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102240556|NCT03204097|Alendronate|alendronate|mesh-list
102240557|NCT03204097|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102240558|NCT03204097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240559|NCT03223519|Ibuprofen|ibuprofen|mesh-list
102240560|NCT03223519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240561|NCT03223519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102240562|NCT03223519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102240563|NCT03223519|Analgesics|analgesics|mesh-ancestor
102240564|NCT03223519|Sensory System Agents|sensory system agents|mesh-ancestor
102240565|NCT03223519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102240566|NCT03223519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102240567|NCT03223519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102240568|NCT03223519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102240569|NCT03223519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102240570|NCT03223519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240571|NCT03320915|Cholecalciferol|cholecalciferol|mesh-list
102240572|NCT03320915|Vitamin D|vitamin d|mesh-list
102240573|NCT03320915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102240574|NCT03320915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240575|NCT03320915|Vitamins|vitamins|mesh-ancestor
102240576|NCT03320915|Micronutrients|micronutrients|mesh-ancestor
102612996|NCT00002579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102240577|NCT03320915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102240578|NCT02488889|Ethanol|ethanol|mesh-list
102240579|NCT02488889|Varenicline|varenicline|mesh-list
102240580|NCT02488889|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102240581|NCT02488889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102240582|NCT02488889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102240583|NCT02488889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240584|NCT02488889|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102240585|NCT02488889|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102240586|NCT02488889|Cholinergic Agents|cholinergic agents|mesh-ancestor
102240587|NCT02488889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102240588|NCT02488889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240589|NCT03220009|Nivolumab|nivolumab|mesh-list
102240590|NCT03220009|Ipilimumab|ipilimumab|mesh-list
102240591|NCT03220009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102240592|NCT03220009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102240593|NCT03220009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102240594|NCT03220009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240595|NCT02485613|Dexamethasone|dexamethasone|mesh-list
102240596|NCT02485613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102240597|NCT02485613|Antiemetics|antiemetics|mesh-ancestor
102240598|NCT02485613|Autonomic Agents|autonomic agents|mesh-ancestor
102240599|NCT02485613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102240600|NCT02485613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240601|NCT02485613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102240602|NCT02485613|Glucocorticoids|glucocorticoids|mesh-ancestor
102240603|NCT02485613|Hormones|hormones|mesh-ancestor
102240604|NCT02485613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102240605|NCT02485613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102240606|NCT02485613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102240607|NCT02484833|Cetuximab|cetuximab|mesh-list
102240608|NCT02484833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102240609|NCT02484833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102240610|NCT03204019|Thalidomide|thalidomide|mesh-list
102240611|NCT03204019|Temozolomide|temozolomide|mesh-list
102240612|NCT03204019|Tegafur|tegafur|mesh-list
102240613|NCT03204019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102240614|NCT03204019|Alkylating Agents|alkylating agents|mesh-ancestor
102240615|NCT03204019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240616|NCT03204019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102240617|NCT03204019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102240618|NCT03204019|Immunologic Factors|immunologic factors|mesh-ancestor
102240619|NCT03204019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240620|NCT03204019|Leprostatic Agents|leprostatic agents|mesh-ancestor
102240621|NCT03204019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102240622|NCT03204019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102240623|NCT03204019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102240624|NCT03204019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102240625|NCT03204019|Growth Substances|growth substances|mesh-ancestor
102240626|NCT03204019|Growth Inhibitors|growth inhibitors|mesh-ancestor
102240627|NCT03204019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102240628|NCT03204019|Antimetabolites|antimetabolites|mesh-ancestor
102240629|NCT02485145|Diclofenac|diclofenac|mesh-list
102240630|NCT02485145|Orphenadrine|orphenadrine|mesh-list
102240631|NCT02485145|Bupivacaine|bupivacaine|mesh-list
102240632|NCT02485145|Baclofen|baclofen|mesh-list
102240633|NCT02485145|Anesthetics, Local|anesthetics, local|mesh-ancestor
102240634|NCT02485145|Anesthetics|anesthetics|mesh-ancestor
102240635|NCT02485145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102240636|NCT02485145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240637|NCT02485145|Sensory System Agents|sensory system agents|mesh-ancestor
102240638|NCT02485145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102240639|NCT02485145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102240640|NCT02485145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102240641|NCT02485145|Analgesics|analgesics|mesh-ancestor
102240642|NCT02485145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102240643|NCT02485145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102240644|NCT02485145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102240645|NCT02485145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102240646|NCT02485145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240647|NCT02485145|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102240648|NCT02485145|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102240649|NCT02485145|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101642429|NCT00603434|Dopamine Agents|dopamine agents|mesh-ancestor
102612997|NCT00002579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102612998|NCT00002579|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102240650|NCT02485145|GABA Agonists|gaba agonists|mesh-ancestor
102240651|NCT02485145|GABA Agents|gaba agents|mesh-ancestor
102240652|NCT02485145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102240653|NCT02485145|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102240654|NCT02485145|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102240655|NCT02485145|Parasympatholytics|parasympatholytics|mesh-ancestor
102240656|NCT02485145|Autonomic Agents|autonomic agents|mesh-ancestor
102240657|NCT02485145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102240658|NCT02485145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102240659|NCT02485145|Cholinergic Agents|cholinergic agents|mesh-ancestor
102240660|NCT02485145|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
102240661|NCT02485145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102240662|NCT02484755|Gefitinib|gefitinib|mesh-list
102240663|NCT02484755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102240664|NCT02484755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102240665|NCT02484755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102240666|NCT02484755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240667|NCT03316469|Clomiphene|clomiphene|mesh-list
102240668|NCT03316469|Enclomiphene|enclomiphene|mesh-list
102240669|NCT03316469|Zuclomiphene|zuclomiphene|mesh-list
102240670|NCT03316469|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102240671|NCT03316469|Hormone Antagonists|hormone antagonists|mesh-ancestor
102240672|NCT03316469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102240673|NCT03316469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240674|NCT03316469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102240675|NCT03316469|Fertility Agents|fertility agents|mesh-ancestor
102240676|NCT03316469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102240677|NCT03316469|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102240678|NCT03316469|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102240679|NCT02485067|Tolterodine Tartrate|tolterodine tartrate|mesh-list
102240680|NCT02485067|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102240681|NCT02485067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102240682|NCT02485067|Cholinergic Agents|cholinergic agents|mesh-ancestor
102240683|NCT02485067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102240684|NCT02485067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240685|NCT02485067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240686|NCT02485067|Urological Agents|urological agents|mesh-ancestor
102240687|NCT03075579|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102240688|NCT03075579|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102240689|NCT03075579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102240690|NCT03075579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102240691|NCT03075579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240692|NCT03075579|Adrenergic Agents|adrenergic agents|mesh-ancestor
102240693|NCT03075579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102240694|NCT03075579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240695|NCT03203317|Insulin|insulin|mesh-list
102240696|NCT03203317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102240697|NCT03203317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240698|NCT03316313|Antibodies|antibodies|mesh-list
102240699|NCT03316313|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
102240700|NCT03316313|Immunologic Factors|immunologic factors|mesh-ancestor
102240701|NCT03316313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240702|NCT03201601|Inositol|inositol|mesh-list
102240703|NCT03201601|Vitamin B Complex|vitamin b complex|mesh-ancestor
102240704|NCT03201601|Vitamins|vitamins|mesh-ancestor
102240705|NCT03201601|Micronutrients|micronutrients|mesh-ancestor
102240706|NCT03201601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240707|NCT02480387|Sofosbuvir|sofosbuvir|mesh-list
102240708|NCT02480387|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102240709|NCT02480387|Ledipasvir|ledipasvir|mesh-list
102240710|NCT02480387|Antiviral Agents|antiviral agents|mesh-ancestor
102240711|NCT02480387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102240712|NCT04999293|Clopidogrel|clopidogrel|mesh-list
102240713|NCT04999293|Ticagrelor|ticagrelor|mesh-list
102240714|NCT04999293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102240715|NCT04999293|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102240716|NCT04999293|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102240717|NCT04999293|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102240718|NCT04999293|Purinergic Agents|purinergic agents|mesh-ancestor
102240719|NCT04999293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102240720|NCT04999293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240721|NCT04999293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102612999|NCT00002579|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102240722|NCT03315923|Rituximab|rituximab|mesh-list
102240723|NCT03315923|Glatiramer Acetate|glatiramer acetate|mesh-list
102240724|NCT03315923|(T,G)-A-L|(t,g)-a-l|mesh-list
102240725|NCT03315923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102240726|NCT03315923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102240727|NCT03315923|Immunologic Factors|immunologic factors|mesh-ancestor
102240728|NCT03315923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642483|NCT00943124|Niacinamide|niacinamide|mesh-list
102240729|NCT03315923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102240730|NCT03315923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102240731|NCT03315923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102240732|NCT03315845|Anesthetics|anesthetics|mesh-list
102240733|NCT03315845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102240734|NCT03315845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240735|NCT03201367|Rivaroxaban|rivaroxaban|mesh-list
102240736|NCT03201367|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102240737|NCT03201367|Antithrombins|antithrombins|mesh-ancestor
102240738|NCT03201367|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102240739|NCT03201367|Protease Inhibitors|protease inhibitors|mesh-ancestor
102240740|NCT03201367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102240741|NCT03201367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240742|NCT03201367|Anticoagulants|anticoagulants|mesh-ancestor
102240743|NCT04998903|Dimercaprol|dimercaprol|mesh-list
102240744|NCT04998903|Chelating Agents|chelating agents|mesh-ancestor
102240745|NCT04998903|Sequestering Agents|sequestering agents|mesh-ancestor
102240746|NCT04998903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240747|NCT04991961|Antihypertensive Agents|antihypertensive agents|mesh-list
102240748|NCT03203005|Cyclophosphamide|cyclophosphamide|mesh-list
102240749|NCT03203005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102240750|NCT03203005|Immunologic Factors|immunologic factors|mesh-ancestor
102240751|NCT03203005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240752|NCT03203005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102240753|NCT03203005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102240754|NCT03203005|Alkylating Agents|alkylating agents|mesh-ancestor
102240755|NCT03203005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240756|NCT03203005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102240757|NCT03203005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102240758|NCT02484209|Metformin|metformin|mesh-list
102240759|NCT02484209|Glimepiride|glimepiride|mesh-list
102240760|NCT02484209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102240761|NCT02484209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240762|NCT02484209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102240763|NCT02484209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102240764|NCT02484209|Immunologic Factors|immunologic factors|mesh-ancestor
102240765|NCT04999137|Vitamins|vitamins|mesh-list
102240766|NCT04999137|Thiamine|thiamine|mesh-list
102240767|NCT04999137|Micronutrients|micronutrients|mesh-ancestor
102240768|NCT04999137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240769|NCT04999137|Vitamin B Complex|vitamin b complex|mesh-ancestor
102240770|NCT02484053|Rituximab|rituximab|mesh-list
102240771|NCT02484053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102240772|NCT02484053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102240773|NCT02484053|Immunologic Factors|immunologic factors|mesh-ancestor
102240774|NCT02484053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240775|NCT02484053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102240776|NCT03200821|Gemcitabine|gemcitabine|mesh-list
102240777|NCT03200821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102240778|NCT03200821|Antimetabolites|antimetabolites|mesh-ancestor
102240779|NCT03200821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240780|NCT03200821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102240782|NCT05353361|Pertuzumab|pertuzumab|mesh-list
102240783|NCT05353361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102240784|NCT05353361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102240785|NCT05353361|Tubulin Modulators|tubulin modulators|mesh-ancestor
102240786|NCT05353361|Antimitotic Agents|antimitotic agents|mesh-ancestor
102240787|NCT05353361|Mitosis Modulators|mitosis modulators|mesh-ancestor
102240788|NCT05353361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240789|NCT05353361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102240790|NCT02483897|Tetracaine|tetracaine|mesh-list
102240791|NCT02483897|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102240792|NCT02483897|Anesthetics, Local|anesthetics, local|mesh-ancestor
102240793|NCT02483897|Anesthetics|anesthetics|mesh-ancestor
102240794|NCT02483897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102240795|NCT02483897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613000|NCT00002579|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102613001|NCT00002585|NSC 366140|nsc 366140|mesh-list
102240796|NCT02483897|Sensory System Agents|sensory system agents|mesh-ancestor
102240797|NCT02483897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102240798|NCT02483897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102240799|NCT01374919|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102240801|NCT01374919|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102240802|NCT01374919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102240803|NCT03202615|Lactoferrin|lactoferrin|mesh-list
101642556|NCT00685945|Isosorbide|isosorbide|mesh-list
102240804|NCT03202615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102240805|NCT03202459|Pregabalin|pregabalin|mesh-list
102240806|NCT03202459|Gabapentin|gabapentin|mesh-list
102240807|NCT03202459|Analgesics|analgesics|mesh-ancestor
102240808|NCT03202459|Sensory System Agents|sensory system agents|mesh-ancestor
102240809|NCT03202459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102240810|NCT03202459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240811|NCT03202459|Anticonvulsants|anticonvulsants|mesh-ancestor
102240812|NCT03202459|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102240813|NCT03202459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102240814|NCT03202459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240815|NCT03202459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102240816|NCT03202459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102240817|NCT03202459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102240818|NCT03202459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102240819|NCT03202459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102240820|NCT03202459|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102240821|NCT03202459|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102240822|NCT03202459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102240823|NCT03202459|Antimanic Agents|antimanic agents|mesh-ancestor
102240824|NCT04991181|Zamicastat|zamicastat|mesh-list
102240825|NCT04991181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102240826|NCT04991181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240827|NCT04492319|Neostigmine|neostigmine|mesh-list
102240828|NCT04492319|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102240829|NCT04492319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102240830|NCT04492319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240831|NCT04492319|Cholinergic Agents|cholinergic agents|mesh-ancestor
102240832|NCT04492319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102240833|NCT04492319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240834|NCT04492319|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102240835|NCT04492319|Autonomic Agents|autonomic agents|mesh-ancestor
102240836|NCT04492319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102240837|NCT04456959|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
102240838|NCT04456959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102240839|NCT04456959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102240840|NCT04456959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102240841|NCT04456959|Immunotoxins|immunotoxins|mesh-ancestor
102240842|NCT04456959|Immunoconjugates|immunoconjugates|mesh-ancestor
102240843|NCT04456959|Immunologic Factors|immunologic factors|mesh-ancestor
102240844|NCT04456959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240845|NCT05713721|Dopamine|dopamine|mesh-list
102240846|NCT05713721|Dopamine Agonists|dopamine agonists|mesh-list
102240847|NCT05713721|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102240848|NCT05713721|Sympathomimetics|sympathomimetics|mesh-ancestor
102240849|NCT05713721|Autonomic Agents|autonomic agents|mesh-ancestor
102240850|NCT05713721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102240851|NCT05713721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240852|NCT05713721|Dopamine Agents|dopamine agents|mesh-ancestor
102240853|NCT05713721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102240854|NCT05713721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240855|NCT05713721|Protective Agents|protective agents|mesh-ancestor
102240856|NCT05002725|Lidocaine|lidocaine|mesh-list
102240857|NCT05002725|Anesthetics, Local|anesthetics, local|mesh-ancestor
102240858|NCT05002725|Anesthetics|anesthetics|mesh-ancestor
102240859|NCT05002725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102240860|NCT05002725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901466|NCT01181882|Aspirin|aspirin|mesh-list
102613002|NCT00002585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613003|NCT00002609|Cytarabine|cytarabine|mesh-list
102613004|NCT00002609|Idarubicin|idarubicin|mesh-list
102613005|NCT00002609|Lintuzumab|lintuzumab|mesh-list
102613006|NCT00002609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102613007|NCT00002609|Antimetabolites|antimetabolites|mesh-ancestor
102613008|NCT00002609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613009|NCT00002609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613010|NCT00002609|Antiviral Agents|antiviral agents|mesh-ancestor
102613011|NCT00002609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102613012|NCT00002609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102613013|NCT00002609|Immunologic Factors|immunologic factors|mesh-ancestor
102240861|NCT05002725|Sensory System Agents|sensory system agents|mesh-ancestor
102240862|NCT05002725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102240863|NCT05002725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102240864|NCT05002725|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102240865|NCT05002725|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102240866|NCT05002725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102240867|NCT05002725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240868|NCT03315533|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102240869|NCT03315533|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102240870|NCT03315533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102240871|NCT03315533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102240872|NCT03315533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240873|NCT03315533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102240874|NCT03315533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240875|NCT03315533|Analgesics|analgesics|mesh-ancestor
102240876|NCT03315533|Sensory System Agents|sensory system agents|mesh-ancestor
102240877|NCT03315533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102240878|NCT03315533|Antidepressive Agents|antidepressive agents|mesh-ancestor
102240879|NCT03315533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102240880|NCT03315533|Dopamine Agents|dopamine agents|mesh-ancestor
102240881|NCT05437835|Ropivacaine|ropivacaine|mesh-list
102240882|NCT05437835|Anesthetics, Local|anesthetics, local|mesh-ancestor
102240883|NCT05437835|Anesthetics|anesthetics|mesh-ancestor
102240884|NCT05437835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102240885|NCT05437835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240886|NCT05437835|Sensory System Agents|sensory system agents|mesh-ancestor
102240887|NCT05437835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102240888|NCT03200197|Menthol|menthol|mesh-list
102240889|NCT03200197|Antipruritics|antipruritics|mesh-ancestor
102240890|NCT03200197|Dermatologic Agents|dermatologic agents|mesh-ancestor
102240891|NCT04997967|Ketamine|ketamine|mesh-list
102240892|NCT04997967|Propofol|propofol|mesh-list
102240893|NCT04997967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102240894|NCT04997967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102240895|NCT04997967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240896|NCT04997967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102240897|NCT04997967|Anesthetics, General|anesthetics, general|mesh-ancestor
102240898|NCT04997967|Anesthetics|anesthetics|mesh-ancestor
102240899|NCT04997967|Analgesics|analgesics|mesh-ancestor
102240900|NCT04997967|Sensory System Agents|sensory system agents|mesh-ancestor
102240901|NCT04997967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102240902|NCT04997967|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102240903|NCT04997967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102240904|NCT04997967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102240905|NCT04997967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102240906|NCT04997967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240907|NCT02483195|Minoxidil|minoxidil|mesh-list
102240908|NCT02483195|Spironolactone|spironolactone|mesh-list
102240909|NCT02483195|Finasteride|finasteride|mesh-list
102240910|NCT02483195|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102240911|NCT02483195|Hormone Antagonists|hormone antagonists|mesh-ancestor
102240912|NCT02483195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102240913|NCT02483195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240914|NCT02483195|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102240915|NCT02483195|Diuretics|diuretics|mesh-ancestor
102240916|NCT02483195|Natriuretic Agents|natriuretic agents|mesh-ancestor
102240917|NCT02483195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102240918|NCT02483195|Vasodilator Agents|vasodilator agents|mesh-ancestor
102240919|NCT02483195|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102240920|NCT02483195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102240921|NCT02483195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102240922|NCT02483195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240923|NCT02483195|Urological Agents|urological agents|mesh-ancestor
102240924|NCT02450149|Sorafenib|sorafenib|mesh-list
102240925|NCT02450149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102240926|NCT02450149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102240927|NCT02450149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101949744|NCT04793958|Cetuximab|cetuximab|mesh-list
102240928|NCT02450149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240929|NCT02479217|Docetaxel|docetaxel|mesh-list
102240930|NCT02479217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613014|NCT00002609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613015|NCT00002609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102613016|NCT00002609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102240931|NCT02479217|Tubulin Modulators|tubulin modulators|mesh-ancestor
102240932|NCT02479217|Antimitotic Agents|antimitotic agents|mesh-ancestor
102240933|NCT02479217|Mitosis Modulators|mitosis modulators|mesh-ancestor
102240934|NCT02479217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642655|NCT00747799|Sorafenib|sorafenib|mesh-list
102240935|NCT02479529|Norepinephrine|norepinephrine|mesh-list
102240936|NCT02479529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102240937|NCT02479529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102240938|NCT02479529|Adrenergic Agents|adrenergic agents|mesh-ancestor
102240939|NCT02479529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102240940|NCT02479529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240941|NCT02479529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240942|NCT02479529|Sympathomimetics|sympathomimetics|mesh-ancestor
102240943|NCT02479529|Autonomic Agents|autonomic agents|mesh-ancestor
102240944|NCT02479529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102240945|NCT02479529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102240946|NCT03202147|Cromolyn Sodium|cromolyn sodium|mesh-list
102240947|NCT03202147|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
102240948|NCT03202147|Immunologic Factors|immunologic factors|mesh-ancestor
102240949|NCT03202147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240950|NCT03202147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102240951|NCT03202147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102240952|NCT03202147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102240953|NCT03202147|Respiratory System Agents|respiratory system agents|mesh-ancestor
102240954|NCT03213769|Ubiquinone|ubiquinone|mesh-list
102240955|NCT03213769|Coenzyme Q10|coenzyme q10|mesh-list
102240956|NCT03213769|Micronutrients|micronutrients|mesh-ancestor
102240957|NCT03213769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240958|NCT03213769|Vitamins|vitamins|mesh-ancestor
102240959|NCT05002101|Zinc|zinc|mesh-list
102240960|NCT05002101|Zinc Sulfate|zinc sulfate|mesh-list
102240961|NCT05002101|Trace Elements|trace elements|mesh-ancestor
102240962|NCT05002101|Micronutrients|micronutrients|mesh-ancestor
102240963|NCT05002101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240964|NCT05002101|Astringents|astringents|mesh-ancestor
102240965|NCT05002101|Dermatologic Agents|dermatologic agents|mesh-ancestor
102240966|NCT03201913|Estrogens|estrogens|mesh-list
102240967|NCT03201913|Hormones|hormones|mesh-ancestor
102240968|NCT03201913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102240969|NCT03201913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240970|NCT03199729|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102240971|NCT03199729|Luteolytic Agents|luteolytic agents|mesh-ancestor
102240972|NCT03199729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102240973|NCT03199729|Contraceptive Agents|contraceptive agents|mesh-ancestor
102240974|NCT03199729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102240975|NCT03199729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240976|NCT03199729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102240977|NCT03199729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102240978|NCT03199729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102240979|NCT03212677|Iron|iron|mesh-list
102240980|NCT03212677|Trace Elements|trace elements|mesh-ancestor
102240981|NCT03212677|Micronutrients|micronutrients|mesh-ancestor
101642676|NCT01001429|Propofol|propofol|mesh-list
102240982|NCT03212677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240983|NCT03199339|Midazolam|midazolam|mesh-list
102240984|NCT03199339|Bupropion|bupropion|mesh-list
102240985|NCT03199339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102240986|NCT03199339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102240987|NCT03199339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102240988|NCT03199339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102240989|NCT03199339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102240990|NCT03199339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102240991|NCT03199339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102240992|NCT03199339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102240993|NCT03199339|Anesthetics, General|anesthetics, general|mesh-ancestor
102240994|NCT03199339|Anesthetics|anesthetics|mesh-ancestor
102240995|NCT03199339|GABA Modulators|gaba modulators|mesh-ancestor
102240996|NCT03199339|GABA Agents|gaba agents|mesh-ancestor
102240997|NCT03199339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102240998|NCT03199339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102240999|NCT03199339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102241000|NCT03199339|Antidepressive Agents|antidepressive agents|mesh-ancestor
102241001|NCT03199339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102241002|NCT03199339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102241003|NCT03199339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102241004|NCT03199339|Dopamine Agents|dopamine agents|mesh-ancestor
102613017|NCT00002609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102613018|NCT00002609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102613019|NCT00002609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102241005|NCT03199339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102241006|NCT03199339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102241007|NCT03199339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241008|NCT03071679|Antimicrobial Cationic Peptides|antimicrobial cationic peptides|mesh-list
102241009|NCT03071679|Imiquimod|imiquimod|mesh-list
102241010|NCT03071679|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102241011|NCT03071679|Immunologic Factors|immunologic factors|mesh-ancestor
102241012|NCT03071679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241013|NCT03071679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102241014|NCT03071679|Interferon Inducers|interferon inducers|mesh-ancestor
102241015|NCT03071679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102241016|NCT03199261|Exenatide|exenatide|mesh-list
102241017|NCT03199261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102241018|NCT03199261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241019|NCT03199261|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102241020|NCT03199261|Incretins|incretins|mesh-ancestor
102241021|NCT03199261|Hormones|hormones|mesh-ancestor
102241022|NCT03199261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102241023|NCT02482961|Colistin|colistin|mesh-list
102241024|NCT02482961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102241025|NCT02482961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102241026|NCT04990713|Ropivacaine|ropivacaine|mesh-list
102241027|NCT04990713|Anesthetics, Local|anesthetics, local|mesh-list
102241028|NCT04990713|Anesthetics|anesthetics|mesh-list
102241029|NCT04990713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102241030|NCT04990713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241031|NCT04990713|Sensory System Agents|sensory system agents|mesh-ancestor
102241032|NCT04990713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102241033|NCT04990791|Aspirin|aspirin|mesh-list
102241034|NCT04990791|Rivaroxaban|rivaroxaban|mesh-list
102241035|NCT04990791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102241036|NCT04990791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102241037|NCT04990791|Analgesics|analgesics|mesh-ancestor
102241038|NCT04990791|Sensory System Agents|sensory system agents|mesh-ancestor
102241039|NCT04990791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102241040|NCT04990791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241041|NCT04990791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102241042|NCT04990791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102241043|NCT04990791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102241044|NCT04990791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102241045|NCT04990791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241046|NCT04990791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102241047|NCT04990791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102241048|NCT04990791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241049|NCT04990791|Antipyretics|antipyretics|mesh-ancestor
102241050|NCT04990791|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102241051|NCT04990791|Antithrombins|antithrombins|mesh-ancestor
102241052|NCT04990791|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102241053|NCT04990791|Protease Inhibitors|protease inhibitors|mesh-ancestor
102241054|NCT04990791|Anticoagulants|anticoagulants|mesh-ancestor
102241055|NCT03201835|Nabiximols|nabiximols|mesh-list
102241056|NCT03201835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241057|NCT03201835|Analgesics|analgesics|mesh-ancestor
102241058|NCT03201835|Sensory System Agents|sensory system agents|mesh-ancestor
102241059|NCT03201835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102241060|NCT02478515|Ranibizumab|ranibizumab|mesh-list
102241061|NCT02478515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102241062|NCT02478515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102241063|NCT02478515|Growth Substances|growth substances|mesh-ancestor
102241064|NCT02478515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241065|NCT02478515|Growth Inhibitors|growth inhibitors|mesh-ancestor
102241066|NCT02478515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102241067|NCT02448199|Meloxicam|meloxicam|mesh-list
102241068|NCT02448199|Antirheumatic Agents|antirheumatic agents|mesh-list
102241069|NCT02448199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102241070|NCT02448199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102241071|NCT02448199|Analgesics|analgesics|mesh-ancestor
102241072|NCT02448199|Sensory System Agents|sensory system agents|mesh-ancestor
102241073|NCT02448199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102241074|NCT02448199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241075|NCT02448199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102241076|NCT02448199|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102613020|NCT00002615|Fluorouracil|fluorouracil|mesh-list
102241077|NCT02448199|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101949900|NCT04628767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102613021|NCT00002615|Epirubicin|epirubicin|mesh-list
102613022|NCT00002615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102241078|NCT02448199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241079|NCT02448199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241080|NCT03071289|Cisplatin|cisplatin|mesh-list
102241081|NCT03071289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102241082|NCT03199105|Tetracaine|tetracaine|mesh-list
102241083|NCT03199105|Anesthetics, Local|anesthetics, local|mesh-ancestor
102241084|NCT03199105|Anesthetics|anesthetics|mesh-ancestor
102241085|NCT03199105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102241086|NCT03199105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241087|NCT03199105|Sensory System Agents|sensory system agents|mesh-ancestor
102241088|NCT03199105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102241089|NCT02482649|Methylphenidate|methylphenidate|mesh-list
102241090|NCT02482649|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102241091|NCT02482649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102241092|NCT02482649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241093|NCT02482649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102241094|NCT02482649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102241095|NCT02482649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102241096|NCT02482649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241097|NCT02482649|Dopamine Agents|dopamine agents|mesh-ancestor
102241098|NCT02482649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102241099|NCT02482649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102241100|NCT02482649|Adrenergic Agents|adrenergic agents|mesh-ancestor
102241101|NCT03198637|Cisatracurium|cisatracurium|mesh-list
102241102|NCT03198637|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102241103|NCT03198637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102241104|NCT03198637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102241105|NCT03198637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241106|NCT02478281|Methylene Blue|methylene blue|mesh-list
102241107|NCT02478281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241108|NCT02478281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241109|NCT02478125|Docetaxel|docetaxel|mesh-list
102241110|NCT02478125|Lenograstim|lenograstim|mesh-list
102241111|NCT02478125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102241112|NCT02478125|Tubulin Modulators|tubulin modulators|mesh-ancestor
102241113|NCT02478125|Antimitotic Agents|antimitotic agents|mesh-ancestor
102241114|NCT02478125|Mitosis Modulators|mitosis modulators|mesh-ancestor
102241115|NCT02478125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241116|NCT02478125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102241117|NCT02478125|Immunologic Factors|immunologic factors|mesh-ancestor
102241118|NCT02478125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241119|NCT02478047|Dexamethasone|dexamethasone|mesh-list
102241120|NCT02478047|Ramosetron|ramosetron|mesh-list
102241121|NCT02478047|Antiemetics|antiemetics|mesh-list
102241122|NCT02478047|Tropisetron|tropisetron|mesh-list
102241123|NCT02478047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102241124|NCT02478047|Autonomic Agents|autonomic agents|mesh-ancestor
102241125|NCT02478047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102241126|NCT02478047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241127|NCT02478047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102241128|NCT02478047|Glucocorticoids|glucocorticoids|mesh-ancestor
102241129|NCT02478047|Hormones|hormones|mesh-ancestor
102241634|NCT03070665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102241130|NCT02478047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102241131|NCT02478047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102241132|NCT02478047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102241133|NCT02478047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102241134|NCT02478047|Serotonin Agents|serotonin agents|mesh-ancestor
102241135|NCT02478047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102241136|NCT02478047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241137|NCT02478047|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102241138|NCT04996485|Ustekinumab|ustekinumab|mesh-list
102241139|NCT04996485|Dermatologic Agents|dermatologic agents|mesh-ancestor
102241140|NCT02447965|Bupivacaine|bupivacaine|mesh-list
102241141|NCT02447965|Anesthetics, Local|anesthetics, local|mesh-ancestor
102241142|NCT02447965|Anesthetics|anesthetics|mesh-ancestor
102241143|NCT02447965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102241144|NCT02447965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241145|NCT02447965|Sensory System Agents|sensory system agents|mesh-ancestor
102241146|NCT02447965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102241147|NCT03070275|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102241148|NCT03070275|Hemostatics|hemostatics|mesh-ancestor
102241149|NCT03070275|Coagulants|coagulants|mesh-ancestor
102241150|NCT05713019|Adenosine|adenosine|mesh-list
102241151|NCT05713019|Capsaicin|capsaicin|mesh-list
102613023|NCT00002615|Antimetabolites|antimetabolites|mesh-ancestor
102241152|NCT05713019|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102241153|NCT05713019|Antipruritics|antipruritics|mesh-ancestor
102241154|NCT05713019|Dermatologic Agents|dermatologic agents|mesh-ancestor
102241155|NCT05713019|Sensory System Agents|sensory system agents|mesh-ancestor
102241156|NCT05713019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102241157|NCT05713019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241159|NCT05713019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102241160|NCT05713019|Vasodilator Agents|vasodilator agents|mesh-ancestor
102241161|NCT05713019|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102241162|NCT05713019|Purinergic Agonists|purinergic agonists|mesh-ancestor
102241163|NCT05713019|Purinergic Agents|purinergic agents|mesh-ancestor
102241164|NCT05713019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102241165|NCT05713019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241166|NCT03198403|Epinephrine|epinephrine|mesh-list
102241167|NCT03198403|Bupivacaine|bupivacaine|mesh-list
102241168|NCT03198403|Anesthetics, Local|anesthetics, local|mesh-ancestor
102241169|NCT03198403|Anesthetics|anesthetics|mesh-ancestor
102241170|NCT03198403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102241171|NCT03198403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241172|NCT03198403|Sensory System Agents|sensory system agents|mesh-ancestor
102241173|NCT03198403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102241174|NCT03198403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102241175|NCT03198403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102241176|NCT03198403|Adrenergic Agents|adrenergic agents|mesh-ancestor
102241177|NCT03198403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102241178|NCT03198403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241179|NCT03198403|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102241180|NCT03198403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102241181|NCT03198403|Autonomic Agents|autonomic agents|mesh-ancestor
102241182|NCT03198403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102241183|NCT03198403|Respiratory System Agents|respiratory system agents|mesh-ancestor
102241184|NCT03198403|Mydriatics|mydriatics|mesh-ancestor
102241185|NCT03198403|Sympathomimetics|sympathomimetics|mesh-ancestor
102241186|NCT03198403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102241188|NCT03198949|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102241189|NCT03198949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102241190|NCT03198949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241191|NCT03198949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241192|NCT03198949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102241193|NCT03198949|Immunologic Factors|immunologic factors|mesh-ancestor
102241194|NCT03198949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241195|NCT03198949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102241196|NCT02447809|Aspirin|aspirin|mesh-list
102241197|NCT02447809|Clopidogrel|clopidogrel|mesh-list
102241198|NCT02447809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102241199|NCT02447809|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102241200|NCT02447809|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102241201|NCT02447809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102241202|NCT02447809|Purinergic Agents|purinergic agents|mesh-ancestor
102241203|NCT02447809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102241204|NCT02447809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241205|NCT02447809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241206|NCT02447809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102241207|NCT02447809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102241208|NCT02447809|Analgesics|analgesics|mesh-ancestor
102241209|NCT02447809|Sensory System Agents|sensory system agents|mesh-ancestor
102241210|NCT02447809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102241211|NCT02447809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102241212|NCT02447809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102241213|NCT02447809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102241214|NCT02447809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102241215|NCT02447809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102241216|NCT02447809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241217|NCT02447809|Antipyretics|antipyretics|mesh-ancestor
102241218|NCT04989855|Tislelizumab|tislelizumab|mesh-list
102241219|NCT04989855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102241220|NCT04989855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102241221|NCT04915287|Maleic acid|maleic acid|mesh-list
102241222|NCT04915287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241223|NCT04915287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241224|NCT05709353|Methamphetamine|methamphetamine|mesh-list
102241225|NCT05709353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102241227|NCT05709353|Sympathomimetics|sympathomimetics|mesh-ancestor
102241228|NCT05709353|Autonomic Agents|autonomic agents|mesh-ancestor
102241229|NCT05709353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102241230|NCT05709353|Dopamine Agents|dopamine agents|mesh-ancestor
102241231|NCT05709353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102241232|NCT05709353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241233|NCT05709353|Adrenergic Agents|adrenergic agents|mesh-ancestor
102241234|NCT05709353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102241235|NCT05709353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102241236|NCT05709353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102241237|NCT05709353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102241238|NCT03195673|Terazosin|terazosin|mesh-list
102241239|NCT03195673|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102241240|NCT03195673|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102241241|NCT03195673|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102241242|NCT03195673|Adrenergic Agents|adrenergic agents|mesh-ancestor
102241243|NCT03195673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102241244|NCT03195673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241245|NCT03195673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241246|NCT03195673|Urological Agents|urological agents|mesh-ancestor
102241247|NCT02481791|Remifentanil|remifentanil|mesh-list
102241248|NCT02481791|Propofol|propofol|mesh-list
102241249|NCT02481791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102241250|NCT02481791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102241251|NCT02481791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241252|NCT02481791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102241253|NCT02481791|Anesthetics, General|anesthetics, general|mesh-ancestor
102241254|NCT02481791|Anesthetics|anesthetics|mesh-ancestor
102241255|NCT02481791|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102241256|NCT02481791|Narcotics|narcotics|mesh-ancestor
102241257|NCT02481791|Analgesics|analgesics|mesh-ancestor
102241258|NCT02481791|Sensory System Agents|sensory system agents|mesh-ancestor
102241259|NCT02481791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102241260|NCT04484467|Menthol|menthol|mesh-list
102241261|NCT04484467|Antipruritics|antipruritics|mesh-ancestor
102241262|NCT04484467|Dermatologic Agents|dermatologic agents|mesh-ancestor
102241263|NCT03198169|Anti-Infective Agents|anti-infective agents|mesh-list
102241264|NCT03198169|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102241265|NCT02726399|Capecitabine|capecitabine|mesh-list
102241266|NCT02726399|Trastuzumab|trastuzumab|mesh-list
102241267|NCT02726399|Ramucirumab|ramucirumab|mesh-list
102241268|NCT02726399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102241269|NCT02726399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102241270|NCT02726399|Antimetabolites|antimetabolites|mesh-ancestor
102241271|NCT02726399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241272|NCT02726399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102241273|NCT02477969|Metformin|metformin|mesh-list
102241274|NCT02477969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102241275|NCT02477969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241276|NCT03195205|Antibodies|antibodies|mesh-list
102241277|NCT03195205|Immunologic Factors|immunologic factors|mesh-ancestor
102241278|NCT03195205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241279|NCT03209011|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102241280|NCT03209011|Antiviral Agents|antiviral agents|mesh-ancestor
102241281|NCT03209011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102241282|NCT02481323|Cilostazol|cilostazol|mesh-list
102241283|NCT02481323|Isosorbide|isosorbide|mesh-list
102241284|NCT02481323|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
102241285|NCT02481323|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
102241286|NCT02481323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102241287|NCT02481323|Autonomic Agents|autonomic agents|mesh-ancestor
102241288|NCT02481323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102241289|NCT02481323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241290|NCT02481323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102241291|NCT02481323|Respiratory System Agents|respiratory system agents|mesh-ancestor
102241292|NCT02481323|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102241293|NCT02481323|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102241294|NCT02481323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241295|NCT02481323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102241296|NCT02481323|Vasodilator Agents|vasodilator agents|mesh-ancestor
102241297|NCT02481323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102241298|NCT02481323|Protective Agents|protective agents|mesh-ancestor
102241299|NCT02481323|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102241300|NCT02481323|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102241302|NCT02481323|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102241303|NCT02481323|Diuretics|diuretics|mesh-ancestor
102241304|NCT02481323|Natriuretic Agents|natriuretic agents|mesh-ancestor
102241305|NCT02481323|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102241306|NCT03197779|Aspirin|aspirin|mesh-list
102241307|NCT03197779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102241308|NCT03197779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102241309|NCT03197779|Analgesics|analgesics|mesh-ancestor
102241310|NCT03197779|Sensory System Agents|sensory system agents|mesh-ancestor
102241311|NCT03197779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102241312|NCT03197779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241313|NCT03197779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102241314|NCT03197779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102241315|NCT03197779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102241316|NCT03197779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102241317|NCT03197779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241318|NCT03197779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102241319|NCT03197779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102241320|NCT03197779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241321|NCT03197779|Antipyretics|antipyretics|mesh-ancestor
102241322|NCT03197623|Alendronate|alendronate|mesh-list
102241323|NCT03197623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102241324|NCT03197623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241325|NCT02449603|Insulin Aspart|insulin aspart|mesh-list
102241326|NCT02449603|Exenatide|exenatide|mesh-list
102241327|NCT02449603|Biphasic Insulins|biphasic insulins|mesh-list
102241328|NCT02449603|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
102241329|NCT02449603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102241330|NCT02449603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241331|NCT02449603|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102241332|NCT02449603|Incretins|incretins|mesh-ancestor
102241333|NCT02449603|Hormones|hormones|mesh-ancestor
102241334|NCT02449603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102241335|NCT02481479|Saxagliptin|saxagliptin|mesh-list
102241336|NCT02481479|Incretins|incretins|mesh-ancestor
102241337|NCT02481479|Hormones|hormones|mesh-ancestor
102241338|NCT02481479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102241339|NCT02481479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241340|NCT02481479|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102241341|NCT02481479|Protease Inhibitors|protease inhibitors|mesh-ancestor
102241342|NCT02481479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241343|NCT02481479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241344|NCT02481479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102241345|NCT03195049|Bilirubin|bilirubin|mesh-list
102241346|NCT03195049|Antioxidants|antioxidants|mesh-ancestor
102241347|NCT03195049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241348|NCT03195049|Protective Agents|protective agents|mesh-ancestor
102241349|NCT03195049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241350|NCT03198013|Prednisolone|prednisolone|mesh-list
102241351|NCT03198013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102241352|NCT03198013|Glucocorticoids|glucocorticoids|mesh-ancestor
102241353|NCT03198013|Hormones|hormones|mesh-ancestor
102241354|NCT03198013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102241355|NCT03198013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241356|NCT03198013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102241357|NCT03198013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102241358|NCT05651399|Propofol|propofol|mesh-list
102241359|NCT05651399|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102241360|NCT05651399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102241361|NCT05651399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241362|NCT05651399|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102241363|NCT05651399|Anesthetics, General|anesthetics, general|mesh-ancestor
102241364|NCT05651399|Anesthetics|anesthetics|mesh-ancestor
102241365|NCT02477891|Daratumumab|daratumumab|mesh-list
102241366|NCT02477891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102241367|NCT02477813|Temozolomide|temozolomide|mesh-list
102241368|NCT02477813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102241369|NCT02477813|Alkylating Agents|alkylating agents|mesh-ancestor
102241370|NCT02477813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241371|NCT02477813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102241372|NCT02480543|Misoprostol|misoprostol|mesh-list
102241373|NCT02480543|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102241374|NCT02480543|Abortifacient Agents|abortifacient agents|mesh-ancestor
102241375|NCT02480543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102241376|NCT02480543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241377|NCT02480543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102241378|NCT02480543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102241380|NCT03197233|Vitamin D|vitamin d|mesh-list
102241381|NCT03197233|Vitamins|vitamins|mesh-list
102241382|NCT03197233|Vitamin A|vitamin a|mesh-list
102241383|NCT03197233|Retinol palmitate|retinol palmitate|mesh-list
102241384|NCT03197233|Micronutrients|micronutrients|mesh-ancestor
102241385|NCT03197233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241386|NCT03197233|Antioxidants|antioxidants|mesh-ancestor
102241387|NCT03197233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241388|NCT03197233|Protective Agents|protective agents|mesh-ancestor
102241389|NCT03197233|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102241390|NCT03197233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102241391|NCT03197233|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102241392|NCT02447185|Triamcinolone|triamcinolone|mesh-list
102241393|NCT02447185|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102241394|NCT02447185|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102241395|NCT02447185|Ranibizumab|ranibizumab|mesh-list
102241396|NCT02447185|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102241397|NCT02447185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102241398|NCT02447185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102241399|NCT02447185|Growth Substances|growth substances|mesh-ancestor
102241400|NCT02447185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241401|NCT02447185|Growth Inhibitors|growth inhibitors|mesh-ancestor
102241402|NCT02447185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102241403|NCT02447185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102241404|NCT02447185|Glucocorticoids|glucocorticoids|mesh-ancestor
102241405|NCT02447185|Hormones|hormones|mesh-ancestor
102241406|NCT02447185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102241407|NCT02447185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102241408|NCT02447185|Immunologic Factors|immunologic factors|mesh-ancestor
102241409|NCT02447185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241410|NCT02447185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241411|NCT03196921|Amphotericin B|amphotericin b|mesh-list
102241412|NCT03196921|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102241413|NCT03196921|Amebicides|amebicides|mesh-ancestor
102241414|NCT03196921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102241415|NCT03196921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102241416|NCT03196921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102241417|NCT03196921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102241418|NCT03196921|Antifungal Agents|antifungal agents|mesh-ancestor
102241419|NCT02480465|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102241420|NCT02480465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102241421|NCT02480465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241422|NCT02480465|Incretins|incretins|mesh-ancestor
102241423|NCT02480465|Hormones|hormones|mesh-ancestor
102241424|NCT02480465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102241425|NCT02480465|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102241426|NCT02480465|Protease Inhibitors|protease inhibitors|mesh-ancestor
102241427|NCT02480465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241428|NCT02480465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241429|NCT03208465|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102241430|NCT03208465|Empagliflozin|empagliflozin|mesh-list
102241431|NCT03208465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102241432|NCT03208465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241433|NCT03208465|Incretins|incretins|mesh-ancestor
102241434|NCT03208465|Hormones|hormones|mesh-ancestor
102241435|NCT03208465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102241436|NCT03208465|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102241437|NCT03208465|Protease Inhibitors|protease inhibitors|mesh-ancestor
102241438|NCT03208465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101642899|NCT04614545|Phentermine|phentermine|mesh-list
102241439|NCT03208465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241440|NCT03208465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102241441|NCT03197155|Antiviral Agents|antiviral agents|mesh-list
102241442|NCT03197155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102241443|NCT04484779|Insulin|insulin|mesh-list
102241444|NCT04484779|Insulin Glargine|insulin glargine|mesh-list
102241445|NCT04484779|Insulin Lispro|insulin lispro|mesh-list
102241446|NCT04484779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102241447|NCT04484779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241448|NCT02477501|Norepinephrine|norepinephrine|mesh-list
102241449|NCT02477501|Ephedrine|ephedrine|mesh-list
102241450|NCT02477501|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102241452|NCT02477501|Adrenergic Agents|adrenergic agents|mesh-ancestor
102241453|NCT02477501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102241454|NCT02477501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241455|NCT02477501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241456|NCT02477501|Sympathomimetics|sympathomimetics|mesh-ancestor
102241457|NCT02477501|Autonomic Agents|autonomic agents|mesh-ancestor
102241458|NCT02477501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102241459|NCT02477501|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102241460|NCT02477501|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102241461|NCT02446795|Sunitinib|sunitinib|mesh-list
102241462|NCT02446795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102241463|NCT02446795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102241464|NCT02446795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102241465|NCT02446795|Growth Substances|growth substances|mesh-ancestor
102241466|NCT02446795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241467|NCT02446795|Growth Inhibitors|growth inhibitors|mesh-ancestor
102241468|NCT02446795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102241469|NCT02446795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241470|NCT02446795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241471|NCT02477267|Buprenorphine|buprenorphine|mesh-list
102241472|NCT02477267|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102241473|NCT02477267|Naloxone|naloxone|mesh-list
102241474|NCT02477267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102241475|NCT02477267|Narcotics|narcotics|mesh-ancestor
102241476|NCT02477267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102241477|NCT02477267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241478|NCT02477267|Analgesics|analgesics|mesh-ancestor
102241479|NCT02477267|Sensory System Agents|sensory system agents|mesh-ancestor
101642916|NCT01031381|Growth Substances|growth substances|mesh-ancestor
102241480|NCT02477267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102241481|NCT02477267|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102241482|NCT03196843|Raltitrexed|raltitrexed|mesh-list
102241483|NCT03196843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102241484|NCT03196843|Antimetabolites|antimetabolites|mesh-ancestor
102241485|NCT03196843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241486|NCT03196843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102241487|NCT03196843|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102241488|NCT03196843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241489|NCT02476955|Paclitaxel|paclitaxel|mesh-list
102241490|NCT02476955|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102241491|NCT02476955|Carboplatin|carboplatin|mesh-list
102241492|NCT02476955|Anastrozole|anastrozole|mesh-list
102241493|NCT02476955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102241494|NCT02476955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102241495|NCT02476955|Tubulin Modulators|tubulin modulators|mesh-ancestor
102241496|NCT02476955|Antimitotic Agents|antimitotic agents|mesh-ancestor
102241497|NCT02476955|Mitosis Modulators|mitosis modulators|mesh-ancestor
102241498|NCT02476955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241499|NCT02476955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102241500|NCT02476955|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102241501|NCT02476955|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102241502|NCT02476955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241503|NCT02476955|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102241504|NCT02476955|Hormone Antagonists|hormone antagonists|mesh-ancestor
102241505|NCT02476955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102241506|NCT02476955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241507|NCT02634801|Methotrexate|methotrexate|mesh-list
102241508|NCT02634801|Ixekizumab|ixekizumab|mesh-list
102241509|NCT02634801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102241510|NCT02634801|Abortifacient Agents|abortifacient agents|mesh-ancestor
102241511|NCT02634801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102241512|NCT02634801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241513|NCT02634801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102241514|NCT02634801|Antimetabolites|antimetabolites|mesh-ancestor
102241515|NCT02634801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241516|NCT02634801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102241517|NCT02634801|Dermatologic Agents|dermatologic agents|mesh-ancestor
102241518|NCT02634801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241519|NCT02634801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102241520|NCT02634801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102241521|NCT02634801|Immunologic Factors|immunologic factors|mesh-ancestor
102241522|NCT02634801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102241523|NCT02634801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102241525|NCT03196531|Antipruritics|antipruritics|mesh-ancestor
102241526|NCT03196531|Dermatologic Agents|dermatologic agents|mesh-ancestor
101642959|NCT00753103|Antiemetics|antiemetics|mesh-ancestor
102241527|NCT03196531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102241528|NCT03196531|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101950352|NCT03456076|Carboplatin|carboplatin|mesh-list
102241529|NCT03196531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102241530|NCT03196531|Histamine Antagonists|histamine antagonists|mesh-ancestor
102241531|NCT03196531|Histamine Agents|histamine agents|mesh-ancestor
102241532|NCT03196531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102241533|NCT03196531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241534|NCT03196531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241535|NCT02476799|Ketorolac|ketorolac|mesh-list
102241536|NCT02476799|Fentanyl|fentanyl|mesh-list
102241537|NCT02476799|Ropivacaine|ropivacaine|mesh-list
102241538|NCT02476799|Anesthetics, Local|anesthetics, local|mesh-ancestor
102241539|NCT02476799|Anesthetics|anesthetics|mesh-ancestor
102241540|NCT02476799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102241541|NCT02476799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241542|NCT02476799|Sensory System Agents|sensory system agents|mesh-ancestor
102241543|NCT02476799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102241544|NCT02476799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102241545|NCT02476799|Narcotics|narcotics|mesh-ancestor
102241546|NCT02476799|Analgesics|analgesics|mesh-ancestor
102241547|NCT02476799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102241548|NCT02476799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102241549|NCT02476799|Anesthetics, General|anesthetics, general|mesh-ancestor
102241550|NCT02476799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102241551|NCT02476799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102241552|NCT02476799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102241553|NCT02476799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102241554|NCT02476799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102241555|NCT02476799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241556|NCT02476799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241557|NCT02449369|Acetaminophen|acetaminophen|mesh-list
102241558|NCT02449369|Oxycodone|oxycodone|mesh-list
102241559|NCT02449369|Hydromorphone|hydromorphone|mesh-list
102241560|NCT02449369|Orphenadrine|orphenadrine|mesh-list
102241561|NCT02449369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102241562|NCT02449369|Analgesics|analgesics|mesh-ancestor
101642981|NCT00685165|GABA Agents|gaba agents|mesh-ancestor
102241563|NCT02449369|Sensory System Agents|sensory system agents|mesh-ancestor
102241564|NCT02449369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102241565|NCT02449369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241566|NCT02449369|Antipyretics|antipyretics|mesh-ancestor
102241567|NCT02449369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102241568|NCT02449369|Narcotics|narcotics|mesh-ancestor
102241569|NCT02449369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102241570|NCT02449369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102241571|NCT02449369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102241572|NCT02449369|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102241573|NCT02449369|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102241574|NCT02449369|Parasympatholytics|parasympatholytics|mesh-ancestor
102241575|NCT02449369|Autonomic Agents|autonomic agents|mesh-ancestor
102241576|NCT02449369|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102241577|NCT02449369|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102241578|NCT02449369|Cholinergic Agents|cholinergic agents|mesh-ancestor
102241579|NCT02449369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102241580|NCT02449369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241581|NCT02449369|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
102241582|NCT02449369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102241583|NCT02449369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241584|NCT03192943|Nivolumab|nivolumab|mesh-list
102241585|NCT03192943|Linrodostat|linrodostat|mesh-list
102241586|NCT03192943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102241587|NCT03192943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102241588|NCT03192943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102241589|NCT03192943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241590|NCT03192943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241591|NCT04986813|Tranexamic Acid|tranexamic acid|mesh-list
102241592|NCT04986813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102241593|NCT04986813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102241594|NCT04986813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241595|NCT04986813|Hemostatics|hemostatics|mesh-ancestor
102241596|NCT04986813|Coagulants|coagulants|mesh-ancestor
102241597|NCT04986735|Empagliflozin|empagliflozin|mesh-list
101901479|NCT01181882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102241598|NCT04986735|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102241599|NCT04986735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241600|NCT04986735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102241646|NCT04891809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102241647|NCT04891809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102241648|NCT04891809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102241649|NCT04891809|Immunologic Factors|immunologic factors|mesh-ancestor
102241650|NCT04891809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102241651|NCT04891809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102241652|NCT04891809|Growth Substances|growth substances|mesh-ancestor
102241653|NCT04891809|Growth Inhibitors|growth inhibitors|mesh-ancestor
102241654|NCT02472509|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102241655|NCT02472509|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102241656|NCT02472509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102241657|NCT02475161|Rabeprazole|rabeprazole|mesh-list
102241658|NCT02475161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102241659|NCT02475161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102241660|NCT02475161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102241661|NCT02475161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241662|NCT02475161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241663|NCT03074097|Bupivacaine|bupivacaine|mesh-list
102241664|NCT03074097|Anesthetics, Local|anesthetics, local|mesh-ancestor
102241665|NCT03074097|Anesthetics|anesthetics|mesh-ancestor
102241666|NCT03074097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102241667|NCT03074097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241668|NCT03074097|Sensory System Agents|sensory system agents|mesh-ancestor
102241669|NCT03074097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102241670|NCT04433481|Dabigatran|dabigatran|mesh-list
102241671|NCT04433481|Antithrombins|antithrombins|mesh-ancestor
102613024|NCT00002615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241672|NCT04433481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102241673|NCT04433481|Protease Inhibitors|protease inhibitors|mesh-ancestor
102241674|NCT04433481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241675|NCT04433481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241676|NCT04433481|Anticoagulants|anticoagulants|mesh-ancestor
102241677|NCT04860635|Celecoxib|celecoxib|mesh-list
102241678|NCT04860635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102241679|NCT04860635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102241680|NCT04860635|Analgesics|analgesics|mesh-ancestor
102241681|NCT04860635|Sensory System Agents|sensory system agents|mesh-ancestor
102241682|NCT04860635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102241683|NCT04860635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241684|NCT04860635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102241685|NCT04860635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102241686|NCT04860635|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102241687|NCT04860635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102241688|NCT04860635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241689|NCT04860635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241690|NCT04988607|Bevacizumab|bevacizumab|mesh-list
102241691|NCT04988607|Osimertinib|osimertinib|mesh-list
102241692|NCT04988607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102241693|NCT04988607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102241694|NCT04988607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102241695|NCT04988607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102241696|NCT04988607|Growth Substances|growth substances|mesh-ancestor
102241697|NCT04988607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241698|NCT04988607|Growth Inhibitors|growth inhibitors|mesh-ancestor
102241699|NCT04988607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102241700|NCT04988607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241701|NCT04988607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241702|NCT02475317|Volixibat|volixibat|mesh-list
102241703|NCT02475317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102241704|NCT03070509|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102241705|NCT03070509|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102241706|NCT03070509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241707|NCT03070509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102241708|NCT03070509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101991130|NCT03917459|Enalaprilat|enalaprilat|mesh-list
102241709|NCT03070509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102241710|NCT03070509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241711|NCT03070509|Dopamine Agents|dopamine agents|mesh-ancestor
102241712|NCT03070509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102241713|NCT05322473|Adalimumab|adalimumab|mesh-list
102241714|NCT05322473|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102241715|NCT05322473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102241716|NCT05322473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102241717|NCT02472275|Ascorbic Acid|ascorbic acid|mesh-list
102241718|NCT02472275|Methyltestosterone|methyltestosterone|mesh-list
102241719|NCT02472275|Hormones|hormones|mesh-list
102241720|NCT02472275|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
102241721|NCT02472275|Androgens|androgens|mesh-list
102241722|NCT02472275|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102241723|NCT02472275|Androgen Antagonists|androgen antagonists|mesh-list
102241724|NCT02472275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102241725|NCT02472275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241726|NCT02472275|Antioxidants|antioxidants|mesh-ancestor
102241727|NCT02472275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241728|NCT02472275|Protective Agents|protective agents|mesh-ancestor
102241729|NCT02472275|Vitamins|vitamins|mesh-ancestor
102241730|NCT02472275|Micronutrients|micronutrients|mesh-ancestor
102241731|NCT02472275|Estrogens|estrogens|mesh-ancestor
102241732|NCT02472275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102241733|NCT02472275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102241734|NCT02472275|Anabolic Agents|anabolic agents|mesh-ancestor
102241735|NCT02472275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102241736|NCT02472275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241737|NCT02472275|Hormone Antagonists|hormone antagonists|mesh-ancestor
102241738|NCT04491773|Tadalafil|tadalafil|mesh-list
102241739|NCT04491773|Vasodilator Agents|vasodilator agents|mesh-ancestor
102241740|NCT04491773|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102241741|NCT04491773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102241742|NCT04491773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241743|NCT04491773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241744|NCT04491773|Urological Agents|urological agents|mesh-ancestor
102613025|NCT00002615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102241745|NCT03070353|Dextrans|dextrans|mesh-list
102241746|NCT03070353|Anticoagulants|anticoagulants|mesh-ancestor
102241747|NCT03070353|Plasma Substitutes|plasma substitutes|mesh-ancestor
102241748|NCT03070353|Blood Substitutes|blood substitutes|mesh-ancestor
102241749|NCT03073863|Atorvastatin|atorvastatin|mesh-list
102241750|NCT03073863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102241751|NCT03073863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102241752|NCT03073863|Antimetabolites|antimetabolites|mesh-ancestor
102241753|NCT03073863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241754|NCT03073863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101950577|NCT02620007|Rifaximin|rifaximin|mesh-list
102241755|NCT03073863|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102241756|NCT03073863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241757|NCT02471963|Empagliflozin|empagliflozin|mesh-list
102241758|NCT02471963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102241759|NCT02471963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241760|NCT02471963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102241761|NCT02471963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241762|NCT01375751|Evolocumab|evolocumab|mesh-list
102241763|NCT01375751|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102241764|NCT01375751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102241765|NCT01375751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102241766|NCT01375751|Antimetabolites|antimetabolites|mesh-ancestor
102241767|NCT01375751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241768|NCT01375751|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102241769|NCT01375751|Protease Inhibitors|protease inhibitors|mesh-ancestor
102241770|NCT01375751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241771|NCT01375751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102241772|NCT05249621|Mannitol|mannitol|mesh-list
102241773|NCT05249621|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102241774|NCT05249621|Diuretics|diuretics|mesh-ancestor
102241775|NCT05249621|Natriuretic Agents|natriuretic agents|mesh-ancestor
102241776|NCT05249621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241777|NCT00705575|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102241778|NCT00705575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102241779|NCT00705575|Diuretics|diuretics|mesh-ancestor
102241780|NCT00705575|Natriuretic Agents|natriuretic agents|mesh-ancestor
102241781|NCT00705575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241782|NCT00705575|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102241783|NCT00705575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102241784|NCT00705575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241785|NCT03068247|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102241786|NCT03068247|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102241787|NCT03068247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102241788|NCT03068247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102241789|NCT03068247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241790|NCT03068247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102241791|NCT03068247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241792|NCT03068247|Analgesics|analgesics|mesh-ancestor
102241793|NCT03068247|Sensory System Agents|sensory system agents|mesh-ancestor
102241794|NCT03068247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102241795|NCT03068247|Antidepressive Agents|antidepressive agents|mesh-ancestor
102241796|NCT03068247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102241797|NCT03068247|Dopamine Agents|dopamine agents|mesh-ancestor
102241798|NCT03108833|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102241799|NCT03108833|Saruplase|saruplase|mesh-list
102241800|NCT03108833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102241801|NCT03108833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102241802|NCT03108833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241803|NCT02636361|Insulin Lispro|insulin lispro|mesh-list
102241804|NCT02636361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102241805|NCT02636361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241806|NCT02636283|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102241807|NCT02636283|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102241808|NCT02636283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241809|NCT04450953|Eplerenone|eplerenone|mesh-list
102241810|NCT04450953|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102241811|NCT04450953|Hormone Antagonists|hormone antagonists|mesh-ancestor
102241812|NCT04450953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102241813|NCT04450953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901482|NCT01181960|Risperidone|risperidone|mesh-list
102613026|NCT00002615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102613027|NCT00002615|Immunologic Factors|immunologic factors|mesh-ancestor
102241815|NCT04450953|Diuretics|diuretics|mesh-ancestor
102241816|NCT04450953|Natriuretic Agents|natriuretic agents|mesh-ancestor
102241817|NCT04450953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102241818|NCT04983849|Metronidazole|metronidazole|mesh-list
102241819|NCT04983849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102241820|NCT04983849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102241821|NCT04983849|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102241822|NCT04983849|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102241823|NCT02474303|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102241824|NCT02474303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102241825|NCT02474303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102241826|NCT02474303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241827|NCT02474303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241828|NCT02474303|Antiviral Agents|antiviral agents|mesh-ancestor
102241829|NCT02474303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102241830|NCT02474303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102241831|NCT02474303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102241832|NCT02474225|Bevacizumab|bevacizumab|mesh-list
102241833|NCT02474225|Ranibizumab|ranibizumab|mesh-list
102241834|NCT02474225|Endothelial Growth Factors|endothelial growth factors|mesh-list
102241835|NCT02474225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102241836|NCT02474225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102241837|NCT02474225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102241838|NCT02474225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102241839|NCT02474225|Growth Substances|growth substances|mesh-ancestor
102241840|NCT02474225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241841|NCT02474225|Growth Inhibitors|growth inhibitors|mesh-ancestor
102241842|NCT04448873|Sirolimus|sirolimus|mesh-list
102241843|NCT04448873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102241844|NCT04448873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102241845|NCT04448873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102241846|NCT04448873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102241847|NCT04448873|Antifungal Agents|antifungal agents|mesh-ancestor
102241848|NCT04448873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102241849|NCT04448873|Immunologic Factors|immunologic factors|mesh-ancestor
102241850|NCT04448873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241851|NCT04430855|Upadacitinib|upadacitinib|mesh-list
102241852|NCT04430855|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102241853|NCT04430855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102241854|NCT04430855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241855|NCT04430855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241856|NCT04430855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102241857|NCT02471105|Bimatoprost|bimatoprost|mesh-list
102241858|NCT02471105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102241859|NCT03108989|Neostigmine|neostigmine|mesh-list
102241860|NCT03108989|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102241861|NCT03108989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241862|NCT03108989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241863|NCT03108989|Cholinergic Agents|cholinergic agents|mesh-ancestor
102241864|NCT03108989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102241865|NCT03108989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241866|NCT03108989|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102241867|NCT03108989|Autonomic Agents|autonomic agents|mesh-ancestor
102241868|NCT03108989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102241869|NCT02473601|Mivacurium|mivacurium|mesh-list
102241870|NCT02473601|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102241871|NCT02473601|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102241872|NCT02473601|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102241873|NCT02473601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102241874|NCT02473601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241875|NCT04359017|Lidocaine|lidocaine|mesh-list
102241876|NCT04359017|Anesthetics, Local|anesthetics, local|mesh-ancestor
102241877|NCT04359017|Anesthetics|anesthetics|mesh-ancestor
102241878|NCT04359017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102241879|NCT04359017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241880|NCT04359017|Sensory System Agents|sensory system agents|mesh-ancestor
102241881|NCT04359017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102241882|NCT04359017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102241883|NCT04359017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102241884|NCT04359017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102241885|NCT04359017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102241886|NCT04359017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613028|NCT00002615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241887|NCT02470559|Aldesleukin|aldesleukin|mesh-list
102241888|NCT02470559|Interleukin-2|interleukin-2|mesh-list
102241889|NCT02470559|Sargramostim|sargramostim|mesh-list
102241890|NCT02470559|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102241891|NCT02470559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102241892|NCT02470559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102241893|NCT02470559|Analgesics|analgesics|mesh-ancestor
102241894|NCT02470559|Sensory System Agents|sensory system agents|mesh-ancestor
102241895|NCT02470559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102241896|NCT02470559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241897|NCT02470559|Immunologic Factors|immunologic factors|mesh-ancestor
102241898|NCT02470559|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102241899|NCT02470559|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102241900|NCT02470559|Antiviral Agents|antiviral agents|mesh-ancestor
102241901|NCT02470559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102241903|NCT02473211|Antiviral Agents|antiviral agents|mesh-ancestor
102241904|NCT02473211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102241905|NCT02470637|Insulin|insulin|mesh-list
102241906|NCT02470637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102241907|NCT02470637|Insulin Lispro|insulin lispro|mesh-list
102241908|NCT02470637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102241909|NCT02470637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241910|NCT03652961|Abatacept|abatacept|mesh-list
102241911|NCT03652961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102241912|NCT03652961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241913|NCT03652961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102241914|NCT03652961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102241915|NCT03652961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102241916|NCT03652961|Immunologic Factors|immunologic factors|mesh-ancestor
102241917|NCT03652961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241918|NCT03652961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102241919|NCT03948347|Liraglutide|liraglutide|mesh-list
102241920|NCT03948347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102241921|NCT03948347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241922|NCT03948347|Incretins|incretins|mesh-ancestor
102241923|NCT03948347|Hormones|hormones|mesh-ancestor
102241924|NCT03948347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102241925|NCT02723591|Tacrolimus|tacrolimus|mesh-list
102241926|NCT02723591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102241927|NCT02723591|Immunologic Factors|immunologic factors|mesh-ancestor
102241928|NCT02723591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241929|NCT02723591|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102241930|NCT02723591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241931|NCT02723591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241932|NCT00705341|Fluticasone|fluticasone|mesh-list
102241933|NCT00705341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102241934|NCT00705341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102241935|NCT00705341|Autonomic Agents|autonomic agents|mesh-ancestor
102241936|NCT00705341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102241937|NCT00705341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241938|NCT00705341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102241939|NCT00705341|Respiratory System Agents|respiratory system agents|mesh-ancestor
102241940|NCT00705341|Dermatologic Agents|dermatologic agents|mesh-ancestor
102241941|NCT00705341|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102241942|NCT03193931|Pembrolizumab|pembrolizumab|mesh-list
102241943|NCT03193931|Methotrexate|methotrexate|mesh-list
102241944|NCT03193931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102241945|NCT03193931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102241946|NCT03193931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102241947|NCT03193931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241948|NCT03193931|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102241949|NCT03193931|Abortifacient Agents|abortifacient agents|mesh-ancestor
102241950|NCT03193931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102241951|NCT03193931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241952|NCT03193931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102241953|NCT03193931|Antimetabolites|antimetabolites|mesh-ancestor
102241954|NCT03193931|Dermatologic Agents|dermatologic agents|mesh-ancestor
102241955|NCT03193931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241956|NCT03193931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102241957|NCT03193931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102241958|NCT03193931|Immunologic Factors|immunologic factors|mesh-ancestor
102241959|NCT03193931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102613029|NCT00002615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102241960|NCT03193931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102613030|NCT00002615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102241961|NCT00705263|Ribavirin|ribavirin|mesh-list
102241962|NCT00705263|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102241963|NCT00705263|Antimetabolites|antimetabolites|mesh-ancestor
102241964|NCT00705263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241965|NCT00705263|Antiviral Agents|antiviral agents|mesh-ancestor
102241966|NCT00705263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102241967|NCT02767427|Chlorhexidine|chlorhexidine|mesh-list
102241968|NCT02767427|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102241969|NCT02767427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102241970|NCT02767427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102241971|NCT02767427|Disinfectants|disinfectants|mesh-ancestor
102241972|NCT02767427|Dermatologic Agents|dermatologic agents|mesh-ancestor
102241973|NCT03310463|Durlobactam|durlobactam|mesh-list
102241974|NCT03310463|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101950813|NCT01182129|Nicotine|nicotine|mesh-list
102241975|NCT03310463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102241976|NCT03310463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241977|NCT03310463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102241978|NCT03310463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102241979|NCT00704405|Interferons|interferons|mesh-list
102241980|NCT00704405|Ribavirin|ribavirin|mesh-list
102241981|NCT00704405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102241982|NCT00704405|Antiviral Agents|antiviral agents|mesh-ancestor
102241983|NCT00704405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102241984|NCT00704405|Antimetabolites|antimetabolites|mesh-ancestor
102241985|NCT00704405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102241986|NCT01470755|Albuterol|albuterol|mesh-list
102241987|NCT01470755|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102241988|NCT01470755|Autonomic Agents|autonomic agents|mesh-ancestor
102241989|NCT01470755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102241990|NCT01470755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102241991|NCT01470755|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102241992|NCT01470755|Respiratory System Agents|respiratory system agents|mesh-ancestor
102241993|NCT01470755|Tocolytic Agents|tocolytic agents|mesh-ancestor
102241994|NCT01470755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102241995|NCT01470755|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102241996|NCT01470755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102241997|NCT01470755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102241998|NCT01470755|Adrenergic Agents|adrenergic agents|mesh-ancestor
102241999|NCT01470755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102242000|NCT01470755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242001|NCT03310073|Vaccines|vaccines|mesh-list
102242002|NCT03310073|Immunologic Factors|immunologic factors|mesh-ancestor
102242003|NCT03310073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242004|NCT03309527|Diphenhydramine|diphenhydramine|mesh-list
102242005|NCT03309527|Promethazine|promethazine|mesh-list
102242006|NCT03309527|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102242007|NCT03309527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102242008|NCT03309527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102242009|NCT03309527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242010|NCT03309527|Anesthetics, Local|anesthetics, local|mesh-ancestor
102242011|NCT03309527|Anesthetics|anesthetics|mesh-ancestor
102242012|NCT03309527|Sensory System Agents|sensory system agents|mesh-ancestor
102242013|NCT03309527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102242014|NCT03309527|Antiemetics|antiemetics|mesh-ancestor
102242015|NCT03309527|Autonomic Agents|autonomic agents|mesh-ancestor
102242016|NCT03309527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102242017|NCT03309527|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102242018|NCT03309527|Histamine Antagonists|histamine antagonists|mesh-ancestor
102242019|NCT03309527|Histamine Agents|histamine agents|mesh-ancestor
102242020|NCT03309527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102242021|NCT03309527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242022|NCT03309527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102242023|NCT03309527|Antipruritics|antipruritics|mesh-ancestor
102242024|NCT03309527|Dermatologic Agents|dermatologic agents|mesh-ancestor
102242025|NCT03313661|Gliclazide|gliclazide|mesh-list
102242026|NCT03313661|Cabergoline|cabergoline|mesh-list
102242027|NCT03313661|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102242028|NCT03313661|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102242029|NCT03313661|Dopamine Agonists|dopamine agonists|mesh-ancestor
102242030|NCT03313661|Dopamine Agents|dopamine agents|mesh-ancestor
102613031|NCT00002615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102613032|NCT00002615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102242031|NCT03313661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102242032|NCT03313661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242033|NCT03313661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613033|NCT00002621|Interferons|interferons|mesh-list
102242034|NCT03313661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102242035|NCT00703781|Bromfenac|bromfenac|mesh-list
102242036|NCT00703781|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102242037|NCT00703781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102242038|NCT00703781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102242039|NCT00703781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102242040|NCT00703781|Analgesics|analgesics|mesh-ancestor
102242041|NCT00703781|Sensory System Agents|sensory system agents|mesh-ancestor
102242042|NCT00703781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102242043|NCT00703781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242044|NCT00703781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102242045|NCT00703781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102242046|NCT03309215|Nickel|nickel|mesh-list
101950877|NCT01180179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102242047|NCT03309215|Trace Elements|trace elements|mesh-ancestor
102242048|NCT03309215|Micronutrients|micronutrients|mesh-ancestor
102242049|NCT03309215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242050|NCT03309059|Zinc Oxide|zinc oxide|mesh-list
102242051|NCT03309059|Dermatologic Agents|dermatologic agents|mesh-ancestor
102242052|NCT03309059|Sunscreening Agents|sunscreening agents|mesh-ancestor
102242053|NCT03309059|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102242054|NCT03309059|Protective Agents|protective agents|mesh-ancestor
102242055|NCT03309059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242056|NCT02469545|Sertraline|sertraline|mesh-list
102242057|NCT02469545|Escitalopram|escitalopram|mesh-list
102242058|NCT02469545|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102242059|NCT02469545|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102242060|NCT02469545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102242061|NCT02469545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242062|NCT02469545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102242063|NCT02469545|Serotonin Agents|serotonin agents|mesh-ancestor
102242064|NCT02469545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242065|NCT02469545|Antidepressive Agents|antidepressive agents|mesh-ancestor
102242066|NCT02469545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102242067|NCT03308357|Infliximab|infliximab|mesh-list
102242068|NCT03308357|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102242069|NCT03308357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102242070|NCT03308357|Dermatologic Agents|dermatologic agents|mesh-ancestor
102242071|NCT03308357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102242072|NCT03308357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102242073|NCT02469311|Chlorhexidine|chlorhexidine|mesh-list
102242074|NCT02469311|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102242075|NCT02469311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102242076|NCT02469311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102242077|NCT02469311|Disinfectants|disinfectants|mesh-ancestor
102242078|NCT03308201|Letrozole|letrozole|mesh-list
102242079|NCT03308201|Fulvestrant|fulvestrant|mesh-list
102242080|NCT03308201|Exemestane|exemestane|mesh-list
102242081|NCT03308201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102242082|NCT03308201|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102242083|NCT03308201|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102242084|NCT03308201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102242085|NCT03308201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242086|NCT03308201|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102242087|NCT03308201|Hormone Antagonists|hormone antagonists|mesh-ancestor
102242088|NCT03308201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102242089|NCT03308201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242090|NCT03308201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102242091|NCT03308201|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102242092|NCT03312413|Dexmedetomidine|dexmedetomidine|mesh-list
102242093|NCT03312413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102242094|NCT03312413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102242095|NCT03312413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242096|NCT03312413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102242097|NCT03312413|Analgesics|analgesics|mesh-ancestor
102242098|NCT03312413|Sensory System Agents|sensory system agents|mesh-ancestor
102242099|NCT03312413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102242100|NCT03312413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102242101|NCT03312413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102242102|NCT03312413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102613035|NCT00002621|Interferon alpha-2|interferon alpha-2|mesh-list
102242103|NCT03312413|Adrenergic Agents|adrenergic agents|mesh-ancestor
102242104|NCT03312413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102242105|NCT03312413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242107|NCT02722967|Antidepressive Agents|antidepressive agents|mesh-ancestor
102242108|NCT02722967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102242109|NCT02722967|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102242110|NCT02722967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102242111|NCT02722967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102242112|NCT02722967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242113|NCT02722967|Dopamine Agonists|dopamine agonists|mesh-ancestor
102242114|NCT02722967|Dopamine Agents|dopamine agents|mesh-ancestor
102242115|NCT02722967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102242116|NCT02722967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242117|NCT02722967|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102242118|NCT02722967|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102242119|NCT02722967|Serotonin Agents|serotonin agents|mesh-ancestor
102242120|NCT02722967|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102242121|NCT02722967|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102242122|NCT02722967|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102242123|NCT02722967|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102242124|NCT04442633|Miconazole|miconazole|mesh-list
102242125|NCT04442633|Antifungal Agents|antifungal agents|mesh-ancestor
102242126|NCT04442633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102242127|NCT04442633|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102242128|NCT04442633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102242129|NCT04442633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102242130|NCT04442633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242131|NCT04442633|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102242132|NCT04442633|Hormone Antagonists|hormone antagonists|mesh-ancestor
102242133|NCT04442633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102242134|NCT04442633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242135|NCT04442633|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102242136|NCT04442633|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102242137|NCT03312335|Aldesleukin|aldesleukin|mesh-list
102242138|NCT03312335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102242139|NCT03312335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102242140|NCT03312335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102242141|NCT03312335|Antiviral Agents|antiviral agents|mesh-ancestor
102242142|NCT03312335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102242143|NCT03312179|Incretins|incretins|mesh-list
102242144|NCT03312179|Hormones|hormones|mesh-ancestor
102242145|NCT03312179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102242146|NCT03312179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242147|NCT02468531|Xenon|xenon|mesh-list
102242148|NCT02468531|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102242149|NCT02468531|Anesthetics, General|anesthetics, general|mesh-ancestor
102242150|NCT02468531|Anesthetics|anesthetics|mesh-ancestor
102242151|NCT02468531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102242152|NCT02468531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242153|NCT03311945|Lamivudine|lamivudine|mesh-list
102242154|NCT03311945|Raltegravir Potassium|raltegravir potassium|mesh-list
102242155|NCT03311945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102242156|NCT03311945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102242157|NCT03311945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102242158|NCT03311945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242159|NCT03311945|Antiviral Agents|antiviral agents|mesh-ancestor
102242160|NCT03311945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102242161|NCT03311945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102242162|NCT03311945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102242163|NCT03311945|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102242164|NCT03311945|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102242165|NCT03311789|Gemcitabine|gemcitabine|mesh-list
102242166|NCT03311789|Nivolumab|nivolumab|mesh-list
102242167|NCT03311789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102242168|NCT03311789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102242169|NCT03311789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102242170|NCT03311789|Antimetabolites|antimetabolites|mesh-ancestor
102242171|NCT03311789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242172|NCT03311789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102242173|NCT02468999|Insulin|insulin|mesh-list
102242174|NCT02468999|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102242175|NCT02468999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102242176|NCT02468999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242177|NCT03311321|Vitamin K|vitamin k|mesh-list
102242178|NCT03311321|Vitamin K 2|vitamin k 2|mesh-list
102242179|NCT03311321|Menaquinone 7|menaquinone 7|mesh-list
102242180|NCT03311321|Vitamins|vitamins|mesh-ancestor
102613036|NCT00002621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613037|NCT00002621|Antiviral Agents|antiviral agents|mesh-ancestor
102613038|NCT00002621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102613039|NCT00002621|Immunologic Factors|immunologic factors|mesh-ancestor
102613040|NCT00002621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613041|NCT00002627|Paclitaxel|paclitaxel|mesh-list
102613042|NCT00002627|Cyclophosphamide|cyclophosphamide|mesh-list
102613043|NCT00002627|Carboplatin|carboplatin|mesh-list
102613044|NCT00002627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102242181|NCT03311321|Micronutrients|micronutrients|mesh-ancestor
102242182|NCT03311321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242183|NCT03311321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102242184|NCT03311321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102242185|NCT03311321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242186|NCT03311321|Hemostatics|hemostatics|mesh-ancestor
102242187|NCT03311321|Coagulants|coagulants|mesh-ancestor
102242188|NCT02468297|Ibuprofen|ibuprofen|mesh-list
102242189|NCT02468297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102242190|NCT02468297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102242191|NCT02468297|Analgesics|analgesics|mesh-ancestor
102242192|NCT02468297|Sensory System Agents|sensory system agents|mesh-ancestor
102242193|NCT02468297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102242194|NCT02468297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242195|NCT02468297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102242196|NCT02468297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102242197|NCT02468297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102242198|NCT02468297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102242199|NCT02468297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242200|NCT02468375|Mirabegron|mirabegron|mesh-list
102242201|NCT02468375|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102242202|NCT02468375|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102242203|NCT02468375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102242204|NCT02468375|Adrenergic Agents|adrenergic agents|mesh-ancestor
102242205|NCT02468375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102242206|NCT02468375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242207|NCT02468375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242208|NCT02468375|Urological Agents|urological agents|mesh-ancestor
102242210|NCT03304457|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102242211|NCT03304457|Antiemetics|antiemetics|mesh-ancestor
102242212|NCT03304457|Autonomic Agents|autonomic agents|mesh-ancestor
102242213|NCT03304457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102242214|NCT03304457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242215|NCT03304457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102242216|NCT03304457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102242217|NCT03304457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102242218|NCT03304457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102242219|NCT03304457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102242220|NCT03304457|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102242221|NCT03304457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102242222|NCT03304457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102242223|NCT03304457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242224|NCT03304457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102242225|NCT03304457|Serotonin Agents|serotonin agents|mesh-ancestor
102242226|NCT03304457|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102242227|NCT03304457|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102242228|NCT03304457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102242229|NCT03304457|Adrenergic Agents|adrenergic agents|mesh-ancestor
102242230|NCT03304457|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102242231|NCT03304457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102242232|NCT03304457|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102242233|NCT03304457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102242234|NCT03304457|Dopamine Agents|dopamine agents|mesh-ancestor
102242235|NCT04490837|Antibodies|antibodies|mesh-list
102242236|NCT04490837|Immunologic Factors|immunologic factors|mesh-ancestor
102242237|NCT04490837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242238|NCT03305471|Sevelamer|sevelamer|mesh-list
102242239|NCT03305471|Chelating Agents|chelating agents|mesh-ancestor
102242240|NCT03305471|Sequestering Agents|sequestering agents|mesh-ancestor
102242241|NCT03305471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242242|NCT03303677|Vancomycin|vancomycin|mesh-list
102242243|NCT03303677|Ciprofloxacin|ciprofloxacin|mesh-list
102242244|NCT03303677|Gentamicins|gentamicins|mesh-list
102613045|NCT00002627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613046|NCT00002627|Tubulin Modulators|tubulin modulators|mesh-ancestor
102613047|NCT00002627|Antimitotic Agents|antimitotic agents|mesh-ancestor
102242245|NCT03303677|Mupirocin|mupirocin|mesh-list
102242246|NCT03303677|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102242247|NCT03303677|Trimethoprim|trimethoprim|mesh-list
102242248|NCT03303677|Sulfamethoxazole|sulfamethoxazole|mesh-list
102242249|NCT03303677|Budesonide|budesonide|mesh-list
102242250|NCT03303677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102242251|NCT03303677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102242252|NCT03303677|Autonomic Agents|autonomic agents|mesh-ancestor
102242253|NCT03303677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102242254|NCT03303677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242255|NCT03303677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102242256|NCT03303677|Respiratory System Agents|respiratory system agents|mesh-ancestor
102242257|NCT03303677|Glucocorticoids|glucocorticoids|mesh-ancestor
102242258|NCT03303677|Hormones|hormones|mesh-ancestor
102242259|NCT03303677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102242260|NCT03303677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102242261|NCT03303677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102242262|NCT03303677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102242263|NCT03303677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102242264|NCT03303677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242265|NCT03303677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102242266|NCT03303677|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102242267|NCT03303677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102242268|NCT03303677|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102242269|NCT03303677|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102242270|NCT03303677|Antimalarials|antimalarials|mesh-ancestor
102242271|NCT03303677|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102242272|NCT03303677|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102242273|NCT03303677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102242274|NCT03303677|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102242275|NCT03303677|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102242276|NCT02468063|Terlipressin|terlipressin|mesh-list
102242277|NCT02468063|Norepinephrine|norepinephrine|mesh-list
102242278|NCT02468063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102242279|NCT02468063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102242280|NCT02468063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102242281|NCT02468063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102242282|NCT02468063|Adrenergic Agents|adrenergic agents|mesh-ancestor
102242283|NCT02468063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102242284|NCT02468063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242285|NCT02468063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242286|NCT02468063|Sympathomimetics|sympathomimetics|mesh-ancestor
102242287|NCT02468063|Autonomic Agents|autonomic agents|mesh-ancestor
102242288|NCT02468063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102242289|NCT04490681|Ertugliflozin|ertugliflozin|mesh-list
102242290|NCT04490681|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102242291|NCT04490681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242292|NCT04490681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102242293|NCT04490681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242294|NCT03303209|Analgesics, Opioid|analgesics, opioid|mesh-list
102242295|NCT03303209|Narcotics|narcotics|mesh-ancestor
102242296|NCT03303209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102242297|NCT03303209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242298|NCT03303209|Analgesics|analgesics|mesh-ancestor
102242299|NCT03303209|Sensory System Agents|sensory system agents|mesh-ancestor
102242300|NCT03303209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102242301|NCT03303053|Prednisolone|prednisolone|mesh-list
102242302|NCT03303053|Cholestyramine Resin|cholestyramine resin|mesh-list
102242303|NCT03303053|Carbimazole|carbimazole|mesh-list
102242304|NCT03303053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102242305|NCT03303053|Glucocorticoids|glucocorticoids|mesh-ancestor
102242306|NCT03303053|Hormones|hormones|mesh-ancestor
102242307|NCT03303053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102242308|NCT03303053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242309|NCT03303053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102242310|NCT03303053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102242311|NCT03303053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102242312|NCT03303053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102242313|NCT03303053|Antimetabolites|antimetabolites|mesh-ancestor
102242314|NCT03303053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242315|NCT03303053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102242316|NCT03303053|Antithyroid Agents|antithyroid agents|mesh-ancestor
102242317|NCT03303053|Hormone Antagonists|hormone antagonists|mesh-ancestor
102242318|NCT02467907|Paclitaxel|paclitaxel|mesh-list
102242320|NCT02467907|Carboplatin|carboplatin|mesh-list
102242321|NCT02467907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102242322|NCT02467907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102242323|NCT02467907|Tubulin Modulators|tubulin modulators|mesh-ancestor
102242324|NCT02467907|Antimitotic Agents|antimitotic agents|mesh-ancestor
102242325|NCT02467907|Mitosis Modulators|mitosis modulators|mesh-ancestor
102242326|NCT02467907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242327|NCT02467907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102242328|NCT02467907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102242329|NCT02467907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102242330|NCT02467907|Growth Substances|growth substances|mesh-ancestor
102242331|NCT02467907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242332|NCT02467907|Growth Inhibitors|growth inhibitors|mesh-ancestor
102242333|NCT02467127|Vitamin D|vitamin d|mesh-list
102242334|NCT02467127|Vitamins|vitamins|mesh-ancestor
102242335|NCT02467127|Micronutrients|micronutrients|mesh-ancestor
102242336|NCT02467127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242337|NCT02467127|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102242338|NCT03302585|Vitamin D|vitamin d|mesh-list
102242339|NCT03302585|Ergocalciferols|ergocalciferols|mesh-list
102242340|NCT03302585|Cholecalciferol|cholecalciferol|mesh-list
102242341|NCT03302585|Vitamins|vitamins|mesh-list
102242342|NCT03302585|Micronutrients|micronutrients|mesh-ancestor
102242343|NCT03302585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242344|NCT03302585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102242345|NCT03302585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102242346|NCT05727761|Metformin|metformin|mesh-list
102242347|NCT05727761|Pioglitazone|pioglitazone|mesh-list
102242348|NCT05727761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102242349|NCT05727761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242350|NCT03302351|Dexmedetomidine|dexmedetomidine|mesh-list
102242351|NCT03302351|Ketamine|ketamine|mesh-list
102242352|NCT03302351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102242353|NCT03302351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102242354|NCT03302351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242355|NCT03302351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102242356|NCT03302351|Analgesics|analgesics|mesh-ancestor
102242357|NCT03302351|Sensory System Agents|sensory system agents|mesh-ancestor
102242358|NCT03302351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102242359|NCT03302351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102242360|NCT03302351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102242361|NCT03302351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102242362|NCT03302351|Adrenergic Agents|adrenergic agents|mesh-ancestor
102242363|NCT03302351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102242364|NCT03302351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242365|NCT03302351|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102242366|NCT03302351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102242367|NCT03302351|Anesthetics, General|anesthetics, general|mesh-ancestor
102242368|NCT03302351|Anesthetics|anesthetics|mesh-ancestor
102242369|NCT03302351|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102242370|NCT03302351|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102242371|NCT05727683|Cyclophosphamide|cyclophosphamide|mesh-list
102242372|NCT05727683|Fludarabine|fludarabine|mesh-list
102242373|NCT05727683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102242374|NCT05727683|Immunologic Factors|immunologic factors|mesh-ancestor
102242375|NCT05727683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242376|NCT05727683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102242377|NCT05727683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102242378|NCT05727683|Alkylating Agents|alkylating agents|mesh-ancestor
102242379|NCT05727683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242380|NCT05727683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102242381|NCT05727683|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102242382|NCT03302039|Phenylephrine|phenylephrine|mesh-list
102242383|NCT03302039|Oxymetazoline|oxymetazoline|mesh-list
102242384|NCT03302039|Bupivacaine|bupivacaine|mesh-list
102242385|NCT03302039|Anesthetics, Local|anesthetics, local|mesh-ancestor
102242386|NCT03302039|Anesthetics|anesthetics|mesh-ancestor
102242387|NCT03302039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102242388|NCT03302039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242389|NCT03302039|Sensory System Agents|sensory system agents|mesh-ancestor
102242390|NCT03302039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102242391|NCT03302039|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102242392|NCT03302039|Mydriatics|mydriatics|mesh-ancestor
102242393|NCT03302039|Autonomic Agents|autonomic agents|mesh-ancestor
102242394|NCT03302039|Sympathomimetics|sympathomimetics|mesh-ancestor
102242395|NCT03302039|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102242396|NCT03302039|Nasal Decongestants|nasal decongestants|mesh-ancestor
102242397|NCT03302039|Respiratory System Agents|respiratory system agents|mesh-ancestor
102242398|NCT03302039|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102242399|NCT03302039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102242400|NCT03302039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102242401|NCT03302039|Adrenergic Agents|adrenergic agents|mesh-ancestor
102242402|NCT03302039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102242403|NCT03302039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242404|NCT03302039|Protective Agents|protective agents|mesh-ancestor
102242405|NCT02721875|Azacitidine|azacitidine|mesh-list
102242406|NCT02721875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102242407|NCT02721875|Antimetabolites|antimetabolites|mesh-ancestor
102242408|NCT02721875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242409|NCT02721875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102242410|NCT02721875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102242411|NCT02466503|Fluticasone|fluticasone|mesh-list
102242412|NCT02466503|Xhance|xhance|mesh-list
102242413|NCT02466503|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102242414|NCT02466503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102242415|NCT02466503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102242416|NCT02466503|Autonomic Agents|autonomic agents|mesh-ancestor
102242417|NCT02466503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102242418|NCT02466503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242419|NCT02466503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102242420|NCT02466503|Respiratory System Agents|respiratory system agents|mesh-ancestor
102242421|NCT02466503|Dermatologic Agents|dermatologic agents|mesh-ancestor
102242422|NCT02466503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102242423|NCT02466503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102242424|NCT02466503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102242425|NCT02466503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102242426|NCT02466503|Adrenergic Agents|adrenergic agents|mesh-ancestor
102242427|NCT02466503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102242428|NCT02466503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242429|NCT03301181|Itraconazole|itraconazole|mesh-list
102242430|NCT03301181|Rifampin|rifampin|mesh-list
102242431|NCT03301181|Zanubrutinib|zanubrutinib|mesh-list
102242432|NCT03301181|Antifungal Agents|antifungal agents|mesh-ancestor
102242433|NCT03301181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102242434|NCT03301181|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102242435|NCT03301181|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102242436|NCT03301181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102242437|NCT03301181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242438|NCT03301181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102242439|NCT03301181|Hormone Antagonists|hormone antagonists|mesh-ancestor
102242440|NCT03301181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102242441|NCT03301181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242442|NCT03301181|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102242443|NCT03301181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102242444|NCT03301181|Antitubercular Agents|antitubercular agents|mesh-ancestor
102242445|NCT03301181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102242446|NCT03301181|Leprostatic Agents|leprostatic agents|mesh-ancestor
102242447|NCT03301181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102242448|NCT03301181|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102242449|NCT03301181|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102242450|NCT03301181|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102242451|NCT03301181|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102242452|NCT03301181|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102242453|NCT03301181|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102242454|NCT03301181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102242455|NCT03301181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102242456|NCT00702221|Vaccines|vaccines|mesh-list
102242457|NCT00702221|Immunologic Factors|immunologic factors|mesh-ancestor
102242458|NCT00702221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242459|NCT03301025|Pregabalin|pregabalin|mesh-list
102242460|NCT03301025|Analgesics|analgesics|mesh-ancestor
102242461|NCT03301025|Sensory System Agents|sensory system agents|mesh-ancestor
102242462|NCT03301025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102242463|NCT03301025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242464|NCT03301025|Anticonvulsants|anticonvulsants|mesh-ancestor
102613048|NCT00002627|Mitosis Modulators|mitosis modulators|mesh-ancestor
102613049|NCT00002627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613050|NCT00002627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102242465|NCT03301025|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102242466|NCT03301025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102242467|NCT03301025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242468|NCT03301025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102242469|NCT03301025|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102242470|NCT03301025|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102242471|NCT03301025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102242472|NCT03301025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102242473|NCT05726903|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102242474|NCT05726903|Medroxyprogesterone|medroxyprogesterone|mesh-list
102242475|NCT05726903|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102242476|NCT05726903|Contraceptive Agents|contraceptive agents|mesh-ancestor
102242477|NCT05726903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102242478|NCT05726903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242479|NCT05726903|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102242480|NCT05726903|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102242481|NCT05726903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102242482|NCT05726903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102242483|NCT05726903|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102242484|NCT05726903|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102242485|NCT05726903|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102242486|NCT02467595|Fentanyl|fentanyl|mesh-list
102242487|NCT02467595|Bromides|bromides|mesh-list
102242488|NCT02467595|Propofol|propofol|mesh-list
102242489|NCT02467595|Sevoflurane|sevoflurane|mesh-list
102242490|NCT02467595|Rocuronium|rocuronium|mesh-list
102242491|NCT02467595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102242492|NCT02467595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102242493|NCT02467595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242494|NCT02467595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102242495|NCT02467595|Anesthetics, General|anesthetics, general|mesh-ancestor
102242496|NCT02467595|Anesthetics|anesthetics|mesh-ancestor
102242497|NCT02467595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102242498|NCT02467595|Narcotics|narcotics|mesh-ancestor
102242499|NCT02467595|Analgesics|analgesics|mesh-ancestor
102242500|NCT02467595|Sensory System Agents|sensory system agents|mesh-ancestor
102242501|NCT02467595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102242502|NCT02467595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102242503|NCT02467595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102242504|NCT02467595|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102242505|NCT02467595|Anticonvulsants|anticonvulsants|mesh-ancestor
102242506|NCT02467595|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102242507|NCT02467595|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102242508|NCT02467595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102242509|NCT02467517|Magnesium Sulfate|magnesium sulfate|mesh-list
102242510|NCT02467517|Ketamine|ketamine|mesh-list
102242511|NCT02467517|Analgesics|analgesics|mesh-ancestor
102242512|NCT02467517|Sensory System Agents|sensory system agents|mesh-ancestor
102242513|NCT02467517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102242514|NCT02467517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712336|NCT00683306|Gefitinib|gefitinib|mesh-list
102242515|NCT02467517|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102242516|NCT02467517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102242517|NCT02467517|Anesthetics, General|anesthetics, general|mesh-ancestor
102242518|NCT02467517|Anesthetics|anesthetics|mesh-ancestor
102242519|NCT02467517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102242520|NCT02467517|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102242521|NCT02467517|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102242522|NCT02467517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102242523|NCT02467517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242524|NCT02467517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102242525|NCT02467517|Anticonvulsants|anticonvulsants|mesh-ancestor
102242526|NCT02467517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102242527|NCT02467517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102242528|NCT02467517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102242529|NCT02467517|Tocolytic Agents|tocolytic agents|mesh-ancestor
102242530|NCT02467517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102242531|NCT02467673|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102242532|NCT02467673|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102242533|NCT02467673|Estradiol|estradiol|mesh-list
102242534|NCT02467673|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102242535|NCT02467673|Progesterone|progesterone|mesh-list
102242536|NCT02467673|Estrogens|estrogens|mesh-ancestor
102613051|NCT00002627|Immunologic Factors|immunologic factors|mesh-ancestor
102613052|NCT00002627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613053|NCT00002627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102242537|NCT02467673|Hormones|hormones|mesh-ancestor
102242538|NCT02467673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102242539|NCT02467673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242540|NCT02467673|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102242541|NCT02467673|Contraceptive Agents|contraceptive agents|mesh-ancestor
102242542|NCT02467673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102242543|NCT02467673|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102242544|NCT02467673|Progestins|progestins|mesh-ancestor
102242545|NCT02953145|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102242546|NCT02953145|Hemostatics|hemostatics|mesh-ancestor
102242547|NCT02953145|Coagulants|coagulants|mesh-ancestor
102242548|NCT03300089|Anesthetics|anesthetics|mesh-list
102242549|NCT03300089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102242550|NCT03300089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242551|NCT04983615|Fentanyl|fentanyl|mesh-list
102242552|NCT04983615|Midazolam|midazolam|mesh-list
102242553|NCT04983615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102242554|NCT04983615|Narcotics|narcotics|mesh-ancestor
102242555|NCT04983615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102242556|NCT04983615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242557|NCT04983615|Analgesics|analgesics|mesh-ancestor
102242558|NCT04983615|Sensory System Agents|sensory system agents|mesh-ancestor
102242559|NCT04983615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102242560|NCT04983615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102242561|NCT04983615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102242562|NCT04983615|Anesthetics, General|anesthetics, general|mesh-ancestor
102242563|NCT04983615|Anesthetics|anesthetics|mesh-ancestor
102242564|NCT04983615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102242565|NCT04983615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102242566|NCT04983615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102242567|NCT04983615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102242568|NCT04983615|GABA Modulators|gaba modulators|mesh-ancestor
102242569|NCT04983615|GABA Agents|gaba agents|mesh-ancestor
102242570|NCT04983615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102242571|NCT04983615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242572|NCT00702923|Tremelimumab|tremelimumab|mesh-list
102242573|NCT00702923|Bicalutamide|bicalutamide|mesh-list
102242574|NCT00702923|Ipilimumab|ipilimumab|mesh-list
101951401|NCT01297023|Vitamin D|vitamin d|mesh-list
102242575|NCT00702923|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102242576|NCT00702923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102242577|NCT00702923|Immunologic Factors|immunologic factors|mesh-ancestor
102242578|NCT00702923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242579|NCT00702923|Androgen Antagonists|androgen antagonists|mesh-ancestor
102242580|NCT00702923|Hormone Antagonists|hormone antagonists|mesh-ancestor
102242581|NCT00702923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102242582|NCT00702923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102242583|NCT00702923|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102242584|NCT00702923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242585|NCT05294055|Cyclophosphamide|cyclophosphamide|mesh-list
102242586|NCT05294055|Etoposide|etoposide|mesh-list
102242587|NCT05294055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102242588|NCT05294055|Immunologic Factors|immunologic factors|mesh-ancestor
102242589|NCT05294055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242590|NCT05294055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102242591|NCT05294055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102242592|NCT05294055|Alkylating Agents|alkylating agents|mesh-ancestor
102242593|NCT05294055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242594|NCT05294055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102242595|NCT05294055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102242596|NCT05294055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102242597|NCT05294055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102242598|NCT05294055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102242599|NCT05294055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102242600|NCT03299621|Rocuronium|rocuronium|mesh-list
102242601|NCT03299621|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102242602|NCT03299621|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102613054|NCT00002627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102613055|NCT00002627|Alkylating Agents|alkylating agents|mesh-ancestor
102613056|NCT00002627|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102613057|NCT00002633|Leuprolide|leuprolide|mesh-list
102613058|NCT00002633|Goserelin|goserelin|mesh-list
102613059|NCT00002633|Flutamide|flutamide|mesh-list
102242603|NCT03299621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102242604|NCT03299621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102613060|NCT00002633|Bicalutamide|bicalutamide|mesh-list
102613061|NCT00002633|Nilutamide|nilutamide|mesh-list
102242605|NCT03299621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242606|NCT05718167|Tislelizumab|tislelizumab|mesh-list
102242607|NCT05718167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102242608|NCT05718167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102242609|NCT03299387|Gentamicins|gentamicins|mesh-list
102242610|NCT03299387|Nitrofurantoin|nitrofurantoin|mesh-list
102242611|NCT03299387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102242612|NCT03299387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102242613|NCT03299387|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102242614|NCT03299387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102242615|NCT03299387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242616|NCT03299387|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102242617|NCT04954313|Chlorhexidine|chlorhexidine|mesh-list
102242618|NCT04954313|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102242619|NCT04954313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102242620|NCT04954313|Disinfectants|disinfectants|mesh-ancestor
102242621|NCT02658981|Nivolumab|nivolumab|mesh-list
102242622|NCT02658981|Relatlimab|relatlimab|mesh-list
102242623|NCT02658981|Antibodies|antibodies|mesh-list
102242624|NCT02658981|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102242625|NCT02658981|Immunologic Factors|immunologic factors|mesh-ancestor
102242626|NCT02658981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242627|NCT02658981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102242628|NCT02658981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102242629|NCT02658981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102242630|NCT02658981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242631|NCT04794699|Paclitaxel|paclitaxel|mesh-list
102242632|NCT04794699|Docetaxel|docetaxel|mesh-list
102242633|NCT04794699|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102242634|NCT04794699|Gemcitabine|gemcitabine|mesh-list
102242635|NCT04794699|Pemetrexed|pemetrexed|mesh-list
102242636|NCT04794699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102242637|NCT04794699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102242638|NCT04794699|Tubulin Modulators|tubulin modulators|mesh-ancestor
102242639|NCT04794699|Antimitotic Agents|antimitotic agents|mesh-ancestor
102242640|NCT04794699|Mitosis Modulators|mitosis modulators|mesh-ancestor
102242641|NCT04794699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242642|NCT04794699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102242643|NCT04794699|Antimetabolites|antimetabolites|mesh-ancestor
102242644|NCT04794699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102242645|NCT04794699|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102242646|NCT04794699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102242647|NCT04782687|Dexamethasone|dexamethasone|mesh-list
102242648|NCT04782687|Lenalidomide|lenalidomide|mesh-list
102242649|NCT04782687|Daratumumab|daratumumab|mesh-list
102242650|NCT04782687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102242652|NCT04782687|Autonomic Agents|autonomic agents|mesh-ancestor
102242653|NCT04782687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102242654|NCT04782687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242655|NCT04782687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102242656|NCT04782687|Glucocorticoids|glucocorticoids|mesh-ancestor
102242657|NCT04782687|Hormones|hormones|mesh-ancestor
102242658|NCT04782687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102242659|NCT04782687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102242660|NCT04782687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102242661|NCT04782687|Immunologic Factors|immunologic factors|mesh-ancestor
102242662|NCT04782687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102242663|NCT04782687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102242664|NCT04782687|Growth Substances|growth substances|mesh-ancestor
102242665|NCT04782687|Growth Inhibitors|growth inhibitors|mesh-ancestor
102242666|NCT05655689|Moxifloxacin|moxifloxacin|mesh-list
102242667|NCT05655689|Vancomycin|vancomycin|mesh-list
102242668|NCT05655689|Gentamicins|gentamicins|mesh-list
102242669|NCT05655689|Ceftazidime|ceftazidime|mesh-list
102242670|NCT05655689|Natamycin|natamycin|mesh-list
102242671|NCT05655689|Voriconazole|voriconazole|mesh-list
102242672|NCT05655689|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102242673|NCT05655689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102242674|NCT05655689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102242675|NCT05655689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102242676|NCT05655689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102242677|NCT05655689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102242678|NCT05655689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102242679|NCT05655689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613062|NCT00002633|Buserelin|buserelin|mesh-list
102242680|NCT05655689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101901519|NCT03307252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102613063|NCT00002633|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102242681|NCT05655689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242682|NCT05655689|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102242683|NCT05655689|Antifungal Agents|antifungal agents|mesh-ancestor
102242684|NCT05655689|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102242685|NCT05655689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102242686|NCT05655689|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102242687|NCT05655689|Hormone Antagonists|hormone antagonists|mesh-ancestor
102242688|NCT05655689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102242689|NCT05655689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102242690|NCT05655689|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102242691|NCT02466347|Fluticasone|fluticasone|mesh-list
102242692|NCT02466347|Xhance|xhance|mesh-list
102242693|NCT02466347|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102242694|NCT02466347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102242695|NCT02466347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102242696|NCT02466347|Autonomic Agents|autonomic agents|mesh-ancestor
102242697|NCT02466347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102242698|NCT02466347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242699|NCT02466347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102242700|NCT02466347|Respiratory System Agents|respiratory system agents|mesh-ancestor
102242701|NCT02466347|Dermatologic Agents|dermatologic agents|mesh-ancestor
102242702|NCT02466347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102242703|NCT02466347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102242704|NCT02466347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102242705|NCT02466347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102242706|NCT02466347|Adrenergic Agents|adrenergic agents|mesh-ancestor
102242707|NCT02466347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102242708|NCT02466347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242709|NCT03067935|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
102242710|NCT03067935|Immunoconjugates|immunoconjugates|mesh-ancestor
102242711|NCT03067935|Immunologic Factors|immunologic factors|mesh-ancestor
102242712|NCT03067935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242713|NCT03067935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102242714|NCT03067935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102242715|NCT02466191|Gabapentin|gabapentin|mesh-list
102242716|NCT02466191|Memantine|memantine|mesh-list
102242717|NCT02466191|Analgesics|analgesics|mesh-ancestor
102242718|NCT02466191|Sensory System Agents|sensory system agents|mesh-ancestor
102242719|NCT02466191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102242720|NCT02466191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242721|NCT02466191|Anticonvulsants|anticonvulsants|mesh-ancestor
102242722|NCT02466191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102242723|NCT02466191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102242724|NCT02466191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102242725|NCT02466191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102242726|NCT02466191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102242727|NCT02466191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102242728|NCT02466191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102242729|NCT02466191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242730|NCT02466191|Antimanic Agents|antimanic agents|mesh-ancestor
102242731|NCT02466191|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102242732|NCT02466191|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102242733|NCT02466191|Dopamine Agents|dopamine agents|mesh-ancestor
102242734|NCT05555069|Menthol|menthol|mesh-list
102242735|NCT05555069|Antipruritics|antipruritics|mesh-ancestor
102242736|NCT05555069|Dermatologic Agents|dermatologic agents|mesh-ancestor
102242737|NCT03067701|Carbon Monoxide|carbon monoxide|mesh-list
102242738|NCT03067701|Antimetabolites|antimetabolites|mesh-ancestor
102242739|NCT03067701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242740|NCT03067701|Gasotransmitters|gasotransmitters|mesh-ancestor
102242741|NCT03067701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102242742|NCT03067701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242743|NCT03069339|Carvedilol|carvedilol|mesh-list
102242744|NCT03069339|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102242745|NCT03069339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102242746|NCT03069339|Adrenergic Agents|adrenergic agents|mesh-ancestor
102242747|NCT03069339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102242748|NCT03069339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242749|NCT03069339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242750|NCT03069339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102242751|NCT03069339|Antioxidants|antioxidants|mesh-ancestor
102242752|NCT03069339|Protective Agents|protective agents|mesh-ancestor
101901521|NCT03307252|Natriuretic Agents|natriuretic agents|mesh-ancestor
102613065|NCT00002633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102242753|NCT03069339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102242754|NCT03069339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102242755|NCT03069339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102242756|NCT03069339|Vasodilator Agents|vasodilator agents|mesh-ancestor
102242757|NCT03069339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102242758|NCT03069339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102242759|NCT05542589|Phenytoin|phenytoin|mesh-list
102242760|NCT05542589|Anticonvulsants|anticonvulsants|mesh-ancestor
102242761|NCT05542589|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102242762|NCT05542589|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102242763|NCT05542589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102242764|NCT05542589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242765|NCT05542589|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102242766|NCT05542589|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102242767|NCT03069027|Lidocaine|lidocaine|mesh-list
102242768|NCT03069027|Epinephrine|epinephrine|mesh-list
102242769|NCT03069027|Racepinephrine|racepinephrine|mesh-list
102242770|NCT03069027|Epinephryl borate|epinephryl borate|mesh-list
102242771|NCT03069027|Anesthetics, Local|anesthetics, local|mesh-ancestor
102242772|NCT03069027|Anesthetics|anesthetics|mesh-ancestor
102242773|NCT03069027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102242774|NCT03069027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242775|NCT03069027|Sensory System Agents|sensory system agents|mesh-ancestor
102242776|NCT03069027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102242777|NCT03069027|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102242778|NCT03069027|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102242779|NCT03069027|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102242780|NCT03069027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102242781|NCT03069027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242782|NCT03069027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102242783|NCT03069027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102242784|NCT03069027|Adrenergic Agents|adrenergic agents|mesh-ancestor
102242785|NCT03069027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102242786|NCT03069027|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102242787|NCT03069027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102242788|NCT03069027|Autonomic Agents|autonomic agents|mesh-ancestor
102242789|NCT03069027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102242790|NCT03069027|Respiratory System Agents|respiratory system agents|mesh-ancestor
102242791|NCT03069027|Mydriatics|mydriatics|mesh-ancestor
102242792|NCT03069027|Sympathomimetics|sympathomimetics|mesh-ancestor
102242793|NCT03069027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102242794|NCT05635071|Nintedanib|nintedanib|mesh-list
102242795|NCT05635071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102242796|NCT05635071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102242797|NCT05635071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102242798|NCT05635071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242799|NCT04489979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102242800|NCT04489979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102242801|NCT02720081|Albuterol|albuterol|mesh-list
102242802|NCT02720081|Montelukast|montelukast|mesh-list
102242803|NCT02720081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102242804|NCT02720081|Respiratory System Agents|respiratory system agents|mesh-ancestor
102242805|NCT02720081|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102242806|NCT02720081|Hormone Antagonists|hormone antagonists|mesh-ancestor
102242807|NCT02720081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102242808|NCT02720081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242809|NCT02720081|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102242810|NCT02720081|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102242811|NCT02720081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242812|NCT02720081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102242813|NCT02720081|Autonomic Agents|autonomic agents|mesh-ancestor
102242814|NCT02720081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102242815|NCT02720081|Tocolytic Agents|tocolytic agents|mesh-ancestor
102242816|NCT02720081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102242817|NCT02720081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102242818|NCT02720081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102242819|NCT02720081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101712409|NCT00689624|Antidotes|antidotes|mesh-ancestor
102242820|NCT02720081|Adrenergic Agents|adrenergic agents|mesh-ancestor
102242821|NCT02720081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102242822|NCT04552197|Tofacitinib|tofacitinib|mesh-list
102242823|NCT04552197|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102242824|NCT04552197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102613066|NCT00002633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242825|NCT04552197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102242826|NCT04552197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242827|NCT05244473|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102242828|NCT05244473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102242829|NCT05244473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102242830|NCT05244473|Immunotoxins|immunotoxins|mesh-ancestor
102242831|NCT05244473|Immunoconjugates|immunoconjugates|mesh-ancestor
102242832|NCT05244473|Immunologic Factors|immunologic factors|mesh-ancestor
102242833|NCT05244473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242834|NCT05634759|Azithromycin|azithromycin|mesh-list
102242835|NCT05634759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102242836|NCT05634759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102242837|NCT04809233|Tipifarnib|tipifarnib|mesh-list
102242838|NCT04809233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102242839|NCT02310269|Pasireotide|pasireotide|mesh-list
102242840|NCT02310269|Hormones|hormones|mesh-ancestor
102242841|NCT02310269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102242842|NCT02310269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242843|NCT03069183|Ropivacaine|ropivacaine|mesh-list
102242844|NCT03069183|Anesthetics, Local|anesthetics, local|mesh-ancestor
102242845|NCT03069183|Anesthetics|anesthetics|mesh-ancestor
102242846|NCT03069183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102242847|NCT03069183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242848|NCT03069183|Sensory System Agents|sensory system agents|mesh-ancestor
102242849|NCT03069183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102242850|NCT04489745|Androgens|androgens|mesh-list
102242851|NCT04489745|Hormones|hormones|mesh-ancestor
102242852|NCT04489745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102242853|NCT04489745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242854|NCT02464865|Thiamine|thiamine|mesh-list
102242855|NCT02464865|Vitamin B Complex|vitamin b complex|mesh-ancestor
102242856|NCT02464865|Vitamins|vitamins|mesh-ancestor
102242857|NCT02464865|Micronutrients|micronutrients|mesh-ancestor
102242858|NCT02464865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242859|NCT02466035|Caseins|caseins|mesh-list
102242860|NCT02466035|Chelating Agents|chelating agents|mesh-ancestor
102242861|NCT02466035|Sequestering Agents|sequestering agents|mesh-ancestor
102242862|NCT02466035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242863|NCT05173337|Nefopam|nefopam|mesh-list
102242864|NCT05173337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102242865|NCT05173337|Analgesics|analgesics|mesh-ancestor
102242866|NCT05173337|Sensory System Agents|sensory system agents|mesh-ancestor
102242867|NCT05173337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102242868|NCT05173337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242869|NCT02464631|Ribavirin|ribavirin|mesh-list
102242870|NCT02464631|Sofosbuvir|sofosbuvir|mesh-list
102242871|NCT02464631|Antimetabolites|antimetabolites|mesh-ancestor
102242872|NCT02464631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242873|NCT02464631|Antiviral Agents|antiviral agents|mesh-ancestor
102242874|NCT02464631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102242875|NCT04880577|Tenofovir|tenofovir|mesh-list
102242876|NCT04880577|Rituximab|rituximab|mesh-list
102242877|NCT04880577|Ocrelizumab|ocrelizumab|mesh-list
102242878|NCT04880577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102242879|NCT04880577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102242880|NCT04880577|Immunologic Factors|immunologic factors|mesh-ancestor
102242881|NCT04880577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242882|NCT04880577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102242883|NCT04880577|Antiviral Agents|antiviral agents|mesh-ancestor
102242884|NCT04880577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102242885|NCT04880577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102242886|NCT04880577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102242887|NCT04880577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102242888|NCT04880577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242889|NCT04880577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102242890|NCT04880577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102242891|NCT04490213|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102242892|NCT04490213|Laxatives|laxatives|mesh-ancestor
102242893|NCT04490213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102242894|NCT04562597|Acetylcysteine|acetylcysteine|mesh-list
102242895|NCT04562597|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102242896|NCT04562597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242897|NCT04562597|Antiviral Agents|antiviral agents|mesh-ancestor
102242898|NCT04562597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102242899|NCT04562597|Expectorants|expectorants|mesh-ancestor
102242900|NCT04562597|Respiratory System Agents|respiratory system agents|mesh-ancestor
102242901|NCT04562597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102613067|NCT00002633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102613068|NCT00002633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613069|NCT00002633|Androgen Antagonists|androgen antagonists|mesh-ancestor
102613070|NCT00002633|Hormone Antagonists|hormone antagonists|mesh-ancestor
102613071|NCT00002633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102613072|NCT00002639|Suramin|suramin|mesh-list
102613073|NCT00002639|Antinematodal Agents|antinematodal agents|mesh-ancestor
102613074|NCT00002639|Anthelmintics|anthelmintics|mesh-ancestor
102613075|NCT00002639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102613076|NCT00002639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102613077|NCT00002639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613078|NCT00002639|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102242902|NCT04562597|Antioxidants|antioxidants|mesh-ancestor
102242903|NCT04562597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242904|NCT04562597|Protective Agents|protective agents|mesh-ancestor
102242905|NCT04562597|Antidotes|antidotes|mesh-ancestor
102242906|NCT04504175|Ketamine|ketamine|mesh-list
102242907|NCT04504175|Analgesics|analgesics|mesh-ancestor
102242908|NCT04504175|Sensory System Agents|sensory system agents|mesh-ancestor
102242909|NCT04504175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102242910|NCT04504175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242911|NCT04504175|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102242912|NCT04504175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102242913|NCT04504175|Anesthetics, General|anesthetics, general|mesh-ancestor
102242914|NCT04504175|Anesthetics|anesthetics|mesh-ancestor
102242915|NCT04504175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102242916|NCT04504175|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102242917|NCT04504175|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102242918|NCT04504175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102242919|NCT04504175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242920|NCT05723367|Anesthetics|anesthetics|mesh-list
102242921|NCT05723367|Anesthetics, Local|anesthetics, local|mesh-list
102242922|NCT05723367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102242923|NCT05723367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242924|NCT05723367|Sensory System Agents|sensory system agents|mesh-ancestor
102242925|NCT05723367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102242926|NCT03853395|Antibodies|antibodies|mesh-list
101712433|NCT02622854|Insulin|insulin|mesh-list
102242927|NCT03853395|Immunologic Factors|immunologic factors|mesh-ancestor
102242928|NCT03853395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242929|NCT04433169|Tretinoin|tretinoin|mesh-list
102242930|NCT04433169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102242931|NCT04433169|Keratolytic Agents|keratolytic agents|mesh-ancestor
102242932|NCT04433169|Dermatologic Agents|dermatologic agents|mesh-ancestor
102242933|NCT02717195|Olanzapine|olanzapine|mesh-list
102242934|NCT02717195|Risperidone|risperidone|mesh-list
102242935|NCT02717195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102242936|NCT02717195|Serotonin Agents|serotonin agents|mesh-ancestor
102242937|NCT02717195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102242938|NCT02717195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242939|NCT02717195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242940|NCT02717195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102242941|NCT02717195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102242942|NCT02717195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102242943|NCT02717195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102242944|NCT02717195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102242945|NCT02717195|Dopamine Agents|dopamine agents|mesh-ancestor
102242946|NCT02717195|Antiemetics|antiemetics|mesh-ancestor
102242947|NCT02717195|Autonomic Agents|autonomic agents|mesh-ancestor
102242948|NCT02717195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102242949|NCT02717195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102242950|NCT02717195|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102242951|NCT02717195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102242952|NCT02717195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102242953|NCT05582811|Riociguat|riociguat|mesh-list
102242954|NCT05582811|Enzyme Activators|enzyme activators|mesh-ancestor
102242955|NCT05582811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242956|NCT05582031|Tislelizumab|tislelizumab|mesh-list
102242957|NCT05582031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102242958|NCT05582031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102242959|NCT04424225|Niacin|niacin|mesh-list
102242960|NCT04424225|Psilocybin|psilocybin|mesh-list
102242961|NCT04424225|Vitamins|vitamins|mesh-ancestor
102242962|NCT04424225|Micronutrients|micronutrients|mesh-ancestor
102242963|NCT04424225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613079|NCT00002639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102242964|NCT04424225|Vitamin B Complex|vitamin b complex|mesh-ancestor
102242965|NCT04424225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102242966|NCT04424225|Antimetabolites|antimetabolites|mesh-ancestor
102242967|NCT04424225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242968|NCT04424225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102242969|NCT04424225|Vasodilator Agents|vasodilator agents|mesh-ancestor
102242970|NCT04424225|Hallucinogens|hallucinogens|mesh-ancestor
102242971|NCT04424225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102242973|NCT05581719|Tislelizumab|tislelizumab|mesh-list
102242974|NCT05581719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102242975|NCT05581719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102242976|NCT05581719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102242977|NCT05581719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242978|NCT05626101|Gemcitabine|gemcitabine|mesh-list
102242979|NCT05626101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102242980|NCT05626101|Antimetabolites|antimetabolites|mesh-ancestor
102242981|NCT05626101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242982|NCT05626101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102242983|NCT02465801|Lenograstim|lenograstim|mesh-list
102242984|NCT02465801|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102242985|NCT02465801|Immunologic Factors|immunologic factors|mesh-ancestor
102242986|NCT02465801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102242987|NCT02465645|Carvedilol|carvedilol|mesh-list
102242988|NCT02465645|Simvastatin|simvastatin|mesh-list
102242989|NCT02465645|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102242990|NCT02465645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102242991|NCT02465645|Antimetabolites|antimetabolites|mesh-ancestor
102242992|NCT02465645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102242993|NCT02465645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102242994|NCT02465645|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102242995|NCT02465645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102242996|NCT02465645|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102242997|NCT02465645|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102242998|NCT02465645|Adrenergic Agents|adrenergic agents|mesh-ancestor
102242999|NCT02465645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102243000|NCT02465645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243001|NCT02465645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102243002|NCT02465645|Antioxidants|antioxidants|mesh-ancestor
102243003|NCT02465645|Protective Agents|protective agents|mesh-ancestor
102243004|NCT02465645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102243005|NCT02465645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102243006|NCT02465645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102243007|NCT02465645|Vasodilator Agents|vasodilator agents|mesh-ancestor
102243008|NCT02465645|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102243009|NCT02465645|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102243010|NCT04872257|Vitamin D|vitamin d|mesh-list
102243011|NCT04872257|Vitamins|vitamins|mesh-ancestor
102243012|NCT04872257|Micronutrients|micronutrients|mesh-ancestor
102243013|NCT04872257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243014|NCT04872257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102243015|NCT04970121|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102243016|NCT04970121|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102243017|NCT04970121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102243018|NCT04970121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102243019|NCT04970121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243020|NCT04970121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102243021|NCT04970121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243022|NCT04970121|Analgesics|analgesics|mesh-ancestor
102243023|NCT04970121|Sensory System Agents|sensory system agents|mesh-ancestor
102243024|NCT04970121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102243025|NCT04970121|Antidepressive Agents|antidepressive agents|mesh-ancestor
102243026|NCT04970121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102243027|NCT04970121|Dopamine Agents|dopamine agents|mesh-ancestor
102243028|NCT02463929|Diphenhydramine|diphenhydramine|mesh-list
102243029|NCT02463929|Promethazine|promethazine|mesh-list
102243030|NCT02463929|Ketamine|ketamine|mesh-list
102243031|NCT02463929|Bupivacaine|bupivacaine|mesh-list
102243032|NCT02463929|Sevoflurane|sevoflurane|mesh-list
102243033|NCT02463929|Anesthetics, Local|anesthetics, local|mesh-ancestor
102243034|NCT02463929|Anesthetics|anesthetics|mesh-ancestor
102613080|NCT00002657|Interferons|interferons|mesh-list
102613081|NCT00002657|Cytarabine|cytarabine|mesh-list
102243035|NCT02463929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102243036|NCT02463929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243037|NCT02463929|Sensory System Agents|sensory system agents|mesh-ancestor
102613082|NCT00002657|Interferon-alpha|interferon-alpha|mesh-list
102243038|NCT02463929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102243039|NCT02463929|Analgesics|analgesics|mesh-ancestor
102243040|NCT02463929|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102243041|NCT02463929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102243042|NCT02463929|Anesthetics, General|anesthetics, general|mesh-ancestor
102243043|NCT02463929|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102243044|NCT02463929|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102243045|NCT02463929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102243046|NCT02463929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243047|NCT02463929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102243048|NCT02463929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102243049|NCT02463929|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102243050|NCT02463929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102243051|NCT02463929|Antiemetics|antiemetics|mesh-ancestor
102243052|NCT02463929|Autonomic Agents|autonomic agents|mesh-ancestor
102243053|NCT02463929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102243054|NCT02463929|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102243055|NCT02463929|Histamine Antagonists|histamine antagonists|mesh-ancestor
102243056|NCT02463929|Histamine Agents|histamine agents|mesh-ancestor
102243057|NCT02463929|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102243058|NCT02463929|Antipruritics|antipruritics|mesh-ancestor
102243059|NCT02463929|Dermatologic Agents|dermatologic agents|mesh-ancestor
102243060|NCT02465255|Acetaminophen|acetaminophen|mesh-list
102243061|NCT02465255|Ketorolac|ketorolac|mesh-list
102243062|NCT02465255|Tramadol|tramadol|mesh-list
102243063|NCT02465255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102243064|NCT02465255|Analgesics|analgesics|mesh-ancestor
102243065|NCT02465255|Sensory System Agents|sensory system agents|mesh-ancestor
102243066|NCT02465255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102243067|NCT02465255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243068|NCT02465255|Antipyretics|antipyretics|mesh-ancestor
102243069|NCT02465255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102243070|NCT02465255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102243071|NCT02465255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102243072|NCT02465255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102243073|NCT02465255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102243074|NCT02465255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243075|NCT02465255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102243076|NCT02465255|Narcotics|narcotics|mesh-ancestor
102243077|NCT02465255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102243078|NCT02464709|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102243079|NCT02464709|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
102243080|NCT02464709|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102243081|NCT02464709|Dermatologic Agents|dermatologic agents|mesh-ancestor
102243082|NCT02462915|Lidocaine|lidocaine|mesh-list
102243083|NCT02462915|Fentanyl|fentanyl|mesh-list
102243084|NCT02462915|Propofol|propofol|mesh-list
102243085|NCT02462915|Cisatracurium|cisatracurium|mesh-list
102243086|NCT02462915|Anesthetics, Local|anesthetics, local|mesh-ancestor
102243087|NCT02462915|Anesthetics|anesthetics|mesh-ancestor
102243088|NCT02462915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102243089|NCT02462915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243090|NCT02462915|Sensory System Agents|sensory system agents|mesh-ancestor
102243091|NCT02462915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102243092|NCT02462915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102243093|NCT02462915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102243094|NCT02462915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102243095|NCT02462915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102243096|NCT02462915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243097|NCT02462915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102243098|NCT02462915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101951928|NCT01201005|Hematinics|hematinics|mesh-ancestor
102243099|NCT02462915|Anesthetics, General|anesthetics, general|mesh-ancestor
102243100|NCT02462915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102243101|NCT02462915|Narcotics|narcotics|mesh-ancestor
102243102|NCT02462915|Analgesics|analgesics|mesh-ancestor
102243103|NCT02462915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102243104|NCT02462915|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102243105|NCT02462915|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102243107|NCT05505123|Sevoflurane|sevoflurane|mesh-list
102243108|NCT05505123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102613083|NCT00002657|Prednisone|prednisone|mesh-list
102243109|NCT05505123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102613084|NCT00002657|Cyclophosphamide|cyclophosphamide|mesh-list
101901537|NCT03307252|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102613085|NCT00002657|Doxorubicin|doxorubicin|mesh-list
102613086|NCT00002657|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102243110|NCT05505123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243111|NCT05505123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102243112|NCT05505123|Anesthetics, General|anesthetics, general|mesh-ancestor
102243113|NCT05505123|Anesthetics|anesthetics|mesh-ancestor
102243114|NCT05505123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102243115|NCT05505123|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102243116|NCT02462525|Dexamethasone|dexamethasone|mesh-list
102243117|NCT02462525|Pomalidomide|pomalidomide|mesh-list
102243118|NCT02462525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102243119|NCT02462525|Antiemetics|antiemetics|mesh-ancestor
102243120|NCT02462525|Autonomic Agents|autonomic agents|mesh-ancestor
102243121|NCT02462525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102243122|NCT02462525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243123|NCT02462525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102243124|NCT02462525|Glucocorticoids|glucocorticoids|mesh-ancestor
102243125|NCT02462525|Hormones|hormones|mesh-ancestor
102243126|NCT02462525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102243127|NCT02462525|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102243128|NCT02462525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102243129|NCT02462525|Immunologic Factors|immunologic factors|mesh-ancestor
102243130|NCT02462525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102243131|NCT02462525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102243132|NCT02462525|Growth Substances|growth substances|mesh-ancestor
102243133|NCT02462525|Growth Inhibitors|growth inhibitors|mesh-ancestor
102243134|NCT04111419|Amlodipine|amlodipine|mesh-list
102243135|NCT04111419|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
102243136|NCT04111419|Atorvastatin|atorvastatin|mesh-list
102243137|NCT04111419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102243138|NCT04111419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102243139|NCT04111419|Antimetabolites|antimetabolites|mesh-ancestor
102243140|NCT04111419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243141|NCT04111419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102243142|NCT04111419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102243143|NCT04111419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102243144|NCT04111419|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102243145|NCT04111419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102243146|NCT04111419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102243147|NCT04111419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102243148|NCT04111419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243149|NCT04111419|Vasodilator Agents|vasodilator agents|mesh-ancestor
102243150|NCT02462447|Choline|choline|mesh-list
102243151|NCT02462447|Lipotropic Agents|lipotropic agents|mesh-ancestor
102243152|NCT02462447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102243153|NCT02462447|Antimetabolites|antimetabolites|mesh-ancestor
102243154|NCT02462447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243155|NCT02462447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102243156|NCT02462447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102243157|NCT02462447|Nootropic Agents|nootropic agents|mesh-ancestor
102243158|NCT02462681|Ketamine|ketamine|mesh-list
102243159|NCT02462681|Analgesics|analgesics|mesh-ancestor
102243160|NCT02462681|Sensory System Agents|sensory system agents|mesh-ancestor
102243161|NCT02462681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102243162|NCT02462681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243163|NCT02462681|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102243164|NCT02462681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102243165|NCT02462681|Anesthetics, General|anesthetics, general|mesh-ancestor
102243166|NCT02462681|Anesthetics|anesthetics|mesh-ancestor
102243167|NCT02462681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102243168|NCT02462681|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102243169|NCT02462681|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101712492|NCT00696566|Clopidogrel|clopidogrel|mesh-list
102243170|NCT02462681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102243171|NCT02462681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243172|NCT04129151|Palbociclib|palbociclib|mesh-list
102243173|NCT04129151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102243174|NCT04129151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102243175|NCT04129151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102243176|NCT04129151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243177|NCT02462369|Glimepiride|glimepiride|mesh-list
102243178|NCT02462369|Saxagliptin|saxagliptin|mesh-list
102243179|NCT02462369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102243180|NCT02462369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102243181|NCT02462369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243182|NCT02462369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102613087|NCT00002657|Methotrexate|methotrexate|mesh-list
102613088|NCT00002657|Etoposide|etoposide|mesh-list
102613089|NCT00002657|Vincristine|vincristine|mesh-list
102613090|NCT00002657|Bleomycin|bleomycin|mesh-list
102613091|NCT00002657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102613092|NCT00002657|Immunologic Factors|immunologic factors|mesh-ancestor
102243183|NCT02462369|Immunologic Factors|immunologic factors|mesh-ancestor
102243184|NCT02462369|Incretins|incretins|mesh-ancestor
102243185|NCT02462369|Hormones|hormones|mesh-ancestor
102243186|NCT02462369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102243187|NCT02462369|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102243188|NCT02462369|Protease Inhibitors|protease inhibitors|mesh-ancestor
102243189|NCT02462369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102243190|NCT02462369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243191|NCT04072835|Etripamil|etripamil|mesh-list
102243192|NCT04072835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102243193|NCT04072835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102243194|NCT04072835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243195|NCT04072835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102243196|NCT04072835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243197|NCT04083963|Paclitaxel|paclitaxel|mesh-list
102243198|NCT04083963|Cyclophosphamide|cyclophosphamide|mesh-list
102243199|NCT04083963|Carboplatin|carboplatin|mesh-list
102243200|NCT04083963|Doxorubicin|doxorubicin|mesh-list
102243201|NCT04083963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102243202|NCT04083963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102243203|NCT04083963|Tubulin Modulators|tubulin modulators|mesh-ancestor
102243204|NCT04083963|Antimitotic Agents|antimitotic agents|mesh-ancestor
102243205|NCT04083963|Mitosis Modulators|mitosis modulators|mesh-ancestor
102243206|NCT04083963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243207|NCT04083963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102243208|NCT04083963|Immunologic Factors|immunologic factors|mesh-ancestor
102243209|NCT04083963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243210|NCT04083963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102243211|NCT04083963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102243212|NCT04083963|Alkylating Agents|alkylating agents|mesh-ancestor
102243213|NCT04083963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102243214|NCT04083963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102243215|NCT04083963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102243216|NCT04083963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102243217|NCT04083963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102243218|NCT02463383|Ibuprofen|ibuprofen|mesh-list
102243219|NCT02463383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102243220|NCT02463383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102243221|NCT02463383|Analgesics|analgesics|mesh-ancestor
102243222|NCT02463383|Sensory System Agents|sensory system agents|mesh-ancestor
102243223|NCT02463383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102243224|NCT02463383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243225|NCT02463383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102243226|NCT02463383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102243227|NCT02463383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102243228|NCT02463383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101797720|NCT00885872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102243229|NCT02463383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243230|NCT03433469|Osimertinib|osimertinib|mesh-list
102243231|NCT03433469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102243232|NCT03433469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102243233|NCT03433469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102243234|NCT03433469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243235|NCT03108365|Hemostatics|hemostatics|mesh-list
102243236|NCT03108365|Chitosan|chitosan|mesh-list
102243237|NCT03108365|Coagulants|coagulants|mesh-ancestor
102243238|NCT03108365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102243239|NCT03108365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102243240|NCT03108365|Antimetabolites|antimetabolites|mesh-ancestor
102243241|NCT03108365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243242|NCT03108365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102243243|NCT03108365|Chelating Agents|chelating agents|mesh-ancestor
102243244|NCT03108365|Sequestering Agents|sequestering agents|mesh-ancestor
102243245|NCT05345457|Amoxicillin|amoxicillin|mesh-list
102243246|NCT05345457|Azithromycin|azithromycin|mesh-list
102243247|NCT05345457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102243248|NCT05345457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102243249|NCT03922139|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102613093|NCT00002657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952087|NCT01204125|Paclitaxel|paclitaxel|mesh-list
101584943|NCT02661373|Cobicistat|cobicistat|mesh-list
102613094|NCT00002657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102243251|NCT03922139|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102243252|NCT03922139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102243253|NCT03922139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243254|NCT03922139|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102243255|NCT03922139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102243256|NCT03922139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243257|NCT03922139|Cholinergic Agents|cholinergic agents|mesh-ancestor
102243258|NCT03922139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102243260|NCT04729179|Anticonvulsants|anticonvulsants|mesh-ancestor
102243261|NCT04706715|Cemiplimab|cemiplimab|mesh-list
102243262|NCT04706715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102243263|NCT04706715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102243264|NCT03064191|Calcium, Dietary|calcium, dietary|mesh-list
102243265|NCT03064191|Chlorhexidine|chlorhexidine|mesh-list
102243266|NCT03064191|Calcium|calcium|mesh-list
102243267|NCT03064191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102243268|NCT03064191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243269|NCT03064191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102243270|NCT03064191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102243271|NCT03064191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102243272|NCT03064191|Disinfectants|disinfectants|mesh-ancestor
102243273|NCT02629965|Tiotropium Bromide|tiotropium bromide|mesh-list
102243274|NCT02629965|Olodaterol|olodaterol|mesh-list
102243275|NCT02629965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102243276|NCT02629965|Autonomic Agents|autonomic agents|mesh-ancestor
102243277|NCT02629965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102243278|NCT02629965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243279|NCT02629965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102243280|NCT02629965|Respiratory System Agents|respiratory system agents|mesh-ancestor
102243281|NCT02629965|Parasympatholytics|parasympatholytics|mesh-ancestor
102243282|NCT02629965|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102243283|NCT02629965|Cholinergic Agents|cholinergic agents|mesh-ancestor
102243284|NCT02629965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102243285|NCT02629965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243286|NCT03062787|Triamcinolone|triamcinolone|mesh-list
102243287|NCT03062787|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102243288|NCT03062787|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102243289|NCT03062787|Hyaluronic Acid|hyaluronic acid|mesh-list
102243290|NCT03062787|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102243291|NCT03062787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102243292|NCT03062787|Glucocorticoids|glucocorticoids|mesh-ancestor
102243293|NCT03062787|Hormones|hormones|mesh-ancestor
102243294|NCT03062787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102243295|NCT03062787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243296|NCT03062787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102243297|NCT03062787|Immunologic Factors|immunologic factors|mesh-ancestor
102243298|NCT03062787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102243299|NCT03062787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243300|NCT03062787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102243301|NCT03062787|Viscosupplements|viscosupplements|mesh-ancestor
102243302|NCT03062787|Protective Agents|protective agents|mesh-ancestor
102243303|NCT04601883|Colchicine|colchicine|mesh-list
102243304|NCT04601883|Gout Suppressants|gout suppressants|mesh-ancestor
102243305|NCT04601883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102243306|NCT04601883|Tubulin Modulators|tubulin modulators|mesh-ancestor
102243307|NCT04601883|Antimitotic Agents|antimitotic agents|mesh-ancestor
102243308|NCT04601883|Mitosis Modulators|mitosis modulators|mesh-ancestor
102243309|NCT04601883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243310|NCT04601883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102243311|NCT05223075|Lidocaine|lidocaine|mesh-list
102243312|NCT05223075|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
102243313|NCT05223075|Carticaine|carticaine|mesh-list
102243314|NCT05223075|Anesthetics, Local|anesthetics, local|mesh-ancestor
102243315|NCT05223075|Anesthetics|anesthetics|mesh-ancestor
102243316|NCT05223075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102243317|NCT05223075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243318|NCT05223075|Sensory System Agents|sensory system agents|mesh-ancestor
102243319|NCT05223075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102243320|NCT05223075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101952156|NCT03559010|Norgestrel|norgestrel|mesh-list
102243321|NCT05223075|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102243322|NCT05223075|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102243323|NCT05223075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102243324|NCT05223075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243326|NCT03719313|Ritonavir|ritonavir|mesh-list
102243327|NCT03719313|Interferon-alpha|interferon-alpha|mesh-list
102243328|NCT03719313|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102243329|NCT03719313|Interferon alpha-2|interferon alpha-2|mesh-list
102243330|NCT03719313|Lonafarnib|lonafarnib|mesh-list
102243331|NCT03719313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102243332|NCT03719313|Antiviral Agents|antiviral agents|mesh-ancestor
102243333|NCT03719313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102243334|NCT03719313|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102243335|NCT03719313|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102243336|NCT03719313|Protease Inhibitors|protease inhibitors|mesh-ancestor
102243337|NCT03719313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102243338|NCT03719313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243339|NCT03719313|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102243340|NCT03719313|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102243341|NCT03719313|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102243342|NCT03719313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102243343|NCT03719313|Immunologic Factors|immunologic factors|mesh-ancestor
102243344|NCT03719313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243345|NCT03063879|Sofosbuvir|sofosbuvir|mesh-list
102243346|NCT03063879|Antiviral Agents|antiviral agents|mesh-ancestor
102243347|NCT03063879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102243348|NCT03063723|Sofosbuvir|sofosbuvir|mesh-list
102243349|NCT03063723|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102243350|NCT03063723|Ledipasvir|ledipasvir|mesh-list
102243351|NCT03063723|Antiviral Agents|antiviral agents|mesh-ancestor
102243352|NCT03063723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102243353|NCT04338321|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102243354|NCT04338321|Esketamine|esketamine|mesh-list
102243355|NCT04338321|Antidepressive Agents|antidepressive agents|mesh-ancestor
102243356|NCT04338321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102243357|NCT04338321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102243358|NCT04338321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102243359|NCT04338321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102243360|NCT04338321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243361|NCT00379041|Prednisone|prednisone|mesh-list
102243362|NCT00379041|Doxorubicin|doxorubicin|mesh-list
102243363|NCT00379041|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102243364|NCT00379041|Bleomycin|bleomycin|mesh-list
102243365|NCT00379041|Vincristine|vincristine|mesh-list
102243366|NCT00379041|Vinblastine|vinblastine|mesh-list
102243367|NCT00379041|Procarbazine|procarbazine|mesh-list
102243368|NCT00379041|Mechlorethamine|mechlorethamine|mesh-list
102243369|NCT00379041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102243370|NCT00379041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102243371|NCT00379041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102243372|NCT00379041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102243373|NCT00379041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102243374|NCT00379041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243375|NCT00379041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102243376|NCT00379041|Glucocorticoids|glucocorticoids|mesh-ancestor
102243377|NCT00379041|Hormones|hormones|mesh-ancestor
102243378|NCT00379041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102243379|NCT00379041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243380|NCT00379041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102243381|NCT00379041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102243382|NCT00379041|Tubulin Modulators|tubulin modulators|mesh-ancestor
102243383|NCT00379041|Antimitotic Agents|antimitotic agents|mesh-ancestor
102243384|NCT00379041|Mitosis Modulators|mitosis modulators|mesh-ancestor
102243385|NCT00379041|Alkylating Agents|alkylating agents|mesh-ancestor
102243386|NCT00379041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102243387|NCT03063489|Loteprednol Etabonate|loteprednol etabonate|mesh-list
102243388|NCT03063489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102243389|NCT03305445|Nivolumab|nivolumab|mesh-list
102243390|NCT03305445|Ipilimumab|ipilimumab|mesh-list
102243391|NCT03305445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102243392|NCT03305445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102243393|NCT03305445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102243394|NCT03305445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243395|NCT04436913|Fluorides|fluorides|mesh-list
102243396|NCT04436913|Fluorides, Topical|fluorides, topical|mesh-list
102243397|NCT04436913|Cariostatic Agents|cariostatic agents|mesh-ancestor
102613095|NCT00002657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102243398|NCT04436913|Protective Agents|protective agents|mesh-ancestor
101901547|NCT03307252|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102243399|NCT04436913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243400|NCT02487095|Topotecan|topotecan|mesh-list
102243401|NCT02487095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102243402|NCT02487095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102243403|NCT02487095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102243404|NCT02487095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243405|NCT02487095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102243406|NCT03756077|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102243407|NCT03756077|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102243408|NCT03756077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243409|NCT03742193|Apatinib|apatinib|mesh-list
102243410|NCT03742193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102243411|NCT03742193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102243412|NCT03742193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102243413|NCT03742193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243414|NCT03108287|Amoxicillin|amoxicillin|mesh-list
102243415|NCT03108287|Clarithromycin|clarithromycin|mesh-list
102243416|NCT03108287|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
102243417|NCT03108287|Rabeprazole|rabeprazole|mesh-list
102243418|NCT03108287|Bismuth|bismuth|mesh-list
102243419|NCT03108287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102243420|NCT03108287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102243421|NCT03108287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102243422|NCT03108287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102243423|NCT03108287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243424|NCT03108287|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102243425|NCT03108287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102243426|NCT03108287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102243427|NCT03108287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102243428|NCT03108287|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102243429|NCT03108287|Antacids|antacids|mesh-ancestor
102243430|NCT02461121|Cyclosporine|cyclosporine|mesh-list
102243431|NCT02461121|Mycophenolic Acid|mycophenolic acid|mesh-list
102243432|NCT02461121|Cyclophosphamide|cyclophosphamide|mesh-list
102243433|NCT02461121|Fludarabine|fludarabine|mesh-list
102243434|NCT02461121|Cyclosporins|cyclosporins|mesh-list
102243435|NCT02461121|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102243436|NCT02461121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102243437|NCT02461121|Immunologic Factors|immunologic factors|mesh-ancestor
102243438|NCT02461121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243439|NCT02461121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102243440|NCT02461121|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102243441|NCT02461121|Alkylating Agents|alkylating agents|mesh-ancestor
102243442|NCT02461121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243443|NCT02461121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102243444|NCT02461121|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102243445|NCT02461121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102243446|NCT02461121|Antifungal Agents|antifungal agents|mesh-ancestor
102243447|NCT02461121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102243448|NCT02461121|Dermatologic Agents|dermatologic agents|mesh-ancestor
102243449|NCT02461121|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102243450|NCT02461121|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102243451|NCT02461121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102243452|NCT02461121|Antitubercular Agents|antitubercular agents|mesh-ancestor
102243453|NCT02461121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102243454|NCT00701363|Lanreotide|lanreotide|mesh-list
102243455|NCT00701363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102243456|NCT02461043|Paclitaxel|paclitaxel|mesh-list
102243457|NCT02461043|Cisplatin|cisplatin|mesh-list
102243458|NCT02461043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102243459|NCT02461043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102243460|NCT02461043|Tubulin Modulators|tubulin modulators|mesh-ancestor
102243461|NCT02461043|Antimitotic Agents|antimitotic agents|mesh-ancestor
102243462|NCT02461043|Mitosis Modulators|mitosis modulators|mesh-ancestor
102243463|NCT02461043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243464|NCT03296657|Fluorides|fluorides|mesh-list
102243465|NCT03296657|Tin Fluorides|tin fluorides|mesh-list
102243466|NCT03296657|Cariostatic Agents|cariostatic agents|mesh-ancestor
102243467|NCT03296657|Protective Agents|protective agents|mesh-ancestor
102243468|NCT03296657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243469|NCT03296579|Magnesium Sulfate|magnesium sulfate|mesh-list
102243470|NCT03296579|Aminophylline|aminophylline|mesh-list
102613096|NCT00002657|Alkylating Agents|alkylating agents|mesh-ancestor
102613097|NCT00002657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613098|NCT00002657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102243471|NCT03296579|Albuterol|albuterol|mesh-list
102243472|NCT03296579|Ipratropium|ipratropium|mesh-list
102243473|NCT03296579|Analgesics|analgesics|mesh-ancestor
102243474|NCT03296579|Sensory System Agents|sensory system agents|mesh-ancestor
102243475|NCT03296579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102243476|NCT03296579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243477|NCT03296579|Anesthetics|anesthetics|mesh-ancestor
102243478|NCT03296579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102243479|NCT03296579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102243480|NCT03296579|Anticonvulsants|anticonvulsants|mesh-ancestor
102243481|NCT03296579|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102243482|NCT03296579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102243483|NCT03296579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243484|NCT03296579|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102243485|NCT03296579|Tocolytic Agents|tocolytic agents|mesh-ancestor
102243486|NCT03296579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102243487|NCT03296579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102243488|NCT03296579|Autonomic Agents|autonomic agents|mesh-ancestor
102243489|NCT03296579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102243490|NCT03296579|Respiratory System Agents|respiratory system agents|mesh-ancestor
102243491|NCT03296579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102243492|NCT03296579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102243493|NCT03296579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102243494|NCT03296579|Adrenergic Agents|adrenergic agents|mesh-ancestor
102243495|NCT03296579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102243496|NCT03296579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102243497|NCT03296579|Cholinergic Agents|cholinergic agents|mesh-ancestor
102243498|NCT03296579|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102243499|NCT03296579|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102243500|NCT03296579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102243501|NCT03296579|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102243502|NCT03296579|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102243503|NCT03296579|Purinergic Agents|purinergic agents|mesh-ancestor
102243504|NCT03296579|Protective Agents|protective agents|mesh-ancestor
102243505|NCT02461667|Alendronate|alendronate|mesh-list
102243506|NCT02461667|Metformin|metformin|mesh-list
102243507|NCT02461667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102243508|NCT02461667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243509|NCT02461667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102243510|NCT01670877|Trastuzumab|trastuzumab|mesh-list
102243511|NCT01670877|Fulvestrant|fulvestrant|mesh-list
102243512|NCT01670877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102243513|NCT01670877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102243514|NCT01670877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102243515|NCT01670877|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102243516|NCT01670877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102243517|NCT01670877|Hormone Antagonists|hormone antagonists|mesh-ancestor
102243518|NCT01670877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102243519|NCT01670877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243520|NCT00701129|Rituximab|rituximab|mesh-list
102243521|NCT00701129|Methotrexate|methotrexate|mesh-list
102243522|NCT00701129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102243523|NCT00701129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102243524|NCT00701129|Immunologic Factors|immunologic factors|mesh-ancestor
102243525|NCT00701129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243526|NCT00701129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102243527|NCT00701129|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102243528|NCT00701129|Abortifacient Agents|abortifacient agents|mesh-ancestor
102243529|NCT00701129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102243530|NCT00701129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102243531|NCT00701129|Antimetabolites|antimetabolites|mesh-ancestor
102243532|NCT00701129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243533|NCT00701129|Dermatologic Agents|dermatologic agents|mesh-ancestor
102243534|NCT00701129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102243535|NCT00701129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102243536|NCT00701129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102243537|NCT00701129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102243538|NCT03296189|Dexamethasone|dexamethasone|mesh-list
102243539|NCT03296189|Dexamethasone acetate|dexamethasone acetate|mesh-list
102243540|NCT03296189|Levobupivacaine|levobupivacaine|mesh-list
102243541|NCT03296189|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102243542|NCT03296189|BB 1101|bb 1101|mesh-list
102243543|NCT03296189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102243544|NCT03296189|Antiemetics|antiemetics|mesh-ancestor
102243545|NCT03296189|Autonomic Agents|autonomic agents|mesh-ancestor
102613099|NCT00002657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102613100|NCT00002657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102243546|NCT03296189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102243547|NCT03296189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243548|NCT03296189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102243549|NCT03296189|Glucocorticoids|glucocorticoids|mesh-ancestor
102243550|NCT03296189|Hormones|hormones|mesh-ancestor
102243551|NCT03296189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102243552|NCT03296189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102243553|NCT03296189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102243554|NCT03296189|Anesthetics, Local|anesthetics, local|mesh-ancestor
102243555|NCT03296189|Anesthetics|anesthetics|mesh-ancestor
102243556|NCT03296189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102243557|NCT03296189|Sensory System Agents|sensory system agents|mesh-ancestor
102243558|NCT03296189|Protease Inhibitors|protease inhibitors|mesh-ancestor
102243559|NCT03296189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102243560|NCT03296189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243561|NCT03295955|Amoxicillin|amoxicillin|mesh-list
102243562|NCT03295955|Clavulanic Acid|clavulanic acid|mesh-list
102243563|NCT03295955|Clavulanic Acids|clavulanic acids|mesh-list
102243564|NCT03295955|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102243565|NCT03295955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102243566|NCT03295955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102243567|NCT03295955|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102243568|NCT03295955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102243569|NCT03295955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243570|NCT03298373|Nandrolone Decanoate|nandrolone decanoate|mesh-list
102243571|NCT03298373|Nandrolone|nandrolone|mesh-list
102243572|NCT03298373|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
102243573|NCT03298373|Androgens|androgens|mesh-ancestor
102243574|NCT03298373|Hormones|hormones|mesh-ancestor
102243575|NCT03298373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102243576|NCT03298373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243577|NCT03298373|Anabolic Agents|anabolic agents|mesh-ancestor
102243578|NCT03298373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102243579|NCT01670721|Leucovorin|leucovorin|mesh-list
102243580|NCT01670721|Fluorouracil|fluorouracil|mesh-list
102243581|NCT01670721|Irinotecan|irinotecan|mesh-list
102243582|NCT01670721|Aflibercept|aflibercept|mesh-list
102243583|NCT01670721|Antimetabolites|antimetabolites|mesh-ancestor
102243584|NCT01670721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243585|NCT01670721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102243586|NCT01670721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102243587|NCT01670721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102243588|NCT01670721|Immunologic Factors|immunologic factors|mesh-ancestor
102243589|NCT01670721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243590|NCT01670721|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102243591|NCT01670721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102243592|NCT01670721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102243593|NCT01670721|Antidotes|antidotes|mesh-ancestor
102243594|NCT01670721|Protective Agents|protective agents|mesh-ancestor
102243595|NCT01670721|Vitamin B Complex|vitamin b complex|mesh-ancestor
102243596|NCT01670721|Vitamins|vitamins|mesh-ancestor
102243597|NCT01670721|Micronutrients|micronutrients|mesh-ancestor
102243598|NCT01670721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102243599|NCT01670721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102243600|NCT01670721|Growth Substances|growth substances|mesh-ancestor
102243601|NCT01670721|Growth Inhibitors|growth inhibitors|mesh-ancestor
102243602|NCT03287427|Tislelizumab|tislelizumab|mesh-list
102243603|NCT03287427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102243604|NCT03287427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102243605|NCT04491695|Tirofiban|tirofiban|mesh-list
102243606|NCT04491695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102243607|NCT04491695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102243608|NCT04491695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243609|NCT04491695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102243610|NCT04982055|Nadroparin|nadroparin|mesh-list
102243611|NCT04982055|Anticoagulants|anticoagulants|mesh-ancestor
102243612|NCT04982055|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102243613|NCT04982055|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102243614|NCT04982055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243615|NCT04981743|Vitamin D|vitamin d|mesh-list
102613101|NCT00002657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102613102|NCT00002657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102243616|NCT04981743|Vitamins|vitamins|mesh-ancestor
102243617|NCT04981743|Micronutrients|micronutrients|mesh-ancestor
102243618|NCT04981743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901553|NCT03307174|Fentanyl|fentanyl|mesh-list
102613103|NCT00002657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102613104|NCT00002657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102243619|NCT04981743|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102243620|NCT04489121|Omalizumab|omalizumab|mesh-list
102243621|NCT04489121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102243622|NCT04489121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102243623|NCT04489121|Respiratory System Agents|respiratory system agents|mesh-ancestor
102243624|NCT04973787|Antirheumatic Agents|antirheumatic agents|mesh-list
102243625|NCT04982211|Propranolol|propranolol|mesh-list
102243626|NCT04982211|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102243627|NCT04982211|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102243628|NCT04982211|Adrenergic Agents|adrenergic agents|mesh-ancestor
102243629|NCT04982211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102243630|NCT04982211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243631|NCT04982211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243632|NCT04982211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102243633|NCT04982211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102243634|NCT04982211|Vasodilator Agents|vasodilator agents|mesh-ancestor
102243635|NCT03290963|Ketamine|ketamine|mesh-list
102243636|NCT03290963|Analgesics|analgesics|mesh-ancestor
102243637|NCT03290963|Sensory System Agents|sensory system agents|mesh-ancestor
102243638|NCT03290963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102243639|NCT03290963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243640|NCT03290963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102243641|NCT03290963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102243642|NCT03290963|Anesthetics, General|anesthetics, general|mesh-ancestor
102243643|NCT03290963|Anesthetics|anesthetics|mesh-ancestor
102243644|NCT03290963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102243645|NCT03290963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102243646|NCT03290963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102243647|NCT03290963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102243648|NCT03290963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243649|NCT03294707|Coal Tar|coal tar|mesh-list
102243650|NCT03294707|Keratolytic Agents|keratolytic agents|mesh-ancestor
102243651|NCT03294707|Dermatologic Agents|dermatologic agents|mesh-ancestor
102243652|NCT03062319|Anticoagulants|anticoagulants|mesh-list
102243653|NCT03062319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
102243654|NCT03290495|Ketamine|ketamine|mesh-list
102243655|NCT03290495|Analgesics|analgesics|mesh-ancestor
102243656|NCT03290495|Sensory System Agents|sensory system agents|mesh-ancestor
102243657|NCT03290495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102243658|NCT03290495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243659|NCT03290495|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102243660|NCT03290495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102243661|NCT03290495|Anesthetics, General|anesthetics, general|mesh-ancestor
102243662|NCT03290495|Anesthetics|anesthetics|mesh-ancestor
102243663|NCT03290495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102243664|NCT03290495|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102243665|NCT03290495|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102243666|NCT03290495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102243667|NCT03290495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243668|NCT04429893|Magnesium Sulfate|magnesium sulfate|mesh-list
102243669|NCT04429893|Bupivacaine|bupivacaine|mesh-list
102243670|NCT04429893|Anesthetics, Local|anesthetics, local|mesh-ancestor
102243671|NCT04429893|Anesthetics|anesthetics|mesh-ancestor
102243672|NCT04429893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102243673|NCT04429893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243674|NCT04429893|Sensory System Agents|sensory system agents|mesh-ancestor
102243675|NCT04429893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102243676|NCT04429893|Analgesics|analgesics|mesh-ancestor
102243677|NCT04429893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102243678|NCT04429893|Anticonvulsants|anticonvulsants|mesh-ancestor
102243679|NCT04429893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102243680|NCT04429893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102243681|NCT04429893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243682|NCT04429893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102243683|NCT04429893|Tocolytic Agents|tocolytic agents|mesh-ancestor
102243684|NCT04429893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102243685|NCT03290417|Vitamin D|vitamin d|mesh-list
102243686|NCT03290417|Ergocalciferols|ergocalciferols|mesh-list
102243687|NCT03290417|Cholecalciferol|cholecalciferol|mesh-list
102243688|NCT03290417|Vitamins|vitamins|mesh-list
102243689|NCT03290417|Curcumin|curcumin|mesh-list
102243690|NCT03290417|Turmeric extract|turmeric extract|mesh-list
102243691|NCT03290417|Micronutrients|micronutrients|mesh-ancestor
102243692|NCT03290417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243693|NCT03290417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102243694|NCT03290417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102243695|NCT03290417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102243696|NCT03290417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102243697|NCT03290417|Analgesics|analgesics|mesh-ancestor
102243698|NCT03290417|Sensory System Agents|sensory system agents|mesh-ancestor
102243699|NCT03290417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102243700|NCT03290417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102243701|NCT03290417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102243702|NCT03290417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102243703|NCT03290417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102243704|NCT03290417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243705|NCT03290417|Antioxidants|antioxidants|mesh-ancestor
102243706|NCT03290417|Protective Agents|protective agents|mesh-ancestor
102243707|NCT04429347|Gabapentin|gabapentin|mesh-list
102243708|NCT04429347|Tizanidine|tizanidine|mesh-list
102243709|NCT04429347|Analgesics|analgesics|mesh-ancestor
102243710|NCT04429347|Sensory System Agents|sensory system agents|mesh-ancestor
102243711|NCT04429347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102243712|NCT04429347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243713|NCT04429347|Anticonvulsants|anticonvulsants|mesh-ancestor
102243714|NCT04429347|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102243715|NCT04429347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102243716|NCT04429347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102243717|NCT04429347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102243718|NCT04429347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102243719|NCT04429347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102243720|NCT04429347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102243721|NCT04429347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243722|NCT04429347|Antimanic Agents|antimanic agents|mesh-ancestor
102243723|NCT04429347|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102243724|NCT04429347|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102243725|NCT04429347|Parasympatholytics|parasympatholytics|mesh-ancestor
102243726|NCT04429347|Autonomic Agents|autonomic agents|mesh-ancestor
102243727|NCT04429347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102243728|NCT04429347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102243729|NCT04429347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102243730|NCT04429347|Adrenergic Agents|adrenergic agents|mesh-ancestor
102243731|NCT03294551|Vaccines|vaccines|mesh-list
102243732|NCT03294551|Immunologic Factors|immunologic factors|mesh-ancestor
102243733|NCT03294551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243734|NCT04156581|Dexamethasone|dexamethasone|mesh-list
102243735|NCT04156581|Bupivacaine|bupivacaine|mesh-list
102243736|NCT04156581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102243737|NCT04156581|Antiemetics|antiemetics|mesh-ancestor
102243738|NCT04156581|Autonomic Agents|autonomic agents|mesh-ancestor
102243739|NCT04156581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102243740|NCT04156581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243741|NCT04156581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102243742|NCT04156581|Glucocorticoids|glucocorticoids|mesh-ancestor
102243743|NCT04156581|Hormones|hormones|mesh-ancestor
102243744|NCT04156581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102243745|NCT04156581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102243746|NCT04156581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102243747|NCT04156581|Anesthetics, Local|anesthetics, local|mesh-ancestor
102243748|NCT04156581|Anesthetics|anesthetics|mesh-ancestor
102243749|NCT04156581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102243750|NCT04156581|Sensory System Agents|sensory system agents|mesh-ancestor
102243751|NCT02983071|Fulvestrant|fulvestrant|mesh-list
102243752|NCT02983071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102243753|NCT02983071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102243754|NCT02983071|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102243755|NCT02983071|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102243756|NCT02983071|Hormone Antagonists|hormone antagonists|mesh-ancestor
102243757|NCT02983071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102243758|NCT02983071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243759|NCT03294395|Gentamicins|gentamicins|mesh-list
102243760|NCT03294395|Ceftriaxone|ceftriaxone|mesh-list
102243761|NCT03294395|Ertapenem|ertapenem|mesh-list
102243762|NCT03294395|Fosfomycin|fosfomycin|mesh-list
102243763|NCT03294395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102243764|NCT03294395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102243765|NCT03294395|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102243766|NCT03294395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101585444|NCT00650611|Serotonin Agents|serotonin agents|mesh-ancestor
102613105|NCT00002657|Glucocorticoids|glucocorticoids|mesh-ancestor
102243767|NCT03294395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243768|NCT04980105|Methylprednisolone|methylprednisolone|mesh-list
102243769|NCT04980105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102243770|NCT04980105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102243771|NCT04980105|Prednisolone|prednisolone|mesh-list
102243772|NCT04980105|Prednisolone acetate|prednisolone acetate|mesh-list
102243773|NCT04980105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102243774|NCT04980105|Prednisolone phosphate|prednisolone phosphate|mesh-list
102243775|NCT04980105|Hyaluronic Acid|hyaluronic acid|mesh-list
102243776|NCT04980105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102243777|NCT04980105|Antiemetics|antiemetics|mesh-ancestor
102243778|NCT04980105|Autonomic Agents|autonomic agents|mesh-ancestor
102243779|NCT04980105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102243780|NCT04980105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243781|NCT04980105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102243782|NCT04980105|Glucocorticoids|glucocorticoids|mesh-ancestor
102243783|NCT04980105|Hormones|hormones|mesh-ancestor
102243784|NCT04980105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102243785|NCT04980105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102243786|NCT04980105|Protective Agents|protective agents|mesh-ancestor
102243787|NCT04980105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102243788|NCT04980105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102243789|NCT04980105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102243790|NCT04980105|Immunologic Factors|immunologic factors|mesh-ancestor
102243791|NCT04980105|Viscosupplements|viscosupplements|mesh-ancestor
102243792|NCT04973319|Trastuzumab|trastuzumab|mesh-list
102243793|NCT04973319|Pertuzumab|pertuzumab|mesh-list
102243794|NCT04973319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102243795|NCT04973319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102243796|NCT03294161|Meglumine Antimoniate|meglumine antimoniate|mesh-list
102243797|NCT03294161|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102243798|NCT03294161|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102243799|NCT03294161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102243800|NCT03289871|Amorolfine|amorolfine|mesh-list
102243801|NCT03289871|Antifungal Agents|antifungal agents|mesh-ancestor
102243802|NCT03289871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102243803|NCT03289637|Vitamin D|vitamin d|mesh-list
102243804|NCT03289637|Vitamins|vitamins|mesh-ancestor
102243805|NCT03289637|Micronutrients|micronutrients|mesh-ancestor
102243806|NCT03289637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243807|NCT03289637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101952681|NCT03814629|Vitamins|vitamins|mesh-list
102243808|NCT04854837|Remdesivir|remdesivir|mesh-list
102243809|NCT04854837|Antimetabolites|antimetabolites|mesh-ancestor
102243810|NCT04854837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243811|NCT04854837|Antiviral Agents|antiviral agents|mesh-ancestor
102243812|NCT04854837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102243813|NCT03289559|Testosterone|testosterone|mesh-list
102243814|NCT03289559|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102243815|NCT03289559|Androgens|androgens|mesh-ancestor
102243816|NCT03289559|Hormones|hormones|mesh-ancestor
102243817|NCT03289559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102243818|NCT03289559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243819|NCT03289559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102243820|NCT03289559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102243821|NCT03289559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243822|NCT03289559|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102243823|NCT03289559|Hormone Antagonists|hormone antagonists|mesh-ancestor
102243824|NCT03293927|Fentanyl|fentanyl|mesh-list
102243825|NCT03293927|Dexmedetomidine|dexmedetomidine|mesh-list
102243826|NCT03293927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102243827|NCT03293927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102243828|NCT03293927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243829|NCT03293927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102243830|NCT03293927|Analgesics|analgesics|mesh-ancestor
102243831|NCT03293927|Sensory System Agents|sensory system agents|mesh-ancestor
102243832|NCT03293927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102243833|NCT03293927|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102243834|NCT03293927|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102243835|NCT03293927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102243836|NCT03293927|Adrenergic Agents|adrenergic agents|mesh-ancestor
102243837|NCT03293927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102243838|NCT03293927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243839|NCT03293927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102243840|NCT03293927|Narcotics|narcotics|mesh-ancestor
102243841|NCT03293927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102243842|NCT03293927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102243843|NCT03293927|Anesthetics, General|anesthetics, general|mesh-ancestor
102243844|NCT03293927|Anesthetics|anesthetics|mesh-ancestor
102243845|NCT02730429|Letrozole|letrozole|mesh-list
102243846|NCT02730429|Palbociclib|palbociclib|mesh-list
102243847|NCT02730429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102243848|NCT02730429|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102243849|NCT02730429|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102243850|NCT02730429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102243851|NCT02730429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243852|NCT02730429|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102243853|NCT02730429|Hormone Antagonists|hormone antagonists|mesh-ancestor
102243854|NCT02730429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102243855|NCT02730429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243856|NCT02730429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102243857|NCT04971759|Fentanyl|fentanyl|mesh-list
102243858|NCT04971759|Dexmedetomidine|dexmedetomidine|mesh-list
102243859|NCT04971759|Levobupivacaine|levobupivacaine|mesh-list
102243860|NCT04971759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102243861|NCT04971759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102243862|NCT04971759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243863|NCT04971759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102243864|NCT04971759|Analgesics|analgesics|mesh-ancestor
102243865|NCT04971759|Sensory System Agents|sensory system agents|mesh-ancestor
102243866|NCT04971759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102243867|NCT04971759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102243868|NCT04971759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102243869|NCT04971759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102243870|NCT04971759|Adrenergic Agents|adrenergic agents|mesh-ancestor
102243871|NCT04971759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102243872|NCT04971759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243873|NCT04971759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102243874|NCT04971759|Narcotics|narcotics|mesh-ancestor
102243875|NCT04971759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102243876|NCT04971759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102243877|NCT04971759|Anesthetics, General|anesthetics, general|mesh-ancestor
102243878|NCT04971759|Anesthetics|anesthetics|mesh-ancestor
102243879|NCT04971759|Anesthetics, Local|anesthetics, local|mesh-ancestor
102243880|NCT03289169|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102243881|NCT03289169|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102243882|NCT03289169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102243883|NCT03289169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243884|NCT03289169|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102243885|NCT03289169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102243886|NCT03289169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243887|NCT03289169|Cholinergic Agents|cholinergic agents|mesh-ancestor
102243888|NCT03289169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102243889|NCT04979091|Hormones|hormones|mesh-list
102243890|NCT04979091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102243891|NCT04979091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243892|NCT04971291|Bupropion|bupropion|mesh-list
102243893|NCT04971291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102243894|NCT04971291|Antidepressive Agents|antidepressive agents|mesh-ancestor
102243895|NCT04971291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102243896|NCT04971291|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102243897|NCT04971291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102243898|NCT04971291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102243899|NCT04971291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243900|NCT04971291|Dopamine Agents|dopamine agents|mesh-ancestor
102243901|NCT04971291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102243902|NCT04971291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243903|NCT04971291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102243904|NCT04971291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102243905|NCT04971291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102243906|NCT03107507|Levetiracetam|levetiracetam|mesh-list
102243907|NCT03107507|Phenobarbital|phenobarbital|mesh-list
102243908|NCT03107507|Anticonvulsants|anticonvulsants|mesh-ancestor
102243909|NCT03107507|Nootropic Agents|nootropic agents|mesh-ancestor
102243910|NCT03107507|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102243911|NCT03107507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102243912|NCT03107507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243913|NCT03107507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102243914|NCT03107507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102613106|NCT00002657|Hormones|hormones|mesh-ancestor
102243915|NCT03107507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102243916|NCT03107507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243917|NCT03107507|GABA Modulators|gaba modulators|mesh-ancestor
102243918|NCT03107507|GABA Agents|gaba agents|mesh-ancestor
102243919|NCT03107507|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102243920|NCT03107507|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102243921|NCT03107507|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102243922|NCT02711137|Paclitaxel|paclitaxel|mesh-list
102243923|NCT02711137|Gemcitabine|gemcitabine|mesh-list
102243924|NCT02711137|Azacitidine|azacitidine|mesh-list
102243925|NCT02711137|Rucaparib|rucaparib|mesh-list
102243926|NCT02711137|INCB057643|incb057643|mesh-list
102243927|NCT02711137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102243928|NCT02711137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102243929|NCT02711137|Tubulin Modulators|tubulin modulators|mesh-ancestor
102243930|NCT02711137|Antimitotic Agents|antimitotic agents|mesh-ancestor
102243931|NCT02711137|Mitosis Modulators|mitosis modulators|mesh-ancestor
102243932|NCT02711137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243933|NCT02711137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102243934|NCT02711137|Antimetabolites|antimetabolites|mesh-ancestor
102243935|NCT02711137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102243936|NCT02711137|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102243937|NCT04155411|Dasatinib|dasatinib|mesh-list
102243938|NCT04155411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102243939|NCT04155411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102243940|NCT04155411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102243941|NCT04155411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243942|NCT04970667|Flupenthixol|flupenthixol|mesh-list
102243943|NCT04970667|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
102243944|NCT04970667|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102243945|NCT04970667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102243946|NCT04970667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102243947|NCT04970667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243948|NCT04970667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102243949|NCT04970667|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102243950|NCT04970667|Dopamine Agents|dopamine agents|mesh-ancestor
102243951|NCT04970667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102243952|NCT04970667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243953|NCT03288233|Carbon Monoxide|carbon monoxide|mesh-list
102243954|NCT03288233|Antimetabolites|antimetabolites|mesh-ancestor
102243955|NCT03288233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243956|NCT03288233|Gasotransmitters|gasotransmitters|mesh-ancestor
102243957|NCT03288233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102243958|NCT03288233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243959|NCT03288077|Tryptophan|tryptophan|mesh-list
102243960|NCT03288077|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102243961|NCT03288077|Antidepressive Agents|antidepressive agents|mesh-ancestor
102243962|NCT03288077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102243963|NCT00777127|Diclofenac|diclofenac|mesh-list
102243964|NCT00777127|Imiquimod|imiquimod|mesh-list
102243965|NCT00777127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102243966|NCT00777127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102243967|NCT00777127|Analgesics|analgesics|mesh-ancestor
102243968|NCT00777127|Sensory System Agents|sensory system agents|mesh-ancestor
102243969|NCT00777127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102243970|NCT00777127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243971|NCT00777127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102243972|NCT00777127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102243973|NCT00777127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102243974|NCT00777127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102243975|NCT00777127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243976|NCT00777127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102243977|NCT00777127|Immunologic Factors|immunologic factors|mesh-ancestor
102243978|NCT00777127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102243979|NCT00777127|Interferon Inducers|interferon inducers|mesh-ancestor
102243980|NCT00761371|Imiquimod|imiquimod|mesh-list
102243981|NCT00761371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102243982|NCT00761371|Immunologic Factors|immunologic factors|mesh-ancestor
102243983|NCT00761371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243984|NCT00761371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102243985|NCT00761371|Interferon Inducers|interferon inducers|mesh-ancestor
102243986|NCT03287921|Bronchodilator Agents|bronchodilator agents|mesh-list
102243987|NCT03287921|Autonomic Agents|autonomic agents|mesh-ancestor
102613107|NCT00002657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102613108|NCT00002657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102243988|NCT03287921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102243989|NCT03287921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102243990|NCT03287921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102243991|NCT03287921|Respiratory System Agents|respiratory system agents|mesh-ancestor
102243992|NCT03287609|Evolocumab|evolocumab|mesh-list
102243993|NCT03287609|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102243994|NCT03287609|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102243995|NCT03287609|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102243996|NCT03287609|Antimetabolites|antimetabolites|mesh-ancestor
102243997|NCT03287609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102243998|NCT03287609|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102243999|NCT03287609|Protease Inhibitors|protease inhibitors|mesh-ancestor
102244000|NCT03287609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102244001|NCT03287609|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102244002|NCT03291899|Folfirinox|folfirinox|mesh-list
102244003|NCT03291899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102244004|NCT03194815|Rituximab|rituximab|mesh-list
102244005|NCT03194815|Immunoglobulins|immunoglobulins|mesh-list
102244006|NCT03194815|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102244007|NCT03194815|Antibodies|antibodies|mesh-list
102244008|NCT03194815|gamma-Globulins|gamma-globulins|mesh-list
102244009|NCT03194815|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102244010|NCT03194815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102244011|NCT03194815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102244012|NCT03194815|Immunologic Factors|immunologic factors|mesh-ancestor
102244013|NCT03194815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244014|NCT03194815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102244015|NCT03291821|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102244016|NCT03291821|Cetrorelix|cetrorelix|mesh-list
102244017|NCT03291821|Menotropins|menotropins|mesh-list
102244018|NCT03291821|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
102244019|NCT03291821|Ganirelix|ganirelix|mesh-list
102244020|NCT03291821|Hormones|hormones|mesh-ancestor
102244021|NCT03291821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102244022|NCT03291821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244023|NCT03291821|Luteolytic Agents|luteolytic agents|mesh-ancestor
102244024|NCT03291821|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102244025|NCT03291821|Contraceptive Agents|contraceptive agents|mesh-ancestor
102244026|NCT03291821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102244027|NCT03291821|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102244028|NCT03291821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102244029|NCT03291821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102244030|NCT03291821|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101952908|NCT05577117|Narcotics|narcotics|mesh-ancestor
102244031|NCT03291821|Fertility Agents|fertility agents|mesh-ancestor
102244032|NCT03291821|Hormone Antagonists|hormone antagonists|mesh-ancestor
102244034|NCT02448901|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102244035|NCT02448901|Antithrombins|antithrombins|mesh-ancestor
102244036|NCT02448901|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102244037|NCT02448901|Protease Inhibitors|protease inhibitors|mesh-ancestor
102244038|NCT02448901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102244039|NCT02448901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244040|NCT02448901|Anticoagulants|anticoagulants|mesh-ancestor
102244041|NCT03291353|Pembrolizumab|pembrolizumab|mesh-list
102244042|NCT03291353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102244043|NCT03291353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102244044|NCT03291353|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102244045|NCT03291353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244046|NCT02460341|Ondansetron|ondansetron|mesh-list
102244047|NCT02460341|Antiemetics|antiemetics|mesh-ancestor
102244048|NCT02460341|Autonomic Agents|autonomic agents|mesh-ancestor
102244049|NCT02460341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102244050|NCT02460341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244051|NCT02460341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102244052|NCT02460341|Antipruritics|antipruritics|mesh-ancestor
102244053|NCT02460341|Dermatologic Agents|dermatologic agents|mesh-ancestor
102244054|NCT02460341|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102244055|NCT02460341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102244056|NCT02460341|Serotonin Agents|serotonin agents|mesh-ancestor
102244057|NCT02460341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102244058|NCT02460341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244059|NCT00189319|Flecainide|flecainide|mesh-list
102244060|NCT00189319|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102244061|NCT00189319|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102244062|NCT00189319|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102613109|NCT00002657|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102613110|NCT00002657|Abortifacient Agents|abortifacient agents|mesh-ancestor
102244063|NCT00189319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102613111|NCT00002657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102613112|NCT00002657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102613113|NCT00002657|Antimetabolites|antimetabolites|mesh-ancestor
102613114|NCT00002657|Dermatologic Agents|dermatologic agents|mesh-ancestor
102613115|NCT00002657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102613116|NCT00002657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102613117|NCT00002657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102613118|NCT00002657|Antiviral Agents|antiviral agents|mesh-ancestor
102613119|NCT00002657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102613120|NCT00002657|Tubulin Modulators|tubulin modulators|mesh-ancestor
102613121|NCT00002657|Antimitotic Agents|antimitotic agents|mesh-ancestor
102613122|NCT00002657|Mitosis Modulators|mitosis modulators|mesh-ancestor
102613124|NCT05673785|Cyclophosphamide|cyclophosphamide|mesh-list
102613125|NCT05673785|Doxorubicin|doxorubicin|mesh-list
102613126|NCT05673785|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102613127|NCT05673785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102613128|NCT05673785|Immunologic Factors|immunologic factors|mesh-ancestor
102244064|NCT00189319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244065|NCT00189241|Imiquimod|imiquimod|mesh-list
102244066|NCT00189241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102244067|NCT00189241|Immunologic Factors|immunologic factors|mesh-ancestor
102244068|NCT00189241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244069|NCT00189241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102244070|NCT00189241|Interferon Inducers|interferon inducers|mesh-ancestor
102244071|NCT02460107|Botulinum Toxins|botulinum toxins|mesh-list
102244072|NCT02460107|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102244073|NCT02460107|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102244074|NCT02460107|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102244075|NCT02460107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102244076|NCT02460107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244077|NCT02460107|Cholinergic Agents|cholinergic agents|mesh-ancestor
102244078|NCT02460107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102244079|NCT02460107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244080|NCT02460107|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102244081|NCT02460107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102244082|NCT03286673|Calcium, Dietary|calcium, dietary|mesh-list
102244083|NCT03286673|Calcium Carbonate|calcium carbonate|mesh-list
102244084|NCT03286673|Calcium|calcium|mesh-list
102244085|NCT03286673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102244086|NCT03286673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244087|NCT03286673|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102244088|NCT03286673|Antacids|antacids|mesh-ancestor
102244089|NCT03286673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244090|NCT03286673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102244091|NCT02448589|TAS-119|tas-119|mesh-list
102244092|NCT02448589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102244093|NCT02448589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102244094|NCT02448589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102244095|NCT02448589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244096|NCT02445703|Vaccines|vaccines|mesh-list
102244097|NCT02445703|Immunologic Factors|immunologic factors|mesh-ancestor
102244098|NCT02445703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244099|NCT03194659|Choline|choline|mesh-list
102244100|NCT03194659|Lipotropic Agents|lipotropic agents|mesh-ancestor
102244101|NCT03194659|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102244102|NCT03194659|Antimetabolites|antimetabolites|mesh-ancestor
102244103|NCT03194659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244104|NCT03194659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102244105|NCT03194659|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101952984|NCT03804177|Melatonin|melatonin|mesh-list
102244106|NCT03194659|Nootropic Agents|nootropic agents|mesh-ancestor
102244107|NCT02445547|Hormones|hormones|mesh-list
102244108|NCT02445547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102244109|NCT02445547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244110|NCT03190603|Celecoxib|celecoxib|mesh-list
102244111|NCT03190603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102244112|NCT03190603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102244113|NCT03190603|Analgesics|analgesics|mesh-ancestor
102244114|NCT03190603|Sensory System Agents|sensory system agents|mesh-ancestor
102244115|NCT03190603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102613129|NCT05673785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901578|NCT01290926|Sorafenib|sorafenib|mesh-list
102613130|NCT05673785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102244116|NCT03190603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244117|NCT03190603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102244118|NCT03190603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102244119|NCT03190603|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102244120|NCT03190603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102244121|NCT03190603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102244122|NCT03190603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244123|NCT03285503|Aripiprazole|aripiprazole|mesh-list
102244124|NCT03285503|Antidepressive Agents|antidepressive agents|mesh-ancestor
102244125|NCT03285503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102244126|NCT03285503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102244127|NCT03285503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102244128|NCT03285503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102244129|NCT03285503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244130|NCT03285503|Dopamine Agonists|dopamine agonists|mesh-ancestor
102244131|NCT03285503|Dopamine Agents|dopamine agents|mesh-ancestor
102244132|NCT03285503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102244133|NCT03285503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244134|NCT03285503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102244135|NCT03285503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102244136|NCT03285503|Serotonin Agents|serotonin agents|mesh-ancestor
102244137|NCT03285503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102244138|NCT03285503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102244139|NCT03285503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102244140|NCT03285503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102244141|NCT02439697|Darbepoetin alfa|darbepoetin alfa|mesh-list
102244142|NCT02439697|Hematinics|hematinics|mesh-ancestor
102244143|NCT05179603|Pembrolizumab|pembrolizumab|mesh-list
102244144|NCT05179603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102244145|NCT05179603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102244146|NCT05179603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102244147|NCT05179603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244148|NCT03284645|Tenofovir|tenofovir|mesh-list
102244149|NCT03284645|Lamivudine|lamivudine|mesh-list
102244150|NCT03284645|Zidovudine|zidovudine|mesh-list
102244151|NCT03284645|Efavirenz|efavirenz|mesh-list
102244152|NCT03284645|Abacavir|abacavir|mesh-list
102244153|NCT03284645|Antiviral Agents|antiviral agents|mesh-ancestor
102244154|NCT03284645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102244155|NCT03284645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102244156|NCT03284645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102244157|NCT03284645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102244158|NCT03284645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244159|NCT03284645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102244160|NCT03284645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102244161|NCT03284645|Antimetabolites|antimetabolites|mesh-ancestor
102244162|NCT03284645|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102244163|NCT03284645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102244164|NCT03284645|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102244165|NCT03284645|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102244166|NCT03284645|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102244167|NCT03284645|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102244168|NCT03190447|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102244169|NCT03190447|Laxatives|laxatives|mesh-ancestor
102244170|NCT03190447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102244171|NCT03284177|Calcium|calcium|mesh-list
102244172|NCT03284177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102244173|NCT03284177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244174|NCT03192709|Sildenafil Citrate|sildenafil citrate|mesh-list
102244175|NCT03192709|Vasodilator Agents|vasodilator agents|mesh-ancestor
102244176|NCT03192709|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102244177|NCT03192709|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102244178|NCT03192709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102244179|NCT03192709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244180|NCT03192709|Urological Agents|urological agents|mesh-ancestor
102244181|NCT03283943|Durvalumab|durvalumab|mesh-list
102244182|NCT03283943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102244183|NCT03283943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102244184|NCT02710045|Vaccines|vaccines|mesh-list
102244185|NCT02710045|Immunologic Factors|immunologic factors|mesh-ancestor
102244186|NCT02710045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244187|NCT02444767|Bimatoprost|bimatoprost|mesh-list
102613131|NCT05673785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102244188|NCT02444767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102613132|NCT05673785|Alkylating Agents|alkylating agents|mesh-ancestor
102244189|NCT02443285|Ceftriaxone|ceftriaxone|mesh-list
102244190|NCT02443285|Cefotaxime|cefotaxime|mesh-list
102244191|NCT02443285|Cefoxitin|cefoxitin|mesh-list
102244192|NCT02443285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102244193|NCT02443285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102244194|NCT03193957|Etanercept|etanercept|mesh-list
102244195|NCT03193957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102244196|NCT03193957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102244197|NCT03193957|Analgesics|analgesics|mesh-ancestor
102244198|NCT03193957|Sensory System Agents|sensory system agents|mesh-ancestor
102244199|NCT03193957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102244200|NCT03193957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244201|NCT03193957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102244202|NCT03193957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102244203|NCT03193957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102244204|NCT03193957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102244205|NCT03193957|Immunologic Factors|immunologic factors|mesh-ancestor
102244206|NCT03281681|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
102244207|NCT03281681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102244208|NCT03281681|Alkylating Agents|alkylating agents|mesh-ancestor
102244209|NCT03281681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244210|NCT03281681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102244211|NCT02444611|Vaccines|vaccines|mesh-list
102244212|NCT02444611|BCG Vaccine|bcg vaccine|mesh-list
102244213|NCT02444611|Immunologic Factors|immunologic factors|mesh-ancestor
102244214|NCT02444611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244215|NCT02444611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102244216|NCT02438761|Gedatolisib|gedatolisib|mesh-list
102244217|NCT02438761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102244218|NCT02438761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102244219|NCT02438761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244220|NCT03536429|Acetazolamide|acetazolamide|mesh-list
102244221|NCT03536429|Anticonvulsants|anticonvulsants|mesh-ancestor
102244222|NCT03536429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102244223|NCT03536429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102244224|NCT03536429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244225|NCT03536429|Diuretics|diuretics|mesh-ancestor
102244226|NCT03536429|Natriuretic Agents|natriuretic agents|mesh-ancestor
102244227|NCT03536429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244228|NCT02438683|BI 409306|bi 409306|mesh-list
102244229|NCT02438683|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102244230|NCT02438683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102244231|NCT02438683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244232|NCT03270839|Meclizine|meclizine|mesh-list
102244233|NCT03270839|Scopolamine|scopolamine|mesh-list
102244234|NCT03270839|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102244235|NCT03270839|Antiemetics|antiemetics|mesh-ancestor
102244236|NCT03270839|Autonomic Agents|autonomic agents|mesh-ancestor
102244237|NCT03270839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102244238|NCT03270839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244239|NCT03270839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102244240|NCT03270839|Mydriatics|mydriatics|mesh-ancestor
102244241|NCT03270839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102244242|NCT03270839|Cholinergic Agents|cholinergic agents|mesh-ancestor
102244243|NCT03270839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102244244|NCT03270839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244245|NCT03270839|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102244246|NCT03270839|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102244247|NCT03270839|Histamine Antagonists|histamine antagonists|mesh-ancestor
102244248|NCT03270839|Histamine Agents|histamine agents|mesh-ancestor
102244249|NCT03270839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102244250|NCT02458547|Bupivacaine|bupivacaine|mesh-list
102244251|NCT02458547|Propofol|propofol|mesh-list
102244252|NCT02458547|Desflurane|desflurane|mesh-list
102244253|NCT02458547|Anesthetics, Local|anesthetics, local|mesh-ancestor
101953149|NCT02940860|Iron|iron|mesh-list
102244254|NCT02458547|Anesthetics|anesthetics|mesh-ancestor
102244255|NCT02458547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102244256|NCT02458547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244257|NCT02458547|Sensory System Agents|sensory system agents|mesh-ancestor
102244258|NCT02458547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102244259|NCT02458547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102244260|NCT02458547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102244261|NCT02458547|Anesthetics, General|anesthetics, general|mesh-ancestor
102244262|NCT02458547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102244263|NCT02458625|Iron|iron|mesh-list
102613133|NCT05673785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244264|NCT02458625|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102244265|NCT02458625|Trace Elements|trace elements|mesh-ancestor
102244266|NCT02458625|Micronutrients|micronutrients|mesh-ancestor
102244267|NCT02458625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244269|NCT04978155|Anesthetics|anesthetics|mesh-list
102244270|NCT04978155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102244271|NCT04978155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244272|NCT04970043|Pemetrexed|pemetrexed|mesh-list
102244273|NCT04970043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102244274|NCT04970043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102244275|NCT04970043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244276|NCT04970043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102244277|NCT04970043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102244278|NCT04977843|Dimercaprol|dimercaprol|mesh-list
102244279|NCT04977843|Chelating Agents|chelating agents|mesh-ancestor
102244280|NCT04977843|Sequestering Agents|sequestering agents|mesh-ancestor
102244281|NCT04977843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244282|NCT04432233|Metronidazole|metronidazole|mesh-list
102244283|NCT04432233|Levofloxacin|levofloxacin|mesh-list
102244284|NCT04432233|Esomeprazole|esomeprazole|mesh-list
102244285|NCT04432233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102244286|NCT04432233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102244287|NCT04432233|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102244288|NCT04432233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102244289|NCT04432233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102244290|NCT04432233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102244291|NCT04432233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102244292|NCT04432233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102244293|NCT04432233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244294|NCT04432233|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102244295|NCT04432233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102244296|NCT04432233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102244297|NCT04432233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102244298|NCT04432233|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102244299|NCT04432233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102244300|NCT03269747|Prednisone|prednisone|mesh-list
102244301|NCT03269747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102244302|NCT03269747|Glucocorticoids|glucocorticoids|mesh-ancestor
102244303|NCT03269747|Hormones|hormones|mesh-ancestor
102244304|NCT03269747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101712665|NCT00498433|Amlodipine|amlodipine|mesh-list
102244305|NCT03269747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244306|NCT03269747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102244307|NCT03269747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102244308|NCT04369469|Ravulizumab|ravulizumab|mesh-list
102244309|NCT04369469|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102244310|NCT04369469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102244311|NCT04369469|Immunologic Factors|immunologic factors|mesh-ancestor
102244312|NCT04369469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244313|NCT03269591|Diclofenac|diclofenac|mesh-list
102244314|NCT03269591|Progesterone|progesterone|mesh-list
102244315|NCT03269591|Progestins|progestins|mesh-ancestor
102244316|NCT03269591|Hormones|hormones|mesh-ancestor
102244317|NCT03269591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102244318|NCT03269591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244319|NCT03269591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102244320|NCT03269591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102244321|NCT03269591|Analgesics|analgesics|mesh-ancestor
102244322|NCT03269591|Sensory System Agents|sensory system agents|mesh-ancestor
102244323|NCT03269591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102244324|NCT03269591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102244325|NCT03269591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102244326|NCT03269591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102244327|NCT03269591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102244328|NCT03269591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244329|NCT03989609|Midazolam|midazolam|mesh-list
102244330|NCT03989609|Dexmedetomidine|dexmedetomidine|mesh-list
102244331|NCT03989609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102244332|NCT03989609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102244333|NCT03989609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244334|NCT03989609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102244335|NCT03989609|Analgesics|analgesics|mesh-ancestor
102244336|NCT03989609|Sensory System Agents|sensory system agents|mesh-ancestor
102244337|NCT03989609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102244338|NCT03989609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102244339|NCT03989609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102244341|NCT03989609|Adrenergic Agents|adrenergic agents|mesh-ancestor
102244342|NCT03989609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102244343|NCT03989609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244344|NCT03989609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102244345|NCT03989609|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102244346|NCT03989609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102244347|NCT03989609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102244348|NCT03989609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102244349|NCT03989609|Anesthetics, General|anesthetics, general|mesh-ancestor
102244350|NCT03989609|Anesthetics|anesthetics|mesh-ancestor
102244351|NCT03989609|GABA Modulators|gaba modulators|mesh-ancestor
102244352|NCT03989609|GABA Agents|gaba agents|mesh-ancestor
102244353|NCT03988205|Cytarabine|cytarabine|mesh-list
102244354|NCT03988205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102244355|NCT03988205|Antimetabolites|antimetabolites|mesh-ancestor
102244356|NCT03988205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244357|NCT03988205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102244358|NCT03988205|Antiviral Agents|antiviral agents|mesh-ancestor
102244359|NCT03988205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102244360|NCT03988205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102244361|NCT03988205|Immunologic Factors|immunologic factors|mesh-ancestor
102244362|NCT03988205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244363|NCT03280277|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102244364|NCT03280277|Hematinics|hematinics|mesh-ancestor
102244365|NCT03280277|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102244366|NCT03280277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102244367|NCT03269357|Contraceptive Agents|contraceptive agents|mesh-list
102244368|NCT03269357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102244369|NCT03269357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244370|NCT03269279|Misoprostol|misoprostol|mesh-list
102244371|NCT03269279|Mifepristone|mifepristone|mesh-list
101370102|NCT04729491|Azithromycin|azithromycin|mesh-list
102244372|NCT03269279|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102244373|NCT03269279|Abortifacient Agents|abortifacient agents|mesh-ancestor
102244374|NCT03269279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102244375|NCT03269279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244376|NCT03269279|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102244377|NCT03269279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102244378|NCT03269279|Oxytocics|oxytocics|mesh-ancestor
102244379|NCT03269279|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102244380|NCT03269279|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102244381|NCT03269279|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102244382|NCT03269279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102244383|NCT03269279|Contraceptive Agents|contraceptive agents|mesh-ancestor
102244384|NCT03269279|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102244385|NCT03269279|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102244386|NCT03269279|Hormone Antagonists|hormone antagonists|mesh-ancestor
102244387|NCT03269279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102244388|NCT03269279|Luteolytic Agents|luteolytic agents|mesh-ancestor
102244389|NCT03269279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102244390|NCT03269279|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102244391|NCT03278483|Rifampin|rifampin|mesh-list
102244392|NCT03278483|Isoniazid|isoniazid|mesh-list
102244393|NCT03278483|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102244394|NCT03278483|Antitubercular Agents|antitubercular agents|mesh-ancestor
102244395|NCT03278483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102244396|NCT03278483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102244397|NCT03278483|Leprostatic Agents|leprostatic agents|mesh-ancestor
102244398|NCT03278483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102244399|NCT03278483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102244400|NCT03278483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244401|NCT03278483|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102244402|NCT03278483|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102244403|NCT03278483|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102244404|NCT03278483|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102244405|NCT03278483|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102244406|NCT03278483|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102244407|NCT03278483|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102244408|NCT03278483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102244409|NCT03278483|Antimetabolites|antimetabolites|mesh-ancestor
102613134|NCT05673785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102244410|NCT03278483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102244411|NCT03268733|Folic Acid|folic acid|mesh-list
102244412|NCT03268733|Hematinics|hematinics|mesh-ancestor
102244413|NCT03268733|Vitamin B Complex|vitamin b complex|mesh-ancestor
102244414|NCT03268733|Vitamins|vitamins|mesh-ancestor
102244415|NCT03268733|Micronutrients|micronutrients|mesh-ancestor
102244416|NCT03268733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244417|NCT03277391|Droperidol|droperidol|mesh-list
102244418|NCT03277391|Morphine|morphine|mesh-list
102244419|NCT03277391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102244420|NCT03277391|Narcotics|narcotics|mesh-ancestor
102244421|NCT03277391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102244422|NCT03277391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244423|NCT03277391|Analgesics|analgesics|mesh-ancestor
102244424|NCT03277391|Sensory System Agents|sensory system agents|mesh-ancestor
102244425|NCT03277391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102244426|NCT03277391|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102244427|NCT03277391|Antiemetics|antiemetics|mesh-ancestor
102244428|NCT03277391|Autonomic Agents|autonomic agents|mesh-ancestor
102244429|NCT03277391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102244430|NCT03277391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102244431|NCT03277391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102244432|NCT03277391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102244433|NCT03277391|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102244434|NCT03277391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102244435|NCT03277391|Dopamine Agents|dopamine agents|mesh-ancestor
102244436|NCT03277391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101712675|NCT02689583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102244437|NCT03277391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244438|NCT03277001|Enoxaparin|enoxaparin|mesh-list
102244439|NCT03277001|Rivaroxaban|rivaroxaban|mesh-list
102244440|NCT03277001|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102244441|NCT03277001|Antithrombins|antithrombins|mesh-ancestor
102244442|NCT03277001|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102244443|NCT03277001|Protease Inhibitors|protease inhibitors|mesh-ancestor
102244444|NCT03277001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102244445|NCT03277001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244446|NCT03277001|Anticoagulants|anticoagulants|mesh-ancestor
102244447|NCT03277001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102244448|NCT03277001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102244449|NCT03273881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102244450|NCT03272711|Vortioxetine|vortioxetine|mesh-list
102244451|NCT03272711|Antidepressive Agents|antidepressive agents|mesh-ancestor
102244452|NCT03272711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102244453|NCT03272711|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102244454|NCT03272711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102244455|NCT03272711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102244456|NCT03272711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244457|NCT03272711|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102244458|NCT03272711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102244459|NCT03272711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102244460|NCT03272711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244461|NCT03272711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102244462|NCT03272711|Serotonin Agents|serotonin agents|mesh-ancestor
102244463|NCT03272711|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102244464|NCT03272711|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102244465|NCT03272711|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102244466|NCT03272711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102244467|NCT03961919|Fludarabine|fludarabine|mesh-list
102244468|NCT03961919|Treosulfan|treosulfan|mesh-list
102244469|NCT03961919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102244470|NCT03961919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244471|NCT03961919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102244472|NCT03961919|Alkylating Agents|alkylating agents|mesh-ancestor
102244473|NCT03267407|Fluconazole|fluconazole|mesh-list
102244474|NCT03267407|Antifungal Agents|antifungal agents|mesh-ancestor
102244475|NCT03267407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102244476|NCT03267407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102244477|NCT03267407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102244478|NCT03267407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101953356|NCT02806024|Hemostatics|hemostatics|mesh-ancestor
102244479|NCT03267407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244481|NCT03267407|Hormone Antagonists|hormone antagonists|mesh-ancestor
102244482|NCT03267407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102244483|NCT03267407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244484|NCT03267407|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102244485|NCT03267407|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102244487|NCT03267329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102244488|NCT03267329|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102244489|NCT03267329|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102244490|NCT03267329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244491|NCT05074043|Antiviral Agents|antiviral agents|mesh-list
102244492|NCT05074043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102244493|NCT05073965|Vitamin D|vitamin d|mesh-list
102244494|NCT05073965|Vitamins|vitamins|mesh-ancestor
102244495|NCT05073965|Micronutrients|micronutrients|mesh-ancestor
102244496|NCT05073965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244497|NCT05073965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102244498|NCT03266549|Botulinum Toxins|botulinum toxins|mesh-list
102244499|NCT03266549|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102244500|NCT03266549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102244501|NCT03266549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244502|NCT03266549|Cholinergic Agents|cholinergic agents|mesh-ancestor
102244503|NCT03266549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102244504|NCT03266549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244505|NCT05065775|Dexmedetomidine|dexmedetomidine|mesh-list
102244506|NCT05065775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102244507|NCT05065775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102244508|NCT05065775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244509|NCT05065775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102244510|NCT05065775|Analgesics|analgesics|mesh-ancestor
102244511|NCT05065775|Sensory System Agents|sensory system agents|mesh-ancestor
102244512|NCT05065775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102244513|NCT05065775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102244514|NCT05065775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102244515|NCT05065775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102244516|NCT05065775|Adrenergic Agents|adrenergic agents|mesh-ancestor
102244517|NCT05065775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102244518|NCT05065775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244519|NCT03266159|Trametinib|trametinib|mesh-list
102244520|NCT03266159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102244521|NCT03266159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102244522|NCT03266159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102244523|NCT03266159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244524|NCT02458781|Metronidazole|metronidazole|mesh-list
102244525|NCT02458781|Ciprofloxacin|ciprofloxacin|mesh-list
102244526|NCT02458781|Fluoroquinolones|fluoroquinolones|mesh-list
102244527|NCT02458781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102244528|NCT02458781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102244529|NCT02458781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102244530|NCT02458781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102244531|NCT02458781|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102244532|NCT02458781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102244533|NCT02458781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102244534|NCT02458781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244535|NCT02458781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102244536|NCT02458781|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102244537|NCT02458781|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102244538|NCT02458781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102244539|NCT04647383|Lemborexant|lemborexant|mesh-list
102244540|NCT04647383|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102244541|NCT04647383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102244542|NCT04647383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244543|NCT04647383|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102244544|NCT04647383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102244545|NCT04647383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102244546|NCT04647383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244547|NCT02458157|Furosemide|furosemide|mesh-list
102244548|NCT02458157|Diuretics|diuretics|mesh-ancestor
102244549|NCT02458157|Natriuretic Agents|natriuretic agents|mesh-ancestor
102244550|NCT02458157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244551|NCT02458157|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102244552|NCT02458157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102244553|NCT02458157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244554|NCT02458079|Pentoxifylline|pentoxifylline|mesh-list
102244555|NCT02458079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102244556|NCT02458079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102244557|NCT02458079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244558|NCT02458079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102244559|NCT02458079|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102244560|NCT02458079|Protective Agents|protective agents|mesh-ancestor
102244561|NCT02458079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244562|NCT02458079|Vasodilator Agents|vasodilator agents|mesh-ancestor
102244563|NCT02458079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102244565|NCT03264911|Amoxicillin|amoxicillin|mesh-list
102244566|NCT03264911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102244567|NCT03264911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102244568|NCT03265223|Ropivacaine|ropivacaine|mesh-list
102244569|NCT03265223|Anesthetics, Local|anesthetics, local|mesh-ancestor
102244570|NCT03265223|Anesthetics|anesthetics|mesh-ancestor
102244571|NCT03265223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102244572|NCT03265223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244573|NCT03265223|Sensory System Agents|sensory system agents|mesh-ancestor
102244574|NCT03265223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102244575|NCT02456363|Sulfasalazine|sulfasalazine|mesh-list
102244576|NCT02456363|Adalimumab|adalimumab|mesh-list
102244577|NCT02456363|Golimumab|golimumab|mesh-list
102244578|NCT02456363|Etanercept|etanercept|mesh-list
102244579|NCT02456363|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102244580|NCT02456363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102244581|NCT02456363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102244582|NCT02456363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102244583|NCT02456363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102244584|NCT02456363|Analgesics|analgesics|mesh-ancestor
102244585|NCT02456363|Sensory System Agents|sensory system agents|mesh-ancestor
102244586|NCT02456363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102244587|NCT02456363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244588|NCT02456363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102244589|NCT02456363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102244590|NCT02456363|Immunologic Factors|immunologic factors|mesh-ancestor
102244591|NCT02456363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102244592|NCT03259607|Nicotine|nicotine|mesh-list
102244593|NCT03259607|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102244594|NCT03259607|Autonomic Agents|autonomic agents|mesh-ancestor
102244595|NCT03259607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102244596|NCT03259607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244597|NCT03259607|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102244598|NCT03259607|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102244599|NCT03259607|Cholinergic Agents|cholinergic agents|mesh-ancestor
102244600|NCT03259607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102244601|NCT03259607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244602|NCT02456129|Itraconazole|itraconazole|mesh-list
102244603|NCT02456129|Antifungal Agents|antifungal agents|mesh-ancestor
102244604|NCT02456129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102244605|NCT02456129|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102244606|NCT02456129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102244607|NCT02456129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102244608|NCT02456129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244609|NCT02456129|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102244610|NCT02456129|Hormone Antagonists|hormone antagonists|mesh-ancestor
102244611|NCT02456129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102244612|NCT02456129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244613|NCT02456129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102244614|NCT03263741|Paclitaxel|paclitaxel|mesh-list
102244615|NCT03263741|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102244616|NCT03263741|Oxaliplatin|oxaliplatin|mesh-list
102244617|NCT03263741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102244618|NCT03263741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102244619|NCT03263741|Tubulin Modulators|tubulin modulators|mesh-ancestor
102244620|NCT03263741|Antimitotic Agents|antimitotic agents|mesh-ancestor
102244621|NCT03263741|Mitosis Modulators|mitosis modulators|mesh-ancestor
102244622|NCT03263741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244623|NCT02456207|Rituximab|rituximab|mesh-list
102244624|NCT02456207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102244625|NCT02456207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613135|NCT05673785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102613136|NCT05673785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102244626|NCT02456207|Immunologic Factors|immunologic factors|mesh-ancestor
102613137|NCT05673785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102244627|NCT02456207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244628|NCT02456207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102244629|NCT03258749|Formoterol Fumarate|formoterol fumarate|mesh-list
102244630|NCT03258749|Tiotropium Bromide|tiotropium bromide|mesh-list
102244631|NCT03258749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102244632|NCT03258749|Autonomic Agents|autonomic agents|mesh-ancestor
102244633|NCT03258749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102244634|NCT03258749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244635|NCT03258749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102244636|NCT03258749|Respiratory System Agents|respiratory system agents|mesh-ancestor
102244637|NCT03258749|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102244638|NCT03258749|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102244639|NCT03258749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102244640|NCT03258749|Adrenergic Agents|adrenergic agents|mesh-ancestor
102244641|NCT03258749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102244642|NCT03258749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244643|NCT03258749|Parasympatholytics|parasympatholytics|mesh-ancestor
102244644|NCT03258749|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102244645|NCT03258749|Cholinergic Agents|cholinergic agents|mesh-ancestor
102244646|NCT03258515|Moxifloxacin|moxifloxacin|mesh-list
102244647|NCT03258515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102244648|NCT03258515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102244649|NCT03258515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102244650|NCT03258515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102244651|NCT03258515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102244652|NCT03258515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244653|NCT03258515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102244654|NCT04976673|Triamcinolone|triamcinolone|mesh-list
102244655|NCT04976673|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102244656|NCT04976673|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102244657|NCT04976673|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102244658|NCT04976673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102244659|NCT04976673|Glucocorticoids|glucocorticoids|mesh-ancestor
102244660|NCT04976673|Hormones|hormones|mesh-ancestor
102244661|NCT04976673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102244662|NCT04976673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244663|NCT04976673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102244664|NCT04976673|Immunologic Factors|immunologic factors|mesh-ancestor
102244665|NCT04976673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102244666|NCT04976673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244667|NCT04969497|Zolmitriptan|zolmitriptan|mesh-list
102244668|NCT04969497|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102244669|NCT04969497|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102244670|NCT04969497|Serotonin Agents|serotonin agents|mesh-ancestor
102244671|NCT04969497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102244672|NCT04969497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244673|NCT04969497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244674|NCT04976829|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102244675|NCT04976829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102244676|NCT03263039|Pembrolizumab|pembrolizumab|mesh-list
102244677|NCT03263039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102244678|NCT03263039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102244679|NCT03263039|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102244680|NCT03263039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244681|NCT03262961|Sildenafil Citrate|sildenafil citrate|mesh-list
102244682|NCT03262961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244683|NCT03262961|Vasodilator Agents|vasodilator agents|mesh-ancestor
102244684|NCT03262961|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102244685|NCT03262961|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102244686|NCT03262961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102244687|NCT03262961|Urological Agents|urological agents|mesh-ancestor
102244688|NCT01670097|Dexamethasone|dexamethasone|mesh-list
102244689|NCT01670097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102244690|NCT01670097|Antiemetics|antiemetics|mesh-ancestor
102244691|NCT01670097|Autonomic Agents|autonomic agents|mesh-ancestor
101712714|NCT01011751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102244692|NCT01670097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102244693|NCT01670097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244694|NCT01670097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102244695|NCT01670097|Glucocorticoids|glucocorticoids|mesh-ancestor
102244696|NCT01670097|Hormones|hormones|mesh-ancestor
102244697|NCT01670097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102244698|NCT01670097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102613138|NCT05673785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102613139|NCT05673785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102244699|NCT01670097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102244700|NCT03257423|Moxifloxacin|moxifloxacin|mesh-list
102244701|NCT03257423|Metronidazole|metronidazole|mesh-list
102244702|NCT03257423|Levofloxacin|levofloxacin|mesh-list
102244703|NCT03257423|Ertapenem|ertapenem|mesh-list
102244704|NCT03257423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102244705|NCT03257423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102244706|NCT03257423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102244707|NCT03257423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102244708|NCT03257423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102244709|NCT03257423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244710|NCT03257423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102244711|NCT03257423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102244712|NCT03257423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102244713|NCT03257423|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102244714|NCT03257423|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102244715|NCT03257423|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102244716|NCT01670019|Asenapine|asenapine|mesh-list
102244717|NCT01670019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102244718|NCT01670019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102244719|NCT01670019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102244720|NCT01670019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244721|NCT01670019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102244722|NCT03262727|Deucravacitinib|deucravacitinib|mesh-list
102244723|NCT03262727|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102244724|NCT03262727|Norethindrone|norethindrone|mesh-list
102244725|NCT03262727|Norethindrone Acetate|norethindrone acetate|mesh-list
102244726|NCT03262727|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
102244727|NCT03262727|Estradiol|estradiol|mesh-list
102244728|NCT03262727|Estrogens|estrogens|mesh-ancestor
102244729|NCT03262727|Hormones|hormones|mesh-ancestor
102244730|NCT03262727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102244731|NCT03262727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244732|NCT03262727|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102244733|NCT03262727|Contraceptive Agents|contraceptive agents|mesh-ancestor
102244734|NCT03262727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102244735|NCT03262727|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102244736|NCT03262727|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102244737|NCT03262727|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102244738|NCT03262727|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102244739|NCT03262727|Dermatologic Agents|dermatologic agents|mesh-ancestor
102244740|NCT03262727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102244741|NCT03262727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102244742|NCT03262727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244743|NCT03262727|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102244744|NCT03262727|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
102244745|NCT04975971|Dexamethasone|dexamethasone|mesh-list
102244746|NCT04975971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102244747|NCT04975971|Antiemetics|antiemetics|mesh-ancestor
102244748|NCT04975971|Autonomic Agents|autonomic agents|mesh-ancestor
102244749|NCT04975971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102244750|NCT04975971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244751|NCT04975971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102244752|NCT04975971|Glucocorticoids|glucocorticoids|mesh-ancestor
102244753|NCT04975971|Hormones|hormones|mesh-ancestor
102244754|NCT04975971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102244755|NCT04975971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102244756|NCT04975971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102244757|NCT03062163|Thioctic Acid|thioctic acid|mesh-list
102244758|NCT03062163|Resveratrol|resveratrol|mesh-list
102244759|NCT03062163|Antioxidants|antioxidants|mesh-ancestor
102244760|NCT03062163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244761|NCT03062163|Protective Agents|protective agents|mesh-ancestor
102244762|NCT03062163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244763|NCT03062163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102244764|NCT03062163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102244765|NCT03062163|Vitamin B Complex|vitamin b complex|mesh-ancestor
102244766|NCT03062163|Vitamins|vitamins|mesh-ancestor
102244767|NCT03062163|Micronutrients|micronutrients|mesh-ancestor
102244768|NCT02456597|Lidocaine|lidocaine|mesh-list
102244769|NCT02456597|Anesthetics, Local|anesthetics, local|mesh-ancestor
102244770|NCT02456597|Anesthetics|anesthetics|mesh-ancestor
102244771|NCT02456597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101953656|NCT05624853|Analgesics|analgesics|mesh-ancestor
102244772|NCT02456597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244773|NCT02456597|Sensory System Agents|sensory system agents|mesh-ancestor
102244774|NCT02456597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102244775|NCT02456597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102244776|NCT02456597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102244777|NCT02456597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102244778|NCT02456597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102244779|NCT02456597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244780|NCT03261635|Indomethacin|indomethacin|mesh-list
102244781|NCT03261635|Ranibizumab|ranibizumab|mesh-list
102244782|NCT03261635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102244783|NCT03261635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102244784|NCT03261635|Growth Substances|growth substances|mesh-ancestor
102244785|NCT03261635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244786|NCT03261635|Growth Inhibitors|growth inhibitors|mesh-ancestor
102244787|NCT03261635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102244788|NCT03261635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102244789|NCT03261635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102244790|NCT03261635|Analgesics|analgesics|mesh-ancestor
102244791|NCT03261635|Sensory System Agents|sensory system agents|mesh-ancestor
102244792|NCT03261635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102244793|NCT03261635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102244794|NCT03261635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102244795|NCT03261635|Gout Suppressants|gout suppressants|mesh-ancestor
102244796|NCT03261635|Tocolytic Agents|tocolytic agents|mesh-ancestor
102244797|NCT03261635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102244798|NCT03261635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102244799|NCT03261635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102244800|NCT03261635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244801|NCT03059979|Methylprednisolone|methylprednisolone|mesh-list
102244802|NCT03059979|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102244803|NCT03059979|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102244804|NCT03059979|Prednisolone|prednisolone|mesh-list
102244805|NCT03059979|Prednisolone acetate|prednisolone acetate|mesh-list
102244806|NCT03059979|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102244807|NCT03059979|Prednisolone phosphate|prednisolone phosphate|mesh-list
102244808|NCT03059979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102244809|NCT03059979|Antiemetics|antiemetics|mesh-ancestor
102244810|NCT03059979|Autonomic Agents|autonomic agents|mesh-ancestor
102244811|NCT03059979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102244812|NCT03059979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244813|NCT03059979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102244814|NCT03059979|Glucocorticoids|glucocorticoids|mesh-ancestor
102244815|NCT03059979|Hormones|hormones|mesh-ancestor
102244816|NCT03059979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102244817|NCT03059979|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102244818|NCT03059979|Protective Agents|protective agents|mesh-ancestor
102244819|NCT03059979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102244820|NCT03059979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102244821|NCT03256721|Docetaxel|docetaxel|mesh-list
102244822|NCT03256721|Pemetrexed|pemetrexed|mesh-list
102244823|NCT03256721|Apatinib|apatinib|mesh-list
102244824|NCT03256721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102244825|NCT03256721|Tubulin Modulators|tubulin modulators|mesh-ancestor
102244826|NCT03256721|Antimitotic Agents|antimitotic agents|mesh-ancestor
102244827|NCT03256721|Mitosis Modulators|mitosis modulators|mesh-ancestor
102244828|NCT03256721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244829|NCT03256721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102244830|NCT03256721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102244831|NCT03256721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102244832|NCT03256721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102244833|NCT04967859|Gentamicins|gentamicins|mesh-list
102244834|NCT04967859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102244835|NCT04967859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102244836|NCT04967859|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102244837|NCT04967859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102244838|NCT04967859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244839|NCT03256487|Morphine|morphine|mesh-list
102244840|NCT03256487|Buprenorphine|buprenorphine|mesh-list
102244841|NCT03256487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102244842|NCT03256487|Narcotics|narcotics|mesh-ancestor
102244843|NCT03256487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102244844|NCT03256487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613140|NCT05673785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102244845|NCT03256487|Analgesics|analgesics|mesh-ancestor
102244846|NCT03256487|Sensory System Agents|sensory system agents|mesh-ancestor
102244847|NCT03256487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102244848|NCT03256487|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102244849|NCT03061227|Glucagon|glucagon|mesh-list
102244850|NCT03061227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102244851|NCT03061227|Hormones|hormones|mesh-ancestor
102244852|NCT03061227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102244853|NCT03061227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244854|NCT03261791|Apatinib|apatinib|mesh-list
102244855|NCT03261791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102244856|NCT03261791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102244857|NCT03261791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102244858|NCT03261791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244859|NCT03643367|Propofol|propofol|mesh-list
102244860|NCT03643367|Sevoflurane|sevoflurane|mesh-list
102244861|NCT03643367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102244862|NCT03643367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102244863|NCT03643367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244864|NCT03643367|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102244865|NCT03643367|Anesthetics, General|anesthetics, general|mesh-ancestor
102244866|NCT03643367|Anesthetics|anesthetics|mesh-ancestor
102244867|NCT03643367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102244868|NCT03643367|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102244869|NCT03060603|Epoetin Alfa|epoetin alfa|mesh-list
102244870|NCT03060603|Hematinics|hematinics|mesh-ancestor
102244871|NCT04488107|Letrozole|letrozole|mesh-list
102244872|NCT04488107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102244873|NCT04488107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102244874|NCT04488107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102244875|NCT04488107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102244876|NCT04488107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244877|NCT04488107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102244878|NCT04488107|Hormone Antagonists|hormone antagonists|mesh-ancestor
102244879|NCT04488107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102244880|NCT04488107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244881|NCT04974723|Teriparatide|teriparatide|mesh-list
102244882|NCT04974723|Abaloparatide|abaloparatide|mesh-list
102244883|NCT04974723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102244884|NCT04974723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244885|NCT04974723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102244886|NCT03060681|Bupivacaine|bupivacaine|mesh-list
102244887|NCT03060681|Anesthetics, Local|anesthetics, local|mesh-ancestor
102244888|NCT03060681|Anesthetics|anesthetics|mesh-ancestor
102244889|NCT03060681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102244890|NCT03060681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244891|NCT03060681|Sensory System Agents|sensory system agents|mesh-ancestor
102244892|NCT03060681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102244893|NCT04967469|Calcitriol|calcitriol|mesh-list
102244894|NCT04967469|Alfacalcidol|alfacalcidol|mesh-list
102244895|NCT04967469|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
102244896|NCT04967469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102244897|NCT04967469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244898|NCT04967469|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102244899|NCT04967469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102244900|NCT04967469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244901|NCT04967469|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102244902|NCT04967469|Vitamins|vitamins|mesh-ancestor
102244903|NCT04967469|Micronutrients|micronutrients|mesh-ancestor
102244904|NCT04967469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102244905|NCT03254849|Empagliflozin|empagliflozin|mesh-list
102244906|NCT03254849|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102244907|NCT03254849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102244908|NCT03254849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244909|NCT03254849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102244910|NCT03254849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244911|NCT03254849|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102244912|NCT03254849|Diuretics|diuretics|mesh-ancestor
102244913|NCT03254849|Natriuretic Agents|natriuretic agents|mesh-ancestor
102244914|NCT03254849|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102244915|NCT03254849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102244916|NCT04963881|Antibodies|antibodies|mesh-list
102244917|NCT04963881|Immunologic Factors|immunologic factors|mesh-ancestor
102613141|NCT05673785|Glucocorticoids|glucocorticoids|mesh-ancestor
102613142|NCT05673785|Hormones|hormones|mesh-ancestor
102244918|NCT04963881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244919|NCT04432155|Xenon|xenon|mesh-list
102244920|NCT04432155|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102244921|NCT04432155|Anesthetics, General|anesthetics, general|mesh-ancestor
102244922|NCT04432155|Anesthetics|anesthetics|mesh-ancestor
102244923|NCT04432155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102244924|NCT04432155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244925|NCT04487951|Vitamin D|vitamin d|mesh-list
102244926|NCT04487951|Vitamins|vitamins|mesh-ancestor
102244927|NCT04487951|Micronutrients|micronutrients|mesh-ancestor
102244928|NCT04487951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244929|NCT04487951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102244930|NCT04963257|Aripiprazole|aripiprazole|mesh-list
102244931|NCT04963257|Fluvoxamine|fluvoxamine|mesh-list
102244932|NCT04963257|Sertraline|sertraline|mesh-list
102244933|NCT04963257|Antidepressive Agents|antidepressive agents|mesh-ancestor
102244934|NCT04963257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102244935|NCT04963257|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102244936|NCT04963257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102244937|NCT04963257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102244938|NCT04963257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244939|NCT04963257|Dopamine Agonists|dopamine agonists|mesh-ancestor
102244940|NCT04963257|Dopamine Agents|dopamine agents|mesh-ancestor
102244941|NCT04963257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102244942|NCT04963257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244943|NCT04963257|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102244944|NCT04963257|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102244945|NCT04963257|Serotonin Agents|serotonin agents|mesh-ancestor
102244946|NCT04963257|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102244947|NCT04963257|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102244948|NCT04963257|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102244949|NCT04963257|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102244950|NCT04963257|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102244951|NCT04963257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102244952|NCT04963257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102244953|NCT04963257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102244954|NCT04963257|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102244955|NCT04963257|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102244956|NCT04963257|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102244957|NCT04963257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102244958|NCT04963257|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102244959|NCT04966845|Carbon Monoxide|carbon monoxide|mesh-list
102244960|NCT04966845|Antimetabolites|antimetabolites|mesh-ancestor
102244961|NCT04966845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244962|NCT04966845|Gasotransmitters|gasotransmitters|mesh-ancestor
102244963|NCT04966845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102244964|NCT04966845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244965|NCT04953741|Fluticasone|fluticasone|mesh-list
102244966|NCT04953741|Xhance|xhance|mesh-list
102244967|NCT04953741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102244968|NCT04953741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102244969|NCT04953741|Autonomic Agents|autonomic agents|mesh-ancestor
102244970|NCT04953741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102244971|NCT04953741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244972|NCT04953741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102244973|NCT04953741|Respiratory System Agents|respiratory system agents|mesh-ancestor
102244974|NCT04953741|Dermatologic Agents|dermatologic agents|mesh-ancestor
102244975|NCT04953741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102244976|NCT03259919|Metformin|metformin|mesh-list
102244977|NCT03259919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102244978|NCT03259919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244979|NCT04965831|Aflutinib|aflutinib|mesh-list
102244980|NCT04965831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102244981|NCT04965831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102244982|NCT04965831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102244983|NCT04953117|Paclitaxel|paclitaxel|mesh-list
102244984|NCT04953117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102244985|NCT04953117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102244986|NCT04953117|Tubulin Modulators|tubulin modulators|mesh-ancestor
102244987|NCT04953117|Antimitotic Agents|antimitotic agents|mesh-ancestor
102244988|NCT04953117|Mitosis Modulators|mitosis modulators|mesh-ancestor
102613143|NCT05673785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102613144|NCT05673785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102244989|NCT04953117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613145|NCT05673785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102244990|NCT03259529|Rituximab|rituximab|mesh-list
102244991|NCT03259529|Nivolumab|nivolumab|mesh-list
102244992|NCT03259529|Gemcitabine|gemcitabine|mesh-list
102244993|NCT03259529|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102244994|NCT03259529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102244995|NCT03259529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102244996|NCT03259529|Immunologic Factors|immunologic factors|mesh-ancestor
102244997|NCT03259529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102244998|NCT03259529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102244999|NCT03259529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102245000|NCT03259529|Antimetabolites|antimetabolites|mesh-ancestor
102245001|NCT03259529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245002|NCT03259529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102245003|NCT03259529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102245004|NCT03259529|Alkylating Agents|alkylating agents|mesh-ancestor
102245005|NCT03252665|Nicorandil|nicorandil|mesh-list
102245006|NCT03252665|Nitroglycerin|nitroglycerin|mesh-list
102245007|NCT03252665|Alprostadil|alprostadil|mesh-list
102245008|NCT03252665|Vasodilator Agents|vasodilator agents|mesh-ancestor
102245009|NCT03252665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102245010|NCT03252665|Urological Agents|urological agents|mesh-ancestor
102245011|NCT03252665|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102245012|NCT03252665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102245013|NCT03252665|Vitamin B Complex|vitamin b complex|mesh-ancestor
102245014|NCT03252665|Vitamins|vitamins|mesh-ancestor
102245015|NCT03252665|Micronutrients|micronutrients|mesh-ancestor
102245016|NCT03252665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245017|NCT03059667|Carboplatin|carboplatin|mesh-list
102245018|NCT03059667|Etoposide|etoposide|mesh-list
102245019|NCT03059667|Atezolizumab|atezolizumab|mesh-list
102245020|NCT03059667|Topotecan|topotecan|mesh-list
102245021|NCT03059667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102245022|NCT03059667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102245023|NCT03059667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102245024|NCT03059667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102245025|NCT03059667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102245026|NCT03059667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245027|NCT03059667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102245028|NCT03059667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102245029|NCT03059667|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102245030|NCT03058419|Midazolam|midazolam|mesh-list
102245031|NCT03058419|Dextromethorphan|dextromethorphan|mesh-list
102245032|NCT03058419|Caffeine|caffeine|mesh-list
102245033|NCT03058419|Bupropion|bupropion|mesh-list
102245034|NCT03058419|Omeprazole|omeprazole|mesh-list
102245035|NCT03058419|Warfarin|warfarin|mesh-list
102245036|NCT03058419|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102245037|NCT03058419|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102245038|NCT03058419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102245039|NCT03058419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245040|NCT03058419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102245041|NCT03058419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102245042|NCT03058419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102245043|NCT03058419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102245044|NCT03058419|Anesthetics, General|anesthetics, general|mesh-ancestor
102245045|NCT03058419|Anesthetics|anesthetics|mesh-ancestor
102245046|NCT03058419|GABA Modulators|gaba modulators|mesh-ancestor
102245047|NCT03058419|GABA Agents|gaba agents|mesh-ancestor
102245048|NCT03058419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102245049|NCT03058419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245050|NCT03058419|Anticoagulants|anticoagulants|mesh-ancestor
102245051|NCT03058419|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102245052|NCT03058419|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102245053|NCT03058419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102245054|NCT03058419|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102245055|NCT03058419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102245056|NCT03058419|Purinergic Agents|purinergic agents|mesh-ancestor
102245057|NCT03058419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102245058|NCT03058419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102245059|NCT03058419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102245060|NCT03058419|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102245061|NCT03058419|Antidepressive Agents|antidepressive agents|mesh-ancestor
102245062|NCT03058419|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102245063|NCT03058419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102245064|NCT03058419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102245065|NCT03058419|Dopamine Agents|dopamine agents|mesh-ancestor
102245066|NCT03058419|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102245067|NCT03058419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102245068|NCT03058419|Antitussive Agents|antitussive agents|mesh-ancestor
102245069|NCT03058419|Respiratory System Agents|respiratory system agents|mesh-ancestor
102245070|NCT03058419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102245071|NCT03058419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101953963|NCT03712917|Histamine Agents|histamine agents|mesh-ancestor
102245073|NCT04965051|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102245074|NCT04965051|Insulin Aspart|insulin aspart|mesh-list
102245075|NCT04965051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102245076|NCT04965051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245077|NCT02455271|Eszopiclone|eszopiclone|mesh-list
102245078|NCT02455271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102245079|NCT02455271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102245080|NCT02455271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245081|NCT04964583|Azithromycin|azithromycin|mesh-list
102245082|NCT04964583|Hydroxychloroquine|hydroxychloroquine|mesh-list
102245083|NCT04964583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102245084|NCT04964583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102245085|NCT04964583|Antimalarials|antimalarials|mesh-ancestor
102245086|NCT04964583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102245087|NCT04964583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102245088|NCT04964583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102245089|NCT04964583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245090|NCT04964583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102245091|NCT03251417|Irinotecan|irinotecan|mesh-list
102245092|NCT03251417|Apatinib|apatinib|mesh-list
102245093|NCT03251417|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102245094|NCT03251417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102245095|NCT03251417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102245096|NCT03251417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245097|NCT03251417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102245098|NCT03251417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102245099|NCT04961931|Empagliflozin|empagliflozin|mesh-list
102245100|NCT04961931|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102245101|NCT04961931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245102|NCT04961931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102245103|NCT04961931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245104|NCT02454881|Dexmedetomidine|dexmedetomidine|mesh-list
102245105|NCT02454881|Oxycodone|oxycodone|mesh-list
102245106|NCT02454881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102245107|NCT02454881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102245108|NCT02454881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245109|NCT02454881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102245110|NCT02454881|Analgesics|analgesics|mesh-ancestor
102245111|NCT02454881|Sensory System Agents|sensory system agents|mesh-ancestor
102245112|NCT02454881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102245113|NCT02454881|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102245114|NCT02454881|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102245115|NCT02454881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102245116|NCT02454881|Adrenergic Agents|adrenergic agents|mesh-ancestor
102245117|NCT02454881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102245118|NCT02454881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245119|NCT02454881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102245120|NCT02454881|Narcotics|narcotics|mesh-ancestor
102245121|NCT03058341|Propofol|propofol|mesh-list
102245122|NCT03058341|Sevoflurane|sevoflurane|mesh-list
102245123|NCT03058341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102245124|NCT03058341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102245125|NCT03058341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245126|NCT03058341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102245127|NCT03058341|Anesthetics, General|anesthetics, general|mesh-ancestor
102245128|NCT03058341|Anesthetics|anesthetics|mesh-ancestor
102245129|NCT03058341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102245130|NCT03058341|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102245131|NCT04951791|SMOFlipid|smoflipid|mesh-list
102245132|NCT04951791|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102245133|NCT04951791|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102245134|NCT04951791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102245135|NCT04951713|Clarithromycin|clarithromycin|mesh-list
102245136|NCT04951713|Rifampin|rifampin|mesh-list
102245137|NCT04951713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102245138|NCT04951713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102245139|NCT04951713|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102245140|NCT04951713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102245141|NCT04951713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245142|NCT04951713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102245143|NCT04951713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102245144|NCT04951713|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102245145|NCT04951713|Antitubercular Agents|antitubercular agents|mesh-ancestor
102245146|NCT04951713|Leprostatic Agents|leprostatic agents|mesh-ancestor
102245147|NCT04951713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101712762|NCT00688636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102245148|NCT04951713|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102245149|NCT04951713|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102245150|NCT04951713|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102245151|NCT04951713|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102245152|NCT04951713|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102245153|NCT04951713|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102245154|NCT04944069|Bevacizumab|bevacizumab|mesh-list
102245155|NCT04944069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102245156|NCT04944069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102245157|NCT04944069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102245158|NCT04944069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102245159|NCT04944069|Growth Substances|growth substances|mesh-ancestor
102245160|NCT04944069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245161|NCT04944069|Growth Inhibitors|growth inhibitors|mesh-ancestor
102245162|NCT04951167|Norepinephrine|norepinephrine|mesh-list
102245163|NCT04951167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102245164|NCT04951167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102245165|NCT04951167|Adrenergic Agents|adrenergic agents|mesh-ancestor
102245166|NCT04951167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102245167|NCT04951167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245168|NCT04951167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245169|NCT04951167|Sympathomimetics|sympathomimetics|mesh-ancestor
102245170|NCT04951167|Autonomic Agents|autonomic agents|mesh-ancestor
102245171|NCT04951167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102245172|NCT04951167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102245173|NCT04950933|Riluzole|riluzole|mesh-list
102245174|NCT04950933|Anticonvulsants|anticonvulsants|mesh-ancestor
102245175|NCT04950933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102245176|NCT04950933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102245177|NCT04950933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102245178|NCT04950933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245179|NCT04950933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245180|NCT04950933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102245181|NCT04950933|Protective Agents|protective agents|mesh-ancestor
102245182|NCT04961307|Trastuzumab|trastuzumab|mesh-list
102245183|NCT04961307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102245184|NCT04961307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102245185|NCT03058263|Neostigmine|neostigmine|mesh-list
102245186|NCT03058263|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102245187|NCT03058263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102245188|NCT03058263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245189|NCT03058263|Cholinergic Agents|cholinergic agents|mesh-ancestor
102245190|NCT03058263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102245191|NCT03058263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245192|NCT03058263|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102245193|NCT03058263|Autonomic Agents|autonomic agents|mesh-ancestor
102245194|NCT03058263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102245195|NCT04415853|Irinotecan|irinotecan|mesh-list
102245196|NCT04415853|Tegafur|tegafur|mesh-list
102245197|NCT04415853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102245198|NCT04415853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102245199|NCT04415853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102245200|NCT04415853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245201|NCT04415853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102245202|NCT04415853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102245203|NCT04415853|Antimetabolites|antimetabolites|mesh-ancestor
102245204|NCT04415151|Tofacitinib|tofacitinib|mesh-list
102245205|NCT04415151|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102245206|NCT04415151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102245207|NCT04415151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102245208|NCT04415151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245209|NCT03059277|Aflibercept|aflibercept|mesh-list
102245210|NCT03059277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101586900|NCT01135992|Insulin|insulin|mesh-list
102613147|NCT05673785|Immunoconjugates|immunoconjugates|mesh-ancestor
102245211|NCT03059277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102245212|NCT03059277|Growth Substances|growth substances|mesh-ancestor
102245213|NCT03059277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245214|NCT03059277|Growth Inhibitors|growth inhibitors|mesh-ancestor
102245215|NCT03059277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102245217|NCT00700817|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102245218|NCT00700817|Liraglutide|liraglutide|mesh-list
102245219|NCT00700817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101954114|NCT03785067|Amlodipine|amlodipine|mesh-list
102245220|NCT00700817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245222|NCT00700817|Hormones|hormones|mesh-ancestor
102245223|NCT00700817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102245224|NCT00700817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102245225|NCT00700817|Protease Inhibitors|protease inhibitors|mesh-ancestor
102245226|NCT00700817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102245227|NCT00700817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245228|NCT04960293|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
102245229|NCT04960293|Hemostatics|hemostatics|mesh-ancestor
102245230|NCT04960293|Coagulants|coagulants|mesh-ancestor
102245231|NCT04941417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102245232|NCT04941417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245233|NCT04941417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102245234|NCT04941417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102245235|NCT04948125|Apatinib|apatinib|mesh-list
102245236|NCT04948125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102245237|NCT04948125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102245238|NCT04948125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102245239|NCT04948125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245240|NCT02455115|Chromium|chromium|mesh-list
102245241|NCT02455115|Norepinephrine|norepinephrine|mesh-list
102245242|NCT02455115|Edetic Acid|edetic acid|mesh-list
102245243|NCT02455115|Pentetic Acid|pentetic acid|mesh-list
102245244|NCT02455115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102245245|NCT02455115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102245246|NCT02455115|Adrenergic Agents|adrenergic agents|mesh-ancestor
102245247|NCT02455115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102245248|NCT02455115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245249|NCT02455115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245250|NCT02455115|Sympathomimetics|sympathomimetics|mesh-ancestor
102245251|NCT02455115|Autonomic Agents|autonomic agents|mesh-ancestor
102245252|NCT02455115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102245253|NCT02455115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102245254|NCT02455115|Trace Elements|trace elements|mesh-ancestor
102245255|NCT02455115|Micronutrients|micronutrients|mesh-ancestor
102245256|NCT02455115|Anticoagulants|anticoagulants|mesh-ancestor
102245257|NCT02455115|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102245258|NCT02455115|Chelating Agents|chelating agents|mesh-ancestor
102245259|NCT02455115|Sequestering Agents|sequestering agents|mesh-ancestor
102245260|NCT02455115|Antidotes|antidotes|mesh-ancestor
102245261|NCT02455115|Protective Agents|protective agents|mesh-ancestor
102245262|NCT02455115|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102245263|NCT03094247|Amoxicillin|amoxicillin|mesh-list
102245264|NCT03094247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102245265|NCT03094247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102245266|NCT04947423|Scopolamine|scopolamine|mesh-list
102245267|NCT04947423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102245268|NCT04947423|Antiemetics|antiemetics|mesh-ancestor
102245269|NCT04947423|Autonomic Agents|autonomic agents|mesh-ancestor
102245270|NCT04947423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102245271|NCT04947423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245272|NCT04947423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102245273|NCT04947423|Mydriatics|mydriatics|mesh-ancestor
102245274|NCT04947423|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102245275|NCT04947423|Cholinergic Agents|cholinergic agents|mesh-ancestor
102245276|NCT04947423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102245277|NCT04947423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245278|NCT04947423|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102245279|NCT03250481|Oxycodone|oxycodone|mesh-list
102245280|NCT03250481|Propofol|propofol|mesh-list
102245281|NCT03250481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101712785|NCT02685449|Insulin|insulin|mesh-list
102245282|NCT03250481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102245283|NCT03250481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245284|NCT03250481|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102245285|NCT03250481|Anesthetics, General|anesthetics, general|mesh-ancestor
102245286|NCT03250481|Anesthetics|anesthetics|mesh-ancestor
101586987|NCT00632554|Hormones|hormones|mesh-ancestor
102245287|NCT03250481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102245288|NCT03250481|Narcotics|narcotics|mesh-ancestor
102245289|NCT03250481|Analgesics|analgesics|mesh-ancestor
102245290|NCT03250481|Sensory System Agents|sensory system agents|mesh-ancestor
102245291|NCT03250481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101954185|NCT04662567|Analgesics|analgesics|mesh-ancestor
102245292|NCT04947267|Epinephrine|epinephrine|mesh-list
102245293|NCT04947267|Mepivacaine|mepivacaine|mesh-list
102245294|NCT04947267|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102245295|NCT04947267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102245296|NCT04947267|Adrenergic Agents|adrenergic agents|mesh-ancestor
102245297|NCT04947267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102245298|NCT04947267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245299|NCT04947267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245300|NCT04947267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102245301|NCT04947267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102245302|NCT04947267|Autonomic Agents|autonomic agents|mesh-ancestor
102245303|NCT04947267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102245304|NCT04947267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102245305|NCT04947267|Respiratory System Agents|respiratory system agents|mesh-ancestor
102245306|NCT04947267|Mydriatics|mydriatics|mesh-ancestor
102245307|NCT04947267|Sympathomimetics|sympathomimetics|mesh-ancestor
102245308|NCT04947267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102245309|NCT04947267|Anesthetics, Local|anesthetics, local|mesh-ancestor
102245310|NCT04947267|Anesthetics|anesthetics|mesh-ancestor
102245311|NCT04947267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102245312|NCT04947267|Sensory System Agents|sensory system agents|mesh-ancestor
102245313|NCT04941885|Cyclophosphamide|cyclophosphamide|mesh-list
102245314|NCT04941885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102245315|NCT04941885|Immunologic Factors|immunologic factors|mesh-ancestor
102245316|NCT04941885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245317|NCT04941885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102245318|NCT04941885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102245319|NCT04941885|Alkylating Agents|alkylating agents|mesh-ancestor
102245320|NCT04941885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245321|NCT04941885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102245322|NCT04941885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102245324|NCT04423731|Paclitaxel|paclitaxel|mesh-list
102245325|NCT04423731|Gemcitabine|gemcitabine|mesh-list
102245326|NCT04423731|Fluorouracil|fluorouracil|mesh-list
102245327|NCT04423731|Folfirinox|folfirinox|mesh-list
102245328|NCT04423731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102245329|NCT04423731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102245330|NCT04423731|Tubulin Modulators|tubulin modulators|mesh-ancestor
102245331|NCT04423731|Antimitotic Agents|antimitotic agents|mesh-ancestor
102245332|NCT04423731|Mitosis Modulators|mitosis modulators|mesh-ancestor
102245333|NCT04423731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245334|NCT04423731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102245335|NCT04423731|Antimetabolites|antimetabolites|mesh-ancestor
102245336|NCT04423731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102245337|NCT04423731|Immunologic Factors|immunologic factors|mesh-ancestor
102245338|NCT04423731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245339|NCT04423731|Antidotes|antidotes|mesh-ancestor
102245340|NCT04423731|Protective Agents|protective agents|mesh-ancestor
102245341|NCT04423731|Vitamin B Complex|vitamin b complex|mesh-ancestor
102245342|NCT04423731|Vitamins|vitamins|mesh-ancestor
102245343|NCT04423731|Micronutrients|micronutrients|mesh-ancestor
102245344|NCT04947111|Antibodies|antibodies|mesh-list
102245345|NCT04947111|Immunoglobulins|immunoglobulins|mesh-list
102245346|NCT04947111|Antibodies, Blocking|antibodies, blocking|mesh-list
102245347|NCT04947111|Immunologic Factors|immunologic factors|mesh-ancestor
102245348|NCT04947111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245349|NCT04947345|Propofol|propofol|mesh-list
102245350|NCT04947345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102245351|NCT04947345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102245352|NCT04947345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245353|NCT04947345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102245354|NCT04947345|Anesthetics, General|anesthetics, general|mesh-ancestor
102245355|NCT04947345|Anesthetics|anesthetics|mesh-ancestor
102245356|NCT04947189|Dexamethasone|dexamethasone|mesh-list
102613148|NCT00381875|Sargramostim|sargramostim|mesh-list
102613149|NCT00381875|Freund's Adjuvant|freund's adjuvant|mesh-list
102245357|NCT04947189|Docetaxel|docetaxel|mesh-list
102245358|NCT04947189|Seviteronel|seviteronel|mesh-list
102245359|NCT04947189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102245360|NCT04947189|Antiemetics|antiemetics|mesh-ancestor
102245361|NCT04947189|Autonomic Agents|autonomic agents|mesh-ancestor
102245362|NCT04947189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102613150|NCT00381875|Immunologic Factors|immunologic factors|mesh-ancestor
102613151|NCT00381875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245363|NCT04947189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245364|NCT04947189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102245366|NCT04947189|Hormones|hormones|mesh-ancestor
102245367|NCT04947189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102245368|NCT04947189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102245369|NCT04947189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102245370|NCT04947189|Tubulin Modulators|tubulin modulators|mesh-ancestor
101954262|NCT01560663|Carboplatin|carboplatin|mesh-list
102245371|NCT04947189|Antimitotic Agents|antimitotic agents|mesh-ancestor
102245372|NCT04947189|Mitosis Modulators|mitosis modulators|mesh-ancestor
102245373|NCT04947189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245374|NCT04947189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102245375|NCT04947189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102245376|NCT03249311|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102245377|NCT03249311|Milnacipran|milnacipran|mesh-list
102245378|NCT03249311|Levomilnacipran|levomilnacipran|mesh-list
102245379|NCT03249311|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102245380|NCT03249311|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102245381|NCT03249311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102245382|NCT03249311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245383|NCT03249311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102245384|NCT03249311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245385|NCT03249311|Analgesics|analgesics|mesh-ancestor
102245386|NCT03249311|Sensory System Agents|sensory system agents|mesh-ancestor
102245387|NCT03249311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102245388|NCT03249311|Antidepressive Agents|antidepressive agents|mesh-ancestor
102245389|NCT03249311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102245390|NCT03249311|Dopamine Agents|dopamine agents|mesh-ancestor
102245391|NCT03249311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102245392|NCT02454491|Verapamil|verapamil|mesh-list
102245393|NCT02454491|Heparin|heparin|mesh-list
102245394|NCT02454491|Anticoagulants|anticoagulants|mesh-ancestor
102245395|NCT02454491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102245396|NCT02454491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102245397|NCT02454491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245398|NCT02454491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102245399|NCT02454491|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102245400|NCT02454491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102245401|NCT02454491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102245402|NCT02454491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245403|NCT02454491|Vasodilator Agents|vasodilator agents|mesh-ancestor
102245404|NCT03248765|Analgesics, Opioid|analgesics, opioid|mesh-list
102245405|NCT03248765|Narcotics|narcotics|mesh-ancestor
102245406|NCT03248765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102245407|NCT03248765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245408|NCT03248765|Analgesics|analgesics|mesh-ancestor
102245409|NCT03248765|Sensory System Agents|sensory system agents|mesh-ancestor
102245410|NCT03248765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102245411|NCT04939857|Trimetazidine|trimetazidine|mesh-list
102245412|NCT04939857|Vasodilator Agents|vasodilator agents|mesh-ancestor
102245413|NCT04939779|Delpazolid|delpazolid|mesh-list
102245414|NCT04939779|Oxazolidinones|oxazolidinones|mesh-list
102245415|NCT04939779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102245416|NCT04939779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102245417|NCT04939779|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102245418|NCT04939779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102245419|NCT04939779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245420|NCT03247595|Magnesium citrate|magnesium citrate|mesh-list
102245421|NCT03247595|Bisacodyl|bisacodyl|mesh-list
102245422|NCT03247595|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
102245423|NCT03247595|Cathartics|cathartics|mesh-ancestor
102245424|NCT03247595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102245425|NCT03247595|Laxatives|laxatives|mesh-ancestor
102245426|NCT03247283|Linrodostat|linrodostat|mesh-list
102245427|NCT03247283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102245428|NCT03247283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245429|NCT04938297|Rituximab|rituximab|mesh-list
102245430|NCT04938297|Lenalidomide|lenalidomide|mesh-list
102245431|NCT04938297|Zanubrutinib|zanubrutinib|mesh-list
102245432|NCT04938297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102245433|NCT04938297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102245434|NCT04938297|Immunologic Factors|immunologic factors|mesh-ancestor
102613152|NCT00381875|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102245435|NCT04938297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245436|NCT04938297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102245437|NCT04938297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102245438|NCT04938297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102245439|NCT04938297|Growth Substances|growth substances|mesh-ancestor
102245440|NCT04938297|Growth Inhibitors|growth inhibitors|mesh-ancestor
102245441|NCT04938297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102245442|NCT04938297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102245443|NCT04938297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245444|NCT04937907|Hydroxychloroquine|hydroxychloroquine|mesh-list
102245445|NCT04937907|Benazepril|benazepril|mesh-list
102245446|NCT04937907|Antimalarials|antimalarials|mesh-ancestor
102245447|NCT04937907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102245448|NCT04937907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102245449|NCT04937907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102245451|NCT04937907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245452|NCT04937907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102245453|NCT04937907|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102245454|NCT04937907|Protease Inhibitors|protease inhibitors|mesh-ancestor
102245455|NCT04937907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102245456|NCT02625909|Sofosbuvir|sofosbuvir|mesh-list
102245457|NCT02625909|Velpatasvir|velpatasvir|mesh-list
102245458|NCT02625909|Antiviral Agents|antiviral agents|mesh-ancestor
102245459|NCT02625909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102245460|NCT03246659|Polygeline|polygeline|mesh-list
102245461|NCT03246659|Gastrins|gastrins|mesh-list
102245462|NCT03246659|Plasma Substitutes|plasma substitutes|mesh-ancestor
102245463|NCT03246659|Blood Substitutes|blood substitutes|mesh-ancestor
102245464|NCT03246659|Hormones|hormones|mesh-ancestor
102245465|NCT03246659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102245466|NCT03246659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245467|NCT03246581|Tiotropium Bromide|tiotropium bromide|mesh-list
102245468|NCT03246581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102245469|NCT03246581|Autonomic Agents|autonomic agents|mesh-ancestor
102245470|NCT03246581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102245471|NCT03246581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245472|NCT03246581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102245473|NCT03246581|Respiratory System Agents|respiratory system agents|mesh-ancestor
102245474|NCT03246581|Parasympatholytics|parasympatholytics|mesh-ancestor
102245475|NCT03246581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102245476|NCT03246581|Cholinergic Agents|cholinergic agents|mesh-ancestor
102245477|NCT03246581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102245478|NCT03246581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245479|NCT03246113|Temozolomide|temozolomide|mesh-list
102245480|NCT03246113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102245481|NCT03246113|Alkylating Agents|alkylating agents|mesh-ancestor
102245482|NCT03246113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245483|NCT03246113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102245484|NCT04937673|Paclitaxel|paclitaxel|mesh-list
102245485|NCT04937673|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102245486|NCT04937673|Cisplatin|cisplatin|mesh-list
102245487|NCT04937673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102245488|NCT04937673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102245489|NCT04937673|Tubulin Modulators|tubulin modulators|mesh-ancestor
102245490|NCT04937673|Antimitotic Agents|antimitotic agents|mesh-ancestor
102245491|NCT04937673|Mitosis Modulators|mitosis modulators|mesh-ancestor
102245492|NCT04937673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245493|NCT04944381|Vaccines|vaccines|mesh-list
102245494|NCT04944381|Immunologic Factors|immunologic factors|mesh-ancestor
102245495|NCT04944381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245496|NCT03245177|Pembrolizumab|pembrolizumab|mesh-list
102245497|NCT03245177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102245498|NCT03245177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102245499|NCT03245177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102245500|NCT03245177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245501|NCT03245333|Hormones|hormones|mesh-list
102245502|NCT03245333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102245503|NCT03245333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245504|NCT04958187|Mitogens|mitogens|mesh-list
102245505|NCT04958187|Mitosis Modulators|mitosis modulators|mesh-ancestor
102245506|NCT04958187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245507|NCT03244319|Warfarin|warfarin|mesh-list
102245508|NCT03244319|Edoxaban|edoxaban|mesh-list
102613153|NCT00002669|Interferons|interferons|mesh-list
102613154|NCT00002669|Interferon-alpha|interferon-alpha|mesh-list
102245509|NCT03244319|Anticoagulants|anticoagulants|mesh-list
102245510|NCT03244319|Coagulants|coagulants|mesh-list
102245511|NCT03244319|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102245512|NCT03244319|Antithrombins|antithrombins|mesh-ancestor
102245513|NCT03244319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102245514|NCT03244319|Protease Inhibitors|protease inhibitors|mesh-ancestor
102245515|NCT03244319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102245516|NCT03244319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245517|NCT03244553|Prucalopride|prucalopride|mesh-list
102245518|NCT03244553|Laxatives|laxatives|mesh-ancestor
102245519|NCT03244553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102245520|NCT03244553|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
102245521|NCT03244553|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102245522|NCT03244553|Serotonin Agents|serotonin agents|mesh-ancestor
102245523|NCT03244553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102245524|NCT03244553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245525|NCT03244553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245526|NCT03244241|Insulin|insulin|mesh-list
102245527|NCT03244241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102245528|NCT03244241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245529|NCT03243851|Metformin|metformin|mesh-list
102245530|NCT03243851|Temozolomide|temozolomide|mesh-list
102245531|NCT03243851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102245532|NCT03243851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245533|NCT03243851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102245534|NCT03243851|Alkylating Agents|alkylating agents|mesh-ancestor
102245535|NCT03243851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245536|NCT03243851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102245537|NCT02623959|Doxycycline|doxycycline|mesh-list
102245538|NCT02623959|Fentanyl|fentanyl|mesh-list
102245539|NCT02623959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102245540|NCT02623959|Narcotics|narcotics|mesh-ancestor
102245541|NCT02623959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102245542|NCT02623959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245543|NCT02623959|Analgesics|analgesics|mesh-ancestor
102245544|NCT02623959|Sensory System Agents|sensory system agents|mesh-ancestor
102245545|NCT02623959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102245546|NCT02623959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102245547|NCT02623959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102245548|NCT02623959|Anesthetics, General|anesthetics, general|mesh-ancestor
102245549|NCT02623959|Anesthetics|anesthetics|mesh-ancestor
102245550|NCT02623959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102245551|NCT02623959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102245552|NCT02623959|Antimalarials|antimalarials|mesh-ancestor
102245553|NCT02623959|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102245554|NCT02623959|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102245555|NCT03242993|Folic Acid|folic acid|mesh-list
102245556|NCT03242993|Hematinics|hematinics|mesh-ancestor
102245557|NCT03242993|Vitamin B Complex|vitamin b complex|mesh-ancestor
102245558|NCT03242993|Vitamins|vitamins|mesh-ancestor
102245559|NCT03242993|Micronutrients|micronutrients|mesh-ancestor
102245560|NCT03242993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245561|NCT04487093|Vaccines|vaccines|mesh-list
102245562|NCT04487093|Immunologic Factors|immunologic factors|mesh-ancestor
102245563|NCT04487093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245564|NCT04936971|Mycophenolic Acid|mycophenolic acid|mesh-list
102245565|NCT04936971|Everolimus|everolimus|mesh-list
102245566|NCT04936971|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102245567|NCT04936971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102245568|NCT04936971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102245569|NCT04936971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245570|NCT04936971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102245571|NCT04936971|Immunologic Factors|immunologic factors|mesh-ancestor
102245572|NCT04936971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245573|NCT04936971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102245574|NCT04936971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102245575|NCT04936971|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102245576|NCT04936971|Antitubercular Agents|antitubercular agents|mesh-ancestor
102245577|NCT04936971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102245578|NCT04936971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102245579|NCT04931433|Lidocaine|lidocaine|mesh-list
102245580|NCT04931433|Anesthetics, Local|anesthetics, local|mesh-ancestor
102245581|NCT04931433|Anesthetics|anesthetics|mesh-ancestor
102245582|NCT04931433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102245583|NCT04931433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245584|NCT04931433|Sensory System Agents|sensory system agents|mesh-ancestor
102245585|NCT04931433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102613155|NCT00002669|Aldesleukin|aldesleukin|mesh-list
102245586|NCT04931433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102245587|NCT04931433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102245588|NCT04931433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102245589|NCT04931433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102245590|NCT04931433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245591|NCT04931121|Viscosupplements|viscosupplements|mesh-list
102245592|NCT04931121|Protective Agents|protective agents|mesh-ancestor
102245593|NCT04931121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245594|NCT03241901|Lumefantrine|lumefantrine|mesh-list
102245595|NCT03241901|Artemether|artemether|mesh-list
102245596|NCT03241901|Primaquine|primaquine|mesh-list
102245597|NCT03241901|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102245598|NCT03241901|Antimalarials|antimalarials|mesh-ancestor
102245599|NCT03241901|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101954484|NCT02059876|Paclitaxel|paclitaxel|mesh-list
102245600|NCT03241901|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102245601|NCT03241901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102245603|NCT03241199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102245604|NCT03241199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102245605|NCT03241199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102245606|NCT03241199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245607|NCT03241043|Tacrolimus|tacrolimus|mesh-list
102245608|NCT03241043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102245609|NCT03241043|Immunologic Factors|immunologic factors|mesh-ancestor
102245610|NCT03241043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245611|NCT03241043|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102245612|NCT03241043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102245613|NCT03241043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245614|NCT02453867|Tacrolimus|tacrolimus|mesh-list
102245615|NCT02453867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102245616|NCT02453867|Immunologic Factors|immunologic factors|mesh-ancestor
102245617|NCT02453867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245618|NCT02453867|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102245619|NCT02453867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102245620|NCT02453867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245621|NCT03057561|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
102245622|NCT03057561|Chelating Agents|chelating agents|mesh-ancestor
102245623|NCT03057561|Sequestering Agents|sequestering agents|mesh-ancestor
102245624|NCT03057561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245625|NCT03239327|Alprostadil|alprostadil|mesh-list
102245626|NCT03239327|Misoprostol|misoprostol|mesh-list
102245627|NCT03239327|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102245628|NCT03239327|Abortifacient Agents|abortifacient agents|mesh-ancestor
102245629|NCT03239327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102245630|NCT03239327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245631|NCT03239327|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102245632|NCT03239327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102245633|NCT03239327|Oxytocics|oxytocics|mesh-ancestor
102245634|NCT03239327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102245635|NCT03239327|Vasodilator Agents|vasodilator agents|mesh-ancestor
102245636|NCT03239327|Urological Agents|urological agents|mesh-ancestor
102245637|NCT04930185|Vaccines|vaccines|mesh-list
102245638|NCT04930185|Immunologic Factors|immunologic factors|mesh-ancestor
102245639|NCT04930185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245640|NCT02314559|Propofol|propofol|mesh-list
102245641|NCT02314559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102245642|NCT02314559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102245643|NCT02314559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245644|NCT02314559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102245645|NCT02314559|Anesthetics, General|anesthetics, general|mesh-ancestor
102245646|NCT02314559|Anesthetics|anesthetics|mesh-ancestor
102245647|NCT03238703|Tamoxifen|tamoxifen|mesh-list
102245648|NCT03238703|Toremifene|toremifene|mesh-list
102245649|NCT03238703|Letrozole|letrozole|mesh-list
102245650|NCT03238703|Anastrozole|anastrozole|mesh-list
102245651|NCT03238703|Exemestane|exemestane|mesh-list
102245652|NCT03238703|Citric Acid|citric acid|mesh-list
102245653|NCT03238703|Sodium Citrate|sodium citrate|mesh-list
102245654|NCT03238703|Anticoagulants|anticoagulants|mesh-ancestor
102245655|NCT03238703|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102245656|NCT03238703|Chelating Agents|chelating agents|mesh-ancestor
102245657|NCT03238703|Sequestering Agents|sequestering agents|mesh-ancestor
102613156|NCT00002669|Dacarbazine|dacarbazine|mesh-list
102245658|NCT03238703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245659|NCT03238703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613157|NCT00002669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613158|NCT00002669|Antiviral Agents|antiviral agents|mesh-ancestor
102245660|NCT03238703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102245661|NCT03238703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102245662|NCT03238703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102245663|NCT03238703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102245664|NCT03238703|Hormone Antagonists|hormone antagonists|mesh-ancestor
102245665|NCT03238703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102245666|NCT03238703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245667|NCT03238703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102245668|NCT03238703|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102245669|NCT03238703|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102245670|NCT03238703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102245671|NCT03238625|Lidocaine|lidocaine|mesh-list
102245672|NCT03238625|Anesthetics, Local|anesthetics, local|mesh-ancestor
102245673|NCT03238625|Anesthetics|anesthetics|mesh-ancestor
102245674|NCT03238625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102245675|NCT03238625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245676|NCT03238625|Sensory System Agents|sensory system agents|mesh-ancestor
102245677|NCT03238625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102245678|NCT03238625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102245679|NCT03238625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102245680|NCT03238625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102245681|NCT03238625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102245682|NCT03238625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245683|NCT03238079|Immunoglobulins|immunoglobulins|mesh-list
102245684|NCT03238079|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102245685|NCT03238079|Immunologic Factors|immunologic factors|mesh-ancestor
102245686|NCT03238079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245687|NCT05387681|Endostatins|endostatins|mesh-list
102245688|NCT05387681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102245689|NCT05387681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102245690|NCT05387681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102245691|NCT05387681|Growth Substances|growth substances|mesh-ancestor
102245692|NCT05387681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245693|NCT05387681|Growth Inhibitors|growth inhibitors|mesh-ancestor
102245694|NCT03238157|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
102245695|NCT03238157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102245696|NCT03238157|Glucocorticoids|glucocorticoids|mesh-ancestor
102245697|NCT03238157|Hormones|hormones|mesh-ancestor
102245698|NCT03238157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102245699|NCT03238157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245700|NCT04485845|Metformin|metformin|mesh-list
102245701|NCT04485845|Vildagliptin|vildagliptin|mesh-list
102245702|NCT04485845|Captopril|captopril|mesh-list
102245703|NCT04485845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102245704|NCT04485845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245705|NCT04485845|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102245706|NCT04485845|Protease Inhibitors|protease inhibitors|mesh-ancestor
102245707|NCT04485845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102245708|NCT04485845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245709|NCT04485845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102245710|NCT04485845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102245711|NCT00700427|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102245712|NCT00700427|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102245713|NCT00700427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102245714|NCT00700427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102245715|NCT00700427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245716|NCT00700427|Adrenergic Agents|adrenergic agents|mesh-ancestor
102245717|NCT00700427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102245718|NCT00700427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245719|NCT03237533|Promethazine|promethazine|mesh-list
102245720|NCT03237533|Doxycycline|doxycycline|mesh-list
102245721|NCT03237533|Nystatin|nystatin|mesh-list
102245722|NCT03237533|Dexamethasone|dexamethasone|mesh-list
102245723|NCT03237533|Triamcinolone|triamcinolone|mesh-list
102245724|NCT03237533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102245725|NCT03237533|Antiemetics|antiemetics|mesh-ancestor
102245726|NCT03237533|Autonomic Agents|autonomic agents|mesh-ancestor
102245727|NCT03237533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102245728|NCT03237533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245729|NCT03237533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102245730|NCT03237533|Glucocorticoids|glucocorticoids|mesh-ancestor
102613159|NCT00002669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102613160|NCT00002669|Immunologic Factors|immunologic factors|mesh-ancestor
102245731|NCT03237533|Hormones|hormones|mesh-ancestor
102245732|NCT03237533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102245733|NCT03237533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102245734|NCT03237533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102245735|NCT03237533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245736|NCT03237533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102245737|NCT03237533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102245738|NCT03237533|Antimalarials|antimalarials|mesh-ancestor
102245739|NCT03237533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102245740|NCT03237533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102245741|NCT03237533|Antipruritics|antipruritics|mesh-ancestor
102245742|NCT03237533|Dermatologic Agents|dermatologic agents|mesh-ancestor
102245743|NCT03237533|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102245744|NCT03237533|Histamine Antagonists|histamine antagonists|mesh-ancestor
102245745|NCT03237533|Histamine Agents|histamine agents|mesh-ancestor
102245746|NCT03237533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102245747|NCT03237533|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102245748|NCT03237533|Antifungal Agents|antifungal agents|mesh-ancestor
102245749|NCT03237533|Ionophores|ionophores|mesh-ancestor
102245750|NCT03237533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102245751|NCT03235973|Fludarabine|fludarabine|mesh-list
102245752|NCT03235973|Busulfan|busulfan|mesh-list
102245753|NCT03235973|Cladribine|cladribine|mesh-list
102245754|NCT03235973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102245755|NCT03235973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245756|NCT03235973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102245757|NCT03235973|Immunologic Factors|immunologic factors|mesh-ancestor
102245758|NCT03235973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245759|NCT03235973|Alkylating Agents|alkylating agents|mesh-ancestor
102245760|NCT03235973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102245761|NCT03235973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102245762|NCT02453087|Rituximab|rituximab|mesh-list
102245763|NCT02453087|Obinutuzumab|obinutuzumab|mesh-list
102245764|NCT02453087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102245765|NCT02453087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102245766|NCT02453087|Immunologic Factors|immunologic factors|mesh-ancestor
102245767|NCT02453087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245768|NCT02453087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102245769|NCT02124772|Trametinib|trametinib|mesh-list
102245770|NCT02124772|Dabrafenib|dabrafenib|mesh-list
102245771|NCT02124772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102245772|NCT02124772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102245773|NCT02124772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102245774|NCT02124772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245775|NCT02159482|Interferons|interferons|mesh-list
102245776|NCT02159482|Interferon-alpha|interferon-alpha|mesh-list
102245777|NCT02159482|Interferon alpha-2|interferon alpha-2|mesh-list
102245778|NCT02159482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102245779|NCT02159482|Antiviral Agents|antiviral agents|mesh-ancestor
102245780|NCT02159482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102245781|NCT02159482|Immunologic Factors|immunologic factors|mesh-ancestor
102245782|NCT02159482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245783|NCT05269030|Ivermectin|ivermectin|mesh-list
102245784|NCT05269030|Budesonide|budesonide|mesh-list
102245785|NCT05269030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102245786|NCT05269030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102245787|NCT05269030|Autonomic Agents|autonomic agents|mesh-ancestor
102245788|NCT05269030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102245789|NCT05269030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245790|NCT05269030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102245791|NCT05269030|Respiratory System Agents|respiratory system agents|mesh-ancestor
102245792|NCT05269030|Glucocorticoids|glucocorticoids|mesh-ancestor
102245793|NCT05269030|Hormones|hormones|mesh-ancestor
102245794|NCT05269030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102245795|NCT05269030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102245796|NCT05269030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102245797|NCT02622321|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
102245798|NCT02622321|Coagulants|coagulants|mesh-ancestor
102245799|NCT02187172|Ustekinumab|ustekinumab|mesh-list
102245800|NCT02187172|Dermatologic Agents|dermatologic agents|mesh-ancestor
102245801|NCT03057015|Dexamethasone|dexamethasone|mesh-list
102245802|NCT03057015|Clonidine|clonidine|mesh-list
102245803|NCT03057015|Epinephrine|epinephrine|mesh-list
102245804|NCT03057015|Ropivacaine|ropivacaine|mesh-list
102245805|NCT03057015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102245806|NCT03057015|Antiemetics|antiemetics|mesh-ancestor
102245807|NCT03057015|Autonomic Agents|autonomic agents|mesh-ancestor
102245808|NCT03057015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102245809|NCT03057015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245811|NCT03057015|Glucocorticoids|glucocorticoids|mesh-ancestor
102245812|NCT03057015|Hormones|hormones|mesh-ancestor
102245813|NCT03057015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102245814|NCT03057015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102245815|NCT03057015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102245816|NCT03057015|Anesthetics, Local|anesthetics, local|mesh-ancestor
102245817|NCT03057015|Anesthetics|anesthetics|mesh-ancestor
102245818|NCT03057015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102245819|NCT03057015|Sensory System Agents|sensory system agents|mesh-ancestor
102245820|NCT03057015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102245821|NCT03057015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102245822|NCT03057015|Adrenergic Agents|adrenergic agents|mesh-ancestor
102245823|NCT03057015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102245824|NCT03057015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245825|NCT03057015|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102245826|NCT03057015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102245827|NCT03057015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102245828|NCT03057015|Respiratory System Agents|respiratory system agents|mesh-ancestor
102245829|NCT03057015|Mydriatics|mydriatics|mesh-ancestor
102245830|NCT03057015|Sympathomimetics|sympathomimetics|mesh-ancestor
102245831|NCT03057015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102245832|NCT03057015|Analgesics|analgesics|mesh-ancestor
102245833|NCT03057015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102245834|NCT03057015|Sympatholytics|sympatholytics|mesh-ancestor
102245835|NCT03057015|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102245836|NCT04934475|Lenalidomide|lenalidomide|mesh-list
102245837|NCT04934475|Immunologic Factors|immunologic factors|mesh-ancestor
102245838|NCT04934475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245839|NCT04934475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102245840|NCT04934475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102245841|NCT04934475|Growth Substances|growth substances|mesh-ancestor
102245842|NCT04934475|Growth Inhibitors|growth inhibitors|mesh-ancestor
102245843|NCT04934475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102245844|NCT03057483|Vaccines|vaccines|mesh-list
102245845|NCT03057483|Immunologic Factors|immunologic factors|mesh-ancestor
102245846|NCT03057483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245847|NCT04922151|Ranibizumab|ranibizumab|mesh-list
102245848|NCT04922151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102245849|NCT04922151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102245850|NCT04922151|Growth Substances|growth substances|mesh-ancestor
102245851|NCT04922151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245852|NCT04922151|Growth Inhibitors|growth inhibitors|mesh-ancestor
102245853|NCT04922151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102245854|NCT04928313|Glatiramer Acetate|glatiramer acetate|mesh-list
102245855|NCT04928313|(T,G)-A-L|(t,g)-a-l|mesh-list
102245856|NCT04928313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102245857|NCT04928313|Immunologic Factors|immunologic factors|mesh-ancestor
102245858|NCT04928313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245859|NCT04928313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102245860|NCT04928313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102245861|NCT04928079|Antiparkinson Agents|antiparkinson agents|mesh-list
102245862|NCT04928079|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102245863|NCT04920747|Taxane|taxane|mesh-list
102245864|NCT04920747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102245865|NCT04927299|Losartan|losartan|mesh-list
102245866|NCT04927299|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102245867|NCT04927299|Chlorthalidone|chlorthalidone|mesh-list
102245868|NCT04927299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102245869|NCT04927299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102245870|NCT04927299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102245871|NCT04927299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102245872|NCT04927299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245873|NCT04927299|Diuretics|diuretics|mesh-ancestor
102245874|NCT04927299|Natriuretic Agents|natriuretic agents|mesh-ancestor
102245875|NCT04927299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245876|NCT04927299|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102245877|NCT04927299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102245878|NCT03056625|Vitamin A|vitamin a|mesh-list
102245879|NCT03056625|Vitamins|vitamins|mesh-ancestor
102245880|NCT03056625|Micronutrients|micronutrients|mesh-ancestor
102245881|NCT03056625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245882|NCT04913103|Rituximab|rituximab|mesh-list
102245883|NCT04913103|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102245884|NCT04913103|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
102245885|NCT04913103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102613161|NCT00002669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613162|NCT00002669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102613163|NCT00002669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102613164|NCT00002669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102245886|NCT04913103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102245887|NCT04913103|Immunologic Factors|immunologic factors|mesh-ancestor
102245888|NCT04913103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245889|NCT04913103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102245890|NCT04913103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102245891|NCT04913103|Alkylating Agents|alkylating agents|mesh-ancestor
102245892|NCT04913103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245893|NCT04913103|Immunoconjugates|immunoconjugates|mesh-ancestor
102245894|NCT04920669|Dexmedetomidine|dexmedetomidine|mesh-list
102245895|NCT04920669|Bupivacaine|bupivacaine|mesh-list
102245896|NCT04920669|Anesthetics, Local|anesthetics, local|mesh-ancestor
102245897|NCT04920669|Anesthetics|anesthetics|mesh-ancestor
102245898|NCT04920669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102245899|NCT04920669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245900|NCT04920669|Sensory System Agents|sensory system agents|mesh-ancestor
102245901|NCT04920669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102245902|NCT04920669|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101954791|NCT01321047|Anesthetics|anesthetics|mesh-ancestor
102245903|NCT04920669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102245904|NCT04920669|Analgesics|analgesics|mesh-ancestor
102245905|NCT04920669|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102245906|NCT04920669|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102245907|NCT04920669|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102245908|NCT04920669|Adrenergic Agents|adrenergic agents|mesh-ancestor
102245909|NCT04920669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102245910|NCT04920669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245911|NCT04926753|Fluorouracil|fluorouracil|mesh-list
102245912|NCT04926753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102245913|NCT04926753|Antimetabolites|antimetabolites|mesh-ancestor
102245914|NCT04926753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245915|NCT04926753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102245916|NCT04926753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102245917|NCT04926753|Immunologic Factors|immunologic factors|mesh-ancestor
102245918|NCT04926753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245919|NCT02621931|Calcitonin|calcitonin|mesh-list
102245920|NCT02621931|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
102245921|NCT02621931|Katacalcin|katacalcin|mesh-list
102245922|NCT02621931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102245923|NCT02621931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245924|NCT02621931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102245925|NCT02621931|Vasodilator Agents|vasodilator agents|mesh-ancestor
102245926|NCT04925973|Tofacitinib|tofacitinib|mesh-list
102245927|NCT04925973|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102245928|NCT04925973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102245929|NCT04925973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102245930|NCT04925973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245931|NCT04912167|Valsartan|valsartan|mesh-list
102245932|NCT04912167|Enalapril|enalapril|mesh-list
102245933|NCT04912167|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102245934|NCT04912167|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102245935|NCT04912167|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102245936|NCT04912167|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102245937|NCT04912167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245938|NCT04912167|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102245939|NCT04912167|Protease Inhibitors|protease inhibitors|mesh-ancestor
102245940|NCT04912167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102245941|NCT03056703|Aspirin|aspirin|mesh-list
102245942|NCT03056703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102245943|NCT03056703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102245944|NCT03056703|Analgesics|analgesics|mesh-ancestor
102245945|NCT03056703|Sensory System Agents|sensory system agents|mesh-ancestor
102245946|NCT03056703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102245947|NCT03056703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245948|NCT03056703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102245949|NCT03056703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102245950|NCT03056703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102245951|NCT03056703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102613165|NCT00002669|Alkylating Agents|alkylating agents|mesh-ancestor
102613166|NCT00002669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245952|NCT03056703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245953|NCT03056703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102245954|NCT03056703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102245955|NCT03056703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102245956|NCT03056703|Antipyretics|antipyretics|mesh-ancestor
102245957|NCT02158936|Azacitidine|azacitidine|mesh-list
102245958|NCT02158936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102245959|NCT02158936|Antimetabolites|antimetabolites|mesh-ancestor
102245960|NCT02158936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245961|NCT02158936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102245962|NCT02158936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102245963|NCT04924647|Dexamethasone|dexamethasone|mesh-list
102245964|NCT04924647|Lenalidomide|lenalidomide|mesh-list
102245965|NCT04924647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102245966|NCT04924647|Antiemetics|antiemetics|mesh-ancestor
102245967|NCT04924647|Autonomic Agents|autonomic agents|mesh-ancestor
102245968|NCT04924647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102245969|NCT04924647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245970|NCT04924647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102245971|NCT04924647|Glucocorticoids|glucocorticoids|mesh-ancestor
102245972|NCT04924647|Hormones|hormones|mesh-ancestor
102245973|NCT04924647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102245974|NCT04924647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102245975|NCT04924647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102245976|NCT04924647|Immunologic Factors|immunologic factors|mesh-ancestor
102245977|NCT04924647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102245978|NCT04924647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102245979|NCT04924647|Growth Substances|growth substances|mesh-ancestor
102245980|NCT04924647|Growth Inhibitors|growth inhibitors|mesh-ancestor
102245981|NCT04912011|Canrenoic Acid|canrenoic acid|mesh-list
102245982|NCT04912011|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102245983|NCT04912011|Hormone Antagonists|hormone antagonists|mesh-ancestor
102245984|NCT04912011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102245985|NCT04912011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102245986|NCT04912011|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102245987|NCT04912011|Diuretics|diuretics|mesh-ancestor
102245988|NCT04912011|Natriuretic Agents|natriuretic agents|mesh-ancestor
102245989|NCT04918719|Acetylcysteine|acetylcysteine|mesh-list
102245990|NCT04918719|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102245991|NCT04918719|Antiviral Agents|antiviral agents|mesh-ancestor
102245992|NCT04918719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102245993|NCT04918719|Expectorants|expectorants|mesh-ancestor
102245994|NCT04918719|Respiratory System Agents|respiratory system agents|mesh-ancestor
102245995|NCT04918719|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102245996|NCT04918719|Antioxidants|antioxidants|mesh-ancestor
102245997|NCT04918719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102245998|NCT04918719|Protective Agents|protective agents|mesh-ancestor
102245999|NCT04918719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246000|NCT04918719|Antidotes|antidotes|mesh-ancestor
102246001|NCT03056391|Acetaminophen|acetaminophen|mesh-list
102246002|NCT03056391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102246003|NCT03056391|Analgesics|analgesics|mesh-ancestor
102246004|NCT03056391|Sensory System Agents|sensory system agents|mesh-ancestor
102246005|NCT03056391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102246006|NCT03056391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246007|NCT03056391|Antipyretics|antipyretics|mesh-ancestor
102246008|NCT04924413|Tislelizumab|tislelizumab|mesh-list
102246009|NCT04924413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102246010|NCT04924413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102246011|NCT04747054|Pembrolizumab|pembrolizumab|mesh-list
102246012|NCT04747054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102246013|NCT04747054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102246014|NCT04747054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102246015|NCT04747054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246016|NCT04918563|Nitroglycerin|nitroglycerin|mesh-list
102246017|NCT04918563|Acetylcholine|acetylcholine|mesh-list
102246018|NCT04918563|Vasodilator Agents|vasodilator agents|mesh-ancestor
102246019|NCT04918563|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102246020|NCT04918563|Cholinergic Agents|cholinergic agents|mesh-ancestor
102246021|NCT04918563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102246022|NCT04918563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246023|NCT04918563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246024|NCT02123446|Cephalexin|cephalexin|mesh-list
102613167|NCT00002675|Cyclophosphamide|cyclophosphamide|mesh-list
102613168|NCT00002675|Carboplatin|carboplatin|mesh-list
102246025|NCT02123446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102246026|NCT02123446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102246027|NCT04918953|Methylprednisolone|methylprednisolone|mesh-list
102246028|NCT04918953|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102246029|NCT04918953|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102246030|NCT04918953|Prednisolone|prednisolone|mesh-list
102246031|NCT04918953|Prednisolone acetate|prednisolone acetate|mesh-list
102246032|NCT04918953|Budesonide|budesonide|mesh-list
102246033|NCT04918953|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102246034|NCT04918953|Prednisolone phosphate|prednisolone phosphate|mesh-list
102246035|NCT04918953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102246036|NCT04918953|Antiemetics|antiemetics|mesh-ancestor
102246037|NCT04918953|Autonomic Agents|autonomic agents|mesh-ancestor
102246038|NCT04918953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102246039|NCT04918953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246040|NCT04918953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102246041|NCT04918953|Glucocorticoids|glucocorticoids|mesh-ancestor
102246042|NCT04918953|Hormones|hormones|mesh-ancestor
102246043|NCT04918953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102246044|NCT04918953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102246045|NCT04918953|Protective Agents|protective agents|mesh-ancestor
102246046|NCT04918953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102246047|NCT04918953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102246048|NCT04918953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102246049|NCT04918953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102246050|NCT04918953|Respiratory System Agents|respiratory system agents|mesh-ancestor
102246051|NCT02123134|Deoxycholic Acid|deoxycholic acid|mesh-list
102246052|NCT02123134|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102246053|NCT02123134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102246055|NCT03054207|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102246056|NCT03054207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102246057|NCT03054207|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102246058|NCT03054207|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102246059|NCT03054207|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102246060|NCT03054207|Purinergic Agents|purinergic agents|mesh-ancestor
102246061|NCT03054207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102246062|NCT03054207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246063|NCT03054207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246064|NCT02185534|Clopidogrel|clopidogrel|mesh-list
102246065|NCT02185534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102246066|NCT02185534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102246067|NCT02185534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102246068|NCT02185534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102246069|NCT02185534|Purinergic Agents|purinergic agents|mesh-ancestor
102246070|NCT02185534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102246071|NCT02185534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246072|NCT02185534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246073|NCT03056079|Aflibercept|aflibercept|mesh-list
102246074|NCT03056079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102246075|NCT03056079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102246076|NCT03056079|Growth Substances|growth substances|mesh-ancestor
102246077|NCT03056079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246078|NCT03056079|Growth Inhibitors|growth inhibitors|mesh-ancestor
102246079|NCT03056079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102246080|NCT03055767|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102246081|NCT03055767|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102246082|NCT03055767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102246083|NCT03055767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102246084|NCT03055767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246085|NCT03055767|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102246086|NCT03055767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102246087|NCT03055767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246088|NCT03055767|Cholinergic Agents|cholinergic agents|mesh-ancestor
102246089|NCT03055767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102246090|NCT02157376|Esomeprazole|esomeprazole|mesh-list
102246091|NCT02157376|Cimetidine|cimetidine|mesh-list
102246092|NCT02157376|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102246093|NCT02157376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102246094|NCT02157376|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102246095|NCT02157376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102246096|NCT02157376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613169|NCT00002675|Etoposide|etoposide|mesh-list
102613170|NCT00002675|Vincristine|vincristine|mesh-list
102613171|NCT00002675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102613172|NCT00002675|Immunologic Factors|immunologic factors|mesh-ancestor
102246097|NCT02157376|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102246098|NCT02157376|Histamine Antagonists|histamine antagonists|mesh-ancestor
102246099|NCT02157376|Histamine Agents|histamine agents|mesh-ancestor
102246100|NCT02157376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102246101|NCT02157376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246102|NCT02157376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102246103|NCT02157376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102246104|NCT04922541|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102246105|NCT04922541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246106|NCT04922541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102246107|NCT04922541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102246108|NCT02157298|Dapagliflozin|dapagliflozin|mesh-list
102246109|NCT02157298|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102246110|NCT02157298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246111|NCT02157298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102246112|NCT02157298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246113|NCT03054285|Levetiracetam|levetiracetam|mesh-list
102246114|NCT03054285|Anticonvulsants|anticonvulsants|mesh-ancestor
102246115|NCT03054285|Nootropic Agents|nootropic agents|mesh-ancestor
102246116|NCT04917627|Vancomycin|vancomycin|mesh-list
102246117|NCT04917627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102246118|NCT04917627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102246119|NCT04903743|Magnesium Sulfate|magnesium sulfate|mesh-list
101712907|NCT02685137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101712908|NCT02685137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712909|NCT01012063|Epoetin Alfa|epoetin alfa|mesh-list
101712910|NCT01012063|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101712911|NCT01012063|Hematinics|hematinics|mesh-ancestor
102246120|NCT04903743|Bupivacaine|bupivacaine|mesh-list
102246121|NCT04903743|Anesthetics, Local|anesthetics, local|mesh-ancestor
102246122|NCT04903743|Anesthetics|anesthetics|mesh-ancestor
102246123|NCT04903743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102246124|NCT04903743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246125|NCT04903743|Sensory System Agents|sensory system agents|mesh-ancestor
102246126|NCT04903743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102246127|NCT04903743|Analgesics|analgesics|mesh-ancestor
102246128|NCT04903743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102246129|NCT04903743|Anticonvulsants|anticonvulsants|mesh-ancestor
102246130|NCT04903743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102246131|NCT04903743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102246132|NCT04903743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246133|NCT04903743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102246134|NCT04903743|Tocolytic Agents|tocolytic agents|mesh-ancestor
102246135|NCT04903743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102246136|NCT04753840|Antihypertensive Agents|antihypertensive agents|mesh-list
102246137|NCT04903275|Fluorides|fluorides|mesh-list
102246138|NCT04903275|Fluorides, Topical|fluorides, topical|mesh-list
102246139|NCT04903275|Cariostatic Agents|cariostatic agents|mesh-ancestor
102246140|NCT04903275|Protective Agents|protective agents|mesh-ancestor
102246141|NCT04903275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246142|NCT02121262|Dexamethasone|dexamethasone|mesh-list
102246143|NCT02121262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102246144|NCT02121262|Antiemetics|antiemetics|mesh-ancestor
102246145|NCT02121262|Autonomic Agents|autonomic agents|mesh-ancestor
102246146|NCT02121262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102246147|NCT02121262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246148|NCT02121262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102246149|NCT02121262|Glucocorticoids|glucocorticoids|mesh-ancestor
102246150|NCT02121262|Hormones|hormones|mesh-ancestor
102246151|NCT02121262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102246152|NCT02121262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102246153|NCT02121262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102246154|NCT03053739|Bosentan|bosentan|mesh-list
102246155|NCT03053739|Sildenafil Citrate|sildenafil citrate|mesh-list
102246156|NCT03053739|Vasodilator Agents|vasodilator agents|mesh-ancestor
102246157|NCT03053739|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102246158|NCT03053739|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102246159|NCT03053739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102246160|NCT03053739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246161|NCT03053739|Urological Agents|urological agents|mesh-ancestor
102246162|NCT03053739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102246163|NCT03053739|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102246164|NCT04916925|Vitamin D|vitamin d|mesh-list
102246165|NCT04916925|Vitamins|vitamins|mesh-ancestor
102246166|NCT04916925|Micronutrients|micronutrients|mesh-ancestor
102246167|NCT04916925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246168|NCT04916925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102246169|NCT04902261|Paclitaxel|paclitaxel|mesh-list
102246170|NCT04902261|Gemcitabine|gemcitabine|mesh-list
102246171|NCT04902261|Tislelizumab|tislelizumab|mesh-list
102246172|NCT04902261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102246173|NCT04902261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102246174|NCT04902261|Tubulin Modulators|tubulin modulators|mesh-ancestor
102246175|NCT04902261|Antimitotic Agents|antimitotic agents|mesh-ancestor
102246176|NCT04902261|Mitosis Modulators|mitosis modulators|mesh-ancestor
102246177|NCT04902261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246178|NCT04902261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102246179|NCT04902261|Antimetabolites|antimetabolites|mesh-ancestor
102246180|NCT04902261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102246181|NCT04902027|Mitoxantrone|mitoxantrone|mesh-list
102246182|NCT04902027|Analgesics|analgesics|mesh-ancestor
102246183|NCT04902027|Sensory System Agents|sensory system agents|mesh-ancestor
102246184|NCT04902027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102246185|NCT04902027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246186|NCT04902027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101712922|NCT00861744|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101712923|NCT00861744|Immunologic Factors|immunologic factors|mesh-ancestor
101712924|NCT00861744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712925|NCT02685059|Paclitaxel|paclitaxel|mesh-list
102246187|NCT04902027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102246188|NCT04902027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102246189|NCT04902027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102246190|NCT04902027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246191|NCT04902105|Mefenamic Acid|mefenamic acid|mesh-list
102246192|NCT04902105|Valproic Acid|valproic acid|mesh-list
102246194|NCT04902105|Anticonvulsants|anticonvulsants|mesh-ancestor
102246195|NCT04902105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102246196|NCT04902105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246197|NCT04902105|GABA Agents|gaba agents|mesh-ancestor
102246198|NCT04902105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102246199|NCT04902105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246200|NCT04902105|Antimanic Agents|antimanic agents|mesh-ancestor
102246201|NCT04902105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102246202|NCT04902105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102246203|NCT04902105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102246204|NCT04902105|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102246205|NCT04902105|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102246206|NCT04902105|Dopamine Agents|dopamine agents|mesh-ancestor
102246207|NCT04902105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102246208|NCT04902105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102246209|NCT04902105|Analgesics|analgesics|mesh-ancestor
102246210|NCT04902105|Sensory System Agents|sensory system agents|mesh-ancestor
102246211|NCT04902105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102246212|NCT04902105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102246213|NCT04902105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102246214|NCT04902105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102246215|NCT02120950|Aflibercept|aflibercept|mesh-list
102246216|NCT02120950|Verteporfin|verteporfin|mesh-list
102246217|NCT02120950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102246218|NCT02120950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102246219|NCT02120950|Growth Substances|growth substances|mesh-ancestor
102246220|NCT02120950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246221|NCT02120950|Growth Inhibitors|growth inhibitors|mesh-ancestor
102246222|NCT02120950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102246223|NCT02120950|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102246224|NCT02120950|Dermatologic Agents|dermatologic agents|mesh-ancestor
102246225|NCT02120794|Insulin|insulin|mesh-list
102246226|NCT02120794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102246227|NCT02120794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246228|NCT03053583|Pyrithione zinc|pyrithione zinc|mesh-list
102246229|NCT03053583|Keratolytic Agents|keratolytic agents|mesh-ancestor
102246230|NCT03053583|Dermatologic Agents|dermatologic agents|mesh-ancestor
102246231|NCT04900311|Paclitaxel|paclitaxel|mesh-list
102246232|NCT04900311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102246233|NCT04900311|Trastuzumab|trastuzumab|mesh-list
102246234|NCT04900311|Pertuzumab|pertuzumab|mesh-list
102246235|NCT04900311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102246236|NCT04900311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102246237|NCT04900311|Tubulin Modulators|tubulin modulators|mesh-ancestor
102246238|NCT04900311|Antimitotic Agents|antimitotic agents|mesh-ancestor
102613173|NCT00002675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613174|NCT00002675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102613175|NCT00002675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102613176|NCT00002675|Alkylating Agents|alkylating agents|mesh-ancestor
102246239|NCT04900311|Mitosis Modulators|mitosis modulators|mesh-ancestor
102246240|NCT04900311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901615|NCT01185470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246241|NCT04900311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102246242|NCT04900155|Atorvastatin|atorvastatin|mesh-list
102246243|NCT04900155|Ezetimibe|ezetimibe|mesh-list
102246244|NCT04900155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102246245|NCT04900155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102246246|NCT04900155|Antimetabolites|antimetabolites|mesh-ancestor
102246247|NCT04900155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246248|NCT04900155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102246249|NCT04900155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102246250|NCT04900155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102246251|NCT02155738|Acetaminophen|acetaminophen|mesh-list
102246252|NCT02155738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102246253|NCT02155738|Analgesics|analgesics|mesh-ancestor
102246254|NCT02155738|Sensory System Agents|sensory system agents|mesh-ancestor
102246255|NCT02155738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102246256|NCT02155738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246257|NCT02155738|Antipyretics|antipyretics|mesh-ancestor
102246258|NCT03053505|Vancomycin|vancomycin|mesh-list
102246259|NCT03053505|Fidaxomicin|fidaxomicin|mesh-list
102246260|NCT03053505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102246261|NCT03053505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102246262|NCT02181790|Acitretin|acitretin|mesh-list
102246263|NCT02181790|Keratolytic Agents|keratolytic agents|mesh-ancestor
102246264|NCT02181790|Dermatologic Agents|dermatologic agents|mesh-ancestor
102246265|NCT03051945|Ketamine|ketamine|mesh-list
102246266|NCT03051945|Analgesics|analgesics|mesh-ancestor
102246267|NCT03051945|Sensory System Agents|sensory system agents|mesh-ancestor
102246268|NCT03051945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102246269|NCT03051945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246270|NCT03051945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102246271|NCT03051945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102246272|NCT03051945|Anesthetics, General|anesthetics, general|mesh-ancestor
102246273|NCT03051945|Anesthetics|anesthetics|mesh-ancestor
102246274|NCT03051945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102246275|NCT03051945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102246276|NCT03051945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102246277|NCT03051945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102246278|NCT03051945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246279|NCT04899765|Vaccines|vaccines|mesh-list
102246280|NCT04899765|BCG Vaccine|bcg vaccine|mesh-list
102246281|NCT04899765|Immunologic Factors|immunologic factors|mesh-ancestor
102246282|NCT04899765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246283|NCT04899765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102246284|NCT04899453|Rituximab|rituximab|mesh-list
102246285|NCT04899453|Methotrexate|methotrexate|mesh-list
102246286|NCT04899453|Zanubrutinib|zanubrutinib|mesh-list
102246287|NCT04899453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102246288|NCT04899453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102246289|NCT04899453|Immunologic Factors|immunologic factors|mesh-ancestor
102246290|NCT04899453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246291|NCT04899453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102246292|NCT04899453|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102246293|NCT04899453|Abortifacient Agents|abortifacient agents|mesh-ancestor
102246294|NCT04899453|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102246295|NCT04899453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102246296|NCT04899453|Antimetabolites|antimetabolites|mesh-ancestor
102246297|NCT04899453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246298|NCT04899453|Dermatologic Agents|dermatologic agents|mesh-ancestor
102246299|NCT04899453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102246300|NCT04899453|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102246301|NCT04899453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102246302|NCT04899453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102246303|NCT04899453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102246304|NCT03051555|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102246305|NCT03051555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102246306|NCT03051555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246307|NCT04898751|Pembrolizumab|pembrolizumab|mesh-list
102246308|NCT04898751|Nivolumab|nivolumab|mesh-list
102246309|NCT04898751|Ipilimumab|ipilimumab|mesh-list
102246310|NCT04898751|Atezolizumab|atezolizumab|mesh-list
102246311|NCT04898751|Durvalumab|durvalumab|mesh-list
102613177|NCT00002675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613178|NCT00002675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102246312|NCT04898751|Avelumab|avelumab|mesh-list
102246313|NCT04898751|Cemiplimab|cemiplimab|mesh-list
102246314|NCT04898751|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102246315|NCT04898751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102613179|NCT00002675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102246316|NCT04898751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102246317|NCT04898751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246318|NCT04898907|Moxifloxacin|moxifloxacin|mesh-list
102246319|NCT04898907|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102246320|NCT04898907|Mitogens|mitogens|mesh-list
102246321|NCT04898907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102246322|NCT04898907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102246323|NCT04898907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102246324|NCT04898907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102246325|NCT04898907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102246326|NCT04898907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246327|NCT04898907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102246328|NCT04898907|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102246329|NCT04898907|Contraceptive Agents|contraceptive agents|mesh-ancestor
102246330|NCT04898907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102246331|NCT04898907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246332|NCT04898907|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102246333|NCT04898907|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102246334|NCT04898907|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102246335|NCT04898907|Mitosis Modulators|mitosis modulators|mesh-ancestor
102246336|NCT04908813|Capecitabine|capecitabine|mesh-list
102246337|NCT04908813|Oxaliplatin|oxaliplatin|mesh-list
102246338|NCT04908813|Trastuzumab|trastuzumab|mesh-list
102246339|NCT04908813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102246340|NCT04908813|Antimetabolites|antimetabolites|mesh-ancestor
102246341|NCT04908813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246342|NCT04908813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102246343|NCT04908813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102246344|NCT04913571|Tislelizumab|tislelizumab|mesh-list
102246345|NCT04913571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102246346|NCT04913571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102246347|NCT03051711|Pyrazole|pyrazole|mesh-list
102246348|NCT03051711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102246349|NCT03051711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246350|NCT04908345|Fentanyl|fentanyl|mesh-list
102246351|NCT04908345|Methadone|methadone|mesh-list
102246352|NCT04908345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101955240|NCT05418699|Insulin|insulin|mesh-list
102246353|NCT04908345|Narcotics|narcotics|mesh-ancestor
102246354|NCT04908345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102246355|NCT04908345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246356|NCT04908345|Analgesics|analgesics|mesh-ancestor
102246357|NCT04908345|Sensory System Agents|sensory system agents|mesh-ancestor
102246358|NCT04908345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102246359|NCT04908345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102246360|NCT04908345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102246361|NCT04908345|Anesthetics, General|anesthetics, general|mesh-ancestor
102246362|NCT04908345|Anesthetics|anesthetics|mesh-ancestor
102246363|NCT04908345|Antitussive Agents|antitussive agents|mesh-ancestor
102246364|NCT04908345|Respiratory System Agents|respiratory system agents|mesh-ancestor
102246365|NCT04893993|Thiamine|thiamine|mesh-list
102246366|NCT04893993|Vitamin B Complex|vitamin b complex|mesh-ancestor
102246367|NCT04893993|Vitamins|vitamins|mesh-ancestor
102246368|NCT04893993|Micronutrients|micronutrients|mesh-ancestor
102246369|NCT04893993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246370|NCT03051243|Insulin|insulin|mesh-list
102246371|NCT03051243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102246372|NCT03051243|Linagliptin|linagliptin|mesh-list
102246373|NCT03051243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102246374|NCT03051243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246375|NCT03051243|Incretins|incretins|mesh-ancestor
102246376|NCT03051243|Hormones|hormones|mesh-ancestor
102246377|NCT03051243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102246378|NCT03051243|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102246379|NCT03051243|Protease Inhibitors|protease inhibitors|mesh-ancestor
102246380|NCT03051243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102246381|NCT03051243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246382|NCT04897737|Tenofovir|tenofovir|mesh-list
102246383|NCT04897737|Antiviral Agents|antiviral agents|mesh-ancestor
102246384|NCT04897737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102246385|NCT04897737|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102246386|NCT04897737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102246387|NCT04897737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102613180|NCT00002675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101588075|NCT02634541|Adalimumab|adalimumab|mesh-list
102246388|NCT04897737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246389|NCT04897737|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102246390|NCT04897737|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102246391|NCT04148781|4-Aminopyridine|4-aminopyridine|mesh-list
102246392|NCT04148781|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102246393|NCT04148781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102246394|NCT04148781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246395|NCT04897269|Progesterone|progesterone|mesh-list
102246396|NCT04897269|Progestins|progestins|mesh-ancestor
102246397|NCT04897269|Hormones|hormones|mesh-ancestor
102246398|NCT04897269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102246399|NCT04897269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246400|NCT04891497|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102246401|NCT04891497|Dermatologic Agents|dermatologic agents|mesh-ancestor
102246402|NCT04891497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102246403|NCT04891497|Immunologic Factors|immunologic factors|mesh-ancestor
102246404|NCT04891497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246405|NCT04896177|Sirolimus|sirolimus|mesh-list
102246406|NCT04896177|Paclitaxel|paclitaxel|mesh-list
102246407|NCT04896177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102246408|NCT04896177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102246409|NCT04896177|Tubulin Modulators|tubulin modulators|mesh-ancestor
102246410|NCT04896177|Antimitotic Agents|antimitotic agents|mesh-ancestor
102246411|NCT04896177|Mitosis Modulators|mitosis modulators|mesh-ancestor
102246412|NCT04896177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246413|NCT04896177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102246414|NCT04896177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102246415|NCT04896177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102246416|NCT04896177|Antifungal Agents|antifungal agents|mesh-ancestor
102246417|NCT04896177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102246418|NCT04896177|Immunologic Factors|immunologic factors|mesh-ancestor
102246419|NCT04896177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246420|NCT03052569|Agerafenib|agerafenib|mesh-list
102246421|NCT03052569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102246422|NCT03052569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102246423|NCT03052569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246424|NCT04906317|Midazolam|midazolam|mesh-list
102246425|NCT04906317|Dezocine|dezocine|mesh-list
102246426|NCT04906317|Propofol|propofol|mesh-list
102246427|NCT04906317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102246428|NCT04906317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102246429|NCT04906317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246430|NCT04906317|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102246432|NCT04906317|Anesthetics|anesthetics|mesh-ancestor
102246433|NCT04906317|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102246434|NCT04906317|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102246435|NCT04906317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102246436|NCT04906317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102246437|NCT04906317|GABA Modulators|gaba modulators|mesh-ancestor
102246438|NCT04906317|GABA Agents|gaba agents|mesh-ancestor
102246439|NCT04906317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102246440|NCT04906317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246441|NCT04906317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102246442|NCT04906317|Narcotics|narcotics|mesh-ancestor
102246443|NCT04906317|Analgesics|analgesics|mesh-ancestor
102246444|NCT04906317|Sensory System Agents|sensory system agents|mesh-ancestor
102246445|NCT04906317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102246446|NCT03051087|Ganirelix|ganirelix|mesh-list
102246447|NCT03051087|Hormone Antagonists|hormone antagonists|mesh-ancestor
102246448|NCT03051087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102246449|NCT03051087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246450|NCT04430361|Dexamethasone|dexamethasone|mesh-list
102246451|NCT04430361|Megestrol|megestrol|mesh-list
102246452|NCT04430361|Megestrol Acetate|megestrol acetate|mesh-list
102246453|NCT04430361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102246454|NCT04430361|Antiemetics|antiemetics|mesh-ancestor
102246455|NCT04430361|Autonomic Agents|autonomic agents|mesh-ancestor
102246456|NCT04430361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102246457|NCT04430361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246458|NCT04430361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102246459|NCT04430361|Glucocorticoids|glucocorticoids|mesh-ancestor
102246460|NCT04430361|Hormones|hormones|mesh-ancestor
102246461|NCT04430361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102246462|NCT04430361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102246463|NCT04430361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102246464|NCT04430361|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102613181|NCT00002675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102246465|NCT04430361|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102246466|NCT04430361|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102246467|NCT04430361|Contraceptive Agents|contraceptive agents|mesh-ancestor
102246468|NCT04430361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102246469|NCT04430361|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102246470|NCT04430361|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102246471|NCT04430361|Appetite Stimulants|appetite stimulants|mesh-ancestor
102246472|NCT04430361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102246473|NCT04906083|Mitogens|mitogens|mesh-list
102246474|NCT04906083|Mitosis Modulators|mitosis modulators|mesh-ancestor
102246475|NCT04906083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246476|NCT02616783|Lamivudine|lamivudine|mesh-list
102246477|NCT02616783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102246478|NCT02616783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102246479|NCT02616783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102246480|NCT02616783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246481|NCT02616783|Antiviral Agents|antiviral agents|mesh-ancestor
102246482|NCT02616783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102246483|NCT02616783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102246484|NCT02616783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102246485|NCT04895007|Vaccines|vaccines|mesh-list
102246486|NCT04895007|Immunologic Factors|immunologic factors|mesh-ancestor
102246487|NCT04895007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246488|NCT04890561|Lemborexant|lemborexant|mesh-list
102246489|NCT04890561|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102246490|NCT04890561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102246491|NCT04890561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246492|NCT04890561|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102246493|NCT04890561|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102246494|NCT04890561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102246495|NCT04890561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246496|NCT04894617|Amantadine|amantadine|mesh-list
102246497|NCT04894617|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102246498|NCT04894617|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102246499|NCT04894617|Antiviral Agents|antiviral agents|mesh-ancestor
102246500|NCT04894617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101955386|NCT05320107|Ketamine|ketamine|mesh-list
102246501|NCT04894617|Dopamine Agents|dopamine agents|mesh-ancestor
102246502|NCT04894617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102246503|NCT04894617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246504|NCT04894617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246505|NCT04894617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102246506|NCT04894617|Analgesics|analgesics|mesh-ancestor
102246507|NCT04894617|Sensory System Agents|sensory system agents|mesh-ancestor
102246508|NCT04894617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102246509|NCT04398537|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102246510|NCT04398537|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
102246511|NCT04398537|beta-Endorphin|beta-endorphin|mesh-list
102246512|NCT04398537|Hormones|hormones|mesh-ancestor
102246513|NCT04398537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102246514|NCT04398537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246515|NCT04398537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102246516|NCT04398537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246517|NCT04397991|Furosemide|furosemide|mesh-list
102246518|NCT04397991|Diuretics|diuretics|mesh-ancestor
102246519|NCT04397991|Natriuretic Agents|natriuretic agents|mesh-ancestor
102246520|NCT04397991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246521|NCT04397991|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102246522|NCT04397991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102246523|NCT04397991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246524|NCT04906161|Vitamin D|vitamin d|mesh-list
102246525|NCT04906161|Calcium|calcium|mesh-list
102246526|NCT04906161|Vitamins|vitamins|mesh-ancestor
102246527|NCT04906161|Micronutrients|micronutrients|mesh-ancestor
102246528|NCT04906161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246529|NCT04906161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102246530|NCT04906161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102246531|NCT03051009|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
102246532|NCT03051009|Hemostatics|hemostatics|mesh-ancestor
102246533|NCT03051009|Coagulants|coagulants|mesh-ancestor
102246534|NCT03051009|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102246535|NCT03051009|Natriuretic Agents|natriuretic agents|mesh-ancestor
102613182|NCT00002675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102246536|NCT03051009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613183|NCT00002675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102246537|NCT04889781|Dexamethasone|dexamethasone|mesh-list
102246538|NCT04889781|Dexamethasone acetate|dexamethasone acetate|mesh-list
102246539|NCT04889781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102246540|NCT04889781|Antiemetics|antiemetics|mesh-ancestor
102246541|NCT04889781|Autonomic Agents|autonomic agents|mesh-ancestor
102246542|NCT04889781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102246543|NCT04889781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246544|NCT04889781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102246545|NCT04889781|Glucocorticoids|glucocorticoids|mesh-ancestor
102246546|NCT04889781|Hormones|hormones|mesh-ancestor
102246547|NCT04889781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102246548|NCT04889781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102246549|NCT04889781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102246550|NCT02616393|XL647|xl647|mesh-list
102246551|NCT02616393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102246552|NCT02616393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102246553|NCT02616393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102246554|NCT02616393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246555|NCT04905147|Mosapride|mosapride|mesh-list
102246556|NCT04905147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102246557|NCT04905147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102246558|NCT04905147|Serotonin Agents|serotonin agents|mesh-ancestor
102246559|NCT04905147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102246560|NCT04905147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246561|NCT04905147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246562|NCT03050229|Empagliflozin|empagliflozin|mesh-list
102246563|NCT03050229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102246564|NCT03050229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246565|NCT03050229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102246566|NCT03050229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246567|NCT04882683|Prednisone|prednisone|mesh-list
102246568|NCT04882683|Adalimumab|adalimumab|mesh-list
102246569|NCT04882683|Azathioprine|azathioprine|mesh-list
102246570|NCT04882683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102246571|NCT04882683|Glucocorticoids|glucocorticoids|mesh-ancestor
102246572|NCT04882683|Hormones|hormones|mesh-ancestor
102246573|NCT04882683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102246574|NCT04882683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246575|NCT04882683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102246576|NCT04882683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102246577|NCT04882683|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102246578|NCT04882683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102246579|NCT04882683|Antimetabolites|antimetabolites|mesh-ancestor
102246580|NCT04882683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246581|NCT04882683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102246582|NCT04882683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102246583|NCT04882683|Immunologic Factors|immunologic factors|mesh-ancestor
102246584|NCT02155660|Benralizumab|benralizumab|mesh-list
102246585|NCT02155660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102246586|NCT02155660|Respiratory System Agents|respiratory system agents|mesh-ancestor
102246587|NCT04753372|Aspirin|aspirin|mesh-list
102246588|NCT04753372|Rivaroxaban|rivaroxaban|mesh-list
102246589|NCT04753372|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102246590|NCT04753372|Antithrombins|antithrombins|mesh-ancestor
102246591|NCT04753372|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102246592|NCT04753372|Protease Inhibitors|protease inhibitors|mesh-ancestor
102246593|NCT04753372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102246594|NCT04753372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246595|NCT04753372|Anticoagulants|anticoagulants|mesh-ancestor
102246596|NCT04753372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102246597|NCT04753372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102246598|NCT04753372|Analgesics|analgesics|mesh-ancestor
102246599|NCT04753372|Sensory System Agents|sensory system agents|mesh-ancestor
102246600|NCT04753372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102246601|NCT04753372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246602|NCT04753372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102246603|NCT04753372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102246604|NCT04753372|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102246605|NCT04753372|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102246606|NCT04753372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102246607|NCT04753372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102613184|NCT00002675|Tubulin Modulators|tubulin modulators|mesh-ancestor
102613185|NCT00002675|Antimitotic Agents|antimitotic agents|mesh-ancestor
102246608|NCT04753372|Antipyretics|antipyretics|mesh-ancestor
102246609|NCT05154123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102246610|NCT05154123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102246611|NCT05154123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102246612|NCT05154123|Antimetabolites|antimetabolites|mesh-ancestor
102246613|NCT05154123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246614|NCT05154123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102246615|NCT05154123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102246616|NCT05154123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102246617|NCT04880811|Afatinib|afatinib|mesh-list
102246618|NCT04880811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102246619|NCT04880811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102246620|NCT04880811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102246621|NCT04880811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246622|NCT02181634|Paclitaxel|paclitaxel|mesh-list
102246623|NCT02181634|Gemcitabine|gemcitabine|mesh-list
102246624|NCT02181634|Antimetabolites|antimetabolites|mesh-list
102246625|NCT02181634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102246626|NCT02181634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102246627|NCT02181634|Tubulin Modulators|tubulin modulators|mesh-ancestor
102246628|NCT02181634|Antimitotic Agents|antimitotic agents|mesh-ancestor
102246629|NCT02181634|Mitosis Modulators|mitosis modulators|mesh-ancestor
102246630|NCT02181634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246631|NCT02181634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102246632|NCT04569045|Lidocaine|lidocaine|mesh-list
102246633|NCT04569045|Anesthetics, Local|anesthetics, local|mesh-ancestor
102246634|NCT04569045|Anesthetics|anesthetics|mesh-ancestor
102246635|NCT04569045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102246636|NCT04569045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246637|NCT04569045|Sensory System Agents|sensory system agents|mesh-ancestor
102246638|NCT04569045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102246639|NCT04569045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102246640|NCT04569045|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102246641|NCT04569045|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102246642|NCT04569045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102246643|NCT04569045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246644|NCT04425291|Vaccines|vaccines|mesh-list
102246645|NCT04425291|Immunologic Factors|immunologic factors|mesh-ancestor
102246646|NCT04425291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246647|NCT04886193|Leucovorin|leucovorin|mesh-list
102246648|NCT04886193|Docetaxel|docetaxel|mesh-list
102246649|NCT04886193|Oxaliplatin|oxaliplatin|mesh-list
102246650|NCT04886193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102246651|NCT04886193|Tubulin Modulators|tubulin modulators|mesh-ancestor
102246652|NCT04886193|Antimitotic Agents|antimitotic agents|mesh-ancestor
102246653|NCT04886193|Mitosis Modulators|mitosis modulators|mesh-ancestor
102246654|NCT04886193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246656|NCT04886193|Protective Agents|protective agents|mesh-ancestor
102246657|NCT04886193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246658|NCT04886193|Vitamin B Complex|vitamin b complex|mesh-ancestor
102246659|NCT04886193|Vitamins|vitamins|mesh-ancestor
102246660|NCT04886193|Micronutrients|micronutrients|mesh-ancestor
102246661|NCT04337073|Propofol|propofol|mesh-list
102246662|NCT04337073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102246663|NCT04337073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102246664|NCT04337073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246665|NCT04337073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102246666|NCT04337073|Anesthetics, General|anesthetics, general|mesh-ancestor
102246667|NCT04337073|Anesthetics|anesthetics|mesh-ancestor
102246668|NCT04885803|Vitamin D|vitamin d|mesh-list
102246669|NCT04885803|Ergocalciferols|ergocalciferols|mesh-list
102246670|NCT04885803|Cholecalciferol|cholecalciferol|mesh-list
102246671|NCT04885803|Vitamins|vitamins|mesh-list
102246672|NCT04885803|Micronutrients|micronutrients|mesh-ancestor
102246673|NCT04885803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246674|NCT04885803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102246675|NCT04885803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102246676|NCT03049059|Hydroquinone|hydroquinone|mesh-list
102246677|NCT03049059|Antioxidants|antioxidants|mesh-ancestor
102246678|NCT03049059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246679|NCT03049059|Protective Agents|protective agents|mesh-ancestor
102246680|NCT03049059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246681|NCT03049059|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102246682|NCT04885413|Niraparib|niraparib|mesh-list
102246683|NCT04885413|Antibodies|antibodies|mesh-list
102613186|NCT00002675|Mitosis Modulators|mitosis modulators|mesh-ancestor
102613187|NCT00002681|Aldesleukin|aldesleukin|mesh-list
102246684|NCT04885413|Immunologic Factors|immunologic factors|mesh-ancestor
102246685|NCT04885413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246686|NCT04885413|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102246687|NCT04885413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102246688|NCT04885413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246689|NCT04885413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102246691|NCT03049293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102246692|NCT03049293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102246693|NCT03049293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102246694|NCT03049293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246695|NCT03049293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102246696|NCT03049293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102246697|NCT03049293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102246698|NCT03049293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102246699|NCT03049293|Anesthetics, General|anesthetics, general|mesh-ancestor
102246700|NCT03049293|Anesthetics|anesthetics|mesh-ancestor
102246701|NCT03049293|GABA Modulators|gaba modulators|mesh-ancestor
102246702|NCT03049293|GABA Agents|gaba agents|mesh-ancestor
102246703|NCT03049293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102246704|NCT03049293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246705|NCT01595529|Trimethoprim|trimethoprim|mesh-list
102246706|NCT01595529|Sulfamethoxazole|sulfamethoxazole|mesh-list
102246707|NCT01595529|Cephalexin|cephalexin|mesh-list
102246708|NCT01595529|Cefixime|cefixime|mesh-list
102246709|NCT01595529|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102246710|NCT01595529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102246711|NCT01595529|Antimalarials|antimalarials|mesh-ancestor
102246712|NCT01595529|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102246713|NCT01595529|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102246714|NCT01595529|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102246715|NCT01595529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102246716|NCT01595529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246717|NCT01595529|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102246718|NCT01595529|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102246719|NCT01595529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102246720|NCT01595529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102246721|NCT04368507|Monoclonal antibody YYB-101|monoclonal antibody yyb-101|mesh-list
102246722|NCT04368507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102246723|NCT05257395|Letrozole|letrozole|mesh-list
102246724|NCT05257395|Anastrozole|anastrozole|mesh-list
102246725|NCT05257395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101955621|NCT02793622|Artenimol|artenimol|mesh-list
102246726|NCT05257395|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102246727|NCT05257395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102246729|NCT05257395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246730|NCT05257395|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102246731|NCT05257395|Hormone Antagonists|hormone antagonists|mesh-ancestor
102246732|NCT05257395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102246733|NCT05257395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246734|NCT05257395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102246735|NCT05256693|Vancomycin|vancomycin|mesh-list
102246736|NCT05256693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102246737|NCT05256693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102246738|NCT03046953|Avelumab|avelumab|mesh-list
102246739|NCT03046953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102246740|NCT03046953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102246741|NCT03047109|Phenylephrine|phenylephrine|mesh-list
102246742|NCT03047109|Oxymetazoline|oxymetazoline|mesh-list
102246743|NCT03047109|Ephedrine|ephedrine|mesh-list
102246744|NCT03047109|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102246745|NCT03047109|Mydriatics|mydriatics|mesh-ancestor
102246746|NCT03047109|Autonomic Agents|autonomic agents|mesh-ancestor
102246747|NCT03047109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102246748|NCT03047109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246749|NCT03047109|Sympathomimetics|sympathomimetics|mesh-ancestor
102246750|NCT03047109|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102246751|NCT03047109|Nasal Decongestants|nasal decongestants|mesh-ancestor
102246752|NCT03047109|Respiratory System Agents|respiratory system agents|mesh-ancestor
102246753|NCT03047109|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102246754|NCT03047109|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102246755|NCT03047109|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102613188|NCT00002681|Daclizumab|daclizumab|mesh-list
102246756|NCT03047109|Adrenergic Agents|adrenergic agents|mesh-ancestor
101901627|NCT00056160|Glucocorticoids|glucocorticoids|mesh-ancestor
102613189|NCT00002681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613190|NCT00002681|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102246757|NCT03047109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102246758|NCT03047109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246759|NCT03047109|Protective Agents|protective agents|mesh-ancestor
102246760|NCT03047109|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102246761|NCT03047265|Paclitaxel|paclitaxel|mesh-list
102246762|NCT03047265|Cisplatin|cisplatin|mesh-list
102246763|NCT03047265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102246764|NCT03047265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102246765|NCT03047265|Tubulin Modulators|tubulin modulators|mesh-ancestor
102246766|NCT03047265|Antimitotic Agents|antimitotic agents|mesh-ancestor
102246767|NCT03047265|Mitosis Modulators|mitosis modulators|mesh-ancestor
102246768|NCT03047265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246769|NCT05256147|Ibuprofen|ibuprofen|mesh-list
102246770|NCT05256147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102246771|NCT05256147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102246772|NCT05256147|Analgesics|analgesics|mesh-ancestor
102246773|NCT05256147|Sensory System Agents|sensory system agents|mesh-ancestor
101713066|NCT00487747|Antiviral Agents|antiviral agents|mesh-ancestor
102246774|NCT05256147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102246775|NCT05256147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246776|NCT05256147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102246777|NCT05256147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102246778|NCT05256147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102246779|NCT05256147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101713076|NCT00487435|Narcotics|narcotics|mesh-ancestor
102246780|NCT05256147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246781|NCT05255913|Fluorides|fluorides|mesh-list
102246782|NCT05255913|Cariostatic Agents|cariostatic agents|mesh-ancestor
102246783|NCT05255913|Protective Agents|protective agents|mesh-ancestor
102246784|NCT05255913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246785|NCT05214417|Ketamine|ketamine|mesh-list
102246786|NCT05214417|Analgesics|analgesics|mesh-ancestor
101713149|NCT00701532|Modafinil|modafinil|mesh-list
102246787|NCT05214417|Sensory System Agents|sensory system agents|mesh-ancestor
102246788|NCT05214417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102246789|NCT05214417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246790|NCT05214417|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102246791|NCT05214417|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102246792|NCT05214417|Anesthetics, General|anesthetics, general|mesh-ancestor
102246793|NCT05214417|Anesthetics|anesthetics|mesh-ancestor
102246794|NCT05214417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101713206|NCT02614118|Antipyretics|antipyretics|mesh-ancestor
102246795|NCT05214417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102246796|NCT05214417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102246797|NCT05214417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102246798|NCT05214417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246799|NCT04870671|Tenofovir|tenofovir|mesh-list
102246800|NCT04870671|Antiviral Agents|antiviral agents|mesh-ancestor
102246801|NCT04870671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102246802|NCT04870671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101713272|NCT04126304|Azithromycin|azithromycin|mesh-list
102246803|NCT04870671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102246804|NCT04870671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102246805|NCT04870671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246806|NCT04870671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102246807|NCT04870671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102246808|NCT04387461|Pembrolizumab|pembrolizumab|mesh-list
102246809|NCT04387461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102246810|NCT04387461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102246811|NCT04387461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102246812|NCT04387461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246813|NCT03046719|Bupivacaine|bupivacaine|mesh-list
102246814|NCT03046719|Anesthetics, Local|anesthetics, local|mesh-ancestor
102246815|NCT03046719|Anesthetics|anesthetics|mesh-ancestor
102246816|NCT03046719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102246817|NCT03046719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246818|NCT03046719|Sensory System Agents|sensory system agents|mesh-ancestor
102246819|NCT03046719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102246820|NCT04876755|TEMPO|tempo|mesh-list
102246821|NCT04876755|TEMPOL-H|tempol-h|mesh-list
102246822|NCT04876755|Antioxidants|antioxidants|mesh-ancestor
102246823|NCT04876755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246824|NCT04876755|Protective Agents|protective agents|mesh-ancestor
102246825|NCT04876755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246826|NCT04876755|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102246827|NCT04876521|Olanzapine|olanzapine|mesh-list
102246828|NCT04876521|Amisulpride|amisulpride|mesh-list
102246829|NCT04876521|Fluoxetine|fluoxetine|mesh-list
102246830|NCT04876521|Antiemetics|antiemetics|mesh-ancestor
102613191|NCT00002681|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102613192|NCT00002681|Antiviral Agents|antiviral agents|mesh-ancestor
102246831|NCT04876521|Autonomic Agents|autonomic agents|mesh-ancestor
102246832|NCT04876521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101713472|NCT02618876|Nalbuphine|nalbuphine|mesh-list
102246833|NCT04876521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246834|NCT04876521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102246835|NCT04876521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102246836|NCT04876521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101713530|NCT00866918|Antioxidants|antioxidants|mesh-ancestor
102246837|NCT04876521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102246838|NCT04876521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102246839|NCT04876521|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102246840|NCT04876521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102246841|NCT04876521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102246842|NCT04876521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246843|NCT04876521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102246844|NCT04876521|Serotonin Agents|serotonin agents|mesh-ancestor
102246845|NCT04876521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102246846|NCT04876521|Antidepressive Agents|antidepressive agents|mesh-ancestor
102246847|NCT04876521|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102246848|NCT04876521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102246849|NCT04876521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102246850|NCT04876521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102246851|NCT04876521|Dopamine Agents|dopamine agents|mesh-ancestor
102246852|NCT02119156|Belimumab|belimumab|mesh-list
102246853|NCT02119156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102246854|NCT02119156|Immunologic Factors|immunologic factors|mesh-ancestor
102246855|NCT02119156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246856|NCT02181556|Aflibercept|aflibercept|mesh-list
102246857|NCT02181556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102246858|NCT02181556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102246859|NCT02181556|Growth Substances|growth substances|mesh-ancestor
102246860|NCT02181556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246861|NCT02181556|Growth Inhibitors|growth inhibitors|mesh-ancestor
102246862|NCT02181556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102246863|NCT04865991|Propofol|propofol|mesh-list
102246864|NCT04865991|Sevoflurane|sevoflurane|mesh-list
102246865|NCT04865991|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102246866|NCT04865991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102246867|NCT04865991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246868|NCT04865991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102246869|NCT04865991|Anesthetics, General|anesthetics, general|mesh-ancestor
102246870|NCT04865991|Anesthetics|anesthetics|mesh-ancestor
102246871|NCT04865991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102246872|NCT04865991|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102246873|NCT04865211|Bupivacaine|bupivacaine|mesh-list
102246874|NCT04865211|Anesthetics, Local|anesthetics, local|mesh-ancestor
102246875|NCT04865211|Anesthetics|anesthetics|mesh-ancestor
102246876|NCT04865211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102246877|NCT04865211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246878|NCT04865211|Sensory System Agents|sensory system agents|mesh-ancestor
102246879|NCT04865211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102246880|NCT04865445|Midazolam|midazolam|mesh-list
102246881|NCT04865445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102246882|NCT04865445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102246883|NCT04865445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102246884|NCT04865445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246885|NCT04865445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102246886|NCT04865445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102246887|NCT04865445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102246888|NCT04865445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102246889|NCT04865445|Anesthetics, General|anesthetics, general|mesh-ancestor
102246890|NCT04865445|Anesthetics|anesthetics|mesh-ancestor
102246891|NCT04865445|GABA Modulators|gaba modulators|mesh-ancestor
102246892|NCT04865445|GABA Agents|gaba agents|mesh-ancestor
102246893|NCT04865445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102246894|NCT04865445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246895|NCT04875819|Vaccines|vaccines|mesh-list
102246896|NCT04875819|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102246897|NCT04875819|Immunologic Factors|immunologic factors|mesh-ancestor
102246898|NCT04875819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246899|NCT04864977|Insulin|insulin|mesh-list
102246900|NCT04864977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102246901|NCT04864977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246902|NCT03046173|Mitogens|mitogens|mesh-list
102246903|NCT03046173|Mitosis Modulators|mitosis modulators|mesh-ancestor
102246904|NCT03046173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613193|NCT00002681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102246905|NCT04869579|Selenium|selenium|mesh-list
102246906|NCT04869579|Selenious Acid|selenious acid|mesh-list
102246907|NCT04869579|Antioxidants|antioxidants|mesh-ancestor
102246908|NCT04869579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246909|NCT04869579|Protective Agents|protective agents|mesh-ancestor
102246910|NCT04869579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246911|NCT04869579|Trace Elements|trace elements|mesh-ancestor
102246912|NCT04869579|Micronutrients|micronutrients|mesh-ancestor
102246913|NCT03235037|Levodopa|levodopa|mesh-list
102246914|NCT03235037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102246915|NCT03235037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102246916|NCT03235037|Dopamine Agents|dopamine agents|mesh-ancestor
102246917|NCT03235037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102246918|NCT03235037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246919|NCT03235037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246920|NCT00700271|Amlodipine|amlodipine|mesh-list
102246921|NCT00700271|Valsartan|valsartan|mesh-list
102246922|NCT00700271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102246923|NCT00700271|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102246924|NCT00700271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102246925|NCT00700271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246926|NCT00700271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102246927|NCT00700271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246928|NCT00700271|Vasodilator Agents|vasodilator agents|mesh-ancestor
102246929|NCT00700271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102246930|NCT00700271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102246931|NCT02613507|Docetaxel|docetaxel|mesh-list
102246932|NCT02613507|Nivolumab|nivolumab|mesh-list
102246933|NCT02613507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102246934|NCT02613507|Tubulin Modulators|tubulin modulators|mesh-ancestor
102246935|NCT02613507|Antimitotic Agents|antimitotic agents|mesh-ancestor
102246936|NCT02613507|Mitosis Modulators|mitosis modulators|mesh-ancestor
102246937|NCT02613507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246938|NCT02613507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102246939|NCT02613507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102246940|NCT03228797|Ropivacaine|ropivacaine|mesh-list
102246941|NCT03228797|Anesthetics, Local|anesthetics, local|mesh-ancestor
102246942|NCT03228797|Anesthetics|anesthetics|mesh-ancestor
102246943|NCT03228797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102246944|NCT03228797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246945|NCT03228797|Sensory System Agents|sensory system agents|mesh-ancestor
102246946|NCT03228797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102246947|NCT03044379|Dapivirine|dapivirine|mesh-list
102246948|NCT03044379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102246949|NCT03044379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102246950|NCT03044379|Antiviral Agents|antiviral agents|mesh-ancestor
102246951|NCT03044379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102246952|NCT04864509|Melatonin|melatonin|mesh-list
102246953|NCT04864509|Antioxidants|antioxidants|mesh-ancestor
102246954|NCT04864509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246955|NCT04864509|Protective Agents|protective agents|mesh-ancestor
101714024|NCT00638807|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101714025|NCT00638807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101714026|NCT00638807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101714027|NCT00638807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714028|NCT00856856|Everolimus|everolimus|mesh-list
101714029|NCT00856856|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101714030|NCT00856856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101714031|NCT00856856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101714037|NCT00782327|Losartan|losartan|mesh-list
102246956|NCT04864509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246957|NCT04864509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102246958|NCT04875039|Dexamethasone|dexamethasone|mesh-list
102246959|NCT04875039|Dexamethasone acetate|dexamethasone acetate|mesh-list
102246960|NCT04875039|Dexmedetomidine|dexmedetomidine|mesh-list
102246961|NCT04875039|BB 1101|bb 1101|mesh-list
102246962|NCT04875039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102246963|NCT04875039|Antiemetics|antiemetics|mesh-ancestor
102246964|NCT04875039|Autonomic Agents|autonomic agents|mesh-ancestor
102246965|NCT04875039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102246966|NCT04875039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102246967|NCT04875039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102246968|NCT04875039|Glucocorticoids|glucocorticoids|mesh-ancestor
102246969|NCT04875039|Hormones|hormones|mesh-ancestor
102246970|NCT04875039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102246971|NCT04875039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102246972|NCT04875039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102246973|NCT04875039|Protease Inhibitors|protease inhibitors|mesh-ancestor
102246974|NCT04875039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102613194|NCT00002681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102246975|NCT04875039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246976|NCT04875039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102613195|NCT00002681|Immunologic Factors|immunologic factors|mesh-ancestor
102246977|NCT04875039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102246978|NCT04875039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102246979|NCT04875039|Analgesics|analgesics|mesh-ancestor
102246980|NCT04875039|Sensory System Agents|sensory system agents|mesh-ancestor
102246981|NCT04875039|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102246982|NCT04875039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102246983|NCT04875039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102246984|NCT04875039|Adrenergic Agents|adrenergic agents|mesh-ancestor
102246985|NCT04875039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102246986|NCT02452385|Vorolanib|vorolanib|mesh-list
102246987|NCT02452385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102246988|NCT02452385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102246989|NCT02452385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102246990|NCT03045783|Cefotiam|cefotiam|mesh-list
102246991|NCT03045783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102246992|NCT03045783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102246993|NCT01375049|Aztreonam|aztreonam|mesh-list
102246994|NCT01375049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102246995|NCT01375049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102246996|NCT04146207|Prednisone|prednisone|mesh-list
102246997|NCT04146207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102246998|NCT04146207|Glucocorticoids|glucocorticoids|mesh-ancestor
102246999|NCT04146207|Hormones|hormones|mesh-ancestor
101714121|NCT02680379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102247000|NCT04146207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102247001|NCT04146207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247002|NCT04146207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102247003|NCT04146207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102247004|NCT04863807|Anesthetics|anesthetics|mesh-list
102247005|NCT04863807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102247006|NCT04863807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247007|NCT02452307|Imiquimod|imiquimod|mesh-list
102247008|NCT02452307|Molgramostim|molgramostim|mesh-list
102247009|NCT02452307|Protamines|protamines|mesh-list
102247010|NCT02452307|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
102247011|NCT02452307|Sargramostim|sargramostim|mesh-list
102247012|NCT02452307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102247013|NCT02452307|Immunologic Factors|immunologic factors|mesh-ancestor
102247014|NCT02452307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247015|NCT02452307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102247016|NCT02452307|Interferon Inducers|interferon inducers|mesh-ancestor
102247017|NCT02452307|Heparin Antagonists|heparin antagonists|mesh-ancestor
101714250|NCT02678117|Anticonvulsants|anticonvulsants|mesh-ancestor
102247018|NCT02452307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247019|NCT02452307|Coagulants|coagulants|mesh-ancestor
102247020|NCT02452151|Infliximab|infliximab|mesh-list
102247021|NCT02452151|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102247022|NCT02452151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102247023|NCT02452151|Dermatologic Agents|dermatologic agents|mesh-ancestor
102247024|NCT02452151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102247025|NCT02452151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102247026|NCT04485299|Listerine|listerine|mesh-list
102247027|NCT04485299|Fluorides|fluorides|mesh-list
102247028|NCT04485299|Sodium Fluoride|sodium fluoride|mesh-list
101955922|NCT02070406|Antimetabolites|antimetabolites|mesh-ancestor
102247029|NCT04485299|Fluorides, Topical|fluorides, topical|mesh-list
102247030|NCT04485299|Cariostatic Agents|cariostatic agents|mesh-ancestor
102247031|NCT04485299|Protective Agents|protective agents|mesh-ancestor
102247032|NCT04485299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247033|NCT04485299|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102247034|NCT04485299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102247035|NCT01594749|Dexamethasone|dexamethasone|mesh-list
102247036|NCT01594749|Dexamethasone acetate|dexamethasone acetate|mesh-list
102247037|NCT01594749|Ondansetron|ondansetron|mesh-list
102247038|NCT01594749|Fosaprepitant|fosaprepitant|mesh-list
102247039|NCT01594749|Aprepitant|aprepitant|mesh-list
102247040|NCT01594749|BB 1101|bb 1101|mesh-list
102247041|NCT01594749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102247042|NCT01594749|Antiemetics|antiemetics|mesh-ancestor
102247043|NCT01594749|Autonomic Agents|autonomic agents|mesh-ancestor
102247044|NCT01594749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102247045|NCT01594749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247046|NCT01594749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102247047|NCT01594749|Glucocorticoids|glucocorticoids|mesh-ancestor
102247048|NCT01594749|Hormones|hormones|mesh-ancestor
102247049|NCT01594749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102247050|NCT01594749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102247051|NCT01594749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102247052|NCT01594749|Protease Inhibitors|protease inhibitors|mesh-ancestor
102247053|NCT01594749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101714380|NCT02679833|Hematinics|hematinics|mesh-ancestor
102613196|NCT00002681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613197|NCT02973113|Nivolumab|nivolumab|mesh-list
102247054|NCT01594749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247055|NCT01594749|Antipruritics|antipruritics|mesh-ancestor
102247056|NCT01594749|Dermatologic Agents|dermatologic agents|mesh-ancestor
102247057|NCT01594749|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102247058|NCT01594749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102247059|NCT01594749|Serotonin Agents|serotonin agents|mesh-ancestor
102247060|NCT01594749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102247061|NCT01594749|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102247062|NCT03226145|Scopolamine|scopolamine|mesh-list
102247063|NCT03226145|Bisacodyl|bisacodyl|mesh-list
102247064|NCT03226145|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102247065|NCT03226145|Cathartics|cathartics|mesh-ancestor
102247066|NCT03226145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102247067|NCT03226145|Laxatives|laxatives|mesh-ancestor
102247068|NCT03226145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102247069|NCT03226145|Antiemetics|antiemetics|mesh-ancestor
102247070|NCT03226145|Autonomic Agents|autonomic agents|mesh-ancestor
102247071|NCT03226145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102247072|NCT03226145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247073|NCT03226145|Mydriatics|mydriatics|mesh-ancestor
102247074|NCT03226145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102247075|NCT03226145|Cholinergic Agents|cholinergic agents|mesh-ancestor
102247076|NCT03226145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102247077|NCT03226145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247078|NCT03226145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102247079|NCT03226145|Parasympatholytics|parasympatholytics|mesh-ancestor
102247080|NCT04863183|Triamcinolone|triamcinolone|mesh-list
102247081|NCT04863183|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102247082|NCT04863183|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102247083|NCT04863183|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102247084|NCT04863183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102247085|NCT04863183|Glucocorticoids|glucocorticoids|mesh-ancestor
102247086|NCT04863183|Hormones|hormones|mesh-ancestor
102247087|NCT04863183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102247088|NCT04863183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247089|NCT04863183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102247090|NCT04863183|Immunologic Factors|immunologic factors|mesh-ancestor
102247091|NCT04863183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102247092|NCT04863183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247093|NCT03234413|Botulinum Toxins|botulinum toxins|mesh-list
102247094|NCT03234413|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102247095|NCT03234413|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102247096|NCT03234413|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102247097|NCT03234413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102247098|NCT03234413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247099|NCT03234413|Cholinergic Agents|cholinergic agents|mesh-ancestor
102247100|NCT03234413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102247101|NCT03234413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247102|NCT03234413|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102247103|NCT03234413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102247104|NCT04380753|Sotorasib|sotorasib|mesh-list
102247105|NCT04380753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102247106|NCT04380753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247107|NCT04380753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102247108|NCT04380753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102247109|NCT04379973|Ethiodized Oil|ethiodized oil|mesh-list
102247110|NCT04379973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102247111|NCT02453009|Prednisone|prednisone|mesh-list
102247112|NCT02453009|Docetaxel|docetaxel|mesh-list
102247113|NCT02453009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102247114|NCT02453009|Tubulin Modulators|tubulin modulators|mesh-ancestor
102247115|NCT02453009|Antimitotic Agents|antimitotic agents|mesh-ancestor
102247116|NCT02453009|Mitosis Modulators|mitosis modulators|mesh-ancestor
102247117|NCT02453009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247118|NCT02453009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102247119|NCT02453009|Glucocorticoids|glucocorticoids|mesh-ancestor
102247120|NCT02453009|Hormones|hormones|mesh-ancestor
102247121|NCT02453009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102247122|NCT02453009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247123|NCT02453009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102247124|NCT04868175|Timolol|timolol|mesh-list
102247125|NCT04868175|Travoprost|travoprost|mesh-list
102247126|NCT04868175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102613198|NCT02973113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102247127|NCT04868175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102247128|NCT04868175|Adrenergic Agents|adrenergic agents|mesh-ancestor
102247129|NCT04868175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102247130|NCT04868175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247131|NCT04868175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247132|NCT04868175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102247133|NCT04868175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102247134|NCT02452775|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
102247135|NCT02452775|Poly ICLC|poly iclc|mesh-list
102247136|NCT02452775|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102247137|NCT02452775|Immunologic Factors|immunologic factors|mesh-ancestor
102247138|NCT02452775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247139|NCT02452775|Interferon Inducers|interferon inducers|mesh-ancestor
102247140|NCT03045627|Cytarabine|cytarabine|mesh-list
102247141|NCT03045627|Aclarubicin|aclarubicin|mesh-list
102247142|NCT03045627|Lenograstim|lenograstim|mesh-list
102247143|NCT03045627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102247144|NCT03045627|Antimetabolites|antimetabolites|mesh-ancestor
102247145|NCT03045627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247146|NCT03045627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102247147|NCT03045627|Antiviral Agents|antiviral agents|mesh-ancestor
102247148|NCT03045627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102247149|NCT03045627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102247150|NCT03045627|Immunologic Factors|immunologic factors|mesh-ancestor
102247151|NCT03045627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247152|NCT03045627|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102247153|NCT03045627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102247154|NCT03045627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102247155|NCT03045627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102247156|NCT03045627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102247157|NCT04868019|Fenofibrate|fenofibrate|mesh-list
102247158|NCT04868019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102247159|NCT04868019|Antimetabolites|antimetabolites|mesh-ancestor
102247160|NCT04868019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247161|NCT04868019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102247162|NCT04863105|Abiraterone Acetate|abiraterone acetate|mesh-list
102247163|NCT04863105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102247164|NCT04863105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102247165|NCT04863105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102247166|NCT04863105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247167|NCT04863105|Hormone Antagonists|hormone antagonists|mesh-ancestor
102247168|NCT04863105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102247169|NCT04863105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247170|NCT04863105|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102247171|NCT02179918|Pembrolizumab|pembrolizumab|mesh-list
102247172|NCT02179918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102247173|NCT02179918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102247174|NCT02179918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102247175|NCT02179918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247176|NCT03233321|Heparin|heparin|mesh-list
102247177|NCT03233321|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101956062|NCT05459649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102247178|NCT03233321|Tinzaparin|tinzaparin|mesh-list
102247179|NCT03233321|Dalteparin|dalteparin|mesh-list
102247180|NCT03233321|Anticoagulants|anticoagulants|mesh-ancestor
102247181|NCT03233321|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102247182|NCT03233321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102247183|NCT03233321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247184|NCT04868253|Oxazepam|oxazepam|mesh-list
102247185|NCT04868253|Metyrapone|metyrapone|mesh-list
102247186|NCT04868253|Antimetabolites|antimetabolites|mesh-ancestor
102247187|NCT04868253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247188|NCT04868253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102247189|NCT04868253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102247190|NCT04868253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102247191|NCT04868253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247192|NCT04868253|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102247193|NCT04868253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102247194|NCT04868253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102247195|NCT04868253|GABA Modulators|gaba modulators|mesh-ancestor
102247196|NCT04868253|GABA Agents|gaba agents|mesh-ancestor
102247197|NCT04868253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102247198|NCT02153788|Temazepam|temazepam|mesh-list
101588886|NCT00657865|Ramipril|ramipril|mesh-list
102247199|NCT02153788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102247200|NCT02153788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102247201|NCT02153788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247202|NCT02153788|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102247203|NCT02153788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102247204|NCT02153788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102247205|NCT02153788|GABA Modulators|gaba modulators|mesh-ancestor
102247206|NCT02153788|GABA Agents|gaba agents|mesh-ancestor
102247207|NCT02153788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102247208|NCT02153788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247209|NCT03224039|Sufentanil|sufentanil|mesh-list
102247210|NCT03224039|Morphine|morphine|mesh-list
102247211|NCT03224039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102247212|NCT03224039|Narcotics|narcotics|mesh-ancestor
102247213|NCT03224039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102247214|NCT03224039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247215|NCT03224039|Analgesics|analgesics|mesh-ancestor
102247216|NCT03224039|Sensory System Agents|sensory system agents|mesh-ancestor
102247217|NCT03224039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102247218|NCT03224039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102247219|NCT03224039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102247220|NCT03224039|Anesthetics, General|anesthetics, general|mesh-ancestor
102247221|NCT03224039|Anesthetics|anesthetics|mesh-ancestor
102247222|NCT04862091|Abiraterone Acetate|abiraterone acetate|mesh-list
102247223|NCT04862091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102247224|NCT04862091|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102247225|NCT04862091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102247226|NCT04862091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247227|NCT04862091|Hormone Antagonists|hormone antagonists|mesh-ancestor
102247228|NCT04862091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102247229|NCT04862091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247230|NCT04862091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102247231|NCT03223961|Epoetin Alfa|epoetin alfa|mesh-list
102247232|NCT03223961|Hematinics|hematinics|mesh-ancestor
102247233|NCT03045471|Prednisolone|prednisolone|mesh-list
102247234|NCT03045471|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102247235|NCT03045471|Methylprednisolone|methylprednisolone|mesh-list
102247236|NCT03045471|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102247237|NCT03045471|Prednisolone acetate|prednisolone acetate|mesh-list
102247238|NCT03045471|Cyclophosphamide|cyclophosphamide|mesh-list
102247239|NCT03045471|Rituximab|rituximab|mesh-list
102247240|NCT03045471|Etoposide|etoposide|mesh-list
102247241|NCT03045471|Vincristine|vincristine|mesh-list
102247242|NCT03045471|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102247243|NCT03045471|Prednisolone phosphate|prednisolone phosphate|mesh-list
102247244|NCT03045471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102247245|NCT03045471|Immunologic Factors|immunologic factors|mesh-ancestor
102247246|NCT03045471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247247|NCT03045471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101715029|NCT02669303|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102247248|NCT03045471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102247249|NCT03045471|Alkylating Agents|alkylating agents|mesh-ancestor
102247250|NCT03045471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247251|NCT03045471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102247252|NCT03045471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102247253|NCT03045471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101956146|NCT04428411|Etanercept|etanercept|mesh-list
102247254|NCT03045471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102247256|NCT03045471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102247257|NCT03045471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102247258|NCT03045471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102247259|NCT03045471|Glucocorticoids|glucocorticoids|mesh-ancestor
102247260|NCT03045471|Hormones|hormones|mesh-ancestor
102247261|NCT03045471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102247262|NCT03045471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102247263|NCT03045471|Antiemetics|antiemetics|mesh-ancestor
102247264|NCT03045471|Autonomic Agents|autonomic agents|mesh-ancestor
102247265|NCT03045471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102247266|NCT03045471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102247267|NCT03045471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102613200|NCT02973113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102247268|NCT03045471|Protective Agents|protective agents|mesh-ancestor
102247269|NCT03045471|Tubulin Modulators|tubulin modulators|mesh-ancestor
102247270|NCT03045471|Antimitotic Agents|antimitotic agents|mesh-ancestor
102247271|NCT03045471|Mitosis Modulators|mitosis modulators|mesh-ancestor
102247275|NCT03047499|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102247276|NCT03047499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102247277|NCT03047499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247278|NCT03047499|Cholinergic Agents|cholinergic agents|mesh-ancestor
102247279|NCT03047499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102247280|NCT03047499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715212|NCT02667353|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102247281|NCT03047499|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102247282|NCT03047499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102247287|NCT04867941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102247288|NCT04873479|Ketamine|ketamine|mesh-list
102247289|NCT04873479|Esketamine|esketamine|mesh-list
102247290|NCT04873479|Analgesics|analgesics|mesh-ancestor
102247291|NCT04873479|Sensory System Agents|sensory system agents|mesh-ancestor
102247292|NCT04873479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102247293|NCT04873479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247294|NCT04873479|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102247295|NCT04873479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102247296|NCT04873479|Anesthetics, General|anesthetics, general|mesh-ancestor
102247297|NCT04873479|Anesthetics|anesthetics|mesh-ancestor
102247298|NCT04873479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102247299|NCT04873479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102247300|NCT04873479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102247301|NCT04873479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102247302|NCT04873479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247303|NCT04873479|Antidepressive Agents|antidepressive agents|mesh-ancestor
102247304|NCT04873479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102247305|NCT02451527|Digoxin|digoxin|mesh-list
102247306|NCT02451527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102247307|NCT02451527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102247308|NCT02451527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101715326|NCT00646529|Glucocorticoids|glucocorticoids|mesh-ancestor
102247309|NCT02451527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247310|NCT02451527|Protective Agents|protective agents|mesh-ancestor
102247311|NCT02451527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247312|NCT04873011|Quinine|quinine|mesh-list
102247313|NCT04873011|Antimalarials|antimalarials|mesh-ancestor
102247314|NCT04873011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102247315|NCT04873011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102247316|NCT04873011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102247317|NCT04873011|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102247318|NCT04873011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247319|NCT04873011|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102247320|NCT04873011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102247321|NCT04873011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102247322|NCT04873011|Analgesics|analgesics|mesh-ancestor
102247323|NCT04873011|Sensory System Agents|sensory system agents|mesh-ancestor
102247324|NCT02451605|Analgesics|analgesics|mesh-list
102247325|NCT02451605|Ropivacaine|ropivacaine|mesh-list
102247326|NCT02451605|Anesthetics, Local|anesthetics, local|mesh-ancestor
102247327|NCT02451605|Anesthetics|anesthetics|mesh-ancestor
101956218|NCT02083510|Colchicine|colchicine|mesh-list
102247328|NCT02451605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102247329|NCT02451605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247330|NCT02451605|Sensory System Agents|sensory system agents|mesh-ancestor
102247331|NCT02451605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102247332|NCT03222323|Dexmedetomidine|dexmedetomidine|mesh-list
102247333|NCT03222323|Ropivacaine|ropivacaine|mesh-list
102247334|NCT03222323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102247335|NCT03222323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102247336|NCT03222323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247337|NCT03222323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102247338|NCT03222323|Analgesics|analgesics|mesh-ancestor
102247339|NCT03222323|Sensory System Agents|sensory system agents|mesh-ancestor
102247340|NCT03222323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102247341|NCT03222323|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102613201|NCT02973113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247342|NCT03222323|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102247343|NCT03222323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102247344|NCT03222323|Adrenergic Agents|adrenergic agents|mesh-ancestor
102247345|NCT03222323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102247346|NCT03222323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247347|NCT03222323|Anesthetics, Local|anesthetics, local|mesh-ancestor
102247348|NCT03222323|Anesthetics|anesthetics|mesh-ancestor
102247349|NCT03043677|Adalimumab|adalimumab|mesh-list
102247350|NCT03043677|Infliximab|infliximab|mesh-list
102247351|NCT03043677|Golimumab|golimumab|mesh-list
102247352|NCT03043677|Ustekinumab|ustekinumab|mesh-list
102247353|NCT03043677|Vedolizumab|vedolizumab|mesh-list
102247354|NCT03043677|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102247355|NCT03043677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102247356|NCT03043677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102247357|NCT03043677|Dermatologic Agents|dermatologic agents|mesh-ancestor
102247358|NCT03043677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102247359|NCT03043677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102247360|NCT03043677|Immunologic Factors|immunologic factors|mesh-ancestor
102247361|NCT03043677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247362|NCT03222089|Leucovorin|leucovorin|mesh-list
102247363|NCT03222089|Fluorouracil|fluorouracil|mesh-list
102247364|NCT03222089|Oxaliplatin|oxaliplatin|mesh-list
102247365|NCT03222089|Irinotecan|irinotecan|mesh-list
102247366|NCT03222089|Interleukin-2|interleukin-2|mesh-list
102247367|NCT03222089|Molgramostim|molgramostim|mesh-list
102247368|NCT03222089|Sargramostim|sargramostim|mesh-list
102247369|NCT03222089|Levoleucovorin|levoleucovorin|mesh-list
102247370|NCT03222089|Antimetabolites|antimetabolites|mesh-ancestor
102247371|NCT03222089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247372|NCT03222089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102247373|NCT03222089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102247374|NCT03222089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102247375|NCT03222089|Immunologic Factors|immunologic factors|mesh-ancestor
102247376|NCT03222089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247377|NCT03222089|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102247378|NCT03222089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102247379|NCT03222089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102247380|NCT03222089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102247381|NCT03222089|Analgesics|analgesics|mesh-ancestor
102247382|NCT03222089|Sensory System Agents|sensory system agents|mesh-ancestor
102247383|NCT03222089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102247384|NCT03222089|Antidotes|antidotes|mesh-ancestor
102247385|NCT03222089|Protective Agents|protective agents|mesh-ancestor
102247386|NCT03222089|Vitamin B Complex|vitamin b complex|mesh-ancestor
102247387|NCT03222089|Vitamins|vitamins|mesh-ancestor
102247388|NCT03222089|Micronutrients|micronutrients|mesh-ancestor
102247389|NCT03043989|Clarithromycin|clarithromycin|mesh-list
102247390|NCT03043989|Docetaxel|docetaxel|mesh-list
102247391|NCT03043989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102247392|NCT03043989|Tubulin Modulators|tubulin modulators|mesh-ancestor
102247393|NCT03043989|Antimitotic Agents|antimitotic agents|mesh-ancestor
102247394|NCT03043989|Mitosis Modulators|mitosis modulators|mesh-ancestor
102247395|NCT03043989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247396|NCT03043989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102247397|NCT03043989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102247398|NCT03043989|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102247399|NCT03043989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102247400|NCT03043989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101715567|NCT04171349|Anesthetics|anesthetics|mesh-ancestor
102247401|NCT03043989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102247402|NCT03222167|Grazoprevir|grazoprevir|mesh-list
102247403|NCT03222167|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
102247404|NCT03222167|Antiviral Agents|antiviral agents|mesh-ancestor
102247405|NCT03222167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102247406|NCT03221855|Domperidone|domperidone|mesh-list
102247407|NCT03221855|Antiemetics|antiemetics|mesh-ancestor
102247408|NCT03221855|Autonomic Agents|autonomic agents|mesh-ancestor
102247409|NCT03221855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102247410|NCT03221855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247411|NCT03221855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102247412|NCT03221855|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102247413|NCT03221855|Dopamine Agents|dopamine agents|mesh-ancestor
102247414|NCT03221855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102247415|NCT03221855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613203|NCT00002687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613204|NCT00002687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102247416|NCT03043521|Dexlansoprazole|dexlansoprazole|mesh-list
102247417|NCT03043521|Lansoprazole|lansoprazole|mesh-list
102247418|NCT03043521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102247419|NCT03043521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102247420|NCT03043521|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102247422|NCT03043521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247423|NCT03047733|Tacrolimus|tacrolimus|mesh-list
102247424|NCT03047733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102247425|NCT03047733|Immunologic Factors|immunologic factors|mesh-ancestor
102247426|NCT03047733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247427|NCT03047733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102247428|NCT03047733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102247429|NCT03047733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247430|NCT03221231|Acetylcysteine|acetylcysteine|mesh-list
102247431|NCT03221231|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102247432|NCT03221231|Antiviral Agents|antiviral agents|mesh-ancestor
102247433|NCT03221231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102247434|NCT03221231|Expectorants|expectorants|mesh-ancestor
102247435|NCT03221231|Respiratory System Agents|respiratory system agents|mesh-ancestor
102247436|NCT03221231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102247437|NCT03221231|Antioxidants|antioxidants|mesh-ancestor
102247438|NCT03221231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247439|NCT03221231|Protective Agents|protective agents|mesh-ancestor
102247440|NCT03221231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247441|NCT03221231|Antidotes|antidotes|mesh-ancestor
102247442|NCT03221621|Adalimumab|adalimumab|mesh-list
102247443|NCT03221621|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102247444|NCT03221621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102247445|NCT03221621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102247446|NCT03220841|Adalimumab|adalimumab|mesh-list
102247447|NCT03220841|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102247448|NCT03220841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102247449|NCT03220841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102247450|NCT03045393|Maytansine|maytansine|mesh-list
102247451|NCT03045393|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
102247452|NCT03045393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102247453|NCT03045393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102247454|NCT03045393|Tubulin Modulators|tubulin modulators|mesh-ancestor
102247455|NCT03045393|Antimitotic Agents|antimitotic agents|mesh-ancestor
102247456|NCT03045393|Mitosis Modulators|mitosis modulators|mesh-ancestor
102247457|NCT03045393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247458|NCT03045393|Immunoconjugates|immunoconjugates|mesh-ancestor
102247459|NCT03045393|Immunologic Factors|immunologic factors|mesh-ancestor
102247460|NCT03045393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247461|NCT01374971|Certolizumab Pegol|certolizumab pegol|mesh-list
102247462|NCT01374971|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102247463|NCT01374971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102247464|NCT01374971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102247465|NCT01374971|Immunologic Factors|immunologic factors|mesh-ancestor
102247466|NCT01374971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247467|NCT01374971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102247468|NCT02505815|Hydrocortisone|hydrocortisone|mesh-list
102247469|NCT02505815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102247470|NCT02505971|Propranolol|propranolol|mesh-list
102247471|NCT02505971|Nadolol|nadolol|mesh-list
102247472|NCT02505971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102247473|NCT02505971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102247474|NCT02505971|Adrenergic Agents|adrenergic agents|mesh-ancestor
102247475|NCT02505971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102247476|NCT02505971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247477|NCT02505971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247478|NCT02505971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102247479|NCT02505971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102247480|NCT02505971|Vasodilator Agents|vasodilator agents|mesh-ancestor
102247481|NCT02505971|Sympatholytics|sympatholytics|mesh-ancestor
102247482|NCT02505971|Autonomic Agents|autonomic agents|mesh-ancestor
102247483|NCT02505971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102247484|NCT02505581|Metronidazole|metronidazole|mesh-list
102247485|NCT02505581|Ciprofloxacin|ciprofloxacin|mesh-list
102247486|NCT02505581|Cefuroxime|cefuroxime|mesh-list
102247487|NCT02505581|Cefuroxime axetil|cefuroxime axetil|mesh-list
102247488|NCT02505581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102247489|NCT02505581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102247490|NCT02505581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102247491|NCT02505581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102247492|NCT02505581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102247493|NCT02505581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102247494|NCT02505581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102247495|NCT02505581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247496|NCT02505581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613205|NCT00002687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102247497|NCT02505581|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102613206|NCT00002687|Antiviral Agents|antiviral agents|mesh-ancestor
102247498|NCT02505581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102247499|NCT02451293|Melatonin|melatonin|mesh-list
102247500|NCT02451293|Antioxidants|antioxidants|mesh-ancestor
102247501|NCT02451293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247502|NCT02451293|Protective Agents|protective agents|mesh-ancestor
102247503|NCT02451293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247504|NCT02451293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102247505|NCT02505113|Montelukast|montelukast|mesh-list
102247506|NCT02505113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102247507|NCT02505113|Respiratory System Agents|respiratory system agents|mesh-ancestor
102247508|NCT02505113|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102247509|NCT02505113|Hormone Antagonists|hormone antagonists|mesh-ancestor
102247510|NCT02505113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102247511|NCT02505113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247512|NCT02505113|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102247513|NCT02505113|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102247514|NCT02505113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247515|NCT02504801|Budesonide|budesonide|mesh-list
102247516|NCT02504801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102247517|NCT02504801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102247518|NCT02504801|Autonomic Agents|autonomic agents|mesh-ancestor
102247519|NCT02504801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102247520|NCT02504801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247521|NCT02504801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102247522|NCT02504801|Respiratory System Agents|respiratory system agents|mesh-ancestor
102247523|NCT02504801|Glucocorticoids|glucocorticoids|mesh-ancestor
102247524|NCT02504801|Hormones|hormones|mesh-ancestor
102247525|NCT02504801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102247526|NCT02504333|Paclitaxel|paclitaxel|mesh-list
102247527|NCT02504333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102247528|NCT02504333|Gemcitabine|gemcitabine|mesh-list
102247529|NCT02504333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102247530|NCT02504333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102247531|NCT02504333|Tubulin Modulators|tubulin modulators|mesh-ancestor
102247532|NCT02504333|Antimitotic Agents|antimitotic agents|mesh-ancestor
102247533|NCT02504333|Mitosis Modulators|mitosis modulators|mesh-ancestor
102247534|NCT02504333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247535|NCT02504333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102247536|NCT02504333|Antimetabolites|antimetabolites|mesh-ancestor
102247537|NCT02504177|Anticoagulants|anticoagulants|mesh-list
102247538|NCT02450981|Bevacizumab|bevacizumab|mesh-list
102247539|NCT02450981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102247540|NCT02450981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102247541|NCT02450981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102247542|NCT02450981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102247543|NCT02450981|Growth Substances|growth substances|mesh-ancestor
102247544|NCT02450981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247545|NCT02450981|Growth Inhibitors|growth inhibitors|mesh-ancestor
102247546|NCT02503943|Metformin|metformin|mesh-list
102247547|NCT02503943|Liraglutide|liraglutide|mesh-list
102247548|NCT02503943|Mitiglinide|mitiglinide|mesh-list
102247549|NCT02503943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102247550|NCT02503943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247551|NCT02503943|Incretins|incretins|mesh-ancestor
102247552|NCT02503943|Hormones|hormones|mesh-ancestor
102247553|NCT02503943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102247554|NCT03213743|Dexmedetomidine|dexmedetomidine|mesh-list
102247555|NCT03213743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101956465|NCT00153101|Ramipril|ramipril|mesh-list
102247556|NCT03213743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102247557|NCT03213743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247558|NCT03213743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102247560|NCT03213743|Sensory System Agents|sensory system agents|mesh-ancestor
102247561|NCT03213743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102247562|NCT03213743|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102247563|NCT03213743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102247564|NCT03213743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102247565|NCT03213743|Adrenergic Agents|adrenergic agents|mesh-ancestor
102247566|NCT03213743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102247567|NCT03213743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247568|NCT03212495|Neostigmine|neostigmine|mesh-list
102247569|NCT03212495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247570|NCT03212495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102247571|NCT03212495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102247572|NCT03212495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247573|NCT03212495|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102247574|NCT03212495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102247575|NCT03212495|Cholinergic Agents|cholinergic agents|mesh-ancestor
102247576|NCT03212495|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102247577|NCT03212495|Autonomic Agents|autonomic agents|mesh-ancestor
102247578|NCT02503319|Tranexamic Acid|tranexamic acid|mesh-list
102247579|NCT02503319|Oxytocin|oxytocin|mesh-list
102247580|NCT02503319|Oxytocics|oxytocics|mesh-ancestor
102247581|NCT02503319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102247582|NCT02503319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247583|NCT02503319|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102247584|NCT02503319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102247585|NCT02503319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247586|NCT02503319|Hemostatics|hemostatics|mesh-ancestor
102247587|NCT02503319|Coagulants|coagulants|mesh-ancestor
102247588|NCT02610777|Azacitidine|azacitidine|mesh-list
102247589|NCT02610777|Pevonedistat|pevonedistat|mesh-list
102247590|NCT02610777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102247591|NCT02610777|Antimetabolites|antimetabolites|mesh-ancestor
102247592|NCT02610777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247593|NCT02610777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102247594|NCT02610777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102247595|NCT01628692|Ribavirin|ribavirin|mesh-list
102247596|NCT01628692|Simeprevir|simeprevir|mesh-list
102247597|NCT01628692|Antimetabolites|antimetabolites|mesh-ancestor
102247598|NCT01628692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247599|NCT01628692|Antiviral Agents|antiviral agents|mesh-ancestor
102247600|NCT01628692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102247601|NCT01628692|Protease Inhibitors|protease inhibitors|mesh-ancestor
102247602|NCT01628692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102247603|NCT02503163|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102247604|NCT02503163|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102247605|NCT04496921|Vitamins|vitamins|mesh-list
102247606|NCT04496921|Vitamin K|vitamin k|mesh-list
102247607|NCT04496921|Micronutrients|micronutrients|mesh-ancestor
102247608|NCT04496921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247609|NCT04496921|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102247610|NCT04496921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102247611|NCT04496921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247612|NCT04496921|Hemostatics|hemostatics|mesh-ancestor
102247613|NCT04496921|Coagulants|coagulants|mesh-ancestor
102247614|NCT03043287|Botulinum Toxins|botulinum toxins|mesh-list
102247615|NCT03043287|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102247616|NCT03043287|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102247617|NCT03043287|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102247618|NCT03043287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102247619|NCT03043287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247620|NCT03043287|Cholinergic Agents|cholinergic agents|mesh-ancestor
102247621|NCT03043287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102247622|NCT03043287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247623|NCT03043287|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102247624|NCT03043287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102247625|NCT03043443|Melatonin|melatonin|mesh-list
102247626|NCT03043443|Antioxidants|antioxidants|mesh-ancestor
102247627|NCT03043443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247628|NCT03043443|Protective Agents|protective agents|mesh-ancestor
102247629|NCT03043443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247630|NCT03043443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102247631|NCT04383795|Antithyroid Agents|antithyroid agents|mesh-list
102247632|NCT04383795|Hormone Antagonists|hormone antagonists|mesh-ancestor
102247633|NCT04383795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102247634|NCT04383795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247635|NCT03043131|Plasma-lyte 148|plasma-lyte 148|mesh-list
102247636|NCT03043131|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102247637|NCT03043131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102247638|NCT03209297|Salicylic Acid|salicylic acid|mesh-list
102247639|NCT03209297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102247640|NCT03209297|Antifungal Agents|antifungal agents|mesh-ancestor
102247641|NCT03209297|Keratolytic Agents|keratolytic agents|mesh-ancestor
102247642|NCT03209297|Dermatologic Agents|dermatologic agents|mesh-ancestor
102613207|NCT00002687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102247643|NCT03209219|Interferons|interferons|mesh-list
102247644|NCT03209219|Interferon-alpha|interferon-alpha|mesh-list
102247645|NCT03209219|Interferon alpha-2|interferon alpha-2|mesh-list
102247646|NCT03209219|Cyclosporine|cyclosporine|mesh-list
102247647|NCT03209219|Cyclosporins|cyclosporins|mesh-list
102247648|NCT03209219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102247649|NCT03209219|Antiviral Agents|antiviral agents|mesh-ancestor
102247650|NCT03209219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102247651|NCT03209219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102247652|NCT03209219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247653|NCT03209219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102247654|NCT03209219|Immunologic Factors|immunologic factors|mesh-ancestor
102247655|NCT03209219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247656|NCT03209219|Antifungal Agents|antifungal agents|mesh-ancestor
102247657|NCT03209219|Dermatologic Agents|dermatologic agents|mesh-ancestor
102247658|NCT03209219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102247659|NCT03209219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102247660|NCT04872231|Voriconazole|voriconazole|mesh-list
102247661|NCT04872231|Antifungal Agents|antifungal agents|mesh-ancestor
102247662|NCT04872231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102247663|NCT04872231|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102247664|NCT04872231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102247665|NCT04872231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102247666|NCT04872231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247667|NCT04872231|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102247668|NCT04872231|Hormone Antagonists|hormone antagonists|mesh-ancestor
102247669|NCT04872231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102247670|NCT04872231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247671|NCT04872231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102247672|NCT04860531|Betamethasone|betamethasone|mesh-list
102247673|NCT04860531|Lidocaine|lidocaine|mesh-list
102247674|NCT04860531|Anesthetics, Local|anesthetics, local|mesh-ancestor
102247675|NCT04860531|Anesthetics|anesthetics|mesh-ancestor
102247676|NCT04860531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102247677|NCT04860531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247678|NCT04860531|Sensory System Agents|sensory system agents|mesh-ancestor
102247679|NCT04860531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101715732|NCT02654171|Antiviral Agents|antiviral agents|mesh-ancestor
102247680|NCT04860531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102247681|NCT04860531|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102247682|NCT04860531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102247683|NCT04860531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102247684|NCT04860531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247685|NCT04860531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102247686|NCT04860531|Glucocorticoids|glucocorticoids|mesh-ancestor
102247687|NCT04860531|Hormones|hormones|mesh-ancestor
102247688|NCT04860531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102247689|NCT04860531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102247690|NCT04860531|Respiratory System Agents|respiratory system agents|mesh-ancestor
102247691|NCT01594827|Chlorhexidine|chlorhexidine|mesh-list
102247692|NCT01594827|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102247693|NCT01594827|Vancomycin|vancomycin|mesh-list
102247694|NCT01594827|Doxycycline|doxycycline|mesh-list
102247695|NCT01594827|Rifampin|rifampin|mesh-list
102247696|NCT01594827|Trimethoprim|trimethoprim|mesh-list
102247697|NCT01594827|Sulfamethoxazole|sulfamethoxazole|mesh-list
102247698|NCT01594827|Mupirocin|mupirocin|mesh-list
102247699|NCT01594827|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102247700|NCT01594827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102247701|NCT01594827|Disinfectants|disinfectants|mesh-ancestor
102247702|NCT01594827|Dermatologic Agents|dermatologic agents|mesh-ancestor
102247703|NCT01594827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102247704|NCT01594827|Antimalarials|antimalarials|mesh-ancestor
102247705|NCT01594827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102247706|NCT01594827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102247707|NCT01594827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102247708|NCT01594827|Antitubercular Agents|antitubercular agents|mesh-ancestor
102247709|NCT01594827|Leprostatic Agents|leprostatic agents|mesh-ancestor
102247710|NCT01594827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102247711|NCT01594827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102247712|NCT01594827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247713|NCT01594827|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102247714|NCT01594827|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102247715|NCT01594827|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102247716|NCT01594827|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102613208|NCT00002693|Carboplatin|carboplatin|mesh-list
102613209|NCT00002693|Topotecan|topotecan|mesh-list
102247717|NCT01594827|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102247718|NCT01594827|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102247719|NCT01594827|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102247720|NCT01594827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102247721|NCT01594827|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102247722|NCT01594827|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102247723|NCT01594827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102247724|NCT01594827|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102247726|NCT04849845|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102247727|NCT04849845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102247728|NCT04849845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247729|NCT04429191|Antibodies|antibodies|mesh-list
102247730|NCT04429191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102247731|NCT04429191|Immunologic Factors|immunologic factors|mesh-ancestor
102247732|NCT04429191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247733|NCT02610231|Istradefylline|istradefylline|mesh-list
102247734|NCT02610231|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
102247735|NCT02610231|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102247736|NCT02610231|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102247737|NCT02610231|Purinergic Agents|purinergic agents|mesh-ancestor
101715745|NCT00848354|Etanercept|etanercept|mesh-list
102247738|NCT02610231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102247739|NCT02610231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247740|NCT02610231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247741|NCT04850157|Tislelizumab|tislelizumab|mesh-list
102247742|NCT04850157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102247743|NCT04850157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102247744|NCT04849533|Mycophenolic Acid|mycophenolic acid|mesh-list
102247745|NCT04849533|Prednisone|prednisone|mesh-list
102247746|NCT04849533|Everolimus|everolimus|mesh-list
102247747|NCT04849533|Abatacept|abatacept|mesh-list
102247748|NCT04849533|Thymoglobulin|thymoglobulin|mesh-list
102247749|NCT04849533|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102247750|NCT04849533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102247751|NCT04849533|Glucocorticoids|glucocorticoids|mesh-ancestor
102247752|NCT04849533|Hormones|hormones|mesh-ancestor
102247753|NCT04849533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102247754|NCT04849533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247755|NCT04849533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102247756|NCT04849533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102247757|NCT04849533|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102247758|NCT04849533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102247759|NCT04849533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102247760|NCT04849533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247761|NCT04849533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102247762|NCT04849533|Immunologic Factors|immunologic factors|mesh-ancestor
102247763|NCT04849533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102247764|NCT04849533|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102247765|NCT04849533|Antitubercular Agents|antitubercular agents|mesh-ancestor
102247766|NCT04849533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102247767|NCT04849533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102247768|NCT04849533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102247769|NCT04849533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102247770|NCT04849533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102247771|NCT03040635|Risdiplam|risdiplam|mesh-list
102247772|NCT03040635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102247773|NCT03040635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102247774|NCT03040635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247775|NCT02178358|Sorafenib|sorafenib|mesh-list
102247776|NCT02178358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102247777|NCT02178358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102247778|NCT02178358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102247779|NCT02178358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956673|NCT02088502|Expectorants|expectorants|mesh-ancestor
102247780|NCT01598896|Clonidine|clonidine|mesh-list
102247781|NCT01598896|Dronabinol|dronabinol|mesh-list
102247782|NCT01598896|Analgesics|analgesics|mesh-ancestor
102247783|NCT01598896|Sensory System Agents|sensory system agents|mesh-ancestor
102247784|NCT01598896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101715764|NCT00848354|Analgesics|analgesics|mesh-ancestor
102247785|NCT01598896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247786|NCT01598896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102247787|NCT01598896|Sympatholytics|sympatholytics|mesh-ancestor
102247788|NCT01598896|Autonomic Agents|autonomic agents|mesh-ancestor
102613210|NCT00002693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101901641|NCT01290146|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102247789|NCT01598896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102613211|NCT00002693|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102247790|NCT01598896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102247791|NCT01598896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102247792|NCT01598896|Adrenergic Agents|adrenergic agents|mesh-ancestor
102247793|NCT01598896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102247794|NCT01598896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247795|NCT01598896|Hallucinogens|hallucinogens|mesh-ancestor
102247796|NCT01598896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102247797|NCT01598896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102247798|NCT01598896|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102247799|NCT01598896|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102247801|NCT01598896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102247802|NCT01598662|Levonorgestrel|levonorgestrel|mesh-list
102247803|NCT01598662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102247804|NCT01598662|Contraceptive Agents|contraceptive agents|mesh-ancestor
102247805|NCT01598662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102247806|NCT01598662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247807|NCT01598662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102247808|NCT01598662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102247809|NCT01598662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102247810|NCT03042429|Cyclophosphamide|cyclophosphamide|mesh-list
102247811|NCT03042429|Ifosfamide|ifosfamide|mesh-list
102247812|NCT03042429|Cisplatin|cisplatin|mesh-list
102247813|NCT03042429|Doxorubicin|doxorubicin|mesh-list
102247814|NCT03042429|Etoposide|etoposide|mesh-list
102247815|NCT03042429|Topotecan|topotecan|mesh-list
102247816|NCT03042429|Vindesine|vindesine|mesh-list
102247817|NCT03042429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102247818|NCT03042429|Immunologic Factors|immunologic factors|mesh-ancestor
102247819|NCT03042429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247820|NCT03042429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102247821|NCT03042429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102247822|NCT03042429|Alkylating Agents|alkylating agents|mesh-ancestor
102247823|NCT03042429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247824|NCT03042429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102247825|NCT03042429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102247826|NCT03042429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102247827|NCT03042429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102247828|NCT03042429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102247829|NCT03042429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102247830|NCT03042429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101715839|NCT00649649|Quinapril|quinapril|mesh-list
102247831|NCT03042429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102247832|NCT03042429|Tubulin Modulators|tubulin modulators|mesh-ancestor
102247833|NCT03042429|Antimitotic Agents|antimitotic agents|mesh-ancestor
102247834|NCT03042429|Mitosis Modulators|mitosis modulators|mesh-ancestor
102247835|NCT04849299|Cyclosporine|cyclosporine|mesh-list
102247836|NCT04849299|Cyclosporins|cyclosporins|mesh-list
102247837|NCT04849299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102247838|NCT04849299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247839|NCT04849299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102247840|NCT04849299|Immunologic Factors|immunologic factors|mesh-ancestor
102247841|NCT04849299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247842|NCT04849299|Antifungal Agents|antifungal agents|mesh-ancestor
102247843|NCT04849299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102247844|NCT04849299|Dermatologic Agents|dermatologic agents|mesh-ancestor
102247845|NCT04849299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102247846|NCT04849299|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102247847|NCT02117050|Interferons|interferons|mesh-list
102247848|NCT02117050|Interferon-beta|interferon-beta|mesh-list
102247849|NCT02117050|Interferon beta-1a|interferon beta-1a|mesh-list
102247850|NCT02117050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102247851|NCT02117050|Antiviral Agents|antiviral agents|mesh-ancestor
102247852|NCT02117050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102247853|NCT02117050|Immunologic Factors|immunologic factors|mesh-ancestor
102247854|NCT02117050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247855|NCT02117050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102247856|NCT04860219|Lactoferrin|lactoferrin|mesh-list
102247857|NCT04860219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102247858|NCT02728895|Vedolizumab|vedolizumab|mesh-list
102247859|NCT02728895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102247860|NCT04847895|Ranibizumab|ranibizumab|mesh-list
102247861|NCT04847895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102247862|NCT04847895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102247863|NCT04847895|Growth Substances|growth substances|mesh-ancestor
102613212|NCT00002693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102247864|NCT04847895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247865|NCT04847895|Growth Inhibitors|growth inhibitors|mesh-ancestor
102247866|NCT04847895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102247867|NCT02450513|Adalimumab|adalimumab|mesh-list
102247868|NCT02450513|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102247869|NCT02450513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102247870|NCT02450513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102247871|NCT04859283|Dexmedetomidine|dexmedetomidine|mesh-list
102247872|NCT04859283|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102247873|NCT04859283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102247874|NCT04859283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247875|NCT04859283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102247876|NCT04859283|Analgesics|analgesics|mesh-ancestor
102247877|NCT04859283|Sensory System Agents|sensory system agents|mesh-ancestor
102247878|NCT04859283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102247879|NCT04859283|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102247880|NCT04859283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102247881|NCT04859283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102247882|NCT04859283|Adrenergic Agents|adrenergic agents|mesh-ancestor
102247883|NCT04859283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102247884|NCT04859283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247885|NCT04857801|Teduglutide|teduglutide|mesh-list
102247886|NCT04857801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102247887|NCT04857801|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102247888|NCT04857801|Protective Agents|protective agents|mesh-ancestor
102247889|NCT04857801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247890|NCT03208361|Amoxicillin|amoxicillin|mesh-list
102247891|NCT03208361|Penicillins|penicillins|mesh-list
102247892|NCT03208361|Penicillin V|penicillin v|mesh-list
102247893|NCT03208361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102247894|NCT03208361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102247895|NCT02501837|Oxytocin|oxytocin|mesh-list
102247896|NCT02501837|Oxytocics|oxytocics|mesh-ancestor
102247897|NCT02501837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102247898|NCT02501837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247899|NCT04859361|Imiquimod|imiquimod|mesh-list
102247900|NCT04859361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102247901|NCT04859361|Immunologic Factors|immunologic factors|mesh-ancestor
102247902|NCT04859361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247903|NCT04859361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102247904|NCT04859361|Interferon Inducers|interferon inducers|mesh-ancestor
102247905|NCT04496141|Antibodies|antibodies|mesh-list
102247906|NCT04496141|Immunologic Factors|immunologic factors|mesh-ancestor
102247907|NCT04496141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247908|NCT03039075|Metformin|metformin|mesh-list
102247909|NCT03039075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102247910|NCT03039075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247911|NCT04857177|Ranibizumab|ranibizumab|mesh-list
102247912|NCT04857177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102247913|NCT04857177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102247914|NCT04857177|Growth Substances|growth substances|mesh-ancestor
102247915|NCT04857177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247916|NCT04857177|Growth Inhibitors|growth inhibitors|mesh-ancestor
102247917|NCT04857177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102247918|NCT02606877|Pirfenidone|pirfenidone|mesh-list
102247919|NCT02606877|Nintedanib|nintedanib|mesh-list
101716131|NCT00744250|Pancreatin|pancreatin|mesh-list
102247920|NCT02606877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102247921|NCT02606877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102247922|NCT02606877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102247923|NCT02606877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247924|NCT02606877|Analgesics|analgesics|mesh-ancestor
102247925|NCT02606877|Sensory System Agents|sensory system agents|mesh-ancestor
102247926|NCT02606877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102247927|NCT02606877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247928|NCT02606877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102247929|NCT02606877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102247930|NCT02606877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102247931|NCT02606877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102247932|NCT03206957|Endostatins|endostatins|mesh-list
102247933|NCT03206957|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-list
102247934|NCT03206957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102247935|NCT03206957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102247936|NCT03206957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102247937|NCT03206957|Growth Substances|growth substances|mesh-ancestor
102247938|NCT03206957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247939|NCT03206957|Growth Inhibitors|growth inhibitors|mesh-ancestor
101716161|NCT00866294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102247940|NCT03206723|Hydrocodone|hydrocodone|mesh-list
102247941|NCT03206723|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102247942|NCT03206723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102247943|NCT03206723|Narcotics|narcotics|mesh-ancestor
102247944|NCT03206723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102247945|NCT03206723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247946|NCT03206723|Analgesics|analgesics|mesh-ancestor
102247947|NCT03206723|Sensory System Agents|sensory system agents|mesh-ancestor
102247948|NCT03206723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102247949|NCT03206723|Antitussive Agents|antitussive agents|mesh-ancestor
102247950|NCT03206723|Respiratory System Agents|respiratory system agents|mesh-ancestor
102247951|NCT03206723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102247952|NCT03201185|Ramipril|ramipril|mesh-list
102247953|NCT03201185|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102247954|NCT03201185|Protease Inhibitors|protease inhibitors|mesh-ancestor
102247955|NCT03201185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102247956|NCT03201185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247957|NCT03201185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102247958|NCT04856787|Fluorouracil|fluorouracil|mesh-list
102247959|NCT04856787|Antimetabolites|antimetabolites|mesh-ancestor
102247960|NCT04856787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247961|NCT04856787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102247962|NCT04856787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102247963|NCT04856787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102247964|NCT04856787|Immunologic Factors|immunologic factors|mesh-ancestor
102247965|NCT04856787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247966|NCT03206177|Paclitaxel|paclitaxel|mesh-list
102247967|NCT03206177|Carboplatin|carboplatin|mesh-list
102247968|NCT03206177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102247969|NCT03206177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102247970|NCT03206177|Tubulin Modulators|tubulin modulators|mesh-ancestor
102247971|NCT03206177|Antimitotic Agents|antimitotic agents|mesh-ancestor
102247972|NCT03206177|Mitosis Modulators|mitosis modulators|mesh-ancestor
102247973|NCT03206177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247974|NCT04839471|Afatinib|afatinib|mesh-list
102247975|NCT04839471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102247976|NCT04839471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102247977|NCT04839471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102247978|NCT04839471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102247979|NCT04839237|Metformin|metformin|mesh-list
102247980|NCT04839237|Liraglutide|liraglutide|mesh-list
102247981|NCT04839237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102247982|NCT04839237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247983|NCT04839237|Incretins|incretins|mesh-ancestor
102247984|NCT04839237|Hormones|hormones|mesh-ancestor
102247985|NCT04839237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102247986|NCT04844775|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
102247987|NCT04844775|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102247988|NCT04844775|Immunologic Factors|immunologic factors|mesh-ancestor
102247989|NCT04844775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247990|NCT03038607|Aspirin|aspirin|mesh-list
102247991|NCT03038607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102247992|NCT03038607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102247993|NCT03038607|Analgesics|analgesics|mesh-ancestor
102247994|NCT03038607|Sensory System Agents|sensory system agents|mesh-ancestor
102247995|NCT03038607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102247996|NCT03038607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102247997|NCT03038607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102247998|NCT03038607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102247999|NCT03038607|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102248000|NCT03038607|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102248001|NCT03038607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248002|NCT03038607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102248003|NCT03038607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102248004|NCT03038607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102248005|NCT03038607|Antipyretics|antipyretics|mesh-ancestor
102248006|NCT03038451|Amlodipine|amlodipine|mesh-list
102248007|NCT03038451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102248008|NCT03038451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101956897|NCT05571332|Immunologic Factors|immunologic factors|mesh-ancestor
102248009|NCT03038451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102248010|NCT03038451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901644|NCT01290146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102613213|NCT00002693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102248011|NCT03038451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102248012|NCT03038451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248013|NCT03038451|Vasodilator Agents|vasodilator agents|mesh-ancestor
102248015|NCT03040401|Interleukin-2|interleukin-2|mesh-list
102248016|NCT03040401|Histamine|histamine|mesh-list
102248017|NCT03040401|Histamine phosphate|histamine phosphate|mesh-list
102248018|NCT03040401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102248019|NCT03040401|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102248020|NCT03040401|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102248021|NCT03040401|Antiviral Agents|antiviral agents|mesh-ancestor
102248022|NCT03040401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102248023|NCT03040401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102248024|NCT03040401|Analgesics|analgesics|mesh-ancestor
102248025|NCT03040401|Sensory System Agents|sensory system agents|mesh-ancestor
102248026|NCT03040401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102248027|NCT03040401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248028|NCT03040401|Histamine Agonists|histamine agonists|mesh-ancestor
102248029|NCT03040401|Histamine Agents|histamine agents|mesh-ancestor
102248030|NCT03040401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102248031|NCT03040401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248032|NCT03038295|Propranolol|propranolol|mesh-list
102248033|NCT03038295|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102248034|NCT03038295|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102248035|NCT03038295|Adrenergic Agents|adrenergic agents|mesh-ancestor
102248036|NCT03038295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102248037|NCT03038295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248038|NCT03038295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248039|NCT03038295|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102248040|NCT03038295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102248041|NCT03038295|Vasodilator Agents|vasodilator agents|mesh-ancestor
102248042|NCT03038217|Capecitabine|capecitabine|mesh-list
102248043|NCT03038217|Oxaliplatin|oxaliplatin|mesh-list
102248044|NCT03038217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102248045|NCT03038217|Antimetabolites|antimetabolites|mesh-ancestor
101716781|NCT02562664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248046|NCT03038217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248047|NCT03038217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102248048|NCT02609607|Bisacodyl|bisacodyl|mesh-list
102248049|NCT02609607|Cathartics|cathartics|mesh-ancestor
102248050|NCT02609607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102248051|NCT02609607|Laxatives|laxatives|mesh-ancestor
102248052|NCT03040167|Epinephrine|epinephrine|mesh-list
102248053|NCT03040167|Bupivacaine|bupivacaine|mesh-list
102248054|NCT03040167|Anesthetics, Local|anesthetics, local|mesh-ancestor
102248055|NCT03040167|Anesthetics|anesthetics|mesh-ancestor
102248056|NCT03040167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102248057|NCT03040167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248058|NCT03040167|Sensory System Agents|sensory system agents|mesh-ancestor
102248059|NCT03040167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102248060|NCT03040167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102248061|NCT03040167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102248062|NCT03040167|Adrenergic Agents|adrenergic agents|mesh-ancestor
102248063|NCT03040167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102248064|NCT03040167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248065|NCT03040167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102248066|NCT03040167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102248067|NCT03040167|Autonomic Agents|autonomic agents|mesh-ancestor
102248068|NCT03040167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102248069|NCT03040167|Respiratory System Agents|respiratory system agents|mesh-ancestor
102248070|NCT03040167|Mydriatics|mydriatics|mesh-ancestor
102248071|NCT03040167|Sympathomimetics|sympathomimetics|mesh-ancestor
102248072|NCT03040167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102248073|NCT04843839|Nepafenac|nepafenac|mesh-list
102248074|NCT04843839|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102248075|NCT04843839|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102248076|NCT04843839|Lubricant Eye Drops|lubricant eye drops|mesh-list
102248077|NCT04843839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102248078|NCT04843839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102248079|NCT04843839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102248080|NCT04843839|Analgesics|analgesics|mesh-ancestor
102613214|NCT00002693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613215|NCT00002705|Topotecan|topotecan|mesh-list
102613216|NCT00002705|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102248081|NCT04843839|Sensory System Agents|sensory system agents|mesh-ancestor
102248082|NCT04843839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101901645|NCT01290146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102613217|NCT00002705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102248083|NCT04843839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248084|NCT04843839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102248085|NCT04843839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102248086|NCT04843839|Laxatives|laxatives|mesh-ancestor
102248087|NCT04843839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102248088|NCT04838145|Ribavirin|ribavirin|mesh-list
102248089|NCT04838145|Pleconaril|pleconaril|mesh-list
102248090|NCT04838145|Antimetabolites|antimetabolites|mesh-ancestor
102248091|NCT04838145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248092|NCT04838145|Antiviral Agents|antiviral agents|mesh-ancestor
102248093|NCT04838145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102248094|NCT04855383|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102248095|NCT04855383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102248096|NCT04855383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248097|NCT03041259|Ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium D-pantothenate drug combination|ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium d-pantothenate drug combination|mesh-list
102248098|NCT03041259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102248099|NCT03041259|Antioxidants|antioxidants|mesh-ancestor
102248100|NCT03041259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248101|NCT03041259|Protective Agents|protective agents|mesh-ancestor
102248102|NCT03041259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248103|NCT04429035|Vitamin K|vitamin k|mesh-list
102248104|NCT04429035|Vitamin K 2|vitamin k 2|mesh-list
102248105|NCT04429035|Vitamins|vitamins|mesh-ancestor
102248106|NCT04429035|Micronutrients|micronutrients|mesh-ancestor
102248107|NCT04429035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248108|NCT04429035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102248109|NCT04429035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102248110|NCT04429035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248111|NCT04429035|Hemostatics|hemostatics|mesh-ancestor
102248112|NCT04429035|Coagulants|coagulants|mesh-ancestor
102248113|NCT04843449|Itraconazole|itraconazole|mesh-list
102248114|NCT04843449|Rifampin|rifampin|mesh-list
102248115|NCT04843449|Antifungal Agents|antifungal agents|mesh-ancestor
102248116|NCT04843449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102248117|NCT04843449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102248118|NCT04843449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102248119|NCT04843449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102248120|NCT04843449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248121|NCT04843449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102248122|NCT04843449|Hormone Antagonists|hormone antagonists|mesh-ancestor
102248123|NCT04843449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102248124|NCT04843449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248125|NCT04843449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102248126|NCT04843449|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102248127|NCT04843449|Antitubercular Agents|antitubercular agents|mesh-ancestor
102248128|NCT04843449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102248129|NCT04843449|Leprostatic Agents|leprostatic agents|mesh-ancestor
102248130|NCT04843449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102248131|NCT04843449|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102248132|NCT04843449|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102248133|NCT04843449|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102248134|NCT04843449|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102248135|NCT04843449|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102248136|NCT04843449|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102248137|NCT03037593|Vitamin D|vitamin d|mesh-list
102248138|NCT03037593|Cholecalciferol|cholecalciferol|mesh-list
102248139|NCT03037593|Vitamins|vitamins|mesh-ancestor
102248140|NCT03037593|Micronutrients|micronutrients|mesh-ancestor
102248141|NCT03037593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248142|NCT03037593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102248143|NCT03037593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102248144|NCT03037515|Tranexamic Acid|tranexamic acid|mesh-list
102248145|NCT03037515|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102248146|NCT03037515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102248147|NCT03037515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248148|NCT03037515|Hemostatics|hemostatics|mesh-ancestor
102248149|NCT03037515|Coagulants|coagulants|mesh-ancestor
102248150|NCT04842825|Cetrorelix|cetrorelix|mesh-list
102248151|NCT04842825|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102248152|NCT04842825|Hormones|hormones|mesh-ancestor
102613218|NCT00002705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102248153|NCT04842825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102248154|NCT04842825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248155|NCT04842825|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102248156|NCT04842825|Fertility Agents|fertility agents|mesh-ancestor
102248157|NCT04842825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102248158|NCT04842825|Hormone Antagonists|hormone antagonists|mesh-ancestor
102248159|NCT02606253|Metolazone|metolazone|mesh-list
102248160|NCT02606253|Chlorothiazide|chlorothiazide|mesh-list
102248161|NCT02606253|Tolvaptan|tolvaptan|mesh-list
102248162|NCT02606253|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101716934|NCT02562118|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102248163|NCT02606253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248164|NCT02606253|Natriuretic Agents|natriuretic agents|mesh-ancestor
102248165|NCT02606253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248166|NCT02606253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102248167|NCT02606253|Diuretics|diuretics|mesh-ancestor
102248168|NCT02606253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102248169|NCT02606253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102248170|NCT04779645|Volagidemab|volagidemab|mesh-list
102248171|NCT04779645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102248172|NCT04779645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248173|NCT04854759|Amantadine|amantadine|mesh-list
102248174|NCT04854759|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102248175|NCT04854759|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102248176|NCT04854759|Antiviral Agents|antiviral agents|mesh-ancestor
102248177|NCT04854759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102248178|NCT04854759|Dopamine Agents|dopamine agents|mesh-ancestor
102248179|NCT04854759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102248180|NCT04854759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248181|NCT04854759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248182|NCT04854759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102248183|NCT04854759|Analgesics|analgesics|mesh-ancestor
102248184|NCT04854759|Sensory System Agents|sensory system agents|mesh-ancestor
102248185|NCT04854759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102248186|NCT04842435|Immunoglobulins|immunoglobulins|mesh-list
102248187|NCT04842435|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102248188|NCT04842435|Immunologic Factors|immunologic factors|mesh-ancestor
102248189|NCT04842435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248190|NCT04774419|Dostarlimab|dostarlimab|mesh-list
102248191|NCT04774419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102248192|NCT02607735|Sofosbuvir|sofosbuvir|mesh-list
102248193|NCT02607735|Velpatasvir|velpatasvir|mesh-list
102248194|NCT02607735|Antiviral Agents|antiviral agents|mesh-ancestor
102248195|NCT02607735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102248196|NCT04772313|Methotrexate|methotrexate|mesh-list
102248197|NCT04772313|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102248198|NCT04772313|Abortifacient Agents|abortifacient agents|mesh-ancestor
102248199|NCT04772313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102248200|NCT04772313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248201|NCT04772313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102248202|NCT04772313|Antimetabolites|antimetabolites|mesh-ancestor
102248203|NCT04772313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248204|NCT04772313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102248205|NCT04772313|Dermatologic Agents|dermatologic agents|mesh-ancestor
102248206|NCT04772313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102248207|NCT04772313|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102248208|NCT04772313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102248209|NCT04772313|Immunologic Factors|immunologic factors|mesh-ancestor
102248210|NCT04772313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102248211|NCT04772313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102248212|NCT03040791|Nivolumab|nivolumab|mesh-list
102248213|NCT03040791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102248214|NCT03040791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102248215|NCT03040791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102248216|NCT03040791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248217|NCT04428879|Topotecan|topotecan|mesh-list
102248218|NCT04428879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102248219|NCT04428879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102248220|NCT04428879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102248221|NCT04428879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248222|NCT04428879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102248223|NCT04836819|Lidocaine|lidocaine|mesh-list
102248224|NCT04836819|Dexmedetomidine|dexmedetomidine|mesh-list
102248225|NCT04836819|Ketamine|ketamine|mesh-list
102613219|NCT00002705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248226|NCT04836819|Anesthetics, Local|anesthetics, local|mesh-ancestor
102248227|NCT04836819|Anesthetics|anesthetics|mesh-ancestor
102248228|NCT04836819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102248229|NCT04836819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248230|NCT04836819|Sensory System Agents|sensory system agents|mesh-ancestor
102248231|NCT04836819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102248233|NCT04836819|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102248234|NCT04836819|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102248235|NCT04836819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102248236|NCT04836819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248237|NCT04836819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102248238|NCT04836819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102248239|NCT04836819|Analgesics|analgesics|mesh-ancestor
102248240|NCT04836819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102248241|NCT04836819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102248242|NCT04836819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102248243|NCT04836819|Adrenergic Agents|adrenergic agents|mesh-ancestor
102248244|NCT04836819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102248245|NCT04836819|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102248246|NCT04836819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102248247|NCT04836819|Anesthetics, General|anesthetics, general|mesh-ancestor
102248248|NCT04836819|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102248249|NCT04836819|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102248250|NCT04836507|Cyclophosphamide|cyclophosphamide|mesh-list
102248251|NCT04836507|Fludarabine|fludarabine|mesh-list
102248252|NCT04836507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102248253|NCT04836507|Immunologic Factors|immunologic factors|mesh-ancestor
102248254|NCT04836507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248255|NCT04836507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102248256|NCT04836507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102248257|NCT04836507|Alkylating Agents|alkylating agents|mesh-ancestor
102248258|NCT04836507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248259|NCT04836507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102248260|NCT04836507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102248261|NCT04835259|Selenium|selenium|mesh-list
102248262|NCT04835259|Antioxidants|antioxidants|mesh-ancestor
102248263|NCT04835259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248264|NCT04835259|Protective Agents|protective agents|mesh-ancestor
102248265|NCT04835259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248266|NCT04835259|Trace Elements|trace elements|mesh-ancestor
102248267|NCT04835259|Micronutrients|micronutrients|mesh-ancestor
102248268|NCT04853901|Remdesivir|remdesivir|mesh-list
102248269|NCT04853901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102248270|NCT04853901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248271|NCT04853901|Antimetabolites|antimetabolites|mesh-ancestor
102248272|NCT04853901|Antiviral Agents|antiviral agents|mesh-ancestor
102248273|NCT01668537|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
102248274|NCT01668537|Antiviral Agents|antiviral agents|mesh-ancestor
101717366|NCT00750802|Antiemetics|antiemetics|mesh-ancestor
102248275|NCT01668537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102248276|NCT04834791|Letrozole|letrozole|mesh-list
102248277|NCT04834791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102248278|NCT04834791|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102248279|NCT04834791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102248280|NCT04834791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102248281|NCT04834791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248282|NCT04834791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102248283|NCT04834791|Hormone Antagonists|hormone antagonists|mesh-ancestor
102248284|NCT04834791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102248285|NCT04834791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248286|NCT04835025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102248287|NCT04835025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248288|NCT04835025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102248289|NCT04835025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101717422|NCT00598481|Busulfan|busulfan|mesh-list
102248290|NCT03038919|Methyltestosterone|methyltestosterone|mesh-list
102248291|NCT03038919|Testosterone|testosterone|mesh-list
102248292|NCT03038919|Testosterone undecanoate|testosterone undecanoate|mesh-list
102248293|NCT03038919|Testosterone enanthate|testosterone enanthate|mesh-list
102248294|NCT03038919|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102248295|NCT03038919|Androgens|androgens|mesh-ancestor
102248296|NCT03038919|Hormones|hormones|mesh-ancestor
102248297|NCT03038919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102248298|NCT03038919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613220|NCT00002705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102248299|NCT03038919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102248300|NCT03038919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102248301|NCT03038919|Anabolic Agents|anabolic agents|mesh-ancestor
102248302|NCT03036891|Naloxegol|naloxegol|mesh-list
102248303|NCT03036891|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102248304|NCT03036891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248305|NCT03036891|Sensory System Agents|sensory system agents|mesh-ancestor
102248306|NCT03036891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102248307|NCT01668147|Ritonavir|ritonavir|mesh-list
102248308|NCT01668147|Efavirenz|efavirenz|mesh-list
102248309|NCT01668147|Loperamide|loperamide|mesh-list
102248310|NCT01668147|Antidiarrheals|antidiarrheals|mesh-list
102248311|NCT01668147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102248312|NCT01668147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102248313|NCT01668147|Protease Inhibitors|protease inhibitors|mesh-ancestor
102248314|NCT01668147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102248315|NCT01668147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248316|NCT01668147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102248317|NCT01668147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102248318|NCT01668147|Antiviral Agents|antiviral agents|mesh-ancestor
102248319|NCT01668147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102248320|NCT01668147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101717599|NCT00658931|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101717606|NCT00658931|Analgesics|analgesics|mesh-ancestor
102248321|NCT01668147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102248322|NCT01668147|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102248323|NCT01668147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102248324|NCT01668147|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102248325|NCT01668147|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102248326|NCT01668147|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102248327|NCT01668147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102248328|NCT01668147|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102248329|NCT01668147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102248330|NCT04833777|Lidocaine|lidocaine|mesh-list
102248331|NCT04833777|Bupivacaine|bupivacaine|mesh-list
102248332|NCT04833777|Anesthetics, Local|anesthetics, local|mesh-list
102248333|NCT04833777|Anesthetics|anesthetics|mesh-list
102248334|NCT04833777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102248335|NCT04833777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248336|NCT04833777|Sensory System Agents|sensory system agents|mesh-ancestor
102248337|NCT04833777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102248338|NCT04833777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102248339|NCT04833777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102248340|NCT04833777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102248341|NCT04833777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102248342|NCT04833777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248343|NCT03036501|Risdiplam|risdiplam|mesh-list
102248344|NCT03036501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102248345|NCT03036501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102248346|NCT03036501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248347|NCT04851015|Trimethoprim|trimethoprim|mesh-list
102248348|NCT04851015|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102248349|NCT04851015|Sulfamethoxazole|sulfamethoxazole|mesh-list
102248350|NCT04851015|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102248351|NCT04851015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102248352|NCT04851015|Antimalarials|antimalarials|mesh-ancestor
102248353|NCT04851015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102248354|NCT04851015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102248355|NCT04851015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102248356|NCT04851015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102248357|NCT04851015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248358|NCT04851015|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102248359|NCT04851015|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102248360|NCT04851015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102248361|NCT04851015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102248362|NCT04365933|Interferons|interferons|mesh-list
102248363|NCT04365933|Interferon-alpha|interferon-alpha|mesh-list
102248364|NCT04365933|Interferon alpha-2|interferon alpha-2|mesh-list
102248365|NCT04365933|Entecavir|entecavir|mesh-list
102248366|NCT04365933|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102248367|NCT04365933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102248368|NCT04365933|Antiviral Agents|antiviral agents|mesh-ancestor
102248369|NCT04365933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102248370|NCT04365933|Immunologic Factors|immunologic factors|mesh-ancestor
102248371|NCT04365933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248372|NCT04824261|Clotrimazole|clotrimazole|mesh-list
102613221|NCT00002711|Paclitaxel|paclitaxel|mesh-list
102613222|NCT00002711|Cisplatin|cisplatin|mesh-list
102613223|NCT00002711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102248373|NCT04824261|Miconazole|miconazole|mesh-list
102248374|NCT04824261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102248375|NCT04824261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102248376|NCT04824261|Antifungal Agents|antifungal agents|mesh-ancestor
102248377|NCT04824261|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101957275|NCT02098330|Hormones|hormones|mesh-ancestor
102248378|NCT04824261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102248379|NCT04824261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102248380|NCT04824261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717901|NCT05861648|Folic Acid|folic acid|mesh-list
102248381|NCT04824261|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102248382|NCT04824261|Hormone Antagonists|hormone antagonists|mesh-ancestor
102248383|NCT04824261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102248384|NCT04824261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248385|NCT04824261|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102248386|NCT04824261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102248387|NCT04850235|Paclitaxel|paclitaxel|mesh-list
102248388|NCT04850235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102248389|NCT04850235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102248390|NCT04850235|Tubulin Modulators|tubulin modulators|mesh-ancestor
102248391|NCT04850235|Antimitotic Agents|antimitotic agents|mesh-ancestor
102248392|NCT04850235|Mitosis Modulators|mitosis modulators|mesh-ancestor
102248393|NCT04850235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248394|NCT04850001|Aspirin|aspirin|mesh-list
102248395|NCT04850001|Clopidogrel|clopidogrel|mesh-list
102248396|NCT04850001|Atorvastatin|atorvastatin|mesh-list
102248397|NCT04850001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102248398|NCT04850001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102248399|NCT04850001|Analgesics|analgesics|mesh-ancestor
102248400|NCT04850001|Sensory System Agents|sensory system agents|mesh-ancestor
102248401|NCT04850001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102248402|NCT04850001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248403|NCT04850001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102248404|NCT04850001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102248405|NCT04850001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102248406|NCT04850001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102248407|NCT04850001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248408|NCT04850001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102248409|NCT04850001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102248410|NCT04850001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102248411|NCT04850001|Antipyretics|antipyretics|mesh-ancestor
102248412|NCT04850001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102248413|NCT04850001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102248414|NCT04850001|Antimetabolites|antimetabolites|mesh-ancestor
101717972|NCT05686564|Choline|choline|mesh-list
102248415|NCT04850001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102248416|NCT04850001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102248417|NCT04850001|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102248418|NCT04850001|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102248419|NCT04850001|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102248420|NCT04850001|Purinergic Agents|purinergic agents|mesh-ancestor
102248421|NCT04850001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102248422|NCT03036111|Trimebutine|trimebutine|mesh-list
102248423|NCT03036111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102248424|NCT03036111|Parasympatholytics|parasympatholytics|mesh-ancestor
102248425|NCT03036111|Autonomic Agents|autonomic agents|mesh-ancestor
102248426|NCT03036111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102248427|NCT03036111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248428|NCT04830579|Etoricoxib|etoricoxib|mesh-list
102248429|NCT04830579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102248430|NCT04830579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102248431|NCT04830579|Analgesics|analgesics|mesh-ancestor
102248432|NCT04830579|Sensory System Agents|sensory system agents|mesh-ancestor
102248433|NCT04830579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102248434|NCT04830579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248435|NCT04830579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102248436|NCT04830579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102248437|NCT04830579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102248438|NCT04830579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102248439|NCT04830579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102248440|NCT04830579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248441|NCT04816461|Piperaquine|piperaquine|mesh-list
102248442|NCT04816461|Sulfadoxine|sulfadoxine|mesh-list
102248443|NCT04816461|Amodiaquine|amodiaquine|mesh-list
102248445|NCT04816461|Antimalarials|antimalarials|mesh-ancestor
102248446|NCT04816461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102248447|NCT04816461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102248448|NCT04816461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102248449|NCT04816461|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102248450|NCT04427865|Lactoferrin|lactoferrin|mesh-list
102248451|NCT04427865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102248452|NCT02600559|Ciprofloxacin|ciprofloxacin|mesh-list
102248453|NCT02600559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102248454|NCT02600559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102248455|NCT02600559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102248456|NCT02600559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102248457|NCT02600559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102248458|NCT02600559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248459|NCT02600559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102248460|NCT02600559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102248461|NCT02600559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102248462|NCT04427787|Lanreotide|lanreotide|mesh-list
102248463|NCT04427787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102248464|NCT04821843|Paclitaxel|paclitaxel|mesh-list
102248465|NCT04821843|Nimotuzumab|nimotuzumab|mesh-list
102248466|NCT04821843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102248467|NCT04821843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102248468|NCT04821843|Tubulin Modulators|tubulin modulators|mesh-ancestor
102248469|NCT04821843|Antimitotic Agents|antimitotic agents|mesh-ancestor
102248470|NCT04821843|Mitosis Modulators|mitosis modulators|mesh-ancestor
102248471|NCT04821843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248472|NCT04821843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102248473|NCT04829487|Vitamin D|vitamin d|mesh-list
102248474|NCT04829487|Ergocalciferols|ergocalciferols|mesh-list
102248475|NCT04829487|Vitamins|vitamins|mesh-ancestor
102248476|NCT04829487|Micronutrients|micronutrients|mesh-ancestor
102248477|NCT04829487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248478|NCT04829487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102248479|NCT04829487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102248480|NCT04829565|Botulinum Toxins|botulinum toxins|mesh-list
102248481|NCT04829565|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102248482|NCT04829565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102248483|NCT04829565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248484|NCT04829565|Cholinergic Agents|cholinergic agents|mesh-ancestor
102248485|NCT04829565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102248486|NCT04829565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248487|NCT04821765|Paclitaxel|paclitaxel|mesh-list
102248488|NCT04821765|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102248489|NCT04821765|Antibodies|antibodies|mesh-list
102248490|NCT04821765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102248491|NCT04821765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102248492|NCT04821765|Tubulin Modulators|tubulin modulators|mesh-ancestor
102248493|NCT04821765|Antimitotic Agents|antimitotic agents|mesh-ancestor
102248494|NCT04821765|Mitosis Modulators|mitosis modulators|mesh-ancestor
102248495|NCT04821765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248496|NCT04821765|Immunologic Factors|immunologic factors|mesh-ancestor
102248497|NCT04821765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248498|NCT04829097|Temozolomide|temozolomide|mesh-list
102248499|NCT04829097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102248500|NCT04829097|Alkylating Agents|alkylating agents|mesh-ancestor
102248501|NCT04829097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248502|NCT04829097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102248503|NCT04829019|Osimertinib|osimertinib|mesh-list
102248504|NCT04829019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102248505|NCT04829019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102248506|NCT04829019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102248507|NCT04829019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248508|NCT04821063|Moxifloxacin|moxifloxacin|mesh-list
102248509|NCT04821063|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102248510|NCT04821063|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
102248511|NCT04821063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102248512|NCT04821063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102248513|NCT04821063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102248514|NCT04821063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102248515|NCT04821063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102248516|NCT04821063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248517|NCT04821063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613224|NCT00002711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102248518|NCT04821063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102248519|NCT04821063|Contraceptive Agents|contraceptive agents|mesh-ancestor
102248520|NCT04821063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102248521|NCT04821063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248522|NCT04821063|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102248523|NCT04821063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102248524|NCT04821063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102248525|NCT04821063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102248526|NCT03976245|Etanercept|etanercept|mesh-list
102248527|NCT03976245|Tofacitinib|tofacitinib|mesh-list
102248528|NCT03976245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102248529|NCT03976245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102248530|NCT03976245|Analgesics|analgesics|mesh-ancestor
102248531|NCT03976245|Sensory System Agents|sensory system agents|mesh-ancestor
102248532|NCT03976245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102248533|NCT03976245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248534|NCT03976245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102248535|NCT03976245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102248536|NCT03976245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102248537|NCT03976245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102248538|NCT03976245|Immunologic Factors|immunologic factors|mesh-ancestor
102248539|NCT03976245|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102248540|NCT03976245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102248541|NCT03976245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102248542|NCT03976245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248543|NCT04820751|Cyproheptadine|cyproheptadine|mesh-list
102248544|NCT04820751|Antipruritics|antipruritics|mesh-ancestor
102248545|NCT04820751|Dermatologic Agents|dermatologic agents|mesh-ancestor
102248546|NCT04820751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102248547|NCT04820751|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102248548|NCT04820751|Histamine Antagonists|histamine antagonists|mesh-ancestor
102248549|NCT04820751|Histamine Agents|histamine agents|mesh-ancestor
102248550|NCT04820751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102248551|NCT04820751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248552|NCT04820751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248553|NCT04820751|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102248554|NCT04820751|Serotonin Agents|serotonin agents|mesh-ancestor
102248555|NCT04820751|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102248556|NCT04828395|Paclitaxel|paclitaxel|mesh-list
102248557|NCT04828395|Etoposide|etoposide|mesh-list
102248558|NCT04828395|Cisplatin|cisplatin|mesh-list
102248559|NCT04828395|Carboplatin|carboplatin|mesh-list
102248560|NCT04828395|Pemetrexed|pemetrexed|mesh-list
102248561|NCT04828395|Fluzoparib|fluzoparib|mesh-list
102248562|NCT04828395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102248563|NCT04828395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102248564|NCT04828395|Tubulin Modulators|tubulin modulators|mesh-ancestor
102248565|NCT04828395|Antimitotic Agents|antimitotic agents|mesh-ancestor
102248566|NCT04828395|Mitosis Modulators|mitosis modulators|mesh-ancestor
102248567|NCT04828395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248568|NCT04828395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102248569|NCT04828395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102248570|NCT04828395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102248571|NCT04828395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102248572|NCT04828395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102248573|NCT04828395|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102248574|NCT04820439|Pertuzumab|pertuzumab|mesh-list
102248575|NCT04820439|Antibodies|antibodies|mesh-list
102248576|NCT04820439|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102248577|NCT04820439|Mitogens|mitogens|mesh-list
102248578|NCT04820439|Immunologic Factors|immunologic factors|mesh-ancestor
102248579|NCT04820439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248580|NCT04820439|Mitosis Modulators|mitosis modulators|mesh-ancestor
102248581|NCT04820439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248582|NCT04820439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102248583|NCT04820439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102248584|NCT05619315|Calcium Carbonate|calcium carbonate|mesh-list
102248585|NCT05619315|Calcium|calcium|mesh-list
102248586|NCT05619315|Charcoal|charcoal|mesh-list
102248587|NCT05619315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102248588|NCT05619315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248589|NCT05619315|Antacids|antacids|mesh-ancestor
102248590|NCT05619315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718485|NCT03851159|Mannitol|mannitol|mesh-list
102248591|NCT05619315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102613225|NCT00002711|Tubulin Modulators|tubulin modulators|mesh-ancestor
102613226|NCT00002711|Antimitotic Agents|antimitotic agents|mesh-ancestor
102248593|NCT05619315|Protective Agents|protective agents|mesh-ancestor
102248594|NCT04814511|Permethrin|permethrin|mesh-list
102248595|NCT04814511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102248596|NCT04814511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248597|NCT04814043|Lenvatinib|lenvatinib|mesh-list
102248598|NCT04814043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102248599|NCT04814043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102248600|NCT04814043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102248601|NCT04814043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102248602|NCT04814043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248603|NCT04814043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102248605|NCT04814589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102248606|NCT04814589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102248607|NCT04814589|Antimetabolites|antimetabolites|mesh-ancestor
102248608|NCT04814589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248609|NCT04814589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102248610|NCT04819503|Anesthetics|anesthetics|mesh-list
102248611|NCT04819503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102248612|NCT04819503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248613|NCT04826679|Paclitaxel|paclitaxel|mesh-list
102248614|NCT04826679|Cisplatin|cisplatin|mesh-list
102248615|NCT04826679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102248616|NCT04826679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102248617|NCT04826679|Tubulin Modulators|tubulin modulators|mesh-ancestor
102248618|NCT04826679|Antimitotic Agents|antimitotic agents|mesh-ancestor
102248619|NCT04826679|Mitosis Modulators|mitosis modulators|mesh-ancestor
102248620|NCT04826679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248621|NCT02601573|Ribavirin|ribavirin|mesh-list
102248622|NCT02601573|Sofosbuvir|sofosbuvir|mesh-list
102248623|NCT02601573|Grazoprevir|grazoprevir|mesh-list
102248624|NCT02601573|Antimetabolites|antimetabolites|mesh-ancestor
102248625|NCT02601573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248626|NCT02601573|Antiviral Agents|antiviral agents|mesh-ancestor
102248627|NCT02601573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102248628|NCT04818723|Montelukast|montelukast|mesh-list
102248629|NCT04818723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102248630|NCT04818723|Respiratory System Agents|respiratory system agents|mesh-ancestor
102248631|NCT04818723|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102248632|NCT04818723|Hormone Antagonists|hormone antagonists|mesh-ancestor
102248633|NCT04818723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102248634|NCT04818723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248635|NCT04818723|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102248636|NCT04818723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102248637|NCT04818723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248638|NCT02601027|Acetaminophen|acetaminophen|mesh-list
102248639|NCT02601027|Oxycodone|oxycodone|mesh-list
102248640|NCT02601027|Hydromorphone|hydromorphone|mesh-list
102248641|NCT02601027|Ondansetron|ondansetron|mesh-list
102248642|NCT02601027|Bupivacaine|bupivacaine|mesh-list
102248643|NCT02601027|Anesthetics, Local|anesthetics, local|mesh-ancestor
102248644|NCT02601027|Anesthetics|anesthetics|mesh-ancestor
102248645|NCT02601027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102248646|NCT02601027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248647|NCT02601027|Sensory System Agents|sensory system agents|mesh-ancestor
102248648|NCT02601027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102248649|NCT02601027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102248650|NCT02601027|Narcotics|narcotics|mesh-ancestor
102248651|NCT02601027|Analgesics|analgesics|mesh-ancestor
102248652|NCT02601027|Antiemetics|antiemetics|mesh-ancestor
102248653|NCT02601027|Autonomic Agents|autonomic agents|mesh-ancestor
102248654|NCT02601027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102248655|NCT02601027|Antipruritics|antipruritics|mesh-ancestor
101718710|NCT02578680|Glucocorticoids|glucocorticoids|mesh-ancestor
102248656|NCT02601027|Dermatologic Agents|dermatologic agents|mesh-ancestor
102248657|NCT02601027|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102248658|NCT02601027|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102248659|NCT02601027|Serotonin Agents|serotonin agents|mesh-ancestor
102248660|NCT02601027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102248661|NCT02601027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248662|NCT02601027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102248663|NCT02601027|Antipyretics|antipyretics|mesh-ancestor
102248664|NCT04411875|Amlodipine|amlodipine|mesh-list
102248665|NCT04411875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102248666|NCT04411875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102248667|NCT04411875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101718763|NCT00858273|Insulin|insulin|mesh-list
102248668|NCT04411875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248669|NCT04411875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102248670|NCT04411875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248671|NCT04411875|Vasodilator Agents|vasodilator agents|mesh-ancestor
102248672|NCT02600871|Povidone-Iodine|povidone-iodine|mesh-list
102248673|NCT02600871|Povidone|povidone|mesh-list
102248674|NCT02600871|Plasma Substitutes|plasma substitutes|mesh-ancestor
101957565|NCT02107690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102248675|NCT02600871|Blood Substitutes|blood substitutes|mesh-ancestor
102248676|NCT02600871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102248677|NCT02600871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102248678|NCT04817865|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102248679|NCT04817865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102248680|NCT04818099|Vortioxetine|vortioxetine|mesh-list
101718819|NCT00834834|Serotonin Agents|serotonin agents|mesh-ancestor
102248681|NCT04818099|Antidepressive Agents|antidepressive agents|mesh-ancestor
102248682|NCT04818099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102248683|NCT04818099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102248684|NCT04818099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102248685|NCT04818099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102248686|NCT04818099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248687|NCT04818099|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102248688|NCT04818099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102248689|NCT04818099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102248690|NCT04818099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248691|NCT04818099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102248692|NCT04818099|Serotonin Agents|serotonin agents|mesh-ancestor
102248693|NCT04818099|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102248694|NCT04818099|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102248695|NCT04818099|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102248696|NCT04818099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102248697|NCT04357899|Hypolipidemic Agents|hypolipidemic agents|mesh-list
102248698|NCT04357899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248699|NCT04357899|Antimetabolites|antimetabolites|mesh-ancestor
102248700|NCT04357899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102248701|NCT04807569|Tamsulosin|tamsulosin|mesh-list
102248702|NCT04807569|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102248703|NCT04807569|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102248704|NCT04807569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102248705|NCT04807569|Adrenergic Agents|adrenergic agents|mesh-ancestor
102248706|NCT04807569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102248707|NCT04807569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248708|NCT04807569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248709|NCT04807569|Urological Agents|urological agents|mesh-ancestor
102248710|NCT04807413|Nitric Oxide|nitric oxide|mesh-list
102248711|NCT04807413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102248712|NCT04807413|Autonomic Agents|autonomic agents|mesh-ancestor
102248713|NCT04807413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102248714|NCT04807413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248715|NCT04807413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102248716|NCT04807413|Respiratory System Agents|respiratory system agents|mesh-ancestor
102248717|NCT04807413|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102248718|NCT04807413|Antioxidants|antioxidants|mesh-ancestor
102248719|NCT04807413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248720|NCT04807413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102248721|NCT04807413|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102248722|NCT04807413|Vasodilator Agents|vasodilator agents|mesh-ancestor
102248723|NCT04807413|Gasotransmitters|gasotransmitters|mesh-ancestor
102248724|NCT04807413|Protective Agents|protective agents|mesh-ancestor
102248725|NCT04356729|Bevacizumab|bevacizumab|mesh-list
102248726|NCT04356729|Atezolizumab|atezolizumab|mesh-list
102248727|NCT04356729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102248728|NCT04356729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102248729|NCT04356729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102248730|NCT04356729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102248731|NCT04356729|Growth Substances|growth substances|mesh-ancestor
102248732|NCT04356729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248733|NCT04356729|Growth Inhibitors|growth inhibitors|mesh-ancestor
102248734|NCT04356729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102248735|NCT04356729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248736|NCT04807335|Sufentanil|sufentanil|mesh-list
102613227|NCT00002711|Mitosis Modulators|mitosis modulators|mesh-ancestor
102248738|NCT04807335|Analgesics|analgesics|mesh-ancestor
102248739|NCT04807335|Sensory System Agents|sensory system agents|mesh-ancestor
102248740|NCT04807335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102248741|NCT04807335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248742|NCT04807335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102248743|NCT04807335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102248744|NCT04807335|Anesthetics, General|anesthetics, general|mesh-ancestor
102248745|NCT04807335|Anesthetics|anesthetics|mesh-ancestor
102248746|NCT04807335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102248747|NCT04807335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102248748|NCT04807335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102248749|NCT04807335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102248750|NCT04807335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248751|NCT04807335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102248752|NCT04807335|Narcotics|narcotics|mesh-ancestor
102248753|NCT04807335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102248754|NCT05616507|Fucoidan|fucoidan|mesh-list
102248755|NCT05616507|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102248756|NCT05616507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102248757|NCT05616507|Anticoagulants|anticoagulants|mesh-ancestor
102248758|NCT05616507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102248759|NCT04806945|Paclitaxel|paclitaxel|mesh-list
102248760|NCT04806945|Carboplatin|carboplatin|mesh-list
102248761|NCT04806945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102248762|NCT04806945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102248763|NCT04806945|Tubulin Modulators|tubulin modulators|mesh-ancestor
102248764|NCT04806945|Antimitotic Agents|antimitotic agents|mesh-ancestor
102248765|NCT04806945|Mitosis Modulators|mitosis modulators|mesh-ancestor
102248766|NCT04806945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248767|NCT04806633|Dapagliflozin|dapagliflozin|mesh-list
102248768|NCT04806633|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102248769|NCT04806633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248770|NCT04806633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102248771|NCT04806633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248772|NCT04805229|Analgesics, Opioid|analgesics, opioid|mesh-list
102248773|NCT04805229|Narcotics|narcotics|mesh-ancestor
102248774|NCT04805229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102248775|NCT04805229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248776|NCT04805229|Analgesics|analgesics|mesh-ancestor
102248777|NCT04805229|Sensory System Agents|sensory system agents|mesh-ancestor
102248778|NCT04805229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102248779|NCT04811313|Bupivacaine|bupivacaine|mesh-list
102248780|NCT04811313|Tranexamic Acid|tranexamic acid|mesh-list
102248781|NCT04811313|Anesthetics, Local|anesthetics, local|mesh-ancestor
102248782|NCT04811313|Anesthetics|anesthetics|mesh-ancestor
102248783|NCT04811313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102248784|NCT04811313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248785|NCT04811313|Sensory System Agents|sensory system agents|mesh-ancestor
102248786|NCT04811313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102248787|NCT04811313|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102248788|NCT04811313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102248789|NCT04811313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248790|NCT04811313|Hemostatics|hemostatics|mesh-ancestor
102248791|NCT04811313|Coagulants|coagulants|mesh-ancestor
102248792|NCT04352439|Aspirin|aspirin|mesh-list
102248793|NCT04352439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102248794|NCT04352439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102248795|NCT04352439|Analgesics|analgesics|mesh-ancestor
102248796|NCT04352439|Sensory System Agents|sensory system agents|mesh-ancestor
102248797|NCT04352439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102248798|NCT04352439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248799|NCT04352439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102248800|NCT04352439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102248801|NCT04352439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102248802|NCT04352439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101719141|NCT00667433|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102248803|NCT04352439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248804|NCT04352439|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102248805|NCT04352439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102248806|NCT04352439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102248807|NCT04352439|Antipyretics|antipyretics|mesh-ancestor
102248808|NCT04796025|Bevacizumab|bevacizumab|mesh-list
102248809|NCT04796025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102248810|NCT04796025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613228|NCT00002711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248811|NCT04796025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102248812|NCT04796025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102248813|NCT04796025|Growth Substances|growth substances|mesh-ancestor
102248814|NCT04796025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248815|NCT04796025|Growth Inhibitors|growth inhibitors|mesh-ancestor
102248816|NCT04795479|Moxifloxacin|moxifloxacin|mesh-list
102248817|NCT04795479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102248818|NCT04795479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102248819|NCT04795479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102248820|NCT04795479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102248821|NCT04795479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102248822|NCT04795479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248823|NCT04795479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102248824|NCT02595723|Megestrol|megestrol|mesh-list
102248825|NCT02595723|Megestrol Acetate|megestrol acetate|mesh-list
102248826|NCT02595723|Phenytoin|phenytoin|mesh-list
102248827|NCT02595723|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102248828|NCT02595723|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102248829|NCT02595723|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102248830|NCT02595723|Contraceptive Agents|contraceptive agents|mesh-ancestor
102248831|NCT02595723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102248832|NCT02595723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248833|NCT02595723|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102248834|NCT02595723|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102248835|NCT02595723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102248836|NCT02595723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102248837|NCT02595723|Appetite Stimulants|appetite stimulants|mesh-ancestor
102248838|NCT02595723|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102248839|NCT02595723|Anticonvulsants|anticonvulsants|mesh-ancestor
102248840|NCT02595723|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102248841|NCT02595723|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102248842|NCT02595723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102248843|NCT02595723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248844|NCT02595723|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102248845|NCT02595723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102248846|NCT01667679|Sumatriptan|sumatriptan|mesh-list
102248847|NCT01667679|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102248848|NCT01667679|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102248849|NCT01667679|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102248850|NCT01667679|Serotonin Agents|serotonin agents|mesh-ancestor
102248851|NCT01667679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102248852|NCT01667679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248853|NCT01667679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248854|NCT02597049|Metformin|metformin|mesh-list
102248855|NCT02597049|Dapagliflozin|dapagliflozin|mesh-list
102248856|NCT02597049|Empagliflozin|empagliflozin|mesh-list
102248857|NCT02597049|Canagliflozin|canagliflozin|mesh-list
102248858|NCT02597049|Dulaglutide|dulaglutide|mesh-list
102248859|NCT02597049|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102248860|NCT02597049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102248861|NCT02597049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248862|NCT02597049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248863|NCT04809675|Salicylic Acid|salicylic acid|mesh-list
102248864|NCT04809675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102613229|NCT00002717|Paclitaxel|paclitaxel|mesh-list
102613230|NCT00002717|Cisplatin|cisplatin|mesh-list
102613231|NCT00002717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102613232|NCT00002717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613233|NCT00002717|Tubulin Modulators|tubulin modulators|mesh-ancestor
101719258|NCT02631239|Glucocorticoids|glucocorticoids|mesh-ancestor
102613234|NCT00002717|Antimitotic Agents|antimitotic agents|mesh-ancestor
102613235|NCT00002717|Mitosis Modulators|mitosis modulators|mesh-ancestor
102613236|NCT00002717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613237|NCT00002723|Suramin|suramin|mesh-list
102613238|NCT00002723|Antinematodal Agents|antinematodal agents|mesh-ancestor
102613239|NCT00002723|Anthelmintics|anthelmintics|mesh-ancestor
102613240|NCT00002723|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102613241|NCT00002723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102613242|NCT00002723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613243|NCT00002723|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102613244|NCT00002723|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102613245|NCT00002735|Cobalt|cobalt|mesh-list
102613246|NCT00002735|Cisplatin|cisplatin|mesh-list
102613247|NCT00002735|Fluorouracil|fluorouracil|mesh-list
102613248|NCT00002735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613249|NCT00002735|Antimetabolites|antimetabolites|mesh-ancestor
102248865|NCT04809675|Antifungal Agents|antifungal agents|mesh-ancestor
102248866|NCT04809675|Keratolytic Agents|keratolytic agents|mesh-ancestor
102248867|NCT04809675|Dermatologic Agents|dermatologic agents|mesh-ancestor
102248868|NCT04802967|Ketoprofen|ketoprofen|mesh-list
102248869|NCT04802967|Ketoprofen lysine|ketoprofen lysine|mesh-list
102248870|NCT04802967|Gabapentin|gabapentin|mesh-list
102248871|NCT04802967|Analgesics|analgesics|mesh-ancestor
102248872|NCT04802967|Sensory System Agents|sensory system agents|mesh-ancestor
102248873|NCT04802967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102248874|NCT04802967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248875|NCT04802967|Anticonvulsants|anticonvulsants|mesh-ancestor
102248876|NCT04802967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102248877|NCT04802967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102248878|NCT04802967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102248879|NCT04802967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102248880|NCT04802967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102248881|NCT04802967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102248882|NCT04802967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102248883|NCT04802967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248884|NCT04802967|Antimanic Agents|antimanic agents|mesh-ancestor
102248885|NCT04802967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102248886|NCT04802967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102248887|NCT04802967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102248888|NCT04802967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102248889|NCT04802967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102248890|NCT04802967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102248891|NCT04282785|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102248892|NCT04282785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102248893|NCT05616117|Vitamin D|vitamin d|mesh-list
102248894|NCT05616117|Vitamins|vitamins|mesh-list
102248895|NCT05616117|Micronutrients|micronutrients|mesh-ancestor
102248896|NCT05616117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248897|NCT05616117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102248898|NCT02594163|Rituximab|rituximab|mesh-list
102248899|NCT02594163|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102248900|NCT02594163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102248901|NCT02594163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102248902|NCT02594163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102248903|NCT02594163|Immunologic Factors|immunologic factors|mesh-ancestor
102248904|NCT02594163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248905|NCT02594163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102248906|NCT02594163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102248907|NCT02594163|Alkylating Agents|alkylating agents|mesh-ancestor
102248908|NCT02594163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248909|NCT02594163|Immunotoxins|immunotoxins|mesh-ancestor
102248910|NCT02594163|Immunoconjugates|immunoconjugates|mesh-ancestor
102248911|NCT03206255|Vaccines|vaccines|mesh-list
102248912|NCT03206255|Immunologic Factors|immunologic factors|mesh-ancestor
102248913|NCT03206255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248914|NCT03206411|Hormones|hormones|mesh-list
102248915|NCT03206411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102248916|NCT03206411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248917|NCT03206021|Carboplatin|carboplatin|mesh-list
102248918|NCT03206021|Azacitidine|azacitidine|mesh-list
102248919|NCT03206021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102248920|NCT03206021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102248921|NCT03206021|Antimetabolites|antimetabolites|mesh-ancestor
102248922|NCT03206021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248923|NCT03206021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102248924|NCT03200561|Prednisolone|prednisolone|mesh-list
102248925|NCT03200561|Immunoglobulins|immunoglobulins|mesh-list
102248926|NCT03200561|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102248927|NCT03200561|Antibodies|antibodies|mesh-list
102248928|NCT03200561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102248929|NCT03200561|Glucocorticoids|glucocorticoids|mesh-ancestor
102248930|NCT03200561|Hormones|hormones|mesh-ancestor
102248931|NCT03200561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102248932|NCT03200561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248933|NCT03200561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102248934|NCT03200561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102248935|NCT03200561|Immunologic Factors|immunologic factors|mesh-ancestor
102613250|NCT00002735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613251|NCT00002735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102248936|NCT02449811|Amlodipine|amlodipine|mesh-list
101901677|NCT01089348|Metronidazole|metronidazole|mesh-list
102248937|NCT02449811|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102248938|NCT02449811|Olmesartan|olmesartan|mesh-list
102248939|NCT02449811|Perindopril|perindopril|mesh-list
102248940|NCT02449811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102248941|NCT02449811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101719339|NCT00669773|Docetaxel|docetaxel|mesh-list
102248942|NCT02449811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102248943|NCT02449811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248944|NCT02449811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102248945|NCT02449811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248946|NCT02449811|Vasodilator Agents|vasodilator agents|mesh-ancestor
102248947|NCT02449811|Diuretics|diuretics|mesh-ancestor
102248948|NCT02449811|Natriuretic Agents|natriuretic agents|mesh-ancestor
102248949|NCT02449811|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102248950|NCT02449811|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102248951|NCT02449811|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102248952|NCT02449811|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102248953|NCT02449811|Protease Inhibitors|protease inhibitors|mesh-ancestor
102248954|NCT02449811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102248955|NCT03200093|Vancomycin|vancomycin|mesh-list
102248956|NCT03200093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102248957|NCT03200093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102248958|NCT03204929|Copper|copper|mesh-list
102248959|NCT03204929|Trace Elements|trace elements|mesh-ancestor
102248960|NCT03204929|Micronutrients|micronutrients|mesh-ancestor
102248961|NCT03204929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248962|NCT02596971|Prednisone|prednisone|mesh-list
102248963|NCT02596971|Cyclophosphamide|cyclophosphamide|mesh-list
102248964|NCT02596971|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102248965|NCT02596971|Rituximab|rituximab|mesh-list
102248966|NCT02596971|Doxorubicin|doxorubicin|mesh-list
102248967|NCT02596971|Vincristine|vincristine|mesh-list
102248968|NCT02596971|Atezolizumab|atezolizumab|mesh-list
102248969|NCT02596971|Obinutuzumab|obinutuzumab|mesh-list
102248970|NCT02596971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102248971|NCT02596971|Immunologic Factors|immunologic factors|mesh-ancestor
102248972|NCT02596971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102248973|NCT02596971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102248974|NCT02596971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102248975|NCT02596971|Alkylating Agents|alkylating agents|mesh-ancestor
102248976|NCT02596971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102248977|NCT02596971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102248978|NCT02596971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102248979|NCT02596971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102248980|NCT02596971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102248981|NCT02596971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102248982|NCT02596971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102248983|NCT02596971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102248984|NCT02596971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102248985|NCT02596971|Glucocorticoids|glucocorticoids|mesh-ancestor
102248986|NCT02596971|Hormones|hormones|mesh-ancestor
102248987|NCT02596971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102248988|NCT02596971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102248989|NCT02596971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102248990|NCT02596971|Tubulin Modulators|tubulin modulators|mesh-ancestor
102248991|NCT02596971|Antimitotic Agents|antimitotic agents|mesh-ancestor
102248992|NCT02596971|Mitosis Modulators|mitosis modulators|mesh-ancestor
102248993|NCT02596971|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102248994|NCT04808739|Adalimumab|adalimumab|mesh-list
102248995|NCT04808739|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102248996|NCT04808739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102248997|NCT04808739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102248998|NCT04808895|Aspirin|aspirin|mesh-list
102248999|NCT04808895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102249000|NCT04808895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102249001|NCT04808895|Analgesics|analgesics|mesh-ancestor
102249002|NCT04808895|Sensory System Agents|sensory system agents|mesh-ancestor
102249003|NCT04808895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102249004|NCT04808895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249005|NCT04808895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102249006|NCT04808895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102249007|NCT04808895|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102249008|NCT04808895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102249009|NCT04808895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249010|NCT04808895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102249011|NCT04808895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102613252|NCT00002735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102249012|NCT04808895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102249014|NCT04485689|Capsaicin|capsaicin|mesh-list
102249015|NCT04485689|Antipruritics|antipruritics|mesh-ancestor
102249016|NCT04485689|Dermatologic Agents|dermatologic agents|mesh-ancestor
102249017|NCT04485689|Sensory System Agents|sensory system agents|mesh-ancestor
102249018|NCT04485689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102249019|NCT04485689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249020|NCT03204071|Metformin|metformin|mesh-list
102249021|NCT03204071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102249022|NCT03204071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249023|NCT04801017|Artemisinins|artemisinins|mesh-list
102249024|NCT04801017|Artemisinin|artemisinin|mesh-list
102249025|NCT04801017|Trabedersen|trabedersen|mesh-list
102249026|NCT04801017|Antimalarials|antimalarials|mesh-ancestor
102249027|NCT04801017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102249028|NCT04801017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102249029|NCT04801017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102249030|NCT04801017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102249031|NCT03107429|Acetazolamide|acetazolamide|mesh-list
102249032|NCT03107429|Anticonvulsants|anticonvulsants|mesh-ancestor
102249033|NCT03107429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102249034|NCT03107429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102249035|NCT03107429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249036|NCT03107429|Diuretics|diuretics|mesh-ancestor
102249037|NCT03107429|Natriuretic Agents|natriuretic agents|mesh-ancestor
102249038|NCT03107429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249039|NCT04794231|Chlorhexidine|chlorhexidine|mesh-list
102249040|NCT04794231|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102249041|NCT04794231|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102249042|NCT04794231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102249043|NCT04794231|Disinfectants|disinfectants|mesh-ancestor
102249044|NCT04794231|Dermatologic Agents|dermatologic agents|mesh-ancestor
102249045|NCT04800081|Valsartan|valsartan|mesh-list
102249046|NCT04800081|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102249047|NCT04800081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102249048|NCT04800081|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102249049|NCT04800081|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102249050|NCT04800081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249051|NCT03202979|Trazodone|trazodone|mesh-list
102249052|NCT03202979|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102249053|NCT03202979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102249054|NCT03202979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102249055|NCT03202979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249056|NCT03202979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102249057|NCT03202979|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102249058|NCT03202979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102249059|NCT03202979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102249060|NCT03202979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249061|NCT03202979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102249062|NCT03202979|Serotonin Agents|serotonin agents|mesh-ancestor
102249063|NCT03202979|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102249064|NCT03202979|Antidepressive Agents|antidepressive agents|mesh-ancestor
102249065|NCT04799925|Febuxostat|febuxostat|mesh-list
102249066|NCT04799925|Gout Suppressants|gout suppressants|mesh-ancestor
102249067|NCT04799925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102249068|NCT03232307|Dexamethasone|dexamethasone|mesh-list
102249069|NCT03232307|Dexamethasone acetate|dexamethasone acetate|mesh-list
102249070|NCT03232307|Rituximab|rituximab|mesh-list
102249071|NCT03232307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102249072|NCT03232307|Lenalidomide|lenalidomide|mesh-list
102249073|NCT03232307|Antibodies|antibodies|mesh-list
102249074|NCT03232307|Immunoglobulins|immunoglobulins|mesh-list
102249075|NCT03232307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102249076|NCT03232307|BB 1101|bb 1101|mesh-list
102249077|NCT03232307|Immunologic Factors|immunologic factors|mesh-ancestor
102249078|NCT03232307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249079|NCT03232307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102249080|NCT03232307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102249081|NCT03232307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102249082|NCT03232307|Antiemetics|antiemetics|mesh-ancestor
102249083|NCT03232307|Autonomic Agents|autonomic agents|mesh-ancestor
102249084|NCT03232307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102249085|NCT03232307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102249086|NCT03232307|Glucocorticoids|glucocorticoids|mesh-ancestor
102249087|NCT03232307|Hormones|hormones|mesh-ancestor
102249088|NCT03232307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102249089|NCT03232307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102249090|NCT03232307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102249091|NCT03232307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102249092|NCT03232307|Growth Substances|growth substances|mesh-ancestor
102249093|NCT03232307|Growth Inhibitors|growth inhibitors|mesh-ancestor
102249094|NCT03232307|Protease Inhibitors|protease inhibitors|mesh-ancestor
102249095|NCT03232307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102249096|NCT03232307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249097|NCT05615727|Dexmedetomidine|dexmedetomidine|mesh-list
102249098|NCT05615727|Zolpidem|zolpidem|mesh-list
102249099|NCT05615727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102249100|NCT05615727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102249101|NCT05615727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249102|NCT05615727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102249103|NCT05615727|Analgesics|analgesics|mesh-ancestor
102249104|NCT05615727|Sensory System Agents|sensory system agents|mesh-ancestor
102249105|NCT05615727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102249106|NCT05615727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102249107|NCT05615727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102249108|NCT05615727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102249109|NCT05615727|Adrenergic Agents|adrenergic agents|mesh-ancestor
102249110|NCT05615727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102249111|NCT05615727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249112|NCT05615727|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102249113|NCT05615727|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102249114|NCT05615727|GABA Agonists|gaba agonists|mesh-ancestor
102249115|NCT05615727|GABA Agents|gaba agents|mesh-ancestor
102249116|NCT02450279|Edetic Acid|edetic acid|mesh-list
102249117|NCT02450279|Pentetic Acid|pentetic acid|mesh-list
102249118|NCT02450279|Antidotes|antidotes|mesh-ancestor
102249119|NCT02450279|Protective Agents|protective agents|mesh-ancestor
102249120|NCT02450279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249121|NCT02450279|Chelating Agents|chelating agents|mesh-ancestor
102249122|NCT02450279|Sequestering Agents|sequestering agents|mesh-ancestor
102249123|NCT02450279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249124|NCT02450279|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102249125|NCT02450279|Anticoagulants|anticoagulants|mesh-ancestor
101958015|NCT04052139|Anticonvulsants|anticonvulsants|mesh-ancestor
102249126|NCT02450279|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102249127|NCT03231683|Ketamine|ketamine|mesh-list
102249128|NCT03231683|Remifentanil|remifentanil|mesh-list
102249129|NCT03231683|Propofol|propofol|mesh-list
102249130|NCT03231683|Esketamine|esketamine|mesh-list
102249131|NCT03231683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102249132|NCT03231683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102249133|NCT03231683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249134|NCT03231683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102249135|NCT03231683|Anesthetics, General|anesthetics, general|mesh-ancestor
102249136|NCT03231683|Anesthetics|anesthetics|mesh-ancestor
102249137|NCT03231683|Analgesics|analgesics|mesh-ancestor
102249138|NCT03231683|Sensory System Agents|sensory system agents|mesh-ancestor
102249139|NCT03231683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102249140|NCT03231683|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102249141|NCT03231683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102249142|NCT03231683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101719738|NCT00676637|Timolol|timolol|mesh-list
102249143|NCT03231683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102249144|NCT03231683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249145|NCT03231683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102249146|NCT03231683|Narcotics|narcotics|mesh-ancestor
102249147|NCT03231683|Antidepressive Agents|antidepressive agents|mesh-ancestor
102249148|NCT03231683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102249149|NCT02593773|Interferons|interferons|mesh-list
102249150|NCT02593773|Interferon-gamma|interferon-gamma|mesh-list
102249151|NCT02593773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102249152|NCT02593773|Antiviral Agents|antiviral agents|mesh-ancestor
102249153|NCT02593773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102249154|NCT04798443|Hyaluronic Acid|hyaluronic acid|mesh-list
102249155|NCT04798443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102249156|NCT04798443|Immunologic Factors|immunologic factors|mesh-ancestor
102249157|NCT04798443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249158|NCT04798443|Viscosupplements|viscosupplements|mesh-ancestor
102249159|NCT04798443|Protective Agents|protective agents|mesh-ancestor
102249160|NCT02450045|Bupivacaine|bupivacaine|mesh-list
102249161|NCT02450045|Ropivacaine|ropivacaine|mesh-list
102249162|NCT02450045|Anesthetics, Local|anesthetics, local|mesh-list
102249163|NCT02450045|Anesthetics|anesthetics|mesh-list
102249164|NCT02450045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102249165|NCT02450045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249166|NCT02450045|Sensory System Agents|sensory system agents|mesh-ancestor
102249167|NCT02450045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102249168|NCT02593539|Nemiralisib|nemiralisib|mesh-list
102249169|NCT02593539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102249170|NCT02593539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102249171|NCT02593539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249172|NCT02593305|Methamphetamine|methamphetamine|mesh-list
102249173|NCT02593305|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102249174|NCT02593305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249175|NCT02593305|Sympathomimetics|sympathomimetics|mesh-ancestor
102249176|NCT02593305|Autonomic Agents|autonomic agents|mesh-ancestor
102249177|NCT02593305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102249178|NCT02593305|Dopamine Agents|dopamine agents|mesh-ancestor
102249179|NCT02593305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102249180|NCT02593305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249181|NCT02593305|Adrenergic Agents|adrenergic agents|mesh-ancestor
102249182|NCT02593305|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102249183|NCT02593305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102249184|NCT02593305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102249185|NCT02593305|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102249186|NCT04389411|Montelukast|montelukast|mesh-list
102249187|NCT04389411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102249188|NCT04389411|Respiratory System Agents|respiratory system agents|mesh-ancestor
102249189|NCT04389411|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102249190|NCT04389411|Hormone Antagonists|hormone antagonists|mesh-ancestor
102249191|NCT04389411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102249192|NCT04389411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249193|NCT04389411|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102249194|NCT04389411|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102249195|NCT04389411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249196|NCT02448251|Abivertinib|abivertinib|mesh-list
102249197|NCT02448251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102249198|NCT02448251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102249199|NCT02448251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958107|NCT03238352|Listerine|listerine|mesh-list
102249200|NCT03195569|Paclitaxel|paclitaxel|mesh-list
102249201|NCT03195569|Bevacizumab|bevacizumab|mesh-list
102249202|NCT03195569|Carboplatin|carboplatin|mesh-list
102249203|NCT03195569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102249204|NCT03195569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102249205|NCT03195569|Tubulin Modulators|tubulin modulators|mesh-ancestor
102249206|NCT03195569|Antimitotic Agents|antimitotic agents|mesh-ancestor
102249207|NCT03195569|Mitosis Modulators|mitosis modulators|mesh-ancestor
102249208|NCT03195569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249209|NCT03195569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102249210|NCT03195569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102249211|NCT03195569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102249212|NCT03195569|Growth Substances|growth substances|mesh-ancestor
101719907|NCT00674141|Dexamethasone|dexamethasone|mesh-list
102249213|NCT03195569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249214|NCT03195569|Growth Inhibitors|growth inhibitors|mesh-ancestor
102249215|NCT02447939|Trametinib|trametinib|mesh-list
102249216|NCT02447939|Dabrafenib|dabrafenib|mesh-list
102249217|NCT02447939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102249218|NCT02447939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102249219|NCT02447939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102249220|NCT02447939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249221|NCT04785183|Melatonin|melatonin|mesh-list
102249222|NCT04785183|Antioxidants|antioxidants|mesh-ancestor
102249223|NCT04785183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249224|NCT04785183|Protective Agents|protective agents|mesh-ancestor
102249225|NCT04785183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249226|NCT04785183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102249227|NCT03195491|Nivolumab|nivolumab|mesh-list
102249228|NCT03195491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102249229|NCT03195491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102249230|NCT03195491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102249231|NCT03195491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613254|NCT00002735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249232|NCT03195413|Lidocaine|lidocaine|mesh-list
102249233|NCT03195413|Epinephrine|epinephrine|mesh-list
102249234|NCT03195413|Racepinephrine|racepinephrine|mesh-list
102249235|NCT03195413|Bupivacaine|bupivacaine|mesh-list
102249236|NCT03195413|Epinephryl borate|epinephryl borate|mesh-list
102249237|NCT03195413|Anesthetics, Local|anesthetics, local|mesh-ancestor
102249238|NCT03195413|Anesthetics|anesthetics|mesh-ancestor
102249239|NCT03195413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102249240|NCT03195413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249241|NCT03195413|Sensory System Agents|sensory system agents|mesh-ancestor
102249242|NCT03195413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102249243|NCT03195413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102249244|NCT03195413|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102249245|NCT03195413|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102249246|NCT03195413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102249247|NCT03195413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249248|NCT03195413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102249249|NCT03195413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102249250|NCT03195413|Adrenergic Agents|adrenergic agents|mesh-ancestor
102249251|NCT03195413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102249252|NCT03195413|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102249253|NCT03195413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102249254|NCT03195413|Autonomic Agents|autonomic agents|mesh-ancestor
102249255|NCT03195413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102249256|NCT03195413|Respiratory System Agents|respiratory system agents|mesh-ancestor
102249257|NCT03195413|Mydriatics|mydriatics|mesh-ancestor
102249258|NCT03195413|Sympathomimetics|sympathomimetics|mesh-ancestor
102249259|NCT03195413|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102249260|NCT04338399|Paclitaxel|paclitaxel|mesh-list
102249261|NCT04338399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102249262|NCT04338399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102249263|NCT04338399|Tubulin Modulators|tubulin modulators|mesh-ancestor
102249264|NCT04338399|Antimitotic Agents|antimitotic agents|mesh-ancestor
102249265|NCT04338399|Mitosis Modulators|mitosis modulators|mesh-ancestor
102249266|NCT04338399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249267|NCT02447705|Telbivudine|telbivudine|mesh-list
102249268|NCT02447705|Antiviral Agents|antiviral agents|mesh-ancestor
102249269|NCT02447705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102249270|NCT02447705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102249271|NCT02447705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102249272|NCT02447705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249273|NCT03195257|Glucagon|glucagon|mesh-list
102249274|NCT03195257|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
102249276|NCT03195257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102249277|NCT03195257|Hormones|hormones|mesh-ancestor
102249278|NCT03195257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102249279|NCT03195257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249280|NCT03195257|Incretins|incretins|mesh-ancestor
102249281|NCT02447393|Cetirizine|cetirizine|mesh-list
102249282|NCT02447393|Levocetirizine|levocetirizine|mesh-list
102249283|NCT02447393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102249284|NCT02447393|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102249285|NCT02447393|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102249286|NCT02447393|Histamine Antagonists|histamine antagonists|mesh-ancestor
102249287|NCT02447393|Histamine Agents|histamine agents|mesh-ancestor
102249288|NCT02447393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102249289|NCT02447393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249290|NCT02447393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720273|NCT00702936|Ramipril|ramipril|mesh-list
102249291|NCT02447315|Pilocarpine|pilocarpine|mesh-list
102249292|NCT02447315|Miotics|miotics|mesh-ancestor
102249293|NCT02447315|Autonomic Agents|autonomic agents|mesh-ancestor
102249294|NCT02447315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102249295|NCT02447315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249296|NCT02447315|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102249297|NCT02447315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102249298|NCT02447315|Cholinergic Agents|cholinergic agents|mesh-ancestor
102249299|NCT02447315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102249300|NCT02447315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249301|NCT04792515|Apatinib|apatinib|mesh-list
102249302|NCT04792515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102249303|NCT04792515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102249304|NCT04792515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102249305|NCT04792515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613255|NCT00002735|Trace Elements|trace elements|mesh-ancestor
102613256|NCT00002735|Micronutrients|micronutrients|mesh-ancestor
102613257|NCT00002747|Cobalt|cobalt|mesh-list
102613258|NCT00002747|Fluorouracil|fluorouracil|mesh-list
102249306|NCT02446379|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102249307|NCT02446379|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102249308|NCT02446379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249309|NCT03195023|Amlodipine|amlodipine|mesh-list
102249310|NCT03195023|Lisinopril|lisinopril|mesh-list
102249311|NCT03195023|Lercanidipine|lercanidipine|mesh-list
102249312|NCT03195023|Furosemide|furosemide|mesh-list
102249313|NCT03195023|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102249314|NCT03195023|Enzyme Inhibitors|enzyme inhibitors|mesh-list
102249315|NCT03195023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102249316|NCT03195023|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102249317|NCT03195023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102249318|NCT03195023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249319|NCT03195023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102249320|NCT03195023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249321|NCT03195023|Vasodilator Agents|vasodilator agents|mesh-ancestor
102249322|NCT03195023|Diuretics|diuretics|mesh-ancestor
102249323|NCT03195023|Natriuretic Agents|natriuretic agents|mesh-ancestor
102249324|NCT03195023|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102249325|NCT03195023|Protease Inhibitors|protease inhibitors|mesh-ancestor
102249326|NCT03195023|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102249327|NCT03195023|Protective Agents|protective agents|mesh-ancestor
102249328|NCT02446301|Nalbuphine|nalbuphine|mesh-list
101720452|NCT05957822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720453|NCT05957822|Hemostatics|hemostatics|mesh-ancestor
101720454|NCT05957822|Coagulants|coagulants|mesh-ancestor
101720462|NCT05957666|Misoprostol|misoprostol|mesh-list
101720463|NCT05957666|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101720464|NCT05957666|Abortifacient Agents|abortifacient agents|mesh-ancestor
101720465|NCT05957666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102249329|NCT02446301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102249330|NCT02446301|Narcotics|narcotics|mesh-ancestor
102249331|NCT02446301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102249332|NCT02446301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249333|NCT02446301|Analgesics|analgesics|mesh-ancestor
102249334|NCT02446301|Sensory System Agents|sensory system agents|mesh-ancestor
102249335|NCT02446301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102249336|NCT04791345|Dexamethasone|dexamethasone|mesh-list
102249337|NCT04791345|Dexamethasone acetate|dexamethasone acetate|mesh-list
102249338|NCT04791345|Methylprednisolone|methylprednisolone|mesh-list
102249339|NCT04791345|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102249340|NCT04791345|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102249341|NCT04791345|Prednisolone|prednisolone|mesh-list
102249342|NCT04791345|Prednisolone acetate|prednisolone acetate|mesh-list
102249343|NCT04791345|Deflazacort|deflazacort|mesh-list
102249344|NCT04791345|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102249345|NCT04791345|Prednisolone phosphate|prednisolone phosphate|mesh-list
102249346|NCT04791345|BB 1101|bb 1101|mesh-list
102249347|NCT04791345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102249348|NCT04791345|Antiemetics|antiemetics|mesh-ancestor
101958248|NCT00179621|Lenalidomide|lenalidomide|mesh-list
102249349|NCT04791345|Autonomic Agents|autonomic agents|mesh-ancestor
102249350|NCT04791345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102249351|NCT04791345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249352|NCT04791345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102249353|NCT04791345|Glucocorticoids|glucocorticoids|mesh-ancestor
102249354|NCT04791345|Hormones|hormones|mesh-ancestor
102249355|NCT04791345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102249356|NCT04791345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102249357|NCT04791345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102249358|NCT04791345|Protease Inhibitors|protease inhibitors|mesh-ancestor
102249359|NCT04791345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102249360|NCT04791345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249361|NCT04791345|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102249362|NCT04791345|Protective Agents|protective agents|mesh-ancestor
102249363|NCT04791345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101720564|NCT05957055|Methylphenidate|methylphenidate|mesh-list
102249364|NCT04791345|Immunologic Factors|immunologic factors|mesh-ancestor
102249365|NCT02445989|Contraceptive Agents|contraceptive agents|mesh-list
102249366|NCT02445989|NuvaRing|nuvaring|mesh-list
102249367|NCT02445989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102249368|NCT02445989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249369|NCT02445989|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102249370|NCT03674853|Gamma-oryzanol|gamma-oryzanol|mesh-list
102249371|NCT03674853|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102249372|NCT03674853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102249373|NCT03674853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102249374|NCT03674853|Antimetabolites|antimetabolites|mesh-ancestor
102249375|NCT03674853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249376|NCT03674853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102613259|NCT00002747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102249377|NCT03231215|Dexamethasone|dexamethasone|mesh-list
102249378|NCT03231215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102249379|NCT03231215|Antiemetics|antiemetics|mesh-ancestor
102613260|NCT00002747|Antimetabolites|antimetabolites|mesh-ancestor
102249381|NCT03231215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102249382|NCT03231215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249383|NCT03231215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102249384|NCT03231215|Glucocorticoids|glucocorticoids|mesh-ancestor
102249385|NCT03231215|Hormones|hormones|mesh-ancestor
101720620|NCT05947448|Nifedipine|nifedipine|mesh-list
101720632|NCT05941715|Aflibercept|aflibercept|mesh-list
102249386|NCT03231215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102249387|NCT03231215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102249388|NCT03231215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102249389|NCT04784481|Ivermectin|ivermectin|mesh-list
102249390|NCT04784481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102249391|NCT04784481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102249392|NCT03230825|Contraceptive Agents|contraceptive agents|mesh-list
102249393|NCT03230825|Contraceptives, Oral|contraceptives, oral|mesh-list
102249394|NCT03230825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102249395|NCT03230825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249396|NCT03230825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102249397|NCT03526185|Nivolumab|nivolumab|mesh-list
102249398|NCT03526185|Ipilimumab|ipilimumab|mesh-list
102249399|NCT03526185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102249400|NCT03526185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102249401|NCT03526185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102249402|NCT03526185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249403|NCT02445599|Dipyrone|dipyrone|mesh-list
102249404|NCT02445599|Diclofenac|diclofenac|mesh-list
102249405|NCT02445599|Atropine|atropine|mesh-list
102249406|NCT02445599|Fentanyl|fentanyl|mesh-list
102249407|NCT02445599|Midazolam|midazolam|mesh-list
102249408|NCT02445599|Tramadol|tramadol|mesh-list
102249409|NCT02445599|Nalbuphine|nalbuphine|mesh-list
102249410|NCT02445599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102249411|NCT02445599|Narcotics|narcotics|mesh-ancestor
102249412|NCT02445599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102249413|NCT02445599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249414|NCT02445599|Analgesics|analgesics|mesh-ancestor
102249415|NCT02445599|Sensory System Agents|sensory system agents|mesh-ancestor
102249416|NCT02445599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102249417|NCT02445599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102249418|NCT02445599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102249419|NCT02445599|Anesthetics, General|anesthetics, general|mesh-ancestor
102249420|NCT02445599|Anesthetics|anesthetics|mesh-ancestor
102249421|NCT02445599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102249422|NCT02445599|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102249423|NCT02445599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102249424|NCT02445599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102249425|NCT02445599|GABA Modulators|gaba modulators|mesh-ancestor
102249426|NCT02445599|GABA Agents|gaba agents|mesh-ancestor
102249427|NCT02445599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102249428|NCT02445599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249429|NCT02445599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102249431|NCT02445599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102249432|NCT02445599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102249433|NCT02445599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102249434|NCT02445599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102249435|NCT02445599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102249436|NCT02445599|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102249437|NCT02445599|Autonomic Agents|autonomic agents|mesh-ancestor
102249438|NCT02445599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102249439|NCT02445599|Respiratory System Agents|respiratory system agents|mesh-ancestor
101720962|NCT05371600|Midazolam|midazolam|mesh-list
102249440|NCT02445599|Mydriatics|mydriatics|mesh-ancestor
102249441|NCT02445599|Parasympatholytics|parasympatholytics|mesh-ancestor
102249442|NCT02445599|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102249443|NCT02445599|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102249444|NCT02445599|Cholinergic Agents|cholinergic agents|mesh-ancestor
102249445|NCT02445599|Antipyretics|antipyretics|mesh-ancestor
102249446|NCT03194633|Nifedipine|nifedipine|mesh-list
102249447|NCT03194633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102249448|NCT03194633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102249449|NCT03194633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249450|NCT03194633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102249451|NCT03194633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249452|NCT03194633|Vasodilator Agents|vasodilator agents|mesh-ancestor
102249453|NCT03194633|Tocolytic Agents|tocolytic agents|mesh-ancestor
102249454|NCT03194633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102249455|NCT03194555|Acetaminophen|acetaminophen|mesh-list
101192533|NCT01270932|Autonomic Agents|autonomic agents|mesh-ancestor
101721000|NCT05342584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101721001|NCT05342584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101721002|NCT05342584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101721003|NCT05342584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102249456|NCT03194555|Naltrexone|naltrexone|mesh-list
102613261|NCT00002747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249457|NCT03194555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102249458|NCT03194555|Analgesics|analgesics|mesh-ancestor
102249459|NCT03194555|Sensory System Agents|sensory system agents|mesh-ancestor
102249460|NCT03194555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102249461|NCT03194555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249462|NCT03194555|Antipyretics|antipyretics|mesh-ancestor
102249463|NCT03194555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102249464|NCT03194555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102249465|NCT04344717|Apixaban|apixaban|mesh-list
102249466|NCT04344717|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102249467|NCT04344717|Antithrombins|antithrombins|mesh-ancestor
102249468|NCT04344717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102249469|NCT04344717|Protease Inhibitors|protease inhibitors|mesh-ancestor
102249470|NCT04344717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102249471|NCT04344717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249472|NCT04344717|Anticoagulants|anticoagulants|mesh-ancestor
101721123|NCT05133531|Eculizumab|eculizumab|mesh-list
102249473|NCT04790487|Chlorpheniramine|chlorpheniramine|mesh-list
102249474|NCT04790487|Antipruritics|antipruritics|mesh-ancestor
102249475|NCT04790487|Dermatologic Agents|dermatologic agents|mesh-ancestor
102249476|NCT04790487|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102249477|NCT04790487|Histamine Antagonists|histamine antagonists|mesh-ancestor
102249478|NCT04790487|Histamine Agents|histamine agents|mesh-ancestor
102249479|NCT04790487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102249480|NCT04790487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249481|NCT04790487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249482|NCT04790487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102249483|NCT04790331|Verapamil|verapamil|mesh-list
102249484|NCT04790331|Diltiazem|diltiazem|mesh-list
102249485|NCT04790331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102249486|NCT04790331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102249487|NCT04790331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102249488|NCT04790331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249489|NCT04790331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102249490|NCT04790331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249491|NCT04790331|Vasodilator Agents|vasodilator agents|mesh-ancestor
102249492|NCT04790331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102249493|NCT04789941|Irinotecan|irinotecan|mesh-list
102249494|NCT04789941|Cisplatin|cisplatin|mesh-list
102249495|NCT04789941|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101721254|NCT04607954|Immunoglobulin G|immunoglobulin g|mesh-list
102249496|NCT04789941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102249497|NCT04789941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102249498|NCT04789941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249499|NCT04789941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102249500|NCT02445053|Ivacaftor|ivacaftor|mesh-list
102249501|NCT02445053|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102249502|NCT02445053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102249503|NCT02445053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249505|NCT02444897|Nefopam|nefopam|mesh-list
102249506|NCT02444897|Ramosetron|ramosetron|mesh-list
102249507|NCT02444897|Ropivacaine|ropivacaine|mesh-list
102249508|NCT02444897|Anesthetics, Local|anesthetics, local|mesh-ancestor
102249509|NCT02444897|Anesthetics|anesthetics|mesh-ancestor
102249510|NCT02444897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102249511|NCT02444897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249512|NCT02444897|Sensory System Agents|sensory system agents|mesh-ancestor
102249513|NCT02444897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102249514|NCT02444897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102249515|NCT02444897|Narcotics|narcotics|mesh-ancestor
102249516|NCT02444897|Analgesics|analgesics|mesh-ancestor
102249517|NCT02444897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102249518|NCT02444897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102249519|NCT02444897|Anesthetics, General|anesthetics, general|mesh-ancestor
102249520|NCT02444897|Antiemetics|antiemetics|mesh-ancestor
102249521|NCT02444897|Autonomic Agents|autonomic agents|mesh-ancestor
102249522|NCT02444897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102249523|NCT02444897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102249524|NCT02444897|Serotonin Agents|serotonin agents|mesh-ancestor
102249525|NCT02444897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102249526|NCT02444897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249527|NCT02444897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102249528|NCT03016533|Lamivudine|lamivudine|mesh-list
102249529|NCT03016533|Dolutegravir|dolutegravir|mesh-list
102613262|NCT00002747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102249530|NCT03016533|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102249531|NCT03016533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102613263|NCT00002747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102249532|NCT03016533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102249533|NCT03016533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249534|NCT03016533|Antiviral Agents|antiviral agents|mesh-ancestor
102249535|NCT03016533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102249536|NCT03016533|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102249537|NCT03016533|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102249538|NCT03016533|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102249539|NCT03016533|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102249540|NCT03229889|Tadalafil|tadalafil|mesh-list
102249541|NCT03229889|Tamsulosin|tamsulosin|mesh-list
102249542|NCT03229889|Vasodilator Agents|vasodilator agents|mesh-ancestor
102249543|NCT03229889|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102249544|NCT03229889|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102249545|NCT03229889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102249546|NCT03229889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249547|NCT03229889|Urological Agents|urological agents|mesh-ancestor
102249548|NCT03229889|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102249549|NCT03229889|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102249550|NCT03229889|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102249551|NCT03229889|Adrenergic Agents|adrenergic agents|mesh-ancestor
102249552|NCT03229889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102249553|NCT03229889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249554|NCT02444585|Denosumab|denosumab|mesh-list
102249555|NCT02444585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102249556|NCT02444585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249557|NCT03120221|Iodine|iodine|mesh-list
102249558|NCT03120221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102249559|NCT03120221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102249560|NCT03120221|Trace Elements|trace elements|mesh-ancestor
102249561|NCT03120221|Micronutrients|micronutrients|mesh-ancestor
102249562|NCT03120221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249563|NCT03193073|Mitogens|mitogens|mesh-list
102249564|NCT03193073|Mitosis Modulators|mitosis modulators|mesh-ancestor
102249565|NCT03193073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249566|NCT02444507|Esomeprazole|esomeprazole|mesh-list
102249567|NCT02444507|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102249568|NCT02444507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102249569|NCT02444507|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102249570|NCT02444507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102249571|NCT02444507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249572|NCT01626352|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102249573|NCT01626352|Ofatumumab|ofatumumab|mesh-list
102249574|NCT01626352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102249575|NCT01626352|Alkylating Agents|alkylating agents|mesh-ancestor
102249576|NCT01626352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249577|NCT01626352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102249578|NCT02080767|Tecovirimat|tecovirimat|mesh-list
102249579|NCT02080767|Antiviral Agents|antiviral agents|mesh-ancestor
102249580|NCT02080767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102249581|NCT01626118|Indomethacin|indomethacin|mesh-list
102249582|NCT01626118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102249583|NCT01626118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102249584|NCT01626118|Analgesics|analgesics|mesh-ancestor
102249585|NCT01626118|Sensory System Agents|sensory system agents|mesh-ancestor
102249586|NCT01626118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102249587|NCT01626118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249588|NCT01626118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102249589|NCT01626118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102249590|NCT01626118|Gout Suppressants|gout suppressants|mesh-ancestor
102249591|NCT01626118|Tocolytic Agents|tocolytic agents|mesh-ancestor
102249592|NCT01626118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102249593|NCT01626118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102249594|NCT01626118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102249595|NCT01626118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249596|NCT04789005|Phenylephrine|phenylephrine|mesh-list
102249597|NCT04789005|Oxymetazoline|oxymetazoline|mesh-list
102249598|NCT04789005|Norepinephrine|norepinephrine|mesh-list
102249599|NCT04789005|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102249600|NCT04789005|Mydriatics|mydriatics|mesh-ancestor
102249601|NCT04789005|Autonomic Agents|autonomic agents|mesh-ancestor
102249602|NCT04789005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102249603|NCT04789005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249604|NCT04789005|Sympathomimetics|sympathomimetics|mesh-ancestor
102249605|NCT04789005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102249606|NCT04789005|Nasal Decongestants|nasal decongestants|mesh-ancestor
102249607|NCT04789005|Respiratory System Agents|respiratory system agents|mesh-ancestor
102249608|NCT04789005|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102249609|NCT04789005|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102249610|NCT04789005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102249611|NCT04789005|Adrenergic Agents|adrenergic agents|mesh-ancestor
102249612|NCT04789005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102249613|NCT04789005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249614|NCT04789005|Protective Agents|protective agents|mesh-ancestor
102249615|NCT02152384|Insulin|insulin|mesh-list
102249616|NCT02152384|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102249617|NCT02152384|Insulin Glargine|insulin glargine|mesh-list
102249618|NCT02152384|Insulin Lispro|insulin lispro|mesh-list
102249619|NCT02152384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102249620|NCT02152384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249621|NCT05469243|Hallucinogens|hallucinogens|mesh-list
102249622|NCT05469243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249623|NCT05469243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102249624|NCT02177266|Colchicine|colchicine|mesh-list
102249625|NCT02177266|Gout Suppressants|gout suppressants|mesh-ancestor
102249626|NCT02177266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102249627|NCT02177266|Tubulin Modulators|tubulin modulators|mesh-ancestor
102249628|NCT02177266|Antimitotic Agents|antimitotic agents|mesh-ancestor
102249629|NCT02177266|Mitosis Modulators|mitosis modulators|mesh-ancestor
102249630|NCT02177266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249631|NCT02177266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102249632|NCT04788381|Bevacizumab|bevacizumab|mesh-list
102249633|NCT04788381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102249634|NCT04788381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102249635|NCT04788381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102249636|NCT04788381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102249637|NCT04788381|Growth Substances|growth substances|mesh-ancestor
102249638|NCT04788381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249639|NCT04788381|Growth Inhibitors|growth inhibitors|mesh-ancestor
102249640|NCT05474937|Midazolam|midazolam|mesh-list
102249641|NCT05474937|Ketamine|ketamine|mesh-list
102249642|NCT05474937|Propofol|propofol|mesh-list
102249643|NCT05474937|Sevoflurane|sevoflurane|mesh-list
102249644|NCT05474937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102249645|NCT05474937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102249646|NCT05474937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613264|NCT00002747|Immunologic Factors|immunologic factors|mesh-ancestor
102613265|NCT00002747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613266|NCT00002747|Trace Elements|trace elements|mesh-ancestor
102613267|NCT00002747|Micronutrients|micronutrients|mesh-ancestor
102613268|NCT02973035|Amlodipine|amlodipine|mesh-list
102613269|NCT02973035|Valsartan|valsartan|mesh-list
102613270|NCT02973035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102249647|NCT05474937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102249648|NCT05474937|Anesthetics, General|anesthetics, general|mesh-ancestor
102249649|NCT05474937|Anesthetics|anesthetics|mesh-ancestor
102249650|NCT05474937|Analgesics|analgesics|mesh-ancestor
102249651|NCT05474937|Sensory System Agents|sensory system agents|mesh-ancestor
102249652|NCT05474937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102249653|NCT05474937|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102249654|NCT05474937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102249655|NCT05474937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102249656|NCT05474937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101722107|NCT05428306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102249657|NCT05474937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249658|NCT05474937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102249660|NCT05474937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102249661|NCT05474937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102249662|NCT05474937|GABA Modulators|gaba modulators|mesh-ancestor
102249663|NCT05474937|GABA Agents|gaba agents|mesh-ancestor
102249664|NCT05474937|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102249665|NCT05474937|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102249666|NCT05474781|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
101722168|NCT00754780|Pirfenidone|pirfenidone|mesh-list
102249667|NCT05474781|Antiviral Agents|antiviral agents|mesh-ancestor
102249668|NCT05474781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102249669|NCT02177032|Vaccines|vaccines|mesh-list
102249670|NCT02177032|Immunoglobulins|immunoglobulins|mesh-list
102249671|NCT02177032|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102249672|NCT02177032|Antibodies|antibodies|mesh-list
102249673|NCT02177032|Immunologic Factors|immunologic factors|mesh-ancestor
102613271|NCT02973035|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102613272|NCT02973035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102249674|NCT02177032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249675|NCT02116972|FX006|fx006|mesh-list
102249676|NCT02116972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102613273|NCT02973035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249677|NCT02116972|Glucocorticoids|glucocorticoids|mesh-ancestor
102249678|NCT02116972|Hormones|hormones|mesh-ancestor
102249679|NCT02116972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102249680|NCT02116972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249681|NCT02116972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102249682|NCT02116972|Immunologic Factors|immunologic factors|mesh-ancestor
102249683|NCT02176642|Oxybutynin|oxybutynin|mesh-list
102249684|NCT02176642|Parasympatholytics|parasympatholytics|mesh-ancestor
102249685|NCT02176642|Autonomic Agents|autonomic agents|mesh-ancestor
102249686|NCT02176642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102249687|NCT02176642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249688|NCT02176642|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102249689|NCT02176642|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102249690|NCT02176642|Cholinergic Agents|cholinergic agents|mesh-ancestor
102249691|NCT02176642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102249692|NCT02176642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249693|NCT02176642|Urological Agents|urological agents|mesh-ancestor
102249694|NCT02116660|Ritonavir|ritonavir|mesh-list
102249695|NCT02116660|Lopinavir|lopinavir|mesh-list
102249696|NCT02116660|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102249697|NCT02116660|Darunavir|darunavir|mesh-list
102249698|NCT02116660|Tenofovir|tenofovir|mesh-list
102249699|NCT02116660|Lamivudine|lamivudine|mesh-list
102249700|NCT02116660|Emtricitabine|emtricitabine|mesh-list
102249701|NCT02116660|Raltegravir Potassium|raltegravir potassium|mesh-list
102249702|NCT02116660|Nevirapine|nevirapine|mesh-list
102249703|NCT02116660|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102249704|NCT02116660|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102249705|NCT02116660|Protease Inhibitors|protease inhibitors|mesh-ancestor
102249706|NCT02116660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102249707|NCT02116660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249708|NCT02116660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102249709|NCT02116660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102249710|NCT02116660|Antiviral Agents|antiviral agents|mesh-ancestor
102249711|NCT02116660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102249712|NCT02116660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102249713|NCT02116660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102249714|NCT02116660|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102249715|NCT02116660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102249716|NCT02116660|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102249717|NCT02116660|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102249718|NCT02116660|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102249719|NCT02116660|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102249720|NCT02589405|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102249721|NCT02589405|Dermatologic Agents|dermatologic agents|mesh-ancestor
102249722|NCT02176018|Quinidine|quinidine|mesh-list
102249723|NCT02176018|Dextromethorphan|dextromethorphan|mesh-list
102249724|NCT02176018|Antitussive Agents|antitussive agents|mesh-ancestor
102249725|NCT02176018|Respiratory System Agents|respiratory system agents|mesh-ancestor
102249726|NCT02176018|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102249727|NCT02176018|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102249728|NCT02176018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102249729|NCT02176018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249730|NCT02176018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249731|NCT02176018|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102249732|NCT02176018|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102249733|NCT02176018|Adrenergic Agents|adrenergic agents|mesh-ancestor
102249734|NCT02176018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102249735|NCT02176018|Antimalarials|antimalarials|mesh-ancestor
102249736|NCT02176018|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102249737|NCT02176018|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102249738|NCT02176018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102249739|NCT02176018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102249740|NCT02176018|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102249741|NCT02176018|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102249742|NCT02176018|Cholinergic Agents|cholinergic agents|mesh-ancestor
102249743|NCT02176018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102249744|NCT02176018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102249745|NCT02176018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102249746|NCT02176018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101722664|NCT00762658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102249747|NCT02176018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102613274|NCT02973035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102249748|NCT05611827|Quercetin|quercetin|mesh-list
102249749|NCT05611827|Antioxidants|antioxidants|mesh-ancestor
102613275|NCT02973035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613276|NCT02973035|Vasodilator Agents|vasodilator agents|mesh-ancestor
102249750|NCT05611827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249751|NCT05611827|Protective Agents|protective agents|mesh-ancestor
102249752|NCT05611827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249753|NCT05612607|Immunoglobulins|immunoglobulins|mesh-list
102249754|NCT05612607|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102249755|NCT05612607|Antibodies|antibodies|mesh-list
102249756|NCT05612607|Immunologic Factors|immunologic factors|mesh-ancestor
102249757|NCT05612607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249758|NCT02589639|Empagliflozin|empagliflozin|mesh-list
102249759|NCT02589639|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102249760|NCT02589639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249761|NCT02589639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102249762|NCT02589639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249763|NCT05611749|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102249764|NCT05611749|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102249765|NCT05611749|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102249766|NCT05611749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102249767|NCT05611749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249768|NCT05611749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102249769|NCT05611749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249770|NCT05611749|Analgesics|analgesics|mesh-ancestor
102249771|NCT05611749|Sensory System Agents|sensory system agents|mesh-ancestor
102249772|NCT05611749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102249773|NCT05611749|Antidepressive Agents|antidepressive agents|mesh-ancestor
102249774|NCT05611749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102249775|NCT05611749|Dopamine Agents|dopamine agents|mesh-ancestor
102249776|NCT05611593|Finasteride|finasteride|mesh-list
102249777|NCT05611593|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102249778|NCT05611593|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102249779|NCT05611593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102249780|NCT05611593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722781|NCT00759070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102249781|NCT05611593|Hormone Antagonists|hormone antagonists|mesh-ancestor
102249782|NCT05611593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102249783|NCT05611593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249784|NCT05611593|Urological Agents|urological agents|mesh-ancestor
102249785|NCT05612451|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102249786|NCT05612451|Calcium|calcium|mesh-list
102249787|NCT05612451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102249788|NCT05612451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249789|NCT05612451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102249790|NCT02151682|Morphine|morphine|mesh-list
102249791|NCT02151682|Tapentadol|tapentadol|mesh-list
102249792|NCT02151682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102249793|NCT02151682|Narcotics|narcotics|mesh-ancestor
102249794|NCT02151682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102249795|NCT02151682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249796|NCT02151682|Analgesics|analgesics|mesh-ancestor
102249797|NCT02151682|Sensory System Agents|sensory system agents|mesh-ancestor
102249798|NCT02151682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102249799|NCT02151682|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102249800|NCT02151682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102249801|NCT02151682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102249802|NCT02151682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249803|NCT02151682|Adrenergic Agents|adrenergic agents|mesh-ancestor
102249804|NCT02151682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102249805|NCT04331691|Amiloride|amiloride|mesh-list
102249806|NCT04331691|Spironolactone|spironolactone|mesh-list
102249807|NCT04331691|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102249808|NCT04331691|Hormone Antagonists|hormone antagonists|mesh-ancestor
102249809|NCT04331691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102249810|NCT04331691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249811|NCT04331691|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102249812|NCT04331691|Diuretics|diuretics|mesh-ancestor
102249813|NCT04331691|Natriuretic Agents|natriuretic agents|mesh-ancestor
102249814|NCT04331691|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
102249815|NCT04331691|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102249816|NCT04331691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101722900|NCT02557984|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102249817|NCT04331691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249818|NCT04331691|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
102249819|NCT05304273|Letrozole|letrozole|mesh-list
102249820|NCT05304273|Misoprostol|misoprostol|mesh-list
102249821|NCT05304273|Mifepristone|mifepristone|mesh-list
102249822|NCT05304273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102249823|NCT05304273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102249824|NCT05304273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102249825|NCT05304273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102249826|NCT05304273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249827|NCT05304273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102249828|NCT05304273|Hormone Antagonists|hormone antagonists|mesh-ancestor
102249829|NCT05304273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102249830|NCT05304273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249831|NCT05304273|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102249832|NCT05304273|Abortifacient Agents|abortifacient agents|mesh-ancestor
102249833|NCT05304273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102249834|NCT05304273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102249835|NCT05304273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102249836|NCT05304273|Oxytocics|oxytocics|mesh-ancestor
102249837|NCT05304273|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102249838|NCT05304273|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102249839|NCT05304273|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102249840|NCT05304273|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102249841|NCT05304273|Contraceptive Agents|contraceptive agents|mesh-ancestor
102249842|NCT05304273|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102249843|NCT05304273|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102249844|NCT05304273|Luteolytic Agents|luteolytic agents|mesh-ancestor
102249845|NCT05304273|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102249846|NCT05304273|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102249847|NCT02174848|Deferiprone|deferiprone|mesh-list
102249848|NCT02174848|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102249849|NCT02174848|Chelating Agents|chelating agents|mesh-ancestor
102249850|NCT02174848|Sequestering Agents|sequestering agents|mesh-ancestor
102249851|NCT02174848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249852|NCT02151058|Listerine|listerine|mesh-list
102249853|NCT02151058|Sodium Fluoride|sodium fluoride|mesh-list
102249854|NCT02151058|Cariostatic Agents|cariostatic agents|mesh-ancestor
102249855|NCT02151058|Protective Agents|protective agents|mesh-ancestor
102249856|NCT02151058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249857|NCT02151058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102249858|NCT02151058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102249859|NCT05205759|Sotrovimab|sotrovimab|mesh-list
102249860|NCT05205759|Bamlanivimab|bamlanivimab|mesh-list
102249861|NCT05205759|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
102249862|NCT05205759|Antiviral Agents|antiviral agents|mesh-ancestor
102249863|NCT05205759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102249864|NCT02149264|Testosterone|testosterone|mesh-list
102249865|NCT02149264|Androgens|androgens|mesh-ancestor
102249866|NCT02149264|Hormones|hormones|mesh-ancestor
102249867|NCT02149264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101723152|NCT00772798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102249868|NCT02149264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249869|NCT05610969|Midazolam|midazolam|mesh-list
102249870|NCT05610969|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102249871|NCT05610969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102249872|NCT05610969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102249873|NCT05610969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249874|NCT05610969|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102249875|NCT05610969|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102249876|NCT05610969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102249877|NCT05610969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102249878|NCT05610969|Anesthetics, General|anesthetics, general|mesh-ancestor
102249879|NCT05610969|Anesthetics|anesthetics|mesh-ancestor
102249880|NCT05610969|GABA Modulators|gaba modulators|mesh-ancestor
102249881|NCT05610969|GABA Agents|gaba agents|mesh-ancestor
102249882|NCT05610969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102249883|NCT05610969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249884|NCT05557149|Cocaine|cocaine|mesh-list
102249885|NCT05557149|Anesthetics, Local|anesthetics, local|mesh-ancestor
102249886|NCT05557149|Anesthetics|anesthetics|mesh-ancestor
102249887|NCT05557149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102613277|NCT02973035|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102613278|NCT02973035|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102613279|NCT00002753|Antibodies|antibodies|mesh-list
102613280|NCT00002753|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102249888|NCT05557149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901703|NCT00060840|Autonomic Agents|autonomic agents|mesh-ancestor
102613281|NCT00002753|Immunologic Factors|immunologic factors|mesh-ancestor
102613282|NCT00002753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613283|NCT00002759|Cyclosporine|cyclosporine|mesh-list
102613284|NCT00002759|Irinotecan|irinotecan|mesh-list
102613285|NCT00002759|Phenobarbital|phenobarbital|mesh-list
102613286|NCT00002759|Cyclosporins|cyclosporins|mesh-list
102613287|NCT00002759|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102613288|NCT00002759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102613289|NCT00002759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102613290|NCT00002759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613291|NCT00002759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102249889|NCT05557149|Sensory System Agents|sensory system agents|mesh-ancestor
102249890|NCT05557149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102249891|NCT05557149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102249892|NCT05557149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102613292|NCT00002759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102613293|NCT00002759|Immunologic Factors|immunologic factors|mesh-ancestor
102613294|NCT00002759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613295|NCT00002759|Antifungal Agents|antifungal agents|mesh-ancestor
102613296|NCT00002759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102249893|NCT05557149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102249894|NCT05557149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102249895|NCT05557149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249896|NCT05557149|Dopamine Agents|dopamine agents|mesh-ancestor
102249897|NCT05557149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102249898|NCT02115256|Nitroglycerin|nitroglycerin|mesh-list
102249899|NCT02115256|Terbutaline|terbutaline|mesh-list
102249900|NCT02115256|Vasodilator Agents|vasodilator agents|mesh-ancestor
102249901|NCT02115256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102249902|NCT02115256|Autonomic Agents|autonomic agents|mesh-ancestor
102249903|NCT02115256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102249904|NCT02115256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249905|NCT02115256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102249906|NCT02115256|Respiratory System Agents|respiratory system agents|mesh-ancestor
102249907|NCT02115256|Sympathomimetics|sympathomimetics|mesh-ancestor
102249908|NCT02115256|Tocolytic Agents|tocolytic agents|mesh-ancestor
102249909|NCT02115256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102249910|NCT02115256|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102249911|NCT02115256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102249912|NCT02115256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102249913|NCT02115256|Adrenergic Agents|adrenergic agents|mesh-ancestor
102249914|NCT02115256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101723367|NCT00774358|Interleukin-2|interleukin-2|mesh-list
102249915|NCT02115256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249916|NCT02173054|Adapalene|adapalene|mesh-list
102249917|NCT02173054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102249918|NCT02173054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102249919|NCT02173054|Analgesics|analgesics|mesh-ancestor
102249920|NCT02173054|Sensory System Agents|sensory system agents|mesh-ancestor
102249921|NCT02173054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102249922|NCT02173054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249923|NCT02173054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102249924|NCT02173054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102249925|NCT02173054|Dermatologic Agents|dermatologic agents|mesh-ancestor
102249926|NCT04225221|Leuprolide|leuprolide|mesh-list
102249927|NCT04225221|Estradiol|estradiol|mesh-list
102249928|NCT04225221|Progesterone|progesterone|mesh-list
102249929|NCT04225221|Estrogens|estrogens|mesh-ancestor
102249930|NCT04225221|Hormones|hormones|mesh-ancestor
102249931|NCT04225221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102249932|NCT04225221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249933|NCT04225221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102249934|NCT04225221|Progestins|progestins|mesh-ancestor
102249935|NCT04225221|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102249936|NCT04225221|Fertility Agents|fertility agents|mesh-ancestor
102249937|NCT04225221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102249938|NCT04225221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102249939|NCT04425993|Indomethacin|indomethacin|mesh-list
102249940|NCT04425993|Isosorbide|isosorbide|mesh-list
102249941|NCT04425993|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
102249942|NCT04425993|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
102249943|NCT04425993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102249944|NCT04425993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102249945|NCT04425993|Analgesics|analgesics|mesh-ancestor
102249946|NCT04425993|Sensory System Agents|sensory system agents|mesh-ancestor
102613297|NCT00002759|Dermatologic Agents|dermatologic agents|mesh-ancestor
102249947|NCT04425993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101901713|NCT00060840|Vasodilator Agents|vasodilator agents|mesh-ancestor
102613298|NCT00002759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102249948|NCT04425993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249949|NCT04425993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102249950|NCT04425993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102249951|NCT04425993|Gout Suppressants|gout suppressants|mesh-ancestor
102249952|NCT04425993|Tocolytic Agents|tocolytic agents|mesh-ancestor
102249953|NCT04425993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102249954|NCT04425993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102249955|NCT04425993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102249956|NCT04425993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249957|NCT04425993|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102249958|NCT04425993|Diuretics|diuretics|mesh-ancestor
102249959|NCT04425993|Natriuretic Agents|natriuretic agents|mesh-ancestor
102249960|NCT04425993|Vasodilator Agents|vasodilator agents|mesh-ancestor
102249961|NCT04425993|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102249962|NCT03971643|Vilobelimab|vilobelimab|mesh-list
102249963|NCT03971643|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102249964|NCT03971643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102249965|NCT03971643|Immunologic Factors|immunologic factors|mesh-ancestor
102249966|NCT03971643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723498|NCT00594815|Leucovorin|leucovorin|mesh-list
102249967|NCT04745559|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102249968|NCT04745559|Immunologic Factors|immunologic factors|mesh-ancestor
102249969|NCT04745559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249971|NCT02149108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102249972|NCT02149108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102249973|NCT02149108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102249974|NCT02149108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249975|NCT02148718|Adalimumab|adalimumab|mesh-list
102249976|NCT02148718|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102249977|NCT02148718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102249978|NCT02148718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102249979|NCT03397953|Vinorelbine|vinorelbine|mesh-list
102249980|NCT03397953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102249981|NCT03397953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102249982|NCT03397953|Tubulin Modulators|tubulin modulators|mesh-ancestor
102249983|NCT03397953|Antimitotic Agents|antimitotic agents|mesh-ancestor
102249984|NCT03397953|Mitosis Modulators|mitosis modulators|mesh-ancestor
102249985|NCT03397953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102249986|NCT05549973|Dexamethasone|dexamethasone|mesh-list
102249987|NCT05549973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102249988|NCT05549973|Antiemetics|antiemetics|mesh-ancestor
102249989|NCT05549973|Autonomic Agents|autonomic agents|mesh-ancestor
102249990|NCT05549973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102249991|NCT05549973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102249992|NCT05549973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102249993|NCT05549973|Glucocorticoids|glucocorticoids|mesh-ancestor
102249994|NCT05549973|Hormones|hormones|mesh-ancestor
102249995|NCT05549973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102249996|NCT05549973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102249997|NCT05549973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102249998|NCT02148250|Insulin|insulin|mesh-list
102249999|NCT02148250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102250000|NCT02148250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102250001|NCT02148250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250002|NCT04870359|Prednisolone|prednisolone|mesh-list
102250003|NCT04870359|Immunosuppressive Agents|immunosuppressive agents|mesh-list
102250004|NCT04870359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102250005|NCT04870359|Glucocorticoids|glucocorticoids|mesh-ancestor
102250006|NCT04870359|Hormones|hormones|mesh-ancestor
102250007|NCT04870359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102250008|NCT04870359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250009|NCT04870359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102250010|NCT04870359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102250011|NCT04870359|Immunologic Factors|immunologic factors|mesh-ancestor
102250012|NCT02705859|Trastuzumab|trastuzumab|mesh-list
102250013|NCT02705859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102250014|NCT02705859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102250015|NCT05549583|Metformin|metformin|mesh-list
102250016|NCT05549583|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102250017|NCT05549583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102250018|NCT05549583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250019|NCT05549583|Incretins|incretins|mesh-ancestor
102250020|NCT05549583|Hormones|hormones|mesh-ancestor
102250021|NCT05549583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102613299|NCT00002759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102250022|NCT05549583|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102250023|NCT05549583|Protease Inhibitors|protease inhibitors|mesh-ancestor
102250024|NCT05549583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102250025|NCT05549583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250026|NCT05554731|Hemostatics|hemostatics|mesh-list
102250027|NCT05554731|Coagulants|coagulants|mesh-ancestor
102250028|NCT02172040|Celecoxib|celecoxib|mesh-list
102250029|NCT02172040|Amlodipine|amlodipine|mesh-list
102250030|NCT02172040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102250031|NCT02172040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102250032|NCT02172040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102250033|NCT02172040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250034|NCT02172040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102250035|NCT02172040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250036|NCT02172040|Vasodilator Agents|vasodilator agents|mesh-ancestor
102250037|NCT02172040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102250038|NCT02172040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102250039|NCT02172040|Analgesics|analgesics|mesh-ancestor
102250040|NCT02172040|Sensory System Agents|sensory system agents|mesh-ancestor
102250041|NCT02172040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102250042|NCT02172040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102250043|NCT02172040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102250044|NCT02172040|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102250045|NCT02172040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102250046|NCT02172040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102250047|NCT02367105|Testosterone|testosterone|mesh-list
102250048|NCT02367105|Androgens|androgens|mesh-ancestor
102250049|NCT02367105|Hormones|hormones|mesh-ancestor
102250050|NCT02367105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102250051|NCT02367105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250052|NCT02153229|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
102250053|NCT02153229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102250054|NCT02153229|Dermatologic Agents|dermatologic agents|mesh-ancestor
102250055|NCT02153229|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102250056|NCT01318317|Plerixafor|plerixafor|mesh-list
102250057|NCT01318317|Rituximab|rituximab|mesh-list
102250058|NCT01318317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102250059|NCT01318317|Antibodies|antibodies|mesh-list
102250060|NCT01318317|Immunoglobulins|immunoglobulins|mesh-list
102250061|NCT01318317|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102250062|NCT01318317|Lenograstim|lenograstim|mesh-list
102250063|NCT01318317|Immunologic Factors|immunologic factors|mesh-ancestor
102250064|NCT01318317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250065|NCT01318317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102250066|NCT01318317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102250067|NCT01318317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102250068|NCT01318317|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102250069|NCT01318317|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102250070|NCT01318317|Antiviral Agents|antiviral agents|mesh-ancestor
102250071|NCT01318317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102250072|NCT05554185|Aspirin|aspirin|mesh-list
102250073|NCT05554185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102250074|NCT05554185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102250075|NCT05554185|Analgesics|analgesics|mesh-ancestor
102250076|NCT05554185|Sensory System Agents|sensory system agents|mesh-ancestor
102250077|NCT05554185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102250078|NCT05554185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250079|NCT05554185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102250080|NCT05554185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102250081|NCT05554185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102250082|NCT05554185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102250083|NCT05554185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250084|NCT05554185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102250085|NCT05554185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102250086|NCT05554185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102250087|NCT05554185|Antipyretics|antipyretics|mesh-ancestor
102250088|NCT05558397|Morphine|morphine|mesh-list
102250089|NCT05558397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102250090|NCT05558397|Narcotics|narcotics|mesh-ancestor
102250091|NCT05558397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102250092|NCT05558397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250093|NCT05558397|Analgesics|analgesics|mesh-ancestor
102250094|NCT05558397|Sensory System Agents|sensory system agents|mesh-ancestor
102613300|NCT00002759|Anticonvulsants|anticonvulsants|mesh-ancestor
102250095|NCT05558397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102613301|NCT00002759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102250097|NCT05558319|Lenalidomide|lenalidomide|mesh-list
102250098|NCT05558319|Bortezomib|bortezomib|mesh-list
102250099|NCT05558319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102250100|NCT05558319|Antiemetics|antiemetics|mesh-ancestor
102250101|NCT05558319|Autonomic Agents|autonomic agents|mesh-ancestor
102250102|NCT05558319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102250103|NCT05558319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250104|NCT05558319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102250105|NCT05558319|Glucocorticoids|glucocorticoids|mesh-ancestor
102250106|NCT05558319|Hormones|hormones|mesh-ancestor
102250107|NCT05558319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102250108|NCT05558319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102250109|NCT05558319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102250110|NCT05558319|Immunologic Factors|immunologic factors|mesh-ancestor
102250111|NCT05558319|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102250112|NCT05558319|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102250113|NCT05558319|Growth Substances|growth substances|mesh-ancestor
102250114|NCT05558319|Growth Inhibitors|growth inhibitors|mesh-ancestor
102250115|NCT05553717|Carvedilol|carvedilol|mesh-list
102250116|NCT05553717|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101724134|NCT04142411|Insulin|insulin|mesh-list
102250117|NCT05553717|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102250118|NCT05553717|Adrenergic Agents|adrenergic agents|mesh-ancestor
102250119|NCT05553717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102250120|NCT05553717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250121|NCT05553717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250122|NCT05553717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102250123|NCT05553717|Antioxidants|antioxidants|mesh-ancestor
102250124|NCT05553717|Protective Agents|protective agents|mesh-ancestor
102250125|NCT05553717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102250126|NCT05553717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102250127|NCT05553717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102250128|NCT05553717|Vasodilator Agents|vasodilator agents|mesh-ancestor
102250129|NCT05553717|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102250130|NCT05553717|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102250131|NCT02147158|Ulipristal acetate|ulipristal acetate|mesh-list
102250132|NCT02147158|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102250133|NCT02147158|Contraceptive Agents|contraceptive agents|mesh-ancestor
102250134|NCT02147158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102250135|NCT02147158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250136|NCT02147158|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102250137|NCT05553093|Insulin|insulin|mesh-list
102250138|NCT05553093|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102250139|NCT05553093|Insulin Glargine|insulin glargine|mesh-list
102250140|NCT05553093|Tirzepatide|tirzepatide|mesh-list
102250141|NCT05553093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102250142|NCT05553093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250143|NCT05553093|Incretins|incretins|mesh-ancestor
102250144|NCT05553093|Hormones|hormones|mesh-ancestor
101724267|NCT04141319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102250145|NCT05553093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102250146|NCT04757740|Methylprednisolone|methylprednisolone|mesh-list
102250147|NCT04757740|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102250148|NCT04757740|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102250149|NCT04757740|Prednisolone|prednisolone|mesh-list
102250150|NCT04757740|Prednisolone acetate|prednisolone acetate|mesh-list
102250151|NCT04757740|Lidocaine|lidocaine|mesh-list
102250152|NCT04757740|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102250153|NCT04757740|Prednisolone phosphate|prednisolone phosphate|mesh-list
102250154|NCT04757740|Anesthetics, Local|anesthetics, local|mesh-ancestor
102250155|NCT04757740|Anesthetics|anesthetics|mesh-ancestor
102250156|NCT04757740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102250157|NCT04757740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250158|NCT04757740|Sensory System Agents|sensory system agents|mesh-ancestor
101724339|NCT00781300|Hormones|hormones|mesh-ancestor
102250159|NCT04757740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102250160|NCT04757740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102250161|NCT04757740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102250162|NCT04757740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102250163|NCT04757740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102250164|NCT04757740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250165|NCT04757740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102250166|NCT04757740|Antiemetics|antiemetics|mesh-ancestor
102250167|NCT04757740|Autonomic Agents|autonomic agents|mesh-ancestor
102250168|NCT04757740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101591875|NCT04237090|Promethazine|promethazine|mesh-list
102613302|NCT00002759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102250169|NCT04757740|Glucocorticoids|glucocorticoids|mesh-ancestor
102250170|NCT04757740|Hormones|hormones|mesh-ancestor
102250171|NCT04757740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102250172|NCT04757740|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102250173|NCT04757740|Protective Agents|protective agents|mesh-ancestor
102250174|NCT04757740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102250175|NCT04757740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102250176|NCT05552937|Lenalidomide|lenalidomide|mesh-list
102250177|NCT05552937|Immunologic Factors|immunologic factors|mesh-ancestor
102250178|NCT05552937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250179|NCT05552937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102250180|NCT05552937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102250181|NCT05552937|Growth Substances|growth substances|mesh-ancestor
102250182|NCT05552937|Growth Inhibitors|growth inhibitors|mesh-ancestor
102250183|NCT05552937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102250184|NCT02112448|Acetaminophen|acetaminophen|mesh-list
102250186|NCT02112448|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102250187|NCT02112448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102250188|NCT02112448|Analgesics|analgesics|mesh-ancestor
102250189|NCT02112448|Sensory System Agents|sensory system agents|mesh-ancestor
102250190|NCT02112448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102250191|NCT02112448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250192|NCT02112448|Antipyretics|antipyretics|mesh-ancestor
102250193|NCT02112448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102250194|NCT02112448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102250195|NCT02112448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102250196|NCT02112448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102250197|NCT02112448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102250198|NCT02112448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250199|NCT02109562|Risperidone|risperidone|mesh-list
102250200|NCT02109562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102250201|NCT02109562|Serotonin Agents|serotonin agents|mesh-ancestor
102250202|NCT02109562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102250203|NCT02109562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250204|NCT02109562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250205|NCT02109562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102250206|NCT02109562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102250207|NCT02109562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102250208|NCT02109562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102250209|NCT02109562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102250210|NCT02109562|Dopamine Agents|dopamine agents|mesh-ancestor
102250211|NCT02109484|Vaccines|vaccines|mesh-list
102250212|NCT02109484|Immunologic Factors|immunologic factors|mesh-ancestor
102250213|NCT02109484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250214|NCT05134792|Immunoglobulins|immunoglobulins|mesh-list
102250215|NCT05134792|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102250216|NCT05134792|Antibodies|antibodies|mesh-list
102250217|NCT05134792|gamma-Globulins|gamma-globulins|mesh-list
102250218|NCT05134792|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102250219|NCT05134792|Immunologic Factors|immunologic factors|mesh-ancestor
102250220|NCT05134792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250221|NCT02105974|Fluticasone|fluticasone|mesh-list
102250222|NCT02105974|Xhance|xhance|mesh-list
102250223|NCT02105974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102250224|NCT02105974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102250225|NCT02105974|Autonomic Agents|autonomic agents|mesh-ancestor
102250226|NCT02105974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102250227|NCT02105974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250228|NCT02105974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102250229|NCT02105974|Respiratory System Agents|respiratory system agents|mesh-ancestor
102250230|NCT02105974|Dermatologic Agents|dermatologic agents|mesh-ancestor
102250231|NCT02105974|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102250232|NCT02105662|Grazoprevir|grazoprevir|mesh-list
102250233|NCT02105662|Antiviral Agents|antiviral agents|mesh-ancestor
102250234|NCT02105662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102250235|NCT02142712|Diphenhydramine|diphenhydramine|mesh-list
102250236|NCT02142712|Promethazine|promethazine|mesh-list
102250237|NCT02142712|Dextromethorphan|dextromethorphan|mesh-list
102250238|NCT02142712|Pantoprazole|pantoprazole|mesh-list
102250239|NCT02142712|Famotidine|famotidine|mesh-list
102250240|NCT02142712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102250241|NCT02142712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102250242|NCT02142712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102250243|NCT02142712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102250244|NCT02142712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250245|NCT02142712|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102613303|NCT00002759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102613304|NCT00002759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101724670|NCT00695201|Antimetabolites|antimetabolites|mesh-ancestor
102613305|NCT00002759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102613306|NCT00002759|GABA Modulators|gaba modulators|mesh-ancestor
102613307|NCT00002759|GABA Agents|gaba agents|mesh-ancestor
102613308|NCT00002759|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102613309|NCT00002759|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102250246|NCT02142712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102250247|NCT02142712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102250248|NCT02142712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250249|NCT02142712|Anesthetics, Local|anesthetics, local|mesh-ancestor
102250250|NCT02142712|Anesthetics|anesthetics|mesh-ancestor
102250251|NCT02142712|Sensory System Agents|sensory system agents|mesh-ancestor
102250252|NCT02142712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102250253|NCT02142712|Antiemetics|antiemetics|mesh-ancestor
102250254|NCT02142712|Autonomic Agents|autonomic agents|mesh-ancestor
102250255|NCT02142712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101959144|NCT02137954|Lidocaine|lidocaine|mesh-list
102250256|NCT02142712|Histamine Antagonists|histamine antagonists|mesh-ancestor
102250257|NCT02142712|Histamine Agents|histamine agents|mesh-ancestor
102613310|NCT00002759|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102613311|NCT00002765|Immunotoxins|immunotoxins|mesh-list
102613312|NCT00002765|Immunoconjugates|immunoconjugates|mesh-ancestor
102613313|NCT00002765|Immunologic Factors|immunologic factors|mesh-ancestor
102613314|NCT00002765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613315|NCT00002771|Interferons|interferons|mesh-list
102250258|NCT02142712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102250259|NCT02142712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102250260|NCT02142712|Antipruritics|antipruritics|mesh-ancestor
102250261|NCT02142712|Dermatologic Agents|dermatologic agents|mesh-ancestor
102250262|NCT02142712|Antitussive Agents|antitussive agents|mesh-ancestor
102250263|NCT02142712|Respiratory System Agents|respiratory system agents|mesh-ancestor
102250264|NCT02142712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102250265|NCT02142712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102250266|NCT02142712|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102250267|NCT02105272|Carteolol|carteolol|mesh-list
102250268|NCT02105272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102250269|NCT02105272|Latanoprost|latanoprost|mesh-list
102250270|NCT02105272|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102250271|NCT02105272|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102250272|NCT02105272|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101724861|NCT00700466|Metoprolol|metoprolol|mesh-list
102250273|NCT02105272|Adrenergic Agents|adrenergic agents|mesh-ancestor
102250274|NCT02105272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102250275|NCT02105272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250276|NCT02105272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250277|NCT02105272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102250278|NCT02105272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102250279|NCT02105272|Sympatholytics|sympatholytics|mesh-ancestor
102250280|NCT02105272|Autonomic Agents|autonomic agents|mesh-ancestor
102250281|NCT02105272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102250282|NCT02141854|Fluticasone|fluticasone|mesh-list
102250283|NCT02141854|Xhance|xhance|mesh-list
102250284|NCT02141854|Albuterol|albuterol|mesh-list
102250285|NCT02141854|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102250286|NCT02141854|Adrenergic Agonists|adrenergic agonists|mesh-list
102250287|NCT02141854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102250288|NCT02141854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102250289|NCT02141854|Autonomic Agents|autonomic agents|mesh-ancestor
102250290|NCT02141854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102250291|NCT02141854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250292|NCT02141854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102250293|NCT02141854|Respiratory System Agents|respiratory system agents|mesh-ancestor
102250294|NCT02141854|Dermatologic Agents|dermatologic agents|mesh-ancestor
102250295|NCT02141854|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102250296|NCT02141854|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102250297|NCT02141854|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102250298|NCT02141854|Adrenergic Agents|adrenergic agents|mesh-ancestor
102250299|NCT02141854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102250300|NCT02141854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250301|NCT02141854|Tocolytic Agents|tocolytic agents|mesh-ancestor
102250302|NCT02141854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102250303|NCT02141620|Acetylcysteine|acetylcysteine|mesh-list
102613316|NCT00002771|Cytarabine|cytarabine|mesh-list
102250304|NCT02141620|Cocaine|cocaine|mesh-list
102250305|NCT02141620|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102250306|NCT02141620|Antiviral Agents|antiviral agents|mesh-ancestor
101901730|NCT01185860|Antimetabolites|antimetabolites|mesh-ancestor
102613317|NCT00002771|Interferon-alpha|interferon-alpha|mesh-list
102250311|NCT02141620|Antioxidants|antioxidants|mesh-ancestor
102250312|NCT02141620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250313|NCT02141620|Protective Agents|protective agents|mesh-ancestor
102250314|NCT02141620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250315|NCT02141620|Antidotes|antidotes|mesh-ancestor
102250316|NCT02141620|Anesthetics, Local|anesthetics, local|mesh-ancestor
102250317|NCT02141620|Anesthetics|anesthetics|mesh-ancestor
102250318|NCT02141620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102250319|NCT02141620|Sensory System Agents|sensory system agents|mesh-ancestor
102250320|NCT02141620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102250321|NCT02141620|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102250322|NCT02141620|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102250323|NCT02141620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102250324|NCT02141620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102250325|NCT02141620|Dopamine Agents|dopamine agents|mesh-ancestor
102250326|NCT02141620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102250327|NCT01664949|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102250328|NCT01664949|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102250329|NCT01664949|Lubricant Eye Drops|lubricant eye drops|mesh-list
102250330|NCT01664949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102250331|NCT01664949|Laxatives|laxatives|mesh-ancestor
102250332|NCT01664949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102250333|NCT02587143|Ethyl Chloride|ethyl chloride|mesh-list
102250334|NCT02587143|Anesthetics, Local|anesthetics, local|mesh-ancestor
102250335|NCT02587143|Anesthetics|anesthetics|mesh-ancestor
102250336|NCT02587143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102250337|NCT02587143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250338|NCT02587143|Sensory System Agents|sensory system agents|mesh-ancestor
102250339|NCT02587143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102250349|NCT02106832|Ciprofloxacin|ciprofloxacin|mesh-list
102250350|NCT02106832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102250351|NCT02106832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101725094|NCT00784966|Etanercept|etanercept|mesh-list
102250352|NCT02106832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102250353|NCT02106832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102250354|NCT02106832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102250355|NCT02106832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250356|NCT02106832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102250357|NCT02106832|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102250358|NCT02106832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102250359|NCT05552391|Dexmedetomidine|dexmedetomidine|mesh-list
102250360|NCT05552391|Ketamine|ketamine|mesh-list
102250361|NCT05552391|Bupivacaine|bupivacaine|mesh-list
102250362|NCT05552391|Anesthetics, Local|anesthetics, local|mesh-ancestor
102250363|NCT05552391|Anesthetics|anesthetics|mesh-ancestor
102250364|NCT05552391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102250365|NCT05552391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250366|NCT05552391|Sensory System Agents|sensory system agents|mesh-ancestor
102250367|NCT05552391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102250368|NCT05552391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102250369|NCT05552391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102250370|NCT05552391|Analgesics|analgesics|mesh-ancestor
101725226|NCT00785122|Imiquimod|imiquimod|mesh-list
102250371|NCT05552391|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102250372|NCT05552391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102250373|NCT05552391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102250374|NCT05552391|Adrenergic Agents|adrenergic agents|mesh-ancestor
102613324|NCT00002771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102613325|NCT00002771|Antimetabolites|antimetabolites|mesh-ancestor
102613326|NCT00002771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613327|NCT00002771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102250376|NCT05552391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250377|NCT05552391|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102250378|NCT05552391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101725283|NCT00795262|Quinapril|quinapril|mesh-list
102250379|NCT05552391|Anesthetics, General|anesthetics, general|mesh-ancestor
102250380|NCT05552391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102250381|NCT05552391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102250382|NCT02106442|Risedronic Acid|risedronic acid|mesh-list
102250383|NCT02106442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102250384|NCT02106442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102250385|NCT02106442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250386|NCT02106442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102250387|NCT02106442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250388|NCT02106442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102250389|NCT04740814|Certolizumab Pegol|certolizumab pegol|mesh-list
102250390|NCT04740814|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102250391|NCT04740814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102250392|NCT04740814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102250393|NCT04740814|Immunologic Factors|immunologic factors|mesh-ancestor
102250394|NCT04740814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250395|NCT04740814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102250396|NCT02105116|Cytarabine|cytarabine|mesh-list
102250397|NCT02105116|Fludarabine|fludarabine|mesh-list
102250398|NCT02105116|Fludarabine phosphate|fludarabine phosphate|mesh-list
102250399|NCT02105116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102250400|NCT02105116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102250401|NCT02105116|Antimetabolites|antimetabolites|mesh-ancestor
102250402|NCT02105116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250403|NCT02105116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102250404|NCT02105116|Immunologic Factors|immunologic factors|mesh-ancestor
102250405|NCT02105116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250406|NCT02105116|Antiviral Agents|antiviral agents|mesh-ancestor
102250407|NCT02105116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101959290|NCT05578456|Glucocorticoids|glucocorticoids|mesh-ancestor
102250408|NCT05551767|Cisplatin|cisplatin|mesh-list
102250409|NCT05551767|Pembrolizumab|pembrolizumab|mesh-list
102250410|NCT05551767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102250411|NCT05551767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102250412|NCT05551767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102250413|NCT05551767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250414|NCT05551689|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102250415|NCT05551689|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102250416|NCT05551689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250417|NCT05551689|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102250418|NCT05551689|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102250419|NCT05551689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102250420|NCT05551689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250421|NCT05551689|Dopamine Agents|dopamine agents|mesh-ancestor
102250422|NCT05551689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102250423|NCT05547789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102250424|NCT05547789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
102250425|NCT05547789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102250426|NCT05547789|Analgesics|analgesics|mesh-ancestor
102250427|NCT05547789|Sensory System Agents|sensory system agents|mesh-ancestor
102250428|NCT05547789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102250429|NCT05547789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250430|NCT05547789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102250431|NCT05542095|Simvastatin|simvastatin|mesh-list
102250432|NCT05542095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102250433|NCT05542095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102250434|NCT05542095|Antimetabolites|antimetabolites|mesh-ancestor
101725589|NCT02619929|Mitosis Modulators|mitosis modulators|mesh-ancestor
102250435|NCT05542095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250436|NCT05542095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102250437|NCT05542095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102250438|NCT05542095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102250439|NCT05551221|Tamsulosin|tamsulosin|mesh-list
102250440|NCT05551221|Silodosin|silodosin|mesh-list
102250441|NCT05551221|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101725662|NCT00814632|Apremilast|apremilast|mesh-list
102613328|NCT00002771|Immunologic Factors|immunologic factors|mesh-ancestor
102250442|NCT05551221|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102250443|NCT05551221|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102250444|NCT05551221|Adrenergic Agents|adrenergic agents|mesh-ancestor
102250445|NCT05551221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102250446|NCT05551221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725717|NCT00851318|Dermatologic Agents|dermatologic agents|mesh-ancestor
102250447|NCT05551221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250448|NCT05551221|Urological Agents|urological agents|mesh-ancestor
102250449|NCT02104804|Insulin|insulin|mesh-list
102250450|NCT02104804|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102250451|NCT02104804|Metformin|metformin|mesh-list
102250452|NCT02104804|Saxagliptin|saxagliptin|mesh-list
102250453|NCT02104804|Insulin, Short-Acting|insulin, short-acting|mesh-list
102250454|NCT02104804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102250455|NCT02104804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250456|NCT02104804|Incretins|incretins|mesh-ancestor
102250457|NCT02104804|Hormones|hormones|mesh-ancestor
102250458|NCT02104804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102250459|NCT02104804|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102250460|NCT02104804|Protease Inhibitors|protease inhibitors|mesh-ancestor
102250461|NCT02104804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102250462|NCT02104804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250463|NCT05550441|Dapagliflozin|dapagliflozin|mesh-list
102250464|NCT05550441|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101725852|NCT02617199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102250465|NCT05550441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250466|NCT05550441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102250467|NCT05550441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250468|NCT05550207|Meloxicam|meloxicam|mesh-list
102250469|NCT05550207|Rizatriptan|rizatriptan|mesh-list
102250470|NCT05550207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102250471|NCT05550207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102250472|NCT05550207|Analgesics|analgesics|mesh-ancestor
102250473|NCT05550207|Sensory System Agents|sensory system agents|mesh-ancestor
102250474|NCT05550207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102250475|NCT05550207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250476|NCT05550207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102250477|NCT05550207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102250478|NCT05550207|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102250479|NCT05550207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101725988|NCT04030988|Hormones|hormones|mesh-ancestor
102250480|NCT05550207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102250481|NCT05550207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250482|NCT05550207|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102250483|NCT05550207|Serotonin Agents|serotonin agents|mesh-ancestor
102250484|NCT05550207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102250485|NCT05546853|Leucovorin|leucovorin|mesh-list
102250486|NCT05546853|Oxaliplatin|oxaliplatin|mesh-list
102250487|NCT05546853|Irinotecan|irinotecan|mesh-list
102250488|NCT05546853|Calcium|calcium|mesh-list
102250489|NCT05546853|Levoleucovorin|levoleucovorin|mesh-list
102250490|NCT05546853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102250491|NCT05546853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250492|NCT05546853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102250493|NCT05546853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102250494|NCT05546853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102250495|NCT05546853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102250496|NCT05546853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250497|NCT05546853|Antidotes|antidotes|mesh-ancestor
102250498|NCT05546853|Protective Agents|protective agents|mesh-ancestor
102250499|NCT05546853|Vitamin B Complex|vitamin b complex|mesh-ancestor
102250500|NCT05546853|Vitamins|vitamins|mesh-ancestor
102250501|NCT05546853|Micronutrients|micronutrients|mesh-ancestor
102250502|NCT05546619|Tislelizumab|tislelizumab|mesh-list
102250503|NCT05546619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102250504|NCT05546619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102250505|NCT05540145|Paclitaxel|paclitaxel|mesh-list
102250506|NCT05540145|Antibodies|antibodies|mesh-list
102250507|NCT05540145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102250508|NCT05540145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102250509|NCT05540145|Tubulin Modulators|tubulin modulators|mesh-ancestor
102250510|NCT05540145|Antimitotic Agents|antimitotic agents|mesh-ancestor
102250511|NCT05540145|Mitosis Modulators|mitosis modulators|mesh-ancestor
102250512|NCT05540145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250513|NCT05540145|Immunologic Factors|immunologic factors|mesh-ancestor
102250514|NCT05540145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250515|NCT05592327|Citric Acid|citric acid|mesh-list
102250516|NCT05592327|Sodium Citrate|sodium citrate|mesh-list
102250517|NCT05592327|Anticoagulants|anticoagulants|mesh-ancestor
102613329|NCT00002771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613330|NCT00002771|Alkylating Agents|alkylating agents|mesh-ancestor
102613331|NCT00002771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102613332|NCT00002771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102613333|NCT00002771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102613334|NCT00002771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102613335|NCT00002771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102613336|NCT00002771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102613337|NCT00002771|Antisickling Agents|antisickling agents|mesh-ancestor
102613338|NCT00002771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102250518|NCT05592327|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102250519|NCT05592327|Chelating Agents|chelating agents|mesh-ancestor
102250520|NCT05592327|Sequestering Agents|sequestering agents|mesh-ancestor
101726159|NCT00798460|Adefovir|adefovir|mesh-list
102250521|NCT05592327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250522|NCT05592171|Chlorotrianisene|chlorotrianisene|mesh-list
102250523|NCT05592171|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102250524|NCT05592171|Estrogens|estrogens|mesh-ancestor
102250525|NCT05592171|Hormones|hormones|mesh-ancestor
102250526|NCT05592171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102250527|NCT05592171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250528|NCT05592171|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102250529|NCT05592171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102250530|NCT05539521|Propofol|propofol|mesh-list
102250531|NCT05539521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102250532|NCT05539521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102250533|NCT05539521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250534|NCT05539521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102250535|NCT05539521|Anesthetics, General|anesthetics, general|mesh-ancestor
102250536|NCT05539521|Anesthetics|anesthetics|mesh-ancestor
102250537|NCT05592015|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
102250538|NCT05592015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102250539|NCT05592015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101726284|NCT04137029|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101726285|NCT04137029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101726286|NCT04137029|Adrenergic Agents|adrenergic agents|mesh-ancestor
101726287|NCT04137029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101726288|NCT04137029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726289|NCT04137029|Parasympatholytics|parasympatholytics|mesh-ancestor
102250540|NCT05592015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250541|NCT05538507|Memantine|memantine|mesh-list
102250542|NCT05538507|Donepezil|donepezil|mesh-list
102250543|NCT05538507|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102250544|NCT05538507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102250545|NCT05538507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250546|NCT05538507|Cholinergic Agents|cholinergic agents|mesh-ancestor
102250547|NCT05538507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102250548|NCT05538507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250549|NCT05538507|Nootropic Agents|nootropic agents|mesh-ancestor
102250550|NCT05538507|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102250551|NCT05538507|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102250552|NCT05538507|Dopamine Agents|dopamine agents|mesh-ancestor
102250553|NCT05538507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102250554|NCT05538507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102250555|NCT05591235|Metformin|metformin|mesh-list
102250556|NCT05591235|Pioglitazone|pioglitazone|mesh-list
102250557|NCT05591235|Dapagliflozin|dapagliflozin|mesh-list
102250558|NCT05591235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101726350|NCT04031027|Analgesics|analgesics|mesh-ancestor
102250559|NCT05591235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250560|NCT05591235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102250561|NCT05591235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250562|NCT05545527|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
102250563|NCT05545527|Ferric Compounds|ferric compounds|mesh-list
102250564|NCT05545527|Hematinics|hematinics|mesh-ancestor
102250565|NCT01666119|Buprenorphine|buprenorphine|mesh-list
102250566|NCT01666119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102250567|NCT01666119|Narcotics|narcotics|mesh-ancestor
102250568|NCT01666119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102250569|NCT01666119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250570|NCT01666119|Analgesics|analgesics|mesh-ancestor
102250571|NCT01666119|Sensory System Agents|sensory system agents|mesh-ancestor
102250572|NCT01666119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102250573|NCT01666119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102250574|NCT05361993|Aripiprazole|aripiprazole|mesh-list
102250575|NCT05361993|Antidepressive Agents|antidepressive agents|mesh-ancestor
102250576|NCT05361993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102250577|NCT05361993|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102250578|NCT05361993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102613339|NCT00002777|Tamoxifen|tamoxifen|mesh-list
102250579|NCT05361993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102250580|NCT05361993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250581|NCT05361993|Dopamine Agonists|dopamine agonists|mesh-ancestor
102613340|NCT00002777|Exemestane|exemestane|mesh-list
102250582|NCT05361993|Dopamine Agents|dopamine agents|mesh-ancestor
102250583|NCT05361993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101726464|NCT05754684|Sensory System Agents|sensory system agents|mesh-ancestor
102250584|NCT05361993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250585|NCT05361993|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102250586|NCT05361993|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102250587|NCT05361993|Serotonin Agents|serotonin agents|mesh-ancestor
102250588|NCT05361993|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102250589|NCT05361993|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102250590|NCT05361993|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102250591|NCT05361993|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102250592|NCT04425681|Bevacizumab|bevacizumab|mesh-list
102250593|NCT04425681|Osimertinib|osimertinib|mesh-list
101726541|NCT00871871|Diuretics|diuretics|mesh-ancestor
102250594|NCT04425681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102250595|NCT04425681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102250596|NCT04425681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102250597|NCT04425681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102250598|NCT04425681|Growth Substances|growth substances|mesh-ancestor
102250599|NCT04425681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250600|NCT04425681|Growth Inhibitors|growth inhibitors|mesh-ancestor
102250601|NCT04425681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102250602|NCT04425681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101726589|NCT00866723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102250603|NCT04425681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250604|NCT05545059|Amlodipine|amlodipine|mesh-list
102250605|NCT05545059|Valsartan|valsartan|mesh-list
102250606|NCT05545059|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102250607|NCT05545059|Spironolactone|spironolactone|mesh-list
102250608|NCT05545059|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102250609|NCT05545059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102250610|NCT05545059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102250611|NCT05545059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102250612|NCT05545059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250613|NCT05545059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102250614|NCT05545059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250615|NCT05545059|Vasodilator Agents|vasodilator agents|mesh-ancestor
102250616|NCT05545059|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102250617|NCT05545059|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102250618|NCT05545059|Diuretics|diuretics|mesh-ancestor
102250619|NCT05545059|Natriuretic Agents|natriuretic agents|mesh-ancestor
102250620|NCT05545059|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102250621|NCT05545059|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102250622|NCT05545059|Hormone Antagonists|hormone antagonists|mesh-ancestor
102250623|NCT05545059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102250624|NCT05545059|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102250625|NCT05128773|Tamoxifen|tamoxifen|mesh-list
102250626|NCT05128773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102250627|NCT05128773|Hormone Antagonists|hormone antagonists|mesh-ancestor
102250628|NCT05128773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102250629|NCT05128773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250630|NCT05128773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102250631|NCT05128773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102250632|NCT05128773|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102250633|NCT05128773|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102250634|NCT05128773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102250635|NCT05536011|Sodium Oxybate|sodium oxybate|mesh-list
102250636|NCT05536011|Methylphenidate|methylphenidate|mesh-list
102250637|NCT05536011|Modafinil|modafinil|mesh-list
102250638|NCT05536011|Amphetamine|amphetamine|mesh-list
102250639|NCT05536011|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101726721|NCT00827918|Serotonin Agents|serotonin agents|mesh-ancestor
102250640|NCT05536011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250641|NCT05536011|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102250642|NCT05536011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102250643|NCT05536011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102250644|NCT05536011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250645|NCT05536011|Dopamine Agents|dopamine agents|mesh-ancestor
102250646|NCT05536011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102250647|NCT05536011|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102250648|NCT05536011|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102250649|NCT05536011|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102250650|NCT05536011|Sympathomimetics|sympathomimetics|mesh-ancestor
102250651|NCT05536011|Autonomic Agents|autonomic agents|mesh-ancestor
102613341|NCT00002777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250652|NCT05536011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102250653|NCT05536011|Adrenergic Agents|adrenergic agents|mesh-ancestor
102250654|NCT05536011|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102250655|NCT05536011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102250656|NCT05536011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102250657|NCT05536011|Anesthetics, General|anesthetics, general|mesh-ancestor
102250658|NCT05536011|Anesthetics|anesthetics|mesh-ancestor
102250659|NCT05536011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102250660|NCT04809051|Metronidazole|metronidazole|mesh-list
102250661|NCT04809051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102250662|NCT04809051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102250663|NCT04809051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102250664|NCT04809051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102250665|NCT04015869|Pregnanolone|pregnanolone|mesh-list
102250666|NCT04015869|Anesthetics|anesthetics|mesh-ancestor
102250667|NCT04015869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102250668|NCT04015869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250669|NCT04677855|Prednisone|prednisone|mesh-list
102250670|NCT04677855|Dutasteride|dutasteride|mesh-list
102250671|NCT04677855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102250672|NCT04677855|Glucocorticoids|glucocorticoids|mesh-ancestor
102250673|NCT04677855|Hormones|hormones|mesh-ancestor
102250674|NCT04677855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102250675|NCT04677855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250676|NCT04677855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102250677|NCT04677855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102250678|NCT04677855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102250679|NCT04677855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102250680|NCT04677855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102250681|NCT04677855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250682|NCT04677855|Hormone Antagonists|hormone antagonists|mesh-ancestor
102250683|NCT02584959|Complement C1s|complement c1s|mesh-list
102250684|NCT02584959|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
102250685|NCT02584959|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
102250686|NCT02584959|Immunologic Factors|immunologic factors|mesh-ancestor
102250687|NCT02584959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250688|NCT02584959|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102250689|NCT02584959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102250690|NCT05544045|Calcium Carbonate|calcium carbonate|mesh-list
102250691|NCT05544045|Antacids|antacids|mesh-ancestor
102250692|NCT05544045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250693|NCT05544045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102250694|NCT02584257|Albuterol|albuterol|mesh-list
102250695|NCT02584257|Procaterol|procaterol|mesh-list
102250696|NCT02584257|Methacholine Chloride|methacholine chloride|mesh-list
102250697|NCT02584257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102250698|NCT02584257|Autonomic Agents|autonomic agents|mesh-ancestor
102250699|NCT02584257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102250700|NCT02584257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250701|NCT02584257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101959596|NCT02217267|Lidocaine|lidocaine|mesh-list
102250702|NCT02584257|Respiratory System Agents|respiratory system agents|mesh-ancestor
102250703|NCT02584257|Tocolytic Agents|tocolytic agents|mesh-ancestor
102250704|NCT02584257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102250705|NCT02584257|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102250706|NCT02584257|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102250707|NCT02584257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102250708|NCT02584257|Adrenergic Agents|adrenergic agents|mesh-ancestor
102250709|NCT02584257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102250710|NCT02584257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250712|NCT02584257|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102250713|NCT02584257|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
102250714|NCT02584257|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102250715|NCT02584257|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102250716|NCT02584257|Cholinergic Agents|cholinergic agents|mesh-ancestor
102250717|NCT02584257|Sympathomimetics|sympathomimetics|mesh-ancestor
102250718|NCT04090203|Immunomodulating Agents|immunomodulating agents|mesh-list
102250719|NCT04090203|Immunologic Factors|immunologic factors|mesh-ancestor
102250720|NCT04090203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250721|NCT04062201|Levofloxacin|levofloxacin|mesh-list
102250722|NCT04062201|Ofloxacin|ofloxacin|mesh-list
102250723|NCT04062201|Isoniazid|isoniazid|mesh-list
102250724|NCT04062201|Linezolid|linezolid|mesh-list
102250725|NCT04062201|Pyrazinamide|pyrazinamide|mesh-list
102250726|NCT04062201|Ethambutol|ethambutol|mesh-list
102250727|NCT04062201|Bedaquiline|bedaquiline|mesh-list
102613342|NCT00002777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102250728|NCT04062201|Clofazimine|clofazimine|mesh-list
102250729|NCT04062201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102250730|NCT04062201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102250731|NCT04062201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102250732|NCT04062201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102250733|NCT04062201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102250734|NCT04062201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102250735|NCT04062201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250736|NCT04062201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102250737|NCT04062201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101726901|NCT00793468|Nicotine|nicotine|mesh-list
102250738|NCT04062201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102250739|NCT04062201|Antitubercular Agents|antitubercular agents|mesh-ancestor
102250740|NCT04062201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102250741|NCT04062201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102250742|NCT04062201|Antimetabolites|antimetabolites|mesh-ancestor
102250743|NCT04062201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102250744|NCT04062201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102250745|NCT04062201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102250746|NCT04062201|Leprostatic Agents|leprostatic agents|mesh-ancestor
102250747|NCT02583477|Paclitaxel|paclitaxel|mesh-list
102250748|NCT02583477|Gemcitabine|gemcitabine|mesh-list
102250749|NCT02583477|Durvalumab|durvalumab|mesh-list
102250750|NCT02583477|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102250751|NCT02583477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102250752|NCT02583477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102250753|NCT02583477|Tubulin Modulators|tubulin modulators|mesh-ancestor
102250754|NCT02583477|Antimitotic Agents|antimitotic agents|mesh-ancestor
102250755|NCT02583477|Mitosis Modulators|mitosis modulators|mesh-ancestor
101727036|NCT00801268|Emodin|emodin|mesh-list
102250756|NCT02583477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250757|NCT02583477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102250758|NCT02583477|Antimetabolites|antimetabolites|mesh-ancestor
102250759|NCT02583477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102250760|NCT02583477|Immunologic Factors|immunologic factors|mesh-ancestor
102250761|NCT02583477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250762|NCT02583399|Ibuprofen|ibuprofen|mesh-list
102250763|NCT02583399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102250764|NCT02583399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102250765|NCT02583399|Analgesics|analgesics|mesh-ancestor
102250766|NCT02583399|Sensory System Agents|sensory system agents|mesh-ancestor
102250767|NCT02583399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102250768|NCT02583399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250769|NCT02583399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102250770|NCT02583399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102250771|NCT02583399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102250772|NCT02583399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102250773|NCT02583399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250774|NCT02580591|Empagliflozin|empagliflozin|mesh-list
102250775|NCT02580591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102250776|NCT02580591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250777|NCT02580591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102250778|NCT02580591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250779|NCT05552001|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
102250780|NCT05552001|Immunoconjugates|immunoconjugates|mesh-ancestor
102250781|NCT05552001|Immunologic Factors|immunologic factors|mesh-ancestor
102250782|NCT05552001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250783|NCT05390307|Dapagliflozin|dapagliflozin|mesh-list
102250784|NCT05390307|Liraglutide|liraglutide|mesh-list
102250785|NCT05390307|Glucagon|glucagon|mesh-list
102250786|NCT05390307|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102250787|NCT05390307|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101727158|NCT02606994|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102250788|NCT05390307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250789|NCT05390307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102250790|NCT05390307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250791|NCT05390307|Incretins|incretins|mesh-ancestor
102250792|NCT05390307|Hormones|hormones|mesh-ancestor
102250793|NCT05390307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102250794|NCT05390307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102250795|NCT05319249|Talazoparib|talazoparib|mesh-list
102250796|NCT05319249|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102250797|NCT05319249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102250798|NCT05319249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250799|NCT05319249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102250800|NCT03849885|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102250801|NCT03849885|Dermatologic Agents|dermatologic agents|mesh-ancestor
102250802|NCT02577315|Metformin|metformin|mesh-list
102250803|NCT02577315|Empagliflozin|empagliflozin|mesh-list
102250804|NCT02577315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102250805|NCT02577315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250806|NCT02577315|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102250807|NCT02577315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250808|NCT01582269|Lomustine|lomustine|mesh-list
102250809|NCT01582269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102250810|NCT01582269|Alkylating Agents|alkylating agents|mesh-ancestor
102250811|NCT01582269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250812|NCT01582269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102250813|NCT03526887|Pembrolizumab|pembrolizumab|mesh-list
102250814|NCT03526887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102250815|NCT03526887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102250816|NCT03526887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102250817|NCT03526887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250818|NCT03496779|Gemcitabine|gemcitabine|mesh-list
102250819|NCT03496779|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102250820|NCT03496779|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102250821|NCT03496779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102250822|NCT03496779|Antimetabolites|antimetabolites|mesh-ancestor
102250823|NCT03496779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250824|NCT03496779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102250825|NCT03496779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102250826|NCT03496779|Immunotoxins|immunotoxins|mesh-ancestor
102250827|NCT03496779|Immunoconjugates|immunoconjugates|mesh-ancestor
102250828|NCT03496779|Immunologic Factors|immunologic factors|mesh-ancestor
101727335|NCT00803530|Antioxidants|antioxidants|mesh-ancestor
102250829|NCT03496779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250830|NCT03398655|Paclitaxel|paclitaxel|mesh-list
102250831|NCT03398655|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102250832|NCT03398655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102250833|NCT03398655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102250834|NCT03398655|Tubulin Modulators|tubulin modulators|mesh-ancestor
102250835|NCT03398655|Antimitotic Agents|antimitotic agents|mesh-ancestor
102250836|NCT03398655|Mitosis Modulators|mitosis modulators|mesh-ancestor
102250837|NCT03398655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250838|NCT05695287|Propofol|propofol|mesh-list
102250839|NCT05695287|Sevoflurane|sevoflurane|mesh-list
102250840|NCT05695287|Isoflurane|isoflurane|mesh-list
102250841|NCT05695287|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102250842|NCT05695287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102250843|NCT05695287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250844|NCT05695287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102250845|NCT05695287|Anesthetics, General|anesthetics, general|mesh-ancestor
102250846|NCT05695287|Anesthetics|anesthetics|mesh-ancestor
102250847|NCT05695287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102250848|NCT05695287|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102250849|NCT03808025|Analgesics, Opioid|analgesics, opioid|mesh-list
102250850|NCT03808025|Narcotics|narcotics|mesh-ancestor
102250851|NCT03808025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102250852|NCT03808025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959765|NCT04012996|Meloxicam|meloxicam|mesh-list
102250853|NCT03808025|Analgesics|analgesics|mesh-ancestor
102250854|NCT03808025|Sensory System Agents|sensory system agents|mesh-ancestor
102250855|NCT03808025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102250856|NCT00591227|Insulin|insulin|mesh-list
102250857|NCT00591227|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102250858|NCT00591227|Insulin Aspart|insulin aspart|mesh-list
102250859|NCT00591227|Insulin Detemir|insulin detemir|mesh-list
102250860|NCT00591227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102250861|NCT00591227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250862|NCT00408473|Flecainide|flecainide|mesh-list
102250863|NCT00408473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102250864|NCT00408473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102250865|NCT00408473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102250866|NCT00408473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102250867|NCT00408473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250868|NCT00328601|Thioctic Acid|thioctic acid|mesh-list
102250869|NCT00328601|Antioxidants|antioxidants|mesh-ancestor
102250870|NCT00328601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250871|NCT00328601|Protective Agents|protective agents|mesh-ancestor
102250872|NCT00328601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613343|NCT00002777|Hormone Antagonists|hormone antagonists|mesh-ancestor
102613344|NCT00002777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102613345|NCT00002777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613346|NCT00002777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102613347|NCT00002777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613348|NCT00002777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102613349|NCT00002777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102613350|NCT00002777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102613351|NCT00002777|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102613352|NCT00002777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102613353|NCT00002777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102613354|NCT00002783|Leucovorin|leucovorin|mesh-list
102613355|NCT00002783|Fluorouracil|fluorouracil|mesh-list
102250873|NCT00328601|Vitamin B Complex|vitamin b complex|mesh-ancestor
102250874|NCT00328601|Vitamins|vitamins|mesh-ancestor
102250875|NCT00328601|Micronutrients|micronutrients|mesh-ancestor
102250876|NCT00189293|Imiquimod|imiquimod|mesh-list
102250877|NCT00189293|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102250878|NCT00189293|Immunologic Factors|immunologic factors|mesh-ancestor
102250879|NCT00189293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250880|NCT00189293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102250881|NCT00189293|Interferon Inducers|interferon inducers|mesh-ancestor
102250882|NCT03194009|Metformin|metformin|mesh-list
102250883|NCT03194009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102250884|NCT03194009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250885|NCT02581995|Aflibercept|aflibercept|mesh-list
102250886|NCT02581995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102250887|NCT02581995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102250888|NCT02581995|Growth Substances|growth substances|mesh-ancestor
102250889|NCT02581995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250890|NCT02581995|Growth Inhibitors|growth inhibitors|mesh-ancestor
102250891|NCT02581995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102250892|NCT03193307|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
102250893|NCT03193307|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
102250894|NCT03193307|BI 409306|bi 409306|mesh-list
102250895|NCT03193307|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102250896|NCT03193307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102250897|NCT03193307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250898|NCT03193307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102250899|NCT03193307|Contraceptive Agents|contraceptive agents|mesh-ancestor
102250900|NCT03193307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102250901|NCT03193307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250902|NCT03193307|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102250903|NCT03193307|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102250904|NCT03193307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102250905|NCT03193307|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102250906|NCT03193307|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102250907|NCT03193307|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
102250908|NCT03193307|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102250909|NCT03193307|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102250910|NCT02910843|Capecitabine|capecitabine|mesh-list
102250911|NCT02910843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102250912|NCT02910843|Antimetabolites|antimetabolites|mesh-ancestor
102250913|NCT02910843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250914|NCT02910843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102250915|NCT03192527|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102250916|NCT03192527|Luteolytic Agents|luteolytic agents|mesh-ancestor
102250917|NCT03192527|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102250918|NCT03192527|Contraceptive Agents|contraceptive agents|mesh-ancestor
102250919|NCT03192527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102250920|NCT03192527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250921|NCT03192527|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102250922|NCT03192527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102250923|NCT03192527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102250924|NCT02444351|Botulinum Toxins|botulinum toxins|mesh-list
102250925|NCT02444351|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102250926|NCT02444351|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102250927|NCT02444351|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102250928|NCT02444351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102250929|NCT02444351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250930|NCT02444351|Cholinergic Agents|cholinergic agents|mesh-ancestor
102250931|NCT02444351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102250932|NCT02444351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613357|NCT00002783|Calcium|calcium|mesh-list
102250933|NCT02444351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102250934|NCT02444351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102250935|NCT03193463|Topotecan|topotecan|mesh-list
102250936|NCT03193463|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102250937|NCT03193463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102250938|NCT03193463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102250939|NCT03193463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250940|NCT03193463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102250941|NCT02577003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102250942|NCT02577003|Ipragliflozin|ipragliflozin|mesh-list
102250943|NCT02577003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102250944|NCT02577003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250945|NCT02577003|Incretins|incretins|mesh-ancestor
102250946|NCT02577003|Hormones|hormones|mesh-ancestor
102250947|NCT02577003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102250948|NCT02577003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102250949|NCT02577003|Protease Inhibitors|protease inhibitors|mesh-ancestor
102250950|NCT02577003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102250951|NCT02577003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250952|NCT02577003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102250953|NCT05487417|Minocycline|minocycline|mesh-list
102250954|NCT05487417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102250955|NCT05487417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102250956|NCT03471611|Lenograstim|lenograstim|mesh-list
102250957|NCT03471611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102250958|NCT03471611|Immunologic Factors|immunologic factors|mesh-ancestor
102250959|NCT03471611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250960|NCT05694819|Goserelin|goserelin|mesh-list
102250961|NCT05694819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102250962|NCT05694819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102250963|NCT02600897|Rituximab|rituximab|mesh-list
102250964|NCT02600897|Obinutuzumab|obinutuzumab|mesh-list
102250965|NCT02600897|Lenalidomide|lenalidomide|mesh-list
102250966|NCT02600897|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
102250967|NCT02600897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102250968|NCT02600897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102250969|NCT02600897|Immunologic Factors|immunologic factors|mesh-ancestor
102250970|NCT02600897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250971|NCT02600897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102250972|NCT02600897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102250973|NCT02600897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102250974|NCT02600897|Growth Substances|growth substances|mesh-ancestor
102250975|NCT02600897|Growth Inhibitors|growth inhibitors|mesh-ancestor
102250976|NCT02600897|Immunoconjugates|immunoconjugates|mesh-ancestor
102250977|NCT05674305|Cisplatin|cisplatin|mesh-list
102250978|NCT05674305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102250979|NCT03192449|Albendazole|albendazole|mesh-list
102250980|NCT03192449|Anthelmintics|anthelmintics|mesh-ancestor
102250981|NCT03192449|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102250982|NCT03192449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102250983|NCT03192449|Anticestodal Agents|anticestodal agents|mesh-ancestor
102250984|NCT03192449|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102250985|NCT03192449|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102250986|NCT03192449|Tubulin Modulators|tubulin modulators|mesh-ancestor
102250987|NCT03192449|Antimitotic Agents|antimitotic agents|mesh-ancestor
102250988|NCT03192449|Mitosis Modulators|mitosis modulators|mesh-ancestor
102250989|NCT03192449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102250990|NCT03192449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102250991|NCT05691933|Morphine|morphine|mesh-list
102250992|NCT05691933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102250993|NCT05691933|Narcotics|narcotics|mesh-ancestor
102250994|NCT05691933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102250995|NCT05691933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102250996|NCT05691933|Analgesics|analgesics|mesh-ancestor
102250997|NCT05691933|Sensory System Agents|sensory system agents|mesh-ancestor
102250998|NCT05691933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102250999|NCT00977483|Thioctic Acid|thioctic acid|mesh-list
102251000|NCT00977483|Antioxidants|antioxidants|mesh-ancestor
102251001|NCT00977483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251002|NCT00977483|Protective Agents|protective agents|mesh-ancestor
102613358|NCT00002783|Levoleucovorin|levoleucovorin|mesh-list
102251003|NCT00977483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251004|NCT00977483|Vitamin B Complex|vitamin b complex|mesh-ancestor
102251006|NCT00977483|Micronutrients|micronutrients|mesh-ancestor
102251007|NCT02439905|Dexmedetomidine|dexmedetomidine|mesh-list
102251009|NCT02439905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102251010|NCT02439905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251011|NCT02439905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102251012|NCT02439905|Analgesics|analgesics|mesh-ancestor
102251013|NCT02439905|Sensory System Agents|sensory system agents|mesh-ancestor
102251014|NCT02439905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102251015|NCT02439905|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102251016|NCT02439905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102251017|NCT02439905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102251018|NCT02439905|Adrenergic Agents|adrenergic agents|mesh-ancestor
102251019|NCT02439905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102251020|NCT02439905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251021|NCT03192371|Vaccines|vaccines|mesh-list
102251022|NCT03192371|Immunologic Factors|immunologic factors|mesh-ancestor
102251023|NCT03192371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251024|NCT02709785|Chlorhexidine|chlorhexidine|mesh-list
102251025|NCT02709785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102251026|NCT02709785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102251027|NCT02709785|Disinfectants|disinfectants|mesh-ancestor
102251028|NCT02442791|Exenatide|exenatide|mesh-list
102251029|NCT02442791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102251030|NCT02442791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251031|NCT02442791|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102251032|NCT02442791|Incretins|incretins|mesh-ancestor
102251033|NCT02442791|Hormones|hormones|mesh-ancestor
102251034|NCT02442791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102251035|NCT04756557|Fluorides|fluorides|mesh-list
102251036|NCT04756557|Sodium Fluoride|sodium fluoride|mesh-list
102251037|NCT04756557|Cariostatic Agents|cariostatic agents|mesh-ancestor
102251038|NCT04756557|Protective Agents|protective agents|mesh-ancestor
102251039|NCT04756557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251040|NCT04742673|Guanfacine|guanfacine|mesh-list
102251041|NCT04742673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102251042|NCT04742673|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102251043|NCT04742673|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102251044|NCT04742673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102251045|NCT04742673|Adrenergic Agents|adrenergic agents|mesh-ancestor
102251046|NCT04742673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102251047|NCT04742673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251048|NCT04742673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251049|NCT02442713|Fluvoxamine|fluvoxamine|mesh-list
102251050|NCT02442713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102251051|NCT02442713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102251052|NCT02442713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102251053|NCT02442713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251054|NCT02442713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102251055|NCT02442713|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102251056|NCT02442713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102251057|NCT02442713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102251058|NCT02442713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251059|NCT02442713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102251060|NCT02442713|Serotonin Agents|serotonin agents|mesh-ancestor
102251061|NCT02442713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102251062|NCT02442713|Antidepressive Agents|antidepressive agents|mesh-ancestor
102251063|NCT02442713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102251064|NCT02442713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102251065|NCT02442713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102251066|NCT02442713|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102251067|NCT03189953|Exenatide|exenatide|mesh-list
102251068|NCT03189953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102251069|NCT03189953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251070|NCT03189953|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102251071|NCT03189953|Incretins|incretins|mesh-ancestor
102251072|NCT03189953|Hormones|hormones|mesh-ancestor
102251073|NCT03189953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102251074|NCT02204085|Decitabine|decitabine|mesh-list
102251075|NCT02204085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102251076|NCT02204085|Antimetabolites|antimetabolites|mesh-ancestor
102251077|NCT02204085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251078|NCT02204085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102251079|NCT02204085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102251080|NCT04314843|Lenzilumab|lenzilumab|mesh-list
102613359|NCT00002783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613360|NCT00002783|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102613361|NCT00002783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613362|NCT00002783|Antimetabolites|antimetabolites|mesh-ancestor
102613363|NCT00002783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613364|NCT00002783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102251081|NCT04314843|Cyclophosphamide|cyclophosphamide|mesh-list
102251082|NCT04314843|Fludarabine|fludarabine|mesh-list
102251083|NCT04314843|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
102251084|NCT04314843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102251085|NCT04314843|Immunologic Factors|immunologic factors|mesh-ancestor
102251086|NCT04314843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251087|NCT04314843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102251088|NCT04314843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102251089|NCT04314843|Alkylating Agents|alkylating agents|mesh-ancestor
102251090|NCT04314843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251091|NCT04314843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102251092|NCT04314843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102251093|NCT04314843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102251094|NCT04314843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102251095|NCT03192293|Metformin|metformin|mesh-list
102251096|NCT03192293|Fulvestrant|fulvestrant|mesh-list
102251097|NCT03192293|Simvastatin|simvastatin|mesh-list
102251098|NCT03192293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102251099|NCT03192293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251100|NCT03192293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102251101|NCT03192293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102251102|NCT03192293|Antimetabolites|antimetabolites|mesh-ancestor
102251103|NCT03192293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251104|NCT03192293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102251105|NCT03192293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102251106|NCT03192293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101727756|NCT00704990|Zinc|zinc|mesh-list
102251107|NCT03192293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102251108|NCT03192293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102251109|NCT03192293|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102251110|NCT03192293|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102251111|NCT03192293|Hormone Antagonists|hormone antagonists|mesh-ancestor
102251112|NCT03192293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102251113|NCT02439125|Eltoprazine|eltoprazine|mesh-list
102251114|NCT02439125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102251115|NCT02439125|Serotonin Agents|serotonin agents|mesh-ancestor
102251116|NCT02439125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102251117|NCT02439125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251118|NCT02439125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251119|NCT02441933|Carboplatin|carboplatin|mesh-list
102251120|NCT02441933|Taxane|taxane|mesh-list
102251121|NCT02441933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102251122|NCT01604265|Nabiximols|nabiximols|mesh-list
102251123|NCT01604265|Analgesics|analgesics|mesh-ancestor
102251124|NCT01604265|Sensory System Agents|sensory system agents|mesh-ancestor
102251125|NCT01604265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102251126|NCT01604265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251127|NCT04483427|Ketorolac|ketorolac|mesh-list
102251128|NCT04483427|Nalbuphine|nalbuphine|mesh-list
102251129|NCT04483427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102251130|NCT04483427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102251131|NCT04483427|Analgesics|analgesics|mesh-ancestor
102251132|NCT04483427|Sensory System Agents|sensory system agents|mesh-ancestor
102251133|NCT04483427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102251134|NCT04483427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251135|NCT04483427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102251136|NCT04483427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102251137|NCT04483427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102251138|NCT04483427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102251139|NCT04483427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251140|NCT04483427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102251141|NCT04483427|Narcotics|narcotics|mesh-ancestor
102251142|NCT04483427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102251143|NCT01664247|Liraglutide|liraglutide|mesh-list
102251144|NCT01664247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102251145|NCT01664247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251146|NCT01664247|Incretins|incretins|mesh-ancestor
102251147|NCT01664247|Hormones|hormones|mesh-ancestor
102251148|NCT01664247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102251149|NCT02441465|Vemurafenib|vemurafenib|mesh-list
102613365|NCT00002783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102613366|NCT00002783|Immunologic Factors|immunologic factors|mesh-ancestor
102613367|NCT00002783|Antidotes|antidotes|mesh-ancestor
102613368|NCT00002783|Protective Agents|protective agents|mesh-ancestor
102613369|NCT00002783|Vitamin B Complex|vitamin b complex|mesh-ancestor
102613370|NCT00002783|Vitamins|vitamins|mesh-ancestor
102613371|NCT00002783|Micronutrients|micronutrients|mesh-ancestor
102613372|NCT00002789|Cyclosporine|cyclosporine|mesh-list
102613373|NCT00002789|Cyclophosphamide|cyclophosphamide|mesh-list
102613374|NCT00002789|Busulfan|busulfan|mesh-list
102613375|NCT00002789|Methotrexate|methotrexate|mesh-list
102613376|NCT00002789|Cyclosporins|cyclosporins|mesh-list
102613377|NCT00002789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102613378|NCT00002789|Immunologic Factors|immunologic factors|mesh-ancestor
102613379|NCT00002789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613380|NCT00002789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102613381|NCT00002789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102613382|NCT00002789|Alkylating Agents|alkylating agents|mesh-ancestor
102613383|NCT00002789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613384|NCT00002789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613385|NCT00002789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102613386|NCT00002789|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102613387|NCT00002789|Abortifacient Agents|abortifacient agents|mesh-ancestor
102251150|NCT02441465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102251151|NCT02441465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102251153|NCT02441465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251154|NCT02438657|Lidocaine|lidocaine|mesh-list
102251155|NCT02438657|Epinephrine|epinephrine|mesh-list
102251156|NCT02438657|Anesthetics, Local|anesthetics, local|mesh-ancestor
102251157|NCT02438657|Anesthetics|anesthetics|mesh-ancestor
102251158|NCT02438657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102251159|NCT02438657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251160|NCT02438657|Sensory System Agents|sensory system agents|mesh-ancestor
102251161|NCT02438657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102251162|NCT02438657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102251163|NCT02438657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102251164|NCT02438657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102251165|NCT02438657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102251166|NCT02438657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251167|NCT02438657|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102251168|NCT02438657|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102251169|NCT02438657|Adrenergic Agents|adrenergic agents|mesh-ancestor
101727803|NCT00803712|Vitamin D|vitamin d|mesh-list
102251170|NCT02438657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102251171|NCT02438657|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102251172|NCT02438657|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102251173|NCT02438657|Autonomic Agents|autonomic agents|mesh-ancestor
102251174|NCT02438657|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102251175|NCT02438657|Respiratory System Agents|respiratory system agents|mesh-ancestor
102251176|NCT02438657|Mydriatics|mydriatics|mesh-ancestor
102251177|NCT02438657|Sympathomimetics|sympathomimetics|mesh-ancestor
102251178|NCT02438657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102251179|NCT02441387|Antidepressive Agents|antidepressive agents|mesh-list
102251180|NCT02441387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102251181|NCT01441947|Fulvestrant|fulvestrant|mesh-list
102251182|NCT01441947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102251183|NCT01441947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102251184|NCT01441947|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102251185|NCT01441947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102251186|NCT01441947|Hormone Antagonists|hormone antagonists|mesh-ancestor
102251187|NCT01441947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102251188|NCT01441947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251189|NCT03192059|Aspirin|aspirin|mesh-list
102251190|NCT03192059|Vitamin D|vitamin d|mesh-list
102251191|NCT03192059|Curcumin|curcumin|mesh-list
102251192|NCT03192059|Cyclophosphamide|cyclophosphamide|mesh-list
102251193|NCT03192059|Pembrolizumab|pembrolizumab|mesh-list
102251194|NCT03192059|Lansoprazole|lansoprazole|mesh-list
102251195|NCT03192059|Dexlansoprazole|dexlansoprazole|mesh-list
102251196|NCT03192059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102251197|NCT03192059|Immunologic Factors|immunologic factors|mesh-ancestor
102613388|NCT00002789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102613389|NCT00002789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102251198|NCT03192059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251199|NCT03192059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102613390|NCT00002789|Antimetabolites|antimetabolites|mesh-ancestor
102613391|NCT00002789|Dermatologic Agents|dermatologic agents|mesh-ancestor
102251200|NCT03192059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102251201|NCT03192059|Alkylating Agents|alkylating agents|mesh-ancestor
102251202|NCT03192059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251203|NCT03192059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102251204|NCT03192059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102251205|NCT03192059|Vitamins|vitamins|mesh-ancestor
102251206|NCT03192059|Micronutrients|micronutrients|mesh-ancestor
102251207|NCT03192059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102251208|NCT03192059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102251209|NCT03192059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102251210|NCT03192059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102251211|NCT03192059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102251212|NCT03192059|Analgesics|analgesics|mesh-ancestor
102251213|NCT03192059|Sensory System Agents|sensory system agents|mesh-ancestor
102251214|NCT03192059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102251215|NCT03192059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102251216|NCT03192059|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102251217|NCT03192059|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102251218|NCT03192059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102251219|NCT03192059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102251220|NCT03192059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102251221|NCT03192059|Antipyretics|antipyretics|mesh-ancestor
102251222|NCT03192059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102251223|NCT03192059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102251224|NCT03192059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102251225|NCT02441075|Ethanol|ethanol|mesh-list
102251226|NCT02441075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102251227|NCT02441075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102251228|NCT02441075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102251229|NCT02441075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251230|NCT05562999|Bromides|bromides|mesh-list
102251231|NCT05562999|Rocuronium|rocuronium|mesh-list
102251232|NCT05562999|Anticonvulsants|anticonvulsants|mesh-ancestor
102251233|NCT05562999|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102251234|NCT05562999|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102251235|NCT05562999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101727894|NCT00705692|Levamisole|levamisole|mesh-list
102251236|NCT05562999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102251237|NCT05562999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251238|NCT02438345|Leronlimab|leronlimab|mesh-list
102251239|NCT02438345|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102251240|NCT02438345|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102251241|NCT02438345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251242|NCT02438345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102251243|NCT02438345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102251244|NCT02438345|Antiviral Agents|antiviral agents|mesh-ancestor
102251245|NCT02438345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102251246|NCT03191981|Cyclophosphamide|cyclophosphamide|mesh-list
102251247|NCT03191981|Pembrolizumab|pembrolizumab|mesh-list
102251248|NCT03191981|Lenalidomide|lenalidomide|mesh-list
102251249|NCT03191981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102251250|NCT03191981|Immunologic Factors|immunologic factors|mesh-ancestor
102251251|NCT03191981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251252|NCT03191981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102251253|NCT03191981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102251254|NCT03191981|Alkylating Agents|alkylating agents|mesh-ancestor
102251255|NCT03191981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251256|NCT03191981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102251257|NCT03191981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102251258|NCT03191981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102251259|NCT03191981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102251260|NCT03191981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102251261|NCT03191981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102251262|NCT03191981|Growth Substances|growth substances|mesh-ancestor
102251263|NCT03191981|Growth Inhibitors|growth inhibitors|mesh-ancestor
102251264|NCT05535075|Vancomycin|vancomycin|mesh-list
102251265|NCT05535075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102251266|NCT05535075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102251267|NCT05530785|Bevacizumab|bevacizumab|mesh-list
102251268|NCT05530785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102251269|NCT05530785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102251270|NCT05530785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102251271|NCT05530785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102613392|NCT00002789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102613393|NCT00002789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102251272|NCT05530785|Growth Substances|growth substances|mesh-ancestor
102251273|NCT05530785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251274|NCT05530785|Growth Inhibitors|growth inhibitors|mesh-ancestor
102251275|NCT05530395|Testosterone|testosterone|mesh-list
102251276|NCT05530395|Androgens|androgens|mesh-ancestor
102251278|NCT05530395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102251279|NCT05530395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251280|NCT05389995|Potassium Citrate|potassium citrate|mesh-list
102251281|NCT05389995|Methamphetamine|methamphetamine|mesh-list
102251282|NCT05389995|Citric Acid|citric acid|mesh-list
102251283|NCT05389995|Sodium Citrate|sodium citrate|mesh-list
102251284|NCT05389995|Anticoagulants|anticoagulants|mesh-ancestor
102251285|NCT05389995|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102251286|NCT05389995|Chelating Agents|chelating agents|mesh-ancestor
102251287|NCT05389995|Sequestering Agents|sequestering agents|mesh-ancestor
102251288|NCT05389995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251289|NCT05389995|Diuretics|diuretics|mesh-ancestor
102251290|NCT05389995|Natriuretic Agents|natriuretic agents|mesh-ancestor
102251291|NCT05389995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251292|NCT05389995|Expectorants|expectorants|mesh-ancestor
102251293|NCT05389995|Respiratory System Agents|respiratory system agents|mesh-ancestor
102251294|NCT05389995|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102251295|NCT05389995|Sympathomimetics|sympathomimetics|mesh-ancestor
102251296|NCT05389995|Autonomic Agents|autonomic agents|mesh-ancestor
102251297|NCT05389995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102251298|NCT05389995|Dopamine Agents|dopamine agents|mesh-ancestor
102251299|NCT05389995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102251300|NCT05389995|Adrenergic Agents|adrenergic agents|mesh-ancestor
102251301|NCT05389995|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102251302|NCT05389995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102251303|NCT05389995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101727958|NCT02608320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102251304|NCT05389995|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102251305|NCT04529265|Methylene Blue|methylene blue|mesh-list
102251306|NCT04529265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102251307|NCT04529265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251308|NCT03191903|Triamcinolone|triamcinolone|mesh-list
102251309|NCT03191903|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102251310|NCT03191903|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102251311|NCT03191903|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102251312|NCT03191903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102251313|NCT03191903|Glucocorticoids|glucocorticoids|mesh-ancestor
102251314|NCT03191903|Hormones|hormones|mesh-ancestor
102251315|NCT03191903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102251316|NCT03191903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251317|NCT03191903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102251318|NCT03191903|Immunologic Factors|immunologic factors|mesh-ancestor
102251319|NCT03191903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102251320|NCT03191903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251321|NCT05534685|Budesonide|budesonide|mesh-list
102251322|NCT05534685|Pulmonary Surfactants|pulmonary surfactants|mesh-list
102251323|NCT05534685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102251324|NCT05534685|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102251325|NCT05534685|Autonomic Agents|autonomic agents|mesh-ancestor
102251326|NCT05534685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102251327|NCT05534685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251328|NCT05534685|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102251329|NCT05534685|Respiratory System Agents|respiratory system agents|mesh-ancestor
102251330|NCT05534685|Glucocorticoids|glucocorticoids|mesh-ancestor
102251331|NCT05534685|Hormones|hormones|mesh-ancestor
102251332|NCT05534685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102251333|NCT02437955|Ferrous fumarate|ferrous fumarate|mesh-list
102251334|NCT02437955|Trace Elements|trace elements|mesh-ancestor
102251335|NCT02437955|Micronutrients|micronutrients|mesh-ancestor
102251336|NCT02437955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251337|NCT05529927|Dextroamphetamine|dextroamphetamine|mesh-list
102251338|NCT05529927|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102251339|NCT05529927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251340|NCT05529927|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102251341|NCT05529927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102251342|NCT05529927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102251343|NCT05529927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251344|NCT05529927|Dopamine Agents|dopamine agents|mesh-ancestor
102251345|NCT05529927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102613394|NCT00002789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102251347|NCT02437721|Vitamin B Complex|vitamin b complex|mesh-list
102251348|NCT02437721|Hematinics|hematinics|mesh-ancestor
102251349|NCT02437721|Vitamins|vitamins|mesh-ancestor
102251350|NCT02437721|Micronutrients|micronutrients|mesh-ancestor
102251351|NCT02437721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251352|NCT02437565|Salicylic Acid|salicylic acid|mesh-list
102251353|NCT02437565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102251354|NCT02437565|Antifungal Agents|antifungal agents|mesh-ancestor
102251355|NCT02437565|Keratolytic Agents|keratolytic agents|mesh-ancestor
102251356|NCT02437565|Dermatologic Agents|dermatologic agents|mesh-ancestor
102251357|NCT05533983|Nivolumab|nivolumab|mesh-list
102251358|NCT05533983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102251359|NCT05533983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102251360|NCT05533983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102251361|NCT05533983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251362|NCT02436395|Povidone-Iodine|povidone-iodine|mesh-list
102251363|NCT02436395|Povidone|povidone|mesh-list
102251364|NCT02436395|Plasma Substitutes|plasma substitutes|mesh-ancestor
102251365|NCT02436395|Blood Substitutes|blood substitutes|mesh-ancestor
102251366|NCT02436395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102251367|NCT02436395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102251368|NCT02436083|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102251369|NCT02436083|Cefuroxime|cefuroxime|mesh-list
102251370|NCT02436083|Cefuroxime axetil|cefuroxime axetil|mesh-list
102251371|NCT02436083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102251372|NCT03117335|Endostatins|endostatins|mesh-list
102251373|NCT03117335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102251374|NCT03117335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102251375|NCT03117335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102251376|NCT03117335|Growth Substances|growth substances|mesh-ancestor
102251377|NCT03117335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251378|NCT03117335|Growth Inhibitors|growth inhibitors|mesh-ancestor
102251379|NCT02435927|Leucovorin|leucovorin|mesh-list
102251380|NCT02435927|Fluorouracil|fluorouracil|mesh-list
102251381|NCT02435927|Capecitabine|capecitabine|mesh-list
102251382|NCT02435927|Oxaliplatin|oxaliplatin|mesh-list
102251383|NCT02435927|Antimetabolites|antimetabolites|mesh-ancestor
102251384|NCT02435927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251385|NCT02435927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102251386|NCT02435927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102251387|NCT02435927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102251388|NCT02435927|Immunologic Factors|immunologic factors|mesh-ancestor
102251389|NCT02435927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251390|NCT02435927|Antidotes|antidotes|mesh-ancestor
102251391|NCT02435927|Protective Agents|protective agents|mesh-ancestor
102251392|NCT02435927|Vitamin B Complex|vitamin b complex|mesh-ancestor
102251393|NCT02435927|Vitamins|vitamins|mesh-ancestor
102251394|NCT02435927|Micronutrients|micronutrients|mesh-ancestor
102251395|NCT02435771|Ergocalciferols|ergocalciferols|mesh-list
102251396|NCT02435771|Vitamin D|vitamin d|mesh-list
102251397|NCT02435771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102251398|NCT02435771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251399|NCT02435771|Vitamins|vitamins|mesh-ancestor
102251400|NCT02435771|Micronutrients|micronutrients|mesh-ancestor
102251401|NCT02435771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102251402|NCT02440841|Itraconazole|itraconazole|mesh-list
102251403|NCT02440841|Rifampin|rifampin|mesh-list
102251404|NCT02440841|Antifungal Agents|antifungal agents|mesh-ancestor
102251405|NCT02440841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102251406|NCT02440841|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102251407|NCT02440841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102251408|NCT02440841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102251409|NCT02440841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251410|NCT02440841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102251411|NCT02440841|Hormone Antagonists|hormone antagonists|mesh-ancestor
102251412|NCT02440841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102251413|NCT02440841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251414|NCT02440841|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102251415|NCT02440841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102251416|NCT02440841|Antitubercular Agents|antitubercular agents|mesh-ancestor
102251417|NCT02440841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102251418|NCT02440841|Leprostatic Agents|leprostatic agents|mesh-ancestor
102613395|NCT00002789|Antifungal Agents|antifungal agents|mesh-ancestor
102251419|NCT02440841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102251420|NCT02440841|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102251421|NCT02440841|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102613396|NCT00002789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102613397|NCT00002789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102613398|NCT00381953|Interferons|interferons|mesh-list
102613399|NCT00381953|Ribavirin|ribavirin|mesh-list
102613400|NCT00381953|Interferon-alpha|interferon-alpha|mesh-list
102613401|NCT00381953|Interferon alpha-2|interferon alpha-2|mesh-list
102613402|NCT00381953|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102613403|NCT00381953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102251422|NCT02440841|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102251423|NCT02440841|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102251424|NCT02440841|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102251425|NCT02440841|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102251426|NCT02576145|Daclizumab|daclizumab|mesh-list
102251427|NCT02576145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102251428|NCT02576145|Immunologic Factors|immunologic factors|mesh-ancestor
102251429|NCT02576145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251430|NCT02435537|Dexmedetomidine|dexmedetomidine|mesh-list
102251431|NCT02435537|Morphine|morphine|mesh-list
102251432|NCT02435537|Bupivacaine|bupivacaine|mesh-list
102251433|NCT02435537|Anesthetics, Local|anesthetics, local|mesh-ancestor
102251434|NCT02435537|Anesthetics|anesthetics|mesh-ancestor
102251435|NCT02435537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102251436|NCT02435537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251437|NCT02435537|Sensory System Agents|sensory system agents|mesh-ancestor
102251438|NCT02435537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102251439|NCT02435537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102251440|NCT02435537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102251441|NCT02435537|Analgesics|analgesics|mesh-ancestor
102251442|NCT02435537|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102251443|NCT02435537|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102251444|NCT02435537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102251445|NCT02435537|Adrenergic Agents|adrenergic agents|mesh-ancestor
102251446|NCT02435537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102251447|NCT02435537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251448|NCT02435537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102251449|NCT02435537|Narcotics|narcotics|mesh-ancestor
102251450|NCT02576067|Methotrexate|methotrexate|mesh-list
102251451|NCT02576067|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102251452|NCT02576067|Abortifacient Agents|abortifacient agents|mesh-ancestor
102251453|NCT02576067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102251454|NCT02576067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251455|NCT02576067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102251456|NCT02576067|Antimetabolites|antimetabolites|mesh-ancestor
102251457|NCT02576067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251458|NCT02576067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102251459|NCT02576067|Dermatologic Agents|dermatologic agents|mesh-ancestor
102251460|NCT02576067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102251461|NCT02576067|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102251462|NCT02576067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102251463|NCT02576067|Immunologic Factors|immunologic factors|mesh-ancestor
102251464|NCT02576067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102251465|NCT02576067|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102251466|NCT02435459|Calcium|calcium|mesh-list
102251467|NCT02435459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102251468|NCT02435459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251469|NCT05199909|Zanubrutinib|zanubrutinib|mesh-list
102251470|NCT05199909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102251471|NCT05199909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102251472|NCT05199909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101728191|NCT03746275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102251473|NCT05199909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251474|NCT02435303|Sildenafil Citrate|sildenafil citrate|mesh-list
102251475|NCT02435303|Vasodilator Agents|vasodilator agents|mesh-ancestor
102251476|NCT02435303|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102251477|NCT02435303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102251478|NCT02435303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102251479|NCT02435303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251480|NCT02435303|Urological Agents|urological agents|mesh-ancestor
102251481|NCT02434757|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102251482|NCT02434757|Hormones|hormones|mesh-ancestor
102251483|NCT02434757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102251484|NCT02434757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251485|NCT03189329|Lidocaine|lidocaine|mesh-list
102251486|NCT03189329|Levobupivacaine|levobupivacaine|mesh-list
101901827|NCT01177514|Gabapentin|gabapentin|mesh-list
102613404|NCT00381953|Antiviral Agents|antiviral agents|mesh-ancestor
102251488|NCT03189329|Anesthetics|anesthetics|mesh-ancestor
102251489|NCT03189329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102251490|NCT03189329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251491|NCT03189329|Sensory System Agents|sensory system agents|mesh-ancestor
102251492|NCT03189329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102251493|NCT03189329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102251494|NCT03189329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102251495|NCT03189329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102251496|NCT03189329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102251497|NCT03189329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251498|NCT02575833|Erenumab|erenumab|mesh-list
102251499|NCT02575833|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
102251500|NCT02575833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251501|NCT02575833|Analgesics|analgesics|mesh-ancestor
102251502|NCT02575833|Sensory System Agents|sensory system agents|mesh-ancestor
102251503|NCT02575833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102251504|NCT02575833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251505|NCT02709083|Imatinib Mesylate|imatinib mesylate|mesh-list
102251506|NCT02709083|Dasatinib|dasatinib|mesh-list
102251507|NCT02709083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102251508|NCT02709083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102251509|NCT02709083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102251510|NCT02709083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251511|NCT02709005|Monolaurin|monolaurin|mesh-list
102251512|NCT02709005|Cariostatic Agents|cariostatic agents|mesh-ancestor
102251513|NCT02709005|Protective Agents|protective agents|mesh-ancestor
102251514|NCT02709005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251515|NCT05353335|Antihypertensive Agents|antihypertensive agents|mesh-list
102251516|NCT03188471|Aspirin|aspirin|mesh-list
102251517|NCT03188471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251518|NCT03188471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102251519|NCT03188471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102251520|NCT03188471|Analgesics|analgesics|mesh-ancestor
102251521|NCT03188471|Sensory System Agents|sensory system agents|mesh-ancestor
102251522|NCT03188471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102251523|NCT03188471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102251524|NCT03188471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102251525|NCT03188471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101960415|NCT02146222|Docetaxel|docetaxel|mesh-list
102251526|NCT03188471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102251527|NCT03188471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251528|NCT03188471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102251529|NCT03188471|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102251530|NCT03188471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102251531|NCT03188471|Antipyretics|antipyretics|mesh-ancestor
102251532|NCT04650087|Apixaban|apixaban|mesh-list
102251533|NCT04650087|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102251534|NCT04650087|Antithrombins|antithrombins|mesh-ancestor
102251535|NCT04650087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102251536|NCT04650087|Protease Inhibitors|protease inhibitors|mesh-ancestor
102251537|NCT04650087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102251538|NCT04650087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251539|NCT04650087|Anticoagulants|anticoagulants|mesh-ancestor
102251540|NCT03188159|Vinorelbine|vinorelbine|mesh-list
102251541|NCT03188159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102251542|NCT03188159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102251543|NCT03188159|Tubulin Modulators|tubulin modulators|mesh-ancestor
102251544|NCT03188159|Antimitotic Agents|antimitotic agents|mesh-ancestor
102251545|NCT03188159|Mitosis Modulators|mitosis modulators|mesh-ancestor
102251546|NCT03188159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251547|NCT05532501|Oxytocin|oxytocin|mesh-list
102251548|NCT05532501|Oxytocics|oxytocics|mesh-ancestor
102251549|NCT05532501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102251550|NCT05532501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251551|NCT05524857|Decitabine|decitabine|mesh-list
102251552|NCT05524857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102251553|NCT05524857|Antimetabolites|antimetabolites|mesh-ancestor
102251554|NCT05524857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251555|NCT05524857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102251556|NCT05524857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102251557|NCT05192889|Leucovorin|leucovorin|mesh-list
102251558|NCT05192889|Cytarabine|cytarabine|mesh-list
102251559|NCT05192889|Dexamethasone|dexamethasone|mesh-list
102613405|NCT00381953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102613406|NCT00381953|Antimetabolites|antimetabolites|mesh-ancestor
102613407|NCT00381953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613408|NCT00381953|Immunologic Factors|immunologic factors|mesh-ancestor
102613409|NCT00381953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613410|NCT00382343|Trimethoprim|trimethoprim|mesh-list
102613411|NCT00382343|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102613412|NCT00382343|Sulfamethoxazole|sulfamethoxazole|mesh-list
102613413|NCT00382343|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102613414|NCT00382343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102613415|NCT00382343|Antimalarials|antimalarials|mesh-ancestor
102251560|NCT05192889|Hydrocortisone|hydrocortisone|mesh-list
102251561|NCT05192889|Cyclophosphamide|cyclophosphamide|mesh-list
102251562|NCT05192889|Methotrexate|methotrexate|mesh-list
102251563|NCT05192889|Etoposide|etoposide|mesh-list
102251564|NCT05192889|Vincristine|vincristine|mesh-list
102251565|NCT05192889|Venetoclax|venetoclax|mesh-list
102251566|NCT05192889|Asparaginase|asparaginase|mesh-list
102251567|NCT05192889|Dasatinib|dasatinib|mesh-list
102251568|NCT05192889|Mercaptopurine|mercaptopurine|mesh-list
102251569|NCT05192889|Pegaspargase|pegaspargase|mesh-list
102251570|NCT05192889|Blinatumomab|blinatumomab|mesh-list
102251571|NCT05192889|Navitoclax|navitoclax|mesh-list
102251572|NCT05192889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102251573|NCT05192889|Immunologic Factors|immunologic factors|mesh-ancestor
102251574|NCT05192889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251575|NCT05192889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102251576|NCT05192889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102251577|NCT05192889|Alkylating Agents|alkylating agents|mesh-ancestor
102251578|NCT05192889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251579|NCT05192889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102251580|NCT05192889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102251581|NCT05192889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102251582|NCT05192889|Antiemetics|antiemetics|mesh-ancestor
102251583|NCT05192889|Autonomic Agents|autonomic agents|mesh-ancestor
102251584|NCT05192889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102251585|NCT05192889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102251586|NCT05192889|Glucocorticoids|glucocorticoids|mesh-ancestor
102251587|NCT05192889|Hormones|hormones|mesh-ancestor
102251588|NCT05192889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102251589|NCT05192889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102251590|NCT05192889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102251591|NCT05192889|Abortifacient Agents|abortifacient agents|mesh-ancestor
102251592|NCT05192889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102251593|NCT05192889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102251594|NCT05192889|Antimetabolites|antimetabolites|mesh-ancestor
102251595|NCT05192889|Dermatologic Agents|dermatologic agents|mesh-ancestor
102251596|NCT05192889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102251597|NCT05192889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102251598|NCT05192889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102251599|NCT05192889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102251600|NCT05192889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102251601|NCT05192889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102251602|NCT05192889|Antiviral Agents|antiviral agents|mesh-ancestor
102251603|NCT05192889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102251604|NCT05192889|Antidotes|antidotes|mesh-ancestor
102251605|NCT05192889|Protective Agents|protective agents|mesh-ancestor
102251606|NCT05192889|Vitamin B Complex|vitamin b complex|mesh-ancestor
102251607|NCT05192889|Vitamins|vitamins|mesh-ancestor
102251608|NCT05192889|Micronutrients|micronutrients|mesh-ancestor
102251609|NCT05192889|Tubulin Modulators|tubulin modulators|mesh-ancestor
102251610|NCT05192889|Antimitotic Agents|antimitotic agents|mesh-ancestor
102251611|NCT05192889|Mitosis Modulators|mitosis modulators|mesh-ancestor
102251612|NCT05192889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102251613|NCT05327439|Nicotine|nicotine|mesh-list
102251614|NCT05327439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102251615|NCT05327439|Autonomic Agents|autonomic agents|mesh-ancestor
102251616|NCT05327439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102251617|NCT05327439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251618|NCT05327439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102251619|NCT05327439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102251620|NCT05327439|Cholinergic Agents|cholinergic agents|mesh-ancestor
102251621|NCT05327439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102251622|NCT05327439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251623|NCT03187691|Amphotericin B|amphotericin b|mesh-list
102251624|NCT03187691|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102251625|NCT03187691|Amebicides|amebicides|mesh-ancestor
102251626|NCT03187691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102613416|NCT00382343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102251627|NCT03187691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102251628|NCT03187691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102251629|NCT03187691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102251630|NCT03187691|Antifungal Agents|antifungal agents|mesh-ancestor
102251631|NCT02433899|Chlorhexidine|chlorhexidine|mesh-list
102251632|NCT02433899|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102251633|NCT02433899|Dexamethasone|dexamethasone|mesh-list
102251634|NCT02433899|Epinephrine|epinephrine|mesh-list
102251635|NCT02433899|Mepivacaine|mepivacaine|mesh-list
102251636|NCT02433899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102251637|NCT02433899|Antiemetics|antiemetics|mesh-ancestor
102251638|NCT02433899|Autonomic Agents|autonomic agents|mesh-ancestor
102251639|NCT02433899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102251640|NCT02433899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251641|NCT02433899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102251642|NCT02433899|Glucocorticoids|glucocorticoids|mesh-ancestor
102251644|NCT02433899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102251645|NCT02433899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102251646|NCT02433899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102251647|NCT02433899|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102251648|NCT02433899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102251649|NCT02433899|Disinfectants|disinfectants|mesh-ancestor
102251650|NCT02433899|Dermatologic Agents|dermatologic agents|mesh-ancestor
102251651|NCT02433899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102251652|NCT02433899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102251653|NCT02433899|Adrenergic Agents|adrenergic agents|mesh-ancestor
102251654|NCT02433899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101728771|NCT00448591|Bevacizumab|bevacizumab|mesh-list
102251655|NCT02433899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251656|NCT02433899|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102251657|NCT02433899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102251658|NCT02433899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102251659|NCT02433899|Respiratory System Agents|respiratory system agents|mesh-ancestor
102251660|NCT02433899|Mydriatics|mydriatics|mesh-ancestor
101728837|NCT00448435|Xhance|xhance|mesh-list
102251661|NCT02433899|Sympathomimetics|sympathomimetics|mesh-ancestor
102251662|NCT02433899|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102251663|NCT02433899|Anesthetics, Local|anesthetics, local|mesh-ancestor
102251664|NCT02433899|Anesthetics|anesthetics|mesh-ancestor
102251665|NCT02433899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102251666|NCT02433899|Sensory System Agents|sensory system agents|mesh-ancestor
102251667|NCT05532267|Ciprofloxacin|ciprofloxacin|mesh-list
102251668|NCT05532267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102251669|NCT05532267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102251670|NCT05532267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102251671|NCT05532267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102251672|NCT05532267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101728906|NCT00804856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102251673|NCT05532267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251674|NCT05532267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102251675|NCT05532267|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102251676|NCT05532267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102251677|NCT03187457|Metronidazole|metronidazole|mesh-list
102251678|NCT03187457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102251679|NCT03187457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102251680|NCT03187457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102251681|NCT03187457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102251682|NCT03187223|Melphalan|melphalan|mesh-list
102251683|NCT03187223|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102251684|NCT03187223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102251685|NCT03187223|Alkylating Agents|alkylating agents|mesh-ancestor
102251686|NCT03187223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251687|NCT03187223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102251688|NCT03187223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102251689|NCT03187223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102251690|NCT03187223|Immunologic Factors|immunologic factors|mesh-ancestor
102251691|NCT03187223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251692|NCT05532111|Cyclophosphamide|cyclophosphamide|mesh-list
102251693|NCT05532111|Rituximab|rituximab|mesh-list
102251694|NCT05532111|Tacrolimus|tacrolimus|mesh-list
102251695|NCT05532111|Glucocorticoids|glucocorticoids|mesh-list
101728980|NCT00810862|Pimecrolimus|pimecrolimus|mesh-list
102251696|NCT05532111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102251697|NCT05532111|Immunologic Factors|immunologic factors|mesh-ancestor
102251698|NCT05532111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613417|NCT00382343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102251699|NCT05532111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102251700|NCT05532111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102251702|NCT05532111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251703|NCT05532111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102251704|NCT05532111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102251705|NCT05532111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102251706|NCT05532111|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101729016|NCT00651118|Fluticasone|fluticasone|mesh-list
102251707|NCT05532111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102251708|NCT05532111|Hormones|hormones|mesh-ancestor
102251709|NCT05532111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102251710|NCT05524077|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
102251711|NCT04299867|Metronidazole|metronidazole|mesh-list
102251712|NCT04299867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102251713|NCT04299867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102251714|NCT04299867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102251715|NCT04299867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102251716|NCT02433587|Aspirin|aspirin|mesh-list
102251717|NCT02433587|Clopidogrel|clopidogrel|mesh-list
102251718|NCT02433587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102251719|NCT02433587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102251720|NCT02433587|Analgesics|analgesics|mesh-ancestor
102251721|NCT02433587|Sensory System Agents|sensory system agents|mesh-ancestor
102251722|NCT02433587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102251723|NCT02433587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251724|NCT02433587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102251725|NCT02433587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102251726|NCT02433587|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102251727|NCT02433587|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102251728|NCT02433587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251729|NCT02433587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102251730|NCT02433587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102251731|NCT02433587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102251732|NCT02433587|Antipyretics|antipyretics|mesh-ancestor
102251733|NCT02433587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102251734|NCT02433587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102251735|NCT02433587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102251736|NCT02433587|Purinergic Agents|purinergic agents|mesh-ancestor
102251737|NCT02433587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102251738|NCT02433353|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102251739|NCT02433353|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102251740|NCT02433353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102251741|NCT02433353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102251742|NCT02433353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251743|NCT02433353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102251744|NCT02433353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251745|NCT02433353|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102251746|NCT02433353|Antidepressive Agents|antidepressive agents|mesh-ancestor
102251747|NCT02433353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102251748|NCT03190733|Fludarabine|fludarabine|mesh-list
102251749|NCT03190733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102251750|NCT04425135|Carboplatin|carboplatin|mesh-list
102251751|NCT04425135|Apatinib|apatinib|mesh-list
102251752|NCT04425135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102251753|NCT04425135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101960636|NCT03818399|Buprenorphine|buprenorphine|mesh-list
102251754|NCT04425135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102251755|NCT04425135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251756|NCT02573883|Clobetasol|clobetasol|mesh-list
102251757|NCT02573883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102251758|NCT02573883|Glucocorticoids|glucocorticoids|mesh-ancestor
102251759|NCT02573883|Hormones|hormones|mesh-ancestor
102251760|NCT02573883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102251761|NCT02573883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251762|NCT02432885|Enalapril|enalapril|mesh-list
102251763|NCT02432885|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102251764|NCT02432885|Protease Inhibitors|protease inhibitors|mesh-ancestor
102251765|NCT02432885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101729249|NCT00446797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102251766|NCT02432885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251767|NCT02432885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102251768|NCT02433041|Ketamine|ketamine|mesh-list
102251769|NCT02433041|Haloperidol|haloperidol|mesh-list
102251770|NCT02433041|Haloperidol decanoate|haloperidol decanoate|mesh-list
102251771|NCT02433041|Analgesics|analgesics|mesh-ancestor
102251772|NCT02433041|Sensory System Agents|sensory system agents|mesh-ancestor
102251773|NCT02433041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102251774|NCT02433041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251775|NCT02433041|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102251776|NCT02433041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102251777|NCT02433041|Anesthetics, General|anesthetics, general|mesh-ancestor
102251778|NCT02433041|Anesthetics|anesthetics|mesh-ancestor
102251779|NCT02433041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102251780|NCT02433041|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102251781|NCT02433041|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102251782|NCT02433041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102251783|NCT02433041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251784|NCT02433041|Antiemetics|antiemetics|mesh-ancestor
102251785|NCT02433041|Autonomic Agents|autonomic agents|mesh-ancestor
102251786|NCT02433041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102251787|NCT02433041|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102251788|NCT02433041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102251789|NCT02433041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102251790|NCT02433041|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102251791|NCT02433041|Dopamine Agents|dopamine agents|mesh-ancestor
102251792|NCT02433041|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102251793|NCT02429921|Selenium|selenium|mesh-list
102251794|NCT02429921|Antioxidants|antioxidants|mesh-ancestor
102251795|NCT02429921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251796|NCT02429921|Protective Agents|protective agents|mesh-ancestor
102251797|NCT02429921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251798|NCT02429921|Trace Elements|trace elements|mesh-ancestor
102251799|NCT02429921|Micronutrients|micronutrients|mesh-ancestor
102251800|NCT02575365|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102251801|NCT02575365|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102251802|NCT02575365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251803|NCT02575365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102251804|NCT02575365|Immunologic Factors|immunologic factors|mesh-ancestor
102251805|NCT02575365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251806|NCT02432807|Vancomycin|vancomycin|mesh-list
102251807|NCT02432807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102251808|NCT02432807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102251809|NCT05527275|Mitoxantrone|mitoxantrone|mesh-list
102251810|NCT05527275|Analgesics|analgesics|mesh-ancestor
102251811|NCT05527275|Sensory System Agents|sensory system agents|mesh-ancestor
102251812|NCT05527275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102251813|NCT05527275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251814|NCT05527275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102251815|NCT05527275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102251816|NCT05527275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102251817|NCT05527275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102251818|NCT05527275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251819|NCT02429765|Formoterol Fumarate|formoterol fumarate|mesh-list
102251820|NCT02429765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102251821|NCT02429765|Autonomic Agents|autonomic agents|mesh-ancestor
102251822|NCT02429765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102251823|NCT02429765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251824|NCT02429765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102251825|NCT02429765|Respiratory System Agents|respiratory system agents|mesh-ancestor
102251826|NCT02429765|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102251827|NCT02429765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102251828|NCT02429765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102251829|NCT02429765|Adrenergic Agents|adrenergic agents|mesh-ancestor
102251830|NCT02429765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102251831|NCT02429765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251832|NCT03186053|Phosphocreatine|phosphocreatine|mesh-list
102251833|NCT03186053|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102251834|NCT03186053|Protective Agents|protective agents|mesh-ancestor
102251835|NCT03186053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251836|NCT02429219|Ethanol|ethanol|mesh-list
102251837|NCT02429219|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102251838|NCT02429219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102251839|NCT02429219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102251840|NCT02429219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251841|NCT02429531|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102251842|NCT02429531|Immunologic Factors|immunologic factors|mesh-ancestor
102613418|NCT00382343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102613419|NCT00382343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102613420|NCT00382343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251844|NCT02429453|Thrombin|thrombin|mesh-list
102251845|NCT02429453|Hemostatics|hemostatics|mesh-ancestor
102251846|NCT02429453|Coagulants|coagulants|mesh-ancestor
102251847|NCT02428751|Prednisone|prednisone|mesh-list
102251848|NCT02428751|Rituximab|rituximab|mesh-list
102251849|NCT02428751|Doxorubicin|doxorubicin|mesh-list
102251850|NCT02428751|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102251851|NCT02428751|Vincristine|vincristine|mesh-list
102251852|NCT02428751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102251853|NCT02428751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102251854|NCT02428751|Immunologic Factors|immunologic factors|mesh-ancestor
102251855|NCT02428751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251856|NCT02428751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102251857|NCT02428751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102251858|NCT02428751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102251859|NCT02428751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102251860|NCT02428751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102251861|NCT02428751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251862|NCT02428751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102251863|NCT02428751|Glucocorticoids|glucocorticoids|mesh-ancestor
102251864|NCT02428751|Hormones|hormones|mesh-ancestor
102251865|NCT02428751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102251866|NCT02428751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102251867|NCT02428751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102251868|NCT02428751|Tubulin Modulators|tubulin modulators|mesh-ancestor
102251869|NCT02428751|Antimitotic Agents|antimitotic agents|mesh-ancestor
102251870|NCT02428751|Mitosis Modulators|mitosis modulators|mesh-ancestor
102251871|NCT05526807|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102251872|NCT05526807|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102251873|NCT05526807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102251874|NCT03185195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102251875|NCT03186365|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
102251876|NCT03186365|Antiviral Agents|antiviral agents|mesh-ancestor
102251877|NCT03186365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102251878|NCT02432651|Xanthohumol|xanthohumol|mesh-list
102251879|NCT02432651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102251880|NCT02432651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102251881|NCT02432651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102251882|NCT02432651|Growth Substances|growth substances|mesh-ancestor
102251883|NCT02432651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251884|NCT02432651|Growth Inhibitors|growth inhibitors|mesh-ancestor
102251885|NCT02707757|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102251886|NCT02707757|Hematinics|hematinics|mesh-ancestor
102251887|NCT02432339|Mycophenolic Acid|mycophenolic acid|mesh-list
102251888|NCT02432339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102251889|NCT02432339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102251890|NCT02432339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102251891|NCT02432339|Antitubercular Agents|antitubercular agents|mesh-ancestor
102251892|NCT02432339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102251893|NCT02432339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102251894|NCT02432339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102251895|NCT02432339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251896|NCT03184805|Aspirin|aspirin|mesh-list
102251897|NCT03184805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102251898|NCT03184805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102251899|NCT03184805|Analgesics|analgesics|mesh-ancestor
102251900|NCT03184805|Sensory System Agents|sensory system agents|mesh-ancestor
102251901|NCT03184805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102251902|NCT03184805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251903|NCT03184805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102251904|NCT03184805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102251905|NCT03184805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102251906|NCT03184805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102251907|NCT03184805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251908|NCT03184805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102251909|NCT03184805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102251910|NCT03184805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102251911|NCT03184805|Antipyretics|antipyretics|mesh-ancestor
102251912|NCT05518383|Cytarabine|cytarabine|mesh-list
102251913|NCT05518383|Dexamethasone|dexamethasone|mesh-list
102251914|NCT05518383|Dexamethasone acetate|dexamethasone acetate|mesh-list
102251915|NCT05518383|Cyclophosphamide|cyclophosphamide|mesh-list
102251916|NCT05518383|Melphalan|melphalan|mesh-list
102251917|NCT05518383|Ifosfamide|ifosfamide|mesh-list
102251918|NCT05518383|Isophosphamide mustard|isophosphamide mustard|mesh-list
102613421|NCT00382343|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102251919|NCT05518383|Doxorubicin|doxorubicin|mesh-list
102251920|NCT05518383|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102251921|NCT05518383|Methotrexate|methotrexate|mesh-list
102251923|NCT05518383|Etoposide phosphate|etoposide phosphate|mesh-list
102251924|NCT05518383|Vincristine|vincristine|mesh-list
102251925|NCT05518383|Idarubicin|idarubicin|mesh-list
102251926|NCT05518383|Carboplatin|carboplatin|mesh-list
102251927|NCT05518383|BB 1101|bb 1101|mesh-list
102251928|NCT05518383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102251929|NCT05518383|Immunologic Factors|immunologic factors|mesh-ancestor
102251930|NCT05518383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729690|NCT02604498|Nemonoxacin|nemonoxacin|mesh-list
102251931|NCT05518383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102251932|NCT05518383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102251933|NCT05518383|Alkylating Agents|alkylating agents|mesh-ancestor
102251934|NCT05518383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251935|NCT05518383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102251936|NCT05518383|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102251937|NCT05518383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102251938|NCT05518383|Antiemetics|antiemetics|mesh-ancestor
102251939|NCT05518383|Autonomic Agents|autonomic agents|mesh-ancestor
101729743|NCT00795132|Fludarabine|fludarabine|mesh-list
102251940|NCT05518383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102251941|NCT05518383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102251942|NCT05518383|Glucocorticoids|glucocorticoids|mesh-ancestor
102251943|NCT05518383|Hormones|hormones|mesh-ancestor
102251944|NCT05518383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102251945|NCT05518383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102251946|NCT05518383|Protease Inhibitors|protease inhibitors|mesh-ancestor
102251947|NCT05518383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102251948|NCT05518383|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102251949|NCT05518383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102251950|NCT05518383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102251951|NCT05518383|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102251952|NCT05518383|Abortifacient Agents|abortifacient agents|mesh-ancestor
102251953|NCT05518383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102251954|NCT05518383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102251955|NCT05518383|Antimetabolites|antimetabolites|mesh-ancestor
102251956|NCT05518383|Dermatologic Agents|dermatologic agents|mesh-ancestor
102251957|NCT05518383|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102251958|NCT05518383|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102251959|NCT05518383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102251960|NCT05518383|Antiviral Agents|antiviral agents|mesh-ancestor
102251961|NCT05518383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102251962|NCT05518383|Tubulin Modulators|tubulin modulators|mesh-ancestor
102251963|NCT05518383|Antimitotic Agents|antimitotic agents|mesh-ancestor
102251964|NCT05518383|Mitosis Modulators|mitosis modulators|mesh-ancestor
102251965|NCT02432027|Betamethasone|betamethasone|mesh-list
102251966|NCT02432027|Calcipotriene|calcipotriene|mesh-list
102251967|NCT02432027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102251968|NCT02432027|Glucocorticoids|glucocorticoids|mesh-ancestor
102251969|NCT02432027|Hormones|hormones|mesh-ancestor
102251970|NCT02432027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101199504|NCT03777462|Paclitaxel|paclitaxel|mesh-list
102251971|NCT02432027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251972|NCT02432027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102251973|NCT02432027|Respiratory System Agents|respiratory system agents|mesh-ancestor
102251974|NCT02432027|Dermatologic Agents|dermatologic agents|mesh-ancestor
102251975|NCT02428439|Lamotrigine|lamotrigine|mesh-list
102251976|NCT02428439|Bupropion|bupropion|mesh-list
102251977|NCT02428439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102251978|NCT02428439|Antidepressive Agents|antidepressive agents|mesh-ancestor
102251979|NCT02428439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101730004|NCT03995563|Anesthetics|anesthetics|mesh-ancestor
102251980|NCT02428439|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102251981|NCT02428439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102251982|NCT02428439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102251983|NCT02428439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102251984|NCT02428439|Dopamine Agents|dopamine agents|mesh-ancestor
102251985|NCT02428439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102251986|NCT02428439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102251987|NCT02428439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102251988|NCT02428439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102251989|NCT02428439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102251990|NCT02428439|Anticonvulsants|anticonvulsants|mesh-ancestor
102251991|NCT02428439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102251992|NCT02428439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102251993|NCT02428439|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102251994|NCT02428439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102251995|NCT02428439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102251996|NCT02428439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102251998|NCT03186443|Gabapentin|gabapentin|mesh-list
102251999|NCT03186443|Analgesics|analgesics|mesh-ancestor
102252000|NCT03186443|Sensory System Agents|sensory system agents|mesh-ancestor
102252001|NCT03186443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102252002|NCT03186443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252003|NCT03186443|Anticonvulsants|anticonvulsants|mesh-ancestor
102252004|NCT03186443|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102252005|NCT03186443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101730126|NCT00444925|Urological Agents|urological agents|mesh-ancestor
102252006|NCT03186443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252007|NCT03186443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102252008|NCT03186443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102252009|NCT03186443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102252010|NCT03186443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102252011|NCT03186443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102252012|NCT03186443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102252013|NCT03186443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102252014|NCT03186443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102252015|NCT03186443|Antimanic Agents|antimanic agents|mesh-ancestor
102252016|NCT03186131|Vitamin D|vitamin d|mesh-list
102252017|NCT03186131|Ibandronic Acid|ibandronic acid|mesh-list
102252018|NCT03186131|Vitamins|vitamins|mesh-ancestor
102252019|NCT03186131|Micronutrients|micronutrients|mesh-ancestor
102252020|NCT03186131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252021|NCT03186131|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102252022|NCT03184649|Acetaminophen|acetaminophen|mesh-list
102252023|NCT03184649|Ibuprofen|ibuprofen|mesh-list
102252024|NCT03184649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102252025|NCT03184649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102252026|NCT03184649|Analgesics|analgesics|mesh-ancestor
102252027|NCT03184649|Sensory System Agents|sensory system agents|mesh-ancestor
102252028|NCT03184649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102252029|NCT03184649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252030|NCT03184649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102252031|NCT03184649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102252032|NCT03184649|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102252033|NCT03184649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102252034|NCT03184649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252035|NCT03184649|Antipyretics|antipyretics|mesh-ancestor
102252036|NCT02432261|Methyltestosterone|methyltestosterone|mesh-list
102252037|NCT02432261|ST 1435|st 1435|mesh-list
102252038|NCT02432261|Testosterone|testosterone|mesh-list
102252039|NCT02432261|Testosterone undecanoate|testosterone undecanoate|mesh-list
102252040|NCT02432261|Testosterone enanthate|testosterone enanthate|mesh-list
102252041|NCT02432261|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102252042|NCT02432261|Androgens|androgens|mesh-ancestor
102252043|NCT02432261|Hormones|hormones|mesh-ancestor
102252044|NCT02432261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102252045|NCT02432261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252046|NCT02432261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102252047|NCT02432261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102252048|NCT02432261|Anabolic Agents|anabolic agents|mesh-ancestor
102252049|NCT02432261|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102252050|NCT02432261|Contraceptive Agents|contraceptive agents|mesh-ancestor
102252051|NCT02432261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102252052|NCT02432261|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102252053|NCT02428283|Remifentanil|remifentanil|mesh-list
101960936|NCT00121199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102252054|NCT02428283|Ropivacaine|ropivacaine|mesh-list
102252055|NCT02428283|Sevoflurane|sevoflurane|mesh-list
102252056|NCT02428283|Anesthetics, Local|anesthetics, local|mesh-ancestor
102252057|NCT02428283|Anesthetics|anesthetics|mesh-ancestor
102252058|NCT02428283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102252059|NCT02428283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252060|NCT02428283|Sensory System Agents|sensory system agents|mesh-ancestor
102252061|NCT02428283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102252062|NCT02428283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102252063|NCT02428283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102252064|NCT02428283|Anesthetics, General|anesthetics, general|mesh-ancestor
102252065|NCT02428283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102252066|NCT02428283|Narcotics|narcotics|mesh-ancestor
102252067|NCT02428283|Analgesics|analgesics|mesh-ancestor
102252068|NCT02427893|Vemurafenib|vemurafenib|mesh-list
102252069|NCT02427893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102252070|NCT02427893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102252071|NCT02427893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102252072|NCT02427893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252074|NCT03184493|Celecoxib|celecoxib|mesh-list
101730507|NCT04109742|Curcumin|curcumin|mesh-list
102252075|NCT03184493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102252076|NCT03184493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252077|NCT03184493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102252078|NCT03184493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102252079|NCT03184493|Analgesics|analgesics|mesh-ancestor
102252080|NCT03184493|Sensory System Agents|sensory system agents|mesh-ancestor
102252081|NCT03184493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102252082|NCT03184493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101730551|NCT04107480|Dopamine|dopamine|mesh-list
102252083|NCT03184493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102252084|NCT03184493|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102252085|NCT03184493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102252086|NCT03184493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102252087|NCT03184493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252088|NCT02431403|Imatinib Mesylate|imatinib mesylate|mesh-list
102252089|NCT02431403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102252090|NCT02431403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102252091|NCT02431403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102252092|NCT02431403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252093|NCT02431325|Teduglutide|teduglutide|mesh-list
102252094|NCT02431325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102252095|NCT02431325|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102252096|NCT02431325|Protective Agents|protective agents|mesh-ancestor
102252097|NCT02431325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252098|NCT03184103|Complement System Proteins|complement system proteins|mesh-list
102252099|NCT03184103|Antistreptolysin|antistreptolysin|mesh-list
102252100|NCT03184103|Immunologic Factors|immunologic factors|mesh-ancestor
101730682|NCT02608112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102252101|NCT03184103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252102|NCT02103478|Decitabine|decitabine|mesh-list
102252103|NCT02103478|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
102252104|NCT02103478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102252105|NCT02103478|Antimetabolites|antimetabolites|mesh-ancestor
102252106|NCT02103478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252107|NCT02103478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101730749|NCT00827554|Nadroparin|nadroparin|mesh-list
102252108|NCT02103478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102252109|NCT02431013|Cilostazol|cilostazol|mesh-list
102252110|NCT02431013|Simvastatin|simvastatin|mesh-list
102252111|NCT02431013|Pravastatin|pravastatin|mesh-list
102252112|NCT02431013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102252113|NCT02431013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102252114|NCT02431013|Antimetabolites|antimetabolites|mesh-ancestor
102252115|NCT02431013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252116|NCT02431013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102252117|NCT02431013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101730823|NCT04104204|Morphine|morphine|mesh-list
102252118|NCT02431013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102252119|NCT02431013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102252120|NCT02431013|Autonomic Agents|autonomic agents|mesh-ancestor
102252121|NCT02431013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102252122|NCT02431013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252123|NCT02431013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102252124|NCT02431013|Respiratory System Agents|respiratory system agents|mesh-ancestor
102252125|NCT02431013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102252126|NCT02431013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102252127|NCT02431013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102252128|NCT02431013|Vasodilator Agents|vasodilator agents|mesh-ancestor
102252129|NCT02431013|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101730887|NCT00823186|Paclitaxel|paclitaxel|mesh-list
102252131|NCT02431013|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102252132|NCT02431013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102252133|NCT03185429|Cyclophosphamide|cyclophosphamide|mesh-list
102252134|NCT03185429|Immunologic Factors|immunologic factors|mesh-ancestor
102252135|NCT03185429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252136|NCT03185429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102252137|NCT03185429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102252138|NCT03185429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102252139|NCT03185429|Alkylating Agents|alkylating agents|mesh-ancestor
102252140|NCT03185429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613422|NCT00382343|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102613423|NCT00382343|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102252141|NCT03185429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102252142|NCT03185429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102252144|NCT02430545|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102252145|NCT02430545|Antitubercular Agents|antitubercular agents|mesh-ancestor
102252146|NCT02430545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102252147|NCT02430545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102252148|NCT02430545|Leprostatic Agents|leprostatic agents|mesh-ancestor
102252149|NCT02430545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102252150|NCT02430545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102252151|NCT02430545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252152|NCT02430545|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102252153|NCT02430545|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102252154|NCT02430545|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102252155|NCT02430545|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102252156|NCT02430545|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102252157|NCT02430545|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102252158|NCT03117725|Melatonin|melatonin|mesh-list
102252159|NCT03117725|Antioxidants|antioxidants|mesh-ancestor
102252160|NCT03117725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252161|NCT03117725|Protective Agents|protective agents|mesh-ancestor
102252162|NCT03117725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252163|NCT03117725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102252164|NCT03185351|Midazolam|midazolam|mesh-list
102252165|NCT03185351|Bupivacaine|bupivacaine|mesh-list
102252166|NCT03185351|Anesthetics, Local|anesthetics, local|mesh-ancestor
102252167|NCT03185351|Anesthetics|anesthetics|mesh-ancestor
102252168|NCT03185351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102252169|NCT03185351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252170|NCT03185351|Sensory System Agents|sensory system agents|mesh-ancestor
102252171|NCT03185351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102252172|NCT03185351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102252173|NCT03185351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102252174|NCT03185351|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102252175|NCT03185351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102252176|NCT03185351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102252177|NCT03185351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102252178|NCT03185351|Anesthetics, General|anesthetics, general|mesh-ancestor
102252179|NCT03185351|GABA Modulators|gaba modulators|mesh-ancestor
102252180|NCT03185351|GABA Agents|gaba agents|mesh-ancestor
102252181|NCT03185351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102252182|NCT03185351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252183|NCT02707601|Sofosbuvir|sofosbuvir|mesh-list
102252184|NCT02707601|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102252185|NCT02707601|Ledipasvir|ledipasvir|mesh-list
102252186|NCT02707601|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102252187|NCT02707601|Antiviral Agents|antiviral agents|mesh-ancestor
102252188|NCT02707601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102252189|NCT02707601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102252190|NCT02707601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102252191|NCT03183557|Vitamin D|vitamin d|mesh-list
102252192|NCT03183557|Zoledronic Acid|zoledronic acid|mesh-list
102252193|NCT03183557|Alfacalcidol|alfacalcidol|mesh-list
102252194|NCT03183557|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
102252195|NCT03183557|Vitamins|vitamins|mesh-ancestor
102252196|NCT03183557|Micronutrients|micronutrients|mesh-ancestor
102252197|NCT03183557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252198|NCT03183557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102252199|NCT02426723|Dexamethasone|dexamethasone|mesh-list
102252200|NCT02426723|Lenalidomide|lenalidomide|mesh-list
102252201|NCT02426723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102252202|NCT02426723|Antiemetics|antiemetics|mesh-ancestor
102252203|NCT02426723|Autonomic Agents|autonomic agents|mesh-ancestor
102252204|NCT02426723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102252205|NCT02426723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252206|NCT02426723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102252207|NCT02426723|Glucocorticoids|glucocorticoids|mesh-ancestor
102252208|NCT02426723|Hormones|hormones|mesh-ancestor
102252209|NCT02426723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102252210|NCT02426723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102252211|NCT02426723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102252212|NCT02426723|Immunologic Factors|immunologic factors|mesh-ancestor
102252213|NCT02426723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102252214|NCT02426723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102252216|NCT02426723|Growth Inhibitors|growth inhibitors|mesh-ancestor
102252217|NCT00709865|1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine|1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine|mesh-list
102252218|NCT00709865|Adenosine A1 Receptor Antagonists|adenosine a1 receptor antagonists|mesh-ancestor
102252219|NCT00709865|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102252220|NCT00709865|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102252221|NCT00709865|Purinergic Agents|purinergic agents|mesh-ancestor
102252222|NCT00709865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102252223|NCT00709865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252224|NCT00709865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252225|NCT02425241|Vaccines|vaccines|mesh-list
102252226|NCT02425241|Immunologic Factors|immunologic factors|mesh-ancestor
102252227|NCT02425241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252228|NCT03182855|Ticagrelor|ticagrelor|mesh-list
102252229|NCT03182855|Cangrelor|cangrelor|mesh-list
102252230|NCT03182855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102252231|NCT03182855|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102252232|NCT03182855|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102252233|NCT03182855|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102252234|NCT03182855|Purinergic Agents|purinergic agents|mesh-ancestor
102252235|NCT03182855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102252236|NCT03182855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252237|NCT03182855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252238|NCT02426333|Abiraterone Acetate|abiraterone acetate|mesh-list
102252239|NCT02426333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102252240|NCT02426333|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102252241|NCT02426333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102252242|NCT02426333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252243|NCT02426333|Hormone Antagonists|hormone antagonists|mesh-ancestor
102252244|NCT02426333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102252245|NCT02426333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252246|NCT02426333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102252247|NCT02426177|Labetalol|labetalol|mesh-list
102252248|NCT02426177|Nifedipine|nifedipine|mesh-list
102252249|NCT02426177|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102252250|NCT02426177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102252251|NCT02426177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252252|NCT02426177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102252253|NCT02426177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252254|NCT02426177|Vasodilator Agents|vasodilator agents|mesh-ancestor
102252255|NCT02426177|Tocolytic Agents|tocolytic agents|mesh-ancestor
102252256|NCT02426177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102252257|NCT02426177|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102252258|NCT02426177|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102252259|NCT02426177|Adrenergic Agents|adrenergic agents|mesh-ancestor
102252260|NCT02426177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102252261|NCT02426177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102252262|NCT02426177|Sympathomimetics|sympathomimetics|mesh-ancestor
102252263|NCT02426177|Autonomic Agents|autonomic agents|mesh-ancestor
102252264|NCT02426177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102252265|NCT02426177|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102252266|NCT02426177|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102252267|NCT02426099|Antihypertensive Agents|antihypertensive agents|mesh-list
102252268|NCT02426099|Spironolactone|spironolactone|mesh-list
102252269|NCT02426099|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102252270|NCT02426099|Hormone Antagonists|hormone antagonists|mesh-ancestor
102252271|NCT02426099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102252272|NCT02426099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252273|NCT02426099|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102252274|NCT02426099|Diuretics|diuretics|mesh-ancestor
102252276|NCT02426021|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102252277|NCT02426021|Immunologic Factors|immunologic factors|mesh-ancestor
102252278|NCT02426021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252279|NCT02425709|Diclofenac|diclofenac|mesh-list
102252280|NCT02425709|Tramadol|tramadol|mesh-list
102252281|NCT02425709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102252282|NCT02425709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102252283|NCT02425709|Analgesics|analgesics|mesh-ancestor
102252284|NCT02425709|Sensory System Agents|sensory system agents|mesh-ancestor
102252285|NCT02425709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102252286|NCT02425709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613424|NCT00382343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102613425|NCT05749445|Ritonavir|ritonavir|mesh-list
102613426|NCT05749445|Nirmatrelvir|nirmatrelvir|mesh-list
102613427|NCT05749445|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
102613428|NCT05749445|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102613429|NCT05749445|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102613430|NCT05749445|Protease Inhibitors|protease inhibitors|mesh-ancestor
102252287|NCT02425709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102252288|NCT02425709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102252289|NCT02425709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101731473|NCT02602938|Aspirin|aspirin|mesh-list
102252290|NCT02425709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102252291|NCT02425709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252292|NCT02425709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102252293|NCT02425709|Narcotics|narcotics|mesh-ancestor
102252294|NCT02425709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102252295|NCT02073682|Heparin|heparin|mesh-list
102252296|NCT02073682|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102252297|NCT02073682|Tinzaparin|tinzaparin|mesh-list
102252298|NCT02073682|Dalteparin|dalteparin|mesh-list
102252299|NCT02073682|Edoxaban|edoxaban|mesh-list
102252300|NCT02073682|Anticoagulants|anticoagulants|mesh-ancestor
102252301|NCT02073682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102252302|NCT02073682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102252303|NCT02073682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252304|NCT02073682|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102252305|NCT02073682|Antithrombins|antithrombins|mesh-ancestor
102252306|NCT02073682|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102252307|NCT02073682|Protease Inhibitors|protease inhibitors|mesh-ancestor
102252308|NCT02073682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102252309|NCT03181919|Letrozole|letrozole|mesh-list
102252310|NCT03181919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102252311|NCT03181919|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102252312|NCT03181919|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102252313|NCT03181919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102252314|NCT03181919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252315|NCT03181919|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102252316|NCT03181919|Hormone Antagonists|hormone antagonists|mesh-ancestor
102252317|NCT03181919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102252318|NCT03181919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252319|NCT02706899|Azacitidine|azacitidine|mesh-list
102252320|NCT02706899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102252321|NCT02706899|Antimetabolites|antimetabolites|mesh-ancestor
102252322|NCT02706899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252323|NCT02706899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102252324|NCT02706899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102252325|NCT02421575|Hydroxychloroquine|hydroxychloroquine|mesh-list
102252326|NCT02421575|Antimalarials|antimalarials|mesh-ancestor
102252327|NCT02421575|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102252328|NCT02421575|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102252329|NCT02421575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102252330|NCT02421575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102252331|NCT02421575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252332|NCT02421575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102252333|NCT02424695|Gabapentin|gabapentin|mesh-list
102252334|NCT02424695|Analgesics|analgesics|mesh-ancestor
102252335|NCT02424695|Sensory System Agents|sensory system agents|mesh-ancestor
101731731|NCT04105140|Oxytocin|oxytocin|mesh-list
102252336|NCT02424695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102252337|NCT02424695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252338|NCT02424695|Anticonvulsants|anticonvulsants|mesh-ancestor
102252339|NCT02424695|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102252340|NCT02424695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102252341|NCT02424695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102252342|NCT02424695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102252343|NCT02424695|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102252344|NCT02424695|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102252345|NCT02424695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102252346|NCT02424695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252347|NCT02424695|Antimanic Agents|antimanic agents|mesh-ancestor
102252348|NCT02422277|Sildenafil Citrate|sildenafil citrate|mesh-list
101961235|NCT00118157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102252349|NCT02422277|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
102252350|NCT02422277|Vasodilator Agents|vasodilator agents|mesh-ancestor
102252351|NCT02422277|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102252352|NCT02422277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101901857|NCT03856502|BB 1101|bb 1101|mesh-list
102252353|NCT02422277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252354|NCT02422277|Urological Agents|urological agents|mesh-ancestor
102252355|NCT02422121|RNS60|rns60|mesh-list
102252356|NCT02422121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102252357|NCT02422121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102252358|NCT02422121|Analgesics|analgesics|mesh-ancestor
102252359|NCT02422121|Sensory System Agents|sensory system agents|mesh-ancestor
102252360|NCT02422121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101731827|NCT00784875|Zolpidem|zolpidem|mesh-list
102252361|NCT02422121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252362|NCT02422121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102252363|NCT02422121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102252364|NCT02422121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102252365|NCT02424461|Ceftriaxone|ceftriaxone|mesh-list
102252366|NCT02424461|Ofloxacin|ofloxacin|mesh-list
102252367|NCT02424461|Levofloxacin|levofloxacin|mesh-list
102252368|NCT02424461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102252369|NCT02424461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102252370|NCT02424461|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102252371|NCT02424461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101731885|NCT00845897|Botulinum Toxins|botulinum toxins|mesh-list
102252372|NCT02424461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102252373|NCT02424461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102252374|NCT02424461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252375|NCT02424461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102252376|NCT02424461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102252377|NCT02424461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102252378|NCT02072824|Pregabalin|pregabalin|mesh-list
102252379|NCT02072824|Analgesics|analgesics|mesh-ancestor
102252380|NCT02072824|Sensory System Agents|sensory system agents|mesh-ancestor
101731949|NCT00700583|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102252381|NCT02072824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102252382|NCT02072824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252383|NCT02072824|Anticonvulsants|anticonvulsants|mesh-ancestor
102252384|NCT02072824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102252385|NCT02072824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101732014|NCT00767325|Dermatologic Agents|dermatologic agents|mesh-ancestor
102252386|NCT02072824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252387|NCT02072824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102252388|NCT02072824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102252389|NCT02072824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102252390|NCT02072824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102252391|NCT02072824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102252392|NCT03117257|Cisplatin|cisplatin|mesh-list
102252393|NCT03117257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102252394|NCT02072668|Rivaroxaban|rivaroxaban|mesh-list
102252395|NCT02072668|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102252396|NCT02072668|Antithrombins|antithrombins|mesh-ancestor
102252397|NCT02072668|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102252398|NCT02072668|Protease Inhibitors|protease inhibitors|mesh-ancestor
102252399|NCT02072668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102252400|NCT02072668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252401|NCT02072668|Anticoagulants|anticoagulants|mesh-ancestor
102252402|NCT03181685|Cetrorelix|cetrorelix|mesh-list
102252403|NCT03181685|Progesterone|progesterone|mesh-list
102252404|NCT03181685|Progestins|progestins|mesh-ancestor
102252405|NCT03181685|Hormones|hormones|mesh-ancestor
102252406|NCT03181685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102252407|NCT03181685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252408|NCT03181685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102252409|NCT03181685|Fertility Agents|fertility agents|mesh-ancestor
102252410|NCT03181685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102252411|NCT03181685|Hormone Antagonists|hormone antagonists|mesh-ancestor
102252412|NCT02424071|Melatonin|melatonin|mesh-list
102252413|NCT02424071|Antioxidants|antioxidants|mesh-ancestor
102252414|NCT02424071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252415|NCT02424071|Protective Agents|protective agents|mesh-ancestor
102252416|NCT02424071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252417|NCT02424071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102252418|NCT03178955|Etanercept|etanercept|mesh-list
102252419|NCT03178955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102252420|NCT03178955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102252421|NCT03178955|Analgesics|analgesics|mesh-ancestor
102252422|NCT03178955|Sensory System Agents|sensory system agents|mesh-ancestor
102252423|NCT03178955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102252424|NCT03178955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252425|NCT03178955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102613432|NCT05749445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252426|NCT03178955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102252427|NCT03178955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102252428|NCT03178955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102252429|NCT03178955|Immunologic Factors|immunologic factors|mesh-ancestor
102252430|NCT01598506|Hydromorphone|hydromorphone|mesh-list
102252431|NCT01598506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102252432|NCT01598506|Narcotics|narcotics|mesh-ancestor
102252433|NCT01598506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102252434|NCT01598506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252435|NCT01598506|Analgesics|analgesics|mesh-ancestor
102252436|NCT01598506|Sensory System Agents|sensory system agents|mesh-ancestor
102252437|NCT01598506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102252438|NCT02423915|Mycophenolic Acid|mycophenolic acid|mesh-list
102252439|NCT02423915|Sirolimus|sirolimus|mesh-list
102252440|NCT02423915|Cyclophosphamide|cyclophosphamide|mesh-list
102252441|NCT02423915|Rituximab|rituximab|mesh-list
102252442|NCT02423915|Fludarabine|fludarabine|mesh-list
102252443|NCT02423915|Fludarabine phosphate|fludarabine phosphate|mesh-list
102252444|NCT02423915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102252445|NCT02423915|Immunologic Factors|immunologic factors|mesh-ancestor
102252446|NCT02423915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252447|NCT02423915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102252448|NCT02423915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102252449|NCT02423915|Alkylating Agents|alkylating agents|mesh-ancestor
101732253|NCT04116827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252450|NCT02423915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252451|NCT02423915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102252452|NCT02423915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102252453|NCT02423915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102252454|NCT02423915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102252455|NCT02423915|Antimetabolites|antimetabolites|mesh-ancestor
102252456|NCT02423915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102252457|NCT02423915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102252458|NCT02423915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102252459|NCT02423915|Antitubercular Agents|antitubercular agents|mesh-ancestor
102252460|NCT02423915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102252461|NCT02423915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102252462|NCT02423915|Antifungal Agents|antifungal agents|mesh-ancestor
102252463|NCT02423837|Rituximab|rituximab|mesh-list
102252464|NCT02423837|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102252465|NCT02423837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102252466|NCT02423837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102252467|NCT02423837|Immunologic Factors|immunologic factors|mesh-ancestor
102252468|NCT02423837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252469|NCT02423837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102252470|NCT02423837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102252471|NCT02423837|Alkylating Agents|alkylating agents|mesh-ancestor
102252472|NCT02423837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252473|NCT02140060|Travoprost|travoprost|mesh-list
102252474|NCT02140060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102252475|NCT02140060|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102252476|NCT02140060|Brinzolamide|brinzolamide|mesh-list
102252477|NCT02140060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102252478|NCT02140060|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102252479|NCT02140060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102252480|NCT02140060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252481|NCT03178721|Calcium|calcium|mesh-list
102252482|NCT03178721|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102252483|NCT03178721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252484|NCT02421029|Calcium, Dietary|calcium, dietary|mesh-list
102252485|NCT02421029|Edetic Acid|edetic acid|mesh-list
102252486|NCT02421029|Calcium|calcium|mesh-list
102252487|NCT02421029|Pentetic Acid|pentetic acid|mesh-list
102252488|NCT02421029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102252489|NCT02421029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252490|NCT02421029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102252491|NCT02421029|Anticoagulants|anticoagulants|mesh-ancestor
102252492|NCT02421029|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102252493|NCT02421029|Chelating Agents|chelating agents|mesh-ancestor
102252494|NCT02421029|Sequestering Agents|sequestering agents|mesh-ancestor
102252495|NCT02421029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252496|NCT02421029|Antidotes|antidotes|mesh-ancestor
102252497|NCT02421029|Protective Agents|protective agents|mesh-ancestor
102252498|NCT02421029|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101961392|NCT02777242|Hormones|hormones|mesh-ancestor
102252499|NCT02139982|Ropivacaine|ropivacaine|mesh-list
102252500|NCT02139982|Anesthetics, Local|anesthetics, local|mesh-ancestor
102252501|NCT02139982|Anesthetics|anesthetics|mesh-ancestor
102252502|NCT02139982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102252503|NCT02139982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252504|NCT02139982|Sensory System Agents|sensory system agents|mesh-ancestor
102252505|NCT02139982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102252506|NCT03178643|Piperaquine|piperaquine|mesh-list
102252507|NCT03178643|Sulfadoxine|sulfadoxine|mesh-list
102252508|NCT03178643|Amodiaquine|amodiaquine|mesh-list
102252509|NCT03178643|Artenimol|artenimol|mesh-list
102252510|NCT03178643|Proguanil|proguanil|mesh-list
102252511|NCT03178643|Antimalarials|antimalarials|mesh-ancestor
102252512|NCT03178643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102252513|NCT03178643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102252514|NCT03178643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101732571|NCT05591339|BCG Vaccine|bcg vaccine|mesh-list
102252515|NCT03178643|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102252516|NCT03178643|Antimetabolites|antimetabolites|mesh-ancestor
102252517|NCT03178643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252518|NCT02139592|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102252519|NCT02139592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102252520|NCT02139592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102252521|NCT02139592|Immunotoxins|immunotoxins|mesh-ancestor
102252522|NCT02139592|Immunoconjugates|immunoconjugates|mesh-ancestor
102252523|NCT02139592|Immunologic Factors|immunologic factors|mesh-ancestor
102252524|NCT02139592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252525|NCT02139280|Cyclophosphamide|cyclophosphamide|mesh-list
102252526|NCT02139280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102252527|NCT02139280|Immunologic Factors|immunologic factors|mesh-ancestor
101732620|NCT00766506|Fentanyl|fentanyl|mesh-list
102252528|NCT02139280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252529|NCT02139280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102252530|NCT02139280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102252531|NCT02139280|Alkylating Agents|alkylating agents|mesh-ancestor
102252532|NCT02139280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252533|NCT02139280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102252534|NCT02139280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102252535|NCT02072434|Enoxaparin|enoxaparin|mesh-list
102252536|NCT02072434|Warfarin|warfarin|mesh-list
102252537|NCT02072434|Edoxaban|edoxaban|mesh-list
102252538|NCT02072434|Anticoagulants|anticoagulants|mesh-ancestor
102252539|NCT02072434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102252540|NCT02072434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102252541|NCT02072434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252542|NCT02072434|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102252543|NCT02072434|Antithrombins|antithrombins|mesh-ancestor
102252544|NCT02072434|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102252545|NCT02072434|Protease Inhibitors|protease inhibitors|mesh-ancestor
102252546|NCT02072434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102252547|NCT04725994|Irinotecan|irinotecan|mesh-list
102252548|NCT04725994|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102252549|NCT04725994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102252550|NCT04725994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101732748|NCT04100226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252551|NCT04725994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252552|NCT04725994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102252553|NCT02139046|Naproxen|naproxen|mesh-list
102252554|NCT02139046|Colchicine|colchicine|mesh-list
102252555|NCT02139046|Febuxostat|febuxostat|mesh-list
102252556|NCT02139046|Lansoprazole|lansoprazole|mesh-list
102252557|NCT02139046|Dexlansoprazole|dexlansoprazole|mesh-list
102252558|NCT02139046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102252559|NCT02139046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102252560|NCT02139046|Analgesics|analgesics|mesh-ancestor
102252561|NCT02139046|Sensory System Agents|sensory system agents|mesh-ancestor
102252562|NCT02139046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102252563|NCT02139046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252564|NCT02139046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102252565|NCT02139046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102252566|NCT02139046|Gout Suppressants|gout suppressants|mesh-ancestor
102252567|NCT02139046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102252568|NCT02139046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102252569|NCT02139046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252570|NCT02139046|Tubulin Modulators|tubulin modulators|mesh-ancestor
102613433|NCT05749445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102252571|NCT02139046|Antimitotic Agents|antimitotic agents|mesh-ancestor
102252572|NCT02139046|Mitosis Modulators|mitosis modulators|mesh-ancestor
102252573|NCT02139046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102252574|NCT02139046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102252575|NCT02139046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102613434|NCT05749445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102613435|NCT05749445|Antiviral Agents|antiviral agents|mesh-ancestor
102252576|NCT02139046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102252577|NCT04734262|Paclitaxel|paclitaxel|mesh-list
102252578|NCT04734262|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102252579|NCT04734262|Tislelizumab|tislelizumab|mesh-list
102252580|NCT04734262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102252581|NCT04734262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102252582|NCT04734262|Tubulin Modulators|tubulin modulators|mesh-ancestor
102252583|NCT04734262|Antimitotic Agents|antimitotic agents|mesh-ancestor
102252584|NCT04734262|Mitosis Modulators|mitosis modulators|mesh-ancestor
102252585|NCT04734262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252586|NCT04734262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102252587|NCT02100670|Diclofenac|diclofenac|mesh-list
102252588|NCT02100670|Menthol|menthol|mesh-list
102252589|NCT02100670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102252590|NCT02100670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102252591|NCT02100670|Analgesics|analgesics|mesh-ancestor
102252592|NCT02100670|Sensory System Agents|sensory system agents|mesh-ancestor
102252593|NCT02100670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102252594|NCT02100670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252595|NCT02100670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102252596|NCT02100670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102252597|NCT02100670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102252598|NCT02100670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102252599|NCT02100670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252600|NCT02100670|Antipruritics|antipruritics|mesh-ancestor
102252601|NCT02100670|Dermatologic Agents|dermatologic agents|mesh-ancestor
102252602|NCT02100514|Bococizumab|bococizumab|mesh-list
102252603|NCT02100514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102252604|NCT02100514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102252605|NCT02100514|Antimetabolites|antimetabolites|mesh-ancestor
102252606|NCT02100514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252607|NCT02100514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102252608|NCT02069392|Nicotine|nicotine|mesh-list
102252609|NCT02069392|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102252610|NCT02069392|Autonomic Agents|autonomic agents|mesh-ancestor
102252611|NCT02069392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102252612|NCT02069392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252613|NCT02069392|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102252614|NCT02069392|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102252615|NCT02069392|Cholinergic Agents|cholinergic agents|mesh-ancestor
102252616|NCT02069392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102252617|NCT02069392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252618|NCT05522361|Risdiplam|risdiplam|mesh-list
102252619|NCT05522361|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102252620|NCT05522361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102252621|NCT05522361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252622|NCT02100124|Contraceptive Agents|contraceptive agents|mesh-list
102252623|NCT02100124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102252624|NCT02100124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252625|NCT02046616|Methotrexate|methotrexate|mesh-list
102252626|NCT02046616|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102252627|NCT02046616|Abortifacient Agents|abortifacient agents|mesh-ancestor
102252628|NCT02046616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102252629|NCT02046616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252630|NCT02046616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102252631|NCT02046616|Antimetabolites|antimetabolites|mesh-ancestor
102252632|NCT02046616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252633|NCT02046616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102252634|NCT02046616|Dermatologic Agents|dermatologic agents|mesh-ancestor
102252635|NCT02046616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102252636|NCT02046616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102252637|NCT02046616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102252638|NCT02046616|Immunologic Factors|immunologic factors|mesh-ancestor
102252639|NCT02046616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102252640|NCT02046616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102252641|NCT05525481|Tamoxifen|tamoxifen|mesh-list
102252642|NCT05525481|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102252643|NCT05525481|Hormone Antagonists|hormone antagonists|mesh-ancestor
102252644|NCT05525481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102252645|NCT05525481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733018|NCT00833261|Cetuximab|cetuximab|mesh-list
102252646|NCT05525481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102252647|NCT05525481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102252648|NCT05525481|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102613436|NCT05749445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102613437|NCT05749445|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102252649|NCT05525481|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101961531|NCT03731091|Betamethasone|betamethasone|mesh-list
102252650|NCT05525481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102252651|NCT02068222|Ritonavir|ritonavir|mesh-list
102252652|NCT02068222|Ribavirin|ribavirin|mesh-list
102252653|NCT02068222|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101733086|NCT04095390|Hormone Antagonists|hormone antagonists|mesh-ancestor
102252654|NCT02068222|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102252655|NCT02068222|Protease Inhibitors|protease inhibitors|mesh-ancestor
102252656|NCT02068222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102252657|NCT02068222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252658|NCT02068222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102252659|NCT02068222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102252660|NCT02068222|Antiviral Agents|antiviral agents|mesh-ancestor
102252661|NCT02068222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102252662|NCT02068222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102252663|NCT02068222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102252664|NCT02068222|Antimetabolites|antimetabolites|mesh-ancestor
101733152|NCT04093713|Nordefrin|nordefrin|mesh-list
102252665|NCT05517213|Cyclophosphamide|cyclophosphamide|mesh-list
102252666|NCT05517213|Etoposide|etoposide|mesh-list
102252667|NCT05517213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102252668|NCT05517213|Immunologic Factors|immunologic factors|mesh-ancestor
102252669|NCT05517213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252670|NCT05517213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102252671|NCT05517213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102252672|NCT05517213|Alkylating Agents|alkylating agents|mesh-ancestor
102252673|NCT05517213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252674|NCT05517213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102252675|NCT05517213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102252676|NCT05517213|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102252677|NCT05517213|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102252678|NCT05517213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102252679|NCT05517213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102252680|NCT05516745|Respiratory System Agents|respiratory system agents|mesh-list
102252681|NCT05516589|Paclitaxel|paclitaxel|mesh-list
102252682|NCT05516589|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102252683|NCT05516589|Tislelizumab|tislelizumab|mesh-list
102252684|NCT05516589|Afatinib|afatinib|mesh-list
101733215|NCT02599701|Anticonvulsants|anticonvulsants|mesh-ancestor
102252685|NCT05516589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102252686|NCT05516589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102252687|NCT05516589|Tubulin Modulators|tubulin modulators|mesh-ancestor
102252688|NCT05516589|Antimitotic Agents|antimitotic agents|mesh-ancestor
102252689|NCT05516589|Mitosis Modulators|mitosis modulators|mesh-ancestor
102252690|NCT05516589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252691|NCT05516589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102252692|NCT05516589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102252693|NCT05516589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102252694|NCT02099110|Metformin|metformin|mesh-list
101733267|NCT02608034|Itraconazole|itraconazole|mesh-list
102252695|NCT02099110|Insulin Glargine|insulin glargine|mesh-list
102252696|NCT02099110|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102252697|NCT02099110|Glimepiride|glimepiride|mesh-list
102252698|NCT02099110|Ertugliflozin|ertugliflozin|mesh-list
102252699|NCT02099110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102252700|NCT02099110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252701|NCT02099110|Incretins|incretins|mesh-ancestor
102252702|NCT02099110|Hormones|hormones|mesh-ancestor
102252703|NCT02099110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102252704|NCT02099110|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102252705|NCT02099110|Protease Inhibitors|protease inhibitors|mesh-ancestor
102252706|NCT02099110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102252707|NCT02099110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252708|NCT02099110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102252709|NCT02099110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102252710|NCT02099110|Immunologic Factors|immunologic factors|mesh-ancestor
102252711|NCT02099110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102252712|NCT02098876|Everolimus|everolimus|mesh-list
102252713|NCT02098876|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102252714|NCT02098876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102252715|NCT02098876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102252716|NCT02098876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252717|NCT02098876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102252718|NCT02098876|Immunologic Factors|immunologic factors|mesh-ancestor
102252719|NCT02098876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252720|NCT02098876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102252722|NCT01624090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102252723|NCT01624090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252724|NCT01624090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102252725|NCT01624090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102252726|NCT01624090|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102252727|NCT01624090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102252728|NCT01624090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252729|NCT01624090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102252730|NCT02571777|Fluticasone|fluticasone|mesh-list
102252731|NCT02571777|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102252732|NCT02571777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102252733|NCT02571777|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102252734|NCT02571777|Autonomic Agents|autonomic agents|mesh-ancestor
102252735|NCT02571777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102252736|NCT02571777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252737|NCT02571777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102252738|NCT02571777|Respiratory System Agents|respiratory system agents|mesh-ancestor
102252739|NCT02571777|Dermatologic Agents|dermatologic agents|mesh-ancestor
102252740|NCT02571777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102252741|NCT02571777|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102252742|NCT02571777|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102252743|NCT02571777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102252744|NCT02571777|Adrenergic Agents|adrenergic agents|mesh-ancestor
102252745|NCT02571777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102252746|NCT02571777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252747|NCT05511831|Ketotifen|ketotifen|mesh-list
102252748|NCT05511831|Antipruritics|antipruritics|mesh-ancestor
102252749|NCT05511831|Dermatologic Agents|dermatologic agents|mesh-ancestor
102252750|NCT05511831|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102252751|NCT05511831|Histamine Antagonists|histamine antagonists|mesh-ancestor
102252752|NCT05511831|Histamine Agents|histamine agents|mesh-ancestor
102252753|NCT05511831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102252754|NCT05511831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252755|NCT05511831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252756|NCT05511831|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102252757|NCT02705105|Nivolumab|nivolumab|mesh-list
102252758|NCT02705105|Mogamulizumab|mogamulizumab|mesh-list
102252759|NCT02705105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102252760|NCT02705105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102252761|NCT02705105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102252762|NCT02705105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252763|NCT05521347|Caffeine|caffeine|mesh-list
101733579|NCT00751881|Teriflunomide|teriflunomide|mesh-list
102252764|NCT05521347|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102252765|NCT05521347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252766|NCT05521347|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102252767|NCT05521347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102252768|NCT05521347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252769|NCT05521347|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102252770|NCT05521347|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102252771|NCT05521347|Purinergic Agents|purinergic agents|mesh-ancestor
101733634|NCT05406726|Hormones|hormones|mesh-ancestor
102252772|NCT05521347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102252773|NCT02097472|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102252774|NCT02097472|Immunologic Factors|immunologic factors|mesh-ancestor
102252775|NCT02097472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252776|NCT03180671|Salicylic Acid|salicylic acid|mesh-list
102252777|NCT03180671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102252778|NCT03180671|Antifungal Agents|antifungal agents|mesh-ancestor
102252779|NCT03180671|Keratolytic Agents|keratolytic agents|mesh-ancestor
102252780|NCT03180671|Dermatologic Agents|dermatologic agents|mesh-ancestor
102252781|NCT05093517|Volagidemab|volagidemab|mesh-list
102252782|NCT05093517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102252783|NCT05093517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252784|NCT02420171|Insulin|insulin|mesh-list
102252785|NCT02420171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102252786|NCT02420171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252787|NCT03180593|Valsartan|valsartan|mesh-list
102252788|NCT03180593|Nebivolol|nebivolol|mesh-list
102252789|NCT03180593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102252790|NCT03180593|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101733762|NCT00829829|Rilonacept|rilonacept|mesh-list
102252791|NCT03180593|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102252792|NCT03180593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252793|NCT03180593|Vasodilator Agents|vasodilator agents|mesh-ancestor
102613438|NCT05749445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102252794|NCT03180593|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102252795|NCT03180593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102252796|NCT03180593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102252797|NCT03180593|Adrenergic Agents|adrenergic agents|mesh-ancestor
102252798|NCT03180593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102252799|NCT03180593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252801|NCT02423759|Gentamicins|gentamicins|mesh-list
102252802|NCT02423759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102252803|NCT02423759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102252804|NCT02423759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102252805|NCT02423759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102252806|NCT02423759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102252807|NCT02423759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252808|NCT02423759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101733908|NCT04091178|Vitamin D|vitamin d|mesh-list
102252809|NCT02423759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102252810|NCT02423759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102252811|NCT02423759|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102252812|NCT01623310|Fluticasone|fluticasone|mesh-list
102252813|NCT01623310|Xhance|xhance|mesh-list
102252814|NCT01623310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102252815|NCT01623310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102252816|NCT01623310|Autonomic Agents|autonomic agents|mesh-ancestor
102252817|NCT01623310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102252818|NCT01623310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252819|NCT01623310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102252820|NCT01623310|Respiratory System Agents|respiratory system agents|mesh-ancestor
102252821|NCT01623310|Dermatologic Agents|dermatologic agents|mesh-ancestor
102252822|NCT01623310|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102252823|NCT03180125|Lidocaine|lidocaine|mesh-list
102252824|NCT03180125|Hyaluronic Acid|hyaluronic acid|mesh-list
102252825|NCT03180125|Anesthetics, Local|anesthetics, local|mesh-ancestor
102252826|NCT03180125|Anesthetics|anesthetics|mesh-ancestor
102252827|NCT03180125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102252828|NCT03180125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252829|NCT03180125|Sensory System Agents|sensory system agents|mesh-ancestor
102252830|NCT03180125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102252831|NCT03180125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102252832|NCT03180125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102252833|NCT03180125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102252834|NCT03180125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102252835|NCT03180125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252836|NCT03180125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102252837|NCT03180125|Immunologic Factors|immunologic factors|mesh-ancestor
102252838|NCT03180125|Viscosupplements|viscosupplements|mesh-ancestor
102252839|NCT03180125|Protective Agents|protective agents|mesh-ancestor
102252840|NCT02423603|Paclitaxel|paclitaxel|mesh-list
102252841|NCT02423603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102252842|NCT02423603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102252843|NCT02423603|Tubulin Modulators|tubulin modulators|mesh-ancestor
102252844|NCT02423603|Antimitotic Agents|antimitotic agents|mesh-ancestor
102252845|NCT02423603|Mitosis Modulators|mitosis modulators|mesh-ancestor
102252846|NCT02423603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252847|NCT03178409|Liver Extracts|liver extracts|mesh-list
102252848|NCT03178409|Hematinics|hematinics|mesh-ancestor
102252849|NCT03180281|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102252850|NCT03180281|Glimepiride|glimepiride|mesh-list
102252851|NCT03180281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102252852|NCT03180281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252853|NCT03180281|Incretins|incretins|mesh-ancestor
102252854|NCT03180281|Hormones|hormones|mesh-ancestor
102252855|NCT03180281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102252856|NCT03180281|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102252857|NCT03180281|Protease Inhibitors|protease inhibitors|mesh-ancestor
102252858|NCT03180281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102252859|NCT03180281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252860|NCT03180281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102252861|NCT03180281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102252862|NCT03180281|Immunologic Factors|immunologic factors|mesh-ancestor
102252863|NCT03116945|Gallium citrate|gallium citrate|mesh-list
102252864|NCT03116945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252865|NCT03116945|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102252866|NCT03117023|Dexmedetomidine|dexmedetomidine|mesh-list
102252867|NCT03117023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102613439|NCT05749367|Ropivacaine|ropivacaine|mesh-list
102252868|NCT03117023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102252869|NCT03117023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252870|NCT03117023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102252871|NCT03117023|Analgesics|analgesics|mesh-ancestor
102252872|NCT03117023|Sensory System Agents|sensory system agents|mesh-ancestor
102252873|NCT03117023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102252874|NCT03117023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102252875|NCT03117023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102252876|NCT03117023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102252877|NCT03117023|Adrenergic Agents|adrenergic agents|mesh-ancestor
102252878|NCT03117023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102252879|NCT03117023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252880|NCT02097238|Halichondrin B|halichondrin b|mesh-list
102252881|NCT02097238|Tubulin Modulators|tubulin modulators|mesh-ancestor
102252882|NCT02097238|Antimitotic Agents|antimitotic agents|mesh-ancestor
102252883|NCT02097238|Mitosis Modulators|mitosis modulators|mesh-ancestor
102252884|NCT02097238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252885|NCT02097238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102252886|NCT03179813|Hydrocortisone|hydrocortisone|mesh-list
102252887|NCT03179813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102252888|NCT03179735|Cetylpyridinium|cetylpyridinium|mesh-list
102252889|NCT03179735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102252890|NCT03179735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102252891|NCT02419859|Insulin|insulin|mesh-list
102252892|NCT02419859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102252893|NCT02419859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102252894|NCT02419859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252895|NCT02419391|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
102252896|NCT02419391|Antiviral Agents|antiviral agents|mesh-ancestor
102252897|NCT02419391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102252898|NCT02419235|Ethanol|ethanol|mesh-list
102252899|NCT02419235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102252900|NCT02419235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102252901|NCT02419235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102252902|NCT02419235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252903|NCT02422823|Epinephrine|epinephrine|mesh-list
102252904|NCT02422823|Carticaine|carticaine|mesh-list
102252905|NCT02422823|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102252906|NCT02422823|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102252907|NCT02422823|Adrenergic Agents|adrenergic agents|mesh-ancestor
102252908|NCT02422823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102252909|NCT02422823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252910|NCT02422823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252911|NCT02422823|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102252912|NCT02422823|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102252913|NCT02422823|Autonomic Agents|autonomic agents|mesh-ancestor
101734313|NCT00728949|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102252914|NCT02422823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102252915|NCT02422823|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102252916|NCT02422823|Respiratory System Agents|respiratory system agents|mesh-ancestor
102252917|NCT02422823|Mydriatics|mydriatics|mesh-ancestor
102252918|NCT02422823|Sympathomimetics|sympathomimetics|mesh-ancestor
102252919|NCT02422823|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102252920|NCT02422823|Anesthetics, Local|anesthetics, local|mesh-ancestor
102252921|NCT02422823|Anesthetics|anesthetics|mesh-ancestor
102252922|NCT02422823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102252923|NCT02422823|Sensory System Agents|sensory system agents|mesh-ancestor
102252924|NCT02422589|Ceritinib|ceritinib|mesh-list
102252925|NCT02422589|Midazolam|midazolam|mesh-list
102252926|NCT02422589|Warfarin|warfarin|mesh-list
102252927|NCT02422589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102252928|NCT02422589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102252929|NCT02422589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102252930|NCT02422589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252931|NCT02422589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102252932|NCT02422589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102252933|NCT02422589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102613440|NCT05749367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102613441|NCT05749367|Anesthetics, Local|anesthetics, local|mesh-ancestor
102613442|NCT05749367|Anesthetics|anesthetics|mesh-ancestor
101734432|NCT03466346|Fluoxetine|fluoxetine|mesh-list
102613443|NCT05749367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102613444|NCT05749367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613445|NCT05749367|Sensory System Agents|sensory system agents|mesh-ancestor
102613446|NCT05749367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101901873|NCT03856502|Anesthetics|anesthetics|mesh-ancestor
102613447|NCT05749289|Octreotide|octreotide|mesh-list
102252934|NCT02422589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102613448|NCT05749289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102252935|NCT02422589|Anesthetics, General|anesthetics, general|mesh-ancestor
102252936|NCT02422589|Anesthetics|anesthetics|mesh-ancestor
102252937|NCT02422589|GABA Modulators|gaba modulators|mesh-ancestor
102252938|NCT02422589|GABA Agents|gaba agents|mesh-ancestor
102252939|NCT02422589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102252940|NCT02422589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252941|NCT02422589|Anticoagulants|anticoagulants|mesh-ancestor
102252942|NCT02422589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102252943|NCT02422589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102252944|NCT02422589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102252945|NCT02422199|Capecitabine|capecitabine|mesh-list
102252946|NCT02422199|Lapatinib|lapatinib|mesh-list
102252947|NCT02422199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102252948|NCT02422199|Antimetabolites|antimetabolites|mesh-ancestor
102252949|NCT02422199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252951|NCT02422199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102252952|NCT02422199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102252953|NCT02416739|Niacinamide|niacinamide|mesh-list
102252954|NCT02416739|Niacin|niacin|mesh-list
102252955|NCT02416739|Nicotinic Acids|nicotinic acids|mesh-list
102252956|NCT02416739|Vitamin B Complex|vitamin b complex|mesh-ancestor
102252957|NCT02416739|Vitamins|vitamins|mesh-ancestor
102252958|NCT02416739|Micronutrients|micronutrients|mesh-ancestor
102252959|NCT02416739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252960|NCT02416739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102252961|NCT02416739|Antimetabolites|antimetabolites|mesh-ancestor
102252962|NCT02416739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252963|NCT02416739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102252964|NCT02416739|Vasodilator Agents|vasodilator agents|mesh-ancestor
102252965|NCT02416583|Oxytocin|oxytocin|mesh-list
102252966|NCT02416583|Dinoprostone|dinoprostone|mesh-list
102252967|NCT02416583|Oxytocics|oxytocics|mesh-ancestor
102252968|NCT02416583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102252969|NCT02416583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252970|NCT02416427|Atorvastatin|atorvastatin|mesh-list
102252971|NCT02416427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102252972|NCT02416427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102252973|NCT02416427|Antimetabolites|antimetabolites|mesh-ancestor
102252974|NCT02416427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102252975|NCT02416427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102252976|NCT02416427|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102252977|NCT02416427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102252978|NCT02416271|Vitamin D|vitamin d|mesh-list
102252979|NCT02416271|Alendronate|alendronate|mesh-list
102252980|NCT02416271|Teriparatide|teriparatide|mesh-list
102252981|NCT02416271|Calcium|calcium|mesh-list
102252982|NCT02416271|Vitamins|vitamins|mesh-ancestor
102252983|NCT02416271|Micronutrients|micronutrients|mesh-ancestor
102252984|NCT02416271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252985|NCT02416271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101734678|NCT02608931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101734680|NCT02608931|Analgesics|analgesics|mesh-ancestor
102252986|NCT02416271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102252987|NCT02416115|Morphine|morphine|mesh-list
102252988|NCT02416115|Ramosetron|ramosetron|mesh-list
102252989|NCT02416115|Naloxone|naloxone|mesh-list
102252990|NCT02416115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102252991|NCT02416115|Narcotics|narcotics|mesh-ancestor
102252992|NCT02416115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102252993|NCT02416115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102252994|NCT02416115|Analgesics|analgesics|mesh-ancestor
102252995|NCT02416115|Sensory System Agents|sensory system agents|mesh-ancestor
102252996|NCT02416115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102252997|NCT02416115|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102252998|NCT02416115|Antiemetics|antiemetics|mesh-ancestor
102252999|NCT02416115|Autonomic Agents|autonomic agents|mesh-ancestor
102253000|NCT02416115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102253001|NCT02416115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102253002|NCT02416115|Serotonin Agents|serotonin agents|mesh-ancestor
101734811|NCT00801632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102253003|NCT02416115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102253004|NCT02416115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253005|NCT02415881|Panitumumab|panitumumab|mesh-list
102253006|NCT02415881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102253007|NCT02415881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102253008|NCT02415803|Clopidogrel|clopidogrel|mesh-list
102253009|NCT02415803|Ticagrelor|ticagrelor|mesh-list
102253010|NCT02415803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102253011|NCT02415803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102613449|NCT05749289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102613450|NCT05749289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102253012|NCT02415803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102253013|NCT02415803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102253014|NCT02415803|Purinergic Agents|purinergic agents|mesh-ancestor
102253015|NCT02415803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102253016|NCT02415803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253017|NCT02415803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253018|NCT04482881|Isosorbide|isosorbide|mesh-list
102253019|NCT04482881|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
102253020|NCT04482881|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
102253021|NCT04482881|Misoprostol|misoprostol|mesh-list
102253022|NCT04482881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102253023|NCT04482881|Abortifacient Agents|abortifacient agents|mesh-ancestor
102253024|NCT04482881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101961911|NCT01067417|Hydroxychloroquine|hydroxychloroquine|mesh-list
102253025|NCT04482881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253027|NCT04482881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102253028|NCT04482881|Oxytocics|oxytocics|mesh-ancestor
102253029|NCT04482881|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102253030|NCT04482881|Diuretics|diuretics|mesh-ancestor
102253031|NCT04482881|Natriuretic Agents|natriuretic agents|mesh-ancestor
101734936|NCT00800540|Brinzolamide|brinzolamide|mesh-list
102253032|NCT04482881|Vasodilator Agents|vasodilator agents|mesh-ancestor
102253033|NCT04482881|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102253034|NCT04482881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253035|NCT03176693|Doxazosin|doxazosin|mesh-list
102253036|NCT03176693|Phenoxybenzamine|phenoxybenzamine|mesh-list
102253037|NCT03176693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102253038|NCT03176693|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102253039|NCT03176693|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102253040|NCT03176693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102253041|NCT03176693|Adrenergic Agents|adrenergic agents|mesh-ancestor
102253042|NCT03176693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102253043|NCT03176693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253044|NCT03176693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253045|NCT03176693|Vasodilator Agents|vasodilator agents|mesh-ancestor
102253046|NCT02415569|Bisacodyl|bisacodyl|mesh-list
102253047|NCT02415569|Cathartics|cathartics|mesh-ancestor
102253048|NCT02415569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102253049|NCT02415569|Laxatives|laxatives|mesh-ancestor
102253050|NCT02415335|Dexamethasone|dexamethasone|mesh-list
102253051|NCT02415335|Dexamethasone acetate|dexamethasone acetate|mesh-list
102253052|NCT02415335|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102253053|NCT02415335|BB 1101|bb 1101|mesh-list
102253054|NCT02415335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102253055|NCT02415335|Antiemetics|antiemetics|mesh-ancestor
102253056|NCT02415335|Autonomic Agents|autonomic agents|mesh-ancestor
102253057|NCT02415335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102253058|NCT02415335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735066|NCT04113668|Analgesics|analgesics|mesh-ancestor
102253059|NCT02415335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102253060|NCT02415335|Glucocorticoids|glucocorticoids|mesh-ancestor
102253061|NCT02415335|Hormones|hormones|mesh-ancestor
102253062|NCT02415335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102253063|NCT02415335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102253064|NCT02415335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101735127|NCT00724971|Rituximab|rituximab|mesh-list
102253065|NCT02415335|Protease Inhibitors|protease inhibitors|mesh-ancestor
102253066|NCT02415335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102253067|NCT02415335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253068|NCT02415257|Gentamicins|gentamicins|mesh-list
102253069|NCT02415257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102253070|NCT02415257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102253071|NCT02415257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102253072|NCT02415257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102253073|NCT02415257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253074|NCT02415179|Fluticasone|fluticasone|mesh-list
102253075|NCT02415179|Mometasone Furoate|mometasone furoate|mesh-list
102253076|NCT02415179|Formoterol Fumarate|formoterol fumarate|mesh-list
102253077|NCT02415179|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102253078|NCT02415179|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102253079|NCT02415179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102253080|NCT02415179|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102253081|NCT02415179|Autonomic Agents|autonomic agents|mesh-ancestor
102253082|NCT02415179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102253083|NCT02415179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253084|NCT02415179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102613451|NCT02972957|Azithromycin|azithromycin|mesh-list
102613452|NCT02972957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102253085|NCT02415179|Respiratory System Agents|respiratory system agents|mesh-ancestor
102253086|NCT02415179|Dermatologic Agents|dermatologic agents|mesh-ancestor
102253087|NCT02415179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102253088|NCT02415179|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102253089|NCT02415179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102253090|NCT02415179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102253091|NCT02415179|Adrenergic Agents|adrenergic agents|mesh-ancestor
102253092|NCT02415179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102253093|NCT02415179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253095|NCT02415179|Hormones|hormones|mesh-ancestor
101735321|NCT00791648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102253096|NCT02415179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102253097|NCT02415179|Sympathomimetics|sympathomimetics|mesh-ancestor
102253098|NCT02415023|Paclitaxel|paclitaxel|mesh-list
102253099|NCT02415023|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102253100|NCT02415023|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102253101|NCT02415023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102253102|NCT02415023|Tubulin Modulators|tubulin modulators|mesh-ancestor
102253103|NCT02415023|Antimitotic Agents|antimitotic agents|mesh-ancestor
102253104|NCT02415023|Mitosis Modulators|mitosis modulators|mesh-ancestor
102253105|NCT02415023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253107|NCT02414945|Fludarabine|fludarabine|mesh-list
102253108|NCT02414945|Interleukin-2|interleukin-2|mesh-list
102253109|NCT02414945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102253110|NCT02414945|Immunologic Factors|immunologic factors|mesh-ancestor
102253111|NCT02414945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253112|NCT02414945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102253113|NCT02414945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102253114|NCT02414945|Alkylating Agents|alkylating agents|mesh-ancestor
102253115|NCT02414945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253116|NCT02414945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102253117|NCT02414945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102253118|NCT02414945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102253119|NCT02414945|Analgesics|analgesics|mesh-ancestor
102253120|NCT02414945|Sensory System Agents|sensory system agents|mesh-ancestor
102253121|NCT02414945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102253122|NCT02414555|Phenylephrine|phenylephrine|mesh-list
102253123|NCT02414555|Norepinephrine|norepinephrine|mesh-list
102253124|NCT02414555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
102253125|NCT02414555|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102253126|NCT02414555|Mydriatics|mydriatics|mesh-ancestor
102253127|NCT02414555|Autonomic Agents|autonomic agents|mesh-ancestor
102253128|NCT02414555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102253129|NCT02414555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253130|NCT02414555|Sympathomimetics|sympathomimetics|mesh-ancestor
102253131|NCT02414555|Nasal Decongestants|nasal decongestants|mesh-ancestor
102253132|NCT02414555|Respiratory System Agents|respiratory system agents|mesh-ancestor
102253133|NCT02414555|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102253134|NCT02414555|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102253135|NCT02414555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102253136|NCT02414555|Adrenergic Agents|adrenergic agents|mesh-ancestor
102253137|NCT02414555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102253138|NCT02414555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253139|NCT02414555|Protective Agents|protective agents|mesh-ancestor
102253140|NCT02414399|Azithromycin|azithromycin|mesh-list
102253141|NCT02414399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102253142|NCT02414399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102253143|NCT02046070|Dexamethasone|dexamethasone|mesh-list
102253144|NCT02046070|Cyclophosphamide|cyclophosphamide|mesh-list
102253145|NCT02046070|Ixazomib|ixazomib|mesh-list
102253146|NCT02046070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102253147|NCT02046070|Immunologic Factors|immunologic factors|mesh-ancestor
102253148|NCT02046070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253149|NCT02046070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102253150|NCT02046070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102253151|NCT02046070|Alkylating Agents|alkylating agents|mesh-ancestor
102253152|NCT02046070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253153|NCT02046070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102253154|NCT02046070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102253155|NCT02046070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102253156|NCT02046070|Antiemetics|antiemetics|mesh-ancestor
102253157|NCT02046070|Autonomic Agents|autonomic agents|mesh-ancestor
102253158|NCT02046070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102253159|NCT02046070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102253160|NCT02046070|Glucocorticoids|glucocorticoids|mesh-ancestor
102613453|NCT02972957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102613454|NCT05545319|Ritonavir|ritonavir|mesh-list
102253161|NCT02046070|Hormones|hormones|mesh-ancestor
102253162|NCT02046070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102253163|NCT02046070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102253164|NCT02046070|Protease Inhibitors|protease inhibitors|mesh-ancestor
102253165|NCT02046070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102253166|NCT01663857|Carboplatin|carboplatin|mesh-list
102253167|NCT01663857|Gemcitabine|gemcitabine|mesh-list
102253168|NCT01663857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102253169|NCT01663857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102253170|NCT01663857|Antimetabolites|antimetabolites|mesh-ancestor
102253171|NCT01663857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253172|NCT02414165|Flucytosine|flucytosine|mesh-list
102253173|NCT02414165|Bevacizumab|bevacizumab|mesh-list
102253174|NCT02414165|Temozolomide|temozolomide|mesh-list
102253175|NCT02414165|Lomustine|lomustine|mesh-list
102253176|NCT02414165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102253177|NCT02414165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102253178|NCT02414165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102253179|NCT02414165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102253180|NCT02414165|Growth Substances|growth substances|mesh-ancestor
102253181|NCT02414165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253182|NCT02414165|Growth Inhibitors|growth inhibitors|mesh-ancestor
101735692|NCT00727272|Antimalarials|antimalarials|mesh-ancestor
102253183|NCT02414165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102253184|NCT02414165|Alkylating Agents|alkylating agents|mesh-ancestor
102253185|NCT02414165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253186|NCT02414165|Antifungal Agents|antifungal agents|mesh-ancestor
102253187|NCT02414165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102253188|NCT02414165|Antimetabolites|antimetabolites|mesh-ancestor
102253189|NCT02094898|Ketamine|ketamine|mesh-list
102253190|NCT02094898|Analgesics|analgesics|mesh-ancestor
102253191|NCT02094898|Sensory System Agents|sensory system agents|mesh-ancestor
102253192|NCT02094898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102253193|NCT02094898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253194|NCT02094898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102253195|NCT02094898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102253196|NCT02094898|Anesthetics, General|anesthetics, general|mesh-ancestor
102253197|NCT02094898|Anesthetics|anesthetics|mesh-ancestor
102253198|NCT02094898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102253199|NCT02094898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102253200|NCT02094898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102253201|NCT02094898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101796174|NCT01019746|Propofol|propofol|mesh-list
102253202|NCT02094898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253203|NCT04887831|Carboplatin|carboplatin|mesh-list
102253204|NCT04887831|Gemcitabine|gemcitabine|mesh-list
102253205|NCT04887831|Avelumab|avelumab|mesh-list
102253206|NCT04887831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102253207|NCT04887831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102253208|NCT04887831|Antimetabolites|antimetabolites|mesh-ancestor
102253209|NCT04887831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253210|NCT04887831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102253211|NCT02414009|Leucovorin|leucovorin|mesh-list
102253212|NCT02414009|Fluorouracil|fluorouracil|mesh-list
102253213|NCT02414009|Capecitabine|capecitabine|mesh-list
102253214|NCT02414009|Irinotecan|irinotecan|mesh-list
102253215|NCT02414009|Temozolomide|temozolomide|mesh-list
102253216|NCT02414009|Antimetabolites|antimetabolites|mesh-ancestor
102253217|NCT02414009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253218|NCT02414009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102253219|NCT02414009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101796310|NCT00482170|Etanercept|etanercept|mesh-list
102253220|NCT02414009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102253221|NCT02414009|Immunologic Factors|immunologic factors|mesh-ancestor
102253222|NCT02414009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253223|NCT02414009|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102253224|NCT02414009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102253225|NCT02414009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102253226|NCT02414009|Antidotes|antidotes|mesh-ancestor
102253227|NCT02414009|Protective Agents|protective agents|mesh-ancestor
102253228|NCT02414009|Vitamin B Complex|vitamin b complex|mesh-ancestor
102253229|NCT02414009|Vitamins|vitamins|mesh-ancestor
102253230|NCT02414009|Micronutrients|micronutrients|mesh-ancestor
101796372|NCT01004601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102253231|NCT02414009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102253232|NCT02414009|Alkylating Agents|alkylating agents|mesh-ancestor
102253233|NCT02413853|Leucovorin|leucovorin|mesh-list
102253234|NCT02413853|Bevacizumab|bevacizumab|mesh-list
102253235|NCT02413853|Fluorouracil|fluorouracil|mesh-list
102253236|NCT02413853|Oxaliplatin|oxaliplatin|mesh-list
102253237|NCT02413853|Calcium|calcium|mesh-list
102253238|NCT02413853|Levoleucovorin|levoleucovorin|mesh-list
102253239|NCT02413853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102253240|NCT02413853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102253241|NCT02413853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102253242|NCT02413853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102253243|NCT02413853|Growth Substances|growth substances|mesh-ancestor
102253244|NCT02413853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253245|NCT02413853|Growth Inhibitors|growth inhibitors|mesh-ancestor
102253246|NCT02413853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102253247|NCT02413853|Antimetabolites|antimetabolites|mesh-ancestor
102253248|NCT02413853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253249|NCT02413853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101962143|NCT02169154|Diclofenac|diclofenac|mesh-list
102253250|NCT02413853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102253251|NCT02413853|Immunologic Factors|immunologic factors|mesh-ancestor
102253252|NCT02413853|Antidotes|antidotes|mesh-ancestor
102253253|NCT02413853|Protective Agents|protective agents|mesh-ancestor
102253254|NCT02413853|Vitamin B Complex|vitamin b complex|mesh-ancestor
102253255|NCT02413853|Vitamins|vitamins|mesh-ancestor
101796500|NCT00615056|Irinotecan|irinotecan|mesh-list
102253256|NCT02413853|Micronutrients|micronutrients|mesh-ancestor
102253257|NCT00704483|Ferric Compounds|ferric compounds|mesh-list
102253258|NCT00704483|Sevelamer|sevelamer|mesh-list
102253259|NCT00704483|Chelating Agents|chelating agents|mesh-ancestor
102253260|NCT00704483|Sequestering Agents|sequestering agents|mesh-ancestor
102253261|NCT00704483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253262|NCT00704483|Hematinics|hematinics|mesh-ancestor
102253263|NCT04596189|Mometasone Furoate|mometasone furoate|mesh-list
102253264|NCT04596189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102253265|NCT04596189|Dermatologic Agents|dermatologic agents|mesh-ancestor
102253266|NCT04596189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102253267|NCT03176537|Testosterone|testosterone|mesh-list
102253268|NCT03176537|Androgens|androgens|mesh-ancestor
102253269|NCT03176537|Hormones|hormones|mesh-ancestor
102253270|NCT03176537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102253271|NCT03176537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253272|NCT05511441|Aspirin|aspirin|mesh-list
102253273|NCT05511441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102253274|NCT05511441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102253275|NCT05511441|Analgesics|analgesics|mesh-ancestor
102253276|NCT05511441|Sensory System Agents|sensory system agents|mesh-ancestor
102253277|NCT05511441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102253278|NCT05511441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253279|NCT05511441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102253280|NCT05511441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102253281|NCT05511441|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102253282|NCT05511441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102253283|NCT05511441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253284|NCT05511441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102253285|NCT05511441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102253286|NCT05511441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102253287|NCT05511441|Antipyretics|antipyretics|mesh-ancestor
102253288|NCT05515731|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102253289|NCT05515731|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102253290|NCT02413541|Polymyxins|polymyxins|mesh-list
102253291|NCT02413541|Polymyxin B|polymyxin b|mesh-list
102253292|NCT02413541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102253293|NCT02413541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102253294|NCT02045836|Vaccines|vaccines|mesh-list
102253295|NCT02045836|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102253296|NCT02045836|Immunologic Factors|immunologic factors|mesh-ancestor
102253297|NCT02045836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253298|NCT02412917|Valacyclovir|valacyclovir|mesh-list
102253299|NCT02412917|Antiviral Agents|antiviral agents|mesh-ancestor
102253300|NCT02412917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102253301|NCT02412683|Oxaliplatin|oxaliplatin|mesh-list
102253302|NCT02412683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102253303|NCT02569437|Fluticasone|fluticasone|mesh-list
102253304|NCT02569437|Doxycycline|doxycycline|mesh-list
102253305|NCT02569437|Methylprednisolone|methylprednisolone|mesh-list
102253306|NCT02569437|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102613456|NCT05545319|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102253307|NCT02569437|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102253308|NCT02569437|Prednisolone|prednisolone|mesh-list
102253309|NCT02569437|Prednisolone acetate|prednisolone acetate|mesh-list
102253310|NCT02569437|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102613457|NCT05545319|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101796750|NCT01006863|Adrenergic Agents|adrenergic agents|mesh-ancestor
101796751|NCT01006863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101796752|NCT01006863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796753|NCT01006863|Protective Agents|protective agents|mesh-ancestor
101796754|NCT01006863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101796755|NCT03535727|Paclitaxel|paclitaxel|mesh-list
101796757|NCT03535727|Cisplatin|cisplatin|mesh-list
102613458|NCT05545319|Protease Inhibitors|protease inhibitors|mesh-ancestor
102253311|NCT02569437|Prednisolone phosphate|prednisolone phosphate|mesh-list
102253312|NCT02569437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102253313|NCT02569437|Antiemetics|antiemetics|mesh-ancestor
102253314|NCT02569437|Autonomic Agents|autonomic agents|mesh-ancestor
102253315|NCT02569437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102253316|NCT02569437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253317|NCT02569437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102253318|NCT02569437|Glucocorticoids|glucocorticoids|mesh-ancestor
102253319|NCT02569437|Hormones|hormones|mesh-ancestor
102253320|NCT02569437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102253321|NCT02569437|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102253322|NCT02569437|Protective Agents|protective agents|mesh-ancestor
102253323|NCT02569437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102253324|NCT02569437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102253325|NCT02569437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102253326|NCT02569437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102253327|NCT02569437|Antimalarials|antimalarials|mesh-ancestor
102253328|NCT02569437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102253329|NCT02569437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102253330|NCT02569437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102253331|NCT02569437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102253332|NCT02569437|Respiratory System Agents|respiratory system agents|mesh-ancestor
102253333|NCT02569437|Dermatologic Agents|dermatologic agents|mesh-ancestor
102253334|NCT02569437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102253335|NCT02412449|Glycine|glycine|mesh-list
102253336|NCT02412449|Glycine Agents|glycine agents|mesh-ancestor
102253337|NCT02412449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102253338|NCT02412449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253339|NCT02412449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253340|NCT02412059|Prednisolone|prednisolone|mesh-list
102253341|NCT02412059|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101796954|NCT02758847|Paclitaxel|paclitaxel|mesh-list
102253342|NCT02412059|Methylprednisolone|methylprednisolone|mesh-list
102253343|NCT02412059|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102253344|NCT02412059|Prednisolone acetate|prednisolone acetate|mesh-list
102253345|NCT02412059|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102253346|NCT02412059|Prednisolone phosphate|prednisolone phosphate|mesh-list
102253347|NCT02412059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102253348|NCT02412059|Glucocorticoids|glucocorticoids|mesh-ancestor
102253349|NCT02412059|Hormones|hormones|mesh-ancestor
102253350|NCT02412059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102253351|NCT02412059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253352|NCT02412059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102253353|NCT02412059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102253354|NCT02412059|Antiemetics|antiemetics|mesh-ancestor
102253355|NCT02412059|Autonomic Agents|autonomic agents|mesh-ancestor
102253356|NCT02412059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102253357|NCT02412059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102253358|NCT02412059|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102253359|NCT02412059|Protective Agents|protective agents|mesh-ancestor
102253360|NCT03175679|Interleukin-2|interleukin-2|mesh-list
102253361|NCT03175679|Tegafur|tegafur|mesh-list
102253362|NCT03175679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102253363|NCT03175679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102253364|NCT03175679|Analgesics|analgesics|mesh-ancestor
102253365|NCT03175679|Sensory System Agents|sensory system agents|mesh-ancestor
102253366|NCT03175679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102253367|NCT03175679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253368|NCT03175679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102253369|NCT03175679|Antimetabolites|antimetabolites|mesh-ancestor
102253370|NCT03175679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253371|NCT05520645|Propofol|propofol|mesh-list
102253372|NCT05520645|Etomidate|etomidate|mesh-list
102253373|NCT05520645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102253374|NCT05520645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102253375|NCT05520645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253376|NCT05520645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102253377|NCT05520645|Anesthetics, General|anesthetics, general|mesh-ancestor
102253378|NCT05520645|Anesthetics|anesthetics|mesh-ancestor
102253379|NCT03175835|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102253380|NCT03175835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102253381|NCT03175835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102253382|NCT03175835|Antimetabolites|antimetabolites|mesh-ancestor
102253383|NCT03175835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253384|NCT03175835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102613459|NCT05545319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102253385|NCT03175835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102253386|NCT03175835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102253387|NCT05515185|Cyclophosphamide|cyclophosphamide|mesh-list
102253388|NCT05515185|Fludarabine|fludarabine|mesh-list
102253389|NCT05515185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102253390|NCT05515185|Immunologic Factors|immunologic factors|mesh-ancestor
102253391|NCT05515185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253392|NCT05515185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102253393|NCT05515185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102253394|NCT05515185|Alkylating Agents|alkylating agents|mesh-ancestor
102253395|NCT05515185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253396|NCT05515185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102253397|NCT05515185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102253398|NCT02044822|Rituximab|rituximab|mesh-list
102253399|NCT02044822|Idelalisib|idelalisib|mesh-list
102253400|NCT02044822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102253401|NCT02044822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102253402|NCT02044822|Immunologic Factors|immunologic factors|mesh-ancestor
102253403|NCT02044822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253404|NCT02044822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102253405|NCT02044822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102253406|NCT02044822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253407|NCT03116555|Irinotecan|irinotecan|mesh-list
102253408|NCT03116555|Apatinib|apatinib|mesh-list
102253409|NCT03116555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102253410|NCT03116555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102253411|NCT03116555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101797335|NCT00201643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102253412|NCT03116555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253413|NCT03116555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102253414|NCT03116555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102253415|NCT02044510|Mirabegron|mirabegron|mesh-list
102253416|NCT02044510|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102253417|NCT02044510|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102253418|NCT02044510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102253419|NCT02044510|Adrenergic Agents|adrenergic agents|mesh-ancestor
102253420|NCT02044510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102253421|NCT02044510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253422|NCT02044510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253423|NCT02044510|Urological Agents|urological agents|mesh-ancestor
102253424|NCT02411903|Clopidogrel|clopidogrel|mesh-list
102253425|NCT02411903|Atorvastatin|atorvastatin|mesh-list
102253426|NCT02411903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102253427|NCT02411903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102253428|NCT02411903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102253429|NCT02411903|Antimetabolites|antimetabolites|mesh-ancestor
102253430|NCT02411903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253431|NCT02411903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102253432|NCT02411903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102253433|NCT02411903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101797457|NCT00875030|Artesunate|artesunate|mesh-list
102253434|NCT02411903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102253435|NCT02411903|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102253436|NCT02411903|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102253437|NCT02411903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102253438|NCT02411903|Purinergic Agents|purinergic agents|mesh-ancestor
102253439|NCT02411903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102253440|NCT02411903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253441|NCT02411825|Metformin|metformin|mesh-list
102253442|NCT02411825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102253443|NCT02411825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253444|NCT05514405|Propofol|propofol|mesh-list
102253445|NCT05514405|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102253446|NCT05514405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102253447|NCT05514405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253448|NCT05514405|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102253449|NCT05514405|Anesthetics, General|anesthetics, general|mesh-ancestor
102253450|NCT05514405|Anesthetics|anesthetics|mesh-ancestor
102253451|NCT02410655|Oxytocin|oxytocin|mesh-list
102253452|NCT02410655|Oxytocics|oxytocics|mesh-ancestor
102253453|NCT02410655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102253454|NCT02410655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253455|NCT02410499|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102253456|NCT02410499|Immunologic Factors|immunologic factors|mesh-ancestor
102253457|NCT02410499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253458|NCT05510505|Antibodies|antibodies|mesh-list
102613460|NCT05545319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253459|NCT05510505|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102253460|NCT05510505|Immunologic Factors|immunologic factors|mesh-ancestor
102253461|NCT05510505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253462|NCT05514015|Cyclophosphamide|cyclophosphamide|mesh-list
102253463|NCT05514015|Rituximab|rituximab|mesh-list
102253464|NCT05514015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102253465|NCT05514015|Immunologic Factors|immunologic factors|mesh-ancestor
102253466|NCT05514015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253467|NCT05514015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102253468|NCT05514015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102253469|NCT05514015|Alkylating Agents|alkylating agents|mesh-ancestor
102253470|NCT05514015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253471|NCT05514015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102253472|NCT05514015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102253473|NCT05514015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102253474|NCT03174821|Insulin|insulin|mesh-list
102253475|NCT03174821|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102253476|NCT03174821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102253477|NCT03174821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253478|NCT05520021|Magnesium Sulfate|magnesium sulfate|mesh-list
101962359|NCT02170792|Ranitidine|ranitidine|mesh-list
102253479|NCT05520021|Nifedipine|nifedipine|mesh-list
102253480|NCT05520021|Analgesics|analgesics|mesh-ancestor
102253481|NCT05520021|Sensory System Agents|sensory system agents|mesh-ancestor
102253482|NCT05520021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102253483|NCT05520021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253484|NCT05520021|Anesthetics|anesthetics|mesh-ancestor
102253485|NCT05520021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102253486|NCT05520021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102253487|NCT05520021|Anticonvulsants|anticonvulsants|mesh-ancestor
102253488|NCT05520021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102253489|NCT05520021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102253490|NCT05520021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253491|NCT05520021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102253492|NCT05520021|Tocolytic Agents|tocolytic agents|mesh-ancestor
102253493|NCT05520021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102253494|NCT05520021|Vasodilator Agents|vasodilator agents|mesh-ancestor
102253495|NCT02410031|Cyproterone Acetate|cyproterone acetate|mesh-list
102253496|NCT02410031|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102253497|NCT02410031|Cyproterone|cyproterone|mesh-list
102253498|NCT02410031|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
102253499|NCT02410031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102253500|NCT02410031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102253501|NCT02410031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102253502|NCT02410031|Contraceptive Agents|contraceptive agents|mesh-ancestor
102253503|NCT02410031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102253504|NCT02410031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253505|NCT02410031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102253506|NCT02410031|Estrogens|estrogens|mesh-ancestor
102253507|NCT02410031|Hormones|hormones|mesh-ancestor
102253508|NCT02410031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102253509|NCT02410031|Androgen Antagonists|androgen antagonists|mesh-ancestor
102253510|NCT02410031|Hormone Antagonists|hormone antagonists|mesh-ancestor
102253511|NCT02410031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102253512|NCT02410031|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102253513|NCT05513625|Pritelivir|pritelivir|mesh-list
102253514|NCT05513625|Antiviral Agents|antiviral agents|mesh-ancestor
102253515|NCT05513625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102253516|NCT05513625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102253517|NCT05513625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253518|NCT02409641|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101797761|NCT00939588|Valsartan|valsartan|mesh-list
102253519|NCT02409641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102253520|NCT02067676|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102253521|NCT02067676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102253522|NCT02067676|Immunologic Factors|immunologic factors|mesh-ancestor
102253523|NCT02067676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253524|NCT02067676|Antacids|antacids|mesh-ancestor
102253525|NCT02067676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253526|NCT02067676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102253527|NCT02409407|Alprostadil|alprostadil|mesh-list
102253528|NCT02409407|Misoprostol|misoprostol|mesh-list
102613461|NCT05545319|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102253529|NCT02409407|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102253530|NCT02409407|Abortifacient Agents|abortifacient agents|mesh-ancestor
102253531|NCT02409407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102253532|NCT02409407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253533|NCT02409407|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102253534|NCT02409407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102253535|NCT02409407|Oxytocics|oxytocics|mesh-ancestor
102253536|NCT02409407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102253537|NCT02409407|Vasodilator Agents|vasodilator agents|mesh-ancestor
102253538|NCT02409407|Urological Agents|urological agents|mesh-ancestor
102253539|NCT02409563|Budesonide|budesonide|mesh-list
102253540|NCT02409563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101797873|NCT02543060|Fluorides|fluorides|mesh-list
102253541|NCT02409563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102253542|NCT02409563|Autonomic Agents|autonomic agents|mesh-ancestor
102253543|NCT02409563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102253544|NCT02409563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253545|NCT02409563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102253546|NCT02409563|Respiratory System Agents|respiratory system agents|mesh-ancestor
102253547|NCT02409563|Glucocorticoids|glucocorticoids|mesh-ancestor
102253548|NCT02409563|Hormones|hormones|mesh-ancestor
101797939|NCT00889694|Analgesics|analgesics|mesh-ancestor
101797946|NCT00529035|Interleukin-2|interleukin-2|mesh-list
102253549|NCT02409563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102253550|NCT05513313|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
102253551|NCT05513313|Antiviral Agents|antiviral agents|mesh-ancestor
102253552|NCT05513313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102253553|NCT02409017|Insulin|insulin|mesh-list
102253554|NCT02409017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102253555|NCT02409017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253556|NCT00702689|Imatinib Mesylate|imatinib mesylate|mesh-list
102253557|NCT00702689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102253558|NCT00702689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102253559|NCT00702689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102253560|NCT00702689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253561|NCT02065570|Adalimumab|adalimumab|mesh-list
102253562|NCT02065570|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102253563|NCT02065570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102253564|NCT02065570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102253565|NCT02408705|Acetaminophen|acetaminophen|mesh-list
102253566|NCT02408705|Liraglutide|liraglutide|mesh-list
102253567|NCT02408705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102253568|NCT02408705|Analgesics|analgesics|mesh-ancestor
102253569|NCT02408705|Sensory System Agents|sensory system agents|mesh-ancestor
102253570|NCT02408705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102253571|NCT02408705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253572|NCT02408705|Antipyretics|antipyretics|mesh-ancestor
102253573|NCT02408705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102253574|NCT02408705|Incretins|incretins|mesh-ancestor
102253575|NCT02408705|Hormones|hormones|mesh-ancestor
101798066|NCT04037774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102253576|NCT02408705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102253577|NCT05509569|Icatibant|icatibant|mesh-list
102253578|NCT05509569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102253579|NCT05509569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102253580|NCT05509569|Analgesics|analgesics|mesh-ancestor
102253581|NCT05509569|Sensory System Agents|sensory system agents|mesh-ancestor
102253582|NCT05509569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102253583|NCT05509569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253584|NCT05509569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102253585|NCT05509569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102253586|NCT05509569|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
102253587|NCT05509569|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
102253588|NCT05509569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253589|NCT05509569|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101798129|NCT00890630|Oxytocin|oxytocin|mesh-list
102253590|NCT05509569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102253591|NCT05509569|Immunologic Factors|immunologic factors|mesh-ancestor
102253592|NCT02408939|Hydrocortisone|hydrocortisone|mesh-list
102253593|NCT02408939|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102253594|NCT02408939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102253595|NCT05507697|Thioctic Acid|thioctic acid|mesh-list
102253596|NCT05507697|Antioxidants|antioxidants|mesh-ancestor
102253597|NCT05507697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253598|NCT05507697|Protective Agents|protective agents|mesh-ancestor
102253599|NCT05507697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253600|NCT05507697|Vitamin B Complex|vitamin b complex|mesh-ancestor
102253601|NCT05507697|Vitamins|vitamins|mesh-ancestor
102253602|NCT05507697|Micronutrients|micronutrients|mesh-ancestor
102613462|NCT05545319|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102253603|NCT04292223|Pimavanserin|pimavanserin|mesh-list
102253604|NCT04292223|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102613463|NCT05545319|Antiviral Agents|antiviral agents|mesh-ancestor
102613464|NCT05545319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102613465|NCT05545319|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101798189|NCT02542124|Growth Substances|growth substances|mesh-ancestor
102613466|NCT05545319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102613468|NCT05523869|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102253605|NCT04292223|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102253606|NCT04292223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102253607|NCT04292223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102253608|NCT04292223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102253609|NCT04292223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253610|NCT04292223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102253611|NCT04292223|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102253612|NCT04292223|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102253613|NCT04292223|Serotonin Agents|serotonin agents|mesh-ancestor
102253614|NCT04292223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102253615|NCT04292223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253616|NCT03116321|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102253617|NCT03116321|Anticonvulsants|anticonvulsants|mesh-ancestor
102253618|NCT03116321|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102253619|NCT03116321|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102253620|NCT03116321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102253621|NCT03116321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253622|NCT03174041|Itraconazole|itraconazole|mesh-list
102253623|NCT03174041|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
102253624|NCT03174041|Midazolam|midazolam|mesh-list
102253625|NCT03174041|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102253626|NCT03174041|Simvastatin|simvastatin|mesh-list
102253627|NCT03174041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102253628|NCT03174041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102253629|NCT03174041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102253630|NCT03174041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253631|NCT03174041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102253632|NCT03174041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102253633|NCT03174041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102253634|NCT03174041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102253635|NCT03174041|Anesthetics, General|anesthetics, general|mesh-ancestor
102253636|NCT03174041|Anesthetics|anesthetics|mesh-ancestor
102253637|NCT03174041|GABA Modulators|gaba modulators|mesh-ancestor
102253638|NCT03174041|GABA Agents|gaba agents|mesh-ancestor
102253639|NCT03174041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102253640|NCT03174041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253641|NCT03174041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102253642|NCT03174041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102253643|NCT03174041|Antimetabolites|antimetabolites|mesh-ancestor
102253644|NCT03174041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102253645|NCT03174041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102253646|NCT03174041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102253647|NCT03174041|Antifungal Agents|antifungal agents|mesh-ancestor
102253648|NCT03174041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102253649|NCT03174041|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102253650|NCT03174041|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102253651|NCT03174041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102253652|NCT03174041|Hormone Antagonists|hormone antagonists|mesh-ancestor
102253653|NCT03174041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102253654|NCT03174041|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102253655|NCT02566005|Misoprostol|misoprostol|mesh-list
102253656|NCT02566005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102253657|NCT02566005|Abortifacient Agents|abortifacient agents|mesh-ancestor
102253658|NCT02566005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102253659|NCT02566005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253660|NCT02566005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102253661|NCT02566005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101798355|NCT00892112|Antibodies|antibodies|mesh-list
102253662|NCT02566005|Oxytocics|oxytocics|mesh-ancestor
102253663|NCT02408393|Ropivacaine|ropivacaine|mesh-list
102253664|NCT02408393|Anesthetics, Local|anesthetics, local|mesh-ancestor
102253665|NCT02408393|Anesthetics|anesthetics|mesh-ancestor
102253666|NCT02408393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102253667|NCT02408393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253668|NCT02408393|Sensory System Agents|sensory system agents|mesh-ancestor
102253669|NCT02408393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102253670|NCT05041335|Heparin|heparin|mesh-list
102253671|NCT05041335|Anticoagulants|anticoagulants|mesh-ancestor
101901889|NCT01093638|Insulin|insulin|mesh-list
102253672|NCT05041335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102253673|NCT05041335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102253674|NCT05041335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253675|NCT03173963|Empagliflozin|empagliflozin|mesh-list
102253676|NCT03173963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102253677|NCT03173963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253678|NCT03173963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102253679|NCT03173963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253680|NCT05507229|Vaccines|vaccines|mesh-list
102253681|NCT05507229|Immunologic Factors|immunologic factors|mesh-ancestor
102253682|NCT05507229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253683|NCT03173417|Cyclophosphamide|cyclophosphamide|mesh-list
102253684|NCT03173417|Fludarabine|fludarabine|mesh-list
102253685|NCT03173417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102253686|NCT03173417|Immunologic Factors|immunologic factors|mesh-ancestor
102253687|NCT03173417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253688|NCT03173417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102253689|NCT03173417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102253690|NCT03173417|Alkylating Agents|alkylating agents|mesh-ancestor
102253691|NCT03173417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253692|NCT03173417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102253693|NCT03173417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102253694|NCT03173339|Remifentanil|remifentanil|mesh-list
102253695|NCT03173339|Sevoflurane|sevoflurane|mesh-list
102253696|NCT03173339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102253697|NCT03173339|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102253698|NCT03173339|Anesthetics, General|anesthetics, general|mesh-ancestor
102253699|NCT03173339|Anesthetics|anesthetics|mesh-ancestor
102253700|NCT03173339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101798470|NCT00892658|Sorafenib|sorafenib|mesh-list
102253701|NCT03173339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253702|NCT03173339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102253703|NCT03173339|Narcotics|narcotics|mesh-ancestor
102253704|NCT03173339|Analgesics|analgesics|mesh-ancestor
102253705|NCT03173339|Sensory System Agents|sensory system agents|mesh-ancestor
102253706|NCT03173339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102253707|NCT03172871|Aripiprazole|aripiprazole|mesh-list
102253708|NCT03172871|Antidepressive Agents|antidepressive agents|mesh-ancestor
102253709|NCT03172871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102253710|NCT03172871|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102253711|NCT03172871|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102253712|NCT03172871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102253713|NCT03172871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253714|NCT03172871|Dopamine Agonists|dopamine agonists|mesh-ancestor
102253715|NCT03172871|Dopamine Agents|dopamine agents|mesh-ancestor
102253716|NCT03172871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102253717|NCT03172871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253718|NCT03172871|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102253719|NCT03172871|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102253720|NCT03172871|Serotonin Agents|serotonin agents|mesh-ancestor
102253721|NCT03172871|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102253722|NCT03172871|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102253723|NCT03172871|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102253724|NCT03172871|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102253725|NCT02065336|Chlorpheniramine|chlorpheniramine|mesh-list
102253726|NCT02065336|Entecavir|entecavir|mesh-list
102253727|NCT02065336|Antiviral Agents|antiviral agents|mesh-ancestor
102253728|NCT02065336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102253729|NCT02065336|Antipruritics|antipruritics|mesh-ancestor
102253730|NCT02065336|Dermatologic Agents|dermatologic agents|mesh-ancestor
102253731|NCT02065336|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102253732|NCT02065336|Histamine Antagonists|histamine antagonists|mesh-ancestor
102253733|NCT02065336|Histamine Agents|histamine agents|mesh-ancestor
102253734|NCT02065336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102253735|NCT02065336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253736|NCT02065336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253737|NCT02065336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102253738|NCT02408003|Simendan|simendan|mesh-list
102253739|NCT02408003|Milrinone|milrinone|mesh-list
102253740|NCT02408003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102253741|NCT02408003|Vasodilator Agents|vasodilator agents|mesh-ancestor
102253742|NCT02408003|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102253743|NCT02408003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102253744|NCT02408003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102253745|NCT02408003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253746|NCT02408003|Protective Agents|protective agents|mesh-ancestor
102613469|NCT05523869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102613470|NCT05523869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102253747|NCT02408003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253748|NCT02408003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102253749|NCT05518929|Propofol|propofol|mesh-list
102253750|NCT05518929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102253751|NCT05518929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102253752|NCT05518929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253753|NCT05518929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102253754|NCT05518929|Anesthetics, General|anesthetics, general|mesh-ancestor
102253755|NCT05518929|Anesthetics|anesthetics|mesh-ancestor
102253756|NCT02406911|Ticagrelor|ticagrelor|mesh-list
102253757|NCT02406911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102253758|NCT02406911|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102253759|NCT02406911|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102253760|NCT02406911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102253761|NCT02406911|Purinergic Agents|purinergic agents|mesh-ancestor
102253762|NCT02406911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102253763|NCT02406911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253764|NCT02406911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253765|NCT03172793|Telavancin|telavancin|mesh-list
102253766|NCT03172793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102253767|NCT03172793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102253768|NCT03116087|Methyltestosterone|methyltestosterone|mesh-list
102253769|NCT03116087|Testosterone|testosterone|mesh-list
102253770|NCT03116087|Testosterone undecanoate|testosterone undecanoate|mesh-list
102253771|NCT03116087|Testosterone enanthate|testosterone enanthate|mesh-list
102253772|NCT03116087|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102253773|NCT03116087|Androgens|androgens|mesh-ancestor
102253774|NCT03116087|Hormones|hormones|mesh-ancestor
102253775|NCT03116087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102253776|NCT03116087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253777|NCT03116087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102253778|NCT03116087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101962663|NCT03536494|Mirabegron|mirabegron|mesh-list
102253779|NCT03116087|Anabolic Agents|anabolic agents|mesh-ancestor
102253780|NCT02701985|Petesicatib|petesicatib|mesh-list
102253781|NCT02701985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102253782|NCT02701985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253783|NCT02406521|Sorafenib|sorafenib|mesh-list
102253784|NCT02406521|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
102253785|NCT02406521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102253786|NCT02406521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102253787|NCT02406521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102253788|NCT02406521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253789|NCT02406287|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102253790|NCT02406287|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102253791|NCT02406053|Antioxidants|antioxidants|mesh-list
102253792|NCT02406053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253793|NCT02406053|Protective Agents|protective agents|mesh-ancestor
102253794|NCT02406053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253795|NCT02064166|Insulin|insulin|mesh-list
102253796|NCT02064166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102253797|NCT02064166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253798|NCT03171623|Globalagliatin|globalagliatin|mesh-list
102253799|NCT03171623|Enzyme Activators|enzyme activators|mesh-ancestor
102253800|NCT03171623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253801|NCT03171389|Ponatinib|ponatinib|mesh-list
102253802|NCT03171389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102253803|NCT03171389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102253804|NCT03171389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102253805|NCT03171389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253806|NCT05508633|Mebeverine|mebeverine|mesh-list
102253807|NCT05508633|Alverine|alverine|mesh-list
102253808|NCT05508633|Parasympatholytics|parasympatholytics|mesh-ancestor
102253809|NCT05508633|Autonomic Agents|autonomic agents|mesh-ancestor
102253810|NCT05508633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102253811|NCT05508633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253812|NCT05508633|Anticonvulsants|anticonvulsants|mesh-ancestor
102253813|NCT04482257|Irinotecan|irinotecan|mesh-list
102253814|NCT04482257|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102253815|NCT04482257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102253816|NCT04482257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102253817|NCT04482257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253818|NCT04482257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613471|NCT05523869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253819|NCT05502705|Lidocaine|lidocaine|mesh-list
102253820|NCT05502705|Anesthetics, Local|anesthetics, local|mesh-ancestor
102253821|NCT05502705|Anesthetics|anesthetics|mesh-ancestor
102253822|NCT05502705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102253823|NCT05502705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253824|NCT05502705|Sensory System Agents|sensory system agents|mesh-ancestor
102253825|NCT05502705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102253826|NCT05502705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102253827|NCT05502705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102253828|NCT05502705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102253829|NCT05502705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102253830|NCT05502705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253831|NCT05506137|Pilocarpine|pilocarpine|mesh-list
102253832|NCT05506137|Miotics|miotics|mesh-ancestor
102253833|NCT05506137|Autonomic Agents|autonomic agents|mesh-ancestor
102253834|NCT05506137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102253835|NCT05506137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253836|NCT05506137|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102253837|NCT05506137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102253838|NCT05506137|Cholinergic Agents|cholinergic agents|mesh-ancestor
102253839|NCT05506137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102253840|NCT05506137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253841|NCT04742283|Timolol|timolol|mesh-list
102253842|NCT04742283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102253843|NCT04742283|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102253844|NCT04742283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253845|NCT04742283|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102253846|NCT04742283|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102253847|NCT04742283|Adrenergic Agents|adrenergic agents|mesh-ancestor
102253848|NCT04742283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102253849|NCT04742283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253850|NCT04742283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102253851|NCT04742283|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102253852|NCT04289805|Letrozole|letrozole|mesh-list
102253853|NCT04289805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102253854|NCT04289805|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102253855|NCT04289805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102253856|NCT04289805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102253857|NCT04289805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253858|NCT04289805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102253859|NCT04289805|Hormone Antagonists|hormone antagonists|mesh-ancestor
102253860|NCT04289805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102253861|NCT04289805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253862|NCT05505591|Cangrelor|cangrelor|mesh-list
102253863|NCT05505591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102253864|NCT05505591|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102253865|NCT05505591|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102253866|NCT05505591|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102253867|NCT05505591|Purinergic Agents|purinergic agents|mesh-ancestor
102253868|NCT05505591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102253869|NCT05505591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253870|NCT05505591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253871|NCT05448807|Phentolamine|phentolamine|mesh-list
102253872|NCT05448807|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102253873|NCT05448807|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102253874|NCT05448807|Adrenergic Agents|adrenergic agents|mesh-ancestor
102253875|NCT05448807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102253876|NCT05448807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253877|NCT05448807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253878|NCT05448807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102253879|NCT01662999|Dapagliflozin|dapagliflozin|mesh-list
102253880|NCT01662999|Saxagliptin|saxagliptin|mesh-list
102253881|NCT01662999|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102253882|NCT01662999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253883|NCT01662999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102253884|NCT01662999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253885|NCT01662999|Incretins|incretins|mesh-ancestor
102253886|NCT01662999|Hormones|hormones|mesh-ancestor
102253887|NCT01662999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101901892|NCT01287962|Apatinib|apatinib|mesh-list
102613472|NCT05523869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102253888|NCT01662999|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102253889|NCT01662999|Protease Inhibitors|protease inhibitors|mesh-ancestor
102253890|NCT01662999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102253891|NCT05366283|Sargramostim|sargramostim|mesh-list
102253892|NCT05366283|Immunologic Factors|immunologic factors|mesh-ancestor
102253893|NCT05366283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253894|NCT02565381|Nicotine|nicotine|mesh-list
102253895|NCT02565381|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102253896|NCT02565381|Autonomic Agents|autonomic agents|mesh-ancestor
102253897|NCT02565381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102253898|NCT02565381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253899|NCT02565381|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102253900|NCT02565381|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102253901|NCT02565381|Cholinergic Agents|cholinergic agents|mesh-ancestor
102253902|NCT02565381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102253903|NCT02565381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253904|NCT02063854|Risedronic Acid|risedronic acid|mesh-list
102253905|NCT02063854|Etidronic Acid|etidronic acid|mesh-list
102253906|NCT02063854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102253907|NCT02063854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102253908|NCT02063854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253909|NCT02063854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102253910|NCT02063854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253911|NCT02063854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102253912|NCT02063698|Auranofin|auranofin|mesh-list
102253913|NCT02063698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102253914|NCT04701333|Cabergoline|cabergoline|mesh-list
102253915|NCT04701333|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102253916|NCT04701333|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102253917|NCT04701333|Dopamine Agonists|dopamine agonists|mesh-ancestor
102253918|NCT04701333|Dopamine Agents|dopamine agents|mesh-ancestor
102253919|NCT04701333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102253920|NCT04701333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253921|NCT04701333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253922|NCT04701034|Prednisolone|prednisolone|mesh-list
102253923|NCT04701034|Immunoglobulins|immunoglobulins|mesh-list
102253924|NCT04701034|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102253925|NCT04701034|Antibodies|antibodies|mesh-list
101962805|NCT02183428|Protease Inhibitors|protease inhibitors|mesh-ancestor
102253926|NCT04701034|gamma-Globulins|gamma-globulins|mesh-list
102253927|NCT04701034|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102253928|NCT04701034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102253929|NCT04701034|Glucocorticoids|glucocorticoids|mesh-ancestor
102253930|NCT04701034|Hormones|hormones|mesh-ancestor
102253931|NCT04701034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102253932|NCT04701034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253933|NCT04701034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102253934|NCT04701034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102253935|NCT04701034|Immunologic Factors|immunologic factors|mesh-ancestor
102253936|NCT01663623|Azathioprine|azathioprine|mesh-list
102253937|NCT01663623|Belimumab|belimumab|mesh-list
102253938|NCT01663623|Antimetabolites|antimetabolites|mesh-ancestor
102253939|NCT01663623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253940|NCT01663623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102253941|NCT01663623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102253942|NCT01663623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102253943|NCT01663623|Immunologic Factors|immunologic factors|mesh-ancestor
102253944|NCT01663623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253945|NCT01663623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102253946|NCT04582305|Bleomycin|bleomycin|mesh-list
102253947|NCT04582305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102253948|NCT04582305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102253949|NCT05504967|Dexamethasone|dexamethasone|mesh-list
102253950|NCT05504967|Ropivacaine|ropivacaine|mesh-list
102253951|NCT05504967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102253952|NCT05504967|Antiemetics|antiemetics|mesh-ancestor
102253953|NCT05504967|Autonomic Agents|autonomic agents|mesh-ancestor
102253954|NCT05504967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102253955|NCT05504967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253956|NCT05504967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102253957|NCT05504967|Glucocorticoids|glucocorticoids|mesh-ancestor
102253958|NCT05504967|Hormones|hormones|mesh-ancestor
102253959|NCT05504967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102253960|NCT05504967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102253961|NCT05504967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102253962|NCT05504967|Anesthetics, Local|anesthetics, local|mesh-ancestor
102613473|NCT05522465|Dexamethasone|dexamethasone|mesh-list
102253963|NCT05504967|Anesthetics|anesthetics|mesh-ancestor
102253964|NCT05504967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102253965|NCT05504967|Sensory System Agents|sensory system agents|mesh-ancestor
102253966|NCT02565147|Heparin|heparin|mesh-list
102253967|NCT02565147|Bivalirudin|bivalirudin|mesh-list
102253968|NCT02565147|Anticoagulants|anticoagulants|mesh-ancestor
102253969|NCT02565147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102253970|NCT02565147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102253971|NCT02565147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253972|NCT02565147|Antithrombins|antithrombins|mesh-ancestor
102253973|NCT02565147|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102253974|NCT02565147|Protease Inhibitors|protease inhibitors|mesh-ancestor
102253975|NCT02565147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102253976|NCT02061280|Fluticasone|fluticasone|mesh-list
102253977|NCT02061280|Xhance|xhance|mesh-list
102253978|NCT02061280|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102253979|NCT02061280|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102253980|NCT02061280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102253981|NCT02061280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102253982|NCT02061280|Autonomic Agents|autonomic agents|mesh-ancestor
102253983|NCT02061280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102253984|NCT02061280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102253985|NCT02061280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102253986|NCT02061280|Respiratory System Agents|respiratory system agents|mesh-ancestor
102253987|NCT02061280|Dermatologic Agents|dermatologic agents|mesh-ancestor
102253988|NCT02061280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102253989|NCT02061280|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102253990|NCT02061280|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102253991|NCT02061280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102253992|NCT02061280|Adrenergic Agents|adrenergic agents|mesh-ancestor
102253993|NCT02061280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102253994|NCT02061280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102253995|NCT02061280|Glucocorticoids|glucocorticoids|mesh-ancestor
102253996|NCT02061280|Hormones|hormones|mesh-ancestor
102253997|NCT02061280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102253998|NCT02061280|Sympathomimetics|sympathomimetics|mesh-ancestor
102253999|NCT02061202|Mometasone Furoate|mometasone furoate|mesh-list
102254000|NCT02061202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102254001|NCT02061202|Dermatologic Agents|dermatologic agents|mesh-ancestor
102254002|NCT02061202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102254003|NCT04664361|Niacinamide|niacinamide|mesh-list
102254005|NCT04664361|Nicotinic Acids|nicotinic acids|mesh-list
102254006|NCT04664361|Vitamin B Complex|vitamin b complex|mesh-ancestor
102254007|NCT04664361|Vitamins|vitamins|mesh-ancestor
102254008|NCT04664361|Micronutrients|micronutrients|mesh-ancestor
102254009|NCT04664361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254010|NCT04664361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102254011|NCT04664361|Antimetabolites|antimetabolites|mesh-ancestor
102254012|NCT04664361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254013|NCT04664361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102254014|NCT04664361|Vasodilator Agents|vasodilator agents|mesh-ancestor
102254015|NCT04698850|Ranibizumab|ranibizumab|mesh-list
102254016|NCT04698850|Aflibercept|aflibercept|mesh-list
102254017|NCT04698850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102254018|NCT04698850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102254019|NCT04698850|Growth Substances|growth substances|mesh-ancestor
102254020|NCT04698850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254021|NCT04698850|Growth Inhibitors|growth inhibitors|mesh-ancestor
102254022|NCT04698850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102254023|NCT04698226|Temazepam|temazepam|mesh-list
102254024|NCT04698226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102254025|NCT04698226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102254026|NCT04698226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254027|NCT04698226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102254028|NCT04698226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102254029|NCT04698226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102254030|NCT04698226|GABA Modulators|gaba modulators|mesh-ancestor
102254031|NCT04698226|GABA Agents|gaba agents|mesh-ancestor
102254032|NCT04698226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102254033|NCT04698226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254034|NCT05504577|Tranylcypromine|tranylcypromine|mesh-list
102254035|NCT05504577|Tranexamic Acid|tranexamic acid|mesh-list
102254036|NCT05504577|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102254037|NCT05504577|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102254038|NCT05504577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254039|NCT05504577|Hemostatics|hemostatics|mesh-ancestor
102254041|NCT05504577|Antidepressive Agents|antidepressive agents|mesh-ancestor
102254042|NCT05504577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102254043|NCT05504577|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102254044|NCT05504577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102254045|NCT05504577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102254046|NCT05504577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102254047|NCT05504577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102254048|NCT05504577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254049|NCT05016297|Hydroxychloroquine|hydroxychloroquine|mesh-list
102254050|NCT05016297|Antimalarials|antimalarials|mesh-ancestor
102254051|NCT05016297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102254052|NCT05016297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102254053|NCT05016297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102254054|NCT05016297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102254055|NCT05016297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254056|NCT05016297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102254057|NCT05504265|Flurbiprofen|flurbiprofen|mesh-list
102254058|NCT05504265|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
102254059|NCT05504265|Analgesics|analgesics|mesh-ancestor
102254060|NCT05504265|Sensory System Agents|sensory system agents|mesh-ancestor
102254061|NCT05504265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102254062|NCT05504265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254063|NCT05504265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102254064|NCT05504265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102254065|NCT05504265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102254066|NCT05504265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102254067|NCT05504265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102254068|NCT05504265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102254069|NCT05504265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254070|NCT01625338|Sofosbuvir|sofosbuvir|mesh-list
102254071|NCT01625338|Antiviral Agents|antiviral agents|mesh-ancestor
102254072|NCT01625338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102254073|NCT04740099|Naloxone|naloxone|mesh-list
102254074|NCT04740099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102254075|NCT04740099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254076|NCT04740099|Sensory System Agents|sensory system agents|mesh-ancestor
101962957|NCT02184364|Estrogens|estrogens|mesh-ancestor
102254077|NCT04740099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102254078|NCT02560389|Levodopa|levodopa|mesh-list
102254079|NCT02560389|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102254080|NCT02560389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102254081|NCT02560389|Dopamine Agents|dopamine agents|mesh-ancestor
102254082|NCT02560389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101798993|NCT00949962|Androgen Antagonists|androgen antagonists|mesh-list
102254083|NCT02560389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254084|NCT02560389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254085|NCT02564211|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102254086|NCT02564211|Ipragliflozin|ipragliflozin|mesh-list
102254087|NCT02564211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102254088|NCT02564211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254089|NCT02564211|Incretins|incretins|mesh-ancestor
102254090|NCT02564211|Hormones|hormones|mesh-ancestor
102254091|NCT02564211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102254092|NCT02564211|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102254093|NCT02564211|Protease Inhibitors|protease inhibitors|mesh-ancestor
102254094|NCT02564211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102254095|NCT02564211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254096|NCT02564211|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102254097|NCT04596579|Antibodies|antibodies|mesh-list
102254098|NCT04596579|Immunologic Factors|immunologic factors|mesh-ancestor
102254099|NCT04596579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254100|NCT04465383|Propofol|propofol|mesh-list
102254101|NCT04465383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102254102|NCT04465383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102254103|NCT04465383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254104|NCT04465383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102254105|NCT04465383|Anesthetics, General|anesthetics, general|mesh-ancestor
102254106|NCT04465383|Anesthetics|anesthetics|mesh-ancestor
102254107|NCT05500677|Lidocaine|lidocaine|mesh-list
102254108|NCT05500677|Fentanyl|fentanyl|mesh-list
102254109|NCT05500677|Tramadol|tramadol|mesh-list
102254110|NCT05500677|Anesthetics, Local|anesthetics, local|mesh-ancestor
102254111|NCT05500677|Anesthetics|anesthetics|mesh-ancestor
102613474|NCT05522465|Prednisone|prednisone|mesh-list
102254112|NCT05500677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102254113|NCT05500677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254115|NCT05500677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102254116|NCT05500677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102254117|NCT05500677|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102254118|NCT05500677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102254119|NCT05500677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102254120|NCT05500677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254121|NCT05500677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102254122|NCT05500677|Narcotics|narcotics|mesh-ancestor
102254123|NCT05500677|Analgesics|analgesics|mesh-ancestor
102254124|NCT05500677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102254125|NCT05500677|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102254126|NCT05500677|Anesthetics, General|anesthetics, general|mesh-ancestor
102254127|NCT02093026|Folic Acid|folic acid|mesh-list
102254128|NCT02093026|Methylprednisolone|methylprednisolone|mesh-list
102254129|NCT02093026|Rituximab|rituximab|mesh-list
102254130|NCT02093026|Methotrexate|methotrexate|mesh-list
101799095|NCT00520845|Celecoxib|celecoxib|mesh-list
102254131|NCT02093026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102254132|NCT02093026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102254133|NCT02093026|Immunologic Factors|immunologic factors|mesh-ancestor
102254134|NCT02093026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254135|NCT02093026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102254136|NCT02093026|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102254137|NCT02093026|Abortifacient Agents|abortifacient agents|mesh-ancestor
102254138|NCT02093026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102254139|NCT02093026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102254140|NCT02093026|Antimetabolites|antimetabolites|mesh-ancestor
102254141|NCT02093026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254142|NCT02093026|Dermatologic Agents|dermatologic agents|mesh-ancestor
102254143|NCT02093026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101799136|NCT00520767|BB 1101|bb 1101|mesh-list
102254144|NCT02093026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102254145|NCT02093026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102254146|NCT02093026|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102254147|NCT02093026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102254148|NCT02093026|Antiemetics|antiemetics|mesh-ancestor
102254149|NCT02093026|Autonomic Agents|autonomic agents|mesh-ancestor
102254150|NCT02093026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102254151|NCT02093026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102254152|NCT02093026|Glucocorticoids|glucocorticoids|mesh-ancestor
102254153|NCT02093026|Hormones|hormones|mesh-ancestor
102254154|NCT02093026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102254155|NCT02093026|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102254156|NCT02093026|Protective Agents|protective agents|mesh-ancestor
102254157|NCT02093026|Hematinics|hematinics|mesh-ancestor
102254158|NCT02093026|Vitamin B Complex|vitamin b complex|mesh-ancestor
102254160|NCT02093026|Micronutrients|micronutrients|mesh-ancestor
102254161|NCT04697602|Colchicine|colchicine|mesh-list
102254162|NCT04697602|Febuxostat|febuxostat|mesh-list
102254163|NCT04697602|Gout Suppressants|gout suppressants|mesh-ancestor
102254164|NCT04697602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102254165|NCT04697602|Tubulin Modulators|tubulin modulators|mesh-ancestor
102254166|NCT04697602|Antimitotic Agents|antimitotic agents|mesh-ancestor
102254167|NCT04697602|Mitosis Modulators|mitosis modulators|mesh-ancestor
102254168|NCT04697602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254169|NCT04697602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102254170|NCT02059174|Insulin Aspart|insulin aspart|mesh-list
102254171|NCT02059174|MK-1293|mk-1293|mesh-list
102254172|NCT02059174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102254173|NCT02059174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254174|NCT02059174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102254175|NCT02059174|Antimetabolites|antimetabolites|mesh-ancestor
102254176|NCT02059174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254177|NCT02059174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102254178|NCT04417582|Liraglutide|liraglutide|mesh-list
102254179|NCT04417582|Orlistat|orlistat|mesh-list
102254180|NCT04417582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102254181|NCT04417582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254182|NCT04417582|Incretins|incretins|mesh-ancestor
102254183|NCT04417582|Hormones|hormones|mesh-ancestor
102254184|NCT04417582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102254185|NCT04417582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102254186|NCT04417582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254187|NCT04417582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102254188|NCT04417582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102254189|NCT02040766|Beclomethasone|beclomethasone|mesh-list
102254190|NCT02040766|Albuterol|albuterol|mesh-list
102254191|NCT02040766|Bronchodilator Agents|bronchodilator agents|mesh-list
102254192|NCT02040766|Autonomic Agents|autonomic agents|mesh-ancestor
102254193|NCT02040766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102254194|NCT02040766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254195|NCT02040766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102254196|NCT02040766|Respiratory System Agents|respiratory system agents|mesh-ancestor
102254197|NCT02040766|Tocolytic Agents|tocolytic agents|mesh-ancestor
102254198|NCT02040766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102254199|NCT02040766|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102254200|NCT02040766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102254201|NCT02040766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102254202|NCT02040766|Adrenergic Agents|adrenergic agents|mesh-ancestor
102254203|NCT02040766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102254204|NCT02040766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254205|NCT02040766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102254206|NCT02040766|Glucocorticoids|glucocorticoids|mesh-ancestor
102254208|NCT02040766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102254209|NCT02040532|Gabapentin|gabapentin|mesh-list
102254210|NCT02040532|Analgesics|analgesics|mesh-ancestor
102254211|NCT02040532|Sensory System Agents|sensory system agents|mesh-ancestor
102254212|NCT02040532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102254213|NCT02040532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254214|NCT02040532|Anticonvulsants|anticonvulsants|mesh-ancestor
102254215|NCT02040532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102254216|NCT02040532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102254217|NCT02040532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102254218|NCT02040532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102254219|NCT02040532|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102254220|NCT02040532|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102254221|NCT02040532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102254222|NCT02040532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254223|NCT02040532|Antimanic Agents|antimanic agents|mesh-ancestor
102254224|NCT02039908|Methylphenidate|methylphenidate|mesh-list
102254225|NCT02039908|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102254226|NCT02039908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254227|NCT02039908|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102254228|NCT02039908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102254229|NCT02039908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102254230|NCT02039908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254232|NCT02039908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102254233|NCT04417348|Tretinoin|tretinoin|mesh-list
102254234|NCT04417348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102254235|NCT04417348|Keratolytic Agents|keratolytic agents|mesh-ancestor
102254236|NCT04417348|Dermatologic Agents|dermatologic agents|mesh-ancestor
102254237|NCT02058940|Exenatide|exenatide|mesh-list
102254238|NCT02058940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102254239|NCT02058940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254240|NCT02058940|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102254241|NCT02058940|Incretins|incretins|mesh-ancestor
102254242|NCT02058940|Hormones|hormones|mesh-ancestor
102254243|NCT02058940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102254244|NCT02058628|Clindamycin|clindamycin|mesh-list
102254245|NCT02058628|Clindamycin palmitate|clindamycin palmitate|mesh-list
102254246|NCT02058628|Clindamycin phosphate|clindamycin phosphate|mesh-list
102254247|NCT02058628|Azelaic acid|azelaic acid|mesh-list
102254248|NCT02058628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102254249|NCT02058628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102254250|NCT02058628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102254251|NCT02058628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102254252|NCT02058628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254253|NCT02058628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102254254|NCT02058628|Dermatologic Agents|dermatologic agents|mesh-ancestor
102254255|NCT02058160|Insulin|insulin|mesh-list
102254256|NCT02058160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102254257|NCT02058160|Metformin|metformin|mesh-list
102254258|NCT02058160|Insulin Glargine|insulin glargine|mesh-list
102254259|NCT02058160|Lixisenatide|lixisenatide|mesh-list
102254260|NCT02058160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102254261|NCT02058160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254262|NCT02090764|Ozenoxacin|ozenoxacin|mesh-list
102254263|NCT02090764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102254264|NCT02090764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102254265|NCT02090764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102254266|NCT02090764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102254267|NCT02090764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254268|NCT02090764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102254269|NCT02088034|Metformin|metformin|mesh-list
102254270|NCT02088034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102254271|NCT02088034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254272|NCT02037256|Bortezomib|bortezomib|mesh-list
102254273|NCT02037256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102254274|NCT02035696|Vaccines|vaccines|mesh-list
102254275|NCT02035696|Immunologic Factors|immunologic factors|mesh-ancestor
102254276|NCT02035696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254277|NCT02057458|Sildenafil Citrate|sildenafil citrate|mesh-list
102254278|NCT02057458|Vasodilator Agents|vasodilator agents|mesh-ancestor
102254279|NCT02057458|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102254280|NCT02057458|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102254281|NCT02057458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102254282|NCT02057458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254283|NCT02057458|Urological Agents|urological agents|mesh-ancestor
102254284|NCT02087176|Antimitotic Agents|antimitotic agents|mesh-list
102254285|NCT02087176|Adavosertib|adavosertib|mesh-list
102254286|NCT02087176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102254287|NCT02087176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254288|NCT02087176|Mitosis Modulators|mitosis modulators|mesh-ancestor
102254289|NCT02087176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102254290|NCT02056288|Fentanyl|fentanyl|mesh-list
102254291|NCT02056288|Ropivacaine|ropivacaine|mesh-list
102254292|NCT02056288|Anesthetics, Local|anesthetics, local|mesh-ancestor
102254293|NCT02056288|Anesthetics|anesthetics|mesh-ancestor
102254294|NCT02056288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102254295|NCT02056288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254296|NCT02056288|Sensory System Agents|sensory system agents|mesh-ancestor
102254297|NCT02056288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102254298|NCT02056288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102254299|NCT02056288|Narcotics|narcotics|mesh-ancestor
102254300|NCT02056288|Analgesics|analgesics|mesh-ancestor
102254301|NCT02056288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101963176|NCT02190526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102254302|NCT02056288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102254303|NCT02056288|Anesthetics, General|anesthetics, general|mesh-ancestor
102254304|NCT03115697|Rifaximin|rifaximin|mesh-list
102254305|NCT03115697|Lactulose|lactulose|mesh-list
102254306|NCT03115697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102254307|NCT03115697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102254308|NCT03115697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102254309|NCT03115775|Vitamin D|vitamin d|mesh-list
102254310|NCT03115775|Ergocalciferols|ergocalciferols|mesh-list
102254311|NCT03115775|Cholecalciferol|cholecalciferol|mesh-list
102254312|NCT03115775|Vitamins|vitamins|mesh-list
102254313|NCT03115775|Micronutrients|micronutrients|mesh-ancestor
102254314|NCT03115775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254315|NCT03115775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102254316|NCT03115775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102254317|NCT02404259|Ritonavir|ritonavir|mesh-list
102254318|NCT02404259|Lopinavir|lopinavir|mesh-list
102254319|NCT02404259|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102254320|NCT02404259|Tenofovir|tenofovir|mesh-list
102254321|NCT02404259|Efavirenz|efavirenz|mesh-list
102254322|NCT02404259|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102254323|NCT02404259|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102254324|NCT02404259|Protease Inhibitors|protease inhibitors|mesh-ancestor
102254325|NCT02404259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102254326|NCT02404259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254327|NCT02404259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102254328|NCT02404259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102254329|NCT02404259|Antiviral Agents|antiviral agents|mesh-ancestor
102254330|NCT02404259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102254331|NCT02404259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102254332|NCT02404259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102254333|NCT02404259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102254334|NCT02404259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102254335|NCT02404259|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102254336|NCT02404259|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102254337|NCT02404259|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102254338|NCT02404259|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102254339|NCT02404259|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102254340|NCT03170687|Calpastatin|calpastatin|mesh-list
102254341|NCT03170687|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
102254342|NCT03170687|Protease Inhibitors|protease inhibitors|mesh-ancestor
102613475|NCT05522465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102254343|NCT03170687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102254344|NCT03170687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254345|NCT03169751|Caffeine|caffeine|mesh-list
101799556|NCT00183391|Dopamine Agents|dopamine agents|mesh-ancestor
102254346|NCT03169751|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102254347|NCT03169751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254348|NCT03169751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102254349|NCT03169751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102254350|NCT03169751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254351|NCT03169751|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102254352|NCT03169751|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102254353|NCT03169751|Purinergic Agents|purinergic agents|mesh-ancestor
102254354|NCT03169751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102254355|NCT02403713|Fluticasone|fluticasone|mesh-list
102254356|NCT02403713|Xhance|xhance|mesh-list
102254357|NCT02403713|Formoterol Fumarate|formoterol fumarate|mesh-list
102254358|NCT02403713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102254359|NCT02403713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102254360|NCT02403713|Autonomic Agents|autonomic agents|mesh-ancestor
102254361|NCT02403713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102254362|NCT02403713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254363|NCT02403713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102254364|NCT02403713|Respiratory System Agents|respiratory system agents|mesh-ancestor
102254365|NCT02403713|Dermatologic Agents|dermatologic agents|mesh-ancestor
102254366|NCT02403713|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102254367|NCT02403713|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102254368|NCT02403713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102254369|NCT02403713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102254370|NCT02403713|Adrenergic Agents|adrenergic agents|mesh-ancestor
102254371|NCT02403713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101799662|NCT00487240|Protamines|protamines|mesh-list
102254372|NCT02403713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254373|NCT02700815|Diclofenac|diclofenac|mesh-list
102254374|NCT02700815|Capsaicin|capsaicin|mesh-list
102254375|NCT02700815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102254376|NCT02700815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102254377|NCT02700815|Analgesics|analgesics|mesh-ancestor
102254378|NCT02700815|Sensory System Agents|sensory system agents|mesh-ancestor
102254379|NCT02700815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101963253|NCT02190994|Prednisone|prednisone|mesh-list
102254380|NCT02700815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254381|NCT02700815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102254382|NCT02700815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102254383|NCT02700815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102254384|NCT02700815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102254385|NCT02700815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254386|NCT02700815|Antipruritics|antipruritics|mesh-ancestor
102254387|NCT02700815|Dermatologic Agents|dermatologic agents|mesh-ancestor
102254388|NCT02403401|Levonorgestrel|levonorgestrel|mesh-list
101457082|NCT00559312|Hormones|hormones|mesh-ancestor
102254389|NCT02403401|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102254390|NCT02403401|Contraceptive Agents|contraceptive agents|mesh-ancestor
102254391|NCT02403401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102254392|NCT02403401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254393|NCT02403401|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102254394|NCT02403401|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102254395|NCT02403401|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102254396|NCT02402621|Fentanyl|fentanyl|mesh-list
102254397|NCT02402621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102254398|NCT02402621|Narcotics|narcotics|mesh-ancestor
102254399|NCT02402621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102254400|NCT02402621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254401|NCT02402621|Analgesics|analgesics|mesh-ancestor
102254402|NCT02402621|Sensory System Agents|sensory system agents|mesh-ancestor
102254403|NCT02402621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102254404|NCT02402621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102254405|NCT02402621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102254406|NCT02402621|Anesthetics, General|anesthetics, general|mesh-ancestor
102254407|NCT02402621|Anesthetics|anesthetics|mesh-ancestor
102254408|NCT04481789|Furosemide|furosemide|mesh-list
102254409|NCT04481789|Sildenafil Citrate|sildenafil citrate|mesh-list
102254410|NCT04481789|Edaravone|edaravone|mesh-list
102254411|NCT04481789|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102254412|NCT04481789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102254413|NCT04481789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102254414|NCT04481789|Antimetabolites|antimetabolites|mesh-ancestor
102254415|NCT04481789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613476|NCT05522465|Antiemetics|antiemetics|mesh-ancestor
102254416|NCT04481789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102254417|NCT04481789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102254418|NCT04481789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102254419|NCT04481789|Vasodilator Agents|vasodilator agents|mesh-ancestor
102254420|NCT04481789|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102254421|NCT04481789|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102254422|NCT04481789|Urological Agents|urological agents|mesh-ancestor
102254423|NCT04481789|Diuretics|diuretics|mesh-ancestor
102254424|NCT04481789|Natriuretic Agents|natriuretic agents|mesh-ancestor
102254425|NCT04481789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254426|NCT04481789|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102254427|NCT04481789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102254428|NCT04481789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102254429|NCT04481789|Antioxidants|antioxidants|mesh-ancestor
102254430|NCT04481789|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102254431|NCT04481789|Protective Agents|protective agents|mesh-ancestor
102254432|NCT02402465|Fluticasone|fluticasone|mesh-list
102254433|NCT02402465|Xhance|xhance|mesh-list
102254434|NCT02402465|Azelastine|azelastine|mesh-list
102254435|NCT02402465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102254436|NCT02402465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102254437|NCT02402465|Autonomic Agents|autonomic agents|mesh-ancestor
102254438|NCT02402465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101799901|NCT03987022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102254439|NCT02402465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254440|NCT02402465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102254441|NCT02402465|Respiratory System Agents|respiratory system agents|mesh-ancestor
102254442|NCT02402465|Dermatologic Agents|dermatologic agents|mesh-ancestor
102254443|NCT02402465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102254444|NCT02402465|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
102254445|NCT02402465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102254446|NCT02402465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254447|NCT02402465|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102254448|NCT02402465|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102254449|NCT02402465|Histamine Antagonists|histamine antagonists|mesh-ancestor
102254450|NCT02402465|Histamine Agents|histamine agents|mesh-ancestor
102254451|NCT02402465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102254452|NCT02402231|Omalizumab|omalizumab|mesh-list
102254453|NCT02402231|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102254454|NCT02402231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102254455|NCT02402231|Respiratory System Agents|respiratory system agents|mesh-ancestor
102254456|NCT02402543|Acetaminophen|acetaminophen|mesh-list
102254457|NCT02402543|Dexamethasone|dexamethasone|mesh-list
102254458|NCT02402543|Ketamine|ketamine|mesh-list
102254459|NCT02402543|Gabapentin|gabapentin|mesh-list
102254460|NCT02402543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102254461|NCT02402543|Antiemetics|antiemetics|mesh-ancestor
102254462|NCT02402543|Autonomic Agents|autonomic agents|mesh-ancestor
102254463|NCT02402543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102254464|NCT02402543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254465|NCT02402543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102254466|NCT02402543|Glucocorticoids|glucocorticoids|mesh-ancestor
102254467|NCT02402543|Hormones|hormones|mesh-ancestor
102254468|NCT02402543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102254469|NCT02402543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102254470|NCT02402543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102254471|NCT02402543|Analgesics|analgesics|mesh-ancestor
102254472|NCT02402543|Sensory System Agents|sensory system agents|mesh-ancestor
102254473|NCT02402543|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102254474|NCT02402543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102254475|NCT02402543|Anesthetics, General|anesthetics, general|mesh-ancestor
102254476|NCT02402543|Anesthetics|anesthetics|mesh-ancestor
102254477|NCT02402543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102254478|NCT02402543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102254479|NCT02402543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102254480|NCT02402543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102254481|NCT02402543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254482|NCT02402543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102254483|NCT02402543|Antipyretics|antipyretics|mesh-ancestor
102254484|NCT02402543|Anticonvulsants|anticonvulsants|mesh-ancestor
102254485|NCT02402543|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102254486|NCT02402543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102613478|NCT05522465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102254487|NCT02402543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102254488|NCT02402543|Antimanic Agents|antimanic agents|mesh-ancestor
102254489|NCT02401295|Itraconazole|itraconazole|mesh-list
102254491|NCT02401295|Tretinoin|tretinoin|mesh-list
102254492|NCT02401295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102254493|NCT02401295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102254494|NCT02401295|Analgesics|analgesics|mesh-ancestor
102254495|NCT02401295|Sensory System Agents|sensory system agents|mesh-ancestor
102254496|NCT02401295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102254497|NCT02401295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254498|NCT02401295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102254499|NCT02401295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102254500|NCT02401295|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102254501|NCT02401295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102254502|NCT02401295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102254503|NCT02401295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254504|NCT02401295|Antifungal Agents|antifungal agents|mesh-ancestor
102254505|NCT02401295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102254506|NCT02401295|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102254507|NCT02401295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102254508|NCT02401295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102254509|NCT02401295|Hormone Antagonists|hormone antagonists|mesh-ancestor
102254510|NCT02401295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102254511|NCT02401295|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102254512|NCT02401295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102254513|NCT02401295|Keratolytic Agents|keratolytic agents|mesh-ancestor
102254514|NCT02401295|Dermatologic Agents|dermatologic agents|mesh-ancestor
102254515|NCT00708305|Listerine|listerine|mesh-list
102254516|NCT00708305|Fluorides|fluorides|mesh-list
102254517|NCT00708305|Sodium Fluoride|sodium fluoride|mesh-list
102254518|NCT00708305|Cariostatic Agents|cariostatic agents|mesh-ancestor
102254519|NCT00708305|Protective Agents|protective agents|mesh-ancestor
102254520|NCT00708305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254521|NCT00708305|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102254522|NCT00708305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102254523|NCT03169127|Ibuprofen|ibuprofen|mesh-list
102254524|NCT03169127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102254525|NCT03169127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102254526|NCT03169127|Analgesics|analgesics|mesh-ancestor
102254527|NCT03169127|Sensory System Agents|sensory system agents|mesh-ancestor
102254528|NCT03169127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102254529|NCT03169127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254530|NCT03169127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102254531|NCT03169127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102254532|NCT03169127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102254533|NCT03169127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102254534|NCT03169127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254535|NCT03115307|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102254536|NCT03115307|Luteolytic Agents|luteolytic agents|mesh-ancestor
102254537|NCT03115307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102254538|NCT03115307|Contraceptive Agents|contraceptive agents|mesh-ancestor
102254539|NCT03115307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102254540|NCT03115307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800248|NCT00463606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102254541|NCT03115307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102254542|NCT03115307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102254543|NCT03115307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102254544|NCT02418533|Menotropins|menotropins|mesh-list
102254546|NCT02418533|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102254547|NCT02418533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102254548|NCT02418533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254549|NCT02418533|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102254550|NCT02418533|Fertility Agents|fertility agents|mesh-ancestor
102254551|NCT02418533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102254552|NCT02418065|Testosterone|testosterone|mesh-list
102254553|NCT02418065|Androgens|androgens|mesh-ancestor
102254554|NCT02418065|Hormones|hormones|mesh-ancestor
102254555|NCT02418065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102254556|NCT02418065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254557|NCT05058443|Denosumab|denosumab|mesh-list
102254558|NCT05058443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101800301|NCT01326559|Mitosis Modulators|mitosis modulators|mesh-ancestor
102254559|NCT05058443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254560|NCT02400281|Cytarabine|cytarabine|mesh-list
102254561|NCT02400281|Fludarabine|fludarabine|mesh-list
102254562|NCT02400281|Fludarabine phosphate|fludarabine phosphate|mesh-list
102254563|NCT02400281|Etoposide|etoposide|mesh-list
101596266|NCT00637403|Megestrol|megestrol|mesh-list
102254564|NCT02400281|Etoposide phosphate|etoposide phosphate|mesh-list
102254565|NCT02400281|Azacitidine|azacitidine|mesh-list
102254566|NCT02400281|Mitoxantrone|mitoxantrone|mesh-list
102254568|NCT02400281|Crenolanib|crenolanib|mesh-list
102254569|NCT02400281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102254570|NCT02400281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102254571|NCT02400281|Antimetabolites|antimetabolites|mesh-ancestor
102254572|NCT02400281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254573|NCT02400281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102254574|NCT02400281|Immunologic Factors|immunologic factors|mesh-ancestor
102254575|NCT02400281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254576|NCT02400281|Antiviral Agents|antiviral agents|mesh-ancestor
102254577|NCT02400281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102254578|NCT02400281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102254579|NCT02400281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102254580|NCT02400281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102254581|NCT02400281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102254582|NCT02400281|Analgesics|analgesics|mesh-ancestor
102254583|NCT02400281|Sensory System Agents|sensory system agents|mesh-ancestor
102254584|NCT02400281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102254585|NCT02400281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102254586|NCT02055976|Ezetimibe|ezetimibe|mesh-list
102254587|NCT02055976|Bococizumab|bococizumab|mesh-list
102254588|NCT02055976|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102254589|NCT02055976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102254590|NCT02055976|Antimetabolites|antimetabolites|mesh-ancestor
102254591|NCT02055976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254592|NCT02055976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102254593|NCT02055898|Sodium Oxybate|sodium oxybate|mesh-list
102254594|NCT02055898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102254595|NCT02055898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102254596|NCT02055898|Anesthetics, General|anesthetics, general|mesh-ancestor
102254597|NCT02055898|Anesthetics|anesthetics|mesh-ancestor
102254598|NCT02055898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102254599|NCT02055898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254600|NCT04406259|Verapamil|verapamil|mesh-list
102254601|NCT04406259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102254602|NCT04406259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102254603|NCT04406259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102254604|NCT04406259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254605|NCT04406259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102254606|NCT04406259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254607|NCT04406259|Vasodilator Agents|vasodilator agents|mesh-ancestor
102254608|NCT05498025|Charcoal|charcoal|mesh-list
102254609|NCT05498025|Antidotes|antidotes|mesh-ancestor
102254610|NCT05498025|Protective Agents|protective agents|mesh-ancestor
102254611|NCT05498025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254612|NCT03972111|Tecovirimat|tecovirimat|mesh-list
102254613|NCT03972111|Antiviral Agents|antiviral agents|mesh-ancestor
102254614|NCT03972111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102254615|NCT02699099|Vitamin A|vitamin a|mesh-list
102254616|NCT02699099|Vaccines|vaccines|mesh-list
102254617|NCT02699099|Immunologic Factors|immunologic factors|mesh-ancestor
102254618|NCT02699099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254619|NCT02699099|Vitamins|vitamins|mesh-ancestor
102254620|NCT02699099|Micronutrients|micronutrients|mesh-ancestor
102254621|NCT02400047|Dexamethasone|dexamethasone|mesh-list
102254622|NCT02400047|Dexamethasone acetate|dexamethasone acetate|mesh-list
102254623|NCT02400047|Ketoprofen|ketoprofen|mesh-list
102254624|NCT02400047|BB 1101|bb 1101|mesh-list
102254625|NCT02400047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102254626|NCT02400047|Antiemetics|antiemetics|mesh-ancestor
102254627|NCT02400047|Autonomic Agents|autonomic agents|mesh-ancestor
102254628|NCT02400047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102254629|NCT02400047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254630|NCT02400047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102254631|NCT02400047|Glucocorticoids|glucocorticoids|mesh-ancestor
102254632|NCT02400047|Hormones|hormones|mesh-ancestor
102254633|NCT02400047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102254634|NCT02400047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102254635|NCT02400047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102254636|NCT02400047|Protease Inhibitors|protease inhibitors|mesh-ancestor
102254637|NCT02400047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102254638|NCT02400047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254639|NCT02400047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102254640|NCT02400047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102254642|NCT02400047|Sensory System Agents|sensory system agents|mesh-ancestor
102254643|NCT02400047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102254644|NCT02400047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102254645|NCT02698865|Hyaluronic Acid|hyaluronic acid|mesh-list
102254646|NCT02698865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102254647|NCT02698865|Immunologic Factors|immunologic factors|mesh-ancestor
101800505|NCT00956748|Antioxidants|antioxidants|mesh-ancestor
102254648|NCT02698865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254649|NCT02698865|Viscosupplements|viscosupplements|mesh-ancestor
102254650|NCT02698865|Protective Agents|protective agents|mesh-ancestor
102254651|NCT05499897|Anesthetics|anesthetics|mesh-list
102254652|NCT05499897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102254653|NCT05499897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254654|NCT02417207|Entecavir|entecavir|mesh-list
102254655|NCT02417207|Antiviral Agents|antiviral agents|mesh-ancestor
102254656|NCT02417207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102254657|NCT02698475|Ustekinumab|ustekinumab|mesh-list
102254658|NCT02698475|Dermatologic Agents|dermatologic agents|mesh-ancestor
102254659|NCT02399657|Dexamethasone|dexamethasone|mesh-list
102254660|NCT02399657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102254661|NCT02399657|Antiemetics|antiemetics|mesh-ancestor
102254662|NCT02399657|Autonomic Agents|autonomic agents|mesh-ancestor
102254663|NCT02399657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101800644|NCT00718601|Imetelstat|imetelstat|mesh-list
102254664|NCT02399657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254665|NCT02399657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102254666|NCT02399657|Glucocorticoids|glucocorticoids|mesh-ancestor
102254667|NCT02399657|Hormones|hormones|mesh-ancestor
102254668|NCT02399657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102254669|NCT02399657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102254670|NCT02399657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102254671|NCT02559687|Pembrolizumab|pembrolizumab|mesh-list
102254672|NCT02559687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102254673|NCT02559687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102254674|NCT02559687|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102254675|NCT02559687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254676|NCT04278729|Apixaban|apixaban|mesh-list
102254677|NCT04278729|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102254678|NCT04278729|Antithrombins|antithrombins|mesh-ancestor
102254679|NCT04278729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102254680|NCT04278729|Protease Inhibitors|protease inhibitors|mesh-ancestor
101963558|NCT03535558|Azithromycin|azithromycin|mesh-list
102254681|NCT04278729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102254682|NCT04278729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254683|NCT04278729|Anticoagulants|anticoagulants|mesh-ancestor
102254685|NCT03177317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102254686|NCT03177317|Antiemetics|antiemetics|mesh-ancestor
102254687|NCT03177317|Autonomic Agents|autonomic agents|mesh-ancestor
102254688|NCT03177317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102254689|NCT03177317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254690|NCT03177317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102254691|NCT03177317|Glucocorticoids|glucocorticoids|mesh-ancestor
102254692|NCT03177317|Hormones|hormones|mesh-ancestor
102254693|NCT03177317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102254694|NCT03177317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102254695|NCT03177317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102254696|NCT03177239|Nivolumab|nivolumab|mesh-list
102254697|NCT03177239|Ipilimumab|ipilimumab|mesh-list
102254698|NCT03177239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102254699|NCT03177239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102254700|NCT03177239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102254701|NCT03177239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254702|NCT04480775|Methylprednisolone|methylprednisolone|mesh-list
102254703|NCT04480775|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102254704|NCT04480775|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102254705|NCT04480775|Prednisolone|prednisolone|mesh-list
102254706|NCT04480775|Prednisolone acetate|prednisolone acetate|mesh-list
102254707|NCT04480775|Triamcinolone|triamcinolone|mesh-list
102254708|NCT04480775|Bupivacaine|bupivacaine|mesh-list
102254709|NCT04480775|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102254710|NCT04480775|Prednisolone phosphate|prednisolone phosphate|mesh-list
102254711|NCT04480775|Anesthetics, Local|anesthetics, local|mesh-ancestor
102254712|NCT04480775|Anesthetics|anesthetics|mesh-ancestor
102254713|NCT04480775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102254714|NCT04480775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254715|NCT04480775|Sensory System Agents|sensory system agents|mesh-ancestor
102254716|NCT04480775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102613479|NCT05522465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613480|NCT05522465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102613481|NCT05522465|Glucocorticoids|glucocorticoids|mesh-ancestor
102613482|NCT05522465|Hormones|hormones|mesh-ancestor
102613483|NCT05522465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102613484|NCT05522465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102254717|NCT04480775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102254718|NCT04480775|Antiemetics|antiemetics|mesh-ancestor
102254719|NCT04480775|Autonomic Agents|autonomic agents|mesh-ancestor
102254720|NCT04480775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102254721|NCT04480775|Glucocorticoids|glucocorticoids|mesh-ancestor
102254722|NCT04480775|Hormones|hormones|mesh-ancestor
102254723|NCT04480775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102254724|NCT04480775|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102254725|NCT04480775|Protective Agents|protective agents|mesh-ancestor
102254726|NCT04480775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102254727|NCT04480775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102254728|NCT02416817|Thrombin|thrombin|mesh-list
102254729|NCT02416817|Hemostatics|hemostatics|mesh-ancestor
102254730|NCT02416817|Coagulants|coagulants|mesh-ancestor
102254731|NCT02399189|Methotrexate|methotrexate|mesh-list
102254732|NCT02399189|Temozolomide|temozolomide|mesh-list
102254733|NCT02399189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102254734|NCT02399189|Immunologic Factors|immunologic factors|mesh-ancestor
102254735|NCT02399189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254736|NCT02399189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102254737|NCT02399189|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102254738|NCT02399189|Abortifacient Agents|abortifacient agents|mesh-ancestor
102254739|NCT02399189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102254740|NCT02399189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102254741|NCT02399189|Antimetabolites|antimetabolites|mesh-ancestor
102254742|NCT02399189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254743|NCT02399189|Dermatologic Agents|dermatologic agents|mesh-ancestor
102254744|NCT02399189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102254745|NCT02399189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102254746|NCT02399189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102254747|NCT02399189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102254748|NCT02399189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102254749|NCT02399189|Alkylating Agents|alkylating agents|mesh-ancestor
102254750|NCT03176849|Vitamin D|vitamin d|mesh-list
102254751|NCT03176849|Ergocalciferols|ergocalciferols|mesh-list
102254752|NCT03176849|Cholecalciferol|cholecalciferol|mesh-list
102254753|NCT03176849|Vitamins|vitamins|mesh-list
102254754|NCT03176849|Micronutrients|micronutrients|mesh-ancestor
102254755|NCT03176849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254756|NCT03176849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102254757|NCT03176849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102254758|NCT03106571|Methamphetamine|methamphetamine|mesh-list
101801093|NCT00712049|Niacin|niacin|mesh-list
102254759|NCT03106571|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102254760|NCT03106571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254761|NCT03106571|Sympathomimetics|sympathomimetics|mesh-ancestor
102254762|NCT03106571|Autonomic Agents|autonomic agents|mesh-ancestor
102254763|NCT03106571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102254764|NCT03106571|Dopamine Agents|dopamine agents|mesh-ancestor
102254765|NCT03106571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102254766|NCT03106571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254767|NCT03106571|Adrenergic Agents|adrenergic agents|mesh-ancestor
102254768|NCT03106571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102254769|NCT03106571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102254770|NCT03106571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102254771|NCT03106571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102254772|NCT03177083|Interferons|interferons|mesh-list
102254773|NCT03177083|Interferon-beta|interferon-beta|mesh-list
101801145|NCT00712439|Gabapentin|gabapentin|mesh-list
102254774|NCT03177083|Interferon beta-1a|interferon beta-1a|mesh-list
102254775|NCT03177083|Interferon beta-1b|interferon beta-1b|mesh-list
102254776|NCT03177083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102254777|NCT03177083|Antiviral Agents|antiviral agents|mesh-ancestor
102254778|NCT03177083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102254779|NCT03177083|Immunologic Factors|immunologic factors|mesh-ancestor
102254780|NCT03177083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254781|NCT03177083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102254782|NCT03629925|Carboplatin|carboplatin|mesh-list
102254783|NCT03629925|Gemcitabine|gemcitabine|mesh-list
102254784|NCT03629925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101901902|NCT00058422|Vincristine|vincristine|mesh-list
102613485|NCT05522465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102254785|NCT03629925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102254786|NCT03629925|Antimetabolites|antimetabolites|mesh-ancestor
102254787|NCT03629925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254788|NCT02398487|Nicotine|nicotine|mesh-list
102254789|NCT02398487|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102254790|NCT02398487|Autonomic Agents|autonomic agents|mesh-ancestor
102254791|NCT02398487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102254792|NCT02398487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254793|NCT02398487|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102254794|NCT02398487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102254795|NCT02398487|Cholinergic Agents|cholinergic agents|mesh-ancestor
102254796|NCT02398487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102254797|NCT02398487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254798|NCT03250299|Lisavanbulin|lisavanbulin|mesh-list
102254799|NCT03250299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102254800|NCT03250299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254801|NCT03250299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102254802|NCT03250299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102254803|NCT02697617|Pioglitazone|pioglitazone|mesh-list
102254804|NCT02697617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102254805|NCT02697617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254806|NCT02396225|Voriconazole|voriconazole|mesh-list
102254807|NCT02396225|Antifungal Agents|antifungal agents|mesh-ancestor
102254808|NCT02396225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102254809|NCT02396225|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102254810|NCT02396225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102254811|NCT02396225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801322|NCT00167245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254812|NCT02396225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254813|NCT02396225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102254814|NCT02396225|Hormone Antagonists|hormone antagonists|mesh-ancestor
102254815|NCT02396225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102254816|NCT02396225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254817|NCT02396225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102254818|NCT04272801|Tamoxifen|tamoxifen|mesh-list
102254819|NCT04272801|Letrozole|letrozole|mesh-list
102254820|NCT04272801|Anastrozole|anastrozole|mesh-list
102254821|NCT04272801|Exemestane|exemestane|mesh-list
102254822|NCT04272801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102254823|NCT04272801|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102254824|NCT04272801|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102254825|NCT04272801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801391|NCT00451204|Estrogens|estrogens|mesh-list
102254826|NCT04272801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254827|NCT04272801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102254828|NCT04272801|Hormone Antagonists|hormone antagonists|mesh-ancestor
102254829|NCT04272801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102254830|NCT04272801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254831|NCT04272801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102254832|NCT04272801|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102254833|NCT04272801|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102254834|NCT04272801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102254835|NCT02396303|Carbetocin|carbetocin|mesh-list
102254836|NCT02396303|Oxytocics|oxytocics|mesh-ancestor
102254837|NCT02396303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102254838|NCT02396303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254839|NCT01918527|Capecitabine|capecitabine|mesh-list
102254840|NCT01918527|Oxaliplatin|oxaliplatin|mesh-list
102254841|NCT01918527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102254842|NCT01918527|Antimetabolites|antimetabolites|mesh-ancestor
102254843|NCT01918527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254844|NCT01918527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102254845|NCT02397863|Cannabidiol|cannabidiol|mesh-list
102254846|NCT02397863|Anticonvulsants|anticonvulsants|mesh-ancestor
102254847|NCT03168035|NC-4016|nc-4016|mesh-list
102254848|NCT03168035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102254849|NCT02397395|Simeprevir|simeprevir|mesh-list
102254850|NCT02397395|Antiviral Agents|antiviral agents|mesh-ancestor
102254851|NCT02397395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102254852|NCT02397395|Protease Inhibitors|protease inhibitors|mesh-ancestor
102254853|NCT02397395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102254854|NCT02397395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254855|NCT02397551|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102254856|NCT02397551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101901910|NCT00058422|Alkylating Agents|alkylating agents|mesh-ancestor
102613486|NCT05215691|Morphine|morphine|mesh-list
102613487|NCT05215691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102254857|NCT02397551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254858|NCT03168191|Menthol|menthol|mesh-list
102254859|NCT03168191|Nicotine|nicotine|mesh-list
102254860|NCT03168191|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102254861|NCT03168191|Autonomic Agents|autonomic agents|mesh-ancestor
102254862|NCT03168191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101801600|NCT00722579|Cobalt|cobalt|mesh-list
102254863|NCT03168191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254864|NCT03168191|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102254865|NCT03168191|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102254866|NCT03168191|Cholinergic Agents|cholinergic agents|mesh-ancestor
102254867|NCT03168191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102254868|NCT03168191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254869|NCT03168191|Antipruritics|antipruritics|mesh-ancestor
102254870|NCT03168191|Dermatologic Agents|dermatologic agents|mesh-ancestor
102254871|NCT05496075|Orlistat|orlistat|mesh-list
102254872|NCT05496075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102254873|NCT05496075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254874|NCT05496075|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102254875|NCT05496075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102254876|NCT04280055|Psilocybin|psilocybin|mesh-list
102254877|NCT04280055|Hallucinogens|hallucinogens|mesh-ancestor
102254878|NCT04280055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254879|NCT04280055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102254880|NCT05499117|Fluoxetine|fluoxetine|mesh-list
102254881|NCT05499117|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102254882|NCT05499117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102254883|NCT05499117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102254884|NCT05499117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254885|NCT05499117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102254886|NCT05499117|Serotonin Agents|serotonin agents|mesh-ancestor
102254887|NCT05499117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254888|NCT05499117|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101801750|NCT02571491|Narcotics|narcotics|mesh-ancestor
102254889|NCT05499117|Antidepressive Agents|antidepressive agents|mesh-ancestor
102254890|NCT05499117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102254891|NCT05499117|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102254892|NCT05499117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102254893|NCT05499117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102254894|NCT05498337|Calcium|calcium|mesh-list
102254895|NCT05498337|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102254896|NCT05498337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254897|NCT01663233|Amlodipine|amlodipine|mesh-list
102254898|NCT01663233|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102254899|NCT01663233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102254900|NCT01663233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102254901|NCT01663233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102254902|NCT01663233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254903|NCT01663233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102254904|NCT01663233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254905|NCT01663233|Vasodilator Agents|vasodilator agents|mesh-ancestor
101963778|NCT02201602|Gliclazide|gliclazide|mesh-list
102254906|NCT01663233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102254907|NCT05494281|Anesthetics|anesthetics|mesh-list
102254908|NCT05494281|Anesthetics, Local|anesthetics, local|mesh-list
102254909|NCT05494281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102254910|NCT05494281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254911|NCT05494281|Sensory System Agents|sensory system agents|mesh-ancestor
102254912|NCT05494281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102254913|NCT05494047|Vaccines|vaccines|mesh-list
102254914|NCT05494047|Immunologic Factors|immunologic factors|mesh-ancestor
102254915|NCT05494047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254916|NCT05493969|Lamivudine|lamivudine|mesh-list
102254917|NCT05493969|Dolutegravir|dolutegravir|mesh-list
102254918|NCT05493969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102254919|NCT05493969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102254920|NCT05493969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801894|NCT00450580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102254921|NCT05493969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254922|NCT05493969|Antiviral Agents|antiviral agents|mesh-ancestor
102254923|NCT05493969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102254924|NCT05493969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102254925|NCT05493969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102254926|NCT05493969|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102254927|NCT05493969|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102613488|NCT05215691|Narcotics|narcotics|mesh-ancestor
102613489|NCT05215691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102254928|NCT05493657|Aspirin|aspirin|mesh-list
102254929|NCT05493657|Clopidogrel|clopidogrel|mesh-list
102254930|NCT05493657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102254931|NCT05493657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102254932|NCT05493657|Analgesics|analgesics|mesh-ancestor
102254933|NCT05493657|Sensory System Agents|sensory system agents|mesh-ancestor
102254934|NCT05493657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102254935|NCT05493657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254936|NCT05493657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102254937|NCT05493657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101801973|NCT01078519|Anesthetics|anesthetics|mesh-list
102254938|NCT05493657|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102254939|NCT05493657|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102254940|NCT05493657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254941|NCT05493657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102254942|NCT05493657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102254943|NCT05493657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102254944|NCT05493657|Antipyretics|antipyretics|mesh-ancestor
102254945|NCT05493657|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102254946|NCT05493657|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102254947|NCT05493657|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102254948|NCT05493657|Purinergic Agents|purinergic agents|mesh-ancestor
102254949|NCT05493657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102254950|NCT05493267|Zoledronic Acid|zoledronic acid|mesh-list
102254951|NCT05493267|Interleukin-2|interleukin-2|mesh-list
102254952|NCT05493267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254953|NCT05493267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102254954|NCT05493267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102254955|NCT05493267|Analgesics|analgesics|mesh-ancestor
102254956|NCT05493267|Sensory System Agents|sensory system agents|mesh-ancestor
102254957|NCT05493267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102254958|NCT05493267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102254959|NCT05492565|Tenofovir|tenofovir|mesh-list
102254960|NCT05492565|Emtricitabine|emtricitabine|mesh-list
102254961|NCT05492565|Antiviral Agents|antiviral agents|mesh-ancestor
102254962|NCT05492565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102254963|NCT05492565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102254964|NCT05492565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102254965|NCT05492565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102254966|NCT05492565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102254967|NCT05492565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102254968|NCT05492565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102254969|NCT05492487|Megestrol Acetate|megestrol acetate|mesh-list
102254970|NCT05492487|Levonorgestrel|levonorgestrel|mesh-list
102254971|NCT05492487|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102254972|NCT05492487|Contraceptive Agents|contraceptive agents|mesh-ancestor
102254973|NCT05492487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102254974|NCT05492487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802146|NCT00907166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102254975|NCT05492487|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102254976|NCT05492487|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102254977|NCT05492487|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102254978|NCT05492487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102254979|NCT05492487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102254980|NCT05492487|Appetite Stimulants|appetite stimulants|mesh-ancestor
102254981|NCT05492487|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102254982|NCT05492019|Doxycycline|doxycycline|mesh-list
102254983|NCT05492019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102254984|NCT05492019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102254985|NCT05492019|Antimalarials|antimalarials|mesh-ancestor
102254986|NCT05492019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102254987|NCT05492019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102254988|NCT05491785|Oxycodone|oxycodone|mesh-list
102254989|NCT05491785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102254990|NCT05491785|Narcotics|narcotics|mesh-ancestor
101802215|NCT01028482|Sertraline|sertraline|mesh-list
102254991|NCT05491785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102254992|NCT05491785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102254993|NCT05491785|Analgesics|analgesics|mesh-ancestor
102254994|NCT05491785|Sensory System Agents|sensory system agents|mesh-ancestor
102254995|NCT05491785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102254996|NCT05484375|Capecitabine|capecitabine|mesh-list
102254997|NCT05484375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102254998|NCT05484375|Antimetabolites|antimetabolites|mesh-ancestor
102254999|NCT05484375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613490|NCT05215691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596707|NCT02753218|Midazolam|midazolam|mesh-list
102613491|NCT05215691|Analgesics|analgesics|mesh-ancestor
102255000|NCT05484375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102255001|NCT05480007|Metformin|metformin|mesh-list
102255002|NCT05480007|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102255003|NCT05480007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102255004|NCT05480007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255005|NCT05480007|Incretins|incretins|mesh-ancestor
102255006|NCT05480007|Hormones|hormones|mesh-ancestor
102255007|NCT05480007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102255008|NCT05480007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102255009|NCT05480007|Protease Inhibitors|protease inhibitors|mesh-ancestor
102255010|NCT05480007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101802278|NCT00449956|Timolol|timolol|mesh-list
102255011|NCT05480007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255012|NCT05489601|Oxycodone|oxycodone|mesh-list
102255013|NCT05489601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102255014|NCT05489601|Narcotics|narcotics|mesh-ancestor
102255015|NCT05489601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102255016|NCT05489601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255017|NCT05489601|Analgesics|analgesics|mesh-ancestor
102255018|NCT05489601|Sensory System Agents|sensory system agents|mesh-ancestor
102255019|NCT05489601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102255020|NCT04276155|Anticoagulants|anticoagulants|mesh-list
102255022|NCT05488899|Cadexomer iodine|cadexomer iodine|mesh-list
102255023|NCT05488899|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102255024|NCT05488899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102255025|NCT05488899|Trace Elements|trace elements|mesh-ancestor
102255026|NCT05488899|Micronutrients|micronutrients|mesh-ancestor
101802326|NCT00730067|Urological Agents|urological agents|mesh-ancestor
102255027|NCT05488899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255028|NCT05483439|Cyclophosphamide|cyclophosphamide|mesh-list
102255029|NCT05483439|Carboplatin|carboplatin|mesh-list
102255030|NCT05483439|Docetaxel|docetaxel|mesh-list
102255031|NCT05483439|Trastuzumab|trastuzumab|mesh-list
102255032|NCT05483439|Epirubicin|epirubicin|mesh-list
102255033|NCT05483439|Pertuzumab|pertuzumab|mesh-list
102255034|NCT05483439|Antibodies|antibodies|mesh-list
102255035|NCT05483439|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102255036|NCT05483439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102255037|NCT05483439|Immunologic Factors|immunologic factors|mesh-ancestor
102255038|NCT05483439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255039|NCT05483439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102255040|NCT05483439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102255041|NCT05483439|Alkylating Agents|alkylating agents|mesh-ancestor
102255042|NCT05483439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255043|NCT05483439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101802386|NCT00509067|Autonomic Agents|autonomic agents|mesh-ancestor
101802400|NCT00509067|Antimetabolites|antimetabolites|mesh-ancestor
102255044|NCT05483439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102255045|NCT05483439|Tubulin Modulators|tubulin modulators|mesh-ancestor
102255046|NCT05483439|Antimitotic Agents|antimitotic agents|mesh-ancestor
102255047|NCT05483439|Mitosis Modulators|mitosis modulators|mesh-ancestor
102255048|NCT05483439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102255049|NCT05483439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102255050|NCT05483439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101963928|NCT02204020|Azacitidine|azacitidine|mesh-list
102255051|NCT05483439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102255052|NCT05483439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102255053|NCT03748095|Tazobactam|tazobactam|mesh-list
102255054|NCT03748095|Piperacillin|piperacillin|mesh-list
101802467|NCT00909506|Metformin|metformin|mesh-list
102255055|NCT03748095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102255056|NCT03748095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102255057|NCT03748095|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102255058|NCT03748095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102255059|NCT03748095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255060|NCT04275375|Anesthetics|anesthetics|mesh-list
102255061|NCT04275375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102255062|NCT04275375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255063|NCT05488353|Disitamab vedotin|disitamab vedotin|mesh-list
102255064|NCT05488353|Immunoconjugates|immunoconjugates|mesh-ancestor
102255065|NCT05488353|Immunologic Factors|immunologic factors|mesh-ancestor
102255066|NCT05488353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255067|NCT04543071|Paclitaxel|paclitaxel|mesh-list
102255068|NCT04543071|Gemcitabine|gemcitabine|mesh-list
102255069|NCT04543071|Cemiplimab|cemiplimab|mesh-list
102255070|NCT04543071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102255071|NCT04543071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101802519|NCT00927524|Insulin|insulin|mesh-list
102255072|NCT04543071|Tubulin Modulators|tubulin modulators|mesh-ancestor
102255073|NCT04543071|Antimitotic Agents|antimitotic agents|mesh-ancestor
102613492|NCT05215691|Sensory System Agents|sensory system agents|mesh-ancestor
102255074|NCT04543071|Mitosis Modulators|mitosis modulators|mesh-ancestor
101901915|NCT00058422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102255075|NCT04543071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255076|NCT04543071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102255078|NCT04543071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102255079|NCT05487963|Tofacitinib|tofacitinib|mesh-list
102255080|NCT05487963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255081|NCT05487963|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102255082|NCT05487963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102255083|NCT05487963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102255084|NCT05487807|Nicotine|nicotine|mesh-list
102255085|NCT05487807|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102255086|NCT05487807|Autonomic Agents|autonomic agents|mesh-ancestor
102255087|NCT05487807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102255088|NCT05487807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255089|NCT05487807|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102255090|NCT05487807|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102255091|NCT05487807|Cholinergic Agents|cholinergic agents|mesh-ancestor
102255092|NCT05487807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102255093|NCT05487807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255094|NCT04274595|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102255095|NCT04274595|Antiviral Agents|antiviral agents|mesh-ancestor
102255096|NCT04274595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102255097|NCT05476731|Antifungal Agents|antifungal agents|mesh-list
102255098|NCT05476731|Clotrimazole|clotrimazole|mesh-list
102255099|NCT05476731|Miconazole|miconazole|mesh-list
102255100|NCT05476731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102255101|NCT05476731|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102255102|NCT05476731|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102255103|NCT05476731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102255104|NCT05476731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102255105|NCT05476731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255106|NCT05476731|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102255107|NCT05476731|Hormone Antagonists|hormone antagonists|mesh-ancestor
102255108|NCT05476731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102255109|NCT05476731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255110|NCT05476731|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102255111|NCT05476731|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102255112|NCT05482113|Bupivacaine|bupivacaine|mesh-list
102255113|NCT05482113|Anesthetics, Local|anesthetics, local|mesh-ancestor
102255114|NCT05482113|Anesthetics|anesthetics|mesh-ancestor
102255115|NCT05482113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102255116|NCT05482113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255117|NCT05482113|Sensory System Agents|sensory system agents|mesh-ancestor
102255118|NCT05482113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102255119|NCT05481957|Vortioxetine|vortioxetine|mesh-list
102255120|NCT05481957|Antidepressive Agents|antidepressive agents|mesh-ancestor
102255121|NCT05481957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102255122|NCT05481957|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101802713|NCT02538926|Cyclophosphamide|cyclophosphamide|mesh-list
102255123|NCT05481957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102255124|NCT05481957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102255125|NCT05481957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255126|NCT05481957|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102255127|NCT05481957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102255128|NCT05481957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102255129|NCT05481957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255130|NCT05481957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102255131|NCT05481957|Serotonin Agents|serotonin agents|mesh-ancestor
102255132|NCT05481957|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102255133|NCT05481957|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102255134|NCT05481957|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102255135|NCT05481957|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102255136|NCT05475561|Bupivacaine|bupivacaine|mesh-list
102255137|NCT05475561|Anesthetics, Local|anesthetics, local|mesh-ancestor
102255138|NCT05475561|Anesthetics|anesthetics|mesh-ancestor
102255139|NCT05475561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102255140|NCT05475561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255141|NCT05475561|Sensory System Agents|sensory system agents|mesh-ancestor
102255142|NCT05475561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102255143|NCT05476341|Bevacizumab|bevacizumab|mesh-list
102255144|NCT05476341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102613493|NCT05215691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102613494|NCT05204147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102613495|NCT05204147|Antibodies|antibodies|mesh-list
102255145|NCT05476341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102255146|NCT05476341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102255147|NCT05476341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102255148|NCT05476341|Growth Substances|growth substances|mesh-ancestor
102255149|NCT05476341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255150|NCT05476341|Growth Inhibitors|growth inhibitors|mesh-ancestor
102255151|NCT05481723|Norepinephrine|norepinephrine|mesh-list
102255152|NCT05481723|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102255153|NCT05481723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102255154|NCT05481723|Adrenergic Agents|adrenergic agents|mesh-ancestor
102255155|NCT05481723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101802839|NCT04629872|Immunologic Factors|immunologic factors|mesh-ancestor
102255156|NCT05481723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255157|NCT05481723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255158|NCT05481723|Sympathomimetics|sympathomimetics|mesh-ancestor
102255159|NCT05481723|Autonomic Agents|autonomic agents|mesh-ancestor
102255160|NCT05481723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102255161|NCT05481723|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102255162|NCT04272021|Methylphenidate|methylphenidate|mesh-list
102255163|NCT04272021|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102255164|NCT04272021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255165|NCT04272021|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102255166|NCT04272021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102255167|NCT04272021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102255168|NCT04272021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255169|NCT04272021|Dopamine Agents|dopamine agents|mesh-ancestor
102255170|NCT04272021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102255171|NCT02697773|Tanezumab|tanezumab|mesh-list
102255172|NCT02697773|Analgesics|analgesics|mesh-ancestor
102255173|NCT02697773|Sensory System Agents|sensory system agents|mesh-ancestor
102255174|NCT02697773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102255175|NCT02697773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255176|NCT02394821|Metronidazole|metronidazole|mesh-list
102255177|NCT02394821|Polihexanide|polihexanide|mesh-list
102255178|NCT02394821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102255179|NCT02394821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102255180|NCT02394821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102255181|NCT02394821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102255182|NCT02394821|Disinfectants|disinfectants|mesh-ancestor
102255183|NCT02394743|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102255184|NCT02394743|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102255185|NCT02394743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255186|NCT05745857|Bevacizumab|bevacizumab|mesh-list
102255187|NCT05745857|Cetuximab|cetuximab|mesh-list
102255188|NCT05745857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102255189|NCT05745857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102255190|NCT05745857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102255191|NCT05745857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102255192|NCT05745857|Growth Substances|growth substances|mesh-ancestor
102255193|NCT05745857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255194|NCT05745857|Growth Inhibitors|growth inhibitors|mesh-ancestor
102255195|NCT05745779|Vitamin D|vitamin d|mesh-list
102255196|NCT05745779|Vitamins|vitamins|mesh-list
102255197|NCT05745779|Vitamin B 12|vitamin b 12|mesh-list
102255198|NCT05745779|Hydroxocobalamin|hydroxocobalamin|mesh-list
102255199|NCT05745779|Micronutrients|micronutrients|mesh-ancestor
102255200|NCT05745779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255201|NCT05745779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102255202|NCT05745779|Vitamin B Complex|vitamin b complex|mesh-ancestor
102255203|NCT05745779|Hematinics|hematinics|mesh-ancestor
102255204|NCT02394197|Chloroquine|chloroquine|mesh-list
102255205|NCT02394197|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
101964131|NCT02205580|Dsuvia|dsuvia|mesh-list
102255206|NCT02394197|Primaquine|primaquine|mesh-list
102255207|NCT02394197|Amebicides|amebicides|mesh-ancestor
102255208|NCT02394197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102255209|NCT02394197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102255210|NCT02394197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102255211|NCT02394197|Antimalarials|antimalarials|mesh-ancestor
102255212|NCT02394197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102255213|NCT02394197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102255214|NCT02394197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102255215|NCT02394197|Analgesics|analgesics|mesh-ancestor
102255216|NCT02394197|Sensory System Agents|sensory system agents|mesh-ancestor
102255217|NCT02394197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102255218|NCT02394197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613496|NCT05204147|Immunoglobulins|immunoglobulins|mesh-list
102255219|NCT02394197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102255220|NCT02394197|Filaricides|filaricides|mesh-ancestor
102255221|NCT02394197|Antinematodal Agents|antinematodal agents|mesh-ancestor
102255222|NCT02394197|Anthelmintics|anthelmintics|mesh-ancestor
102255223|NCT02394119|Rituximab|rituximab|mesh-list
102255224|NCT02394119|Ofatumumab|ofatumumab|mesh-list
102255225|NCT02394119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102255226|NCT02394119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102255227|NCT02394119|Immunologic Factors|immunologic factors|mesh-ancestor
102255228|NCT02394119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255229|NCT02394119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102255230|NCT03167333|Hyaluronic Acid|hyaluronic acid|mesh-list
102255231|NCT03167333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102255232|NCT03167333|Immunologic Factors|immunologic factors|mesh-ancestor
102255233|NCT03167333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255234|NCT03167333|Viscosupplements|viscosupplements|mesh-ancestor
102255235|NCT03167333|Protective Agents|protective agents|mesh-ancestor
102255236|NCT02393963|Tranexamic Acid|tranexamic acid|mesh-list
102255237|NCT02393963|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102255238|NCT02393963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102255239|NCT02393963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255240|NCT02393963|Hemostatics|hemostatics|mesh-ancestor
102255241|NCT02393963|Coagulants|coagulants|mesh-ancestor
102255242|NCT03115619|Pirfenidone|pirfenidone|mesh-list
102255243|NCT03115619|Analgesics|analgesics|mesh-ancestor
102255244|NCT03115619|Sensory System Agents|sensory system agents|mesh-ancestor
102255245|NCT03115619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102255246|NCT03115619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255247|NCT03115619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102255248|NCT03115619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102255249|NCT03115619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102255250|NCT03115619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102255251|NCT03115619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102255252|NCT02393573|Metformin|metformin|mesh-list
102255253|NCT02393573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102255254|NCT02393573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255255|NCT05745467|Povidone-Iodine|povidone-iodine|mesh-list
102255256|NCT05745467|Povidone|povidone|mesh-list
102255257|NCT05745467|Plasma Substitutes|plasma substitutes|mesh-ancestor
102255258|NCT05745467|Blood Substitutes|blood substitutes|mesh-ancestor
102255259|NCT05745467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102255260|NCT05745467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102255261|NCT02393261|Dialysis Solutions|dialysis solutions|mesh-list
102255262|NCT02393261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102255263|NCT02693171|Dinutuximab|dinutuximab|mesh-list
102255264|NCT02693171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102255265|NCT02392793|Irinotecan|irinotecan|mesh-list
102255266|NCT02392793|Temozolomide|temozolomide|mesh-list
102255267|NCT02392793|Talazoparib|talazoparib|mesh-list
102255268|NCT02392793|Lenograstim|lenograstim|mesh-list
102255269|NCT02392793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102255270|NCT02392793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102255271|NCT02392793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102255272|NCT02392793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255273|NCT02392793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102255274|NCT02392793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102255275|NCT02392793|Immunologic Factors|immunologic factors|mesh-ancestor
102255276|NCT02392793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255277|NCT02392793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102255278|NCT02392793|Alkylating Agents|alkylating agents|mesh-ancestor
102255279|NCT02392793|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102255280|NCT03167177|Leucovorin|leucovorin|mesh-list
102255281|NCT03167177|Paclitaxel|paclitaxel|mesh-list
102255282|NCT03167177|Cyclophosphamide|cyclophosphamide|mesh-list
102255283|NCT03167177|Bevacizumab|bevacizumab|mesh-list
102255284|NCT03167177|Fluorouracil|fluorouracil|mesh-list
102255285|NCT03167177|Capecitabine|capecitabine|mesh-list
102255286|NCT03167177|Nivolumab|nivolumab|mesh-list
102255287|NCT03167177|Avelumab|avelumab|mesh-list
102255288|NCT03167177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102255289|NCT03167177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102255290|NCT03167177|Tubulin Modulators|tubulin modulators|mesh-ancestor
102255291|NCT03167177|Antimitotic Agents|antimitotic agents|mesh-ancestor
102255292|NCT03167177|Mitosis Modulators|mitosis modulators|mesh-ancestor
102255293|NCT03167177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255294|NCT03167177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102255295|NCT03167177|Immunologic Factors|immunologic factors|mesh-ancestor
102255296|NCT03167177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255297|NCT03167177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102613497|NCT05204147|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102255298|NCT03167177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102255299|NCT03167177|Alkylating Agents|alkylating agents|mesh-ancestor
102255300|NCT03167177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102255301|NCT03167177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102255302|NCT03167177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102255303|NCT03167177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102255304|NCT03167177|Growth Substances|growth substances|mesh-ancestor
102255305|NCT03167177|Growth Inhibitors|growth inhibitors|mesh-ancestor
102255306|NCT03167177|Antimetabolites|antimetabolites|mesh-ancestor
102255307|NCT03167177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102255308|NCT03167177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102255309|NCT03167177|Antidotes|antidotes|mesh-ancestor
102255310|NCT03167177|Protective Agents|protective agents|mesh-ancestor
102255311|NCT03167177|Vitamin B Complex|vitamin b complex|mesh-ancestor
102255312|NCT03167177|Vitamins|vitamins|mesh-ancestor
102255313|NCT03167177|Micronutrients|micronutrients|mesh-ancestor
102255314|NCT02392169|Methylphenidate|methylphenidate|mesh-list
102255315|NCT02392169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102255316|NCT02392169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255317|NCT02392169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102255318|NCT02392169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102255319|NCT02392169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102255320|NCT02392169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255321|NCT02392169|Dopamine Agents|dopamine agents|mesh-ancestor
102255322|NCT02392169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101803415|NCT01082809|Sunitinib|sunitinib|mesh-list
102255323|NCT03166865|Hyaluronic Acid|hyaluronic acid|mesh-list
102255324|NCT03166865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102255325|NCT03166865|Immunologic Factors|immunologic factors|mesh-ancestor
102255326|NCT03166865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255327|NCT03166865|Viscosupplements|viscosupplements|mesh-ancestor
102255328|NCT03166865|Protective Agents|protective agents|mesh-ancestor
102255329|NCT03166787|Tadalafil|tadalafil|mesh-list
102255330|NCT03166787|Charcoal|charcoal|mesh-list
102255331|NCT03166787|Carbon Monoxide|carbon monoxide|mesh-list
102255332|NCT03166787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255333|NCT03166787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255334|NCT03166787|Protective Agents|protective agents|mesh-ancestor
102255335|NCT03166787|Vasodilator Agents|vasodilator agents|mesh-ancestor
102255336|NCT03166787|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101803437|NCT01079065|Histamine Agents|histamine agents|mesh-ancestor
102255337|NCT03166787|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102255338|NCT03166787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102255339|NCT03166787|Urological Agents|urological agents|mesh-ancestor
102255340|NCT03166787|Antidotes|antidotes|mesh-ancestor
102255341|NCT03166787|Antimetabolites|antimetabolites|mesh-ancestor
102255342|NCT03166787|Gasotransmitters|gasotransmitters|mesh-ancestor
102255343|NCT03166787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102255344|NCT03166553|Oxaliplatin|oxaliplatin|mesh-list
102255345|NCT03166553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102255346|NCT03167957|Amphotericin B|amphotericin b|mesh-list
102255347|NCT03167957|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102255348|NCT03167957|Amebicides|amebicides|mesh-ancestor
102255349|NCT03167957|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102255350|NCT03167957|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102255351|NCT03167957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102255352|NCT03167957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102255353|NCT03167957|Antifungal Agents|antifungal agents|mesh-ancestor
102255354|NCT03166397|Cyclophosphamide|cyclophosphamide|mesh-list
102255355|NCT03166397|Nivolumab|nivolumab|mesh-list
102255356|NCT03166397|Fludarabine|fludarabine|mesh-list
102255357|NCT03166397|Ipilimumab|ipilimumab|mesh-list
102255358|NCT03166397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102255359|NCT03166397|Immunologic Factors|immunologic factors|mesh-ancestor
102255360|NCT03166397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255361|NCT03166397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102255362|NCT03166397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102255363|NCT03166397|Alkylating Agents|alkylating agents|mesh-ancestor
102255364|NCT03166397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255365|NCT03166397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102255366|NCT03166397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102255367|NCT03166397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101803638|NCT00567164|Diuretics|diuretics|mesh-ancestor
102255368|NCT03166397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102255369|NCT05745935|Oxytocin|oxytocin|mesh-list
102255370|NCT05745935|Oxytocics|oxytocics|mesh-ancestor
102613498|NCT05204147|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
102613499|NCT05204147|Immunologic Factors|immunologic factors|mesh-ancestor
102613500|NCT05204147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255371|NCT05745935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102255372|NCT05745935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255373|NCT02552121|Tisotumab vedotin|tisotumab vedotin|mesh-list
102255374|NCT02552121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102255375|NCT02552121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102255376|NCT02552355|Metformin|metformin|mesh-list
102255377|NCT02552355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102255378|NCT02552355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255379|NCT02551731|Cannabidiol|cannabidiol|mesh-list
102255380|NCT02551731|Anticonvulsants|anticonvulsants|mesh-ancestor
102255381|NCT04479657|Cefuroxime|cefuroxime|mesh-list
102255382|NCT04479657|Cefuroxime axetil|cefuroxime axetil|mesh-list
102255383|NCT04479657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102255384|NCT04479657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102255385|NCT05475873|Ondansetron|ondansetron|mesh-list
102255386|NCT05475873|Antiemetics|antiemetics|mesh-ancestor
102255387|NCT05475873|Autonomic Agents|autonomic agents|mesh-ancestor
102255388|NCT05475873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102255389|NCT05475873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255390|NCT05475873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102255391|NCT05475873|Antipruritics|antipruritics|mesh-ancestor
102255392|NCT05475873|Dermatologic Agents|dermatologic agents|mesh-ancestor
102255393|NCT05475873|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102255394|NCT05475873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102255395|NCT05475873|Serotonin Agents|serotonin agents|mesh-ancestor
102255396|NCT05475873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102255397|NCT05475873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255398|NCT05471661|PENTA|penta|mesh-list
102255399|NCT05471661|Anticoagulants|anticoagulants|mesh-ancestor
102255400|NCT05471661|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102255401|NCT05471661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102255402|NCT05471661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255403|NCT05480631|Mitogens|mitogens|mesh-list
102255404|NCT05480631|Mitosis Modulators|mitosis modulators|mesh-ancestor
102255405|NCT05480631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255406|NCT02542605|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
102255407|NCT02542605|Erenumab|erenumab|mesh-list
102255408|NCT02542605|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
102255409|NCT02542605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255410|NCT02542605|Analgesics|analgesics|mesh-ancestor
102255411|NCT02542605|Sensory System Agents|sensory system agents|mesh-ancestor
102255412|NCT02542605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102255413|NCT02542605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255414|NCT02542605|Growth Substances|growth substances|mesh-ancestor
102255415|NCT02542605|Vasodilator Agents|vasodilator agents|mesh-ancestor
102255416|NCT02542605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102255417|NCT03299049|Rilpivirine|rilpivirine|mesh-list
102255418|NCT03299049|Cabotegravir|cabotegravir|mesh-list
102255419|NCT03299049|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102255420|NCT03299049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102255421|NCT03299049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102255422|NCT03299049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255423|NCT03299049|Antiviral Agents|antiviral agents|mesh-ancestor
102255424|NCT03299049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102255425|NCT03299049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102255426|NCT03299049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102255427|NCT03299049|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102255428|NCT03299049|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102255429|NCT02550795|Dexamethasone|dexamethasone|mesh-list
102255430|NCT02550795|Dexmedetomidine|dexmedetomidine|mesh-list
102255431|NCT02550795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102255432|NCT02550795|Antiemetics|antiemetics|mesh-ancestor
102255433|NCT02550795|Autonomic Agents|autonomic agents|mesh-ancestor
102255434|NCT02550795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102255435|NCT02550795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255436|NCT02550795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102255437|NCT02550795|Glucocorticoids|glucocorticoids|mesh-ancestor
102255438|NCT02550795|Hormones|hormones|mesh-ancestor
102255439|NCT02550795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102255440|NCT02550795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102255441|NCT02550795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102255442|NCT02550795|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102255443|NCT02550795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102255444|NCT02550795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102613501|NCT05204147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102255446|NCT02550795|Sensory System Agents|sensory system agents|mesh-ancestor
102255447|NCT02550795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102255448|NCT02550795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102255449|NCT02550795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102255450|NCT02550795|Adrenergic Agents|adrenergic agents|mesh-ancestor
102255451|NCT02550795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102255452|NCT02550795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255453|NCT02541903|Afatinib|afatinib|mesh-list
102255454|NCT02541903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102255455|NCT02541903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102255456|NCT02541903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101804003|NCT00933374|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102255457|NCT02541903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255458|NCT02541669|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
102255459|NCT02541669|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102255460|NCT02541669|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102255461|NCT02541669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255462|NCT05455047|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102255463|NCT05455047|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102255464|NCT05455047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255465|NCT05454891|Insulin|insulin|mesh-list
102255466|NCT05454891|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102255467|NCT05454891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102255468|NCT05454891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255469|NCT02688647|Belumosudil|belumosudil|mesh-list
102255470|NCT02688647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102255471|NCT02688647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102255472|NCT02688647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255473|NCT05453799|Antibodies|antibodies|mesh-list
102255474|NCT05453799|Immunoglobulins|immunoglobulins|mesh-list
102255475|NCT05453799|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102255476|NCT05453799|Immunologic Factors|immunologic factors|mesh-ancestor
102255477|NCT05453799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255478|NCT05453487|Vaccines|vaccines|mesh-list
102255479|NCT05453487|Immunologic Factors|immunologic factors|mesh-ancestor
102255480|NCT05453487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255481|NCT05431725|Vaccines|vaccines|mesh-list
102255482|NCT05431725|Immunologic Factors|immunologic factors|mesh-ancestor
102255483|NCT05431725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255484|NCT02548455|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
102255485|NCT02548455|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102255486|NCT02548455|Contraceptive Agents|contraceptive agents|mesh-ancestor
102255487|NCT02548455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102255488|NCT02548455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255489|NCT02548455|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102255490|NCT02548455|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102255491|NCT02548455|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102255492|NCT05451615|Abatacept|abatacept|mesh-list
102255493|NCT05451615|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
102255494|NCT05451615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101804194|NCT00934232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102255495|NCT05451615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255496|NCT05451615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102255497|NCT05451615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102255498|NCT05451615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102255499|NCT05451615|Immunologic Factors|immunologic factors|mesh-ancestor
102255500|NCT05451615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255501|NCT05451615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102255502|NCT05451615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102255503|NCT05451615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102255504|NCT05727527|Anesthetics|anesthetics|mesh-list
102255505|NCT05727527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102255506|NCT05727527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255507|NCT02534883|Misoprostol|misoprostol|mesh-list
102255508|NCT02534883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102255509|NCT02534883|Abortifacient Agents|abortifacient agents|mesh-ancestor
101964376|NCT00094757|Protease Inhibitors|protease inhibitors|mesh-ancestor
102255510|NCT02534883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102255511|NCT02534883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255512|NCT02534883|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102255513|NCT02534883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102255514|NCT02534883|Oxytocics|oxytocics|mesh-ancestor
102613502|NCT05204147|Chelating Agents|chelating agents|mesh-ancestor
102255516|NCT05626439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102255517|NCT05626439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102255518|NCT05626439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255519|NCT05626439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102255520|NCT05626439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102255521|NCT05626439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102255522|NCT05626439|GABA Modulators|gaba modulators|mesh-ancestor
102255523|NCT05626439|GABA Agents|gaba agents|mesh-ancestor
102255524|NCT05626439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102255525|NCT05626439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255526|NCT05430009|Pembrolizumab|pembrolizumab|mesh-list
102255527|NCT05430009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102255528|NCT05430009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102255529|NCT05430009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102255530|NCT05430009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255531|NCT05429697|Pembrolizumab|pembrolizumab|mesh-list
102255532|NCT05429697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102255533|NCT05429697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101804322|NCT00492297|Sorafenib|sorafenib|mesh-list
102255534|NCT05429697|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102255535|NCT05429697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255536|NCT02540265|Meloxicam|meloxicam|mesh-list
102255537|NCT02540265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102255538|NCT02540265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102255539|NCT02540265|Analgesics|analgesics|mesh-ancestor
102255540|NCT02540265|Sensory System Agents|sensory system agents|mesh-ancestor
102255541|NCT02540265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102255542|NCT02540265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255543|NCT02540265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102255544|NCT02540265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102255545|NCT02540265|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102255546|NCT02540265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102255547|NCT02540265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102255548|NCT02540265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255549|NCT02684357|Ustekinumab|ustekinumab|mesh-list
102255550|NCT02684357|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102255551|NCT02684357|Dermatologic Agents|dermatologic agents|mesh-ancestor
102255552|NCT02684357|Immunologic Factors|immunologic factors|mesh-ancestor
102255553|NCT02684357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255554|NCT03115073|Clotrimazole|clotrimazole|mesh-list
102255555|NCT03115073|Miconazole|miconazole|mesh-list
102255556|NCT03115073|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102255557|NCT03115073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102255558|NCT03115073|Antifungal Agents|antifungal agents|mesh-ancestor
102255559|NCT03115073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102255560|NCT03115073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102255561|NCT03115073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102255562|NCT03115073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255563|NCT03115073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102255564|NCT03115073|Hormone Antagonists|hormone antagonists|mesh-ancestor
102255565|NCT03115073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102255566|NCT03115073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255567|NCT03115073|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102255568|NCT03115073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102255569|NCT03166163|Chlorhexidine|chlorhexidine|mesh-list
102255570|NCT03166163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102255571|NCT03166163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102255572|NCT03166163|Disinfectants|disinfectants|mesh-ancestor
102255573|NCT03165929|Flurbiprofen|flurbiprofen|mesh-list
102255574|NCT03165929|Analgesics|analgesics|mesh-ancestor
102255575|NCT03165929|Sensory System Agents|sensory system agents|mesh-ancestor
102255576|NCT03165929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102255577|NCT03165929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255578|NCT03165929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102255579|NCT03165929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102255580|NCT03165929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102255581|NCT03165929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102255582|NCT03165929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102255583|NCT03165929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102255584|NCT03165929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255585|NCT03206073|Durvalumab|durvalumab|mesh-list
102613503|NCT05204147|Sequestering Agents|sequestering agents|mesh-ancestor
102613504|NCT05204147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613505|NCT04824053|Selenium|selenium|mesh-list
102255586|NCT03206073|Tremelimumab|tremelimumab|mesh-list
102255587|NCT03206073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102255588|NCT03206073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102255589|NCT03142893|Ketoconazole|ketoconazole|mesh-list
102255590|NCT03142893|Dexamethasone|dexamethasone|mesh-list
102255591|NCT03142893|Dexamethasone acetate|dexamethasone acetate|mesh-list
102255592|NCT03142893|Hydrocortisone|hydrocortisone|mesh-list
102255593|NCT03142893|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102255594|NCT03142893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102255595|NCT03142893|Hormones|hormones|mesh-list
102255596|NCT03142893|Cosyntropin|cosyntropin|mesh-list
102255597|NCT03142893|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
102255598|NCT03142893|BB 1101|bb 1101|mesh-list
102255599|NCT03142893|Ganirelix|ganirelix|mesh-list
102255600|NCT03142893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102255601|NCT03142893|Antiemetics|antiemetics|mesh-ancestor
102255602|NCT03142893|Autonomic Agents|autonomic agents|mesh-ancestor
102255603|NCT03142893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102255604|NCT03142893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255605|NCT03142893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102255606|NCT03142893|Glucocorticoids|glucocorticoids|mesh-ancestor
102255607|NCT03142893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102255608|NCT03142893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102255609|NCT03142893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102255610|NCT03142893|Protease Inhibitors|protease inhibitors|mesh-ancestor
102255611|NCT03142893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102255612|NCT03142893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255613|NCT03142893|Antifungal Agents|antifungal agents|mesh-ancestor
102255614|NCT03142893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102255615|NCT03142893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101804616|NCT01023490|Vitamin D|vitamin d|mesh-list
102255616|NCT03142893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102255617|NCT03142893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102255618|NCT03142893|Hormone Antagonists|hormone antagonists|mesh-ancestor
102255619|NCT03142893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102255620|NCT02547129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102255621|NCT02547129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102255622|NCT02547129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102255623|NCT02547129|Antitubercular Agents|antitubercular agents|mesh-ancestor
102255624|NCT02546193|Misoprostol|misoprostol|mesh-list
102255625|NCT02546193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102255626|NCT02546193|Abortifacient Agents|abortifacient agents|mesh-ancestor
102255627|NCT02546193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102255628|NCT02546193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255629|NCT02546193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102255630|NCT02546193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102255631|NCT02546193|Oxytocics|oxytocics|mesh-ancestor
102255632|NCT01661595|Sildenafil Citrate|sildenafil citrate|mesh-list
102255633|NCT01661595|Tadalafil|tadalafil|mesh-list
102255634|NCT01661595|Vasodilator Agents|vasodilator agents|mesh-ancestor
102255635|NCT01661595|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102255636|NCT01661595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102255637|NCT01661595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102255638|NCT01661595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255639|NCT01661595|Urological Agents|urological agents|mesh-ancestor
102255640|NCT04262661|Insulin Glargine|insulin glargine|mesh-list
102255641|NCT04262661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102255642|NCT04262661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255643|NCT02957097|Gabapentin|gabapentin|mesh-list
102255644|NCT02957097|Analgesics|analgesics|mesh-ancestor
101804697|NCT05472779|Estradiol|estradiol|mesh-list
102255645|NCT02957097|Sensory System Agents|sensory system agents|mesh-ancestor
102255646|NCT02957097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102255647|NCT02957097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255648|NCT02957097|Anticonvulsants|anticonvulsants|mesh-ancestor
102255649|NCT02957097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102255650|NCT02957097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102255651|NCT02957097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102255652|NCT02957097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102255653|NCT02957097|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102255654|NCT02957097|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102255655|NCT02957097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102255656|NCT02957097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804738|NCT05324891|Fentanyl|fentanyl|mesh-list
102255657|NCT02957097|Antimanic Agents|antimanic agents|mesh-ancestor
102255658|NCT03165383|Morphine|morphine|mesh-list
102255659|NCT03165383|Bupivacaine|bupivacaine|mesh-list
102613506|NCT04824053|Caseins|caseins|mesh-list
102255660|NCT03165383|Anesthetics, Local|anesthetics, local|mesh-ancestor
102255661|NCT03165383|Anesthetics|anesthetics|mesh-ancestor
102255662|NCT03165383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102255663|NCT03165383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255664|NCT03165383|Sensory System Agents|sensory system agents|mesh-ancestor
102255665|NCT03165383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102255666|NCT03165383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102255667|NCT03165383|Narcotics|narcotics|mesh-ancestor
102255668|NCT03165383|Analgesics|analgesics|mesh-ancestor
102255669|NCT03162185|Escitalopram|escitalopram|mesh-list
102255670|NCT03162185|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102255671|NCT03162185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102255672|NCT03162185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102255673|NCT03162185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255674|NCT03162185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102255675|NCT03162185|Serotonin Agents|serotonin agents|mesh-ancestor
102255676|NCT03162185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255677|NCT02678351|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102255678|NCT02678351|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102255679|NCT02678351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255680|NCT05286437|Pembrolizumab|pembrolizumab|mesh-list
102255681|NCT05286437|Letrozole|letrozole|mesh-list
102255682|NCT05286437|Lenvatinib|lenvatinib|mesh-list
102255683|NCT05286437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102255684|NCT05286437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102255685|NCT05286437|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102255686|NCT05286437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255687|NCT05286437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102255688|NCT05286437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102255689|NCT05286437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102255690|NCT05286437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102255691|NCT05286437|Hormone Antagonists|hormone antagonists|mesh-ancestor
102255692|NCT05286437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102255693|NCT05286437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255694|NCT05286437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102255695|NCT05464173|Fulvestrant|fulvestrant|mesh-list
102255696|NCT05464173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102255697|NCT05464173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102255698|NCT05464173|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102255699|NCT05464173|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102255700|NCT05464173|Hormone Antagonists|hormone antagonists|mesh-ancestor
102255701|NCT05464173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102255702|NCT05464173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255703|NCT02683187|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102255704|NCT02683187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102255705|NCT02683187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255706|NCT02683187|Incretins|incretins|mesh-ancestor
102255707|NCT02683187|Hormones|hormones|mesh-ancestor
102255708|NCT02683187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102255709|NCT02683187|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102255710|NCT02683187|Protease Inhibitors|protease inhibitors|mesh-ancestor
102255711|NCT02683187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102255712|NCT02683187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255713|NCT05515601|Mirikizumab|mirikizumab|mesh-list
102255714|NCT05515601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102255715|NCT05515601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102255716|NCT05515601|Analgesics|analgesics|mesh-ancestor
102255717|NCT05515601|Sensory System Agents|sensory system agents|mesh-ancestor
102255718|NCT05515601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102255719|NCT05515601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255720|NCT05515601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102255721|NCT05515601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102255722|NCT05515601|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102255723|NCT05515601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102255724|NCT02683109|Tiotropium Bromide|tiotropium bromide|mesh-list
102255725|NCT02683109|Olodaterol|olodaterol|mesh-list
102255726|NCT02683109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102255727|NCT02683109|Autonomic Agents|autonomic agents|mesh-ancestor
102255728|NCT02683109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102255729|NCT02683109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613507|NCT04824053|Antioxidants|antioxidants|mesh-ancestor
102613508|NCT04824053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613509|NCT04824053|Protective Agents|protective agents|mesh-ancestor
102255730|NCT02683109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102255731|NCT02683109|Respiratory System Agents|respiratory system agents|mesh-ancestor
102255732|NCT02683109|Parasympatholytics|parasympatholytics|mesh-ancestor
102255733|NCT02683109|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102255734|NCT02683109|Cholinergic Agents|cholinergic agents|mesh-ancestor
102255735|NCT02683109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102255736|NCT02683109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255737|NCT02544321|Bromocriptine|bromocriptine|mesh-list
102255738|NCT02544321|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102255739|NCT02544321|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102255740|NCT02544321|Hormone Antagonists|hormone antagonists|mesh-ancestor
102255741|NCT02544321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102255742|NCT02544321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255743|NCT02544321|Dopamine Agonists|dopamine agonists|mesh-ancestor
102255744|NCT02544321|Dopamine Agents|dopamine agents|mesh-ancestor
102255745|NCT02544321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102255746|NCT02544321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255747|NCT02533401|Cyclophosphamide|cyclophosphamide|mesh-list
102255748|NCT02533401|Rituximab|rituximab|mesh-list
102255749|NCT02533401|Fludarabine|fludarabine|mesh-list
102255750|NCT02533401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102255751|NCT02533401|Immunologic Factors|immunologic factors|mesh-ancestor
102255752|NCT02533401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255753|NCT02533401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102255754|NCT02533401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102255755|NCT02533401|Alkylating Agents|alkylating agents|mesh-ancestor
102255756|NCT02533401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255757|NCT02533401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102255758|NCT02533401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102255759|NCT02533401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102255760|NCT03164837|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
102255761|NCT03164837|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102255762|NCT03164837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255763|NCT05178173|Ethanol|ethanol|mesh-list
102255764|NCT05178173|Cetylpyridinium|cetylpyridinium|mesh-list
102255765|NCT05178173|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102255766|NCT05178173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102255767|NCT05178173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102255768|NCT05178173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255769|NCT02536833|Lorecivivint|lorecivivint|mesh-list
102255770|NCT02536833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102255771|NCT02680847|Naltrexone|naltrexone|mesh-list
102255772|NCT02680847|Oxycodone|oxycodone|mesh-list
102255773|NCT02680847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102255774|NCT02680847|Narcotics|narcotics|mesh-ancestor
102255775|NCT02680847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102255776|NCT02680847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255777|NCT02680847|Analgesics|analgesics|mesh-ancestor
102255778|NCT02680847|Sensory System Agents|sensory system agents|mesh-ancestor
102255779|NCT02680847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102255780|NCT02680847|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102255781|NCT02680847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102255782|NCT03959241|Mycophenolic Acid|mycophenolic acid|mesh-list
102255783|NCT03959241|Cyclophosphamide|cyclophosphamide|mesh-list
102255784|NCT03959241|Methotrexate|methotrexate|mesh-list
102255785|NCT03959241|Tacrolimus|tacrolimus|mesh-list
102255786|NCT03959241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102255787|NCT03959241|Immunologic Factors|immunologic factors|mesh-ancestor
102255788|NCT03959241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255789|NCT03959241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102255790|NCT03959241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102255791|NCT03959241|Alkylating Agents|alkylating agents|mesh-ancestor
102255792|NCT03959241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255793|NCT03959241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102255794|NCT03959241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102255795|NCT03959241|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102255796|NCT03959241|Abortifacient Agents|abortifacient agents|mesh-ancestor
102255797|NCT03959241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102255798|NCT03959241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102255799|NCT03959241|Antimetabolites|antimetabolites|mesh-ancestor
102255800|NCT03959241|Dermatologic Agents|dermatologic agents|mesh-ancestor
102613510|NCT04824053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613511|NCT04824053|Trace Elements|trace elements|mesh-ancestor
102255801|NCT03959241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101805440|NCT00954200|Ibuprofen|ibuprofen|mesh-list
102255802|NCT03959241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102255803|NCT03959241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102255804|NCT03959241|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102255805|NCT03959241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101964680|NCT04174612|Cytarabine|cytarabine|mesh-list
102255806|NCT03959241|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102255807|NCT03959241|Antitubercular Agents|antitubercular agents|mesh-ancestor
102255808|NCT03959241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102255809|NCT03959241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102255811|NCT02532855|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102255812|NCT02532855|Dapagliflozin|dapagliflozin|mesh-list
102255813|NCT02532855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102255814|NCT02532855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255815|NCT02532855|Incretins|incretins|mesh-ancestor
102255816|NCT02532855|Hormones|hormones|mesh-ancestor
102255817|NCT02532855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102255818|NCT02532855|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102255819|NCT02532855|Protease Inhibitors|protease inhibitors|mesh-ancestor
102255820|NCT02532855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102255821|NCT02532855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255822|NCT02532855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102255823|NCT04262427|Cyclophosphamide|cyclophosphamide|mesh-list
102255824|NCT04262427|Pembrolizumab|pembrolizumab|mesh-list
102255825|NCT04262427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102255826|NCT04262427|Immunologic Factors|immunologic factors|mesh-ancestor
102255827|NCT04262427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255828|NCT04262427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102255829|NCT04262427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102255830|NCT04262427|Alkylating Agents|alkylating agents|mesh-ancestor
102255831|NCT04262427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255832|NCT04262427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102255833|NCT04262427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102255834|NCT04262427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102255835|NCT04262427|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102255836|NCT02530125|Pidilizumab|pidilizumab|mesh-list
102255837|NCT02530125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102255838|NCT02530125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102255839|NCT05422521|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102255840|NCT05422521|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102255841|NCT05422521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255842|NCT05421819|Calcium, Dietary|calcium, dietary|mesh-list
102255843|NCT05421819|Vitamin D|vitamin d|mesh-list
102255844|NCT05421819|Ergocalciferols|ergocalciferols|mesh-list
102255845|NCT05421819|Cholecalciferol|cholecalciferol|mesh-list
102255846|NCT05421819|Vitamins|vitamins|mesh-list
102255847|NCT05421819|Calcium|calcium|mesh-list
102255848|NCT05421819|Micronutrients|micronutrients|mesh-ancestor
102255849|NCT05421819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255850|NCT05421819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102255851|NCT05421819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102255852|NCT02055820|Prednisone|prednisone|mesh-list
102255853|NCT02055820|Cyclophosphamide|cyclophosphamide|mesh-list
102255854|NCT02055820|Rituximab|rituximab|mesh-list
102255855|NCT02055820|Doxorubicin|doxorubicin|mesh-list
102255856|NCT02055820|Vincristine|vincristine|mesh-list
102255857|NCT02055820|Venetoclax|venetoclax|mesh-list
102255858|NCT02055820|Obinutuzumab|obinutuzumab|mesh-list
102255859|NCT02055820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102255860|NCT02055820|Immunologic Factors|immunologic factors|mesh-ancestor
102255861|NCT02055820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255862|NCT02055820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102255863|NCT02055820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102255864|NCT02055820|Alkylating Agents|alkylating agents|mesh-ancestor
102255865|NCT02055820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255866|NCT02055820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102255867|NCT02055820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102255868|NCT02055820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102255869|NCT02055820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102255870|NCT02055820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102255871|NCT02055820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102255872|NCT02055820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102255873|NCT02055820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102255874|NCT02055820|Glucocorticoids|glucocorticoids|mesh-ancestor
102255875|NCT02055820|Hormones|hormones|mesh-ancestor
101901937|NCT01094964|Immunologic Factors|immunologic factors|mesh-ancestor
102613512|NCT04824053|Micronutrients|micronutrients|mesh-ancestor
102613513|NCT04824053|Chelating Agents|chelating agents|mesh-ancestor
102613514|NCT04824053|Sequestering Agents|sequestering agents|mesh-ancestor
102255876|NCT02055820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102255877|NCT02055820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102255878|NCT02055820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102255879|NCT02055820|Tubulin Modulators|tubulin modulators|mesh-ancestor
101964748|NCT01589471|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102255880|NCT02055820|Antimitotic Agents|antimitotic agents|mesh-ancestor
102255881|NCT02055820|Mitosis Modulators|mitosis modulators|mesh-ancestor
102255882|NCT05408559|Sulforaphane|sulforaphane|mesh-list
102255883|NCT05408559|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102255884|NCT05408559|Protective Agents|protective agents|mesh-ancestor
102255885|NCT05408559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255886|NCT05408559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102255887|NCT02055352|Fluticasone|fluticasone|mesh-list
102255888|NCT02055352|Budesonide|budesonide|mesh-list
102255889|NCT02055352|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102255890|NCT02055352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102255891|NCT02055352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102255892|NCT02055352|Autonomic Agents|autonomic agents|mesh-ancestor
102255893|NCT02055352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102255894|NCT02055352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805804|NCT00549848|Antiemetics|antiemetics|mesh-ancestor
102255895|NCT02055352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102255896|NCT02055352|Respiratory System Agents|respiratory system agents|mesh-ancestor
102255897|NCT02055352|Dermatologic Agents|dermatologic agents|mesh-ancestor
102255898|NCT02055352|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102255899|NCT02055352|Glucocorticoids|glucocorticoids|mesh-ancestor
102255900|NCT02055352|Hormones|hormones|mesh-ancestor
102255901|NCT02055352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102255902|NCT02055352|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102255903|NCT02055352|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102255904|NCT02055352|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102255905|NCT02055352|Adrenergic Agents|adrenergic agents|mesh-ancestor
102255906|NCT02055352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102255907|NCT02055352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255908|NCT02034916|Talazoparib|talazoparib|mesh-list
102255909|NCT02034916|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102255910|NCT02034916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102255911|NCT02034916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255912|NCT02034916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102255913|NCT01374425|Leucovorin|leucovorin|mesh-list
102255914|NCT01374425|Bevacizumab|bevacizumab|mesh-list
102255915|NCT01374425|Fluorouracil|fluorouracil|mesh-list
102255916|NCT01374425|Capecitabine|capecitabine|mesh-list
102255917|NCT01374425|Oxaliplatin|oxaliplatin|mesh-list
102255918|NCT01374425|Irinotecan|irinotecan|mesh-list
102255919|NCT01374425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102255920|NCT01374425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102255921|NCT01374425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102255922|NCT01374425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102255923|NCT01374425|Growth Substances|growth substances|mesh-ancestor
102255924|NCT01374425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255925|NCT01374425|Growth Inhibitors|growth inhibitors|mesh-ancestor
102255926|NCT01374425|Antimetabolites|antimetabolites|mesh-ancestor
102255927|NCT01374425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255928|NCT01374425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102255929|NCT01374425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102255930|NCT01374425|Immunologic Factors|immunologic factors|mesh-ancestor
102255931|NCT01374425|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102255932|NCT01374425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102255933|NCT01374425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102255934|NCT01374425|Antidotes|antidotes|mesh-ancestor
102255935|NCT01374425|Protective Agents|protective agents|mesh-ancestor
102255936|NCT01374425|Vitamin B Complex|vitamin b complex|mesh-ancestor
102255937|NCT01374425|Vitamins|vitamins|mesh-ancestor
102255938|NCT01374425|Micronutrients|micronutrients|mesh-ancestor
102255939|NCT02085460|Rebamipide|rebamipide|mesh-list
102255940|NCT02085460|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102255941|NCT02085460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102255942|NCT02085460|Antioxidants|antioxidants|mesh-ancestor
101805969|NCT02730923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102255943|NCT02085460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255944|NCT02085460|Protective Agents|protective agents|mesh-ancestor
102613515|NCT04811339|Bismuth|bismuth|mesh-list
102255945|NCT02085460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255946|NCT02085460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102255947|NCT03164291|Rifabutin|rifabutin|mesh-list
102613516|NCT04811339|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
102255948|NCT03164291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102255949|NCT03164291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102255950|NCT03164291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102255951|NCT03164291|Antitubercular Agents|antitubercular agents|mesh-ancestor
102255952|NCT02084134|Dexamethasone|dexamethasone|mesh-list
102255953|NCT02084134|Dexamethasone acetate|dexamethasone acetate|mesh-list
102255954|NCT02084134|Hydrocortisone|hydrocortisone|mesh-list
102255955|NCT02084134|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102255956|NCT02084134|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102255957|NCT02084134|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102255958|NCT02084134|BB 1101|bb 1101|mesh-list
102255959|NCT02084134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102255960|NCT02084134|Antiemetics|antiemetics|mesh-ancestor
102255961|NCT02084134|Autonomic Agents|autonomic agents|mesh-ancestor
102255962|NCT02084134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102255963|NCT02084134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255964|NCT02084134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102255965|NCT02084134|Glucocorticoids|glucocorticoids|mesh-ancestor
102255966|NCT02084134|Hormones|hormones|mesh-ancestor
102255967|NCT02084134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102255968|NCT02084134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102255969|NCT02084134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102255970|NCT02084134|Protease Inhibitors|protease inhibitors|mesh-ancestor
102255971|NCT02084134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102255972|NCT02084134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255973|NCT01374269|Acetaminophen|acetaminophen|mesh-list
102255974|NCT01374269|Celecoxib|celecoxib|mesh-list
102255975|NCT01374269|Naproxen|naproxen|mesh-list
102255976|NCT01374269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
102255977|NCT01374269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102255978|NCT01374269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102255979|NCT01374269|Analgesics|analgesics|mesh-ancestor
102255980|NCT01374269|Sensory System Agents|sensory system agents|mesh-ancestor
102255981|NCT01374269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102255982|NCT01374269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102255983|NCT01374269|Antipyretics|antipyretics|mesh-ancestor
102255984|NCT01374269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102255985|NCT01374269|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102255986|NCT01374269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102255987|NCT01374269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102255988|NCT01374269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255989|NCT01374269|Gout Suppressants|gout suppressants|mesh-ancestor
102255990|NCT03163979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102255991|NCT03163979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102255992|NCT03163979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102255993|NCT03163589|Epoetin Alfa|epoetin alfa|mesh-list
102255994|NCT03163589|Hematinics|hematinics|mesh-ancestor
102255995|NCT03163277|Emtricitabine|emtricitabine|mesh-list
102255996|NCT03163277|Maraviroc|maraviroc|mesh-list
102255997|NCT03163277|Darunavir|darunavir|mesh-list
102255998|NCT03163277|Cobicistat|cobicistat|mesh-list
102255999|NCT03163277|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
102256000|NCT03163277|Antiviral Agents|antiviral agents|mesh-ancestor
102256001|NCT03163277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102256002|NCT03163277|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102256003|NCT03163277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102256004|NCT03163277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102256005|NCT03163277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256006|NCT03163277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102256007|NCT03163277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102256008|NCT03163277|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102256009|NCT03163277|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102256010|NCT03163277|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102256011|NCT03163277|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102256012|NCT03163277|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102256013|NCT03163277|Protease Inhibitors|protease inhibitors|mesh-ancestor
102256014|NCT03163277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102256015|NCT03163277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102256016|NCT05419817|Pembrolizumab|pembrolizumab|mesh-list
102256017|NCT05419817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102256018|NCT05419817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256019|NCT05419817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102256020|NCT05419817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256021|NCT05676749|Aldesleukin|aldesleukin|mesh-list
102613518|NCT04811339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256022|NCT05676749|Pembrolizumab|pembrolizumab|mesh-list
101806279|NCT00955214|Paclitaxel|paclitaxel|mesh-list
102256023|NCT05676749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102256024|NCT05676749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256025|NCT05676749|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102256026|NCT05676749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256027|NCT05676749|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102256028|NCT05676749|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102256029|NCT05676749|Antiviral Agents|antiviral agents|mesh-ancestor
102256030|NCT05676749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102256031|NCT05392205|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102256032|NCT05392205|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102256033|NCT05392205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256035|NCT02679755|Palbociclib|palbociclib|mesh-list
102256036|NCT02679755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256037|NCT02679755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102256038|NCT02679755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102256039|NCT02679755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102256040|NCT02679755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256041|NCT02679755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102256042|NCT02679755|Hormone Antagonists|hormone antagonists|mesh-ancestor
101806393|NCT02564003|Narcotics|narcotics|mesh-ancestor
102256043|NCT02679755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102256044|NCT02679755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256045|NCT02679755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102256046|NCT02675231|Trastuzumab|trastuzumab|mesh-list
102256047|NCT02675231|Fulvestrant|fulvestrant|mesh-list
102256048|NCT02675231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102256049|NCT02675231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256050|NCT02675231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102256051|NCT02675231|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102256052|NCT02675231|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102256053|NCT02675231|Hormone Antagonists|hormone antagonists|mesh-ancestor
102256054|NCT02675231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102256055|NCT02675231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256056|NCT03163121|Vaccines|vaccines|mesh-list
102256057|NCT03163121|Immunologic Factors|immunologic factors|mesh-ancestor
102256058|NCT03163121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256059|NCT03114371|Oxytocin|oxytocin|mesh-list
102256060|NCT03114371|Oxytocics|oxytocics|mesh-ancestor
102256061|NCT03114371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102256062|NCT03114371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256063|NCT04905407|Azacitidine|azacitidine|mesh-list
102256064|NCT04905407|Venetoclax|venetoclax|mesh-list
102256065|NCT04905407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102256066|NCT04905407|Antimetabolites|antimetabolites|mesh-ancestor
102256067|NCT04905407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256068|NCT04905407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256069|NCT04905407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102256070|NCT03114215|Biotin|biotin|mesh-list
102256071|NCT03114215|Vitamin B Complex|vitamin b complex|mesh-ancestor
102256072|NCT03114215|Vitamins|vitamins|mesh-ancestor
102256073|NCT03114215|Micronutrients|micronutrients|mesh-ancestor
102256074|NCT03114215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256075|NCT05675813|Azacitidine|azacitidine|mesh-list
102256076|NCT05675813|Tislelizumab|tislelizumab|mesh-list
102256077|NCT05675813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101806584|NCT00549302|Tadalafil|tadalafil|mesh-list
102256078|NCT05675813|Antimetabolites|antimetabolites|mesh-ancestor
102256079|NCT05675813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256080|NCT05675813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256081|NCT05675813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102256082|NCT05675813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102256083|NCT02397083|Everolimus|everolimus|mesh-list
102256084|NCT02397083|Levonorgestrel|levonorgestrel|mesh-list
102256085|NCT02397083|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102256086|NCT02397083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102256087|NCT02397083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102256088|NCT02397083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256089|NCT02397083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102256090|NCT02397083|Immunologic Factors|immunologic factors|mesh-ancestor
102256091|NCT02397083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256092|NCT02397083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256093|NCT02397083|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102256094|NCT02397083|Contraceptive Agents|contraceptive agents|mesh-ancestor
102256095|NCT02397083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102613519|NCT04811339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102256096|NCT02397083|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102256097|NCT02397083|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101207603|NCT05382312|Bedaquiline|bedaquiline|mesh-list
102256098|NCT02397083|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102256099|NCT02667275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102256100|NCT01738139|Ipilimumab|ipilimumab|mesh-list
102256101|NCT01738139|Imatinib Mesylate|imatinib mesylate|mesh-list
102256102|NCT01738139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102256103|NCT01738139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256104|NCT01738139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102256105|NCT01738139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256106|NCT01738139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102256107|NCT01738139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102256108|NCT01729091|Lenalidomide|lenalidomide|mesh-list
102256109|NCT01729091|Melphalan|melphalan|mesh-list
102256110|NCT01729091|Mechlorethamine|mechlorethamine|mesh-list
102256111|NCT01729091|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102256112|NCT01729091|Elotuzumab|elotuzumab|mesh-list
102256113|NCT01729091|Immunologic Factors|immunologic factors|mesh-ancestor
102256114|NCT01729091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256115|NCT01729091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102256116|NCT01729091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102256117|NCT01729091|Growth Substances|growth substances|mesh-ancestor
102256118|NCT01729091|Growth Inhibitors|growth inhibitors|mesh-ancestor
102256119|NCT01729091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256120|NCT01729091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102256121|NCT01729091|Alkylating Agents|alkylating agents|mesh-ancestor
102256122|NCT01729091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256123|NCT01729091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102256124|NCT01729091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102256125|NCT04205903|Paclitaxel|paclitaxel|mesh-list
102256126|NCT04205903|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102256127|NCT04205903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102256128|NCT04205903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256129|NCT04205903|Tubulin Modulators|tubulin modulators|mesh-ancestor
102256130|NCT04205903|Antimitotic Agents|antimitotic agents|mesh-ancestor
102256131|NCT04205903|Mitosis Modulators|mitosis modulators|mesh-ancestor
102256132|NCT04205903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256133|NCT02670551|Cariprazine|cariprazine|mesh-list
102256134|NCT02670551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102256135|NCT02670551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102256136|NCT02670551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102256137|NCT02670551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256138|NCT02670551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102256139|NCT01430351|Metformin|metformin|mesh-list
102256140|NCT01430351|Mefloquine|mefloquine|mesh-list
102256141|NCT01430351|Temozolomide|temozolomide|mesh-list
102256142|NCT01430351|Memantine|memantine|mesh-list
102256143|NCT01430351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102256144|NCT01430351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256145|NCT01430351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102256146|NCT01430351|Alkylating Agents|alkylating agents|mesh-ancestor
102256147|NCT01430351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256148|NCT01430351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256149|NCT01430351|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102256150|NCT01430351|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102256151|NCT01430351|Dopamine Agents|dopamine agents|mesh-ancestor
102256152|NCT01430351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102256153|NCT01430351|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102256154|NCT01430351|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102256155|NCT01430351|Antimalarials|antimalarials|mesh-ancestor
102256156|NCT01430351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101806883|NCT00964080|Antidotes|antidotes|mesh-ancestor
102256157|NCT01430351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102256158|NCT01430351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102256159|NCT00893399|Gemtuzumab|gemtuzumab|mesh-list
102256160|NCT00893399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102256161|NCT00893399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256162|NCT00893399|Immunotoxins|immunotoxins|mesh-ancestor
102256163|NCT00893399|Immunoconjugates|immunoconjugates|mesh-ancestor
102256164|NCT00893399|Immunologic Factors|immunologic factors|mesh-ancestor
102256165|NCT00893399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256166|NCT05675033|Bevacizumab|bevacizumab|mesh-list
102256167|NCT05675033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102613520|NCT04811339|Antidiarrheals|antidiarrheals|mesh-ancestor
102256168|NCT05675033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256169|NCT05675033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102613521|NCT04783415|Acalabrutinib|acalabrutinib|mesh-list
102613522|NCT04783415|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102256170|NCT05675033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102256171|NCT05675033|Growth Substances|growth substances|mesh-ancestor
102256172|NCT05675033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256173|NCT05675033|Growth Inhibitors|growth inhibitors|mesh-ancestor
102256174|NCT04103489|Eculizumab|eculizumab|mesh-list
102256175|NCT04103489|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102256176|NCT04103489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102256177|NCT04103489|Immunologic Factors|immunologic factors|mesh-ancestor
102256178|NCT04103489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256179|NCT04479527|Apatinib|apatinib|mesh-list
102256180|NCT04479527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256181|NCT04479527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102256182|NCT04479527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102256183|NCT04479527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256184|NCT02391077|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102256185|NCT02391077|Chlorhexidine|chlorhexidine|mesh-list
102256186|NCT02391077|Povidone-Iodine|povidone-iodine|mesh-list
102256187|NCT02391077|Povidone|povidone|mesh-list
102256188|NCT02391077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102256189|NCT02391077|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102256190|NCT02391077|Disinfectants|disinfectants|mesh-ancestor
102256191|NCT02391077|Plasma Substitutes|plasma substitutes|mesh-ancestor
102256192|NCT02391077|Blood Substitutes|blood substitutes|mesh-ancestor
102256193|NCT02390921|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102256194|NCT02390921|Hematinics|hematinics|mesh-ancestor
102256195|NCT02390843|Cyclophosphamide|cyclophosphamide|mesh-list
102256196|NCT02390843|Topotecan|topotecan|mesh-list
102256197|NCT02390843|Simvastatin|simvastatin|mesh-list
102256198|NCT02390843|Lenograstim|lenograstim|mesh-list
102256199|NCT02390843|Mitogens|mitogens|mesh-list
102256200|NCT02390843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102256201|NCT02390843|Immunologic Factors|immunologic factors|mesh-ancestor
102256202|NCT02390843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256203|NCT02390843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102256204|NCT02390843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102256205|NCT02390843|Alkylating Agents|alkylating agents|mesh-ancestor
102256206|NCT02390843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256207|NCT02390843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256208|NCT02390843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102256209|NCT02390843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102256210|NCT02390843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102256211|NCT02390843|Antimetabolites|antimetabolites|mesh-ancestor
102256212|NCT02390843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102256213|NCT02390843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102256214|NCT02390843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102256215|NCT02390843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102256216|NCT02390843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102256217|NCT02390843|Mitosis Modulators|mitosis modulators|mesh-ancestor
102256218|NCT02390843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102256219|NCT02390375|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102256220|NCT02390375|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102256221|NCT02390375|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102256222|NCT02390375|Antimetabolites|antimetabolites|mesh-ancestor
102256223|NCT02390375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807111|NCT00744887|Darunavir|darunavir|mesh-list
102256224|NCT02390375|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102256225|NCT02390375|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102256226|NCT02390375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102256227|NCT03806309|Leucovorin|leucovorin|mesh-list
102256228|NCT03806309|Fluorouracil|fluorouracil|mesh-list
102256229|NCT03806309|Irinotecan|irinotecan|mesh-list
102256230|NCT03806309|Antimetabolites|antimetabolites|mesh-ancestor
102256231|NCT03806309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256232|NCT03806309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102256233|NCT03806309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256234|NCT03806309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102256235|NCT03806309|Immunologic Factors|immunologic factors|mesh-ancestor
102256236|NCT03806309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256237|NCT03806309|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102256238|NCT03806309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102256239|NCT03806309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102256240|NCT03806309|Antidotes|antidotes|mesh-ancestor
102256241|NCT03806309|Protective Agents|protective agents|mesh-ancestor
102256242|NCT03806309|Vitamin B Complex|vitamin b complex|mesh-ancestor
102613523|NCT04783415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613524|NCT04783415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102256244|NCT03806309|Micronutrients|micronutrients|mesh-ancestor
102256245|NCT03489629|Chlorhexidine|chlorhexidine|mesh-list
102256246|NCT03489629|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102256247|NCT03489629|Minocycline|minocycline|mesh-list
102256248|NCT03489629|Trimethoprim|trimethoprim|mesh-list
102256249|NCT03489629|Sulfamethoxazole|sulfamethoxazole|mesh-list
102256250|NCT03489629|Mupirocin|mupirocin|mesh-list
102256251|NCT03489629|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102256252|NCT03489629|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102256253|NCT03489629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102256254|NCT03489629|Disinfectants|disinfectants|mesh-ancestor
102256255|NCT03489629|Dermatologic Agents|dermatologic agents|mesh-ancestor
102256256|NCT03489629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102256257|NCT03489629|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102256258|NCT03489629|Antimalarials|antimalarials|mesh-ancestor
102256259|NCT03489629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102256260|NCT03489629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102256261|NCT03489629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102256262|NCT03489629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102256263|NCT03489629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256264|NCT03489629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102256265|NCT03489629|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102256266|NCT03489629|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102256267|NCT03489629|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102256268|NCT02389751|Paclitaxel|paclitaxel|mesh-list
102256269|NCT02389751|Carboplatin|carboplatin|mesh-list
102256270|NCT02389751|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102256271|NCT02389751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102256272|NCT02389751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256273|NCT02389751|Tubulin Modulators|tubulin modulators|mesh-ancestor
102256274|NCT02389751|Antimitotic Agents|antimitotic agents|mesh-ancestor
102256275|NCT02389751|Mitosis Modulators|mitosis modulators|mesh-ancestor
102256276|NCT02389751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256277|NCT02390063|Cyclophosphamide|cyclophosphamide|mesh-list
102256278|NCT02390063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102256279|NCT02390063|Immunologic Factors|immunologic factors|mesh-ancestor
102256280|NCT02390063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256281|NCT02390063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102256282|NCT02390063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102256283|NCT02390063|Alkylating Agents|alkylating agents|mesh-ancestor
102256284|NCT02390063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256285|NCT02390063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256286|NCT02390063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102256287|NCT02388035|Cefotaxime|cefotaxime|mesh-list
102256288|NCT02388035|Cefoxitin|cefoxitin|mesh-list
102256289|NCT02388035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102256290|NCT02388035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102256291|NCT02389439|Artesunate|artesunate|mesh-list
102256292|NCT02389439|Pyronaridine|pyronaridine|mesh-list
101807392|NCT00747695|Rabeprazole|rabeprazole|mesh-list
102256293|NCT02389439|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
102256294|NCT02389439|Antimalarials|antimalarials|mesh-ancestor
102256295|NCT02389439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102256296|NCT02389439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102256297|NCT02389439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102256298|NCT02389439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256299|NCT02389439|Antiviral Agents|antiviral agents|mesh-ancestor
102256300|NCT02389439|Schistosomicides|schistosomicides|mesh-ancestor
102256301|NCT02389439|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102256302|NCT02389439|Anthelmintics|anthelmintics|mesh-ancestor
102256303|NCT02663687|Complement C1s|complement c1s|mesh-list
102256304|NCT02663687|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
102256305|NCT02663687|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
102256306|NCT02663687|Immunologic Factors|immunologic factors|mesh-ancestor
102256307|NCT02663687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256308|NCT02663687|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102256309|NCT02663687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102256310|NCT02663453|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102256311|NCT02663453|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102256312|NCT02663453|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102256313|NCT02663453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102256314|NCT04439825|Botulinum Toxins|botulinum toxins|mesh-list
102256315|NCT04439825|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102256316|NCT04439825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102256317|NCT04439825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256318|NCT04439825|Cholinergic Agents|cholinergic agents|mesh-ancestor
102256319|NCT04439825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102256320|NCT04439825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256321|NCT02388581|Amoxicillin|amoxicillin|mesh-list
102256322|NCT02388581|Metronidazole|metronidazole|mesh-list
102256323|NCT02388581|Clarithromycin|clarithromycin|mesh-list
102256324|NCT02388581|Lansoprazole|lansoprazole|mesh-list
101807457|NCT00960830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102256325|NCT02388581|Dexlansoprazole|dexlansoprazole|mesh-list
102256326|NCT02388581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102256327|NCT02388581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102256328|NCT02388581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102256329|NCT02388581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102256330|NCT02388581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102256331|NCT02388581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102256332|NCT02388581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256333|NCT02388581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102256334|NCT02388581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102256335|NCT02388581|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102256336|NCT02388581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102256337|NCT02388581|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102256339|NCT02387567|Anesthetics, Local|anesthetics, local|mesh-ancestor
102256340|NCT02387567|Anesthetics|anesthetics|mesh-ancestor
102256341|NCT02387567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102256342|NCT02387567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256343|NCT02387567|Sensory System Agents|sensory system agents|mesh-ancestor
102256344|NCT02387567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102256345|NCT02387567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102256346|NCT02387567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102256347|NCT02387567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102256348|NCT02387567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102256349|NCT02387567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256350|NCT02383121|Midodrine|midodrine|mesh-list
102256351|NCT02383121|Sympathomimetics|sympathomimetics|mesh-ancestor
102256352|NCT02383121|Autonomic Agents|autonomic agents|mesh-ancestor
102256353|NCT02383121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102256354|NCT02383121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256355|NCT02383121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102256356|NCT02383121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102256357|NCT02383121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102256358|NCT02383121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102256359|NCT02383121|Adrenergic Agents|adrenergic agents|mesh-ancestor
102256360|NCT02383121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102256361|NCT02383121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256362|NCT02387021|Ropivacaine|ropivacaine|mesh-list
102256363|NCT02387021|Anesthetics, Local|anesthetics, local|mesh-ancestor
102256364|NCT02387021|Anesthetics|anesthetics|mesh-ancestor
102256365|NCT02387021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102256366|NCT02387021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256367|NCT02387021|Sensory System Agents|sensory system agents|mesh-ancestor
101807633|NCT03942042|Ixekizumab|ixekizumab|mesh-list
102256368|NCT02387021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102256369|NCT02386943|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102256370|NCT02386943|Saxagliptin|saxagliptin|mesh-list
102256371|NCT02386943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102256372|NCT02386943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256373|NCT02386943|Incretins|incretins|mesh-ancestor
102256374|NCT02386943|Hormones|hormones|mesh-ancestor
102256375|NCT02386943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102256376|NCT02386943|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102256377|NCT02386943|Protease Inhibitors|protease inhibitors|mesh-ancestor
102256378|NCT02386943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102256379|NCT02386943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256380|NCT02084056|Metformin|metformin|mesh-list
102256381|NCT02084056|Linagliptin|linagliptin|mesh-list
102256382|NCT02084056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102256383|NCT02084056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256384|NCT02084056|Incretins|incretins|mesh-ancestor
102256385|NCT02084056|Hormones|hormones|mesh-ancestor
102256386|NCT02084056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102256387|NCT02084056|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102256388|NCT02084056|Protease Inhibitors|protease inhibitors|mesh-ancestor
102256389|NCT02084056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102256390|NCT02084056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256391|NCT04714372|Cyclophosphamide|cyclophosphamide|mesh-list
102613525|NCT04783415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102256392|NCT04714372|Fludarabine|fludarabine|mesh-list
102256393|NCT04714372|Daratumumab|daratumumab|mesh-list
102256394|NCT04714372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102256395|NCT04714372|Immunologic Factors|immunologic factors|mesh-ancestor
102256396|NCT04714372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256397|NCT04714372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102256398|NCT04714372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102256399|NCT04714372|Alkylating Agents|alkylating agents|mesh-ancestor
102256400|NCT04714372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256401|NCT04714372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256402|NCT04714372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102256403|NCT04787471|Riboflavin|riboflavin|mesh-list
102256404|NCT04787471|Vitamin B Complex|vitamin b complex|mesh-ancestor
102256405|NCT04787471|Vitamins|vitamins|mesh-ancestor
102256406|NCT04787471|Micronutrients|micronutrients|mesh-ancestor
102256407|NCT04787471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965280|NCT01090895|Ascorbic Acid|ascorbic acid|mesh-list
102256408|NCT04787471|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102256410|NCT02386397|Gemcitabine|gemcitabine|mesh-list
102256411|NCT02386397|Oxaliplatin|oxaliplatin|mesh-list
102256412|NCT02386397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102256413|NCT02386397|Antimetabolites|antimetabolites|mesh-ancestor
102256414|NCT02386397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256415|NCT02386397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256416|NCT02386475|Dexetimide|dexetimide|mesh-list
102256417|NCT02386475|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102256418|NCT02386475|Citalopram|citalopram|mesh-list
102256419|NCT02386475|Escitalopram|escitalopram|mesh-list
102256420|NCT02386475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102256421|NCT02386475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102256422|NCT02386475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102256423|NCT02386475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256424|NCT02386475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102256425|NCT02386475|Serotonin Agents|serotonin agents|mesh-ancestor
102256426|NCT02386475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256427|NCT02386475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102256428|NCT02386475|Antidepressive Agents|antidepressive agents|mesh-ancestor
102256429|NCT02386475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102256430|NCT02386475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102256431|NCT02386475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102256432|NCT02386475|Parasympatholytics|parasympatholytics|mesh-ancestor
102256433|NCT02386475|Autonomic Agents|autonomic agents|mesh-ancestor
102256434|NCT02386475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102256435|NCT02386475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102256436|NCT02386475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102256437|NCT02386475|Cholinergic Agents|cholinergic agents|mesh-ancestor
102256438|NCT02386475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102256439|NCT02386475|Immunologic Factors|immunologic factors|mesh-ancestor
102256440|NCT02386475|Dopamine Agonists|dopamine agonists|mesh-ancestor
102256441|NCT02386475|Dopamine Agents|dopamine agents|mesh-ancestor
102256442|NCT05136443|Loteprednol Etabonate|loteprednol etabonate|mesh-list
102256443|NCT05136443|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102256444|NCT02382653|Piroxicam|piroxicam|mesh-list
102256445|NCT02382653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102256446|NCT02382653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102256447|NCT02382653|Analgesics|analgesics|mesh-ancestor
102256448|NCT02382653|Sensory System Agents|sensory system agents|mesh-ancestor
102256449|NCT02382653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102256450|NCT02382653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256451|NCT02382653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102256452|NCT02382653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102256453|NCT02382653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102256454|NCT02382653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102256455|NCT02382653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256456|NCT02382263|Paclitaxel|paclitaxel|mesh-list
102256457|NCT02382263|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102256458|NCT02382263|Gemcitabine|gemcitabine|mesh-list
102256459|NCT02382263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101807958|NCT00965874|Anesthetics|anesthetics|mesh-ancestor
102256460|NCT02382263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256461|NCT02382263|Tubulin Modulators|tubulin modulators|mesh-ancestor
102256462|NCT02382263|Antimitotic Agents|antimitotic agents|mesh-ancestor
102256463|NCT02382263|Mitosis Modulators|mitosis modulators|mesh-ancestor
102256464|NCT02382263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256465|NCT02382263|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102256466|NCT02382263|Antimetabolites|antimetabolites|mesh-ancestor
102256467|NCT02382029|Clonazepam|clonazepam|mesh-list
102256469|NCT02382029|GABA Modulators|gaba modulators|mesh-ancestor
102256470|NCT02382029|GABA Agents|gaba agents|mesh-ancestor
102256471|NCT02382029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102256472|NCT02382029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256473|NCT02382029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256474|NCT02385617|Octreotide|octreotide|mesh-list
102256475|NCT02385617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102256476|NCT02385617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102256477|NCT02385617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256478|NCT02385539|Levobupivacaine|levobupivacaine|mesh-list
102256479|NCT02385539|Anesthetics, Local|anesthetics, local|mesh-ancestor
102256480|NCT02385539|Anesthetics|anesthetics|mesh-ancestor
101965353|NCT01091207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102256481|NCT02385539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102256482|NCT02385539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256483|NCT02385539|Sensory System Agents|sensory system agents|mesh-ancestor
102256484|NCT02385539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102256485|NCT02385461|Heparin|heparin|mesh-list
102256486|NCT02385461|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102256487|NCT02385461|Tinzaparin|tinzaparin|mesh-list
102256488|NCT02385461|Dalteparin|dalteparin|mesh-list
102256489|NCT02385461|Anticoagulants|anticoagulants|mesh-ancestor
102256490|NCT02385461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102256491|NCT02385461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102256492|NCT02385461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256493|NCT02381717|Morphine|morphine|mesh-list
102256494|NCT02381717|Bupivacaine|bupivacaine|mesh-list
102256495|NCT02381717|Anesthetics, Local|anesthetics, local|mesh-ancestor
102256496|NCT02381717|Anesthetics|anesthetics|mesh-ancestor
102256497|NCT02381717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102256498|NCT02381717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256499|NCT02381717|Sensory System Agents|sensory system agents|mesh-ancestor
102256500|NCT02381717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102256501|NCT02381717|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102256502|NCT02381717|Narcotics|narcotics|mesh-ancestor
102256503|NCT02381717|Analgesics|analgesics|mesh-ancestor
102256504|NCT02385305|Anesthetics|anesthetics|mesh-list
102256505|NCT02385305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102256506|NCT02385305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256507|NCT02385227|Nicotine|nicotine|mesh-list
102256508|NCT02385227|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102256509|NCT02385227|Autonomic Agents|autonomic agents|mesh-ancestor
102256510|NCT02385227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102256511|NCT02385227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256512|NCT02385227|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102256513|NCT02385227|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102256514|NCT02385227|Cholinergic Agents|cholinergic agents|mesh-ancestor
102256515|NCT02385227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102256516|NCT02385227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256517|NCT02381249|Octreotide|octreotide|mesh-list
102256518|NCT02381249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102256519|NCT02381249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102256520|NCT02381249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256521|NCT02385071|Simeprevir|simeprevir|mesh-list
102256522|NCT02385071|Antiviral Agents|antiviral agents|mesh-ancestor
102256523|NCT02385071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102256524|NCT02385071|Protease Inhibitors|protease inhibitors|mesh-ancestor
102256525|NCT02385071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102256526|NCT02385071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256527|NCT02384915|Prilocaine|prilocaine|mesh-list
102256528|NCT02384915|Mepivacaine|mepivacaine|mesh-list
102256529|NCT02384915|Anesthetics|anesthetics|mesh-ancestor
102256530|NCT02384915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102256531|NCT02384915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256532|NCT02384915|Anesthetics, Local|anesthetics, local|mesh-ancestor
102256533|NCT02384915|Sensory System Agents|sensory system agents|mesh-ancestor
102256534|NCT02384915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102256535|NCT04895735|Pembrolizumab|pembrolizumab|mesh-list
102256536|NCT04895735|Pemetrexed|pemetrexed|mesh-list
102256537|NCT04895735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102256538|NCT04895735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256539|NCT04895735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102256540|NCT04895735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256541|NCT04895735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102256542|NCT04895735|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102256543|NCT04895735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102256545|NCT02384837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102256546|NCT02384837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102256547|NCT02384837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102256548|NCT02384837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256549|NCT02384837|Antifungal Agents|antifungal agents|mesh-ancestor
102256550|NCT02384837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102256551|NCT02384837|Immunologic Factors|immunologic factors|mesh-ancestor
102256552|NCT02384837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256553|NCT03105791|Analgesics, Opioid|analgesics, opioid|mesh-list
102256554|NCT03105791|Narcotics|narcotics|mesh-ancestor
102256555|NCT03105791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102256556|NCT03105791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256557|NCT03105791|Analgesics|analgesics|mesh-ancestor
102256558|NCT03105791|Sensory System Agents|sensory system agents|mesh-ancestor
102256559|NCT03105791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102256560|NCT02384135|Fibrin fragment D|fibrin fragment d|mesh-list
102256561|NCT02384135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102256562|NCT02384135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102256563|NCT02384135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256564|NCT02384135|Hemostatics|hemostatics|mesh-ancestor
102256565|NCT02384135|Coagulants|coagulants|mesh-ancestor
102256566|NCT02380625|Azithromycin|azithromycin|mesh-list
102256567|NCT02380625|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102256568|NCT02380625|Sunitinib|sunitinib|mesh-list
102256569|NCT02380625|Irbesartan|irbesartan|mesh-list
102256570|NCT02380625|Atorvastatin|atorvastatin|mesh-list
102256571|NCT02380625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102256572|NCT02380625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102256573|NCT02380625|Antimetabolites|antimetabolites|mesh-ancestor
102256574|NCT02380625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256575|NCT02380625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102256576|NCT02380625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102256577|NCT02380625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102256578|NCT02380625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256579|NCT02380625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102256580|NCT02380625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102256581|NCT02380625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102256582|NCT02380625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102256583|NCT02380625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102256584|NCT02380625|Growth Substances|growth substances|mesh-ancestor
102256585|NCT02380625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256586|NCT02380625|Growth Inhibitors|growth inhibitors|mesh-ancestor
102256587|NCT02380625|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102256588|NCT02380625|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102256589|NCT02380625|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102256590|NCT02380313|Prednisone|prednisone|mesh-list
102256591|NCT02380313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102256592|NCT02380313|Glucocorticoids|glucocorticoids|mesh-ancestor
102256593|NCT02380313|Hormones|hormones|mesh-ancestor
102256594|NCT02380313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102256595|NCT02380313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256596|NCT02380313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102256597|NCT02380313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256598|NCT01625182|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102256599|NCT01625182|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102256600|NCT01625182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256601|NCT01625182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102256602|NCT01625182|Immunologic Factors|immunologic factors|mesh-ancestor
102256603|NCT01625182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256604|NCT02383901|Methotrexate|methotrexate|mesh-list
102256605|NCT02383901|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102256606|NCT02383901|Abortifacient Agents|abortifacient agents|mesh-ancestor
102256607|NCT02383901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102256608|NCT02383901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256609|NCT02383901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102256610|NCT02383901|Antimetabolites|antimetabolites|mesh-ancestor
102256611|NCT02383901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256612|NCT02383901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256613|NCT02383901|Dermatologic Agents|dermatologic agents|mesh-ancestor
102256614|NCT02383901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102256615|NCT02383901|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102256616|NCT02383901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102256617|NCT02383901|Immunologic Factors|immunologic factors|mesh-ancestor
102256618|NCT02383901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102256619|NCT02383901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102256620|NCT02383823|Estradiol|estradiol|mesh-list
102256621|NCT02383823|Estrogens|estrogens|mesh-list
102256622|NCT02383823|Hormones|hormones|mesh-ancestor
102256623|NCT02383823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102256624|NCT02383823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256625|NCT02380001|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
102256626|NCT02380001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102256627|NCT02380001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102256628|NCT02380001|Analgesics|analgesics|mesh-ancestor
102256629|NCT02380001|Sensory System Agents|sensory system agents|mesh-ancestor
102256630|NCT02380001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102256631|NCT02380001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256632|NCT02380001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102256633|NCT02380001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102256634|NCT02379767|Harmine|harmine|mesh-list
102256635|NCT02379767|Hallucinogens|hallucinogens|mesh-ancestor
102256636|NCT02379767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256637|NCT02379767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102256638|NCT02379767|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102256639|NCT02379767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102256640|NCT02379767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256641|NCT02661815|Paclitaxel|paclitaxel|mesh-list
102256642|NCT02661815|Bevacizumab|bevacizumab|mesh-list
102256643|NCT02661815|Ricolinostat|ricolinostat|mesh-list
102256644|NCT02661815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102256645|NCT02661815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256646|NCT02661815|Tubulin Modulators|tubulin modulators|mesh-ancestor
102256647|NCT02661815|Antimitotic Agents|antimitotic agents|mesh-ancestor
102256648|NCT02661815|Mitosis Modulators|mitosis modulators|mesh-ancestor
102256649|NCT02661815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256650|NCT02661815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102256651|NCT02661815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102256652|NCT02661815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102256653|NCT02661815|Growth Substances|growth substances|mesh-ancestor
102256654|NCT02661815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256655|NCT02661815|Growth Inhibitors|growth inhibitors|mesh-ancestor
101808287|NCT04082910|Etanercept|etanercept|mesh-list
102256656|NCT02661815|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102256657|NCT02661815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102256658|NCT02377193|Mycophenolic Acid|mycophenolic acid|mesh-list
102256659|NCT02377193|Tacrolimus|tacrolimus|mesh-list
102256660|NCT02377193|Basiliximab|basiliximab|mesh-list
102256661|NCT02377193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102256662|NCT02377193|Immunologic Factors|immunologic factors|mesh-ancestor
102256663|NCT02377193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256664|NCT02377193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102256665|NCT02377193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102256666|NCT02377193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256667|NCT02377193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102256668|NCT02377193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256669|NCT02377193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102256670|NCT02377193|Antitubercular Agents|antitubercular agents|mesh-ancestor
102256671|NCT02377193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102256672|NCT02377193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102256673|NCT04688021|Cytarabine|cytarabine|mesh-list
102256674|NCT04688021|Cyclosporine|cyclosporine|mesh-list
102256675|NCT04688021|Mycophenolic Acid|mycophenolic acid|mesh-list
102256676|NCT04688021|Cyclophosphamide|cyclophosphamide|mesh-list
102256677|NCT04688021|Busulfan|busulfan|mesh-list
102256678|NCT04688021|Cyclosporins|cyclosporins|mesh-list
102256679|NCT04688021|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102256680|NCT04688021|Thymoglobulin|thymoglobulin|mesh-list
102256681|NCT04688021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102256682|NCT04688021|Immunologic Factors|immunologic factors|mesh-ancestor
101215832|NCT01477203|Serotonin Agents|serotonin agents|mesh-ancestor
102256683|NCT04688021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256684|NCT04688021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102256685|NCT04688021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102613526|NCT04783415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256686|NCT04688021|Alkylating Agents|alkylating agents|mesh-ancestor
102256687|NCT04688021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256688|NCT04688021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256689|NCT04688021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102613527|NCT04331093|Apatinib|apatinib|mesh-list
102256690|NCT04688021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102256692|NCT04688021|Antiviral Agents|antiviral agents|mesh-ancestor
102256693|NCT04688021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102256694|NCT04688021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102256695|NCT04688021|Antifungal Agents|antifungal agents|mesh-ancestor
102256696|NCT04688021|Dermatologic Agents|dermatologic agents|mesh-ancestor
102256697|NCT04688021|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102256698|NCT04688021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102256699|NCT04688021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102256700|NCT04688021|Antitubercular Agents|antitubercular agents|mesh-ancestor
102256701|NCT04688021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102256702|NCT02053246|Nebivolol|nebivolol|mesh-list
102256703|NCT02053246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102256704|NCT02053246|Vasodilator Agents|vasodilator agents|mesh-ancestor
102256705|NCT02053246|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102256706|NCT02053246|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102256707|NCT02053246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102256708|NCT02053246|Adrenergic Agents|adrenergic agents|mesh-ancestor
102256709|NCT02053246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102256710|NCT02053246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256711|NCT02053246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256712|NCT04678661|Insulin|insulin|mesh-list
102256713|NCT04678661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102256714|NCT04678661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256715|NCT02379299|Hormones|hormones|mesh-list
102256716|NCT02379299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102256717|NCT02379299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256718|NCT02376881|Epoetin Alfa|epoetin alfa|mesh-list
102256719|NCT02376881|Hematinics|hematinics|mesh-ancestor
102256720|NCT02032888|Sofosbuvir|sofosbuvir|mesh-list
102256721|NCT02032888|Antiviral Agents|antiviral agents|mesh-ancestor
102256722|NCT02032888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102256723|NCT02376803|Warfarin|warfarin|mesh-list
102256724|NCT02376803|Anticoagulants|anticoagulants|mesh-ancestor
102256725|NCT04132427|Vancomycin|vancomycin|mesh-list
102256726|NCT04132427|Magnesium citrate|magnesium citrate|mesh-list
102256727|NCT04132427|Citric Acid|citric acid|mesh-list
102256728|NCT04132427|Sodium Citrate|sodium citrate|mesh-list
102256729|NCT04132427|Anticoagulants|anticoagulants|mesh-ancestor
102256730|NCT04132427|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102256731|NCT04132427|Chelating Agents|chelating agents|mesh-ancestor
102256732|NCT04132427|Sequestering Agents|sequestering agents|mesh-ancestor
102256733|NCT04132427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256734|NCT04132427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102256735|NCT04132427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102256736|NCT04132427|Cathartics|cathartics|mesh-ancestor
102256737|NCT04132427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102256738|NCT02031640|Beclomethasone|beclomethasone|mesh-list
102256739|NCT02031640|Albuterol|albuterol|mesh-list
102256740|NCT02031640|Bronchodilator Agents|bronchodilator agents|mesh-list
102256741|NCT02031640|Autonomic Agents|autonomic agents|mesh-ancestor
102256742|NCT02031640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102256743|NCT02031640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256744|NCT02031640|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102256745|NCT02031640|Respiratory System Agents|respiratory system agents|mesh-ancestor
102256746|NCT02031640|Tocolytic Agents|tocolytic agents|mesh-ancestor
102256747|NCT02031640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102256748|NCT02031640|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102256749|NCT02031640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102256750|NCT02031640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102256751|NCT02031640|Adrenergic Agents|adrenergic agents|mesh-ancestor
102256752|NCT02031640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102256753|NCT02031640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256754|NCT02031640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101808575|NCT04006470|Fluorides|fluorides|mesh-list
102256755|NCT02031640|Glucocorticoids|glucocorticoids|mesh-ancestor
102256756|NCT02031640|Hormones|hormones|mesh-ancestor
102256757|NCT02031640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102256758|NCT02376413|Trastuzumab|trastuzumab|mesh-list
102256759|NCT02376413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102256760|NCT02376413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256761|NCT02378441|Metformin|metformin|mesh-list
102256762|NCT02378441|Atorvastatin|atorvastatin|mesh-list
101808638|NCT04007328|Hormones|hormones|mesh-ancestor
102256763|NCT02378441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102256764|NCT02378441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256765|NCT02378441|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102256766|NCT02378441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102256767|NCT02378441|Antimetabolites|antimetabolites|mesh-ancestor
102256768|NCT02378441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256769|NCT02378441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102256770|NCT02378441|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102256771|NCT02378441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102256772|NCT04600427|Anesthetics|anesthetics|mesh-list
102256773|NCT04600427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102256774|NCT04600427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256775|NCT02378129|Methamphetamine|methamphetamine|mesh-list
102256776|NCT02378129|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102256777|NCT02378129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256778|NCT02378129|Sympathomimetics|sympathomimetics|mesh-ancestor
101965665|NCT01096199|Cisplatin|cisplatin|mesh-list
102256779|NCT02378129|Autonomic Agents|autonomic agents|mesh-ancestor
102256780|NCT02378129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102256781|NCT02378129|Dopamine Agents|dopamine agents|mesh-ancestor
102256782|NCT02378129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102256783|NCT02378129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256784|NCT02378129|Adrenergic Agents|adrenergic agents|mesh-ancestor
102256785|NCT02378129|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102256786|NCT02378129|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102256787|NCT02378129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102256788|NCT02378129|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102256789|NCT02376335|Rituximab|rituximab|mesh-list
101808814|NCT00545298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102256790|NCT02376335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102256791|NCT02376335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256792|NCT02376335|Immunologic Factors|immunologic factors|mesh-ancestor
102256793|NCT02376335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256794|NCT02376335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102256795|NCT02375867|Methylprednisolone|methylprednisolone|mesh-list
102256796|NCT02375867|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102256797|NCT02375867|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102256798|NCT02375867|Prednisolone|prednisolone|mesh-list
102256799|NCT02375867|Prednisolone acetate|prednisolone acetate|mesh-list
102256800|NCT02375867|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102256801|NCT02375867|Prednisolone phosphate|prednisolone phosphate|mesh-list
102256802|NCT02375867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102256803|NCT02375867|Antiemetics|antiemetics|mesh-ancestor
102256804|NCT02375867|Autonomic Agents|autonomic agents|mesh-ancestor
102256805|NCT02375867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102256806|NCT02375867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256807|NCT02375867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102256808|NCT02375867|Glucocorticoids|glucocorticoids|mesh-ancestor
102256809|NCT02375867|Hormones|hormones|mesh-ancestor
102256810|NCT02375867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102256811|NCT02375867|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102256812|NCT02375867|Protective Agents|protective agents|mesh-ancestor
102256813|NCT02375867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102256814|NCT02375867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256815|NCT04540133|Dexamethasone|dexamethasone|mesh-list
101217343|NCT01486511|Liver Extracts|liver extracts|mesh-list
102256816|NCT04540133|Dexamethasone acetate|dexamethasone acetate|mesh-list
102256817|NCT04540133|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102256818|NCT04540133|BB 1101|bb 1101|mesh-list
102256819|NCT04540133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102256820|NCT04540133|Antiemetics|antiemetics|mesh-ancestor
102256821|NCT04540133|Autonomic Agents|autonomic agents|mesh-ancestor
102256822|NCT04540133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102256823|NCT04540133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256824|NCT04540133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102256825|NCT04540133|Glucocorticoids|glucocorticoids|mesh-ancestor
102256826|NCT04540133|Hormones|hormones|mesh-ancestor
102256827|NCT04540133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102256828|NCT04540133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102256829|NCT04540133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256830|NCT04540133|Protease Inhibitors|protease inhibitors|mesh-ancestor
102256831|NCT04540133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102256832|NCT04540133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256833|NCT02375243|Dexmedetomidine|dexmedetomidine|mesh-list
102256834|NCT02375243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102256835|NCT02375243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102256836|NCT02375243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256837|NCT02375243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102613528|NCT04331093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613529|NCT04331093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102256838|NCT02375243|Analgesics|analgesics|mesh-ancestor
102256839|NCT02375243|Sensory System Agents|sensory system agents|mesh-ancestor
102256840|NCT02375243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102256841|NCT02375243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102256842|NCT02375243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102256843|NCT02375243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102256844|NCT02375243|Adrenergic Agents|adrenergic agents|mesh-ancestor
102256845|NCT02375243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102256846|NCT02375243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256847|NCT02374931|Estradiol|estradiol|mesh-list
102256848|NCT02374931|Estrogens|estrogens|mesh-ancestor
102256849|NCT02374931|Hormones|hormones|mesh-ancestor
102256850|NCT02374931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102256851|NCT02374931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256852|NCT02377661|Amlodipine|amlodipine|mesh-list
102256853|NCT02377661|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102256854|NCT02377661|Olmesartan|olmesartan|mesh-list
102256855|NCT02377661|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
102256856|NCT02377661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102256857|NCT02377661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102256858|NCT02377661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102256859|NCT02377661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256860|NCT02377661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102256861|NCT02377661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256862|NCT02377661|Vasodilator Agents|vasodilator agents|mesh-ancestor
102256863|NCT02377661|Diuretics|diuretics|mesh-ancestor
102256864|NCT02377661|Natriuretic Agents|natriuretic agents|mesh-ancestor
102256865|NCT02377661|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102256866|NCT02377661|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102256867|NCT02377661|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102256868|NCT02372357|Posaconazole|posaconazole|mesh-list
102256869|NCT02372357|Antifungal Agents|antifungal agents|mesh-ancestor
102256870|NCT02372357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102256871|NCT02372357|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102256872|NCT02372357|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102256873|NCT02372357|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102256874|NCT02372357|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102256875|NCT02372357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102256876|NCT02372357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102256877|NCT02372357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256878|NCT02372357|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102256879|NCT02372357|Hormone Antagonists|hormone antagonists|mesh-ancestor
102256880|NCT02372357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102256881|NCT02372357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256882|NCT03672773|Temozolomide|temozolomide|mesh-list
102256883|NCT03672773|Talazoparib|talazoparib|mesh-list
102256884|NCT03672773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102256885|NCT03672773|Alkylating Agents|alkylating agents|mesh-ancestor
102256886|NCT03672773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256887|NCT03672773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256888|NCT03672773|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102256889|NCT03672773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102256890|NCT03625349|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
102256891|NCT03625349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102256892|NCT03625349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256893|NCT02371577|Lenalidomide|lenalidomide|mesh-list
102256894|NCT02371577|Immunologic Factors|immunologic factors|mesh-ancestor
102256895|NCT02371577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256896|NCT02371577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101809617|NCT05525858|Maytansine|maytansine|mesh-list
102256897|NCT02371577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102256898|NCT02371577|Growth Substances|growth substances|mesh-ancestor
102256899|NCT02371577|Growth Inhibitors|growth inhibitors|mesh-ancestor
102256900|NCT02371577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256901|NCT02373449|Ketamine|ketamine|mesh-list
102256902|NCT02373449|Analgesics|analgesics|mesh-ancestor
102256903|NCT02373449|Sensory System Agents|sensory system agents|mesh-ancestor
102256904|NCT02373449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102256905|NCT02373449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809678|NCT05498220|Antimetabolites|antimetabolites|mesh-ancestor
102256906|NCT02373449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102256907|NCT02373449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102256908|NCT02373449|Anesthetics, General|anesthetics, general|mesh-ancestor
102256910|NCT02373449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102256911|NCT02373449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102256912|NCT02373449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102256913|NCT02373449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102256914|NCT02373449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256915|NCT02371421|Allopurinol|allopurinol|mesh-list
102256916|NCT02371421|Antimetabolites|antimetabolites|mesh-ancestor
102256917|NCT02371421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256918|NCT02371421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102256919|NCT02371421|Gout Suppressants|gout suppressants|mesh-ancestor
102256920|NCT02371421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102256921|NCT02371421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102256922|NCT02371421|Antioxidants|antioxidants|mesh-ancestor
102256923|NCT02371421|Protective Agents|protective agents|mesh-ancestor
102256924|NCT02371421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256925|NCT02371031|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
102256926|NCT02371031|Dopamine Agents|dopamine agents|mesh-ancestor
102256927|NCT02371031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102256928|NCT02371031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256929|NCT02371031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256930|NCT03959891|Letrozole|letrozole|mesh-list
102256931|NCT03959891|Fulvestrant|fulvestrant|mesh-list
102256932|NCT03959891|Palbociclib|palbociclib|mesh-list
102256933|NCT03959891|Ipatasertib|ipatasertib|mesh-list
102256934|NCT03959891|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102256935|NCT03959891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256936|NCT03959891|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102256937|NCT03959891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102256938|NCT03959891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256939|NCT03959891|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102256940|NCT03959891|Hormone Antagonists|hormone antagonists|mesh-ancestor
102256941|NCT03959891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102256942|NCT03959891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256943|NCT03959891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102256944|NCT03959891|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102256945|NCT03959891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102256946|NCT02373215|Nalbuphine|nalbuphine|mesh-list
102256947|NCT02373215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102256948|NCT02373215|Narcotics|narcotics|mesh-ancestor
102256949|NCT02373215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102256950|NCT02373215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256951|NCT02373215|Analgesics|analgesics|mesh-ancestor
102256952|NCT02373215|Sensory System Agents|sensory system agents|mesh-ancestor
102256953|NCT02373215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102256954|NCT03785249|Pembrolizumab|pembrolizumab|mesh-list
102256955|NCT03785249|Cetuximab|cetuximab|mesh-list
102256956|NCT03785249|Afatinib|afatinib|mesh-list
102256957|NCT03785249|Adagrasib|adagrasib|mesh-list
102256958|NCT03785249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102256959|NCT03785249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256960|NCT03785249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102256961|NCT03785249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220246|NCT01502605|Dermatologic Agents|dermatologic agents|mesh-ancestor
101809874|NCT05050448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101809875|NCT05050448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101809876|NCT05050448|Analgesics|analgesics|mesh-ancestor
101809877|NCT05050448|Sensory System Agents|sensory system agents|mesh-ancestor
101809878|NCT05050448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102256962|NCT03785249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102256963|NCT03785249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102256964|NCT03765983|Trastuzumab|trastuzumab|mesh-list
102256965|NCT03765983|GDC-0084|gdc-0084|mesh-list
102256966|NCT03765983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102256967|NCT03765983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102256968|NCT03765983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102256969|NCT03765983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256970|NCT02372903|Palmidrol|palmidrol|mesh-list
102256971|NCT02372903|Analgesics|analgesics|mesh-ancestor
102256972|NCT02372903|Sensory System Agents|sensory system agents|mesh-ancestor
102256973|NCT02372903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102256974|NCT02372903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256975|NCT02372903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102256976|NCT02372903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102256977|NCT02372903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102256978|NCT02372903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101809929|NCT04781088|Pembrolizumab|pembrolizumab|mesh-list
102256979|NCT02372903|Antiviral Agents|antiviral agents|mesh-ancestor
102256980|NCT02372903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102256981|NCT02372903|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102256982|NCT02372903|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102256983|NCT02372903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102256984|NCT02372903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102256985|NCT02372903|Hormones|hormones|mesh-ancestor
102256986|NCT02372903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102256987|NCT02372591|Buprenorphine|buprenorphine|mesh-list
102256988|NCT02372591|Hydromorphone|hydromorphone|mesh-list
102256989|NCT02372591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102256990|NCT02372591|Narcotics|narcotics|mesh-ancestor
102256991|NCT02372591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102256992|NCT02372591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102256993|NCT02372591|Analgesics|analgesics|mesh-ancestor
102256994|NCT02372591|Sensory System Agents|sensory system agents|mesh-ancestor
102256995|NCT02372591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102256996|NCT02372591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102256997|NCT02372669|Chitosan|chitosan|mesh-list
102256998|NCT02372669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102256999|NCT02372669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102257000|NCT02372669|Antimetabolites|antimetabolites|mesh-ancestor
101809979|NCT04680910|Propofol|propofol|mesh-list
102257001|NCT02372669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257002|NCT02372669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102257003|NCT02372669|Chelating Agents|chelating agents|mesh-ancestor
102257004|NCT02372669|Sequestering Agents|sequestering agents|mesh-ancestor
101965871|NCT02263690|Anesthetics, Local|anesthetics, local|mesh-ancestor
102257005|NCT02372669|Hemostatics|hemostatics|mesh-ancestor
102257006|NCT02372669|Coagulants|coagulants|mesh-ancestor
102257007|NCT02369861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102257008|NCT02369861|Lubricant Eye Drops|lubricant eye drops|mesh-list
102257009|NCT02369861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102257010|NCT02369939|Fluorouracil|fluorouracil|mesh-list
102257011|NCT02369939|Mitomycins|mitomycins|mesh-list
102257012|NCT02369939|Mitomycin|mitomycin|mesh-list
101810031|NCT04606914|Tubulin Modulators|tubulin modulators|mesh-ancestor
101810032|NCT04606914|Antimitotic Agents|antimitotic agents|mesh-ancestor
101810033|NCT04606914|Mitosis Modulators|mitosis modulators|mesh-ancestor
101810034|NCT04606914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810035|NCT04600648|Insulin|insulin|mesh-list
101810036|NCT04600648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101810037|NCT04600648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810038|NCT04564885|Meloxicam|meloxicam|mesh-list
101810041|NCT04564885|Analgesics|analgesics|mesh-ancestor
102257013|NCT02369939|Antimetabolites|antimetabolites|mesh-ancestor
102257014|NCT02369939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257015|NCT02369939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102257016|NCT02369939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102257017|NCT02369939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102257018|NCT02369939|Immunologic Factors|immunologic factors|mesh-ancestor
102257019|NCT02369939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257020|NCT02369939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102257021|NCT02369939|Alkylating Agents|alkylating agents|mesh-ancestor
102257022|NCT02369939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102257023|NCT02369939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102257024|NCT02369549|Curcumin|curcumin|mesh-list
102257025|NCT02369549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102257026|NCT02369549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102257027|NCT02369549|Analgesics|analgesics|mesh-ancestor
102257028|NCT02369549|Sensory System Agents|sensory system agents|mesh-ancestor
102257029|NCT02369549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102257030|NCT02369549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257031|NCT02369549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102257032|NCT02369549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102257033|NCT02369549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102257034|NCT02369549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102257035|NCT02369549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257036|NCT02365415|Sirolimus|sirolimus|mesh-list
102257037|NCT02365415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102257038|NCT02365415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102257039|NCT02365415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102257040|NCT02365415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102257041|NCT02365415|Antifungal Agents|antifungal agents|mesh-ancestor
102257042|NCT02365415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102257043|NCT02365415|Immunologic Factors|immunologic factors|mesh-ancestor
102257044|NCT02365415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257045|NCT02369081|Bisoprolol|bisoprolol|mesh-list
102257046|NCT02369081|Doxazosin|doxazosin|mesh-list
102257047|NCT02369081|Spironolactone|spironolactone|mesh-list
102257048|NCT02369081|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102257049|NCT02369081|Hormone Antagonists|hormone antagonists|mesh-ancestor
102257050|NCT02369081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102257051|NCT02369081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257052|NCT02369081|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102257053|NCT02369081|Diuretics|diuretics|mesh-ancestor
102257054|NCT02369081|Natriuretic Agents|natriuretic agents|mesh-ancestor
102257055|NCT02369081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102257056|NCT02369081|Sympatholytics|sympatholytics|mesh-ancestor
102613531|NCT04331093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613532|NCT05124977|Anti-Infective Agents|anti-infective agents|mesh-list
102257057|NCT02369081|Autonomic Agents|autonomic agents|mesh-ancestor
102257058|NCT02369081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102257059|NCT02369081|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102257060|NCT02369081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102257061|NCT02369081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102257062|NCT02369081|Adrenergic Agents|adrenergic agents|mesh-ancestor
102257063|NCT02369081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102257064|NCT02369081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257065|NCT02369081|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102257066|NCT02369081|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102257067|NCT02365493|Cefazolin|cefazolin|mesh-list
102257068|NCT02365493|Lactams|lactams|mesh-list
102257069|NCT02365493|beta-Lactams|beta-lactams|mesh-list
102257070|NCT02365493|Floxacillin|floxacillin|mesh-list
102257071|NCT02365493|Cloxacillin|cloxacillin|mesh-list
102257072|NCT02365493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102257073|NCT02365493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102257074|NCT02365181|Ropivacaine|ropivacaine|mesh-list
102257075|NCT02365181|Anesthetics, Local|anesthetics, local|mesh-list
102257076|NCT02365181|Anesthetics|anesthetics|mesh-list
102257077|NCT02365181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102257078|NCT02365181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257079|NCT02365181|Sensory System Agents|sensory system agents|mesh-ancestor
102257080|NCT02365181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102257081|NCT05653895|Metformin|metformin|mesh-list
102257082|NCT05653895|Resveratrol|resveratrol|mesh-list
102257083|NCT05653895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102257084|NCT05653895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257085|NCT05653895|Antioxidants|antioxidants|mesh-ancestor
102257086|NCT05653895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257087|NCT05653895|Protective Agents|protective agents|mesh-ancestor
102257088|NCT05653895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102257089|NCT05653895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102257090|NCT02364479|Etanercept|etanercept|mesh-list
102257091|NCT02364479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102257092|NCT02364479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102257093|NCT02364479|Analgesics|analgesics|mesh-ancestor
102257094|NCT02364479|Sensory System Agents|sensory system agents|mesh-ancestor
102257095|NCT02364479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102257096|NCT02364479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257097|NCT02364479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102257098|NCT02364479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102257099|NCT02364479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102257100|NCT02364479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102257101|NCT02364479|Immunologic Factors|immunologic factors|mesh-ancestor
102257102|NCT05653817|Paclitaxel|paclitaxel|mesh-list
102257103|NCT05653817|Apatinib|apatinib|mesh-list
102257104|NCT05653817|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102257105|NCT05653817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102257106|NCT05653817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102257107|NCT05653817|Tubulin Modulators|tubulin modulators|mesh-ancestor
102257108|NCT05653817|Antimitotic Agents|antimitotic agents|mesh-ancestor
102257109|NCT05653817|Mitosis Modulators|mitosis modulators|mesh-ancestor
102257110|NCT05653817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257111|NCT05653817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102257112|NCT05653817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102257113|NCT02052310|Epoetin Alfa|epoetin alfa|mesh-list
102257114|NCT02052310|Hematinics|hematinics|mesh-ancestor
102257115|NCT02368379|Metyrapone|metyrapone|mesh-list
102257116|NCT02368379|Antimetabolites|antimetabolites|mesh-ancestor
102257117|NCT02368379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257118|NCT02368379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102257119|NCT02051296|Minocycline|minocycline|mesh-list
102257120|NCT02051296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102257121|NCT02051296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102257122|NCT02367755|Lorazepam|lorazepam|mesh-list
102257123|NCT02367755|Propofol|propofol|mesh-list
101810529|NCT02919917|Midodrine|midodrine|mesh-list
102257124|NCT02367755|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102257125|NCT02367755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102257126|NCT02367755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257127|NCT02367755|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102257128|NCT02367755|Anesthetics, General|anesthetics, general|mesh-ancestor
102257129|NCT02367755|Anesthetics|anesthetics|mesh-ancestor
102257130|NCT02367755|Anticonvulsants|anticonvulsants|mesh-ancestor
102613533|NCT05124977|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102257131|NCT02367755|Antiemetics|antiemetics|mesh-ancestor
102257132|NCT02367755|Autonomic Agents|autonomic agents|mesh-ancestor
102613534|NCT00382421|Aspirin|aspirin|mesh-list
102613535|NCT00382421|Amlodipine|amlodipine|mesh-list
102257133|NCT02367755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102257134|NCT02367755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102257135|NCT02367755|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102257136|NCT02367755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102257137|NCT02367755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101810591|NCT02507687|Bimatoprost|bimatoprost|mesh-list
102257138|NCT02367755|GABA Modulators|gaba modulators|mesh-ancestor
102257139|NCT02367755|GABA Agents|gaba agents|mesh-ancestor
102257140|NCT02367755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102257141|NCT02367755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257142|NCT02363699|Lidocaine|lidocaine|mesh-list
102257143|NCT02363699|Anesthetics, Local|anesthetics, local|mesh-ancestor
102257144|NCT02363699|Anesthetics|anesthetics|mesh-ancestor
102257145|NCT02363699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102257146|NCT02363699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257147|NCT02363699|Sensory System Agents|sensory system agents|mesh-ancestor
102257148|NCT02363699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102257149|NCT02363699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102257150|NCT02363699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102257151|NCT02363699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102257152|NCT02363699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102257153|NCT02363699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257154|NCT02049814|Metformin|metformin|mesh-list
102257155|NCT02049814|Acarbose|acarbose|mesh-list
101966033|NCT01357642|Epinephrine|epinephrine|mesh-list
102257156|NCT02049814|Voglibose|voglibose|mesh-list
101810649|NCT00901511|Sargramostim|sargramostim|mesh-list
102257157|NCT02049814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102257158|NCT02049814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257159|NCT02049814|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102257160|NCT02049814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102257161|NCT02049814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257162|NCT03344159|Spironolactone|spironolactone|mesh-list
102257163|NCT03344159|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102257164|NCT03344159|Hormone Antagonists|hormone antagonists|mesh-ancestor
101810710|NCT00098839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102257165|NCT03344159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102257166|NCT03344159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257167|NCT03344159|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102257168|NCT03344159|Diuretics|diuretics|mesh-ancestor
102257169|NCT03344159|Natriuretic Agents|natriuretic agents|mesh-ancestor
102257170|NCT03324113|Diphenhydramine|diphenhydramine|mesh-list
102257171|NCT03324113|Promethazine|promethazine|mesh-list
102257172|NCT03324113|Dexamethasone|dexamethasone|mesh-list
102257173|NCT03324113|Naphazoline|naphazoline|mesh-list
102257174|NCT03324113|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102257175|NCT03324113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102257176|NCT03324113|Antiemetics|antiemetics|mesh-ancestor
102257177|NCT03324113|Autonomic Agents|autonomic agents|mesh-ancestor
102257178|NCT03324113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102257179|NCT03324113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257180|NCT03324113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102257181|NCT03324113|Glucocorticoids|glucocorticoids|mesh-ancestor
102257182|NCT03324113|Hormones|hormones|mesh-ancestor
102257183|NCT03324113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102257184|NCT03324113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102257185|NCT03324113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102257186|NCT03324113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102257187|NCT03324113|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102257188|NCT03324113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102257189|NCT03324113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102257190|NCT03324113|Anesthetics, Local|anesthetics, local|mesh-ancestor
102257191|NCT03324113|Anesthetics|anesthetics|mesh-ancestor
102257192|NCT03324113|Sensory System Agents|sensory system agents|mesh-ancestor
102257193|NCT03324113|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102257194|NCT03324113|Histamine Antagonists|histamine antagonists|mesh-ancestor
102257195|NCT03324113|Histamine Agents|histamine agents|mesh-ancestor
102257196|NCT03324113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102257197|NCT03324113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257198|NCT03324113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102257199|NCT03324113|Antipruritics|antipruritics|mesh-ancestor
102257200|NCT03324113|Dermatologic Agents|dermatologic agents|mesh-ancestor
102257201|NCT03324113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102257202|NCT03324113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102257203|NCT03324113|Adrenergic Agents|adrenergic agents|mesh-ancestor
102257204|NCT03324113|Nasal Decongestants|nasal decongestants|mesh-ancestor
102613536|NCT00382421|Bisoprolol|bisoprolol|mesh-list
102257205|NCT03324113|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102257206|NCT03324113|Respiratory System Agents|respiratory system agents|mesh-ancestor
102257207|NCT02079844|Antipsychotic Agents|antipsychotic agents|mesh-list
102257208|NCT02079844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102257209|NCT02079844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102257210|NCT02079844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257211|NCT02079844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102257212|NCT02363075|Dextroamphetamine|dextroamphetamine|mesh-list
102257213|NCT02363075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102257214|NCT02363075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257215|NCT02363075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102257216|NCT02363075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102257217|NCT02363075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102257218|NCT02363075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257219|NCT02363075|Dopamine Agents|dopamine agents|mesh-ancestor
102257220|NCT02363075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102257221|NCT02367053|Glucagon|glucagon|mesh-list
102257222|NCT02367053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102257223|NCT02367053|Hormones|hormones|mesh-ancestor
101811032|NCT01085617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102257224|NCT02367053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102257225|NCT02367053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257226|NCT04417114|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102257227|NCT04417114|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102257228|NCT04417114|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102257229|NCT04417114|Antimetabolites|antimetabolites|mesh-ancestor
102257230|NCT04417114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966102|NCT01337752|Hormones|hormones|mesh-ancestor
102257232|NCT04417114|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102257233|NCT04417114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102257234|NCT02366975|Testosterone|testosterone|mesh-list
102257235|NCT02366975|Androgens|androgens|mesh-ancestor
102257236|NCT02366975|Hormones|hormones|mesh-ancestor
102257237|NCT02366975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102257238|NCT02366975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257239|NCT04479371|Bupivacaine|bupivacaine|mesh-list
102257240|NCT04479371|Anesthetics, Local|anesthetics, local|mesh-ancestor
102257241|NCT04479371|Anesthetics|anesthetics|mesh-ancestor
102257242|NCT04479371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101811160|NCT00751205|Antiemetics|antiemetics|mesh-ancestor
102257243|NCT04479371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257244|NCT04479371|Sensory System Agents|sensory system agents|mesh-ancestor
102257245|NCT04479371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102257246|NCT03112655|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
102257247|NCT03112655|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102257248|NCT03112655|Antidepressive Agents|antidepressive agents|mesh-ancestor
102257249|NCT03112655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102257250|NCT02366585|Cyclosporine|cyclosporine|mesh-list
102257251|NCT02366585|Cyclosporins|cyclosporins|mesh-list
102257252|NCT02366585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102257253|NCT02366585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257254|NCT02366585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102257255|NCT02366585|Immunologic Factors|immunologic factors|mesh-ancestor
102257256|NCT02366585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257257|NCT02366585|Antifungal Agents|antifungal agents|mesh-ancestor
102257258|NCT02366585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102257259|NCT02366585|Dermatologic Agents|dermatologic agents|mesh-ancestor
102257260|NCT02366585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102257261|NCT02366585|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102257262|NCT02079532|Rituximab|rituximab|mesh-list
102257263|NCT02079532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102257264|NCT02079532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102257265|NCT02079532|Immunologic Factors|immunologic factors|mesh-ancestor
102257266|NCT02079532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257267|NCT02079532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102257268|NCT02958917|Pirfenidone|pirfenidone|mesh-list
102257269|NCT02958917|Analgesics|analgesics|mesh-ancestor
102257270|NCT02958917|Sensory System Agents|sensory system agents|mesh-ancestor
101811354|NCT00684203|Aspirin|aspirin|mesh-list
102257271|NCT02958917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102257272|NCT02958917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257273|NCT02958917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102257274|NCT02958917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102257275|NCT02958917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101901959|NCT02530632|Propofol|propofol|mesh-list
102613537|NCT00382421|Molsidomine|molsidomine|mesh-list
102613538|NCT00382421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102257276|NCT02958917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101811423|NCT00683657|Hormones|hormones|mesh-ancestor
102257277|NCT02958917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102257278|NCT02362529|Minocycline|minocycline|mesh-list
102257279|NCT02362529|Celecoxib|celecoxib|mesh-list
102257280|NCT02362529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102257281|NCT02362529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102257282|NCT02362529|Analgesics|analgesics|mesh-ancestor
102257283|NCT02362529|Sensory System Agents|sensory system agents|mesh-ancestor
102257284|NCT02362529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102257285|NCT02362529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257286|NCT02362529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102257287|NCT02362529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102257288|NCT02362529|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102257289|NCT02362529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102257290|NCT02362529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102257291|NCT02362529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257292|NCT02362529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102257293|NCT02362529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102257294|NCT02794571|Paclitaxel|paclitaxel|mesh-list
102257295|NCT02794571|Etoposide|etoposide|mesh-list
102257296|NCT02794571|Bevacizumab|bevacizumab|mesh-list
102257297|NCT02794571|Carboplatin|carboplatin|mesh-list
102257298|NCT02794571|Pembrolizumab|pembrolizumab|mesh-list
102257299|NCT02794571|Capecitabine|capecitabine|mesh-list
102257300|NCT02794571|Pemetrexed|pemetrexed|mesh-list
102257301|NCT02794571|Atezolizumab|atezolizumab|mesh-list
101811544|NCT00757679|Analgesics|analgesics|mesh-ancestor
102257302|NCT02794571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102257303|NCT02794571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102257304|NCT02794571|Tubulin Modulators|tubulin modulators|mesh-ancestor
102257305|NCT02794571|Antimitotic Agents|antimitotic agents|mesh-ancestor
102257306|NCT02794571|Mitosis Modulators|mitosis modulators|mesh-ancestor
102257307|NCT02794571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257308|NCT02794571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102257309|NCT02794571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102257310|NCT02794571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102257311|NCT02794571|Growth Substances|growth substances|mesh-ancestor
102257312|NCT02794571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257313|NCT02794571|Growth Inhibitors|growth inhibitors|mesh-ancestor
102257314|NCT02794571|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101811603|NCT01324180|Glucocorticoids|glucocorticoids|mesh-ancestor
102257315|NCT02794571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102257316|NCT02794571|Antimetabolites|antimetabolites|mesh-ancestor
102257317|NCT02794571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102257318|NCT02794571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102257319|NCT02794571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102257320|NCT02794571|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102257321|NCT02794571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102257322|NCT02769689|Methylprednisolone|methylprednisolone|mesh-list
102257323|NCT02769689|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102257324|NCT02769689|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102257326|NCT02769689|Prednisolone acetate|prednisolone acetate|mesh-list
102257327|NCT02769689|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102257328|NCT02769689|Prednisolone phosphate|prednisolone phosphate|mesh-list
102257329|NCT02769689|Natalizumab|natalizumab|mesh-list
102257330|NCT02769689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102257331|NCT02769689|Antiemetics|antiemetics|mesh-ancestor
102257332|NCT02769689|Autonomic Agents|autonomic agents|mesh-ancestor
102257333|NCT02769689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102257334|NCT02769689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257335|NCT02769689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102257336|NCT02769689|Glucocorticoids|glucocorticoids|mesh-ancestor
102257337|NCT02769689|Hormones|hormones|mesh-ancestor
102257338|NCT02769689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102257339|NCT02769689|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102257340|NCT02769689|Protective Agents|protective agents|mesh-ancestor
102257341|NCT02769689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102257342|NCT02769689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102257343|NCT02769689|Immunologic Factors|immunologic factors|mesh-ancestor
102257344|NCT02365571|Itraconazole|itraconazole|mesh-list
102257345|NCT02365571|Antifungal Agents|antifungal agents|mesh-ancestor
102257346|NCT02365571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102257347|NCT02365571|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102257348|NCT02365571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102257349|NCT02365571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102613539|NCT00382421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101811793|NCT01015053|Anesthetics|anesthetics|mesh-ancestor
102257350|NCT02365571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613540|NCT00382421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102257352|NCT02365571|Hormone Antagonists|hormone antagonists|mesh-ancestor
102257353|NCT02365571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102257354|NCT02365571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257355|NCT02365571|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102257356|NCT02365727|Clonidine|clonidine|mesh-list
102257357|NCT02365727|Epinephrine|epinephrine|mesh-list
102257358|NCT02365727|Bupivacaine|bupivacaine|mesh-list
102257359|NCT02365727|Ropivacaine|ropivacaine|mesh-list
102257360|NCT02365727|Anesthetics, Local|anesthetics, local|mesh-ancestor
102257361|NCT02365727|Anesthetics|anesthetics|mesh-ancestor
101811858|NCT00413218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102257362|NCT02365727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102257363|NCT02365727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257364|NCT02365727|Sensory System Agents|sensory system agents|mesh-ancestor
102257365|NCT02365727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102257366|NCT02365727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102257367|NCT02365727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102257368|NCT02365727|Adrenergic Agents|adrenergic agents|mesh-ancestor
102257369|NCT02365727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102257370|NCT02365727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257371|NCT02365727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102257372|NCT02365727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102257373|NCT02365727|Autonomic Agents|autonomic agents|mesh-ancestor
102257374|NCT02365727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102257375|NCT02365727|Respiratory System Agents|respiratory system agents|mesh-ancestor
102257376|NCT02365727|Mydriatics|mydriatics|mesh-ancestor
102257377|NCT02365727|Sympathomimetics|sympathomimetics|mesh-ancestor
102257378|NCT02365727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102257379|NCT02365727|Analgesics|analgesics|mesh-ancestor
101966252|NCT01097213|Ethanol|ethanol|mesh-list
102257380|NCT02365727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102257381|NCT02365727|Sympatholytics|sympatholytics|mesh-ancestor
102257382|NCT02365727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102257383|NCT02365805|Paclitaxel|paclitaxel|mesh-list
102257384|NCT02365805|Docetaxel|docetaxel|mesh-list
102257385|NCT02365805|Fluorouracil|fluorouracil|mesh-list
102257386|NCT02365805|Epirubicin|epirubicin|mesh-list
102257387|NCT02365805|Cyclophosphamide|cyclophosphamide|mesh-list
102257388|NCT02365805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102257389|NCT02365805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101812008|NCT00494091|Sirolimus|sirolimus|mesh-list
102257390|NCT02365805|Tubulin Modulators|tubulin modulators|mesh-ancestor
102257391|NCT02365805|Antimitotic Agents|antimitotic agents|mesh-ancestor
102257392|NCT02365805|Mitosis Modulators|mitosis modulators|mesh-ancestor
102257393|NCT02365805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257394|NCT02365805|Antimetabolites|antimetabolites|mesh-ancestor
102257395|NCT02365805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102257396|NCT02365805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102257397|NCT02365805|Immunologic Factors|immunologic factors|mesh-ancestor
102257398|NCT02365805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257399|NCT02365805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102257400|NCT02365805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102257401|NCT02365805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102257402|NCT02365805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102257403|NCT02365805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102257404|NCT02365805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102257405|NCT02365805|Alkylating Agents|alkylating agents|mesh-ancestor
102257406|NCT02365805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102257407|NCT03112889|Valproic Acid|valproic acid|mesh-list
102257408|NCT03112889|Anticonvulsants|anticonvulsants|mesh-ancestor
102257409|NCT03112889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102257410|NCT03112889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812109|NCT00571649|Enoxaparin|enoxaparin|mesh-list
102257411|NCT03112889|GABA Agents|gaba agents|mesh-ancestor
102257412|NCT03112889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102257413|NCT03112889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257414|NCT03112889|Antimanic Agents|antimanic agents|mesh-ancestor
102257415|NCT03112889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102257416|NCT03112889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102257417|NCT03112889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102257418|NCT03112577|Fluticasone|fluticasone|mesh-list
102257419|NCT03112577|Xhance|xhance|mesh-list
102257420|NCT03112577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102257421|NCT03112577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102257422|NCT03112577|Autonomic Agents|autonomic agents|mesh-ancestor
102257423|NCT03112577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102257424|NCT03112577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257425|NCT03112577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102257426|NCT03112577|Respiratory System Agents|respiratory system agents|mesh-ancestor
102257427|NCT03112577|Dermatologic Agents|dermatologic agents|mesh-ancestor
102257428|NCT03112577|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102257430|NCT02361905|Ulipristal acetate|ulipristal acetate|mesh-list
102257431|NCT02361905|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102257432|NCT02361905|Fertility Agents|fertility agents|mesh-ancestor
102257433|NCT02361905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102257434|NCT02361905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257435|NCT02361905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102257436|NCT02361905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102257437|NCT02361905|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102257438|NCT02361905|Contraceptive Agents|contraceptive agents|mesh-ancestor
102257439|NCT02361905|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102257440|NCT02361749|Botulinum Toxins|botulinum toxins|mesh-list
102257441|NCT02361749|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102257442|NCT02361749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101812192|NCT00969566|Metformin|metformin|mesh-list
102257443|NCT02361749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257444|NCT02361749|Cholinergic Agents|cholinergic agents|mesh-ancestor
102257445|NCT02361749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102257446|NCT02361749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257447|NCT04372433|Azacitidine|azacitidine|mesh-list
102257448|NCT04372433|Venetoclax|venetoclax|mesh-list
102257449|NCT04372433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102257450|NCT04372433|Antimetabolites|antimetabolites|mesh-ancestor
102257451|NCT04372433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257452|NCT04372433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102257453|NCT04372433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102257454|NCT02358707|Ibuprofen|ibuprofen|mesh-list
102257455|NCT02358707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102257456|NCT02358707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102257458|NCT02358707|Sensory System Agents|sensory system agents|mesh-ancestor
101812203|NCT00755495|Doxepin|doxepin|mesh-list
102257459|NCT02358707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102257460|NCT02358707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257461|NCT02358707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102257462|NCT02358707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102257463|NCT02358707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102257464|NCT02358707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102257465|NCT02358707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257466|NCT02360501|Docetaxel|docetaxel|mesh-list
102257467|NCT02360501|Capecitabine|capecitabine|mesh-list
102257468|NCT02360501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102257469|NCT02360501|Tubulin Modulators|tubulin modulators|mesh-ancestor
102257470|NCT02360501|Antimitotic Agents|antimitotic agents|mesh-ancestor
102257471|NCT02360501|Mitosis Modulators|mitosis modulators|mesh-ancestor
102257472|NCT02360501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257473|NCT02360501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102257474|NCT02360501|Antimetabolites|antimetabolites|mesh-ancestor
102257475|NCT02360423|Sirolimus|sirolimus|mesh-list
102257476|NCT02360423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102257477|NCT02360423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102257478|NCT02360423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102257479|NCT02360423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102257480|NCT02360423|Antifungal Agents|antifungal agents|mesh-ancestor
102257481|NCT02360423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102257482|NCT02360423|Immunologic Factors|immunologic factors|mesh-ancestor
102257483|NCT02360423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257484|NCT02358161|Paclitaxel|paclitaxel|mesh-list
102257485|NCT02358161|Gemcitabine|gemcitabine|mesh-list
102257486|NCT02358161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102257487|NCT02358161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102257488|NCT02358161|Tubulin Modulators|tubulin modulators|mesh-ancestor
102257489|NCT02358161|Antimitotic Agents|antimitotic agents|mesh-ancestor
102257490|NCT02358161|Mitosis Modulators|mitosis modulators|mesh-ancestor
101469560|NCT00244907|Hormones|hormones|mesh-ancestor
102257491|NCT02358161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257492|NCT02358161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102257493|NCT02358161|Antimetabolites|antimetabolites|mesh-ancestor
102257494|NCT02357849|Aripiprazole|aripiprazole|mesh-list
102257495|NCT02357849|Fluoxetine|fluoxetine|mesh-list
102257496|NCT02357849|Antidepressive Agents|antidepressive agents|mesh-ancestor
102257497|NCT02357849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102257498|NCT02357849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102613541|NCT00382421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257499|NCT02357849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101599196|NCT04189198|Carticaine|carticaine|mesh-list
102613542|NCT00382421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102257500|NCT02357849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102257501|NCT02357849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257502|NCT02357849|Dopamine Agonists|dopamine agonists|mesh-ancestor
102257503|NCT02357849|Dopamine Agents|dopamine agents|mesh-ancestor
102257504|NCT02357849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102257505|NCT02357849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257506|NCT02357849|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102257507|NCT02357849|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102257508|NCT02357849|Serotonin Agents|serotonin agents|mesh-ancestor
102257509|NCT02357849|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102257510|NCT02357849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102257511|NCT02357849|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102257512|NCT02357849|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102257513|NCT02357849|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102257514|NCT02357849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102257515|NCT02357849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102257516|NCT02357849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102257517|NCT02357849|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102257518|NCT02357849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102257519|NCT02357849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102257521|NCT02357693|Antiemetics|antiemetics|mesh-ancestor
102257522|NCT02357693|Autonomic Agents|autonomic agents|mesh-ancestor
102257523|NCT02357693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102257524|NCT02357693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257525|NCT02357693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102257526|NCT02357693|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102257527|NCT02357693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102257528|NCT02357693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257529|NCT02357537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102257531|NCT02357615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102257532|NCT02357615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102257533|NCT02357615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257534|NCT02357615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102257535|NCT02357615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257536|NCT02357615|Vasodilator Agents|vasodilator agents|mesh-ancestor
102257537|NCT02357615|Tocolytic Agents|tocolytic agents|mesh-ancestor
102257538|NCT02357615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102257539|NCT03160001|Niclosamide|niclosamide|mesh-list
102257540|NCT03160001|Etanercept|etanercept|mesh-list
102257541|NCT03160001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102257542|NCT03160001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102257543|NCT03160001|Analgesics|analgesics|mesh-ancestor
102257544|NCT03160001|Sensory System Agents|sensory system agents|mesh-ancestor
101822769|NCT04234048|Retinamide|retinamide|mesh-list
102257545|NCT03160001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102257546|NCT03160001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257547|NCT03160001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102257548|NCT03160001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102257549|NCT03160001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102257550|NCT03160001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102257551|NCT03160001|Immunologic Factors|immunologic factors|mesh-ancestor
102257552|NCT03160001|Anticestodal Agents|anticestodal agents|mesh-ancestor
102257553|NCT03160001|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102257554|NCT03160001|Anthelmintics|anthelmintics|mesh-ancestor
102257555|NCT03160001|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102257556|NCT03160001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102257557|NCT03160001|Antinematodal Agents|antinematodal agents|mesh-ancestor
102257558|NCT02359643|Aspirin|aspirin|mesh-list
102257559|NCT02359643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102257560|NCT02359643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102257561|NCT02359643|Analgesics|analgesics|mesh-ancestor
102257562|NCT02359643|Sensory System Agents|sensory system agents|mesh-ancestor
102257563|NCT02359643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102257564|NCT02359643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257565|NCT02359643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102257566|NCT02359643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102257567|NCT02359643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102257568|NCT02359643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102257569|NCT02359643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257570|NCT02359643|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101812294|NCT00964730|Moxifloxacin|moxifloxacin|mesh-list
102613543|NCT00382421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257571|NCT02359643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102257572|NCT02359643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102257574|NCT02359721|Clarithromycin|clarithromycin|mesh-list
102257575|NCT02359721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102257576|NCT02359721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102257577|NCT02359721|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102257578|NCT02359721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102257579|NCT02359721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257580|NCT02359721|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102257581|NCT02359721|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102257582|NCT02357303|Acetylcysteine|acetylcysteine|mesh-list
102257583|NCT02357303|Simethicone|simethicone|mesh-list
102257584|NCT02357303|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102257585|NCT02357303|Antiviral Agents|antiviral agents|mesh-ancestor
102257586|NCT02357303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102257587|NCT02357303|Expectorants|expectorants|mesh-ancestor
102257588|NCT02357303|Respiratory System Agents|respiratory system agents|mesh-ancestor
102257589|NCT02357303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102257590|NCT02357303|Antioxidants|antioxidants|mesh-ancestor
102257591|NCT02357303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257592|NCT02357303|Protective Agents|protective agents|mesh-ancestor
102257593|NCT02357303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257594|NCT02357303|Antidotes|antidotes|mesh-ancestor
102257595|NCT02357303|Antifoaming Agents|antifoaming agents|mesh-ancestor
102257596|NCT02357303|Emollients|emollients|mesh-ancestor
102257597|NCT02357303|Dermatologic Agents|dermatologic agents|mesh-ancestor
102257598|NCT02357225|Bromides|bromides|mesh-list
102257599|NCT02357225|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
102257600|NCT02357225|Anticonvulsants|anticonvulsants|mesh-ancestor
102257601|NCT02357225|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102257602|NCT02357225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102257603|NCT02357225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257604|NCT02357225|Cholinergic Agents|cholinergic agents|mesh-ancestor
102257605|NCT02357225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102257606|NCT02357225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257607|NCT02357069|Etanercept|etanercept|mesh-list
102257608|NCT02357069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102257609|NCT02357069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102257610|NCT02357069|Analgesics|analgesics|mesh-ancestor
102257611|NCT02357069|Sensory System Agents|sensory system agents|mesh-ancestor
102257612|NCT02357069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102257613|NCT02357069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257614|NCT02357069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102257615|NCT02357069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102257616|NCT02357069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102257617|NCT02357069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102257618|NCT02357069|Immunologic Factors|immunologic factors|mesh-ancestor
102257619|NCT02356913|Nicotine|nicotine|mesh-list
102257620|NCT02356913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102257621|NCT02356913|Autonomic Agents|autonomic agents|mesh-ancestor
102257622|NCT02356913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102257623|NCT02356913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257624|NCT02356913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102257625|NCT02356913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102257626|NCT02356913|Cholinergic Agents|cholinergic agents|mesh-ancestor
102257627|NCT02356913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102257628|NCT02356913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257629|NCT02352545|Montelukast|montelukast|mesh-list
102257630|NCT02352545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102257631|NCT02352545|Respiratory System Agents|respiratory system agents|mesh-ancestor
102257632|NCT02352545|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102257633|NCT02352545|Hormone Antagonists|hormone antagonists|mesh-ancestor
102257634|NCT02352545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102257635|NCT02352545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257636|NCT02352545|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102257637|NCT02352545|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102257638|NCT02352545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257639|NCT02356835|Nitric Oxide|nitric oxide|mesh-list
102257640|NCT02356835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102257641|NCT02356835|Autonomic Agents|autonomic agents|mesh-ancestor
102257642|NCT02356835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102257643|NCT02356835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257644|NCT02356835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102257645|NCT02356835|Respiratory System Agents|respiratory system agents|mesh-ancestor
102257646|NCT02356835|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102257647|NCT02356835|Antioxidants|antioxidants|mesh-ancestor
102257648|NCT02356835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257649|NCT02356835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102257650|NCT02356835|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102257651|NCT02356835|Vasodilator Agents|vasodilator agents|mesh-ancestor
102257652|NCT02356835|Gasotransmitters|gasotransmitters|mesh-ancestor
102257653|NCT02356835|Protective Agents|protective agents|mesh-ancestor
102257654|NCT02352701|Amoxicillin|amoxicillin|mesh-list
102257655|NCT02352701|Levofloxacin|levofloxacin|mesh-list
102257656|NCT02352701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102257657|NCT02352701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102257658|NCT02352701|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102257659|NCT02352701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102257660|NCT02352701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102257661|NCT02352701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102257662|NCT02352701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257663|NCT02352701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102257664|NCT02352701|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102257665|NCT02352701|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102257666|NCT02356445|Infliximab|infliximab|mesh-list
102257667|NCT02356445|Methotrexate|methotrexate|mesh-list
102257668|NCT02356445|Azathioprine|azathioprine|mesh-list
102257669|NCT02356445|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102257670|NCT02356445|Abortifacient Agents|abortifacient agents|mesh-ancestor
102257671|NCT02356445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102257672|NCT02356445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257673|NCT02356445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102257674|NCT02356445|Antimetabolites|antimetabolites|mesh-ancestor
102257675|NCT02356445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966552|NCT02261896|Ciprofloxacin|ciprofloxacin|mesh-list
102257676|NCT02356445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102257677|NCT02356445|Dermatologic Agents|dermatologic agents|mesh-ancestor
102257678|NCT02356445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102257679|NCT02356445|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102257680|NCT02356445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102257681|NCT02356445|Immunologic Factors|immunologic factors|mesh-ancestor
102257682|NCT02356445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102257683|NCT02356445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102257684|NCT02356445|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102257685|NCT02356445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102257686|NCT02356445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102257687|NCT02356679|Ethanol|ethanol|mesh-list
102257688|NCT02356679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102257689|NCT02356679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102257690|NCT02356679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102257691|NCT02356679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257692|NCT02352155|Epinephrine|epinephrine|mesh-list
102257693|NCT02352155|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102257694|NCT02352155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102257695|NCT02352155|Adrenergic Agents|adrenergic agents|mesh-ancestor
102257696|NCT02352155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102257697|NCT02352155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257698|NCT02352155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257699|NCT02352155|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102257700|NCT02352155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102257701|NCT02352155|Autonomic Agents|autonomic agents|mesh-ancestor
102257702|NCT02352155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102257703|NCT02352155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102257704|NCT02352155|Respiratory System Agents|respiratory system agents|mesh-ancestor
102257705|NCT02352155|Mydriatics|mydriatics|mesh-ancestor
102257706|NCT02352155|Sympathomimetics|sympathomimetics|mesh-ancestor
102257707|NCT02352155|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102257708|NCT02352311|Tadalafil|tadalafil|mesh-list
102257709|NCT02352311|Dutasteride|dutasteride|mesh-list
102257710|NCT02352311|Vasodilator Agents|vasodilator agents|mesh-ancestor
102257711|NCT02352311|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102257712|NCT02352311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102257713|NCT02352311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102257714|NCT02352311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613544|NCT00382421|Vasodilator Agents|vasodilator agents|mesh-ancestor
102613545|NCT00382421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102257715|NCT02352311|Urological Agents|urological agents|mesh-ancestor
102613546|NCT00382421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102257716|NCT02352311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102257717|NCT02352311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102257718|NCT02352311|Hormone Antagonists|hormone antagonists|mesh-ancestor
102257719|NCT02352311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102257720|NCT02352311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257721|NCT02355431|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102257722|NCT02355431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102257723|NCT02355431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102257724|NCT02355431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102257725|NCT02355431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257726|NCT02351687|Pyrimethamine|pyrimethamine|mesh-list
102257727|NCT02351687|Sulfadoxine|sulfadoxine|mesh-list
102257728|NCT02351687|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
102257729|NCT02351687|Albendazole|albendazole|mesh-list
102257730|NCT02351687|Antimalarials|antimalarials|mesh-ancestor
102257731|NCT02351687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102257732|NCT02351687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102257733|NCT02351687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102257734|NCT02351687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102257735|NCT02351687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102257736|NCT02351687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257737|NCT02351687|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102257738|NCT02351687|Anthelmintics|anthelmintics|mesh-ancestor
102257739|NCT02351687|Anticestodal Agents|anticestodal agents|mesh-ancestor
102257740|NCT02351687|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102257741|NCT02351687|Tubulin Modulators|tubulin modulators|mesh-ancestor
102257742|NCT02351687|Antimitotic Agents|antimitotic agents|mesh-ancestor
102257743|NCT02351687|Mitosis Modulators|mitosis modulators|mesh-ancestor
102257744|NCT02351687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102257746|NCT02355509|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102257747|NCT02355509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102257748|NCT02355509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257749|NCT02355509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102257750|NCT02355509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257752|NCT02355197|Vitamins|vitamins|mesh-ancestor
102257753|NCT02355197|Micronutrients|micronutrients|mesh-ancestor
102257754|NCT02355197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257755|NCT02355197|Antioxidants|antioxidants|mesh-ancestor
102257756|NCT02355197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257757|NCT02355197|Protective Agents|protective agents|mesh-ancestor
102257758|NCT02351297|Caseins|caseins|mesh-list
102257759|NCT02351297|Chelating Agents|chelating agents|mesh-ancestor
102257760|NCT02351297|Sequestering Agents|sequestering agents|mesh-ancestor
102257761|NCT02351297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257762|NCT02355119|Gemcitabine|gemcitabine|mesh-list
102257763|NCT02355119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102257764|NCT02355119|Antimetabolites|antimetabolites|mesh-ancestor
102257765|NCT02355119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257766|NCT02355119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102257767|NCT03149939|Febuxostat|febuxostat|mesh-list
102257768|NCT03149939|Gout Suppressants|gout suppressants|mesh-ancestor
102257769|NCT03149939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102257770|NCT03149783|Ropivacaine|ropivacaine|mesh-list
102257771|NCT03149783|Anesthetics, Local|anesthetics, local|mesh-ancestor
102257772|NCT03149783|Anesthetics|anesthetics|mesh-ancestor
102257773|NCT03149783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102257774|NCT03149783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257775|NCT03149783|Sensory System Agents|sensory system agents|mesh-ancestor
102257776|NCT03149783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102257777|NCT02354885|Tranexamic Acid|tranexamic acid|mesh-list
102257778|NCT02354885|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102257779|NCT02354885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102257780|NCT02354885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257781|NCT02354885|Hemostatics|hemostatics|mesh-ancestor
102257782|NCT02354885|Coagulants|coagulants|mesh-ancestor
102257783|NCT02354807|Mirabegron|mirabegron|mesh-list
102257784|NCT02354807|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102257785|NCT02354807|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102257786|NCT02354807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102257787|NCT02354807|Adrenergic Agents|adrenergic agents|mesh-ancestor
102257788|NCT02354807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101901969|NCT01183364|Docetaxel|docetaxel|mesh-list
102613547|NCT00382421|Analgesics|analgesics|mesh-ancestor
102613548|NCT00382421|Sensory System Agents|sensory system agents|mesh-ancestor
102613549|NCT00382421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102257789|NCT02354807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257790|NCT02354807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257791|NCT02354807|Urological Agents|urological agents|mesh-ancestor
102257792|NCT03159845|Levofloxacin|levofloxacin|mesh-list
102257793|NCT03159845|Fluconazole|fluconazole|mesh-list
102257794|NCT03159845|Acyclovir|acyclovir|mesh-list
102257795|NCT03159845|Zinc Sulfate|zinc sulfate|mesh-list
102257796|NCT03159845|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102257797|NCT03159845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102257798|NCT03159845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102257799|NCT03159845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102257800|NCT03159845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102257801|NCT03159845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102257802|NCT03159845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257803|NCT03159845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102257804|NCT03159845|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102257805|NCT03159845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102257806|NCT03159845|Antifungal Agents|antifungal agents|mesh-ancestor
102257807|NCT03159845|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102257808|NCT03159845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102257809|NCT03159845|Hormone Antagonists|hormone antagonists|mesh-ancestor
102257810|NCT03159845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102257811|NCT03159845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257812|NCT03159845|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102257813|NCT03159845|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102257814|NCT03159845|Antiviral Agents|antiviral agents|mesh-ancestor
102257815|NCT03159845|Astringents|astringents|mesh-ancestor
102257816|NCT03159845|Dermatologic Agents|dermatologic agents|mesh-ancestor
102257817|NCT02350751|MEDI8852|medi8852|mesh-list
102257818|NCT02350751|Antiviral Agents|antiviral agents|mesh-ancestor
102257819|NCT02350751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102257820|NCT02350985|Propranolol|propranolol|mesh-list
101812523|NCT00972140|Formoterol Fumarate|formoterol fumarate|mesh-list
102257821|NCT02350985|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102257822|NCT02350985|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102257823|NCT02350985|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102257824|NCT02350985|Adrenergic Agents|adrenergic agents|mesh-ancestor
102257825|NCT02350985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102257826|NCT02350985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257827|NCT02350985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257828|NCT02350985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102257829|NCT02350985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102257831|NCT02350985|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102257832|NCT02350985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102257833|NCT02350985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102257834|NCT02350985|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102257835|NCT02350985|Antidepressive Agents|antidepressive agents|mesh-ancestor
102257836|NCT02350985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102257837|NCT02354261|Itraconazole|itraconazole|mesh-list
102257838|NCT02354261|Antifungal Agents|antifungal agents|mesh-ancestor
102257839|NCT02354261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102257840|NCT02354261|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102257841|NCT02354261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102257842|NCT02354261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102257843|NCT02354261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257844|NCT02354261|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102257845|NCT02354261|Hormone Antagonists|hormone antagonists|mesh-ancestor
102257846|NCT02354261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102257847|NCT02354261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257848|NCT02354261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102257849|NCT02350439|Adenosine|adenosine|mesh-list
102257850|NCT02350439|Analgesics|analgesics|mesh-ancestor
102257851|NCT02350439|Sensory System Agents|sensory system agents|mesh-ancestor
102257852|NCT02350439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102257853|NCT02350439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257854|NCT02350439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102257855|NCT02350439|Vasodilator Agents|vasodilator agents|mesh-ancestor
102257856|NCT02350439|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101812566|NCT03927950|Dopamine Agents|dopamine agents|mesh-ancestor
102257857|NCT02350439|Purinergic Agonists|purinergic agonists|mesh-ancestor
102613550|NCT00382421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102257858|NCT02350439|Purinergic Agents|purinergic agents|mesh-ancestor
102257859|NCT02350439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102257860|NCT02350439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257861|NCT02350673|Atezolizumab|atezolizumab|mesh-list
102257862|NCT02350673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101812574|NCT00972842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101812576|NCT00972842|Growth Substances|growth substances|mesh-ancestor
102257863|NCT02350673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257864|NCT02350673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102257865|NCT02350673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102257866|NCT02350361|Endostatins|endostatins|mesh-list
102257867|NCT02350361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102257868|NCT02350361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102257869|NCT02350361|Growth Substances|growth substances|mesh-ancestor
102257870|NCT02350361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257871|NCT02350361|Growth Inhibitors|growth inhibitors|mesh-ancestor
102257872|NCT02350361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102257873|NCT02353949|Flutemetamol|flutemetamol|mesh-list
102257874|NCT02353949|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101812582|NCT00975494|Sildenafil Citrate|sildenafil citrate|mesh-list
101812583|NCT00975494|Vasodilator Agents|vasodilator agents|mesh-ancestor
101812586|NCT00975494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102257875|NCT02353949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257876|NCT02354027|Metformin|metformin|mesh-list
102257877|NCT02354027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102257878|NCT02354027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257879|NCT03149393|Mosapride|mosapride|mesh-list
102257880|NCT03149393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257881|NCT03149393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102257882|NCT03149393|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102257883|NCT03149393|Serotonin Agents|serotonin agents|mesh-ancestor
102257884|NCT03149393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101812593|NCT00965666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102257885|NCT03149393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257886|NCT02353715|Abiraterone Acetate|abiraterone acetate|mesh-list
102257887|NCT02353715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102257888|NCT02353715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102257889|NCT02353715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102257890|NCT02353715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257891|NCT02353715|Hormone Antagonists|hormone antagonists|mesh-ancestor
102257892|NCT02353715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102257893|NCT02353715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966776|NCT00978016|Baclofen|baclofen|mesh-list
102257894|NCT02353715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102257895|NCT02353325|Ascorbic Acid|ascorbic acid|mesh-list
102257896|NCT02353325|Fesoterodine|fesoterodine|mesh-list
102257897|NCT02353325|Antioxidants|antioxidants|mesh-ancestor
101812603|NCT00965666|Immunologic Factors|immunologic factors|mesh-ancestor
101812604|NCT00975728|Antioxidants|antioxidants|mesh-list
101812606|NCT00975728|Protective Agents|protective agents|mesh-ancestor
102257898|NCT02353325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257899|NCT02353325|Protective Agents|protective agents|mesh-ancestor
102257900|NCT02353325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257901|NCT02353325|Vitamins|vitamins|mesh-ancestor
102257902|NCT02353325|Micronutrients|micronutrients|mesh-ancestor
102257903|NCT02353325|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102257904|NCT02353325|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102257905|NCT02353325|Cholinergic Agents|cholinergic agents|mesh-ancestor
102257906|NCT02353325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102257907|NCT02353325|Urological Agents|urological agents|mesh-ancestor
102257908|NCT03157505|Immunomodulating Agents|immunomodulating agents|mesh-list
102257909|NCT03157505|Immunologic Factors|immunologic factors|mesh-list
102257910|NCT03157505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257911|NCT03157193|Hyaluronic Acid|hyaluronic acid|mesh-list
102257912|NCT03157193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102257913|NCT03157193|Immunologic Factors|immunologic factors|mesh-ancestor
102257914|NCT03157193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257915|NCT03157193|Viscosupplements|viscosupplements|mesh-ancestor
102257916|NCT03157193|Protective Agents|protective agents|mesh-ancestor
101812633|NCT00965900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812634|NCT00965900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812635|NCT00965900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101812636|NCT00965900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101812637|NCT00965900|Vasodilator Agents|vasodilator agents|mesh-ancestor
102257917|NCT03149159|Nivolumab|nivolumab|mesh-list
102257918|NCT03149159|Ipilimumab|ipilimumab|mesh-list
102257919|NCT03149159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102257920|NCT03149159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102257921|NCT03149159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102257922|NCT03149159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257923|NCT03155477|Cholecalciferol|cholecalciferol|mesh-list
102257924|NCT03155477|Vitamin D|vitamin d|mesh-list
102257925|NCT03155477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102257926|NCT03155477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613551|NCT00382421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102257927|NCT03155477|Vitamins|vitamins|mesh-ancestor
102257928|NCT03155477|Micronutrients|micronutrients|mesh-ancestor
101901973|NCT01183364|Mitosis Modulators|mitosis modulators|mesh-ancestor
101312053|NCT00006190|Antimetabolites|antimetabolites|mesh-ancestor
101812643|NCT00973232|Acetaminophen|acetaminophen|mesh-list
101812644|NCT00973232|Tramadol|tramadol|mesh-list
101824002|NCT00360334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102613552|NCT00382421|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102613553|NCT00382421|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102257929|NCT03155477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102257930|NCT02349581|Bupivacaine|bupivacaine|mesh-list
102257931|NCT02349581|Anesthetics, Local|anesthetics, local|mesh-ancestor
102257932|NCT02349581|Anesthetics|anesthetics|mesh-ancestor
102257933|NCT02349581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102257934|NCT02349581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257935|NCT02349581|Sensory System Agents|sensory system agents|mesh-ancestor
102257936|NCT02349581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102257937|NCT03154385|Rituximab|rituximab|mesh-list
102257938|NCT03154385|Belimumab|belimumab|mesh-list
102257939|NCT03154385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102257940|NCT03154385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102257941|NCT03154385|Immunologic Factors|immunologic factors|mesh-ancestor
102257942|NCT03154385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257943|NCT03154385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102257944|NCT03154385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101812645|NCT00973232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101812646|NCT00973232|Analgesics|analgesics|mesh-ancestor
102257945|NCT03112187|Iron|iron|mesh-list
102257946|NCT03112187|Trace Elements|trace elements|mesh-ancestor
102257947|NCT03112187|Micronutrients|micronutrients|mesh-ancestor
102257948|NCT03112187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257949|NCT03147677|Alfacalcidol|alfacalcidol|mesh-list
102257950|NCT03147677|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
102257951|NCT03147677|Irbesartan|irbesartan|mesh-list
102257952|NCT03147677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102257953|NCT03147677|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102257954|NCT03147677|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102257955|NCT03147677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257956|NCT03147677|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102257957|NCT03147677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257958|NCT03147677|Vitamins|vitamins|mesh-ancestor
102257959|NCT03147677|Micronutrients|micronutrients|mesh-ancestor
102257960|NCT03148535|Lithium Carbonate|lithium carbonate|mesh-list
102257961|NCT03148535|Antidepressive Agents|antidepressive agents|mesh-list
102257962|NCT03148535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102257963|NCT03148535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102257964|NCT03148535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257965|NCT03148535|Antimanic Agents|antimanic agents|mesh-ancestor
102257966|NCT03148535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102257967|NCT03148535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102257968|NCT03148535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812662|NCT00973388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102257969|NCT03147599|Mebeverine|mebeverine|mesh-list
102257970|NCT03147599|Anticonvulsants|anticonvulsants|mesh-ancestor
102257971|NCT03147599|Parasympatholytics|parasympatholytics|mesh-ancestor
102257972|NCT03147599|Autonomic Agents|autonomic agents|mesh-ancestor
102257973|NCT03147599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102257974|NCT03147599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257975|NCT02349113|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102257976|NCT02349113|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102257977|NCT02349113|Estrogens|estrogens|mesh-list
102257978|NCT02349113|Estradiol|estradiol|mesh-list
102257979|NCT02349113|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102257980|NCT02349113|Hormones|hormones|mesh-ancestor
102257981|NCT02349113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101812686|NCT00979706|Interleukin-2|interleukin-2|mesh-list
101812687|NCT00979706|Cyclosporins|cyclosporins|mesh-list
101812688|NCT00979706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101812690|NCT00979706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102257982|NCT02349113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257983|NCT02349113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102257984|NCT02349113|Contraceptive Agents|contraceptive agents|mesh-ancestor
102257985|NCT02349113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102257986|NCT02349113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102257987|NCT04183205|Sertraline|sertraline|mesh-list
102257988|NCT04183205|Antidepressive Agents|antidepressive agents|mesh-ancestor
102257989|NCT04183205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102257990|NCT04183205|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102257991|NCT04183205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102257992|NCT04183205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102257993|NCT04183205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257994|NCT04183205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102257995|NCT04183205|Serotonin Agents|serotonin agents|mesh-ancestor
102257996|NCT04183205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102257997|NCT04151849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102257998|NCT04151849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102257999|NCT04151849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101812696|NCT00979706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101812697|NCT00979706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101812698|NCT00979706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102258000|NCT04151849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258001|NCT02348177|Ritonavir|ritonavir|mesh-list
102258002|NCT02348177|Lopinavir|lopinavir|mesh-list
102258003|NCT02348177|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102258004|NCT02348177|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102258005|NCT02348177|Protease Inhibitors|protease inhibitors|mesh-ancestor
102258006|NCT02348177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102258007|NCT02348177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258008|NCT02348177|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102258009|NCT02348177|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102258010|NCT02348177|Antiviral Agents|antiviral agents|mesh-ancestor
102258011|NCT02348177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102258012|NCT02348177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102258013|NCT02348177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102258014|NCT02348255|Bevacizumab|bevacizumab|mesh-list
102258015|NCT02348255|Carmustine|carmustine|mesh-list
102258016|NCT02348255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101812716|NCT00966368|Insulin, Long-Acting|insulin, long-acting|mesh-list
101812717|NCT00966368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101812718|NCT00966368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258017|NCT02348255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102258018|NCT02348255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102258019|NCT02348255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102258020|NCT02348255|Growth Substances|growth substances|mesh-ancestor
102258021|NCT02348255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258022|NCT02348255|Growth Inhibitors|growth inhibitors|mesh-ancestor
102258023|NCT02348255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102258024|NCT02348255|Alkylating Agents|alkylating agents|mesh-ancestor
102258025|NCT02348255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812733|NCT00980408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101812734|NCT00980408|Antimetabolites|antimetabolites|mesh-ancestor
101824247|NCT00828815|Etravirine|etravirine|mesh-list
102258026|NCT02348333|Dotinurad|dotinurad|mesh-list
102258027|NCT02348333|Uricosuric Agents|uricosuric agents|mesh-ancestor
102258028|NCT02348333|Gout Suppressants|gout suppressants|mesh-ancestor
102258029|NCT02348333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102258030|NCT02343419|Methacholine Chloride|methacholine chloride|mesh-list
102258031|NCT02343419|Miotics|miotics|mesh-ancestor
102258032|NCT02343419|Autonomic Agents|autonomic agents|mesh-ancestor
102258033|NCT02343419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102258034|NCT02343419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258035|NCT02343419|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102258036|NCT02343419|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
102258037|NCT02343419|Respiratory System Agents|respiratory system agents|mesh-ancestor
102258038|NCT02343419|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102258039|NCT02343419|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102258040|NCT02343419|Cholinergic Agents|cholinergic agents|mesh-ancestor
101966923|NCT01088477|Hormones|hormones|mesh-ancestor
102258041|NCT02343419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102258042|NCT02343419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258043|NCT02342717|Itraconazole|itraconazole|mesh-list
102258044|NCT02342717|BI 425809|bi 425809|mesh-list
102258045|NCT02342717|Antifungal Agents|antifungal agents|mesh-ancestor
102258046|NCT02342717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102258047|NCT02342717|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102258048|NCT02342717|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102258049|NCT02342717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102258050|NCT02342717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258051|NCT02342717|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102258052|NCT02342717|Hormone Antagonists|hormone antagonists|mesh-ancestor
102258053|NCT02342717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102258054|NCT02342717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258055|NCT02342717|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102258056|NCT02342717|Nootropic Agents|nootropic agents|mesh-ancestor
102258057|NCT04478357|Fesoterodine|fesoterodine|mesh-list
102258058|NCT04478357|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102258059|NCT04478357|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102258060|NCT04478357|Cholinergic Agents|cholinergic agents|mesh-ancestor
102258061|NCT04478357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102258062|NCT04478357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258063|NCT04478357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258064|NCT04478357|Urological Agents|urological agents|mesh-ancestor
102258065|NCT04478513|Fluvoxamine|fluvoxamine|mesh-list
102258066|NCT04478513|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102258067|NCT04478513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102258068|NCT04478513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102258069|NCT04478513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258070|NCT04478513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102258071|NCT04478513|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102258072|NCT04478513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102258073|NCT04478513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102613554|NCT00382421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101812744|NCT00980876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102258074|NCT04478513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258075|NCT04478513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102258076|NCT04478513|Serotonin Agents|serotonin agents|mesh-ancestor
102258077|NCT04478513|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102258078|NCT04478513|Antidepressive Agents|antidepressive agents|mesh-ancestor
102258079|NCT04478513|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102258080|NCT04478513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102258081|NCT04478513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102258082|NCT04478513|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102258083|NCT02342093|Drospirenone|drospirenone|mesh-list
102258084|NCT02342093|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102258085|NCT02342093|Hormone Antagonists|hormone antagonists|mesh-ancestor
102258086|NCT02342093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102258087|NCT02342093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258088|NCT02342093|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102258089|NCT02342093|Diuretics|diuretics|mesh-ancestor
102258090|NCT02342093|Natriuretic Agents|natriuretic agents|mesh-ancestor
102258091|NCT02347319|Silymarin|silymarin|mesh-list
102258092|NCT02347319|Antioxidants|antioxidants|mesh-ancestor
102258093|NCT02347319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258094|NCT02347319|Protective Agents|protective agents|mesh-ancestor
102258095|NCT02347319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258096|NCT02347163|Zoledronic Acid|zoledronic acid|mesh-list
102258097|NCT02347163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102258098|NCT02347163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258099|NCT02341703|Metformin|metformin|mesh-list
102258100|NCT02341703|Pioglitazone|pioglitazone|mesh-list
102258101|NCT02341703|Letrozole|letrozole|mesh-list
102258102|NCT02341703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102258103|NCT02341703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258104|NCT02341703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102258105|NCT02341703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102258106|NCT02341703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102258107|NCT02341703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102258108|NCT02341703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258109|NCT02341703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102258110|NCT02341703|Hormone Antagonists|hormone antagonists|mesh-ancestor
102258111|NCT02341703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102258112|NCT02341547|Epoetin Alfa|epoetin alfa|mesh-list
102258113|NCT02341547|Hematinics|hematinics|mesh-ancestor
102258114|NCT02341079|Bupivacaine|bupivacaine|mesh-list
102258115|NCT02341079|Anesthetics, Local|anesthetics, local|mesh-ancestor
102258116|NCT02341079|Anesthetics|anesthetics|mesh-ancestor
102258117|NCT02341079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102258118|NCT02341079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258119|NCT02341079|Sensory System Agents|sensory system agents|mesh-ancestor
102258120|NCT02341079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102258121|NCT02346539|Nicotine|nicotine|mesh-list
101812832|NCT02797548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258122|NCT02346539|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102258123|NCT02346539|Autonomic Agents|autonomic agents|mesh-ancestor
102258124|NCT02346539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102258125|NCT02346539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258126|NCT02346539|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102258127|NCT02346539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102258128|NCT02346539|Cholinergic Agents|cholinergic agents|mesh-ancestor
102258129|NCT02346539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101812843|NCT00990678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101812844|NCT00990678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101812845|NCT00990678|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102258130|NCT02346539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258131|NCT05254223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102258132|NCT02340455|Pregabalin|pregabalin|mesh-list
102258133|NCT02340455|Analgesics|analgesics|mesh-ancestor
102258134|NCT02340455|Sensory System Agents|sensory system agents|mesh-ancestor
102258135|NCT02340455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102258136|NCT02340455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258137|NCT02340455|Anticonvulsants|anticonvulsants|mesh-ancestor
102258138|NCT02340455|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102258139|NCT02340455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102258140|NCT02340455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812851|NCT00538590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102258141|NCT02340455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102258142|NCT02340455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102258143|NCT02340455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102258144|NCT02340455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102258145|NCT02340455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102613555|NCT00382421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102613556|NCT00382421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102258146|NCT02345837|Clomiphene|clomiphene|mesh-list
102258147|NCT02345837|Enclomiphene|enclomiphene|mesh-list
102258148|NCT02345837|Zuclomiphene|zuclomiphene|mesh-list
102258149|NCT02345837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102258150|NCT02345837|Hormone Antagonists|hormone antagonists|mesh-ancestor
102258151|NCT02345837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102258152|NCT02345837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258153|NCT02345837|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102258154|NCT02345837|Fertility Agents|fertility agents|mesh-ancestor
102258155|NCT02345837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101812861|NCT00990834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812862|NCT00990834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101812864|NCT00990834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102258156|NCT02345837|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102258157|NCT02345837|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102258158|NCT02345993|Beclomethasone|beclomethasone|mesh-list
102258159|NCT02345993|Formoterol Fumarate|formoterol fumarate|mesh-list
102258160|NCT02345993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102258161|NCT02345993|Autonomic Agents|autonomic agents|mesh-ancestor
102258162|NCT02345993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102258163|NCT02345993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258164|NCT02345993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102258165|NCT02345993|Respiratory System Agents|respiratory system agents|mesh-ancestor
102258166|NCT02345993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101812884|NCT00466947|Vaccines|vaccines|mesh-list
102258167|NCT02345993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102258168|NCT02345993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102258169|NCT02345993|Adrenergic Agents|adrenergic agents|mesh-ancestor
102258170|NCT02345993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102258171|NCT02345993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258172|NCT02345993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102258173|NCT02345993|Glucocorticoids|glucocorticoids|mesh-ancestor
102258174|NCT02345993|Hormones|hormones|mesh-ancestor
102258175|NCT02345993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102258176|NCT02345681|Furosemide|furosemide|mesh-list
102258177|NCT02345681|Diuretics|diuretics|mesh-ancestor
102258178|NCT02345681|Natriuretic Agents|natriuretic agents|mesh-ancestor
101812888|NCT00537810|Sibutramine|sibutramine|mesh-list
101812889|NCT00537810|Antidepressive Agents|antidepressive agents|mesh-ancestor
101812890|NCT00537810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101812891|NCT00537810|Appetite Depressants|appetite depressants|mesh-ancestor
101812892|NCT00537810|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101812893|NCT01829568|Rituximab|rituximab|mesh-list
102258179|NCT02345681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258180|NCT02345681|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102258181|NCT02345681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102258182|NCT02345681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258183|NCT02340611|Olaparib|olaparib|mesh-list
102258184|NCT02340611|Cediranib|cediranib|mesh-list
102258185|NCT02340611|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102258186|NCT02340611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102258187|NCT02340611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967095|NCT00872014|Sorafenib|sorafenib|mesh-list
102258188|NCT02340611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102258189|NCT02340611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102258190|NCT03145649|Insulin|insulin|mesh-list
102258191|NCT03145649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102258192|NCT03145649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258193|NCT02345213|Donepezil|donepezil|mesh-list
102258194|NCT02345213|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102258195|NCT02345213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102258196|NCT02345213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258197|NCT02345213|Cholinergic Agents|cholinergic agents|mesh-ancestor
102258198|NCT02345213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102258199|NCT02345213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812900|NCT01829568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812901|NCT01829568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101812907|NCT00848328|Rituximab|rituximab|mesh-list
102258200|NCT02345213|Nootropic Agents|nootropic agents|mesh-ancestor
102258201|NCT02339753|Carboplatin|carboplatin|mesh-list
102258202|NCT02339753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102258203|NCT02339441|Mycophenolic Acid|mycophenolic acid|mesh-list
102258204|NCT02339441|Cyclophosphamide|cyclophosphamide|mesh-list
102258205|NCT02339441|Methotrexate|methotrexate|mesh-list
102258206|NCT02339441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102258207|NCT02339441|Immunologic Factors|immunologic factors|mesh-ancestor
102258208|NCT02339441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258209|NCT02339441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102258210|NCT02339441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102258211|NCT02339441|Alkylating Agents|alkylating agents|mesh-ancestor
101812922|NCT00989352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101812923|NCT00989352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101812924|NCT00989352|Immunologic Factors|immunologic factors|mesh-ancestor
101812925|NCT00989352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258212|NCT02339441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258213|NCT02339441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102258214|NCT02339441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102258215|NCT02339441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102613557|NCT00382421|Antipyretics|antipyretics|mesh-ancestor
102613558|NCT00382421|Sympatholytics|sympatholytics|mesh-ancestor
102613559|NCT00382421|Autonomic Agents|autonomic agents|mesh-ancestor
102258216|NCT02339441|Abortifacient Agents|abortifacient agents|mesh-ancestor
102613560|NCT00382421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102613561|NCT00382421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101812932|NCT00989352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812933|NCT00989352|Dermatologic Agents|dermatologic agents|mesh-ancestor
101812934|NCT00989352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101812935|NCT00989352|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101812936|NCT00989352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101812937|NCT00989352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101812938|NCT00989352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101812939|NCT00989352|Alkylating Agents|alkylating agents|mesh-ancestor
101812940|NCT05566626|Tropicamide|tropicamide|mesh-list
102613562|NCT00382421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102613563|NCT00382421|Adrenergic Agents|adrenergic agents|mesh-ancestor
102613564|NCT00382421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102613565|NCT00382421|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102613566|NCT05069831|Abrocitinib|abrocitinib|mesh-list
102258217|NCT02339441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102258218|NCT02339441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102258219|NCT02339441|Antimetabolites|antimetabolites|mesh-ancestor
102258220|NCT02339441|Dermatologic Agents|dermatologic agents|mesh-ancestor
102258221|NCT02339441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102258222|NCT02339441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102258223|NCT02339441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102258224|NCT02339441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102258225|NCT02339441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102258226|NCT02339441|Antitubercular Agents|antitubercular agents|mesh-ancestor
102258227|NCT02339441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102258228|NCT02339441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102258229|NCT02344823|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
102258230|NCT02344823|Vasodilator Agents|vasodilator agents|mesh-ancestor
101812943|NCT05566626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102258231|NCT02344823|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102258232|NCT02344823|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102258233|NCT02344823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102258234|NCT02344823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258235|NCT02344823|Urological Agents|urological agents|mesh-ancestor
102258236|NCT03145961|Pembrolizumab|pembrolizumab|mesh-list
102258237|NCT03145961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102258238|NCT03145961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102258239|NCT03145961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102258240|NCT03145961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258241|NCT02339207|Adafosbuvir|adafosbuvir|mesh-list
102258242|NCT02339207|Antiviral Agents|antiviral agents|mesh-ancestor
101812961|NCT05360394|Tubulin Modulators|tubulin modulators|mesh-ancestor
101812962|NCT05360394|Antimitotic Agents|antimitotic agents|mesh-ancestor
101812963|NCT05360394|Mitosis Modulators|mitosis modulators|mesh-ancestor
101812964|NCT05360394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812965|NCT00090259|Losartan|losartan|mesh-list
101812966|NCT00090259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101812967|NCT00090259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101812968|NCT00090259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101812969|NCT00090259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101824752|NCT00621023|Antimetabolites|antimetabolites|mesh-ancestor
102258243|NCT02339207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102258245|NCT02344511|Cefazolin|cefazolin|mesh-list
102258246|NCT02344511|Dalbavancin|dalbavancin|mesh-list
102258247|NCT02344511|Oxacillin|oxacillin|mesh-list
102258248|NCT02344511|Nafcillin|nafcillin|mesh-list
102258249|NCT02344511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102258250|NCT02344511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102258251|NCT02344589|Lidocaine|lidocaine|mesh-list
102258252|NCT02344589|Anesthetics, Local|anesthetics, local|mesh-ancestor
102258253|NCT02344589|Anesthetics|anesthetics|mesh-ancestor
102258254|NCT02344589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102258255|NCT02344589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258256|NCT02344589|Sensory System Agents|sensory system agents|mesh-ancestor
101812973|NCT00079183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101812974|NCT00079183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101812975|NCT00079183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101812976|NCT00079183|Antifungal Agents|antifungal agents|mesh-ancestor
101812977|NCT00079183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101812978|NCT00079183|Immunologic Factors|immunologic factors|mesh-ancestor
101812979|NCT00079183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812980|NCT01086085|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102258257|NCT02344589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102258258|NCT02344589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102258259|NCT02344589|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102258260|NCT02344589|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102258261|NCT02344589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102258262|NCT02344589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258263|NCT02338115|Paclitaxel|paclitaxel|mesh-list
102258264|NCT02338115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102258265|NCT02338115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102258266|NCT02338115|Tubulin Modulators|tubulin modulators|mesh-ancestor
102258267|NCT02338115|Antimitotic Agents|antimitotic agents|mesh-ancestor
102258268|NCT02338115|Mitosis Modulators|mitosis modulators|mesh-ancestor
102258269|NCT02338115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258270|NCT02337881|Sildenafil Citrate|sildenafil citrate|mesh-list
102258271|NCT02337881|Vasodilator Agents|vasodilator agents|mesh-ancestor
101812985|NCT01086085|Immunologic Factors|immunologic factors|mesh-ancestor
101812991|NCT01589419|Capecitabine|capecitabine|mesh-list
102258272|NCT02337881|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102258273|NCT02337881|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102258274|NCT02337881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102258275|NCT02337881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258276|NCT02337881|Urological Agents|urological agents|mesh-ancestor
102258277|NCT02337257|Vitamin D|vitamin d|mesh-list
102258278|NCT02337257|Cholecalciferol|cholecalciferol|mesh-list
102258279|NCT02337257|Vitamins|vitamins|mesh-ancestor
102613567|NCT05069831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102613568|NCT05069831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102258280|NCT02337257|Micronutrients|micronutrients|mesh-ancestor
102258281|NCT02337257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258282|NCT02337257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102258283|NCT02337257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102258284|NCT02337413|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
102258285|NCT02337413|Laxatives|laxatives|mesh-ancestor
102258286|NCT02337413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102258287|NCT02337023|Technetium Tc 99m bicisate|technetium tc 99m bicisate|mesh-list
102258288|NCT02337023|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102258289|NCT02337023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258290|NCT04477811|Vitamins|vitamins|mesh-list
102258291|NCT04477811|Vitamin K|vitamin k|mesh-list
102258292|NCT04477811|Vitamin K 2|vitamin k 2|mesh-list
102258293|NCT04477811|Vitamin K 1|vitamin k 1|mesh-list
102258294|NCT04477811|Micronutrients|micronutrients|mesh-ancestor
102258295|NCT04477811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258296|NCT04477811|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102258297|NCT04477811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102258298|NCT04477811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258299|NCT04477811|Hemostatics|hemostatics|mesh-ancestor
102258300|NCT04477811|Coagulants|coagulants|mesh-ancestor
102258301|NCT02332031|Sorafenib|sorafenib|mesh-list
102258302|NCT02332031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102258303|NCT02332031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102258304|NCT02332031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101813000|NCT00676403|Analgesics|analgesics|mesh-ancestor
101813004|NCT00676403|Anticonvulsants|anticonvulsants|mesh-ancestor
102258305|NCT02332031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258306|NCT03112031|Tamoxifen|tamoxifen|mesh-list
102258307|NCT03112031|Fluconazole|fluconazole|mesh-list
102258308|NCT03112031|Amphotericin B|amphotericin b|mesh-list
102258309|NCT03112031|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102258310|NCT03112031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102258311|NCT03112031|Hormone Antagonists|hormone antagonists|mesh-ancestor
102258312|NCT03112031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102258313|NCT03112031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258314|NCT03112031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102258315|NCT03112031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102258316|NCT03112031|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102258317|NCT03112031|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102258318|NCT03112031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102258319|NCT03112031|Antifungal Agents|antifungal agents|mesh-ancestor
102258320|NCT03112031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102258321|NCT03112031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102258322|NCT03112031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102258323|NCT03112031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101813034|NCT03961867|Antimitotic Agents|antimitotic agents|mesh-ancestor
101813035|NCT03961867|Mitosis Modulators|mitosis modulators|mesh-ancestor
102258324|NCT03112031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258325|NCT03112031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102258326|NCT03112031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102258327|NCT03112031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102258328|NCT03112031|Amebicides|amebicides|mesh-ancestor
102258329|NCT03112031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102258330|NCT03112031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102258331|NCT03112031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102258332|NCT03111797|Morphine|morphine|mesh-list
102258333|NCT03111797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102258334|NCT03111797|Narcotics|narcotics|mesh-ancestor
102258335|NCT03111797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102258336|NCT03111797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258337|NCT03111797|Analgesics|analgesics|mesh-ancestor
102258338|NCT03111797|Sensory System Agents|sensory system agents|mesh-ancestor
102258339|NCT03111797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102258340|NCT02938013|Sofosbuvir|sofosbuvir|mesh-list
102258341|NCT02938013|Velpatasvir|velpatasvir|mesh-list
102258342|NCT02938013|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102258343|NCT02938013|Antiviral Agents|antiviral agents|mesh-ancestor
102258344|NCT02938013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102258345|NCT02820311|Moxifloxacin|moxifloxacin|mesh-list
102258346|NCT02820311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102258347|NCT02820311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102258348|NCT02820311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102258349|NCT02820311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101813053|NCT00545402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102258350|NCT02820311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102258351|NCT02820311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258352|NCT02820311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102258353|NCT02336633|Resveratrol|resveratrol|mesh-list
102613569|NCT05069831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613570|NCT05312255|Propranolol|propranolol|mesh-list
102258354|NCT02336633|Antioxidants|antioxidants|mesh-ancestor
101813078|NCT03963115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102258355|NCT02336633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258356|NCT02336633|Protective Agents|protective agents|mesh-ancestor
102258357|NCT02336633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258358|NCT02336633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102258359|NCT02336633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102258360|NCT02336477|Mexiletine|mexiletine|mesh-list
102258361|NCT02336477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102258362|NCT02336477|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102258363|NCT02336477|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102258364|NCT02336477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101813085|NCT01583023|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102258365|NCT02336477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258366|NCT04624451|Dalbavancin|dalbavancin|mesh-list
102258367|NCT04624451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102258368|NCT04624451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102258369|NCT02642315|Gabapentin|gabapentin|mesh-list
102258370|NCT02642315|Analgesics|analgesics|mesh-ancestor
102258371|NCT02642315|Sensory System Agents|sensory system agents|mesh-ancestor
102258372|NCT02642315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102258373|NCT02642315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258374|NCT02642315|Anticonvulsants|anticonvulsants|mesh-ancestor
102258375|NCT02642315|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102258376|NCT02642315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102258377|NCT02642315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102258378|NCT02642315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102258379|NCT02642315|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102258380|NCT02642315|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102258381|NCT02642315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102258382|NCT02642315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258383|NCT02642315|Antimanic Agents|antimanic agents|mesh-ancestor
102258384|NCT02518139|Tiotropium Bromide|tiotropium bromide|mesh-list
102258385|NCT02518139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102258386|NCT02518139|Autonomic Agents|autonomic agents|mesh-ancestor
102258387|NCT02518139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102258388|NCT02518139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258389|NCT02518139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102258390|NCT02518139|Respiratory System Agents|respiratory system agents|mesh-ancestor
102258391|NCT02518139|Parasympatholytics|parasympatholytics|mesh-ancestor
102258392|NCT02518139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102258393|NCT02518139|Cholinergic Agents|cholinergic agents|mesh-ancestor
102258394|NCT02518139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102258395|NCT02518139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258396|NCT02709889|Dexamethasone|dexamethasone|mesh-list
102258397|NCT02709889|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
102258398|NCT02709889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102258399|NCT02709889|Antiemetics|antiemetics|mesh-ancestor
102258400|NCT02709889|Autonomic Agents|autonomic agents|mesh-ancestor
102258401|NCT02709889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102258402|NCT02709889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258403|NCT02709889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102258404|NCT02709889|Glucocorticoids|glucocorticoids|mesh-ancestor
102258405|NCT02709889|Hormones|hormones|mesh-ancestor
102258406|NCT02709889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102258407|NCT02709889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102258408|NCT02709889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102258409|NCT02709889|Immunoconjugates|immunoconjugates|mesh-ancestor
102258410|NCT02709889|Immunologic Factors|immunologic factors|mesh-ancestor
102258411|NCT03189901|Simendan|simendan|mesh-list
102258412|NCT03189901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102258413|NCT03189901|Vasodilator Agents|vasodilator agents|mesh-ancestor
102258414|NCT03189901|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102258415|NCT03189901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102258416|NCT03189901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102258417|NCT03189901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258418|NCT03189901|Protective Agents|protective agents|mesh-ancestor
102258419|NCT03189901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258420|NCT02711995|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102258422|NCT02711995|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102258423|NCT02711995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102258424|NCT02711995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258425|NCT02711995|Cholinergic Agents|cholinergic agents|mesh-ancestor
102258426|NCT02711995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101901991|NCT01183442|Vitamins|vitamins|mesh-list
102613571|NCT05312255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102613572|NCT05312255|Adrenergic Agents|adrenergic agents|mesh-list
102258427|NCT02711995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258428|NCT02711995|Laxatives|laxatives|mesh-ancestor
102258429|NCT02711995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102258430|NCT03193723|Anesthetics|anesthetics|mesh-list
102258431|NCT03193723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102258432|NCT03193723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258433|NCT02437825|Octreotide|octreotide|mesh-list
102258434|NCT02437825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102258435|NCT02437825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102258436|NCT02437825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102258437|NCT02442817|Linagliptin|linagliptin|mesh-list
102258438|NCT02442817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102258439|NCT02442817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258440|NCT02442817|Incretins|incretins|mesh-ancestor
102258441|NCT02442817|Hormones|hormones|mesh-ancestor
102258442|NCT02442817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102258443|NCT02442817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102258444|NCT02442817|Protease Inhibitors|protease inhibitors|mesh-ancestor
102258445|NCT02442817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102258446|NCT02442817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258447|NCT02437591|Fidaxomicin|fidaxomicin|mesh-list
102258448|NCT02437591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102258449|NCT02437591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102258450|NCT02442739|Ketamine|ketamine|mesh-list
102258451|NCT02442739|Analgesics|analgesics|mesh-ancestor
102258452|NCT02442739|Sensory System Agents|sensory system agents|mesh-ancestor
102258453|NCT02442739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102258454|NCT02442739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813175|NCT00966836|Valganciclovir|valganciclovir|mesh-list
102258455|NCT02442739|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102258456|NCT02442739|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102258457|NCT02442739|Anesthetics, General|anesthetics, general|mesh-ancestor
102258458|NCT02442739|Anesthetics|anesthetics|mesh-ancestor
102258459|NCT02442739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102258460|NCT02442739|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102258461|NCT02442739|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102258462|NCT02442739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101825462|NCT00573755|Sorafenib|sorafenib|mesh-list
102258463|NCT02442739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258464|NCT03022903|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102258465|NCT03022903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102258466|NCT03022903|Dermatologic Agents|dermatologic agents|mesh-ancestor
102258467|NCT02442427|Palivizumab|palivizumab|mesh-list
102258468|NCT02442427|Antiviral Agents|antiviral agents|mesh-ancestor
102258469|NCT02442427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102258470|NCT03189043|Anti-Infective Agents|anti-infective agents|mesh-list
102258471|NCT03189043|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102258472|NCT05233735|Betamethasone|betamethasone|mesh-list
102258473|NCT05233735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102258474|NCT05233735|Glucocorticoids|glucocorticoids|mesh-ancestor
102258475|NCT05233735|Hormones|hormones|mesh-ancestor
102258476|NCT05233735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102258477|NCT05233735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258478|NCT05233735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102258479|NCT05233735|Respiratory System Agents|respiratory system agents|mesh-ancestor
102258480|NCT02436499|Botulinum Toxins|botulinum toxins|mesh-list
102258481|NCT02436499|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102258482|NCT02436499|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102258483|NCT02436499|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102258484|NCT02436499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102258485|NCT02436499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258486|NCT02436499|Cholinergic Agents|cholinergic agents|mesh-ancestor
102258487|NCT02436499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102258488|NCT02436499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258489|NCT02436499|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102258490|NCT02436499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102258491|NCT02331563|Dexmedetomidine|dexmedetomidine|mesh-list
102258492|NCT02331563|Bupivacaine|bupivacaine|mesh-list
102258493|NCT02331563|Anesthetics, Local|anesthetics, local|mesh-ancestor
102258494|NCT02331563|Anesthetics|anesthetics|mesh-ancestor
102258495|NCT02331563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102258496|NCT02331563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258497|NCT02331563|Sensory System Agents|sensory system agents|mesh-ancestor
102613573|NCT05312255|Adrenergic Antagonists|adrenergic antagonists|mesh-list
101825627|NCT00617669|Docetaxel|docetaxel|mesh-list
102613574|NCT05312255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102258498|NCT02331563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102258499|NCT02331563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102258500|NCT02331563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102258502|NCT02331563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102258503|NCT02331563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102258504|NCT02331563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102258505|NCT02331563|Adrenergic Agents|adrenergic agents|mesh-ancestor
102258506|NCT02331563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102258507|NCT02331563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258508|NCT02331173|Dorzolamide|dorzolamide|mesh-list
102258509|NCT02331173|Brinzolamide|brinzolamide|mesh-list
102258510|NCT02331173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102258511|NCT02331173|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102258512|NCT02331173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102258513|NCT02331173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258514|NCT02709109|Ivacaftor|ivacaftor|mesh-list
102258515|NCT02709109|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102258516|NCT02709109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102258517|NCT02709109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258518|NCT03117595|Fentanyl|fentanyl|mesh-list
102258519|NCT03117595|Morphine|morphine|mesh-list
102258520|NCT03117595|Bupivacaine|bupivacaine|mesh-list
102258521|NCT03117595|Anesthetics, Local|anesthetics, local|mesh-ancestor
102258522|NCT03117595|Anesthetics|anesthetics|mesh-ancestor
102258523|NCT03117595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102258524|NCT03117595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258525|NCT03117595|Sensory System Agents|sensory system agents|mesh-ancestor
102258526|NCT03117595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102258527|NCT03117595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102258528|NCT03117595|Narcotics|narcotics|mesh-ancestor
102258529|NCT03117595|Analgesics|analgesics|mesh-ancestor
102258530|NCT03117595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102258531|NCT03117595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102258532|NCT03117595|Anesthetics, General|anesthetics, general|mesh-ancestor
102258533|NCT02039531|Mitogens|mitogens|mesh-list
102258534|NCT02039531|Hyaluronic Acid|hyaluronic acid|mesh-list
102258535|NCT02039531|Mitosis Modulators|mitosis modulators|mesh-ancestor
102258536|NCT02039531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258537|NCT02039531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102258538|NCT02039531|Immunologic Factors|immunologic factors|mesh-ancestor
102258539|NCT02039531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258540|NCT02039531|Viscosupplements|viscosupplements|mesh-ancestor
102258541|NCT02039531|Protective Agents|protective agents|mesh-ancestor
102258542|NCT02331251|Paclitaxel|paclitaxel|mesh-list
102258543|NCT02331251|Vinorelbine|vinorelbine|mesh-list
102258544|NCT02331251|Docetaxel|docetaxel|mesh-list
102258545|NCT02331251|Gemcitabine|gemcitabine|mesh-list
102258546|NCT02331251|Doxorubicin|doxorubicin|mesh-list
102258547|NCT02331251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102258548|NCT02331251|Pembrolizumab|pembrolizumab|mesh-list
102258549|NCT02331251|Irinotecan|irinotecan|mesh-list
102258550|NCT02331251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102258551|NCT02331251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102258552|NCT02331251|Tubulin Modulators|tubulin modulators|mesh-ancestor
102258553|NCT02331251|Antimitotic Agents|antimitotic agents|mesh-ancestor
102258554|NCT02331251|Mitosis Modulators|mitosis modulators|mesh-ancestor
102258555|NCT02331251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258556|NCT02331251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102258557|NCT02331251|Antimetabolites|antimetabolites|mesh-ancestor
102258558|NCT02331251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102258559|NCT02331251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102258560|NCT02331251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102258561|NCT02331251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102258562|NCT02331251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102258563|NCT02331251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102258564|NCT02331251|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102258565|NCT02435797|Nicorandil|nicorandil|mesh-list
102258566|NCT02435797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102258567|NCT02435797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102258568|NCT02435797|Vasodilator Agents|vasodilator agents|mesh-ancestor
102258569|NCT02435797|Vitamin B Complex|vitamin b complex|mesh-ancestor
102258570|NCT02435797|Vitamins|vitamins|mesh-ancestor
102258571|NCT02435797|Micronutrients|micronutrients|mesh-ancestor
102258572|NCT02435797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258573|NCT02330705|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102258574|NCT02330705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101600287|NCT03172780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102613575|NCT05312255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258575|NCT02330705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258576|NCT02330783|Bevacizumab|bevacizumab|mesh-list
102258577|NCT02330783|Sorafenib|sorafenib|mesh-list
102258578|NCT02330783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102258579|NCT02330783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102258580|NCT02330783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102258581|NCT02330783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102258582|NCT02330783|Growth Substances|growth substances|mesh-ancestor
102258583|NCT02330783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258584|NCT02330783|Growth Inhibitors|growth inhibitors|mesh-ancestor
102258585|NCT02330783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102258586|NCT02330783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102258587|NCT02330783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258588|NCT02335151|Desflurane|desflurane|mesh-list
102258589|NCT02335151|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102258590|NCT02335151|Anesthetics, General|anesthetics, general|mesh-ancestor
102258591|NCT02335151|Anesthetics|anesthetics|mesh-ancestor
102258592|NCT02335151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102258593|NCT02335151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258594|NCT02441803|Cytarabine|cytarabine|mesh-list
102258595|NCT02441803|Mycophenolic Acid|mycophenolic acid|mesh-list
102258596|NCT02441803|Cyclophosphamide|cyclophosphamide|mesh-list
102258597|NCT02441803|Busulfan|busulfan|mesh-list
102258598|NCT02441803|Fludarabine|fludarabine|mesh-list
102258599|NCT02441803|Fludarabine phosphate|fludarabine phosphate|mesh-list
102258600|NCT02441803|Decitabine|decitabine|mesh-list
102258601|NCT02441803|Idarubicin|idarubicin|mesh-list
102258602|NCT02441803|Clofarabine|clofarabine|mesh-list
102258603|NCT02441803|Tacrolimus|tacrolimus|mesh-list
102258604|NCT02441803|Thymoglobulin|thymoglobulin|mesh-list
102258605|NCT02441803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102258606|NCT02441803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102258607|NCT02441803|Immunologic Factors|immunologic factors|mesh-ancestor
102258608|NCT02441803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258609|NCT02441803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102258610|NCT02441803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102258611|NCT02441803|Alkylating Agents|alkylating agents|mesh-ancestor
102258612|NCT02441803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258613|NCT02441803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102258614|NCT02441803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102258615|NCT02441803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102258616|NCT02441803|Antimetabolites|antimetabolites|mesh-ancestor
102258617|NCT02441803|Antiviral Agents|antiviral agents|mesh-ancestor
102258618|NCT02441803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102258619|NCT02441803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102258620|NCT02441803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102258621|NCT02441803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102258622|NCT02441803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102258623|NCT02441803|Antitubercular Agents|antitubercular agents|mesh-ancestor
102258624|NCT02441803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102258625|NCT02441803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102258626|NCT02441803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102258627|NCT02709655|Vortioxetine|vortioxetine|mesh-list
102258628|NCT02709655|Fluoxetine|fluoxetine|mesh-list
102258629|NCT02709655|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102258630|NCT02709655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102258631|NCT02709655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102258632|NCT02709655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258633|NCT02709655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102258634|NCT02709655|Serotonin Agents|serotonin agents|mesh-ancestor
102258635|NCT02709655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967524|NCT03636308|Paclitaxel|paclitaxel|mesh-list
102258636|NCT02709655|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102258637|NCT02709655|Antidepressive Agents|antidepressive agents|mesh-ancestor
102258638|NCT02709655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102258639|NCT02709655|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102258640|NCT02709655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102258641|NCT02709655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102258642|NCT02709655|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101813355|NCT00984152|Antiviral Agents|antiviral agents|mesh-ancestor
102258643|NCT02709655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102258644|NCT02709655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102258645|NCT02709655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102258646|NCT02709655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102258647|NCT02709655|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102258648|NCT02709655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102258650|NCT02334605|Antipruritics|antipruritics|mesh-ancestor
102258651|NCT02334605|Dermatologic Agents|dermatologic agents|mesh-ancestor
102258652|NCT02334605|Sensory System Agents|sensory system agents|mesh-ancestor
102258653|NCT02334605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102258654|NCT02334605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258655|NCT02329535|Progesterone|progesterone|mesh-list
102258656|NCT02329535|Progestins|progestins|mesh-ancestor
102258657|NCT02329535|Hormones|hormones|mesh-ancestor
102258658|NCT02329535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102258659|NCT02329535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258660|NCT03187795|Mirabegron|mirabegron|mesh-list
102258661|NCT03187795|Oxybutynin|oxybutynin|mesh-list
102258662|NCT03187795|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102258663|NCT03187795|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102258664|NCT03187795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102258665|NCT03187795|Adrenergic Agents|adrenergic agents|mesh-ancestor
102258666|NCT03187795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102258667|NCT03187795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258668|NCT03187795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258669|NCT03187795|Urological Agents|urological agents|mesh-ancestor
102258670|NCT03187795|Parasympatholytics|parasympatholytics|mesh-ancestor
102258671|NCT03187795|Autonomic Agents|autonomic agents|mesh-ancestor
102258672|NCT03187795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102258673|NCT03187795|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102258674|NCT03187795|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102258675|NCT03187795|Cholinergic Agents|cholinergic agents|mesh-ancestor
102258676|NCT02435563|Ritonavir|ritonavir|mesh-list
102258677|NCT02435563|Ticagrelor|ticagrelor|mesh-list
102258678|NCT02435563|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102258679|NCT02435563|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102258680|NCT02435563|Protease Inhibitors|protease inhibitors|mesh-ancestor
102258681|NCT02435563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102258682|NCT02435563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258683|NCT02435563|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102258684|NCT02435563|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102258685|NCT02435563|Antiviral Agents|antiviral agents|mesh-ancestor
102258686|NCT02435563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102258687|NCT02435563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102258688|NCT02435563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102258689|NCT02435563|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101813387|NCT00984464|Paclitaxel|paclitaxel|mesh-list
102258690|NCT02435563|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102258691|NCT02435563|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102258692|NCT02435563|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102258693|NCT02435563|Purinergic Agents|purinergic agents|mesh-ancestor
102258694|NCT02435563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102258695|NCT02435563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258696|NCT02433847|Mosapride|mosapride|mesh-list
102258697|NCT02433847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102258698|NCT02433847|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102258699|NCT02433847|Serotonin Agents|serotonin agents|mesh-ancestor
102258700|NCT02433847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102258701|NCT02433847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813404|NCT04445246|Vasodilator Agents|vasodilator agents|mesh-ancestor
102258702|NCT02433847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258703|NCT02435095|Antipsychotic Agents|antipsychotic agents|mesh-list
102258704|NCT02435095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102258705|NCT02435095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102258706|NCT02435095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258707|NCT02435095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102258708|NCT02328521|Nicorandil|nicorandil|mesh-list
102258709|NCT02328521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102258710|NCT02328521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101967589|NCT00835354|Cefprozil|cefprozil|mesh-list
102258711|NCT02328521|Vasodilator Agents|vasodilator agents|mesh-ancestor
102258712|NCT02328521|Vitamin B Complex|vitamin b complex|mesh-ancestor
102258713|NCT02328521|Vitamins|vitamins|mesh-ancestor
102258714|NCT02328521|Micronutrients|micronutrients|mesh-ancestor
102258715|NCT02328521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258716|NCT03831503|Antibodies|antibodies|mesh-list
102258717|NCT03831503|Immunologic Factors|immunologic factors|mesh-ancestor
102258718|NCT03831503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258719|NCT03187093|Vortioxetine|vortioxetine|mesh-list
102258720|NCT03187093|Escitalopram|escitalopram|mesh-list
102258721|NCT03187093|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102613576|NCT05312255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613577|NCT05312255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102613578|NCT05312255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102613579|NCT05312255|Vasodilator Agents|vasodilator agents|mesh-ancestor
102258722|NCT03187093|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102258723|NCT03187093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102258724|NCT03187093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258725|NCT03187093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102258726|NCT03187093|Serotonin Agents|serotonin agents|mesh-ancestor
102258727|NCT03187093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813431|NCT05498090|Fenofibrate|fenofibrate|mesh-list
102258728|NCT03187093|Antidepressive Agents|antidepressive agents|mesh-ancestor
102258729|NCT03187093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102258730|NCT03187093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102258731|NCT03187093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102258732|NCT03187093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102258733|NCT03187093|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102258734|NCT03187093|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102258735|NCT03187093|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102258736|NCT03187093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102258737|NCT02039999|Citric Acid|citric acid|mesh-list
102258738|NCT02039999|Sodium Citrate|sodium citrate|mesh-list
102258739|NCT02039999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102258740|NCT02039999|Anticoagulants|anticoagulants|mesh-ancestor
102258741|NCT02039999|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102258742|NCT02039999|Chelating Agents|chelating agents|mesh-ancestor
102258743|NCT02039999|Sequestering Agents|sequestering agents|mesh-ancestor
102258744|NCT02039999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258745|NCT02434861|Sulfasalazine|sulfasalazine|mesh-list
102258746|NCT02434861|Digoxin|digoxin|mesh-list
102258747|NCT02434861|Rolapitant|rolapitant|mesh-list
102258748|NCT02434861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102258749|NCT02434861|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102258750|NCT02434861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102258751|NCT02434861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258752|NCT02434861|Protective Agents|protective agents|mesh-ancestor
101813453|NCT00540644|Prednisone|prednisone|mesh-list
102258753|NCT02434861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258754|NCT02434861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102258755|NCT02434861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102258756|NCT02434861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102258757|NCT02434861|Analgesics|analgesics|mesh-ancestor
102258758|NCT02434861|Sensory System Agents|sensory system agents|mesh-ancestor
102258759|NCT02434861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102258760|NCT02434861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102258761|NCT02434861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102258762|NCT02434861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102258763|NCT02434861|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102258764|NCT02434861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102258765|NCT03187015|Entinostat|entinostat|mesh-list
102258766|NCT03187015|Midazolam|midazolam|mesh-list
102258767|NCT03187015|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102258768|NCT03187015|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102258769|NCT03187015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102258770|NCT03187015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258771|NCT03187015|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102258772|NCT03187015|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102258773|NCT03187015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102258774|NCT03187015|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101813490|NCT00986336|Topiramate|topiramate|mesh-list
102258775|NCT03187015|Anesthetics, General|anesthetics, general|mesh-ancestor
102258776|NCT03187015|Anesthetics|anesthetics|mesh-ancestor
102258777|NCT03187015|GABA Modulators|gaba modulators|mesh-ancestor
102258778|NCT03187015|GABA Agents|gaba agents|mesh-ancestor
102258779|NCT03187015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102258780|NCT03187015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258781|NCT03187015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102258782|NCT03187015|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102258783|NCT03187015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102258784|NCT02328053|Voriconazole|voriconazole|mesh-list
102258785|NCT02328053|Natamycin|natamycin|mesh-list
102258786|NCT02328053|Antifungal Agents|antifungal agents|mesh-list
102258787|NCT02328053|Clotrimazole|clotrimazole|mesh-list
102258788|NCT02328053|Miconazole|miconazole|mesh-list
102258789|NCT02328053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102258790|NCT02328053|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102258791|NCT02328053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102258792|NCT02328053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102613580|NCT05015621|Leucovorin|leucovorin|mesh-list
102613581|NCT05015621|Fluorouracil|fluorouracil|mesh-list
101901996|NCT01187108|Acetylcysteine|acetylcysteine|mesh-list
102613582|NCT05015621|Irinotecan|irinotecan|mesh-list
102258793|NCT02328053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258794|NCT02328053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102258795|NCT02328053|Hormone Antagonists|hormone antagonists|mesh-ancestor
102258796|NCT02328053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102258797|NCT02328053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258798|NCT02328053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102258799|NCT02328053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102258800|NCT02328053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102258801|NCT02328053|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102258802|NCT02022748|Ticagrelor|ticagrelor|mesh-list
102258803|NCT02022748|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102258804|NCT02022748|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102258805|NCT02022748|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102258806|NCT02022748|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102258807|NCT02022748|Purinergic Agents|purinergic agents|mesh-ancestor
102258808|NCT02022748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102258809|NCT02022748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258810|NCT02022748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258811|NCT02333513|Vincristine|vincristine|mesh-list
102258812|NCT02333513|Lomustine|lomustine|mesh-list
102258813|NCT02333513|Procarbazine|procarbazine|mesh-list
102258814|NCT02333513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102258815|NCT02333513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102258816|NCT02333513|Tubulin Modulators|tubulin modulators|mesh-ancestor
102258817|NCT02333513|Antimitotic Agents|antimitotic agents|mesh-ancestor
102258818|NCT02333513|Mitosis Modulators|mitosis modulators|mesh-ancestor
102258819|NCT02333513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258820|NCT02333513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102258821|NCT02333513|Alkylating Agents|alkylating agents|mesh-ancestor
101813533|NCT00543062|Loxapine|loxapine|mesh-list
102258822|NCT02434549|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102258823|NCT02434549|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102258824|NCT02434549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102258825|NCT02434549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258826|NCT02434549|Cholinergic Agents|cholinergic agents|mesh-ancestor
102258827|NCT02434549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102258828|NCT02434549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258829|NCT02328209|Ranibizumab|ranibizumab|mesh-list
102258830|NCT02328209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102258831|NCT02328209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102258832|NCT02328209|Growth Substances|growth substances|mesh-ancestor
102258833|NCT02328209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258834|NCT02328209|Growth Inhibitors|growth inhibitors|mesh-ancestor
102258835|NCT02328209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102258836|NCT02328443|Itraconazole|itraconazole|mesh-list
102258837|NCT02328443|Rifampin|rifampin|mesh-list
102258838|NCT02328443|Midazolam|midazolam|mesh-list
102258839|NCT02328443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102258840|NCT02328443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102258841|NCT02328443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102258842|NCT02328443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258843|NCT02328443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102258844|NCT02328443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102258845|NCT02328443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102258846|NCT02328443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102258847|NCT02328443|Anesthetics, General|anesthetics, general|mesh-ancestor
102258848|NCT02328443|Anesthetics|anesthetics|mesh-ancestor
102258849|NCT02328443|GABA Modulators|gaba modulators|mesh-ancestor
102258850|NCT02328443|GABA Agents|gaba agents|mesh-ancestor
102258851|NCT02328443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102258852|NCT02328443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258853|NCT02328443|Antifungal Agents|antifungal agents|mesh-ancestor
102258854|NCT02328443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102258855|NCT02328443|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102258856|NCT02328443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102258857|NCT02328443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102258858|NCT02328443|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102258859|NCT02328443|Hormone Antagonists|hormone antagonists|mesh-ancestor
102258860|NCT02328443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102258861|NCT02328443|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102258862|NCT02328443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102613584|NCT05015621|Levoleucovorin|levoleucovorin|mesh-list
102258863|NCT02328443|Antitubercular Agents|antitubercular agents|mesh-ancestor
102258864|NCT02328443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102258865|NCT02328443|Leprostatic Agents|leprostatic agents|mesh-ancestor
102258866|NCT02328443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102258867|NCT02328443|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102258868|NCT02328443|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101813572|NCT00678041|Nitrofurantoin|nitrofurantoin|mesh-list
101813573|NCT00678041|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101813574|NCT00678041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101813575|NCT00678041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101813576|NCT03903822|PF-06700841|pf-06700841|mesh-list
102258869|NCT02328443|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102258870|NCT02328443|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102258871|NCT02328443|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102258872|NCT02328443|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102258873|NCT02039765|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102258874|NCT02039765|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101813594|NCT04003350|Anticonvulsants|anticonvulsants|mesh-ancestor
102258875|NCT02039765|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102258876|NCT02039765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102258877|NCT02039765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102258878|NCT02039765|Adrenergic Agents|adrenergic agents|mesh-ancestor
102258879|NCT02039765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102258880|NCT02039765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258881|NCT02039765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258883|NCT03191539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102258884|NCT03191539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102258885|NCT03191539|Analgesics|analgesics|mesh-ancestor
102258886|NCT03191539|Sensory System Agents|sensory system agents|mesh-ancestor
102258887|NCT03191539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102258888|NCT03191539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258889|NCT03191539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102258890|NCT03191539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102258891|NCT03191539|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102258892|NCT03191539|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102258893|NCT03191539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102258894|NCT03191539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258895|NCT02433925|Resveratrol|resveratrol|mesh-list
102258896|NCT02433925|Antioxidants|antioxidants|mesh-ancestor
102258897|NCT02433925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813615|NCT00748007|Rivastigmine|rivastigmine|mesh-list
102258898|NCT02433925|Protective Agents|protective agents|mesh-ancestor
102258899|NCT02433925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258900|NCT02433925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102258901|NCT02433925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102258902|NCT02332967|Palmitic Acid|palmitic acid|mesh-list
102258903|NCT02332967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102258904|NCT02332967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258905|NCT02327663|Emtricitabine|emtricitabine|mesh-list
102258906|NCT02327663|Antiviral Agents|antiviral agents|mesh-ancestor
102258907|NCT02327663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102258908|NCT02327663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101813624|NCT00748163|Paclitaxel|paclitaxel|mesh-list
102258909|NCT02327663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102258910|NCT02327663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102258911|NCT02327663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258912|NCT02327663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102258913|NCT02327663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102258914|NCT02333123|Aspirin|aspirin|mesh-list
102258915|NCT02333123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102258916|NCT02333123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102258917|NCT02333123|Analgesics|analgesics|mesh-ancestor
101827196|NCT05864755|Bevacizumab|bevacizumab|mesh-list
102258918|NCT02333123|Sensory System Agents|sensory system agents|mesh-ancestor
102258919|NCT02333123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102258920|NCT02333123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258921|NCT02333123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102258922|NCT02333123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102258923|NCT02333123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102258924|NCT02333123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102258925|NCT02333123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258926|NCT02333123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102258927|NCT02333123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102258928|NCT02333123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102258929|NCT02333123|Antipyretics|antipyretics|mesh-ancestor
102258930|NCT02332811|Sevelamer|sevelamer|mesh-list
102258931|NCT02332811|Chelating Agents|chelating agents|mesh-ancestor
101967817|NCT03197324|Digoxin|digoxin|mesh-list
102613585|NCT05015621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102613586|NCT05015621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258932|NCT02332811|Sequestering Agents|sequestering agents|mesh-ancestor
102613587|NCT05015621|Antimetabolites|antimetabolites|mesh-ancestor
102258933|NCT02332811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258934|NCT02433457|Omeprazole|omeprazole|mesh-list
102258935|NCT02433457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102258936|NCT02433457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102258937|NCT02433457|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102258938|NCT02433457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102258939|NCT02433457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258940|NCT02021656|Sofosbuvir|sofosbuvir|mesh-list
102258941|NCT02021656|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102258942|NCT02021656|Ledipasvir|ledipasvir|mesh-list
102258943|NCT02021656|Antiviral Agents|antiviral agents|mesh-ancestor
102258944|NCT02021656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102258945|NCT03145025|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
102258946|NCT03145025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102258947|NCT03145025|Glucocorticoids|glucocorticoids|mesh-ancestor
102258948|NCT03145025|Hormones|hormones|mesh-ancestor
102258949|NCT03145025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102258950|NCT03145025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258951|NCT03144947|Docetaxel|docetaxel|mesh-list
102258952|NCT03144947|Trastuzumab|trastuzumab|mesh-list
102258953|NCT03144947|Pertuzumab|pertuzumab|mesh-list
102258954|NCT03144947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102258955|NCT03144947|Tubulin Modulators|tubulin modulators|mesh-ancestor
102258956|NCT03144947|Antimitotic Agents|antimitotic agents|mesh-ancestor
102258957|NCT03144947|Mitosis Modulators|mitosis modulators|mesh-ancestor
102258958|NCT03144947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258959|NCT03144947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102258960|NCT02433535|Simvastatin|simvastatin|mesh-list
102258961|NCT02433535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102258962|NCT02433535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102258963|NCT02433535|Antimetabolites|antimetabolites|mesh-ancestor
102258964|NCT02433535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102258965|NCT02433535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102258966|NCT02433535|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102258967|NCT02433535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102258968|NCT03144713|Terlipressin|terlipressin|mesh-list
102258969|NCT03144713|Midodrine|midodrine|mesh-list
102258970|NCT03144713|Sympathomimetics|sympathomimetics|mesh-ancestor
102258971|NCT03144713|Autonomic Agents|autonomic agents|mesh-ancestor
102258972|NCT03144713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102258973|NCT03144713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258974|NCT03144713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102258975|NCT03144713|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102258976|NCT03144713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102258977|NCT03144713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102258978|NCT03144713|Adrenergic Agents|adrenergic agents|mesh-ancestor
102258979|NCT03144713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102258980|NCT03144713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827501|NCT05656521|Hormones|hormones|mesh-ancestor
102258981|NCT03144713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102258982|NCT03191383|Vaccines|vaccines|mesh-list
102258983|NCT03191383|Immunologic Factors|immunologic factors|mesh-ancestor
102258984|NCT03191383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258985|NCT02075632|Alclometasone dipropionate|alclometasone dipropionate|mesh-list
102258986|NCT02075632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102258987|NCT02075632|Glucocorticoids|glucocorticoids|mesh-ancestor
102258988|NCT02075632|Hormones|hormones|mesh-ancestor
102258989|NCT02075632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102258990|NCT02075632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102258991|NCT02430259|Isoniazid|isoniazid|mesh-list
102258992|NCT02430259|Rifapentine|rifapentine|mesh-list
102258993|NCT02430259|Antitubercular Agents|antitubercular agents|mesh-ancestor
102258994|NCT02430259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102258995|NCT02430259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102258996|NCT02430259|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102258997|NCT02430259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102258998|NCT02430259|Antimetabolites|antimetabolites|mesh-ancestor
102258999|NCT02430259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259000|NCT02430259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102259001|NCT02430259|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102259002|NCT02430259|Leprostatic Agents|leprostatic agents|mesh-ancestor
102259003|NCT02327039|Dapagliflozin|dapagliflozin|mesh-list
102259004|NCT02327039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102259005|NCT02327039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259006|NCT02327039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102259007|NCT02327039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259008|NCT03142607|Chlorhexidine|chlorhexidine|mesh-list
102259009|NCT03142607|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102259010|NCT03142607|Metronidazole|metronidazole|mesh-list
102259011|NCT03142607|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102259012|NCT03142607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102259013|NCT03142607|Disinfectants|disinfectants|mesh-ancestor
102259014|NCT03142607|Dermatologic Agents|dermatologic agents|mesh-ancestor
102259015|NCT03142607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102259016|NCT03142607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102259017|NCT03142607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102259018|NCT03186547|Botulinum Toxins|botulinum toxins|mesh-list
102259019|NCT03186547|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102259020|NCT03186547|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102259021|NCT03186547|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102259022|NCT03186547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102259023|NCT03186547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259024|NCT03186547|Cholinergic Agents|cholinergic agents|mesh-ancestor
102259025|NCT03186547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102259026|NCT03186547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259027|NCT03186547|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102259028|NCT03186547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102259029|NCT05077475|Cryptophycin 52|cryptophycin 52|mesh-list
102259030|NCT05077475|Antimitotic Agents|antimitotic agents|mesh-ancestor
102259031|NCT05077475|Mitosis Modulators|mitosis modulators|mesh-ancestor
102259032|NCT05077475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259033|NCT05077475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102259034|NCT02326727|Fentanyl|fentanyl|mesh-list
102259035|NCT02326727|Nitrous Oxide|nitrous oxide|mesh-list
102259036|NCT02326727|Propofol|propofol|mesh-list
102259037|NCT02326727|Ropivacaine|ropivacaine|mesh-list
102259038|NCT02326727|Isoflurane|isoflurane|mesh-list
102259039|NCT02326727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101813736|NCT05357820|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101813737|NCT05357820|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101312144|NCT00006226|Growth Substances|growth substances|mesh-ancestor
102259040|NCT02326727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102259041|NCT02326727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259042|NCT02326727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102259043|NCT02326727|Anesthetics, General|anesthetics, general|mesh-ancestor
102259044|NCT02326727|Anesthetics|anesthetics|mesh-ancestor
102259045|NCT02326727|Anesthetics, Local|anesthetics, local|mesh-ancestor
102259046|NCT02326727|Sensory System Agents|sensory system agents|mesh-ancestor
102259047|NCT02326727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102259048|NCT02326727|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102259049|NCT02326727|Narcotics|narcotics|mesh-ancestor
102259050|NCT02326727|Analgesics|analgesics|mesh-ancestor
102259051|NCT02326727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102259052|NCT02326727|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101813744|NCT00748787|Calcium polycarbophil|calcium polycarbophil|mesh-list
101813745|NCT00748787|Cathartics|cathartics|mesh-ancestor
101813746|NCT00748787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101813747|NCT00748787|Antidiarrheals|antidiarrheals|mesh-ancestor
101813748|NCT05712044|Folic Acid|folic acid|mesh-list
101813749|NCT05712044|Vitamin B Complex|vitamin b complex|mesh-list
101813750|NCT05712044|Hematinics|hematinics|mesh-ancestor
101813751|NCT05712044|Vitamins|vitamins|mesh-ancestor
101813752|NCT05712044|Micronutrients|micronutrients|mesh-ancestor
101813753|NCT05712044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259053|NCT02326727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102259054|NCT02432911|Cytarabine|cytarabine|mesh-list
102259055|NCT02432911|Aclacinomycins|aclacinomycins|mesh-list
102259056|NCT02432911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102259057|NCT02432911|Antimetabolites|antimetabolites|mesh-ancestor
102259058|NCT02432911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259059|NCT02432911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102259060|NCT02432911|Antiviral Agents|antiviral agents|mesh-ancestor
102259061|NCT02432911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102259062|NCT02432911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102259063|NCT02432911|Immunologic Factors|immunologic factors|mesh-ancestor
102259064|NCT02432911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259065|NCT02432911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102259066|NCT02432911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102259067|NCT03588767|Vitamin D|vitamin d|mesh-list
102259068|NCT03588767|Ergocalciferols|ergocalciferols|mesh-list
102259069|NCT03588767|Cholecalciferol|cholecalciferol|mesh-list
102259070|NCT03588767|Vitamins|vitamins|mesh-list
102259071|NCT03588767|Anabolic Androgenic Steroids|anabolic androgenic steroids|mesh-list
102259072|NCT03588767|Testosterone Congeners|testosterone congeners|mesh-list
102259073|NCT03588767|Micronutrients|micronutrients|mesh-ancestor
102259074|NCT03588767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259075|NCT03588767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102259076|NCT03588767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102259077|NCT03588767|Anabolic Agents|anabolic agents|mesh-ancestor
102259078|NCT03588767|Hormones|hormones|mesh-ancestor
102259079|NCT03588767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102259080|NCT03588767|Performance-Enhancing Substances|performance-enhancing substances|mesh-ancestor
102259081|NCT02440399|Acetaminophen|acetaminophen|mesh-list
102259082|NCT02440399|Diclofenac|diclofenac|mesh-list
102259083|NCT02440399|Morphine|morphine|mesh-list
102613588|NCT05015621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613589|NCT05015621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102613590|NCT05015621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613591|NCT05015621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102259084|NCT02440399|Oxycodone|oxycodone|mesh-list
102259085|NCT02440399|Tramadol|tramadol|mesh-list
102259086|NCT02440399|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102259087|NCT02440399|Narcotics|narcotics|mesh-ancestor
102259088|NCT02440399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102259089|NCT02440399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259090|NCT02440399|Analgesics|analgesics|mesh-ancestor
102259091|NCT02440399|Sensory System Agents|sensory system agents|mesh-ancestor
102259092|NCT02440399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102259093|NCT02440399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102259094|NCT02440399|Antipyretics|antipyretics|mesh-ancestor
102259095|NCT02440399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102259096|NCT02440399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102259097|NCT02440399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102259098|NCT02440399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102259099|NCT02440399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102259100|NCT02440399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259101|NCT02429713|Oxymetazoline|oxymetazoline|mesh-list
101813793|NCT00749021|Growth Substances|growth substances|mesh-ancestor
102259102|NCT02429713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102259103|NCT02429713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102259104|NCT02429713|Adrenergic Agents|adrenergic agents|mesh-ancestor
102259105|NCT02429713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102259106|NCT02429713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259107|NCT02429713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259108|NCT02429713|Sympathomimetics|sympathomimetics|mesh-ancestor
102259109|NCT02429713|Autonomic Agents|autonomic agents|mesh-ancestor
102259110|NCT02429713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102259111|NCT02429713|Nasal Decongestants|nasal decongestants|mesh-ancestor
102259112|NCT02429713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102259113|NCT02429713|Respiratory System Agents|respiratory system agents|mesh-ancestor
102259114|NCT03191305|Warfarin|warfarin|mesh-list
102259115|NCT03191305|Anticoagulants|anticoagulants|mesh-ancestor
102259116|NCT03144401|Misoprostol|misoprostol|mesh-list
102259117|NCT03144401|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102259118|NCT03144401|Abortifacient Agents|abortifacient agents|mesh-ancestor
102259119|NCT03144401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102259120|NCT03144401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813816|NCT00987038|GABA Modulators|gaba modulators|mesh-ancestor
102259121|NCT03144401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102259122|NCT03144401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102259123|NCT03144401|Oxytocics|oxytocics|mesh-ancestor
102259124|NCT04483765|Anesthetics|anesthetics|mesh-list
102259125|NCT04483765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102259126|NCT04483765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259127|NCT03186313|Ribavirin|ribavirin|mesh-list
102259128|NCT03186313|Sofosbuvir|sofosbuvir|mesh-list
102259129|NCT03186313|Antimetabolites|antimetabolites|mesh-ancestor
102259130|NCT03186313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259131|NCT03186313|Antiviral Agents|antiviral agents|mesh-ancestor
102259132|NCT03186313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102259133|NCT03144245|Pembrolizumab|pembrolizumab|mesh-list
102259134|NCT03144245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102259135|NCT03144245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102259136|NCT03144245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102259137|NCT03144245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259138|NCT04996199|Zileuton|zileuton|mesh-list
102259139|NCT04996199|Carbamazepine|carbamazepine|mesh-list
102259140|NCT04996199|Oxcarbazepine|oxcarbazepine|mesh-list
102259141|NCT04996199|Anticonvulsants|anticonvulsants|mesh-ancestor
102259142|NCT04996199|Antimanic Agents|antimanic agents|mesh-ancestor
102259143|NCT04996199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102259144|NCT04996199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102259145|NCT04996199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259146|NCT04996199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101813843|NCT05711810|Dopamine Agents|dopamine agents|mesh-ancestor
102259147|NCT04996199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102259148|NCT04996199|Analgesics|analgesics|mesh-ancestor
102259149|NCT04996199|Sensory System Agents|sensory system agents|mesh-ancestor
102259150|NCT04996199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102259151|NCT04996199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102259152|NCT04996199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102259153|NCT04996199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259154|NCT04996199|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102613592|NCT05015621|Immunologic Factors|immunologic factors|mesh-ancestor
102259155|NCT04996199|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102259156|NCT04996199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102259157|NCT04996199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102259158|NCT04996199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102259159|NCT04996199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102259160|NCT04996199|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
102259161|NCT04996199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102259162|NCT04996199|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102259163|NCT04996199|Hormone Antagonists|hormone antagonists|mesh-ancestor
102259164|NCT04996199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102259165|NCT02432833|Tacrolimus|tacrolimus|mesh-list
102259166|NCT02432833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102259167|NCT02432833|Immunologic Factors|immunologic factors|mesh-ancestor
102259168|NCT02432833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259169|NCT02432833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102259170|NCT02432833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102259171|NCT02432833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259172|NCT02429323|Sevoflurane|sevoflurane|mesh-list
102259173|NCT02429323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102259174|NCT02429323|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102259175|NCT02429323|Anesthetics, General|anesthetics, general|mesh-ancestor
102259176|NCT02429323|Anesthetics|anesthetics|mesh-ancestor
102259177|NCT02429323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102259178|NCT02429323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613593|NCT05015621|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102613594|NCT05015621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102613595|NCT05015621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102613596|NCT05015621|Antidotes|antidotes|mesh-ancestor
102613597|NCT05015621|Protective Agents|protective agents|mesh-ancestor
102613598|NCT05015621|Vitamin B Complex|vitamin b complex|mesh-ancestor
102613599|NCT05015621|Vitamins|vitamins|mesh-ancestor
102613600|NCT05015621|Micronutrients|micronutrients|mesh-ancestor
102613601|NCT05007509|Vaccines|vaccines|mesh-list
102613602|NCT05007509|Immunologic Factors|immunologic factors|mesh-ancestor
102613603|NCT05007509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613604|NCT05289167|Cyclophosphamide|cyclophosphamide|mesh-list
102613605|NCT05289167|Bortezomib|bortezomib|mesh-list
102613606|NCT05289167|Abatacept|abatacept|mesh-list
102613607|NCT05289167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102613608|NCT05289167|Immunologic Factors|immunologic factors|mesh-ancestor
102613609|NCT05289167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613610|NCT05289167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102613611|NCT05289167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102613612|NCT05289167|Alkylating Agents|alkylating agents|mesh-ancestor
102613613|NCT05289167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613614|NCT05289167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613615|NCT05289167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102613616|NCT05289167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102613617|NCT05289167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102259179|NCT02326103|Ciprofloxacin|ciprofloxacin|mesh-list
102259180|NCT02326103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102259181|NCT02326103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102259182|NCT02326103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102259183|NCT02326103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101813909|NCT03902574|Brexpiprazole|brexpiprazole|mesh-list
102259184|NCT02326103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102259185|NCT02326103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259186|NCT02326103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102259187|NCT02326103|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102259188|NCT02326103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102259189|NCT04984733|Nivolumab|nivolumab|mesh-list
102259190|NCT04984733|Temozolomide|temozolomide|mesh-list
102259191|NCT04984733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102259192|NCT04984733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102259193|NCT04984733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102259194|NCT04984733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259195|NCT04984733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102259196|NCT04984733|Alkylating Agents|alkylating agents|mesh-ancestor
102259197|NCT02707861|Ibalizumab|ibalizumab|mesh-list
102259198|NCT02707861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102259199|NCT02707861|Antiviral Agents|antiviral agents|mesh-ancestor
101902014|NCT01187888|Rasagiline|rasagiline|mesh-list
102613618|NCT00382499|Lidocaine|lidocaine|mesh-list
102613619|NCT00382499|Anesthetics, Local|anesthetics, local|mesh-ancestor
102613620|NCT00382499|Anesthetics|anesthetics|mesh-ancestor
102259201|NCT02707861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102259202|NCT02432599|Choline|choline|mesh-list
102259203|NCT02432599|Lipotropic Agents|lipotropic agents|mesh-ancestor
102259204|NCT02432599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102259205|NCT02432599|Antimetabolites|antimetabolites|mesh-ancestor
101813916|NCT01004874|Bevacizumab|bevacizumab|mesh-list
102259206|NCT02432599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259207|NCT02432599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102259208|NCT02432599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102259209|NCT02432599|Nootropic Agents|nootropic agents|mesh-ancestor
102259210|NCT03185143|Acetaminophen|acetaminophen|mesh-list
102259211|NCT03185143|Sumatriptan|sumatriptan|mesh-list
102259212|NCT03185143|Naltrexone|naltrexone|mesh-list
102259213|NCT03185143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102259214|NCT03185143|Analgesics|analgesics|mesh-ancestor
102259215|NCT03185143|Sensory System Agents|sensory system agents|mesh-ancestor
102259216|NCT03185143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102259217|NCT03185143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259218|NCT03185143|Antipyretics|antipyretics|mesh-ancestor
102259219|NCT03185143|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102259220|NCT03185143|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101813945|NCT00987116|Immunologic Factors|immunologic factors|mesh-ancestor
102259221|NCT03185143|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102259222|NCT03185143|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102259223|NCT03185143|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102259224|NCT03185143|Serotonin Agents|serotonin agents|mesh-ancestor
102259225|NCT03185143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102259226|NCT03185143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259227|NCT05076773|Morphine|morphine|mesh-list
102259228|NCT05076773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102259229|NCT05076773|Narcotics|narcotics|mesh-ancestor
102259230|NCT05076773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102259231|NCT05076773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259232|NCT05076773|Analgesics|analgesics|mesh-ancestor
102259233|NCT05076773|Sensory System Agents|sensory system agents|mesh-ancestor
102259234|NCT05076773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102259235|NCT02432677|Remifentanil|remifentanil|mesh-list
102259236|NCT02432677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102259237|NCT02432677|Narcotics|narcotics|mesh-ancestor
102259238|NCT02432677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102259239|NCT02432677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259240|NCT02432677|Analgesics|analgesics|mesh-ancestor
102259241|NCT02432677|Sensory System Agents|sensory system agents|mesh-ancestor
102259242|NCT02432677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102259243|NCT03442673|Gemcitabine|gemcitabine|mesh-list
102259244|NCT03442673|Vinorelbine|vinorelbine|mesh-list
102259245|NCT03442673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102259246|NCT03442673|Antimetabolites|antimetabolites|mesh-ancestor
102259247|NCT03442673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259248|NCT03442673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102259249|NCT03442673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102259250|NCT03442673|Tubulin Modulators|tubulin modulators|mesh-ancestor
102259251|NCT03442673|Antimitotic Agents|antimitotic agents|mesh-ancestor
102259252|NCT03442673|Mitosis Modulators|mitosis modulators|mesh-ancestor
102259254|NCT02432365|Cisplatin|cisplatin|mesh-list
102259255|NCT02432365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102259256|NCT02432365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102259257|NCT02432365|Tubulin Modulators|tubulin modulators|mesh-ancestor
102259258|NCT02432365|Antimitotic Agents|antimitotic agents|mesh-ancestor
102259259|NCT02432365|Mitosis Modulators|mitosis modulators|mesh-ancestor
102259260|NCT02432365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259261|NCT05076695|Trastuzumab|trastuzumab|mesh-list
102259262|NCT05076695|Fulvestrant|fulvestrant|mesh-list
102259263|NCT05076695|Palbociclib|palbociclib|mesh-list
102259264|NCT05076695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102259265|NCT05076695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101813971|NCT00987662|Amlodipine|amlodipine|mesh-list
102259266|NCT05076695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102259267|NCT05076695|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102259268|NCT05076695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102259269|NCT05076695|Hormone Antagonists|hormone antagonists|mesh-ancestor
102259270|NCT05076695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102259271|NCT05076695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613621|NCT00382499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102259272|NCT05076695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102259273|NCT05076695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101902038|NCT00054132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259274|NCT05076695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613622|NCT00382499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259275|NCT03143933|Fentanyl|fentanyl|mesh-list
102259276|NCT03143933|Propofol|propofol|mesh-list
102259277|NCT03143933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102259278|NCT03143933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102259279|NCT03143933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259280|NCT03143933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102259281|NCT03143933|Anesthetics, General|anesthetics, general|mesh-ancestor
102259282|NCT03143933|Anesthetics|anesthetics|mesh-ancestor
102259283|NCT03143933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102259284|NCT03143933|Narcotics|narcotics|mesh-ancestor
102259285|NCT03143933|Analgesics|analgesics|mesh-ancestor
102259286|NCT03143933|Sensory System Agents|sensory system agents|mesh-ancestor
102259287|NCT03143933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102259288|NCT03143933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102259289|NCT02440243|Vaccines|vaccines|mesh-list
102259290|NCT02440243|Immunologic Factors|immunologic factors|mesh-ancestor
102259291|NCT02440243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259292|NCT04705259|Anti-Infective Agents|anti-infective agents|mesh-list
102259293|NCT04705259|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102259294|NCT05076461|Ondansetron|ondansetron|mesh-list
102259295|NCT05076461|Antiemetics|antiemetics|mesh-ancestor
102613623|NCT00382499|Sensory System Agents|sensory system agents|mesh-ancestor
102613624|NCT00382499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102613625|NCT00382499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102613626|NCT00382499|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102613627|NCT00382499|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102613628|NCT00382499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102613629|NCT00382499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613630|NCT04330547|Analgesics|analgesics|mesh-list
102613631|NCT04330547|Sensory System Agents|sensory system agents|mesh-ancestor
102613632|NCT04330547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102613633|NCT04330547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613634|NCT00382889|Beclomethasone|beclomethasone|mesh-list
102613635|NCT00382889|Albuterol|albuterol|mesh-list
102613636|NCT00382889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102613637|NCT00382889|Autonomic Agents|autonomic agents|mesh-ancestor
102613638|NCT00382889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102613639|NCT00382889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613640|NCT00382889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102613641|NCT00382889|Respiratory System Agents|respiratory system agents|mesh-ancestor
102259296|NCT05076461|Autonomic Agents|autonomic agents|mesh-ancestor
102259297|NCT05076461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102259298|NCT05076461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259299|NCT05076461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102259300|NCT05076461|Antipruritics|antipruritics|mesh-ancestor
102259301|NCT05076461|Dermatologic Agents|dermatologic agents|mesh-ancestor
102259302|NCT05076461|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102259303|NCT05076461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102259304|NCT05076461|Serotonin Agents|serotonin agents|mesh-ancestor
102259305|NCT05076461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101814052|NCT00541658|Risedronic Acid|risedronic acid|mesh-list
102259306|NCT05076461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259307|NCT02428933|Bromocriptine|bromocriptine|mesh-list
102259308|NCT02428933|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101968191|NCT00003631|Alkylating Agents|alkylating agents|mesh-ancestor
102259309|NCT02428933|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102259310|NCT02428933|Hormone Antagonists|hormone antagonists|mesh-ancestor
102259311|NCT02428933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102259312|NCT02428933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259313|NCT02428933|Dopamine Agonists|dopamine agonists|mesh-ancestor
102259314|NCT02428933|Dopamine Agents|dopamine agents|mesh-ancestor
102259315|NCT02428933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102259316|NCT02428933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259317|NCT02428777|Diclofenac|diclofenac|mesh-list
102259318|NCT02428777|Tramadol|tramadol|mesh-list
102259319|NCT02428777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102259320|NCT02428777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102259321|NCT02428777|Analgesics|analgesics|mesh-ancestor
102259322|NCT02428777|Sensory System Agents|sensory system agents|mesh-ancestor
102259323|NCT02428777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102259324|NCT02428777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613642|NCT00382889|Tocolytic Agents|tocolytic agents|mesh-ancestor
102613643|NCT00382889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102259325|NCT02428777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102613644|NCT00382889|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102259326|NCT02428777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102259327|NCT02428777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102259328|NCT02428777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102259329|NCT02428777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259330|NCT02428777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102259332|NCT02428777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102259333|NCT02432053|Tacrolimus|tacrolimus|mesh-list
102259334|NCT02432053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102259335|NCT02432053|Immunologic Factors|immunologic factors|mesh-ancestor
101814073|NCT00987974|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101814074|NCT00987974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101814075|NCT00987974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101814076|NCT00987974|Antimetabolites|antimetabolites|mesh-ancestor
101814077|NCT00987974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814078|NCT00987974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101814079|NCT00987974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101814080|NCT00987974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101814081|NCT03519074|Cisplatin|cisplatin|mesh-list
101814082|NCT03519074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101814091|NCT03905642|Amikacin|amikacin|mesh-list
101814092|NCT03905642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101830206|NCT02458014|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101830207|NCT02458014|Muromonab-CD3|muromonab-cd3|mesh-list
101830208|NCT02458014|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101830209|NCT02458014|Immunologic Factors|immunologic factors|mesh-ancestor
101830210|NCT02458014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830211|NCT02458014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830212|NCT02458014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101830213|NCT02451982|Cyclophosphamide|cyclophosphamide|mesh-list
101830215|NCT02451982|Immunologic Factors|immunologic factors|mesh-ancestor
101830216|NCT02451982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830226|NCT02444741|Pembrolizumab|pembrolizumab|mesh-list
102259336|NCT02432053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259337|NCT02432053|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102259338|NCT02432053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102259339|NCT02432053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259340|NCT03141827|Insulin|insulin|mesh-list
102259341|NCT03141827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102259342|NCT03141827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259343|NCT03190681|Methylphenidate|methylphenidate|mesh-list
102259344|NCT03190681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102259345|NCT03190681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259346|NCT03190681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102259347|NCT03190681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102259348|NCT03190681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102259349|NCT03190681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259350|NCT03190681|Dopamine Agents|dopamine agents|mesh-ancestor
102259351|NCT03190681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102259352|NCT03186001|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102259353|NCT03186001|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102259354|NCT03186001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102259355|NCT03186001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102259356|NCT03186001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259357|NCT03186001|Cholinergic Agents|cholinergic agents|mesh-ancestor
102259358|NCT03186001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102259359|NCT03186001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259360|NCT03186001|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102259361|NCT03186001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102259362|NCT04593563|Psilocybin|psilocybin|mesh-list
102259363|NCT04593563|Hallucinogens|hallucinogens|mesh-ancestor
102259364|NCT04593563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259365|NCT04593563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102259366|NCT04551911|Calcifediol|calcifediol|mesh-list
102259367|NCT04551911|Vitamins|vitamins|mesh-ancestor
102259368|NCT04551911|Micronutrients|micronutrients|mesh-ancestor
102259369|NCT04551911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259370|NCT04551911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102259371|NCT02431975|Ritonavir|ritonavir|mesh-list
102259372|NCT02431975|Lopinavir|lopinavir|mesh-list
102259373|NCT02431975|Lamivudine|lamivudine|mesh-list
102259374|NCT02431975|Zidovudine|zidovudine|mesh-list
102259375|NCT02431975|Nevirapine|nevirapine|mesh-list
102259376|NCT02431975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102259377|NCT02431975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102259378|NCT02431975|Protease Inhibitors|protease inhibitors|mesh-ancestor
102259379|NCT02431975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102259380|NCT02431975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259381|NCT02431975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102259382|NCT02431975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102259383|NCT02431975|Antiviral Agents|antiviral agents|mesh-ancestor
102259384|NCT02431975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102259385|NCT02431975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102259386|NCT02431975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102259387|NCT02431975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102259388|NCT02431975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102259389|NCT02431975|Antimetabolites|antimetabolites|mesh-ancestor
102259390|NCT02431975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102259391|NCT02431975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102259393|NCT03143465|Salmon calcitonin|salmon calcitonin|mesh-list
102259394|NCT03143465|Sildenafil Citrate|sildenafil citrate|mesh-list
102259395|NCT03143465|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
102259396|NCT03143465|Katacalcin|katacalcin|mesh-list
102259397|NCT03143465|Vasodilator Agents|vasodilator agents|mesh-ancestor
101814143|NCT00539864|Hemagglutinins|hemagglutinins|mesh-list
102259398|NCT03143465|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102259399|NCT03143465|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102259401|NCT03143465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259402|NCT03143465|Urological Agents|urological agents|mesh-ancestor
102259403|NCT03143465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102259404|NCT03143465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259405|NCT03143465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102259406|NCT05034809|Melatonin|melatonin|mesh-list
102259407|NCT05034809|Antioxidants|antioxidants|mesh-ancestor
101814153|NCT04003376|Vitamins|vitamins|mesh-ancestor
102259408|NCT05034809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259409|NCT05034809|Protective Agents|protective agents|mesh-ancestor
102259410|NCT05034809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259411|NCT05034809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102259412|NCT02428543|Cytarabine|cytarabine|mesh-list
102259413|NCT02428543|Ponatinib|ponatinib|mesh-list
102259414|NCT02428543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102259415|NCT02428543|Antimetabolites|antimetabolites|mesh-ancestor
102259416|NCT02428543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259417|NCT02428543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102259418|NCT02428543|Antiviral Agents|antiviral agents|mesh-ancestor
102259419|NCT02428543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102259420|NCT02428543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102259421|NCT02428543|Immunologic Factors|immunologic factors|mesh-ancestor
102259422|NCT02428543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259423|NCT02428543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102259424|NCT02428543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102259425|NCT04428203|Cannabidiol|cannabidiol|mesh-list
102259426|NCT04428203|Anticonvulsants|anticonvulsants|mesh-ancestor
102259427|NCT02431663|Ketamine|ketamine|mesh-list
102259428|NCT02431663|Analgesics|analgesics|mesh-ancestor
102259429|NCT02431663|Sensory System Agents|sensory system agents|mesh-ancestor
102259430|NCT02431663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102259431|NCT02431663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259432|NCT02431663|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102259433|NCT02431663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102259434|NCT02431663|Anesthetics, General|anesthetics, general|mesh-ancestor
102259435|NCT02431663|Anesthetics|anesthetics|mesh-ancestor
101471496|NCT01680952|Sirolimus|sirolimus|mesh-list
102259436|NCT02431663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102259437|NCT02431663|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102259438|NCT02431663|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102259439|NCT02431663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102259440|NCT02431663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259441|NCT03185845|Warfarin|warfarin|mesh-list
102259442|NCT03185845|Anticoagulants|anticoagulants|mesh-ancestor
102259443|NCT03182803|Antibodies|antibodies|mesh-list
102259444|NCT03182803|Immunologic Factors|immunologic factors|mesh-ancestor
102259445|NCT03182803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259446|NCT04596917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
102259447|NCT04596917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102259448|NCT04596917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259449|NCT03185611|Rifaximin|rifaximin|mesh-list
102259450|NCT03185611|Azathioprine|azathioprine|mesh-list
102259451|NCT03185611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102259452|NCT03185611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102259453|NCT03185611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102259454|NCT03185611|Antimetabolites|antimetabolites|mesh-ancestor
102259455|NCT03185611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259456|NCT03185611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102259457|NCT03185611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101968341|NCT04371380|Cabotegravir|cabotegravir|mesh-list
102259458|NCT03185611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102259459|NCT03185611|Immunologic Factors|immunologic factors|mesh-ancestor
102259460|NCT03185611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259461|NCT03185611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102259462|NCT02431429|Miltefosine|miltefosine|mesh-list
102259463|NCT02431429|Antifungal Agents|antifungal agents|mesh-ancestor
102259464|NCT02431429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102259465|NCT02431429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102259466|NCT02431429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102259467|NCT02431429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102259468|NCT02027428|Paclitaxel|paclitaxel|mesh-list
102259469|NCT02027428|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102259470|NCT02027428|Carboplatin|carboplatin|mesh-list
102259471|NCT02027428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102259472|NCT02027428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102259473|NCT02027428|Tubulin Modulators|tubulin modulators|mesh-ancestor
102259474|NCT02027428|Antimitotic Agents|antimitotic agents|mesh-ancestor
102259475|NCT02027428|Mitosis Modulators|mitosis modulators|mesh-ancestor
102259476|NCT02027428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259477|NCT03184363|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102259478|NCT03184363|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102259479|NCT03184363|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102259480|NCT03184363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102259481|NCT03184363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259482|NCT03184363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102259483|NCT03184363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102259484|NCT03184363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259485|NCT03184363|Cholinergic Agents|cholinergic agents|mesh-ancestor
102259486|NCT03184363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102259487|NCT02431039|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102259488|NCT02431039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102259490|NCT01995136|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102259491|NCT01995136|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102259492|NCT01995136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102259493|NCT03141593|Vitamin D|vitamin d|mesh-list
102259494|NCT03141593|Ergocalciferols|ergocalciferols|mesh-list
102259495|NCT03141593|Cholecalciferol|cholecalciferol|mesh-list
102259496|NCT03141593|Vitamins|vitamins|mesh-list
102259497|NCT03141593|Micronutrients|micronutrients|mesh-ancestor
101266118|NCT01779843|Cytarabine|cytarabine|mesh-list
102259498|NCT03141593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259499|NCT03141593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102259500|NCT03141593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102259501|NCT04102241|Hemay005|hemay005|mesh-list
102259502|NCT04102241|Dermatologic Agents|dermatologic agents|mesh-ancestor
102259503|NCT04102241|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102259504|NCT04102241|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102259505|NCT04102241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102259506|NCT04102241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259507|NCT03576443|Idelalisib|idelalisib|mesh-list
102259508|NCT03576443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102259509|NCT03576443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102259510|NCT03576443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259511|NCT02427529|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102259512|NCT02427529|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102259513|NCT02427529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259514|NCT04438733|Anastrozole|anastrozole|mesh-list
102259515|NCT04438733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102259516|NCT04438733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102259517|NCT04438733|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102259518|NCT04438733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102259519|NCT04438733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102259520|NCT04438733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259521|NCT04438733|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102259522|NCT04438733|Hormone Antagonists|hormone antagonists|mesh-ancestor
102259523|NCT04438733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102259524|NCT04438733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259525|NCT04438811|Anesthetics|anesthetics|mesh-list
102259526|NCT04438811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102259527|NCT04438811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259528|NCT02427295|Octreotide|octreotide|mesh-list
102259529|NCT02427295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102259530|NCT02427295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102259531|NCT02427295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102259532|NCT01994590|Prednisone|prednisone|mesh-list
102259533|NCT01994590|Abiraterone Acetate|abiraterone acetate|mesh-list
102259534|NCT01994590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102259535|NCT01994590|Glucocorticoids|glucocorticoids|mesh-ancestor
102259536|NCT01994590|Hormones|hormones|mesh-ancestor
102259537|NCT01994590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102259538|NCT01994590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259539|NCT01994590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102259540|NCT01994590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102259541|NCT01994590|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102259542|NCT01994590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102259543|NCT01994590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259544|NCT01994590|Hormone Antagonists|hormone antagonists|mesh-ancestor
102259545|NCT01994590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101601270|NCT02612701|Nicotine|nicotine|mesh-list
102613645|NCT00382889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102259546|NCT05387603|Capecitabine|capecitabine|mesh-list
102259547|NCT05387603|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
102259548|NCT05387603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102259549|NCT05387603|Antimetabolites|antimetabolites|mesh-ancestor
102259550|NCT05387603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259551|NCT05387603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102259552|NCT05387603|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102259553|NCT03182413|Modafinil|modafinil|mesh-list
102259554|NCT03182413|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102259555|NCT03182413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259556|NCT03182413|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102259557|NCT03182413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102259558|NCT03182413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101814300|NCT00764855|Propofol|propofol|mesh-list
102259559|NCT03182413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259560|NCT03182257|ONO-7579|ono-7579|mesh-list
102259561|NCT03182257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102259562|NCT03182257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102259563|NCT03182257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259564|NCT03183739|ASP8062|asp8062|mesh-list
102259565|NCT03183739|Analgesics|analgesics|mesh-ancestor
102259566|NCT03183739|Sensory System Agents|sensory system agents|mesh-ancestor
102259567|NCT03183739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102259568|NCT03183739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259569|NCT03183739|GABA Modulators|gaba modulators|mesh-ancestor
102259570|NCT03183739|GABA Agents|gaba agents|mesh-ancestor
102259571|NCT03183739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102259572|NCT03183739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259573|NCT03117439|Antifungal Agents|antifungal agents|mesh-list
102259574|NCT03117439|Clotrimazole|clotrimazole|mesh-list
102259575|NCT03117439|Miconazole|miconazole|mesh-list
102259576|NCT03117439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102259577|NCT03117439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102259578|NCT03117439|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102259579|NCT03117439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102259580|NCT03117439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102259581|NCT03117439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259582|NCT03117439|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102259583|NCT03117439|Hormone Antagonists|hormone antagonists|mesh-ancestor
101814323|NCT01041040|Immunologic Factors|immunologic factors|mesh-ancestor
102259584|NCT03117439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102259585|NCT03117439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259586|NCT03117439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102259587|NCT03117439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102259588|NCT02426905|Trientine|trientine|mesh-list
102259589|NCT02426905|Chelating Agents|chelating agents|mesh-ancestor
102259590|NCT02426905|Sequestering Agents|sequestering agents|mesh-ancestor
102259591|NCT02426905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259592|NCT02421289|Efavirenz|efavirenz|mesh-list
102259593|NCT02421289|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102259594|NCT02421289|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102259595|NCT02421289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102259596|NCT02421289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259597|NCT02421289|Antiviral Agents|antiviral agents|mesh-ancestor
102259598|NCT02421289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102259599|NCT02421289|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102259600|NCT02421289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102259601|NCT02421289|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102259602|NCT02421289|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102259603|NCT02421289|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102259604|NCT02421289|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102259605|NCT03141125|Ethanol|ethanol|mesh-list
102259606|NCT03141125|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102259607|NCT03141125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102259608|NCT03141125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102259609|NCT03141125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259610|NCT02426983|Dextromethorphan|dextromethorphan|mesh-list
102259611|NCT02426983|Antitussive Agents|antitussive agents|mesh-ancestor
102259612|NCT02426983|Respiratory System Agents|respiratory system agents|mesh-ancestor
101814335|NCT00765167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102259613|NCT02426983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102259614|NCT02426983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102259615|NCT02426983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102613646|NCT00382889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102259616|NCT02426983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259617|NCT02426983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259618|NCT03142763|Choline|choline|mesh-list
102259619|NCT03142763|Lipotropic Agents|lipotropic agents|mesh-ancestor
102259620|NCT03142763|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102259621|NCT03142763|Antimetabolites|antimetabolites|mesh-ancestor
102259622|NCT03142763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259623|NCT03142763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102259624|NCT03142763|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102259625|NCT03142763|Nootropic Agents|nootropic agents|mesh-ancestor
102259626|NCT03511391|Pembrolizumab|pembrolizumab|mesh-list
102259627|NCT03511391|Nivolumab|nivolumab|mesh-list
102259628|NCT03511391|Atezolizumab|atezolizumab|mesh-list
102259629|NCT03511391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102259630|NCT03511391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102259631|NCT03511391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102259632|NCT03511391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259633|NCT05081765|Olaparib|olaparib|mesh-list
102259634|NCT05081765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102259635|NCT05081765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102259636|NCT05081765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259637|NCT05081765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102259638|NCT05078177|Rituximab|rituximab|mesh-list
102259639|NCT05078177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102259640|NCT05078177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102259641|NCT05078177|Immunologic Factors|immunologic factors|mesh-ancestor
102259642|NCT05078177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259643|NCT05078177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101814382|NCT00761501|Naproxen|naproxen|mesh-list
102259644|NCT05081687|Oxaliplatin|oxaliplatin|mesh-list
102259645|NCT05081687|Irinotecan|irinotecan|mesh-list
102259646|NCT05081687|Folfirinox|folfirinox|mesh-list
102259647|NCT05081687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102259648|NCT05081687|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102259649|NCT05081687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102259650|NCT05081687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102259651|NCT05081687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259652|NCT05387369|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
102259653|NCT05387369|Antiviral Agents|antiviral agents|mesh-ancestor
102259654|NCT05387369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102259655|NCT05080985|Bupivacaine|bupivacaine|mesh-list
102259656|NCT05080985|Anesthetics, Local|anesthetics, local|mesh-ancestor
102259657|NCT05080985|Anesthetics|anesthetics|mesh-ancestor
102259658|NCT05080985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102259659|NCT05080985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259660|NCT05080985|Sensory System Agents|sensory system agents|mesh-ancestor
102259661|NCT05080985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102259662|NCT03139487|Dalteparin|dalteparin|mesh-list
102259663|NCT03139487|Tinzaparin|tinzaparin|mesh-list
102259664|NCT03139487|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102259665|NCT03139487|Rivaroxaban|rivaroxaban|mesh-list
102259666|NCT03139487|Apixaban|apixaban|mesh-list
102259667|NCT03139487|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102259668|NCT03139487|Antithrombins|antithrombins|mesh-ancestor
102259669|NCT03139487|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102259670|NCT03139487|Protease Inhibitors|protease inhibitors|mesh-ancestor
102259671|NCT03139487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102259672|NCT03139487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259673|NCT03139487|Anticoagulants|anticoagulants|mesh-ancestor
102259674|NCT03139487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102259675|NCT03139487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102259676|NCT03139253|Amoxicillin|amoxicillin|mesh-list
102259677|NCT03139253|Clarithromycin|clarithromycin|mesh-list
102259678|NCT03139253|Levofloxacin|levofloxacin|mesh-list
102259679|NCT03139253|Tetracycline|tetracycline|mesh-list
102259680|NCT03139253|Tinidazole|tinidazole|mesh-list
102259681|NCT03139253|Furazolidone|furazolidone|mesh-list
102259682|NCT03139253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102259683|NCT03139253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102259684|NCT03139253|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102259685|NCT03139253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102259686|NCT03139253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259687|NCT03139253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102259688|NCT03139253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102259689|NCT03139253|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102259690|NCT03139253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102259691|NCT03139253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102259692|NCT03139253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102259693|NCT03139253|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102259694|NCT03139253|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102259695|NCT03139253|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
102259696|NCT03139253|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102259697|NCT03139253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102259698|NCT03139253|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102259699|NCT03139253|Alkylating Agents|alkylating agents|mesh-ancestor
102259701|NCT03139409|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102259702|NCT03139409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102259703|NCT03139409|Disinfectants|disinfectants|mesh-ancestor
102259704|NCT02019472|Adalimumab|adalimumab|mesh-list
102259705|NCT02019472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102259706|NCT02019472|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102259707|NCT02019472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102259708|NCT02019472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102259709|NCT02019472|Immunologic Factors|immunologic factors|mesh-ancestor
102259710|NCT02019472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259711|NCT00157937|Theophylline|theophylline|mesh-list
102259712|NCT00157937|Montelukast|montelukast|mesh-list
102259713|NCT00157937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102259714|NCT00157937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259715|NCT00157937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259716|NCT00157937|Autonomic Agents|autonomic agents|mesh-ancestor
102259717|NCT00157937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102259718|NCT00157937|Respiratory System Agents|respiratory system agents|mesh-ancestor
102259719|NCT00157937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102259720|NCT00157937|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102259721|NCT00157937|Hormone Antagonists|hormone antagonists|mesh-ancestor
102259722|NCT00157937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101814429|NCT01035190|Glucocorticoids|glucocorticoids|mesh-ancestor
102259723|NCT00157937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102259724|NCT00157937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102259725|NCT00157937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102259726|NCT00157937|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102259727|NCT00157937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102259728|NCT00157937|Vasodilator Agents|vasodilator agents|mesh-ancestor
102259729|NCT00157937|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102259730|NCT00157937|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102259731|NCT00157937|Purinergic Agents|purinergic agents|mesh-ancestor
102259732|NCT03139565|Vaccines|vaccines|mesh-list
102259733|NCT03139565|Immunologic Factors|immunologic factors|mesh-ancestor
102259734|NCT03139565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259735|NCT03139331|Irinotecan|irinotecan|mesh-list
102259736|NCT03139331|Temozolomide|temozolomide|mesh-list
102259737|NCT03139331|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102259738|NCT03139331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102259739|NCT03139331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102259740|NCT03139331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259741|NCT03139331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102259742|NCT03139331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102259743|NCT03139331|Alkylating Agents|alkylating agents|mesh-ancestor
102259744|NCT04423601|Itraconazole|itraconazole|mesh-list
102259745|NCT04423601|Antifungal Agents|antifungal agents|mesh-ancestor
102259746|NCT04423601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102259747|NCT04423601|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102259748|NCT04423601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102259749|NCT04423601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101814483|NCT00766025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102259750|NCT04423601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259751|NCT04423601|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102259752|NCT04423601|Hormone Antagonists|hormone antagonists|mesh-ancestor
102259753|NCT04423601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102259754|NCT04423601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259755|NCT04423601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102259756|NCT04983095|Hormones|hormones|mesh-list
102259757|NCT04983095|Androgens|androgens|mesh-list
102259758|NCT04983095|Hormone Antagonists|hormone antagonists|mesh-list
102259759|NCT04983095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102259760|NCT04983095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259761|NCT02936687|Ambrisentan|ambrisentan|mesh-list
102259762|NCT02936687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102613647|NCT00382889|Adrenergic Agents|adrenergic agents|mesh-ancestor
102613648|NCT00382889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102613649|NCT00382889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613650|NCT00382889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102613651|NCT00382889|Glucocorticoids|glucocorticoids|mesh-ancestor
102613653|NCT00382889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102613654|NCT04977167|Antibodies|antibodies|mesh-list
102613655|NCT04977167|Immunologic Factors|immunologic factors|mesh-ancestor
102613656|NCT04977167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613657|NCT04482959|Carbetocin|carbetocin|mesh-list
102613658|NCT04482959|Oxytocics|oxytocics|mesh-ancestor
102613659|NCT04482959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102613660|NCT04482959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613661|NCT04571879|Lidocaine|lidocaine|mesh-list
102259763|NCT04722809|Botulinum Toxins|botulinum toxins|mesh-list
102259764|NCT04722809|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102259765|NCT04722809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102259766|NCT04722809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259767|NCT04722809|Cholinergic Agents|cholinergic agents|mesh-ancestor
102259768|NCT04722809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102259769|NCT04722809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259770|NCT05083793|Pregabalin|pregabalin|mesh-list
102259771|NCT05083793|Analgesics|analgesics|mesh-ancestor
102259772|NCT05083793|Sensory System Agents|sensory system agents|mesh-ancestor
102259773|NCT05083793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102259774|NCT05083793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259775|NCT05083793|Anticonvulsants|anticonvulsants|mesh-ancestor
102259776|NCT05083793|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102259777|NCT05083793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102259778|NCT05083793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259779|NCT05083793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102259780|NCT05083793|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102259781|NCT05083793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102259782|NCT05083793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102259783|NCT05083793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102259784|NCT05083013|Chrysarobin|chrysarobin|mesh-list
102259785|NCT05083013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102259786|NCT05083013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102259787|NCT05083013|Analgesics|analgesics|mesh-ancestor
102259788|NCT05083013|Sensory System Agents|sensory system agents|mesh-ancestor
102259789|NCT05083013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102259790|NCT05083013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259791|NCT05083013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102259792|NCT05083013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102259793|NCT05073653|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102259794|NCT05073653|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102613662|NCT04571879|Midazolam|midazolam|mesh-list
102613663|NCT04571879|Anesthetics, Local|anesthetics, local|mesh-ancestor
102613664|NCT04571879|Anesthetics|anesthetics|mesh-ancestor
102613665|NCT04571879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102613666|NCT04571879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613667|NCT04571879|Sensory System Agents|sensory system agents|mesh-ancestor
102613668|NCT04571879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102613669|NCT04571879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102613670|NCT04571879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102613671|NCT04571879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102613672|NCT04571879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102613673|NCT04571879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613674|NCT04571879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102613675|NCT04571879|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102613676|NCT04571879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102613677|NCT04571879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102613678|NCT04571879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102259795|NCT05073653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259796|NCT03223883|Curcumin|curcumin|mesh-list
102259797|NCT03223883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102259798|NCT03223883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102259799|NCT03223883|Analgesics|analgesics|mesh-ancestor
102259800|NCT03223883|Sensory System Agents|sensory system agents|mesh-ancestor
102259801|NCT03223883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102259802|NCT03223883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259803|NCT03223883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102613679|NCT04571879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102259804|NCT03223883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102259805|NCT03223883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102259806|NCT03223883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102259807|NCT03223883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259808|NCT02420899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102259809|NCT02420899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102259810|NCT02420899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102259811|NCT02420899|Antimetabolites|antimetabolites|mesh-ancestor
102259812|NCT02420899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259813|NCT02420899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102259814|NCT02420899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102259815|NCT02420899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102259817|NCT05048069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102259818|NCT05048069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102259819|NCT05048069|Antioxidants|antioxidants|mesh-ancestor
101814577|NCT00766805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102259820|NCT05048069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259821|NCT05048069|Protective Agents|protective agents|mesh-ancestor
102259822|NCT05048069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259823|NCT05048069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102259824|NCT03194165|Ritonavir|ritonavir|mesh-list
102259825|NCT03194165|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102259826|NCT03194165|Darunavir|darunavir|mesh-list
102259827|NCT03194165|Raltegravir Potassium|raltegravir potassium|mesh-list
102259828|NCT03194165|Nevirapine|nevirapine|mesh-list
102259829|NCT03194165|Dolutegravir|dolutegravir|mesh-list
102259830|NCT03194165|Rilpivirine|rilpivirine|mesh-list
102259831|NCT03194165|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102259832|NCT03194165|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102259833|NCT03194165|Protease Inhibitors|protease inhibitors|mesh-ancestor
102259834|NCT03194165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102259835|NCT03194165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259836|NCT03194165|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102259837|NCT03194165|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102259838|NCT03194165|Antiviral Agents|antiviral agents|mesh-ancestor
102259839|NCT03194165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102259840|NCT03194165|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102259841|NCT03194165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102259842|NCT03194165|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102259843|NCT03194165|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102259844|NCT03194165|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102259845|NCT03194165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102259846|NCT03194165|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102259847|NCT03194165|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102259848|NCT04065113|Ethanol|ethanol|mesh-list
102259849|NCT04065113|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102259850|NCT04065113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102259851|NCT04065113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102259852|NCT04065113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259853|NCT03116737|Benzocaine|benzocaine|mesh-list
102259854|NCT03116737|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102259855|NCT03116737|Anesthetics, Local|anesthetics, local|mesh-ancestor
102259856|NCT03116737|Anesthetics|anesthetics|mesh-ancestor
102259857|NCT03116737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102259858|NCT03116737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259859|NCT03116737|Sensory System Agents|sensory system agents|mesh-ancestor
102259860|NCT03116737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102259861|NCT03116659|Doxycycline|doxycycline|mesh-list
102259862|NCT03116659|Imiquimod|imiquimod|mesh-list
102259863|NCT03116659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102259864|NCT03116659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102259865|NCT03116659|Antimalarials|antimalarials|mesh-ancestor
102259866|NCT03116659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102259867|NCT03116659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102259868|NCT03116659|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102259869|NCT03116659|Immunologic Factors|immunologic factors|mesh-ancestor
102259870|NCT03116659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259871|NCT03116659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102259872|NCT03116659|Interferon Inducers|interferon inducers|mesh-ancestor
102259873|NCT01993888|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102259874|NCT01993888|Hemostatics|hemostatics|mesh-ancestor
102259875|NCT01993888|Coagulants|coagulants|mesh-ancestor
102259876|NCT02425813|Methylprednisolone|methylprednisolone|mesh-list
102259877|NCT02425813|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102259878|NCT02425813|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102613680|NCT04571879|Anesthetics, General|anesthetics, general|mesh-ancestor
102259879|NCT02425813|Prednisolone|prednisolone|mesh-list
102259880|NCT02425813|Prednisolone acetate|prednisolone acetate|mesh-list
102259881|NCT02425813|Budesonide|budesonide|mesh-list
102259882|NCT02425813|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102259883|NCT02425813|Prednisolone phosphate|prednisolone phosphate|mesh-list
102259884|NCT02425813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102259885|NCT02425813|Antiemetics|antiemetics|mesh-ancestor
102259886|NCT02425813|Autonomic Agents|autonomic agents|mesh-ancestor
102259887|NCT02425813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102259888|NCT02425813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259889|NCT02425813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102259890|NCT02425813|Glucocorticoids|glucocorticoids|mesh-ancestor
102259891|NCT02425813|Hormones|hormones|mesh-ancestor
102259892|NCT02425813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102259893|NCT02425813|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102259894|NCT02425813|Protective Agents|protective agents|mesh-ancestor
102259895|NCT02425813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102259896|NCT02425813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102259897|NCT02425813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102259898|NCT02425813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102259899|NCT02425813|Respiratory System Agents|respiratory system agents|mesh-ancestor
102259900|NCT03106831|Norepinephrine|norepinephrine|mesh-list
102259901|NCT03106831|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102259902|NCT03106831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102259903|NCT03106831|Adrenergic Agents|adrenergic agents|mesh-ancestor
102259904|NCT03106831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102259905|NCT03106831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259907|NCT03106831|Sympathomimetics|sympathomimetics|mesh-ancestor
102259908|NCT03106831|Autonomic Agents|autonomic agents|mesh-ancestor
102259909|NCT03106831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102259910|NCT03106831|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102259911|NCT03138785|Itraconazole|itraconazole|mesh-list
102259912|NCT03138785|Voriconazole|voriconazole|mesh-list
102259913|NCT03138785|Levofloxacin|levofloxacin|mesh-list
102259914|NCT03138785|Antifungal Agents|antifungal agents|mesh-ancestor
102259915|NCT03138785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102259916|NCT03138785|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102259917|NCT03138785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102259918|NCT03138785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102259919|NCT03138785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259920|NCT03138785|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102259921|NCT03138785|Hormone Antagonists|hormone antagonists|mesh-ancestor
102259922|NCT03138785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102259923|NCT03138785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259924|NCT03138785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101266808|NCT01785004|Vitamins|vitamins|mesh-ancestor
102259925|NCT03138785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102259926|NCT03138785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102259927|NCT03138785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102259928|NCT03138785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102259929|NCT03138785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102259930|NCT03138785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102259931|NCT03106597|Amlodipine|amlodipine|mesh-list
102259932|NCT03106597|Manidipine|manidipine|mesh-list
102259933|NCT03106597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102259934|NCT03106597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102259935|NCT03106597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102259936|NCT03106597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259937|NCT03106597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102259938|NCT03106597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259939|NCT03106597|Vasodilator Agents|vasodilator agents|mesh-ancestor
102259940|NCT02018458|Paclitaxel|paclitaxel|mesh-list
102259941|NCT02018458|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102259942|NCT02018458|Cyclophosphamide|cyclophosphamide|mesh-list
102259943|NCT02018458|Carboplatin|carboplatin|mesh-list
102259944|NCT02018458|Doxorubicin|doxorubicin|mesh-list
102259945|NCT02018458|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102259946|NCT02018458|Vaccines|vaccines|mesh-list
101814723|NCT00767975|Rifampin|rifampin|mesh-list
102259947|NCT02018458|Immunologic Factors|immunologic factors|mesh-ancestor
102259948|NCT02018458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259949|NCT02018458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102259950|NCT02018458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613681|NCT04571879|GABA Modulators|gaba modulators|mesh-ancestor
102613682|NCT04571879|GABA Agents|gaba agents|mesh-ancestor
102613683|NCT04571879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102259951|NCT02018458|Tubulin Modulators|tubulin modulators|mesh-ancestor
102613684|NCT04563533|Vaccines|vaccines|mesh-list
102613685|NCT04563533|Immunologic Factors|immunologic factors|mesh-ancestor
102613686|NCT04563533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613687|NCT04332107|Azithromycin|azithromycin|mesh-list
102613688|NCT04332107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102613689|NCT04332107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102613690|NCT04328285|Ritonavir|ritonavir|mesh-list
102613691|NCT04328285|Lopinavir|lopinavir|mesh-list
102613692|NCT04328285|Hydroxychloroquine|hydroxychloroquine|mesh-list
102613693|NCT04328285|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102613694|NCT04328285|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102613695|NCT04328285|Protease Inhibitors|protease inhibitors|mesh-ancestor
102613696|NCT04328285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102613697|NCT04328285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613698|NCT04328285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102613699|NCT04328285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102613700|NCT04328285|Antiviral Agents|antiviral agents|mesh-ancestor
102613701|NCT04328285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102613702|NCT04328285|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102613703|NCT04328285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102613704|NCT04328285|Antimalarials|antimalarials|mesh-ancestor
102613705|NCT04328285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102613706|NCT04328285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102613707|NCT04328285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102259952|NCT02018458|Antimitotic Agents|antimitotic agents|mesh-ancestor
102259953|NCT02018458|Mitosis Modulators|mitosis modulators|mesh-ancestor
102259954|NCT02018458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259955|NCT02018458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102259956|NCT02018458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102259957|NCT02018458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102259958|NCT02018458|Alkylating Agents|alkylating agents|mesh-ancestor
102259959|NCT02018458|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102259960|NCT02018458|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102259961|NCT02018458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102259962|NCT02018458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102259963|NCT02018458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102259964|NCT02423083|Guanabenz|guanabenz|mesh-list
102259965|NCT02423083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102259966|NCT02423083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102259967|NCT02423083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102259968|NCT02423083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102259969|NCT02423083|Adrenergic Agents|adrenergic agents|mesh-ancestor
102259970|NCT02423083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102259971|NCT02423083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259972|NCT02423083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259973|NCT02423863|Pembrolizumab|pembrolizumab|mesh-list
102259974|NCT02423863|Nivolumab|nivolumab|mesh-list
102259975|NCT02423863|Atezolizumab|atezolizumab|mesh-list
102259976|NCT02423863|Durvalumab|durvalumab|mesh-list
102259977|NCT02423863|Cemiplimab|cemiplimab|mesh-list
102259978|NCT02423863|Poly ICLC|poly iclc|mesh-list
102259979|NCT02423863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102259980|NCT02423863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102259981|NCT02423863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102259982|NCT02423863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259983|NCT02423863|Interferon Inducers|interferon inducers|mesh-ancestor
102259984|NCT02423863|Immunologic Factors|immunologic factors|mesh-ancestor
102259985|NCT02423863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259986|NCT03178747|Methylene Blue|methylene blue|mesh-list
102259987|NCT03178747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102259988|NCT03178747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259989|NCT05392673|Bilirubin|bilirubin|mesh-list
102259990|NCT05392673|Antioxidants|antioxidants|mesh-ancestor
102259991|NCT05392673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259992|NCT05392673|Protective Agents|protective agents|mesh-ancestor
102259993|NCT05392673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102259994|NCT02425579|Carbon Monoxide|carbon monoxide|mesh-list
102259995|NCT02425579|Antimetabolites|antimetabolites|mesh-ancestor
102259996|NCT02425579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102259997|NCT02425579|Gasotransmitters|gasotransmitters|mesh-ancestor
102259998|NCT02425579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102259999|NCT02425579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260000|NCT03178591|Dapagliflozin|dapagliflozin|mesh-list
102260001|NCT03178591|Vildagliptin|vildagliptin|mesh-list
102613708|NCT04928261|Trastuzumab|trastuzumab|mesh-list
102260002|NCT03178591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102613709|NCT04928261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102613710|NCT04928261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102260003|NCT03178591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260004|NCT03178591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102260005|NCT03178591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260006|NCT03178591|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102260007|NCT03178591|Protease Inhibitors|protease inhibitors|mesh-ancestor
102260008|NCT03178591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102260010|NCT01993186|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102260011|NCT01993186|Protective Agents|protective agents|mesh-ancestor
102260012|NCT01993186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260013|NCT03181243|Anesthetics|anesthetics|mesh-list
102260014|NCT03181243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102260015|NCT03181243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260016|NCT02420665|Acetic Acid|acetic acid|mesh-list
102260017|NCT02420665|Proflavine|proflavine|mesh-list
102260018|NCT02420665|Retinol acetate|retinol acetate|mesh-list
102260019|NCT02420665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102260020|NCT02420665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102260021|NCT02420665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102260022|NCT02420665|Immunologic Factors|immunologic factors|mesh-ancestor
102260023|NCT02420665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260024|NCT02420665|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102260025|NCT02420665|Protective Agents|protective agents|mesh-ancestor
102260026|NCT02420665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102260027|NCT02420665|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102260028|NCT02016898|Mitomycins|mitomycins|mesh-list
102260029|NCT02016898|Mitomycin|mitomycin|mesh-list
102260030|NCT02016898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102260031|NCT02016898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102260032|NCT02016898|Alkylating Agents|alkylating agents|mesh-ancestor
102260033|NCT02016898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260034|NCT02016898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102613711|NCT04920539|Dronabinol|dronabinol|mesh-list
102613712|NCT04920539|Hallucinogens|hallucinogens|mesh-ancestor
102613713|NCT04920539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613714|NCT04920539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102613715|NCT04920539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102613716|NCT04920539|Analgesics|analgesics|mesh-ancestor
102613717|NCT04920539|Sensory System Agents|sensory system agents|mesh-ancestor
102613718|NCT04920539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102613719|NCT04920539|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102613720|NCT04920539|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102613721|NCT04920539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102613722|NCT04920539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613723|NCT04920539|Hormones|hormones|mesh-ancestor
102613724|NCT04920539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102613725|NCT04882241|Leucovorin|leucovorin|mesh-list
102613726|NCT04882241|Docetaxel|docetaxel|mesh-list
102613727|NCT04882241|Pembrolizumab|pembrolizumab|mesh-list
102613728|NCT04882241|Fluorouracil|fluorouracil|mesh-list
102613729|NCT04882241|Capecitabine|capecitabine|mesh-list
102613730|NCT04882241|Oxaliplatin|oxaliplatin|mesh-list
102613731|NCT04882241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613732|NCT04882241|Tubulin Modulators|tubulin modulators|mesh-ancestor
102613733|NCT04882241|Antimitotic Agents|antimitotic agents|mesh-ancestor
102613734|NCT04882241|Mitosis Modulators|mitosis modulators|mesh-ancestor
102613735|NCT04882241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613736|NCT04882241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102613737|NCT04882241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102613738|NCT04882241|Antimetabolites|antimetabolites|mesh-ancestor
102613739|NCT04882241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102260035|NCT02016898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102260036|NCT04482907|Hormones|hormones|mesh-list
102260037|NCT04482907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102260038|NCT04482907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260039|NCT02420509|Leucovorin|leucovorin|mesh-list
102260040|NCT02420509|Capecitabine|capecitabine|mesh-list
102260041|NCT02420509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102260042|NCT02420509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260043|NCT02420509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102260044|NCT02420509|Antimetabolites|antimetabolites|mesh-ancestor
102260045|NCT02420509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260046|NCT02420509|Antidotes|antidotes|mesh-ancestor
102260047|NCT02420509|Protective Agents|protective agents|mesh-ancestor
102260049|NCT02420509|Vitamins|vitamins|mesh-ancestor
102260050|NCT02420509|Micronutrients|micronutrients|mesh-ancestor
102260051|NCT02416531|Clobetasol|clobetasol|mesh-list
102260052|NCT02416531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101968935|NCT02280070|Leucovorin|leucovorin|mesh-list
102260053|NCT02416531|Glucocorticoids|glucocorticoids|mesh-ancestor
102260054|NCT02416531|Hormones|hormones|mesh-ancestor
102260055|NCT02416531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102260056|NCT02416531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260057|NCT04483063|Chlorhexidine|chlorhexidine|mesh-list
102260058|NCT04483063|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102260059|NCT04483063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102260060|NCT04483063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102260061|NCT04483063|Disinfectants|disinfectants|mesh-ancestor
102260062|NCT04483063|Dermatologic Agents|dermatologic agents|mesh-ancestor
102260063|NCT02416141|Tramadol|tramadol|mesh-list
102260064|NCT02416141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102260065|NCT02416141|Narcotics|narcotics|mesh-ancestor
102260066|NCT02416141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102260067|NCT02416141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260068|NCT02416141|Analgesics|analgesics|mesh-ancestor
102260069|NCT02416141|Sensory System Agents|sensory system agents|mesh-ancestor
102260070|NCT02416141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102260071|NCT03138239|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102260072|NCT03138239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102260073|NCT03138239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260074|NCT02416063|Dexmedetomidine|dexmedetomidine|mesh-list
102260075|NCT02416063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102260076|NCT02416063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102260077|NCT02416063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260078|NCT02416063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102260079|NCT02416063|Analgesics|analgesics|mesh-ancestor
102260080|NCT02416063|Sensory System Agents|sensory system agents|mesh-ancestor
102260081|NCT02416063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102260082|NCT02416063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102260083|NCT02416063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102260084|NCT02416063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102260085|NCT02416063|Adrenergic Agents|adrenergic agents|mesh-ancestor
102260086|NCT02416063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102260087|NCT02416063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260088|NCT01828697|Enoxaparin|enoxaparin|mesh-list
102260089|NCT01828697|Dalteparin|dalteparin|mesh-list
102260090|NCT01828697|Tinzaparin|tinzaparin|mesh-list
102260091|NCT01828697|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102260092|NCT01828697|Nadroparin|nadroparin|mesh-list
102260093|NCT01828697|Enoxaparin sodium|enoxaparin sodium|mesh-list
102260094|NCT01828697|Anticoagulants|anticoagulants|mesh-ancestor
102260095|NCT01828697|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102260096|NCT01828697|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102260097|NCT01828697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260098|NCT02415985|Lopinavir|lopinavir|mesh-list
102260099|NCT02415985|Rifabutin|rifabutin|mesh-list
102260100|NCT02415985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102260101|NCT02415985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102260102|NCT02415985|Protease Inhibitors|protease inhibitors|mesh-ancestor
102260103|NCT02415985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102260104|NCT02415985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260105|NCT02415985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102260106|NCT02415985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102260107|NCT02415985|Antiviral Agents|antiviral agents|mesh-ancestor
102260108|NCT02415985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102260109|NCT02415985|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102260110|NCT02415985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102260111|NCT02415985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102260112|NCT02415985|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102260113|NCT02415985|Antitubercular Agents|antitubercular agents|mesh-ancestor
102260114|NCT02415907|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
102260115|NCT02415907|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102260116|NCT02415907|Serotonin Agents|serotonin agents|mesh-ancestor
102260117|NCT02415907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102260118|NCT02415907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260119|NCT02415907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260120|NCT02415829|Capecitabine|capecitabine|mesh-list
102260121|NCT02415829|Oxaliplatin|oxaliplatin|mesh-list
102260123|NCT02415829|Antimetabolites|antimetabolites|mesh-ancestor
102260124|NCT02415829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260125|NCT02415829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102260126|NCT04631393|Alfentanil|alfentanil|mesh-list
101969012|NCT02880956|Tilavonemab|tilavonemab|mesh-list
102260127|NCT04631393|Propofol|propofol|mesh-list
102260128|NCT04631393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102260129|NCT04631393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102260130|NCT04631393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260131|NCT04631393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102260132|NCT04631393|Anesthetics, General|anesthetics, general|mesh-ancestor
102260133|NCT04631393|Anesthetics|anesthetics|mesh-ancestor
102260134|NCT04631393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102260135|NCT04631393|Narcotics|narcotics|mesh-ancestor
102260136|NCT04631393|Analgesics|analgesics|mesh-ancestor
102260137|NCT04631393|Sensory System Agents|sensory system agents|mesh-ancestor
102260138|NCT04631393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102260139|NCT03180775|Glycine|glycine|mesh-list
102260140|NCT03180775|Glycine Agents|glycine agents|mesh-ancestor
102260141|NCT03180775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102260142|NCT03180775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260143|NCT03180775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260144|NCT03137927|Vaccines|vaccines|mesh-list
102260145|NCT03137927|Immunologic Factors|immunologic factors|mesh-ancestor
102260146|NCT03137927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260147|NCT04482985|Meclizine|meclizine|mesh-list
102260148|NCT04482985|Antiemetics|antiemetics|mesh-ancestor
102260149|NCT04482985|Autonomic Agents|autonomic agents|mesh-ancestor
102260150|NCT04482985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102260151|NCT04482985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260152|NCT04482985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102260153|NCT04482985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102260154|NCT04482985|Histamine Antagonists|histamine antagonists|mesh-ancestor
102260155|NCT04482985|Histamine Agents|histamine agents|mesh-ancestor
102260156|NCT04482985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102260157|NCT04482985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260158|NCT04482985|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102260159|NCT04482985|Cholinergic Agents|cholinergic agents|mesh-ancestor
102260160|NCT04482985|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102260161|NCT05385263|Nivolumab|nivolumab|mesh-list
102260162|NCT05385263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102260163|NCT05385263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102260164|NCT05385263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102260165|NCT05385263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260166|NCT03180229|Granisetron|granisetron|mesh-list
102260167|NCT03180229|Antiemetics|antiemetics|mesh-ancestor
102260168|NCT03180229|Autonomic Agents|autonomic agents|mesh-ancestor
102260169|NCT03180229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102260170|NCT03180229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260171|NCT03180229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102260172|NCT03180229|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102260173|NCT03180229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102260174|NCT03180229|Serotonin Agents|serotonin agents|mesh-ancestor
102260175|NCT03180229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102260176|NCT03180229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260177|NCT03178123|Interferons|interferons|mesh-list
102260178|NCT03178123|Antibodies|antibodies|mesh-list
102260179|NCT03178123|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102260180|NCT03178123|Immunologic Factors|immunologic factors|mesh-ancestor
102260181|NCT03178123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260182|NCT03178123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102260183|NCT03178123|Antiviral Agents|antiviral agents|mesh-ancestor
102260184|NCT03178123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102260185|NCT03820817|Rifaximin|rifaximin|mesh-list
102260186|NCT03820817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102260187|NCT03820817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102260188|NCT03820817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102260189|NCT05111197|Immunomodulating Agents|immunomodulating agents|mesh-list
102260190|NCT05111197|Immunologic Factors|immunologic factors|mesh-ancestor
102260191|NCT05111197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260192|NCT05106517|Zoledronic Acid|zoledronic acid|mesh-list
102260193|NCT05106517|Denosumab|denosumab|mesh-list
102260194|NCT05106517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102260195|NCT05106517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260196|NCT03140033|Misoprostol|misoprostol|mesh-list
102260197|NCT03140033|Ranitidine|ranitidine|mesh-list
102260198|NCT03140033|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
102260199|NCT03140033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102260200|NCT03140033|Abortifacient Agents|abortifacient agents|mesh-ancestor
102260201|NCT03140033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102260202|NCT03140033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260203|NCT03140033|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102260204|NCT03140033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102260205|NCT03140033|Oxytocics|oxytocics|mesh-ancestor
102260206|NCT03140033|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102260207|NCT03140033|Histamine Antagonists|histamine antagonists|mesh-ancestor
102260208|NCT03140033|Histamine Agents|histamine agents|mesh-ancestor
102260209|NCT03140033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102260210|NCT03140033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260211|NCT05338931|Gossypol acetic acid|gossypol acetic acid|mesh-list
102260212|NCT05338931|Gossypol|gossypol|mesh-list
102260213|NCT05338931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102260214|NCT05338931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102260215|NCT05338931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102260216|NCT05338931|Contraceptive Agents|contraceptive agents|mesh-ancestor
102260217|NCT05338931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102260218|NCT05338931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260219|NCT05338931|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
102260220|NCT05338931|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
102260221|NCT05338931|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102260222|NCT02706691|Infigratinib|infigratinib|mesh-list
102260223|NCT02706691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102260224|NCT02419729|Estrogens|estrogens|mesh-list
102260225|NCT02419729|Hormones|hormones|mesh-ancestor
102260226|NCT02419729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102260227|NCT02419729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260228|NCT03697031|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102260229|NCT03697031|Hormones|hormones|mesh-ancestor
102260230|NCT03697031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102260231|NCT03697031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260232|NCT02419651|Diclofenac|diclofenac|mesh-list
102260233|NCT02419651|Tramadol|tramadol|mesh-list
102260234|NCT02419651|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102260235|NCT02419651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102260236|NCT02419651|Analgesics|analgesics|mesh-ancestor
102260237|NCT02419651|Sensory System Agents|sensory system agents|mesh-ancestor
102260238|NCT02419651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102260239|NCT02419651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260240|NCT02419651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102260241|NCT02419651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102260242|NCT02419651|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102260243|NCT02419651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102260244|NCT02419651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260245|NCT02419651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102260246|NCT02419651|Narcotics|narcotics|mesh-ancestor
102260247|NCT02419651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102260248|NCT05088239|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102260249|NCT05088239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102260250|NCT02419261|Analgesics|analgesics|mesh-list
102260251|NCT02419261|Ropivacaine|ropivacaine|mesh-list
102260252|NCT02419261|Anesthetics, Local|anesthetics, local|mesh-ancestor
102260253|NCT02419261|Anesthetics|anesthetics|mesh-ancestor
102260254|NCT02419261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102260255|NCT02419261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260256|NCT02419261|Sensory System Agents|sensory system agents|mesh-ancestor
102260257|NCT02419261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102260258|NCT02414503|Oxytocin|oxytocin|mesh-list
102260259|NCT02414503|Oxytocics|oxytocics|mesh-ancestor
102260260|NCT02414503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102260261|NCT02414503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260262|NCT03137615|Anesthetics|anesthetics|mesh-list
102260263|NCT03137615|Anesthetics, Local|anesthetics, local|mesh-list
102260264|NCT03137615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102260265|NCT03137615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260266|NCT03137615|Sensory System Agents|sensory system agents|mesh-ancestor
102260267|NCT03137615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102260268|NCT03415061|Insulin|insulin|mesh-list
102260269|NCT03415061|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102613740|NCT04882241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102260270|NCT03415061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102613741|NCT04882241|Immunologic Factors|immunologic factors|mesh-ancestor
102613742|NCT04882241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260271|NCT03415061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260273|NCT05088083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102260274|NCT05088083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102260275|NCT05088083|Tubulin Modulators|tubulin modulators|mesh-ancestor
102260276|NCT05088083|Antimitotic Agents|antimitotic agents|mesh-ancestor
102260277|NCT05088083|Mitosis Modulators|mitosis modulators|mesh-ancestor
102260278|NCT05088083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260279|NCT03110159|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102260280|NCT03110159|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102260281|NCT03110159|Dermatologic Agents|dermatologic agents|mesh-ancestor
102260282|NCT01990768|Tranexamic Acid|tranexamic acid|mesh-list
102260283|NCT01990768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102260284|NCT01990768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102260285|NCT01990768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260286|NCT01990768|Hemostatics|hemostatics|mesh-ancestor
102260287|NCT01990768|Coagulants|coagulants|mesh-ancestor
102260288|NCT05228327|Salicylic Acid|salicylic acid|mesh-list
102260289|NCT05228327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102260290|NCT05228327|Antifungal Agents|antifungal agents|mesh-ancestor
102260291|NCT05228327|Keratolytic Agents|keratolytic agents|mesh-ancestor
102260292|NCT05228327|Dermatologic Agents|dermatologic agents|mesh-ancestor
102260293|NCT02624765|Digoxin|digoxin|mesh-list
102260294|NCT02624765|Sotalol|sotalol|mesh-list
102260295|NCT02624765|Flecainide|flecainide|mesh-list
102260296|NCT02624765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102260297|NCT02624765|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102260298|NCT02624765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102260299|NCT02624765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260300|NCT02624765|Protective Agents|protective agents|mesh-ancestor
102260301|NCT02624765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260302|NCT02624765|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102260303|NCT02624765|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102260304|NCT02624765|Adrenergic Agents|adrenergic agents|mesh-ancestor
102260305|NCT02624765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102260306|NCT02624765|Sympatholytics|sympatholytics|mesh-ancestor
102260307|NCT02624765|Autonomic Agents|autonomic agents|mesh-ancestor
102260308|NCT02624765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102260309|NCT02624765|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102260310|NCT02624765|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102260311|NCT02624765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102260312|NCT05085587|Fluticasone|fluticasone|mesh-list
102260313|NCT05085587|Xhance|xhance|mesh-list
102260314|NCT05085587|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102260315|NCT05085587|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102260316|NCT05085587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102260317|NCT05085587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102260318|NCT05085587|Autonomic Agents|autonomic agents|mesh-ancestor
102260319|NCT05085587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102260320|NCT05085587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260321|NCT05085587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102260322|NCT05085587|Respiratory System Agents|respiratory system agents|mesh-ancestor
102260323|NCT05085587|Dermatologic Agents|dermatologic agents|mesh-ancestor
102260324|NCT05085587|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102260325|NCT05085587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102260326|NCT05085587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102260327|NCT05085587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102260328|NCT05085587|Adrenergic Agents|adrenergic agents|mesh-ancestor
102260329|NCT05085587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102260330|NCT05085587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260331|NCT05085587|Glucocorticoids|glucocorticoids|mesh-ancestor
102260332|NCT05085587|Hormones|hormones|mesh-ancestor
102260333|NCT05085587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102260334|NCT05085587|Sympathomimetics|sympathomimetics|mesh-ancestor
102260335|NCT01990534|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102260336|NCT01990534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102260337|NCT01990534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102260338|NCT01990534|Immunotoxins|immunotoxins|mesh-ancestor
102260339|NCT01990534|Immunoconjugates|immunoconjugates|mesh-ancestor
102260340|NCT01990534|Immunologic Factors|immunologic factors|mesh-ancestor
102260341|NCT01990534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260342|NCT05084573|Bupivacaine|bupivacaine|mesh-list
102613743|NCT04882241|Antidotes|antidotes|mesh-ancestor
102260343|NCT05084573|Anesthetics, Local|anesthetics, local|mesh-ancestor
102260344|NCT05084573|Anesthetics|anesthetics|mesh-ancestor
102260345|NCT05084573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101815184|NCT00775073|Everolimus|everolimus|mesh-list
102260346|NCT05084573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260347|NCT05084573|Sensory System Agents|sensory system agents|mesh-ancestor
102260348|NCT05084573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102260349|NCT05088707|Misoprostol|misoprostol|mesh-list
102260350|NCT05088707|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102260351|NCT05088707|Abortifacient Agents|abortifacient agents|mesh-ancestor
102260352|NCT05088707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102260353|NCT05088707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260354|NCT05088707|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102260355|NCT05088707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102260356|NCT05088707|Oxytocics|oxytocics|mesh-ancestor
102260357|NCT05028257|Vaccines|vaccines|mesh-list
102260358|NCT05028257|Immunologic Factors|immunologic factors|mesh-ancestor
102260359|NCT05028257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260360|NCT01990300|Pioglitazone|pioglitazone|mesh-list
102260361|NCT01990300|Alogliptin|alogliptin|mesh-list
102260362|NCT01990300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102260363|NCT01990300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260364|NCT01990300|Incretins|incretins|mesh-ancestor
102260365|NCT01990300|Hormones|hormones|mesh-ancestor
102260366|NCT01990300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102260367|NCT01990300|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102260368|NCT01990300|Protease Inhibitors|protease inhibitors|mesh-ancestor
102260369|NCT01990300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102260370|NCT01990300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260371|NCT03135977|Etoposide|etoposide|mesh-list
102260372|NCT03135977|Apatinib|apatinib|mesh-list
102260373|NCT03135977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102260374|NCT03135977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102260375|NCT03135977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102260376|NCT03135977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102260377|NCT03135977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102260378|NCT03135977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815219|NCT00775151|Amlodipine|amlodipine|mesh-list
102260379|NCT03135977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102260380|NCT04850651|Fluconazole|fluconazole|mesh-list
102260381|NCT04850651|Antifungal Agents|antifungal agents|mesh-ancestor
102260382|NCT04850651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102260383|NCT04850651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102260384|NCT04850651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102260385|NCT04850651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102260386|NCT04850651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260387|NCT04850651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102260388|NCT04850651|Hormone Antagonists|hormone antagonists|mesh-ancestor
102260389|NCT04850651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102260390|NCT04850651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260391|NCT04850651|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102260392|NCT04850651|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102260393|NCT04837235|Hemay005|hemay005|mesh-list
102260394|NCT04837235|Dermatologic Agents|dermatologic agents|mesh-ancestor
102260395|NCT04837235|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102260396|NCT04837235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102260397|NCT04837235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102260398|NCT04837235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260399|NCT02702401|Pembrolizumab|pembrolizumab|mesh-list
102260400|NCT02702401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102260401|NCT02702401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102260402|NCT02702401|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102260403|NCT02702401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260404|NCT03116971|Etoposide|etoposide|mesh-list
102260405|NCT03116971|Peposertib|peposertib|mesh-list
102260406|NCT03116971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102260407|NCT03116971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102260408|NCT03116971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102260409|NCT03116971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102260410|NCT03116971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102260411|NCT03116971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260412|NCT03116971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102260413|NCT02414581|Ethanol|ethanol|mesh-list
102260414|NCT02414581|Chlorhexidine|chlorhexidine|mesh-list
102613744|NCT04882241|Protective Agents|protective agents|mesh-ancestor
102613745|NCT04882241|Vitamin B Complex|vitamin b complex|mesh-ancestor
102613746|NCT04882241|Vitamins|vitamins|mesh-ancestor
102260415|NCT02414581|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102260416|NCT02414581|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102260417|NCT02414581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102260418|NCT02414581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102260419|NCT02414581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260420|NCT02414581|Disinfectants|disinfectants|mesh-ancestor
102260421|NCT02414581|Dermatologic Agents|dermatologic agents|mesh-ancestor
102260422|NCT02419105|Vitamin D|vitamin d|mesh-list
102260423|NCT02419105|Cholecalciferol|cholecalciferol|mesh-list
102260424|NCT02419105|Testosterone|testosterone|mesh-list
102260425|NCT02419105|Vitamins|vitamins|mesh-ancestor
102260426|NCT02419105|Micronutrients|micronutrients|mesh-ancestor
102260427|NCT02419105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260428|NCT02419105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102260429|NCT02419105|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102260431|NCT02419105|Hormones|hormones|mesh-ancestor
102260432|NCT02419105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102260433|NCT04643249|Repaglinide|repaglinide|mesh-list
102260434|NCT04643249|Flurbiprofen|flurbiprofen|mesh-list
102260435|NCT04643249|Midazolam|midazolam|mesh-list
102260436|NCT04643249|Dextromethorphan|dextromethorphan|mesh-list
102260437|NCT04643249|Caffeine|caffeine|mesh-list
102260438|NCT04643249|Bupropion|bupropion|mesh-list
102260439|NCT04643249|Omeprazole|omeprazole|mesh-list
102260440|NCT04643249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102260441|NCT04643249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102260442|NCT04643249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102260443|NCT04643249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260444|NCT04643249|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102260445|NCT04643249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102260446|NCT04643249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102260447|NCT04643249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102260448|NCT04643249|Anesthetics, General|anesthetics, general|mesh-ancestor
102260449|NCT04643249|Anesthetics|anesthetics|mesh-ancestor
102260450|NCT04643249|GABA Modulators|gaba modulators|mesh-ancestor
102260451|NCT04643249|GABA Agents|gaba agents|mesh-ancestor
102260452|NCT04643249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102260453|NCT04643249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260454|NCT04643249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102260455|NCT04643249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102260456|NCT04643249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102260457|NCT04643249|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102260458|NCT04643249|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102260459|NCT04643249|Purinergic Agents|purinergic agents|mesh-ancestor
102260460|NCT04643249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102260461|NCT04643249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102260462|NCT04643249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102260463|NCT04643249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102260464|NCT04643249|Antidepressive Agents|antidepressive agents|mesh-ancestor
102260465|NCT04643249|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102260466|NCT04643249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102260467|NCT04643249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102260468|NCT04643249|Dopamine Agents|dopamine agents|mesh-ancestor
102260469|NCT04643249|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102260470|NCT04643249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102260471|NCT04643249|Antitussive Agents|antitussive agents|mesh-ancestor
101266972|NCT01785862|Ibuprofen|ibuprofen|mesh-list
102260472|NCT04643249|Respiratory System Agents|respiratory system agents|mesh-ancestor
102260473|NCT04643249|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102260474|NCT04643249|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102260475|NCT04643249|Analgesics|analgesics|mesh-ancestor
102260476|NCT04643249|Sensory System Agents|sensory system agents|mesh-ancestor
102260477|NCT04643249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102260478|NCT04643249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102260479|NCT04643249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102260480|NCT04643249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102260481|NCT04643249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102260482|NCT04643249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102260483|NCT04643249|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102260484|NCT02414425|Botulinum Toxins|botulinum toxins|mesh-list
102260485|NCT02414425|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102260486|NCT02414425|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102260487|NCT02414425|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102260488|NCT02414425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102260489|NCT02414425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260490|NCT02414425|Cholinergic Agents|cholinergic agents|mesh-ancestor
102260491|NCT02414425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102260492|NCT02414425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260493|NCT02414425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102260494|NCT02414425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102260495|NCT03116893|Itraconazole|itraconazole|mesh-list
102260496|NCT03116893|Rifampin|rifampin|mesh-list
102260497|NCT03116893|Antifungal Agents|antifungal agents|mesh-ancestor
102260498|NCT03116893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102260499|NCT03116893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102260500|NCT03116893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102260501|NCT03116893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101969392|NCT00379990|Glucocorticoids|glucocorticoids|mesh-ancestor
102260502|NCT03116893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260503|NCT03116893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102260504|NCT03116893|Hormone Antagonists|hormone antagonists|mesh-ancestor
102260505|NCT03116893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102260506|NCT03116893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260507|NCT03116893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102260508|NCT03116893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102260509|NCT03116893|Antitubercular Agents|antitubercular agents|mesh-ancestor
102260510|NCT03116893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102260511|NCT03116893|Leprostatic Agents|leprostatic agents|mesh-ancestor
102260512|NCT03116893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102260513|NCT03116893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102260514|NCT03116893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102260515|NCT03116893|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102260516|NCT03116893|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102260517|NCT03116893|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102260518|NCT03116893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102260519|NCT05737511|Diazepam|diazepam|mesh-list
102260520|NCT05737511|Gabapentin|gabapentin|mesh-list
102260521|NCT05737511|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102260522|NCT05737511|Milnacipran|milnacipran|mesh-list
102260523|NCT05737511|Levetiracetam|levetiracetam|mesh-list
102260524|NCT05737511|Lorazepam|lorazepam|mesh-list
102260525|NCT05737511|Clonazepam|clonazepam|mesh-list
102260526|NCT05737511|Dexetimide|dexetimide|mesh-list
102260527|NCT05737511|Olanzapine|olanzapine|mesh-list
102260528|NCT05737511|Alprazolam|alprazolam|mesh-list
102260529|NCT05737511|Mirtazapine|mirtazapine|mesh-list
102260530|NCT05737511|Fluvoxamine|fluvoxamine|mesh-list
102260531|NCT05737511|Tranylcypromine|tranylcypromine|mesh-list
102260532|NCT05737511|Risperidone|risperidone|mesh-list
102260533|NCT05737511|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102260534|NCT05737511|Citalopram|citalopram|mesh-list
102260535|NCT05737511|Bupropion|bupropion|mesh-list
102260536|NCT05737511|Sertraline|sertraline|mesh-list
102260537|NCT05737511|Fluoxetine|fluoxetine|mesh-list
102260538|NCT05737511|Paroxetine|paroxetine|mesh-list
102260539|NCT05737511|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102260540|NCT05737511|Reboxetine|reboxetine|mesh-list
102260541|NCT05737511|Imipramine|imipramine|mesh-list
102260542|NCT05737511|Clomipramine|clomipramine|mesh-list
102260543|NCT05737511|Phenelzine|phenelzine|mesh-list
102260544|NCT05737511|Moclobemide|moclobemide|mesh-list
102260545|NCT05737511|Hydroxyzine|hydroxyzine|mesh-list
102260546|NCT05737511|Escitalopram|escitalopram|mesh-list
102260547|NCT05737511|Analgesics|analgesics|mesh-ancestor
102260548|NCT05737511|Sensory System Agents|sensory system agents|mesh-ancestor
102260549|NCT05737511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102260550|NCT05737511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260551|NCT05737511|Anticonvulsants|anticonvulsants|mesh-ancestor
102260552|NCT05737511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102260553|NCT05737511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102260554|NCT05737511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102260555|NCT05737511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102260556|NCT05737511|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102260557|NCT05737511|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102260558|NCT05737511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101815416|NCT05357066|Nitrous Oxide|nitrous oxide|mesh-list
102260559|NCT05737511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260560|NCT05737511|Antimanic Agents|antimanic agents|mesh-ancestor
102260561|NCT05737511|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102260562|NCT05737511|Serotonin Agents|serotonin agents|mesh-ancestor
102260563|NCT05737511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102260564|NCT05737511|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102260565|NCT05737511|Dopamine Agents|dopamine agents|mesh-ancestor
102613747|NCT04882241|Micronutrients|micronutrients|mesh-ancestor
102260566|NCT05737511|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102260567|NCT05737511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102613748|NCT04481243|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102260568|NCT05737511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102260569|NCT05737511|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102260570|NCT05737511|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102260571|NCT05737511|Parasympatholytics|parasympatholytics|mesh-ancestor
102260572|NCT05737511|Autonomic Agents|autonomic agents|mesh-ancestor
102260573|NCT05737511|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102260574|NCT05737511|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102260575|NCT05737511|Cholinergic Agents|cholinergic agents|mesh-ancestor
102260576|NCT05737511|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102260577|NCT05737511|Antidepressive Agents|antidepressive agents|mesh-ancestor
102260578|NCT05737511|Antiemetics|antiemetics|mesh-ancestor
102260579|NCT05737511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102260580|NCT05737511|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102260581|NCT05737511|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102260582|NCT05737511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102260583|NCT05737511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102260584|NCT05737511|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102260585|NCT05737511|Nootropic Agents|nootropic agents|mesh-ancestor
102260586|NCT05737511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102260587|NCT05737511|GABA Modulators|gaba modulators|mesh-ancestor
102260588|NCT05737511|GABA Agents|gaba agents|mesh-ancestor
102260589|NCT05737511|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102260590|NCT05737511|Histamine Antagonists|histamine antagonists|mesh-ancestor
102260591|NCT05737511|Histamine Agents|histamine agents|mesh-ancestor
102260592|NCT05737511|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102260593|NCT05737511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102260594|NCT05737511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102260595|NCT05737511|Adrenergic Agents|adrenergic agents|mesh-ancestor
102260596|NCT05737511|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102260597|NCT05737511|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102260598|NCT05737511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102260599|NCT05737511|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102260600|NCT05737511|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102260601|NCT05737511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102260602|NCT05737511|Anesthetics, General|anesthetics, general|mesh-ancestor
102260603|NCT05737511|Anesthetics|anesthetics|mesh-ancestor
102260604|NCT05737511|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102260605|NCT05737511|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102260606|NCT05737511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102260607|NCT05737511|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102260608|NCT05737511|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102260609|NCT05737511|Antipruritics|antipruritics|mesh-ancestor
102260610|NCT05737511|Dermatologic Agents|dermatologic agents|mesh-ancestor
102260611|NCT05737511|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102260612|NCT03179839|Fluvoxamine|fluvoxamine|mesh-list
102260613|NCT03179839|Sertraline|sertraline|mesh-list
102260614|NCT03179839|Antidepressive Agents|antidepressive agents|mesh-ancestor
102260615|NCT03179839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102260616|NCT03179839|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102260617|NCT03179839|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102260618|NCT03179839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102260619|NCT03179839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260620|NCT03179839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102260621|NCT03179839|Serotonin Agents|serotonin agents|mesh-ancestor
102260622|NCT03179839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260623|NCT03179839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102260624|NCT03179839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101815474|NCT00779831|Ephedrine|ephedrine|mesh-list
102260625|NCT03179839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102260626|NCT03179839|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102260627|NCT03179839|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102260628|NCT03179839|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102260629|NCT03179839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102260630|NCT03179839|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102260631|NCT05736887|Acetylcysteine|acetylcysteine|mesh-list
102260632|NCT05736887|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102260633|NCT05736887|Antiviral Agents|antiviral agents|mesh-ancestor
102260634|NCT05736887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102260635|NCT05736887|Expectorants|expectorants|mesh-ancestor
102260636|NCT05736887|Respiratory System Agents|respiratory system agents|mesh-ancestor
102260637|NCT05736887|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102613749|NCT04481243|Immunologic Factors|immunologic factors|mesh-ancestor
102260638|NCT05736887|Antioxidants|antioxidants|mesh-ancestor
102260639|NCT05736887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260640|NCT05736887|Protective Agents|protective agents|mesh-ancestor
102260641|NCT05736887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260642|NCT05736887|Antidotes|antidotes|mesh-ancestor
102260643|NCT02703337|Insulin Lispro|insulin lispro|mesh-list
102260644|NCT02703337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102260645|NCT02703337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260646|NCT05735639|Enoxaparin|enoxaparin|mesh-list
102260647|NCT05735639|Dalteparin|dalteparin|mesh-list
102260648|NCT05735639|Tinzaparin|tinzaparin|mesh-list
102260649|NCT05735639|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102260650|NCT05735639|Rivaroxaban|rivaroxaban|mesh-list
102260651|NCT05735639|Apixaban|apixaban|mesh-list
102260652|NCT05735639|Enoxaparin sodium|enoxaparin sodium|mesh-list
102260653|NCT05735639|Dabigatran|dabigatran|mesh-list
102260654|NCT05735639|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102260655|NCT05735639|Antithrombins|antithrombins|mesh-ancestor
102260656|NCT05735639|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102260657|NCT05735639|Protease Inhibitors|protease inhibitors|mesh-ancestor
102260658|NCT05735639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102260659|NCT05735639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260660|NCT05735639|Anticoagulants|anticoagulants|mesh-ancestor
102260661|NCT05735639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102260662|NCT05735639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102260663|NCT04483219|Antibodies|antibodies|mesh-list
102260664|NCT04483219|Immunologic Factors|immunologic factors|mesh-ancestor
102260665|NCT04483219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260666|NCT03176563|Fosfomycin|fosfomycin|mesh-list
102260667|NCT03176563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102260668|NCT03176563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102260669|NCT03827447|Vancomycin|vancomycin|mesh-list
102260670|NCT03827447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102260671|NCT03827447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102260672|NCT01680497|Hyaluronic Acid|hyaluronic acid|mesh-list
102260673|NCT01680497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102260674|NCT01680497|Immunologic Factors|immunologic factors|mesh-ancestor
102260675|NCT01680497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260676|NCT01680497|Viscosupplements|viscosupplements|mesh-ancestor
102260677|NCT01680497|Protective Agents|protective agents|mesh-ancestor
102260678|NCT02423395|Orphenadrine|orphenadrine|mesh-list
102260679|NCT02423395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260680|NCT02423395|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102260681|NCT02423395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102260682|NCT02423395|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102260683|NCT02423395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102260684|NCT02423395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102260685|NCT02423395|Parasympatholytics|parasympatholytics|mesh-ancestor
102260686|NCT02423395|Autonomic Agents|autonomic agents|mesh-ancestor
102260687|NCT02423395|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102260688|NCT02423395|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102260689|NCT02423395|Cholinergic Agents|cholinergic agents|mesh-ancestor
102260690|NCT02423395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102260691|NCT02423395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260692|NCT02423395|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
102260693|NCT02423395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102260694|NCT02423395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102260695|NCT05694689|Vitamin D|vitamin d|mesh-list
102260696|NCT05694689|Cholecalciferol|cholecalciferol|mesh-list
102260697|NCT05694689|Vitamins|vitamins|mesh-ancestor
102260698|NCT05694689|Micronutrients|micronutrients|mesh-ancestor
102260699|NCT05694689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260700|NCT05694689|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102260701|NCT05694689|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102260702|NCT02423239|Paclitaxel|paclitaxel|mesh-list
102260703|NCT02423239|Gemcitabine|gemcitabine|mesh-list
102260704|NCT02423239|Sorafenib|sorafenib|mesh-list
102260705|NCT02423239|HU 211|hu 211|mesh-list
102260706|NCT02423239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102260707|NCT02423239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102260708|NCT02423239|Tubulin Modulators|tubulin modulators|mesh-ancestor
102613750|NCT04481243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260709|NCT02423239|Antimitotic Agents|antimitotic agents|mesh-ancestor
102260710|NCT02423239|Mitosis Modulators|mitosis modulators|mesh-ancestor
102613751|NCT03575195|Rifaximin|rifaximin|mesh-list
102260711|NCT02423239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260712|NCT02423239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102260713|NCT02423239|Antimetabolites|antimetabolites|mesh-ancestor
101902172|NCT01184144|Pioglitazone|pioglitazone|mesh-list
102260715|NCT02423239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102260716|NCT02423239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102260717|NCT02423239|Antiemetics|antiemetics|mesh-ancestor
102260718|NCT02423239|Autonomic Agents|autonomic agents|mesh-ancestor
102260719|NCT02423239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102260720|NCT02423239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260721|NCT02423239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102260722|NCT02423239|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102260723|NCT02423239|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102260724|NCT02423239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102260725|NCT02423239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102260726|NCT02423239|Protective Agents|protective agents|mesh-ancestor
102260727|NCT02449733|Tenofovir|tenofovir|mesh-list
102260728|NCT02449733|Emtricitabine|emtricitabine|mesh-list
102260729|NCT02449733|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102260730|NCT02449733|Antiviral Agents|antiviral agents|mesh-ancestor
102260731|NCT02449733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102260732|NCT02449733|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102260733|NCT02449733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102260734|NCT02449733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102260735|NCT02449733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260736|NCT02449733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102260737|NCT02449733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102260738|NCT02417467|Nicotine|nicotine|mesh-list
102260739|NCT02417467|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102260740|NCT02417467|Autonomic Agents|autonomic agents|mesh-ancestor
102260741|NCT02417467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102260742|NCT02417467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260743|NCT02417467|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102260744|NCT02417467|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102260745|NCT02417467|Cholinergic Agents|cholinergic agents|mesh-ancestor
102260746|NCT02417467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102260747|NCT02417467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260748|NCT02417389|Alendronate|alendronate|mesh-list
102260749|NCT02417389|Cinacalcet|cinacalcet|mesh-list
102260750|NCT02417389|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102260751|NCT02417389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260752|NCT02417389|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102260753|NCT02417389|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
102260754|NCT02417389|Hormone Antagonists|hormone antagonists|mesh-ancestor
102260755|NCT02417389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102260756|NCT02413021|Cytarabine|cytarabine|mesh-list
102260757|NCT02413021|Deferasirox|deferasirox|mesh-list
101472920|NCT00270777|Hydrocortisone|hydrocortisone|mesh-list
102260758|NCT02413021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102260759|NCT02413021|Antimetabolites|antimetabolites|mesh-ancestor
102260760|NCT02413021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260761|NCT02413021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102260762|NCT02413021|Antiviral Agents|antiviral agents|mesh-ancestor
102260763|NCT02413021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102260764|NCT02413021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102260765|NCT02413021|Immunologic Factors|immunologic factors|mesh-ancestor
102260766|NCT02413021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260767|NCT02413021|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102260768|NCT02413021|Chelating Agents|chelating agents|mesh-ancestor
102260769|NCT02413021|Sequestering Agents|sequestering agents|mesh-ancestor
102260770|NCT01680341|Insulin|insulin|mesh-list
102260771|NCT01680341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102260772|NCT01680341|Insulin Aspart|insulin aspart|mesh-list
102260773|NCT01680341|Insulin, Long-Acting|insulin, long-acting|mesh-list
102260774|NCT01680341|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102260775|NCT01680341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102260776|NCT01680341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260777|NCT03177811|Acetazolamide|acetazolamide|mesh-list
102260778|NCT03177811|Anticonvulsants|anticonvulsants|mesh-ancestor
102260779|NCT03177811|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102260780|NCT03177811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102260781|NCT03177811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260782|NCT03177811|Diuretics|diuretics|mesh-ancestor
102260783|NCT03177811|Natriuretic Agents|natriuretic agents|mesh-ancestor
102260784|NCT03177811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260785|NCT03175939|Fluorouracil|fluorouracil|mesh-list
102260786|NCT03175939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102260787|NCT03175939|Antimetabolites|antimetabolites|mesh-ancestor
102260788|NCT03175939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613752|NCT03575195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102260789|NCT03175939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102260790|NCT03175939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102260792|NCT03175939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260793|NCT03199625|Antidepressive Agents|antidepressive agents|mesh-list
102260794|NCT03199625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102260795|NCT02417077|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102260796|NCT02417077|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102260797|NCT02417077|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102260798|NCT02417077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102260799|NCT02417077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260800|NCT02417077|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102260801|NCT02417077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102260802|NCT02417077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260803|NCT02417077|Cholinergic Agents|cholinergic agents|mesh-ancestor
102260804|NCT02417077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102260805|NCT03179527|Vasodilator Agents|vasodilator agents|mesh-list
102260806|NCT03179527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
102260807|NCT03179527|Lipid Regulating Agents|lipid regulating agents|mesh-list
102260808|NCT02412475|Cytarabine|cytarabine|mesh-list
102260809|NCT02412475|Fludarabine|fludarabine|mesh-list
102260810|NCT02412475|Sorafenib|sorafenib|mesh-list
102260811|NCT02412475|Decitabine|decitabine|mesh-list
102260812|NCT02412475|Vorinostat|vorinostat|mesh-list
102260813|NCT02412475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102260814|NCT02412475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102260815|NCT02412475|Antimetabolites|antimetabolites|mesh-ancestor
102260816|NCT02412475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260817|NCT02412475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102260818|NCT02412475|Immunologic Factors|immunologic factors|mesh-ancestor
102260819|NCT02412475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260820|NCT02412475|Antiviral Agents|antiviral agents|mesh-ancestor
102260821|NCT02412475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102260822|NCT02412475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102260823|NCT02412475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102260824|NCT02412475|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102260825|NCT04543643|Carvedilol|carvedilol|mesh-list
102260826|NCT04543643|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102260827|NCT04543643|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102260828|NCT04543643|Adrenergic Agents|adrenergic agents|mesh-ancestor
102260829|NCT04543643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102260830|NCT04543643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260831|NCT04543643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815688|NCT03809611|Choline|choline|mesh-list
102260832|NCT04543643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102260833|NCT04543643|Antioxidants|antioxidants|mesh-ancestor
102260834|NCT04543643|Protective Agents|protective agents|mesh-ancestor
102260835|NCT04543643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102260836|NCT04543643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102260837|NCT04543643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102260838|NCT04543643|Vasodilator Agents|vasodilator agents|mesh-ancestor
102260839|NCT04543643|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102260840|NCT04543643|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102260841|NCT05377619|Buspirone|buspirone|mesh-list
102260842|NCT05377619|Prucalopride|prucalopride|mesh-list
102260843|NCT05377619|Laxatives|laxatives|mesh-ancestor
102260844|NCT05377619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102260845|NCT05377619|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
102260846|NCT05377619|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102260847|NCT05377619|Serotonin Agents|serotonin agents|mesh-ancestor
102260848|NCT05377619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102260849|NCT05377619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260850|NCT05377619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260851|NCT05377619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102260852|NCT05377619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102260853|NCT05377619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102260854|NCT05377619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102260855|NCT03199157|Fentanyl|fentanyl|mesh-list
102260856|NCT03199157|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102260857|NCT03199157|Narcotics|narcotics|mesh-ancestor
102260858|NCT03199157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102260859|NCT03199157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260860|NCT03199157|Analgesics|analgesics|mesh-ancestor
102613753|NCT03575195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102260861|NCT03199157|Sensory System Agents|sensory system agents|mesh-ancestor
102260862|NCT03199157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102260863|NCT03199157|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102260864|NCT03199157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102260865|NCT03199157|Anesthetics, General|anesthetics, general|mesh-ancestor
102260866|NCT03199157|Anesthetics|anesthetics|mesh-ancestor
102260867|NCT00641381|Cyclophosphamide|cyclophosphamide|mesh-list
102260868|NCT00641381|Carmustine|carmustine|mesh-list
102260869|NCT00641381|Etoposide|etoposide|mesh-list
102260870|NCT00641381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102260871|NCT00641381|Immunologic Factors|immunologic factors|mesh-ancestor
102260872|NCT00641381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260873|NCT00641381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102260874|NCT00641381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102260875|NCT00641381|Alkylating Agents|alkylating agents|mesh-ancestor
102260876|NCT00641381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260877|NCT00641381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102260878|NCT00641381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101969766|NCT00439738|Valsartan|valsartan|mesh-list
102260879|NCT00641381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102260880|NCT00641381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101815732|NCT04424264|Efavirenz|efavirenz|mesh-list
102260881|NCT00641381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102260882|NCT00641381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102260883|NCT02416999|Bevacizumab|bevacizumab|mesh-list
102260884|NCT02416999|Temozolomide|temozolomide|mesh-list
102260885|NCT02416999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102260886|NCT02416999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102260887|NCT02416999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102260888|NCT02416999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102260889|NCT02416999|Growth Substances|growth substances|mesh-ancestor
102260890|NCT02416999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260891|NCT02416999|Growth Inhibitors|growth inhibitors|mesh-ancestor
102260892|NCT02416999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102260893|NCT02416999|Alkylating Agents|alkylating agents|mesh-ancestor
102260894|NCT02416999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260895|NCT02412085|Golimumab|golimumab|mesh-list
102260896|NCT02412085|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102260897|NCT02412085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102260898|NCT02412085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102260899|NCT02412085|Immunologic Factors|immunologic factors|mesh-ancestor
102260900|NCT02412085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260901|NCT01679405|Cisplatin|cisplatin|mesh-list
102260902|NCT01679405|Gemcitabine|gemcitabine|mesh-list
102260903|NCT01679405|Afatinib|afatinib|mesh-list
102260904|NCT01679405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102260905|NCT01679405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102260906|NCT01679405|Antimetabolites|antimetabolites|mesh-ancestor
101815757|NCT04424264|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102260907|NCT01679405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260908|NCT01679405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102260909|NCT01679405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102260910|NCT03175705|Interleukin-2|interleukin-2|mesh-list
102260911|NCT03175705|Tegafur|tegafur|mesh-list
102260912|NCT03175705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102260913|NCT03175705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102260914|NCT03175705|Analgesics|analgesics|mesh-ancestor
102260915|NCT03175705|Sensory System Agents|sensory system agents|mesh-ancestor
101815766|NCT00398086|Tubulin Modulators|tubulin modulators|mesh-ancestor
102260916|NCT03175705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102260917|NCT03175705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260918|NCT03175705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102260919|NCT03175705|Antimetabolites|antimetabolites|mesh-ancestor
102260920|NCT03175705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260921|NCT00301457|Anastrozole|anastrozole|mesh-list
102260922|NCT00301457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102260923|NCT00301457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102260924|NCT00301457|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102260925|NCT00301457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101267699|NCT01795248|Incretins|incretins|mesh-ancestor
102260926|NCT00301457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102260927|NCT00301457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260928|NCT00301457|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102260929|NCT00301457|Hormone Antagonists|hormone antagonists|mesh-ancestor
102260930|NCT00301457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102260931|NCT00301457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260932|NCT03177109|Fluorides|fluorides|mesh-list
102260933|NCT03177109|Fluorides, Topical|fluorides, topical|mesh-list
102260934|NCT03177109|Cariostatic Agents|cariostatic agents|mesh-ancestor
102260935|NCT03177109|Protective Agents|protective agents|mesh-ancestor
102260936|NCT03177109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260937|NCT05094947|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
102260938|NCT05094947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102260939|NCT05094947|Adrenergic Agents|adrenergic agents|mesh-ancestor
102260940|NCT05094947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102260941|NCT05094947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260942|NCT05094947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260943|NCT02421913|Ketamine|ketamine|mesh-list
102260944|NCT02421913|Analgesics|analgesics|mesh-ancestor
102260945|NCT02421913|Sensory System Agents|sensory system agents|mesh-ancestor
102260946|NCT02421913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102260947|NCT02421913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260948|NCT02421913|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102260949|NCT02421913|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102260950|NCT02421913|Anesthetics, General|anesthetics, general|mesh-ancestor
102260951|NCT02421913|Anesthetics|anesthetics|mesh-ancestor
102260952|NCT02421913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102260953|NCT02421913|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102260954|NCT02421913|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102260955|NCT02421913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102260956|NCT02421913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260957|NCT03179293|Propofol|propofol|mesh-list
102260958|NCT03179293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102260959|NCT03179293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102260960|NCT03179293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260961|NCT03179293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102260962|NCT03179293|Anesthetics, General|anesthetics, general|mesh-ancestor
102260963|NCT03179293|Anesthetics|anesthetics|mesh-ancestor
102260964|NCT02416765|Glucagon|glucagon|mesh-list
102260965|NCT02416765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815813|NCT00057811|Prednisolone|prednisolone|mesh-list
102260966|NCT02416765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102260967|NCT02416765|Hormones|hormones|mesh-ancestor
102260968|NCT02416765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102260969|NCT02703259|Acetaminophen|acetaminophen|mesh-list
102260970|NCT02703259|Celecoxib|celecoxib|mesh-list
102260971|NCT02703259|Gabapentin|gabapentin|mesh-list
102260972|NCT02703259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102260973|NCT02703259|Analgesics|analgesics|mesh-ancestor
101815824|NCT00057811|Etoposide|etoposide|mesh-list
102260974|NCT02703259|Sensory System Agents|sensory system agents|mesh-ancestor
102260975|NCT02703259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102260976|NCT02703259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260977|NCT02703259|Antipyretics|antipyretics|mesh-ancestor
102260978|NCT02703259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102260979|NCT02703259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102260980|NCT02703259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102260981|NCT02703259|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102260982|NCT02703259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102260983|NCT02703259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102260984|NCT02703259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102260985|NCT02703259|Anticonvulsants|anticonvulsants|mesh-ancestor
102260986|NCT02703259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102260987|NCT02703259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102260988|NCT02703259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102260989|NCT02703259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102260990|NCT02703259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102260991|NCT02703259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102260992|NCT02703259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102260993|NCT02703259|Antimanic Agents|antimanic agents|mesh-ancestor
102260994|NCT02416687|Etonogestrel|etonogestrel|mesh-list
102260995|NCT02416687|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102260996|NCT02416687|Contraceptive Agents|contraceptive agents|mesh-ancestor
102260997|NCT02416687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102260998|NCT02416687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102260999|NCT02416687|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102261000|NCT02411695|Brexpiprazole|brexpiprazole|mesh-list
102261001|NCT02411695|Serotonin Agents|serotonin agents|mesh-ancestor
102261002|NCT02411695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102261003|NCT02411695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902177|NCT01291628|Micronutrients|micronutrients|mesh-ancestor
102613754|NCT03575195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102613755|NCT00002897|Fluorouracil|fluorouracil|mesh-list
102613756|NCT00002897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613757|NCT00002897|Antimetabolites|antimetabolites|mesh-ancestor
102613758|NCT00002897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261004|NCT02411695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261005|NCT02411695|Dopamine Agonists|dopamine agonists|mesh-ancestor
102261006|NCT02411695|Dopamine Agents|dopamine agents|mesh-ancestor
102261007|NCT05093231|Pembrolizumab|pembrolizumab|mesh-list
102261008|NCT05093231|Olaparib|olaparib|mesh-list
102261009|NCT05093231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102261010|NCT05093231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102261011|NCT05093231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102261012|NCT05093231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261013|NCT05093231|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102261014|NCT05093231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102261015|NCT02411149|Epinephrine|epinephrine|mesh-list
102261016|NCT02411149|Racepinephrine|racepinephrine|mesh-list
102261017|NCT02411149|Morphine|morphine|mesh-list
102261018|NCT02411149|Ropivacaine|ropivacaine|mesh-list
102261019|NCT02411149|Epinephryl borate|epinephryl borate|mesh-list
102261020|NCT02411149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102261021|NCT02411149|Narcotics|narcotics|mesh-ancestor
102261022|NCT02411149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102261023|NCT02411149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261024|NCT02411149|Analgesics|analgesics|mesh-ancestor
102261025|NCT02411149|Sensory System Agents|sensory system agents|mesh-ancestor
102261026|NCT02411149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102261027|NCT02411149|Anesthetics, Local|anesthetics, local|mesh-ancestor
102261028|NCT02411149|Anesthetics|anesthetics|mesh-ancestor
102261029|NCT02411149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102261030|NCT02411149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102261031|NCT02411149|Adrenergic Agents|adrenergic agents|mesh-ancestor
102261032|NCT02411149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102261033|NCT02411149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261034|NCT02411149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102261035|NCT02411149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102261036|NCT02411149|Autonomic Agents|autonomic agents|mesh-ancestor
102261037|NCT02411149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102261038|NCT02411149|Respiratory System Agents|respiratory system agents|mesh-ancestor
102261039|NCT02411149|Mydriatics|mydriatics|mesh-ancestor
102261040|NCT02411149|Sympathomimetics|sympathomimetics|mesh-ancestor
102261041|NCT02411149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102261042|NCT04413227|Docetaxel|docetaxel|mesh-list
102261043|NCT04413227|Endostatins|endostatins|mesh-list
102261044|NCT04413227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102261045|NCT04413227|Tubulin Modulators|tubulin modulators|mesh-ancestor
102261046|NCT04413227|Antimitotic Agents|antimitotic agents|mesh-ancestor
102261047|NCT04413227|Mitosis Modulators|mitosis modulators|mesh-ancestor
102261048|NCT04413227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261049|NCT04413227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102261050|NCT04413227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102261051|NCT04413227|Growth Substances|growth substances|mesh-ancestor
102261052|NCT04413227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261053|NCT04413227|Growth Inhibitors|growth inhibitors|mesh-ancestor
102261054|NCT02410135|Mirabegron|mirabegron|mesh-list
102261055|NCT02410135|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102261056|NCT02410135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102261057|NCT02410135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102261058|NCT02410135|Adrenergic Agents|adrenergic agents|mesh-ancestor
102261059|NCT02410135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102261060|NCT02410135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261061|NCT02410135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261062|NCT02410135|Urological Agents|urological agents|mesh-ancestor
102261063|NCT02410759|Carbetocin|carbetocin|mesh-list
102261064|NCT02410759|Ergonovine|ergonovine|mesh-list
102261065|NCT02410759|Oxytocics|oxytocics|mesh-ancestor
102261066|NCT02410759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102261067|NCT02410759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261068|NCT03175081|Ropivacaine|ropivacaine|mesh-list
102261069|NCT03175081|Anesthetics, Local|anesthetics, local|mesh-ancestor
102261070|NCT03175081|Anesthetics|anesthetics|mesh-ancestor
102613759|NCT00002897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102261071|NCT03175081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102261072|NCT03175081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261073|NCT03175081|Sensory System Agents|sensory system agents|mesh-ancestor
102261074|NCT03175081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102261075|NCT02409823|Antipsychotic Agents|antipsychotic agents|mesh-list
102261076|NCT02409823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102261077|NCT02409823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102261078|NCT02409823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261079|NCT02409823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102261080|NCT02401477|Amoxicillin|amoxicillin|mesh-list
102261081|NCT02401477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102261082|NCT02401477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102261083|NCT03174457|Micafungin|micafungin|mesh-list
102261084|NCT03174457|Antifungal Agents|antifungal agents|mesh-ancestor
102261085|NCT03174457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102261086|NCT02401243|Insulin Glargine|insulin glargine|mesh-list
102261087|NCT02401243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102261088|NCT02401243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261089|NCT02409433|Lacosamide|lacosamide|mesh-list
102261090|NCT02409433|Phenytoin|phenytoin|mesh-list
102261091|NCT02409433|Anticonvulsants|anticonvulsants|mesh-ancestor
102261092|NCT02409433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102261093|NCT02409433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101815937|NCT00992030|Rituximab|rituximab|mesh-list
102261094|NCT02409433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102261095|NCT02409433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261096|NCT02409433|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102261097|NCT02409433|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102261098|NCT01989754|Canagliflozin|canagliflozin|mesh-list
102261099|NCT01989754|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102261100|NCT01989754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261101|NCT01989754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102261102|NCT01989754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261103|NCT01619878|Lumefantrine|lumefantrine|mesh-list
102261104|NCT01619878|Artemether|artemether|mesh-list
102261105|NCT01619878|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102261106|NCT01619878|Antimalarials|antimalarials|mesh-ancestor
102261107|NCT01619878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102261108|NCT01619878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102261109|NCT01619878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102261110|NCT02015104|BCG Vaccine|bcg vaccine|mesh-list
102261111|NCT02015104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102261112|NCT02015104|Immunologic Factors|immunologic factors|mesh-ancestor
102261113|NCT02015104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261114|NCT01989208|Sodium sulfate|sodium sulfate|mesh-list
102261115|NCT01989208|Cathartics|cathartics|mesh-ancestor
102261116|NCT01989208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102261117|NCT01619410|Clindamycin|clindamycin|mesh-list
102261118|NCT01619410|Clindamycin palmitate|clindamycin palmitate|mesh-list
102261119|NCT01619410|Clindamycin phosphate|clindamycin phosphate|mesh-list
102261120|NCT01619410|Linezolid|linezolid|mesh-list
102261121|NCT01619410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102261122|NCT01619410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102261123|NCT01619410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102261124|NCT01619410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102261125|NCT01619410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261126|NCT04666714|Pregabalin|pregabalin|mesh-list
102261127|NCT04666714|Analgesics|analgesics|mesh-ancestor
102261128|NCT04666714|Sensory System Agents|sensory system agents|mesh-ancestor
102261129|NCT04666714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102261130|NCT04666714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261131|NCT04666714|Anticonvulsants|anticonvulsants|mesh-ancestor
102261132|NCT04666714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102261133|NCT04666714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102261134|NCT04666714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261135|NCT04666714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102261136|NCT04666714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102261137|NCT04666714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102261138|NCT04666714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102261139|NCT04666714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102261140|NCT01261247|Panobinostat|panobinostat|mesh-list
102261141|NCT01261247|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
102261142|NCT01261247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102261143|NCT01261247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102261144|NCT01261247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261145|NCT03233243|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102261146|NCT03233243|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102261147|NCT03233243|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102261148|NCT03233243|Antimetabolites|antimetabolites|mesh-ancestor
102261149|NCT03233243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261150|NCT03233243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102613760|NCT00002897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101902183|NCT00053898|Hormone Antagonists|hormone antagonists|mesh-ancestor
101816005|NCT00669617|Dermatologic Agents|dermatologic agents|mesh-ancestor
102261151|NCT03233243|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102261152|NCT03233243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102261153|NCT02449655|Paclitaxel|paclitaxel|mesh-list
102261154|NCT02449655|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102261155|NCT02449655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102261156|NCT02449655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102261157|NCT02449655|Tubulin Modulators|tubulin modulators|mesh-ancestor
102261158|NCT02449655|Antimitotic Agents|antimitotic agents|mesh-ancestor
102261159|NCT02449655|Mitosis Modulators|mitosis modulators|mesh-ancestor
102261160|NCT02449655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261161|NCT04254731|Methadone|methadone|mesh-list
102261162|NCT04254731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102261163|NCT04254731|Narcotics|narcotics|mesh-ancestor
102261164|NCT04254731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102261165|NCT04254731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261166|NCT04254731|Analgesics|analgesics|mesh-ancestor
102261167|NCT04254731|Sensory System Agents|sensory system agents|mesh-ancestor
102261168|NCT04254731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102261169|NCT04254731|Antitussive Agents|antitussive agents|mesh-ancestor
102261170|NCT04254731|Respiratory System Agents|respiratory system agents|mesh-ancestor
102261171|NCT01603277|Antibodies|antibodies|mesh-list
102261172|NCT01603277|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102261173|NCT01603277|Immunologic Factors|immunologic factors|mesh-ancestor
102261174|NCT01603277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261175|NCT01678313|Celecoxib|celecoxib|mesh-list
102261176|NCT01678313|Doxazosin|doxazosin|mesh-list
102261177|NCT01678313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102261178|NCT01678313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102261179|NCT01678313|Analgesics|analgesics|mesh-ancestor
102261180|NCT01678313|Sensory System Agents|sensory system agents|mesh-ancestor
102261181|NCT01678313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102261182|NCT01678313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261183|NCT01678313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102261184|NCT01678313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102261185|NCT01678313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102261186|NCT01678313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102261187|NCT01678313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102261188|NCT01678313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261189|NCT01678313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102261190|NCT01678313|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102261191|NCT01678313|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102261192|NCT01678313|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102261193|NCT01678313|Adrenergic Agents|adrenergic agents|mesh-ancestor
102261194|NCT01678313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102261195|NCT03197207|Camphor|camphor|mesh-list
102261196|NCT03197207|Salicylates|salicylates|mesh-list
102261197|NCT03197207|Methyl salicylate|methyl salicylate|mesh-list
102261198|NCT03197207|Menthol|menthol|mesh-list
102261199|NCT03197207|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102261200|NCT03197207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102261201|NCT03197207|Antipruritics|antipruritics|mesh-ancestor
102261202|NCT03197207|Dermatologic Agents|dermatologic agents|mesh-ancestor
102261203|NCT03197207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102261204|NCT03197207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102261205|NCT03197207|Analgesics|analgesics|mesh-ancestor
102261206|NCT03197207|Sensory System Agents|sensory system agents|mesh-ancestor
102261207|NCT03197207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102261208|NCT03197207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261209|NCT03197207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102261210|NCT03197207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101816050|NCT00992576|Analgesics|analgesics|mesh-ancestor
102261211|NCT03197207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102261212|NCT03197207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102261213|NCT03197207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261214|NCT01603121|Lisofylline|lisofylline|mesh-list
102261215|NCT01603121|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102261216|NCT01603121|Immunologic Factors|immunologic factors|mesh-ancestor
102261217|NCT01603121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261218|NCT01603121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102261219|NCT01603121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102261220|NCT01603121|Analgesics|analgesics|mesh-ancestor
102261221|NCT01603121|Sensory System Agents|sensory system agents|mesh-ancestor
102613761|NCT00002897|Immunologic Factors|immunologic factors|mesh-ancestor
102261222|NCT01603121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102261223|NCT01603121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102613762|NCT00002897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261224|NCT01603121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102261225|NCT01603121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102261226|NCT02449265|Prednisone|prednisone|mesh-list
102261227|NCT02449265|Cyclophosphamide|cyclophosphamide|mesh-list
102261228|NCT02449265|Doxorubicin|doxorubicin|mesh-list
102261229|NCT02449265|Vincristine|vincristine|mesh-list
102261230|NCT02449265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102261231|NCT02449265|Immunologic Factors|immunologic factors|mesh-ancestor
102261232|NCT02449265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261233|NCT02449265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102261234|NCT02449265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102261235|NCT02449265|Alkylating Agents|alkylating agents|mesh-ancestor
102261236|NCT02449265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261237|NCT02449265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102261238|NCT02449265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102261239|NCT02449265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102261240|NCT02449265|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102261241|NCT02449265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102261242|NCT02449265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102261243|NCT02449265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102261244|NCT02449265|Glucocorticoids|glucocorticoids|mesh-ancestor
102261245|NCT02449265|Hormones|hormones|mesh-ancestor
102261246|NCT02449265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102261247|NCT02449265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102261248|NCT02449265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102261249|NCT02449265|Tubulin Modulators|tubulin modulators|mesh-ancestor
102261250|NCT02449265|Antimitotic Agents|antimitotic agents|mesh-ancestor
102261251|NCT02449265|Mitosis Modulators|mitosis modulators|mesh-ancestor
102261252|NCT03196817|Betamethasone|betamethasone|mesh-list
102261253|NCT03196817|Betamethasone Valerate|betamethasone valerate|mesh-list
102261254|NCT03196817|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102261255|NCT03196817|Betamethasone benzoate|betamethasone benzoate|mesh-list
102261256|NCT03196817|Lidocaine|lidocaine|mesh-list
102261257|NCT03196817|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102261258|NCT03196817|Anesthetics, Local|anesthetics, local|mesh-ancestor
102261259|NCT03196817|Anesthetics|anesthetics|mesh-ancestor
102261260|NCT03196817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102261261|NCT03196817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261262|NCT03196817|Sensory System Agents|sensory system agents|mesh-ancestor
102261263|NCT03196817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102261264|NCT03196817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102261265|NCT03196817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102261266|NCT03196817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102261267|NCT03196817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102261268|NCT03196817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261269|NCT03196817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102261270|NCT03196817|Glucocorticoids|glucocorticoids|mesh-ancestor
102261271|NCT03196817|Hormones|hormones|mesh-ancestor
102261272|NCT03196817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102261273|NCT03196817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102261274|NCT03196817|Respiratory System Agents|respiratory system agents|mesh-ancestor
102261275|NCT05091359|Calcium|calcium|mesh-list
102261276|NCT05091359|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102261277|NCT05091359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261278|NCT03564821|Ivosidenib|ivosidenib|mesh-list
102261279|NCT03564821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102261280|NCT03564821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102261281|NCT03564821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261282|NCT02014402|Thrombin|thrombin|mesh-list
102261283|NCT02014402|Hemostatics|hemostatics|mesh-ancestor
102261284|NCT02014402|Coagulants|coagulants|mesh-ancestor
102261285|NCT01988662|Ranibizumab|ranibizumab|mesh-list
102261286|NCT01988662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102261287|NCT01988662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102261288|NCT01988662|Growth Substances|growth substances|mesh-ancestor
102261289|NCT01988662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261290|NCT01988662|Growth Inhibitors|growth inhibitors|mesh-ancestor
102261291|NCT01988662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102261292|NCT00127673|Sertraline|sertraline|mesh-list
102261293|NCT00127673|Antidepressive Agents|antidepressive agents|mesh-ancestor
101268904|NCT01810848|Hylan|hylan|mesh-list
102261294|NCT00127673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102261295|NCT00127673|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102261296|NCT00127673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102261297|NCT00127673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102613763|NCT00002903|Docetaxel|docetaxel|mesh-list
102613764|NCT00002903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102261298|NCT00127673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261299|NCT00127673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102261300|NCT00127673|Serotonin Agents|serotonin agents|mesh-ancestor
102261301|NCT00127673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261302|NCT02449187|Calcium, Dietary|calcium, dietary|mesh-list
102261304|NCT02449187|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102261305|NCT02449187|Calcium|calcium|mesh-list
102261306|NCT02449187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102261307|NCT02449187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261308|NCT02449187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102261309|NCT02449187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102261310|NCT02449187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102261311|NCT02449187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102261312|NCT02449187|Antimetabolites|antimetabolites|mesh-ancestor
102261313|NCT02449187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261314|NCT02449187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102261315|NCT02449187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102261316|NCT02449187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102261317|NCT05095571|Niacinamide|niacinamide|mesh-list
102261318|NCT05095571|Niacin|niacin|mesh-list
102261319|NCT05095571|Nicotinic Acids|nicotinic acids|mesh-list
102261320|NCT05095571|Vitamin B Complex|vitamin b complex|mesh-ancestor
102261321|NCT05095571|Vitamins|vitamins|mesh-ancestor
102261322|NCT05095571|Micronutrients|micronutrients|mesh-ancestor
102261323|NCT05095571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261324|NCT05095571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102261325|NCT05095571|Antimetabolites|antimetabolites|mesh-ancestor
102261326|NCT05095571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261327|NCT05095571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102261328|NCT05095571|Vasodilator Agents|vasodilator agents|mesh-ancestor
102261329|NCT02677181|Mycophenolic Acid|mycophenolic acid|mesh-list
101269049|NCT01811836|Zinc|zinc|mesh-list
102261330|NCT02677181|Methotrexate|methotrexate|mesh-list
102261331|NCT02677181|Thymoglobulin|thymoglobulin|mesh-list
101970217|NCT05966688|Azithromycin|azithromycin|mesh-list
102261332|NCT02677181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102261333|NCT02677181|Abortifacient Agents|abortifacient agents|mesh-ancestor
102261334|NCT02677181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102261335|NCT02677181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261336|NCT02677181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102261337|NCT02677181|Antimetabolites|antimetabolites|mesh-ancestor
102261338|NCT02677181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816178|NCT00778271|Gabapentin|gabapentin|mesh-list
102261339|NCT02677181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102261340|NCT02677181|Dermatologic Agents|dermatologic agents|mesh-ancestor
102261341|NCT02677181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102261342|NCT02677181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102261343|NCT02677181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102261344|NCT02677181|Immunologic Factors|immunologic factors|mesh-ancestor
102261345|NCT02677181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102261346|NCT02677181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102261347|NCT02677181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102261348|NCT02677181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102261349|NCT02677181|Antitubercular Agents|antitubercular agents|mesh-ancestor
102261350|NCT02677181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102261351|NCT02677181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102261352|NCT05095025|Bupivacaine|bupivacaine|mesh-list
102261353|NCT05095025|Anesthetics, Local|anesthetics, local|mesh-ancestor
102261354|NCT05095025|Anesthetics|anesthetics|mesh-ancestor
102261355|NCT05095025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102261356|NCT05095025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261357|NCT05095025|Sensory System Agents|sensory system agents|mesh-ancestor
102261358|NCT05095025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102261359|NCT05056259|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102261360|NCT05056259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102261361|NCT05056259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261362|NCT01987960|Brexpiprazole|brexpiprazole|mesh-list
102261363|NCT01987960|Serotonin Agents|serotonin agents|mesh-ancestor
102261364|NCT01987960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102261365|NCT01987960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261366|NCT01987960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261367|NCT01987960|Dopamine Agonists|dopamine agonists|mesh-ancestor
102261368|NCT01987960|Dopamine Agents|dopamine agents|mesh-ancestor
102613765|NCT00002903|Tubulin Modulators|tubulin modulators|mesh-ancestor
102261369|NCT05084027|Fludarabine|fludarabine|mesh-list
102613766|NCT00002903|Antimitotic Agents|antimitotic agents|mesh-ancestor
102613767|NCT00002903|Mitosis Modulators|mitosis modulators|mesh-ancestor
102261370|NCT05084027|Melphalan|melphalan|mesh-list
102261371|NCT05084027|Venetoclax|venetoclax|mesh-list
102261372|NCT05084027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102261373|NCT05084027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261374|NCT05084027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102261375|NCT05084027|Immunologic Factors|immunologic factors|mesh-ancestor
102261376|NCT05084027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261377|NCT05084027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102261378|NCT05084027|Alkylating Agents|alkylating agents|mesh-ancestor
102261379|NCT05084027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102261380|NCT02013622|Brexpiprazole|brexpiprazole|mesh-list
102261381|NCT02013622|Serotonin Agents|serotonin agents|mesh-ancestor
102261382|NCT02013622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102261383|NCT02013622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261384|NCT02013622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261385|NCT02013622|Dopamine Agonists|dopamine agonists|mesh-ancestor
102261386|NCT02013622|Dopamine Agents|dopamine agents|mesh-ancestor
102261387|NCT02448797|Vinorelbine|vinorelbine|mesh-list
102261388|NCT02448797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102261389|NCT02448797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102261390|NCT02448797|Tubulin Modulators|tubulin modulators|mesh-ancestor
102261391|NCT02448797|Antimitotic Agents|antimitotic agents|mesh-ancestor
102261392|NCT02448797|Mitosis Modulators|mitosis modulators|mesh-ancestor
102261393|NCT02448797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261394|NCT04438421|Chlorhexidine|chlorhexidine|mesh-list
102261395|NCT04438421|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102261396|NCT04438421|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102261397|NCT04438421|Hyaluronic Acid|hyaluronic acid|mesh-list
102261398|NCT04438421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102261399|NCT04438421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102261400|NCT04438421|Disinfectants|disinfectants|mesh-ancestor
102261401|NCT04438421|Dermatologic Agents|dermatologic agents|mesh-ancestor
102261402|NCT04438421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102261403|NCT04438421|Immunologic Factors|immunologic factors|mesh-ancestor
102261404|NCT04438421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261405|NCT04438421|Viscosupplements|viscosupplements|mesh-ancestor
102261406|NCT04438421|Protective Agents|protective agents|mesh-ancestor
102261408|NCT05099081|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102261409|NCT05099081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102261410|NCT04438577|Lidocaine|lidocaine|mesh-list
102261411|NCT04438577|Anesthetics, Local|anesthetics, local|mesh-ancestor
102261412|NCT04438577|Anesthetics|anesthetics|mesh-ancestor
102261413|NCT04438577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102261414|NCT04438577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261415|NCT04438577|Sensory System Agents|sensory system agents|mesh-ancestor
102261416|NCT04438577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102261417|NCT04438577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102261418|NCT04438577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102261419|NCT04438577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102261420|NCT04438577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102261421|NCT04438577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261422|NCT05087615|Ondansetron|ondansetron|mesh-list
102261423|NCT05087615|Metoclopramide|metoclopramide|mesh-list
102261424|NCT05087615|Granisetron|granisetron|mesh-list
102261425|NCT05087615|Antiemetics|antiemetics|mesh-ancestor
102261426|NCT05087615|Autonomic Agents|autonomic agents|mesh-ancestor
102261427|NCT05087615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102261428|NCT05087615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261429|NCT05087615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102261430|NCT05087615|Antipruritics|antipruritics|mesh-ancestor
102261431|NCT05087615|Dermatologic Agents|dermatologic agents|mesh-ancestor
102261432|NCT05087615|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102261433|NCT05087615|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102261434|NCT05087615|Serotonin Agents|serotonin agents|mesh-ancestor
102261435|NCT05087615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102261436|NCT05087615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261437|NCT05087615|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102261438|NCT05087615|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102261439|NCT05087615|Dopamine Agents|dopamine agents|mesh-ancestor
102261440|NCT01987102|Leucovorin|leucovorin|mesh-list
102261441|NCT01987102|Calcium|calcium|mesh-list
102613768|NCT00002903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261442|NCT01987102|Levoleucovorin|levoleucovorin|mesh-list
102261443|NCT01987102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102261444|NCT01987102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261445|NCT01987102|Antidotes|antidotes|mesh-ancestor
102261446|NCT01987102|Protective Agents|protective agents|mesh-ancestor
102261447|NCT01987102|Vitamin B Complex|vitamin b complex|mesh-ancestor
102261448|NCT01987102|Vitamins|vitamins|mesh-ancestor
102261449|NCT01987102|Micronutrients|micronutrients|mesh-ancestor
102261450|NCT02013544|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
102261451|NCT02013544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102261452|NCT02013544|Immunologic Factors|immunologic factors|mesh-ancestor
102261453|NCT02013544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261454|NCT03968939|Diphenhydramine|diphenhydramine|mesh-list
102261455|NCT03968939|Promethazine|promethazine|mesh-list
102261456|NCT03968939|Melatonin|melatonin|mesh-list
102261457|NCT03968939|Antioxidants|antioxidants|mesh-ancestor
102261458|NCT03968939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261459|NCT03968939|Protective Agents|protective agents|mesh-ancestor
102261460|NCT03968939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261461|NCT03968939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102261462|NCT03968939|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102261463|NCT03968939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102261464|NCT03968939|Anesthetics, Local|anesthetics, local|mesh-ancestor
102261465|NCT03968939|Anesthetics|anesthetics|mesh-ancestor
102261466|NCT03968939|Sensory System Agents|sensory system agents|mesh-ancestor
102261467|NCT03968939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102261468|NCT03968939|Antiemetics|antiemetics|mesh-ancestor
102261469|NCT03968939|Autonomic Agents|autonomic agents|mesh-ancestor
102261470|NCT03968939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102261471|NCT03968939|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102261472|NCT03968939|Histamine Antagonists|histamine antagonists|mesh-ancestor
102261473|NCT03968939|Histamine Agents|histamine agents|mesh-ancestor
102261474|NCT03968939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102261475|NCT03968939|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102261476|NCT03968939|Antipruritics|antipruritics|mesh-ancestor
102261477|NCT03968939|Dermatologic Agents|dermatologic agents|mesh-ancestor
102261478|NCT03856619|Teriflunomide|teriflunomide|mesh-list
102261479|NCT03856619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101970367|NCT05801172|Ketoprofen|ketoprofen|mesh-list
102261480|NCT03856619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102261481|NCT03856619|Analgesics|analgesics|mesh-ancestor
102261482|NCT03856619|Sensory System Agents|sensory system agents|mesh-ancestor
102261483|NCT03856619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102261484|NCT03856619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261485|NCT03856619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102261486|NCT03856619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102261487|NCT03856619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102261488|NCT03856619|Immunologic Factors|immunologic factors|mesh-ancestor
102261489|NCT02448407|Hyaluronic Acid|hyaluronic acid|mesh-list
102261490|NCT02448407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102261491|NCT02448407|Immunologic Factors|immunologic factors|mesh-ancestor
102261492|NCT02448407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261493|NCT02448407|Viscosupplements|viscosupplements|mesh-ancestor
102261494|NCT02448407|Protective Agents|protective agents|mesh-ancestor
102261495|NCT05098847|Lenvatinib|lenvatinib|mesh-list
102261496|NCT05098847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102261497|NCT05098847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102261498|NCT05098847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102261499|NCT05098847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261500|NCT04517357|Apatinib|apatinib|mesh-list
102261501|NCT04517357|Fluzoparib|fluzoparib|mesh-list
102261502|NCT04517357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102261503|NCT04517357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102261504|NCT04517357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102261505|NCT04517357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261506|NCT04517357|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102261507|NCT02012296|Mifepristone|mifepristone|mesh-list
102261508|NCT02012296|Androgens|androgens|mesh-list
102261509|NCT02012296|Hormones|hormones|mesh-ancestor
102261510|NCT02012296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102261511|NCT02012296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261512|NCT02012296|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102261513|NCT02012296|Abortifacient Agents|abortifacient agents|mesh-ancestor
102613769|NCT03375203|Zolpidem|zolpidem|mesh-list
102613770|NCT03375203|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102261514|NCT02012296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102261515|NCT02012296|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102261516|NCT02012296|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102261517|NCT02012296|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102613771|NCT03375203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102261518|NCT02012296|Contraceptive Agents|contraceptive agents|mesh-ancestor
102261519|NCT02012296|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102261520|NCT02012296|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102261521|NCT02012296|Hormone Antagonists|hormone antagonists|mesh-ancestor
102261522|NCT02012296|Luteolytic Agents|luteolytic agents|mesh-ancestor
102261523|NCT02012296|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102261524|NCT02012296|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102261526|NCT02012218|Serotonin Agents|serotonin agents|mesh-ancestor
102261527|NCT02012218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102261528|NCT02012218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261529|NCT02012218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816314|NCT00774605|Varenicline|varenicline|mesh-list
102261530|NCT02012218|Dopamine Agonists|dopamine agonists|mesh-ancestor
102261531|NCT02012218|Dopamine Agents|dopamine agents|mesh-ancestor
102261532|NCT04177498|ON 01910|on 01910|mesh-list
102261533|NCT04177498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102261534|NCT04177498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102261535|NCT04177498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102261536|NCT04177498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261537|NCT04658836|Triamcinolone|triamcinolone|mesh-list
102261538|NCT04658836|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102261539|NCT04658836|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102261540|NCT04658836|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102261541|NCT04658836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102261542|NCT04658836|Glucocorticoids|glucocorticoids|mesh-ancestor
102261543|NCT04658836|Hormones|hormones|mesh-ancestor
102261544|NCT04658836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102261545|NCT04658836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261546|NCT04658836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102261547|NCT04658836|Immunologic Factors|immunologic factors|mesh-ancestor
102261548|NCT04658836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102261549|NCT04658836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261550|NCT01677377|Risperidone|risperidone|mesh-list
102261551|NCT01677377|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102261552|NCT01677377|Serotonin Agents|serotonin agents|mesh-ancestor
102261553|NCT01677377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102261554|NCT01677377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261555|NCT01677377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261556|NCT01677377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102261557|NCT01677377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102261558|NCT01677377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102261559|NCT01677377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102261560|NCT01677377|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102261561|NCT01677377|Dopamine Agents|dopamine agents|mesh-ancestor
102261563|NCT05097911|Atezolizumab|atezolizumab|mesh-list
102261564|NCT05097911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102261565|NCT05097911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102261566|NCT05097911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102261567|NCT05097911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102261568|NCT05097911|Growth Substances|growth substances|mesh-ancestor
102261569|NCT05097911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261570|NCT05097911|Growth Inhibitors|growth inhibitors|mesh-ancestor
102261571|NCT05097911|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102261572|NCT05097911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261573|NCT05097365|Folic Acid|folic acid|mesh-list
102261574|NCT05097365|Vitamin B 12|vitamin b 12|mesh-list
102261575|NCT05097365|Hydroxocobalamin|hydroxocobalamin|mesh-list
102261576|NCT05097365|Vitamins|vitamins|mesh-ancestor
102261577|NCT05097365|Micronutrients|micronutrients|mesh-ancestor
102261578|NCT05097365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261579|NCT05097365|Hematinics|hematinics|mesh-ancestor
102261580|NCT05097365|Vitamin B Complex|vitamin b complex|mesh-ancestor
102261581|NCT01964716|Vaccines|vaccines|mesh-list
102261582|NCT01964716|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102261583|NCT01964716|Immunologic Factors|immunologic factors|mesh-ancestor
102261584|NCT01964716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261585|NCT01964560|Lacosamide|lacosamide|mesh-list
102261586|NCT01964560|Anticonvulsants|anticonvulsants|mesh-ancestor
102261587|NCT01964560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102261588|NCT01964560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102261589|NCT01964560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102261590|NCT01964560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261591|NCT02659943|Cyclophosphamide|cyclophosphamide|mesh-list
102261592|NCT02659943|Fludarabine|fludarabine|mesh-list
102261593|NCT02659943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102261594|NCT02659943|Immunologic Factors|immunologic factors|mesh-ancestor
102261595|NCT02659943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261596|NCT02659943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102261597|NCT02659943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102261598|NCT02659943|Alkylating Agents|alkylating agents|mesh-ancestor
102261599|NCT02659943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261600|NCT02659943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102261601|NCT02659943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102261602|NCT05083325|Oseltamivir|oseltamivir|mesh-list
102261603|NCT05083325|Antiviral Agents|antiviral agents|mesh-ancestor
102261604|NCT05083325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102261605|NCT05083325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102261606|NCT05083325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261607|NCT01677299|Metformin|metformin|mesh-list
102261608|NCT01677299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102261609|NCT01677299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261610|NCT04999631|Ethanol|ethanol|mesh-list
102261611|NCT04999631|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
102261612|NCT04999631|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102261613|NCT04999631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102261614|NCT04999631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102261615|NCT04999631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261616|NCT04999631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102261617|NCT04999631|Immunologic Factors|immunologic factors|mesh-ancestor
102261618|NCT02718833|Dexamethasone|dexamethasone|mesh-list
102261619|NCT02718833|Bortezomib|bortezomib|mesh-list
102261620|NCT02718833|Pomalidomide|pomalidomide|mesh-list
102261621|NCT02718833|Elotuzumab|elotuzumab|mesh-list
102261622|NCT02718833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102261623|NCT02718833|Antiemetics|antiemetics|mesh-ancestor
102261624|NCT02718833|Autonomic Agents|autonomic agents|mesh-ancestor
102261625|NCT02718833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102261626|NCT02718833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261627|NCT02718833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102261628|NCT02718833|Glucocorticoids|glucocorticoids|mesh-ancestor
102261629|NCT02718833|Hormones|hormones|mesh-ancestor
102261630|NCT02718833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102261631|NCT02718833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102261632|NCT02718833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102261633|NCT02718833|Immunologic Factors|immunologic factors|mesh-ancestor
102261634|NCT02718833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102261635|NCT02718833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102261636|NCT02718833|Growth Substances|growth substances|mesh-ancestor
102261637|NCT02718833|Growth Inhibitors|growth inhibitors|mesh-ancestor
102261638|NCT04908293|Listerine|listerine|mesh-list
102261639|NCT04908293|Sodium Fluoride|sodium fluoride|mesh-list
102261640|NCT04908293|Cariostatic Agents|cariostatic agents|mesh-ancestor
102261641|NCT04908293|Protective Agents|protective agents|mesh-ancestor
102261642|NCT04908293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261643|NCT04908293|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102261644|NCT04908293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102261645|NCT01964326|Atorvastatin|atorvastatin|mesh-list
102261646|NCT01964326|Calcium|calcium|mesh-list
102261647|NCT01964326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102261648|NCT01964326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261649|NCT01964326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102261650|NCT01964326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102261651|NCT01964326|Antimetabolites|antimetabolites|mesh-ancestor
102261652|NCT01964326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261653|NCT01964326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102261654|NCT01964326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102261655|NCT01964326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102261656|NCT05102045|Memantine|memantine|mesh-list
102261657|NCT05102045|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
102261658|NCT05102045|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102261659|NCT05102045|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102261660|NCT05102045|Dopamine Agents|dopamine agents|mesh-ancestor
102261661|NCT05102045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102261662|NCT05102045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261663|NCT05102045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261664|NCT05102045|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102261665|NCT05102045|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102613772|NCT03375203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102261666|NCT05102045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102261667|NCT05102045|Cholinergic Agents|cholinergic agents|mesh-ancestor
102261668|NCT04414241|Hydroxychloroquine|hydroxychloroquine|mesh-list
102261669|NCT04414241|Antimalarials|antimalarials|mesh-ancestor
102261670|NCT04414241|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102261671|NCT04414241|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102261672|NCT04414241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102261673|NCT04414241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102261674|NCT04414241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261675|NCT04414241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102261676|NCT04531553|Levobupivacaine|levobupivacaine|mesh-list
102261677|NCT04531553|Anesthetics, Local|anesthetics, local|mesh-ancestor
102261678|NCT04531553|Anesthetics|anesthetics|mesh-ancestor
102261679|NCT04531553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102261680|NCT04531553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261681|NCT04531553|Sensory System Agents|sensory system agents|mesh-ancestor
102261682|NCT04531553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102261683|NCT05101811|Vitamin D|vitamin d|mesh-list
102261684|NCT05101811|Ergocalciferols|ergocalciferols|mesh-list
102261685|NCT05101811|Cholecalciferol|cholecalciferol|mesh-list
102261686|NCT05101811|Vitamins|vitamins|mesh-list
102261687|NCT05101811|Micronutrients|micronutrients|mesh-ancestor
102261688|NCT05101811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261689|NCT05101811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102261690|NCT05101811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102261691|NCT04088123|Ticagrelor|ticagrelor|mesh-list
102261692|NCT04088123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102261693|NCT04088123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102261694|NCT04088123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102261695|NCT04088123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102261696|NCT04088123|Purinergic Agents|purinergic agents|mesh-ancestor
102261697|NCT04088123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101816547|NCT00997022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102261698|NCT04088123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261699|NCT04088123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261700|NCT05164367|Atropine|atropine|mesh-list
102261701|NCT05164367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102261702|NCT05164367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102261703|NCT05164367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102261704|NCT05164367|Autonomic Agents|autonomic agents|mesh-ancestor
102261705|NCT05164367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102261706|NCT05164367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261707|NCT05164367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102261708|NCT05164367|Respiratory System Agents|respiratory system agents|mesh-ancestor
102261709|NCT05164367|Mydriatics|mydriatics|mesh-ancestor
102261710|NCT05164367|Parasympatholytics|parasympatholytics|mesh-ancestor
102261711|NCT05164367|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102261712|NCT05164367|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102261713|NCT05164367|Cholinergic Agents|cholinergic agents|mesh-ancestor
102261714|NCT05164367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102261715|NCT05164367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261716|NCT03847181|Vitamin K|vitamin k|mesh-list
102261717|NCT03847181|Warfarin|warfarin|mesh-list
102261718|NCT03847181|Rivaroxaban|rivaroxaban|mesh-list
102261719|NCT03847181|Apixaban|apixaban|mesh-list
102261720|NCT03847181|Anticoagulants|anticoagulants|mesh-list
102261721|NCT03847181|Vitamins|vitamins|mesh-ancestor
102261722|NCT03847181|Micronutrients|micronutrients|mesh-ancestor
102261723|NCT03847181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261724|NCT03847181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102261725|NCT03847181|Antithrombins|antithrombins|mesh-ancestor
102261726|NCT03847181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102261727|NCT03847181|Protease Inhibitors|protease inhibitors|mesh-ancestor
102261728|NCT03847181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101816565|NCT00782951|Morphine|morphine|mesh-list
102261729|NCT03847181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261730|NCT03847181|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102261731|NCT03847181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102261732|NCT03847181|Hemostatics|hemostatics|mesh-ancestor
102261733|NCT03847181|Coagulants|coagulants|mesh-ancestor
102261734|NCT03477851|Tramadol|tramadol|mesh-list
102261735|NCT03477851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102261736|NCT03477851|Narcotics|narcotics|mesh-ancestor
102261737|NCT03477851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102613773|NCT03375203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261738|NCT03477851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261739|NCT03477851|Analgesics|analgesics|mesh-ancestor
102261740|NCT03477851|Sensory System Agents|sensory system agents|mesh-ancestor
102261741|NCT03477851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102613774|NCT03375203|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102261743|NCT02409199|Apatinib|apatinib|mesh-list
102261744|NCT02409199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102261745|NCT02409199|Tubulin Modulators|tubulin modulators|mesh-ancestor
102261746|NCT02409199|Antimitotic Agents|antimitotic agents|mesh-ancestor
102261747|NCT02409199|Mitosis Modulators|mitosis modulators|mesh-ancestor
102261748|NCT02409199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261749|NCT02409199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102261750|NCT02409199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102261751|NCT03115489|Ketamine|ketamine|mesh-list
102261752|NCT03115489|Propofol|propofol|mesh-list
102261753|NCT03115489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102261754|NCT03115489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102261755|NCT03115489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261756|NCT03115489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102261757|NCT03115489|Anesthetics, General|anesthetics, general|mesh-ancestor
102261758|NCT03115489|Anesthetics|anesthetics|mesh-ancestor
102261759|NCT03115489|Analgesics|analgesics|mesh-ancestor
102261760|NCT03115489|Sensory System Agents|sensory system agents|mesh-ancestor
102261761|NCT03115489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102261762|NCT03115489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102261763|NCT03115489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102261764|NCT03115489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102261765|NCT03115489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101816594|NCT00783107|Cyclosporins|cyclosporins|mesh-list
102261766|NCT03115489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261767|NCT03168997|Memantine|memantine|mesh-list
102261768|NCT03168997|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102261769|NCT03168997|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102261770|NCT03168997|Dopamine Agents|dopamine agents|mesh-ancestor
102261771|NCT03168997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102261772|NCT03168997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261773|NCT03168997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261774|NCT03168997|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102261775|NCT03168997|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102261776|NCT03171727|Heparin|heparin|mesh-list
102261777|NCT03171727|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102261778|NCT03171727|Tinzaparin|tinzaparin|mesh-list
102261779|NCT03171727|Dalteparin|dalteparin|mesh-list
102261780|NCT03171727|Anticoagulants|anticoagulants|mesh-ancestor
102261781|NCT03171727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102261782|NCT03171727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102261783|NCT03171727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261784|NCT02400931|Rocuronium|rocuronium|mesh-list
102261785|NCT02400931|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102261786|NCT02400931|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102261787|NCT02400931|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102261788|NCT02400931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102261789|NCT02400931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261791|NCT03116269|Cilostazol|cilostazol|mesh-list
102261792|NCT03116269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102261793|NCT03116269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102261794|NCT03116269|Analgesics|analgesics|mesh-ancestor
102261795|NCT03116269|Sensory System Agents|sensory system agents|mesh-ancestor
102261796|NCT03116269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102261797|NCT03116269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261798|NCT03116269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102261799|NCT03116269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102261800|NCT03116269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102261801|NCT03116269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102261802|NCT03116269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261803|NCT03116269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102261804|NCT03116269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102261805|NCT03116269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102261806|NCT03116269|Antipyretics|antipyretics|mesh-ancestor
102261807|NCT03116269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102261808|NCT03116269|Autonomic Agents|autonomic agents|mesh-ancestor
102261809|NCT03116269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102261810|NCT03116269|Respiratory System Agents|respiratory system agents|mesh-ancestor
102261811|NCT03116269|Vasodilator Agents|vasodilator agents|mesh-ancestor
102261812|NCT03116269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102261813|NCT03116269|Protective Agents|protective agents|mesh-ancestor
102261814|NCT03116269|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102261815|NCT03116269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102261816|NCT03174067|Clonidine|clonidine|mesh-list
102261817|NCT03174067|Buprenorphine|buprenorphine|mesh-list
102261818|NCT03174067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102261819|NCT03174067|Narcotics|narcotics|mesh-ancestor
102261820|NCT03174067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102261821|NCT03174067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261822|NCT03174067|Analgesics|analgesics|mesh-ancestor
102261823|NCT03174067|Sensory System Agents|sensory system agents|mesh-ancestor
102261824|NCT03174067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102261825|NCT03174067|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102261826|NCT03174067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102261827|NCT03174067|Sympatholytics|sympatholytics|mesh-ancestor
102261828|NCT03174067|Autonomic Agents|autonomic agents|mesh-ancestor
101816653|NCT00790595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102261829|NCT03174067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102261830|NCT03174067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102261831|NCT03174067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102261832|NCT03174067|Adrenergic Agents|adrenergic agents|mesh-ancestor
102261833|NCT03174067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102261834|NCT03174067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261835|NCT02408185|Colistin|colistin|mesh-list
102261836|NCT02408185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102261837|NCT02408185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102261838|NCT02408419|Bupivacaine|bupivacaine|mesh-list
102261839|NCT02408419|Anesthetics, Local|anesthetics, local|mesh-ancestor
102261840|NCT02408419|Anesthetics|anesthetics|mesh-ancestor
102261841|NCT02408419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102261842|NCT02408419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261843|NCT02408419|Sensory System Agents|sensory system agents|mesh-ancestor
102261844|NCT02408419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102261845|NCT00708097|Fluorides|fluorides|mesh-list
102261846|NCT00708097|Cariostatic Agents|cariostatic agents|mesh-ancestor
102261847|NCT00708097|Protective Agents|protective agents|mesh-ancestor
102261848|NCT00708097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261849|NCT02400775|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
102261850|NCT02400775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102261851|NCT02400775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102261852|NCT02400775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261853|NCT02405689|Dexmedetomidine|dexmedetomidine|mesh-list
102261854|NCT02405689|Remifentanil|remifentanil|mesh-list
102261855|NCT02405689|Sevoflurane|sevoflurane|mesh-list
102261856|NCT02405689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102261857|NCT02405689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102261858|NCT02405689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261859|NCT02405689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102261860|NCT02405689|Analgesics|analgesics|mesh-ancestor
102261861|NCT02405689|Sensory System Agents|sensory system agents|mesh-ancestor
102261862|NCT02405689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102261863|NCT02405689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102261864|NCT02405689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102261865|NCT02405689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102261866|NCT02405689|Adrenergic Agents|adrenergic agents|mesh-ancestor
102261867|NCT02405689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102261868|NCT02405689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261869|NCT02405689|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102261870|NCT02405689|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102261871|NCT02405689|Anesthetics, General|anesthetics, general|mesh-ancestor
102261872|NCT02405689|Anesthetics|anesthetics|mesh-ancestor
102261873|NCT02405689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102261874|NCT02405689|Narcotics|narcotics|mesh-ancestor
102261875|NCT02400619|Botulinum Toxins|botulinum toxins|mesh-list
102261876|NCT02400619|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102261877|NCT02400619|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102261878|NCT02400619|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102261879|NCT02400619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102261880|NCT02400619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261881|NCT02400619|Cholinergic Agents|cholinergic agents|mesh-ancestor
102261882|NCT02400619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102261883|NCT02400619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261884|NCT02400619|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102261885|NCT02400619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102261886|NCT02699125|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102261887|NCT02699125|Guanfacine|guanfacine|mesh-list
102261888|NCT02699125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102261889|NCT02699125|Diuretics|diuretics|mesh-ancestor
102613775|NCT03375203|GABA Agonists|gaba agonists|mesh-ancestor
102613776|NCT03375203|GABA Agents|gaba agents|mesh-ancestor
101603630|NCT02682862|Bromides|bromides|mesh-list
102613777|NCT03375203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102261890|NCT02699125|Natriuretic Agents|natriuretic agents|mesh-ancestor
102261891|NCT02699125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261892|NCT02699125|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102261893|NCT02699125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102261894|NCT02699125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261895|NCT02699125|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102261896|NCT02699125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102261897|NCT02699125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102261898|NCT02699125|Adrenergic Agents|adrenergic agents|mesh-ancestor
102261899|NCT02699125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102261900|NCT04279535|Ascorbic Acid|ascorbic acid|mesh-list
102261901|NCT04279535|Antioxidants|antioxidants|mesh-ancestor
102261902|NCT04279535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261903|NCT04279535|Protective Agents|protective agents|mesh-ancestor
102261904|NCT04279535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261905|NCT04279535|Vitamins|vitamins|mesh-ancestor
102261906|NCT04279535|Micronutrients|micronutrients|mesh-ancestor
102261907|NCT02400151|Vitamin D|vitamin d|mesh-list
102261908|NCT02400151|Vitamins|vitamins|mesh-ancestor
102261909|NCT02400151|Micronutrients|micronutrients|mesh-ancestor
102261910|NCT02400151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261911|NCT02400151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102261912|NCT02400385|Nivolumab|nivolumab|mesh-list
102261913|NCT02400385|Sunitinib|sunitinib|mesh-list
102261914|NCT02400385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102261915|NCT02400385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102261916|NCT02400385|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102261917|NCT02400385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261918|NCT02400385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102261919|NCT02400385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102261920|NCT02400385|Growth Substances|growth substances|mesh-ancestor
102261921|NCT02400385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261922|NCT02400385|Growth Inhibitors|growth inhibitors|mesh-ancestor
101269867|NCT01816620|Hormones|hormones|mesh-ancestor
102261923|NCT02400385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102261924|NCT02400385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102261925|NCT03173365|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102261926|NCT03173365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102261927|NCT03173365|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101269916|NCT01817023|Cisplatin|cisplatin|mesh-list
102261928|NCT03173365|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102261929|NCT03173365|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102261930|NCT03173365|Adrenergic Agents|adrenergic agents|mesh-ancestor
102261931|NCT03173365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102261932|NCT03173365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261933|NCT03173365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261934|NCT05100719|Mebeverine|mebeverine|mesh-list
102261935|NCT05100719|Simethicone|simethicone|mesh-list
102261936|NCT05100719|Citric Acid|citric acid|mesh-list
102261937|NCT05100719|Sodium Citrate|sodium citrate|mesh-list
102261938|NCT05100719|Alverine|alverine|mesh-list
102261939|NCT05100719|Anticoagulants|anticoagulants|mesh-ancestor
102261940|NCT05100719|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102261941|NCT05100719|Chelating Agents|chelating agents|mesh-ancestor
102261942|NCT05100719|Sequestering Agents|sequestering agents|mesh-ancestor
102261943|NCT05100719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261944|NCT05100719|Antifoaming Agents|antifoaming agents|mesh-ancestor
102261945|NCT05100719|Emollients|emollients|mesh-ancestor
102261946|NCT05100719|Dermatologic Agents|dermatologic agents|mesh-ancestor
101816771|NCT00391222|Olanzapine|olanzapine|mesh-list
102261947|NCT05100719|Parasympatholytics|parasympatholytics|mesh-ancestor
102261948|NCT05100719|Autonomic Agents|autonomic agents|mesh-ancestor
102261949|NCT05100719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102261950|NCT05100719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261951|NCT05100719|Anticonvulsants|anticonvulsants|mesh-ancestor
102261952|NCT05100563|Naltrexone|naltrexone|mesh-list
102261953|NCT05100563|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102261954|NCT05100563|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102261955|NCT05100563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816784|NCT00391222|Antiemetics|antiemetics|mesh-ancestor
102261956|NCT05100563|Sensory System Agents|sensory system agents|mesh-ancestor
102261957|NCT05100563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102261958|NCT05100329|Mitoxantrone|mitoxantrone|mesh-list
102261959|NCT05100329|Analgesics|analgesics|mesh-ancestor
102261960|NCT05100329|Sensory System Agents|sensory system agents|mesh-ancestor
101816791|NCT00409006|Pemetrexed|pemetrexed|mesh-list
102261961|NCT05100329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102261962|NCT05100329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261963|NCT05100329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102261964|NCT05100329|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102261965|NCT05100329|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102261966|NCT05100329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102261967|NCT05100329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261968|NCT04530539|Ascorbic Acid|ascorbic acid|mesh-list
102261969|NCT04530539|Melatonin|melatonin|mesh-list
102261970|NCT04530539|Vitamins|vitamins|mesh-ancestor
102261971|NCT04530539|Micronutrients|micronutrients|mesh-ancestor
102261972|NCT04530539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261973|NCT04530539|Antioxidants|antioxidants|mesh-ancestor
102261974|NCT04530539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261975|NCT04530539|Protective Agents|protective agents|mesh-ancestor
102261976|NCT04530539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102261977|NCT02698891|Paclitaxel|paclitaxel|mesh-list
102261978|NCT02698891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102261979|NCT02698891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102261980|NCT02698891|Tubulin Modulators|tubulin modulators|mesh-ancestor
102261981|NCT02698891|Antimitotic Agents|antimitotic agents|mesh-ancestor
102261982|NCT02698891|Mitosis Modulators|mitosis modulators|mesh-ancestor
102261983|NCT02698891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261984|NCT04719065|Mitoxantrone|mitoxantrone|mesh-list
102261985|NCT04719065|Analgesics|analgesics|mesh-ancestor
102261986|NCT04719065|Sensory System Agents|sensory system agents|mesh-ancestor
102261987|NCT04719065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101816794|NCT00409006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102261988|NCT04719065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102261989|NCT04719065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102261990|NCT04719065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102261991|NCT04719065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102261992|NCT04719065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102261993|NCT04719065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102261994|NCT02399059|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102261995|NCT02399059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102261996|NCT05108051|Oseltamivir|oseltamivir|mesh-list
102261997|NCT05108051|Antiviral Agents|antiviral agents|mesh-ancestor
102261998|NCT05108051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102261999|NCT05108051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102262000|NCT05108051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262001|NCT03765359|Metformin|metformin|mesh-list
102262002|NCT03765359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102262003|NCT03765359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262004|NCT04351295|Chloroquine|chloroquine|mesh-list
102262005|NCT04351295|Favipiravir|favipiravir|mesh-list
102262006|NCT04351295|Amebicides|amebicides|mesh-ancestor
102262007|NCT04351295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102262008|NCT04351295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102262009|NCT04351295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102262010|NCT04351295|Antimalarials|antimalarials|mesh-ancestor
102262011|NCT04351295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102262012|NCT04351295|Antiviral Agents|antiviral agents|mesh-ancestor
102262013|NCT02399137|Paclitaxel|paclitaxel|mesh-list
102262014|NCT02399137|Gemcitabine|gemcitabine|mesh-list
102262015|NCT02399137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101816839|NCT05254808|Nitrofurantoin|nitrofurantoin|mesh-list
102262016|NCT02399137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102262017|NCT02399137|Tubulin Modulators|tubulin modulators|mesh-ancestor
102262018|NCT02399137|Antimitotic Agents|antimitotic agents|mesh-ancestor
102262019|NCT02399137|Mitosis Modulators|mitosis modulators|mesh-ancestor
102262020|NCT02399137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262021|NCT02399137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102262022|NCT02399137|Antimetabolites|antimetabolites|mesh-ancestor
102262023|NCT05093387|Carboplatin|carboplatin|mesh-list
102262024|NCT05093387|Pembrolizumab|pembrolizumab|mesh-list
102262025|NCT05093387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102262026|NCT05093387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102262027|NCT05093387|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102262028|NCT05093387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262029|NCT02407171|Pembrolizumab|pembrolizumab|mesh-list
102262030|NCT02407171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102262031|NCT02407171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102262032|NCT02407171|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102262033|NCT02407171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262034|NCT02850263|Aflibercept|aflibercept|mesh-list
102262035|NCT02850263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102262036|NCT02850263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102262037|NCT02850263|Growth Substances|growth substances|mesh-ancestor
102262038|NCT02850263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613778|NCT03375203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613779|NCT00002909|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
102262039|NCT02850263|Growth Inhibitors|growth inhibitors|mesh-ancestor
102262040|NCT02850263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102262041|NCT04481815|Rituximab|rituximab|mesh-list
102262042|NCT04481815|Methotrexate|methotrexate|mesh-list
102262043|NCT04481815|Lenalidomide|lenalidomide|mesh-list
102262044|NCT04481815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102262045|NCT04481815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102262046|NCT04481815|Immunologic Factors|immunologic factors|mesh-ancestor
102262047|NCT04481815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262048|NCT04481815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102262049|NCT04481815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102262050|NCT04481815|Abortifacient Agents|abortifacient agents|mesh-ancestor
102262051|NCT04481815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102262052|NCT04481815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102262053|NCT04481815|Antimetabolites|antimetabolites|mesh-ancestor
102262054|NCT04481815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262055|NCT04481815|Dermatologic Agents|dermatologic agents|mesh-ancestor
102262056|NCT04481815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102262057|NCT04481815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102262058|NCT04481815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102262059|NCT04481815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102262060|NCT04481815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102262061|NCT04481815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102262062|NCT04481815|Growth Substances|growth substances|mesh-ancestor
102262063|NCT04481815|Growth Inhibitors|growth inhibitors|mesh-ancestor
102262064|NCT05106803|Amoxicillin|amoxicillin|mesh-list
102262065|NCT05106803|Vancomycin|vancomycin|mesh-list
102262066|NCT05106803|Ciprofloxacin|ciprofloxacin|mesh-list
102262067|NCT05106803|Clindamycin|clindamycin|mesh-list
102262068|NCT05106803|Gentamicins|gentamicins|mesh-list
102262069|NCT05106803|Tetracycline|tetracycline|mesh-list
102262070|NCT05106803|Penicillins|penicillins|mesh-list
102262071|NCT05106803|Erythromycin|erythromycin|mesh-list
102262072|NCT05106803|Ampicillin|ampicillin|mesh-list
102262073|NCT05106803|Clavulanic Acids|clavulanic acids|mesh-list
102262074|NCT05106803|Clavulanic Acid|clavulanic acid|mesh-list
102262075|NCT05106803|Cefepime|cefepime|mesh-list
102262076|NCT05106803|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102262077|NCT05106803|Norfloxacin|norfloxacin|mesh-list
102262078|NCT05106803|Oxacillin|oxacillin|mesh-list
102262079|NCT05106803|Chloramphenicol|chloramphenicol|mesh-list
102262080|NCT05106803|Trimethoprim|trimethoprim|mesh-list
102262081|NCT05106803|Sulfamethoxazole|sulfamethoxazole|mesh-list
102262082|NCT05106803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102262083|NCT05106803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102262084|NCT05106803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102262085|NCT05106803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102262086|NCT05106803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102262087|NCT05106803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262088|NCT05106803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102262089|NCT05106803|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102262090|NCT05106803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102262091|NCT05106803|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102262092|NCT05106803|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102262093|NCT05106803|Antimalarials|antimalarials|mesh-ancestor
102262094|NCT05106803|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102262095|NCT05106803|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102262096|NCT05106803|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102262097|NCT05106803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102262098|NCT05106803|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102262099|NCT05106803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102262100|NCT05106803|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102262102|NCT02398357|Warfarin|warfarin|mesh-list
102262103|NCT02398357|Calcium|calcium|mesh-list
102262104|NCT02398357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102262105|NCT02398357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262106|NCT02398357|Anticoagulants|anticoagulants|mesh-ancestor
101816908|NCT00533702|Dacarbazine|dacarbazine|mesh-list
102262107|NCT02398357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102262108|NCT02398357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102262109|NCT02398357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262110|NCT02398201|Bezafibrate|bezafibrate|mesh-list
102262111|NCT02398201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102262112|NCT02398201|Antimetabolites|antimetabolites|mesh-ancestor
102613780|NCT00002909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102262113|NCT02398201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262114|NCT02398201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101270530|NCT01821248|Cisplatin|cisplatin|mesh-list
102262115|NCT05106179|Propranolol|propranolol|mesh-list
102262116|NCT05106179|Atenolol|atenolol|mesh-list
102262117|NCT05106179|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102262118|NCT05106179|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102262119|NCT05106179|Adrenergic Agents|adrenergic agents|mesh-ancestor
102262120|NCT05106179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102262121|NCT05106179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262122|NCT05106179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262123|NCT05106179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102262124|NCT05106179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102262125|NCT05106179|Vasodilator Agents|vasodilator agents|mesh-ancestor
102262126|NCT05106179|Sympatholytics|sympatholytics|mesh-ancestor
102262127|NCT05106179|Autonomic Agents|autonomic agents|mesh-ancestor
102262128|NCT05106179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101816945|NCT00999206|Vaccines|vaccines|mesh-list
102262129|NCT05106179|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102262130|NCT04670471|Remifentanil|remifentanil|mesh-list
102262131|NCT04670471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102262132|NCT04670471|Narcotics|narcotics|mesh-ancestor
102262133|NCT04670471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102262134|NCT04670471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262135|NCT04670471|Analgesics|analgesics|mesh-ancestor
102262136|NCT04670471|Sensory System Agents|sensory system agents|mesh-ancestor
102262137|NCT04670471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102262138|NCT02406781|Pembrolizumab|pembrolizumab|mesh-list
102262139|NCT02406781|Cyclophosphamide|cyclophosphamide|mesh-list
102262140|NCT02406781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102262141|NCT02406781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102262142|NCT02406781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102262143|NCT02406781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262144|NCT02406781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102262145|NCT02406781|Immunologic Factors|immunologic factors|mesh-ancestor
102262146|NCT02406781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262147|NCT02406781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102262148|NCT02406781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102262149|NCT02406781|Alkylating Agents|alkylating agents|mesh-ancestor
102262150|NCT02406781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102262151|NCT05106023|Temozolomide|temozolomide|mesh-list
102262152|NCT05106023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102262153|NCT05106023|Alkylating Agents|alkylating agents|mesh-ancestor
102262154|NCT05106023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262155|NCT05106023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102262156|NCT02398123|Bupivacaine|bupivacaine|mesh-list
102262157|NCT02398123|Anesthetics, Local|anesthetics, local|mesh-ancestor
102262158|NCT02398123|Anesthetics|anesthetics|mesh-ancestor
102262159|NCT02398123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102262160|NCT02398123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262161|NCT02398123|Sensory System Agents|sensory system agents|mesh-ancestor
102262162|NCT02398123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102262163|NCT02404363|Clopidogrel|clopidogrel|mesh-list
102262164|NCT02404363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102262165|NCT02404363|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102262166|NCT02404363|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102262167|NCT02404363|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102262169|NCT02404363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102262170|NCT02404363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262171|NCT02404363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262172|NCT02404519|Vitamin K 2|vitamin k 2|mesh-list
102262173|NCT02404519|Vitamin K|vitamin k|mesh-list
102262174|NCT02404519|Menaquinone 7|menaquinone 7|mesh-list
102262175|NCT02404519|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102262176|NCT02404519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102262177|NCT02404519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262178|NCT02404519|Hemostatics|hemostatics|mesh-ancestor
102262179|NCT02404519|Coagulants|coagulants|mesh-ancestor
102262180|NCT02404519|Vitamins|vitamins|mesh-ancestor
102262181|NCT02404519|Micronutrients|micronutrients|mesh-ancestor
102262182|NCT02404519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262183|NCT03173131|Analgesics, Opioid|analgesics, opioid|mesh-list
102262184|NCT03173131|Narcotics|narcotics|mesh-ancestor
102262185|NCT03173131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102262186|NCT03173131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262187|NCT03173131|Analgesics|analgesics|mesh-ancestor
102262188|NCT03173131|Sensory System Agents|sensory system agents|mesh-ancestor
102262189|NCT03173131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102262190|NCT04524611|Ustekinumab|ustekinumab|mesh-list
102262191|NCT04524611|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102262192|NCT04524611|Dermatologic Agents|dermatologic agents|mesh-ancestor
102262193|NCT04524611|Immunologic Factors|immunologic factors|mesh-ancestor
102262194|NCT04524611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262195|NCT02658149|Ketorolac|ketorolac|mesh-list
102262196|NCT02658149|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102262197|NCT02658149|Epinephrine|epinephrine|mesh-list
102262198|NCT02658149|Morphine|morphine|mesh-list
102262199|NCT02658149|Ropivacaine|ropivacaine|mesh-list
102262200|NCT02658149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102262201|NCT02658149|Narcotics|narcotics|mesh-ancestor
102262202|NCT02658149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102262203|NCT02658149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262204|NCT02658149|Analgesics|analgesics|mesh-ancestor
102262205|NCT02658149|Sensory System Agents|sensory system agents|mesh-ancestor
102262206|NCT02658149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102262207|NCT02658149|Anesthetics, Local|anesthetics, local|mesh-ancestor
102262208|NCT02658149|Anesthetics|anesthetics|mesh-ancestor
102262209|NCT02658149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102262210|NCT02658149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102262211|NCT02658149|Adrenergic Agents|adrenergic agents|mesh-ancestor
102262212|NCT02658149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102262213|NCT02658149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262214|NCT02658149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102262215|NCT02658149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102262216|NCT02658149|Autonomic Agents|autonomic agents|mesh-ancestor
102262217|NCT02658149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102262218|NCT02658149|Respiratory System Agents|respiratory system agents|mesh-ancestor
102262219|NCT02658149|Mydriatics|mydriatics|mesh-ancestor
102262220|NCT02658149|Sympathomimetics|sympathomimetics|mesh-ancestor
102262221|NCT02658149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102262222|NCT02658149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102262223|NCT02658149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102262224|NCT02658149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102262225|NCT02658149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102262226|NCT02658149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102262227|NCT02658149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102262228|NCT04481971|Prednisolone|prednisolone|mesh-list
102262229|NCT04481971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102262230|NCT04481971|Glucocorticoids|glucocorticoids|mesh-ancestor
102262231|NCT04481971|Hormones|hormones|mesh-ancestor
102262232|NCT04481971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102262233|NCT04481971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262234|NCT04481971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102262235|NCT04481971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102262236|NCT03172741|Dronabinol|dronabinol|mesh-list
102262237|NCT03172741|Cannabidiol|cannabidiol|mesh-list
102262238|NCT03172741|Anticonvulsants|anticonvulsants|mesh-ancestor
102262239|NCT03172741|Hallucinogens|hallucinogens|mesh-ancestor
101971119|NCT04844918|Hormones|hormones|mesh-ancestor
102262240|NCT03172741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262241|NCT03172741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102262242|NCT03172741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102262243|NCT03172741|Analgesics|analgesics|mesh-ancestor
102262244|NCT03172741|Sensory System Agents|sensory system agents|mesh-ancestor
102262245|NCT03172741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102262246|NCT03172741|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102262247|NCT03172741|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102262248|NCT03172741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102262249|NCT03172741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262250|NCT03172741|Hormones|hormones|mesh-ancestor
102262251|NCT03172741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102262252|NCT02702011|Empagliflozin|empagliflozin|mesh-list
102262253|NCT02702011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102262254|NCT02702011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262255|NCT02702011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102262256|NCT02702011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262257|NCT03170713|Ibuprofen|ibuprofen|mesh-list
102262258|NCT03170713|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
102262259|NCT03170713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102262260|NCT03170713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102262261|NCT03170713|Analgesics|analgesics|mesh-ancestor
102613781|NCT00002915|Penclomedine|penclomedine|mesh-list
102262262|NCT03170713|Sensory System Agents|sensory system agents|mesh-ancestor
102262263|NCT03170713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102262264|NCT03170713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262265|NCT03170713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102262266|NCT03170713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102262267|NCT03170713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102262268|NCT03170713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102262269|NCT03170713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262270|NCT02657369|Lenvatinib|lenvatinib|mesh-list
102262271|NCT02657369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102262272|NCT02657369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102262273|NCT02657369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102262274|NCT02657369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262275|NCT02397421|Dapagliflozin|dapagliflozin|mesh-list
102262276|NCT02397421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102262277|NCT02397421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262278|NCT02397421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102262279|NCT02397421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817092|NCT00054691|Gefitinib|gefitinib|mesh-list
102262280|NCT04832009|Ascorbic Acid|ascorbic acid|mesh-list
102262281|NCT04832009|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102262282|NCT04832009|Antioxidants|antioxidants|mesh-ancestor
102262283|NCT04832009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262284|NCT04832009|Protective Agents|protective agents|mesh-ancestor
102262285|NCT04832009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262286|NCT04832009|Vitamins|vitamins|mesh-ancestor
102262287|NCT04832009|Micronutrients|micronutrients|mesh-ancestor
102262288|NCT04832009|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102262289|NCT04832009|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102262290|NCT04832009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102262291|NCT03129113|Metformin|metformin|mesh-list
102262292|NCT03129113|Maraviroc|maraviroc|mesh-list
102262293|NCT03129113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102262294|NCT03129113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262295|NCT03129113|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102262296|NCT03129113|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102262297|NCT03129113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262298|NCT03129113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102262299|NCT03129113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102262300|NCT03129113|Antiviral Agents|antiviral agents|mesh-ancestor
102262301|NCT03129113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102262302|NCT03129113|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102262303|NCT05105009|Furosemide|furosemide|mesh-list
102262304|NCT05105009|Diuretics|diuretics|mesh-ancestor
102262305|NCT05105009|Natriuretic Agents|natriuretic agents|mesh-ancestor
102262306|NCT05105009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262307|NCT05105009|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102262308|NCT05105009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102262309|NCT05105009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262310|NCT05104931|Piroxicam|piroxicam|mesh-list
102262311|NCT05104931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102262312|NCT05104931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102262313|NCT05104931|Analgesics|analgesics|mesh-ancestor
102262314|NCT05104931|Sensory System Agents|sensory system agents|mesh-ancestor
102262315|NCT05104931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102262316|NCT05104931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262317|NCT05104931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102262318|NCT05104931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102262319|NCT05104931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102262320|NCT05104931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102262321|NCT05104931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262322|NCT02397499|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102262323|NCT02397499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102262324|NCT02397499|Autonomic Agents|autonomic agents|mesh-ancestor
102262325|NCT02397499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102262326|NCT02397499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262327|NCT02397499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102262328|NCT02397499|Respiratory System Agents|respiratory system agents|mesh-ancestor
102262329|NCT02397499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102262330|NCT02397499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102262331|NCT02397499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102262332|NCT02397499|Adrenergic Agents|adrenergic agents|mesh-ancestor
102262333|NCT02397499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102262334|NCT02397499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262335|NCT02406703|Mepivacaine|mepivacaine|mesh-list
102613782|NCT00002915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613783|NCT00002921|Suramin|suramin|mesh-list
102262336|NCT02406703|Chloroprocaine|chloroprocaine|mesh-list
102262337|NCT02406703|Anesthetics, Local|anesthetics, local|mesh-ancestor
102262338|NCT02406703|Anesthetics|anesthetics|mesh-ancestor
102262339|NCT02406703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102262340|NCT02406703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262341|NCT02406703|Sensory System Agents|sensory system agents|mesh-ancestor
102262342|NCT02406703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102262343|NCT02682641|Rituximab|rituximab|mesh-list
102262344|NCT02682641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102262345|NCT02682641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102262346|NCT02682641|Immunologic Factors|immunologic factors|mesh-ancestor
102262347|NCT02682641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262348|NCT02682641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102262349|NCT05110469|Magnesium Sulfate|magnesium sulfate|mesh-list
102262350|NCT05110469|Meperidine|meperidine|mesh-list
102262351|NCT05110469|Analgesics|analgesics|mesh-ancestor
102262352|NCT05110469|Sensory System Agents|sensory system agents|mesh-ancestor
102262353|NCT05110469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102262354|NCT05110469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262355|NCT05110469|Anesthetics|anesthetics|mesh-ancestor
102262356|NCT05110469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102262357|NCT05110469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102262358|NCT05110469|Anticonvulsants|anticonvulsants|mesh-ancestor
102262359|NCT05110469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102262360|NCT05110469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102262361|NCT05110469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262362|NCT05110469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102262363|NCT05110469|Tocolytic Agents|tocolytic agents|mesh-ancestor
102262364|NCT05110469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102262365|NCT05110469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102262366|NCT05110469|Narcotics|narcotics|mesh-ancestor
102262367|NCT05110469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102262368|NCT02404051|Everolimus|everolimus|mesh-list
102262369|NCT02404051|Fulvestrant|fulvestrant|mesh-list
102262370|NCT02404051|Exemestane|exemestane|mesh-list
102262371|NCT02404051|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102262372|NCT02404051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102262373|NCT02404051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102262374|NCT02404051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262375|NCT02404051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102262376|NCT02404051|Immunologic Factors|immunologic factors|mesh-ancestor
102262377|NCT02404051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262378|NCT02404051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102262379|NCT02404051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102262380|NCT02404051|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102262381|NCT02404051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102262382|NCT02404051|Hormone Antagonists|hormone antagonists|mesh-ancestor
102262383|NCT02404051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102262384|NCT02404051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102262385|NCT02404051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102262386|NCT05101109|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102262387|NCT05101109|Immunologic Factors|immunologic factors|mesh-ancestor
102262388|NCT05101109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262389|NCT05094323|Bupivacaine|bupivacaine|mesh-list
102262390|NCT05094323|Anesthetics, Local|anesthetics, local|mesh-ancestor
102262391|NCT05094323|Anesthetics|anesthetics|mesh-ancestor
102262392|NCT05094323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102262393|NCT05094323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262394|NCT05094323|Sensory System Agents|sensory system agents|mesh-ancestor
101817188|NCT00072475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102262395|NCT05094323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102262396|NCT03170323|Cyclosporine|cyclosporine|mesh-list
102262397|NCT03170323|Mycophenolic Acid|mycophenolic acid|mesh-list
102262398|NCT03170323|Cyclosporins|cyclosporins|mesh-list
102262399|NCT03170323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102262400|NCT03170323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262401|NCT03170323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102262402|NCT03170323|Immunologic Factors|immunologic factors|mesh-ancestor
102262403|NCT03170323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262404|NCT03170323|Antifungal Agents|antifungal agents|mesh-ancestor
102262405|NCT03170323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102262406|NCT03170323|Dermatologic Agents|dermatologic agents|mesh-ancestor
102262407|NCT03170323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101817200|NCT00066469|Rituximab|rituximab|mesh-list
102262408|NCT03170323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102262409|NCT03170323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102262410|NCT03170323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102262411|NCT03170323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102613785|NCT00002921|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102262412|NCT03170323|Antitubercular Agents|antitubercular agents|mesh-ancestor
102262413|NCT03170323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102262415|NCT02396563|Anesthetics, Local|anesthetics, local|mesh-ancestor
102262416|NCT02396563|Anesthetics|anesthetics|mesh-ancestor
102262417|NCT02396563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102262418|NCT02396563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262419|NCT02396563|Sensory System Agents|sensory system agents|mesh-ancestor
102262420|NCT02396563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102262421|NCT05109377|Tadalafil|tadalafil|mesh-list
102262422|NCT05109377|Vasodilator Agents|vasodilator agents|mesh-ancestor
102262423|NCT05109377|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102262424|NCT05109377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102262425|NCT05109377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102262426|NCT05109377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262427|NCT05109377|Urological Agents|urological agents|mesh-ancestor
102262428|NCT05109299|Fluorides|fluorides|mesh-list
102262429|NCT05109299|Cariostatic Agents|cariostatic agents|mesh-ancestor
102262430|NCT05109299|Protective Agents|protective agents|mesh-ancestor
102262431|NCT05109299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262432|NCT05108597|Misoprostol|misoprostol|mesh-list
102262433|NCT05108597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102262434|NCT05108597|Abortifacient Agents|abortifacient agents|mesh-ancestor
102262435|NCT05108597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102262436|NCT05108597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262437|NCT05108597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102262438|NCT05108597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102262439|NCT05108597|Oxytocics|oxytocics|mesh-ancestor
102262440|NCT02396329|Chlorhexidine|chlorhexidine|mesh-list
102262441|NCT02396329|Povidone-Iodine|povidone-iodine|mesh-list
102262442|NCT02396329|Povidone|povidone|mesh-list
102262443|NCT02396329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102262444|NCT02396329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102262445|NCT02396329|Disinfectants|disinfectants|mesh-ancestor
102262446|NCT02396329|Plasma Substitutes|plasma substitutes|mesh-ancestor
102262447|NCT02396329|Blood Substitutes|blood substitutes|mesh-ancestor
102262448|NCT03168139|Pembrolizumab|pembrolizumab|mesh-list
102262449|NCT03168139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102262450|NCT03168139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102262451|NCT03168139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102262452|NCT03168139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262453|NCT02395783|Melatonin|melatonin|mesh-list
102262454|NCT02395783|Antioxidants|antioxidants|mesh-ancestor
102262455|NCT02395783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262456|NCT02395783|Protective Agents|protective agents|mesh-ancestor
102262457|NCT02395783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262458|NCT02395783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102262459|NCT04555343|Tranexamic Acid|tranexamic acid|mesh-list
102262460|NCT04555343|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102262461|NCT04555343|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102262462|NCT04555343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262463|NCT04555343|Hemostatics|hemostatics|mesh-ancestor
102262464|NCT04555343|Coagulants|coagulants|mesh-ancestor
102262465|NCT04528667|Abivertinib|abivertinib|mesh-list
102262466|NCT04528667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102262467|NCT04528667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262468|NCT04528667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102262469|NCT04383119|Gemcitabine|gemcitabine|mesh-list
101817253|NCT01095211|Vitamins|vitamins|mesh-ancestor
102262470|NCT04383119|Trabectedin|trabectedin|mesh-list
102262471|NCT04383119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102262472|NCT04383119|Antimetabolites|antimetabolites|mesh-ancestor
102262473|NCT04383119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262474|NCT04383119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102262475|NCT04383119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102262476|NCT04383119|Alkylating Agents|alkylating agents|mesh-ancestor
102262477|NCT04522739|Spironolactone|spironolactone|mesh-list
102262478|NCT04522739|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102262479|NCT04522739|Hormone Antagonists|hormone antagonists|mesh-ancestor
101817257|NCT01089985|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102262480|NCT04522739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102262481|NCT04522739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613786|NCT00002921|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102613787|NCT00002921|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102262482|NCT04522739|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102262484|NCT04522739|Natriuretic Agents|natriuretic agents|mesh-ancestor
102262485|NCT04309877|Theophylline|theophylline|mesh-list
102262486|NCT04309877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102262487|NCT04309877|Autonomic Agents|autonomic agents|mesh-ancestor
102262488|NCT04309877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102262489|NCT04309877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262490|NCT04309877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102262491|NCT04309877|Respiratory System Agents|respiratory system agents|mesh-ancestor
102262492|NCT04309877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102262493|NCT04309877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102262494|NCT04309877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262495|NCT04309877|Vasodilator Agents|vasodilator agents|mesh-ancestor
102262496|NCT04309877|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102262497|NCT04309877|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102262498|NCT04309877|Purinergic Agents|purinergic agents|mesh-ancestor
102262499|NCT04309877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102262500|NCT04367909|Carboplatin|carboplatin|mesh-list
102262501|NCT04367909|Docetaxel|docetaxel|mesh-list
102262502|NCT04367909|Nimotuzumab|nimotuzumab|mesh-list
102262503|NCT04367909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102262504|NCT04367909|Tubulin Modulators|tubulin modulators|mesh-ancestor
102262505|NCT04367909|Antimitotic Agents|antimitotic agents|mesh-ancestor
102262506|NCT04367909|Mitosis Modulators|mitosis modulators|mesh-ancestor
102262507|NCT04367909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262508|NCT04367909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102262509|NCT04058873|Levonorgestrel|levonorgestrel|mesh-list
102262510|NCT04058873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102262511|NCT04058873|Contraceptive Agents|contraceptive agents|mesh-ancestor
102262512|NCT04058873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101817268|NCT00387010|Analgesics|analgesics|mesh-ancestor
102262513|NCT04058873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262514|NCT04058873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102262515|NCT04058873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102262516|NCT04058873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102262517|NCT04196075|Andrographolide|andrographolide|mesh-list
101271832|NCT01836614|Lidocaine|lidocaine|mesh-list
102262518|NCT04196075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102262519|NCT04196075|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102262520|NCT04196075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102262521|NCT04196075|Analgesics|analgesics|mesh-ancestor
102262522|NCT04196075|Sensory System Agents|sensory system agents|mesh-ancestor
102262523|NCT04196075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102262524|NCT04196075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262525|NCT04196075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102262526|NCT04196075|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102262527|NCT04196075|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102262528|NCT04196075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102262529|NCT04196075|Antiviral Agents|antiviral agents|mesh-ancestor
102262530|NCT04196075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102262531|NCT03863483|Docetaxel|docetaxel|mesh-list
102262532|NCT03863483|Pemetrexed|pemetrexed|mesh-list
102262533|NCT03863483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102262534|NCT03863483|Tubulin Modulators|tubulin modulators|mesh-ancestor
102262535|NCT03863483|Antimitotic Agents|antimitotic agents|mesh-ancestor
101971422|NCT04310930|Clofazimine|clofazimine|mesh-list
102262537|NCT03863483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262538|NCT03863483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102262539|NCT03863483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102262540|NCT03863483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102262541|NCT03830411|Docetaxel|docetaxel|mesh-list
102262542|NCT03830411|Pemetrexed|pemetrexed|mesh-list
102262543|NCT03830411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102262544|NCT03830411|Tubulin Modulators|tubulin modulators|mesh-ancestor
102262545|NCT03830411|Antimitotic Agents|antimitotic agents|mesh-ancestor
102262546|NCT03830411|Mitosis Modulators|mitosis modulators|mesh-ancestor
102262547|NCT03830411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262548|NCT03830411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102262549|NCT03830411|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102262550|NCT03830411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102262551|NCT03300479|Urapidil|urapidil|mesh-list
102262552|NCT03300479|Clevidipine|clevidipine|mesh-list
102262553|NCT03300479|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102262554|NCT03300479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102262555|NCT03300479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262556|NCT03300479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102613788|NCT00002921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102262557|NCT03300479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817308|NCT03955705|Nefopam|nefopam|mesh-list
102262558|NCT03300479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102262559|NCT03300479|Vasodilator Agents|vasodilator agents|mesh-ancestor
102262560|NCT03300479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102262561|NCT03300479|Serotonin Agents|serotonin agents|mesh-ancestor
102262562|NCT03300479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102262563|NCT03300479|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102262564|NCT03300479|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102262565|NCT03300479|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102262566|NCT03300479|Adrenergic Agents|adrenergic agents|mesh-ancestor
102262567|NCT03012425|Hydrocortisone|hydrocortisone|mesh-list
102262568|NCT03012425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102262569|NCT03540875|Remifentanil|remifentanil|mesh-list
102262570|NCT03540875|Propofol|propofol|mesh-list
102262571|NCT03540875|Anesthetics|anesthetics|mesh-ancestor
102262572|NCT03540875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102262573|NCT03540875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262574|NCT03540875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102262575|NCT03540875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102262576|NCT03540875|Anesthetics, General|anesthetics, general|mesh-ancestor
102262577|NCT03540875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102262578|NCT03540875|Narcotics|narcotics|mesh-ancestor
102262579|NCT03540875|Analgesics|analgesics|mesh-ancestor
102262580|NCT03540875|Sensory System Agents|sensory system agents|mesh-ancestor
102262581|NCT03540875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102262582|NCT03536507|Acetazolamide|acetazolamide|mesh-list
102262583|NCT03536507|Anticonvulsants|anticonvulsants|mesh-ancestor
102262584|NCT03536507|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102262585|NCT03536507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102262586|NCT03536507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262587|NCT03536507|Diuretics|diuretics|mesh-ancestor
102262588|NCT03536507|Natriuretic Agents|natriuretic agents|mesh-ancestor
102262589|NCT03536507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262590|NCT04765787|Acetaminophen|acetaminophen|mesh-list
102262591|NCT04765787|Orphenadrine|orphenadrine|mesh-list
102262592|NCT04765787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102262593|NCT04765787|Analgesics|analgesics|mesh-ancestor
102262594|NCT04765787|Sensory System Agents|sensory system agents|mesh-ancestor
102262595|NCT04765787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102262596|NCT04765787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262597|NCT04765787|Antipyretics|antipyretics|mesh-ancestor
102262598|NCT04765787|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102262599|NCT04765787|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102262600|NCT04765787|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102262601|NCT04765787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102262602|NCT04765787|Parasympatholytics|parasympatholytics|mesh-ancestor
102262603|NCT04765787|Autonomic Agents|autonomic agents|mesh-ancestor
102262604|NCT04765787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102262605|NCT04765787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102262606|NCT04765787|Cholinergic Agents|cholinergic agents|mesh-ancestor
102262607|NCT04765787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102262608|NCT04765787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262609|NCT04765787|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
101971497|NCT04047628|Immunologic Factors|immunologic factors|mesh-ancestor
102262610|NCT04765787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102262611|NCT04765787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102262612|NCT02944799|Vitamin D|vitamin d|mesh-list
102262613|NCT02944799|Alendronate|alendronate|mesh-list
102262614|NCT02944799|Calcium|calcium|mesh-list
102262615|NCT02944799|Vitamins|vitamins|mesh-ancestor
102262616|NCT02944799|Micronutrients|micronutrients|mesh-ancestor
102262617|NCT02944799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262618|NCT02944799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102262619|NCT02944799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102262620|NCT05115149|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
102262621|NCT05115149|Antioxidants|antioxidants|mesh-ancestor
102262622|NCT05115149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262623|NCT05115149|Protective Agents|protective agents|mesh-ancestor
102262624|NCT05115149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262625|NCT05115149|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102262626|NCT05115149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102262627|NCT04638803|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
102262628|NCT04638803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613789|NCT00002921|Antinematodal Agents|antinematodal agents|mesh-ancestor
102262629|NCT04592783|Antihypertensive Agents|antihypertensive agents|mesh-list
102262630|NCT04521881|Tranexamic Acid|tranexamic acid|mesh-list
101817377|NCT00385762|Paroxetine|paroxetine|mesh-list
102262631|NCT04521881|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102262632|NCT04521881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102262633|NCT04521881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262634|NCT04521881|Hemostatics|hemostatics|mesh-ancestor
102262635|NCT04521881|Coagulants|coagulants|mesh-ancestor
102262636|NCT04305899|Deucravacitinib|deucravacitinib|mesh-list
102262637|NCT04305899|Dermatologic Agents|dermatologic agents|mesh-ancestor
102262638|NCT04305899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102262639|NCT04305899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102262640|NCT04305899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262641|NCT01675661|Acetylcysteine|acetylcysteine|mesh-list
102262642|NCT01675661|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101817393|NCT00385684|Acetaminophen|acetaminophen|mesh-list
102262643|NCT01675661|Antiviral Agents|antiviral agents|mesh-ancestor
102262644|NCT01675661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102262645|NCT01675661|Expectorants|expectorants|mesh-ancestor
102262646|NCT01675661|Respiratory System Agents|respiratory system agents|mesh-ancestor
102262647|NCT01675661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102262648|NCT01675661|Antioxidants|antioxidants|mesh-ancestor
102262649|NCT01675661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262650|NCT01675661|Protective Agents|protective agents|mesh-ancestor
102262651|NCT01675661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262652|NCT01675661|Antidotes|antidotes|mesh-ancestor
102262653|NCT05113511|Bevacizumab|bevacizumab|mesh-list
102262654|NCT05113511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102262655|NCT05113511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102262656|NCT05113511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102262657|NCT05113511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102262658|NCT05113511|Growth Substances|growth substances|mesh-ancestor
102262659|NCT05113511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262660|NCT05113511|Growth Inhibitors|growth inhibitors|mesh-ancestor
102262661|NCT03169985|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102262662|NCT03169985|Ezetimibe|ezetimibe|mesh-list
102262663|NCT03169985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102262664|NCT03169985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102262665|NCT03169985|Antimetabolites|antimetabolites|mesh-ancestor
102262666|NCT03169985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262667|NCT03169985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102262668|NCT03169985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102262669|NCT03169985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102262670|NCT04161989|Progesterone|progesterone|mesh-list
102262671|NCT04161989|Progestins|progestins|mesh-ancestor
102262672|NCT04161989|Hormones|hormones|mesh-ancestor
102262673|NCT04161989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102262674|NCT04161989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262675|NCT01986010|Aluminum phosphate|aluminum phosphate|mesh-list
102262676|NCT01986010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102262677|NCT01986010|Immunologic Factors|immunologic factors|mesh-ancestor
102262678|NCT01986010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262679|NCT01986010|Antacids|antacids|mesh-ancestor
102262680|NCT01986010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262681|NCT01986010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102262682|NCT04160117|Colchicine|colchicine|mesh-list
102262683|NCT04160117|Gout Suppressants|gout suppressants|mesh-ancestor
102262684|NCT04160117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102262685|NCT04160117|Tubulin Modulators|tubulin modulators|mesh-ancestor
102262686|NCT04160117|Antimitotic Agents|antimitotic agents|mesh-ancestor
101312362|NCT00006229|Carboplatin|carboplatin|mesh-list
102262687|NCT04160117|Mitosis Modulators|mitosis modulators|mesh-ancestor
102262688|NCT04160117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262689|NCT04160117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102262690|NCT04414631|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
102262691|NCT04414631|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102262692|NCT04414631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102262693|NCT04414631|Immunologic Factors|immunologic factors|mesh-ancestor
102262694|NCT04414631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262695|NCT03115255|Ranibizumab|ranibizumab|mesh-list
102262696|NCT03115255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102262697|NCT03115255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102262698|NCT03115255|Growth Substances|growth substances|mesh-ancestor
102262699|NCT03115255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262700|NCT03115255|Growth Inhibitors|growth inhibitors|mesh-ancestor
102262701|NCT03115255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102262702|NCT02009878|Tolvaptan|tolvaptan|mesh-list
102262703|NCT02009878|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102613790|NCT00002921|Anthelmintics|anthelmintics|mesh-ancestor
102613791|NCT00002921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102262704|NCT02009878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262705|NCT02009878|Natriuretic Agents|natriuretic agents|mesh-ancestor
102262706|NCT02009878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262707|NCT02009722|Morphine|morphine|mesh-list
102262708|NCT02009722|Hydromorphone|hydromorphone|mesh-list
102262709|NCT02009722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102262710|NCT02009722|Narcotics|narcotics|mesh-ancestor
102262711|NCT02009722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102262712|NCT02009722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262713|NCT02009722|Analgesics|analgesics|mesh-ancestor
102262714|NCT02009722|Sensory System Agents|sensory system agents|mesh-ancestor
102262715|NCT02009722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102262716|NCT02655419|Metronidazole|metronidazole|mesh-list
102262717|NCT02655419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102262718|NCT02655419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102262719|NCT02655419|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102262720|NCT02655419|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102262721|NCT01962922|Tacrolimus|tacrolimus|mesh-list
102262722|NCT01962922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102262723|NCT01962922|Immunologic Factors|immunologic factors|mesh-ancestor
101817454|NCT01096927|Clavulanic Acid|clavulanic acid|mesh-list
102262724|NCT01962922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262725|NCT01962922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102262726|NCT01962922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102262727|NCT01962922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262728|NCT04198961|Analgesics, Opioid|analgesics, opioid|mesh-list
102262729|NCT04198961|Narcotics|narcotics|mesh-ancestor
102262730|NCT04198961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102262731|NCT04198961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262732|NCT04198961|Analgesics|analgesics|mesh-ancestor
102262733|NCT04198961|Sensory System Agents|sensory system agents|mesh-ancestor
102262734|NCT04198961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102262735|NCT01984684|Vancomycin|vancomycin|mesh-list
102262736|NCT01984684|Aztreonam|aztreonam|mesh-list
102262737|NCT01984684|Delafloxacin|delafloxacin|mesh-list
102262738|NCT01984684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102262739|NCT01984684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102262740|NCT02694523|Adalimumab|adalimumab|mesh-list
102262741|NCT02694523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102262742|NCT02694523|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102262743|NCT02694523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102262744|NCT02694523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102262745|NCT02694523|Immunologic Factors|immunologic factors|mesh-ancestor
102262746|NCT02694523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262747|NCT05038475|Antibodies|antibodies|mesh-list
102262748|NCT05038475|Immunologic Factors|immunologic factors|mesh-ancestor
102262749|NCT05038475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262750|NCT02009332|Sirolimus|sirolimus|mesh-list
102262751|NCT02009332|Gemcitabine|gemcitabine|mesh-list
102262752|NCT02009332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102262753|NCT02009332|Antimetabolites|antimetabolites|mesh-ancestor
102262754|NCT02009332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262755|NCT02009332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102262756|NCT02009332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102262757|NCT02009332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102262758|NCT02009332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102262759|NCT02009332|Antifungal Agents|antifungal agents|mesh-ancestor
102262760|NCT02009332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102262761|NCT02009332|Immunologic Factors|immunologic factors|mesh-ancestor
102262762|NCT02009332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262763|NCT04518293|Amlodipine|amlodipine|mesh-list
102262764|NCT04518293|Telmisartan|telmisartan|mesh-list
102262765|NCT04518293|Indapamide|indapamide|mesh-list
101817491|NCT00570323|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102262766|NCT04518293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102262767|NCT04518293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102262768|NCT04518293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102262769|NCT04518293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262770|NCT04518293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102262771|NCT04518293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262772|NCT04518293|Vasodilator Agents|vasodilator agents|mesh-ancestor
102262773|NCT04518293|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102262774|NCT04518293|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102613792|NCT00002921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102262775|NCT04518293|Diuretics|diuretics|mesh-ancestor
102613793|NCT00002921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102262776|NCT04518293|Natriuretic Agents|natriuretic agents|mesh-ancestor
102262777|NCT04518293|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102262779|NCT01984294|Antiviral Agents|antiviral agents|mesh-ancestor
102262780|NCT01984294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102262781|NCT01984294|Antimetabolites|antimetabolites|mesh-ancestor
102262782|NCT01984294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262783|NCT03170479|Vitamin D|vitamin d|mesh-list
102262784|NCT03170479|Vitamins|vitamins|mesh-ancestor
102262785|NCT03170479|Micronutrients|micronutrients|mesh-ancestor
102262786|NCT03170479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262787|NCT03170479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102262788|NCT01962298|Rocuronium|rocuronium|mesh-list
102262789|NCT01962298|Neostigmine|neostigmine|mesh-list
102262790|NCT01962298|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102262791|NCT01962298|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102262792|NCT01962298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102262793|NCT01962298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101817522|NCT00795587|Natriuretic Agents|natriuretic agents|mesh-ancestor
102262794|NCT01962298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262795|NCT01962298|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102262796|NCT01962298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102262797|NCT01962298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262798|NCT01962298|Cholinergic Agents|cholinergic agents|mesh-ancestor
102262799|NCT01962298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102262800|NCT01962298|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102262801|NCT01962298|Autonomic Agents|autonomic agents|mesh-ancestor
102262802|NCT03169933|Androgens|androgens|mesh-list
102262803|NCT03169933|Hormones|hormones|mesh-ancestor
101817532|NCT00795899|Epirubicin|epirubicin|mesh-list
102262804|NCT03169933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102262805|NCT03169933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262806|NCT04416334|Acetaminophen|acetaminophen|mesh-list
102262807|NCT04416334|Colchicine|colchicine|mesh-list
102262808|NCT04416334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102262809|NCT04416334|Analgesics|analgesics|mesh-ancestor
102262810|NCT04416334|Sensory System Agents|sensory system agents|mesh-ancestor
102262811|NCT04416334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102262812|NCT04416334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262813|NCT04416334|Antipyretics|antipyretics|mesh-ancestor
102262814|NCT04416334|Gout Suppressants|gout suppressants|mesh-ancestor
102262815|NCT04416334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102262816|NCT04416334|Tubulin Modulators|tubulin modulators|mesh-ancestor
102262817|NCT04416334|Antimitotic Agents|antimitotic agents|mesh-ancestor
102262818|NCT04416334|Mitosis Modulators|mitosis modulators|mesh-ancestor
102262819|NCT04416334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262820|NCT04416334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102262821|NCT02403349|Atenolol|atenolol|mesh-list
102262822|NCT02403349|Valsartan|valsartan|mesh-list
102262823|NCT02403349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102262824|NCT02403349|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101817550|NCT00795899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102262825|NCT02403349|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102262826|NCT02403349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262827|NCT02403349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102262828|NCT02403349|Sympatholytics|sympatholytics|mesh-ancestor
102262829|NCT02403349|Autonomic Agents|autonomic agents|mesh-ancestor
102262830|NCT02403349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102262831|NCT02403349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262832|NCT02403349|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102262833|NCT02403349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102262834|NCT02403349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102262835|NCT02403349|Adrenergic Agents|adrenergic agents|mesh-ancestor
102262836|NCT02403349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102262838|NCT04735822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102262839|NCT04735822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102262840|NCT04735822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262841|NCT01984138|Estradiol|estradiol|mesh-list
102262842|NCT01984138|Estrogens|estrogens|mesh-ancestor
102262843|NCT01984138|Hormones|hormones|mesh-ancestor
102262844|NCT01984138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102262845|NCT01984138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262846|NCT01982812|Levetiracetam|levetiracetam|mesh-list
102262847|NCT01982812|Anticonvulsants|anticonvulsants|mesh-ancestor
102262848|NCT01982812|Nootropic Agents|nootropic agents|mesh-ancestor
102262849|NCT02007070|Pembrolizumab|pembrolizumab|mesh-list
102613794|NCT00002921|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102262850|NCT02007070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102262851|NCT02007070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613795|NCT00002921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102262852|NCT02007070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102262853|NCT02007070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262854|NCT03906617|Dexamethasone|dexamethasone|mesh-list
102262855|NCT03906617|Epinephrine|epinephrine|mesh-list
102262856|NCT03906617|Bupivacaine|bupivacaine|mesh-list
102262857|NCT03906617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102262858|NCT03906617|Antiemetics|antiemetics|mesh-ancestor
102262859|NCT03906617|Autonomic Agents|autonomic agents|mesh-ancestor
101817585|NCT00050011|Letrozole|letrozole|mesh-list
102262860|NCT03906617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102262861|NCT03906617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262862|NCT03906617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102262863|NCT03906617|Glucocorticoids|glucocorticoids|mesh-ancestor
102262864|NCT03906617|Hormones|hormones|mesh-ancestor
102262865|NCT03906617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102262866|NCT03906617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102262867|NCT03906617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102262868|NCT03906617|Anesthetics, Local|anesthetics, local|mesh-ancestor
102262869|NCT03906617|Anesthetics|anesthetics|mesh-ancestor
102262870|NCT03906617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102262871|NCT03906617|Sensory System Agents|sensory system agents|mesh-ancestor
102262872|NCT03906617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102262873|NCT03906617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102262874|NCT03906617|Adrenergic Agents|adrenergic agents|mesh-ancestor
101817607|NCT01092481|Oxaliplatin|oxaliplatin|mesh-list
102262875|NCT03906617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102262876|NCT03906617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262877|NCT03906617|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102262878|NCT03906617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102262879|NCT03906617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102262880|NCT03906617|Respiratory System Agents|respiratory system agents|mesh-ancestor
102262881|NCT03906617|Mydriatics|mydriatics|mesh-ancestor
102262882|NCT03906617|Sympathomimetics|sympathomimetics|mesh-ancestor
102262883|NCT03906617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101817609|NCT00035815|Mitogens|mitogens|mesh-list
102262884|NCT04655482|Aflibercept|aflibercept|mesh-list
102262885|NCT04655482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102262886|NCT04655482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102262887|NCT04655482|Growth Substances|growth substances|mesh-ancestor
102262888|NCT04655482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262889|NCT04655482|Growth Inhibitors|growth inhibitors|mesh-ancestor
102262890|NCT04655482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102262891|NCT04515797|Antiviral Agents|antiviral agents|mesh-list
102262892|NCT04515797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102262893|NCT02184767|Loxapine|loxapine|mesh-list
102262894|NCT02184767|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102262895|NCT02184767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101817619|NCT02555423|Anesthetics|anesthetics|mesh-list
102262896|NCT02184767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102262897|NCT02184767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262898|NCT02184767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102262899|NCT02184767|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102262900|NCT02184767|Dopamine Agents|dopamine agents|mesh-ancestor
102262901|NCT02184767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102262902|NCT02184767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262903|NCT01981954|Solifenacin Succinate|solifenacin succinate|mesh-list
102262904|NCT01981954|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102262905|NCT01981954|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102262906|NCT01981954|Cholinergic Agents|cholinergic agents|mesh-ancestor
102262907|NCT01981954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102262908|NCT01981954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262909|NCT01981954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262910|NCT01981954|Urological Agents|urological agents|mesh-ancestor
102262911|NCT03727139|Rasagiline|rasagiline|mesh-list
102262912|NCT03727139|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102262913|NCT03727139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102262914|NCT03727139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262915|NCT03727139|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102262916|NCT03727139|Protective Agents|protective agents|mesh-ancestor
102262917|NCT03727139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262918|NCT05120687|Cyclosporine|cyclosporine|mesh-list
102262919|NCT05120687|Mycophenolic Acid|mycophenolic acid|mesh-list
102262920|NCT05120687|Adalimumab|adalimumab|mesh-list
102262921|NCT05120687|Cyclophosphamide|cyclophosphamide|mesh-list
102262922|NCT05120687|Methotrexate|methotrexate|mesh-list
102262923|NCT05120687|Cyclosporins|cyclosporins|mesh-list
102262924|NCT05120687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102262925|NCT05120687|Immunologic Factors|immunologic factors|mesh-ancestor
102262926|NCT05120687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262927|NCT05120687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102262928|NCT05120687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102262929|NCT05120687|Alkylating Agents|alkylating agents|mesh-ancestor
102262930|NCT05120687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262931|NCT05120687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102262932|NCT05120687|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102262933|NCT05120687|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102262934|NCT05120687|Abortifacient Agents|abortifacient agents|mesh-ancestor
102262935|NCT05120687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102262936|NCT05120687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102262938|NCT05120687|Dermatologic Agents|dermatologic agents|mesh-ancestor
102262939|NCT05120687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102262940|NCT05120687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102262941|NCT05120687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102262942|NCT05120687|Antifungal Agents|antifungal agents|mesh-ancestor
102262943|NCT05120687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102262944|NCT05120687|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102262945|NCT05120687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102262946|NCT05120687|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102262947|NCT05120687|Antitubercular Agents|antitubercular agents|mesh-ancestor
101817665|NCT00789503|Vitamin D|vitamin d|mesh-list
102262948|NCT05120687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102262949|NCT05120687|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102262950|NCT05120687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102262951|NCT03416855|Insulin|insulin|mesh-list
102262952|NCT03416855|Insulin Aspart|insulin aspart|mesh-list
102262953|NCT03416855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102262954|NCT03416855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262955|NCT05121779|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102262956|NCT05121779|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102262957|NCT05121779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262958|NCT02693119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102262959|NCT02693119|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102262960|NCT04224545|Colchicine|colchicine|mesh-list
102262961|NCT04224545|Gout Suppressants|gout suppressants|mesh-ancestor
102262962|NCT04224545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102262963|NCT04224545|Tubulin Modulators|tubulin modulators|mesh-ancestor
102262964|NCT04224545|Antimitotic Agents|antimitotic agents|mesh-ancestor
102262965|NCT04224545|Mitosis Modulators|mitosis modulators|mesh-ancestor
102262966|NCT04224545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262967|NCT04224545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102262968|NCT05121233|Diclofenac|diclofenac|mesh-list
102262969|NCT05121233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102262970|NCT05121233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102262971|NCT05121233|Analgesics|analgesics|mesh-ancestor
101817682|NCT00661193|Carboplatin|carboplatin|mesh-list
102262972|NCT05121233|Sensory System Agents|sensory system agents|mesh-ancestor
102262973|NCT05121233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102262974|NCT05121233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262975|NCT05121233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102262976|NCT05121233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102262977|NCT05121233|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102262978|NCT05121233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101817693|NCT00801047|Bupivacaine|bupivacaine|mesh-list
102262979|NCT05121233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262980|NCT05745259|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102262981|NCT05745259|Tenecteplase|tenecteplase|mesh-list
102262982|NCT05745259|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102262983|NCT05745259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102262984|NCT05745259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262985|NCT02893241|Cafedrine|cafedrine|mesh-list
101971876|NCT00508066|Bupivacaine|bupivacaine|mesh-list
102262987|NCT02893241|Ephedrine|ephedrine|mesh-list
102262988|NCT02893241|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102262989|NCT02893241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102262990|NCT02893241|Sympathomimetics|sympathomimetics|mesh-ancestor
102262991|NCT02893241|Autonomic Agents|autonomic agents|mesh-ancestor
102262992|NCT02893241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102262993|NCT02893241|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102262994|NCT02893241|Adrenergic Agents|adrenergic agents|mesh-ancestor
102262995|NCT02893241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102262996|NCT02893241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102262997|NCT02893241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102262998|NCT02893241|Vasodilator Agents|vasodilator agents|mesh-ancestor
102262999|NCT02395237|Glimepiride|glimepiride|mesh-list
102263000|NCT02395237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102263001|NCT02395237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102263002|NCT02395237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263003|NCT02395237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102263004|NCT02395237|Immunologic Factors|immunologic factors|mesh-ancestor
102263005|NCT02394847|Propofol|propofol|mesh-list
102263006|NCT02394847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102263007|NCT02394847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102263008|NCT02394847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263009|NCT02394847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102263010|NCT02394847|Anesthetics, General|anesthetics, general|mesh-ancestor
102263011|NCT02394847|Anesthetics|anesthetics|mesh-ancestor
102263012|NCT05021861|Cyproterone Acetate|cyproterone acetate|mesh-list
102263013|NCT05021861|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102263014|NCT05021861|Estradiol|estradiol|mesh-list
102263015|NCT05021861|Cyproterone|cyproterone|mesh-list
102263016|NCT05021861|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
102263017|NCT05021861|Estrogens|estrogens|mesh-ancestor
102263018|NCT05021861|Hormones|hormones|mesh-ancestor
102263019|NCT05021861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102263020|NCT05021861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263021|NCT05021861|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102263022|NCT05021861|Contraceptive Agents|contraceptive agents|mesh-ancestor
102263023|NCT05021861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102263024|NCT05021861|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102263025|NCT05021861|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102263026|NCT05021861|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102263027|NCT05021861|Androgen Antagonists|androgen antagonists|mesh-ancestor
102263028|NCT05021861|Hormone Antagonists|hormone antagonists|mesh-ancestor
102263029|NCT05021861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102263030|NCT05021861|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102263031|NCT02403037|Dexamethasone|dexamethasone|mesh-list
102263032|NCT02403037|Dexamethasone acetate|dexamethasone acetate|mesh-list
102263033|NCT02403037|Antiemetics|antiemetics|mesh-list
102263034|NCT02403037|Emetics|emetics|mesh-list
102263035|NCT02403037|BB 1101|bb 1101|mesh-list
102263036|NCT02403037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102263037|NCT02403037|Autonomic Agents|autonomic agents|mesh-ancestor
102263038|NCT02403037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102263039|NCT02403037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263040|NCT02403037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102263041|NCT02403037|Glucocorticoids|glucocorticoids|mesh-ancestor
102263042|NCT02403037|Hormones|hormones|mesh-ancestor
102263043|NCT02403037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102263044|NCT02403037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102263045|NCT02403037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102263046|NCT02403037|Protease Inhibitors|protease inhibitors|mesh-ancestor
102263047|NCT02403037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101817759|NCT00797927|Antipsychotic Agents|antipsychotic agents|mesh-list
102263048|NCT02403037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263049|NCT02653625|Cenicriviroc|cenicriviroc|mesh-list
102263050|NCT02653625|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102263051|NCT02653625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263052|NCT02653625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102263053|NCT02653625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102263054|NCT02653625|Antiviral Agents|antiviral agents|mesh-ancestor
102263055|NCT02653625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102263056|NCT04480333|Antiviral Agents|antiviral agents|mesh-list
102263057|NCT04480333|Remdesivir|remdesivir|mesh-list
102263058|NCT04480333|Neuroprotective Agents|neuroprotective agents|mesh-list
102263059|NCT04480333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101971946|NCT00412828|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
102263060|NCT04480333|Antimetabolites|antimetabolites|mesh-ancestor
102263061|NCT04480333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263062|NCT04480333|Protective Agents|protective agents|mesh-ancestor
102263063|NCT04480333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263064|NCT03166891|Chiauranib|chiauranib|mesh-list
102263065|NCT03166891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102263066|NCT03166891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102263067|NCT03166891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101817782|NCT00798083|Anesthetics, General|anesthetics, general|mesh-ancestor
102263068|NCT03166891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263069|NCT01980940|Etoricoxib|etoricoxib|mesh-list
102263070|NCT01980940|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
102613796|NCT00383045|Naltrexone|naltrexone|mesh-list
102263071|NCT01980940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102263072|NCT01980940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102263073|NCT01980940|Analgesics|analgesics|mesh-ancestor
102263074|NCT01980940|Sensory System Agents|sensory system agents|mesh-ancestor
102263075|NCT01980940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102263076|NCT01980940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263077|NCT01980940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102263078|NCT01980940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102263079|NCT01980940|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102263080|NCT01980940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102263081|NCT01980940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101817785|NCT00798083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102263082|NCT01980940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263083|NCT01980940|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102263084|NCT01980940|Protective Agents|protective agents|mesh-ancestor
102263085|NCT01980940|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102263086|NCT01980940|Antioxidants|antioxidants|mesh-ancestor
102263087|NCT01960114|Acetaminophen|acetaminophen|mesh-list
102263088|NCT01960114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102263089|NCT01960114|Analgesics|analgesics|mesh-ancestor
102263090|NCT01960114|Sensory System Agents|sensory system agents|mesh-ancestor
102263091|NCT01960114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102263092|NCT01960114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263093|NCT01960114|Antipyretics|antipyretics|mesh-ancestor
102263094|NCT04752527|Sorafenib|sorafenib|mesh-list
102263095|NCT04752527|Decitabine|decitabine|mesh-list
102263096|NCT04752527|Venetoclax|venetoclax|mesh-list
102263097|NCT04752527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102263098|NCT04752527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102263099|NCT04752527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102263100|NCT04752527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263101|NCT04752527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102263102|NCT04752527|Antimetabolites|antimetabolites|mesh-ancestor
102263103|NCT05229497|Carboplatin|carboplatin|mesh-list
102263104|NCT05229497|Fluorouracil|fluorouracil|mesh-list
102263105|NCT05229497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102263106|NCT05229497|Antimetabolites|antimetabolites|mesh-ancestor
102263107|NCT05229497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263108|NCT05229497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102263109|NCT05229497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102263110|NCT05229497|Immunologic Factors|immunologic factors|mesh-ancestor
102263111|NCT05229497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263112|NCT03169777|Leucovorin|leucovorin|mesh-list
102263113|NCT03169777|Cyclophosphamide|cyclophosphamide|mesh-list
102263114|NCT03169777|Bevacizumab|bevacizumab|mesh-list
102263115|NCT03169777|Fluorouracil|fluorouracil|mesh-list
102263116|NCT03169777|Capecitabine|capecitabine|mesh-list
102263117|NCT03169777|Oxaliplatin|oxaliplatin|mesh-list
102263118|NCT03169777|Nivolumab|nivolumab|mesh-list
102263119|NCT03169777|Cetuximab|cetuximab|mesh-list
102263120|NCT03169777|Fulvestrant|fulvestrant|mesh-list
102263121|NCT03169777|Avelumab|avelumab|mesh-list
102263122|NCT03169777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101817818|NCT00801905|Analgesics|analgesics|mesh-ancestor
102263123|NCT03169777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263124|NCT03169777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102263125|NCT03169777|Immunologic Factors|immunologic factors|mesh-ancestor
102263126|NCT03169777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263127|NCT03169777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102263128|NCT03169777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102263129|NCT03169777|Alkylating Agents|alkylating agents|mesh-ancestor
102263130|NCT03169777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102263131|NCT03169777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102263132|NCT03169777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102263133|NCT03169777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102263134|NCT03169777|Growth Substances|growth substances|mesh-ancestor
102263135|NCT03169777|Growth Inhibitors|growth inhibitors|mesh-ancestor
102263136|NCT03169777|Antimetabolites|antimetabolites|mesh-ancestor
102263137|NCT03169777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102263138|NCT03169777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102263139|NCT03169777|Antidotes|antidotes|mesh-ancestor
102263140|NCT03169777|Protective Agents|protective agents|mesh-ancestor
102263141|NCT03169777|Vitamin B Complex|vitamin b complex|mesh-ancestor
102263142|NCT03169777|Vitamins|vitamins|mesh-ancestor
102263143|NCT03169777|Micronutrients|micronutrients|mesh-ancestor
102263144|NCT03169777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102263145|NCT03169777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102263146|NCT03169777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102613797|NCT00383045|Buprenorphine|buprenorphine|mesh-list
102263147|NCT03169777|Hormone Antagonists|hormone antagonists|mesh-ancestor
102263148|NCT03169777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102263149|NCT01980706|Baclofen|baclofen|mesh-list
102263150|NCT01980706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102613798|NCT00383045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101817848|NCT00802217|Capsaicin|capsaicin|mesh-list
102263151|NCT01980706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263152|NCT01980706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102263153|NCT01980706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102263154|NCT01980706|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102263156|NCT01980706|GABA Agents|gaba agents|mesh-ancestor
102263157|NCT01980706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102263158|NCT01980706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263159|NCT02092571|Progesterone|progesterone|mesh-list
102263160|NCT02092571|Progestins|progestins|mesh-ancestor
102263161|NCT02092571|Hormones|hormones|mesh-ancestor
102263162|NCT02092571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102263163|NCT02092571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263164|NCT02402725|Dexamethasone|dexamethasone|mesh-list
102263165|NCT02402725|Dexamethasone acetate|dexamethasone acetate|mesh-list
102263166|NCT02402725|BB 1101|bb 1101|mesh-list
102263167|NCT02402725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102263168|NCT02402725|Antiemetics|antiemetics|mesh-ancestor
102263169|NCT02402725|Autonomic Agents|autonomic agents|mesh-ancestor
102263170|NCT02402725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102263171|NCT02402725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263172|NCT02402725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102263173|NCT02402725|Glucocorticoids|glucocorticoids|mesh-ancestor
102263174|NCT02402725|Hormones|hormones|mesh-ancestor
102263175|NCT02402725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102263176|NCT02402725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102263177|NCT02402725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102263178|NCT02402725|Protease Inhibitors|protease inhibitors|mesh-ancestor
102263179|NCT02402725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102263180|NCT02402725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263181|NCT02394145|Clopidogrel|clopidogrel|mesh-list
102263182|NCT02394145|Ticagrelor|ticagrelor|mesh-list
102263183|NCT02394145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102263184|NCT02394145|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102263185|NCT02394145|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102263186|NCT02394145|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102263187|NCT02394145|Purinergic Agents|purinergic agents|mesh-ancestor
102263188|NCT02394145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102263189|NCT02394145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263190|NCT02394145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263191|NCT02004886|Metformin|metformin|mesh-list
102263192|NCT02004886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102263193|NCT02004886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263194|NCT05228483|Mometasone Furoate|mometasone furoate|mesh-list
102263195|NCT05228483|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102263196|NCT05228483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102263197|NCT05228483|Dermatologic Agents|dermatologic agents|mesh-ancestor
102263198|NCT05228483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102263199|NCT05228483|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102263200|NCT04255277|Moxifloxacin|moxifloxacin|mesh-list
102263201|NCT04255277|Levonorgestrel|levonorgestrel|mesh-list
102263202|NCT04255277|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102263203|NCT04255277|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
102263204|NCT04255277|Contraceptive Agents|contraceptive agents|mesh-list
102263205|NCT04255277|Contraceptives, Oral|contraceptives, oral|mesh-list
102263206|NCT04255277|Charcoal|charcoal|mesh-list
102263207|NCT04255277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102263208|NCT04255277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102263209|NCT04255277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101972094|NCT02287870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263210|NCT04255277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102263211|NCT04255277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102263212|NCT04255277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263213|NCT04255277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102263214|NCT04255277|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102263215|NCT04255277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102263216|NCT04255277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263217|NCT04255277|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101817930|NCT01097551|Mydriatics|mydriatics|mesh-ancestor
102263218|NCT04255277|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102263219|NCT04255277|Antidotes|antidotes|mesh-ancestor
102263220|NCT04255277|Protective Agents|protective agents|mesh-ancestor
102263221|NCT04255277|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102263222|NCT04255277|Estrogens|estrogens|mesh-ancestor
102263223|NCT04255277|Hormones|hormones|mesh-ancestor
101902212|NCT01293734|Purinergic Agents|purinergic agents|mesh-ancestor
102263224|NCT04255277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102263225|NCT04007705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102263227|NCT04435925|Remifentanil|remifentanil|mesh-list
102263228|NCT04435925|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102263229|NCT04435925|Narcotics|narcotics|mesh-ancestor
102263230|NCT04435925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102263231|NCT04435925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263232|NCT04435925|Analgesics|analgesics|mesh-ancestor
102263233|NCT04435925|Sensory System Agents|sensory system agents|mesh-ancestor
102263234|NCT04435925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102263235|NCT04435925|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102263236|NCT04435925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102263237|NCT04435925|Anesthetics, General|anesthetics, general|mesh-ancestor
102263238|NCT04435925|Anesthetics|anesthetics|mesh-ancestor
102263239|NCT04649476|Cisplatin|cisplatin|mesh-list
102263240|NCT04649476|Docetaxel|docetaxel|mesh-list
102263241|NCT04649476|Fluorouracil|fluorouracil|mesh-list
102263242|NCT04649476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102263243|NCT04649476|Tubulin Modulators|tubulin modulators|mesh-ancestor
102263244|NCT04649476|Antimitotic Agents|antimitotic agents|mesh-ancestor
102263245|NCT04649476|Mitosis Modulators|mitosis modulators|mesh-ancestor
102263246|NCT04649476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263247|NCT04649476|Antimetabolites|antimetabolites|mesh-ancestor
102263248|NCT04649476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102263249|NCT04649476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102263250|NCT04649476|Immunologic Factors|immunologic factors|mesh-ancestor
102263251|NCT04649476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263252|NCT05117957|Sorafenib|sorafenib|mesh-list
102263253|NCT05117957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102263254|NCT05117957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102263255|NCT05117957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102263256|NCT05117957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263257|NCT03343301|Bemarituzumab|bemarituzumab|mesh-list
102263258|NCT03343301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101817954|NCT03953209|Spironolactone|spironolactone|mesh-list
102263259|NCT03343301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102263260|NCT04507919|Dabrafenib|dabrafenib|mesh-list
102263261|NCT04507919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102263262|NCT04507919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102263263|NCT04507919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102263264|NCT04507919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263265|NCT03251729|Progesterone|progesterone|mesh-list
102263266|NCT03251729|Progestins|progestins|mesh-ancestor
102263267|NCT03251729|Hormones|hormones|mesh-ancestor
102263268|NCT03251729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102263269|NCT03251729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263270|NCT02696785|Adalimumab|adalimumab|mesh-list
102263271|NCT02696785|Ixekizumab|ixekizumab|mesh-list
102263272|NCT02696785|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102263273|NCT02696785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102263274|NCT02696785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102263275|NCT02696785|Dermatologic Agents|dermatologic agents|mesh-ancestor
102263276|NCT02004262|Cyclophosphamide|cyclophosphamide|mesh-list
101817968|NCT00803387|Travoprost|travoprost|mesh-list
102263277|NCT02004262|Pancrelipase|pancrelipase|mesh-list
102263278|NCT02004262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102263279|NCT02004262|Immunologic Factors|immunologic factors|mesh-ancestor
102263280|NCT02004262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263281|NCT02004262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102263282|NCT02004262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102263283|NCT02004262|Alkylating Agents|alkylating agents|mesh-ancestor
102263284|NCT02004262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972226|NCT00393952|Xhance|xhance|mesh-list
102263285|NCT02004262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102263286|NCT02004262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102263287|NCT02004262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102263288|NCT02393599|Cocaine|cocaine|mesh-list
102263289|NCT02393599|Anesthetics, Local|anesthetics, local|mesh-ancestor
102263290|NCT02393599|Anesthetics|anesthetics|mesh-ancestor
102263291|NCT02393599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102263292|NCT02393599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263293|NCT02393599|Sensory System Agents|sensory system agents|mesh-ancestor
102263294|NCT02393599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102263295|NCT02393599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102613799|NCT00383045|Narcotics|narcotics|mesh-ancestor
102263296|NCT02393599|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102263297|NCT02393599|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102613800|NCT00383045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102263298|NCT02393599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102263299|NCT02393599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263300|NCT02393599|Dopamine Agents|dopamine agents|mesh-ancestor
102263301|NCT02393599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102263302|NCT02402491|Aspirin|aspirin|mesh-list
102263303|NCT02402491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
102263304|NCT02402491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102263305|NCT02402491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102263306|NCT02402491|Analgesics|analgesics|mesh-ancestor
102263307|NCT02402491|Sensory System Agents|sensory system agents|mesh-ancestor
102263308|NCT02402491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102263309|NCT02402491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263310|NCT02402491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102263311|NCT02402491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102263312|NCT02402491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102263313|NCT02402491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102263314|NCT02402491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263315|NCT02402491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102263316|NCT02402491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102263317|NCT02402491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102263318|NCT02402491|Antipyretics|antipyretics|mesh-ancestor
102263319|NCT02402491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102263320|NCT02402491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102263321|NCT02402491|Purinergic Agents|purinergic agents|mesh-ancestor
102263322|NCT02402491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102263323|NCT02402413|Androgens|androgens|mesh-list
102263324|NCT02402413|Hormones|hormones|mesh-ancestor
102263325|NCT02402413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102263326|NCT02402413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263327|NCT02393443|Oxytocin|oxytocin|mesh-list
102263328|NCT02393443|Oxytocics|oxytocics|mesh-ancestor
102263329|NCT02393443|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102263330|NCT02393443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263331|NCT01977898|Morphine|morphine|mesh-list
102263332|NCT01977898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102263333|NCT01977898|Narcotics|narcotics|mesh-ancestor
102263334|NCT01977898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102263335|NCT01977898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263336|NCT01977898|Analgesics|analgesics|mesh-ancestor
102263337|NCT01977898|Sensory System Agents|sensory system agents|mesh-ancestor
102263338|NCT01977898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102263339|NCT05744479|Metformin|metformin|mesh-list
102263340|NCT05744479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102263341|NCT05744479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263342|NCT02003638|Niacin|niacin|mesh-list
102263343|NCT02003638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102263344|NCT02003638|Antimetabolites|antimetabolites|mesh-ancestor
102263345|NCT02003638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263346|NCT02003638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102263347|NCT02003638|Vasodilator Agents|vasodilator agents|mesh-ancestor
102263348|NCT02003638|Vitamin B Complex|vitamin b complex|mesh-ancestor
102263349|NCT02003638|Vitamins|vitamins|mesh-ancestor
102263350|NCT02003638|Micronutrients|micronutrients|mesh-ancestor
102263351|NCT02003638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263352|NCT04649398|Nimodipine|nimodipine|mesh-list
102263353|NCT04649398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102263354|NCT04649398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102263355|NCT04649398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102263356|NCT04649398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263357|NCT04649398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102263358|NCT04649398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263359|NCT04649398|Vasodilator Agents|vasodilator agents|mesh-ancestor
102263360|NCT02402179|Tryptophan|tryptophan|mesh-list
102263361|NCT02402179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102263362|NCT02402179|Antidepressive Agents|antidepressive agents|mesh-ancestor
102263363|NCT02402179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102263364|NCT02401945|Aflibercept|aflibercept|mesh-list
102263365|NCT02401945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102263366|NCT02401945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102263367|NCT02401945|Growth Substances|growth substances|mesh-ancestor
102263368|NCT02401945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263369|NCT02401945|Growth Inhibitors|growth inhibitors|mesh-ancestor
102263370|NCT02401945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102263371|NCT02003014|Pioglitazone|pioglitazone|mesh-list
101818080|NCT00804245|Choline|choline|mesh-list
102613801|NCT00383045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613802|NCT00383045|Analgesics|analgesics|mesh-ancestor
102263372|NCT02003014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102263373|NCT02003014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263374|NCT01977352|Bupivacaine|bupivacaine|mesh-list
102263375|NCT01977352|Anesthetics, Local|anesthetics, local|mesh-ancestor
102263376|NCT01977352|Anesthetics|anesthetics|mesh-ancestor
102263377|NCT01977352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102263378|NCT01977352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263379|NCT01977352|Sensory System Agents|sensory system agents|mesh-ancestor
102263380|NCT01977352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102263381|NCT03166111|Lidocaine|lidocaine|mesh-list
102263382|NCT03166111|Anesthetics, Local|anesthetics, local|mesh-ancestor
102263383|NCT03166111|Anesthetics|anesthetics|mesh-ancestor
102263384|NCT03166111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102263385|NCT03166111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263386|NCT03166111|Sensory System Agents|sensory system agents|mesh-ancestor
102263387|NCT03166111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102263388|NCT03166111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102263389|NCT03166111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102263390|NCT03166111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102263391|NCT03166111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102263392|NCT03166111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263393|NCT05117021|Bupivacaine|bupivacaine|mesh-list
102263394|NCT05117021|Anesthetics, Local|anesthetics, local|mesh-ancestor
102263395|NCT05117021|Anesthetics|anesthetics|mesh-ancestor
102263396|NCT05117021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102263397|NCT05117021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263398|NCT05117021|Sensory System Agents|sensory system agents|mesh-ancestor
102263399|NCT05117021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102263400|NCT02392663|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102263401|NCT02392117|Insulin|insulin|mesh-list
102263402|NCT02392117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102263403|NCT02392117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263404|NCT02812433|Sildenafil Citrate|sildenafil citrate|mesh-list
102263405|NCT02812433|Vasodilator Agents|vasodilator agents|mesh-ancestor
102263406|NCT02812433|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102263407|NCT02812433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102263408|NCT02812433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102263409|NCT02812433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263410|NCT02812433|Urological Agents|urological agents|mesh-ancestor
102263411|NCT02392039|Loratadine|loratadine|mesh-list
102263412|NCT02392039|Antipruritics|antipruritics|mesh-ancestor
102263413|NCT02392039|Dermatologic Agents|dermatologic agents|mesh-ancestor
102263414|NCT02392039|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102263415|NCT02392039|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102263416|NCT02392039|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102263417|NCT02392039|Histamine Antagonists|histamine antagonists|mesh-ancestor
102263418|NCT02392039|Histamine Agents|histamine agents|mesh-ancestor
102263419|NCT02392039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102263420|NCT02392039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263421|NCT02392039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263422|NCT03106363|Ethanol|ethanol|mesh-list
102263423|NCT03106363|Dronabinol|dronabinol|mesh-list
101818117|NCT00804947|Melphalan|melphalan|mesh-list
102263424|NCT03106363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102263425|NCT03106363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102263426|NCT03106363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102263427|NCT03106363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263428|NCT03106363|Hallucinogens|hallucinogens|mesh-ancestor
102263429|NCT03106363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102263430|NCT03106363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102263431|NCT03106363|Analgesics|analgesics|mesh-ancestor
102263432|NCT03106363|Sensory System Agents|sensory system agents|mesh-ancestor
102263433|NCT03106363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102263434|NCT03106363|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101972318|NCT00065728|Anecortave|anecortave|mesh-list
102263435|NCT03106363|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102263436|NCT03106363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102263437|NCT03106363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263438|NCT03106363|Hormones|hormones|mesh-ancestor
102263439|NCT03106363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102613803|NCT00383045|Sensory System Agents|sensory system agents|mesh-ancestor
102263440|NCT03106519|Bupivacaine|bupivacaine|mesh-list
102263441|NCT03106519|Anesthetics, Local|anesthetics, local|mesh-ancestor
102263442|NCT03106519|Anesthetics|anesthetics|mesh-ancestor
102263443|NCT03106519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102263444|NCT03106519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263445|NCT03106519|Sensory System Agents|sensory system agents|mesh-ancestor
102263446|NCT03106519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102263447|NCT02687815|Vitamin D|vitamin d|mesh-list
102263448|NCT02687815|Cholecalciferol|cholecalciferol|mesh-list
102263449|NCT02687815|Vitamins|vitamins|mesh-ancestor
102263450|NCT02687815|Micronutrients|micronutrients|mesh-ancestor
102263451|NCT02687815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263452|NCT02687815|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102263453|NCT02687815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102263454|NCT03915665|Chlorhexidine|chlorhexidine|mesh-list
102263455|NCT03915665|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102263456|NCT03915665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102263457|NCT03915665|Disinfectants|disinfectants|mesh-ancestor
102263458|NCT01959334|Glucagon|glucagon|mesh-list
102263459|NCT01959334|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102263460|NCT01959334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102263461|NCT01959334|Hormones|hormones|mesh-ancestor
102263462|NCT01959334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102263463|NCT01959334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263464|NCT01959334|Incretins|incretins|mesh-ancestor
102263465|NCT01958476|Morphine|morphine|mesh-list
102263466|NCT01958476|Methadone|methadone|mesh-list
102263467|NCT01958476|Phenobarbital|phenobarbital|mesh-list
102263468|NCT01958476|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102263469|NCT01958476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102263470|NCT01958476|Narcotics|narcotics|mesh-ancestor
102263471|NCT01958476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102263472|NCT01958476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263473|NCT01958476|Analgesics|analgesics|mesh-ancestor
102263474|NCT01958476|Sensory System Agents|sensory system agents|mesh-ancestor
102263475|NCT01958476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102263476|NCT01958476|Antitussive Agents|antitussive agents|mesh-ancestor
102263477|NCT01958476|Respiratory System Agents|respiratory system agents|mesh-ancestor
102263478|NCT01958476|Anticonvulsants|anticonvulsants|mesh-ancestor
102263479|NCT01958476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102263480|NCT01958476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102263481|NCT01958476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102263482|NCT01958476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102263483|NCT01958476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818190|NCT00807053|Hormones|hormones|mesh-ancestor
102263484|NCT01958476|GABA Modulators|gaba modulators|mesh-ancestor
102263485|NCT01958476|GABA Agents|gaba agents|mesh-ancestor
102263486|NCT01958476|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102263487|NCT01958476|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102263488|NCT01958476|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102263489|NCT04809181|Azacitidine|azacitidine|mesh-list
102263490|NCT04809181|Venetoclax|venetoclax|mesh-list
102263491|NCT04809181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102263492|NCT04809181|Antimetabolites|antimetabolites|mesh-ancestor
102263493|NCT04809181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263494|NCT04809181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102263495|NCT04809181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102263496|NCT05734807|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
101818203|NCT00658775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102263497|NCT05734807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102263498|NCT05734807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102263499|NCT05734807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263500|NCT05734807|Antiviral Agents|antiviral agents|mesh-ancestor
102263501|NCT05734807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102263502|NCT01057121|Lenalidomide|lenalidomide|mesh-list
102263503|NCT01057121|Immunologic Factors|immunologic factors|mesh-ancestor
102263504|NCT01057121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263505|NCT01057121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102263506|NCT01057121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102263507|NCT01057121|Growth Substances|growth substances|mesh-ancestor
102263508|NCT01057121|Growth Inhibitors|growth inhibitors|mesh-ancestor
102263509|NCT01057121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102263510|NCT02695537|Cannabidiol|cannabidiol|mesh-list
102263511|NCT02695537|Anticonvulsants|anticonvulsants|mesh-ancestor
102263512|NCT04620941|Chrysarobin|chrysarobin|mesh-list
102263513|NCT04620941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102263514|NCT04620941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102263515|NCT04620941|Analgesics|analgesics|mesh-ancestor
102263516|NCT04620941|Sensory System Agents|sensory system agents|mesh-ancestor
102613804|NCT00383045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102263517|NCT04620941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102263518|NCT04620941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263519|NCT04620941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102263520|NCT04620941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102263522|NCT04210349|Immunologic Factors|immunologic factors|mesh-ancestor
102263523|NCT04210349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263524|NCT01353313|Hydrocortisone|hydrocortisone|mesh-list
102263525|NCT01353313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102263526|NCT04746989|Allopurinol|allopurinol|mesh-list
102263527|NCT04746989|Probenecid|probenecid|mesh-list
102263528|NCT04746989|Antimetabolites|antimetabolites|mesh-ancestor
102263529|NCT04746989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263530|NCT04746989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102263531|NCT04746989|Gout Suppressants|gout suppressants|mesh-ancestor
102263532|NCT04746989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102263533|NCT04746989|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102263534|NCT04746989|Antioxidants|antioxidants|mesh-ancestor
102263535|NCT04746989|Protective Agents|protective agents|mesh-ancestor
102263536|NCT04746989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263537|NCT04746989|Uricosuric Agents|uricosuric agents|mesh-ancestor
102263538|NCT04671953|Metformin|metformin|mesh-list
102263539|NCT04671953|Deucravacitinib|deucravacitinib|mesh-list
102263540|NCT04671953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102263541|NCT04671953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263542|NCT04671953|Dermatologic Agents|dermatologic agents|mesh-ancestor
102263543|NCT04671953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102263544|NCT04671953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102263545|NCT04671953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263546|NCT04585061|Lidocaine|lidocaine|mesh-list
102263547|NCT04585061|Anesthetics, Local|anesthetics, local|mesh-ancestor
102263548|NCT04585061|Anesthetics|anesthetics|mesh-ancestor
102263549|NCT04585061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102263550|NCT04585061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263551|NCT04585061|Sensory System Agents|sensory system agents|mesh-ancestor
102263552|NCT04585061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102263553|NCT04585061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102263554|NCT04585061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102263555|NCT04585061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102263556|NCT04585061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102263557|NCT04585061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263558|NCT03874091|Epinephrine|epinephrine|mesh-list
102263559|NCT03874091|Racepinephrine|racepinephrine|mesh-list
102263560|NCT03874091|Morphine|morphine|mesh-list
102263561|NCT03874091|Bupivacaine|bupivacaine|mesh-list
102263562|NCT03874091|Epinephryl borate|epinephryl borate|mesh-list
102263563|NCT03874091|Anesthetics, Local|anesthetics, local|mesh-ancestor
102263564|NCT03874091|Anesthetics|anesthetics|mesh-ancestor
102263565|NCT03874091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102263566|NCT03874091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263567|NCT03874091|Sensory System Agents|sensory system agents|mesh-ancestor
102263568|NCT03874091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102263569|NCT03874091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102263570|NCT03874091|Narcotics|narcotics|mesh-ancestor
102263571|NCT03874091|Analgesics|analgesics|mesh-ancestor
102263572|NCT03874091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102263573|NCT03874091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102263574|NCT03874091|Adrenergic Agents|adrenergic agents|mesh-ancestor
102263575|NCT03874091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102263576|NCT03874091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263577|NCT03874091|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102263578|NCT03874091|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102263579|NCT03874091|Autonomic Agents|autonomic agents|mesh-ancestor
102263580|NCT03874091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102263581|NCT03874091|Respiratory System Agents|respiratory system agents|mesh-ancestor
102263582|NCT03874091|Mydriatics|mydriatics|mesh-ancestor
102263583|NCT03874091|Sympathomimetics|sympathomimetics|mesh-ancestor
102263584|NCT03874091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102263585|NCT01362491|Ibuprofen|ibuprofen|mesh-list
102263586|NCT01362491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102263587|NCT01362491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102613805|NCT00383045|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102263588|NCT01362491|Analgesics|analgesics|mesh-ancestor
102263589|NCT01362491|Sensory System Agents|sensory system agents|mesh-ancestor
102263590|NCT01362491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102613806|NCT00383045|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102613807|NCT00383591|Vaccines|vaccines|mesh-list
102263591|NCT01362491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263592|NCT01362491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102263593|NCT01362491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102263594|NCT01362491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102263595|NCT01362491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102263596|NCT01362491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263597|NCT03560297|Nitrazepam|nitrazepam|mesh-list
102263598|NCT03560297|Anticonvulsants|anticonvulsants|mesh-ancestor
102263599|NCT03560297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102263600|NCT03560297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102263601|NCT03560297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263602|NCT03560297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102263603|NCT03560297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102263604|NCT03560297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102263605|NCT03560297|GABA Modulators|gaba modulators|mesh-ancestor
102263606|NCT03560297|GABA Agents|gaba agents|mesh-ancestor
102263607|NCT03560297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102263608|NCT03560297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263609|NCT04122287|Levofloxacin|levofloxacin|mesh-list
102263610|NCT04122287|Tinidazole|tinidazole|mesh-list
102263611|NCT04122287|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102263612|NCT04122287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102263613|NCT04122287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102263614|NCT04122287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102263615|NCT04122287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102263616|NCT04122287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101818307|NCT00651755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102263617|NCT04122287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263618|NCT04122287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102263619|NCT04122287|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102263620|NCT04122287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102263621|NCT04122287|Alkylating Agents|alkylating agents|mesh-ancestor
102263622|NCT04122287|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
102263623|NCT04122287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101818319|NCT00651755|Glucocorticoids|glucocorticoids|mesh-ancestor
102263624|NCT04122287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102263625|NCT05746351|Fentanyl|fentanyl|mesh-list
102263626|NCT05746351|Dexmedetomidine|dexmedetomidine|mesh-list
102263627|NCT05746351|Nalbuphine|nalbuphine|mesh-list
102263628|NCT05746351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102263629|NCT05746351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102263630|NCT05746351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263631|NCT05746351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102263632|NCT05746351|Analgesics|analgesics|mesh-ancestor
102263633|NCT05746351|Sensory System Agents|sensory system agents|mesh-ancestor
102263634|NCT05746351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101818324|NCT00651755|Tubulin Modulators|tubulin modulators|mesh-ancestor
102263635|NCT05746351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102263636|NCT05746351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102263637|NCT05746351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102263638|NCT05746351|Adrenergic Agents|adrenergic agents|mesh-ancestor
102263639|NCT05746351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102263640|NCT05746351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263641|NCT05746351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102263642|NCT05746351|Narcotics|narcotics|mesh-ancestor
102263643|NCT05746351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102263644|NCT05746351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102263645|NCT05746351|Anesthetics, General|anesthetics, general|mesh-ancestor
102263646|NCT05746351|Anesthetics|anesthetics|mesh-ancestor
102263647|NCT05403281|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102263648|NCT05403281|Dapagliflozin|dapagliflozin|mesh-list
102263649|NCT05403281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102263650|NCT05403281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263651|NCT05403281|Incretins|incretins|mesh-ancestor
102263652|NCT05403281|Hormones|hormones|mesh-ancestor
102263653|NCT05403281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102263654|NCT05403281|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101818338|NCT00807755|Carboplatin|carboplatin|mesh-list
102263655|NCT05403281|Protease Inhibitors|protease inhibitors|mesh-ancestor
102263656|NCT05403281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102263657|NCT05403281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263658|NCT05403281|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102263659|NCT03115099|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102263660|NCT03115099|Liraglutide|liraglutide|mesh-list
102263661|NCT03115099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102263662|NCT03115099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263663|NCT03115099|Incretins|incretins|mesh-ancestor
102263664|NCT03115099|Hormones|hormones|mesh-ancestor
102263665|NCT03115099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102613808|NCT00383591|Immunologic Factors|immunologic factors|mesh-ancestor
102613809|NCT00383591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263666|NCT03115099|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102263667|NCT03115099|Protease Inhibitors|protease inhibitors|mesh-ancestor
102263668|NCT03115099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102263669|NCT03115099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263670|NCT03165097|ACT-709478|act-709478|mesh-list
102263671|NCT03165097|Midazolam|midazolam|mesh-list
102263672|NCT03165097|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102263673|NCT03165097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102263674|NCT03165097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102263675|NCT03165097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263676|NCT03165097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102263677|NCT03165097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102263678|NCT03165097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102263679|NCT03165097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102263680|NCT03165097|Anesthetics, General|anesthetics, general|mesh-ancestor
102263681|NCT03165097|Anesthetics|anesthetics|mesh-ancestor
102263682|NCT03165097|GABA Modulators|gaba modulators|mesh-ancestor
102263683|NCT03165097|GABA Agents|gaba agents|mesh-ancestor
102263684|NCT03165097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102263685|NCT03165097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263686|NCT03165097|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102263687|NCT03165097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102263688|NCT03165097|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102263689|NCT03165409|Nivolumab|nivolumab|mesh-list
102263690|NCT03165409|Ipilimumab|ipilimumab|mesh-list
102263691|NCT03165409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102263692|NCT03165409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102263693|NCT03165409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102263694|NCT03165409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263695|NCT05403125|Listerine|listerine|mesh-list
102263696|NCT05403125|Fluorides|fluorides|mesh-list
102263697|NCT05403125|Sodium Fluoride|sodium fluoride|mesh-list
102263698|NCT05403125|Cariostatic Agents|cariostatic agents|mesh-ancestor
102263699|NCT05403125|Protective Agents|protective agents|mesh-ancestor
102263700|NCT05403125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263701|NCT05403125|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102263702|NCT05403125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102263703|NCT05701423|Natalizumab|natalizumab|mesh-list
102263704|NCT05701423|Immunologic Factors|immunologic factors|mesh-ancestor
102263705|NCT05701423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263706|NCT02795351|Sildenafil Citrate|sildenafil citrate|mesh-list
102263707|NCT02795351|Vasodilator Agents|vasodilator agents|mesh-ancestor
102263708|NCT02795351|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102263709|NCT02795351|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102263710|NCT02795351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102263711|NCT02795351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263712|NCT02795351|Urological Agents|urological agents|mesh-ancestor
102263713|NCT05403047|Tenofovir|tenofovir|mesh-list
102263714|NCT05403047|Antiviral Agents|antiviral agents|mesh-ancestor
102263715|NCT05403047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102263716|NCT05403047|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102263717|NCT05403047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102263718|NCT05403047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102263719|NCT05403047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263720|NCT05403047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102263721|NCT05403047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102263722|NCT04563845|Moxifloxacin|moxifloxacin|mesh-list
102263723|NCT04563845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102263724|NCT04563845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102263725|NCT04563845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102263726|NCT04563845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102263727|NCT04563845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102263728|NCT04563845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263729|NCT04563845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102263730|NCT03927443|Bimatoprost|bimatoprost|mesh-list
102263731|NCT03927443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102263732|NCT05124353|Cerebrolysin|cerebrolysin|mesh-list
102263733|NCT05124353|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102263734|NCT05124353|Protective Agents|protective agents|mesh-ancestor
102263735|NCT05124353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263736|NCT05124353|Nootropic Agents|nootropic agents|mesh-ancestor
102263737|NCT03805841|Bromides|bromides|mesh-list
102263738|NCT03805841|Anticonvulsants|anticonvulsants|mesh-ancestor
102263739|NCT02684617|Pembrolizumab|pembrolizumab|mesh-list
102263740|NCT02684617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102263741|NCT02684617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102263742|NCT02684617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101818428|NCT00808223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263743|NCT02684617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263744|NCT01999972|Axitinib|axitinib|mesh-list
102263745|NCT01999972|Crizotinib|crizotinib|mesh-list
102263746|NCT01999972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102263747|NCT01999972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102263748|NCT01999972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102263749|NCT01999972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263750|NCT04055389|Antithrombins|antithrombins|mesh-list
102263751|NCT04055389|Antithrombin III|antithrombin iii|mesh-list
102263752|NCT04055389|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102263753|NCT04055389|Protease Inhibitors|protease inhibitors|mesh-ancestor
102263754|NCT04055389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102263755|NCT04055389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263756|NCT04055389|Anticoagulants|anticoagulants|mesh-ancestor
102263757|NCT05697055|Ritonavir|ritonavir|mesh-list
102263758|NCT05697055|Nirmatrelvir|nirmatrelvir|mesh-list
102263759|NCT05697055|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
102263760|NCT05697055|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102263761|NCT05697055|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102263762|NCT05697055|Protease Inhibitors|protease inhibitors|mesh-ancestor
102263763|NCT05697055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102263764|NCT05697055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263765|NCT05697055|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102263766|NCT05697055|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102263767|NCT05697055|Antiviral Agents|antiviral agents|mesh-ancestor
102263768|NCT05697055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102263769|NCT05697055|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102263770|NCT05697055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102263771|NCT03162367|Sulfadiazine|sulfadiazine|mesh-list
102263772|NCT03162367|Silver Sulfadiazine|silver sulfadiazine|mesh-list
102263773|NCT03162367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102263774|NCT03162367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102263775|NCT03162367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102263776|NCT03162367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102263777|NCT03162367|Coccidiostats|coccidiostats|mesh-ancestor
102263778|NCT03162367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102263779|NCT01999894|Memantine|memantine|mesh-list
102263780|NCT01999894|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102263781|NCT01999894|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102263782|NCT01999894|Dopamine Agents|dopamine agents|mesh-ancestor
102263783|NCT01999894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102263784|NCT01999894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818460|NCT00811967|Ribavirin|ribavirin|mesh-list
102263785|NCT01999894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263786|NCT01999894|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102263787|NCT01999894|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102263788|NCT01976806|Aspirin|aspirin|mesh-list
102263789|NCT01976806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102263790|NCT01976806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102263791|NCT01976806|Analgesics|analgesics|mesh-ancestor
102263792|NCT01976806|Sensory System Agents|sensory system agents|mesh-ancestor
102263793|NCT01976806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102263794|NCT01976806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263795|NCT01976806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102263796|NCT01976806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102263797|NCT01976806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102263798|NCT01976806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101818475|NCT04046159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102263799|NCT01976806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263800|NCT01976806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102263801|NCT01976806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102263802|NCT01976806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102263803|NCT01976806|Antipyretics|antipyretics|mesh-ancestor
102263804|NCT01976728|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
102263805|NCT01976728|Hormones|hormones|mesh-ancestor
102263806|NCT01976728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102263807|NCT01976728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263808|NCT02689219|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102263809|NCT02689219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102263810|NCT02689219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102263811|NCT02689219|Immunotoxins|immunotoxins|mesh-ancestor
102263812|NCT02689219|Immunoconjugates|immunoconjugates|mesh-ancestor
102613810|NCT00002933|Irinotecan|irinotecan|mesh-list
102613811|NCT00002933|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102263813|NCT02689219|Immunologic Factors|immunologic factors|mesh-ancestor
102263814|NCT02689219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263815|NCT03165253|Amoxicillin|amoxicillin|mesh-list
102263816|NCT03165253|Clarithromycin|clarithromycin|mesh-list
102263817|NCT03165253|Omeprazole|omeprazole|mesh-list
102263818|NCT03165253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102263819|NCT03165253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102263820|NCT03165253|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102263821|NCT03165253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102263822|NCT03165253|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102263823|NCT03165253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101818507|NCT00812123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102263824|NCT03165253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263825|NCT03165253|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102263826|NCT03165253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102263827|NCT03165253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102263828|NCT05543317|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102263829|NCT05543317|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102263830|NCT05543317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263831|NCT04718389|Benralizumab|benralizumab|mesh-list
102263832|NCT04718389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102263833|NCT04718389|Respiratory System Agents|respiratory system agents|mesh-ancestor
102263834|NCT03161977|Mannitol|mannitol|mesh-list
102263835|NCT03161977|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102263836|NCT03161977|Diuretics|diuretics|mesh-ancestor
102263837|NCT03161977|Natriuretic Agents|natriuretic agents|mesh-ancestor
102263838|NCT03161977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263839|NCT02683525|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102263840|NCT02683525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102263841|NCT02683525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263842|NCT02683525|Incretins|incretins|mesh-ancestor
102263843|NCT02683525|Hormones|hormones|mesh-ancestor
102263844|NCT02683525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102263845|NCT02683525|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102263846|NCT02683525|Protease Inhibitors|protease inhibitors|mesh-ancestor
101277667|NCT05294965|Fenoterol|fenoterol|mesh-list
102263847|NCT02683525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102263848|NCT02683525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263849|NCT01976338|Ranibizumab|ranibizumab|mesh-list
102263850|NCT01976338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102263851|NCT01976338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102263852|NCT01976338|Growth Substances|growth substances|mesh-ancestor
102263853|NCT01976338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263854|NCT01976338|Growth Inhibitors|growth inhibitors|mesh-ancestor
102263855|NCT01976338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102263856|NCT02651987|Lanreotide|lanreotide|mesh-list
102263857|NCT02651987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102263858|NCT05115773|Anesthetics|anesthetics|mesh-list
102263859|NCT05115773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102263860|NCT05115773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263861|NCT04657939|Pioglitazone|pioglitazone|mesh-list
102263862|NCT04657939|Liraglutide|liraglutide|mesh-list
102263863|NCT04657939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101818535|NCT00809237|Hydroxychloroquine|hydroxychloroquine|mesh-list
102263864|NCT04657939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263865|NCT04657939|Incretins|incretins|mesh-ancestor
102263866|NCT04657939|Hormones|hormones|mesh-ancestor
102263867|NCT04657939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102263868|NCT01999114|Moxifloxacin|moxifloxacin|mesh-list
102263869|NCT01999114|Naltrexone|naltrexone|mesh-list
102263870|NCT01999114|Buprenorphine|buprenorphine|mesh-list
102263871|NCT01999114|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102263872|NCT01999114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101818559|NCT00817661|Vitamins|vitamins|mesh-ancestor
102263873|NCT01999114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102263874|NCT01999114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102263875|NCT01999114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102263876|NCT01999114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102263877|NCT01999114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263878|NCT01999114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102263879|NCT01999114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102263880|NCT01999114|Contraceptive Agents|contraceptive agents|mesh-ancestor
102263881|NCT01999114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101972759|NCT03942757|Protective Agents|protective agents|mesh-ancestor
102263882|NCT01999114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263883|NCT01999114|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102263884|NCT01999114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101902222|NCT01184378|Caseins|caseins|mesh-list
102613812|NCT00002933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102263885|NCT01999114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102263886|NCT01999114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102263887|NCT01999114|Narcotics|narcotics|mesh-ancestor
102263888|NCT01999114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102263889|NCT01999114|Analgesics|analgesics|mesh-ancestor
102263890|NCT01999114|Sensory System Agents|sensory system agents|mesh-ancestor
102263891|NCT01999114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102263892|NCT01999114|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102263893|NCT01999114|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102263895|NCT04500275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102263896|NCT04500275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102263897|NCT04503161|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102263898|NCT04503161|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102263899|NCT04503161|Estradiol|estradiol|mesh-list
102263900|NCT04503161|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102263901|NCT04503161|Estrogens|estrogens|mesh-ancestor
102263902|NCT04503161|Hormones|hormones|mesh-ancestor
102263903|NCT04503161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102263904|NCT04503161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263905|NCT04503161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102263906|NCT04503161|Contraceptive Agents|contraceptive agents|mesh-ancestor
102263907|NCT04503161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102263908|NCT04503161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102263909|NCT02214407|Decitabine|decitabine|mesh-list
102263910|NCT02214407|Hydroxyurea|hydroxyurea|mesh-list
102263911|NCT02214407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102263912|NCT02214407|Antimetabolites|antimetabolites|mesh-ancestor
102263913|NCT02214407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263914|NCT02214407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102263915|NCT02214407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102263916|NCT02214407|Antisickling Agents|antisickling agents|mesh-ancestor
102263917|NCT02214407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102263918|NCT02261285|Nivolumab|nivolumab|mesh-list
102263919|NCT02261285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102263920|NCT02261285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102263921|NCT02261285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102263922|NCT02261285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263923|NCT01288625|Amifostine|amifostine|mesh-list
102263924|NCT01288625|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102263925|NCT01288625|Protective Agents|protective agents|mesh-ancestor
102263926|NCT01288625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263927|NCT01374451|Everolimus|everolimus|mesh-list
102263928|NCT01374451|Pasireotide|pasireotide|mesh-list
102263929|NCT01374451|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102263930|NCT01374451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102263931|NCT01374451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102263932|NCT01374451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263933|NCT01374451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102263934|NCT01374451|Immunologic Factors|immunologic factors|mesh-ancestor
102263935|NCT01374451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263936|NCT01374451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102263937|NCT01374451|Hormones|hormones|mesh-ancestor
102263938|NCT01374451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102263939|NCT02674399|Hylan|hylan|mesh-list
101818616|NCT00061945|Leucovorin|leucovorin|mesh-list
102263940|NCT02674399|Viscosupplements|viscosupplements|mesh-ancestor
102263941|NCT02674399|Protective Agents|protective agents|mesh-ancestor
102263942|NCT02674399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263943|NCT03161509|Acetaminophen|acetaminophen|mesh-list
102263944|NCT03161509|Lamotrigine|lamotrigine|mesh-list
102263945|NCT03161509|Carbamazepine|carbamazepine|mesh-list
102263946|NCT03161509|Phenytoin|phenytoin|mesh-list
102263947|NCT03161509|Valproic Acid|valproic acid|mesh-list
102263948|NCT03161509|Anticonvulsants|anticonvulsants|mesh-list
102263949|NCT03161509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102263950|NCT03161509|Analgesics|analgesics|mesh-ancestor
102263951|NCT03161509|Sensory System Agents|sensory system agents|mesh-ancestor
102263952|NCT03161509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102263953|NCT03161509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263954|NCT03161509|Antipyretics|antipyretics|mesh-ancestor
102263955|NCT03161509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102263956|NCT03161509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102263957|NCT03161509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263958|NCT03161509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102613814|NCT00002933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613815|NCT00002933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102263959|NCT03161509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102263960|NCT03161509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102263961|NCT03161509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102263962|NCT03161509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102263963|NCT03161509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102263964|NCT03161509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102263965|NCT03161509|GABA Agents|gaba agents|mesh-ancestor
102263966|NCT03161509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102263967|NCT03161509|Antimanic Agents|antimanic agents|mesh-ancestor
102263968|NCT03161509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102263969|NCT03161509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102263970|NCT03161509|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102263971|NCT03161509|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102263972|NCT02676895|Vaccines|vaccines|mesh-list
102263973|NCT02676895|Immunologic Factors|immunologic factors|mesh-ancestor
102263974|NCT02676895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263975|NCT04440085|Midodrine|midodrine|mesh-list
102263976|NCT04440085|Sympathomimetics|sympathomimetics|mesh-ancestor
102263977|NCT04440085|Autonomic Agents|autonomic agents|mesh-ancestor
102263978|NCT04440085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102263979|NCT04440085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263980|NCT04440085|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102263981|NCT04440085|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102263982|NCT04440085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102263983|NCT04440085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102263984|NCT04440085|Adrenergic Agents|adrenergic agents|mesh-ancestor
102263985|NCT04440085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102263986|NCT04440085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102263987|NCT05129033|Omalizumab|omalizumab|mesh-list
102263988|NCT05129033|Itraconazole|itraconazole|mesh-list
102263989|NCT05129033|Prednisone|prednisone|mesh-list
102263990|NCT05129033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102263991|NCT05129033|Glucocorticoids|glucocorticoids|mesh-ancestor
102263992|NCT05129033|Hormones|hormones|mesh-ancestor
102263993|NCT05129033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102263994|NCT05129033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102263995|NCT05129033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101818662|NCT00061945|Antidotes|antidotes|mesh-ancestor
101818663|NCT00061945|Protective Agents|protective agents|mesh-ancestor
101818664|NCT00061945|Vitamin B Complex|vitamin b complex|mesh-ancestor
101818665|NCT00061945|Vitamins|vitamins|mesh-ancestor
101818666|NCT00061945|Micronutrients|micronutrients|mesh-ancestor
101818667|NCT00061945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101818668|NCT00061945|Tubulin Modulators|tubulin modulators|mesh-ancestor
101278279|NCT03582488|Corticosterone|corticosterone|mesh-list
102263996|NCT05129033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102263997|NCT05129033|Antifungal Agents|antifungal agents|mesh-ancestor
102263998|NCT05129033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102263999|NCT05129033|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102264000|NCT05129033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102264001|NCT05129033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102264002|NCT05129033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264003|NCT05129033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102264004|NCT05129033|Hormone Antagonists|hormone antagonists|mesh-ancestor
101818674|NCT00061945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102264005|NCT05129033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102264006|NCT05129033|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102264007|NCT05129033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102264008|NCT05129033|Respiratory System Agents|respiratory system agents|mesh-ancestor
102264009|NCT05128721|Vaccines|vaccines|mesh-list
102264010|NCT05128721|Immunologic Factors|immunologic factors|mesh-ancestor
102264011|NCT05128721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264012|NCT05128175|Levodopa|levodopa|mesh-list
102264013|NCT05128175|Carbidopa|carbidopa|mesh-list
102264014|NCT05128175|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102264015|NCT05128175|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102264016|NCT05128175|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102264017|NCT05128175|Dopamine Agents|dopamine agents|mesh-ancestor
102264018|NCT05128175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102264019|NCT05128175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264020|NCT05128175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264021|NCT05128175|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102264022|NCT05128175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102264023|NCT05128175|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102264024|NCT05128175|Immunologic Factors|immunologic factors|mesh-ancestor
102264025|NCT05128175|Dopamine Agonists|dopamine agonists|mesh-ancestor
102264026|NCT04184453|Deferiprone|deferiprone|mesh-list
102264027|NCT04184453|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102613816|NCT00002939|Paclitaxel|paclitaxel|mesh-list
102264028|NCT04184453|Chelating Agents|chelating agents|mesh-ancestor
102264029|NCT04184453|Sequestering Agents|sequestering agents|mesh-ancestor
102264030|NCT04184453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613817|NCT00002939|Irinotecan|irinotecan|mesh-list
102613818|NCT00002939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102264031|NCT05127707|Analgesics, Opioid|analgesics, opioid|mesh-list
102264032|NCT05127707|Narcotics|narcotics|mesh-ancestor
102264033|NCT05127707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102264034|NCT05127707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264035|NCT05127707|Analgesics|analgesics|mesh-ancestor
102264036|NCT05127707|Sensory System Agents|sensory system agents|mesh-ancestor
102264037|NCT05127707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102264038|NCT05205109|Pembrolizumab|pembrolizumab|mesh-list
102264039|NCT05205109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102264040|NCT05205109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102264041|NCT05205109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102264042|NCT05205109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264043|NCT02207465|Paclitaxel|paclitaxel|mesh-list
102264044|NCT02207465|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102264045|NCT02207465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102264046|NCT02207465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102264047|NCT02207465|Tubulin Modulators|tubulin modulators|mesh-ancestor
102264048|NCT02207465|Antimitotic Agents|antimitotic agents|mesh-ancestor
102264049|NCT02207465|Mitosis Modulators|mitosis modulators|mesh-ancestor
102264050|NCT02207465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264051|NCT00719225|Abatacept|abatacept|mesh-list
102264052|NCT00719225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102264053|NCT00719225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264054|NCT00719225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102264055|NCT00719225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102264056|NCT00719225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102264057|NCT00719225|Immunologic Factors|immunologic factors|mesh-ancestor
102264058|NCT00719225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264059|NCT00719225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102264060|NCT05134337|Itraconazole|itraconazole|mesh-list
102264061|NCT05134337|Rifampin|rifampin|mesh-list
102264062|NCT05134337|Antifungal Agents|antifungal agents|mesh-ancestor
102264063|NCT05134337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102264064|NCT05134337|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102264065|NCT05134337|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102264066|NCT05134337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102264067|NCT05134337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264068|NCT05134337|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102264069|NCT05134337|Hormone Antagonists|hormone antagonists|mesh-ancestor
102264070|NCT05134337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102264071|NCT05134337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264072|NCT05134337|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102264073|NCT05134337|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102264074|NCT05134337|Antitubercular Agents|antitubercular agents|mesh-ancestor
102264075|NCT05134337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102264076|NCT05134337|Leprostatic Agents|leprostatic agents|mesh-ancestor
102264077|NCT05134337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102264078|NCT05134337|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101818746|NCT01093261|Hydrocortisone|hydrocortisone|mesh-list
102264079|NCT05134337|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102264080|NCT05134337|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102264081|NCT05134337|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102264082|NCT05134337|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102264083|NCT05134337|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102264084|NCT04499495|Aminosalicylic Acid|aminosalicylic acid|mesh-list
102264085|NCT04499495|Mesalamine|mesalamine|mesh-list
102264086|NCT04499495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101818758|NCT02550977|Progestins|progestins|mesh-ancestor
102264087|NCT04499495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102264088|NCT04499495|Analgesics|analgesics|mesh-ancestor
102264089|NCT04499495|Sensory System Agents|sensory system agents|mesh-ancestor
102264090|NCT04499495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102264091|NCT04499495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264092|NCT04499495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102264093|NCT04499495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102264094|NCT04499495|Antitubercular Agents|antitubercular agents|mesh-ancestor
102264095|NCT04499495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102264096|NCT04499495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102264097|NCT05323175|Ropivacaine|ropivacaine|mesh-list
102264098|NCT05323175|Anesthetics, Local|anesthetics, local|mesh-ancestor
102264099|NCT05323175|Anesthetics|anesthetics|mesh-ancestor
102264100|NCT05323175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102264101|NCT05323175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264106|NCT05279963|Antidepressive Agents|antidepressive agents|mesh-ancestor
102264107|NCT05279963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102264108|NCT05279963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102264109|NCT05279963|Analgesics|analgesics|mesh-ancestor
102264110|NCT05279963|Sensory System Agents|sensory system agents|mesh-ancestor
102264111|NCT05279963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102264112|NCT05279963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264113|NCT05279963|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102264114|NCT05279963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102264115|NCT05279963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102264116|NCT05279963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264117|NCT05279963|Adrenergic Agents|adrenergic agents|mesh-ancestor
102264118|NCT05279963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102264119|NCT05126693|Botulinum Toxins|botulinum toxins|mesh-list
102264120|NCT05126693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102264121|NCT05126693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102264122|NCT05126693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264123|NCT05126693|Cholinergic Agents|cholinergic agents|mesh-ancestor
102264124|NCT05126693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102264125|NCT05126693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264129|NCT05133635|Methylprednisolone|methylprednisolone|mesh-list
102264130|NCT05133635|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102264131|NCT05133635|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102264132|NCT05133635|Prednisolone|prednisolone|mesh-list
102264133|NCT05133635|Prednisolone acetate|prednisolone acetate|mesh-list
102264134|NCT05133635|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102264135|NCT05133635|Prednisolone phosphate|prednisolone phosphate|mesh-list
102264136|NCT05133635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102264137|NCT05133635|Antiemetics|antiemetics|mesh-ancestor
102264138|NCT05133635|Autonomic Agents|autonomic agents|mesh-ancestor
102264139|NCT05133635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102264140|NCT05133635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264141|NCT05133635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102264142|NCT05133635|Glucocorticoids|glucocorticoids|mesh-ancestor
102264143|NCT05133635|Hormones|hormones|mesh-ancestor
102264144|NCT05133635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102264145|NCT05133635|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102264146|NCT05133635|Protective Agents|protective agents|mesh-ancestor
102264147|NCT05133635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102264148|NCT05133635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102264149|NCT04219969|Deoxyglucose|deoxyglucose|mesh-list
102264150|NCT04219969|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102264151|NCT04219969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102264152|NCT04219969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264153|NCT04219969|Antimetabolites|antimetabolites|mesh-ancestor
102264154|NCT04219969|Antiviral Agents|antiviral agents|mesh-ancestor
102264155|NCT04219969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102264156|NCT05132777|Osimertinib|osimertinib|mesh-list
102264157|NCT05132777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102264158|NCT05132777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102264159|NCT05132777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102264160|NCT05132777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264161|NCT05422027|Dexamethasone|dexamethasone|mesh-list
102264162|NCT05422027|Dexamethasone acetate|dexamethasone acetate|mesh-list
102264163|NCT05422027|Lenalidomide|lenalidomide|mesh-list
102264164|NCT05422027|Bortezomib|bortezomib|mesh-list
102264165|NCT05422027|BB 1101|bb 1101|mesh-list
102264166|NCT05422027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102264167|NCT05422027|Antiemetics|antiemetics|mesh-ancestor
102264168|NCT05422027|Autonomic Agents|autonomic agents|mesh-ancestor
102264169|NCT05422027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101818811|NCT01049620|Capecitabine|capecitabine|mesh-list
102264170|NCT05422027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264171|NCT05422027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102264172|NCT05422027|Glucocorticoids|glucocorticoids|mesh-ancestor
102264173|NCT05422027|Hormones|hormones|mesh-ancestor
102264174|NCT05422027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102264175|NCT05422027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102264176|NCT05422027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102264177|NCT05422027|Protease Inhibitors|protease inhibitors|mesh-ancestor
102264178|NCT05422027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102264179|NCT05422027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264180|NCT05422027|Immunologic Factors|immunologic factors|mesh-ancestor
102264181|NCT05422027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102264182|NCT05422027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102264183|NCT05422027|Growth Substances|growth substances|mesh-ancestor
102264184|NCT05422027|Growth Inhibitors|growth inhibitors|mesh-ancestor
102264185|NCT05072821|Botulinum Toxins|botulinum toxins|mesh-list
102264186|NCT05072821|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102264187|NCT05072821|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102264188|NCT05072821|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102264189|NCT05072821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102264190|NCT05072821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264191|NCT05072821|Cholinergic Agents|cholinergic agents|mesh-ancestor
102264192|NCT05072821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102264193|NCT05072821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264194|NCT05072821|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102264195|NCT05072821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102264196|NCT01674725|Ribavirin|ribavirin|mesh-list
102264197|NCT01674725|Antimetabolites|antimetabolites|mesh-ancestor
102264198|NCT01674725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264199|NCT01674725|Antiviral Agents|antiviral agents|mesh-ancestor
102264200|NCT01674725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102264201|NCT05404061|Hormones|hormones|mesh-list
102264202|NCT05404061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102264203|NCT05404061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264204|NCT05051293|Testosterone|testosterone|mesh-list
102264205|NCT05051293|Estrogens|estrogens|mesh-list
102264206|NCT05051293|Androgens|androgens|mesh-ancestor
102264207|NCT05051293|Hormones|hormones|mesh-ancestor
102264208|NCT05051293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102264209|NCT05051293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264210|NCT03161041|Bevacizumab|bevacizumab|mesh-list
102264211|NCT03161041|Oxaliplatin|oxaliplatin|mesh-list
102264212|NCT03161041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102264213|NCT03161041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102264214|NCT03161041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102264215|NCT03161041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102264216|NCT03161041|Growth Substances|growth substances|mesh-ancestor
102264217|NCT03161041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264218|NCT03161041|Growth Inhibitors|growth inhibitors|mesh-ancestor
102264219|NCT04139317|Pembrolizumab|pembrolizumab|mesh-list
102264220|NCT04139317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102264221|NCT04139317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102264222|NCT04139317|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102264223|NCT04139317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264224|NCT03163693|Dexmedetomidine|dexmedetomidine|mesh-list
102264225|NCT03163693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102264226|NCT03163693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101818868|NCT00058825|Cyclosporine|cyclosporine|mesh-list
102264227|NCT03163693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264228|NCT03163693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102264229|NCT03163693|Analgesics|analgesics|mesh-ancestor
102264230|NCT03163693|Sensory System Agents|sensory system agents|mesh-ancestor
102264231|NCT03163693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102264232|NCT03163693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101279333|NCT01878695|Acetylcysteine|acetylcysteine|mesh-list
102264233|NCT03163693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102264234|NCT03163693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102264235|NCT03163693|Adrenergic Agents|adrenergic agents|mesh-ancestor
102264236|NCT03163693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102264237|NCT03163693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264238|NCT05030545|Eplerenone|eplerenone|mesh-list
102264239|NCT05030545|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
102264240|NCT05030545|Mineralocorticoids|mineralocorticoids|mesh-list
102264241|NCT05030545|Hormone Antagonists|hormone antagonists|mesh-ancestor
102264242|NCT05030545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102264243|NCT05030545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264244|NCT05030545|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102264245|NCT05030545|Diuretics|diuretics|mesh-ancestor
102264246|NCT05030545|Natriuretic Agents|natriuretic agents|mesh-ancestor
102613819|NCT00002939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102264247|NCT05030545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102264248|NCT05030545|Hormones|hormones|mesh-ancestor
102264249|NCT03164161|Endorphins|endorphins|mesh-list
102264250|NCT03164161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102264251|NCT03164161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264252|NCT03164161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264253|NCT00754949|Azithromycin|azithromycin|mesh-list
102264254|NCT00754949|Dexamethasone|dexamethasone|mesh-list
102264255|NCT00754949|Dexamethasone acetate|dexamethasone acetate|mesh-list
102264256|NCT00754949|BB 1101|bb 1101|mesh-list
102264257|NCT00754949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102264258|NCT00754949|Antiemetics|antiemetics|mesh-ancestor
102264259|NCT00754949|Autonomic Agents|autonomic agents|mesh-ancestor
102264260|NCT00754949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102264261|NCT00754949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264262|NCT00754949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102264263|NCT00754949|Glucocorticoids|glucocorticoids|mesh-ancestor
102264264|NCT00754949|Hormones|hormones|mesh-ancestor
102264265|NCT00754949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102264266|NCT00754949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102264267|NCT00754949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102264268|NCT00754949|Protease Inhibitors|protease inhibitors|mesh-ancestor
102264269|NCT00754949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102264270|NCT00754949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264271|NCT00754949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102264272|NCT00754949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102264273|NCT03160807|Levofloxacin|levofloxacin|mesh-list
102264274|NCT03160807|Ofloxacin|ofloxacin|mesh-list
102264275|NCT03160807|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102264276|NCT03160807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102264277|NCT03160807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102264278|NCT03160807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102264279|NCT03160807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102264280|NCT03160807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102264281|NCT03160807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264282|NCT03160807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102264283|NCT03160807|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102264284|NCT03160807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102264285|NCT01674569|Ranibizumab|ranibizumab|mesh-list
102264286|NCT01674569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102264287|NCT01674569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102264288|NCT01674569|Growth Substances|growth substances|mesh-ancestor
102264289|NCT01674569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264290|NCT01674569|Growth Inhibitors|growth inhibitors|mesh-ancestor
102264291|NCT01674569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102264292|NCT03160729|Dexamethasone|dexamethasone|mesh-list
102264293|NCT03160729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102264294|NCT03160729|Antiemetics|antiemetics|mesh-ancestor
102264295|NCT03160729|Autonomic Agents|autonomic agents|mesh-ancestor
102264296|NCT03160729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102264297|NCT03160729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264298|NCT03160729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102264299|NCT03160729|Glucocorticoids|glucocorticoids|mesh-ancestor
102264300|NCT03160729|Hormones|hormones|mesh-ancestor
102264301|NCT03160729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102264302|NCT03160729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102264303|NCT03160729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102264304|NCT04439929|Adalimumab|adalimumab|mesh-list
102264305|NCT04439929|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102264306|NCT04439929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102264307|NCT04439929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102264308|NCT05131841|Vinorelbine|vinorelbine|mesh-list
102264309|NCT05131841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102264310|NCT05131841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102264311|NCT05131841|Tubulin Modulators|tubulin modulators|mesh-ancestor
101818947|NCT01093807|Enalapril|enalapril|mesh-list
102264312|NCT05131841|Antimitotic Agents|antimitotic agents|mesh-ancestor
102264313|NCT05131841|Mitosis Modulators|mitosis modulators|mesh-ancestor
102264314|NCT05131841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264315|NCT03163849|Sofosbuvir|sofosbuvir|mesh-list
102264316|NCT03163849|Antiviral Agents|antiviral agents|mesh-ancestor
102264317|NCT03163849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102264318|NCT03163381|Apatinib|apatinib|mesh-list
102264319|NCT03163381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613820|NCT00002939|Tubulin Modulators|tubulin modulators|mesh-ancestor
101818959|NCT00044083|Tolcapone|tolcapone|mesh-list
102613821|NCT00002939|Antimitotic Agents|antimitotic agents|mesh-ancestor
102264320|NCT03163381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102264321|NCT03163381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102264322|NCT03163381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264323|NCT05131295|Dapsone|dapsone|mesh-list
102264324|NCT05131295|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102264325|NCT05131295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102264326|NCT05131295|Antimalarials|antimalarials|mesh-ancestor
102264327|NCT05131295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102264328|NCT05131295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102264329|NCT05131295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102264330|NCT05131295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102264331|NCT05131295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264332|NCT05131295|Leprostatic Agents|leprostatic agents|mesh-ancestor
102264333|NCT05131295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102264334|NCT05131295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102264335|NCT05131295|Immunologic Factors|immunologic factors|mesh-ancestor
102264336|NCT05131295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264337|NCT05131295|Antacids|antacids|mesh-ancestor
102264338|NCT05131295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102264339|NCT01374217|Clarithromycin|clarithromycin|mesh-list
102264340|NCT01374217|Dexamethasone|dexamethasone|mesh-list
102264341|NCT01374217|Lenalidomide|lenalidomide|mesh-list
102264342|NCT01374217|Tadalafil|tadalafil|mesh-list
102264343|NCT01374217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102264344|NCT01374217|Antiemetics|antiemetics|mesh-ancestor
102264345|NCT01374217|Autonomic Agents|autonomic agents|mesh-ancestor
102264346|NCT01374217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102264347|NCT01374217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264348|NCT01374217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102264349|NCT01374217|Glucocorticoids|glucocorticoids|mesh-ancestor
102264350|NCT01374217|Hormones|hormones|mesh-ancestor
102264351|NCT01374217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102264352|NCT01374217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102264353|NCT01374217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102264354|NCT01374217|Immunologic Factors|immunologic factors|mesh-ancestor
102264355|NCT01374217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102264356|NCT01374217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102264357|NCT01374217|Growth Substances|growth substances|mesh-ancestor
102264358|NCT01374217|Growth Inhibitors|growth inhibitors|mesh-ancestor
102264359|NCT01374217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102264360|NCT01374217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102264361|NCT01374217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102264362|NCT01374217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102264363|NCT01374217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818987|NCT02688790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102264364|NCT01374217|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102264365|NCT01374217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102264366|NCT01374217|Vasodilator Agents|vasodilator agents|mesh-ancestor
102264367|NCT01374217|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102264368|NCT01374217|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102264369|NCT01374217|Urological Agents|urological agents|mesh-ancestor
102264370|NCT04494503|Rituximab|rituximab|mesh-list
102264371|NCT04494503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102264372|NCT04494503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102264373|NCT04494503|Immunologic Factors|immunologic factors|mesh-ancestor
102264374|NCT04494503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264375|NCT04494503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102264376|NCT04941937|Thalidomide|thalidomide|mesh-list
102264377|NCT04941937|Dexamethasone|dexamethasone|mesh-list
102264378|NCT04941937|Lenalidomide|lenalidomide|mesh-list
102264379|NCT04941937|Pomalidomide|pomalidomide|mesh-list
102264380|NCT04941937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102264381|NCT04941937|Antiemetics|antiemetics|mesh-ancestor
102264382|NCT04941937|Autonomic Agents|autonomic agents|mesh-ancestor
102264383|NCT04941937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102264384|NCT04941937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264385|NCT04941937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102264386|NCT04941937|Glucocorticoids|glucocorticoids|mesh-ancestor
102264387|NCT04941937|Hormones|hormones|mesh-ancestor
102264388|NCT04941937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102264389|NCT04941937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102264390|NCT04941937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102264391|NCT04941937|Immunologic Factors|immunologic factors|mesh-ancestor
102264392|NCT04941937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102613822|NCT00002939|Mitosis Modulators|mitosis modulators|mesh-ancestor
102613823|NCT00002939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613824|NCT00002939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101902231|NCT02459392|Methylprednisolone|methylprednisolone|mesh-list
102264393|NCT04941937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102264394|NCT04941937|Growth Substances|growth substances|mesh-ancestor
102264395|NCT04941937|Growth Inhibitors|growth inhibitors|mesh-ancestor
102264396|NCT04941937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102264397|NCT04941937|Leprostatic Agents|leprostatic agents|mesh-ancestor
102264398|NCT04941937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102264399|NCT04941937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102264401|NCT05124431|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102264402|NCT05124431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102264403|NCT05124431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102264404|NCT05124431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264405|NCT05124431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102264406|NCT05124431|Immunologic Factors|immunologic factors|mesh-ancestor
102264407|NCT05124431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264408|NCT05124431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102264409|NCT04877275|Dexamethasone|dexamethasone|mesh-list
102264410|NCT04877275|Cyclophosphamide|cyclophosphamide|mesh-list
102264411|NCT04877275|Doxorubicin|doxorubicin|mesh-list
102264412|NCT04877275|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102264413|NCT04877275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102264414|NCT04877275|Immunologic Factors|immunologic factors|mesh-ancestor
102264415|NCT04877275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264416|NCT04877275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102264417|NCT04877275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102264418|NCT04877275|Alkylating Agents|alkylating agents|mesh-ancestor
102264419|NCT04877275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264420|NCT04877275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102264421|NCT04877275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102264422|NCT04877275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102264423|NCT04877275|Antiemetics|antiemetics|mesh-ancestor
102264424|NCT04877275|Autonomic Agents|autonomic agents|mesh-ancestor
102264425|NCT04877275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102264426|NCT04877275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102264427|NCT04877275|Glucocorticoids|glucocorticoids|mesh-ancestor
102264428|NCT04877275|Hormones|hormones|mesh-ancestor
102264429|NCT04877275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102264430|NCT04877275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102264431|NCT04877275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102264432|NCT04877275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102264433|NCT04877275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102264434|NCT04877275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102264435|NCT04955249|Dexmedetomidine|dexmedetomidine|mesh-list
102264436|NCT04955249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102264437|NCT04955249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102264438|NCT04955249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264439|NCT04955249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102264440|NCT04955249|Analgesics|analgesics|mesh-ancestor
102264441|NCT04955249|Sensory System Agents|sensory system agents|mesh-ancestor
102264442|NCT04955249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102264443|NCT04955249|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102264444|NCT04955249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102264445|NCT04955249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102264446|NCT04955249|Adrenergic Agents|adrenergic agents|mesh-ancestor
102264447|NCT04955249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102264448|NCT04955249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264449|NCT05676463|Ascorbic Acid|ascorbic acid|mesh-list
102264450|NCT05676463|Methyltestosterone|methyltestosterone|mesh-list
102264451|NCT05676463|Hormones|hormones|mesh-list
102264452|NCT05676463|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
102264453|NCT05676463|Androgens|androgens|mesh-list
102264454|NCT05676463|Androgen Antagonists|androgen antagonists|mesh-list
102264455|NCT05676463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102264456|NCT05676463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264457|NCT05676463|Antioxidants|antioxidants|mesh-ancestor
102264458|NCT05676463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264459|NCT05676463|Protective Agents|protective agents|mesh-ancestor
102264460|NCT05676463|Vitamins|vitamins|mesh-ancestor
102264461|NCT05676463|Micronutrients|micronutrients|mesh-ancestor
102264462|NCT05676463|Estrogens|estrogens|mesh-ancestor
102264463|NCT05676463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102264464|NCT05676463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102264465|NCT05676463|Anabolic Agents|anabolic agents|mesh-ancestor
102264466|NCT05676463|Hormone Antagonists|hormone antagonists|mesh-ancestor
102264467|NCT03114085|Capecitabine|capecitabine|mesh-list
102264469|NCT03114085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102264470|NCT03114085|Antimetabolites|antimetabolites|mesh-ancestor
102264471|NCT03114085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264472|NCT03114085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102264473|NCT03114085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101280698|NCT01888393|Ivacaftor|ivacaftor|mesh-list
102264474|NCT03114085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102264475|NCT04886453|Morphine|morphine|mesh-list
102264476|NCT04886453|Anesthetics|anesthetics|mesh-list
102264477|NCT04886453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102264478|NCT04886453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264479|NCT04886453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102264480|NCT04886453|Narcotics|narcotics|mesh-ancestor
102264481|NCT04886453|Analgesics|analgesics|mesh-ancestor
101973358|NCT01116583|Anticonvulsants|anticonvulsants|mesh-ancestor
102264482|NCT04886453|Sensory System Agents|sensory system agents|mesh-ancestor
102264483|NCT04886453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102264484|NCT05136521|Trazodone|trazodone|mesh-list
102264485|NCT05136521|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102264486|NCT05136521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102264487|NCT05136521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102264488|NCT05136521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264489|NCT05136521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102264490|NCT05136521|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102264491|NCT05136521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102264492|NCT05136521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102264493|NCT05136521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264494|NCT05136521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102264495|NCT05136521|Serotonin Agents|serotonin agents|mesh-ancestor
102264496|NCT05136521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102264497|NCT05136521|Antidepressive Agents|antidepressive agents|mesh-ancestor
102264498|NCT05343013|Trifluridine|trifluridine|mesh-list
102264499|NCT05343013|Antimetabolites|antimetabolites|mesh-ancestor
102264500|NCT05343013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264501|NCT05343013|Antiviral Agents|antiviral agents|mesh-ancestor
102264502|NCT05343013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102264503|NCT02388373|Fluticasone|fluticasone|mesh-list
102264504|NCT02388373|Xhance|xhance|mesh-list
102264505|NCT02388373|Formoterol Fumarate|formoterol fumarate|mesh-list
102264506|NCT02388373|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102264507|NCT02388373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102264508|NCT02388373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102264509|NCT02388373|Autonomic Agents|autonomic agents|mesh-ancestor
102264510|NCT02388373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102264511|NCT02388373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264512|NCT02388373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102264513|NCT02388373|Respiratory System Agents|respiratory system agents|mesh-ancestor
102264514|NCT02388373|Dermatologic Agents|dermatologic agents|mesh-ancestor
102264515|NCT02388373|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102264516|NCT02388373|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102264517|NCT02388373|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102264518|NCT02388373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102264519|NCT02388373|Adrenergic Agents|adrenergic agents|mesh-ancestor
102264520|NCT02388373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101819135|NCT00486837|Protease Inhibitors|protease inhibitors|mesh-list
102264521|NCT02388373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264522|NCT01674647|Vitamin K|vitamin k|mesh-list
102264523|NCT01674647|Rivaroxaban|rivaroxaban|mesh-list
102264524|NCT01674647|Vitamins|vitamins|mesh-ancestor
102264525|NCT01674647|Micronutrients|micronutrients|mesh-ancestor
102264526|NCT01674647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264527|NCT01674647|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102264528|NCT01674647|Antithrombins|antithrombins|mesh-ancestor
102264529|NCT01674647|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102264530|NCT01674647|Protease Inhibitors|protease inhibitors|mesh-ancestor
102264531|NCT01674647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102264532|NCT01674647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264533|NCT01674647|Anticoagulants|anticoagulants|mesh-ancestor
101281126|NCT01895049|Prednisone|prednisone|mesh-list
102264534|NCT01674647|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102264535|NCT01674647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102264536|NCT01674647|Hemostatics|hemostatics|mesh-ancestor
102264537|NCT01674647|Coagulants|coagulants|mesh-ancestor
102264538|NCT02669407|Lidocaine|lidocaine|mesh-list
102264539|NCT02669407|Anesthetics, Local|anesthetics, local|mesh-list
102264540|NCT02669407|Anesthetics|anesthetics|mesh-list
102264541|NCT02669407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101606291|NCT02649478|Glucocorticoids|glucocorticoids|mesh-ancestor
102264542|NCT02669407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264544|NCT02669407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102264545|NCT02669407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102264546|NCT02669407|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102264547|NCT02669407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102264548|NCT02669407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102264549|NCT02669407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264550|NCT04637555|Valsartan|valsartan|mesh-list
102264551|NCT04637555|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102264552|NCT04637555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102264553|NCT04637555|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102264554|NCT04637555|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101973430|NCT01217125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102264555|NCT04637555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264556|NCT02388061|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102264557|NCT02388061|Plasminogen|plasminogen|mesh-list
102264558|NCT02388061|Tenecteplase|tenecteplase|mesh-list
102264559|NCT02388061|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102264560|NCT02388061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102264561|NCT02388061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264562|NCT04556357|Phenylephrine|phenylephrine|mesh-list
102264563|NCT04556357|Oxymetazoline|oxymetazoline|mesh-list
102264564|NCT04556357|Norepinephrine|norepinephrine|mesh-list
102264565|NCT04556357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
102264566|NCT04556357|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102264567|NCT04556357|Mydriatics|mydriatics|mesh-ancestor
102264568|NCT04556357|Autonomic Agents|autonomic agents|mesh-ancestor
102264569|NCT04556357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102264570|NCT04556357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264571|NCT04556357|Sympathomimetics|sympathomimetics|mesh-ancestor
102264572|NCT04556357|Nasal Decongestants|nasal decongestants|mesh-ancestor
102264573|NCT04556357|Respiratory System Agents|respiratory system agents|mesh-ancestor
102264574|NCT04556357|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102264575|NCT04556357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102264576|NCT04556357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102264577|NCT04556357|Adrenergic Agents|adrenergic agents|mesh-ancestor
102264578|NCT04556357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102264579|NCT04556357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264580|NCT04556357|Protective Agents|protective agents|mesh-ancestor
102264581|NCT04553939|Gemcitabine|gemcitabine|mesh-list
102264582|NCT04553939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102264583|NCT04553939|Antimetabolites|antimetabolites|mesh-ancestor
101819201|NCT00462501|Antimetabolites|antimetabolites|mesh-ancestor
102264584|NCT04553939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264585|NCT04553939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102264586|NCT03113773|Aldesleukin|aldesleukin|mesh-list
102264587|NCT03113773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102264588|NCT03113773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102264589|NCT03113773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102264590|NCT03113773|Antiviral Agents|antiviral agents|mesh-ancestor
101819209|NCT00462501|Vitamins|vitamins|mesh-ancestor
102264591|NCT03113773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102264592|NCT05306041|Inavolisib|inavolisib|mesh-list
102264593|NCT05306041|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
102264594|NCT05306041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102264595|NCT05306041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264596|NCT04874831|Avelumab|avelumab|mesh-list
102264597|NCT04874831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102264598|NCT04874831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102264599|NCT05122169|Iodine|iodine|mesh-list
102264600|NCT05122169|Chlorhexidine|chlorhexidine|mesh-list
102264601|NCT05122169|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102264602|NCT05122169|Povidone-Iodine|povidone-iodine|mesh-list
102264603|NCT05122169|Povidone|povidone|mesh-list
102264604|NCT05122169|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102264605|NCT05122169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102264606|NCT05122169|Disinfectants|disinfectants|mesh-ancestor
102264607|NCT05122169|Dermatologic Agents|dermatologic agents|mesh-ancestor
102264608|NCT05122169|Trace Elements|trace elements|mesh-ancestor
102264609|NCT05122169|Micronutrients|micronutrients|mesh-ancestor
102264610|NCT05122169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264611|NCT05122169|Plasma Substitutes|plasma substitutes|mesh-ancestor
102264612|NCT05122169|Blood Substitutes|blood substitutes|mesh-ancestor
102264613|NCT04359329|Estradiol|estradiol|mesh-list
102264614|NCT04359329|Estrogens|estrogens|mesh-ancestor
102264615|NCT04359329|Hormones|hormones|mesh-ancestor
102264616|NCT04359329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102264617|NCT04359329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264618|NCT05403749|Aflibercept|aflibercept|mesh-list
102613826|NCT00002939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102613827|NCT04009967|Pembrolizumab|pembrolizumab|mesh-list
102613828|NCT04009967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102613829|NCT04009967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613830|NCT04009967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102613831|NCT04009967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613832|NCT03085823|Sirolimus|sirolimus|mesh-list
102613833|NCT03085823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102613834|NCT03085823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102613835|NCT03085823|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102613836|NCT03085823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613837|NCT03085823|Antifungal Agents|antifungal agents|mesh-ancestor
102613838|NCT03085823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102613839|NCT03085823|Immunologic Factors|immunologic factors|mesh-ancestor
102264619|NCT05403749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102264620|NCT05403749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102264621|NCT05403749|Growth Substances|growth substances|mesh-ancestor
102264622|NCT05403749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264623|NCT05403749|Growth Inhibitors|growth inhibitors|mesh-ancestor
102264624|NCT05403749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102264625|NCT04203875|Abatacept|abatacept|mesh-list
102264626|NCT04203875|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101819247|NCT01047202|Vaccines|vaccines|mesh-list
102264627|NCT04203875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264628|NCT04203875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102264629|NCT04203875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102264630|NCT04203875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102264631|NCT04203875|Immunologic Factors|immunologic factors|mesh-ancestor
102264632|NCT04203875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264633|NCT04203875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102264634|NCT04491383|Tocovid|tocovid|mesh-list
102264635|NCT04491383|Vitamins|vitamins|mesh-ancestor
102264636|NCT04491383|Micronutrients|micronutrients|mesh-ancestor
102264637|NCT04491383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264638|NCT05900674|Reteplase|reteplase|mesh-list
102264639|NCT05900674|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102264640|NCT05900674|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102264641|NCT05900674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264642|NCT05900661|Inositol|inositol|mesh-list
102264643|NCT05900661|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
102264644|NCT05900661|Vitamin B Complex|vitamin b complex|mesh-ancestor
102264645|NCT05900661|Vitamins|vitamins|mesh-ancestor
102264646|NCT05900661|Micronutrients|micronutrients|mesh-ancestor
102264647|NCT05900661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264648|NCT05900661|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102264649|NCT05900661|Immunologic Factors|immunologic factors|mesh-ancestor
102264650|NCT05900635|Lactoferrin|lactoferrin|mesh-list
102264651|NCT05900635|Glycine|glycine|mesh-list
102264652|NCT05900635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102264653|NCT05900635|Glycine Agents|glycine agents|mesh-ancestor
102264654|NCT05900635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102264655|NCT05900635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264656|NCT05900635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264657|NCT05900531|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102264658|NCT05900531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102264659|NCT05900531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264660|NCT05900531|Incretins|incretins|mesh-ancestor
102613840|NCT03085823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613841|NCT00002945|Cytarabine|cytarabine|mesh-list
102613842|NCT00002945|Aldesleukin|aldesleukin|mesh-list
102613843|NCT00002945|Cyclophosphamide|cyclophosphamide|mesh-list
102613844|NCT00002945|Melphalan|melphalan|mesh-list
102613845|NCT00002945|Etoposide|etoposide|mesh-list
102613846|NCT00002945|Idarubicin|idarubicin|mesh-list
102613847|NCT00002945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102613848|NCT00002945|Immunologic Factors|immunologic factors|mesh-ancestor
102613849|NCT00002945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613850|NCT00002945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102613851|NCT00002945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102613852|NCT00002945|Alkylating Agents|alkylating agents|mesh-ancestor
102264661|NCT05900531|Hormones|hormones|mesh-ancestor
102264662|NCT05900531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101902249|NCT02459392|Hormones|hormones|mesh-ancestor
102613853|NCT00002945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264663|NCT05900531|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102264664|NCT05900531|Protease Inhibitors|protease inhibitors|mesh-ancestor
102264665|NCT05900531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102264666|NCT05900531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264667|NCT05900401|Cyclophosphamide|cyclophosphamide|mesh-list
102264668|NCT05900401|Rituximab|rituximab|mesh-list
102264669|NCT05900401|Fludarabine|fludarabine|mesh-list
102264670|NCT05900401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102264671|NCT05900401|Immunologic Factors|immunologic factors|mesh-ancestor
102264672|NCT05900401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264673|NCT05900401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102264674|NCT05900401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102264675|NCT05900401|Alkylating Agents|alkylating agents|mesh-ancestor
102264676|NCT05900401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281849|NCT01903694|Sorafenib|sorafenib|mesh-list
102264677|NCT05900401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102264678|NCT05900401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102264679|NCT05900401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102264680|NCT05900349|Caffeine|caffeine|mesh-list
102264681|NCT05900349|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102264682|NCT05900349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264683|NCT05900349|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102264684|NCT05900349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102264685|NCT05900349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264686|NCT05900349|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102264687|NCT05900349|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102264688|NCT05900349|Purinergic Agents|purinergic agents|mesh-ancestor
102264689|NCT05900349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102264690|NCT05900336|Naproxen|naproxen|mesh-list
102264691|NCT05900336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102264692|NCT05900336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102264693|NCT05900336|Analgesics|analgesics|mesh-ancestor
102264694|NCT05900336|Sensory System Agents|sensory system agents|mesh-ancestor
101819320|NCT00371566|Lapatinib|lapatinib|mesh-list
102264695|NCT05900336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102264696|NCT05900336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264697|NCT05900336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102264698|NCT05900336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102264699|NCT05900336|Gout Suppressants|gout suppressants|mesh-ancestor
102264700|NCT05900336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102264701|NCT05900336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102264702|NCT05900336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264703|NCT05900258|Tirbanibulin|tirbanibulin|mesh-list
102264704|NCT05900258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102264705|NCT05900258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264706|NCT05900245|Propofol|propofol|mesh-list
102264707|NCT05900245|Anesthetics|anesthetics|mesh-list
102264708|NCT05900245|Succinylcholine|succinylcholine|mesh-list
102264709|NCT05900245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102264710|NCT05900245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102264711|NCT05900245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264712|NCT05900245|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102264713|NCT05900245|Anesthetics, General|anesthetics, general|mesh-ancestor
102264714|NCT05900245|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
102264715|NCT05900245|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102264716|NCT05900245|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102264717|NCT05900245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102264718|NCT05900232|Antibodies|antibodies|mesh-list
102264719|NCT05900232|Immunologic Factors|immunologic factors|mesh-ancestor
102264720|NCT05900232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264721|NCT05900219|Vemurafenib|vemurafenib|mesh-list
102264722|NCT05900219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102264723|NCT05900219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102264724|NCT05900219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102264725|NCT05900219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264726|NCT05900206|Paclitaxel|paclitaxel|mesh-list
102264727|NCT05900206|Docetaxel|docetaxel|mesh-list
102264728|NCT05900206|Cyclophosphamide|cyclophosphamide|mesh-list
102264729|NCT05900206|Carboplatin|carboplatin|mesh-list
102264730|NCT05900206|Trastuzumab|trastuzumab|mesh-list
102264731|NCT05900206|Letrozole|letrozole|mesh-list
102264732|NCT05900206|Epirubicin|epirubicin|mesh-list
102264733|NCT05900206|Pertuzumab|pertuzumab|mesh-list
102264734|NCT05900206|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
102264735|NCT05900206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102264736|NCT05900206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102264737|NCT05900206|Tubulin Modulators|tubulin modulators|mesh-ancestor
102264738|NCT05900206|Antimitotic Agents|antimitotic agents|mesh-ancestor
101819351|NCT00469833|Insulin Glargine|insulin glargine|mesh-list
102264739|NCT05900206|Mitosis Modulators|mitosis modulators|mesh-ancestor
102264740|NCT05900206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264741|NCT05900206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102264742|NCT05900206|Immunologic Factors|immunologic factors|mesh-ancestor
102264743|NCT05900206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264744|NCT05900206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102264745|NCT05900206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102264746|NCT05900206|Alkylating Agents|alkylating agents|mesh-ancestor
102264747|NCT05900206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102264748|NCT05900206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102264749|NCT05900206|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102264750|NCT05900206|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102264751|NCT05900206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102264752|NCT05900206|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102264753|NCT05900206|Hormone Antagonists|hormone antagonists|mesh-ancestor
101819371|NCT00814541|Hormones|hormones|mesh-ancestor
102264754|NCT05900206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102264755|NCT05900206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102264756|NCT05900206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102264757|NCT05900206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102264758|NCT05900206|Immunoconjugates|immunoconjugates|mesh-ancestor
102264759|NCT05899829|Rifampin|rifampin|mesh-list
102264760|NCT05899829|Rabeprazole|rabeprazole|mesh-list
102264761|NCT05899829|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102264762|NCT05899829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102264763|NCT05899829|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102264764|NCT05899829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102264765|NCT05899829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264766|NCT05899829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102264767|NCT05899829|Antitubercular Agents|antitubercular agents|mesh-ancestor
102264768|NCT05899829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102264769|NCT05899829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102264770|NCT05899829|Leprostatic Agents|leprostatic agents|mesh-ancestor
102264771|NCT05899829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102264772|NCT05899829|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102264773|NCT05899829|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102264774|NCT05899829|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102264775|NCT05899829|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102264776|NCT05899829|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102264777|NCT05899829|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102264778|NCT05899764|Brivaracetam|brivaracetam|mesh-list
102264779|NCT05899764|Anticonvulsants|anticonvulsants|mesh-ancestor
102264780|NCT05899751|Methotrexate|methotrexate|mesh-list
101819380|NCT00814619|Capecitabine|capecitabine|mesh-list
102264781|NCT05899751|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102264782|NCT05899751|Abortifacient Agents|abortifacient agents|mesh-ancestor
102264783|NCT05899751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102264784|NCT05899751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264785|NCT05899751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102264786|NCT05899751|Antimetabolites|antimetabolites|mesh-ancestor
101819399|NCT00460239|Morphine|morphine|mesh-list
102264787|NCT05899751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264788|NCT05899751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102264789|NCT05899751|Dermatologic Agents|dermatologic agents|mesh-ancestor
102264790|NCT05899751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102264791|NCT05899751|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102264792|NCT05899751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102264793|NCT05899751|Immunologic Factors|immunologic factors|mesh-ancestor
102264794|NCT05899751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102264795|NCT05899751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102264796|NCT05899621|Prednisone|prednisone|mesh-list
102264797|NCT05899621|Cyclophosphamide|cyclophosphamide|mesh-list
102264798|NCT05899621|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102264799|NCT05899621|Doxorubicin|doxorubicin|mesh-list
102264800|NCT05899621|Vincristine|vincristine|mesh-list
102264801|NCT05899621|Lenalidomide|lenalidomide|mesh-list
102264802|NCT05899621|Obinutuzumab|obinutuzumab|mesh-list
102264803|NCT05899621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102264804|NCT05899621|Immunologic Factors|immunologic factors|mesh-ancestor
102264805|NCT05899621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613854|NCT00002945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102264806|NCT05899621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102264807|NCT05899621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102264808|NCT05899621|Alkylating Agents|alkylating agents|mesh-ancestor
101902266|NCT03637582|Lidocaine|lidocaine|mesh-list
102613855|NCT00002945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102264809|NCT05899621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264810|NCT05899621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102264811|NCT05899621|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102264812|NCT05899621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102264813|NCT05899621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102264814|NCT05899621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102264815|NCT05899621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102264816|NCT05899621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102264817|NCT05899621|Glucocorticoids|glucocorticoids|mesh-ancestor
102264819|NCT05899621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102264820|NCT05899621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102264821|NCT05899621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102264822|NCT05899621|Tubulin Modulators|tubulin modulators|mesh-ancestor
102264823|NCT05899621|Antimitotic Agents|antimitotic agents|mesh-ancestor
102264824|NCT05899621|Mitosis Modulators|mitosis modulators|mesh-ancestor
102264825|NCT05899621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102264826|NCT05899621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102264827|NCT05899621|Growth Substances|growth substances|mesh-ancestor
102264828|NCT05899621|Growth Inhibitors|growth inhibitors|mesh-ancestor
102264829|NCT05899621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102264830|NCT05899517|Oxytocin|oxytocin|mesh-list
102264831|NCT05899517|Oxytocics|oxytocics|mesh-ancestor
102264832|NCT05899517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102264833|NCT05899517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264834|NCT05899465|Tranexamic Acid|tranexamic acid|mesh-list
101819439|NCT02551133|Autonomic Agents|autonomic agents|mesh-ancestor
102264835|NCT05899465|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102264836|NCT05899465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102264837|NCT05899465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264838|NCT05899465|Hemostatics|hemostatics|mesh-ancestor
102264839|NCT05899465|Coagulants|coagulants|mesh-ancestor
102264840|NCT05899127|Lidocaine|lidocaine|mesh-list
102264841|NCT05899127|Sufentanil|sufentanil|mesh-list
102264842|NCT05899127|Remifentanil|remifentanil|mesh-list
102264844|NCT05899127|Propofol|propofol|mesh-list
102264845|NCT05899127|Etomidate|etomidate|mesh-list
102264846|NCT05899127|Rocuronium|rocuronium|mesh-list
102264847|NCT05899127|Anesthetics, Local|anesthetics, local|mesh-ancestor
102264848|NCT05899127|Anesthetics|anesthetics|mesh-ancestor
102264849|NCT05899127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102264850|NCT05899127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264851|NCT05899127|Sensory System Agents|sensory system agents|mesh-ancestor
102264852|NCT05899127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102264853|NCT05899127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102264854|NCT05899127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101819462|NCT01023087|Colistin|colistin|mesh-list
102264855|NCT05899127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102264856|NCT05899127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102264857|NCT05899127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264858|NCT05899127|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102264859|NCT05899127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102264860|NCT05899127|Anesthetics, General|anesthetics, general|mesh-ancestor
102264861|NCT05899127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102264862|NCT05899127|Narcotics|narcotics|mesh-ancestor
102264863|NCT05899127|Analgesics|analgesics|mesh-ancestor
102264864|NCT05899127|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102264865|NCT05899127|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102264866|NCT05899127|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102264867|NCT05899127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102264868|NCT05899049|Pembrolizumab|pembrolizumab|mesh-list
102264869|NCT05899049|Lenvatinib|lenvatinib|mesh-list
102264870|NCT05899049|Belzutifan|belzutifan|mesh-list
102264871|NCT05899049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102264872|NCT05899049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102264873|NCT05899049|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102264874|NCT05899049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264875|NCT05899049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102264876|NCT05899049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102264877|NCT05898984|Beclomethasone|beclomethasone|mesh-list
102264878|NCT05898984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102264879|NCT05898984|Glucocorticoids|glucocorticoids|mesh-ancestor
102264880|NCT05898984|Hormones|hormones|mesh-ancestor
102613856|NCT00002945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102613857|NCT00002945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102613858|NCT00002945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102264881|NCT05898984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102264888|NCT05898763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102264889|NCT05898763|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102264890|NCT05898763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264891|NCT05898763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102264892|NCT05898763|Immunologic Factors|immunologic factors|mesh-ancestor
102264893|NCT05898763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264894|NCT05898633|Pulmonary Surfactants|pulmonary surfactants|mesh-list
102264895|NCT05898633|Pulmonary Surfactant-Associated Protein D|pulmonary surfactant-associated protein d|mesh-list
102264896|NCT05898633|Respiratory System Agents|respiratory system agents|mesh-ancestor
102264897|NCT05898451|Cisplatin|cisplatin|mesh-list
102264898|NCT05898451|Dacarbazine|dacarbazine|mesh-list
102264899|NCT05898451|Lomustine|lomustine|mesh-list
102264900|NCT05898451|Thymalfasin|thymalfasin|mesh-list
102264901|NCT05898451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102264902|NCT05898451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102264903|NCT05898451|Alkylating Agents|alkylating agents|mesh-ancestor
102264904|NCT05898451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264905|NCT05898451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102264906|NCT05898451|Immunologic Factors|immunologic factors|mesh-ancestor
102264907|NCT05898451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264908|NCT05898373|Antineoplastic Agents|antineoplastic agents|mesh-list
102264909|NCT05898321|Goserelin|goserelin|mesh-list
102264910|NCT05898321|Mifepristone|mifepristone|mesh-list
102264911|NCT05898321|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102264912|NCT05898321|Abortifacient Agents|abortifacient agents|mesh-ancestor
102264913|NCT05898321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102264914|NCT05898321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264915|NCT05898321|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101283187|NCT01912534|Valsartan|valsartan|mesh-list
102264916|NCT05898321|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102264917|NCT05898321|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102264918|NCT05898321|Contraceptive Agents|contraceptive agents|mesh-ancestor
102264919|NCT05898321|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102264920|NCT05898321|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102264921|NCT05898321|Hormone Antagonists|hormone antagonists|mesh-ancestor
102264922|NCT05898321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102264923|NCT05898321|Luteolytic Agents|luteolytic agents|mesh-ancestor
102264924|NCT05898321|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102264925|NCT05898321|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102264926|NCT05898321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102264927|NCT05898321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102264928|NCT05898308|Rituximab|rituximab|mesh-list
102264929|NCT05898308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102264930|NCT05898308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102264931|NCT05898308|Immunologic Factors|immunologic factors|mesh-ancestor
102264932|NCT05898308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264933|NCT05898308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102264934|NCT05898256|Gemcitabine|gemcitabine|mesh-list
102264935|NCT05898256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102264936|NCT05898256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102264937|NCT05898256|Antimetabolites|antimetabolites|mesh-ancestor
102264938|NCT05898256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264939|NCT05898087|Bupivacaine|bupivacaine|mesh-list
102264940|NCT05898087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102264941|NCT05898087|Anesthetics, Local|anesthetics, local|mesh-ancestor
102264942|NCT05898087|Anesthetics|anesthetics|mesh-ancestor
102264943|NCT05898087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102264944|NCT05898087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264945|NCT05898087|Sensory System Agents|sensory system agents|mesh-ancestor
102264946|NCT05898087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102613860|NCT00002945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102264954|NCT05897918|Tranexamic Acid|tranexamic acid|mesh-list
102264955|NCT05897918|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102264956|NCT05897918|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102264957|NCT05897918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264958|NCT05897918|Hemostatics|hemostatics|mesh-ancestor
102264959|NCT05897918|Coagulants|coagulants|mesh-ancestor
102264960|NCT05897034|Doxycycline|doxycycline|mesh-list
102264961|NCT05897034|Nitazoxanide|nitazoxanide|mesh-list
102264962|NCT05897034|Pentoxifylline|pentoxifylline|mesh-list
102264963|NCT05897034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102264964|NCT05897034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102264965|NCT05897034|Antimalarials|antimalarials|mesh-ancestor
102264966|NCT05897034|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102264967|NCT05897034|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102264968|NCT05897034|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102264969|NCT05897034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102264970|NCT05897034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264971|NCT05897034|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102264972|NCT05897034|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102264973|NCT05897034|Protective Agents|protective agents|mesh-ancestor
102264974|NCT05897034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264975|NCT05897034|Vasodilator Agents|vasodilator agents|mesh-ancestor
102264976|NCT05897034|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102264977|NCT05897034|Antioxidants|antioxidants|mesh-ancestor
102264978|NCT05897008|Omalizumab|omalizumab|mesh-list
102264979|NCT05897008|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102264980|NCT05897008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102264981|NCT05897008|Respiratory System Agents|respiratory system agents|mesh-ancestor
102264982|NCT05892939|Oxytocin|oxytocin|mesh-list
102264983|NCT05892939|Oxytocics|oxytocics|mesh-ancestor
102264984|NCT05892939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102264985|NCT05892939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264986|NCT05890534|Pycnogenols|pycnogenols|mesh-list
102264987|NCT05890534|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102264988|NCT05890534|Immunologic Factors|immunologic factors|mesh-ancestor
102264989|NCT05890534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102264990|NCT05890534|Antioxidants|antioxidants|mesh-ancestor
102264991|NCT05890534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102264992|NCT05890534|Protective Agents|protective agents|mesh-ancestor
102264993|NCT05890534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102264994|NCT05888896|Antihypertensive Agents|antihypertensive agents|mesh-list
102264995|NCT05888896|Methyldopa|methyldopa|mesh-list
102264996|NCT05888896|Sympatholytics|sympatholytics|mesh-ancestor
102264997|NCT05888896|Autonomic Agents|autonomic agents|mesh-ancestor
102264998|NCT05888896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102264999|NCT05888896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265000|NCT05888896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102265001|NCT05888896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102265002|NCT05888896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102265003|NCT05888896|Adrenergic Agents|adrenergic agents|mesh-ancestor
102265004|NCT05888896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101973881|NCT03781375|Etanercept|etanercept|mesh-list
102265005|NCT05888896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265006|NCT05886049|Cytarabine|cytarabine|mesh-list
102265007|NCT05886049|Daunorubicin|daunorubicin|mesh-list
102265008|NCT05886049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102265009|NCT05886049|Antimetabolites|antimetabolites|mesh-ancestor
102265010|NCT05886049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265011|NCT05886049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613861|NCT00002945|Antimetabolites|antimetabolites|mesh-ancestor
102613862|NCT00002945|Antiviral Agents|antiviral agents|mesh-ancestor
102613863|NCT00002945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102613864|NCT00002945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102613865|NCT00002945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102613866|NCT00002945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102613867|NCT00002951|Fluorouracil|fluorouracil|mesh-list
102613868|NCT00002951|Hydroxyurea|hydroxyurea|mesh-list
102613869|NCT00002951|Antimetabolites|antimetabolites|mesh-ancestor
102613870|NCT00002951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613871|NCT00002951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102613872|NCT00002951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613873|NCT00002951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102613874|NCT00002951|Immunologic Factors|immunologic factors|mesh-ancestor
102613875|NCT00002951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265012|NCT05886049|Antiviral Agents|antiviral agents|mesh-ancestor
102613876|NCT00002951|Antisickling Agents|antisickling agents|mesh-ancestor
102265017|NCT05886049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102265018|NCT05886049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102265019|NCT05886049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102265020|NCT05886049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101819615|NCT03762915|Minocycline|minocycline|mesh-list
102265026|NCT05861765|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102265027|NCT05861765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102265028|NCT05861765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265029|NCT05861765|Vasodilator Agents|vasodilator agents|mesh-ancestor
102265030|NCT05861765|Urological Agents|urological agents|mesh-ancestor
102265031|NCT05849207|Cyclophosphamide|cyclophosphamide|mesh-list
102265032|NCT05849207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102265033|NCT05849207|Immunologic Factors|immunologic factors|mesh-ancestor
102265034|NCT05849207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265035|NCT05849207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102265036|NCT05849207|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102265037|NCT05849207|Alkylating Agents|alkylating agents|mesh-ancestor
102265038|NCT05849207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265039|NCT05849207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265040|NCT05849207|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102265041|NCT05818618|Clobetasol|clobetasol|mesh-list
102265042|NCT05818618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102265043|NCT05818618|Glucocorticoids|glucocorticoids|mesh-ancestor
102265044|NCT05818618|Hormones|hormones|mesh-ancestor
102265045|NCT05818618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102265046|NCT05818618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265047|NCT05809921|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102265048|NCT05809921|Tenecteplase|tenecteplase|mesh-list
102265049|NCT05809921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102265050|NCT05809921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102265051|NCT05809921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265052|NCT05804513|Lixisenatide|lixisenatide|mesh-list
102265053|NCT05804513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102265054|NCT05804513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265055|NCT05783219|Lidocaine|lidocaine|mesh-list
102265056|NCT05783219|Anesthetics, Local|anesthetics, local|mesh-ancestor
102265057|NCT05783219|Anesthetics|anesthetics|mesh-ancestor
102265058|NCT05783219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102265059|NCT05783219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265060|NCT05783219|Sensory System Agents|sensory system agents|mesh-ancestor
102265061|NCT05783219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102265062|NCT05783219|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102265063|NCT05783219|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102265064|NCT05783219|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102265065|NCT05783219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102265066|NCT05783219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265067|NCT05747352|Insulin|insulin|mesh-list
102265068|NCT05747352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102265069|NCT05747352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265070|NCT05746520|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102265071|NCT05746520|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102265072|NCT05746520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102265073|NCT05746520|Antitubercular Agents|antitubercular agents|mesh-ancestor
102265074|NCT05733598|Bevacizumab|bevacizumab|mesh-list
102265075|NCT05733598|Atezolizumab|atezolizumab|mesh-list
102265076|NCT05733598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102265077|NCT05733598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265078|NCT05733598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102265079|NCT05733598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102265080|NCT05733598|Growth Substances|growth substances|mesh-ancestor
102265081|NCT05733598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265082|NCT05733598|Growth Inhibitors|growth inhibitors|mesh-ancestor
102265083|NCT05733598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102265084|NCT05733598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613877|NCT00002951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102265085|NCT05733507|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102265086|NCT05733507|Tenecteplase|tenecteplase|mesh-list
102265087|NCT05733507|Tirofiban|tirofiban|mesh-list
102265088|NCT05733507|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102265089|NCT05733507|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102265090|NCT05733507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265091|NCT05733507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102265092|NCT05709444|Angiotensin II|angiotensin ii|mesh-list
102265093|NCT05709444|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
102265094|NCT05709444|alpha-MSH|alpha-msh|mesh-list
102265095|NCT05709444|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102265096|NCT05709444|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102265097|NCT05709444|Protease Inhibitors|protease inhibitors|mesh-ancestor
102265098|NCT05709444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102265099|NCT05709444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265100|NCT05709444|Hormones|hormones|mesh-ancestor
102265101|NCT05709444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102265102|NCT05709444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265103|NCT05704036|Estradiol|estradiol|mesh-list
102265104|NCT05704036|Estrogens|estrogens|mesh-list
102265105|NCT05704036|Progesterone|progesterone|mesh-list
102265106|NCT05704036|Hormones|hormones|mesh-ancestor
102265107|NCT05704036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102265108|NCT05704036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265109|NCT05704036|Progestins|progestins|mesh-ancestor
102265110|NCT05583110|Trastuzumab|trastuzumab|mesh-list
102265111|NCT05583110|Vinorelbine|vinorelbine|mesh-list
102265112|NCT05583110|Tucatinib|tucatinib|mesh-list
102265113|NCT05583110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102265114|NCT05583110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265115|NCT05583110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102265116|NCT05583110|Tubulin Modulators|tubulin modulators|mesh-ancestor
102265117|NCT05583110|Antimitotic Agents|antimitotic agents|mesh-ancestor
102265118|NCT05583110|Mitosis Modulators|mitosis modulators|mesh-ancestor
102265119|NCT05583110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819702|NCT01023399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102265120|NCT05583110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102265121|NCT05583110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102265122|NCT05565937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102265123|NCT05537935|Naltrexone|naltrexone|mesh-list
102265124|NCT05537935|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102265125|NCT05537935|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102265126|NCT05537935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265127|NCT05537935|Sensory System Agents|sensory system agents|mesh-ancestor
102265128|NCT05537935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102265129|NCT05455697|Prednisone|prednisone|mesh-list
102265130|NCT05455697|Cyclophosphamide|cyclophosphamide|mesh-list
102265131|NCT05455697|Rituximab|rituximab|mesh-list
102265132|NCT05455697|Doxorubicin|doxorubicin|mesh-list
102265133|NCT05455697|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102265134|NCT05455697|Vincristine|vincristine|mesh-list
102265135|NCT05455697|Daunorubicin|daunorubicin|mesh-list
102265136|NCT05455697|Immunoglobulins|immunoglobulins|mesh-list
102265137|NCT05455697|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102265138|NCT05455697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102265139|NCT05455697|Immunologic Factors|immunologic factors|mesh-ancestor
102265140|NCT05455697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265141|NCT05455697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102265142|NCT05455697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102265143|NCT05455697|Alkylating Agents|alkylating agents|mesh-ancestor
102265144|NCT05455697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265145|NCT05455697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265146|NCT05455697|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102265147|NCT05455697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102265148|NCT05455697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102265149|NCT05455697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102265150|NCT05455697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102265151|NCT05455697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102265152|NCT05455697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101974026|NCT01222975|Risperidone|risperidone|mesh-list
102265153|NCT05455697|Glucocorticoids|glucocorticoids|mesh-ancestor
102265154|NCT05455697|Hormones|hormones|mesh-ancestor
102265155|NCT05455697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102265156|NCT05455697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102265157|NCT05455697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102265158|NCT05455697|Tubulin Modulators|tubulin modulators|mesh-ancestor
102265159|NCT05455697|Antimitotic Agents|antimitotic agents|mesh-ancestor
102265161|NCT05455697|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102265162|NCT05411679|Olaparib|olaparib|mesh-list
102265163|NCT05411679|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102265164|NCT05411679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102265165|NCT05411679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265166|NCT05411679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265167|NCT05406479|Bedaquiline|bedaquiline|mesh-list
102265168|NCT05406479|Antitubercular Agents|antitubercular agents|mesh-ancestor
102265169|NCT05406479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102265170|NCT05406479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102265171|NCT05384665|Sufentanil|sufentanil|mesh-list
102265172|NCT05384665|Remifentanil|remifentanil|mesh-list
102265173|NCT05384665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102265174|NCT05384665|Narcotics|narcotics|mesh-ancestor
102265175|NCT05384665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102265176|NCT05384665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265177|NCT05384665|Analgesics|analgesics|mesh-ancestor
102265178|NCT05384665|Sensory System Agents|sensory system agents|mesh-ancestor
102265179|NCT05384665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102265180|NCT05384665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102265181|NCT05384665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102265182|NCT05384665|Anesthetics, General|anesthetics, general|mesh-ancestor
102265183|NCT05384665|Anesthetics|anesthetics|mesh-ancestor
102265184|NCT05363319|Cemiplimab|cemiplimab|mesh-list
102265185|NCT05363319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102265186|NCT05363319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265187|NCT05325281|Thioctic Acid|thioctic acid|mesh-list
102265188|NCT05325281|Gemcitabine|gemcitabine|mesh-list
102265189|NCT05325281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102265190|NCT05325281|Antimetabolites|antimetabolites|mesh-ancestor
102265191|NCT05325281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265192|NCT05325281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265193|NCT05325281|Antioxidants|antioxidants|mesh-ancestor
102265194|NCT05325281|Protective Agents|protective agents|mesh-ancestor
102265195|NCT05325281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265196|NCT05325281|Vitamin B Complex|vitamin b complex|mesh-ancestor
102265197|NCT05325281|Vitamins|vitamins|mesh-ancestor
102265198|NCT05325281|Micronutrients|micronutrients|mesh-ancestor
102265199|NCT05254275|Chlorhexidine|chlorhexidine|mesh-list
102265200|NCT05254275|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102265201|NCT05254275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102265202|NCT05254275|Disinfectants|disinfectants|mesh-ancestor
102265203|NCT05193994|Lamivudine|lamivudine|mesh-list
102265204|NCT05193994|Abacavir|abacavir|mesh-list
102265205|NCT05193994|Dolutegravir|dolutegravir|mesh-list
102265206|NCT05193994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102265207|NCT05193994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102265208|NCT05193994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102265209|NCT05193994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265210|NCT05193994|Antiviral Agents|antiviral agents|mesh-ancestor
102265211|NCT05193994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102265212|NCT05193994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102265213|NCT05193994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102265214|NCT05193994|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102265215|NCT05193994|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102265216|NCT05191784|Bevacizumab|bevacizumab|mesh-list
102265217|NCT05191784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102265218|NCT05191784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265219|NCT05191784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102265220|NCT05191784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102265221|NCT05191784|Growth Substances|growth substances|mesh-ancestor
102265222|NCT05191784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265223|NCT05191784|Growth Inhibitors|growth inhibitors|mesh-ancestor
102265224|NCT05177263|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102265225|NCT05159934|Nicotine|nicotine|mesh-list
102265226|NCT05159934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102265227|NCT05159934|Autonomic Agents|autonomic agents|mesh-ancestor
101819803|NCT00450801|Serotonin Agents|serotonin agents|mesh-ancestor
102265228|NCT05159934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102265229|NCT05159934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265230|NCT05159934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102265231|NCT05159934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102265232|NCT05159934|Cholinergic Agents|cholinergic agents|mesh-ancestor
102265233|NCT05159934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102265234|NCT05159934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265235|NCT05137717|Maribavir|maribavir|mesh-list
102265236|NCT05137717|Antiviral Agents|antiviral agents|mesh-ancestor
102613878|NCT00002951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102265237|NCT05137717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102265238|NCT05077709|Pembrolizumab|pembrolizumab|mesh-list
102265239|NCT05077709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102265240|NCT05077709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265241|NCT05077709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102265242|NCT05077709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265243|NCT05020821|Dexmedetomidine|dexmedetomidine|mesh-list
102265244|NCT05020821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101819817|NCT00458211|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102265245|NCT05020821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102265246|NCT05020821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265247|NCT05020821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102265248|NCT05020821|Analgesics|analgesics|mesh-ancestor
102265249|NCT05020821|Sensory System Agents|sensory system agents|mesh-ancestor
102265250|NCT05020821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102265251|NCT05020821|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102265252|NCT05020821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102265253|NCT05020821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102265254|NCT05020821|Adrenergic Agents|adrenergic agents|mesh-ancestor
102265255|NCT05020821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102265256|NCT05020821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265257|NCT05020665|Cytarabine|cytarabine|mesh-list
102265258|NCT05020665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102265259|NCT05020665|Antimetabolites|antimetabolites|mesh-ancestor
102265260|NCT05020665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265261|NCT05020665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265262|NCT05020665|Antiviral Agents|antiviral agents|mesh-ancestor
102265263|NCT05020665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102265264|NCT05020665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102265265|NCT05020665|Immunologic Factors|immunologic factors|mesh-ancestor
102265266|NCT05020665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265267|NCT04996264|Varespladib methyl|varespladib methyl|mesh-list
102265268|NCT04996264|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
102265269|NCT04996264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102265270|NCT04996264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265271|NCT04941716|Venetoclax|venetoclax|mesh-list
102265272|NCT04941716|Acalabrutinib|acalabrutinib|mesh-list
102265273|NCT04941716|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102265274|NCT04941716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265275|NCT04941716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102265276|NCT04941716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102265277|NCT04941716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265278|NCT04911062|Epinephrine|epinephrine|mesh-list
102265279|NCT04911062|Bupivacaine|bupivacaine|mesh-list
102265280|NCT04911062|Anesthetics, Local|anesthetics, local|mesh-ancestor
102265281|NCT04911062|Anesthetics|anesthetics|mesh-ancestor
102265282|NCT04911062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102265283|NCT04911062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265284|NCT04911062|Sensory System Agents|sensory system agents|mesh-ancestor
102265285|NCT04911062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102265286|NCT04911062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102265287|NCT04911062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102265288|NCT04911062|Adrenergic Agents|adrenergic agents|mesh-ancestor
102265289|NCT04911062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102265290|NCT04911062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265291|NCT04911062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102265292|NCT04911062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102265293|NCT04911062|Autonomic Agents|autonomic agents|mesh-ancestor
102265294|NCT04911062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102265295|NCT04911062|Respiratory System Agents|respiratory system agents|mesh-ancestor
102265296|NCT04911062|Mydriatics|mydriatics|mesh-ancestor
102265297|NCT04911062|Sympathomimetics|sympathomimetics|mesh-ancestor
102265298|NCT04911062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102265299|NCT04892472|Pembrolizumab|pembrolizumab|mesh-list
102265300|NCT04892472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102265301|NCT04892472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265302|NCT04892472|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102265303|NCT04892472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265304|NCT04818749|Dexamethasone|dexamethasone|mesh-list
102265305|NCT04818749|Dexamethasone acetate|dexamethasone acetate|mesh-list
102265306|NCT04818749|Dexmedetomidine|dexmedetomidine|mesh-list
102265307|NCT04818749|BB 1101|bb 1101|mesh-list
102265308|NCT04818749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102613879|NCT03058289|Pembrolizumab|pembrolizumab|mesh-list
102613880|NCT03058289|Ipilimumab|ipilimumab|mesh-list
102265309|NCT04818749|Antiemetics|antiemetics|mesh-ancestor
102265310|NCT04818749|Autonomic Agents|autonomic agents|mesh-ancestor
102265311|NCT04818749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102265312|NCT04818749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265313|NCT04818749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102265314|NCT04818749|Glucocorticoids|glucocorticoids|mesh-ancestor
102265315|NCT04818749|Hormones|hormones|mesh-ancestor
102265316|NCT04818749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102265317|NCT04818749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102265318|NCT04818749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265319|NCT04818749|Protease Inhibitors|protease inhibitors|mesh-ancestor
102265320|NCT04818749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102265321|NCT04818749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265322|NCT04818749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102265323|NCT04818749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102265324|NCT04818749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102265325|NCT04818749|Analgesics|analgesics|mesh-ancestor
102265326|NCT04818749|Sensory System Agents|sensory system agents|mesh-ancestor
102265327|NCT04818749|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102265328|NCT04818749|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102265329|NCT04818749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102265330|NCT04818749|Adrenergic Agents|adrenergic agents|mesh-ancestor
102265331|NCT04818749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102265332|NCT04776395|Dexamethasone|dexamethasone|mesh-list
102265333|NCT04776395|Dexamethasone acetate|dexamethasone acetate|mesh-list
102265334|NCT04776395|Ichthammol|ichthammol|mesh-list
102265335|NCT04776395|BB 1101|bb 1101|mesh-list
102265336|NCT04776395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102265337|NCT04776395|Antiemetics|antiemetics|mesh-ancestor
102265338|NCT04776395|Autonomic Agents|autonomic agents|mesh-ancestor
102265339|NCT04776395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102265340|NCT04776395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265341|NCT04776395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102265342|NCT04776395|Glucocorticoids|glucocorticoids|mesh-ancestor
102265343|NCT04776395|Hormones|hormones|mesh-ancestor
102265344|NCT04776395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102265345|NCT04776395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102265346|NCT04776395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265347|NCT04776395|Protease Inhibitors|protease inhibitors|mesh-ancestor
102265348|NCT04776395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102265349|NCT04776395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265350|NCT04776395|Dermatologic Agents|dermatologic agents|mesh-ancestor
102265351|NCT04738643|Varenicline|varenicline|mesh-list
102265352|NCT04738643|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102265353|NCT04738643|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102265354|NCT04738643|Cholinergic Agents|cholinergic agents|mesh-ancestor
101285617|NCT01936025|Hormones|hormones|mesh-ancestor
102265355|NCT04738643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102265356|NCT04738643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265357|NCT04738643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265358|NCT04588688|Mifepristone|mifepristone|mesh-list
102265359|NCT04588688|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102265360|NCT04588688|Abortifacient Agents|abortifacient agents|mesh-ancestor
102265361|NCT04588688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102265362|NCT04588688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265363|NCT04588688|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102265364|NCT04588688|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102265365|NCT04588688|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102265366|NCT04588688|Contraceptive Agents|contraceptive agents|mesh-ancestor
102265367|NCT04588688|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102265368|NCT04588688|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102265369|NCT04588688|Hormone Antagonists|hormone antagonists|mesh-ancestor
102265370|NCT04588688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102265371|NCT04588688|Luteolytic Agents|luteolytic agents|mesh-ancestor
102265372|NCT04588688|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102265373|NCT04588688|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102265374|NCT04587830|Temozolomide|temozolomide|mesh-list
102265375|NCT04587830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102265376|NCT04587830|Alkylating Agents|alkylating agents|mesh-ancestor
102265377|NCT04587830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265378|NCT04587830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265379|NCT04558281|Ropivacaine|ropivacaine|mesh-list
102265380|NCT04558281|Anesthetics, Local|anesthetics, local|mesh-ancestor
102265381|NCT04558281|Anesthetics|anesthetics|mesh-ancestor
102613882|NCT03058289|Immunoglobulins|immunoglobulins|mesh-list
102265382|NCT04558281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102265383|NCT04558281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265384|NCT04558281|Sensory System Agents|sensory system agents|mesh-ancestor
102265385|NCT04558281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102265386|NCT04498468|Dexamethasone|dexamethasone|mesh-list
102265387|NCT04498468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102265388|NCT04498468|Antiemetics|antiemetics|mesh-ancestor
102265389|NCT04498468|Autonomic Agents|autonomic agents|mesh-ancestor
102265390|NCT04498468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102265391|NCT04498468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265392|NCT04498468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102265393|NCT04498468|Glucocorticoids|glucocorticoids|mesh-ancestor
102265394|NCT04498468|Hormones|hormones|mesh-ancestor
102265395|NCT04498468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102265396|NCT04498468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102265397|NCT04498468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265398|NCT04401267|Antihypertensive Agents|antihypertensive agents|mesh-list
102265399|NCT04343222|Bromfenac|bromfenac|mesh-list
102265400|NCT04343222|Lubricant Eye Drops|lubricant eye drops|mesh-list
102265401|NCT04343222|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102265402|NCT04343222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102265403|NCT04343222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102265404|NCT04343222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102265405|NCT04343222|Analgesics|analgesics|mesh-ancestor
102265406|NCT04343222|Sensory System Agents|sensory system agents|mesh-ancestor
102265407|NCT04343222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102265408|NCT04343222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265409|NCT04343222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102265410|NCT04343222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102265411|NCT04342039|Budesonide|budesonide|mesh-list
102265412|NCT04342039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102265413|NCT04342039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102265414|NCT04342039|Autonomic Agents|autonomic agents|mesh-ancestor
102265415|NCT04342039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102265416|NCT04342039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265417|NCT04342039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102265418|NCT04342039|Respiratory System Agents|respiratory system agents|mesh-ancestor
102265419|NCT04342039|Glucocorticoids|glucocorticoids|mesh-ancestor
102265420|NCT04342039|Hormones|hormones|mesh-ancestor
102265421|NCT04342039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102265422|NCT04311671|Ivermectin|ivermectin|mesh-list
102265423|NCT04311671|Albendazole|albendazole|mesh-list
102265424|NCT04311671|Moxidectin|moxidectin|mesh-list
102265425|NCT04311671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102265426|NCT04311671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102265427|NCT04311671|Anthelmintics|anthelmintics|mesh-ancestor
102265428|NCT04311671|Anticestodal Agents|anticestodal agents|mesh-ancestor
102265429|NCT04311671|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102265430|NCT04311671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101819980|NCT00467649|Insulin|insulin|mesh-list
102265431|NCT04311671|Tubulin Modulators|tubulin modulators|mesh-ancestor
102265432|NCT04311671|Antimitotic Agents|antimitotic agents|mesh-ancestor
102265433|NCT04311671|Mitosis Modulators|mitosis modulators|mesh-ancestor
102265434|NCT04311671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265435|NCT04311671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265436|NCT04311671|Antinematodal Agents|antinematodal agents|mesh-ancestor
102265437|NCT04281108|Fluticasone|fluticasone|mesh-list
102265439|NCT04281108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102265440|NCT04281108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102265441|NCT04281108|Autonomic Agents|autonomic agents|mesh-ancestor
102265442|NCT04281108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102265443|NCT04281108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265444|NCT04281108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102265445|NCT04281108|Respiratory System Agents|respiratory system agents|mesh-ancestor
102265446|NCT04281108|Dermatologic Agents|dermatologic agents|mesh-ancestor
102265447|NCT04281108|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102265448|NCT04268849|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102265449|NCT04268849|Hematinics|hematinics|mesh-ancestor
102265450|NCT04268849|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102265451|NCT04268849|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102265452|NCT04258046|Trametinib|trametinib|mesh-list
102265453|NCT04258046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265454|NCT04258046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102265455|NCT04258046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102265456|NCT04258046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613883|NCT03058289|Immunologic Factors|immunologic factors|mesh-ancestor
102265457|NCT04215978|Tislelizumab|tislelizumab|mesh-list
101820012|NCT00450255|Growth Inhibitors|growth inhibitors|mesh-ancestor
102265458|NCT04215978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102265459|NCT04215978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265460|NCT04189055|Irinotecan|irinotecan|mesh-list
102265461|NCT04189055|Cetuximab|cetuximab|mesh-list
102265462|NCT04189055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102265463|NCT04189055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102265464|NCT04189055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102265465|NCT04189055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265466|NCT04189055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101820025|NCT01024179|Sirolimus|sirolimus|mesh-list
102265467|NCT04189055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102265468|NCT04147806|Dexamethasone|dexamethasone|mesh-list
102265469|NCT04147806|Tamsulosin|tamsulosin|mesh-list
102265470|NCT04147806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102265471|NCT04147806|Antiemetics|antiemetics|mesh-ancestor
102265472|NCT04147806|Autonomic Agents|autonomic agents|mesh-ancestor
102265473|NCT04147806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102265474|NCT04147806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265475|NCT04147806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102265476|NCT04147806|Glucocorticoids|glucocorticoids|mesh-ancestor
102265477|NCT04147806|Hormones|hormones|mesh-ancestor
102265478|NCT04147806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102265479|NCT04147806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102265480|NCT04147806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265481|NCT04147806|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102265482|NCT04147806|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102265483|NCT04147806|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102265484|NCT04147806|Adrenergic Agents|adrenergic agents|mesh-ancestor
102265485|NCT04147806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102265486|NCT04147806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265487|NCT04147806|Urological Agents|urological agents|mesh-ancestor
102265488|NCT04122625|Nivolumab|nivolumab|mesh-list
102265489|NCT04122625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102265490|NCT04122625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265491|NCT04122625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102265492|NCT04122625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265493|NCT04117945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102265494|NCT04117945|Cetuximab|cetuximab|mesh-list
102265495|NCT04117945|Panitumumab|panitumumab|mesh-list
102265496|NCT04117945|Irinotecan|irinotecan|mesh-list
102265497|NCT04117945|Antibodies|antibodies|mesh-list
102265498|NCT04117945|Immunoglobulins|immunoglobulins|mesh-list
101820055|NCT02551367|Fertility Agents|fertility agents|mesh-ancestor
102265499|NCT04117945|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102265500|NCT04117945|Immunologic Factors|immunologic factors|mesh-ancestor
102265501|NCT04117945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265502|NCT04117945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265503|NCT04117945|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102265504|NCT04117945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102265505|NCT04117945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102265506|NCT04117945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265507|NCT04097561|Belimumab|belimumab|mesh-list
102265508|NCT04097561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102265509|NCT04097561|Immunologic Factors|immunologic factors|mesh-ancestor
102265510|NCT04097561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265511|NCT04077346|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
102265512|NCT04077346|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102265513|NCT04077346|Immunologic Factors|immunologic factors|mesh-ancestor
102265514|NCT04077346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265515|NCT04076462|Octreotide|octreotide|mesh-list
102265516|NCT04076462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102265517|NCT04076462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102265518|NCT04076462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265519|NCT04066348|Etanercept|etanercept|mesh-list
102265520|NCT04066348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102265521|NCT04066348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102265522|NCT04066348|Analgesics|analgesics|mesh-ancestor
102265523|NCT04066348|Sensory System Agents|sensory system agents|mesh-ancestor
102265524|NCT04066348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102265525|NCT04066348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265526|NCT04066348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102265527|NCT04066348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102265528|NCT04066348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102265529|NCT04066348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102265530|NCT04066348|Immunologic Factors|immunologic factors|mesh-ancestor
102613884|NCT03058289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265532|NCT04057898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102265533|NCT04057898|Autonomic Agents|autonomic agents|mesh-ancestor
102265534|NCT04057898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102265535|NCT04057898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265536|NCT04057898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102265537|NCT04057898|Respiratory System Agents|respiratory system agents|mesh-ancestor
102265538|NCT04057898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102265539|NCT04057898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101820064|NCT00813449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265540|NCT04057898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265541|NCT04057898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102265542|NCT04057898|Vasodilator Agents|vasodilator agents|mesh-ancestor
102265543|NCT04044313|Lenvatinib|lenvatinib|mesh-list
102265544|NCT04044313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265545|NCT04044313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102265546|NCT04044313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102265547|NCT04044313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265548|NCT04032990|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
102265549|NCT04032990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102265550|NCT04032990|Immunologic Factors|immunologic factors|mesh-ancestor
102265551|NCT04032990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265552|NCT03847428|Bevacizumab|bevacizumab|mesh-list
102265553|NCT03847428|Durvalumab|durvalumab|mesh-list
102265554|NCT03847428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102265555|NCT03847428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265556|NCT03847428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102265557|NCT03847428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102265558|NCT03847428|Growth Substances|growth substances|mesh-ancestor
102265559|NCT03847428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265560|NCT03847428|Growth Inhibitors|growth inhibitors|mesh-ancestor
102265561|NCT03828201|Levofloxacin|levofloxacin|mesh-list
102265562|NCT03828201|Linezolid|linezolid|mesh-list
102265563|NCT03828201|Bedaquiline|bedaquiline|mesh-list
102265564|NCT03828201|Clofazimine|clofazimine|mesh-list
102265565|NCT03828201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102265566|NCT03828201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102265567|NCT03828201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102265568|NCT03828201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102265569|NCT03828201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102265570|NCT03828201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102265571|NCT03828201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265572|NCT03828201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265573|NCT03828201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102265574|NCT03828201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102265575|NCT03828201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102265576|NCT03828201|Antitubercular Agents|antitubercular agents|mesh-ancestor
102265577|NCT03828201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102265578|NCT03828201|Leprostatic Agents|leprostatic agents|mesh-ancestor
102265579|NCT03824704|Nivolumab|nivolumab|mesh-list
102265580|NCT03824704|Rucaparib|rucaparib|mesh-list
102265581|NCT03824704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102265582|NCT03824704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265583|NCT03824704|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101820118|NCT00449787|Serotonin Agents|serotonin agents|mesh-ancestor
102265584|NCT03824704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265585|NCT03824704|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102265586|NCT03824704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102265587|NCT03798106|Durvalumab|durvalumab|mesh-list
102265588|NCT03798106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102265589|NCT03798106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265590|NCT03767075|Atezolizumab|atezolizumab|mesh-list
102265591|NCT03767075|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
102265592|NCT03767075|Futibatinib|futibatinib|mesh-list
102265593|NCT03767075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102265594|NCT03767075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265595|NCT03767075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102265596|NCT03767075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265597|NCT03766581|Aspirin|aspirin|mesh-list
102265598|NCT03766581|Clopidogrel|clopidogrel|mesh-list
102265599|NCT03766581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102265600|NCT03766581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102265601|NCT03766581|Analgesics|analgesics|mesh-ancestor
102265602|NCT03766581|Sensory System Agents|sensory system agents|mesh-ancestor
102613885|NCT03058289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102613886|NCT03058289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265603|NCT03766581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101974473|NCT05767086|Hormones|hormones|mesh-list
102265604|NCT03766581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265605|NCT03766581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102265606|NCT03766581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102265607|NCT03766581|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102265608|NCT03766581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102265609|NCT03766581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265610|NCT03766581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102265611|NCT03766581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102265612|NCT03766581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102265613|NCT03766581|Antipyretics|antipyretics|mesh-ancestor
102265614|NCT03766581|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102265615|NCT03766581|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102265616|NCT03766581|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102265617|NCT03766581|Purinergic Agents|purinergic agents|mesh-ancestor
102265618|NCT03766581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102265619|NCT03702725|Dexamethasone|dexamethasone|mesh-list
102265620|NCT03702725|Lenalidomide|lenalidomide|mesh-list
102265621|NCT03702725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102265622|NCT03702725|Antiemetics|antiemetics|mesh-ancestor
102265623|NCT03702725|Autonomic Agents|autonomic agents|mesh-ancestor
102265624|NCT03702725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102265625|NCT03702725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265626|NCT03702725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102265627|NCT03702725|Glucocorticoids|glucocorticoids|mesh-ancestor
102265628|NCT03702725|Hormones|hormones|mesh-ancestor
101820165|NCT00457665|Efavirenz|efavirenz|mesh-list
102265629|NCT03702725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102265630|NCT03702725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102265631|NCT03702725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265632|NCT03702725|Immunologic Factors|immunologic factors|mesh-ancestor
102265633|NCT03702725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102265634|NCT03702725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102265635|NCT03702725|Growth Substances|growth substances|mesh-ancestor
102265636|NCT03702725|Growth Inhibitors|growth inhibitors|mesh-ancestor
102265637|NCT03670966|Mycophenolic Acid|mycophenolic acid|mesh-list
102265638|NCT03670966|Cyclophosphamide|cyclophosphamide|mesh-list
102265639|NCT03670966|Fludarabine|fludarabine|mesh-list
102265640|NCT03670966|Fludarabine phosphate|fludarabine phosphate|mesh-list
102265641|NCT03670966|Tacrolimus|tacrolimus|mesh-list
102265642|NCT03670966|Antibodies|antibodies|mesh-list
102265643|NCT03670966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102265644|NCT03670966|Lenograstim|lenograstim|mesh-list
102265645|NCT03670966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102265646|NCT03670966|Immunologic Factors|immunologic factors|mesh-ancestor
102265647|NCT03670966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265648|NCT03670966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102265649|NCT03670966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101820182|NCT00457665|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102265650|NCT03670966|Alkylating Agents|alkylating agents|mesh-ancestor
102265651|NCT03670966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265652|NCT03670966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265653|NCT03670966|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102265654|NCT03670966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102265655|NCT03670966|Antimetabolites|antimetabolites|mesh-ancestor
102265656|NCT03670966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102265657|NCT03670966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102265658|NCT03670966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102265659|NCT03670966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102265660|NCT03670966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102265661|NCT03670966|Antitubercular Agents|antitubercular agents|mesh-ancestor
102265662|NCT03670966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102265663|NCT03670966|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102265664|NCT03653247|Plerixafor|plerixafor|mesh-list
102265665|NCT03653247|Busulfan|busulfan|mesh-list
102265666|NCT03653247|Alkylating Agents|alkylating agents|mesh-ancestor
102265667|NCT03653247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265668|NCT03653247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102265669|NCT03653247|Immunologic Factors|immunologic factors|mesh-ancestor
102265670|NCT03653247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265671|NCT03653247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102265672|NCT03653247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265673|NCT03653247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102265674|NCT03653247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102265675|NCT03653247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102265677|NCT03653247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102265678|NCT03527745|Albendazole|albendazole|mesh-list
102265679|NCT03527745|Anthelmintics|anthelmintics|mesh-ancestor
102265680|NCT03527745|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102265681|NCT03527745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102265682|NCT03527745|Anticestodal Agents|anticestodal agents|mesh-ancestor
102265683|NCT03527745|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102265684|NCT03527745|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102265685|NCT03527745|Tubulin Modulators|tubulin modulators|mesh-ancestor
102265686|NCT03527745|Antimitotic Agents|antimitotic agents|mesh-ancestor
102265687|NCT03527745|Mitosis Modulators|mitosis modulators|mesh-ancestor
102265688|NCT03527745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265689|NCT03527745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265690|NCT03522584|Durvalumab|durvalumab|mesh-list
102265691|NCT03522584|Ipilimumab|ipilimumab|mesh-list
102265692|NCT03522584|Tremelimumab|tremelimumab|mesh-list
102265693|NCT03522584|Immunoglobulins|immunoglobulins|mesh-list
102265694|NCT03522584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102265695|NCT03522584|Immunoglobulin G|immunoglobulin g|mesh-list
102265696|NCT03522584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102265697|NCT03522584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265698|NCT03522584|Immunologic Factors|immunologic factors|mesh-ancestor
102265699|NCT03522584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265700|NCT03522584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101287228|NCT05155527|Ivermectin|ivermectin|mesh-list
102265701|NCT03522584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265702|NCT03377361|Nivolumab|nivolumab|mesh-list
102265703|NCT03377361|Ipilimumab|ipilimumab|mesh-list
102265704|NCT03377361|Trametinib|trametinib|mesh-list
102265705|NCT03377361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102265706|NCT03377361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265707|NCT03377361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102265708|NCT03377361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265709|NCT03377361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102265710|NCT03377361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102265711|NCT03330405|Avelumab|avelumab|mesh-list
102265712|NCT03330405|Talazoparib|talazoparib|mesh-list
102265713|NCT03330405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102265714|NCT03330405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102265715|NCT03330405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265716|NCT03330405|Immunologic Factors|immunologic factors|mesh-ancestor
102265717|NCT03330405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265718|NCT03330405|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102265719|NCT03330405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102265720|NCT03330405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265721|NCT03284463|Glyburide|glyburide|mesh-list
102265722|NCT03284463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102265723|NCT03284463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265724|NCT03223103|Poly ICLC|poly iclc|mesh-list
102265725|NCT03223103|Interferon Inducers|interferon inducers|mesh-ancestor
102265726|NCT03223103|Immunologic Factors|immunologic factors|mesh-ancestor
102265727|NCT03223103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265728|NCT03174782|Bupivacaine|bupivacaine|mesh-list
102265729|NCT03174782|Anesthetics, Local|anesthetics, local|mesh-ancestor
102265730|NCT03174782|Anesthetics|anesthetics|mesh-ancestor
102265731|NCT03174782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102265732|NCT03174782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265733|NCT03174782|Sensory System Agents|sensory system agents|mesh-ancestor
102265734|NCT03174782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102265735|NCT03128034|Cyclosporine|cyclosporine|mesh-list
102265736|NCT03128034|Mycophenolic Acid|mycophenolic acid|mesh-list
102265737|NCT03128034|Fludarabine|fludarabine|mesh-list
102265738|NCT03128034|Fludarabine phosphate|fludarabine phosphate|mesh-list
102265739|NCT03128034|Cyclosporins|cyclosporins|mesh-list
102265740|NCT03128034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265741|NCT03128034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102265742|NCT03128034|Antimetabolites|antimetabolites|mesh-ancestor
102265743|NCT03128034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265744|NCT03128034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102265745|NCT03128034|Immunologic Factors|immunologic factors|mesh-ancestor
102265746|NCT03128034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265747|NCT03128034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102265748|NCT03128034|Antifungal Agents|antifungal agents|mesh-ancestor
102265749|NCT03128034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102265750|NCT03128034|Dermatologic Agents|dermatologic agents|mesh-ancestor
101974630|NCT05499832|Tenecteplase|tenecteplase|mesh-list
102613888|NCT03058289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265751|NCT03128034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102265752|NCT03128034|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102265753|NCT03128034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102265754|NCT03128034|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102265755|NCT03128034|Antitubercular Agents|antitubercular agents|mesh-ancestor
102265756|NCT03128034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102265758|NCT03064490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102265759|NCT03064490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265760|NCT03064490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102265761|NCT03064490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265762|NCT02919969|Pembrolizumab|pembrolizumab|mesh-list
102265763|NCT02919969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102265764|NCT02919969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265765|NCT02919969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101287643|NCT05077800|Losartan|losartan|mesh-list
102265766|NCT02919969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265767|NCT02837263|Pembrolizumab|pembrolizumab|mesh-list
102265768|NCT02837263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102265769|NCT02837263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265770|NCT02837263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102265771|NCT02837263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265772|NCT02616640|Dexamethasone|dexamethasone|mesh-list
102265773|NCT02616640|Durvalumab|durvalumab|mesh-list
102265774|NCT02616640|Pomalidomide|pomalidomide|mesh-list
102265775|NCT02616640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102265776|NCT02616640|Antiemetics|antiemetics|mesh-ancestor
102265777|NCT02616640|Autonomic Agents|autonomic agents|mesh-ancestor
102265778|NCT02616640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102265779|NCT02616640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265780|NCT02616640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102265781|NCT02616640|Glucocorticoids|glucocorticoids|mesh-ancestor
102265782|NCT02616640|Hormones|hormones|mesh-ancestor
102265783|NCT02616640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102265784|NCT02616640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101820304|NCT01027065|Tenofovir|tenofovir|mesh-list
102265785|NCT02616640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265786|NCT02616640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102265787|NCT02616640|Immunologic Factors|immunologic factors|mesh-ancestor
102265788|NCT02616640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102265789|NCT02616640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102265790|NCT02616640|Growth Substances|growth substances|mesh-ancestor
102265791|NCT02616640|Growth Inhibitors|growth inhibitors|mesh-ancestor
102265792|NCT02352883|Hormones|hormones|mesh-list
102265793|NCT02352883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102265794|NCT02352883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265795|NCT02270632|Methotrexate|methotrexate|mesh-list
102265796|NCT02270632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102265797|NCT02270632|Abortifacient Agents|abortifacient agents|mesh-ancestor
102265798|NCT02270632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102265799|NCT02270632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265800|NCT02270632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102265801|NCT02270632|Antimetabolites|antimetabolites|mesh-ancestor
102265802|NCT02270632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265803|NCT02270632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265804|NCT02270632|Dermatologic Agents|dermatologic agents|mesh-ancestor
102265805|NCT02270632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102265806|NCT02270632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102265807|NCT02270632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102265808|NCT02270632|Immunologic Factors|immunologic factors|mesh-ancestor
102265809|NCT02270632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102265810|NCT02270632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102265811|NCT02003209|Carboplatin|carboplatin|mesh-list
102265812|NCT02003209|Docetaxel|docetaxel|mesh-list
102265813|NCT02003209|Trastuzumab|trastuzumab|mesh-list
102265814|NCT02003209|Pertuzumab|pertuzumab|mesh-list
102265815|NCT02003209|Goserelin|goserelin|mesh-list
102265816|NCT02003209|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
102265817|NCT02003209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102265818|NCT02003209|Antibodies|antibodies|mesh-list
102265819|NCT02003209|Immunoglobulins|immunoglobulins|mesh-list
102265820|NCT02003209|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102265821|NCT02003209|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102265822|NCT02003209|Immunologic Factors|immunologic factors|mesh-ancestor
102265823|NCT02003209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265824|NCT02003209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613889|NCT00002963|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102265825|NCT02003209|Tubulin Modulators|tubulin modulators|mesh-ancestor
101288083|NCT05409365|Antibodies|antibodies|mesh-list
102265826|NCT02003209|Antimitotic Agents|antimitotic agents|mesh-ancestor
102265827|NCT02003209|Mitosis Modulators|mitosis modulators|mesh-ancestor
102265828|NCT02003209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265829|NCT02003209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102265830|NCT02003209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102265831|NCT02003209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102265832|NCT02003209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102265833|NCT02003209|Hormone Antagonists|hormone antagonists|mesh-ancestor
102265834|NCT02003209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102265835|NCT01968109|Nivolumab|nivolumab|mesh-list
102265836|NCT01968109|Relatlimab|relatlimab|mesh-list
102265837|NCT01968109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102265838|NCT01968109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265839|NCT01968109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102265840|NCT01968109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265841|NCT01891344|Rucaparib|rucaparib|mesh-list
102265842|NCT01891344|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102265843|NCT01891344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102265844|NCT01891344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265845|NCT01891344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265846|NCT01188096|Poly ICLC|poly iclc|mesh-list
102265847|NCT01188096|Interferon Inducers|interferon inducers|mesh-ancestor
102265848|NCT01188096|Immunologic Factors|immunologic factors|mesh-ancestor
102265849|NCT01188096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265850|NCT00632853|Carboplatin|carboplatin|mesh-list
102265851|NCT00632853|Etoposide|etoposide|mesh-list
102265852|NCT00632853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265853|NCT00632853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102265854|NCT00632853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102265855|NCT00632853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102265856|NCT00632853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102265857|NCT00632853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265858|NCT00579826|Letrozole|letrozole|mesh-list
102265859|NCT00579826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265860|NCT00579826|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101820370|NCT01028079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102265861|NCT00579826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102265862|NCT00579826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102265863|NCT00579826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265864|NCT00579826|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102265865|NCT00579826|Hormone Antagonists|hormone antagonists|mesh-ancestor
102265866|NCT00579826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102265867|NCT00579826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265868|NCT00106691|Toremifene|toremifene|mesh-list
102265869|NCT00106691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102265870|NCT00106691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265871|NCT00106691|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102265872|NCT00106691|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102265873|NCT00106691|Hormone Antagonists|hormone antagonists|mesh-ancestor
102265874|NCT00106691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102265875|NCT00106691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265876|NCT00106691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102265877|NCT04576325|Voriconazole|voriconazole|mesh-list
102265878|NCT04576325|Antifungal Agents|antifungal agents|mesh-ancestor
102265879|NCT04576325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102265880|NCT04576325|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102265881|NCT04576325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102265882|NCT04576325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102265883|NCT04576325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265884|NCT04576325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102265885|NCT04576325|Hormone Antagonists|hormone antagonists|mesh-ancestor
101820381|NCT01028079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102265886|NCT04576325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102265887|NCT04576325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265888|NCT04576325|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102265889|NCT03126617|Elotuzumab|elotuzumab|mesh-list
102265890|NCT03126617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265891|NCT04422743|Tramiprosate|tramiprosate|mesh-list
102265892|NCT04422743|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
102265893|NCT04422743|Nootropic Agents|nootropic agents|mesh-ancestor
102265894|NCT04422743|Anticonvulsants|anticonvulsants|mesh-ancestor
102613890|NCT00002963|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102265895|NCT04422743|GABA Agonists|gaba agonists|mesh-ancestor
102613891|NCT00002963|Dermatologic Agents|dermatologic agents|mesh-ancestor
102265896|NCT04422743|GABA Agents|gaba agents|mesh-ancestor
102265897|NCT04422743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102265898|NCT04422743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265899|NCT04422743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265900|NCT02535221|Epirubicin|epirubicin|mesh-list
102265901|NCT02535221|Goserelin|goserelin|mesh-list
102265902|NCT02535221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102265903|NCT02535221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102265904|NCT02535221|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102265905|NCT02535221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101820397|NCT00443703|Antiviral Agents|antiviral agents|mesh-ancestor
102265906|NCT02535221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102265907|NCT02535221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265908|NCT02535221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102265909|NCT00000587|Epoetin Alfa|epoetin alfa|mesh-list
102265910|NCT00000587|Hematinics|hematinics|mesh-ancestor
102265911|NCT04592159|Nabiximols|nabiximols|mesh-list
102265912|NCT04592159|Analgesics|analgesics|mesh-ancestor
101820420|NCT00381706|Antidotes|antidotes|mesh-ancestor
102265913|NCT04592159|Sensory System Agents|sensory system agents|mesh-ancestor
102265914|NCT04592159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102265915|NCT04592159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265916|NCT05137145|Linaclotide|linaclotide|mesh-list
102265917|NCT05137145|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102265918|NCT05137145|Enzyme Activators|enzyme activators|mesh-ancestor
102265919|NCT05137145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265920|NCT05137145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102265921|NCT05304845|Aspirin|aspirin|mesh-list
102265922|NCT05304845|Fexuprazan|fexuprazan|mesh-list
102265923|NCT05304845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102265924|NCT05304845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102265925|NCT05304845|Analgesics|analgesics|mesh-ancestor
102265926|NCT05304845|Sensory System Agents|sensory system agents|mesh-ancestor
102265927|NCT05304845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102265928|NCT05304845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265929|NCT05304845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102265930|NCT05304845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102265931|NCT05304845|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102265932|NCT05304845|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102265933|NCT05304845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265934|NCT05304845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102265935|NCT05304845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102265936|NCT05304845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102265937|NCT05304845|Antipyretics|antipyretics|mesh-ancestor
102265938|NCT05304845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102265939|NCT05303597|Lidocaine|lidocaine|mesh-list
102265940|NCT05303597|Anesthetics, Local|anesthetics, local|mesh-ancestor
102265941|NCT05303597|Anesthetics|anesthetics|mesh-ancestor
102265942|NCT05303597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102265943|NCT05303597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265944|NCT05303597|Sensory System Agents|sensory system agents|mesh-ancestor
102265945|NCT05303597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102265946|NCT05303597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101820446|NCT00370552|Tubulin Modulators|tubulin modulators|mesh-ancestor
102265947|NCT05303597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102265948|NCT05303597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102265949|NCT05303597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102265950|NCT05303597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265951|NCT04892459|Vaccines|vaccines|mesh-list
102265952|NCT04892459|Immunologic Factors|immunologic factors|mesh-ancestor
102265953|NCT04892459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265954|NCT04881539|Cannabidiol|cannabidiol|mesh-list
102265955|NCT04881539|Anticonvulsants|anticonvulsants|mesh-ancestor
102265956|NCT05303285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102265957|NCT05303285|Immunologic Factors|immunologic factors|mesh-ancestor
102265958|NCT05303285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265959|NCT04280939|Anesthetics|anesthetics|mesh-list
102265960|NCT04280939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102265961|NCT04280939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265962|NCT04489589|Midodrine|midodrine|mesh-list
102265963|NCT04489589|Sympathomimetics|sympathomimetics|mesh-ancestor
102265964|NCT04489589|Autonomic Agents|autonomic agents|mesh-ancestor
102265965|NCT04489589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102265966|NCT04489589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265967|NCT04489589|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102613892|NCT00002969|Paclitaxel|paclitaxel|mesh-list
101902298|NCT05571202|Anesthetics|anesthetics|mesh-list
102265968|NCT04489589|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102265969|NCT04489589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102265971|NCT04489589|Adrenergic Agents|adrenergic agents|mesh-ancestor
102265972|NCT04489589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102265973|NCT04489589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265974|NCT04328441|BCG Vaccine|bcg vaccine|mesh-list
101974845|NCT04790513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102265975|NCT04328441|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102265976|NCT04328441|Immunologic Factors|immunologic factors|mesh-ancestor
102265977|NCT04328441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265978|NCT04314713|Scopolamine|scopolamine|mesh-list
102265979|NCT04314713|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102265980|NCT04314713|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102265981|NCT04314713|Antiemetics|antiemetics|mesh-ancestor
102265982|NCT04314713|Autonomic Agents|autonomic agents|mesh-ancestor
102265983|NCT04314713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102265984|NCT04314713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265985|NCT04314713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102265986|NCT04314713|Mydriatics|mydriatics|mesh-ancestor
102265987|NCT04314713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102265988|NCT04314713|Cholinergic Agents|cholinergic agents|mesh-ancestor
102265989|NCT04314713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102265990|NCT04314713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102265991|NCT04314713|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102265992|NCT04314713|Parasympatholytics|parasympatholytics|mesh-ancestor
102265993|NCT04121507|Cyclophosphamide|cyclophosphamide|mesh-list
102265994|NCT04121507|Thiotepa|thiotepa|mesh-list
102265995|NCT04121507|Fludarabine|fludarabine|mesh-list
102265996|NCT04121507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102265997|NCT04121507|Immunologic Factors|immunologic factors|mesh-ancestor
102265998|NCT04121507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102265999|NCT04121507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102266000|NCT04121507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102266001|NCT04121507|Alkylating Agents|alkylating agents|mesh-ancestor
102266002|NCT04121507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266003|NCT04121507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101820502|NCT01047982|Folic Acid|folic acid|mesh-list
102266004|NCT04121507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102266005|NCT04719221|Evolocumab|evolocumab|mesh-list
102266006|NCT04719221|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102266007|NCT04719221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102266008|NCT04719221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102266009|NCT04719221|Antimetabolites|antimetabolites|mesh-ancestor
102266010|NCT04719221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266011|NCT04719221|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102266012|NCT04719221|Protease Inhibitors|protease inhibitors|mesh-ancestor
102266013|NCT04719221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102266014|NCT04719221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102266015|NCT03790397|Osimertinib|osimertinib|mesh-list
102266016|NCT03790397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266017|NCT03790397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102266018|NCT03790397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102266019|NCT03790397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102266020|NCT03718559|Edoxaban|edoxaban|mesh-list
102266021|NCT03718559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
102266022|NCT03718559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102266023|NCT03718559|Antithrombins|antithrombins|mesh-ancestor
102266024|NCT03718559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102266025|NCT03718559|Protease Inhibitors|protease inhibitors|mesh-ancestor
102266026|NCT03718559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102266027|NCT03718559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266028|NCT03718559|Anticoagulants|anticoagulants|mesh-ancestor
102266029|NCT01228331|Cytarabine|cytarabine|mesh-list
102266030|NCT01228331|Dexamethasone|dexamethasone|mesh-list
102266031|NCT01228331|Methylprednisolone|methylprednisolone|mesh-list
102266032|NCT01228331|Cyclophosphamide|cyclophosphamide|mesh-list
102266033|NCT01228331|Doxorubicin|doxorubicin|mesh-list
102266034|NCT01228331|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102266035|NCT01228331|Methotrexate|methotrexate|mesh-list
102266036|NCT01228331|Etoposide|etoposide|mesh-list
102266037|NCT01228331|Vincristine|vincristine|mesh-list
102266038|NCT01228331|Daunorubicin|daunorubicin|mesh-list
102266039|NCT01228331|Mercaptopurine|mercaptopurine|mesh-list
102266040|NCT01228331|Clofarabine|clofarabine|mesh-list
102266041|NCT01228331|Pegaspargase|pegaspargase|mesh-list
102266042|NCT01228331|Thioguanine|thioguanine|mesh-list
102266043|NCT01228331|Etoposide phosphate|etoposide phosphate|mesh-list
102266044|NCT01228331|Amsacrine|amsacrine|mesh-list
102266045|NCT01228331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102613893|NCT00002969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102266046|NCT01228331|Immunologic Factors|immunologic factors|mesh-ancestor
102266047|NCT01228331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266048|NCT01228331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102266049|NCT01228331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102266050|NCT01228331|Alkylating Agents|alkylating agents|mesh-ancestor
102266051|NCT01228331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266052|NCT01228331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102266053|NCT01228331|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102266054|NCT01228331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102266055|NCT01228331|Antiemetics|antiemetics|mesh-ancestor
102266056|NCT01228331|Autonomic Agents|autonomic agents|mesh-ancestor
102266057|NCT01228331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102266058|NCT01228331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102266059|NCT01228331|Glucocorticoids|glucocorticoids|mesh-ancestor
102266060|NCT01228331|Hormones|hormones|mesh-ancestor
102266061|NCT01228331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102266062|NCT01228331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102266063|NCT01228331|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102266064|NCT01228331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102266065|NCT01228331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101820555|NCT00992004|Turmeric extract|turmeric extract|mesh-list
102266066|NCT01228331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102266067|NCT01228331|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102266068|NCT01228331|Abortifacient Agents|abortifacient agents|mesh-ancestor
102266069|NCT01228331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102266070|NCT01228331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102266071|NCT01228331|Antimetabolites|antimetabolites|mesh-ancestor
102266072|NCT01228331|Dermatologic Agents|dermatologic agents|mesh-ancestor
102266073|NCT01228331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102266074|NCT01228331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102266075|NCT01228331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101820560|NCT03862716|Insulin|insulin|mesh-list
101820561|NCT03862716|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101820562|NCT03862716|Metformin|metformin|mesh-list
101820563|NCT03862716|Liraglutide|liraglutide|mesh-list
101820564|NCT03862716|Insulin, Long-Acting|insulin, long-acting|mesh-list
101820565|NCT03862716|Xultophy|xultophy|mesh-list
101820566|NCT03862716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101820567|NCT03862716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820568|NCT03862716|Incretins|incretins|mesh-ancestor
101820569|NCT03862716|Hormones|hormones|mesh-ancestor
101820570|NCT03862716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101820571|NCT00992082|Ketorolac|ketorolac|mesh-list
101820572|NCT00992082|Epinephrine|epinephrine|mesh-list
101289651|NCT05875285|Antimetabolites|antimetabolites|mesh-ancestor
101289652|NCT05875285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289653|NCT05875285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101289654|NCT05875285|Dermatologic Agents|dermatologic agents|mesh-ancestor
101289655|NCT05875285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101289656|NCT05875285|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102266076|NCT01228331|Antiviral Agents|antiviral agents|mesh-ancestor
102266077|NCT01228331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102266078|NCT01228331|Tubulin Modulators|tubulin modulators|mesh-ancestor
102266079|NCT01228331|Antimitotic Agents|antimitotic agents|mesh-ancestor
102266080|NCT01228331|Mitosis Modulators|mitosis modulators|mesh-ancestor
102266081|NCT01228331|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102266082|NCT01228331|Protective Agents|protective agents|mesh-ancestor
102266083|NCT01171937|Risperidone|risperidone|mesh-list
102266084|NCT01171937|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102266085|NCT01171937|Serotonin Agents|serotonin agents|mesh-ancestor
102266086|NCT01171937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102266087|NCT01171937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266088|NCT01171937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266089|NCT01171937|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102266090|NCT01171937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102266091|NCT01171937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102266092|NCT01171937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102266093|NCT01171937|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102266094|NCT01171937|Dopamine Agents|dopamine agents|mesh-ancestor
102266095|NCT03136445|Tranexamic Acid|tranexamic acid|mesh-list
102266096|NCT03136445|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102266097|NCT03136445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102266098|NCT03136445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266099|NCT03136445|Hemostatics|hemostatics|mesh-ancestor
102266100|NCT03136445|Coagulants|coagulants|mesh-ancestor
102266101|NCT00887783|Vinorelbine|vinorelbine|mesh-list
102266102|NCT00887783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102266103|NCT00887783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102266104|NCT00887783|Tubulin Modulators|tubulin modulators|mesh-ancestor
102266105|NCT00887783|Antimitotic Agents|antimitotic agents|mesh-ancestor
102266106|NCT00887783|Mitosis Modulators|mitosis modulators|mesh-ancestor
102266107|NCT00887783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266108|NCT02047097|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102266109|NCT02047097|Dermatologic Agents|dermatologic agents|mesh-ancestor
102266110|NCT02047097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102266111|NCT02047097|Immunologic Factors|immunologic factors|mesh-ancestor
102266112|NCT02047097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266113|NCT01125371|Ethanol|ethanol|mesh-list
102266114|NCT01125371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102266115|NCT01125371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102266116|NCT01125371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102266117|NCT01125371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266118|NCT03199547|Azithromycin|azithromycin|mesh-list
102266119|NCT03199547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102266120|NCT03199547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102266121|NCT03189641|Cilostazol|cilostazol|mesh-list
102266122|NCT03189641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102266123|NCT03189641|Autonomic Agents|autonomic agents|mesh-ancestor
102266124|NCT03189641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102266125|NCT03189641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266126|NCT03189641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102266127|NCT03189641|Respiratory System Agents|respiratory system agents|mesh-ancestor
102266128|NCT03189641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102266129|NCT03189641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102266130|NCT03189641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266131|NCT03189641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102266132|NCT03189641|Vasodilator Agents|vasodilator agents|mesh-ancestor
102266133|NCT03189641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102266134|NCT03189641|Protective Agents|protective agents|mesh-ancestor
102266135|NCT03189641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102266136|NCT03189641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102266137|NCT03189641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102266138|NCT00416351|Clofarabine|clofarabine|mesh-list
102266139|NCT00416351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102266140|NCT00416351|Antimetabolites|antimetabolites|mesh-ancestor
102266141|NCT00416351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266142|NCT00416351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102266143|NCT03938831|Fentanyl|fentanyl|mesh-list
102266144|NCT03938831|Dexmedetomidine|dexmedetomidine|mesh-list
102266145|NCT03938831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102266146|NCT03938831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102266147|NCT03938831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266148|NCT03938831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102266149|NCT03938831|Analgesics|analgesics|mesh-ancestor
102266150|NCT03938831|Sensory System Agents|sensory system agents|mesh-ancestor
102266151|NCT03938831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102266152|NCT03938831|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102266153|NCT03938831|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102266154|NCT03938831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102266155|NCT03938831|Adrenergic Agents|adrenergic agents|mesh-ancestor
102266156|NCT03938831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102266157|NCT03938831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266158|NCT03938831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102266159|NCT03938831|Narcotics|narcotics|mesh-ancestor
102266160|NCT03938831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102266161|NCT03938831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102266162|NCT03938831|Anesthetics, General|anesthetics, general|mesh-ancestor
102266163|NCT03938831|Anesthetics|anesthetics|mesh-ancestor
102266164|NCT03855917|Sofosbuvir|sofosbuvir|mesh-list
102266165|NCT03855917|Antiviral Agents|antiviral agents|mesh-ancestor
102266166|NCT03855917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102266167|NCT03104855|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
102266168|NCT03104855|Calcifediol|calcifediol|mesh-list
102266169|NCT03104855|Vitamins|vitamins|mesh-ancestor
102266170|NCT03104855|Micronutrients|micronutrients|mesh-ancestor
102266171|NCT03104855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266172|NCT03104855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102266173|NCT03104621|Benzalkonium Compounds|benzalkonium compounds|mesh-list
102266174|NCT03104621|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102266175|NCT03104621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102266176|NCT03102359|Dexmedetomidine|dexmedetomidine|mesh-list
102266177|NCT03102359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102266178|NCT03102359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102266179|NCT03102359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266180|NCT03102359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102266181|NCT03102359|Analgesics|analgesics|mesh-ancestor
102266182|NCT03102359|Sensory System Agents|sensory system agents|mesh-ancestor
102266183|NCT03102359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102266184|NCT03102359|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102266185|NCT03102359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102266186|NCT03102359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102266187|NCT03102359|Adrenergic Agents|adrenergic agents|mesh-ancestor
102266188|NCT03102359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102266189|NCT03102359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266190|NCT03104309|Levonorgestrel|levonorgestrel|mesh-list
102266191|NCT03104309|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102613894|NCT00002969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101820643|NCT00363298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101820644|NCT00363298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102613895|NCT00002969|Tubulin Modulators|tubulin modulators|mesh-ancestor
102266192|NCT03104309|Contraceptive Agents|contraceptive agents|mesh-ancestor
102266193|NCT03104309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102266194|NCT03104309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266195|NCT03104309|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102266196|NCT03104309|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102266197|NCT03104309|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102266198|NCT03832049|Vaccines|vaccines|mesh-list
102266199|NCT03832049|Immunologic Factors|immunologic factors|mesh-ancestor
102266200|NCT03832049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266201|NCT02102477|Androgens|androgens|mesh-list
102266203|NCT02102477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102266204|NCT02102477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266205|NCT03103685|Clopidogrel|clopidogrel|mesh-list
102266206|NCT03103685|Ticagrelor|ticagrelor|mesh-list
102266207|NCT03103685|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102266208|NCT03103685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102266209|NCT03103685|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102266210|NCT03103685|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102266211|NCT03103685|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102266212|NCT03103685|Purinergic Agents|purinergic agents|mesh-ancestor
102266213|NCT03103685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102266214|NCT03103685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266215|NCT03103685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266216|NCT03748433|Insulin|insulin|mesh-list
102266217|NCT03748433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102266218|NCT03748433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266219|NCT00540995|Etoposide|etoposide|mesh-list
102266220|NCT00540995|Podophyllotoxin|podophyllotoxin|mesh-list
102266221|NCT00540995|Etoposide phosphate|etoposide phosphate|mesh-list
102266222|NCT00540995|Busulfan|busulfan|mesh-list
102266223|NCT00540995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102266224|NCT00540995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102266225|NCT00540995|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102266226|NCT00540995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102266227|NCT00540995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102266228|NCT00540995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266229|NCT00540995|Alkylating Agents|alkylating agents|mesh-ancestor
102266230|NCT00540995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102266231|NCT00540995|Immunologic Factors|immunologic factors|mesh-ancestor
102266232|NCT00540995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266233|NCT00540995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102266234|NCT00540995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102266235|NCT00540995|Keratolytic Agents|keratolytic agents|mesh-ancestor
102266236|NCT00540995|Dermatologic Agents|dermatologic agents|mesh-ancestor
102266237|NCT00540995|Tubulin Modulators|tubulin modulators|mesh-ancestor
102266238|NCT00540995|Antimitotic Agents|antimitotic agents|mesh-ancestor
102266239|NCT00540995|Mitosis Modulators|mitosis modulators|mesh-ancestor
102266240|NCT03103451|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102266241|NCT03103451|Immunologic Factors|immunologic factors|mesh-ancestor
102266242|NCT03103451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266243|NCT05103215|Lidocaine|lidocaine|mesh-list
102266244|NCT05103215|Anesthetics, Local|anesthetics, local|mesh-ancestor
102266245|NCT05103215|Anesthetics|anesthetics|mesh-ancestor
102266246|NCT05103215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102266247|NCT05103215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266248|NCT05103215|Sensory System Agents|sensory system agents|mesh-ancestor
102266249|NCT05103215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102266250|NCT05103215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101820693|NCT04002024|Salicylic Acid|salicylic acid|mesh-list
102266251|NCT05103215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102266252|NCT05103215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102266253|NCT05103215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102266254|NCT05103215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266255|NCT05001815|Insulin|insulin|mesh-list
102266256|NCT05001815|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102266257|NCT05001815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102266258|NCT05001815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266259|NCT02644967|Ipilimumab|ipilimumab|mesh-list
102266260|NCT02644967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102266261|NCT02644967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102266262|NCT02644967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102266263|NCT02644967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613896|NCT00002969|Antimitotic Agents|antimitotic agents|mesh-ancestor
102266264|NCT04771637|Dexmedetomidine|dexmedetomidine|mesh-list
102266265|NCT04771637|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102266266|NCT04771637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102266267|NCT04771637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266268|NCT04771637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102266269|NCT04771637|Analgesics|analgesics|mesh-ancestor
102266270|NCT04771637|Sensory System Agents|sensory system agents|mesh-ancestor
102266271|NCT04771637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102266272|NCT04771637|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102266273|NCT04771637|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101975141|NCT03593018|Azacitidine|azacitidine|mesh-list
102266274|NCT04771637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102266275|NCT04771637|Adrenergic Agents|adrenergic agents|mesh-ancestor
102266276|NCT04771637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102266277|NCT04771637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266278|NCT03101735|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102266279|NCT03101735|Dermatologic Agents|dermatologic agents|mesh-ancestor
102266280|NCT03101735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102266281|NCT03101735|Immunologic Factors|immunologic factors|mesh-ancestor
102266282|NCT03101735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266283|NCT04701593|Triamcinolone|triamcinolone|mesh-list
102266284|NCT04701593|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102266285|NCT04701593|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102266286|NCT04701593|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102266287|NCT04701593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102266288|NCT04701593|Glucocorticoids|glucocorticoids|mesh-ancestor
102266289|NCT04701593|Hormones|hormones|mesh-ancestor
102266290|NCT04701593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101820740|NCT04001712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102266291|NCT04701593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266292|NCT04701593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102266293|NCT04701593|Immunologic Factors|immunologic factors|mesh-ancestor
102266294|NCT04701593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102266295|NCT04701593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266296|NCT05243693|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102266297|NCT05243693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102266298|NCT05243693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102266299|NCT05243693|Immunotoxins|immunotoxins|mesh-ancestor
102266300|NCT05243693|Immunoconjugates|immunoconjugates|mesh-ancestor
102266301|NCT05243693|Immunologic Factors|immunologic factors|mesh-ancestor
102266302|NCT05243693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266303|NCT04552847|Octreotide|octreotide|mesh-list
102266304|NCT04552847|Al18F-NOTA-octreotide|al18f-nota-octreotide|mesh-list
102266305|NCT04552847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102266306|NCT04552847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102266307|NCT04552847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102266308|NCT04552847|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102266309|NCT04552847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266310|NCT05167331|Nitrous Oxide|nitrous oxide|mesh-list
102266311|NCT05167331|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102266312|NCT05167331|Anesthetics, General|anesthetics, general|mesh-ancestor
102266313|NCT05167331|Anesthetics|anesthetics|mesh-ancestor
102266314|NCT05167331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102266315|NCT05167331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266316|NCT05167331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102266317|NCT05167331|Analgesics|analgesics|mesh-ancestor
102266318|NCT05167331|Sensory System Agents|sensory system agents|mesh-ancestor
102266319|NCT05167331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102266320|NCT04509401|Vitamins|vitamins|mesh-list
102266321|NCT04509401|Vitamin B 6|vitamin b 6|mesh-list
102266322|NCT04509401|Pyridoxal|pyridoxal|mesh-list
102266323|NCT04509401|Pyridoxine|pyridoxine|mesh-list
102266324|NCT04509401|Vitamin B Complex|vitamin b complex|mesh-list
102266325|NCT04509401|Micronutrients|micronutrients|mesh-ancestor
102266326|NCT04509401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266327|NCT05155007|Cyclosporine|cyclosporine|mesh-list
102266328|NCT05155007|Cyclosporins|cyclosporins|mesh-list
102266329|NCT05155007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102266330|NCT05155007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266331|NCT05155007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102266332|NCT05155007|Immunologic Factors|immunologic factors|mesh-ancestor
102266333|NCT05155007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266334|NCT05155007|Antifungal Agents|antifungal agents|mesh-ancestor
102266335|NCT05155007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102266336|NCT05155007|Dermatologic Agents|dermatologic agents|mesh-ancestor
102613897|NCT00002969|Mitosis Modulators|mitosis modulators|mesh-ancestor
102266337|NCT05155007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102266339|NCT01641107|Ponatinib|ponatinib|mesh-list
102266340|NCT01641107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102266341|NCT01641107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102266342|NCT01641107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102266343|NCT01641107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266344|NCT03101423|Interleukin-2|interleukin-2|mesh-list
102266345|NCT03101423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102266346|NCT03101423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102266347|NCT03101423|Analgesics|analgesics|mesh-ancestor
102266348|NCT03101423|Sensory System Agents|sensory system agents|mesh-ancestor
101975219|NCT03358017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101820789|NCT03453840|Lumefantrine|lumefantrine|mesh-list
102266349|NCT03101423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102266350|NCT03101423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266351|NCT05073029|Vitamin D|vitamin d|mesh-list
102266352|NCT05073029|Cholecalciferol|cholecalciferol|mesh-list
102266353|NCT05073029|Vitamins|vitamins|mesh-ancestor
102266354|NCT05073029|Micronutrients|micronutrients|mesh-ancestor
102266355|NCT05073029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266356|NCT05073029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102266357|NCT05073029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102266358|NCT02642159|Nicotinic Acids|nicotinic acids|mesh-list
102266359|NCT02642159|Niacin|niacin|mesh-list
102266360|NCT02642159|Niacinamide|niacinamide|mesh-list
102266361|NCT02642159|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102266362|NCT02642159|Ezetimibe|ezetimibe|mesh-list
102266363|NCT02642159|Alirocumab|alirocumab|mesh-list
102266364|NCT02642159|Fenofibrate|fenofibrate|mesh-list
102266365|NCT02642159|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102266366|NCT02642159|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102266367|NCT02642159|Antimetabolites|antimetabolites|mesh-ancestor
102266368|NCT02642159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266369|NCT02642159|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102266370|NCT02642159|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102266371|NCT02642159|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102266372|NCT02642159|Protease Inhibitors|protease inhibitors|mesh-ancestor
102266373|NCT02642159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102266374|NCT02642159|Vitamin B Complex|vitamin b complex|mesh-ancestor
102266375|NCT02642159|Vitamins|vitamins|mesh-ancestor
102266376|NCT02642159|Micronutrients|micronutrients|mesh-ancestor
102266377|NCT02642159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266378|NCT02642159|Vasodilator Agents|vasodilator agents|mesh-ancestor
102266379|NCT05072873|Tranexamic Acid|tranexamic acid|mesh-list
102266380|NCT05072873|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102266381|NCT05072873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102266382|NCT05072873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266383|NCT05072873|Hemostatics|hemostatics|mesh-ancestor
102266384|NCT05072873|Coagulants|coagulants|mesh-ancestor
102266385|NCT05072405|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102266386|NCT05072405|Simvastatin|simvastatin|mesh-list
102266387|NCT05072405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102266388|NCT05072405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102266389|NCT05072405|Antimetabolites|antimetabolites|mesh-ancestor
102266390|NCT05072405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266391|NCT05072405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102266392|NCT05072405|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102266393|NCT05072405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102266394|NCT03101579|Folic Acid|folic acid|mesh-list
102266395|NCT03101579|Vitamin B 12|vitamin b 12|mesh-list
102266396|NCT03101579|Dexamethasone|dexamethasone|mesh-list
102266397|NCT03101579|Pemetrexed|pemetrexed|mesh-list
102266398|NCT03101579|Vitamins|vitamins|mesh-ancestor
102266399|NCT03101579|Micronutrients|micronutrients|mesh-ancestor
102266400|NCT03101579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266401|NCT03101579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102266402|NCT03101579|Antiemetics|antiemetics|mesh-ancestor
102266403|NCT03101579|Autonomic Agents|autonomic agents|mesh-ancestor
102266404|NCT03101579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102266405|NCT03101579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102266406|NCT03101579|Glucocorticoids|glucocorticoids|mesh-ancestor
102266407|NCT03101579|Hormones|hormones|mesh-ancestor
102266408|NCT03101579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102266409|NCT03101579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102266410|NCT03101579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102266411|NCT03101579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101820846|NCT00993096|Insulin, Isophane|insulin, isophane|mesh-list
102266412|NCT03101579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266413|NCT03101579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101608184|NCT01076075|Metformin|metformin|mesh-list
102266414|NCT03101579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102266415|NCT03101579|Hematinics|hematinics|mesh-ancestor
102266416|NCT03101579|Vitamin B Complex|vitamin b complex|mesh-ancestor
102266417|NCT05071781|Hormones|hormones|mesh-list
102266418|NCT05071781|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102266419|NCT05071781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102266420|NCT05071781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266421|NCT03882905|Ezetimibe|ezetimibe|mesh-list
102266422|NCT03882905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102266423|NCT03882905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102266424|NCT03882905|Antimetabolites|antimetabolites|mesh-ancestor
102266425|NCT03882905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266426|NCT03882905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102266427|NCT02669017|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
102266428|NCT02669017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102266429|NCT02669017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102266430|NCT04479865|Donepezil|donepezil|mesh-list
102266431|NCT04479865|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102266432|NCT04479865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102266433|NCT04479865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266434|NCT04479865|Cholinergic Agents|cholinergic agents|mesh-ancestor
102266435|NCT04479865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102266436|NCT04479865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266437|NCT04479865|Nootropic Agents|nootropic agents|mesh-ancestor
102266438|NCT02668393|Docetaxel|docetaxel|mesh-list
102266439|NCT02668393|Nintedanib|nintedanib|mesh-list
102266440|NCT02668393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102266441|NCT02668393|Tubulin Modulators|tubulin modulators|mesh-ancestor
102266442|NCT02668393|Antimitotic Agents|antimitotic agents|mesh-ancestor
102266443|NCT02668393|Mitosis Modulators|mitosis modulators|mesh-ancestor
102266444|NCT02668393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266445|NCT02668393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102266446|NCT02668393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102266447|NCT05251129|Atorvastatin|atorvastatin|mesh-list
102266448|NCT05251129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102266449|NCT05251129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102266450|NCT05251129|Antimetabolites|antimetabolites|mesh-ancestor
101312697|NCT00008190|Aldesleukin|aldesleukin|mesh-list
102266451|NCT05251129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266452|NCT05251129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102266453|NCT05251129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102266454|NCT05251129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102266455|NCT01797523|Metformin|metformin|mesh-list
102266456|NCT01797523|Everolimus|everolimus|mesh-list
102266457|NCT01797523|Letrozole|letrozole|mesh-list
102266458|NCT01797523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102266459|NCT01797523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266460|NCT01797523|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102266461|NCT01797523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102266462|NCT01797523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102266463|NCT01797523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266464|NCT01797523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102266465|NCT01797523|Immunologic Factors|immunologic factors|mesh-ancestor
102266466|NCT01797523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102266467|NCT01797523|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102266468|NCT01797523|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102266469|NCT01797523|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101291856|NCT01958684|Copper|copper|mesh-list
102266470|NCT01797523|Hormone Antagonists|hormone antagonists|mesh-ancestor
102266471|NCT01797523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102266472|NCT03412591|Suvorexant|suvorexant|mesh-list
102266473|NCT03412591|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102266474|NCT03412591|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102266475|NCT03412591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102266476|NCT03412591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266477|NCT03412591|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102266478|NCT03412591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102266479|NCT03412591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266480|NCT01226563|Calcium|calcium|mesh-list
102266481|NCT01226563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102266482|NCT01226563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266483|NCT02382757|Insulin|insulin|mesh-list
102266484|NCT02382757|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102266485|NCT02382757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101902305|NCT03245398|Antinematodal Agents|antinematodal agents|mesh-ancestor
102613898|NCT00002969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266486|NCT02382757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266487|NCT02382679|Vitamins|vitamins|mesh-list
102266488|NCT02382679|Micronutrients|micronutrients|mesh-ancestor
102266489|NCT02382679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266490|NCT00916747|Zoledronic Acid|zoledronic acid|mesh-list
102266491|NCT00916747|Pravastatin|pravastatin|mesh-list
102266492|NCT00916747|Lonafarnib|lonafarnib|mesh-list
102266493|NCT00916747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102266494|NCT00916747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266495|NCT00916747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102266496|NCT00916747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102266497|NCT00916747|Antimetabolites|antimetabolites|mesh-ancestor
102266498|NCT00916747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266499|NCT00916747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102266500|NCT00916747|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102266501|NCT00916747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102266502|NCT02391883|Clopidogrel|clopidogrel|mesh-list
102266503|NCT02391883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102266504|NCT02391883|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102266505|NCT02391883|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102266506|NCT02391883|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102266507|NCT02391883|Purinergic Agents|purinergic agents|mesh-ancestor
102266508|NCT02391883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102266509|NCT02391883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266510|NCT02391883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266511|NCT02382523|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102266512|NCT02382523|Hormones|hormones|mesh-ancestor
102266513|NCT02382523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102266514|NCT02382523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266515|NCT02391805|Tenofovir|tenofovir|mesh-list
102266516|NCT02391805|Entecavir|entecavir|mesh-list
102266517|NCT02391805|Antiviral Agents|antiviral agents|mesh-ancestor
102266518|NCT02391805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101820948|NCT01031589|Rilpivirine|rilpivirine|mesh-list
102266519|NCT02391805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102266520|NCT02391805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102266521|NCT02391805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102266522|NCT02391805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266523|NCT02391805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102266524|NCT02391805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102266525|NCT02391181|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102266526|NCT02391181|Hematinics|hematinics|mesh-ancestor
102266527|NCT02381899|Rituximab|rituximab|mesh-list
102266528|NCT02381899|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102266529|NCT02381899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102266530|NCT02381899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102266531|NCT02381899|Immunologic Factors|immunologic factors|mesh-ancestor
102266532|NCT02381899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266533|NCT02381899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102266534|NCT02381899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102266535|NCT02381899|Alkylating Agents|alkylating agents|mesh-ancestor
102266536|NCT02381899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266537|NCT01998958|Esketamine|esketamine|mesh-list
102266538|NCT01998958|Antidepressive Agents|antidepressive agents|mesh-ancestor
102266539|NCT01998958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102266540|NCT02386111|Sunitinib|sunitinib|mesh-list
101820967|NCT00993876|Citalopram|citalopram|mesh-list
102266541|NCT02386111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102266542|NCT02386111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102266543|NCT02386111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102266544|NCT02386111|Growth Substances|growth substances|mesh-ancestor
102266545|NCT02386111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266546|NCT02386111|Growth Inhibitors|growth inhibitors|mesh-ancestor
102266547|NCT02386111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102266548|NCT02386111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102266549|NCT02386111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266550|NCT02386033|Atorvastatin|atorvastatin|mesh-list
102266551|NCT02386033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102266552|NCT02386033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102266553|NCT02386033|Antimetabolites|antimetabolites|mesh-ancestor
102266554|NCT02386033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266555|NCT02386033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102266556|NCT02386033|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102266557|NCT02386033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102613899|NCT00002987|Prednisolone|prednisolone|mesh-list
102613900|NCT00002987|Cyclophosphamide|cyclophosphamide|mesh-list
102266558|NCT01958164|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102613901|NCT00002987|Doxorubicin|doxorubicin|mesh-list
102266559|NCT01958164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102266560|NCT01958164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102266561|NCT01958164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266562|NCT02381275|Tenofovir|tenofovir|mesh-list
102266563|NCT02381275|Antiviral Agents|antiviral agents|mesh-ancestor
101820996|NCT01646814|Antipyretics|antipyretics|mesh-ancestor
102266564|NCT02381275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102266565|NCT02381275|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102266566|NCT02381275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102266567|NCT02381275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102266568|NCT02381275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266569|NCT02381275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102266570|NCT02381275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102266571|NCT04693507|Antarelix|antarelix|mesh-list
102266572|NCT04693507|Hormone Antagonists|hormone antagonists|mesh-ancestor
102266573|NCT04693507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102266574|NCT04693507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266576|NCT03105661|Labetalol|labetalol|mesh-list
102266577|NCT03105661|Nifedipine|nifedipine|mesh-list
101292515|NCT01963962|Copper|copper|mesh-list
102266578|NCT03105661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102266579|NCT03105661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102266580|NCT03105661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266581|NCT03105661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102266582|NCT03105661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266583|NCT03105661|Vasodilator Agents|vasodilator agents|mesh-ancestor
102266584|NCT03105661|Tocolytic Agents|tocolytic agents|mesh-ancestor
102266585|NCT03105661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102266586|NCT03105661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102266587|NCT03105661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102266588|NCT03105661|Sympatholytics|sympatholytics|mesh-ancestor
102266589|NCT03105661|Autonomic Agents|autonomic agents|mesh-ancestor
102266590|NCT03105661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102266591|NCT03105661|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101821017|NCT01416636|Treprostinil|treprostinil|mesh-list
102266592|NCT03105661|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102266593|NCT03105661|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102266594|NCT03105661|Adrenergic Agents|adrenergic agents|mesh-ancestor
102266595|NCT03105661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102266596|NCT03105661|Sympathomimetics|sympathomimetics|mesh-ancestor
102266597|NCT03105661|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102266598|NCT03105661|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102266599|NCT01998880|Rituximab|rituximab|mesh-list
102266600|NCT01998880|Obinutuzumab|obinutuzumab|mesh-list
102266601|NCT01998880|Chlorambucil|chlorambucil|mesh-list
102266602|NCT01998880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102266603|NCT01998880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102266604|NCT01998880|Immunologic Factors|immunologic factors|mesh-ancestor
102266605|NCT01998880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266606|NCT01998880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102266607|NCT01998880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102266608|NCT01998880|Alkylating Agents|alkylating agents|mesh-ancestor
102266609|NCT01998880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266610|NCT04747561|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102266611|NCT04747561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102266612|NCT04747561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266613|NCT02385019|Immunomodulating Agents|immunomodulating agents|mesh-list
102266614|NCT02385019|Immunologic Factors|immunologic factors|mesh-ancestor
102266615|NCT02385019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266616|NCT02380417|Ropivacaine|ropivacaine|mesh-list
102266617|NCT02380417|Anesthetics, Local|anesthetics, local|mesh-ancestor
102266618|NCT02380417|Anesthetics|anesthetics|mesh-ancestor
102266619|NCT02380417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101821047|NCT00994734|Contraceptive Agents|contraceptive agents|mesh-ancestor
102266620|NCT02380417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266621|NCT02380417|Sensory System Agents|sensory system agents|mesh-ancestor
102266622|NCT02380417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102266623|NCT02390089|Capsaicin|capsaicin|mesh-list
102266624|NCT02390089|Antipruritics|antipruritics|mesh-ancestor
102266625|NCT02390089|Dermatologic Agents|dermatologic agents|mesh-ancestor
102266626|NCT02390089|Sensory System Agents|sensory system agents|mesh-ancestor
102266627|NCT02390089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102266628|NCT02390089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266629|NCT02379793|Mineral Oil|mineral oil|mesh-list
102266630|NCT02379793|Emollients|emollients|mesh-ancestor
102613902|NCT00002987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102266631|NCT02379793|Dermatologic Agents|dermatologic agents|mesh-ancestor
102266632|NCT01975246|Amlodipine|amlodipine|mesh-list
102266633|NCT01975246|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102266634|NCT01975246|Telmisartan|telmisartan|mesh-list
102266635|NCT01975246|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
102266636|NCT01975246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102266637|NCT01975246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102266638|NCT01975246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102266639|NCT01975246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266640|NCT01975246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102266641|NCT01975246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266642|NCT01975246|Vasodilator Agents|vasodilator agents|mesh-ancestor
102266643|NCT01975246|Diuretics|diuretics|mesh-ancestor
102266644|NCT01975246|Natriuretic Agents|natriuretic agents|mesh-ancestor
101821061|NCT00994968|Cyclophosphamide|cyclophosphamide|mesh-list
102266645|NCT01975246|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102266646|NCT01975246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102266647|NCT01975246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101975517|NCT04481672|Tocolytic Agents|tocolytic agents|mesh-ancestor
102266648|NCT02389933|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102266649|NCT02389933|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102266650|NCT02389933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266651|NCT02379715|Remifentanil|remifentanil|mesh-list
102266652|NCT02379715|Desflurane|desflurane|mesh-list
102266653|NCT02379715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102266654|NCT02379715|Narcotics|narcotics|mesh-ancestor
102266655|NCT02379715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102266656|NCT02379715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266657|NCT02379715|Analgesics|analgesics|mesh-ancestor
102266658|NCT02379715|Sensory System Agents|sensory system agents|mesh-ancestor
102266659|NCT02379715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102266660|NCT02379715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102266661|NCT02379715|Anesthetics, General|anesthetics, general|mesh-ancestor
102266662|NCT02379715|Anesthetics|anesthetics|mesh-ancestor
102266663|NCT04439773|Lidocaine|lidocaine|mesh-list
102266664|NCT04439773|Anesthetics, Local|anesthetics, local|mesh-ancestor
102266665|NCT04439773|Anesthetics|anesthetics|mesh-ancestor
102266666|NCT04439773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102266667|NCT04439773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266668|NCT04439773|Sensory System Agents|sensory system agents|mesh-ancestor
102266669|NCT04439773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102266670|NCT04439773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102266671|NCT04439773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102266672|NCT04439773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102266673|NCT04439773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102266674|NCT04439773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266675|NCT02389231|Interleukin-2|interleukin-2|mesh-list
102266676|NCT02389231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102266677|NCT02389231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102266678|NCT02389231|Analgesics|analgesics|mesh-ancestor
102266679|NCT02389231|Sensory System Agents|sensory system agents|mesh-ancestor
102266680|NCT02389231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102266681|NCT02389231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266682|NCT02383927|Tipifarnib|tipifarnib|mesh-list
102266683|NCT02383927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102266684|NCT02383771|Aspirin|aspirin|mesh-list
102266685|NCT02383771|Ticagrelor|ticagrelor|mesh-list
101821112|NCT04000932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102266686|NCT02383771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102266687|NCT02383771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102266688|NCT02383771|Analgesics|analgesics|mesh-ancestor
102266689|NCT02383771|Sensory System Agents|sensory system agents|mesh-ancestor
102266690|NCT02383771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102266691|NCT02383771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266692|NCT02383771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102266693|NCT02383771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102266694|NCT02383771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102266695|NCT02383771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102266696|NCT02383771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266697|NCT02383771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102266698|NCT02383771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102266699|NCT02383771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102266700|NCT02383771|Antipyretics|antipyretics|mesh-ancestor
102266701|NCT02383771|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102613903|NCT00002987|Etoposide|etoposide|mesh-list
102613904|NCT00002987|Vincristine|vincristine|mesh-list
102266702|NCT02383771|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102266703|NCT02383771|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102266704|NCT02383771|Purinergic Agents|purinergic agents|mesh-ancestor
102266705|NCT02383771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102266706|NCT02378623|Apixaban|apixaban|mesh-list
102266707|NCT02378623|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102266708|NCT02378623|Antithrombins|antithrombins|mesh-ancestor
102266709|NCT02378623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102266710|NCT02378623|Protease Inhibitors|protease inhibitors|mesh-ancestor
102266711|NCT02378623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102266712|NCT02378623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266713|NCT02378623|Anticoagulants|anticoagulants|mesh-ancestor
102266714|NCT02372149|Immunoglobulins|immunoglobulins|mesh-list
102266715|NCT02372149|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102266716|NCT02372149|Antibodies|antibodies|mesh-list
102266717|NCT02372149|gamma-Globulins|gamma-globulins|mesh-list
102266718|NCT02372149|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102266719|NCT02372149|Immunologic Factors|immunologic factors|mesh-ancestor
102266720|NCT02372149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266721|NCT02661061|Midazolam|midazolam|mesh-list
102266722|NCT02661061|Ketamine|ketamine|mesh-list
102266723|NCT02661061|Analgesics|analgesics|mesh-ancestor
102266724|NCT02661061|Sensory System Agents|sensory system agents|mesh-ancestor
102266725|NCT02661061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102266726|NCT02661061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266727|NCT02661061|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102266728|NCT02661061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102266729|NCT02661061|Anesthetics, General|anesthetics, general|mesh-ancestor
102266730|NCT02661061|Anesthetics|anesthetics|mesh-ancestor
102266731|NCT02661061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102266732|NCT02661061|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102266733|NCT02661061|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102266734|NCT02661061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101821141|NCT00997074|Analgesics|analgesics|mesh-ancestor
102266735|NCT02661061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266736|NCT02661061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102266737|NCT02661061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102266738|NCT02661061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102266739|NCT02661061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102266740|NCT02661061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102266741|NCT02661061|GABA Modulators|gaba modulators|mesh-ancestor
102266742|NCT02661061|GABA Agents|gaba agents|mesh-ancestor
102266743|NCT02376985|Everolimus|everolimus|mesh-list
102266744|NCT02376985|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102266745|NCT02376985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102266746|NCT02376985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101821149|NCT05249712|Androgens|androgens|mesh-list
102266747|NCT02376985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266748|NCT02376985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102266749|NCT02376985|Immunologic Factors|immunologic factors|mesh-ancestor
102266750|NCT02376985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266751|NCT02376985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102266752|NCT02371993|Choline|choline|mesh-list
102266753|NCT02371993|Lipotropic Agents|lipotropic agents|mesh-ancestor
102266754|NCT02371993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102266755|NCT02371993|Antimetabolites|antimetabolites|mesh-ancestor
102266756|NCT02371993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266757|NCT02371993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102266758|NCT02371993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102266759|NCT02371993|Nootropic Agents|nootropic agents|mesh-ancestor
102266760|NCT02371603|Pioglitazone|pioglitazone|mesh-list
102266761|NCT02371603|Trimethoprim|trimethoprim|mesh-list
102266762|NCT02371603|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102266763|NCT02371603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102266764|NCT02371603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102266765|NCT02371603|Antimetabolites|antimetabolites|mesh-ancestor
102266766|NCT02371603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821170|NCT00997542|Antioxidants|antioxidants|mesh-ancestor
102266767|NCT02371603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102266768|NCT02371603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102266769|NCT02371603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102266770|NCT02371603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102266771|NCT02371603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266772|NCT02371603|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102266773|NCT02371603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102266774|NCT02371603|Antimalarials|antimalarials|mesh-ancestor
102266775|NCT02371603|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102266776|NCT02371603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101902311|NCT03245398|Mitosis Modulators|mitosis modulators|mesh-ancestor
102613905|NCT00002987|Bleomycin|bleomycin|mesh-list
102266777|NCT02371603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102266778|NCT02371603|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102266779|NCT02371603|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102266780|NCT02371603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102266781|NCT04149145|Niraparib|niraparib|mesh-list
102266782|NCT04149145|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102266783|NCT04149145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102266784|NCT04149145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266785|NCT04149145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102266786|NCT02378389|Docetaxel|docetaxel|mesh-list
102266787|NCT02378389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102266788|NCT02378389|Tubulin Modulators|tubulin modulators|mesh-ancestor
102266789|NCT02378389|Antimitotic Agents|antimitotic agents|mesh-ancestor
102266790|NCT02378389|Mitosis Modulators|mitosis modulators|mesh-ancestor
101821196|NCT01001364|Formoterol Fumarate|formoterol fumarate|mesh-list
102266791|NCT02378389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266792|NCT02376595|Bromides|bromides|mesh-list
102266793|NCT02376595|Rocuronium|rocuronium|mesh-list
102266794|NCT02376595|Anticonvulsants|anticonvulsants|mesh-ancestor
102266795|NCT02376595|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102266796|NCT02376595|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102266797|NCT02376595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102266798|NCT02376595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102266799|NCT02376595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266800|NCT02370745|Insulin|insulin|mesh-list
102266801|NCT02370745|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102266802|NCT02370745|Incretins|incretins|mesh-list
102266803|NCT02370745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102266804|NCT02370745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266805|NCT02370745|Hormones|hormones|mesh-ancestor
102266806|NCT02370745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102266807|NCT02376049|Betamethasone|betamethasone|mesh-list
102266808|NCT02376049|Betamethasone Valerate|betamethasone valerate|mesh-list
102266809|NCT02376049|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101821213|NCT01031667|Cilostazol|cilostazol|mesh-list
102266810|NCT02376049|Betamethasone benzoate|betamethasone benzoate|mesh-list
102266811|NCT02376049|Clobetasol|clobetasol|mesh-list
102266812|NCT02376049|Pimecrolimus|pimecrolimus|mesh-list
102266813|NCT02376049|Emollients|emollients|mesh-list
102266814|NCT02376049|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102266815|NCT02376049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102266816|NCT02376049|Glucocorticoids|glucocorticoids|mesh-ancestor
102266817|NCT02376049|Hormones|hormones|mesh-ancestor
102266818|NCT02376049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102266819|NCT02376049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266820|NCT02376049|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101293821|NCT01971918|Antibodies|antibodies|mesh-list
102266821|NCT02376049|Respiratory System Agents|respiratory system agents|mesh-ancestor
102266822|NCT02376049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102266823|NCT02376049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102266824|NCT02376049|Analgesics|analgesics|mesh-ancestor
102266825|NCT02376049|Sensory System Agents|sensory system agents|mesh-ancestor
102266826|NCT02376049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102266827|NCT02376049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102266828|NCT02376049|Dermatologic Agents|dermatologic agents|mesh-ancestor
102266829|NCT02376049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102266830|NCT02376049|Immunologic Factors|immunologic factors|mesh-ancestor
102266831|NCT02376049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102266832|NCT02376049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102266833|NCT02376049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266834|NCT02376205|Bupivacaine|bupivacaine|mesh-list
102266835|NCT02376205|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102266836|NCT02376205|Anesthetics, Local|anesthetics, local|mesh-ancestor
102266837|NCT02376205|Anesthetics|anesthetics|mesh-ancestor
102266838|NCT02376205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101821235|NCT01031667|Antioxidants|antioxidants|mesh-ancestor
102266839|NCT02376205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266840|NCT02376205|Sensory System Agents|sensory system agents|mesh-ancestor
102266841|NCT02376205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102266842|NCT02370433|Glycopyrrolate|glycopyrrolate|mesh-list
102266843|NCT02370433|Neostigmine|neostigmine|mesh-list
102266844|NCT02370433|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102266845|NCT02370433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102266846|NCT02370433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266847|NCT02370433|Cholinergic Agents|cholinergic agents|mesh-ancestor
102266848|NCT02370433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102266849|NCT02370433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266850|NCT02370433|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102613906|NCT00002987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101821247|NCT00998088|Epoetin Alfa|epoetin alfa|mesh-list
102266851|NCT02370433|Autonomic Agents|autonomic agents|mesh-ancestor
102266852|NCT02370433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102266853|NCT02370433|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102266854|NCT02370433|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102266855|NCT02370433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102266856|NCT01957150|Fluticasone|fluticasone|mesh-list
102266858|NCT01957150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102266859|NCT01957150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102266860|NCT01957150|Autonomic Agents|autonomic agents|mesh-ancestor
102266861|NCT01957150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102266862|NCT01957150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266863|NCT01957150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102266864|NCT01957150|Respiratory System Agents|respiratory system agents|mesh-ancestor
102266865|NCT01957150|Dermatologic Agents|dermatologic agents|mesh-ancestor
102266866|NCT01957150|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102266867|NCT01995526|Insulin|insulin|mesh-list
102266868|NCT01995526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102266869|NCT01995526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266870|NCT01973218|Vaccines|vaccines|mesh-list
102266871|NCT01973218|Immunologic Factors|immunologic factors|mesh-ancestor
102266872|NCT01973218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266873|NCT01946152|Dexamethasone|dexamethasone|mesh-list
102266874|NCT01946152|Dexamethasone acetate|dexamethasone acetate|mesh-list
102266875|NCT01946152|Pomalidomide|pomalidomide|mesh-list
102266876|NCT01946152|Ichthammol|ichthammol|mesh-list
102266877|NCT01946152|Lenograstim|lenograstim|mesh-list
102266878|NCT01946152|BB 1101|bb 1101|mesh-list
102266879|NCT01946152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102266880|NCT01946152|Antiemetics|antiemetics|mesh-ancestor
102266881|NCT01946152|Autonomic Agents|autonomic agents|mesh-ancestor
102266882|NCT01946152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102266883|NCT01946152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266884|NCT01946152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102266885|NCT01946152|Glucocorticoids|glucocorticoids|mesh-ancestor
102266886|NCT01946152|Hormones|hormones|mesh-ancestor
101294230|NCT01975129|Oxytocin|oxytocin|mesh-list
102266887|NCT01946152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102266888|NCT01946152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102266889|NCT01946152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102266890|NCT01946152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102266891|NCT01946152|Immunologic Factors|immunologic factors|mesh-ancestor
102266892|NCT01946152|Protease Inhibitors|protease inhibitors|mesh-ancestor
102266893|NCT01946152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102266894|NCT01946152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266895|NCT01946152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102266896|NCT01946152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102266897|NCT01946152|Growth Substances|growth substances|mesh-ancestor
102266898|NCT01946152|Growth Inhibitors|growth inhibitors|mesh-ancestor
102266899|NCT01946152|Dermatologic Agents|dermatologic agents|mesh-ancestor
102266900|NCT01971346|Etanercept|etanercept|mesh-list
102266901|NCT01971346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102266902|NCT01971346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102266903|NCT01971346|Analgesics|analgesics|mesh-ancestor
102266904|NCT01971346|Sensory System Agents|sensory system agents|mesh-ancestor
102266905|NCT01971346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102266906|NCT01971346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266907|NCT01971346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102266908|NCT01971346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102266909|NCT01971346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102266910|NCT01971346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102266911|NCT01971346|Immunologic Factors|immunologic factors|mesh-ancestor
102266912|NCT01945216|Alogliptin|alogliptin|mesh-list
102266913|NCT01945216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102266914|NCT01945216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266915|NCT01945216|Incretins|incretins|mesh-ancestor
102266916|NCT01945216|Hormones|hormones|mesh-ancestor
102266917|NCT01945216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102266918|NCT01945216|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102266919|NCT01945216|Protease Inhibitors|protease inhibitors|mesh-ancestor
102266920|NCT01945216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101821309|NCT00369382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102266921|NCT01945216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266922|NCT02641379|Ribavirin|ribavirin|mesh-list
102266923|NCT02641379|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102266924|NCT02641379|Antimetabolites|antimetabolites|mesh-ancestor
102266925|NCT02641379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266926|NCT02641379|Antiviral Agents|antiviral agents|mesh-ancestor
101608697|NCT00972504|Cetirizine|cetirizine|mesh-list
102613907|NCT00002987|Immunologic Factors|immunologic factors|mesh-ancestor
102266927|NCT02641379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102266928|NCT02660983|Donepezil|donepezil|mesh-list
102266929|NCT02660983|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102266930|NCT02660983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102266931|NCT02660983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266932|NCT02660983|Cholinergic Agents|cholinergic agents|mesh-ancestor
102266933|NCT02660983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102266934|NCT02660983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266935|NCT02660983|Nootropic Agents|nootropic agents|mesh-ancestor
102266936|NCT05070221|Axitinib|axitinib|mesh-list
102266937|NCT05070221|Antibodies|antibodies|mesh-list
102266938|NCT05070221|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102266939|NCT05070221|Immunologic Factors|immunologic factors|mesh-ancestor
102266940|NCT05070221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266941|NCT05070221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102266942|NCT05070221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102266943|NCT05070221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102266944|NCT05070221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266945|NCT04404439|Topiramate|topiramate|mesh-list
102266946|NCT04404439|Verapamil|verapamil|mesh-list
102266947|NCT04404439|Paroxetine|paroxetine|mesh-list
102266948|NCT04404439|Nortriptyline|nortriptyline|mesh-list
102266949|NCT04404439|Anticonvulsants|anticonvulsants|mesh-ancestor
102266950|NCT04404439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102266951|NCT04404439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266952|NCT04404439|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102266953|NCT04404439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102266954|NCT04404439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102266955|NCT04404439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266956|NCT04404439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102266957|NCT04404439|Serotonin Agents|serotonin agents|mesh-ancestor
102266958|NCT04404439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102266959|NCT04404439|Antidepressive Agents|antidepressive agents|mesh-ancestor
102266960|NCT04404439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102266961|NCT04404439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102266962|NCT04404439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102266963|NCT04404439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102266964|NCT04404439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102266965|NCT04404439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102266966|NCT04404439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102266967|NCT04404439|Vasodilator Agents|vasodilator agents|mesh-ancestor
102266968|NCT04404439|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101821355|NCT00436605|Dasatinib|dasatinib|mesh-list
102266969|NCT04404439|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102266970|NCT04404439|Adrenergic Agents|adrenergic agents|mesh-ancestor
102266971|NCT01953328|Atorvastatin|atorvastatin|mesh-list
102266972|NCT01953328|Evolocumab|evolocumab|mesh-list
102266973|NCT01953328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102266974|NCT01953328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102266975|NCT01953328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101294737|NCT01979354|Morphine|morphine|mesh-list
102266976|NCT01953328|Antimetabolites|antimetabolites|mesh-ancestor
102266977|NCT01953328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266978|NCT01953328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102266979|NCT01953328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102266980|NCT01953328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102266981|NCT01953328|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102266982|NCT01953328|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102266983|NCT01953328|Protease Inhibitors|protease inhibitors|mesh-ancestor
102266984|NCT01953328|Immunologic Factors|immunologic factors|mesh-ancestor
102266985|NCT01953328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102266986|NCT03100955|Cisplatin|cisplatin|mesh-list
102266987|NCT03100955|Etoposide|etoposide|mesh-list
102266988|NCT03100955|Etoposide phosphate|etoposide phosphate|mesh-list
102266989|NCT03100955|Apatinib|apatinib|mesh-list
102266990|NCT03100955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102266991|NCT03100955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102266992|NCT03100955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102266993|NCT03100955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102266994|NCT03100955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102266995|NCT03100955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102266996|NCT03100955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102266997|NCT02377609|Tacrolimus|tacrolimus|mesh-list
102266998|NCT02377609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102266999|NCT02377609|Immunologic Factors|immunologic factors|mesh-ancestor
102267000|NCT02377609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613908|NCT00002987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613909|NCT00002987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102613910|NCT00002987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102613911|NCT00002987|Alkylating Agents|alkylating agents|mesh-ancestor
102613912|NCT00002987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613913|NCT00002987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613914|NCT00002987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102267001|NCT02377609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102267002|NCT02377609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102267003|NCT02377609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267005|NCT02369965|Lopinavir|lopinavir|mesh-list
102267006|NCT02369965|Tenofovir|tenofovir|mesh-list
102267007|NCT02369965|Lamivudine|lamivudine|mesh-list
102267008|NCT02369965|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101821397|NCT00368992|Tubulin Modulators|tubulin modulators|mesh-ancestor
102267009|NCT02369965|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102267010|NCT02369965|Protease Inhibitors|protease inhibitors|mesh-ancestor
102267011|NCT02369965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102267012|NCT02369965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267013|NCT02369965|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102267014|NCT02369965|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102267015|NCT02369965|Antiviral Agents|antiviral agents|mesh-ancestor
102267016|NCT02369965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102267017|NCT02369965|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102267018|NCT02369965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102267019|NCT02369965|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101821414|NCT00375934|Diclofenac|diclofenac|mesh-list
102267020|NCT02369965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102267021|NCT02640755|Paclitaxel|paclitaxel|mesh-list
102267022|NCT02640755|Fulvestrant|fulvestrant|mesh-list
102267023|NCT02640755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102267024|NCT02640755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102267025|NCT02640755|Tubulin Modulators|tubulin modulators|mesh-ancestor
102267026|NCT02640755|Antimitotic Agents|antimitotic agents|mesh-ancestor
102267027|NCT02640755|Mitosis Modulators|mitosis modulators|mesh-ancestor
102267028|NCT02640755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267029|NCT02640755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102267030|NCT02640755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102267031|NCT02640755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102267032|NCT02640755|Hormone Antagonists|hormone antagonists|mesh-ancestor
102267033|NCT02640755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102267034|NCT02640755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267036|NCT04400539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102267037|NCT04400539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102267038|NCT04400539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102267039|NCT04400539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267040|NCT03099785|Rifamycins|rifamycins|mesh-list
102267041|NCT03099785|Rifamycin SV|rifamycin sv|mesh-list
102267042|NCT03099785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102267043|NCT03099785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102267044|NCT03099785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102267045|NCT02375503|Vitamin D|vitamin d|mesh-list
102267046|NCT02375503|Calcium|calcium|mesh-list
102267047|NCT02375503|Vitamins|vitamins|mesh-ancestor
102267048|NCT02375503|Micronutrients|micronutrients|mesh-ancestor
102267049|NCT02375503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267050|NCT02375503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102267051|NCT02375503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102267052|NCT00867191|Desloratadine|desloratadine|mesh-list
102267053|NCT00867191|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102267054|NCT00867191|Cholinergic Agents|cholinergic agents|mesh-ancestor
102267055|NCT00867191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102267056|NCT00867191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267057|NCT00867191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821455|NCT00531960|Bevacizumab|bevacizumab|mesh-list
102267058|NCT00867191|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102267059|NCT00867191|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102267060|NCT00867191|Histamine Antagonists|histamine antagonists|mesh-ancestor
102267061|NCT00867191|Histamine Agents|histamine agents|mesh-ancestor
102267062|NCT00834119|Mometasone Furoate|mometasone furoate|mesh-list
102267063|NCT00834119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102267064|NCT00834119|Dermatologic Agents|dermatologic agents|mesh-ancestor
102267065|NCT00834119|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102267066|NCT02299141|Nintedanib|nintedanib|mesh-list
102267067|NCT02299141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101902316|NCT01291940|Emollients|emollients|mesh-ancestor
102613915|NCT00002987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102267068|NCT02299141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102267069|NCT02299141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102267070|NCT02299141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267071|NCT02643251|Clonidine|clonidine|mesh-list
102267072|NCT02643251|Analgesics|analgesics|mesh-ancestor
102267073|NCT02643251|Sensory System Agents|sensory system agents|mesh-ancestor
102267074|NCT02643251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102267075|NCT02643251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267076|NCT02643251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102267077|NCT02643251|Sympatholytics|sympatholytics|mesh-ancestor
102267078|NCT02643251|Autonomic Agents|autonomic agents|mesh-ancestor
102267079|NCT02643251|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102267080|NCT02643251|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102267081|NCT02643251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102267082|NCT02643251|Adrenergic Agents|adrenergic agents|mesh-ancestor
102267083|NCT02643251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102267084|NCT02643251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267085|NCT02375191|Fentanyl|fentanyl|mesh-list
101295355|NCT01984008|Antacids|antacids|mesh-ancestor
102267086|NCT02375191|Dexmedetomidine|dexmedetomidine|mesh-list
102267087|NCT02375191|Ropivacaine|ropivacaine|mesh-list
102267088|NCT02375191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102267089|NCT02375191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102267090|NCT02375191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267091|NCT02375191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102267092|NCT02375191|Analgesics|analgesics|mesh-ancestor
102267093|NCT02375191|Sensory System Agents|sensory system agents|mesh-ancestor
102267094|NCT02375191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102267095|NCT02375191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102267096|NCT02375191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102267097|NCT02375191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102267098|NCT02375191|Adrenergic Agents|adrenergic agents|mesh-ancestor
102267099|NCT02375191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101821486|NCT01001754|Ribavirin|ribavirin|mesh-list
102267100|NCT02375191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267101|NCT02375191|Anesthetics, Local|anesthetics, local|mesh-ancestor
102267102|NCT02375191|Anesthetics|anesthetics|mesh-ancestor
102267103|NCT02375191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102267104|NCT02375191|Narcotics|narcotics|mesh-ancestor
102267105|NCT02375191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102267106|NCT02375191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102267107|NCT02375191|Anesthetics, General|anesthetics, general|mesh-ancestor
102267108|NCT03100877|Cyclophosphamide|cyclophosphamide|mesh-list
102267109|NCT03100877|Melphalan|melphalan|mesh-list
102267110|NCT03100877|Mechlorethamine|mechlorethamine|mesh-list
102267111|NCT03100877|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102267112|NCT03100877|Lenalidomide|lenalidomide|mesh-list
102267113|NCT03100877|Lenograstim|lenograstim|mesh-list
102267114|NCT03100877|Mitogens|mitogens|mesh-list
102267115|NCT03100877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102267116|NCT03100877|Immunologic Factors|immunologic factors|mesh-ancestor
102267117|NCT03100877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267118|NCT03100877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102267119|NCT03100877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102267120|NCT03100877|Alkylating Agents|alkylating agents|mesh-ancestor
102267121|NCT03100877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267122|NCT03100877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102267123|NCT03100877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102267124|NCT03100877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102267125|NCT03100877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102267126|NCT03100877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102267127|NCT03100877|Growth Substances|growth substances|mesh-ancestor
102267128|NCT03100877|Growth Inhibitors|growth inhibitors|mesh-ancestor
102267129|NCT03100877|Mitosis Modulators|mitosis modulators|mesh-ancestor
102267130|NCT00794495|Cetirizine|cetirizine|mesh-list
102267131|NCT00794495|Desloratadine|desloratadine|mesh-list
102267132|NCT00794495|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102267133|NCT00794495|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102267134|NCT00794495|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102267135|NCT00794495|Histamine Antagonists|histamine antagonists|mesh-ancestor
102267136|NCT00794495|Histamine Agents|histamine agents|mesh-ancestor
102267137|NCT00794495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102267138|NCT00794495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267139|NCT00794495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267140|NCT00794495|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102267141|NCT00794495|Cholinergic Agents|cholinergic agents|mesh-ancestor
102267142|NCT04157075|Bupivacaine|bupivacaine|mesh-list
102267143|NCT04157075|Anesthetics, Local|anesthetics, local|mesh-ancestor
102267145|NCT04157075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102267146|NCT04157075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267147|NCT04157075|Sensory System Agents|sensory system agents|mesh-ancestor
102267148|NCT04157075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102267149|NCT00763529|Fluticasone|fluticasone|mesh-list
102267150|NCT00763529|Mometasone Furoate|mometasone furoate|mesh-list
102267151|NCT00763529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102267152|NCT00763529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102267153|NCT00763529|Autonomic Agents|autonomic agents|mesh-ancestor
102267154|NCT00763529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102267155|NCT00763529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267156|NCT00763529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102267157|NCT00763529|Respiratory System Agents|respiratory system agents|mesh-ancestor
102267158|NCT00763529|Dermatologic Agents|dermatologic agents|mesh-ancestor
102267159|NCT00763529|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102267160|NCT03105505|Fusidic Acid|fusidic acid|mesh-list
102267161|NCT03105505|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102267162|NCT03105505|Permethrin|permethrin|mesh-list
102267163|NCT03105505|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102267164|NCT03105505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102267165|NCT03105505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267166|NCT03105505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102267167|NCT03105505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102267168|NCT03105505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102267169|NCT03105193|Lidocaine|lidocaine|mesh-list
102267170|NCT03105193|Anesthetics, Local|anesthetics, local|mesh-ancestor
102267171|NCT03105193|Anesthetics|anesthetics|mesh-ancestor
102267172|NCT03105193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102267173|NCT03105193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267174|NCT03105193|Sensory System Agents|sensory system agents|mesh-ancestor
102267175|NCT03105193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102267176|NCT03105193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102267177|NCT03105193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102267178|NCT03105193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102267179|NCT03105193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102267180|NCT03105193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267181|NCT05066633|Metoprolol|metoprolol|mesh-list
102267182|NCT05066633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102267183|NCT05066633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102267184|NCT05066633|Sympatholytics|sympatholytics|mesh-ancestor
102267185|NCT05066633|Autonomic Agents|autonomic agents|mesh-ancestor
102267186|NCT05066633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102267187|NCT05066633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267188|NCT05066633|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102267189|NCT05066633|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102267190|NCT05066633|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102267191|NCT05066633|Adrenergic Agents|adrenergic agents|mesh-ancestor
102267192|NCT05066633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102267193|NCT05066633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267194|NCT04439305|Dasatinib|dasatinib|mesh-list
102267195|NCT04439305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102267196|NCT04439305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102267197|NCT04439305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102267198|NCT04439305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267199|NCT02368951|Aprutumab ixadotin|aprutumab ixadotin|mesh-list
102267200|NCT02368951|Immunoconjugates|immunoconjugates|mesh-ancestor
102267201|NCT02368951|Immunologic Factors|immunologic factors|mesh-ancestor
102267202|NCT02368951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267203|NCT02368795|Indomethacin|indomethacin|mesh-list
102267204|NCT02368795|Isosorbide|isosorbide|mesh-list
102267205|NCT02368795|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
102267206|NCT02368795|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
102267207|NCT02368795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102267208|NCT02368795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102267209|NCT02368795|Analgesics|analgesics|mesh-ancestor
102267210|NCT02368795|Sensory System Agents|sensory system agents|mesh-ancestor
102267211|NCT02368795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102267212|NCT02368795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267213|NCT02368795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102267214|NCT02368795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102613916|NCT00002987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102613917|NCT00002987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102613918|NCT00002987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102613919|NCT00002987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102613920|NCT00002987|Tubulin Modulators|tubulin modulators|mesh-ancestor
102267215|NCT02368795|Gout Suppressants|gout suppressants|mesh-ancestor
102267217|NCT02368795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102267218|NCT02368795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102267219|NCT02368795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102267220|NCT02368795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267221|NCT02368795|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102267222|NCT02368795|Diuretics|diuretics|mesh-ancestor
102267223|NCT02368795|Natriuretic Agents|natriuretic agents|mesh-ancestor
102267224|NCT02368795|Vasodilator Agents|vasodilator agents|mesh-ancestor
102267225|NCT02368795|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102267226|NCT00650663|Simvastatin|simvastatin|mesh-list
102267227|NCT00650663|Ezetimibe|ezetimibe|mesh-list
102267228|NCT00650663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102267229|NCT00650663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102267230|NCT00650663|Antimetabolites|antimetabolites|mesh-ancestor
102267231|NCT00650663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267232|NCT00650663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101296124|NCT01989507|Nicotine|nicotine|mesh-list
102267233|NCT00650663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102267234|NCT00650663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102267235|NCT02368717|Mesalamine|mesalamine|mesh-list
102267236|NCT02368717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102267237|NCT02368717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102267238|NCT02368717|Analgesics|analgesics|mesh-ancestor
102267239|NCT02368717|Sensory System Agents|sensory system agents|mesh-ancestor
102267240|NCT02368717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102267241|NCT02368717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821621|NCT00817271|Glucagon|glucagon|mesh-list
102267242|NCT02368717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102267243|NCT02368717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102267244|NCT04231565|Tenofovir|tenofovir|mesh-list
102267245|NCT04231565|Antiviral Agents|antiviral agents|mesh-ancestor
102267246|NCT04231565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102267247|NCT04231565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102267248|NCT04231565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102267249|NCT04231565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101976119|NCT01228279|Icodextrin|icodextrin|mesh-list
102267250|NCT04231565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267251|NCT04231565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102267252|NCT04231565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102267253|NCT03100565|Lidocaine|lidocaine|mesh-list
102267254|NCT03100565|Anesthetics, Local|anesthetics, local|mesh-ancestor
102267255|NCT03100565|Anesthetics|anesthetics|mesh-ancestor
102267256|NCT03100565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102267257|NCT03100565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267258|NCT03100565|Sensory System Agents|sensory system agents|mesh-ancestor
102267259|NCT03100565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102267260|NCT03100565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102267261|NCT03100565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102267262|NCT03100565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101821638|NCT01052896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102267263|NCT03100565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102267264|NCT03100565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267265|NCT05035277|Aspirin|aspirin|mesh-list
102267266|NCT05035277|Rivaroxaban|rivaroxaban|mesh-list
102267267|NCT05035277|Apixaban|apixaban|mesh-list
102267268|NCT05035277|Edoxaban|edoxaban|mesh-list
102267269|NCT05035277|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102267270|NCT05035277|Antithrombins|antithrombins|mesh-ancestor
102267271|NCT05035277|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102267272|NCT05035277|Protease Inhibitors|protease inhibitors|mesh-ancestor
102267273|NCT05035277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102267274|NCT05035277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267275|NCT05035277|Anticoagulants|anticoagulants|mesh-ancestor
102267276|NCT05035277|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102267277|NCT05035277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102267278|NCT05035277|Analgesics|analgesics|mesh-ancestor
102267279|NCT05035277|Sensory System Agents|sensory system agents|mesh-ancestor
102267280|NCT05035277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102267281|NCT05035277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267282|NCT05035277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102267283|NCT05035277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102267284|NCT05035277|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102267285|NCT05035277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102613921|NCT00002987|Antimitotic Agents|antimitotic agents|mesh-ancestor
102267286|NCT05035277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102267287|NCT05035277|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102267288|NCT05035277|Antipyretics|antipyretics|mesh-ancestor
102267289|NCT02374645|Gefitinib|gefitinib|mesh-list
102267290|NCT02374645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102267291|NCT02374645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102267292|NCT02374645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102267293|NCT02374645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267294|NCT02368561|Hyaluronic Acid|hyaluronic acid|mesh-list
102267295|NCT02368561|Hylan|hylan|mesh-list
102267296|NCT02368561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102267297|NCT02368561|Immunologic Factors|immunologic factors|mesh-ancestor
102267298|NCT02368561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267299|NCT02368561|Viscosupplements|viscosupplements|mesh-ancestor
102267300|NCT02368561|Protective Agents|protective agents|mesh-ancestor
102267301|NCT04095845|Tacrine|tacrine|mesh-list
102267302|NCT04095845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102267303|NCT04095845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102267304|NCT04095845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267305|NCT04095845|Cholinergic Agents|cholinergic agents|mesh-ancestor
102267306|NCT04095845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102267307|NCT04095845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267308|NCT04095845|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102267309|NCT04095845|Autonomic Agents|autonomic agents|mesh-ancestor
102267310|NCT04095845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102267311|NCT04095845|Nootropic Agents|nootropic agents|mesh-ancestor
102267312|NCT02374489|Ceritinib|ceritinib|mesh-list
102267313|NCT02374489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102267314|NCT02374489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102267315|NCT02374489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102267316|NCT02374489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267317|NCT02374567|Topiramate|topiramate|mesh-list
102267318|NCT02374567|Diphenhydramine|diphenhydramine|mesh-list
102267319|NCT02374567|Promethazine|promethazine|mesh-list
102267320|NCT02374567|Pregabalin|pregabalin|mesh-list
102267321|NCT02374567|Lamotrigine|lamotrigine|mesh-list
102267322|NCT02374567|Lacosamide|lacosamide|mesh-list
102267323|NCT02374567|Carbamazepine|carbamazepine|mesh-list
102267324|NCT02374567|Phenytoin|phenytoin|mesh-list
102267325|NCT02374567|Oxcarbazepine|oxcarbazepine|mesh-list
102267326|NCT02374567|Nicergoline|nicergoline|mesh-list
102267327|NCT02374567|Midazolam|midazolam|mesh-list
102267328|NCT02374567|Diazepam|diazepam|mesh-list
102267329|NCT02374567|Triazolam|triazolam|mesh-list
102267330|NCT02374567|Acamprosate|acamprosate|mesh-list
102267331|NCT02374567|Gabapentin|gabapentin|mesh-list
102267332|NCT02374567|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102267333|NCT02374567|Amitriptyline|amitriptyline|mesh-list
102267334|NCT02374567|Methotrimeprazine|methotrimeprazine|mesh-list
102267335|NCT02374567|Levetiracetam|levetiracetam|mesh-list
102267336|NCT02374567|Valproic Acid|valproic acid|mesh-list
102267337|NCT02374567|Lorazepam|lorazepam|mesh-list
102267338|NCT02374567|Clonazepam|clonazepam|mesh-list
102267339|NCT02374567|Phenobarbital|phenobarbital|mesh-list
102267340|NCT02374567|Clobazam|clobazam|mesh-list
102267341|NCT02374567|Zaleplon|zaleplon|mesh-list
102267342|NCT02374567|Nitrazepam|nitrazepam|mesh-list
102267343|NCT02374567|Chlormethiazole|chlormethiazole|mesh-list
102267344|NCT02374567|Memantine|memantine|mesh-list
102267345|NCT02374567|Biperiden|biperiden|mesh-list
102267346|NCT02374567|Haloperidol|haloperidol|mesh-list
102267347|NCT02374567|Pimozide|pimozide|mesh-list
102267348|NCT02374567|Olanzapine|olanzapine|mesh-list
102267349|NCT02374567|Zolpidem|zolpidem|mesh-list
102267350|NCT02374567|Alprazolam|alprazolam|mesh-list
102267351|NCT02374567|Zopiclone|zopiclone|mesh-list
102267352|NCT02374567|Agomelatine|agomelatine|mesh-list
102267353|NCT02374567|Doxepin|doxepin|mesh-list
102267354|NCT02374567|Chloral Hydrate|chloral hydrate|mesh-list
102267355|NCT02374567|Oxazepam|oxazepam|mesh-list
102267356|NCT02374567|Temazepam|temazepam|mesh-list
102267357|NCT02374567|Brotizolam|brotizolam|mesh-list
102267358|NCT02374567|Lormetazepam|lormetazepam|mesh-list
102267359|NCT02374567|Flurazepam|flurazepam|mesh-list
102267360|NCT02374567|Mirtazapine|mirtazapine|mesh-list
102267361|NCT02374567|Fluvoxamine|fluvoxamine|mesh-list
102267362|NCT02374567|Buspirone|buspirone|mesh-list
102267363|NCT02374567|Trazodone|trazodone|mesh-list
102267364|NCT02374567|Tranylcypromine|tranylcypromine|mesh-list
102267365|NCT02374567|Bromazepam|bromazepam|mesh-list
102267366|NCT02374567|Risperidone|risperidone|mesh-list
102267367|NCT02374567|Melatonin|melatonin|mesh-list
102267368|NCT02374567|Aripiprazole|aripiprazole|mesh-list
102267369|NCT02374567|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102267370|NCT02374567|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102267371|NCT02374567|Ziprasidone|ziprasidone|mesh-list
102267372|NCT02374567|Clozapine|clozapine|mesh-list
102267373|NCT02374567|Amisulpride|amisulpride|mesh-list
102267374|NCT02374567|Flupenthixol|flupenthixol|mesh-list
102613922|NCT00002987|Mitosis Modulators|mitosis modulators|mesh-ancestor
102267375|NCT02374567|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
102267376|NCT02374567|Perphenazine|perphenazine|mesh-list
102267377|NCT02374567|Sertindole|sertindole|mesh-list
102267378|NCT02374567|Sulpiride|sulpiride|mesh-list
102267379|NCT02374567|Fluphenazine|fluphenazine|mesh-list
102267380|NCT02374567|Fluphenazine depot|fluphenazine depot|mesh-list
102267381|NCT02374567|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
102267382|NCT02374567|Thioridazine|thioridazine|mesh-list
102267383|NCT02374567|Clopenthixol|clopenthixol|mesh-list
102267384|NCT02374567|Pipamperone|pipamperone|mesh-list
102267385|NCT02374567|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
102267386|NCT02374567|Chlorprothixene|chlorprothixene|mesh-list
102267387|NCT02374567|Fluspirilene|fluspirilene|mesh-list
102267388|NCT02374567|Benperidol|benperidol|mesh-list
102267389|NCT02374567|Bromperidol|bromperidol|mesh-list
102267390|NCT02374567|Perazine|perazine|mesh-list
102267391|NCT02374567|Rivastigmine|rivastigmine|mesh-list
102267392|NCT02374567|Piracetam|piracetam|mesh-list
102267393|NCT02374567|Donepezil|donepezil|mesh-list
102267394|NCT02374567|Galantamine|galantamine|mesh-list
102267395|NCT02374567|Citalopram|citalopram|mesh-list
102267396|NCT02374567|Bupropion|bupropion|mesh-list
102267397|NCT02374567|Sertraline|sertraline|mesh-list
102267398|NCT02374567|Fluoxetine|fluoxetine|mesh-list
102267399|NCT02374567|Paroxetine|paroxetine|mesh-list
102267400|NCT02374567|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102267401|NCT02374567|Nortriptyline|nortriptyline|mesh-list
102267402|NCT02374567|Reboxetine|reboxetine|mesh-list
102267403|NCT02374567|Imipramine|imipramine|mesh-list
102267404|NCT02374567|Clomipramine|clomipramine|mesh-list
102267405|NCT02374567|Moclobemide|moclobemide|mesh-list
102267406|NCT02374567|Mianserin|mianserin|mesh-list
102267407|NCT02374567|Opipramol|opipramol|mesh-list
102267408|NCT02374567|Trimipramine|trimipramine|mesh-list
102267409|NCT02374567|Maprotiline|maprotiline|mesh-list
102267410|NCT02374567|Hydroxyzine|hydroxyzine|mesh-list
102267411|NCT02374567|Escitalopram|escitalopram|mesh-list
102267412|NCT02374567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102267413|NCT02374567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102267414|NCT02374567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102267415|NCT02374567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267416|NCT02374567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102267417|NCT02374567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102267418|NCT02374567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102267419|NCT02374567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102267420|NCT02374567|Anesthetics, General|anesthetics, general|mesh-ancestor
102267421|NCT02374567|Anesthetics|anesthetics|mesh-ancestor
102267422|NCT02374567|GABA Modulators|gaba modulators|mesh-ancestor
102267423|NCT02374567|GABA Agents|gaba agents|mesh-ancestor
102267424|NCT02374567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102267425|NCT02374567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267426|NCT02374567|Analgesics|analgesics|mesh-ancestor
102267427|NCT02374567|Sensory System Agents|sensory system agents|mesh-ancestor
102267428|NCT02374567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102267429|NCT02374567|Anticonvulsants|anticonvulsants|mesh-ancestor
102267430|NCT02374567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102267431|NCT02374567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102267432|NCT02374567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102267433|NCT02374567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101821778|NCT01032057|Antimetabolites|antimetabolites|mesh-ancestor
102267434|NCT02374567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102267435|NCT02374567|Antimanic Agents|antimanic agents|mesh-ancestor
102267436|NCT02374567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102267437|NCT02374567|Serotonin Agents|serotonin agents|mesh-ancestor
102267438|NCT02374567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102267439|NCT02374567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102267440|NCT02374567|Dopamine Agents|dopamine agents|mesh-ancestor
102267441|NCT02374567|Antioxidants|antioxidants|mesh-ancestor
102267442|NCT02374567|Protective Agents|protective agents|mesh-ancestor
102267443|NCT02374567|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102267444|NCT02374567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102267445|NCT02374567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102267446|NCT02374567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102267447|NCT02374567|Parasympatholytics|parasympatholytics|mesh-ancestor
101821796|NCT01006668|Anesthetics|anesthetics|mesh-ancestor
102267448|NCT02374567|Autonomic Agents|autonomic agents|mesh-ancestor
102267449|NCT02374567|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102267450|NCT02374567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102267451|NCT02374567|Cholinergic Agents|cholinergic agents|mesh-ancestor
102267452|NCT02374567|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102267453|NCT02374567|Antidepressive Agents|antidepressive agents|mesh-ancestor
102267454|NCT02374567|Antiemetics|antiemetics|mesh-ancestor
102267455|NCT02374567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102267456|NCT02374567|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102267457|NCT02374567|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102613923|NCT00002987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102267458|NCT02374567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102267459|NCT02374567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102267460|NCT02374567|Dopamine Agonists|dopamine agonists|mesh-ancestor
101821800|NCT00360568|Carbidopa|carbidopa|mesh-list
102267461|NCT02374567|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102267462|NCT02374567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102267463|NCT02374567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102267464|NCT02374567|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102267465|NCT02374567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102267466|NCT02374567|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102267467|NCT02374567|Nootropic Agents|nootropic agents|mesh-ancestor
102267468|NCT02374567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102267469|NCT02374567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102267470|NCT02374567|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102267471|NCT02374567|Anesthetics, Local|anesthetics, local|mesh-ancestor
102267472|NCT02374567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102267473|NCT02374567|Histamine Antagonists|histamine antagonists|mesh-ancestor
102267474|NCT02374567|Histamine Agents|histamine agents|mesh-ancestor
102267475|NCT02374567|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102267476|NCT02374567|Antipruritics|antipruritics|mesh-ancestor
102267477|NCT02374567|Dermatologic Agents|dermatologic agents|mesh-ancestor
102267478|NCT02374567|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102267479|NCT02374567|GABA Agonists|gaba agonists|mesh-ancestor
102267480|NCT02374567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102267481|NCT02374567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102267482|NCT02374567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102267483|NCT02374567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102267484|NCT02374567|Adrenergic Agents|adrenergic agents|mesh-ancestor
102267485|NCT02374567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102267486|NCT02374567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102267487|NCT02374567|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102267488|NCT02374567|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102267489|NCT02374567|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102267490|NCT02374567|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102267491|NCT02374567|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102267492|NCT02374567|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102267493|NCT02374567|GABA Antagonists|gaba antagonists|mesh-ancestor
102267494|NCT02374567|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102267495|NCT02374567|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102267496|NCT02374567|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102267497|NCT02374567|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102267498|NCT02374567|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102267499|NCT02374567|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102267500|NCT02374567|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102267501|NCT02374567|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102267502|NCT02374567|Vasodilator Agents|vasodilator agents|mesh-ancestor
102267504|NCT03965741|Apixaban|apixaban|mesh-list
102267505|NCT03965741|Dabigatran|dabigatran|mesh-list
102267506|NCT03965741|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102267507|NCT03965741|Antithrombins|antithrombins|mesh-ancestor
102267508|NCT03965741|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102267509|NCT03965741|Protease Inhibitors|protease inhibitors|mesh-ancestor
102267510|NCT03965741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102267511|NCT03965741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267512|NCT03965741|Anticoagulants|anticoagulants|mesh-ancestor
102267513|NCT02368171|Nitric Oxide|nitric oxide|mesh-list
102267514|NCT02368171|Carbon Monoxide|carbon monoxide|mesh-list
102267515|NCT02368171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102267516|NCT02368171|Autonomic Agents|autonomic agents|mesh-ancestor
102267517|NCT02368171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102267518|NCT02368171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267519|NCT02368171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102267520|NCT02368171|Respiratory System Agents|respiratory system agents|mesh-ancestor
102267521|NCT02368171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102267522|NCT02368171|Antioxidants|antioxidants|mesh-ancestor
102267523|NCT02368171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267524|NCT02368171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102267525|NCT02368171|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102267526|NCT02368171|Vasodilator Agents|vasodilator agents|mesh-ancestor
102267527|NCT02368171|Gasotransmitters|gasotransmitters|mesh-ancestor
102267528|NCT02368171|Protective Agents|protective agents|mesh-ancestor
102267529|NCT02368171|Antimetabolites|antimetabolites|mesh-ancestor
102267530|NCT05063513|Mycophenolic Acid|mycophenolic acid|mesh-list
102267531|NCT05063513|Rituximab|rituximab|mesh-list
102267532|NCT05063513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102267533|NCT05063513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102267534|NCT05063513|Immunologic Factors|immunologic factors|mesh-ancestor
102267535|NCT05063513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267536|NCT05063513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102267537|NCT05063513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102267538|NCT05063513|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102267539|NCT05063513|Antitubercular Agents|antitubercular agents|mesh-ancestor
102267540|NCT05063513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102267541|NCT05063513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102267542|NCT05063513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102267543|NCT05063513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267544|NCT02364583|Primaquine|primaquine|mesh-list
102267545|NCT02364583|Antimalarials|antimalarials|mesh-ancestor
102267546|NCT02364583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102267547|NCT02364583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102267548|NCT02364583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102267549|NCT02368015|Cefazolin|cefazolin|mesh-list
102267550|NCT02368015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102267551|NCT02368015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102267552|NCT02373943|Carotenoids|carotenoids|mesh-list
102267553|NCT02373943|Antioxidants|antioxidants|mesh-ancestor
102267554|NCT02373943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267555|NCT02373943|Protective Agents|protective agents|mesh-ancestor
101821891|NCT00626561|Growth Substances|growth substances|mesh-ancestor
102267556|NCT02373943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267557|NCT04632433|Cemiplimab|cemiplimab|mesh-list
102267558|NCT04632433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102267559|NCT04632433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102267560|NCT02368249|Terlipressin|terlipressin|mesh-list
102267561|NCT02368249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102267562|NCT02368249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102267563|NCT02367937|Flurbiprofen|flurbiprofen|mesh-list
102267564|NCT02367937|Midazolam|midazolam|mesh-list
102267565|NCT02367937|Omeprazole|omeprazole|mesh-list
102267566|NCT02367937|Simvastatin|simvastatin|mesh-list
102267567|NCT02367937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101821902|NCT00423891|Entecavir|entecavir|mesh-list
102267568|NCT02367937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102267569|NCT02367937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102267570|NCT02367937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267571|NCT02367937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102267572|NCT02367937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102267573|NCT02367937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102267574|NCT02367937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102267575|NCT02367937|Anesthetics, General|anesthetics, general|mesh-ancestor
102267576|NCT02367937|Anesthetics|anesthetics|mesh-ancestor
102267577|NCT02367937|GABA Modulators|gaba modulators|mesh-ancestor
102267578|NCT02367937|GABA Agents|gaba agents|mesh-ancestor
102267579|NCT02367937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102267580|NCT02367937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267581|NCT02367937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102267582|NCT02367937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102267583|NCT02367937|Antimetabolites|antimetabolites|mesh-ancestor
102267584|NCT02367937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102267585|NCT02367937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102267586|NCT02367937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102267587|NCT02367937|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102267588|NCT02367937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102267589|NCT02367937|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102267590|NCT02367937|Analgesics|analgesics|mesh-ancestor
102267591|NCT02367937|Sensory System Agents|sensory system agents|mesh-ancestor
102267592|NCT02367937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102267593|NCT02367937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102267594|NCT02367937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102267595|NCT02367937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102267596|NCT02367937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102267597|NCT02367937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102267598|NCT05011487|Pemetrexed|pemetrexed|mesh-list
102267599|NCT05011487|Osimertinib|osimertinib|mesh-list
102267600|NCT05011487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102267601|NCT05011487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102267602|NCT05011487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267603|NCT05011487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102267604|NCT05011487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102613924|NCT00002987|Glucocorticoids|glucocorticoids|mesh-ancestor
102613925|NCT00002987|Hormones|hormones|mesh-ancestor
102267605|NCT05011487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102267606|NCT02367547|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102267607|NCT02367547|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
102267608|NCT02367547|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102267609|NCT02367547|Dermatologic Agents|dermatologic agents|mesh-ancestor
102267610|NCT05061641|Progesterone|progesterone|mesh-list
102267611|NCT05061641|Progestins|progestins|mesh-ancestor
102267612|NCT05061641|Hormones|hormones|mesh-ancestor
102267613|NCT05061641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102267614|NCT05061641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267615|NCT03100019|Resveratrol|resveratrol|mesh-list
102267616|NCT03100019|Antioxidants|antioxidants|mesh-ancestor
102267617|NCT03100019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267618|NCT03100019|Protective Agents|protective agents|mesh-ancestor
102267619|NCT03100019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267620|NCT03100019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102267621|NCT03100019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102267622|NCT05047055|Moxifloxacin|moxifloxacin|mesh-list
102267623|NCT05047055|Rifampin|rifampin|mesh-list
102267624|NCT05047055|Isoniazid|isoniazid|mesh-list
102267625|NCT05047055|Pyrazinamide|pyrazinamide|mesh-list
102267626|NCT05047055|Ethambutol|ethambutol|mesh-list
102267627|NCT05047055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102267628|NCT05047055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102267629|NCT05047055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102267630|NCT05047055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102267631|NCT05047055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102267632|NCT05047055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267633|NCT05047055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102267634|NCT05047055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102267635|NCT05047055|Antitubercular Agents|antitubercular agents|mesh-ancestor
102267636|NCT05047055|Leprostatic Agents|leprostatic agents|mesh-ancestor
102267637|NCT05047055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102267638|NCT05047055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102267639|NCT05047055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102267640|NCT05047055|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102267641|NCT05047055|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102267642|NCT05047055|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102267643|NCT05047055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102267644|NCT05047055|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102267645|NCT05047055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101976502|NCT01349270|Prednisone|prednisone|mesh-list
101298426|NCT02005523|RNS60|rns60|mesh-list
102267646|NCT05047055|Antimetabolites|antimetabolites|mesh-ancestor
102267647|NCT05047055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102267648|NCT03098537|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
102267649|NCT03098537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102267650|NCT03098537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267651|NCT05046041|Misoprostol|misoprostol|mesh-list
102267652|NCT05046041|Mifepristone|mifepristone|mesh-list
102267653|NCT05046041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102267654|NCT05046041|Abortifacient Agents|abortifacient agents|mesh-ancestor
102267655|NCT05046041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102267656|NCT05046041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267657|NCT05046041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102267658|NCT05046041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102267659|NCT05046041|Oxytocics|oxytocics|mesh-ancestor
101822004|NCT01050556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822005|NCT05889871|Apatinib|apatinib|mesh-list
102267660|NCT05046041|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102267661|NCT05046041|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102267662|NCT05046041|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102267663|NCT05046041|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102267664|NCT05046041|Contraceptive Agents|contraceptive agents|mesh-ancestor
102267665|NCT05046041|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102267666|NCT05046041|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102267667|NCT05046041|Hormone Antagonists|hormone antagonists|mesh-ancestor
101479293|NCT00417326|Sivelestat|sivelestat|mesh-list
102267668|NCT05046041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102267669|NCT05046041|Luteolytic Agents|luteolytic agents|mesh-ancestor
102267670|NCT05046041|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102267671|NCT05046041|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102267672|NCT01970878|Bromides|bromides|mesh-list
102267673|NCT01970878|Tiotropium Bromide|tiotropium bromide|mesh-list
102267674|NCT01970878|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102267675|NCT01970878|Autonomic Agents|autonomic agents|mesh-ancestor
102267676|NCT01970878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102267677|NCT01970878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613926|NCT00002987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102613927|NCT00002987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101822025|NCT05889455|Sildenafil Citrate|sildenafil citrate|mesh-list
101822026|NCT05889455|Vasodilator Agents|vasodilator agents|mesh-ancestor
101822027|NCT05889455|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101298715|NCT05969847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298717|NCT05969834|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101298718|NCT05969834|Luteolytic Agents|luteolytic agents|mesh-ancestor
101298719|NCT05969834|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102613928|NCT02919683|Nivolumab|nivolumab|mesh-list
102613929|NCT02919683|Ipilimumab|ipilimumab|mesh-list
102267678|NCT01970878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102267679|NCT01970878|Respiratory System Agents|respiratory system agents|mesh-ancestor
102267680|NCT01970878|Parasympatholytics|parasympatholytics|mesh-ancestor
102267681|NCT01970878|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102267682|NCT01970878|Cholinergic Agents|cholinergic agents|mesh-ancestor
102267683|NCT01970878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102267684|NCT01970878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267685|NCT01970878|Anticonvulsants|anticonvulsants|mesh-ancestor
102267686|NCT05045651|Cimetidine|cimetidine|mesh-list
102267687|NCT05045651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102267688|NCT05045651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101298720|NCT05969834|Contraceptive Agents|contraceptive agents|mesh-ancestor
102267689|NCT05045651|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102267690|NCT05045651|Histamine Antagonists|histamine antagonists|mesh-ancestor
102267691|NCT05045651|Histamine Agents|histamine agents|mesh-ancestor
102267692|NCT05045651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102267693|NCT05045651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267694|NCT05045651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267695|NCT05045651|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102267696|NCT05045651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102267697|NCT05045651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102267698|NCT05059145|Chlorhexidine|chlorhexidine|mesh-list
102267699|NCT05059145|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102267700|NCT05059145|Fluconazole|fluconazole|mesh-list
102267701|NCT05059145|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102267702|NCT05059145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102267703|NCT05059145|Disinfectants|disinfectants|mesh-ancestor
102267704|NCT05059145|Dermatologic Agents|dermatologic agents|mesh-ancestor
102267705|NCT05059145|Antifungal Agents|antifungal agents|mesh-ancestor
102267706|NCT05059145|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102267707|NCT05059145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102267708|NCT05059145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101822035|NCT05889442|Autonomic Agents|autonomic agents|mesh-ancestor
102267709|NCT05059145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267710|NCT05059145|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102267711|NCT05059145|Hormone Antagonists|hormone antagonists|mesh-ancestor
102267712|NCT05059145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102267713|NCT05059145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267714|NCT05059145|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102267715|NCT05059145|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102267716|NCT05058677|Lidocaine|lidocaine|mesh-list
102267717|NCT05058677|Anesthetics, Local|anesthetics, local|mesh-ancestor
102267718|NCT05058677|Anesthetics|anesthetics|mesh-ancestor
102267719|NCT05058677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101976568|NCT02296762|Sirolimus|sirolimus|mesh-list
102267720|NCT05058677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267722|NCT05058677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102267723|NCT05058677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102267724|NCT05058677|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102267725|NCT05058677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102267726|NCT05058677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102267727|NCT05058677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267728|NCT01970488|Adalimumab|adalimumab|mesh-list
102267729|NCT01970488|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101822063|NCT05889338|Adalimumab|adalimumab|mesh-list
102267730|NCT01970488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102267731|NCT01970488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102267732|NCT03097835|Anesthetics|anesthetics|mesh-list
102267733|NCT03097835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102267734|NCT03097835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267735|NCT03097601|Sunitinib|sunitinib|mesh-list
102267736|NCT03097601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102267737|NCT03097601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102267738|NCT03097601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102267739|NCT03097601|Growth Substances|growth substances|mesh-ancestor
102267740|NCT03097601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267741|NCT03097601|Growth Inhibitors|growth inhibitors|mesh-ancestor
102267742|NCT03097601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102267743|NCT03097601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102267744|NCT03097601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267745|NCT05058755|Etoposide|etoposide|mesh-list
102267746|NCT05058755|Lenalidomide|lenalidomide|mesh-list
102267747|NCT05058755|Azacitidine|azacitidine|mesh-list
102267748|NCT05058755|Tislelizumab|tislelizumab|mesh-list
102613930|NCT02919683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102613931|NCT02919683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102267750|NCT05058755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102267751|NCT05058755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102267752|NCT05058755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102267753|NCT05058755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102267754|NCT05058755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102267755|NCT05058755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267756|NCT05058755|Immunologic Factors|immunologic factors|mesh-ancestor
102267757|NCT05058755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267758|NCT05058755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102267759|NCT05058755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102267760|NCT05058755|Growth Substances|growth substances|mesh-ancestor
102267761|NCT05058755|Growth Inhibitors|growth inhibitors|mesh-ancestor
102267762|NCT05058755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102267763|NCT05058755|Antimetabolites|antimetabolites|mesh-ancestor
102267764|NCT05058755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102267765|NCT05044169|Broncho-Vaxom|broncho-vaxom|mesh-list
102267766|NCT05044169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102267767|NCT05044169|Immunologic Factors|immunologic factors|mesh-ancestor
102267768|NCT05044169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267769|NCT05058209|Triamcinolone|triamcinolone|mesh-list
102267770|NCT05058209|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102267771|NCT05058209|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102267772|NCT05058209|Betamethasone|betamethasone|mesh-list
102267773|NCT05058209|Betamethasone Valerate|betamethasone valerate|mesh-list
102267774|NCT05058209|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102267775|NCT05058209|Betamethasone benzoate|betamethasone benzoate|mesh-list
102267776|NCT05058209|Betamethasone acetate|betamethasone acetate|mesh-list
102267777|NCT05058209|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102267778|NCT05058209|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101822096|NCT05889052|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101822097|NCT05889052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101822098|NCT05889052|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101822099|NCT05889052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102267779|NCT05058209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102267780|NCT05058209|Glucocorticoids|glucocorticoids|mesh-ancestor
102267781|NCT05058209|Hormones|hormones|mesh-ancestor
102267782|NCT05058209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102267783|NCT05058209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267784|NCT05058209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102267785|NCT05058209|Immunologic Factors|immunologic factors|mesh-ancestor
102267786|NCT05058209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102267787|NCT05058209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267788|NCT05058209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102267789|NCT05058209|Respiratory System Agents|respiratory system agents|mesh-ancestor
102267790|NCT05057663|Fluorouracil|fluorouracil|mesh-list
101976635|NCT02296996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102267791|NCT05057663|Bleomycin|bleomycin|mesh-list
102267792|NCT05057663|Antimetabolites|antimetabolites|mesh-ancestor
102267793|NCT05057663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267794|NCT05057663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102267795|NCT05057663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102267796|NCT05057663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102267797|NCT05057663|Immunologic Factors|immunologic factors|mesh-ancestor
102267798|NCT05057663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267799|NCT05057663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102267800|NCT03097445|Nicotine|nicotine|mesh-list
102267801|NCT03097445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102267802|NCT03097445|Autonomic Agents|autonomic agents|mesh-ancestor
102267803|NCT03097445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102267804|NCT03097445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267805|NCT03097445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102267806|NCT03097445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102267807|NCT03097445|Cholinergic Agents|cholinergic agents|mesh-ancestor
102267808|NCT03097445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102267809|NCT03097445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267810|NCT05057351|Glycerol|glycerol|mesh-list
102267811|NCT05057351|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102267812|NCT05057351|Protective Agents|protective agents|mesh-ancestor
102267813|NCT05057351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267814|NCT03097211|Levodopa|levodopa|mesh-list
102267815|NCT03097211|Benserazide|benserazide|mesh-list
102267816|NCT03097211|Resveratrol|resveratrol|mesh-list
101822135|NCT05887947|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101822136|NCT05887947|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101822137|NCT05887947|Cholinergic Agents|cholinergic agents|mesh-ancestor
101822138|NCT05887947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101822139|NCT05887947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822140|NCT05887908|Imipenem|imipenem|mesh-list
101822141|NCT05887908|Cefepime|cefepime|mesh-list
101822142|NCT05887908|Aztreonam|aztreonam|mesh-list
101822143|NCT05887908|Cilastatin|cilastatin|mesh-list
101822144|NCT05887908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101299307|NCT05845359|Sensory System Agents|sensory system agents|mesh-ancestor
101299308|NCT05845359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101299309|NCT05845359|Antitussive Agents|antitussive agents|mesh-ancestor
101299310|NCT05845359|Respiratory System Agents|respiratory system agents|mesh-ancestor
102267817|NCT03097211|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
102267818|NCT03097211|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102267819|NCT03097211|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102267820|NCT03097211|Dopamine Agents|dopamine agents|mesh-ancestor
101609580|NCT02667886|Axitinib|axitinib|mesh-list
102613932|NCT02919683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102613933|NCT02919683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613935|NCT03933293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102613936|NCT03933293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102613937|NCT03933293|Antimetabolites|antimetabolites|mesh-ancestor
102613938|NCT03933293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267821|NCT03097211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102267822|NCT03097211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267823|NCT03097211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267824|NCT03097211|Antioxidants|antioxidants|mesh-ancestor
102267825|NCT03097211|Protective Agents|protective agents|mesh-ancestor
102267826|NCT03097211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102267827|NCT03097211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101822154|NCT05887778|Autonomic Agents|autonomic agents|mesh-ancestor
102267828|NCT05043935|Anti-Infective Agents|anti-infective agents|mesh-list
102267829|NCT05043935|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102267830|NCT05056337|Lenvatinib|lenvatinib|mesh-list
102267831|NCT05056337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102267832|NCT05056337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102267833|NCT05056337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101822166|NCT05887765|Dexamethasone|dexamethasone|mesh-list
102267834|NCT05056337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267835|NCT05056025|Vitamins|vitamins|mesh-list
102267836|NCT05056025|Micronutrients|micronutrients|mesh-ancestor
102267837|NCT05056025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267838|NCT02661217|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102267839|NCT02661217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102267840|NCT02661217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267841|NCT05044091|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
101822171|NCT05887765|Autonomic Agents|autonomic agents|mesh-ancestor
101822175|NCT05887765|Glucocorticoids|glucocorticoids|mesh-ancestor
102267842|NCT05044091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102267843|NCT05044091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267844|NCT05044091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102267845|NCT01952080|Teduglutide|teduglutide|mesh-list
102267846|NCT01952080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102267847|NCT01952080|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102267848|NCT01952080|Protective Agents|protective agents|mesh-ancestor
102267849|NCT01952080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267850|NCT01951378|Albuterol|albuterol|mesh-list
102267851|NCT01951378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102267852|NCT01951378|Autonomic Agents|autonomic agents|mesh-ancestor
102267853|NCT01951378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102267854|NCT01951378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267855|NCT01951378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102267856|NCT01951378|Respiratory System Agents|respiratory system agents|mesh-ancestor
102267857|NCT01951378|Tocolytic Agents|tocolytic agents|mesh-ancestor
102267858|NCT01951378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102267859|NCT01951378|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102267860|NCT01951378|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102267861|NCT01951378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102267862|NCT01951378|Adrenergic Agents|adrenergic agents|mesh-ancestor
102267863|NCT01951378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102267864|NCT01951378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976710|NCT01232023|Analgesics|analgesics|mesh-ancestor
102267865|NCT05043233|Methimazole|methimazole|mesh-list
102267866|NCT05043233|Antithyroid Agents|antithyroid agents|mesh-ancestor
102267867|NCT05043233|Hormone Antagonists|hormone antagonists|mesh-ancestor
102267868|NCT05043233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102267869|NCT05043233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267870|NCT05054465|Venetoclax|venetoclax|mesh-list
102267871|NCT05054465|Navitoclax|navitoclax|mesh-list
102267872|NCT05054465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102267873|NCT03860233|Oxytocin|oxytocin|mesh-list
102267874|NCT03860233|Oxytocics|oxytocics|mesh-ancestor
102267875|NCT03860233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102267876|NCT03860233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267877|NCT02373085|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102267878|NCT02373085|Anti-Infective Agents|anti-infective agents|mesh-list
102267879|NCT01361009|Pramipexole|pramipexole|mesh-list
102267880|NCT01361009|Antioxidants|antioxidants|mesh-ancestor
102267881|NCT01361009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267882|NCT01361009|Protective Agents|protective agents|mesh-ancestor
102267883|NCT01361009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267884|NCT01361009|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101822183|NCT05886712|Naloxone|naloxone|mesh-list
102267885|NCT01361009|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102613939|NCT03933293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102267886|NCT01361009|Dopamine Agonists|dopamine agonists|mesh-ancestor
102267887|NCT01361009|Dopamine Agents|dopamine agents|mesh-ancestor
102267888|NCT01361009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102267889|NCT02373163|Amlodipine|amlodipine|mesh-list
102267890|NCT02373163|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102267891|NCT02373163|Telmisartan|telmisartan|mesh-list
102267892|NCT02373163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102267893|NCT02373163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102267894|NCT02373163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102267895|NCT02373163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267896|NCT02373163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101822226|NCT05743946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101822227|NCT05743946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822228|NCT05742789|Propofol|propofol|mesh-list
101822229|NCT05742789|Sevoflurane|sevoflurane|mesh-list
101822230|NCT05742789|Isoflurane|isoflurane|mesh-list
102267897|NCT02373163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267898|NCT02373163|Vasodilator Agents|vasodilator agents|mesh-ancestor
102267899|NCT02373163|Diuretics|diuretics|mesh-ancestor
102267900|NCT02373163|Natriuretic Agents|natriuretic agents|mesh-ancestor
102267901|NCT02373163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102267902|NCT02373163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102267903|NCT02373163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102267904|NCT02366377|Metformin|metformin|mesh-list
102267905|NCT02366377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102267906|NCT02366377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267907|NCT02366299|Dexmedetomidine|dexmedetomidine|mesh-list
102267908|NCT02366299|Propofol|propofol|mesh-list
102267909|NCT02366299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102267910|NCT02366299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102267911|NCT02366299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267912|NCT02366299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102267913|NCT02366299|Analgesics|analgesics|mesh-ancestor
102267914|NCT02366299|Sensory System Agents|sensory system agents|mesh-ancestor
102267915|NCT02366299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102267916|NCT02366299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102267917|NCT02366299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101299811|NCT05468957|Hemostatics|hemostatics|mesh-list
102267918|NCT02366299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102267919|NCT02366299|Adrenergic Agents|adrenergic agents|mesh-ancestor
102267920|NCT02366299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102267921|NCT02366299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267922|NCT02366299|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102267923|NCT02366299|Anesthetics, General|anesthetics, general|mesh-ancestor
102267924|NCT02366299|Anesthetics|anesthetics|mesh-ancestor
102267925|NCT05041985|Diazepam|diazepam|mesh-list
102267926|NCT05041985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102267927|NCT05041985|Anticonvulsants|anticonvulsants|mesh-ancestor
102267928|NCT05041985|Antiemetics|antiemetics|mesh-ancestor
102267929|NCT05041985|Autonomic Agents|autonomic agents|mesh-ancestor
102267930|NCT05041985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102267931|NCT05041985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267932|NCT05041985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102267933|NCT05041985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102267934|NCT05041985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102267935|NCT05041985|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102267936|NCT05041985|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102267937|NCT05041985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102267938|NCT05041985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102267939|NCT05041985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101976785|NCT01356758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102267940|NCT05041985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102267941|NCT05041985|Anesthetics, General|anesthetics, general|mesh-ancestor
102267942|NCT05041985|Anesthetics|anesthetics|mesh-ancestor
102267943|NCT05041985|GABA Modulators|gaba modulators|mesh-ancestor
102267944|NCT05041985|GABA Agents|gaba agents|mesh-ancestor
102267945|NCT05041985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102267946|NCT05041985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267947|NCT05053841|Metformin|metformin|mesh-list
102267948|NCT05053841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102267949|NCT05053841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267950|NCT02372461|Amoxicillin|amoxicillin|mesh-list
102267951|NCT02372461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101822271|NCT05741385|Autonomic Agents|autonomic agents|mesh-ancestor
102267952|NCT02372461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102267953|NCT02859337|Ulipristal acetate|ulipristal acetate|mesh-list
102267954|NCT02859337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102267955|NCT02859337|Contraceptive Agents|contraceptive agents|mesh-ancestor
102267956|NCT02859337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102613940|NCT00002993|Doxorubicin|doxorubicin|mesh-list
102267957|NCT02859337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267958|NCT02859337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102267960|NCT04499131|Progestins|progestins|mesh-ancestor
102267961|NCT04499131|Hormones|hormones|mesh-ancestor
102267962|NCT04499131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102267963|NCT04499131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267964|NCT02366065|Acetaminophen|acetaminophen|mesh-list
102267965|NCT02366065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102267966|NCT02366065|Analgesics|analgesics|mesh-ancestor
102267967|NCT02366065|Sensory System Agents|sensory system agents|mesh-ancestor
101822289|NCT05696613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102267968|NCT02366065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102267969|NCT02366065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267970|NCT02366065|Antipyretics|antipyretics|mesh-ancestor
102267971|NCT02362945|Oxytocin|oxytocin|mesh-list
102267972|NCT02362945|Oxytocics|oxytocics|mesh-ancestor
101822298|NCT05645146|Nicotine|nicotine|mesh-list
102267973|NCT02362945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102267974|NCT02362945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267975|NCT02365909|Bupivacaine|bupivacaine|mesh-list
102267976|NCT02365909|Anesthetics, Local|anesthetics, local|mesh-ancestor
102267977|NCT02365909|Anesthetics|anesthetics|mesh-ancestor
102267978|NCT02365909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102267979|NCT02365909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102267980|NCT02365909|Sensory System Agents|sensory system agents|mesh-ancestor
102267981|NCT02365909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102267982|NCT05052515|Choline|choline|mesh-list
102267983|NCT05052515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102267984|NCT05052515|Lipotropic Agents|lipotropic agents|mesh-ancestor
102267985|NCT05052515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102267986|NCT05052515|Antimetabolites|antimetabolites|mesh-ancestor
102267987|NCT05052515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102267988|NCT05052515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102267989|NCT05052515|Nootropic Agents|nootropic agents|mesh-ancestor
102267990|NCT02365675|Petrolatum|petrolatum|mesh-list
102267991|NCT02365675|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102267992|NCT02365675|Laxatives|laxatives|mesh-ancestor
102267993|NCT02365675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102267994|NCT02365675|Emollients|emollients|mesh-ancestor
102267995|NCT02365675|Dermatologic Agents|dermatologic agents|mesh-ancestor
102267996|NCT05052437|Capecitabine|capecitabine|mesh-list
102267997|NCT05052437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102267998|NCT05052437|Antimetabolites|antimetabolites|mesh-ancestor
102267999|NCT05052437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268000|NCT05052437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102268001|NCT05052359|Lectins|lectins|mesh-list
102268002|NCT05052359|Agglutinins|agglutinins|mesh-ancestor
102268003|NCT05052359|Immunologic Factors|immunologic factors|mesh-ancestor
102268004|NCT05052359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268005|NCT05052359|Coagulants|coagulants|mesh-ancestor
102268006|NCT02362711|Levonorgestrel|levonorgestrel|mesh-list
102268007|NCT02362711|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102268008|NCT02362711|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102268009|NCT02362711|Contraceptive Agents|contraceptive agents|mesh-ancestor
102268010|NCT02362711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102268011|NCT02362711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268012|NCT02362711|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101822330|NCT05610072|Antioxidants|antioxidants|mesh-ancestor
102268013|NCT02362711|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102268014|NCT02362711|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102268015|NCT02362711|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102268016|NCT02362711|Estrogens|estrogens|mesh-ancestor
102268017|NCT02362711|Hormones|hormones|mesh-ancestor
102268018|NCT02362711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102268019|NCT01944046|Oxytocin|oxytocin|mesh-list
102268020|NCT01944046|Oxytocics|oxytocics|mesh-ancestor
102268021|NCT01944046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102268022|NCT01944046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268023|NCT00773695|Paclitaxel|paclitaxel|mesh-list
102268024|NCT00773695|Docetaxel|docetaxel|mesh-list
102268025|NCT00773695|Cyclophosphamide|cyclophosphamide|mesh-list
102268026|NCT00773695|Bevacizumab|bevacizumab|mesh-list
102268027|NCT00773695|Fluorouracil|fluorouracil|mesh-list
102268028|NCT00773695|Epirubicin|epirubicin|mesh-list
102268029|NCT00773695|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102268030|NCT00773695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102268031|NCT00773695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102268032|NCT00773695|Tubulin Modulators|tubulin modulators|mesh-ancestor
102268033|NCT00773695|Antimitotic Agents|antimitotic agents|mesh-ancestor
102268034|NCT00773695|Mitosis Modulators|mitosis modulators|mesh-ancestor
102268035|NCT00773695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268036|NCT00773695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102613941|NCT00002993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102268037|NCT00773695|Immunologic Factors|immunologic factors|mesh-ancestor
102268038|NCT00773695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268039|NCT00773695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102268040|NCT00773695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102268041|NCT00773695|Alkylating Agents|alkylating agents|mesh-ancestor
102268042|NCT00773695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102268043|NCT00773695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102268044|NCT00773695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102268045|NCT00773695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102268046|NCT00773695|Growth Substances|growth substances|mesh-ancestor
102268047|NCT00773695|Growth Inhibitors|growth inhibitors|mesh-ancestor
102268048|NCT00773695|Antimetabolites|antimetabolites|mesh-ancestor
102268049|NCT00773695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101300817|NCT04321408|Ziconotide|ziconotide|mesh-list
102268050|NCT00773695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102268051|NCT00773695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102268052|NCT00773695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102268053|NCT00773695|Hormone Antagonists|hormone antagonists|mesh-ancestor
102268054|NCT00773695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102268055|NCT00773695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102268056|NCT00773695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102268057|NCT00773695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102268058|NCT01969084|Linagliptin|linagliptin|mesh-list
102268059|NCT01969084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102268060|NCT01969084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268061|NCT01969084|Incretins|incretins|mesh-ancestor
102268062|NCT01969084|Hormones|hormones|mesh-ancestor
102268063|NCT01969084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102268064|NCT01969084|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102268065|NCT01969084|Protease Inhibitors|protease inhibitors|mesh-ancestor
102268066|NCT01969084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102268067|NCT01969084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268068|NCT02362399|Sildenafil Citrate|sildenafil citrate|mesh-list
101822374|NCT05389514|Cyclophosphamide|cyclophosphamide|mesh-list
102268069|NCT02362399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268070|NCT02362399|Vasodilator Agents|vasodilator agents|mesh-ancestor
102268071|NCT02362399|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102268072|NCT02362399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102268073|NCT02362399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102268074|NCT02362399|Urological Agents|urological agents|mesh-ancestor
102268075|NCT04410887|Olaparib|olaparib|mesh-list
102268076|NCT04410887|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102268077|NCT04410887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102268078|NCT04410887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268079|NCT04410887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102268080|NCT02358499|Posaconazole|posaconazole|mesh-list
102268081|NCT02358499|Antifungal Agents|antifungal agents|mesh-ancestor
102268082|NCT02358499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102268083|NCT02358499|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102268084|NCT02358499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102268085|NCT02358499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102268086|NCT02358499|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102268087|NCT02358499|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102268088|NCT02358499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102268089|NCT02358499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822390|NCT05327777|Oxycodone|oxycodone|mesh-list
102268090|NCT02358499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101976939|NCT03515200|Autonomic Agents|autonomic agents|mesh-ancestor
102268091|NCT02358499|Hormone Antagonists|hormone antagonists|mesh-ancestor
102268092|NCT02358499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102268093|NCT02358499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268094|NCT02358265|Cyproheptadine|cyproheptadine|mesh-list
102268095|NCT02358265|Antipruritics|antipruritics|mesh-ancestor
102268096|NCT02358265|Dermatologic Agents|dermatologic agents|mesh-ancestor
102268097|NCT02358265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101822403|NCT05304546|Pembrolizumab|pembrolizumab|mesh-list
102268098|NCT02358265|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102268099|NCT02358265|Histamine Antagonists|histamine antagonists|mesh-ancestor
102268100|NCT02358265|Histamine Agents|histamine agents|mesh-ancestor
102268101|NCT02358265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102268102|NCT02358265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268103|NCT02358265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268104|NCT02358265|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102268105|NCT02358265|Serotonin Agents|serotonin agents|mesh-ancestor
102268106|NCT02358265|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102613942|NCT00002993|Mitomycins|mitomycins|mesh-list
102268108|NCT01968694|Promethazine|promethazine|mesh-list
102268109|NCT01968694|Lidocaine|lidocaine|mesh-list
102268110|NCT01968694|Anesthetics, Local|anesthetics, local|mesh-ancestor
102268111|NCT01968694|Anesthetics|anesthetics|mesh-ancestor
102268112|NCT01968694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102268113|NCT01968694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268114|NCT01968694|Sensory System Agents|sensory system agents|mesh-ancestor
102268115|NCT01968694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102268116|NCT01968694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102268117|NCT01968694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102268118|NCT01968694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102268119|NCT01968694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102268120|NCT01968694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268121|NCT01968694|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102268122|NCT01968694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102268123|NCT01968694|Antiemetics|antiemetics|mesh-ancestor
102268124|NCT01968694|Autonomic Agents|autonomic agents|mesh-ancestor
102268125|NCT01968694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102268126|NCT01968694|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101822419|NCT05180773|Bromocriptine|bromocriptine|mesh-list
102268127|NCT01968694|Histamine Antagonists|histamine antagonists|mesh-ancestor
102268128|NCT01968694|Histamine Agents|histamine agents|mesh-ancestor
102268129|NCT01968694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102268130|NCT01968694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102268131|NCT01968694|Antipruritics|antipruritics|mesh-ancestor
102268132|NCT01968694|Dermatologic Agents|dermatologic agents|mesh-ancestor
102268133|NCT05038007|Bupivacaine|bupivacaine|mesh-list
102268134|NCT05038007|Anesthetics, Local|anesthetics, local|mesh-ancestor
102268135|NCT05038007|Anesthetics|anesthetics|mesh-ancestor
102268136|NCT05038007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102268137|NCT05038007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268138|NCT05038007|Sensory System Agents|sensory system agents|mesh-ancestor
102268139|NCT05038007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102268140|NCT02362165|Dexamethasone|dexamethasone|mesh-list
102268141|NCT02362165|Cyclophosphamide|cyclophosphamide|mesh-list
102268142|NCT02362165|Doxorubicin|doxorubicin|mesh-list
102268143|NCT02362165|Bortezomib|bortezomib|mesh-list
102268144|NCT02362165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102268145|NCT02362165|Immunologic Factors|immunologic factors|mesh-ancestor
102268146|NCT02362165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268147|NCT02362165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102268148|NCT02362165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102268149|NCT02362165|Alkylating Agents|alkylating agents|mesh-ancestor
102268150|NCT02362165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268151|NCT02362165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102268152|NCT02362165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102268153|NCT02362165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102268154|NCT02362165|Antiemetics|antiemetics|mesh-ancestor
102268155|NCT02362165|Autonomic Agents|autonomic agents|mesh-ancestor
102268156|NCT02362165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102268157|NCT02362165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102268158|NCT02362165|Glucocorticoids|glucocorticoids|mesh-ancestor
102268159|NCT02362165|Hormones|hormones|mesh-ancestor
102268160|NCT02362165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102268161|NCT02362165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102268162|NCT02362165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101977015|NCT02298010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102268163|NCT02362165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102268164|NCT02362165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102268165|NCT02362165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102268166|NCT05049473|Cytarabine|cytarabine|mesh-list
102268167|NCT05049473|Dexamethasone|dexamethasone|mesh-list
102268168|NCT05049473|Prednisone|prednisone|mesh-list
102268169|NCT05049473|Hydrocortisone|hydrocortisone|mesh-list
102268170|NCT05049473|Cyclophosphamide|cyclophosphamide|mesh-list
102268171|NCT05049473|Rituximab|rituximab|mesh-list
102268172|NCT05049473|Doxorubicin|doxorubicin|mesh-list
102268173|NCT05049473|Methotrexate|methotrexate|mesh-list
102268174|NCT05049473|Etoposide|etoposide|mesh-list
102268175|NCT05049473|Vincristine|vincristine|mesh-list
102268176|NCT05049473|Vindesine|vindesine|mesh-list
102268177|NCT05049473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102613943|NCT00002993|Mitomycin|mitomycin|mesh-list
102613944|NCT00002993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102268178|NCT05049473|Immunologic Factors|immunologic factors|mesh-ancestor
102268179|NCT05049473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268180|NCT05049473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102268181|NCT05049473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102268183|NCT05049473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268184|NCT05049473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102268185|NCT05049473|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101822481|NCT04957758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268186|NCT05049473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102268187|NCT05049473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102268188|NCT05049473|Antiemetics|antiemetics|mesh-ancestor
102268189|NCT05049473|Autonomic Agents|autonomic agents|mesh-ancestor
102268190|NCT05049473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101301434|NCT03631199|Pemetrexed|pemetrexed|mesh-list
102268191|NCT05049473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102268192|NCT05049473|Glucocorticoids|glucocorticoids|mesh-ancestor
102268193|NCT05049473|Hormones|hormones|mesh-ancestor
102268194|NCT05049473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102268195|NCT05049473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102268196|NCT05049473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102268197|NCT05049473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102268198|NCT05049473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102268199|NCT05049473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102268200|NCT05049473|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102268201|NCT05049473|Abortifacient Agents|abortifacient agents|mesh-ancestor
102268202|NCT05049473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102268203|NCT05049473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102268204|NCT05049473|Antimetabolites|antimetabolites|mesh-ancestor
102268205|NCT05049473|Dermatologic Agents|dermatologic agents|mesh-ancestor
102268206|NCT05049473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102268207|NCT05049473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102268208|NCT05049473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102268209|NCT05049473|Antiviral Agents|antiviral agents|mesh-ancestor
102268210|NCT05049473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102268211|NCT05049473|Tubulin Modulators|tubulin modulators|mesh-ancestor
102268212|NCT05049473|Antimitotic Agents|antimitotic agents|mesh-ancestor
102268213|NCT05049473|Mitosis Modulators|mitosis modulators|mesh-ancestor
102268214|NCT02357797|Vortioxetine|vortioxetine|mesh-list
102268215|NCT02357797|Antidepressive Agents|antidepressive agents|mesh-ancestor
102268216|NCT02357797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102268217|NCT02357797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102268218|NCT02357797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102268219|NCT02357797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102268220|NCT02357797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268221|NCT02357797|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102268222|NCT02357797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102268223|NCT02357797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102268224|NCT02357797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268225|NCT02357797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102268226|NCT02357797|Serotonin Agents|serotonin agents|mesh-ancestor
102268227|NCT02357797|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102268228|NCT02357797|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101822524|NCT04850599|Growth Inhibitors|growth inhibitors|mesh-ancestor
102268229|NCT02357797|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102268230|NCT02357797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102268231|NCT02361931|Epoetin Alfa|epoetin alfa|mesh-list
102268232|NCT02361931|Hematinics|hematinics|mesh-ancestor
102268233|NCT05037695|Empagliflozin|empagliflozin|mesh-list
102268234|NCT05037695|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102268235|NCT05037695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268236|NCT05037695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102268237|NCT05037695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977087|NCT01358396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102268238|NCT02357563|Leuprolide|leuprolide|mesh-list
102268239|NCT02357563|Ulipristal acetate|ulipristal acetate|mesh-list
102268240|NCT02357563|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102268241|NCT02357563|Fertility Agents|fertility agents|mesh-ancestor
102268242|NCT02357563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102268243|NCT02357563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268244|NCT02357563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102268245|NCT02357563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102268246|NCT02357563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102268247|NCT02357563|Contraceptive Agents|contraceptive agents|mesh-ancestor
102268248|NCT02357563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102268250|NCT02640053|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102268251|NCT02640053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102268252|NCT02640053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102268253|NCT02640053|Tubulin Modulators|tubulin modulators|mesh-ancestor
102268254|NCT02640053|Antimitotic Agents|antimitotic agents|mesh-ancestor
102268255|NCT02640053|Mitosis Modulators|mitosis modulators|mesh-ancestor
102268256|NCT02640053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268257|NCT03160261|Exenatide|exenatide|mesh-list
102268258|NCT03160261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102268259|NCT03160261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268260|NCT03160261|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102268261|NCT03160261|Incretins|incretins|mesh-ancestor
102268262|NCT03160261|Hormones|hormones|mesh-ancestor
102268263|NCT03160261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102268264|NCT02361775|Ropivacaine|ropivacaine|mesh-list
102268265|NCT02361775|Anesthetics, Local|anesthetics, local|mesh-ancestor
102268266|NCT02361775|Anesthetics|anesthetics|mesh-ancestor
102268267|NCT02361775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102268268|NCT02361775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268269|NCT02361775|Sensory System Agents|sensory system agents|mesh-ancestor
102268270|NCT02361775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102268271|NCT02361619|Clarithromycin|clarithromycin|mesh-list
102268272|NCT02361619|Diclofenac|diclofenac|mesh-list
102268273|NCT02361619|Metoprolol|metoprolol|mesh-list
102268274|NCT02361619|Midazolam|midazolam|mesh-list
102268275|NCT02361619|Caffeine|caffeine|mesh-list
102268276|NCT02361619|Esomeprazole|esomeprazole|mesh-list
102268277|NCT02361619|Dabigatran|dabigatran|mesh-list
102268278|NCT02361619|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102268279|NCT02361619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102268280|NCT02361619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102268281|NCT02361619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268282|NCT02361619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102268283|NCT02361619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102268284|NCT02361619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102268285|NCT02361619|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102268286|NCT02361619|Anesthetics, General|anesthetics, general|mesh-ancestor
102268287|NCT02361619|Anesthetics|anesthetics|mesh-ancestor
102268288|NCT02361619|GABA Modulators|gaba modulators|mesh-ancestor
102268289|NCT02361619|GABA Agents|gaba agents|mesh-ancestor
102268290|NCT02361619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102268291|NCT02361619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268292|NCT02361619|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102268293|NCT02361619|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102268294|NCT02361619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102268295|NCT02361619|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102268296|NCT02361619|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102268297|NCT02361619|Purinergic Agents|purinergic agents|mesh-ancestor
101822605|NCT04680975|Belumosudil|belumosudil|mesh-list
102268298|NCT02361619|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102268299|NCT02361619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102268300|NCT02361619|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102268301|NCT02361619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102268302|NCT02361619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102268303|NCT02361619|Analgesics|analgesics|mesh-ancestor
101822609|NCT04673786|Ustekinumab|ustekinumab|mesh-list
102268304|NCT02361619|Sensory System Agents|sensory system agents|mesh-ancestor
102268305|NCT02361619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102268306|NCT02361619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102268307|NCT02361619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102268308|NCT02361619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102268309|NCT02361619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102268310|NCT02361619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102268311|NCT02361619|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102268312|NCT02361619|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102268313|NCT02361619|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101977163|NCT03514810|Ketoprofen|ketoprofen|mesh-list
102268314|NCT02361619|Antithrombins|antithrombins|mesh-ancestor
102268315|NCT02361619|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102268316|NCT02361619|Protease Inhibitors|protease inhibitors|mesh-ancestor
102268318|NCT02361619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102268319|NCT02361619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102268320|NCT02361619|Sympatholytics|sympatholytics|mesh-ancestor
102268321|NCT02361619|Autonomic Agents|autonomic agents|mesh-ancestor
102268322|NCT02361619|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102268323|NCT02361619|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102268324|NCT02361619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102268325|NCT02361619|Adrenergic Agents|adrenergic agents|mesh-ancestor
102613945|NCT00002993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102268327|NCT02352025|Phytoestrogens|phytoestrogens|mesh-ancestor
102268328|NCT02352025|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102268329|NCT02352025|Estrogens|estrogens|mesh-ancestor
102613946|NCT00002993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102613947|NCT00002993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102268330|NCT02352025|Hormones|hormones|mesh-ancestor
102268331|NCT02352025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102268332|NCT02352025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268333|NCT01950364|Rifampin|rifampin|mesh-list
102268334|NCT01950364|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102268335|NCT01950364|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102268336|NCT01950364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102268337|NCT01950364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102268338|NCT01950364|Immunotoxins|immunotoxins|mesh-ancestor
102268339|NCT01950364|Immunoconjugates|immunoconjugates|mesh-ancestor
102268340|NCT01950364|Immunologic Factors|immunologic factors|mesh-ancestor
102268341|NCT01950364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268342|NCT01950364|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101822648|NCT04486833|Osimertinib|osimertinib|mesh-list
102268343|NCT01950364|Antitubercular Agents|antitubercular agents|mesh-ancestor
102268344|NCT01950364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102268345|NCT01950364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102268346|NCT01950364|Leprostatic Agents|leprostatic agents|mesh-ancestor
102268347|NCT01950364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102268348|NCT01950364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102268349|NCT01950364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268350|NCT01950364|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102268351|NCT01950364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102268352|NCT01950364|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102268353|NCT01950364|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102268354|NCT01950364|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102268355|NCT01950364|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102268356|NCT05047991|Leucovorin|leucovorin|mesh-list
102268357|NCT05047991|Paclitaxel|paclitaxel|mesh-list
102268358|NCT05047991|Gemcitabine|gemcitabine|mesh-list
102268359|NCT05047991|Fluorouracil|fluorouracil|mesh-list
102268360|NCT05047991|Oxaliplatin|oxaliplatin|mesh-list
102268361|NCT05047991|Irinotecan|irinotecan|mesh-list
102268362|NCT05047991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102268363|NCT05047991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102268364|NCT05047991|Tubulin Modulators|tubulin modulators|mesh-ancestor
102268365|NCT05047991|Antimitotic Agents|antimitotic agents|mesh-ancestor
102268366|NCT05047991|Mitosis Modulators|mitosis modulators|mesh-ancestor
102268367|NCT05047991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268368|NCT05047991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102268369|NCT05047991|Antimetabolites|antimetabolites|mesh-ancestor
102268370|NCT05047991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101822681|NCT04416269|Insulin|insulin|mesh-list
102268371|NCT05047991|Immunologic Factors|immunologic factors|mesh-ancestor
102268372|NCT05047991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268373|NCT05047991|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102268374|NCT05047991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102268375|NCT05047991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102268376|NCT05047991|Antidotes|antidotes|mesh-ancestor
102268377|NCT05047991|Protective Agents|protective agents|mesh-ancestor
102268378|NCT05047991|Vitamin B Complex|vitamin b complex|mesh-ancestor
102268379|NCT05047991|Vitamins|vitamins|mesh-ancestor
102268380|NCT05047991|Micronutrients|micronutrients|mesh-ancestor
102268381|NCT00014443|Thalidomide|thalidomide|mesh-list
102268382|NCT00014443|Topotecan|topotecan|mesh-list
102268383|NCT00014443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102268384|NCT00014443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102268385|NCT00014443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102268386|NCT00014443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268387|NCT00014443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102268388|NCT00014443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102268389|NCT00014443|Immunologic Factors|immunologic factors|mesh-ancestor
102268390|NCT00014443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268392|NCT00014443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102268393|NCT00014443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102268394|NCT00014443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102268395|NCT00014443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102268396|NCT00014443|Growth Substances|growth substances|mesh-ancestor
102268397|NCT00014443|Growth Inhibitors|growth inhibitors|mesh-ancestor
102268398|NCT05047133|Tranexamic Acid|tranexamic acid|mesh-list
102268399|NCT05047133|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102268400|NCT05047133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102268401|NCT05047133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268402|NCT05047133|Hemostatics|hemostatics|mesh-ancestor
102268403|NCT05047133|Coagulants|coagulants|mesh-ancestor
102268404|NCT04334863|Tyrphostins|tyrphostins|mesh-list
102613948|NCT00002993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102268405|NCT04334863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102268406|NCT04334863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102268407|NCT04334863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268408|NCT02357407|Ciprofloxacin|ciprofloxacin|mesh-list
102268409|NCT02357407|Ofloxacin|ofloxacin|mesh-list
102268410|NCT02357407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102268411|NCT02357407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102268412|NCT02357407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102268413|NCT02357407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102268414|NCT02357407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102268415|NCT02357407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268416|NCT02357407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102268417|NCT02357407|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101836517|NCT01059604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101836518|NCT01059604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101836519|NCT01059604|Analgesics|analgesics|mesh-ancestor
101836520|NCT01059604|Sensory System Agents|sensory system agents|mesh-ancestor
101836521|NCT01059604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101836522|NCT01059604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836523|NCT01059604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101836524|NCT01059604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101836525|NCT01059604|Gout Suppressants|gout suppressants|mesh-ancestor
101836526|NCT01059604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101836527|NCT01059604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101836528|NCT01059604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836529|NCT01059604|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101836530|NCT01059604|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101836531|NCT01059604|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101836532|NCT01059604|Serotonin Agents|serotonin agents|mesh-ancestor
101836533|NCT01059604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101836534|NCT02532634|Dexamethasone|dexamethasone|mesh-list
101836535|NCT02532634|Dexamethasone acetate|dexamethasone acetate|mesh-list
101836536|NCT02532634|Aprepitant|aprepitant|mesh-list
101836537|NCT02532634|Fosaprepitant|fosaprepitant|mesh-list
101836538|NCT02532634|Palonosetron|palonosetron|mesh-list
101836539|NCT02532634|Ramosetron|ramosetron|mesh-list
101836540|NCT02532634|BB 1101|bb 1101|mesh-list
101836541|NCT02532634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101836542|NCT02532634|Antiemetics|antiemetics|mesh-ancestor
101836543|NCT02532634|Autonomic Agents|autonomic agents|mesh-ancestor
101836544|NCT02532634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101836545|NCT02532634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836546|NCT02532634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101836547|NCT02532634|Glucocorticoids|glucocorticoids|mesh-ancestor
101836548|NCT02532634|Hormones|hormones|mesh-ancestor
101836549|NCT02532634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101836550|NCT02532634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101836551|NCT02532634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101836552|NCT02532634|Protease Inhibitors|protease inhibitors|mesh-ancestor
101836553|NCT02532634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101836554|NCT02532634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836555|NCT02532634|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101836556|NCT02532634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101836557|NCT02532634|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101836558|NCT02532634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101836559|NCT02532634|Serotonin Agents|serotonin agents|mesh-ancestor
101836560|NCT00501540|Lithium Carbonate|lithium carbonate|mesh-list
101836561|NCT00501540|Antidepressive Agents|antidepressive agents|mesh-ancestor
101836562|NCT00501540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101836563|NCT00501540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101977319|NCT01232257|Acetylcysteine|acetylcysteine|mesh-list
102268418|NCT02357407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102268419|NCT02357407|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102268420|NCT02038699|TIC10 compound|tic10 compound|mesh-list
102268421|NCT02038699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102268422|NCT03160651|Methylprednisolone|methylprednisolone|mesh-list
102268423|NCT03160651|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101646628|NCT00768859|Trastuzumab|trastuzumab|mesh-list
102268424|NCT03160651|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102268425|NCT03160651|Prednisolone|prednisolone|mesh-list
102268426|NCT03160651|Prednisolone acetate|prednisolone acetate|mesh-list
102268427|NCT03160651|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102268428|NCT03160651|Prednisolone phosphate|prednisolone phosphate|mesh-list
102268429|NCT03160651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102268430|NCT03160651|Antiemetics|antiemetics|mesh-ancestor
102268431|NCT03160651|Autonomic Agents|autonomic agents|mesh-ancestor
102268433|NCT03160651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268434|NCT03160651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102268435|NCT03160651|Glucocorticoids|glucocorticoids|mesh-ancestor
102268436|NCT03160651|Hormones|hormones|mesh-ancestor
102268437|NCT03160651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102268438|NCT03160651|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102268439|NCT03160651|Protective Agents|protective agents|mesh-ancestor
102268440|NCT03160651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102268441|NCT03160651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102268442|NCT05034965|Hyaluronic Acid|hyaluronic acid|mesh-list
102268443|NCT05034965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102268444|NCT05034965|Immunologic Factors|immunologic factors|mesh-ancestor
102268445|NCT05034965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268446|NCT05034965|Viscosupplements|viscosupplements|mesh-ancestor
102268447|NCT05034965|Protective Agents|protective agents|mesh-ancestor
102268448|NCT03160339|Vaccines|vaccines|mesh-list
102268449|NCT03160339|Immunologic Factors|immunologic factors|mesh-ancestor
102268450|NCT03160339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268451|NCT05034887|Trastuzumab|trastuzumab|mesh-list
102268452|NCT05034887|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
102268453|NCT05034887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102268454|NCT05034887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102268455|NCT05034887|Immunoconjugates|immunoconjugates|mesh-ancestor
102268456|NCT05034887|Immunologic Factors|immunologic factors|mesh-ancestor
102268457|NCT05034887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268458|NCT02039011|Tiotropium Bromide|tiotropium bromide|mesh-list
102268459|NCT02039011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102268460|NCT02039011|Autonomic Agents|autonomic agents|mesh-ancestor
102268461|NCT02039011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102268462|NCT02039011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268463|NCT02039011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102268464|NCT02039011|Respiratory System Agents|respiratory system agents|mesh-ancestor
102268465|NCT02039011|Parasympatholytics|parasympatholytics|mesh-ancestor
102268466|NCT02039011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102268467|NCT02039011|Cholinergic Agents|cholinergic agents|mesh-ancestor
102268468|NCT02039011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102268469|NCT02039011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268470|NCT05024825|Acetaminophen|acetaminophen|mesh-list
102268471|NCT05024825|Ibuprofen|ibuprofen|mesh-list
102268472|NCT05024825|Gabapentin|gabapentin|mesh-list
102268473|NCT05024825|Hydrocodone|hydrocodone|mesh-list
102268474|NCT05024825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102268475|NCT05024825|Analgesics|analgesics|mesh-ancestor
102268476|NCT05024825|Sensory System Agents|sensory system agents|mesh-ancestor
102268477|NCT05024825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102268478|NCT05024825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268479|NCT05024825|Antipyretics|antipyretics|mesh-ancestor
102268480|NCT05024825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102268481|NCT05024825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102268482|NCT05024825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102268483|NCT05024825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102268484|NCT05024825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102268485|NCT05024825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268486|NCT05024825|Anticonvulsants|anticonvulsants|mesh-ancestor
102268487|NCT05024825|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102268488|NCT05024825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102268489|NCT05024825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102268490|NCT05024825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102268491|NCT05024825|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102268492|NCT05024825|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102268493|NCT05024825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102268494|NCT05024825|Antimanic Agents|antimanic agents|mesh-ancestor
102268495|NCT05024825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102268496|NCT05024825|Narcotics|narcotics|mesh-ancestor
102268497|NCT05024825|Antitussive Agents|antitussive agents|mesh-ancestor
102268498|NCT05024825|Respiratory System Agents|respiratory system agents|mesh-ancestor
102268499|NCT05024435|Pulmonary Surfactants|pulmonary surfactants|mesh-list
102268500|NCT05024435|Respiratory System Agents|respiratory system agents|mesh-ancestor
102268501|NCT03093467|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
102268502|NCT03093467|Antipsychotic Agents|antipsychotic agents|mesh-list
102268503|NCT03093467|Antidepressive Agents|antidepressive agents|mesh-list
102268504|NCT03093467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102268505|NCT03093467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102268506|NCT03093467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102268507|NCT03093467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268509|NCT03149653|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102268510|NCT03149653|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101647066|NCT00778765|Gabapentin|gabapentin|mesh-list
102268511|NCT03149653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102268512|NCT03093545|Immunoglobulins|immunoglobulins|mesh-list
102268513|NCT03093545|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102268514|NCT03093545|Antibodies|antibodies|mesh-list
102268515|NCT03093545|Immunologic Factors|immunologic factors|mesh-ancestor
101647133|NCT00929864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102268516|NCT03093545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268517|NCT05024357|Dasatinib|dasatinib|mesh-list
102268518|NCT05024357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102268519|NCT05024357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102268520|NCT05024357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102268521|NCT05024357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268522|NCT03095105|Resveratrol|resveratrol|mesh-list
102268523|NCT03095105|Antioxidants|antioxidants|mesh-ancestor
101647202|NCT02633007|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102268524|NCT03095105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268525|NCT03095105|Protective Agents|protective agents|mesh-ancestor
102268526|NCT03095105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268527|NCT03095105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102268528|NCT03095105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102268529|NCT01968070|Celecoxib|celecoxib|mesh-list
102268530|NCT01968070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102268531|NCT01968070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102268532|NCT01968070|Analgesics|analgesics|mesh-ancestor
102268533|NCT01968070|Sensory System Agents|sensory system agents|mesh-ancestor
102268534|NCT01968070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102268535|NCT01968070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268536|NCT01968070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102268537|NCT01968070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102268538|NCT01968070|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102268539|NCT01968070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102268540|NCT01968070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102268541|NCT01968070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268542|NCT03093389|Resveratrol|resveratrol|mesh-list
102268543|NCT03093389|Antioxidants|antioxidants|mesh-ancestor
102268544|NCT03093389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268545|NCT03093389|Protective Agents|protective agents|mesh-ancestor
102268546|NCT03093389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268547|NCT03093389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102268548|NCT03093389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102268549|NCT01949116|Folic Acid|folic acid|mesh-list
102268550|NCT01949116|Methotrexate|methotrexate|mesh-list
102268551|NCT01949116|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102268552|NCT01949116|Abortifacient Agents|abortifacient agents|mesh-ancestor
102268553|NCT01949116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102268554|NCT01949116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647398|NCT04155879|Colchicine|colchicine|mesh-list
102268555|NCT01949116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102268556|NCT01949116|Antimetabolites|antimetabolites|mesh-ancestor
102268557|NCT01949116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268558|NCT01949116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102268559|NCT01949116|Dermatologic Agents|dermatologic agents|mesh-ancestor
102268560|NCT01949116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102268561|NCT01949116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102268562|NCT01949116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102268563|NCT01949116|Immunologic Factors|immunologic factors|mesh-ancestor
102268564|NCT01949116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102268565|NCT01949116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102268566|NCT01949116|Hematinics|hematinics|mesh-ancestor
102268567|NCT01949116|Vitamin B Complex|vitamin b complex|mesh-ancestor
102268568|NCT01949116|Vitamins|vitamins|mesh-ancestor
101977425|NCT01230775|Anagrelide|anagrelide|mesh-list
102268570|NCT01673009|Imatinib Mesylate|imatinib mesylate|mesh-list
102268571|NCT01673009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102268572|NCT01673009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102268573|NCT01673009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102268574|NCT01673009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268575|NCT02350387|Oxymetazoline|oxymetazoline|mesh-list
102268576|NCT02350387|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102268577|NCT02350387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102268578|NCT02350387|Adrenergic Agents|adrenergic agents|mesh-ancestor
102268579|NCT02350387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102268580|NCT02350387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268582|NCT02350387|Sympathomimetics|sympathomimetics|mesh-ancestor
102268583|NCT02350387|Autonomic Agents|autonomic agents|mesh-ancestor
102268584|NCT02350387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102268585|NCT02350387|Nasal Decongestants|nasal decongestants|mesh-ancestor
102268586|NCT02350387|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102268587|NCT02350387|Respiratory System Agents|respiratory system agents|mesh-ancestor
102268588|NCT02350543|Aspirin|aspirin|mesh-list
102268589|NCT02350543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102268590|NCT02350543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102268591|NCT02350543|Analgesics|analgesics|mesh-ancestor
102268592|NCT02350543|Sensory System Agents|sensory system agents|mesh-ancestor
102268593|NCT02350543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102268594|NCT02350543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268595|NCT02350543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102268596|NCT02350543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102268597|NCT02350543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102268598|NCT02350543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102268599|NCT02350543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268600|NCT02350543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102268601|NCT02350543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102268602|NCT02350543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102268603|NCT02350543|Antipyretics|antipyretics|mesh-ancestor
102268604|NCT05023577|Metronidazole|metronidazole|mesh-list
102268605|NCT05023577|Clarithromycin|clarithromycin|mesh-list
102268606|NCT05023577|Levofloxacin|levofloxacin|mesh-list
102268607|NCT05023577|Potassium Citrate|potassium citrate|mesh-list
102268608|NCT05023577|Rabeprazole|rabeprazole|mesh-list
102268609|NCT05023577|Bismuth|bismuth|mesh-list
102268610|NCT05023577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268611|NCT05023577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102268612|NCT05023577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102268613|NCT05023577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102268614|NCT05023577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102268615|NCT05023577|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102268616|NCT05023577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102268617|NCT05023577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102268618|NCT05023577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102268619|NCT05023577|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102268620|NCT05023577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101647856|NCT00672165|Antibodies|antibodies|mesh-list
102268621|NCT05023577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102268622|NCT05023577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102268623|NCT05023577|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102268624|NCT05023577|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102268625|NCT05023577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102268626|NCT05023577|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102268627|NCT05023577|Antacids|antacids|mesh-ancestor
102268628|NCT05023577|Diuretics|diuretics|mesh-ancestor
102268629|NCT05023577|Natriuretic Agents|natriuretic agents|mesh-ancestor
101647925|NCT04152681|Apatinib|apatinib|mesh-list
102268630|NCT05023577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268631|NCT05023577|Expectorants|expectorants|mesh-ancestor
102268632|NCT05023577|Respiratory System Agents|respiratory system agents|mesh-ancestor
102268633|NCT03149419|Paroxetine|paroxetine|mesh-list
102268634|NCT03149419|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102268635|NCT03149419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102268636|NCT03149419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102268637|NCT03149419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268638|NCT03149419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102268639|NCT03149419|Serotonin Agents|serotonin agents|mesh-ancestor
102268640|NCT03149419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268641|NCT03149419|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101977494|NCT01233583|Analgesics|analgesics|mesh-ancestor
102268642|NCT03149419|Antidepressive Agents|antidepressive agents|mesh-ancestor
102268643|NCT03149419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102268644|NCT03149419|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102268645|NCT03149419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102268646|NCT03149419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102268648|NCT03092765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102268649|NCT01939366|Pregabalin|pregabalin|mesh-list
102268650|NCT01939366|Analgesics|analgesics|mesh-ancestor
102268651|NCT01939366|Sensory System Agents|sensory system agents|mesh-ancestor
102268652|NCT01939366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102268653|NCT01939366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268654|NCT01939366|Anticonvulsants|anticonvulsants|mesh-ancestor
102268656|NCT01939366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102268657|NCT01939366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268658|NCT01939366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102268659|NCT01939366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102268660|NCT01939366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102268661|NCT01939366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102268662|NCT01939366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102268663|NCT04434365|Aspirin|aspirin|mesh-list
102268664|NCT04434365|Clopidogrel|clopidogrel|mesh-list
102268665|NCT04434365|Atorvastatin|atorvastatin|mesh-list
102268666|NCT04434365|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102268667|NCT04434365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102268668|NCT04434365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102268669|NCT04434365|Analgesics|analgesics|mesh-ancestor
102268670|NCT04434365|Sensory System Agents|sensory system agents|mesh-ancestor
102268671|NCT04434365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102268672|NCT04434365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268673|NCT04434365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102268674|NCT04434365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102268675|NCT04434365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102268676|NCT04434365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102268677|NCT04434365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268678|NCT04434365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102268679|NCT04434365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102268680|NCT04434365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102268681|NCT04434365|Antipyretics|antipyretics|mesh-ancestor
102268682|NCT04434365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102268683|NCT04434365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102268684|NCT04434365|Antimetabolites|antimetabolites|mesh-ancestor
102268685|NCT04434365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102268686|NCT04434365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102268687|NCT04434365|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102268688|NCT04434365|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102268689|NCT04434365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102268690|NCT04434365|Purinergic Agents|purinergic agents|mesh-ancestor
102268691|NCT04434365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102268692|NCT05032235|Fluzoparib|fluzoparib|mesh-list
102268693|NCT05032235|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102268694|NCT05032235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102613949|NCT00002993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613950|NCT00002993|Alkylating Agents|alkylating agents|mesh-ancestor
102613951|NCT00002993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102613952|NCT01928082|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102613953|NCT01928082|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102613954|NCT01928082|Estradiol|estradiol|mesh-list
102613955|NCT01928082|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102613956|NCT01928082|Estrogens|estrogens|mesh-ancestor
102613957|NCT01928082|Hormones|hormones|mesh-ancestor
102613958|NCT01928082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102613959|NCT01928082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613960|NCT01928082|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102613961|NCT01928082|Contraceptive Agents|contraceptive agents|mesh-ancestor
102613962|NCT01928082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102613963|NCT01928082|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102613964|NCT00002999|Fluorouracil|fluorouracil|mesh-list
102613965|NCT00002999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613966|NCT00002999|Antimetabolites|antimetabolites|mesh-ancestor
101648082|NCT00787657|Immunologic Factors|immunologic factors|mesh-ancestor
102613967|NCT00002999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613968|NCT00002999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102613969|NCT00002999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102613970|NCT00002999|Immunologic Factors|immunologic factors|mesh-ancestor
102613971|NCT00002999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613972|NCT00003005|Cordycepin|cordycepin|mesh-list
102613973|NCT00003005|Pentostatin|pentostatin|mesh-list
102613974|NCT00003005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613975|NCT00003005|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
102613976|NCT00003005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102613977|NCT00003005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613978|NCT00003005|Antifungal Agents|antifungal agents|mesh-ancestor
102613979|NCT00003005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102613980|NCT03905603|Cosyntropin|cosyntropin|mesh-list
102613981|NCT03905603|Hormones|hormones|mesh-ancestor
102268695|NCT05032235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268696|NCT05032235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102268697|NCT05031923|Anti-Infective Agents|anti-infective agents|mesh-list
102268698|NCT05031923|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102268699|NCT03149575|Carboplatin|carboplatin|mesh-list
102613982|NCT03905603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102268700|NCT03149575|Temozolomide|temozolomide|mesh-list
102268701|NCT03149575|Lomustine|lomustine|mesh-list
102268702|NCT03149575|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
102268703|NCT03149575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102268704|NCT03149575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102268705|NCT03149575|Alkylating Agents|alkylating agents|mesh-ancestor
102268706|NCT03149575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268707|NCT05032001|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102268708|NCT05032001|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
102268709|NCT05032001|Biguanides|biguanides|mesh-list
102268710|NCT05032001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268711|NCT05032001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102268712|NCT05032001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268713|NCT05032001|Protease Inhibitors|protease inhibitors|mesh-ancestor
101977511|NCT02304250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102613983|NCT03905603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613984|NCT00003011|Marimastat|marimastat|mesh-list
102613985|NCT00003011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102613986|NCT00003011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102613987|NCT00003017|Interleukin-12|interleukin-12|mesh-list
102613988|NCT00003017|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102613989|NCT00003017|Immunologic Factors|immunologic factors|mesh-ancestor
102613990|NCT00003017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102613991|NCT00003017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102613992|NCT00003017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102613993|NCT00003017|Growth Substances|growth substances|mesh-ancestor
102613994|NCT00003017|Growth Inhibitors|growth inhibitors|mesh-ancestor
102613995|NCT00003017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102613996|NCT00003023|Vaccines|vaccines|mesh-list
102613997|NCT00003023|Antibodies|antibodies|mesh-list
102613998|NCT00003023|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102613999|NCT00003023|BCG Vaccine|bcg vaccine|mesh-list
102614000|NCT00003023|Immunologic Factors|immunologic factors|mesh-ancestor
102614001|NCT00003023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268714|NCT05032001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102268715|NCT05031689|Sunscreening Agents|sunscreening agents|mesh-list
102268716|NCT05031689|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102268717|NCT05031689|Protective Agents|protective agents|mesh-ancestor
102268718|NCT05031689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268719|NCT05031689|Dermatologic Agents|dermatologic agents|mesh-ancestor
102268720|NCT02350231|Progesterone|progesterone|mesh-list
102268721|NCT02350231|Progestins|progestins|mesh-ancestor
102268722|NCT02350231|Hormones|hormones|mesh-ancestor
102268723|NCT02350231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102268724|NCT02350231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268725|NCT01918306|Cisplatin|cisplatin|mesh-list
102268726|NCT01918306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102268727|NCT05031143|Triamcinolone|triamcinolone|mesh-list
102268728|NCT05031143|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102268729|NCT05031143|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102268730|NCT05031143|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102268731|NCT05031143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102268732|NCT05031143|Glucocorticoids|glucocorticoids|mesh-ancestor
102268733|NCT05031143|Hormones|hormones|mesh-ancestor
102268734|NCT05031143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102268735|NCT05031143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268736|NCT05031143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102268737|NCT05031143|Immunologic Factors|immunologic factors|mesh-ancestor
102268738|NCT05031143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102268739|NCT05031143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268740|NCT01916980|Desloratadine|desloratadine|mesh-list
102268741|NCT01916980|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102268742|NCT01916980|Cholinergic Agents|cholinergic agents|mesh-ancestor
102268743|NCT01916980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102268744|NCT01916980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268745|NCT01916980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268746|NCT01916980|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102268747|NCT01916980|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102614002|NCT00003023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102268748|NCT01916980|Histamine Antagonists|histamine antagonists|mesh-ancestor
102268749|NCT01916980|Histamine Agents|histamine agents|mesh-ancestor
102268750|NCT02348281|Bicalutamide|bicalutamide|mesh-list
102268751|NCT02348281|Androgen Antagonists|androgen antagonists|mesh-ancestor
102268752|NCT02348281|Hormone Antagonists|hormone antagonists|mesh-ancestor
102268753|NCT02348281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102268754|NCT02348281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268755|NCT02348281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102268756|NCT04638400|Simvastatin|simvastatin|mesh-list
102268757|NCT04638400|Ezetimibe|ezetimibe|mesh-list
102268758|NCT04638400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102268759|NCT04638400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102268760|NCT04638400|Antimetabolites|antimetabolites|mesh-ancestor
102268761|NCT04638400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268762|NCT04638400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102268763|NCT04638400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102268764|NCT04638400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102268765|NCT02349919|Procaterol|procaterol|mesh-list
102268766|NCT02349919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102268767|NCT02349919|Autonomic Agents|autonomic agents|mesh-ancestor
102268768|NCT02349919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102268769|NCT02349919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268770|NCT02349919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102268771|NCT02349919|Respiratory System Agents|respiratory system agents|mesh-ancestor
102268772|NCT02349919|Sympathomimetics|sympathomimetics|mesh-ancestor
102268773|NCT02349919|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102268774|NCT02349919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102268775|NCT02349919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102268776|NCT02349919|Adrenergic Agents|adrenergic agents|mesh-ancestor
102268777|NCT02349919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102268778|NCT02349919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268779|NCT02349763|Dexamethasone|dexamethasone|mesh-list
102268780|NCT02349763|Dexamethasone acetate|dexamethasone acetate|mesh-list
102268781|NCT02349763|BB 1101|bb 1101|mesh-list
102268782|NCT02349763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102268783|NCT02349763|Antiemetics|antiemetics|mesh-ancestor
102268784|NCT02349763|Autonomic Agents|autonomic agents|mesh-ancestor
102268785|NCT02349763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102268786|NCT02349763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268787|NCT02349763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102268788|NCT02349763|Glucocorticoids|glucocorticoids|mesh-ancestor
102268789|NCT02349763|Hormones|hormones|mesh-ancestor
102268790|NCT02349763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102268791|NCT02349763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102268792|NCT02349763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102268793|NCT02349763|Protease Inhibitors|protease inhibitors|mesh-ancestor
102268794|NCT02349763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102614003|NCT03850067|Carboplatin|carboplatin|mesh-list
102614004|NCT03850067|Nivolumab|nivolumab|mesh-list
102614005|NCT03850067|Etoposide|etoposide|mesh-list
102614006|NCT03850067|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
102614007|NCT03850067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614008|NCT03850067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102614009|NCT03850067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102614010|NCT03850067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614011|NCT03850067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102614012|NCT03850067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102614013|NCT03850067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102614014|NCT03850067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102614015|NCT00003029|Fluorouracil|fluorouracil|mesh-list
102614016|NCT00003029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614017|NCT00003029|Antimetabolites|antimetabolites|mesh-ancestor
102614018|NCT00003029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614019|NCT00003029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102614020|NCT00003029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102614021|NCT00003029|Immunologic Factors|immunologic factors|mesh-ancestor
102614022|NCT00003029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614023|NCT00003035|Tamoxifen|tamoxifen|mesh-list
102614024|NCT00003035|Paclitaxel|paclitaxel|mesh-list
102614025|NCT00003035|Doxorubicin|doxorubicin|mesh-list
102614026|NCT00003035|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102614027|NCT00003035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102268795|NCT02349763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268796|NCT02349841|Amoxicillin|amoxicillin|mesh-list
102268797|NCT02349841|Meropenem|meropenem|mesh-list
102614028|NCT00003035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102268798|NCT02349841|Clavulanic Acids|clavulanic acids|mesh-list
102268799|NCT02349841|Clavulanic Acid|clavulanic acid|mesh-list
102268800|NCT02349841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102268801|NCT02349841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102268802|NCT02349841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102268803|NCT02349841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268804|NCT02349841|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102268805|NCT02354053|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
102268806|NCT02354053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102268807|NCT02354053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102268808|NCT02354053|Antiviral Agents|antiviral agents|mesh-ancestor
102268809|NCT02354053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102268810|NCT05028803|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
102268811|NCT05028803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102268812|NCT03094481|Epinephrine|epinephrine|mesh-list
102268813|NCT03094481|Bupivacaine|bupivacaine|mesh-list
102268814|NCT03094481|Anesthetics, Local|anesthetics, local|mesh-ancestor
102268815|NCT03094481|Anesthetics|anesthetics|mesh-ancestor
102268816|NCT03094481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102268817|NCT03094481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268818|NCT03094481|Sensory System Agents|sensory system agents|mesh-ancestor
102268819|NCT03094481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102268820|NCT03094481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102268821|NCT03094481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102268822|NCT03094481|Adrenergic Agents|adrenergic agents|mesh-ancestor
102268823|NCT03094481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102268824|NCT03094481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268825|NCT03094481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102268826|NCT03094481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102268827|NCT03094481|Autonomic Agents|autonomic agents|mesh-ancestor
102268828|NCT03094481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102268829|NCT03094481|Respiratory System Agents|respiratory system agents|mesh-ancestor
102268830|NCT03094481|Mydriatics|mydriatics|mesh-ancestor
102268831|NCT03094481|Sympathomimetics|sympathomimetics|mesh-ancestor
102268832|NCT03094481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102268833|NCT04438837|Hydroxychloroquine|hydroxychloroquine|mesh-list
102268834|NCT04438837|Antimalarials|antimalarials|mesh-ancestor
102268835|NCT04438837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102268836|NCT04438837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102268837|NCT04438837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102268838|NCT04438837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102268839|NCT04438837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268840|NCT04438837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102268841|NCT02348125|Thioctic Acid|thioctic acid|mesh-list
102268842|NCT02348125|Antioxidants|antioxidants|mesh-ancestor
102268843|NCT02348125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268844|NCT02348125|Protective Agents|protective agents|mesh-ancestor
102268845|NCT02348125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268846|NCT02348125|Vitamin B Complex|vitamin b complex|mesh-ancestor
102268847|NCT02348125|Vitamins|vitamins|mesh-ancestor
102268848|NCT02348125|Micronutrients|micronutrients|mesh-ancestor
102268849|NCT05028335|Carbamide Peroxide|carbamide peroxide|mesh-list
102268850|NCT05028335|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102268851|NCT05028335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102268852|NCT03094403|Azelaic acid|azelaic acid|mesh-list
102268853|NCT03094403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102268854|NCT03094403|Dermatologic Agents|dermatologic agents|mesh-ancestor
102268855|NCT02347891|Belimumab|belimumab|mesh-list
102268856|NCT02347891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102268857|NCT02347891|Immunologic Factors|immunologic factors|mesh-ancestor
102268858|NCT02347891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268859|NCT03147157|Tacrolimus|tacrolimus|mesh-list
102268860|NCT03147157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102268861|NCT03147157|Immunologic Factors|immunologic factors|mesh-ancestor
101977672|NCT02312440|Hemostatics|hemostatics|mesh-ancestor
102268862|NCT03147157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268863|NCT03147157|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102268864|NCT03147157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102268865|NCT03147157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614029|NCT00003035|Tubulin Modulators|tubulin modulators|mesh-ancestor
102268867|NCT02347501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102268868|NCT02347501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268869|NCT02347501|Incretins|incretins|mesh-ancestor
102268870|NCT02347501|Hormones|hormones|mesh-ancestor
102268871|NCT02347501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102268872|NCT02347501|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102268873|NCT02347501|Protease Inhibitors|protease inhibitors|mesh-ancestor
102268874|NCT02347501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102268875|NCT02347501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268876|NCT03148717|Misoprostol|misoprostol|mesh-list
102268877|NCT03148717|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102268878|NCT03148717|Abortifacient Agents|abortifacient agents|mesh-ancestor
102268879|NCT03148717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102268880|NCT03148717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268881|NCT03148717|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102268882|NCT03148717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102268883|NCT03148717|Oxytocics|oxytocics|mesh-ancestor
102268884|NCT02349607|Ibuprofen|ibuprofen|mesh-list
102268885|NCT02349607|Pregabalin|pregabalin|mesh-list
102268886|NCT02349607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102268887|NCT02349607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102268888|NCT02349607|Analgesics|analgesics|mesh-ancestor
102268889|NCT02349607|Sensory System Agents|sensory system agents|mesh-ancestor
102268890|NCT02349607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102268891|NCT02349607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268892|NCT02349607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102268893|NCT02349607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102268894|NCT02349607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102268895|NCT02349607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102268896|NCT02349607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268897|NCT02349607|Anticonvulsants|anticonvulsants|mesh-ancestor
102268898|NCT02349607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102268899|NCT02349607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102268900|NCT02349607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102268901|NCT02349607|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102268902|NCT02349607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102268903|NCT02349607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102268904|NCT02349607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102268905|NCT05019755|Varespladib methyl|varespladib methyl|mesh-list
102268906|NCT05019755|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
102268907|NCT05019755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102268908|NCT05019755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268909|NCT04478461|Antibodies|antibodies|mesh-list
102268910|NCT04478461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102268911|NCT04478461|Immunologic Factors|immunologic factors|mesh-ancestor
102268912|NCT04478461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268913|NCT04108481|Durvalumab|durvalumab|mesh-list
102268914|NCT04108481|Methamphetamine|methamphetamine|mesh-list
102268915|NCT04108481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102268916|NCT04108481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102268917|NCT04108481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102268918|NCT04108481|Immunologic Factors|immunologic factors|mesh-ancestor
102268919|NCT04108481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268920|NCT04108481|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102268921|NCT04108481|Sympathomimetics|sympathomimetics|mesh-ancestor
102268922|NCT04108481|Autonomic Agents|autonomic agents|mesh-ancestor
102268923|NCT04108481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102268924|NCT04108481|Dopamine Agents|dopamine agents|mesh-ancestor
102268925|NCT04108481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102268926|NCT04108481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268927|NCT04108481|Adrenergic Agents|adrenergic agents|mesh-ancestor
102268928|NCT04108481|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102268929|NCT04108481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102268930|NCT04108481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101648535|NCT05003102|Fentanyl|fentanyl|mesh-list
102268931|NCT04108481|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102268932|NCT02353507|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102268933|NCT02353507|Laxatives|laxatives|mesh-ancestor
102268934|NCT02353507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102268935|NCT03148561|Misoprostol|misoprostol|mesh-list
102268936|NCT03148561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102268937|NCT03148561|Abortifacient Agents|abortifacient agents|mesh-ancestor
102268938|NCT03148561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102268939|NCT03148561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268941|NCT03148561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102268942|NCT03148561|Oxytocics|oxytocics|mesh-ancestor
102268943|NCT02353429|Toremifene|toremifene|mesh-list
102268944|NCT02353429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102614030|NCT00003035|Antimitotic Agents|antimitotic agents|mesh-ancestor
102268945|NCT02353429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102268946|NCT02353429|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102268947|NCT02353429|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102268948|NCT02353429|Hormone Antagonists|hormone antagonists|mesh-ancestor
101648583|NCT04152057|Trastuzumab|trastuzumab|mesh-list
102268949|NCT02353429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102268950|NCT02353429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268951|NCT02353429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102268952|NCT05027243|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102268953|NCT05027243|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102268954|NCT05027243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102268955|NCT05027243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268956|NCT05027243|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101648640|NCT04992572|Anesthetics, General|anesthetics, general|mesh-ancestor
102268957|NCT05027243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102268958|NCT05027243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268959|NCT05027243|Cholinergic Agents|cholinergic agents|mesh-ancestor
102268960|NCT05027243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102268961|NCT03112135|Epinephrine|epinephrine|mesh-list
102268962|NCT03112135|Tranexamic Acid|tranexamic acid|mesh-list
102268963|NCT03112135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102268964|NCT03112135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102268965|NCT03112135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268966|NCT03112135|Hemostatics|hemostatics|mesh-ancestor
102268967|NCT03112135|Coagulants|coagulants|mesh-ancestor
102268968|NCT03112135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102268969|NCT03112135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101648710|NCT00994643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102268970|NCT03112135|Adrenergic Agents|adrenergic agents|mesh-ancestor
102268971|NCT03112135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102268972|NCT03112135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268973|NCT03112135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102268974|NCT03112135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102268975|NCT03112135|Autonomic Agents|autonomic agents|mesh-ancestor
102268976|NCT03112135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102268977|NCT03112135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102268978|NCT03112135|Respiratory System Agents|respiratory system agents|mesh-ancestor
102268979|NCT03112135|Mydriatics|mydriatics|mesh-ancestor
102268980|NCT03112135|Sympathomimetics|sympathomimetics|mesh-ancestor
102268981|NCT03112135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101648841|NCT00993473|Insulin|insulin|mesh-list
102268982|NCT04477993|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
102268983|NCT04477993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102268984|NCT04477993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102268985|NCT04477993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268986|NCT03146533|Cyclophosphamide|cyclophosphamide|mesh-list
102268987|NCT03146533|Fludarabine|fludarabine|mesh-list
102268988|NCT03146533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102268989|NCT03146533|Immunologic Factors|immunologic factors|mesh-ancestor
102268990|NCT03146533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102268991|NCT03146533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102268992|NCT03146533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102268993|NCT03146533|Alkylating Agents|alkylating agents|mesh-ancestor
102268994|NCT03146533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102268995|NCT03146533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102268996|NCT03146533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102268997|NCT03090971|Diclofenac|diclofenac|mesh-list
102268998|NCT03090971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102268999|NCT03090971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102269000|NCT03090971|Analgesics|analgesics|mesh-ancestor
102269001|NCT03090971|Sensory System Agents|sensory system agents|mesh-ancestor
102269002|NCT03090971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102269003|NCT03090971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269004|NCT03090971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102269005|NCT03090971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102269006|NCT03090971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102269007|NCT03090971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102269008|NCT03090971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269009|NCT03146689|Ibuprofen|ibuprofen|mesh-list
102269010|NCT03146689|Capsaicin|capsaicin|mesh-list
102269011|NCT03146689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102269012|NCT03146689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102269014|NCT03146689|Sensory System Agents|sensory system agents|mesh-ancestor
102269015|NCT03146689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102269016|NCT03146689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902439|NCT01090128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102269017|NCT03146689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102269018|NCT03146689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102269019|NCT03146689|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102269020|NCT03146689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102269021|NCT03146689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269022|NCT03146689|Antipruritics|antipruritics|mesh-ancestor
102269023|NCT03146689|Dermatologic Agents|dermatologic agents|mesh-ancestor
102269024|NCT05255575|Ertapenem|ertapenem|mesh-list
102269025|NCT05255575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102269026|NCT05255575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102269027|NCT05026229|Cytarabine|cytarabine|mesh-list
102269028|NCT05026229|Prednisone|prednisone|mesh-list
102269029|NCT05026229|Methotrexate|methotrexate|mesh-list
102269030|NCT05026229|Vincristine|vincristine|mesh-list
102269031|NCT05026229|Dasatinib|dasatinib|mesh-list
102269032|NCT05026229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102269033|NCT05026229|Glucocorticoids|glucocorticoids|mesh-ancestor
102269034|NCT05026229|Hormones|hormones|mesh-ancestor
102269035|NCT05026229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102269036|NCT05026229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269037|NCT05026229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102269038|NCT05026229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102269039|NCT05026229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102269040|NCT05026229|Abortifacient Agents|abortifacient agents|mesh-ancestor
102269041|NCT05026229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102269042|NCT05026229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102269043|NCT05026229|Antimetabolites|antimetabolites|mesh-ancestor
102269044|NCT05026229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269045|NCT05026229|Dermatologic Agents|dermatologic agents|mesh-ancestor
102269046|NCT05026229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102269047|NCT05026229|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102269048|NCT05026229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102269049|NCT05026229|Immunologic Factors|immunologic factors|mesh-ancestor
102269050|NCT05026229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102269051|NCT05026229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102269052|NCT05026229|Antiviral Agents|antiviral agents|mesh-ancestor
101649371|NCT00794443|Diphosphonates|diphosphonates|mesh-list
102269053|NCT05026229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102269054|NCT05026229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102269055|NCT05026229|Tubulin Modulators|tubulin modulators|mesh-ancestor
102269056|NCT05026229|Antimitotic Agents|antimitotic agents|mesh-ancestor
102269057|NCT05026229|Mitosis Modulators|mitosis modulators|mesh-ancestor
102269058|NCT05026229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102269059|NCT02343679|Ceritinib|ceritinib|mesh-list
102269060|NCT02343679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102269061|NCT02343679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102269062|NCT02343679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102269063|NCT02343679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269064|NCT04954781|Tislelizumab|tislelizumab|mesh-list
102269065|NCT04954781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102269066|NCT04954781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102269067|NCT02348905|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102269068|NCT02348905|Hormones|hormones|mesh-ancestor
102269069|NCT02348905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102269070|NCT02348905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269071|NCT02347033|Sertraline|sertraline|mesh-list
102269072|NCT02347033|Antidepressive Agents|antidepressive agents|mesh-ancestor
102269073|NCT02347033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102269074|NCT02347033|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102269075|NCT02347033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102269076|NCT02347033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102269077|NCT02347033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269078|NCT02347033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102269079|NCT02347033|Serotonin Agents|serotonin agents|mesh-ancestor
102269080|NCT02347033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269081|NCT04949633|Oxytocin|oxytocin|mesh-list
102269082|NCT04949633|Oxytocics|oxytocics|mesh-ancestor
102269083|NCT04949633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101977889|NCT01139749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102269084|NCT04949633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269085|NCT03146377|Capecitabine|capecitabine|mesh-list
102269086|NCT03146377|Oxaliplatin|oxaliplatin|mesh-list
102269087|NCT03146377|Irinotecan|irinotecan|mesh-list
101902441|NCT01090128|Alkylating Agents|alkylating agents|mesh-ancestor
102614032|NCT00003035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614033|NCT00003035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102614034|NCT00003035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102614035|NCT00003035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102269088|NCT03146377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102269090|NCT03146377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269091|NCT03146377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102269092|NCT03146377|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102269093|NCT03146377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102269094|NCT03146377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102269095|NCT02346955|Pembrolizumab|pembrolizumab|mesh-list
101649714|NCT04031157|Antidepressive Agents|antidepressive agents|mesh-list
102269096|NCT02346955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102269097|NCT02346955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102269098|NCT02346955|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102269099|NCT02346955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269100|NCT03079505|Dasatinib|dasatinib|mesh-list
102269101|NCT03079505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102269102|NCT03079505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102269103|NCT03079505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102269104|NCT03079505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269105|NCT02343211|Immunoglobulins|immunoglobulins|mesh-list
102269106|NCT02343211|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102269107|NCT02343211|Antibodies|antibodies|mesh-list
102269108|NCT02343211|Immunologic Factors|immunologic factors|mesh-ancestor
102269109|NCT02343211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269110|NCT03090503|Risperidone|risperidone|mesh-list
102269111|NCT03090503|Aripiprazole|aripiprazole|mesh-list
102269112|NCT03090503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102269113|NCT03090503|Serotonin Agents|serotonin agents|mesh-ancestor
102269114|NCT03090503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102269115|NCT03090503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269116|NCT03090503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269117|NCT03090503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102269118|NCT03090503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102269119|NCT03090503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102269120|NCT03090503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102269121|NCT03090503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102269122|NCT03090503|Dopamine Agents|dopamine agents|mesh-ancestor
102269123|NCT03090503|Antidepressive Agents|antidepressive agents|mesh-ancestor
102269124|NCT03090503|Dopamine Agonists|dopamine agonists|mesh-ancestor
102269125|NCT03090503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102269126|NCT03090503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102269127|NCT03090503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102269128|NCT03090503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102269129|NCT02343289|Clarithromycin|clarithromycin|mesh-list
102269130|NCT02343289|Esketamine|esketamine|mesh-list
102269131|NCT02343289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102269132|NCT02343289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102269133|NCT02343289|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102269134|NCT02343289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102269135|NCT02343289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269136|NCT02343289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102269137|NCT02343289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102269138|NCT02343289|Antidepressive Agents|antidepressive agents|mesh-ancestor
102269139|NCT02343289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102269140|NCT05008523|Analgesics, Opioid|analgesics, opioid|mesh-list
102269141|NCT05008523|Narcotics|narcotics|mesh-ancestor
102269142|NCT05008523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102269143|NCT05008523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269144|NCT05008523|Analgesics|analgesics|mesh-ancestor
102269145|NCT05008523|Sensory System Agents|sensory system agents|mesh-ancestor
102269146|NCT05008523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102269147|NCT03090269|Methylphenidate|methylphenidate|mesh-list
102269148|NCT03090269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102269149|NCT03090269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269150|NCT03090269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102269151|NCT03090269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102269152|NCT03090269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102269153|NCT03090269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269154|NCT03090269|Dopamine Agents|dopamine agents|mesh-ancestor
102269155|NCT03090269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102269156|NCT05008679|Oseltamivir|oseltamivir|mesh-list
101977972|NCT02313922|Etanercept|etanercept|mesh-list
101650218|NCT05589844|Vaccines|vaccines|mesh-list
102269157|NCT05008679|Antiviral Agents|antiviral agents|mesh-ancestor
102614036|NCT00003035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102269158|NCT05008679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102269159|NCT05008679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102269160|NCT05008679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269161|NCT03090035|Interferons|interferons|mesh-list
102269162|NCT03090035|Ribavirin|ribavirin|mesh-list
102269163|NCT03090035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102269164|NCT03090035|Antiviral Agents|antiviral agents|mesh-ancestor
102269165|NCT03090035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102269166|NCT03090035|Antimetabolites|antimetabolites|mesh-ancestor
102269167|NCT03090035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269168|NCT05008367|Dexamethasone|dexamethasone|mesh-list
102269169|NCT05008367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102269170|NCT05008367|Antiemetics|antiemetics|mesh-ancestor
102269171|NCT05008367|Autonomic Agents|autonomic agents|mesh-ancestor
102269172|NCT05008367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102269173|NCT05008367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269174|NCT05008367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102269175|NCT05008367|Glucocorticoids|glucocorticoids|mesh-ancestor
102269176|NCT05008367|Hormones|hormones|mesh-ancestor
102269177|NCT05008367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102269178|NCT05008367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102269179|NCT05008367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102269180|NCT02342587|Lapatinib|lapatinib|mesh-list
102269181|NCT02342587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102269182|NCT02342587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102269183|NCT02342587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102269184|NCT02342587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269185|NCT02346331|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102269186|NCT02346331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102269187|NCT02342509|Sevoflurane|sevoflurane|mesh-list
102269188|NCT02342509|Desflurane|desflurane|mesh-list
102269189|NCT02342509|Isoflurane|isoflurane|mesh-list
102269190|NCT02342509|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102269191|NCT02342509|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102269192|NCT02342509|Anesthetics, General|anesthetics, general|mesh-ancestor
102269193|NCT02342509|Anesthetics|anesthetics|mesh-ancestor
102269194|NCT02342509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102269195|NCT02342509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269196|NCT03079271|Benzocaine|benzocaine|mesh-list
102269197|NCT03079271|Anesthetics, Local|anesthetics, local|mesh-ancestor
102269198|NCT03079271|Anesthetics|anesthetics|mesh-ancestor
102269199|NCT03079271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102269200|NCT03079271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269201|NCT03079271|Sensory System Agents|sensory system agents|mesh-ancestor
102269202|NCT03079271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101650593|NCT03842696|Tacrolimus|tacrolimus|mesh-list
102269203|NCT02342353|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102269204|NCT02342353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102269205|NCT02342353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102269206|NCT02342353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102269207|NCT02342353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269208|NCT02337127|Lamivudine|lamivudine|mesh-list
102269209|NCT02337127|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102269210|NCT02337127|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102269211|NCT02337127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102269212|NCT02337127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269213|NCT02337127|Antiviral Agents|antiviral agents|mesh-ancestor
102269214|NCT02337127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102269215|NCT02337127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102269216|NCT02337127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102269217|NCT02337205|Tirbanibulin|tirbanibulin|mesh-list
102269218|NCT02337205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102269219|NCT02337205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269220|NCT05007587|Leucovorin|leucovorin|mesh-list
102269221|NCT05007587|Fluorouracil|fluorouracil|mesh-list
102269222|NCT05007587|Raltitrexed|raltitrexed|mesh-list
102269223|NCT05007587|Oxaliplatin|oxaliplatin|mesh-list
102269224|NCT05007587|Lenvatinib|lenvatinib|mesh-list
102269225|NCT05007587|Antimetabolites|antimetabolites|mesh-ancestor
102269226|NCT05007587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269227|NCT05007587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102269228|NCT05007587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102269229|NCT05007587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102269230|NCT05007587|Immunologic Factors|immunologic factors|mesh-ancestor
102269231|NCT05007587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978038|NCT02314312|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102269233|NCT05007587|Protective Agents|protective agents|mesh-ancestor
102269234|NCT05007587|Vitamin B Complex|vitamin b complex|mesh-ancestor
102269235|NCT05007587|Vitamins|vitamins|mesh-ancestor
102269236|NCT05007587|Micronutrients|micronutrients|mesh-ancestor
102269237|NCT05007587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102269238|NCT05007587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102269239|NCT05007587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102269240|NCT02039323|Tenofovir|tenofovir|mesh-list
102269241|NCT02039323|Maraviroc|maraviroc|mesh-list
102269242|NCT02039323|Antiviral Agents|antiviral agents|mesh-ancestor
102269243|NCT02039323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102269244|NCT02039323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101650919|NCT00629213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102269245|NCT02039323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102269246|NCT02039323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102269247|NCT02039323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269248|NCT02039323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102269249|NCT02039323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102269250|NCT02039323|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102269251|NCT02039323|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102269252|NCT02039323|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102269253|NCT03079115|Atorvastatin|atorvastatin|mesh-list
102269254|NCT03079115|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102269255|NCT03079115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102269256|NCT03079115|Antimetabolites|antimetabolites|mesh-ancestor
102269257|NCT03079115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269258|NCT03079115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102269259|NCT03079115|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102269260|NCT03079115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102269261|NCT05917431|Tislelizumab|tislelizumab|mesh-list
102269262|NCT05917431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102269263|NCT05917431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102269264|NCT05917405|Fludarabine|fludarabine|mesh-list
102269265|NCT05917405|Busulfan|busulfan|mesh-list
102269266|NCT05917405|Clofarabine|clofarabine|mesh-list
102269267|NCT05917405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102269268|NCT05917405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102269269|NCT05917405|Antimetabolites|antimetabolites|mesh-ancestor
102269270|NCT05917405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269271|NCT05917405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102269272|NCT05917405|Immunologic Factors|immunologic factors|mesh-ancestor
102269273|NCT05917405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269274|NCT05917405|Alkylating Agents|alkylating agents|mesh-ancestor
102269275|NCT05917405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102269276|NCT05917405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102269277|NCT05917288|Belimumab|belimumab|mesh-list
102269278|NCT05917288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102269279|NCT05917288|Immunologic Factors|immunologic factors|mesh-ancestor
102269280|NCT05917288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269281|NCT05917275|Amlodipine|amlodipine|mesh-list
102269282|NCT05917275|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102269283|NCT05917275|Olmesartan|olmesartan|mesh-list
102269284|NCT05917275|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
102269285|NCT05917275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102269286|NCT05917275|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102269287|NCT05917275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102269288|NCT05917275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269289|NCT05917275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102269290|NCT05917275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269291|NCT05917275|Vasodilator Agents|vasodilator agents|mesh-ancestor
102269292|NCT05917275|Diuretics|diuretics|mesh-ancestor
102269293|NCT05917275|Natriuretic Agents|natriuretic agents|mesh-ancestor
102269294|NCT05917275|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102269295|NCT05917275|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102269296|NCT05917275|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102269297|NCT05917223|Caseins|caseins|mesh-list
102269298|NCT05917223|Chelating Agents|chelating agents|mesh-ancestor
102269299|NCT05917223|Sequestering Agents|sequestering agents|mesh-ancestor
102269300|NCT05917223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269301|NCT05991622|Rilpivirine|rilpivirine|mesh-list
102269302|NCT05991622|Cabotegravir, rilpivirine drug combination|cabotegravir, rilpivirine drug combination|mesh-list
102269303|NCT05991622|Buprenorphine|buprenorphine|mesh-list
102269304|NCT05991622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102269305|NCT05991622|Narcotics|narcotics|mesh-ancestor
102269306|NCT05991622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102269307|NCT05991622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269309|NCT05991622|Sensory System Agents|sensory system agents|mesh-ancestor
101651037|NCT02866253|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
102269310|NCT05991622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102269311|NCT05991622|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102269312|NCT05991622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102269313|NCT05991622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102269314|NCT05991622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102269315|NCT05991622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269316|NCT05991622|Antiviral Agents|antiviral agents|mesh-ancestor
102269317|NCT05991622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102269318|NCT05991622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102269319|NCT05991622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102269320|NCT05991518|Cisplatin|cisplatin|mesh-list
102269321|NCT05991518|Gemcitabine|gemcitabine|mesh-list
102269322|NCT05991518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102269323|NCT05991518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102269324|NCT05991518|Antimetabolites|antimetabolites|mesh-ancestor
102269325|NCT05991518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269326|NCT05991466|Dexmedetomidine|dexmedetomidine|mesh-list
102269327|NCT05991466|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102269328|NCT05991466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102269329|NCT05991466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269330|NCT05991466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102269331|NCT05991466|Analgesics|analgesics|mesh-ancestor
102269332|NCT05991466|Sensory System Agents|sensory system agents|mesh-ancestor
102269333|NCT05991466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102269334|NCT05991466|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102269335|NCT05991466|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102269336|NCT05991466|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102269337|NCT05991466|Adrenergic Agents|adrenergic agents|mesh-ancestor
102269338|NCT05991466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102269339|NCT05991466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269340|NCT05991453|Propofol|propofol|mesh-list
102269341|NCT05991453|Anesthetics|anesthetics|mesh-list
102269342|NCT05991453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102269343|NCT05991453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102269344|NCT05991453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269345|NCT05991453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102269346|NCT05991453|Anesthetics, General|anesthetics, general|mesh-ancestor
102269347|NCT05991427|Vaccines|vaccines|mesh-list
102269348|NCT05991427|Immunologic Factors|immunologic factors|mesh-ancestor
102269349|NCT05991427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269350|NCT05991388|Dexamethasone|dexamethasone|mesh-list
102269351|NCT05991388|Rituximab|rituximab|mesh-list
102269352|NCT05991388|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
102269353|NCT05991388|Carboplatin|carboplatin|mesh-list
102269354|NCT05991388|Etoposide|etoposide|mesh-list
102269355|NCT05991388|Etoposide phosphate|etoposide phosphate|mesh-list
102269356|NCT05991388|Ifosfamide|ifosfamide|mesh-list
102269357|NCT05991388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102269358|NCT05991388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102269359|NCT05991388|Immunologic Factors|immunologic factors|mesh-ancestor
102269360|NCT05991388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269361|NCT05991388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102269362|NCT05991388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102269363|NCT05991388|Antiemetics|antiemetics|mesh-ancestor
102269364|NCT05991388|Autonomic Agents|autonomic agents|mesh-ancestor
102269365|NCT05991388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101651117|NCT00629447|Tinzaparin|tinzaparin|mesh-list
102269366|NCT05991388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102269367|NCT05991388|Glucocorticoids|glucocorticoids|mesh-ancestor
102269368|NCT05991388|Hormones|hormones|mesh-ancestor
102269369|NCT05991388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102269370|NCT05991388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102269371|NCT05991388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102269372|NCT05991388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102269373|NCT05991388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102269374|NCT05991388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102269375|NCT05991388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269376|NCT05991388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102269377|NCT05991388|Alkylating Agents|alkylating agents|mesh-ancestor
102269378|NCT05991375|Dexmedetomidine|dexmedetomidine|mesh-list
102269379|NCT05991375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102269380|NCT05991375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102269381|NCT05991375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269383|NCT05991375|Analgesics|analgesics|mesh-ancestor
102269384|NCT05991375|Sensory System Agents|sensory system agents|mesh-ancestor
102269385|NCT05991375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102269386|NCT05991375|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102269387|NCT05991375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102269388|NCT05991375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102269389|NCT05991375|Adrenergic Agents|adrenergic agents|mesh-ancestor
102269390|NCT05991375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102269391|NCT05991375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269392|NCT05991284|Valsartan|valsartan|mesh-list
102269393|NCT05991284|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102269394|NCT05991284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102269395|NCT05991284|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102269396|NCT05991284|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102269397|NCT05991284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269398|NCT05991232|Ketamine|ketamine|mesh-list
102269399|NCT05991232|Analgesics|analgesics|mesh-ancestor
102269400|NCT05991232|Sensory System Agents|sensory system agents|mesh-ancestor
102269401|NCT05991232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102269402|NCT05991232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269403|NCT05991232|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102269404|NCT05991232|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102269405|NCT05991232|Anesthetics, General|anesthetics, general|mesh-ancestor
102269406|NCT05991232|Anesthetics|anesthetics|mesh-ancestor
102269407|NCT05991232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102269408|NCT05991232|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102269409|NCT05991232|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102269410|NCT05991232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102269411|NCT05991232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269412|NCT05991037|Psychotropic Drugs|psychotropic drugs|mesh-list
102269413|NCT05990933|Epinephrine|epinephrine|mesh-list
102269414|NCT05990933|Racepinephrine|racepinephrine|mesh-list
102269415|NCT05990933|Epinephryl borate|epinephryl borate|mesh-list
102269416|NCT05990933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102269417|NCT05990933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102269418|NCT05990933|Adrenergic Agents|adrenergic agents|mesh-ancestor
102269419|NCT05990933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102269420|NCT05990933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269421|NCT05990933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269422|NCT05990933|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102269423|NCT05990933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102269424|NCT05990933|Autonomic Agents|autonomic agents|mesh-ancestor
102269425|NCT05990933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102269426|NCT05990933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102269427|NCT05990933|Respiratory System Agents|respiratory system agents|mesh-ancestor
102269428|NCT05990933|Mydriatics|mydriatics|mesh-ancestor
102269429|NCT05990933|Sympathomimetics|sympathomimetics|mesh-ancestor
102269430|NCT05990933|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102269431|NCT05990881|Botulinum Toxins|botulinum toxins|mesh-list
102269432|NCT05990881|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102269433|NCT05990881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102269434|NCT05990881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269435|NCT05990881|Cholinergic Agents|cholinergic agents|mesh-ancestor
102269436|NCT05990881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102269437|NCT05990881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269438|NCT05990868|Acetaminophen|acetaminophen|mesh-list
102269439|NCT05990868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102269440|NCT05990868|Analgesics|analgesics|mesh-ancestor
102269441|NCT05990868|Sensory System Agents|sensory system agents|mesh-ancestor
102269442|NCT05990868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102269443|NCT05990868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269444|NCT05990868|Antipyretics|antipyretics|mesh-ancestor
102269445|NCT05990842|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102269446|NCT05990842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102269447|NCT05990829|Aflibercept|aflibercept|mesh-list
102269448|NCT05990829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102269449|NCT05990829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102269450|NCT05990829|Growth Substances|growth substances|mesh-ancestor
102269451|NCT05990829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269452|NCT05990829|Growth Inhibitors|growth inhibitors|mesh-ancestor
102269453|NCT05990829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102269454|NCT05990738|Topotecan|topotecan|mesh-list
102269455|NCT05990738|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102269456|NCT05990738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102269457|NCT05990738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102269458|NCT05990738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269459|NCT05990738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102269460|NCT05990686|Fentanyl|fentanyl|mesh-list
102269461|NCT05990686|Tramadol|tramadol|mesh-list
102269462|NCT05990686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102269463|NCT05990686|Narcotics|narcotics|mesh-ancestor
102269464|NCT05990686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102269465|NCT05990686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269466|NCT05990686|Analgesics|analgesics|mesh-ancestor
101651254|NCT00976391|Insulin|insulin|mesh-list
102269467|NCT05990686|Sensory System Agents|sensory system agents|mesh-ancestor
102269468|NCT05990686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102269469|NCT05990686|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102269470|NCT05990686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102269471|NCT05990686|Anesthetics, General|anesthetics, general|mesh-ancestor
102269472|NCT05990686|Anesthetics|anesthetics|mesh-ancestor
102269473|NCT05990543|Capecitabine|capecitabine|mesh-list
102269474|NCT05990543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102269475|NCT05990543|Antimetabolites|antimetabolites|mesh-ancestor
102614037|NCT00003035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614038|NCT00003035|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102614039|NCT00003035|Hormone Antagonists|hormone antagonists|mesh-ancestor
102614040|NCT00003035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102614041|NCT00003035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102614042|NCT00003035|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102614043|NCT00003035|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102614044|NCT00003035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102614045|NCT00003041|NSC 366140|nsc 366140|mesh-list
102614046|NCT00003041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614047|NCT00003053|Etoposide|etoposide|mesh-list
102614048|NCT00003053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614049|NCT00003053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102614050|NCT00003053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102614051|NCT00003053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102614052|NCT00003053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102614053|NCT00003053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614054|NCT00003065|Paclitaxel|paclitaxel|mesh-list
102614055|NCT00003065|Topotecan|topotecan|mesh-list
102614056|NCT00003065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102614057|NCT00003065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614058|NCT00003065|Tubulin Modulators|tubulin modulators|mesh-ancestor
102614059|NCT00003065|Antimitotic Agents|antimitotic agents|mesh-ancestor
102614060|NCT00003065|Mitosis Modulators|mitosis modulators|mesh-ancestor
102614061|NCT00003065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614062|NCT00003065|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102614063|NCT00003065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102614064|NCT00003065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102614065|NCT04329611|Hydroxychloroquine|hydroxychloroquine|mesh-list
102614066|NCT04329611|Antimalarials|antimalarials|mesh-ancestor
102614067|NCT04329611|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102614068|NCT04329611|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102614069|NCT04329611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102614070|NCT04329611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102614071|NCT04329611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614072|NCT04329611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102614073|NCT00383357|Zolpidem|zolpidem|mesh-list
102614074|NCT00383357|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102614075|NCT00383357|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102269476|NCT05990543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269477|NCT05990543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102269478|NCT05990465|Pirtobrutinib|pirtobrutinib|mesh-list
102269479|NCT05990465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102269480|NCT05990465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102269481|NCT05990465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269482|NCT05990387|Mirabegron|mirabegron|mesh-list
102269483|NCT05990387|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102269484|NCT05990387|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102269485|NCT05990387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102269486|NCT05990387|Adrenergic Agents|adrenergic agents|mesh-ancestor
102269487|NCT05990387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101902445|NCT01090128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102269488|NCT05990387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269489|NCT05990387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269491|NCT05990374|Tirzepatide|tirzepatide|mesh-list
102269492|NCT05990374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101651335|NCT02619513|Ropivacaine|ropivacaine|mesh-list
102269493|NCT05990374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269494|NCT05990374|Incretins|incretins|mesh-ancestor
102269495|NCT05990374|Hormones|hormones|mesh-ancestor
102269496|NCT05990374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102269497|NCT05990205|Metformin|metformin|mesh-list
102269498|NCT05990205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102269499|NCT05990205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269500|NCT05990192|Niraparib|niraparib|mesh-list
102269501|NCT05990192|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102269502|NCT05990192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102269503|NCT05990192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269504|NCT05990192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102269505|NCT05990127|Paclitaxel|paclitaxel|mesh-list
102269506|NCT05990127|Carboplatin|carboplatin|mesh-list
102269507|NCT05990127|Pemetrexed|pemetrexed|mesh-list
102269508|NCT05990127|Tislelizumab|tislelizumab|mesh-list
102269509|NCT05990127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102269510|NCT05990127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102269511|NCT05990127|Tubulin Modulators|tubulin modulators|mesh-ancestor
102269512|NCT05990127|Antimitotic Agents|antimitotic agents|mesh-ancestor
102269513|NCT05990127|Mitosis Modulators|mitosis modulators|mesh-ancestor
102269514|NCT05990127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269515|NCT05990127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102269516|NCT05990127|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102269517|NCT05990127|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102269518|NCT05990127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102269519|NCT05989984|Iron|iron|mesh-list
102269520|NCT05989984|Trace Elements|trace elements|mesh-ancestor
102269521|NCT05989984|Micronutrients|micronutrients|mesh-ancestor
102269522|NCT05989984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269523|NCT05989932|Upadacitinib|upadacitinib|mesh-list
102269524|NCT05989932|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102269525|NCT05989932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102269526|NCT05989932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102269527|NCT05989932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269528|NCT05989932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102269529|NCT05989828|Aldesleukin|aldesleukin|mesh-list
102269530|NCT05989828|Cyclophosphamide|cyclophosphamide|mesh-list
102269531|NCT05989828|Fludarabine|fludarabine|mesh-list
102269532|NCT05989828|Interleukin-2|interleukin-2|mesh-list
102269533|NCT05989828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102269534|NCT05989828|Immunologic Factors|immunologic factors|mesh-ancestor
102269535|NCT05989828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269536|NCT05989828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101651616|NCT04252274|Cobicistat|cobicistat|mesh-list
102269537|NCT05989828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102269538|NCT05989828|Alkylating Agents|alkylating agents|mesh-ancestor
102269539|NCT05989828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269540|NCT05989828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102269541|NCT05989828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102269542|NCT05989828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102269543|NCT05989828|Analgesics|analgesics|mesh-ancestor
102269544|NCT05989828|Sensory System Agents|sensory system agents|mesh-ancestor
101651687|NCT04623944|Cyclophosphamide|cyclophosphamide|mesh-list
102269545|NCT05989828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102269546|NCT05989828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102269547|NCT05989828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102269548|NCT05989828|Antiviral Agents|antiviral agents|mesh-ancestor
102269549|NCT05989828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102269550|NCT05989633|Selenium|selenium|mesh-list
102269551|NCT05989633|Antioxidants|antioxidants|mesh-ancestor
102269552|NCT05989633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269553|NCT05989633|Protective Agents|protective agents|mesh-ancestor
102269554|NCT05989633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269555|NCT05989633|Trace Elements|trace elements|mesh-ancestor
102269556|NCT05989633|Micronutrients|micronutrients|mesh-ancestor
102269557|NCT05988879|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102269558|NCT05988879|Antiviral Agents|antiviral agents|mesh-ancestor
102269559|NCT05988879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102269560|NCT05988372|Paclitaxel|paclitaxel|mesh-list
102269561|NCT05988372|Gemcitabine|gemcitabine|mesh-list
102269562|NCT05988372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102269563|NCT05988372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102269564|NCT05988372|Tubulin Modulators|tubulin modulators|mesh-ancestor
102269565|NCT05988372|Antimitotic Agents|antimitotic agents|mesh-ancestor
102269566|NCT05988372|Mitosis Modulators|mitosis modulators|mesh-ancestor
102269567|NCT05988372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269568|NCT05988372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102269569|NCT05988372|Antimetabolites|antimetabolites|mesh-ancestor
102269571|NCT05987826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102269572|NCT05987826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102269573|NCT05987826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269574|NCT05975060|Vaccines|vaccines|mesh-list
102269575|NCT05975060|Immunologic Factors|immunologic factors|mesh-ancestor
102269576|NCT05975060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269577|NCT05973006|Vaccines|vaccines|mesh-list
102269578|NCT05973006|Immunologic Factors|immunologic factors|mesh-ancestor
102269579|NCT05973006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269580|NCT05965570|Clarithromycin|clarithromycin|mesh-list
102269581|NCT05965570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102269582|NCT05965570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102269583|NCT05965570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102269584|NCT05965570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102269585|NCT05965570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269586|NCT05965570|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102269587|NCT05965570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102269588|NCT05964647|Ketanserin|ketanserin|mesh-list
102269589|NCT05964647|Lorazepam|lorazepam|mesh-list
102269590|NCT05964647|Olanzapine|olanzapine|mesh-list
102269591|NCT05964647|Antiemetics|antiemetics|mesh-ancestor
102269592|NCT05964647|Autonomic Agents|autonomic agents|mesh-ancestor
102269593|NCT05964647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102269594|NCT05964647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269595|NCT05964647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102269596|NCT05964647|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102269597|NCT05964647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102269598|NCT05964647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102269599|NCT05964647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101652020|NCT00658021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269600|NCT05964647|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102269601|NCT05964647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102269602|NCT05964647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102269603|NCT05964647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978413|NCT01359722|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102269604|NCT05964647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102269605|NCT05964647|Serotonin Agents|serotonin agents|mesh-ancestor
102269606|NCT05964647|Anticonvulsants|anticonvulsants|mesh-ancestor
102269607|NCT05964647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102269608|NCT05964647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102269609|NCT05964647|GABA Modulators|gaba modulators|mesh-ancestor
102269610|NCT05964647|GABA Agents|gaba agents|mesh-ancestor
102269611|NCT05964647|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102269612|NCT05964647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102269613|NCT05964647|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102269614|NCT05952804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101652152|NCT00858117|Rituximab|rituximab|mesh-list
102269615|NCT05952804|Immunoglobulins|immunoglobulins|mesh-list
102269616|NCT05952804|Antibodies|antibodies|mesh-list
102269617|NCT05952804|gamma-Globulins|gamma-globulins|mesh-list
102269618|NCT05952804|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102269619|NCT05952804|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102269620|NCT05952804|Immunologic Factors|immunologic factors|mesh-ancestor
102269621|NCT05952804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269622|NCT05949190|Azithromycin|azithromycin|mesh-list
102269623|NCT05949190|Pyrimethamine|pyrimethamine|mesh-list
102269624|NCT05949190|Sulfadoxine|sulfadoxine|mesh-list
102269625|NCT05949190|Albendazole|albendazole|mesh-list
102269626|NCT05949190|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
102269627|NCT05949190|Choline|choline|mesh-list
102269628|NCT05949190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102269629|NCT05949190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102269630|NCT05949190|Lipotropic Agents|lipotropic agents|mesh-ancestor
102269631|NCT05949190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102269632|NCT05949190|Antimetabolites|antimetabolites|mesh-ancestor
102269633|NCT05949190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269634|NCT05949190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102269635|NCT05949190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102614076|NCT00383357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102269636|NCT05949190|Nootropic Agents|nootropic agents|mesh-ancestor
102269637|NCT05949190|Antimalarials|antimalarials|mesh-ancestor
102614078|NCT00383357|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102614079|NCT00383357|GABA Agonists|gaba agonists|mesh-ancestor
102614080|NCT00383357|GABA Agents|gaba agents|mesh-ancestor
102614081|NCT00383357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102269638|NCT05949190|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102269639|NCT05949190|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102269640|NCT05949190|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102269641|NCT05949190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102269642|NCT05949190|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102269643|NCT05949190|Anthelmintics|anthelmintics|mesh-ancestor
102269644|NCT05949190|Anticestodal Agents|anticestodal agents|mesh-ancestor
102269645|NCT05949190|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101652425|NCT00654355|Tacrolimus|tacrolimus|mesh-list
102269646|NCT05949190|Tubulin Modulators|tubulin modulators|mesh-ancestor
102269647|NCT05949190|Antimitotic Agents|antimitotic agents|mesh-ancestor
102269648|NCT05949190|Mitosis Modulators|mitosis modulators|mesh-ancestor
102269649|NCT05949190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102269650|NCT05915949|Dapagliflozin|dapagliflozin|mesh-list
102269651|NCT05915949|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102269652|NCT05915949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269653|NCT05915949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102269654|NCT05915949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269655|NCT05909904|Tislelizumab|tislelizumab|mesh-list
102269656|NCT05909904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102269657|NCT05909904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102269658|NCT05890352|Lenalidomide|lenalidomide|mesh-list
102269659|NCT05890352|Zanubrutinib|zanubrutinib|mesh-list
101652565|NCT00844857|Olanzapine|olanzapine|mesh-list
102269660|NCT05890352|Immunoglobulins|immunoglobulins|mesh-list
102269661|NCT05890352|Immunologic Factors|immunologic factors|mesh-ancestor
102269662|NCT05890352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269663|NCT05890352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102269664|NCT05890352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102269665|NCT05890352|Growth Substances|growth substances|mesh-ancestor
102269666|NCT05890352|Growth Inhibitors|growth inhibitors|mesh-ancestor
102269667|NCT05890352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102269668|NCT05890352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102269669|NCT05890352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102269670|NCT05890352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269671|NCT05881265|Venetoclax|venetoclax|mesh-list
102269672|NCT05881265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102269673|NCT05874037|Fluvoxamine|fluvoxamine|mesh-list
102269674|NCT05874037|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102269675|NCT05874037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101652759|NCT00808795|Antioxidants|antioxidants|mesh-ancestor
102269676|NCT05874037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101978494|NCT01351298|Nasal Decongestants|nasal decongestants|mesh-ancestor
102269677|NCT05874037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269678|NCT05874037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102269679|NCT05874037|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102269680|NCT05874037|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102269681|NCT05874037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102269682|NCT05874037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269683|NCT05874037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102269684|NCT05874037|Serotonin Agents|serotonin agents|mesh-ancestor
102269685|NCT05874037|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102269686|NCT05874037|Antidepressive Agents|antidepressive agents|mesh-ancestor
102269687|NCT05874037|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102269688|NCT05874037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102269689|NCT05874037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102269690|NCT05874037|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102269691|NCT05858710|Doxorubicin|doxorubicin|mesh-list
102269692|NCT05858710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102269693|NCT05858710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102269694|NCT05858710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102269695|NCT05858710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102269696|NCT05858710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102269697|NCT05858710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269698|NCT05832229|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102269699|NCT05832229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101652969|NCT04045015|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
102269700|NCT05832229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102269701|NCT05832229|Antimetabolites|antimetabolites|mesh-ancestor
102269702|NCT05832229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269703|NCT05832229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101611520|NCT00595582|Curcumin|curcumin|mesh-list
101653027|NCT00912782|Micronutrients|micronutrients|mesh-ancestor
102614082|NCT00383357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614083|NCT00003089|Paclitaxel|paclitaxel|mesh-list
102614084|NCT00003089|Carboplatin|carboplatin|mesh-list
102614085|NCT00003089|Amifostine|amifostine|mesh-list
102614086|NCT00003089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102269704|NCT05832229|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102269705|NCT05832229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102269706|NCT05814939|Tofacitinib|tofacitinib|mesh-list
101653098|NCT00911300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102269707|NCT05814939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269708|NCT05814939|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102269709|NCT05814939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102269710|NCT05814939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102269711|NCT05800860|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
102269712|NCT05800860|Hallucinogens|hallucinogens|mesh-ancestor
102269713|NCT05800860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269714|NCT05800860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102269715|NCT05800860|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102269716|NCT05800860|Serotonin Agents|serotonin agents|mesh-ancestor
102269717|NCT05800860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102269718|NCT05800860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269719|NCT05800860|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102269720|NCT05753956|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
102269721|NCT05753956|Hallucinogens|hallucinogens|mesh-ancestor
102269722|NCT05753956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269723|NCT05753956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102269724|NCT05753956|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102269725|NCT05753956|Serotonin Agents|serotonin agents|mesh-ancestor
102269726|NCT05753956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101653237|NCT00816205|Nifedipine|nifedipine|mesh-list
102269727|NCT05753956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269728|NCT05753956|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102269729|NCT05732389|Nivolumab|nivolumab|mesh-list
102269730|NCT05732389|Ipilimumab|ipilimumab|mesh-list
102269731|NCT05732389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102269732|NCT05732389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102269733|NCT05732389|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102269734|NCT05732389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269735|NCT05729282|Diazoxide|diazoxide|mesh-list
102269736|NCT05729282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102269737|NCT05729282|Vasodilator Agents|vasodilator agents|mesh-ancestor
102269738|NCT05708638|Anesthetics|anesthetics|mesh-list
102269739|NCT05708638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102269740|NCT05708638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269741|NCT05698511|Psilocybin|psilocybin|mesh-list
102269742|NCT05698511|Hallucinogens|hallucinogens|mesh-ancestor
102269743|NCT05698511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269744|NCT05698511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102269745|NCT05686044|Phenserine|phenserine|mesh-list
102269746|NCT05686044|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102269747|NCT05686044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102269748|NCT05686044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269749|NCT05686044|Cholinergic Agents|cholinergic agents|mesh-ancestor
102269750|NCT05686044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102269751|NCT05686044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269752|NCT05671029|Moxifloxacin|moxifloxacin|mesh-list
102269753|NCT05671029|Pritelivir|pritelivir|mesh-list
102269754|NCT05671029|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102269755|NCT05671029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102269756|NCT05671029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102269757|NCT05671029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101653504|NCT00975221|Cinacalcet|cinacalcet|mesh-list
102269758|NCT05671029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102269759|NCT05671029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102269760|NCT05671029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269761|NCT05671029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102269762|NCT05671029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102269763|NCT05671029|Contraceptive Agents|contraceptive agents|mesh-ancestor
102269764|NCT05671029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102269765|NCT05671029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269766|NCT05671029|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102269767|NCT05671029|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102269768|NCT05671029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102269769|NCT05671029|Antiviral Agents|antiviral agents|mesh-ancestor
102269770|NCT05659537|Dulaglutide|dulaglutide|mesh-list
102269771|NCT05659537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101902495|NCT01188824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102614087|NCT00003089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614088|NCT00003089|Tubulin Modulators|tubulin modulators|mesh-ancestor
102614089|NCT00003089|Antimitotic Agents|antimitotic agents|mesh-ancestor
102614090|NCT00003089|Mitosis Modulators|mitosis modulators|mesh-ancestor
102614091|NCT00003089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614092|NCT00003089|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102614093|NCT00003089|Protective Agents|protective agents|mesh-ancestor
102614094|NCT00003089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614095|NCT00003101|Vincristine|vincristine|mesh-list
102614096|NCT00003101|Busulfan|busulfan|mesh-list
102614097|NCT00003101|Thiotepa|thiotepa|mesh-list
102614098|NCT00003101|Lomustine|lomustine|mesh-list
102614099|NCT00003101|Procarbazine|procarbazine|mesh-list
102614100|NCT00003101|Immunologic Factors|immunologic factors|mesh-ancestor
102614101|NCT00003101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614102|NCT00003101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102614103|NCT00003101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614104|NCT00003101|Tubulin Modulators|tubulin modulators|mesh-ancestor
102614105|NCT00003101|Antimitotic Agents|antimitotic agents|mesh-ancestor
102614106|NCT00003101|Mitosis Modulators|mitosis modulators|mesh-ancestor
102269772|NCT05659537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269773|NCT05644665|Ozanimod|ozanimod|mesh-list
102269774|NCT05644665|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102269775|NCT05644665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269776|NCT05644665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102269777|NCT05644665|Immunologic Factors|immunologic factors|mesh-ancestor
102269778|NCT05644665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269779|NCT05640245|Adalimumab|adalimumab|mesh-list
102269780|NCT05640245|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102269781|NCT05640245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102269782|NCT05640245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102269783|NCT05633615|Cyclophosphamide|cyclophosphamide|mesh-list
102269784|NCT05633615|Fludarabine|fludarabine|mesh-list
102269785|NCT05633615|Tisagenlecleucel|tisagenlecleucel|mesh-list
102269786|NCT05633615|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
102269787|NCT05633615|Antibodies|antibodies|mesh-list
102269788|NCT05633615|Immunoglobulins|immunoglobulins|mesh-list
102269789|NCT05633615|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102269790|NCT05633615|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102269791|NCT05633615|Immunoconjugates|immunoconjugates|mesh-list
102269792|NCT05633615|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
102269793|NCT05633615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102269794|NCT05633615|Immunologic Factors|immunologic factors|mesh-ancestor
102269795|NCT05633615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269796|NCT05633615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102269797|NCT05633615|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102269798|NCT05633615|Alkylating Agents|alkylating agents|mesh-ancestor
102269799|NCT05633615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269800|NCT05633615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102269801|NCT05633615|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102269802|NCT05633615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102269803|NCT05632211|Golimumab|golimumab|mesh-list
102269804|NCT05632211|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102269805|NCT05632211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102269806|NCT05632211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102269807|NCT05632211|Immunologic Factors|immunologic factors|mesh-ancestor
102269808|NCT05632211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269809|NCT05608291|Pembrolizumab|pembrolizumab|mesh-list
102269810|NCT05608291|Cemiplimab|cemiplimab|mesh-list
102269811|NCT05608291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102269812|NCT05608291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102269813|NCT05608291|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102269814|NCT05608291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269815|NCT05608070|Oxytocin|oxytocin|mesh-list
102269816|NCT05608070|Oxytocics|oxytocics|mesh-ancestor
102269817|NCT05608070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102269818|NCT05608070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269819|NCT05577702|Tislelizumab|tislelizumab|mesh-list
102269820|NCT05577702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102269821|NCT05577702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102269822|NCT05561387|Dexamethasone|dexamethasone|mesh-list
102269823|NCT05561387|Dexamethasone acetate|dexamethasone acetate|mesh-list
102269824|NCT05561387|Lenalidomide|lenalidomide|mesh-list
102614107|NCT00003101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269825|NCT05561387|Bortezomib|bortezomib|mesh-list
101654254|NCT00903344|Vitamin D|vitamin d|mesh-list
102269826|NCT05561387|Daratumumab|daratumumab|mesh-list
102614108|NCT00003101|Alkylating Agents|alkylating agents|mesh-ancestor
102269828|NCT05561387|BB 1101|bb 1101|mesh-list
102269829|NCT05561387|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102269830|NCT05561387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101978631|NCT01360424|Teriparatide|teriparatide|mesh-list
102269831|NCT05561387|Antiemetics|antiemetics|mesh-ancestor
102269832|NCT05561387|Autonomic Agents|autonomic agents|mesh-ancestor
102269833|NCT05561387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102269834|NCT05561387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269835|NCT05561387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102269836|NCT05561387|Glucocorticoids|glucocorticoids|mesh-ancestor
102269837|NCT05561387|Hormones|hormones|mesh-ancestor
102269838|NCT05561387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102269839|NCT05561387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102269840|NCT05561387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102269841|NCT05561387|Protease Inhibitors|protease inhibitors|mesh-ancestor
101654387|NCT00824239|Midazolam|midazolam|mesh-list
102269842|NCT05561387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102269843|NCT05561387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269844|NCT05561387|Immunologic Factors|immunologic factors|mesh-ancestor
102269845|NCT05561387|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102269846|NCT05561387|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102269847|NCT05561387|Growth Substances|growth substances|mesh-ancestor
102269848|NCT05561387|Growth Inhibitors|growth inhibitors|mesh-ancestor
102269849|NCT05561387|Dermatologic Agents|dermatologic agents|mesh-ancestor
101654445|NCT02847806|Androgens|androgens|mesh-ancestor
102269850|NCT05553691|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
102269851|NCT05553691|Hallucinogens|hallucinogens|mesh-ancestor
102269852|NCT05553691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269853|NCT05553691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102269854|NCT05553691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102269855|NCT05553691|Serotonin Agents|serotonin agents|mesh-ancestor
102269856|NCT05553691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102269857|NCT05553691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269858|NCT05553691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102269859|NCT05547542|Carfentanil|carfentanil|mesh-list
102269860|NCT05547542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102269861|NCT05547542|Narcotics|narcotics|mesh-ancestor
102269862|NCT05547542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102269863|NCT05547542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269864|NCT05547542|Analgesics|analgesics|mesh-ancestor
102269865|NCT05547542|Sensory System Agents|sensory system agents|mesh-ancestor
102269866|NCT05547542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102269867|NCT05530655|Lisinopril|lisinopril|mesh-list
101654571|NCT00825019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269868|NCT05530655|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102269869|NCT05530655|Protease Inhibitors|protease inhibitors|mesh-ancestor
102269870|NCT05530655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102269871|NCT05530655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269872|NCT05530655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102269873|NCT05530655|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102269874|NCT05530655|Protective Agents|protective agents|mesh-ancestor
101654644|NCT05337332|Glucocorticoids|glucocorticoids|mesh-ancestor
102269875|NCT05530655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269876|NCT05405166|Dexamethasone|dexamethasone|mesh-list
102269877|NCT05405166|Pomalidomide|pomalidomide|mesh-list
102269878|NCT05405166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102269879|NCT05405166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102269880|NCT05405166|Antiemetics|antiemetics|mesh-ancestor
102269881|NCT05405166|Autonomic Agents|autonomic agents|mesh-ancestor
102269882|NCT05405166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102269883|NCT05405166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269884|NCT05405166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102269885|NCT05405166|Glucocorticoids|glucocorticoids|mesh-ancestor
102269886|NCT05405166|Hormones|hormones|mesh-ancestor
102269887|NCT05405166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102269888|NCT05405166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102269889|NCT05405166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102269890|NCT05405166|Immunologic Factors|immunologic factors|mesh-ancestor
102269891|NCT05405166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102269892|NCT05405166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102269893|NCT05405166|Growth Substances|growth substances|mesh-ancestor
102269894|NCT05405166|Growth Inhibitors|growth inhibitors|mesh-ancestor
102269895|NCT05382286|Paclitaxel|paclitaxel|mesh-list
102269896|NCT05382286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102269897|NCT05382286|Carboplatin|carboplatin|mesh-list
102269898|NCT05382286|Gemcitabine|gemcitabine|mesh-list
102269899|NCT05382286|Pembrolizumab|pembrolizumab|mesh-list
102269900|NCT05382286|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
101654769|NCT04224584|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102269901|NCT05382286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102269902|NCT05382286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102269903|NCT05382286|Tubulin Modulators|tubulin modulators|mesh-ancestor
102269904|NCT05382286|Antimitotic Agents|antimitotic agents|mesh-ancestor
102269905|NCT05382286|Mitosis Modulators|mitosis modulators|mesh-ancestor
102269906|NCT05382286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269907|NCT05382286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102269908|NCT05382286|Antimetabolites|antimetabolites|mesh-ancestor
102269909|NCT05382286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102269910|NCT05382286|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102269911|NCT05382286|Immunoconjugates|immunoconjugates|mesh-ancestor
102269912|NCT05382286|Immunologic Factors|immunologic factors|mesh-ancestor
102269913|NCT05382286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269914|NCT05374564|Flutemetamol|flutemetamol|mesh-list
102269915|NCT05374564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102269916|NCT05374564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269918|NCT05370599|Amlodipine|amlodipine|mesh-list
102269919|NCT05370599|Chlorthalidone|chlorthalidone|mesh-list
102269920|NCT05370599|Antihypertensive Agents|antihypertensive agents|mesh-list
102269921|NCT05370599|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102269922|NCT05370599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102269923|NCT05370599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269924|NCT05370599|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102269925|NCT05370599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269926|NCT05370599|Vasodilator Agents|vasodilator agents|mesh-ancestor
102269927|NCT05370599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101654974|NCT02834676|Ethanol|ethanol|mesh-list
102269928|NCT05370599|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102269929|NCT05370599|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102269930|NCT05370599|Diuretics|diuretics|mesh-ancestor
102269931|NCT05370599|Natriuretic Agents|natriuretic agents|mesh-ancestor
102269932|NCT05370599|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102269933|NCT05301712|Naloxone|naloxone|mesh-list
102269934|NCT05301712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101655061|NCT00830323|Amantadine|amantadine|mesh-list
102269935|NCT05301712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269936|NCT05301712|Sensory System Agents|sensory system agents|mesh-ancestor
102269937|NCT05301712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102269938|NCT05301062|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
102269939|NCT05301062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102269940|NCT05280548|Venglustat|venglustat|mesh-list
102269941|NCT05280548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102269942|NCT05280548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269943|NCT05266612|Nivolumab|nivolumab|mesh-list
102269944|NCT05266612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102269945|NCT05266612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102269946|NCT05266612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102269947|NCT05266612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269948|NCT05263206|Loratadine|loratadine|mesh-list
102269949|NCT05263206|Fexofenadine|fexofenadine|mesh-list
102269950|NCT05263206|Antipruritics|antipruritics|mesh-ancestor
102269951|NCT05263206|Dermatologic Agents|dermatologic agents|mesh-ancestor
102269952|NCT05263206|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102269953|NCT05263206|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102269954|NCT05263206|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101655175|NCT02833584|Antipyretics|antipyretics|mesh-ancestor
102269955|NCT05263206|Histamine Antagonists|histamine antagonists|mesh-ancestor
102269956|NCT05263206|Histamine Agents|histamine agents|mesh-ancestor
102269957|NCT05263206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102269958|NCT05263206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269959|NCT05263206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269960|NCT05222191|Chlorthalidone|chlorthalidone|mesh-list
102269961|NCT05222191|Spironolactone|spironolactone|mesh-list
102269962|NCT05222191|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102269963|NCT05222191|Hormone Antagonists|hormone antagonists|mesh-ancestor
102269964|NCT05222191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102269965|NCT05222191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269966|NCT05222191|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102269967|NCT05222191|Diuretics|diuretics|mesh-ancestor
102269968|NCT05222191|Natriuretic Agents|natriuretic agents|mesh-ancestor
102269969|NCT05222191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101655240|NCT05878262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101655241|NCT05878262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101655242|NCT05878262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101655243|NCT05878262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101655244|NCT05878262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655245|NCT05878249|Sodium Hypochlorite|sodium hypochlorite|mesh-list
102269970|NCT05222191|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101902521|NCT01295294|Mefenamic Acid|mefenamic acid|mesh-list
102614109|NCT00003101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102614110|NCT00003101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102614111|NCT00003101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102614112|NCT00003107|Interleukin-12|interleukin-12|mesh-list
102614113|NCT00003107|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102614114|NCT00003107|Immunologic Factors|immunologic factors|mesh-ancestor
102614115|NCT00003107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102269971|NCT05222191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102269972|NCT05222191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269973|NCT05189015|Olmesartan|olmesartan|mesh-list
102269974|NCT05189015|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
102269975|NCT05189015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102269976|NCT05189015|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102269977|NCT05189015|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102269978|NCT05189015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269979|NCT05171075|Dalteparin|dalteparin|mesh-list
102269980|NCT05171075|Tinzaparin|tinzaparin|mesh-list
102269981|NCT05171075|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102269982|NCT05171075|Anticoagulants|anticoagulants|mesh-ancestor
102269983|NCT05171075|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102269984|NCT05171075|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102269985|NCT05171075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269986|NCT05171049|Apixaban|apixaban|mesh-list
102269987|NCT05171049|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102269988|NCT05171049|Antithrombins|antithrombins|mesh-ancestor
102269989|NCT05171049|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102269990|NCT05171049|Protease Inhibitors|protease inhibitors|mesh-ancestor
102269991|NCT05171049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101655304|NCT05877807|Baclofen|baclofen|mesh-list
101655314|NCT05877781|Palmidrol|palmidrol|mesh-list
102269992|NCT05171049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269993|NCT05171049|Anticoagulants|anticoagulants|mesh-ancestor
102269994|NCT05153070|Cyclosporine|cyclosporine|mesh-list
102269995|NCT05153070|Cyclosporins|cyclosporins|mesh-list
102269996|NCT05153070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102269997|NCT05153070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102269998|NCT05153070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102269999|NCT05153070|Immunologic Factors|immunologic factors|mesh-ancestor
102270000|NCT05153070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270001|NCT05153070|Antifungal Agents|antifungal agents|mesh-ancestor
102270002|NCT05153070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102270003|NCT05153070|Dermatologic Agents|dermatologic agents|mesh-ancestor
102270004|NCT05153070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102270005|NCT05153070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102270006|NCT05132075|Docetaxel|docetaxel|mesh-list
102270007|NCT05132075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270008|NCT05132075|Tubulin Modulators|tubulin modulators|mesh-ancestor
102270009|NCT05132075|Antimitotic Agents|antimitotic agents|mesh-ancestor
102270010|NCT05132075|Mitosis Modulators|mitosis modulators|mesh-ancestor
102270011|NCT05132075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270012|NCT05084196|Melatonin|melatonin|mesh-list
102270013|NCT05084196|Antioxidants|antioxidants|mesh-ancestor
102270014|NCT05084196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270015|NCT05084196|Protective Agents|protective agents|mesh-ancestor
102270016|NCT05084196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270017|NCT05084196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102270018|NCT05065671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102270019|NCT05065671|Tolcapone|tolcapone|mesh-list
102270020|NCT05065671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102270021|NCT05065671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102270022|NCT05065671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102270023|NCT05065671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270024|NCT05065671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102270025|NCT05065671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270026|NCT05065671|Analgesics|analgesics|mesh-ancestor
102270027|NCT05065671|Sensory System Agents|sensory system agents|mesh-ancestor
102270028|NCT05065671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102270029|NCT05065671|Antidepressive Agents|antidepressive agents|mesh-ancestor
102270030|NCT05065671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102270031|NCT05065671|Dopamine Agents|dopamine agents|mesh-ancestor
102270032|NCT05065671|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102270033|NCT05065671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102270034|NCT05065671|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102270035|NCT05065671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102270036|NCT05045638|Sotorasib|sotorasib|mesh-list
102270037|NCT05045638|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101655622|NCT05123053|Amifampridine|amifampridine|mesh-list
102270038|NCT05045638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102270039|NCT05045638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102614116|NCT00003107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102614117|NCT00003107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102270040|NCT05045638|Antimetabolites|antimetabolites|mesh-ancestor
102270041|NCT05045638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270042|NCT05045638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102270043|NCT05045638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102270044|NCT05045638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102614118|NCT00003107|Growth Substances|growth substances|mesh-ancestor
102614119|NCT00003107|Growth Inhibitors|growth inhibitors|mesh-ancestor
102614120|NCT00003107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614121|NCT00003113|Cyclophosphamide|cyclophosphamide|mesh-list
102614122|NCT00003113|Lomustine|lomustine|mesh-list
102270045|NCT05045638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102270046|NCT05045638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102270047|NCT05045638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270048|NCT05044819|Cannabidiol|cannabidiol|mesh-list
102270049|NCT05044819|Anticonvulsants|anticonvulsants|mesh-ancestor
102270050|NCT05040360|Capecitabine|capecitabine|mesh-list
102270051|NCT05040360|Temozolomide|temozolomide|mesh-list
102270052|NCT05040360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102270054|NCT05040360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655838|NCT04315701|Cemiplimab|cemiplimab|mesh-list
102270055|NCT05040360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270056|NCT05040360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102270057|NCT05040360|Alkylating Agents|alkylating agents|mesh-ancestor
102270058|NCT05011513|Ritonavir|ritonavir|mesh-list
102270059|NCT05011513|Nirmatrelvir|nirmatrelvir|mesh-list
102270060|NCT05011513|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102270061|NCT05011513|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102270062|NCT05011513|Protease Inhibitors|protease inhibitors|mesh-ancestor
102270063|NCT05011513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102270064|NCT05011513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270065|NCT05011513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102270066|NCT05011513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102270067|NCT05011513|Antiviral Agents|antiviral agents|mesh-ancestor
102270068|NCT05011513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102270069|NCT05011513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102270070|NCT05011513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102270071|NCT05006573|Benralizumab|benralizumab|mesh-list
102270072|NCT05006573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102270073|NCT05006573|Respiratory System Agents|respiratory system agents|mesh-ancestor
102270074|NCT04970901|Obinutuzumab|obinutuzumab|mesh-list
102270075|NCT04970901|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
102270076|NCT04970901|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
102270077|NCT04970901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102270078|NCT04970901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270079|NCT04970901|Immunoconjugates|immunoconjugates|mesh-ancestor
102270080|NCT04970901|Immunologic Factors|immunologic factors|mesh-ancestor
101656037|NCT03032783|Mycophenolic Acid|mycophenolic acid|mesh-list
101656038|NCT03032783|Cyclophosphamide|cyclophosphamide|mesh-list
101656039|NCT03032783|Tacrolimus|tacrolimus|mesh-list
101656040|NCT03032783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101656041|NCT03032783|Immunologic Factors|immunologic factors|mesh-ancestor
101656042|NCT03032783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656043|NCT03032783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101656044|NCT03032783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101656045|NCT03032783|Alkylating Agents|alkylating agents|mesh-ancestor
101656046|NCT03032783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656047|NCT03032783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101656048|NCT03032783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101656049|NCT03032783|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101656050|NCT03032783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101656051|NCT03032783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101656052|NCT03032783|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102270081|NCT04970901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270082|NCT04936542|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102270083|NCT04936542|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102270084|NCT04936542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102270085|NCT04936542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270086|NCT04936542|Cholinergic Agents|cholinergic agents|mesh-ancestor
102270087|NCT04936542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102270088|NCT04936542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270089|NCT04849416|Pirtobrutinib|pirtobrutinib|mesh-list
102270090|NCT04849416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101656089|NCT02728531|Cytarabine|cytarabine|mesh-list
102270091|NCT04849416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102270092|NCT04849416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270093|NCT04825223|Vaccines|vaccines|mesh-list
102270094|NCT04825223|Immunologic Factors|immunologic factors|mesh-ancestor
102270095|NCT04825223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270096|NCT04818034|Dapagliflozin|dapagliflozin|mesh-list
101656151|NCT02456857|Growth Substances|growth substances|mesh-ancestor
102270097|NCT04818034|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102270098|NCT04818034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270099|NCT04818034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102270100|NCT04818034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270101|NCT04812028|Magnesium Sulfate|magnesium sulfate|mesh-list
102270102|NCT04812028|Analgesics|analgesics|mesh-ancestor
102270103|NCT04812028|Sensory System Agents|sensory system agents|mesh-ancestor
102270104|NCT04812028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102270105|NCT04812028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270106|NCT04812028|Anesthetics|anesthetics|mesh-ancestor
102270107|NCT04812028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102614123|NCT00003113|Etoposide|etoposide|mesh-list
102614124|NCT00003113|Procarbazine|procarbazine|mesh-list
102614125|NCT00003113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101656291|NCT04474938|Dexamethasone|dexamethasone|mesh-list
102614126|NCT00003113|Immunologic Factors|immunologic factors|mesh-ancestor
102614127|NCT00003113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614128|NCT00003113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102270108|NCT04812028|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102270109|NCT04812028|Anticonvulsants|anticonvulsants|mesh-ancestor
102270110|NCT04812028|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102270111|NCT04812028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102270112|NCT04812028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656356|NCT05333640|Sirolimus|sirolimus|mesh-list
102270113|NCT04812028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102270114|NCT04812028|Tocolytic Agents|tocolytic agents|mesh-ancestor
102270115|NCT04812028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102270116|NCT04807972|Folfirinox|folfirinox|mesh-list
102270117|NCT04807972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270118|NCT04792190|Dapagliflozin|dapagliflozin|mesh-list
102270119|NCT04792190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102270120|NCT04792190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270121|NCT04792190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102270122|NCT04792190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270123|NCT04770012|Aspirin|aspirin|mesh-list
102270124|NCT04770012|Clopidogrel|clopidogrel|mesh-list
101978934|NCT02320240|Citalopram|citalopram|mesh-list
102270125|NCT04770012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102270126|NCT04770012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102270127|NCT04770012|Analgesics|analgesics|mesh-ancestor
102270128|NCT04770012|Sensory System Agents|sensory system agents|mesh-ancestor
102270129|NCT04770012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102270130|NCT04770012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270131|NCT04770012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102270132|NCT04770012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102270133|NCT04770012|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102270134|NCT04770012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102270135|NCT04770012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270136|NCT04770012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102270137|NCT04770012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102270138|NCT04770012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102270139|NCT04770012|Antipyretics|antipyretics|mesh-ancestor
102270140|NCT04770012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102270141|NCT04770012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102270142|NCT04770012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102270143|NCT04770012|Purinergic Agents|purinergic agents|mesh-ancestor
102270144|NCT04770012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102270145|NCT04755244|Azacitidine|azacitidine|mesh-list
102270146|NCT04755244|Venetoclax|venetoclax|mesh-list
102270147|NCT04755244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102270148|NCT04755244|Antimetabolites|antimetabolites|mesh-ancestor
102270149|NCT04755244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270150|NCT04755244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270151|NCT04755244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102270152|NCT04718740|Vitamin K|vitamin k|mesh-list
102270153|NCT04718740|Repaglinide|repaglinide|mesh-list
102270154|NCT04718740|Fluzoparib|fluzoparib|mesh-list
102270155|NCT04718740|Midazolam|midazolam|mesh-list
102270156|NCT04718740|Caffeine|caffeine|mesh-list
102270157|NCT04718740|Bupropion|bupropion|mesh-list
102270158|NCT04718740|Omeprazole|omeprazole|mesh-list
102270159|NCT04718740|Warfarin|warfarin|mesh-list
102270160|NCT04718740|Vitamins|vitamins|mesh-ancestor
102270161|NCT04718740|Micronutrients|micronutrients|mesh-ancestor
102270162|NCT04718740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270163|NCT04718740|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102270164|NCT04718740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102270165|NCT04718740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102270166|NCT04718740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102270167|NCT04718740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102270168|NCT04718740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102270169|NCT04718740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102270170|NCT04718740|Anesthetics, General|anesthetics, general|mesh-ancestor
102270171|NCT04718740|Anesthetics|anesthetics|mesh-ancestor
102270172|NCT04718740|GABA Modulators|gaba modulators|mesh-ancestor
102270173|NCT04718740|GABA Agents|gaba agents|mesh-ancestor
102270174|NCT04718740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102614129|NCT00003113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102614130|NCT00003113|Alkylating Agents|alkylating agents|mesh-ancestor
102270175|NCT04718740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270176|NCT04718740|Anticoagulants|anticoagulants|mesh-ancestor
102270177|NCT04718740|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102270178|NCT04718740|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102614131|NCT00003113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614132|NCT00003113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614133|NCT00003113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102614134|NCT00003113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102614135|NCT00003113|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102614136|NCT00003113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102614137|NCT00003113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102614138|NCT01545557|Lidocaine|lidocaine|mesh-list
102614139|NCT01545557|Hyaluronic Acid|hyaluronic acid|mesh-list
101656973|NCT04247646|Melatonin|melatonin|mesh-list
102614140|NCT01545557|Anesthetics, Local|anesthetics, local|mesh-ancestor
102614141|NCT01545557|Anesthetics|anesthetics|mesh-ancestor
102614142|NCT01545557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102614143|NCT01545557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614144|NCT01545557|Sensory System Agents|sensory system agents|mesh-ancestor
102614145|NCT01545557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102614146|NCT01545557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102614147|NCT01545557|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101657064|NCT02830230|Cefixime|cefixime|mesh-list
102614148|NCT01545557|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102614149|NCT01545557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102614150|NCT01545557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614151|NCT01545557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102614152|NCT01545557|Immunologic Factors|immunologic factors|mesh-ancestor
102614153|NCT01545557|Viscosupplements|viscosupplements|mesh-ancestor
102614154|NCT01545557|Protective Agents|protective agents|mesh-ancestor
102614155|NCT00003119|Cyclophosphamide|cyclophosphamide|mesh-list
102614156|NCT00003119|Carboplatin|carboplatin|mesh-list
102614157|NCT00003119|Doxorubicin|doxorubicin|mesh-list
102614158|NCT00003119|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102614159|NCT00003119|Etoposide|etoposide|mesh-list
102270179|NCT04718740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102270180|NCT04718740|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102270181|NCT04718740|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102270182|NCT04718740|Purinergic Agents|purinergic agents|mesh-ancestor
102270183|NCT04718740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102270184|NCT04718740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102270185|NCT04718740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102270186|NCT04718740|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102270187|NCT04718740|Antidepressive Agents|antidepressive agents|mesh-ancestor
102270188|NCT04718740|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102270189|NCT04718740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102270190|NCT04718740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102270191|NCT04718740|Dopamine Agents|dopamine agents|mesh-ancestor
102270192|NCT04718740|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102270193|NCT04718740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102270194|NCT04718740|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102270195|NCT04718740|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102270196|NCT04718740|Hemostatics|hemostatics|mesh-ancestor
102270197|NCT04718740|Coagulants|coagulants|mesh-ancestor
102270198|NCT04718740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102270199|NCT04718740|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102270200|NCT04718740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270201|NCT04708470|Entinostat|entinostat|mesh-list
102270202|NCT04708470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270203|NCT04708470|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102270204|NCT04708470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102270205|NCT04708470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270206|NCT04647916|Camptothecin|camptothecin|mesh-list
102270207|NCT04647916|Irinotecan|irinotecan|mesh-list
102270208|NCT04647916|Immunoconjugates|immunoconjugates|mesh-list
102270209|NCT04647916|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
102270210|NCT04647916|Immunologic Factors|immunologic factors|mesh-ancestor
102270211|NCT04647916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270212|NCT04647916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102270213|NCT04647916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270214|NCT04647916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102270215|NCT04647916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102270216|NCT04647916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102270217|NCT04647916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270218|NCT04633252|Prednisone|prednisone|mesh-list
102270219|NCT04633252|Docetaxel|docetaxel|mesh-list
102270220|NCT04633252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270221|NCT04633252|Tubulin Modulators|tubulin modulators|mesh-ancestor
102270222|NCT04633252|Antimitotic Agents|antimitotic agents|mesh-ancestor
102270223|NCT04633252|Mitosis Modulators|mitosis modulators|mesh-ancestor
101902542|NCT01295294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102614161|NCT00003119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102270224|NCT04633252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657447|NCT00621517|Bupropion|bupropion|mesh-list
102270225|NCT04633252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102270226|NCT04633252|Glucocorticoids|glucocorticoids|mesh-ancestor
102270227|NCT04633252|Hormones|hormones|mesh-ancestor
102270228|NCT04633252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102270229|NCT04633252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270230|NCT04633252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102270231|NCT04590248|Adavosertib|adavosertib|mesh-list
102270232|NCT04590248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102270233|NCT04590248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270234|NCT04586231|Lenvatinib|lenvatinib|mesh-list
102270235|NCT04586231|Belzutifan|belzutifan|mesh-list
102270236|NCT04586231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270237|NCT04586231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102270238|NCT04586231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102270239|NCT04586231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270240|NCT04576156|Imetelstat|imetelstat|mesh-list
102270241|NCT04576156|Motesanib diphosphate|motesanib diphosphate|mesh-list
102270242|NCT04576156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102270243|NCT04576156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270244|NCT04576156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102270245|NCT04560816|Moxifloxacin|moxifloxacin|mesh-list
102270246|NCT04560816|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
102270247|NCT04560816|Choline|choline|mesh-list
102270248|NCT04560816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102270249|NCT04560816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102270250|NCT04560816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102270251|NCT04560816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102270252|NCT04560816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102270253|NCT04560816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270254|NCT04560816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270255|NCT04560816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270256|NCT04560816|Lipotropic Agents|lipotropic agents|mesh-ancestor
102270257|NCT04560816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102270258|NCT04560816|Antimetabolites|antimetabolites|mesh-ancestor
101657553|NCT02826408|Rabeprazole|rabeprazole|mesh-list
102270259|NCT04560816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102270260|NCT04560816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102270261|NCT04560816|Nootropic Agents|nootropic agents|mesh-ancestor
102270262|NCT04560816|Chelating Agents|chelating agents|mesh-ancestor
102270263|NCT04560816|Sequestering Agents|sequestering agents|mesh-ancestor
102270264|NCT04560816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102270265|NCT04560816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102270266|NCT04560816|Growth Substances|growth substances|mesh-ancestor
102270267|NCT04560816|Growth Inhibitors|growth inhibitors|mesh-ancestor
102270268|NCT04535401|Calcium, Dietary|calcium, dietary|mesh-list
102270269|NCT04535401|Leucovorin|leucovorin|mesh-list
102270270|NCT04535401|Folic Acid|folic acid|mesh-list
102270271|NCT04535401|Fluorouracil|fluorouracil|mesh-list
102270272|NCT04535401|Irinotecan|irinotecan|mesh-list
102270273|NCT04535401|Camptothecin|camptothecin|mesh-list
102270274|NCT04535401|Calcium|calcium|mesh-list
102270275|NCT04535401|Levoleucovorin|levoleucovorin|mesh-list
102270276|NCT04535401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101657673|NCT00845689|Purinergic Agents|purinergic agents|mesh-ancestor
102270277|NCT04535401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270278|NCT04535401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102270280|NCT04535401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270281|NCT04535401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102270282|NCT04535401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270283|NCT04535401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102270284|NCT04535401|Immunologic Factors|immunologic factors|mesh-ancestor
102270285|NCT04535401|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102270286|NCT04535401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102270287|NCT04535401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102270288|NCT04535401|Antidotes|antidotes|mesh-ancestor
102270289|NCT04535401|Protective Agents|protective agents|mesh-ancestor
102270290|NCT04535401|Vitamin B Complex|vitamin b complex|mesh-ancestor
102270291|NCT04535401|Vitamins|vitamins|mesh-ancestor
102270292|NCT04535401|Micronutrients|micronutrients|mesh-ancestor
102270293|NCT04535401|Hematinics|hematinics|mesh-ancestor
102270294|NCT04535401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102270295|NCT04511013|Nivolumab|nivolumab|mesh-list
102270296|NCT04511013|Ipilimumab|ipilimumab|mesh-list
102270297|NCT04511013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102270298|NCT04511013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101902571|NCT01292408|Hydroxychloroquine|hydroxychloroquine|mesh-list
102614162|NCT00003119|Immunologic Factors|immunologic factors|mesh-ancestor
102614163|NCT00003119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614164|NCT00003119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102614165|NCT00003119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102614166|NCT00003119|Alkylating Agents|alkylating agents|mesh-ancestor
102614167|NCT00003119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270299|NCT04511013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102270300|NCT04511013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270301|NCT04508725|Mitogens|mitogens|mesh-list
102270302|NCT04508725|Endothelial Growth Factors|endothelial growth factors|mesh-list
102270303|NCT04508725|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102270304|NCT04508725|Mitosis Modulators|mitosis modulators|mesh-ancestor
102614168|NCT00003119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614169|NCT00003119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102614170|NCT00003119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102614171|NCT00003119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102614172|NCT00003119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102614173|NCT00003119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102614174|NCT00003119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102614175|NCT00003395|Arsenic Trioxide|arsenic trioxide|mesh-list
102614176|NCT00003395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101657935|NCT02822586|Immunotoxins|immunotoxins|mesh-ancestor
102270305|NCT04508725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270306|NCT04508725|Growth Substances|growth substances|mesh-ancestor
102270307|NCT04508725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270308|NCT04508725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102270309|NCT04508725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102270310|NCT04504318|Enoxaparin|enoxaparin|mesh-list
102270311|NCT04504318|Apixaban|apixaban|mesh-list
102270312|NCT04504318|Anticoagulants|anticoagulants|mesh-ancestor
102270313|NCT04504318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102270314|NCT04504318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102270315|NCT04504318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270316|NCT04504318|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102270317|NCT04504318|Antithrombins|antithrombins|mesh-ancestor
102270318|NCT04504318|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102270319|NCT04504318|Protease Inhibitors|protease inhibitors|mesh-ancestor
102270320|NCT04504318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102270321|NCT04468061|Pembrolizumab|pembrolizumab|mesh-list
102270322|NCT04468061|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
101658069|NCT00849745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270323|NCT04468061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102270324|NCT04468061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270325|NCT04468061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102270326|NCT04468061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270327|NCT04468061|Immunoconjugates|immunoconjugates|mesh-ancestor
102270328|NCT04468061|Immunologic Factors|immunologic factors|mesh-ancestor
102270329|NCT04468061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270330|NCT04458831|Dexamethasone|dexamethasone|mesh-list
102270331|NCT04458831|Pomalidomide|pomalidomide|mesh-list
102270332|NCT04458831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102270333|NCT04458831|Antiemetics|antiemetics|mesh-ancestor
102270334|NCT04458831|Autonomic Agents|autonomic agents|mesh-ancestor
101658134|NCT05659368|Incretins|incretins|mesh-ancestor
102270335|NCT04458831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102270336|NCT04458831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270337|NCT04458831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102270338|NCT04458831|Glucocorticoids|glucocorticoids|mesh-ancestor
102270339|NCT04458831|Hormones|hormones|mesh-ancestor
102270340|NCT04458831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102270341|NCT04458831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102270342|NCT04458831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270343|NCT04458831|Immunologic Factors|immunologic factors|mesh-ancestor
102270344|NCT04458831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102270345|NCT04458831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102270346|NCT04458831|Growth Substances|growth substances|mesh-ancestor
102270347|NCT04458831|Growth Inhibitors|growth inhibitors|mesh-ancestor
102270348|NCT04417517|Azacitidine|azacitidine|mesh-list
102270349|NCT04417517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102270350|NCT04417517|Antimetabolites|antimetabolites|mesh-ancestor
102270351|NCT04417517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270352|NCT04417517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270354|NCT04417257|Fenretinide|fenretinide|mesh-list
102270355|NCT04417257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614177|NCT00003401|Dexamethasone|dexamethasone|mesh-list
102270356|NCT04417257|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102270357|NCT04417257|Protective Agents|protective agents|mesh-ancestor
102614178|NCT00003401|Paclitaxel|paclitaxel|mesh-list
102614179|NCT00003401|Etoposide|etoposide|mesh-list
102614180|NCT00003401|Cyclophosphamide|cyclophosphamide|mesh-list
102270358|NCT04417257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270359|NCT04402073|Vincristine|vincristine|mesh-list
102270360|NCT04402073|Lomustine|lomustine|mesh-list
102270361|NCT04402073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101658264|NCT03372941|Dalbavancin|dalbavancin|mesh-list
102270362|NCT04402073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102270363|NCT04402073|Tubulin Modulators|tubulin modulators|mesh-ancestor
102270364|NCT04402073|Antimitotic Agents|antimitotic agents|mesh-ancestor
102270365|NCT04402073|Mitosis Modulators|mitosis modulators|mesh-ancestor
102270366|NCT04402073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270367|NCT04402073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102270368|NCT04402073|Alkylating Agents|alkylating agents|mesh-ancestor
102270369|NCT04337177|Temozolomide|temozolomide|mesh-list
101658317|NCT02819544|Anesthetics|anesthetics|mesh-ancestor
102270370|NCT04337177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102270371|NCT04337177|Alkylating Agents|alkylating agents|mesh-ancestor
102270372|NCT04337177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270373|NCT04337177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270374|NCT04205968|Calcium, Dietary|calcium, dietary|mesh-list
102270375|NCT04205968|Leucovorin|leucovorin|mesh-list
102270376|NCT04205968|Folic Acid|folic acid|mesh-list
102270377|NCT04205968|Paclitaxel|paclitaxel|mesh-list
102270378|NCT04205968|Camptothecin|camptothecin|mesh-list
102270379|NCT04205968|Fluorouracil|fluorouracil|mesh-list
102270380|NCT04205968|Irinotecan|irinotecan|mesh-list
101658382|NCT00619957|Risedronic Acid|risedronic acid|mesh-list
102270381|NCT04205968|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102270382|NCT04205968|Ramucirumab|ramucirumab|mesh-list
102270383|NCT04205968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102270384|NCT04205968|Antibodies|antibodies|mesh-list
102270385|NCT04205968|Immunoglobulins|immunoglobulins|mesh-list
102270386|NCT04205968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102270387|NCT04205968|Lexatumumab|lexatumumab|mesh-list
102270388|NCT04205968|Calcium|calcium|mesh-list
102270389|NCT04205968|Levoleucovorin|levoleucovorin|mesh-list
102270390|NCT04205968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102270391|NCT04205968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270392|NCT04205968|Tubulin Modulators|tubulin modulators|mesh-ancestor
102270393|NCT04205968|Antimitotic Agents|antimitotic agents|mesh-ancestor
102270394|NCT04205968|Mitosis Modulators|mitosis modulators|mesh-ancestor
102270395|NCT04205968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270396|NCT04205968|Immunologic Factors|immunologic factors|mesh-ancestor
102270397|NCT04205968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270398|NCT04205968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102270399|NCT04205968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102270400|NCT04205968|Antimetabolites|antimetabolites|mesh-ancestor
102270401|NCT04205968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102270402|NCT04205968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102270403|NCT04205968|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101658517|NCT02810886|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102270404|NCT04205968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102270405|NCT04205968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102270406|NCT04205968|Antidotes|antidotes|mesh-ancestor
102270407|NCT04205968|Protective Agents|protective agents|mesh-ancestor
102270408|NCT04205968|Vitamin B Complex|vitamin b complex|mesh-ancestor
102270409|NCT04205968|Vitamins|vitamins|mesh-ancestor
102270410|NCT04205968|Micronutrients|micronutrients|mesh-ancestor
102270411|NCT04205968|Hematinics|hematinics|mesh-ancestor
102270412|NCT04204941|Doxorubicin|doxorubicin|mesh-list
102270413|NCT04204941|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102270414|NCT04204941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102270415|NCT04204941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270416|NCT04204941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102270417|NCT04204941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102270418|NCT04204941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102270419|NCT04204941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270420|NCT04180215|Pembrolizumab|pembrolizumab|mesh-list
102270421|NCT04180215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102270422|NCT04180215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270423|NCT04180215|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101658581|NCT00852163|Antimetabolites|antimetabolites|mesh-ancestor
102270424|NCT04180215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270425|NCT04179864|Prednisone|prednisone|mesh-list
102270426|NCT04179864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102270427|NCT04179864|Glucocorticoids|glucocorticoids|mesh-ancestor
102614181|NCT00003401|Gemcitabine|gemcitabine|mesh-list
102614182|NCT00003401|Melphalan|melphalan|mesh-list
102614183|NCT00003401|Carmustine|carmustine|mesh-list
102270428|NCT04179864|Hormones|hormones|mesh-ancestor
102270429|NCT04179864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102270430|NCT04179864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614184|NCT00003401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102270431|NCT04179864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102270432|NCT04179864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270433|NCT04164199|Capecitabine|capecitabine|mesh-list
102270434|NCT04164199|Pemetrexed|pemetrexed|mesh-list
102270435|NCT04164199|Temozolomide|temozolomide|mesh-list
102270436|NCT04164199|Tislelizumab|tislelizumab|mesh-list
102270437|NCT04164199|Pamiparib|pamiparib|mesh-list
102270438|NCT04164199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102270439|NCT04164199|Antimetabolites|antimetabolites|mesh-ancestor
102270440|NCT04164199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270441|NCT04164199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270442|NCT04164199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102270443|NCT04164199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102270444|NCT04164199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102270445|NCT04164199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102270446|NCT04164199|Alkylating Agents|alkylating agents|mesh-ancestor
102270447|NCT04164199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102270448|NCT04164199|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102270449|NCT04146922|Anti-Infective Agents|anti-infective agents|mesh-list
102270450|NCT04146922|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102270451|NCT04143061|Vaccines|vaccines|mesh-list
102270452|NCT04143061|Immunologic Factors|immunologic factors|mesh-ancestor
101658759|NCT00861367|Antipyretics|antipyretics|mesh-ancestor
102270453|NCT04143061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270454|NCT04141020|Sirolimus|sirolimus|mesh-list
102270455|NCT04141020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102270456|NCT04141020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102270457|NCT04141020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102270458|NCT04141020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270459|NCT04141020|Antifungal Agents|antifungal agents|mesh-ancestor
102270460|NCT04141020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102270461|NCT04141020|Immunologic Factors|immunologic factors|mesh-ancestor
102270462|NCT04141020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270463|NCT04083235|Leucovorin|leucovorin|mesh-list
102270464|NCT04083235|Paclitaxel|paclitaxel|mesh-list
102270465|NCT04083235|Gemcitabine|gemcitabine|mesh-list
102270466|NCT04083235|Fluorouracil|fluorouracil|mesh-list
102270467|NCT04083235|Oxaliplatin|oxaliplatin|mesh-list
102270468|NCT04083235|Irinotecan|irinotecan|mesh-list
102270469|NCT04083235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102270470|NCT04083235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270471|NCT04083235|Tubulin Modulators|tubulin modulators|mesh-ancestor
102270472|NCT04083235|Antimitotic Agents|antimitotic agents|mesh-ancestor
102270473|NCT04083235|Mitosis Modulators|mitosis modulators|mesh-ancestor
102270474|NCT04083235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270475|NCT04083235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101658886|NCT02807610|Propofol|propofol|mesh-list
102270476|NCT04083235|Antimetabolites|antimetabolites|mesh-ancestor
102270477|NCT04083235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102270478|NCT04083235|Immunologic Factors|immunologic factors|mesh-ancestor
102270479|NCT04083235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270480|NCT04083235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102270481|NCT04083235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102270482|NCT04083235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102270483|NCT04083235|Antidotes|antidotes|mesh-ancestor
102270484|NCT04083235|Protective Agents|protective agents|mesh-ancestor
102270485|NCT04083235|Vitamin B Complex|vitamin b complex|mesh-ancestor
102270486|NCT04083235|Vitamins|vitamins|mesh-ancestor
102270487|NCT04083235|Micronutrients|micronutrients|mesh-ancestor
102270488|NCT04071457|Lenalidomide|lenalidomide|mesh-list
102270489|NCT04071457|Daratumumab|daratumumab|mesh-list
102270490|NCT04071457|Immunologic Factors|immunologic factors|mesh-ancestor
102270491|NCT04071457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270492|NCT04071457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102270493|NCT04071457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102270494|NCT04071457|Growth Substances|growth substances|mesh-ancestor
102270495|NCT04071457|Growth Inhibitors|growth inhibitors|mesh-ancestor
101659024|NCT02610933|Vitamin K|vitamin k|mesh-list
102270496|NCT04071457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270497|NCT04060719|Rifampin|rifampin|mesh-list
102270498|NCT04060719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102270499|NCT04060719|Antitubercular Agents|antitubercular agents|mesh-ancestor
102614185|NCT00003401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614186|NCT00003401|Tubulin Modulators|tubulin modulators|mesh-ancestor
102614187|NCT00003401|Antimitotic Agents|antimitotic agents|mesh-ancestor
102614188|NCT00003401|Mitosis Modulators|mitosis modulators|mesh-ancestor
102614189|NCT00003401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614190|NCT00003401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102614191|NCT00003401|Immunologic Factors|immunologic factors|mesh-ancestor
102614192|NCT00003401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614193|NCT00003401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102270500|NCT04060719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102270501|NCT04060719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102270502|NCT04060719|Leprostatic Agents|leprostatic agents|mesh-ancestor
102270503|NCT04060719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102270504|NCT04060719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101979316|NCT03491410|Aspirin|aspirin|mesh-list
102270505|NCT04060719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270506|NCT04060719|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102270507|NCT04060719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102270508|NCT04060719|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102270509|NCT04060719|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102270510|NCT04060719|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102270511|NCT04060719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102270512|NCT04047862|Paclitaxel|paclitaxel|mesh-list
102270513|NCT04047862|Etoposide|etoposide|mesh-list
102270514|NCT04047862|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102270515|NCT04047862|Carboplatin|carboplatin|mesh-list
102270516|NCT04047862|Fluorouracil|fluorouracil|mesh-list
102270517|NCT04047862|Capecitabine|capecitabine|mesh-list
102270518|NCT04047862|Oxaliplatin|oxaliplatin|mesh-list
102270519|NCT04047862|Pemetrexed|pemetrexed|mesh-list
102270520|NCT04047862|Tislelizumab|tislelizumab|mesh-list
102270521|NCT04047862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102270522|NCT04047862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270523|NCT04047862|Tubulin Modulators|tubulin modulators|mesh-ancestor
102270524|NCT04047862|Antimitotic Agents|antimitotic agents|mesh-ancestor
102270525|NCT04047862|Mitosis Modulators|mitosis modulators|mesh-ancestor
102270526|NCT04047862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270527|NCT04047862|Antimetabolites|antimetabolites|mesh-ancestor
102270528|NCT04047862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102270529|NCT04047862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102270530|NCT04047862|Immunologic Factors|immunologic factors|mesh-ancestor
102270531|NCT04047862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270532|NCT04047862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102270533|NCT04047862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102270534|NCT04047862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102270535|NCT04047862|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102270536|NCT04047862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102270537|NCT04047862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102270538|NCT04039204|Contraceptive Agents|contraceptive agents|mesh-list
102270539|NCT04039204|Contraceptives, Oral|contraceptives, oral|mesh-list
102270540|NCT04039204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102270541|NCT04039204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270542|NCT04039204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102270543|NCT03877406|Empagliflozin|empagliflozin|mesh-list
102270544|NCT03877406|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102270545|NCT03877406|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102270546|NCT03877406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270547|NCT03877406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270548|NCT03826628|Sirolimus|sirolimus|mesh-list
102270549|NCT03826628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102270550|NCT03826628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102270551|NCT03826628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102270552|NCT03826628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270553|NCT03826628|Antifungal Agents|antifungal agents|mesh-ancestor
102270554|NCT03826628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102270555|NCT03826628|Immunologic Factors|immunologic factors|mesh-ancestor
102270556|NCT03826628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270557|NCT03765918|Cisplatin|cisplatin|mesh-list
102270558|NCT03765918|Pembrolizumab|pembrolizumab|mesh-list
102270559|NCT03765918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270560|NCT03765918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102270561|NCT03765918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102270562|NCT03765918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270563|NCT03746106|Thiamine|thiamine|mesh-list
102270564|NCT03746106|Metformin|metformin|mesh-list
102270565|NCT03746106|Trimethoprim|trimethoprim|mesh-list
102270566|NCT03746106|Vitamins|vitamins|mesh-ancestor
102270567|NCT03746106|Micronutrients|micronutrients|mesh-ancestor
102270568|NCT03746106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270569|NCT03746106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102270570|NCT03746106|Vitamin B Complex|vitamin b complex|mesh-ancestor
102270571|NCT03746106|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102270572|NCT03746106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102270573|NCT03746106|Antimalarials|antimalarials|mesh-ancestor
102270575|NCT03746106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102270576|NCT03746106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102270577|NCT03746106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101659464|NCT05979948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659465|NCT05979948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101659466|NCT05979948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101659467|NCT05979909|Mitomycins|mitomycins|mesh-list
102270578|NCT03746106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270579|NCT03746106|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102270580|NCT03746106|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102270581|NCT03746106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102270582|NCT03737461|Lidocaine|lidocaine|mesh-list
102270583|NCT03737461|Anesthetics, Local|anesthetics, local|mesh-ancestor
102270584|NCT03737461|Anesthetics|anesthetics|mesh-ancestor
102270585|NCT03737461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102270586|NCT03737461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270587|NCT03737461|Sensory System Agents|sensory system agents|mesh-ancestor
102270588|NCT03737461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102270589|NCT03737461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102270590|NCT03737461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102270591|NCT03737461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102270592|NCT03737461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102270593|NCT03737461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270594|NCT03722173|Itraconazole|itraconazole|mesh-list
102270595|NCT03722173|Antifungal Agents|antifungal agents|mesh-ancestor
102270596|NCT03722173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102270597|NCT03722173|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102270598|NCT03722173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102270599|NCT03722173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101659590|NCT05978687|Anesthetics, Local|anesthetics, local|mesh-ancestor
102270600|NCT03722173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270601|NCT03722173|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102270602|NCT03722173|Hormone Antagonists|hormone antagonists|mesh-ancestor
102270603|NCT03722173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102270604|NCT03722173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270605|NCT03722173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102270606|NCT03717194|Ertugliflozin|ertugliflozin|mesh-list
102270607|NCT03717194|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102270608|NCT03717194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270609|NCT03717194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102270610|NCT03717194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270611|NCT03695380|Atezolizumab|atezolizumab|mesh-list
102270612|NCT03695380|Niraparib|niraparib|mesh-list
102270613|NCT03695380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102270614|NCT03695380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270615|NCT03695380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102270616|NCT03695380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270617|NCT03695380|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102270618|NCT03695380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102270619|NCT03691610|Vaccines|vaccines|mesh-list
102270620|NCT03691610|Immunologic Factors|immunologic factors|mesh-ancestor
102270621|NCT03691610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270622|NCT03678025|Prednisone|prednisone|mesh-list
102270623|NCT03678025|Cortisone|cortisone|mesh-list
102270624|NCT03678025|Docetaxel|docetaxel|mesh-list
102270625|NCT03678025|Leuprolide|leuprolide|mesh-list
102270626|NCT03678025|Goserelin|goserelin|mesh-list
102270627|NCT03678025|Bicalutamide|bicalutamide|mesh-list
102270628|NCT03678025|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102270629|NCT03678025|Flutamide|flutamide|mesh-list
102270630|NCT03678025|Nilutamide|nilutamide|mesh-list
102270631|NCT03678025|Tryptophan|tryptophan|mesh-list
102270632|NCT03678025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270633|NCT03678025|Tubulin Modulators|tubulin modulators|mesh-ancestor
102270634|NCT03678025|Antimitotic Agents|antimitotic agents|mesh-ancestor
102270635|NCT03678025|Mitosis Modulators|mitosis modulators|mesh-ancestor
102270636|NCT03678025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270637|NCT03678025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102270638|NCT03678025|Glucocorticoids|glucocorticoids|mesh-ancestor
102270639|NCT03678025|Hormones|hormones|mesh-ancestor
102270640|NCT03678025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102270641|NCT03678025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270642|NCT03678025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102270643|NCT03678025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102270644|NCT03678025|Fertility Agents|fertility agents|mesh-ancestor
102270645|NCT03678025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102270646|NCT03678025|Androgen Antagonists|androgen antagonists|mesh-ancestor
102270652|NCT03678025|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102270653|NCT03678025|Antidepressive Agents|antidepressive agents|mesh-ancestor
102270654|NCT03678025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102270655|NCT03644485|Mycophenolic Acid|mycophenolic acid|mesh-list
102270657|NCT03644485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102270658|NCT03644485|Immunologic Factors|immunologic factors|mesh-ancestor
102270659|NCT03644485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270660|NCT03644485|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102270661|NCT03644485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102270662|NCT03644485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270663|NCT03644485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102270664|NCT03644485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270665|NCT03644485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102270666|NCT03644485|Antitubercular Agents|antitubercular agents|mesh-ancestor
102270667|NCT03644485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102270668|NCT03644485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102270669|NCT03636256|Docetaxel|docetaxel|mesh-list
102270670|NCT03636256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270671|NCT03636256|Tubulin Modulators|tubulin modulators|mesh-ancestor
102270672|NCT03636256|Antimitotic Agents|antimitotic agents|mesh-ancestor
102270673|NCT03636256|Mitosis Modulators|mitosis modulators|mesh-ancestor
102270674|NCT03636256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270675|NCT03600701|Atezolizumab|atezolizumab|mesh-list
102270676|NCT03600701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102270677|NCT03600701|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102270678|NCT03600701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270679|NCT03600701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102270680|NCT03600701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270681|NCT03600701|Immunologic Factors|immunologic factors|mesh-ancestor
102270682|NCT03600701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270683|NCT03555149|Bevacizumab|bevacizumab|mesh-list
102270684|NCT03555149|Atezolizumab|atezolizumab|mesh-list
102270685|NCT03555149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102270686|NCT03555149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270687|NCT03555149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102270688|NCT03555149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102270689|NCT03555149|Growth Substances|growth substances|mesh-ancestor
102270690|NCT03555149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270691|NCT03555149|Growth Inhibitors|growth inhibitors|mesh-ancestor
102270692|NCT03555149|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102270693|NCT03555149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659953|NCT05782270|Warfarin|warfarin|mesh-list
102270694|NCT03493945|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
102270695|NCT03493945|Antiviral Agents|antiviral agents|mesh-ancestor
102270696|NCT03493945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102270703|NCT03451331|Carboplatin|carboplatin|mesh-list
102270704|NCT03451331|Gemcitabine|gemcitabine|mesh-list
102270705|NCT03451331|Oxaliplatin|oxaliplatin|mesh-list
102270706|NCT03451331|Nivolumab|nivolumab|mesh-list
102270707|NCT03451331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270708|NCT03451331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102270709|NCT03451331|Antimetabolites|antimetabolites|mesh-ancestor
102270710|NCT03451331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270711|NCT03451331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102270712|NCT03451331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102270713|NCT03418961|Carvedilol|carvedilol|mesh-list
102270714|NCT03418961|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102270715|NCT03418961|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102270716|NCT03418961|Adrenergic Agents|adrenergic agents|mesh-ancestor
102270717|NCT03418961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101612517|NCT02853864|Analgesics|analgesics|mesh-ancestor
102270718|NCT03418961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660018|NCT05631236|Sympathomimetics|sympathomimetics|mesh-ancestor
101660019|NCT05631236|Autonomic Agents|autonomic agents|mesh-ancestor
101660020|NCT05631236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101660021|NCT05631236|Dopamine Agents|dopamine agents|mesh-ancestor
101660022|NCT05631236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101660023|NCT05631236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660024|NCT05631236|Adrenergic Agents|adrenergic agents|mesh-ancestor
101660025|NCT05631236|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101660026|NCT05631236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101660027|NCT05631236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102270719|NCT03418961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270720|NCT03418961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102270721|NCT03418961|Antioxidants|antioxidants|mesh-ancestor
102270722|NCT03418961|Protective Agents|protective agents|mesh-ancestor
102270723|NCT03418961|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102270724|NCT03418961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102270725|NCT03418961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102270726|NCT03418961|Vasodilator Agents|vasodilator agents|mesh-ancestor
102270727|NCT03418961|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102270728|NCT03418961|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102270729|NCT03388632|Nivolumab|nivolumab|mesh-list
102270730|NCT03388632|Ipilimumab|ipilimumab|mesh-list
102270731|NCT03388632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102270732|NCT03388632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270733|NCT03388632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102270734|NCT03388632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270735|NCT03386357|Pembrolizumab|pembrolizumab|mesh-list
102270736|NCT03386357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102270737|NCT03386357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270738|NCT03386357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102270739|NCT03386357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270740|NCT03294460|Ethanol|ethanol|mesh-list
101660155|NCT05485805|Naproxen|naproxen|mesh-list
102270741|NCT03294460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102270742|NCT03294460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102270743|NCT03294460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102270744|NCT03294460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270745|NCT03293784|Infliximab|infliximab|mesh-list
102270746|NCT03293784|Certolizumab Pegol|certolizumab pegol|mesh-list
102270747|NCT03293784|Nivolumab|nivolumab|mesh-list
102270748|NCT03293784|Ipilimumab|ipilimumab|mesh-list
102270749|NCT03293784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102270750|NCT03293784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270751|NCT03293784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102270752|NCT03293784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270753|NCT03293784|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102270754|NCT03293784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102270755|NCT03293784|Dermatologic Agents|dermatologic agents|mesh-ancestor
102270756|NCT03293784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102270757|NCT03293784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102270758|NCT03293784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102270759|NCT03293784|Immunologic Factors|immunologic factors|mesh-ancestor
102270760|NCT03293784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270761|NCT03109288|Pioglitazone|pioglitazone|mesh-list
102270762|NCT03109288|Clemastine|clemastine|mesh-list
102270763|NCT03109288|Pirfenidone|pirfenidone|mesh-list
102270764|NCT03109288|Dantrolene|dantrolene|mesh-list
102270765|NCT03109288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102270766|NCT03109288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270767|NCT03109288|Analgesics|analgesics|mesh-ancestor
102270768|NCT03109288|Sensory System Agents|sensory system agents|mesh-ancestor
102270769|NCT03109288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102270770|NCT03109288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102270771|NCT03109288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102270772|NCT03109288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102270773|NCT03109288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102270774|NCT03109288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270775|NCT03109288|Antipruritics|antipruritics|mesh-ancestor
102270776|NCT03109288|Dermatologic Agents|dermatologic agents|mesh-ancestor
102270777|NCT03109288|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102270778|NCT03109288|Histamine Antagonists|histamine antagonists|mesh-ancestor
102270779|NCT03109288|Histamine Agents|histamine agents|mesh-ancestor
102270780|NCT03109288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102270781|NCT03109288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660346|NCT05135910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101660347|NCT05135910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660348|NCT05105035|Meropenem|meropenem|mesh-list
101660349|NCT05105035|Ceftazidime|ceftazidime|mesh-list
101660350|NCT05105035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101660351|NCT05105035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101660361|NCT05074121|Acetylcysteine|acetylcysteine|mesh-list
101660362|NCT05074121|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101660363|NCT05074121|Antiviral Agents|antiviral agents|mesh-ancestor
101660365|NCT05074121|Expectorants|expectorants|mesh-ancestor
102270782|NCT03109288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102270783|NCT03109288|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102270784|NCT03109288|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102270785|NCT03013218|Paclitaxel|paclitaxel|mesh-list
102270786|NCT03013218|Rituximab|rituximab|mesh-list
102270787|NCT03013218|Pembrolizumab|pembrolizumab|mesh-list
102270788|NCT03013218|Trastuzumab|trastuzumab|mesh-list
102270789|NCT03013218|Ramucirumab|ramucirumab|mesh-list
102270790|NCT03013218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102270791|NCT03013218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270792|NCT03013218|Tubulin Modulators|tubulin modulators|mesh-ancestor
102270793|NCT03013218|Antimitotic Agents|antimitotic agents|mesh-ancestor
102614195|NCT00003401|Alkylating Agents|alkylating agents|mesh-ancestor
102270794|NCT03013218|Mitosis Modulators|mitosis modulators|mesh-ancestor
102270795|NCT03013218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270796|NCT03013218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102270797|NCT03013218|Immunologic Factors|immunologic factors|mesh-ancestor
102270798|NCT03013218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270799|NCT03013218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101660523|NCT04691986|Niacin|niacin|mesh-list
102270800|NCT03013218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102270801|NCT03006068|Upadacitinib|upadacitinib|mesh-list
102270802|NCT03006068|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102270803|NCT03006068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102270804|NCT03006068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102270805|NCT03006068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270806|NCT03006068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102270807|NCT02996487|Vancomycin|vancomycin|mesh-list
102270808|NCT02996487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102270809|NCT02996487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102270810|NCT02980276|Metformin|metformin|mesh-list
102270811|NCT02980276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101660550|NCT04644029|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101660551|NCT04644029|Islatravir|islatravir|mesh-list
101660552|NCT04644029|Antiviral Agents|antiviral agents|mesh-ancestor
102270812|NCT02980276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270813|NCT02940496|Ribavirin|ribavirin|mesh-list
102270814|NCT02940496|Grazoprevir|grazoprevir|mesh-list
102270815|NCT02940496|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
102270816|NCT02940496|Pembrolizumab|pembrolizumab|mesh-list
102270817|NCT02940496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102270818|NCT02940496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270819|NCT02940496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102270820|NCT02940496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270821|NCT02940496|Antimetabolites|antimetabolites|mesh-ancestor
102270822|NCT02940496|Antiviral Agents|antiviral agents|mesh-ancestor
102270823|NCT02940496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102270824|NCT02937818|Carboplatin|carboplatin|mesh-list
102270825|NCT02937818|Durvalumab|durvalumab|mesh-list
102270826|NCT02937818|Olaparib|olaparib|mesh-list
102270827|NCT02937818|Tremelimumab|tremelimumab|mesh-list
102270828|NCT02937818|Adavosertib|adavosertib|mesh-list
102270829|NCT02937818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270830|NCT02937818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102270831|NCT02937818|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102270832|NCT02937818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102270833|NCT02937818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270834|NCT02933255|Nivolumab|nivolumab|mesh-list
102270835|NCT02933255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102270836|NCT02933255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270837|NCT02933255|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102270838|NCT02933255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270839|NCT02752035|Azacitidine|azacitidine|mesh-list
102270840|NCT02752035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102270841|NCT02752035|Antimetabolites|antimetabolites|mesh-ancestor
102270842|NCT02752035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270843|NCT02752035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270844|NCT02752035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102270845|NCT02614794|Capecitabine|capecitabine|mesh-list
102270846|NCT02614794|Trastuzumab|trastuzumab|mesh-list
102270847|NCT02614794|Tucatinib|tucatinib|mesh-list
102270848|NCT02614794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102270849|NCT02614794|Antimetabolites|antimetabolites|mesh-ancestor
102270850|NCT02614794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270851|NCT02614794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660775|NCT04158258|Capecitabine|capecitabine|mesh-list
102270852|NCT02614794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102270853|NCT02614794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102270854|NCT02614794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102270855|NCT02495896|Paclitaxel|paclitaxel|mesh-list
102270856|NCT02495896|Docetaxel|docetaxel|mesh-list
102270857|NCT02495896|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102270858|NCT02495896|Cisplatin|cisplatin|mesh-list
102270859|NCT02495896|Gemcitabine|gemcitabine|mesh-list
102270860|NCT02495896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102270861|NCT02495896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270862|NCT02495896|Tubulin Modulators|tubulin modulators|mesh-ancestor
102270863|NCT02495896|Antimitotic Agents|antimitotic agents|mesh-ancestor
102270864|NCT02495896|Mitosis Modulators|mitosis modulators|mesh-ancestor
102270865|NCT02495896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270866|NCT02495896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102270867|NCT02495896|Antimetabolites|antimetabolites|mesh-ancestor
102270868|NCT02125968|Oxymetazoline|oxymetazoline|mesh-list
102270869|NCT02125968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102270870|NCT02125968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102270871|NCT02125968|Adrenergic Agents|adrenergic agents|mesh-ancestor
102270872|NCT02125968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102270873|NCT02125968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270874|NCT02125968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270875|NCT02125968|Sympathomimetics|sympathomimetics|mesh-ancestor
102270876|NCT02125968|Autonomic Agents|autonomic agents|mesh-ancestor
102270877|NCT02125968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102270878|NCT02125968|Nasal Decongestants|nasal decongestants|mesh-ancestor
102270879|NCT02125968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102270880|NCT02125968|Respiratory System Agents|respiratory system agents|mesh-ancestor
102270881|NCT01782443|Aflibercept|aflibercept|mesh-list
102270882|NCT01782443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102270883|NCT01782443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102270884|NCT01782443|Growth Substances|growth substances|mesh-ancestor
102270885|NCT01782443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270886|NCT01782443|Growth Inhibitors|growth inhibitors|mesh-ancestor
102270887|NCT01782443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270888|NCT01712815|Clevudine|clevudine|mesh-list
102270889|NCT01712815|Antiviral Agents|antiviral agents|mesh-ancestor
102270890|NCT01712815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102270891|NCT01555632|Atorvastatin|atorvastatin|mesh-list
102270892|NCT01555632|Calcium|calcium|mesh-list
102270893|NCT01555632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102270894|NCT01555632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270895|NCT01555632|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102270896|NCT01555632|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102270897|NCT01555632|Antimetabolites|antimetabolites|mesh-ancestor
102270898|NCT01555632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270899|NCT01555632|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102270900|NCT01555632|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102270901|NCT01555632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102270902|NCT01274026|Verapamil|verapamil|mesh-list
102270903|NCT01274026|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102270904|NCT01274026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102270905|NCT01274026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102270906|NCT01274026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270907|NCT01274026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102270908|NCT01274026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270909|NCT01274026|Vasodilator Agents|vasodilator agents|mesh-ancestor
102270910|NCT01186029|Aprepitant|aprepitant|mesh-list
102270911|NCT01186029|Antiemetics|antiemetics|mesh-ancestor
102270912|NCT01186029|Autonomic Agents|autonomic agents|mesh-ancestor
102270913|NCT01186029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102270914|NCT01186029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270915|NCT01186029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102270916|NCT01186029|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102270917|NCT01186029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102270918|NCT01186029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660940|NCT03653832|Sympatholytics|sympatholytics|mesh-ancestor
101660941|NCT03653832|Autonomic Agents|autonomic agents|mesh-ancestor
101660942|NCT03599245|Ocrelizumab|ocrelizumab|mesh-list
101660945|NCT03565991|Avelumab|avelumab|mesh-list
102270919|NCT00955968|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102270920|NCT00955968|Antiviral Agents|antiviral agents|mesh-ancestor
102270921|NCT00955968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102270922|NCT00903110|Mecasermin|mecasermin|mesh-list
102270923|NCT00903110|Growth Substances|growth substances|mesh-ancestor
102270924|NCT00903110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270925|NCT00896012|Sirolimus|sirolimus|mesh-list
102270926|NCT00896012|Tacrolimus|tacrolimus|mesh-list
102270927|NCT00896012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102270928|NCT00896012|Immunologic Factors|immunologic factors|mesh-ancestor
102270929|NCT00896012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270930|NCT00896012|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102270931|NCT00896012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101660993|NCT03492437|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101660994|NCT03492437|Protease Inhibitors|protease inhibitors|mesh-ancestor
101660995|NCT03492437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101660996|NCT03492437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660997|NCT03492437|Anticoagulants|anticoagulants|mesh-ancestor
101660998|NCT03492437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660999|NCT03473756|Atezolizumab|atezolizumab|mesh-list
102270932|NCT00896012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270933|NCT00896012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102270934|NCT00896012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102270935|NCT00896012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102270936|NCT00896012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270937|NCT00896012|Antifungal Agents|antifungal agents|mesh-ancestor
102270938|NCT00876226|Citalopram|citalopram|mesh-list
102270939|NCT00876226|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102270940|NCT00876226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102270941|NCT00876226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102614196|NCT00003401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102614197|NCT00003401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102270942|NCT00876226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270943|NCT00876226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102270944|NCT00876226|Serotonin Agents|serotonin agents|mesh-ancestor
102270945|NCT00876226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270946|NCT00876226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102270947|NCT00876226|Antidepressive Agents|antidepressive agents|mesh-ancestor
102270948|NCT00876226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102270949|NCT00816413|Cyclosporine|cyclosporine|mesh-list
102270950|NCT00816413|Mycophenolic Acid|mycophenolic acid|mesh-list
101661056|NCT03193853|Paclitaxel|paclitaxel|mesh-list
102270951|NCT00816413|Pentostatin|pentostatin|mesh-list
102270952|NCT00816413|Cyclosporins|cyclosporins|mesh-list
102270953|NCT00816413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102270954|NCT00816413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270955|NCT00816413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102270956|NCT00816413|Immunologic Factors|immunologic factors|mesh-ancestor
102270957|NCT00816413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270958|NCT00816413|Antifungal Agents|antifungal agents|mesh-ancestor
102270959|NCT00816413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102270960|NCT00816413|Dermatologic Agents|dermatologic agents|mesh-ancestor
102270961|NCT00816413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102270962|NCT00816413|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102270963|NCT00816413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102270964|NCT00816413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270965|NCT00816413|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101661106|NCT03005366|Flecainide|flecainide|mesh-list
102270966|NCT00816413|Antitubercular Agents|antitubercular agents|mesh-ancestor
102270967|NCT00816413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102270968|NCT00816413|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
102270970|NCT00254384|Docetaxel|docetaxel|mesh-list
102270971|NCT00254384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102270972|NCT00254384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102270973|NCT00254384|Tubulin Modulators|tubulin modulators|mesh-ancestor
102270974|NCT00254384|Antimitotic Agents|antimitotic agents|mesh-ancestor
102270975|NCT00254384|Mitosis Modulators|mitosis modulators|mesh-ancestor
102270976|NCT00254384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270977|NCT00254384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102270978|NCT00254384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102270979|NCT05917067|Parathyroid Hormone|parathyroid hormone|mesh-list
102270980|NCT05917067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102270981|NCT05917067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270982|NCT05916963|Furosemide|furosemide|mesh-list
102270983|NCT05916963|Diuretics|diuretics|mesh-ancestor
102270984|NCT05916963|Natriuretic Agents|natriuretic agents|mesh-ancestor
102270985|NCT05916963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270986|NCT05916963|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102270987|NCT05916963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101661235|NCT01950520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270988|NCT05916963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102270989|NCT05916937|Omalizumab|omalizumab|mesh-list
102270990|NCT05916937|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102270991|NCT05916937|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102270992|NCT05916937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102270993|NCT05916937|Respiratory System Agents|respiratory system agents|mesh-ancestor
102270994|NCT05916937|Immunologic Factors|immunologic factors|mesh-ancestor
102270995|NCT05916937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102270996|NCT02342977|Lacosamide|lacosamide|mesh-list
102270997|NCT02342977|Anticonvulsants|anticonvulsants|mesh-ancestor
102270998|NCT02342977|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102270999|NCT02342977|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102271000|NCT02342977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102271001|NCT02342977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271002|NCT05916781|Mycophenolic Acid|mycophenolic acid|mesh-list
102271003|NCT05916781|Tacrolimus|tacrolimus|mesh-list
102271004|NCT05916781|Glucocorticoids|glucocorticoids|mesh-list
102271005|NCT05916781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102271006|NCT05916781|Immunologic Factors|immunologic factors|mesh-ancestor
102271007|NCT05916781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271008|NCT05916781|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102271009|NCT05916781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101661368|NCT00375609|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102271010|NCT05916781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271011|NCT05916781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102271012|NCT05916781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102271013|NCT05916781|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102614198|NCT00003401|Antiemetics|antiemetics|mesh-ancestor
102614199|NCT00003401|Autonomic Agents|autonomic agents|mesh-ancestor
102271014|NCT05916781|Antitubercular Agents|antitubercular agents|mesh-ancestor
102271015|NCT05916781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102271016|NCT05916781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102271017|NCT05916781|Hormones|hormones|mesh-ancestor
102271018|NCT05916781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102271019|NCT05916755|Cyclophosphamide|cyclophosphamide|mesh-list
102271020|NCT05916755|Carboplatin|carboplatin|mesh-list
102271021|NCT05916755|Pembrolizumab|pembrolizumab|mesh-list
102271022|NCT05916755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102271023|NCT05916755|Immunologic Factors|immunologic factors|mesh-ancestor
102271024|NCT05916755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271025|NCT05916755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102271026|NCT05916755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102271027|NCT05916755|Alkylating Agents|alkylating agents|mesh-ancestor
102271028|NCT05916755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271029|NCT05916755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102271030|NCT05916755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101661488|NCT00855049|Antipyretics|antipyretics|mesh-ancestor
102271031|NCT05916755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102271032|NCT05916755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102271033|NCT05916742|Dipyrone|dipyrone|mesh-list
102271034|NCT05916742|Amoxicillin|amoxicillin|mesh-list
102271035|NCT05916742|Chlorhexidine|chlorhexidine|mesh-list
102271036|NCT05916742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102271037|NCT05916742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102271038|NCT05916742|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102271039|NCT05916742|Disinfectants|disinfectants|mesh-ancestor
102271040|NCT05916742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102271041|NCT05916742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102271042|NCT05916742|Analgesics|analgesics|mesh-ancestor
102271043|NCT05916742|Sensory System Agents|sensory system agents|mesh-ancestor
102271044|NCT05916742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102271045|NCT05916742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271046|NCT05916742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102271047|NCT05916742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102271048|NCT05916742|Antipyretics|antipyretics|mesh-ancestor
102271049|NCT05916729|Miconazole|miconazole|mesh-list
102271050|NCT05916729|Antifungal Agents|antifungal agents|mesh-ancestor
102271051|NCT05916729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102271052|NCT05916729|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102271053|NCT05916729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102271054|NCT05916729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101661617|NCT05550636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102271055|NCT05916729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271056|NCT05916729|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102271057|NCT05916729|Hormone Antagonists|hormone antagonists|mesh-ancestor
102271058|NCT05916729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102271059|NCT05916729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271060|NCT05916729|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102271061|NCT05916729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102271062|NCT05916716|Dipyrone|dipyrone|mesh-list
102271063|NCT05916716|Amoxicillin|amoxicillin|mesh-list
102271064|NCT05916716|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102271065|NCT05916716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102271066|NCT05916716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102271067|NCT05916716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102271068|NCT05916716|Analgesics|analgesics|mesh-ancestor
102271069|NCT05916716|Sensory System Agents|sensory system agents|mesh-ancestor
102271070|NCT05916716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102271071|NCT05916716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271072|NCT05916716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102271073|NCT05916716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102271074|NCT05916716|Antipyretics|antipyretics|mesh-ancestor
102271075|NCT05916690|Bleomycin|bleomycin|mesh-list
102271076|NCT05916690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102271077|NCT05916690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102271078|NCT05916586|Prednisone|prednisone|mesh-list
102271079|NCT05916586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102271080|NCT05916586|Glucocorticoids|glucocorticoids|mesh-ancestor
102271081|NCT05916586|Hormones|hormones|mesh-ancestor
102271082|NCT05916586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102271083|NCT05916586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271084|NCT05916586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102271085|NCT05916586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102271086|NCT05916521|Fluorides|fluorides|mesh-list
102614200|NCT00003401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102614201|NCT00003401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102271087|NCT05916521|Tin Fluorides|tin fluorides|mesh-list
102271088|NCT05916521|Fluorophosphate|fluorophosphate|mesh-list
102271089|NCT05916521|Cariostatic Agents|cariostatic agents|mesh-ancestor
102271090|NCT05916521|Protective Agents|protective agents|mesh-ancestor
101661874|NCT00860899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102271091|NCT05916521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271092|NCT05916508|Fluorides|fluorides|mesh-list
102271093|NCT05916508|Tin Fluorides|tin fluorides|mesh-list
102271094|NCT05916508|Fluorophosphate|fluorophosphate|mesh-list
102271095|NCT05916508|Cariostatic Agents|cariostatic agents|mesh-ancestor
102271096|NCT05916508|Protective Agents|protective agents|mesh-ancestor
102271097|NCT05916508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271098|NCT05916469|Levonorgestrel|levonorgestrel|mesh-list
102271099|NCT05916469|Norethindrone|norethindrone|mesh-list
102271100|NCT05916469|Norethindrone Acetate|norethindrone acetate|mesh-list
102271101|NCT05916469|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102271102|NCT05916469|Contraceptive Agents|contraceptive agents|mesh-ancestor
101661939|NCT02805426|Abortifacient Agents|abortifacient agents|mesh-ancestor
102271103|NCT05916469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102271104|NCT05916469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271105|NCT05916469|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102271106|NCT05916469|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102271107|NCT05916469|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102271108|NCT05916469|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102271109|NCT05916339|Methylphenidate|methylphenidate|mesh-list
102271110|NCT05916339|Amphetamine|amphetamine|mesh-list
102271111|NCT05916339|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
102271112|NCT05916339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662008|NCT00866437|Estropipate|estropipate|mesh-list
102271113|NCT05916339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102271114|NCT05916339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102271115|NCT05916339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102271116|NCT05916339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271117|NCT05916339|Dopamine Agents|dopamine agents|mesh-ancestor
102271118|NCT05916339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102271119|NCT05916339|Sympathomimetics|sympathomimetics|mesh-ancestor
102271120|NCT05916339|Autonomic Agents|autonomic agents|mesh-ancestor
102271121|NCT05916339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102271122|NCT05916339|Adrenergic Agents|adrenergic agents|mesh-ancestor
102271123|NCT05916339|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102271124|NCT05916105|Ciprofloxacin|ciprofloxacin|mesh-list
102271125|NCT05916105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102271126|NCT05916105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102271127|NCT05916105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102271128|NCT05916105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102271129|NCT05916105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102271130|NCT05916105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271131|NCT05916105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102271132|NCT05916105|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102271133|NCT05916105|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102271134|NCT05916066|Niacinamide|niacinamide|mesh-list
102271136|NCT05916066|Nicotinic Acids|nicotinic acids|mesh-list
102271137|NCT05916066|Vitamin B Complex|vitamin b complex|mesh-ancestor
102271138|NCT05916066|Vitamins|vitamins|mesh-ancestor
102271139|NCT05916066|Micronutrients|micronutrients|mesh-ancestor
102271140|NCT05916066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662128|NCT00870571|Amlodipine|amlodipine|mesh-list
102271141|NCT05916066|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102271142|NCT05916066|Antimetabolites|antimetabolites|mesh-ancestor
102271143|NCT05916066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271144|NCT05916066|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102271145|NCT05916066|Vasodilator Agents|vasodilator agents|mesh-ancestor
102271146|NCT05915884|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102271147|NCT05915884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271148|NCT05915884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102271149|NCT05915884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271150|NCT05915871|Clarithromycin|clarithromycin|mesh-list
102271151|NCT05915871|Bismuth|bismuth|mesh-list
102271152|NCT05915871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102271153|NCT05915871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102271154|NCT05915871|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102271155|NCT05915871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102271156|NCT05915871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614202|NCT00003401|Glucocorticoids|glucocorticoids|mesh-ancestor
102271157|NCT05915871|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102271158|NCT05915871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102271159|NCT05915871|Antacids|antacids|mesh-ancestor
102271160|NCT05915871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102271161|NCT05915676|Immunoglobulins|immunoglobulins|mesh-list
102271162|NCT05915676|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102271163|NCT05915676|Antibodies|antibodies|mesh-list
102271164|NCT05915676|Immunologic Factors|immunologic factors|mesh-ancestor
102271165|NCT05915676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271166|NCT05915520|Pantoprazole|pantoprazole|mesh-list
102271167|NCT05915520|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102271168|NCT05915520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102271169|NCT05915520|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102271170|NCT05915520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101662334|NCT02794584|Dsuvia|dsuvia|mesh-list
102271171|NCT05915520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271172|NCT05915481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102271173|NCT05915481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271174|NCT05915481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102271175|NCT05915481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102271176|NCT05915286|Chlorthalidone|chlorthalidone|mesh-list
102271177|NCT05915286|Furosemide|furosemide|mesh-list
102271178|NCT05915286|Diuretics|diuretics|mesh-ancestor
102271179|NCT05915286|Natriuretic Agents|natriuretic agents|mesh-ancestor
102271180|NCT05915286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271181|NCT05915286|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102271182|NCT05915286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102271183|NCT05915286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271184|NCT05915286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102271185|NCT05915286|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102271187|NCT05915260|Analgesics|analgesics|mesh-ancestor
102271188|NCT05915260|Sensory System Agents|sensory system agents|mesh-ancestor
102271189|NCT05915260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102271190|NCT05915260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271191|NCT05915260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102271192|NCT05915260|Vasodilator Agents|vasodilator agents|mesh-ancestor
102271193|NCT05915260|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102271194|NCT05915260|Purinergic Agonists|purinergic agonists|mesh-ancestor
102271195|NCT05915260|Purinergic Agents|purinergic agents|mesh-ancestor
101662444|NCT03847506|Amlodipine|amlodipine|mesh-list
102271196|NCT05915260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102271197|NCT05915260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271198|NCT05915169|Chrysarobin|chrysarobin|mesh-list
102271199|NCT05915169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102271200|NCT05915169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102271201|NCT05915169|Analgesics|analgesics|mesh-ancestor
102271202|NCT05915169|Sensory System Agents|sensory system agents|mesh-ancestor
102271203|NCT05915169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102271204|NCT05915169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271205|NCT05915169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101662510|NCT02792946|Ambroxol|ambroxol|mesh-list
102271206|NCT05915169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102271207|NCT05915104|Budesonide|budesonide|mesh-list
102271208|NCT05915104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102271209|NCT05915104|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102271210|NCT05915104|Autonomic Agents|autonomic agents|mesh-ancestor
102271211|NCT05915104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102271212|NCT05915104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271213|NCT05915104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102271214|NCT05915104|Respiratory System Agents|respiratory system agents|mesh-ancestor
102271215|NCT05915104|Glucocorticoids|glucocorticoids|mesh-ancestor
102271216|NCT05915104|Hormones|hormones|mesh-ancestor
102271217|NCT05915104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102271218|NCT05915013|Ketamine|ketamine|mesh-list
102271219|NCT05915013|Analgesics|analgesics|mesh-ancestor
102271220|NCT05915013|Sensory System Agents|sensory system agents|mesh-ancestor
102271221|NCT05915013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102271222|NCT05915013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271223|NCT05915013|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102271224|NCT05915013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102271225|NCT05915013|Anesthetics, General|anesthetics, general|mesh-ancestor
102271226|NCT05915013|Anesthetics|anesthetics|mesh-ancestor
102271227|NCT05915013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102271228|NCT05915013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102271229|NCT05915013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102271230|NCT05915013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102271231|NCT05915013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614203|NCT00003401|Hormones|hormones|mesh-ancestor
102614204|NCT00003401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102271232|NCT05914805|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102271233|NCT05914779|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102271234|NCT05914779|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102271235|NCT05914779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102271236|NCT05914779|Antitubercular Agents|antitubercular agents|mesh-ancestor
102271237|NCT05914753|Cyclophosphamide|cyclophosphamide|mesh-list
102271238|NCT05914753|Docetaxel|docetaxel|mesh-list
102271239|NCT05914753|Epirubicin|epirubicin|mesh-list
102271240|NCT05914753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102271241|NCT05914753|Immunologic Factors|immunologic factors|mesh-ancestor
102271242|NCT05914753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271243|NCT05914753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102271244|NCT05914753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102271245|NCT05914753|Alkylating Agents|alkylating agents|mesh-ancestor
102271246|NCT05914753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271247|NCT05914753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102271248|NCT05914753|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102271249|NCT05914753|Tubulin Modulators|tubulin modulators|mesh-ancestor
102271250|NCT05914753|Antimitotic Agents|antimitotic agents|mesh-ancestor
102271251|NCT05914753|Mitosis Modulators|mitosis modulators|mesh-ancestor
102271252|NCT05914753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102271253|NCT05914753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102271254|NCT05914753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102271255|NCT05914753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102271257|NCT05914701|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102271258|NCT05914701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102271259|NCT05914701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271260|NCT05914701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102271261|NCT05914701|Antiviral Agents|antiviral agents|mesh-ancestor
102271262|NCT05914701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102271263|NCT05914675|Letermovir|letermovir|mesh-list
102271264|NCT05914675|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102271265|NCT05914675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102271266|NCT05914675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271267|NCT05914675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102271268|NCT05914675|Antiviral Agents|antiviral agents|mesh-ancestor
102271269|NCT05914675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102271270|NCT05914662|Rituximab|rituximab|mesh-list
102271271|NCT05914662|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102271272|NCT05914662|Zanubrutinib|zanubrutinib|mesh-list
102271273|NCT05914662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102271274|NCT05914662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102271275|NCT05914662|Immunologic Factors|immunologic factors|mesh-ancestor
102271276|NCT05914662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271277|NCT05914662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102271278|NCT05914662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102271279|NCT05914662|Alkylating Agents|alkylating agents|mesh-ancestor
102271280|NCT05914662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271281|NCT05914662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102271282|NCT05914662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102271283|NCT05914610|Oxaliplatin|oxaliplatin|mesh-list
102271284|NCT05914610|Tegafur|tegafur|mesh-list
102271285|NCT05914610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102271286|NCT05914610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102271287|NCT05914610|Antimetabolites|antimetabolites|mesh-ancestor
102271288|NCT05914610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271289|NCT05914545|Immunoconjugates|immunoconjugates|mesh-list
102271290|NCT05914545|Immunologic Factors|immunologic factors|mesh-ancestor
102271291|NCT05914545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271292|NCT05914454|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102271293|NCT05914454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102271294|NCT05914350|Methylprednisolone|methylprednisolone|mesh-list
102271295|NCT05914350|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102271296|NCT05914350|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102271297|NCT05914350|Prednisolone|prednisolone|mesh-list
102271298|NCT05914350|Prednisolone acetate|prednisolone acetate|mesh-list
102271299|NCT05914350|Lidocaine|lidocaine|mesh-list
102271300|NCT05914350|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102271301|NCT05914350|Prednisolone phosphate|prednisolone phosphate|mesh-list
102271302|NCT05914350|Anesthetics, Local|anesthetics, local|mesh-ancestor
102271303|NCT05914350|Anesthetics|anesthetics|mesh-ancestor
102614205|NCT00003401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102271304|NCT05914350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102614206|NCT00003401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101902613|NCT01297010|Protease Inhibitors|protease inhibitors|mesh-ancestor
102271305|NCT05914350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271306|NCT05914350|Sensory System Agents|sensory system agents|mesh-ancestor
102271307|NCT05914350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102271308|NCT05914350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102271309|NCT05914350|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102271310|NCT05914350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102271311|NCT05914350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102271312|NCT05914350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271313|NCT05914350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102271314|NCT05914350|Antiemetics|antiemetics|mesh-ancestor
102271315|NCT05914350|Autonomic Agents|autonomic agents|mesh-ancestor
102271316|NCT05914350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102271317|NCT05914350|Glucocorticoids|glucocorticoids|mesh-ancestor
102271319|NCT05914350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102271320|NCT05914350|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102271321|NCT05914350|Protective Agents|protective agents|mesh-ancestor
102271322|NCT05914350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102271323|NCT05914350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102271324|NCT05914285|Albuterol|albuterol|mesh-list
102271325|NCT05914285|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102271326|NCT05914285|Autonomic Agents|autonomic agents|mesh-ancestor
102271327|NCT05914285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102271328|NCT05914285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271329|NCT05914285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102271330|NCT05914285|Respiratory System Agents|respiratory system agents|mesh-ancestor
102271331|NCT05914285|Tocolytic Agents|tocolytic agents|mesh-ancestor
102271332|NCT05914285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102271333|NCT05914285|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102271334|NCT05914285|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102271335|NCT05914285|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102271336|NCT05914285|Adrenergic Agents|adrenergic agents|mesh-ancestor
102271337|NCT05914285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102271338|NCT05914285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271339|NCT05914194|Mazindol|mazindol|mesh-list
102271340|NCT05914194|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102271341|NCT05914194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271342|NCT05914194|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102271343|NCT05914194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102271344|NCT05914194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102271345|NCT05914194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271346|NCT05914194|Adrenergic Agents|adrenergic agents|mesh-ancestor
102271347|NCT05914194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102271348|NCT05914194|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102271349|NCT05914194|Dopamine Agents|dopamine agents|mesh-ancestor
102271350|NCT05914129|Liver Extracts|liver extracts|mesh-list
102271351|NCT05914129|Hematinics|hematinics|mesh-ancestor
102271352|NCT05914077|Secretin|secretin|mesh-list
102271353|NCT05914077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102271354|NCT05914077|Hormones|hormones|mesh-ancestor
102271355|NCT05914077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102271356|NCT05914077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271357|NCT05913947|Cariprazine|cariprazine|mesh-list
102271358|NCT05913947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102271359|NCT05913947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101663106|NCT00573391|Hormones|hormones|mesh-ancestor
102271360|NCT05913947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102271361|NCT05913947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271362|NCT05913947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102271363|NCT05913921|Amphotericin B|amphotericin b|mesh-list
102271364|NCT05913921|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102271365|NCT05913921|Amebicides|amebicides|mesh-ancestor
102271366|NCT05913921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102271367|NCT05913921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102271368|NCT05913921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102271369|NCT05913921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102271370|NCT05913921|Antifungal Agents|antifungal agents|mesh-ancestor
102271371|NCT05913856|Chlorhexidine|chlorhexidine|mesh-list
102271372|NCT05913856|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102271373|NCT05913856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102271374|NCT05913856|Disinfectants|disinfectants|mesh-ancestor
102271375|NCT05913661|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102614207|NCT00003401|Antimetabolites|antimetabolites|mesh-ancestor
102614208|NCT00003401|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102614209|NCT00003401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102271376|NCT05913661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271377|NCT05913661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102271378|NCT05913661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102271379|NCT05913596|Daratumumab|daratumumab|mesh-list
102271380|NCT05913596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102271381|NCT05913583|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101663305|NCT05752929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102271382|NCT05913583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271383|NCT05913583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102271384|NCT05913583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102271385|NCT05913570|Antibodies|antibodies|mesh-list
102271386|NCT05913570|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102271387|NCT05913570|Immunologic Factors|immunologic factors|mesh-ancestor
102271388|NCT05913570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271389|NCT05913466|Tranexamic Acid|tranexamic acid|mesh-list
102271390|NCT05913466|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102271391|NCT05913466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102271392|NCT05913466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271393|NCT05913466|Hemostatics|hemostatics|mesh-ancestor
102271394|NCT05913466|Coagulants|coagulants|mesh-ancestor
102271395|NCT05913427|Cisplatin|cisplatin|mesh-list
102271396|NCT05913427|Doxorubicin|doxorubicin|mesh-list
102271397|NCT05913427|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102271398|NCT05913427|Etoposide|etoposide|mesh-list
102271399|NCT05913427|Etoposide phosphate|etoposide phosphate|mesh-list
102271400|NCT05913427|Megestrol|megestrol|mesh-list
101980207|NCT01374308|Interferons|interferons|mesh-list
102271401|NCT05913427|Megestrol Acetate|megestrol acetate|mesh-list
102271402|NCT05913427|Mitotane|mitotane|mesh-list
102271403|NCT05913427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102271404|NCT05913427|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102271405|NCT05913427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102271406|NCT05913427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102271407|NCT05913427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102271408|NCT05913427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271409|NCT05913427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102271410|NCT05913427|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102271411|NCT05913427|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102271412|NCT05913427|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102271413|NCT05913427|Contraceptive Agents|contraceptive agents|mesh-ancestor
102271414|NCT05913427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102271415|NCT05913427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271416|NCT05913427|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102271417|NCT05913427|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102271418|NCT05913427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102271419|NCT05913427|Appetite Stimulants|appetite stimulants|mesh-ancestor
102271420|NCT05913427|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102271422|NCT05913414|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
102271423|NCT05913414|Ferric Compounds|ferric compounds|mesh-list
102271424|NCT05913414|Trace Elements|trace elements|mesh-ancestor
102271425|NCT05913414|Micronutrients|micronutrients|mesh-ancestor
102271426|NCT05913414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271427|NCT05913414|Hematinics|hematinics|mesh-ancestor
102271428|NCT05913232|Timolol|timolol|mesh-list
102271429|NCT05913232|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102271430|NCT05913232|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102271431|NCT05913232|Adrenergic Agents|adrenergic agents|mesh-ancestor
102271432|NCT05913232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102271433|NCT05913232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271434|NCT05913232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271435|NCT05913232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102271436|NCT05913232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102271437|NCT05913180|Ascorbic Acid|ascorbic acid|mesh-list
102271438|NCT05913180|Vitamins|vitamins|mesh-ancestor
102271439|NCT05913180|Micronutrients|micronutrients|mesh-ancestor
102271440|NCT05913180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271441|NCT05913180|Antioxidants|antioxidants|mesh-ancestor
102271442|NCT05913180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271443|NCT05913180|Protective Agents|protective agents|mesh-ancestor
102271444|NCT05913115|Bemarituzumab|bemarituzumab|mesh-list
102271445|NCT05913115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102271446|NCT05913115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102271447|NCT05912946|Interferons|interferons|mesh-list
102271448|NCT05912946|Hyaluronic Acid|hyaluronic acid|mesh-list
102271449|NCT05912946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614210|NCT00003401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102271450|NCT05912946|Antiviral Agents|antiviral agents|mesh-ancestor
102271451|NCT05912946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102271452|NCT05912946|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102271453|NCT05912946|Immunologic Factors|immunologic factors|mesh-ancestor
102271454|NCT05912946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271455|NCT05912946|Viscosupplements|viscosupplements|mesh-ancestor
102271456|NCT05912946|Protective Agents|protective agents|mesh-ancestor
102271457|NCT05912816|Tislelizumab|tislelizumab|mesh-list
102271458|NCT05912816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102271459|NCT05912816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102271460|NCT05912712|Infliximab|infliximab|mesh-list
102271461|NCT05912712|Mesalamine|mesalamine|mesh-list
102271462|NCT05912712|Thrombin|thrombin|mesh-list
101663699|NCT04649203|Riboflavin|riboflavin|mesh-list
102271463|NCT05912712|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102271464|NCT05912712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102271465|NCT05912712|Dermatologic Agents|dermatologic agents|mesh-ancestor
102271466|NCT05912712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102271467|NCT05912712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102271468|NCT05912712|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102271469|NCT05912712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102271470|NCT05912712|Analgesics|analgesics|mesh-ancestor
102271471|NCT05912712|Sensory System Agents|sensory system agents|mesh-ancestor
102271472|NCT05912712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102271473|NCT05912712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271474|NCT05912712|Hemostatics|hemostatics|mesh-ancestor
102271475|NCT05912712|Coagulants|coagulants|mesh-ancestor
102271476|NCT05912686|Atorvastatin|atorvastatin|mesh-list
102271477|NCT05912686|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102271478|NCT05912686|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102271479|NCT05912686|Antimetabolites|antimetabolites|mesh-ancestor
102271480|NCT05912686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271481|NCT05912686|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102271482|NCT05912686|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102271483|NCT05912686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102271484|NCT05912621|Tirzepatide|tirzepatide|mesh-list
102271485|NCT05912621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102271486|NCT05912621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271487|NCT05912621|Incretins|incretins|mesh-ancestor
102271489|NCT05912621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102271490|NCT05912387|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102271491|NCT05912387|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102271492|NCT05912387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102271493|NCT05912387|Antimetabolites|antimetabolites|mesh-ancestor
102271494|NCT05912387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271495|NCT05912387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102271496|NCT05912387|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102271497|NCT05912387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102271498|NCT05912335|Anesthetics|anesthetics|mesh-list
102271499|NCT05912335|Anesthetics, Local|anesthetics, local|mesh-list
101663806|NCT03894345|Prazosin|prazosin|mesh-list
102271500|NCT05912335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102271501|NCT05912335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271502|NCT05912335|Sensory System Agents|sensory system agents|mesh-ancestor
102271503|NCT05912335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102271504|NCT05912205|Disitamab vedotin|disitamab vedotin|mesh-list
102271505|NCT05912205|Immunoconjugates|immunoconjugates|mesh-ancestor
102271506|NCT05912205|Immunologic Factors|immunologic factors|mesh-ancestor
102271507|NCT05912205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271508|NCT05912192|Mometasone Furoate|mometasone furoate|mesh-list
102271509|NCT05912192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102271510|NCT05912192|Dermatologic Agents|dermatologic agents|mesh-ancestor
102271511|NCT05912192|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102271512|NCT05912179|Liver Extracts|liver extracts|mesh-list
102271513|NCT05912179|Hematinics|hematinics|mesh-ancestor
102271514|NCT05912114|Mannitol|mannitol|mesh-list
102271515|NCT05912114|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102271516|NCT05912114|Diuretics|diuretics|mesh-ancestor
102271517|NCT05912114|Natriuretic Agents|natriuretic agents|mesh-ancestor
102271518|NCT05912114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271519|NCT05912075|Capecitabine|capecitabine|mesh-list
102271520|NCT05912075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102271521|NCT05912075|Antimetabolites|antimetabolites|mesh-ancestor
102271522|NCT05912075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271523|NCT05912075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614211|NCT00003125|Aldesleukin|aldesleukin|mesh-list
102271524|NCT05911906|Remdesivir|remdesivir|mesh-list
102271525|NCT05911906|Antimetabolites|antimetabolites|mesh-ancestor
101902619|NCT01192490|Lidocaine|lidocaine|mesh-list
102614212|NCT00003125|Vaccines|vaccines|mesh-list
101663991|NCT04227990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102271526|NCT05911906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271527|NCT05911906|Antiviral Agents|antiviral agents|mesh-ancestor
102271528|NCT05911906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102271530|NCT05911828|Antimalarials|antimalarials|mesh-ancestor
102271531|NCT05911828|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102271532|NCT05911828|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102271533|NCT05911828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102271534|NCT05911659|Ticagrelor|ticagrelor|mesh-list
102271535|NCT05911659|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102271536|NCT05911659|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102271537|NCT05911659|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102271538|NCT05911659|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102271539|NCT05911659|Purinergic Agents|purinergic agents|mesh-ancestor
102271540|NCT05911659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101664127|NCT02858843|Ivacaftor|ivacaftor|mesh-list
102271541|NCT05911659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271542|NCT05911659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271543|NCT05911503|Ganciclovir|ganciclovir|mesh-list
102271544|NCT05911503|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102271545|NCT05911503|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101664190|NCT02232737|Autonomic Agents|autonomic agents|mesh-ancestor
102271546|NCT05911503|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102271547|NCT05911503|Antiviral Agents|antiviral agents|mesh-ancestor
102271548|NCT05911503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102271549|NCT05911503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102271550|NCT05911503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102271551|NCT05911503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271552|NCT05911438|Epoetin Alfa|epoetin alfa|mesh-list
102271553|NCT05911438|Hematinics|hematinics|mesh-ancestor
102271554|NCT05911347|Psyllium|psyllium|mesh-list
102271555|NCT05911347|Cathartics|cathartics|mesh-ancestor
102271556|NCT05911347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102271557|NCT05911308|Paclitaxel|paclitaxel|mesh-list
102271558|NCT05911308|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102271559|NCT05911308|Carboplatin|carboplatin|mesh-list
102271560|NCT05911308|Pemetrexed|pemetrexed|mesh-list
102271561|NCT05911308|Durvalumab|durvalumab|mesh-list
102271562|NCT05911308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102271563|NCT05911308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101664331|NCT02775474|Anesthetics|anesthetics|mesh-ancestor
102271564|NCT05911308|Tubulin Modulators|tubulin modulators|mesh-ancestor
102271565|NCT05911308|Antimitotic Agents|antimitotic agents|mesh-ancestor
102271566|NCT05911308|Mitosis Modulators|mitosis modulators|mesh-ancestor
102271567|NCT05911308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271568|NCT05911308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102271569|NCT05911308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102271570|NCT05911308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102271571|NCT05911308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102271572|NCT05911282|Acetylcysteine|acetylcysteine|mesh-list
102271573|NCT05911282|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102271574|NCT05911282|Antiviral Agents|antiviral agents|mesh-ancestor
102271575|NCT05911282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102271576|NCT05911282|Expectorants|expectorants|mesh-ancestor
102271577|NCT05911282|Respiratory System Agents|respiratory system agents|mesh-ancestor
102271578|NCT05911282|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102271579|NCT05911282|Antioxidants|antioxidants|mesh-ancestor
102271580|NCT05911282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271581|NCT05911282|Protective Agents|protective agents|mesh-ancestor
102271582|NCT05911282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271583|NCT05911282|Antidotes|antidotes|mesh-ancestor
102271584|NCT05911022|Colchicine|colchicine|mesh-list
102271585|NCT05911022|Gout Suppressants|gout suppressants|mesh-ancestor
102271586|NCT05911022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102271587|NCT05911022|Tubulin Modulators|tubulin modulators|mesh-ancestor
101664457|NCT04910178|Vasodilator Agents|vasodilator agents|mesh-ancestor
101664458|NCT04910178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101664459|NCT04910178|Antioxidants|antioxidants|mesh-ancestor
101664460|NCT04910178|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101664461|NCT04910178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101664462|NCT02778594|Levodopa|levodopa|mesh-list
101664463|NCT02778594|Benserazide|benserazide|mesh-list
101664464|NCT02778594|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101664465|NCT02778594|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102271588|NCT05911022|Antimitotic Agents|antimitotic agents|mesh-ancestor
102271589|NCT05911022|Mitosis Modulators|mitosis modulators|mesh-ancestor
102271590|NCT05911022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271591|NCT05911022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102271592|NCT05909150|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102271593|NCT05907655|Nitroglycerin|nitroglycerin|mesh-list
102271594|NCT05907655|Vasodilator Agents|vasodilator agents|mesh-ancestor
102271595|NCT05907525|Propofol|propofol|mesh-list
102271596|NCT05907525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102271597|NCT05907525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102271598|NCT05907525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271599|NCT05907525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102271600|NCT05907525|Anesthetics, General|anesthetics, general|mesh-ancestor
102614213|NCT00003125|Sargramostim|sargramostim|mesh-list
102271601|NCT05907525|Anesthetics|anesthetics|mesh-ancestor
102614214|NCT00003125|Immunologic Factors|immunologic factors|mesh-ancestor
102271603|NCT05907512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102271604|NCT05907512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102271605|NCT05907512|Growth Substances|growth substances|mesh-ancestor
102271606|NCT05907512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271607|NCT05907512|Growth Inhibitors|growth inhibitors|mesh-ancestor
102271608|NCT05907512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102271609|NCT05906056|Zoledronic Acid|zoledronic acid|mesh-list
102271610|NCT05906056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102271611|NCT05906056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271612|NCT05905770|Alemtuzumab|alemtuzumab|mesh-list
102271613|NCT05905770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102271614|NCT05905770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102271615|NCT05905510|Anesthetics|anesthetics|mesh-list
102271616|NCT05905510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102271617|NCT05905510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271618|NCT05904964|Disitamab vedotin|disitamab vedotin|mesh-list
102271619|NCT05904964|Immunoconjugates|immunoconjugates|mesh-ancestor
101664653|NCT00890552|Melphalan|melphalan|mesh-list
102271620|NCT05904964|Immunologic Factors|immunologic factors|mesh-ancestor
102271621|NCT05904964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271622|NCT05904353|Zoledronic Acid|zoledronic acid|mesh-list
102271623|NCT05904353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102271624|NCT05904353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271625|NCT05903417|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102271626|NCT05903417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102271627|NCT05903417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101664719|NCT04783194|Anesthetics, Local|anesthetics, local|mesh-ancestor
102271628|NCT05903417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271629|NCT05903014|Acetylcysteine|acetylcysteine|mesh-list
102271630|NCT05903014|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102271631|NCT05903014|Antiviral Agents|antiviral agents|mesh-ancestor
102271632|NCT05903014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102271633|NCT05903014|Expectorants|expectorants|mesh-ancestor
102271634|NCT05903014|Respiratory System Agents|respiratory system agents|mesh-ancestor
102271635|NCT05903014|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102271636|NCT05903014|Antioxidants|antioxidants|mesh-ancestor
102271637|NCT05903014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271638|NCT05903014|Protective Agents|protective agents|mesh-ancestor
102271639|NCT05903014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271640|NCT05903014|Antidotes|antidotes|mesh-ancestor
102271641|NCT05897554|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102271642|NCT05897554|Plasminogen|plasminogen|mesh-list
102271643|NCT05897554|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102271644|NCT05897554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102271645|NCT05897554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271646|NCT05888870|Daratumumab|daratumumab|mesh-list
102271647|NCT05888870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102271648|NCT05888532|Copper|copper|mesh-list
102271649|NCT05888532|Trace Elements|trace elements|mesh-ancestor
102271650|NCT05888532|Micronutrients|micronutrients|mesh-ancestor
102271651|NCT05888532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271652|NCT05874492|Dermatologic Agents|dermatologic agents|mesh-list
102271653|NCT05872854|Hypericin|hypericin|mesh-list
102271654|NCT05872854|Antidepressive Agents|antidepressive agents|mesh-ancestor
102271655|NCT05872854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102271656|NCT05872854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102271657|NCT05872854|Antiviral Agents|antiviral agents|mesh-ancestor
102271658|NCT05872854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102271659|NCT05872854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101664852|NCT00884767|Leucovorin|leucovorin|mesh-list
102271660|NCT05872854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271661|NCT05872854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102271662|NCT05872854|Immunologic Factors|immunologic factors|mesh-ancestor
102271663|NCT05872854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271664|NCT05867329|Cyclosporine|cyclosporine|mesh-list
102271665|NCT05867329|Prednisone|prednisone|mesh-list
102271666|NCT05867329|Methylprednisolone|methylprednisolone|mesh-list
102271667|NCT05867329|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102271668|NCT05867329|Upadacitinib|upadacitinib|mesh-list
102271669|NCT05867329|Cyclosporins|cyclosporins|mesh-list
102271670|NCT05867329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102271671|NCT05867329|Glucocorticoids|glucocorticoids|mesh-ancestor
102271672|NCT05867329|Hormones|hormones|mesh-ancestor
102271673|NCT05867329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102271674|NCT05867329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664906|NCT02773602|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102271675|NCT05867329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101613504|NCT00380523|Etoricoxib|etoricoxib|mesh-list
102271677|NCT05867329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102271678|NCT05867329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271679|NCT05867329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102271680|NCT05867329|Immunologic Factors|immunologic factors|mesh-ancestor
102271681|NCT05867329|Antifungal Agents|antifungal agents|mesh-ancestor
102271682|NCT05867329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102271683|NCT05867329|Dermatologic Agents|dermatologic agents|mesh-ancestor
102271684|NCT05867329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102271685|NCT05867329|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102271686|NCT05867329|Antiemetics|antiemetics|mesh-ancestor
102271687|NCT05867329|Autonomic Agents|autonomic agents|mesh-ancestor
102271688|NCT05867329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102271689|NCT05867329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102271690|NCT05867329|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102271691|NCT05867329|Protective Agents|protective agents|mesh-ancestor
102271692|NCT05867329|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102271693|NCT05867329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102271694|NCT05860881|Sirolimus|sirolimus|mesh-list
102271695|NCT05860881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102271696|NCT05860881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102271697|NCT05860881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102271698|NCT05860881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102271699|NCT05860881|Antifungal Agents|antifungal agents|mesh-ancestor
102271700|NCT05860881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102271701|NCT05860881|Immunologic Factors|immunologic factors|mesh-ancestor
102271702|NCT05860881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271703|NCT05856305|Copper|copper|mesh-list
102271704|NCT05856305|Chlorophyllin|chlorophyllin|mesh-list
102271705|NCT05856305|Trace Elements|trace elements|mesh-ancestor
102271706|NCT05856305|Micronutrients|micronutrients|mesh-ancestor
102271707|NCT05856305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271708|NCT05856305|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
102271709|NCT05856305|Protective Agents|protective agents|mesh-ancestor
102271710|NCT05845450|Trastuzumab|trastuzumab|mesh-list
102271711|NCT05845450|Durvalumab|durvalumab|mesh-list
102271712|NCT05845450|Panitumumab|panitumumab|mesh-list
102271713|NCT05845450|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
102271714|NCT05845450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102271715|NCT05845450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102271716|NCT05845450|Immunoconjugates|immunoconjugates|mesh-ancestor
102271717|NCT05845450|Immunologic Factors|immunologic factors|mesh-ancestor
102271718|NCT05845450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271719|NCT05838664|Rivaroxaban|rivaroxaban|mesh-list
102271720|NCT05838664|Apixaban|apixaban|mesh-list
102271721|NCT05838664|Dabigatran|dabigatran|mesh-list
102271722|NCT05838664|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102271723|NCT05838664|Antithrombins|antithrombins|mesh-ancestor
102271724|NCT05838664|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102271725|NCT05838664|Protease Inhibitors|protease inhibitors|mesh-ancestor
102271726|NCT05838664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102271727|NCT05838664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271728|NCT05838664|Anticoagulants|anticoagulants|mesh-ancestor
102271729|NCT05823896|Ritonavir|ritonavir|mesh-list
102271730|NCT05823896|Nirmatrelvir|nirmatrelvir|mesh-list
102271731|NCT05823896|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
102271732|NCT05823896|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102271733|NCT05823896|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102271734|NCT05823896|Protease Inhibitors|protease inhibitors|mesh-ancestor
102271735|NCT05823896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102271736|NCT05823896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271737|NCT05823896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102271738|NCT05823896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102271739|NCT05823896|Antiviral Agents|antiviral agents|mesh-ancestor
102271740|NCT05823896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102271741|NCT05823896|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102271742|NCT05823896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102271743|NCT05821088|Carboplatin|carboplatin|mesh-list
102271744|NCT05821088|Etoposide|etoposide|mesh-list
102271745|NCT05821088|Lenalidomide|lenalidomide|mesh-list
102271746|NCT05821088|Etoposide phosphate|etoposide phosphate|mesh-list
102271747|NCT05821088|Ifosfamide|ifosfamide|mesh-list
102271748|NCT05821088|Isophosphamide mustard|isophosphamide mustard|mesh-list
102271749|NCT05821088|Podophyllotoxin|podophyllotoxin|mesh-list
102271750|NCT05821088|Immunoglobulins|immunoglobulins|mesh-list
102271751|NCT05821088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102271752|NCT05821088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102271753|NCT05821088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102271754|NCT05821088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102271755|NCT05821088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102271756|NCT05821088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271757|NCT05821088|Immunologic Factors|immunologic factors|mesh-ancestor
102271758|NCT05821088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271759|NCT05821088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102271760|NCT05821088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102271761|NCT05821088|Growth Substances|growth substances|mesh-ancestor
102271762|NCT05821088|Growth Inhibitors|growth inhibitors|mesh-ancestor
102271763|NCT05821088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102271764|NCT05821088|Alkylating Agents|alkylating agents|mesh-ancestor
102271765|NCT05821088|Keratolytic Agents|keratolytic agents|mesh-ancestor
102271766|NCT05821088|Dermatologic Agents|dermatologic agents|mesh-ancestor
102271767|NCT05821088|Tubulin Modulators|tubulin modulators|mesh-ancestor
102271768|NCT05821088|Antimitotic Agents|antimitotic agents|mesh-ancestor
102271769|NCT05821088|Mitosis Modulators|mitosis modulators|mesh-ancestor
102271770|NCT05794581|Liraglutide|liraglutide|mesh-list
102271771|NCT05794581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102271772|NCT05794581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271773|NCT05794581|Incretins|incretins|mesh-ancestor
102271774|NCT05794581|Hormones|hormones|mesh-ancestor
102271775|NCT05794581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102271776|NCT05794555|Lactulose|lactulose|mesh-list
102271777|NCT05794555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102271778|NCT05784012|Niraparib|niraparib|mesh-list
102271779|NCT05784012|Dostarlimab|dostarlimab|mesh-list
102271780|NCT05784012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102271781|NCT05784012|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102271782|NCT05784012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102271783|NCT05784012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271784|NCT05777993|Mitapivat|mitapivat|mesh-list
101665473|NCT02768610|Dexmedetomidine|dexmedetomidine|mesh-list
102271785|NCT05777993|Enzyme Activators|enzyme activators|mesh-ancestor
102271786|NCT05777993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271787|NCT05776524|Paclitaxel|paclitaxel|mesh-list
102271788|NCT05776524|Gemcitabine|gemcitabine|mesh-list
102271789|NCT05776524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102271790|NCT05776524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102271791|NCT05776524|Tubulin Modulators|tubulin modulators|mesh-ancestor
102271792|NCT05776524|Antimitotic Agents|antimitotic agents|mesh-ancestor
102271793|NCT05776524|Mitosis Modulators|mitosis modulators|mesh-ancestor
102271794|NCT05776524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271795|NCT05776524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102271796|NCT05776524|Antimetabolites|antimetabolites|mesh-ancestor
102271797|NCT05769153|Aflibercept|aflibercept|mesh-list
102271798|NCT05769153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102271799|NCT05769153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102271800|NCT05769153|Growth Substances|growth substances|mesh-ancestor
102271801|NCT05769153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271802|NCT05769153|Growth Inhibitors|growth inhibitors|mesh-ancestor
102271803|NCT05769153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102271804|NCT05767944|Anesthetics|anesthetics|mesh-list
102271805|NCT05767944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102271806|NCT05767944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271807|NCT05751265|Paclitaxel|paclitaxel|mesh-list
102271808|NCT05751265|Tislelizumab|tislelizumab|mesh-list
102271809|NCT05751265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102271810|NCT05751265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102271811|NCT05751265|Tubulin Modulators|tubulin modulators|mesh-ancestor
102271812|NCT05751265|Antimitotic Agents|antimitotic agents|mesh-ancestor
102271813|NCT05751265|Mitosis Modulators|mitosis modulators|mesh-ancestor
102271814|NCT05751265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271815|NCT05751265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102271816|NCT05716854|Moxifloxacin|moxifloxacin|mesh-list
102271817|NCT05716854|Clarithromycin|clarithromycin|mesh-list
102271818|NCT05716854|Cobicistat|cobicistat|mesh-list
102271819|NCT05716854|Pimozide|pimozide|mesh-list
102271820|NCT05716854|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102271821|NCT05716854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102271822|NCT05716854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102271823|NCT05716854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102271824|NCT05716854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102271825|NCT05716854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102271826|NCT05716854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614215|NCT00003125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614216|NCT00003125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614217|NCT00003125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102271827|NCT05716854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102271828|NCT05716854|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102271829|NCT05716854|Contraceptive Agents|contraceptive agents|mesh-ancestor
102271830|NCT05716854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102271831|NCT05716854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271832|NCT05716854|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102271833|NCT05716854|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101665579|NCT02768220|Protease Inhibitors|protease inhibitors|mesh-ancestor
102271834|NCT05716854|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102271835|NCT05716854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102271836|NCT05716854|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102271837|NCT05716854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102271838|NCT05716854|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102271839|NCT05716854|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102271840|NCT05716854|Antiviral Agents|antiviral agents|mesh-ancestor
102271841|NCT05716854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102271842|NCT05716854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102271843|NCT05716854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102271844|NCT05716854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102271845|NCT05716854|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102271846|NCT05716854|Dopamine Agents|dopamine agents|mesh-ancestor
102271847|NCT05716854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102271848|NCT05716854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102271850|NCT05714553|Docetaxel|docetaxel|mesh-list
102271851|NCT05714553|Pembrolizumab|pembrolizumab|mesh-list
102271852|NCT05714553|Levoleucovorin|levoleucovorin|mesh-list
102271853|NCT05714553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102271854|NCT05714553|Tubulin Modulators|tubulin modulators|mesh-ancestor
102271855|NCT05714553|Antimitotic Agents|antimitotic agents|mesh-ancestor
102271856|NCT05714553|Mitosis Modulators|mitosis modulators|mesh-ancestor
102271857|NCT05714553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271858|NCT05714553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102271859|NCT05714553|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102271860|NCT05714553|Antidotes|antidotes|mesh-ancestor
102271861|NCT05714553|Protective Agents|protective agents|mesh-ancestor
102271862|NCT05714553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271863|NCT05714553|Vitamin B Complex|vitamin b complex|mesh-ancestor
102271864|NCT05714553|Vitamins|vitamins|mesh-ancestor
102271865|NCT05714553|Micronutrients|micronutrients|mesh-ancestor
102271866|NCT05713760|Tirbanibulin|tirbanibulin|mesh-list
102271867|NCT05713760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102271868|NCT05713760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271869|NCT05713630|Tranexamic Acid|tranexamic acid|mesh-list
102271870|NCT05713630|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102271871|NCT05713630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102271872|NCT05713630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271873|NCT05713630|Hemostatics|hemostatics|mesh-ancestor
102271874|NCT05713630|Coagulants|coagulants|mesh-ancestor
102271875|NCT05710783|Vaccines|vaccines|mesh-list
102271876|NCT05710783|Immunologic Factors|immunologic factors|mesh-ancestor
102271877|NCT05710783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271878|NCT05702853|Cyclophosphamide|cyclophosphamide|mesh-list
102271879|NCT05702853|Fludarabine|fludarabine|mesh-list
102271880|NCT05702853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102271881|NCT05702853|Immunologic Factors|immunologic factors|mesh-ancestor
102271882|NCT05702853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271883|NCT05702853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102271884|NCT05702853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102271885|NCT05702853|Alkylating Agents|alkylating agents|mesh-ancestor
102271886|NCT05702853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271887|NCT05702853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102271888|NCT05702853|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102271889|NCT05701488|Durvalumab|durvalumab|mesh-list
102271890|NCT05701488|Tremelimumab|tremelimumab|mesh-list
102271891|NCT05701488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102271892|NCT05701488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102271893|NCT05695261|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102271894|NCT05695261|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102271895|NCT05695261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102271896|NCT05695261|Antitubercular Agents|antitubercular agents|mesh-ancestor
102271897|NCT05685407|Caffeine|caffeine|mesh-list
102271898|NCT05685407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102271899|NCT05685407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271900|NCT05685407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102271901|NCT05685407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102271902|NCT05685407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271903|NCT05685407|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102271904|NCT05685407|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102271905|NCT05685407|Purinergic Agents|purinergic agents|mesh-ancestor
102271906|NCT05685407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102271907|NCT05684276|Paclitaxel|paclitaxel|mesh-list
102271908|NCT05684276|Carboplatin|carboplatin|mesh-list
102271909|NCT05684276|Nivolumab|nivolumab|mesh-list
101665894|NCT00894283|PENTA|penta|mesh-list
102271910|NCT05684276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102271911|NCT05684276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102271912|NCT05684276|Tubulin Modulators|tubulin modulators|mesh-ancestor
102271913|NCT05684276|Antimitotic Agents|antimitotic agents|mesh-ancestor
102271914|NCT05684276|Mitosis Modulators|mitosis modulators|mesh-ancestor
102271915|NCT05684276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271916|NCT05684276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102271917|NCT05684276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102271918|NCT05672459|Cyclophosphamide|cyclophosphamide|mesh-list
102271919|NCT05672459|Fludarabine|fludarabine|mesh-list
102271920|NCT05672459|Fludarabine phosphate|fludarabine phosphate|mesh-list
102271921|NCT05672459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102271922|NCT05672459|Immunologic Factors|immunologic factors|mesh-ancestor
102271923|NCT05672459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271924|NCT05672459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102271925|NCT05672459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102271926|NCT05672459|Alkylating Agents|alkylating agents|mesh-ancestor
102271927|NCT05672459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271928|NCT05672459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102271929|NCT05672459|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102271930|NCT05672459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102271931|NCT05672459|Antimetabolites|antimetabolites|mesh-ancestor
102271932|NCT05672342|Dronabinol|dronabinol|mesh-list
102271933|NCT05672342|Cannabidiol|cannabidiol|mesh-list
102271934|NCT05672342|Anticonvulsants|anticonvulsants|mesh-ancestor
102271935|NCT05672342|Hallucinogens|hallucinogens|mesh-ancestor
102271936|NCT05672342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271937|NCT05672342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102271938|NCT05672342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102271939|NCT05672342|Analgesics|analgesics|mesh-ancestor
102271940|NCT05672342|Sensory System Agents|sensory system agents|mesh-ancestor
102271941|NCT05672342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102271942|NCT05672342|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102271943|NCT05672342|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102271944|NCT05672342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102271945|NCT05672342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271946|NCT05672342|Hormones|hormones|mesh-ancestor
102271947|NCT05672342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102271948|NCT05672095|Selenium|selenium|mesh-list
102271949|NCT05672095|Niraparib|niraparib|mesh-list
102271950|NCT05672095|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102271951|NCT05672095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102271952|NCT05672095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271953|NCT05672095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102271954|NCT05672095|Antioxidants|antioxidants|mesh-ancestor
102271955|NCT05672095|Protective Agents|protective agents|mesh-ancestor
102271956|NCT05672095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271957|NCT05672095|Trace Elements|trace elements|mesh-ancestor
102271958|NCT05672095|Micronutrients|micronutrients|mesh-ancestor
102271959|NCT05669820|Antisecretory factor|antisecretory factor|mesh-list
102271960|NCT05669820|Antidiarrheals|antidiarrheals|mesh-ancestor
102271961|NCT05669820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102271962|NCT05667116|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
102271963|NCT05667116|Antiviral Agents|antiviral agents|mesh-ancestor
102271964|NCT05667116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102271965|NCT05655182|Vaccines|vaccines|mesh-list
102271966|NCT05655182|Immunologic Factors|immunologic factors|mesh-ancestor
102271967|NCT05655182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271968|NCT05644600|Nintedanib|nintedanib|mesh-list
102271969|NCT05644600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102271970|NCT05644600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102271971|NCT05644600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102271972|NCT05644600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271973|NCT05641051|Metoclopramide|metoclopramide|mesh-list
102271974|NCT05641051|Antiemetics|antiemetics|mesh-ancestor
101613800|NCT00937560|Paclitaxel|paclitaxel|mesh-list
102614218|NCT00003125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102614219|NCT00003125|Antiviral Agents|antiviral agents|mesh-ancestor
102271976|NCT05641051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102271977|NCT05641051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271978|NCT05641051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102271979|NCT05641051|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102271980|NCT05641051|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102271981|NCT05641051|Dopamine Agents|dopamine agents|mesh-ancestor
102271982|NCT05641051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102271983|NCT05641051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271984|NCT05631626|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
102271985|NCT05631626|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102271986|NCT05631626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102271987|NCT05631626|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102271988|NCT05631626|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102271989|NCT05631626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102271990|NCT05631626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102271991|NCT05631626|Dopamine Agents|dopamine agents|mesh-ancestor
101666163|NCT00894751|Dexmedetomidine|dexmedetomidine|mesh-list
102271992|NCT05631626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102271993|NCT05625932|Tinzaparin|tinzaparin|mesh-list
102271994|NCT05625932|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102271995|NCT05625932|Dalteparin|dalteparin|mesh-list
102271996|NCT05625932|Anticoagulants|anticoagulants|mesh-ancestor
102271997|NCT05625932|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102271998|NCT05625932|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102271999|NCT05625932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272000|NCT05618366|Venetoclax|venetoclax|mesh-list
102272001|NCT05618366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272002|NCT05587998|Morphine|morphine|mesh-list
102272003|NCT05587998|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102272004|NCT05587998|Narcotics|narcotics|mesh-ancestor
102272005|NCT05587998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102272006|NCT05587998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272007|NCT05587998|Analgesics|analgesics|mesh-ancestor
102272008|NCT05587998|Sensory System Agents|sensory system agents|mesh-ancestor
102272009|NCT05587998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102272010|NCT05585398|Botulinum Toxins|botulinum toxins|mesh-list
101980805|NCT03477136|Vitamin D|vitamin d|mesh-list
102272011|NCT05585398|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102272012|NCT05585398|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102272013|NCT05585398|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102272014|NCT05585398|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102272015|NCT05585398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102272016|NCT05585398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272017|NCT05585398|Cholinergic Agents|cholinergic agents|mesh-ancestor
102272018|NCT05585398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102272019|NCT05585398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272020|NCT05585398|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102272021|NCT05585398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102272022|NCT05571735|Vaccines|vaccines|mesh-list
102272023|NCT05571735|Immunologic Factors|immunologic factors|mesh-ancestor
102272024|NCT05571735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272025|NCT05569512|Fludarabine|fludarabine|mesh-list
102272026|NCT05569512|Busulfan|busulfan|mesh-list
102272027|NCT05569512|Clofarabine|clofarabine|mesh-list
102272028|NCT05569512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272029|NCT05569512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102272030|NCT05569512|Antimetabolites|antimetabolites|mesh-ancestor
102272031|NCT05569512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272032|NCT05569512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102272033|NCT05569512|Immunologic Factors|immunologic factors|mesh-ancestor
102272034|NCT05569512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272035|NCT05569512|Alkylating Agents|alkylating agents|mesh-ancestor
102272036|NCT05569512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102272037|NCT05569512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102272038|NCT05556616|Lenalidomide|lenalidomide|mesh-list
102272039|NCT05556616|Pomalidomide|pomalidomide|mesh-list
102272040|NCT05556616|Bortezomib|bortezomib|mesh-list
102272041|NCT05556616|Daratumumab|daratumumab|mesh-list
102272042|NCT05556616|Immunologic Factors|immunologic factors|mesh-ancestor
102272043|NCT05556616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614220|NCT00003125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102614221|NCT00003131|Gemtuzumab|gemtuzumab|mesh-list
102272044|NCT05556616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102272045|NCT05556616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102272046|NCT05556616|Growth Substances|growth substances|mesh-ancestor
102272047|NCT05556616|Growth Inhibitors|growth inhibitors|mesh-ancestor
102272048|NCT05556616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272050|NCT05554237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102272051|NCT05554237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102272052|NCT05550870|Fenugreek seed meal|fenugreek seed meal|mesh-list
102272053|NCT05550870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102272054|NCT05550870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272055|NCT05544695|Hyaluronic Acid|hyaluronic acid|mesh-list
102272056|NCT05544695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102272057|NCT05544695|Immunologic Factors|immunologic factors|mesh-ancestor
101666478|NCT02853071|Alkylating Agents|alkylating agents|mesh-ancestor
102272058|NCT05544695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272059|NCT05544695|Viscosupplements|viscosupplements|mesh-ancestor
102272060|NCT05544695|Protective Agents|protective agents|mesh-ancestor
102272061|NCT05543278|Amiodarone|amiodarone|mesh-list
102272062|NCT05543278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102272063|NCT05543278|Vasodilator Agents|vasodilator agents|mesh-ancestor
102272064|NCT05543278|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102272065|NCT05543278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102272066|NCT05543278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272067|NCT05543278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102272068|NCT05543278|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102272069|NCT05543278|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102272070|NCT05543278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102272071|NCT05543278|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102272072|NCT05543278|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102272073|NCT05543278|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102272074|NCT05538312|Itraconazole|itraconazole|mesh-list
102272075|NCT05538312|Antifungal Agents|antifungal agents|mesh-ancestor
102272076|NCT05538312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102272077|NCT05538312|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102272078|NCT05538312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102272079|NCT05538312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102272080|NCT05538312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272081|NCT05538312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102272082|NCT05538312|Hormone Antagonists|hormone antagonists|mesh-ancestor
102272083|NCT05538312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101980885|NCT03480646|Hormones|hormones|mesh-ancestor
102272084|NCT05538312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272085|NCT05538312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102272086|NCT05512819|Vaccines|vaccines|mesh-list
102272087|NCT05512819|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102272088|NCT05512819|Immunologic Factors|immunologic factors|mesh-ancestor
102272089|NCT05512819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272090|NCT05507476|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
102272091|NCT05507476|Epinephrine|epinephrine|mesh-list
102272092|NCT05507476|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102272093|NCT05507476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102272094|NCT05507476|Adrenergic Agents|adrenergic agents|mesh-ancestor
102272095|NCT05507476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102272096|NCT05507476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272097|NCT05507476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272098|NCT05507476|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102272099|NCT05507476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102272100|NCT05507476|Autonomic Agents|autonomic agents|mesh-ancestor
102272101|NCT05507476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102272102|NCT05507476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102272103|NCT05507476|Respiratory System Agents|respiratory system agents|mesh-ancestor
102272104|NCT05507476|Mydriatics|mydriatics|mesh-ancestor
102272105|NCT05507476|Sympathomimetics|sympathomimetics|mesh-ancestor
102272106|NCT05507476|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102272107|NCT05507476|Hemostatics|hemostatics|mesh-ancestor
102272108|NCT05507476|Coagulants|coagulants|mesh-ancestor
102272109|NCT05507476|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102272110|NCT05507476|Natriuretic Agents|natriuretic agents|mesh-ancestor
102614222|NCT00003131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102614223|NCT00003131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614224|NCT00003131|Immunotoxins|immunotoxins|mesh-ancestor
102614225|NCT00003131|Immunoconjugates|immunoconjugates|mesh-ancestor
102614226|NCT00003131|Immunologic Factors|immunologic factors|mesh-ancestor
102614227|NCT00003131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614228|NCT00384371|Botulinum Toxins|botulinum toxins|mesh-list
102614229|NCT00384371|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102272111|NCT05501756|Alemtuzumab|alemtuzumab|mesh-list
102614230|NCT00384371|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102272112|NCT05501756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102272113|NCT05501756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272114|NCT05500326|Ivermectin|ivermectin|mesh-list
102272115|NCT05500326|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102272116|NCT05500326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102272117|NCT05494125|Ropivacaine|ropivacaine|mesh-list
102272118|NCT05494125|Anesthetics, Local|anesthetics, local|mesh-ancestor
102272119|NCT05494125|Anesthetics|anesthetics|mesh-ancestor
102272120|NCT05494125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102272121|NCT05494125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272122|NCT05494125|Sensory System Agents|sensory system agents|mesh-ancestor
102272123|NCT05494125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102272124|NCT05484401|Ibuprofen|ibuprofen|mesh-list
102272125|NCT05484401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102272126|NCT05484401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102272127|NCT05484401|Analgesics|analgesics|mesh-ancestor
102272128|NCT05484401|Sensory System Agents|sensory system agents|mesh-ancestor
102272129|NCT05484401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102272130|NCT05484401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272131|NCT05484401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102272132|NCT05484401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102272133|NCT05484401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102272134|NCT05484401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102272135|NCT05484401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272136|NCT05447676|4-Aminopyridine|4-aminopyridine|mesh-list
102272137|NCT05447676|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102272138|NCT05447676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102272139|NCT05447676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272140|NCT05442580|Cyclophosphamide|cyclophosphamide|mesh-list
102272141|NCT05442580|Fludarabine|fludarabine|mesh-list
102272142|NCT05442580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102272143|NCT05442580|Immunologic Factors|immunologic factors|mesh-ancestor
102272144|NCT05442580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272145|NCT05442580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102272146|NCT05442580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102272147|NCT05442580|Alkylating Agents|alkylating agents|mesh-ancestor
102272148|NCT05442580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272149|NCT05442580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272150|NCT05442580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102272151|NCT05435573|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
102272152|NCT05435573|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102272153|NCT05435573|Plasma Substitutes|plasma substitutes|mesh-ancestor
102272154|NCT05435573|Blood Substitutes|blood substitutes|mesh-ancestor
102272155|NCT05428969|Azacitidine|azacitidine|mesh-list
102272156|NCT05428969|Venetoclax|venetoclax|mesh-list
102272157|NCT05428969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102272158|NCT05428969|Antimetabolites|antimetabolites|mesh-ancestor
102272159|NCT05428969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272160|NCT05428969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101667100|NCT02602197|Antipyretics|antipyretics|mesh-ancestor
102272161|NCT05428969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102272163|NCT05423340|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102272164|NCT05423340|Autonomic Agents|autonomic agents|mesh-ancestor
102272165|NCT05423340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102272166|NCT05423340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272167|NCT05423340|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102272168|NCT05423340|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102272169|NCT05423340|Cholinergic Agents|cholinergic agents|mesh-ancestor
102272170|NCT05423340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102272171|NCT05423340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272172|NCT05418582|Carbamazepine|carbamazepine|mesh-list
102272173|NCT05418582|Anticonvulsants|anticonvulsants|mesh-ancestor
102272174|NCT05418582|Antimanic Agents|antimanic agents|mesh-ancestor
102272175|NCT05418582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102272176|NCT05418582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102272177|NCT05418582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272178|NCT05418582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102272179|NCT05418582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102272180|NCT05418582|Analgesics|analgesics|mesh-ancestor
102272181|NCT05418582|Sensory System Agents|sensory system agents|mesh-ancestor
102272182|NCT05418582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102272183|NCT05418582|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102272184|NCT05418582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102272185|NCT05418582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272186|NCT05418582|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102272187|NCT05418582|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102272188|NCT05417425|Lidocaine|lidocaine|mesh-list
102272189|NCT05417425|Protective Agents|protective agents|mesh-list
102272190|NCT05417425|Anesthetics, Local|anesthetics, local|mesh-ancestor
102272191|NCT05417425|Anesthetics|anesthetics|mesh-ancestor
102272192|NCT05417425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102272193|NCT05417425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272194|NCT05417425|Sensory System Agents|sensory system agents|mesh-ancestor
102272195|NCT05417425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102272196|NCT05417425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102272197|NCT05417425|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102272198|NCT05417425|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102272199|NCT05417425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102272200|NCT05417425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272201|NCT05413915|Imatinib Mesylate|imatinib mesylate|mesh-list
102272202|NCT05413915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272203|NCT05413915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102272204|NCT05413915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102272205|NCT05413915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272206|NCT05406401|Prednisone|prednisone|mesh-list
102272207|NCT05406401|Prednisolone|prednisolone|mesh-list
102272208|NCT05406401|Cyclophosphamide|cyclophosphamide|mesh-list
102272209|NCT05406401|Rituximab|rituximab|mesh-list
102272210|NCT05406401|Doxorubicin|doxorubicin|mesh-list
102272211|NCT05406401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102272212|NCT05406401|Immunologic Factors|immunologic factors|mesh-ancestor
102272213|NCT05406401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272214|NCT05406401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102272215|NCT05406401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102272216|NCT05406401|Alkylating Agents|alkylating agents|mesh-ancestor
102272217|NCT05406401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272218|NCT05406401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272219|NCT05406401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102272220|NCT05406401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101667413|NCT00899197|Tamoxifen|tamoxifen|mesh-list
102272221|NCT05406401|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102272222|NCT05406401|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102272223|NCT05406401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102272224|NCT05406401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102272225|NCT05406401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102272226|NCT05406401|Glucocorticoids|glucocorticoids|mesh-ancestor
102272227|NCT05406401|Hormones|hormones|mesh-ancestor
102272228|NCT05406401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102272229|NCT05406401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102272230|NCT05394103|Pembrolizumab|pembrolizumab|mesh-list
102272231|NCT05394103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102272232|NCT05394103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272233|NCT05394103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102272234|NCT05394103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272235|NCT05388474|Ibalizumab|ibalizumab|mesh-list
102272236|NCT05388474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102272237|NCT05388474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102272238|NCT05388474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102272239|NCT05388474|Antiviral Agents|antiviral agents|mesh-ancestor
102272240|NCT05388474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102272241|NCT05388474|Immunologic Factors|immunologic factors|mesh-ancestor
102272242|NCT05388474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272243|NCT05372744|Antidepressive Agents|antidepressive agents|mesh-list
102272244|NCT05372744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102272245|NCT05362318|Nicotine|nicotine|mesh-list
102272246|NCT05362318|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102272247|NCT05362318|Autonomic Agents|autonomic agents|mesh-ancestor
102272248|NCT05362318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102272249|NCT05362318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272250|NCT05362318|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102272251|NCT05362318|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102272252|NCT05362318|Cholinergic Agents|cholinergic agents|mesh-ancestor
102272253|NCT05362318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102272254|NCT05362318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272255|NCT05359068|Valsartan|valsartan|mesh-list
102272256|NCT05359068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102614231|NCT00384371|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102272257|NCT05359068|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102272258|NCT05359068|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102614232|NCT00384371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101667598|NCT00779259|Vasodilator Agents|vasodilator agents|mesh-ancestor
102614233|NCT00384371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614234|NCT00384371|Cholinergic Agents|cholinergic agents|mesh-ancestor
102614235|NCT00384371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102614236|NCT00384371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614237|NCT00384371|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102614238|NCT00384371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102272259|NCT05359068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272260|NCT05358886|BPN14770|bpn14770|mesh-list
102272261|NCT05358886|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102272262|NCT05358886|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102272263|NCT05358886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102272264|NCT05358886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272265|NCT05357794|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102272266|NCT05357794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102272267|NCT05357794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272268|NCT05357794|Immunotoxins|immunotoxins|mesh-ancestor
102272269|NCT05357794|Immunoconjugates|immunoconjugates|mesh-ancestor
102272270|NCT05357794|Immunologic Factors|immunologic factors|mesh-ancestor
102272271|NCT05357794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667740|NCT02823236|Triamcinolone|triamcinolone|mesh-list
102272272|NCT05347771|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102272273|NCT05347771|Immunologic Factors|immunologic factors|mesh-ancestor
102272274|NCT05347771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272275|NCT05342844|Dexmedetomidine|dexmedetomidine|mesh-list
102272276|NCT05342844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102272277|NCT05342844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102272278|NCT05342844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272279|NCT05342844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102272280|NCT05342844|Analgesics|analgesics|mesh-ancestor
102272281|NCT05342844|Sensory System Agents|sensory system agents|mesh-ancestor
102272282|NCT05342844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102272283|NCT05342844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102272284|NCT05342844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102272285|NCT05342844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102272286|NCT05342844|Adrenergic Agents|adrenergic agents|mesh-ancestor
102272287|NCT05342844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102272288|NCT05342844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272289|NCT05339087|Riociguat|riociguat|mesh-list
102272290|NCT05339087|Enzyme Activators|enzyme activators|mesh-ancestor
102272291|NCT05339087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272292|NCT05323617|Cyclosporine|cyclosporine|mesh-list
102272293|NCT05323617|Cyclosporins|cyclosporins|mesh-list
102272294|NCT05323617|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102272295|NCT05323617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101667863|NCT02851433|Propofol|propofol|mesh-list
102272296|NCT05323617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272297|NCT05323617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102272298|NCT05323617|Immunologic Factors|immunologic factors|mesh-ancestor
102272299|NCT05323617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272300|NCT05323617|Antifungal Agents|antifungal agents|mesh-ancestor
102272301|NCT05323617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102272302|NCT05323617|Dermatologic Agents|dermatologic agents|mesh-ancestor
102272303|NCT05323617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102272304|NCT05323617|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102272305|NCT05306873|Mycophenolic Acid|mycophenolic acid|mesh-list
102272306|NCT05306873|Cyclosporine|cyclosporine|mesh-list
102272307|NCT05306873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102272308|NCT05306873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272309|NCT05306873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102272310|NCT05306873|Antitubercular Agents|antitubercular agents|mesh-ancestor
102272311|NCT05306873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102272312|NCT05306873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102272313|NCT05306873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102272314|NCT05306873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272315|NCT05306873|Antifungal Agents|antifungal agents|mesh-ancestor
102272316|NCT05306873|Dermatologic Agents|dermatologic agents|mesh-ancestor
102272317|NCT05306873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102272318|NCT05306873|Immunologic Factors|immunologic factors|mesh-ancestor
102272319|NCT05306873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272320|NCT05306873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102272321|NCT05306873|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102272322|NCT05289687|Daratumumab|daratumumab|mesh-list
102272323|NCT05289687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102272324|NCT05289687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101902639|NCT01192724|Analgesics|analgesics|mesh-ancestor
102272325|NCT05289687|Immunologic Factors|immunologic factors|mesh-ancestor
102272326|NCT05289687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272327|NCT05272384|Nivolumab|nivolumab|mesh-list
102272328|NCT05272384|Decitabine|decitabine|mesh-list
102272329|NCT05272384|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
102272330|NCT05272384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102272331|NCT05272384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272332|NCT05272384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102272333|NCT05272384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272334|NCT05272384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101667987|NCT02749656|Hormones|hormones|mesh-ancestor
102272335|NCT05272384|Antimetabolites|antimetabolites|mesh-ancestor
102272336|NCT05272384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102272337|NCT05251233|Pantoprazole|pantoprazole|mesh-list
102272338|NCT05251233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102272339|NCT05251233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102272340|NCT05251233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102272341|NCT05251233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102272342|NCT05251233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272343|NCT05229965|Acetaminophen|acetaminophen|mesh-list
102272344|NCT05229965|Codeine|codeine|mesh-list
102272345|NCT05229965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102272346|NCT05229965|Analgesics|analgesics|mesh-ancestor
102272347|NCT05229965|Sensory System Agents|sensory system agents|mesh-ancestor
102272348|NCT05229965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102272349|NCT05229965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272350|NCT05229965|Antipyretics|antipyretics|mesh-ancestor
102272351|NCT05229965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102272352|NCT05229965|Narcotics|narcotics|mesh-ancestor
101668106|NCT04216758|Paclitaxel|paclitaxel|mesh-list
102272353|NCT05229965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102272354|NCT05229965|Antitussive Agents|antitussive agents|mesh-ancestor
102272355|NCT05229965|Respiratory System Agents|respiratory system agents|mesh-ancestor
102272356|NCT05227391|Letrozole|letrozole|mesh-list
102272357|NCT05227391|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102272358|NCT05227391|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102272359|NCT05227391|Estradiol|estradiol|mesh-list
102272360|NCT05227391|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102272361|NCT05227391|Estrogens|estrogens|mesh-ancestor
102272362|NCT05227391|Hormones|hormones|mesh-ancestor
102272363|NCT05227391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102272364|NCT05227391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272365|NCT05227391|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102272366|NCT05227391|Contraceptive Agents|contraceptive agents|mesh-ancestor
102272367|NCT05227391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102272368|NCT05227391|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102272369|NCT05227391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272370|NCT05227391|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102272371|NCT05227391|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102272372|NCT05227391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102272373|NCT05227391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272374|NCT05227391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102272375|NCT05227391|Hormone Antagonists|hormone antagonists|mesh-ancestor
102272376|NCT05224141|Carboplatin|carboplatin|mesh-list
102272377|NCT05224141|Pembrolizumab|pembrolizumab|mesh-list
102272378|NCT05224141|Etoposide|etoposide|mesh-list
102272379|NCT05224141|Atezolizumab|atezolizumab|mesh-list
102272380|NCT05224141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272381|NCT05224141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102614239|NCT00423215|Insulin Glargine|insulin glargine|mesh-list
102614240|NCT00423215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102614241|NCT00423215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614242|NCT00003413|Paclitaxel|paclitaxel|mesh-list
102614243|NCT00003413|Melphalan|melphalan|mesh-list
102614244|NCT00003413|Carmustine|carmustine|mesh-list
102614245|NCT00003413|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102614246|NCT00003413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614247|NCT00003413|Tubulin Modulators|tubulin modulators|mesh-ancestor
102614248|NCT00003413|Antimitotic Agents|antimitotic agents|mesh-ancestor
102614249|NCT00003413|Mitosis Modulators|mitosis modulators|mesh-ancestor
102614250|NCT00003413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102614251|NCT00003413|Immunologic Factors|immunologic factors|mesh-ancestor
102614252|NCT00003413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614253|NCT00003413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102614254|NCT00003413|Alkylating Agents|alkylating agents|mesh-ancestor
102272382|NCT05224141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102614255|NCT00003413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102614256|NCT00003413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102272383|NCT05224141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272384|NCT05224141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102272385|NCT05224141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102272386|NCT05224141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102272387|NCT05224141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102272388|NCT05207709|Paclitaxel|paclitaxel|mesh-list
102272389|NCT05207709|Letrozole|letrozole|mesh-list
102272390|NCT05207709|Fulvestrant|fulvestrant|mesh-list
102272391|NCT05207709|Tislelizumab|tislelizumab|mesh-list
102272392|NCT05207709|Palbociclib|palbociclib|mesh-list
102272393|NCT05207709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102272394|NCT05207709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272395|NCT05207709|Tubulin Modulators|tubulin modulators|mesh-ancestor
102272396|NCT05207709|Antimitotic Agents|antimitotic agents|mesh-ancestor
102272397|NCT05207709|Mitosis Modulators|mitosis modulators|mesh-ancestor
101668346|NCT05658692|Simendan|simendan|mesh-list
102272398|NCT05207709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272399|NCT05207709|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102272400|NCT05207709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102272401|NCT05207709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102272402|NCT05207709|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102272403|NCT05207709|Hormone Antagonists|hormone antagonists|mesh-ancestor
102272404|NCT05207709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102272405|NCT05207709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272406|NCT05207709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101668400|NCT05658692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101668401|NCT05658692|Respiratory System Agents|respiratory system agents|mesh-ancestor
101668402|NCT05658692|Mydriatics|mydriatics|mesh-ancestor
101668403|NCT05658692|Sympathomimetics|sympathomimetics|mesh-ancestor
101668404|NCT05658692|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101668405|NCT05658692|Anticonvulsants|anticonvulsants|mesh-ancestor
101668406|NCT05658692|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101668407|NCT05658692|Vasodilator Agents|vasodilator agents|mesh-ancestor
101668410|NCT05658692|Protective Agents|protective agents|mesh-ancestor
102272407|NCT05207709|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102272408|NCT05207709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102272409|NCT05207709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102272410|NCT05203276|Endostar protein|endostar protein|mesh-list
102272411|NCT05203276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102272412|NCT05203276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102272413|NCT05203276|Growth Substances|growth substances|mesh-ancestor
102272414|NCT05203276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272415|NCT05203276|Growth Inhibitors|growth inhibitors|mesh-ancestor
102272416|NCT05203276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272417|NCT05201066|Azacitidine|azacitidine|mesh-list
102272418|NCT05201066|Decitabine|decitabine|mesh-list
102272419|NCT05201066|Venetoclax|venetoclax|mesh-list
102272420|NCT05201066|Spartalizumab|spartalizumab|mesh-list
102272421|NCT05201066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102272422|NCT05201066|Antimetabolites|antimetabolites|mesh-ancestor
102272423|NCT05201066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272424|NCT05201066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272425|NCT05201066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102272426|NCT05201066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102272427|NCT05201066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102272428|NCT05192200|Interferons|interferons|mesh-list
102272429|NCT05192200|Interferon-beta|interferon-beta|mesh-list
102272430|NCT05192200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272431|NCT05192200|Antiviral Agents|antiviral agents|mesh-ancestor
102272432|NCT05192200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102272433|NCT05192200|Immunologic Factors|immunologic factors|mesh-ancestor
102272434|NCT05192200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272435|NCT05175105|Mitapivat|mitapivat|mesh-list
102272436|NCT05175105|Enzyme Activators|enzyme activators|mesh-ancestor
102272437|NCT05175105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272438|NCT05169437|Niraparib|niraparib|mesh-list
102272439|NCT05169437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102272440|NCT05169437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102272441|NCT05169437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272442|NCT05169437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272443|NCT05167487|Cisplatin|cisplatin|mesh-list
102272444|NCT05167487|Carboplatin|carboplatin|mesh-list
102272445|NCT05167487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272446|NCT05163808|BPN14770|bpn14770|mesh-list
102272447|NCT05163808|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102272448|NCT05163808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102272449|NCT05163808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102272450|NCT05163808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272451|NCT05159778|Pembrolizumab|pembrolizumab|mesh-list
102272452|NCT05159778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102272453|NCT05159778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272454|NCT05159778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102272455|NCT05159778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272456|NCT05159050|Paclitaxel|paclitaxel|mesh-list
102614257|NCT00003137|Irinotecan|irinotecan|mesh-list
102272457|NCT05159050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101668652|NCT00606983|Tamsulosin|tamsulosin|mesh-list
102272458|NCT05159050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272459|NCT05159050|Tubulin Modulators|tubulin modulators|mesh-ancestor
102272460|NCT05159050|Antimitotic Agents|antimitotic agents|mesh-ancestor
102272461|NCT05159050|Mitosis Modulators|mitosis modulators|mesh-ancestor
102272462|NCT05159050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272463|NCT05152888|Evolocumab|evolocumab|mesh-list
102272464|NCT05152888|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102272465|NCT05152888|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102272466|NCT05152888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102272467|NCT05152888|Antimetabolites|antimetabolites|mesh-ancestor
102272468|NCT05152888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272469|NCT05152888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102272470|NCT05152888|Protease Inhibitors|protease inhibitors|mesh-ancestor
102272471|NCT05152888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102272472|NCT05152888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102272473|NCT05151484|Alendronate|alendronate|mesh-list
102272474|NCT05151484|Teriparatide|teriparatide|mesh-list
102272475|NCT05151484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102272476|NCT05151484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272477|NCT05151484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102272478|NCT05144256|Mitapivat|mitapivat|mesh-list
102272479|NCT05144256|Enzyme Activators|enzyme activators|mesh-ancestor
102272480|NCT05144256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272481|NCT05131828|Metformin|metformin|mesh-list
102272482|NCT05131828|Clemastine|clemastine|mesh-list
102272483|NCT05131828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102272484|NCT05131828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272485|NCT05131828|Antipruritics|antipruritics|mesh-ancestor
102272486|NCT05131828|Dermatologic Agents|dermatologic agents|mesh-ancestor
102272487|NCT05131828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102272488|NCT05131828|Histamine Antagonists|histamine antagonists|mesh-ancestor
102272489|NCT05131828|Histamine Agents|histamine agents|mesh-ancestor
102272490|NCT05131828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102272491|NCT05131828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272492|NCT05131828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102272493|NCT05122546|Nivolumab|nivolumab|mesh-list
101668840|NCT04239170|Antimetabolites|antimetabolites|mesh-ancestor
102272494|NCT05122546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102272495|NCT05122546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272496|NCT05122546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102272497|NCT05122546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272498|NCT05120895|Pravastatin|pravastatin|mesh-list
102272499|NCT05120895|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102272500|NCT05120895|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102272501|NCT05120895|Antimetabolites|antimetabolites|mesh-ancestor
102272502|NCT05120895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272503|NCT05120895|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102272504|NCT05120895|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102272505|NCT05120895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102272506|NCT05113537|177Lu-PSMA-617|177lu-psma-617|mesh-list
102272507|NCT05113537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272508|NCT05113537|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102272509|NCT05110300|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102272510|NCT05110300|Luteolytic Agents|luteolytic agents|mesh-ancestor
102272511|NCT05110300|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102272512|NCT05110300|Contraceptive Agents|contraceptive agents|mesh-ancestor
102272513|NCT05110300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102272514|NCT05110300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272515|NCT05110300|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102272516|NCT05110300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102272517|NCT05110300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272518|NCT05104554|Folic Acid|folic acid|mesh-list
102272519|NCT05104554|Micronutrients|micronutrients|mesh-list
102272520|NCT05104554|Trace Elements|trace elements|mesh-list
102272521|NCT05104554|Hematinics|hematinics|mesh-ancestor
102272522|NCT05104554|Vitamin B Complex|vitamin b complex|mesh-ancestor
102272523|NCT05104554|Vitamins|vitamins|mesh-ancestor
102272524|NCT05104554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272525|NCT05101551|Gemcitabine|gemcitabine|mesh-list
102272526|NCT05101551|Topotecan|topotecan|mesh-list
102272527|NCT05101551|Talazoparib|talazoparib|mesh-list
102272528|NCT05101551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102614258|NCT00003137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102614259|NCT00003137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102614260|NCT00003137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102272529|NCT05101551|Antimetabolites|antimetabolites|mesh-ancestor
102272530|NCT05101551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272531|NCT05101551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272532|NCT05101551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102272533|NCT05101551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102272534|NCT05101551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102272535|NCT05101551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102272536|NCT05088252|Propofol|propofol|mesh-list
102272537|NCT05088252|Desflurane|desflurane|mesh-list
102272538|NCT05088252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102272539|NCT05088252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102272540|NCT05088252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272541|NCT05088252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102272542|NCT05088252|Anesthetics, General|anesthetics, general|mesh-ancestor
102272543|NCT05088252|Anesthetics|anesthetics|mesh-ancestor
102272544|NCT05088252|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102272545|NCT05073575|Hyaluronic Acid|hyaluronic acid|mesh-list
102272546|NCT05073575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102272547|NCT05073575|Immunologic Factors|immunologic factors|mesh-ancestor
102272548|NCT05073575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272549|NCT05073575|Viscosupplements|viscosupplements|mesh-ancestor
102272550|NCT05073575|Protective Agents|protective agents|mesh-ancestor
102272551|NCT05073003|Vaccines|vaccines|mesh-list
102272552|NCT05073003|Immunologic Factors|immunologic factors|mesh-ancestor
102272553|NCT05073003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272554|NCT05069298|Silybin|silybin|mesh-list
102272555|NCT05069298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102272556|NCT05069298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272557|NCT05069298|Protective Agents|protective agents|mesh-ancestor
101669240|NCT00939341|Hormones|hormones|mesh-ancestor
102272558|NCT05069298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272559|NCT05047640|Vaccines|vaccines|mesh-list
102272560|NCT05047640|Immunologic Factors|immunologic factors|mesh-ancestor
102272561|NCT05047640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272562|NCT05046314|Vincristine|vincristine|mesh-list
102272563|NCT05046314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102272564|NCT05046314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272565|NCT05046314|Tubulin Modulators|tubulin modulators|mesh-ancestor
102272566|NCT05046314|Antimitotic Agents|antimitotic agents|mesh-ancestor
102272567|NCT05046314|Mitosis Modulators|mitosis modulators|mesh-ancestor
102272568|NCT05046314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272569|NCT05043714|Nivolumab|nivolumab|mesh-list
102272570|NCT05043714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102272571|NCT05043714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272572|NCT05043714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102272573|NCT05043714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272574|NCT05039073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102272575|NCT05039073|Nivolumab|nivolumab|mesh-list
102272576|NCT05039073|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102272577|NCT05039073|Antibodies|antibodies|mesh-list
102272578|NCT05039073|Immunoglobulins|immunoglobulins|mesh-list
102272579|NCT05039073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102272580|NCT05039073|Immunoconjugates|immunoconjugates|mesh-list
102272581|NCT05039073|Immunologic Factors|immunologic factors|mesh-ancestor
102272582|NCT05039073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272583|NCT05039073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272584|NCT05039073|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102272585|NCT05039073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272586|NCT05039073|Immunotoxins|immunotoxins|mesh-ancestor
102272587|NCT05038228|Vitamin K|vitamin k|mesh-list
102272588|NCT05038228|Rivaroxaban|rivaroxaban|mesh-list
102272589|NCT05038228|Apixaban|apixaban|mesh-list
102272590|NCT05038228|Dabigatran|dabigatran|mesh-list
102272591|NCT05038228|Vitamins|vitamins|mesh-ancestor
102272592|NCT05038228|Micronutrients|micronutrients|mesh-ancestor
102272593|NCT05038228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272594|NCT05038228|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102272595|NCT05038228|Antithrombins|antithrombins|mesh-ancestor
102272596|NCT05038228|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102272597|NCT05038228|Protease Inhibitors|protease inhibitors|mesh-ancestor
102272598|NCT05038228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102272599|NCT05038228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272600|NCT05038228|Anticoagulants|anticoagulants|mesh-ancestor
102272601|NCT05038228|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102272602|NCT05038228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102272603|NCT05038228|Hemostatics|hemostatics|mesh-ancestor
102272604|NCT05038228|Coagulants|coagulants|mesh-ancestor
102272605|NCT05031780|Mitapivat|mitapivat|mesh-list
102272606|NCT05031780|Enzyme Activators|enzyme activators|mesh-ancestor
101981407|NCT03473340|Pirfenidone|pirfenidone|mesh-list
102272607|NCT05031780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272608|NCT05029999|Doxorubicin|doxorubicin|mesh-list
102272609|NCT05029999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102272610|NCT05029999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102272611|NCT05029999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272612|NCT05029999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102272613|NCT05029999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102272614|NCT05029999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102272615|NCT05029999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272617|NCT05023967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102272618|NCT05023967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272619|NCT05022004|Brinzolamide|brinzolamide|mesh-list
102272620|NCT05022004|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102272621|NCT05022004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102272622|NCT05022004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272623|NCT05012254|Paclitaxel|paclitaxel|mesh-list
102272624|NCT05012254|Cisplatin|cisplatin|mesh-list
102272625|NCT05012254|Carboplatin|carboplatin|mesh-list
102272626|NCT05012254|Nivolumab|nivolumab|mesh-list
102272627|NCT05012254|Pemetrexed|pemetrexed|mesh-list
102272628|NCT05012254|Ipilimumab|ipilimumab|mesh-list
102272629|NCT05012254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102272630|NCT05012254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272631|NCT05012254|Tubulin Modulators|tubulin modulators|mesh-ancestor
102272632|NCT05012254|Antimitotic Agents|antimitotic agents|mesh-ancestor
102272633|NCT05012254|Mitosis Modulators|mitosis modulators|mesh-ancestor
102272634|NCT05012254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669570|NCT05702827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669571|NCT05702827|Sensory System Agents|sensory system agents|mesh-ancestor
101669572|NCT05702827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101669573|NCT05702827|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101669574|NCT05702827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101669575|NCT05702827|Analgesics|analgesics|mesh-ancestor
101669576|NCT05702827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101669577|NCT05702827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101669578|NCT05702827|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101669579|NCT05702827|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101669580|NCT05702827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101669581|NCT05702827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669583|NCT05685628|Antidotes|antidotes|mesh-ancestor
101669584|NCT05685628|Protective Agents|protective agents|mesh-ancestor
101669585|NCT05685628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669586|NCT05673889|Dabigatran|dabigatran|mesh-list
101669587|NCT05673889|Antithrombins|antithrombins|mesh-ancestor
101669588|NCT05673889|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102272635|NCT05012254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102272636|NCT05012254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102272637|NCT05012254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102272638|NCT05012254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102272639|NCT05012254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102272640|NCT04995978|Pioglitazone|pioglitazone|mesh-list
102272641|NCT04995978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102272642|NCT04995978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272643|NCT04987294|Rasburicase|rasburicase|mesh-list
102272644|NCT04987294|Gout Suppressants|gout suppressants|mesh-ancestor
102272645|NCT04987294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102272646|NCT04987242|Rasburicase|rasburicase|mesh-list
102272647|NCT04987242|Gout Suppressants|gout suppressants|mesh-ancestor
102272648|NCT04987242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102272649|NCT04976192|Omalizumab|omalizumab|mesh-list
102272650|NCT04976192|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102272651|NCT04976192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102272652|NCT04976192|Respiratory System Agents|respiratory system agents|mesh-ancestor
102272653|NCT04958486|Trastuzumab|trastuzumab|mesh-list
102272654|NCT04958486|Azacitidine|azacitidine|mesh-list
102272655|NCT04958486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102272656|NCT04958486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272657|NCT04958486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102272658|NCT04958486|Antimetabolites|antimetabolites|mesh-ancestor
102272659|NCT04958486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272660|NCT04958486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102272661|NCT04942210|Vaccines|vaccines|mesh-list
102272662|NCT04942210|Immunologic Factors|immunologic factors|mesh-ancestor
102272663|NCT04942210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272664|NCT04940767|Minocycline|minocycline|mesh-list
102272665|NCT04940767|Isotretinoin|isotretinoin|mesh-list
102272666|NCT04940767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102272667|NCT04940767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102272668|NCT04940767|Dermatologic Agents|dermatologic agents|mesh-ancestor
102272669|NCT04929223|Bevacizumab|bevacizumab|mesh-list
102272670|NCT04929223|Cetuximab|cetuximab|mesh-list
102272671|NCT04929223|Atezolizumab|atezolizumab|mesh-list
102272672|NCT04929223|Inavolisib|inavolisib|mesh-list
102272673|NCT04929223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102272674|NCT04929223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272675|NCT04929223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102272676|NCT04929223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102272677|NCT04929223|Growth Substances|growth substances|mesh-ancestor
102272678|NCT04929223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614261|NCT00003137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669825|NCT05136560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102614262|NCT00003137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614263|NCT00003419|Antiviral Agents|antiviral agents|mesh-list
102614264|NCT00003419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102272679|NCT04929223|Growth Inhibitors|growth inhibitors|mesh-ancestor
102272680|NCT04929223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102272681|NCT04929223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272682|NCT04929223|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
102272683|NCT04929223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102272685|NCT04925986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102272686|NCT04925986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272687|NCT04925986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102272688|NCT04925986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272689|NCT04913805|Niacinamide|niacinamide|mesh-list
102272690|NCT04913805|Niacin|niacin|mesh-list
102272691|NCT04913805|Nicotinic Acids|nicotinic acids|mesh-list
102272692|NCT04913805|Vitamin B Complex|vitamin b complex|mesh-ancestor
102272693|NCT04913805|Vitamins|vitamins|mesh-ancestor
102272694|NCT04913805|Micronutrients|micronutrients|mesh-ancestor
102272695|NCT04913805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272696|NCT04913805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102272697|NCT04913805|Antimetabolites|antimetabolites|mesh-ancestor
102272698|NCT04913805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272699|NCT04913805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102272700|NCT04913805|Vasodilator Agents|vasodilator agents|mesh-ancestor
102272701|NCT04907968|Carboplatin|carboplatin|mesh-list
102272702|NCT04907968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272703|NCT04900220|Methylprednisolone|methylprednisolone|mesh-list
102272704|NCT04900220|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102272705|NCT04900220|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102272706|NCT04900220|Prednisolone|prednisolone|mesh-list
102272707|NCT04900220|Prednisolone acetate|prednisolone acetate|mesh-list
102272708|NCT04900220|Betamethasone|betamethasone|mesh-list
102272709|NCT04900220|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102272710|NCT04900220|Prednisolone phosphate|prednisolone phosphate|mesh-list
102272711|NCT04900220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102272712|NCT04900220|Antiemetics|antiemetics|mesh-ancestor
102272713|NCT04900220|Autonomic Agents|autonomic agents|mesh-ancestor
102272714|NCT04900220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102272715|NCT04900220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272716|NCT04900220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102272717|NCT04900220|Glucocorticoids|glucocorticoids|mesh-ancestor
102272718|NCT04900220|Hormones|hormones|mesh-ancestor
102272719|NCT04900220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102272720|NCT04900220|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102272721|NCT04900220|Protective Agents|protective agents|mesh-ancestor
102272722|NCT04900220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102272723|NCT04900220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272724|NCT04900220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102272725|NCT04900220|Respiratory System Agents|respiratory system agents|mesh-ancestor
102272726|NCT04896320|Tucatinib|tucatinib|mesh-list
102272727|NCT04896320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272728|NCT04896320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102272729|NCT04896320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101670102|NCT04303195|Metopimazine|metopimazine|mesh-list
102272730|NCT04896320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272731|NCT04887259|Interleukin-2|interleukin-2|mesh-list
102272732|NCT04887259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272733|NCT04887259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102272734|NCT04887259|Analgesics|analgesics|mesh-ancestor
102272735|NCT04887259|Sensory System Agents|sensory system agents|mesh-ancestor
102272736|NCT04887259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102272737|NCT04887259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272738|NCT04877613|Cyclophosphamide|cyclophosphamide|mesh-list
102272739|NCT04877613|Fludarabine|fludarabine|mesh-list
102272740|NCT04877613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102272741|NCT04877613|Immunologic Factors|immunologic factors|mesh-ancestor
102272742|NCT04877613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272743|NCT04877613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102272744|NCT04877613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102272745|NCT04877613|Alkylating Agents|alkylating agents|mesh-ancestor
102272746|NCT04877613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272747|NCT04877613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272748|NCT04877613|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102272749|NCT04875195|Pembrolizumab|pembrolizumab|mesh-list
102272750|NCT04875195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102272751|NCT04875195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272752|NCT04875195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101670224|NCT03958565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272753|NCT04875195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272754|NCT04871607|Cytarabine|cytarabine|mesh-list
102272755|NCT04871607|Etoposide|etoposide|mesh-list
102272756|NCT04871607|Podophyllotoxin|podophyllotoxin|mesh-list
102272757|NCT04871607|Etoposide phosphate|etoposide phosphate|mesh-list
102272758|NCT04871607|Carmustine|carmustine|mesh-list
102272759|NCT04871607|Basiliximab|basiliximab|mesh-list
102272760|NCT04871607|Lenograstim|lenograstim|mesh-list
102272761|NCT04871607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102272762|NCT04871607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272763|NCT04871607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102272764|NCT04871607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102272765|NCT04871607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101670310|NCT03164564|Tenofovir|tenofovir|mesh-list
102272766|NCT04871607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272767|NCT04871607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102272768|NCT04871607|Antimetabolites|antimetabolites|mesh-ancestor
102272769|NCT04871607|Antiviral Agents|antiviral agents|mesh-ancestor
102272770|NCT04871607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102272771|NCT04871607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102272772|NCT04871607|Immunologic Factors|immunologic factors|mesh-ancestor
102272773|NCT04871607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272774|NCT04871607|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102272775|NCT04871607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102272776|NCT04871607|Alkylating Agents|alkylating agents|mesh-ancestor
102272777|NCT04871607|Keratolytic Agents|keratolytic agents|mesh-ancestor
102272778|NCT04871607|Dermatologic Agents|dermatologic agents|mesh-ancestor
102272779|NCT04871607|Tubulin Modulators|tubulin modulators|mesh-ancestor
102272780|NCT04871607|Antimitotic Agents|antimitotic agents|mesh-ancestor
102272781|NCT04871607|Mitosis Modulators|mitosis modulators|mesh-ancestor
102272782|NCT04865042|Gabapentin|gabapentin|mesh-list
102272783|NCT04865042|Analgesics|analgesics|mesh-ancestor
102272784|NCT04865042|Sensory System Agents|sensory system agents|mesh-ancestor
101670372|NCT02987257|Analgesics|analgesics|mesh-ancestor
102272785|NCT04865042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102272786|NCT04865042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272787|NCT04865042|Anticonvulsants|anticonvulsants|mesh-ancestor
102272788|NCT04865042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102272789|NCT04865042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102272790|NCT04865042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102272791|NCT04865042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102272792|NCT04865042|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102272793|NCT04865042|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102272794|NCT04865042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102272795|NCT04865042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272796|NCT04865042|Antimanic Agents|antimanic agents|mesh-ancestor
102272797|NCT04851964|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102272798|NCT04851964|Immunologic Factors|immunologic factors|mesh-ancestor
102272799|NCT04851964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272800|NCT04833790|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102272801|NCT04833790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102272802|NCT04830592|Pembrolizumab|pembrolizumab|mesh-list
102272803|NCT04830592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102272804|NCT04830592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272805|NCT04830592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102272806|NCT04830592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272807|NCT04824131|Tenofovir|tenofovir|mesh-list
102272808|NCT04824131|Emtricitabine|emtricitabine|mesh-list
102272809|NCT04824131|Cabotegravir|cabotegravir|mesh-list
102272810|NCT04824131|Antiviral Agents|antiviral agents|mesh-ancestor
102272811|NCT04824131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102272812|NCT04824131|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102272813|NCT04824131|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102272814|NCT04824131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102272815|NCT04824131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272816|NCT04824131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102272817|NCT04824131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102272818|NCT04824131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102272819|NCT04824131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102272820|NCT04776447|Carboplatin|carboplatin|mesh-list
102272821|NCT04776447|Atezolizumab|atezolizumab|mesh-list
102272822|NCT04776447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272823|NCT04776447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102272824|NCT04776447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272825|NCT04776447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102272826|NCT04770779|Mitapivat|mitapivat|mesh-list
102272827|NCT04770779|Enzyme Activators|enzyme activators|mesh-ancestor
102272828|NCT04770779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272829|NCT04770753|Mitapivat|mitapivat|mesh-list
102614265|NCT00003425|Cyclophosphamide|cyclophosphamide|mesh-list
102614266|NCT00003425|Melphalan|melphalan|mesh-list
102272830|NCT04770753|Enzyme Activators|enzyme activators|mesh-ancestor
102272831|NCT04770753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272832|NCT04768504|Tofacitinib|tofacitinib|mesh-list
102272833|NCT04768504|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102272834|NCT04768504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102272835|NCT04768504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102272836|NCT04768504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272837|NCT04748172|Antibodies|antibodies|mesh-list
102272838|NCT04748172|Immunologic Factors|immunologic factors|mesh-ancestor
102272839|NCT04748172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272840|NCT04736823|Paclitaxel|paclitaxel|mesh-list
102272841|NCT04736823|Docetaxel|docetaxel|mesh-list
102272842|NCT04736823|Carboplatin|carboplatin|mesh-list
102272843|NCT04736823|Pemetrexed|pemetrexed|mesh-list
102272844|NCT04736823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102272845|NCT04736823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272846|NCT04736823|Tubulin Modulators|tubulin modulators|mesh-ancestor
102272847|NCT04736823|Antimitotic Agents|antimitotic agents|mesh-ancestor
102272848|NCT04736823|Mitosis Modulators|mitosis modulators|mesh-ancestor
102272849|NCT04736823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272850|NCT04736823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102272851|NCT04736823|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102272852|NCT04736823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102272853|NCT04729621|Denosumab|denosumab|mesh-list
102272854|NCT04729621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102272855|NCT04729621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272856|NCT04725383|Amitriptyline|amitriptyline|mesh-list
102272857|NCT04725383|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102272858|NCT04725383|Antidepressive Agents|antidepressive agents|mesh-ancestor
102272859|NCT04725383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102272860|NCT04725383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102272861|NCT04725383|Analgesics|analgesics|mesh-ancestor
102272862|NCT04725383|Sensory System Agents|sensory system agents|mesh-ancestor
102272863|NCT04725383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102272864|NCT04725383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272865|NCT04725383|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102272866|NCT04725383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102272867|NCT04725383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102272868|NCT04725383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272869|NCT04725383|Adrenergic Agents|adrenergic agents|mesh-ancestor
102272870|NCT04725383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102272871|NCT04664023|Vaccines|vaccines|mesh-list
102272872|NCT04664023|Immunologic Factors|immunologic factors|mesh-ancestor
102272873|NCT04664023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272874|NCT04655755|Decitabine|decitabine|mesh-list
102272875|NCT04655755|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
102272876|NCT04655755|Venetoclax|venetoclax|mesh-list
102272877|NCT04655755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102272878|NCT04655755|Antimetabolites|antimetabolites|mesh-ancestor
102272879|NCT04655755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272880|NCT04655755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272881|NCT04655755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102272882|NCT04633889|Deferoxamine|deferoxamine|mesh-list
102272883|NCT04633889|Siderophores|siderophores|mesh-ancestor
101670619|NCT02808104|Dopamine Agents|dopamine agents|mesh-ancestor
102272884|NCT04633889|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102272885|NCT04633889|Chelating Agents|chelating agents|mesh-ancestor
102272886|NCT04633889|Sequestering Agents|sequestering agents|mesh-ancestor
102272887|NCT04633889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272888|NCT04630886|Lidocaine|lidocaine|mesh-list
102272889|NCT04630886|Epinephrine|epinephrine|mesh-list
102272890|NCT04630886|Tranexamic Acid|tranexamic acid|mesh-list
102272891|NCT04630886|Anesthetics, Local|anesthetics, local|mesh-ancestor
102272892|NCT04630886|Anesthetics|anesthetics|mesh-ancestor
102272893|NCT04630886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102272894|NCT04630886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272895|NCT04630886|Sensory System Agents|sensory system agents|mesh-ancestor
102272896|NCT04630886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102272897|NCT04630886|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102272898|NCT04630886|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102272899|NCT04630886|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102272900|NCT04630886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102272901|NCT04630886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272902|NCT04630886|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101902670|NCT01192802|Anticestodal Agents|anticestodal agents|mesh-ancestor
102614267|NCT00003425|Amifostine|amifostine|mesh-list
102614268|NCT00003425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102272903|NCT04630886|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102272904|NCT04630886|Hemostatics|hemostatics|mesh-ancestor
102272905|NCT04630886|Coagulants|coagulants|mesh-ancestor
102272906|NCT04630886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102272907|NCT04630886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102272908|NCT04630886|Adrenergic Agents|adrenergic agents|mesh-ancestor
102272909|NCT04630886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101981701|NCT03574792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102272910|NCT04630886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102272911|NCT04630886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102272913|NCT04630886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102272914|NCT04630886|Respiratory System Agents|respiratory system agents|mesh-ancestor
102272915|NCT04630886|Mydriatics|mydriatics|mesh-ancestor
102272916|NCT04630886|Sympathomimetics|sympathomimetics|mesh-ancestor
102272917|NCT04630886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102272918|NCT04622228|Carboplatin|carboplatin|mesh-list
102272919|NCT04622228|Etoposide|etoposide|mesh-list
102272920|NCT04622228|Atezolizumab|atezolizumab|mesh-list
102272921|NCT04622228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272922|NCT04622228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102272923|NCT04622228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102272924|NCT04622228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102272925|NCT04622228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102272926|NCT04622228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272927|NCT04622228|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102272928|NCT04622228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102272929|NCT04619316|Trametinib|trametinib|mesh-list
102272930|NCT04619316|Dabrafenib|dabrafenib|mesh-list
102272931|NCT04619316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272932|NCT04619316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102272933|NCT04619316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102272934|NCT04619316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272935|NCT04610528|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
102272936|NCT04610528|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102272937|NCT04610528|Immunologic Factors|immunologic factors|mesh-ancestor
101670901|NCT02739204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102272938|NCT04610528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272939|NCT04610528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102272940|NCT04610528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272941|NCT04609111|Aspirin|aspirin|mesh-list
102272942|NCT04609111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102272943|NCT04609111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102272944|NCT04609111|Analgesics|analgesics|mesh-ancestor
102272945|NCT04609111|Sensory System Agents|sensory system agents|mesh-ancestor
102272946|NCT04609111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102272947|NCT04609111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670976|NCT02805920|Bupivacaine|bupivacaine|mesh-list
102272948|NCT04609111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102272949|NCT04609111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102272950|NCT04609111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102272951|NCT04609111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102272952|NCT04609111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272953|NCT04609111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102272954|NCT04609111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102272955|NCT04609111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102272956|NCT04609111|Antipyretics|antipyretics|mesh-ancestor
102272957|NCT04599062|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
102272958|NCT04599062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102272959|NCT04599062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272960|NCT04590196|Curcumin|curcumin|mesh-list
102272961|NCT04590196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102272962|NCT04590196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102272963|NCT04590196|Analgesics|analgesics|mesh-ancestor
102272964|NCT04590196|Sensory System Agents|sensory system agents|mesh-ancestor
102272965|NCT04590196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102272966|NCT04590196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102272967|NCT04590196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102272968|NCT04590196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102272969|NCT04590196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272970|NCT04590196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102272971|NCT04590196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272972|NCT04589208|Ketamine|ketamine|mesh-list
102272973|NCT04589208|Analgesics|analgesics|mesh-ancestor
102272974|NCT04589208|Sensory System Agents|sensory system agents|mesh-ancestor
102272975|NCT04589208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102272976|NCT04589208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614269|NCT00003425|Immunologic Factors|immunologic factors|mesh-ancestor
102272977|NCT04589208|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102272978|NCT04589208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102272979|NCT04589208|Anesthetics, General|anesthetics, general|mesh-ancestor
102272980|NCT04589208|Anesthetics|anesthetics|mesh-ancestor
102272981|NCT04589208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102272982|NCT04589208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102272983|NCT04589208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102272984|NCT04589208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102272985|NCT04589208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272987|NCT04585815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272988|NCT04585815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102272989|NCT04585815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102272990|NCT04585815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272991|NCT04573192|Lomustine|lomustine|mesh-list
102272992|NCT04573192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102272993|NCT04573192|Alkylating Agents|alkylating agents|mesh-ancestor
102272994|NCT04573192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102272995|NCT04573192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102272996|NCT04566328|Dexamethasone|dexamethasone|mesh-list
102272997|NCT04566328|Dexamethasone acetate|dexamethasone acetate|mesh-list
102272998|NCT04566328|Lenalidomide|lenalidomide|mesh-list
102272999|NCT04566328|Bortezomib|bortezomib|mesh-list
102273000|NCT04566328|Daratumumab|daratumumab|mesh-list
102273001|NCT04566328|Ichthammol|ichthammol|mesh-list
102273002|NCT04566328|BB 1101|bb 1101|mesh-list
102273003|NCT04566328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102273004|NCT04566328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102273005|NCT04566328|Antiemetics|antiemetics|mesh-ancestor
102273006|NCT04566328|Autonomic Agents|autonomic agents|mesh-ancestor
102273007|NCT04566328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102273008|NCT04566328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273009|NCT04566328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102273010|NCT04566328|Glucocorticoids|glucocorticoids|mesh-ancestor
102273011|NCT04566328|Hormones|hormones|mesh-ancestor
102273012|NCT04566328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102273013|NCT04566328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102273014|NCT04566328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273015|NCT04566328|Protease Inhibitors|protease inhibitors|mesh-ancestor
102273016|NCT04566328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102273017|NCT04566328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671289|NCT05906433|Hormones|hormones|mesh-ancestor
102273018|NCT04566328|Immunologic Factors|immunologic factors|mesh-ancestor
102273019|NCT04566328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102273020|NCT04566328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102273021|NCT04566328|Growth Substances|growth substances|mesh-ancestor
102273022|NCT04566328|Growth Inhibitors|growth inhibitors|mesh-ancestor
102273023|NCT04566328|Dermatologic Agents|dermatologic agents|mesh-ancestor
102273024|NCT04559139|Cisplatin|cisplatin|mesh-list
102273025|NCT04559139|Gemcitabine|gemcitabine|mesh-list
102273026|NCT04559139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273027|NCT04559139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102273028|NCT04559139|Antimetabolites|antimetabolites|mesh-ancestor
102273029|NCT04559139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273030|NCT04557449|Letrozole|letrozole|mesh-list
102273031|NCT04557449|Fulvestrant|fulvestrant|mesh-list
102273032|NCT04557449|Midazolam|midazolam|mesh-list
102273033|NCT04557449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102273034|NCT04557449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102273035|NCT04557449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102273036|NCT04557449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273037|NCT04557449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102273038|NCT04557449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102273039|NCT04557449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102273040|NCT04557449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102273041|NCT04557449|Anesthetics, General|anesthetics, general|mesh-ancestor
102273042|NCT04557449|Anesthetics|anesthetics|mesh-ancestor
102273043|NCT04557449|GABA Modulators|gaba modulators|mesh-ancestor
102273044|NCT04557449|GABA Agents|gaba agents|mesh-ancestor
102273045|NCT04557449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102273046|NCT04557449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273047|NCT04557449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273048|NCT04557449|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102273049|NCT04557449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102273050|NCT04557449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101671464|NCT05843565|Cobalt|cobalt|mesh-list
102614270|NCT00003425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614271|NCT00003425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102273051|NCT04557449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102273052|NCT04557449|Hormone Antagonists|hormone antagonists|mesh-ancestor
102273053|NCT04557449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102273054|NCT04557449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102273055|NCT04557449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102273056|NCT04556773|Paclitaxel|paclitaxel|mesh-list
102273057|NCT04556773|Capecitabine|capecitabine|mesh-list
102273058|NCT04556773|Trastuzumab|trastuzumab|mesh-list
102273059|NCT04556773|Durvalumab|durvalumab|mesh-list
102273060|NCT04556773|Fulvestrant|fulvestrant|mesh-list
102273061|NCT04556773|Anastrozole|anastrozole|mesh-list
102273063|NCT04556773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102273064|NCT04556773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273065|NCT04556773|Tubulin Modulators|tubulin modulators|mesh-ancestor
102273066|NCT04556773|Antimitotic Agents|antimitotic agents|mesh-ancestor
102273067|NCT04556773|Mitosis Modulators|mitosis modulators|mesh-ancestor
102273068|NCT04556773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273069|NCT04556773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102273070|NCT04556773|Antimetabolites|antimetabolites|mesh-ancestor
102273071|NCT04556773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102273072|NCT04556773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102273073|NCT04556773|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102273074|NCT04556773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102273075|NCT04556773|Hormone Antagonists|hormone antagonists|mesh-ancestor
102273076|NCT04556773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102273077|NCT04556773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273078|NCT04556773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102273079|NCT04556773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102273080|NCT04556773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102273081|NCT04556773|Immunoconjugates|immunoconjugates|mesh-ancestor
102273082|NCT04556773|Immunologic Factors|immunologic factors|mesh-ancestor
102273083|NCT04551222|Probenecid|probenecid|mesh-list
102273084|NCT04551222|Uricosuric Agents|uricosuric agents|mesh-ancestor
102273085|NCT04551222|Gout Suppressants|gout suppressants|mesh-ancestor
101671612|NCT05538767|Albendazole|albendazole|mesh-list
102273086|NCT04551222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102273087|NCT04542148|Insulin|insulin|mesh-list
102273088|NCT04542148|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102273089|NCT04542148|Insulin Aspart|insulin aspart|mesh-list
102273090|NCT04542148|Insulin Lispro|insulin lispro|mesh-list
102273091|NCT04542148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102273092|NCT04542148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273093|NCT04527991|Paclitaxel|paclitaxel|mesh-list
102273094|NCT04527991|Docetaxel|docetaxel|mesh-list
102273095|NCT04527991|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
102273096|NCT04527991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102273097|NCT04527991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273098|NCT04527991|Tubulin Modulators|tubulin modulators|mesh-ancestor
102273099|NCT04527991|Antimitotic Agents|antimitotic agents|mesh-ancestor
102273100|NCT04527991|Mitosis Modulators|mitosis modulators|mesh-ancestor
102273101|NCT04527991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273102|NCT04527991|Immunoconjugates|immunoconjugates|mesh-ancestor
102273103|NCT04527991|Immunologic Factors|immunologic factors|mesh-ancestor
102273104|NCT04527991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273105|NCT04527549|Hydroxychloroquine|hydroxychloroquine|mesh-list
102273106|NCT04527549|Trametinib|trametinib|mesh-list
102273107|NCT04527549|Dabrafenib|dabrafenib|mesh-list
102273108|NCT04527549|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
102273109|NCT04527549|Antimalarials|antimalarials|mesh-ancestor
102273110|NCT04527549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102273111|NCT04527549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102273112|NCT04527549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102273113|NCT04527549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102273114|NCT04527549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273115|NCT04527549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102273116|NCT04527549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273117|NCT04527549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101671799|NCT05290727|Protective Agents|protective agents|mesh-ancestor
101671800|NCT05282706|Peppermint oil|peppermint oil|mesh-list
101671801|NCT05282706|Antiemetics|antiemetics|mesh-ancestor
101671802|NCT05282706|Autonomic Agents|autonomic agents|mesh-ancestor
101671803|NCT05282706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101671804|NCT05282706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671805|NCT05282706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101671806|NCT05282706|Parasympatholytics|parasympatholytics|mesh-ancestor
101671807|NCT05222984|Decitabine|decitabine|mesh-list
102273118|NCT04527549|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102273119|NCT04527549|Protective Agents|protective agents|mesh-ancestor
102273120|NCT04527549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273121|NCT04527549|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102273122|NCT04527549|Antioxidants|antioxidants|mesh-ancestor
102273123|NCT04512430|Bevacizumab|bevacizumab|mesh-list
102273124|NCT04512430|Atezolizumab|atezolizumab|mesh-list
102614272|NCT00003425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102273125|NCT04512430|Carboplatin|carboplatin|mesh-list
102273126|NCT04512430|Pemetrexed|pemetrexed|mesh-list
101671867|NCT04716725|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102273127|NCT04512430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102273129|NCT04512430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102273130|NCT04512430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102273131|NCT04512430|Growth Substances|growth substances|mesh-ancestor
102273132|NCT04512430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273133|NCT04512430|Growth Inhibitors|growth inhibitors|mesh-ancestor
102273134|NCT04512430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102273135|NCT04512430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273136|NCT04512430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102273137|NCT04512430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101671945|NCT04462523|Hormones|hormones|mesh-ancestor
102273138|NCT04512430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102273139|NCT04504669|Durvalumab|durvalumab|mesh-list
102273140|NCT04504669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102273141|NCT04504669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273142|NCT04502433|Poractant alfa|poractant alfa|mesh-list
102273143|NCT04502433|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
102273144|NCT04502433|Respiratory System Agents|respiratory system agents|mesh-ancestor
102273145|NCT04484818|Leuprolide|leuprolide|mesh-list
102273146|NCT04484818|Goserelin|goserelin|mesh-list
102273147|NCT04484818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102273148|NCT04484818|Tryptophan|tryptophan|mesh-list
102273149|NCT04484818|Androgen Antagonists|androgen antagonists|mesh-list
102273150|NCT04484818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101671998|NCT04352205|Bortezomib|bortezomib|mesh-list
102273151|NCT04484818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273152|NCT04484818|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102273153|NCT04484818|Fertility Agents|fertility agents|mesh-ancestor
102273154|NCT04484818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102273155|NCT04484818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102273156|NCT04484818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273157|NCT04484818|Luteolytic Agents|luteolytic agents|mesh-ancestor
102273158|NCT04484818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102273159|NCT04484818|Contraceptive Agents|contraceptive agents|mesh-ancestor
102273160|NCT04484818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102273161|NCT04484818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102273162|NCT04484818|Antidepressive Agents|antidepressive agents|mesh-ancestor
102273163|NCT04484818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102273164|NCT04484818|Hormone Antagonists|hormone antagonists|mesh-ancestor
102273165|NCT04484012|Acalabrutinib|acalabrutinib|mesh-list
102273166|NCT04484012|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102273167|NCT04484012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273168|NCT04484012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102273169|NCT04484012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102273170|NCT04484012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273171|NCT04477200|Mycophenolic Acid|mycophenolic acid|mesh-list
102273172|NCT04477200|Temozolomide|temozolomide|mesh-list
102273173|NCT04477200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102273174|NCT04477200|Alkylating Agents|alkylating agents|mesh-ancestor
102273175|NCT04477200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273176|NCT04477200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273177|NCT04477200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102273178|NCT04477200|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102273179|NCT04477200|Antitubercular Agents|antitubercular agents|mesh-ancestor
102273180|NCT04477200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102273181|NCT04477200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102273182|NCT04477200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102273183|NCT04455802|Morphine|morphine|mesh-list
102273184|NCT04455802|Buprenorphine|buprenorphine|mesh-list
102273185|NCT04455802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102273186|NCT04455802|Narcotics|narcotics|mesh-ancestor
102273187|NCT04455802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102273188|NCT04455802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273189|NCT04455802|Analgesics|analgesics|mesh-ancestor
101672183|NCT04007276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672184|NCT03969446|Pembrolizumab|pembrolizumab|mesh-list
101672185|NCT03969446|Decitabine|decitabine|mesh-list
101672186|NCT03969446|Venetoclax|venetoclax|mesh-list
101672187|NCT03969446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101672188|NCT03969446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672189|NCT03969446|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101672190|NCT03969446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672191|NCT03969446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101672192|NCT03969446|Antimetabolites|antimetabolites|mesh-ancestor
102273190|NCT04455802|Sensory System Agents|sensory system agents|mesh-ancestor
102273191|NCT04455802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102273192|NCT04455802|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102273193|NCT04443088|Pembrolizumab|pembrolizumab|mesh-list
102273194|NCT04443088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102273195|NCT04443088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273196|NCT04443088|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102273197|NCT04443088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273198|NCT04438382|Prednisone|prednisone|mesh-list
102273199|NCT04438382|Infliximab|infliximab|mesh-list
102614273|NCT00003425|Alkylating Agents|alkylating agents|mesh-ancestor
102273200|NCT04438382|Cortisone|cortisone|mesh-list
102614274|NCT00003425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273201|NCT04438382|Immunoglobulins|immunoglobulins|mesh-list
102273202|NCT04438382|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102273204|NCT04438382|gamma-Globulins|gamma-globulins|mesh-list
102273205|NCT04438382|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102273206|NCT04438382|Immunoglobulin G|immunoglobulin g|mesh-list
102273207|NCT04438382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102273208|NCT04438382|Glucocorticoids|glucocorticoids|mesh-ancestor
102273209|NCT04438382|Hormones|hormones|mesh-ancestor
102273210|NCT04438382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102273211|NCT04438382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273212|NCT04438382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102273213|NCT04438382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273214|NCT04438382|Immunologic Factors|immunologic factors|mesh-ancestor
102273215|NCT04438382|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102273216|NCT04438382|Dermatologic Agents|dermatologic agents|mesh-ancestor
102273217|NCT04438382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102273218|NCT04438382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102273219|NCT04434040|Atezolizumab|atezolizumab|mesh-list
102273220|NCT04434040|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
102273221|NCT04434040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101672375|NCT03370367|Tretinoin|tretinoin|mesh-list
102273222|NCT04434040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273223|NCT04434040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102273224|NCT04434040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273225|NCT04434040|Immunoconjugates|immunoconjugates|mesh-ancestor
102273226|NCT04434040|Immunologic Factors|immunologic factors|mesh-ancestor
102273227|NCT04434040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273228|NCT04426890|Omalizumab|omalizumab|mesh-list
102273229|NCT04426890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102273230|NCT04426890|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102273231|NCT04426890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102273232|NCT04426890|Respiratory System Agents|respiratory system agents|mesh-ancestor
102273233|NCT04426890|Immunologic Factors|immunologic factors|mesh-ancestor
102273234|NCT04426890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273235|NCT04417062|Olaparib|olaparib|mesh-list
102273236|NCT04417062|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102273237|NCT04417062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102273238|NCT04417062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273239|NCT04417062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273240|NCT04411914|Clavulanic Acids|clavulanic acids|mesh-list
102273241|NCT04411914|Clavulanic Acid|clavulanic acid|mesh-list
102273242|NCT04411914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102273243|NCT04411914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102273244|NCT04411914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102273245|NCT04411914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273246|NCT04411914|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102273247|NCT04411836|Primaquine|primaquine|mesh-list
102273248|NCT04411836|Tafenoquine|tafenoquine|mesh-list
102273249|NCT04411836|Antimalarials|antimalarials|mesh-ancestor
102273250|NCT04411836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102273251|NCT04411836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102273252|NCT04411836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102273253|NCT04395365|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102273254|NCT04395365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102273255|NCT04395365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102273256|NCT04395365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102273257|NCT04395365|Antimalarials|antimalarials|mesh-ancestor
102273258|NCT04395365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102273259|NCT04395365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102273260|NCT04389671|Pulmonary Surfactants|pulmonary surfactants|mesh-list
102273261|NCT04389671|Respiratory System Agents|respiratory system agents|mesh-ancestor
102273262|NCT04386057|Hydroxychloroquine|hydroxychloroquine|mesh-list
102273263|NCT04386057|Antimalarials|antimalarials|mesh-ancestor
102273264|NCT04386057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102273265|NCT04386057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102273266|NCT04386057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102273267|NCT04386057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102273268|NCT04386057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273269|NCT04386057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102273270|NCT04380545|Interferons|interferons|mesh-list
102273271|NCT04380545|Interferon-alpha|interferon-alpha|mesh-list
102273272|NCT04380545|Interferon alpha-2|interferon alpha-2|mesh-list
102273273|NCT04380545|Fluorouracil|fluorouracil|mesh-list
102273274|NCT04380545|Nivolumab|nivolumab|mesh-list
102273275|NCT04380545|Antimetabolites|antimetabolites|mesh-ancestor
102614275|NCT00003425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614276|NCT00003425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102273276|NCT04380545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273277|NCT04380545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102273278|NCT04380545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273279|NCT04380545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102273280|NCT04380545|Immunologic Factors|immunologic factors|mesh-ancestor
102273281|NCT04380545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273282|NCT04380545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102273283|NCT04380545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102273284|NCT04380545|Antiviral Agents|antiviral agents|mesh-ancestor
102273285|NCT04380545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102273286|NCT04364048|Cisplatin|cisplatin|mesh-list
102273287|NCT04364048|Carboplatin|carboplatin|mesh-list
102273288|NCT04364048|Etoposide|etoposide|mesh-list
102273289|NCT04364048|Pemetrexed|pemetrexed|mesh-list
102273290|NCT04364048|Durvalumab|durvalumab|mesh-list
102273291|NCT04364048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102273292|NCT04364048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672751|NCT00641030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102273293|NCT04364048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102273294|NCT04364048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102273295|NCT04364048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102273296|NCT04364048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102273297|NCT04364048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273298|NCT04364048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102273299|NCT04364048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102273300|NCT04364048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102273301|NCT04364048|Immunologic Factors|immunologic factors|mesh-ancestor
102273302|NCT04364048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273303|NCT04338269|Atezolizumab|atezolizumab|mesh-list
102273304|NCT04338269|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102273305|NCT04338269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273306|NCT04338269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102273307|NCT04338269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273308|NCT04328727|Cyclosporine|cyclosporine|mesh-list
102273309|NCT04328727|Cyclosporins|cyclosporins|mesh-list
102273310|NCT04328727|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102273311|NCT04328727|Thymoglobulin|thymoglobulin|mesh-list
102273312|NCT04328727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102273313|NCT04328727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273314|NCT04328727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102273315|NCT04328727|Immunologic Factors|immunologic factors|mesh-ancestor
102273316|NCT04328727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273317|NCT04328727|Antifungal Agents|antifungal agents|mesh-ancestor
102273318|NCT04328727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102273319|NCT04328727|Dermatologic Agents|dermatologic agents|mesh-ancestor
102273320|NCT04328727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102273321|NCT04328727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102273322|NCT04316117|Deoxyglucose|deoxyglucose|mesh-list
102273323|NCT04316117|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102273324|NCT04316117|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102273325|NCT04316117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273326|NCT04316117|Antimetabolites|antimetabolites|mesh-ancestor
102273327|NCT04316117|Antiviral Agents|antiviral agents|mesh-ancestor
102273328|NCT04316117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102273329|NCT04313634|Dasatinib|dasatinib|mesh-list
102273330|NCT04313634|Quercetin|quercetin|mesh-list
102273331|NCT04313634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273332|NCT04313634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102273333|NCT04313634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102273334|NCT04313634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273335|NCT04313634|Antioxidants|antioxidants|mesh-ancestor
102273336|NCT04313634|Protective Agents|protective agents|mesh-ancestor
102273337|NCT04313634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273338|NCT04311580|Mitomycins|mitomycins|mesh-list
102273339|NCT04311580|Mitomycin|mitomycin|mesh-list
102273340|NCT04311580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102273341|NCT04311580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273342|NCT04311580|Alkylating Agents|alkylating agents|mesh-ancestor
102273343|NCT04311580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273344|NCT04311580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102273345|NCT04311580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102273346|NCT04301492|Vortioxetine|vortioxetine|mesh-list
101672997|NCT00003701|Methotrexate|methotrexate|mesh-list
102614277|NCT00003425|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102273347|NCT04301492|Antidepressive Agents|antidepressive agents|mesh-ancestor
101902678|NCT01292720|Vitamin D|vitamin d|mesh-list
102273348|NCT04301492|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102273349|NCT04301492|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102273350|NCT04301492|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102273351|NCT04301492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102273352|NCT04301492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273353|NCT04301492|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101673061|NCT00003283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273354|NCT04301492|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102273355|NCT04301492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102273356|NCT04301492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273357|NCT04301492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102273358|NCT04301492|Serotonin Agents|serotonin agents|mesh-ancestor
102273359|NCT04301492|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102273360|NCT04301492|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102273361|NCT04301492|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102273362|NCT04301492|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102273363|NCT04301076|Prednisone|prednisone|mesh-list
102273364|NCT04301076|Cortisone|cortisone|mesh-list
102273365|NCT04301076|Cyclophosphamide|cyclophosphamide|mesh-list
102273366|NCT04301076|Doxorubicin|doxorubicin|mesh-list
102273367|NCT04301076|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102273368|NCT04301076|Etoposide|etoposide|mesh-list
102273369|NCT04301076|Vincristine|vincristine|mesh-list
102273370|NCT04301076|Lenalidomide|lenalidomide|mesh-list
102273371|NCT04301076|Etoposide phosphate|etoposide phosphate|mesh-list
102273372|NCT04301076|Podophyllotoxin|podophyllotoxin|mesh-list
102273373|NCT04301076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102273374|NCT04301076|Immunologic Factors|immunologic factors|mesh-ancestor
101673191|NCT00930865|Dapagliflozin|dapagliflozin|mesh-list
102273375|NCT04301076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273376|NCT04301076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102273377|NCT04301076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102273378|NCT04301076|Alkylating Agents|alkylating agents|mesh-ancestor
102273379|NCT04301076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273380|NCT04301076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273381|NCT04301076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102273382|NCT04301076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102273383|NCT04301076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102273384|NCT04301076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102273385|NCT04301076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102273386|NCT04301076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102273387|NCT04301076|Glucocorticoids|glucocorticoids|mesh-ancestor
102273388|NCT04301076|Hormones|hormones|mesh-ancestor
102273389|NCT04301076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102273390|NCT04301076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102273391|NCT04301076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102273392|NCT04301076|Tubulin Modulators|tubulin modulators|mesh-ancestor
101673332|NCT02811692|Aflibercept|aflibercept|mesh-list
102273393|NCT04301076|Antimitotic Agents|antimitotic agents|mesh-ancestor
102273394|NCT04301076|Mitosis Modulators|mitosis modulators|mesh-ancestor
102273395|NCT04301076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102273396|NCT04301076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102273397|NCT04301076|Growth Substances|growth substances|mesh-ancestor
102273398|NCT04301076|Growth Inhibitors|growth inhibitors|mesh-ancestor
102273399|NCT04301076|Keratolytic Agents|keratolytic agents|mesh-ancestor
102273400|NCT04301076|Dermatologic Agents|dermatologic agents|mesh-ancestor
102273401|NCT04290039|Atropine|atropine|mesh-list
102273402|NCT04290039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102273403|NCT04290039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102273404|NCT04290039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102273405|NCT04290039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102273406|NCT04290039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102273407|NCT04290039|Autonomic Agents|autonomic agents|mesh-ancestor
102273408|NCT04290039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102273409|NCT04290039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273410|NCT04290039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102273411|NCT04290039|Respiratory System Agents|respiratory system agents|mesh-ancestor
102273412|NCT04290039|Mydriatics|mydriatics|mesh-ancestor
102273413|NCT04290039|Parasympatholytics|parasympatholytics|mesh-ancestor
102273414|NCT04290039|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102273415|NCT04290039|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102273416|NCT04290039|Cholinergic Agents|cholinergic agents|mesh-ancestor
102273417|NCT04290039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102273418|NCT04290039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273419|NCT04266249|Paclitaxel|paclitaxel|mesh-list
102273420|NCT04266249|Maytansine|maytansine|mesh-list
102273421|NCT04266249|Docetaxel|docetaxel|mesh-list
102273422|NCT04266249|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102273423|NCT04266249|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101673381|NCT02727504|Dobutamine|dobutamine|mesh-list
102614278|NCT00003425|Protective Agents|protective agents|mesh-ancestor
102273424|NCT04266249|Trastuzumab|trastuzumab|mesh-list
102273425|NCT04266249|Pertuzumab|pertuzumab|mesh-list
102273426|NCT04266249|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
102273427|NCT04266249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102273428|NCT04266249|Antibodies|antibodies|mesh-list
102273429|NCT04266249|Immunoglobulins|immunoglobulins|mesh-list
102273430|NCT04266249|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102273431|NCT04266249|Immunoconjugates|immunoconjugates|mesh-list
102273432|NCT04266249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102273433|NCT04266249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273434|NCT04266249|Tubulin Modulators|tubulin modulators|mesh-ancestor
102273435|NCT04266249|Antimitotic Agents|antimitotic agents|mesh-ancestor
101982223|NCT03101930|Incretins|incretins|mesh-ancestor
102273436|NCT04266249|Mitosis Modulators|mitosis modulators|mesh-ancestor
102273437|NCT04266249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273438|NCT04266249|Immunologic Factors|immunologic factors|mesh-ancestor
102273439|NCT04266249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273440|NCT04266249|Immunotoxins|immunotoxins|mesh-ancestor
102273441|NCT04260126|Pembrolizumab|pembrolizumab|mesh-list
102273442|NCT04260126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102273443|NCT04260126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273444|NCT04260126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102273445|NCT04260126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273446|NCT04248452|Calcium, Dietary|calcium, dietary|mesh-list
102273447|NCT04248452|Leucovorin|leucovorin|mesh-list
102273448|NCT04248452|Folic Acid|folic acid|mesh-list
102273449|NCT04248452|Fluorouracil|fluorouracil|mesh-list
102273450|NCT04248452|Capecitabine|capecitabine|mesh-list
102273451|NCT04248452|Oxaliplatin|oxaliplatin|mesh-list
102273452|NCT04248452|Calcium|calcium|mesh-list
102273453|NCT04248452|Levoleucovorin|levoleucovorin|mesh-list
102273454|NCT04248452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102273455|NCT04248452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273456|NCT04248452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102273457|NCT04248452|Antimetabolites|antimetabolites|mesh-ancestor
102273458|NCT04248452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273459|NCT04248452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102273460|NCT04248452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273461|NCT04248452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102273462|NCT04248452|Immunologic Factors|immunologic factors|mesh-ancestor
102273463|NCT04248452|Antidotes|antidotes|mesh-ancestor
102273464|NCT04248452|Protective Agents|protective agents|mesh-ancestor
102273465|NCT04248452|Vitamin B Complex|vitamin b complex|mesh-ancestor
102273466|NCT04248452|Vitamins|vitamins|mesh-ancestor
102273467|NCT04248452|Micronutrients|micronutrients|mesh-ancestor
102273468|NCT04248452|Hematinics|hematinics|mesh-ancestor
102273469|NCT04240054|Dexamethasone|dexamethasone|mesh-list
102273470|NCT04240054|Cyclophosphamide|cyclophosphamide|mesh-list
102273471|NCT04240054|Bortezomib|bortezomib|mesh-list
102273472|NCT04240054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102273473|NCT04240054|Immunologic Factors|immunologic factors|mesh-ancestor
102273474|NCT04240054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273475|NCT04240054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102273476|NCT04240054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102273477|NCT04240054|Alkylating Agents|alkylating agents|mesh-ancestor
102273478|NCT04240054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273479|NCT04240054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273480|NCT04240054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102273481|NCT04240054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102273482|NCT04240054|Antiemetics|antiemetics|mesh-ancestor
102273483|NCT04240054|Autonomic Agents|autonomic agents|mesh-ancestor
102273484|NCT04240054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102273485|NCT04240054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102273486|NCT04240054|Glucocorticoids|glucocorticoids|mesh-ancestor
102273487|NCT04240054|Hormones|hormones|mesh-ancestor
102273488|NCT04240054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102273489|NCT04240054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102273490|NCT04233866|Calcium, Dietary|calcium, dietary|mesh-list
102273491|NCT04233866|Leucovorin|leucovorin|mesh-list
102273492|NCT04233866|Folic Acid|folic acid|mesh-list
102273493|NCT04233866|Paclitaxel|paclitaxel|mesh-list
102273494|NCT04233866|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102273495|NCT04233866|Gemcitabine|gemcitabine|mesh-list
102273496|NCT04233866|Fluorouracil|fluorouracil|mesh-list
102273497|NCT04233866|Irinotecan|irinotecan|mesh-list
102273498|NCT04233866|Calcium|calcium|mesh-list
102273499|NCT04233866|Levoleucovorin|levoleucovorin|mesh-list
102273500|NCT04233866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102273501|NCT04233866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614279|NCT00330551|Risperidone|risperidone|mesh-list
102273502|NCT04233866|Tubulin Modulators|tubulin modulators|mesh-ancestor
102273503|NCT04233866|Antimitotic Agents|antimitotic agents|mesh-ancestor
102273504|NCT04233866|Mitosis Modulators|mitosis modulators|mesh-ancestor
102273505|NCT04233866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273506|NCT04233866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102273507|NCT04233866|Antimetabolites|antimetabolites|mesh-ancestor
102273508|NCT04233866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102273509|NCT04233866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273510|NCT04233866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102273511|NCT04233866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102273512|NCT04233866|Immunologic Factors|immunologic factors|mesh-ancestor
102273513|NCT04233866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102273514|NCT04233866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102273515|NCT04233866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102273516|NCT04233866|Antidotes|antidotes|mesh-ancestor
102273517|NCT04233866|Protective Agents|protective agents|mesh-ancestor
102273518|NCT04233866|Vitamin B Complex|vitamin b complex|mesh-ancestor
102273520|NCT04233866|Micronutrients|micronutrients|mesh-ancestor
102273521|NCT04233866|Hematinics|hematinics|mesh-ancestor
102273522|NCT04233112|Melatonin|melatonin|mesh-list
102273523|NCT04233112|Antioxidants|antioxidants|mesh-ancestor
102273524|NCT04233112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273525|NCT04233112|Protective Agents|protective agents|mesh-ancestor
102273526|NCT04233112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273527|NCT04233112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102273528|NCT04221438|Alovudine|alovudine|mesh-list
102273529|NCT04221438|Antiviral Agents|antiviral agents|mesh-ancestor
102273530|NCT04221438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102273531|NCT04217954|Bevacizumab|bevacizumab|mesh-list
102273532|NCT04217954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102273533|NCT04217954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273534|NCT04217954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102273535|NCT04217954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102273536|NCT04217954|Growth Substances|growth substances|mesh-ancestor
102273537|NCT04217954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273538|NCT04217954|Growth Inhibitors|growth inhibitors|mesh-ancestor
102273539|NCT04210427|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
102273540|NCT04210427|Laxatives|laxatives|mesh-ancestor
102273541|NCT04210427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102273542|NCT04194034|Flucytosine|flucytosine|mesh-list
102273543|NCT04194034|Antifungal Agents|antifungal agents|mesh-ancestor
102273544|NCT04194034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102273545|NCT04194034|Antimetabolites|antimetabolites|mesh-ancestor
102273546|NCT04194034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273547|NCT04191187|Fludarabine|fludarabine|mesh-list
102273548|NCT04191187|Melphalan|melphalan|mesh-list
102273549|NCT04191187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273550|NCT04191187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273551|NCT04191187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102273552|NCT04191187|Immunologic Factors|immunologic factors|mesh-ancestor
102273553|NCT04191187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273554|NCT04191187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102273555|NCT04191187|Alkylating Agents|alkylating agents|mesh-ancestor
102273556|NCT04191187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102273557|NCT04191135|Carboplatin|carboplatin|mesh-list
102273558|NCT04191135|Gemcitabine|gemcitabine|mesh-list
102273559|NCT04191135|Pembrolizumab|pembrolizumab|mesh-list
102273560|NCT04191135|Olaparib|olaparib|mesh-list
102273561|NCT04191135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273562|NCT04191135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102273563|NCT04191135|Antimetabolites|antimetabolites|mesh-ancestor
102273564|NCT04191135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273565|NCT04191135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102273566|NCT04191135|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102273567|NCT04191135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102273568|NCT04191135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102273569|NCT04356170|Docetaxel|docetaxel|mesh-list
102273570|NCT04356170|Fluorouracil|fluorouracil|mesh-list
102273571|NCT04356170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273572|NCT04356170|Tubulin Modulators|tubulin modulators|mesh-ancestor
102273573|NCT04356170|Antimitotic Agents|antimitotic agents|mesh-ancestor
102273574|NCT04356170|Mitosis Modulators|mitosis modulators|mesh-ancestor
102273575|NCT04356170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273576|NCT04356170|Antimetabolites|antimetabolites|mesh-ancestor
101674115|NCT00940069|Pemetrexed|pemetrexed|mesh-list
102273577|NCT04356170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102273578|NCT04356170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102273579|NCT04356170|Immunologic Factors|immunologic factors|mesh-ancestor
102273580|NCT04356170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273581|NCT04188418|Fentanyl|fentanyl|mesh-list
102273582|NCT04188418|Morphine|morphine|mesh-list
102273583|NCT04188418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102273584|NCT04188418|Narcotics|narcotics|mesh-ancestor
102273585|NCT04188418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102273586|NCT04188418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273587|NCT04188418|Analgesics|analgesics|mesh-ancestor
102273588|NCT04188418|Sensory System Agents|sensory system agents|mesh-ancestor
102273589|NCT04188418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102273590|NCT04188418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102273591|NCT04188418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102273592|NCT04188418|Anesthetics, General|anesthetics, general|mesh-ancestor
102273593|NCT04188418|Anesthetics|anesthetics|mesh-ancestor
102273594|NCT04166318|Fluorouracil|fluorouracil|mesh-list
102273595|NCT04166318|Capecitabine|capecitabine|mesh-list
102273596|NCT04166318|Mitomycins|mitomycins|mesh-list
102273597|NCT04166318|Mitomycin|mitomycin|mesh-list
102273598|NCT04166318|Antimetabolites|antimetabolites|mesh-ancestor
102273599|NCT04166318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273600|NCT04166318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102273601|NCT04166318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101674254|NCT02715024|Tamsulosin|tamsulosin|mesh-list
102273602|NCT04166318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102273603|NCT04166318|Immunologic Factors|immunologic factors|mesh-ancestor
102273604|NCT04166318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273605|NCT04166318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102273606|NCT04166318|Alkylating Agents|alkylating agents|mesh-ancestor
102273607|NCT04166318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102273608|NCT04166318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102273609|NCT04150614|Dexamethasone|dexamethasone|mesh-list
102273610|NCT04150614|Ondansetron|ondansetron|mesh-list
102273611|NCT04150614|Granisetron|granisetron|mesh-list
102273612|NCT04150614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102273613|NCT04150614|Antiemetics|antiemetics|mesh-ancestor
102273614|NCT04150614|Autonomic Agents|autonomic agents|mesh-ancestor
102273615|NCT04150614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102273616|NCT04150614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273617|NCT04150614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102273618|NCT04150614|Glucocorticoids|glucocorticoids|mesh-ancestor
102273620|NCT04150614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102273621|NCT04150614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102273622|NCT04150614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273623|NCT04150614|Antipruritics|antipruritics|mesh-ancestor
102273624|NCT04150614|Dermatologic Agents|dermatologic agents|mesh-ancestor
102273625|NCT04150614|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102273626|NCT04150614|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102273627|NCT04150614|Serotonin Agents|serotonin agents|mesh-ancestor
102273628|NCT04150614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102273629|NCT04150614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273630|NCT04148911|Paclitaxel|paclitaxel|mesh-list
102273631|NCT04148911|Atezolizumab|atezolizumab|mesh-list
102273632|NCT04148911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102273633|NCT04148911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273634|NCT04148911|Tubulin Modulators|tubulin modulators|mesh-ancestor
102273635|NCT04148911|Antimitotic Agents|antimitotic agents|mesh-ancestor
102273636|NCT04148911|Mitosis Modulators|mitosis modulators|mesh-ancestor
102273637|NCT04148911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674422|NCT02792816|Artenimol|artenimol|mesh-list
102273638|NCT04148911|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102273639|NCT04148911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102273640|NCT04145297|Hydroxychloroquine|hydroxychloroquine|mesh-list
102273641|NCT04145297|Antimalarials|antimalarials|mesh-ancestor
102273642|NCT04145297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102273643|NCT04145297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102273644|NCT04145297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102273645|NCT04145297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102273646|NCT04145297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273647|NCT04145297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102273648|NCT04126096|Lactams|lactams|mesh-list
102273649|NCT04126096|beta-Lactams|beta-lactams|mesh-list
102273650|NCT04126096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102273651|NCT04126096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102614280|NCT00330551|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102273652|NCT04125836|Octreotide|octreotide|mesh-list
101902680|NCT01292720|Vitamins|vitamins|mesh-ancestor
102614281|NCT00330551|Serotonin Agents|serotonin agents|mesh-ancestor
102273653|NCT04125836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102273654|NCT04125836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102273655|NCT04125836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273656|NCT04121455|Bevacizumab|bevacizumab|mesh-list
102273657|NCT04121455|Pembrolizumab|pembrolizumab|mesh-list
102273658|NCT04121455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102273659|NCT04121455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273660|NCT04121455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102273661|NCT04121455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102273662|NCT04121455|Growth Substances|growth substances|mesh-ancestor
102273663|NCT04121455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273664|NCT04121455|Growth Inhibitors|growth inhibitors|mesh-ancestor
102273665|NCT04121455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102273666|NCT04121455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273667|NCT04117672|Antisecretory factor|antisecretory factor|mesh-list
102273668|NCT04117672|Antidiarrheals|antidiarrheals|mesh-ancestor
102273669|NCT04117672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102273670|NCT04115631|Cytarabine|cytarabine|mesh-list
102273671|NCT04115631|Rituximab|rituximab|mesh-list
102273672|NCT04115631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102273673|NCT04115631|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102273674|NCT04115631|Acalabrutinib|acalabrutinib|mesh-list
102273675|NCT04115631|Antibodies|antibodies|mesh-list
102273676|NCT04115631|Immunoglobulins|immunoglobulins|mesh-list
102273677|NCT04115631|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102273678|NCT04115631|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102273679|NCT04115631|Immunologic Factors|immunologic factors|mesh-ancestor
102273680|NCT04115631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273681|NCT04115631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273682|NCT04115631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102273683|NCT04115631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102273684|NCT04115631|Antimetabolites|antimetabolites|mesh-ancestor
102273685|NCT04115631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273686|NCT04115631|Antiviral Agents|antiviral agents|mesh-ancestor
102273687|NCT04115631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102273688|NCT04115631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102273689|NCT04115631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102273690|NCT04115631|Alkylating Agents|alkylating agents|mesh-ancestor
102273691|NCT04115631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102273692|NCT04115631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102273693|NCT04109482|Cyclophosphamide|cyclophosphamide|mesh-list
102273694|NCT04109482|Fludarabine|fludarabine|mesh-list
102273695|NCT04109482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102273696|NCT04109482|Immunologic Factors|immunologic factors|mesh-ancestor
102273697|NCT04109482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273698|NCT04109482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102273699|NCT04109482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102273700|NCT04109482|Alkylating Agents|alkylating agents|mesh-ancestor
102273701|NCT04109482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273702|NCT04109482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273703|NCT04109482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102273704|NCT04094584|Naltrexone|naltrexone|mesh-list
102273705|NCT04094584|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102273706|NCT04094584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102273707|NCT04094584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273708|NCT04094584|Sensory System Agents|sensory system agents|mesh-ancestor
102273709|NCT04094584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102273710|NCT04086264|Azacitidine|azacitidine|mesh-list
102273711|NCT04086264|Decitabine|decitabine|mesh-list
102273712|NCT04086264|Venetoclax|venetoclax|mesh-list
102273713|NCT04086264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102273714|NCT04086264|Antimetabolites|antimetabolites|mesh-ancestor
102273715|NCT04086264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273716|NCT04086264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273717|NCT04086264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102273718|NCT04082754|Antibodies|antibodies|mesh-list
102273719|NCT04082754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102273720|NCT04082754|Immunologic Factors|immunologic factors|mesh-ancestor
102273721|NCT04082754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273722|NCT04075292|Rituximab|rituximab|mesh-list
101674991|NCT06004882|Hormones|hormones|mesh-ancestor
102273723|NCT04075292|Acalabrutinib|acalabrutinib|mesh-list
102273724|NCT04075292|Chlorambucil|chlorambucil|mesh-list
102614282|NCT00330551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102273725|NCT04075292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102273726|NCT04075292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273727|NCT04075292|Immunologic Factors|immunologic factors|mesh-ancestor
102273787|NCT04020341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102273788|NCT04020341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102273789|NCT04020341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102273790|NCT04020341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102273791|NCT04020341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102273792|NCT04020341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273793|NCT04020341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273794|NCT04011280|Varenicline|varenicline|mesh-list
102273795|NCT04011280|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102273796|NCT04011280|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102273797|NCT04011280|Cholinergic Agents|cholinergic agents|mesh-ancestor
102273798|NCT04011280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102273799|NCT04011280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273800|NCT04011280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273801|NCT04002934|Bazedoxifene|bazedoxifene|mesh-list
102273802|NCT04002934|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102273803|NCT04002934|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102614283|NCT00330551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273804|NCT04002934|Hormone Antagonists|hormone antagonists|mesh-ancestor
102273805|NCT04002934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102273806|NCT04002934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273807|NCT04002934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102273808|NCT04001829|Paclitaxel|paclitaxel|mesh-list
102273809|NCT04001829|Docetaxel|docetaxel|mesh-list
102273810|NCT04001829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102273811|NCT04001829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102273812|NCT04001829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273813|NCT04001829|Tubulin Modulators|tubulin modulators|mesh-ancestor
102273814|NCT04001829|Antimitotic Agents|antimitotic agents|mesh-ancestor
102273815|NCT04001829|Mitosis Modulators|mitosis modulators|mesh-ancestor
102273816|NCT04001829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273817|NCT03987711|Warfarin|warfarin|mesh-list
102273818|NCT03987711|Apixaban|apixaban|mesh-list
102273819|NCT03987711|Anticoagulants|anticoagulants|mesh-ancestor
102273820|NCT03987711|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102273821|NCT03987711|Antithrombins|antithrombins|mesh-ancestor
102273822|NCT03987711|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102273823|NCT03987711|Protease Inhibitors|protease inhibitors|mesh-ancestor
102273824|NCT03987711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101982595|NCT01152931|Tocotrienols|tocotrienols|mesh-list
102273825|NCT03987711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273826|NCT03937635|Dexamethasone|dexamethasone|mesh-list
102273827|NCT03937635|Dexamethasone acetate|dexamethasone acetate|mesh-list
102273828|NCT03937635|Lenalidomide|lenalidomide|mesh-list
102273829|NCT03937635|Daratumumab|daratumumab|mesh-list
102273830|NCT03937635|Ichthammol|ichthammol|mesh-list
102273831|NCT03937635|BB 1101|bb 1101|mesh-list
102273832|NCT03937635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102273833|NCT03937635|Antiemetics|antiemetics|mesh-ancestor
102273834|NCT03937635|Autonomic Agents|autonomic agents|mesh-ancestor
102273835|NCT03937635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102273836|NCT03937635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675280|NCT05874219|Mupirocin|mupirocin|mesh-list
102273837|NCT03937635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102273838|NCT03937635|Glucocorticoids|glucocorticoids|mesh-ancestor
102273839|NCT03937635|Hormones|hormones|mesh-ancestor
102273840|NCT03937635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102273841|NCT03937635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102273842|NCT03937635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273843|NCT03937635|Immunologic Factors|immunologic factors|mesh-ancestor
102273844|NCT03937635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102273845|NCT03937635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102273846|NCT03937635|Growth Substances|growth substances|mesh-ancestor
102273847|NCT03937635|Growth Inhibitors|growth inhibitors|mesh-ancestor
102273848|NCT03937635|Protease Inhibitors|protease inhibitors|mesh-ancestor
102273849|NCT03937635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102273850|NCT03937635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273851|NCT03937635|Dermatologic Agents|dermatologic agents|mesh-ancestor
102273852|NCT03892044|Nivolumab|nivolumab|mesh-list
102273853|NCT03892044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102273854|NCT03892044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273855|NCT03892044|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102273856|NCT03892044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273857|NCT03891953|Spartalizumab|spartalizumab|mesh-list
102273858|NCT03891953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102273859|NCT03891953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273860|NCT03891953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102273861|NCT03891953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273862|NCT03885037|Infliximab|infliximab|mesh-list
102273863|NCT03885037|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102273864|NCT03885037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102273865|NCT03885037|Dermatologic Agents|dermatologic agents|mesh-ancestor
101675498|NCT05685602|Gemcitabine|gemcitabine|mesh-list
102273866|NCT03885037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102273867|NCT03885037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102273868|NCT03884439|Infliximab|infliximab|mesh-list
102273869|NCT03884439|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102273870|NCT03884439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102273871|NCT03884439|Dermatologic Agents|dermatologic agents|mesh-ancestor
102273872|NCT03884439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102273873|NCT03884439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102273874|NCT03879629|Carvedilol|carvedilol|mesh-list
102273875|NCT03879629|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101675570|NCT05600894|Decitabine|decitabine|mesh-list
102273876|NCT03879629|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102273877|NCT03879629|Adrenergic Agents|adrenergic agents|mesh-ancestor
102273878|NCT03879629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102273879|NCT03879629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273880|NCT03879629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273881|NCT03879629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102273882|NCT03879629|Antioxidants|antioxidants|mesh-ancestor
102273883|NCT03879629|Protective Agents|protective agents|mesh-ancestor
102273884|NCT03879629|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102273885|NCT03879629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101675640|NCT05502237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101675641|NCT05502237|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101675642|NCT05502237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101675643|NCT05502237|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101675644|NCT05502237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102273886|NCT03879629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102273887|NCT03879629|Vasodilator Agents|vasodilator agents|mesh-ancestor
102273888|NCT03879629|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102273889|NCT03879629|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102273890|NCT03873389|Ocrelizumab|ocrelizumab|mesh-list
102273891|NCT03873389|Immunologic Factors|immunologic factors|mesh-ancestor
102273892|NCT03873389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273893|NCT03867851|Heparin|heparin|mesh-list
102273894|NCT03867851|Anticoagulants|anticoagulants|mesh-ancestor
102273895|NCT03867851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102273896|NCT03867851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102273897|NCT03867851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273898|NCT03860207|Antibodies|antibodies|mesh-list
102273899|NCT03860207|Immunoglobulins|immunoglobulins|mesh-list
102273900|NCT03860207|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102273901|NCT03860207|Immunologic Factors|immunologic factors|mesh-ancestor
102273902|NCT03860207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273904|NCT03850691|Nivolumab|nivolumab|mesh-list
102273905|NCT03850691|Ipilimumab|ipilimumab|mesh-list
101675775|NCT05307731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102273906|NCT03850691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102273907|NCT03850691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273908|NCT03850691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102273909|NCT03850691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273910|NCT03850691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102273911|NCT03850691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102273912|NCT03850691|Antiviral Agents|antiviral agents|mesh-ancestor
102273913|NCT03850691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102273914|NCT03822793|Tranexamic Acid|tranexamic acid|mesh-list
102273915|NCT03822793|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102273916|NCT03822793|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102273917|NCT03822793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273918|NCT03822793|Hemostatics|hemostatics|mesh-ancestor
102273919|NCT03822793|Coagulants|coagulants|mesh-ancestor
102273920|NCT03809780|Dexamethasone|dexamethasone|mesh-list
102273921|NCT03809780|Lenalidomide|lenalidomide|mesh-list
102273922|NCT03809780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102273923|NCT03809780|Antiemetics|antiemetics|mesh-ancestor
102273924|NCT03809780|Autonomic Agents|autonomic agents|mesh-ancestor
102273925|NCT03809780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102273926|NCT03809780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273927|NCT03809780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102273928|NCT03809780|Glucocorticoids|glucocorticoids|mesh-ancestor
102273929|NCT03809780|Hormones|hormones|mesh-ancestor
102273930|NCT03809780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102273931|NCT03809780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102273932|NCT03809780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273933|NCT03809780|Immunologic Factors|immunologic factors|mesh-ancestor
102273934|NCT03809780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102273935|NCT03809780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102273936|NCT03809780|Growth Substances|growth substances|mesh-ancestor
102273937|NCT03809780|Growth Inhibitors|growth inhibitors|mesh-ancestor
102273938|NCT03808818|Nicotine|nicotine|mesh-list
102273939|NCT03808818|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102273940|NCT03808818|Autonomic Agents|autonomic agents|mesh-ancestor
102273941|NCT03808818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102273942|NCT03808818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273943|NCT03808818|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102273944|NCT03808818|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102273945|NCT03808818|Cholinergic Agents|cholinergic agents|mesh-ancestor
102273946|NCT03808818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102273947|NCT03808818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273948|NCT03802604|Atezolizumab|atezolizumab|mesh-list
102273949|NCT03802604|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
102273950|NCT03802604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102273951|NCT03802604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273952|NCT03802604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102614284|NCT00330551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273953|NCT03802604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273954|NCT03785873|Leucovorin|leucovorin|mesh-list
102273955|NCT03785873|Fluorouracil|fluorouracil|mesh-list
102273956|NCT03785873|Nivolumab|nivolumab|mesh-list
102273957|NCT03785873|Irinotecan|irinotecan|mesh-list
102273958|NCT03785873|Antimetabolites|antimetabolites|mesh-ancestor
102273959|NCT03785873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273960|NCT03785873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102273961|NCT03785873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273962|NCT03785873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102273963|NCT03785873|Immunologic Factors|immunologic factors|mesh-ancestor
102273964|NCT03785873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273965|NCT03785873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102273966|NCT03785873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102273967|NCT03785873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102273968|NCT03785873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102273969|NCT03785873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102273970|NCT03785873|Antidotes|antidotes|mesh-ancestor
102273971|NCT03785873|Protective Agents|protective agents|mesh-ancestor
102273972|NCT03785873|Vitamin B Complex|vitamin b complex|mesh-ancestor
102273973|NCT03785873|Vitamins|vitamins|mesh-ancestor
102273974|NCT03785873|Micronutrients|micronutrients|mesh-ancestor
102273975|NCT03784677|SOR-C13|sor-c13|mesh-list
102273976|NCT03784677|Calcium|calcium|mesh-list
102273977|NCT03784677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102273978|NCT03784677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102273979|NCT03784677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273980|NCT03784677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102273981|NCT03784677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102273982|NCT03784677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273983|NCT03782064|Nivolumab|nivolumab|mesh-list
102273984|NCT03782064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102273985|NCT03782064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273986|NCT03782064|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102273987|NCT03782064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273988|NCT03764488|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
102273989|NCT03764488|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102273990|NCT03764488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273991|NCT03764293|Sorafenib|sorafenib|mesh-list
102273992|NCT03764293|Apatinib|apatinib|mesh-list
102273993|NCT03764293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102273994|NCT03764293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102273995|NCT03764293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102273996|NCT03764293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102273997|NCT03763643|Rituximab|rituximab|mesh-list
101676501|NCT04078568|Immunologic Factors|immunologic factors|mesh-ancestor
102273998|NCT03763643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102273999|NCT03763643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274000|NCT03763643|Immunologic Factors|immunologic factors|mesh-ancestor
102274001|NCT03763643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274002|NCT03763643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102274003|NCT03747042|Letrozole|letrozole|mesh-list
102274004|NCT03747042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274005|NCT03747042|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102274006|NCT03747042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102274007|NCT03747042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102274008|NCT03747042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274009|NCT03747042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102274010|NCT03747042|Hormone Antagonists|hormone antagonists|mesh-ancestor
102274011|NCT03747042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102274012|NCT03747042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274013|NCT03739112|Vaccines|vaccines|mesh-list
102274014|NCT03739112|Immunologic Factors|immunologic factors|mesh-ancestor
102274015|NCT03739112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274016|NCT03734237|Vaccines|vaccines|mesh-list
102274017|NCT03734237|Immunologic Factors|immunologic factors|mesh-ancestor
102274018|NCT03734237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274019|NCT03724071|Flucytosine|flucytosine|mesh-list
102274020|NCT03724071|Antifungal Agents|antifungal agents|mesh-ancestor
102274021|NCT03724071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102274022|NCT03724071|Antimetabolites|antimetabolites|mesh-ancestor
102274023|NCT03724071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274024|NCT03709446|Leflunomide|leflunomide|mesh-list
102614285|NCT00330551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102274025|NCT03709446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102614286|NCT00330551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101615853|NCT00866788|Omalizumab|omalizumab|mesh-list
102614287|NCT00330551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102614288|NCT00330551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102274026|NCT03709446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274027|NCT03709446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102274028|NCT03709446|Immunologic Factors|immunologic factors|mesh-ancestor
102274029|NCT03709446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274030|NCT03678350|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
102274031|NCT03678350|Trioxsalen|trioxsalen|mesh-list
102274032|NCT03678350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274033|NCT03678350|Dermatologic Agents|dermatologic agents|mesh-ancestor
102274034|NCT03678350|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102274035|NCT03671525|Nimodipine|nimodipine|mesh-list
102274036|NCT03671525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102274037|NCT03671525|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102274038|NCT03671525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102274039|NCT03671525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274040|NCT03671525|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102274041|NCT03671525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274042|NCT03671525|Vasodilator Agents|vasodilator agents|mesh-ancestor
102274043|NCT03648437|Acetaminophen|acetaminophen|mesh-list
102274044|NCT03648437|Ibuprofen|ibuprofen|mesh-list
102274045|NCT03648437|Indomethacin|indomethacin|mesh-list
102274046|NCT03648437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102274047|NCT03648437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102274048|NCT03648437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102274049|NCT03648437|Analgesics|analgesics|mesh-ancestor
102274050|NCT03648437|Sensory System Agents|sensory system agents|mesh-ancestor
102274051|NCT03648437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102274052|NCT03648437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274053|NCT03648437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102274054|NCT03648437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102274055|NCT03648437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102274056|NCT03648437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102274057|NCT03648437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274058|NCT03648437|Antipyretics|antipyretics|mesh-ancestor
102274059|NCT03648437|Gout Suppressants|gout suppressants|mesh-ancestor
102274060|NCT03648437|Tocolytic Agents|tocolytic agents|mesh-ancestor
102274061|NCT03648437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102274062|NCT03646058|Buprenorphine|buprenorphine|mesh-list
102274063|NCT03646058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102274064|NCT03646058|Narcotics|narcotics|mesh-ancestor
102274065|NCT03646058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101676661|NCT03811002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101676662|NCT03811002|Immunologic Factors|immunologic factors|mesh-ancestor
101676663|NCT03811002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676664|NCT03811002|Keratolytic Agents|keratolytic agents|mesh-ancestor
101676665|NCT03811002|Dermatologic Agents|dermatologic agents|mesh-ancestor
101676666|NCT03811002|Tubulin Modulators|tubulin modulators|mesh-ancestor
101676667|NCT03811002|Antimitotic Agents|antimitotic agents|mesh-ancestor
101676668|NCT03811002|Mitosis Modulators|mitosis modulators|mesh-ancestor
101676683|NCT03728933|Dopamine Agonists|dopamine agonists|mesh-ancestor
101676684|NCT03728933|Dopamine Agents|dopamine agents|mesh-ancestor
101676685|NCT03728933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101676686|NCT03728933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274066|NCT03646058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274067|NCT03646058|Analgesics|analgesics|mesh-ancestor
102274068|NCT03646058|Sensory System Agents|sensory system agents|mesh-ancestor
102274069|NCT03646058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102274070|NCT03646058|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102274071|NCT03641209|Acetaminophen|acetaminophen|mesh-list
102274072|NCT03641209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102274073|NCT03641209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102274074|NCT03641209|Analgesics|analgesics|mesh-ancestor
102274075|NCT03641209|Sensory System Agents|sensory system agents|mesh-ancestor
102274076|NCT03641209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102274077|NCT03641209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274078|NCT03641209|Antipyretics|antipyretics|mesh-ancestor
102274079|NCT03622593|Aflibercept|aflibercept|mesh-list
102274080|NCT03622593|Faricimab|faricimab|mesh-list
102274081|NCT03622593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102274082|NCT03622593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102274083|NCT03622593|Growth Substances|growth substances|mesh-ancestor
102274084|NCT03622593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274085|NCT03622593|Growth Inhibitors|growth inhibitors|mesh-ancestor
102274086|NCT03622593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274087|NCT03602066|Chlorine dioxide|chlorine dioxide|mesh-list
102274088|NCT03602066|Dental Disinfectants|dental disinfectants|mesh-ancestor
102274089|NCT03602066|Disinfectants|disinfectants|mesh-ancestor
102274090|NCT03602066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102274091|NCT03597581|Bevacizumab|bevacizumab|mesh-list
102274092|NCT03597581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102274093|NCT03597581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274094|NCT03597581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102274095|NCT03597581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102274096|NCT03597581|Growth Substances|growth substances|mesh-ancestor
102274097|NCT03597581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274098|NCT03597581|Growth Inhibitors|growth inhibitors|mesh-ancestor
102274099|NCT03593655|Tenofovir|tenofovir|mesh-list
102274101|NCT03593655|Dapivirine|dapivirine|mesh-list
102274102|NCT03593655|Antiviral Agents|antiviral agents|mesh-ancestor
102274103|NCT03593655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102274104|NCT03593655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102274105|NCT03593655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102274106|NCT03593655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102274107|NCT03593655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274108|NCT03593655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102274109|NCT03593655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102274110|NCT03586661|Niraparib|niraparib|mesh-list
102274111|NCT03586661|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102274112|NCT03586661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102274113|NCT03586661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274114|NCT03586661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274115|NCT03572530|Azacitidine|azacitidine|mesh-list
102274116|NCT03572530|Decitabine|decitabine|mesh-list
102274117|NCT03572530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102274118|NCT03572530|Antimetabolites|antimetabolites|mesh-ancestor
102274119|NCT03572530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274120|NCT03572530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274121|NCT03572530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102274122|NCT03570619|Nivolumab|nivolumab|mesh-list
102274123|NCT03570619|Ipilimumab|ipilimumab|mesh-list
101982898|NCT03718182|Cholecalciferol|cholecalciferol|mesh-list
102274124|NCT03570619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102274125|NCT03570619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274126|NCT03570619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102274127|NCT03570619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274128|NCT03568383|Pyridoxine|pyridoxine|mesh-list
102274129|NCT03568383|Pyridoxal|pyridoxal|mesh-list
102274130|NCT03568383|Vitamin B 6|vitamin b 6|mesh-list
102274131|NCT03568383|Isoniazid|isoniazid|mesh-list
102274132|NCT03568383|Vitamins|vitamins|mesh-ancestor
102274133|NCT03568383|Micronutrients|micronutrients|mesh-ancestor
102274134|NCT03568383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274135|NCT03568383|Vitamin B Complex|vitamin b complex|mesh-ancestor
102274136|NCT03568383|Antitubercular Agents|antitubercular agents|mesh-ancestor
102274137|NCT03568383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102274138|NCT03568383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102274139|NCT03568383|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102274140|NCT03568383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102274141|NCT03568383|Antimetabolites|antimetabolites|mesh-ancestor
102274142|NCT03568383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274143|NCT03568383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102274144|NCT03558087|Gemcitabine|gemcitabine|mesh-list
102274145|NCT03558087|Nivolumab|nivolumab|mesh-list
102274146|NCT03558087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274147|NCT03558087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102274148|NCT03558087|Antimetabolites|antimetabolites|mesh-ancestor
102274149|NCT03558087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274150|NCT03558087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102274151|NCT03558087|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102274152|NCT03542695|Alendronate|alendronate|mesh-list
102274154|NCT03542695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102274155|NCT03542695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274156|NCT03542695|Trace Elements|trace elements|mesh-ancestor
102274157|NCT03542695|Micronutrients|micronutrients|mesh-ancestor
102274158|NCT03541902|Sunitinib|sunitinib|mesh-list
102274159|NCT03541902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274160|NCT03541902|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102274161|NCT03541902|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102274162|NCT03541902|Growth Substances|growth substances|mesh-ancestor
102274163|NCT03541902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274164|NCT03541902|Growth Inhibitors|growth inhibitors|mesh-ancestor
102274165|NCT03541902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102274166|NCT03541902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102274167|NCT03541902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274168|NCT03534180|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102274169|NCT03534180|Venetoclax|venetoclax|mesh-list
102274170|NCT03534180|Romidepsin|romidepsin|mesh-list
102274171|NCT03534180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102274172|NCT03534180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274173|NCT03534180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102274174|NCT03534180|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102274175|NCT03534180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102614289|NCT00330551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102274176|NCT03534180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274177|NCT03516279|Pembrolizumab|pembrolizumab|mesh-list
102274178|NCT03516279|Imatinib Mesylate|imatinib mesylate|mesh-list
102274179|NCT03516279|Dasatinib|dasatinib|mesh-list
102274180|NCT03516279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102274181|NCT03516279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274182|NCT03516279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102274183|NCT03516279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274184|NCT03516279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102274185|NCT03516279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102274186|NCT03512405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102274187|NCT03512405|Pembrolizumab|pembrolizumab|mesh-list
102274188|NCT03512405|Blinatumomab|blinatumomab|mesh-list
102274189|NCT03512405|Antibodies|antibodies|mesh-list
102274190|NCT03512405|Immunoglobulins|immunoglobulins|mesh-list
102274191|NCT03512405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102274192|NCT03512405|Muromonab-CD3|muromonab-cd3|mesh-list
102274193|NCT03512405|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102274194|NCT03512405|Immunologic Factors|immunologic factors|mesh-ancestor
102274195|NCT03512405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274196|NCT03512405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274197|NCT03512405|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102274198|NCT03512405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274199|NCT03512405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102274200|NCT03493425|Cisplatin|cisplatin|mesh-list
102274201|NCT03493425|Carboplatin|carboplatin|mesh-list
102274202|NCT03493425|Docetaxel|docetaxel|mesh-list
102274203|NCT03493425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274204|NCT03493425|Tubulin Modulators|tubulin modulators|mesh-ancestor
102274205|NCT03493425|Antimitotic Agents|antimitotic agents|mesh-ancestor
102274206|NCT03493425|Mitosis Modulators|mitosis modulators|mesh-ancestor
102274207|NCT03493425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274208|NCT03458416|Cannabidiol|cannabidiol|mesh-list
102274209|NCT03458416|Anticonvulsants|anticonvulsants|mesh-ancestor
102274210|NCT03441113|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
102274211|NCT03441113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102274212|NCT03441113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102274213|NCT03441113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274214|NCT03430219|Calcium|calcium|mesh-list
102274215|NCT03430219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102274216|NCT03430219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677384|NCT00944359|Zinc|zinc|mesh-list
102274217|NCT03419234|Ascorbic Acid|ascorbic acid|mesh-list
102274218|NCT03419234|Prednisone|prednisone|mesh-list
102274219|NCT03419234|Cortisone|cortisone|mesh-list
102274220|NCT03419234|Methyltestosterone|methyltestosterone|mesh-list
102274221|NCT03419234|Abiraterone Acetate|abiraterone acetate|mesh-list
102274222|NCT03419234|Hormones|hormones|mesh-list
102274223|NCT03419234|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
102274224|NCT03419234|Androgens|androgens|mesh-list
102274225|NCT03419234|Androgen Antagonists|androgen antagonists|mesh-list
102274226|NCT03419234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102274227|NCT03419234|Glucocorticoids|glucocorticoids|mesh-ancestor
102274228|NCT03419234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102274229|NCT03419234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274230|NCT03419234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102274231|NCT03419234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274232|NCT03419234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102274233|NCT03419234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102274234|NCT03419234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274235|NCT03419234|Hormone Antagonists|hormone antagonists|mesh-ancestor
102274236|NCT03419234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102274237|NCT03419234|Antioxidants|antioxidants|mesh-ancestor
102274238|NCT03419234|Protective Agents|protective agents|mesh-ancestor
102274239|NCT03419234|Vitamins|vitamins|mesh-ancestor
102274240|NCT03419234|Micronutrients|micronutrients|mesh-ancestor
102274241|NCT03419234|Estrogens|estrogens|mesh-ancestor
102274242|NCT03419234|Anabolic Agents|anabolic agents|mesh-ancestor
102274243|NCT03384914|Vaccines|vaccines|mesh-list
102274244|NCT03384914|Immunologic Factors|immunologic factors|mesh-list
102274245|NCT03384914|Immunomodulating Agents|immunomodulating agents|mesh-list
101677480|NCT00754065|Estradiol|estradiol|mesh-list
102274246|NCT03384914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274247|NCT03339128|Eluxadoline|eluxadoline|mesh-list
102274248|NCT03339128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102274249|NCT03280563|Tamoxifen|tamoxifen|mesh-list
102274250|NCT03280563|Bevacizumab|bevacizumab|mesh-list
102274251|NCT03280563|Atezolizumab|atezolizumab|mesh-list
102274252|NCT03280563|Fulvestrant|fulvestrant|mesh-list
102274253|NCT03280563|Exemestane|exemestane|mesh-list
102274254|NCT03280563|Entinostat|entinostat|mesh-list
102274255|NCT03280563|Ipatasertib|ipatasertib|mesh-list
102274256|NCT03280563|Antibodies|antibodies|mesh-list
102274257|NCT03280563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102274258|NCT03280563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274259|NCT03280563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102274260|NCT03280563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102274261|NCT03280563|Growth Substances|growth substances|mesh-ancestor
102274262|NCT03280563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274263|NCT03280563|Growth Inhibitors|growth inhibitors|mesh-ancestor
102274264|NCT03280563|Immunologic Factors|immunologic factors|mesh-ancestor
102274265|NCT03280563|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102274266|NCT03280563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274267|NCT03280563|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102274268|NCT03280563|Hormone Antagonists|hormone antagonists|mesh-ancestor
102274269|NCT03280563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102274270|NCT03280563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102274271|NCT03280563|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102274272|NCT03280563|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102274273|NCT03280563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102274274|NCT03280563|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102274275|NCT03280563|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102274276|NCT03280563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102274277|NCT03280563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102274278|NCT03280563|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101983049|NCT03880357|Hormones|hormones|mesh-ancestor
102274279|NCT03280563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102274280|NCT03267433|Rituximab|rituximab|mesh-list
102274281|NCT03267433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102274282|NCT03267433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274283|NCT03267433|Immunologic Factors|immunologic factors|mesh-ancestor
102274284|NCT03267433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274285|NCT03267433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102274286|NCT03238300|Acetylcysteine|acetylcysteine|mesh-list
102274287|NCT03238300|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102274288|NCT03238300|Antiviral Agents|antiviral agents|mesh-ancestor
102274289|NCT03238300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102274290|NCT03238300|Expectorants|expectorants|mesh-ancestor
102274291|NCT03238300|Respiratory System Agents|respiratory system agents|mesh-ancestor
102274292|NCT03238300|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102274293|NCT03238300|Antioxidants|antioxidants|mesh-ancestor
102274294|NCT03238300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274295|NCT03238300|Protective Agents|protective agents|mesh-ancestor
101677670|NCT02784392|Metoclopramide|metoclopramide|mesh-list
102274296|NCT03238300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274297|NCT03238300|Antidotes|antidotes|mesh-ancestor
102274298|NCT03215511|Selitrectinib|selitrectinib|mesh-list
102274299|NCT03215511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102274300|NCT03215511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274301|NCT03214003|Cisplatin|cisplatin|mesh-list
102274302|NCT03214003|Etoposide|etoposide|mesh-list
102274303|NCT03214003|Etoposide phosphate|etoposide phosphate|mesh-list
102274304|NCT03214003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677716|NCT02783846|Analgesics|analgesics|mesh-ancestor
102274305|NCT03214003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102274306|NCT03214003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102274307|NCT03214003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102274308|NCT03214003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102274309|NCT03214003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274310|NCT03181100|Paclitaxel|paclitaxel|mesh-list
102274311|NCT03181100|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102274312|NCT03181100|Bevacizumab|bevacizumab|mesh-list
102274313|NCT03181100|Atezolizumab|atezolizumab|mesh-list
102274314|NCT03181100|Vemurafenib|vemurafenib|mesh-list
102274315|NCT03181100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102274316|NCT03181100|Endothelial Growth Factors|endothelial growth factors|mesh-list
102274317|NCT03181100|Antibodies|antibodies|mesh-list
102274318|NCT03181100|Immunoglobulins|immunoglobulins|mesh-list
102274319|NCT03181100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102274320|NCT03181100|Immunoglobulin G|immunoglobulin g|mesh-list
102274321|NCT03181100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102274322|NCT03181100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274323|NCT03181100|Tubulin Modulators|tubulin modulators|mesh-ancestor
102274324|NCT03181100|Antimitotic Agents|antimitotic agents|mesh-ancestor
102614290|NCT00330551|Dopamine Agents|dopamine agents|mesh-ancestor
102614291|NCT00001259|Leuprolide|leuprolide|mesh-list
102274325|NCT03181100|Mitosis Modulators|mitosis modulators|mesh-ancestor
102614292|NCT00001259|Estradiol|estradiol|mesh-list
102614293|NCT00001259|Progesterone|progesterone|mesh-list
102274326|NCT03181100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274327|NCT03181100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102274328|NCT03181100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102274329|NCT03181100|Growth Substances|growth substances|mesh-ancestor
102274330|NCT03181100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274331|NCT03181100|Growth Inhibitors|growth inhibitors|mesh-ancestor
102274332|NCT03181100|Immunologic Factors|immunologic factors|mesh-ancestor
102274333|NCT03181100|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102274334|NCT03181100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102274335|NCT03181100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102274336|NCT03139370|Cyclophosphamide|cyclophosphamide|mesh-list
102274337|NCT03139370|Fludarabine|fludarabine|mesh-list
102274338|NCT03139370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102274339|NCT03139370|Immunologic Factors|immunologic factors|mesh-ancestor
102274340|NCT03139370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274341|NCT03139370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101677913|NCT02546934|Cisplatin|cisplatin|mesh-list
102274342|NCT03139370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102274343|NCT03139370|Alkylating Agents|alkylating agents|mesh-ancestor
102274344|NCT03139370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274345|NCT03139370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274346|NCT03139370|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102274347|NCT03133221|Idelalisib|idelalisib|mesh-list
102274348|NCT03133221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274349|NCT03133221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102274350|NCT03133221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274351|NCT03113500|Prednisone|prednisone|mesh-list
102274352|NCT03113500|Cortisone|cortisone|mesh-list
102274353|NCT03113500|Cyclophosphamide|cyclophosphamide|mesh-list
102274354|NCT03113500|Doxorubicin|doxorubicin|mesh-list
102274355|NCT03113500|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102274356|NCT03113500|Etoposide|etoposide|mesh-list
102274357|NCT03113500|Etoposide phosphate|etoposide phosphate|mesh-list
102274358|NCT03113500|Daunorubicin|daunorubicin|mesh-list
102274359|NCT03113500|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102274360|NCT03113500|Podophyllotoxin|podophyllotoxin|mesh-list
102274361|NCT03113500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102274362|NCT03113500|Antibodies|antibodies|mesh-list
102274363|NCT03113500|Immunoglobulins|immunoglobulins|mesh-list
102274364|NCT03113500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102274365|NCT03113500|Immunoconjugates|immunoconjugates|mesh-list
102274366|NCT03113500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102274367|NCT03113500|Immunologic Factors|immunologic factors|mesh-ancestor
102274368|NCT03113500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274369|NCT03113500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102274370|NCT03113500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102274371|NCT03113500|Alkylating Agents|alkylating agents|mesh-ancestor
102274372|NCT03113500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274373|NCT03113500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274374|NCT03113500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102274375|NCT03113500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102274376|NCT03113500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102274377|NCT03113500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102274378|NCT03113500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102274379|NCT03113500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102274380|NCT03113500|Glucocorticoids|glucocorticoids|mesh-ancestor
102274381|NCT03113500|Hormones|hormones|mesh-ancestor
102274382|NCT03113500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102274383|NCT03113500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102274384|NCT03113500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102274385|NCT03113500|Immunotoxins|immunotoxins|mesh-ancestor
102274386|NCT03113500|Keratolytic Agents|keratolytic agents|mesh-ancestor
102274387|NCT03113500|Dermatologic Agents|dermatologic agents|mesh-ancestor
101678084|NCT00923195|Cyclophosphamide|cyclophosphamide|mesh-list
102274388|NCT03113500|Tubulin Modulators|tubulin modulators|mesh-ancestor
102274389|NCT03113500|Antimitotic Agents|antimitotic agents|mesh-ancestor
102274390|NCT03113500|Mitosis Modulators|mitosis modulators|mesh-ancestor
102274391|NCT03108131|Atezolizumab|atezolizumab|mesh-list
102274392|NCT03108131|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102274393|NCT03108131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102274394|NCT03108131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274395|NCT03108131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102274396|NCT03108131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102614294|NCT00001259|Estrogens|estrogens|mesh-ancestor
102274397|NCT03108131|Immunologic Factors|immunologic factors|mesh-ancestor
102274398|NCT03108131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102614295|NCT00001259|Hormones|hormones|mesh-ancestor
102274399|NCT03089203|Cyclophosphamide|cyclophosphamide|mesh-list
102274400|NCT03089203|Fludarabine|fludarabine|mesh-list
102274401|NCT03089203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102274402|NCT03089203|Immunologic Factors|immunologic factors|mesh-ancestor
102274403|NCT03089203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274404|NCT03089203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102274405|NCT03089203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102274406|NCT03089203|Alkylating Agents|alkylating agents|mesh-ancestor
102274407|NCT03089203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274408|NCT03089203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274409|NCT03089203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102274410|NCT03087071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102274411|NCT03087071|Panitumumab|panitumumab|mesh-list
102274412|NCT03087071|Trametinib|trametinib|mesh-list
102274413|NCT03087071|Antibodies|antibodies|mesh-list
102274414|NCT03087071|Immunoglobulins|immunoglobulins|mesh-list
102274415|NCT03087071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102274416|NCT03087071|Immunologic Factors|immunologic factors|mesh-ancestor
102274417|NCT03087071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274418|NCT03087071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274419|NCT03087071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102274420|NCT03087071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102274421|NCT03087071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274422|NCT03049540|Tadalafil|tadalafil|mesh-list
102274423|NCT03049540|Vasodilator Agents|vasodilator agents|mesh-ancestor
102274424|NCT03049540|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102274425|NCT03049540|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102274426|NCT03049540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102274427|NCT03049540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274428|NCT03049540|Urological Agents|urological agents|mesh-ancestor
102274429|NCT03040596|Fluticasone|fluticasone|mesh-list
102274430|NCT03040596|Xhance|xhance|mesh-list
102274431|NCT03040596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102274433|NCT03040596|Autonomic Agents|autonomic agents|mesh-ancestor
102274434|NCT03040596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102274435|NCT03040596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274436|NCT03040596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102274437|NCT03040596|Respiratory System Agents|respiratory system agents|mesh-ancestor
102274438|NCT03040596|Dermatologic Agents|dermatologic agents|mesh-ancestor
102274439|NCT03040596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102274440|NCT03012880|Dexamethasone|dexamethasone|mesh-list
102274441|NCT03012880|Dexamethasone acetate|dexamethasone acetate|mesh-list
102274442|NCT03012880|Lenalidomide|lenalidomide|mesh-list
101678400|NCT04089657|Apatinib|apatinib|mesh-list
102274443|NCT03012880|Daratumumab|daratumumab|mesh-list
102274444|NCT03012880|Ixazomib|ixazomib|mesh-list
102274445|NCT03012880|Ichthammol|ichthammol|mesh-list
102274446|NCT03012880|BB 1101|bb 1101|mesh-list
102274447|NCT03012880|Glycine|glycine|mesh-list
102274448|NCT03012880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102274449|NCT03012880|Antiemetics|antiemetics|mesh-ancestor
102274450|NCT03012880|Autonomic Agents|autonomic agents|mesh-ancestor
102274451|NCT03012880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102274452|NCT03012880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274453|NCT03012880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102274454|NCT03012880|Glucocorticoids|glucocorticoids|mesh-ancestor
102274455|NCT03012880|Hormones|hormones|mesh-ancestor
102274456|NCT03012880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102274457|NCT03012880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102274458|NCT03012880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274459|NCT03012880|Immunologic Factors|immunologic factors|mesh-ancestor
102274460|NCT03012880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102274461|NCT03012880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102274462|NCT03012880|Growth Substances|growth substances|mesh-ancestor
102274463|NCT03012880|Growth Inhibitors|growth inhibitors|mesh-ancestor
102274464|NCT03012880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274465|NCT03012880|Protease Inhibitors|protease inhibitors|mesh-ancestor
102274466|NCT03012880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102274467|NCT03012880|Dermatologic Agents|dermatologic agents|mesh-ancestor
102274468|NCT03012880|Glycine Agents|glycine agents|mesh-ancestor
102274469|NCT03012880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102274470|NCT02999087|Cetuximab|cetuximab|mesh-list
102274471|NCT02999087|Avelumab|avelumab|mesh-list
102274472|NCT02999087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274473|NCT02999087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102274474|NCT02983461|Sildenafil Citrate|sildenafil citrate|mesh-list
102274475|NCT02983461|Vasodilator Agents|vasodilator agents|mesh-ancestor
102274476|NCT02983461|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102274477|NCT02983461|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102274478|NCT02983461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102274479|NCT02983461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274480|NCT02983461|Urological Agents|urological agents|mesh-ancestor
102274481|NCT02936102|Spartalizumab|spartalizumab|mesh-list
102274482|NCT02936102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102274483|NCT02936102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274484|NCT02936102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102274485|NCT02936102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274486|NCT02927301|Atezolizumab|atezolizumab|mesh-list
102274487|NCT02927301|Antibodies|antibodies|mesh-list
102274488|NCT02927301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102274489|NCT02927301|Immunologic Factors|immunologic factors|mesh-ancestor
102274490|NCT02927301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274491|NCT02927301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102274492|NCT02927301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274493|NCT02927301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102274494|NCT02927301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274495|NCT02924727|Valsartan|valsartan|mesh-list
102274496|NCT02924727|Ramipril|ramipril|mesh-list
102274497|NCT02924727|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102274498|NCT02924727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102274499|NCT02924727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102274500|NCT02924727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102274501|NCT02924727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274502|NCT02924727|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102274503|NCT02924727|Protease Inhibitors|protease inhibitors|mesh-ancestor
102274504|NCT02924727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102274505|NCT02905110|Methotrexate|methotrexate|mesh-list
102274506|NCT02905110|Etoposide|etoposide|mesh-list
102274507|NCT02905110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102274508|NCT02905110|Abortifacient Agents|abortifacient agents|mesh-ancestor
102274509|NCT02905110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102274510|NCT02905110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274511|NCT02905110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102274512|NCT02905110|Antimetabolites|antimetabolites|mesh-ancestor
102274513|NCT02905110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274514|NCT02905110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274515|NCT02905110|Dermatologic Agents|dermatologic agents|mesh-ancestor
102274516|NCT02905110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102274517|NCT02905110|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102274518|NCT02905110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102274519|NCT02905110|Immunologic Factors|immunologic factors|mesh-ancestor
102274520|NCT02905110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102274521|NCT02905110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102274522|NCT02905110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102274523|NCT02905110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102274524|NCT02905110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102274525|NCT02798523|Methylprednisolone|methylprednisolone|mesh-list
102274526|NCT02798523|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102274527|NCT02798523|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102274528|NCT02798523|Prednisolone|prednisolone|mesh-list
102274529|NCT02798523|Prednisolone acetate|prednisolone acetate|mesh-list
102274530|NCT02798523|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
102274531|NCT02798523|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102274532|NCT02798523|Prednisolone phosphate|prednisolone phosphate|mesh-list
102274533|NCT02798523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102274534|NCT02798523|Antiemetics|antiemetics|mesh-ancestor
102274535|NCT02798523|Autonomic Agents|autonomic agents|mesh-ancestor
102274536|NCT02798523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102274537|NCT02798523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274538|NCT02798523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102274539|NCT02798523|Glucocorticoids|glucocorticoids|mesh-ancestor
102274540|NCT02798523|Hormones|hormones|mesh-ancestor
102274541|NCT02798523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102274542|NCT02798523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102274543|NCT02798523|Protective Agents|protective agents|mesh-ancestor
102274544|NCT02798523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102274545|NCT02798523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274546|NCT02797977|Gemcitabine|gemcitabine|mesh-list
102614296|NCT00001259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102614297|NCT00001259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274547|NCT02797977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274548|NCT02797977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102274549|NCT02797977|Antimetabolites|antimetabolites|mesh-ancestor
101679028|NCT02709720|Cisplatin|cisplatin|mesh-list
102274550|NCT02797977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274551|NCT02772588|Leuprolide|leuprolide|mesh-list
102274552|NCT02772588|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102274553|NCT02772588|Fertility Agents|fertility agents|mesh-ancestor
102274554|NCT02772588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102274555|NCT02772588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274556|NCT02772588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102274557|NCT02772588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274558|NCT02766582|Paclitaxel|paclitaxel|mesh-list
102274559|NCT02766582|Carboplatin|carboplatin|mesh-list
102274560|NCT02766582|Pembrolizumab|pembrolizumab|mesh-list
102274561|NCT02766582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102274562|NCT02766582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274563|NCT02766582|Tubulin Modulators|tubulin modulators|mesh-ancestor
102274564|NCT02766582|Antimitotic Agents|antimitotic agents|mesh-ancestor
102274565|NCT02766582|Mitosis Modulators|mitosis modulators|mesh-ancestor
102274566|NCT02766582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274567|NCT02766582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102274568|NCT02766582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102274569|NCT02720692|Meloxicam|meloxicam|mesh-list
102274570|NCT02720692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102274571|NCT02720692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102274572|NCT02720692|Analgesics|analgesics|mesh-ancestor
102274573|NCT02720692|Sensory System Agents|sensory system agents|mesh-ancestor
102274574|NCT02720692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102274575|NCT02720692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274576|NCT02720692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102274577|NCT02720692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102274578|NCT02720692|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102274579|NCT02720692|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101983346|NCT01266811|Dexamethasone|dexamethasone|mesh-list
102274580|NCT02720692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102274581|NCT02720692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274582|NCT02712151|Ropivacaine|ropivacaine|mesh-list
102274583|NCT02712151|Anesthetics, Local|anesthetics, local|mesh-ancestor
102274584|NCT02712151|Anesthetics|anesthetics|mesh-ancestor
102274585|NCT02712151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102274586|NCT02712151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274587|NCT02712151|Sensory System Agents|sensory system agents|mesh-ancestor
102274588|NCT02712151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102274589|NCT02707484|Thalidomide|thalidomide|mesh-list
102274590|NCT02707484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102274591|NCT02707484|Immunologic Factors|immunologic factors|mesh-ancestor
102274592|NCT02707484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274593|NCT02707484|Leprostatic Agents|leprostatic agents|mesh-ancestor
102274594|NCT02707484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102274595|NCT02707484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102274596|NCT02707484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102274597|NCT02707484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102274598|NCT02707484|Growth Substances|growth substances|mesh-ancestor
102274599|NCT02707484|Growth Inhibitors|growth inhibitors|mesh-ancestor
102274600|NCT02707484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274601|NCT02651662|Cemiplimab|cemiplimab|mesh-list
102274602|NCT02651662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102274603|NCT02651662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274604|NCT02646683|Vedolizumab|vedolizumab|mesh-list
102274605|NCT02646683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102274606|NCT02628626|Clonidine|clonidine|mesh-list
102274607|NCT02628626|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
102274608|NCT02628626|Analgesics|analgesics|mesh-ancestor
102274609|NCT02628626|Sensory System Agents|sensory system agents|mesh-ancestor
102274610|NCT02628626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102274611|NCT02628626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274612|NCT02628626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102274613|NCT02628626|Sympatholytics|sympatholytics|mesh-ancestor
102274614|NCT02628626|Autonomic Agents|autonomic agents|mesh-ancestor
102274615|NCT02628626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102274616|NCT02628626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102274617|NCT02628626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102274618|NCT02628626|Adrenergic Agents|adrenergic agents|mesh-ancestor
101679350|NCT00613470|Citalopram|citalopram|mesh-list
102274619|NCT02628626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102614298|NCT00001259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102614299|NCT00001259|Progestins|progestins|mesh-ancestor
102274620|NCT02628626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274621|NCT02628626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102274623|NCT02628626|Antimetabolites|antimetabolites|mesh-ancestor
102274624|NCT02628626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102274625|NCT02616965|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102274626|NCT02616965|Romidepsin|romidepsin|mesh-list
102274627|NCT02616965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102274628|NCT02616965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274629|NCT02616965|Immunotoxins|immunotoxins|mesh-ancestor
102274630|NCT02616965|Immunoconjugates|immunoconjugates|mesh-ancestor
102274631|NCT02616965|Immunologic Factors|immunologic factors|mesh-ancestor
102274632|NCT02616965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274633|NCT02616965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101679413|NCT00924443|Clofarabine|clofarabine|mesh-list
102274634|NCT02616965|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102274635|NCT02616965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102274636|NCT02616965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274637|NCT02595424|Carboplatin|carboplatin|mesh-list
102274638|NCT02595424|Capecitabine|capecitabine|mesh-list
102274639|NCT02595424|Etoposide|etoposide|mesh-list
102274640|NCT02595424|Temozolomide|temozolomide|mesh-list
102274641|NCT02595424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274642|NCT02595424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102274643|NCT02595424|Antimetabolites|antimetabolites|mesh-ancestor
102274644|NCT02595424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274645|NCT02595424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102274646|NCT02595424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102274647|NCT02595424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102274648|NCT02595424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102274649|NCT02595424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102274650|NCT02595424|Alkylating Agents|alkylating agents|mesh-ancestor
102274651|NCT02554812|Avelumab|avelumab|mesh-list
102274652|NCT02554812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102274653|NCT02554812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274654|NCT02544815|Digoxin|digoxin|mesh-list
102274655|NCT02544815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102274656|NCT02544815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102274657|NCT02544815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101679522|NCT02771600|Sensory System Agents|sensory system agents|mesh-ancestor
102274658|NCT02544815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274659|NCT02544815|Protective Agents|protective agents|mesh-ancestor
102274660|NCT02544815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274661|NCT02527707|Ritonavir|ritonavir|mesh-list
102274662|NCT02527707|Lonafarnib|lonafarnib|mesh-list
102274663|NCT02527707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102274664|NCT02527707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102274665|NCT02527707|Protease Inhibitors|protease inhibitors|mesh-ancestor
102274666|NCT02527707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102274667|NCT02527707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274668|NCT02527707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102274669|NCT02527707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102274670|NCT02527707|Antiviral Agents|antiviral agents|mesh-ancestor
102274671|NCT02527707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102274672|NCT02527707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102274673|NCT02527707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102274674|NCT02453191|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
102274675|NCT02453191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102274676|NCT02453191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274677|NCT02437136|Pembrolizumab|pembrolizumab|mesh-list
102274678|NCT02437136|Entinostat|entinostat|mesh-list
101679637|NCT00643071|Tacrolimus|tacrolimus|mesh-list
102274679|NCT02437136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102274680|NCT02437136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274681|NCT02437136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102274682|NCT02437136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274683|NCT02437136|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102274684|NCT02437136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102274685|NCT02367924|Trabectedin|trabectedin|mesh-list
102274686|NCT02367924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102274687|NCT02367924|Alkylating Agents|alkylating agents|mesh-ancestor
102274688|NCT02367924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274689|NCT02367924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274690|NCT02352090|Dienogest|dienogest|mesh-list
102274691|NCT02352090|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102274692|NCT02352090|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102274693|NCT02352090|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102614300|NCT00001259|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102274694|NCT02352090|Estradiol|estradiol|mesh-list
102274695|NCT02352090|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102274696|NCT02352090|Nandrolone|nandrolone|mesh-list
102274697|NCT02352090|Estrogens|estrogens|mesh-ancestor
102274698|NCT02352090|Hormones|hormones|mesh-ancestor
102274699|NCT02352090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102274700|NCT02352090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274701|NCT02352090|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102274702|NCT02352090|Contraceptive Agents|contraceptive agents|mesh-ancestor
102274703|NCT02352090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102274704|NCT02352090|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102274705|NCT02352090|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102274706|NCT02352090|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102274707|NCT02352090|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102274708|NCT02352090|Hormone Antagonists|hormone antagonists|mesh-ancestor
102274709|NCT02352090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102274710|NCT02352090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274711|NCT02352090|Androgens|androgens|mesh-ancestor
102274712|NCT02352090|Anabolic Agents|anabolic agents|mesh-ancestor
102274713|NCT02135107|Rabeprazole|rabeprazole|mesh-list
102274714|NCT02135107|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102274715|NCT02135107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102274716|NCT02135107|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102274717|NCT02135107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102274718|NCT02135107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274719|NCT02025010|Abiraterone Acetate|abiraterone acetate|mesh-list
102274720|NCT02025010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274721|NCT02025010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102274722|NCT02025010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102274723|NCT02025010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274724|NCT02025010|Hormone Antagonists|hormone antagonists|mesh-ancestor
102274725|NCT02025010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102274726|NCT02025010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274727|NCT02025010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102274728|NCT01982448|Paclitaxel|paclitaxel|mesh-list
102274729|NCT01982448|Cisplatin|cisplatin|mesh-list
102274730|NCT01982448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102274731|NCT01982448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274732|NCT01982448|Tubulin Modulators|tubulin modulators|mesh-ancestor
102274733|NCT01982448|Antimitotic Agents|antimitotic agents|mesh-ancestor
102274734|NCT01982448|Mitosis Modulators|mitosis modulators|mesh-ancestor
102274735|NCT01982448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274736|NCT01938261|Acetaminophen|acetaminophen|mesh-list
102274737|NCT01938261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102274738|NCT01938261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102274739|NCT01938261|Analgesics|analgesics|mesh-ancestor
102274740|NCT01938261|Sensory System Agents|sensory system agents|mesh-ancestor
102274741|NCT01938261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102274742|NCT01938261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274743|NCT01938261|Antipyretics|antipyretics|mesh-ancestor
102274744|NCT01844986|Olaparib|olaparib|mesh-list
102274745|NCT01844986|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102274746|NCT01844986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101680003|NCT04691726|Narcotics|narcotics|mesh-ancestor
102274747|NCT01844986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274748|NCT01844986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274749|NCT01809041|Remifentanil|remifentanil|mesh-list
102274750|NCT01809041|Propofol|propofol|mesh-list
102274751|NCT01809041|Sevoflurane|sevoflurane|mesh-list
102274752|NCT01809041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102274753|NCT01809041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102274754|NCT01809041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274755|NCT01809041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102274756|NCT01809041|Anesthetics, General|anesthetics, general|mesh-ancestor
102274757|NCT01809041|Anesthetics|anesthetics|mesh-ancestor
102274758|NCT01809041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102274759|NCT01809041|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102274760|NCT01809041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102274761|NCT01809041|Narcotics|narcotics|mesh-ancestor
102274762|NCT01809041|Analgesics|analgesics|mesh-ancestor
102274763|NCT01809041|Sensory System Agents|sensory system agents|mesh-ancestor
102274764|NCT01809041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102274765|NCT01689727|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
102274766|NCT01689727|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102614301|NCT00001259|Fertility Agents|fertility agents|mesh-ancestor
102274767|NCT01689727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274768|NCT01689714|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
101680132|NCT00920699|Vitamins|vitamins|mesh-ancestor
102274769|NCT01689714|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102274770|NCT01689714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274771|NCT01689662|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
102274772|NCT01689662|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102274773|NCT01689662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274774|NCT01689636|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
102274775|NCT01689636|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102274776|NCT01689636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274777|NCT01686256|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
102274778|NCT01686256|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102274779|NCT01686256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274780|NCT01684098|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
102274781|NCT01684098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102274782|NCT01684098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274783|NCT01659151|Aldesleukin|aldesleukin|mesh-list
102274784|NCT01659151|Cyclophosphamide|cyclophosphamide|mesh-list
102274785|NCT01659151|Fludarabine|fludarabine|mesh-list
102274786|NCT01659151|Interleukin-2|interleukin-2|mesh-list
102274787|NCT01659151|Vemurafenib|vemurafenib|mesh-list
102274788|NCT01659151|Enzyme Inhibitors|enzyme inhibitors|mesh-list
102274789|NCT01659151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102274790|NCT01659151|Immunologic Factors|immunologic factors|mesh-ancestor
102274791|NCT01659151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102274792|NCT01659151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102274793|NCT01659151|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102274794|NCT01659151|Alkylating Agents|alkylating agents|mesh-ancestor
102274795|NCT01659151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274796|NCT01659151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274797|NCT01659151|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102274798|NCT01659151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102274799|NCT01659151|Analgesics|analgesics|mesh-ancestor
102274800|NCT01659151|Sensory System Agents|sensory system agents|mesh-ancestor
101680261|NCT00910455|SRX246|srx246|mesh-list
102274801|NCT01659151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102274802|NCT01659151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102274803|NCT01659151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102274804|NCT01659151|Antiviral Agents|antiviral agents|mesh-ancestor
102274805|NCT01659151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102274806|NCT01659151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102274807|NCT01593254|Imatinib Mesylate|imatinib mesylate|mesh-list
102274809|NCT01593254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274810|NCT01593254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102274811|NCT01593254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102274812|NCT01593254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274813|NCT01537601|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102274814|NCT01537601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102274815|NCT01525394|Moxifloxacin|moxifloxacin|mesh-list
102274816|NCT01525394|Lenvatinib|lenvatinib|mesh-list
102274817|NCT01525394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102274818|NCT01525394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102274819|NCT01525394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102274820|NCT01525394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102274821|NCT01525394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102274822|NCT01525394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274823|NCT01525394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274824|NCT01525394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102274825|NCT01454934|Gemcitabine|gemcitabine|mesh-list
102274826|NCT01454934|Docetaxel|docetaxel|mesh-list
102274827|NCT01454934|Pemetrexed|pemetrexed|mesh-list
102274828|NCT01454934|Vinorelbine|vinorelbine|mesh-list
102274829|NCT01454934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102274830|NCT01454934|Antimetabolites|antimetabolites|mesh-ancestor
102274831|NCT01454934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102274832|NCT01454934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102274833|NCT01454934|Tubulin Modulators|tubulin modulators|mesh-ancestor
102274834|NCT01454934|Antimitotic Agents|antimitotic agents|mesh-ancestor
102274835|NCT01454934|Mitosis Modulators|mitosis modulators|mesh-ancestor
102274836|NCT01454934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102274837|NCT01454934|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102274838|NCT01454934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102614302|NCT00001259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101893193|NCT01105208|Cephalexin|cephalexin|mesh-list
101893194|NCT01105208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101689697|NCT02831933|Antiviral Agents|antiviral agents|mesh-ancestor
101893195|NCT01105208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101893196|NCT01105286|Vitamin D|vitamin d|mesh-list
101893197|NCT01105286|Calcipotriene|calcipotriene|mesh-list
101893198|NCT01105286|Vitamins|vitamins|mesh-ancestor
101893199|NCT01105286|Micronutrients|micronutrients|mesh-ancestor
101893200|NCT01105286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893201|NCT01105286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101893202|NCT01105286|Dermatologic Agents|dermatologic agents|mesh-ancestor
101893203|NCT00041132|Leucovorin|leucovorin|mesh-list
101893204|NCT00041132|Cytarabine|cytarabine|mesh-list
101893205|NCT00041132|Dexamethasone|dexamethasone|mesh-list
101893206|NCT00041132|Cyclophosphamide|cyclophosphamide|mesh-list
101893207|NCT00041132|Rituximab|rituximab|mesh-list
101893208|NCT00041132|Doxorubicin|doxorubicin|mesh-list
101893209|NCT00041132|Methotrexate|methotrexate|mesh-list
101893210|NCT00041132|Vincristine|vincristine|mesh-list
101893211|NCT00041132|Levoleucovorin|levoleucovorin|mesh-list
101893212|NCT00041132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101893213|NCT00041132|Immunologic Factors|immunologic factors|mesh-ancestor
101893214|NCT00041132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893215|NCT00041132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101893216|NCT00041132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101893217|NCT00041132|Alkylating Agents|alkylating agents|mesh-ancestor
101893218|NCT00041132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893219|NCT00041132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101612986|NCT04202289|Sulfadiazine|sulfadiazine|mesh-list
101612987|NCT04202289|Silver Sulfadiazine|silver sulfadiazine|mesh-list
101612988|NCT04202289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101612989|NCT04202289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101893220|NCT00041132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101893221|NCT00041132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101893222|NCT00041132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101893224|NCT00041132|Autonomic Agents|autonomic agents|mesh-ancestor
101893225|NCT00041132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101893226|NCT00041132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101893227|NCT00041132|Glucocorticoids|glucocorticoids|mesh-ancestor
101893228|NCT00041132|Hormones|hormones|mesh-ancestor
101893229|NCT00041132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101893230|NCT00041132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101893231|NCT00041132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101893232|NCT00041132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101893233|NCT00041132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101893234|NCT00041132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101893235|NCT00041132|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101893236|NCT00041132|Abortifacient Agents|abortifacient agents|mesh-ancestor
101893237|NCT00041132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101893238|NCT00041132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101893239|NCT00041132|Antimetabolites|antimetabolites|mesh-ancestor
101893240|NCT00041132|Dermatologic Agents|dermatologic agents|mesh-ancestor
101893241|NCT00041132|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101893242|NCT00041132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101893243|NCT00041132|Antiviral Agents|antiviral agents|mesh-ancestor
101893244|NCT00041132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101893245|NCT00041132|Antidotes|antidotes|mesh-ancestor
101893246|NCT00041132|Protective Agents|protective agents|mesh-ancestor
101893247|NCT00041132|Vitamin B Complex|vitamin b complex|mesh-ancestor
101893248|NCT00041132|Vitamins|vitamins|mesh-ancestor
101893249|NCT00041132|Micronutrients|micronutrients|mesh-ancestor
101893250|NCT00041132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101893251|NCT00041132|Tubulin Modulators|tubulin modulators|mesh-ancestor
101893252|NCT00041132|Antimitotic Agents|antimitotic agents|mesh-ancestor
101893253|NCT00041132|Mitosis Modulators|mitosis modulators|mesh-ancestor
101893254|NCT00040664|Ritonavir|ritonavir|mesh-list
101893255|NCT00040664|Fosamprenavir|fosamprenavir|mesh-list
101893256|NCT00040664|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101893257|NCT00040664|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101893258|NCT00040664|Protease Inhibitors|protease inhibitors|mesh-ancestor
101893259|NCT00040664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101893260|NCT00040664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893261|NCT00040664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101893262|NCT00040664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101893263|NCT00040664|Antiviral Agents|antiviral agents|mesh-ancestor
101893264|NCT00040664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101893265|NCT00040664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101893266|NCT00040664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101893267|NCT02952586|Avelumab|avelumab|mesh-list
101893268|NCT02952586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101893269|NCT02952586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101893270|NCT05098574|Drospirenone|drospirenone|mesh-list
101893271|NCT05098574|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101893272|NCT05098574|Estradiol|estradiol|mesh-list
101893273|NCT05098574|Estrogens|estrogens|mesh-ancestor
101893274|NCT05098574|Hormones|hormones|mesh-ancestor
101893275|NCT05098574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101893276|NCT05098574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893277|NCT05098574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101893278|NCT05098574|Contraceptive Agents|contraceptive agents|mesh-ancestor
101893279|NCT05098574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101893280|NCT05098574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101680930|NCT00649467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101893281|NCT05098574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101893282|NCT05098574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101893283|NCT05098574|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101893284|NCT05098574|Hormone Antagonists|hormone antagonists|mesh-ancestor
101893285|NCT05098574|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101893286|NCT05098574|Diuretics|diuretics|mesh-ancestor
101893287|NCT05098574|Natriuretic Agents|natriuretic agents|mesh-ancestor
101893288|NCT01096706|Aspirin|aspirin|mesh-list
101893289|NCT01096706|Fluconazole|fluconazole|mesh-list
101893290|NCT01096706|Substance P|substance p|mesh-list
101893291|NCT01096706|Neurokinin A|neurokinin a|mesh-list
101893292|NCT01096706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101893293|NCT01096706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101893294|NCT01096706|Analgesics|analgesics|mesh-ancestor
101893295|NCT01096706|Sensory System Agents|sensory system agents|mesh-ancestor
101893296|NCT01096706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101893297|NCT01096706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893298|NCT01096706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101893299|NCT01096706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101893300|NCT01096706|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101893301|NCT01096706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101893302|NCT01096706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893303|NCT01096706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101893304|NCT01096706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101893305|NCT01096706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101893307|NCT01096706|Antifungal Agents|antifungal agents|mesh-ancestor
101893308|NCT01096706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101893309|NCT01096706|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101893310|NCT01096706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101893311|NCT01096706|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101893312|NCT01096706|Hormone Antagonists|hormone antagonists|mesh-ancestor
101893313|NCT01096706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101893314|NCT01096706|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101681199|NCT02702700|Verteporfin|verteporfin|mesh-list
101893315|NCT01096706|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101893316|NCT01096706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101893317|NCT01102478|Losartan|losartan|mesh-list
101893318|NCT01102478|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101893319|NCT01102478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101893320|NCT01102478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101893321|NCT01102478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101893322|NCT01102478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101893323|NCT01102478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893324|NCT01102478|Diuretics|diuretics|mesh-ancestor
101893325|NCT01102478|Natriuretic Agents|natriuretic agents|mesh-ancestor
101893326|NCT01102478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893327|NCT01102478|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101893328|NCT01102478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101893329|NCT01105598|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
101893330|NCT01105598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101893331|NCT01105598|Antimetabolites|antimetabolites|mesh-ancestor
101893332|NCT01105598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893333|NCT01105598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101893334|NCT01105598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101893335|NCT01105598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101893336|NCT01105598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893337|NCT03384316|Vaccines|vaccines|mesh-list
101893338|NCT03384316|Immunologic Factors|immunologic factors|mesh-ancestor
101893339|NCT03384316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893340|NCT01105832|Teriparatide|teriparatide|mesh-list
101681319|NCT02705274|Bevacizumab|bevacizumab|mesh-list
101893341|NCT01105832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101893342|NCT01105832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893343|NCT01105832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101893344|NCT01105910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101893345|NCT01105910|Lubricant Eye Drops|lubricant eye drops|mesh-list
101893346|NCT01105910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101893347|NCT00356525|Carboplatin|carboplatin|mesh-list
101681399|NCT04433858|Psilocybin|psilocybin|mesh-list
101893348|NCT00356525|Gemcitabine|gemcitabine|mesh-list
101893349|NCT00356525|Pemetrexed|pemetrexed|mesh-list
101893350|NCT00356525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101893351|NCT00356525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101893352|NCT00356525|Antimetabolites|antimetabolites|mesh-ancestor
101893353|NCT00356525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893354|NCT00356525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101893355|NCT00356525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101893356|NCT00356525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101893357|NCT01106066|Oxaliplatin|oxaliplatin|mesh-list
101893358|NCT01106066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101893359|NCT01052129|Naproxen|naproxen|mesh-list
101893360|NCT01052129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101893361|NCT01052129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101893362|NCT01052129|Analgesics|analgesics|mesh-ancestor
101893363|NCT01052129|Sensory System Agents|sensory system agents|mesh-ancestor
101893364|NCT01052129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101893365|NCT01052129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893366|NCT01052129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101613149|NCT01106690|Metformin|metformin|mesh-list
101893367|NCT01052129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101893368|NCT01052129|Gout Suppressants|gout suppressants|mesh-ancestor
101893369|NCT01052129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101893370|NCT01052129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101893371|NCT01052129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893372|NCT01053377|Oseltamivir|oseltamivir|mesh-list
101893373|NCT01053377|Antiviral Agents|antiviral agents|mesh-ancestor
101893374|NCT01053377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101893375|NCT01053377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101893376|NCT01053377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893377|NCT03991559|Manganese|manganese|mesh-list
101893378|NCT03991559|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101893379|NCT03991559|Antibodies|antibodies|mesh-list
101893380|NCT03991559|Immunoglobulins|immunoglobulins|mesh-list
101893381|NCT03991559|Immunologic Factors|immunologic factors|mesh-ancestor
101893382|NCT03991559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893383|NCT03991559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893384|NCT03991559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101893385|NCT03991559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101893386|NCT03991559|Trace Elements|trace elements|mesh-ancestor
101893387|NCT03991559|Micronutrients|micronutrients|mesh-ancestor
101893388|NCT03949634|Paclitaxel|paclitaxel|mesh-list
101893389|NCT03949634|Docetaxel|docetaxel|mesh-list
101893390|NCT03949634|Doxorubicin|doxorubicin|mesh-list
101893391|NCT03949634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101893392|NCT03949634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101893393|NCT03949634|Tubulin Modulators|tubulin modulators|mesh-ancestor
101893394|NCT03949634|Antimitotic Agents|antimitotic agents|mesh-ancestor
101893395|NCT03949634|Mitosis Modulators|mitosis modulators|mesh-ancestor
101893396|NCT03949634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893397|NCT03949634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101893398|NCT03949634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101893399|NCT03949634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101893400|NCT03949634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101893401|NCT01108874|Metaraminol|metaraminol|mesh-list
101893402|NCT01108874|Sympathomimetics|sympathomimetics|mesh-ancestor
101893403|NCT01108874|Autonomic Agents|autonomic agents|mesh-ancestor
101893404|NCT01108874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101893405|NCT01108874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893406|NCT01108874|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101893407|NCT01108874|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101893408|NCT01108874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101893409|NCT01108874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101893410|NCT01108874|Adrenergic Agents|adrenergic agents|mesh-ancestor
101893411|NCT01108874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101893412|NCT01108874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893413|NCT03383614|Emodepside|emodepside|mesh-list
101893414|NCT03383614|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101893415|NCT03383614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101893416|NCT03403036|Brodalumab|brodalumab|mesh-list
101893417|NCT03403036|Dermatologic Agents|dermatologic agents|mesh-ancestor
101893418|NCT00356135|Clopidogrel|clopidogrel|mesh-list
101893419|NCT00356135|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101893420|NCT00356135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101893421|NCT00356135|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101893422|NCT00356135|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101893423|NCT00356135|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101893424|NCT00356135|Purinergic Agents|purinergic agents|mesh-ancestor
101893425|NCT00356135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101681907|NCT03324035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101893426|NCT00356135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893427|NCT00356135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893428|NCT01052363|Bevacizumab|bevacizumab|mesh-list
101893429|NCT01052363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101893430|NCT01052363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101893431|NCT01052363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101893432|NCT01052363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101893433|NCT01052363|Growth Substances|growth substances|mesh-ancestor
101893434|NCT01052363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893435|NCT01052363|Growth Inhibitors|growth inhibitors|mesh-ancestor
101893436|NCT01053611|Remifentanil|remifentanil|mesh-list
101893437|NCT01053611|Propofol|propofol|mesh-list
101893438|NCT01053611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101893439|NCT01053611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101893440|NCT01053611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893441|NCT01053611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101893442|NCT01053611|Anesthetics, General|anesthetics, general|mesh-ancestor
101893444|NCT01053611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101893445|NCT01053611|Narcotics|narcotics|mesh-ancestor
101893446|NCT01053611|Analgesics|analgesics|mesh-ancestor
101893447|NCT01053611|Sensory System Agents|sensory system agents|mesh-ancestor
101893448|NCT01053611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101893449|NCT00350519|Epoetin Alfa|epoetin alfa|mesh-list
101893450|NCT00350519|Hematinics|hematinics|mesh-ancestor
101893451|NCT01053689|Glimepiride|glimepiride|mesh-list
101893452|NCT01053689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101893453|NCT01053689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101893454|NCT01053689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893455|NCT01053689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101893456|NCT01053689|Immunologic Factors|immunologic factors|mesh-ancestor
101893457|NCT01111448|Sirolimus|sirolimus|mesh-list
101893458|NCT01111448|Temsirolimus|temsirolimus|mesh-list
101893459|NCT01111448|MTOR Inhibitors|mtor inhibitors|mesh-list
101893460|NCT01111448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101893461|NCT01111448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101893462|NCT01111448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893463|NCT01111448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101893464|NCT01111448|Immunologic Factors|immunologic factors|mesh-ancestor
101893465|NCT01111448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893466|NCT01111448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101893467|NCT01111448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101893468|NCT01111448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101893469|NCT01111448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101893470|NCT01111448|Antifungal Agents|antifungal agents|mesh-ancestor
101893471|NCT03382912|Nivolumab|nivolumab|mesh-list
101893472|NCT03382912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101893473|NCT03382912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101893474|NCT03382912|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101893475|NCT03382912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893476|NCT03942926|Sirolimus|sirolimus|mesh-list
101893477|NCT03942926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101893478|NCT03942926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101893479|NCT03942926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101893480|NCT03942926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101893482|NCT03942926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101893483|NCT03942926|Immunologic Factors|immunologic factors|mesh-ancestor
101893484|NCT03942926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893485|NCT00350207|Bromides|bromides|mesh-list
101893486|NCT00350207|Tiotropium Bromide|tiotropium bromide|mesh-list
101893487|NCT00350207|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101893488|NCT00350207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101893489|NCT00350207|Autonomic Agents|autonomic agents|mesh-ancestor
101893491|NCT00350207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893492|NCT00350207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101893493|NCT00350207|Respiratory System Agents|respiratory system agents|mesh-ancestor
101893494|NCT00350207|Parasympatholytics|parasympatholytics|mesh-ancestor
101893495|NCT00350207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101893496|NCT00350207|Cholinergic Agents|cholinergic agents|mesh-ancestor
101893497|NCT00350207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101893498|NCT00350207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893499|NCT00350207|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101893500|NCT00350207|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101893501|NCT00350207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101893502|NCT00350207|Adrenergic Agents|adrenergic agents|mesh-ancestor
101893503|NCT00350207|Anticonvulsants|anticonvulsants|mesh-ancestor
101893504|NCT03946826|Halometasone|halometasone|mesh-list
101893505|NCT03946826|Petrolatum|petrolatum|mesh-list
101893506|NCT03946826|Emollients|emollients|mesh-ancestor
101893507|NCT03946826|Dermatologic Agents|dermatologic agents|mesh-ancestor
101893508|NCT03946826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101893509|NCT03946826|Glucocorticoids|glucocorticoids|mesh-ancestor
101893510|NCT03946826|Hormones|hormones|mesh-ancestor
101893511|NCT03946826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101893512|NCT03946826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893513|NCT01311622|Warfarin|warfarin|mesh-list
101893514|NCT01311622|Anticoagulants|anticoagulants|mesh-ancestor
101893515|NCT00349973|Dipyridamole|dipyridamole|mesh-list
101893516|NCT00349973|Olanzapine|olanzapine|mesh-list
101613289|NCT02879006|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101893517|NCT00349973|Antiemetics|antiemetics|mesh-ancestor
101893518|NCT00349973|Autonomic Agents|autonomic agents|mesh-ancestor
101893519|NCT00349973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101682482|NCT00910715|Doxycycline|doxycycline|mesh-list
101893520|NCT00349973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893521|NCT00349973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101893522|NCT00349973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101893523|NCT00349973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101893524|NCT00349973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101893525|NCT00349973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101893526|NCT00349973|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101893527|NCT00349973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101893528|NCT00349973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101893529|NCT00349973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893530|NCT00349973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101893531|NCT00349973|Serotonin Agents|serotonin agents|mesh-ancestor
101893532|NCT00349973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101893533|NCT00349973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101893534|NCT00349973|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101893535|NCT00349973|Vasodilator Agents|vasodilator agents|mesh-ancestor
101893536|NCT01111682|Mannitol|mannitol|mesh-list
101893537|NCT01111682|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101893538|NCT01111682|Diuretics|diuretics|mesh-ancestor
101893539|NCT01111682|Natriuretic Agents|natriuretic agents|mesh-ancestor
101893540|NCT01111682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893541|NCT04464122|Somatostatin|somatostatin|mesh-list
101893542|NCT04464122|Hormones|hormones|mesh-ancestor
101893543|NCT04464122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101893544|NCT04464122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893545|NCT01111994|Clindamycin|clindamycin|mesh-list
101893546|NCT01111994|Clindamycin palmitate|clindamycin palmitate|mesh-list
101893547|NCT01111994|Clindamycin phosphate|clindamycin phosphate|mesh-list
101893548|NCT01111994|Tretinoin|tretinoin|mesh-list
101893549|NCT01111994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101893550|NCT01111994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101893551|NCT01111994|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101893552|NCT01111994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101893553|NCT01111994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893554|NCT01111994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101893555|NCT01111994|Keratolytic Agents|keratolytic agents|mesh-ancestor
101893556|NCT01111994|Dermatologic Agents|dermatologic agents|mesh-ancestor
101893557|NCT03187262|Daratumumab|daratumumab|mesh-list
101893558|NCT03187262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101893559|NCT03944252|Cetuximab|cetuximab|mesh-list
101893560|NCT03944252|Avelumab|avelumab|mesh-list
101893561|NCT03944252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101682706|NCT02728466|Proanthocyanidin|proanthocyanidin|mesh-list
101893562|NCT03944252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101893563|NCT01209026|Fluticasone|fluticasone|mesh-list
101893565|NCT01209026|Moxifloxacin|moxifloxacin|mesh-list
101893566|NCT01209026|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101893567|NCT01209026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101893568|NCT01209026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101893569|NCT01209026|Autonomic Agents|autonomic agents|mesh-ancestor
101893570|NCT01209026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101893571|NCT01209026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893572|NCT01209026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101893573|NCT01209026|Respiratory System Agents|respiratory system agents|mesh-ancestor
101893574|NCT01209026|Dermatologic Agents|dermatologic agents|mesh-ancestor
101893575|NCT01209026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101893576|NCT01209026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101893577|NCT01209026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101893578|NCT01209026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101893579|NCT01209026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101893580|NCT01209026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101893581|NCT01209026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893582|NCT01209026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101893583|NCT01209026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101893584|NCT01209026|Contraceptive Agents|contraceptive agents|mesh-ancestor
101893585|NCT01209026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101893586|NCT01209026|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101893587|NCT01209026|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101893588|NCT01209026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101893589|NCT01107470|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101893590|NCT01107470|Hormones|hormones|mesh-ancestor
101893591|NCT01107470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101893592|NCT01107470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682864|NCT02737124|Analgesics|analgesics|mesh-ancestor
101893593|NCT01109264|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101893595|NCT01109264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101893596|NCT01109264|Alkylating Agents|alkylating agents|mesh-ancestor
101893597|NCT01109264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893598|NCT01109264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101893599|NCT01311700|Metoprolol|metoprolol|mesh-list
101893600|NCT01311700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101682936|NCT02746796|Capecitabine|capecitabine|mesh-list
101893601|NCT01311700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101893602|NCT01311700|Sympatholytics|sympatholytics|mesh-ancestor
101893603|NCT01311700|Autonomic Agents|autonomic agents|mesh-ancestor
101893604|NCT01311700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101893605|NCT01311700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893606|NCT01311700|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101893607|NCT01311700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101893608|NCT01311700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101893609|NCT01311700|Adrenergic Agents|adrenergic agents|mesh-ancestor
101893610|NCT01311700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101893611|NCT01311700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893612|NCT01107782|Sildenafil Citrate|sildenafil citrate|mesh-list
101893613|NCT01107782|Vasodilator Agents|vasodilator agents|mesh-ancestor
101893614|NCT01107782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101893615|NCT01107782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101893616|NCT01107782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101893617|NCT01107782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893618|NCT01107782|Urological Agents|urological agents|mesh-ancestor
101893619|NCT01107938|Esomeprazole|esomeprazole|mesh-list
101893620|NCT01107938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101893621|NCT01107938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101893622|NCT01107938|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101893623|NCT01107938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101683056|NCT03015974|Antitubercular Agents|antitubercular agents|mesh-ancestor
101893624|NCT01107938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893625|NCT02950558|Ropivacaine|ropivacaine|mesh-list
101893626|NCT02950558|Anesthetics, Local|anesthetics, local|mesh-ancestor
101893627|NCT02950558|Anesthetics|anesthetics|mesh-ancestor
101893628|NCT02950558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101893629|NCT02950558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893630|NCT02950558|Sensory System Agents|sensory system agents|mesh-ancestor
101893631|NCT02950558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101893632|NCT02791334|Ramucirumab|ramucirumab|mesh-list
101893633|NCT02791334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101893634|NCT03945344|Tiotropium Bromide|tiotropium bromide|mesh-list
101893635|NCT03945344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101683138|NCT02724332|Sirolimus|sirolimus|mesh-list
101893636|NCT03945344|Autonomic Agents|autonomic agents|mesh-ancestor
101689705|NCT05368766|Diuretics|diuretics|mesh-list
101893637|NCT03945344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101893638|NCT03945344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893639|NCT03945344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101893640|NCT03945344|Respiratory System Agents|respiratory system agents|mesh-ancestor
101893641|NCT03945344|Parasympatholytics|parasympatholytics|mesh-ancestor
101893642|NCT03945344|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101893643|NCT03945344|Cholinergic Agents|cholinergic agents|mesh-ancestor
101893644|NCT03945344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101893645|NCT03945344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893647|NCT01209416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101893648|NCT01209416|Antimetabolites|antimetabolites|mesh-ancestor
101893649|NCT01209416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893650|NCT01209416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101893651|NCT00349349|Ofatumumab|ofatumumab|mesh-list
101893652|NCT00349349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101893653|NCT01112462|Acetaminophen|acetaminophen|mesh-list
101893654|NCT01112462|Phenylephrine|phenylephrine|mesh-list
101893655|NCT01112462|Oxymetazoline|oxymetazoline|mesh-list
101613441|NCT02690883|Exenatide|exenatide|mesh-list
101613442|NCT02690883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101613443|NCT02690883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613444|NCT02690883|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101613445|NCT02690883|Incretins|incretins|mesh-ancestor
101613446|NCT02690883|Hormones|hormones|mesh-ancestor
101613447|NCT02690883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101613459|NCT04385589|Dapagliflozin|dapagliflozin|mesh-list
101613460|NCT04385589|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
101613461|NCT04385589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101613462|NCT04385589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893656|NCT01112462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101893657|NCT01112462|Analgesics|analgesics|mesh-ancestor
101683318|NCT02651727|Gemcitabine|gemcitabine|mesh-list
101893658|NCT01112462|Sensory System Agents|sensory system agents|mesh-ancestor
101893659|NCT01112462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101893660|NCT01112462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893661|NCT01112462|Antipyretics|antipyretics|mesh-ancestor
101893662|NCT01112462|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101893663|NCT01112462|Mydriatics|mydriatics|mesh-ancestor
101893664|NCT01112462|Autonomic Agents|autonomic agents|mesh-ancestor
101893665|NCT01112462|Sympathomimetics|sympathomimetics|mesh-ancestor
101893666|NCT01112462|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101893667|NCT01112462|Nasal Decongestants|nasal decongestants|mesh-ancestor
101893668|NCT01112462|Respiratory System Agents|respiratory system agents|mesh-ancestor
101893669|NCT01112462|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101893670|NCT01112462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101893671|NCT01112462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101893672|NCT01112462|Adrenergic Agents|adrenergic agents|mesh-ancestor
101893673|NCT01112462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101893674|NCT01112462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893675|NCT01112462|Protective Agents|protective agents|mesh-ancestor
101893676|NCT02950480|Zafirlukast|zafirlukast|mesh-list
101893677|NCT02950480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101893678|NCT02950480|Respiratory System Agents|respiratory system agents|mesh-ancestor
101893679|NCT02950480|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101893680|NCT02950480|Hormone Antagonists|hormone antagonists|mesh-ancestor
101304315|NCT02012166|Glucagon|glucagon|mesh-list
101893681|NCT02950480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101893682|NCT02950480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893684|NCT01109030|Chlordiazepoxide|chlordiazepoxide|mesh-list
101893685|NCT01109030|Dexetimide|dexetimide|mesh-list
101893686|NCT01109030|Citalopram|citalopram|mesh-list
101893687|NCT01109030|Escitalopram|escitalopram|mesh-list
101893688|NCT01109030|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101893689|NCT01109030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683454|NCT00650871|Casopitant|casopitant|mesh-list
101893690|NCT01109030|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101893691|NCT01109030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101893692|NCT01109030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101893693|NCT01109030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893694|NCT01109030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101893695|NCT01109030|Serotonin Agents|serotonin agents|mesh-ancestor
101893696|NCT01109030|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101893697|NCT01109030|Antidepressive Agents|antidepressive agents|mesh-ancestor
101893698|NCT01109030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101893699|NCT01109030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101893700|NCT01109030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101893701|NCT01109030|Parasympatholytics|parasympatholytics|mesh-ancestor
101893702|NCT01109030|Autonomic Agents|autonomic agents|mesh-ancestor
101893703|NCT01109030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101893704|NCT01109030|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101893705|NCT01109030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101893706|NCT01109030|Cholinergic Agents|cholinergic agents|mesh-ancestor
101893707|NCT01109030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101893708|NCT01109030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101893709|NCT01109030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101893710|NCT01109030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101893711|NCT01109030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101893712|NCT01109030|GABA Modulators|gaba modulators|mesh-ancestor
101893713|NCT01109030|GABA Agents|gaba agents|mesh-ancestor
101893714|NCT05494528|Entecavir|entecavir|mesh-list
101893715|NCT05494528|Antiviral Agents|antiviral agents|mesh-ancestor
101893716|NCT05494528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101893717|NCT03987815|Nivolumab|nivolumab|mesh-list
101893718|NCT03987815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101893719|NCT03987815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101893720|NCT03987815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101893721|NCT03987815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893722|NCT00348881|Vaccines|vaccines|mesh-list
101893723|NCT00348881|Immunologic Factors|immunologic factors|mesh-ancestor
101893724|NCT00348881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893725|NCT02257580|Aminocaproic Acid|aminocaproic acid|mesh-list
101893726|NCT02257580|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101893727|NCT02257580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101893728|NCT02257580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893729|NCT02257580|Hemostatics|hemostatics|mesh-ancestor
101613517|NCT00319995|Loratadine|loratadine|mesh-list
101893730|NCT02257580|Coagulants|coagulants|mesh-ancestor
101893731|NCT01055795|Bevacizumab|bevacizumab|mesh-list
101893732|NCT01055795|Everolimus|everolimus|mesh-list
101893733|NCT01055795|Panobinostat|panobinostat|mesh-list
101893734|NCT01055795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101893735|NCT01055795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101893736|NCT01055795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101893737|NCT01055795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101893738|NCT01055795|Growth Substances|growth substances|mesh-ancestor
101893739|NCT01055795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893740|NCT01055795|Growth Inhibitors|growth inhibitors|mesh-ancestor
101893741|NCT01055795|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101893742|NCT01055795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101683784|NCT02641899|Hormones|hormones|mesh-ancestor
101893743|NCT01055795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101893744|NCT01055795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893745|NCT01055795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101893746|NCT01055795|Immunologic Factors|immunologic factors|mesh-ancestor
101893747|NCT01055795|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101893748|NCT03943784|Propranolol|propranolol|mesh-list
101893749|NCT03943784|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101893750|NCT03943784|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101893751|NCT03943784|Adrenergic Agents|adrenergic agents|mesh-ancestor
101893753|NCT03943784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893754|NCT03943784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893755|NCT03943784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101893756|NCT03943784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101893757|NCT03943784|Vasodilator Agents|vasodilator agents|mesh-ancestor
101893758|NCT00347009|Adefovir|adefovir|mesh-list
101893759|NCT00347009|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101893760|NCT00347009|Antiviral Agents|antiviral agents|mesh-ancestor
101893761|NCT00347009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101893762|NCT00347009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101893763|NCT00347009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101893764|NCT00347009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101893765|NCT00347009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893766|NCT01209650|Afatinib|afatinib|mesh-list
101893767|NCT01209650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101893768|NCT01209650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101893769|NCT01209650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101893770|NCT01209650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893771|NCT01947140|Romidepsin|romidepsin|mesh-list
101893772|NCT01947140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101893773|NCT01947140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101893774|NCT01947140|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101893775|NCT01947140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101893776|NCT01947140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893777|NCT00346775|Beclomethasone|beclomethasone|mesh-list
101893778|NCT00346775|Flunisolide|flunisolide|mesh-list
101893779|NCT00346775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101893780|NCT00346775|Glucocorticoids|glucocorticoids|mesh-ancestor
101893781|NCT00346775|Hormones|hormones|mesh-ancestor
101893782|NCT00346775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101893783|NCT00346775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893784|NCT00346775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101893785|NCT00346775|Respiratory System Agents|respiratory system agents|mesh-ancestor
101893786|NCT01108562|Lidocaine|lidocaine|mesh-list
101893787|NCT01108562|Anesthetics, Local|anesthetics, local|mesh-ancestor
101893788|NCT01108562|Anesthetics|anesthetics|mesh-ancestor
101684090|NCT03773276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101893789|NCT01108562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101893790|NCT01108562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893791|NCT01108562|Sensory System Agents|sensory system agents|mesh-ancestor
101893792|NCT01108562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101893793|NCT01108562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101893794|NCT01108562|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101893795|NCT01108562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101893796|NCT01108562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101893797|NCT01108562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893798|NCT01112540|Morphine|morphine|mesh-list
101893799|NCT01112540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101893800|NCT01112540|Narcotics|narcotics|mesh-ancestor
101893801|NCT01112540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101893802|NCT01112540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893803|NCT01112540|Analgesics|analgesics|mesh-ancestor
101893804|NCT01112540|Sensory System Agents|sensory system agents|mesh-ancestor
101893805|NCT01112540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101893806|NCT03400852|Cosyntropin|cosyntropin|mesh-list
101893807|NCT03400852|Hormones|hormones|mesh-ancestor
101893808|NCT03400852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101893809|NCT03400852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893810|NCT01056419|Propylthiouracil|propylthiouracil|mesh-list
101684228|NCT04470674|Carboplatin|carboplatin|mesh-list
101893811|NCT01056419|Antimetabolites|antimetabolites|mesh-ancestor
101893812|NCT01056419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893813|NCT01056419|Antithyroid Agents|antithyroid agents|mesh-ancestor
101893814|NCT01056419|Hormone Antagonists|hormone antagonists|mesh-ancestor
101893815|NCT01056419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101893816|NCT01056419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893818|NCT01056497|Antioxidants|antioxidants|mesh-ancestor
101893819|NCT01056497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893820|NCT01056497|Protective Agents|protective agents|mesh-ancestor
101893821|NCT01056497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893822|NCT01056497|Vitamin B Complex|vitamin b complex|mesh-ancestor
101893823|NCT01056497|Vitamins|vitamins|mesh-ancestor
101893824|NCT01056497|Micronutrients|micronutrients|mesh-ancestor
101893825|NCT03398356|Metformin|metformin|mesh-list
101893826|NCT03398356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101893827|NCT03398356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893829|NCT00346151|Methylprednisolone|methylprednisolone|mesh-list
101893830|NCT00346151|Abatacept|abatacept|mesh-list
101893831|NCT00346151|Thymoglobulin|thymoglobulin|mesh-list
101893832|NCT00346151|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101893833|NCT00346151|Immunoglobulins|immunoglobulins|mesh-list
101893834|NCT00346151|Glucocorticoids|glucocorticoids|mesh-list
101893835|NCT00346151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101893836|NCT00346151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101893837|NCT00346151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101893838|NCT00346151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101893839|NCT00346151|Antifungal Agents|antifungal agents|mesh-ancestor
101893840|NCT00346151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101893841|NCT00346151|Immunologic Factors|immunologic factors|mesh-ancestor
101893842|NCT00346151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893843|NCT00346151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893844|NCT00346151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101893845|NCT00346151|Antiemetics|antiemetics|mesh-ancestor
101893846|NCT00346151|Autonomic Agents|autonomic agents|mesh-ancestor
101893847|NCT00346151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101893848|NCT00346151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101893849|NCT00346151|Hormones|hormones|mesh-ancestor
101893850|NCT00346151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101893851|NCT00346151|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101893852|NCT00346151|Protective Agents|protective agents|mesh-ancestor
101893853|NCT00346151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101893854|NCT00346151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101893855|NCT00346151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101893856|NCT03940976|Afatinib|afatinib|mesh-list
101893857|NCT03940976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101893858|NCT03940976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101893859|NCT03940976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101893860|NCT03940976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893861|NCT01109498|Cyclosporine|cyclosporine|mesh-list
101893862|NCT01109498|Mycophenolic Acid|mycophenolic acid|mesh-list
101893863|NCT01109498|Cyclosporins|cyclosporins|mesh-list
101893864|NCT01109498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101684607|NCT00879333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101893865|NCT01109498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893866|NCT01109498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101893867|NCT01109498|Immunologic Factors|immunologic factors|mesh-ancestor
101893868|NCT01109498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893869|NCT01109498|Antifungal Agents|antifungal agents|mesh-ancestor
101893870|NCT01109498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101893871|NCT01109498|Dermatologic Agents|dermatologic agents|mesh-ancestor
101893872|NCT01109498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101893873|NCT01109498|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101893874|NCT01109498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101893875|NCT01109498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101893876|NCT01109498|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101893877|NCT01109498|Antitubercular Agents|antitubercular agents|mesh-ancestor
101893878|NCT01109498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101893879|NCT00130286|Rosiglitazone|rosiglitazone|mesh-list
101893880|NCT00130286|Hormones|hormones|mesh-list
101893881|NCT00130286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101893883|NCT00130286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101893884|NCT03940664|Formaldehyde|formaldehyde|mesh-list
101893885|NCT03940664|Disinfectants|disinfectants|mesh-ancestor
101893886|NCT03940664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101893887|NCT01211834|Antirheumatic Agents|antirheumatic agents|mesh-list
101893888|NCT03941990|Nitrous Oxide|nitrous oxide|mesh-list
101893889|NCT03941990|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101893890|NCT03941990|Anesthetics, General|anesthetics, general|mesh-ancestor
101893891|NCT03941990|Anesthetics|anesthetics|mesh-ancestor
101893892|NCT03941990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101893893|NCT03941990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893894|NCT03941990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101893896|NCT03941990|Sensory System Agents|sensory system agents|mesh-ancestor
101893897|NCT03941990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101893898|NCT03374488|Pembrolizumab|pembrolizumab|mesh-list
101684801|NCT00668109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101893899|NCT03374488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101893900|NCT03374488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101893901|NCT03374488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101893902|NCT03374488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893903|NCT01209728|Ethanol|ethanol|mesh-list
101893904|NCT01209728|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101893905|NCT01209728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101893906|NCT01209728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101893907|NCT01209728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893908|NCT00345683|Vaccines|vaccines|mesh-list
101893909|NCT00345683|Immunologic Factors|immunologic factors|mesh-ancestor
101893910|NCT00345683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893911|NCT01211912|Acetaminophen|acetaminophen|mesh-list
101893912|NCT01211912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101893913|NCT01211912|Analgesics|analgesics|mesh-ancestor
101893914|NCT01211912|Sensory System Agents|sensory system agents|mesh-ancestor
101893915|NCT01211912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101893916|NCT01211912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893917|NCT01211912|Antipyretics|antipyretics|mesh-ancestor
101893918|NCT03943472|Cyclophosphamide|cyclophosphamide|mesh-list
101893919|NCT03943472|Fludarabine|fludarabine|mesh-list
101893920|NCT03943472|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
101893921|NCT03943472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101893922|NCT03943472|Immunologic Factors|immunologic factors|mesh-ancestor
101893923|NCT03943472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893924|NCT03943472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101893925|NCT03943472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101893926|NCT03943472|Alkylating Agents|alkylating agents|mesh-ancestor
101893927|NCT03943472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893928|NCT03943472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101893929|NCT03943472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101893930|NCT03943472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101893931|NCT01114490|Anacetrapib|anacetrapib|mesh-list
101893932|NCT01114490|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101893933|NCT01114490|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101893934|NCT01114490|Antimetabolites|antimetabolites|mesh-ancestor
101685002|NCT02699840|Vaccines|vaccines|mesh-list
101893935|NCT01114490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893936|NCT01114490|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101893937|NCT01209806|Simethicone|simethicone|mesh-list
101893938|NCT01209806|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
101893939|NCT01209806|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101893940|NCT01209806|Magnesium Hydroxide|magnesium hydroxide|mesh-list
101893941|NCT01209806|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
101893942|NCT01209806|TEMPO|tempo|mesh-list
101893943|NCT01209806|Antifoaming Agents|antifoaming agents|mesh-ancestor
101893944|NCT01209806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893945|NCT01209806|Emollients|emollients|mesh-ancestor
101685044|NCT03930446|Ethanol|ethanol|mesh-list
101893946|NCT01209806|Dermatologic Agents|dermatologic agents|mesh-ancestor
101893947|NCT01209806|Antacids|antacids|mesh-ancestor
101893948|NCT01209806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101893949|NCT01209806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101893950|NCT01209806|Immunologic Factors|immunologic factors|mesh-ancestor
101893951|NCT01209806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893952|NCT01209806|Antioxidants|antioxidants|mesh-ancestor
101893953|NCT01209806|Protective Agents|protective agents|mesh-ancestor
101893954|NCT01114568|Ertugliflozin|ertugliflozin|mesh-list
101893955|NCT01114568|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101893956|NCT01114568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893957|NCT01114568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101893958|NCT01114568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893959|NCT01109654|Cetrorelix|cetrorelix|mesh-list
101893960|NCT01109654|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101893961|NCT01109654|Hormones|hormones|mesh-ancestor
101893962|NCT01109654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101893963|NCT01109654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969359|NCT00092690|Antimetabolites|antimetabolites|mesh-ancestor
101893964|NCT01109654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101893965|NCT01109654|Fertility Agents|fertility agents|mesh-ancestor
101893966|NCT01109654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101893967|NCT01109654|Hormone Antagonists|hormone antagonists|mesh-ancestor
101893968|NCT01054001|Sildenafil Citrate|sildenafil citrate|mesh-list
101893969|NCT01054001|Vasodilator Agents|vasodilator agents|mesh-ancestor
101893970|NCT01054001|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101893971|NCT01054001|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101893972|NCT01054001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101893973|NCT01054001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893974|NCT01054001|Urological Agents|urological agents|mesh-ancestor
101893975|NCT01057355|Ethanol|ethanol|mesh-list
101893976|NCT01057355|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101893977|NCT01057355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101893978|NCT01057355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101893979|NCT01057355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893980|NCT01057511|Progesterone|progesterone|mesh-list
101893981|NCT01057511|Progestins|progestins|mesh-ancestor
101893982|NCT01057511|Hormones|hormones|mesh-ancestor
101893983|NCT01057511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101893984|NCT01057511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893985|NCT00345605|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
101893986|NCT00345605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101893987|NCT01210040|Folic Acid|folic acid|mesh-list
101893988|NCT01210040|Vitamin B Complex|vitamin b complex|mesh-list
101893989|NCT01210040|Hematinics|hematinics|mesh-ancestor
101893990|NCT01210040|Vitamins|vitamins|mesh-ancestor
101893991|NCT01210040|Micronutrients|micronutrients|mesh-ancestor
101893992|NCT01210040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893993|NCT01054313|Sirolimus|sirolimus|mesh-list
101893994|NCT01054313|Prednisone|prednisone|mesh-list
101893995|NCT01054313|Docetaxel|docetaxel|mesh-list
101893996|NCT01054313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101893997|NCT01054313|Tubulin Modulators|tubulin modulators|mesh-ancestor
101893998|NCT01054313|Antimitotic Agents|antimitotic agents|mesh-ancestor
101893999|NCT01054313|Mitosis Modulators|mitosis modulators|mesh-ancestor
101894000|NCT01054313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894001|NCT01054313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101894002|NCT01054313|Glucocorticoids|glucocorticoids|mesh-ancestor
101894003|NCT01054313|Hormones|hormones|mesh-ancestor
101685221|NCT03188354|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101894004|NCT01054313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101894005|NCT01054313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894006|NCT01054313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101894007|NCT01054313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101894008|NCT01054313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101894009|NCT01054313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101894010|NCT01054313|Antifungal Agents|antifungal agents|mesh-ancestor
101894011|NCT01054313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101894012|NCT01054313|Immunologic Factors|immunologic factors|mesh-ancestor
101894013|NCT01114958|Cisplatin|cisplatin|mesh-list
101685289|NCT02703194|Prednisolone|prednisolone|mesh-list
101894014|NCT01114958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101894015|NCT03742115|Dexamethasone|dexamethasone|mesh-list
101894016|NCT03742115|Etoposide|etoposide|mesh-list
101894017|NCT03742115|Etoposide phosphate|etoposide phosphate|mesh-list
101894018|NCT03742115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101894019|NCT03742115|Antiemetics|antiemetics|mesh-ancestor
101894020|NCT03742115|Autonomic Agents|autonomic agents|mesh-ancestor
101894021|NCT03742115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101894022|NCT03742115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894023|NCT03742115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101894024|NCT03742115|Glucocorticoids|glucocorticoids|mesh-ancestor
101894025|NCT03742115|Hormones|hormones|mesh-ancestor
101549997|NCT04334837|Copper|copper|mesh-list
101894026|NCT03742115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101894027|NCT03742115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101894028|NCT03742115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101894029|NCT03742115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101894030|NCT03742115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101894031|NCT03742115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101894032|NCT03742115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101894033|NCT03742115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894034|NCT01115036|Panobinostat|panobinostat|mesh-list
101894035|NCT01115036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101894036|NCT01115036|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101894037|NCT01115036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101894038|NCT01115036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894039|NCT01207622|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101894040|NCT01207622|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101894041|NCT01207622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101894042|NCT01207622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101894043|NCT01207622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894044|NCT01207622|Adrenergic Agents|adrenergic agents|mesh-ancestor
101894045|NCT01207622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101894046|NCT01207622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894048|NCT03942068|Apatinib|apatinib|mesh-list
101894049|NCT03942068|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101894050|NCT03942068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101894051|NCT03942068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101894052|NCT03942068|Tubulin Modulators|tubulin modulators|mesh-ancestor
101894053|NCT03942068|Antimitotic Agents|antimitotic agents|mesh-ancestor
101894054|NCT03942068|Mitosis Modulators|mitosis modulators|mesh-ancestor
101894055|NCT03942068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894056|NCT03942068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101894057|NCT03942068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101894058|NCT01112852|Terlipressin|terlipressin|mesh-list
101894059|NCT01112852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
101894060|NCT01112852|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101894061|NCT01112852|Somatostatin|somatostatin|mesh-list
101894062|NCT01112852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101894063|NCT01112852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894064|NCT01112852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101894065|NCT01112852|Hormones|hormones|mesh-ancestor
101894066|NCT01112852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101894067|NCT01112852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894068|NCT01054469|Ropivacaine|ropivacaine|mesh-list
101894069|NCT01054469|Anesthetics, Local|anesthetics, local|mesh-ancestor
101894070|NCT01054469|Anesthetics|anesthetics|mesh-ancestor
101894071|NCT01054469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101894072|NCT01054469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894073|NCT01054469|Sensory System Agents|sensory system agents|mesh-ancestor
101894074|NCT01054469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101894075|NCT03940430|Lactoferrin|lactoferrin|mesh-list
101894076|NCT03940430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101894077|NCT00355121|Vaccines|vaccines|mesh-list
101894078|NCT00355121|Immunologic Factors|immunologic factors|mesh-ancestor
101894079|NCT00355121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894080|NCT02533349|Pantoprazole|pantoprazole|mesh-list
101894081|NCT02533349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101894082|NCT02533349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101894083|NCT02533349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101894084|NCT02533349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101894085|NCT02533349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894086|NCT01115426|Losartan|losartan|mesh-list
101894087|NCT01115426|Ramipril|ramipril|mesh-list
101894088|NCT01115426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101894089|NCT01115426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101894090|NCT01115426|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101894091|NCT01115426|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101894092|NCT01115426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894093|NCT01115426|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101894094|NCT01115426|Protease Inhibitors|protease inhibitors|mesh-ancestor
101894095|NCT01115426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101894096|NCT03942458|Clopidogrel|clopidogrel|mesh-list
101894097|NCT03942458|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101894098|NCT03942458|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101894099|NCT03942458|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101894100|NCT03942458|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101894101|NCT03942458|Purinergic Agents|purinergic agents|mesh-ancestor
101894102|NCT03942458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101894103|NCT03942458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894104|NCT03942458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894106|NCT01115504|Vitamin B Complex|vitamin b complex|mesh-ancestor
101894107|NCT01115504|Vitamins|vitamins|mesh-ancestor
101894108|NCT01115504|Micronutrients|micronutrients|mesh-ancestor
101894109|NCT01115504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894110|NCT00343889|Vaccines|vaccines|mesh-list
101894111|NCT00343889|Immunologic Factors|immunologic factors|mesh-ancestor
101894112|NCT00343889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894113|NCT03939884|Diclofenac|diclofenac|mesh-list
101894114|NCT03939884|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101894116|NCT03939884|Analgesics|analgesics|mesh-ancestor
101894117|NCT03939884|Sensory System Agents|sensory system agents|mesh-ancestor
101894118|NCT03939884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101894119|NCT03939884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894120|NCT03939884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101894121|NCT03939884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101894122|NCT03939884|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101894123|NCT03939884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101894124|NCT03939884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894125|NCT01054547|Anesthetics|anesthetics|mesh-list
101894126|NCT01054547|Ropivacaine|ropivacaine|mesh-list
101894127|NCT01054547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101894128|NCT01054547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894129|NCT01054547|Anesthetics, Local|anesthetics, local|mesh-ancestor
101894130|NCT01054547|Sensory System Agents|sensory system agents|mesh-ancestor
101894131|NCT01054547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101894132|NCT01115894|Naltrexone|naltrexone|mesh-list
101894133|NCT01115894|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101894134|NCT01115894|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101894135|NCT01115894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894136|NCT01115894|Sensory System Agents|sensory system agents|mesh-ancestor
101894137|NCT01115894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101894138|NCT01115972|Valsartan|valsartan|mesh-list
101894139|NCT01115972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101894140|NCT01115972|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101894141|NCT01115972|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101894142|NCT01115972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894143|NCT01116050|Misoprostol|misoprostol|mesh-list
101894144|NCT01116050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101894145|NCT01116050|Abortifacient Agents|abortifacient agents|mesh-ancestor
101894146|NCT01116050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101894147|NCT01116050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894148|NCT01116050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101894149|NCT01116050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101894150|NCT01116050|Oxytocics|oxytocics|mesh-ancestor
101894151|NCT01054781|Rituximab|rituximab|mesh-list
101894152|NCT01054781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101894153|NCT01054781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101894154|NCT01054781|Immunologic Factors|immunologic factors|mesh-ancestor
101894155|NCT01054781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894156|NCT01054781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101894157|NCT05282290|Antihypertensive Agents|antihypertensive agents|mesh-list
101894158|NCT01311778|Fentanyl|fentanyl|mesh-list
101894159|NCT01311778|Cannabidiol|cannabidiol|mesh-list
101894160|NCT01311778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101894161|NCT01311778|Narcotics|narcotics|mesh-ancestor
101894162|NCT01311778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101894163|NCT01311778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894164|NCT01311778|Analgesics|analgesics|mesh-ancestor
101894165|NCT01311778|Sensory System Agents|sensory system agents|mesh-ancestor
101894166|NCT01311778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101894167|NCT01311778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101894168|NCT01311778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101894169|NCT01311778|Anesthetics, General|anesthetics, general|mesh-ancestor
101894170|NCT01311778|Anesthetics|anesthetics|mesh-ancestor
101894171|NCT01311778|Anticonvulsants|anticonvulsants|mesh-ancestor
101894172|NCT00354341|Epoetin Alfa|epoetin alfa|mesh-list
101894173|NCT00354341|Hematinics|hematinics|mesh-ancestor
101894174|NCT03708718|Prednisolone|prednisolone|mesh-list
101894175|NCT03708718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101894176|NCT03708718|Glucocorticoids|glucocorticoids|mesh-ancestor
101894177|NCT03708718|Hormones|hormones|mesh-ancestor
101894178|NCT03708718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101894179|NCT03708718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894180|NCT03708718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101894181|NCT03708718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101894182|NCT00354107|Cytarabine|cytarabine|mesh-list
101894183|NCT00354107|Hydrocortisone|hydrocortisone|mesh-list
101894184|NCT00354107|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101894185|NCT00354107|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101894186|NCT00354107|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101894187|NCT00354107|Carboplatin|carboplatin|mesh-list
101894189|NCT00354107|Etoposide|etoposide|mesh-list
101894190|NCT00354107|Etoposide phosphate|etoposide phosphate|mesh-list
101894191|NCT00354107|Ifosfamide|ifosfamide|mesh-list
101894192|NCT00354107|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101894193|NCT00354107|Antibodies|antibodies|mesh-list
101894194|NCT00354107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101894195|NCT00354107|Immunologic Factors|immunologic factors|mesh-ancestor
101894196|NCT00354107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894197|NCT00354107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101894198|NCT00354107|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101894199|NCT00354107|Abortifacient Agents|abortifacient agents|mesh-ancestor
101894200|NCT00354107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101894201|NCT00354107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101894202|NCT00354107|Antimetabolites|antimetabolites|mesh-ancestor
101894203|NCT00354107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894204|NCT00354107|Dermatologic Agents|dermatologic agents|mesh-ancestor
101894205|NCT00354107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101894206|NCT00354107|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101894207|NCT00354107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101894208|NCT00354107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101894209|NCT00354107|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101894210|NCT00354107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101894211|NCT00354107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101894212|NCT00354107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101894213|NCT00354107|Antiviral Agents|antiviral agents|mesh-ancestor
101894214|NCT00354107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101894215|NCT00354107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101894216|NCT00354107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101894217|NCT00354107|Alkylating Agents|alkylating agents|mesh-ancestor
101894218|NCT00354107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101894219|NCT00354107|Immunotoxins|immunotoxins|mesh-ancestor
101894220|NCT00354107|Immunoconjugates|immunoconjugates|mesh-ancestor
101894221|NCT00354029|Ketamine|ketamine|mesh-list
101894222|NCT00354029|Analgesics|analgesics|mesh-ancestor
101894223|NCT00354029|Sensory System Agents|sensory system agents|mesh-ancestor
101894224|NCT00354029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101894225|NCT00354029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894226|NCT00354029|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101894227|NCT00354029|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101894228|NCT00354029|Anesthetics, General|anesthetics, general|mesh-ancestor
101894229|NCT00354029|Anesthetics|anesthetics|mesh-ancestor
101894230|NCT00354029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101894231|NCT00354029|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101894232|NCT00354029|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101894233|NCT00354029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101894234|NCT00354029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894235|NCT00353873|Fluticasone|fluticasone|mesh-list
101894236|NCT00353873|Xhance|xhance|mesh-list
101894237|NCT00353873|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101894238|NCT00353873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101894239|NCT00353873|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101894240|NCT00353873|Autonomic Agents|autonomic agents|mesh-ancestor
101894241|NCT00353873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101894242|NCT00353873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894243|NCT00353873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101894244|NCT00353873|Respiratory System Agents|respiratory system agents|mesh-ancestor
101894245|NCT00353873|Dermatologic Agents|dermatologic agents|mesh-ancestor
101894246|NCT00353873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101894247|NCT00353873|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101894248|NCT00353873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101894249|NCT00353873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101894250|NCT00353873|Adrenergic Agents|adrenergic agents|mesh-ancestor
101894251|NCT00353873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101894252|NCT00353873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894253|NCT01058057|Atorvastatin|atorvastatin|mesh-list
101894254|NCT01058057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101894255|NCT01058057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101894256|NCT01058057|Antimetabolites|antimetabolites|mesh-ancestor
101894257|NCT01058057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894258|NCT01058057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101894259|NCT01058057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101894260|NCT01058057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101894261|NCT03796676|Abrocitinib|abrocitinib|mesh-list
101894262|NCT03796676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101894263|NCT03796676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101894264|NCT03796676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894265|NCT00339833|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
101894266|NCT00339833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101894267|NCT00339833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101894268|NCT00339833|Analgesics|analgesics|mesh-ancestor
101894269|NCT00339833|Sensory System Agents|sensory system agents|mesh-ancestor
101894270|NCT00339833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101894271|NCT00339833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894272|NCT00339833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101894273|NCT00339833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101894274|NCT01058291|Apomorphine|apomorphine|mesh-list
101894275|NCT01058291|Emetics|emetics|mesh-ancestor
101894276|NCT01058291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894277|NCT01058291|Autonomic Agents|autonomic agents|mesh-ancestor
101894278|NCT01058291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101894279|NCT01058291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101894280|NCT01058291|Dopamine Agonists|dopamine agonists|mesh-ancestor
101894281|NCT01058291|Dopamine Agents|dopamine agents|mesh-ancestor
101894282|NCT01058291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101894283|NCT01058291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894284|NCT01055249|Ibuprofen|ibuprofen|mesh-list
101894285|NCT01055249|Hydrocortisone|hydrocortisone|mesh-list
101894286|NCT01055249|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101894287|NCT01055249|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101894288|NCT01055249|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101894289|NCT01055249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101342923|NCT00012116|Temozolomide|temozolomide|mesh-list
101894290|NCT01055249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101894291|NCT01055249|Analgesics|analgesics|mesh-ancestor
101894292|NCT01055249|Sensory System Agents|sensory system agents|mesh-ancestor
101894293|NCT01055249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101894294|NCT01055249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894295|NCT01055249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101894296|NCT01055249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101894297|NCT01055249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101894298|NCT01055249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101894299|NCT01055249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894300|NCT01055327|Lamotrigine|lamotrigine|mesh-list
101894301|NCT01055327|Anticonvulsants|anticonvulsants|mesh-list
101894302|NCT01055327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101894303|NCT01055327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101894304|NCT01055327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894305|NCT01055327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101894306|NCT01055327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894307|NCT01055327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101894308|NCT01055327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101894309|NCT01055327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101894310|NCT01055327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101894311|NCT01055327|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101894312|NCT03793556|Omeprazole|omeprazole|mesh-list
101894313|NCT03793556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101894314|NCT03793556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101894315|NCT03793556|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101894316|NCT03793556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101894317|NCT03793556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894318|NCT01113164|Ondansetron|ondansetron|mesh-list
101894319|NCT01113164|Sertraline|sertraline|mesh-list
101894320|NCT01113164|Antiemetics|antiemetics|mesh-ancestor
101894321|NCT01113164|Autonomic Agents|autonomic agents|mesh-ancestor
101894322|NCT01113164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101894323|NCT01113164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894324|NCT01113164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101894325|NCT01113164|Antipruritics|antipruritics|mesh-ancestor
101894326|NCT01113164|Dermatologic Agents|dermatologic agents|mesh-ancestor
101894327|NCT01113164|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101894328|NCT01113164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101894329|NCT01113164|Serotonin Agents|serotonin agents|mesh-ancestor
101894330|NCT01113164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101894331|NCT01113164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894332|NCT01113164|Antidepressive Agents|antidepressive agents|mesh-ancestor
101894333|NCT01113164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101894334|NCT01113164|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101506432|NCT00518583|Paclitaxel|paclitaxel|mesh-list
101894335|NCT01113164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101894336|NCT01113164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101894337|NCT01210430|Vitamins|vitamins|mesh-list
101894338|NCT01210430|Ascorbic Acid|ascorbic acid|mesh-list
101894339|NCT01210430|Losartan|losartan|mesh-list
101894340|NCT01210430|Micronutrients|micronutrients|mesh-ancestor
101894341|NCT01210430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894342|NCT01210430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101894343|NCT01210430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101894344|NCT01210430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101894345|NCT01210430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101894346|NCT01210430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894347|NCT01210430|Antioxidants|antioxidants|mesh-ancestor
101894348|NCT01210430|Protective Agents|protective agents|mesh-ancestor
101894349|NCT01210742|Hylan|hylan|mesh-list
101894350|NCT01210742|Viscosupplements|viscosupplements|mesh-ancestor
101894351|NCT01210742|Protective Agents|protective agents|mesh-ancestor
101894352|NCT01210742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894353|NCT01116128|Prednisone|prednisone|mesh-list
101894354|NCT01116128|Melphalan|melphalan|mesh-list
101894355|NCT01116128|Dasatinib|dasatinib|mesh-list
101894356|NCT01116128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101894357|NCT01116128|Glucocorticoids|glucocorticoids|mesh-ancestor
101894358|NCT01116128|Hormones|hormones|mesh-ancestor
101894359|NCT01116128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101894360|NCT01116128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894361|NCT01116128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101894362|NCT01116128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101894363|NCT01116128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101894364|NCT01116128|Alkylating Agents|alkylating agents|mesh-ancestor
101894365|NCT01116128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894366|NCT01116128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101894367|NCT01116128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101894368|NCT01116128|Immunologic Factors|immunologic factors|mesh-ancestor
101894369|NCT01116128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101894370|NCT01116128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101894371|NCT03390166|Vaccines|vaccines|mesh-list
101894372|NCT03390166|Immunologic Factors|immunologic factors|mesh-ancestor
101894373|NCT03390166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894374|NCT01116206|Prucalopride|prucalopride|mesh-list
101894375|NCT01116206|Laxatives|laxatives|mesh-ancestor
101894376|NCT01116206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101894377|NCT01116206|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101894378|NCT01116206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101894379|NCT01116206|Serotonin Agents|serotonin agents|mesh-ancestor
101894380|NCT01116206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101894381|NCT01116206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894382|NCT01116206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894383|NCT01210976|Simendan|simendan|mesh-list
101894384|NCT01210976|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101894385|NCT01210976|Vasodilator Agents|vasodilator agents|mesh-ancestor
101894386|NCT01210976|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101894387|NCT01210976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101894388|NCT01210976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101894389|NCT01210976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894390|NCT01210976|Protective Agents|protective agents|mesh-ancestor
101894391|NCT01210976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894392|NCT03828539|Topiramate|topiramate|mesh-list
101894393|NCT03828539|Erenumab|erenumab|mesh-list
101685692|NCT02698280|Nimustine|nimustine|mesh-list
101894394|NCT03828539|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101894395|NCT03828539|Anticonvulsants|anticonvulsants|mesh-ancestor
101257237|NCT01715220|Nitroglycerin|nitroglycerin|mesh-list
101894396|NCT03828539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101894397|NCT03828539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894398|NCT03828539|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
101894399|NCT03828539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894400|NCT03828539|Analgesics|analgesics|mesh-ancestor
101894401|NCT03828539|Sensory System Agents|sensory system agents|mesh-ancestor
101894402|NCT03828539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101894403|NCT03828539|Immunologic Factors|immunologic factors|mesh-ancestor
101894404|NCT01109888|Cetrorelix|cetrorelix|mesh-list
101894405|NCT01109888|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101894406|NCT01109888|Fertility Agents|fertility agents|mesh-ancestor
101894407|NCT01109888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101894408|NCT01109888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894409|NCT01109888|Hormone Antagonists|hormone antagonists|mesh-ancestor
101894410|NCT01109888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101894411|NCT03336502|Posaconazole|posaconazole|mesh-list
101894412|NCT03336502|Antifungal Agents|antifungal agents|mesh-ancestor
101894413|NCT03336502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101894414|NCT03336502|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101894415|NCT03336502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101894416|NCT03336502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101894417|NCT03336502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101894418|NCT03336502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101894419|NCT03336502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101894420|NCT03336502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894421|NCT03336502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101894422|NCT03336502|Hormone Antagonists|hormone antagonists|mesh-ancestor
101894423|NCT03336502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101894424|NCT03336502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894425|NCT01325051|Raltegravir Potassium|raltegravir potassium|mesh-list
101894426|NCT01325051|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101894427|NCT01325051|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101894428|NCT01325051|Antiviral Agents|antiviral agents|mesh-ancestor
101894429|NCT01325051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101894430|NCT01325051|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101894431|NCT01325051|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101894432|NCT01325051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101894433|NCT01325051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894434|NCT01055405|Sildenafil Citrate|sildenafil citrate|mesh-list
101894435|NCT01055405|Vasodilator Agents|vasodilator agents|mesh-ancestor
101894436|NCT01055405|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101894437|NCT01055405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101894438|NCT01055405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101894439|NCT01055405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894440|NCT01055405|Urological Agents|urological agents|mesh-ancestor
101894441|NCT01055483|Panobinostat|panobinostat|mesh-list
101894442|NCT01055483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101894443|NCT01055483|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101894444|NCT01055483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101894445|NCT01055483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894446|NCT03370510|Oxytocin|oxytocin|mesh-list
101894447|NCT03370510|Oxytocics|oxytocics|mesh-ancestor
101894448|NCT03370510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101894449|NCT03370510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894450|NCT03985865|Quinine|quinine|mesh-list
101894451|NCT03985865|Denatonium|denatonium|mesh-list
101894452|NCT03985865|Antimalarials|antimalarials|mesh-ancestor
101685705|NCT02705612|Nimotuzumab|nimotuzumab|mesh-list
101894453|NCT03985865|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101894454|NCT03985865|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101894456|NCT03985865|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101894457|NCT03985865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894458|NCT03985865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101894459|NCT03985865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101894460|NCT03985865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101894461|NCT03985865|Analgesics|analgesics|mesh-ancestor
101894462|NCT03985865|Sensory System Agents|sensory system agents|mesh-ancestor
101894463|NCT03985865|Aversive Agents|aversive agents|mesh-ancestor
101894464|NCT03985865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894465|NCT03985865|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
101894467|NCT01116596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101894468|NCT01116596|Analgesics|analgesics|mesh-ancestor
101894469|NCT01116596|Sensory System Agents|sensory system agents|mesh-ancestor
101894470|NCT01116596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101894471|NCT01116596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894472|NCT01116596|Antipyretics|antipyretics|mesh-ancestor
101894473|NCT00351611|Pregabalin|pregabalin|mesh-list
101894474|NCT00351611|Analgesics|analgesics|mesh-ancestor
101894475|NCT00351611|Sensory System Agents|sensory system agents|mesh-ancestor
101894476|NCT00351611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101894477|NCT00351611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894478|NCT00351611|Anticonvulsants|anticonvulsants|mesh-ancestor
101894479|NCT00351611|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101894480|NCT00351611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101894481|NCT00351611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894482|NCT00351611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101894483|NCT00351611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101894484|NCT00351611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101894485|NCT00351611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101894486|NCT00351611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101894488|NCT01211210|Oxaliplatin|oxaliplatin|mesh-list
101894489|NCT01211210|Antimetabolites|antimetabolites|mesh-ancestor
101894490|NCT01211210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894491|NCT01211210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101894492|NCT01211210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101894493|NCT01211210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101894494|NCT01211210|Immunologic Factors|immunologic factors|mesh-ancestor
101894495|NCT01211210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894496|NCT01116830|Antipsychotic Agents|antipsychotic agents|mesh-list
101894497|NCT01116830|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101894498|NCT01116830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101894499|NCT01116830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894500|NCT01116830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101894501|NCT01208012|Liraglutide|liraglutide|mesh-list
101894502|NCT01208012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101894503|NCT01208012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894504|NCT01208012|Incretins|incretins|mesh-ancestor
101894505|NCT01208012|Hormones|hormones|mesh-ancestor
101894506|NCT01208012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101894507|NCT03939806|Oxytocin|oxytocin|mesh-list
101894508|NCT03939806|Carbetocin|carbetocin|mesh-list
101894509|NCT03939806|Oxytocics|oxytocics|mesh-ancestor
101894510|NCT03939806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101894511|NCT03939806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894512|NCT00351377|Mycophenolic Acid|mycophenolic acid|mesh-list
101894513|NCT00351377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101894514|NCT00351377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101685717|NCT02698124|Antimetabolites|antimetabolites|mesh-ancestor
101894515|NCT00351377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101894516|NCT00351377|Antitubercular Agents|antitubercular agents|mesh-ancestor
101894517|NCT00351377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101894518|NCT00351377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101894519|NCT00351377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101894520|NCT00351377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894521|NCT00337727|Dexamethasone|dexamethasone|mesh-list
101894522|NCT00337727|Dexamethasone acetate|dexamethasone acetate|mesh-list
101894523|NCT00337727|Ondansetron|ondansetron|mesh-list
101894524|NCT00337727|Aprepitant|aprepitant|mesh-list
101894525|NCT00337727|Fosaprepitant|fosaprepitant|mesh-list
101894526|NCT00337727|BB 1101|bb 1101|mesh-list
101894527|NCT00337727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101894528|NCT00337727|Antiemetics|antiemetics|mesh-ancestor
101894529|NCT00337727|Autonomic Agents|autonomic agents|mesh-ancestor
101894530|NCT00337727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101894531|NCT00337727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894532|NCT00337727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101894533|NCT00337727|Glucocorticoids|glucocorticoids|mesh-ancestor
101894534|NCT00337727|Hormones|hormones|mesh-ancestor
101894535|NCT00337727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101894536|NCT00337727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101894537|NCT00337727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101894538|NCT00337727|Protease Inhibitors|protease inhibitors|mesh-ancestor
101894539|NCT00337727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101894540|NCT00337727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894541|NCT00337727|Antipruritics|antipruritics|mesh-ancestor
101894542|NCT00337727|Dermatologic Agents|dermatologic agents|mesh-ancestor
101894543|NCT00337727|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101894544|NCT00337727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101894545|NCT00337727|Serotonin Agents|serotonin agents|mesh-ancestor
101894546|NCT00337727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101894547|NCT00337727|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101894548|NCT03987893|Lactulose|lactulose|mesh-list
101894549|NCT03987893|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101894550|NCT03987893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101894551|NCT03987893|Laxatives|laxatives|mesh-ancestor
101894552|NCT01208480|Carboplatin|carboplatin|mesh-list
101894553|NCT01208480|Docetaxel|docetaxel|mesh-list
101894554|NCT01208480|Bevacizumab|bevacizumab|mesh-list
101894555|NCT01208480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101894557|NCT01208480|Antimitotic Agents|antimitotic agents|mesh-ancestor
101894558|NCT01208480|Mitosis Modulators|mitosis modulators|mesh-ancestor
101894559|NCT01208480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894560|NCT01208480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101894561|NCT01208480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101894562|NCT01208480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101894563|NCT01208480|Growth Substances|growth substances|mesh-ancestor
101894564|NCT01208480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894565|NCT01208480|Growth Inhibitors|growth inhibitors|mesh-ancestor
101894566|NCT04774120|Propofol|propofol|mesh-list
101894567|NCT04774120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101894568|NCT04774120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101894569|NCT04774120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894570|NCT04774120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101894571|NCT04774120|Anesthetics, General|anesthetics, general|mesh-ancestor
101894572|NCT04774120|Anesthetics|anesthetics|mesh-ancestor
101894573|NCT01117220|Ziprasidone|ziprasidone|mesh-list
101894574|NCT01117220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101894575|NCT01117220|Serotonin Agents|serotonin agents|mesh-ancestor
101894576|NCT01117220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101894577|NCT01117220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894578|NCT01117220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894579|NCT01117220|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101894580|NCT01117220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101894581|NCT01117220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101894582|NCT01117220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101894583|NCT01117220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101894584|NCT01117220|Dopamine Agents|dopamine agents|mesh-ancestor
101894585|NCT05236972|Capecitabine|capecitabine|mesh-list
101894586|NCT05236972|Oxaliplatin|oxaliplatin|mesh-list
101894587|NCT05236972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101894588|NCT05236972|Antimetabolites|antimetabolites|mesh-ancestor
101894589|NCT05236972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894590|NCT05236972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101894591|NCT01114100|Sertraline|sertraline|mesh-list
101894592|NCT01114100|Antidepressive Agents|antidepressive agents|mesh-ancestor
101894593|NCT01114100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101894594|NCT01114100|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101894595|NCT01114100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101894596|NCT01114100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101894597|NCT01114100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894598|NCT01114100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101894599|NCT01114100|Serotonin Agents|serotonin agents|mesh-ancestor
101894600|NCT01114100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894601|NCT01110590|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101894602|NCT01110590|Vasodilator Agents|vasodilator agents|mesh-ancestor
101894603|NCT01110590|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101894604|NCT01110590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101894605|NCT01110590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101894606|NCT01110590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894607|NCT01110590|Urological Agents|urological agents|mesh-ancestor
101894609|NCT01117298|Vasodilator Agents|vasodilator agents|mesh-ancestor
101894610|NCT01117298|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101894611|NCT01117298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101894612|NCT01117298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101894613|NCT01117298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894614|NCT01117298|Urological Agents|urological agents|mesh-ancestor
101894615|NCT01117376|Erythromycin|erythromycin|mesh-list
101894616|NCT01117376|Erythromycin Estolate|erythromycin estolate|mesh-list
101894617|NCT01117376|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101894618|NCT01117376|Erythromycin stearate|erythromycin stearate|mesh-list
101894619|NCT01117376|Methylnaltrexone|methylnaltrexone|mesh-list
101894620|NCT01117376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101894621|NCT01117376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101894622|NCT01117376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101894623|NCT01117376|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101894624|NCT01117376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101894625|NCT01117376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894626|NCT01117376|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101894627|NCT01117376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614418|NCT00689494|Levonorgestrel|levonorgestrel|mesh-list
101894628|NCT01117376|Sensory System Agents|sensory system agents|mesh-ancestor
101894629|NCT01117376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101894631|NCT01213238|Capecitabine|capecitabine|mesh-list
101894632|NCT01213238|Oxaliplatin|oxaliplatin|mesh-list
101894633|NCT01213238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101894634|NCT01213238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101894635|NCT01213238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101894636|NCT01213238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101894637|NCT01213238|Growth Substances|growth substances|mesh-ancestor
101894638|NCT01213238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894639|NCT01213238|Growth Inhibitors|growth inhibitors|mesh-ancestor
101894640|NCT01213238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101894641|NCT01213238|Antimetabolites|antimetabolites|mesh-ancestor
101894642|NCT01213238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894643|NCT01110824|Carvedilol|carvedilol|mesh-list
101894644|NCT01110824|Enalapril|enalapril|mesh-list
101894645|NCT01110824|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101894646|NCT01110824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101894647|NCT01110824|Adrenergic Agents|adrenergic agents|mesh-ancestor
101894648|NCT01110824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101894649|NCT01110824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894650|NCT01110824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894651|NCT01110824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101894652|NCT01110824|Antioxidants|antioxidants|mesh-ancestor
101685737|NCT03059147|Nivolumab|nivolumab|mesh-list
101894653|NCT01110824|Protective Agents|protective agents|mesh-ancestor
101894654|NCT01110824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101894655|NCT01110824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101894656|NCT01110824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101894657|NCT01110824|Vasodilator Agents|vasodilator agents|mesh-ancestor
101894658|NCT01110824|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101894659|NCT01110824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101894660|NCT01110824|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101894661|NCT01110824|Protease Inhibitors|protease inhibitors|mesh-ancestor
101894662|NCT01110824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101894663|NCT03936140|Iloprost|iloprost|mesh-list
101894664|NCT03936140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101894665|NCT03936140|Vasodilator Agents|vasodilator agents|mesh-ancestor
101894666|NCT01117610|Ropivacaine|ropivacaine|mesh-list
101894667|NCT01117610|Anesthetics, Local|anesthetics, local|mesh-ancestor
101894668|NCT01117610|Anesthetics|anesthetics|mesh-ancestor
101894669|NCT01117610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101894670|NCT01117610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894671|NCT01117610|Sensory System Agents|sensory system agents|mesh-ancestor
101894672|NCT01117610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101894673|NCT01215890|Risedronic Acid|risedronic acid|mesh-list
101894674|NCT01215890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101894675|NCT01215890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101894676|NCT01215890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894677|NCT01215890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101894678|NCT01215890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894679|NCT01215890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101894680|NCT01213394|Mycophenolic Acid|mycophenolic acid|mesh-list
101894681|NCT01213394|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101894682|NCT01213394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101894683|NCT01213394|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101894684|NCT01213394|Antitubercular Agents|antitubercular agents|mesh-ancestor
101894685|NCT01213394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101894686|NCT01213394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101894687|NCT01213394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101894688|NCT01213394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894689|NCT03368170|Mesdopetam|mesdopetam|mesh-list
101894690|NCT03368170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101894691|NCT03368170|Dopamine Agents|dopamine agents|mesh-ancestor
101894692|NCT03368170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101894693|NCT03368170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894694|NCT03368170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894695|NCT01121744|Sirolimus|sirolimus|mesh-list
101894696|NCT01121744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101894697|NCT01121744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101894698|NCT01121744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101894699|NCT01121744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101894700|NCT01121744|Antifungal Agents|antifungal agents|mesh-ancestor
101894701|NCT01121744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101894702|NCT01121744|Immunologic Factors|immunologic factors|mesh-ancestor
101894703|NCT01121744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894704|NCT01121822|Vaccines|vaccines|mesh-list
101894705|NCT01121822|Immunologic Factors|immunologic factors|mesh-ancestor
101894706|NCT01121822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894707|NCT01213550|Chlorhexidine|chlorhexidine|mesh-list
101894708|NCT01213550|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101894709|NCT01213550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101894710|NCT01213550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101894711|NCT01213550|Disinfectants|disinfectants|mesh-ancestor
101894712|NCT01213550|Dermatologic Agents|dermatologic agents|mesh-ancestor
101894713|NCT01213784|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101894714|NCT01213784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894715|NCT01216046|Ivacaftor|ivacaftor|mesh-list
101894716|NCT01216046|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101894717|NCT01216046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101685743|NCT03356834|Antiviral Agents|antiviral agents|mesh-ancestor
101894718|NCT01216046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894719|NCT01216124|Docetaxel|docetaxel|mesh-list
101894720|NCT01216124|Oxaliplatin|oxaliplatin|mesh-list
101894721|NCT01216124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101894722|NCT01216124|Tubulin Modulators|tubulin modulators|mesh-ancestor
101894723|NCT01216124|Antimitotic Agents|antimitotic agents|mesh-ancestor
101894724|NCT01216124|Mitosis Modulators|mitosis modulators|mesh-ancestor
101894725|NCT01216124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894726|NCT01219010|Siltuximab|siltuximab|mesh-list
101894727|NCT01219010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101894728|NCT01118234|Rituximab|rituximab|mesh-list
101894729|NCT01118234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101894730|NCT01118234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101894731|NCT01118234|Immunologic Factors|immunologic factors|mesh-ancestor
101894732|NCT01118234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894733|NCT01118234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101894734|NCT00324155|Ipilimumab|ipilimumab|mesh-list
101894735|NCT00324155|Dacarbazine|dacarbazine|mesh-list
101894736|NCT00324155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101894737|NCT00324155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101894738|NCT00324155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101894739|NCT00324155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969399|NCT00377182|Antiviral Agents|antiviral agents|mesh-ancestor
101894740|NCT00324155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101894741|NCT00324155|Alkylating Agents|alkylating agents|mesh-ancestor
101894742|NCT03937544|Cyclophosphamide|cyclophosphamide|mesh-list
101894744|NCT03937544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101894745|NCT03937544|Immunologic Factors|immunologic factors|mesh-ancestor
101894746|NCT03937544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894747|NCT03937544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101894748|NCT03937544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101894749|NCT03937544|Alkylating Agents|alkylating agents|mesh-ancestor
101894750|NCT03937544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894751|NCT03937544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101894752|NCT03937544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101894753|NCT01122056|Interferons|interferons|mesh-list
101894754|NCT01122056|Interferon beta-1b|interferon beta-1b|mesh-list
101894755|NCT01122056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101894756|NCT01122056|Antiviral Agents|antiviral agents|mesh-ancestor
101894757|NCT01122056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101894758|NCT01122056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101894759|NCT01122056|Immunologic Factors|immunologic factors|mesh-ancestor
101894760|NCT01122056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894761|NCT01219088|Morphine|morphine|mesh-list
101894762|NCT01219088|Bupivacaine|bupivacaine|mesh-list
101894763|NCT01219088|Anesthetics, Local|anesthetics, local|mesh-ancestor
101894764|NCT01219088|Anesthetics|anesthetics|mesh-ancestor
101894765|NCT01219088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101894766|NCT01219088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894767|NCT01219088|Sensory System Agents|sensory system agents|mesh-ancestor
101894768|NCT01219088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101894769|NCT01219088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101894770|NCT01219088|Narcotics|narcotics|mesh-ancestor
101894771|NCT01219088|Analgesics|analgesics|mesh-ancestor
101894772|NCT01122134|Artesunate|artesunate|mesh-list
101894773|NCT01122134|Antimalarials|antimalarials|mesh-ancestor
101894774|NCT01122134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101894775|NCT01122134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101894776|NCT01122134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101894777|NCT01122134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101894779|NCT01122134|Schistosomicides|schistosomicides|mesh-ancestor
101894780|NCT01122134|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101894781|NCT01122134|Anthelmintics|anthelmintics|mesh-ancestor
101894782|NCT01118702|Methylphenidate|methylphenidate|mesh-list
101894783|NCT01118702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101894784|NCT01118702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894785|NCT01118702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101894786|NCT01118702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101894787|NCT01118702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101894788|NCT01118702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894789|NCT01118702|Dopamine Agents|dopamine agents|mesh-ancestor
101894790|NCT01118702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101894791|NCT01118936|Magnesium Hydroxide|magnesium hydroxide|mesh-list
101894792|NCT01118936|Antacids|antacids|mesh-ancestor
101894793|NCT01118936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894794|NCT01118936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101894795|NCT01119014|Aripiprazole|aripiprazole|mesh-list
101894796|NCT01119014|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101894797|NCT01119014|Antidepressive Agents|antidepressive agents|mesh-ancestor
101894798|NCT01119014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101894799|NCT01119014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101894800|NCT01119014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101894801|NCT01119014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101894802|NCT01119014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894803|NCT01119014|Dopamine Agonists|dopamine agonists|mesh-ancestor
101894804|NCT01119014|Dopamine Agents|dopamine agents|mesh-ancestor
101894805|NCT01119014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101969405|NCT01341938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894806|NCT01119014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894807|NCT01119014|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101894809|NCT01119014|Serotonin Agents|serotonin agents|mesh-ancestor
101894810|NCT01119014|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101894811|NCT01119014|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101894812|NCT01119014|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101894813|NCT01119014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101894814|NCT01219244|Resveratrol|resveratrol|mesh-list
101894815|NCT01219244|Antioxidants|antioxidants|mesh-ancestor
101894816|NCT01219244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894817|NCT01219244|Protective Agents|protective agents|mesh-ancestor
101894818|NCT01219244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894819|NCT01219244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101894820|NCT01219244|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101894821|NCT01119482|Vaccines|vaccines|mesh-list
101894822|NCT01119482|Immunologic Factors|immunologic factors|mesh-ancestor
101894823|NCT01119482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894824|NCT01119638|Risperidone|risperidone|mesh-list
101894825|NCT01119638|Escitalopram|escitalopram|mesh-list
101894826|NCT01119638|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101894827|NCT01119638|Serotonin Agents|serotonin agents|mesh-ancestor
101894828|NCT01119638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101894829|NCT01119638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894830|NCT01119638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894831|NCT01119638|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101894832|NCT01119638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101894833|NCT01119638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101894834|NCT01119638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101894835|NCT01119638|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101894836|NCT01119638|Dopamine Agents|dopamine agents|mesh-ancestor
101894837|NCT01119638|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101894838|NCT01119638|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101894839|NCT01119638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101894840|NCT03338998|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101894841|NCT03338998|Siponimod|siponimod|mesh-list
101894842|NCT03338998|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101894843|NCT03338998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894844|NCT03338998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101894845|NCT03338998|Immunologic Factors|immunologic factors|mesh-ancestor
101894846|NCT03338998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894847|NCT03935984|Calcitonin|calcitonin|mesh-list
101894848|NCT03935984|Salmon calcitonin|salmon calcitonin|mesh-list
101894849|NCT03935984|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
101894850|NCT03935984|Katacalcin|katacalcin|mesh-list
101894851|NCT03935984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101894852|NCT03935984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894853|NCT03935984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101894854|NCT03935984|Vasodilator Agents|vasodilator agents|mesh-ancestor
101894855|NCT01219400|Vildagliptin|vildagliptin|mesh-list
101894856|NCT01219400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101894857|NCT01219400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894858|NCT01219400|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101894859|NCT01219400|Protease Inhibitors|protease inhibitors|mesh-ancestor
101894860|NCT01219400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101894861|NCT01219400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894862|NCT01124630|Leucovorin|leucovorin|mesh-list
101894863|NCT01124630|Fluorouracil|fluorouracil|mesh-list
101894864|NCT01124630|Irinotecan|irinotecan|mesh-list
101894865|NCT01124630|Antimetabolites|antimetabolites|mesh-ancestor
101894866|NCT01124630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894867|NCT01124630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101894868|NCT01124630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101894869|NCT01124630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101894870|NCT01124630|Immunologic Factors|immunologic factors|mesh-ancestor
101894871|NCT01124630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894872|NCT01124630|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101894873|NCT01124630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101894874|NCT01124630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101894875|NCT01124630|Antidotes|antidotes|mesh-ancestor
101894877|NCT01124630|Vitamin B Complex|vitamin b complex|mesh-ancestor
101894878|NCT01124630|Vitamins|vitamins|mesh-ancestor
101894879|NCT01124630|Micronutrients|micronutrients|mesh-ancestor
101894880|NCT05683054|Adalimumab|adalimumab|mesh-list
101894881|NCT05683054|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101894882|NCT05683054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101894883|NCT05683054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101894884|NCT01120106|Simendan|simendan|mesh-list
101894885|NCT01120106|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101894886|NCT01120106|Vasodilator Agents|vasodilator agents|mesh-ancestor
101894887|NCT01120106|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101894888|NCT01120106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101894889|NCT01120106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101894890|NCT01120106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894891|NCT01120106|Protective Agents|protective agents|mesh-ancestor
101894892|NCT01120106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894894|NCT01122368|Antifungal Agents|antifungal agents|mesh-ancestor
101894895|NCT01122368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101894896|NCT03338062|Iminodiacetic acid|iminodiacetic acid|mesh-list
101894897|NCT03338062|Chelating Agents|chelating agents|mesh-ancestor
101894898|NCT03338062|Sequestering Agents|sequestering agents|mesh-ancestor
101894899|NCT03338062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894900|NCT01216826|Everolimus|everolimus|mesh-list
101894901|NCT01216826|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101894902|NCT01216826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101894903|NCT01216826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101507807|NCT02946684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101894904|NCT01216826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894905|NCT01216826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101894906|NCT01216826|Immunologic Factors|immunologic factors|mesh-ancestor
101894907|NCT01216826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894908|NCT01216826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101894909|NCT01120340|Mesalamine|mesalamine|mesh-list
101894910|NCT01120340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101894911|NCT01120340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101894912|NCT01120340|Analgesics|analgesics|mesh-ancestor
101894913|NCT01120340|Sensory System Agents|sensory system agents|mesh-ancestor
101894914|NCT01120340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101894915|NCT01120340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894916|NCT01120340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101894917|NCT01120340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101894918|NCT01214408|Pantoprazole|pantoprazole|mesh-list
101894919|NCT01214408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101894920|NCT01214408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101894921|NCT01214408|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101894922|NCT01214408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101894923|NCT01214408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894924|NCT01214486|Raltegravir Potassium|raltegravir potassium|mesh-list
101894925|NCT01214486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101894926|NCT01214486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101894927|NCT01214486|Antiviral Agents|antiviral agents|mesh-ancestor
101894928|NCT01214486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101894929|NCT01214486|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101894930|NCT01214486|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101894931|NCT01214486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101894932|NCT01214486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894933|NCT01216904|Nicotine|nicotine|mesh-list
101894934|NCT01216904|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101894935|NCT01216904|Autonomic Agents|autonomic agents|mesh-ancestor
101894936|NCT01216904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101894937|NCT01216904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894938|NCT01216904|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101894939|NCT01216904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101894940|NCT01216904|Cholinergic Agents|cholinergic agents|mesh-ancestor
101894941|NCT01216904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101894942|NCT01216904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894943|NCT01125020|Gemcitabine|gemcitabine|mesh-list
101894944|NCT01125020|Doxorubicin|doxorubicin|mesh-list
101894945|NCT01125020|Oxaliplatin|oxaliplatin|mesh-list
101894946|NCT01125020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101894947|NCT01125020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101894948|NCT01125020|Antimetabolites|antimetabolites|mesh-ancestor
101894949|NCT01125020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894950|NCT01125020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101894951|NCT01125020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101894952|NCT01125020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101894953|NCT01125020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101894954|NCT01312012|Antiviral Agents|antiviral agents|mesh-list
101894955|NCT01312012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101894956|NCT01125254|Amlodipine|amlodipine|mesh-list
101894957|NCT01125254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101894958|NCT01125254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101894959|NCT01125254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101894960|NCT01125254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894961|NCT01125254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101894962|NCT01125254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894963|NCT01125254|Vasodilator Agents|vasodilator agents|mesh-ancestor
101894964|NCT03710434|Lansoprazole|lansoprazole|mesh-list
101894965|NCT03710434|Dexlansoprazole|dexlansoprazole|mesh-list
101894966|NCT03710434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101894967|NCT03710434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101894968|NCT03710434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101894969|NCT03710434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101894970|NCT03710434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894971|NCT03706924|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101894972|NCT03706924|Elsulfavirine|elsulfavirine|mesh-list
101894973|NCT03706924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101894974|NCT03706924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101894975|NCT03706924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101894976|NCT03706924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894977|NCT03706924|Antiviral Agents|antiviral agents|mesh-ancestor
101894978|NCT03706924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101894979|NCT03706924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101894980|NCT03706924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101894981|NCT05682586|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
101894982|NCT05682586|Antiviral Agents|antiviral agents|mesh-ancestor
101894983|NCT05682586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101894984|NCT01217138|Epinephrine|epinephrine|mesh-list
101894985|NCT01217138|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101894986|NCT01217138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101894987|NCT01217138|Adrenergic Agents|adrenergic agents|mesh-ancestor
101894988|NCT01217138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101894989|NCT01217138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101894990|NCT01217138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101894991|NCT01217138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101894992|NCT01217138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101894993|NCT01217138|Autonomic Agents|autonomic agents|mesh-ancestor
101894994|NCT01217138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101894995|NCT01217138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101894996|NCT01217138|Respiratory System Agents|respiratory system agents|mesh-ancestor
101894997|NCT01217138|Mydriatics|mydriatics|mesh-ancestor
101894998|NCT01217138|Sympathomimetics|sympathomimetics|mesh-ancestor
101894999|NCT01217138|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101895001|NCT03710356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101895002|NCT03710356|Hormone Antagonists|hormone antagonists|mesh-ancestor
101895003|NCT03710356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101895004|NCT03710356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895006|NCT01217294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101895007|NCT01217294|Narcotics|narcotics|mesh-ancestor
101895008|NCT01217294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101895009|NCT01217294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895010|NCT01217294|Analgesics|analgesics|mesh-ancestor
101895011|NCT01217294|Sensory System Agents|sensory system agents|mesh-ancestor
101895012|NCT01217294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101895013|NCT03361228|Pembrolizumab|pembrolizumab|mesh-list
101895014|NCT03361228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101895015|NCT03361228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101895016|NCT03361228|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101895017|NCT03361228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895018|NCT01121042|Ondansetron|ondansetron|mesh-list
101895019|NCT01121042|Antiemetics|antiemetics|mesh-ancestor
101895020|NCT01121042|Autonomic Agents|autonomic agents|mesh-ancestor
101895021|NCT01121042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101895022|NCT01121042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895023|NCT01121042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101895024|NCT01121042|Antipruritics|antipruritics|mesh-ancestor
101895025|NCT01121042|Dermatologic Agents|dermatologic agents|mesh-ancestor
101895026|NCT01121042|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101895027|NCT01121042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101895028|NCT01121042|Serotonin Agents|serotonin agents|mesh-ancestor
101895029|NCT01121042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101895030|NCT01121042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895031|NCT01121120|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
101895032|NCT01121120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101895033|NCT01121120|Vasodilator Agents|vasodilator agents|mesh-ancestor
101895034|NCT01217450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101895036|NCT01217450|Antibodies|antibodies|mesh-list
101895037|NCT01217450|Immunoglobulins|immunoglobulins|mesh-list
101895038|NCT01217450|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101895039|NCT01217450|Immunologic Factors|immunologic factors|mesh-ancestor
101685796|NCT04213898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895040|NCT01217450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895041|NCT01217450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101895042|NCT01219556|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101895043|NCT01219556|Olmesartan|olmesartan|mesh-list
101895044|NCT01219556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101895045|NCT01219556|Diuretics|diuretics|mesh-ancestor
101895046|NCT01219556|Natriuretic Agents|natriuretic agents|mesh-ancestor
101895047|NCT01219556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895048|NCT01219556|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101895049|NCT01219556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101895050|NCT01219556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895051|NCT01219556|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101895052|NCT01219556|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101895053|NCT01121198|Ipragliflozin|ipragliflozin|mesh-list
101895054|NCT01121198|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101895055|NCT01121198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895056|NCT01121198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101895057|NCT01121198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895058|NCT01121276|Insulin|insulin|mesh-list
101895059|NCT01121276|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101895060|NCT01121276|Insulin Aspart|insulin aspart|mesh-list
101895061|NCT01121276|Insulin, Long-Acting|insulin, long-acting|mesh-list
101895062|NCT01121276|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101895063|NCT01121276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101895064|NCT01121276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895065|NCT05175508|Azacitidine|azacitidine|mesh-list
101895066|NCT05175508|Tretinoin|tretinoin|mesh-list
101895067|NCT05175508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101895068|NCT05175508|Antimetabolites|antimetabolites|mesh-ancestor
101895069|NCT05175508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895070|NCT05175508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101895071|NCT05175508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895072|NCT05175508|Keratolytic Agents|keratolytic agents|mesh-ancestor
101895073|NCT05175508|Dermatologic Agents|dermatologic agents|mesh-ancestor
101895074|NCT01125410|Clindamycin|clindamycin|mesh-list
101895075|NCT01125410|Clindamycin palmitate|clindamycin palmitate|mesh-list
101895076|NCT01125410|Clindamycin phosphate|clindamycin phosphate|mesh-list
101895078|NCT01125410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101895079|NCT01125410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101895080|NCT01125410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101895081|NCT01125410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895082|NCT01125410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895083|NCT01125410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101895084|NCT01328834|Tacrolimus|tacrolimus|mesh-list
101895085|NCT01328834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101895086|NCT01328834|Immunologic Factors|immunologic factors|mesh-ancestor
101895087|NCT01328834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895088|NCT01328834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101895089|NCT01328834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895090|NCT01328834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895091|NCT01121354|Cefazolin|cefazolin|mesh-list
101895092|NCT01121354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101895093|NCT01121354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101895094|NCT01122602|Aspirin|aspirin|mesh-list
101895095|NCT01122602|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101895096|NCT01122602|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101895097|NCT01122602|Analgesics|analgesics|mesh-ancestor
101895098|NCT01122602|Sensory System Agents|sensory system agents|mesh-ancestor
101895099|NCT01122602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101895100|NCT01122602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895101|NCT01122602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101895102|NCT01122602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101895103|NCT01122602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101895104|NCT01122602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101895105|NCT01122602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895106|NCT01122602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101895107|NCT01122602|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101895108|NCT01122602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895109|NCT01122602|Antipyretics|antipyretics|mesh-ancestor
101895110|NCT03359590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101895111|NCT03359590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101895112|NCT03359590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895113|NCT03359590|Incretins|incretins|mesh-ancestor
101895114|NCT03359590|Hormones|hormones|mesh-ancestor
101895115|NCT03359590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101895116|NCT03359590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101895117|NCT03359590|Protease Inhibitors|protease inhibitors|mesh-ancestor
101895118|NCT03359590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895119|NCT03359590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895120|NCT01219712|Simendan|simendan|mesh-list
101895121|NCT01219712|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101895122|NCT01219712|Vasodilator Agents|vasodilator agents|mesh-ancestor
101895123|NCT01219712|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101895124|NCT01219712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101895125|NCT01219712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895126|NCT01219712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895127|NCT01219712|Protective Agents|protective agents|mesh-ancestor
101895128|NCT01219712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895129|NCT01215266|Sorafenib|sorafenib|mesh-list
101895130|NCT01215266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101895131|NCT01215266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101895132|NCT01215266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895133|NCT01215266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895134|NCT05682196|Rituximab|rituximab|mesh-list
101895135|NCT05682196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101895136|NCT05682196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101895137|NCT05682196|Immunologic Factors|immunologic factors|mesh-ancestor
101895138|NCT05682196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895139|NCT05682196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101895140|NCT03936374|Omeprazole|omeprazole|mesh-list
101895141|NCT03936374|Linrodostat|linrodostat|mesh-list
101895142|NCT03936374|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101895143|NCT03936374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101895144|NCT03936374|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101895145|NCT03936374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895146|NCT03936374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895147|NCT01125488|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101895148|NCT01125488|Luteolytic Agents|luteolytic agents|mesh-ancestor
101895149|NCT01125488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101895150|NCT01125488|Contraceptive Agents|contraceptive agents|mesh-ancestor
101895151|NCT01125488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101895152|NCT01125488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895153|NCT01125488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101895154|NCT01125488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101895155|NCT01125488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101895157|NCT01215578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101895158|NCT01215578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101895159|NCT01215578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101895160|NCT01215578|Growth Substances|growth substances|mesh-ancestor
101895161|NCT01215578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895162|NCT01215578|Growth Inhibitors|growth inhibitors|mesh-ancestor
101895163|NCT01215578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101895164|NCT01215578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895165|NCT01215578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895166|NCT01120418|Besifloxacin|besifloxacin|mesh-list
101895167|NCT01120418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101895168|NCT01120418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101895169|NCT01120418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101895170|NCT01120418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101895171|NCT01120418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895172|NCT01120418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895173|NCT01120418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101895174|NCT05577988|Aspirin|aspirin|mesh-list
101895175|NCT05577988|Clopidogrel|clopidogrel|mesh-list
101895176|NCT05577988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101895177|NCT05577988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101895178|NCT05577988|Analgesics|analgesics|mesh-ancestor
101895179|NCT05577988|Sensory System Agents|sensory system agents|mesh-ancestor
101895180|NCT05577988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101895181|NCT05577988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895182|NCT05577988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101895183|NCT05577988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101895184|NCT05577988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101895185|NCT05577988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101895186|NCT05577988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895187|NCT05577988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101895188|NCT05577988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101895189|NCT05577988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895190|NCT05577988|Antipyretics|antipyretics|mesh-ancestor
101895191|NCT05577988|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101895192|NCT05577988|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101895193|NCT05577988|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101895194|NCT05577988|Purinergic Agents|purinergic agents|mesh-ancestor
101895195|NCT05577988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101895196|NCT01222052|Cyclophosphamide|cyclophosphamide|mesh-list
101895197|NCT01222052|Docetaxel|docetaxel|mesh-list
101895198|NCT01222052|Fluorouracil|fluorouracil|mesh-list
101895199|NCT01222052|Epirubicin|epirubicin|mesh-list
101895200|NCT01222052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101895201|NCT01222052|Immunologic Factors|immunologic factors|mesh-ancestor
101895202|NCT01222052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895203|NCT01222052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101895204|NCT01222052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101895205|NCT01222052|Alkylating Agents|alkylating agents|mesh-ancestor
101895206|NCT01222052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895207|NCT01222052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101895208|NCT01222052|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101895209|NCT01222052|Tubulin Modulators|tubulin modulators|mesh-ancestor
101895210|NCT01222052|Antimitotic Agents|antimitotic agents|mesh-ancestor
101895211|NCT01222052|Mitosis Modulators|mitosis modulators|mesh-ancestor
101895212|NCT01222052|Antimetabolites|antimetabolites|mesh-ancestor
101895213|NCT01222052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101895214|NCT01222052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101895215|NCT01222052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101895216|NCT01222052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101895217|NCT01222052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895218|NCT03710044|Cyclosporine|cyclosporine|mesh-list
101895219|NCT03710044|Cyclosporins|cyclosporins|mesh-list
101895220|NCT03710044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895221|NCT03710044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895222|NCT03710044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101895223|NCT03710044|Immunologic Factors|immunologic factors|mesh-ancestor
101895224|NCT03710044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895225|NCT03710044|Antifungal Agents|antifungal agents|mesh-ancestor
101895226|NCT03710044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101895227|NCT03710044|Dermatologic Agents|dermatologic agents|mesh-ancestor
101685831|NCT00618644|Ranibizumab|ranibizumab|mesh-list
101895228|NCT03710044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101895229|NCT03710044|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101895230|NCT03706300|Phenylpropanolamine|phenylpropanolamine|mesh-list
101895231|NCT03706300|Pseudoephedrine|pseudoephedrine|mesh-list
101895232|NCT03706300|Ephedrine|ephedrine|mesh-list
101895233|NCT03706300|Guaifenesin|guaifenesin|mesh-list
101895234|NCT03706300|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
101895235|NCT03706300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101895236|NCT03706300|Autonomic Agents|autonomic agents|mesh-ancestor
101895237|NCT03706300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101895238|NCT03706300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895239|NCT03706300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101895240|NCT03706300|Respiratory System Agents|respiratory system agents|mesh-ancestor
101895241|NCT03706300|Nasal Decongestants|nasal decongestants|mesh-ancestor
101895242|NCT03706300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101895243|NCT03706300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101895245|NCT03706300|Adrenergic Agents|adrenergic agents|mesh-ancestor
101895246|NCT03706300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101895247|NCT03706300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895248|NCT03706300|Expectorants|expectorants|mesh-ancestor
101895249|NCT03706300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101895250|NCT03706300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101895251|NCT03706300|Appetite Depressants|appetite depressants|mesh-ancestor
101895252|NCT03706300|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101895253|NCT05155540|Plasminogen|plasminogen|mesh-list
101895254|NCT05155540|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101895255|NCT05155540|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101895256|NCT05155540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101895257|NCT05155540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895258|NCT01122914|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101895259|NCT01122914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101895260|NCT01222442|Moxifloxacin|moxifloxacin|mesh-list
101895261|NCT01222442|AZD-3199|azd-3199|mesh-list
101895262|NCT01222442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101895263|NCT01222442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101895264|NCT01222442|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101895265|NCT01222442|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101895266|NCT01222442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895267|NCT01222442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895268|NCT01222442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101895269|NCT01222442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895270|NCT01222442|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101895271|NCT01222442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101895272|NCT01222442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101895273|NCT01222442|Adrenergic Agents|adrenergic agents|mesh-ancestor
101895274|NCT01222442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101895275|NCT03706222|Grazoprevir|grazoprevir|mesh-list
101895276|NCT03706222|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
101895277|NCT03706222|Antiviral Agents|antiviral agents|mesh-ancestor
101895278|NCT03706222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101895279|NCT01222676|Gemcitabine|gemcitabine|mesh-list
101895280|NCT01222676|Sorafenib|sorafenib|mesh-list
101895281|NCT01222676|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101895282|NCT01222676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101895283|NCT01222676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101895284|NCT01222676|Antimetabolites|antimetabolites|mesh-ancestor
101895285|NCT01222676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895286|NCT01222676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101895287|NCT01222676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895288|NCT01222676|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101895289|NCT05681728|Paclitaxel|paclitaxel|mesh-list
101895290|NCT05681728|Cyclophosphamide|cyclophosphamide|mesh-list
101895291|NCT05681728|Pembrolizumab|pembrolizumab|mesh-list
101895292|NCT05681728|Epirubicin|epirubicin|mesh-list
101895293|NCT05681728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101895294|NCT05681728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101895295|NCT05681728|Tubulin Modulators|tubulin modulators|mesh-ancestor
101895296|NCT05681728|Antimitotic Agents|antimitotic agents|mesh-ancestor
101895297|NCT05681728|Mitosis Modulators|mitosis modulators|mesh-ancestor
101895298|NCT05681728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895299|NCT05681728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101895300|NCT05681728|Immunologic Factors|immunologic factors|mesh-ancestor
101895301|NCT05681728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895302|NCT05681728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101895303|NCT05681728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101895304|NCT05681728|Alkylating Agents|alkylating agents|mesh-ancestor
101895305|NCT05681728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101969433|NCT00544960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101895306|NCT05681728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101895307|NCT05681728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101895308|NCT05681728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101895309|NCT05681728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101895310|NCT05681728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101895311|NCT05681728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895312|NCT03931928|Tamoxifen|tamoxifen|mesh-list
101895313|NCT03931928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101895314|NCT03931928|Hormone Antagonists|hormone antagonists|mesh-ancestor
101895315|NCT03931928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101895316|NCT03931928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895317|NCT03931928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101895318|NCT03931928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101895319|NCT03931928|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101895320|NCT03931928|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101895321|NCT03931928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101895323|NCT01220102|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101895324|NCT01220102|Dermatologic Agents|dermatologic agents|mesh-ancestor
101895325|NCT01220102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101895326|NCT01220102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101895327|NCT01220102|Analgesics|analgesics|mesh-ancestor
101895328|NCT01220102|Sensory System Agents|sensory system agents|mesh-ancestor
101895329|NCT01220102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101895330|NCT01220102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895331|NCT01220102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101895332|NCT01220102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101895333|NCT05133310|Simvastatin|simvastatin|mesh-list
101895334|NCT05133310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101895335|NCT05133310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101895336|NCT05133310|Antimetabolites|antimetabolites|mesh-ancestor
101895337|NCT05133310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895338|NCT05133310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101895339|NCT05133310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101895340|NCT05133310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895341|NCT04576000|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
101895342|NCT04576000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101895343|NCT04576000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895344|NCT04576000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895345|NCT01222910|Valacyclovir|valacyclovir|mesh-list
101895346|NCT01222910|Antiviral Agents|antiviral agents|mesh-ancestor
101895347|NCT01222910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101895348|NCT04533568|Ibuprofen|ibuprofen|mesh-list
101895349|NCT04533568|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
101895350|NCT04533568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101895351|NCT04533568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101895352|NCT04533568|Analgesics|analgesics|mesh-ancestor
101895353|NCT04533568|Sensory System Agents|sensory system agents|mesh-ancestor
101895354|NCT04533568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101895355|NCT04533568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895356|NCT04533568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101895357|NCT04533568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101895358|NCT04533568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101895359|NCT04533568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895360|NCT04533568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895361|NCT03932864|Plerixafor|plerixafor|mesh-list
101895362|NCT03932864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101895363|NCT03932864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101895364|NCT03932864|Antiviral Agents|antiviral agents|mesh-ancestor
101895365|NCT03932864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101895366|NCT05268562|Ketamine|ketamine|mesh-list
101895367|NCT05268562|Propofol|propofol|mesh-list
101895368|NCT05268562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101895369|NCT05268562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101895370|NCT05268562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895371|NCT05268562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101895372|NCT05268562|Anesthetics, General|anesthetics, general|mesh-ancestor
101895373|NCT05268562|Anesthetics|anesthetics|mesh-ancestor
101895374|NCT05268562|Analgesics|analgesics|mesh-ancestor
101895376|NCT05268562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101895377|NCT05268562|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101895378|NCT05268562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101895379|NCT05268562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101895380|NCT05268562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101895381|NCT05268562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895382|NCT05245552|Vaccines|vaccines|mesh-list
101895383|NCT05245552|Immunologic Factors|immunologic factors|mesh-ancestor
101895384|NCT05245552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895385|NCT01312324|Docetaxel|docetaxel|mesh-list
101895386|NCT01312324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101895387|NCT01312324|Tubulin Modulators|tubulin modulators|mesh-ancestor
101895388|NCT01312324|Antimitotic Agents|antimitotic agents|mesh-ancestor
101895389|NCT01312324|Mitosis Modulators|mitosis modulators|mesh-ancestor
101895390|NCT01312324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895391|NCT05482516|Bevacizumab|bevacizumab|mesh-list
101895392|NCT05482516|Atezolizumab|atezolizumab|mesh-list
101895393|NCT05482516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101895394|NCT05482516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101895395|NCT05482516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101895396|NCT05482516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101895397|NCT05482516|Growth Substances|growth substances|mesh-ancestor
101895398|NCT05482516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895399|NCT05482516|Growth Inhibitors|growth inhibitors|mesh-ancestor
101895400|NCT05482516|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101895401|NCT05482516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895402|NCT01127594|Temozolomide|temozolomide|mesh-list
101895403|NCT01127594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101895404|NCT01127594|Alkylating Agents|alkylating agents|mesh-ancestor
101895405|NCT01127594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895406|NCT01127594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101895407|NCT01127672|Betamethasone|betamethasone|mesh-list
101895408|NCT01127672|Lidocaine|lidocaine|mesh-list
101895409|NCT01127672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101895410|NCT01127672|Glucocorticoids|glucocorticoids|mesh-ancestor
101895411|NCT01127672|Hormones|hormones|mesh-ancestor
101895412|NCT01127672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101685862|NCT00907517|Cytarabine|cytarabine|mesh-list
101895413|NCT01127672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895414|NCT01127672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101895415|NCT01127672|Respiratory System Agents|respiratory system agents|mesh-ancestor
101895416|NCT01127672|Anesthetics, Local|anesthetics, local|mesh-ancestor
101895417|NCT01127672|Anesthetics|anesthetics|mesh-ancestor
101895418|NCT01127672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101895419|NCT01127672|Sensory System Agents|sensory system agents|mesh-ancestor
101895420|NCT01127672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101895421|NCT01127672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101895422|NCT01127672|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101895423|NCT01127672|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101895424|NCT01127672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101895425|NCT01127672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895426|NCT01220258|Azithromycin|azithromycin|mesh-list
101895427|NCT01220258|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101895428|NCT01220258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101895429|NCT01220258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101895430|NCT01220258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101895431|NCT01223534|Isoniazid|isoniazid|mesh-list
101895432|NCT01223534|Antitubercular Agents|antitubercular agents|mesh-ancestor
101895433|NCT01223534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101895434|NCT01223534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101895435|NCT01223534|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101895436|NCT01223534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101895437|NCT01223534|Antimetabolites|antimetabolites|mesh-ancestor
101895438|NCT01223534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895439|NCT01223534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101895440|NCT01223612|Ranibizumab|ranibizumab|mesh-list
101895441|NCT01223612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101969443|NCT01339286|Adrenergic Agents|adrenergic agents|mesh-ancestor
101895442|NCT01223612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101895443|NCT01223612|Growth Substances|growth substances|mesh-ancestor
101895444|NCT01223612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895445|NCT01223612|Growth Inhibitors|growth inhibitors|mesh-ancestor
101895446|NCT01223612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101895447|NCT01127750|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101895448|NCT01127750|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101895449|NCT01127750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895450|NCT01127750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101895451|NCT01127750|Immunologic Factors|immunologic factors|mesh-ancestor
101895452|NCT01127750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895453|NCT02946580|Naloxegol|naloxegol|mesh-list
101895454|NCT02946580|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101895455|NCT02946580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895456|NCT02946580|Sensory System Agents|sensory system agents|mesh-ancestor
101895457|NCT02946580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101895458|NCT01223690|Clarithromycin|clarithromycin|mesh-list
101895459|NCT01223690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101895460|NCT01223690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101895461|NCT01223690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101895462|NCT01223690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895463|NCT01223690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895464|NCT01223690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101895465|NCT01223690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101895466|NCT05381350|Vaccines|vaccines|mesh-list
101895467|NCT05381350|Immunologic Factors|immunologic factors|mesh-ancestor
101895468|NCT05381350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895469|NCT01223768|Acetylcarnitine|acetylcarnitine|mesh-list
101895470|NCT01223768|Vitamin B Complex|vitamin b complex|mesh-ancestor
101895471|NCT01223768|Vitamins|vitamins|mesh-ancestor
101895472|NCT01223768|Micronutrients|micronutrients|mesh-ancestor
101895473|NCT01223768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895474|NCT01223768|Nootropic Agents|nootropic agents|mesh-ancestor
101895475|NCT01126112|Panitumumab|panitumumab|mesh-list
101895476|NCT01126112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101895477|NCT01126112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101895478|NCT05024032|Tirzepatide|tirzepatide|mesh-list
101895479|NCT05024032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101895480|NCT05024032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895481|NCT05024032|Incretins|incretins|mesh-ancestor
101895482|NCT05024032|Hormones|hormones|mesh-ancestor
101895483|NCT05024032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101895484|NCT01123538|Chlormadinone Acetate|chlormadinone acetate|mesh-list
101895485|NCT01123538|Progesterone|progesterone|mesh-list
101895486|NCT01123538|Progestins|progestins|mesh-ancestor
101895487|NCT01123538|Hormones|hormones|mesh-ancestor
101895488|NCT01123538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101895489|NCT01123538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895490|NCT01123538|Androgen Antagonists|androgen antagonists|mesh-ancestor
101895491|NCT01123538|Hormone Antagonists|hormone antagonists|mesh-ancestor
101895492|NCT01123538|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101895493|NCT01123538|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101895494|NCT01123538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101895495|NCT01123538|Contraceptive Agents|contraceptive agents|mesh-ancestor
101895496|NCT01123538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101895497|NCT01123538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101895498|NCT01123538|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101895499|NCT03930992|Zoledronic Acid|zoledronic acid|mesh-list
101895500|NCT03930992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101895501|NCT03930992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895502|NCT01220570|Sirolimus|sirolimus|mesh-list
101895503|NCT01220570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101895504|NCT01220570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101895505|NCT01220570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101895506|NCT01220570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101895507|NCT01220570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101895508|NCT01220570|Antifungal Agents|antifungal agents|mesh-ancestor
101895509|NCT01220570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101969449|NCT00468442|Daclizumab|daclizumab|mesh-list
101895510|NCT01220570|Immunologic Factors|immunologic factors|mesh-ancestor
101895511|NCT01220570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895512|NCT04682860|Scopolamine|scopolamine|mesh-list
101895513|NCT04682860|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101895514|NCT04682860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101895515|NCT04682860|Antiemetics|antiemetics|mesh-ancestor
101895516|NCT04682860|Autonomic Agents|autonomic agents|mesh-ancestor
101615313|NCT04133428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101895517|NCT04682860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101895518|NCT04682860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895519|NCT04682860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101895520|NCT04682860|Mydriatics|mydriatics|mesh-ancestor
101895521|NCT04682860|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101895522|NCT04682860|Cholinergic Agents|cholinergic agents|mesh-ancestor
101895523|NCT04682860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101895524|NCT04682860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895525|NCT04682860|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101895526|NCT04682860|Parasympatholytics|parasympatholytics|mesh-ancestor
101895527|NCT01127906|Oxycodone|oxycodone|mesh-list
101895528|NCT01127906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101895529|NCT01127906|Narcotics|narcotics|mesh-ancestor
101895530|NCT01127906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101895531|NCT01127906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895532|NCT01127906|Analgesics|analgesics|mesh-ancestor
101895533|NCT01127906|Sensory System Agents|sensory system agents|mesh-ancestor
101895534|NCT01127906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101895535|NCT01127984|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101895536|NCT01127984|Hemostatics|hemostatics|mesh-ancestor
101895537|NCT01127984|Coagulants|coagulants|mesh-ancestor
101895538|NCT01220648|Interferons|interferons|mesh-list
101895539|NCT01220648|Interferon-alpha|interferon-alpha|mesh-list
101895540|NCT01220648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101895541|NCT01220648|Antiviral Agents|antiviral agents|mesh-ancestor
101895542|NCT01220648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101895543|NCT01220648|Immunologic Factors|immunologic factors|mesh-ancestor
101895544|NCT01220648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685882|NCT00905021|Sunitinib|sunitinib|mesh-list
101895545|NCT01218386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101895546|NCT01218386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101895547|NCT01218386|Estradiol|estradiol|mesh-list
101895548|NCT01218386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101895549|NCT01218386|Estrogens|estrogens|mesh-ancestor
101895550|NCT01218386|Hormones|hormones|mesh-ancestor
101895551|NCT01218386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101895552|NCT01218386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895553|NCT01218386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101895554|NCT01218386|Contraceptive Agents|contraceptive agents|mesh-ancestor
101895555|NCT01218386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101895556|NCT01218386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101895557|NCT03933098|Vaccines|vaccines|mesh-list
101895558|NCT03933098|Immunologic Factors|immunologic factors|mesh-ancestor
101895559|NCT03933098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895560|NCT05111314|Edetic Acid|edetic acid|mesh-list
101895561|NCT05111314|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101895562|NCT05111314|Chelating Agents|chelating agents|mesh-ancestor
101895563|NCT05111314|Sequestering Agents|sequestering agents|mesh-ancestor
101895564|NCT05111314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895565|NCT05111314|Anticoagulants|anticoagulants|mesh-ancestor
101895566|NCT05111314|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101895567|NCT05111314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101895568|NCT01224314|Dialysis Solutions|dialysis solutions|mesh-list
101895569|NCT01224314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101895570|NCT01224392|Capecitabine|capecitabine|mesh-list
101895571|NCT01224392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101895572|NCT01224392|Antimetabolites|antimetabolites|mesh-ancestor
101895573|NCT01224392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895574|NCT01224392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101895575|NCT01224470|Dexmedetomidine|dexmedetomidine|mesh-list
101895576|NCT01224470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101895577|NCT01224470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101895578|NCT01224470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895579|NCT01224470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101895580|NCT01224470|Analgesics|analgesics|mesh-ancestor
101895581|NCT01224470|Sensory System Agents|sensory system agents|mesh-ancestor
101895582|NCT01224470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101969455|NCT00468442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101895583|NCT01224470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101895584|NCT01224470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101895586|NCT01224470|Adrenergic Agents|adrenergic agents|mesh-ancestor
101895587|NCT01224470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101895588|NCT01224470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895589|NCT01128218|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101895590|NCT01128218|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101895591|NCT01128218|Dermatologic Agents|dermatologic agents|mesh-ancestor
101895592|NCT03740516|Apremilast|apremilast|mesh-list
101895593|NCT03740516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101895594|NCT03740516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101895595|NCT03740516|Analgesics|analgesics|mesh-ancestor
101895596|NCT03740516|Sensory System Agents|sensory system agents|mesh-ancestor
101895597|NCT03740516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101895598|NCT03740516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895599|NCT03740516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101895600|NCT03740516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101895601|NCT03740516|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101895602|NCT03740516|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101895603|NCT03740516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895604|NCT03740516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895605|NCT03933956|Empagliflozin|empagliflozin|mesh-list
101895606|NCT03933956|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101895607|NCT03933956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895608|NCT03933956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101895609|NCT03933956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895610|NCT01218620|Tolbutamide|tolbutamide|mesh-list
101895611|NCT01218620|Rifampin|rifampin|mesh-list
101895612|NCT01218620|Ketoconazole|ketoconazole|mesh-list
101895613|NCT01218620|Midazolam|midazolam|mesh-list
101895614|NCT01218620|Dextromethorphan|dextromethorphan|mesh-list
101895615|NCT01218620|Omeprazole|omeprazole|mesh-list
101895616|NCT01218620|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
101895617|NCT01218620|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
101895618|NCT01218620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101895619|NCT01218620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101895620|NCT01218620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101895621|NCT01218620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895622|NCT01218620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101895623|NCT01218620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101895624|NCT01218620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101895625|NCT01218620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101895626|NCT01218620|Anesthetics, General|anesthetics, general|mesh-ancestor
101895627|NCT01218620|Anesthetics|anesthetics|mesh-ancestor
101895628|NCT01218620|GABA Modulators|gaba modulators|mesh-ancestor
101895629|NCT01218620|GABA Agents|gaba agents|mesh-ancestor
101895630|NCT01218620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101895631|NCT01218620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895632|NCT01218620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101895633|NCT01218620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101895634|NCT01218620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101895635|NCT01218620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895636|NCT01218620|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101895637|NCT01218620|Antitubercular Agents|antitubercular agents|mesh-ancestor
101895638|NCT01218620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101895639|NCT01218620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101895640|NCT01218620|Leprostatic Agents|leprostatic agents|mesh-ancestor
101895641|NCT01218620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101895642|NCT01218620|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101895643|NCT01218620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101895644|NCT01218620|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101895645|NCT01218620|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101895646|NCT01218620|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101895647|NCT01218620|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101895648|NCT01218620|Antifungal Agents|antifungal agents|mesh-ancestor
101895649|NCT01218620|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101895650|NCT01218620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101895651|NCT01218620|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101895653|NCT01218620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101895654|NCT01218620|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101895655|NCT01218620|Antitussive Agents|antitussive agents|mesh-ancestor
101895656|NCT01218620|Respiratory System Agents|respiratory system agents|mesh-ancestor
101895657|NCT01218620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101895658|NCT01218620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101895659|NCT01218620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101895660|NCT00323297|Bosentan|bosentan|mesh-list
101895661|NCT00323297|Sildenafil Citrate|sildenafil citrate|mesh-list
101895662|NCT00323297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895663|NCT00323297|Vasodilator Agents|vasodilator agents|mesh-ancestor
101895664|NCT00323297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101895665|NCT00323297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101895666|NCT00323297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895667|NCT00323297|Urological Agents|urological agents|mesh-ancestor
101895668|NCT00323297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101895669|NCT00323297|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101895671|NCT01218698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101895672|NCT01218698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101895673|NCT01218698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101895674|NCT01218698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101895675|NCT01218698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895676|NCT01224860|Losartan|losartan|mesh-list
101895677|NCT01224860|Telmisartan|telmisartan|mesh-list
101895678|NCT01224860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101895679|NCT01224860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101258535|NCT01731756|Petrolatum|petrolatum|mesh-list
101895680|NCT01224860|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101895681|NCT01224860|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101895682|NCT01224860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895683|NCT00323063|Gemcitabine|gemcitabine|mesh-list
101895684|NCT00323063|Imatinib Mesylate|imatinib mesylate|mesh-list
101895685|NCT00323063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101895686|NCT00323063|Antimetabolites|antimetabolites|mesh-ancestor
101895687|NCT00323063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895688|NCT00323063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101895689|NCT00323063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101895690|NCT00323063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895691|NCT01328990|Pyrimethamine|pyrimethamine|mesh-list
101895692|NCT01328990|Sulfadoxine|sulfadoxine|mesh-list
101895693|NCT01328990|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101895694|NCT01328990|Amodiaquine|amodiaquine|mesh-list
101895695|NCT01328990|Antimalarials|antimalarials|mesh-ancestor
101895696|NCT01328990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101895697|NCT01328990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101895698|NCT01328990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101895699|NCT01328990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101895700|NCT01328990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895701|NCT01328990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895702|NCT01328990|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101895703|NCT01225094|Curcumin|curcumin|mesh-list
101895704|NCT01225094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101895705|NCT01225094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101895706|NCT01225094|Analgesics|analgesics|mesh-ancestor
101895707|NCT01225094|Sensory System Agents|sensory system agents|mesh-ancestor
101895708|NCT01225094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101895709|NCT01225094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895710|NCT01225094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101895711|NCT01225094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101895712|NCT01225094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101895713|NCT01225094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895714|NCT01225094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895715|NCT00322049|Vaccines|vaccines|mesh-list
101895716|NCT00322049|Immunologic Factors|immunologic factors|mesh-ancestor
101895717|NCT00322049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895718|NCT01124240|Temozolomide|temozolomide|mesh-list
101895719|NCT01124240|Procarbazine|procarbazine|mesh-list
101895720|NCT01124240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101895721|NCT01124240|Alkylating Agents|alkylating agents|mesh-ancestor
101895722|NCT01124240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895723|NCT01124240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101895724|NCT01124318|Lactulose|lactulose|mesh-list
101895725|NCT01124318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101895726|NCT01221116|Simendan|simendan|mesh-list
101895727|NCT01221116|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101895728|NCT01221116|Vasodilator Agents|vasodilator agents|mesh-ancestor
101895729|NCT01221116|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101895730|NCT01221116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101895731|NCT01221116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895732|NCT01221116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895733|NCT01221116|Protective Agents|protective agents|mesh-ancestor
101895734|NCT01221116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895735|NCT03929744|Midazolam|midazolam|mesh-list
101895736|NCT03929744|Atorvastatin|atorvastatin|mesh-list
101895737|NCT03929744|Simvastatin|simvastatin|mesh-list
101895738|NCT03929744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101895739|NCT03929744|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101895740|NCT03929744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101895741|NCT03929744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895743|NCT03929744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101895744|NCT03929744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101895745|NCT03929744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101895746|NCT03929744|Anesthetics, General|anesthetics, general|mesh-ancestor
101895747|NCT03929744|Anesthetics|anesthetics|mesh-ancestor
101895748|NCT03929744|GABA Modulators|gaba modulators|mesh-ancestor
101895749|NCT03929744|GABA Agents|gaba agents|mesh-ancestor
101895750|NCT03929744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101895751|NCT03929744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258607|NCT01732198|Immunologic Factors|immunologic factors|mesh-ancestor
101895752|NCT03929744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101895753|NCT03929744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101895754|NCT03929744|Antimetabolites|antimetabolites|mesh-ancestor
101895755|NCT03929744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101895756|NCT03929744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101895757|NCT03929744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895758|NCT01225406|Tenofovir|tenofovir|mesh-list
101895759|NCT01225406|Antiviral Agents|antiviral agents|mesh-ancestor
101895760|NCT01225406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101895761|NCT01225406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101895762|NCT01225406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101895763|NCT01225406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895764|NCT01225406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895765|NCT01225406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101895766|NCT01225406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101895767|NCT01126814|Imatinib Mesylate|imatinib mesylate|mesh-list
101895768|NCT01126814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101895769|NCT01126814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101895770|NCT01126814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895771|NCT01126814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895772|NCT01225484|Ropivacaine|ropivacaine|mesh-list
101895773|NCT01225484|Anesthetics, Local|anesthetics, local|mesh-ancestor
101895774|NCT01225484|Anesthetics|anesthetics|mesh-ancestor
101895775|NCT01225484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101895776|NCT01225484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895777|NCT01225484|Sensory System Agents|sensory system agents|mesh-ancestor
101895778|NCT01225484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101895779|NCT03928496|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101895780|NCT03928496|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101895781|NCT03928496|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101895782|NCT03928496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101895783|NCT03928496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895784|NCT03928496|Cholinergic Agents|cholinergic agents|mesh-ancestor
101895785|NCT03928496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101895786|NCT03928496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895787|NCT03928496|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101895788|NCT03928496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101895789|NCT01128998|Sorafenib|sorafenib|mesh-list
101895790|NCT01128998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101895791|NCT01128998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101895792|NCT01128998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895793|NCT01128998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895794|NCT00321893|Budesonide|budesonide|mesh-list
101895795|NCT00321893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101895796|NCT00321893|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101895797|NCT00321893|Autonomic Agents|autonomic agents|mesh-ancestor
101895798|NCT00321893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101895799|NCT00321893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895800|NCT00321893|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101685963|NCT05116007|Carboplatin|carboplatin|mesh-list
101895801|NCT00321893|Respiratory System Agents|respiratory system agents|mesh-ancestor
101895802|NCT00321893|Glucocorticoids|glucocorticoids|mesh-ancestor
101895803|NCT00321893|Hormones|hormones|mesh-ancestor
101895804|NCT00321893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101895805|NCT01225874|Cytarabine|cytarabine|mesh-list
101895806|NCT01225874|Dexamethasone|dexamethasone|mesh-list
101895807|NCT01225874|Prednisone|prednisone|mesh-list
101895808|NCT01225874|Methotrexate|methotrexate|mesh-list
101895809|NCT01225874|Vincristine|vincristine|mesh-list
101895810|NCT01225874|Daunorubicin|daunorubicin|mesh-list
101895811|NCT01225874|Asparaginase|asparaginase|mesh-list
101895812|NCT01225874|Pegaspargase|pegaspargase|mesh-list
101895813|NCT01225874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101895814|NCT01225874|Antiemetics|antiemetics|mesh-ancestor
101895815|NCT01225874|Autonomic Agents|autonomic agents|mesh-ancestor
101895816|NCT01225874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101615614|NCT04263402|Hormones|hormones|mesh-ancestor
101895817|NCT01225874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895819|NCT01225874|Glucocorticoids|glucocorticoids|mesh-ancestor
101895820|NCT01225874|Hormones|hormones|mesh-ancestor
101895821|NCT01225874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101895822|NCT01225874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101895823|NCT01225874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101895824|NCT01225874|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101895825|NCT01225874|Abortifacient Agents|abortifacient agents|mesh-ancestor
101895826|NCT01225874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101895827|NCT01225874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101895828|NCT01225874|Antimetabolites|antimetabolites|mesh-ancestor
101895829|NCT01225874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895830|NCT01225874|Dermatologic Agents|dermatologic agents|mesh-ancestor
101895831|NCT01225874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895832|NCT01225874|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101895833|NCT01225874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101895834|NCT01225874|Immunologic Factors|immunologic factors|mesh-ancestor
101895835|NCT01225874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101895836|NCT01225874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101895837|NCT01225874|Antiviral Agents|antiviral agents|mesh-ancestor
101895838|NCT01225874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101895839|NCT01225874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101895840|NCT01225874|Tubulin Modulators|tubulin modulators|mesh-ancestor
101895841|NCT01225874|Antimitotic Agents|antimitotic agents|mesh-ancestor
101895842|NCT01225874|Mitosis Modulators|mitosis modulators|mesh-ancestor
101895843|NCT01225874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101895844|NCT01225874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101895845|NCT01225874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101895846|NCT03928340|Metformin|metformin|mesh-list
101895847|NCT03928340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101895848|NCT03928340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895849|NCT00371345|Dasatinib|dasatinib|mesh-list
101895850|NCT00371345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101895851|NCT00371345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101895852|NCT00371345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895853|NCT00371345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895854|NCT01226186|Morphine|morphine|mesh-list
101895855|NCT01226186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101895856|NCT01226186|Narcotics|narcotics|mesh-ancestor
101895857|NCT01226186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101895858|NCT01226186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895859|NCT01226186|Analgesics|analgesics|mesh-ancestor
101895860|NCT01226186|Sensory System Agents|sensory system agents|mesh-ancestor
101895861|NCT01226186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101895862|NCT01228214|Aspirin|aspirin|mesh-list
101895863|NCT01228214|Amiloride|amiloride|mesh-list
101895864|NCT01228214|Clopidogrel|clopidogrel|mesh-list
101895865|NCT01228214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101895866|NCT01228214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101895867|NCT01228214|Analgesics|analgesics|mesh-ancestor
101895868|NCT01228214|Sensory System Agents|sensory system agents|mesh-ancestor
101895869|NCT01228214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101895870|NCT01228214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895871|NCT01228214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101895872|NCT01228214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101895873|NCT01228214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101895874|NCT01228214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101895875|NCT01228214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895876|NCT01228214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101895877|NCT01228214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101895878|NCT01228214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895879|NCT01228214|Antipyretics|antipyretics|mesh-ancestor
101895880|NCT01228214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101895881|NCT01228214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101895882|NCT01228214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101895883|NCT01228214|Purinergic Agents|purinergic agents|mesh-ancestor
101895884|NCT01228214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101895885|NCT01228214|Diuretics|diuretics|mesh-ancestor
101895886|NCT01228214|Natriuretic Agents|natriuretic agents|mesh-ancestor
101895887|NCT01228214|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
101615696|NCT00862654|Hormones|hormones|mesh-ancestor
101895888|NCT01228214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101895889|NCT01228214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101895890|NCT01228214|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101895891|NCT01228214|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101895893|NCT00321737|Lansoprazole|lansoprazole|mesh-list
101895894|NCT00321737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101895895|NCT00321737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101895896|NCT00321737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101895897|NCT00321737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895898|NCT00321737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895899|NCT03928262|Benralizumab|benralizumab|mesh-list
101895900|NCT03928262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101895901|NCT03928262|Respiratory System Agents|respiratory system agents|mesh-ancestor
101895902|NCT03740438|Chrysarobin|chrysarobin|mesh-list
101895903|NCT03740438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101895904|NCT03740438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101895905|NCT03740438|Analgesics|analgesics|mesh-ancestor
101895906|NCT03740438|Sensory System Agents|sensory system agents|mesh-ancestor
101895907|NCT03740438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101895908|NCT03740438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895909|NCT03740438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101895910|NCT03740438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101895911|NCT01129154|Panitumumab|panitumumab|mesh-list
101895912|NCT01129154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101895913|NCT01129154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101895914|NCT01047995|Ritonavir|ritonavir|mesh-list
101895915|NCT01047995|Darunavir|darunavir|mesh-list
101895916|NCT01047995|Raltegravir Potassium|raltegravir potassium|mesh-list
101895917|NCT01047995|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101895918|NCT01047995|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101895919|NCT01047995|Protease Inhibitors|protease inhibitors|mesh-ancestor
101895920|NCT01047995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895921|NCT01047995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895922|NCT01047995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101895923|NCT01047995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101895924|NCT01047995|Antiviral Agents|antiviral agents|mesh-ancestor
101895925|NCT01047995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101895926|NCT01047995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101895927|NCT01047995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101895928|NCT01047995|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101895929|NCT01047995|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101895930|NCT01129310|Capecitabine|capecitabine|mesh-list
101895931|NCT01129310|Oxaliplatin|oxaliplatin|mesh-list
101895932|NCT01129310|Irinotecan|irinotecan|mesh-list
101895933|NCT01129310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101895934|NCT01129310|Antimetabolites|antimetabolites|mesh-ancestor
101895935|NCT01129310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895936|NCT01129310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101895937|NCT01129310|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101895938|NCT01129310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101895939|NCT01129310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895940|NCT01129388|Omeprazole|omeprazole|mesh-list
101895941|NCT01129388|Clopidogrel|clopidogrel|mesh-list
101895942|NCT01129388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101895943|NCT01129388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101895944|NCT01129388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101895945|NCT01129388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101895946|NCT01129388|Purinergic Agents|purinergic agents|mesh-ancestor
101895947|NCT01129388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101895948|NCT01129388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895949|NCT01129388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895950|NCT01129388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101895951|NCT01129388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101895952|NCT01129388|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101895953|NCT01129388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895954|NCT01228292|Heparin|heparin|mesh-list
101895955|NCT01228292|Calcium heparin|calcium heparin|mesh-list
101895956|NCT01228292|Anticoagulants|anticoagulants|mesh-ancestor
101895957|NCT01228292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101895958|NCT01228292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101895959|NCT01228292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895960|NCT03924596|Boswellic acid|boswellic acid|mesh-list
101895961|NCT03924596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101895962|NCT03924596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101895963|NCT03924596|Analgesics|analgesics|mesh-ancestor
101895964|NCT03924596|Sensory System Agents|sensory system agents|mesh-ancestor
101895965|NCT03924596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101895966|NCT03924596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895967|NCT03924596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101895968|NCT03924596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101895969|NCT00320801|Buprenorphine|buprenorphine|mesh-list
101895970|NCT00320801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101895971|NCT00320801|Narcotics|narcotics|mesh-ancestor
101895972|NCT00320801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101895973|NCT00320801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895974|NCT00320801|Analgesics|analgesics|mesh-ancestor
101895975|NCT00320801|Sensory System Agents|sensory system agents|mesh-ancestor
101895976|NCT00320801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101895977|NCT00320801|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101895978|NCT01127204|Lamivudine|lamivudine|mesh-list
101895979|NCT01127204|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101895980|NCT01127204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101895981|NCT01127204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101895982|NCT01127204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895983|NCT01127204|Antiviral Agents|antiviral agents|mesh-ancestor
101895984|NCT01127204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101895985|NCT01127204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101895986|NCT01127204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101895987|NCT01228370|Silodosin|silodosin|mesh-list
101895988|NCT01228370|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101895989|NCT01228370|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101895990|NCT01228370|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101895991|NCT01228370|Adrenergic Agents|adrenergic agents|mesh-ancestor
101895992|NCT01228370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101895993|NCT01228370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101895994|NCT01228370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101895995|NCT01228370|Urological Agents|urological agents|mesh-ancestor
101895996|NCT01221740|Milnacipran|milnacipran|mesh-list
101895997|NCT01221740|Levomilnacipran|levomilnacipran|mesh-list
101895998|NCT01221740|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101895999|NCT01221740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101896000|NCT01221740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101896001|NCT01221740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896002|NCT01221740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101896003|NCT01221740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896004|NCT01221740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101896005|NCT01221740|Analgesics|analgesics|mesh-ancestor
101896006|NCT01221740|Sensory System Agents|sensory system agents|mesh-ancestor
101896007|NCT01221740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101896008|NCT01221740|Antidepressive Agents|antidepressive agents|mesh-ancestor
101896009|NCT01221740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101896010|NCT00320489|Olanzapine|olanzapine|mesh-list
101896011|NCT00320489|Antiemetics|antiemetics|mesh-ancestor
101896012|NCT00320489|Autonomic Agents|autonomic agents|mesh-ancestor
101896013|NCT00320489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101896014|NCT00320489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896015|NCT00320489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101896016|NCT00320489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101896017|NCT00320489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101896018|NCT00320489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101896019|NCT00320489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101896020|NCT00320489|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101896021|NCT00320489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101896022|NCT00320489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101896023|NCT00320489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896024|NCT00320489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101896025|NCT00320489|Serotonin Agents|serotonin agents|mesh-ancestor
101896026|NCT01127282|Vitamins|vitamins|mesh-list
101896027|NCT01127282|Vitamin A|vitamin a|mesh-list
101896028|NCT01127282|Micronutrients|micronutrients|mesh-ancestor
101896029|NCT01127282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896030|NCT01127360|Bevacizumab|bevacizumab|mesh-list
101896031|NCT01127360|Ranibizumab|ranibizumab|mesh-list
101896032|NCT01127360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101896033|NCT01127360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101896034|NCT01127360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101896035|NCT01127360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101896036|NCT01127360|Growth Substances|growth substances|mesh-ancestor
101896037|NCT01127360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896038|NCT01127360|Growth Inhibitors|growth inhibitors|mesh-ancestor
101896039|NCT01228604|Methylphenidate|methylphenidate|mesh-list
101896040|NCT01228604|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101896041|NCT01228604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896042|NCT01228604|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101896043|NCT01228604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101896044|NCT01228604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101896045|NCT01228604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896046|NCT01228604|Dopamine Agents|dopamine agents|mesh-ancestor
101896047|NCT01228604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101896048|NCT01228682|Tolvaptan|tolvaptan|mesh-list
101896049|NCT01228682|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101896050|NCT01228682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896051|NCT01228682|Natriuretic Agents|natriuretic agents|mesh-ancestor
101896052|NCT01228682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896053|NCT01221896|Choline|choline|mesh-list
101896054|NCT01221896|Lipotropic Agents|lipotropic agents|mesh-ancestor
101896055|NCT01221896|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101896056|NCT01221896|Antimetabolites|antimetabolites|mesh-ancestor
101896057|NCT01221896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896058|NCT01221896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101896059|NCT01221896|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101896060|NCT01221896|Nootropic Agents|nootropic agents|mesh-ancestor
101896061|NCT03923114|Exenatide|exenatide|mesh-list
101896062|NCT03923114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101896063|NCT03923114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896064|NCT03923114|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101896065|NCT03923114|Incretins|incretins|mesh-ancestor
101896066|NCT03923114|Hormones|hormones|mesh-ancestor
101896067|NCT03923114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101896068|NCT00320411|Lapatinib|lapatinib|mesh-list
101896069|NCT00320411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101896070|NCT00320411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101896071|NCT00320411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101896072|NCT00320411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896073|NCT01132040|Primidone|primidone|mesh-list
101896074|NCT01132040|Anticonvulsants|anticonvulsants|mesh-ancestor
101896075|NCT01132040|GABA Modulators|gaba modulators|mesh-ancestor
101896076|NCT01132040|GABA Agents|gaba agents|mesh-ancestor
101896077|NCT01132040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101896078|NCT01132040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896079|NCT01132040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896080|NCT01226966|Liraglutide|liraglutide|mesh-list
101896081|NCT01226966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101896082|NCT01226966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896083|NCT01226966|Incretins|incretins|mesh-ancestor
101896084|NCT01226966|Hormones|hormones|mesh-ancestor
101896085|NCT01226966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101896086|NCT03923036|Cetuximab|cetuximab|mesh-list
101896087|NCT03923036|Panitumumab|panitumumab|mesh-list
101896088|NCT03923036|Aflibercept|aflibercept|mesh-list
101896089|NCT03923036|Capecitabine|capecitabine|mesh-list
101896090|NCT03923036|Irinotecan|irinotecan|mesh-list
101896091|NCT03923036|Antineoplastic Agents|antineoplastic agents|mesh-list
101896092|NCT03923036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101896093|NCT03923036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101896094|NCT03923036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101896095|NCT03923036|Growth Substances|growth substances|mesh-ancestor
101896096|NCT03923036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896097|NCT03923036|Growth Inhibitors|growth inhibitors|mesh-ancestor
101896098|NCT03923036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101896099|NCT03923036|Antimetabolites|antimetabolites|mesh-ancestor
101896100|NCT03923036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896101|NCT03923036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101896102|NCT03923036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101896103|NCT03923036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101896104|NCT01129856|Dexamethasone|dexamethasone|mesh-list
101896105|NCT01129856|Citric Acid|citric acid|mesh-list
101896106|NCT01129856|Sodium Citrate|sodium citrate|mesh-list
101896107|NCT01129856|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101896108|NCT01129856|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101896109|NCT01129856|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101896110|NCT01129856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101896111|NCT01129856|Antiemetics|antiemetics|mesh-ancestor
101896112|NCT01129856|Autonomic Agents|autonomic agents|mesh-ancestor
101615907|NCT00860470|Folic Acid|folic acid|mesh-list
101896113|NCT01129856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101896114|NCT01129856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896115|NCT01129856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101896116|NCT01129856|Glucocorticoids|glucocorticoids|mesh-ancestor
101896117|NCT01129856|Hormones|hormones|mesh-ancestor
101896118|NCT01129856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101896119|NCT01129856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101896120|NCT01129856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101896121|NCT01129856|Anticoagulants|anticoagulants|mesh-ancestor
101896122|NCT01129856|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101896123|NCT01129856|Chelating Agents|chelating agents|mesh-ancestor
101896124|NCT01129856|Sequestering Agents|sequestering agents|mesh-ancestor
101896125|NCT01129856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896126|NCT01129934|Promethazine|promethazine|mesh-list
101896127|NCT01129934|Diphenhydramine|diphenhydramine|mesh-list
101896128|NCT01129934|Morphine|morphine|mesh-list
101896129|NCT01129934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101896130|NCT01129934|Narcotics|narcotics|mesh-ancestor
101896131|NCT01129934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101896132|NCT01129934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896133|NCT01129934|Analgesics|analgesics|mesh-ancestor
101896134|NCT01129934|Sensory System Agents|sensory system agents|mesh-ancestor
101896135|NCT01129934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101896136|NCT01129934|Antipruritics|antipruritics|mesh-ancestor
101896137|NCT01129934|Dermatologic Agents|dermatologic agents|mesh-ancestor
101896138|NCT01129934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101896139|NCT01129934|Histamine Antagonists|histamine antagonists|mesh-ancestor
101896140|NCT01129934|Histamine Agents|histamine agents|mesh-ancestor
101896141|NCT01129934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101896142|NCT01129934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896143|NCT01129934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101896144|NCT01129934|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101896145|NCT01129934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101896146|NCT01129934|Anesthetics, Local|anesthetics, local|mesh-ancestor
101896147|NCT01129934|Anesthetics|anesthetics|mesh-ancestor
101896148|NCT01129934|Antiemetics|antiemetics|mesh-ancestor
101896149|NCT01129934|Autonomic Agents|autonomic agents|mesh-ancestor
101896150|NCT01129934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101896151|NCT01131572|Acetylcysteine|acetylcysteine|mesh-list
101896152|NCT01131572|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101896153|NCT01131572|Antiviral Agents|antiviral agents|mesh-ancestor
101896154|NCT01131572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101896155|NCT01131572|Expectorants|expectorants|mesh-ancestor
101896156|NCT01131572|Respiratory System Agents|respiratory system agents|mesh-ancestor
101896157|NCT01131572|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101896158|NCT01131572|Antioxidants|antioxidants|mesh-ancestor
101896159|NCT01131572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896160|NCT01131572|Protective Agents|protective agents|mesh-ancestor
101896161|NCT01131572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896162|NCT01131572|Antidotes|antidotes|mesh-ancestor
101896163|NCT01132196|Valproic Acid|valproic acid|mesh-list
101896164|NCT01132196|Anticonvulsants|anticonvulsants|mesh-ancestor
101896165|NCT01132196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101896166|NCT01132196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896167|NCT01132196|GABA Agents|gaba agents|mesh-ancestor
101896168|NCT01132196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101896169|NCT01132196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896170|NCT01132196|Antimanic Agents|antimanic agents|mesh-ancestor
101896171|NCT01132196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101896172|NCT01132196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101896173|NCT01132196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101896174|NCT01228994|Baclofen|baclofen|mesh-list
101896175|NCT01228994|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101896176|NCT01228994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896177|NCT01228994|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101896178|NCT01228994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101896179|NCT01228994|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101896180|NCT01228994|GABA Agonists|gaba agonists|mesh-ancestor
101896181|NCT01228994|GABA Agents|gaba agents|mesh-ancestor
101896182|NCT01228994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101896183|NCT01228994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896184|NCT03927170|Metformin|metformin|mesh-list
101896185|NCT03927170|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101896186|NCT03927170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101896187|NCT03927170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896188|NCT03927170|Incretins|incretins|mesh-ancestor
101896189|NCT03927170|Hormones|hormones|mesh-ancestor
101896190|NCT03927170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101896191|NCT03927170|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101896192|NCT03927170|Protease Inhibitors|protease inhibitors|mesh-ancestor
101896193|NCT03927170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101896194|NCT03927170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896196|NCT01227200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101896197|NCT01227200|Narcotics|narcotics|mesh-ancestor
101896198|NCT01227200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101896199|NCT01227200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896200|NCT01227200|Analgesics|analgesics|mesh-ancestor
101896201|NCT01227200|Sensory System Agents|sensory system agents|mesh-ancestor
101896202|NCT01227200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101896203|NCT01227356|Interferons|interferons|mesh-list
101896204|NCT01227356|Imatinib Mesylate|imatinib mesylate|mesh-list
101896205|NCT01227356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101896206|NCT01227356|Antiviral Agents|antiviral agents|mesh-ancestor
101896207|NCT01227356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101896208|NCT01227356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101896209|NCT01227356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101896210|NCT01227356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896211|NCT01132352|Levetiracetam|levetiracetam|mesh-list
101896212|NCT01132352|Anticonvulsants|anticonvulsants|mesh-ancestor
101896213|NCT01132352|Nootropic Agents|nootropic agents|mesh-ancestor
101896214|NCT01131728|Naproxen|naproxen|mesh-list
101896215|NCT01131728|Pseudoephedrine|pseudoephedrine|mesh-list
101896216|NCT01131728|Ephedrine|ephedrine|mesh-list
101896217|NCT01131728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101896218|NCT01131728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101896219|NCT01131728|Analgesics|analgesics|mesh-ancestor
101896220|NCT01131728|Sensory System Agents|sensory system agents|mesh-ancestor
101896221|NCT01131728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101896222|NCT01131728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896223|NCT01131728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101896224|NCT01131728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101896225|NCT01131728|Gout Suppressants|gout suppressants|mesh-ancestor
101896226|NCT01131728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101896227|NCT01131728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101896228|NCT01131728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896229|NCT01131728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101896230|NCT01131728|Autonomic Agents|autonomic agents|mesh-ancestor
101896231|NCT01131728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101896232|NCT01131728|Respiratory System Agents|respiratory system agents|mesh-ancestor
101896233|NCT01131728|Nasal Decongestants|nasal decongestants|mesh-ancestor
101896234|NCT01131728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101896235|NCT01131728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101896236|NCT01131728|Sympathomimetics|sympathomimetics|mesh-ancestor
101896237|NCT01131728|Adrenergic Agents|adrenergic agents|mesh-ancestor
101896238|NCT01131728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101896239|NCT01132586|Cytarabine|cytarabine|mesh-list
101896240|NCT01132586|Lenalidomide|lenalidomide|mesh-list
101896241|NCT01132586|Idarubicin|idarubicin|mesh-list
101896242|NCT01132586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101896243|NCT01132586|Antimetabolites|antimetabolites|mesh-ancestor
101896244|NCT01132586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896245|NCT01132586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101896246|NCT01132586|Antiviral Agents|antiviral agents|mesh-ancestor
101896247|NCT01132586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101896248|NCT01132586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101896249|NCT01132586|Immunologic Factors|immunologic factors|mesh-ancestor
101689841|NCT04167306|Dopamine Agents|dopamine agents|mesh-ancestor
101896250|NCT01132586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896251|NCT01132586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101896252|NCT01132586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101896253|NCT01132586|Growth Substances|growth substances|mesh-ancestor
101896254|NCT01132586|Growth Inhibitors|growth inhibitors|mesh-ancestor
101896255|NCT01132586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101896256|NCT01132586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101896257|NCT01132586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101896258|NCT01132586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101896259|NCT01130246|Varespladib methyl|varespladib methyl|mesh-list
101896260|NCT01130246|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
101896261|NCT01130246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101896262|NCT01130246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896263|NCT03921086|Antihypertensive Agents|antihypertensive agents|mesh-list
101896264|NCT01227590|Ritonavir|ritonavir|mesh-list
101896265|NCT01227590|Lopinavir|lopinavir|mesh-list
101896266|NCT01227590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101896267|NCT01227590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101896268|NCT01227590|Protease Inhibitors|protease inhibitors|mesh-ancestor
101896269|NCT01227590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101896270|NCT01227590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896271|NCT01227590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101896272|NCT01227590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101896273|NCT01227590|Antiviral Agents|antiviral agents|mesh-ancestor
101896274|NCT01227590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101896275|NCT01227590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101896276|NCT01227590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101896277|NCT03927248|Nivolumab|nivolumab|mesh-list
101896278|NCT03927248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101896279|NCT03927248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101896280|NCT03927248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101896281|NCT03927248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896282|NCT03926780|Warfarin|warfarin|mesh-list
101896283|NCT03926780|Rivaroxaban|rivaroxaban|mesh-list
101896284|NCT03926780|Anticoagulants|anticoagulants|mesh-ancestor
101896285|NCT03926780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101896286|NCT03926780|Antithrombins|antithrombins|mesh-ancestor
101896287|NCT03926780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101896288|NCT03926780|Protease Inhibitors|protease inhibitors|mesh-ancestor
101896289|NCT03926780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101896290|NCT03926780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896291|NCT03926936|Fulvestrant|fulvestrant|mesh-list
101896292|NCT03926936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101896293|NCT03926936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101896294|NCT03926936|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101896295|NCT03926936|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101896296|NCT03926936|Hormone Antagonists|hormone antagonists|mesh-ancestor
101896297|NCT03926936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101896298|NCT03926936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896299|NCT03920618|Tenofovir|tenofovir|mesh-list
101896300|NCT03920618|Entecavir|entecavir|mesh-list
101896301|NCT03920618|Antiviral Agents|antiviral agents|mesh-ancestor
101896302|NCT03920618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101896303|NCT03920618|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101896304|NCT03920618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101896305|NCT03920618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101896306|NCT03920618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896307|NCT03920618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101896308|NCT03920618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101896309|NCT01131806|Fluticasone|fluticasone|mesh-list
101896310|NCT01131806|Xhance|xhance|mesh-list
101896311|NCT01131806|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101896312|NCT01131806|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101896313|NCT01131806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101896314|NCT01131806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101896315|NCT01131806|Autonomic Agents|autonomic agents|mesh-ancestor
101896316|NCT01131806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101896317|NCT01131806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896318|NCT01131806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101896319|NCT01131806|Respiratory System Agents|respiratory system agents|mesh-ancestor
101896320|NCT01131806|Dermatologic Agents|dermatologic agents|mesh-ancestor
101896321|NCT01131806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101896322|NCT01131806|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101896323|NCT01131806|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101896324|NCT01131806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101896325|NCT01131806|Adrenergic Agents|adrenergic agents|mesh-ancestor
101896326|NCT01131806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101896327|NCT01131806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896328|NCT01131806|Glucocorticoids|glucocorticoids|mesh-ancestor
101896329|NCT01131806|Hormones|hormones|mesh-ancestor
101896330|NCT01131806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101896331|NCT01131806|Sympathomimetics|sympathomimetics|mesh-ancestor
101896332|NCT01229930|Paclitaxel|paclitaxel|mesh-list
101896333|NCT01229930|Carboplatin|carboplatin|mesh-list
101896334|NCT01229930|Cediranib|cediranib|mesh-list
101896335|NCT01229930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101896336|NCT01229930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101896337|NCT01229930|Tubulin Modulators|tubulin modulators|mesh-ancestor
101896338|NCT01229930|Antimitotic Agents|antimitotic agents|mesh-ancestor
101896339|NCT01229930|Mitosis Modulators|mitosis modulators|mesh-ancestor
101896340|NCT01229930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616163|NCT00858988|Rifaximin|rifaximin|mesh-list
101896341|NCT01229930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101896342|NCT01229930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101896343|NCT03805100|Ranibizumab|ranibizumab|mesh-list
101896344|NCT03805100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101896345|NCT03805100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101896346|NCT03805100|Growth Substances|growth substances|mesh-ancestor
101896347|NCT03805100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896348|NCT03805100|Growth Inhibitors|growth inhibitors|mesh-ancestor
101896349|NCT03805100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101896350|NCT03920150|Vitamin D|vitamin d|mesh-list
101896351|NCT03920150|Ergocalciferols|ergocalciferols|mesh-list
101896352|NCT03920150|Cholecalciferol|cholecalciferol|mesh-list
101896353|NCT03920150|Vitamins|vitamins|mesh-list
101896354|NCT03920150|Micronutrients|micronutrients|mesh-ancestor
101686086|NCT00620646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101896355|NCT03920150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896356|NCT03920150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101896357|NCT03920150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101896358|NCT01131962|Sclerosing Solutions|sclerosing solutions|mesh-list
101896359|NCT01131962|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101896360|NCT01130324|Telavancin|telavancin|mesh-list
101896361|NCT01130324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101896362|NCT01130324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101896363|NCT01229774|Diclofenac|diclofenac|mesh-list
101896364|NCT01229774|Etoricoxib|etoricoxib|mesh-list
101896365|NCT01229774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101896366|NCT01229774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101896367|NCT01229774|Analgesics|analgesics|mesh-ancestor
101896368|NCT01229774|Sensory System Agents|sensory system agents|mesh-ancestor
101896369|NCT01229774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101896370|NCT01229774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896371|NCT01229774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101896372|NCT01229774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101896373|NCT01229774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101896374|NCT01229774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101896375|NCT01229774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896376|NCT01229774|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101896378|NCT03918590|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101896379|NCT03918590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101896380|NCT03918590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101896381|NCT03918590|Analgesics|analgesics|mesh-ancestor
101896382|NCT03918590|Sensory System Agents|sensory system agents|mesh-ancestor
101896383|NCT03918590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101896384|NCT03918590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896385|NCT03918590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101896386|NCT03918590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101896387|NCT03918590|Laxatives|laxatives|mesh-ancestor
101896389|NCT00320255|Apixaban|apixaban|mesh-list
101896390|NCT00320255|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101896391|NCT00320255|Antithrombins|antithrombins|mesh-ancestor
101896392|NCT00320255|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101896393|NCT00320255|Protease Inhibitors|protease inhibitors|mesh-ancestor
101896394|NCT00320255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101896395|NCT00320255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896396|NCT00320255|Anticoagulants|anticoagulants|mesh-ancestor
101896397|NCT01231802|Leucovorin|leucovorin|mesh-list
101896398|NCT01231802|Fluorouracil|fluorouracil|mesh-list
101896399|NCT01231802|Capecitabine|capecitabine|mesh-list
101896400|NCT01231802|Eniluracil|eniluracil|mesh-list
101896401|NCT01231802|Antimetabolites|antimetabolites|mesh-ancestor
101896402|NCT01231802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896403|NCT01231802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101896404|NCT01231802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101896405|NCT01231802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101896406|NCT01231802|Immunologic Factors|immunologic factors|mesh-ancestor
101896407|NCT01231802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896408|NCT01231802|Antidotes|antidotes|mesh-ancestor
101896409|NCT01231802|Protective Agents|protective agents|mesh-ancestor
101896410|NCT01231802|Vitamin B Complex|vitamin b complex|mesh-ancestor
101896411|NCT01231802|Vitamins|vitamins|mesh-ancestor
101896412|NCT01231802|Micronutrients|micronutrients|mesh-ancestor
101896413|NCT01231802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101896414|NCT01329614|Nicotine|nicotine|mesh-list
101616209|NCT00699478|Vitamin B 12|vitamin b 12|mesh-list
101896415|NCT01329614|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101896416|NCT01329614|Autonomic Agents|autonomic agents|mesh-ancestor
101896417|NCT01329614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101896418|NCT01329614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896419|NCT01329614|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101896420|NCT01329614|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101896421|NCT01329614|Cholinergic Agents|cholinergic agents|mesh-ancestor
101896422|NCT01329614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101896423|NCT01329614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896424|NCT01231880|Piperaquine|piperaquine|mesh-list
101896425|NCT01231880|Artenimol|artenimol|mesh-list
101896426|NCT01231880|Antimalarials|antimalarials|mesh-ancestor
101896427|NCT01231880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101896428|NCT01231880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101896429|NCT01231880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101896430|NCT01232036|Metformin|metformin|mesh-list
101896431|NCT01232036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101896432|NCT01232036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896433|NCT01130636|Oseltamivir|oseltamivir|mesh-list
101896434|NCT01130636|Antiviral Agents|antiviral agents|mesh-ancestor
101896435|NCT01130636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101896436|NCT01130636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101896437|NCT01130636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896438|NCT03926156|Warfarin|warfarin|mesh-list
101896439|NCT03926156|Rivaroxaban|rivaroxaban|mesh-list
101896440|NCT03926156|Anticoagulants|anticoagulants|mesh-ancestor
101896441|NCT03926156|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101896442|NCT03926156|Antithrombins|antithrombins|mesh-ancestor
101896443|NCT03926156|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101896444|NCT03926156|Protease Inhibitors|protease inhibitors|mesh-ancestor
101896445|NCT03926156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101896446|NCT03926156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896447|NCT01134536|Tapentadol|tapentadol|mesh-list
101896448|NCT01134536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101896449|NCT01134536|Narcotics|narcotics|mesh-ancestor
101896450|NCT01134536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101896451|NCT01134536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896452|NCT01134536|Analgesics|analgesics|mesh-ancestor
101896453|NCT01134536|Sensory System Agents|sensory system agents|mesh-ancestor
101896454|NCT01134536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101896455|NCT01134536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101896456|NCT01134536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101896457|NCT01134536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101896458|NCT01134536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896459|NCT01134536|Adrenergic Agents|adrenergic agents|mesh-ancestor
101896460|NCT01134536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101896461|NCT01134692|Norfloxacin|norfloxacin|mesh-list
101896462|NCT01134692|Propranolol|propranolol|mesh-list
101896463|NCT01134692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101896464|NCT01134692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101896465|NCT01134692|Adrenergic Agents|adrenergic agents|mesh-ancestor
101896466|NCT01134692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101896467|NCT01134692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896468|NCT01134692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896469|NCT01134692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101896470|NCT01134692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101896471|NCT01134692|Vasodilator Agents|vasodilator agents|mesh-ancestor
101896472|NCT01134692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101896473|NCT01134692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101896474|NCT01134692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101896475|NCT01134692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101896476|NCT01134692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101896477|NCT01134692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101896478|NCT01134692|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101896479|NCT01134692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101896480|NCT01134848|Morphine|morphine|mesh-list
101896481|NCT01134848|Secretin|secretin|mesh-list
101896482|NCT01134848|Neostigmine|neostigmine|mesh-list
101896483|NCT01134848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101896484|NCT01134848|Narcotics|narcotics|mesh-ancestor
101896485|NCT01134848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101896486|NCT01134848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896487|NCT01134848|Analgesics|analgesics|mesh-ancestor
101896488|NCT01134848|Sensory System Agents|sensory system agents|mesh-ancestor
101896489|NCT01134848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101896490|NCT01134848|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101896491|NCT01134848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101969512|NCT00462202|Anticoagulants|anticoagulants|mesh-ancestor
101896492|NCT01134848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896493|NCT01134848|Cholinergic Agents|cholinergic agents|mesh-ancestor
101896494|NCT01134848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101896495|NCT01134848|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101896496|NCT01134848|Autonomic Agents|autonomic agents|mesh-ancestor
101896497|NCT01134848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101896498|NCT01134848|Hormones|hormones|mesh-ancestor
101896499|NCT01134848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101896500|NCT03926000|Pregabalin|pregabalin|mesh-list
101896501|NCT03926000|Analgesics|analgesics|mesh-ancestor
101896502|NCT03926000|Sensory System Agents|sensory system agents|mesh-ancestor
101896503|NCT03926000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101896504|NCT03926000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896505|NCT03926000|Anticonvulsants|anticonvulsants|mesh-ancestor
101896506|NCT03926000|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101896507|NCT03926000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101896508|NCT03926000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896509|NCT03926000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101896510|NCT03926000|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101896511|NCT03926000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101896512|NCT03926000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101896513|NCT03926000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101896514|NCT01134926|Misoprostol|misoprostol|mesh-list
101896515|NCT01134926|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101896516|NCT01134926|Abortifacient Agents|abortifacient agents|mesh-ancestor
101896517|NCT01134926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101896518|NCT01134926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896519|NCT01134926|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101896520|NCT01134926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101896521|NCT01134926|Oxytocics|oxytocics|mesh-ancestor
101896522|NCT01228136|Tranexamic Acid|tranexamic acid|mesh-list
101896523|NCT01228136|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101896524|NCT01228136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101896525|NCT01228136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896526|NCT01228136|Hemostatics|hemostatics|mesh-ancestor
101896527|NCT01228136|Coagulants|coagulants|mesh-ancestor
101896528|NCT03140176|Sunitinib|sunitinib|mesh-list
101896529|NCT03140176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101896530|NCT03140176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101896531|NCT03140176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101896532|NCT03140176|Growth Substances|growth substances|mesh-ancestor
101896533|NCT03140176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896534|NCT03140176|Growth Inhibitors|growth inhibitors|mesh-ancestor
101896535|NCT03140176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101896537|NCT03140176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896538|NCT04259164|Mometasone Furoate|mometasone furoate|mesh-list
101896539|NCT04259164|Glycopyrrolate|glycopyrrolate|mesh-list
101896540|NCT04259164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101896541|NCT04259164|Dermatologic Agents|dermatologic agents|mesh-ancestor
101896542|NCT04259164|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101896543|NCT04259164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101896544|NCT04259164|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101896545|NCT04259164|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101896546|NCT04259164|Cholinergic Agents|cholinergic agents|mesh-ancestor
101896547|NCT04259164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101896548|NCT04259164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896549|NCT04259164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896550|NCT01230476|Cetuximab|cetuximab|mesh-list
101896551|NCT01230476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101896552|NCT01230476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101896553|NCT01135472|Esomeprazole|esomeprazole|mesh-list
101896554|NCT01135472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101686128|NCT04209426|Cholinergic Agents|cholinergic agents|mesh-ancestor
101896555|NCT01135472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101896556|NCT01135472|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101896557|NCT01135472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101896558|NCT01135472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896559|NCT01133210|Maraviroc|maraviroc|mesh-list
101896560|NCT01133210|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101896561|NCT01133210|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101896562|NCT01133210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896563|NCT01133210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101896564|NCT01133210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101896566|NCT01133210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101896567|NCT01133210|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101896568|NCT01135550|Dexamethasone|dexamethasone|mesh-list
101896569|NCT01135550|Dexamethasone acetate|dexamethasone acetate|mesh-list
101896570|NCT01135550|BB 1101|bb 1101|mesh-list
101896571|NCT01135550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101896572|NCT01135550|Antiemetics|antiemetics|mesh-ancestor
101896573|NCT01135550|Autonomic Agents|autonomic agents|mesh-ancestor
101896574|NCT01135550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101896575|NCT01135550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896576|NCT01135550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101896577|NCT01135550|Glucocorticoids|glucocorticoids|mesh-ancestor
101896578|NCT01135550|Hormones|hormones|mesh-ancestor
101896579|NCT01135550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101896580|NCT01135550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101896581|NCT01135550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101896582|NCT01135550|Protease Inhibitors|protease inhibitors|mesh-ancestor
101896583|NCT01135550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101896584|NCT01135550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896585|NCT05401370|Methylene Blue|methylene blue|mesh-list
101896586|NCT05401370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101896587|NCT05401370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896588|NCT01131026|Amoxicillin|amoxicillin|mesh-list
101896589|NCT01131026|Levofloxacin|levofloxacin|mesh-list
101896590|NCT01131026|Lansoprazole|lansoprazole|mesh-list
101896591|NCT01131026|Dexlansoprazole|dexlansoprazole|mesh-list
101896592|NCT01131026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101896593|NCT01131026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101896594|NCT01131026|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101896595|NCT01131026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101896596|NCT01131026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101896597|NCT01131026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101896598|NCT01131026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896599|NCT01131026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101896600|NCT01131026|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101896601|NCT01131026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101896602|NCT01131026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101896603|NCT01131026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101896604|NCT01131026|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101896605|NCT01135628|Nitazoxanide|nitazoxanide|mesh-list
101896606|NCT01135628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101896607|NCT01135628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101896609|NCT01133366|Mipomersen|mipomersen|mesh-list
101896610|NCT01133366|Anticoagulants|anticoagulants|mesh-ancestor
101896611|NCT01133366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101896612|NCT01133366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101896613|NCT01133366|Antimetabolites|antimetabolites|mesh-ancestor
101896614|NCT01133366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896615|NCT01133366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101896616|NCT01232270|Propofol|propofol|mesh-list
101896617|NCT01232270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101896618|NCT01232270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101896619|NCT01232270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896620|NCT01232270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101896621|NCT01232270|Anesthetics, General|anesthetics, general|mesh-ancestor
101896622|NCT01232270|Anesthetics|anesthetics|mesh-ancestor
101896623|NCT05400902|Apatinib|apatinib|mesh-list
101896624|NCT05400902|Tislelizumab|tislelizumab|mesh-list
101896625|NCT05400902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101896626|NCT05400902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101896627|NCT05400902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101896628|NCT05400902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896629|NCT05400902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101896630|NCT01233206|Metformin|metformin|mesh-list
101896631|NCT01233206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101896632|NCT01233206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896633|NCT00369941|Tenofovir|tenofovir|mesh-list
101896634|NCT00369941|Emtricitabine|emtricitabine|mesh-list
101896635|NCT00369941|Efavirenz|efavirenz|mesh-list
101896636|NCT00369941|Raltegravir Potassium|raltegravir potassium|mesh-list
101896637|NCT00369941|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101896638|NCT00369941|Antiviral Agents|antiviral agents|mesh-ancestor
101896639|NCT00369941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101896640|NCT00369941|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101896641|NCT00369941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101896643|NCT00369941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896644|NCT00369941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101896645|NCT00369941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101896646|NCT00369941|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101896647|NCT00369941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101896648|NCT00369941|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101896649|NCT00369941|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101896650|NCT00369941|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101896651|NCT00369941|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101896652|NCT00369941|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101896653|NCT00369941|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101896654|NCT01133444|Finasteride|finasteride|mesh-list
101896655|NCT01133444|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101896656|NCT01133444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101896657|NCT01133444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101896658|NCT01133444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896659|NCT01133444|Hormone Antagonists|hormone antagonists|mesh-ancestor
101896660|NCT01133444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101896661|NCT01133444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896662|NCT01133444|Urological Agents|urological agents|mesh-ancestor
101896663|NCT01137656|Acetylcholine|acetylcholine|mesh-list
101896664|NCT01137656|Vasodilator Agents|vasodilator agents|mesh-ancestor
101896665|NCT01137656|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101896666|NCT01137656|Cholinergic Agents|cholinergic agents|mesh-ancestor
101896667|NCT01137656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101896668|NCT01137656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896669|NCT01137656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896670|NCT00369785|Donepezil|donepezil|mesh-list
101896671|NCT00369785|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101896672|NCT00369785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101896673|NCT00369785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896674|NCT00369785|Cholinergic Agents|cholinergic agents|mesh-ancestor
101689863|NCT04244591|Glucocorticoids|glucocorticoids|mesh-ancestor
101896675|NCT00369785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101896676|NCT00369785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896677|NCT00369785|Nootropic Agents|nootropic agents|mesh-ancestor
101896678|NCT05476562|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101896679|NCT05476562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101896680|NCT05476562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101896681|NCT05476562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896683|NCT01136252|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101896684|NCT01136252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101896685|NCT01136252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101896686|NCT00369707|Rituximab|rituximab|mesh-list
101896687|NCT00369707|Bortezomib|bortezomib|mesh-list
101896688|NCT00369707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101896689|NCT00369707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101896690|NCT00369707|Immunologic Factors|immunologic factors|mesh-ancestor
101896691|NCT00369707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896692|NCT00369707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101896693|NCT01232660|Hydroxychloroquine|hydroxychloroquine|mesh-list
101896694|NCT01232660|Antimalarials|antimalarials|mesh-ancestor
101896695|NCT01232660|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101896696|NCT01232660|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101896697|NCT01232660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101896698|NCT01232660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101896699|NCT01232660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896700|NCT01232660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101896701|NCT01233362|Vaccines|vaccines|mesh-list
101896702|NCT01233362|Immunologic Factors|immunologic factors|mesh-ancestor
101896703|NCT01233362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896704|NCT01136642|Nicotine|nicotine|mesh-list
101896705|NCT01136642|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101896706|NCT01136642|Autonomic Agents|autonomic agents|mesh-ancestor
101896707|NCT01136642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101896708|NCT01136642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896709|NCT01136642|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101896710|NCT01136642|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101896711|NCT01136642|Cholinergic Agents|cholinergic agents|mesh-ancestor
101896712|NCT01136642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101896713|NCT01136642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896714|NCT00369629|Gemcitabine|gemcitabine|mesh-list
101896716|NCT00369629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101896717|NCT00369629|Antimetabolites|antimetabolites|mesh-ancestor
101616515|NCT02605213|Vancomycin|vancomycin|mesh-list
101896718|NCT00369629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896719|NCT00369629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101896720|NCT00369629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101896721|NCT00369629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101896722|NCT00369629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101896723|NCT01133600|Vancomycin|vancomycin|mesh-list
101896724|NCT01133600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101896725|NCT01133600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101896726|NCT01133912|Paclitaxel|paclitaxel|mesh-list
101896727|NCT01133912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101896728|NCT01133912|Gemcitabine|gemcitabine|mesh-list
101896729|NCT01133912|Lapatinib|lapatinib|mesh-list
101896730|NCT01133912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101896731|NCT01133912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101896732|NCT01133912|Tubulin Modulators|tubulin modulators|mesh-ancestor
101896733|NCT01133912|Antimitotic Agents|antimitotic agents|mesh-ancestor
101896734|NCT01133912|Mitosis Modulators|mitosis modulators|mesh-ancestor
101686176|NCT04019015|Thrombin|thrombin|mesh-list
101896735|NCT01133912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896736|NCT01133912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101896737|NCT01133912|Antimetabolites|antimetabolites|mesh-ancestor
101896738|NCT01133912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101896739|NCT01133912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101896740|NCT05320094|Sorbitol|sorbitol|mesh-list
101896741|NCT05320094|Charcoal|charcoal|mesh-list
101896742|NCT05320094|Antidotes|antidotes|mesh-ancestor
101896743|NCT05320094|Protective Agents|protective agents|mesh-ancestor
101896744|NCT05320094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896745|NCT05320094|Cathartics|cathartics|mesh-ancestor
101896746|NCT05320094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101896747|NCT01233752|Morphine|morphine|mesh-list
101896748|NCT01233752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101896749|NCT01233752|Narcotics|narcotics|mesh-ancestor
101896750|NCT01233752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101896751|NCT01233752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896752|NCT01233752|Analgesics|analgesics|mesh-ancestor
101896753|NCT01233752|Sensory System Agents|sensory system agents|mesh-ancestor
101896754|NCT01233752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101896755|NCT01140620|Ketamine|ketamine|mesh-list
101896756|NCT01140620|Risperidone|risperidone|mesh-list
101896757|NCT01140620|Analgesics|analgesics|mesh-ancestor
101896758|NCT01140620|Sensory System Agents|sensory system agents|mesh-ancestor
101896759|NCT01140620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101896760|NCT01140620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896761|NCT01140620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101896762|NCT01140620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101896763|NCT01140620|Anesthetics, General|anesthetics, general|mesh-ancestor
101896764|NCT01140620|Anesthetics|anesthetics|mesh-ancestor
101896765|NCT01140620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101896766|NCT01140620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101896767|NCT01140620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101896768|NCT01140620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101896769|NCT01140620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896770|NCT01140620|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101896771|NCT01140620|Serotonin Agents|serotonin agents|mesh-ancestor
101896772|NCT01140620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101896773|NCT01140620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101896774|NCT01140620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101896775|NCT01140620|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101896776|NCT01140620|Dopamine Agents|dopamine agents|mesh-ancestor
101896777|NCT03917186|Sevoflurane|sevoflurane|mesh-list
101896778|NCT03917186|Desflurane|desflurane|mesh-list
101896779|NCT03917186|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101896780|NCT03917186|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101896781|NCT03917186|Anesthetics, General|anesthetics, general|mesh-ancestor
101896782|NCT03917186|Anesthetics|anesthetics|mesh-ancestor
101896783|NCT03917186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101896784|NCT03917186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896785|NCT04713098|Coal Tar|coal tar|mesh-list
101896786|NCT04713098|Keratolytic Agents|keratolytic agents|mesh-ancestor
101896787|NCT04713098|Dermatologic Agents|dermatologic agents|mesh-ancestor
101896788|NCT01140932|Prednisolone|prednisolone|mesh-list
101896789|NCT01140932|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101896790|NCT01140932|Methylprednisolone|methylprednisolone|mesh-list
101896791|NCT01140932|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101896792|NCT01140932|Prednisolone acetate|prednisolone acetate|mesh-list
101896793|NCT01140932|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101896794|NCT01140932|Prednisolone phosphate|prednisolone phosphate|mesh-list
101896795|NCT01140932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101896796|NCT01140932|Glucocorticoids|glucocorticoids|mesh-ancestor
101896797|NCT01140932|Hormones|hormones|mesh-ancestor
101896798|NCT01140932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101896799|NCT01140932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896800|NCT01140932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101896801|NCT01140932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101896802|NCT01140932|Antiemetics|antiemetics|mesh-ancestor
101896803|NCT01140932|Autonomic Agents|autonomic agents|mesh-ancestor
101896804|NCT01140932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101896805|NCT01140932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101896806|NCT01140932|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101896807|NCT01140932|Protective Agents|protective agents|mesh-ancestor
101896808|NCT01138904|Oxaliplatin|oxaliplatin|mesh-list
101896809|NCT01138904|Irinotecan|irinotecan|mesh-list
101896810|NCT01138904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101896811|NCT01138904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101896812|NCT01138904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101896813|NCT01138904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101896814|NCT01138904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896815|NCT04582448|Insulin|insulin|mesh-list
101896816|NCT04582448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101896817|NCT04582448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896818|NCT05280314|Pembrolizumab|pembrolizumab|mesh-list
101896819|NCT05280314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101896820|NCT05280314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101896821|NCT05280314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101689870|NCT02649582|Temozolomide|temozolomide|mesh-list
101896822|NCT05280314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896823|NCT01139138|Irinotecan|irinotecan|mesh-list
101896824|NCT01139138|Everolimus|everolimus|mesh-list
101896825|NCT01139138|Panitumumab|panitumumab|mesh-list
101896826|NCT01139138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101896827|NCT01139138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101896828|NCT01139138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101896829|NCT01139138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896830|NCT01139138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101896831|NCT01139138|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101896832|NCT01139138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101896833|NCT01139138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101896834|NCT01139138|Immunologic Factors|immunologic factors|mesh-ancestor
101896835|NCT01139138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896836|NCT01139138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101896837|NCT01134224|Insulin|insulin|mesh-list
101896838|NCT01134224|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101896839|NCT01134224|Insulin Aspart|insulin aspart|mesh-list
101896840|NCT01134224|Insulin, Long-Acting|insulin, long-acting|mesh-list
101896841|NCT01134224|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101896842|NCT01134224|Biphasic Insulins|biphasic insulins|mesh-list
101896843|NCT01134224|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101896844|NCT01134224|Insulin, Isophane|insulin, isophane|mesh-list
101896845|NCT01134224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101969536|NCT00535366|Tiotropium Bromide|tiotropium bromide|mesh-list
101896846|NCT01134224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896847|NCT05308888|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101896848|NCT05308888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101896849|NCT05308888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896851|NCT01231490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101896852|NCT01231490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101896853|NCT01231490|Analgesics|analgesics|mesh-ancestor
101896854|NCT01231490|Sensory System Agents|sensory system agents|mesh-ancestor
101896855|NCT01231490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101896856|NCT01231490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686197|NCT02847455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101896857|NCT01231490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101896858|NCT01231490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101896859|NCT01231490|Gout Suppressants|gout suppressants|mesh-ancestor
101896860|NCT01231490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101896861|NCT01231490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101896862|NCT01231490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896863|NCT01141244|Sirolimus|sirolimus|mesh-list
101896864|NCT01141244|Irinotecan|irinotecan|mesh-list
101896865|NCT01141244|Temozolomide|temozolomide|mesh-list
101896866|NCT01141244|Temsirolimus|temsirolimus|mesh-list
101896867|NCT01141244|MTOR Inhibitors|mtor inhibitors|mesh-list
101896868|NCT01141244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101896869|NCT01141244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101896870|NCT01141244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101896871|NCT01141244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896872|NCT01141244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101896873|NCT01141244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101896874|NCT01141244|Alkylating Agents|alkylating agents|mesh-ancestor
101896875|NCT01141244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101896876|NCT01141244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101896877|NCT01141244|Immunologic Factors|immunologic factors|mesh-ancestor
101896878|NCT01141244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896879|NCT01141244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101896880|NCT01141244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101896881|NCT01141244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101896882|NCT01141244|Antifungal Agents|antifungal agents|mesh-ancestor
101896883|NCT01141322|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101896884|NCT01141322|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101896885|NCT01141322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101896886|NCT01141556|Selenium|selenium|mesh-list
101896887|NCT01141556|Antioxidants|antioxidants|mesh-ancestor
101896888|NCT01141556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896889|NCT01141556|Protective Agents|protective agents|mesh-ancestor
101896890|NCT01141556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896891|NCT01141556|Trace Elements|trace elements|mesh-ancestor
101896892|NCT01141556|Micronutrients|micronutrients|mesh-ancestor
101896893|NCT01139372|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101896894|NCT01139372|Lubricant Eye Drops|lubricant eye drops|mesh-list
101896895|NCT01139372|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101896896|NCT03638440|Naloxegol|naloxegol|mesh-list
101896897|NCT03638440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101896898|NCT03638440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896899|NCT03638440|Sensory System Agents|sensory system agents|mesh-ancestor
101896900|NCT03638440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101896901|NCT01719640|Insulin|insulin|mesh-list
101896902|NCT01719640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101896903|NCT01719640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896904|NCT02439658|Sotalol|sotalol|mesh-list
101896905|NCT02439658|Dofetilide|dofetilide|mesh-list
101896906|NCT02439658|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101896907|NCT02439658|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101896908|NCT02439658|Adrenergic Agents|adrenergic agents|mesh-ancestor
101896909|NCT02439658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101896910|NCT02439658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896911|NCT02439658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896912|NCT02439658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101896913|NCT02439658|Sympatholytics|sympatholytics|mesh-ancestor
101896914|NCT02439658|Autonomic Agents|autonomic agents|mesh-ancestor
101896915|NCT02439658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101896916|NCT02439658|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101896917|NCT02439658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101896918|NCT05191394|Antibodies|antibodies|mesh-list
101896919|NCT05191394|Immunologic Factors|immunologic factors|mesh-ancestor
101896920|NCT05191394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896921|NCT04895098|Ezetimibe|ezetimibe|mesh-list
101896922|NCT04895098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
101896923|NCT04895098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101896924|NCT04895098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101896925|NCT04895098|Antimetabolites|antimetabolites|mesh-ancestor
101896926|NCT04895098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896927|NCT04895098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101896928|NCT04895098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101896929|NCT00318461|Metformin|metformin|mesh-list
101896930|NCT00318461|Liraglutide|liraglutide|mesh-list
101896931|NCT00318461|Glimepiride|glimepiride|mesh-list
101896932|NCT00318461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101896933|NCT00318461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896934|NCT00318461|Incretins|incretins|mesh-ancestor
101896935|NCT00318461|Hormones|hormones|mesh-ancestor
101896936|NCT00318461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101896937|NCT00318461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101896938|NCT00318461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101896939|NCT00318461|Immunologic Factors|immunologic factors|mesh-ancestor
101896940|NCT01142258|Trazodone|trazodone|mesh-list
101896941|NCT01142258|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101896942|NCT01142258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101896943|NCT01142258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101616729|NCT02617810|GABA Modulators|gaba modulators|mesh-ancestor
101896944|NCT01142258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896945|NCT01142258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101896946|NCT01142258|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101896947|NCT01142258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101896948|NCT01142258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101896949|NCT01142258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896950|NCT01142258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101896951|NCT01142258|Serotonin Agents|serotonin agents|mesh-ancestor
101896952|NCT01142258|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101896953|NCT01142258|Antidepressive Agents|antidepressive agents|mesh-ancestor
101896955|NCT05152940|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101896956|NCT05152940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896957|NCT05152940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101896958|NCT05152940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896959|NCT01139840|Vitamin D|vitamin d|mesh-list
101896960|NCT01139840|Ergocalciferols|ergocalciferols|mesh-list
101896961|NCT01139840|Cholecalciferol|cholecalciferol|mesh-list
101896962|NCT01139840|Vitamins|vitamins|mesh-list
101896963|NCT01139840|Micronutrients|micronutrients|mesh-ancestor
101896964|NCT01139840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896965|NCT01139840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101896966|NCT01139840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101896967|NCT02945410|Vitamin D|vitamin d|mesh-list
101896968|NCT02945410|Calcium|calcium|mesh-list
101896969|NCT02945410|Vitamins|vitamins|mesh-ancestor
101896970|NCT02945410|Micronutrients|micronutrients|mesh-ancestor
101896971|NCT02945410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896972|NCT02945410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101896973|NCT02945410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101896974|NCT03727724|Cetuximab|cetuximab|mesh-list
101896975|NCT03727724|Afatinib|afatinib|mesh-list
101896976|NCT03727724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101896977|NCT03727724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101896978|NCT03727724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101896979|NCT03727724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101896980|NCT03727724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896981|NCT05032508|Lidocaine|lidocaine|mesh-list
101896982|NCT05032508|Anesthetics, Local|anesthetics, local|mesh-ancestor
101896983|NCT05032508|Anesthetics|anesthetics|mesh-ancestor
101896984|NCT05032508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101896985|NCT05032508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896986|NCT05032508|Sensory System Agents|sensory system agents|mesh-ancestor
101896987|NCT05032508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101896988|NCT05032508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101896989|NCT05032508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101896990|NCT05032508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101896991|NCT05032508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101896992|NCT05032508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101896993|NCT01140074|Zinc Sulfate|zinc sulfate|mesh-list
101896994|NCT01140074|Astringents|astringents|mesh-ancestor
101896995|NCT01140074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101896996|NCT01140074|Dermatologic Agents|dermatologic agents|mesh-ancestor
101896997|NCT03913442|Colchicine|colchicine|mesh-list
101896998|NCT03913442|Gout Suppressants|gout suppressants|mesh-ancestor
101896999|NCT03913442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101897000|NCT03913442|Tubulin Modulators|tubulin modulators|mesh-ancestor
101897001|NCT03913442|Antimitotic Agents|antimitotic agents|mesh-ancestor
101897002|NCT03913442|Mitosis Modulators|mitosis modulators|mesh-ancestor
101897003|NCT03913442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897004|NCT03913442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101897005|NCT01142414|Fluorouracil|fluorouracil|mesh-list
101897006|NCT01142414|Panitumumab|panitumumab|mesh-list
101897007|NCT01142414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101897008|NCT01142414|Antimetabolites|antimetabolites|mesh-ancestor
101897009|NCT01142414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897010|NCT01142414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101897011|NCT01142414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101897012|NCT01142414|Immunologic Factors|immunologic factors|mesh-ancestor
101897013|NCT01142414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897014|NCT01142414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101897015|NCT01236482|Oxytocin|oxytocin|mesh-list
101897016|NCT01236482|Ergonovine|ergonovine|mesh-list
101897017|NCT01236482|Oxytocics|oxytocics|mesh-ancestor
101897018|NCT01236482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101616805|NCT00895245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101897019|NCT01236482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897020|NCT01142492|Interferons|interferons|mesh-list
101897021|NCT01142492|Interferon-beta|interferon-beta|mesh-list
101897022|NCT01142492|Interferon beta-1a|interferon beta-1a|mesh-list
101897023|NCT01142492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101897024|NCT01142492|Antiviral Agents|antiviral agents|mesh-ancestor
101897025|NCT01142492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101897026|NCT01142492|Immunologic Factors|immunologic factors|mesh-ancestor
101897027|NCT01142492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897028|NCT01142492|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101897029|NCT03958474|Remifentanil|remifentanil|mesh-list
101897030|NCT03958474|Oxycodone|oxycodone|mesh-list
101897031|NCT03958474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101897032|NCT03958474|Narcotics|narcotics|mesh-ancestor
101897033|NCT03958474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101897034|NCT03958474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897035|NCT03958474|Analgesics|analgesics|mesh-ancestor
101897036|NCT03958474|Sensory System Agents|sensory system agents|mesh-ancestor
101897037|NCT03958474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101897038|NCT04956692|Paclitaxel|paclitaxel|mesh-list
101897039|NCT04956692|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101897040|NCT04956692|Carboplatin|carboplatin|mesh-list
101897041|NCT04956692|Pembrolizumab|pembrolizumab|mesh-list
101897042|NCT04956692|Pemetrexed|pemetrexed|mesh-list
101897043|NCT04956692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101897044|NCT04956692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101897045|NCT04956692|Tubulin Modulators|tubulin modulators|mesh-ancestor
101897046|NCT04956692|Antimitotic Agents|antimitotic agents|mesh-ancestor
101897047|NCT04956692|Mitosis Modulators|mitosis modulators|mesh-ancestor
101897048|NCT04956692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897049|NCT04956692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101897050|NCT04956692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101897051|NCT04956692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101897052|NCT04956692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101897053|NCT04956692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101897054|NCT01234142|Varenicline|varenicline|mesh-list
101897055|NCT01234142|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101897056|NCT01234142|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101897057|NCT01234142|Cholinergic Agents|cholinergic agents|mesh-ancestor
101897058|NCT01234142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101897059|NCT01234142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897060|NCT01234142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897061|NCT01140308|Ubiquinone|ubiquinone|mesh-list
101897062|NCT01140308|Coenzyme Q10|coenzyme q10|mesh-list
101897063|NCT01140308|Micronutrients|micronutrients|mesh-ancestor
101897064|NCT01140308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897065|NCT01140308|Vitamins|vitamins|mesh-ancestor
101897066|NCT01142648|Glycopyrrolate|glycopyrrolate|mesh-list
101897067|NCT01142648|Neostigmine|neostigmine|mesh-list
101897068|NCT01142648|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101897069|NCT01142648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101897070|NCT01142648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897071|NCT01142648|Cholinergic Agents|cholinergic agents|mesh-ancestor
101897072|NCT01142648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101897073|NCT01142648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897074|NCT01142648|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101897075|NCT01142648|Autonomic Agents|autonomic agents|mesh-ancestor
101897076|NCT01142648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101897077|NCT01142648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101897078|NCT01142648|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101897079|NCT01142648|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101897080|NCT02143726|Everolimus|everolimus|mesh-list
101897081|NCT02143726|Sorafenib|sorafenib|mesh-list
101897082|NCT02143726|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101897083|NCT02143726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101897084|NCT02143726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101897085|NCT02143726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897086|NCT02143726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101897087|NCT02143726|Immunologic Factors|immunologic factors|mesh-ancestor
101897088|NCT02143726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897089|NCT02143726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101897090|NCT03503864|Arsenic Trioxide|arsenic trioxide|mesh-list
101897091|NCT03503864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101897092|NCT02088112|Durvalumab|durvalumab|mesh-list
101897093|NCT02088112|Gefitinib|gefitinib|mesh-list
101897094|NCT02088112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101897095|NCT02088112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101616903|NCT00899847|Melphalan|melphalan|mesh-list
101897096|NCT02088112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101897097|NCT02088112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101897098|NCT02088112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897099|NCT01144910|Methacholine Chloride|methacholine chloride|mesh-list
101897101|NCT01144910|Autonomic Agents|autonomic agents|mesh-ancestor
101897102|NCT01144910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101897103|NCT01144910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897104|NCT01144910|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101897105|NCT01144910|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
101897106|NCT01144910|Respiratory System Agents|respiratory system agents|mesh-ancestor
101897107|NCT01144910|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101897108|NCT01144910|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101897109|NCT01144910|Cholinergic Agents|cholinergic agents|mesh-ancestor
101897110|NCT01144910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101897111|NCT01144910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897112|NCT01234298|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101897113|NCT01234298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101897114|NCT01234298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897115|NCT01234298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101897116|NCT01234298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101897117|NCT01234298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101897118|NCT01234298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897119|NCT01234298|Dopamine Agents|dopamine agents|mesh-ancestor
101897120|NCT01234298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101897121|NCT05308342|Hormones|hormones|mesh-list
101897122|NCT05308342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101897123|NCT05308342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897124|NCT03332212|Empagliflozin|empagliflozin|mesh-list
101897125|NCT03332212|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101897126|NCT03332212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897127|NCT03332212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101897128|NCT03332212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897129|NCT01144988|Bevacizumab|bevacizumab|mesh-list
101897130|NCT01144988|Irinotecan|irinotecan|mesh-list
101897131|NCT01144988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101897132|NCT01144988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101897133|NCT01144988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101897134|NCT01144988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101897135|NCT01144988|Growth Substances|growth substances|mesh-ancestor
101897136|NCT01144988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897137|NCT01144988|Growth Inhibitors|growth inhibitors|mesh-ancestor
101897138|NCT01144988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101897139|NCT01144988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101897140|NCT01144988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101897141|NCT01144988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897142|NCT03331666|Evolocumab|evolocumab|mesh-list
101897143|NCT03331666|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101897144|NCT03331666|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101897145|NCT03331666|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101897146|NCT03331666|Antimetabolites|antimetabolites|mesh-ancestor
101897147|NCT03331666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897148|NCT03331666|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101897149|NCT03331666|Protease Inhibitors|protease inhibitors|mesh-ancestor
101897150|NCT03331666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101897151|NCT03331666|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101897152|NCT04828538|Vitamin D|vitamin d|mesh-list
101897153|NCT04828538|Vitamins|vitamins|mesh-list
101897154|NCT04828538|Folic Acid|folic acid|mesh-list
101897155|NCT04828538|Vitamin B Complex|vitamin b complex|mesh-list
101897156|NCT04828538|Micronutrients|micronutrients|mesh-ancestor
101897157|NCT04828538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897158|NCT04828538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101897159|NCT04828538|Hematinics|hematinics|mesh-ancestor
101897160|NCT01145144|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101897161|NCT01145144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101897162|NCT01145144|Immunologic Factors|immunologic factors|mesh-ancestor
101897163|NCT01145144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897164|NCT03638206|Immunomodulating Agents|immunomodulating agents|mesh-list
101897165|NCT03638206|Immunologic Factors|immunologic factors|mesh-ancestor
101897166|NCT03638206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897167|NCT00566488|Parathyroid Hormone|parathyroid hormone|mesh-list
101897168|NCT00566488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101897169|NCT00566488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897170|NCT04943302|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101897171|NCT04943302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101897172|NCT04943302|Alkylating Agents|alkylating agents|mesh-ancestor
101897173|NCT04943302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897174|NCT04943302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101897176|NCT01234454|Risperidone|risperidone|mesh-list
101897177|NCT01234454|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101897178|NCT01234454|Serotonin Agents|serotonin agents|mesh-ancestor
101897179|NCT01234454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101897180|NCT01234454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897181|NCT01234454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897182|NCT01234454|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101897183|NCT01234454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101897184|NCT01234454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101897185|NCT01234454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101897186|NCT01234454|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101897187|NCT01234454|Dopamine Agents|dopamine agents|mesh-ancestor
101897188|NCT01234454|Antiemetics|antiemetics|mesh-ancestor
101897189|NCT01234454|Autonomic Agents|autonomic agents|mesh-ancestor
101897190|NCT01234454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101897191|NCT01234454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101897192|NCT01234454|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101897193|NCT01234454|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101897194|NCT01234454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101897195|NCT01145456|Gemcitabine|gemcitabine|mesh-list
101897196|NCT01145456|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
101897197|NCT01145456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101897198|NCT01145456|Antimetabolites|antimetabolites|mesh-ancestor
101897199|NCT01145456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897200|NCT01145456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101897201|NCT01145456|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101897202|NCT01145456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101897203|NCT04939636|Vitamin D|vitamin d|mesh-list
101897204|NCT04939636|Ergocalciferols|ergocalciferols|mesh-list
101897205|NCT04939636|Cholecalciferol|cholecalciferol|mesh-list
101897206|NCT04939636|Vitamins|vitamins|mesh-list
101897207|NCT04939636|Micronutrients|micronutrients|mesh-ancestor
101897208|NCT04939636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897209|NCT04939636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101897210|NCT04939636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101897211|NCT01238276|Cefazolin|cefazolin|mesh-list
101897212|NCT01238276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101897213|NCT01238276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101897214|NCT01145534|Glyburide|glyburide|mesh-list
101897215|NCT01145534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101897216|NCT01145534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897217|NCT01145612|Losartan|losartan|mesh-list
101897218|NCT01145612|Atenolol|atenolol|mesh-list
101897219|NCT01145612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101897220|NCT01145612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101686285|NCT01497509|Anesthetics, General|anesthetics, general|mesh-ancestor
101897221|NCT01145612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101897222|NCT01145612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101897223|NCT01145612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897224|NCT01145612|Sympatholytics|sympatholytics|mesh-ancestor
101897225|NCT01145612|Autonomic Agents|autonomic agents|mesh-ancestor
101897226|NCT01145612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101897227|NCT01145612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897228|NCT01145612|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101897229|NCT01145612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101897230|NCT01145612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101897231|NCT01145612|Adrenergic Agents|adrenergic agents|mesh-ancestor
101897232|NCT01145612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101897233|NCT05293366|Dermatologic Agents|dermatologic agents|mesh-list
101897234|NCT03621670|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101897235|NCT03621670|Immunologic Factors|immunologic factors|mesh-ancestor
101897236|NCT03621670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897237|NCT01143584|Dopamine|dopamine|mesh-list
101897238|NCT01143584|Cabergoline|cabergoline|mesh-list
101897239|NCT01143584|Dopamine Agonists|dopamine agonists|mesh-list
101897240|NCT01143584|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101897241|NCT01143584|Sympathomimetics|sympathomimetics|mesh-ancestor
101897242|NCT01143584|Autonomic Agents|autonomic agents|mesh-ancestor
101897243|NCT01143584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101897244|NCT01143584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897245|NCT01143584|Dopamine Agents|dopamine agents|mesh-ancestor
101897246|NCT01143584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101897247|NCT01143584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897248|NCT01143584|Protective Agents|protective agents|mesh-ancestor
101897249|NCT01143584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101897250|NCT01143584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101897251|NCT01145846|Cytarabine|cytarabine|mesh-list
101897252|NCT01145846|Daunorubicin|daunorubicin|mesh-list
101897253|NCT01145846|Idarubicin|idarubicin|mesh-list
101897254|NCT01145846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101897255|NCT01145846|Antimetabolites|antimetabolites|mesh-ancestor
101689883|NCT04167696|Alkylating Agents|alkylating agents|mesh-ancestor
101897256|NCT01145846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897257|NCT01145846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101897258|NCT01145846|Antiviral Agents|antiviral agents|mesh-ancestor
101897259|NCT01145846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101897260|NCT01145846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101897261|NCT01145846|Immunologic Factors|immunologic factors|mesh-ancestor
101897262|NCT01145846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897263|NCT01145846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101897264|NCT01145846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101897265|NCT01145846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101897266|NCT01145846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101897267|NCT03134456|Pembrolizumab|pembrolizumab|mesh-list
101897268|NCT03134456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101897269|NCT03134456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101897270|NCT03134456|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101897271|NCT03134456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897272|NCT01143662|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101897273|NCT01143662|Antiviral Agents|antiviral agents|mesh-ancestor
101897274|NCT01143662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101897275|NCT05173688|Propofol|propofol|mesh-list
101897276|NCT05173688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101897277|NCT05173688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101897278|NCT05173688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897279|NCT05173688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101897280|NCT05173688|Anesthetics, General|anesthetics, general|mesh-ancestor
101897281|NCT05173688|Anesthetics|anesthetics|mesh-ancestor
101897282|NCT01146548|Fluoxetine|fluoxetine|mesh-list
101897283|NCT01146548|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101897284|NCT01146548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101897285|NCT01146548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101897286|NCT01146548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897287|NCT01146548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101897288|NCT01146548|Serotonin Agents|serotonin agents|mesh-ancestor
101897289|NCT01146548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897290|NCT01146548|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101897291|NCT01146548|Antidepressive Agents|antidepressive agents|mesh-ancestor
101897292|NCT01146548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101897293|NCT01146548|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101897294|NCT01146548|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101897295|NCT01146548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101897296|NCT03478930|Omalizumab|omalizumab|mesh-list
101897297|NCT03478930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101897298|NCT03478930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101897299|NCT03478930|Respiratory System Agents|respiratory system agents|mesh-ancestor
101897300|NCT01312714|Vitamin D|vitamin d|mesh-list
101897301|NCT01312714|Cholecalciferol|cholecalciferol|mesh-list
101897302|NCT01312714|Vitamins|vitamins|mesh-ancestor
101897303|NCT01312714|Micronutrients|micronutrients|mesh-ancestor
101897304|NCT01312714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897305|NCT01312714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101897306|NCT01312714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101897307|NCT04188028|Dextromethorphan|dextromethorphan|mesh-list
101897308|NCT04188028|Paroxetine|paroxetine|mesh-list
101897309|NCT04188028|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101897310|NCT04188028|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101897311|NCT04188028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101897312|NCT04188028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897313|NCT04188028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101897314|NCT04188028|Serotonin Agents|serotonin agents|mesh-ancestor
101897315|NCT04188028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897316|NCT04188028|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101897317|NCT04188028|Antidepressive Agents|antidepressive agents|mesh-ancestor
101897318|NCT04188028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101897319|NCT04188028|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101897320|NCT04188028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101897321|NCT04188028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101897322|NCT04188028|Antitussive Agents|antitussive agents|mesh-ancestor
101897323|NCT04188028|Respiratory System Agents|respiratory system agents|mesh-ancestor
101897324|NCT04188028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101897325|NCT04188028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101897327|NCT01312792|Cephradine|cephradine|mesh-list
101897328|NCT01312792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101897329|NCT01312792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101897330|NCT03523000|Fentanyl|fentanyl|mesh-list
101897331|NCT03523000|Bupivacaine|bupivacaine|mesh-list
101897332|NCT03523000|Anesthetics, Local|anesthetics, local|mesh-ancestor
101897333|NCT03523000|Anesthetics|anesthetics|mesh-ancestor
101897334|NCT03523000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101897335|NCT03523000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897336|NCT03523000|Sensory System Agents|sensory system agents|mesh-ancestor
101897337|NCT03523000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101897338|NCT03523000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101897339|NCT03523000|Narcotics|narcotics|mesh-ancestor
101897340|NCT03523000|Analgesics|analgesics|mesh-ancestor
101897341|NCT03523000|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101897342|NCT03523000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101897343|NCT03523000|Anesthetics, General|anesthetics, general|mesh-ancestor
101897344|NCT04705480|Pregabalin|pregabalin|mesh-list
101897345|NCT04705480|Gabapentin|gabapentin|mesh-list
101897346|NCT04705480|Analgesics|analgesics|mesh-ancestor
101897347|NCT04705480|Sensory System Agents|sensory system agents|mesh-ancestor
101897348|NCT04705480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101897349|NCT04705480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897350|NCT04705480|Anticonvulsants|anticonvulsants|mesh-ancestor
101897351|NCT04705480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101897352|NCT04705480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101897353|NCT04705480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897354|NCT04705480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101897355|NCT04705480|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101897356|NCT04705480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101897357|NCT04705480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101897358|NCT04705480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101897359|NCT04705480|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101897360|NCT04705480|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101897361|NCT04705480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101897362|NCT04705480|Antimanic Agents|antimanic agents|mesh-ancestor
101897363|NCT01238978|Vildagliptin|vildagliptin|mesh-list
101897364|NCT01238978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101897365|NCT01238978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897366|NCT01238978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101897367|NCT01238978|Protease Inhibitors|protease inhibitors|mesh-ancestor
101897368|NCT01238978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101897369|NCT01238978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897370|NCT00318149|Vaccines|vaccines|mesh-list
101897371|NCT00318149|Immunologic Factors|immunologic factors|mesh-ancestor
101897372|NCT00318149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897373|NCT04648696|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101897374|NCT04648696|Vancomycin|vancomycin|mesh-list
101897375|NCT04648696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101897376|NCT04648696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101897377|NCT04648696|Antitubercular Agents|antitubercular agents|mesh-ancestor
101897378|NCT01236716|Paclitaxel|paclitaxel|mesh-list
101897379|NCT01236716|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101897380|NCT01236716|Carboplatin|carboplatin|mesh-list
101897381|NCT01236716|Gemcitabine|gemcitabine|mesh-list
101897382|NCT01236716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101897383|NCT01236716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101897384|NCT01236716|Tubulin Modulators|tubulin modulators|mesh-ancestor
101897385|NCT01236716|Antimitotic Agents|antimitotic agents|mesh-ancestor
101897386|NCT01236716|Mitosis Modulators|mitosis modulators|mesh-ancestor
101897387|NCT01236716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897388|NCT01236716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101897389|NCT01236716|Antimetabolites|antimetabolites|mesh-ancestor
101897390|NCT04154800|Itraconazole|itraconazole|mesh-list
101897391|NCT04154800|Diltiazem|diltiazem|mesh-list
101897392|NCT04154800|Antifungal Agents|antifungal agents|mesh-ancestor
101897393|NCT04154800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101897394|NCT04154800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101897395|NCT04154800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101897396|NCT04154800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101897397|NCT04154800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897398|NCT04154800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101897399|NCT04154800|Hormone Antagonists|hormone antagonists|mesh-ancestor
101969578|NCT02284204|Midazolam|midazolam|mesh-list
101969579|NCT02284204|Ketamine|ketamine|mesh-list
101897400|NCT04154800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101897401|NCT04154800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897402|NCT04154800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101897404|NCT04154800|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101897405|NCT04154800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101897406|NCT04154800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101897407|NCT04154800|Vasodilator Agents|vasodilator agents|mesh-ancestor
101897408|NCT01048229|Pramipexole|pramipexole|mesh-list
101897409|NCT01048229|Rasagiline|rasagiline|mesh-list
101897410|NCT01048229|Antioxidants|antioxidants|mesh-ancestor
101897411|NCT01048229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897412|NCT01048229|Protective Agents|protective agents|mesh-ancestor
101897413|NCT01048229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897414|NCT01048229|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101897415|NCT01048229|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101897416|NCT01048229|Dopamine Agonists|dopamine agonists|mesh-ancestor
101897417|NCT01048229|Dopamine Agents|dopamine agents|mesh-ancestor
101897418|NCT01048229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101897419|NCT01048229|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101897420|NCT01048229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101897421|NCT01048229|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101897422|NCT01048307|Polihexanide|polihexanide|mesh-list
101897423|NCT01048307|Betaine|betaine|mesh-list
101897424|NCT01048307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101897425|NCT01048307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101897426|NCT01048307|Lipotropic Agents|lipotropic agents|mesh-ancestor
101897427|NCT01048307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101897428|NCT01048307|Antimetabolites|antimetabolites|mesh-ancestor
101897429|NCT01048307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897430|NCT01048307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101897431|NCT01048307|Disinfectants|disinfectants|mesh-ancestor
101897432|NCT01048307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101897433|NCT04017832|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101897434|NCT04017832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101897435|NCT04017832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897436|NCT04017832|Incretins|incretins|mesh-ancestor
101897437|NCT04017832|Hormones|hormones|mesh-ancestor
101897438|NCT04017832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101897439|NCT04017832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101897440|NCT04017832|Protease Inhibitors|protease inhibitors|mesh-ancestor
101897441|NCT04017832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101897442|NCT04017832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897443|NCT02049905|Gemcitabine|gemcitabine|mesh-list
101897444|NCT02049905|Docetaxel|docetaxel|mesh-list
101897445|NCT02049905|Doxorubicin|doxorubicin|mesh-list
101897446|NCT02049905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101897447|NCT02049905|Ifosfamide|ifosfamide|mesh-list
101897448|NCT02049905|Isophosphamide mustard|isophosphamide mustard|mesh-list
101897449|NCT02049905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101897450|NCT02049905|Antimetabolites|antimetabolites|mesh-ancestor
101897451|NCT02049905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897452|NCT02049905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101897453|NCT02049905|Tubulin Modulators|tubulin modulators|mesh-ancestor
101897454|NCT02049905|Antimitotic Agents|antimitotic agents|mesh-ancestor
101897455|NCT02049905|Mitosis Modulators|mitosis modulators|mesh-ancestor
101897456|NCT02049905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101897457|NCT02049905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101897458|NCT02049905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101897459|NCT02049905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686336|NCT03711305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101897460|NCT02049905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101897461|NCT02049905|Alkylating Agents|alkylating agents|mesh-ancestor
101897462|NCT01062191|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101897463|NCT01062191|Laxatives|laxatives|mesh-ancestor
101897464|NCT01062191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101897465|NCT01058759|Enoxaparin|enoxaparin|mesh-list
101897466|NCT01058759|Enoxaparin sodium|enoxaparin sodium|mesh-list
101897467|NCT01058759|Anticoagulants|anticoagulants|mesh-ancestor
101897468|NCT01058759|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101897469|NCT01058759|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101897470|NCT01058759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897471|NCT01239368|Sirolimus|sirolimus|mesh-list
101897472|NCT01239368|Immunologic Factors|immunologic factors|mesh-ancestor
101897473|NCT01239368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897474|NCT01239368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101897475|NCT01239368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101897476|NCT01239368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101897477|NCT01239368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101897478|NCT01239368|Antifungal Agents|antifungal agents|mesh-ancestor
101897479|NCT01239368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101897480|NCT01146002|Guanfacine|guanfacine|mesh-list
101897481|NCT01146002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101897482|NCT01146002|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101897483|NCT01146002|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101897484|NCT01146002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101897485|NCT01146002|Adrenergic Agents|adrenergic agents|mesh-ancestor
101897486|NCT01146002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101897487|NCT01146002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897488|NCT01146002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897489|NCT01146626|Vitamin D|vitamin d|mesh-list
101897490|NCT01146626|Ribavirin|ribavirin|mesh-list
101897491|NCT01146626|Vitamins|vitamins|mesh-ancestor
101897492|NCT01146626|Micronutrients|micronutrients|mesh-ancestor
101897493|NCT01146626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897494|NCT01146626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101897495|NCT01146626|Antimetabolites|antimetabolites|mesh-ancestor
101897496|NCT01146626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897497|NCT01146626|Antiviral Agents|antiviral agents|mesh-ancestor
101897498|NCT01146626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101897499|NCT02924324|Propofol|propofol|mesh-list
101897500|NCT02924324|Ropivacaine|ropivacaine|mesh-list
101897501|NCT02924324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101897502|NCT02924324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101897503|NCT02924324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897504|NCT02924324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101897505|NCT02924324|Anesthetics, General|anesthetics, general|mesh-ancestor
101897506|NCT02924324|Anesthetics|anesthetics|mesh-ancestor
101897507|NCT02924324|Anesthetics, Local|anesthetics, local|mesh-ancestor
101897508|NCT02924324|Sensory System Agents|sensory system agents|mesh-ancestor
101897509|NCT02924324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101897510|NCT03518606|Durvalumab|durvalumab|mesh-list
101897511|NCT03518606|Vinorelbine|vinorelbine|mesh-list
101897512|NCT03518606|Tremelimumab|tremelimumab|mesh-list
101897513|NCT03518606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101897514|NCT03518606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101897515|NCT03518606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101897516|NCT03518606|Tubulin Modulators|tubulin modulators|mesh-ancestor
101897517|NCT03518606|Antimitotic Agents|antimitotic agents|mesh-ancestor
101897518|NCT03518606|Mitosis Modulators|mitosis modulators|mesh-ancestor
101897519|NCT03518606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897520|NCT05137574|Ketamine|ketamine|mesh-list
101897521|NCT05137574|Propofol|propofol|mesh-list
101897522|NCT05137574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101897523|NCT05137574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101897524|NCT05137574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897525|NCT05137574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101897526|NCT05137574|Anesthetics, General|anesthetics, general|mesh-ancestor
101897527|NCT05137574|Anesthetics|anesthetics|mesh-ancestor
101897528|NCT05137574|Analgesics|analgesics|mesh-ancestor
101897529|NCT05137574|Sensory System Agents|sensory system agents|mesh-ancestor
101897530|NCT05137574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101897531|NCT05137574|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101897532|NCT05137574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101897533|NCT05137574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101897534|NCT05137574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101897535|NCT05137574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897536|NCT02842424|Ramipril|ramipril|mesh-list
101897537|NCT02842424|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101897538|NCT02842424|Protease Inhibitors|protease inhibitors|mesh-ancestor
101897539|NCT02842424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101897540|NCT02842424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897541|NCT02842424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101897542|NCT01236950|Listerine|listerine|mesh-list
101897543|NCT01236950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101897544|NCT01236950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101897545|NCT04971746|Pirfenidone|pirfenidone|mesh-list
101897546|NCT04971746|Nintedanib|nintedanib|mesh-list
101897547|NCT04971746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101897548|NCT04971746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101897549|NCT04971746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101897550|NCT04971746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897551|NCT04971746|Analgesics|analgesics|mesh-ancestor
101897552|NCT04971746|Sensory System Agents|sensory system agents|mesh-ancestor
101897553|NCT04971746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101897554|NCT04971746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897555|NCT04971746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101897556|NCT04971746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101897557|NCT04971746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101897558|NCT04971746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101897559|NCT00369161|Everolimus|everolimus|mesh-list
101897560|NCT00369161|Tacrolimus|tacrolimus|mesh-list
101897561|NCT00369161|Basiliximab|basiliximab|mesh-list
101897562|NCT00369161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101897563|NCT00369161|Immunologic Factors|immunologic factors|mesh-ancestor
101897564|NCT00369161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897565|NCT00369161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101897566|NCT00369161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101897567|NCT00369161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897568|NCT00369161|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101897569|NCT00369161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101897570|NCT00369161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101897571|NCT01143974|Pemetrexed|pemetrexed|mesh-list
101897572|NCT01143974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101897573|NCT01143974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101897574|NCT01143974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897575|NCT01143974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101897576|NCT01143974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101897577|NCT00337571|Aripiprazole|aripiprazole|mesh-list
101897578|NCT00337571|Antidepressive Agents|antidepressive agents|mesh-ancestor
101897579|NCT00337571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101897580|NCT00337571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101897581|NCT00337571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101897582|NCT00337571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101897583|NCT00337571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897584|NCT00337571|Dopamine Agonists|dopamine agonists|mesh-ancestor
101897585|NCT00337571|Dopamine Agents|dopamine agents|mesh-ancestor
101897586|NCT00337571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101897587|NCT00337571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897588|NCT00337571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101897589|NCT00337571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101897590|NCT00337571|Serotonin Agents|serotonin agents|mesh-ancestor
101897591|NCT00337571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101897592|NCT00337571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101897593|NCT00337571|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101897594|NCT00337571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101897595|NCT01247870|Metformin|metformin|mesh-list
101897596|NCT01247870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101897597|NCT01247870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897598|NCT02528396|Insulin Lispro|insulin lispro|mesh-list
101897599|NCT02528396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101897600|NCT02528396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897601|NCT03985319|Esomeprazole|esomeprazole|mesh-list
101897602|NCT03985319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101897603|NCT03985319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101897604|NCT03985319|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101897605|NCT03985319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101897606|NCT03985319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897607|NCT01237028|Calcitriol|calcitriol|mesh-list
101689907|NCT02649504|Dexamethasone|dexamethasone|mesh-list
101897608|NCT01237028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101897609|NCT01237028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897610|NCT01237028|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101897611|NCT01237028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101897612|NCT01237028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897613|NCT01237028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101897615|NCT01237028|Micronutrients|micronutrients|mesh-ancestor
101897616|NCT01237028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101897619|NCT01240850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101897620|NCT01240850|Glucocorticoids|glucocorticoids|mesh-ancestor
101897621|NCT01240850|Hormones|hormones|mesh-ancestor
101897622|NCT01240850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101897623|NCT01240850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897624|NCT01240850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101897625|NCT01240850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101897626|NCT01240850|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101897627|NCT01240850|Abortifacient Agents|abortifacient agents|mesh-ancestor
101897628|NCT01240850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101897629|NCT01240850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101897630|NCT01240850|Antimetabolites|antimetabolites|mesh-ancestor
101897631|NCT01240850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897632|NCT01240850|Dermatologic Agents|dermatologic agents|mesh-ancestor
101897633|NCT01240850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101897634|NCT01240850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101897635|NCT01240850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101897636|NCT01240850|Immunologic Factors|immunologic factors|mesh-ancestor
101897637|NCT01240850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101897638|NCT01240850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101897639|NCT04813016|Dexmedetomidine|dexmedetomidine|mesh-list
101897640|NCT04813016|Tramadol|tramadol|mesh-list
101897641|NCT04813016|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101897642|NCT04813016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101897643|NCT04813016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897644|NCT04813016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101897645|NCT04813016|Analgesics|analgesics|mesh-ancestor
101897646|NCT04813016|Sensory System Agents|sensory system agents|mesh-ancestor
101897647|NCT04813016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101897648|NCT04813016|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101897649|NCT04813016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101897650|NCT04813016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101897651|NCT04813016|Adrenergic Agents|adrenergic agents|mesh-ancestor
101897652|NCT04813016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101897653|NCT04813016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897654|NCT04813016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101897655|NCT04813016|Narcotics|narcotics|mesh-ancestor
101897656|NCT00368927|Sulindac|sulindac|mesh-list
101897657|NCT00368927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101897658|NCT00368927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101897659|NCT00368927|Analgesics|analgesics|mesh-ancestor
101897660|NCT00368927|Sensory System Agents|sensory system agents|mesh-ancestor
101897661|NCT00368927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101897662|NCT00368927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897663|NCT00368927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101897664|NCT00368927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101897665|NCT00368927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101897666|NCT00368927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101897667|NCT00368927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101897668|NCT00368927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897669|NCT01242410|Silicon|silicon|mesh-list
101897670|NCT01242410|Trace Elements|trace elements|mesh-ancestor
101897671|NCT01242410|Micronutrients|micronutrients|mesh-ancestor
101897672|NCT01242410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897673|NCT02655692|Ketamine|ketamine|mesh-list
101897674|NCT02655692|Analgesics|analgesics|mesh-ancestor
101897675|NCT02655692|Sensory System Agents|sensory system agents|mesh-ancestor
101897676|NCT02655692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101897677|NCT02655692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897678|NCT02655692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101897679|NCT02655692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101897680|NCT02655692|Anesthetics, General|anesthetics, general|mesh-ancestor
101897681|NCT02655692|Anesthetics|anesthetics|mesh-ancestor
101897682|NCT02655692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101897683|NCT02655692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101897684|NCT02655692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101897685|NCT02655692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101897686|NCT02655692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897687|NCT01237262|Adalimumab|adalimumab|mesh-list
101897688|NCT01237262|Infliximab|infliximab|mesh-list
101897689|NCT01237262|Etanercept|etanercept|mesh-list
101897690|NCT01237262|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101897691|NCT01237262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101897692|NCT01237262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101897693|NCT01237262|Dermatologic Agents|dermatologic agents|mesh-ancestor
101897694|NCT01237262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101897695|NCT01237262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101897696|NCT01237262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101897697|NCT01237262|Analgesics|analgesics|mesh-ancestor
101897698|NCT01237262|Sensory System Agents|sensory system agents|mesh-ancestor
101897699|NCT01237262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101897700|NCT01237262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897701|NCT01237262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101897702|NCT01237262|Immunologic Factors|immunologic factors|mesh-ancestor
101897703|NCT01329770|Vitamins|vitamins|mesh-list
101897704|NCT01329770|Ascorbic Acid|ascorbic acid|mesh-list
101897705|NCT01329770|Vitamin E|vitamin e|mesh-list
101897706|NCT01329770|Tocopherols|tocopherols|mesh-list
101897707|NCT01329770|alpha-Tocopherol|alpha-tocopherol|mesh-list
101897708|NCT01329770|Micronutrients|micronutrients|mesh-ancestor
101897709|NCT01329770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897710|NCT01329770|Antioxidants|antioxidants|mesh-ancestor
101897711|NCT01329770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897712|NCT01329770|Protective Agents|protective agents|mesh-ancestor
101686384|NCT04211298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101897713|NCT00316589|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
101897714|NCT00316589|Antiviral Agents|antiviral agents|mesh-ancestor
101897715|NCT00316589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101897716|NCT01048385|Ubiquinone|ubiquinone|mesh-list
101897717|NCT01048385|Coenzyme Q10|coenzyme q10|mesh-list
101897718|NCT01048385|Micronutrients|micronutrients|mesh-ancestor
101897719|NCT01048385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897720|NCT01048385|Vitamins|vitamins|mesh-ancestor
101897721|NCT03916640|Insulin Lispro|insulin lispro|mesh-list
101897722|NCT03916640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101897723|NCT03916640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897724|NCT03916250|Petrolatum|petrolatum|mesh-list
101897725|NCT03916250|PF-06700841|pf-06700841|mesh-list
101897726|NCT03916250|Emollients|emollients|mesh-ancestor
101897727|NCT03916250|Dermatologic Agents|dermatologic agents|mesh-ancestor
101897728|NCT03916250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101897729|NCT03916250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101897730|NCT03916250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897731|NCT01062503|Zoledronic Acid|zoledronic acid|mesh-list
101897732|NCT01062503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101897733|NCT01062503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897734|NCT03916406|Midazolam|midazolam|mesh-list
101897735|NCT03916406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101897736|NCT03916406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101897737|NCT03916406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101897738|NCT03916406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897739|NCT03916406|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101897740|NCT03916406|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101897741|NCT03916406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101897742|NCT03916406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101897743|NCT03916406|Anesthetics, General|anesthetics, general|mesh-ancestor
101897744|NCT03916406|Anesthetics|anesthetics|mesh-ancestor
101897745|NCT03916406|GABA Modulators|gaba modulators|mesh-ancestor
101897746|NCT03916406|GABA Agents|gaba agents|mesh-ancestor
101897747|NCT03916406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101897748|NCT03916406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897749|NCT00316277|Opiate Alkaloids|opiate alkaloids|mesh-list
101260605|NCT01745601|Dexetimide|dexetimide|mesh-list
101897750|NCT00316277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101897751|NCT00316277|Narcotics|narcotics|mesh-ancestor
101897752|NCT00316277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101897753|NCT00316277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897754|NCT00316277|Analgesics|analgesics|mesh-ancestor
101897755|NCT00316277|Sensory System Agents|sensory system agents|mesh-ancestor
101897756|NCT00316277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101897757|NCT01249352|Fluorouracil|fluorouracil|mesh-list
101897758|NCT01249352|Nimotuzumab|nimotuzumab|mesh-list
101897759|NCT01249352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101897760|NCT01249352|Antimetabolites|antimetabolites|mesh-ancestor
101897761|NCT01249352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897762|NCT01249352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101897763|NCT01249352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101897764|NCT01249352|Immunologic Factors|immunologic factors|mesh-ancestor
101897765|NCT01249352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897766|NCT01249352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101897767|NCT03912974|Escitalopram|escitalopram|mesh-list
101897768|NCT03912974|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101897769|NCT03912974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101897770|NCT03912974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101897771|NCT03912974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897772|NCT03912974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101897773|NCT03912974|Serotonin Agents|serotonin agents|mesh-ancestor
101897774|NCT03912974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897775|NCT00368849|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101897776|NCT00368849|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101897777|NCT00368849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101897778|NCT00368849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101897779|NCT00368849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897780|NCT00368849|Adrenergic Agents|adrenergic agents|mesh-ancestor
101897781|NCT00368849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101897782|NCT00368849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897783|NCT01144676|Dapivirine|dapivirine|mesh-list
101897784|NCT01144676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101897785|NCT01144676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101897786|NCT01144676|Antiviral Agents|antiviral agents|mesh-ancestor
101897787|NCT01144676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101897788|NCT00316199|Paclitaxel|paclitaxel|mesh-list
101897789|NCT00316199|Gemcitabine|gemcitabine|mesh-list
101897790|NCT00316199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101897791|NCT00316199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101897792|NCT00316199|Tubulin Modulators|tubulin modulators|mesh-ancestor
101897793|NCT00316199|Antimitotic Agents|antimitotic agents|mesh-ancestor
101897794|NCT00316199|Mitosis Modulators|mitosis modulators|mesh-ancestor
101897795|NCT00316199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897796|NCT00316199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101897797|NCT00316199|Antimetabolites|antimetabolites|mesh-ancestor
101897798|NCT01147718|Digoxin|digoxin|mesh-list
101897799|NCT01147718|rGLP-1 protein|rglp-1 protein|mesh-list
101897800|NCT01147718|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101897801|NCT01147718|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101897802|NCT01147718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101897803|NCT01147718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897804|NCT01147718|Protective Agents|protective agents|mesh-ancestor
101897805|NCT01147718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897806|NCT01147718|Incretins|incretins|mesh-ancestor
101897807|NCT01147718|Hormones|hormones|mesh-ancestor
101897808|NCT01147718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101897809|NCT03913052|Viscosupplements|viscosupplements|mesh-list
101897810|NCT03913052|Protective Agents|protective agents|mesh-ancestor
101897811|NCT03913052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897812|NCT03915938|Ketamine|ketamine|mesh-list
101897813|NCT03915938|Analgesics|analgesics|mesh-ancestor
101897814|NCT03915938|Sensory System Agents|sensory system agents|mesh-ancestor
101897815|NCT03915938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101897816|NCT03915938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897817|NCT03915938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101897818|NCT03915938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101897819|NCT03915938|Anesthetics, General|anesthetics, general|mesh-ancestor
101897820|NCT03915938|Anesthetics|anesthetics|mesh-ancestor
101897821|NCT03915938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101897822|NCT03915938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101897823|NCT03915938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101617624|NCT02838615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617625|NCT02838615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101617626|NCT02838615|Glucocorticoids|glucocorticoids|mesh-ancestor
101617627|NCT02838615|Hormones|hormones|mesh-ancestor
101617628|NCT02838615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101617629|NCT02838615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101617630|NCT02838615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101617651|NCT02838225|Cyclophosphamide|cyclophosphamide|mesh-list
101617653|NCT02838225|Doxorubicin|doxorubicin|mesh-list
101617654|NCT02838225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101617655|NCT02838225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101617656|NCT02838225|Immunologic Factors|immunologic factors|mesh-ancestor
101617657|NCT02838225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617658|NCT02838225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101617659|NCT02838225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101617660|NCT02838225|Alkylating Agents|alkylating agents|mesh-ancestor
101617661|NCT02838225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897824|NCT03915938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101897825|NCT03915938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897826|NCT01237496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101897827|NCT01237496|Antiviral Agents|antiviral agents|mesh-ancestor
101897828|NCT01237496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101897829|NCT01251458|Temsirolimus|temsirolimus|mesh-list
101897830|NCT01251458|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101897831|NCT01251458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101897832|NCT01251458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101897833|NCT01251458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897834|NCT01251458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101897835|NCT01251458|Immunologic Factors|immunologic factors|mesh-ancestor
101897836|NCT01251458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897837|NCT01251458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101897838|NCT03912740|Dexmedetomidine|dexmedetomidine|mesh-list
101897839|NCT03912740|Remifentanil|remifentanil|mesh-list
101897840|NCT03912740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101897841|NCT03912740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101897842|NCT03912740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897843|NCT03912740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101897844|NCT03912740|Analgesics|analgesics|mesh-ancestor
101897845|NCT03912740|Sensory System Agents|sensory system agents|mesh-ancestor
101897846|NCT03912740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101897847|NCT03912740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101897848|NCT03912740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101897849|NCT03912740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101897850|NCT03912740|Adrenergic Agents|adrenergic agents|mesh-ancestor
101897851|NCT03912740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101897852|NCT03912740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897853|NCT03912740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101897854|NCT03912740|Narcotics|narcotics|mesh-ancestor
101897855|NCT01058915|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101897856|NCT01058915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101897857|NCT01058915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101897858|NCT01058915|Antimetabolites|antimetabolites|mesh-ancestor
101897859|NCT01058915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897860|NCT01058915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101897861|NCT01058915|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101897862|NCT01058915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101897863|NCT01144754|Rituximab|rituximab|mesh-list
101897864|NCT01144754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101897865|NCT01144754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101897866|NCT01144754|Immunologic Factors|immunologic factors|mesh-ancestor
101897867|NCT01144754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897868|NCT01144754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101897869|NCT01144832|Ebastine|ebastine|mesh-list
101897870|NCT01144832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101897871|NCT01144832|Histamine Antagonists|histamine antagonists|mesh-ancestor
101897872|NCT01144832|Histamine Agents|histamine agents|mesh-ancestor
101897873|NCT01144832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101686417|NCT02845661|Adrenergic Agents|adrenergic agents|mesh-ancestor
101897874|NCT01144832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689918|NCT02649504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101897875|NCT01144832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897876|NCT01251848|Ritonavir|ritonavir|mesh-list
101897877|NCT01251848|Sitaxsentan|sitaxsentan|mesh-list
101897878|NCT01251848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101897879|NCT01251848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101969603|NCT01352416|Ranolazine|ranolazine|mesh-list
101897880|NCT01251848|Protease Inhibitors|protease inhibitors|mesh-ancestor
101897881|NCT01251848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101897882|NCT01251848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897883|NCT01251848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101897884|NCT01251848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101897885|NCT01251848|Antiviral Agents|antiviral agents|mesh-ancestor
101897886|NCT01251848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101897887|NCT01251848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101897888|NCT01251848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101897889|NCT01251848|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101897890|NCT01251926|Bevacizumab|bevacizumab|mesh-list
101897891|NCT01251926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101897892|NCT01251926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101897893|NCT01251926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101897894|NCT01251926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101897895|NCT01251926|Growth Substances|growth substances|mesh-ancestor
101897896|NCT01251926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617707|NCT02835183|Insulin|insulin|mesh-list
101897898|NCT03911648|Lidocaine|lidocaine|mesh-list
101897899|NCT03911648|Bupivacaine|bupivacaine|mesh-list
101897900|NCT03911648|Anesthetics, Local|anesthetics, local|mesh-ancestor
101897901|NCT03911648|Anesthetics|anesthetics|mesh-ancestor
101897902|NCT03911648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101897903|NCT03911648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897904|NCT03911648|Sensory System Agents|sensory system agents|mesh-ancestor
101897905|NCT03911648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101897906|NCT03911648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101897907|NCT03911648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101897908|NCT03911648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101897909|NCT03911648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101897910|NCT03911648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897911|NCT01237730|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101897912|NCT01237730|Cefuroxime|cefuroxime|mesh-list
101897913|NCT01237730|Cefuroxime axetil|cefuroxime axetil|mesh-list
101897914|NCT01237730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101897915|NCT01148030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
101897916|NCT01148030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101897917|NCT01252160|Capsaicin|capsaicin|mesh-list
101897918|NCT01252160|Antipruritics|antipruritics|mesh-ancestor
101897919|NCT01252160|Dermatologic Agents|dermatologic agents|mesh-ancestor
101897920|NCT01252160|Sensory System Agents|sensory system agents|mesh-ancestor
101897921|NCT01252160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101897922|NCT01252160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897923|NCT00337103|Capecitabine|capecitabine|mesh-list
101897924|NCT00337103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101897925|NCT00337103|Antimetabolites|antimetabolites|mesh-ancestor
101897926|NCT00337103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897927|NCT00337103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101897928|NCT03911570|Acetaminophen|acetaminophen|mesh-list
101897929|NCT03911570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101897930|NCT03911570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101897931|NCT03911570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101897932|NCT03911570|Analgesics|analgesics|mesh-ancestor
101897933|NCT03911570|Sensory System Agents|sensory system agents|mesh-ancestor
101897934|NCT03911570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101897935|NCT03911570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897936|NCT03911570|Antipyretics|antipyretics|mesh-ancestor
101897937|NCT03911570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101897938|NCT01250366|Ribavirin|ribavirin|mesh-list
101897939|NCT01250366|Antimetabolites|antimetabolites|mesh-ancestor
101897940|NCT01250366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897941|NCT01250366|Antiviral Agents|antiviral agents|mesh-ancestor
101897942|NCT01250366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101897943|NCT00075504|Gemcitabine|gemcitabine|mesh-list
101897944|NCT00075504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101897945|NCT00075504|Antimetabolites|antimetabolites|mesh-ancestor
101897946|NCT00075504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897947|NCT00075504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101897949|NCT01092624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101897950|NCT01092624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101897951|NCT01092624|Cholinergic Agents|cholinergic agents|mesh-ancestor
101897952|NCT01092624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101897953|NCT01092624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897954|NCT01092624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897955|NCT01092624|Urological Agents|urological agents|mesh-ancestor
101897956|NCT00321464|Zoledronic Acid|zoledronic acid|mesh-list
101897957|NCT00321464|Denosumab|denosumab|mesh-list
101897958|NCT00321464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101897959|NCT00321464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897960|NCT02889796|Adalimumab|adalimumab|mesh-list
101897961|NCT02889796|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101897962|NCT02889796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101897963|NCT02889796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101897964|NCT01237808|Cytarabine|cytarabine|mesh-list
101897965|NCT01237808|Etoposide|etoposide|mesh-list
101897966|NCT01237808|Tretinoin|tretinoin|mesh-list
101897967|NCT01237808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101897968|NCT01237808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101897969|NCT01237808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101897970|NCT01237808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101897971|NCT01237808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101897972|NCT01237808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897973|NCT01237808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101897974|NCT01237808|Antimetabolites|antimetabolites|mesh-ancestor
101897975|NCT01237808|Antiviral Agents|antiviral agents|mesh-ancestor
101897976|NCT01237808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101897977|NCT01237808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101897978|NCT01237808|Immunologic Factors|immunologic factors|mesh-ancestor
101897979|NCT01237808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897980|NCT01237808|Keratolytic Agents|keratolytic agents|mesh-ancestor
101897981|NCT01237808|Dermatologic Agents|dermatologic agents|mesh-ancestor
101897982|NCT03910634|Carboplatin|carboplatin|mesh-list
101897983|NCT03910634|Fluorouracil|fluorouracil|mesh-list
101897984|NCT03910634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101897985|NCT03910634|Antimetabolites|antimetabolites|mesh-ancestor
101897986|NCT03910634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101897987|NCT03910634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101897988|NCT03910634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101897989|NCT03910634|Immunologic Factors|immunologic factors|mesh-ancestor
101897990|NCT03910634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101897991|NCT03910712|Trastuzumab|trastuzumab|mesh-list
101897992|NCT03910712|Letrozole|letrozole|mesh-list
101897993|NCT03910712|Anastrozole|anastrozole|mesh-list
101897994|NCT03910712|Exemestane|exemestane|mesh-list
101897995|NCT03910712|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101897996|NCT03910712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101897997|NCT03910712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101897998|NCT03910712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101897999|NCT03910712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101898000|NCT03910712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898001|NCT03910712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101898002|NCT03910712|Hormone Antagonists|hormone antagonists|mesh-ancestor
101898003|NCT03910712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101686443|NCT00620100|Docetaxel|docetaxel|mesh-list
101898004|NCT03910712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898005|NCT03910712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101898006|NCT03910556|Propofol|propofol|mesh-list
101898007|NCT03910556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101898008|NCT03910556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101898009|NCT03910556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898010|NCT03910556|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101898011|NCT03910556|Anesthetics, General|anesthetics, general|mesh-ancestor
101898012|NCT03910556|Anesthetics|anesthetics|mesh-ancestor
101898013|NCT03659578|Thymalfasin|thymalfasin|mesh-list
101898014|NCT03659578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101898015|NCT03659578|Immunologic Factors|immunologic factors|mesh-ancestor
101898016|NCT03659578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898017|NCT02889562|Warfarin|warfarin|mesh-list
101898018|NCT02889562|Apixaban|apixaban|mesh-list
101898019|NCT02889562|Anticoagulants|anticoagulants|mesh-ancestor
101898020|NCT02889562|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101898021|NCT02889562|Antithrombins|antithrombins|mesh-ancestor
101898022|NCT02889562|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101898023|NCT02889562|Protease Inhibitors|protease inhibitors|mesh-ancestor
101304563|NCT02013960|Oxytocics|oxytocics|mesh-ancestor
101898024|NCT02889562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101898025|NCT02889562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898027|NCT03323164|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101898028|NCT03323164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898029|NCT03323164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101898030|NCT03323164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101898031|NCT03323164|Adrenergic Agents|adrenergic agents|mesh-ancestor
101898032|NCT03323164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101898033|NCT03323164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898034|NCT03323164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101898035|NCT03323164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101898036|NCT03323164|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101898037|NCT03323164|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101898038|NCT03323164|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101898039|NCT03914690|Epoetin Alfa|epoetin alfa|mesh-list
101898040|NCT03914690|Hematinics|hematinics|mesh-ancestor
101898041|NCT03914534|Valproic Acid|valproic acid|mesh-list
101898042|NCT03914534|Anticonvulsants|anticonvulsants|mesh-ancestor
101898043|NCT03914534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101898044|NCT03914534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898045|NCT03914534|GABA Agents|gaba agents|mesh-ancestor
101898046|NCT03914534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101898047|NCT03914534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898049|NCT03914534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101898050|NCT03914534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101898051|NCT03914534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101898052|NCT03910088|Acetaminophen|acetaminophen|mesh-list
101898053|NCT03910088|Hydrocortisone|hydrocortisone|mesh-list
101898054|NCT03910088|Diclofenac|diclofenac|mesh-list
101898055|NCT03910088|Pregabalin|pregabalin|mesh-list
101898056|NCT03910088|Caffeine|caffeine|mesh-list
101898057|NCT03910088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101898058|NCT03910088|Analgesics|analgesics|mesh-ancestor
101898059|NCT03910088|Sensory System Agents|sensory system agents|mesh-ancestor
101898060|NCT03910088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101898061|NCT03910088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898062|NCT03910088|Antipyretics|antipyretics|mesh-ancestor
101898063|NCT03910088|Anticonvulsants|anticonvulsants|mesh-ancestor
101898064|NCT03910088|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101898065|NCT03910088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101898066|NCT03910088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898067|NCT03910088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101898068|NCT03910088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101898069|NCT03910088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101898070|NCT03910088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101898071|NCT03910088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101898072|NCT03910088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101898073|NCT03910088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101898074|NCT03910088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101898075|NCT03910088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101898076|NCT03910088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101898077|NCT03910088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101898078|NCT03910088|Purinergic Agents|purinergic agents|mesh-ancestor
101898079|NCT03910088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101898080|NCT03910088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101898081|NCT03910088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101898082|NCT03910088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101898083|NCT03610438|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
101898084|NCT03610438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101898085|NCT03610438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101898086|NCT03610438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101898087|NCT03610438|Immunotoxins|immunotoxins|mesh-ancestor
101898088|NCT03610438|Immunoconjugates|immunoconjugates|mesh-ancestor
101898089|NCT03610438|Immunologic Factors|immunologic factors|mesh-ancestor
101898090|NCT03610438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898091|NCT03908372|Docetaxel|docetaxel|mesh-list
101898092|NCT03908372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101898093|NCT03908372|Tubulin Modulators|tubulin modulators|mesh-ancestor
101898095|NCT03908372|Mitosis Modulators|mitosis modulators|mesh-ancestor
101898096|NCT03908372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898097|NCT05617664|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101898098|NCT05617664|Mirabegron|mirabegron|mesh-list
101898099|NCT05617664|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101898100|NCT05617664|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101898101|NCT05617664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101898102|NCT05617664|Adrenergic Agents|adrenergic agents|mesh-ancestor
101898103|NCT05617664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101898104|NCT05617664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898105|NCT05617664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898106|NCT05617664|Urological Agents|urological agents|mesh-ancestor
101898107|NCT05617664|Hemostatics|hemostatics|mesh-ancestor
101898108|NCT05617664|Coagulants|coagulants|mesh-ancestor
101898109|NCT05617664|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101898110|NCT05617664|Natriuretic Agents|natriuretic agents|mesh-ancestor
101898111|NCT03909776|Cisplatin|cisplatin|mesh-list
101898112|NCT03909776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101898113|NCT01148264|Olanzapine|olanzapine|mesh-list
101898114|NCT01148264|Metoclopramide|metoclopramide|mesh-list
101898115|NCT01148264|Antiemetics|antiemetics|mesh-ancestor
101898116|NCT01148264|Autonomic Agents|autonomic agents|mesh-ancestor
101898117|NCT01148264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101898118|NCT01148264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898119|NCT01148264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101898120|NCT01148264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101898121|NCT01148264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101898122|NCT01148264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101898123|NCT01148264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101898124|NCT01148264|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101898125|NCT01148264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101898126|NCT01148264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101898127|NCT01148264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898128|NCT01148264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101898129|NCT01148264|Serotonin Agents|serotonin agents|mesh-ancestor
101898130|NCT01148264|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101898131|NCT01148264|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101898132|NCT01148264|Dopamine Agents|dopamine agents|mesh-ancestor
101898133|NCT01253252|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101898134|NCT01253252|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101898135|NCT01253252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898136|NCT00086580|Vidarabine|vidarabine|mesh-list
101898137|NCT00086580|Fludarabine|fludarabine|mesh-list
101898138|NCT00086580|Fludarabine phosphate|fludarabine phosphate|mesh-list
101898139|NCT00086580|Alemtuzumab|alemtuzumab|mesh-list
101898140|NCT00086580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101898141|NCT00086580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101898142|NCT00086580|Antimetabolites|antimetabolites|mesh-ancestor
101898143|NCT00086580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898144|NCT00086580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101898145|NCT00086580|Immunologic Factors|immunologic factors|mesh-ancestor
101898146|NCT00086580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898147|NCT00086580|Antiviral Agents|antiviral agents|mesh-ancestor
101898148|NCT00086580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101898149|NCT00086580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101898150|NCT03908528|Thioctic Acid|thioctic acid|mesh-list
101898151|NCT03908528|Cyclophosphamide|cyclophosphamide|mesh-list
101898152|NCT03908528|Doxorubicin|doxorubicin|mesh-list
101898153|NCT03908528|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101898154|NCT03908528|Paclitaxel|paclitaxel|mesh-list
101898155|NCT03908528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101898156|NCT03908528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101898157|NCT03908528|Immunologic Factors|immunologic factors|mesh-ancestor
101898158|NCT03908528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898159|NCT03908528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101898160|NCT03908528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101898161|NCT03908528|Alkylating Agents|alkylating agents|mesh-ancestor
101898162|NCT03908528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898163|NCT03908528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101898164|NCT03908528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101898165|NCT03908528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101898166|NCT03908528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101898167|NCT03908528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101898168|NCT03908528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101898169|NCT03908528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101898170|NCT03908528|Tubulin Modulators|tubulin modulators|mesh-ancestor
101898171|NCT03908528|Antimitotic Agents|antimitotic agents|mesh-ancestor
101898172|NCT03908528|Mitosis Modulators|mitosis modulators|mesh-ancestor
101898173|NCT03908528|Antioxidants|antioxidants|mesh-ancestor
101898174|NCT03908528|Protective Agents|protective agents|mesh-ancestor
101898175|NCT03908528|Vitamin B Complex|vitamin b complex|mesh-ancestor
101898176|NCT03908528|Vitamins|vitamins|mesh-ancestor
101898177|NCT03908528|Micronutrients|micronutrients|mesh-ancestor
101898178|NCT03903458|Nivolumab|nivolumab|mesh-list
101898179|NCT03903458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101898180|NCT03903458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101898181|NCT03903458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101898182|NCT03903458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898183|NCT00086502|Metformin|metformin|mesh-list
101898184|NCT00086502|Pioglitazone|pioglitazone|mesh-list
101898185|NCT00086502|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101898186|NCT00086502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101898187|NCT00086502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898188|NCT00086502|Incretins|incretins|mesh-ancestor
101898189|NCT00086502|Hormones|hormones|mesh-ancestor
101898190|NCT00086502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101898191|NCT00086502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101898192|NCT00086502|Protease Inhibitors|protease inhibitors|mesh-ancestor
101521068|NCT04643483|Adalimumab|adalimumab|mesh-list
101898193|NCT00086502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101898194|NCT00086502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898195|NCT03903302|Valproic Acid|valproic acid|mesh-list
101898196|NCT03903302|Anticonvulsants|anticonvulsants|mesh-ancestor
101898197|NCT03903302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101898198|NCT03903302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898199|NCT03903302|GABA Agents|gaba agents|mesh-ancestor
101898200|NCT03903302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101898201|NCT03903302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898202|NCT03903302|Antimanic Agents|antimanic agents|mesh-ancestor
101898203|NCT03903302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101898204|NCT03903302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101898205|NCT03903302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101898206|NCT03636542|Bupivacaine|bupivacaine|mesh-list
101898207|NCT03636542|Anesthetics, Local|anesthetics, local|mesh-ancestor
101898208|NCT03636542|Anesthetics|anesthetics|mesh-ancestor
101898209|NCT03636542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101898210|NCT03636542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898211|NCT03636542|Sensory System Agents|sensory system agents|mesh-ancestor
101898212|NCT03636542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101898213|NCT00086190|Paroxetine|paroxetine|mesh-list
101898214|NCT00086190|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101898215|NCT00086190|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101898216|NCT00086190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101898217|NCT00086190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101898218|NCT00086190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898219|NCT00086190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101898220|NCT00086190|Serotonin Agents|serotonin agents|mesh-ancestor
101898221|NCT00086190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898222|NCT00086190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101898223|NCT00086190|Antidepressive Agents|antidepressive agents|mesh-ancestor
101898224|NCT00086190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101898225|NCT00086190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101898226|NCT00086190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101898227|NCT00086190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101898228|NCT00086190|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101898230|NCT03275350|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101898231|NCT03275350|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101898232|NCT03275350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898233|NCT03275350|Sensory System Agents|sensory system agents|mesh-ancestor
101898234|NCT03275350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101898235|NCT01148342|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
101898236|NCT01148342|Hallucinogens|hallucinogens|mesh-ancestor
101898237|NCT01148342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898238|NCT01148342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101898239|NCT01148342|Serotonin Agents|serotonin agents|mesh-ancestor
101898240|NCT01148342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101898241|NCT01148342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898242|NCT01148342|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101898243|NCT01148342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101898244|NCT01148342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101898245|NCT01148342|Adrenergic Agents|adrenergic agents|mesh-ancestor
101898246|NCT03557242|Aspirin|aspirin|mesh-list
101898247|NCT03557242|Warfarin|warfarin|mesh-list
101898248|NCT03557242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101898249|NCT03557242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101898250|NCT03557242|Analgesics|analgesics|mesh-ancestor
101898251|NCT03557242|Sensory System Agents|sensory system agents|mesh-ancestor
101898252|NCT03557242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101898253|NCT03557242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898254|NCT03557242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101898255|NCT03557242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101898256|NCT03557242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101898257|NCT03557242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101898258|NCT03557242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898259|NCT03557242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101898260|NCT03557242|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101898261|NCT03557242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101898262|NCT03557242|Antipyretics|antipyretics|mesh-ancestor
101898263|NCT03557242|Anticoagulants|anticoagulants|mesh-ancestor
101898264|NCT04774666|Antibodies|antibodies|mesh-list
101898265|NCT04774666|Immunologic Factors|immunologic factors|mesh-ancestor
101898266|NCT04774666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898267|NCT01150448|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101898268|NCT01150448|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101898269|NCT01150448|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101898270|NCT01150448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101898271|NCT01150448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898272|NCT01150448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101898273|NCT01150448|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101898274|NCT01150448|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101898275|NCT01150448|Serotonin Agents|serotonin agents|mesh-ancestor
101898276|NCT01150448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101898277|NCT01150448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898278|NCT01150448|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101898279|NCT01150448|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101898280|NCT01150448|Dopamine Agents|dopamine agents|mesh-ancestor
101898281|NCT03898466|Fluticasone|fluticasone|mesh-list
101898282|NCT03898466|Xhance|xhance|mesh-list
101898283|NCT03898466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101898284|NCT03898466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101898285|NCT03898466|Autonomic Agents|autonomic agents|mesh-ancestor
101898286|NCT03898466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101898287|NCT03898466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898288|NCT03898466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101898289|NCT03898466|Respiratory System Agents|respiratory system agents|mesh-ancestor
101898290|NCT03898466|Dermatologic Agents|dermatologic agents|mesh-ancestor
101898291|NCT03898466|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101898292|NCT03907124|Psychotropic Drugs|psychotropic drugs|mesh-list
101898293|NCT02527772|Leucovorin|leucovorin|mesh-list
101898294|NCT02527772|Gemcitabine|gemcitabine|mesh-list
101898295|NCT02527772|Fluorouracil|fluorouracil|mesh-list
101898296|NCT02527772|Doxorubicin|doxorubicin|mesh-list
101898297|NCT02527772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101898298|NCT02527772|Oxaliplatin|oxaliplatin|mesh-list
101898299|NCT02527772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101898300|NCT02527772|Antimetabolites|antimetabolites|mesh-ancestor
101898301|NCT02527772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898302|NCT02527772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101898303|NCT02527772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101898304|NCT02527772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101898305|NCT02527772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101898306|NCT02527772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101898307|NCT02527772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101898308|NCT02527772|Immunologic Factors|immunologic factors|mesh-ancestor
101898309|NCT02527772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898310|NCT02527772|Antidotes|antidotes|mesh-ancestor
101898311|NCT02527772|Protective Agents|protective agents|mesh-ancestor
101898312|NCT02527772|Vitamin B Complex|vitamin b complex|mesh-ancestor
101898314|NCT02527772|Micronutrients|micronutrients|mesh-ancestor
101898315|NCT03273946|Fluticasone|fluticasone|mesh-list
101898316|NCT03273946|Xhance|xhance|mesh-list
101898317|NCT03273946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101898318|NCT03273946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101898319|NCT03273946|Autonomic Agents|autonomic agents|mesh-ancestor
101898320|NCT03273946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101898321|NCT03273946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898322|NCT03273946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101898323|NCT03273946|Respiratory System Agents|respiratory system agents|mesh-ancestor
101898324|NCT03273946|Dermatologic Agents|dermatologic agents|mesh-ancestor
101898325|NCT03273946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101898326|NCT00660218|Paclitaxel|paclitaxel|mesh-list
101898327|NCT00660218|Cetuximab|cetuximab|mesh-list
101898328|NCT00660218|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
101898329|NCT00660218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101898330|NCT00660218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101898331|NCT00660218|Tubulin Modulators|tubulin modulators|mesh-ancestor
101898332|NCT00660218|Antimitotic Agents|antimitotic agents|mesh-ancestor
101898333|NCT00660218|Mitosis Modulators|mitosis modulators|mesh-ancestor
101898334|NCT00660218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898335|NCT00660218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101898336|NCT00314951|Vancomycin|vancomycin|mesh-list
101898337|NCT00314951|Fidaxomicin|fidaxomicin|mesh-list
101898338|NCT00314951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101898339|NCT00314951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101898340|NCT00085644|Adalimumab|adalimumab|mesh-list
101898341|NCT00085644|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101898342|NCT00085644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101898343|NCT00085644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101898344|NCT01257074|Acyclovir|acyclovir|mesh-list
101898345|NCT01257074|Penciclovir|penciclovir|mesh-list
101898346|NCT01257074|Antiviral Agents|antiviral agents|mesh-ancestor
101898347|NCT01257074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101898348|NCT04597918|Faricimab|faricimab|mesh-list
101898349|NCT04597918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101898350|NCT04597918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101898352|NCT04597918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898353|NCT04597918|Growth Inhibitors|growth inhibitors|mesh-ancestor
101898354|NCT04597918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101898355|NCT01149278|Benzocaine|benzocaine|mesh-list
101898356|NCT01149278|Anesthetics, Local|anesthetics, local|mesh-ancestor
101898357|NCT01149278|Anesthetics|anesthetics|mesh-ancestor
101898358|NCT01149278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101898359|NCT01149278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898360|NCT01149278|Sensory System Agents|sensory system agents|mesh-ancestor
101898361|NCT01149278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101898362|NCT01086774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101898363|NCT01086774|Lubricant Eye Drops|lubricant eye drops|mesh-list
101898364|NCT01086774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101898365|NCT03902522|Leronlimab|leronlimab|mesh-list
101898366|NCT03902522|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101898367|NCT03902522|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101898368|NCT03902522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898369|NCT03902522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101898370|NCT03902522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101898371|NCT03902522|Antiviral Agents|antiviral agents|mesh-ancestor
101898372|NCT03902522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101898373|NCT01092858|Methyltestosterone|methyltestosterone|mesh-list
101898374|NCT01092858|Testosterone|testosterone|mesh-list
101898375|NCT01092858|Testosterone undecanoate|testosterone undecanoate|mesh-list
101898376|NCT01092858|Testosterone enanthate|testosterone enanthate|mesh-list
101898377|NCT01092858|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101898378|NCT01092858|Androgens|androgens|mesh-ancestor
101898379|NCT01092858|Hormones|hormones|mesh-ancestor
101898380|NCT01092858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101898381|NCT01092858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898382|NCT01092858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101898383|NCT01092858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101898384|NCT01092858|Anabolic Agents|anabolic agents|mesh-ancestor
101898385|NCT00314327|Risperidone|risperidone|mesh-list
101898386|NCT00314327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101898387|NCT00314327|Serotonin Agents|serotonin agents|mesh-ancestor
101898388|NCT00314327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101689939|NCT00650910|Lapatinib|lapatinib|mesh-list
101898389|NCT00314327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690152|NCT02827331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898390|NCT00314327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898391|NCT00314327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101898393|NCT00314327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101690753|NCT02642484|Antacids|antacids|mesh-ancestor
101898394|NCT00314327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101898395|NCT00314327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101898396|NCT00314327|Dopamine Agents|dopamine agents|mesh-ancestor
101898397|NCT03897452|Fentanyl|fentanyl|mesh-list
101898398|NCT03897452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101898399|NCT03897452|Narcotics|narcotics|mesh-ancestor
101690964|NCT00622622|Gemcitabine|gemcitabine|mesh-list
101691035|NCT00681213|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101691209|NCT02626845|Rituximab|rituximab|mesh-list
101898400|NCT03897452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101898401|NCT03897452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691482|NCT02687984|Dopamine Agents|dopamine agents|mesh-ancestor
101898403|NCT03897452|Sensory System Agents|sensory system agents|mesh-ancestor
101898404|NCT03897452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101898405|NCT03897452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101898406|NCT03897452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101898409|NCT01151072|Insulin|insulin|mesh-list
101898410|NCT01151072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101692220|NCT04236323|Analgesics|analgesics|mesh-ancestor
101692292|NCT03973177|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101692443|NCT02677532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101898411|NCT01151072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692599|NCT02802215|Folic Acid|folic acid|mesh-list
101898412|NCT01257386|Mesalamine|mesalamine|mesh-list
101692670|NCT02817191|BB 1101|bb 1101|mesh-list
101692745|NCT00962299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101692965|NCT02797067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101898413|NCT01257386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101898414|NCT01257386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101898415|NCT01257386|Analgesics|analgesics|mesh-ancestor
101693277|NCT00644306|Prednisone|prednisone|mesh-list
101898416|NCT01257386|Sensory System Agents|sensory system agents|mesh-ancestor
101898417|NCT01257386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101898418|NCT01257386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898419|NCT01257386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101898420|NCT01257386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101898421|NCT01257464|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101693628|NCT00959881|Donepezil|donepezil|mesh-list
101898422|NCT01257464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
101898423|NCT01257464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101898424|NCT01257464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693999|NCT00659412|Alefacept|alefacept|mesh-list
101694074|NCT00961753|Ibuprofen|ibuprofen|mesh-list
101694147|NCT00966745|Milrinone|milrinone|mesh-list
101694220|NCT04160598|Anesthetics, General|anesthetics, general|mesh-ancestor
101694309|NCT00967057|Analgesics|analgesics|mesh-ancestor
101694368|NCT00967135|Pregabalin|pregabalin|mesh-list
101694443|NCT00884832|Autonomic Agents|autonomic agents|mesh-ancestor
101694519|NCT00657306|Hydrocortisone|hydrocortisone|mesh-list
101694593|NCT00973609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101694815|NCT00661596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101694891|NCT00873093|Etoposide phosphate|etoposide phosphate|mesh-list
101694965|NCT00647660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101695043|NCT02624973|Immunologic Factors|immunologic factors|mesh-ancestor
101941634|NCT01131429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941635|NCT01131429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101941636|NCT01131429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101941637|NCT03645304|Ropivacaine|ropivacaine|mesh-list
101941638|NCT03645304|Anesthetics, Local|anesthetics, local|mesh-ancestor
101941639|NCT03645304|Anesthetics|anesthetics|mesh-ancestor
101695409|NCT00693927|Fludarabine|fludarabine|mesh-list
101695492|NCT03921151|Serotonin Agents|serotonin agents|mesh-ancestor
101941640|NCT03645304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101695642|NCT02663570|Melatonin|melatonin|mesh-list
101695765|NCT00980707|Xhance|xhance|mesh-list
101941641|NCT03645304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695930|NCT00977353|Citalopram|citalopram|mesh-list
101696000|NCT02616315|Antidepressive Agents|antidepressive agents|mesh-ancestor
101941643|NCT03645304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101696300|NCT04227041|Antimetabolites|antimetabolites|mesh-ancestor
101696380|NCT02671864|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101696382|NCT02671864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696383|NCT02671864|Hormones|hormones|mesh-ancestor
101696384|NCT02671864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101696522|NCT04226885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101696600|NCT02660684|Abortifacient Agents|abortifacient agents|mesh-ancestor
101696673|NCT02778659|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101696821|NCT00985387|Cholinergic Agents|cholinergic agents|mesh-ancestor
101696826|NCT02776943|Hyaluronic Acid|hyaluronic acid|mesh-list
101898427|NCT01257464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101898428|NCT01257464|Protease Inhibitors|protease inhibitors|mesh-ancestor
101898429|NCT01257464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101898430|NCT01257464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898431|NCT01255046|Donepezil|donepezil|mesh-list
101898432|NCT01255046|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101898433|NCT01255046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101898434|NCT01255046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898435|NCT01255046|Cholinergic Agents|cholinergic agents|mesh-ancestor
101898436|NCT01255046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101898437|NCT01255046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898438|NCT01255046|Nootropic Agents|nootropic agents|mesh-ancestor
101898440|NCT01149356|Goserelin|goserelin|mesh-list
101697330|NCT00650468|Mycophenolic Acid|mycophenolic acid|mesh-list
101898441|NCT01149356|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
101697404|NCT00649532|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101898442|NCT01149356|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
101697473|NCT02766647|Immunologic Factors|immunologic factors|mesh-ancestor
101898443|NCT01149356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101898444|NCT01149356|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101697769|NCT04225325|Antiviral Agents|antiviral agents|mesh-ancestor
101898445|NCT01149356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101898446|NCT01149356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101898447|NCT01149356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898448|NCT01149356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101898449|NCT01149356|Hormone Antagonists|hormone antagonists|mesh-ancestor
101898450|NCT01149356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101698213|NCT02763761|Infliximab|infliximab|mesh-list
101698286|NCT00987493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101898451|NCT01149356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698367|NCT02762123|Analgesics|analgesics|mesh-ancestor
101898453|NCT01148576|Vitamin E|vitamin e|mesh-list
101898454|NCT01148576|Entecavir|entecavir|mesh-list
101898455|NCT01148576|Essential 303 forte|essential 303 forte|mesh-list
101698737|NCT04154748|Omeprazole|omeprazole|mesh-list
101898459|NCT01148576|Antioxidants|antioxidants|mesh-ancestor
101699033|NCT02576626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101699105|NCT02575222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101898460|NCT01148576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898461|NCT01148576|Protective Agents|protective agents|mesh-ancestor
101898462|NCT01148576|Antiviral Agents|antiviral agents|mesh-ancestor
101686534|NCT02771249|Micronutrients|micronutrients|mesh-ancestor
101898463|NCT01148576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101898464|NCT01148576|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101898465|NCT01148576|Immunologic Factors|immunologic factors|mesh-ancestor
101898466|NCT01148576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101898467|NCT01148576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101898468|NCT01148576|Antimetabolites|antimetabolites|mesh-ancestor
101699775|NCT00635921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101898469|NCT01148576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101898470|NCT01148576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101699993|NCT02643602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101700069|NCT02647268|Tocolytic Agents|tocolytic agents|mesh-ancestor
101898471|NCT01148576|Antitubercular Agents|antitubercular agents|mesh-ancestor
101898472|NCT01148576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101898473|NCT01148576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101898474|NCT03905486|Pregabalin|pregabalin|mesh-list
101898475|NCT03905486|Analgesics|analgesics|mesh-ancestor
101898476|NCT03905486|Sensory System Agents|sensory system agents|mesh-ancestor
101898477|NCT03905486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101898478|NCT03905486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700516|NCT00990847|Procaterol|procaterol|mesh-list
101700582|NCT00682656|Meglumine Antimoniate|meglumine antimoniate|mesh-list
101700736|NCT02744417|Autonomic Agents|autonomic agents|mesh-ancestor
101700890|NCT02742623|Anticoagulants|anticoagulants|mesh-ancestor
101898479|NCT03905486|Anticonvulsants|anticonvulsants|mesh-ancestor
101898480|NCT03905486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101898481|NCT03905486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101898482|NCT03905486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898483|NCT03905486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101898484|NCT03905486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101898485|NCT03905486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101898486|NCT03905486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101898487|NCT03905486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101898488|NCT03901118|Paclitaxel|paclitaxel|mesh-list
101898489|NCT03901118|Etoposide|etoposide|mesh-list
101898490|NCT03901118|Chiauranib|chiauranib|mesh-list
101701631|NCT02732249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101701779|NCT03214250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101701852|NCT00653510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898491|NCT03901118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101702074|NCT00691548|Cetuximab|cetuximab|mesh-list
101898492|NCT03901118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702303|NCT02726867|Anesthetics, General|anesthetics, general|mesh-ancestor
101898493|NCT03901118|Tubulin Modulators|tubulin modulators|mesh-ancestor
101898494|NCT03901118|Antimitotic Agents|antimitotic agents|mesh-ancestor
101898495|NCT03901118|Mitosis Modulators|mitosis modulators|mesh-ancestor
101898496|NCT03901118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898497|NCT03901118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101898498|NCT03901118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101898499|NCT03901118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101898500|NCT03901118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101898501|NCT03895892|Caffeine|caffeine|mesh-list
101898502|NCT03895892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101898503|NCT03895892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898504|NCT03895892|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101898505|NCT03895892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101898506|NCT03895892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898507|NCT03895892|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101898508|NCT03895892|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101898509|NCT03895892|Purinergic Agents|purinergic agents|mesh-ancestor
101898510|NCT03895892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101898511|NCT01151306|Simvastatin|simvastatin|mesh-list
101898512|NCT01151306|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101898513|NCT01151306|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101898514|NCT01151306|Antimetabolites|antimetabolites|mesh-ancestor
101898515|NCT01151306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898516|NCT01151306|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101898517|NCT01151306|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101898518|NCT01151306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101898519|NCT05570786|Gestrinone|gestrinone|mesh-list
101898520|NCT05570786|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101898521|NCT05570786|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101898522|NCT05570786|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101898523|NCT05570786|Contraceptive Agents|contraceptive agents|mesh-ancestor
101898524|NCT05570786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101898525|NCT05570786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898526|NCT05570786|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101898527|NCT05570786|Progestins|progestins|mesh-ancestor
101898528|NCT05570786|Hormones|hormones|mesh-ancestor
101898529|NCT05570786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101898530|NCT03895970|Pembrolizumab|pembrolizumab|mesh-list
101898531|NCT03895970|Lenvatinib|lenvatinib|mesh-list
101898532|NCT03895970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101898533|NCT03895970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101898534|NCT03895970|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101898535|NCT03895970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898536|NCT03895970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101898537|NCT03895970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101898538|NCT00336479|Interferons|interferons|mesh-list
101898539|NCT00336479|Ribavirin|ribavirin|mesh-list
101898540|NCT00336479|Interferon-alpha|interferon-alpha|mesh-list
101898541|NCT00336479|Interferon alpha-2|interferon alpha-2|mesh-list
101898542|NCT00336479|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101898543|NCT00336479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101898544|NCT00336479|Antiviral Agents|antiviral agents|mesh-ancestor
101898545|NCT00336479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101898546|NCT00336479|Antimetabolites|antimetabolites|mesh-ancestor
101898547|NCT00336479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898548|NCT00336479|Immunologic Factors|immunologic factors|mesh-ancestor
101898549|NCT00336479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898550|NCT03905564|Pyridoxine|pyridoxine|mesh-list
101898551|NCT03905564|Vitamin B 6|vitamin b 6|mesh-list
101898552|NCT03905564|Doxylamine|doxylamine|mesh-list
101898553|NCT03905564|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
101898554|NCT03905564|Doxylamine succinate|doxylamine succinate|mesh-list
101898555|NCT03905564|Vitamin B Complex|vitamin b complex|mesh-ancestor
101898556|NCT03905564|Vitamins|vitamins|mesh-ancestor
101898557|NCT03905564|Micronutrients|micronutrients|mesh-ancestor
101898558|NCT03905564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898559|NCT03905564|Antiemetics|antiemetics|mesh-ancestor
101898560|NCT03905564|Autonomic Agents|autonomic agents|mesh-ancestor
101898561|NCT03905564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101898562|NCT03905564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101898563|NCT03905564|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101898564|NCT03905564|Histamine Antagonists|histamine antagonists|mesh-ancestor
101898565|NCT03905564|Histamine Agents|histamine agents|mesh-ancestor
101898566|NCT03905564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101898567|NCT03905564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898568|NCT01151384|Docetaxel|docetaxel|mesh-list
101898569|NCT01151384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101898570|NCT01151384|Tubulin Modulators|tubulin modulators|mesh-ancestor
101898571|NCT01151384|Antimitotic Agents|antimitotic agents|mesh-ancestor
101898572|NCT01151384|Mitosis Modulators|mitosis modulators|mesh-ancestor
101898573|NCT01151384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898574|NCT01258010|Tranexamic Acid|tranexamic acid|mesh-list
101898575|NCT01258010|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101898576|NCT01258010|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101898577|NCT01258010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898578|NCT01258010|Hemostatics|hemostatics|mesh-ancestor
101898579|NCT01258010|Coagulants|coagulants|mesh-ancestor
101898580|NCT00314249|Milnacipran|milnacipran|mesh-list
101898581|NCT00314249|Levomilnacipran|levomilnacipran|mesh-list
101898582|NCT00314249|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101898583|NCT00314249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101898584|NCT00314249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101898585|NCT00314249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898586|NCT00314249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101898587|NCT00314249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898588|NCT00314249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101898589|NCT00314249|Analgesics|analgesics|mesh-ancestor
101898590|NCT00314249|Sensory System Agents|sensory system agents|mesh-ancestor
101898591|NCT00314249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101898593|NCT00314249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101898594|NCT03905018|Tadalafil|tadalafil|mesh-list
101898595|NCT03905018|Vasodilator Agents|vasodilator agents|mesh-ancestor
101898596|NCT03905018|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101898597|NCT03905018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101898598|NCT03905018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101898599|NCT03905018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898600|NCT03905018|Urological Agents|urological agents|mesh-ancestor
101898601|NCT03894722|Povidone-Iodine|povidone-iodine|mesh-list
101898602|NCT03894722|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101898603|NCT03894722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101898604|NCT03894800|Fentanyl|fentanyl|mesh-list
101898605|NCT03894800|Methoxyflurane|methoxyflurane|mesh-list
101898606|NCT03894800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101898607|NCT03894800|Narcotics|narcotics|mesh-ancestor
101898608|NCT03894800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101898609|NCT03894800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898610|NCT03894800|Analgesics|analgesics|mesh-ancestor
101898611|NCT03894800|Sensory System Agents|sensory system agents|mesh-ancestor
101898612|NCT03894800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101898613|NCT03894800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101898614|NCT03894800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101898615|NCT03894800|Anesthetics, General|anesthetics, general|mesh-ancestor
101898616|NCT03894800|Anesthetics|anesthetics|mesh-ancestor
101898617|NCT03894800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101898618|NCT03900026|Evolocumab|evolocumab|mesh-list
101898619|NCT03900026|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101898620|NCT03900026|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101898621|NCT03900026|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101898622|NCT03900026|Antimetabolites|antimetabolites|mesh-ancestor
101898623|NCT03900026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898624|NCT03900026|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101898625|NCT03900026|Protease Inhibitors|protease inhibitors|mesh-ancestor
101898626|NCT03900026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101898627|NCT03900026|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101898628|NCT01149668|Abexinostat|abexinostat|mesh-list
101898629|NCT01149668|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101898630|NCT01149668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101898631|NCT01149668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898632|NCT01149746|Tamsulosin|tamsulosin|mesh-list
101898633|NCT01149746|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101898634|NCT01149746|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101898635|NCT01149746|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101898636|NCT01149746|Adrenergic Agents|adrenergic agents|mesh-ancestor
101898637|NCT01149746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101898638|NCT01149746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898639|NCT01149746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898640|NCT01149746|Urological Agents|urological agents|mesh-ancestor
101898641|NCT01149824|Salvinorin A|salvinorin a|mesh-list
101898642|NCT01149824|Hallucinogens|hallucinogens|mesh-ancestor
101898643|NCT01149824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898644|NCT01149824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101898645|NCT01149902|Cyclophosphamide|cyclophosphamide|mesh-list
101898646|NCT01149902|Docetaxel|docetaxel|mesh-list
101898647|NCT01149902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101898648|NCT01149902|Immunologic Factors|immunologic factors|mesh-ancestor
101898649|NCT01149902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898650|NCT01149902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101898651|NCT01149902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101898652|NCT01149902|Alkylating Agents|alkylating agents|mesh-ancestor
101898653|NCT01149902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898654|NCT01149902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101898655|NCT01149902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101898656|NCT01149902|Tubulin Modulators|tubulin modulators|mesh-ancestor
101898657|NCT01149902|Antimitotic Agents|antimitotic agents|mesh-ancestor
101898658|NCT01149902|Mitosis Modulators|mitosis modulators|mesh-ancestor
101898659|NCT01151696|Hydroxyzine|hydroxyzine|mesh-list
101898660|NCT01151696|Antipruritics|antipruritics|mesh-ancestor
101898661|NCT01151696|Dermatologic Agents|dermatologic agents|mesh-ancestor
101898662|NCT01151696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101898663|NCT01151696|Histamine Antagonists|histamine antagonists|mesh-ancestor
101898665|NCT01151696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101898666|NCT01151696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898667|NCT01151696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898668|NCT01149980|Dexetimide|dexetimide|mesh-list
101898669|NCT01149980|Citalopram|citalopram|mesh-list
101898670|NCT01149980|Escitalopram|escitalopram|mesh-list
101898671|NCT01149980|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101898672|NCT01149980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101898673|NCT01149980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101898674|NCT01149980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898675|NCT01149980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101898676|NCT01149980|Serotonin Agents|serotonin agents|mesh-ancestor
101898677|NCT01149980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898678|NCT01149980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101898679|NCT01149980|Antidepressive Agents|antidepressive agents|mesh-ancestor
101898680|NCT01149980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101898681|NCT01149980|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101898682|NCT01149980|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101898683|NCT01149980|Parasympatholytics|parasympatholytics|mesh-ancestor
101898684|NCT01149980|Autonomic Agents|autonomic agents|mesh-ancestor
101898685|NCT01149980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101898686|NCT01149980|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101898687|NCT01149980|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101898688|NCT01149980|Cholinergic Agents|cholinergic agents|mesh-ancestor
101898689|NCT01258322|Pioglitazone|pioglitazone|mesh-list
101898690|NCT01258322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101898691|NCT01258322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898692|NCT01255358|Dexamethasone|dexamethasone|mesh-list
101898693|NCT01255358|Dexamethasone acetate|dexamethasone acetate|mesh-list
101898694|NCT01255358|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101898695|NCT01255358|BB 1101|bb 1101|mesh-list
101898696|NCT01255358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101898697|NCT01255358|Antiemetics|antiemetics|mesh-ancestor
101898698|NCT01255358|Autonomic Agents|autonomic agents|mesh-ancestor
101898699|NCT01255358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101898700|NCT01255358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898701|NCT01255358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101898702|NCT01255358|Glucocorticoids|glucocorticoids|mesh-ancestor
101898703|NCT01255358|Hormones|hormones|mesh-ancestor
101898704|NCT01255358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101898705|NCT01255358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101898706|NCT01255358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101898707|NCT01255358|Protease Inhibitors|protease inhibitors|mesh-ancestor
101898708|NCT01255358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101898709|NCT01255358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898710|NCT03899246|Capsaicin|capsaicin|mesh-list
101898711|NCT03899246|Antipruritics|antipruritics|mesh-ancestor
101898712|NCT03899246|Dermatologic Agents|dermatologic agents|mesh-ancestor
101898713|NCT03899246|Sensory System Agents|sensory system agents|mesh-ancestor
101898714|NCT03899246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101898715|NCT03899246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898716|NCT03893864|Ubiquinone|ubiquinone|mesh-list
101898717|NCT03893864|Coenzyme Q10|coenzyme q10|mesh-list
101898718|NCT03893864|Antioxidants|antioxidants|mesh-list
101261583|NCT01750801|Propolis|propolis|mesh-list
101898719|NCT03893864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898720|NCT03893864|Protective Agents|protective agents|mesh-ancestor
101898721|NCT03893864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898722|NCT03893864|Micronutrients|micronutrients|mesh-ancestor
101898724|NCT03899324|Bumetanide|bumetanide|mesh-list
101898725|NCT03899324|Diuretics|diuretics|mesh-ancestor
101898726|NCT03899324|Natriuretic Agents|natriuretic agents|mesh-ancestor
101898727|NCT03899324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898728|NCT03899324|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101898729|NCT03899324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101898730|NCT03899324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898731|NCT01148966|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101898732|NCT01148966|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101969667|NCT02284282|Lidocaine|lidocaine|mesh-list
101898733|NCT01148966|Dermatologic Agents|dermatologic agents|mesh-ancestor
101898734|NCT01258634|Leucovorin|leucovorin|mesh-list
101898735|NCT01258634|Doxorubicin|doxorubicin|mesh-list
101898736|NCT01258634|Etoposide|etoposide|mesh-list
101898737|NCT01258634|Ifosfamide|ifosfamide|mesh-list
101898738|NCT01258634|Dexrazoxane|dexrazoxane|mesh-list
101898739|NCT01258634|Razoxane|razoxane|mesh-list
101898740|NCT01258634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101898741|NCT01258634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101898742|NCT01258634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101898743|NCT01258634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101898744|NCT01258634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101898745|NCT01258634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898746|NCT01258634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101898747|NCT01258634|Antidotes|antidotes|mesh-ancestor
101898748|NCT01258634|Protective Agents|protective agents|mesh-ancestor
101898749|NCT01258634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898750|NCT01258634|Vitamin B Complex|vitamin b complex|mesh-ancestor
101898751|NCT01258634|Vitamins|vitamins|mesh-ancestor
101898752|NCT01258634|Micronutrients|micronutrients|mesh-ancestor
101898753|NCT01258634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101898754|NCT01258634|Alkylating Agents|alkylating agents|mesh-ancestor
101898755|NCT01258634|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101898756|NCT01258634|Antimitotic Agents|antimitotic agents|mesh-ancestor
101898757|NCT01258634|Mitosis Modulators|mitosis modulators|mesh-ancestor
101898758|NCT01258712|Methotrexate|methotrexate|mesh-list
101898759|NCT01258712|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101898760|NCT01258712|Abortifacient Agents|abortifacient agents|mesh-ancestor
101898761|NCT01258712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101898762|NCT01258712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898763|NCT01258712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101898764|NCT01258712|Antimetabolites|antimetabolites|mesh-ancestor
101898765|NCT01258712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898766|NCT01258712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101898767|NCT01258712|Dermatologic Agents|dermatologic agents|mesh-ancestor
101898768|NCT01258712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101898769|NCT01258712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101898770|NCT01258712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101898771|NCT01258712|Immunologic Factors|immunologic factors|mesh-ancestor
101898772|NCT01258712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101898773|NCT01258712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101898774|NCT01258868|Celecoxib|celecoxib|mesh-list
101898775|NCT01258868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101898776|NCT01258868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101898777|NCT01258868|Analgesics|analgesics|mesh-ancestor
101898778|NCT01258868|Sensory System Agents|sensory system agents|mesh-ancestor
101898779|NCT01258868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101898780|NCT01258868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898781|NCT01258868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101898782|NCT01258868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101898783|NCT01258868|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101898784|NCT01258868|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101898785|NCT01258868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101898786|NCT01258868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898787|NCT01254578|Lenalidomide|lenalidomide|mesh-list
101898788|NCT01254578|Immunologic Factors|immunologic factors|mesh-ancestor
101898789|NCT01254578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898790|NCT01254578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101898791|NCT01254578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101898792|NCT01254578|Growth Substances|growth substances|mesh-ancestor
101898793|NCT01254578|Growth Inhibitors|growth inhibitors|mesh-ancestor
101898794|NCT01254578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101898795|NCT03892928|Dexmedetomidine|dexmedetomidine|mesh-list
101898796|NCT03892928|Propofol|propofol|mesh-list
101898797|NCT03892928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101898798|NCT03892928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101898799|NCT03892928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898800|NCT03892928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101898801|NCT03892928|Analgesics|analgesics|mesh-ancestor
101898802|NCT03892928|Sensory System Agents|sensory system agents|mesh-ancestor
101898803|NCT03892928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101898804|NCT03892928|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101969669|NCT02284282|Bupivacaine|bupivacaine|mesh-list
101898805|NCT03892928|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101898806|NCT03892928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101898807|NCT03892928|Adrenergic Agents|adrenergic agents|mesh-ancestor
101898808|NCT03892928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101898809|NCT03892928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898810|NCT03892928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101898811|NCT03892928|Anesthetics, General|anesthetics, general|mesh-ancestor
101898812|NCT03892928|Anesthetics|anesthetics|mesh-ancestor
101898813|NCT01152242|Insulin Glargine|insulin glargine|mesh-list
101898814|NCT01152242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101898815|NCT01152242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898816|NCT03341806|Avelumab|avelumab|mesh-list
101898817|NCT03341806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101898818|NCT03341806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101898819|NCT03904004|Botulinum Toxins|botulinum toxins|mesh-list
101898820|NCT03904004|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101898821|NCT03904004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101898822|NCT03904004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898823|NCT03904004|Cholinergic Agents|cholinergic agents|mesh-ancestor
101898824|NCT03904004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101898825|NCT03904004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898826|NCT01149122|Gemcitabine|gemcitabine|mesh-list
101898827|NCT01149122|Oxaliplatin|oxaliplatin|mesh-list
101898828|NCT01149122|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101898829|NCT01149122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101898830|NCT01149122|Antimetabolites|antimetabolites|mesh-ancestor
101898831|NCT01149122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898832|NCT01149122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101898833|NCT01149122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101898834|NCT01149122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101898835|NCT01152398|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
101898836|NCT01152398|Antiviral Agents|antiviral agents|mesh-ancestor
101898837|NCT01152398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101898838|NCT03892148|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101898839|NCT03892148|Furosemide|furosemide|mesh-list
101898840|NCT03892148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101898841|NCT03892148|Diuretics|diuretics|mesh-ancestor
101898842|NCT03892148|Natriuretic Agents|natriuretic agents|mesh-ancestor
101898843|NCT03892148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898844|NCT03892148|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101898845|NCT03892148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101898846|NCT03892148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898847|NCT03892148|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101898848|NCT01152476|Remifentanil|remifentanil|mesh-list
101898849|NCT01152476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101898850|NCT01152476|Narcotics|narcotics|mesh-ancestor
101898851|NCT01152476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101898852|NCT01152476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898853|NCT01152476|Analgesics|analgesics|mesh-ancestor
101898854|NCT01152476|Sensory System Agents|sensory system agents|mesh-ancestor
101898855|NCT01152476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101898856|NCT03892070|Mannitol|mannitol|mesh-list
101898857|NCT03892070|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101898858|NCT03892070|Diuretics|diuretics|mesh-ancestor
101898859|NCT03892070|Natriuretic Agents|natriuretic agents|mesh-ancestor
101898860|NCT03892070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898861|NCT01155440|Lidocaine|lidocaine|mesh-list
101898862|NCT01155440|Anesthetics, Local|anesthetics, local|mesh-ancestor
101898863|NCT01155440|Anesthetics|anesthetics|mesh-ancestor
101898864|NCT01155440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101898865|NCT01155440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898866|NCT01155440|Sensory System Agents|sensory system agents|mesh-ancestor
101898867|NCT01155440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101898868|NCT01155440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101898869|NCT01155440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101898870|NCT01155440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101898871|NCT01155440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101969672|NCT02284282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101898872|NCT01155440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898874|NCT01259336|Antifungal Agents|antifungal agents|mesh-ancestor
101898875|NCT01259336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101898876|NCT01259336|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101898877|NCT01259336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101898878|NCT01259336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101898879|NCT01259336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898880|NCT01259336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101898881|NCT01259336|Hormone Antagonists|hormone antagonists|mesh-ancestor
101898882|NCT01259336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101898883|NCT01259336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898884|NCT01259336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101898885|NCT01259414|Ethiodized Oil|ethiodized oil|mesh-list
101898886|NCT01259414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101898887|NCT03314662|Vaccines|vaccines|mesh-list
101898888|NCT03314662|MF59 oil emulsion|mf59 oil emulsion|mesh-list
101898889|NCT03314662|Immunologic Factors|immunologic factors|mesh-ancestor
101898890|NCT03314662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898891|NCT03314662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101898892|NCT01152710|Capecitabine|capecitabine|mesh-list
101898893|NCT01152710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101898894|NCT01152710|Antimetabolites|antimetabolites|mesh-ancestor
101898895|NCT01152710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898896|NCT01152710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101898897|NCT03271528|Lacosamide|lacosamide|mesh-list
101898898|NCT03271528|Anticonvulsants|anticonvulsants|mesh-ancestor
101898899|NCT03271528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101898900|NCT03271528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101898901|NCT03271528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101898902|NCT03271528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898903|NCT04480372|Gemcitabine|gemcitabine|mesh-list
101898904|NCT04480372|Atezolizumab|atezolizumab|mesh-list
101898905|NCT04480372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101898906|NCT04480372|Antimetabolites|antimetabolites|mesh-ancestor
101898907|NCT04480372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898908|NCT04480372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101898909|NCT04480372|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101898910|NCT04480372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101898911|NCT04462276|Atezolizumab|atezolizumab|mesh-list
101898912|NCT04462276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101898913|NCT04462276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898914|NCT04462276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101898915|NCT04462276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101898916|NCT03890510|Anesthetics|anesthetics|mesh-list
101898917|NCT03890510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101898918|NCT03890510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898919|NCT01152866|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101898920|NCT01152866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101898921|NCT01152866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898922|NCT01153568|Vitamin D|vitamin d|mesh-list
101898923|NCT01153568|Cholecalciferol|cholecalciferol|mesh-list
101898924|NCT01153568|Vitamins|vitamins|mesh-ancestor
101898925|NCT01153568|Micronutrients|micronutrients|mesh-ancestor
101898926|NCT01153568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898927|NCT01153568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101898928|NCT01153568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101898929|NCT03889808|Antitoxins|antitoxins|mesh-list
101898930|NCT03889808|Immunologic Factors|immunologic factors|mesh-ancestor
101898931|NCT03889808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898932|NCT03890042|Dienogest|dienogest|mesh-list
101898933|NCT03890042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101898934|NCT03890042|Gestodene|gestodene|mesh-list
101898935|NCT03890042|Femovan|femovan|mesh-list
101898936|NCT03890042|Estradiol|estradiol|mesh-list
101898937|NCT03890042|Estrogens|estrogens|mesh-ancestor
101898938|NCT03890042|Hormones|hormones|mesh-ancestor
101898939|NCT03890042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101702521|NCT02646020|Cholinergic Agents|cholinergic agents|mesh-ancestor
101898940|NCT03890042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898941|NCT03890042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101898942|NCT03890042|Contraceptive Agents|contraceptive agents|mesh-ancestor
101898943|NCT03890042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101898944|NCT03890042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101898945|NCT03890042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101898946|NCT03890042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101618751|NCT00776659|Hormone Antagonists|hormone antagonists|mesh-ancestor
101898947|NCT03890042|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101898948|NCT03890042|Hormone Antagonists|hormone antagonists|mesh-ancestor
101898949|NCT03890042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101898950|NCT03890042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101898951|NCT03890042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101898952|NCT03890042|Progestins|progestins|mesh-ancestor
101898953|NCT03890042|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101898954|NCT01153802|Dopamine|dopamine|mesh-list
101898955|NCT01153802|Norepinephrine|norepinephrine|mesh-list
101898956|NCT01153802|Serotonin|serotonin|mesh-list
101898957|NCT01153802|Neurotransmitter Agents|neurotransmitter agents|mesh-list
101686621|NCT05662410|Growth Inhibitors|growth inhibitors|mesh-ancestor
101898958|NCT01153802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101898959|NCT01153802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101898960|NCT01153802|Adrenergic Agents|adrenergic agents|mesh-ancestor
101898961|NCT01153802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898962|NCT01153802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898963|NCT01153802|Sympathomimetics|sympathomimetics|mesh-ancestor
101898964|NCT01153802|Autonomic Agents|autonomic agents|mesh-ancestor
101898965|NCT01153802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101898966|NCT01153802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101898967|NCT01153802|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101898968|NCT01153802|Dopamine Agents|dopamine agents|mesh-ancestor
101898969|NCT01153802|Protective Agents|protective agents|mesh-ancestor
101898970|NCT01153802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101898971|NCT01153802|Serotonin Agents|serotonin agents|mesh-ancestor
101898972|NCT01153100|Insulin Glargine|insulin glargine|mesh-list
101898973|NCT01153100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101898974|NCT01153100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898975|NCT01153256|Magnesium Sulfate|magnesium sulfate|mesh-list
101898976|NCT01153256|Analgesics|analgesics|mesh-ancestor
101898977|NCT01153256|Sensory System Agents|sensory system agents|mesh-ancestor
101898978|NCT01153256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101898979|NCT01153256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101898980|NCT01153256|Anesthetics|anesthetics|mesh-ancestor
101898981|NCT01153256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101898982|NCT01153256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101898983|NCT01153256|Anticonvulsants|anticonvulsants|mesh-ancestor
101898984|NCT01153256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101898985|NCT01153256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101898986|NCT01153256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898987|NCT01153256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101898988|NCT01153256|Tocolytic Agents|tocolytic agents|mesh-ancestor
101898989|NCT01153256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101898990|NCT01153334|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101898991|NCT01153334|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101898992|NCT01153334|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101898993|NCT01153334|Antimetabolites|antimetabolites|mesh-ancestor
101898994|NCT01153334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101898995|NCT01153334|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101898996|NCT01153334|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101898997|NCT01153334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101898998|NCT01259804|Immunomodulating Agents|immunomodulating agents|mesh-list
101898999|NCT01259804|Immunologic Factors|immunologic factors|mesh-ancestor
101899000|NCT01259804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899001|NCT01153880|Mupirocin|mupirocin|mesh-list
101899002|NCT01153880|Retapamulin|retapamulin|mesh-list
101899003|NCT01153880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101899004|NCT01153880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101899005|NCT01153880|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101899006|NCT01153880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101899007|NCT01153880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899008|NCT01260506|Bevacizumab|bevacizumab|mesh-list
101899009|NCT01260506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101899010|NCT01260506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101899011|NCT01260506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101899012|NCT01260506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101899013|NCT01260506|Growth Substances|growth substances|mesh-ancestor
101899014|NCT01260506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899015|NCT01260506|Growth Inhibitors|growth inhibitors|mesh-ancestor
101899016|NCT03884972|Venetoclax|venetoclax|mesh-list
101899017|NCT03884972|Trabectedin|trabectedin|mesh-list
101899018|NCT03884972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101899019|NCT03884972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101899020|NCT03884972|Alkylating Agents|alkylating agents|mesh-ancestor
101618827|NCT00778375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101899021|NCT03884972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899022|NCT01154114|Darapladib|darapladib|mesh-list
101899023|NCT01154114|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
101899024|NCT01154114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101899025|NCT01154114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899026|NCT01157312|Citric Acid|citric acid|mesh-list
101899027|NCT01157312|Sodium Citrate|sodium citrate|mesh-list
101899028|NCT01157312|Clomiphene|clomiphene|mesh-list
101899029|NCT01157312|Enclomiphene|enclomiphene|mesh-list
101899030|NCT01157312|Zuclomiphene|zuclomiphene|mesh-list
101899031|NCT01157312|Anticoagulants|anticoagulants|mesh-ancestor
101899032|NCT01157312|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101899033|NCT01157312|Chelating Agents|chelating agents|mesh-ancestor
101899034|NCT01157312|Sequestering Agents|sequestering agents|mesh-ancestor
101899035|NCT01157312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899036|NCT01157312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101899037|NCT01157312|Hormone Antagonists|hormone antagonists|mesh-ancestor
101899038|NCT01157312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101899039|NCT01157312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899040|NCT01157312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101899041|NCT01157312|Fertility Agents|fertility agents|mesh-ancestor
101899042|NCT01157312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101899043|NCT01157312|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101899044|NCT01157312|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101899045|NCT01157546|Lidocaine|lidocaine|mesh-list
101899046|NCT01157546|Anesthetics, Local|anesthetics, local|mesh-ancestor
101899047|NCT01157546|Anesthetics|anesthetics|mesh-ancestor
101899048|NCT01157546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101899049|NCT01157546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899050|NCT01157546|Sensory System Agents|sensory system agents|mesh-ancestor
101899051|NCT01157546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101899052|NCT01157546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101899053|NCT01157546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101899054|NCT01157546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101899055|NCT01157546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101899056|NCT01157546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899057|NCT02527460|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101899058|NCT02527460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101899059|NCT01263860|Ribavirin|ribavirin|mesh-list
101899060|NCT01263860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101899061|NCT01263860|Interferon-alpha|interferon-alpha|mesh-list
101899062|NCT01263860|Antimetabolites|antimetabolites|mesh-ancestor
101899063|NCT01263860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899064|NCT01263860|Antiviral Agents|antiviral agents|mesh-ancestor
101899065|NCT01263860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101899066|NCT01263860|Immunologic Factors|immunologic factors|mesh-ancestor
101899067|NCT01263860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899068|NCT03881306|Oxaliplatin|oxaliplatin|mesh-list
101899069|NCT03881306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101899070|NCT01154348|Metformin|metformin|mesh-list
101899071|NCT01154348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101899072|NCT01154348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899073|NCT00075270|Paclitaxel|paclitaxel|mesh-list
101899074|NCT00075270|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101899075|NCT00075270|Lapatinib|lapatinib|mesh-list
101899076|NCT00075270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101899077|NCT00075270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101899078|NCT00075270|Tubulin Modulators|tubulin modulators|mesh-ancestor
101899079|NCT00075270|Antimitotic Agents|antimitotic agents|mesh-ancestor
101686647|NCT00622206|Antiviral Agents|antiviral agents|mesh-ancestor
101899080|NCT00075270|Mitosis Modulators|mitosis modulators|mesh-ancestor
101969682|NCT02284282|Narcotics|narcotics|mesh-ancestor
101899081|NCT00075270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899082|NCT00075270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101899083|NCT00075270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101899084|NCT01264094|Clevudine|clevudine|mesh-list
101899085|NCT01264094|Antiviral Agents|antiviral agents|mesh-ancestor
101899086|NCT01264094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101899087|NCT03884348|Amoxicillin|amoxicillin|mesh-list
101899088|NCT03884348|Metronidazole|metronidazole|mesh-list
101899089|NCT03884348|Clarithromycin|clarithromycin|mesh-list
101899090|NCT03884348|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101899091|NCT03884348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101899092|NCT03884348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101899093|NCT03884348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101899094|NCT03884348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101899095|NCT03884348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101899096|NCT03884348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101899097|NCT03884348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899098|NCT03884348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101899099|NCT03884348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101899100|NCT01154426|Gemcitabine|gemcitabine|mesh-list
101899101|NCT01154426|Veliparib|veliparib|mesh-list
101899102|NCT01154426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101899103|NCT01154426|Antimetabolites|antimetabolites|mesh-ancestor
101899104|NCT01154426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899105|NCT01154426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101899106|NCT01154426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101899107|NCT01154426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101899108|NCT01589744|Hemostatics|hemostatics|mesh-list
101899109|NCT01589744|Coagulants|coagulants|mesh-ancestor
101899110|NCT01154504|Adrenomedullin|adrenomedullin|mesh-list
101899111|NCT01154504|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101899112|NCT01154504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101899113|NCT01154504|Autonomic Agents|autonomic agents|mesh-ancestor
101899114|NCT01154504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101899115|NCT01154504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899116|NCT01154504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101899117|NCT01154504|Respiratory System Agents|respiratory system agents|mesh-ancestor
101899118|NCT01154504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101899119|NCT01154504|Vasodilator Agents|vasodilator agents|mesh-ancestor
101899120|NCT01154504|Protective Agents|protective agents|mesh-ancestor
101899121|NCT03880916|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101899122|NCT03880916|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101899123|NCT03880916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101899124|NCT03880916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101899125|NCT03880916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899126|NCT03880916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101899127|NCT03880916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899128|NCT03880916|Analgesics|analgesics|mesh-ancestor
101899129|NCT03880916|Sensory System Agents|sensory system agents|mesh-ancestor
101899130|NCT03880916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101899131|NCT03880916|Antidepressive Agents|antidepressive agents|mesh-ancestor
101899132|NCT03880916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101899133|NCT03880916|Dopamine Agents|dopamine agents|mesh-ancestor
101899134|NCT01155908|Amlodipine|amlodipine|mesh-list
101899135|NCT01155908|Benazepril|benazepril|mesh-list
101899136|NCT01155908|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101686657|NCT03574337|Neostigmine|neostigmine|mesh-list
101899137|NCT01155908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101899138|NCT01155908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101899139|NCT01155908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899140|NCT01155908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101899141|NCT01155908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899142|NCT01155908|Vasodilator Agents|vasodilator agents|mesh-ancestor
101899143|NCT01155908|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101899144|NCT01155908|Protease Inhibitors|protease inhibitors|mesh-ancestor
101899145|NCT01155908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101899146|NCT03880448|Metronidazole|metronidazole|mesh-list
101899147|NCT03880448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101899148|NCT03880448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101899149|NCT03880448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101899150|NCT03880448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101899151|NCT03298984|Cytarabine|cytarabine|mesh-list
101899152|NCT03298984|Daunorubicin|daunorubicin|mesh-list
101899153|NCT03298984|Alvocidib|alvocidib|mesh-list
101899154|NCT03298984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101899155|NCT03298984|Antimetabolites|antimetabolites|mesh-ancestor
101899156|NCT03298984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899157|NCT03298984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101899158|NCT03298984|Antiviral Agents|antiviral agents|mesh-ancestor
101899159|NCT03298984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101899160|NCT03298984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101899161|NCT03298984|Immunologic Factors|immunologic factors|mesh-ancestor
101899162|NCT03298984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899163|NCT03298984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101899164|NCT03298984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101899165|NCT03298984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101899166|NCT03298984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101899167|NCT03298984|Growth Inhibitors|growth inhibitors|mesh-ancestor
101899168|NCT03298984|Growth Substances|growth substances|mesh-ancestor
101899169|NCT03298984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101618981|NCT00845650|Immunoglobulins|immunoglobulins|mesh-list
101899170|NCT03887858|Tamsulosin|tamsulosin|mesh-list
101899171|NCT03887858|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101899172|NCT03887858|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101899173|NCT03887858|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101899174|NCT03887858|Adrenergic Agents|adrenergic agents|mesh-ancestor
101899175|NCT03887858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101899176|NCT03887858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899177|NCT03887858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899178|NCT03887858|Urological Agents|urological agents|mesh-ancestor
101899179|NCT02940574|Oxytocin|oxytocin|mesh-list
101899180|NCT02940574|Oxytocics|oxytocics|mesh-ancestor
101899181|NCT02940574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101899182|NCT02940574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899183|NCT01264328|Paclitaxel|paclitaxel|mesh-list
101899184|NCT01264328|Panitumumab|panitumumab|mesh-list
101899185|NCT01264328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101899186|NCT01264328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101899187|NCT01264328|Tubulin Modulators|tubulin modulators|mesh-ancestor
101899188|NCT01264328|Antimitotic Agents|antimitotic agents|mesh-ancestor
101899189|NCT01264328|Mitosis Modulators|mitosis modulators|mesh-ancestor
101899190|NCT01264328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899191|NCT01264328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101899192|NCT01157858|Everolimus|everolimus|mesh-list
101899193|NCT01157858|Octreotide|octreotide|mesh-list
101899194|NCT01157858|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101899195|NCT01157858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101899196|NCT01157858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101899197|NCT01157858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899198|NCT01157858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101899199|NCT01157858|Immunologic Factors|immunologic factors|mesh-ancestor
101899200|NCT01157858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899201|NCT01157858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101899202|NCT01157858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101899203|NCT01157858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101899204|NCT01157936|Allopurinol|allopurinol|mesh-list
101899205|NCT01157936|Antimetabolites|antimetabolites|mesh-ancestor
101899206|NCT01157936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899207|NCT01157936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101899208|NCT01157936|Gout Suppressants|gout suppressants|mesh-ancestor
101899209|NCT01157936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101899210|NCT01157936|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101899211|NCT01157936|Antioxidants|antioxidants|mesh-ancestor
101899212|NCT01157936|Protective Agents|protective agents|mesh-ancestor
101899213|NCT01157936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899214|NCT01264484|Imidacloprid|imidacloprid|mesh-list
101899215|NCT01264484|Cholinergic Agents|cholinergic agents|mesh-ancestor
101899216|NCT01264484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101899217|NCT01264484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899218|NCT01264484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899219|NCT01260818|Tranexamic Acid|tranexamic acid|mesh-list
101899220|NCT01260818|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101899221|NCT01260818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101899222|NCT01260818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899223|NCT01260818|Hemostatics|hemostatics|mesh-ancestor
101899225|NCT01262612|Cediranib|cediranib|mesh-list
101899226|NCT01262612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101899227|NCT01262612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101899228|NCT01262612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101899229|NCT01262612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899230|NCT01158014|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101899231|NCT01158014|Hemostatics|hemostatics|mesh-ancestor
101899232|NCT01158014|Coagulants|coagulants|mesh-ancestor
101899233|NCT03884036|Vitamin D|vitamin d|mesh-list
101899234|NCT03884036|Vitamins|vitamins|mesh-ancestor
101899235|NCT03884036|Micronutrients|micronutrients|mesh-ancestor
101899236|NCT03884036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899237|NCT03884036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101899238|NCT01158170|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101899239|NCT01158170|Gefitinib|gefitinib|mesh-list
101899240|NCT01158170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101899241|NCT01158170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101899242|NCT01158170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101619052|NCT00833482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101899243|NCT01158170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899244|NCT01260974|Caspofungin|caspofungin|mesh-list
101899245|NCT01260974|Antifungal Agents|antifungal agents|mesh-ancestor
101899246|NCT01260974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101899247|NCT01260974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101899248|NCT01260974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899249|NCT01264640|Aspirin|aspirin|mesh-list
101899250|NCT01264640|Clopidogrel|clopidogrel|mesh-list
101899251|NCT01264640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101899252|NCT01264640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101899253|NCT01264640|Analgesics|analgesics|mesh-ancestor
101899254|NCT01264640|Sensory System Agents|sensory system agents|mesh-ancestor
101899255|NCT01264640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101899256|NCT01264640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899257|NCT01264640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101899258|NCT01264640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101899259|NCT01264640|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101899260|NCT01264640|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101899261|NCT01264640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899262|NCT01264640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101899263|NCT01264640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101899264|NCT01264640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101899265|NCT01264640|Antipyretics|antipyretics|mesh-ancestor
101899266|NCT01264640|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101899267|NCT01264640|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101899268|NCT01264640|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101899269|NCT01264640|Purinergic Agents|purinergic agents|mesh-ancestor
101899270|NCT01264640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101899271|NCT01155986|Lidocaine|lidocaine|mesh-list
101899272|NCT01155986|Anesthetics, Local|anesthetics, local|mesh-ancestor
101899273|NCT01155986|Anesthetics|anesthetics|mesh-ancestor
101899274|NCT01155986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101899275|NCT01155986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899276|NCT01155986|Sensory System Agents|sensory system agents|mesh-ancestor
101899277|NCT01155986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101899278|NCT01155986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101899279|NCT01155986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101899280|NCT01155986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101899281|NCT01155986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101899282|NCT01155986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899283|NCT01261130|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101899284|NCT01261130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101899285|NCT01261130|Immunologic Factors|immunologic factors|mesh-ancestor
101899286|NCT01261130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899287|NCT01261130|Antacids|antacids|mesh-ancestor
101899288|NCT01261130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899289|NCT01261130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101899290|NCT01158248|Panitumumab|panitumumab|mesh-list
101899291|NCT01158248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101899292|NCT01158248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101899293|NCT01264874|Vitamin D|vitamin d|mesh-list
101899294|NCT01264874|Cholecalciferol|cholecalciferol|mesh-list
101899295|NCT01264874|Vitamins|vitamins|mesh-ancestor
101899296|NCT01264874|Micronutrients|micronutrients|mesh-ancestor
101899297|NCT01264874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899298|NCT01264874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101899299|NCT01264874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101899300|NCT01262924|Vaccines|vaccines|mesh-list
101899301|NCT01262924|Immunologic Factors|immunologic factors|mesh-ancestor
101899302|NCT01262924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899303|NCT01158560|Vitamin D|vitamin d|mesh-list
101899304|NCT01158560|Cholecalciferol|cholecalciferol|mesh-list
101899305|NCT01158560|Vitamins|vitamins|mesh-ancestor
101899306|NCT01158560|Micronutrients|micronutrients|mesh-ancestor
101899307|NCT01158560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262170|NCT01755559|Schistosomicides|schistosomicides|mesh-ancestor
101899308|NCT01158560|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101899309|NCT01158560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101899310|NCT03879746|Paroxetine|paroxetine|mesh-list
101899311|NCT03879746|Tamsulosin|tamsulosin|mesh-list
101899312|NCT03879746|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101899313|NCT03879746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101899314|NCT03879746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101899315|NCT03879746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899316|NCT03879746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101899317|NCT03879746|Serotonin Agents|serotonin agents|mesh-ancestor
101899318|NCT03879746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899319|NCT03879746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101899321|NCT03879746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101899322|NCT03879746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101899323|NCT03879746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101899324|NCT03879746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101899325|NCT03879746|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101899326|NCT03879746|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101899327|NCT03879746|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101899328|NCT03879746|Adrenergic Agents|adrenergic agents|mesh-ancestor
101899329|NCT03879746|Urological Agents|urological agents|mesh-ancestor
101899330|NCT03879590|Budesonide|budesonide|mesh-list
101899331|NCT03879590|Doxofylline|doxofylline|mesh-list
101899332|NCT03879590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101899333|NCT03879590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101899334|NCT03879590|Autonomic Agents|autonomic agents|mesh-ancestor
101899335|NCT03879590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101899336|NCT03879590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899337|NCT03879590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101899338|NCT03879590|Respiratory System Agents|respiratory system agents|mesh-ancestor
101899339|NCT03879590|Glucocorticoids|glucocorticoids|mesh-ancestor
101899340|NCT03879590|Hormones|hormones|mesh-ancestor
101899341|NCT03879590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101899342|NCT03879590|Antitussive Agents|antitussive agents|mesh-ancestor
101899343|NCT03879590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101899344|NCT03879590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101899345|NCT03879590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899346|NCT01265108|Iron|iron|mesh-list
101899347|NCT01265108|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101899348|NCT01265108|Trace Elements|trace elements|mesh-ancestor
101899349|NCT01265108|Micronutrients|micronutrients|mesh-ancestor
101899350|NCT01265108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899351|NCT01265108|Hematinics|hematinics|mesh-ancestor
101899352|NCT01154738|Lidocaine|lidocaine|mesh-list
101899353|NCT01154738|Anesthetics, Local|anesthetics, local|mesh-ancestor
101899354|NCT01154738|Anesthetics|anesthetics|mesh-ancestor
101899355|NCT01154738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101899356|NCT01154738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899357|NCT01154738|Sensory System Agents|sensory system agents|mesh-ancestor
101899358|NCT01154738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101899359|NCT01154738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101899360|NCT01154738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101899361|NCT01154738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101899362|NCT01154738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101899363|NCT01154738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899364|NCT01263002|Adefovir|adefovir|mesh-list
101899366|NCT01263002|Antiviral Agents|antiviral agents|mesh-ancestor
101899367|NCT01263002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101899368|NCT01263002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101899369|NCT01263002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101899370|NCT01263002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101899371|NCT01263002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899372|NCT01261286|Verapamil|verapamil|mesh-list
101899373|NCT01261286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101899374|NCT01261286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101899375|NCT01261286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101899376|NCT01261286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899377|NCT01261286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101899378|NCT01261286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899379|NCT01261286|Vasodilator Agents|vasodilator agents|mesh-ancestor
101899380|NCT01263080|Folic Acid|folic acid|mesh-list
101899381|NCT01263080|Vitamin B Complex|vitamin b complex|mesh-list
101899382|NCT01263080|Mirtazapine|mirtazapine|mesh-list
101899383|NCT01263080|Vitamins|vitamins|mesh-ancestor
101899384|NCT01263080|Micronutrients|micronutrients|mesh-ancestor
101899385|NCT01263080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899386|NCT01263080|Hematinics|hematinics|mesh-ancestor
101899387|NCT01263080|Antidepressive Agents|antidepressive agents|mesh-ancestor
101899388|NCT01263080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101899389|NCT01263080|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101899390|NCT01263080|Histamine Antagonists|histamine antagonists|mesh-ancestor
101899391|NCT01263080|Histamine Agents|histamine agents|mesh-ancestor
101899392|NCT01263080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101899393|NCT01263080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899394|NCT01263080|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101899395|NCT01263080|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101899396|NCT01263080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101899397|NCT01263080|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101899398|NCT01263080|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101899399|NCT01263080|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101899400|NCT01263080|Adrenergic Agents|adrenergic agents|mesh-ancestor
101899401|NCT01263080|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101899402|NCT01263080|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101899403|NCT01263080|Serotonin Agents|serotonin agents|mesh-ancestor
101899404|NCT01263080|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101899405|NCT01263158|Oxytocin|oxytocin|mesh-list
101899406|NCT01263158|Oxytocics|oxytocics|mesh-ancestor
101899407|NCT01263158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101899408|NCT01263158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899409|NCT03879356|Acetylcysteine|acetylcysteine|mesh-list
101899410|NCT03879356|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101899411|NCT03879356|Antiviral Agents|antiviral agents|mesh-ancestor
101899412|NCT03879356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101899413|NCT03879356|Expectorants|expectorants|mesh-ancestor
101899414|NCT03879356|Respiratory System Agents|respiratory system agents|mesh-ancestor
101899415|NCT03879356|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101899416|NCT03879356|Antioxidants|antioxidants|mesh-ancestor
101899417|NCT03879356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899418|NCT03879356|Protective Agents|protective agents|mesh-ancestor
101899419|NCT03879356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899420|NCT03879356|Antidotes|antidotes|mesh-ancestor
101899421|NCT01159418|Paclitaxel|paclitaxel|mesh-list
101899422|NCT01159418|Carboplatin|carboplatin|mesh-list
101899423|NCT01159418|Panobinostat|panobinostat|mesh-list
101899424|NCT01159418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101899425|NCT01159418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101899426|NCT01159418|Tubulin Modulators|tubulin modulators|mesh-ancestor
101899427|NCT01159418|Antimitotic Agents|antimitotic agents|mesh-ancestor
101899428|NCT01159418|Mitosis Modulators|mitosis modulators|mesh-ancestor
101899429|NCT01159418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899430|NCT01159418|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101899431|NCT01159418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101899432|NCT03886766|Efavirenz|efavirenz|mesh-list
101899433|NCT03886766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101899434|NCT03886766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101899435|NCT03886766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101899436|NCT03886766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899437|NCT03886766|Antiviral Agents|antiviral agents|mesh-ancestor
101899438|NCT03886766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101899439|NCT03886766|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101899440|NCT03886766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101899441|NCT03886766|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101899442|NCT03886766|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101899443|NCT03886766|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101899444|NCT03886766|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101899446|NCT01265342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101899447|NCT01265342|Glucocorticoids|glucocorticoids|mesh-ancestor
101899448|NCT01265342|Hormones|hormones|mesh-ancestor
101899449|NCT01265342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101899450|NCT01265342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899451|NCT01265342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101899452|NCT01265342|Respiratory System Agents|respiratory system agents|mesh-ancestor
101899453|NCT03883334|Inosine Pranobex|inosine pranobex|mesh-list
101899454|NCT03883334|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101899455|NCT03883334|Immunologic Factors|immunologic factors|mesh-ancestor
101899456|NCT03883334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899457|NCT03883334|Antiviral Agents|antiviral agents|mesh-ancestor
101899458|NCT03883334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101899460|NCT01265576|Sorafenib|sorafenib|mesh-list
101899461|NCT01265576|Propranolol|propranolol|mesh-list
101899462|NCT01265576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101899463|NCT01265576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101899464|NCT01265576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101899465|NCT01265576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899466|NCT01265576|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101899467|NCT01265576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101899468|NCT01265576|Adrenergic Agents|adrenergic agents|mesh-ancestor
101899469|NCT01265576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101899470|NCT01265576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899471|NCT01265576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101899472|NCT01265576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101899473|NCT01265576|Vasodilator Agents|vasodilator agents|mesh-ancestor
101899474|NCT01265576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101899475|NCT01265576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101899476|NCT01265576|Analgesics|analgesics|mesh-ancestor
101899477|NCT01265576|Sensory System Agents|sensory system agents|mesh-ancestor
101899478|NCT01265576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101899479|NCT01265576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101899480|NCT01265576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101899481|NCT01265576|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101899482|NCT01265576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101899483|NCT03883022|Vancomycin|vancomycin|mesh-list
101899484|NCT03883022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101899485|NCT03883022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101899486|NCT01159652|Zaleplon|zaleplon|mesh-list
101899487|NCT01159652|Zolpidem|zolpidem|mesh-list
101899488|NCT01159652|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101899489|NCT01159652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101899490|NCT01159652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101899491|NCT01159652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899492|NCT01159652|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101899493|NCT01159652|GABA Agonists|gaba agonists|mesh-ancestor
101899494|NCT01159652|GABA Agents|gaba agents|mesh-ancestor
101899495|NCT01159652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101899496|NCT01159652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899497|NCT01159652|Anticonvulsants|anticonvulsants|mesh-ancestor
101899498|NCT01159652|GABA Modulators|gaba modulators|mesh-ancestor
101899499|NCT01261832|Cilostazol|cilostazol|mesh-list
101899500|NCT01261832|Clopidogrel|clopidogrel|mesh-list
101899501|NCT01261832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101899502|NCT01261832|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101899503|NCT01261832|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101899504|NCT01261832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101899505|NCT01261832|Purinergic Agents|purinergic agents|mesh-ancestor
101899506|NCT01261832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101899507|NCT01261832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899508|NCT01261832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899509|NCT01261832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101899510|NCT01261832|Autonomic Agents|autonomic agents|mesh-ancestor
101899511|NCT01261832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101899512|NCT01261832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101899513|NCT01261832|Respiratory System Agents|respiratory system agents|mesh-ancestor
101899514|NCT01261832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101899515|NCT01261832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101899516|NCT01261832|Vasodilator Agents|vasodilator agents|mesh-ancestor
101899517|NCT01261832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101899518|NCT01261832|Protective Agents|protective agents|mesh-ancestor
101899519|NCT01261832|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101899520|NCT01261832|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101899521|NCT01261832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101899522|NCT01265810|Calcium|calcium|mesh-list
101899523|NCT01265810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101899524|NCT01265810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899525|NCT01265888|Nitric Oxide|nitric oxide|mesh-list
101899526|NCT01265888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101899527|NCT01265888|Autonomic Agents|autonomic agents|mesh-ancestor
101899528|NCT01265888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101899529|NCT01265888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262397|NCT01756651|Anesthetics|anesthetics|mesh-ancestor
101899530|NCT01265888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101899531|NCT01265888|Respiratory System Agents|respiratory system agents|mesh-ancestor
101899532|NCT01265888|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101899533|NCT01265888|Antioxidants|antioxidants|mesh-ancestor
101899534|NCT01265888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899535|NCT01265888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101899536|NCT01265888|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101899537|NCT01265888|Vasodilator Agents|vasodilator agents|mesh-ancestor
101899538|NCT01265888|Gasotransmitters|gasotransmitters|mesh-ancestor
101899539|NCT01265888|Protective Agents|protective agents|mesh-ancestor
101899540|NCT01155206|Glucagon|glucagon|mesh-list
101899541|NCT01155206|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101899542|NCT01155206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101899543|NCT01155206|Hormones|hormones|mesh-ancestor
101899544|NCT01155206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101899545|NCT01155206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899546|NCT01155206|Incretins|incretins|mesh-ancestor
101899547|NCT03879278|Immunoglobulins|immunoglobulins|mesh-list
101899548|NCT03879278|Immunoglobulin G|immunoglobulin g|mesh-list
101899549|NCT03879278|Immunologic Factors|immunologic factors|mesh-ancestor
101899550|NCT03879278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899551|NCT03878888|Bupivacaine|bupivacaine|mesh-list
101899552|NCT03878888|Anesthetics, Local|anesthetics, local|mesh-ancestor
101899553|NCT03878888|Anesthetics|anesthetics|mesh-ancestor
101899554|NCT03878888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101899555|NCT03878888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899556|NCT03878888|Sensory System Agents|sensory system agents|mesh-ancestor
101899557|NCT03878888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101899558|NCT03882710|Metoprolol|metoprolol|mesh-list
101899559|NCT03882710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101899560|NCT03882710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101899561|NCT03882710|Sympatholytics|sympatholytics|mesh-ancestor
101899562|NCT03882710|Autonomic Agents|autonomic agents|mesh-ancestor
101899563|NCT03882710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101899564|NCT03882710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899565|NCT03882710|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101899566|NCT03882710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101899567|NCT03882710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101899568|NCT03882710|Adrenergic Agents|adrenergic agents|mesh-ancestor
101899569|NCT03882710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101899570|NCT03882710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899571|NCT01161836|Iniparib|iniparib|mesh-list
101899572|NCT01161836|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101899573|NCT01161836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101969709|NCT03133780|GABA Agents|gaba agents|mesh-ancestor
101899574|NCT01161836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899575|NCT01161836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101899576|NCT01266434|Simvastatin|simvastatin|mesh-list
101899577|NCT01266434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101899578|NCT01266434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101899579|NCT01266434|Antimetabolites|antimetabolites|mesh-ancestor
101899580|NCT01266434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899581|NCT01266434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101899582|NCT01266434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101899583|NCT01266434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101899584|NCT01266512|Docetaxel|docetaxel|mesh-list
101899585|NCT01266512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101899586|NCT01266512|Tubulin Modulators|tubulin modulators|mesh-ancestor
101899587|NCT01266512|Antimitotic Agents|antimitotic agents|mesh-ancestor
101899588|NCT01266512|Mitosis Modulators|mitosis modulators|mesh-ancestor
101899589|NCT01266512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899590|NCT01160042|Metformin|metformin|mesh-list
101899591|NCT01160042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101899592|NCT01160042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899593|NCT03882788|Fentanyl|fentanyl|mesh-list
101899594|NCT03882788|Isoflurane|isoflurane|mesh-list
101899595|NCT03882788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101899596|NCT03882788|Narcotics|narcotics|mesh-ancestor
101899597|NCT03882788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101899598|NCT03882788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899599|NCT03882788|Analgesics|analgesics|mesh-ancestor
101899600|NCT03882788|Sensory System Agents|sensory system agents|mesh-ancestor
101899601|NCT03882788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101899602|NCT03882788|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101899603|NCT03882788|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101899604|NCT03882788|Anesthetics, General|anesthetics, general|mesh-ancestor
101899606|NCT03882788|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101899607|NCT01156688|Misoprostol|misoprostol|mesh-list
101899608|NCT01156688|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101899609|NCT01156688|Abortifacient Agents|abortifacient agents|mesh-ancestor
101899610|NCT01156688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101899611|NCT01156688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899612|NCT01156688|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101899613|NCT01156688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101899614|NCT01156688|Oxytocics|oxytocics|mesh-ancestor
101899615|NCT03876704|Vitamins|vitamins|mesh-list
101899616|NCT03876704|Micronutrients|micronutrients|mesh-ancestor
101899617|NCT03876704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899619|NCT03878654|Antiviral Agents|antiviral agents|mesh-ancestor
101899620|NCT03878654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101899621|NCT03878654|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101899622|NCT03878654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101899623|NCT03878264|Cortisone|cortisone|mesh-list
101899624|NCT03878264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101899625|NCT03882164|Tacrolimus|tacrolimus|mesh-list
101899626|NCT03882164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101899627|NCT03882164|Immunologic Factors|immunologic factors|mesh-ancestor
101899628|NCT03882164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899629|NCT03882164|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101899630|NCT03882164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101899631|NCT03882164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899632|NCT01160276|Cyclosporine|cyclosporine|mesh-list
101899633|NCT01160276|Colchicine|colchicine|mesh-list
101899634|NCT01160276|Tacrolimus|tacrolimus|mesh-list
101899635|NCT01160276|Cyclosporins|cyclosporins|mesh-list
101899636|NCT01160276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101899637|NCT01160276|Immunologic Factors|immunologic factors|mesh-ancestor
101899638|NCT01160276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899639|NCT01160276|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101899640|NCT01160276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101899641|NCT01160276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899642|NCT01160276|Antifungal Agents|antifungal agents|mesh-ancestor
101899643|NCT01160276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101899644|NCT01160276|Dermatologic Agents|dermatologic agents|mesh-ancestor
101899645|NCT01160276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101899646|NCT01160276|Gout Suppressants|gout suppressants|mesh-ancestor
101899647|NCT01160276|Tubulin Modulators|tubulin modulators|mesh-ancestor
101899648|NCT01160276|Antimitotic Agents|antimitotic agents|mesh-ancestor
101899650|NCT01160276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101899651|NCT01263548|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101899652|NCT01263548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101899653|NCT01263548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899654|NCT01263548|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101899655|NCT01263548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101899656|NCT01263548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101899657|NCT01263548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899658|NCT01263548|Dopamine Agents|dopamine agents|mesh-ancestor
101899659|NCT01263548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101899660|NCT01160432|Methadone|methadone|mesh-list
101899661|NCT01160432|Naloxone|naloxone|mesh-list
101899662|NCT01160432|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101899663|NCT01160432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899664|NCT01160432|Sensory System Agents|sensory system agents|mesh-ancestor
101899665|NCT01160432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101899666|NCT01160432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101899667|NCT01160432|Narcotics|narcotics|mesh-ancestor
101899668|NCT01160432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101899669|NCT01160432|Analgesics|analgesics|mesh-ancestor
101899670|NCT01160432|Antitussive Agents|antitussive agents|mesh-ancestor
101899671|NCT01160432|Respiratory System Agents|respiratory system agents|mesh-ancestor
101899672|NCT03877718|Promethazine|promethazine|mesh-list
101899673|NCT03877718|Diphenhydramine|diphenhydramine|mesh-list
101899674|NCT03877718|Sumatriptan|sumatriptan|mesh-list
101899675|NCT03877718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101899676|NCT03877718|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101899677|NCT03877718|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101899678|NCT03877718|Serotonin Agents|serotonin agents|mesh-ancestor
101899679|NCT03877718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101899680|NCT03877718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899681|NCT03877718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899682|NCT03877718|Antipruritics|antipruritics|mesh-ancestor
101899683|NCT03877718|Dermatologic Agents|dermatologic agents|mesh-ancestor
101899684|NCT03877718|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101899685|NCT03877718|Histamine Antagonists|histamine antagonists|mesh-ancestor
101899686|NCT03877718|Histamine Agents|histamine agents|mesh-ancestor
101899687|NCT03877718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101899688|NCT03877718|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101899689|NCT03877718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101899690|NCT03877718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101899691|NCT03877718|Anesthetics, Local|anesthetics, local|mesh-ancestor
101899692|NCT03877718|Anesthetics|anesthetics|mesh-ancestor
101899693|NCT03877718|Sensory System Agents|sensory system agents|mesh-ancestor
101899694|NCT03877718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101899695|NCT03877718|Antiemetics|antiemetics|mesh-ancestor
101899696|NCT03877718|Autonomic Agents|autonomic agents|mesh-ancestor
101899697|NCT03877718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101899698|NCT01267058|Vaccines|vaccines|mesh-list
101899699|NCT01267058|Immunologic Factors|immunologic factors|mesh-ancestor
101899700|NCT01267058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899701|NCT02526914|Vasopressins|vasopressins|mesh-list
101899702|NCT02526914|Arginine Vasopressin|arginine vasopressin|mesh-list
101899703|NCT02526914|Oxytocin|oxytocin|mesh-list
101899704|NCT02526914|Oxytocics|oxytocics|mesh-ancestor
101899705|NCT02526914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101899706|NCT02526914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899707|NCT02526914|Hemostatics|hemostatics|mesh-ancestor
101899708|NCT02526914|Coagulants|coagulants|mesh-ancestor
101899709|NCT02526914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101899710|NCT02526914|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101899711|NCT02526914|Natriuretic Agents|natriuretic agents|mesh-ancestor
101899712|NCT03876938|Olanzapine|olanzapine|mesh-list
101899713|NCT03876938|Aprepitant|aprepitant|mesh-list
101899714|NCT03876938|Antiemetics|antiemetics|mesh-ancestor
101899715|NCT03876938|Autonomic Agents|autonomic agents|mesh-ancestor
101899716|NCT03876938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101899717|NCT03876938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899718|NCT03876938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101899719|NCT03876938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101899720|NCT03876938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101899721|NCT03876938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101899722|NCT03876938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101969717|NCT02282956|Analgesics|analgesics|mesh-ancestor
101899723|NCT03876938|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101899724|NCT03876938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101899725|NCT03876938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101899726|NCT03876938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899727|NCT03876938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101899728|NCT03876938|Serotonin Agents|serotonin agents|mesh-ancestor
101899729|NCT03876938|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101899730|NCT01162460|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
101899731|NCT01162460|Anticonvulsants|anticonvulsants|mesh-ancestor
101899732|NCT01162460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101899733|NCT01162460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101899734|NCT01162460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101899735|NCT01162460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899736|NCT03882008|Abatacept|abatacept|mesh-list
101899737|NCT03882008|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101899738|NCT03882008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899739|NCT03882008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101899740|NCT03882008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101899741|NCT03882008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101899742|NCT03882008|Immunologic Factors|immunologic factors|mesh-ancestor
101899743|NCT03882008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899744|NCT03882008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101899745|NCT01267214|Hyaluronic Acid|hyaluronic acid|mesh-list
101899746|NCT01267214|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101899747|NCT01267214|Immunologic Factors|immunologic factors|mesh-ancestor
101899748|NCT01267214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899749|NCT01267214|Viscosupplements|viscosupplements|mesh-ancestor
101899750|NCT01267214|Protective Agents|protective agents|mesh-ancestor
101899751|NCT01156922|Rituximab|rituximab|mesh-list
101899752|NCT01156922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101899753|NCT01156922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101899754|NCT01156922|Immunologic Factors|immunologic factors|mesh-ancestor
101899755|NCT01156922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899756|NCT01156922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101899757|NCT03877874|Terbutaline|terbutaline|mesh-list
101899758|NCT03877874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101899759|NCT03877874|Autonomic Agents|autonomic agents|mesh-ancestor
101899760|NCT03877874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101899761|NCT03877874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899762|NCT03877874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101899763|NCT03877874|Respiratory System Agents|respiratory system agents|mesh-ancestor
101899764|NCT03877874|Sympathomimetics|sympathomimetics|mesh-ancestor
101899765|NCT03877874|Tocolytic Agents|tocolytic agents|mesh-ancestor
101899766|NCT03877874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101899767|NCT03877874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101899768|NCT03877874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101899769|NCT03877874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101899770|NCT03877874|Adrenergic Agents|adrenergic agents|mesh-ancestor
101899771|NCT03877874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101899772|NCT03877874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899773|NCT01160588|Sertraline|sertraline|mesh-list
101686770|NCT03535116|Analgesics|analgesics|mesh-ancestor
101899774|NCT01160588|Antidepressive Agents|antidepressive agents|mesh-ancestor
101899775|NCT01160588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101899776|NCT01160588|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101899777|NCT01160588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101899778|NCT01160588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101899779|NCT01160588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899780|NCT01160588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101899781|NCT01160588|Serotonin Agents|serotonin agents|mesh-ancestor
101899782|NCT01160588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899783|NCT03877562|Olanzapine|olanzapine|mesh-list
101899784|NCT03877562|Antiemetics|antiemetics|mesh-ancestor
101899785|NCT03877562|Autonomic Agents|autonomic agents|mesh-ancestor
101899786|NCT03877562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101899787|NCT03877562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899788|NCT03877562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101899789|NCT03877562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101899790|NCT03877562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101899791|NCT03877562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101899792|NCT03877562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101899793|NCT03877562|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101899794|NCT03877562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101899795|NCT03877562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101899796|NCT03877562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899797|NCT03877562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101899799|NCT01160666|Belimumab|belimumab|mesh-list
101899800|NCT01160666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101899801|NCT01160666|Immunologic Factors|immunologic factors|mesh-ancestor
101899802|NCT01160666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899803|NCT03876548|Iodine|iodine|mesh-list
101899804|NCT03876548|Cadexomer iodine|cadexomer iodine|mesh-list
101899805|NCT03876548|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101899806|NCT03876548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101899807|NCT03876548|Trace Elements|trace elements|mesh-ancestor
101899808|NCT03876548|Micronutrients|micronutrients|mesh-ancestor
101899809|NCT03876548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899810|NCT03760250|Imiquimod|imiquimod|mesh-list
101899811|NCT03760250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101899812|NCT03760250|Immunologic Factors|immunologic factors|mesh-ancestor
101899813|NCT03760250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899814|NCT03760250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101899815|NCT03760250|Interferon Inducers|interferon inducers|mesh-ancestor
101702690|NCT02732795|Analgesics|analgesics|mesh-ancestor
101899816|NCT01157000|Canagliflozin|canagliflozin|mesh-list
101702839|NCT02645240|Calcium heparin|calcium heparin|mesh-list
101702995|NCT04002349|Budesonide|budesonide|mesh-list
101899817|NCT01157000|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101703087|NCT04137432|Oxytocin|oxytocin|mesh-list
101703294|NCT00653822|Dermatologic Agents|dermatologic agents|mesh-ancestor
101703370|NCT00726700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101703444|NCT00729976|Sensory System Agents|sensory system agents|mesh-ancestor
101703519|NCT00689442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101703595|NCT00693342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703673|NCT00693732|Serotonin Agents|serotonin agents|mesh-ancestor
101703749|NCT04136886|Cisplatin|cisplatin|mesh-list
101703821|NCT02717819|Vitamin D|vitamin d|mesh-list
101703892|NCT03903406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101703967|NCT02616822|Resveratrol|resveratrol|mesh-list
101899818|NCT01157000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899819|NCT01157000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101899820|NCT01157000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899821|NCT01160900|Bivalirudin|bivalirudin|mesh-list
101899822|NCT01160900|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101899823|NCT01160900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101899824|NCT01160900|Antithrombins|antithrombins|mesh-ancestor
101899825|NCT01160900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101899826|NCT01160900|Protease Inhibitors|protease inhibitors|mesh-ancestor
101899827|NCT01160900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101899828|NCT01160900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899829|NCT01160900|Anticoagulants|anticoagulants|mesh-ancestor
101899830|NCT01160978|Simvastatin|simvastatin|mesh-list
101899831|NCT01160978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101899832|NCT01160978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101899833|NCT01160978|Antimetabolites|antimetabolites|mesh-ancestor
101899834|NCT01160978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899835|NCT01160978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101704257|NCT00996385|Oxaliplatin|oxaliplatin|mesh-list
101704333|NCT00857259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101899836|NCT01160978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101899837|NCT01160978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101899838|NCT01161134|Meloxicam|meloxicam|mesh-list
101899839|NCT01161134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101899840|NCT01161134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101899841|NCT01161134|Analgesics|analgesics|mesh-ancestor
101899842|NCT01161134|Sensory System Agents|sensory system agents|mesh-ancestor
101704628|NCT00997477|Hormones|hormones|mesh-ancestor
101704859|NCT00853905|Glucocorticoids|glucocorticoids|mesh-ancestor
101704931|NCT01002157|Hemostatics|hemostatics|mesh-ancestor
101899843|NCT01161134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101705010|NCT02714075|Citric Acid|citric acid|mesh-list
101705080|NCT00883688|Growth Inhibitors|growth inhibitors|mesh-ancestor
101899844|NCT01161134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899845|NCT01161134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101899846|NCT01161134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101899847|NCT01161134|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101899848|NCT01161134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101899849|NCT01161134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101899850|NCT01161134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899851|NCT01268384|Gemcitabine|gemcitabine|mesh-list
101899852|NCT01268384|Capecitabine|capecitabine|mesh-list
101899853|NCT01268384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101899854|NCT01268384|Antimetabolites|antimetabolites|mesh-ancestor
101899855|NCT01268384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899856|NCT01268384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101899858|NCT01269476|Methanesulfonyl fluoride|methanesulfonyl fluoride|mesh-list
101899859|NCT01269476|Cariostatic Agents|cariostatic agents|mesh-ancestor
101899860|NCT01269476|Protective Agents|protective agents|mesh-ancestor
101899861|NCT01269476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899862|NCT01269476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101899863|NCT01269476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101705357|NCT00654446|Simvastatin|simvastatin|mesh-list
101705434|NCT00913029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705586|NCT00870870|Immunologic Factors|immunologic factors|mesh-ancestor
101705810|NCT00733564|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101705885|NCT01007773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101706110|NCT00712270|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101899864|NCT01269476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706260|NCT01008631|Chelating Agents|chelating agents|mesh-ancestor
101899865|NCT01269476|Cholinergic Agents|cholinergic agents|mesh-ancestor
101706406|NCT00612599|Insulin Aspart|insulin aspart|mesh-list
101899866|NCT01269476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101899867|NCT01161368|Vinorelbine|vinorelbine|mesh-list
101706841|NCT00636935|Dapsone|dapsone|mesh-list
101899868|NCT01161368|Lapatinib|lapatinib|mesh-list
101899869|NCT01161368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101899870|NCT01161368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101899871|NCT01161368|Tubulin Modulators|tubulin modulators|mesh-ancestor
101899872|NCT01161368|Antimitotic Agents|antimitotic agents|mesh-ancestor
101899873|NCT01161368|Mitosis Modulators|mitosis modulators|mesh-ancestor
101899874|NCT01161368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899875|NCT01161368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101899876|NCT01161368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101899877|NCT01267760|Dialysis Solutions|dialysis solutions|mesh-list
101899878|NCT01267760|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101899879|NCT01280162|Piperaquine|piperaquine|mesh-list
101899880|NCT01280162|Artenimol|artenimol|mesh-list
101899881|NCT01280162|Antimalarials|antimalarials|mesh-ancestor
101899882|NCT01280162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101899883|NCT01280162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101899884|NCT01280162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101899885|NCT01167062|Tamsulosin|tamsulosin|mesh-list
101706939|NCT00736294|Ramipril|ramipril|mesh-list
101706988|NCT00849693|Antidepressive Agents|antidepressive agents|mesh-ancestor
101899886|NCT01167062|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101899887|NCT01167062|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101707209|NCT03640949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101899888|NCT01167062|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101707285|NCT03435107|Durvalumab|durvalumab|mesh-list
101899890|NCT01167062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101707426|NCT02623920|Immunotoxins|immunotoxins|mesh-ancestor
101707500|NCT02617758|Anesthetics, General|anesthetics, general|mesh-ancestor
101707650|NCT02623452|Insulin Lispro|insulin lispro|mesh-list
101707798|NCT00699504|Moxifloxacin|moxifloxacin|mesh-list
101707874|NCT00524173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101707946|NCT03393611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101899891|NCT01167062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899892|NCT01167062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899893|NCT01167062|Urological Agents|urological agents|mesh-ancestor
101899894|NCT01280240|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
101899895|NCT01280240|Hematinics|hematinics|mesh-ancestor
101899896|NCT01165268|Dapagliflozin|dapagliflozin|mesh-list
101708385|NCT03362099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101708458|NCT00615875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101708535|NCT00707746|Mipomersen|mipomersen|mesh-list
101708685|NCT00667472|Ranibizumab|ranibizumab|mesh-list
101708836|NCT00616031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101708912|NCT00505921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101899897|NCT01165268|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101708990|NCT00505687|Rotigotine|rotigotine|mesh-list
101899898|NCT01165268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709066|NCT01009567|Dopamine Agents|dopamine agents|mesh-ancestor
101899899|NCT01165268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101899900|NCT01165268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709358|NCT00595868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101899902|NCT03874364|Anesthetics, Local|anesthetics, local|mesh-ancestor
101899903|NCT03874364|Anesthetics|anesthetics|mesh-ancestor
101899904|NCT03874364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101899905|NCT03874364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899906|NCT03874364|Sensory System Agents|sensory system agents|mesh-ancestor
101899907|NCT03874364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101899908|NCT03874364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101709501|NCT01015339|Tubulin Modulators|tubulin modulators|mesh-ancestor
101899909|NCT03874364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101899910|NCT03874364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101899911|NCT03874364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101899912|NCT03874364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899914|NCT01163396|Bevacizumab|bevacizumab|mesh-list
101899915|NCT01163396|Fluorouracil|fluorouracil|mesh-list
101899916|NCT01163396|Oxaliplatin|oxaliplatin|mesh-list
101899917|NCT01163396|Irinotecan|irinotecan|mesh-list
101709950|NCT02622672|Coenzyme Q10|coenzyme q10|mesh-list
101899918|NCT01163396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101899919|NCT01163396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101710089|NCT00679250|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101899920|NCT01163396|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101710164|NCT02627456|Antimalarials|antimalarials|mesh-ancestor
101899921|NCT01163396|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101899922|NCT01163396|Growth Substances|growth substances|mesh-ancestor
101899923|NCT01163396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710547|NCT02625506|Tramadol|tramadol|mesh-list
101899924|NCT01163396|Growth Inhibitors|growth inhibitors|mesh-ancestor
101710688|NCT00742768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101899925|NCT01163396|Antimetabolites|antimetabolites|mesh-ancestor
101899926|NCT01163396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899927|NCT01163396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101899928|NCT01163396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101899929|NCT01163396|Immunologic Factors|immunologic factors|mesh-ancestor
101710913|NCT00620789|Serotonin Agents|serotonin agents|mesh-ancestor
101710981|NCT00686114|Tubulin Modulators|tubulin modulators|mesh-ancestor
101899930|NCT01163396|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101899931|NCT01163396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101899932|NCT01163396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101899933|NCT01163396|Antidotes|antidotes|mesh-ancestor
101899934|NCT01163396|Protective Agents|protective agents|mesh-ancestor
101899935|NCT01163396|Vitamin B Complex|vitamin b complex|mesh-ancestor
101711359|NCT00691886|Dexmedetomidine|dexmedetomidine|mesh-list
101899936|NCT01163396|Vitamins|vitamins|mesh-ancestor
101899937|NCT01163396|Micronutrients|micronutrients|mesh-ancestor
101899939|NCT01269788|Omeprazole|omeprazole|mesh-list
101899940|NCT01269788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101711805|NCT03800381|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101711949|NCT00693524|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101899941|NCT01269788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101712103|NCT01016821|Oxycodone|oxycodone|mesh-list
101899942|NCT01269788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101899943|NCT01269788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101712320|NCT01614899|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101712395|NCT00689624|Fluorouracil|fluorouracil|mesh-list
101712473|NCT01014637|Clotrimazole|clotrimazole|mesh-list
101712548|NCT00696722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101899944|NCT01269788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712848|NCT02686385|Antioxidants|antioxidants|mesh-ancestor
101713000|NCT00701298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101713075|NCT00487435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101899945|NCT01269788|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101713306|NCT02619578|Propofol|propofol|mesh-list
101899946|NCT01269788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101713369|NCT00868166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101899947|NCT01269788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101899948|NCT01269788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101899949|NCT01269788|Serotonin Agents|serotonin agents|mesh-ancestor
101713741|NCT02615288|Vitamins|vitamins|mesh-ancestor
101713818|NCT00697892|Protease Inhibitors|protease inhibitors|mesh-ancestor
101714043|NCT00559091|Ribavirin|ribavirin|mesh-list
101899950|NCT01269788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899951|NCT01269788|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101899952|NCT01269788|Antidepressive Agents|antidepressive agents|mesh-ancestor
101899953|NCT01269788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101899954|NCT01269788|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101899955|NCT01269788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101899956|NCT01163630|Esomeprazole|esomeprazole|mesh-list
101899957|NCT01163630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101714941|NCT02670317|Cyclophosphamide|cyclophosphamide|mesh-list
101899958|NCT01163630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101715027|NCT02669303|Hormones|hormones|mesh-ancestor
101899959|NCT01163630|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101899960|NCT01163630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101715379|NCT00856388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101899961|NCT01163630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899962|NCT03874130|Scopolamine|scopolamine|mesh-list
101715460|NCT00648713|Terbinafine|terbinafine|mesh-list
101899963|NCT03874130|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101715592|NCT04401059|Gefitinib|gefitinib|mesh-list
101899964|NCT03874130|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101899965|NCT03874130|Antiemetics|antiemetics|mesh-ancestor
101899966|NCT03874130|Autonomic Agents|autonomic agents|mesh-ancestor
101715961|NCT05298020|Gemcitabine|gemcitabine|mesh-list
101716035|NCT00691210|Niacinamide|niacinamide|mesh-list
101899967|NCT03874130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101716183|NCT02660177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101899968|NCT03874130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899969|NCT03874130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101716405|NCT02643563|Anesthetics|anesthetics|mesh-ancestor
101899970|NCT03874130|Mydriatics|mydriatics|mesh-ancestor
101899971|NCT03874130|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101899972|NCT03874130|Cholinergic Agents|cholinergic agents|mesh-ancestor
101899973|NCT03874130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101899974|NCT03874130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899975|NCT03874130|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101899976|NCT03874130|Parasympatholytics|parasympatholytics|mesh-ancestor
101716556|NCT02641457|Ranibizumab|ranibizumab|mesh-list
101899977|NCT01269866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101899978|NCT01269866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101716700|NCT00652379|Hormones|hormones|mesh-ancestor
101899979|NCT01269866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101899980|NCT01269866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101716917|NCT00707070|Acitretin|acitretin|mesh-list
101899981|NCT01269866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101899982|NCT01269866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101717065|NCT05483400|Atezolizumab|atezolizumab|mesh-list
101899983|NCT01269866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717288|NCT00656123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101899985|NCT01269866|Sensory System Agents|sensory system agents|mesh-ancestor
101717364|NCT00750802|Lorazepam|lorazepam|mesh-list
101899986|NCT01269866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101899987|NCT01269866|Antidepressive Agents|antidepressive agents|mesh-ancestor
101899988|NCT01269866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101899989|NCT01269866|Dopamine Agents|dopamine agents|mesh-ancestor
101899990|NCT05387642|Pramoxine|pramoxine|mesh-list
101899991|NCT05387642|Anesthetics, Local|anesthetics, local|mesh-ancestor
101899992|NCT05387642|Anesthetics|anesthetics|mesh-ancestor
101899993|NCT05387642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101899994|NCT05387642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101899995|NCT05387642|Sensory System Agents|sensory system agents|mesh-ancestor
101899996|NCT05387642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101717503|NCT04158947|Trastuzumab|trastuzumab|mesh-list
101899997|NCT03871322|Vitamin D|vitamin d|mesh-list
101717675|NCT00659321|Nicotine|nicotine|mesh-list
101717729|NCT05863195|Antimetabolites|antimetabolites|mesh-ancestor
101899998|NCT03871322|Ergocalciferols|ergocalciferols|mesh-list
101717875|NCT05861713|Dimenhydrinate|dimenhydrinate|mesh-list
101899999|NCT03871322|Cholecalciferol|cholecalciferol|mesh-list
101900001|NCT03871322|Micronutrients|micronutrients|mesh-ancestor
101718100|NCT05221892|Vitamins|vitamins|mesh-ancestor
101718251|NCT04634799|Plasminogen|plasminogen|mesh-list
101718479|NCT03874052|Venetoclax|venetoclax|mesh-list
101718550|NCT03459092|Botulinum Toxins|botulinum toxins|mesh-list
101900003|NCT03871322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101900004|NCT03871322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101900005|NCT00313781|Prednisone|prednisone|mesh-list
101900006|NCT00313781|Docetaxel|docetaxel|mesh-list
101718769|NCT00858273|Protective Agents|protective agents|mesh-ancestor
101718914|NCT00661349|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101900007|NCT00313781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101900008|NCT00313781|Tubulin Modulators|tubulin modulators|mesh-ancestor
101900009|NCT00313781|Antimitotic Agents|antimitotic agents|mesh-ancestor
101719149|NCT00667901|Riluzole|riluzole|mesh-list
101900010|NCT00313781|Mitosis Modulators|mitosis modulators|mesh-ancestor
101900011|NCT00313781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900012|NCT00313781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101900013|NCT00313781|Glucocorticoids|glucocorticoids|mesh-ancestor
101900014|NCT00313781|Hormones|hormones|mesh-ancestor
101719575|NCT00595517|Esomeprazole|esomeprazole|mesh-list
101719722|NCT00676559|Ranibizumab|ranibizumab|mesh-list
101719797|NCT00672659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101719870|NCT02628197|Calcium|calcium|mesh-list
101719946|NCT00674687|Sensory System Agents|sensory system agents|mesh-ancestor
101720020|NCT00674999|Ionophores|ionophores|mesh-ancestor
101720172|NCT00808509|Immunologic Factors|immunologic factors|mesh-ancestor
101900015|NCT00313781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101900016|NCT00313781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900017|NCT00313781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101900018|NCT03871478|Lidocaine|lidocaine|mesh-list
101900019|NCT03871478|Bupivacaine|bupivacaine|mesh-list
101900020|NCT03871478|Anesthetics, Local|anesthetics, local|mesh-ancestor
101720851|NCT05626478|Hormones|hormones|mesh-ancestor
101900021|NCT03871478|Anesthetics|anesthetics|mesh-ancestor
101720924|NCT05481645|Antimetabolites|antimetabolites|mesh-ancestor
101721056|NCT05256719|Abatacept|abatacept|mesh-list
101900022|NCT03871478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101900023|NCT03871478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900024|NCT03871478|Sensory System Agents|sensory system agents|mesh-ancestor
101721221|NCT04767984|Calcium|calcium|mesh-list
101721295|NCT04521140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900025|NCT03871478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101721369|NCT04314570|Anesthetics, Local|anesthetics, local|mesh-ancestor
101721442|NCT04028050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101900026|NCT03871478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101687030|NCT00639522|Capecitabine|capecitabine|mesh-list
101721591|NCT03539900|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101721592|NCT03539900|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101721593|NCT03539900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101721594|NCT03539900|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101721595|NCT03526250|Palbociclib|palbociclib|mesh-list
101721596|NCT03526250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721597|NCT03526250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101721598|NCT03526250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101721599|NCT03526250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721600|NCT03479476|Metformin|metformin|mesh-list
101721601|NCT03479476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101721602|NCT03479476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721630|NCT03399539|Dexamethasone|dexamethasone|mesh-list
101721631|NCT03399539|Dexamethasone acetate|dexamethasone acetate|mesh-list
101721632|NCT03399539|Venetoclax|venetoclax|mesh-list
101721633|NCT03399539|Ixazomib|ixazomib|mesh-list
101721634|NCT03399539|Ichthammol|ichthammol|mesh-list
101721635|NCT03399539|BB 1101|bb 1101|mesh-list
101721636|NCT03399539|Glycine|glycine|mesh-list
101721637|NCT03399539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101721638|NCT03399539|Antiemetics|antiemetics|mesh-ancestor
101721639|NCT03399539|Autonomic Agents|autonomic agents|mesh-ancestor
101721640|NCT03399539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101721641|NCT03399539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721642|NCT03399539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101721643|NCT03399539|Glucocorticoids|glucocorticoids|mesh-ancestor
101721644|NCT03399539|Hormones|hormones|mesh-ancestor
101721646|NCT03399539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101900027|NCT03871478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101721822|NCT03008408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900028|NCT03871478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101687091|NCT02697162|Octenidine|octenidine|mesh-list
101900029|NCT03871478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101900030|NCT03871478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900031|NCT01281566|Cisapride|cisapride|mesh-list
101900033|NCT01281566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101900034|NCT01281566|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101900035|NCT01281566|Serotonin Agents|serotonin agents|mesh-ancestor
101900036|NCT01281566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101900037|NCT01281566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722267|NCT00703170|Sirolimus|sirolimus|mesh-list
101900038|NCT01281566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900040|NCT00368537|Tigecycline|tigecycline|mesh-list
101900041|NCT00368537|Sulbactam|sulbactam|mesh-list
101900042|NCT00368537|Sultamicillin|sultamicillin|mesh-list
101900043|NCT00368537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101900044|NCT00368537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101722478|NCT00804687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101900045|NCT00368537|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101900047|NCT00368537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900048|NCT00368537|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101900049|NCT01165580|Valganciclovir|valganciclovir|mesh-list
101900050|NCT01165580|Antiviral Agents|antiviral agents|mesh-ancestor
101722766|NCT00758914|Micronutrients|micronutrients|mesh-ancestor
101900051|NCT01165580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101900052|NCT01048619|ON 01910|on 01910|mesh-list
101900053|NCT01048619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101900054|NCT01048619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101900055|NCT01048619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101722910|NCT02557984|Dopamine Agents|dopamine agents|mesh-ancestor
101722984|NCT04049344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101900056|NCT01048619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900057|NCT01281800|Gemcitabine|gemcitabine|mesh-list
101900058|NCT01281800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101900059|NCT01281800|Antimetabolites|antimetabolites|mesh-ancestor
101900060|NCT01281800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900061|NCT01281800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101900063|NCT03982121|Ipilimumab|ipilimumab|mesh-list
101900064|NCT03982121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101900065|NCT03982121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101900066|NCT03982121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101723576|NCT04150367|Leprostatic Agents|leprostatic agents|mesh-ancestor
101900067|NCT03982121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900069|NCT01167530|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101723795|NCT02633579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101900070|NCT01167530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101900071|NCT01167530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101723942|NCT00777322|Riboflavin|riboflavin|mesh-list
101900072|NCT01167530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900073|NCT01167530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101724245|NCT00667420|Oxaliplatin|oxaliplatin|mesh-list
101900074|NCT01167530|Immunologic Factors|immunologic factors|mesh-ancestor
101900075|NCT01167530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900076|NCT01167530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101900077|NCT01167764|Tranexamic Acid|tranexamic acid|mesh-list
101900078|NCT01167764|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101900079|NCT01167764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101900080|NCT01167764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900081|NCT01167764|Hemostatics|hemostatics|mesh-ancestor
101900082|NCT01167764|Coagulants|coagulants|mesh-ancestor
101900083|NCT01164176|Everolimus|everolimus|mesh-list
101724319|NCT00853658|Enalapril|enalapril|mesh-list
101900084|NCT01164176|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101900085|NCT01164176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101900086|NCT01164176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101900087|NCT01164176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900088|NCT01164176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101900089|NCT01164176|Immunologic Factors|immunologic factors|mesh-ancestor
101724383|NCT00694343|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101900090|NCT01164176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900091|NCT01164176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101900092|NCT00313313|Metformin|metformin|mesh-list
101900093|NCT00313313|Saxagliptin|saxagliptin|mesh-list
101900094|NCT00313313|Glyburide|glyburide|mesh-list
101724530|NCT00769522|Rituximab|rituximab|mesh-list
101900095|NCT00313313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101900096|NCT00313313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900097|NCT00313313|Incretins|incretins|mesh-ancestor
101900098|NCT00313313|Hormones|hormones|mesh-ancestor
101724662|NCT00695201|Irinotecan|irinotecan|mesh-list
101900099|NCT00313313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101900100|NCT00313313|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101900101|NCT00313313|Protease Inhibitors|protease inhibitors|mesh-ancestor
101900102|NCT00313313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101900103|NCT00313313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900104|NCT01167920|Calcium Channel Blockers|calcium channel blockers|mesh-list
101900106|NCT01167920|Diuretics|diuretics|mesh-list
101900107|NCT01167920|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101900108|NCT01167920|Renin Inhibitors|renin inhibitors|mesh-list
101900109|NCT01167920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101900110|NCT01167920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900111|NCT01167920|Natriuretic Agents|natriuretic agents|mesh-ancestor
101900112|NCT01167920|Protease Inhibitors|protease inhibitors|mesh-ancestor
101900113|NCT01167920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101900114|NCT01167920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900115|NCT01167920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101900116|NCT01167920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101900118|NCT03873974|Immunoglobulin M|immunoglobulin m|mesh-list
101900119|NCT03873974|Immunologic Factors|immunologic factors|mesh-ancestor
101900120|NCT03873974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900121|NCT01268930|Hemostatics|hemostatics|mesh-list
101900122|NCT01268930|Coagulants|coagulants|mesh-ancestor
101900123|NCT02526758|Budesonide|budesonide|mesh-list
101900124|NCT02526758|Beclomethasone|beclomethasone|mesh-list
101900125|NCT02526758|Formoterol Fumarate|formoterol fumarate|mesh-list
101725462|NCT04135781|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101900126|NCT02526758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101900127|NCT02526758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101900128|NCT02526758|Autonomic Agents|autonomic agents|mesh-ancestor
101900129|NCT02526758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101725611|NCT00796276|Serotonin Agents|serotonin agents|mesh-ancestor
101900131|NCT02526758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101900132|NCT02526758|Respiratory System Agents|respiratory system agents|mesh-ancestor
101725754|NCT00786448|Darifenacin|darifenacin|mesh-list
101900134|NCT02526758|Hormones|hormones|mesh-ancestor
101725824|NCT02621957|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101900135|NCT02526758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101900136|NCT02526758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101900137|NCT02526758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101687497|NCT04748783|Listerine|listerine|mesh-list
101900138|NCT02526758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101900139|NCT02526758|Adrenergic Agents|adrenergic agents|mesh-ancestor
101900140|NCT02526758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101726118|NCT00809328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101900141|NCT02526758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726193|NCT02609334|Pemirolast|pemirolast|mesh-list
101900142|NCT01281878|Vitamin B 6|vitamin b 6|mesh-list
101900143|NCT01281878|Pyridoxal|pyridoxal|mesh-list
101900145|NCT01281878|Vitamins|vitamins|mesh-ancestor
101900146|NCT01281878|Micronutrients|micronutrients|mesh-ancestor
101900147|NCT01281878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726426|NCT02608710|Verinurad|verinurad|mesh-list
101900148|NCT01281878|Vitamin B Complex|vitamin b complex|mesh-ancestor
101900149|NCT01164488|Ritonavir|ritonavir|mesh-list
101900150|NCT01164488|Ketoconazole|ketoconazole|mesh-list
101900151|NCT01164488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101900152|NCT01164488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101900153|NCT01164488|Protease Inhibitors|protease inhibitors|mesh-ancestor
101900154|NCT01164488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101900155|NCT01164488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900156|NCT01164488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101900157|NCT01164488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101900158|NCT01164488|Antiviral Agents|antiviral agents|mesh-ancestor
101900159|NCT01164488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101900160|NCT01164488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101900161|NCT01164488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101900162|NCT01164488|Antifungal Agents|antifungal agents|mesh-ancestor
101900163|NCT01164488|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101900164|NCT01164488|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101900165|NCT01164488|Hormone Antagonists|hormone antagonists|mesh-ancestor
101969738|NCT02287558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101900166|NCT01164488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101900168|NCT00312845|Rituximab|rituximab|mesh-list
101900169|NCT00312845|Bortezomib|bortezomib|mesh-list
101727142|NCT02606994|Sensory System Agents|sensory system agents|mesh-ancestor
101727217|NCT00802048|Sensory System Agents|sensory system agents|mesh-ancestor
101900171|NCT00312845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101727362|NCT00803842|Doxycycline|doxycycline|mesh-list
101900172|NCT00312845|Immunologic Factors|immunologic factors|mesh-ancestor
101900173|NCT00312845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900174|NCT00312845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101900176|NCT01168544|Ergocalciferols|ergocalciferols|mesh-list
101900177|NCT01168544|Cholecalciferol|cholecalciferol|mesh-list
101900179|NCT01168544|Micronutrients|micronutrients|mesh-ancestor
101727730|NCT00839306|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101727805|NCT00803712|Cholecalciferol|cholecalciferol|mesh-list
101900180|NCT01168544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727957|NCT02608320|Fentanyl|fentanyl|mesh-list
101900181|NCT01168544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101900182|NCT01168544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101900183|NCT00368069|Levetiracetam|levetiracetam|mesh-list
101900184|NCT00368069|Anticonvulsants|anticonvulsants|mesh-ancestor
101900185|NCT00368069|Nootropic Agents|nootropic agents|mesh-ancestor
101900186|NCT01165814|Naproxen|naproxen|mesh-list
101900187|NCT01165814|Tramadol|tramadol|mesh-list
101900188|NCT01165814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101900189|NCT01165814|Narcotics|narcotics|mesh-ancestor
101728473|NCT01023919|Immunologic Factors|immunologic factors|mesh-ancestor
101728475|NCT04028622|Anesthetics|anesthetics|mesh-list
101900190|NCT01165814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101728548|NCT02603679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101900191|NCT01165814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900192|NCT01165814|Analgesics|analgesics|mesh-ancestor
101900193|NCT01165814|Sensory System Agents|sensory system agents|mesh-ancestor
101900194|NCT01165814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101900195|NCT01165814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101900196|NCT01165814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101900197|NCT01165814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101900198|NCT01165814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101900199|NCT01165814|Gout Suppressants|gout suppressants|mesh-ancestor
101900200|NCT01165814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101728923|NCT00807196|Rituximab|rituximab|mesh-list
101900201|NCT01165814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101729059|NCT00657358|Sensory System Agents|sensory system agents|mesh-ancestor
101900202|NCT01165814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900203|NCT00367991|Epoetin Alfa|epoetin alfa|mesh-list
101900204|NCT00367991|Hematinics|hematinics|mesh-ancestor
101900205|NCT00367835|Guanfacine|guanfacine|mesh-list
101729277|NCT00811486|Hormone Antagonists|hormone antagonists|mesh-ancestor
101900206|NCT00367835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101900207|NCT00367835|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101900208|NCT00367835|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101729509|NCT00862979|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101900209|NCT00367835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101900210|NCT00367835|Adrenergic Agents|adrenergic agents|mesh-ancestor
101900211|NCT00367835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101900212|NCT00367835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900213|NCT00367835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900214|NCT03874832|Dihydroergotamine|dihydroergotamine|mesh-list
101900215|NCT03874832|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101900216|NCT03874832|Dopamine Agonists|dopamine agonists|mesh-ancestor
101620023|NCT02804841|Cholecalciferol|cholecalciferol|mesh-list
101900217|NCT03874832|Dopamine Agents|dopamine agents|mesh-ancestor
101900218|NCT03874832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101730310|NCT00923000|Sensory System Agents|sensory system agents|mesh-ancestor
101900219|NCT03874832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900220|NCT03874832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900221|NCT03874832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101900223|NCT03874832|Sensory System Agents|sensory system agents|mesh-ancestor
101900224|NCT03874832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101900225|NCT01164800|Trandolapril|trandolapril|mesh-list
101730676|NCT02608112|Abortifacient Agents|abortifacient agents|mesh-ancestor
101900226|NCT01164800|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101900228|NCT01164800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101900229|NCT01164800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900230|NCT01164800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101900231|NCT01169012|Clofarabine|clofarabine|mesh-list
101900232|NCT01169012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101900233|NCT01169012|Antimetabolites|antimetabolites|mesh-ancestor
101730965|NCT00821158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101731113|NCT00829192|Dermatologic Agents|dermatologic agents|mesh-ancestor
101731189|NCT00831376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101900234|NCT01169012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900235|NCT01169012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101900236|NCT01169090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101900237|NCT01169090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101900238|NCT01169090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900239|NCT01169090|Incretins|incretins|mesh-ancestor
101900240|NCT01169090|Hormones|hormones|mesh-ancestor
101731560|NCT00838396|Baclofen|baclofen|mesh-list
101900241|NCT01169090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101900242|NCT01169090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101900243|NCT01169090|Protease Inhibitors|protease inhibitors|mesh-ancestor
101900244|NCT01169090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101900245|NCT01169090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900246|NCT01282502|Midostaurin|midostaurin|mesh-list
101900247|NCT01282502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101900248|NCT01282502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101900249|NCT01282502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101900250|NCT01282502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900251|NCT01269242|Bindarit|bindarit|mesh-list
101900252|NCT01269242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101900253|NCT01269242|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101900254|NCT01269242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101900255|NCT01269242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900258|NCT01169792|Hormone Antagonists|hormone antagonists|mesh-ancestor
101900259|NCT01169792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101900260|NCT01169792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900261|NCT01169792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101900262|NCT01169792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101900263|NCT01169792|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101731977|NCT00844883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101900264|NCT01169792|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101900265|NCT01169792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101900267|NCT01169402|Antifungal Agents|antifungal agents|mesh-ancestor
101732123|NCT00764517|Vorinostat|vorinostat|mesh-list
101900268|NCT01169402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101732339|NCT00840827|Dermatologic Agents|dermatologic agents|mesh-ancestor
101900269|NCT01169402|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101900270|NCT01169402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101900271|NCT01169402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101732487|NCT00771810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101900272|NCT01169402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900273|NCT01169402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101900274|NCT01169402|Hormone Antagonists|hormone antagonists|mesh-ancestor
101732639|NCT00770328|Protective Agents|protective agents|mesh-ancestor
101732711|NCT00707135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732786|NCT00809354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101732858|NCT03908060|Narcotics|narcotics|mesh-ancestor
101732931|NCT00707369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101732932|NCT00707369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101733008|NCT00762372|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101733081|NCT04095390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101900275|NCT01169402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101900276|NCT01169402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900277|NCT01169402|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101900278|NCT01169402|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101900279|NCT01274780|Ritonavir|ritonavir|mesh-list
101900280|NCT01274780|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101900281|NCT01274780|Darunavir|darunavir|mesh-list
101900282|NCT01274780|Tenofovir|tenofovir|mesh-list
101900283|NCT01274780|Emtricitabine|emtricitabine|mesh-list
101900284|NCT01274780|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101900285|NCT01274780|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101900286|NCT01274780|Protease Inhibitors|protease inhibitors|mesh-ancestor
101900287|NCT01274780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101900288|NCT01274780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900289|NCT01274780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101900290|NCT01274780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101733449|NCT00758394|Listerine|listerine|mesh-list
101900291|NCT01274780|Antiviral Agents|antiviral agents|mesh-ancestor
101733517|NCT02607410|Insulin|insulin|mesh-list
101900292|NCT01274780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101900293|NCT01274780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101733669|NCT00751101|Nicotine|nicotine|mesh-list
101900294|NCT01274780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101900295|NCT01274780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101900296|NCT01274780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101900298|NCT01169870|genexol-PM|genexol-pm|mesh-list
101733810|NCT00706277|Anesthetics, General|anesthetics, general|mesh-ancestor
101900299|NCT01169870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101900300|NCT01169870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101900301|NCT01169870|Tubulin Modulators|tubulin modulators|mesh-ancestor
101900302|NCT01169870|Antimitotic Agents|antimitotic agents|mesh-ancestor
101900303|NCT01169870|Mitosis Modulators|mitosis modulators|mesh-ancestor
101900304|NCT01169870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900305|NCT01165970|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101900307|NCT01165970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101900308|NCT01166048|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101734092|NCT00585975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101900309|NCT01166048|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101900310|NCT01166048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101900311|NCT01166048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101900312|NCT01166048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900313|NCT01166048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101900314|NCT01166048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900315|NCT01166048|Analgesics|analgesics|mesh-ancestor
101900316|NCT01166048|Sensory System Agents|sensory system agents|mesh-ancestor
101900317|NCT01166048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101900318|NCT01166048|Antidepressive Agents|antidepressive agents|mesh-ancestor
101900319|NCT01166048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101900320|NCT01166048|Dopamine Agents|dopamine agents|mesh-ancestor
101900321|NCT03869762|Denosumab|denosumab|mesh-list
101900322|NCT03869762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101900323|NCT03869762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900324|NCT01283126|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101900325|NCT01283126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900326|NCT01283048|Bevacizumab|bevacizumab|mesh-list
101900327|NCT01283048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101900328|NCT01283048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101900329|NCT01283048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101900330|NCT01283048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101900331|NCT01283048|Growth Substances|growth substances|mesh-ancestor
101900332|NCT01283048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900333|NCT01283048|Growth Inhibitors|growth inhibitors|mesh-ancestor
101900334|NCT03873740|Vaccines|vaccines|mesh-list
101900335|NCT03873740|Immunologic Factors|immunologic factors|mesh-ancestor
101900336|NCT03873740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900337|NCT01172756|Riociguat|riociguat|mesh-list
101900338|NCT01172756|Enzyme Activators|enzyme activators|mesh-ancestor
101900339|NCT01172756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900340|NCT02525822|Tazarotene|tazarotene|mesh-list
101900341|NCT02525822|Dermatologic Agents|dermatologic agents|mesh-ancestor
101900342|NCT02525822|Keratolytic Agents|keratolytic agents|mesh-ancestor
101900343|NCT01172912|Dexamethasone|dexamethasone|mesh-list
101900344|NCT01172912|Carboplatin|carboplatin|mesh-list
101900345|NCT01172912|Etoposide|etoposide|mesh-list
101900346|NCT01172912|Ifosfamide|ifosfamide|mesh-list
101900347|NCT01172912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101900348|NCT01172912|Antiemetics|antiemetics|mesh-ancestor
101900349|NCT01172912|Autonomic Agents|autonomic agents|mesh-ancestor
101900350|NCT01172912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101900351|NCT01172912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900352|NCT01172912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101900353|NCT01172912|Glucocorticoids|glucocorticoids|mesh-ancestor
101900354|NCT01172912|Hormones|hormones|mesh-ancestor
101734423|NCT00726609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101734495|NCT00807248|GABA Agonists|gaba agonists|mesh-ancestor
101687567|NCT02679456|Antifungal Agents|antifungal agents|mesh-ancestor
101900355|NCT01172912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101900356|NCT01172912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101900357|NCT01172912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101900358|NCT01172912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101734864|NCT04111328|Anesthetics|anesthetics|mesh-ancestor
101900359|NCT01172912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101900360|NCT01172912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101900361|NCT01172912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101735014|NCT00915200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101900362|NCT01172912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735238|NCT01020253|Vitamins|vitamins|mesh-ancestor
101900363|NCT01172912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101620171|NCT00770653|Pioglitazone|pioglitazone|mesh-list
101900364|NCT01172912|Alkylating Agents|alkylating agents|mesh-ancestor
101900365|NCT01283204|Leucovorin|leucovorin|mesh-list
101900366|NCT01283204|Paclitaxel|paclitaxel|mesh-list
101900368|NCT01283204|Cisplatin|cisplatin|mesh-list
101900369|NCT01283204|Oxaliplatin|oxaliplatin|mesh-list
101900370|NCT01283204|Levoleucovorin|levoleucovorin|mesh-list
101900371|NCT01283204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101900372|NCT01283204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101900373|NCT01283204|Tubulin Modulators|tubulin modulators|mesh-ancestor
101735603|NCT00720057|Naproxen|naproxen|mesh-list
101900374|NCT01283204|Antimitotic Agents|antimitotic agents|mesh-ancestor
101900375|NCT01283204|Mitosis Modulators|mitosis modulators|mesh-ancestor
101735747|NCT04041791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101735748|NCT04041791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101735749|NCT04041791|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101735750|NCT04041791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101735751|NCT04041791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735752|NCT04041791|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101735753|NCT02605226|Bicalutamide|bicalutamide|mesh-list
101735754|NCT02605226|Hormones|hormones|mesh-list
101735755|NCT02605226|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101735756|NCT02605226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101735757|NCT02605226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735758|NCT02605226|Androgen Antagonists|androgen antagonists|mesh-ancestor
101735759|NCT02605226|Hormone Antagonists|hormone antagonists|mesh-ancestor
101735760|NCT02605226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101735761|NCT05571878|Insulin Lispro|insulin lispro|mesh-list
101735762|NCT05571878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101735821|NCT02606981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735896|NCT00733824|Antiviral Agents|antiviral agents|mesh-ancestor
101900376|NCT01283204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900377|NCT01283204|Antidotes|antidotes|mesh-ancestor
101900378|NCT01283204|Protective Agents|protective agents|mesh-ancestor
101900379|NCT01283204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900380|NCT01283204|Vitamin B Complex|vitamin b complex|mesh-ancestor
101900381|NCT01283204|Vitamins|vitamins|mesh-ancestor
101900382|NCT01283204|Micronutrients|micronutrients|mesh-ancestor
101900383|NCT03869528|Lidocaine|lidocaine|mesh-list
101900384|NCT03869528|Anesthetics, Local|anesthetics, local|mesh-ancestor
101900385|NCT03869528|Anesthetics|anesthetics|mesh-ancestor
101900386|NCT03869528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101900387|NCT03869528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900388|NCT03869528|Sensory System Agents|sensory system agents|mesh-ancestor
101736635|NCT05216055|Protease Inhibitors|protease inhibitors|mesh-ancestor
101900389|NCT03869528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101900390|NCT03869528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101900391|NCT03869528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101900392|NCT03869528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101736786|NCT02593968|Interferons|interferons|mesh-list
101900393|NCT03869528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101736860|NCT04082715|Dopamine Agents|dopamine agents|mesh-ancestor
101900394|NCT03869528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900395|NCT01283360|Tenofovir|tenofovir|mesh-list
101737006|NCT04101812|Doxorubicin|doxorubicin|mesh-list
101900396|NCT01283360|Antiviral Agents|antiviral agents|mesh-ancestor
101900397|NCT01283360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101900398|NCT01283360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101900399|NCT01283360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101900400|NCT01283360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101900401|NCT01283360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900402|NCT01283360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101900403|NCT01283360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101900404|NCT01173068|Ertapenem|ertapenem|mesh-list
101900405|NCT01173068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101900406|NCT01173068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101900407|NCT03267940|Atezolizumab|atezolizumab|mesh-list
101737377|NCT00761306|Vortioxetine|vortioxetine|mesh-list
101900408|NCT03267940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101737517|NCT02596269|Analgesics|analgesics|mesh-ancestor
101737591|NCT00760214|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101900409|NCT03267940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900410|NCT03267940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101737757|NCT00759356|Morphine|morphine|mesh-list
101737832|NCT00771914|Aspirin|aspirin|mesh-list
101900411|NCT03267940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101900412|NCT01284452|Hydrocortisone|hydrocortisone|mesh-list
101738115|NCT05277285|Chelating Agents|chelating agents|mesh-ancestor
101900413|NCT01284452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101900415|NCT01170104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101900416|NCT01170104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101900417|NCT01170104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101900418|NCT01170104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900419|NCT01284764|Mosapride|mosapride|mesh-list
101900420|NCT01284764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101900421|NCT01284764|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101900423|NCT01284764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101738556|NCT04075227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101900424|NCT01284764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738706|NCT00789035|Metformin|metformin|mesh-list
101900425|NCT01284764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900426|NCT01170182|Omeprazole|omeprazole|mesh-list
101900427|NCT01170182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101738925|NCT02600780|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101900428|NCT01170182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101739013|NCT01021501|Nifedipine|nifedipine|mesh-list
101900429|NCT01170182|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101900430|NCT01170182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101900431|NCT01170182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739226|NCT00768560|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101739300|NCT00751790|Contraceptive Agents|contraceptive agents|mesh-ancestor
101900433|NCT01170260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101900434|NCT01170260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101739447|NCT04090112|Sensory System Agents|sensory system agents|mesh-ancestor
101900435|NCT01170260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101900436|NCT01170260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900437|NCT00312377|Docetaxel|docetaxel|mesh-list
101900438|NCT00312377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101900439|NCT00312377|Tubulin Modulators|tubulin modulators|mesh-ancestor
101900441|NCT00312377|Mitosis Modulators|mitosis modulators|mesh-ancestor
101900442|NCT00312377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900443|NCT01173536|Moxifloxacin|moxifloxacin|mesh-list
101900444|NCT01173536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101900445|NCT01173536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101900446|NCT01173536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101900447|NCT01173536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101900448|NCT01173536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101739820|NCT00719472|Doxorubicin|doxorubicin|mesh-list
101739894|NCT04086186|Bupivacaine|bupivacaine|mesh-list
101900449|NCT01173536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740037|NCT04084158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101900450|NCT01173536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101900451|NCT01580891|Naftifine|naftifine|mesh-list
101900452|NCT01580891|Antifungal Agents|antifungal agents|mesh-ancestor
101900455|NCT01059383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101740638|NCT00720447|Cytarabine|cytarabine|mesh-list
101900456|NCT01059383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101900457|NCT01059383|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101900458|NCT01059383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101900459|NCT01059383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900460|NCT01285232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101900461|NCT01285232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101900462|NCT01170338|Varenicline|varenicline|mesh-list
101900463|NCT01170338|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101900464|NCT01170338|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101900465|NCT01170338|Cholinergic Agents|cholinergic agents|mesh-ancestor
101900466|NCT01170338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101900467|NCT01170338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900468|NCT01170338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900470|NCT00312221|Buprenorphine|buprenorphine|mesh-list
101900471|NCT00312221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101900472|NCT00312221|Narcotics|narcotics|mesh-ancestor
101900473|NCT00312221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101740921|NCT00740714|Coenzyme Q10|coenzyme q10|mesh-list
101900474|NCT00312221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900476|NCT00312221|Sensory System Agents|sensory system agents|mesh-ancestor
101741069|NCT00722475|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101741146|NCT00794963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101900477|NCT00312221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101900478|NCT00312221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101900479|NCT03872570|Phenylephrine|phenylephrine|mesh-list
101900480|NCT03872570|Oxymetazoline|oxymetazoline|mesh-list
101900481|NCT03872570|Norepinephrine|norepinephrine|mesh-list
101900482|NCT03872570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101900483|NCT03872570|Mydriatics|mydriatics|mesh-ancestor
101900484|NCT03872570|Autonomic Agents|autonomic agents|mesh-ancestor
101900485|NCT03872570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101900486|NCT03872570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741592|NCT02603783|Capsaicin|capsaicin|mesh-list
101900487|NCT03872570|Sympathomimetics|sympathomimetics|mesh-ancestor
101900488|NCT03872570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101900489|NCT03872570|Nasal Decongestants|nasal decongestants|mesh-ancestor
101900490|NCT03872570|Respiratory System Agents|respiratory system agents|mesh-ancestor
101900491|NCT03872570|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101900492|NCT03872570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101900493|NCT03872570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101900494|NCT03872570|Adrenergic Agents|adrenergic agents|mesh-ancestor
101900495|NCT03872570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101900496|NCT03872570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900497|NCT03872570|Protective Agents|protective agents|mesh-ancestor
101900498|NCT01173926|Insulin|insulin|mesh-list
101900499|NCT01173926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101900500|NCT01173926|Insulin Aspart|insulin aspart|mesh-list
101900501|NCT01173926|Insulin, Long-Acting|insulin, long-acting|mesh-list
101900502|NCT01173926|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101900503|NCT01173926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101900504|NCT01173926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900505|NCT03349268|Xenon|xenon|mesh-list
101900506|NCT03349268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101900507|NCT03349268|Anesthetics, General|anesthetics, general|mesh-ancestor
101900508|NCT03349268|Anesthetics|anesthetics|mesh-ancestor
101900509|NCT03349268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101900510|NCT03349268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526890|NCT04813653|Hormones|hormones|mesh-ancestor
101900511|NCT01170494|Cholecalciferol|cholecalciferol|mesh-list
101620329|NCT02798913|Clopidogrel|clopidogrel|mesh-list
101900512|NCT01170494|Vitamin D|vitamin d|mesh-list
101900513|NCT01170494|Ergocalciferols|ergocalciferols|mesh-list
101900514|NCT01170494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101900515|NCT01170494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900516|NCT01170494|Vitamins|vitamins|mesh-ancestor
101742393|NCT00738777|Tamoxifen|tamoxifen|mesh-list
101742465|NCT00707031|Hormones|hormones|mesh-ancestor
101900517|NCT01170494|Micronutrients|micronutrients|mesh-ancestor
101900518|NCT01170494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101900519|NCT01587326|Escitalopram|escitalopram|mesh-list
101900520|NCT01587326|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101900521|NCT01587326|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101900522|NCT01587326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101742986|NCT05742243|Immunologic Factors|immunologic factors|mesh-ancestor
101373664|NCT00224146|Oxybutynin|oxybutynin|mesh-list
101900523|NCT01587326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900526|NCT01587326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743224|NCT04137354|Iron|iron|mesh-list
101900527|NCT03294538|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101900528|NCT03294538|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101743359|NCT04075188|Aflibercept|aflibercept|mesh-list
101400916|NCT04793906|Iron|iron|mesh-list
101743578|NCT03980925|Carboplatin|carboplatin|mesh-list
101743666|NCT04061265|Autonomic Agents|autonomic agents|mesh-ancestor
101900531|NCT03294538|Estrogens|estrogens|mesh-ancestor
101900533|NCT03294538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101900534|NCT03294538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900535|NCT03294538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101900536|NCT03294538|Contraceptive Agents|contraceptive agents|mesh-ancestor
101900537|NCT03294538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101900538|NCT03294538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101900539|NCT03872336|Labetalol|labetalol|mesh-list
101900540|NCT03872336|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101900541|NCT03872336|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101900542|NCT03872336|Adrenergic Agents|adrenergic agents|mesh-ancestor
101743951|NCT02592122|Bromides|bromides|mesh-list
101900543|NCT03872336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101744015|NCT00744393|Sodium Oxybate|sodium oxybate|mesh-list
101900544|NCT03872336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900545|NCT03872336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900546|NCT03872336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101900547|NCT03872336|Sympathomimetics|sympathomimetics|mesh-ancestor
101900548|NCT03872336|Autonomic Agents|autonomic agents|mesh-ancestor
101900549|NCT03872336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101900550|NCT03872336|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101900551|NCT03872336|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101900553|NCT02987530|Emtricitabine|emtricitabine|mesh-list
101900554|NCT02987530|Dolutegravir|dolutegravir|mesh-list
101900555|NCT02987530|Darunavir|darunavir|mesh-list
101900556|NCT02987530|Cobicistat|cobicistat|mesh-list
101900557|NCT02987530|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
101900558|NCT02987530|Antiviral Agents|antiviral agents|mesh-ancestor
101900559|NCT02987530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101900560|NCT02987530|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101900561|NCT02987530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101900562|NCT02987530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101900563|NCT02987530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900564|NCT02987530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101745128|NCT00753909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101745129|NCT00753909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101745130|NCT00753909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101745131|NCT00753909|Growth Substances|growth substances|mesh-ancestor
101745132|NCT00753909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745134|NCT02560155|Chlorhexidine|chlorhexidine|mesh-list
101745204|NCT00682929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101745299|NCT00754689|Metformin|metformin|mesh-list
101900565|NCT02987530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101745357|NCT00682539|Triamcinolone|triamcinolone|mesh-list
101900566|NCT02987530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101900567|NCT02987530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101900568|NCT02987530|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101900569|NCT02987530|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101900570|NCT02987530|Protease Inhibitors|protease inhibitors|mesh-ancestor
101745797|NCT00673179|Doxorubicin|doxorubicin|mesh-list
101900571|NCT02987530|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101745883|NCT02582996|Caffeine|caffeine|mesh-list
101900572|NCT02987530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101746043|NCT05332730|Golimumab|golimumab|mesh-list
101900573|NCT03865550|Ketamine|ketamine|mesh-list
101900574|NCT03865550|Analgesics|analgesics|mesh-ancestor
101900575|NCT03865550|Sensory System Agents|sensory system agents|mesh-ancestor
101900576|NCT03865550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101900577|NCT03865550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900578|NCT03865550|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101900579|NCT03865550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101900581|NCT03865550|Anesthetics|anesthetics|mesh-ancestor
101900582|NCT03865550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101900583|NCT03865550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101900584|NCT03865550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101900585|NCT03865550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101746834|NCT00772395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900586|NCT03865550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900587|NCT02965690|Cimetidine|cimetidine|mesh-list
101746989|NCT03704480|Durvalumab|durvalumab|mesh-list
101900588|NCT02965690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101900589|NCT02965690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101900590|NCT02965690|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101900591|NCT02965690|Histamine Antagonists|histamine antagonists|mesh-ancestor
101900592|NCT02965690|Histamine Agents|histamine agents|mesh-ancestor
101900593|NCT02965690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101747286|NCT00778245|Cefprozil|cefprozil|mesh-list
101747352|NCT00774111|Antiviral Agents|antiviral agents|mesh-ancestor
101900594|NCT02965690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747427|NCT00784797|Oxytocin|oxytocin|mesh-list
101900595|NCT02965690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900596|NCT02965690|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101900597|NCT02965690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101900598|NCT02965690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101747570|NCT00440947|Antimetabolites|antimetabolites|mesh-ancestor
101900600|NCT01285388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101900601|NCT01285388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101900602|NCT01285388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101900603|NCT01285388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101900604|NCT01285388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900605|NCT01285388|Antiviral Agents|antiviral agents|mesh-ancestor
101748005|NCT00440401|Thrombin|thrombin|mesh-list
101900606|NCT01285466|Paclitaxel|paclitaxel|mesh-list
101748153|NCT00430573|Cycloserine|cycloserine|mesh-list
101900607|NCT01285466|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101900608|NCT01285466|Trastuzumab|trastuzumab|mesh-list
101900609|NCT01285466|Dactolisib|dactolisib|mesh-list
101900610|NCT01285466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101900612|NCT01285466|Tubulin Modulators|tubulin modulators|mesh-ancestor
101900613|NCT01285466|Antimitotic Agents|antimitotic agents|mesh-ancestor
101748629|NCT00712478|Insulin|insulin|mesh-list
101900614|NCT01285466|Mitosis Modulators|mitosis modulators|mesh-ancestor
101900615|NCT01285466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900616|NCT01285466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101900618|NCT01285544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101900619|NCT01285544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101900620|NCT01285544|Antimetabolites|antimetabolites|mesh-ancestor
101748895|NCT00793845|Immunologic Factors|immunologic factors|mesh-ancestor
101900621|NCT01285544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900622|NCT01285544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101900623|NCT01285544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101900624|NCT01285544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101900625|NCT01174394|Fluoxetine|fluoxetine|mesh-list
101900626|NCT01174394|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101749114|NCT00801255|Lactams|lactams|mesh-list
101749199|NCT04330820|Venetoclax|venetoclax|mesh-list
101900627|NCT01174394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101900628|NCT01174394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101900629|NCT01174394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900630|NCT01174394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101900631|NCT01174394|Serotonin Agents|serotonin agents|mesh-ancestor
101900632|NCT01174394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749559|NCT00718796|Vitamins|vitamins|mesh-ancestor
101900633|NCT01174394|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101900634|NCT01174394|Antidepressive Agents|antidepressive agents|mesh-ancestor
101900635|NCT01174394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101749774|NCT00439777|Protease Inhibitors|protease inhibitors|mesh-ancestor
101900636|NCT01174394|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101900637|NCT01174394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101900638|NCT01174394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101900639|NCT01174472|Paclitaxel|paclitaxel|mesh-list
101900640|NCT01174472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101750075|NCT00424489|Antiemetics|antiemetics|mesh-ancestor
101750216|NCT04101383|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101900641|NCT01174472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101900642|NCT01174472|Tubulin Modulators|tubulin modulators|mesh-ancestor
101900643|NCT01174472|Antimitotic Agents|antimitotic agents|mesh-ancestor
101900644|NCT01174472|Mitosis Modulators|mitosis modulators|mesh-ancestor
101750440|NCT02573610|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101750512|NCT04070742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101900645|NCT01174472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900646|NCT00335153|Levodopa|levodopa|mesh-list
101900647|NCT00335153|Carbidopa|carbidopa|mesh-list
101750666|NCT05808946|Vitamins|vitamins|mesh-ancestor
101900648|NCT00335153|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101900649|NCT00335153|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101750816|NCT05532215|Misoprostol|misoprostol|mesh-list
101750894|NCT05366166|Cisplatin|cisplatin|mesh-list
101900650|NCT00335153|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101900651|NCT00335153|Dopamine Agents|dopamine agents|mesh-ancestor
101900652|NCT00335153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101900653|NCT00335153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900654|NCT00335153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751338|NCT04306900|Antimetabolites|antimetabolites|mesh-ancestor
101900655|NCT00335153|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101900656|NCT00335153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101900657|NCT00335153|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101900658|NCT00335153|Immunologic Factors|immunologic factors|mesh-ancestor
101900659|NCT00335153|Dopamine Agonists|dopamine agonists|mesh-ancestor
101900660|NCT01170806|Orlistat|orlistat|mesh-list
101900661|NCT01170806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101900662|NCT01170806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900663|NCT01170806|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101900664|NCT01170806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101900665|NCT03868436|Methoxyflurane|methoxyflurane|mesh-list
101900666|NCT03868436|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101900667|NCT03868436|Anesthetics, General|anesthetics, general|mesh-ancestor
101900668|NCT03868436|Anesthetics|anesthetics|mesh-ancestor
101900669|NCT03868436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101900670|NCT03868436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900671|NCT01280006|Celecoxib|celecoxib|mesh-list
101900672|NCT01280006|Indomethacin|indomethacin|mesh-list
101900673|NCT01280006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101900674|NCT01280006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101900675|NCT01280006|Analgesics|analgesics|mesh-ancestor
101900676|NCT01280006|Sensory System Agents|sensory system agents|mesh-ancestor
101687793|NCT02673606|Estrogens|estrogens|mesh-ancestor
101751865|NCT02138617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101900677|NCT01280006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101751940|NCT01612351|Carboplatin|carboplatin|mesh-list
101900678|NCT01280006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900679|NCT01280006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101900680|NCT01280006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101900681|NCT01280006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101900682|NCT01280006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101900683|NCT01280006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101752238|NCT02545738|Incretins|incretins|mesh-ancestor
101900684|NCT01280006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900685|NCT01280006|Gout Suppressants|gout suppressants|mesh-ancestor
101900686|NCT01280006|Tocolytic Agents|tocolytic agents|mesh-ancestor
101900687|NCT01280006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101752611|NCT00713622|GABA Agents|gaba agents|mesh-ancestor
101900688|NCT03265132|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101900690|NCT03865160|Atropine|atropine|mesh-list
101752906|NCT00714090|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101752982|NCT00859534|Afamelanotide|afamelanotide|mesh-list
101900692|NCT03865160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101900693|NCT03865160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101900694|NCT03865160|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101900695|NCT03865160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101900696|NCT03865160|Autonomic Agents|autonomic agents|mesh-ancestor
101900697|NCT03865160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101900698|NCT03865160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900699|NCT03865160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101900700|NCT03865160|Respiratory System Agents|respiratory system agents|mesh-ancestor
101900701|NCT03865160|Mydriatics|mydriatics|mesh-ancestor
101900702|NCT03865160|Parasympatholytics|parasympatholytics|mesh-ancestor
101900703|NCT03865160|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101900704|NCT03865160|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101900705|NCT03865160|Cholinergic Agents|cholinergic agents|mesh-ancestor
101900706|NCT03865160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101900707|NCT03865160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900708|NCT01059461|Cerebrolysin|cerebrolysin|mesh-list
101900709|NCT01059461|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101900710|NCT01059461|Protective Agents|protective agents|mesh-ancestor
101900711|NCT01059461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900712|NCT01059461|Nootropic Agents|nootropic agents|mesh-ancestor
101900713|NCT01324739|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101900714|NCT01324739|Natriuretic Agents|natriuretic agents|mesh-ancestor
101900715|NCT01324739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900716|NCT01286246|Progesterone|progesterone|mesh-list
101900717|NCT01286246|Progestins|progestins|mesh-ancestor
101900718|NCT01286246|Hormones|hormones|mesh-ancestor
101900719|NCT01286246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101900720|NCT01286246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900721|NCT03981887|Nafithromycin|nafithromycin|mesh-list
101753406|NCT00861328|Glycine|glycine|mesh-list
101900722|NCT03981887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101753483|NCT04130204|Colchicine|colchicine|mesh-list
101900723|NCT03981887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101900724|NCT03981887|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101900725|NCT03981887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101753568|NCT00724802|Triacetin|triacetin|mesh-list
101900726|NCT03981887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753702|NCT03491540|Laxatives|laxatives|mesh-ancestor
101753874|NCT00866944|Leucovorin|leucovorin|mesh-list
101900728|NCT01063127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101900729|NCT01063127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900730|NCT03865004|Acetaminophen|acetaminophen|mesh-list
101900731|NCT03865004|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
101900733|NCT03865004|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101900734|NCT03865004|Narcotics|narcotics|mesh-ancestor
101754227|NCT02950766|Ipilimumab|ipilimumab|mesh-list
101900735|NCT03865004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101620555|NCT04235985|Chlorhexidine|chlorhexidine|mesh-list
101900736|NCT03865004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900737|NCT03865004|Analgesics|analgesics|mesh-ancestor
101754436|NCT00732836|Paclitaxel|paclitaxel|mesh-list
101900738|NCT03865004|Sensory System Agents|sensory system agents|mesh-ancestor
101900739|NCT03865004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101900740|NCT03865004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101900741|NCT03865004|Antipyretics|antipyretics|mesh-ancestor
101754730|NCT00868426|Glucocorticoids|glucocorticoids|mesh-ancestor
101900742|NCT03865004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101754808|NCT00809913|Ciprofloxacin|ciprofloxacin|mesh-list
101900743|NCT03865004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101900744|NCT03865004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101900746|NCT00334295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101900747|NCT00334295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101900748|NCT00334295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101900749|NCT00334295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101900750|NCT00334295|Hormone Antagonists|hormone antagonists|mesh-ancestor
101900751|NCT00334295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101900752|NCT00334295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900753|NCT01285778|Panitumumab|panitumumab|mesh-list
101900754|NCT01285778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101900755|NCT01285778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101900756|NCT01063205|Acetylcysteine|acetylcysteine|mesh-list
101900757|NCT01063205|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101900758|NCT01063205|Antiviral Agents|antiviral agents|mesh-ancestor
101900759|NCT01063205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101900760|NCT01063205|Expectorants|expectorants|mesh-ancestor
101900761|NCT01063205|Respiratory System Agents|respiratory system agents|mesh-ancestor
101900762|NCT01063205|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101900763|NCT01063205|Antioxidants|antioxidants|mesh-ancestor
101900764|NCT01063205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900765|NCT01063205|Protective Agents|protective agents|mesh-ancestor
101900766|NCT01063205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900767|NCT01063205|Antidotes|antidotes|mesh-ancestor
101900768|NCT01175096|Everolimus|everolimus|mesh-list
101900769|NCT01175096|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101755024|NCT00729768|Antifungal Agents|antifungal agents|mesh-ancestor
101900770|NCT01175096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101900771|NCT01175096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101900772|NCT01175096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900773|NCT01175096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101900774|NCT01175096|Immunologic Factors|immunologic factors|mesh-ancestor
101900775|NCT01175096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900776|NCT01175096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101900777|NCT01285934|Insulin|insulin|mesh-list
101900778|NCT01285934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101900779|NCT01285934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900780|NCT01060163|Tranexamic Acid|tranexamic acid|mesh-list
101755297|NCT05157412|Hormones|hormones|mesh-ancestor
101900781|NCT01060163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101900782|NCT01060163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101900783|NCT01060163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755444|NCT02568176|Midazolam|midazolam|mesh-list
101900785|NCT01060163|Coagulants|coagulants|mesh-ancestor
101900786|NCT01063439|Cytarabine|cytarabine|mesh-list
101900788|NCT01063439|Melphalan|melphalan|mesh-list
101900790|NCT01063439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101755960|NCT00873886|Oseltamivir|oseltamivir|mesh-list
101900792|NCT01063439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101900793|NCT01063439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101756186|NCT00404755|Bupropion|bupropion|mesh-list
101900794|NCT01063439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101900795|NCT01063439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900796|NCT01063439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101900797|NCT01063439|Antimetabolites|antimetabolites|mesh-ancestor
101900798|NCT01063439|Antiviral Agents|antiviral agents|mesh-ancestor
101900799|NCT01063439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101900800|NCT01063439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101900801|NCT01063439|Immunologic Factors|immunologic factors|mesh-ancestor
101900802|NCT01063439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900803|NCT01063439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101900804|NCT01063439|Alkylating Agents|alkylating agents|mesh-ancestor
101900805|NCT01063439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101900806|NCT05275270|Oxytocin|oxytocin|mesh-list
101900807|NCT05275270|Oxytocics|oxytocics|mesh-ancestor
101756389|NCT05741814|Anesthetics, General|anesthetics, general|mesh-ancestor
101756460|NCT00612586|Growth Substances|growth substances|mesh-ancestor
101900808|NCT05275270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101900809|NCT05275270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900810|NCT03868202|Estradiol|estradiol|mesh-list
101900811|NCT03868202|Progesterone|progesterone|mesh-list
101900812|NCT03868202|Estrogens|estrogens|mesh-ancestor
101900813|NCT03868202|Hormones|hormones|mesh-ancestor
101756684|NCT04038034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900814|NCT03868202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101900815|NCT03868202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900816|NCT03868202|Progestins|progestins|mesh-ancestor
101900817|NCT00311363|Gabapentin|gabapentin|mesh-list
101900818|NCT00311363|Analgesics|analgesics|mesh-ancestor
101757132|NCT00886132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101900819|NCT00311363|Sensory System Agents|sensory system agents|mesh-ancestor
101900820|NCT00311363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101900821|NCT00311363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900822|NCT00311363|Anticonvulsants|anticonvulsants|mesh-ancestor
101900823|NCT00311363|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101900824|NCT00311363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101900825|NCT00311363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101900826|NCT00311363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101900827|NCT00311363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101900828|NCT00311363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101900829|NCT00311363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101900830|NCT00311363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900832|NCT01175330|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101900833|NCT01175330|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101757945|NCT00627393|Hormones|hormones|mesh-ancestor
101900834|NCT01175330|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101900835|NCT01175330|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101900836|NCT03262012|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101900837|NCT03262012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101758371|NCT00822783|Omalizumab|omalizumab|mesh-list
101758474|NCT00817245|Omeprazole|omeprazole|mesh-list
101900838|NCT03262012|Respiratory System Agents|respiratory system agents|mesh-ancestor
101900839|NCT01286090|Cisapride|cisapride|mesh-list
101900840|NCT01286090|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101900841|NCT01286090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101900842|NCT01286090|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101758607|NCT00712712|Morphine|morphine|mesh-list
101900843|NCT01286090|Serotonin Agents|serotonin agents|mesh-ancestor
101900844|NCT01286090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101758736|NCT00894010|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101900845|NCT01286090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900846|NCT01286090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900848|NCT00310817|Immunologic Factors|immunologic factors|mesh-ancestor
101759035|NCT00397033|Serotonin Agents|serotonin agents|mesh-ancestor
101900849|NCT00310817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900850|NCT03783286|Ivacaftor|ivacaftor|mesh-list
101900851|NCT03783286|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101900852|NCT03783286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101900853|NCT03783286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900854|NCT03863366|Prucalopride|prucalopride|mesh-list
101759473|NCT00900874|Adrenergic Agents|adrenergic agents|mesh-ancestor
101900855|NCT03863366|Laxatives|laxatives|mesh-ancestor
101900856|NCT03863366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101759620|NCT00837915|Dermatologic Agents|dermatologic agents|mesh-ancestor
101900857|NCT03863366|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101900858|NCT03863366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101900859|NCT03863366|Serotonin Agents|serotonin agents|mesh-ancestor
101900860|NCT03863366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101759773|NCT00903838|Pramipexole|pramipexole|mesh-list
101900861|NCT03863366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759840|NCT01037101|Antitubercular Agents|antitubercular agents|mesh-ancestor
101900862|NCT03863366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900863|NCT01175486|Pioglitazone|pioglitazone|mesh-list
101900864|NCT01175486|Acarbose|acarbose|mesh-list
101900865|NCT01175486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101900866|NCT01175486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900867|NCT01175486|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101900868|NCT01175486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101760141|NCT00928330|Trastuzumab|trastuzumab|mesh-list
101900869|NCT01175486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900870|NCT01177904|Progesterone|progesterone|mesh-list
101900871|NCT01177904|Progestins|progestins|mesh-ancestor
101900872|NCT01177904|Hormones|hormones|mesh-ancestor
101900873|NCT01177904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101900874|NCT01177904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900875|NCT02940886|Iron|iron|mesh-list
101900876|NCT02940886|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101900877|NCT02940886|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
101900878|NCT02940886|Trace Elements|trace elements|mesh-ancestor
101900879|NCT02940886|Micronutrients|micronutrients|mesh-ancestor
101900880|NCT02940886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900881|NCT02940886|Hematinics|hematinics|mesh-ancestor
101900882|NCT05216614|Fluvoxamine|fluvoxamine|mesh-list
101900883|NCT05216614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101900884|NCT05216614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101900885|NCT05216614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101900886|NCT05216614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760719|NCT00828477|Nepafenac|nepafenac|mesh-list
101900887|NCT05216614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101760861|NCT00930358|Anesthetics|anesthetics|mesh-list
101760936|NCT00930670|Antimetabolites|antimetabolites|mesh-ancestor
101761009|NCT00931138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101761013|NCT00931138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101900888|NCT05216614|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101900889|NCT05216614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101900890|NCT05216614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101900891|NCT05216614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900892|NCT05216614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101900893|NCT05216614|Serotonin Agents|serotonin agents|mesh-ancestor
101374120|NCT00226096|Metoprolol|metoprolol|mesh-list
101761300|NCT00830193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900894|NCT05216614|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101900895|NCT05216614|Antidepressive Agents|antidepressive agents|mesh-ancestor
101687967|NCT02673840|Ketotifen|ketotifen|mesh-list
101900896|NCT05216614|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101900897|NCT05216614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101900898|NCT05216614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101900899|NCT05216614|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101761522|NCT00742248|Autonomic Agents|autonomic agents|mesh-ancestor
101761601|NCT00840801|Vaccines|vaccines|mesh-list
101761662|NCT00842205|Interferons|interferons|mesh-list
101761737|NCT00842595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101900900|NCT03860636|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101900901|NCT03860636|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101900903|NCT03860636|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101900904|NCT03860636|Progesterone|progesterone|mesh-list
101900905|NCT03860636|Estrogens|estrogens|mesh-ancestor
101762034|NCT00390013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101762106|NCT00687804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419523|NCT00141596|Furosemide|furosemide|mesh-list
101762181|NCT00749112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101900907|NCT03860636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101900908|NCT03860636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762253|NCT00945022|Anesthetics|anesthetics|mesh-list
101900909|NCT03860636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101900910|NCT03860636|Contraceptive Agents|contraceptive agents|mesh-ancestor
101900911|NCT03860636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101900912|NCT03860636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101900913|NCT03860636|Progestins|progestins|mesh-ancestor
101900915|NCT03860480|Anesthetics, Local|anesthetics, local|mesh-ancestor
101900916|NCT03860480|Anesthetics|anesthetics|mesh-ancestor
101900917|NCT03860480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101762926|NCT00854451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101900918|NCT03860480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900919|NCT03860480|Sensory System Agents|sensory system agents|mesh-ancestor
101900920|NCT03860480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101763222|NCT00865371|Dopamine Agents|dopamine agents|mesh-ancestor
101900922|NCT03285646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101900923|NCT03285646|Analgesics|analgesics|mesh-ancestor
101900924|NCT03285646|Sensory System Agents|sensory system agents|mesh-ancestor
101900925|NCT03285646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101900926|NCT03285646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900928|NCT03860012|Hematinics|hematinics|mesh-ancestor
101900930|NCT03860012|Vitamins|vitamins|mesh-ancestor
101900931|NCT03860012|Micronutrients|micronutrients|mesh-ancestor
101900932|NCT03860012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900933|NCT03859934|Melatonin|melatonin|mesh-list
101763891|NCT00694304|Serotonin Agents|serotonin agents|mesh-ancestor
101900934|NCT03859934|Antioxidants|antioxidants|mesh-ancestor
101900935|NCT03859934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900936|NCT03859934|Protective Agents|protective agents|mesh-ancestor
101900937|NCT03859934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900938|NCT03859934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101900939|NCT01178372|Lactulose|lactulose|mesh-list
101900940|NCT01178372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101900942|NCT01178450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101900943|NCT01178450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900944|NCT01178450|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101900945|NCT01178450|Hormone Antagonists|hormone antagonists|mesh-ancestor
101900946|NCT01178450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101900947|NCT00074490|Prednisone|prednisone|mesh-list
101900948|NCT00074490|Cyclophosphamide|cyclophosphamide|mesh-list
101900949|NCT00074490|Rituximab|rituximab|mesh-list
101900950|NCT00074490|Doxorubicin|doxorubicin|mesh-list
101764558|NCT03680352|Cefepime|cefepime|mesh-list
101900951|NCT00074490|Fludarabine|fludarabine|mesh-list
101900952|NCT00074490|Etoposide|etoposide|mesh-list
101900953|NCT00074490|Vincristine|vincristine|mesh-list
101900954|NCT00074490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101900955|NCT00074490|Immunologic Factors|immunologic factors|mesh-ancestor
101900956|NCT00074490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900957|NCT00074490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101900958|NCT00074490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101900959|NCT00074490|Alkylating Agents|alkylating agents|mesh-ancestor
101969782|NCT00435916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101900960|NCT00074490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900961|NCT00074490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101900963|NCT00074490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101900964|NCT00074490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101900965|NCT00074490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101900966|NCT00074490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101900967|NCT00074490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101900968|NCT00074490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101900969|NCT00074490|Glucocorticoids|glucocorticoids|mesh-ancestor
101764909|NCT00872625|Antimetabolites|antimetabolites|mesh-ancestor
101764983|NCT00383149|Cetuximab|cetuximab|mesh-list
101765048|NCT00873483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101765122|NCT00879099|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101765197|NCT00873795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765272|NCT00614991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101900971|NCT00074490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101900972|NCT00074490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101900973|NCT00074490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101900974|NCT00074490|Tubulin Modulators|tubulin modulators|mesh-ancestor
101900975|NCT00074490|Antimitotic Agents|antimitotic agents|mesh-ancestor
101900976|NCT00074490|Mitosis Modulators|mitosis modulators|mesh-ancestor
101765563|NCT00612807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101900978|NCT03859856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101900979|NCT03859856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900981|NCT01094028|Oxytocics|oxytocics|mesh-ancestor
101900982|NCT01094028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101900983|NCT01094028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900985|NCT01288508|Cathartics|cathartics|mesh-ancestor
101765937|NCT02543073|Hormones|hormones|mesh-ancestor
101900986|NCT01288508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101900987|NCT01175954|Lacosamide|lacosamide|mesh-list
101900988|NCT01175954|Anticonvulsants|anticonvulsants|mesh-ancestor
101900989|NCT01175954|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101900990|NCT01175954|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101900991|NCT01175954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101900992|NCT01175954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101900993|NCT01288664|Tacrolimus|tacrolimus|mesh-list
101900994|NCT01288664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101900995|NCT01288664|Immunologic Factors|immunologic factors|mesh-ancestor
101900996|NCT01288664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101900997|NCT01288664|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101900999|NCT01288664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901000|NCT03285490|Tirbanibulin|tirbanibulin|mesh-list
101901001|NCT03285490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101901002|NCT03285490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901003|NCT02525276|Hormones|hormones|mesh-list
101901004|NCT02525276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101901005|NCT02525276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901006|NCT01172444|Mesalamine|mesalamine|mesh-list
101901007|NCT01172444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101901008|NCT01172444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101901009|NCT01172444|Analgesics|analgesics|mesh-ancestor
101901010|NCT01172444|Sensory System Agents|sensory system agents|mesh-ancestor
101766382|NCT05794659|Paclitaxel|paclitaxel|mesh-list
101901011|NCT01172444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101766523|NCT05551104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766524|NCT05551104|Vasodilator Agents|vasodilator agents|mesh-ancestor
101766537|NCT05539872|Insulin|insulin|mesh-list
101901012|NCT01172444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901013|NCT01172444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101901014|NCT01172444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101901015|NCT01288742|Simeprevir|simeprevir|mesh-list
101901016|NCT01288742|Digoxin|digoxin|mesh-list
101901017|NCT01288742|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101901018|NCT01288742|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101766817|NCT05016310|Vitamin D|vitamin d|mesh-list
101766907|NCT04861051|Ketamine|ketamine|mesh-list
101901019|NCT01288742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101901020|NCT01288742|Antimetabolites|antimetabolites|mesh-ancestor
101969785|NCT00523042|Insulin Aspart|insulin aspart|mesh-list
101767042|NCT04539249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101901021|NCT01288742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901022|NCT01288742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101901023|NCT01288742|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101901024|NCT01288742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101901025|NCT01288742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101901026|NCT01288742|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101901027|NCT01288742|Protective Agents|protective agents|mesh-ancestor
101901028|NCT01288742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901029|NCT01288742|Antiviral Agents|antiviral agents|mesh-ancestor
101901030|NCT01288742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101901031|NCT01288742|Protease Inhibitors|protease inhibitors|mesh-ancestor
101901033|NCT01178996|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101901034|NCT01178996|Thymalfasin|thymalfasin|mesh-list
101901035|NCT01178996|Antimetabolites|antimetabolites|mesh-ancestor
101901036|NCT01178996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901037|NCT01178996|Antiviral Agents|antiviral agents|mesh-ancestor
101901038|NCT01178996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101901039|NCT01178996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101901040|NCT01178996|Immunologic Factors|immunologic factors|mesh-ancestor
101901041|NCT01178996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901042|NCT03862586|Acetylcysteine|acetylcysteine|mesh-list
101901043|NCT03862586|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101901044|NCT03862586|Antiviral Agents|antiviral agents|mesh-ancestor
101901045|NCT03862586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101901046|NCT03862586|Expectorants|expectorants|mesh-ancestor
101901047|NCT03862586|Respiratory System Agents|respiratory system agents|mesh-ancestor
101901048|NCT03862586|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101901049|NCT03862586|Antioxidants|antioxidants|mesh-ancestor
101901050|NCT03862586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901051|NCT03862586|Protective Agents|protective agents|mesh-ancestor
101901052|NCT03862586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901053|NCT03862586|Antidotes|antidotes|mesh-ancestor
101901054|NCT01180946|Vitamin D|vitamin d|mesh-list
101901055|NCT01180946|Ergocalciferols|ergocalciferols|mesh-list
101901056|NCT01180946|Vitamins|vitamins|mesh-ancestor
101901058|NCT01180946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901059|NCT01180946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101767386|NCT03572582|Nivolumab|nivolumab|mesh-list
101901060|NCT01180946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101901061|NCT01179152|Budesonide|budesonide|mesh-list
101901062|NCT01179152|Formoterol Fumarate|formoterol fumarate|mesh-list
101767604|NCT02828358|Thioguanine|thioguanine|mesh-list
101901063|NCT01179152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101687996|NCT02670954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101901064|NCT01179152|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101901065|NCT01179152|Autonomic Agents|autonomic agents|mesh-ancestor
101901066|NCT01179152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101767830|NCT01267604|Inositol|inositol|mesh-list
101767917|NCT04017741|Hormones|hormones|mesh-ancestor
101901067|NCT01179152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901068|NCT01179152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101901069|NCT01179152|Respiratory System Agents|respiratory system agents|mesh-ancestor
101901071|NCT01179152|Hormones|hormones|mesh-ancestor
101901072|NCT01179152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101901073|NCT01179152|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101901074|NCT01179152|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101901075|NCT01179152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101901076|NCT01179152|Adrenergic Agents|adrenergic agents|mesh-ancestor
101901077|NCT01179152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101901078|NCT01179152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901079|NCT01179230|Dipyridamole|dipyridamole|mesh-list
101901080|NCT01179230|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101901081|NCT01179230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101768708|NCT00770406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101768797|NCT00609609|Hormones|hormones|mesh-ancestor
101768852|NCT00975052|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101768926|NCT00378703|Antibodies|antibodies|mesh-list
101768927|NCT00378703|Immunoglobulins|immunoglobulins|mesh-list
101901082|NCT01179230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901083|NCT01179230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101901084|NCT01179230|Vasodilator Agents|vasodilator agents|mesh-ancestor
101901085|NCT01286948|Levonorgestrel|levonorgestrel|mesh-list
101901086|NCT01286948|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101901088|NCT01286948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101901089|NCT01286948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901090|NCT01286948|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101901091|NCT01286948|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101901092|NCT01286948|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101901093|NCT01179308|Anesthetics|anesthetics|mesh-list
101901094|NCT01179308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101901095|NCT01179308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901096|NCT03088826|Acetaminophen|acetaminophen|mesh-list
101901097|NCT03088826|Morphine|morphine|mesh-list
101901098|NCT03088826|Oxycodone|oxycodone|mesh-list
101901100|NCT03088826|Narcotics|narcotics|mesh-ancestor
101901101|NCT03088826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101901102|NCT03088826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901103|NCT03088826|Analgesics|analgesics|mesh-ancestor
101901104|NCT03088826|Sensory System Agents|sensory system agents|mesh-ancestor
101901105|NCT03088826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101901106|NCT03088826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101901107|NCT03088826|Antipyretics|antipyretics|mesh-ancestor
101901108|NCT00367133|Triamcinolone|triamcinolone|mesh-list
101901109|NCT00367133|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101901110|NCT00367133|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101901111|NCT00367133|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101901112|NCT00367133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101901113|NCT00367133|Glucocorticoids|glucocorticoids|mesh-ancestor
101901114|NCT00367133|Hormones|hormones|mesh-ancestor
101901115|NCT00367133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101901116|NCT00367133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901117|NCT00367133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101901118|NCT00367133|Immunologic Factors|immunologic factors|mesh-ancestor
101901119|NCT00367133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101901120|NCT00367133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901121|NCT01179464|Simvastatin|simvastatin|mesh-list
101901122|NCT01179464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101901123|NCT01179464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101901124|NCT01179464|Antimetabolites|antimetabolites|mesh-ancestor
101901125|NCT01179464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901126|NCT01179464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101770822|NCT00986518|Immunomodulating Agents|immunomodulating agents|mesh-list
101770897|NCT00983320|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101901127|NCT01179464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101770978|NCT05004987|Dexetimide|dexetimide|mesh-list
101901128|NCT01179464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101901130|NCT01179620|Anticoagulants|anticoagulants|mesh-ancestor
101901131|NCT01288820|Artesunate|artesunate|mesh-list
101901132|NCT01288820|Primaquine|primaquine|mesh-list
101901133|NCT01288820|Piperaquine|piperaquine|mesh-list
101901134|NCT01288820|Amodiaquine|amodiaquine|mesh-list
101901135|NCT01288820|Artenimol|artenimol|mesh-list
101901136|NCT01288820|Antimalarials|antimalarials|mesh-ancestor
101901137|NCT01288820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101901139|NCT01288820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101771567|NCT00689936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101771641|NCT00671034|Abortifacient Agents|abortifacient agents|mesh-ancestor
101771718|NCT04394182|Tinzaparin|tinzaparin|mesh-list
101901140|NCT01288820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101901141|NCT01288820|Antiviral Agents|antiviral agents|mesh-ancestor
101901143|NCT01288820|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101901144|NCT01288820|Anthelmintics|anthelmintics|mesh-ancestor
101901145|NCT00367055|Metformin|metformin|mesh-list
101901147|NCT00367055|Gliclazide|gliclazide|mesh-list
101901148|NCT00367055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101901149|NCT00367055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901151|NCT00057330|Vaccines|vaccines|mesh-list
101901153|NCT00057330|Immunologic Factors|immunologic factors|mesh-ancestor
101901154|NCT00057330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901155|NCT00057330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101901156|NCT00057330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101901158|NCT00057330|Antiviral Agents|antiviral agents|mesh-ancestor
101901159|NCT00057330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101772754|NCT00778674|Benazepril|benazepril|mesh-list
101901160|NCT00057330|Interferon Inducers|interferon inducers|mesh-ancestor
101772974|NCT04498923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101901161|NCT00057330|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101901163|NCT03857672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
101901164|NCT03857672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101901165|NCT03857672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901167|NCT03283696|Ifosfamide|ifosfamide|mesh-list
101901168|NCT03283696|Olaratumab|olaratumab|mesh-list
101901169|NCT03283696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101901170|NCT03283696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101901171|NCT03283696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101901172|NCT03283696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101901173|NCT03283696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101901174|NCT03283696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901175|NCT03283696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101901176|NCT03283696|Alkylating Agents|alkylating agents|mesh-ancestor
101901177|NCT01176344|Vitamin D|vitamin d|mesh-list
101901178|NCT01176344|Vitamins|vitamins|mesh-ancestor
101901179|NCT01176344|Micronutrients|micronutrients|mesh-ancestor
101901180|NCT01176344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901181|NCT01176344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101901182|NCT02530788|Selenium|selenium|mesh-list
101901183|NCT02530788|Selenious Acid|selenious acid|mesh-list
101901184|NCT02530788|Sodium Selenite|sodium selenite|mesh-list
101901185|NCT02530788|Antioxidants|antioxidants|mesh-ancestor
101901186|NCT02530788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901187|NCT02530788|Protective Agents|protective agents|mesh-ancestor
101901188|NCT02530788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901189|NCT02530788|Trace Elements|trace elements|mesh-ancestor
101901190|NCT02530788|Micronutrients|micronutrients|mesh-ancestor
101901191|NCT01288898|Ipragliflozin|ipragliflozin|mesh-list
101901192|NCT01288898|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101901193|NCT01288898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901194|NCT01288898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101773768|NCT04046016|Paclitaxel|paclitaxel|mesh-list
101901195|NCT01288898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901196|NCT01089192|Metformin|metformin|mesh-list
101901197|NCT01089192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101901198|NCT01089192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901199|NCT02564380|Pembrolizumab|pembrolizumab|mesh-list
101901200|NCT02564380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101901201|NCT02564380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101901202|NCT02564380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101773981|NCT00792324|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101901203|NCT02564380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901205|NCT01093092|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
101901206|NCT01093092|Gemcitabine|gemcitabine|mesh-list
101901207|NCT01093092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101901208|NCT01093092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101901209|NCT01093092|Antimetabolites|antimetabolites|mesh-ancestor
101901210|NCT01093092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901211|NCT01093092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101901212|NCT01093092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901213|NCT01093092|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101901214|NCT01093092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101901215|NCT01093092|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101901216|NCT01093092|Vitamins|vitamins|mesh-ancestor
101901217|NCT01093092|Micronutrients|micronutrients|mesh-ancestor
101901218|NCT01093092|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101901219|NCT01289054|Imatinib Mesylate|imatinib mesylate|mesh-list
101901220|NCT01289054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101901221|NCT01289054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101901222|NCT01289054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101901223|NCT01289054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901224|NCT01179776|Iloprost|iloprost|mesh-list
101901225|NCT01179776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101774121|NCT00685802|Cilostazol|cilostazol|mesh-list
101901226|NCT01179776|Vasodilator Agents|vasodilator agents|mesh-ancestor
101901227|NCT01181414|Amiodarone|amiodarone|mesh-list
101901228|NCT01181414|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101901229|NCT01181414|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101901230|NCT01181414|Adrenergic Agents|adrenergic agents|mesh-ancestor
101901231|NCT01181414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101901232|NCT01181414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901233|NCT01181414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901234|NCT01181414|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101901235|NCT01181414|Vasodilator Agents|vasodilator agents|mesh-ancestor
101774184|NCT03827473|Ascorbic Acid|ascorbic acid|mesh-list
101901236|NCT01181414|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101774326|NCT00800826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101901237|NCT01181414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101774472|NCT00685334|Serotonin Agents|serotonin agents|mesh-ancestor
101901238|NCT01181414|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101901239|NCT01181414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101901240|NCT01181414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101901241|NCT01181414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101901242|NCT01181414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101901243|NCT01181414|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101901244|NCT01181414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101774988|NCT00802230|Sympathomimetics|sympathomimetics|mesh-ancestor
101901245|NCT01094340|Thalidomide|thalidomide|mesh-list
101901246|NCT01094340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101901247|NCT01094340|Immunologic Factors|immunologic factors|mesh-ancestor
101901248|NCT01094340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901249|NCT01094340|Leprostatic Agents|leprostatic agents|mesh-ancestor
101901250|NCT01094340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101901251|NCT01094340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101901252|NCT01094340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101775134|NCT00939939|Glimepiride|glimepiride|mesh-list
101901253|NCT01094340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101775200|NCT00935571|Narcotics|narcotics|mesh-ancestor
101621076|NCT05350085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101621077|NCT05350085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101575064|NCT02750995|Azacitidine|azacitidine|mesh-list
101621078|NCT05350085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101621079|NCT05350085|Anesthetics, General|anesthetics, general|mesh-ancestor
101621081|NCT05350085|GABA Modulators|gaba modulators|mesh-ancestor
101621082|NCT05350085|GABA Agents|gaba agents|mesh-ancestor
101621083|NCT05350085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101575351|NCT02735239|Paclitaxel|paclitaxel|mesh-list
101621084|NCT05350085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621085|NCT05313308|Midazolam|midazolam|mesh-list
101901254|NCT01094340|Growth Substances|growth substances|mesh-ancestor
101901256|NCT01094340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101901257|NCT00056862|Ribavirin|ribavirin|mesh-list
101901258|NCT00056862|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101901259|NCT00056862|Interferon-alpha|interferon-alpha|mesh-list
101901261|NCT00056862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901262|NCT00056862|Antiviral Agents|antiviral agents|mesh-ancestor
101901263|NCT00056862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101901265|NCT00056862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901266|NCT01289132|Candesartan|candesartan|mesh-list
101901267|NCT01289132|Candesartan cilexetil|candesartan cilexetil|mesh-list
101901268|NCT01289132|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
101901269|NCT01289132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101901270|NCT01289132|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101901271|NCT01289132|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101901272|NCT01289132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901273|NCT01287260|Nifedipine|nifedipine|mesh-list
101901274|NCT01287260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101576315|NCT02722369|Etoposide|etoposide|mesh-list
101901276|NCT01287260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901277|NCT01287260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101576464|NCT01220297|Antitubercular Agents|antitubercular agents|mesh-ancestor
101901278|NCT01287260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901279|NCT01287260|Vasodilator Agents|vasodilator agents|mesh-ancestor
101901280|NCT01287260|Tocolytic Agents|tocolytic agents|mesh-ancestor
101576690|NCT02711215|Citalopram|citalopram|mesh-list
101901281|NCT01287260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101901284|NCT01181570|Citric Acid|citric acid|mesh-list
101901285|NCT01181570|Sodium Citrate|sodium citrate|mesh-list
101901286|NCT01181570|Anticoagulants|anticoagulants|mesh-ancestor
101901287|NCT01181570|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101901288|NCT01181570|Chelating Agents|chelating agents|mesh-ancestor
101901289|NCT01181570|Sequestering Agents|sequestering agents|mesh-ancestor
101577204|NCT04611139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101577277|NCT01009983|Tubulin Modulators|tubulin modulators|mesh-ancestor
101901290|NCT01181570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901291|NCT01181570|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101901292|NCT01181570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101901293|NCT01181570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101901294|NCT01181570|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101901295|NCT01181570|Diuretics|diuretics|mesh-ancestor
101577583|NCT02118727|Memantine|memantine|mesh-list
101901296|NCT01181570|Natriuretic Agents|natriuretic agents|mesh-ancestor
101901297|NCT01181570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901299|NCT05200312|Cyclophosphamide|cyclophosphamide|mesh-list
101577876|NCT01012713|Vitamins|vitamins|mesh-ancestor
101901301|NCT05200312|Doxorubicin|doxorubicin|mesh-list
101901302|NCT05200312|Vincristine|vincristine|mesh-list
101578029|NCT00615667|Tacrolimus|tacrolimus|mesh-list
101901303|NCT05200312|Lenalidomide|lenalidomide|mesh-list
101901304|NCT05200312|Zanubrutinib|zanubrutinib|mesh-list
101901305|NCT05200312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101578163|NCT02700685|Pycnogenols|pycnogenols|mesh-list
101901306|NCT05200312|Immunologic Factors|immunologic factors|mesh-ancestor
101578235|NCT02699827|Anesthetics|anesthetics|mesh-ancestor
101901307|NCT05200312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901308|NCT05200312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101901309|NCT05200312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101901310|NCT05200312|Alkylating Agents|alkylating agents|mesh-ancestor
101901311|NCT05200312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901312|NCT05200312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101901313|NCT05200312|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101901314|NCT05200312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101901315|NCT05200312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101901316|NCT05200312|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101901317|NCT05200312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101901318|NCT05200312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101901319|NCT05200312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101901320|NCT05200312|Glucocorticoids|glucocorticoids|mesh-ancestor
101901322|NCT05200312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101578812|NCT00620971|Gemcitabine|gemcitabine|mesh-list
101901323|NCT05200312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101901324|NCT05200312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101901326|NCT05200312|Antimitotic Agents|antimitotic agents|mesh-ancestor
101901327|NCT05200312|Mitosis Modulators|mitosis modulators|mesh-ancestor
101901329|NCT05200312|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101901330|NCT05200312|Growth Substances|growth substances|mesh-ancestor
101901331|NCT05200312|Growth Inhibitors|growth inhibitors|mesh-ancestor
101901332|NCT05200312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101901334|NCT01180166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101901335|NCT01180166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101901336|NCT02940730|Dalbavancin|dalbavancin|mesh-list
101901337|NCT02940730|Teicoplanin|teicoplanin|mesh-list
101901338|NCT02940730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101901339|NCT02940730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101901340|NCT01587638|Metoprolol|metoprolol|mesh-list
101901341|NCT01587638|Atenolol|atenolol|mesh-list
101901342|NCT01587638|Carvedilol|carvedilol|mesh-list
101579410|NCT02686645|Vancomycin|vancomycin|mesh-list
101901343|NCT01587638|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-list
101901344|NCT01587638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101901345|NCT01587638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101901346|NCT01587638|Sympatholytics|sympatholytics|mesh-ancestor
101901347|NCT01587638|Autonomic Agents|autonomic agents|mesh-ancestor
101901348|NCT01587638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101901349|NCT01587638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901350|NCT01587638|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101901351|NCT01587638|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101901352|NCT01587638|Adrenergic Agents|adrenergic agents|mesh-ancestor
101901353|NCT01587638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101688063|NCT00644982|Serotonin Agents|serotonin agents|mesh-ancestor
101901354|NCT01587638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901355|NCT01587638|Antioxidants|antioxidants|mesh-ancestor
101901356|NCT01587638|Protective Agents|protective agents|mesh-ancestor
101901357|NCT01587638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101901358|NCT01587638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101901359|NCT01587638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101901360|NCT01587638|Vasodilator Agents|vasodilator agents|mesh-ancestor
101901361|NCT01587638|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101901362|NCT01587638|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101901363|NCT01287338|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
101901364|NCT01287338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101901365|NCT01287338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101901366|NCT01287338|Analgesics|analgesics|mesh-ancestor
101901367|NCT01287338|Sensory System Agents|sensory system agents|mesh-ancestor
101901368|NCT01287338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101901369|NCT01287338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901370|NCT01287338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101901371|NCT01287338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101901372|NCT01287338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101901373|NCT01287338|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101579675|NCT02684071|Antimetabolites|antimetabolites|mesh-ancestor
101901374|NCT01287338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101901375|NCT01287338|Histamine Antagonists|histamine antagonists|mesh-ancestor
101901376|NCT01287338|Histamine Agents|histamine agents|mesh-ancestor
101901377|NCT01287338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101901378|NCT01287338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901379|NCT01180322|Cytarabine|cytarabine|mesh-list
101901380|NCT01180322|Etoposide|etoposide|mesh-list
101901381|NCT01180322|Idarubicin|idarubicin|mesh-list
101901382|NCT01180322|Azacitidine|azacitidine|mesh-list
101901383|NCT01180322|Lenograstim|lenograstim|mesh-list
101901384|NCT01180322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101901385|NCT01180322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101901386|NCT01180322|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101901387|NCT01180322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101901388|NCT01180322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101901389|NCT01180322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579805|NCT02680717|Clobetasol|clobetasol|mesh-list
101901390|NCT01180322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101901391|NCT01180322|Antimetabolites|antimetabolites|mesh-ancestor
101901393|NCT01180322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101580105|NCT04124562|Nitrous Oxide|nitrous oxide|mesh-list
101901394|NCT01180322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101901395|NCT01180322|Immunologic Factors|immunologic factors|mesh-ancestor
101580176|NCT02867397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101901396|NCT01180322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901397|NCT01180322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101901398|NCT01180322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101901399|NCT01287494|Sertraline|sertraline|mesh-list
101580399|NCT00608374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101901400|NCT01287494|Antidepressive Agents|antidepressive agents|mesh-ancestor
101901401|NCT01287494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101580630|NCT01172808|Tiotropium Bromide|tiotropium bromide|mesh-list
101901402|NCT01287494|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101901403|NCT01287494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101901404|NCT01287494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101901405|NCT01287494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901406|NCT01287494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101901408|NCT01287494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901409|NCT02524964|Tanshinone|tanshinone|mesh-list
101901410|NCT02524964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101901411|NCT02524964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101901412|NCT02524964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101901414|NCT02524964|Sensory System Agents|sensory system agents|mesh-ancestor
101580775|NCT01134042|Xhance|xhance|mesh-list
101901415|NCT02524964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101901416|NCT02524964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901417|NCT02524964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101901418|NCT02524964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101901419|NCT02524964|Anticoagulants|anticoagulants|mesh-ancestor
101901420|NCT02524964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101901421|NCT02524964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101901422|NCT02524964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101901423|NCT02524964|Immunologic Factors|immunologic factors|mesh-ancestor
101901424|NCT02639702|Clozapine|clozapine|mesh-list
101901425|NCT02639702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101901426|NCT02639702|Serotonin Agents|serotonin agents|mesh-ancestor
101901427|NCT02639702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101581348|NCT02675335|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101901428|NCT02639702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901429|NCT02639702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901430|NCT02639702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101901431|NCT02639702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101901432|NCT02639702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101901433|NCT02639702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101901434|NCT02639702|GABA Antagonists|gaba antagonists|mesh-ancestor
101901435|NCT02639702|GABA Agents|gaba agents|mesh-ancestor
101901436|NCT01289756|Clarithromycin|clarithromycin|mesh-list
101901437|NCT01289756|Paroxetine|paroxetine|mesh-list
101901438|NCT01289756|Clomiphene|clomiphene|mesh-list
101901440|NCT01289756|Zuclomiphene|zuclomiphene|mesh-list
101901441|NCT01289756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101901442|NCT01289756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101901443|NCT01289756|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101901444|NCT01289756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101582023|NCT05006417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901445|NCT01289756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901446|NCT01289756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101901447|NCT01289756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101901448|NCT01289756|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101901449|NCT01289756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101901450|NCT01289756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101901452|NCT01289756|Serotonin Agents|serotonin agents|mesh-ancestor
101901453|NCT01289756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901454|NCT01289756|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101582169|NCT04205838|Vidarabine|vidarabine|mesh-list
101582238|NCT04086485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101901455|NCT01289756|Antidepressive Agents|antidepressive agents|mesh-ancestor
101901456|NCT01289756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101582313|NCT03836209|Cytarabine|cytarabine|mesh-list
101901457|NCT01289756|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101901458|NCT01289756|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101901459|NCT01289756|Hormone Antagonists|hormone antagonists|mesh-ancestor
101582458|NCT04218851|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101901460|NCT01289756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101901461|NCT01289756|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101901462|NCT01289756|Fertility Agents|fertility agents|mesh-ancestor
101901463|NCT01289756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101901464|NCT01289756|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101901465|NCT01289756|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101901467|NCT01181882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101901468|NCT01181882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101901469|NCT01181882|Analgesics|analgesics|mesh-ancestor
101901470|NCT01181882|Sensory System Agents|sensory system agents|mesh-ancestor
101901471|NCT01181882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101901472|NCT01181882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901473|NCT01181882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101901474|NCT01181882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101582679|NCT02097134|Melphalan|melphalan|mesh-list
101901475|NCT01181882|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101582751|NCT00999804|Hormone Antagonists|hormone antagonists|mesh-ancestor
101901476|NCT01181882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101582825|NCT00003764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101901477|NCT01181882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901478|NCT01181882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101583050|NCT01175213|gamma-Globulins|gamma-globulins|mesh-list
101583196|NCT00644137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101901480|NCT01181882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101901481|NCT01181882|Antipyretics|antipyretics|mesh-ancestor
101901483|NCT01181960|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101901484|NCT01181960|Antipsychotic Agents|antipsychotic agents|mesh-list
101901485|NCT01181960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101901486|NCT01181960|Serotonin Agents|serotonin agents|mesh-ancestor
101901487|NCT01181960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101901488|NCT01181960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901489|NCT01181960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901490|NCT01181960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101901491|NCT01181960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101901492|NCT01181960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101901493|NCT01181960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101901494|NCT01181960|Dopamine Agents|dopamine agents|mesh-ancestor
101901495|NCT01181960|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101901496|NCT01181960|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101901497|NCT03858062|Insulin|insulin|mesh-list
101901498|NCT03858062|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101901499|NCT03858062|Pancrelipase|pancrelipase|mesh-list
101901500|NCT03858062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101901501|NCT03858062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901502|NCT03858062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101901503|NCT03307252|Metformin|metformin|mesh-list
101901504|NCT03307252|Rifampin|rifampin|mesh-list
101901505|NCT03307252|Probenecid|probenecid|mesh-list
101901506|NCT03307252|Digoxin|digoxin|mesh-list
101901507|NCT03307252|Verapamil|verapamil|mesh-list
101901508|NCT03307252|Furosemide|furosemide|mesh-list
101901509|NCT03307252|Cimetidine|cimetidine|mesh-list
101901510|NCT03307252|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101901511|NCT03307252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101901512|NCT03307252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901513|NCT03307252|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101901514|NCT03307252|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101901515|NCT03307252|Antimetabolites|antimetabolites|mesh-ancestor
101901516|NCT03307252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901517|NCT03307252|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101901518|NCT03307252|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101901520|NCT03307252|Diuretics|diuretics|mesh-ancestor
101584431|NCT00966693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101584506|NCT00963807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901522|NCT03307252|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101901523|NCT03307252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101901524|NCT03307252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101901525|NCT03307252|Antitubercular Agents|antitubercular agents|mesh-ancestor
101901526|NCT03307252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101901527|NCT03307252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101901528|NCT03307252|Leprostatic Agents|leprostatic agents|mesh-ancestor
101901529|NCT03307252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101901530|NCT03307252|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101901531|NCT03307252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101901532|NCT03307252|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101901533|NCT03307252|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101901534|NCT03307252|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101901535|NCT03307252|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101584749|NCT01215032|Metformin|metformin|mesh-list
101901536|NCT03307252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101901538|NCT03307252|Protective Agents|protective agents|mesh-ancestor
101901539|NCT03307252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101584870|NCT00648973|Sympathomimetics|sympathomimetics|mesh-ancestor
101901540|NCT03307252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101901541|NCT03307252|Vasodilator Agents|vasodilator agents|mesh-ancestor
101901542|NCT03307252|Uricosuric Agents|uricosuric agents|mesh-ancestor
101901543|NCT03307252|Gout Suppressants|gout suppressants|mesh-ancestor
101901544|NCT03307252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101901545|NCT03307252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101901546|NCT03307252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101585015|NCT01140906|Vortioxetine|vortioxetine|mesh-list
101901548|NCT03307252|Histamine Antagonists|histamine antagonists|mesh-ancestor
101901549|NCT03307252|Histamine Agents|histamine agents|mesh-ancestor
101901550|NCT03307252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101901551|NCT03307252|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101901552|NCT03307252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101901554|NCT03307174|Bupivacaine|bupivacaine|mesh-list
101585312|NCT02651623|Serotonin Agents|serotonin agents|mesh-ancestor
101901555|NCT03307174|Anesthetics, Local|anesthetics, local|mesh-ancestor
101901556|NCT03307174|Anesthetics|anesthetics|mesh-ancestor
101901557|NCT03307174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101901558|NCT03307174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901559|NCT03307174|Sensory System Agents|sensory system agents|mesh-ancestor
101585745|NCT00599755|Carboplatin|carboplatin|mesh-list
101901560|NCT03307174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101901561|NCT03307174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101901562|NCT03307174|Narcotics|narcotics|mesh-ancestor
101901563|NCT03307174|Analgesics|analgesics|mesh-ancestor
101901564|NCT03307174|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101901565|NCT03307174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101901566|NCT03307174|Anesthetics, General|anesthetics, general|mesh-ancestor
101901567|NCT03448978|Cyclophosphamide|cyclophosphamide|mesh-list
101901568|NCT03448978|Fludarabine|fludarabine|mesh-list
101901569|NCT03448978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101901570|NCT03448978|Immunologic Factors|immunologic factors|mesh-ancestor
101901571|NCT03448978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901572|NCT03448978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101901573|NCT03448978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101901574|NCT03448978|Alkylating Agents|alkylating agents|mesh-ancestor
101901575|NCT03448978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901576|NCT03448978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101901577|NCT03448978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101901579|NCT01290926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101585824|NCT04524130|Lidocaine|lidocaine|mesh-list
101901580|NCT01290926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101901581|NCT01290926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101585944|NCT00915772|Metformin|metformin|mesh-list
101901582|NCT01290926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901583|NCT01185158|Gefitinib|gefitinib|mesh-list
101586096|NCT03017833|Metformin|metformin|mesh-list
101901584|NCT01185158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101586240|NCT00911170|Bevacizumab|bevacizumab|mesh-list
101901585|NCT01185158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101901586|NCT01185158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101586390|NCT04167007|Gemcitabine|gemcitabine|mesh-list
101901587|NCT01185158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901588|NCT01185236|Atorvastatin|atorvastatin|mesh-list
101901589|NCT01185236|Simvastatin|simvastatin|mesh-list
101901590|NCT01185236|Ezetimibe|ezetimibe|mesh-list
101586608|NCT03223155|Nivolumab|nivolumab|mesh-list
101901591|NCT01185236|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101901592|NCT01185236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101901593|NCT01185236|Antimetabolites|antimetabolites|mesh-ancestor
101586751|NCT02645461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101586826|NCT01123980|Immunologic Factors|immunologic factors|mesh-ancestor
101901594|NCT01185236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587056|NCT02994069|Cisplatin|cisplatin|mesh-list
101901595|NCT01185236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101901596|NCT01185236|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101901597|NCT01185236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101901598|NCT02524652|Ropivacaine|ropivacaine|mesh-list
101901599|NCT02524652|Anesthetics, Local|anesthetics, local|mesh-ancestor
101901600|NCT02524652|Anesthetics|anesthetics|mesh-ancestor
101901601|NCT02524652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101901602|NCT02524652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901603|NCT02524652|Sensory System Agents|sensory system agents|mesh-ancestor
101587566|NCT02847286|Antifungal Agents|antifungal agents|mesh-ancestor
101901604|NCT02524652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101901605|NCT01182272|Sorafenib|sorafenib|mesh-list
101901606|NCT01182272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101901607|NCT01182272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101901608|NCT01182272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101901609|NCT01182272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587716|NCT00952419|Vaccines|vaccines|mesh-list
101901610|NCT03861416|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101901611|NCT01185470|Morphine|morphine|mesh-list
101901612|NCT01185470|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101901613|NCT01185470|Narcotics|narcotics|mesh-ancestor
101587854|NCT00632866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101901614|NCT01185470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101901616|NCT01185470|Analgesics|analgesics|mesh-ancestor
101901617|NCT01185470|Sensory System Agents|sensory system agents|mesh-ancestor
101587932|NCT00885703|Fluconazole|fluconazole|mesh-list
101901618|NCT01185470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101901619|NCT00056160|Dexamethasone|dexamethasone|mesh-list
101901620|NCT00056160|Lenalidomide|lenalidomide|mesh-list
101901621|NCT00056160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101901622|NCT00056160|Antiemetics|antiemetics|mesh-ancestor
101901623|NCT00056160|Autonomic Agents|autonomic agents|mesh-ancestor
101901624|NCT00056160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101901625|NCT00056160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901626|NCT00056160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101621449|NCT03867500|Niacin|niacin|mesh-list
101901628|NCT00056160|Hormones|hormones|mesh-ancestor
101588447|NCT00598273|Darbepoetin alfa|darbepoetin alfa|mesh-list
101588519|NCT05404724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101901629|NCT00056160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101588592|NCT04160611|Midazolam|midazolam|mesh-list
101901630|NCT00056160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101588682|NCT00665743|Naproxen|naproxen|mesh-list
101901631|NCT00056160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101901632|NCT00056160|Immunologic Factors|immunologic factors|mesh-ancestor
101588808|NCT02837614|Dexamethasone|dexamethasone|mesh-list
101901633|NCT00056160|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101901634|NCT00056160|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101901635|NCT00056160|Growth Substances|growth substances|mesh-ancestor
101588961|NCT02630485|Vitamins|vitamins|mesh-ancestor
101901636|NCT00056160|Growth Inhibitors|growth inhibitors|mesh-ancestor
101901637|NCT01290146|Simendan|simendan|mesh-list
101901638|NCT01290146|Diuretics|diuretics|mesh-list
101901639|NCT01290146|Natriuretic Agents|natriuretic agents|mesh-ancestor
101589106|NCT00667147|Paclitaxel|paclitaxel|mesh-list
101589177|NCT00662233|Cyclophosphamide|cyclophosphamide|mesh-list
101589251|NCT00633412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101589327|NCT00669643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101901640|NCT01290146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589478|NCT01162421|Adalimumab|adalimumab|mesh-list
101901642|NCT01290146|Vasodilator Agents|vasodilator agents|mesh-ancestor
101589549|NCT01188551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101901643|NCT01290146|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101901646|NCT01290146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901647|NCT01290146|Protective Agents|protective agents|mesh-ancestor
101901648|NCT00061932|Irinotecan|irinotecan|mesh-list
101901649|NCT00061932|Bortezomib|bortezomib|mesh-list
101901650|NCT00061932|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101901651|NCT00061932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101589920|NCT00670813|Modafinil|modafinil|mesh-list
101901652|NCT00061932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101590065|NCT00660283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101590137|NCT04153123|Epinephrine|epinephrine|mesh-list
101590153|NCT00671593|Phenol|phenol|mesh-list
101590213|NCT00660751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101590287|NCT04154449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901653|NCT00061932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901654|NCT00061932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101590433|NCT01104558|Bisoprolol|bisoprolol|mesh-list
101590506|NCT00676741|Biphasic Insulins|biphasic insulins|mesh-list
101901655|NCT03856970|Glyburide|glyburide|mesh-list
101901656|NCT03856970|Digoxin|digoxin|mesh-list
101901657|NCT03856970|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101901658|NCT03856970|Norethindrone|norethindrone|mesh-list
101901659|NCT03856970|Estradiol|estradiol|mesh-list
101901660|NCT03856970|Estrogens|estrogens|mesh-ancestor
101901661|NCT03856970|Hormones|hormones|mesh-ancestor
101901662|NCT03856970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101901663|NCT03856970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901664|NCT03856970|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101901665|NCT03856970|Contraceptive Agents|contraceptive agents|mesh-ancestor
101901666|NCT03856970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101901667|NCT03856970|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101901668|NCT03856970|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101901669|NCT03856970|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101901670|NCT03856970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101901671|NCT03856970|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101901672|NCT03856970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101901673|NCT03856970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901674|NCT03856970|Protective Agents|protective agents|mesh-ancestor
101901675|NCT03856970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101901676|NCT03856970|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101901678|NCT01089348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101901679|NCT01089348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101590784|NCT00674713|Serotonin Agents|serotonin agents|mesh-ancestor
101901680|NCT01089348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101901681|NCT01089348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101901682|NCT01291316|Clonazepam|clonazepam|mesh-list
101901683|NCT01291316|Clobazam|clobazam|mesh-list
101901684|NCT01291316|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101901685|NCT01291316|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101901686|NCT01291316|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101591078|NCT01100034|Analgesics|analgesics|mesh-ancestor
101901687|NCT01291316|Cholinergic Agents|cholinergic agents|mesh-ancestor
101901688|NCT01291316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101901689|NCT01291316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591224|NCT04745728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101591303|NCT05658640|Antiemetics|antiemetics|mesh-ancestor
101901690|NCT01291316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901691|NCT01291316|Urological Agents|urological agents|mesh-ancestor
101901692|NCT01291316|Anticonvulsants|anticonvulsants|mesh-ancestor
101901693|NCT01291316|GABA Modulators|gaba modulators|mesh-ancestor
101901694|NCT01291316|GABA Agents|gaba agents|mesh-ancestor
101901695|NCT01291316|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101901696|NCT01291316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101901697|NCT01291316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101591378|NCT00678457|Olanzapine|olanzapine|mesh-list
101901698|NCT01291316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101901699|NCT01291316|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101901700|NCT01291316|GABA Agonists|gaba agonists|mesh-ancestor
101901701|NCT00060840|Nitric Oxide|nitric oxide|mesh-list
101901702|NCT00060840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101901704|NCT00060840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101901705|NCT00060840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901706|NCT00060840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101901707|NCT00060840|Respiratory System Agents|respiratory system agents|mesh-ancestor
101901708|NCT00060840|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101688122|NCT00644748|Gabapentin|gabapentin|mesh-list
101901710|NCT00060840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901711|NCT00060840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101901712|NCT00060840|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101901714|NCT00060840|Gasotransmitters|gasotransmitters|mesh-ancestor
101901715|NCT00060840|Protective Agents|protective agents|mesh-ancestor
101901716|NCT01185860|Ritonavir|ritonavir|mesh-list
101901717|NCT01185860|Ribavirin|ribavirin|mesh-list
101901718|NCT01185860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101901719|NCT01185860|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101901720|NCT01185860|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101901721|NCT01185860|Protease Inhibitors|protease inhibitors|mesh-ancestor
101901722|NCT01185860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101901723|NCT01185860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901724|NCT01185860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101901725|NCT01185860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101901726|NCT01185860|Antiviral Agents|antiviral agents|mesh-ancestor
101901727|NCT01185860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101901728|NCT01185860|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101901729|NCT01185860|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101901731|NCT01290302|Azacitidine|azacitidine|mesh-list
101901732|NCT01290302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101901733|NCT01290302|Antimetabolites|antimetabolites|mesh-ancestor
101901734|NCT01290302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901735|NCT01290302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101901736|NCT01290302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101901737|NCT01089660|Vaccines|vaccines|mesh-list
101901738|NCT01089660|Immunologic Factors|immunologic factors|mesh-ancestor
101901739|NCT01089660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901740|NCT01182662|Cyclosporine|cyclosporine|mesh-list
101901741|NCT01182662|Cyclosporins|cyclosporins|mesh-list
101901742|NCT01182662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101901743|NCT01182662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901744|NCT01182662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101901745|NCT01182662|Immunologic Factors|immunologic factors|mesh-ancestor
101901746|NCT01182662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901747|NCT01182662|Antifungal Agents|antifungal agents|mesh-ancestor
101901748|NCT01182662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101901749|NCT01182662|Dermatologic Agents|dermatologic agents|mesh-ancestor
101901750|NCT01182662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101901751|NCT01182662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101901752|NCT01185938|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101901753|NCT01185938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101901754|NCT01185938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101901755|NCT01185938|Antimetabolites|antimetabolites|mesh-ancestor
101901756|NCT01185938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901757|NCT01185938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101901758|NCT01185938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101901759|NCT01185938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101901760|NCT00059202|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101901761|NCT00059202|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101901762|NCT00059202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101901763|NCT01177358|Botulinum Toxins|botulinum toxins|mesh-list
101901764|NCT01177358|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101901765|NCT01177358|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101901766|NCT01177358|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101592283|NCT02806492|Autonomic Agents|autonomic agents|mesh-ancestor
101592346|NCT01154153|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101901767|NCT01177358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101592493|NCT00691951|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101592569|NCT02800486|Diuretics|diuretics|mesh-ancestor
101901768|NCT01177358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901769|NCT01177358|Cholinergic Agents|cholinergic agents|mesh-ancestor
101901770|NCT01177358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101901771|NCT01177358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901772|NCT01177358|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101901773|NCT01177358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101901774|NCT03854942|Naltrexone|naltrexone|mesh-list
101901775|NCT03854942|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101901776|NCT03854942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101901777|NCT03854942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901778|NCT03854942|Sensory System Agents|sensory system agents|mesh-ancestor
101901779|NCT03854942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101901780|NCT03278626|Paclitaxel|paclitaxel|mesh-list
101901781|NCT03278626|Carboplatin|carboplatin|mesh-list
101901782|NCT03278626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101901783|NCT03278626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101901784|NCT03278626|Tubulin Modulators|tubulin modulators|mesh-ancestor
101901785|NCT03278626|Antimitotic Agents|antimitotic agents|mesh-ancestor
101901786|NCT03278626|Mitosis Modulators|mitosis modulators|mesh-ancestor
101901787|NCT03278626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901788|NCT01186094|Sirolimus|sirolimus|mesh-list
101901789|NCT01186094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101901790|NCT01186094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101592848|NCT00693121|Amantadine|amantadine|mesh-list
101901791|NCT01186094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101901792|NCT01186094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101901793|NCT01186094|Antifungal Agents|antifungal agents|mesh-ancestor
101901794|NCT01186094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101901795|NCT01186094|Immunologic Factors|immunologic factors|mesh-ancestor
101901796|NCT01186094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901797|NCT01287806|Urinastatin|urinastatin|mesh-list
101901798|NCT01287806|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101901799|NCT01287806|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101901800|NCT01287806|Protease Inhibitors|protease inhibitors|mesh-ancestor
101901801|NCT01287806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101901802|NCT01287806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901803|NCT01186172|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101901804|NCT01186172|Ethanol|ethanol|mesh-list
101901805|NCT01186172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101901806|NCT01186172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101901807|NCT01186172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101901808|NCT01186172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901809|NCT03854708|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
101901810|NCT03854708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101901811|NCT03854708|Hormones|hormones|mesh-ancestor
101901812|NCT03854708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101901813|NCT03854708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901814|NCT03860870|Clenbuterol|clenbuterol|mesh-list
101901815|NCT03860870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101901816|NCT03860870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101901817|NCT03860870|Adrenergic Agents|adrenergic agents|mesh-ancestor
101901818|NCT03860870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101901819|NCT03860870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901820|NCT03860870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901821|NCT03860870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101901822|NCT03860870|Autonomic Agents|autonomic agents|mesh-ancestor
101901823|NCT03860870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101901824|NCT03860870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101901825|NCT03860870|Respiratory System Agents|respiratory system agents|mesh-ancestor
101901826|NCT03860870|Sympathomimetics|sympathomimetics|mesh-ancestor
101901828|NCT01177514|Analgesics|analgesics|mesh-ancestor
101901829|NCT01177514|Sensory System Agents|sensory system agents|mesh-ancestor
101593259|NCT02789566|Antimalarials|antimalarials|mesh-ancestor
101901830|NCT01177514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101901831|NCT01177514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901832|NCT01177514|Anticonvulsants|anticonvulsants|mesh-ancestor
101901833|NCT01177514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101901834|NCT01177514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101901835|NCT01177514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101901836|NCT01177514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101901837|NCT01177514|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101901838|NCT01177514|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101688140|NCT00910416|Atracurium|atracurium|mesh-list
101901839|NCT01177514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101593335|NCT00693979|Tubulin Modulators|tubulin modulators|mesh-ancestor
101901840|NCT01177514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901841|NCT01177514|Antimanic Agents|antimanic agents|mesh-ancestor
101901842|NCT00073008|Lapatinib|lapatinib|mesh-list
101901843|NCT00073008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101901844|NCT00073008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101901845|NCT00073008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101593619|NCT00870103|Dexamethasone|dexamethasone|mesh-list
101901846|NCT00073008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901847|NCT01182974|Acetaminophen|acetaminophen|mesh-list
101901848|NCT01182974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101901849|NCT01182974|Analgesics|analgesics|mesh-ancestor
101901850|NCT01182974|Sensory System Agents|sensory system agents|mesh-ancestor
101901851|NCT01182974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101901852|NCT01182974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901853|NCT01182974|Antipyretics|antipyretics|mesh-ancestor
101901854|NCT03856502|Dexamethasone|dexamethasone|mesh-list
101901855|NCT03856502|Dexamethasone acetate|dexamethasone acetate|mesh-list
101901856|NCT03856502|Levobupivacaine|levobupivacaine|mesh-list
101901858|NCT03856502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101901859|NCT03856502|Antiemetics|antiemetics|mesh-ancestor
101901860|NCT03856502|Autonomic Agents|autonomic agents|mesh-ancestor
101594129|NCT02782624|Empagliflozin|empagliflozin|mesh-list
101901861|NCT03856502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101901862|NCT03856502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594328|NCT02744092|PENTA|penta|mesh-list
101901863|NCT03856502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101901864|NCT03856502|Glucocorticoids|glucocorticoids|mesh-ancestor
101901865|NCT03856502|Hormones|hormones|mesh-ancestor
101594422|NCT02781064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594498|NCT01092780|Modafinil|modafinil|mesh-list
101594571|NCT02200978|Immunologic Factors|immunologic factors|mesh-ancestor
101901866|NCT03856502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101901867|NCT03856502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101901868|NCT03856502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101901869|NCT03856502|Protease Inhibitors|protease inhibitors|mesh-ancestor
101901870|NCT03856502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101901871|NCT03856502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901872|NCT03856502|Anesthetics, Local|anesthetics, local|mesh-ancestor
101901874|NCT03856502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101901875|NCT03856502|Sensory System Agents|sensory system agents|mesh-ancestor
101901876|NCT01583478|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
101594865|NCT02777710|Durvalumab|durvalumab|mesh-list
101901877|NCT01583478|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101594939|NCT01192178|Autonomic Agents|autonomic agents|mesh-ancestor
101901878|NCT01583478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101901879|NCT01583478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901880|NCT01583478|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101595085|NCT01090050|Serotonin Agents|serotonin agents|mesh-ancestor
101595156|NCT04224922|Carboplatin|carboplatin|mesh-list
101901881|NCT01583478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101969833|NCT05982522|Paclitaxel|paclitaxel|mesh-list
101595231|NCT02771392|Sensory System Agents|sensory system agents|mesh-ancestor
101901882|NCT01583478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901883|NCT01583478|Cholinergic Agents|cholinergic agents|mesh-ancestor
101901884|NCT01583478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101901885|NCT03854396|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101901886|NCT03854396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101901887|NCT03854396|Immunologic Factors|immunologic factors|mesh-ancestor
101901888|NCT03854396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901890|NCT01093638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101595523|NCT02696590|Vitamins|vitamins|mesh-ancestor
101901891|NCT01093638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595627|NCT00869323|Rituximab|rituximab|mesh-list
101901893|NCT01287962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101901894|NCT01287962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101901895|NCT01287962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101595973|NCT00603759|Celecoxib|celecoxib|mesh-list
101901896|NCT01287962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901897|NCT00058422|Prednisone|prednisone|mesh-list
101901898|NCT00058422|Cyclophosphamide|cyclophosphamide|mesh-list
101901899|NCT00058422|Rituximab|rituximab|mesh-list
101901900|NCT00058422|Doxorubicin|doxorubicin|mesh-list
101901901|NCT00058422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101901903|NCT00058422|Darbepoetin alfa|darbepoetin alfa|mesh-list
101901904|NCT00058422|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101901905|NCT00058422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101901906|NCT00058422|Immunologic Factors|immunologic factors|mesh-ancestor
101901907|NCT00058422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901908|NCT00058422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101901909|NCT00058422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101901911|NCT00058422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901912|NCT00058422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101901913|NCT00058422|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101901914|NCT00058422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101901916|NCT00058422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101901917|NCT00058422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101901918|NCT00058422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101901919|NCT00058422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101901920|NCT00058422|Glucocorticoids|glucocorticoids|mesh-ancestor
101901921|NCT00058422|Hormones|hormones|mesh-ancestor
101901922|NCT00058422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101597074|NCT02876718|Rivaroxaban|rivaroxaban|mesh-list
101597144|NCT02749162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101901923|NCT00058422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101901924|NCT00058422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101901925|NCT00058422|Tubulin Modulators|tubulin modulators|mesh-ancestor
101901926|NCT00058422|Antimitotic Agents|antimitotic agents|mesh-ancestor
101901927|NCT00058422|Mitosis Modulators|mitosis modulators|mesh-ancestor
101901928|NCT00058422|Hematinics|hematinics|mesh-ancestor
101621815|NCT01439802|Copper|copper|mesh-list
101901929|NCT01094964|Interferons|interferons|mesh-list
101901930|NCT01094964|Interferon-alpha|interferon-alpha|mesh-list
101901932|NCT01094964|Mitomycins|mitomycins|mesh-list
101901933|NCT01094964|Mitomycin|mitomycin|mesh-list
101901934|NCT01094964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101901935|NCT01094964|Antiviral Agents|antiviral agents|mesh-ancestor
101901936|NCT01094964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101901938|NCT01094964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901939|NCT01094964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101901940|NCT01094964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101597724|NCT02737696|Analgesics, Opioid|analgesics, opioid|mesh-list
101901941|NCT01094964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101597795|NCT02732314|Desonide|desonide|mesh-list
101901942|NCT01094964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101901943|NCT01094964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901944|NCT01094964|Alkylating Agents|alkylating agents|mesh-ancestor
101901945|NCT01094964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101901946|NCT01291472|Ketorolac|ketorolac|mesh-list
101597948|NCT00627354|Analgesics|analgesics|mesh-ancestor
101901947|NCT01291472|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101598241|NCT00854581|Antiviral Agents|antiviral agents|mesh-ancestor
101598317|NCT02718976|Epinephrine|epinephrine|mesh-list
101901948|NCT01291472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101901949|NCT01291472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101901950|NCT01291472|Analgesics|analgesics|mesh-ancestor
101969837|NCT05982522|Tubulin Modulators|tubulin modulators|mesh-ancestor
101901951|NCT01291472|Sensory System Agents|sensory system agents|mesh-ancestor
101901952|NCT01291472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101901953|NCT01291472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598684|NCT02710552|Perindopril|perindopril|mesh-list
101901954|NCT01291472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101901955|NCT01291472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101901956|NCT01291472|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101901957|NCT01291472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101901958|NCT01291472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901960|NCT02530632|Sevoflurane|sevoflurane|mesh-list
101901961|NCT02530632|Anesthetics|anesthetics|mesh-ancestor
101901962|NCT02530632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101599124|NCT05241340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101901963|NCT02530632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101901964|NCT02530632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101901965|NCT02530632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101901966|NCT02530632|Anesthetics, General|anesthetics, general|mesh-ancestor
101599338|NCT01119131|Vitamins|vitamins|mesh-ancestor
101901967|NCT02530632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101599413|NCT01118663|Antidotes|antidotes|mesh-ancestor
101901968|NCT02530632|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101901970|NCT01183364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101901971|NCT01183364|Tubulin Modulators|tubulin modulators|mesh-ancestor
101901972|NCT01183364|Antimitotic Agents|antimitotic agents|mesh-ancestor
101599561|NCT01117181|Dopamine Agents|dopamine agents|mesh-ancestor
101599626|NCT01108055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101599696|NCT01033734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101901974|NCT01183364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901975|NCT00072384|Carboplatin|carboplatin|mesh-list
101901976|NCT00072384|Etoposide|etoposide|mesh-list
101901977|NCT00072384|Vincristine|vincristine|mesh-list
101901978|NCT00072384|Etoposide phosphate|etoposide phosphate|mesh-list
101901979|NCT00072384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101901980|NCT00072384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101901981|NCT00072384|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101901982|NCT00072384|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101901983|NCT00072384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101901984|NCT00072384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101901985|NCT00072384|Tubulin Modulators|tubulin modulators|mesh-ancestor
101901986|NCT00072384|Antimitotic Agents|antimitotic agents|mesh-ancestor
101901987|NCT00072384|Mitosis Modulators|mitosis modulators|mesh-ancestor
101901988|NCT01183442|Vitamin D|vitamin d|mesh-list
101901989|NCT01183442|Ergocalciferols|ergocalciferols|mesh-list
101901990|NCT01183442|Cholecalciferol|cholecalciferol|mesh-list
101600128|NCT01032018|Bupropion|bupropion|mesh-list
101901992|NCT01183442|Micronutrients|micronutrients|mesh-ancestor
101901993|NCT01183442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600217|NCT00627250|Antiviral Agents|antiviral agents|mesh-ancestor
101901994|NCT01183442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101901995|NCT01183442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101901997|NCT01187108|Acetazolamide|acetazolamide|mesh-list
101901998|NCT01187108|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101901999|NCT01187108|Antiviral Agents|antiviral agents|mesh-ancestor
101902000|NCT01187108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101902001|NCT01187108|Expectorants|expectorants|mesh-ancestor
101902002|NCT01187108|Respiratory System Agents|respiratory system agents|mesh-ancestor
101902003|NCT01187108|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101902004|NCT01187108|Antioxidants|antioxidants|mesh-ancestor
101600653|NCT02702128|Hemostatics|hemostatics|mesh-ancestor
101600726|NCT02705950|GABA Agonists|gaba agonists|mesh-ancestor
101902005|NCT01187108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902007|NCT01187108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902008|NCT01187108|Antidotes|antidotes|mesh-ancestor
101902009|NCT01187108|Anticonvulsants|anticonvulsants|mesh-ancestor
101600877|NCT02699710|Vitamins|vitamins|mesh-ancestor
101902010|NCT01187108|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101902011|NCT01187108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101902012|NCT01187108|Diuretics|diuretics|mesh-ancestor
101902013|NCT01187108|Natriuretic Agents|natriuretic agents|mesh-ancestor
101902015|NCT01187888|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101902016|NCT01187888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101902017|NCT01187888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902018|NCT01187888|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101902019|NCT01187888|Protective Agents|protective agents|mesh-ancestor
101902020|NCT01187888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902021|NCT01187186|Ipragliflozin|ipragliflozin|mesh-list
101902022|NCT01187186|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101902023|NCT01187186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902024|NCT01187186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101902025|NCT01187186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902026|NCT00054132|Bevacizumab|bevacizumab|mesh-list
101902027|NCT00054132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101902028|NCT00054132|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101902029|NCT00054132|Endothelial Growth Factors|endothelial growth factors|mesh-list
101902030|NCT00054132|Antibodies|antibodies|mesh-list
101902031|NCT00054132|Immunoglobulins|immunoglobulins|mesh-list
101902032|NCT00054132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101902033|NCT00054132|Immunoglobulin G|immunoglobulin g|mesh-list
101902034|NCT00054132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101902035|NCT00054132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101902036|NCT00054132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101902037|NCT00054132|Growth Substances|growth substances|mesh-ancestor
101902039|NCT00054132|Growth Inhibitors|growth inhibitors|mesh-ancestor
101902040|NCT00054132|Immunologic Factors|immunologic factors|mesh-ancestor
101902041|NCT00054132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101902042|NCT00054132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101902043|NCT00054132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902044|NCT01187264|Methotrexate|methotrexate|mesh-list
101902045|NCT01187264|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101902046|NCT01187264|Abortifacient Agents|abortifacient agents|mesh-ancestor
101902047|NCT01187264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101902048|NCT01187264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902049|NCT01187264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101902050|NCT01187264|Antimetabolites|antimetabolites|mesh-ancestor
101902051|NCT01187264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902052|NCT01187264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101902053|NCT01187264|Dermatologic Agents|dermatologic agents|mesh-ancestor
101902054|NCT01187264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101902055|NCT01187264|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101902056|NCT01187264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101902057|NCT01187264|Immunologic Factors|immunologic factors|mesh-ancestor
101902058|NCT01187264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101902059|NCT01187264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101902060|NCT01183676|Valproic Acid|valproic acid|mesh-list
101902061|NCT01183676|Anticonvulsants|anticonvulsants|mesh-ancestor
101902062|NCT01183676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101601118|NCT01015560|Immunologic Factors|immunologic factors|mesh-ancestor
101601192|NCT00833833|Antiemetics|antiemetics|mesh-ancestor
101601343|NCT04559412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601415|NCT01021332|Cholinergic Agents|cholinergic agents|mesh-ancestor
101902063|NCT01183676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902064|NCT01183676|GABA Agents|gaba agents|mesh-ancestor
101902065|NCT01183676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101902066|NCT01183676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902067|NCT01183676|Antimanic Agents|antimanic agents|mesh-ancestor
101902068|NCT01183676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101902069|NCT01183676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101902070|NCT01183676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101902071|NCT03856112|Dexamethasone|dexamethasone|mesh-list
101902072|NCT03856112|Dexamethasone acetate|dexamethasone acetate|mesh-list
101902073|NCT03856112|Venetoclax|venetoclax|mesh-list
101902074|NCT03856112|Ixazomib|ixazomib|mesh-list
101902075|NCT03856112|Ichthammol|ichthammol|mesh-list
101902076|NCT03856112|BB 1101|bb 1101|mesh-list
101902077|NCT03856112|Glycine|glycine|mesh-list
101902078|NCT03856112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101902079|NCT03856112|Antiemetics|antiemetics|mesh-ancestor
101902080|NCT03856112|Autonomic Agents|autonomic agents|mesh-ancestor
101902081|NCT03856112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101902082|NCT03856112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902083|NCT03856112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101902084|NCT03856112|Glucocorticoids|glucocorticoids|mesh-ancestor
101902085|NCT03856112|Hormones|hormones|mesh-ancestor
101902086|NCT03856112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101902087|NCT03856112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101902088|NCT03856112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101902089|NCT03856112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902090|NCT03856112|Protease Inhibitors|protease inhibitors|mesh-ancestor
101902091|NCT03856112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101902092|NCT03856112|Glycine Agents|glycine agents|mesh-ancestor
101902093|NCT03856112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101902094|NCT03856112|Dermatologic Agents|dermatologic agents|mesh-ancestor
101902095|NCT01290380|Vadimezan|vadimezan|mesh-list
101902096|NCT01290380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101902097|NCT00071760|Ritonavir|ritonavir|mesh-list
101902098|NCT00071760|Fosamprenavir|fosamprenavir|mesh-list
101902099|NCT00071760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101902100|NCT00071760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101902101|NCT00071760|Protease Inhibitors|protease inhibitors|mesh-ancestor
101902102|NCT00071760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101902103|NCT00071760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902104|NCT00071760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101902105|NCT00071760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101902106|NCT00071760|Antiviral Agents|antiviral agents|mesh-ancestor
101902107|NCT00071760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101902108|NCT00071760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101902109|NCT00071760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101902110|NCT01183910|Calcium Carbonate|calcium carbonate|mesh-list
101902111|NCT01183910|Calcium|calcium|mesh-list
101902112|NCT01183910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101902113|NCT01183910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902114|NCT01183910|Antacids|antacids|mesh-ancestor
101902115|NCT01183910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902116|NCT01183910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101902117|NCT03852914|Hyaluronic Acid|hyaluronic acid|mesh-list
101902118|NCT03852914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101902119|NCT03852914|Immunologic Factors|immunologic factors|mesh-ancestor
101902120|NCT03852914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902121|NCT03852914|Viscosupplements|viscosupplements|mesh-ancestor
101902122|NCT03852914|Protective Agents|protective agents|mesh-ancestor
101902123|NCT05234684|Prednisone|prednisone|mesh-list
101902124|NCT05234684|Cyclophosphamide|cyclophosphamide|mesh-list
101902125|NCT05234684|Vincristine|vincristine|mesh-list
101902126|NCT05234684|Rituximab|rituximab|mesh-list
101902127|NCT05234684|Doxorubicin|doxorubicin|mesh-list
101902128|NCT05234684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101902129|NCT05234684|Immunologic Factors|immunologic factors|mesh-ancestor
101902130|NCT05234684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902131|NCT05234684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101902132|NCT05234684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101902133|NCT05234684|Alkylating Agents|alkylating agents|mesh-ancestor
101902134|NCT05234684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902135|NCT05234684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101902136|NCT05234684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101902137|NCT05234684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101902138|NCT05234684|Glucocorticoids|glucocorticoids|mesh-ancestor
101902139|NCT05234684|Hormones|hormones|mesh-ancestor
101902140|NCT05234684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101902141|NCT05234684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101902142|NCT05234684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101902143|NCT05234684|Tubulin Modulators|tubulin modulators|mesh-ancestor
101902144|NCT05234684|Antimitotic Agents|antimitotic agents|mesh-ancestor
101902145|NCT05234684|Mitosis Modulators|mitosis modulators|mesh-ancestor
101902146|NCT05234684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101902147|NCT05234684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101902148|NCT05234684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101902149|NCT05234684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101902150|NCT05234684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101902151|NCT03853538|Petrolatum|petrolatum|mesh-list
101902152|NCT03853538|Emollients|emollients|mesh-ancestor
101902153|NCT03853538|Dermatologic Agents|dermatologic agents|mesh-ancestor
101902154|NCT03853304|Folic Acid|folic acid|mesh-list
101902155|NCT03853304|Vitamin B 12|vitamin b 12|mesh-list
101902156|NCT03853304|Hydroxocobalamin|hydroxocobalamin|mesh-list
101902157|NCT03853304|Vitamins|vitamins|mesh-ancestor
101902158|NCT03853304|Micronutrients|micronutrients|mesh-ancestor
101902159|NCT03853304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902160|NCT03853304|Hematinics|hematinics|mesh-ancestor
101902161|NCT03853304|Vitamin B Complex|vitamin b complex|mesh-ancestor
101902163|NCT01290458|Ascorbic Acid|ascorbic acid|mesh-list
101902164|NCT01290458|Vitamin E|vitamin e|mesh-list
101902165|NCT01290458|Tocopherols|tocopherols|mesh-list
101902166|NCT01290458|alpha-Tocopherol|alpha-tocopherol|mesh-list
101902167|NCT01290458|Antioxidants|antioxidants|mesh-list
101902168|NCT01290458|Micronutrients|micronutrients|mesh-ancestor
101902169|NCT01290458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902170|NCT01290458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902171|NCT01290458|Protective Agents|protective agents|mesh-ancestor
101902173|NCT01184144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101602439|NCT00621400|Hormones|hormones|mesh-ancestor
101902174|NCT01184144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902175|NCT01291628|Copper|copper|mesh-list
101602586|NCT01016262|Analgesics|analgesics|mesh-ancestor
101902176|NCT01291628|Trace Elements|trace elements|mesh-ancestor
101902178|NCT01291628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902179|NCT00053898|Tamoxifen|tamoxifen|mesh-list
101902180|NCT00053898|Anastrozole|anastrozole|mesh-list
101902181|NCT00053898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902182|NCT00053898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101602892|NCT01178138|Prazosin|prazosin|mesh-list
101902184|NCT00053898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101902185|NCT00053898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902186|NCT00053898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101902187|NCT00053898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101902188|NCT00053898|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101902189|NCT00053898|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101902190|NCT00053898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101902191|NCT00053898|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101902192|NCT00053898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101603327|NCT01162304|Oxycodone|oxycodone|mesh-list
101902193|NCT00053898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101902194|NCT01293734|Budesonide|budesonide|mesh-list
101902195|NCT01293734|Theophylline|theophylline|mesh-list
101902196|NCT01293734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101902197|NCT01293734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101603698|NCT01174238|Paclitaxel|paclitaxel|mesh-list
101902198|NCT01293734|Autonomic Agents|autonomic agents|mesh-ancestor
101603778|NCT02683564|Infliximab|infliximab|mesh-list
101902199|NCT01293734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101603849|NCT04183738|Antiviral Agents|antiviral agents|mesh-ancestor
101902200|NCT01293734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902201|NCT01293734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101604073|NCT00642226|Triamcinolone|triamcinolone|mesh-list
101604146|NCT02674906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101902202|NCT01293734|Respiratory System Agents|respiratory system agents|mesh-ancestor
101902203|NCT01293734|Glucocorticoids|glucocorticoids|mesh-ancestor
101902204|NCT01293734|Hormones|hormones|mesh-ancestor
101604296|NCT01172288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101902205|NCT01293734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101902206|NCT01293734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101902207|NCT01293734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101604521|NCT02670616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101902208|NCT01293734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902209|NCT01293734|Vasodilator Agents|vasodilator agents|mesh-ancestor
101902210|NCT01293734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101902211|NCT01293734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101605035|NCT02663830|Fertility Agents|fertility agents|mesh-ancestor
101605108|NCT00647608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902213|NCT01293734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101902214|NCT01184300|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101605181|NCT00647686|Anesthetics|anesthetics|mesh-ancestor
101902215|NCT01184300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101902216|NCT01188278|Imatinib Mesylate|imatinib mesylate|mesh-list
101902217|NCT01188278|Dasatinib|dasatinib|mesh-list
101902218|NCT01188278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101902219|NCT01188278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101902220|NCT01188278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101902221|NCT01188278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605628|NCT00842257|Panitumumab|panitumumab|mesh-list
101902223|NCT01184378|Chelating Agents|chelating agents|mesh-ancestor
101902224|NCT01184378|Sequestering Agents|sequestering agents|mesh-ancestor
101605703|NCT00706225|Bazedoxifene|bazedoxifene|mesh-list
101902225|NCT01184378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902226|NCT03852602|Analgesics|analgesics|mesh-list
101902227|NCT03852602|Sensory System Agents|sensory system agents|mesh-ancestor
101605919|NCT02536690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101902228|NCT03852602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101902229|NCT03852602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902230|NCT02459392|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101902232|NCT02459392|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101902233|NCT02459392|Prednisolone|prednisolone|mesh-list
101902234|NCT02459392|Prednisolone acetate|prednisolone acetate|mesh-list
101902235|NCT02459392|Hyaluronic Acid|hyaluronic acid|mesh-list
101902236|NCT02459392|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101902237|NCT02459392|Prednisolone phosphate|prednisolone phosphate|mesh-list
101902238|NCT02459392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101902239|NCT02459392|Immunologic Factors|immunologic factors|mesh-ancestor
101902240|NCT02459392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902241|NCT02459392|Viscosupplements|viscosupplements|mesh-ancestor
101902242|NCT02459392|Protective Agents|protective agents|mesh-ancestor
101902243|NCT02459392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101902244|NCT02459392|Antiemetics|antiemetics|mesh-ancestor
101902245|NCT02459392|Autonomic Agents|autonomic agents|mesh-ancestor
101902246|NCT02459392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101902247|NCT02459392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101902248|NCT02459392|Glucocorticoids|glucocorticoids|mesh-ancestor
101902250|NCT02459392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101902251|NCT02459392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101688228|NCT00645372|Ziprasidone|ziprasidone|mesh-list
101902252|NCT02459392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101902253|NCT02459392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101902254|NCT03256552|Glycopyrrolate|glycopyrrolate|mesh-list
101902255|NCT03256552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101902256|NCT03256552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101902257|NCT03256552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101902258|NCT03256552|Cholinergic Agents|cholinergic agents|mesh-ancestor
101902259|NCT03256552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101902260|NCT03256552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902261|NCT03256552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902262|NCT03852446|Tryptophan|tryptophan|mesh-list
101902263|NCT03852446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101902264|NCT03852446|Antidepressive Agents|antidepressive agents|mesh-ancestor
101902265|NCT03852446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101902267|NCT03637582|Anesthetics, Local|anesthetics, local|mesh-ancestor
101902268|NCT03637582|Anesthetics|anesthetics|mesh-ancestor
101902269|NCT03637582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101902270|NCT03637582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606631|NCT04166890|Epinephrine|epinephrine|mesh-list
101606703|NCT00817063|Dermatologic Agents|dermatologic agents|mesh-ancestor
101902271|NCT03637582|Sensory System Agents|sensory system agents|mesh-ancestor
101902272|NCT03637582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101902273|NCT03637582|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101902274|NCT03637582|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101902275|NCT03637582|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101902276|NCT03637582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101902277|NCT03637582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902278|NCT00053352|Etoposide|etoposide|mesh-list
101902279|NCT00053352|Etoposide phosphate|etoposide phosphate|mesh-list
101902280|NCT00053352|Bleomycin|bleomycin|mesh-list
101902281|NCT00053352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101902282|NCT00053352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101902283|NCT00053352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101902284|NCT00053352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101902285|NCT00053352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101606780|NCT00653926|Autonomic Agents|autonomic agents|mesh-ancestor
101902286|NCT00053352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606994|NCT02641990|Exenatide|exenatide|mesh-list
101902287|NCT00053352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101902288|NCT01193816|Loxapine|loxapine|mesh-list
101902289|NCT01193816|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101902290|NCT01193816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101607215|NCT02867904|Prednisolone|prednisolone|mesh-list
101902291|NCT01193816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101902292|NCT01193816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902293|NCT01193816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101902294|NCT01193816|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101902295|NCT01193816|Dopamine Agents|dopamine agents|mesh-ancestor
101607435|NCT01147250|Lixisenatide|lixisenatide|mesh-list
101607512|NCT00652132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101902296|NCT01193816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101902297|NCT01193816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607734|NCT02634970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101607811|NCT00880906|Fluticasone|fluticasone|mesh-list
101902299|NCT05571202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101902300|NCT05571202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902301|NCT03245398|Mebendazole|mebendazole|mesh-list
101902302|NCT03245398|Piperazine|piperazine|mesh-list
101902303|NCT03245398|Piperazine citrate|piperazine citrate|mesh-list
101902304|NCT03245398|DMP 777|dmp 777|mesh-list
101902306|NCT03245398|Anthelmintics|anthelmintics|mesh-ancestor
101902307|NCT03245398|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101902308|NCT03245398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101902309|NCT03245398|Tubulin Modulators|tubulin modulators|mesh-ancestor
101902310|NCT03245398|Antimitotic Agents|antimitotic agents|mesh-ancestor
101608479|NCT00973674|Estrogens|estrogens|mesh-list
101902312|NCT03245398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902313|NCT03245398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101902314|NCT03245398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101902317|NCT01291940|Dermatologic Agents|dermatologic agents|mesh-ancestor
101902318|NCT03244618|Fluorides|fluorides|mesh-list
101902319|NCT03244618|Cariostatic Agents|cariostatic agents|mesh-ancestor
101902320|NCT03244618|Protective Agents|protective agents|mesh-ancestor
101902321|NCT03244618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902322|NCT05571046|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
101902323|NCT05571046|Glucocorticoids|glucocorticoids|mesh-list
101902324|NCT05571046|Hormones|hormones|mesh-ancestor
101902325|NCT05571046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101902326|NCT05571046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902327|NCT05571046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101902328|NCT03849404|Adalimumab|adalimumab|mesh-list
101902329|NCT03849404|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101609129|NCT05023070|Cannabidiol|cannabidiol|mesh-list
101902330|NCT03849404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101902331|NCT03849404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101902332|NCT00051636|Vitamin D|vitamin d|mesh-list
101902333|NCT00051636|Zoledronic Acid|zoledronic acid|mesh-list
101902334|NCT00051636|Risedronic Acid|risedronic acid|mesh-list
101902335|NCT00051636|Etidronic Acid|etidronic acid|mesh-list
101902336|NCT00051636|Calcium|calcium|mesh-list
101902337|NCT00051636|Vitamins|vitamins|mesh-ancestor
101902338|NCT00051636|Micronutrients|micronutrients|mesh-ancestor
101609511|NCT03236987|Azithromycin|azithromycin|mesh-list
101902339|NCT00051636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902340|NCT00051636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101902341|NCT00051636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101902342|NCT00051636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101902343|NCT00051636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101902344|NCT00051636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902345|NCT01294826|Cetuximab|cetuximab|mesh-list
101902346|NCT01294826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101902347|NCT01294826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101902348|NCT03847922|Lidocaine|lidocaine|mesh-list
101902349|NCT03847922|Nitrous Oxide|nitrous oxide|mesh-list
101902350|NCT03847922|Anesthetics, Local|anesthetics, local|mesh-ancestor
101902351|NCT03847922|Anesthetics|anesthetics|mesh-ancestor
101902352|NCT03847922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101609934|NCT01129622|Letrozole|letrozole|mesh-list
101610001|NCT05132595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101902353|NCT03847922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902354|NCT03847922|Sensory System Agents|sensory system agents|mesh-ancestor
101610150|NCT04282902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101610219|NCT04158076|Vasodilator Agents|vasodilator agents|mesh-ancestor
101902355|NCT03847922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101610381|NCT00912093|Icatibant|icatibant|mesh-list
101902356|NCT03847922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101902357|NCT03847922|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101902358|NCT03847922|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101902359|NCT03847922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101902360|NCT03847922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902361|NCT03847922|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101902362|NCT03847922|Anesthetics, General|anesthetics, general|mesh-ancestor
101902363|NCT03847922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101902364|NCT03847922|Analgesics|analgesics|mesh-ancestor
101902365|NCT01194284|Mifamurtide|mifamurtide|mesh-list
101902366|NCT01194284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101902367|NCT01194284|Immunologic Factors|immunologic factors|mesh-ancestor
101902368|NCT01194284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902369|NCT03255382|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101902370|NCT03255382|Dermatologic Agents|dermatologic agents|mesh-ancestor
101902371|NCT03255382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101902372|NCT03255382|Immunologic Factors|immunologic factors|mesh-ancestor
101902373|NCT03255382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902374|NCT01191554|Tranexamic Acid|tranexamic acid|mesh-list
101902375|NCT01191554|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101902376|NCT01191554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101902377|NCT01191554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902378|NCT01191554|Hemostatics|hemostatics|mesh-ancestor
101902379|NCT01191554|Coagulants|coagulants|mesh-ancestor
101902380|NCT01296464|Carbidopa|carbidopa|mesh-list
101902381|NCT01296464|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101902382|NCT01296464|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101902383|NCT01296464|Dopamine Agents|dopamine agents|mesh-ancestor
101902384|NCT01296464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101902385|NCT01296464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902386|NCT01296464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902387|NCT01296464|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101902388|NCT01296464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101902389|NCT00038142|Cyclophosphamide|cyclophosphamide|mesh-list
101902390|NCT00038142|Doxorubicin|doxorubicin|mesh-list
101902391|NCT00038142|Vincristine|vincristine|mesh-list
101902392|NCT00038142|Dexrazoxane|dexrazoxane|mesh-list
101902393|NCT00038142|Razoxane|razoxane|mesh-list
101902394|NCT00038142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101902395|NCT00038142|Immunologic Factors|immunologic factors|mesh-ancestor
101902396|NCT00038142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902397|NCT00038142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101902398|NCT00038142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101902399|NCT00038142|Alkylating Agents|alkylating agents|mesh-ancestor
101902400|NCT00038142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902401|NCT00038142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101902402|NCT00038142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101902403|NCT00038142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101902404|NCT00038142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101902405|NCT00038142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101902406|NCT00038142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101902407|NCT00038142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101902408|NCT00038142|Tubulin Modulators|tubulin modulators|mesh-ancestor
101902409|NCT00038142|Antimitotic Agents|antimitotic agents|mesh-ancestor
101902410|NCT00038142|Mitosis Modulators|mitosis modulators|mesh-ancestor
101902411|NCT00038142|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101902412|NCT00038142|Protective Agents|protective agents|mesh-ancestor
101902413|NCT00366899|Vaccines|vaccines|mesh-list
101902414|NCT00366899|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101902415|NCT00366899|Immunologic Factors|immunologic factors|mesh-ancestor
101902416|NCT00366899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902417|NCT03847376|Rilpivirine|rilpivirine|mesh-list
101902418|NCT03847376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101902419|NCT03847376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101902420|NCT03847376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101902421|NCT03847376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902422|NCT03847376|Antiviral Agents|antiviral agents|mesh-ancestor
101902423|NCT03847376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101902424|NCT03847376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101902425|NCT03847376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101902426|NCT01090128|Paclitaxel|paclitaxel|mesh-list
101902427|NCT01090128|Cyclophosphamide|cyclophosphamide|mesh-list
101902428|NCT01090128|Doxorubicin|doxorubicin|mesh-list
101902429|NCT01090128|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101902430|NCT01090128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101902431|NCT01090128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101902432|NCT01090128|Tubulin Modulators|tubulin modulators|mesh-ancestor
101902433|NCT01090128|Antimitotic Agents|antimitotic agents|mesh-ancestor
101902434|NCT01090128|Mitosis Modulators|mitosis modulators|mesh-ancestor
101902435|NCT01090128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610614|NCT01126268|Retapamulin|retapamulin|mesh-list
101902436|NCT01090128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101902437|NCT01090128|Immunologic Factors|immunologic factors|mesh-ancestor
101902438|NCT01090128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902440|NCT01090128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101902442|NCT01090128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101610891|NCT05143164|Gentamicins|gentamicins|mesh-list
101902443|NCT01090128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101610952|NCT00664222|Natriuretic Agents|natriuretic agents|mesh-ancestor
101902444|NCT01090128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101611174|NCT00809341|Mitosis Modulators|mitosis modulators|mesh-ancestor
101611250|NCT00910299|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101902446|NCT01090128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101902447|NCT01292174|Ibalizumab|ibalizumab|mesh-list
101902448|NCT01292174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101902449|NCT01292174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101902450|NCT01292174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101902451|NCT01292174|Antiviral Agents|antiviral agents|mesh-ancestor
101902452|NCT01292174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101902453|NCT01292174|Immunologic Factors|immunologic factors|mesh-ancestor
101902454|NCT01292174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902455|NCT01090206|Vitamin D|vitamin d|mesh-list
101902456|NCT01090206|Calcium|calcium|mesh-list
101902457|NCT01090206|Vitamins|vitamins|mesh-ancestor
101902458|NCT01090206|Micronutrients|micronutrients|mesh-ancestor
101902459|NCT01090206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902460|NCT01090206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101902461|NCT01090206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101902462|NCT04728646|Dexamethasone|dexamethasone|mesh-list
101902463|NCT04728646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101902464|NCT04728646|Antiemetics|antiemetics|mesh-ancestor
101902465|NCT04728646|Autonomic Agents|autonomic agents|mesh-ancestor
101902466|NCT04728646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101902467|NCT04728646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902468|NCT04728646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101902469|NCT04728646|Glucocorticoids|glucocorticoids|mesh-ancestor
101902470|NCT04728646|Hormones|hormones|mesh-ancestor
101902471|NCT04728646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101902472|NCT04728646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101902473|NCT04728646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101902474|NCT04674826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101902475|NCT04674826|Immunologic Factors|immunologic factors|mesh-ancestor
101902476|NCT04674826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902477|NCT01295138|Lactulose|lactulose|mesh-list
101902478|NCT01295138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101902479|NCT01188824|Cilostazol|cilostazol|mesh-list
101902480|NCT01188824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101902481|NCT01188824|Autonomic Agents|autonomic agents|mesh-ancestor
101902482|NCT01188824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101902483|NCT01188824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902484|NCT01188824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101902485|NCT01188824|Respiratory System Agents|respiratory system agents|mesh-ancestor
101902486|NCT01188824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101611325|NCT00671320|Diclofenac|diclofenac|mesh-list
101902487|NCT01188824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101902488|NCT01188824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902489|NCT01188824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101902490|NCT01188824|Vasodilator Agents|vasodilator agents|mesh-ancestor
101902491|NCT01188824|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101902492|NCT01188824|Protective Agents|protective agents|mesh-ancestor
101902493|NCT01188824|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101902494|NCT01188824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101902496|NCT01060475|Tacrolimus|tacrolimus|mesh-list
101902497|NCT01060475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101902498|NCT01060475|Immunologic Factors|immunologic factors|mesh-ancestor
101611580|NCT00680758|Paclitaxel|paclitaxel|mesh-list
101902499|NCT01060475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969863|NCT05982392|Naproxen|naproxen|mesh-list
101902500|NCT01060475|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101902501|NCT01060475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101902502|NCT01060475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902503|NCT01060631|Propofol|propofol|mesh-list
101902504|NCT01060631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101902505|NCT01060631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101902506|NCT01060631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902507|NCT01060631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101902508|NCT01060631|Anesthetics, General|anesthetics, general|mesh-ancestor
101902509|NCT01060631|Anesthetics|anesthetics|mesh-ancestor
101902510|NCT03254134|Warfarin|warfarin|mesh-list
101902511|NCT03254134|Dabigatran|dabigatran|mesh-list
101902512|NCT03254134|Anticoagulants|anticoagulants|mesh-ancestor
101902513|NCT03254134|Antithrombins|antithrombins|mesh-ancestor
101902514|NCT03254134|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101902515|NCT03254134|Protease Inhibitors|protease inhibitors|mesh-ancestor
101902516|NCT03254134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101902517|NCT03254134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902518|NCT03953196|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
101902519|NCT03953196|Antiviral Agents|antiviral agents|mesh-ancestor
101902520|NCT03953196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101902522|NCT01295294|Tranexamic Acid|tranexamic acid|mesh-list
101902523|NCT01295294|Levonorgestrel|levonorgestrel|mesh-list
101902524|NCT01295294|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101902525|NCT01295294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101902526|NCT01295294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902527|NCT01295294|Hemostatics|hemostatics|mesh-ancestor
101902528|NCT01295294|Coagulants|coagulants|mesh-ancestor
101902529|NCT01295294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101902530|NCT01295294|Contraceptive Agents|contraceptive agents|mesh-ancestor
101902531|NCT01295294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101902532|NCT01295294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902533|NCT01295294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101902534|NCT01295294|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101902535|NCT01295294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101611913|NCT00805675|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101902536|NCT01295294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101902537|NCT01295294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101902538|NCT01295294|Analgesics|analgesics|mesh-ancestor
101902539|NCT01295294|Sensory System Agents|sensory system agents|mesh-ancestor
101902540|NCT01295294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101902541|NCT01295294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101902543|NCT01295294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101902544|NCT01295294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101902545|NCT01191710|Progesterone|progesterone|mesh-list
101902546|NCT01191710|Progestins|progestins|mesh-ancestor
101902547|NCT01191710|Hormones|hormones|mesh-ancestor
101902548|NCT01191710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101902549|NCT01191710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902550|NCT04367740|Antibodies|antibodies|mesh-list
101902551|NCT04367740|Immunoglobulin G|immunoglobulin g|mesh-list
101902552|NCT04367740|Immunologic Factors|immunologic factors|mesh-ancestor
101902553|NCT04367740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902554|NCT03852056|Fluorides|fluorides|mesh-list
101902555|NCT03852056|Tin Fluorides|tin fluorides|mesh-list
101902556|NCT03852056|Cariostatic Agents|cariostatic agents|mesh-ancestor
101902557|NCT03852056|Protective Agents|protective agents|mesh-ancestor
101902558|NCT03852056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902559|NCT03242434|Mannitol|mannitol|mesh-list
101902560|NCT03242434|Lactulose|lactulose|mesh-list
101902561|NCT03242434|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101902562|NCT03242434|Diuretics|diuretics|mesh-ancestor
101902563|NCT03242434|Natriuretic Agents|natriuretic agents|mesh-ancestor
101902564|NCT03242434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902565|NCT03242434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101902566|NCT04222426|Atezolizumab|atezolizumab|mesh-list
101902567|NCT04222426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101902568|NCT04222426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902569|NCT04222426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101902570|NCT04222426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101612071|NCT02857842|Hormones|hormones|mesh-ancestor
101612094|NCT05697211|Ferric maltol|ferric maltol|mesh-list
101902573|NCT01292408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101902574|NCT01292408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101902575|NCT01292408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101902576|NCT01292408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101902577|NCT01292408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902578|NCT01292408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101902579|NCT01295372|Risperidone|risperidone|mesh-list
101902580|NCT01295372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101902581|NCT01295372|Serotonin Agents|serotonin agents|mesh-ancestor
101902582|NCT01295372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101902583|NCT01295372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902584|NCT01295372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902585|NCT01295372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101902586|NCT01295372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101902587|NCT01295372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101902588|NCT01295372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101902589|NCT01295372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101902590|NCT01295372|Dopamine Agents|dopamine agents|mesh-ancestor
101902591|NCT05283278|Lactoferrin|lactoferrin|mesh-list
101902592|NCT05283278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101902593|NCT05179018|Autoantibodies|autoantibodies|mesh-list
101612244|NCT02854722|Vitamin D|vitamin d|mesh-list
101902594|NCT05179018|Immunologic Factors|immunologic factors|mesh-ancestor
101902595|NCT05179018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902596|NCT01295450|Vitamins|vitamins|mesh-list
101902597|NCT01295450|Micronutrients|micronutrients|mesh-ancestor
101902598|NCT01295450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902599|NCT01297010|Dexamethasone|dexamethasone|mesh-list
101902600|NCT01297010|Dexamethasone acetate|dexamethasone acetate|mesh-list
101902601|NCT01297010|BB 1101|bb 1101|mesh-list
101902602|NCT01297010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101612306|NCT00907335|Tretinoin|tretinoin|mesh-list
101612380|NCT03198741|Aspirin|aspirin|mesh-list
101902603|NCT01297010|Antiemetics|antiemetics|mesh-ancestor
101902604|NCT01297010|Autonomic Agents|autonomic agents|mesh-ancestor
101612663|NCT00680212|Provitamins|provitamins|mesh-ancestor
101902605|NCT01297010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101902606|NCT01297010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902607|NCT01297010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101902608|NCT01297010|Glucocorticoids|glucocorticoids|mesh-ancestor
101902609|NCT01297010|Hormones|hormones|mesh-ancestor
101902610|NCT01297010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101612959|NCT02821923|Erythritol|erythritol|mesh-list
101902611|NCT01297010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101902612|NCT01297010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101902614|NCT01297010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101613114|NCT05034783|Incretins|incretins|mesh-ancestor
101902615|NCT01297010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902616|NCT03851432|Metformin|metformin|mesh-list
101902617|NCT03851432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101902618|NCT03851432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902620|NCT01192490|Anesthetics, Local|anesthetics, local|mesh-ancestor
101902621|NCT01192490|Anesthetics|anesthetics|mesh-ancestor
101902622|NCT01192490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101613575|NCT02842125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101902623|NCT01192490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902624|NCT01192490|Sensory System Agents|sensory system agents|mesh-ancestor
101613720|NCT00938886|Sensory System Agents|sensory system agents|mesh-ancestor
101902625|NCT01192490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101902626|NCT01192490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101902627|NCT01192490|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101902628|NCT01192490|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101902629|NCT01192490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101902630|NCT01192490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902631|NCT01295606|Cefazolin|cefazolin|mesh-list
101902632|NCT01295606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101902633|NCT01295606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101902634|NCT01192724|Aspirin|aspirin|mesh-list
101902635|NCT01192724|Cilostazol|cilostazol|mesh-list
101902636|NCT01192724|Clopidogrel|clopidogrel|mesh-list
101614001|NCT04139824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101902637|NCT01192724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101902638|NCT01192724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101902640|NCT01192724|Sensory System Agents|sensory system agents|mesh-ancestor
101902641|NCT01192724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101902642|NCT01192724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902643|NCT01192724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101902645|NCT01192724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101902646|NCT01192724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101902647|NCT01192724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902648|NCT01192724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101902649|NCT01192724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101902650|NCT01192724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101902651|NCT01192724|Antipyretics|antipyretics|mesh-ancestor
101902652|NCT01192724|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101902653|NCT01192724|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101902654|NCT01192724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101902655|NCT01192724|Purinergic Agents|purinergic agents|mesh-ancestor
101902656|NCT01192724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101902657|NCT01192724|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101902658|NCT01192724|Autonomic Agents|autonomic agents|mesh-ancestor
101902659|NCT01192724|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101902660|NCT01192724|Respiratory System Agents|respiratory system agents|mesh-ancestor
101902661|NCT01192724|Vasodilator Agents|vasodilator agents|mesh-ancestor
101902662|NCT01192724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101902663|NCT01192724|Protective Agents|protective agents|mesh-ancestor
101902664|NCT01192724|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101614350|NCT00688480|Allopurinol|allopurinol|mesh-list
101902665|NCT01192724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101902666|NCT01192802|Albendazole|albendazole|mesh-list
101902667|NCT01192802|Anthelmintics|anthelmintics|mesh-ancestor
101902668|NCT01192802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101614499|NCT04204044|Folic Acid|folic acid|mesh-list
101614571|NCT04136782|Paclitaxel|paclitaxel|mesh-list
101902669|NCT01192802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101614793|NCT00872170|Sildenafil Citrate|sildenafil citrate|mesh-list
101902671|NCT01192802|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101902672|NCT01192802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101902673|NCT01192802|Tubulin Modulators|tubulin modulators|mesh-ancestor
101614941|NCT00696826|Incretins|incretins|mesh-ancestor
101902674|NCT01192802|Antimitotic Agents|antimitotic agents|mesh-ancestor
101615016|NCT02623114|Dopamine Agents|dopamine agents|mesh-ancestor
101902675|NCT01192802|Mitosis Modulators|mitosis modulators|mesh-ancestor
101615087|NCT01097330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101902676|NCT01192802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902677|NCT01192802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101615311|NCT04133428|Valsartan|valsartan|mesh-list
101902679|NCT01292720|Cholecalciferol|cholecalciferol|mesh-list
101615463|NCT00931710|Losartan|losartan|mesh-list
101902681|NCT01292720|Micronutrients|micronutrients|mesh-ancestor
101615529|NCT01078922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101902682|NCT01292720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902683|NCT01292720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101902684|NCT01292720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101902685|NCT02939014|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101902686|NCT02939014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101616048|NCT04258098|Metronidazole|metronidazole|mesh-list
101902687|NCT02939014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101902688|NCT02939014|Immunotoxins|immunotoxins|mesh-ancestor
101902689|NCT02939014|Immunoconjugates|immunoconjugates|mesh-ancestor
101902690|NCT02939014|Immunologic Factors|immunologic factors|mesh-ancestor
101616200|NCT00610350|Protective Agents|protective agents|mesh-ancestor
101902691|NCT02939014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902692|NCT05177926|Tenofovir|tenofovir|mesh-list
101902693|NCT05177926|Antiviral Agents|antiviral agents|mesh-list
101902694|NCT05177926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101902695|NCT05177926|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101616489|NCT00697372|Immunologic Factors|immunologic factors|mesh-ancestor
101902696|NCT05177926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101902697|NCT05177926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101616638|NCT00092703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101969320|NCT00383578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101969321|NCT00383578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365161|NCT00049361|Alkylating Agents|alkylating agents|mesh-ancestor
101969322|NCT00383578|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101969323|NCT00383578|Protease Inhibitors|protease inhibitors|mesh-ancestor
101969324|NCT00383578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101969325|NCT00383578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969326|NCT00383422|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101969327|NCT00383422|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101969328|NCT00383422|Hormone Antagonists|hormone antagonists|mesh-ancestor
101304303|NCT02012140|Ticagrelor|ticagrelor|mesh-list
101969329|NCT00383422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101969330|NCT00383422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969331|NCT00383422|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101969332|NCT00383422|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101969333|NCT00383422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101969334|NCT02286622|Deflazacort|deflazacort|mesh-list
101969335|NCT02286622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101969336|NCT02286622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101969337|NCT02286622|Immunologic Factors|immunologic factors|mesh-ancestor
101969338|NCT02286622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969339|NCT00564226|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101969340|NCT00564226|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101969341|NCT00564226|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101969342|NCT00564226|Cholinergic Agents|cholinergic agents|mesh-ancestor
101969343|NCT00564226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101969344|NCT00564226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969345|NCT00564226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969346|NCT00564226|Urological Agents|urological agents|mesh-ancestor
101969347|NCT03635684|Acetaminophen|acetaminophen|mesh-list
101969348|NCT03635684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101969349|NCT03635684|Analgesics|analgesics|mesh-ancestor
101969350|NCT03635684|Sensory System Agents|sensory system agents|mesh-ancestor
101969351|NCT03635684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101969352|NCT03635684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969353|NCT03635684|Antipyretics|antipyretics|mesh-ancestor
101365780|NCT00152815|Vitamin E|vitamin e|mesh-list
101969354|NCT00092690|Atorvastatin|atorvastatin|mesh-list
101969355|NCT00092690|Simvastatin|simvastatin|mesh-list
101969356|NCT00092690|Ezetimibe|ezetimibe|mesh-list
101969357|NCT00092690|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101969358|NCT00092690|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101333837|NCT00017316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101365995|NCT00153634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101969360|NCT00092690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969361|NCT00092690|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101969362|NCT00092690|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101969363|NCT00092690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101969364|NCT02286700|Desonide|desonide|mesh-list
101969365|NCT02286700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101969366|NCT01338896|Rotigotine|rotigotine|mesh-list
101969367|NCT01338896|Dopamine Agonists|dopamine agonists|mesh-ancestor
101969368|NCT01338896|Dopamine Agents|dopamine agents|mesh-ancestor
101304343|NCT02012322|Vitamins|vitamins|mesh-ancestor
101969369|NCT01338896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101969370|NCT01338896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304344|NCT02012335|Ketamine|ketamine|mesh-list
101969371|NCT01338896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969372|NCT05185544|Pemetrexed|pemetrexed|mesh-list
101969373|NCT05185544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101969374|NCT05185544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101969375|NCT05185544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969376|NCT05185544|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101969377|NCT05185544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101969378|NCT00382096|Metformin|metformin|mesh-list
101969379|NCT00382096|Vildagliptin|vildagliptin|mesh-list
101969380|NCT00382096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101969381|NCT00382096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969382|NCT00382096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101969383|NCT00382096|Protease Inhibitors|protease inhibitors|mesh-ancestor
101969384|NCT00382096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101969385|NCT00382096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969386|NCT00482092|Remestemcel-l|remestemcel-l|mesh-list
101969387|NCT00482092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101969388|NCT00482092|Antiviral Agents|antiviral agents|mesh-ancestor
101304352|NCT02012335|Anesthetics|anesthetics|mesh-ancestor
101969389|NCT00482092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101969390|NCT00379990|Prednisolone|prednisolone|mesh-list
101969391|NCT00379990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101969393|NCT00379990|Hormones|hormones|mesh-ancestor
101304366|NCT02012465|Insulin|insulin|mesh-list
101969394|NCT00379990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101969395|NCT00379990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969396|NCT00379990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101969397|NCT00379990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101969398|NCT00377182|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101969400|NCT00377182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101969401|NCT01341938|Nicotine|nicotine|mesh-list
101969402|NCT01341938|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101969403|NCT01341938|Autonomic Agents|autonomic agents|mesh-ancestor
101969404|NCT01341938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101969406|NCT01341938|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101969407|NCT01341938|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101969408|NCT01341938|Cholinergic Agents|cholinergic agents|mesh-ancestor
101969409|NCT01341938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101969410|NCT01341938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969411|NCT02284048|Ticagrelor|ticagrelor|mesh-list
101969412|NCT02284048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101969413|NCT02284048|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101969414|NCT02284048|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101969415|NCT02284048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101969416|NCT02284048|Purinergic Agents|purinergic agents|mesh-ancestor
101969417|NCT02284048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101969418|NCT02284048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969419|NCT02284048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969420|NCT00374296|Mocetinostat|mocetinostat|mesh-list
101969421|NCT00374296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101969422|NCT00374296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101969423|NCT00374296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969424|NCT00547066|Veltuzumab|veltuzumab|mesh-list
101969425|NCT00547066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101969426|NCT01315496|Immunoglobulins|immunoglobulins|mesh-list
101969427|NCT01315496|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101969428|NCT01315496|Antibodies|antibodies|mesh-list
101969429|NCT01315496|Immunoglobulin G|immunoglobulin g|mesh-list
101367251|NCT00052832|Vitamins|vitamins|mesh-ancestor
101969430|NCT01315496|Immunologic Factors|immunologic factors|mesh-ancestor
101969431|NCT01315496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969432|NCT00544960|Docetaxel|docetaxel|mesh-list
101969434|NCT00544960|Tubulin Modulators|tubulin modulators|mesh-ancestor
101969435|NCT00544960|Antimitotic Agents|antimitotic agents|mesh-ancestor
101969436|NCT00544960|Mitosis Modulators|mitosis modulators|mesh-ancestor
101969437|NCT00544960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969438|NCT01339286|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101969439|NCT01339286|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101969440|NCT01339286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101969441|NCT01339286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101969442|NCT01339286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969444|NCT01339286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101969445|NCT01339286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969446|NCT00468442|Sirolimus|sirolimus|mesh-list
101969447|NCT00468442|Rituximab|rituximab|mesh-list
101969448|NCT00468442|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101969450|NCT00468442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101969451|NCT00468442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101969452|NCT00468442|Immunologic Factors|immunologic factors|mesh-ancestor
101969453|NCT00468442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969454|NCT00468442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101304425|NCT02012946|Sympathomimetics|sympathomimetics|mesh-ancestor
101969456|NCT00468442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101969457|NCT00468442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101969458|NCT00468442|Antifungal Agents|antifungal agents|mesh-ancestor
101969459|NCT00468442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101969460|NCT01339442|Fulvestrant|fulvestrant|mesh-list
101969461|NCT01339442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101969462|NCT01339442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101969880|NCT05982340|Lithium Carbonate|lithium carbonate|mesh-list
101969463|NCT01339442|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101969464|NCT01339442|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101969465|NCT01339442|Hormone Antagonists|hormone antagonists|mesh-ancestor
101969466|NCT01339442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101969467|NCT01339442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969469|NCT02286934|Isoproterenol|isoproterenol|mesh-list
101969470|NCT02286934|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101969471|NCT02286934|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101304442|NCT02013115|Budesonide|budesonide|mesh-list
101969472|NCT02286934|Adrenergic Agents|adrenergic agents|mesh-ancestor
101969473|NCT02286934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101969474|NCT02286934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688321|NCT00647322|Anticonvulsants|anticonvulsants|mesh-list
101969475|NCT02286934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969476|NCT02286934|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101969477|NCT02286934|Antioxidants|antioxidants|mesh-ancestor
101969478|NCT02286934|Protective Agents|protective agents|mesh-ancestor
101969479|NCT02286934|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101368264|NCT00167557|Interferons|interferons|mesh-list
101969480|NCT02286934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101969481|NCT02286934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101304450|NCT02013115|Glucocorticoids|glucocorticoids|mesh-ancestor
101969482|NCT02286934|Vasodilator Agents|vasodilator agents|mesh-ancestor
101969483|NCT02286934|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101969484|NCT02286934|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101969485|NCT02286934|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101969486|NCT02286934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101688366|NCT02836847|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101969487|NCT02286934|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101969488|NCT02286934|Autonomic Agents|autonomic agents|mesh-ancestor
101969489|NCT02286934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101969490|NCT02286934|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101969491|NCT02286934|Respiratory System Agents|respiratory system agents|mesh-ancestor
101969492|NCT02286934|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101368612|NCT00169546|Xhance|xhance|mesh-list
101969493|NCT02286934|Sympathomimetics|sympathomimetics|mesh-ancestor
101969494|NCT02282410|Factor VIII|factor viii|mesh-list
101969495|NCT02282410|Coagulants|coagulants|mesh-ancestor
101969496|NCT00092612|Ezetimibe|ezetimibe|mesh-list
101969497|NCT00092612|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101969498|NCT00092612|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101969499|NCT00092612|Antimetabolites|antimetabolites|mesh-ancestor
101969500|NCT00092612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969501|NCT00092612|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101969502|NCT00540358|Carboplatin|carboplatin|mesh-list
101969503|NCT00540358|Gemcitabine|gemcitabine|mesh-list
101969504|NCT00540358|Iniparib|iniparib|mesh-list
101969505|NCT00540358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101969506|NCT00540358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101969507|NCT00540358|Antimetabolites|antimetabolites|mesh-ancestor
101969508|NCT00540358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969509|NCT00540358|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101969510|NCT00540358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101969511|NCT00462202|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
101969513|NCT00462202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101969514|NCT00462202|Antimetabolites|antimetabolites|mesh-ancestor
101969515|NCT00462202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688491|NCT00647946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101969516|NCT00462202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101969517|NCT00462202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101969518|NCT00462202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101969519|NCT00462202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101969520|NCT00462202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969521|NCT02287246|Bupivacaine|bupivacaine|mesh-list
101969522|NCT02287246|Anesthetics, Local|anesthetics, local|mesh-ancestor
101969523|NCT02287246|Anesthetics|anesthetics|mesh-ancestor
101969524|NCT02287246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101969525|NCT02287246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969526|NCT02287246|Sensory System Agents|sensory system agents|mesh-ancestor
101969527|NCT02287246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101969528|NCT04470544|Camostat|camostat|mesh-list
101969529|NCT04470544|Protease Inhibitors|protease inhibitors|mesh-ancestor
101969530|NCT04470544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101969531|NCT04470544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969532|NCT04470544|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101234754|NCT01579929|Etoposide|etoposide|mesh-list
101969533|NCT04470544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101969534|NCT00535366|Fluticasone|fluticasone|mesh-list
101969535|NCT00535366|Ciclesonide|ciclesonide|mesh-list
101969537|NCT00535366|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101969538|NCT00535366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101969539|NCT00535366|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101969540|NCT00535366|Autonomic Agents|autonomic agents|mesh-ancestor
101969541|NCT00535366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101969542|NCT00535366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969543|NCT00535366|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101969544|NCT00535366|Respiratory System Agents|respiratory system agents|mesh-ancestor
101969545|NCT00535366|Dermatologic Agents|dermatologic agents|mesh-ancestor
101969546|NCT00535366|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101969547|NCT00535366|Parasympatholytics|parasympatholytics|mesh-ancestor
101969548|NCT00535366|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101969549|NCT00535366|Cholinergic Agents|cholinergic agents|mesh-ancestor
101969550|NCT00535366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101688628|NCT00648726|Cefuroxime|cefuroxime|mesh-list
101969551|NCT00535366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969552|NCT00535366|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101969553|NCT00535366|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101969554|NCT00535366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101969555|NCT00535366|Adrenergic Agents|adrenergic agents|mesh-ancestor
101969556|NCT00535366|Glucocorticoids|glucocorticoids|mesh-ancestor
101969557|NCT00535366|Hormones|hormones|mesh-ancestor
101969558|NCT00535366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101969559|NCT00369070|Paclitaxel|paclitaxel|mesh-list
101969560|NCT00369070|Bevacizumab|bevacizumab|mesh-list
101969561|NCT00369070|Carboplatin|carboplatin|mesh-list
101969562|NCT00369070|Motesanib diphosphate|motesanib diphosphate|mesh-list
101969563|NCT00369070|Imetelstat|imetelstat|mesh-list
101236719|NCT01599312|Cobalt|cobalt|mesh-list
101969564|NCT00369070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101969565|NCT00369070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101969566|NCT00369070|Tubulin Modulators|tubulin modulators|mesh-ancestor
101969567|NCT00369070|Antimitotic Agents|antimitotic agents|mesh-ancestor
101969568|NCT00369070|Mitosis Modulators|mitosis modulators|mesh-ancestor
101969569|NCT00369070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969570|NCT00369070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101969571|NCT00369070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101304527|NCT02013453|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101969572|NCT00369070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101969573|NCT00369070|Growth Substances|growth substances|mesh-ancestor
101304531|NCT02013570|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101688723|NCT02659488|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101969574|NCT00369070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969575|NCT00369070|Growth Inhibitors|growth inhibitors|mesh-ancestor
101969576|NCT00369070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101969577|NCT00369070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101969580|NCT02284204|Sevoflurane|sevoflurane|mesh-list
101969581|NCT02284204|Analgesics|analgesics|mesh-ancestor
101969582|NCT02284204|Sensory System Agents|sensory system agents|mesh-ancestor
101969583|NCT02284204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101969584|NCT02284204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969585|NCT02284204|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101969586|NCT02284204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101969587|NCT02284204|Anesthetics, General|anesthetics, general|mesh-ancestor
101969588|NCT02284204|Anesthetics|anesthetics|mesh-ancestor
101969589|NCT02284204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101304544|NCT02013856|Proanthocyanidin|proanthocyanidin|mesh-list
101969590|NCT02284204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101688781|NCT02662530|Botulinum Toxins|botulinum toxins|mesh-list
101969591|NCT02284204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101969592|NCT02284204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101969593|NCT02284204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969594|NCT02284204|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101969595|NCT02284204|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101969596|NCT02284204|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101969597|NCT02284204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101969598|NCT02284204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101969599|NCT02284204|GABA Modulators|gaba modulators|mesh-ancestor
101969600|NCT02284204|GABA Agents|gaba agents|mesh-ancestor
101304556|NCT02013960|Misoprostol|misoprostol|mesh-list
101969601|NCT02284204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101969602|NCT02284204|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101969604|NCT01352416|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101969605|NCT01352416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101969606|NCT01352416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969607|NCT00531622|Escitalopram|escitalopram|mesh-list
101969608|NCT00531622|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101969609|NCT00531622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101969610|NCT00531622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101969611|NCT00531622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969612|NCT00531622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101969613|NCT00531622|Serotonin Agents|serotonin agents|mesh-ancestor
101969614|NCT00531622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969615|NCT00364546|Tapentadol|tapentadol|mesh-list
101969616|NCT00364546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101969617|NCT00364546|Narcotics|narcotics|mesh-ancestor
101969618|NCT00364546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101969619|NCT00364546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969620|NCT00364546|Analgesics|analgesics|mesh-ancestor
101969621|NCT00364546|Sensory System Agents|sensory system agents|mesh-ancestor
101969622|NCT00364546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101969623|NCT00364546|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101969624|NCT00364546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101304566|NCT02013986|Etomidate|etomidate|mesh-list
101370613|NCT00184990|Pimagedine|pimagedine|mesh-list
101969625|NCT00364546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101969626|NCT00364546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969627|NCT00364546|Adrenergic Agents|adrenergic agents|mesh-ancestor
101969628|NCT00364546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101969629|NCT00361582|Tapentadol|tapentadol|mesh-list
101969630|NCT00361582|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101969631|NCT00361582|Narcotics|narcotics|mesh-ancestor
101969632|NCT00361582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101969633|NCT00361582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969634|NCT00361582|Analgesics|analgesics|mesh-ancestor
101969635|NCT00361582|Sensory System Agents|sensory system agents|mesh-ancestor
101969636|NCT00361582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101969637|NCT00361582|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101969638|NCT00361582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101969639|NCT00361582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101969640|NCT00361582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969641|NCT00361582|Adrenergic Agents|adrenergic agents|mesh-ancestor
101969642|NCT00361582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101969643|NCT00450970|Satraplatin|satraplatin|mesh-list
101969644|NCT00450970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101969645|NCT02282800|Vitamin D|vitamin d|mesh-list
101969646|NCT02282800|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
101969647|NCT02282800|Vitamins|vitamins|mesh-ancestor
101969648|NCT02282800|Micronutrients|micronutrients|mesh-ancestor
101969649|NCT02282800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969650|NCT02282800|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101969651|NCT05208034|Methotrexate|methotrexate|mesh-list
101688948|NCT00894803|Eptifibatide|eptifibatide|mesh-list
101969652|NCT05208034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101969653|NCT05208034|Abortifacient Agents|abortifacient agents|mesh-ancestor
101969654|NCT05208034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101969655|NCT05208034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969656|NCT05208034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101969657|NCT05208034|Antimetabolites|antimetabolites|mesh-ancestor
101969658|NCT05208034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969659|NCT05208034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101304601|NCT02013089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969660|NCT05208034|Dermatologic Agents|dermatologic agents|mesh-ancestor
101969661|NCT05208034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101969662|NCT05208034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101969663|NCT05208034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101969664|NCT05208034|Immunologic Factors|immunologic factors|mesh-ancestor
101969665|NCT05208034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101969666|NCT05208034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101969668|NCT02284282|Morphine|morphine|mesh-list
101969670|NCT02284282|Anesthetics, Local|anesthetics, local|mesh-ancestor
101969671|NCT02284282|Anesthetics|anesthetics|mesh-ancestor
101304620|NCT02014337|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101969673|NCT02284282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969674|NCT02284282|Sensory System Agents|sensory system agents|mesh-ancestor
101969675|NCT02284282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101969676|NCT02284282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101969677|NCT02284282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101969678|NCT02284282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101969679|NCT02284282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101969680|NCT02284282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969681|NCT02284282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101969683|NCT02284282|Analgesics|analgesics|mesh-ancestor
101969684|NCT00359086|Mocetinostat|mocetinostat|mesh-list
101969685|NCT00359086|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101969686|NCT00359086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101969687|NCT00359086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969688|NCT03133780|Midazolam|midazolam|mesh-list
101969689|NCT03133780|Ketamine|ketamine|mesh-list
101969690|NCT03133780|Analgesics|analgesics|mesh-ancestor
101969691|NCT03133780|Sensory System Agents|sensory system agents|mesh-ancestor
101969692|NCT03133780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101969693|NCT03133780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969694|NCT03133780|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101969695|NCT03133780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101969696|NCT03133780|Anesthetics, General|anesthetics, general|mesh-ancestor
101969697|NCT03133780|Anesthetics|anesthetics|mesh-ancestor
101969698|NCT03133780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101969699|NCT03133780|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101969700|NCT03133780|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101969701|NCT03133780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101969702|NCT03133780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304647|NCT02014454|Vasodilator Agents|vasodilator agents|mesh-ancestor
101969703|NCT03133780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101969704|NCT03133780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101969705|NCT03133780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101304649|NCT02014506|Fludarabine|fludarabine|mesh-list
101969706|NCT03133780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101689056|NCT04209920|Nickel|nickel|mesh-list
101969707|NCT03133780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101969708|NCT03133780|GABA Modulators|gaba modulators|mesh-ancestor
101969710|NCT02282956|Droperidol|droperidol|mesh-list
101969711|NCT02282956|Morphine|morphine|mesh-list
101969712|NCT02282956|Ropivacaine|ropivacaine|mesh-list
101969713|NCT02282956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101969714|NCT02282956|Narcotics|narcotics|mesh-ancestor
101969715|NCT02282956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101969716|NCT02282956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969718|NCT02282956|Sensory System Agents|sensory system agents|mesh-ancestor
101969719|NCT02282956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101969720|NCT02282956|Anesthetics, Local|anesthetics, local|mesh-ancestor
101969721|NCT02282956|Anesthetics|anesthetics|mesh-ancestor
101969722|NCT02282956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101969723|NCT02282956|Antiemetics|antiemetics|mesh-ancestor
101969724|NCT02282956|Autonomic Agents|autonomic agents|mesh-ancestor
101969725|NCT02282956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101969900|NCT05982197|Curcumin|curcumin|mesh-list
101969726|NCT02282956|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101969727|NCT02282956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101969728|NCT02282956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101969729|NCT02282956|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101969730|NCT02282956|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101372836|NCT00199147|Etoposide|etoposide|mesh-list
101969731|NCT02282956|Dopamine Agents|dopamine agents|mesh-ancestor
101969732|NCT02282956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101969733|NCT02282956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969734|NCT02287558|Pomalidomide|pomalidomide|mesh-list
101969735|NCT02287558|Immunologic Factors|immunologic factors|mesh-ancestor
101304670|NCT02014545|Lucanthone|lucanthone|mesh-list
101969736|NCT02287558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969737|NCT02287558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101373086|NCT00061256|Calcium|calcium|mesh-list
101969739|NCT02287558|Growth Substances|growth substances|mesh-ancestor
101969740|NCT02287558|Growth Inhibitors|growth inhibitors|mesh-ancestor
101969741|NCT02287558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101969742|NCT04470076|Carboplatin|carboplatin|mesh-list
101969743|NCT04470076|Gemcitabine|gemcitabine|mesh-list
101969744|NCT04470076|Pemetrexed|pemetrexed|mesh-list
101969745|NCT04470076|Afatinib|afatinib|mesh-list
101969746|NCT04470076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101969747|NCT04470076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101969748|NCT04470076|Antimetabolites|antimetabolites|mesh-ancestor
101969749|NCT04470076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969750|NCT04470076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101689081|NCT02660502|Insulin|insulin|mesh-list
101969751|NCT04470076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101304683|NCT02014558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101969752|NCT04470076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101969753|NCT04470076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101969754|NCT00445198|Navitoclax|navitoclax|mesh-list
101969755|NCT00445198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101969756|NCT00345748|Abatacept|abatacept|mesh-list
101969757|NCT00345748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101304689|NCT02014558|GABA Modulators|gaba modulators|mesh-ancestor
101969758|NCT00345748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969759|NCT00345748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101969760|NCT00345748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101969761|NCT00345748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101969762|NCT00345748|Immunologic Factors|immunologic factors|mesh-ancestor
101969763|NCT00345748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689528|NCT02650596|Incretins|incretins|mesh-ancestor
101969764|NCT00345748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101969765|NCT00439738|Amlodipine|amlodipine|mesh-list
101969767|NCT00439738|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101373817|NCT00224809|Spironolactone|spironolactone|mesh-list
101969768|NCT00439738|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101969769|NCT00439738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101969770|NCT00439738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101689121|NCT00891839|Rituximab|rituximab|mesh-list
101969771|NCT00439738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969772|NCT00439738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101969773|NCT00439738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969774|NCT00439738|Vasodilator Agents|vasodilator agents|mesh-ancestor
101969775|NCT00439738|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101969776|NCT00439738|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101969777|NCT00439738|Diuretics|diuretics|mesh-ancestor
101969778|NCT00439738|Natriuretic Agents|natriuretic agents|mesh-ancestor
101969779|NCT00439738|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101969780|NCT00435916|Dacetuzumab|dacetuzumab|mesh-list
101969781|NCT00435916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101969783|NCT00523042|Insulin|insulin|mesh-list
101969784|NCT00523042|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101969786|NCT00523042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101969787|NCT00523042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969788|NCT00338104|Insulin|insulin|mesh-list
101969789|NCT00338104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101969790|NCT00338104|Insulin Glargine|insulin glargine|mesh-list
101969791|NCT00338104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101969792|NCT00338104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969793|NCT00519142|Mitiglinide|mitiglinide|mesh-list
101969794|NCT00519142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101304724|NCT02014714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101969795|NCT00519142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969796|NCT02284672|Dexmedetomidine|dexmedetomidine|mesh-list
101969797|NCT02284672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101969798|NCT02284672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101304725|NCT02014714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101969799|NCT02284672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969800|NCT02284672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101969801|NCT02284672|Analgesics|analgesics|mesh-ancestor
101969802|NCT02284672|Sensory System Agents|sensory system agents|mesh-ancestor
101969803|NCT02284672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101969804|NCT02284672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101969805|NCT02284672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101969806|NCT02284672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101969807|NCT02284672|Adrenergic Agents|adrenergic agents|mesh-ancestor
101969808|NCT02284672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101969809|NCT02284672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969810|NCT02283190|Asparaginase|asparaginase|mesh-list
101969811|NCT02283190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101969812|NCT00333502|Camptothecin|camptothecin|mesh-list
101969813|NCT00333502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101969814|NCT00333502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101969815|NCT00333502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101969816|NCT00333502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101969817|NCT00333502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101969818|NCT00333502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304746|NCT02014753|Trace Elements|trace elements|mesh-ancestor
101969819|NCT05982704|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
101969820|NCT05982704|Antiviral Agents|antiviral agents|mesh-ancestor
101375096|NCT00231829|Celecoxib|celecoxib|mesh-list
101969821|NCT05982704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101969822|NCT05982678|Trastuzumab|trastuzumab|mesh-list
101969823|NCT05982678|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
101969824|NCT05982678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101969825|NCT05982678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101969826|NCT05982678|Immunoconjugates|immunoconjugates|mesh-ancestor
101969827|NCT05982678|Immunologic Factors|immunologic factors|mesh-ancestor
101969828|NCT05982678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969829|NCT05982587|Calcium Carbonate|calcium carbonate|mesh-list
101969830|NCT05982587|Antacids|antacids|mesh-ancestor
101969831|NCT05982587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969832|NCT05982587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101969834|NCT05982522|Tislelizumab|tislelizumab|mesh-list
101304765|NCT02014922|Micronutrients|micronutrients|mesh-ancestor
101969835|NCT05982522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101969836|NCT05982522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101969838|NCT05982522|Antimitotic Agents|antimitotic agents|mesh-ancestor
101969839|NCT05982522|Mitosis Modulators|mitosis modulators|mesh-ancestor
101969840|NCT05982522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304770|NCT02015169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101969841|NCT05982522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101969842|NCT05982483|Bupivacaine|bupivacaine|mesh-list
101969843|NCT05982483|Anesthetics, Local|anesthetics, local|mesh-ancestor
101969844|NCT05982483|Anesthetics|anesthetics|mesh-ancestor
101969845|NCT05982483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101969846|NCT05982483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969847|NCT05982483|Sensory System Agents|sensory system agents|mesh-ancestor
101304775|NCT02015182|Anesthetics, Local|anesthetics, local|mesh-ancestor
101969848|NCT05982483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101969849|NCT05982470|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101969850|NCT05982470|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101969851|NCT05982470|Estradiol|estradiol|mesh-list
101969852|NCT05982470|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101969853|NCT05982470|Progesterone|progesterone|mesh-list
101969854|NCT05982470|Estrogens|estrogens|mesh-ancestor
101969855|NCT05982470|Hormones|hormones|mesh-ancestor
101971976|NCT01336322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969856|NCT05982470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101969857|NCT05982470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969858|NCT05982470|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101969859|NCT05982470|Contraceptive Agents|contraceptive agents|mesh-ancestor
101969860|NCT05982470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101969861|NCT05982470|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101969862|NCT05982470|Progestins|progestins|mesh-ancestor
101969864|NCT05982392|Tramadol|tramadol|mesh-list
101969865|NCT05982392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101969866|NCT05982392|Narcotics|narcotics|mesh-ancestor
101969867|NCT05982392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101969868|NCT05982392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969869|NCT05982392|Analgesics|analgesics|mesh-ancestor
101969870|NCT05982392|Sensory System Agents|sensory system agents|mesh-ancestor
101969871|NCT05982392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101304799|NCT02015312|Mannitol|mannitol|mesh-list
101969872|NCT05982392|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101969873|NCT05982392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101969874|NCT05982392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101969875|NCT05982392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101969876|NCT05982392|Gout Suppressants|gout suppressants|mesh-ancestor
101969877|NCT05982392|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101969878|NCT05982392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101969879|NCT05982392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969881|NCT05982340|Antidepressive Agents|antidepressive agents|mesh-ancestor
101969882|NCT05982340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101969883|NCT05982340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101969884|NCT05982340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969885|NCT05982340|Antimanic Agents|antimanic agents|mesh-ancestor
101969886|NCT05982340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101969887|NCT05982340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101969888|NCT05982340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969889|NCT05982314|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101969890|NCT05982314|Immunologic Factors|immunologic factors|mesh-ancestor
101969891|NCT05982314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969892|NCT05982301|Paclitaxel|paclitaxel|mesh-list
101379265|NCT00257569|Cetirizine|cetirizine|mesh-list
101969893|NCT05982301|Oxaliplatin|oxaliplatin|mesh-list
101969894|NCT05982301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101969895|NCT05982301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101304824|NCT02015403|Antidotes|antidotes|mesh-ancestor
101969896|NCT05982301|Tubulin Modulators|tubulin modulators|mesh-ancestor
101969897|NCT05982301|Antimitotic Agents|antimitotic agents|mesh-ancestor
101969898|NCT05982301|Mitosis Modulators|mitosis modulators|mesh-ancestor
101969899|NCT05982301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969901|NCT05982197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101969902|NCT05982197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101969903|NCT05982197|Analgesics|analgesics|mesh-ancestor
101969904|NCT05982197|Sensory System Agents|sensory system agents|mesh-ancestor
101969905|NCT05982197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101969906|NCT05982197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969907|NCT05982197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101969908|NCT05982197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101969909|NCT05982197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101969910|NCT05982197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101969911|NCT05982197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969912|NCT05982093|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101969913|NCT05982093|Luteolytic Agents|luteolytic agents|mesh-ancestor
101969914|NCT05982093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101969915|NCT05982093|Contraceptive Agents|contraceptive agents|mesh-ancestor
101969916|NCT05982093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101969917|NCT05982093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969918|NCT05982093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101969919|NCT05982093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101969920|NCT05982093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101969921|NCT05981976|Abatacept|abatacept|mesh-list
101969922|NCT05981976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101969923|NCT05981976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969924|NCT05981976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101969925|NCT05981976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101969926|NCT05981976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101969927|NCT05981976|Immunologic Factors|immunologic factors|mesh-ancestor
101969928|NCT05981976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969929|NCT05981976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101969930|NCT05981742|Metformin|metformin|mesh-list
101969931|NCT05981742|Cabergoline|cabergoline|mesh-list
101969932|NCT05981742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101969933|NCT05981742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969934|NCT05981742|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101969935|NCT05981742|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101969936|NCT05981742|Dopamine Agonists|dopamine agonists|mesh-ancestor
101969937|NCT05981742|Dopamine Agents|dopamine agents|mesh-ancestor
101969938|NCT05981742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101969939|NCT05981742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969940|NCT05981534|Vitamin D|vitamin d|mesh-list
101969941|NCT05981534|Vitamins|vitamins|mesh-ancestor
101969942|NCT05981534|Micronutrients|micronutrients|mesh-ancestor
101969943|NCT05981534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969944|NCT05981534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101969945|NCT05981365|Metformin|metformin|mesh-list
101969946|NCT05981365|Repaglinide|repaglinide|mesh-list
101969947|NCT05981365|Flurbiprofen|flurbiprofen|mesh-list
101969949|NCT05981365|Midazolam|midazolam|mesh-list
101969950|NCT05981365|Bupropion|bupropion|mesh-list
101969951|NCT05981365|Omeprazole|omeprazole|mesh-list
101969952|NCT05981365|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101969953|NCT05981365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101969954|NCT05981365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969955|NCT05981365|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101969956|NCT05981365|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101969957|NCT05981365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101969958|NCT05981365|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101969959|NCT05981365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101969960|NCT05981365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101969961|NCT05981365|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101969962|NCT05981365|Anesthetics, General|anesthetics, general|mesh-ancestor
101969963|NCT05981365|Anesthetics|anesthetics|mesh-ancestor
101969964|NCT05981365|GABA Modulators|gaba modulators|mesh-ancestor
101969965|NCT05981365|GABA Agents|gaba agents|mesh-ancestor
101969966|NCT05981365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101969967|NCT05981365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250020|NCT05294484|Indapamide|indapamide|mesh-list
101969968|NCT05981365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101969969|NCT05981365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101969970|NCT05981365|Antimetabolites|antimetabolites|mesh-ancestor
101969971|NCT05981365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101969972|NCT05981365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101969973|NCT05981365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101969974|NCT05981365|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101969975|NCT05981365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101969976|NCT05981365|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101969977|NCT05981365|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101969978|NCT05981365|Antidepressive Agents|antidepressive agents|mesh-ancestor
101969979|NCT05981365|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101969980|NCT05981365|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101969981|NCT05981365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101969982|NCT05981365|Dopamine Agents|dopamine agents|mesh-ancestor
101969983|NCT05981365|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101969984|NCT05981365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101969985|NCT05981365|Diuretics|diuretics|mesh-ancestor
101969986|NCT05981365|Natriuretic Agents|natriuretic agents|mesh-ancestor
101379627|NCT00260260|Oxycodone|oxycodone|mesh-list
101970617|NCT05374057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101970618|NCT05374057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970619|NCT05374057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101970620|NCT05374057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101970621|NCT05374057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101970622|NCT05374057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101305456|NCT02019485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689468|NCT03861078|Cholinergic Agents|cholinergic agents|mesh-ancestor
101944312|NCT02239900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101944313|NCT02239900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944314|NCT03573934|Glucagon|glucagon|mesh-list
101944315|NCT03573934|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101944316|NCT03573934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101944317|NCT03573934|Hormones|hormones|mesh-ancestor
101944318|NCT03573934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101944319|NCT03573934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944320|NCT03573934|Incretins|incretins|mesh-ancestor
101944321|NCT02229136|Prednisolone|prednisolone|mesh-list
101944322|NCT02229136|Hydrocortisone|hydrocortisone|mesh-list
101944323|NCT02229136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101944324|NCT02229136|Glucocorticoids|glucocorticoids|mesh-ancestor
101944325|NCT02229136|Hormones|hormones|mesh-ancestor
101779014|NCT01064557|Tretinoin|tretinoin|mesh-list
101945968|NCT01151397|Micronutrients|micronutrients|mesh-ancestor
101945969|NCT01151397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945970|NCT01151397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101945971|NCT01151397|Antimetabolites|antimetabolites|mesh-ancestor
101737346|NCT05520177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101969987|NCT05981365|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101969988|NCT05981365|Analgesics|analgesics|mesh-ancestor
101969989|NCT05981365|Sensory System Agents|sensory system agents|mesh-ancestor
101969990|NCT05981365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101969991|NCT05981365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101969992|NCT05981365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101969993|NCT05981365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101969994|NCT05981365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101969995|NCT05981365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101969996|NCT05981209|Dexamethasone|dexamethasone|mesh-list
101969997|NCT05981209|Dexamethasone acetate|dexamethasone acetate|mesh-list
101969998|NCT05981209|Elotuzumab|elotuzumab|mesh-list
101969999|NCT05981209|Ichthammol|ichthammol|mesh-list
101970000|NCT05981209|BB 1101|bb 1101|mesh-list
101970001|NCT05981209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101970002|NCT05981209|Antiemetics|antiemetics|mesh-ancestor
101970003|NCT05981209|Autonomic Agents|autonomic agents|mesh-ancestor
101970004|NCT05981209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101970005|NCT05981209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970006|NCT05981209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101970007|NCT05981209|Glucocorticoids|glucocorticoids|mesh-ancestor
101945972|NCT01151397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945973|NCT01151397|Antiviral Agents|antiviral agents|mesh-ancestor
101689570|NCT04430894|Glucocorticoids|glucocorticoids|mesh-ancestor
101945974|NCT01151397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101945976|NCT01152801|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101945977|NCT01152801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101945978|NCT01152801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101945979|NCT01152801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945980|NCT01152801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101945981|NCT01152801|Immunologic Factors|immunologic factors|mesh-ancestor
101945982|NCT01152801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798514|NCT03966079|Plasminogen|plasminogen|mesh-list
101946623|NCT01267305|Calcium, Dietary|calcium, dietary|mesh-list
101946624|NCT01267305|PENTA|penta|mesh-list
101946625|NCT01267305|Nadroparin|nadroparin|mesh-list
101946626|NCT01267305|Fondaparinux|fondaparinux|mesh-list
101947005|NCT03881943|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101947007|NCT03881943|Antipyretics|antipyretics|mesh-ancestor
101947008|NCT03881943|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101947733|NCT01171833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101947734|NCT01171833|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101947735|NCT01171833|Anesthetics, General|anesthetics, general|mesh-ancestor
101947736|NCT01171833|Anesthetics|anesthetics|mesh-ancestor
101947737|NCT01171833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101947738|NCT01171833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947740|NCT01172769|Temsirolimus|temsirolimus|mesh-list
101947741|NCT01172769|MTOR Inhibitors|mtor inhibitors|mesh-list
101820467|NCT04928820|Edetic Acid|edetic acid|mesh-list
101828214|NCT05907304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828216|NCT05904743|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101828217|NCT05904743|Insulin, Short-Acting|insulin, short-acting|mesh-list
101828218|NCT05904743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101828219|NCT05904743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101828232|NCT05889182|Upadacitinib|upadacitinib|mesh-list
101828233|NCT05889182|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101485508|NCT00345306|Hormones|hormones|mesh-ancestor
101970012|NCT05981209|Protease Inhibitors|protease inhibitors|mesh-ancestor
101970013|NCT05981209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970014|NCT05981209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970015|NCT05981209|Dermatologic Agents|dermatologic agents|mesh-ancestor
101970016|NCT05981118|Betamethasone|betamethasone|mesh-list
101970017|NCT05981118|Betamethasone Valerate|betamethasone valerate|mesh-list
101828445|NCT05631899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949189|NCT05819541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101949191|NCT05803941|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101949192|NCT05803941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949193|NCT05802264|Amphotericin B|amphotericin b|mesh-list
101949194|NCT05802264|Amebicides|amebicides|mesh-ancestor
101949195|NCT05802264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101949196|NCT05802264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101949197|NCT05802264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101949198|NCT05802264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101949199|NCT05802264|Antifungal Agents|antifungal agents|mesh-ancestor
101949200|NCT05800015|Paclitaxel|paclitaxel|mesh-list
101949201|NCT05800015|Carboplatin|carboplatin|mesh-list
101949202|NCT05800015|Pemetrexed|pemetrexed|mesh-list
101949203|NCT05800015|Cemiplimab|cemiplimab|mesh-list
101949204|NCT05800015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101949205|NCT05800015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949206|NCT05800015|Tubulin Modulators|tubulin modulators|mesh-ancestor
101949207|NCT05800015|Antimitotic Agents|antimitotic agents|mesh-ancestor
101949208|NCT05800015|Mitosis Modulators|mitosis modulators|mesh-ancestor
101949209|NCT05800015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949210|NCT05800015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101949211|NCT05800015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101669039|NCT02741154|Luteolytic Agents|luteolytic agents|mesh-ancestor
101949212|NCT05800015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101949213|NCT05800015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101949214|NCT05799144|Pembrolizumab|pembrolizumab|mesh-list
101949215|NCT05799144|Vaccines|vaccines|mesh-list
101949216|NCT05799144|Immunologic Factors|immunologic factors|mesh-ancestor
101949217|NCT05799144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949218|NCT05799144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101949219|NCT05799144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949220|NCT05799144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101949221|NCT05799144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949222|NCT05797870|Ethiodized Oil|ethiodized oil|mesh-list
101949223|NCT05797870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949224|NCT05790213|Androgens|androgens|mesh-list
101949225|NCT05790213|Hormones|hormones|mesh-ancestor
101949226|NCT05790213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101949227|NCT05790213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949388|NCT05471609|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101949389|NCT05471609|Dopamine Agents|dopamine agents|mesh-ancestor
101949390|NCT05471609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101949391|NCT05471609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949392|NCT05471609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949393|NCT05471609|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101949394|NCT05471609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101949395|NCT05410782|Vitamins|vitamins|mesh-list
101949396|NCT05410782|Micronutrients|micronutrients|mesh-ancestor
101949397|NCT05410782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970018|NCT05981118|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101970019|NCT05981118|Betamethasone benzoate|betamethasone benzoate|mesh-list
101970020|NCT05981118|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101970021|NCT05981118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101970022|NCT05981118|Glucocorticoids|glucocorticoids|mesh-ancestor
101970023|NCT05981118|Hormones|hormones|mesh-ancestor
101304950|NCT02016274|Paclitaxel|paclitaxel|mesh-list
101949398|NCT05384262|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101949399|NCT05384262|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101949400|NCT05384262|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101949401|NCT05384262|Antimetabolites|antimetabolites|mesh-ancestor
101949402|NCT05384262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949403|NCT05384262|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101949404|NCT05384262|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101949405|NCT05384262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101949406|NCT05383482|Paclitaxel|paclitaxel|mesh-list
101949407|NCT05383482|Docetaxel|docetaxel|mesh-list
101949408|NCT05383482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101949409|NCT05383482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949410|NCT05383482|Tubulin Modulators|tubulin modulators|mesh-ancestor
101949411|NCT05383482|Antimitotic Agents|antimitotic agents|mesh-ancestor
101949412|NCT05383482|Mitosis Modulators|mitosis modulators|mesh-ancestor
101949413|NCT05383482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949414|NCT05372315|Dexamethasone|dexamethasone|mesh-list
101949415|NCT05372315|Dexamethasone acetate|dexamethasone acetate|mesh-list
101949416|NCT05372315|BB 1101|bb 1101|mesh-list
101949417|NCT05372315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101949418|NCT05372315|Antiemetics|antiemetics|mesh-ancestor
101950159|NCT04196491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950160|NCT04196491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101950161|NCT04196491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101950162|NCT04196491|Alkylating Agents|alkylating agents|mesh-ancestor
101950163|NCT04196491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950164|NCT04196491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101950165|NCT04196491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101950166|NCT04196491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101950167|NCT04196491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101950168|NCT04196491|Growth Substances|growth substances|mesh-ancestor
101950169|NCT04196491|Growth Inhibitors|growth inhibitors|mesh-ancestor
101950171|NCT04182204|Gemcitabine|gemcitabine|mesh-list
101950564|NCT02754765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101689733|NCT02827643|Calcium|calcium|mesh-list
101950565|NCT02754765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101950566|NCT02754765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101950567|NCT02754765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950568|NCT02754765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101950569|NCT02754765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101950570|NCT02754765|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101950571|NCT02754765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101950572|NCT02754765|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101950573|NCT02754765|Antitubercular Agents|antitubercular agents|mesh-ancestor
101950574|NCT02754765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101950575|NCT02754765|Leprostatic Agents|leprostatic agents|mesh-ancestor
101950576|NCT02620007|Ciprofloxacin|ciprofloxacin|mesh-list
101950578|NCT02620007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101950579|NCT02620007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101950580|NCT02620007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101950581|NCT02620007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101950582|NCT02620007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101950583|NCT02620007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950584|NCT02620007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101950585|NCT02620007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101950586|NCT02620007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101950587|NCT02620007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101950588|NCT02586623|Droxidopa|droxidopa|mesh-list
101950589|NCT02586623|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101950590|NCT02586623|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101950591|NCT02537613|Obinutuzumab|obinutuzumab|mesh-list
101950592|NCT02537613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101970024|NCT05981118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101970025|NCT05981118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970026|NCT05981118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101950593|NCT02537613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101950595|NCT02532257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101950596|NCT02532257|Lenalidomide|lenalidomide|mesh-list
101950597|NCT02532257|Antibodies|antibodies|mesh-list
101950598|NCT02532257|Immunoglobulins|immunoglobulins|mesh-list
101950599|NCT02532257|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101950600|NCT02532257|Immunologic Factors|immunologic factors|mesh-ancestor
101950601|NCT02532257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950602|NCT02532257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101950603|NCT02532257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101950604|NCT02532257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101950605|NCT02532257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101950606|NCT02532257|Growth Substances|growth substances|mesh-ancestor
101950607|NCT02532257|Growth Inhibitors|growth inhibitors|mesh-ancestor
101950608|NCT02498613|Misonidazole|misonidazole|mesh-list
101950609|NCT02498613|Olaparib|olaparib|mesh-list
101950610|NCT02498613|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
101950611|NCT02498613|Cediranib|cediranib|mesh-list
101950612|NCT02498613|Maleic acid|maleic acid|mesh-list
101950613|NCT02498613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101950614|NCT02498613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281420|NCT01900938|Midazolam|midazolam|mesh-list
101951025|NCT03854175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951027|NCT03854175|Hormones|hormones|mesh-ancestor
101951028|NCT03854175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101951029|NCT03854175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951030|NCT03854175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101951031|NCT03854175|Contraceptive Agents|contraceptive agents|mesh-ancestor
101951032|NCT03854175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101951033|NCT03854175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101951034|NCT03854175|Vasodilator Agents|vasodilator agents|mesh-ancestor
101951035|NCT03854175|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101951036|NCT03854175|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101951037|NCT03854175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101951038|NCT03854175|Urological Agents|urological agents|mesh-ancestor
101951039|NCT01183611|Vaccines|vaccines|mesh-list
101951040|NCT01183611|Immunologic Factors|immunologic factors|mesh-ancestor
101951041|NCT01183611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951042|NCT01180569|Lenalidomide|lenalidomide|mesh-list
101951043|NCT01180569|Immunologic Factors|immunologic factors|mesh-ancestor
101951044|NCT01180569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951045|NCT01180569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101951046|NCT01180569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101951047|NCT01180569|Growth Substances|growth substances|mesh-ancestor
101951048|NCT01180569|Growth Inhibitors|growth inhibitors|mesh-ancestor
101951049|NCT01180569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101951050|NCT02942264|Temozolomide|temozolomide|mesh-list
101951051|NCT02942264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101951052|NCT02942264|Alkylating Agents|alkylating agents|mesh-ancestor
101951053|NCT02942264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951054|NCT02942264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101951055|NCT01180725|Psyllium|psyllium|mesh-list
101951056|NCT01180725|Cathartics|cathartics|mesh-ancestor
101951057|NCT01180725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101951058|NCT01183767|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
101951059|NCT01183767|Antioxidants|antioxidants|mesh-ancestor
101951060|NCT01183767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951061|NCT01183767|Protective Agents|protective agents|mesh-ancestor
101951062|NCT01183767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951297|NCT01294059|Analgesics|analgesics|mesh-ancestor
101951298|NCT01294059|Sensory System Agents|sensory system agents|mesh-ancestor
101951299|NCT01294059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101951300|NCT01294059|Antidepressive Agents|antidepressive agents|mesh-ancestor
101951301|NCT01294059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101951302|NCT03847155|Nicotine|nicotine|mesh-list
101951303|NCT03847155|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101951304|NCT03847155|Autonomic Agents|autonomic agents|mesh-ancestor
101951305|NCT03847155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101970027|NCT05981118|Respiratory System Agents|respiratory system agents|mesh-ancestor
101970028|NCT05981079|Tazobactam|tazobactam|mesh-list
101970029|NCT05981079|Piperacillin|piperacillin|mesh-list
101970030|NCT05981079|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101951306|NCT03847155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951307|NCT03847155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101951308|NCT03847155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101951309|NCT03847155|Cholinergic Agents|cholinergic agents|mesh-ancestor
101951310|NCT03847155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101951356|NCT01294293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101951357|NCT01294293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101951358|NCT01294293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101951360|NCT01294605|Edetic Acid|edetic acid|mesh-list
101951361|NCT01294605|Pentetic Acid|pentetic acid|mesh-list
101951362|NCT01294605|Antidotes|antidotes|mesh-ancestor
101951363|NCT01294605|Protective Agents|protective agents|mesh-ancestor
101951364|NCT01294605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951365|NCT01294605|Chelating Agents|chelating agents|mesh-ancestor
101951366|NCT01294605|Sequestering Agents|sequestering agents|mesh-ancestor
101951367|NCT01294605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951368|NCT01294605|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101951369|NCT01294605|Anticoagulants|anticoagulants|mesh-ancestor
101951370|NCT01294605|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101951371|NCT01294761|Raltegravir Potassium|raltegravir potassium|mesh-list
101951372|NCT01294761|Darunavir|darunavir|mesh-list
101951389|NCT03305666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101951390|NCT03305666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951391|NCT03305666|Sensory System Agents|sensory system agents|mesh-ancestor
101951392|NCT03305666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101951393|NCT01194843|Ropivacaine|ropivacaine|mesh-list
101951394|NCT01194843|Anesthetics, Local|anesthetics, local|mesh-ancestor
101951395|NCT01194843|Anesthetics|anesthetics|mesh-ancestor
101951396|NCT01194843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101951397|NCT01194843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951398|NCT01194843|Sensory System Agents|sensory system agents|mesh-ancestor
101951399|NCT01194843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101951400|NCT01297023|Calcium, Dietary|calcium, dietary|mesh-list
101951402|NCT01297023|Ergocalciferols|ergocalciferols|mesh-list
101951403|NCT01297023|Cholecalciferol|cholecalciferol|mesh-list
101951404|NCT01297023|Vitamins|vitamins|mesh-list
101951405|NCT01297023|Calcium|calcium|mesh-list
101951406|NCT01297023|Micronutrients|micronutrients|mesh-ancestor
101951407|NCT01297023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951408|NCT01297023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101951409|NCT01297023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101951410|NCT03846843|Phenylacetic acid|phenylacetic acid|mesh-list
101951411|NCT03846843|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101951412|NCT03846843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101951413|NCT03846843|Antimetabolites|antimetabolites|mesh-ancestor
101951414|NCT03846843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951415|NCT03846843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101951416|NCT01297101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101951417|NCT01297101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101951418|NCT01297101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101951419|NCT01297101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101951420|NCT01297101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951421|NCT04781426|Tenofovir|tenofovir|mesh-list
101951422|NCT04781426|Lamivudine|lamivudine|mesh-list
101951423|NCT04781426|Antiviral Agents|antiviral agents|mesh-ancestor
101951424|NCT04781426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101951425|NCT04781426|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101951426|NCT04781426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101951427|NCT04781426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101951428|NCT04781426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951429|NCT04781426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101951430|NCT04781426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101951431|NCT01292031|Meropenem|meropenem|mesh-list
101951432|NCT01292031|Colistin|colistin|mesh-list
101951433|NCT01292031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101951434|NCT01292031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101951466|NCT01191645|Naloxone|naloxone|mesh-list
101951467|NCT01191645|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101951468|NCT01191645|Narcotics|narcotics|mesh-ancestor
101970031|NCT05981079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101970032|NCT05981079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101970033|NCT05981079|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101970034|NCT05981079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101971977|NCT01339676|Vitamin D|vitamin d|mesh-list
101951469|NCT01191645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101951470|NCT01191645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951471|NCT01191645|Analgesics|analgesics|mesh-ancestor
101951472|NCT01191645|Sensory System Agents|sensory system agents|mesh-ancestor
101951473|NCT01191645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101951474|NCT01191645|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101951475|NCT01191645|Antiemetics|antiemetics|mesh-ancestor
101951476|NCT01191645|Autonomic Agents|autonomic agents|mesh-ancestor
101951477|NCT01191645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101951478|NCT01191645|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101286201|NCT01939574|Bevacizumab|bevacizumab|mesh-list
101951516|NCT01295307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951517|NCT01295307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101951518|NCT01292343|Listerine|listerine|mesh-list
101951519|NCT01292343|Triclosan|triclosan|mesh-list
101951817|NCT05671497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101951818|NCT03915626|Rivastigmine|rivastigmine|mesh-list
101951819|NCT03915626|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101951820|NCT03915626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101951821|NCT03915626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951822|NCT03915626|Cholinergic Agents|cholinergic agents|mesh-ancestor
101951823|NCT03915626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101951824|NCT03915626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951825|NCT03915626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101951826|NCT03915626|Protective Agents|protective agents|mesh-ancestor
101951827|NCT04491968|Methadone|methadone|mesh-list
101951828|NCT04491968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101951829|NCT04491968|Narcotics|narcotics|mesh-ancestor
101951830|NCT04491968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101951831|NCT04491968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951832|NCT04491968|Analgesics|analgesics|mesh-ancestor
101951833|NCT04491968|Sensory System Agents|sensory system agents|mesh-ancestor
101951834|NCT04491968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101951835|NCT04491968|Antitussive Agents|antitussive agents|mesh-ancestor
101951836|NCT04491968|Respiratory System Agents|respiratory system agents|mesh-ancestor
101951837|NCT03313076|Vitamin D|vitamin d|mesh-list
101951838|NCT03313076|Ergocalciferols|ergocalciferols|mesh-list
101951839|NCT03313076|Cholecalciferol|cholecalciferol|mesh-list
101951840|NCT03313076|Vitamins|vitamins|mesh-list
101951841|NCT03313076|Micronutrients|micronutrients|mesh-ancestor
101951842|NCT03313076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951843|NCT03313076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101951844|NCT03313076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101951845|NCT01191021|Propofol|propofol|mesh-list
101951846|NCT01191021|Anesthetics|anesthetics|mesh-ancestor
101951847|NCT01191021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101951848|NCT01191021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951849|NCT01191021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101951850|NCT01191021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101951851|NCT01191021|Anesthetics, General|anesthetics, general|mesh-ancestor
101951852|NCT01200537|Norinyl|norinyl|mesh-list
101951853|NCT01200537|Contraceptive Agents|contraceptive agents|mesh-list
101951854|NCT01200537|Contraceptives, Oral|contraceptives, oral|mesh-list
101951855|NCT01200537|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
101951856|NCT01200537|Estradiol|estradiol|mesh-list
101951857|NCT01200537|Estrogens|estrogens|mesh-ancestor
101951858|NCT01200537|Hormones|hormones|mesh-ancestor
101951859|NCT01200537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101951860|NCT01200537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951861|NCT01200537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101951862|NCT01200537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101951863|NCT01200537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101951864|NCT01200537|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101951865|NCT01198353|Ziprasidone|ziprasidone|mesh-list
101951866|NCT01198353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101951867|NCT01198353|Serotonin Agents|serotonin agents|mesh-ancestor
101951868|NCT01198353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101970035|NCT05981079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970037|NCT05981053|Antioxidants|antioxidants|mesh-ancestor
101970038|NCT05981053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970039|NCT05981053|Protective Agents|protective agents|mesh-ancestor
101970040|NCT05981053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970041|NCT05981053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101951869|NCT01198353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951870|NCT01198353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951871|NCT01198353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101951872|NCT01198353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101951873|NCT01198353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101951874|NCT01198353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101951875|NCT01198353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101951876|NCT01198353|Dopamine Agents|dopamine agents|mesh-ancestor
101951877|NCT01200693|Sirolimus|sirolimus|mesh-list
101951878|NCT01200693|Everolimus|everolimus|mesh-list
101951879|NCT01200693|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101951880|NCT01200693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101951881|NCT01200693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101951882|NCT01200693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951883|NCT01200693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101951884|NCT01200693|Immunologic Factors|immunologic factors|mesh-ancestor
101952150|NCT01566825|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101952151|NCT01566825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101671958|NCT04395079|Durvalumab|durvalumab|mesh-list
101952152|NCT01566825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101952153|NCT01566825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952154|NCT01566825|Adrenergic Agents|adrenergic agents|mesh-ancestor
101952155|NCT01566825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101689862|NCT04244591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101952157|NCT03559010|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101952158|NCT03559010|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101952159|NCT03559010|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101952160|NCT03559010|Contraceptive Agents|contraceptive agents|mesh-ancestor
101952161|NCT03559010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101952162|NCT03559010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952211|NCT03838029|Analgesics|analgesics|mesh-ancestor
101952212|NCT03838029|Sensory System Agents|sensory system agents|mesh-ancestor
101952213|NCT03838029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101952214|NCT03838029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101952215|NCT03838029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101952216|NCT03838029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101952217|NCT03838029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101952218|NCT03838029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101952219|NCT04708340|Ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium D-pantothenate drug combination|ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium d-pantothenate drug combination|mesh-list
101952220|NCT04708340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101952221|NCT04708340|Antioxidants|antioxidants|mesh-ancestor
101952311|NCT02633241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952312|NCT02633241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101952313|NCT02633241|Anesthetics, General|anesthetics, general|mesh-ancestor
101952314|NCT02633241|Anesthetics|anesthetics|mesh-ancestor
101952315|NCT03292016|Apomorphine|apomorphine|mesh-list
101952316|NCT03292016|Emetics|emetics|mesh-ancestor
101952317|NCT03292016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952318|NCT03292016|Autonomic Agents|autonomic agents|mesh-ancestor
101952319|NCT03292016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101952320|NCT03292016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101952321|NCT03292016|Dopamine Agonists|dopamine agonists|mesh-ancestor
101952322|NCT03292016|Dopamine Agents|dopamine agents|mesh-ancestor
101952323|NCT03292016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101952324|NCT03292016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952325|NCT05669391|Antidepressive Agents|antidepressive agents|mesh-list
101952326|NCT05669391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101970042|NCT05981053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101970043|NCT05981014|Paclitaxel|paclitaxel|mesh-list
101970044|NCT05981014|Cyclophosphamide|cyclophosphamide|mesh-list
101970045|NCT05981014|Doxorubicin|doxorubicin|mesh-list
101952327|NCT01206075|Plerixafor|plerixafor|mesh-list
101952328|NCT01206075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101293176|NCT01967758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101952558|NCT03840057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101952559|NCT03840057|Antiemetics|antiemetics|mesh-ancestor
101952560|NCT03840057|Autonomic Agents|autonomic agents|mesh-ancestor
101952561|NCT03840057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101952562|NCT03840057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952563|NCT03840057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101952564|NCT03840057|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101952565|NCT03840057|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101952567|NCT03840057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101296284|NCT01990755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101952568|NCT03840057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952569|NCT01297803|Mitomycins|mitomycins|mesh-list
101952570|NCT01297803|Mitomycin|mitomycin|mesh-list
101952571|NCT01297803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101952572|NCT01297803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101689876|NCT04167696|Fludarabine|fludarabine|mesh-list
101952573|NCT01297803|Alkylating Agents|alkylating agents|mesh-ancestor
101952574|NCT01297803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952575|NCT01297803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101952576|NCT01297803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101952577|NCT03824691|Durvalumab|durvalumab|mesh-list
101952578|NCT03824691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101952579|NCT03824691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101952580|NCT01299831|Hormones|hormones|mesh-list
101296485|NCT01992198|Metronidazole|metronidazole|mesh-list
101952581|NCT01299831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101952582|NCT01299831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952583|NCT01205997|Magnesium Sulfate|magnesium sulfate|mesh-list
101952584|NCT01205997|Fentanyl|fentanyl|mesh-list
101952585|NCT01205997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101952587|NCT01205997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101296633|NCT01993251|Melatonin|melatonin|mesh-list
101952588|NCT01205997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952589|NCT01205997|Analgesics|analgesics|mesh-ancestor
101952590|NCT01205997|Sensory System Agents|sensory system agents|mesh-ancestor
101952591|NCT01205997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101952592|NCT01205997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101952593|NCT01205997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101952594|NCT01205997|Anesthetics, General|anesthetics, general|mesh-ancestor
101952595|NCT01205997|Anesthetics|anesthetics|mesh-ancestor
101952596|NCT01205997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101672404|NCT03267836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101952597|NCT01205997|Anticonvulsants|anticonvulsants|mesh-ancestor
101952598|NCT01205997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101952599|NCT01205997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101952600|NCT01205997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952601|NCT01205997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101952602|NCT01205997|Tocolytic Agents|tocolytic agents|mesh-ancestor
101952603|NCT01205997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101952605|NCT03818997|Atezolizumab|atezolizumab|mesh-list
101952606|NCT03818997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101296996|NCT01996085|Amlodipine|amlodipine|mesh-list
101952608|NCT03818997|Tubulin Modulators|tubulin modulators|mesh-ancestor
101952609|NCT03818997|Antimitotic Agents|antimitotic agents|mesh-ancestor
101952610|NCT03818997|Mitosis Modulators|mitosis modulators|mesh-ancestor
101952611|NCT03818997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952612|NCT03818997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101952613|NCT03818997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101952615|NCT03818919|Celecoxib|celecoxib|mesh-list
101952616|NCT03818919|Ketorolac|ketorolac|mesh-list
101952617|NCT03818919|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
101952618|NCT03818919|Diazepam|diazepam|mesh-list
101952619|NCT03818919|Gabapentin|gabapentin|mesh-list
101952620|NCT03818919|Hydrocodone|hydrocodone|mesh-list
101952621|NCT03818919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101952622|NCT03818919|Analgesics|analgesics|mesh-ancestor
101952623|NCT03818919|Sensory System Agents|sensory system agents|mesh-ancestor
101297208|NCT01997099|Anesthetics|anesthetics|mesh-ancestor
101970046|NCT05981014|Fludarabine|fludarabine|mesh-list
101970047|NCT05981014|Interleukin-2|interleukin-2|mesh-list
101970048|NCT05981014|Epirubicin|epirubicin|mesh-list
101970049|NCT05981014|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101952624|NCT03818919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101952625|NCT03818919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952626|NCT03818919|Antipyretics|antipyretics|mesh-ancestor
101952627|NCT03818919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101297345|NCT01997983|Cholinergic Agents|cholinergic agents|mesh-ancestor
101952628|NCT03818919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101952629|NCT03818919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101952630|NCT03818919|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101952631|NCT03818919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101952632|NCT03818919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101952633|NCT03818919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952635|NCT03818919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101952636|NCT03818919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101952637|NCT03818919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101952638|NCT03818919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101952639|NCT03818919|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101952640|NCT03818919|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101952641|NCT03818919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101952642|NCT03818919|Antimanic Agents|antimanic agents|mesh-ancestor
101952643|NCT03818919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101952644|NCT03818919|Narcotics|narcotics|mesh-ancestor
101952645|NCT03818919|Antitussive Agents|antitussive agents|mesh-ancestor
101297716|NCT02000765|Gepotidacin|gepotidacin|mesh-list
101952646|NCT03818919|Respiratory System Agents|respiratory system agents|mesh-ancestor
101952647|NCT03818919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101952648|NCT03818919|Antiemetics|antiemetics|mesh-ancestor
101952649|NCT03818919|Autonomic Agents|autonomic agents|mesh-ancestor
101952650|NCT03818919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101952651|NCT03818919|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101297864|NCT02001584|Memantine|memantine|mesh-list
101952652|NCT03818919|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101952653|NCT03818919|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101952654|NCT03818919|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101952655|NCT03818919|Anesthetics, General|anesthetics, general|mesh-ancestor
101952656|NCT03818919|Anesthetics|anesthetics|mesh-ancestor
101952657|NCT03818919|GABA Modulators|gaba modulators|mesh-ancestor
101952658|NCT03818919|GABA Agents|gaba agents|mesh-ancestor
101952659|NCT03821493|Itraconazole|itraconazole|mesh-list
101952660|NCT03821493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101952661|NCT03821493|Antifungal Agents|antifungal agents|mesh-ancestor
101952662|NCT03821493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101298003|NCT02002195|Antidotes|antidotes|mesh-ancestor
101952663|NCT03821493|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101952664|NCT03821493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101952665|NCT03821493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101952666|NCT03821493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952667|NCT03821493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101952668|NCT03821493|Hormone Antagonists|hormone antagonists|mesh-ancestor
101952669|NCT03821493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101952670|NCT03821493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952671|NCT03821493|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101298138|NCT02002741|Acetaminophen|acetaminophen|mesh-list
101952672|NCT01301937|Meglumine Antimoniate|meglumine antimoniate|mesh-list
101952673|NCT01301937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101952674|NCT01301937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101952675|NCT01301937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101952676|NCT05618223|Dapagliflozin|dapagliflozin|mesh-list
101952677|NCT05618223|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101952678|NCT05618223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952679|NCT05618223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101952680|NCT05618223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952682|NCT03814629|Micronutrients|micronutrients|mesh-ancestor
101952683|NCT03814629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952684|NCT01585935|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101952685|NCT01585935|SMOFlipid|smoflipid|mesh-list
101952686|NCT01585935|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101952687|NCT01585935|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101952688|NCT01585935|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101970050|NCT05981014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970051|NCT05981014|Tubulin Modulators|tubulin modulators|mesh-ancestor
101970052|NCT05981014|Antimitotic Agents|antimitotic agents|mesh-ancestor
101952689|NCT01300377|Lidocaine|lidocaine|mesh-list
101952690|NCT01300377|Bupivacaine|bupivacaine|mesh-list
101952691|NCT01300377|Anesthetics, Local|anesthetics, local|mesh-ancestor
101952692|NCT01300377|Anesthetics|anesthetics|mesh-ancestor
101952693|NCT01300377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101952694|NCT01300377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952695|NCT01300377|Sensory System Agents|sensory system agents|mesh-ancestor
101952696|NCT01300377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101952697|NCT01300377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101952698|NCT01300377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101952699|NCT01300377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101952700|NCT01300377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101952701|NCT01300377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952702|NCT03814707|Hyaluronic Acid|hyaluronic acid|mesh-list
101952703|NCT03814707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101952704|NCT03814707|Immunologic Factors|immunologic factors|mesh-ancestor
101952705|NCT03814707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952706|NCT03814707|Viscosupplements|viscosupplements|mesh-ancestor
101952707|NCT03814707|Protective Agents|protective agents|mesh-ancestor
101952708|NCT03818295|Praliciguat|praliciguat|mesh-list
101298551|NCT02006043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101952709|NCT03818295|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
101952710|NCT03818295|Enzyme Activators|enzyme activators|mesh-ancestor
101952711|NCT03818295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952712|NCT03818295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101952713|NCT01300611|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
101952714|NCT01300611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101952715|NCT01300611|Vasodilator Agents|vasodilator agents|mesh-ancestor
101952716|NCT01301313|Simendan|simendan|mesh-list
101952717|NCT01301313|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101298693|NCT05970250|Calcium|calcium|mesh-list
101952718|NCT01301313|Vasodilator Agents|vasodilator agents|mesh-ancestor
101952719|NCT01301313|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101952720|NCT01301313|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101952721|NCT01301313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101952722|NCT01301313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952723|NCT01301313|Protective Agents|protective agents|mesh-ancestor
101952724|NCT01301313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952725|NCT03817359|Remifentanil|remifentanil|mesh-list
101952726|NCT03817359|Propofol|propofol|mesh-list
101952727|NCT03817359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101952728|NCT03817359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101952729|NCT03817359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952730|NCT03817359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101952731|NCT03817359|Anesthetics, General|anesthetics, general|mesh-ancestor
101952732|NCT03817359|Anesthetics|anesthetics|mesh-ancestor
101952733|NCT03817359|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101952734|NCT03817359|Narcotics|narcotics|mesh-ancestor
101952735|NCT03817359|Analgesics|analgesics|mesh-ancestor
101952736|NCT03817359|Sensory System Agents|sensory system agents|mesh-ancestor
101952737|NCT03817359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101952738|NCT03813927|Vitamin D|vitamin d|mesh-list
101952739|NCT03813927|Vitamins|vitamins|mesh-ancestor
101952740|NCT03813927|Micronutrients|micronutrients|mesh-ancestor
101952741|NCT03813927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952742|NCT03813927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101952743|NCT02819518|Paclitaxel|paclitaxel|mesh-list
101952744|NCT02819518|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101952745|NCT02819518|Carboplatin|carboplatin|mesh-list
101952746|NCT02819518|Gemcitabine|gemcitabine|mesh-list
101952747|NCT02819518|Pembrolizumab|pembrolizumab|mesh-list
101952748|NCT02819518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101952749|NCT02819518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101952750|NCT02819518|Tubulin Modulators|tubulin modulators|mesh-ancestor
101952751|NCT02819518|Antimitotic Agents|antimitotic agents|mesh-ancestor
101952752|NCT02819518|Mitosis Modulators|mitosis modulators|mesh-ancestor
101952753|NCT02819518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952754|NCT02819518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101952755|NCT02819518|Antimetabolites|antimetabolites|mesh-ancestor
101952756|NCT02819518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101299026|NCT05958875|Clozapine|clozapine|mesh-list
101970053|NCT05981014|Mitosis Modulators|mitosis modulators|mesh-ancestor
101970054|NCT05981014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970055|NCT05981014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101970056|NCT05981014|Immunologic Factors|immunologic factors|mesh-ancestor
101952757|NCT02819518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101952759|NCT03310580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101952760|NCT03813771|Hydroxychloroquine|hydroxychloroquine|mesh-list
101952761|NCT03813771|Sulfasalazine|sulfasalazine|mesh-list
101952762|NCT03813771|Etanercept|etanercept|mesh-list
101952763|NCT03813771|Methotrexate|methotrexate|mesh-list
101952764|NCT03813771|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101952765|NCT03813771|Abortifacient Agents|abortifacient agents|mesh-ancestor
101952766|NCT03813771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101952767|NCT03813771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952768|NCT03813771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101952769|NCT03813771|Antimetabolites|antimetabolites|mesh-ancestor
101299221|NCT05882214|Niacin|niacin|mesh-list
101952770|NCT03813771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952771|NCT03813771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101952772|NCT03813771|Dermatologic Agents|dermatologic agents|mesh-ancestor
101952773|NCT03813771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101952774|NCT03813771|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101952775|NCT03813771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101952776|NCT03813771|Immunologic Factors|immunologic factors|mesh-ancestor
101952777|NCT03813771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101952778|NCT03813771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101952779|NCT03813771|Antimalarials|antimalarials|mesh-ancestor
101952780|NCT03813771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101952781|NCT03813771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101952782|NCT03813771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101952783|NCT03813771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101952784|NCT03813771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101952785|NCT03813771|Analgesics|analgesics|mesh-ancestor
101952786|NCT03813771|Sensory System Agents|sensory system agents|mesh-ancestor
101952787|NCT03813771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101952788|NCT03813771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101952789|NCT03813771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101952790|NCT03813693|Chlorhexidine|chlorhexidine|mesh-list
101952791|NCT03813693|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101952792|NCT03813693|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101952793|NCT03813693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101952794|NCT03813693|Disinfectants|disinfectants|mesh-ancestor
101952795|NCT03813693|Dermatologic Agents|dermatologic agents|mesh-ancestor
101952796|NCT02036242|Sufentanil|sufentanil|mesh-list
101952797|NCT02036242|Ropivacaine|ropivacaine|mesh-list
101952798|NCT02036242|Anesthetics, Local|anesthetics, local|mesh-list
101952799|NCT02036242|Anesthetics|anesthetics|mesh-list
101952800|NCT02036242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101952801|NCT02036242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952802|NCT02036242|Sensory System Agents|sensory system agents|mesh-ancestor
101952803|NCT02036242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101952804|NCT02036242|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101952805|NCT02036242|Narcotics|narcotics|mesh-ancestor
101952806|NCT02036242|Analgesics|analgesics|mesh-ancestor
101952807|NCT02036242|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101952808|NCT02036242|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101952809|NCT02036242|Anesthetics, General|anesthetics, general|mesh-ancestor
101952810|NCT05281107|Calcium, Dietary|calcium, dietary|mesh-list
101952811|NCT05281107|Vitamin D|vitamin d|mesh-list
101952812|NCT05281107|Ergocalciferols|ergocalciferols|mesh-list
101952813|NCT05281107|Cholecalciferol|cholecalciferol|mesh-list
101952814|NCT05281107|Vitamins|vitamins|mesh-list
101952815|NCT05281107|Calcium|calcium|mesh-list
101952816|NCT05281107|Micronutrients|micronutrients|mesh-ancestor
101952817|NCT05281107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952818|NCT05281107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101952819|NCT05281107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101952820|NCT02812186|Rocuronium|rocuronium|mesh-list
101952821|NCT02812186|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101952822|NCT02812186|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101952823|NCT02812186|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101952824|NCT02812186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101952825|NCT02812186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970057|NCT05981014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970058|NCT05981014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101970059|NCT05981014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101970060|NCT05981014|Alkylating Agents|alkylating agents|mesh-ancestor
101970061|NCT05981014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101952827|NCT03310268|Fluorides|fluorides|mesh-list
101952829|NCT03310268|Tin Fluorides|tin fluorides|mesh-list
101952830|NCT03310268|Fluorophosphate|fluorophosphate|mesh-list
101952831|NCT03310268|Cariostatic Agents|cariostatic agents|mesh-ancestor
101952832|NCT03310268|Protective Agents|protective agents|mesh-ancestor
101952833|NCT03310268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952834|NCT03310268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101952835|NCT03310268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101952836|NCT01301469|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101952837|NCT02810392|Insulin|insulin|mesh-list
101952838|NCT02810392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101952839|NCT02810392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101299983|NCT05291221|Analgesics|analgesics|mesh-ancestor
101952840|NCT02810392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952841|NCT03805035|Chlorpheniramine|chlorpheniramine|mesh-list
101952842|NCT03805035|Maleic acid|maleic acid|mesh-list
101952843|NCT03805035|Histamine Antagonists|histamine antagonists|mesh-list
101952844|NCT03805035|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
101952845|NCT03805035|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
101952846|NCT03805035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101952847|NCT03805035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952848|NCT03805035|Histamine Agents|histamine agents|mesh-ancestor
101952849|NCT03805035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101952850|NCT03805035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952851|NCT03805035|Antipruritics|antipruritics|mesh-ancestor
101952852|NCT03805035|Dermatologic Agents|dermatologic agents|mesh-ancestor
101952853|NCT03805035|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101952854|NCT02815540|Cannabidiol|cannabidiol|mesh-list
101952855|NCT02815540|Anticonvulsants|anticonvulsants|mesh-ancestor
101952856|NCT03816267|Albuterol|albuterol|mesh-list
101952857|NCT03816267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101952858|NCT03816267|Autonomic Agents|autonomic agents|mesh-ancestor
101300194|NCT05020860|Doxorubicin|doxorubicin|mesh-list
101952859|NCT03816267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101952860|NCT03816267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952861|NCT03816267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101952862|NCT03816267|Respiratory System Agents|respiratory system agents|mesh-ancestor
101952863|NCT03816267|Tocolytic Agents|tocolytic agents|mesh-ancestor
101952864|NCT03816267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101952865|NCT03816267|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101952866|NCT03816267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101952867|NCT03816267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101300342|NCT04901299|Fulvestrant|fulvestrant|mesh-list
101952868|NCT03816267|Adrenergic Agents|adrenergic agents|mesh-ancestor
101952869|NCT03816267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101952870|NCT03816267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952871|NCT03280550|Omalizumab|omalizumab|mesh-list
101952872|NCT03280550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101952873|NCT03280550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101952874|NCT03280550|Respiratory System Agents|respiratory system agents|mesh-ancestor
101952875|NCT02036554|Mycophenolic Acid|mycophenolic acid|mesh-list
101952877|NCT02036554|Tacrolimus|tacrolimus|mesh-list
101952878|NCT02036554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101952879|NCT02036554|Immunologic Factors|immunologic factors|mesh-ancestor
101952880|NCT02036554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952881|NCT02036554|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101952882|NCT02036554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101952883|NCT02036554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952885|NCT02036554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101952886|NCT02036554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101952887|NCT02036554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101952888|NCT02036554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101952889|NCT02036554|Antitubercular Agents|antitubercular agents|mesh-ancestor
101952890|NCT02036554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101952891|NCT02036554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101952893|NCT05577117|Dexmedetomidine|dexmedetomidine|mesh-list
101689966|NCT00652002|Budesonide|budesonide|mesh-list
101970063|NCT05981014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101970064|NCT05981014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101970065|NCT05981014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970066|NCT05981014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101970067|NCT05981014|Analgesics|analgesics|mesh-ancestor
101970068|NCT05981014|Sensory System Agents|sensory system agents|mesh-ancestor
101970069|NCT05981014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101970070|NCT05981001|Paclitaxel|paclitaxel|mesh-list
101970071|NCT05981001|Cyclophosphamide|cyclophosphamide|mesh-list
101970072|NCT05981001|Carboplatin|carboplatin|mesh-list
101970073|NCT05981001|Gemcitabine|gemcitabine|mesh-list
101970074|NCT05981001|Fludarabine|fludarabine|mesh-list
101970075|NCT05981001|Interleukin-2|interleukin-2|mesh-list
101970076|NCT05981001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101970077|NCT05981001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970078|NCT05981001|Tubulin Modulators|tubulin modulators|mesh-ancestor
101970079|NCT05981001|Antimitotic Agents|antimitotic agents|mesh-ancestor
101970080|NCT05981001|Mitosis Modulators|mitosis modulators|mesh-ancestor
101304988|NCT02016417|Cisplatin|cisplatin|mesh-list
101952894|NCT05577117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101300737|NCT04429022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101952895|NCT05577117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101952896|NCT05577117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952897|NCT05577117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101952898|NCT05577117|Analgesics|analgesics|mesh-ancestor
101952899|NCT05577117|Sensory System Agents|sensory system agents|mesh-ancestor
101952900|NCT05577117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101952901|NCT05577117|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101300880|NCT04254081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101952902|NCT05577117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101952903|NCT05577117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101952904|NCT05577117|Adrenergic Agents|adrenergic agents|mesh-ancestor
101952906|NCT05577117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301024|NCT04106115|Durvalumab|durvalumab|mesh-list
101952907|NCT05577117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101952909|NCT05577117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101952910|NCT05577117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101952912|NCT05577117|Anesthetics|anesthetics|mesh-ancestor
101952913|NCT03813303|Fentanyl|fentanyl|mesh-list
101952914|NCT03813303|Midazolam|midazolam|mesh-list
101952915|NCT03813303|Propofol|propofol|mesh-list
101952916|NCT03813303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101952917|NCT03813303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101952918|NCT03813303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952919|NCT03813303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101952920|NCT03813303|Anesthetics, General|anesthetics, general|mesh-ancestor
101952921|NCT03813303|Anesthetics|anesthetics|mesh-ancestor
101952922|NCT03813303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101952923|NCT03813303|Narcotics|narcotics|mesh-ancestor
101952924|NCT03813303|Analgesics|analgesics|mesh-ancestor
101301317|NCT03830866|Durvalumab|durvalumab|mesh-list
101952925|NCT03813303|Sensory System Agents|sensory system agents|mesh-ancestor
101952926|NCT03813303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101952927|NCT03813303|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101952928|NCT03813303|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101952929|NCT03813303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101952930|NCT03813303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101952932|NCT03813303|GABA Agents|gaba agents|mesh-ancestor
101970081|NCT05981001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970082|NCT05981001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101970083|NCT05981001|Immunologic Factors|immunologic factors|mesh-ancestor
101952933|NCT03813303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101952934|NCT03813303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952935|NCT03637790|Rifampin|rifampin|mesh-list
101952936|NCT03637790|Abrocitinib|abrocitinib|mesh-list
101952937|NCT03637790|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101952938|NCT03637790|Antitubercular Agents|antitubercular agents|mesh-ancestor
101952939|NCT03637790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101952940|NCT03637790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101952941|NCT03637790|Leprostatic Agents|leprostatic agents|mesh-ancestor
101952942|NCT03637790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101952943|NCT03637790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101952944|NCT03637790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952945|NCT03637790|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101952946|NCT03637790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101952947|NCT03637790|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101952948|NCT03637790|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101952949|NCT03637790|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101952950|NCT03637790|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101952951|NCT03637790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101952953|NCT03813069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101952954|NCT03813069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952955|NCT03276026|Neostigmine|neostigmine|mesh-list
101952956|NCT03276026|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101952957|NCT03276026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101952958|NCT03276026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952959|NCT03276026|Cholinergic Agents|cholinergic agents|mesh-ancestor
101301697|NCT02936622|Paclitaxel|paclitaxel|mesh-list
101952960|NCT03276026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101952961|NCT03276026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952963|NCT03276026|Autonomic Agents|autonomic agents|mesh-ancestor
101952964|NCT03276026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101952965|NCT01303497|Paclitaxel|paclitaxel|mesh-list
101952966|NCT01303497|Bevacizumab|bevacizumab|mesh-list
101952967|NCT01303497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101952968|NCT01303497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101952969|NCT01303497|Tubulin Modulators|tubulin modulators|mesh-ancestor
101952970|NCT01303497|Antimitotic Agents|antimitotic agents|mesh-ancestor
101952971|NCT01303497|Mitosis Modulators|mitosis modulators|mesh-ancestor
101301764|NCT02913196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101952972|NCT01303497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952973|NCT01303497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101952974|NCT01303497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101952975|NCT01303497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101952976|NCT01303497|Growth Substances|growth substances|mesh-ancestor
101672786|NCT00082797|Leucovorin|leucovorin|mesh-list
101952977|NCT01303497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952978|NCT01303497|Growth Inhibitors|growth inhibitors|mesh-ancestor
101301900|NCT02744690|Mitomycins|mitomycins|mesh-list
101952979|NCT01589523|Cholic Acids|cholic acids|mesh-list
101952980|NCT01589523|Glycocholic Acid|glycocholic acid|mesh-list
101952981|NCT01589523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101952982|NCT01589523|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101952985|NCT03804177|Hyaluronic Acid|hyaluronic acid|mesh-list
101952986|NCT03804177|Antioxidants|antioxidants|mesh-ancestor
101952987|NCT03804177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952988|NCT03804177|Protective Agents|protective agents|mesh-ancestor
101952989|NCT03804177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952990|NCT03804177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101952991|NCT03804177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101952992|NCT03804177|Immunologic Factors|immunologic factors|mesh-ancestor
101952993|NCT03804177|Viscosupplements|viscosupplements|mesh-ancestor
101952994|NCT03804177|Vitamins|vitamins|mesh-ancestor
101952995|NCT03804177|Micronutrients|micronutrients|mesh-ancestor
101952996|NCT03277352|Pembrolizumab|pembrolizumab|mesh-list
101952997|NCT03277352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101952998|NCT03277352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101952999|NCT03277352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101970084|NCT05981001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970085|NCT05981001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101970086|NCT05981001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101953000|NCT03277352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953001|NCT01302093|Racecadotril|racecadotril|mesh-list
101953002|NCT01302093|Thiorphan|thiorphan|mesh-list
101953003|NCT01302093|Antidiarrheals|antidiarrheals|mesh-ancestor
101953004|NCT01302093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101953005|NCT01302093|Protease Inhibitors|protease inhibitors|mesh-ancestor
101953006|NCT01302093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101302405|NCT00977574|Sirolimus|sirolimus|mesh-list
101953007|NCT01302093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953008|NCT03803007|Glenzocimab|glenzocimab|mesh-list
101953009|NCT03803007|Anticoagulants|anticoagulants|mesh-ancestor
101953010|NCT03802149|Ulipristal acetate|ulipristal acetate|mesh-list
101953011|NCT03802149|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101953012|NCT03802149|Contraceptive Agents|contraceptive agents|mesh-ancestor
101953013|NCT03802149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101953014|NCT03802149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953015|NCT03802149|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101953016|NCT02047552|Iron|iron|mesh-list
101953017|NCT02047552|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101953018|NCT02047552|Oxandrolone|oxandrolone|mesh-list
101953019|NCT02047552|Trace Elements|trace elements|mesh-ancestor
101953020|NCT02047552|Micronutrients|micronutrients|mesh-ancestor
101953021|NCT02047552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953022|NCT02047552|Hematinics|hematinics|mesh-ancestor
101953024|NCT02047552|Hormones|hormones|mesh-ancestor
101953025|NCT02047552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101953026|NCT02047552|Anabolic Agents|anabolic agents|mesh-ancestor
101953027|NCT01303731|Fentanyl|fentanyl|mesh-list
101953028|NCT01303731|Bupivacaine|bupivacaine|mesh-list
101953029|NCT01303731|Anesthetics, Local|anesthetics, local|mesh-ancestor
101953030|NCT01303731|Anesthetics|anesthetics|mesh-ancestor
101953031|NCT01303731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101302837|NCT02008019|Immunologic Factors|immunologic factors|mesh-ancestor
101953032|NCT01303731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302911|NCT02008461|Cholinergic Agents|cholinergic agents|mesh-ancestor
101953033|NCT01303731|Sensory System Agents|sensory system agents|mesh-ancestor
101953034|NCT01303731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101953035|NCT01303731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101953036|NCT01303731|Narcotics|narcotics|mesh-ancestor
101953037|NCT01303731|Analgesics|analgesics|mesh-ancestor
101953038|NCT01303731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101953039|NCT01303731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101953040|NCT01303731|Anesthetics, General|anesthetics, general|mesh-ancestor
101953041|NCT03815487|Insulin|insulin|mesh-list
101953042|NCT03815487|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101303131|NCT05777122|Lidocaine|lidocaine|mesh-list
101953043|NCT03815487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101953044|NCT03815487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953045|NCT03815422|Anesthetics|anesthetics|mesh-list
101303209|NCT05410158|Analgesics|analgesics|mesh-ancestor
101953046|NCT03815422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101953047|NCT03815422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953048|NCT02260024|Pramipexole|pramipexole|mesh-list
101953049|NCT02260024|Antioxidants|antioxidants|mesh-ancestor
101303269|NCT05091905|Anesthetics|anesthetics|mesh-list
101953050|NCT02260024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953051|NCT02260024|Protective Agents|protective agents|mesh-ancestor
101953052|NCT02260024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953054|NCT02260024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101953055|NCT02260024|Dopamine Agonists|dopamine agonists|mesh-ancestor
101953056|NCT02260024|Dopamine Agents|dopamine agents|mesh-ancestor
101953057|NCT02260024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101953058|NCT03800667|Ascorbic Acid|ascorbic acid|mesh-list
101953059|NCT03800667|Antioxidants|antioxidants|mesh-ancestor
101953060|NCT03800667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953061|NCT03800667|Protective Agents|protective agents|mesh-ancestor
101953062|NCT03800667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953063|NCT03800667|Vitamins|vitamins|mesh-ancestor
101953064|NCT03800667|Micronutrients|micronutrients|mesh-ancestor
101953065|NCT01302171|Lenograstim|lenograstim|mesh-list
101953066|NCT01302171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101953067|NCT01302171|Immunologic Factors|immunologic factors|mesh-ancestor
101737347|NCT05520177|Growth Substances|growth substances|mesh-ancestor
101970087|NCT05981001|Alkylating Agents|alkylating agents|mesh-ancestor
101970088|NCT05981001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101970089|NCT05981001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101970090|NCT05981001|Antimetabolites|antimetabolites|mesh-ancestor
101953068|NCT01302171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953070|NCT02047630|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101953071|NCT02047630|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101303637|NCT03350516|Calcium, Dietary|calcium, dietary|mesh-list
101953072|NCT04305470|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101953073|NCT04305470|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101953074|NCT04305470|Dermatologic Agents|dermatologic agents|mesh-ancestor
101953075|NCT03799809|Voriconazole|voriconazole|mesh-list
101953076|NCT03799809|Antifungal Agents|antifungal agents|mesh-ancestor
101953077|NCT03799809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101953078|NCT03799809|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101953079|NCT03799809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101953080|NCT03799809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101953081|NCT03799809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953082|NCT03799809|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101953083|NCT03799809|Hormone Antagonists|hormone antagonists|mesh-ancestor
101303925|NCT02009280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101953084|NCT03799809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101953085|NCT03799809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953086|NCT03799809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101953087|NCT03812523|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101304001|NCT02009709|Vitamins|vitamins|mesh-ancestor
101953088|NCT03812523|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101953089|NCT03812523|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101953090|NCT03812523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101690057|NCT03434366|Anesthetics|anesthetics|mesh-ancestor
101953091|NCT03812523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953092|NCT03812523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101953093|NCT03812523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953094|NCT03812523|Analgesics|analgesics|mesh-ancestor
101953095|NCT03812523|Sensory System Agents|sensory system agents|mesh-ancestor
101953096|NCT03812523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101953097|NCT03812523|Antidepressive Agents|antidepressive agents|mesh-ancestor
101953098|NCT03812523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101953099|NCT03812523|Dopamine Agents|dopamine agents|mesh-ancestor
101953100|NCT04216251|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
101953101|NCT04216251|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101953103|NCT02049970|Dexmedetomidine|dexmedetomidine|mesh-list
101953104|NCT02049970|Bupivacaine|bupivacaine|mesh-list
101953105|NCT02049970|Anesthetics, Local|anesthetics, local|mesh-ancestor
101953106|NCT02049970|Anesthetics|anesthetics|mesh-ancestor
101953107|NCT02049970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101953108|NCT02049970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953109|NCT02049970|Sensory System Agents|sensory system agents|mesh-ancestor
101953110|NCT02049970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101953111|NCT02049970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101953112|NCT02049970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101953113|NCT02049970|Analgesics|analgesics|mesh-ancestor
101953114|NCT02049970|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101953115|NCT02049970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101953116|NCT02049970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101953117|NCT02049970|Adrenergic Agents|adrenergic agents|mesh-ancestor
101953118|NCT02049970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101953119|NCT02049970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953120|NCT02048020|Paclitaxel|paclitaxel|mesh-list
101953121|NCT02048020|Carboplatin|carboplatin|mesh-list
101953122|NCT02048020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101953123|NCT02048020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101953124|NCT02048020|Tubulin Modulators|tubulin modulators|mesh-ancestor
101953125|NCT02048020|Antimitotic Agents|antimitotic agents|mesh-ancestor
101953126|NCT02048020|Mitosis Modulators|mitosis modulators|mesh-ancestor
101953127|NCT02048020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953128|NCT03562390|Irinotecan|irinotecan|mesh-list
101953129|NCT03562390|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101953130|NCT03562390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101953131|NCT03562390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970092|NCT05981001|Analgesics|analgesics|mesh-ancestor
101970093|NCT05981001|Sensory System Agents|sensory system agents|mesh-ancestor
101970094|NCT05981001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101953132|NCT03562390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953133|NCT03562390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101953134|NCT02048098|Misoprostol|misoprostol|mesh-list
101953135|NCT02048098|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101953136|NCT02048098|Abortifacient Agents|abortifacient agents|mesh-ancestor
101953137|NCT02048098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101953138|NCT02048098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953139|NCT02048098|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101953140|NCT02048098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101953141|NCT02048098|Oxytocics|oxytocics|mesh-ancestor
101953142|NCT02050360|Sildenafil Citrate|sildenafil citrate|mesh-list
101953143|NCT02050360|Vasodilator Agents|vasodilator agents|mesh-ancestor
101953144|NCT02050360|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101953145|NCT02050360|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101953146|NCT02050360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101953147|NCT02050360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953148|NCT02050360|Urological Agents|urological agents|mesh-ancestor
101953150|NCT02940860|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101953151|NCT02940860|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
101953152|NCT02940860|Trace Elements|trace elements|mesh-ancestor
101504752|NCT02952573|BB 1101|bb 1101|mesh-list
101953153|NCT02940860|Micronutrients|micronutrients|mesh-ancestor
101953154|NCT02940860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953155|NCT02940860|Hematinics|hematinics|mesh-ancestor
101953156|NCT01303887|Prednisolone|prednisolone|mesh-list
101953157|NCT01303887|Cyclophosphamide|cyclophosphamide|mesh-list
101953159|NCT01303887|Fludarabine|fludarabine|mesh-list
101953160|NCT01303887|Vincristine|vincristine|mesh-list
101953161|NCT01303887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101953162|NCT01303887|Immunologic Factors|immunologic factors|mesh-ancestor
101953163|NCT01303887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953164|NCT01303887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101504807|NCT00501839|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101953165|NCT01303887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101953166|NCT01303887|Alkylating Agents|alkylating agents|mesh-ancestor
101953167|NCT01303887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953168|NCT01303887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101953169|NCT01303887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101953170|NCT01303887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101953171|NCT01303887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101953172|NCT01303887|Tubulin Modulators|tubulin modulators|mesh-ancestor
101953173|NCT01303887|Antimitotic Agents|antimitotic agents|mesh-ancestor
101953174|NCT01303887|Mitosis Modulators|mitosis modulators|mesh-ancestor
101504884|NCT00510705|Metformin|metformin|mesh-list
101953175|NCT01303887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101953176|NCT01303887|Glucocorticoids|glucocorticoids|mesh-ancestor
101953177|NCT01303887|Hormones|hormones|mesh-ancestor
101953178|NCT01303887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101953179|NCT01303887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101953180|NCT02050594|Ipilimumab|ipilimumab|mesh-list
101953181|NCT02050594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101953182|NCT02050594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101953183|NCT02050594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101953184|NCT02050594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953185|NCT02806960|Glucagon|glucagon|mesh-list
101953186|NCT02806960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101953187|NCT02806960|Hormones|hormones|mesh-ancestor
101953188|NCT02806960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101504938|NCT00502112|Growth Substances|growth substances|mesh-ancestor
101953189|NCT02806960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953190|NCT03718143|Adavosertib|adavosertib|mesh-list
101953191|NCT03718143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101953192|NCT03718143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953193|NCT02955134|Hydrotalcite|hydrotalcite|mesh-list
101953194|NCT02955134|Antacids|antacids|mesh-ancestor
101953195|NCT02955134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953196|NCT02955134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101970096|NCT05980871|Ceftriaxone|ceftriaxone|mesh-list
101970097|NCT05980871|Penicillins|penicillins|mesh-list
101970098|NCT05980871|Penicillin G|penicillin g|mesh-list
101305019|NCT02016495|Antioxidants|antioxidants|mesh-ancestor
101953197|NCT02048488|Belizatinib|belizatinib|mesh-list
101953198|NCT02048488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101953199|NCT02048488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101953200|NCT02048488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953201|NCT02050672|Inositol|inositol|mesh-list
101953202|NCT02050672|Vitamin B Complex|vitamin b complex|mesh-ancestor
101953203|NCT02050672|Vitamins|vitamins|mesh-ancestor
101953204|NCT02050672|Micronutrients|micronutrients|mesh-ancestor
101953205|NCT02050672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953206|NCT03811366|Prednisone|prednisone|mesh-list
101953207|NCT03811366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101953208|NCT03811366|Glucocorticoids|glucocorticoids|mesh-ancestor
101953209|NCT03811366|Hormones|hormones|mesh-ancestor
101953210|NCT03811366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101953211|NCT03811366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953212|NCT03811366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101953213|NCT03811366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101953214|NCT03274466|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101953215|NCT03274466|Laxatives|laxatives|mesh-ancestor
101953216|NCT03274466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101953217|NCT02037802|Fentanyl|fentanyl|mesh-list
101953218|NCT02037802|Meperidine|meperidine|mesh-list
101953219|NCT02037802|Bupivacaine|bupivacaine|mesh-list
101953220|NCT02037802|Propofol|propofol|mesh-list
101953221|NCT02037802|Anesthetics, Local|anesthetics, local|mesh-ancestor
101953222|NCT02037802|Anesthetics|anesthetics|mesh-ancestor
101953223|NCT02037802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101953224|NCT02037802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953225|NCT02037802|Sensory System Agents|sensory system agents|mesh-ancestor
101505125|NCT01241006|Hormones|hormones|mesh-ancestor
101953226|NCT02037802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101953227|NCT02037802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101953228|NCT02037802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101953229|NCT02037802|Anesthetics, General|anesthetics, general|mesh-ancestor
101953230|NCT02037802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101953232|NCT02037802|Analgesics|analgesics|mesh-ancestor
101953233|NCT02037802|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101953235|NCT02051530|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101953236|NCT02051530|Antidepressive Agents|antidepressive agents|mesh-ancestor
101953237|NCT02051530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101953238|NCT03797703|Lidocaine|lidocaine|mesh-list
101953239|NCT03797703|Anesthetics, Local|anesthetics, local|mesh-ancestor
101953240|NCT03797703|Anesthetics|anesthetics|mesh-ancestor
101953241|NCT03797703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101953242|NCT03797703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505330|NCT00512616|Ceftriaxone|ceftriaxone|mesh-list
101953244|NCT03797703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101953245|NCT03797703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101953246|NCT03797703|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101505402|NCT00513864|Analgesics|analgesics|mesh-ancestor
101953247|NCT03797703|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101953248|NCT03797703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101953249|NCT03797703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953250|NCT02048644|Beclomethasone|beclomethasone|mesh-list
101953251|NCT02048644|Formoterol Fumarate|formoterol fumarate|mesh-list
101953252|NCT02048644|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101953253|NCT02048644|Autonomic Agents|autonomic agents|mesh-ancestor
101953254|NCT02048644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101953255|NCT02048644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953256|NCT02048644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101953257|NCT02048644|Respiratory System Agents|respiratory system agents|mesh-ancestor
101953258|NCT02048644|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101953259|NCT02048644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101953260|NCT02048644|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101953261|NCT02048644|Adrenergic Agents|adrenergic agents|mesh-ancestor
101953262|NCT02048644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101953263|NCT02048644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953264|NCT02048644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101970099|NCT05980871|Penicillin G Benzathine|penicillin g benzathine|mesh-list
101970100|NCT05980871|Penicillin G Procaine|penicillin g procaine|mesh-list
101970101|NCT05980871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101970102|NCT05980871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101970103|NCT05980871|Antimalarials|antimalarials|mesh-ancestor
101970104|NCT05980871|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101953265|NCT02048644|Glucocorticoids|glucocorticoids|mesh-ancestor
101953266|NCT02048644|Hormones|hormones|mesh-ancestor
101953267|NCT02048644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101953268|NCT02048800|Treosulfan|treosulfan|mesh-list
101953269|NCT02048800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101953270|NCT02048800|Alkylating Agents|alkylating agents|mesh-ancestor
101690082|NCT02648958|Analgesics|analgesics|mesh-ancestor
101953271|NCT02048800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953272|NCT02048800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101953273|NCT03797625|Cisplatin|cisplatin|mesh-list
101953274|NCT03797625|Irinotecan|irinotecan|mesh-list
101953275|NCT03797625|Endostar protein|endostar protein|mesh-list
101953276|NCT03797625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101673079|NCT00003010|Marimastat|marimastat|mesh-list
101953277|NCT03797625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101953278|NCT03797625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101953279|NCT03797625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101953280|NCT03797625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953281|NCT03797625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101953282|NCT03797625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101953283|NCT03797625|Growth Substances|growth substances|mesh-ancestor
101953284|NCT03797625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953285|NCT03797625|Growth Inhibitors|growth inhibitors|mesh-ancestor
101953286|NCT02051842|Metadoxine|metadoxine|mesh-list
101953287|NCT02051842|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101953288|NCT02806414|Ivermectin|ivermectin|mesh-list
101953289|NCT02806414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101505613|NCT00515151|Ethanol|ethanol|mesh-list
101953290|NCT02806414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101953291|NCT02049034|Lixisenatide|lixisenatide|mesh-list
101953292|NCT02049034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101953293|NCT02049034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953294|NCT02049190|Onapristone|onapristone|mesh-list
101953295|NCT02049190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101953296|NCT02049190|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101953297|NCT02049190|Fertility Agents|fertility agents|mesh-ancestor
101953298|NCT02049190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101953299|NCT02049190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953300|NCT02049190|Hormone Antagonists|hormone antagonists|mesh-ancestor
101505797|NCT04511975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101953301|NCT02049190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101953302|NCT03811509|Denosumab|denosumab|mesh-list
101953303|NCT03811509|Diphosphonates|diphosphonates|mesh-list
101953304|NCT03811509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101953305|NCT03811509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953306|NCT02037412|Clopidogrel|clopidogrel|mesh-list
101953307|NCT02037412|Ticagrelor|ticagrelor|mesh-list
101953308|NCT02037412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101953309|NCT02037412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101953310|NCT02037412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101953311|NCT02037412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101953312|NCT02037412|Purinergic Agents|purinergic agents|mesh-ancestor
101953313|NCT02037412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101953314|NCT02037412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953315|NCT02037412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953316|NCT02052154|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101953317|NCT02052154|Immunologic Factors|immunologic factors|mesh-ancestor
101953318|NCT02052154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953320|NCT03797079|Anesthetics, Local|anesthetics, local|mesh-ancestor
101953321|NCT03797079|Anesthetics|anesthetics|mesh-ancestor
101953322|NCT03797079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101953323|NCT03797079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953324|NCT03797079|Sensory System Agents|sensory system agents|mesh-ancestor
101953325|NCT03797079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101953327|NCT02049268|Nicotine|nicotine|mesh-list
101970105|NCT05980871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101970106|NCT05980715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101970107|NCT05980715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970108|NCT05980715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101970109|NCT05980715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101953328|NCT02049268|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101953329|NCT02049268|Autonomic Agents|autonomic agents|mesh-ancestor
101953330|NCT02049268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101953331|NCT02049268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953332|NCT02049268|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101953333|NCT02049268|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101953334|NCT02049268|Cholinergic Agents|cholinergic agents|mesh-ancestor
101953335|NCT02049268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101953336|NCT02049268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953337|NCT02049268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101953339|NCT02049268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101953340|NCT02049346|Epoetin Alfa|epoetin alfa|mesh-list
101953341|NCT02049346|Darbepoetin alfa|darbepoetin alfa|mesh-list
101953342|NCT02049346|Hematinics|hematinics|mesh-ancestor
101953343|NCT03564873|Azacitidine|azacitidine|mesh-list
101953344|NCT03564873|Homoharringtonine|homoharringtonine|mesh-list
101953345|NCT03564873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101953346|NCT03564873|Antimetabolites|antimetabolites|mesh-ancestor
101953347|NCT03564873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953349|NCT03564873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101953350|NCT03564873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101953351|NCT03564873|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101953352|NCT02806024|Tranexamic Acid|tranexamic acid|mesh-list
101953353|NCT02806024|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101953354|NCT02806024|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101953355|NCT02806024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953357|NCT02806024|Coagulants|coagulants|mesh-ancestor
101953358|NCT03811197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
101953359|NCT03811197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101953360|NCT03811197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953362|NCT02049580|Thiotepa|thiotepa|mesh-list
101953363|NCT02049580|Fludarabine|fludarabine|mesh-list
101953364|NCT02049580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101953365|NCT02049580|Immunologic Factors|immunologic factors|mesh-ancestor
101953366|NCT02049580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953367|NCT02049580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101953368|NCT02049580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101953369|NCT02049580|Alkylating Agents|alkylating agents|mesh-ancestor
101953370|NCT02049580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953371|NCT02049580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101953372|NCT02049580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101953373|NCT01302951|Moxifloxacin|moxifloxacin|mesh-list
101953374|NCT01302951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101953375|NCT01302951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101953376|NCT01302951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101953377|NCT01302951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101953378|NCT01302951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101953379|NCT01302951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953380|NCT01302951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101953381|NCT03796533|Posaconazole|posaconazole|mesh-list
101953382|NCT03796533|Antifungal Agents|antifungal agents|mesh-ancestor
101953383|NCT03796533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101953384|NCT03796533|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101953385|NCT03796533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101953386|NCT03796533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101953387|NCT03796533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101953388|NCT03796533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101953389|NCT03796533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101953390|NCT03796533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506638|NCT02949258|Oxaliplatin|oxaliplatin|mesh-list
101953391|NCT03796533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101953392|NCT03796533|Hormone Antagonists|hormone antagonists|mesh-ancestor
101970110|NCT05980702|Paclitaxel|paclitaxel|mesh-list
101970111|NCT05980702|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101953393|NCT03796533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101953394|NCT03796533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953395|NCT03796377|Rivaroxaban|rivaroxaban|mesh-list
101953396|NCT03796377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101953397|NCT03796377|Antithrombins|antithrombins|mesh-ancestor
101953398|NCT03796377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101953399|NCT03796377|Protease Inhibitors|protease inhibitors|mesh-ancestor
101953400|NCT03796377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101953401|NCT03796377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953402|NCT03796377|Anticoagulants|anticoagulants|mesh-ancestor
101953403|NCT02049736|Telbivudine|telbivudine|mesh-list
101953404|NCT02049736|Antiviral Agents|antiviral agents|mesh-ancestor
101953405|NCT02049736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101953406|NCT02049736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101953407|NCT02049736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101953408|NCT02049736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953409|NCT01303029|Gemcitabine|gemcitabine|mesh-list
101953410|NCT01303029|Capecitabine|capecitabine|mesh-list
101953411|NCT01303029|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101953412|NCT01303029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101506811|NCT00521430|Cyclosporine|cyclosporine|mesh-list
101953413|NCT01303029|Antimetabolites|antimetabolites|mesh-ancestor
101953414|NCT01303029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953415|NCT01303029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101953416|NCT01303029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101953417|NCT01303029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101953418|NCT02052388|Daptomycin|daptomycin|mesh-list
101953419|NCT02052388|Brilacidin|brilacidin|mesh-list
101953420|NCT02052388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101953421|NCT02052388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101953422|NCT01303107|Bupivacaine|bupivacaine|mesh-list
101953423|NCT01303107|Anesthetics, Local|anesthetics, local|mesh-ancestor
101953424|NCT01303107|Anesthetics|anesthetics|mesh-ancestor
101953425|NCT01303107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101953426|NCT01303107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953427|NCT01303107|Sensory System Agents|sensory system agents|mesh-ancestor
101953428|NCT01303107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101953429|NCT03795909|Dexamethasone|dexamethasone|mesh-list
101953430|NCT03795909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101953431|NCT03795909|Antiemetics|antiemetics|mesh-ancestor
101953432|NCT03795909|Autonomic Agents|autonomic agents|mesh-ancestor
101953433|NCT03795909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101953434|NCT03795909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953435|NCT03795909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101953436|NCT03795909|Glucocorticoids|glucocorticoids|mesh-ancestor
101953437|NCT03795909|Hormones|hormones|mesh-ancestor
101953438|NCT03795909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101953439|NCT03795909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101953440|NCT03795909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101953441|NCT03795597|Melphalan|melphalan|mesh-list
101953442|NCT03795597|Busulfan|busulfan|mesh-list
101953443|NCT03795597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101953444|NCT03795597|Alkylating Agents|alkylating agents|mesh-ancestor
101953445|NCT03795597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507015|NCT00523380|Doxorubicin|doxorubicin|mesh-list
101953446|NCT03795597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101953447|NCT03795597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101953448|NCT03795597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101953449|NCT03795597|Immunologic Factors|immunologic factors|mesh-ancestor
101953450|NCT03795597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953451|NCT02802592|Epoetin Alfa|epoetin alfa|mesh-list
101953452|NCT02802592|Hematinics|hematinics|mesh-ancestor
101953454|NCT03637972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101953455|NCT03637972|Autonomic Agents|autonomic agents|mesh-ancestor
101953456|NCT03637972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101953457|NCT03637972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953458|NCT03637972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101953459|NCT03637972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101953460|NCT03637972|Cholinergic Agents|cholinergic agents|mesh-ancestor
101953461|NCT03637972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101507290|NCT02276378|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101953462|NCT03637972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970112|NCT05980702|Carboplatin|carboplatin|mesh-list
101970113|NCT05980702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101970114|NCT05980702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970115|NCT05980702|Tubulin Modulators|tubulin modulators|mesh-ancestor
101970116|NCT05980702|Antimitotic Agents|antimitotic agents|mesh-ancestor
101953464|NCT03383679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101953465|NCT03383679|Antimetabolites|antimetabolites|mesh-ancestor
101953466|NCT03383679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953467|NCT03383679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101953468|NCT02037958|Chlorhexidine|chlorhexidine|mesh-list
101953469|NCT02037958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101953470|NCT02037958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101953471|NCT02037958|Disinfectants|disinfectants|mesh-ancestor
101953472|NCT02053402|Vitamin D|vitamin d|mesh-list
101953473|NCT02053402|Cholecalciferol|cholecalciferol|mesh-list
101953474|NCT02053402|Vitamins|vitamins|mesh-ancestor
101953475|NCT02053402|Micronutrients|micronutrients|mesh-ancestor
101953476|NCT02053402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953477|NCT02053402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101953478|NCT02053402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101953479|NCT04639011|Norepinephrine|norepinephrine|mesh-list
101953480|NCT04639011|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101953481|NCT04639011|Serotonin|serotonin|mesh-list
101953482|NCT04639011|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101953483|NCT04639011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101953484|NCT04639011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101953485|NCT04639011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953486|NCT04639011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101953487|NCT04639011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953488|NCT04639011|Analgesics|analgesics|mesh-ancestor
101953489|NCT04639011|Sensory System Agents|sensory system agents|mesh-ancestor
101953490|NCT04639011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101953491|NCT04639011|Antidepressive Agents|antidepressive agents|mesh-ancestor
101953493|NCT04639011|Dopamine Agents|dopamine agents|mesh-ancestor
101953494|NCT04639011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101953495|NCT04639011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101953496|NCT04639011|Adrenergic Agents|adrenergic agents|mesh-ancestor
101953497|NCT04639011|Sympathomimetics|sympathomimetics|mesh-ancestor
101507488|NCT04693026|Remdesivir|remdesivir|mesh-list
101953499|NCT04639011|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101953500|NCT04639011|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101953501|NCT04639011|Serotonin Agents|serotonin agents|mesh-ancestor
101953502|NCT02053558|Lidocaine|lidocaine|mesh-list
101953503|NCT02053558|Ropivacaine|ropivacaine|mesh-list
101953504|NCT02053558|Anesthetics, Local|anesthetics, local|mesh-ancestor
101953505|NCT02053558|Anesthetics|anesthetics|mesh-ancestor
101953506|NCT02053558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101953507|NCT02053558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953508|NCT02053558|Sensory System Agents|sensory system agents|mesh-ancestor
101953509|NCT02053558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101507618|NCT00525447|Growth Substances|growth substances|mesh-ancestor
101953510|NCT02053558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101953511|NCT02053558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101953512|NCT02053558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101953513|NCT02053558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101953514|NCT02053558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953516|NCT03809949|Anesthetics|anesthetics|mesh-list
101507758|NCT00525759|Tubulin Modulators|tubulin modulators|mesh-ancestor
101953517|NCT03809949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101953518|NCT03809949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953519|NCT03809949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101953520|NCT03809949|Narcotics|narcotics|mesh-ancestor
101953521|NCT03809949|Analgesics|analgesics|mesh-ancestor
101953522|NCT03809949|Sensory System Agents|sensory system agents|mesh-ancestor
101953523|NCT03809949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101953524|NCT03809949|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101953525|NCT03809949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101953526|NCT03809949|Anesthetics, General|anesthetics, general|mesh-ancestor
101953527|NCT02052934|Vaccines|vaccines|mesh-list
101953528|NCT02052934|Immunologic Factors|immunologic factors|mesh-ancestor
101970118|NCT05980702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953529|NCT02052934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953530|NCT03810261|Vitamin D|vitamin d|mesh-list
101953531|NCT03810261|Ergocalciferols|ergocalciferols|mesh-list
101953532|NCT03810261|Cholecalciferol|cholecalciferol|mesh-list
101953533|NCT03810261|Vitamins|vitamins|mesh-list
101953534|NCT03810261|Micronutrients|micronutrients|mesh-ancestor
101953535|NCT03810261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953536|NCT03810261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101953537|NCT03810261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101953538|NCT02037724|Iron|iron|mesh-list
101953539|NCT02037724|Trace Elements|trace elements|mesh-ancestor
101953540|NCT02037724|Micronutrients|micronutrients|mesh-ancestor
101953541|NCT02037724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953542|NCT03327675|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101507956|NCT04692285|GABA Agents|gaba agents|mesh-ancestor
101953543|NCT03327675|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101953544|NCT03327675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953545|NCT01569633|Erythromycin|erythromycin|mesh-list
101953546|NCT01569633|Erythromycin Estolate|erythromycin estolate|mesh-list
101508031|NCT00509678|Rituximab|rituximab|mesh-list
101953547|NCT01569633|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101953548|NCT01569633|Erythromycin stearate|erythromycin stearate|mesh-list
101953549|NCT01569633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101953550|NCT01569633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101953551|NCT01569633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101953552|NCT01569633|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101953553|NCT01569633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101508178|NCT01580514|Exenatide|exenatide|mesh-list
101690154|NCT02687204|Enoxaparin|enoxaparin|mesh-list
101953554|NCT01569633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953555|NCT02054182|Vitamin D|vitamin d|mesh-list
101953556|NCT02054182|Cholecalciferol|cholecalciferol|mesh-list
101953557|NCT02054182|Vitamins|vitamins|mesh-ancestor
101953558|NCT02054182|Micronutrients|micronutrients|mesh-ancestor
101953559|NCT02054182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953560|NCT02054182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101953561|NCT02054182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101953562|NCT03323151|Ixazomib|ixazomib|mesh-list
101953563|NCT03323151|Glycine|glycine|mesh-list
101953564|NCT03323151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101953565|NCT03323151|Protease Inhibitors|protease inhibitors|mesh-ancestor
101953566|NCT03323151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101953567|NCT03323151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953568|NCT03323151|Glycine Agents|glycine agents|mesh-ancestor
101953569|NCT03323151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101508382|NCT00515736|Vitamins|vitamins|mesh-list
101953570|NCT03323151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953571|NCT02803138|Ritonavir|ritonavir|mesh-list
101953572|NCT02803138|Ribavirin|ribavirin|mesh-list
101953573|NCT02803138|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101953574|NCT02803138|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101953575|NCT02803138|Protease Inhibitors|protease inhibitors|mesh-ancestor
101953576|NCT02803138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101953577|NCT02803138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953578|NCT02803138|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101953579|NCT02803138|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101953580|NCT02803138|Antiviral Agents|antiviral agents|mesh-ancestor
101953581|NCT02803138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101953582|NCT02803138|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101953583|NCT02803138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101953584|NCT02803138|Antimetabolites|antimetabolites|mesh-ancestor
101953585|NCT03795207|Durvalumab|durvalumab|mesh-list
101953586|NCT03795207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101508453|NCT00513188|Vitamins|vitamins|mesh-ancestor
101953587|NCT03795207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101953588|NCT02056210|Plerixafor|plerixafor|mesh-list
101953589|NCT02056210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101953590|NCT02056210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101953591|NCT02056210|Antiviral Agents|antiviral agents|mesh-ancestor
101953592|NCT02056210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101953593|NCT00131235|Azithromycin|azithromycin|mesh-list
101953594|NCT00131235|Pyrimethamine|pyrimethamine|mesh-list
101953595|NCT00131235|Sulfadoxine|sulfadoxine|mesh-list
101953596|NCT00131235|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101953597|NCT00131235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101970119|NCT05980689|Capecitabine|capecitabine|mesh-list
101970120|NCT05980689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101970121|NCT05980689|Antimetabolites|antimetabolites|mesh-ancestor
101970122|NCT05980689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953598|NCT00131235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101953599|NCT00131235|Antimalarials|antimalarials|mesh-ancestor
101953600|NCT00131235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101953601|NCT00131235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101953602|NCT00131235|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101953603|NCT00131235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101953604|NCT00131235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953605|NCT00131235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101953606|NCT03794505|Methylprednisolone|methylprednisolone|mesh-list
101953607|NCT03794505|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101953608|NCT03794505|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101953609|NCT03794505|Prednisolone|prednisolone|mesh-list
101953610|NCT03794505|Prednisolone acetate|prednisolone acetate|mesh-list
101953611|NCT03794505|Lidocaine|lidocaine|mesh-list
101953613|NCT03794505|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101953614|NCT03794505|Prednisolone phosphate|prednisolone phosphate|mesh-list
101953615|NCT03794505|Anesthetics, Local|anesthetics, local|mesh-ancestor
101953616|NCT03794505|Anesthetics|anesthetics|mesh-ancestor
101690162|NCT00650208|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101953617|NCT03794505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101953618|NCT03794505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953619|NCT03794505|Sensory System Agents|sensory system agents|mesh-ancestor
101953620|NCT03794505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101953621|NCT03794505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101508570|NCT00512291|Olanzapine|olanzapine|mesh-list
101953622|NCT03794505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101953623|NCT03794505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101953624|NCT03794505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101953625|NCT03794505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953626|NCT03794505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101953628|NCT03794505|Autonomic Agents|autonomic agents|mesh-ancestor
101953629|NCT03794505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101953630|NCT03794505|Glucocorticoids|glucocorticoids|mesh-ancestor
101953631|NCT03794505|Hormones|hormones|mesh-ancestor
101953632|NCT03794505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101953633|NCT03794505|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101953634|NCT03794505|Protective Agents|protective agents|mesh-ancestor
101953635|NCT03794505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101953636|NCT03794505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101953637|NCT05625243|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
101953638|NCT05625243|Vasodilator Agents|vasodilator agents|mesh-ancestor
101953639|NCT05625243|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101953640|NCT05625243|Protective Agents|protective agents|mesh-ancestor
101953641|NCT05625243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953642|NCT03023007|Anesthetics|anesthetics|mesh-list
101953643|NCT03023007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101953644|NCT03023007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953645|NCT01304901|Montelukast|montelukast|mesh-list
101953646|NCT01304901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101953647|NCT01304901|Respiratory System Agents|respiratory system agents|mesh-ancestor
101953648|NCT01304901|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101953649|NCT01304901|Hormone Antagonists|hormone antagonists|mesh-ancestor
101953650|NCT01304901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101953651|NCT01304901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953652|NCT01304901|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101953653|NCT01304901|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101953654|NCT01304901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953657|NCT05624853|Sensory System Agents|sensory system agents|mesh-ancestor
101953658|NCT05624853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101953659|NCT05624853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953660|NCT05624853|Anticonvulsants|anticonvulsants|mesh-ancestor
101953661|NCT05624853|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101953662|NCT05624853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101953663|NCT05624853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953664|NCT05624853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101970123|NCT05980689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970124|NCT05980598|Pembrolizumab|pembrolizumab|mesh-list
101970125|NCT05980598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101970126|NCT05980598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101953665|NCT05624853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101953666|NCT05624853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101953667|NCT05624853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101953668|NCT05624853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101953669|NCT03794271|Anesthetics|anesthetics|mesh-list
101953670|NCT03794271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101953671|NCT03794271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953672|NCT03792321|Methyltestosterone|methyltestosterone|mesh-list
101953673|NCT03792321|Testosterone|testosterone|mesh-list
101953674|NCT03792321|Testosterone undecanoate|testosterone undecanoate|mesh-list
101953675|NCT03792321|Testosterone enanthate|testosterone enanthate|mesh-list
101953676|NCT03792321|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101953677|NCT03792321|Androgens|androgens|mesh-ancestor
101953678|NCT03792321|Hormones|hormones|mesh-ancestor
101953679|NCT03792321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101953680|NCT03792321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953681|NCT03792321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101953682|NCT03792321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101953683|NCT03792321|Anabolic Agents|anabolic agents|mesh-ancestor
101953684|NCT01305057|Pyridoxine|pyridoxine|mesh-list
101953685|NCT01305057|Vitamin B Complex|vitamin b complex|mesh-ancestor
101953686|NCT01305057|Vitamins|vitamins|mesh-ancestor
101953687|NCT01305057|Micronutrients|micronutrients|mesh-ancestor
101953688|NCT01305057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953689|NCT03792009|Bupivacaine|bupivacaine|mesh-list
101953690|NCT03792009|Anesthetics, Local|anesthetics, local|mesh-ancestor
101953691|NCT03792009|Anesthetics|anesthetics|mesh-ancestor
101953692|NCT03792009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101953693|NCT03792009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953694|NCT03792009|Sensory System Agents|sensory system agents|mesh-ancestor
101953695|NCT03792009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101953696|NCT01305135|Azacitidine|azacitidine|mesh-list
101953697|NCT01305135|Idarubicin|idarubicin|mesh-list
101953698|NCT01305135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101953699|NCT01305135|Antimetabolites|antimetabolites|mesh-ancestor
101953700|NCT01305135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953701|NCT01305135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101953702|NCT01305135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101953703|NCT01305135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101953704|NCT01305135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101953705|NCT01305135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101953706|NCT01305603|Bupivacaine|bupivacaine|mesh-list
101953707|NCT01305603|Anesthetics, Local|anesthetics, local|mesh-list
101953708|NCT01305603|Anesthetics|anesthetics|mesh-list
101953709|NCT01305603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101953710|NCT01305603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953711|NCT01305603|Sensory System Agents|sensory system agents|mesh-ancestor
101953712|NCT01305603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101953714|NCT03793725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101508769|NCT02943798|Paclitaxel|paclitaxel|mesh-list
101953715|NCT03793725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101953716|NCT03793725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101953717|NCT03793725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953718|NCT01305369|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101953719|NCT01305369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101953721|NCT02056366|Antioxidants|antioxidants|mesh-ancestor
101953722|NCT02056366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953723|NCT02056366|Protective Agents|protective agents|mesh-ancestor
101953724|NCT02056366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953725|NCT02056366|Vitamin B Complex|vitamin b complex|mesh-ancestor
101953726|NCT02056366|Vitamins|vitamins|mesh-ancestor
101953727|NCT02056366|Micronutrients|micronutrients|mesh-ancestor
101953728|NCT02056444|Tranexamic Acid|tranexamic acid|mesh-list
101953729|NCT02056444|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101953730|NCT02056444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101953731|NCT02056444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953732|NCT02056444|Hemostatics|hemostatics|mesh-ancestor
101953733|NCT02056444|Coagulants|coagulants|mesh-ancestor
101970127|NCT05980598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101953734|NCT02665234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101953735|NCT02665234|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101953736|NCT05624229|Esomeprazole|esomeprazole|mesh-list
101953737|NCT05624229|Omeprazole|omeprazole|mesh-list
101953738|NCT05624229|Rabeprazole|rabeprazole|mesh-list
101953739|NCT05624229|Pantoprazole|pantoprazole|mesh-list
101953740|NCT05624229|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101953741|NCT05624229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101953742|NCT05624229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101953743|NCT05624229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101509038|NCT00515489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101953744|NCT05624229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953745|NCT05622370|Brivaracetam|brivaracetam|mesh-list
101953746|NCT05622370|Anticonvulsants|anticonvulsants|mesh-ancestor
101953747|NCT03791775|Polidocanol|polidocanol|mesh-list
101953748|NCT03791775|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
101953749|NCT03791775|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101953750|NCT03789123|Dienogest|dienogest|mesh-list
101953751|NCT03789123|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101953752|NCT03789123|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101953753|NCT03789123|Estradiol|estradiol|mesh-list
101953754|NCT03789123|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101953755|NCT03789123|Nandrolone|nandrolone|mesh-list
101953756|NCT03789123|Estrogens|estrogens|mesh-ancestor
101953757|NCT03789123|Hormones|hormones|mesh-ancestor
101953758|NCT03789123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101953759|NCT03789123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953760|NCT03789123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101953761|NCT03789123|Contraceptive Agents|contraceptive agents|mesh-ancestor
101953762|NCT03789123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101953763|NCT03789123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101953764|NCT03789123|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101953765|NCT03789123|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101953766|NCT03789123|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101953767|NCT03789123|Hormone Antagonists|hormone antagonists|mesh-ancestor
101953768|NCT03789123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101953769|NCT03789123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101953770|NCT03789123|Androgens|androgens|mesh-ancestor
101953771|NCT03789123|Anabolic Agents|anabolic agents|mesh-ancestor
101953772|NCT05471817|Dabigatran|dabigatran|mesh-list
101953773|NCT05471817|Antithrombins|antithrombins|mesh-ancestor
101509241|NCT02940990|Antimetabolites|antimetabolites|mesh-ancestor
101953774|NCT05471817|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101953775|NCT05471817|Protease Inhibitors|protease inhibitors|mesh-ancestor
101953776|NCT05471817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101953777|NCT05471817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953778|NCT05471817|Anticoagulants|anticoagulants|mesh-ancestor
101953779|NCT03788889|Ketamine|ketamine|mesh-list
101953780|NCT03788889|Lorazepam|lorazepam|mesh-list
101953781|NCT03788889|Phenobarbital|phenobarbital|mesh-list
101953782|NCT03788889|Analgesics|analgesics|mesh-ancestor
101953783|NCT03788889|Sensory System Agents|sensory system agents|mesh-ancestor
101953784|NCT03788889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101953785|NCT03788889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953786|NCT03788889|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101509448|NCT00517985|Analgesics|analgesics|mesh-ancestor
101953787|NCT03788889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101953788|NCT03788889|Anesthetics, General|anesthetics, general|mesh-ancestor
101953789|NCT03788889|Anesthetics|anesthetics|mesh-ancestor
101953790|NCT03788889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101953791|NCT03788889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101953792|NCT03788889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101953793|NCT03788889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101953794|NCT03788889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953795|NCT03788889|Anticonvulsants|anticonvulsants|mesh-ancestor
101953796|NCT03788889|Antiemetics|antiemetics|mesh-ancestor
101953797|NCT03788889|Autonomic Agents|autonomic agents|mesh-ancestor
101953798|NCT03788889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101953799|NCT03788889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101953800|NCT03788889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101953801|NCT03788889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101953802|NCT03788889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101953803|NCT03788889|GABA Modulators|gaba modulators|mesh-ancestor
101953804|NCT03788889|GABA Agents|gaba agents|mesh-ancestor
101690191|NCT00652392|Adrenergic Agents|adrenergic agents|mesh-ancestor
101953805|NCT03788889|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101970128|NCT05980598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305049|NCT02016729|Trametinib|trametinib|mesh-list
101953806|NCT03788889|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101509753|NCT00520949|Bismuth|bismuth|mesh-list
101953807|NCT03788889|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101953808|NCT03788733|Melatonin|melatonin|mesh-list
101953809|NCT03788733|Antioxidants|antioxidants|mesh-ancestor
101953810|NCT03788733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953811|NCT03788733|Protective Agents|protective agents|mesh-ancestor
101953812|NCT03788733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953813|NCT03788733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101953814|NCT03791463|Salvianolic acid A|salvianolic acid a|mesh-list
101509948|NCT00522743|Hormones|hormones|mesh-list
101953815|NCT03791463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101953816|NCT03791463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101953817|NCT03791463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953818|NCT03791463|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101953819|NCT04753515|Midazolam|midazolam|mesh-list
101953820|NCT04753515|Dexmedetomidine|dexmedetomidine|mesh-list
101953821|NCT04753515|Remifentanil|remifentanil|mesh-list
101953822|NCT04753515|Propofol|propofol|mesh-list
101953823|NCT04753515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101953824|NCT04753515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101953825|NCT04753515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953826|NCT04753515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101953827|NCT04753515|Analgesics|analgesics|mesh-ancestor
101953828|NCT04753515|Sensory System Agents|sensory system agents|mesh-ancestor
101953829|NCT04753515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101953830|NCT04753515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101953831|NCT04753515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101510302|NCT00524186|Vitamins|vitamins|mesh-ancestor
101953832|NCT04753515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101953833|NCT04753515|Adrenergic Agents|adrenergic agents|mesh-ancestor
101953834|NCT04753515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101953835|NCT04753515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953836|NCT04753515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101953837|NCT04753515|Anesthetics, General|anesthetics, general|mesh-ancestor
101953838|NCT04753515|Anesthetics|anesthetics|mesh-ancestor
101953839|NCT04753515|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101953840|NCT04753515|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101953841|NCT04753515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101953842|NCT04753515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101953843|NCT04753515|GABA Modulators|gaba modulators|mesh-ancestor
101953844|NCT04753515|GABA Agents|gaba agents|mesh-ancestor
101953845|NCT04753515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101953846|NCT04753515|Narcotics|narcotics|mesh-ancestor
101953847|NCT01306461|Timolol|timolol|mesh-list
101953848|NCT01306461|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101953849|NCT01306461|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101953850|NCT01306461|Adrenergic Agents|adrenergic agents|mesh-ancestor
101953851|NCT01306461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101953852|NCT01306461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953853|NCT01306461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953854|NCT01306461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101953855|NCT01306461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101953856|NCT01305837|Methylprednisolone|methylprednisolone|mesh-list
101953857|NCT01305837|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101953860|NCT01305837|Prednisolone acetate|prednisolone acetate|mesh-list
101953861|NCT01305837|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101953862|NCT01305837|Prednisolone phosphate|prednisolone phosphate|mesh-list
101953863|NCT01305837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101953864|NCT01305837|Antiemetics|antiemetics|mesh-ancestor
101953865|NCT01305837|Autonomic Agents|autonomic agents|mesh-ancestor
101510731|NCT02945241|Vancomycin|vancomycin|mesh-list
101953866|NCT01305837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101953867|NCT01305837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953868|NCT01305837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101953869|NCT01305837|Glucocorticoids|glucocorticoids|mesh-ancestor
101953870|NCT01305837|Hormones|hormones|mesh-ancestor
101953871|NCT01305837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101953872|NCT01305837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101953873|NCT01305837|Protective Agents|protective agents|mesh-ancestor
101953874|NCT01305837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101953875|NCT01305837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101381744|NCT00278122|Paclitaxel|paclitaxel|mesh-list
101953876|NCT01306773|Oseltamivir|oseltamivir|mesh-list
101953877|NCT01306773|Antiviral Agents|antiviral agents|mesh-ancestor
101953878|NCT01306773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101953879|NCT01306773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101953880|NCT01306773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953881|NCT03790605|Curcumin|curcumin|mesh-list
101953882|NCT03790605|Iproplatin|iproplatin|mesh-list
101953883|NCT03790605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101953884|NCT03790605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101953885|NCT03790605|Analgesics|analgesics|mesh-ancestor
101953887|NCT03790605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101953888|NCT03790605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953889|NCT03790605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101953890|NCT03790605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101953891|NCT03790605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101953892|NCT03790605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101953893|NCT03790605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953894|NCT03787953|Antibodies|antibodies|mesh-list
101953895|NCT03787953|Immunologic Factors|immunologic factors|mesh-ancestor
101953896|NCT03787953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953897|NCT05590689|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101953898|NCT05590689|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101953899|NCT05590689|Dermatologic Agents|dermatologic agents|mesh-ancestor
101953900|NCT01306851|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101953902|NCT01306851|Coagulants|coagulants|mesh-ancestor
101953903|NCT03790215|Dydrogesterone|dydrogesterone|mesh-list
101953904|NCT03790215|Progestins|progestins|mesh-ancestor
101953905|NCT03790215|Hormones|hormones|mesh-ancestor
101510983|NCT02924337|Moxifloxacin|moxifloxacin|mesh-list
101953906|NCT03790215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101953907|NCT03790215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953908|NCT03790371|Misoprostol|misoprostol|mesh-list
101953909|NCT03790371|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101953910|NCT03790371|Abortifacient Agents|abortifacient agents|mesh-ancestor
101953911|NCT03790371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101953912|NCT03790371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953913|NCT03790371|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101953914|NCT03790371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101953915|NCT03790371|Oxytocics|oxytocics|mesh-ancestor
101953916|NCT01307475|Adenosine|adenosine|mesh-list
101953917|NCT01307475|Analgesics|analgesics|mesh-ancestor
101953918|NCT01307475|Sensory System Agents|sensory system agents|mesh-ancestor
101953919|NCT01307475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101953920|NCT01307475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953921|NCT01307475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101953922|NCT01307475|Vasodilator Agents|vasodilator agents|mesh-ancestor
101953923|NCT01307475|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101953924|NCT01307475|Purinergic Agonists|purinergic agonists|mesh-ancestor
101953925|NCT01307475|Purinergic Agents|purinergic agents|mesh-ancestor
101953926|NCT01307475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101511269|NCT02944292|Propofol|propofol|mesh-list
101953927|NCT01307475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953928|NCT03787641|Protamines|protamines|mesh-list
101953929|NCT03787641|Heparin Antagonists|heparin antagonists|mesh-ancestor
101953930|NCT03787641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953931|NCT03787641|Coagulants|coagulants|mesh-ancestor
101953933|NCT03790293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101953934|NCT03790293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101953935|NCT03790293|Immunologic Factors|immunologic factors|mesh-ancestor
101953936|NCT03790293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953937|NCT03790293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101953938|NCT03245450|Irinotecan|irinotecan|mesh-list
101953939|NCT03245450|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101953940|NCT03245450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101953941|NCT03245450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101953942|NCT03245450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953943|NCT03245450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101953944|NCT05694585|Esmolol|esmolol|mesh-list
101953945|NCT05694585|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101953946|NCT05694585|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101511635|NCT02920710|Hormones|hormones|mesh-ancestor
101953948|NCT05694585|Adrenergic Agents|adrenergic agents|mesh-ancestor
101953949|NCT05694585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101953950|NCT05694585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953951|NCT05694585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953952|NCT03712917|Topiramate|topiramate|mesh-list
101953953|NCT03712917|Flunarizine|flunarizine|mesh-list
101953954|NCT03712917|Anticonvulsants|anticonvulsants|mesh-ancestor
101953955|NCT03712917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101953956|NCT03712917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953957|NCT03712917|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101511768|NCT02920047|Vasodilator Agents|vasodilator agents|mesh-ancestor
101953958|NCT03712917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101953959|NCT03712917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953960|NCT03712917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101953962|NCT03712917|Histamine Antagonists|histamine antagonists|mesh-ancestor
101953964|NCT03712917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101953965|NCT03712917|Vasodilator Agents|vasodilator agents|mesh-ancestor
101953967|NCT03787017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101953968|NCT03787017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953969|NCT01307865|Mannitol|mannitol|mesh-list
101953970|NCT01307865|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101953971|NCT01307865|Diuretics|diuretics|mesh-ancestor
101953972|NCT01307865|Natriuretic Agents|natriuretic agents|mesh-ancestor
101953973|NCT01307865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953975|NCT01308177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101953976|NCT01308177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101512121|NCT02910570|Liraglutide|liraglutide|mesh-list
101953977|NCT01308177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101953978|NCT01308177|Protease Inhibitors|protease inhibitors|mesh-ancestor
101953979|NCT01308177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101953980|NCT01308177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953981|NCT01308177|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101953982|NCT01308177|Protective Agents|protective agents|mesh-ancestor
101953983|NCT01308177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953984|NCT01308177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101953986|NCT01308255|Folic Acid|folic acid|mesh-list
101953987|NCT01308255|Methylprednisolone|methylprednisolone|mesh-list
101953988|NCT01308255|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101953989|NCT01308255|Infliximab|infliximab|mesh-list
101953990|NCT01308255|Methotrexate|methotrexate|mesh-list
101953991|NCT01308255|Micronutrients|micronutrients|mesh-ancestor
101512246|NCT01290718|Trastuzumab|trastuzumab|mesh-list
101953992|NCT01308255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953993|NCT01308255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101953994|NCT01308255|Abortifacient Agents|abortifacient agents|mesh-ancestor
101953995|NCT01308255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101953996|NCT01308255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101953997|NCT01308255|Antimetabolites|antimetabolites|mesh-ancestor
101953998|NCT01308255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953999|NCT01308255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101954000|NCT01308255|Dermatologic Agents|dermatologic agents|mesh-ancestor
101954001|NCT01308255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101954002|NCT01308255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101954003|NCT01308255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101954004|NCT01308255|Immunologic Factors|immunologic factors|mesh-ancestor
101512320|NCT02909751|Vitamin E|vitamin e|mesh-list
101954005|NCT01308255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101954006|NCT01308255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101954007|NCT01308255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101954008|NCT01308255|Antiemetics|antiemetics|mesh-ancestor
101512450|NCT01289782|Simeprevir|simeprevir|mesh-list
101954010|NCT01308255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101954011|NCT01308255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101954012|NCT01308255|Glucocorticoids|glucocorticoids|mesh-ancestor
101954014|NCT01308255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101954015|NCT01308255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101954016|NCT01308255|Protective Agents|protective agents|mesh-ancestor
101954017|NCT01308255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101954018|NCT01308255|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101954019|NCT01308255|Hematinics|hematinics|mesh-ancestor
101954020|NCT01308255|Vitamin B Complex|vitamin b complex|mesh-ancestor
101954021|NCT03782025|Vitamin K 1|vitamin k 1|mesh-list
101954022|NCT03782025|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101954023|NCT03782025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101305054|NCT02016807|Sucralfate|sucralfate|mesh-list
101954024|NCT03782025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954025|NCT03782025|Hemostatics|hemostatics|mesh-ancestor
101954026|NCT03782025|Coagulants|coagulants|mesh-ancestor
101954027|NCT03782025|Vitamins|vitamins|mesh-ancestor
101954028|NCT03782025|Micronutrients|micronutrients|mesh-ancestor
101954030|NCT03781947|Antarelix|antarelix|mesh-list
101954031|NCT03781947|Hormone Antagonists|hormone antagonists|mesh-ancestor
101954032|NCT03781947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101954033|NCT03781947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954034|NCT03781869|Cisplatin|cisplatin|mesh-list
101954035|NCT03781869|Etoposide|etoposide|mesh-list
101673827|NCT02801786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101954036|NCT03781869|Etoposide phosphate|etoposide phosphate|mesh-list
101954037|NCT03781869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101954038|NCT03781869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101954039|NCT03781869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101954040|NCT03781869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101954041|NCT03781869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101512883|NCT02932397|Propofol|propofol|mesh-list
101954042|NCT03781869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954043|NCT01311765|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101954044|NCT01311765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101954045|NCT03781635|Ketamine|ketamine|mesh-list
101954046|NCT03781635|Analgesics|analgesics|mesh-ancestor
101954047|NCT03781635|Sensory System Agents|sensory system agents|mesh-ancestor
101954048|NCT03781635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101954049|NCT03781635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954050|NCT03781635|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101954051|NCT03781635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101954052|NCT03781635|Anesthetics, General|anesthetics, general|mesh-ancestor
101954053|NCT03781635|Anesthetics|anesthetics|mesh-ancestor
101513020|NCT02889835|Disinfectants|disinfectants|mesh-ancestor
101954054|NCT03781635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101954055|NCT03781635|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101954056|NCT03781635|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101954057|NCT03781635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101954058|NCT03781635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954059|NCT03781713|Anti-Infective Agents|anti-infective agents|mesh-list
101954060|NCT03781713|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101954061|NCT03781011|Choline|choline|mesh-list
101954062|NCT03781011|Lipotropic Agents|lipotropic agents|mesh-ancestor
101954063|NCT03781011|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101954064|NCT03781011|Antimetabolites|antimetabolites|mesh-ancestor
101954065|NCT03781011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954066|NCT03781011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101954067|NCT03781011|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101954068|NCT03781011|Nootropic Agents|nootropic agents|mesh-ancestor
101954069|NCT03785613|Buprenorphine|buprenorphine|mesh-list
101954070|NCT03785613|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101954071|NCT03785613|Narcotics|narcotics|mesh-ancestor
101954072|NCT03785613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101954073|NCT03785613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954075|NCT03785613|Sensory System Agents|sensory system agents|mesh-ancestor
101954076|NCT03785613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101954077|NCT03785613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101954078|NCT03785223|Methylphenidate|methylphenidate|mesh-list
101954079|NCT03785223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101954080|NCT03785223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954081|NCT03785223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101954082|NCT03785223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101954083|NCT03785223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101513293|NCT02932761|Goserelin|goserelin|mesh-list
101954084|NCT03785223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954085|NCT03785223|Dopamine Agents|dopamine agents|mesh-ancestor
101954086|NCT03785223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101954088|NCT01308723|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101954089|NCT01308723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101954090|NCT01308723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101954091|NCT01308723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970142|NCT05980559|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
101954092|NCT01308723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954093|NCT01308723|Immunologic Factors|immunologic factors|mesh-ancestor
101954094|NCT01308723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513509|NCT02920658|Betamethasone|betamethasone|mesh-list
101954096|NCT01561131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101954097|NCT01561131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954099|NCT01313403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101954100|NCT03780621|Andrographolide|andrographolide|mesh-list
101954101|NCT03780621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101954102|NCT03780621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101954103|NCT03780621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101954104|NCT03780621|Analgesics|analgesics|mesh-ancestor
101954105|NCT03780621|Sensory System Agents|sensory system agents|mesh-ancestor
101954106|NCT03780621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101513715|NCT02919371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101954107|NCT03780621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954108|NCT03780621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101954109|NCT03780621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101954110|NCT03780621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101954111|NCT03780621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101954112|NCT03780621|Antiviral Agents|antiviral agents|mesh-ancestor
101954113|NCT03780621|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101954116|NCT03785067|Indapamide|indapamide|mesh-list
101954117|NCT03785067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101954118|NCT03785067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101954119|NCT03785067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101954120|NCT03785067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954121|NCT03785067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101954122|NCT03785067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954123|NCT03785067|Vasodilator Agents|vasodilator agents|mesh-ancestor
101954124|NCT03785067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101954125|NCT03785067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101954126|NCT03785067|Diuretics|diuretics|mesh-ancestor
101514147|NCT00532818|Hydralazine|hydralazine|mesh-list
101954128|NCT03785067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101954129|NCT05688111|Tranexamic Acid|tranexamic acid|mesh-list
101954131|NCT05688111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101954132|NCT05688111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954134|NCT05688111|Coagulants|coagulants|mesh-ancestor
101954135|NCT02059018|Diclofenac|diclofenac|mesh-list
101954136|NCT02059018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
101954137|NCT02059018|Nitroglycerin|nitroglycerin|mesh-list
101954138|NCT02059018|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101514439|NCT05471453|Tocotrienols|tocotrienols|mesh-list
101954139|NCT02059018|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101954140|NCT02059018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101954141|NCT02059018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101954143|NCT02059018|Sensory System Agents|sensory system agents|mesh-ancestor
101954144|NCT02059018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101514586|NCT00593710|Sympatholytics|sympatholytics|mesh-ancestor
101954145|NCT02059018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954146|NCT02059018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101954147|NCT02059018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101954148|NCT02059018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101954149|NCT02059018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954150|NCT02059018|Vasodilator Agents|vasodilator agents|mesh-ancestor
101954151|NCT01561209|Amitriptyline|amitriptyline|mesh-list
101954152|NCT01561209|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101954153|NCT01561209|Antidepressive Agents|antidepressive agents|mesh-ancestor
101954154|NCT01561209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101954155|NCT01561209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101954156|NCT01561209|Analgesics|analgesics|mesh-ancestor
101954157|NCT01561209|Sensory System Agents|sensory system agents|mesh-ancestor
101514800|NCT05558449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101954158|NCT01561209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101514901|NCT02888899|Psyllium|psyllium|mesh-list
101954159|NCT01561209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954160|NCT01561209|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101970143|NCT05980559|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101970144|NCT05980559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101970145|NCT05980559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971980|NCT01339676|Micronutrients|micronutrients|mesh-ancestor
101954161|NCT01561209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101954162|NCT01561209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101954163|NCT01561209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954165|NCT01561209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101954166|NCT02800642|Aflibercept|aflibercept|mesh-list
101954167|NCT02800642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101954168|NCT02800642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101954169|NCT02800642|Growth Substances|growth substances|mesh-ancestor
101954170|NCT02800642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954172|NCT02800642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101954173|NCT02056600|Metformin|metformin|mesh-list
101954174|NCT02056600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101954175|NCT02056600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954176|NCT02056678|Acetaminophen|acetaminophen|mesh-list
101954177|NCT02056678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101954178|NCT02056678|Analgesics|analgesics|mesh-ancestor
101954179|NCT02056678|Sensory System Agents|sensory system agents|mesh-ancestor
101954180|NCT02056678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101515154|NCT00598429|Alprostadil|alprostadil|mesh-list
101954181|NCT02056678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954183|NCT04662567|Acetaminophen|acetaminophen|mesh-list
101954184|NCT04662567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101673983|NCT02715336|Leuprolide|leuprolide|mesh-list
101954186|NCT04662567|Sensory System Agents|sensory system agents|mesh-ancestor
101515228|NCT00624208|Droperidol|droperidol|mesh-list
101954187|NCT04662567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101954188|NCT04662567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954189|NCT04662567|Antipyretics|antipyretics|mesh-ancestor
101954190|NCT02799784|Albuterol|albuterol|mesh-list
101515298|NCT05469984|Gentamicins|gentamicins|mesh-list
101954191|NCT02799784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101954192|NCT02799784|Autonomic Agents|autonomic agents|mesh-ancestor
101954193|NCT02799784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101954194|NCT02799784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954196|NCT02799784|Respiratory System Agents|respiratory system agents|mesh-ancestor
101954197|NCT02799784|Tocolytic Agents|tocolytic agents|mesh-ancestor
101954198|NCT02799784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101954199|NCT02799784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101954200|NCT02799784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101954201|NCT02799784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101954202|NCT02799784|Adrenergic Agents|adrenergic agents|mesh-ancestor
101954203|NCT02799784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101954204|NCT02799784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954205|NCT03779685|Anesthetics|anesthetics|mesh-list
101954206|NCT03779685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101954207|NCT03779685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954208|NCT03779451|Progesterone|progesterone|mesh-list
101954209|NCT03779451|Progestins|progestins|mesh-ancestor
101954210|NCT03779451|Hormones|hormones|mesh-ancestor
101954211|NCT03779451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101954212|NCT03779451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954213|NCT02059330|Palbociclib|palbociclib|mesh-list
101954214|NCT02059330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101954215|NCT02059330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101954216|NCT02059330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101515854|NCT03795701|Liraglutide|liraglutide|mesh-list
101954217|NCT02059330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954218|NCT03784443|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
101954219|NCT03784443|Ranibizumab|ranibizumab|mesh-list
101954220|NCT03784443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101954221|NCT03784443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101954222|NCT03784443|Growth Substances|growth substances|mesh-ancestor
101954223|NCT03784443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954224|NCT03784443|Growth Inhibitors|growth inhibitors|mesh-ancestor
101954225|NCT03784443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101954226|NCT03784443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101954227|NCT03784443|Glucocorticoids|glucocorticoids|mesh-ancestor
101954228|NCT03784443|Hormones|hormones|mesh-ancestor
101970146|NCT05980559|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101970147|NCT05980559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101970148|NCT05980559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970149|NCT05980559|Cholinergic Agents|cholinergic agents|mesh-ancestor
101970150|NCT05980559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101970151|NCT05980481|Capecitabine|capecitabine|mesh-list
101970152|NCT05980481|Oxaliplatin|oxaliplatin|mesh-list
101970153|NCT05980481|Trastuzumab|trastuzumab|mesh-list
101970154|NCT05980481|Disitamab vedotin|disitamab vedotin|mesh-list
101970155|NCT05980481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101954229|NCT03784443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101954230|NCT02054806|Pembrolizumab|pembrolizumab|mesh-list
101954231|NCT02054806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101954232|NCT02054806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101954233|NCT02054806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101954234|NCT02054806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954235|NCT02054884|Paclitaxel|paclitaxel|mesh-list
101954236|NCT02054884|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101954237|NCT02054884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101954238|NCT02054884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101954239|NCT02054884|Tubulin Modulators|tubulin modulators|mesh-ancestor
101954240|NCT02054884|Antimitotic Agents|antimitotic agents|mesh-ancestor
101954241|NCT02054884|Mitosis Modulators|mitosis modulators|mesh-ancestor
101954242|NCT02054884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954243|NCT01333072|Risperidone|risperidone|mesh-list
101954244|NCT01333072|Aripiprazole|aripiprazole|mesh-list
101954245|NCT01333072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101954246|NCT01333072|Serotonin Agents|serotonin agents|mesh-ancestor
101954247|NCT01333072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101954248|NCT01333072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954249|NCT01333072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954250|NCT01333072|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101954251|NCT01333072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101954252|NCT01333072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101954253|NCT01333072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101954254|NCT01333072|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101954255|NCT01333072|Dopamine Agents|dopamine agents|mesh-ancestor
101516192|NCT04180436|Anticoagulants|anticoagulants|mesh-ancestor
101954256|NCT01333072|Antidepressive Agents|antidepressive agents|mesh-ancestor
101954257|NCT01333072|Dopamine Agonists|dopamine agonists|mesh-ancestor
101674052|NCT02790164|Rocuronium|rocuronium|mesh-list
101516258|NCT00537888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101954258|NCT01333072|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101954259|NCT01333072|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101954260|NCT01333072|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101516333|NCT01244620|Tadalafil|tadalafil|mesh-list
101954261|NCT01333072|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101954264|NCT01560663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101954265|NCT01560663|Tubulin Modulators|tubulin modulators|mesh-ancestor
101954266|NCT01560663|Antimitotic Agents|antimitotic agents|mesh-ancestor
101954267|NCT01560663|Mitosis Modulators|mitosis modulators|mesh-ancestor
101954268|NCT01560663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954269|NCT02059564|Liraglutide|liraglutide|mesh-list
101954270|NCT02059564|Exenatide|exenatide|mesh-list
101954271|NCT02059564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101954272|NCT02059564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954273|NCT02059564|Incretins|incretins|mesh-ancestor
101954274|NCT02059564|Hormones|hormones|mesh-ancestor
101954275|NCT02059564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101954276|NCT02059564|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101954277|NCT05622058|Cyclophosphamide|cyclophosphamide|mesh-list
101954278|NCT05622058|Docetaxel|docetaxel|mesh-list
101954279|NCT05622058|Doxorubicin|doxorubicin|mesh-list
101954280|NCT05622058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101954281|NCT05622058|Immunologic Factors|immunologic factors|mesh-ancestor
101970156|NCT05980481|Antimetabolites|antimetabolites|mesh-ancestor
101970157|NCT05980481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970158|NCT05980481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970159|NCT05980481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101970160|NCT05980481|Immunoconjugates|immunoconjugates|mesh-ancestor
101970161|NCT05980481|Immunologic Factors|immunologic factors|mesh-ancestor
101970162|NCT05980481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970163|NCT05979597|Dexamethasone|dexamethasone|mesh-list
101970164|NCT05979597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101970165|NCT05979597|Antiemetics|antiemetics|mesh-ancestor
101970166|NCT05979597|Autonomic Agents|autonomic agents|mesh-ancestor
101970167|NCT05979597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101970168|NCT05979597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970169|NCT05979597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101970170|NCT05979597|Glucocorticoids|glucocorticoids|mesh-ancestor
101954282|NCT05622058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954283|NCT05622058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101954284|NCT05622058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101954285|NCT05622058|Alkylating Agents|alkylating agents|mesh-ancestor
101954286|NCT05622058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954287|NCT05622058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101954288|NCT05622058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101954289|NCT05622058|Tubulin Modulators|tubulin modulators|mesh-ancestor
101516527|NCT01266265|Ambrisentan|ambrisentan|mesh-list
101954291|NCT05622058|Mitosis Modulators|mitosis modulators|mesh-ancestor
101954292|NCT05622058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101954293|NCT05622058|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101954294|NCT05622058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101954295|NCT05622058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101954296|NCT02055196|Irinotecan|irinotecan|mesh-list
101954297|NCT02055196|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101954298|NCT02055196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101954299|NCT02055196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101954300|NCT02055196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954301|NCT02055196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101954302|NCT02055274|Rotigotine|rotigotine|mesh-list
101954303|NCT02055274|Dopamine Agonists|dopamine agonists|mesh-ancestor
101954304|NCT02055274|Dopamine Agents|dopamine agents|mesh-ancestor
101954305|NCT02055274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101954306|NCT02055274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954307|NCT02055274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954308|NCT03783897|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101954309|NCT03783897|Norgestimate|norgestimate|mesh-list
101954310|NCT03783897|Contraceptive Agents|contraceptive agents|mesh-list
101954311|NCT03783897|Contraceptives, Oral|contraceptives, oral|mesh-list
101954312|NCT03783897|Estradiol|estradiol|mesh-list
101954313|NCT03783897|Estrogens|estrogens|mesh-ancestor
101954314|NCT03783897|Hormones|hormones|mesh-ancestor
101516877|NCT00945152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101954315|NCT03783897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101954316|NCT03783897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954317|NCT03783897|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101954318|NCT03783897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101954319|NCT03783897|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101954320|NCT03783897|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101954321|NCT03783897|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101954322|NCT03779061|Propofol|propofol|mesh-list
101954323|NCT03779061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101954324|NCT03779061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101970172|NCT05979597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101970173|NCT05979597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101970174|NCT05979597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970175|NCT05979389|Bicalutamide|bicalutamide|mesh-list
101954325|NCT03779061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954326|NCT03779061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101954327|NCT03779061|Anesthetics, General|anesthetics, general|mesh-ancestor
101954328|NCT03779061|Anesthetics|anesthetics|mesh-ancestor
101954329|NCT01316445|Midazolam|midazolam|mesh-list
101954330|NCT01316445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101954331|NCT01316445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101954332|NCT01316445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101954333|NCT01316445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954334|NCT01316445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101954335|NCT01316445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101954336|NCT01316445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101954337|NCT01316445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101954338|NCT01316445|Anesthetics, General|anesthetics, general|mesh-ancestor
101954339|NCT01316445|Anesthetics|anesthetics|mesh-ancestor
101954340|NCT01316445|GABA Modulators|gaba modulators|mesh-ancestor
101954341|NCT01316445|GABA Agents|gaba agents|mesh-ancestor
101954342|NCT01316445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101954343|NCT01316445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954344|NCT03712449|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101954345|NCT03712449|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101954346|NCT03712449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101954347|NCT03712449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101954348|NCT03712449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954349|NCT03712449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101954350|NCT03712449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101954351|NCT03712449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954352|NCT03712449|Cholinergic Agents|cholinergic agents|mesh-ancestor
101954353|NCT03712449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101954354|NCT03517540|Cenicriviroc|cenicriviroc|mesh-list
101954355|NCT03517540|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101954356|NCT03517540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954357|NCT03517540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101954358|NCT03517540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101954359|NCT03517540|Antiviral Agents|antiviral agents|mesh-ancestor
101954360|NCT03517540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101954361|NCT03778359|Leuprolide|leuprolide|mesh-list
101954362|NCT03778359|Dienogest|dienogest|mesh-list
101954363|NCT03778359|Levonorgestrel|levonorgestrel|mesh-list
101954364|NCT03778359|Progestins|progestins|mesh-list
101954365|NCT03778359|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101954366|NCT03778359|Contraceptive Agents|contraceptive agents|mesh-ancestor
101954367|NCT03778359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101954368|NCT03778359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954369|NCT03778359|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101954370|NCT03778359|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101954371|NCT03778359|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101954372|NCT03778359|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101954373|NCT03778359|Fertility Agents|fertility agents|mesh-ancestor
101954374|NCT03778359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101954375|NCT03778359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101954376|NCT03778359|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101954377|NCT03778359|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101954378|NCT03778359|Hormone Antagonists|hormone antagonists|mesh-ancestor
101954379|NCT03778359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101954380|NCT03778359|Hormones|hormones|mesh-ancestor
101954381|NCT03560908|Dasatinib|dasatinib|mesh-list
101954382|NCT03560908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101954383|NCT03560908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101954384|NCT03560908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101954385|NCT03560908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954386|NCT02057770|Cyclophosphamide|cyclophosphamide|mesh-list
101954387|NCT02057770|Busulfan|busulfan|mesh-list
101954388|NCT02057770|Fludarabine|fludarabine|mesh-list
101954389|NCT02057770|Fludarabine phosphate|fludarabine phosphate|mesh-list
101970177|NCT05979389|Hormone Antagonists|hormone antagonists|mesh-ancestor
101970178|NCT05979389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101970179|NCT05979389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970180|NCT05979389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101954390|NCT02057770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101954391|NCT02057770|Immunologic Factors|immunologic factors|mesh-ancestor
101954392|NCT02057770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954393|NCT02057770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101954394|NCT02057770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101517414|NCT00535158|Vitamin D|vitamin d|mesh-list
101954395|NCT02057770|Alkylating Agents|alkylating agents|mesh-ancestor
101954396|NCT02057770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954397|NCT02057770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101954398|NCT02057770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101954399|NCT02057770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101954400|NCT02057770|Antimetabolites|antimetabolites|mesh-ancestor
101954401|NCT03778281|Baclofen|baclofen|mesh-list
101954402|NCT03778281|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101954403|NCT03778281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314763|NCT00001213|Cysteamine|cysteamine|mesh-list
101954404|NCT03778281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101954405|NCT03778281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101954406|NCT03778281|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101674200|NCT00941161|Immunologic Factors|immunologic factors|mesh-ancestor
101954407|NCT03778281|GABA Agonists|gaba agonists|mesh-ancestor
101954408|NCT03778281|GABA Agents|gaba agents|mesh-ancestor
101954409|NCT03778281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101954410|NCT03778281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954411|NCT02055586|Alovudine|alovudine|mesh-list
101954412|NCT02055586|Fluorides|fluorides|mesh-list
101954413|NCT02055586|Cariostatic Agents|cariostatic agents|mesh-ancestor
101954414|NCT02055586|Protective Agents|protective agents|mesh-ancestor
101954415|NCT02055586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954416|NCT02055586|Antiviral Agents|antiviral agents|mesh-ancestor
101954417|NCT02055586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101954418|NCT03778593|Leucovorin|leucovorin|mesh-list
101954419|NCT03778593|Fluorouracil|fluorouracil|mesh-list
101954420|NCT03778593|Oxaliplatin|oxaliplatin|mesh-list
101954421|NCT03778593|Irinotecan|irinotecan|mesh-list
101954422|NCT03778593|Antimetabolites|antimetabolites|mesh-ancestor
101954423|NCT03778593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954424|NCT03778593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101954425|NCT03778593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101954426|NCT03778593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101954427|NCT03778593|Immunologic Factors|immunologic factors|mesh-ancestor
101954428|NCT03778593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954429|NCT03778593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101954430|NCT03778593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101954431|NCT03778593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101954432|NCT03778593|Antidotes|antidotes|mesh-ancestor
101954433|NCT03778593|Protective Agents|protective agents|mesh-ancestor
101954434|NCT03778593|Vitamin B Complex|vitamin b complex|mesh-ancestor
101954435|NCT03778593|Vitamins|vitamins|mesh-ancestor
101954436|NCT03778593|Micronutrients|micronutrients|mesh-ancestor
101954437|NCT02055664|Ropivacaine|ropivacaine|mesh-list
101954438|NCT02055664|Anesthetics, Local|anesthetics, local|mesh-ancestor
101954439|NCT02055664|Anesthetics|anesthetics|mesh-ancestor
101954440|NCT02055664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101954441|NCT02055664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954442|NCT02055664|Sensory System Agents|sensory system agents|mesh-ancestor
101954443|NCT02055664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101954444|NCT01309425|Tapentadol|tapentadol|mesh-list
101954445|NCT01309425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101954446|NCT01309425|Narcotics|narcotics|mesh-ancestor
101954447|NCT01309425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101954448|NCT01309425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954449|NCT01309425|Analgesics|analgesics|mesh-ancestor
101954450|NCT01309425|Sensory System Agents|sensory system agents|mesh-ancestor
101954451|NCT01309425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101954452|NCT01309425|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101954453|NCT01309425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101970181|NCT05979038|Metformin|metformin|mesh-list
101970182|NCT05979038|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101305102|NCT02017340|Nilvadipine|nilvadipine|mesh-list
101954454|NCT01309425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101954455|NCT01309425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954456|NCT01309425|Adrenergic Agents|adrenergic agents|mesh-ancestor
101954457|NCT01309425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101954458|NCT03561298|Zanubrutinib|zanubrutinib|mesh-list
101954459|NCT03561298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101954460|NCT03561298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101690309|NCT00652860|Doxorubicin|doxorubicin|mesh-list
101954461|NCT03561298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101954462|NCT03561298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954463|NCT05648422|Nitazoxanide|nitazoxanide|mesh-list
101954464|NCT05648422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101954465|NCT05648422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101954466|NCT02057926|Tetracycline|tetracycline|mesh-list
101954467|NCT02057926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101954468|NCT02057926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101954469|NCT02057926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101954470|NCT02057926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101954471|NCT02057926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954472|NCT03777579|Paclitaxel|paclitaxel|mesh-list
101954473|NCT03777579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101954474|NCT03777579|Antibodies|antibodies|mesh-list
101954475|NCT03777579|Immunoglobulins|immunoglobulins|mesh-list
101954476|NCT03777579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101954477|NCT03777579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101954478|NCT03777579|Tubulin Modulators|tubulin modulators|mesh-ancestor
101674283|NCT00925769|Antimetabolites|antimetabolites|mesh-ancestor
101954479|NCT03777579|Antimitotic Agents|antimitotic agents|mesh-ancestor
101954480|NCT03777579|Mitosis Modulators|mitosis modulators|mesh-ancestor
101954481|NCT03777579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954482|NCT03777579|Immunologic Factors|immunologic factors|mesh-ancestor
101954483|NCT03777579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954485|NCT02059876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101954486|NCT02059876|Carboplatin|carboplatin|mesh-list
101954487|NCT02059876|Trastuzumab|trastuzumab|mesh-list
101954488|NCT02059876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101954489|NCT02059876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101954490|NCT02059876|Tubulin Modulators|tubulin modulators|mesh-ancestor
101954491|NCT02059876|Antimitotic Agents|antimitotic agents|mesh-ancestor
101954492|NCT02059876|Mitosis Modulators|mitosis modulators|mesh-ancestor
101954493|NCT02059876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954494|NCT02059876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101954495|NCT03777423|Cobalt|cobalt|mesh-list
101954496|NCT03777423|Chromium|chromium|mesh-list
101954497|NCT03777423|Trace Elements|trace elements|mesh-ancestor
101954498|NCT03777423|Micronutrients|micronutrients|mesh-ancestor
101954499|NCT03777423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954500|NCT05654662|Listerine|listerine|mesh-list
101954501|NCT05654662|Chlorhexidine|chlorhexidine|mesh-list
101954502|NCT05654662|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101954503|NCT05654662|Sodium Fluoride|sodium fluoride|mesh-list
101954504|NCT05654662|Cariostatic Agents|cariostatic agents|mesh-ancestor
101954505|NCT05654662|Protective Agents|protective agents|mesh-ancestor
101954506|NCT05654662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954507|NCT05654662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101954508|NCT05654662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101954509|NCT05654662|Disinfectants|disinfectants|mesh-ancestor
101954510|NCT05654662|Dermatologic Agents|dermatologic agents|mesh-ancestor
101954511|NCT03777033|Alfacalcidol|alfacalcidol|mesh-list
101954512|NCT03777033|Calcium|calcium|mesh-list
101954513|NCT03777033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101954514|NCT03777033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954515|NCT03777033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101954516|NCT02060032|Atorvastatin|atorvastatin|mesh-list
101954517|NCT02060032|Simvastatin|simvastatin|mesh-list
101954518|NCT02060032|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101954519|NCT02060032|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101954520|NCT02060032|Antimetabolites|antimetabolites|mesh-ancestor
101954521|NCT02060032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954522|NCT02060032|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101954523|NCT02060032|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101954524|NCT02060032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970183|NCT05979038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970184|NCT05978219|Mirtazapine|mirtazapine|mesh-list
101970185|NCT05978219|Antidepressive Agents|antidepressive agents|mesh-ancestor
101970186|NCT05978219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101970187|NCT05978219|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101954525|NCT03783273|Vitamin D|vitamin d|mesh-list
101954526|NCT03783273|Cholecalciferol|cholecalciferol|mesh-list
101954527|NCT03783273|Vitamins|vitamins|mesh-ancestor
101954528|NCT03783273|Micronutrients|micronutrients|mesh-ancestor
101954529|NCT03783273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954530|NCT03783273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101954531|NCT03783273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101954532|NCT03777345|Cobalt|cobalt|mesh-list
101954533|NCT03777345|Chromium|chromium|mesh-list
101954534|NCT03777345|Trace Elements|trace elements|mesh-ancestor
101954535|NCT03777345|Micronutrients|micronutrients|mesh-ancestor
101954536|NCT03777345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954537|NCT01318005|Contraceptive Agents|contraceptive agents|mesh-list
101954538|NCT01318005|Norinyl|norinyl|mesh-list
101954539|NCT01318005|Contraceptives, Oral|contraceptives, oral|mesh-list
101954540|NCT01318005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101954541|NCT01318005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954542|NCT01318005|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101954543|NCT01318005|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101954544|NCT01318005|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101954545|NCT01318005|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101954546|NCT02799082|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101954547|NCT02799082|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101954548|NCT02799082|Dermatologic Agents|dermatologic agents|mesh-ancestor
101954549|NCT03710889|Abaloparatide|abaloparatide|mesh-list
101954550|NCT03710889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101954551|NCT03710889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954552|NCT02061124|Sevelamer|sevelamer|mesh-list
101954553|NCT02061124|Chelating Agents|chelating agents|mesh-ancestor
101954554|NCT02061124|Sequestering Agents|sequestering agents|mesh-ancestor
101954555|NCT02061124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954556|NCT01318941|Ranibizumab|ranibizumab|mesh-list
101954557|NCT01318941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101954558|NCT01318941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101954559|NCT01318941|Growth Substances|growth substances|mesh-ancestor
101954560|NCT01318941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954561|NCT01318941|Growth Inhibitors|growth inhibitors|mesh-ancestor
101954562|NCT01318941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101954563|NCT03560440|Vancomycin|vancomycin|mesh-list
101954564|NCT03560440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101954565|NCT03560440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101954566|NCT03776955|Carvedilol|carvedilol|mesh-list
101954567|NCT03776955|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101954568|NCT03776955|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101954569|NCT03776955|Adrenergic Agents|adrenergic agents|mesh-ancestor
101954570|NCT03776955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101954571|NCT03776955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954572|NCT03776955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954573|NCT03776955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101954575|NCT03776955|Protective Agents|protective agents|mesh-ancestor
101954576|NCT03776955|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101954577|NCT03776955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101954578|NCT03776955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101954579|NCT03776955|Vasodilator Agents|vasodilator agents|mesh-ancestor
101954580|NCT03776955|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101954581|NCT03776955|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101954582|NCT05102721|Avelumab|avelumab|mesh-list
101954583|NCT05102721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101954584|NCT05102721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101954585|NCT03308942|Pembrolizumab|pembrolizumab|mesh-list
101954586|NCT03308942|Niraparib|niraparib|mesh-list
101954587|NCT03308942|Dostarlimab|dostarlimab|mesh-list
101954588|NCT03308942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101954589|NCT03308942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101954590|NCT03308942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101970189|NCT05978219|Histamine Agents|histamine agents|mesh-ancestor
101970190|NCT05978219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101970191|NCT05978219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305109|NCT02017392|Lidocaine|lidocaine|mesh-list
101954591|NCT03308942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954592|NCT03308942|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101954593|NCT03308942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101954594|NCT01319019|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101954595|NCT01319019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101954596|NCT01319019|Autonomic Agents|autonomic agents|mesh-ancestor
101954597|NCT01319019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101954598|NCT01319019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954599|NCT01319019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101954600|NCT01319019|Respiratory System Agents|respiratory system agents|mesh-ancestor
101954601|NCT01319019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101954602|NCT01319019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101954603|NCT01319019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101954604|NCT01319019|Adrenergic Agents|adrenergic agents|mesh-ancestor
101954605|NCT01319019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101954606|NCT01319019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954607|NCT03308786|Aldesleukin|aldesleukin|mesh-list
101954608|NCT03308786|Interleukin-2|interleukin-2|mesh-list
101954609|NCT03308786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101954610|NCT03308786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101954611|NCT03308786|Analgesics|analgesics|mesh-ancestor
101954612|NCT03308786|Sensory System Agents|sensory system agents|mesh-ancestor
101954613|NCT03308786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101954614|NCT03308786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954615|NCT03308786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101954616|NCT03308786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101954617|NCT03308786|Antiviral Agents|antiviral agents|mesh-ancestor
101954618|NCT03308786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101954619|NCT03776409|Vancomycin|vancomycin|mesh-list
101954620|NCT03776409|Tazobactam|tazobactam|mesh-list
101954621|NCT03776409|Piperacillin|piperacillin|mesh-list
101954622|NCT03776409|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101954623|NCT03776409|Lactams|lactams|mesh-list
101954624|NCT03776409|beta-Lactams|beta-lactams|mesh-list
101954625|NCT03776409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101954626|NCT03776409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101954627|NCT03776409|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101954628|NCT03776409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101954629|NCT03776409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954630|NCT03782805|Cholecalciferol|cholecalciferol|mesh-list
101954631|NCT03782805|Vitamin D|vitamin d|mesh-list
101954632|NCT03782805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101954633|NCT03782805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954634|NCT03782805|Vitamins|vitamins|mesh-ancestor
101954635|NCT03782805|Micronutrients|micronutrients|mesh-ancestor
101954636|NCT03782805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101954637|NCT03775863|Liver Extracts|liver extracts|mesh-list
101954638|NCT03775863|Hematinics|hematinics|mesh-ancestor
101954639|NCT03274076|Tofacitinib|tofacitinib|mesh-list
101954640|NCT03274076|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101954641|NCT03274076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101954642|NCT03274076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101954643|NCT03274076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954644|NCT03775707|Lenvatinib|lenvatinib|mesh-list
101954645|NCT03775707|Antibodies|antibodies|mesh-list
101954646|NCT03775707|Immunologic Factors|immunologic factors|mesh-ancestor
101954647|NCT03775707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954648|NCT03775707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101954649|NCT03775707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101954650|NCT03775707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101954651|NCT03775707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954652|NCT01320501|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101954653|NCT01320501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101954654|NCT01320501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101954655|NCT01320501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970192|NCT05978219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970193|NCT05978219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101970194|NCT05978219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101382580|NCT00283309|Anticonvulsants|anticonvulsants|mesh-ancestor
101954656|NCT01320501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954657|NCT02764268|Apatinib|apatinib|mesh-list
101954658|NCT02764268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101954659|NCT02764268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101954660|NCT02764268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101954661|NCT02764268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954662|NCT01320111|Paclitaxel|paclitaxel|mesh-list
101954663|NCT01320111|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101954664|NCT01320111|Sorafenib|sorafenib|mesh-list
101954665|NCT01320111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101954666|NCT01320111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101954667|NCT01320111|Tubulin Modulators|tubulin modulators|mesh-ancestor
101954668|NCT01320111|Antimitotic Agents|antimitotic agents|mesh-ancestor
101954669|NCT01320111|Mitosis Modulators|mitosis modulators|mesh-ancestor
101954670|NCT01320111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954671|NCT01320111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101954672|NCT01320111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101954673|NCT01320579|Tacrolimus|tacrolimus|mesh-list
101954674|NCT01320579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101954675|NCT01320579|Immunologic Factors|immunologic factors|mesh-ancestor
101954676|NCT01320579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954677|NCT01320579|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101954678|NCT01320579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101954679|NCT01320579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954680|NCT05669001|Mycophenolic Acid|mycophenolic acid|mesh-list
101954681|NCT05669001|Abatacept|abatacept|mesh-list
101954682|NCT05669001|Tacrolimus|tacrolimus|mesh-list
101954683|NCT05669001|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101954684|NCT05669001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101954685|NCT05669001|Immunologic Factors|immunologic factors|mesh-ancestor
101954686|NCT05669001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954687|NCT05669001|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101954688|NCT05669001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101954689|NCT05669001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954690|NCT05669001|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101954691|NCT05669001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101954692|NCT05669001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101954693|NCT05669001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101954694|NCT05669001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101954695|NCT05669001|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101954696|NCT05669001|Antitubercular Agents|antitubercular agents|mesh-ancestor
101954697|NCT05669001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101954698|NCT05669001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101954699|NCT03775395|Sorafenib|sorafenib|mesh-list
101954700|NCT03775395|Lenvatinib|lenvatinib|mesh-list
101954701|NCT03775395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101954702|NCT03775395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101954703|NCT03775395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101954704|NCT03775395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954705|NCT02797522|Acetaminophen|acetaminophen|mesh-list
101954706|NCT02797522|Tenofovir|tenofovir|mesh-list
101954707|NCT02797522|Entecavir|entecavir|mesh-list
101954708|NCT02797522|Histamine Antagonists|histamine antagonists|mesh-list
101954709|NCT02797522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
101954710|NCT02797522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101954711|NCT02797522|Analgesics|analgesics|mesh-ancestor
101954712|NCT02797522|Sensory System Agents|sensory system agents|mesh-ancestor
101954713|NCT02797522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101954714|NCT02797522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954715|NCT02797522|Antipyretics|antipyretics|mesh-ancestor
101954716|NCT02797522|Antiviral Agents|antiviral agents|mesh-ancestor
101954717|NCT02797522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101954718|NCT02797522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101954719|NCT02797522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101954720|NCT02797522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101954721|NCT02797522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954722|NCT02797522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101970195|NCT05978219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101970196|NCT05978219|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101970197|NCT05978219|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101954723|NCT02797522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101954724|NCT02797522|Histamine Agents|histamine agents|mesh-ancestor
101954725|NCT02797522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101954726|NCT03773367|Fluorouracil|fluorouracil|mesh-list
101954727|NCT03773367|Oxaliplatin|oxaliplatin|mesh-list
101954728|NCT03773367|Irinotecan|irinotecan|mesh-list
101954729|NCT03773367|Antimetabolites|antimetabolites|mesh-ancestor
101954730|NCT03773367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954731|NCT03773367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101954732|NCT03773367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101954733|NCT03773367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101954734|NCT03773367|Immunologic Factors|immunologic factors|mesh-ancestor
101954735|NCT03773367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954736|NCT03773367|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101954737|NCT03773367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101954738|NCT03773367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101954739|NCT02060656|Methylprednisolone|methylprednisolone|mesh-list
101954740|NCT02060656|Rituximab|rituximab|mesh-list
101954741|NCT02060656|Gemcitabine|gemcitabine|mesh-list
101954742|NCT02060656|Lenalidomide|lenalidomide|mesh-list
101954743|NCT02060656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101954744|NCT02060656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101954745|NCT02060656|Immunologic Factors|immunologic factors|mesh-ancestor
101954746|NCT02060656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954748|NCT02060656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101954749|NCT02060656|Antimetabolites|antimetabolites|mesh-ancestor
101954750|NCT02060656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954751|NCT02060656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101954752|NCT02060656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101954753|NCT02060656|Growth Substances|growth substances|mesh-ancestor
101954754|NCT02060656|Growth Inhibitors|growth inhibitors|mesh-ancestor
101954755|NCT02060656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101954756|NCT02060656|Antiemetics|antiemetics|mesh-ancestor
101954757|NCT02060656|Autonomic Agents|autonomic agents|mesh-ancestor
101954758|NCT02060656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101954759|NCT02060656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101954760|NCT02060656|Glucocorticoids|glucocorticoids|mesh-ancestor
101954761|NCT02060656|Hormones|hormones|mesh-ancestor
101954762|NCT02060656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101954763|NCT02060656|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101954764|NCT02060656|Protective Agents|protective agents|mesh-ancestor
101954765|NCT03774771|Cinacalcet|cinacalcet|mesh-list
101954766|NCT03774771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101954767|NCT03774771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954768|NCT03774771|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101954769|NCT03774771|Hormone Antagonists|hormone antagonists|mesh-ancestor
101517704|NCT04321837|Vitamin D|vitamin d|mesh-list
101954770|NCT03774771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101954771|NCT03774693|Fentanyl|fentanyl|mesh-list
101954772|NCT03774693|Anesthetics|anesthetics|mesh-ancestor
101954773|NCT03774693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101954774|NCT03774693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954775|NCT03774693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101954776|NCT03774693|Narcotics|narcotics|mesh-ancestor
101954777|NCT03774693|Analgesics|analgesics|mesh-ancestor
101954778|NCT03774693|Sensory System Agents|sensory system agents|mesh-ancestor
101954779|NCT03774693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101954780|NCT03774693|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101954781|NCT03774693|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101954782|NCT03774693|Anesthetics, General|anesthetics, general|mesh-ancestor
101954784|NCT03774615|Hematinics|hematinics|mesh-ancestor
101954785|NCT01321047|Propofol|propofol|mesh-list
101954786|NCT01321047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101517985|NCT02895113|Aspirin|aspirin|mesh-list
101954787|NCT01321047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101954788|NCT01321047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954789|NCT01321047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101954790|NCT01321047|Anesthetics, General|anesthetics, general|mesh-ancestor
101954792|NCT01321125|Chlorhexidine|chlorhexidine|mesh-list
101954793|NCT01321125|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101970198|NCT05978219|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101382729|NCT00284791|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101954794|NCT01321125|Povidone-Iodine|povidone-iodine|mesh-list
101954795|NCT01321125|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
101954796|NCT01321125|Povidone|povidone|mesh-list
101954797|NCT01321125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101954798|NCT01321125|Disinfectants|disinfectants|mesh-ancestor
101954799|NCT01321125|Dermatologic Agents|dermatologic agents|mesh-ancestor
101954800|NCT01321125|Plasma Substitutes|plasma substitutes|mesh-ancestor
101954801|NCT01321125|Blood Substitutes|blood substitutes|mesh-ancestor
101954802|NCT03773991|Nitric Oxide|nitric oxide|mesh-list
101954803|NCT03773991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101954804|NCT03773991|Autonomic Agents|autonomic agents|mesh-ancestor
101954805|NCT03773991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101954806|NCT03773991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954807|NCT03773991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101954808|NCT03773991|Respiratory System Agents|respiratory system agents|mesh-ancestor
101954809|NCT03773991|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101954811|NCT03773991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954812|NCT03773991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101518266|NCT01260922|Donepezil|donepezil|mesh-list
101954813|NCT03773991|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101954814|NCT03773991|Vasodilator Agents|vasodilator agents|mesh-ancestor
101954815|NCT03773991|Gasotransmitters|gasotransmitters|mesh-ancestor
101954816|NCT03773991|Protective Agents|protective agents|mesh-ancestor
101954817|NCT05435313|Oxaliplatin|oxaliplatin|mesh-list
101954818|NCT05435313|Irinotecan|irinotecan|mesh-list
101954819|NCT05435313|Tislelizumab|tislelizumab|mesh-list
101954820|NCT05435313|Raltitrexed|raltitrexed|mesh-list
101954821|NCT05435313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101954822|NCT05435313|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101954823|NCT05435313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101954824|NCT05435313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101954825|NCT05435313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954826|NCT05435313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101954827|NCT05435313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101518546|NCT03540758|Niacin|niacin|mesh-list
101954830|NCT05472675|Bupivacaine|bupivacaine|mesh-list
101954831|NCT05472675|Botulinum Toxins|botulinum toxins|mesh-list
101954832|NCT05472675|Anesthetics, Local|anesthetics, local|mesh-ancestor
101954833|NCT05472675|Anesthetics|anesthetics|mesh-ancestor
101954834|NCT05472675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101954835|NCT05472675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518618|NCT05093205|GABA Agents|gaba agents|mesh-ancestor
101954836|NCT05472675|Sensory System Agents|sensory system agents|mesh-ancestor
101954837|NCT05472675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101954838|NCT05472675|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101954839|NCT05472675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101518685|NCT00554177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101954840|NCT05472675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954841|NCT05472675|Cholinergic Agents|cholinergic agents|mesh-ancestor
101954842|NCT05472675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101954843|NCT01321905|Vitamin D|vitamin d|mesh-list
101954844|NCT01321905|Ergocalciferols|ergocalciferols|mesh-list
101954845|NCT01321905|Vitamins|vitamins|mesh-ancestor
101954846|NCT01321905|Micronutrients|micronutrients|mesh-ancestor
101954847|NCT01321905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518777|NCT03455075|Levonorgestrel|levonorgestrel|mesh-list
101954848|NCT01321905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101954849|NCT01321905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101954851|NCT04570670|Dermatologic Agents|dermatologic agents|mesh-ancestor
101954852|NCT04570670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101954853|NCT04570670|Immunologic Factors|immunologic factors|mesh-ancestor
101954854|NCT04570670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954855|NCT03763227|Ranibizumab|ranibizumab|mesh-list
101954856|NCT03763227|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-list
101954857|NCT03763227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101954858|NCT03763227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101954859|NCT03763227|Growth Substances|growth substances|mesh-ancestor
101954860|NCT03763227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954861|NCT03763227|Growth Inhibitors|growth inhibitors|mesh-ancestor
101954862|NCT03763227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101954863|NCT03763227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970200|NCT05978219|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101970201|NCT05978219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101954864|NCT03763227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954865|NCT04929548|Maleic acid|maleic acid|mesh-list
101954866|NCT04929548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101954867|NCT04929548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954868|NCT04150029|Azacitidine|azacitidine|mesh-list
101954869|NCT04150029|Venetoclax|venetoclax|mesh-list
101954870|NCT04150029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101954871|NCT04150029|Antimetabolites|antimetabolites|mesh-ancestor
101954872|NCT04150029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954873|NCT04150029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101954874|NCT04150029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101954875|NCT02060734|Lidocaine|lidocaine|mesh-list
101954876|NCT02060734|Anesthetics, Local|anesthetics, local|mesh-ancestor
101954877|NCT02060734|Anesthetics|anesthetics|mesh-ancestor
101954878|NCT02060734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101954879|NCT02060734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954881|NCT02060734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101954882|NCT02060734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101954883|NCT02060734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101954884|NCT02060734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101954885|NCT02060734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101954886|NCT02060734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954887|NCT03270644|Propranolol|propranolol|mesh-list
101954888|NCT03270644|Lasmiditan|lasmiditan|mesh-list
101954889|NCT03270644|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101954890|NCT03270644|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101954891|NCT03270644|Adrenergic Agents|adrenergic agents|mesh-ancestor
101954892|NCT03270644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101954893|NCT03270644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954894|NCT03270644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954895|NCT03270644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101954896|NCT03270644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101954897|NCT03270644|Vasodilator Agents|vasodilator agents|mesh-ancestor
101954898|NCT03270644|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101954899|NCT03270644|Serotonin Agents|serotonin agents|mesh-ancestor
101954900|NCT04535102|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
101954901|NCT04535102|Immunoconjugates|immunoconjugates|mesh-ancestor
101954902|NCT04535102|Immunologic Factors|immunologic factors|mesh-ancestor
101954903|NCT04535102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954904|NCT04529720|Vaccines|vaccines|mesh-list
101519596|NCT01208038|Methyltestosterone|methyltestosterone|mesh-list
101954905|NCT04529720|Immunologic Factors|immunologic factors|mesh-ancestor
101954906|NCT04529720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954908|NCT03768609|Cyclosporins|cyclosporins|mesh-list
101954909|NCT03768609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101954910|NCT03768609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954911|NCT03768609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101954912|NCT03768609|Immunologic Factors|immunologic factors|mesh-ancestor
101954913|NCT03768609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954914|NCT03768609|Antifungal Agents|antifungal agents|mesh-ancestor
101954915|NCT03768609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101954916|NCT03768609|Dermatologic Agents|dermatologic agents|mesh-ancestor
101954917|NCT03768609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101954918|NCT03768609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101954919|NCT03269552|Rituximab|rituximab|mesh-list
101954920|NCT03269552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101954921|NCT03269552|Antibodies|antibodies|mesh-list
101954922|NCT03269552|Immunoglobulins|immunoglobulins|mesh-list
101954923|NCT03269552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101954924|NCT03269552|Immunologic Factors|immunologic factors|mesh-ancestor
101954925|NCT03269552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954926|NCT03269552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101954927|NCT03269552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101954928|NCT03771729|Valsartan|valsartan|mesh-list
101954929|NCT03771729|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101954930|NCT03771729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101954931|NCT03771729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101954932|NCT03771729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101954933|NCT03771729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970202|NCT05978219|Serotonin Agents|serotonin agents|mesh-ancestor
101970203|NCT05978219|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101970204|NCT05977673|Tislelizumab|tislelizumab|mesh-list
101970205|NCT05977673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101954934|NCT03560362|Epinephrine|epinephrine|mesh-list
101954935|NCT03560362|Bupivacaine|bupivacaine|mesh-list
101954936|NCT03560362|Anesthetics, Local|anesthetics, local|mesh-ancestor
101954937|NCT03560362|Anesthetics|anesthetics|mesh-ancestor
101674730|NCT00943501|Liraglutide|liraglutide|mesh-list
101954938|NCT03560362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101954939|NCT03560362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520087|NCT04653506|Analgesics|analgesics|mesh-ancestor
101954940|NCT03560362|Sensory System Agents|sensory system agents|mesh-ancestor
101954941|NCT03560362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101954942|NCT03560362|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101954943|NCT03560362|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101954944|NCT03560362|Adrenergic Agents|adrenergic agents|mesh-ancestor
101520164|NCT04652648|Hydroxychloroquine|hydroxychloroquine|mesh-list
101954945|NCT03560362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101954946|NCT03560362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954947|NCT03560362|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101954948|NCT03560362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101954950|NCT03560362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101954951|NCT03560362|Respiratory System Agents|respiratory system agents|mesh-ancestor
101954952|NCT03560362|Mydriatics|mydriatics|mesh-ancestor
101954953|NCT03560362|Sympathomimetics|sympathomimetics|mesh-ancestor
101520301|NCT00557921|Antipyretics|antipyretics|mesh-ancestor
101954954|NCT03560362|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101954955|NCT03768531|Nivolumab|nivolumab|mesh-list
101954956|NCT03768531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101954957|NCT03768531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101954958|NCT03768531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101954959|NCT03768531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954961|NCT01322061|Vitamins|vitamins|mesh-ancestor
101954962|NCT01322061|Micronutrients|micronutrients|mesh-ancestor
101954963|NCT01322061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954964|NCT01322061|Antioxidants|antioxidants|mesh-ancestor
101954965|NCT01322061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954966|NCT01322061|Protective Agents|protective agents|mesh-ancestor
101954967|NCT02062996|Phenylephrine|phenylephrine|mesh-list
101954968|NCT02062996|Oxymetazoline|oxymetazoline|mesh-list
101954969|NCT02062996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101954970|NCT02062996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101954971|NCT02062996|Adrenergic Agents|adrenergic agents|mesh-ancestor
101954972|NCT02062996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101954973|NCT02062996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954974|NCT02062996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954975|NCT02062996|Sympathomimetics|sympathomimetics|mesh-ancestor
101954976|NCT02062996|Autonomic Agents|autonomic agents|mesh-ancestor
101954977|NCT02062996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101954978|NCT02062996|Nasal Decongestants|nasal decongestants|mesh-ancestor
101954979|NCT02062996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101954980|NCT02062996|Respiratory System Agents|respiratory system agents|mesh-ancestor
101954981|NCT02062996|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101954982|NCT02062996|Mydriatics|mydriatics|mesh-ancestor
101954983|NCT02062996|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101954984|NCT02062996|Protective Agents|protective agents|mesh-ancestor
101954985|NCT03762369|Latanoprost|latanoprost|mesh-list
101954986|NCT03762369|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101954987|NCT03762369|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101954988|NCT01321515|Famciclovir|famciclovir|mesh-list
101954989|NCT01321515|Antiviral Agents|antiviral agents|mesh-ancestor
101954990|NCT01321515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101954991|NCT01321515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101954992|NCT01321515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101954993|NCT01321515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954994|NCT02065414|Chlorhexidine|chlorhexidine|mesh-list
101954995|NCT02065414|Listerine|listerine|mesh-list
101954996|NCT02065414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101954997|NCT02065414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101954998|NCT02065414|Disinfectants|disinfectants|mesh-ancestor
101955000|NCT04233879|Emtricitabine|emtricitabine|mesh-list
101970206|NCT05977673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970208|NCT05975489|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101970209|NCT05975489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970210|NCT05975489|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101970211|NCT05975489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101955001|NCT04233879|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
101955002|NCT04233879|Islatravir|islatravir|mesh-list
101955003|NCT04233879|Antiviral Agents|antiviral agents|mesh-ancestor
101955004|NCT04233879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101955005|NCT04233879|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101955006|NCT04233879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101955007|NCT04233879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101955008|NCT04233879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955009|NCT04233879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101955010|NCT04233879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101955011|NCT01370356|Varenicline|varenicline|mesh-list
101955012|NCT01370356|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101955013|NCT01370356|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101955014|NCT01370356|Cholinergic Agents|cholinergic agents|mesh-ancestor
101955015|NCT01370356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101955016|NCT01370356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955017|NCT01370356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955019|NCT03792334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101955020|NCT03792334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955021|NCT04545411|Dapagliflozin|dapagliflozin|mesh-list
101955022|NCT04545411|Volagidemab|volagidemab|mesh-list
101955023|NCT04545411|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101955024|NCT04545411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955025|NCT04545411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101955026|NCT04545411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955027|NCT02065492|Amlodipine|amlodipine|mesh-list
101955028|NCT02065492|Calcium Channel Blockers|calcium channel blockers|mesh-list
101955029|NCT02065492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101521135|NCT02898792|Sensory System Agents|sensory system agents|mesh-ancestor
101955030|NCT02065492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955031|NCT02065492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101955032|NCT02065492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101955033|NCT02065492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955034|NCT02065492|Vasodilator Agents|vasodilator agents|mesh-ancestor
101955035|NCT02063620|Ketamine|ketamine|mesh-list
101955036|NCT02063620|Analgesics|analgesics|mesh-ancestor
101521273|NCT04639817|Levofloxacin|levofloxacin|mesh-list
101955037|NCT02063620|Sensory System Agents|sensory system agents|mesh-ancestor
101955038|NCT02063620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101521344|NCT00559676|Levoleucovorin|levoleucovorin|mesh-list
101955039|NCT02063620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955040|NCT02063620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101955041|NCT02063620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101955042|NCT02063620|Anesthetics, General|anesthetics, general|mesh-ancestor
101955043|NCT02063620|Anesthetics|anesthetics|mesh-ancestor
101955044|NCT02063620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101955045|NCT02063620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101955046|NCT02063620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101521416|NCT04680819|Propolis|propolis|mesh-list
101955047|NCT02063620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101690449|NCT02824601|Calcium|calcium|mesh-list
101955048|NCT02063620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955049|NCT03767439|Nivolumab|nivolumab|mesh-list
101955050|NCT03767439|Ipilimumab|ipilimumab|mesh-list
101955051|NCT03767439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101955053|NCT03767439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101521551|NCT02895672|Incretins|incretins|mesh-ancestor
101955054|NCT03767439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955055|NCT04539405|Sevoflurane|sevoflurane|mesh-list
101955056|NCT04539405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101955057|NCT04539405|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101955058|NCT04539405|Anesthetics, General|anesthetics, general|mesh-ancestor
101970212|NCT05975489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970213|NCT05975489|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101970214|NCT05975489|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101955060|NCT04539405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101955061|NCT04539405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955062|NCT02065804|Bupivacaine|bupivacaine|mesh-list
101955063|NCT02065804|Anesthetics, Local|anesthetics, local|mesh-ancestor
101955064|NCT02065804|Anesthetics|anesthetics|mesh-ancestor
101955065|NCT02065804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101955066|NCT02065804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955067|NCT02065804|Sensory System Agents|sensory system agents|mesh-ancestor
101955068|NCT02065804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101955069|NCT02064010|Calcium, Dietary|calcium, dietary|mesh-list
101955071|NCT02064010|Calcium|calcium|mesh-list
101955072|NCT02064010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101955073|NCT02064010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955074|NCT02064010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101955075|NCT02064010|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101955076|NCT02064088|Levobupivacaine|levobupivacaine|mesh-list
101955077|NCT02064088|Anesthetics, Local|anesthetics, local|mesh-ancestor
101955078|NCT02064088|Anesthetics|anesthetics|mesh-ancestor
101955079|NCT02064088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101955080|NCT02064088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955081|NCT02064088|Sensory System Agents|sensory system agents|mesh-ancestor
101955082|NCT02064088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101955083|NCT02066038|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101955084|NCT02066038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101955085|NCT02066038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101955086|NCT02066038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101955087|NCT02066038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955088|NCT03766893|Naltrexone|naltrexone|mesh-list
101955089|NCT03766893|Buprenorphine|buprenorphine|mesh-list
101955090|NCT03766893|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101955091|NCT03766893|Naloxone|naloxone|mesh-list
101955092|NCT03766893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101955094|NCT03766893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101955095|NCT03766893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521988|NCT02902302|Ibuprofen|ibuprofen|mesh-list
101955096|NCT03766893|Analgesics|analgesics|mesh-ancestor
101955097|NCT03766893|Sensory System Agents|sensory system agents|mesh-ancestor
101955098|NCT03766893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101955100|NCT03766893|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101955101|NCT03760809|Dexmedetomidine|dexmedetomidine|mesh-list
101955102|NCT03760809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101955103|NCT03760809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101955104|NCT03760809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955105|NCT03760809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101955106|NCT03760809|Analgesics|analgesics|mesh-ancestor
101955107|NCT03760809|Sensory System Agents|sensory system agents|mesh-ancestor
101955108|NCT03760809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101955109|NCT03760809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101955110|NCT03760809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101955111|NCT03760809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101955112|NCT03760809|Adrenergic Agents|adrenergic agents|mesh-ancestor
101955113|NCT03760809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101522326|NCT04698941|Paclitaxel|paclitaxel|mesh-list
101955114|NCT03760809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955116|NCT01370590|Ezetimibe|ezetimibe|mesh-list
101955117|NCT01370590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101955118|NCT01370590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101955119|NCT01370590|Antimetabolites|antimetabolites|mesh-ancestor
101955120|NCT01370590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955121|NCT01370590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101522539|NCT01188538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101955122|NCT01370590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101955123|NCT01370590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101955124|NCT01567683|Imiquimod|imiquimod|mesh-list
101955125|NCT01567683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101955126|NCT01567683|Immunologic Factors|immunologic factors|mesh-ancestor
101970215|NCT05975489|Purinergic Agents|purinergic agents|mesh-ancestor
101970216|NCT05975489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101970218|NCT05966688|Ethambutol|ethambutol|mesh-list
101305132|NCT02017561|Metformin|metformin|mesh-list
101955127|NCT01567683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955128|NCT01567683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101955129|NCT01567683|Interferon Inducers|interferon inducers|mesh-ancestor
101955131|NCT03766425|Mitomycins|mitomycins|mesh-list
101955132|NCT03766425|Mitomycin|mitomycin|mesh-list
101955133|NCT03766425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101955134|NCT03766425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101955135|NCT03766425|Growth Substances|growth substances|mesh-ancestor
101955136|NCT03766425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955137|NCT03766425|Growth Inhibitors|growth inhibitors|mesh-ancestor
101955138|NCT03766425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101955139|NCT03766425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101955140|NCT03766425|Alkylating Agents|alkylating agents|mesh-ancestor
101955141|NCT03766425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955142|NCT03766425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101955143|NCT03766425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101955144|NCT01561911|Antibodies|antibodies|mesh-list
101955145|NCT01561911|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101955146|NCT01561911|Immunologic Factors|immunologic factors|mesh-ancestor
101955147|NCT01561911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955149|NCT03770637|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101955150|NCT03770637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101955151|NCT03770637|Hormones|hormones|mesh-ancestor
101955152|NCT03770637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101955153|NCT03770637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955154|NCT03770637|Incretins|incretins|mesh-ancestor
101955155|NCT03766269|Dronabinol|dronabinol|mesh-list
101522899|NCT02930057|Betamethasone|betamethasone|mesh-list
101955156|NCT03766269|Hallucinogens|hallucinogens|mesh-ancestor
101955157|NCT03766269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955158|NCT03766269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101955159|NCT03766269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101955160|NCT03766269|Analgesics|analgesics|mesh-ancestor
101955161|NCT03766269|Sensory System Agents|sensory system agents|mesh-ancestor
101955162|NCT03766269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101955163|NCT03766269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101955164|NCT03766269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101955165|NCT03766269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101955166|NCT03766269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955167|NCT03766269|Hormones|hormones|mesh-ancestor
101523024|NCT03685500|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101955168|NCT03766269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101955170|NCT03894891|Nivolumab|nivolumab|mesh-list
101955171|NCT03894891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101955172|NCT03894891|Tubulin Modulators|tubulin modulators|mesh-ancestor
101955173|NCT03894891|Antimitotic Agents|antimitotic agents|mesh-ancestor
101955174|NCT03894891|Mitosis Modulators|mitosis modulators|mesh-ancestor
101690459|NCT02643732|Dopamine Agents|dopamine agents|mesh-ancestor
101955175|NCT03894891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955176|NCT03894891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101955177|NCT03894891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101955178|NCT03878979|Nivolumab|nivolumab|mesh-list
101955179|NCT03878979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101955180|NCT03878979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101955181|NCT03878979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101523089|NCT02926976|Serotonin Agents|serotonin agents|mesh-ancestor
101955182|NCT03878979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955184|NCT03765645|Piperacillin|piperacillin|mesh-list
101955185|NCT03765645|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101955186|NCT03765645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101955187|NCT03765645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101955188|NCT03765645|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101955189|NCT03765645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101955190|NCT03765645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955191|NCT01321671|Pregabalin|pregabalin|mesh-list
101955192|NCT01321671|Analgesics|analgesics|mesh-ancestor
101955193|NCT01321671|Sensory System Agents|sensory system agents|mesh-ancestor
101955194|NCT01321671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101970219|NCT05966688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101970220|NCT05966688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101970221|NCT05966688|Antitubercular Agents|antitubercular agents|mesh-ancestor
101970222|NCT05965583|Itraconazole|itraconazole|mesh-list
101970223|NCT05965583|Antifungal Agents|antifungal agents|mesh-ancestor
101970224|NCT05965583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101955195|NCT01321671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955196|NCT01321671|Anticonvulsants|anticonvulsants|mesh-ancestor
101955197|NCT01321671|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101955198|NCT01321671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101955199|NCT01321671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955200|NCT01321671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101955201|NCT01321671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101955202|NCT01321671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101523213|NCT03532022|Dexamethasone|dexamethasone|mesh-list
101955203|NCT01321671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101955205|NCT03770013|Clonidine|clonidine|mesh-list
101955206|NCT03770013|Dexmedetomidine|dexmedetomidine|mesh-list
101955207|NCT03770013|Bupivacaine|bupivacaine|mesh-list
101955208|NCT03770013|Anesthetics, Local|anesthetics, local|mesh-ancestor
101955209|NCT03770013|Anesthetics|anesthetics|mesh-ancestor
101955210|NCT03770013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101955211|NCT03770013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955212|NCT03770013|Sensory System Agents|sensory system agents|mesh-ancestor
101955213|NCT03770013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101955214|NCT03770013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101955215|NCT03770013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101955216|NCT03770013|Analgesics|analgesics|mesh-ancestor
101955217|NCT03770013|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101955218|NCT03770013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101955219|NCT03770013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101955220|NCT03770013|Adrenergic Agents|adrenergic agents|mesh-ancestor
101955221|NCT03770013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101955222|NCT03770013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955223|NCT03770013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101955224|NCT03770013|Sympatholytics|sympatholytics|mesh-ancestor
101955225|NCT03770013|Autonomic Agents|autonomic agents|mesh-ancestor
101955226|NCT03769935|Etoposide|etoposide|mesh-list
101955227|NCT03769935|Cisplatin|cisplatin|mesh-list
101955228|NCT03769935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101955229|NCT03769935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101955230|NCT03769935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101955231|NCT03769935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101955232|NCT03769935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101523330|NCT02116998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101955233|NCT03769935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955235|NCT03765021|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101675026|NCT06004687|Mannitol|mannitol|mesh-list
101955236|NCT03765021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101955237|NCT03765021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955238|NCT03765021|Hemostatics|hemostatics|mesh-ancestor
101955239|NCT03765021|Coagulants|coagulants|mesh-ancestor
101955241|NCT05418699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101955242|NCT05418699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955243|NCT03758859|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101955244|NCT03758859|Hyaluronic Acid|hyaluronic acid|mesh-list
101955245|NCT03758859|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101955246|NCT03758859|Immunologic Factors|immunologic factors|mesh-ancestor
101955247|NCT03758859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955248|NCT03758859|Viscosupplements|viscosupplements|mesh-ancestor
101955249|NCT03758859|Protective Agents|protective agents|mesh-ancestor
101955250|NCT03758859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101955251|NCT03759093|Thalidomide|thalidomide|mesh-list
101955252|NCT03759093|Dexamethasone|dexamethasone|mesh-list
101955253|NCT03759093|Dexamethasone acetate|dexamethasone acetate|mesh-list
101955254|NCT03759093|Cyclophosphamide|cyclophosphamide|mesh-list
101955255|NCT03759093|Bortezomib|bortezomib|mesh-list
101955256|NCT03759093|BB 1101|bb 1101|mesh-list
101955257|NCT03759093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101955258|NCT03759093|Immunologic Factors|immunologic factors|mesh-ancestor
101955259|NCT03759093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970225|NCT05965583|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101970226|NCT05965583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101970227|NCT05965583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970228|NCT05965583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955260|NCT03759093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101955261|NCT03759093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101955262|NCT03759093|Alkylating Agents|alkylating agents|mesh-ancestor
101955263|NCT03759093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955264|NCT03759093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101955265|NCT03759093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101955266|NCT03759093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101955267|NCT03759093|Antiemetics|antiemetics|mesh-ancestor
101955268|NCT03759093|Autonomic Agents|autonomic agents|mesh-ancestor
101955269|NCT03759093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101523683|NCT02063685|Hormones|hormones|mesh-ancestor
101955270|NCT03759093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101955271|NCT03759093|Glucocorticoids|glucocorticoids|mesh-ancestor
101955272|NCT03759093|Hormones|hormones|mesh-ancestor
101523741|NCT00555399|Vorinostat|vorinostat|mesh-list
101955273|NCT03759093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101955274|NCT03759093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101955275|NCT03759093|Protease Inhibitors|protease inhibitors|mesh-ancestor
101955276|NCT03759093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101955277|NCT03759093|Leprostatic Agents|leprostatic agents|mesh-ancestor
101955278|NCT03759093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101955279|NCT03759093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101955280|NCT03759093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101690488|NCT04241705|Artemether|artemether|mesh-list
101955281|NCT03759093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101955282|NCT03759093|Growth Substances|growth substances|mesh-ancestor
101955283|NCT03759093|Growth Inhibitors|growth inhibitors|mesh-ancestor
101955284|NCT03764241|Vitamin K|vitamin k|mesh-list
101955285|NCT03764241|Rivaroxaban|rivaroxaban|mesh-list
101955286|NCT03764241|Vitamins|vitamins|mesh-ancestor
101955287|NCT03764241|Micronutrients|micronutrients|mesh-ancestor
101955288|NCT03764241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955289|NCT03764241|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101955290|NCT03764241|Antithrombins|antithrombins|mesh-ancestor
101523952|NCT01972854|Riboflavin|riboflavin|mesh-list
101955291|NCT03764241|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101955292|NCT03764241|Protease Inhibitors|protease inhibitors|mesh-ancestor
101955293|NCT03764241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101955294|NCT03764241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955295|NCT03764241|Anticoagulants|anticoagulants|mesh-ancestor
101955296|NCT03764241|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101524110|NCT02910050|Letrozole|letrozole|mesh-list
101955297|NCT03764241|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101955298|NCT03764241|Hemostatics|hemostatics|mesh-ancestor
101955299|NCT03764241|Coagulants|coagulants|mesh-ancestor
101955301|NCT03764163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101955302|NCT03764163|Anesthetics, General|anesthetics, general|mesh-ancestor
101955303|NCT03764163|Anesthetics|anesthetics|mesh-ancestor
101955304|NCT03764163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101955305|NCT03764163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955307|NCT02556099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101955308|NCT02556099|Antisickling Agents|antisickling agents|mesh-ancestor
101955309|NCT02556099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101524381|NCT05011214|Sevoflurane|sevoflurane|mesh-list
101955310|NCT02556099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955311|NCT02556099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101955312|NCT01321827|Itraconazole|itraconazole|mesh-list
101955313|NCT01321827|Prednisolone|prednisolone|mesh-list
101955314|NCT01321827|Glucocorticoids|glucocorticoids|mesh-list
101955316|NCT01321827|Hormones|hormones|mesh-ancestor
101955317|NCT01321827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101955318|NCT01321827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524528|NCT01780428|Acetaminophen|acetaminophen|mesh-list
101955319|NCT01321827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101955320|NCT01321827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101955322|NCT01321827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101955323|NCT01321827|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101970229|NCT05965583|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101970230|NCT05965583|Hormone Antagonists|hormone antagonists|mesh-ancestor
101971981|NCT01339676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955324|NCT01321827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101955325|NCT01321827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101955326|NCT01321827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955327|NCT01321827|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101955328|NCT01321827|Hormone Antagonists|hormone antagonists|mesh-ancestor
101955329|NCT01321827|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101955330|NCT03753477|Amlodipine|amlodipine|mesh-list
101955331|NCT03753477|Olmesartan|olmesartan|mesh-list
101955332|NCT03753477|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101955333|NCT03753477|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
101955334|NCT03753477|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101955335|NCT03753477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101955336|NCT03753477|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101955337|NCT03753477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101955338|NCT03753477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955339|NCT03753477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101955340|NCT03753477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955341|NCT03753477|Vasodilator Agents|vasodilator agents|mesh-ancestor
101955342|NCT03753477|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101955343|NCT03753477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101955344|NCT03753477|Antimetabolites|antimetabolites|mesh-ancestor
101955345|NCT03753477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101955346|NCT03753477|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101955347|NCT03753477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101955348|NCT03753477|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101955349|NCT03753477|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101955350|NCT05236647|Morphine|morphine|mesh-list
101955351|NCT05236647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101955352|NCT05236647|Narcotics|narcotics|mesh-ancestor
101955353|NCT05236647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101955354|NCT05236647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955355|NCT05236647|Analgesics|analgesics|mesh-ancestor
101955356|NCT05236647|Sensory System Agents|sensory system agents|mesh-ancestor
101955357|NCT05236647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101955358|NCT03758469|Rifampin|rifampin|mesh-list
101955359|NCT03758469|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101955360|NCT03758469|Antitubercular Agents|antitubercular agents|mesh-ancestor
101955361|NCT03758469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101955362|NCT03758469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101955363|NCT03758469|Leprostatic Agents|leprostatic agents|mesh-ancestor
101955364|NCT03758469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101955365|NCT03758469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101955366|NCT03758469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955367|NCT03758469|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101955368|NCT03758469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101525155|NCT03580148|Cortisone|cortisone|mesh-list
101955369|NCT03758469|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101525224|NCT04664244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101955370|NCT03758469|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101955371|NCT03758469|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101955372|NCT03758469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101955373|NCT04646109|Azithromycin|azithromycin|mesh-list
101955375|NCT04646109|Ivermectin|ivermectin|mesh-list
101955376|NCT04646109|Favipiravir|favipiravir|mesh-list
101955377|NCT04646109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101955378|NCT04646109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101955379|NCT04646109|Antimalarials|antimalarials|mesh-ancestor
101955380|NCT04646109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101955381|NCT04646109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101955382|NCT04646109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101955383|NCT04646109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955384|NCT04646109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101955385|NCT04646109|Antiviral Agents|antiviral agents|mesh-ancestor
101675174|NCT05998317|Antiemetics|antiemetics|mesh-ancestor
101955387|NCT05320107|Analgesics|analgesics|mesh-ancestor
101955388|NCT05320107|Sensory System Agents|sensory system agents|mesh-ancestor
101955389|NCT05320107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101970231|NCT05965583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101970232|NCT05965583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525511|NCT04661670|Salicylic Acid|salicylic acid|mesh-list
101955390|NCT05320107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955391|NCT05320107|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101955392|NCT05320107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101955393|NCT05320107|Anesthetics, General|anesthetics, general|mesh-ancestor
101955395|NCT05320107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101955396|NCT05320107|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101955398|NCT05320107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101955399|NCT05320107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955400|NCT03752931|Celiprolol|celiprolol|mesh-list
101955401|NCT03752931|Diltiazem|diltiazem|mesh-list
101955402|NCT03752931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101955403|NCT03752931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101955404|NCT03752931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101955405|NCT03752931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955406|NCT03752931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101955407|NCT03752931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955408|NCT03752931|Vasodilator Agents|vasodilator agents|mesh-ancestor
101955409|NCT03752931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101955410|NCT03752931|Sympathomimetics|sympathomimetics|mesh-ancestor
101955411|NCT03752931|Autonomic Agents|autonomic agents|mesh-ancestor
101955412|NCT03752931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101955413|NCT03752931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101955414|NCT03752931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101955415|NCT03752931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101955416|NCT03752931|Adrenergic Agents|adrenergic agents|mesh-ancestor
101955417|NCT03752931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101525866|NCT00540137|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101955418|NCT03758235|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101955419|NCT03758235|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
101955420|NCT03758235|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101955421|NCT03758235|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101955422|NCT03758235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101955423|NCT03758235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955424|NCT03758235|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101955425|NCT03758235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101955426|NCT03758235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955427|NCT03758235|Cholinergic Agents|cholinergic agents|mesh-ancestor
101955428|NCT03758235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101955429|NCT02066350|Pancrelipase|pancrelipase|mesh-list
101955430|NCT02066350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101955432|NCT02064946|Vitamins|vitamins|mesh-ancestor
101955433|NCT02064946|Micronutrients|micronutrients|mesh-ancestor
101955434|NCT02064946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955435|NCT02064946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101955436|NCT02064556|Amlodipine|amlodipine|mesh-list
101955437|NCT02064556|Candesartan|candesartan|mesh-list
101955438|NCT02064556|Candesartan cilexetil|candesartan cilexetil|mesh-list
101955439|NCT02064556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101955440|NCT02064556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101955441|NCT02064556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101955442|NCT02064556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955443|NCT02064556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101955444|NCT02064556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955445|NCT02064556|Vasodilator Agents|vasodilator agents|mesh-ancestor
101955446|NCT02064556|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101955447|NCT02064556|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101955448|NCT05041647|Dronabinol|dronabinol|mesh-list
101955449|NCT05041647|Hallucinogens|hallucinogens|mesh-ancestor
101955450|NCT05041647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955451|NCT05041647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101955452|NCT05041647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101955453|NCT05041647|Analgesics|analgesics|mesh-ancestor
101955454|NCT05041647|Sensory System Agents|sensory system agents|mesh-ancestor
101955455|NCT05041647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101970233|NCT05965583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101970235|NCT05965544|Bupivacaine|bupivacaine|mesh-list
101970236|NCT05965544|Anesthetics, Local|anesthetics, local|mesh-ancestor
101970237|NCT05965544|Anesthetics|anesthetics|mesh-ancestor
101305152|NCT02017639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101955456|NCT05041647|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101955457|NCT05041647|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101955459|NCT05041647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955460|NCT05041647|Hormones|hormones|mesh-ancestor
101955461|NCT05041647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101955462|NCT03752229|Diazepam|diazepam|mesh-list
101955463|NCT03752229|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101955464|NCT03752229|Anticonvulsants|anticonvulsants|mesh-ancestor
101955465|NCT03752229|Antiemetics|antiemetics|mesh-ancestor
101955466|NCT03752229|Autonomic Agents|autonomic agents|mesh-ancestor
101955467|NCT03752229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101955468|NCT03752229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955469|NCT03752229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101955470|NCT03752229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101955471|NCT03752229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101955472|NCT03752229|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101955473|NCT03752229|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101955474|NCT03752229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101955475|NCT03752229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101955476|NCT03752229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101955477|NCT03752229|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101955478|NCT03752229|Anesthetics, General|anesthetics, general|mesh-ancestor
101955480|NCT03752229|GABA Modulators|gaba modulators|mesh-ancestor
101955482|NCT03752229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101955483|NCT03752229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955484|NCT05359731|Dexamethasone|dexamethasone|mesh-list
101955485|NCT05359731|Bupivacaine|bupivacaine|mesh-list
101955486|NCT05359731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101955487|NCT05359731|Antiemetics|antiemetics|mesh-ancestor
101955488|NCT05359731|Autonomic Agents|autonomic agents|mesh-ancestor
101955489|NCT05359731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101955490|NCT05359731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955491|NCT05359731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101955492|NCT05359731|Glucocorticoids|glucocorticoids|mesh-ancestor
101955493|NCT05359731|Hormones|hormones|mesh-ancestor
101526237|NCT03456713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101955494|NCT05359731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101955495|NCT05359731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101955496|NCT05359731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101955497|NCT05359731|Anesthetics, Local|anesthetics, local|mesh-ancestor
101955498|NCT05359731|Anesthetics|anesthetics|mesh-ancestor
101955499|NCT05359731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101955500|NCT05359731|Sensory System Agents|sensory system agents|mesh-ancestor
101955501|NCT03695367|Acetaminophen|acetaminophen|mesh-list
101955502|NCT03695367|Ibuprofen|ibuprofen|mesh-list
101955503|NCT03695367|Ketorolac|ketorolac|mesh-list
101955504|NCT03695367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101955505|NCT03695367|Analgesics|analgesics|mesh-ancestor
101955506|NCT03695367|Sensory System Agents|sensory system agents|mesh-ancestor
101955507|NCT03695367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101955508|NCT03695367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955509|NCT03695367|Antipyretics|antipyretics|mesh-ancestor
101955510|NCT03695367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101526372|NCT04638582|Paclitaxel|paclitaxel|mesh-list
101955511|NCT03695367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101955512|NCT03695367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101955513|NCT03695367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101955514|NCT03695367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101955515|NCT03695367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955516|NCT03755427|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101955517|NCT03755427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101955518|NCT03755427|Immunologic Factors|immunologic factors|mesh-ancestor
101955519|NCT03755427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955520|NCT03755427|Antacids|antacids|mesh-ancestor
101526501|NCT05824455|Irinotecan|irinotecan|mesh-list
101970238|NCT05965544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101970239|NCT05965544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955521|NCT03755427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955522|NCT03755427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101955524|NCT03758079|Doxepin|doxepin|mesh-list
101955525|NCT03758079|Analgesics|analgesics|mesh-ancestor
101955526|NCT03758079|Sensory System Agents|sensory system agents|mesh-ancestor
101955527|NCT03758079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101955528|NCT03758079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955530|NCT03758079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101955531|NCT03758079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101955532|NCT03758079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101955533|NCT03758079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101955534|NCT03758079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101955535|NCT03758079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101955536|NCT03758079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101955537|NCT03758079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955538|NCT03758079|Antimanic Agents|antimanic agents|mesh-ancestor
101955539|NCT03758079|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101955540|NCT03758079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101955541|NCT03758079|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101955542|NCT03758079|Antidepressive Agents|antidepressive agents|mesh-ancestor
101955543|NCT03758079|Histamine Antagonists|histamine antagonists|mesh-ancestor
101955544|NCT03758079|Histamine Agents|histamine agents|mesh-ancestor
101955546|NCT02067910|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101955547|NCT02067910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955548|NCT02067910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101526711|NCT05681572|Anesthetics|anesthetics|mesh-ancestor
101955549|NCT02067910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101955550|NCT02067910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101955551|NCT02067910|Immunologic Factors|immunologic factors|mesh-ancestor
101955552|NCT02067910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955553|NCT02067910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101955554|NCT02066662|Rivaroxaban|rivaroxaban|mesh-list
101955555|NCT02066662|Phenprocoumon|phenprocoumon|mesh-list
101955556|NCT02066662|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101955557|NCT02066662|Antithrombins|antithrombins|mesh-ancestor
101955558|NCT02066662|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101955559|NCT02066662|Protease Inhibitors|protease inhibitors|mesh-ancestor
101955560|NCT02066662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101955561|NCT02066662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955562|NCT02066662|Anticoagulants|anticoagulants|mesh-ancestor
101955563|NCT05280873|Methylprednisolone|methylprednisolone|mesh-list
101955564|NCT05280873|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101955565|NCT05280873|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101955566|NCT05280873|Prednisolone|prednisolone|mesh-list
101955567|NCT05280873|Prednisolone acetate|prednisolone acetate|mesh-list
101955568|NCT05280873|Pirfenidone|pirfenidone|mesh-list
101955569|NCT05280873|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101955570|NCT05280873|Prednisolone phosphate|prednisolone phosphate|mesh-list
101955571|NCT05280873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101955572|NCT05280873|Antiemetics|antiemetics|mesh-ancestor
101955573|NCT05280873|Autonomic Agents|autonomic agents|mesh-ancestor
101955574|NCT05280873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101955575|NCT05280873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955576|NCT05280873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101955577|NCT05280873|Glucocorticoids|glucocorticoids|mesh-ancestor
101955578|NCT05280873|Hormones|hormones|mesh-ancestor
101955579|NCT05280873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101955580|NCT05280873|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101955581|NCT05280873|Protective Agents|protective agents|mesh-ancestor
101955582|NCT05280873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101955583|NCT05280873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101955584|NCT05280873|Analgesics|analgesics|mesh-ancestor
101955585|NCT05280873|Sensory System Agents|sensory system agents|mesh-ancestor
101955586|NCT05280873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101955587|NCT05280873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101955588|NCT05280873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101955589|NCT02066818|Lidocaine|lidocaine|mesh-list
101955590|NCT02066818|Tetracaine|tetracaine|mesh-list
101955591|NCT02066818|Anesthetics, Local|anesthetics, local|mesh-ancestor
101955592|NCT02066818|Anesthetics|anesthetics|mesh-ancestor
101970240|NCT05965544|Sensory System Agents|sensory system agents|mesh-ancestor
101970241|NCT05965544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101970242|NCT05965544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101955593|NCT02066818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101955594|NCT02066818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955595|NCT02066818|Sensory System Agents|sensory system agents|mesh-ancestor
101955596|NCT02066818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101955597|NCT02066818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101955598|NCT02066818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101955599|NCT02066818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101955600|NCT02066818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101955601|NCT02066818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955602|NCT04558125|Heparin|heparin|mesh-list
101955603|NCT04558125|Calcium heparin|calcium heparin|mesh-list
101955604|NCT04558125|Enoxaparin|enoxaparin|mesh-list
101955605|NCT04558125|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101955606|NCT04558125|Tinzaparin|tinzaparin|mesh-list
101955607|NCT04558125|Dalteparin|dalteparin|mesh-list
101955608|NCT04558125|Tenecteplase|tenecteplase|mesh-list
101955609|NCT04558125|Enoxaparin sodium|enoxaparin sodium|mesh-list
101675403|NCT05773950|Aprepitant|aprepitant|mesh-list
101955610|NCT04558125|Anticoagulants|anticoagulants|mesh-ancestor
101955611|NCT04558125|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101955612|NCT04558125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101955613|NCT04558125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955614|NCT05460195|Immunomodulating Agents|immunomodulating agents|mesh-list
101955615|NCT05460195|Immunologic Factors|immunologic factors|mesh-list
101955616|NCT05460195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955617|NCT02793622|Pyrimethamine|pyrimethamine|mesh-list
101955618|NCT02793622|Piperaquine|piperaquine|mesh-list
101955619|NCT02793622|Sulfadoxine|sulfadoxine|mesh-list
101955620|NCT02793622|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101955622|NCT02793622|Antimalarials|antimalarials|mesh-ancestor
101955623|NCT02793622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101955624|NCT02793622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101955625|NCT02793622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101955626|NCT02793622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101955627|NCT02793622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101955628|NCT02793622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955629|NCT02793622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101955630|NCT04493931|Rifampin|rifampin|mesh-list
101955631|NCT04493931|Gepotidacin|gepotidacin|mesh-list
101955632|NCT04493931|Digoxin|digoxin|mesh-list
101955633|NCT04493931|Midazolam|midazolam|mesh-list
101955634|NCT04493931|Cimetidine|cimetidine|mesh-list
101955635|NCT04493931|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101955636|NCT04493931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101955637|NCT04493931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101955638|NCT04493931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955639|NCT04493931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101955640|NCT04493931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101955641|NCT04493931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101955642|NCT04493931|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101955643|NCT04493931|Anesthetics, General|anesthetics, general|mesh-ancestor
101955644|NCT04493931|Anesthetics|anesthetics|mesh-ancestor
101955645|NCT04493931|GABA Modulators|gaba modulators|mesh-ancestor
101955646|NCT04493931|GABA Agents|gaba agents|mesh-ancestor
101526797|NCT05058287|Antiemetics|antiemetics|mesh-ancestor
101955647|NCT04493931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101955648|NCT04493931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955649|NCT04493931|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101955650|NCT04493931|Antitubercular Agents|antitubercular agents|mesh-ancestor
101955651|NCT04493931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101690549|NCT02640300|GABA Agents|gaba agents|mesh-ancestor
101955652|NCT04493931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101955653|NCT04493931|Leprostatic Agents|leprostatic agents|mesh-ancestor
101955654|NCT04493931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101955655|NCT04493931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101955656|NCT04493931|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101955657|NCT04493931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101955658|NCT04493931|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101955659|NCT04493931|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101955660|NCT04493931|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101955661|NCT04493931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101970244|NCT05965544|Analgesics|analgesics|mesh-ancestor
101955662|NCT04493931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101955663|NCT04493931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101955664|NCT04493931|Protective Agents|protective agents|mesh-ancestor
101955665|NCT04493931|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101955666|NCT04493931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101955667|NCT04493931|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101955668|NCT04493931|Histamine Antagonists|histamine antagonists|mesh-ancestor
101955669|NCT04493931|Histamine Agents|histamine agents|mesh-ancestor
101955670|NCT04493931|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101955671|NCT04493931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101955672|NCT04493931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101955673|NCT04493931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101955675|NCT02260336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101955676|NCT02260336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101955677|NCT02260336|Analgesics|analgesics|mesh-ancestor
101955678|NCT02260336|Sensory System Agents|sensory system agents|mesh-ancestor
101955679|NCT02260336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101955680|NCT02260336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955681|NCT02260336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101955682|NCT02260336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101955683|NCT02260336|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101955684|NCT02260336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101675474|NCT05715229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101955685|NCT02260336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101955686|NCT02260336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955688|NCT04948203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101955689|NCT04948203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101955690|NCT04948203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101955691|NCT04948203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101955692|NCT04948203|Antifungal Agents|antifungal agents|mesh-ancestor
101955693|NCT04948203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101955694|NCT04948203|Immunologic Factors|immunologic factors|mesh-ancestor
101955695|NCT04948203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955696|NCT03755193|Diphosphonates|diphosphonates|mesh-list
101955697|NCT03755193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101955698|NCT03755193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955699|NCT03755115|Epirubicin|epirubicin|mesh-list
101955700|NCT03755115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101955701|NCT03755115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101955702|NCT03755115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101955703|NCT03755115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101955704|NCT03755115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101955705|NCT03755115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955706|NCT03755037|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101955708|NCT03755037|Estrogens|estrogens|mesh-ancestor
101955709|NCT03755037|Hormones|hormones|mesh-ancestor
101955710|NCT03755037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101955711|NCT03755037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955712|NCT03755037|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101955713|NCT03755037|Contraceptive Agents|contraceptive agents|mesh-ancestor
101955714|NCT03755037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101955715|NCT03755037|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101955716|NCT03755037|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101955717|NCT03755037|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101955718|NCT03751917|Arsenic Trioxide|arsenic trioxide|mesh-list
101955719|NCT03751917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101955720|NCT04490499|Vaccines|vaccines|mesh-list
101955721|NCT04490499|Immunologic Factors|immunologic factors|mesh-ancestor
101955722|NCT04490499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955723|NCT01332994|Rituximab|rituximab|mesh-list
101955724|NCT01332994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101955725|NCT01332994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101955726|NCT01332994|Immunologic Factors|immunologic factors|mesh-ancestor
101955727|NCT01332994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955728|NCT01332994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101955729|NCT03754959|Midazolam|midazolam|mesh-list
101955730|NCT03754959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101955731|NCT03754959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101955732|NCT03754959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101955733|NCT03754959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955734|NCT03754959|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101955735|NCT03754959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101955736|NCT03754959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101955737|NCT03754959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101955738|NCT03754959|Anesthetics, General|anesthetics, general|mesh-ancestor
101955739|NCT03754959|Anesthetics|anesthetics|mesh-ancestor
101955740|NCT03754959|GABA Modulators|gaba modulators|mesh-ancestor
101955741|NCT03754959|GABA Agents|gaba agents|mesh-ancestor
101955742|NCT03754959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101955743|NCT03754959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955744|NCT02068690|BI 425809|bi 425809|mesh-list
101955745|NCT02068690|Nootropic Agents|nootropic agents|mesh-ancestor
101955746|NCT02067442|Acetaminophen|acetaminophen|mesh-list
101955747|NCT02067442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101955748|NCT02067442|Analgesics|analgesics|mesh-ancestor
101955749|NCT02067442|Sensory System Agents|sensory system agents|mesh-ancestor
101955750|NCT02067442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101955751|NCT02067442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955752|NCT02067442|Antipyretics|antipyretics|mesh-ancestor
101955753|NCT02067520|Hydromorphone|hydromorphone|mesh-list
101955754|NCT02067520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101955755|NCT02067520|Narcotics|narcotics|mesh-ancestor
101955756|NCT02067520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101955757|NCT02067520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955758|NCT02067520|Analgesics|analgesics|mesh-ancestor
101955759|NCT02067520|Sensory System Agents|sensory system agents|mesh-ancestor
101955760|NCT02067520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101955761|NCT03757923|Metformin|metformin|mesh-list
101955762|NCT03757923|Pioglitazone|pioglitazone|mesh-list
101955763|NCT03757923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101955764|NCT03757923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955765|NCT02071888|Dexamethasone|dexamethasone|mesh-list
101955766|NCT02071888|Dexamethasone acetate|dexamethasone acetate|mesh-list
101955767|NCT02071888|Pomalidomide|pomalidomide|mesh-list
101955768|NCT02071888|BB 1101|bb 1101|mesh-list
101955769|NCT02071888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101955770|NCT02071888|Antiemetics|antiemetics|mesh-ancestor
101955771|NCT02071888|Autonomic Agents|autonomic agents|mesh-ancestor
101955772|NCT02071888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101955773|NCT02071888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955774|NCT02071888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101955775|NCT02071888|Glucocorticoids|glucocorticoids|mesh-ancestor
101955776|NCT02071888|Hormones|hormones|mesh-ancestor
101955777|NCT02071888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101955778|NCT02071888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101955779|NCT02071888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101955780|NCT02071888|Protease Inhibitors|protease inhibitors|mesh-ancestor
101955781|NCT02071888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101955782|NCT02071888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955783|NCT02071888|Immunologic Factors|immunologic factors|mesh-ancestor
101955784|NCT02071888|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101955785|NCT02071888|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101955786|NCT02071888|Growth Substances|growth substances|mesh-ancestor
101690569|NCT02652312|Desflurane|desflurane|mesh-list
101955787|NCT02071888|Growth Inhibitors|growth inhibitors|mesh-ancestor
101955788|NCT02071966|Clopidogrel|clopidogrel|mesh-list
101955789|NCT02071966|Ticagrelor|ticagrelor|mesh-list
101955790|NCT02071966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101955791|NCT02071966|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101955792|NCT02071966|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101955793|NCT02071966|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101955794|NCT02071966|Purinergic Agents|purinergic agents|mesh-ancestor
101955795|NCT02071966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101955796|NCT02071966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955797|NCT02071966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955798|NCT02072278|Vortioxetine|vortioxetine|mesh-list
101955799|NCT02072278|Escitalopram|escitalopram|mesh-list
101955800|NCT02072278|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101955801|NCT02072278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101955802|NCT02072278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101955803|NCT02072278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955804|NCT02072278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101955805|NCT02072278|Serotonin Agents|serotonin agents|mesh-ancestor
101955806|NCT02072278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970246|NCT05965544|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101970247|NCT05965544|Anesthetics, General|anesthetics, general|mesh-ancestor
101970248|NCT05954962|Progesterone|progesterone|mesh-list
101970249|NCT05954962|Ganirelix|ganirelix|mesh-list
101955807|NCT02072278|Antidepressive Agents|antidepressive agents|mesh-ancestor
101955808|NCT02072278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101955809|NCT02072278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101955810|NCT02072278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101955811|NCT02072278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101955812|NCT02072278|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101955813|NCT02072278|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101955814|NCT02072278|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101955815|NCT02072278|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101955816|NCT02072512|Fulvestrant|fulvestrant|mesh-list
101955817|NCT02072512|Anastrozole|anastrozole|mesh-list
101955818|NCT02072512|Goserelin|goserelin|mesh-list
101955819|NCT02072512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101955820|NCT02072512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101955821|NCT02072512|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101955822|NCT02072512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101955823|NCT02072512|Hormone Antagonists|hormone antagonists|mesh-ancestor
101955824|NCT02072512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101955825|NCT02072512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955826|NCT02072512|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101955827|NCT02072512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101955828|NCT02072512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101955829|NCT02072512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955830|NCT04534491|Oxybutynin|oxybutynin|mesh-list
101955831|NCT04534491|Parasympatholytics|parasympatholytics|mesh-ancestor
101955832|NCT04534491|Autonomic Agents|autonomic agents|mesh-ancestor
101955833|NCT04534491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101955834|NCT04534491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955835|NCT04534491|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101955836|NCT04534491|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101955837|NCT04534491|Cholinergic Agents|cholinergic agents|mesh-ancestor
101955838|NCT04534491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101955839|NCT04534491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955840|NCT04534491|Urological Agents|urological agents|mesh-ancestor
101955841|NCT02069080|Plerixafor|plerixafor|mesh-list
101955842|NCT02069080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101955843|NCT02069080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101955844|NCT02069080|Antiviral Agents|antiviral agents|mesh-ancestor
101955845|NCT02069080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101955846|NCT02077348|Hormones|hormones|mesh-list
101955847|NCT02077348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955848|NCT02077348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101955849|NCT03694821|Methylprednisolone|methylprednisolone|mesh-list
101955850|NCT03694821|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101955851|NCT03694821|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101955852|NCT03694821|Prednisolone|prednisolone|mesh-list
101955853|NCT03694821|Prednisolone acetate|prednisolone acetate|mesh-list
101955854|NCT03694821|Ketorolac|ketorolac|mesh-list
101955855|NCT03694821|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101955856|NCT03694821|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101955857|NCT03694821|Prednisolone phosphate|prednisolone phosphate|mesh-list
101955858|NCT03694821|Hylan|hylan|mesh-list
101955859|NCT03694821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101955860|NCT03694821|Antiemetics|antiemetics|mesh-ancestor
101955861|NCT03694821|Autonomic Agents|autonomic agents|mesh-ancestor
101955862|NCT03694821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101955863|NCT03694821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955864|NCT03694821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101955865|NCT03694821|Glucocorticoids|glucocorticoids|mesh-ancestor
101955866|NCT03694821|Hormones|hormones|mesh-ancestor
101955867|NCT03694821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101955868|NCT03694821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101955869|NCT03694821|Protective Agents|protective agents|mesh-ancestor
101955870|NCT03694821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101955871|NCT03694821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101955872|NCT03694821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101955873|NCT03694821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101955874|NCT03694821|Analgesics|analgesics|mesh-ancestor
101970251|NCT05954962|Hormones|hormones|mesh-ancestor
101970252|NCT05954962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101955875|NCT03694821|Sensory System Agents|sensory system agents|mesh-ancestor
101955876|NCT03694821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101955877|NCT03694821|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101955878|NCT03694821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101955879|NCT03694821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955880|NCT03694821|Viscosupplements|viscosupplements|mesh-ancestor
101955881|NCT02069158|Paclitaxel|paclitaxel|mesh-list
101955882|NCT02069158|Carboplatin|carboplatin|mesh-list
101955883|NCT02069158|Gedatolisib|gedatolisib|mesh-list
101955884|NCT02069158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101955885|NCT02069158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101955886|NCT02069158|Tubulin Modulators|tubulin modulators|mesh-ancestor
101955887|NCT02069158|Antimitotic Agents|antimitotic agents|mesh-ancestor
101955888|NCT02069158|Mitosis Modulators|mitosis modulators|mesh-ancestor
101955889|NCT02069158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955890|NCT02069158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101955891|NCT02069158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101955892|NCT04531527|Butenafine|butenafine|mesh-list
101955893|NCT04531527|Antifungal Agents|antifungal agents|mesh-ancestor
101955894|NCT04531527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101955895|NCT02078440|Bromocriptine|bromocriptine|mesh-list
101955896|NCT02078440|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101955897|NCT02078440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101955898|NCT02078440|Hormone Antagonists|hormone antagonists|mesh-ancestor
101955899|NCT02078440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101955900|NCT02078440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955901|NCT02078440|Dopamine Agonists|dopamine agonists|mesh-ancestor
101955902|NCT02078440|Dopamine Agents|dopamine agents|mesh-ancestor
101955903|NCT02078440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101955904|NCT02078440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955905|NCT02070406|Aldesleukin|aldesleukin|mesh-list
101955906|NCT02070406|Cyclophosphamide|cyclophosphamide|mesh-list
101955907|NCT02070406|Fludarabine|fludarabine|mesh-list
101955908|NCT02070406|Fludarabine phosphate|fludarabine phosphate|mesh-list
101955909|NCT02070406|Interleukin-2|interleukin-2|mesh-list
101955910|NCT02070406|Vaccines|vaccines|mesh-list
101955911|NCT02070406|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101955912|NCT02070406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101955913|NCT02070406|Immunologic Factors|immunologic factors|mesh-ancestor
101955914|NCT02070406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955915|NCT02070406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101955916|NCT02070406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101955917|NCT02070406|Alkylating Agents|alkylating agents|mesh-ancestor
101955918|NCT02070406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955919|NCT02070406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101955920|NCT02070406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101955921|NCT02070406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101955923|NCT02070406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101955924|NCT02070406|Analgesics|analgesics|mesh-ancestor
101955925|NCT02070406|Sensory System Agents|sensory system agents|mesh-ancestor
101955926|NCT02070406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101955927|NCT02070406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101955928|NCT02070406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101955929|NCT02070406|Antiviral Agents|antiviral agents|mesh-ancestor
101955930|NCT02070406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101955931|NCT02070406|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101955932|NCT02078596|Valproic Acid|valproic acid|mesh-list
101955933|NCT02078596|Anticonvulsants|anticonvulsants|mesh-ancestor
101955934|NCT02078596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101955935|NCT02078596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955936|NCT02078596|GABA Agents|gaba agents|mesh-ancestor
101955937|NCT02078596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101955938|NCT02078596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955939|NCT02078596|Antimanic Agents|antimanic agents|mesh-ancestor
101955940|NCT02078596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101955941|NCT02078596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101955942|NCT02078596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101955943|NCT02070718|Pentazocine|pentazocine|mesh-list
101955945|NCT02070718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101955946|NCT02070718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970253|NCT05954962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970254|NCT05954962|Hormone Antagonists|hormone antagonists|mesh-ancestor
101970256|NCT05949684|Luspatercept|luspatercept|mesh-list
101970257|NCT05949684|Hematinics|hematinics|mesh-ancestor
101970258|NCT05947201|Paclitaxel|paclitaxel|mesh-list
101955947|NCT02070718|Sensory System Agents|sensory system agents|mesh-ancestor
101955948|NCT02070718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101955949|NCT02070718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101955950|NCT02070718|Narcotics|narcotics|mesh-ancestor
101955951|NCT02070718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101955952|NCT02070718|Analgesics|analgesics|mesh-ancestor
101955953|NCT02070718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101955954|NCT02070796|Rotigotine|rotigotine|mesh-list
101955955|NCT02070796|Dopamine Agonists|dopamine agonists|mesh-ancestor
101955957|NCT02070796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101955958|NCT02070796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955959|NCT02070796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955960|NCT02079064|Propofol|propofol|mesh-list
101955961|NCT02079064|Desflurane|desflurane|mesh-list
101955962|NCT02079064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101955963|NCT02079064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101955964|NCT02079064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955965|NCT02079064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101955966|NCT02079064|Anesthetics, General|anesthetics, general|mesh-ancestor
101955967|NCT02079064|Anesthetics|anesthetics|mesh-ancestor
101955968|NCT02079064|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101955969|NCT02079220|Capecitabine|capecitabine|mesh-list
101955970|NCT02079220|Oxaliplatin|oxaliplatin|mesh-list
101955971|NCT02079220|Aflibercept|aflibercept|mesh-list
101955972|NCT02079220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101955973|NCT02079220|Antimetabolites|antimetabolites|mesh-ancestor
101955974|NCT02079220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955975|NCT02079220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101955976|NCT02079220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101955977|NCT02079220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101955978|NCT02079220|Growth Substances|growth substances|mesh-ancestor
101955979|NCT02079220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955980|NCT02079220|Growth Inhibitors|growth inhibitors|mesh-ancestor
101955981|NCT02079298|Fluconazole|fluconazole|mesh-list
101955982|NCT02079298|Ibuprofen|ibuprofen|mesh-list
101955983|NCT02079298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101955984|NCT02079298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101955985|NCT02079298|Analgesics|analgesics|mesh-ancestor
101955986|NCT02079298|Sensory System Agents|sensory system agents|mesh-ancestor
101955987|NCT02079298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101955988|NCT02079298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955989|NCT02079298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101955990|NCT02079298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101955991|NCT02079298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101955992|NCT02079298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101955993|NCT02079298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955994|NCT02079298|Antifungal Agents|antifungal agents|mesh-ancestor
101955995|NCT02079298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101955996|NCT02079298|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101955997|NCT02079298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101955998|NCT02079298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101955999|NCT02079298|Hormone Antagonists|hormone antagonists|mesh-ancestor
101956000|NCT02079298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101527172|NCT04129086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101956001|NCT02079298|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101956002|NCT02079298|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101956003|NCT02071342|Everolimus|everolimus|mesh-list
101956004|NCT02071342|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101956005|NCT02071342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101956006|NCT02071342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101956007|NCT02071342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956008|NCT02071342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101956009|NCT02071342|Immunologic Factors|immunologic factors|mesh-ancestor
101956010|NCT02071342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970259|NCT05947201|Fluorouracil|fluorouracil|mesh-list
101970260|NCT05947201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101970261|NCT05947201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970262|NCT05947201|Tubulin Modulators|tubulin modulators|mesh-ancestor
101970263|NCT05947201|Antimitotic Agents|antimitotic agents|mesh-ancestor
101956011|NCT02071342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101956012|NCT02080078|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101956013|NCT02080078|Theophylline|theophylline|mesh-list
101956014|NCT02080078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101956015|NCT02080078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101956016|NCT02080078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101956017|NCT02080078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956018|NCT02080078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101956020|NCT02080078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101956021|NCT02080078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956022|NCT02080078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101956023|NCT02080078|Respiratory System Agents|respiratory system agents|mesh-ancestor
101956024|NCT02080078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101956025|NCT02080078|Vasodilator Agents|vasodilator agents|mesh-ancestor
101956026|NCT02080078|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101956027|NCT02080078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101956028|NCT02080078|Purinergic Agents|purinergic agents|mesh-ancestor
101956029|NCT02080078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101956030|NCT02083276|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
101956031|NCT02083276|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101956032|NCT02083276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101956033|NCT02083276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101956034|NCT03559504|Sevoflurane|sevoflurane|mesh-list
101956035|NCT03559504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101956036|NCT03559504|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101956037|NCT03559504|Anesthetics, General|anesthetics, general|mesh-ancestor
101956038|NCT03559504|Anesthetics|anesthetics|mesh-ancestor
101956039|NCT03559504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101956040|NCT03559504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956041|NCT02080234|Gemcitabine|gemcitabine|mesh-list
101956042|NCT02080234|Oxaliplatin|oxaliplatin|mesh-list
101956043|NCT02080234|Asparaginase|asparaginase|mesh-list
101956044|NCT02080234|Pegaspargase|pegaspargase|mesh-list
101956045|NCT02080234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101956046|NCT02080234|Antimetabolites|antimetabolites|mesh-ancestor
101956047|NCT02080234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527288|NCT03186638|Ibuprofen|ibuprofen|mesh-list
101956048|NCT02080234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101956049|NCT05070039|Antibodies|antibodies|mesh-list
101956050|NCT05070039|Immunologic Factors|immunologic factors|mesh-ancestor
101956051|NCT05070039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956052|NCT05459649|Cyclosporine|cyclosporine|mesh-list
101956053|NCT05459649|Prednisone|prednisone|mesh-list
101956054|NCT05459649|Cyclosporins|cyclosporins|mesh-list
101956055|NCT05459649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101956056|NCT05459649|Glucocorticoids|glucocorticoids|mesh-ancestor
101956057|NCT05459649|Hormones|hormones|mesh-ancestor
101956058|NCT05459649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101956059|NCT05459649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956060|NCT05459649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101956061|NCT05459649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675849|NCT05283720|Glucocorticoids|glucocorticoids|mesh-ancestor
101956063|NCT05459649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956064|NCT05459649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101956066|NCT05459649|Antifungal Agents|antifungal agents|mesh-ancestor
101956067|NCT05459649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101956068|NCT05459649|Dermatologic Agents|dermatologic agents|mesh-ancestor
101956069|NCT05459649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101956070|NCT05459649|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101956071|NCT04461795|Erenumab|erenumab|mesh-list
101956072|NCT04461795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101956073|NCT04461795|Immunologic Factors|immunologic factors|mesh-ancestor
101956074|NCT04461795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527459|NCT01356290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101956075|NCT04461795|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
101970265|NCT05947201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970266|NCT05947201|Antimetabolites|antimetabolites|mesh-ancestor
101956076|NCT04461795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956077|NCT04461795|Analgesics|analgesics|mesh-ancestor
101956078|NCT04461795|Sensory System Agents|sensory system agents|mesh-ancestor
101956079|NCT04461795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101956080|NCT04461015|Insulin|insulin|mesh-list
101956081|NCT04461015|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101956082|NCT04461015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101956083|NCT04461015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956084|NCT03754179|Hydroxychloroquine|hydroxychloroquine|mesh-list
101956085|NCT03754179|Trametinib|trametinib|mesh-list
101956086|NCT03754179|Dabrafenib|dabrafenib|mesh-list
101956087|NCT03754179|Antimalarials|antimalarials|mesh-ancestor
101956088|NCT03754179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101956089|NCT03754179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101956090|NCT03754179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101956091|NCT03754179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101956092|NCT03754179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956093|NCT03754179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101956094|NCT03754179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101956095|NCT03754179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101956096|NCT03753867|Acitretin|acitretin|mesh-list
101956097|NCT03753867|Keratolytic Agents|keratolytic agents|mesh-ancestor
101956098|NCT03753867|Dermatologic Agents|dermatologic agents|mesh-ancestor
101956099|NCT04439253|Crizotinib|crizotinib|mesh-list
101690611|NCT04165512|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101956100|NCT04439253|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101956101|NCT04439253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101956102|NCT04439253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101956103|NCT04439253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101956104|NCT04439253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956105|NCT03750669|Folic Acid|folic acid|mesh-list
101956106|NCT03750669|Paclitaxel|paclitaxel|mesh-list
101956107|NCT03750669|Gemcitabine|gemcitabine|mesh-list
101956108|NCT03750669|Fluorouracil|fluorouracil|mesh-list
101956109|NCT03750669|Oxaliplatin|oxaliplatin|mesh-list
101956110|NCT03750669|Irinotecan|irinotecan|mesh-list
101956111|NCT03750669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101956112|NCT03750669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101956113|NCT03750669|Tubulin Modulators|tubulin modulators|mesh-ancestor
101956114|NCT03750669|Antimitotic Agents|antimitotic agents|mesh-ancestor
101956115|NCT03750669|Mitosis Modulators|mitosis modulators|mesh-ancestor
101956116|NCT03750669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956117|NCT03750669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101956118|NCT03750669|Antimetabolites|antimetabolites|mesh-ancestor
101956119|NCT03750669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101956120|NCT03750669|Immunologic Factors|immunologic factors|mesh-ancestor
101956121|NCT03750669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956122|NCT03750669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101956123|NCT03750669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101956124|NCT03750669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101956125|NCT03750669|Hematinics|hematinics|mesh-ancestor
101956126|NCT03750669|Vitamin B Complex|vitamin b complex|mesh-ancestor
101956127|NCT03750669|Vitamins|vitamins|mesh-ancestor
101956128|NCT03750669|Micronutrients|micronutrients|mesh-ancestor
101956129|NCT03757221|Daratumumab|daratumumab|mesh-list
101956130|NCT03757221|Ixazomib|ixazomib|mesh-list
101956131|NCT03757221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101956132|NCT03757221|Protease Inhibitors|protease inhibitors|mesh-ancestor
101956133|NCT03757221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101956134|NCT03757221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956135|NCT03757143|Ethanol|ethanol|mesh-list
101956136|NCT03757143|Chlorhexidine|chlorhexidine|mesh-list
101956137|NCT03757143|Povidone-Iodine|povidone-iodine|mesh-list
101956138|NCT03757143|Povidone|povidone|mesh-list
101956139|NCT03757143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101956140|NCT03757143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101527590|NCT00545675|Serotonin Agents|serotonin agents|mesh-ancestor
101956141|NCT03757143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101956142|NCT03757143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956144|NCT03757143|Plasma Substitutes|plasma substitutes|mesh-ancestor
101956145|NCT03757143|Blood Substitutes|blood substitutes|mesh-ancestor
101956147|NCT04428411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101970267|NCT05947201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101970268|NCT05947201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101305181|NCT02018081|Levofloxacin|levofloxacin|mesh-list
101956148|NCT04428411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101956149|NCT04428411|Analgesics|analgesics|mesh-ancestor
101956150|NCT04428411|Sensory System Agents|sensory system agents|mesh-ancestor
101956151|NCT04428411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101956152|NCT04428411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956153|NCT04428411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101956154|NCT04428411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101956155|NCT04428411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101956156|NCT04428411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101956158|NCT03751059|Dexamethasone|dexamethasone|mesh-list
101956159|NCT03751059|Bromfenac|bromfenac|mesh-list
101956160|NCT03751059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101956161|NCT03751059|Antiemetics|antiemetics|mesh-ancestor
101956162|NCT03751059|Autonomic Agents|autonomic agents|mesh-ancestor
101956163|NCT03751059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101956164|NCT03751059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956165|NCT03751059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101956166|NCT03751059|Glucocorticoids|glucocorticoids|mesh-ancestor
101956167|NCT03751059|Hormones|hormones|mesh-ancestor
101956168|NCT03751059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101956169|NCT03751059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101956170|NCT03751059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101527754|NCT00547664|Narcotics|narcotics|mesh-ancestor
101956172|NCT03751059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101956173|NCT03751059|Analgesics|analgesics|mesh-ancestor
101956174|NCT03751059|Sensory System Agents|sensory system agents|mesh-ancestor
101956175|NCT03751059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101956176|NCT04422561|Ivermectin|ivermectin|mesh-list
101956177|NCT04422561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101956178|NCT04422561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101956179|NCT03756987|Ropivacaine|ropivacaine|mesh-list
101956180|NCT03756987|Anesthetics, Local|anesthetics, local|mesh-ancestor
101956181|NCT03756987|Anesthetics|anesthetics|mesh-ancestor
101956182|NCT03756987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101956183|NCT03756987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956184|NCT03756987|Sensory System Agents|sensory system agents|mesh-ancestor
101956185|NCT03756987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101956186|NCT02072746|Zinc|zinc|mesh-list
101956187|NCT02072746|Zinc Sulfate|zinc sulfate|mesh-list
101956188|NCT02072746|Trace Elements|trace elements|mesh-ancestor
101956189|NCT02072746|Micronutrients|micronutrients|mesh-ancestor
101956190|NCT02072746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956191|NCT02072746|Astringents|astringents|mesh-ancestor
101956192|NCT02072746|Dermatologic Agents|dermatologic agents|mesh-ancestor
101956193|NCT04940338|Dexamethasone|dexamethasone|mesh-list
101956194|NCT04940338|Dexamethasone acetate|dexamethasone acetate|mesh-list
101956195|NCT04940338|Bromfenac|bromfenac|mesh-list
101956196|NCT04940338|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101956197|NCT04940338|BB 1101|bb 1101|mesh-list
101956198|NCT04940338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101956199|NCT04940338|Antiemetics|antiemetics|mesh-ancestor
101956200|NCT04940338|Autonomic Agents|autonomic agents|mesh-ancestor
101956201|NCT04940338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101956202|NCT04940338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956203|NCT04940338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101956204|NCT04940338|Glucocorticoids|glucocorticoids|mesh-ancestor
101956205|NCT04940338|Hormones|hormones|mesh-ancestor
101956206|NCT04940338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101956207|NCT04940338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101956208|NCT04940338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101956209|NCT04940338|Protease Inhibitors|protease inhibitors|mesh-ancestor
101956210|NCT04940338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101956211|NCT04940338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956212|NCT04940338|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101956213|NCT04940338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101956214|NCT04940338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101956215|NCT04940338|Analgesics|analgesics|mesh-ancestor
101956216|NCT04940338|Sensory System Agents|sensory system agents|mesh-ancestor
101956217|NCT04940338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101956219|NCT02083510|Gout Suppressants|gout suppressants|mesh-ancestor
101956220|NCT02083510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101956221|NCT02083510|Tubulin Modulators|tubulin modulators|mesh-ancestor
101970270|NCT05947201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970271|NCT05945823|Calcium, Dietary|calcium, dietary|mesh-list
101956222|NCT02083510|Antimitotic Agents|antimitotic agents|mesh-ancestor
101956223|NCT02083510|Mitosis Modulators|mitosis modulators|mesh-ancestor
101956224|NCT02083510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956225|NCT02083510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101956226|NCT04407507|Ivermectin|ivermectin|mesh-list
101347962|NCT00034983|Antiemetics|antiemetics|mesh-ancestor
101956227|NCT04407507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101956228|NCT04407507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101956229|NCT02080624|Sirolimus|sirolimus|mesh-list
101956230|NCT02080624|Temsirolimus|temsirolimus|mesh-list
101956231|NCT02080624|MTOR Inhibitors|mtor inhibitors|mesh-list
101956232|NCT02080624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101956233|NCT02080624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101956234|NCT02080624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101956235|NCT02080624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101956236|NCT02080624|Antifungal Agents|antifungal agents|mesh-ancestor
101956237|NCT02080624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101956238|NCT02080624|Immunologic Factors|immunologic factors|mesh-ancestor
101956239|NCT02080624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956240|NCT02080624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101956241|NCT02080624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101956242|NCT02080624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956243|NCT02080858|Apixaban|apixaban|mesh-list
101956244|NCT02080858|Ticagrelor|ticagrelor|mesh-list
101956245|NCT02080858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101956246|NCT02080858|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101956247|NCT02080858|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101956248|NCT02080858|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101956249|NCT02080858|Purinergic Agents|purinergic agents|mesh-ancestor
101956250|NCT02080858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101956251|NCT02080858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956252|NCT02080858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956253|NCT02080858|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101956254|NCT02080858|Antithrombins|antithrombins|mesh-ancestor
101956255|NCT02080858|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101956256|NCT02080858|Protease Inhibitors|protease inhibitors|mesh-ancestor
101956257|NCT02080858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101956258|NCT02080858|Anticoagulants|anticoagulants|mesh-ancestor
101956259|NCT02073526|Adalimumab|adalimumab|mesh-list
101956260|NCT02073526|Infliximab|infliximab|mesh-list
101956261|NCT02073526|Certolizumab Pegol|certolizumab pegol|mesh-list
101956262|NCT02073526|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101956263|NCT02073526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101956264|NCT02073526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101956265|NCT02073526|Dermatologic Agents|dermatologic agents|mesh-ancestor
101956266|NCT02073526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101956267|NCT02073526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101956268|NCT02073526|Immunologic Factors|immunologic factors|mesh-ancestor
101956269|NCT02073526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956270|NCT02073916|Paclitaxel|paclitaxel|mesh-list
101956271|NCT02073916|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101956272|NCT02073916|Trastuzumab|trastuzumab|mesh-list
101956273|NCT02073916|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101956274|NCT02073916|Lapatinib|lapatinib|mesh-list
101956275|NCT02073916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101956276|NCT02073916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101956277|NCT02073916|Tubulin Modulators|tubulin modulators|mesh-ancestor
101956278|NCT02073916|Antimitotic Agents|antimitotic agents|mesh-ancestor
101956279|NCT02073916|Mitosis Modulators|mitosis modulators|mesh-ancestor
101956280|NCT02073916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956281|NCT02073916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101956282|NCT02073916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101956283|NCT02073916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101956284|NCT02073916|Immunotoxins|immunotoxins|mesh-ancestor
101956285|NCT02073916|Immunoconjugates|immunoconjugates|mesh-ancestor
101956286|NCT02073916|Immunologic Factors|immunologic factors|mesh-ancestor
101956287|NCT02073916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956288|NCT02084368|Bupivacaine|bupivacaine|mesh-list
101956289|NCT02084368|Ropivacaine|ropivacaine|mesh-list
101956290|NCT02084368|Anesthetics, Local|anesthetics, local|mesh-ancestor
101956291|NCT02084368|Anesthetics|anesthetics|mesh-ancestor
101956292|NCT02084368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101970272|NCT05945823|Leucovorin|leucovorin|mesh-list
101970273|NCT05945823|Pembrolizumab|pembrolizumab|mesh-list
101970274|NCT05945823|Oxaliplatin|oxaliplatin|mesh-list
101970275|NCT05945823|Futibatinib|futibatinib|mesh-list
101970276|NCT05945823|Calcium|calcium|mesh-list
101970277|NCT05945823|Levoleucovorin|levoleucovorin|mesh-list
101956293|NCT02084368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956294|NCT02084368|Sensory System Agents|sensory system agents|mesh-ancestor
101956295|NCT02084368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101956296|NCT02084446|Mycophenolic Acid|mycophenolic acid|mesh-list
101956297|NCT02084446|Prednisone|prednisone|mesh-list
101956298|NCT02084446|Methylprednisolone|methylprednisolone|mesh-list
101956299|NCT02084446|Everolimus|everolimus|mesh-list
101956300|NCT02084446|Tacrolimus|tacrolimus|mesh-list
101956301|NCT02084446|Thymoglobulin|thymoglobulin|mesh-list
101956302|NCT02084446|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101956303|NCT02084446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101956304|NCT02084446|Glucocorticoids|glucocorticoids|mesh-ancestor
101956305|NCT02084446|Hormones|hormones|mesh-ancestor
101956306|NCT02084446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101956307|NCT02084446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956308|NCT02084446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101956309|NCT02084446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101956310|NCT02084446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101956311|NCT02084446|Immunologic Factors|immunologic factors|mesh-ancestor
101956312|NCT02084446|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101956313|NCT02084446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101956314|NCT02084446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956315|NCT02084446|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101956316|NCT02084446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101956317|NCT02084446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101956318|NCT02084446|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101956319|NCT02084446|Antitubercular Agents|antitubercular agents|mesh-ancestor
101956320|NCT02084446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101956321|NCT02084446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101956322|NCT02084446|Antiemetics|antiemetics|mesh-ancestor
101956323|NCT02084446|Autonomic Agents|autonomic agents|mesh-ancestor
101956324|NCT02084446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101956325|NCT02084446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101956326|NCT02084446|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101956327|NCT02084446|Protective Agents|protective agents|mesh-ancestor
101956328|NCT02801656|Vancomycin|vancomycin|mesh-list
101527941|NCT04643691|Losartan|losartan|mesh-list
101956329|NCT02801656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101956330|NCT02801656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101956331|NCT02081482|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101956332|NCT02081482|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101956333|NCT02081482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956335|NCT02084602|Mefloquine|mefloquine|mesh-list
101956336|NCT02084602|Antimalarials|antimalarials|mesh-ancestor
101956337|NCT02084602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101956338|NCT02084602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101956339|NCT02084602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101956340|NCT02084602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101956341|NCT02084602|Antiviral Agents|antiviral agents|mesh-ancestor
101956342|NCT02084602|Schistosomicides|schistosomicides|mesh-ancestor
101956343|NCT02084602|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101956344|NCT02084602|Anthelmintics|anthelmintics|mesh-ancestor
101956345|NCT02081560|Colistin|colistin|mesh-list
101956346|NCT02081560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101956347|NCT02081560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101956348|NCT02074150|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101956349|NCT02074150|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101956350|NCT02074150|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101956351|NCT02074150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101956352|NCT02074150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956353|NCT02074150|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101956354|NCT02074150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101956355|NCT02074150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956356|NCT02074150|Cholinergic Agents|cholinergic agents|mesh-ancestor
101956357|NCT02074150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101956358|NCT02074228|Methylphenidate|methylphenidate|mesh-list
101956359|NCT02074228|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101970278|NCT05945823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970279|NCT05945823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101305192|NCT02018094|Iodine|iodine|mesh-list
101956360|NCT02074228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956361|NCT02074228|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101956362|NCT02074228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101956363|NCT02074228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101956364|NCT02074228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956365|NCT02074228|Dopamine Agents|dopamine agents|mesh-ancestor
101956366|NCT02074228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101956368|NCT04346199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101956369|NCT03558490|Immunomodulating Agents|immunomodulating agents|mesh-list
101956370|NCT03558490|Immunologic Factors|immunologic factors|mesh-ancestor
101956371|NCT03558490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956372|NCT04345653|Hydroxychloroquine|hydroxychloroquine|mesh-list
101956373|NCT04345653|Antimalarials|antimalarials|mesh-ancestor
101956374|NCT04345653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101956375|NCT04345653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101956376|NCT04345653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101956377|NCT04345653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101956378|NCT04345653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956379|NCT04345653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101956380|NCT02085304|Temozolomide|temozolomide|mesh-list
101956381|NCT02085304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101956382|NCT02085304|Alkylating Agents|alkylating agents|mesh-ancestor
101956383|NCT02085304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956384|NCT02085304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101956385|NCT02260414|Tinzaparin|tinzaparin|mesh-list
101956386|NCT02260414|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101956387|NCT02260414|Dalteparin|dalteparin|mesh-list
101956388|NCT02260414|Anticoagulants|anticoagulants|mesh-ancestor
101956389|NCT02260414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101956390|NCT02260414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101956391|NCT02260414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956392|NCT02085538|Palbociclib|palbociclib|mesh-list
101956393|NCT02085538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101956394|NCT02085538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101956395|NCT02085538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101956396|NCT02085538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956397|NCT04169061|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101956398|NCT04169061|Hormones|hormones|mesh-ancestor
101956399|NCT04169061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101956400|NCT04169061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956401|NCT01562691|Petrolatum|petrolatum|mesh-list
101956402|NCT01562691|Emollients|emollients|mesh-ancestor
101956403|NCT01562691|Dermatologic Agents|dermatologic agents|mesh-ancestor
101956404|NCT04681677|Bevacizumab|bevacizumab|mesh-list
101956405|NCT04681677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101956406|NCT04681677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101956407|NCT04681677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101956408|NCT04681677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101956409|NCT04681677|Growth Substances|growth substances|mesh-ancestor
101956410|NCT04681677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956411|NCT04681677|Growth Inhibitors|growth inhibitors|mesh-ancestor
101956412|NCT02792218|Teriflunomide|teriflunomide|mesh-list
101956413|NCT02792218|Ofatumumab|ofatumumab|mesh-list
101956414|NCT02792218|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101956415|NCT02792218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101956416|NCT02792218|Immunologic Factors|immunologic factors|mesh-ancestor
101956417|NCT02792218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956418|NCT02792218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101956419|NCT02792218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101956420|NCT02792218|Analgesics|analgesics|mesh-ancestor
101956421|NCT02792218|Sensory System Agents|sensory system agents|mesh-ancestor
101956422|NCT02792218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101956423|NCT02792218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101956424|NCT02792218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101956425|NCT02792218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101956426|NCT02075086|Bevacizumab|bevacizumab|mesh-list
101956427|NCT02075086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101956428|NCT02075086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970280|NCT05945823|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101970281|NCT05945823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970282|NCT05945823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101970283|NCT05945823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305193|NCT02018094|Chlorhexidine|chlorhexidine|mesh-list
101956429|NCT02075086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101956430|NCT02075086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101956431|NCT02075086|Growth Substances|growth substances|mesh-ancestor
101956432|NCT02075086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956433|NCT02075086|Growth Inhibitors|growth inhibitors|mesh-ancestor
101956435|NCT02082418|Chelating Agents|chelating agents|mesh-ancestor
101956436|NCT02082418|Sequestering Agents|sequestering agents|mesh-ancestor
101956437|NCT02082418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956438|NCT02082496|Liraglutide|liraglutide|mesh-list
101956439|NCT02082496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101956440|NCT02082496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956441|NCT02082496|Incretins|incretins|mesh-ancestor
101956442|NCT02082496|Hormones|hormones|mesh-ancestor
101956443|NCT02082496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101956444|NCT02075242|Mycophenolic Acid|mycophenolic acid|mesh-list
101956445|NCT02075242|Tacrolimus|tacrolimus|mesh-list
101956446|NCT02075242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101956447|NCT02075242|Immunologic Factors|immunologic factors|mesh-ancestor
101956448|NCT02075242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956449|NCT02075242|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101956450|NCT02075242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101956451|NCT02075242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956452|NCT02075242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101956453|NCT02075242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101956454|NCT02075242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101956455|NCT02075242|Antitubercular Agents|antitubercular agents|mesh-ancestor
101956456|NCT02075242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101956457|NCT02075242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101956458|NCT02082652|Etonogestrel|etonogestrel|mesh-list
101956459|NCT02082652|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101956460|NCT02082652|Contraceptive Agents|contraceptive agents|mesh-ancestor
101956461|NCT02082652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101956462|NCT02082652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956463|NCT02082652|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101956464|NCT00153101|Telmisartan|telmisartan|mesh-list
101956466|NCT00153101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101956467|NCT00153101|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101956468|NCT00153101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101956469|NCT00153101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956470|NCT00153101|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101956471|NCT00153101|Protease Inhibitors|protease inhibitors|mesh-ancestor
101956472|NCT00153101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101956473|NCT03558412|Decitabine|decitabine|mesh-list
101956474|NCT03558412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101956475|NCT03558412|Antimetabolites|antimetabolites|mesh-ancestor
101956476|NCT03558412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956477|NCT03558412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101956478|NCT03558412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101956479|NCT04401579|Remdesivir|remdesivir|mesh-list
101956480|NCT04401579|Antimetabolites|antimetabolites|mesh-ancestor
101956481|NCT04401579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956482|NCT04401579|Antiviral Agents|antiviral agents|mesh-ancestor
101956483|NCT04401579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101956484|NCT03558880|Anesthetics|anesthetics|mesh-list
101956485|NCT03558880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101956486|NCT03558880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956487|NCT04401423|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
101956488|NCT04401423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101956489|NCT04401423|Vasodilator Agents|vasodilator agents|mesh-ancestor
101956490|NCT03749733|Megestrol|megestrol|mesh-list
101956491|NCT03749733|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101528289|NCT00561522|Capecitabine|capecitabine|mesh-list
101970284|NCT05945823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101970285|NCT05945823|Antidotes|antidotes|mesh-ancestor
101956492|NCT03749733|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101956494|NCT03749733|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101956495|NCT03749733|Estrogens|estrogens|mesh-ancestor
101956496|NCT03749733|Hormones|hormones|mesh-ancestor
101956497|NCT03749733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101956498|NCT03749733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956499|NCT03749733|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101956500|NCT03749733|Contraceptive Agents|contraceptive agents|mesh-ancestor
101956501|NCT03749733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101956502|NCT03749733|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101956503|NCT03749733|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101956504|NCT03749733|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101956505|NCT03749733|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101956506|NCT03749733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101956507|NCT03749733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101956508|NCT04399161|Chlorhexidine|chlorhexidine|mesh-list
101956509|NCT04399161|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101956510|NCT04399161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101956511|NCT04399161|Disinfectants|disinfectants|mesh-ancestor
101956512|NCT04160091|FX006|fx006|mesh-list
101956513|NCT04160091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101956514|NCT04160091|Glucocorticoids|glucocorticoids|mesh-ancestor
101956515|NCT04160091|Hormones|hormones|mesh-ancestor
101956516|NCT04160091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101690690|NCT02639598|Topiramate|topiramate|mesh-list
101956517|NCT04160091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956518|NCT04160091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101676299|NCT04349579|Rifamycins|rifamycins|mesh-list
101956519|NCT04160091|Immunologic Factors|immunologic factors|mesh-ancestor
101956520|NCT01582607|Fentanyl|fentanyl|mesh-list
101956521|NCT01582607|Bupivacaine|bupivacaine|mesh-list
101956522|NCT01582607|Ropivacaine|ropivacaine|mesh-list
101956523|NCT01582607|Levobupivacaine|levobupivacaine|mesh-list
101956524|NCT01582607|Anesthetics, Local|anesthetics, local|mesh-ancestor
101956525|NCT01582607|Anesthetics|anesthetics|mesh-ancestor
101956526|NCT01582607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101956527|NCT01582607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956528|NCT01582607|Sensory System Agents|sensory system agents|mesh-ancestor
101956529|NCT01582607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101956530|NCT01582607|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101956531|NCT01582607|Narcotics|narcotics|mesh-ancestor
101956532|NCT01582607|Analgesics|analgesics|mesh-ancestor
101956533|NCT01582607|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101956534|NCT01582607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101956535|NCT01582607|Anesthetics, General|anesthetics, general|mesh-ancestor
101956536|NCT00149825|Dexetimide|dexetimide|mesh-list
101956537|NCT00149825|Citalopram|citalopram|mesh-list
101956538|NCT00149825|Escitalopram|escitalopram|mesh-list
101956539|NCT00149825|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101956540|NCT00149825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101956541|NCT00149825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101956542|NCT00149825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956543|NCT00149825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101956544|NCT00149825|Serotonin Agents|serotonin agents|mesh-ancestor
101956545|NCT00149825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956546|NCT00149825|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101956547|NCT00149825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101956548|NCT00149825|Parasympatholytics|parasympatholytics|mesh-ancestor
101956549|NCT00149825|Autonomic Agents|autonomic agents|mesh-ancestor
101956550|NCT00149825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101956551|NCT00149825|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101956552|NCT00149825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101956553|NCT00149825|Cholinergic Agents|cholinergic agents|mesh-ancestor
101956554|NCT00149825|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101956555|NCT00149825|Antidepressive Agents|antidepressive agents|mesh-ancestor
101956556|NCT00149825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101956557|NCT02792062|Relugolix|relugolix|mesh-list
101956558|NCT02792062|Androgen Antagonists|androgen antagonists|mesh-ancestor
101956559|NCT02792062|Hormone Antagonists|hormone antagonists|mesh-ancestor
101956560|NCT02792062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101956561|NCT02792062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956562|NCT05027295|Riboflavin|riboflavin|mesh-list
101970286|NCT05945823|Protective Agents|protective agents|mesh-ancestor
101970287|NCT05945823|Vitamin B Complex|vitamin b complex|mesh-ancestor
101970288|NCT05945823|Vitamins|vitamins|mesh-ancestor
101956563|NCT05027295|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101956564|NCT05027295|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101956565|NCT05027295|Vitamin B Complex|vitamin b complex|mesh-ancestor
101956566|NCT05027295|Vitamins|vitamins|mesh-ancestor
101956567|NCT05027295|Micronutrients|micronutrients|mesh-ancestor
101956568|NCT05027295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956569|NCT05027295|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101956570|NCT05027295|Dermatologic Agents|dermatologic agents|mesh-ancestor
101956571|NCT02090920|Nifedipine|nifedipine|mesh-list
101956572|NCT02090920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101956573|NCT02090920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101956574|NCT02090920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956575|NCT02090920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101956576|NCT02090920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956577|NCT02090920|Vasodilator Agents|vasodilator agents|mesh-ancestor
101956578|NCT02090920|Tocolytic Agents|tocolytic agents|mesh-ancestor
101956579|NCT02090920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101956580|NCT02086474|Bupivacaine|bupivacaine|mesh-list
101956581|NCT02086474|Hyaluronic Acid|hyaluronic acid|mesh-list
101956582|NCT02086474|Anesthetics, Local|anesthetics, local|mesh-ancestor
101956583|NCT02086474|Anesthetics|anesthetics|mesh-ancestor
101956584|NCT02086474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101956585|NCT02086474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956586|NCT02086474|Sensory System Agents|sensory system agents|mesh-ancestor
101956587|NCT02086474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101956588|NCT02086474|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101956589|NCT02086474|Immunologic Factors|immunologic factors|mesh-ancestor
101956590|NCT02086474|Viscosupplements|viscosupplements|mesh-ancestor
101956591|NCT02086474|Protective Agents|protective agents|mesh-ancestor
101956592|NCT02091310|Moxifloxacin|moxifloxacin|mesh-list
101956593|NCT02091310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101956594|NCT02091310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101956595|NCT02091310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101956596|NCT02091310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101956597|NCT02091310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101956598|NCT02091310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956599|NCT02091310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101956600|NCT02621398|Paclitaxel|paclitaxel|mesh-list
101956601|NCT02621398|Carboplatin|carboplatin|mesh-list
101956602|NCT02621398|Pembrolizumab|pembrolizumab|mesh-list
101956603|NCT02621398|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101956604|NCT02621398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101956605|NCT02621398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101956606|NCT02621398|Tubulin Modulators|tubulin modulators|mesh-ancestor
101956607|NCT02621398|Antimitotic Agents|antimitotic agents|mesh-ancestor
101956608|NCT02621398|Mitosis Modulators|mitosis modulators|mesh-ancestor
101956609|NCT02621398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956610|NCT02621398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101956611|NCT02621398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101956612|NCT04397445|Ranitidine|ranitidine|mesh-list
101956613|NCT04397445|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
101956614|NCT04397445|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101956615|NCT04397445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101956616|NCT04397445|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101956617|NCT04397445|Histamine Antagonists|histamine antagonists|mesh-ancestor
101956618|NCT04397445|Histamine Agents|histamine agents|mesh-ancestor
101956619|NCT04397445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101956620|NCT04397445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956621|NCT04397445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956622|NCT02091388|Risperidone|risperidone|mesh-list
101956623|NCT02091388|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101956624|NCT02091388|Serotonin Agents|serotonin agents|mesh-ancestor
101956625|NCT02091388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101956626|NCT02091388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956627|NCT02091388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956628|NCT02091388|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101956629|NCT02091388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101956630|NCT02091388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101956631|NCT02091388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101956632|NCT02091388|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101970289|NCT05945823|Micronutrients|micronutrients|mesh-ancestor
101970291|NCT05944016|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101970292|NCT05944016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956633|NCT02091388|Dopamine Agents|dopamine agents|mesh-ancestor
101956634|NCT02086942|Dexamethasone|dexamethasone|mesh-list
101956635|NCT02086942|Cyclophosphamide|cyclophosphamide|mesh-list
101956636|NCT02086942|Bortezomib|bortezomib|mesh-list
101956637|NCT02086942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101956638|NCT02086942|Immunologic Factors|immunologic factors|mesh-ancestor
101956639|NCT02086942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956640|NCT02086942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101956641|NCT02086942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101956642|NCT02086942|Alkylating Agents|alkylating agents|mesh-ancestor
101956643|NCT02086942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956644|NCT02086942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101956645|NCT02086942|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101956646|NCT02086942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101956647|NCT02086942|Antiemetics|antiemetics|mesh-ancestor
101956648|NCT02086942|Autonomic Agents|autonomic agents|mesh-ancestor
101956649|NCT02086942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101956650|NCT02086942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101956651|NCT02086942|Glucocorticoids|glucocorticoids|mesh-ancestor
101956652|NCT02086942|Hormones|hormones|mesh-ancestor
101956653|NCT02086942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101956654|NCT02086942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101956655|NCT02088424|Insulin|insulin|mesh-list
101956656|NCT02088424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101956657|NCT02088424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956658|NCT00191945|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101956659|NCT00191945|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101956660|NCT00191945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101956661|NCT00191945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101956662|NCT00191945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956663|NCT00191945|Adrenergic Agents|adrenergic agents|mesh-ancestor
101956664|NCT00191945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101956665|NCT00191945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956666|NCT02087020|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101956667|NCT02087020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101956668|NCT02088502|Acetylcysteine|acetylcysteine|mesh-list
101956669|NCT02088502|Theophylline|theophylline|mesh-list
101956670|NCT02088502|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101956671|NCT02088502|Antiviral Agents|antiviral agents|mesh-ancestor
101956672|NCT02088502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101956674|NCT02088502|Respiratory System Agents|respiratory system agents|mesh-ancestor
101956675|NCT02088502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101956676|NCT02088502|Antioxidants|antioxidants|mesh-ancestor
101223617|NCT01519128|Antiviral Agents|antiviral agents|mesh-ancestor
101956677|NCT02088502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956679|NCT02088502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956680|NCT02088502|Antidotes|antidotes|mesh-ancestor
101956681|NCT02088502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101956682|NCT02088502|Autonomic Agents|autonomic agents|mesh-ancestor
101956683|NCT02088502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101956684|NCT02088502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101956685|NCT02088502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101956686|NCT02088502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101956687|NCT02088502|Vasodilator Agents|vasodilator agents|mesh-ancestor
101956688|NCT02088502|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101956689|NCT02088502|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101956690|NCT02088502|Purinergic Agents|purinergic agents|mesh-ancestor
101956691|NCT02088502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101956693|NCT02087098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101956694|NCT02087098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101956695|NCT02087098|Cholinergic Agents|cholinergic agents|mesh-ancestor
101956696|NCT02087098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101956697|NCT02087098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956698|NCT02087098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956699|NCT02087098|Urological Agents|urological agents|mesh-ancestor
101956700|NCT01369342|Ustekinumab|ustekinumab|mesh-list
101970293|NCT05944016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101970294|NCT05944016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970295|NCT05914389|Capecitabine|capecitabine|mesh-list
101956701|NCT01369342|Dermatologic Agents|dermatologic agents|mesh-ancestor
101956702|NCT00191477|Gemcitabine|gemcitabine|mesh-list
101956703|NCT00191477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101956704|NCT00191477|Antimetabolites|antimetabolites|mesh-ancestor
101956705|NCT00191477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956706|NCT00191477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101956708|NCT02087332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101956709|NCT02087332|Diuretics|diuretics|mesh-ancestor
101956710|NCT02087332|Natriuretic Agents|natriuretic agents|mesh-ancestor
101956711|NCT02087332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956712|NCT02087332|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101956713|NCT02087332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101956714|NCT02087332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956715|NCT02092012|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
101956716|NCT02092012|Dexmedetomidine|dexmedetomidine|mesh-list
101956717|NCT02092012|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101956718|NCT02092012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101956719|NCT02092012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956720|NCT02092012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101956721|NCT02092012|Analgesics|analgesics|mesh-ancestor
101956722|NCT02092012|Sensory System Agents|sensory system agents|mesh-ancestor
101956723|NCT02092012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101956724|NCT02092012|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101956725|NCT02092012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101956726|NCT02092012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101956727|NCT02092012|Adrenergic Agents|adrenergic agents|mesh-ancestor
101956728|NCT02092012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101956729|NCT02092012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956730|NCT02092012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101956731|NCT02092012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101956732|NCT02092012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101956733|NCT00187889|Eplerenone|eplerenone|mesh-list
101956734|NCT00187889|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101956736|NCT00187889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101956737|NCT00187889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956738|NCT00187889|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101956739|NCT00187889|Diuretics|diuretics|mesh-ancestor
101956740|NCT00187889|Natriuretic Agents|natriuretic agents|mesh-ancestor
101956741|NCT00187889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101956742|NCT02087488|Eszopiclone|eszopiclone|mesh-list
101676524|NCT03994146|Remifentanil|remifentanil|mesh-list
101956743|NCT02087488|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101956744|NCT02087488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101956745|NCT02087488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956746|NCT02087566|Linezolid|linezolid|mesh-list
101956747|NCT02087566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101956748|NCT02087566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101956749|NCT02087566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101956750|NCT02087566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101956751|NCT02087566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956752|NCT00148109|Cetuximab|cetuximab|mesh-list
101956753|NCT00148109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101956754|NCT00148109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101956755|NCT03746223|Rituximab|rituximab|mesh-list
101956756|NCT03746223|Methotrexate|methotrexate|mesh-list
101956757|NCT03746223|Lenalidomide|lenalidomide|mesh-list
101956758|NCT03746223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101956759|NCT03746223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101956760|NCT03746223|Immunologic Factors|immunologic factors|mesh-ancestor
101956761|NCT03746223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956762|NCT03746223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101956763|NCT03746223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101956764|NCT03746223|Abortifacient Agents|abortifacient agents|mesh-ancestor
101956765|NCT03746223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101956766|NCT03746223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101956767|NCT03746223|Antimetabolites|antimetabolites|mesh-ancestor
101970296|NCT05914389|Oxaliplatin|oxaliplatin|mesh-list
101970297|NCT05914389|Antibodies|antibodies|mesh-list
101956768|NCT03746223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956769|NCT03746223|Dermatologic Agents|dermatologic agents|mesh-ancestor
101956770|NCT03746223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101956772|NCT03746223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101956773|NCT03746223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101956774|NCT03746223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101956775|NCT03746223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101956776|NCT03746223|Growth Substances|growth substances|mesh-ancestor
101956777|NCT03746223|Growth Inhibitors|growth inhibitors|mesh-ancestor
101956778|NCT03969017|Interferons|interferons|mesh-list
101956779|NCT03969017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101956780|NCT03969017|Antiviral Agents|antiviral agents|mesh-ancestor
101956781|NCT03969017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101956782|NCT04596033|Cyclophosphamide|cyclophosphamide|mesh-list
101956783|NCT04596033|Fludarabine|fludarabine|mesh-list
101956784|NCT04596033|Interleukin-2|interleukin-2|mesh-list
101956785|NCT04596033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101956786|NCT04596033|Immunologic Factors|immunologic factors|mesh-ancestor
101956787|NCT04596033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956788|NCT04596033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101956789|NCT04596033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101956790|NCT04596033|Alkylating Agents|alkylating agents|mesh-ancestor
101956791|NCT04596033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956792|NCT04596033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101956793|NCT04596033|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101956794|NCT04596033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101956795|NCT04596033|Analgesics|analgesics|mesh-ancestor
101956796|NCT04596033|Sensory System Agents|sensory system agents|mesh-ancestor
101956797|NCT04596033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101956798|NCT02092558|Nitrofurantoin|nitrofurantoin|mesh-list
101956799|NCT02092558|Cephalosporins|cephalosporins|mesh-list
101956800|NCT02092558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101956801|NCT02092558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101956802|NCT02092558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101956803|NCT01074359|Tocopherylquinone|tocopherylquinone|mesh-list
101956804|NCT01074359|Anticoagulants|anticoagulants|mesh-ancestor
101956805|NCT01074359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101956806|NCT01074359|Antioxidants|antioxidants|mesh-ancestor
101956807|NCT01074359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956808|NCT01074359|Protective Agents|protective agents|mesh-ancestor
101956809|NCT01074359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956810|NCT02087722|Melatonin|melatonin|mesh-list
101956811|NCT02087722|Antioxidants|antioxidants|mesh-ancestor
101956812|NCT02087722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956813|NCT02087722|Protective Agents|protective agents|mesh-ancestor
101956814|NCT02087722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956815|NCT02087722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101956816|NCT01326221|Tenofovir|tenofovir|mesh-list
101956817|NCT01326221|Emtricitabine|emtricitabine|mesh-list
101676608|NCT03939767|Aflibercept|aflibercept|mesh-list
101956818|NCT01326221|Antiviral Agents|antiviral agents|mesh-ancestor
101956819|NCT01326221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101956820|NCT01326221|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101956821|NCT01326221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101956822|NCT01326221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101956823|NCT01326221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956824|NCT01326221|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101956825|NCT01326221|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101956826|NCT04311177|Losartan|losartan|mesh-list
101956827|NCT04311177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101956828|NCT04311177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101956829|NCT04311177|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101956830|NCT04311177|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101956831|NCT04311177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956832|NCT02088892|BCG Vaccine|bcg vaccine|mesh-list
101956833|NCT02088892|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101956834|NCT02088892|Immunologic Factors|immunologic factors|mesh-ancestor
101956835|NCT02088892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956836|NCT01074593|Interferons|interferons|mesh-list
101956837|NCT01074593|Interferon-beta|interferon-beta|mesh-list
101956838|NCT01074593|Interferon beta-1a|interferon beta-1a|mesh-list
101956839|NCT01074593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101956840|NCT01074593|Antiviral Agents|antiviral agents|mesh-ancestor
101970299|NCT05914389|Immunologic Factors|immunologic factors|mesh-ancestor
101970300|NCT05914389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956841|NCT01074593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101956842|NCT01074593|Immunologic Factors|immunologic factors|mesh-ancestor
101956843|NCT01074593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956844|NCT01074593|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101956845|NCT02088970|Riboflavin|riboflavin|mesh-list
101956846|NCT02088970|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101956847|NCT02088970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101956848|NCT02088970|Vitamin B Complex|vitamin b complex|mesh-ancestor
101956849|NCT02088970|Vitamins|vitamins|mesh-ancestor
101956850|NCT02088970|Micronutrients|micronutrients|mesh-ancestor
101223900|NCT01520831|Insulin|insulin|mesh-list
101956851|NCT02088970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956852|NCT02088970|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101956853|NCT02088970|Dermatologic Agents|dermatologic agents|mesh-ancestor
101956854|NCT03968861|Xenon|xenon|mesh-list
101956855|NCT03968861|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101956856|NCT03968861|Anesthetics, General|anesthetics, general|mesh-ancestor
101956857|NCT03968861|Anesthetics|anesthetics|mesh-ancestor
101956858|NCT03968861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101956859|NCT03968861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956860|NCT04292535|Insulin|insulin|mesh-list
101956861|NCT04292535|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101956862|NCT04292535|Insulin Aspart|insulin aspart|mesh-list
101956863|NCT04292535|Insulin, Long-Acting|insulin, long-acting|mesh-list
101690790|NCT00653250|Analgesics|analgesics|mesh-ancestor
101956864|NCT04292535|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101956865|NCT04292535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101956866|NCT04292535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956867|NCT03747081|Warfarin|warfarin|mesh-list
101956868|NCT03747081|Rivaroxaban|rivaroxaban|mesh-list
101956869|NCT03747081|Anticoagulants|anticoagulants|mesh-ancestor
101956870|NCT03747081|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101956871|NCT03747081|Antithrombins|antithrombins|mesh-ancestor
101956872|NCT03747081|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101956873|NCT03747081|Protease Inhibitors|protease inhibitors|mesh-ancestor
101956874|NCT03747081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101956875|NCT03747081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956876|NCT01075841|Cetuximab|cetuximab|mesh-list
101956877|NCT01075841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101956878|NCT01075841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101956879|NCT01313390|Docetaxel|docetaxel|mesh-list
101956880|NCT01313390|Everolimus|everolimus|mesh-list
101956881|NCT01313390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101956882|NCT01313390|Tubulin Modulators|tubulin modulators|mesh-ancestor
101956883|NCT01313390|Antimitotic Agents|antimitotic agents|mesh-ancestor
101956884|NCT01313390|Mitosis Modulators|mitosis modulators|mesh-ancestor
101956885|NCT01313390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956886|NCT01313390|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101956887|NCT01313390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101956888|NCT01313390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101956889|NCT01313390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101956890|NCT01313390|Immunologic Factors|immunologic factors|mesh-ancestor
101956891|NCT01313390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956892|NCT05571332|Cyclosporine|cyclosporine|mesh-list
101956893|NCT05571332|Cyclosporins|cyclosporins|mesh-list
101956894|NCT05571332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101676682|NCT03728933|Rotigotine|rotigotine|mesh-list
101956895|NCT05571332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956896|NCT05571332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101956898|NCT05571332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956899|NCT05571332|Antifungal Agents|antifungal agents|mesh-ancestor
101956900|NCT05571332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101956901|NCT05571332|Dermatologic Agents|dermatologic agents|mesh-ancestor
101956902|NCT05571332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101956903|NCT05571332|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101956904|NCT02791438|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
101956905|NCT02791438|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101956906|NCT02791438|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101956907|NCT02791438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956908|NCT02089048|Auranofin|auranofin|mesh-list
101956909|NCT02089048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101956910|NCT02089126|Glimepiride|glimepiride|mesh-list
101956911|NCT02089126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101970301|NCT05914389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101970302|NCT05914389|Antimetabolites|antimetabolites|mesh-ancestor
101970303|NCT05914389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970304|NCT05914389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101956912|NCT02089126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101956913|NCT02089126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956914|NCT02089126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101956915|NCT02089126|Immunologic Factors|immunologic factors|mesh-ancestor
101956917|NCT05571176|Esketamine|esketamine|mesh-list
101956918|NCT05571176|Analgesics|analgesics|mesh-ancestor
101956919|NCT05571176|Sensory System Agents|sensory system agents|mesh-ancestor
101956920|NCT05571176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101956921|NCT05571176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956922|NCT05571176|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101956923|NCT05571176|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101956924|NCT05571176|Anesthetics, General|anesthetics, general|mesh-ancestor
101956925|NCT05571176|Anesthetics|anesthetics|mesh-ancestor
101956926|NCT05571176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101956927|NCT05571176|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101956928|NCT05571176|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101956929|NCT05571176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101224613|NCT01524744|Pimecrolimus|pimecrolimus|mesh-list
101956930|NCT05571176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956931|NCT05571176|Antidepressive Agents|antidepressive agents|mesh-ancestor
101956932|NCT05571176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101956933|NCT03689582|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101956934|NCT03689582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101224758|NCT01525914|Hormone Antagonists|hormone antagonists|mesh-ancestor
101956935|NCT03689582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956936|NCT02095834|Dexamethasone|dexamethasone|mesh-list
101956937|NCT02095834|Dexamethasone acetate|dexamethasone acetate|mesh-list
101956938|NCT02095834|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101956939|NCT02095834|Ichthammol|ichthammol|mesh-list
101956940|NCT02095834|BB 1101|bb 1101|mesh-list
101956941|NCT02095834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101956942|NCT02095834|Antiemetics|antiemetics|mesh-ancestor
101956943|NCT02095834|Autonomic Agents|autonomic agents|mesh-ancestor
101956944|NCT02095834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101956945|NCT02095834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956946|NCT02095834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101956948|NCT02095834|Hormones|hormones|mesh-ancestor
101956949|NCT02095834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101956950|NCT02095834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101956952|NCT02095834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101956953|NCT02095834|Alkylating Agents|alkylating agents|mesh-ancestor
101956954|NCT02095834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956955|NCT02095834|Protease Inhibitors|protease inhibitors|mesh-ancestor
101956956|NCT02095834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101956957|NCT02095834|Dermatologic Agents|dermatologic agents|mesh-ancestor
101956958|NCT03556852|Misoprostol|misoprostol|mesh-list
101956960|NCT03556852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101956961|NCT03556852|Abortifacient Agents|abortifacient agents|mesh-ancestor
101956962|NCT03556852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101956963|NCT03556852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956964|NCT03556852|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101956965|NCT03556852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101956966|NCT03556852|Oxytocics|oxytocics|mesh-ancestor
101225250|NCT01528007|Naltrexone|naltrexone|mesh-list
101956968|NCT02808572|Mitosis Modulators|mitosis modulators|mesh-ancestor
101676753|NCT03564691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101956969|NCT02808572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956970|NCT02093728|Itraconazole|itraconazole|mesh-list
101956971|NCT02093728|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
101956972|NCT02093728|Fluconazole|fluconazole|mesh-list
101956973|NCT02093728|Antifungal Agents|antifungal agents|mesh-ancestor
101956974|NCT02093728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101956975|NCT02093728|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101956976|NCT02093728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101956977|NCT02093728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970306|NCT05909553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970307|NCT05909267|Carbidopa|carbidopa|mesh-list
101970308|NCT05909267|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101970309|NCT05909267|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101690816|NCT02638896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101956978|NCT02093728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956979|NCT02093728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101956980|NCT02093728|Hormone Antagonists|hormone antagonists|mesh-ancestor
101956981|NCT02093728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101956982|NCT02093728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101956983|NCT02093728|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101956984|NCT02093728|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101956985|NCT02093728|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101956986|NCT02089204|Deoxyglucose|deoxyglucose|mesh-list
101956987|NCT02089204|Fluorides|fluorides|mesh-list
101225633|NCT01529957|Nemonoxacin|nemonoxacin|mesh-list
101956988|NCT02089204|Cariostatic Agents|cariostatic agents|mesh-ancestor
101956989|NCT02089204|Protective Agents|protective agents|mesh-ancestor
101956990|NCT02089204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225675|NCT01530217|Ibuprofen|ibuprofen|mesh-list
101956992|NCT02089204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956993|NCT02089204|Antiviral Agents|antiviral agents|mesh-ancestor
101956994|NCT02089204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101956995|NCT02095990|Hydroquinone|hydroquinone|mesh-list
101956996|NCT02095990|Antioxidants|antioxidants|mesh-ancestor
101225818|NCT01530763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101956997|NCT02095990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101956998|NCT02095990|Protective Agents|protective agents|mesh-ancestor
101956999|NCT02095990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225900|NCT01531309|Agomelatine|agomelatine|mesh-list
101957001|NCT02096068|Dexmedetomidine|dexmedetomidine|mesh-list
101957002|NCT02096068|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101957003|NCT02096068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101957004|NCT02096068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225965|NCT01531712|Antimetabolites|antimetabolites|mesh-ancestor
101957005|NCT02096068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101957006|NCT02096068|Analgesics|analgesics|mesh-ancestor
101957007|NCT02096068|Sensory System Agents|sensory system agents|mesh-ancestor
101957008|NCT02096068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101957009|NCT02096068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101957010|NCT02096068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101957011|NCT02096068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101957012|NCT02096068|Adrenergic Agents|adrenergic agents|mesh-ancestor
101957013|NCT02096068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101957014|NCT02096068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957015|NCT02089438|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101957016|NCT02089438|Vildagliptin|vildagliptin|mesh-list
101957017|NCT02089438|Saxagliptin|saxagliptin|mesh-list
101957018|NCT02089438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101957019|NCT02089438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957020|NCT02089438|Incretins|incretins|mesh-ancestor
101957021|NCT02089438|Hormones|hormones|mesh-ancestor
101957022|NCT02089438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101957023|NCT02089438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101957024|NCT02089438|Protease Inhibitors|protease inhibitors|mesh-ancestor
101957025|NCT02089438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101957026|NCT02089438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957027|NCT05471674|Nivolumab|nivolumab|mesh-list
101957028|NCT05471674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101957029|NCT05471674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101957030|NCT05471674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101957031|NCT05471674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957032|NCT02096224|Sevoflurane|sevoflurane|mesh-list
101957033|NCT02096224|Desflurane|desflurane|mesh-list
101957034|NCT02096224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101957035|NCT02096224|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101957036|NCT02096224|Anesthetics, General|anesthetics, general|mesh-ancestor
101957037|NCT02096224|Anesthetics|anesthetics|mesh-ancestor
101957038|NCT02096224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101970310|NCT05909267|Dopamine Agents|dopamine agents|mesh-ancestor
101970311|NCT05909267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101971982|NCT01339676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101957039|NCT02096224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957040|NCT02096380|Cisplatin|cisplatin|mesh-list
101957041|NCT02096380|Docetaxel|docetaxel|mesh-list
101957042|NCT02096380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101957043|NCT02096380|Tubulin Modulators|tubulin modulators|mesh-ancestor
101957044|NCT02096380|Antimitotic Agents|antimitotic agents|mesh-ancestor
101957045|NCT02096380|Mitosis Modulators|mitosis modulators|mesh-ancestor
101957046|NCT02096380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957048|NCT02250118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101957049|NCT02250118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101957050|NCT02250118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101957051|NCT02250118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101957052|NCT02250118|Growth Substances|growth substances|mesh-ancestor
101957053|NCT02250118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957054|NCT02250118|Growth Inhibitors|growth inhibitors|mesh-ancestor
101957056|NCT03060772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101957057|NCT03060772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957058|NCT02096536|Vancomycin|vancomycin|mesh-list
101957059|NCT02096536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101957060|NCT02096536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101957061|NCT02096614|Cyclophosphamide|cyclophosphamide|mesh-list
101957062|NCT02096614|Fludarabine|fludarabine|mesh-list
101957063|NCT02096614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101957064|NCT02096614|Immunologic Factors|immunologic factors|mesh-ancestor
101957065|NCT02096614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957066|NCT02096614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101957067|NCT02096614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101957068|NCT02096614|Alkylating Agents|alkylating agents|mesh-ancestor
101957069|NCT02096614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957070|NCT02096614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101226583|NCT01535495|Propranolol|propranolol|mesh-list
101957071|NCT02096614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101957072|NCT02094196|Ethanol|ethanol|mesh-list
101957073|NCT02094196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101957074|NCT02094196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101957075|NCT02094196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101957076|NCT02094196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957077|NCT02094274|Fluticasone|fluticasone|mesh-list
101957079|NCT02094274|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101957080|NCT02094274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101957081|NCT02094274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101957082|NCT02094274|Autonomic Agents|autonomic agents|mesh-ancestor
101957083|NCT02094274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101957084|NCT02094274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957085|NCT02094274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101957086|NCT02094274|Respiratory System Agents|respiratory system agents|mesh-ancestor
101226789|NCT01536613|Insulin Aspart|insulin aspart|mesh-list
101957087|NCT02094274|Dermatologic Agents|dermatologic agents|mesh-ancestor
101957088|NCT02094274|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101957089|NCT02094274|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101957090|NCT02094274|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101957091|NCT02094274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101957092|NCT02094274|Adrenergic Agents|adrenergic agents|mesh-ancestor
101957093|NCT02094274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101957094|NCT02094274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957095|NCT02096926|Ibuprofen|ibuprofen|mesh-list
101957096|NCT02096926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101957097|NCT02096926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101957098|NCT02096926|Analgesics|analgesics|mesh-ancestor
101957099|NCT02096926|Sensory System Agents|sensory system agents|mesh-ancestor
101957100|NCT02096926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101957101|NCT02096926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957102|NCT02096926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101957103|NCT02096926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101957104|NCT02096926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101957105|NCT02096926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101957106|NCT02096926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957107|NCT02097004|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101957108|NCT02097004|Entecavir|entecavir|mesh-list
101970312|NCT05909267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970313|NCT05909267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957109|NCT02097004|Antiviral Agents|antiviral agents|mesh-ancestor
101957110|NCT02097004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101957111|NCT02090296|Hydroxyurea|hydroxyurea|mesh-list
101957112|NCT02090296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101957113|NCT02090296|Antisickling Agents|antisickling agents|mesh-ancestor
101957115|NCT02090296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957116|NCT02090296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101957117|NCT03691779|Ivacaftor|ivacaftor|mesh-list
101957118|NCT03691779|Elexacaftor|elexacaftor|mesh-list
101957119|NCT03691779|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101957121|NCT03691779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957122|NCT02095054|Cetuximab|cetuximab|mesh-list
101957123|NCT02095054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101957124|NCT02095054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101957125|NCT03555994|Liraglutide|liraglutide|mesh-list
101957126|NCT03555994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101227118|NCT01538563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101957127|NCT03555994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957128|NCT03555994|Incretins|incretins|mesh-ancestor
101957129|NCT03555994|Hormones|hormones|mesh-ancestor
101957130|NCT03555994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101957132|NCT02095366|Morphine|morphine|mesh-list
101957133|NCT02095366|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101957134|NCT02095366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101957135|NCT02095366|Narcotics|narcotics|mesh-ancestor
101227279|NCT01539174|Hormones|hormones|mesh-ancestor
101957136|NCT02095366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101957137|NCT02095366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957138|NCT02095366|Analgesics|analgesics|mesh-ancestor
101957139|NCT02095366|Sensory System Agents|sensory system agents|mesh-ancestor
101957140|NCT02095366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101957141|NCT02095366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101957142|NCT02095366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101957143|NCT02095366|Anesthetics, General|anesthetics, general|mesh-ancestor
101227343|NCT01539577|Hormones|hormones|mesh-ancestor
101957144|NCT02095366|Anesthetics|anesthetics|mesh-ancestor
101957145|NCT02097082|Paclitaxel|paclitaxel|mesh-list
101957146|NCT02097082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101957147|NCT02097082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101957148|NCT02097082|Tubulin Modulators|tubulin modulators|mesh-ancestor
101957149|NCT02097082|Antimitotic Agents|antimitotic agents|mesh-ancestor
101957150|NCT02097082|Mitosis Modulators|mitosis modulators|mesh-ancestor
101957151|NCT02097082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957152|NCT02097160|Vitamin D|vitamin d|mesh-list
101957153|NCT02097160|Vitamins|vitamins|mesh-ancestor
101957154|NCT02097160|Micronutrients|micronutrients|mesh-ancestor
101957155|NCT02097160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957156|NCT02097160|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101957157|NCT01562223|Motexafin gadolinium|motexafin gadolinium|mesh-list
101957158|NCT01562223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101957159|NCT01562223|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101957160|NCT01562223|Dermatologic Agents|dermatologic agents|mesh-ancestor
101957161|NCT02097316|Insulin|insulin|mesh-list
101957162|NCT02097316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101957163|NCT02097316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957164|NCT02095522|Colchicine|colchicine|mesh-list
101957165|NCT02095522|Gout Suppressants|gout suppressants|mesh-ancestor
101957166|NCT02095522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101957167|NCT02095522|Tubulin Modulators|tubulin modulators|mesh-ancestor
101957168|NCT02095522|Antimitotic Agents|antimitotic agents|mesh-ancestor
101957169|NCT02095522|Mitosis Modulators|mitosis modulators|mesh-ancestor
101957170|NCT02095522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957171|NCT02095522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101957172|NCT02097394|Pancreatin|pancreatin|mesh-list
101957173|NCT02097394|Pancrelipase|pancrelipase|mesh-list
101957174|NCT02097394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101957175|NCT04123665|Fluorides|fluorides|mesh-list
101957176|NCT04123665|Tin Fluorides|tin fluorides|mesh-list
101957177|NCT04123665|Fluorophosphate|fluorophosphate|mesh-list
101957178|NCT04123665|Cariostatic Agents|cariostatic agents|mesh-ancestor
101227519|NCT01540708|Hormones|hormones|mesh-ancestor
101957179|NCT04123665|Protective Agents|protective agents|mesh-ancestor
101957180|NCT04123665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957181|NCT02250508|Factor VIII|factor viii|mesh-list
101970314|NCT05909267|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101970315|NCT05909267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970316|NCT05906589|Psyllium|psyllium|mesh-list
101970317|NCT05906589|Cathartics|cathartics|mesh-ancestor
101957182|NCT02250508|Coagulants|coagulants|mesh-ancestor
101957183|NCT03555526|Amoxicillin|amoxicillin|mesh-list
101957185|NCT03555526|Clarithromycin|clarithromycin|mesh-list
101957186|NCT03555526|Levofloxacin|levofloxacin|mesh-list
101957187|NCT03555526|Tetracycline|tetracycline|mesh-list
101957188|NCT03555526|Esomeprazole|esomeprazole|mesh-list
101957189|NCT03555526|Bismuth|bismuth|mesh-list
101957190|NCT03555526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101957191|NCT03555526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101957192|NCT03555526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101957193|NCT03555526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101957194|NCT03555526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101957195|NCT03555526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101957196|NCT03555526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101957197|NCT03555526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101957198|NCT03555526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957199|NCT03555526|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101957200|NCT03555526|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101957201|NCT03555526|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101957202|NCT03555526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101957203|NCT03555526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101957204|NCT03555526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101957205|NCT03555526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101957206|NCT03555526|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101957207|NCT03555526|Antacids|antacids|mesh-ancestor
101957208|NCT02102620|Lidocaine|lidocaine|mesh-list
101957209|NCT02102620|Anesthetics, Local|anesthetics, local|mesh-ancestor
101957210|NCT02102620|Anesthetics|anesthetics|mesh-ancestor
101957211|NCT02102620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101227788|NCT01541956|Metformin|metformin|mesh-list
101957212|NCT02102620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957213|NCT02102620|Sensory System Agents|sensory system agents|mesh-ancestor
101957214|NCT02102620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101957215|NCT02102620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101957216|NCT02102620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101957217|NCT02102620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101957218|NCT02102620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101957219|NCT02102620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957221|NCT02102698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101957222|NCT02102698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101957223|NCT02102698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101957224|NCT02102698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957225|NCT02102698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101957226|NCT02102698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101957227|NCT02102698|Dopamine Agents|dopamine agents|mesh-ancestor
101957228|NCT02102698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101228063|NCT01543932|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101957229|NCT02102698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957230|NCT02102776|Mitomycins|mitomycins|mesh-list
101957231|NCT02102776|Mitomycin|mitomycin|mesh-list
101957232|NCT02102776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101957233|NCT02102776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101957234|NCT02102776|Alkylating Agents|alkylating agents|mesh-ancestor
101957235|NCT02102776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957236|NCT02102776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101957237|NCT02102776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101957238|NCT02102854|Thymoglobulin|thymoglobulin|mesh-list
101957239|NCT02102854|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101957240|NCT02102854|Immunologic Factors|immunologic factors|mesh-ancestor
101957241|NCT02102854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957242|NCT02102854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101957243|NCT02670044|Venetoclax|venetoclax|mesh-list
101957244|NCT02670044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101957245|NCT02307656|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101957246|NCT02307656|Cobicistat|cobicistat|mesh-list
101957247|NCT02307656|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101957248|NCT02307656|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101957249|NCT02307656|Protease Inhibitors|protease inhibitors|mesh-ancestor
101970318|NCT05906589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101970319|NCT05886140|Paclitaxel|paclitaxel|mesh-list
101305231|NCT02018250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957250|NCT02307656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101957251|NCT02307656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957253|NCT02307656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101957254|NCT02307656|Antiviral Agents|antiviral agents|mesh-ancestor
101957255|NCT02307656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101957256|NCT02307656|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101957257|NCT02307656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101957258|NCT04232943|Vaccines|vaccines|mesh-list
101957259|NCT04232943|Immunologic Factors|immunologic factors|mesh-ancestor
101957260|NCT04232943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957261|NCT02098330|Methylprednisolone|methylprednisolone|mesh-list
101957262|NCT02098330|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101957263|NCT02098330|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101957264|NCT02098330|Prednisolone|prednisolone|mesh-list
101957265|NCT02098330|Prednisolone acetate|prednisolone acetate|mesh-list
101957266|NCT02098330|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101957267|NCT02098330|Prednisolone phosphate|prednisolone phosphate|mesh-list
101957268|NCT02098330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101957270|NCT02098330|Autonomic Agents|autonomic agents|mesh-ancestor
101957271|NCT02098330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101957272|NCT02098330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957273|NCT02098330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101957274|NCT02098330|Glucocorticoids|glucocorticoids|mesh-ancestor
101690883|NCT03513770|Ketorolac|ketorolac|mesh-list
101957276|NCT02098330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101957277|NCT02098330|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101957278|NCT02098330|Protective Agents|protective agents|mesh-ancestor
101957279|NCT02098330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101957280|NCT02098330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101957281|NCT02103166|Scopolamine|scopolamine|mesh-list
101957282|NCT02103166|Bromides|bromides|mesh-list
101957283|NCT02103166|Anticonvulsants|anticonvulsants|mesh-ancestor
101957284|NCT02103166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101957285|NCT02103166|Antiemetics|antiemetics|mesh-ancestor
101957286|NCT02103166|Autonomic Agents|autonomic agents|mesh-ancestor
101957287|NCT02103166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101957288|NCT02103166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957289|NCT02103166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101957290|NCT02103166|Mydriatics|mydriatics|mesh-ancestor
101228610|NCT01547416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101957291|NCT02103166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101957293|NCT02103166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101957294|NCT02103166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957295|NCT02103166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101957296|NCT02103244|Carboplatin|carboplatin|mesh-list
101957297|NCT02103244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101957298|NCT02098486|Moxifloxacin|moxifloxacin|mesh-list
101957299|NCT02098486|Ceftriaxone|ceftriaxone|mesh-list
101957300|NCT02098486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101957301|NCT02098486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101957302|NCT02098486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101957303|NCT02098486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101957304|NCT02098486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101957305|NCT02098486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957306|NCT02098486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101957307|NCT02250820|Pentobarbital|pentobarbital|mesh-list
101957308|NCT02250820|Dexmedetomidine|dexmedetomidine|mesh-list
101957309|NCT02250820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101957310|NCT02250820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101957311|NCT02250820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957312|NCT02250820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101957313|NCT02250820|Analgesics|analgesics|mesh-ancestor
101957314|NCT02250820|Sensory System Agents|sensory system agents|mesh-ancestor
101957315|NCT02250820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101957316|NCT02250820|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101957317|NCT02250820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101957318|NCT02250820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101957319|NCT02250820|Adrenergic Agents|adrenergic agents|mesh-ancestor
101228823|NCT01548859|Midazolam|midazolam|mesh-list
101957320|NCT02250820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101970320|NCT05886140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101970321|NCT05886140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970322|NCT05886140|Tubulin Modulators|tubulin modulators|mesh-ancestor
101970323|NCT05886140|Antimitotic Agents|antimitotic agents|mesh-ancestor
101305234|NCT02018276|Lidocaine|lidocaine|mesh-list
101957321|NCT02250820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957322|NCT02250820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101957323|NCT02250820|GABA Modulators|gaba modulators|mesh-ancestor
101957324|NCT02250820|GABA Agents|gaba agents|mesh-ancestor
101957326|NCT02100046|Anticonvulsants|anticonvulsants|mesh-ancestor
101957327|NCT02100202|Turmeric extract|turmeric extract|mesh-list
101957328|NCT02100202|Antioxidants|antioxidants|mesh-ancestor
101957329|NCT02100202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957330|NCT02100202|Protective Agents|protective agents|mesh-ancestor
101957331|NCT02100202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957332|NCT05423392|Lidocaine|lidocaine|mesh-list
101957333|NCT05423392|Carticaine|carticaine|mesh-list
101957334|NCT05423392|Anesthetics|anesthetics|mesh-list
101957335|NCT05423392|Anesthetics, Local|anesthetics, local|mesh-ancestor
101957336|NCT05423392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101957337|NCT05423392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957338|NCT05423392|Sensory System Agents|sensory system agents|mesh-ancestor
101957339|NCT05423392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101957340|NCT05423392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101957341|NCT05423392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101957342|NCT05423392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101957343|NCT05423392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101957344|NCT05423392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229095|NCT01550445|Hormones|hormones|mesh-ancestor
101957346|NCT02103556|Emollients|emollients|mesh-ancestor
101957347|NCT02103556|Dermatologic Agents|dermatologic agents|mesh-ancestor
101957348|NCT02099890|Curcumin|curcumin|mesh-list
101957349|NCT02099890|Antioxidants|antioxidants|mesh-list
101957350|NCT02099890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101957351|NCT02099890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101957352|NCT02099890|Analgesics|analgesics|mesh-ancestor
101957353|NCT02099890|Sensory System Agents|sensory system agents|mesh-ancestor
101957354|NCT02099890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101957355|NCT02099890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957356|NCT02099890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101957357|NCT02099890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101957358|NCT02099890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101957359|NCT02099890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101229286|NCT01551719|Tigecycline|tigecycline|mesh-list
101957360|NCT02099890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957361|NCT02099890|Protective Agents|protective agents|mesh-ancestor
101957362|NCT03555136|Vortioxetine|vortioxetine|mesh-list
101957363|NCT03555136|Antidepressive Agents|antidepressive agents|mesh-ancestor
101957364|NCT03555136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101957365|NCT03555136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101957366|NCT03555136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101957367|NCT03555136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101957368|NCT03555136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957369|NCT03555136|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101957370|NCT03555136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101957371|NCT03555136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101957372|NCT03555136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957373|NCT03555136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101957374|NCT03555136|Serotonin Agents|serotonin agents|mesh-ancestor
101957375|NCT03555136|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101229575|NCT01554345|Trace Elements|trace elements|mesh-ancestor
101957376|NCT03555136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101957377|NCT03555136|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101957378|NCT03555136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101957379|NCT03554980|Listerine|listerine|mesh-list
101957380|NCT03554980|Fluorides|fluorides|mesh-list
101957381|NCT03554980|Sodium Fluoride|sodium fluoride|mesh-list
101957382|NCT03554980|Fluorides, Topical|fluorides, topical|mesh-list
101957384|NCT03554980|Protective Agents|protective agents|mesh-ancestor
101957385|NCT03554980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970324|NCT05886140|Mitosis Modulators|mitosis modulators|mesh-ancestor
101970325|NCT05886140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970326|NCT05885074|Empagliflozin|empagliflozin|mesh-list
101957386|NCT03554980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101957387|NCT03554980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101957388|NCT04230213|Adalimumab|adalimumab|mesh-list
101957389|NCT04230213|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101957390|NCT04230213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101957391|NCT04230213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101957392|NCT03746691|Citalopram|citalopram|mesh-list
101957393|NCT03746691|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101957394|NCT03746691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101957395|NCT03746691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101957396|NCT03746691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957397|NCT03746691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101957398|NCT03746691|Serotonin Agents|serotonin agents|mesh-ancestor
101957399|NCT03746691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690901|NCT02823977|Dexmedetomidine|dexmedetomidine|mesh-list
101229712|NCT01555216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957400|NCT03746691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101957401|NCT03746691|Antidepressive Agents|antidepressive agents|mesh-ancestor
101957402|NCT03746691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101957403|NCT04222725|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101957404|NCT04222725|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101957405|NCT03745911|Paclitaxel|paclitaxel|mesh-list
101957406|NCT03745911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101957407|NCT03745911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101957408|NCT03745911|Tubulin Modulators|tubulin modulators|mesh-ancestor
101957409|NCT03745911|Antimitotic Agents|antimitotic agents|mesh-ancestor
101957410|NCT03745911|Mitosis Modulators|mitosis modulators|mesh-ancestor
101957411|NCT03745911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957412|NCT03242252|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
101957413|NCT03242252|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101957414|NCT03242252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957415|NCT03242252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101957416|NCT03242252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957417|NCT03554590|Insulin|insulin|mesh-list
101957418|NCT03554590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101957419|NCT03554590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957420|NCT02106286|Bisoprolol|bisoprolol|mesh-list
101957421|NCT02106286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101957422|NCT02106286|Sympatholytics|sympatholytics|mesh-ancestor
101957423|NCT02106286|Autonomic Agents|autonomic agents|mesh-ancestor
101957424|NCT02106286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101229906|NCT05847257|Micronutrients|micronutrients|mesh-ancestor
101957425|NCT02106286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957426|NCT02106286|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101957427|NCT02106286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101957428|NCT02106286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101957429|NCT02106286|Adrenergic Agents|adrenergic agents|mesh-ancestor
101957430|NCT02106286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101957431|NCT02106286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957432|NCT04109391|Trastuzumab|trastuzumab|mesh-list
101957433|NCT04109391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101957434|NCT04109391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101957435|NCT02106364|Insulin|insulin|mesh-list
101957436|NCT02106364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101957437|NCT02106364|Insulin Glargine|insulin glargine|mesh-list
101957438|NCT02106364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101957440|NCT04077866|Temozolomide|temozolomide|mesh-list
101957441|NCT04077866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101957442|NCT04077866|Alkylating Agents|alkylating agents|mesh-ancestor
101957443|NCT04077866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957444|NCT04077866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101957445|NCT02101138|Pramipexole|pramipexole|mesh-list
101957446|NCT02101138|Antioxidants|antioxidants|mesh-ancestor
101230328|NCT05660681|Glycerol|glycerol|mesh-list
101957447|NCT02101138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957448|NCT02101138|Protective Agents|protective agents|mesh-ancestor
101957449|NCT02101138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970327|NCT05885074|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101970328|NCT05885074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957451|NCT02101138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101957452|NCT02101138|Dopamine Agonists|dopamine agonists|mesh-ancestor
101957453|NCT02101138|Dopamine Agents|dopamine agents|mesh-ancestor
101957454|NCT02101138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101957455|NCT02106520|Bevacizumab|bevacizumab|mesh-list
101957456|NCT02106520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101957457|NCT02106520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101230471|NCT05150704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101957458|NCT02106520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101957459|NCT02106520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101690907|NCT02823977|Analgesics|analgesics|mesh-ancestor
101957460|NCT02106520|Growth Substances|growth substances|mesh-ancestor
101230546|NCT04982354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101957461|NCT02106520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957463|NCT02101216|Abacavir|abacavir|mesh-list
101957464|NCT02101216|Dideoxynucleosides|dideoxynucleosides|mesh-list
101957465|NCT02101216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101957466|NCT02101216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101957467|NCT02101216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101957468|NCT02101216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957469|NCT02101216|Antiviral Agents|antiviral agents|mesh-ancestor
101957470|NCT02101216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101957471|NCT02101216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101957472|NCT02101216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101957473|NCT02101216|Antimetabolites|antimetabolites|mesh-ancestor
101957474|NCT04097925|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
101957475|NCT04097925|Antiviral Agents|antiviral agents|mesh-ancestor
101957476|NCT04097925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101957477|NCT04097925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101957478|NCT04097925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101957479|NCT04097925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101957480|NCT04097925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957481|NCT04097925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101957482|NCT04097925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101957483|NCT02104648|Moxifloxacin|moxifloxacin|mesh-list
101957484|NCT02104648|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101957485|NCT02104648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101957486|NCT02104648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101957487|NCT02104648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101957488|NCT02104648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101957489|NCT02104648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101957490|NCT02104648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957491|NCT02104648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101957492|NCT02104648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101957493|NCT02104648|Contraceptive Agents|contraceptive agents|mesh-ancestor
101957494|NCT02104648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101957495|NCT02104648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957496|NCT02104648|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101957497|NCT02104648|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101957498|NCT02104648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101957500|NCT01562301|Docetaxel|docetaxel|mesh-list
101957501|NCT01562301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101230952|NCT04184869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101957502|NCT01562301|Tubulin Modulators|tubulin modulators|mesh-ancestor
101957503|NCT01562301|Antimitotic Agents|antimitotic agents|mesh-ancestor
101957504|NCT01562301|Mitosis Modulators|mitosis modulators|mesh-ancestor
101957505|NCT01562301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957506|NCT02104960|Dermatologic Agents|dermatologic agents|mesh-list
101957507|NCT04094883|Vaccines|vaccines|mesh-list
101957508|NCT04094883|Immunologic Factors|immunologic factors|mesh-ancestor
101957509|NCT04094883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957510|NCT02101606|Tenecteplase|tenecteplase|mesh-list
101957511|NCT02101606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101957512|NCT02101606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101231169|NCT03648905|Dopamine|dopamine|mesh-list
101957513|NCT02101606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957514|NCT02101840|Oxycodone|oxycodone|mesh-list
101957515|NCT02101840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101970330|NCT05885074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970331|NCT05872685|Oxaliplatin|oxaliplatin|mesh-list
101385817|NCT00082862|Interferons|interferons|mesh-list
101957517|NCT02101840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101957518|NCT02101840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957519|NCT02101840|Analgesics|analgesics|mesh-ancestor
101957520|NCT02101840|Sensory System Agents|sensory system agents|mesh-ancestor
101957521|NCT02101840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101957522|NCT02107378|Paclitaxel|paclitaxel|mesh-list
101957523|NCT02107378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101957524|NCT02107378|Doxorubicin|doxorubicin|mesh-list
101957525|NCT02107378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101957526|NCT02107378|Topotecan|topotecan|mesh-list
101957527|NCT02107378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101957528|NCT02107378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101957529|NCT02107378|Tubulin Modulators|tubulin modulators|mesh-ancestor
101957530|NCT02107378|Antimitotic Agents|antimitotic agents|mesh-ancestor
101957531|NCT02107378|Mitosis Modulators|mitosis modulators|mesh-ancestor
101957532|NCT02107378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957533|NCT02107378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101957534|NCT02107378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101957535|NCT02107378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101957536|NCT02107378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101957537|NCT02107378|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101957539|NCT02105350|Oxaliplatin|oxaliplatin|mesh-list
101957540|NCT02105350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101957541|NCT02105350|Antimetabolites|antimetabolites|mesh-ancestor
101957542|NCT02105350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957543|NCT02105350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101957544|NCT02102152|Tobramycin|tobramycin|mesh-list
101957545|NCT02102152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101957546|NCT02102152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101957547|NCT01368562|Methylnaltrexone|methylnaltrexone|mesh-list
101957548|NCT01368562|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101957549|NCT01368562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957550|NCT01368562|Sensory System Agents|sensory system agents|mesh-ancestor
101957551|NCT01368562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101957552|NCT03242018|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
101957553|NCT03242018|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101957554|NCT03242018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231424|NCT03321526|Serotonin Agents|serotonin agents|mesh-ancestor
101957555|NCT03242018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101957556|NCT03242018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957557|NCT02107690|Lidocaine|lidocaine|mesh-list
101957558|NCT02107690|Anesthetics, Local|anesthetics, local|mesh-ancestor
101957559|NCT02107690|Anesthetics|anesthetics|mesh-ancestor
101957560|NCT02107690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101957561|NCT02107690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957562|NCT02107690|Sensory System Agents|sensory system agents|mesh-ancestor
101957563|NCT02107690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101957564|NCT02107690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101677355|NCT02600793|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
101957566|NCT02107690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101957567|NCT02107690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101957568|NCT02107690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957569|NCT05568836|Vitamin D|vitamin d|mesh-list
101957570|NCT05568836|Vitamins|vitamins|mesh-ancestor
101957571|NCT05568836|Micronutrients|micronutrients|mesh-ancestor
101957572|NCT05568836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957573|NCT05568836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101957574|NCT03259490|Metformin|metformin|mesh-list
101957575|NCT03259490|Empagliflozin|empagliflozin|mesh-list
101957576|NCT03259490|Linagliptin|linagliptin|mesh-list
101957577|NCT03259490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101957578|NCT03259490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957579|NCT03259490|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101957580|NCT03259490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957581|NCT03259490|Incretins|incretins|mesh-ancestor
101957582|NCT03259490|Hormones|hormones|mesh-ancestor
101231851|NCT00713323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957583|NCT03259490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101957584|NCT03259490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101957585|NCT03259490|Protease Inhibitors|protease inhibitors|mesh-ancestor
101957586|NCT03259490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101957587|NCT02106130|Rebamipide|rebamipide|mesh-list
101957588|NCT02106130|Mosapride|mosapride|mesh-list
101957589|NCT02106130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957590|NCT02106130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101957591|NCT02106130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101957592|NCT02106130|Antioxidants|antioxidants|mesh-ancestor
101957593|NCT02106130|Protective Agents|protective agents|mesh-ancestor
101957594|NCT02106130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957595|NCT02106130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101957596|NCT02106130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101957597|NCT02106130|Serotonin Agents|serotonin agents|mesh-ancestor
101957598|NCT02106130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101957599|NCT02251132|Ritonavir|ritonavir|mesh-list
101957600|NCT02251132|Erythromycin|erythromycin|mesh-list
101957601|NCT02251132|Erythromycin Estolate|erythromycin estolate|mesh-list
101957602|NCT02251132|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101957603|NCT02251132|Erythromycin stearate|erythromycin stearate|mesh-list
101957604|NCT02251132|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101957605|NCT02251132|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101957606|NCT02251132|Protease Inhibitors|protease inhibitors|mesh-ancestor
101957607|NCT02251132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101957608|NCT02251132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957609|NCT02251132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101957610|NCT02251132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101957611|NCT02251132|Antiviral Agents|antiviral agents|mesh-ancestor
101957612|NCT02251132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101957613|NCT02251132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101957614|NCT02251132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101957615|NCT02251132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101957616|NCT02251132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101957617|NCT02251132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101957618|NCT01331824|Amrubicin|amrubicin|mesh-list
101957619|NCT01331824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101957620|NCT02113774|Anti-Infective Agents|anti-infective agents|mesh-list
101957621|NCT02113774|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101957622|NCT05571722|Vancomycin|vancomycin|mesh-list
101957623|NCT05571722|Linezolid|linezolid|mesh-list
101957624|NCT05571722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101957625|NCT05571722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101957626|NCT05571722|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101690953|NCT00654576|Antiemetics|antiemetics|mesh-ancestor
101957627|NCT05571722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101957628|NCT05571722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957629|NCT02110654|Mometasone Furoate|mometasone furoate|mesh-list
101957631|NCT02110654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101957632|NCT02110654|Respiratory System Agents|respiratory system agents|mesh-ancestor
101957633|NCT02110654|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101957634|NCT02110654|Hormone Antagonists|hormone antagonists|mesh-ancestor
101957635|NCT02110654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101957636|NCT02110654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957637|NCT02110654|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101957638|NCT02110654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101957639|NCT02110654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957640|NCT02110654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101957641|NCT02110654|Dermatologic Agents|dermatologic agents|mesh-ancestor
101957642|NCT02110654|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101957644|NCT03258710|Antiviral Agents|antiviral agents|mesh-ancestor
101957645|NCT03258710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101957646|NCT03258710|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101232840|NCT03205423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101957647|NCT03258710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101957649|NCT03258710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957650|NCT03258710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101957651|NCT03258710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101957653|NCT02110810|Glycerol|glycerol|mesh-list
101957654|NCT02110810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101957656|NCT02110810|Analgesics|analgesics|mesh-ancestor
101957657|NCT02110810|Sensory System Agents|sensory system agents|mesh-ancestor
101970333|NCT05870319|Carboplatin|carboplatin|mesh-list
101970335|NCT05870319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101957658|NCT02110810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101957659|NCT02110810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957660|NCT02110810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101957661|NCT02110810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101957662|NCT02110810|Gout Suppressants|gout suppressants|mesh-ancestor
101957663|NCT02110810|Tocolytic Agents|tocolytic agents|mesh-ancestor
101957664|NCT02110810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101957665|NCT02110810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101957666|NCT02110810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101233119|NCT01568645|Imatinib Mesylate|imatinib mesylate|mesh-list
101957667|NCT02110810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957668|NCT02110810|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101957669|NCT02110810|Protective Agents|protective agents|mesh-ancestor
101957670|NCT02107924|Vancomycin|vancomycin|mesh-list
101957671|NCT02107924|Tobramycin|tobramycin|mesh-list
101957672|NCT02107924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101957673|NCT02107924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101957674|NCT02108002|Vorinostat|vorinostat|mesh-list
101957675|NCT02108002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101957676|NCT02108002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101957677|NCT02108002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101957678|NCT02108002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957679|NCT02114476|Progestins|progestins|mesh-list
101957681|NCT02114476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101957682|NCT02114476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957683|NCT02110966|Tramadol|tramadol|mesh-list
101957684|NCT02110966|Mepivacaine|mepivacaine|mesh-list
101957685|NCT02110966|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101957686|NCT02110966|Narcotics|narcotics|mesh-ancestor
101957687|NCT02110966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101233296|NCT01570985|Hormones|hormones|mesh-ancestor
101957688|NCT02110966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957690|NCT02110966|Sensory System Agents|sensory system agents|mesh-ancestor
101957691|NCT02110966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101957692|NCT02110966|Anesthetics, Local|anesthetics, local|mesh-ancestor
101957693|NCT02110966|Anesthetics|anesthetics|mesh-ancestor
101957694|NCT02937740|Methyltestosterone|methyltestosterone|mesh-list
101957695|NCT02937740|Testosterone|testosterone|mesh-list
101957696|NCT02937740|Testosterone undecanoate|testosterone undecanoate|mesh-list
101957697|NCT02937740|Testosterone enanthate|testosterone enanthate|mesh-list
101957698|NCT02937740|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101957699|NCT02937740|Androgens|androgens|mesh-ancestor
101957700|NCT02937740|Hormones|hormones|mesh-ancestor
101957701|NCT02937740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101957702|NCT02937740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233313|NCT01571024|Antidotes|antidotes|mesh-ancestor
101957703|NCT02937740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101957704|NCT02937740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101957705|NCT02937740|Anabolic Agents|anabolic agents|mesh-ancestor
101957706|NCT02111044|Octreotide|octreotide|mesh-list
101957707|NCT02111044|Somatostatin|somatostatin|mesh-list
101957708|NCT02111044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101957709|NCT02111044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101957710|NCT02111044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101957711|NCT02111044|Hormones|hormones|mesh-ancestor
101957712|NCT02111044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101957713|NCT02111044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957714|NCT02114710|Hydrocortisone|hydrocortisone|mesh-list
101957715|NCT02114710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101957716|NCT02108548|Naproxen|naproxen|mesh-list
101233660|NCT01572597|Metronidazole|metronidazole|mesh-list
101957717|NCT02108548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101957718|NCT02108548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101957719|NCT02108548|Analgesics|analgesics|mesh-ancestor
101957720|NCT02108548|Sensory System Agents|sensory system agents|mesh-ancestor
101957721|NCT02108548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101957722|NCT02108548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957723|NCT02108548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101957724|NCT02108548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101957725|NCT02108548|Gout Suppressants|gout suppressants|mesh-ancestor
101970336|NCT05870319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970337|NCT05870319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970338|NCT05870319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101970339|NCT05870319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101970340|NCT05863364|Rifaximin|rifaximin|mesh-list
101970341|NCT05863364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101970342|NCT05863364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101970343|NCT05863364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101970344|NCT05848375|Levobupivacaine|levobupivacaine|mesh-list
101970345|NCT05848375|Ropivacaine|ropivacaine|mesh-list
101970346|NCT05848375|Anesthetics, Local|anesthetics, local|mesh-ancestor
101970347|NCT05848375|Anesthetics|anesthetics|mesh-ancestor
101957726|NCT02108548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101957727|NCT02108548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101957728|NCT02108548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957730|NCT02111122|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101957731|NCT02111122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101957732|NCT02111122|Anesthetics, General|anesthetics, general|mesh-ancestor
101957733|NCT02111122|Anesthetics|anesthetics|mesh-ancestor
101957734|NCT02111122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101957735|NCT02111122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957736|NCT02108626|Nicotine|nicotine|mesh-list
101957737|NCT02108626|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101957738|NCT02108626|Autonomic Agents|autonomic agents|mesh-ancestor
101957739|NCT02108626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101957740|NCT02108626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957741|NCT02108626|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101957742|NCT02108626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101957743|NCT02108626|Cholinergic Agents|cholinergic agents|mesh-ancestor
101957744|NCT02108626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101957745|NCT02108626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957746|NCT05431322|Dexmedetomidine|dexmedetomidine|mesh-list
101957747|NCT05431322|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101957748|NCT05431322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101957749|NCT05431322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957750|NCT05431322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101957752|NCT05431322|Sensory System Agents|sensory system agents|mesh-ancestor
101957753|NCT05431322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101957754|NCT05431322|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101957755|NCT05431322|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101957756|NCT05431322|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101957757|NCT05431322|Adrenergic Agents|adrenergic agents|mesh-ancestor
101957758|NCT05431322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101957759|NCT05431322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957760|NCT03745599|Diclofenac|diclofenac|mesh-list
101957761|NCT03745599|Flurbiprofen|flurbiprofen|mesh-list
101957762|NCT03745599|Benzydamine|benzydamine|mesh-list
101957763|NCT03745599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101957764|NCT03745599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101957765|NCT03745599|Analgesics|analgesics|mesh-ancestor
101957766|NCT03745599|Sensory System Agents|sensory system agents|mesh-ancestor
101957767|NCT03745599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101957768|NCT03745599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957769|NCT03745599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101957770|NCT03745599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101957771|NCT03745599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101957772|NCT03745599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101234051|NCT01576029|Tubulin Modulators|tubulin modulators|mesh-ancestor
101957773|NCT03745599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957774|NCT02108782|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101957775|NCT02108782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101957776|NCT02108782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970348|NCT05848375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101970349|NCT05848375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970350|NCT05848375|Sensory System Agents|sensory system agents|mesh-ancestor
101970351|NCT05848375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101970352|NCT05840159|Doxycycline|doxycycline|mesh-list
101957777|NCT02108782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957778|NCT02111434|Testosterone|testosterone|mesh-list
101957779|NCT02111434|Androgens|androgens|mesh-ancestor
101957780|NCT02111434|Hormones|hormones|mesh-ancestor
101957781|NCT02111434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101957782|NCT02111434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957784|NCT03230864|Risperidone|risperidone|mesh-list
101957785|NCT03230864|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101957787|NCT03230864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101677579|NCT03110822|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101234333|NCT01578109|Sorafenib|sorafenib|mesh-list
101957788|NCT03230864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957789|NCT03230864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957790|NCT03230864|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101957792|NCT03230864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101957793|NCT03230864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101957794|NCT03230864|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101957795|NCT03230864|Dopamine Agents|dopamine agents|mesh-ancestor
101957796|NCT03230864|Antiemetics|antiemetics|mesh-ancestor
101957797|NCT03230864|Autonomic Agents|autonomic agents|mesh-ancestor
101957798|NCT03230864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101957799|NCT03230864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101957800|NCT03230864|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101957801|NCT03230864|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101957802|NCT03230864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101957803|NCT02111590|Immunoglobulins|immunoglobulins|mesh-list
101957804|NCT02111590|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101957805|NCT02111590|Antibodies|antibodies|mesh-list
101957806|NCT02111590|Immunologic Factors|immunologic factors|mesh-ancestor
101957807|NCT02111590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957808|NCT02937350|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
101957809|NCT02937350|Calcifediol|calcifediol|mesh-list
101957810|NCT02937350|Vitamins|vitamins|mesh-ancestor
101957811|NCT02937350|Micronutrients|micronutrients|mesh-ancestor
101957812|NCT02937350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957813|NCT02937350|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101957814|NCT02109328|Paclitaxel|paclitaxel|mesh-list
101957815|NCT02109328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101957816|NCT02109328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101957817|NCT02109328|Tubulin Modulators|tubulin modulators|mesh-ancestor
101957818|NCT02109328|Antimitotic Agents|antimitotic agents|mesh-ancestor
101957819|NCT02109328|Mitosis Modulators|mitosis modulators|mesh-ancestor
101234748|NCT01579890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101957820|NCT02109328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957821|NCT02115490|Diphosphonates|diphosphonates|mesh-list
101234819|NCT01583062|Amoxicillin|amoxicillin|mesh-list
101957822|NCT02115490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101957823|NCT02115490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957825|NCT02251288|Immunologic Factors|immunologic factors|mesh-ancestor
101957826|NCT02251288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957827|NCT02109718|Sulfadiazine|sulfadiazine|mesh-list
101957828|NCT02109718|Silver Sulfadiazine|silver sulfadiazine|mesh-list
101957829|NCT02109718|Petrolatum|petrolatum|mesh-list
101957830|NCT02109718|Emollients|emollients|mesh-ancestor
101957831|NCT02109718|Dermatologic Agents|dermatologic agents|mesh-ancestor
101957832|NCT02109718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101957833|NCT02109718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101957834|NCT02109718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101957835|NCT02109718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101957836|NCT02109718|Coccidiostats|coccidiostats|mesh-ancestor
101957837|NCT02109718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101957838|NCT03744897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
101957839|NCT03744897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101957840|NCT03744897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957842|NCT02112214|Antacids|antacids|mesh-ancestor
101970353|NCT05840159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101970354|NCT05840159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101957843|NCT02112214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957844|NCT02112214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101957845|NCT02112292|Dronabinol|dronabinol|mesh-list
101957846|NCT02112292|Cannabidiol|cannabidiol|mesh-list
101957847|NCT02112292|Anticonvulsants|anticonvulsants|mesh-ancestor
101957848|NCT02112292|Hallucinogens|hallucinogens|mesh-ancestor
101957849|NCT02112292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957850|NCT02112292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101957851|NCT02112292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101957852|NCT02112292|Analgesics|analgesics|mesh-ancestor
101957853|NCT02112292|Sensory System Agents|sensory system agents|mesh-ancestor
101957854|NCT02112292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101957855|NCT02112292|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101957856|NCT02112292|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101957858|NCT02112292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957859|NCT02112292|Hormones|hormones|mesh-ancestor
101235314|NCT01592201|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101574932|NCT02760355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957860|NCT02112292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101957861|NCT02116036|Rivaroxaban|rivaroxaban|mesh-list
101957862|NCT02116036|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101957863|NCT02116036|Antithrombins|antithrombins|mesh-ancestor
101957864|NCT02116036|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101957865|NCT02116036|Protease Inhibitors|protease inhibitors|mesh-ancestor
101957866|NCT02116036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101957867|NCT02116036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957868|NCT02116036|Anticoagulants|anticoagulants|mesh-ancestor
101957869|NCT04011735|Tiotropium Bromide|tiotropium bromide|mesh-list
101235533|NCT01593410|Hormones|hormones|mesh-ancestor
101957870|NCT04011735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101957871|NCT04011735|Autonomic Agents|autonomic agents|mesh-ancestor
101957872|NCT04011735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101957873|NCT04011735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957874|NCT04011735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101957875|NCT04011735|Respiratory System Agents|respiratory system agents|mesh-ancestor
101957876|NCT04011735|Parasympatholytics|parasympatholytics|mesh-ancestor
101957877|NCT04011735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101957878|NCT04011735|Cholinergic Agents|cholinergic agents|mesh-ancestor
101957879|NCT04011735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101957880|NCT04011735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957882|NCT02118844|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101957883|NCT02118844|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101957884|NCT02118844|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101957885|NCT02118844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101957886|NCT02118844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957887|NCT02116348|Cerebrolysin|cerebrolysin|mesh-list
101957888|NCT02116348|Mitogens|mitogens|mesh-list
101957889|NCT02116348|Mitosis Modulators|mitosis modulators|mesh-ancestor
101957890|NCT02116348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957891|NCT02116348|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101957892|NCT02116348|Protective Agents|protective agents|mesh-ancestor
101957893|NCT02116348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957894|NCT02116348|Nootropic Agents|nootropic agents|mesh-ancestor
101957895|NCT02119000|Bisacodyl|bisacodyl|mesh-list
101957896|NCT02119000|Cathartics|cathartics|mesh-ancestor
101957897|NCT02119000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101957898|NCT02119000|Laxatives|laxatives|mesh-ancestor
101957899|NCT02119234|Beclomethasone|beclomethasone|mesh-list
101957900|NCT02119234|Glycopyrrolate|glycopyrrolate|mesh-list
101957901|NCT02119234|Formoterol Fumarate|formoterol fumarate|mesh-list
101957902|NCT02119234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101957903|NCT02119234|Autonomic Agents|autonomic agents|mesh-ancestor
101957904|NCT02119234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101957905|NCT02119234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957906|NCT02119234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101957907|NCT02119234|Respiratory System Agents|respiratory system agents|mesh-ancestor
101957908|NCT02119234|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101235885|NCT01595594|Doxycycline|doxycycline|mesh-list
101957909|NCT02119234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101970356|NCT05840159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101970357|NCT05840159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101970358|NCT05816252|Carboplatin|carboplatin|mesh-list
101305266|NCT02018367|Proflavine|proflavine|mesh-list
101957910|NCT02119234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101957911|NCT02119234|Adrenergic Agents|adrenergic agents|mesh-ancestor
101957912|NCT02119234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101957913|NCT02119234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957914|NCT02119234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101957915|NCT02119234|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101957916|NCT02119234|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101957917|NCT02119234|Cholinergic Agents|cholinergic agents|mesh-ancestor
101957918|NCT02119234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101957919|NCT02119234|Glucocorticoids|glucocorticoids|mesh-ancestor
101957920|NCT02119234|Hormones|hormones|mesh-ancestor
101957921|NCT02119234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101957922|NCT02112604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
101957923|NCT02112604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101957924|NCT02112604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957925|NCT03694197|Alirocumab|alirocumab|mesh-list
101957926|NCT03694197|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101957927|NCT03694197|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101235939|NCT01595789|Incretins|incretins|mesh-ancestor
101957928|NCT03694197|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101957929|NCT03694197|Antimetabolites|antimetabolites|mesh-ancestor
101957930|NCT03694197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236013|NCT01596010|Estradiol|estradiol|mesh-list
101957931|NCT03694197|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101957933|NCT03694197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101957934|NCT03694197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101957935|NCT04480424|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101574933|NCT02760355|Antiviral Agents|antiviral agents|mesh-ancestor
101957936|NCT04480424|Immunologic Factors|immunologic factors|mesh-ancestor
101957937|NCT04480424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957938|NCT04473716|Paclitaxel|paclitaxel|mesh-list
101957939|NCT04473716|Cisplatin|cisplatin|mesh-list
101957940|NCT04473716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101957941|NCT04473716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101957942|NCT04473716|Tubulin Modulators|tubulin modulators|mesh-ancestor
101957943|NCT04473716|Antimitotic Agents|antimitotic agents|mesh-ancestor
101957944|NCT04473716|Mitosis Modulators|mitosis modulators|mesh-ancestor
101236214|NCT01596764|Analgesics|analgesics|mesh-ancestor
101957945|NCT04473716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957947|NCT04000815|Natriuretic Agents|natriuretic agents|mesh-ancestor
101957948|NCT04000815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957949|NCT03919617|Volagidemab|volagidemab|mesh-list
101957950|NCT03919617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101957951|NCT03919617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957952|NCT03748173|Calfactant|calfactant|mesh-list
101957953|NCT03748173|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
101957954|NCT03748173|Respiratory System Agents|respiratory system agents|mesh-ancestor
101957955|NCT03848403|Ixekizumab|ixekizumab|mesh-list
101957956|NCT03848403|Dermatologic Agents|dermatologic agents|mesh-ancestor
101957957|NCT04054011|Deoxycholic Acid|deoxycholic acid|mesh-list
101957958|NCT04054011|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101957959|NCT04054011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101957961|NCT03743883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101957962|NCT03743883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101957963|NCT03743883|Analgesics|analgesics|mesh-ancestor
101957964|NCT03743883|Sensory System Agents|sensory system agents|mesh-ancestor
101957965|NCT03743883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101236502|NCT01597986|Contraceptives, Oral|contraceptives, oral|mesh-list
101957966|NCT03743883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957967|NCT03743883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101957968|NCT03743883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101957969|NCT03743883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101957970|NCT03743883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101957971|NCT03743883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236574|NCT01598363|Digoxin|digoxin|mesh-list
101957972|NCT03743883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101957974|NCT03743883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101957975|NCT03743883|Antipyretics|antipyretics|mesh-ancestor
101957976|NCT03988803|Memantine|memantine|mesh-list
101957977|NCT03988803|BI 425809|bi 425809|mesh-list
101970359|NCT05816252|Pembrolizumab|pembrolizumab|mesh-list
101970360|NCT05816252|Osimertinib|osimertinib|mesh-list
101305270|NCT02018419|Immunologic Factors|immunologic factors|mesh-ancestor
101957978|NCT03988803|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101957979|NCT03988803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101957980|NCT03988803|Dopamine Agents|dopamine agents|mesh-ancestor
101957981|NCT03988803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101236637|NCT01598623|Oxytocics|oxytocics|mesh-ancestor
101957982|NCT03988803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957983|NCT03988803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957984|NCT03988803|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101957985|NCT03988803|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101957987|NCT00181883|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101957988|NCT00181883|Antidepressive Agents|antidepressive agents|mesh-ancestor
101957989|NCT00181883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101957990|NCT00181883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101957991|NCT00181883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101957992|NCT00181883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101957993|NCT00181883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957994|NCT00180713|Simvastatin|simvastatin|mesh-list
101957995|NCT00180713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101957996|NCT00180713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101957997|NCT00180713|Antimetabolites|antimetabolites|mesh-ancestor
101957998|NCT00180713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958000|NCT00180713|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101958001|NCT00180713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101958002|NCT02531477|Propofol|propofol|mesh-list
101958003|NCT02531477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101958004|NCT02531477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101958005|NCT02531477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958006|NCT02531477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101958007|NCT02531477|Anesthetics, General|anesthetics, general|mesh-ancestor
101958008|NCT02531477|Anesthetics|anesthetics|mesh-ancestor
101958009|NCT04052139|Naltrexone|naltrexone|mesh-list
101958010|NCT04052139|Gabapentin|gabapentin|mesh-list
101958011|NCT04052139|Analgesics|analgesics|mesh-ancestor
101958012|NCT04052139|Sensory System Agents|sensory system agents|mesh-ancestor
101958013|NCT04052139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101958014|NCT04052139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958016|NCT04052139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101958017|NCT04052139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101958018|NCT04052139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101958019|NCT04052139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101236988|NCT05188820|Cortisone|cortisone|mesh-list
101958020|NCT04052139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101958021|NCT04052139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101958022|NCT04052139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101237052|NCT04753216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101958023|NCT04052139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958025|NCT04052139|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101958026|NCT04052139|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101958027|NCT03743805|Naloxone|naloxone|mesh-list
101958028|NCT03743805|Flumazenil|flumazenil|mesh-list
101958029|NCT03743805|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101237194|NCT04229771|Anesthetics|anesthetics|mesh-ancestor
101958030|NCT03743805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958031|NCT03743805|Sensory System Agents|sensory system agents|mesh-ancestor
101958032|NCT03743805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101958033|NCT03743805|Antidotes|antidotes|mesh-ancestor
101958034|NCT03743805|Protective Agents|protective agents|mesh-ancestor
101958035|NCT03743805|GABA Modulators|gaba modulators|mesh-ancestor
101958036|NCT03743805|GABA Agents|gaba agents|mesh-ancestor
101958037|NCT03743805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101958038|NCT03743805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958039|NCT03743727|Sofosbuvir|sofosbuvir|mesh-list
101958040|NCT03743727|Ledipasvir|ledipasvir|mesh-list
101958041|NCT03743727|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
101958042|NCT03743727|Antiviral Agents|antiviral agents|mesh-ancestor
101958043|NCT03743727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101958044|NCT03981861|Metformin|metformin|mesh-list
101958046|NCT03981861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101958047|NCT03981861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958048|NCT03981861|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101958049|NCT03981861|Hormone Antagonists|hormone antagonists|mesh-ancestor
101970361|NCT05816252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970362|NCT05816252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101305272|NCT02018523|Lenalidomide|lenalidomide|mesh-list
101958050|NCT03981861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101958051|NCT03981861|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101958052|NCT03981861|Diuretics|diuretics|mesh-ancestor
101958053|NCT03981861|Natriuretic Agents|natriuretic agents|mesh-ancestor
101958054|NCT03743649|Lorazepam|lorazepam|mesh-list
101958055|NCT03743649|Haloperidol|haloperidol|mesh-list
101958056|NCT03743649|Haloperidol decanoate|haloperidol decanoate|mesh-list
101958057|NCT03743649|Antiemetics|antiemetics|mesh-ancestor
101958058|NCT03743649|Autonomic Agents|autonomic agents|mesh-ancestor
101958059|NCT03743649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101958060|NCT03743649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237388|NCT05704114|Tazarotene|tazarotene|mesh-list
101958061|NCT03743649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101958062|NCT03743649|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101958063|NCT03743649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101958064|NCT03743649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101958065|NCT03743649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101237483|NCT05274243|Phenol|phenol|mesh-list
101958066|NCT03743649|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101958067|NCT03743649|Dopamine Agents|dopamine agents|mesh-ancestor
101958068|NCT03743649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101958069|NCT03743649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237528|NCT04764643|Antioxidants|antioxidants|mesh-ancestor
101958070|NCT03743649|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101958072|NCT03743649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101958073|NCT03743649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101958074|NCT03743649|GABA Modulators|gaba modulators|mesh-ancestor
101958075|NCT03743649|GABA Agents|gaba agents|mesh-ancestor
101958076|NCT01332266|Cetuximab|cetuximab|mesh-list
101958077|NCT01332266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101958078|NCT01332266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101958079|NCT03255824|Fentanyl|fentanyl|mesh-list
101958080|NCT03255824|Midazolam|midazolam|mesh-list
101958081|NCT03255824|Dexmedetomidine|dexmedetomidine|mesh-list
101958082|NCT03255824|Propofol|propofol|mesh-list
101958083|NCT03255824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101958084|NCT03255824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101958085|NCT03255824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958086|NCT03255824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101958087|NCT03255824|Analgesics|analgesics|mesh-ancestor
101958088|NCT03255824|Sensory System Agents|sensory system agents|mesh-ancestor
101958089|NCT03255824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101958090|NCT03255824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101958091|NCT03255824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101958092|NCT03255824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101958093|NCT03255824|Adrenergic Agents|adrenergic agents|mesh-ancestor
101958094|NCT03255824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101958095|NCT03255824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237880|NCT02420821|Immunologic Factors|immunologic factors|mesh-ancestor
101958096|NCT03255824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101958097|NCT03255824|Anesthetics, General|anesthetics, general|mesh-ancestor
101958098|NCT03255824|Anesthetics|anesthetics|mesh-ancestor
101958099|NCT03255824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101958100|NCT03255824|Narcotics|narcotics|mesh-ancestor
101958101|NCT03255824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101958102|NCT03255824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101958103|NCT03255824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101958104|NCT03255824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101958105|NCT03255824|GABA Modulators|gaba modulators|mesh-ancestor
101958106|NCT03255824|GABA Agents|gaba agents|mesh-ancestor
101958108|NCT03238352|Fluorides|fluorides|mesh-list
101958109|NCT03238352|Sodium Fluoride|sodium fluoride|mesh-list
101958110|NCT03238352|Cariostatic Agents|cariostatic agents|mesh-ancestor
101958111|NCT03238352|Protective Agents|protective agents|mesh-ancestor
101958112|NCT03238352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958113|NCT03238352|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101958114|NCT03238352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101958115|NCT01222754|Lenalidomide|lenalidomide|mesh-list
101958116|NCT01222754|Immunologic Factors|immunologic factors|mesh-ancestor
101958117|NCT01222754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958118|NCT01222754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101958119|NCT01222754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101970363|NCT05816252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101970364|NCT05816252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970365|NCT05816252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101970366|NCT05816252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101958120|NCT01222754|Growth Substances|growth substances|mesh-ancestor
101958121|NCT01222754|Growth Inhibitors|growth inhibitors|mesh-ancestor
101958122|NCT01222754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101958124|NCT03850418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101958125|NCT03850418|Antimetabolites|antimetabolites|mesh-ancestor
101958126|NCT03850418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958127|NCT03850418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101958128|NCT03850418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101958129|NCT05256914|Chlorhexidine|chlorhexidine|mesh-list
101958130|NCT05256914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101958131|NCT05256914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101958133|NCT00180479|Paclitaxel|paclitaxel|mesh-list
101958134|NCT00180479|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101958135|NCT00180479|Everolimus|everolimus|mesh-list
101958136|NCT00180479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101958137|NCT00180479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101958138|NCT00180479|Tubulin Modulators|tubulin modulators|mesh-ancestor
101958139|NCT00180479|Antimitotic Agents|antimitotic agents|mesh-ancestor
101958140|NCT00180479|Mitosis Modulators|mitosis modulators|mesh-ancestor
101958141|NCT00180479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958142|NCT00180479|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101958143|NCT00180479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101958144|NCT00180479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101958145|NCT00180479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101238509|NCT01608217|Acetaminophen|acetaminophen|mesh-list
101958146|NCT00180479|Immunologic Factors|immunologic factors|mesh-ancestor
101958147|NCT00180479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958148|NCT05169944|Magrolimab|magrolimab|mesh-list
101238581|NCT01610401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101958149|NCT05169944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101958150|NCT05169944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101958151|NCT02955069|Spartalizumab|spartalizumab|mesh-list
101238663|NCT01611311|BI 409306|bi 409306|mesh-list
101958152|NCT02955069|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101958153|NCT02955069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958154|NCT02955069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101958155|NCT02955069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101958156|NCT03254108|Tolvaptan|tolvaptan|mesh-list
101958157|NCT03254108|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101958158|NCT03254108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958159|NCT03254108|Natriuretic Agents|natriuretic agents|mesh-ancestor
101958160|NCT03254108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958161|NCT02585895|Evolocumab|evolocumab|mesh-list
101958162|NCT02585895|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101958163|NCT02585895|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101958164|NCT02585895|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101958165|NCT02585895|Antimetabolites|antimetabolites|mesh-ancestor
101958166|NCT02585895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958167|NCT02585895|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101958168|NCT02585895|Protease Inhibitors|protease inhibitors|mesh-ancestor
101958169|NCT02585895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101958170|NCT02585895|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101958171|NCT03736161|Methotrexate|methotrexate|mesh-list
101958172|NCT03736161|Tofacitinib|tofacitinib|mesh-list
101958173|NCT03736161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101958174|NCT03736161|Abortifacient Agents|abortifacient agents|mesh-ancestor
101958175|NCT03736161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101958176|NCT03736161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958177|NCT03736161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101958178|NCT03736161|Antimetabolites|antimetabolites|mesh-ancestor
101958179|NCT03736161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958180|NCT03736161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101958181|NCT03736161|Dermatologic Agents|dermatologic agents|mesh-ancestor
101958182|NCT03736161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101958183|NCT03736161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101690120|NCT02645058|Analgesics|analgesics|mesh-list
101970368|NCT05801172|Lidocaine|lidocaine|mesh-list
101970369|NCT05801172|Anesthetics|anesthetics|mesh-list
101958184|NCT03736161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101958185|NCT03736161|Immunologic Factors|immunologic factors|mesh-ancestor
101958186|NCT03736161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101958187|NCT03736161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101958188|NCT03736161|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101238983|NCT01613196|Deoxyglucose|deoxyglucose|mesh-list
101958189|NCT03736161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101958190|NCT02956005|Tacrolimus|tacrolimus|mesh-list
101958191|NCT02956005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101958192|NCT02956005|Immunologic Factors|immunologic factors|mesh-ancestor
101958193|NCT02956005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958194|NCT02956005|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101958195|NCT02956005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101958196|NCT02956005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958197|NCT02579499|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
101958198|NCT02579499|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101958199|NCT02579499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101958200|NCT02579499|Antimetabolites|antimetabolites|mesh-ancestor
101958201|NCT02579499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958202|NCT02579499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101958203|NCT02579499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101958204|NCT03253094|Fluconazole|fluconazole|mesh-list
101958205|NCT03253094|Ibrexafungerp|ibrexafungerp|mesh-list
101691083|NCT02638428|Crizotinib|crizotinib|mesh-list
101958206|NCT03253094|Antifungal Agents|antifungal agents|mesh-ancestor
101958207|NCT03253094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101958208|NCT03253094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101958209|NCT03253094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101958210|NCT03253094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101958211|NCT03253094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958212|NCT03253094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101958213|NCT03253094|Hormone Antagonists|hormone antagonists|mesh-ancestor
101958214|NCT03253094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101958215|NCT03253094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958216|NCT03253094|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101958217|NCT03253094|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101958218|NCT05179070|Carvedilol|carvedilol|mesh-list
101958219|NCT05179070|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101958220|NCT05179070|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101958221|NCT05179070|Adrenergic Agents|adrenergic agents|mesh-ancestor
101958222|NCT05179070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101958223|NCT05179070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958224|NCT05179070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958225|NCT05179070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101958226|NCT05179070|Antioxidants|antioxidants|mesh-ancestor
101958227|NCT05179070|Protective Agents|protective agents|mesh-ancestor
101958228|NCT05179070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101958229|NCT05179070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101958230|NCT05179070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101958231|NCT05179070|Vasodilator Agents|vasodilator agents|mesh-ancestor
101958232|NCT05179070|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101958233|NCT05179070|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101239479|NCT01616186|Sorafenib|sorafenib|mesh-list
101239522|NCT01616485|Sildenafil Citrate|sildenafil citrate|mesh-list
101958249|NCT00179621|Immunologic Factors|immunologic factors|mesh-ancestor
101970371|NCT05801172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101386613|NCT00121407|Verteporfin|verteporfin|mesh-list
101958250|NCT00179621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958251|NCT00179621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101958252|NCT00179621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101958253|NCT00179621|Growth Substances|growth substances|mesh-ancestor
101958254|NCT00179621|Growth Inhibitors|growth inhibitors|mesh-ancestor
101958255|NCT00179621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101958257|NCT04862780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101958258|NCT04862780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101958259|NCT04862780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101958260|NCT04862780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958261|NCT00179309|Docetaxel|docetaxel|mesh-list
101958262|NCT00179309|Sargramostim|sargramostim|mesh-list
101958263|NCT00179309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101958264|NCT00179309|Tubulin Modulators|tubulin modulators|mesh-ancestor
101958265|NCT00179309|Antimitotic Agents|antimitotic agents|mesh-ancestor
101958266|NCT00179309|Mitosis Modulators|mitosis modulators|mesh-ancestor
101958267|NCT00179309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958268|NCT00179309|Immunologic Factors|immunologic factors|mesh-ancestor
101958269|NCT00179309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958270|NCT00177671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101958272|NCT00177671|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101958273|NCT00177671|Escitalopram|escitalopram|mesh-list
101958274|NCT00177671|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101239947|NCT01618890|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101958275|NCT00177671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101958276|NCT00177671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101240017|NCT01619176|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101958277|NCT00177671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958278|NCT00177671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101958279|NCT00177671|Serotonin Agents|serotonin agents|mesh-ancestor
101958280|NCT00177671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691101|NCT02638428|Alkylating Agents|alkylating agents|mesh-ancestor
101958281|NCT00177671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101958282|NCT00177671|Cholinergic Agents|cholinergic agents|mesh-ancestor
101958283|NCT00177671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101958284|NCT00177671|Antidepressive Agents|antidepressive agents|mesh-ancestor
101958285|NCT00177671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101958286|NCT00177671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101958287|NCT00177671|Analgesics|analgesics|mesh-ancestor
101958288|NCT00177671|Sensory System Agents|sensory system agents|mesh-ancestor
101958289|NCT00177671|Dopamine Agents|dopamine agents|mesh-ancestor
101958290|NCT00177671|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101958291|NCT00177671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101958292|NCT00177671|Nootropic Agents|nootropic agents|mesh-ancestor
101958293|NCT03235154|Sofosbuvir|sofosbuvir|mesh-list
101958294|NCT03235154|Velpatasvir|velpatasvir|mesh-list
101958295|NCT03235154|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
101958296|NCT03235154|Antiviral Agents|antiviral agents|mesh-ancestor
101958297|NCT03235154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101958298|NCT03233438|Dalbavancin|dalbavancin|mesh-list
101958299|NCT03233438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101958300|NCT03233438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101958301|NCT02251600|Deflazacort|deflazacort|mesh-list
101240218|NCT01620424|Insulin Aspart|insulin aspart|mesh-list
101958302|NCT02251600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101958303|NCT02251600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101958304|NCT02251600|Immunologic Factors|immunologic factors|mesh-ancestor
101958305|NCT02251600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958306|NCT02113072|Beclomethasone|beclomethasone|mesh-list
101958307|NCT02113072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101958308|NCT02113072|Glucocorticoids|glucocorticoids|mesh-ancestor
101958309|NCT02113072|Hormones|hormones|mesh-ancestor
101958310|NCT02113072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101958311|NCT02113072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958312|NCT02113072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101958313|NCT02113072|Respiratory System Agents|respiratory system agents|mesh-ancestor
101958314|NCT02113150|Ketamine|ketamine|mesh-list
101958316|NCT02113150|Analgesics|analgesics|mesh-ancestor
101958317|NCT02113150|Sensory System Agents|sensory system agents|mesh-ancestor
101958318|NCT02113150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101970372|NCT05801172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970373|NCT05801172|Sensory System Agents|sensory system agents|mesh-ancestor
101970374|NCT05801172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101970375|NCT05801172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101958319|NCT02113150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958320|NCT02113150|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101958321|NCT02113150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101958322|NCT02113150|Anesthetics, General|anesthetics, general|mesh-ancestor
101958323|NCT02113150|Anesthetics|anesthetics|mesh-ancestor
101958324|NCT02113150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101958325|NCT02113150|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101958326|NCT02113150|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101958327|NCT02113150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101958328|NCT02113150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958329|NCT02113150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101958330|NCT02113150|Narcotics|narcotics|mesh-ancestor
101958331|NCT04647500|Methylphenidate|methylphenidate|mesh-list
101958332|NCT04647500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101958333|NCT04647500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958334|NCT04647500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101958335|NCT04647500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101958336|NCT04647500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101958337|NCT04647500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958338|NCT04647500|Dopamine Agents|dopamine agents|mesh-ancestor
101958339|NCT04647500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101958341|NCT03553108|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101958342|NCT03553108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101958343|NCT03553108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958344|NCT03553108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101958345|NCT02119858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101958346|NCT02117128|Tranexamic Acid|tranexamic acid|mesh-list
101958347|NCT02117128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101958348|NCT02117128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101958349|NCT02117128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958350|NCT02117128|Hemostatics|hemostatics|mesh-ancestor
101958351|NCT02117128|Coagulants|coagulants|mesh-ancestor
101958352|NCT00175877|Certolizumab Pegol|certolizumab pegol|mesh-list
101958353|NCT00175877|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101958355|NCT00175877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101958356|NCT00175877|Immunologic Factors|immunologic factors|mesh-ancestor
101958357|NCT00175877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958358|NCT00175877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101958360|NCT02117362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101958361|NCT02117362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101958362|NCT02117362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101958363|NCT02117362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958364|NCT02113540|Atorvastatin|atorvastatin|mesh-list
101958365|NCT02113540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101958366|NCT02113540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101958367|NCT02113540|Antimetabolites|antimetabolites|mesh-ancestor
101241271|NCT01627353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101958368|NCT02113540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958369|NCT02113540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101241344|NCT01627717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101958370|NCT02113540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101958371|NCT02113540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101958373|NCT02123056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101958374|NCT02123056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101958375|NCT02123056|Sympatholytics|sympatholytics|mesh-ancestor
101958376|NCT02123056|Autonomic Agents|autonomic agents|mesh-ancestor
101958377|NCT02123056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101958378|NCT02123056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958379|NCT02123056|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101958380|NCT02123056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101958381|NCT02123056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101958382|NCT02123056|Adrenergic Agents|adrenergic agents|mesh-ancestor
101970376|NCT05801172|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101970377|NCT05801172|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101958383|NCT02123056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101678177|NCT02598687|Tubulin Modulators|tubulin modulators|mesh-ancestor
101958384|NCT02123056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958385|NCT02120092|Clopidogrel|clopidogrel|mesh-list
101958386|NCT02120092|Ticagrelor|ticagrelor|mesh-list
101958387|NCT02120092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101958388|NCT02120092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101958389|NCT02120092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101241486|NCT01629082|Lenalidomide|lenalidomide|mesh-list
101958390|NCT02120092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101958391|NCT02120092|Purinergic Agents|purinergic agents|mesh-ancestor
101241624|NCT01629758|Nivolumab|nivolumab|mesh-list
101958392|NCT02120092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101958393|NCT02120092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958394|NCT02120092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958396|NCT02117596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101958397|NCT02117596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101958398|NCT02117596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101958399|NCT02117596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101958400|NCT02117596|Antifungal Agents|antifungal agents|mesh-ancestor
101958401|NCT02117596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101241915|NCT01631513|Analgesics|analgesics|mesh-ancestor
101958402|NCT02117596|Immunologic Factors|immunologic factors|mesh-ancestor
101958403|NCT02117596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958405|NCT02117752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101958406|NCT02117752|Antimalarials|antimalarials|mesh-ancestor
101958407|NCT02117752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101958408|NCT02117752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101958409|NCT02117752|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101958410|NCT02117752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101958411|NCT02117752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958412|NCT02117752|Leprostatic Agents|leprostatic agents|mesh-ancestor
101958413|NCT02117752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101958414|NCT02117830|Moxifloxacin|moxifloxacin|mesh-list
101958415|NCT02117830|Enclomiphene|enclomiphene|mesh-list
101958416|NCT02117830|Clomiphene|clomiphene|mesh-list
101958417|NCT02117830|Zuclomiphene|zuclomiphene|mesh-list
101958418|NCT02117830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101958419|NCT02117830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101958420|NCT02117830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101958421|NCT02117830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101958422|NCT02117830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101958423|NCT02117830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958424|NCT02117830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101958425|NCT02117830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101958426|NCT02117830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958427|NCT02117830|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101958428|NCT02117830|Hormone Antagonists|hormone antagonists|mesh-ancestor
101958429|NCT02117830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101958430|NCT02117830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101958431|NCT02117830|Fertility Agents|fertility agents|mesh-ancestor
101958432|NCT02117830|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101958433|NCT02117830|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101958434|NCT02120638|Pyrazinamide|pyrazinamide|mesh-list
101958435|NCT02120638|Antitubercular Agents|antitubercular agents|mesh-ancestor
101958436|NCT02120638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101958437|NCT02120638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101958438|NCT03552406|Cetuximab|cetuximab|mesh-list
101958439|NCT03552406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101958440|NCT03552406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101958441|NCT02123368|Hyaluronic Acid|hyaluronic acid|mesh-list
101958442|NCT02123368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101958443|NCT02123368|Immunologic Factors|immunologic factors|mesh-ancestor
101958444|NCT02123368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958445|NCT02123368|Viscosupplements|viscosupplements|mesh-ancestor
101958446|NCT02123368|Protective Agents|protective agents|mesh-ancestor
101958447|NCT02123524|Rivaroxaban|rivaroxaban|mesh-list
101958448|NCT02123524|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101958449|NCT02123524|Antithrombins|antithrombins|mesh-ancestor
101958450|NCT02123524|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101970378|NCT05801172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101970379|NCT05801172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970380|NCT05801172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101958451|NCT02123524|Protease Inhibitors|protease inhibitors|mesh-ancestor
101958452|NCT02123524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101958453|NCT02123524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958454|NCT02123524|Anticoagulants|anticoagulants|mesh-ancestor
101958455|NCT02117986|Colistin|colistin|mesh-list
101958456|NCT02117986|Polymyxins|polymyxins|mesh-list
101958457|NCT02117986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101958458|NCT02117986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101691132|NCT05299203|Verapamil|verapamil|mesh-list
101958460|NCT02118064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101242388|NCT01634958|Antacids|antacids|mesh-ancestor
101958461|NCT02118064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101958462|NCT02118064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101958463|NCT02118064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958465|NCT02120872|Simvastatin|simvastatin|mesh-list
101958466|NCT02120872|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101958467|NCT02120872|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101958468|NCT02120872|Antimetabolites|antimetabolites|mesh-ancestor
101958469|NCT02120872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958470|NCT02120872|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101958471|NCT02120872|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101958472|NCT02120872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101958473|NCT03552016|Riboflavin|riboflavin|mesh-list
101958474|NCT03552016|Vitamins|vitamins|mesh-ancestor
101958475|NCT03552016|Micronutrients|micronutrients|mesh-ancestor
101958476|NCT03552016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958477|NCT03552016|Vitamin B Complex|vitamin b complex|mesh-ancestor
101958478|NCT03552016|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101958479|NCT03552016|Dermatologic Agents|dermatologic agents|mesh-ancestor
101958480|NCT02788474|Nintedanib|nintedanib|mesh-list
101958481|NCT02788474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101958482|NCT02788474|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101958483|NCT02788474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101958484|NCT02788474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958486|NCT02118142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101958487|NCT02118142|Lipotropic Agents|lipotropic agents|mesh-ancestor
101242590|NCT01636245|Vaccines|vaccines|mesh-list
101958488|NCT02118142|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101958489|NCT02118142|Antimetabolites|antimetabolites|mesh-ancestor
101242661|NCT01636557|Anesthetics|anesthetics|mesh-ancestor
101958490|NCT02118142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958491|NCT02118142|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101958492|NCT02118376|Exenatide|exenatide|mesh-list
101958493|NCT02118376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101958494|NCT02118376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958495|NCT02118376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101958496|NCT02118376|Incretins|incretins|mesh-ancestor
101958497|NCT02118376|Hormones|hormones|mesh-ancestor
101242882|NCT01637454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101242953|NCT01637636|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101958498|NCT02118376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101958500|NCT02124070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101958501|NCT02124070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958502|NCT02118532|Paclitaxel|paclitaxel|mesh-list
101958503|NCT02118532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101958504|NCT02118532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101958505|NCT02118532|Tubulin Modulators|tubulin modulators|mesh-ancestor
101958506|NCT02118532|Antimitotic Agents|antimitotic agents|mesh-ancestor
101958507|NCT02118532|Mitosis Modulators|mitosis modulators|mesh-ancestor
101958508|NCT02118532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958509|NCT02118688|Risperidone|risperidone|mesh-list
101958510|NCT02118688|Trazodone|trazodone|mesh-list
101958511|NCT02118688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101958512|NCT02118688|Serotonin Agents|serotonin agents|mesh-ancestor
101958513|NCT02118688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101958514|NCT02118688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243325|NCT01639521|Doxorubicin|doxorubicin|mesh-list
101970381|NCT05801172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101970382|NCT05801172|Analgesics|analgesics|mesh-ancestor
101958515|NCT02118688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958516|NCT02118688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101958517|NCT02118688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101958518|NCT02118688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101958519|NCT02118688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101958520|NCT02118688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101958522|NCT02118688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101958523|NCT02118688|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101958524|NCT02118688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101958525|NCT02118688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101958526|NCT02118688|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101958527|NCT02118688|Antidepressive Agents|antidepressive agents|mesh-ancestor
101958528|NCT03248492|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
101958529|NCT03248492|Immunoconjugates|immunoconjugates|mesh-ancestor
101958530|NCT03248492|Immunologic Factors|immunologic factors|mesh-ancestor
101958531|NCT03248492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958532|NCT02126956|Ponesimod|ponesimod|mesh-list
101958533|NCT02126956|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101958534|NCT02126956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958535|NCT02126956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101958536|NCT02126956|Immunologic Factors|immunologic factors|mesh-ancestor
101958537|NCT02126956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958538|NCT02124148|Leucovorin|leucovorin|mesh-list
101958539|NCT02124148|Fluorouracil|fluorouracil|mesh-list
101958540|NCT02124148|Pemetrexed|pemetrexed|mesh-list
101958541|NCT02124148|Cetuximab|cetuximab|mesh-list
101958542|NCT02124148|Prexasertib|prexasertib|mesh-list
101958543|NCT02124148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101958544|NCT02124148|Antimetabolites|antimetabolites|mesh-ancestor
101958545|NCT02124148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958546|NCT02124148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101958547|NCT02124148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101958548|NCT02124148|Immunologic Factors|immunologic factors|mesh-ancestor
101958549|NCT02124148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958550|NCT02124148|Antidotes|antidotes|mesh-ancestor
101958551|NCT02124148|Protective Agents|protective agents|mesh-ancestor
101958552|NCT02124148|Vitamin B Complex|vitamin b complex|mesh-ancestor
101958553|NCT02124148|Vitamins|vitamins|mesh-ancestor
101958554|NCT02124148|Micronutrients|micronutrients|mesh-ancestor
101958555|NCT02124148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101958556|NCT02124148|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101958557|NCT02124148|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101243803|NCT01651169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958558|NCT02124148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101958559|NCT02124148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101958560|NCT02124226|Methotrexate|methotrexate|mesh-list
101958561|NCT02124226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101958562|NCT02124226|Abortifacient Agents|abortifacient agents|mesh-ancestor
101958563|NCT02124226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101958564|NCT02124226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958565|NCT02124226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101958566|NCT02124226|Antimetabolites|antimetabolites|mesh-ancestor
101958567|NCT02124226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958568|NCT02124226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101958569|NCT02124226|Dermatologic Agents|dermatologic agents|mesh-ancestor
101958570|NCT02124226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101958571|NCT02124226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101958572|NCT02124226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101958573|NCT02124226|Immunologic Factors|immunologic factors|mesh-ancestor
101958574|NCT02124226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101958575|NCT02124226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101958576|NCT02127034|Digoxin|digoxin|mesh-list
101958577|NCT02127034|Solifenacin Succinate|solifenacin succinate|mesh-list
101958578|NCT02127034|Mirabegron|mirabegron|mesh-list
101958579|NCT02127034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101958580|NCT02127034|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101958581|NCT02127034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101958582|NCT02127034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958583|NCT02127034|Protective Agents|protective agents|mesh-ancestor
101958584|NCT02127034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244113|NCT01652417|Hormones|hormones|mesh-ancestor
101970383|NCT05801172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101970384|NCT05801172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101970385|NCT05801172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101958585|NCT02127034|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101958586|NCT02127034|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101958587|NCT02127034|Cholinergic Agents|cholinergic agents|mesh-ancestor
101958588|NCT02127034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101958589|NCT02127034|Urological Agents|urological agents|mesh-ancestor
101958590|NCT02127034|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101958591|NCT02127034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101958592|NCT02127034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101958593|NCT02127034|Adrenergic Agents|adrenergic agents|mesh-ancestor
101958594|NCT02787304|Volixibat|volixibat|mesh-list
101958595|NCT02787304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101958597|NCT00574496|Mycophenolic Acid|mycophenolic acid|mesh-list
101958598|NCT00574496|Prednisone|prednisone|mesh-list
101958599|NCT00574496|Cyclophosphamide|cyclophosphamide|mesh-list
101958600|NCT00574496|Melphalan|melphalan|mesh-list
101958601|NCT00574496|Ifosfamide|ifosfamide|mesh-list
101958602|NCT00574496|Mechlorethamine|mechlorethamine|mesh-list
101958603|NCT00574496|Gemcitabine|gemcitabine|mesh-list
101958604|NCT00574496|Methotrexate|methotrexate|mesh-list
101958605|NCT00574496|Fludarabine|fludarabine|mesh-list
101958606|NCT00574496|Fludarabine phosphate|fludarabine phosphate|mesh-list
101958607|NCT00574496|Vincristine|vincristine|mesh-list
101958608|NCT00574496|Vinorelbine|vinorelbine|mesh-list
101678398|NCT02712528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101958609|NCT00574496|Procarbazine|procarbazine|mesh-list
101958610|NCT00574496|Cyclosporins|cyclosporins|mesh-list
101958611|NCT00574496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101958612|NCT00574496|Immunologic Factors|immunologic factors|mesh-ancestor
101958613|NCT00574496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958614|NCT00574496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101958615|NCT00574496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101958616|NCT00574496|Alkylating Agents|alkylating agents|mesh-ancestor
101958617|NCT00574496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958618|NCT00574496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101958619|NCT00574496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101958620|NCT00574496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101958622|NCT00574496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101958623|NCT00574496|Glucocorticoids|glucocorticoids|mesh-ancestor
101958624|NCT00574496|Hormones|hormones|mesh-ancestor
101958625|NCT00574496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101958626|NCT00574496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101958627|NCT00574496|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101958628|NCT00574496|Abortifacient Agents|abortifacient agents|mesh-ancestor
101958629|NCT00574496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101958630|NCT00574496|Dermatologic Agents|dermatologic agents|mesh-ancestor
101958631|NCT00574496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101958632|NCT00574496|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101958633|NCT00574496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101244859|NCT01656122|Abacavir|abacavir|mesh-list
101958634|NCT00574496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101958635|NCT00574496|Tubulin Modulators|tubulin modulators|mesh-ancestor
101958636|NCT00574496|Antimitotic Agents|antimitotic agents|mesh-ancestor
101958637|NCT00574496|Mitosis Modulators|mitosis modulators|mesh-ancestor
101958638|NCT00574496|Antifungal Agents|antifungal agents|mesh-ancestor
101958639|NCT00574496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101958640|NCT00574496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101958641|NCT00574496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101958642|NCT00574496|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101958643|NCT00574496|Antitubercular Agents|antitubercular agents|mesh-ancestor
101958644|NCT00574496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101958646|NCT02127190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101958647|NCT02932904|Vortioxetine|vortioxetine|mesh-list
101958648|NCT02932904|Paroxetine|paroxetine|mesh-list
101958649|NCT02932904|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101958650|NCT02932904|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101958651|NCT02932904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101958652|NCT02932904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958653|NCT02932904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101958654|NCT02932904|Serotonin Agents|serotonin agents|mesh-ancestor
101958655|NCT02932904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970386|NCT05801172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970388|NCT05775289|Carboplatin|carboplatin|mesh-list
101970389|NCT05775289|Pembrolizumab|pembrolizumab|mesh-list
101970390|NCT05775289|Pemetrexed|pemetrexed|mesh-list
101958656|NCT02932904|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101958657|NCT02932904|Antidepressive Agents|antidepressive agents|mesh-ancestor
101958658|NCT02932904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101958659|NCT02932904|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101958660|NCT02932904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101958661|NCT02932904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101958662|NCT02932904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101958663|NCT02932904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101958664|NCT02932904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101958665|NCT02932904|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101958666|NCT02932904|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101958667|NCT02932904|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101958668|NCT02932904|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101958670|NCT02127736|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101958671|NCT02127736|Antidepressive Agents|antidepressive agents|mesh-ancestor
101958672|NCT02127736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101958673|NCT02127736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101958675|NCT02127736|Sensory System Agents|sensory system agents|mesh-ancestor
101958676|NCT02127736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101958677|NCT02127736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958678|NCT02127736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101245258|NCT01658202|Nicotine|nicotine|mesh-list
101958679|NCT02127736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101958680|NCT02127736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101958681|NCT02127736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958682|NCT02127736|Adrenergic Agents|adrenergic agents|mesh-ancestor
101958683|NCT02127736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101958684|NCT02124850|Nivolumab|nivolumab|mesh-list
101958685|NCT02124850|Cetuximab|cetuximab|mesh-list
101958686|NCT02124850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101958687|NCT02124850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101958688|NCT02124850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101958689|NCT02124850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958690|NCT02125084|Everolimus|everolimus|mesh-list
101958691|NCT02125084|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101958692|NCT02125084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101958693|NCT02125084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101958694|NCT02125084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958695|NCT02125084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101958696|NCT02125084|Immunologic Factors|immunologic factors|mesh-ancestor
101958697|NCT02125084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958698|NCT02125084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101958699|NCT02122510|Dexmedetomidine|dexmedetomidine|mesh-list
101958700|NCT02122510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101958701|NCT02122510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101958702|NCT02122510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958703|NCT02122510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101958704|NCT02122510|Analgesics|analgesics|mesh-ancestor
101958705|NCT02122510|Sensory System Agents|sensory system agents|mesh-ancestor
101958706|NCT02122510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101958707|NCT02122510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101245325|NCT01658527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101958709|NCT02122510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101958710|NCT02122510|Adrenergic Agents|adrenergic agents|mesh-ancestor
101958711|NCT02122510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101245367|NCT01658891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101958712|NCT02122510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958713|NCT02125318|Anagrelide|anagrelide|mesh-list
101958714|NCT02125318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101958715|NCT02125318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101245442|NCT01659242|Analgesics|analgesics|mesh-ancestor
101958716|NCT02125318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958717|NCT02125318|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101958718|NCT02128126|Vaccines|vaccines|mesh-list
101970391|NCT05775289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101970392|NCT05775289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101958720|NCT02128126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245583|NCT01659931|Montelukast|montelukast|mesh-list
101958723|NCT02128204|Anesthetics|anesthetics|mesh-ancestor
101958724|NCT02128204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101958725|NCT02128204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958726|NCT02128204|Sensory System Agents|sensory system agents|mesh-ancestor
101958727|NCT02128204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101958728|NCT02128204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101958729|NCT02128204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101958730|NCT02128204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101958731|NCT02128204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101958732|NCT02128204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958733|NCT02128282|Gemcitabine|gemcitabine|mesh-list
101958734|NCT02128282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101958735|NCT02128282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101958736|NCT02128282|Antimetabolites|antimetabolites|mesh-ancestor
101958737|NCT02128282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958738|NCT02125630|Hormones|hormones|mesh-list
101958739|NCT02125630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101958740|NCT02125630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958741|NCT03551548|Spironolactone|spironolactone|mesh-list
101958742|NCT03551548|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101958743|NCT03551548|Hormone Antagonists|hormone antagonists|mesh-ancestor
101958744|NCT03551548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101958745|NCT03551548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958746|NCT03551548|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101958747|NCT03551548|Diuretics|diuretics|mesh-ancestor
101958748|NCT03551548|Natriuretic Agents|natriuretic agents|mesh-ancestor
101958749|NCT02128360|Letrozole|letrozole|mesh-list
101958750|NCT02128360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101245776|NCT01661101|Omeprazole|omeprazole|mesh-list
101958751|NCT02128360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101958752|NCT02128360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101958753|NCT02128360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101958754|NCT02128360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678549|NCT00950677|Incretins|incretins|mesh-ancestor
101958755|NCT02128360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101958756|NCT02128360|Hormone Antagonists|hormone antagonists|mesh-ancestor
101958757|NCT02128360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101958758|NCT02128360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958759|NCT02126020|Infliximab|infliximab|mesh-list
101958760|NCT02126020|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101958761|NCT02126020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101958762|NCT02126020|Dermatologic Agents|dermatologic agents|mesh-ancestor
101958763|NCT02126020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101958764|NCT02126020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101958766|NCT00688376|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101958767|NCT00688376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101691173|NCT04208516|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101958768|NCT00688376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958770|NCT00688376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101958771|NCT00688376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958772|NCT00688376|Nootropic Agents|nootropic agents|mesh-ancestor
101958773|NCT02126332|Acetaminophen|acetaminophen|mesh-list
101958774|NCT02126332|Sufentanil|sufentanil|mesh-list
101958775|NCT02126332|Nefopam|nefopam|mesh-list
101958776|NCT02126332|Tramadol|tramadol|mesh-list
101958777|NCT02126332|Ropivacaine|ropivacaine|mesh-list
101958778|NCT02126332|Anesthetics, Local|anesthetics, local|mesh-ancestor
101958779|NCT02126332|Anesthetics|anesthetics|mesh-ancestor
101958780|NCT02126332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101246057|NCT01663038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101246121|NCT01663805|Everolimus|everolimus|mesh-list
101958781|NCT02126332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958782|NCT02126332|Sensory System Agents|sensory system agents|mesh-ancestor
101958783|NCT02126332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101958784|NCT02126332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101958785|NCT02126332|Analgesics|analgesics|mesh-ancestor
101958786|NCT02126332|Antipyretics|antipyretics|mesh-ancestor
101958787|NCT02126332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101970393|NCT05775289|Tubulin Modulators|tubulin modulators|mesh-ancestor
101970394|NCT05775289|Antimitotic Agents|antimitotic agents|mesh-ancestor
101958788|NCT02126332|Narcotics|narcotics|mesh-ancestor
101958789|NCT02126332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101958791|NCT02126332|Anesthetics, General|anesthetics, general|mesh-ancestor
101958792|NCT02131246|Insulin|insulin|mesh-list
101958793|NCT02131246|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101958794|NCT02131246|Insulin Aspart|insulin aspart|mesh-list
101958795|NCT02131246|Insulin, Long-Acting|insulin, long-acting|mesh-list
101246404|NCT01665586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101958796|NCT02131246|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101958797|NCT02131246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101958798|NCT02131246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958799|NCT02126644|Glycolic acid|glycolic acid|mesh-list
101958800|NCT02126644|Keratolytic Agents|keratolytic agents|mesh-ancestor
101958801|NCT02126644|Dermatologic Agents|dermatologic agents|mesh-ancestor
101958802|NCT03550534|Calcium Carbonate|calcium carbonate|mesh-list
101958803|NCT03550534|Calcium|calcium|mesh-list
101958804|NCT03550534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101958805|NCT03550534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958806|NCT03550534|Antacids|antacids|mesh-ancestor
101958807|NCT03550534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958808|NCT03550534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101958809|NCT02131480|Doxorubicin|doxorubicin|mesh-list
101958810|NCT02131480|Trabectedin|trabectedin|mesh-list
101958811|NCT02131480|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101958812|NCT02131480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101958813|NCT02131480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101210024|NCT01449344|Cytarabine|cytarabine|mesh-list
101958814|NCT02131480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101958815|NCT02131480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101958816|NCT02131480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958817|NCT02131480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101958818|NCT02131480|Alkylating Agents|alkylating agents|mesh-ancestor
101958820|NCT02128906|Cetuximab|cetuximab|mesh-list
101958821|NCT02128906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101958822|NCT02128906|Tubulin Modulators|tubulin modulators|mesh-ancestor
101958823|NCT02128906|Antimitotic Agents|antimitotic agents|mesh-ancestor
101958824|NCT02128906|Mitosis Modulators|mitosis modulators|mesh-ancestor
101958825|NCT02128906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958826|NCT02128906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101958827|NCT02128984|Antioxidants|antioxidants|mesh-list
101958828|NCT02128984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958829|NCT02128984|Protective Agents|protective agents|mesh-ancestor
101246915|NCT01669213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101958830|NCT02128984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958832|NCT02252302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101958833|NCT02252302|Autonomic Agents|autonomic agents|mesh-ancestor
101958834|NCT02252302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101958835|NCT02252302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958836|NCT02252302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101958837|NCT02252302|Respiratory System Agents|respiratory system agents|mesh-ancestor
101958839|NCT02252302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101958840|NCT02252302|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101958841|NCT02252302|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101958843|NCT02252302|Adrenergic Agents|adrenergic agents|mesh-ancestor
101958844|NCT02252302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101958845|NCT02252302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958846|NCT02252614|Acetaminophen|acetaminophen|mesh-list
101958848|NCT02252614|Codeine|codeine|mesh-list
101958849|NCT02252614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101958850|NCT02252614|Analgesics|analgesics|mesh-ancestor
101958851|NCT02252614|Sensory System Agents|sensory system agents|mesh-ancestor
101958852|NCT02252614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101958853|NCT02252614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958854|NCT02252614|Antipyretics|antipyretics|mesh-ancestor
101247555|NCT05350696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958855|NCT02252614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101958856|NCT02252614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101958857|NCT02252614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101958858|NCT02252614|Gout Suppressants|gout suppressants|mesh-ancestor
101958859|NCT02252614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101958860|NCT02252614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970395|NCT05775289|Mitosis Modulators|mitosis modulators|mesh-ancestor
101970396|NCT05775289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970397|NCT05775289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101958861|NCT02252614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958862|NCT02252614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101958863|NCT02252614|Narcotics|narcotics|mesh-ancestor
101958864|NCT02252614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101958865|NCT02252614|Antitussive Agents|antitussive agents|mesh-ancestor
101958866|NCT02252614|Respiratory System Agents|respiratory system agents|mesh-ancestor
101958867|NCT02260570|Tolcapone|tolcapone|mesh-list
101958868|NCT02260570|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101958869|NCT02260570|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101958870|NCT02260570|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101958871|NCT02260570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101958872|NCT02260570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958874|NCT03681951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101958875|NCT03681951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101958876|NCT03681951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101958877|NCT03681951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958878|NCT02131948|Insulin|insulin|mesh-list
101958879|NCT02131948|Insulin Lispro|insulin lispro|mesh-list
101958880|NCT02131948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101958881|NCT02131948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958882|NCT02132026|Denosumab|denosumab|mesh-list
101958883|NCT02132026|Alendronate|alendronate|mesh-list
101958884|NCT02132026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101958885|NCT02132026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958886|NCT03735771|Bupivacaine|bupivacaine|mesh-list
101958887|NCT03735771|Anesthetics, Local|anesthetics, local|mesh-ancestor
101958888|NCT03735771|Anesthetics|anesthetics|mesh-ancestor
101247901|NCT03518086|Mirikizumab|mirikizumab|mesh-list
101691198|NCT02820935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101958889|NCT03735771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101958890|NCT03735771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958891|NCT03735771|Sensory System Agents|sensory system agents|mesh-ancestor
101958892|NCT03735771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101958893|NCT02132104|Hormones|hormones|mesh-list
101958894|NCT02132104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101958895|NCT02132104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958896|NCT00174785|Dronedarone|dronedarone|mesh-list
101958897|NCT00174785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101958898|NCT03681093|Indoleacetic Acids|indoleacetic acids|mesh-list
101958899|NCT03681093|Plant Growth Regulators|plant growth regulators|mesh-ancestor
101958900|NCT03681093|Growth Substances|growth substances|mesh-ancestor
101958901|NCT03681093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958902|NCT00166439|Cytarabine|cytarabine|mesh-list
101958903|NCT00166439|Dexamethasone|dexamethasone|mesh-list
101958904|NCT00166439|Oxaliplatin|oxaliplatin|mesh-list
101958905|NCT00166439|Rituximab|rituximab|mesh-list
101958906|NCT00166439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101958907|NCT00166439|Antiemetics|antiemetics|mesh-ancestor
101958908|NCT00166439|Autonomic Agents|autonomic agents|mesh-ancestor
101958909|NCT00166439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101958910|NCT00166439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958911|NCT00166439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101958912|NCT00166439|Glucocorticoids|glucocorticoids|mesh-ancestor
101958913|NCT00166439|Hormones|hormones|mesh-ancestor
101958914|NCT00166439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101958915|NCT00166439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101958916|NCT00166439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101958917|NCT00166439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101958918|NCT00166439|Immunologic Factors|immunologic factors|mesh-ancestor
101958919|NCT00166439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101958920|NCT00166439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101958921|NCT00166439|Antimetabolites|antimetabolites|mesh-ancestor
101958922|NCT00166439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958923|NCT00166439|Antiviral Agents|antiviral agents|mesh-ancestor
101958924|NCT00166439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101958925|NCT00166439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101958926|NCT01074905|Artesunate|artesunate|mesh-list
101958927|NCT01074905|Chloroquine|chloroquine|mesh-list
101958928|NCT01074905|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
101970398|NCT05775289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101970399|NCT05775289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970400|NCT05775289|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101970401|NCT05775289|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101958929|NCT01074905|Primaquine|primaquine|mesh-list
101958930|NCT01074905|Antimalarials|antimalarials|mesh-ancestor
101958931|NCT01074905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101958932|NCT01074905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101958933|NCT01074905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101958934|NCT01074905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101958935|NCT01074905|Antiviral Agents|antiviral agents|mesh-ancestor
101958936|NCT01074905|Schistosomicides|schistosomicides|mesh-ancestor
101958937|NCT01074905|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101958938|NCT01074905|Anthelmintics|anthelmintics|mesh-ancestor
101958939|NCT01074905|Amebicides|amebicides|mesh-ancestor
101958940|NCT01074905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101958941|NCT01074905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101958942|NCT01074905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101958943|NCT01074905|Analgesics|analgesics|mesh-ancestor
101958944|NCT01074905|Sensory System Agents|sensory system agents|mesh-ancestor
101248113|NCT02587312|Nicotine|nicotine|mesh-list
101958945|NCT01074905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101958946|NCT01074905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958947|NCT01074905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101958948|NCT01074905|Filaricides|filaricides|mesh-ancestor
101958949|NCT01074905|Antinematodal Agents|antinematodal agents|mesh-ancestor
101958950|NCT03968237|Buprenorphine|buprenorphine|mesh-list
101958951|NCT03968237|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101958952|NCT03968237|Naloxone|naloxone|mesh-list
101958953|NCT03968237|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101958954|NCT03968237|Narcotics|narcotics|mesh-ancestor
101958955|NCT03968237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101958956|NCT03968237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958957|NCT03968237|Analgesics|analgesics|mesh-ancestor
101958958|NCT03968237|Sensory System Agents|sensory system agents|mesh-ancestor
101958959|NCT03968237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101958960|NCT03968237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101958961|NCT00138671|Insulin|insulin|mesh-list
101958962|NCT00138671|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101958963|NCT00138671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101958964|NCT00138671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958965|NCT01367158|Vaccines|vaccines|mesh-list
101958966|NCT01367158|Immunologic Factors|immunologic factors|mesh-ancestor
101958967|NCT01367158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958968|NCT00130637|Daclizumab|daclizumab|mesh-list
101958969|NCT00130637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101958970|NCT00130637|Immunologic Factors|immunologic factors|mesh-ancestor
101958971|NCT00130637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958972|NCT01077479|Metformin|metformin|mesh-list
101958973|NCT01077479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101958974|NCT01077479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958975|NCT02136784|Morphine|morphine|mesh-list
101958976|NCT02136784|Oxycodone|oxycodone|mesh-list
101958977|NCT02136784|Buprenorphine|buprenorphine|mesh-list
101958978|NCT02136784|Hydromorphone|hydromorphone|mesh-list
101958979|NCT02136784|Hydrocodone|hydrocodone|mesh-list
101958980|NCT02136784|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101958981|NCT02136784|Narcotics|narcotics|mesh-ancestor
101958982|NCT02136784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101958983|NCT02136784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958984|NCT02136784|Analgesics|analgesics|mesh-ancestor
101958985|NCT02136784|Sensory System Agents|sensory system agents|mesh-ancestor
101958986|NCT02136784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101958987|NCT02136784|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101958988|NCT02136784|Antitussive Agents|antitussive agents|mesh-ancestor
101958989|NCT02136784|Respiratory System Agents|respiratory system agents|mesh-ancestor
101958990|NCT02129764|Prednisone|prednisone|mesh-list
101958991|NCT02129764|Allopurinol|allopurinol|mesh-list
101958992|NCT02129764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101958993|NCT02129764|Glucocorticoids|glucocorticoids|mesh-ancestor
101958994|NCT02129764|Hormones|hormones|mesh-ancestor
101958995|NCT02129764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101958996|NCT02129764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958997|NCT02129764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101958998|NCT02129764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970403|NCT05772871|Prednisone|prednisone|mesh-list
101970404|NCT05772871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101970405|NCT05772871|Glucocorticoids|glucocorticoids|mesh-ancestor
101970406|NCT05772871|Hormones|hormones|mesh-ancestor
101970407|NCT05772871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101970408|NCT05772871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970409|NCT05772871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101958999|NCT02129764|Antimetabolites|antimetabolites|mesh-ancestor
101959000|NCT02129764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959001|NCT02129764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101959002|NCT02129764|Gout Suppressants|gout suppressants|mesh-ancestor
101959003|NCT02129764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101959004|NCT02129764|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101959005|NCT02129764|Antioxidants|antioxidants|mesh-ancestor
101959006|NCT02129764|Protective Agents|protective agents|mesh-ancestor
101959007|NCT00130247|Rifampin|rifampin|mesh-list
101959008|NCT00130247|Isoniazid|isoniazid|mesh-list
101959009|NCT00130247|Pyrazinamide|pyrazinamide|mesh-list
101959010|NCT00130247|Ethambutol|ethambutol|mesh-list
101959011|NCT00130247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101959012|NCT00130247|Antitubercular Agents|antitubercular agents|mesh-ancestor
101959013|NCT00130247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101959014|NCT00130247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101959015|NCT00130247|Leprostatic Agents|leprostatic agents|mesh-ancestor
101959016|NCT00130247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101959017|NCT00130247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101959018|NCT00130247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959019|NCT00130247|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101959020|NCT00130247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101959021|NCT00130247|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101959022|NCT00130247|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101959023|NCT00130247|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101959024|NCT00130247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101959025|NCT00130247|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101959027|NCT00130247|Antimetabolites|antimetabolites|mesh-ancestor
101959028|NCT00130247|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101959029|NCT02252926|Acetaminophen|acetaminophen|mesh-list
101959030|NCT02252926|Lidocaine|lidocaine|mesh-list
101959031|NCT02252926|Morphine|morphine|mesh-list
101959032|NCT02252926|Gabapentin|gabapentin|mesh-list
101959033|NCT02252926|Bupivacaine|bupivacaine|mesh-list
101959034|NCT02252926|Anesthetics, Local|anesthetics, local|mesh-ancestor
101959035|NCT02252926|Anesthetics|anesthetics|mesh-ancestor
101959036|NCT02252926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101959037|NCT02252926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959038|NCT02252926|Sensory System Agents|sensory system agents|mesh-ancestor
101959039|NCT02252926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101959040|NCT02252926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101959041|NCT02252926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101248517|NCT05180994|Infliximab|infliximab|mesh-list
101959042|NCT02252926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101959043|NCT02252926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101959044|NCT02252926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959045|NCT02252926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101959046|NCT02252926|Narcotics|narcotics|mesh-ancestor
101959047|NCT02252926|Analgesics|analgesics|mesh-ancestor
101959048|NCT02252926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101959049|NCT02252926|Antipyretics|antipyretics|mesh-ancestor
101959050|NCT02252926|Anticonvulsants|anticonvulsants|mesh-ancestor
101959051|NCT02252926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101959052|NCT02252926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101959053|NCT02252926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101959054|NCT02252926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101959055|NCT02252926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101959056|NCT02252926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101959057|NCT02252926|Antimanic Agents|antimanic agents|mesh-ancestor
101959058|NCT02253004|Cilostazol|cilostazol|mesh-list
101959059|NCT02253004|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101959060|NCT02253004|Autonomic Agents|autonomic agents|mesh-ancestor
101959061|NCT02253004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101959062|NCT02253004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959063|NCT02253004|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101959064|NCT02253004|Respiratory System Agents|respiratory system agents|mesh-ancestor
101959065|NCT02253004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101959066|NCT02253004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101959067|NCT02253004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959068|NCT02253004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101959069|NCT02253004|Vasodilator Agents|vasodilator agents|mesh-ancestor
101959070|NCT02253004|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101348549|NCT00393770|Vitamins|vitamins|mesh-ancestor
101959071|NCT02253004|Protective Agents|protective agents|mesh-ancestor
101248795|NCT03187353|Dopamine Agents|dopamine agents|mesh-ancestor
101959072|NCT02253004|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101959073|NCT02253004|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101959074|NCT02253004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101959075|NCT02252458|Fentanyl|fentanyl|mesh-list
101959076|NCT02252458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101959077|NCT02252458|Narcotics|narcotics|mesh-ancestor
101959078|NCT02252458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101959079|NCT02252458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959080|NCT02252458|Analgesics|analgesics|mesh-ancestor
101959081|NCT02252458|Sensory System Agents|sensory system agents|mesh-ancestor
101959083|NCT02252458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101959084|NCT02252458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101248915|NCT01299480|Vaccines|vaccines|mesh-list
101959085|NCT02252458|Anesthetics, General|anesthetics, general|mesh-ancestor
101959086|NCT02252458|Anesthetics|anesthetics|mesh-ancestor
101959087|NCT04032171|Interferon beta-1a|interferon beta-1a|mesh-list
101959088|NCT04032171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101959089|NCT04032171|Immunologic Factors|immunologic factors|mesh-ancestor
101959090|NCT04032171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959091|NCT04032171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101959093|NCT04032171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101959094|NCT02130154|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101959095|NCT02130154|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101959096|NCT02130154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959097|NCT02132260|Naftifine|naftifine|mesh-list
101959098|NCT02132260|Antifungal Agents|antifungal agents|mesh-ancestor
101959099|NCT02132260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101959100|NCT02137564|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
101959101|NCT02137564|Nirogacestat|nirogacestat|mesh-list
101959102|NCT02137564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101959103|NCT02137564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959104|NCT02132416|Acetaminophen|acetaminophen|mesh-list
101959105|NCT02132416|Ibuprofen|ibuprofen|mesh-list
101959106|NCT02132416|Diclofenac|diclofenac|mesh-list
101959107|NCT02132416|Morphine|morphine|mesh-list
101959108|NCT02132416|Oxycodone|oxycodone|mesh-list
101959109|NCT02132416|Tramadol|tramadol|mesh-list
101959110|NCT02132416|Anesthetics|anesthetics|mesh-list
101959111|NCT02132416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101959112|NCT02132416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959113|NCT02132416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101959114|NCT02132416|Narcotics|narcotics|mesh-ancestor
101959115|NCT02132416|Analgesics|analgesics|mesh-ancestor
101959116|NCT02132416|Sensory System Agents|sensory system agents|mesh-ancestor
101959117|NCT02132416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101959118|NCT02132416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101959119|NCT02132416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101959120|NCT02132416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101959121|NCT02132416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101959122|NCT02132416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101212337|NCT04291820|Desflurane|desflurane|mesh-list
101959123|NCT02132416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101959124|NCT02132416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959125|NCT02132416|Antipyretics|antipyretics|mesh-ancestor
101959126|NCT00137423|Sunitinib|sunitinib|mesh-list
101959127|NCT00137423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101959128|NCT00137423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101959129|NCT00137423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101249242|NCT01690572|Viscosupplements|viscosupplements|mesh-ancestor
101959130|NCT00137423|Growth Substances|growth substances|mesh-ancestor
101959131|NCT00137423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970410|NCT05772871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970411|NCT05772871|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101970412|NCT05772871|Immunologic Factors|immunologic factors|mesh-ancestor
101970413|NCT05772871|Antinematodal Agents|antinematodal agents|mesh-ancestor
101691247|NCT04200599|Oxytocin|oxytocin|mesh-list
101970414|NCT05772871|Anthelmintics|anthelmintics|mesh-ancestor
101959132|NCT00137423|Growth Inhibitors|growth inhibitors|mesh-ancestor
101959133|NCT00137423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101959134|NCT00137423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101959135|NCT00137423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959136|NCT01077557|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101959137|NCT01077557|Antiviral Agents|antiviral agents|mesh-ancestor
101959138|NCT01077557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101959139|NCT02130700|Seviteronel|seviteronel|mesh-list
101959140|NCT02130700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101959141|NCT02130700|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101959142|NCT02130700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101959143|NCT02130700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959145|NCT02137954|Anesthetics, Local|anesthetics, local|mesh-ancestor
101959146|NCT02137954|Anesthetics|anesthetics|mesh-ancestor
101959147|NCT02137954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101959148|NCT02137954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959149|NCT02137954|Sensory System Agents|sensory system agents|mesh-ancestor
101959150|NCT02137954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101959151|NCT02137954|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101959152|NCT02137954|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101959153|NCT02137954|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101959154|NCT02137954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101959155|NCT02137954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959156|NCT02131012|Celecoxib|celecoxib|mesh-list
101959157|NCT02131012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101959158|NCT02131012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101959159|NCT02131012|Analgesics|analgesics|mesh-ancestor
101959160|NCT02131012|Sensory System Agents|sensory system agents|mesh-ancestor
101959161|NCT02131012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101959162|NCT02131012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959163|NCT02131012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101959164|NCT02131012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101959165|NCT02131012|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101959166|NCT02131012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101959167|NCT02131012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101249361|NCT01691209|Hydrocortisone|hydrocortisone|mesh-list
101959168|NCT02131012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959169|NCT02138500|PF-06372865|pf-06372865|mesh-list
101959170|NCT02138500|GABA Modulators|gaba modulators|mesh-ancestor
101959171|NCT02138500|GABA Agents|gaba agents|mesh-ancestor
101959172|NCT02138500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101959173|NCT02138500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959174|NCT02138500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959175|NCT01561768|Vaccines|vaccines|mesh-list
101959176|NCT01561768|Immunologic Factors|immunologic factors|mesh-ancestor
101959177|NCT01561768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959178|NCT00137111|Cytarabine|cytarabine|mesh-list
101959179|NCT00137111|Dexamethasone|dexamethasone|mesh-list
101959180|NCT00137111|Prednisone|prednisone|mesh-list
101959181|NCT00137111|Cyclophosphamide|cyclophosphamide|mesh-list
101959182|NCT00137111|Doxorubicin|doxorubicin|mesh-list
101959183|NCT00137111|Methotrexate|methotrexate|mesh-list
101959184|NCT00137111|Etoposide|etoposide|mesh-list
101959185|NCT00137111|Vincristine|vincristine|mesh-list
101959186|NCT00137111|Daunorubicin|daunorubicin|mesh-list
101959187|NCT00137111|Asparaginase|asparaginase|mesh-list
101959188|NCT00137111|Mercaptopurine|mercaptopurine|mesh-list
101959189|NCT00137111|Pegaspargase|pegaspargase|mesh-list
101959190|NCT00137111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101959191|NCT00137111|Immunologic Factors|immunologic factors|mesh-ancestor
101959192|NCT00137111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959193|NCT00137111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101691255|NCT00681993|Docetaxel|docetaxel|mesh-list
101959194|NCT00137111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101959195|NCT00137111|Alkylating Agents|alkylating agents|mesh-ancestor
101959196|NCT00137111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959197|NCT00137111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970415|NCT05772871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101970416|NCT05772871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101970417|NCT05772871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101959198|NCT00137111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101959199|NCT00137111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101959200|NCT00137111|Antiemetics|antiemetics|mesh-ancestor
101959201|NCT00137111|Autonomic Agents|autonomic agents|mesh-ancestor
101959202|NCT00137111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101959203|NCT00137111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101959204|NCT00137111|Glucocorticoids|glucocorticoids|mesh-ancestor
101959206|NCT00137111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101959207|NCT00137111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101959208|NCT00137111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101249478|NCT01692210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101959209|NCT00137111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101959210|NCT00137111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101959211|NCT00137111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101959212|NCT00137111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101959213|NCT00137111|Abortifacient Agents|abortifacient agents|mesh-ancestor
101959214|NCT00137111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101959215|NCT00137111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101959216|NCT00137111|Antimetabolites|antimetabolites|mesh-ancestor
101959217|NCT00137111|Dermatologic Agents|dermatologic agents|mesh-ancestor
101959218|NCT00137111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101959219|NCT00137111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101959220|NCT00137111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101959221|NCT00137111|Antiviral Agents|antiviral agents|mesh-ancestor
101959222|NCT00137111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101959223|NCT00137111|Tubulin Modulators|tubulin modulators|mesh-ancestor
101959224|NCT00137111|Antimitotic Agents|antimitotic agents|mesh-ancestor
101959225|NCT00137111|Mitosis Modulators|mitosis modulators|mesh-ancestor
101959227|NCT02133118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101959228|NCT02133118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959229|NCT02138812|Paclitaxel|paclitaxel|mesh-list
101959230|NCT02138812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101959231|NCT02138812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101959232|NCT02138812|Tubulin Modulators|tubulin modulators|mesh-ancestor
101959233|NCT02138812|Antimitotic Agents|antimitotic agents|mesh-ancestor
101959234|NCT02138812|Mitosis Modulators|mitosis modulators|mesh-ancestor
101959235|NCT02138812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959236|NCT00136955|Irinotecan|irinotecan|mesh-list
101959237|NCT00136955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101959238|NCT00136955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101959239|NCT00136955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101959240|NCT00136955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959241|NCT00136955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101959242|NCT00135707|Vitamins|vitamins|mesh-list
101959243|NCT00135707|Ascorbic Acid|ascorbic acid|mesh-list
101959244|NCT00135707|Vitamin E|vitamin e|mesh-list
101959245|NCT00135707|alpha-Tocopherol|alpha-tocopherol|mesh-list
101959246|NCT00135707|Micronutrients|micronutrients|mesh-ancestor
101959247|NCT00135707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959248|NCT00135707|Antioxidants|antioxidants|mesh-ancestor
101959249|NCT00135707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959250|NCT00135707|Protective Agents|protective agents|mesh-ancestor
101959251|NCT03548818|Interferons|interferons|mesh-list
101959252|NCT03548818|Interferon-gamma|interferon-gamma|mesh-list
101959253|NCT03548818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101959254|NCT03548818|Antiviral Agents|antiviral agents|mesh-ancestor
101959255|NCT03548818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101959257|NCT02252692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101959258|NCT02252692|Protease Inhibitors|protease inhibitors|mesh-ancestor
101959259|NCT02252692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101959260|NCT02252692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959261|NCT02252692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101959262|NCT03548662|Hyaluronic Acid|hyaluronic acid|mesh-list
101959263|NCT03548662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101959264|NCT03548662|Immunologic Factors|immunologic factors|mesh-ancestor
101959265|NCT03548662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959266|NCT03548662|Viscosupplements|viscosupplements|mesh-ancestor
101959267|NCT03548662|Protective Agents|protective agents|mesh-ancestor
101959268|NCT03966209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101959269|NCT03966209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959270|NCT03966209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101959271|NCT03966209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101959272|NCT02252770|Nitric Oxide|nitric oxide|mesh-list
101959273|NCT02252770|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101959274|NCT02252770|Autonomic Agents|autonomic agents|mesh-ancestor
101959275|NCT02252770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101959276|NCT02252770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959277|NCT02252770|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101959278|NCT02252770|Respiratory System Agents|respiratory system agents|mesh-ancestor
101959279|NCT02252770|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101959280|NCT02252770|Antioxidants|antioxidants|mesh-ancestor
101959281|NCT02252770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959282|NCT02252770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101959283|NCT02252770|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101959284|NCT02252770|Vasodilator Agents|vasodilator agents|mesh-ancestor
101959285|NCT02252770|Gasotransmitters|gasotransmitters|mesh-ancestor
101959286|NCT02252770|Protective Agents|protective agents|mesh-ancestor
101959287|NCT05578456|Aspirin|aspirin|mesh-list
101959288|NCT05578456|Prednisone|prednisone|mesh-list
101959289|NCT05578456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101679074|NCT02775734|Acetylcysteine|acetylcysteine|mesh-list
101959291|NCT05578456|Hormones|hormones|mesh-ancestor
101959292|NCT05578456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101959293|NCT05578456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959294|NCT05578456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101959295|NCT05578456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101959296|NCT05578456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101959297|NCT05578456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101959298|NCT05578456|Analgesics|analgesics|mesh-ancestor
101959299|NCT05578456|Sensory System Agents|sensory system agents|mesh-ancestor
101249753|NCT05288192|Hormones|hormones|mesh-ancestor
101959300|NCT05578456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101959301|NCT05578456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101959302|NCT05578456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101959303|NCT05578456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101959304|NCT05578456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959305|NCT05578456|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101959306|NCT05578456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101959307|NCT05578456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101959308|NCT05578456|Antipyretics|antipyretics|mesh-ancestor
101959309|NCT02133820|Analgesics|analgesics|mesh-list
101959310|NCT02133820|Sensory System Agents|sensory system agents|mesh-ancestor
101959311|NCT02133820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101959312|NCT02133820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959313|NCT05578378|Cytarabine|cytarabine|mesh-list
101959314|NCT05578378|Methotrexate|methotrexate|mesh-list
101959315|NCT05578378|Fludarabine|fludarabine|mesh-list
101959316|NCT05578378|Cladribine|cladribine|mesh-list
101959317|NCT05578378|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101959318|NCT05578378|Abortifacient Agents|abortifacient agents|mesh-ancestor
101959319|NCT05578378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101959320|NCT05578378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959321|NCT05578378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101959322|NCT05578378|Antimetabolites|antimetabolites|mesh-ancestor
101959323|NCT05578378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249954|NCT05294822|Insulin|insulin|mesh-list
101959324|NCT05578378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101959325|NCT05578378|Dermatologic Agents|dermatologic agents|mesh-ancestor
101959326|NCT05578378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101959327|NCT05578378|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101959328|NCT05578378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101959329|NCT05578378|Immunologic Factors|immunologic factors|mesh-ancestor
101959330|NCT05578378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101970424|NCT05761223|Pembrolizumab|pembrolizumab|mesh-list
101387779|NCT00312598|Aripiprazole|aripiprazole|mesh-list
101959331|NCT05578378|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101959332|NCT05578378|Antiviral Agents|antiviral agents|mesh-ancestor
101959333|NCT05578378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101959334|NCT00129623|Ibandronic Acid|ibandronic acid|mesh-list
101959335|NCT00129623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101250008|NCT05294640|Autonomic Agents|autonomic agents|mesh-ancestor
101959337|NCT02139904|Vinorelbine|vinorelbine|mesh-list
101959338|NCT02139904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101959339|NCT02139904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101959340|NCT02139904|Tubulin Modulators|tubulin modulators|mesh-ancestor
101959341|NCT02139904|Antimitotic Agents|antimitotic agents|mesh-ancestor
101959342|NCT02139904|Mitosis Modulators|mitosis modulators|mesh-ancestor
101959343|NCT02139904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959344|NCT05578222|Pembrolizumab|pembrolizumab|mesh-list
101959345|NCT05578222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101959346|NCT05578222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101959347|NCT05578222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101250138|NCT05296317|Cyclophosphamide|cyclophosphamide|mesh-list
101959348|NCT05578222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959349|NCT05201638|Calcium, Dietary|calcium, dietary|mesh-list
101959350|NCT05201638|Calcium|calcium|mesh-list
101959351|NCT05201638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101959352|NCT05201638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959353|NCT05201638|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101959354|NCT00129545|Warfarin|warfarin|mesh-list
101959355|NCT00129545|Anticoagulants|anticoagulants|mesh-ancestor
101959356|NCT02134288|Everolimus|everolimus|mesh-list
101959357|NCT02134288|Abatacept|abatacept|mesh-list
101959358|NCT02134288|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101959359|NCT02134288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101959360|NCT02134288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101959361|NCT02134288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959362|NCT02134288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101959363|NCT02134288|Immunologic Factors|immunologic factors|mesh-ancestor
101959364|NCT02134288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959365|NCT02134288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101959366|NCT02134288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101250282|NCT05264896|Vitamins|vitamins|mesh-ancestor
101959367|NCT02134288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101959368|NCT02134288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101959369|NCT00129467|Methylphenidate|methylphenidate|mesh-list
101959371|NCT00129467|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
101959372|NCT00129467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101959373|NCT00129467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959374|NCT00129467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101959375|NCT00129467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101959376|NCT00129467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101959377|NCT00129467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959378|NCT00129467|Dopamine Agents|dopamine agents|mesh-ancestor
101959379|NCT00129467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101959380|NCT00129467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101959381|NCT00129467|Serotonin Agents|serotonin agents|mesh-ancestor
101959382|NCT00129311|Selegiline|selegiline|mesh-list
101959383|NCT00129311|Antidepressive Agents|antidepressive agents|mesh-ancestor
101959384|NCT00129311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101959385|NCT00129311|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101959386|NCT00129311|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101959387|NCT00129311|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101959388|NCT00129311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101959389|NCT00129311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959390|NCT00129311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101959391|NCT00129311|Protective Agents|protective agents|mesh-ancestor
101959392|NCT00129311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959393|NCT01076621|Norethindrone|norethindrone|mesh-list
101959394|NCT01076621|Norethindrone Acetate|norethindrone acetate|mesh-list
101959395|NCT01076621|Estradiol|estradiol|mesh-list
101959396|NCT01076621|Estrogens|estrogens|mesh-ancestor
101959397|NCT01076621|Hormones|hormones|mesh-ancestor
101959398|NCT01076621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101970425|NCT05761223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101970426|NCT05761223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970427|NCT05761223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101970428|NCT05761223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970429|NCT05758818|Moxifloxacin|moxifloxacin|mesh-list
101970430|NCT05758818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101970431|NCT05758818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101959399|NCT01076621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959400|NCT01076621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101959401|NCT01076621|Contraceptive Agents|contraceptive agents|mesh-ancestor
101959402|NCT01076621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101959403|NCT01076621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101959404|NCT01076621|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101959405|NCT01076621|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101959406|NCT01076621|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101959407|NCT03965819|Acetaminophen|acetaminophen|mesh-list
101959408|NCT03965819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101959409|NCT03965819|Analgesics|analgesics|mesh-ancestor
101959410|NCT03965819|Sensory System Agents|sensory system agents|mesh-ancestor
101959411|NCT03965819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101250694|NCT04602078|Atezolizumab|atezolizumab|mesh-list
101959412|NCT03965819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959413|NCT03965819|Antipyretics|antipyretics|mesh-ancestor
101959415|NCT02134366|Clonazepam|clonazepam|mesh-list
101959416|NCT02134366|Clobazam|clobazam|mesh-list
101959417|NCT02134366|Anticonvulsants|anticonvulsants|mesh-ancestor
101959418|NCT02134366|Antiemetics|antiemetics|mesh-ancestor
101959419|NCT02134366|Autonomic Agents|autonomic agents|mesh-ancestor
101959420|NCT02134366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101959421|NCT02134366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959422|NCT02134366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101959423|NCT02134366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101959424|NCT02134366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101959425|NCT02134366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101959426|NCT02134366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101959427|NCT02134366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101959428|NCT02134366|GABA Modulators|gaba modulators|mesh-ancestor
101959429|NCT02134366|GABA Agents|gaba agents|mesh-ancestor
101959430|NCT02134366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101959431|NCT02134366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959432|NCT02134366|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101959433|NCT02134366|GABA Agonists|gaba agonists|mesh-ancestor
101959434|NCT01077947|Anesthetics|anesthetics|mesh-list
101959435|NCT01077947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101959436|NCT01077947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959437|NCT00133991|Leucovorin|leucovorin|mesh-list
101959438|NCT00133991|Cytarabine|cytarabine|mesh-list
101959439|NCT00133991|Prednisone|prednisone|mesh-list
101959440|NCT00133991|Hydrocortisone|hydrocortisone|mesh-list
101959441|NCT00133991|Cyclophosphamide|cyclophosphamide|mesh-list
101959443|NCT00133991|Methotrexate|methotrexate|mesh-list
101959444|NCT00133991|Vincristine|vincristine|mesh-list
101959445|NCT00133991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101959446|NCT00133991|Immunologic Factors|immunologic factors|mesh-ancestor
101959447|NCT00133991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959448|NCT00133991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101959449|NCT00133991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101959450|NCT00133991|Alkylating Agents|alkylating agents|mesh-ancestor
101959451|NCT00133991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959452|NCT00133991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101959453|NCT00133991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101691347|NCT02688374|Nicotine|nicotine|mesh-list
101250877|NCT04264637|Histamine Antagonists|histamine antagonists|mesh-ancestor
101250878|NCT04264637|Histamine Agents|histamine agents|mesh-ancestor
101250879|NCT04264637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101250880|NCT04238546|Sirolimus|sirolimus|mesh-list
101250881|NCT04238546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101250882|NCT04238546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101250883|NCT04238546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101970432|NCT05758818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101959454|NCT00133991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101959455|NCT00133991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101959456|NCT00133991|Glucocorticoids|glucocorticoids|mesh-ancestor
101959457|NCT00133991|Hormones|hormones|mesh-ancestor
101959458|NCT00133991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101959459|NCT00133991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101959460|NCT00133991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101959461|NCT00133991|Abortifacient Agents|abortifacient agents|mesh-ancestor
101959462|NCT00133991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101959463|NCT00133991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101959464|NCT00133991|Antimetabolites|antimetabolites|mesh-ancestor
101959465|NCT00133991|Dermatologic Agents|dermatologic agents|mesh-ancestor
101959466|NCT00133991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101959467|NCT00133991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101959468|NCT00133991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101959469|NCT00133991|Antiviral Agents|antiviral agents|mesh-ancestor
101959470|NCT00133991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101959471|NCT00133991|Antidotes|antidotes|mesh-ancestor
101959472|NCT00133991|Protective Agents|protective agents|mesh-ancestor
101959473|NCT00133991|Vitamin B Complex|vitamin b complex|mesh-ancestor
101959474|NCT00133991|Vitamins|vitamins|mesh-ancestor
101959475|NCT00133991|Micronutrients|micronutrients|mesh-ancestor
101251008|NCT04082676|Bupivacaine|bupivacaine|mesh-list
101959476|NCT00133991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101959477|NCT00133991|Tubulin Modulators|tubulin modulators|mesh-ancestor
101959478|NCT00133991|Antimitotic Agents|antimitotic agents|mesh-ancestor
101959479|NCT00133991|Mitosis Modulators|mitosis modulators|mesh-ancestor
101959480|NCT03549208|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101959481|NCT03549208|Immunologic Factors|immunologic factors|mesh-ancestor
101959482|NCT03549208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959483|NCT02140450|Timolol|timolol|mesh-list
101959484|NCT02140450|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101959485|NCT02140450|Mannitol|mannitol|mesh-list
101959486|NCT02140450|Acetazolamide|acetazolamide|mesh-list
101959487|NCT02140450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101959488|NCT02140450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101959489|NCT02140450|Adrenergic Agents|adrenergic agents|mesh-ancestor
101959490|NCT02140450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101959491|NCT02140450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959492|NCT02140450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959493|NCT02140450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101959494|NCT02140450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101959495|NCT02140450|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101959496|NCT02140450|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101959497|NCT02140450|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101959498|NCT02140450|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101959499|NCT02140450|Diuretics|diuretics|mesh-ancestor
101959500|NCT02140450|Natriuretic Agents|natriuretic agents|mesh-ancestor
101959501|NCT02140450|Anticonvulsants|anticonvulsants|mesh-ancestor
101251137|NCT05802121|Acetic Acid|acetic acid|mesh-list
101959502|NCT02140450|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101959503|NCT02140450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101959505|NCT05577676|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101959506|NCT05577676|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101959507|NCT05577676|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101959508|NCT05577676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101959509|NCT05577676|Glucocorticoids|glucocorticoids|mesh-ancestor
101959510|NCT05577676|Hormones|hormones|mesh-ancestor
101959511|NCT05577676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101959512|NCT05577676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959513|NCT05577676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101959514|NCT05577676|Immunologic Factors|immunologic factors|mesh-ancestor
101959515|NCT05577676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101959516|NCT05577676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959517|NCT03549832|Ritonavir|ritonavir|mesh-list
101959519|NCT03549832|Sofosbuvir|sofosbuvir|mesh-list
101959520|NCT03549832|Simeprevir|simeprevir|mesh-list
101959521|NCT03549832|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101959522|NCT03549832|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101959523|NCT03549832|Protease Inhibitors|protease inhibitors|mesh-ancestor
101959524|NCT03549832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101959525|NCT03549832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970434|NCT05758818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101959526|NCT03549832|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101959527|NCT03549832|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101959528|NCT03549832|Antiviral Agents|antiviral agents|mesh-ancestor
101959529|NCT03549832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101959530|NCT03549832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101959531|NCT03549832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101959532|NCT03549832|Antimetabolites|antimetabolites|mesh-ancestor
101959533|NCT02134990|Docetaxel|docetaxel|mesh-list
101959534|NCT02134990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101959535|NCT02134990|Tubulin Modulators|tubulin modulators|mesh-ancestor
101959536|NCT02134990|Antimitotic Agents|antimitotic agents|mesh-ancestor
101959537|NCT02134990|Mitosis Modulators|mitosis modulators|mesh-ancestor
101251319|NCT05797597|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101959538|NCT02134990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959539|NCT02135224|Fentanyl|fentanyl|mesh-list
101959540|NCT02135224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101959541|NCT02135224|Narcotics|narcotics|mesh-ancestor
101959542|NCT02135224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101959543|NCT02135224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959544|NCT02135224|Analgesics|analgesics|mesh-ancestor
101959545|NCT02135224|Sensory System Agents|sensory system agents|mesh-ancestor
101959546|NCT02135224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101959547|NCT02135224|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101959548|NCT02135224|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101959549|NCT02135224|Anesthetics, General|anesthetics, general|mesh-ancestor
101959550|NCT02135224|Anesthetics|anesthetics|mesh-ancestor
101959551|NCT02785900|Azacitidine|azacitidine|mesh-list
101959552|NCT02785900|Decitabine|decitabine|mesh-list
101959553|NCT02785900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101959554|NCT02785900|Antimetabolites|antimetabolites|mesh-ancestor
101959555|NCT02785900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959556|NCT02785900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101959557|NCT02785900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101959558|NCT00127205|Zoledronic Acid|zoledronic acid|mesh-list
101959559|NCT00127205|Ibandronic Acid|ibandronic acid|mesh-list
101959560|NCT00127205|Clodronic Acid|clodronic acid|mesh-list
101959561|NCT00127205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101959562|NCT00127205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959563|NCT02135770|Heparin|heparin|mesh-list
101959564|NCT02135770|Calcium heparin|calcium heparin|mesh-list
101959565|NCT02135770|Anticoagulants|anticoagulants|mesh-ancestor
101959566|NCT02135770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101959567|NCT02135770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101959568|NCT02135770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959569|NCT05478850|Anesthetics|anesthetics|mesh-list
101959570|NCT05478850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101959571|NCT05478850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959572|NCT05575180|Acetazolamide|acetazolamide|mesh-list
101959573|NCT05575180|Methazolamide|methazolamide|mesh-list
101959574|NCT05575180|Anticonvulsants|anticonvulsants|mesh-ancestor
101959575|NCT05575180|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101959576|NCT05575180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101959577|NCT05575180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959578|NCT05575180|Diuretics|diuretics|mesh-ancestor
101959579|NCT05575180|Natriuretic Agents|natriuretic agents|mesh-ancestor
101959580|NCT05575180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959581|NCT01560754|Nicotine|nicotine|mesh-list
101959582|NCT01560754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101959583|NCT01560754|Autonomic Agents|autonomic agents|mesh-ancestor
101959584|NCT01560754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101959585|NCT01560754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959586|NCT01560754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101959587|NCT01560754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101959588|NCT01560754|Cholinergic Agents|cholinergic agents|mesh-ancestor
101959589|NCT01560754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101959590|NCT01560754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959591|NCT03547804|Apatinib|apatinib|mesh-list
101959592|NCT03547804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101959593|NCT03547804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101959594|NCT03547804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101959595|NCT03547804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959597|NCT02217267|Anesthetics, Local|anesthetics, local|mesh-ancestor
101959598|NCT02217267|Anesthetics|anesthetics|mesh-ancestor
101305342|NCT02018991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101959599|NCT02217267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101959600|NCT02217267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959601|NCT02217267|Sensory System Agents|sensory system agents|mesh-ancestor
101959602|NCT02217267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101959603|NCT02217267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101959604|NCT02217267|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101959605|NCT02217267|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101959606|NCT02217267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101959607|NCT02217267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959608|NCT03670641|Insulin Glargine|insulin glargine|mesh-list
101959609|NCT03670641|Insulin Lispro|insulin lispro|mesh-list
101959610|NCT03670641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101959611|NCT03670641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959612|NCT03546400|Methylphenidate|methylphenidate|mesh-list
101251852|NCT04170946|Talazoparib|talazoparib|mesh-list
101959613|NCT03546400|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101959614|NCT03546400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959615|NCT03546400|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101959616|NCT03546400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101959617|NCT03546400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101959618|NCT03546400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959619|NCT03546400|Dopamine Agents|dopamine agents|mesh-ancestor
101959620|NCT03546400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101959621|NCT03669861|Abatacept|abatacept|mesh-list
101959622|NCT03669861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101959623|NCT03669861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959624|NCT03669861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101959625|NCT03669861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101959626|NCT03669861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101959627|NCT03669861|Immunologic Factors|immunologic factors|mesh-ancestor
101959628|NCT03669861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959629|NCT03669861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101959630|NCT00127127|Vorinostat|vorinostat|mesh-list
101959631|NCT00127127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252054|NCT03253289|Cholinergic Agents|cholinergic agents|mesh-ancestor
101959632|NCT00127127|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101959633|NCT00127127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101959634|NCT00127127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959635|NCT00126659|Sorafenib|sorafenib|mesh-list
101959636|NCT00126659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101959637|NCT00126659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101959638|NCT00126659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101959639|NCT00126659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959640|NCT03669081|Ketorolac|ketorolac|mesh-list
101959641|NCT03669081|Pregabalin|pregabalin|mesh-list
101959642|NCT03669081|Analgesics|analgesics|mesh-ancestor
101959643|NCT03669081|Sensory System Agents|sensory system agents|mesh-ancestor
101959644|NCT03669081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101959645|NCT03669081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959646|NCT03669081|Anticonvulsants|anticonvulsants|mesh-ancestor
101959647|NCT03669081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101959648|NCT03669081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101959649|NCT03669081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959650|NCT03669081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101959651|NCT03669081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101959652|NCT03669081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101959653|NCT03669081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101959654|NCT03669081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101959655|NCT03669081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101959656|NCT03669081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101959657|NCT03669081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101959658|NCT03669081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101959659|NCT03669081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101959660|NCT03669081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101959662|NCT02253940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101959663|NCT02253940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101959664|NCT02253940|Protease Inhibitors|protease inhibitors|mesh-ancestor
101959665|NCT02253940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101959666|NCT02253940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959667|NCT02253940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101970435|NCT05758818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970436|NCT05758818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970437|NCT05757648|Anesthetics|anesthetics|mesh-list
101959668|NCT02253940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101959669|NCT02253940|Antiviral Agents|antiviral agents|mesh-ancestor
101959670|NCT02253940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101959671|NCT02253940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101959672|NCT02253940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101959673|NCT02253550|Sofosbuvir|sofosbuvir|mesh-list
101959674|NCT02253550|Simeprevir|simeprevir|mesh-list
101959675|NCT02253550|Antiviral Agents|antiviral agents|mesh-ancestor
101959676|NCT02253550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101959677|NCT02253550|Protease Inhibitors|protease inhibitors|mesh-ancestor
101252253|NCT00812669|Cyclophosphamide|cyclophosphamide|mesh-list
101959678|NCT02253550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101959679|NCT02253550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959680|NCT05203432|Atropine|atropine|mesh-list
101959681|NCT05203432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101959682|NCT05203432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101959683|NCT05203432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101959684|NCT05203432|Autonomic Agents|autonomic agents|mesh-ancestor
101252370|NCT03770299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101959685|NCT05203432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101959686|NCT05203432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959687|NCT05203432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101959688|NCT05203432|Respiratory System Agents|respiratory system agents|mesh-ancestor
101959690|NCT05203432|Parasympatholytics|parasympatholytics|mesh-ancestor
101959691|NCT05203432|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101959692|NCT05203432|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101959693|NCT05203432|Cholinergic Agents|cholinergic agents|mesh-ancestor
101959694|NCT05203432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101959695|NCT05203432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959696|NCT03667053|Glucagon|glucagon|mesh-list
101959697|NCT03667053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101959698|NCT03667053|Hormones|hormones|mesh-ancestor
101252604|NCT03500549|Eculizumab|eculizumab|mesh-list
101959699|NCT03667053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101959700|NCT03667053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959701|NCT04589728|Venetoclax|venetoclax|mesh-list
101959702|NCT04589728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101959703|NCT05557240|Poly I-C|poly i-c|mesh-list
101252680|NCT03190369|Hylan|hylan|mesh-list
101959704|NCT05557240|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101959705|NCT05557240|Vaccines|vaccines|mesh-list
101959706|NCT05557240|Poly ICLC|poly iclc|mesh-list
101959707|NCT05557240|Immunologic Factors|immunologic factors|mesh-ancestor
101959708|NCT05557240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959709|NCT05557240|Interferon Inducers|interferon inducers|mesh-ancestor
101959710|NCT05557240|Laxatives|laxatives|mesh-ancestor
101959711|NCT05557240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101959712|NCT05557240|Antiviral Agents|antiviral agents|mesh-ancestor
101959713|NCT05557240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101959714|NCT03631407|Pembrolizumab|pembrolizumab|mesh-list
101959715|NCT03631407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101959716|NCT03631407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101959717|NCT03631407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101959718|NCT03631407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959719|NCT03547024|Midazolam|midazolam|mesh-list
101959720|NCT03547024|Dextromethorphan|dextromethorphan|mesh-list
101959721|NCT03547024|Omeprazole|omeprazole|mesh-list
101959722|NCT03547024|Levonorgestrel|levonorgestrel|mesh-list
101959723|NCT03547024|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101959724|NCT03547024|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
101959725|NCT03547024|JNJ-55308942|jnj-55308942|mesh-list
101959726|NCT03547024|Estradiol|estradiol|mesh-list
101959727|NCT03547024|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101252861|NCT03424122|Rituximab|rituximab|mesh-list
101959728|NCT03547024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101959729|NCT03547024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101959730|NCT03547024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959731|NCT03547024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101959732|NCT03547024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101959733|NCT03547024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101959734|NCT03547024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101959735|NCT03547024|Anesthetics, General|anesthetics, general|mesh-ancestor
101970438|NCT05757648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101970439|NCT05757648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959736|NCT03547024|Anesthetics|anesthetics|mesh-ancestor
101959737|NCT03547024|GABA Modulators|gaba modulators|mesh-ancestor
101959738|NCT03547024|GABA Agents|gaba agents|mesh-ancestor
101959739|NCT03547024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101959740|NCT03547024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959741|NCT03547024|Estrogens|estrogens|mesh-ancestor
101959742|NCT03547024|Hormones|hormones|mesh-ancestor
101959743|NCT03547024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101959744|NCT03547024|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101959745|NCT03547024|Contraceptive Agents|contraceptive agents|mesh-ancestor
101959746|NCT03547024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101959747|NCT03547024|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101959748|NCT03547024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101959749|NCT03547024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101253064|NCT02993757|Vaccines|vaccines|mesh-list
101959750|NCT03547024|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101959751|NCT03547024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101959752|NCT03547024|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101959753|NCT03547024|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101959754|NCT03547024|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101959755|NCT03547024|Antitussive Agents|antitussive agents|mesh-ancestor
101959756|NCT03547024|Respiratory System Agents|respiratory system agents|mesh-ancestor
101959757|NCT03547024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101959758|NCT03547024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101959759|NCT03547024|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101959760|NCT03547024|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
101959761|NCT03547024|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101959762|NCT03547024|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101959763|NCT03547024|Purinergic Agents|purinergic agents|mesh-ancestor
101959764|NCT05115994|Antihypertensive Agents|antihypertensive agents|mesh-list
101959766|NCT04012996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101959767|NCT04012996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101959768|NCT04012996|Analgesics|analgesics|mesh-ancestor
101959769|NCT04012996|Sensory System Agents|sensory system agents|mesh-ancestor
101959770|NCT04012996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101959771|NCT04012996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959772|NCT04012996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101959773|NCT04012996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101959774|NCT04012996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101959775|NCT04012996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101959776|NCT04012996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101959777|NCT04012996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959778|NCT02253784|Dexamethasone|dexamethasone|mesh-list
101959779|NCT02253784|Bupivacaine|bupivacaine|mesh-list
101959780|NCT02253784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101959781|NCT02253784|Antiemetics|antiemetics|mesh-ancestor
101959782|NCT02253784|Autonomic Agents|autonomic agents|mesh-ancestor
101959783|NCT02253784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101959784|NCT02253784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959785|NCT02253784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101959786|NCT02253784|Glucocorticoids|glucocorticoids|mesh-ancestor
101959787|NCT02253784|Hormones|hormones|mesh-ancestor
101959788|NCT02253784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101959789|NCT02253784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101959790|NCT02253784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101959791|NCT02253784|Anesthetics, Local|anesthetics, local|mesh-ancestor
101959792|NCT02253784|Anesthetics|anesthetics|mesh-ancestor
101959793|NCT02253784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101959794|NCT02253784|Sensory System Agents|sensory system agents|mesh-ancestor
101959795|NCT03734445|Vitamins|vitamins|mesh-list
101959796|NCT03734445|Micronutrients|micronutrients|mesh-ancestor
101970451|NCT05696093|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101388300|NCT05999890|Analgesics|analgesics|mesh-ancestor
101959797|NCT03734445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959798|NCT04538092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101959799|NCT04538092|Analgesics|analgesics|mesh-list
101959800|NCT04538092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101959801|NCT04538092|Sensory System Agents|sensory system agents|mesh-ancestor
101959802|NCT04538092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101959803|NCT04538092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959804|NCT03546088|Anesthetics|anesthetics|mesh-list
101959805|NCT03546088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101959806|NCT03546088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959807|NCT03866980|Carboplatin|carboplatin|mesh-list
101959808|NCT03866980|Pemetrexed|pemetrexed|mesh-list
101959809|NCT03866980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101959810|NCT03866980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101959811|NCT03866980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959812|NCT03866980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101959813|NCT03866980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101959814|NCT02253862|Ritonavir|ritonavir|mesh-list
101959815|NCT02253862|Tipranavir|tipranavir|mesh-list
101959816|NCT02253862|Tadalafil|tadalafil|mesh-list
101959817|NCT02253862|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101959818|NCT02253862|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101959819|NCT02253862|Protease Inhibitors|protease inhibitors|mesh-ancestor
101959820|NCT02253862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101959821|NCT02253862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959822|NCT02253862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101959823|NCT02253862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101959824|NCT02253862|Antiviral Agents|antiviral agents|mesh-ancestor
101253249|NCT02491333|Metformin|metformin|mesh-list
101959825|NCT02253862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101959826|NCT02253862|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101959827|NCT02253862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101959828|NCT02253862|Vasodilator Agents|vasodilator agents|mesh-ancestor
101959829|NCT02253862|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101959830|NCT02253862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101959831|NCT02253862|Urological Agents|urological agents|mesh-ancestor
101959832|NCT03627195|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
101959833|NCT03627195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101959834|NCT03627195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101959835|NCT03627195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101959836|NCT03627195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959837|NCT03627195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101959838|NCT03627195|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101959839|NCT03627195|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101253290|NCT02368301|Glucocorticoids|glucocorticoids|mesh-ancestor
101959840|NCT03627195|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101959841|NCT03627195|Adrenergic Agents|adrenergic agents|mesh-ancestor
101959842|NCT03627195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101959843|NCT03627195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959844|NCT03627195|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101959845|NCT03627195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101959846|NCT03627195|Serotonin Agents|serotonin agents|mesh-ancestor
101959847|NCT03627195|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101959848|NCT03627195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101959849|NCT03627195|Dopamine Agents|dopamine agents|mesh-ancestor
101970453|NCT05696093|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101970454|NCT05696093|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101959850|NCT03776656|Allopurinol|allopurinol|mesh-list
101959851|NCT03776656|Antimetabolites|antimetabolites|mesh-ancestor
101959852|NCT03776656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959853|NCT03776656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101959854|NCT03776656|Gout Suppressants|gout suppressants|mesh-ancestor
101959855|NCT03776656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101691523|NCT05664074|Ketorolac|ketorolac|mesh-list
101959856|NCT03776656|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101959857|NCT03776656|Antioxidants|antioxidants|mesh-ancestor
101959858|NCT03776656|Protective Agents|protective agents|mesh-ancestor
101959859|NCT03776656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959860|NCT03733587|Cyclophosphamide|cyclophosphamide|mesh-list
101959861|NCT03733587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101959862|NCT03733587|Immunologic Factors|immunologic factors|mesh-ancestor
101959863|NCT03733587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959864|NCT03733587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101959865|NCT03733587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101959866|NCT03733587|Alkylating Agents|alkylating agents|mesh-ancestor
101959867|NCT03733587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959868|NCT03733587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101959869|NCT03733587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101959871|NCT00126581|Carboplatin|carboplatin|mesh-list
101959872|NCT00126581|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101959873|NCT00126581|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101959874|NCT00126581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101959875|NCT00126581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101959876|NCT00126581|Tubulin Modulators|tubulin modulators|mesh-ancestor
101959877|NCT00126581|Antimitotic Agents|antimitotic agents|mesh-ancestor
101959878|NCT00126581|Mitosis Modulators|mitosis modulators|mesh-ancestor
101959879|NCT00126581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959880|NCT00126581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101959881|NCT00126581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101959882|NCT03704584|Methylprednisolone|methylprednisolone|mesh-list
101959883|NCT03704584|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101959884|NCT03704584|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101959885|NCT03704584|Prednisolone|prednisolone|mesh-list
101959886|NCT03704584|Prednisolone acetate|prednisolone acetate|mesh-list
101959887|NCT03704584|Lidocaine|lidocaine|mesh-list
101959888|NCT03704584|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101959889|NCT03704584|Prednisolone phosphate|prednisolone phosphate|mesh-list
101959890|NCT03704584|Anesthetics, Local|anesthetics, local|mesh-ancestor
101959891|NCT03704584|Anesthetics|anesthetics|mesh-ancestor
101959892|NCT03704584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101959893|NCT03704584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959894|NCT03704584|Sensory System Agents|sensory system agents|mesh-ancestor
101959895|NCT03704584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101959896|NCT03704584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101959897|NCT03704584|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101959898|NCT03704584|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101959899|NCT03704584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101959900|NCT03704584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959901|NCT03704584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101959902|NCT03704584|Antiemetics|antiemetics|mesh-ancestor
101959903|NCT03704584|Autonomic Agents|autonomic agents|mesh-ancestor
101959904|NCT03704584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101959905|NCT03704584|Glucocorticoids|glucocorticoids|mesh-ancestor
101959906|NCT03704584|Hormones|hormones|mesh-ancestor
101959907|NCT03704584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101959908|NCT03704584|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101959909|NCT03704584|Protective Agents|protective agents|mesh-ancestor
101959910|NCT03704584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101324290|NCT00006449|Naltrexone|naltrexone|mesh-list
101959911|NCT03704584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101959912|NCT03737721|Avelumab|avelumab|mesh-list
101959913|NCT03737721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101959914|NCT03737721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101959915|NCT03647709|Analgesics, Opioid|analgesics, opioid|mesh-list
101959916|NCT03647709|Narcotics|narcotics|mesh-ancestor
101959917|NCT03647709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101959918|NCT03647709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959919|NCT03647709|Analgesics|analgesics|mesh-ancestor
101970455|NCT05679401|Cyclophosphamide|cyclophosphamide|mesh-list
101970456|NCT05679401|Glucocorticoids|glucocorticoids|mesh-list
101305361|NCT02019056|Vitamins|vitamins|mesh-ancestor
101959920|NCT03647709|Sensory System Agents|sensory system agents|mesh-ancestor
101959921|NCT03647709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101959922|NCT03546634|Vaccines|vaccines|mesh-list
101959923|NCT03546634|Immunologic Factors|immunologic factors|mesh-ancestor
101959924|NCT03546634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959925|NCT03661983|Aripiprazole|aripiprazole|mesh-list
101959926|NCT03661983|Antidepressive Agents|antidepressive agents|mesh-ancestor
101959927|NCT03661983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101959928|NCT03661983|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101959929|NCT03661983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101959930|NCT03661983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101959931|NCT03661983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959932|NCT03661983|Dopamine Agonists|dopamine agonists|mesh-ancestor
101959933|NCT03661983|Dopamine Agents|dopamine agents|mesh-ancestor
101959934|NCT03661983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101959935|NCT03661983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959936|NCT03661983|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101959937|NCT03661983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101959938|NCT03661983|Serotonin Agents|serotonin agents|mesh-ancestor
101959939|NCT03661983|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101959940|NCT03661983|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101959941|NCT03661983|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101959942|NCT03661983|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101959943|NCT02783170|Vaccines|vaccines|mesh-list
101959944|NCT02783170|Immunologic Factors|immunologic factors|mesh-ancestor
101959945|NCT02783170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959946|NCT04307134|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
101959947|NCT04307134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101959948|NCT04307134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101959949|NCT04307134|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101959950|NCT04307134|Immunotoxins|immunotoxins|mesh-ancestor
101959951|NCT04307134|Immunoconjugates|immunoconjugates|mesh-ancestor
101959952|NCT04307134|Immunologic Factors|immunologic factors|mesh-ancestor
101959953|NCT04307134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959954|NCT02254018|Maytansine|maytansine|mesh-list
101959955|NCT02254018|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
101959956|NCT02254018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101959957|NCT02254018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101959958|NCT02254018|Tubulin Modulators|tubulin modulators|mesh-ancestor
101959959|NCT02254018|Antimitotic Agents|antimitotic agents|mesh-ancestor
101959960|NCT02254018|Mitosis Modulators|mitosis modulators|mesh-ancestor
101959961|NCT02254018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959962|NCT02254018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101959963|NCT02254018|Immunotoxins|immunotoxins|mesh-ancestor
101959964|NCT02254018|Immunoconjugates|immunoconjugates|mesh-ancestor
101959965|NCT02254018|Immunologic Factors|immunologic factors|mesh-ancestor
101959966|NCT02254018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959967|NCT04249882|Naltrexone|naltrexone|mesh-list
101959968|NCT04249882|Varenicline|varenicline|mesh-list
101959969|NCT04249882|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101959970|NCT04249882|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101959971|NCT04249882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959972|NCT04249882|Sensory System Agents|sensory system agents|mesh-ancestor
101959973|NCT04249882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101959974|NCT04249882|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101959975|NCT04249882|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101959976|NCT04249882|Cholinergic Agents|cholinergic agents|mesh-ancestor
101959977|NCT04249882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101959978|NCT04249882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959979|NCT03396952|Aspirin|aspirin|mesh-list
101959980|NCT03396952|Pembrolizumab|pembrolizumab|mesh-list
101959981|NCT03396952|Ipilimumab|ipilimumab|mesh-list
101959982|NCT03396952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101959983|NCT03396952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101959984|NCT03396952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101959985|NCT03396952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959986|NCT03396952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101959987|NCT03396952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101959988|NCT03396952|Analgesics|analgesics|mesh-ancestor
101959989|NCT03396952|Sensory System Agents|sensory system agents|mesh-ancestor
101970457|NCT05679401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101959990|NCT03396952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101959991|NCT03396952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959992|NCT03396952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101959993|NCT03396952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101959994|NCT03396952|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101959995|NCT03396952|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101959996|NCT03396952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101959997|NCT03396952|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101959998|NCT03396952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101959999|NCT03396952|Antipyretics|antipyretics|mesh-ancestor
101960000|NCT03378934|Aspirin|aspirin|mesh-list
101960001|NCT03378934|Clopidogrel|clopidogrel|mesh-list
101960002|NCT03378934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101960003|NCT03378934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101960004|NCT03378934|Analgesics|analgesics|mesh-ancestor
101960005|NCT03378934|Sensory System Agents|sensory system agents|mesh-ancestor
101960006|NCT03378934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101960007|NCT03378934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960008|NCT03378934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101960009|NCT03378934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101960010|NCT03378934|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101960011|NCT03378934|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101960012|NCT03378934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960013|NCT03378934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101960014|NCT03378934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101960015|NCT03378934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101960016|NCT03378934|Antipyretics|antipyretics|mesh-ancestor
101960017|NCT03378934|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101960018|NCT03378934|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101960019|NCT03378934|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101960020|NCT03378934|Purinergic Agents|purinergic agents|mesh-ancestor
101960021|NCT03378934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101960022|NCT00126503|Bevacizumab|bevacizumab|mesh-list
101960023|NCT00126503|Sorafenib|sorafenib|mesh-list
101960024|NCT00126503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101960025|NCT00126503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101960026|NCT00126503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101960027|NCT00126503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101960028|NCT00126503|Growth Substances|growth substances|mesh-ancestor
101960029|NCT00126503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960030|NCT00126503|Growth Inhibitors|growth inhibitors|mesh-ancestor
101960031|NCT00126503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101960032|NCT00126503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101960033|NCT00126503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960034|NCT00126425|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
101960035|NCT00126425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101960036|NCT00126425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101960037|NCT00126425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960038|NCT00126425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101960039|NCT00126191|Leucovorin|leucovorin|mesh-list
101960040|NCT00126191|Cytarabine|cytarabine|mesh-list
101960041|NCT00126191|Cyclophosphamide|cyclophosphamide|mesh-list
101960042|NCT00126191|Ifosfamide|ifosfamide|mesh-list
101960043|NCT00126191|Rituximab|rituximab|mesh-list
101960044|NCT00126191|Doxorubicin|doxorubicin|mesh-list
101960045|NCT00126191|Methotrexate|methotrexate|mesh-list
101960046|NCT00126191|Etoposide|etoposide|mesh-list
101960047|NCT00126191|Vincristine|vincristine|mesh-list
101960048|NCT00126191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101960049|NCT00126191|Immunologic Factors|immunologic factors|mesh-ancestor
101960050|NCT00126191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960051|NCT00126191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101960052|NCT00126191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101960053|NCT00126191|Alkylating Agents|alkylating agents|mesh-ancestor
101960054|NCT00126191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960055|NCT00126191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101960056|NCT00126191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101960057|NCT00126191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101960058|NCT00126191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101960059|NCT00126191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101960060|NCT00126191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101960061|NCT00126191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101960062|NCT00126191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101970458|NCT05679401|Immunologic Factors|immunologic factors|mesh-ancestor
101970459|NCT05679401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970460|NCT05679401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101970461|NCT05679401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101970462|NCT05679401|Alkylating Agents|alkylating agents|mesh-ancestor
101970463|NCT05679401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970464|NCT05679401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970465|NCT05679401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101970466|NCT05679401|Hormones|hormones|mesh-ancestor
101305363|NCT02019056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305364|NCT02019095|Dimercaprol|dimercaprol|mesh-list
101960063|NCT00126191|Abortifacient Agents|abortifacient agents|mesh-ancestor
101960064|NCT00126191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101960065|NCT00126191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101960066|NCT00126191|Antimetabolites|antimetabolites|mesh-ancestor
101960067|NCT00126191|Dermatologic Agents|dermatologic agents|mesh-ancestor
101960068|NCT00126191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101960069|NCT00126191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101960070|NCT00126191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101960071|NCT00126191|Antiviral Agents|antiviral agents|mesh-ancestor
101960072|NCT00126191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101960073|NCT00126191|Antidotes|antidotes|mesh-ancestor
101960074|NCT00126191|Protective Agents|protective agents|mesh-ancestor
101960075|NCT00126191|Vitamin B Complex|vitamin b complex|mesh-ancestor
101960076|NCT00126191|Vitamins|vitamins|mesh-ancestor
101960077|NCT00126191|Micronutrients|micronutrients|mesh-ancestor
101960078|NCT00126191|Tubulin Modulators|tubulin modulators|mesh-ancestor
101960079|NCT00126191|Antimitotic Agents|antimitotic agents|mesh-ancestor
101960080|NCT00126191|Mitosis Modulators|mitosis modulators|mesh-ancestor
101960081|NCT03207958|Belimumab|belimumab|mesh-list
101960082|NCT03207958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101960083|NCT03207958|Immunologic Factors|immunologic factors|mesh-ancestor
101960084|NCT03207958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960085|NCT00124943|Paclitaxel|paclitaxel|mesh-list
101960086|NCT00124943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101960087|NCT00124943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101960088|NCT00124943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101960089|NCT00124943|Tubulin Modulators|tubulin modulators|mesh-ancestor
101960090|NCT00124943|Antimitotic Agents|antimitotic agents|mesh-ancestor
101960091|NCT00124943|Mitosis Modulators|mitosis modulators|mesh-ancestor
101960092|NCT00124943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960093|NCT00124709|Pimecrolimus|pimecrolimus|mesh-list
101960094|NCT00124709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101960095|NCT00124709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101960096|NCT00124709|Analgesics|analgesics|mesh-ancestor
101960097|NCT00124709|Sensory System Agents|sensory system agents|mesh-ancestor
101960098|NCT00124709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101960099|NCT00124709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960100|NCT00124709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101960101|NCT00124709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101960102|NCT00124709|Dermatologic Agents|dermatologic agents|mesh-ancestor
101960103|NCT00124709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101960104|NCT00124709|Immunologic Factors|immunologic factors|mesh-ancestor
101960105|NCT00124709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101960106|NCT00124709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101960107|NCT00124709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960108|NCT04139434|Azacitidine|azacitidine|mesh-list
101960109|NCT04139434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101960110|NCT04139434|Antimetabolites|antimetabolites|mesh-ancestor
101960111|NCT04139434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960112|NCT04139434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101960113|NCT04139434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101960114|NCT04130464|Ketorolac|ketorolac|mesh-list
101960115|NCT04130464|Ropivacaine|ropivacaine|mesh-list
101960116|NCT04130464|Anesthetics, Local|anesthetics, local|mesh-ancestor
101960117|NCT04130464|Anesthetics|anesthetics|mesh-ancestor
101960118|NCT04130464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101960119|NCT04130464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960120|NCT04130464|Sensory System Agents|sensory system agents|mesh-ancestor
101960121|NCT04130464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101960122|NCT04130464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101960123|NCT04130464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101960124|NCT04130464|Analgesics|analgesics|mesh-ancestor
101960125|NCT04130464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101960126|NCT04130464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101960127|NCT04130464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101960128|NCT04130464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101960129|NCT04130464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960130|NCT03058354|Propofol|propofol|mesh-list
101960131|NCT03058354|Anesthetics|anesthetics|mesh-ancestor
101960132|NCT03058354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101960133|NCT03058354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960134|NCT03058354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101960135|NCT03058354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101960136|NCT03058354|Anesthetics, General|anesthetics, general|mesh-ancestor
101960137|NCT02911792|Metformin|metformin|mesh-list
101960138|NCT02911792|Dapagliflozin|dapagliflozin|mesh-list
101960139|NCT02911792|Glipizide|glipizide|mesh-list
101960140|NCT02911792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101960141|NCT02911792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960142|NCT02911792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101960143|NCT02911792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960144|NCT02143570|Darifenacin|darifenacin|mesh-list
101960145|NCT02143570|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101960146|NCT02143570|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101960147|NCT02143570|Cholinergic Agents|cholinergic agents|mesh-ancestor
101960148|NCT02143570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101960149|NCT02143570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960150|NCT02143570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960151|NCT02143570|Urological Agents|urological agents|mesh-ancestor
101960152|NCT02143804|Molgramostim|molgramostim|mesh-list
101960153|NCT02143804|Sargramostim|sargramostim|mesh-list
101960154|NCT02143804|Immunologic Factors|immunologic factors|mesh-ancestor
101960155|NCT02143804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960156|NCT02143804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101960157|NCT03544996|Insulin|insulin|mesh-list
101960158|NCT03544996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101960159|NCT03544996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960160|NCT00564850|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101960161|NCT00564850|Luteolytic Agents|luteolytic agents|mesh-ancestor
101960162|NCT00564850|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101960163|NCT00564850|Contraceptive Agents|contraceptive agents|mesh-ancestor
101960164|NCT00564850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101960165|NCT00564850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960166|NCT00564850|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101960167|NCT00564850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101960168|NCT00564850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101960169|NCT02144194|Docetaxel|docetaxel|mesh-list
101960170|NCT02144194|Vinorelbine|vinorelbine|mesh-list
101960171|NCT02144194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101960172|NCT02144194|Tubulin Modulators|tubulin modulators|mesh-ancestor
101960173|NCT02144194|Antimitotic Agents|antimitotic agents|mesh-ancestor
101960174|NCT02144194|Mitosis Modulators|mitosis modulators|mesh-ancestor
101960175|NCT02144194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691641|NCT02811341|Mydriatics|mydriatics|mesh-ancestor
101960176|NCT02144194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101960177|NCT02140840|Trametinib|trametinib|mesh-list
101960178|NCT02140840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101960179|NCT02140840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101960180|NCT02140840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101960181|NCT02140840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960182|NCT02140918|Fludrocortisone|fludrocortisone|mesh-list
101960183|NCT02140918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101960184|NCT00108160|Mupirocin|mupirocin|mesh-list
101960185|NCT00108160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101960186|NCT00108160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101960187|NCT00108160|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101960188|NCT00108160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970467|NCT05679401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101970468|NCT05679258|Daratumumab|daratumumab|mesh-list
101970469|NCT05679258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101970470|NCT05679258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970471|NCT05679258|Immunologic Factors|immunologic factors|mesh-ancestor
101970472|NCT05679258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970473|NCT05674877|Dexmedetomidine|dexmedetomidine|mesh-list
101970474|NCT05674877|Ketamine|ketamine|mesh-list
101970475|NCT05674877|Analgesics, Opioid|analgesics, opioid|mesh-list
101970476|NCT05674877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101970477|NCT05674877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101970478|NCT05674877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960189|NCT00108160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960190|NCT02254174|Tiotropium Bromide|tiotropium bromide|mesh-list
101960191|NCT02254174|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101960192|NCT02254174|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101960193|NCT02254174|Autonomic Agents|autonomic agents|mesh-ancestor
101960194|NCT02254174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101960195|NCT02254174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960196|NCT02254174|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101960197|NCT02254174|Respiratory System Agents|respiratory system agents|mesh-ancestor
101960198|NCT02254174|Parasympatholytics|parasympatholytics|mesh-ancestor
101960199|NCT02254174|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101960200|NCT02254174|Cholinergic Agents|cholinergic agents|mesh-ancestor
101960201|NCT02254174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101960202|NCT02254174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960203|NCT02254174|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101960204|NCT02254174|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101960205|NCT02254174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101960206|NCT02254174|Adrenergic Agents|adrenergic agents|mesh-ancestor
101960207|NCT03545308|Rocuronium|rocuronium|mesh-list
101960208|NCT03545308|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101960209|NCT03545308|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101960210|NCT03545308|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101960211|NCT03545308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101960212|NCT03545308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960213|NCT00108082|Atenolol|atenolol|mesh-list
101960214|NCT00108082|Carvedilol|carvedilol|mesh-list
101960215|NCT00108082|Lisinopril|lisinopril|mesh-list
101960216|NCT00108082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101960217|NCT00108082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101960218|NCT00108082|Adrenergic Agents|adrenergic agents|mesh-ancestor
101960219|NCT00108082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101960220|NCT00108082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960221|NCT00108082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960222|NCT00108082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101960223|NCT00108082|Antioxidants|antioxidants|mesh-ancestor
101960224|NCT00108082|Protective Agents|protective agents|mesh-ancestor
101960225|NCT00108082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101960226|NCT00108082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101960227|NCT00108082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101960228|NCT00108082|Vasodilator Agents|vasodilator agents|mesh-ancestor
101960229|NCT00108082|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101960230|NCT00108082|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101960231|NCT00108082|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101960232|NCT00108082|Protease Inhibitors|protease inhibitors|mesh-ancestor
101960233|NCT00108082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101960234|NCT00108082|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101960235|NCT00108082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101960236|NCT00108082|Sympatholytics|sympatholytics|mesh-ancestor
101960237|NCT00108082|Autonomic Agents|autonomic agents|mesh-ancestor
101970479|NCT05674877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101970480|NCT05674877|Analgesics|analgesics|mesh-ancestor
101970481|NCT05674877|Sensory System Agents|sensory system agents|mesh-ancestor
101970482|NCT05674877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101970483|NCT05674877|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101970484|NCT05674877|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101970485|NCT05674877|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101970486|NCT05674877|Adrenergic Agents|adrenergic agents|mesh-ancestor
101970487|NCT05674877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101970488|NCT05674877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305378|NCT02019186|Vitamin E|vitamin e|mesh-list
101960238|NCT00108082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101960239|NCT00108082|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101960240|NCT02144662|Ranibizumab|ranibizumab|mesh-list
101960241|NCT02144662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101960242|NCT02144662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101960243|NCT02144662|Growth Substances|growth substances|mesh-ancestor
101960244|NCT02144662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960245|NCT02144662|Growth Inhibitors|growth inhibitors|mesh-ancestor
101960246|NCT02144662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101960247|NCT02141698|Esomeprazole|esomeprazole|mesh-list
101960248|NCT02141698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101960249|NCT02141698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101960250|NCT02141698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101960251|NCT02141698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101960252|NCT02141698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960253|NCT02144818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101960254|NCT02144818|Luteolytic Agents|luteolytic agents|mesh-ancestor
101960255|NCT02144818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101960256|NCT02144818|Contraceptive Agents|contraceptive agents|mesh-ancestor
101960257|NCT02144818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101960258|NCT02144818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960259|NCT02144818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101960260|NCT02144818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101960261|NCT02144818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101960262|NCT02147938|Tacrolimus|tacrolimus|mesh-list
101960263|NCT02147938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101960264|NCT02147938|Immunologic Factors|immunologic factors|mesh-ancestor
101960265|NCT02147938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960266|NCT02147938|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101960267|NCT02147938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101960268|NCT02147938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960269|NCT02148016|Levofloxacin|levofloxacin|mesh-list
101960270|NCT02148016|Betamethasone|betamethasone|mesh-list
101960271|NCT02148016|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101960272|NCT02148016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101960273|NCT02148016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101960274|NCT02148016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101960275|NCT02148016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101960276|NCT02148016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101960277|NCT02148016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960278|NCT02148016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101960279|NCT02148016|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101691652|NCT00682383|Antimitotic Agents|antimitotic agents|mesh-ancestor
101960280|NCT02148016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101960281|NCT02148016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101960282|NCT02148016|Glucocorticoids|glucocorticoids|mesh-ancestor
101960283|NCT02148016|Hormones|hormones|mesh-ancestor
101960284|NCT02148016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101960285|NCT02148016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960286|NCT02148016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101960287|NCT02148016|Respiratory System Agents|respiratory system agents|mesh-ancestor
101960288|NCT02148094|Tenofovir|tenofovir|mesh-list
101970489|NCT05674877|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101960289|NCT02148094|Emtricitabine|emtricitabine|mesh-list
101960290|NCT02148094|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101960291|NCT02148094|Antiviral Agents|antiviral agents|mesh-ancestor
101960292|NCT02148094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101960293|NCT02148094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101960294|NCT02148094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101960295|NCT02148094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101960296|NCT02148094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960297|NCT02148094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101960298|NCT02148094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101960299|NCT02148328|Vaccines|vaccines|mesh-list
101960300|NCT02148328|Immunologic Factors|immunologic factors|mesh-ancestor
101960301|NCT02148328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960302|NCT02142010|Paclitaxel|paclitaxel|mesh-list
101960303|NCT02142010|Cisplatin|cisplatin|mesh-list
101960304|NCT02142010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101960305|NCT02142010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101960306|NCT02142010|Tubulin Modulators|tubulin modulators|mesh-ancestor
101960307|NCT02142010|Antimitotic Agents|antimitotic agents|mesh-ancestor
101960308|NCT02142010|Mitosis Modulators|mitosis modulators|mesh-ancestor
101960309|NCT02142010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960310|NCT02142166|Dialysis Solutions|dialysis solutions|mesh-list
101960311|NCT02142166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101960312|NCT05054140|Calcium|calcium|mesh-list
101960313|NCT05054140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101960314|NCT05054140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960315|NCT03543826|Rocuronium|rocuronium|mesh-list
101960316|NCT03543826|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101960317|NCT03543826|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101960318|NCT03543826|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101960319|NCT03543826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101960320|NCT03543826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960321|NCT02148640|Infliximab|infliximab|mesh-list
101960322|NCT02148640|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101960323|NCT02148640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101960324|NCT02148640|Dermatologic Agents|dermatologic agents|mesh-ancestor
101960325|NCT02148640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101960326|NCT02148640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101960327|NCT02142556|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101960328|NCT02142556|Antidepressive Agents|antidepressive agents|mesh-ancestor
101960329|NCT02142556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101960330|NCT02142556|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101960331|NCT02142556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101960332|NCT02142556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101960333|NCT02142556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960334|NCT02142634|Budesonide|budesonide|mesh-list
101960335|NCT02142634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101960336|NCT02142634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101960337|NCT02142634|Autonomic Agents|autonomic agents|mesh-ancestor
101960338|NCT02142634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101960339|NCT02142634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960340|NCT02142634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101960341|NCT02142634|Respiratory System Agents|respiratory system agents|mesh-ancestor
101960342|NCT02142634|Glucocorticoids|glucocorticoids|mesh-ancestor
101960343|NCT02142634|Hormones|hormones|mesh-ancestor
101691665|NCT04237493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101960344|NCT02142634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101960345|NCT02142790|Paclitaxel|paclitaxel|mesh-list
101960346|NCT02142790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101960347|NCT02142790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101960348|NCT02142790|Tubulin Modulators|tubulin modulators|mesh-ancestor
101960349|NCT02142790|Antimitotic Agents|antimitotic agents|mesh-ancestor
101960350|NCT02142790|Mitosis Modulators|mitosis modulators|mesh-ancestor
101960351|NCT02142790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960352|NCT02142868|Letrozole|letrozole|mesh-list
101960353|NCT02142868|Palbociclib|palbociclib|mesh-list
101960354|NCT02142868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101960355|NCT02142868|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101960356|NCT02142868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101960357|NCT02142868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101960358|NCT02142868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960359|NCT02142868|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101960360|NCT02142868|Hormone Antagonists|hormone antagonists|mesh-ancestor
101970490|NCT05674877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101970492|NCT05674877|Anesthetics|anesthetics|mesh-ancestor
101970493|NCT05674877|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101960361|NCT02142868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101960362|NCT02142868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960363|NCT02142868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101960364|NCT02145520|Magnesium Sulfate|magnesium sulfate|mesh-list
101960365|NCT02145520|Analgesics|analgesics|mesh-ancestor
101960366|NCT02145520|Sensory System Agents|sensory system agents|mesh-ancestor
101960367|NCT02145520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101960368|NCT02145520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960369|NCT02145520|Anesthetics|anesthetics|mesh-ancestor
101960370|NCT02145520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101960371|NCT02145520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101960372|NCT02145520|Anticonvulsants|anticonvulsants|mesh-ancestor
101960373|NCT02145520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101960374|NCT02145520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101960375|NCT02145520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960376|NCT02145520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101960377|NCT02145520|Tocolytic Agents|tocolytic agents|mesh-ancestor
101960378|NCT02145520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101960379|NCT02145598|Lenalidomide|lenalidomide|mesh-list
101960380|NCT02145598|Immunologic Factors|immunologic factors|mesh-ancestor
101960381|NCT02145598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960382|NCT02145598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101960383|NCT02145598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101960384|NCT02145598|Growth Substances|growth substances|mesh-ancestor
101960385|NCT02145598|Growth Inhibitors|growth inhibitors|mesh-ancestor
101960386|NCT02145598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101960387|NCT02145832|Fluconazole|fluconazole|mesh-list
101960388|NCT02145832|Micafungin|micafungin|mesh-list
101960389|NCT02145832|Antifungal Agents|antifungal agents|mesh-list
101960390|NCT02145832|Clotrimazole|clotrimazole|mesh-list
101960391|NCT02145832|Miconazole|miconazole|mesh-list
101960392|NCT02145832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101960393|NCT02145832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101960394|NCT02145832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101960395|NCT02145832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101960396|NCT02145832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960397|NCT02145832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101960398|NCT02145832|Hormone Antagonists|hormone antagonists|mesh-ancestor
101960399|NCT02145832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101960400|NCT02145832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960401|NCT02145832|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101960402|NCT02145832|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101960403|NCT02145832|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101960404|NCT02145832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101960405|NCT00104728|Gefitinib|gefitinib|mesh-list
101960406|NCT00104728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101960407|NCT00104728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101960408|NCT00104728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101960409|NCT00104728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960410|NCT02145910|Vemurafenib|vemurafenib|mesh-list
101960411|NCT02145910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101960412|NCT02145910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101680211|NCT02769104|Docetaxel|docetaxel|mesh-list
101960413|NCT02145910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101960414|NCT02145910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960416|NCT02146222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101960417|NCT02146222|Tubulin Modulators|tubulin modulators|mesh-ancestor
101960418|NCT02146222|Antimitotic Agents|antimitotic agents|mesh-ancestor
101960419|NCT02146222|Mitosis Modulators|mitosis modulators|mesh-ancestor
101960420|NCT02146222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960421|NCT02146300|Xylometazoline|xylometazoline|mesh-list
101960422|NCT02146300|Nasal Decongestants|nasal decongestants|mesh-ancestor
101960423|NCT02146300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101960424|NCT02146300|Respiratory System Agents|respiratory system agents|mesh-ancestor
101960425|NCT02146456|Tranexamic Acid|tranexamic acid|mesh-list
101970494|NCT05674877|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101970495|NCT05674877|Narcotics|narcotics|mesh-ancestor
101970496|NCT05659914|Durvalumab|durvalumab|mesh-list
101970497|NCT05659914|Olaparib|olaparib|mesh-list
101970498|NCT05659914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101960426|NCT02146456|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101960427|NCT02146456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101960428|NCT02146456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960429|NCT02146456|Hemostatics|hemostatics|mesh-ancestor
101960430|NCT02146456|Coagulants|coagulants|mesh-ancestor
101960431|NCT02146534|4-Aminopyridine|4-aminopyridine|mesh-list
101960432|NCT02146534|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101960433|NCT02146534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101960434|NCT02146534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960435|NCT02151916|Fluorides|fluorides|mesh-list
101960436|NCT02151916|Fluorides, Topical|fluorides, topical|mesh-list
101960437|NCT02151916|Cariostatic Agents|cariostatic agents|mesh-ancestor
101960438|NCT02151916|Protective Agents|protective agents|mesh-ancestor
101960439|NCT02151916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960440|NCT02146846|Imatinib Mesylate|imatinib mesylate|mesh-list
101960441|NCT02146846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101960442|NCT02146846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101960443|NCT02146846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101960444|NCT02146846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960445|NCT02152228|Teriparatide|teriparatide|mesh-list
101960446|NCT02152228|Hormones|hormones|mesh-list
101960447|NCT02152228|Parathyroid Hormone|parathyroid hormone|mesh-list
101960448|NCT02152228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101960449|NCT02152228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960450|NCT02152228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101960451|NCT02152228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101960452|NCT02152306|Amlodipine|amlodipine|mesh-list
101960453|NCT02152306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101960454|NCT02152306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101960455|NCT02152306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101960456|NCT02152306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960457|NCT02152306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101960458|NCT02152306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960459|NCT02152306|Vasodilator Agents|vasodilator agents|mesh-ancestor
101960460|NCT02261116|Telmisartan|telmisartan|mesh-list
101960461|NCT02261116|Candesartan|candesartan|mesh-list
101960462|NCT02261116|Candesartan cilexetil|candesartan cilexetil|mesh-list
101960463|NCT02261116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101960464|NCT02261116|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101960465|NCT02261116|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101960466|NCT02261116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960467|NCT02254720|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101960468|NCT02147548|Lorazepam|lorazepam|mesh-list
101960469|NCT02147548|Etifoxine|etifoxine|mesh-list
101960470|NCT02147548|Anticonvulsants|anticonvulsants|mesh-ancestor
101960471|NCT02147548|Antiemetics|antiemetics|mesh-ancestor
101960472|NCT02147548|Autonomic Agents|autonomic agents|mesh-ancestor
101960473|NCT02147548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101960474|NCT02147548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960475|NCT02147548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101960476|NCT02147548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101960477|NCT02147548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101960478|NCT02147548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101960479|NCT02147548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101960481|NCT02147548|GABA Modulators|gaba modulators|mesh-ancestor
101960482|NCT02147548|GABA Agents|gaba agents|mesh-ancestor
101960483|NCT02147548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101960484|NCT02147548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960485|NCT00122681|Vaccines|vaccines|mesh-list
101960486|NCT00122681|Immunologic Factors|immunologic factors|mesh-ancestor
101960487|NCT00122681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960488|NCT02774278|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101960489|NCT02774278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101960490|NCT02774278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101960491|NCT02774278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970499|NCT05659914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970500|NCT05659914|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101960492|NCT02774278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960493|NCT05666349|Niraparib|niraparib|mesh-list
101960494|NCT05666349|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101960495|NCT05666349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101960496|NCT05666349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960497|NCT05666349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101960498|NCT03733275|Lidocaine|lidocaine|mesh-list
101960499|NCT03733275|Bupivacaine|bupivacaine|mesh-list
101960500|NCT03733275|Anesthetics, Local|anesthetics, local|mesh-ancestor
101960501|NCT03733275|Anesthetics|anesthetics|mesh-ancestor
101960502|NCT03733275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101960503|NCT03733275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960504|NCT03733275|Sensory System Agents|sensory system agents|mesh-ancestor
101960505|NCT03733275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101960506|NCT03733275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101960507|NCT03733275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101960508|NCT03733275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101960509|NCT03733275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101960510|NCT03733275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960511|NCT03542422|Apatinib|apatinib|mesh-list
101960512|NCT03542422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101960513|NCT03542422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101960514|NCT03542422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101960515|NCT03542422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960516|NCT01077011|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101960517|NCT01077011|Lubricant Eye Drops|lubricant eye drops|mesh-list
101960518|NCT01077011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101960519|NCT02153866|Vaccines|vaccines|mesh-list
101960520|NCT02153866|Immunologic Factors|immunologic factors|mesh-ancestor
101960521|NCT02153866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960522|NCT03645057|Tacrolimus|tacrolimus|mesh-list
101960523|NCT03645057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101960524|NCT03645057|Immunologic Factors|immunologic factors|mesh-ancestor
101960525|NCT03645057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960526|NCT03645057|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101960527|NCT03645057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101960528|NCT03645057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960529|NCT04863430|Oxaliplatin|oxaliplatin|mesh-list
101960530|NCT04863430|Apatinib|apatinib|mesh-list
101960531|NCT04863430|Tegafur|tegafur|mesh-list
101960532|NCT04863430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101960533|NCT04863430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101960534|NCT04863430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101960535|NCT04863430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960536|NCT04863430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101960537|NCT04863430|Antimetabolites|antimetabolites|mesh-ancestor
101960538|NCT05665881|Phenylephrine|phenylephrine|mesh-list
101960539|NCT05665881|Oxymetazoline|oxymetazoline|mesh-list
101960540|NCT05665881|Norepinephrine|norepinephrine|mesh-list
101960541|NCT05665881|Ephedrine|ephedrine|mesh-list
101960543|NCT05665881|Mydriatics|mydriatics|mesh-ancestor
101960544|NCT05665881|Autonomic Agents|autonomic agents|mesh-ancestor
101960545|NCT05665881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101960546|NCT05665881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960547|NCT05665881|Sympathomimetics|sympathomimetics|mesh-ancestor
101960548|NCT05665881|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101960549|NCT05665881|Nasal Decongestants|nasal decongestants|mesh-ancestor
101960550|NCT05665881|Respiratory System Agents|respiratory system agents|mesh-ancestor
101960551|NCT05665881|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101960552|NCT05665881|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101960553|NCT05665881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101960554|NCT05665881|Adrenergic Agents|adrenergic agents|mesh-ancestor
101960555|NCT05665881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101960556|NCT05665881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960557|NCT05665881|Protective Agents|protective agents|mesh-ancestor
101960558|NCT05665881|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101960559|NCT03643575|Phenylpropanolamine|phenylpropanolamine|mesh-list
101960560|NCT03643575|Guaifenesin|guaifenesin|mesh-list
101680361|NCT02696330|Enoxaparin|enoxaparin|mesh-list
101305404|NCT02019329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960561|NCT03643575|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
101960562|NCT03643575|Expectorants|expectorants|mesh-ancestor
101960563|NCT03643575|Respiratory System Agents|respiratory system agents|mesh-ancestor
101960564|NCT03643575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101960565|NCT03643575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101960566|NCT03643575|Adrenergic Agents|adrenergic agents|mesh-ancestor
101960567|NCT03643575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101960568|NCT03643575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960569|NCT03643575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960570|NCT03643575|Appetite Depressants|appetite depressants|mesh-ancestor
101960571|NCT03643575|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101960572|NCT03643575|Sympathomimetics|sympathomimetics|mesh-ancestor
101960573|NCT03643575|Autonomic Agents|autonomic agents|mesh-ancestor
101960574|NCT03643575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101960575|NCT03643575|Nasal Decongestants|nasal decongestants|mesh-ancestor
101960576|NCT03643575|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101960577|NCT02768194|Fluorides|fluorides|mesh-list
101960578|NCT02768194|Tin Fluorides|tin fluorides|mesh-list
101960579|NCT02768194|Fluorophosphate|fluorophosphate|mesh-list
101960580|NCT02768194|Cariostatic Agents|cariostatic agents|mesh-ancestor
101960581|NCT02768194|Protective Agents|protective agents|mesh-ancestor
101960582|NCT02768194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960583|NCT02254954|Temozolomide|temozolomide|mesh-list
101960584|NCT02254954|Macitentan|macitentan|mesh-list
101960585|NCT02254954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101960586|NCT02254954|Alkylating Agents|alkylating agents|mesh-ancestor
101960587|NCT02254954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960588|NCT02254954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101960589|NCT02254954|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101960590|NCT02254954|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101960591|NCT02254954|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
101960592|NCT00130793|Vaccines|vaccines|mesh-list
101960593|NCT00130793|Immunologic Factors|immunologic factors|mesh-ancestor
101960594|NCT00130793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960595|NCT03732105|Apatinib|apatinib|mesh-list
101960596|NCT03732105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
101960597|NCT03732105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101960598|NCT03732105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101960599|NCT03732105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101960600|NCT03732105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960601|NCT03732105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101960602|NCT03732105|Growth Substances|growth substances|mesh-ancestor
101960603|NCT03732105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960604|NCT03732105|Growth Inhibitors|growth inhibitors|mesh-ancestor
101960605|NCT02154334|Mometasone Furoate|mometasone furoate|mesh-list
101960606|NCT02154334|Phenylephrine|phenylephrine|mesh-list
101960607|NCT02154334|Oxymetazoline|oxymetazoline|mesh-list
101960608|NCT02154334|Esketamine|esketamine|mesh-list
101960609|NCT02154334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101960610|NCT02154334|Dermatologic Agents|dermatologic agents|mesh-ancestor
101960611|NCT02154334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101960612|NCT02154334|Antidepressive Agents|antidepressive agents|mesh-ancestor
101960613|NCT02154334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101960614|NCT02154334|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101960615|NCT02154334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101960616|NCT02154334|Adrenergic Agents|adrenergic agents|mesh-ancestor
101960617|NCT02154334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101960618|NCT02154334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960619|NCT02154334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960620|NCT02154334|Sympathomimetics|sympathomimetics|mesh-ancestor
101960621|NCT02154334|Autonomic Agents|autonomic agents|mesh-ancestor
101960622|NCT02154334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101960623|NCT02154334|Nasal Decongestants|nasal decongestants|mesh-ancestor
101960624|NCT02154334|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101960625|NCT02154334|Respiratory System Agents|respiratory system agents|mesh-ancestor
101960626|NCT02154334|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101960627|NCT02154334|Mydriatics|mydriatics|mesh-ancestor
101960628|NCT02154334|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101960629|NCT02154334|Protective Agents|protective agents|mesh-ancestor
101960630|NCT01078961|Bortezomib|bortezomib|mesh-list
101960631|NCT01078961|Sorafenib|sorafenib|mesh-list
101960632|NCT01078961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101960633|NCT01078961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101960634|NCT01078961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101680427|NCT00647673|Verapamil|verapamil|mesh-list
101960635|NCT01078961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960637|NCT03818399|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101960638|NCT03818399|Narcotics|narcotics|mesh-ancestor
101960639|NCT03818399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101960640|NCT03818399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960641|NCT03818399|Analgesics|analgesics|mesh-ancestor
101960642|NCT03818399|Sensory System Agents|sensory system agents|mesh-ancestor
101960643|NCT03818399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101970524|NCT05570812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970525|NCT05570812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970526|NCT05537220|Acetylcysteine|acetylcysteine|mesh-list
101970527|NCT05537220|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101970528|NCT05537220|Antiviral Agents|antiviral agents|mesh-ancestor
101970529|NCT05537220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101970530|NCT05537220|Expectorants|expectorants|mesh-ancestor
101970531|NCT05537220|Respiratory System Agents|respiratory system agents|mesh-ancestor
101970532|NCT05537220|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101970533|NCT05537220|Antioxidants|antioxidants|mesh-ancestor
101970534|NCT05537220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970535|NCT05537220|Protective Agents|protective agents|mesh-ancestor
101970536|NCT05537220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970537|NCT05537220|Antidotes|antidotes|mesh-ancestor
101970538|NCT05534672|Sirolimus|sirolimus|mesh-list
101970539|NCT05534672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101970540|NCT05534672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101305411|NCT02019355|Fluorouracil|fluorouracil|mesh-list
101960644|NCT03818399|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101960645|NCT02154646|Gemcitabine|gemcitabine|mesh-list
101960646|NCT02154646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101960647|NCT02154646|Antimetabolites|antimetabolites|mesh-ancestor
101960648|NCT02154646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960649|NCT02154646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101960650|NCT03642873|Phenylpropanolamine|phenylpropanolamine|mesh-list
101960651|NCT03642873|Hydrocodone|hydrocodone|mesh-list
101960652|NCT03642873|Guaifenesin|guaifenesin|mesh-list
101960653|NCT03642873|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
101960654|NCT03642873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101960655|NCT03642873|Narcotics|narcotics|mesh-ancestor
101960656|NCT03642873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101960657|NCT03642873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960658|NCT03642873|Analgesics|analgesics|mesh-ancestor
101960659|NCT03642873|Sensory System Agents|sensory system agents|mesh-ancestor
101960660|NCT03642873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101960661|NCT03642873|Antitussive Agents|antitussive agents|mesh-ancestor
101960662|NCT03642873|Respiratory System Agents|respiratory system agents|mesh-ancestor
101960663|NCT03642873|Expectorants|expectorants|mesh-ancestor
101960664|NCT03642873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101960665|NCT03642873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101960666|NCT03642873|Adrenergic Agents|adrenergic agents|mesh-ancestor
101960667|NCT03642873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101960668|NCT03642873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960669|NCT03642873|Appetite Depressants|appetite depressants|mesh-ancestor
101960670|NCT03642873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101960671|NCT03642873|Sympathomimetics|sympathomimetics|mesh-ancestor
101960672|NCT03642873|Autonomic Agents|autonomic agents|mesh-ancestor
101960673|NCT03642873|Nasal Decongestants|nasal decongestants|mesh-ancestor
101960674|NCT03642873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101960675|NCT01079819|BMS 708163|bms 708163|mesh-list
101960676|NCT01079819|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101960677|NCT01079819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970541|NCT05534672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101970543|NCT05534672|Antifungal Agents|antifungal agents|mesh-ancestor
101970544|NCT05534672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101960678|NCT01079819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960679|NCT02156596|Ketoprofen|ketoprofen|mesh-list
101960680|NCT02156596|Morphine|morphine|mesh-list
101960681|NCT02156596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101960682|NCT02156596|Narcotics|narcotics|mesh-ancestor
101960683|NCT02156596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101960684|NCT02156596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960685|NCT02156596|Analgesics|analgesics|mesh-ancestor
101960686|NCT02156596|Sensory System Agents|sensory system agents|mesh-ancestor
101960687|NCT02156596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101960688|NCT02156596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101960689|NCT02156596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101960690|NCT02156596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101960691|NCT02156596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101960692|NCT02156596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101960693|NCT02156596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101960694|NCT02156596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960695|NCT01079117|Morphine|morphine|mesh-list
101960696|NCT01079117|Methadone|methadone|mesh-list
101960697|NCT01079117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101960698|NCT01079117|Narcotics|narcotics|mesh-ancestor
101960699|NCT01079117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101960700|NCT01079117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960701|NCT01079117|Analgesics|analgesics|mesh-ancestor
101960702|NCT01079117|Sensory System Agents|sensory system agents|mesh-ancestor
101960703|NCT01079117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101960704|NCT01079117|Antitussive Agents|antitussive agents|mesh-ancestor
101960705|NCT01079117|Respiratory System Agents|respiratory system agents|mesh-ancestor
101960706|NCT03732963|Melatonin|melatonin|mesh-list
101960707|NCT03732963|Antioxidants|antioxidants|mesh-ancestor
101960708|NCT03732963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253509|NCT01913730|Bortezomib|bortezomib|mesh-list
101960709|NCT03732963|Protective Agents|protective agents|mesh-ancestor
101960710|NCT03732963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960711|NCT03732963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101960712|NCT03729687|Capecitabine|capecitabine|mesh-list
101960713|NCT03729687|Oxaliplatin|oxaliplatin|mesh-list
101960714|NCT03729687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101960715|NCT03729687|Antimetabolites|antimetabolites|mesh-ancestor
101960716|NCT03729687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960717|NCT03729687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101960718|NCT03818321|Methenamine|methenamine|mesh-list
101960719|NCT03818321|Methenamine hippurate|methenamine hippurate|mesh-list
101960720|NCT03818321|Methenamine mandelate|methenamine mandelate|mesh-list
101960721|NCT03818321|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101960722|NCT03818321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101960723|NCT03818321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101960724|NCT03616977|Insulin Lispro|insulin lispro|mesh-list
101960725|NCT03616977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101960726|NCT03616977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960727|NCT04996719|Sirolimus|sirolimus|mesh-list
101960728|NCT04996719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101960729|NCT04996719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101960730|NCT04996719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101960731|NCT04996719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101960732|NCT04996719|Antifungal Agents|antifungal agents|mesh-ancestor
101960733|NCT04996719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101960734|NCT04996719|Immunologic Factors|immunologic factors|mesh-ancestor
101960735|NCT04996719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960736|NCT03816761|Insulin Aspart|insulin aspart|mesh-list
101960737|NCT03816761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101960738|NCT03816761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960739|NCT02770612|Analgesics, Opioid|analgesics, opioid|mesh-list
101960740|NCT02770612|Narcotics|narcotics|mesh-ancestor
101960741|NCT02770612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101960742|NCT02770612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960743|NCT02770612|Analgesics|analgesics|mesh-ancestor
101960744|NCT02770612|Sensory System Agents|sensory system agents|mesh-ancestor
101970545|NCT05534672|Immunologic Factors|immunologic factors|mesh-ancestor
101970546|NCT05534672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970547|NCT05527548|Alendronate|alendronate|mesh-list
101970548|NCT05527548|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101960745|NCT02770612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101960746|NCT03542110|Alirocumab|alirocumab|mesh-list
101960747|NCT03542110|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101960748|NCT03542110|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101960749|NCT03542110|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101960750|NCT03542110|Antimetabolites|antimetabolites|mesh-ancestor
101960751|NCT03542110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960752|NCT03542110|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101960753|NCT03542110|Protease Inhibitors|protease inhibitors|mesh-ancestor
101960754|NCT03542110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101960755|NCT03542110|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101960756|NCT03575871|Abrocitinib|abrocitinib|mesh-list
101960757|NCT03575871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101960758|NCT03575871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101960759|NCT03575871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960760|NCT02155504|Itraconazole|itraconazole|mesh-list
101960761|NCT02155504|Antifungal Agents|antifungal agents|mesh-ancestor
101960762|NCT02155504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101960763|NCT02155504|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101960764|NCT02155504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101960765|NCT02155504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101960766|NCT02155504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960767|NCT02155504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101960768|NCT02155504|Hormone Antagonists|hormone antagonists|mesh-ancestor
101960769|NCT02155504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101960770|NCT02155504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960771|NCT02155504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101960772|NCT03642717|Empagliflozin|empagliflozin|mesh-list
101253524|NCT01863186|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101960773|NCT03642717|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101960774|NCT03642717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960775|NCT03642717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101960776|NCT03642717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960777|NCT02766478|Genistein|genistein|mesh-list
101960778|NCT02766478|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101960779|NCT02766478|Protective Agents|protective agents|mesh-ancestor
101960780|NCT02766478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960781|NCT02766478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101960782|NCT02766478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101680572|NCT02664051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101960783|NCT02766478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101960784|NCT02766478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960785|NCT02766478|Phytoestrogens|phytoestrogens|mesh-ancestor
101960786|NCT02766478|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101960787|NCT02766478|Estrogens|estrogens|mesh-ancestor
101960788|NCT02766478|Hormones|hormones|mesh-ancestor
101960789|NCT02766478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101960790|NCT03729375|Bupivacaine|bupivacaine|mesh-list
101960791|NCT03729375|Anesthetics, Local|anesthetics, local|mesh-ancestor
101960792|NCT03729375|Anesthetics|anesthetics|mesh-ancestor
101960793|NCT03729375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101960794|NCT03729375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960795|NCT03729375|Sensory System Agents|sensory system agents|mesh-ancestor
101960796|NCT03729375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101960797|NCT02159326|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
101960798|NCT02159326|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
101960799|NCT02159326|Riociguat|riociguat|mesh-list
101960800|NCT02159326|Enzyme Activators|enzyme activators|mesh-ancestor
101960801|NCT02159326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960802|NCT02159326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101960803|NCT02159326|Contraceptive Agents|contraceptive agents|mesh-ancestor
101960804|NCT02159326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101960805|NCT02159326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960806|NCT02159326|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101960807|NCT02159326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101960808|NCT02159326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101960809|NCT02159326|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101960810|NCT02159326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101960811|NCT02159326|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
101960812|NCT02159326|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101691749|NCT02810015|Cholinergic Agents|cholinergic agents|mesh-ancestor
101960813|NCT02159326|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101960814|NCT02255266|Liraglutide|liraglutide|mesh-list
101960815|NCT02255266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101960816|NCT02255266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960817|NCT02255266|Incretins|incretins|mesh-ancestor
101960818|NCT02255266|Hormones|hormones|mesh-ancestor
101960819|NCT02255266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101960820|NCT00104650|Diphosphonates|diphosphonates|mesh-list
101960821|NCT00104650|Denosumab|denosumab|mesh-list
101960822|NCT00104650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101960823|NCT00104650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960824|NCT02158078|Insulin|insulin|mesh-list
101960825|NCT02158078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101960826|NCT02158078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960827|NCT00104416|Lamotrigine|lamotrigine|mesh-list
101960828|NCT00104416|Anticonvulsants|anticonvulsants|mesh-ancestor
101960829|NCT00104416|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101960830|NCT00104416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101960831|NCT00104416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960832|NCT00104416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101960833|NCT00104416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960834|NCT00104416|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101960835|NCT00104416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101960836|NCT00104416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101960837|NCT00104416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101960838|NCT00104416|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101960839|NCT04817254|Nivolumab|nivolumab|mesh-list
101960840|NCT04817254|Ipilimumab|ipilimumab|mesh-list
101960841|NCT04817254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101960842|NCT04817254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101960843|NCT04817254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101960844|NCT04817254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960845|NCT02149888|Tenofovir|tenofovir|mesh-list
101960846|NCT02149888|Emtricitabine|emtricitabine|mesh-list
101960847|NCT02149888|Antiviral Agents|antiviral agents|mesh-ancestor
101960848|NCT02149888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101960849|NCT02149888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101960850|NCT02149888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101960851|NCT02149888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101960852|NCT02149888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960853|NCT02149888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101960854|NCT02149888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101960855|NCT03639675|Aflibercept|aflibercept|mesh-list
101960856|NCT03639675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101960857|NCT03639675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101960858|NCT03639675|Growth Substances|growth substances|mesh-ancestor
101960859|NCT03639675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960860|NCT03639675|Growth Inhibitors|growth inhibitors|mesh-ancestor
101960861|NCT03639675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101960862|NCT03543436|Meropenem|meropenem|mesh-list
101960863|NCT03543436|Imipenem|imipenem|mesh-list
101960864|NCT03543436|Temocillin|temocillin|mesh-list
101960865|NCT03543436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101960866|NCT03543436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101960867|NCT02149966|Mitapivat|mitapivat|mesh-list
101960868|NCT02149966|Enzyme Activators|enzyme activators|mesh-ancestor
101960869|NCT02149966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960870|NCT03729063|Carbon Monoxide|carbon monoxide|mesh-list
101960871|NCT03729063|Antimetabolites|antimetabolites|mesh-ancestor
101960872|NCT03729063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960873|NCT03729063|Gasotransmitters|gasotransmitters|mesh-ancestor
101960874|NCT03729063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101960875|NCT03729063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960876|NCT01310361|Amoxicillin|amoxicillin|mesh-list
101960877|NCT01310361|Penicillins|penicillins|mesh-list
101960878|NCT01310361|Penicillin G|penicillin g|mesh-list
101970549|NCT05527548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970551|NCT05498675|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101960879|NCT01310361|Penicillin G Benzathine|penicillin g benzathine|mesh-list
101960880|NCT01310361|Penicillin G Procaine|penicillin g procaine|mesh-list
101691754|NCT02809781|Etanercept|etanercept|mesh-list
101960881|NCT01310361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101960882|NCT01310361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101960883|NCT03541798|Anesthetics|anesthetics|mesh-list
101960884|NCT03541798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101960885|NCT03541798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960886|NCT02150122|Vitamin D|vitamin d|mesh-list
101960887|NCT02150122|Cholecalciferol|cholecalciferol|mesh-list
101960888|NCT02150122|Vitamins|vitamins|mesh-ancestor
101960889|NCT02150122|Micronutrients|micronutrients|mesh-ancestor
101960890|NCT02150122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960891|NCT02150122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101960892|NCT02150122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101960893|NCT03728829|Carboplatin|carboplatin|mesh-list
101960894|NCT03728829|Docetaxel|docetaxel|mesh-list
101960895|NCT03728829|Trastuzumab|trastuzumab|mesh-list
101960896|NCT03728829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101960897|NCT03728829|Tubulin Modulators|tubulin modulators|mesh-ancestor
101960898|NCT03728829|Antimitotic Agents|antimitotic agents|mesh-ancestor
101960899|NCT03728829|Mitosis Modulators|mitosis modulators|mesh-ancestor
101960900|NCT03728829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960901|NCT03728829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101960902|NCT00121667|Metformin|metformin|mesh-list
101960903|NCT00121667|Pioglitazone|pioglitazone|mesh-list
101960904|NCT00121667|Saxagliptin|saxagliptin|mesh-list
101960905|NCT00121667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101960906|NCT00121667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960907|NCT00121667|Incretins|incretins|mesh-ancestor
101960908|NCT00121667|Hormones|hormones|mesh-ancestor
101960909|NCT00121667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101960910|NCT00121667|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101960911|NCT00121667|Protease Inhibitors|protease inhibitors|mesh-ancestor
101960912|NCT00121667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101960913|NCT00121667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960914|NCT02954601|Insulin|insulin|mesh-list
101960915|NCT02954601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101960916|NCT02954601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101960917|NCT02954601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960918|NCT00121199|Prednisone|prednisone|mesh-list
101960919|NCT00121199|Cyclophosphamide|cyclophosphamide|mesh-list
101960920|NCT00121199|Bevacizumab|bevacizumab|mesh-list
101960921|NCT00121199|Rituximab|rituximab|mesh-list
101960922|NCT00121199|Doxorubicin|doxorubicin|mesh-list
101960923|NCT00121199|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101960924|NCT00121199|Vincristine|vincristine|mesh-list
101960925|NCT00121199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101960926|NCT00121199|Antibodies|antibodies|mesh-list
101960927|NCT00121199|Immunoglobulins|immunoglobulins|mesh-list
101680761|NCT00649233|Metoprolol|metoprolol|mesh-list
101960928|NCT00121199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101691771|NCT02809937|Analgesics|analgesics|mesh-ancestor
101960929|NCT00121199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101960930|NCT00121199|Immunologic Factors|immunologic factors|mesh-ancestor
101960931|NCT00121199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960932|NCT00121199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101960933|NCT00121199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101960934|NCT00121199|Alkylating Agents|alkylating agents|mesh-ancestor
101960935|NCT00121199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960937|NCT00121199|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101960938|NCT00121199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101960939|NCT00121199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101960940|NCT00121199|Growth Substances|growth substances|mesh-ancestor
101960941|NCT00121199|Growth Inhibitors|growth inhibitors|mesh-ancestor
101960942|NCT00121199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101960943|NCT00121199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101960944|NCT00121199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101960945|NCT00121199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101960946|NCT00121199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101960947|NCT00121199|Glucocorticoids|glucocorticoids|mesh-ancestor
101960948|NCT00121199|Hormones|hormones|mesh-ancestor
101737348|NCT05520177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389715|NCT05768139|Fulvestrant|fulvestrant|mesh-list
101960949|NCT00121199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101960950|NCT00121199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101960951|NCT00121199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101960952|NCT00121199|Tubulin Modulators|tubulin modulators|mesh-ancestor
101960953|NCT00121199|Antimitotic Agents|antimitotic agents|mesh-ancestor
101960954|NCT00121199|Mitosis Modulators|mitosis modulators|mesh-ancestor
101960955|NCT01079897|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
101960956|NCT01079897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101960957|NCT00119015|Fluticasone|fluticasone|mesh-list
101960958|NCT00119015|Xhance|xhance|mesh-list
101960959|NCT00119015|Montelukast|montelukast|mesh-list
101960960|NCT00119015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101960961|NCT00119015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101960962|NCT00119015|Autonomic Agents|autonomic agents|mesh-ancestor
101960963|NCT00119015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101960964|NCT00119015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960965|NCT00119015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101960966|NCT00119015|Respiratory System Agents|respiratory system agents|mesh-ancestor
101960967|NCT00119015|Dermatologic Agents|dermatologic agents|mesh-ancestor
101960968|NCT00119015|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101960969|NCT00119015|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101960970|NCT00119015|Hormone Antagonists|hormone antagonists|mesh-ancestor
101960971|NCT00119015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101960972|NCT00119015|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101960973|NCT00119015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101960974|NCT00119015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960975|NCT03557307|Benralizumab|benralizumab|mesh-list
101960976|NCT03557307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101960977|NCT03557307|Respiratory System Agents|respiratory system agents|mesh-ancestor
101960978|NCT01079351|Carbamazepine|carbamazepine|mesh-list
101960979|NCT01079351|Anticonvulsants|anticonvulsants|mesh-ancestor
101960980|NCT01079351|Antimanic Agents|antimanic agents|mesh-ancestor
101960981|NCT01079351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101960982|NCT01079351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101960983|NCT01079351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960984|NCT01079351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101960985|NCT01079351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101960986|NCT01079351|Analgesics|analgesics|mesh-ancestor
101960987|NCT01079351|Sensory System Agents|sensory system agents|mesh-ancestor
101960988|NCT01079351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101960989|NCT01079351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101960990|NCT01079351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101960991|NCT01079351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960992|NCT01079351|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101960993|NCT01079351|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101960994|NCT00104104|Zoledronic Acid|zoledronic acid|mesh-list
101960995|NCT00104104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101960996|NCT00104104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101960997|NCT02158624|Ranibizumab|ranibizumab|mesh-list
101960998|NCT02158624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101960999|NCT02158624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101961000|NCT02158624|Growth Substances|growth substances|mesh-ancestor
101253586|NCT01499082|Insulin|insulin|mesh-list
101961001|NCT02158624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961002|NCT02158624|Growth Inhibitors|growth inhibitors|mesh-ancestor
101961003|NCT02158624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101961004|NCT00115739|Imatinib Mesylate|imatinib mesylate|mesh-list
101961005|NCT00115739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101961006|NCT00115739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101961007|NCT00115739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101961008|NCT00115739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961009|NCT03639519|Ascorbic Acid|ascorbic acid|mesh-list
101961010|NCT03639519|Antioxidants|antioxidants|mesh-ancestor
101961011|NCT03639519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961012|NCT03639519|Protective Agents|protective agents|mesh-ancestor
101961013|NCT03639519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961014|NCT03639519|Vitamins|vitamins|mesh-ancestor
101961015|NCT03639519|Micronutrients|micronutrients|mesh-ancestor
101961016|NCT02158702|Dexamethasone|dexamethasone|mesh-list
101961017|NCT02158702|Pomalidomide|pomalidomide|mesh-list
101961018|NCT02158702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101961019|NCT02158702|Antiemetics|antiemetics|mesh-ancestor
101961020|NCT02158702|Autonomic Agents|autonomic agents|mesh-ancestor
101970552|NCT05498675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101970553|NCT05498675|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101970554|NCT05498675|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101961021|NCT02158702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101961022|NCT02158702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961023|NCT02158702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101961024|NCT02158702|Glucocorticoids|glucocorticoids|mesh-ancestor
101961025|NCT02158702|Hormones|hormones|mesh-ancestor
101961026|NCT02158702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101961027|NCT02158702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101961028|NCT02158702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101961029|NCT02158702|Immunologic Factors|immunologic factors|mesh-ancestor
101961030|NCT02158702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101961031|NCT02158702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101961032|NCT02158702|Growth Substances|growth substances|mesh-ancestor
101961033|NCT02158702|Growth Inhibitors|growth inhibitors|mesh-ancestor
101961034|NCT03725709|Anesthetics|anesthetics|mesh-list
101961035|NCT03725709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101961036|NCT03725709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961037|NCT01761890|Dasatinib|dasatinib|mesh-list
101961038|NCT01761890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101961039|NCT01761890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101961040|NCT01761890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101961041|NCT01761890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961042|NCT02160028|Anesthetics|anesthetics|mesh-list
101961043|NCT02160028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101961044|NCT02160028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961045|NCT03246152|Bevacizumab|bevacizumab|mesh-list
101961046|NCT03246152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101961047|NCT03246152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101961048|NCT03246152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101961049|NCT03246152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101961050|NCT03246152|Growth Substances|growth substances|mesh-ancestor
101961051|NCT03246152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961052|NCT03246152|Growth Inhibitors|growth inhibitors|mesh-ancestor
101961053|NCT03541564|Moxifloxacin|moxifloxacin|mesh-list
101961054|NCT03541564|Deucravacitinib|deucravacitinib|mesh-list
101961055|NCT03541564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101961056|NCT03541564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101961057|NCT03541564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101961058|NCT03541564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101961059|NCT03541564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101961060|NCT03541564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961061|NCT03541564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101961062|NCT03541564|Dermatologic Agents|dermatologic agents|mesh-ancestor
101961063|NCT03541564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101961064|NCT00115349|Deferiprone|deferiprone|mesh-list
101253610|NCT01411241|Vaccines|vaccines|mesh-list
101961065|NCT00115349|Deferoxamine|deferoxamine|mesh-list
101961066|NCT00115349|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101961067|NCT00115349|Chelating Agents|chelating agents|mesh-ancestor
101961068|NCT00115349|Sequestering Agents|sequestering agents|mesh-ancestor
101961069|NCT00115349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961070|NCT00115349|Siderophores|siderophores|mesh-ancestor
101961072|NCT04804696|Cisplatin|cisplatin|mesh-list
101961073|NCT04804696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101961074|NCT04804696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101961075|NCT04804696|Tubulin Modulators|tubulin modulators|mesh-ancestor
101961076|NCT04804696|Antimitotic Agents|antimitotic agents|mesh-ancestor
101961077|NCT04804696|Mitosis Modulators|mitosis modulators|mesh-ancestor
101961078|NCT04804696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961079|NCT00115037|Naltrexone|naltrexone|mesh-list
101961080|NCT00115037|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101680866|NCT02462538|Imatinib Mesylate|imatinib mesylate|mesh-list
101961081|NCT00115037|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101961082|NCT00115037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961083|NCT00115037|Sensory System Agents|sensory system agents|mesh-ancestor
101961084|NCT00115037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101961085|NCT02160106|Vactosertib|vactosertib|mesh-list
101961086|NCT02160106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101961087|NCT02160106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970555|NCT05498675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970556|NCT05469204|Acetaminophen|acetaminophen|mesh-list
101970557|NCT05469204|Digoxin|digoxin|mesh-list
101970558|NCT05469204|Midazolam|midazolam|mesh-list
101970559|NCT05469204|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101961088|NCT02160106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961089|NCT02160184|Pancrelipase|pancrelipase|mesh-list
101961090|NCT02160184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101961091|NCT03725553|Vasopressins|vasopressins|mesh-list
101961092|NCT03725553|Arginine Vasopressin|arginine vasopressin|mesh-list
101961093|NCT03725553|Hemostatics|hemostatics|mesh-ancestor
101961094|NCT03725553|Coagulants|coagulants|mesh-ancestor
101961095|NCT03725553|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101961096|NCT03725553|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101961097|NCT03725553|Natriuretic Agents|natriuretic agents|mesh-ancestor
101961098|NCT03725553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961099|NCT03213626|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101961100|NCT03213626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101961101|NCT03213626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101961102|NCT03213626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101961103|NCT03213626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961104|NCT03604341|Dronabinol|dronabinol|mesh-list
101961105|NCT03604341|Hallucinogens|hallucinogens|mesh-ancestor
101961106|NCT03604341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961107|NCT03604341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101961108|NCT03604341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101961109|NCT03604341|Analgesics|analgesics|mesh-ancestor
101961110|NCT03604341|Sensory System Agents|sensory system agents|mesh-ancestor
101961111|NCT03604341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101961112|NCT03604341|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101961113|NCT03604341|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101961114|NCT03604341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101961115|NCT03604341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961116|NCT03604341|Hormones|hormones|mesh-ancestor
101961117|NCT03604341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101961119|NCT02160574|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101961120|NCT02160574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101961121|NCT02160574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101961122|NCT02160574|Disinfectants|disinfectants|mesh-ancestor
101961123|NCT02160574|Dermatologic Agents|dermatologic agents|mesh-ancestor
101961124|NCT01186640|Cyclophosphamide|cyclophosphamide|mesh-list
101961125|NCT01186640|Fludarabine|fludarabine|mesh-list
101961126|NCT01186640|Fludarabine phosphate|fludarabine phosphate|mesh-list
101961127|NCT01186640|Mitoxantrone|mitoxantrone|mesh-list
101961128|NCT01186640|Alemtuzumab|alemtuzumab|mesh-list
101961129|NCT01186640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101961130|NCT01186640|Immunologic Factors|immunologic factors|mesh-ancestor
101961131|NCT01186640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961132|NCT01186640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101961133|NCT01186640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101961134|NCT01186640|Alkylating Agents|alkylating agents|mesh-ancestor
101961135|NCT01186640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961136|NCT01186640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101961137|NCT01186640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101961138|NCT01186640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101961139|NCT01186640|Antimetabolites|antimetabolites|mesh-ancestor
101961140|NCT01186640|Analgesics|analgesics|mesh-ancestor
101961141|NCT01186640|Sensory System Agents|sensory system agents|mesh-ancestor
101961142|NCT01186640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101961143|NCT01186640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101961144|NCT01186640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101961145|NCT01186640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101961146|NCT01186640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101961147|NCT04949516|Aspirin|aspirin|mesh-list
101961148|NCT04949516|Colchicine|colchicine|mesh-list
101961149|NCT04949516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101961150|NCT04949516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101961151|NCT04949516|Analgesics|analgesics|mesh-ancestor
101961152|NCT04949516|Sensory System Agents|sensory system agents|mesh-ancestor
101961153|NCT04949516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101961154|NCT04949516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970560|NCT05469204|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101970561|NCT05469204|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101970562|NCT05469204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101970563|NCT05469204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961155|NCT04949516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101961156|NCT04949516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101961157|NCT04949516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101961158|NCT04949516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101961159|NCT04949516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961160|NCT04949516|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101961161|NCT04949516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101961162|NCT04949516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101961163|NCT04949516|Antipyretics|antipyretics|mesh-ancestor
101961164|NCT04949516|Gout Suppressants|gout suppressants|mesh-ancestor
101961165|NCT04949516|Tubulin Modulators|tubulin modulators|mesh-ancestor
101961166|NCT04949516|Antimitotic Agents|antimitotic agents|mesh-ancestor
101961167|NCT04949516|Mitosis Modulators|mitosis modulators|mesh-ancestor
101961168|NCT04949516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101961169|NCT00114959|Imatinib Mesylate|imatinib mesylate|mesh-list
101961170|NCT00114959|Homoharringtonine|homoharringtonine|mesh-list
101253678|NCT01150045|Antidotes|antidotes|mesh-ancestor
101961171|NCT00114959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101961172|NCT00114959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101961173|NCT00114959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101961174|NCT00114959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961175|NCT00114959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101961176|NCT00114959|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101961177|NCT02778100|Phenylephrine|phenylephrine|mesh-list
101961178|NCT02778100|Oxymetazoline|oxymetazoline|mesh-list
101961179|NCT02778100|Glucagon|glucagon|mesh-list
101961180|NCT02778100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101961181|NCT02778100|Hormones|hormones|mesh-ancestor
101961182|NCT02778100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101961183|NCT02778100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961184|NCT02778100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101961185|NCT02778100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101961186|NCT02778100|Adrenergic Agents|adrenergic agents|mesh-ancestor
101961187|NCT02778100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101961188|NCT02778100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961189|NCT02778100|Sympathomimetics|sympathomimetics|mesh-ancestor
101961190|NCT02778100|Autonomic Agents|autonomic agents|mesh-ancestor
101961191|NCT02778100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101961192|NCT02778100|Nasal Decongestants|nasal decongestants|mesh-ancestor
101961193|NCT02778100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101961194|NCT02778100|Respiratory System Agents|respiratory system agents|mesh-ancestor
101961195|NCT02778100|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101961196|NCT02778100|Mydriatics|mydriatics|mesh-ancestor
101961197|NCT02778100|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101961198|NCT02778100|Protective Agents|protective agents|mesh-ancestor
101961199|NCT02159248|Tolfenamic acid|tolfenamic acid|mesh-list
101961200|NCT02159248|Gemcitabine|gemcitabine|mesh-list
101961201|NCT02159248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101961202|NCT02159248|Antimetabolites|antimetabolites|mesh-ancestor
101961203|NCT02159248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961204|NCT02159248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101961205|NCT02159248|Analgesics|analgesics|mesh-ancestor
101961206|NCT02159248|Sensory System Agents|sensory system agents|mesh-ancestor
101961207|NCT02159248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101961208|NCT02159248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961209|NCT02159248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101961210|NCT02159248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101961211|NCT02159248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101961212|NCT02159248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101961213|NCT02159248|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101961214|NCT02159248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101961215|NCT02159248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101961216|NCT02159248|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
101961217|NCT02159248|Hormone Antagonists|hormone antagonists|mesh-ancestor
101961218|NCT02159248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101970564|NCT05469204|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101970565|NCT05469204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101970566|NCT05469204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101970567|NCT05469204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101970568|NCT05469204|Anesthetics, General|anesthetics, general|mesh-ancestor
101961219|NCT02159248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101961220|NCT02159248|Serotonin Agents|serotonin agents|mesh-ancestor
101961221|NCT02159248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101961223|NCT00118157|Lapatinib|lapatinib|mesh-list
101961224|NCT00118157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961225|NCT00118157|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101961226|NCT00118157|Hormone Antagonists|hormone antagonists|mesh-ancestor
101961227|NCT00118157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101961228|NCT00118157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961229|NCT00118157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101961230|NCT00118157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101681011|NCT00649779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101961231|NCT00118157|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101961232|NCT00118157|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101961233|NCT00118157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101961234|NCT00118157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101961236|NCT03543202|Anesthetics|anesthetics|mesh-list
101961237|NCT03543202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101961238|NCT03543202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961239|NCT03552549|Interferons|interferons|mesh-list
101961240|NCT03552549|Interferon-alpha|interferon-alpha|mesh-list
101961241|NCT03552549|Interferon alpha-2|interferon alpha-2|mesh-list
101961242|NCT03552549|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101961243|NCT03552549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101961244|NCT03552549|Antiviral Agents|antiviral agents|mesh-ancestor
101961245|NCT03552549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101961246|NCT03552549|Immunologic Factors|immunologic factors|mesh-ancestor
101961247|NCT03552549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961248|NCT00117845|Denileukin diftitox|denileukin diftitox|mesh-list
101961249|NCT00117845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101961250|NCT02761642|Epoetin Alfa|epoetin alfa|mesh-list
101961251|NCT02761642|Hematinics|hematinics|mesh-ancestor
101961252|NCT03731403|Fluorides|fluorides|mesh-list
101961253|NCT03731403|Cariostatic Agents|cariostatic agents|mesh-ancestor
101961254|NCT03731403|Protective Agents|protective agents|mesh-ancestor
101961255|NCT03731403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961256|NCT03189524|Zanubrutinib|zanubrutinib|mesh-list
101961257|NCT03189524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101961258|NCT03189524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101253764|NCT00579527|Antiemetics|antiemetics|mesh-ancestor
101961259|NCT03189524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101961260|NCT03189524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961261|NCT03600909|Cyclophosphamide|cyclophosphamide|mesh-list
101961262|NCT03600909|Busulfan|busulfan|mesh-list
101961263|NCT03600909|Fludarabine|fludarabine|mesh-list
101961264|NCT03600909|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101961265|NCT03600909|Thymoglobulin|thymoglobulin|mesh-list
101961266|NCT03600909|Lenograstim|lenograstim|mesh-list
101961267|NCT03600909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101961268|NCT03600909|Immunologic Factors|immunologic factors|mesh-ancestor
101961269|NCT03600909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961270|NCT03600909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101961271|NCT03600909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101253807|NCT01694134|Anesthetics|anesthetics|mesh-ancestor
101961272|NCT03600909|Alkylating Agents|alkylating agents|mesh-ancestor
101961273|NCT03600909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961274|NCT03600909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101961275|NCT03600909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101961276|NCT03600909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101961277|NCT03189446|Paclitaxel|paclitaxel|mesh-list
101961278|NCT03189446|Carboplatin|carboplatin|mesh-list
101961279|NCT03189446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101961280|NCT03189446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101961281|NCT03189446|Tubulin Modulators|tubulin modulators|mesh-ancestor
101961282|NCT03189446|Antimitotic Agents|antimitotic agents|mesh-ancestor
101961283|NCT03189446|Mitosis Modulators|mitosis modulators|mesh-ancestor
101961284|NCT03189446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970569|NCT05469204|Anesthetics|anesthetics|mesh-ancestor
101970570|NCT05469204|GABA Modulators|gaba modulators|mesh-ancestor
101970571|NCT05469204|GABA Agents|gaba agents|mesh-ancestor
101970572|NCT05469204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101961285|NCT03568461|Tisagenlecleucel|tisagenlecleucel|mesh-list
101691845|NCT02812199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101961286|NCT03568461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101961287|NCT03568461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101961288|NCT01314482|Minocycline|minocycline|mesh-list
101961289|NCT01314482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101961290|NCT01314482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101961291|NCT03188120|Tiotropium Bromide|tiotropium bromide|mesh-list
101961292|NCT03188120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101961293|NCT03188120|Autonomic Agents|autonomic agents|mesh-ancestor
101961294|NCT03188120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101961295|NCT03188120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961296|NCT03188120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101961297|NCT03188120|Respiratory System Agents|respiratory system agents|mesh-ancestor
101961298|NCT03188120|Parasympatholytics|parasympatholytics|mesh-ancestor
101961299|NCT03188120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101961300|NCT03188120|Cholinergic Agents|cholinergic agents|mesh-ancestor
101961301|NCT03188120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101961302|NCT03188120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961303|NCT02895945|Factor VIII|factor viii|mesh-list
101961304|NCT02895945|Coagulants|coagulants|mesh-ancestor
101961305|NCT02777554|Thalidomide|thalidomide|mesh-list
101961306|NCT02777554|Apremilast|apremilast|mesh-list
101681106|NCT02759198|Celecoxib|celecoxib|mesh-list
101961307|NCT02777554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101961308|NCT02777554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101961309|NCT02777554|Analgesics|analgesics|mesh-ancestor
101961310|NCT02777554|Sensory System Agents|sensory system agents|mesh-ancestor
101961311|NCT02777554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101961312|NCT02777554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961313|NCT02777554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101961314|NCT02777554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101961315|NCT02777554|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101961316|NCT02777554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101961317|NCT02777554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101961318|NCT02777554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961319|NCT02777554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101961320|NCT02777554|Immunologic Factors|immunologic factors|mesh-ancestor
101961321|NCT02777554|Leprostatic Agents|leprostatic agents|mesh-ancestor
101961322|NCT02777554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101961323|NCT02777554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101961324|NCT02777554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101961325|NCT02777554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101961326|NCT02777554|Growth Substances|growth substances|mesh-ancestor
101961327|NCT02777554|Growth Inhibitors|growth inhibitors|mesh-ancestor
101961328|NCT02777554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101961329|NCT03220178|Letrozole|letrozole|mesh-list
101961330|NCT03220178|Fulvestrant|fulvestrant|mesh-list
101961331|NCT03220178|Palbociclib|palbociclib|mesh-list
101961332|NCT03220178|Anastrozole|anastrozole|mesh-list
101961333|NCT03220178|Exemestane|exemestane|mesh-list
101961334|NCT03220178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101961335|NCT03220178|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101961336|NCT03220178|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101961337|NCT03220178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101961338|NCT03220178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961339|NCT03220178|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101961340|NCT03220178|Hormone Antagonists|hormone antagonists|mesh-ancestor
101961341|NCT03220178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101961342|NCT03220178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961343|NCT03220178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101961344|NCT03220178|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101961345|NCT03220178|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101961346|NCT03032510|Levofloxacin|levofloxacin|mesh-list
101961347|NCT03032510|Ertapenem|ertapenem|mesh-list
101961348|NCT03032510|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101961349|NCT03032510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101961350|NCT03032510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101961351|NCT03032510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101961352|NCT03032510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101970573|NCT05469204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970574|NCT05469204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101970575|NCT05469204|Analgesics|analgesics|mesh-ancestor
101970576|NCT05469204|Sensory System Agents|sensory system agents|mesh-ancestor
101305444|NCT02019459|Autonomic Agents|autonomic agents|mesh-ancestor
101961353|NCT03032510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101961354|NCT03032510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961355|NCT03032510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101961356|NCT03032510|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101961357|NCT03032510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101961358|NCT03022292|Aflibercept|aflibercept|mesh-list
101961359|NCT03022292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101961360|NCT03022292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101961361|NCT03022292|Growth Substances|growth substances|mesh-ancestor
101961362|NCT03022292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961363|NCT03022292|Growth Inhibitors|growth inhibitors|mesh-ancestor
101961364|NCT03022292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101961365|NCT03599193|Nicotinic Acids|nicotinic acids|mesh-list
101961366|NCT03599193|Tazarotene|tazarotene|mesh-list
101961367|NCT03599193|Dermatologic Agents|dermatologic agents|mesh-ancestor
101961368|NCT03599193|Keratolytic Agents|keratolytic agents|mesh-ancestor
101961369|NCT03599193|Vitamin B Complex|vitamin b complex|mesh-ancestor
101961370|NCT03599193|Vitamins|vitamins|mesh-ancestor
101961371|NCT03599193|Micronutrients|micronutrients|mesh-ancestor
101961372|NCT03599193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961374|NCT02161354|Naloxone|naloxone|mesh-list
101961375|NCT02161354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101961376|NCT02161354|Narcotics|narcotics|mesh-ancestor
101961377|NCT02161354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101961378|NCT02161354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961379|NCT02161354|Analgesics|analgesics|mesh-ancestor
101681162|NCT03373188|Nivolumab|nivolumab|mesh-list
101961380|NCT02161354|Sensory System Agents|sensory system agents|mesh-ancestor
101961381|NCT02161354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101961382|NCT02161354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101961383|NCT03166124|Insulin Lispro|insulin lispro|mesh-list
101961384|NCT03166124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101961385|NCT03166124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961386|NCT02777242|Methyltestosterone|methyltestosterone|mesh-list
101961387|NCT02777242|Testosterone|testosterone|mesh-list
101961388|NCT02777242|Testosterone undecanoate|testosterone undecanoate|mesh-list
101961389|NCT02777242|Testosterone enanthate|testosterone enanthate|mesh-list
101961390|NCT02777242|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101961391|NCT02777242|Androgens|androgens|mesh-ancestor
101961393|NCT02777242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101961394|NCT02777242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961395|NCT02777242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101961396|NCT02777242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101961397|NCT02777242|Anabolic Agents|anabolic agents|mesh-ancestor
101961398|NCT02163070|Vitamins|vitamins|mesh-list
101961399|NCT02163070|Vitamin E|vitamin e|mesh-list
101961400|NCT02163070|Micronutrients|micronutrients|mesh-ancestor
101253989|NCT01695460|Micronutrients|micronutrients|mesh-ancestor
101961401|NCT02163070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961402|NCT02163070|Antioxidants|antioxidants|mesh-ancestor
101961403|NCT02163070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961404|NCT02163070|Protective Agents|protective agents|mesh-ancestor
101961405|NCT03484520|Venetoclax|venetoclax|mesh-list
101961406|NCT03484520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101961407|NCT03566979|Naproxen|naproxen|mesh-list
101961408|NCT03566979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101961409|NCT03566979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101961410|NCT03566979|Analgesics|analgesics|mesh-ancestor
101961411|NCT03566979|Sensory System Agents|sensory system agents|mesh-ancestor
101961412|NCT03566979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101961413|NCT03566979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961414|NCT03566979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101961415|NCT03566979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101961416|NCT03566979|Gout Suppressants|gout suppressants|mesh-ancestor
101961417|NCT03566979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101254037|NCT01696383|Timolol|timolol|mesh-list
101961418|NCT03566979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970577|NCT05469204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101970578|NCT05469204|Antipyretics|antipyretics|mesh-ancestor
101970579|NCT05469204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101970580|NCT05469204|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101970581|NCT05469204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970582|NCT05469204|Protective Agents|protective agents|mesh-ancestor
101970583|NCT05456295|Carbon Fiber|carbon fiber|mesh-list
101970584|NCT05456295|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101305449|NCT02019459|Cholinergic Agents|cholinergic agents|mesh-ancestor
101961419|NCT03566979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961420|NCT00116831|Rosiglitazone|rosiglitazone|mesh-list
101961421|NCT00116831|Glipizide|glipizide|mesh-list
101961422|NCT00116831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101961423|NCT00116831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961424|NCT02784704|Meropenem|meropenem|mesh-list
101961425|NCT02784704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101961426|NCT02784704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101961427|NCT03540472|Tacrolimus|tacrolimus|mesh-list
101961428|NCT03540472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101961429|NCT03540472|Immunologic Factors|immunologic factors|mesh-ancestor
101961430|NCT03540472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961431|NCT03540472|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101961432|NCT03540472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101961433|NCT03540472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961434|NCT02166814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101961435|NCT02166814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101961436|NCT02166814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101961437|NCT02166814|Antimetabolites|antimetabolites|mesh-ancestor
101961438|NCT02166814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961439|NCT02166814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101961440|NCT02166814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101961441|NCT02166814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101961442|NCT01310283|Fluorides|fluorides|mesh-list
101961443|NCT01310283|Fluorides, Topical|fluorides, topical|mesh-list
101961444|NCT01310283|Cariostatic Agents|cariostatic agents|mesh-ancestor
101961445|NCT01310283|Protective Agents|protective agents|mesh-ancestor
101961446|NCT01310283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961447|NCT02161822|Simvastatin|simvastatin|mesh-list
101961448|NCT02161822|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101254097|NCT01696617|Aripiprazole|aripiprazole|mesh-list
101961449|NCT02161822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101961450|NCT02161822|Antimetabolites|antimetabolites|mesh-ancestor
101961451|NCT02161822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961452|NCT02161822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101961453|NCT02161822|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101961454|NCT02161822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101961455|NCT03183908|Vaccines|vaccines|mesh-list
101961456|NCT03183908|Immunologic Factors|immunologic factors|mesh-ancestor
101961457|NCT03183908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961458|NCT03724851|Vactosertib|vactosertib|mesh-list
101961459|NCT03724851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101961460|NCT03724851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101961461|NCT03724851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961462|NCT03565887|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101961463|NCT03565887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101961464|NCT00113399|Paclitaxel|paclitaxel|mesh-list
101961465|NCT00113399|Docetaxel|docetaxel|mesh-list
101961466|NCT00113399|Fluorouracil|fluorouracil|mesh-list
101961467|NCT00113399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101254138|NCT01696825|Antiemetics|antiemetics|mesh-ancestor
101961468|NCT00113399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101961469|NCT00113399|Tubulin Modulators|tubulin modulators|mesh-ancestor
101961470|NCT00113399|Antimitotic Agents|antimitotic agents|mesh-ancestor
101961471|NCT00113399|Mitosis Modulators|mitosis modulators|mesh-ancestor
101961472|NCT00113399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961473|NCT00113399|Antimetabolites|antimetabolites|mesh-ancestor
101961474|NCT00113399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101961475|NCT00113399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101970585|NCT05456295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101970586|NCT05419362|Avelumab|avelumab|mesh-list
101970587|NCT05419362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101970588|NCT05419362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970589|NCT05390528|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101970590|NCT05390528|Immunologic Factors|immunologic factors|mesh-ancestor
101970591|NCT05390528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970592|NCT05384119|Fulvestrant|fulvestrant|mesh-list
101970593|NCT05384119|Palbociclib|palbociclib|mesh-list
101970594|NCT05384119|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101970595|NCT05384119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101970596|NCT05384119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970597|NCT05384119|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101970598|NCT05384119|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101970599|NCT05384119|Hormone Antagonists|hormone antagonists|mesh-ancestor
101970600|NCT05384119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101970601|NCT05384119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970602|NCT05384119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101970603|NCT05384119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970604|NCT05384119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970605|NCT05384119|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101970606|NCT05376579|Siponimod|siponimod|mesh-list
101970607|NCT05376579|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101970608|NCT05376579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970609|NCT05376579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101970610|NCT05376579|Immunologic Factors|immunologic factors|mesh-ancestor
101970611|NCT05376579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970612|NCT05374057|Ibuprofen|ibuprofen|mesh-list
101970613|NCT05374057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101970614|NCT05374057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101970615|NCT05374057|Analgesics|analgesics|mesh-ancestor
101970616|NCT05374057|Sensory System Agents|sensory system agents|mesh-ancestor
101970623|NCT05374057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970624|NCT05371093|Prednisone|prednisone|mesh-list
101970625|NCT05371093|Cyclophosphamide|cyclophosphamide|mesh-list
101970626|NCT05371093|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101961476|NCT00113399|Immunologic Factors|immunologic factors|mesh-ancestor
101961477|NCT00113399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961478|NCT01326611|Clarithromycin|clarithromycin|mesh-list
101961479|NCT01326611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101961480|NCT01326611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101691883|NCT05569421|Budesonide|budesonide|mesh-list
101961481|NCT01326611|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101961482|NCT01326611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101961483|NCT01326611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961484|NCT01326611|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101961485|NCT01326611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101961486|NCT00113087|Enalapril|enalapril|mesh-list
101961487|NCT00113087|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101961488|NCT00113087|Protease Inhibitors|protease inhibitors|mesh-ancestor
101961489|NCT00113087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101961490|NCT00113087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961491|NCT00113087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101961492|NCT00112463|Romidepsin|romidepsin|mesh-list
101961493|NCT00112463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101961494|NCT00112463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101961495|NCT00112463|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101961496|NCT00112463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101961497|NCT00112463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961498|NCT01083017|Chlorthalidone|chlorthalidone|mesh-list
101961499|NCT01083017|Antihypertensive Agents|antihypertensive agents|mesh-list
101961500|NCT01083017|Diuretics|diuretics|mesh-ancestor
101961501|NCT01083017|Natriuretic Agents|natriuretic agents|mesh-ancestor
101961502|NCT01083017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961503|NCT01083017|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101961504|NCT01083017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101961505|NCT01083017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961506|NCT00112385|Etanercept|etanercept|mesh-list
101961507|NCT00112385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101961508|NCT00112385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101961509|NCT00112385|Analgesics|analgesics|mesh-ancestor
101961510|NCT00112385|Sensory System Agents|sensory system agents|mesh-ancestor
101961511|NCT00112385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101254197|NCT01697098|Hormones|hormones|mesh-ancestor
101961512|NCT00112385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961513|NCT00112385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101961514|NCT00112385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101961515|NCT00112385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101961516|NCT00112385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101961517|NCT00112385|Immunologic Factors|immunologic factors|mesh-ancestor
101961518|NCT03731169|Voriconazole|voriconazole|mesh-list
101961519|NCT03731169|Antifungal Agents|antifungal agents|mesh-ancestor
101961520|NCT03731169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101961521|NCT03731169|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101961522|NCT03731169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101961523|NCT03731169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101961524|NCT03731169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961525|NCT03731169|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101961526|NCT03731169|Hormone Antagonists|hormone antagonists|mesh-ancestor
101961527|NCT03731169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101961528|NCT03731169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961529|NCT03731169|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101961530|NCT03731091|Calcitriol|calcitriol|mesh-list
101961532|NCT03731091|Betamethasone Valerate|betamethasone valerate|mesh-list
101961533|NCT03731091|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101961534|NCT03731091|Betamethasone benzoate|betamethasone benzoate|mesh-list
101961535|NCT03731091|Calcipotriene|calcipotriene|mesh-list
101961536|NCT03731091|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101961537|NCT03731091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101961538|NCT03731091|Glucocorticoids|glucocorticoids|mesh-ancestor
101961539|NCT03731091|Hormones|hormones|mesh-ancestor
101961540|NCT03731091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101970627|NCT05371093|Rituximab|rituximab|mesh-list
101970628|NCT05371093|Doxorubicin|doxorubicin|mesh-list
101970629|NCT05371093|Fludarabine|fludarabine|mesh-list
101970630|NCT05371093|Vincristine|vincristine|mesh-list
101970631|NCT05371093|Lenalidomide|lenalidomide|mesh-list
101970632|NCT05371093|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
101961541|NCT03731091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961542|NCT03731091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101961543|NCT03731091|Respiratory System Agents|respiratory system agents|mesh-ancestor
101961544|NCT03731091|Dermatologic Agents|dermatologic agents|mesh-ancestor
101961545|NCT03731091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101961546|NCT03731091|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101961547|NCT03731091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101961548|NCT03731091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961549|NCT03731091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101961550|NCT03731091|Vitamins|vitamins|mesh-ancestor
101961551|NCT03731091|Micronutrients|micronutrients|mesh-ancestor
101961552|NCT03731091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101961553|NCT03547167|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101961554|NCT03547167|Immunologic Factors|immunologic factors|mesh-ancestor
101961555|NCT03547167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961557|NCT03560739|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101961558|NCT03560739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101961559|NCT03560739|Immunologic Factors|immunologic factors|mesh-ancestor
101961560|NCT03560739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961561|NCT01310673|Allopurinol|allopurinol|mesh-list
101961562|NCT01310673|Antimetabolites|antimetabolites|mesh-ancestor
101961563|NCT01310673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961564|NCT01310673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101961565|NCT01310673|Gout Suppressants|gout suppressants|mesh-ancestor
101961566|NCT01310673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101961567|NCT01310673|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101961568|NCT01310673|Antioxidants|antioxidants|mesh-ancestor
101961569|NCT01310673|Protective Agents|protective agents|mesh-ancestor
101961570|NCT01310673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961571|NCT00101686|Bevacizumab|bevacizumab|mesh-list
101961572|NCT00101686|Capecitabine|capecitabine|mesh-list
101961573|NCT00101686|Irinotecan|irinotecan|mesh-list
101961574|NCT00101686|Fluorouracil|fluorouracil|mesh-list
101961575|NCT00101686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101961576|NCT00101686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101961577|NCT00101686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101961578|NCT00101686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101961579|NCT00101686|Growth Substances|growth substances|mesh-ancestor
101961580|NCT00101686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961581|NCT00101686|Growth Inhibitors|growth inhibitors|mesh-ancestor
101961582|NCT00101686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101961583|NCT00101686|Antimetabolites|antimetabolites|mesh-ancestor
101961584|NCT00101686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961585|NCT00101686|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101961586|NCT00101686|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101254255|NCT01697410|Terlipressin|terlipressin|mesh-list
101961587|NCT00101686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101961588|NCT00101686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101961589|NCT00101686|Immunologic Factors|immunologic factors|mesh-ancestor
101961590|NCT02163616|Misoprostol|misoprostol|mesh-list
101961591|NCT02163616|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101961592|NCT02163616|Abortifacient Agents|abortifacient agents|mesh-ancestor
101961593|NCT02163616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101961594|NCT02163616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961595|NCT02163616|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101691911|NCT02808533|Topiramate|topiramate|mesh-list
101961596|NCT02163616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101961597|NCT02163616|Oxytocics|oxytocics|mesh-ancestor
101961598|NCT00101452|Escitalopram|escitalopram|mesh-list
101961599|NCT00101452|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101961600|NCT00101452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101961601|NCT00101452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101961602|NCT00101452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961603|NCT00101452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101961604|NCT00101452|Serotonin Agents|serotonin agents|mesh-ancestor
101737349|NCT05520177|Growth Inhibitors|growth inhibitors|mesh-ancestor
101970634|NCT05371093|Immunologic Factors|immunologic factors|mesh-ancestor
101970635|NCT05371093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970636|NCT05371093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101970637|NCT05371093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101970638|NCT05371093|Alkylating Agents|alkylating agents|mesh-ancestor
101970639|NCT05371093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970640|NCT05371093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970641|NCT05371093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101970642|NCT05371093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101305466|NCT02019524|Folic Acid|folic acid|mesh-list
101961605|NCT00101452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961606|NCT02162134|Cefuroxime|cefuroxime|mesh-list
101961607|NCT02162134|Cefuroxime axetil|cefuroxime axetil|mesh-list
101961608|NCT02162134|Ketorolac|ketorolac|mesh-list
101961609|NCT02162134|Midazolam|midazolam|mesh-list
101961610|NCT02162134|Propofol|propofol|mesh-list
101961611|NCT02162134|Sevoflurane|sevoflurane|mesh-list
101961612|NCT02162134|Atracurium|atracurium|mesh-list
101961613|NCT02162134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101961614|NCT02162134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101961615|NCT02162134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961616|NCT02162134|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101961617|NCT02162134|Anesthetics, General|anesthetics, general|mesh-ancestor
101961618|NCT02162134|Anesthetics|anesthetics|mesh-ancestor
101961619|NCT02162134|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101961620|NCT02162134|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101961621|NCT02162134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101961622|NCT02162134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101961623|NCT02162134|GABA Modulators|gaba modulators|mesh-ancestor
101961624|NCT02162134|GABA Agents|gaba agents|mesh-ancestor
101961625|NCT02162134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101961626|NCT02162134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961627|NCT02162134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101961628|NCT02162134|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101961629|NCT02162134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101961630|NCT02162134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101961631|NCT02162134|Analgesics|analgesics|mesh-ancestor
101961632|NCT02162134|Sensory System Agents|sensory system agents|mesh-ancestor
101961633|NCT02162134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101961634|NCT02162134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101961635|NCT02162134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101961636|NCT02162134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101961637|NCT02162134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101961638|NCT02162134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101961639|NCT02162134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101961640|NCT02162134|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101961641|NCT02162134|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101961642|NCT02162134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101961643|NCT02162134|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101961644|NCT02162134|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101961645|NCT02162134|Cholinergic Agents|cholinergic agents|mesh-ancestor
101961646|NCT02164006|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101961647|NCT02164006|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101961648|NCT02164006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101961649|NCT02164006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101961650|NCT02164006|Immunotoxins|immunotoxins|mesh-ancestor
101961651|NCT02164006|Immunoconjugates|immunoconjugates|mesh-ancestor
101961652|NCT02164006|Immunologic Factors|immunologic factors|mesh-ancestor
101961653|NCT02164006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961654|NCT02167360|Tisagenlecleucel|tisagenlecleucel|mesh-list
101961655|NCT02167360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101961656|NCT02167360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101961657|NCT03546621|Tenofovir|tenofovir|mesh-list
101970643|NCT05371093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101970644|NCT05371093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101970645|NCT05371093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101961658|NCT03546621|Antiviral Agents|antiviral agents|mesh-ancestor
101961659|NCT03546621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101961660|NCT03546621|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101961661|NCT03546621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101961662|NCT03546621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101961663|NCT03546621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961664|NCT03546621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101961665|NCT03546621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101961666|NCT02761330|Ketamine|ketamine|mesh-list
101961667|NCT02761330|Analgesics|analgesics|mesh-ancestor
101961668|NCT02761330|Sensory System Agents|sensory system agents|mesh-ancestor
101961669|NCT02761330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101961670|NCT02761330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961671|NCT02761330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101961672|NCT02761330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101961673|NCT02761330|Anesthetics, General|anesthetics, general|mesh-ancestor
101961674|NCT02761330|Anesthetics|anesthetics|mesh-ancestor
101961675|NCT02761330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101961676|NCT02761330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101961677|NCT02761330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101961678|NCT02761330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101961679|NCT02761330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961680|NCT03730857|Olanzapine|olanzapine|mesh-list
101961681|NCT03730857|Risperidone|risperidone|mesh-list
101961682|NCT03730857|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101961683|NCT03730857|Antipsychotic Agents|antipsychotic agents|mesh-list
101961684|NCT03730857|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101961685|NCT03730857|Serotonin Agents|serotonin agents|mesh-ancestor
101961686|NCT03730857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101961687|NCT03730857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961688|NCT03730857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961689|NCT03730857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101961690|NCT03730857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101961691|NCT03730857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101961692|NCT03730857|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101961693|NCT03730857|Dopamine Agents|dopamine agents|mesh-ancestor
101961694|NCT03730857|Antiemetics|antiemetics|mesh-ancestor
101961695|NCT03730857|Autonomic Agents|autonomic agents|mesh-ancestor
101961696|NCT03730857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101961697|NCT03730857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101961698|NCT03730857|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101961699|NCT03730857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101961700|NCT03730857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101961701|NCT03730857|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101961702|NCT03730857|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101961704|NCT03726177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101961705|NCT03726177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101691932|NCT02807909|Diltiazem|diltiazem|mesh-list
101961706|NCT03726177|Analgesics|analgesics|mesh-ancestor
101961707|NCT03726177|Sensory System Agents|sensory system agents|mesh-ancestor
101961708|NCT03726177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101961709|NCT03726177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961710|NCT03726177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101961711|NCT03726177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101961712|NCT03726177|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101961713|NCT03726177|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101254503|NCT01699347|Picibanil|picibanil|mesh-list
101961714|NCT03726177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961715|NCT03726177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101961716|NCT03726177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101961717|NCT03726177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101961718|NCT03726177|Antipyretics|antipyretics|mesh-ancestor
101961719|NCT03726099|Amoxicillin|amoxicillin|mesh-list
101961720|NCT03726099|Tetracycline|tetracycline|mesh-list
101961721|NCT03726099|Furazolidone|furazolidone|mesh-list
101961722|NCT03726099|Esomeprazole|esomeprazole|mesh-list
101961723|NCT03726099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101970646|NCT05371093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970647|NCT05371093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101970648|NCT05371093|Glucocorticoids|glucocorticoids|mesh-ancestor
101970649|NCT05371093|Hormones|hormones|mesh-ancestor
101970650|NCT05371093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101970651|NCT05371093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101970652|NCT05371093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101970653|NCT05371093|Tubulin Modulators|tubulin modulators|mesh-ancestor
101970654|NCT05371093|Antimitotic Agents|antimitotic agents|mesh-ancestor
101970655|NCT05371093|Mitosis Modulators|mitosis modulators|mesh-ancestor
101970656|NCT05371093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101970657|NCT05371093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101970658|NCT05371093|Growth Substances|growth substances|mesh-ancestor
101970659|NCT05371093|Growth Inhibitors|growth inhibitors|mesh-ancestor
101970660|NCT05364424|Rituximab|rituximab|mesh-list
101970661|NCT05364424|Obinutuzumab|obinutuzumab|mesh-list
101690438|NCT00599196|Rotigotine|rotigotine|mesh-list
101970662|NCT05364424|Carboplatin|carboplatin|mesh-list
101970663|NCT05364424|Etoposide|etoposide|mesh-list
101970664|NCT05364424|Ifosfamide|ifosfamide|mesh-list
101970665|NCT05364424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101177849|NCT05530278|Midazolam|midazolam|mesh-list
101961724|NCT03726099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101961725|NCT03726099|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101961726|NCT03726099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101961727|NCT03726099|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101961728|NCT03726099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101961729|NCT03726099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961730|NCT03726099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101961731|NCT03726099|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101961732|NCT03726099|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101961733|NCT03726099|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
101961734|NCT03726099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101961735|NCT03726099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101961736|NCT03726099|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101961737|NCT03723759|Insulin Aspart|insulin aspart|mesh-list
101961738|NCT03723759|Insulin, Long-Acting|insulin, long-acting|mesh-list
101961739|NCT03723759|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101961740|NCT03723759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101961741|NCT03723759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961742|NCT03558555|Acetaminophen|acetaminophen|mesh-list
101961743|NCT03558555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101961744|NCT03558555|Analgesics|analgesics|mesh-ancestor
101961745|NCT03558555|Sensory System Agents|sensory system agents|mesh-ancestor
101961746|NCT03558555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101961747|NCT03558555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961748|NCT03558555|Antipyretics|antipyretics|mesh-ancestor
101961749|NCT03726021|Oxaliplatin|oxaliplatin|mesh-list
101961751|NCT03726021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101961752|NCT03726021|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101961753|NCT03726021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101961754|NCT03726021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101961755|NCT03726021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961756|NCT05665023|Bevacizumab|bevacizumab|mesh-list
101961757|NCT05665023|Folfirinox|folfirinox|mesh-list
101970666|NCT05364424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970667|NCT05364424|Immunologic Factors|immunologic factors|mesh-ancestor
101970668|NCT05364424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961758|NCT05665023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101961759|NCT05665023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101961760|NCT05665023|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101961761|NCT05665023|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101961762|NCT05665023|Growth Substances|growth substances|mesh-ancestor
101961763|NCT05665023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961764|NCT05665023|Growth Inhibitors|growth inhibitors|mesh-ancestor
101961765|NCT03557931|Olanzapine|olanzapine|mesh-list
101961766|NCT03557931|Risperidone|risperidone|mesh-list
101961767|NCT03557931|Aripiprazole|aripiprazole|mesh-list
101961768|NCT03557931|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101961769|NCT03557931|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101961770|NCT03557931|Ziprasidone|ziprasidone|mesh-list
101961771|NCT03557931|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
101961772|NCT03557931|Brexpiprazole|brexpiprazole|mesh-list
101961773|NCT03557931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101961774|NCT03557931|Serotonin Agents|serotonin agents|mesh-ancestor
101961775|NCT03557931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101961776|NCT03557931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961777|NCT03557931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961778|NCT03557931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101961779|NCT03557931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101961780|NCT03557931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101961781|NCT03557931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101961782|NCT03557931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101961784|NCT03557931|Antiemetics|antiemetics|mesh-ancestor
101961785|NCT03557931|Autonomic Agents|autonomic agents|mesh-ancestor
101961786|NCT03557931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101961787|NCT03557931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101961788|NCT03557931|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101961789|NCT03557931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101961790|NCT03557931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101961791|NCT03557931|Antidepressive Agents|antidepressive agents|mesh-ancestor
101961792|NCT03557931|Dopamine Agonists|dopamine agonists|mesh-ancestor
101961793|NCT03557931|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101961794|NCT03557931|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101961795|NCT03557931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101961796|NCT03557931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101961797|NCT03557931|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101961798|NCT03557931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101961799|NCT03557931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101961800|NCT03557931|Adrenergic Agents|adrenergic agents|mesh-ancestor
101961801|NCT03977675|Ketamine|ketamine|mesh-list
101961802|NCT03977675|Analgesics|analgesics|mesh-ancestor
101961803|NCT03977675|Sensory System Agents|sensory system agents|mesh-ancestor
101961804|NCT03977675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101961805|NCT03977675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961806|NCT03977675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101961807|NCT03977675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101961808|NCT03977675|Anesthetics, General|anesthetics, general|mesh-ancestor
101961809|NCT03977675|Anesthetics|anesthetics|mesh-ancestor
101961810|NCT03977675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101961811|NCT03977675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101961812|NCT03977675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101961813|NCT03977675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101961814|NCT03977675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961815|NCT01066559|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
101961816|NCT01066559|Vasodilator Agents|vasodilator agents|mesh-ancestor
101961817|NCT01066559|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101254773|NCT01700790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101961818|NCT01066559|Protective Agents|protective agents|mesh-ancestor
101961819|NCT01066559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961821|NCT00293813|Alendronate|alendronate|mesh-list
101961822|NCT00293813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101961823|NCT00293813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961824|NCT00293579|Pemetrexed|pemetrexed|mesh-list
101961825|NCT00293579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101961826|NCT00293579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970669|NCT05364424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101970670|NCT05364424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101970671|NCT05364424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101970672|NCT05364424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101961827|NCT00293579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961828|NCT00293579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101961829|NCT00293579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101961830|NCT00293423|polysaccharide-K|polysaccharide-k|mesh-list
101961831|NCT00293423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101961832|NCT00293423|Immunologic Factors|immunologic factors|mesh-ancestor
101961833|NCT00293423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961834|NCT00293423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101961835|NCT00293423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101961836|NCT00293423|Antiviral Agents|antiviral agents|mesh-ancestor
101961837|NCT00293423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101961838|NCT00293423|Interferon Inducers|interferon inducers|mesh-ancestor
101961839|NCT00293423|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101961840|NCT00293423|Protective Agents|protective agents|mesh-ancestor
101961842|NCT03521817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101961843|NCT03521817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101961844|NCT03521817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101961845|NCT03521817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961846|NCT03538431|Buspirone|buspirone|mesh-list
101961847|NCT03538431|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101961848|NCT03538431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101961849|NCT03538431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101961850|NCT03538431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961851|NCT03538431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101961852|NCT03538431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101961853|NCT03538431|Serotonin Agents|serotonin agents|mesh-ancestor
101961854|NCT03538431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101961855|NCT03538431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961856|NCT03521193|Aspirin|aspirin|mesh-list
101961857|NCT03521193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101961858|NCT03521193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101961859|NCT03521193|Analgesics|analgesics|mesh-ancestor
101961860|NCT03521193|Sensory System Agents|sensory system agents|mesh-ancestor
101961861|NCT03521193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101961862|NCT03521193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961863|NCT03521193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101961864|NCT03521193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101961865|NCT03521193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101961866|NCT03521193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101961867|NCT03521193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961868|NCT03521193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101961869|NCT03521193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101961870|NCT03521193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101961871|NCT03521193|Antipyretics|antipyretics|mesh-ancestor
101961872|NCT00293267|Raltegravir Potassium|raltegravir potassium|mesh-list
101961873|NCT00293267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101961874|NCT00293267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101961875|NCT00293267|Antiviral Agents|antiviral agents|mesh-ancestor
101961876|NCT00293267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101961877|NCT00293267|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101961878|NCT00293267|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101961879|NCT00293267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101961880|NCT00293267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961881|NCT03977441|Pramipexole|pramipexole|mesh-list
101961882|NCT03977441|Agomelatine|agomelatine|mesh-list
101961883|NCT03977441|Antioxidants|antioxidants|mesh-ancestor
101961884|NCT03977441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961885|NCT03977441|Protective Agents|protective agents|mesh-ancestor
101961886|NCT03977441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961887|NCT03977441|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101961888|NCT03977441|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101961889|NCT03977441|Dopamine Agonists|dopamine agonists|mesh-ancestor
101961890|NCT03977441|Dopamine Agents|dopamine agents|mesh-ancestor
101961891|NCT03977441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101961892|NCT03977441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101970673|NCT05364424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970674|NCT05364424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970675|NCT05364424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101970676|NCT05364424|Alkylating Agents|alkylating agents|mesh-ancestor
101970677|NCT05352672|Pembrolizumab|pembrolizumab|mesh-list
101970678|NCT05352672|Cemiplimab|cemiplimab|mesh-list
101305492|NCT02019810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101961893|NCT03977441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101961894|NCT03536949|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101961895|NCT03536949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101961896|NCT01080443|Mycophenolic Acid|mycophenolic acid|mesh-list
101961897|NCT01080443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101961898|NCT01080443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101961899|NCT01080443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101961900|NCT01080443|Antitubercular Agents|antitubercular agents|mesh-ancestor
101961901|NCT01080443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101961902|NCT01080443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101961903|NCT01080443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101961904|NCT01080443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961906|NCT00111917|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101961907|NCT00111917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101961908|NCT00111917|Dermatologic Agents|dermatologic agents|mesh-ancestor
101961909|NCT00111917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101961910|NCT00111917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101961912|NCT01067417|Antimalarials|antimalarials|mesh-ancestor
101961913|NCT01067417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101961914|NCT01067417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101961915|NCT01067417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101961916|NCT01067417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101961917|NCT01067417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961918|NCT01067417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101961920|NCT03520569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101961921|NCT03520569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101961922|NCT03520569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101961923|NCT00111839|Pemetrexed|pemetrexed|mesh-list
101254965|NCT01701882|Tenofovir|tenofovir|mesh-list
101961924|NCT00111839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101961925|NCT00111839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101961926|NCT00111839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961927|NCT00111839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101961928|NCT00111839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101961929|NCT03723291|Tocopherols|tocopherols|mesh-list
101961931|NCT03723291|Tocotrienols|tocotrienols|mesh-list
101961932|NCT03723291|alpha-Tocopherol|alpha-tocopherol|mesh-list
101961933|NCT03723291|Pentoxifylline|pentoxifylline|mesh-list
101961934|NCT03723291|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101961935|NCT03723291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101961936|NCT03723291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961937|NCT03723291|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101961938|NCT03723291|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101961939|NCT03723291|Protective Agents|protective agents|mesh-ancestor
101961940|NCT03723291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961941|NCT03723291|Vasodilator Agents|vasodilator agents|mesh-ancestor
101961942|NCT03723291|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101961943|NCT03723291|Antioxidants|antioxidants|mesh-ancestor
101961944|NCT03723291|Vitamins|vitamins|mesh-ancestor
101961945|NCT03723291|Micronutrients|micronutrients|mesh-ancestor
101961946|NCT00111761|Leucovorin|leucovorin|mesh-list
101961947|NCT00111761|Fluorouracil|fluorouracil|mesh-list
101961948|NCT00111761|Irinotecan|irinotecan|mesh-list
101961949|NCT00111761|Panitumumab|panitumumab|mesh-list
101961950|NCT00111761|Antimetabolites|antimetabolites|mesh-ancestor
101961951|NCT00111761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961952|NCT00111761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101961953|NCT00111761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101961954|NCT00111761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101255022|NCT01702181|Tacrolimus|tacrolimus|mesh-list
101961956|NCT00111761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961957|NCT00111761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101970680|NCT05352672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101178122|NCT01965366|Antiemetics|antiemetics|mesh-ancestor
101961958|NCT00111761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101961959|NCT00111761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101961960|NCT00111761|Antidotes|antidotes|mesh-ancestor
101961961|NCT00111761|Protective Agents|protective agents|mesh-ancestor
101961962|NCT00111761|Vitamin B Complex|vitamin b complex|mesh-ancestor
101961963|NCT00111761|Vitamins|vitamins|mesh-ancestor
101961964|NCT00111761|Micronutrients|micronutrients|mesh-ancestor
101961965|NCT00111761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101961966|NCT03519867|Bromides|bromides|mesh-list
101961967|NCT03519867|Rocuronium|rocuronium|mesh-list
101961968|NCT03519867|Anticonvulsants|anticonvulsants|mesh-ancestor
101961969|NCT03519867|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101961970|NCT03519867|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101961971|NCT03519867|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101961972|NCT03519867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101961973|NCT03519867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961974|NCT03977285|Chlorhexidine|chlorhexidine|mesh-list
101961975|NCT03977285|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101961976|NCT03977285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101961977|NCT03977285|Disinfectants|disinfectants|mesh-ancestor
101961978|NCT03730311|Elsulfavirine|elsulfavirine|mesh-list
101961979|NCT03730311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101961980|NCT03730311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101961981|NCT03730311|Antiviral Agents|antiviral agents|mesh-ancestor
101961982|NCT03730311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101961983|NCT02763046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101961984|NCT02763046|Immunologic Factors|immunologic factors|mesh-ancestor
101961985|NCT02763046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961986|NCT02164552|Vitamin D|vitamin d|mesh-list
101961987|NCT02164552|Ergocalciferols|ergocalciferols|mesh-list
101961988|NCT02164552|Cholecalciferol|cholecalciferol|mesh-list
101961989|NCT02164552|Vitamins|vitamins|mesh-list
101961990|NCT02164552|Micronutrients|micronutrients|mesh-ancestor
101961991|NCT02164552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101961992|NCT02164552|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101961993|NCT02164552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101961994|NCT03723135|Azacitidine|azacitidine|mesh-list
101961995|NCT03723135|Cc-486|cc-486|mesh-list
101961996|NCT03723135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101961997|NCT03723135|Antimetabolites|antimetabolites|mesh-ancestor
101961998|NCT03723135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961999|NCT03723135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101962000|NCT03723135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101962001|NCT02762578|Insulin|insulin|mesh-list
101962002|NCT02762578|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101962003|NCT02762578|Insulin Aspart|insulin aspart|mesh-list
101962004|NCT02762578|Insulin, Long-Acting|insulin, long-acting|mesh-list
101962005|NCT02762578|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101962006|NCT02762578|Biphasic Insulins|biphasic insulins|mesh-list
101962007|NCT02762578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101962008|NCT02762578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962009|NCT03540628|Thiamine|thiamine|mesh-list
101962010|NCT03540628|Vitamins|vitamins|mesh-ancestor
101962011|NCT03540628|Micronutrients|micronutrients|mesh-ancestor
101962012|NCT03540628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962013|NCT03540628|Vitamin B Complex|vitamin b complex|mesh-ancestor
101962014|NCT02170948|Dexmedetomidine|dexmedetomidine|mesh-list
101962015|NCT02170948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101962016|NCT02170948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101962017|NCT02170948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962018|NCT02170948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101962019|NCT02170948|Analgesics|analgesics|mesh-ancestor
101962020|NCT02170948|Sensory System Agents|sensory system agents|mesh-ancestor
101962021|NCT02170948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101962022|NCT02170948|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101962023|NCT02170948|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101962024|NCT02170948|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101962025|NCT02170948|Adrenergic Agents|adrenergic agents|mesh-ancestor
101962026|NCT02170948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101962027|NCT02170948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962028|NCT02171026|Amiodarone|amiodarone|mesh-list
101962029|NCT02171026|Dabigatran|dabigatran|mesh-list
101970681|NCT05352672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101970682|NCT05352672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970683|NCT05352516|Denosumab|denosumab|mesh-list
101970684|NCT05352516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101970685|NCT05352516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970686|NCT05346484|Pembrolizumab|pembrolizumab|mesh-list
101970687|NCT05346484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101970688|NCT05346484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970689|NCT05346484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101970690|NCT05346484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970691|NCT05345613|Epinephrine|epinephrine|mesh-list
101970692|NCT05345613|Tranexamic Acid|tranexamic acid|mesh-list
101970693|NCT05345613|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101970694|NCT05345613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101970695|NCT05345613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970696|NCT05345613|Hemostatics|hemostatics|mesh-ancestor
101962030|NCT02171026|Antithrombins|antithrombins|mesh-ancestor
101962031|NCT02171026|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101962032|NCT02171026|Protease Inhibitors|protease inhibitors|mesh-ancestor
101962033|NCT02171026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101962034|NCT02171026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962035|NCT02171026|Anticoagulants|anticoagulants|mesh-ancestor
101962036|NCT02171026|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101962037|NCT02171026|Vasodilator Agents|vasodilator agents|mesh-ancestor
101962038|NCT02171026|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101962039|NCT02171026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101962040|NCT02171026|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101962041|NCT02171026|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101962042|NCT02171026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101962043|NCT02171026|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101962044|NCT02171026|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101962045|NCT02171026|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101962046|NCT02165020|Hyaluronic Acid|hyaluronic acid|mesh-list
101962047|NCT02165020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101962048|NCT02165020|Immunologic Factors|immunologic factors|mesh-ancestor
101962049|NCT02165020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962050|NCT02165020|Viscosupplements|viscosupplements|mesh-ancestor
101962051|NCT02165020|Protective Agents|protective agents|mesh-ancestor
101962052|NCT03514641|Bexagliflozin|bexagliflozin|mesh-list
101962053|NCT03514641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101962054|NCT03514641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962055|NCT03539224|Lamivudine|lamivudine|mesh-list
101962056|NCT03539224|Dolutegravir|dolutegravir|mesh-list
101962057|NCT03539224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101962058|NCT03539224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101962059|NCT03539224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101962060|NCT03539224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962061|NCT03539224|Antiviral Agents|antiviral agents|mesh-ancestor
101962062|NCT03539224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101962063|NCT03539224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101962064|NCT03539224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101962065|NCT03539224|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101962066|NCT03539224|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101962067|NCT02171182|Capsaicin|capsaicin|mesh-list
101962068|NCT02171182|Antipruritics|antipruritics|mesh-ancestor
101962069|NCT02171182|Dermatologic Agents|dermatologic agents|mesh-ancestor
101970698|NCT05345613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101970699|NCT05345613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101970700|NCT05345613|Adrenergic Agents|adrenergic agents|mesh-ancestor
101970701|NCT05345613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101970702|NCT05345613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970703|NCT05345613|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101970704|NCT05345613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101962070|NCT02171182|Sensory System Agents|sensory system agents|mesh-ancestor
101962071|NCT02171182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101962072|NCT02171182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962073|NCT00100828|Irinotecan|irinotecan|mesh-list
101962074|NCT00100828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101962075|NCT00100828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101962076|NCT00100828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101962077|NCT00100828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962078|NCT00100828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101962079|NCT02165098|Cariprazine|cariprazine|mesh-list
101962080|NCT02165098|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101962081|NCT02165098|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101962082|NCT02165098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101962083|NCT02165098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962084|NCT02165098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101962085|NCT02171338|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101962086|NCT02171338|Azithromycin|azithromycin|mesh-list
101962087|NCT02171338|Clarithromycin|clarithromycin|mesh-list
101962088|NCT02171338|Ciprofloxacin|ciprofloxacin|mesh-list
101962089|NCT02171338|Tazobactam|tazobactam|mesh-list
101962090|NCT02171338|Piperacillin|piperacillin|mesh-list
101962091|NCT02171338|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101962092|NCT02171338|Penicillin G|penicillin g|mesh-list
101962093|NCT02171338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101962094|NCT02171338|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101962095|NCT02171338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101962096|NCT02171338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962097|NCT02171338|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101962098|NCT02171338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101962099|NCT02171338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101962100|NCT02171338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101962101|NCT02171338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101962102|NCT02171338|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101962103|NCT02171338|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101962104|NCT02171416|Rilonacept|rilonacept|mesh-list
101962105|NCT02171416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101962106|NCT02171494|Warfarin|warfarin|mesh-list
101962107|NCT02171494|Anticoagulants|anticoagulants|mesh-ancestor
101962108|NCT02165332|Moxifloxacin|moxifloxacin|mesh-list
101962109|NCT02165332|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101962110|NCT02165332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101962111|NCT02165332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101962112|NCT02165332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101962113|NCT02165332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101962114|NCT02165332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101962115|NCT02165332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962116|NCT02165332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101962117|NCT02165332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101962118|NCT02165332|Contraceptive Agents|contraceptive agents|mesh-ancestor
101962119|NCT02165332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101962120|NCT02165332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962121|NCT02165332|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101962122|NCT02165332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101962123|NCT02165332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101962125|NCT02171572|Antithrombins|antithrombins|mesh-ancestor
101962126|NCT02171572|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101962127|NCT02171572|Protease Inhibitors|protease inhibitors|mesh-ancestor
101962128|NCT02171572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970705|NCT05345613|Autonomic Agents|autonomic agents|mesh-ancestor
101970706|NCT05345613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101970707|NCT05345613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101970708|NCT05345613|Respiratory System Agents|respiratory system agents|mesh-ancestor
101962129|NCT02171572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962130|NCT02171572|Anticoagulants|anticoagulants|mesh-ancestor
101962131|NCT02255578|Clomiphene|clomiphene|mesh-list
101962132|NCT02255578|Enclomiphene|enclomiphene|mesh-list
101962133|NCT02255578|Zuclomiphene|zuclomiphene|mesh-list
101962134|NCT02255578|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101962135|NCT02255578|Hormone Antagonists|hormone antagonists|mesh-ancestor
101962136|NCT02255578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101962137|NCT02255578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962138|NCT02255578|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101962139|NCT02255578|Fertility Agents|fertility agents|mesh-ancestor
101962140|NCT02255578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101962141|NCT02255578|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101962142|NCT02255578|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101962144|NCT02169154|Menthol|menthol|mesh-list
101962145|NCT02169154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101962146|NCT02169154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101962147|NCT02169154|Analgesics|analgesics|mesh-ancestor
101962148|NCT02169154|Sensory System Agents|sensory system agents|mesh-ancestor
101962149|NCT02169154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101962150|NCT02169154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962151|NCT02169154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101962152|NCT02169154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101962153|NCT02169154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101962154|NCT02169154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101962155|NCT02169154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962156|NCT02169154|Antipruritics|antipruritics|mesh-ancestor
101962157|NCT02169154|Dermatologic Agents|dermatologic agents|mesh-ancestor
101962158|NCT00100048|Tenofovir|tenofovir|mesh-list
101962159|NCT00100048|Lamivudine|lamivudine|mesh-list
101962160|NCT00100048|Efavirenz|efavirenz|mesh-list
101962161|NCT00100048|Raltegravir Potassium|raltegravir potassium|mesh-list
101962162|NCT00100048|Antiviral Agents|antiviral agents|mesh-ancestor
101962163|NCT00100048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101962164|NCT00100048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101962165|NCT00100048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101962166|NCT00100048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101962167|NCT00100048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962168|NCT00100048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101962169|NCT00100048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101962170|NCT00100048|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101962171|NCT00100048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101962172|NCT00100048|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101962173|NCT00100048|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101962174|NCT00100048|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101962175|NCT00100048|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101962176|NCT00100048|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101962177|NCT00100048|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101962178|NCT02171650|Afatinib|afatinib|mesh-list
101962179|NCT02171650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101962180|NCT02171650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101962181|NCT02171650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101962182|NCT02171650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962183|NCT02165566|Insulin|insulin|mesh-list
101962184|NCT02165566|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101962185|NCT02165566|Insulin Lispro|insulin lispro|mesh-list
101962186|NCT02165566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101962187|NCT02165566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962188|NCT02171728|Afatinib|afatinib|mesh-list
101962189|NCT02171728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101962190|NCT02171728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101962191|NCT02171728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101962192|NCT02171728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962193|NCT02165644|Nimodipine|nimodipine|mesh-list
101962194|NCT02165644|Acetazolamide|acetazolamide|mesh-list
101962195|NCT02165644|Anticonvulsants|anticonvulsants|mesh-ancestor
101962198|NCT02165644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962199|NCT02165644|Diuretics|diuretics|mesh-ancestor
101962200|NCT02165644|Natriuretic Agents|natriuretic agents|mesh-ancestor
101962201|NCT02165644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962202|NCT02165644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101962203|NCT02165644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101962204|NCT02165644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101255319|NCT01704339|Capsaicin|capsaicin|mesh-list
101962205|NCT02165644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101962206|NCT02165644|Vasodilator Agents|vasodilator agents|mesh-ancestor
101962207|NCT02171806|Olodaterol|olodaterol|mesh-list
101962208|NCT02171806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101962209|NCT02171806|Autonomic Agents|autonomic agents|mesh-ancestor
101962210|NCT02171806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101962211|NCT02171806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962212|NCT02171806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101962213|NCT02171806|Respiratory System Agents|respiratory system agents|mesh-ancestor
101962214|NCT02169544|Abatacept|abatacept|mesh-list
101962215|NCT02169544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101962216|NCT02169544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962217|NCT02169544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101962218|NCT02169544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101962219|NCT02169544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101962220|NCT02169544|Immunologic Factors|immunologic factors|mesh-ancestor
101962221|NCT02169544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962222|NCT02169544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101962223|NCT02169856|Cefuroxime|cefuroxime|mesh-list
101962224|NCT02169856|Cefuroxime axetil|cefuroxime axetil|mesh-list
101962225|NCT02169856|Ketorolac|ketorolac|mesh-list
101962226|NCT02169856|Midazolam|midazolam|mesh-list
101962227|NCT02169856|Propofol|propofol|mesh-list
101962228|NCT02169856|Sevoflurane|sevoflurane|mesh-list
101962229|NCT02169856|Atracurium|atracurium|mesh-list
101962230|NCT02169856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101962231|NCT02169856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101962232|NCT02169856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255353|NCT01704508|Artemether|artemether|mesh-list
101962233|NCT02169856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101962234|NCT02169856|Anesthetics, General|anesthetics, general|mesh-ancestor
101962235|NCT02169856|Anesthetics|anesthetics|mesh-ancestor
101962236|NCT02169856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101962237|NCT02169856|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101962238|NCT02169856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101962239|NCT02169856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101962240|NCT02169856|GABA Modulators|gaba modulators|mesh-ancestor
101962241|NCT02169856|GABA Agents|gaba agents|mesh-ancestor
101962242|NCT02169856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101962243|NCT02169856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962244|NCT02169856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101962245|NCT02169856|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101962246|NCT02169856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101962247|NCT02169856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101962248|NCT02169856|Analgesics|analgesics|mesh-ancestor
101962249|NCT02169856|Sensory System Agents|sensory system agents|mesh-ancestor
101962250|NCT02169856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101962251|NCT02169856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101962252|NCT02169856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101255395|NCT01704690|Fluorouracil|fluorouracil|mesh-list
101962254|NCT02169856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101962255|NCT02169856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101962256|NCT02169856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101962257|NCT02169856|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101962258|NCT02169856|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101962259|NCT02169856|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101962260|NCT02169856|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101962261|NCT02169856|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101962262|NCT02169856|Cholinergic Agents|cholinergic agents|mesh-ancestor
101962263|NCT02170246|Telmisartan|telmisartan|mesh-list
101962264|NCT02170246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101962265|NCT02170246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101962266|NCT02170246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101962267|NCT02170246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962268|NCT02170324|Exenatide|exenatide|mesh-list
101962269|NCT02170324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101962270|NCT02170324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962271|NCT02170324|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101962272|NCT02170324|Incretins|incretins|mesh-ancestor
101962273|NCT02170324|Hormones|hormones|mesh-ancestor
101962274|NCT02170324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101962275|NCT02170402|Factor VIII|factor viii|mesh-list
101962276|NCT02170402|Coagulants|coagulants|mesh-ancestor
101962277|NCT02172196|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101962278|NCT02172196|Empagliflozin|empagliflozin|mesh-list
101962279|NCT02172196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101962280|NCT02172196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962281|NCT02172196|Incretins|incretins|mesh-ancestor
101962282|NCT02172196|Hormones|hormones|mesh-ancestor
101962283|NCT02172196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101962284|NCT02172196|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101962285|NCT02172196|Protease Inhibitors|protease inhibitors|mesh-ancestor
101962286|NCT02172196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101692036|NCT02682524|Sensory System Agents|sensory system agents|mesh-ancestor
101962287|NCT02172196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962288|NCT02172196|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101962289|NCT02172274|Empagliflozin|empagliflozin|mesh-list
101962290|NCT02172274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101962291|NCT02172274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962292|NCT02172274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101962293|NCT02172274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962294|NCT02172352|Tiotropium Bromide|tiotropium bromide|mesh-list
101962295|NCT02172352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101962296|NCT02172352|Autonomic Agents|autonomic agents|mesh-ancestor
101962297|NCT02172352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101962298|NCT02172352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962299|NCT02172352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101255453|NCT01704794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101962300|NCT02172352|Respiratory System Agents|respiratory system agents|mesh-ancestor
101962301|NCT02172352|Parasympatholytics|parasympatholytics|mesh-ancestor
101962302|NCT02172352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101962303|NCT02172352|Cholinergic Agents|cholinergic agents|mesh-ancestor
101962304|NCT02172352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101962305|NCT02172352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962307|NCT02757352|Dermatologic Agents|dermatologic agents|mesh-ancestor
101962308|NCT02172430|Tiotropium Bromide|tiotropium bromide|mesh-list
101962309|NCT02172430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101962310|NCT02172430|Autonomic Agents|autonomic agents|mesh-ancestor
101962311|NCT02172430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101962312|NCT02172430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962313|NCT02172430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101962314|NCT02172430|Respiratory System Agents|respiratory system agents|mesh-ancestor
101962315|NCT02172430|Parasympatholytics|parasympatholytics|mesh-ancestor
101962316|NCT02172430|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101962317|NCT02172430|Cholinergic Agents|cholinergic agents|mesh-ancestor
101962318|NCT02172430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101962319|NCT02172430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962320|NCT02172508|Tiotropium Bromide|tiotropium bromide|mesh-list
101970720|NCT05296278|Bevacizumab|bevacizumab|mesh-list
101970721|NCT05296278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101970722|NCT05296278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970723|NCT05296278|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101970724|NCT05296278|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101970725|NCT05296278|Growth Substances|growth substances|mesh-ancestor
101970726|NCT05296278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970727|NCT05296278|Growth Inhibitors|growth inhibitors|mesh-ancestor
101970728|NCT05255601|Nivolumab|nivolumab|mesh-list
101970729|NCT05255601|Relatlimab|relatlimab|mesh-list
101970730|NCT05255601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101970731|NCT05255601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970732|NCT05255601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101970733|NCT05255601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970734|NCT05246514|Trastuzumab|trastuzumab|mesh-list
101970735|NCT05246514|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
101305519|NCT02020122|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101305520|NCT02020122|Analgesics|analgesics|mesh-ancestor
101962321|NCT02172508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101962322|NCT02172508|Autonomic Agents|autonomic agents|mesh-ancestor
101962323|NCT02172508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101962324|NCT02172508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962325|NCT02172508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101962326|NCT02172508|Respiratory System Agents|respiratory system agents|mesh-ancestor
101962327|NCT02172508|Parasympatholytics|parasympatholytics|mesh-ancestor
101962328|NCT02172508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101962329|NCT02172508|Cholinergic Agents|cholinergic agents|mesh-ancestor
101962330|NCT02172508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101962331|NCT02172508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962332|NCT02172586|Losartan|losartan|mesh-list
101962333|NCT02172586|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101962334|NCT02172586|Telmisartan|telmisartan|mesh-list
101962335|NCT02172586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101962336|NCT02172586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101962337|NCT02172586|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101962338|NCT02172586|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101962339|NCT02172586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962340|NCT02172586|Diuretics|diuretics|mesh-ancestor
101962341|NCT02172586|Natriuretic Agents|natriuretic agents|mesh-ancestor
101962342|NCT02172586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962343|NCT02172586|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101962344|NCT02172586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101962345|NCT02170636|Pantoprazole|pantoprazole|mesh-list
101962346|NCT02170636|Dabigatran|dabigatran|mesh-list
101962347|NCT02170636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101962348|NCT02170636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101962349|NCT02170636|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101962350|NCT02170636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101962351|NCT02170636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962352|NCT02170636|Antithrombins|antithrombins|mesh-ancestor
101962353|NCT02170636|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101962354|NCT02170636|Protease Inhibitors|protease inhibitors|mesh-ancestor
101962355|NCT02170636|Anticoagulants|anticoagulants|mesh-ancestor
101962356|NCT02255734|Acyclovir|acyclovir|mesh-list
101962357|NCT02255734|Antiviral Agents|antiviral agents|mesh-ancestor
101962358|NCT02255734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101682133|NCT02745860|Selexipag|selexipag|mesh-list
101970736|NCT05246514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101970737|NCT05246514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970738|NCT05246514|Immunoconjugates|immunoconjugates|mesh-ancestor
101962360|NCT02170792|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
101962361|NCT02170792|Dabigatran|dabigatran|mesh-list
101962362|NCT02170792|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101962363|NCT02170792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101962364|NCT02170792|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101962365|NCT02170792|Histamine Antagonists|histamine antagonists|mesh-ancestor
101962366|NCT02170792|Histamine Agents|histamine agents|mesh-ancestor
101962367|NCT02170792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101962368|NCT02170792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962369|NCT02170792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962370|NCT02170792|Antithrombins|antithrombins|mesh-ancestor
101962371|NCT02170792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101962372|NCT02170792|Protease Inhibitors|protease inhibitors|mesh-ancestor
101962373|NCT02170792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101962374|NCT02170792|Anticoagulants|anticoagulants|mesh-ancestor
101962375|NCT02172976|Gemcitabine|gemcitabine|mesh-list
101962376|NCT02172976|Fluorouracil|fluorouracil|mesh-list
101962377|NCT02172976|Oxaliplatin|oxaliplatin|mesh-list
101962378|NCT02172976|Irinotecan|irinotecan|mesh-list
101962379|NCT02172976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101962380|NCT02172976|Antimetabolites|antimetabolites|mesh-ancestor
101962381|NCT02172976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962382|NCT02172976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101962383|NCT02172976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101962384|NCT02172976|Immunologic Factors|immunologic factors|mesh-ancestor
101962385|NCT02172976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692084|NCT02684318|Olaparib|olaparib|mesh-list
101962386|NCT02172976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101962387|NCT02172976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101962388|NCT02172976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101962389|NCT02173132|Acetylcarnitine|acetylcarnitine|mesh-list
101962390|NCT02173132|Vitamin B Complex|vitamin b complex|mesh-ancestor
101962391|NCT02173132|Vitamins|vitamins|mesh-ancestor
101962392|NCT02173132|Micronutrients|micronutrients|mesh-ancestor
101962393|NCT02173132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962394|NCT02173132|Nootropic Agents|nootropic agents|mesh-ancestor
101962395|NCT02173288|Furosemide|furosemide|mesh-list
101962396|NCT02173288|Spironolactone|spironolactone|mesh-list
101962397|NCT02173288|Tolvaptan|tolvaptan|mesh-list
101962398|NCT02173288|Midodrine|midodrine|mesh-list
101962399|NCT02173288|Diuretics|diuretics|mesh-ancestor
101962400|NCT02173288|Natriuretic Agents|natriuretic agents|mesh-ancestor
101962401|NCT02173288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962402|NCT02173288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101962403|NCT02173288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101962404|NCT02173288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962405|NCT02173288|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101962406|NCT02173288|Hormone Antagonists|hormone antagonists|mesh-ancestor
101962407|NCT02173288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101962408|NCT02173288|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101962409|NCT02173288|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101962410|NCT02173288|Sympathomimetics|sympathomimetics|mesh-ancestor
101962411|NCT02173288|Autonomic Agents|autonomic agents|mesh-ancestor
101962412|NCT02173288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101962413|NCT02173288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101962414|NCT02173288|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101962415|NCT02173288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101962416|NCT02173288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101962417|NCT02173288|Adrenergic Agents|adrenergic agents|mesh-ancestor
101962418|NCT02173288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101962419|NCT02175394|Linagliptin|linagliptin|mesh-list
101962420|NCT02175394|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
101962421|NCT02175394|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
101962422|NCT02175394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101962423|NCT02175394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962424|NCT02175394|Incretins|incretins|mesh-ancestor
101962426|NCT02175394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101962427|NCT02175394|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101962428|NCT02175394|Protease Inhibitors|protease inhibitors|mesh-ancestor
101970739|NCT05246514|Immunologic Factors|immunologic factors|mesh-ancestor
101970740|NCT05246514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970741|NCT05238831|Paclitaxel|paclitaxel|mesh-list
101970742|NCT05238831|Vinorelbine|vinorelbine|mesh-list
101970743|NCT05238831|Maytansine|maytansine|mesh-list
101962429|NCT02175394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101962430|NCT02175394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962431|NCT02175394|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101962432|NCT02175394|Contraceptive Agents|contraceptive agents|mesh-ancestor
101962433|NCT02175394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101962434|NCT02175394|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101962435|NCT02175394|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101962436|NCT02175394|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101962437|NCT02175394|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101962438|NCT02175394|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101962439|NCT02175394|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
101962440|NCT02175394|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101962441|NCT02175394|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101962442|NCT02256124|Lamotrigine|lamotrigine|mesh-list
101962443|NCT02256124|Anticonvulsants|anticonvulsants|mesh-ancestor
101962444|NCT02256124|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101962445|NCT02256124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101962446|NCT02256124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962447|NCT02256124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101962448|NCT02256124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962449|NCT02256124|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101962450|NCT02256124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101962451|NCT02256124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101962452|NCT02256124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101962453|NCT02256124|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101962454|NCT02173756|Morphine|morphine|mesh-list
101962455|NCT02173756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101962456|NCT02173756|Narcotics|narcotics|mesh-ancestor
101255583|NCT01705743|Nitrous Oxide|nitrous oxide|mesh-list
101962457|NCT02173756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101962458|NCT02173756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962460|NCT02173756|Sensory System Agents|sensory system agents|mesh-ancestor
101962461|NCT02173756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101962462|NCT00102466|Metformin|metformin|mesh-list
101962463|NCT00102466|Vildagliptin|vildagliptin|mesh-list
101962464|NCT00102466|Gliclazide|gliclazide|mesh-list
101962465|NCT00102466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101962466|NCT00102466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962467|NCT00102466|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101962468|NCT00102466|Protease Inhibitors|protease inhibitors|mesh-ancestor
101962469|NCT00102466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101962470|NCT00102466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962471|NCT02173834|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
101962472|NCT02173834|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101962473|NCT02173834|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101962474|NCT02173834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962475|NCT02173834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101255632|NCT01706172|Lidocaine|lidocaine|mesh-list
101962476|NCT02173834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101962477|NCT02173912|Amlodipine|amlodipine|mesh-list
101962478|NCT02173912|Candesartan|candesartan|mesh-list
101962479|NCT02173912|Candesartan cilexetil|candesartan cilexetil|mesh-list
101962480|NCT02173912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101962481|NCT02173912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101962482|NCT02173912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101962483|NCT02173912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962484|NCT02173912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101962485|NCT02173912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962486|NCT02173912|Vasodilator Agents|vasodilator agents|mesh-ancestor
101962487|NCT02173912|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101962488|NCT02173912|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101962489|NCT02173990|Aflibercept|aflibercept|mesh-list
101962490|NCT02173990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101962491|NCT02173990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101970744|NCT05238831|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101962492|NCT02173990|Growth Substances|growth substances|mesh-ancestor
101962493|NCT02173990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962494|NCT02173990|Growth Inhibitors|growth inhibitors|mesh-ancestor
101962495|NCT02173990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101962496|NCT02255812|Quinine|quinine|mesh-list
101962497|NCT02255812|Citric Acid|citric acid|mesh-list
101962498|NCT02255812|Sodium Citrate|sodium citrate|mesh-list
101962499|NCT02255812|Antimalarials|antimalarials|mesh-ancestor
101962500|NCT02255812|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101962501|NCT02255812|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101962502|NCT02255812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101962503|NCT02255812|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101692099|NCT04182854|Diuretics|diuretics|mesh-ancestor
101962504|NCT02255812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962505|NCT02255812|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101682284|NCT02741024|Antiviral Agents|antiviral agents|mesh-ancestor
101255675|NCT01706471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101962506|NCT02255812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101962507|NCT02255812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101962508|NCT02255812|Analgesics|analgesics|mesh-ancestor
101962509|NCT02255812|Sensory System Agents|sensory system agents|mesh-ancestor
101962510|NCT02255812|Anticoagulants|anticoagulants|mesh-ancestor
101962511|NCT02255812|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101962512|NCT02255812|Chelating Agents|chelating agents|mesh-ancestor
101962513|NCT02255812|Sequestering Agents|sequestering agents|mesh-ancestor
101962514|NCT02255812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962515|NCT02175784|Ipragliflozin|ipragliflozin|mesh-list
101962516|NCT02175784|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101962517|NCT02175784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962518|NCT02175784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101962519|NCT02175784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962520|NCT02256280|Neostigmine|neostigmine|mesh-list
101962521|NCT02256280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101962522|NCT02256280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101962523|NCT02256280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962524|NCT02256280|Cholinergic Agents|cholinergic agents|mesh-ancestor
101962525|NCT02256280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101962526|NCT02256280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962527|NCT02256280|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101962528|NCT02256280|Autonomic Agents|autonomic agents|mesh-ancestor
101962529|NCT02256280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101962530|NCT02174068|Acetaminophen|acetaminophen|mesh-list
101962531|NCT02174068|Nefopam|nefopam|mesh-list
101962532|NCT02174068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101962533|NCT02174068|Analgesics|analgesics|mesh-ancestor
101962534|NCT02174068|Sensory System Agents|sensory system agents|mesh-ancestor
101962535|NCT02174068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101962536|NCT02174068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962537|NCT02174068|Antipyretics|antipyretics|mesh-ancestor
101962538|NCT02179294|Meperidine|meperidine|mesh-list
101962539|NCT02179294|Remifentanil|remifentanil|mesh-list
101962540|NCT02179294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101962541|NCT02179294|Narcotics|narcotics|mesh-ancestor
101962542|NCT02179294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101962543|NCT02179294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962544|NCT02179294|Analgesics|analgesics|mesh-ancestor
101962545|NCT02179294|Sensory System Agents|sensory system agents|mesh-ancestor
101962546|NCT02179294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101962547|NCT02179294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101962548|NCT02179528|Etoposide|etoposide|mesh-list
101962549|NCT02179528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101962550|NCT02179528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101962551|NCT02179528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101962552|NCT02179528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101962553|NCT02179528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101962554|NCT02179528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962555|NCT02176564|Bronchodilator Agents|bronchodilator agents|mesh-list
101962556|NCT02176564|Autonomic Agents|autonomic agents|mesh-ancestor
101962557|NCT02176564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101962558|NCT02176564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962559|NCT02176564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101962560|NCT02176564|Respiratory System Agents|respiratory system agents|mesh-ancestor
101962561|NCT02182102|Pemetrexed|pemetrexed|mesh-list
101962562|NCT02182102|Nintedanib|nintedanib|mesh-list
101962563|NCT02182102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101255831|NCT01707407|Analgesics|analgesics|mesh-ancestor
101970745|NCT05238831|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101970746|NCT05238831|Bevacizumab|bevacizumab|mesh-list
101970747|NCT05238831|Carboplatin|carboplatin|mesh-list
101970748|NCT05238831|Capecitabine|capecitabine|mesh-list
101970749|NCT05238831|Trastuzumab|trastuzumab|mesh-list
101962564|NCT02182102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101962565|NCT02182102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962566|NCT02182102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101962567|NCT02182102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101962568|NCT02182102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101962569|NCT02176720|Fluorides|fluorides|mesh-list
101962570|NCT02176720|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
101962571|NCT02176720|Cariostatic Agents|cariostatic agents|mesh-ancestor
101962572|NCT02176720|Protective Agents|protective agents|mesh-ancestor
101962573|NCT02176720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962574|NCT02176720|Dopamine Agents|dopamine agents|mesh-ancestor
101962575|NCT02176720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101962576|NCT02176720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962577|NCT02176876|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101962578|NCT02176876|Immunologic Factors|immunologic factors|mesh-ancestor
101682357|NCT03724994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101962579|NCT02176876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962580|NCT02182258|Nintedanib|nintedanib|mesh-list
101962581|NCT02182258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101962582|NCT02182258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101962583|NCT02182258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101962584|NCT02182258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962585|NCT02182336|Vitamin K|vitamin k|mesh-list
101962586|NCT02182336|Digoxin|digoxin|mesh-list
101962587|NCT02182336|Midazolam|midazolam|mesh-list
101962588|NCT02182336|Dextromethorphan|dextromethorphan|mesh-list
101962589|NCT02182336|Caffeine|caffeine|mesh-list
101962590|NCT02182336|Omeprazole|omeprazole|mesh-list
101962591|NCT02182336|Warfarin|warfarin|mesh-list
101962592|NCT02182336|Vitamins|vitamins|mesh-ancestor
101962593|NCT02182336|Micronutrients|micronutrients|mesh-ancestor
101962594|NCT02182336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962595|NCT02182336|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101962596|NCT02182336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101962597|NCT02182336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101962598|NCT02182336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101962599|NCT02182336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101962600|NCT02182336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101962601|NCT02182336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101962602|NCT02182336|Anesthetics, General|anesthetics, general|mesh-ancestor
101962603|NCT02182336|Anesthetics|anesthetics|mesh-ancestor
101962604|NCT02182336|GABA Modulators|gaba modulators|mesh-ancestor
101962605|NCT02182336|GABA Agents|gaba agents|mesh-ancestor
101962606|NCT02182336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101962607|NCT02182336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962608|NCT02182336|Anticoagulants|anticoagulants|mesh-ancestor
101962609|NCT02182336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101962610|NCT02182336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101962611|NCT02182336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101962612|NCT02182336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101962613|NCT02182336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101962614|NCT02182336|Purinergic Agents|purinergic agents|mesh-ancestor
101962615|NCT02182336|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101962616|NCT02182336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101962617|NCT02182336|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101962618|NCT02182336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101962619|NCT02182336|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101962620|NCT02182336|Protective Agents|protective agents|mesh-ancestor
101962621|NCT02182336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101962622|NCT02182336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101962623|NCT02182336|Hemostatics|hemostatics|mesh-ancestor
101962624|NCT02182336|Coagulants|coagulants|mesh-ancestor
101962625|NCT02182336|Antitussive Agents|antitussive agents|mesh-ancestor
101962626|NCT02182336|Respiratory System Agents|respiratory system agents|mesh-ancestor
101962627|NCT02182336|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101962628|NCT02182336|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101962629|NCT02182570|Epinastine|epinastine|mesh-list
101962630|NCT02182570|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101962631|NCT02182570|Histamine Antagonists|histamine antagonists|mesh-ancestor
101970750|NCT05238831|Irinotecan|irinotecan|mesh-list
101970751|NCT05238831|Atezolizumab|atezolizumab|mesh-list
101970752|NCT05238831|Letrozole|letrozole|mesh-list
101970753|NCT05238831|Fulvestrant|fulvestrant|mesh-list
101970754|NCT05238831|Olaparib|olaparib|mesh-list
101970755|NCT05238831|Palbociclib|palbociclib|mesh-list
101970756|NCT05238831|Pertuzumab|pertuzumab|mesh-list
101962632|NCT02182570|Histamine Agents|histamine agents|mesh-ancestor
101962633|NCT02182570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101962634|NCT02182570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962635|NCT02182570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962636|NCT02182648|Propofol|propofol|mesh-list
101962637|NCT02182648|Etomidate|etomidate|mesh-list
101962638|NCT02182648|Sevoflurane|sevoflurane|mesh-list
101962639|NCT02182648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101962640|NCT02182648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101962641|NCT02182648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962642|NCT02182648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101962643|NCT02182648|Anesthetics, General|anesthetics, general|mesh-ancestor
101962644|NCT02182648|Anesthetics|anesthetics|mesh-ancestor
101962645|NCT02182648|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101962646|NCT02182648|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101962647|NCT02179996|Vaccines|vaccines|mesh-list
101962648|NCT02179996|Immunologic Factors|immunologic factors|mesh-ancestor
101962649|NCT02179996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962650|NCT02177344|Bromides|bromides|mesh-list
101962651|NCT02177344|Ipratropium|ipratropium|mesh-list
101962652|NCT02177344|Anticonvulsants|anticonvulsants|mesh-ancestor
101962653|NCT02177344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101962654|NCT02177344|Autonomic Agents|autonomic agents|mesh-ancestor
101962655|NCT02177344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101962656|NCT02177344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962657|NCT02177344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101962658|NCT02177344|Respiratory System Agents|respiratory system agents|mesh-ancestor
101962659|NCT02177344|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101255982|NCT01708616|Risperidone|risperidone|mesh-list
101962660|NCT02177344|Cholinergic Agents|cholinergic agents|mesh-ancestor
101962661|NCT02177344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101962662|NCT02177344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962664|NCT03536494|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101962665|NCT03536494|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101962666|NCT03536494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101962667|NCT03536494|Adrenergic Agents|adrenergic agents|mesh-ancestor
101962668|NCT03536494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101962669|NCT03536494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962670|NCT03536494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962671|NCT03536494|Urological Agents|urological agents|mesh-ancestor
101962672|NCT02177422|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101962673|NCT02177422|Telmisartan|telmisartan|mesh-list
101962674|NCT02177422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101962675|NCT02177422|Diuretics|diuretics|mesh-ancestor
101962676|NCT02177422|Natriuretic Agents|natriuretic agents|mesh-ancestor
101962677|NCT02177422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962678|NCT02177422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101962679|NCT02177422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101962680|NCT02177422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962681|NCT02177422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101962682|NCT02177422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101962683|NCT02182960|Ibuprofen|ibuprofen|mesh-list
101962684|NCT02182960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101962685|NCT02182960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101962686|NCT02182960|Analgesics|analgesics|mesh-ancestor
101962687|NCT02182960|Sensory System Agents|sensory system agents|mesh-ancestor
101962688|NCT02182960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101962689|NCT02182960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962690|NCT02182960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101962691|NCT02182960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101962692|NCT02182960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101962693|NCT02182960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101962694|NCT02182960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962695|NCT05141968|Vitamin D|vitamin d|mesh-list
101970757|NCT05238831|Anastrozole|anastrozole|mesh-list
101970759|NCT05238831|Vemurafenib|vemurafenib|mesh-list
101970760|NCT05238831|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
101391919|NCT04905277|Atenolol|atenolol|mesh-list
101962696|NCT05141968|Vitamins|vitamins|mesh-ancestor
101962697|NCT05141968|Micronutrients|micronutrients|mesh-ancestor
101962698|NCT05141968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962699|NCT05141968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101962701|NCT00110357|Cetuximab|cetuximab|mesh-list
101962702|NCT00110357|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101962703|NCT00110357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101962704|NCT00110357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101962705|NCT00110357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962706|NCT00110357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101962707|NCT00110357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101962708|NCT02183038|Naproxen|naproxen|mesh-list
101962709|NCT02183038|Meloxicam|meloxicam|mesh-list
101962710|NCT02183038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101962711|NCT02183038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101962712|NCT02183038|Analgesics|analgesics|mesh-ancestor
101962713|NCT02183038|Sensory System Agents|sensory system agents|mesh-ancestor
101962714|NCT02183038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101962715|NCT02183038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962716|NCT02183038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101962717|NCT02183038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101962718|NCT02183038|Gout Suppressants|gout suppressants|mesh-ancestor
101962719|NCT02183038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101962720|NCT02183038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101962721|NCT02183038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962722|NCT02183038|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101962723|NCT02752906|Vaccines|vaccines|mesh-list
101962724|NCT02752906|Immunologic Factors|immunologic factors|mesh-ancestor
101962725|NCT02752906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962726|NCT00293033|Fentanyl|fentanyl|mesh-list
101962727|NCT00293033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101962728|NCT00293033|Narcotics|narcotics|mesh-ancestor
101962729|NCT00293033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101692167|NCT02806349|Cathartics|cathartics|mesh-ancestor
101962730|NCT00293033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682507|NCT03695510|Afatinib|afatinib|mesh-list
101962731|NCT00293033|Analgesics|analgesics|mesh-ancestor
101962732|NCT00293033|Sensory System Agents|sensory system agents|mesh-ancestor
101962733|NCT00293033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101962734|NCT00293033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101962735|NCT00293033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101962736|NCT00293033|Anesthetics, General|anesthetics, general|mesh-ancestor
101962737|NCT00293033|Anesthetics|anesthetics|mesh-ancestor
101962738|NCT02183116|Meloxicam|meloxicam|mesh-list
101962739|NCT02183116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101962740|NCT02183116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101962741|NCT02183116|Analgesics|analgesics|mesh-ancestor
101962742|NCT02183116|Sensory System Agents|sensory system agents|mesh-ancestor
101962743|NCT02183116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101962744|NCT02183116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962745|NCT02183116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101962746|NCT02183116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101256112|NCT01709656|Celecoxib|celecoxib|mesh-list
101962747|NCT02183116|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101962748|NCT02183116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101962749|NCT02183116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101962750|NCT02183116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962752|NCT02183194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101962753|NCT02183194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101962754|NCT02183194|Tubulin Modulators|tubulin modulators|mesh-ancestor
101962755|NCT02183194|Antimitotic Agents|antimitotic agents|mesh-ancestor
101962756|NCT02183194|Mitosis Modulators|mitosis modulators|mesh-ancestor
101962757|NCT02183194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962758|NCT02183272|Ketamine|ketamine|mesh-list
101962759|NCT02183272|Analgesics|analgesics|mesh-ancestor
101962760|NCT02183272|Sensory System Agents|sensory system agents|mesh-ancestor
101962761|NCT02183272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101962762|NCT02183272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970761|NCT05238831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101970762|NCT05238831|Endothelial Growth Factors|endothelial growth factors|mesh-list
101970763|NCT05238831|Antibodies|antibodies|mesh-list
101970764|NCT05238831|Immunoglobulins|immunoglobulins|mesh-list
101970765|NCT05238831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101970766|NCT05238831|Immunoglobulin G|immunoglobulin g|mesh-list
101970767|NCT05238831|Entrectinib|entrectinib|mesh-list
101970768|NCT05238831|Immunoconjugates|immunoconjugates|mesh-list
101962763|NCT02183272|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101962764|NCT02183272|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101962765|NCT02183272|Anesthetics, General|anesthetics, general|mesh-ancestor
101962766|NCT02183272|Anesthetics|anesthetics|mesh-ancestor
101962767|NCT02183272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101962768|NCT02183272|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101962769|NCT02183272|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101962770|NCT02183272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101962771|NCT02183272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962772|NCT02177500|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101962773|NCT02177500|Telmisartan|telmisartan|mesh-list
101962774|NCT02177500|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
101962775|NCT02177500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101962776|NCT02177500|Diuretics|diuretics|mesh-ancestor
101962777|NCT02177500|Natriuretic Agents|natriuretic agents|mesh-ancestor
101962778|NCT02177500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962779|NCT02177500|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101962780|NCT02177500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101962781|NCT02177500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256147|NCT01709682|Autonomic Agents|autonomic agents|mesh-ancestor
101962782|NCT02177500|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101962783|NCT02177500|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101962784|NCT02183350|Linagliptin|linagliptin|mesh-list
101962785|NCT02183350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101962786|NCT02183350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962787|NCT02183350|Incretins|incretins|mesh-ancestor
101962788|NCT02183350|Hormones|hormones|mesh-ancestor
101962789|NCT02183350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101962790|NCT02183350|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101962791|NCT02183350|Protease Inhibitors|protease inhibitors|mesh-ancestor
101962792|NCT02183350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101962793|NCT02183350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962794|NCT03537898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101962795|NCT03537898|Plasma-lyte 148|plasma-lyte 148|mesh-list
101962796|NCT03537898|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101962797|NCT02183428|Glyburide|glyburide|mesh-list
101962798|NCT02183428|Linagliptin|linagliptin|mesh-list
101962799|NCT02183428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101962800|NCT02183428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962801|NCT02183428|Incretins|incretins|mesh-ancestor
101962802|NCT02183428|Hormones|hormones|mesh-ancestor
101962803|NCT02183428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101962804|NCT02183428|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101962806|NCT02183428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101962807|NCT02183428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962808|NCT01080911|Morphine|morphine|mesh-list
101962809|NCT01080911|Analgesics, Opioid|analgesics, opioid|mesh-list
101962810|NCT01080911|Narcotics|narcotics|mesh-ancestor
101962811|NCT01080911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101962812|NCT01080911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962813|NCT01080911|Analgesics|analgesics|mesh-ancestor
101962814|NCT01080911|Sensory System Agents|sensory system agents|mesh-ancestor
101962815|NCT01080911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101962816|NCT02183506|Metformin|metformin|mesh-list
101962817|NCT02183506|Linagliptin|linagliptin|mesh-list
101962818|NCT02183506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101962819|NCT02183506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962820|NCT02183506|Incretins|incretins|mesh-ancestor
101962821|NCT02183506|Hormones|hormones|mesh-ancestor
101970769|NCT05238831|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
101970770|NCT05238831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101970771|NCT05238831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970772|NCT05238831|Tubulin Modulators|tubulin modulators|mesh-ancestor
101970773|NCT05238831|Antimitotic Agents|antimitotic agents|mesh-ancestor
101970774|NCT05238831|Mitosis Modulators|mitosis modulators|mesh-ancestor
101970775|NCT05238831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970776|NCT05238831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101970777|NCT05238831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101970778|NCT05238831|Growth Substances|growth substances|mesh-ancestor
101305565|NCT02020200|Dopamine Agents|dopamine agents|mesh-ancestor
101962822|NCT02183506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101962823|NCT02183506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101962824|NCT02183506|Protease Inhibitors|protease inhibitors|mesh-ancestor
101962825|NCT02183506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101962826|NCT02183506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962827|NCT02177734|Vaccines|vaccines|mesh-list
101962828|NCT02177734|Immunologic Factors|immunologic factors|mesh-ancestor
101962829|NCT02177734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962830|NCT02183584|Linagliptin|linagliptin|mesh-list
101962831|NCT02183584|Rifampin|rifampin|mesh-list
101962832|NCT02183584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101962833|NCT02183584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962834|NCT02183584|Incretins|incretins|mesh-ancestor
101962835|NCT02183584|Hormones|hormones|mesh-ancestor
101962836|NCT02183584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101962837|NCT02183584|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101692179|NCT02806115|Acetic Acid|acetic acid|mesh-list
101962838|NCT02183584|Protease Inhibitors|protease inhibitors|mesh-ancestor
101962839|NCT02183584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101962840|NCT02183584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962841|NCT02183584|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101962842|NCT02183584|Antitubercular Agents|antitubercular agents|mesh-ancestor
101962843|NCT02183584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101962844|NCT02183584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101962845|NCT02183584|Leprostatic Agents|leprostatic agents|mesh-ancestor
101962846|NCT02183584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101962847|NCT02183584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101962848|NCT02183584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101962849|NCT02183584|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101962850|NCT02183584|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101962851|NCT02183584|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101962852|NCT02183584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101962853|NCT03964493|Vancomycin|vancomycin|mesh-list
101962854|NCT03964493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101962855|NCT03964493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101962856|NCT01068353|Etanercept|etanercept|mesh-list
101962857|NCT01068353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101962858|NCT01068353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101962859|NCT01068353|Analgesics|analgesics|mesh-ancestor
101962860|NCT01068353|Sensory System Agents|sensory system agents|mesh-ancestor
101962861|NCT01068353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101962862|NCT01068353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962863|NCT01068353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101962864|NCT01068353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101962865|NCT01068353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101962866|NCT01068353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101962867|NCT01068353|Immunologic Factors|immunologic factors|mesh-ancestor
101962868|NCT01083251|Vitamin D|vitamin d|mesh-list
101962869|NCT01083251|Ergocalciferols|ergocalciferols|mesh-list
101962870|NCT01083251|Cholecalciferol|cholecalciferol|mesh-list
101962871|NCT01083251|Vitamins|vitamins|mesh-list
101962872|NCT01083251|Entecavir|entecavir|mesh-list
101970779|NCT05238831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970780|NCT05238831|Growth Inhibitors|growth inhibitors|mesh-ancestor
101970781|NCT05238831|Immunologic Factors|immunologic factors|mesh-ancestor
101970782|NCT05238831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101392137|NCT04808843|Dienogest|dienogest|mesh-list
101962873|NCT01083251|Micronutrients|micronutrients|mesh-ancestor
101962874|NCT01083251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962875|NCT01083251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101962876|NCT01083251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101962877|NCT01083251|Antiviral Agents|antiviral agents|mesh-ancestor
101962878|NCT01083251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101962879|NCT02184052|Meloxicam|meloxicam|mesh-list
101962880|NCT02184052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101962881|NCT02184052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101962882|NCT02184052|Analgesics|analgesics|mesh-ancestor
101962883|NCT02184052|Sensory System Agents|sensory system agents|mesh-ancestor
101962884|NCT02184052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101962885|NCT02184052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962886|NCT02184052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101962887|NCT02184052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101962888|NCT02184052|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101962889|NCT02184052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101962890|NCT02184052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101962891|NCT02184052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962892|NCT01083329|Nicotinic Acids|nicotinic acids|mesh-list
101962894|NCT01083329|Niacinamide|niacinamide|mesh-list
101962895|NCT01083329|Vitamin B Complex|vitamin b complex|mesh-ancestor
101962896|NCT01083329|Vitamins|vitamins|mesh-ancestor
101962897|NCT01083329|Micronutrients|micronutrients|mesh-ancestor
101962898|NCT01083329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962899|NCT01083329|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101962900|NCT01083329|Antimetabolites|antimetabolites|mesh-ancestor
101962901|NCT01083329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962902|NCT01083329|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101962903|NCT01083329|Vasodilator Agents|vasodilator agents|mesh-ancestor
101962904|NCT01083407|Chlorhexidine|chlorhexidine|mesh-list
101962905|NCT01083407|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101962906|NCT01083407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101962907|NCT01083407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101962908|NCT01083407|Disinfectants|disinfectants|mesh-ancestor
101962909|NCT01083407|Dermatologic Agents|dermatologic agents|mesh-ancestor
101962910|NCT02181322|Meloxicam|meloxicam|mesh-list
101962911|NCT02181322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101962912|NCT02181322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101962913|NCT02181322|Analgesics|analgesics|mesh-ancestor
101962914|NCT02181322|Sensory System Agents|sensory system agents|mesh-ancestor
101962915|NCT02181322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101962916|NCT02181322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962917|NCT02181322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101962918|NCT02181322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101962919|NCT02181322|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101962920|NCT02181322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101962921|NCT02181322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101962922|NCT02181322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962923|NCT02184286|Nevirapine|nevirapine|mesh-list
101962924|NCT02184286|Saquinavir|saquinavir|mesh-list
101962925|NCT02184286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101962926|NCT02184286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101962927|NCT02184286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101962928|NCT02184286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962930|NCT02184286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101962931|NCT02184286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101962932|NCT02184286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101962933|NCT02184286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101962934|NCT02184286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101962935|NCT02184286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101962936|NCT02184286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101962937|NCT02184286|Protease Inhibitors|protease inhibitors|mesh-ancestor
101962938|NCT02184286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101970784|NCT05238831|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101970785|NCT05238831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101970786|NCT05238831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101962939|NCT02184286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101962940|NCT02178124|Donepezil|donepezil|mesh-list
101962941|NCT02178124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101962942|NCT02178124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101962943|NCT02178124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962944|NCT02178124|Cholinergic Agents|cholinergic agents|mesh-ancestor
101962945|NCT02178124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101962946|NCT02178124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962947|NCT02178124|Nootropic Agents|nootropic agents|mesh-ancestor
101962948|NCT02030314|Chlorthalidone|chlorthalidone|mesh-list
101962949|NCT02030314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101962950|NCT02030314|Diuretics|diuretics|mesh-ancestor
101962951|NCT02030314|Natriuretic Agents|natriuretic agents|mesh-ancestor
101962952|NCT02030314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962953|NCT02030314|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101682734|NCT02733380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101962954|NCT02030314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101962955|NCT02030314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962956|NCT02184364|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101962958|NCT02184364|Hormones|hormones|mesh-ancestor
101962959|NCT02184364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101962960|NCT02184364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962961|NCT02181478|Cyclosporine|cyclosporine|mesh-list
101962962|NCT02181478|Mycophenolic Acid|mycophenolic acid|mesh-list
101962963|NCT02181478|Cyclophosphamide|cyclophosphamide|mesh-list
101962964|NCT02181478|Fludarabine|fludarabine|mesh-list
101962965|NCT02181478|Fludarabine phosphate|fludarabine phosphate|mesh-list
101962966|NCT02181478|Cyclosporins|cyclosporins|mesh-list
101962967|NCT02181478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101962968|NCT02181478|Immunologic Factors|immunologic factors|mesh-ancestor
101962969|NCT02181478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962970|NCT02181478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101962971|NCT02181478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101962972|NCT02181478|Alkylating Agents|alkylating agents|mesh-ancestor
101962973|NCT02181478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962974|NCT02181478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101962975|NCT02181478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101962976|NCT02181478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101962977|NCT02181478|Antimetabolites|antimetabolites|mesh-ancestor
101962978|NCT02181478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101962979|NCT02181478|Antifungal Agents|antifungal agents|mesh-ancestor
101962980|NCT02181478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101962981|NCT02181478|Dermatologic Agents|dermatologic agents|mesh-ancestor
101962982|NCT02181478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101962983|NCT02181478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101962984|NCT02181478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101962985|NCT02181478|Antitubercular Agents|antitubercular agents|mesh-ancestor
101962986|NCT02181478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101962987|NCT02755090|Nitrous Oxide|nitrous oxide|mesh-list
101962988|NCT02755090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101962989|NCT02755090|Anesthetics, General|anesthetics, general|mesh-ancestor
101962990|NCT02755090|Anesthetics|anesthetics|mesh-ancestor
101962991|NCT02755090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101962992|NCT02755090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101962993|NCT02755090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101962994|NCT02755090|Analgesics|analgesics|mesh-ancestor
101962995|NCT02755090|Sensory System Agents|sensory system agents|mesh-ancestor
101962996|NCT02755090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101962997|NCT00109343|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101962998|NCT00109343|Immunologic Factors|immunologic factors|mesh-ancestor
101962999|NCT00109343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963000|NCT02185690|Carboplatin|carboplatin|mesh-list
101963002|NCT02185690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101963003|NCT02185690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101963004|NCT02185690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963005|NCT02185690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101970787|NCT05238831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101963006|NCT02185690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101963007|NCT03536806|Canrenone|canrenone|mesh-list
101963008|NCT03536806|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101963009|NCT03536806|Hormone Antagonists|hormone antagonists|mesh-ancestor
101963010|NCT03536806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101963011|NCT03536806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963012|NCT03536806|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101963013|NCT03536806|Diuretics|diuretics|mesh-ancestor
101963014|NCT03536806|Natriuretic Agents|natriuretic agents|mesh-ancestor
101963015|NCT00108485|Niacin|niacin|mesh-list
101963016|NCT00108485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101963017|NCT00108485|Antimetabolites|antimetabolites|mesh-ancestor
101963018|NCT00108485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963019|NCT00108485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101963020|NCT00108485|Vasodilator Agents|vasodilator agents|mesh-ancestor
101963021|NCT00108485|Vitamin B Complex|vitamin b complex|mesh-ancestor
101963022|NCT00108485|Vitamins|vitamins|mesh-ancestor
101963023|NCT00108485|Micronutrients|micronutrients|mesh-ancestor
101963024|NCT00108485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963025|NCT02181946|Fluconazole|fluconazole|mesh-list
101963026|NCT02181946|Nevirapine|nevirapine|mesh-list
101963027|NCT02181946|Antifungal Agents|antifungal agents|mesh-ancestor
101963028|NCT02181946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101963029|NCT02181946|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101963030|NCT02181946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101963031|NCT02181946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101963032|NCT02181946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963033|NCT02181946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101963034|NCT02181946|Hormone Antagonists|hormone antagonists|mesh-ancestor
101963035|NCT02181946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101963036|NCT02181946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963037|NCT02181946|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101963038|NCT02181946|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101963039|NCT02181946|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101963040|NCT02181946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101692261|NCT04010929|Pemetrexed|pemetrexed|mesh-list
101963041|NCT02181946|Antiviral Agents|antiviral agents|mesh-ancestor
101963042|NCT02181946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101963043|NCT02181946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101963044|NCT02181946|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101963045|NCT02181946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101963046|NCT00107783|Nitisinone|nitisinone|mesh-list
101963047|NCT00107783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101963048|NCT00107783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963049|NCT02185768|Idarubicin|idarubicin|mesh-list
101963050|NCT02185768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101963051|NCT02185768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101963052|NCT02185768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101963053|NCT02185768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101963054|NCT02185768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101963055|NCT02185768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963056|NCT02182024|Dabigatran|dabigatran|mesh-list
101963057|NCT02182024|Antithrombins|antithrombins|mesh-ancestor
101963058|NCT02182024|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101963059|NCT02182024|Protease Inhibitors|protease inhibitors|mesh-ancestor
101963060|NCT02182024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101963061|NCT02182024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963062|NCT02182024|Anticoagulants|anticoagulants|mesh-ancestor
101963063|NCT02185846|Dirithromycin|dirithromycin|mesh-list
101963064|NCT02185846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101963065|NCT02185846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101963066|NCT02184832|Metformin|metformin|mesh-list
101963067|NCT02184832|Tryptophan|tryptophan|mesh-list
101963068|NCT02184832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101963069|NCT02184832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963070|NCT02184832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101963071|NCT02184832|Antidepressive Agents|antidepressive agents|mesh-ancestor
101963072|NCT02184832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101963073|NCT01083797|Dexmedetomidine|dexmedetomidine|mesh-list
101963074|NCT01083797|Chloral Hydrate|chloral hydrate|mesh-list
101963075|NCT01083797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101256442|NCT01711320|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101963076|NCT01083797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101970788|NCT05238831|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101970789|NCT05238831|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101970790|NCT05238831|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101179376|NCT02357706|Acetaminophen|acetaminophen|mesh-list
101963077|NCT01083797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963079|NCT01083797|Analgesics|analgesics|mesh-ancestor
101963080|NCT01083797|Sensory System Agents|sensory system agents|mesh-ancestor
101963081|NCT01083797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101963082|NCT01083797|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101963083|NCT01083797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101963084|NCT01083797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101963085|NCT01083797|Adrenergic Agents|adrenergic agents|mesh-ancestor
101963086|NCT01083797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101963087|NCT01083797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963088|NCT01083875|Amlexanox|amlexanox|mesh-list
101963089|NCT01083875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101963090|NCT01068977|Bevacizumab|bevacizumab|mesh-list
101963091|NCT01068977|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101963092|NCT01068977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101963093|NCT01068977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101963094|NCT01068977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101963095|NCT01068977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101963096|NCT01068977|Growth Substances|growth substances|mesh-ancestor
101963097|NCT01068977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963098|NCT01068977|Growth Inhibitors|growth inhibitors|mesh-ancestor
101963099|NCT01068977|Immunologic Factors|immunologic factors|mesh-ancestor
101963100|NCT02184910|Gastrins|gastrins|mesh-list
101963101|NCT02184910|Hormones|hormones|mesh-ancestor
101574934|NCT02760355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101963102|NCT02184910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101963103|NCT02184910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963104|NCT02185924|Parecoxib|parecoxib|mesh-list
101963105|NCT02185924|Ropivacaine|ropivacaine|mesh-list
101963106|NCT02185924|Anesthetics, Local|anesthetics, local|mesh-ancestor
101963107|NCT02185924|Anesthetics|anesthetics|mesh-ancestor
101963108|NCT02185924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101963109|NCT02185924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963110|NCT02185924|Sensory System Agents|sensory system agents|mesh-ancestor
101963111|NCT02185924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101963112|NCT02185924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101963113|NCT02185924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101963114|NCT02185924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101963115|NCT02185924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963116|NCT02185924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101963117|NCT02185924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101963118|NCT02185924|Analgesics|analgesics|mesh-ancestor
101963119|NCT02185924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101963120|NCT02185924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101963121|NCT02185066|Metformin|metformin|mesh-list
101963122|NCT02185066|Atorvastatin|atorvastatin|mesh-list
101963123|NCT02185066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101963124|NCT02185066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963125|NCT02185066|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101963126|NCT02185066|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101963127|NCT02185066|Antimetabolites|antimetabolites|mesh-ancestor
101963128|NCT02185066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963129|NCT02185066|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101963130|NCT02185066|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101963131|NCT02185066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101963132|NCT01081223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
101963133|NCT01081223|Immunologic Factors|immunologic factors|mesh-ancestor
101963134|NCT01081223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963135|NCT01069055|Acetaminophen|acetaminophen|mesh-list
101963136|NCT01069055|Lornoxicam|lornoxicam|mesh-list
101963137|NCT01069055|Piroxicam|piroxicam|mesh-list
101963138|NCT01069055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101963139|NCT01069055|Analgesics|analgesics|mesh-ancestor
101963140|NCT01069055|Sensory System Agents|sensory system agents|mesh-ancestor
101963141|NCT01069055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101963142|NCT01069055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963143|NCT01069055|Antipyretics|antipyretics|mesh-ancestor
101963144|NCT01069055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101970791|NCT05238831|Hormone Antagonists|hormone antagonists|mesh-ancestor
101970792|NCT05238831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101970793|NCT05238831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101392462|NCT04643379|Olaparib|olaparib|mesh-list
101963145|NCT01069055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101963146|NCT01069055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101963147|NCT01069055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101963148|NCT01069055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101963149|NCT01069055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963150|NCT01083953|Sevoflurane|sevoflurane|mesh-list
101963151|NCT01083953|Desflurane|desflurane|mesh-list
101692275|NCT00956215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101963152|NCT01083953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101963153|NCT01083953|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101963154|NCT01083953|Anesthetics, General|anesthetics, general|mesh-ancestor
101963155|NCT01083953|Anesthetics|anesthetics|mesh-ancestor
101963156|NCT01083953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101963157|NCT01083953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963158|NCT02190526|Mesalamine|mesalamine|mesh-list
101963159|NCT02190526|Amitriptyline|amitriptyline|mesh-list
101963160|NCT02190526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101963161|NCT02190526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101963162|NCT02190526|Analgesics|analgesics|mesh-ancestor
101963163|NCT02190526|Sensory System Agents|sensory system agents|mesh-ancestor
101963164|NCT02190526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101963165|NCT02190526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963166|NCT02190526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101963167|NCT02190526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101963168|NCT02190526|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101963169|NCT02190526|Antidepressive Agents|antidepressive agents|mesh-ancestor
101963170|NCT02190526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101963171|NCT02190526|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101963172|NCT02190526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101963173|NCT02190526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101963174|NCT02190526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963175|NCT02190526|Adrenergic Agents|adrenergic agents|mesh-ancestor
101963177|NCT01084031|Propofol|propofol|mesh-list
101963178|NCT01084031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101963179|NCT01084031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101963180|NCT01084031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963181|NCT01084031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101963182|NCT01084031|Anesthetics, General|anesthetics, general|mesh-ancestor
101963183|NCT01084031|Anesthetics|anesthetics|mesh-ancestor
101963184|NCT02185222|Cholecalciferol|cholecalciferol|mesh-list
101963185|NCT02185222|Vitamin D|vitamin d|mesh-list
101963186|NCT02185222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101963187|NCT02185222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963188|NCT02185222|Vitamins|vitamins|mesh-ancestor
101963189|NCT02185222|Micronutrients|micronutrients|mesh-ancestor
101963190|NCT02185222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101963191|NCT01084187|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101963192|NCT01084187|Vasodilator Agents|vasodilator agents|mesh-ancestor
101963193|NCT01084187|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101963194|NCT01084187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101963195|NCT01084187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101963196|NCT01084187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963197|NCT01084187|Urological Agents|urological agents|mesh-ancestor
101963198|NCT02185300|Dolutegravir|dolutegravir|mesh-list
101963199|NCT02185300|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101963200|NCT02185300|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101963201|NCT02185300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101963202|NCT02185300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963203|NCT02185300|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101963204|NCT02185300|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101963205|NCT02185300|Antiviral Agents|antiviral agents|mesh-ancestor
101963206|NCT02185300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101963207|NCT02190760|Dexamethasone|dexamethasone|mesh-list
101963208|NCT02190760|Bupivacaine|bupivacaine|mesh-list
101963209|NCT02190760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101963210|NCT02190760|Antiemetics|antiemetics|mesh-ancestor
101963211|NCT02190760|Autonomic Agents|autonomic agents|mesh-ancestor
101970794|NCT05238831|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101392538|NCT04619797|Carboplatin|carboplatin|mesh-list
101963212|NCT02190760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101963213|NCT02190760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963214|NCT02190760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101963215|NCT02190760|Glucocorticoids|glucocorticoids|mesh-ancestor
101963216|NCT02190760|Hormones|hormones|mesh-ancestor
101963217|NCT02190760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101963218|NCT02190760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101963219|NCT02190760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101963220|NCT02190760|Anesthetics, Local|anesthetics, local|mesh-ancestor
101963221|NCT02190760|Anesthetics|anesthetics|mesh-ancestor
101963222|NCT02190760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101963223|NCT02190760|Sensory System Agents|sensory system agents|mesh-ancestor
101963224|NCT02190838|Metformin|metformin|mesh-list
101963225|NCT02190838|Dacarbazine|dacarbazine|mesh-list
101963226|NCT02190838|Melatonin|melatonin|mesh-list
101963227|NCT02190838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101963228|NCT02190838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963229|NCT02190838|Antioxidants|antioxidants|mesh-ancestor
101963230|NCT02190838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963231|NCT02190838|Protective Agents|protective agents|mesh-ancestor
101963232|NCT02190838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101963233|NCT02190838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101963234|NCT02190838|Alkylating Agents|alkylating agents|mesh-ancestor
101963235|NCT02190838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101963236|NCT02185456|Metronidazole|metronidazole|mesh-list
101963237|NCT02185456|Miconazole|miconazole|mesh-list
101963238|NCT02185456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101963239|NCT02185456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101963240|NCT02185456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101963241|NCT02185456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101963242|NCT02185456|Antifungal Agents|antifungal agents|mesh-ancestor
101963243|NCT02185456|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101963244|NCT02185456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101963245|NCT02185456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101963246|NCT02185456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963247|NCT02185456|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101963248|NCT02185456|Hormone Antagonists|hormone antagonists|mesh-ancestor
101963249|NCT02185456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101574935|NCT01028391|Metformin|metformin|mesh-list
101963250|NCT02185456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963251|NCT02185456|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101963252|NCT02185456|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101963254|NCT02190994|Hydrocortisone|hydrocortisone|mesh-list
101963255|NCT02190994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101963256|NCT02190994|Glucocorticoids|glucocorticoids|mesh-ancestor
101963257|NCT02190994|Hormones|hormones|mesh-ancestor
101256778|NCT01712828|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101963258|NCT02190994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101963259|NCT02190994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963260|NCT02190994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101963261|NCT02190994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101963263|NCT02193568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101963264|NCT02193568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963265|NCT02191072|Omalizumab|omalizumab|mesh-list
101963266|NCT02191072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101963267|NCT02191072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101963268|NCT02191072|Respiratory System Agents|respiratory system agents|mesh-ancestor
101963269|NCT02191228|Linagliptin|linagliptin|mesh-list
101963270|NCT02191228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101963271|NCT02191228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963272|NCT02191228|Incretins|incretins|mesh-ancestor
101963273|NCT02191228|Hormones|hormones|mesh-ancestor
101963274|NCT02191228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101963275|NCT02191228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101963276|NCT02191228|Protease Inhibitors|protease inhibitors|mesh-ancestor
101963277|NCT02191228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101963278|NCT02191228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963279|NCT02186782|Citric Acid|citric acid|mesh-list
101963280|NCT02186782|Sodium Citrate|sodium citrate|mesh-list
101963281|NCT02186782|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101970795|NCT05238831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101970796|NCT05238831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101963282|NCT02186782|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101963283|NCT02186782|Clomiphene|clomiphene|mesh-list
101963284|NCT02186782|Enclomiphene|enclomiphene|mesh-list
101963285|NCT02186782|Zuclomiphene|zuclomiphene|mesh-list
101963286|NCT02186782|Estradiol|estradiol|mesh-list
101963287|NCT02186782|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101963288|NCT02186782|Anticoagulants|anticoagulants|mesh-ancestor
101963289|NCT02186782|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101963290|NCT02186782|Chelating Agents|chelating agents|mesh-ancestor
101963291|NCT02186782|Sequestering Agents|sequestering agents|mesh-ancestor
101963292|NCT02186782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963293|NCT02186782|Estrogens|estrogens|mesh-ancestor
101963294|NCT02186782|Hormones|hormones|mesh-ancestor
101963295|NCT02186782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101963296|NCT02186782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963297|NCT02186782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101963298|NCT02186782|Contraceptive Agents|contraceptive agents|mesh-ancestor
101963299|NCT02186782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101963300|NCT02186782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101963301|NCT02186782|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101963302|NCT02186782|Hormone Antagonists|hormone antagonists|mesh-ancestor
101963303|NCT02186782|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101963304|NCT02186782|Fertility Agents|fertility agents|mesh-ancestor
101963305|NCT02186782|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101963306|NCT02186782|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101963308|NCT02187250|Liraglutide|liraglutide|mesh-list
101963309|NCT02187250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101963310|NCT02187250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963311|NCT02187250|Incretins|incretins|mesh-ancestor
101963312|NCT02187250|Hormones|hormones|mesh-ancestor
101963313|NCT02187250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101963314|NCT03535480|Lenograstim|lenograstim|mesh-list
101963315|NCT03535480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101963316|NCT03535480|Immunologic Factors|immunologic factors|mesh-ancestor
101257012|NCT01714115|Aflibercept|aflibercept|mesh-list
101963317|NCT03535480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963318|NCT02187484|Telmisartan|telmisartan|mesh-list
101963319|NCT02187484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101963320|NCT02187484|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101963321|NCT02187484|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101963322|NCT02187484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963323|NCT02256748|Midazolam|midazolam|mesh-list
101963324|NCT02256748|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101963325|NCT02256748|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101963326|NCT02256748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101257139|NCT01714596|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101963327|NCT02256748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963328|NCT02256748|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101963329|NCT02256748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101963330|NCT02256748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101963331|NCT02256748|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101963332|NCT02256748|Anesthetics, General|anesthetics, general|mesh-ancestor
101963333|NCT02256748|Anesthetics|anesthetics|mesh-ancestor
101963334|NCT02256748|GABA Modulators|gaba modulators|mesh-ancestor
101963335|NCT02256748|GABA Agents|gaba agents|mesh-ancestor
101963336|NCT02256748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101963337|NCT02256748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963338|NCT02187562|Aspirin|aspirin|mesh-list
101963339|NCT02187562|Meloxicam|meloxicam|mesh-list
101963340|NCT02187562|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101963341|NCT02187562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101963342|NCT02187562|Analgesics|analgesics|mesh-ancestor
101963343|NCT02187562|Sensory System Agents|sensory system agents|mesh-ancestor
101963344|NCT02187562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101963345|NCT02187562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257352|NCT01715909|Oseltamivir|oseltamivir|mesh-list
101963346|NCT02187562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101963347|NCT02187562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101963348|NCT02187562|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101963349|NCT02187562|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101970798|NCT05222516|Broncho-Vaxom|broncho-vaxom|mesh-list
101970799|NCT05222516|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101970800|NCT05222516|Immunologic Factors|immunologic factors|mesh-ancestor
101970801|NCT05222516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970802|NCT05209360|Carbon Fiber|carbon fiber|mesh-list
101970803|NCT05209360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101963350|NCT02187562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963351|NCT02187562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101963352|NCT02187562|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101963353|NCT02187562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101963354|NCT02187562|Antipyretics|antipyretics|mesh-ancestor
101963355|NCT02187562|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101963356|NCT02187718|Anesthetics|anesthetics|mesh-list
101257563|NCT01717599|Diclofenac|diclofenac|mesh-list
101963357|NCT02187718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101963358|NCT02187718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963359|NCT03535168|Midazolam|midazolam|mesh-list
101963360|NCT03535168|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101963361|NCT03535168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101963362|NCT03535168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101963363|NCT03535168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963364|NCT03535168|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101963365|NCT03535168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101963366|NCT03535168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101963367|NCT03535168|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101257638|NCT01717950|Antacids|antacids|mesh-ancestor
101963368|NCT03535168|Anesthetics, General|anesthetics, general|mesh-ancestor
101963370|NCT03535168|GABA Modulators|gaba modulators|mesh-ancestor
101963371|NCT03535168|GABA Agents|gaba agents|mesh-ancestor
101963372|NCT03535168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101963373|NCT03535168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963375|NCT02192320|Atorvastatin|atorvastatin|mesh-list
101963376|NCT02192320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101963377|NCT02192320|Antiemetics|antiemetics|mesh-ancestor
101963378|NCT02192320|Autonomic Agents|autonomic agents|mesh-ancestor
101963379|NCT02192320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101963380|NCT02192320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963381|NCT02192320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101963382|NCT02192320|Glucocorticoids|glucocorticoids|mesh-ancestor
101963383|NCT02192320|Hormones|hormones|mesh-ancestor
101963384|NCT02192320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101257834|NCT01718717|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101963385|NCT02192320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101963386|NCT02192320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101963387|NCT02192320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101963388|NCT02192320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101963389|NCT02192320|Antimetabolites|antimetabolites|mesh-ancestor
101963390|NCT02192320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963391|NCT02192320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101963392|NCT02192320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101963393|NCT02192320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101963394|NCT02187874|Oxytocin|oxytocin|mesh-list
101963395|NCT02187874|Oxytocics|oxytocics|mesh-ancestor
101963396|NCT02187874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101963397|NCT02187874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963398|NCT04870138|Azithromycin|azithromycin|mesh-list
101574936|NCT01028391|Pioglitazone|pioglitazone|mesh-list
101683192|NCT04189484|Evolocumab|evolocumab|mesh-list
101963399|NCT04870138|Ciprofloxacin|ciprofloxacin|mesh-list
101963400|NCT04870138|Ceftriaxone|ceftriaxone|mesh-list
101963401|NCT04870138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101963402|NCT04870138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101963403|NCT04870138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101963404|NCT04870138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101963405|NCT04870138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101963406|NCT04870138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963407|NCT04870138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101257961|NCT01719601|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101963408|NCT04870138|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101963409|NCT04870138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101970804|NCT05209360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101970805|NCT05180474|Antibodies|antibodies|mesh-list
101963410|NCT02188186|Metformin|metformin|mesh-list
101963411|NCT02188186|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101963412|NCT02188186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101963413|NCT02188186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963414|NCT02188186|Incretins|incretins|mesh-ancestor
101963415|NCT02188186|Hormones|hormones|mesh-ancestor
101963416|NCT02188186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101963418|NCT02188186|Protease Inhibitors|protease inhibitors|mesh-ancestor
101963419|NCT02188186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101963420|NCT02188186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963421|NCT02192632|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
101963422|NCT02192632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101963423|NCT02192632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101963424|NCT02192632|Analgesics|analgesics|mesh-ancestor
101963425|NCT02192632|Sensory System Agents|sensory system agents|mesh-ancestor
101963426|NCT02192632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101963427|NCT02192632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963428|NCT02192632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101963429|NCT02192632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101963430|NCT02192632|Dermatologic Agents|dermatologic agents|mesh-ancestor
101963431|NCT03535090|Methylprednisolone|methylprednisolone|mesh-list
101963432|NCT03535090|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101963433|NCT03535090|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101963434|NCT03535090|Prednisolone|prednisolone|mesh-list
101963435|NCT03535090|Prednisolone acetate|prednisolone acetate|mesh-list
101963436|NCT03535090|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101963437|NCT03535090|Prednisolone phosphate|prednisolone phosphate|mesh-list
101963438|NCT03535090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101963439|NCT03535090|Antiemetics|antiemetics|mesh-ancestor
101963440|NCT03535090|Autonomic Agents|autonomic agents|mesh-ancestor
101963441|NCT03535090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101963442|NCT03535090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963443|NCT03535090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101963445|NCT03535090|Hormones|hormones|mesh-ancestor
101692358|NCT00601640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101963446|NCT03535090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101963447|NCT03535090|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101258374|NCT01731067|Anesthetics|anesthetics|mesh-ancestor
101963448|NCT03535090|Protective Agents|protective agents|mesh-ancestor
101963449|NCT03535090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101963450|NCT03535090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101963452|NCT03535870|Xhance|xhance|mesh-list
101963454|NCT03535870|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101963455|NCT03535870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101963456|NCT03535870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101963457|NCT03535870|Autonomic Agents|autonomic agents|mesh-ancestor
101963458|NCT03535870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101963459|NCT03535870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963460|NCT03535870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101963461|NCT03535870|Respiratory System Agents|respiratory system agents|mesh-ancestor
101963462|NCT03535870|Dermatologic Agents|dermatologic agents|mesh-ancestor
101963463|NCT03535870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101963464|NCT03535870|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101963465|NCT03535870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101963466|NCT03535870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101963467|NCT03535870|Adrenergic Agents|adrenergic agents|mesh-ancestor
101963468|NCT03535870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101963469|NCT03535870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963470|NCT03535870|Glucocorticoids|glucocorticoids|mesh-ancestor
101963471|NCT03535870|Hormones|hormones|mesh-ancestor
101963472|NCT03535870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101963473|NCT03535870|Sympathomimetics|sympathomimetics|mesh-ancestor
101963474|NCT02192710|Midazolam|midazolam|mesh-list
101963475|NCT02192710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101963476|NCT02192710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101963477|NCT02192710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101963478|NCT02192710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963479|NCT02192710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101963480|NCT02192710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101963481|NCT02192710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101963482|NCT02192710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101963484|NCT02192710|Anesthetics|anesthetics|mesh-ancestor
101970807|NCT05180474|Immunologic Factors|immunologic factors|mesh-ancestor
101970808|NCT05180474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970809|NCT05169515|Obinutuzumab|obinutuzumab|mesh-list
101970810|NCT05169515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101970811|NCT05169515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970812|NCT05149131|Leuprolide|leuprolide|mesh-list
101970813|NCT05149131|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101970814|NCT05149131|Fertility Agents|fertility agents|mesh-ancestor
101970815|NCT05149131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101574939|NCT01028391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970816|NCT05149131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970817|NCT05149131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101970818|NCT05149131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970819|NCT05139043|Dexamethasone|dexamethasone|mesh-list
101970820|NCT05139043|Dexamethasone acetate|dexamethasone acetate|mesh-list
101970821|NCT05139043|Ichthammol|ichthammol|mesh-list
101970822|NCT05139043|BB 1101|bb 1101|mesh-list
101970823|NCT05139043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101963485|NCT02192710|GABA Modulators|gaba modulators|mesh-ancestor
101963486|NCT02192710|GABA Agents|gaba agents|mesh-ancestor
101258946|NCT01735006|Vaccines|vaccines|mesh-list
101963487|NCT02192710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101963488|NCT02192710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963489|NCT02188654|Metformin|metformin|mesh-list
101963490|NCT02188654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101963491|NCT02188654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963492|NCT02192944|Chloroquine|chloroquine|mesh-list
101259078|NCT01735747|Nedaplatin|nedaplatin|mesh-list
101963493|NCT02192944|Piperaquine|piperaquine|mesh-list
101963494|NCT02192944|Artenimol|artenimol|mesh-list
101963495|NCT02192944|Amebicides|amebicides|mesh-ancestor
101963496|NCT02192944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101963497|NCT02192944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101963498|NCT02192944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101963499|NCT02192944|Antimalarials|antimalarials|mesh-ancestor
101963500|NCT02192944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101963501|NCT02193022|Miltefosine|miltefosine|mesh-list
101963502|NCT02193022|Antifungal Agents|antifungal agents|mesh-ancestor
101963503|NCT02193022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101963504|NCT02193022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101963505|NCT02193022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101963506|NCT02193022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101963507|NCT02188810|Vaccines|vaccines|mesh-list
101963508|NCT02188810|Immunologic Factors|immunologic factors|mesh-ancestor
101963509|NCT02188810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963510|NCT02188888|Esmolol|esmolol|mesh-list
101963511|NCT02188888|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101963512|NCT02188888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101963513|NCT02188888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101963514|NCT02188888|Adrenergic Agents|adrenergic agents|mesh-ancestor
101259213|NCT01736670|Immunologic Factors|immunologic factors|mesh-ancestor
101963515|NCT02188888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101963516|NCT02188888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963517|NCT02188888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963518|NCT02256826|Ritonavir|ritonavir|mesh-list
101963519|NCT02256826|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101963520|NCT02256826|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101963521|NCT02256826|Protease Inhibitors|protease inhibitors|mesh-ancestor
101963522|NCT02256826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970824|NCT05139043|Antiemetics|antiemetics|mesh-ancestor
101970825|NCT05139043|Autonomic Agents|autonomic agents|mesh-ancestor
101305597|NCT02020551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101963523|NCT02256826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963524|NCT02256826|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101963525|NCT02256826|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101963526|NCT02256826|Antiviral Agents|antiviral agents|mesh-ancestor
101963527|NCT02256826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101963528|NCT02256826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101963529|NCT02256826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101963530|NCT03535792|Fentanyl|fentanyl|mesh-list
101963531|NCT03535792|Nalbuphine|nalbuphine|mesh-list
101963532|NCT03535792|Bupivacaine|bupivacaine|mesh-list
101963533|NCT03535792|Anesthetics, Local|anesthetics, local|mesh-ancestor
101963534|NCT03535792|Anesthetics|anesthetics|mesh-ancestor
101963535|NCT03535792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101963536|NCT03535792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963537|NCT03535792|Sensory System Agents|sensory system agents|mesh-ancestor
101963538|NCT03535792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101963539|NCT03535792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101963540|NCT03535792|Narcotics|narcotics|mesh-ancestor
101963541|NCT03535792|Analgesics|analgesics|mesh-ancestor
101963542|NCT03535792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101963543|NCT03535792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101963544|NCT03535792|Anesthetics, General|anesthetics, general|mesh-ancestor
101963545|NCT02193256|Prazosin|prazosin|mesh-list
101963546|NCT02193256|Varenicline|varenicline|mesh-list
101963547|NCT02193256|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101963548|NCT02193256|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101963549|NCT02193256|Cholinergic Agents|cholinergic agents|mesh-ancestor
101963550|NCT02193256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101963551|NCT02193256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963552|NCT02193256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963553|NCT02193256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101963554|NCT02193256|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101963555|NCT02193256|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101963557|NCT02193256|Adrenergic Agents|adrenergic agents|mesh-ancestor
101963559|NCT03535558|Fluoroquinolones|fluoroquinolones|mesh-list
101963560|NCT03535558|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101963561|NCT03535558|Trimethoprim|trimethoprim|mesh-list
101963562|NCT03535558|Sulfamethoxazole|sulfamethoxazole|mesh-list
101963563|NCT03535558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101963564|NCT03535558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101963565|NCT03535558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101963567|NCT03535558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101963568|NCT03535558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101963570|NCT03535558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101963571|NCT03535558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963572|NCT03535558|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101963573|NCT03535558|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101963574|NCT03535558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101963575|NCT03535558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101963577|NCT02193334|Mitosis Modulators|mitosis modulators|mesh-ancestor
101963578|NCT02193334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963579|NCT02194192|Ephedrine|ephedrine|mesh-list
101963580|NCT02194192|Ondansetron|ondansetron|mesh-list
101963581|NCT02194192|Antiemetics|antiemetics|mesh-ancestor
101963582|NCT02194192|Autonomic Agents|autonomic agents|mesh-ancestor
101963583|NCT02194192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101963584|NCT02194192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963585|NCT02194192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101963586|NCT02194192|Antipruritics|antipruritics|mesh-ancestor
101963587|NCT02194192|Dermatologic Agents|dermatologic agents|mesh-ancestor
101963588|NCT02194192|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101963589|NCT02194192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101963590|NCT02194192|Serotonin Agents|serotonin agents|mesh-ancestor
101963591|NCT02194192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101963592|NCT02194192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963593|NCT02194192|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101963594|NCT02194192|Sympathomimetics|sympathomimetics|mesh-ancestor
101963595|NCT02194192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101963596|NCT02194192|Adrenergic Agents|adrenergic agents|mesh-ancestor
101963597|NCT02194270|Ambroxol|ambroxol|mesh-list
101970826|NCT05139043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101970827|NCT05139043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970828|NCT05139043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101963598|NCT02194270|Expectorants|expectorants|mesh-ancestor
101963599|NCT02194270|Respiratory System Agents|respiratory system agents|mesh-ancestor
101963600|NCT02190058|DS-1971a|ds-1971a|mesh-list
101963601|NCT02190058|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101963602|NCT02190058|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101963603|NCT02190058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101963604|NCT02190058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963605|NCT02194348|Olcegepant|olcegepant|mesh-list
101963606|NCT02194348|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
101963607|NCT02194348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963608|NCT02194348|Analgesics|analgesics|mesh-ancestor
101963609|NCT02194348|Sensory System Agents|sensory system agents|mesh-ancestor
101963610|NCT02194348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101963611|NCT02194348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963612|NCT02195908|Antiemetics|antiemetics|mesh-list
101963614|NCT02195908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101260606|NCT01745601|Citalopram|citalopram|mesh-list
101963616|NCT02195908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101963617|NCT02197000|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
101963618|NCT02197000|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101963619|NCT02197000|Protective Agents|protective agents|mesh-ancestor
101963620|NCT02197000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963621|NCT02197000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101963622|NCT02196142|Hydrocortisone|hydrocortisone|mesh-list
101963623|NCT02196142|Mannitol|mannitol|mesh-list
101963624|NCT02196142|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101963625|NCT02196142|Diuretics|diuretics|mesh-ancestor
101963626|NCT02196142|Natriuretic Agents|natriuretic agents|mesh-ancestor
101963627|NCT02196142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963628|NCT02196142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101963629|NCT02257294|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101963630|NCT02257294|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101963631|NCT02257294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101963632|NCT02257294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963633|NCT03534388|Sodium Hypochlorite|sodium hypochlorite|mesh-list
101963635|NCT03534388|Disinfectants|disinfectants|mesh-ancestor
101963636|NCT03534388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101963637|NCT04308694|Methadone|methadone|mesh-list
101963638|NCT04308694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101963639|NCT04308694|Narcotics|narcotics|mesh-ancestor
101963640|NCT04308694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101963641|NCT04308694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963642|NCT04308694|Analgesics|analgesics|mesh-ancestor
101963644|NCT04308694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101963645|NCT04308694|Antitussive Agents|antitussive agents|mesh-ancestor
101963646|NCT04308694|Respiratory System Agents|respiratory system agents|mesh-ancestor
101963647|NCT03534310|Liraglutide|liraglutide|mesh-list
101963648|NCT03534310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101963649|NCT03534310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963650|NCT03534310|Incretins|incretins|mesh-ancestor
101963651|NCT03534310|Hormones|hormones|mesh-ancestor
101963652|NCT03534310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101963653|NCT02194894|Acetaminophen|acetaminophen|mesh-list
101963654|NCT02194894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101963655|NCT02194894|Analgesics|analgesics|mesh-ancestor
101963656|NCT02194894|Sensory System Agents|sensory system agents|mesh-ancestor
101963657|NCT02194894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101963658|NCT02194894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963659|NCT02194894|Antipyretics|antipyretics|mesh-ancestor
101963660|NCT03534622|Delafloxacin|delafloxacin|mesh-list
101963661|NCT03534622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101963662|NCT02197702|Vitamin D|vitamin d|mesh-list
101963663|NCT02197702|Cholecalciferol|cholecalciferol|mesh-list
101963664|NCT02197702|Vitamins|vitamins|mesh-ancestor
101963665|NCT02197702|Micronutrients|micronutrients|mesh-ancestor
101963666|NCT02197702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963667|NCT02197702|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101963668|NCT02197702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101963669|NCT02031016|Fentanyl|fentanyl|mesh-list
101963670|NCT02031016|Remifentanil|remifentanil|mesh-list
101970829|NCT05139043|Glucocorticoids|glucocorticoids|mesh-ancestor
101970830|NCT05139043|Hormones|hormones|mesh-ancestor
101305600|NCT02020551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101963671|NCT02031016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101963673|NCT02031016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101963674|NCT02031016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963675|NCT02031016|Analgesics|analgesics|mesh-ancestor
101963676|NCT02031016|Sensory System Agents|sensory system agents|mesh-ancestor
101963677|NCT02031016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101963678|NCT02031016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101963679|NCT02031016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101963680|NCT02031016|Anesthetics, General|anesthetics, general|mesh-ancestor
101963681|NCT02031016|Anesthetics|anesthetics|mesh-ancestor
101963682|NCT00095147|Infliximab|infliximab|mesh-list
101963683|NCT00095147|Methotrexate|methotrexate|mesh-list
101963684|NCT00095147|Abatacept|abatacept|mesh-list
101963685|NCT00095147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101963686|NCT00095147|Abortifacient Agents|abortifacient agents|mesh-ancestor
101963687|NCT00095147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101963688|NCT00095147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963689|NCT00095147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101963690|NCT00095147|Antimetabolites|antimetabolites|mesh-ancestor
101261626|NCT01751074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101963691|NCT00095147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963692|NCT00095147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101963693|NCT00095147|Dermatologic Agents|dermatologic agents|mesh-ancestor
101963694|NCT00095147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101261696|NCT01751854|Escitalopram|escitalopram|mesh-list
101963695|NCT00095147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101963696|NCT00095147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101963697|NCT00095147|Immunologic Factors|immunologic factors|mesh-ancestor
101963698|NCT00095147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101963699|NCT00095147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101963700|NCT00095147|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101963701|NCT00095147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101963702|NCT00095147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101963703|NCT00095147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101963704|NCT00095147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101261969|NCT01754701|Iron|iron|mesh-list
101963706|NCT02198170|Lenvatinib|lenvatinib|mesh-list
101963707|NCT02198170|Antifungal Agents|antifungal agents|mesh-ancestor
101963708|NCT02198170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101963709|NCT02198170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101963710|NCT02198170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101963711|NCT02198170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101262050|NCT01755117|Ropivacaine|ropivacaine|mesh-list
101963712|NCT02198170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963713|NCT02198170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101963714|NCT02198170|Hormone Antagonists|hormone antagonists|mesh-ancestor
101262122|NCT01755468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101963715|NCT02198170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101963716|NCT02198170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963717|NCT02198170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101963718|NCT02198170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101963719|NCT02198170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101963720|NCT02198248|Prednisolone|prednisolone|mesh-list
101963721|NCT02198248|Rituximab|rituximab|mesh-list
101963722|NCT02198248|Glucocorticoids|glucocorticoids|mesh-list
101963723|NCT02198248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101963724|NCT02198248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101963725|NCT02198248|Immunologic Factors|immunologic factors|mesh-ancestor
101963726|NCT02198248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963727|NCT02198248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101963728|NCT02198248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101963729|NCT02198248|Hormones|hormones|mesh-ancestor
101963730|NCT02198248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101963731|NCT02198248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101963732|NCT01069133|Rifaximin|rifaximin|mesh-list
101963733|NCT01069133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101963734|NCT01069133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101963735|NCT01069133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101963737|NCT02198326|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
101970831|NCT05139043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101963738|NCT02198326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963739|NCT02198326|Analgesics|analgesics|mesh-ancestor
101963740|NCT02198326|Sensory System Agents|sensory system agents|mesh-ancestor
101963741|NCT02198326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101963742|NCT02198326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963744|NCT02198404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101963745|NCT02198404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101963746|NCT02198404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262545|NCT01757587|Metformin|metformin|mesh-list
101963747|NCT02198404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101963748|NCT02198404|Anesthetics, General|anesthetics, general|mesh-ancestor
101963749|NCT02198404|Anesthetics|anesthetics|mesh-ancestor
101963751|NCT02198482|Daunorubicin|daunorubicin|mesh-list
101963752|NCT02198482|Mitoxantrone|mitoxantrone|mesh-list
101963753|NCT02198482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101262701|NCT01758263|Nebivolol|nebivolol|mesh-list
101963754|NCT02198482|Antimetabolites|antimetabolites|mesh-ancestor
101963755|NCT02198482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963756|NCT02198482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101963757|NCT02198482|Antiviral Agents|antiviral agents|mesh-ancestor
101963758|NCT02198482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101963759|NCT02198482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101963760|NCT02198482|Immunologic Factors|immunologic factors|mesh-ancestor
101262756|NCT01758666|Calcium|calcium|mesh-list
101963761|NCT02198482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963762|NCT02198482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101963763|NCT02198482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101963764|NCT02198482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101963765|NCT02198482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101963766|NCT02198482|Analgesics|analgesics|mesh-ancestor
101963767|NCT02198482|Sensory System Agents|sensory system agents|mesh-ancestor
101963768|NCT02198482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101963770|NCT03961841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101963771|NCT02201134|Sevoflurane|sevoflurane|mesh-list
101963772|NCT02201134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101963773|NCT02201134|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101963774|NCT02201134|Anesthetics, General|anesthetics, general|mesh-ancestor
101963775|NCT02201134|Anesthetics|anesthetics|mesh-ancestor
101963776|NCT02201134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101963777|NCT02201134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963779|NCT02201602|Glyburide|glyburide|mesh-list
101963780|NCT02201602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101963781|NCT02201602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963782|NCT02201914|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101963783|NCT02201914|Clomiphene|clomiphene|mesh-list
101963784|NCT02201914|Enclomiphene|enclomiphene|mesh-list
101963785|NCT02201914|Zuclomiphene|zuclomiphene|mesh-list
101963786|NCT02201914|Cetrorelix|cetrorelix|mesh-list
101963787|NCT02201914|Luteolytic Agents|luteolytic agents|mesh-ancestor
101963788|NCT02201914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101963789|NCT02201914|Contraceptive Agents|contraceptive agents|mesh-ancestor
101963790|NCT02201914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101963791|NCT02201914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963792|NCT02201914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101963793|NCT02201914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101963794|NCT02201914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101963795|NCT02201914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101963796|NCT02201914|Hormone Antagonists|hormone antagonists|mesh-ancestor
101263096|NCT01760278|Progestins|progestins|mesh-ancestor
101963797|NCT02201914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101963798|NCT02201914|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101963799|NCT02201914|Fertility Agents|fertility agents|mesh-ancestor
101963800|NCT02201914|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101963801|NCT02201914|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101963802|NCT02202070|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101963803|NCT02202070|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101963804|NCT02202070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101692428|NCT02677532|Acetaminophen|acetaminophen|mesh-list
101963805|NCT02202070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101263146|NCT01760577|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101963806|NCT02202070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963807|NCT02202070|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101963808|NCT02202070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101970832|NCT05139043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101970833|NCT05139043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970834|NCT05139043|Protease Inhibitors|protease inhibitors|mesh-ancestor
101970835|NCT05139043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970836|NCT05139043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970837|NCT05139043|Dermatologic Agents|dermatologic agents|mesh-ancestor
101970838|NCT05137054|Lenalidomide|lenalidomide|mesh-list
101970839|NCT05137054|Pomalidomide|pomalidomide|mesh-list
101970840|NCT05137054|Bortezomib|bortezomib|mesh-list
101970841|NCT05137054|Daratumumab|daratumumab|mesh-list
101970842|NCT05137054|Cemiplimab|cemiplimab|mesh-list
101970843|NCT05137054|Nirogacestat|nirogacestat|mesh-list
101970844|NCT05137054|Immunologic Factors|immunologic factors|mesh-ancestor
101970845|NCT05137054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970846|NCT05137054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101970847|NCT05137054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101970848|NCT05137054|Growth Substances|growth substances|mesh-ancestor
101963809|NCT02202070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963810|NCT02202070|Cholinergic Agents|cholinergic agents|mesh-ancestor
101963811|NCT02202070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101963812|NCT02202304|Chlorhexidine|chlorhexidine|mesh-list
101963813|NCT02202304|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101963815|NCT02202304|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101963816|NCT02202304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101963817|NCT02202304|Disinfectants|disinfectants|mesh-ancestor
101963818|NCT02202304|Dermatologic Agents|dermatologic agents|mesh-ancestor
101963819|NCT02202304|Antifungal Agents|antifungal agents|mesh-ancestor
101963820|NCT02207452|Albuterol|albuterol|mesh-list
101963821|NCT02207452|Ipratropium|ipratropium|mesh-list
101963822|NCT02207452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101963823|NCT02207452|Autonomic Agents|autonomic agents|mesh-ancestor
101963824|NCT02207452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101963825|NCT02207452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963826|NCT02207452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101963827|NCT02207452|Respiratory System Agents|respiratory system agents|mesh-ancestor
101263431|NCT01761994|Immunologic Factors|immunologic factors|mesh-ancestor
101963829|NCT02207452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101963830|NCT02207452|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101963831|NCT02207452|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101963832|NCT02207452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101963833|NCT02207452|Adrenergic Agents|adrenergic agents|mesh-ancestor
101963834|NCT02207452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101963835|NCT02207452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963836|NCT02207452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101963837|NCT02207452|Cholinergic Agents|cholinergic agents|mesh-ancestor
101963838|NCT03533062|Botulinum Toxins|botulinum toxins|mesh-list
101963839|NCT03533062|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101963840|NCT03533062|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101963841|NCT03533062|Cholinergic Antagonists|cholinergic antagonists|mesh-list
101963842|NCT03533062|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101963843|NCT03533062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101963844|NCT03533062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963845|NCT03533062|Cholinergic Agents|cholinergic agents|mesh-ancestor
101963846|NCT03533062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101963847|NCT03533062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963848|NCT03533062|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101963849|NCT03533062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101963850|NCT02207920|Vaccines|vaccines|mesh-list
101963851|NCT02207920|Immunologic Factors|immunologic factors|mesh-ancestor
101970849|NCT05137054|Growth Inhibitors|growth inhibitors|mesh-ancestor
101970850|NCT05137054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101305621|NCT02020603|Coagulants|coagulants|mesh-ancestor
101963852|NCT02207920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963853|NCT02208154|Chlorhexidine|chlorhexidine|mesh-list
101963854|NCT02208154|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101963855|NCT02208154|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101963856|NCT02208154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101963857|NCT02208154|Disinfectants|disinfectants|mesh-ancestor
101963858|NCT02208154|Dermatologic Agents|dermatologic agents|mesh-ancestor
101963859|NCT03532906|Bupivacaine|bupivacaine|mesh-list
101963860|NCT03532906|Anesthetics, Local|anesthetics, local|mesh-ancestor
101963861|NCT03532906|Anesthetics|anesthetics|mesh-ancestor
101963862|NCT03532906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101963863|NCT03532906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963864|NCT03532906|Sensory System Agents|sensory system agents|mesh-ancestor
101963865|NCT03532906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101963866|NCT02199418|Paclitaxel|paclitaxel|mesh-list
101963867|NCT02199418|Cisplatin|cisplatin|mesh-list
101963868|NCT02199418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101963869|NCT02199418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101963870|NCT02199418|Tubulin Modulators|tubulin modulators|mesh-ancestor
101263737|NCT01763463|Hormones|hormones|mesh-ancestor
101963871|NCT02199418|Antimitotic Agents|antimitotic agents|mesh-ancestor
101963872|NCT02199418|Mitosis Modulators|mitosis modulators|mesh-ancestor
101963873|NCT02199418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963874|NCT02208778|Remifentanil|remifentanil|mesh-list
101963875|NCT02208778|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101963876|NCT02208778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101963877|NCT02208778|Narcotics|narcotics|mesh-ancestor
101963878|NCT02208778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101963879|NCT02208778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963880|NCT02208778|Analgesics|analgesics|mesh-ancestor
101963881|NCT02208778|Sensory System Agents|sensory system agents|mesh-ancestor
101963882|NCT02208778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101963883|NCT02208778|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101963884|NCT02208778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101963885|NCT02208778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101963886|NCT02208778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963887|NCT02208778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101963888|NCT02208778|Antidepressive Agents|antidepressive agents|mesh-ancestor
101963889|NCT02208778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101963890|NCT02208778|Dopamine Agents|dopamine agents|mesh-ancestor
101963891|NCT02203396|Cyclosporine|cyclosporine|mesh-list
101963892|NCT02203396|Levamisole|levamisole|mesh-list
101963893|NCT02203396|Cyclosporins|cyclosporins|mesh-list
101963894|NCT02203396|Thymoglobulin|thymoglobulin|mesh-list
101963895|NCT02203396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101963896|NCT02203396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963897|NCT02203396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101963898|NCT02203396|Immunologic Factors|immunologic factors|mesh-ancestor
101963899|NCT02203396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963900|NCT02203396|Antifungal Agents|antifungal agents|mesh-ancestor
101963901|NCT02203396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101963902|NCT02203396|Dermatologic Agents|dermatologic agents|mesh-ancestor
101963903|NCT02203396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101963904|NCT02203396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101963905|NCT02203396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101963906|NCT02203396|Antinematodal Agents|antinematodal agents|mesh-ancestor
101963907|NCT02203396|Anthelmintics|anthelmintics|mesh-ancestor
101963908|NCT02203396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101963910|NCT02203552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101963911|NCT02203552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101963912|NCT02209012|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101963913|NCT02209012|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101963914|NCT02209012|Dermatologic Agents|dermatologic agents|mesh-ancestor
101963916|NCT02200354|Pemetrexed|pemetrexed|mesh-list
101963917|NCT02200354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101963918|NCT02200354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101963919|NCT02200354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101963920|NCT02200354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101963921|NCT02200354|Growth Substances|growth substances|mesh-ancestor
101963922|NCT02200354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963923|NCT02200354|Growth Inhibitors|growth inhibitors|mesh-ancestor
101970851|NCT05137054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101970852|NCT05137054|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101970853|NCT05137054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970854|NCT05137054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963924|NCT02200354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101963925|NCT02200354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963926|NCT02200354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101963927|NCT02200354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101963929|NCT02204020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101963930|NCT02204020|Antimetabolites|antimetabolites|mesh-ancestor
101963931|NCT02204020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963932|NCT02204020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101963933|NCT02204020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101963934|NCT02200822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101963935|NCT02200822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101963936|NCT02200822|Adrenergic Agents|adrenergic agents|mesh-ancestor
101963937|NCT02200822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101963938|NCT02200822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963939|NCT02200822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963940|NCT02220634|Regadenoson|regadenoson|mesh-list
101963941|NCT02220634|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
101963942|NCT02220634|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101963943|NCT02220634|Purinergic Agonists|purinergic agonists|mesh-ancestor
101963944|NCT02220634|Purinergic Agents|purinergic agents|mesh-ancestor
101963945|NCT02220634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101963946|NCT02220634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963947|NCT02220634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963948|NCT02204644|Imatinib Mesylate|imatinib mesylate|mesh-list
101963949|NCT02204644|Flumatinib|flumatinib|mesh-list
101963950|NCT02204644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101963951|NCT02204644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101963952|NCT02204644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101963953|NCT02204644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963954|NCT02204722|Imatinib Mesylate|imatinib mesylate|mesh-list
101963955|NCT02204722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101963956|NCT02204722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101963957|NCT02204722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101963958|NCT02204722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963959|NCT02204878|Parecoxib|parecoxib|mesh-list
101963960|NCT02204878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101963961|NCT02204878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101963962|NCT02204878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101963963|NCT02204878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963964|NCT02204878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101963965|NCT02204878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101963966|NCT02204878|Analgesics|analgesics|mesh-ancestor
101963967|NCT02204878|Sensory System Agents|sensory system agents|mesh-ancestor
101963968|NCT02204878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101963969|NCT02204878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963970|NCT02204878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101963971|NCT02204878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101963972|NCT02205034|Oxytocin|oxytocin|mesh-list
101963973|NCT02205034|Oxytocics|oxytocics|mesh-ancestor
101963974|NCT02205034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101963975|NCT02205034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963977|NCT02210728|Amphetamine|amphetamine|mesh-list
101963978|NCT02210728|Adderall|adderall|mesh-list
101963979|NCT02210728|Dextroamphetamine|dextroamphetamine|mesh-list
101963980|NCT02210728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101963981|NCT02210728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101963982|NCT02210728|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101963983|NCT02210728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101963984|NCT02210728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101963985|NCT02210728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963986|NCT02210728|Dopamine Agents|dopamine agents|mesh-ancestor
101970856|NCT05136703|Antiviral Agents|antiviral agents|mesh-ancestor
101970857|NCT05136703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101970858|NCT05116293|Acetaminophen|acetaminophen|mesh-list
101970859|NCT05116293|Digoxin|digoxin|mesh-list
101970860|NCT05116293|Midazolam|midazolam|mesh-list
101970861|NCT05116293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101963987|NCT02210728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101963988|NCT02210728|Sympathomimetics|sympathomimetics|mesh-ancestor
101963989|NCT02210728|Autonomic Agents|autonomic agents|mesh-ancestor
101963990|NCT02210728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101963991|NCT02210728|Adrenergic Agents|adrenergic agents|mesh-ancestor
101963992|NCT02210728|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101963993|NCT02220868|Ribavirin|ribavirin|mesh-list
101963994|NCT02220868|Sofosbuvir|sofosbuvir|mesh-list
101971972|NCT01336322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101963995|NCT02220868|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101963996|NCT02220868|Antimetabolites|antimetabolites|mesh-ancestor
101963997|NCT02220868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963998|NCT02220868|Antiviral Agents|antiviral agents|mesh-ancestor
101574937|NCT01028391|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101963999|NCT02220868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101964000|NCT02220868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101964001|NCT02220868|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101964002|NCT02221024|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101964003|NCT02221102|Aspirin|aspirin|mesh-list
101964004|NCT02221102|Edoxaban|edoxaban|mesh-list
101964005|NCT02221102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101964006|NCT02221102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101964007|NCT02221102|Analgesics|analgesics|mesh-ancestor
101964008|NCT02221102|Sensory System Agents|sensory system agents|mesh-ancestor
101964009|NCT02221102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101964010|NCT02221102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964011|NCT02221102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101964012|NCT02221102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101964013|NCT02221102|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101964014|NCT02221102|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101964015|NCT02221102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964016|NCT02221102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101964017|NCT02221102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101964018|NCT02221102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101964019|NCT02221102|Antipyretics|antipyretics|mesh-ancestor
101964020|NCT02221102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101964021|NCT02221102|Antithrombins|antithrombins|mesh-ancestor
101964022|NCT02221102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101964023|NCT02221102|Protease Inhibitors|protease inhibitors|mesh-ancestor
101964024|NCT02221102|Anticoagulants|anticoagulants|mesh-ancestor
101964025|NCT02213302|Midazolam|midazolam|mesh-list
101964026|NCT02213302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101964027|NCT02213302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101964028|NCT02213302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101964029|NCT02213302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964030|NCT02213302|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101964031|NCT02213302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101964032|NCT02213302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101264663|NCT01768884|Antioxidants|antioxidants|mesh-ancestor
101964033|NCT02213302|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101964034|NCT02213302|Anesthetics, General|anesthetics, general|mesh-ancestor
101964035|NCT02213302|Anesthetics|anesthetics|mesh-ancestor
101964036|NCT02213302|GABA Modulators|gaba modulators|mesh-ancestor
101964037|NCT02213302|GABA Agents|gaba agents|mesh-ancestor
101964038|NCT02213302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101964039|NCT02213302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964040|NCT02221180|Metformin|metformin|mesh-list
101964041|NCT02221180|Canagliflozin|canagliflozin|mesh-list
101964042|NCT02221180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101964043|NCT02221180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964044|NCT02221180|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101692497|NCT00922532|Antioxidants|antioxidants|mesh-ancestor
101964045|NCT02221180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964046|NCT02205112|Levofloxacin|levofloxacin|mesh-list
101970863|NCT05116293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101970864|NCT05116293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970865|NCT05116293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101970866|NCT05116293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101964047|NCT02205112|Nemonoxacin|nemonoxacin|mesh-list
101964048|NCT02205112|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101964049|NCT02205112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101964050|NCT02205112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101964051|NCT02205112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101964052|NCT02205112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101964053|NCT02205112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101964054|NCT02205112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964055|NCT02205112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101964056|NCT02205112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101964057|NCT02205112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101964058|NCT02205190|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101964059|NCT02205190|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101964060|NCT02205190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101964061|NCT02205190|Antimetabolites|antimetabolites|mesh-ancestor
101964062|NCT02205190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964063|NCT02205190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101964064|NCT02205190|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101964065|NCT02205190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101964066|NCT02257918|Ceftriaxone|ceftriaxone|mesh-list
101964067|NCT02257918|Zoliflodacin|zoliflodacin|mesh-list
101964068|NCT02257918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101964069|NCT02257918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101964070|NCT02257918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101964071|NCT02257918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101964072|NCT02257918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101264826|NCT01769768|Dopamine Agents|dopamine agents|mesh-ancestor
101964073|NCT02257918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964074|NCT02257918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101964075|NCT02221414|Metformin|metformin|mesh-list
101964076|NCT02221414|Linagliptin|linagliptin|mesh-list
101964077|NCT02221414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101964078|NCT02221414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964079|NCT02221414|Incretins|incretins|mesh-ancestor
101964080|NCT02221414|Hormones|hormones|mesh-ancestor
101964081|NCT02221414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101264952|NCT01770171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101964082|NCT02221414|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101964083|NCT02221414|Protease Inhibitors|protease inhibitors|mesh-ancestor
101964084|NCT02221414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101964085|NCT02221414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964087|NCT02221492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101964088|NCT02221492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101964089|NCT02221492|Antiviral Agents|antiviral agents|mesh-ancestor
101964090|NCT02221492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101964091|NCT05164978|Antibodies|antibodies|mesh-list
101964092|NCT05164978|Immunologic Factors|immunologic factors|mesh-ancestor
101964093|NCT05164978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964094|NCT02221570|Baclofen|baclofen|mesh-list
101964095|NCT02221570|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101964096|NCT02221570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265160|NCT05318365|Laxatives|laxatives|mesh-ancestor
101964097|NCT02221570|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101964098|NCT02221570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101964099|NCT02221570|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101964100|NCT02221570|GABA Agonists|gaba agonists|mesh-ancestor
101964101|NCT02221570|GABA Agents|gaba agents|mesh-ancestor
101964102|NCT02221570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101692544|NCT02802683|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101964103|NCT02221570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964104|NCT02205502|Lidocaine|lidocaine|mesh-list
101964105|NCT02205502|Anesthetics, Local|anesthetics, local|mesh-ancestor
101964106|NCT02205502|Anesthetics|anesthetics|mesh-ancestor
101964107|NCT02205502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101964108|NCT02205502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970867|NCT05116293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101970868|NCT05116293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101970869|NCT05116293|Anesthetics, General|anesthetics, general|mesh-ancestor
101970870|NCT05116293|Anesthetics|anesthetics|mesh-ancestor
101970871|NCT05116293|GABA Modulators|gaba modulators|mesh-ancestor
101970872|NCT05116293|GABA Agents|gaba agents|mesh-ancestor
101970873|NCT05116293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101970874|NCT05116293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970875|NCT05116293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101964109|NCT02205502|Sensory System Agents|sensory system agents|mesh-ancestor
101964110|NCT02205502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101964111|NCT02205502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101265336|NCT01772979|Trabectedin|trabectedin|mesh-list
101964112|NCT02205502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101964113|NCT02205502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101964114|NCT02205502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101964115|NCT02205502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964116|NCT02219698|Acetaminophen|acetaminophen|mesh-list
101964118|NCT02219698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101964119|NCT02219698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101964120|NCT02219698|Analgesics|analgesics|mesh-ancestor
101964121|NCT02219698|Sensory System Agents|sensory system agents|mesh-ancestor
101308998|NCT00005991|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101964122|NCT02219698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101964123|NCT02219698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964124|NCT02219698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101964125|NCT02219698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101964126|NCT02219698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101964127|NCT02219698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101964128|NCT02219698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964129|NCT02219698|Antipyretics|antipyretics|mesh-ancestor
101964130|NCT02205580|Sufentanil|sufentanil|mesh-list
101964132|NCT02205580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101964133|NCT02205580|Narcotics|narcotics|mesh-ancestor
101309135|NCT00006030|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101964134|NCT02205580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101964135|NCT02205580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964136|NCT02205580|Analgesics|analgesics|mesh-ancestor
101964137|NCT02205580|Sensory System Agents|sensory system agents|mesh-ancestor
101964138|NCT02205580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101964139|NCT02205580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101964140|NCT02205580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101964141|NCT02205580|Anesthetics, General|anesthetics, general|mesh-ancestor
101964142|NCT02205580|Anesthetics|anesthetics|mesh-ancestor
101964143|NCT02221960|Durvalumab|durvalumab|mesh-list
101964144|NCT02221960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101964145|NCT02221960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101964146|NCT02220088|Leucovorin|leucovorin|mesh-list
101964147|NCT02220088|Fluorouracil|fluorouracil|mesh-list
101964148|NCT02220088|Oxaliplatin|oxaliplatin|mesh-list
101683938|NCT02707328|Antimetabolites|antimetabolites|mesh-ancestor
101964149|NCT02220088|Sorafenib|sorafenib|mesh-list
101964150|NCT02220088|Antimetabolites|antimetabolites|mesh-ancestor
101964151|NCT02220088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964152|NCT02220088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101964153|NCT02220088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101964154|NCT02220088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101964155|NCT02220088|Immunologic Factors|immunologic factors|mesh-ancestor
101964156|NCT02220088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964157|NCT02220088|Antidotes|antidotes|mesh-ancestor
101964158|NCT02220088|Protective Agents|protective agents|mesh-ancestor
101964159|NCT02220088|Vitamin B Complex|vitamin b complex|mesh-ancestor
101964160|NCT02220088|Vitamins|vitamins|mesh-ancestor
101964161|NCT02220088|Micronutrients|micronutrients|mesh-ancestor
101309343|NCT04921722|Sirolimus|sirolimus|mesh-list
101964162|NCT02220088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101964163|NCT02220088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970876|NCT05116293|Analgesics|analgesics|mesh-ancestor
101970877|NCT05116293|Sensory System Agents|sensory system agents|mesh-ancestor
101970878|NCT05116293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101970879|NCT05116293|Antipyretics|antipyretics|mesh-ancestor
101970880|NCT05116293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101970881|NCT05116293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101970882|NCT05116293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970883|NCT05116293|Protective Agents|protective agents|mesh-ancestor
101970884|NCT05116189|Paclitaxel|paclitaxel|mesh-list
101964164|NCT02220400|Ketamine|ketamine|mesh-list
101964165|NCT02220400|Analgesics|analgesics|mesh-ancestor
101964166|NCT02220400|Sensory System Agents|sensory system agents|mesh-ancestor
101964167|NCT02220400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101964168|NCT02220400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964169|NCT02220400|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101964170|NCT02220400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101964171|NCT02220400|Anesthetics, General|anesthetics, general|mesh-ancestor
101964172|NCT02220400|Anesthetics|anesthetics|mesh-ancestor
101964173|NCT02220400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101964174|NCT02220400|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101964175|NCT02220400|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101964176|NCT02220400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101964177|NCT02220400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964178|NCT02205892|Lupeol|lupeol|mesh-list
101964179|NCT02205892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101964180|NCT02224768|Ipilimumab|ipilimumab|mesh-list
101964181|NCT02224768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101309464|NCT03741933|Apremilast|apremilast|mesh-list
101964182|NCT02224768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101964183|NCT02224768|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101964184|NCT02224768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964185|NCT05262166|Dexmedetomidine|dexmedetomidine|mesh-list
101964186|NCT05262166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101964187|NCT05262166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101964188|NCT05262166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964189|NCT05262166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101964190|NCT05262166|Analgesics|analgesics|mesh-ancestor
101964191|NCT05262166|Sensory System Agents|sensory system agents|mesh-ancestor
101964192|NCT05262166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101964193|NCT05262166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101964194|NCT05262166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101964195|NCT05262166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101964196|NCT05262166|Adrenergic Agents|adrenergic agents|mesh-ancestor
101964197|NCT05262166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101964198|NCT05262166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964199|NCT02206204|Moxifloxacin|moxifloxacin|mesh-list
101964200|NCT02206204|Selexipag|selexipag|mesh-list
101964201|NCT02206204|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101964202|NCT02206204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101964203|NCT02206204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101964204|NCT02206204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101964205|NCT02206204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101964206|NCT02206204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101964207|NCT02206204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964208|NCT02206204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101964209|NCT02206204|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101964210|NCT02206204|Contraceptive Agents|contraceptive agents|mesh-ancestor
101964211|NCT02206204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101964212|NCT02206204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964213|NCT02206204|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101964214|NCT02206204|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101692562|NCT00641264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101964215|NCT02206204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101964216|NCT02206204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101964217|NCT02230930|Hydrocortisone|hydrocortisone|mesh-list
101964218|NCT02230930|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101964219|NCT02230930|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101970886|NCT05116189|Bevacizumab|bevacizumab|mesh-list
101970887|NCT05116189|Pembrolizumab|pembrolizumab|mesh-list
101970888|NCT05116189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101309526|NCT02931903|Antidepressive Agents|antidepressive agents|mesh-ancestor
101964220|NCT02230930|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101964221|NCT02230930|Apomorphine|apomorphine|mesh-list
101964222|NCT02230930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101964224|NCT02230930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964225|NCT02230930|Autonomic Agents|autonomic agents|mesh-ancestor
101964226|NCT02230930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101964227|NCT02230930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101964228|NCT02230930|Dopamine Agonists|dopamine agonists|mesh-ancestor
101964229|NCT02230930|Dopamine Agents|dopamine agents|mesh-ancestor
101964230|NCT02230930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101964231|NCT02230930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964232|NCT02222350|Firuglipel|firuglipel|mesh-list
101964233|NCT02222350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101964234|NCT02222350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964235|NCT02222428|Olodaterol|olodaterol|mesh-list
101964236|NCT02222428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101964237|NCT02222428|Autonomic Agents|autonomic agents|mesh-ancestor
101964238|NCT02222428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101964239|NCT02222428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964240|NCT02222428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101964241|NCT02222428|Respiratory System Agents|respiratory system agents|mesh-ancestor
101964242|NCT02231320|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
101964243|NCT02231320|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101964244|NCT02231320|Autonomic Agents|autonomic agents|mesh-ancestor
101964245|NCT02231320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101964246|NCT02231320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964247|NCT02231320|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101309560|NCT02373813|Immunologic Factors|immunologic factors|mesh-ancestor
101964248|NCT02231320|Respiratory System Agents|respiratory system agents|mesh-ancestor
101964249|NCT02225470|Vinorelbine|vinorelbine|mesh-list
101964250|NCT02225470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101964251|NCT02225470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101964252|NCT02225470|Tubulin Modulators|tubulin modulators|mesh-ancestor
101964253|NCT02225470|Antimitotic Agents|antimitotic agents|mesh-ancestor
101964254|NCT02225470|Mitosis Modulators|mitosis modulators|mesh-ancestor
101964255|NCT02225470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964256|NCT02225548|Tadalafil|tadalafil|mesh-list
101964257|NCT02225548|Selegiline|selegiline|mesh-list
101964258|NCT02225548|Vasodilator Agents|vasodilator agents|mesh-ancestor
101964259|NCT02225548|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101964260|NCT02225548|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101964261|NCT02225548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101964262|NCT02225548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964263|NCT02225548|Urological Agents|urological agents|mesh-ancestor
101964264|NCT02225548|Antidepressive Agents|antidepressive agents|mesh-ancestor
101309608|NCT00006045|Antimetabolites|antimetabolites|mesh-ancestor
101964265|NCT02225548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101964266|NCT02225548|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101964267|NCT02225548|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101964268|NCT02225548|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101964269|NCT02225548|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101964270|NCT02225548|Protective Agents|protective agents|mesh-ancestor
101964271|NCT02225548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964273|NCT02223052|Cc-486|cc-486|mesh-list
101692572|NCT05484167|Hormones|hormones|mesh-ancestor
101964274|NCT02223052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101964275|NCT02223052|Antimetabolites|antimetabolites|mesh-ancestor
101964276|NCT02223052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964277|NCT02223052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101964278|NCT02223052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101964279|NCT02231632|Vaccines|vaccines|mesh-list
101964280|NCT02231632|Immunologic Factors|immunologic factors|mesh-ancestor
101964281|NCT02231632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964282|NCT02225782|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101964283|NCT02225782|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101964284|NCT02225782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101964285|NCT02225782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970889|NCT05116189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970890|NCT05116189|Tubulin Modulators|tubulin modulators|mesh-ancestor
101970891|NCT05116189|Antimitotic Agents|antimitotic agents|mesh-ancestor
101970892|NCT05116189|Mitosis Modulators|mitosis modulators|mesh-ancestor
101970893|NCT05116189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964286|NCT02231788|Amlodipine|amlodipine|mesh-list
101964287|NCT02231788|Telmisartan|telmisartan|mesh-list
101964288|NCT02231788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101964289|NCT02231788|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101964290|NCT02231788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101309679|NCT00006063|Pancreatin|pancreatin|mesh-list
101964291|NCT02231788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964292|NCT02231788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101964293|NCT02231788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964294|NCT02231788|Vasodilator Agents|vasodilator agents|mesh-ancestor
101964295|NCT02231788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101964296|NCT02231788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101964297|NCT02258620|Isosorbide|isosorbide|mesh-list
101964298|NCT02258620|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
101964299|NCT02258620|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
101964300|NCT02258620|Nitroglycerin|nitroglycerin|mesh-list
101964301|NCT02258620|Vasodilator Agents|vasodilator agents|mesh-ancestor
101964302|NCT02258620|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101964303|NCT02258620|Diuretics|diuretics|mesh-ancestor
101964304|NCT02258620|Natriuretic Agents|natriuretic agents|mesh-ancestor
101964305|NCT02258620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964306|NCT02258620|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101964307|NCT02258620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964308|NCT02223598|Dexamethasone|dexamethasone|mesh-list
101964309|NCT02223598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101964310|NCT02223598|Antiemetics|antiemetics|mesh-ancestor
101964311|NCT02223598|Autonomic Agents|autonomic agents|mesh-ancestor
101964312|NCT02223598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101964313|NCT02223598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964314|NCT02223598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101964315|NCT02223598|Glucocorticoids|glucocorticoids|mesh-ancestor
101964317|NCT02223598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101964318|NCT02223598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101964319|NCT02223598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101964320|NCT00094835|Paclitaxel|paclitaxel|mesh-list
101964321|NCT00094835|Carboplatin|carboplatin|mesh-list
101964322|NCT00094835|Panitumumab|panitumumab|mesh-list
101964323|NCT00094835|Motesanib diphosphate|motesanib diphosphate|mesh-list
101964324|NCT00094835|Imetelstat|imetelstat|mesh-list
101964325|NCT00094835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101964326|NCT00094835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101964327|NCT00094835|Tubulin Modulators|tubulin modulators|mesh-ancestor
101964328|NCT00094835|Antimitotic Agents|antimitotic agents|mesh-ancestor
101964329|NCT00094835|Mitosis Modulators|mitosis modulators|mesh-ancestor
101964330|NCT00094835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964331|NCT00094835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101964332|NCT00094835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101964333|NCT00094835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101964334|NCT02226328|Fentanyl|fentanyl|mesh-list
101964335|NCT02226328|Midazolam|midazolam|mesh-list
101964336|NCT02226328|Propofol|propofol|mesh-list
101964337|NCT02226328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101964338|NCT02226328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101964339|NCT02226328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964340|NCT02226328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101964341|NCT02226328|Anesthetics, General|anesthetics, general|mesh-ancestor
101964342|NCT02226328|Anesthetics|anesthetics|mesh-ancestor
101964343|NCT02226328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101964344|NCT02226328|Narcotics|narcotics|mesh-ancestor
101964345|NCT02226328|Analgesics|analgesics|mesh-ancestor
101964346|NCT02226328|Sensory System Agents|sensory system agents|mesh-ancestor
101964347|NCT02226328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101964348|NCT02226328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101964349|NCT02226328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101964350|NCT02226328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101964351|NCT02226328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101970894|NCT05116189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101970895|NCT05116189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101970896|NCT05116189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101970897|NCT05116189|Growth Substances|growth substances|mesh-ancestor
101964352|NCT02226328|GABA Modulators|gaba modulators|mesh-ancestor
101964353|NCT02226328|GABA Agents|gaba agents|mesh-ancestor
101309776|NCT00006120|Paclitaxel|paclitaxel|mesh-list
101964354|NCT02226328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101964355|NCT02226328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964356|NCT03962777|Chlorhexidine|chlorhexidine|mesh-list
101964357|NCT03962777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101964358|NCT03962777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101964359|NCT03962777|Disinfectants|disinfectants|mesh-ancestor
101964360|NCT02226484|Quercetin|quercetin|mesh-list
101964361|NCT02226484|Antioxidants|antioxidants|mesh-ancestor
101964362|NCT02226484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964363|NCT02226484|Protective Agents|protective agents|mesh-ancestor
101964364|NCT02226484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964365|NCT04453852|Vaccines|vaccines|mesh-list
101964366|NCT04453852|Immunologic Factors|immunologic factors|mesh-ancestor
101964367|NCT04453852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964368|NCT00094757|Pioglitazone|pioglitazone|mesh-list
101964369|NCT00094757|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101964370|NCT00094757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101964371|NCT00094757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964373|NCT00094757|Hormones|hormones|mesh-ancestor
101964374|NCT00094757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101964375|NCT00094757|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101964377|NCT00094757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101964378|NCT00094757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964379|NCT02223832|Ponesimod|ponesimod|mesh-list
101964380|NCT02223832|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101964381|NCT02223832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964382|NCT02223832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101964383|NCT02223832|Immunologic Factors|immunologic factors|mesh-ancestor
101964384|NCT02223832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964385|NCT02224066|Aspirin|aspirin|mesh-list
101964386|NCT02224066|Clopidogrel|clopidogrel|mesh-list
101964387|NCT02224066|Ticagrelor|ticagrelor|mesh-list
101964388|NCT02224066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101964389|NCT02224066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101964390|NCT02224066|Analgesics|analgesics|mesh-ancestor
101964391|NCT02224066|Sensory System Agents|sensory system agents|mesh-ancestor
101964392|NCT02224066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101964393|NCT02224066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964394|NCT02224066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101964395|NCT02224066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101964396|NCT02224066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101964397|NCT02224066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101692589|NCT02676986|Exemestane|exemestane|mesh-list
101964398|NCT02224066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964399|NCT02224066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101964400|NCT02224066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101964401|NCT02224066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101964402|NCT02224066|Antipyretics|antipyretics|mesh-ancestor
101964403|NCT02224066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101964404|NCT02224066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101964405|NCT02224066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101964406|NCT02224066|Purinergic Agents|purinergic agents|mesh-ancestor
101964407|NCT02224066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101964408|NCT02227030|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101964409|NCT04378114|Acetaminophen|acetaminophen|mesh-list
101964410|NCT04378114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101964411|NCT04378114|Analgesics|analgesics|mesh-ancestor
101964413|NCT04378114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101964414|NCT04378114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964415|NCT04378114|Antipyretics|antipyretics|mesh-ancestor
101964416|NCT00082433|Capecitabine|capecitabine|mesh-list
101964417|NCT00082433|Epothilones|epothilones|mesh-list
101964418|NCT00082433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101964419|NCT00082433|Antimetabolites|antimetabolites|mesh-ancestor
101970898|NCT05116189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180884|NCT02517996|Lidocaine|lidocaine|mesh-list
101964420|NCT00082433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964421|NCT00082433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101964422|NCT00082433|Tubulin Modulators|tubulin modulators|mesh-ancestor
101964423|NCT00082433|Antimitotic Agents|antimitotic agents|mesh-ancestor
101964424|NCT00082433|Mitosis Modulators|mitosis modulators|mesh-ancestor
101964425|NCT00094445|Curcumin|curcumin|mesh-list
101964426|NCT00094445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101964427|NCT00094445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101964428|NCT00094445|Analgesics|analgesics|mesh-ancestor
101964429|NCT00094445|Sensory System Agents|sensory system agents|mesh-ancestor
101964430|NCT00094445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101964431|NCT00094445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964432|NCT00094445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101964433|NCT00094445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101964434|NCT00094445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101964435|NCT00094445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101964436|NCT00094445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964437|NCT01081535|Ketorolac|ketorolac|mesh-list
101964438|NCT01081535|Fentanyl|fentanyl|mesh-list
101964439|NCT01081535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101964440|NCT01081535|Narcotics|narcotics|mesh-ancestor
101964441|NCT01081535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101964442|NCT01081535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964443|NCT01081535|Analgesics|analgesics|mesh-ancestor
101964444|NCT01081535|Sensory System Agents|sensory system agents|mesh-ancestor
101964445|NCT01081535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101964446|NCT01081535|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101964447|NCT01081535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101964448|NCT01081535|Anesthetics, General|anesthetics, general|mesh-ancestor
101684229|NCT04470674|Pemetrexed|pemetrexed|mesh-list
101964449|NCT01081535|Anesthetics|anesthetics|mesh-ancestor
101964450|NCT01081535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101964451|NCT01081535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101964452|NCT01081535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101964453|NCT01081535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101964454|NCT01081535|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101964455|NCT01081535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101964456|NCT01081535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964457|NCT01087229|Nitrous Oxide|nitrous oxide|mesh-list
101964458|NCT01087229|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101964459|NCT01087229|Anesthetics, General|anesthetics, general|mesh-ancestor
101964460|NCT01087229|Anesthetics|anesthetics|mesh-ancestor
101964461|NCT01087229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101964462|NCT01087229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964463|NCT01087229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101964464|NCT01087229|Analgesics|analgesics|mesh-ancestor
101964465|NCT01087229|Sensory System Agents|sensory system agents|mesh-ancestor
101964466|NCT01087229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101964467|NCT00082355|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101964468|NCT00082355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101964469|NCT00082355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101964470|NCT00082355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964471|NCT01084577|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101964472|NCT01084577|Laxatives|laxatives|mesh-ancestor
101964473|NCT01084577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101964474|NCT00094055|Axitinib|axitinib|mesh-list
101964475|NCT00094055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101964476|NCT00094055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101964477|NCT00094055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101309992|NCT00006240|Antiemetics|antiemetics|mesh-ancestor
101964478|NCT00094055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964480|NCT02531165|Heparin|heparin|mesh-list
101964481|NCT02531165|Fentanyl|fentanyl|mesh-list
101964482|NCT02531165|Morphine|morphine|mesh-list
101964483|NCT02531165|Ticagrelor|ticagrelor|mesh-list
101964484|NCT02531165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101964485|NCT02531165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101964486|NCT02531165|Analgesics|analgesics|mesh-ancestor
101964487|NCT02531165|Sensory System Agents|sensory system agents|mesh-ancestor
101964488|NCT02531165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101964489|NCT02531165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964490|NCT02531165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101970899|NCT05116189|Growth Inhibitors|growth inhibitors|mesh-ancestor
101970900|NCT05116189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101964491|NCT02531165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101964492|NCT02531165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101964493|NCT02531165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101964494|NCT02531165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964495|NCT02531165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101964496|NCT02531165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101964497|NCT02531165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101964498|NCT02531165|Antipyretics|antipyretics|mesh-ancestor
101964499|NCT02531165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101964500|NCT02531165|Narcotics|narcotics|mesh-ancestor
101964501|NCT02531165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101964502|NCT02531165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101964503|NCT02531165|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101964504|NCT02531165|Anesthetics, General|anesthetics, general|mesh-ancestor
101964505|NCT02531165|Anesthetics|anesthetics|mesh-ancestor
101964506|NCT02531165|Anticoagulants|anticoagulants|mesh-ancestor
101964507|NCT02531165|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101964508|NCT02531165|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101964509|NCT02531165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101964510|NCT02531165|Purinergic Agents|purinergic agents|mesh-ancestor
101964511|NCT02531165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101964512|NCT00099983|Risperidone|risperidone|mesh-list
101964513|NCT00099983|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101964514|NCT00099983|Serotonin Agents|serotonin agents|mesh-ancestor
101964515|NCT00099983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101964516|NCT00099983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692613|NCT02799797|Analgesics|analgesics|mesh-ancestor
101964517|NCT00099983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964518|NCT00099983|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101964519|NCT00099983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101964520|NCT00099983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101964521|NCT00099983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101684313|NCT02635971|Gemcitabine|gemcitabine|mesh-list
101964522|NCT00099983|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101964523|NCT00099983|Dopamine Agents|dopamine agents|mesh-ancestor
101964524|NCT00099359|Lamivudine|lamivudine|mesh-list
101964525|NCT00099359|Zidovudine|zidovudine|mesh-list
101964526|NCT00099359|Nevirapine|nevirapine|mesh-list
101964527|NCT00099359|Nelfinavir|nelfinavir|mesh-list
101964528|NCT00099359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101964529|NCT00099359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101964530|NCT00099359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101964531|NCT00099359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964532|NCT00099359|Antiviral Agents|antiviral agents|mesh-ancestor
101964533|NCT00099359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101964534|NCT00099359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101964535|NCT00099359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101964536|NCT00099359|Antimetabolites|antimetabolites|mesh-ancestor
101964537|NCT00099359|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101964538|NCT00099359|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101964539|NCT00099359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101964540|NCT00099359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101964541|NCT00099359|Protease Inhibitors|protease inhibitors|mesh-ancestor
101964542|NCT00092417|Vaccines|vaccines|mesh-list
101964543|NCT00092417|Immunologic Factors|immunologic factors|mesh-ancestor
101964544|NCT00092417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964545|NCT00091949|Pioglitazone|pioglitazone|mesh-list
101964546|NCT00091949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101964547|NCT00091949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964548|NCT02258542|Benralizumab|benralizumab|mesh-list
101964549|NCT02258542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101964550|NCT02258542|Respiratory System Agents|respiratory system agents|mesh-ancestor
101964551|NCT00091793|Denosumab|denosumab|mesh-list
101964552|NCT00091793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101964553|NCT00091793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964554|NCT00098813|Romidepsin|romidepsin|mesh-list
101964555|NCT00098813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101964556|NCT00098813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101964557|NCT00098813|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101964558|NCT00098813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101964559|NCT00098813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964560|NCT01081613|Bevacizumab|bevacizumab|mesh-list
101964561|NCT01081613|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
101970902|NCT05104567|Cetuximab|cetuximab|mesh-list
101970903|NCT05104567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101970904|NCT05104567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101964562|NCT01081613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101964563|NCT01081613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101964564|NCT01081613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101964565|NCT01081613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101964566|NCT01081613|Growth Substances|growth substances|mesh-ancestor
101964567|NCT01081613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964568|NCT01081613|Growth Inhibitors|growth inhibitors|mesh-ancestor
101964569|NCT01081613|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101964570|NCT01081613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964571|NCT02227264|Parathyroid Hormone|parathyroid hormone|mesh-list
101964572|NCT02227264|Cinacalcet|cinacalcet|mesh-list
101964573|NCT02227264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101964574|NCT02227264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964575|NCT02227264|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101964576|NCT02227264|Hormone Antagonists|hormone antagonists|mesh-ancestor
101964577|NCT02227264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101964578|NCT02227420|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101964579|NCT02227420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101964581|NCT04772248|Infliximab|infliximab|mesh-list
101964582|NCT04772248|Golimumab|golimumab|mesh-list
101964583|NCT04772248|Certolizumab Pegol|certolizumab pegol|mesh-list
101964584|NCT04772248|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
101964585|NCT04772248|Etanercept|etanercept|mesh-list
101964586|NCT04772248|Tofacitinib|tofacitinib|mesh-list
101964587|NCT04772248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101964588|NCT04772248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101964589|NCT04772248|Dermatologic Agents|dermatologic agents|mesh-ancestor
101964590|NCT04772248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101964591|NCT04772248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101964592|NCT04772248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101964593|NCT04772248|Analgesics|analgesics|mesh-ancestor
101964594|NCT04772248|Sensory System Agents|sensory system agents|mesh-ancestor
101964595|NCT04772248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101964596|NCT04772248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964597|NCT04772248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101964598|NCT04772248|Immunologic Factors|immunologic factors|mesh-ancestor
101964599|NCT04772248|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101964600|NCT04772248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101964601|NCT04772248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101964602|NCT04772248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964603|NCT00090857|Letrozole|letrozole|mesh-list
101964604|NCT00090857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101964605|NCT00090857|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101964606|NCT00090857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101964607|NCT00090857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101964608|NCT00090857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964609|NCT00090857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101964610|NCT00090857|Hormone Antagonists|hormone antagonists|mesh-ancestor
101964611|NCT00090857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101964612|NCT00090857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964613|NCT01775644|Bevacizumab|bevacizumab|mesh-list
101964614|NCT01775644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101964615|NCT01775644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101964616|NCT01775644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101964617|NCT01775644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101964618|NCT01775644|Growth Substances|growth substances|mesh-ancestor
101964619|NCT01775644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964620|NCT01775644|Growth Inhibitors|growth inhibitors|mesh-ancestor
101964621|NCT04259086|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101964622|NCT04259086|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101964623|NCT04259086|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101964624|NCT04259086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101964625|NCT04259086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964626|NCT04259086|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101964627|NCT04259086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101970905|NCT05104567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101970906|NCT05104567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970907|NCT05097651|Cannabidiol|cannabidiol|mesh-list
101964628|NCT04259086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964629|NCT04259086|Cholinergic Agents|cholinergic agents|mesh-ancestor
101964630|NCT04259086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101964631|NCT00090779|Ritonavir|ritonavir|mesh-list
101964632|NCT00090779|Lopinavir|lopinavir|mesh-list
101964633|NCT00090779|Tenofovir|tenofovir|mesh-list
101964634|NCT00090779|Emtricitabine|emtricitabine|mesh-list
101964635|NCT00090779|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101964636|NCT00090779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101964637|NCT00090779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101964638|NCT00090779|Protease Inhibitors|protease inhibitors|mesh-ancestor
101964639|NCT00090779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101964640|NCT00090779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964641|NCT00090779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101964642|NCT00090779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101964643|NCT00090779|Antiviral Agents|antiviral agents|mesh-ancestor
101964644|NCT00090779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101692634|NCT02802137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101964645|NCT00090779|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101964646|NCT00090779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101964647|NCT00090779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101964648|NCT00090779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101964649|NCT01081691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101964650|NCT01081691|Immunologic Factors|immunologic factors|mesh-ancestor
101964651|NCT01081691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964652|NCT01081847|Mannitol|mannitol|mesh-list
101964653|NCT01081847|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101964654|NCT01081847|Freund's Adjuvant|freund's adjuvant|mesh-list
101964655|NCT01081847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101964656|NCT01081847|Immunologic Factors|immunologic factors|mesh-ancestor
101964657|NCT01081847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964658|NCT01081847|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101964659|NCT01081847|Diuretics|diuretics|mesh-ancestor
101964660|NCT01081847|Natriuretic Agents|natriuretic agents|mesh-ancestor
101964661|NCT02224456|Tenofovir|tenofovir|mesh-list
101964662|NCT02224456|Antiviral Agents|antiviral agents|mesh-ancestor
101964663|NCT02224456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101964664|NCT02224456|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101310479|NCT00006345|Dexamethasone|dexamethasone|mesh-list
101964665|NCT02224456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101964666|NCT02224456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101964667|NCT02224456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964668|NCT02224456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101964669|NCT02224456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101964670|NCT02224534|Clopidogrel|clopidogrel|mesh-list
101964671|NCT02224534|Ticagrelor|ticagrelor|mesh-list
101964672|NCT02224534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101684448|NCT00880191|Anticonvulsants|anticonvulsants|mesh-ancestor
101964673|NCT02224534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101964674|NCT02224534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101964675|NCT02224534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101964676|NCT02224534|Purinergic Agents|purinergic agents|mesh-ancestor
101964677|NCT02224534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101964678|NCT02224534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964679|NCT02224534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964681|NCT04174612|Daunorubicin|daunorubicin|mesh-list
101964682|NCT04174612|Midostaurin|midostaurin|mesh-list
101964683|NCT04174612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101964684|NCT04174612|Antimetabolites|antimetabolites|mesh-ancestor
101964685|NCT04174612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964686|NCT04174612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101964688|NCT04174612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101964689|NCT04174612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101964690|NCT04174612|Immunologic Factors|immunologic factors|mesh-ancestor
101964691|NCT04174612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964692|NCT04174612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101964693|NCT04174612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101964694|NCT04174612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101964695|NCT04174612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970908|NCT05097651|Anticonvulsants|anticonvulsants|mesh-ancestor
101970909|NCT05086224|Lidocaine|lidocaine|mesh-list
101970910|NCT05086224|Anesthetics, Local|anesthetics, local|mesh-list
101970911|NCT05086224|Anesthetics|anesthetics|mesh-list
101970912|NCT05086224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101970913|NCT05086224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970914|NCT05086224|Sensory System Agents|sensory system agents|mesh-ancestor
101964696|NCT04174612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101964698|NCT01082003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101964699|NCT01082003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101964700|NCT01082003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964701|NCT01082003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101964702|NCT01082003|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101964703|NCT01082003|Protective Agents|protective agents|mesh-ancestor
101964704|NCT01082003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964705|NCT01082003|Vasodilator Agents|vasodilator agents|mesh-ancestor
101964706|NCT01082003|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101964707|NCT01082003|Antioxidants|antioxidants|mesh-ancestor
101964708|NCT01082237|Escitalopram|escitalopram|mesh-list
101964709|NCT01082237|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101964710|NCT01082237|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101964711|NCT01082237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101964712|NCT01082237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964713|NCT01082237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101964714|NCT01082237|Serotonin Agents|serotonin agents|mesh-ancestor
101964715|NCT01082237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964716|NCT02228122|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101964717|NCT02228122|Laxatives|laxatives|mesh-ancestor
101964718|NCT02228122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101964719|NCT01082315|Cetuximab|cetuximab|mesh-list
101964720|NCT01082315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101964721|NCT01082315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101964722|NCT01082471|Morphine|morphine|mesh-list
101964725|NCT01082471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101964726|NCT01082471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964727|NCT01082471|Analgesics|analgesics|mesh-ancestor
101964728|NCT01082471|Sensory System Agents|sensory system agents|mesh-ancestor
101964729|NCT01082471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101964730|NCT03553498|Acetaminophen|acetaminophen|mesh-list
101964731|NCT03553498|Hydromorphone|hydromorphone|mesh-list
101964732|NCT03553498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101964734|NCT03553498|Sensory System Agents|sensory system agents|mesh-ancestor
101964735|NCT03553498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101964736|NCT03553498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964737|NCT03553498|Antipyretics|antipyretics|mesh-ancestor
101964738|NCT03553498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101964739|NCT03553498|Narcotics|narcotics|mesh-ancestor
101964740|NCT03553498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101964741|NCT01589393|Enoxaparin|enoxaparin|mesh-list
101964742|NCT01589393|Anticoagulants|anticoagulants|mesh-ancestor
101964743|NCT01589393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101964744|NCT01589393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101964745|NCT01589393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964746|NCT01589471|Botulinum Toxins|botulinum toxins|mesh-list
101964747|NCT01589471|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101684533|NCT00660153|Tivozanib|tivozanib|mesh-list
101964749|NCT01589471|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101964750|NCT01589471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101964751|NCT01589471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964752|NCT01589471|Cholinergic Agents|cholinergic agents|mesh-ancestor
101964753|NCT01589471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101964754|NCT01589471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964755|NCT01589471|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101964756|NCT01589471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101964757|NCT00096941|Pertuzumab|pertuzumab|mesh-list
101964758|NCT00096941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101964759|NCT00096941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101964760|NCT00096785|Entecavir|entecavir|mesh-list
101305676|NCT02021201|Serotonin Agents|serotonin agents|mesh-ancestor
101964761|NCT00096785|Adefovir|adefovir|mesh-list
101964762|NCT00096785|Antiviral Agents|antiviral agents|mesh-ancestor
101964763|NCT00096785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101964764|NCT00096785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101311555|NCT00006519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101964765|NCT00096785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101964766|NCT00096785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101964767|NCT00096785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964768|NCT01326767|Paclitaxel|paclitaxel|mesh-list
101964769|NCT01326767|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101964770|NCT01326767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101964771|NCT01326767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101964772|NCT01326767|Tubulin Modulators|tubulin modulators|mesh-ancestor
101964773|NCT01326767|Antimitotic Agents|antimitotic agents|mesh-ancestor
101964774|NCT01326767|Mitosis Modulators|mitosis modulators|mesh-ancestor
101964775|NCT01326767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964777|NCT03963479|Pyridoxal|pyridoxal|mesh-list
101964778|NCT03963479|Pyridoxine|pyridoxine|mesh-list
101964779|NCT03963479|Vitamins|vitamins|mesh-ancestor
101964780|NCT03963479|Micronutrients|micronutrients|mesh-ancestor
101964781|NCT03963479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964782|NCT03963479|Vitamin B Complex|vitamin b complex|mesh-ancestor
101964784|NCT02228512|Cyclophosphamide|cyclophosphamide|mesh-list
101964785|NCT02228512|Rituximab|rituximab|mesh-list
101964786|NCT02228512|Doxorubicin|doxorubicin|mesh-list
101964787|NCT02228512|Etoposide|etoposide|mesh-list
101964788|NCT02228512|Vincristine|vincristine|mesh-list
101964789|NCT02228512|Pomalidomide|pomalidomide|mesh-list
101964790|NCT02228512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101964791|NCT02228512|Immunologic Factors|immunologic factors|mesh-ancestor
101311903|NCT00006112|Antidotes|antidotes|mesh-ancestor
101964792|NCT02228512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964793|NCT02228512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101964794|NCT02228512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101964795|NCT02228512|Alkylating Agents|alkylating agents|mesh-ancestor
101964796|NCT02228512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964797|NCT02228512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101964798|NCT02228512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101964799|NCT02228512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101964800|NCT02228512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101964801|NCT02228512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101312054|NCT00006196|Vitamin D|vitamin d|mesh-list
101964802|NCT02228512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101964803|NCT02228512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101964804|NCT02228512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101964805|NCT02228512|Glucocorticoids|glucocorticoids|mesh-ancestor
101964806|NCT02228512|Hormones|hormones|mesh-ancestor
101964807|NCT02228512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101964808|NCT02228512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101964809|NCT02228512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101964810|NCT02228512|Tubulin Modulators|tubulin modulators|mesh-ancestor
101964811|NCT02228512|Antimitotic Agents|antimitotic agents|mesh-ancestor
101964812|NCT02228512|Mitosis Modulators|mitosis modulators|mesh-ancestor
101964813|NCT02228512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101964814|NCT02228512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101964815|NCT02228512|Growth Substances|growth substances|mesh-ancestor
101964816|NCT02228512|Growth Inhibitors|growth inhibitors|mesh-ancestor
101964817|NCT01082627|Somatostatin|somatostatin|mesh-list
101964818|NCT01082627|Hormones|hormones|mesh-ancestor
101964819|NCT01082627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101964820|NCT01082627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964821|NCT03515044|Rifaximin|rifaximin|mesh-list
101964822|NCT03515044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101964823|NCT03515044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101964824|NCT03515044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101964825|NCT01082705|Lumefantrine|lumefantrine|mesh-list
101964826|NCT01082705|Artemether|artemether|mesh-list
101964827|NCT01082705|Piperaquine|piperaquine|mesh-list
101964828|NCT01082705|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101964829|NCT01082705|Artenimol|artenimol|mesh-list
101964830|NCT01082705|Antimalarials|antimalarials|mesh-ancestor
101964831|NCT01082705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101964832|NCT01082705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101964833|NCT01082705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101964834|NCT01582997|Dabrafenib|dabrafenib|mesh-list
101964835|NCT01582997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970915|NCT05086224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101970916|NCT05086224|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101964836|NCT01582997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101964837|NCT01582997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101964838|NCT01582997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964839|NCT01090505|Oxaliplatin|oxaliplatin|mesh-list
101964840|NCT01090505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101964842|NCT01085981|Niacinamide|niacinamide|mesh-list
101964843|NCT01085981|Nicotinic Acids|nicotinic acids|mesh-list
101964844|NCT01085981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101964845|NCT01085981|Antimetabolites|antimetabolites|mesh-ancestor
101964846|NCT01085981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964847|NCT01085981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101964848|NCT01085981|Vasodilator Agents|vasodilator agents|mesh-ancestor
101964849|NCT01085981|Vitamin B Complex|vitamin b complex|mesh-ancestor
101964850|NCT01085981|Vitamins|vitamins|mesh-ancestor
101964851|NCT01085981|Micronutrients|micronutrients|mesh-ancestor
101964852|NCT01085981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964853|NCT03345082|Ranibizumab|ranibizumab|mesh-list
101964854|NCT03345082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101964855|NCT03345082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101964856|NCT03345082|Growth Substances|growth substances|mesh-ancestor
101964857|NCT03345082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964858|NCT03345082|Growth Inhibitors|growth inhibitors|mesh-ancestor
101964859|NCT03345082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101964860|NCT02228902|Ferrous fumarate|ferrous fumarate|mesh-list
101964861|NCT02228902|Ferrous gluconate|ferrous gluconate|mesh-list
101312453|NCT00006361|Semaxinib|semaxinib|mesh-list
101964863|NCT02228902|Micronutrients|micronutrients|mesh-ancestor
101964864|NCT02228902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964865|NCT02228902|Hematinics|hematinics|mesh-ancestor
101964866|NCT03288454|Apixaban|apixaban|mesh-list
101964867|NCT03288454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101964868|NCT03288454|Antithrombins|antithrombins|mesh-ancestor
101964869|NCT03288454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101312507|NCT00006373|Topotecan|topotecan|mesh-list
101964870|NCT03288454|Protease Inhibitors|protease inhibitors|mesh-ancestor
101964871|NCT03288454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101964872|NCT03288454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964873|NCT03288454|Anticoagulants|anticoagulants|mesh-ancestor
101964874|NCT00090545|Sorafenib|sorafenib|mesh-list
101964875|NCT00090545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101964876|NCT00090545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101964877|NCT00090545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101964878|NCT00090545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312590|NCT00006391|Oxaliplatin|oxaliplatin|mesh-list
101964879|NCT02829814|Cyclobenzaprine|cyclobenzaprine|mesh-list
101964880|NCT02829814|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101964881|NCT02829814|Antidepressive Agents|antidepressive agents|mesh-ancestor
101964882|NCT02829814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101964883|NCT02829814|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101964884|NCT02829814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964885|NCT02829814|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101964886|NCT02829814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101964887|NCT02829814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101964888|NCT02829814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101964889|NCT03916042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101964890|NCT03916042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101964891|NCT02229058|Paclitaxel|paclitaxel|mesh-list
101964892|NCT02229058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101964893|NCT02229058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101964894|NCT02229058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101964896|NCT02229058|Antimitotic Agents|antimitotic agents|mesh-ancestor
101964897|NCT02229058|Mitosis Modulators|mitosis modulators|mesh-ancestor
101971973|NCT01336322|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101964898|NCT02229058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964899|NCT02229292|Tranexamic Acid|tranexamic acid|mesh-list
101964900|NCT02229292|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101964901|NCT02229292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101964902|NCT02229292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964903|NCT02229292|Hemostatics|hemostatics|mesh-ancestor
101964904|NCT02229292|Coagulants|coagulants|mesh-ancestor
101964905|NCT00070109|Trabectedin|trabectedin|mesh-list
101970917|NCT05086224|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101970918|NCT05086224|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101394532|NCT02861573|Hormones|hormones|mesh-ancestor
101964906|NCT00070109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101964907|NCT00070109|Alkylating Agents|alkylating agents|mesh-ancestor
101964908|NCT00070109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964909|NCT00070109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101964910|NCT00069953|Paclitaxel|paclitaxel|mesh-list
101964911|NCT00069953|Fluorouracil|fluorouracil|mesh-list
101964912|NCT00069953|Lenograstim|lenograstim|mesh-list
101964913|NCT00069953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101964914|NCT00069953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101964915|NCT00069953|Tubulin Modulators|tubulin modulators|mesh-ancestor
101964916|NCT00069953|Antimitotic Agents|antimitotic agents|mesh-ancestor
101964917|NCT00069953|Mitosis Modulators|mitosis modulators|mesh-ancestor
101964918|NCT00069953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964919|NCT00069953|Antimetabolites|antimetabolites|mesh-ancestor
101964920|NCT00069953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101964921|NCT00069953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101964922|NCT00069953|Immunologic Factors|immunologic factors|mesh-ancestor
101971974|NCT01336322|Protease Inhibitors|protease inhibitors|mesh-ancestor
101964923|NCT00069953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964924|NCT00069953|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101964925|NCT02750800|Adalimumab|adalimumab|mesh-list
101964926|NCT02750800|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101964927|NCT02750800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101964928|NCT02750800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101964929|NCT02229760|Ritonavir|ritonavir|mesh-list
101964930|NCT02229760|Tipranavir|tipranavir|mesh-list
101964931|NCT02229760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101964932|NCT02229760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101964933|NCT02229760|Protease Inhibitors|protease inhibitors|mesh-ancestor
101964934|NCT02229760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101964935|NCT02229760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964936|NCT02229760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101964937|NCT02229760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101964938|NCT02229760|Antiviral Agents|antiviral agents|mesh-ancestor
101964939|NCT02229760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101964940|NCT02229760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101964941|NCT02229760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101964942|NCT03662542|Golimumab|golimumab|mesh-list
101964943|NCT03662542|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101964944|NCT03662542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101964945|NCT03662542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101964946|NCT03662542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101964947|NCT03662542|Immunologic Factors|immunologic factors|mesh-ancestor
101964948|NCT03662542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964949|NCT01329562|Naproxen|naproxen|mesh-list
101964950|NCT01329562|Sumatriptan|sumatriptan|mesh-list
101964951|NCT01329562|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101964952|NCT01329562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101964953|NCT01329562|Analgesics|analgesics|mesh-ancestor
101964954|NCT01329562|Sensory System Agents|sensory system agents|mesh-ancestor
101964955|NCT01329562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101964956|NCT01329562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964957|NCT01329562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101964958|NCT01329562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101964959|NCT01329562|Gout Suppressants|gout suppressants|mesh-ancestor
101964960|NCT01329562|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101313155|NCT00008203|Aldesleukin|aldesleukin|mesh-list
101964961|NCT01329562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101964962|NCT01329562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964963|NCT01329562|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101964964|NCT01329562|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101964965|NCT01329562|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101964966|NCT01329562|Serotonin Agents|serotonin agents|mesh-ancestor
101964967|NCT01329562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101964969|NCT02230228|Retinol acetate|retinol acetate|mesh-list
101964970|NCT02230228|Vitamins|vitamins|mesh-ancestor
101964971|NCT02230228|Micronutrients|micronutrients|mesh-ancestor
101964972|NCT02230228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964973|NCT02230228|Protective Agents|protective agents|mesh-ancestor
101964974|NCT02230228|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101394623|NCT02638701|Infliximab|infliximab|mesh-list
101964975|NCT02230228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101964976|NCT02230228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101964977|NCT02230228|Immunologic Factors|immunologic factors|mesh-ancestor
101964978|NCT01090661|Moxifloxacin|moxifloxacin|mesh-list
101964979|NCT01090661|Mipomersen|mipomersen|mesh-list
101964980|NCT01090661|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101964981|NCT01090661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101964982|NCT01090661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101964983|NCT01090661|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101964984|NCT01090661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101964985|NCT01090661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101964986|NCT01090661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964987|NCT01090661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971975|NCT01336322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101964988|NCT01090661|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101964989|NCT01090661|Contraceptive Agents|contraceptive agents|mesh-ancestor
101964990|NCT01090661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101964991|NCT01090661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964992|NCT01090661|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101964993|NCT01090661|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101964994|NCT01090661|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101964996|NCT01090661|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101964997|NCT01090661|Antimetabolites|antimetabolites|mesh-ancestor
101964998|NCT01090661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101964999|NCT05563480|Cisplatin|cisplatin|mesh-list
101965000|NCT05563480|Gemcitabine|gemcitabine|mesh-list
101965001|NCT05563480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101965002|NCT05563480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101965003|NCT05563480|Antimetabolites|antimetabolites|mesh-ancestor
101965004|NCT05563480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965005|NCT05546398|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
101965006|NCT05546398|Ezetimibe|ezetimibe|mesh-list
101965007|NCT05546398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101965009|NCT05546398|Antimetabolites|antimetabolites|mesh-ancestor
101965010|NCT05546398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965011|NCT05546398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101965012|NCT05546398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101965013|NCT05546398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101965014|NCT05546398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965015|NCT05472766|Anticoagulants|anticoagulants|mesh-list
101965016|NCT05472766|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
101965017|NCT05472766|Antithrombins|antithrombins|mesh-ancestor
101965018|NCT05472766|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101965019|NCT05472766|Protease Inhibitors|protease inhibitors|mesh-ancestor
101965020|NCT05472766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101965021|NCT05472766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965022|NCT03653026|Upadacitinib|upadacitinib|mesh-list
101965024|NCT03653026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101965025|NCT03653026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101965026|NCT03653026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965027|NCT03653026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101965029|NCT02232724|Lipotropic Agents|lipotropic agents|mesh-ancestor
101965030|NCT02232724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101965031|NCT02232724|Antimetabolites|antimetabolites|mesh-ancestor
101965032|NCT02232724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965033|NCT02232724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101314056|NCT00000745|Vaccines|vaccines|mesh-list
101965034|NCT02232724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101965035|NCT02232724|Nootropic Agents|nootropic agents|mesh-ancestor
101965036|NCT02234440|Metformin|metformin|mesh-list
101965037|NCT02234440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101305687|NCT02021214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101965038|NCT02234440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965040|NCT04981678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101965041|NCT04981678|Narcotics|narcotics|mesh-ancestor
101965042|NCT04981678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101965043|NCT04981678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965045|NCT04981678|Sensory System Agents|sensory system agents|mesh-ancestor
101965046|NCT04981678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101965047|NCT04981678|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101965048|NCT02230618|Insulin|insulin|mesh-list
101965049|NCT02230618|Insulin Aspart|insulin aspart|mesh-list
101965050|NCT02230618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101965051|NCT02230618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965052|NCT01337986|4-Aminopyridine|4-aminopyridine|mesh-list
101965053|NCT01337986|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101965054|NCT01337986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101965055|NCT01337986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965056|NCT04669288|Azithromycin|azithromycin|mesh-list
101965057|NCT04669288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101965058|NCT04669288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101965059|NCT02262520|Digoxin|digoxin|mesh-list
101965060|NCT02262520|Apixaban|apixaban|mesh-list
101965061|NCT02262520|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101965062|NCT02262520|Antithrombins|antithrombins|mesh-ancestor
101965063|NCT02262520|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101965064|NCT02262520|Protease Inhibitors|protease inhibitors|mesh-ancestor
101965065|NCT02262520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101965066|NCT02262520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965067|NCT02262520|Anticoagulants|anticoagulants|mesh-ancestor
101314409|NCT00000952|Ritonavir|ritonavir|mesh-list
101965068|NCT02262520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101965069|NCT02262520|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101965070|NCT02262520|Protective Agents|protective agents|mesh-ancestor
101965071|NCT02262520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965072|NCT02233504|Deferasirox|deferasirox|mesh-list
101965073|NCT02233504|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101965074|NCT02233504|Chelating Agents|chelating agents|mesh-ancestor
101965075|NCT02233504|Sequestering Agents|sequestering agents|mesh-ancestor
101314475|NCT00000973|Antimalarials|antimalarials|mesh-ancestor
101965076|NCT02233504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965078|NCT02262598|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101965079|NCT02262598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101314544|NCT00001033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101965080|NCT02262598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101965081|NCT02262598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101965082|NCT02262598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965083|NCT02262598|Diuretics|diuretics|mesh-ancestor
101965084|NCT02262598|Natriuretic Agents|natriuretic agents|mesh-ancestor
101965085|NCT02262598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965086|NCT02262598|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101965087|NCT02262598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101965089|NCT04542382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101965090|NCT04542382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101965091|NCT04542382|Antimetabolites|antimetabolites|mesh-ancestor
101965092|NCT04542382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965093|NCT04542382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101965094|NCT04542382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101965095|NCT04542382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101965096|NCT03723538|Dexmedetomidine|dexmedetomidine|mesh-list
101965097|NCT03723538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101965098|NCT03723538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101965099|NCT03723538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965100|NCT03723538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101965102|NCT03723538|Sensory System Agents|sensory system agents|mesh-ancestor
101965103|NCT03723538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101965104|NCT03723538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101965105|NCT03723538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101965106|NCT03723538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101965107|NCT03723538|Adrenergic Agents|adrenergic agents|mesh-ancestor
101965108|NCT03723538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101965109|NCT03723538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965110|NCT01337674|Metoprolol|metoprolol|mesh-list
101965111|NCT01337674|Amlodipine|amlodipine|mesh-list
101965112|NCT01337674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101965113|NCT01337674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101965114|NCT01337674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101965115|NCT01337674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965116|NCT01337674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101965117|NCT01337674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965118|NCT01337674|Vasodilator Agents|vasodilator agents|mesh-ancestor
101965119|NCT01337674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101965120|NCT01337674|Sympatholytics|sympatholytics|mesh-ancestor
101965121|NCT01337674|Autonomic Agents|autonomic agents|mesh-ancestor
101965122|NCT01337674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101965123|NCT01337674|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101965124|NCT01337674|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101684923|NCT00670293|Raclopride|raclopride|mesh-list
101965125|NCT01337674|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101965126|NCT01337674|Adrenergic Agents|adrenergic agents|mesh-ancestor
101965127|NCT01337674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101965128|NCT02262676|Rivaroxaban|rivaroxaban|mesh-list
101965129|NCT02262676|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101965130|NCT02262676|Antithrombins|antithrombins|mesh-ancestor
101965132|NCT02262676|Protease Inhibitors|protease inhibitors|mesh-ancestor
101965133|NCT02262676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101965134|NCT02262676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965135|NCT02262676|Anticoagulants|anticoagulants|mesh-ancestor
101965136|NCT02233582|Ibuprofen|ibuprofen|mesh-list
101965137|NCT02233582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101965138|NCT02233582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101965139|NCT02233582|Analgesics|analgesics|mesh-ancestor
101965141|NCT02233582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101965142|NCT02233582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965143|NCT02233582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101965144|NCT02233582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101965145|NCT02233582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101965146|NCT02233582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101965147|NCT02233582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965148|NCT02580370|Botulinum Toxins|botulinum toxins|mesh-list
101965149|NCT02580370|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101965150|NCT02580370|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101965151|NCT02580370|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101965152|NCT02580370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101965153|NCT02580370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965154|NCT02580370|Cholinergic Agents|cholinergic agents|mesh-ancestor
101315425|NCT00389935|Thalidomide|thalidomide|mesh-list
101965155|NCT02580370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101965156|NCT02580370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965157|NCT02580370|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101965158|NCT02580370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101965159|NCT02233816|Vaccines|vaccines|mesh-list
101965160|NCT02233816|Immunologic Factors|immunologic factors|mesh-ancestor
101965161|NCT02233816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965162|NCT02750410|Dulaglutide|dulaglutide|mesh-list
101965163|NCT02750410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101965164|NCT02750410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965165|NCT02750332|Nitisinone|nitisinone|mesh-list
101965166|NCT02750332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101965167|NCT02750332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965168|NCT02233894|Ipratropium|ipratropium|mesh-list
101965169|NCT02233894|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101965170|NCT02233894|Autonomic Agents|autonomic agents|mesh-ancestor
101965171|NCT02233894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101965172|NCT02233894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965173|NCT02233894|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101970933|NCT05041309|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
101965174|NCT02233894|Respiratory System Agents|respiratory system agents|mesh-ancestor
101965175|NCT02233894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101965176|NCT02233894|Cholinergic Agents|cholinergic agents|mesh-ancestor
101965177|NCT02233894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101315771|NCT00000645|Antiviral Agents|antiviral agents|mesh-ancestor
101965178|NCT02233894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965180|NCT02233972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101965181|NCT02233972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101315847|NCT00000666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101965182|NCT02233972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101965183|NCT02233972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965184|NCT02233972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101965185|NCT02233972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101965186|NCT02233972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101965187|NCT02233972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101965188|NCT02233972|Anesthetics, General|anesthetics, general|mesh-ancestor
101965189|NCT02233972|Anesthetics|anesthetics|mesh-ancestor
101965190|NCT02233972|GABA Modulators|gaba modulators|mesh-ancestor
101965191|NCT02233972|GABA Agents|gaba agents|mesh-ancestor
101965192|NCT02233972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101965193|NCT02233972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965194|NCT02234050|Trabectedin|trabectedin|mesh-list
101315989|NCT00000708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101965195|NCT02234050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101965196|NCT02234050|Alkylating Agents|alkylating agents|mesh-ancestor
101965197|NCT02234050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965198|NCT02234050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101965199|NCT02263066|Factor VIII|factor viii|mesh-list
101965200|NCT02263066|Coagulants|coagulants|mesh-ancestor
101965201|NCT02235532|Fluorides|fluorides|mesh-list
101965202|NCT02235532|Cariostatic Agents|cariostatic agents|mesh-ancestor
101965203|NCT02235532|Protective Agents|protective agents|mesh-ancestor
101965204|NCT02235532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965205|NCT00069095|Leucovorin|leucovorin|mesh-list
101965206|NCT00069095|Bevacizumab|bevacizumab|mesh-list
101965207|NCT00069095|Fluorouracil|fluorouracil|mesh-list
101965208|NCT00069095|Capecitabine|capecitabine|mesh-list
101965209|NCT00069095|Oxaliplatin|oxaliplatin|mesh-list
101965210|NCT00069095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101965211|NCT00069095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101965212|NCT00069095|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101965213|NCT00069095|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101965214|NCT00069095|Growth Substances|growth substances|mesh-ancestor
101965215|NCT00069095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965216|NCT00069095|Growth Inhibitors|growth inhibitors|mesh-ancestor
101965217|NCT00069095|Antimetabolites|antimetabolites|mesh-ancestor
101965218|NCT00069095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965219|NCT00069095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101965220|NCT00069095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101965221|NCT00069095|Immunologic Factors|immunologic factors|mesh-ancestor
101965222|NCT00069095|Antidotes|antidotes|mesh-ancestor
101965223|NCT00069095|Protective Agents|protective agents|mesh-ancestor
101965224|NCT00069095|Vitamin B Complex|vitamin b complex|mesh-ancestor
101965225|NCT00069095|Vitamins|vitamins|mesh-ancestor
101965226|NCT00069095|Micronutrients|micronutrients|mesh-ancestor
101965227|NCT00086411|Bupropion|bupropion|mesh-list
101965228|NCT00086411|Nicotine|nicotine|mesh-list
101965229|NCT00086411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101965230|NCT00086411|Autonomic Agents|autonomic agents|mesh-ancestor
101965231|NCT00086411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101965232|NCT00086411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965233|NCT00086411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101965234|NCT00086411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101965235|NCT00086411|Cholinergic Agents|cholinergic agents|mesh-ancestor
101965236|NCT00086411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101965237|NCT00086411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316471|NCT00000903|Lamivudine|lamivudine|mesh-list
101737350|NCT05520177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970934|NCT05041309|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
101970935|NCT05041309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101965238|NCT00086411|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101965239|NCT00086411|Antidepressive Agents|antidepressive agents|mesh-ancestor
101965240|NCT00086411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101316546|NCT00000966|Leucovorin|leucovorin|mesh-list
101965241|NCT00086411|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101965242|NCT00086411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101965243|NCT00086411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101965244|NCT00086411|Dopamine Agents|dopamine agents|mesh-ancestor
101965245|NCT00086411|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101965246|NCT00086411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101965247|NCT00086411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101965248|NCT01086527|Montelukast|montelukast|mesh-list
101965249|NCT01086527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101965250|NCT01086527|Respiratory System Agents|respiratory system agents|mesh-ancestor
101965251|NCT01086527|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101965252|NCT01086527|Hormone Antagonists|hormone antagonists|mesh-ancestor
101965253|NCT01086527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101965254|NCT01086527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965255|NCT01086527|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101965256|NCT01086527|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101965257|NCT01086527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965258|NCT01093937|Varenicline|varenicline|mesh-list
101965259|NCT01093937|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101965260|NCT01093937|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101965261|NCT01093937|Cholinergic Agents|cholinergic agents|mesh-ancestor
101965262|NCT01093937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101965263|NCT01093937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965264|NCT01093937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965265|NCT01094015|Lidocaine|lidocaine|mesh-list
101316671|NCT00005822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101965266|NCT01094015|Prilocaine|prilocaine|mesh-list
101965267|NCT01094015|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
101965268|NCT01094015|Anesthetics, Local|anesthetics, local|mesh-ancestor
101965269|NCT01094015|Anesthetics|anesthetics|mesh-ancestor
101965270|NCT01094015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101965271|NCT01094015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965272|NCT01094015|Sensory System Agents|sensory system agents|mesh-ancestor
101316724|NCT00001011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316725|NCT00001011|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101965273|NCT01094015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101965274|NCT01094015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101965275|NCT01094015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101965276|NCT01094015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101965277|NCT01094015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101316791|NCT00005834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101965278|NCT01094015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965279|NCT01094015|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
101965281|NCT01090895|Vitamins|vitamins|mesh-ancestor
101965282|NCT01090895|Micronutrients|micronutrients|mesh-ancestor
101965283|NCT01090895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965284|NCT01090895|Antioxidants|antioxidants|mesh-ancestor
101965285|NCT01090895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965286|NCT01090895|Protective Agents|protective agents|mesh-ancestor
101965287|NCT03956303|Levobupivacaine|levobupivacaine|mesh-list
101965288|NCT03956303|Anesthetics, Local|anesthetics, local|mesh-ancestor
101965289|NCT03956303|Anesthetics|anesthetics|mesh-ancestor
101965290|NCT03956303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101965291|NCT03956303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965292|NCT03956303|Sensory System Agents|sensory system agents|mesh-ancestor
101316939|NCT00001083|Ritonavir|ritonavir|mesh-list
101965293|NCT03956303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101965294|NCT01094249|Valproic Acid|valproic acid|mesh-list
101965295|NCT01094249|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101965296|NCT01094249|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101965297|NCT01094249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101965298|NCT01094249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101316998|NCT00700258|Immunologic Factors|immunologic factors|mesh-ancestor
101737351|NCT00780416|Ribavirin|ribavirin|mesh-list
101970936|NCT05041309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970937|NCT05038904|Acalabrutinib|acalabrutinib|mesh-list
101970938|NCT05038904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970939|NCT05037929|Astegolimab|astegolimab|mesh-list
101970940|NCT05037929|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101970941|NCT05037929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101970942|NCT05037929|Antiviral Agents|antiviral agents|mesh-ancestor
101970943|NCT05037929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101970944|NCT05005182|Hydroxyurea|hydroxyurea|mesh-list
101970945|NCT05005182|Luspatercept|luspatercept|mesh-list
101970946|NCT05005182|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
101970947|NCT05005182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970948|NCT05005182|Antisickling Agents|antisickling agents|mesh-ancestor
101970949|NCT05005182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970950|NCT05005182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970951|NCT05005182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101970952|NCT05005182|Hematinics|hematinics|mesh-ancestor
101970953|NCT05005182|Immunologic Factors|immunologic factors|mesh-ancestor
101970954|NCT05005182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970955|NCT05000216|Mycophenolic Acid|mycophenolic acid|mesh-list
101965299|NCT01094249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965300|NCT01094249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101965301|NCT01094249|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101965302|NCT01094249|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101965303|NCT01094249|Serotonin Agents|serotonin agents|mesh-ancestor
101965304|NCT01094249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101317069|NCT00005870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101692752|NCT02679092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965305|NCT01094249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965306|NCT01094249|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101965307|NCT01094249|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101965308|NCT01094249|Dopamine Agents|dopamine agents|mesh-ancestor
101965309|NCT01094249|Anticonvulsants|anticonvulsants|mesh-ancestor
101965310|NCT01094249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101965311|NCT01094249|GABA Agents|gaba agents|mesh-ancestor
101965312|NCT01094249|Antimanic Agents|antimanic agents|mesh-ancestor
101223187|NCT01516866|Listerine|listerine|mesh-list
101965313|NCT00055601|Paclitaxel|paclitaxel|mesh-list
101965314|NCT00055601|Gemcitabine|gemcitabine|mesh-list
101965315|NCT00055601|Fluorouracil|fluorouracil|mesh-list
101965316|NCT00055601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101965317|NCT00055601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101965318|NCT00055601|Tubulin Modulators|tubulin modulators|mesh-ancestor
101965319|NCT00055601|Antimitotic Agents|antimitotic agents|mesh-ancestor
101965320|NCT00055601|Mitosis Modulators|mitosis modulators|mesh-ancestor
101317207|NCT00009763|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101317208|NCT00009763|Cyclosporins|cyclosporins|mesh-list
101317225|NCT00009802|Paclitaxel|paclitaxel|mesh-list
101965321|NCT00055601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965322|NCT00055601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101965323|NCT00055601|Antimetabolites|antimetabolites|mesh-ancestor
101965324|NCT00055601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101965325|NCT00055601|Immunologic Factors|immunologic factors|mesh-ancestor
101965326|NCT00055601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965327|NCT01583621|Cholecalciferol|cholecalciferol|mesh-list
101965328|NCT01583621|Vitamin D|vitamin d|mesh-list
101965329|NCT01583621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101965330|NCT01583621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970956|NCT05000216|Methotrexate|methotrexate|mesh-list
101970957|NCT05000216|Vaccines|vaccines|mesh-list
101970958|NCT05000216|Immunosuppressive Agents|immunosuppressive agents|mesh-list
101970959|NCT05000216|Immunologic Factors|immunologic factors|mesh-ancestor
101970960|NCT05000216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970961|NCT05000216|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101970962|NCT05000216|Abortifacient Agents|abortifacient agents|mesh-ancestor
101970963|NCT05000216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101970964|NCT05000216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101970965|NCT05000216|Antimetabolites|antimetabolites|mesh-ancestor
101970966|NCT05000216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970967|NCT05000216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970968|NCT05000216|Dermatologic Agents|dermatologic agents|mesh-ancestor
101970969|NCT05000216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970970|NCT05000216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101970971|NCT05000216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101305719|NCT02021409|Darbepoetin alfa|darbepoetin alfa|mesh-list
101965331|NCT01583621|Vitamins|vitamins|mesh-ancestor
101965332|NCT01583621|Micronutrients|micronutrients|mesh-ancestor
101965333|NCT01583621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101965334|NCT03806231|Dinoprostone|dinoprostone|mesh-list
101965335|NCT03806231|Oxytocics|oxytocics|mesh-ancestor
101965336|NCT03806231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101965337|NCT03806231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965338|NCT01091051|Ustekinumab|ustekinumab|mesh-list
101965339|NCT01091051|Dermatologic Agents|dermatologic agents|mesh-ancestor
101965340|NCT01327079|Methadone|methadone|mesh-list
101965341|NCT01327079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101965342|NCT01327079|Narcotics|narcotics|mesh-ancestor
101965343|NCT01327079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101317482|NCT00011362|Glucocorticoids|glucocorticoids|mesh-ancestor
101965344|NCT01327079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965345|NCT01327079|Analgesics|analgesics|mesh-ancestor
101965346|NCT01327079|Sensory System Agents|sensory system agents|mesh-ancestor
101692768|NCT04183088|Tislelizumab|tislelizumab|mesh-list
101965347|NCT01327079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101965348|NCT01327079|Antitussive Agents|antitussive agents|mesh-ancestor
101965349|NCT01327079|Respiratory System Agents|respiratory system agents|mesh-ancestor
101965351|NCT01091207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101965352|NCT01091207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101965354|NCT01091207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965355|NCT00054275|Docetaxel|docetaxel|mesh-list
101965356|NCT00054275|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101965357|NCT00054275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101965358|NCT00054275|Tubulin Modulators|tubulin modulators|mesh-ancestor
101965359|NCT00054275|Antimitotic Agents|antimitotic agents|mesh-ancestor
101965360|NCT00054275|Mitosis Modulators|mitosis modulators|mesh-ancestor
101317680|NCT00001266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101965361|NCT00054275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965362|NCT00054275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101965363|NCT00054275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101965364|NCT01095185|Simvastatin|simvastatin|mesh-list
101965365|NCT01095185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101965366|NCT01095185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101965367|NCT01095185|Antimetabolites|antimetabolites|mesh-ancestor
101965368|NCT01095185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965369|NCT01095185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101965370|NCT01095185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101965371|NCT01095185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101970972|NCT05000216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101970973|NCT05000216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101970974|NCT05000216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101970975|NCT05000216|Antitubercular Agents|antitubercular agents|mesh-ancestor
101970976|NCT05000216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101970977|NCT05000216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101970978|NCT04996251|Bupivacaine|bupivacaine|mesh-list
101970979|NCT04996251|Anesthetics, Local|anesthetics, local|mesh-ancestor
101970980|NCT04996251|Anesthetics|anesthetics|mesh-ancestor
101970981|NCT04996251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101970982|NCT04996251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970983|NCT04996251|Sensory System Agents|sensory system agents|mesh-ancestor
101970984|NCT04996251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101970985|NCT04989803|Cyclophosphamide|cyclophosphamide|mesh-list
101970986|NCT04989803|Fludarabine|fludarabine|mesh-list
101970987|NCT04989803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101970988|NCT04989803|Immunologic Factors|immunologic factors|mesh-ancestor
101965373|NCT01583777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317824|NCT00014092|Aldesleukin|aldesleukin|mesh-list
101965374|NCT01583777|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101965375|NCT01583777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101965376|NCT01583777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965377|NCT00053417|4-Aminopyridine|4-aminopyridine|mesh-list
101965378|NCT00053417|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101965379|NCT00053417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101965380|NCT00053417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965381|NCT00052715|Poly ICLC|poly iclc|mesh-list
101965382|NCT00052715|Interferon Inducers|interferon inducers|mesh-ancestor
101965383|NCT00052715|Immunologic Factors|immunologic factors|mesh-ancestor
101965384|NCT00052715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965385|NCT03955601|Cyclophosphamide|cyclophosphamide|mesh-list
101965386|NCT03955601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101965387|NCT03955601|Immunologic Factors|immunologic factors|mesh-ancestor
101965388|NCT03955601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965389|NCT03955601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101965390|NCT03955601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101965391|NCT03955601|Alkylating Agents|alkylating agents|mesh-ancestor
101965392|NCT03955601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965394|NCT03955601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101965395|NCT00051311|Cyclosporine|cyclosporine|mesh-list
101965396|NCT00051311|Prednisone|prednisone|mesh-list
101965397|NCT00051311|Cyclophosphamide|cyclophosphamide|mesh-list
101965398|NCT00051311|Doxorubicin|doxorubicin|mesh-list
101965399|NCT00051311|Methotrexate|methotrexate|mesh-list
101965400|NCT00051311|Fludarabine|fludarabine|mesh-list
101965401|NCT00051311|Etoposide|etoposide|mesh-list
101965402|NCT00051311|Vincristine|vincristine|mesh-list
101965403|NCT00051311|Cyclosporins|cyclosporins|mesh-list
101965404|NCT00051311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101965405|NCT00051311|Immunologic Factors|immunologic factors|mesh-ancestor
101965406|NCT00051311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965407|NCT00051311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101965408|NCT00051311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101965409|NCT00051311|Alkylating Agents|alkylating agents|mesh-ancestor
101318380|NCT00016588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101965410|NCT00051311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965411|NCT00051311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101965412|NCT00051311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101970989|NCT04989803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101970990|NCT04989803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101970991|NCT04989803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101970992|NCT04989803|Alkylating Agents|alkylating agents|mesh-ancestor
101970993|NCT04989803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101970994|NCT04989803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101970995|NCT04989803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101970996|NCT04976387|Acetaminophen|acetaminophen|mesh-list
101970997|NCT04976387|Ibuprofen|ibuprofen|mesh-list
101970998|NCT04976387|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
101970999|NCT04976387|Hydrocodone|hydrocodone|mesh-list
101971000|NCT04976387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101971001|NCT04976387|Analgesics|analgesics|mesh-ancestor
101971002|NCT04976387|Sensory System Agents|sensory system agents|mesh-ancestor
101965413|NCT00051311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101965414|NCT00051311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101965415|NCT00051311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101965416|NCT00051311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101965417|NCT00051311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101965418|NCT00051311|Glucocorticoids|glucocorticoids|mesh-ancestor
101965420|NCT00051311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101965421|NCT00051311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101965422|NCT00051311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101965423|NCT00051311|Abortifacient Agents|abortifacient agents|mesh-ancestor
101574938|NCT01028391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101965424|NCT00051311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101965425|NCT00051311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101318698|NCT00017602|Oblimersen|oblimersen|mesh-list
101965426|NCT00051311|Antimetabolites|antimetabolites|mesh-ancestor
101965427|NCT00051311|Dermatologic Agents|dermatologic agents|mesh-ancestor
101965428|NCT00051311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101965429|NCT00051311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101965430|NCT00051311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101965431|NCT00051311|Tubulin Modulators|tubulin modulators|mesh-ancestor
101965432|NCT00051311|Antimitotic Agents|antimitotic agents|mesh-ancestor
101965433|NCT00051311|Mitosis Modulators|mitosis modulators|mesh-ancestor
101965434|NCT00051311|Antifungal Agents|antifungal agents|mesh-ancestor
101965435|NCT00051311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101318893|NCT00018460|Vitamins|vitamins|mesh-list
101965436|NCT00051311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101965438|NCT01091753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101965439|NCT01091753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101965440|NCT01091753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101965441|NCT01091753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965442|NCT01091753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101318960|NCT00001644|Nevirapine|nevirapine|mesh-list
101965443|NCT01091753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965444|NCT01091753|Vasodilator Agents|vasodilator agents|mesh-ancestor
101965445|NCT00049673|Thalidomide|thalidomide|mesh-list
101965446|NCT00049673|Prednisone|prednisone|mesh-list
101965447|NCT00049673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101965448|NCT00049673|Glucocorticoids|glucocorticoids|mesh-ancestor
101965449|NCT00049673|Hormones|hormones|mesh-ancestor
101965450|NCT00049673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101965451|NCT00049673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965452|NCT00049673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101965453|NCT00049673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101319166|NCT05156905|Tubulin Modulators|tubulin modulators|mesh-ancestor
101965454|NCT00049673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101965455|NCT00049673|Immunologic Factors|immunologic factors|mesh-ancestor
101971003|NCT04976387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101971004|NCT04976387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965456|NCT00049673|Leprostatic Agents|leprostatic agents|mesh-ancestor
101965457|NCT00049673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101965458|NCT00049673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101965459|NCT00049673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101965460|NCT00049673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101965462|NCT00049673|Growth Inhibitors|growth inhibitors|mesh-ancestor
101965464|NCT00049127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101965465|NCT00049127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101965466|NCT00049127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101319309|NCT05495204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101965467|NCT00049127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965469|NCT00066365|Sargramostim|sargramostim|mesh-list
101965470|NCT00066365|Immunologic Factors|immunologic factors|mesh-ancestor
101965471|NCT00066365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965472|NCT00066365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101965473|NCT00048581|Abatacept|abatacept|mesh-list
101965474|NCT00048581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101965475|NCT00048581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319442|NCT03958981|Castor Oil|castor oil|mesh-list
101965476|NCT00048581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101965477|NCT00048581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101965478|NCT00048581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101965479|NCT00048581|Immunologic Factors|immunologic factors|mesh-ancestor
101965480|NCT00048581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965481|NCT00048581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101965482|NCT00048347|Interferon beta-1a|interferon beta-1a|mesh-list
101965483|NCT00048347|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101965484|NCT00048347|Immunologic Factors|immunologic factors|mesh-ancestor
101965485|NCT00048347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965486|NCT00048347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101965487|NCT00048347|Antiviral Agents|antiviral agents|mesh-ancestor
101965488|NCT00048347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101965489|NCT03957629|Interferons|interferons|mesh-list
101965491|NCT03957629|Interferon-alpha|interferon-alpha|mesh-list
101965492|NCT03957629|Interferon alpha-2|interferon alpha-2|mesh-list
101965493|NCT03957629|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101965494|NCT03957629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101965495|NCT03957629|Antiviral Agents|antiviral agents|mesh-ancestor
101965496|NCT03957629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101965497|NCT03957629|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101965498|NCT03957629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101965499|NCT03957629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101965500|NCT03957629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965501|NCT03957629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101965502|NCT03957629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101965503|NCT03957629|Immunologic Factors|immunologic factors|mesh-ancestor
101965504|NCT03957629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965506|NCT00065507|Adefovir|adefovir|mesh-list
101965507|NCT00065507|Antiviral Agents|antiviral agents|mesh-ancestor
101965508|NCT00065507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101319861|NCT02633098|Schistosomicides|schistosomicides|mesh-ancestor
101319926|NCT00393328|Protease Inhibitors|protease inhibitors|mesh-ancestor
101965509|NCT00065507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101965510|NCT00065507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101965511|NCT00065507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101319997|NCT01807000|Prucalopride|prucalopride|mesh-list
101965512|NCT00065507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965513|NCT01095575|Morphine|morphine|mesh-list
101965514|NCT01095575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101965515|NCT01095575|Narcotics|narcotics|mesh-ancestor
101692847|NCT02681198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101965516|NCT01095575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101965517|NCT01095575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965518|NCT01095575|Analgesics|analgesics|mesh-ancestor
101965519|NCT01095575|Sensory System Agents|sensory system agents|mesh-ancestor
101965520|NCT01095575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101965521|NCT00065429|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
101965522|NCT00065429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101965523|NCT00065429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101965524|NCT00065429|Immunotoxins|immunotoxins|mesh-ancestor
101965525|NCT00065429|Immunoconjugates|immunoconjugates|mesh-ancestor
101971005|NCT04976387|Antipyretics|antipyretics|mesh-ancestor
101971006|NCT04976387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101971007|NCT04976387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101971008|NCT04976387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101965526|NCT00065429|Immunologic Factors|immunologic factors|mesh-ancestor
101965527|NCT00065429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965528|NCT00065429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101965530|NCT01095731|Retinol acetate|retinol acetate|mesh-list
101965531|NCT01095731|Glycine|glycine|mesh-list
101965532|NCT01095731|Glycine Agents|glycine agents|mesh-ancestor
101320353|NCT01057069|Antimitotic Agents|antimitotic agents|mesh-ancestor
101965533|NCT01095731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101965534|NCT01095731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965535|NCT01095731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965536|NCT01095731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101965537|NCT01095731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101965538|NCT01095731|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101965539|NCT01095731|Immunologic Factors|immunologic factors|mesh-ancestor
101965540|NCT01095731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101965541|NCT01095731|Protective Agents|protective agents|mesh-ancestor
101965542|NCT01095731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101965543|NCT01095809|Triamcinolone|triamcinolone|mesh-list
101965544|NCT01095809|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101965545|NCT01095809|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101965546|NCT01095809|Bevacizumab|bevacizumab|mesh-list
101965547|NCT01095809|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101965548|NCT01095809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101965549|NCT01095809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101965550|NCT01095809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101965551|NCT01095809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101965552|NCT01095809|Growth Substances|growth substances|mesh-ancestor
101965554|NCT01095809|Growth Inhibitors|growth inhibitors|mesh-ancestor
101965555|NCT01095809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101965556|NCT01095809|Glucocorticoids|glucocorticoids|mesh-ancestor
101965557|NCT01095809|Hormones|hormones|mesh-ancestor
101965558|NCT01095809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101965559|NCT01095809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101965560|NCT01095809|Immunologic Factors|immunologic factors|mesh-ancestor
101965561|NCT01095809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101965562|NCT01095809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965563|NCT00048035|Epoetin Alfa|epoetin alfa|mesh-list
101965565|NCT01092221|Allopurinol|allopurinol|mesh-list
101965566|NCT01092221|Antimetabolites|antimetabolites|mesh-ancestor
101965567|NCT01092221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965568|NCT01092221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101965569|NCT01092221|Gout Suppressants|gout suppressants|mesh-ancestor
101965570|NCT01092221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101685350|NCT04215770|Penicillins|penicillins|mesh-list
101965571|NCT01092221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101320841|NCT00276250|Abatacept|abatacept|mesh-list
101965573|NCT01092221|Protective Agents|protective agents|mesh-ancestor
101965574|NCT01092221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965576|NCT00047879|Interferon-alpha|interferon-alpha|mesh-list
101965577|NCT00047879|Interferon alpha-2|interferon alpha-2|mesh-list
101965578|NCT00047879|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101320989|NCT02687906|Meropenem|meropenem|mesh-list
101965579|NCT00047879|Thalidomide|thalidomide|mesh-list
101965580|NCT00047879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101965581|NCT00047879|Antiviral Agents|antiviral agents|mesh-ancestor
101965582|NCT00047879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101965583|NCT00047879|Immunologic Factors|immunologic factors|mesh-ancestor
101965584|NCT00047879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965585|NCT00047879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101965586|NCT00047879|Leprostatic Agents|leprostatic agents|mesh-ancestor
101965587|NCT00047879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101965588|NCT00047879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101321117|NCT03802097|Anti-Infective Agents|anti-infective agents|mesh-list
101965589|NCT00047879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101965590|NCT00047879|Growth Substances|growth substances|mesh-ancestor
101321225|NCT02832544|Vitamin K|vitamin k|mesh-list
101965591|NCT00047879|Growth Inhibitors|growth inhibitors|mesh-ancestor
101965592|NCT00064337|Thalidomide|thalidomide|mesh-list
101965593|NCT00064337|Dexamethasone|dexamethasone|mesh-list
101965594|NCT00064337|Cyclophosphamide|cyclophosphamide|mesh-list
101971009|NCT04976387|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101971010|NCT04976387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101971011|NCT04976387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965595|NCT00064337|Melphalan|melphalan|mesh-list
101965596|NCT00064337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101965597|NCT00064337|Immunologic Factors|immunologic factors|mesh-ancestor
101965598|NCT00064337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965599|NCT00064337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101965600|NCT00064337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101965601|NCT00064337|Alkylating Agents|alkylating agents|mesh-ancestor
101965602|NCT00064337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965603|NCT00064337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101965604|NCT00064337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101965605|NCT00064337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101965606|NCT00064337|Antiemetics|antiemetics|mesh-ancestor
101965607|NCT00064337|Autonomic Agents|autonomic agents|mesh-ancestor
101965608|NCT00064337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101965609|NCT00064337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101965610|NCT00064337|Glucocorticoids|glucocorticoids|mesh-ancestor
101965612|NCT00064337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101965613|NCT00064337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101965614|NCT00064337|Leprostatic Agents|leprostatic agents|mesh-ancestor
101965615|NCT00064337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101965616|NCT00064337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101965617|NCT00064337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101965618|NCT00064337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101965619|NCT00064337|Growth Substances|growth substances|mesh-ancestor
101965620|NCT00064337|Growth Inhibitors|growth inhibitors|mesh-ancestor
101965621|NCT01096121|Enalapril|enalapril|mesh-list
101965622|NCT01096121|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101965623|NCT01096121|Protease Inhibitors|protease inhibitors|mesh-ancestor
101965624|NCT01096121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101965625|NCT01096121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965626|NCT01096121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101965627|NCT00064259|Fluorouracil|fluorouracil|mesh-list
101965628|NCT00064259|Oblimersen|oblimersen|mesh-list
101965629|NCT00064259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101965630|NCT00064259|Antimetabolites|antimetabolites|mesh-ancestor
101965631|NCT00064259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965632|NCT00064259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101965633|NCT00064259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101965634|NCT00064259|Immunologic Factors|immunologic factors|mesh-ancestor
101965635|NCT00064259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965636|NCT03954197|Hormones|hormones|mesh-list
101965637|NCT03954197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101965638|NCT03954197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965640|NCT00044213|Edetic Acid|edetic acid|mesh-list
101965641|NCT00044213|Pentetic Acid|pentetic acid|mesh-list
101965642|NCT00044213|Micronutrients|micronutrients|mesh-ancestor
101965643|NCT00044213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965644|NCT00044213|Anticoagulants|anticoagulants|mesh-ancestor
101965645|NCT00044213|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101965646|NCT00044213|Chelating Agents|chelating agents|mesh-ancestor
101965647|NCT00044213|Sequestering Agents|sequestering agents|mesh-ancestor
101322265|NCT00089206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101965648|NCT00044213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685419|NCT01246310|Micronutrients|micronutrients|mesh-ancestor
101965649|NCT00044213|Antidotes|antidotes|mesh-ancestor
101965650|NCT00044213|Protective Agents|protective agents|mesh-ancestor
101965651|NCT00044213|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101965652|NCT00064025|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101965653|NCT00064025|Medroxyprogesterone|medroxyprogesterone|mesh-list
101965654|NCT00064025|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101965655|NCT00064025|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101965656|NCT00064025|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101322478|NCT00091039|Paclitaxel|paclitaxel|mesh-list
101965657|NCT00064025|Contraceptive Agents|contraceptive agents|mesh-ancestor
101965658|NCT00064025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101965659|NCT00064025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965660|NCT00064025|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101322557|NCT04619706|Hormones|hormones|mesh-ancestor
101971012|NCT04976387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101971013|NCT04976387|Narcotics|narcotics|mesh-ancestor
101305777|NCT02021851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101965661|NCT00064025|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101965662|NCT00064025|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101965663|NCT00064025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101965664|NCT00064025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101965666|NCT01096199|Everolimus|everolimus|mesh-list
101965667|NCT01096199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101965668|NCT01096199|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101965669|NCT01096199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101322690|NCT00006215|Vinorelbine|vinorelbine|mesh-list
101965671|NCT01096199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965672|NCT01096199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101965673|NCT01096199|Immunologic Factors|immunologic factors|mesh-ancestor
101965674|NCT01096199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965675|NCT01096277|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101965676|NCT01096277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101965677|NCT01096277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965678|NCT01096277|Incretins|incretins|mesh-ancestor
101965679|NCT01096277|Hormones|hormones|mesh-ancestor
101322831|NCT00093769|Immunologic Factors|immunologic factors|mesh-ancestor
101965680|NCT01096277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101965681|NCT01096277|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101965683|NCT01096277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101965684|NCT01096277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965685|NCT01096355|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
101965686|NCT01096355|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101965688|NCT01096355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965690|NCT01096511|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101965691|NCT01096511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101965692|NCT01096511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101965693|NCT01096511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101965694|NCT01096511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101965695|NCT01096511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101965696|NCT01096511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965697|NCT01096511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101965698|NCT01096511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101965699|NCT01096511|Contraceptive Agents|contraceptive agents|mesh-ancestor
101965700|NCT01096511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101965701|NCT01096511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323255|NCT00096148|Idarubicin|idarubicin|mesh-list
101965702|NCT01096511|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101965703|NCT01096511|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101965704|NCT01096511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101965705|NCT01092455|Heparin|heparin|mesh-list
101965706|NCT01092455|Calcium heparin|calcium heparin|mesh-list
101965707|NCT01092455|Anticoagulants|anticoagulants|mesh-ancestor
101965708|NCT01092455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101965709|NCT01092455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101965710|NCT01092455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965711|NCT02264938|Antioxidants|antioxidants|mesh-list
101965712|NCT02264938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965713|NCT02264938|Protective Agents|protective agents|mesh-ancestor
101965714|NCT02264938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965715|NCT02511886|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
101965716|NCT02511886|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101965717|NCT02511886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965718|NCT02511886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101965719|NCT02511886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101965720|NCT02511886|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101965721|NCT02511886|GABA Agonists|gaba agonists|mesh-ancestor
101692922|NCT00883116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101692923|NCT00883116|Tubulin Modulators|tubulin modulators|mesh-ancestor
101692924|NCT00883116|Antimitotic Agents|antimitotic agents|mesh-ancestor
101692925|NCT00883116|Mitosis Modulators|mitosis modulators|mesh-ancestor
101692926|NCT00883116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692927|NCT00883116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101692928|NCT00883116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101692929|NCT00883116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101692930|NCT00883116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101965722|NCT02511886|GABA Agents|gaba agents|mesh-ancestor
101965723|NCT02511886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101965724|NCT02511886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965726|NCT04235140|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101965727|NCT04235140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101737352|NCT00780416|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101305778|NCT02021851|Protease Inhibitors|protease inhibitors|mesh-ancestor
101965728|NCT04235140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965729|NCT00043979|Cyclosporine|cyclosporine|mesh-list
101965732|NCT00043979|Cyclophosphamide|cyclophosphamide|mesh-list
101965733|NCT00043979|Melphalan|melphalan|mesh-list
101965734|NCT00043979|Doxorubicin|doxorubicin|mesh-list
101965735|NCT00043979|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101965736|NCT00043979|Fludarabine|fludarabine|mesh-list
101965737|NCT00043979|Fludarabine phosphate|fludarabine phosphate|mesh-list
101965738|NCT00043979|Etoposide|etoposide|mesh-list
101965739|NCT00043979|Vincristine|vincristine|mesh-list
101965740|NCT00043979|Tacrolimus|tacrolimus|mesh-list
101965741|NCT00043979|Cyclosporins|cyclosporins|mesh-list
101965742|NCT00043979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101965743|NCT00043979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101965744|NCT00043979|Immunologic Factors|immunologic factors|mesh-ancestor
101965745|NCT00043979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965746|NCT00043979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101965747|NCT00043979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101323732|NCT00099970|Dacarbazine|dacarbazine|mesh-list
101965748|NCT00043979|Alkylating Agents|alkylating agents|mesh-ancestor
101965749|NCT00043979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965750|NCT00043979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101965751|NCT00043979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101965752|NCT00043979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101965753|NCT00043979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101965754|NCT00043979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101965755|NCT00043979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101965756|NCT00043979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101965757|NCT00043979|Glucocorticoids|glucocorticoids|mesh-ancestor
101965758|NCT00043979|Hormones|hormones|mesh-ancestor
101965759|NCT00043979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101965760|NCT00043979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101323938|NCT00006386|Carmustine|carmustine|mesh-list
101965761|NCT00043979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101965762|NCT00043979|Antimetabolites|antimetabolites|mesh-ancestor
101965763|NCT00043979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101965764|NCT00043979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101965765|NCT00043979|Tubulin Modulators|tubulin modulators|mesh-ancestor
101965766|NCT00043979|Antimitotic Agents|antimitotic agents|mesh-ancestor
101965767|NCT00043979|Mitosis Modulators|mitosis modulators|mesh-ancestor
101965768|NCT00043979|Antifungal Agents|antifungal agents|mesh-ancestor
101965769|NCT00043979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101965770|NCT00043979|Dermatologic Agents|dermatologic agents|mesh-ancestor
101965771|NCT00043979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101965772|NCT00043979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101965773|NCT01436032|Ketorolac|ketorolac|mesh-list
101965774|NCT01436032|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101965775|NCT01436032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101965776|NCT01436032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101965777|NCT01436032|Analgesics|analgesics|mesh-ancestor
101965778|NCT01436032|Sensory System Agents|sensory system agents|mesh-ancestor
101965779|NCT01436032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101965780|NCT01436032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965781|NCT01436032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101965782|NCT01436032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101965783|NCT01436032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101965784|NCT01436032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101965785|NCT01436032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965786|NCT01092533|Mycophenolic Acid|mycophenolic acid|mesh-list
101965788|NCT01092533|Prednisone|prednisone|mesh-list
101324357|NCT03879408|Antitussive Agents|antitussive agents|mesh-ancestor
101965789|NCT01092533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101965790|NCT01092533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101965791|NCT01092533|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101965792|NCT01092533|Antitubercular Agents|antitubercular agents|mesh-ancestor
101965793|NCT01092533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101965794|NCT01092533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101965795|NCT01092533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101965796|NCT01092533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965797|NCT01092533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101965798|NCT01092533|Glucocorticoids|glucocorticoids|mesh-ancestor
101965799|NCT01092533|Hormones|hormones|mesh-ancestor
101324503|NCT00105352|Glucagon|glucagon|mesh-list
101737353|NCT00780416|Interferon-alpha|interferon-alpha|mesh-list
101971014|NCT04976387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101971015|NCT04976387|Antitussive Agents|antitussive agents|mesh-ancestor
101971016|NCT04976387|Respiratory System Agents|respiratory system agents|mesh-ancestor
101971017|NCT04975152|Cemiplimab|cemiplimab|mesh-list
101305779|NCT02021851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101965800|NCT01092533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101965801|NCT01092533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965802|NCT01092533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101965803|NCT01431820|Luliconazole|luliconazole|mesh-list
101965804|NCT01431820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101965805|NCT01431820|Antifungal Agents|antifungal agents|mesh-ancestor
101965806|NCT01431820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101965807|NCT01425970|Interferons|interferons|mesh-list
101965808|NCT01425970|Ribavirin|ribavirin|mesh-list
101965809|NCT01425970|Interferon-alpha|interferon-alpha|mesh-list
101965810|NCT01425970|Interferon alpha-2|interferon alpha-2|mesh-list
101965811|NCT01425970|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101965812|NCT01425970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101965813|NCT01425970|Antiviral Agents|antiviral agents|mesh-ancestor
101324787|NCT00006578|Ritonavir|ritonavir|mesh-list
101965814|NCT01425970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101965815|NCT01425970|Antimetabolites|antimetabolites|mesh-ancestor
101965816|NCT01425970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965817|NCT01425970|Immunologic Factors|immunologic factors|mesh-ancestor
101965818|NCT01425970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324933|NCT03625323|Pembrolizumab|pembrolizumab|mesh-list
101965819|NCT01619332|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101965820|NCT01619332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101965821|NCT01619332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965822|NCT01619332|Incretins|incretins|mesh-ancestor
101965823|NCT01619332|Hormones|hormones|mesh-ancestor
101965824|NCT01619332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101965825|NCT01619332|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101965826|NCT01619332|Protease Inhibitors|protease inhibitors|mesh-ancestor
101965827|NCT01619332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101325068|NCT00006929|Anthelmintics|anthelmintics|mesh-ancestor
101965828|NCT01619332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965829|NCT01616524|Interferons|interferons|mesh-list
101965830|NCT01616524|Ribavirin|ribavirin|mesh-list
101965831|NCT01616524|Interferon-alpha|interferon-alpha|mesh-list
101965833|NCT01616524|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101965834|NCT01616524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101965835|NCT01616524|Antiviral Agents|antiviral agents|mesh-ancestor
101965836|NCT01616524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101965837|NCT01616524|Antimetabolites|antimetabolites|mesh-ancestor
101965838|NCT01616524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965839|NCT01616524|Immunologic Factors|immunologic factors|mesh-ancestor
101965840|NCT01616524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965841|NCT02265328|Prednisolone|prednisolone|mesh-list
101965842|NCT02265328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101965843|NCT02265328|Glucocorticoids|glucocorticoids|mesh-ancestor
101965844|NCT02265328|Hormones|hormones|mesh-ancestor
101965845|NCT02265328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101325351|NCT00111436|Analgesics|analgesics|mesh-ancestor
101965846|NCT02265328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965847|NCT02265328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101965848|NCT02265328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101965849|NCT02265406|Anti-Infective Agents|anti-infective agents|mesh-list
101965850|NCT01421056|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
101325492|NCT00007436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101965851|NCT01421056|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101965852|NCT01421056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101965853|NCT01421056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965854|NCT01416064|Molindone|molindone|mesh-list
101965855|NCT01416064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101965856|NCT01416064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101965857|NCT01416064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101965858|NCT01416064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965859|NCT01416064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101965860|NCT01594216|Exemestane|exemestane|mesh-list
101971018|NCT04975152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101971019|NCT04975152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971020|NCT04973163|Midazolam|midazolam|mesh-list
101971021|NCT04973163|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101971022|NCT04973163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101305785|NCT02021851|Serotonin Agents|serotonin agents|mesh-ancestor
101965861|NCT01594216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101965862|NCT01594216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101965863|NCT01594216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101965864|NCT01594216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101965865|NCT01594216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965866|NCT01594216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101965867|NCT01594216|Hormone Antagonists|hormone antagonists|mesh-ancestor
101965868|NCT01594216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101965869|NCT01594216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965872|NCT02263690|Anesthetics|anesthetics|mesh-ancestor
101965873|NCT02263690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101965874|NCT02263690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965875|NCT02263690|Sensory System Agents|sensory system agents|mesh-ancestor
101965876|NCT02263690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101965877|NCT02263690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101965878|NCT02263690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101965879|NCT02263690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101965880|NCT02263690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101965881|NCT02263690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965882|NCT02265562|Alprostadil|alprostadil|mesh-list
101965883|NCT02265562|Misoprostol|misoprostol|mesh-list
101965884|NCT02265562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101965885|NCT02265562|Abortifacient Agents|abortifacient agents|mesh-ancestor
101965886|NCT02265562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101326068|NCT00115414|Doxorubicin|doxorubicin|mesh-list
101965887|NCT02265562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965888|NCT02265562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101965889|NCT02265562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101965890|NCT02265562|Oxytocics|oxytocics|mesh-ancestor
101965891|NCT02265562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101965892|NCT02265562|Vasodilator Agents|vasodilator agents|mesh-ancestor
101965893|NCT02265562|Urological Agents|urological agents|mesh-ancestor
101965894|NCT01399684|Leucovorin|leucovorin|mesh-list
101965895|NCT01399684|Folic Acid|folic acid|mesh-list
101965896|NCT01399684|Bevacizumab|bevacizumab|mesh-list
101965897|NCT01399684|Fluorouracil|fluorouracil|mesh-list
101965898|NCT01399684|Oxaliplatin|oxaliplatin|mesh-list
101965899|NCT01399684|Levoleucovorin|levoleucovorin|mesh-list
101326207|NCT00008333|Vinorelbine|vinorelbine|mesh-list
101965900|NCT01399684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101965902|NCT01399684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101965903|NCT01399684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101965904|NCT01399684|Growth Substances|growth substances|mesh-ancestor
101326281|NCT00116389|Antimetabolites|antimetabolites|mesh-ancestor
101965905|NCT01399684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965906|NCT01399684|Growth Inhibitors|growth inhibitors|mesh-ancestor
101965907|NCT01399684|Antimetabolites|antimetabolites|mesh-ancestor
101965908|NCT01399684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965909|NCT01399684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101965910|NCT01399684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101965911|NCT01399684|Immunologic Factors|immunologic factors|mesh-ancestor
101965912|NCT01399684|Antidotes|antidotes|mesh-ancestor
101965913|NCT01399684|Protective Agents|protective agents|mesh-ancestor
101965914|NCT01399684|Vitamin B Complex|vitamin b complex|mesh-ancestor
101965915|NCT01399684|Vitamins|vitamins|mesh-ancestor
101965916|NCT01399684|Micronutrients|micronutrients|mesh-ancestor
101965917|NCT01399684|Hematinics|hematinics|mesh-ancestor
101965918|NCT01397968|Cenobamate|cenobamate|mesh-list
101965919|NCT01397968|Anticonvulsants|anticonvulsants|mesh-ancestor
101965920|NCT01397578|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101326645|NCT00402142|Vaccines|vaccines|mesh-list
101965921|NCT01397578|Immunologic Factors|immunologic factors|mesh-ancestor
101965922|NCT01397578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965924|NCT02265718|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101737354|NCT00780416|Antimetabolites|antimetabolites|mesh-ancestor
101971023|NCT04973163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101971024|NCT04973163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971025|NCT04973163|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101971026|NCT04973163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101971027|NCT04973163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101971028|NCT04973163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101965925|NCT02265718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965926|NCT02265718|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101965927|NCT02265718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101965928|NCT02265718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101965929|NCT02265718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965930|NCT02265718|Dopamine Agents|dopamine agents|mesh-ancestor
101965931|NCT02265718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101965932|NCT01381666|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101965933|NCT02266030|Aspirin|aspirin|mesh-list
101965934|NCT02266030|Cilostazol|cilostazol|mesh-list
101965935|NCT02266030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101965936|NCT02266030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101965937|NCT02266030|Analgesics|analgesics|mesh-ancestor
101965938|NCT02266030|Sensory System Agents|sensory system agents|mesh-ancestor
101965939|NCT02266030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101965940|NCT02266030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965941|NCT02266030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101965942|NCT02266030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101965943|NCT02266030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101965944|NCT02266030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101965945|NCT02266030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965946|NCT02266030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101965947|NCT02266030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101965948|NCT02266030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101965949|NCT02266030|Antipyretics|antipyretics|mesh-ancestor
101965950|NCT02266030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101965951|NCT02266030|Autonomic Agents|autonomic agents|mesh-ancestor
101965952|NCT02266030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101965953|NCT02266030|Respiratory System Agents|respiratory system agents|mesh-ancestor
101965954|NCT02266030|Vasodilator Agents|vasodilator agents|mesh-ancestor
101965955|NCT02266030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101965956|NCT02266030|Protective Agents|protective agents|mesh-ancestor
101965957|NCT02266030|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101965958|NCT02266030|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101965959|NCT01527916|Donepezil|donepezil|mesh-list
101965960|NCT01527916|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101965961|NCT01527916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101965962|NCT01527916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326926|NCT00121303|Immunotoxins|immunotoxins|mesh-ancestor
101965963|NCT01527916|Cholinergic Agents|cholinergic agents|mesh-ancestor
101965964|NCT01527916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101965965|NCT01527916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965966|NCT01527916|Nootropic Agents|nootropic agents|mesh-ancestor
101965967|NCT01373086|Eplerenone|eplerenone|mesh-list
101965968|NCT01373086|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101965969|NCT01373086|Hormone Antagonists|hormone antagonists|mesh-ancestor
101965970|NCT01373086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101965971|NCT01373086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965972|NCT01373086|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101965973|NCT01373086|Diuretics|diuretics|mesh-ancestor
101965974|NCT01373086|Natriuretic Agents|natriuretic agents|mesh-ancestor
101965975|NCT01373086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101965976|NCT01519804|Paclitaxel|paclitaxel|mesh-list
101965977|NCT01519804|Carboplatin|carboplatin|mesh-list
101965978|NCT01519804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101965979|NCT01519804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101965980|NCT01519804|Tubulin Modulators|tubulin modulators|mesh-ancestor
101965981|NCT01519804|Antimitotic Agents|antimitotic agents|mesh-ancestor
101965982|NCT01519804|Mitosis Modulators|mitosis modulators|mesh-ancestor
101965983|NCT01519804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965984|NCT02263924|Tocotrienols|tocotrienols|mesh-list
101965985|NCT02263924|Vitamin E|vitamin e|mesh-list
101971029|NCT04973163|Anesthetics, General|anesthetics, general|mesh-ancestor
101971030|NCT04973163|Anesthetics|anesthetics|mesh-ancestor
101971031|NCT04973163|GABA Modulators|gaba modulators|mesh-ancestor
101971032|NCT04973163|GABA Agents|gaba agents|mesh-ancestor
101971033|NCT04973163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101971034|NCT04973163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971035|NCT04941872|FAPI-46|fapi-46|mesh-list
101965986|NCT02263924|Tocopherols|tocopherols|mesh-list
101965987|NCT02263924|Antioxidants|antioxidants|mesh-ancestor
101965988|NCT02263924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965989|NCT02263924|Protective Agents|protective agents|mesh-ancestor
101965990|NCT02263924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965992|NCT02263924|Micronutrients|micronutrients|mesh-ancestor
101965993|NCT02264002|Metoprolol|metoprolol|mesh-list
101965994|NCT02264002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101965995|NCT02264002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101965997|NCT02264002|Autonomic Agents|autonomic agents|mesh-ancestor
101965998|NCT02264002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101327311|NCT00009204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101965999|NCT02264002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966000|NCT02264002|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101966001|NCT02264002|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101966002|NCT02264002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101966003|NCT02264002|Adrenergic Agents|adrenergic agents|mesh-ancestor
101966004|NCT02264002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101966005|NCT02264002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966006|NCT01517776|Temozolomide|temozolomide|mesh-list
101966007|NCT01517776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101966008|NCT01517776|Alkylating Agents|alkylating agents|mesh-ancestor
101966009|NCT01517776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966010|NCT01517776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101693094|NCT02537600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966012|NCT02266264|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101966013|NCT02266264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101966014|NCT01516918|Ribavirin|ribavirin|mesh-list
101966015|NCT01516918|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101966016|NCT01516918|Antimetabolites|antimetabolites|mesh-ancestor
101327601|NCT00019669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101966017|NCT01516918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966019|NCT01516918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101966020|NCT01508026|Valsartan|valsartan|mesh-list
101966021|NCT01508026|Nebivolol|nebivolol|mesh-list
101966022|NCT01508026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101966023|NCT01508026|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101966024|NCT01508026|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101966025|NCT01508026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966026|NCT01508026|Vasodilator Agents|vasodilator agents|mesh-ancestor
101966027|NCT01508026|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101966028|NCT01508026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101966029|NCT01508026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101966030|NCT01508026|Adrenergic Agents|adrenergic agents|mesh-ancestor
101966031|NCT01508026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101966032|NCT01508026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966034|NCT01357642|Racepinephrine|racepinephrine|mesh-list
101966035|NCT01357642|Epinephryl borate|epinephryl borate|mesh-list
101966036|NCT01357642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101966037|NCT01357642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101966038|NCT01357642|Adrenergic Agents|adrenergic agents|mesh-ancestor
101966039|NCT01357642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101966040|NCT01357642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328040|NCT00010452|Picibanil|picibanil|mesh-list
101966041|NCT01357642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966042|NCT01357642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101966043|NCT01357642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101966044|NCT01357642|Autonomic Agents|autonomic agents|mesh-ancestor
101966045|NCT01357642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101966046|NCT01357642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101966048|NCT01357642|Mydriatics|mydriatics|mesh-ancestor
101966049|NCT01357642|Sympathomimetics|sympathomimetics|mesh-ancestor
101971036|NCT04941872|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101971037|NCT04941872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971038|NCT04939272|Venetoclax|venetoclax|mesh-list
101971039|NCT04939272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971040|NCT04935359|Paclitaxel|paclitaxel|mesh-list
101971041|NCT04935359|Gemcitabine|gemcitabine|mesh-list
101971042|NCT04935359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101971043|NCT04935359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971044|NCT04935359|Tubulin Modulators|tubulin modulators|mesh-ancestor
101305800|NCT02022163|Antacids|antacids|mesh-ancestor
101966050|NCT01357642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101966051|NCT03135340|Anesthetics|anesthetics|mesh-list
101966052|NCT03135340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101328178|NCT00022165|Selenium|selenium|mesh-list
101966053|NCT03135340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966054|NCT01356160|Ribavirin|ribavirin|mesh-list
101966055|NCT01356160|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101966056|NCT01356160|Ledipasvir|ledipasvir|mesh-list
101966057|NCT01356160|Antimetabolites|antimetabolites|mesh-ancestor
101328248|NCT00000143|Cidofovir|cidofovir|mesh-list
101966058|NCT01356160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966059|NCT01356160|Antiviral Agents|antiviral agents|mesh-ancestor
101966060|NCT01356160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101966061|NCT02264158|Telmisartan|telmisartan|mesh-list
101966062|NCT02264158|Lacidipine|lacidipine|mesh-list
101966064|NCT02264158|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101966065|NCT02264158|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101966066|NCT02264158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966067|NCT02264158|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101966068|NCT02264158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101966069|NCT02264158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101966070|NCT02264158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966071|NCT02264236|Vaccines|vaccines|mesh-list
101328390|NCT00023218|Lopinavir|lopinavir|mesh-list
101966072|NCT02264236|Immunologic Factors|immunologic factors|mesh-ancestor
101966073|NCT02264236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966075|NCT01476904|Racepinephrine|racepinephrine|mesh-list
101966076|NCT01476904|Epinephryl borate|epinephryl borate|mesh-list
101966077|NCT01476904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101966078|NCT01476904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101966079|NCT01476904|Adrenergic Agents|adrenergic agents|mesh-ancestor
101966080|NCT01476904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101966081|NCT01476904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966082|NCT01476904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966083|NCT01476904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101966084|NCT01476904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101966085|NCT01476904|Autonomic Agents|autonomic agents|mesh-ancestor
101966086|NCT01476904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101966087|NCT01476904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101966088|NCT01476904|Respiratory System Agents|respiratory system agents|mesh-ancestor
101966089|NCT01476904|Mydriatics|mydriatics|mesh-ancestor
101966090|NCT01476904|Sympathomimetics|sympathomimetics|mesh-ancestor
101966091|NCT01476904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101966093|NCT01337752|Bortezomib|bortezomib|mesh-list
101966094|NCT01337752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101966095|NCT01337752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101966096|NCT01337752|Antiemetics|antiemetics|mesh-ancestor
101966097|NCT01337752|Autonomic Agents|autonomic agents|mesh-ancestor
101966098|NCT01337752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101966099|NCT01337752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966100|NCT01337752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101966101|NCT01337752|Glucocorticoids|glucocorticoids|mesh-ancestor
101966103|NCT01337752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101328514|NCT00023413|Efavirenz|efavirenz|mesh-list
101966104|NCT01337752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101966105|NCT01337752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101966106|NCT01337752|Immunologic Factors|immunologic factors|mesh-ancestor
101574940|NCT01028391|Incretins|incretins|mesh-ancestor
101971045|NCT04935359|Antimitotic Agents|antimitotic agents|mesh-ancestor
101971046|NCT04935359|Mitosis Modulators|mitosis modulators|mesh-ancestor
101966107|NCT01318642|Gemcitabine|gemcitabine|mesh-list
101966108|NCT01318642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101966109|NCT01318642|Antimetabolites|antimetabolites|mesh-ancestor
101966110|NCT01318642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966111|NCT01318642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101966112|NCT01318252|Latanoprost|latanoprost|mesh-list
101966113|NCT01318252|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101966114|NCT01318252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101966115|NCT01313572|Adenosine|adenosine|mesh-list
101966116|NCT01313572|Analgesics|analgesics|mesh-ancestor
101966117|NCT01313572|Sensory System Agents|sensory system agents|mesh-ancestor
101966118|NCT01313572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101328566|NCT00000176|Estrogens|estrogens|mesh-list
101966119|NCT01313572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966120|NCT01313572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101966121|NCT01313572|Vasodilator Agents|vasodilator agents|mesh-ancestor
101966122|NCT01313572|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101966123|NCT01313572|Purinergic Agonists|purinergic agonists|mesh-ancestor
101966124|NCT01313572|Purinergic Agents|purinergic agents|mesh-ancestor
101966125|NCT01313572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101328626|NCT00023842|BCG Vaccine|bcg vaccine|mesh-list
101966126|NCT01313572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966128|NCT02265484|Bromocriptine|bromocriptine|mesh-list
101966129|NCT02265484|Lactulose|lactulose|mesh-list
101966130|NCT02265484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101966131|NCT02265484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101966132|NCT02265484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101966133|NCT02265484|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101966134|NCT02265484|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101966135|NCT02265484|Hormone Antagonists|hormone antagonists|mesh-ancestor
101328765|NCT00024193|Immunologic Factors|immunologic factors|mesh-ancestor
101693137|NCT02537366|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101966136|NCT02265484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101966137|NCT02265484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966138|NCT02265484|Dopamine Agonists|dopamine agonists|mesh-ancestor
101966139|NCT02265484|Dopamine Agents|dopamine agents|mesh-ancestor
101966140|NCT02265484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101328839|NCT00000251|Anesthetics|anesthetics|mesh-ancestor
101966141|NCT02265484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966142|NCT02264626|Remifentanil|remifentanil|mesh-list
101966143|NCT02264626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101966144|NCT02264626|Narcotics|narcotics|mesh-ancestor
101966145|NCT02264626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101966146|NCT02264626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966147|NCT02264626|Analgesics|analgesics|mesh-ancestor
101966148|NCT02264626|Sensory System Agents|sensory system agents|mesh-ancestor
101966149|NCT02264626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101966150|NCT03993262|Bortezomib|bortezomib|mesh-list
101966151|NCT03993262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101966152|NCT02267044|Ropivacaine|ropivacaine|mesh-list
101966153|NCT02267044|Anesthetics, Local|anesthetics, local|mesh-ancestor
101966154|NCT02267044|Anesthetics|anesthetics|mesh-ancestor
101966155|NCT02267044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101966156|NCT02267044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966157|NCT02267044|Sensory System Agents|sensory system agents|mesh-ancestor
101966158|NCT02267044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101966159|NCT02267122|Mupirocin|mupirocin|mesh-list
101966160|NCT02267122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101966161|NCT02267122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101966162|NCT02267122|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101966163|NCT02267122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966164|NCT02267122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966165|NCT01261312|Guadecitabine|guadecitabine|mesh-list
101966166|NCT01261312|Azacitidine|azacitidine|mesh-list
101966167|NCT01261312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101966168|NCT01261312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101966169|NCT01261312|Antimetabolites|antimetabolites|mesh-ancestor
101966170|NCT01261312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685945|NCT02849873|Tazarotene|tazarotene|mesh-list
101966171|NCT01261312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966172|NCT01254370|Travoprost|travoprost|mesh-list
101966173|NCT01254370|Latanoprost|latanoprost|mesh-list
101966174|NCT01254370|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101971047|NCT04935359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971048|NCT04935359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101971050|NCT04915755|Niraparib|niraparib|mesh-list
101396013|NCT00091806|Panitumumab|panitumumab|mesh-list
101966175|NCT01254370|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101966176|NCT01254370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101966177|NCT01254136|Trastuzumab|trastuzumab|mesh-list
101966178|NCT01254136|Vinorelbine|vinorelbine|mesh-list
101966179|NCT01254136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101966180|NCT01254136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101966181|NCT01254136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101966182|NCT01254136|Tubulin Modulators|tubulin modulators|mesh-ancestor
101966183|NCT01254136|Antimitotic Agents|antimitotic agents|mesh-ancestor
101966184|NCT01254136|Mitosis Modulators|mitosis modulators|mesh-ancestor
101966185|NCT01254136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966186|NCT02268370|Dasatinib|dasatinib|mesh-list
101966187|NCT02268370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101966188|NCT02268370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101966189|NCT02268370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966190|NCT02268370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966191|NCT00039377|Leucovorin|leucovorin|mesh-list
101966192|NCT00039377|Cytarabine|cytarabine|mesh-list
101966193|NCT00039377|Cyclophosphamide|cyclophosphamide|mesh-list
101966194|NCT00039377|Methotrexate|methotrexate|mesh-list
101966195|NCT00039377|Etoposide|etoposide|mesh-list
101966196|NCT00039377|Vincristine|vincristine|mesh-list
101966197|NCT00039377|Etoposide phosphate|etoposide phosphate|mesh-list
101966198|NCT00039377|Imatinib Mesylate|imatinib mesylate|mesh-list
101966199|NCT00039377|Tacrolimus|tacrolimus|mesh-list
101966200|NCT00039377|Levoleucovorin|levoleucovorin|mesh-list
101966201|NCT00039377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101966202|NCT00039377|Immunologic Factors|immunologic factors|mesh-ancestor
101966203|NCT00039377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966204|NCT00039377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101966205|NCT00039377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101966206|NCT00039377|Alkylating Agents|alkylating agents|mesh-ancestor
101966207|NCT00039377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966208|NCT00039377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101966209|NCT00039377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101966210|NCT00039377|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101966211|NCT00039377|Abortifacient Agents|abortifacient agents|mesh-ancestor
101966212|NCT00039377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101966213|NCT00039377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101966215|NCT00039377|Dermatologic Agents|dermatologic agents|mesh-ancestor
101966216|NCT00039377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966217|NCT00039377|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101966218|NCT00039377|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101966219|NCT00039377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101966220|NCT00039377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101966221|NCT00039377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101966222|NCT00039377|Antiviral Agents|antiviral agents|mesh-ancestor
101966223|NCT00039377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101966225|NCT00039377|Protective Agents|protective agents|mesh-ancestor
101966226|NCT00039377|Vitamin B Complex|vitamin b complex|mesh-ancestor
101966227|NCT00039377|Vitamins|vitamins|mesh-ancestor
101966228|NCT00039377|Micronutrients|micronutrients|mesh-ancestor
101966229|NCT00039377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101966230|NCT00039377|Tubulin Modulators|tubulin modulators|mesh-ancestor
101966232|NCT00039377|Mitosis Modulators|mitosis modulators|mesh-ancestor
101966233|NCT00039377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101966234|NCT01096745|Cisplatin|cisplatin|mesh-list
101966235|NCT01096745|Gemcitabine|gemcitabine|mesh-list
101966236|NCT01096745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101966237|NCT01096745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101966238|NCT01096745|Antimetabolites|antimetabolites|mesh-ancestor
101966239|NCT01096745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966240|NCT03953729|Ibuprofen|ibuprofen|mesh-list
101966241|NCT03953729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101966242|NCT03953729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101966243|NCT03953729|Analgesics|analgesics|mesh-ancestor
101966244|NCT03953729|Sensory System Agents|sensory system agents|mesh-ancestor
101971051|NCT04915755|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101971052|NCT04915755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101396091|NCT00092001|Sunitinib|sunitinib|mesh-list
101966245|NCT03953729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101966246|NCT03953729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966247|NCT03953729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101966248|NCT03953729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101966249|NCT03953729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101966250|NCT03953729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966251|NCT03953729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966253|NCT01097213|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101966254|NCT01097213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101693153|NCT00546637|Fesoterodine|fesoterodine|mesh-list
101966255|NCT01097213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101330178|NCT00000494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101966256|NCT01097213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966258|NCT00154102|Folic Acid|folic acid|mesh-list
101966259|NCT00154102|Fluorouracil|fluorouracil|mesh-list
101966260|NCT00154102|Irinotecan|irinotecan|mesh-list
101966261|NCT00154102|Cetuximab|cetuximab|mesh-list
101966262|NCT00154102|Levoleucovorin|levoleucovorin|mesh-list
101966263|NCT00154102|Antimetabolites|antimetabolites|mesh-ancestor
101966264|NCT00154102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966265|NCT00154102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101966266|NCT00154102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101966267|NCT00154102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101966268|NCT00154102|Immunologic Factors|immunologic factors|mesh-ancestor
101330255|NCT00012558|GABA Agents|gaba agents|mesh-ancestor
101966269|NCT00154102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966270|NCT00154102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101966271|NCT00154102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101966272|NCT00154102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966273|NCT00154102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101966274|NCT00154102|Antidotes|antidotes|mesh-ancestor
101966275|NCT00154102|Protective Agents|protective agents|mesh-ancestor
101966276|NCT00154102|Vitamin B Complex|vitamin b complex|mesh-ancestor
101966277|NCT00154102|Vitamins|vitamins|mesh-ancestor
101966278|NCT00154102|Micronutrients|micronutrients|mesh-ancestor
101966279|NCT00154102|Hematinics|hematinics|mesh-ancestor
101966280|NCT01269658|Azithromycin|azithromycin|mesh-list
101966281|NCT01269658|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101966282|NCT01269658|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101966283|NCT01269658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101966284|NCT01269658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101966285|NCT01229644|Crenolanib|crenolanib|mesh-list
101966286|NCT01229644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101966287|NCT02267980|Ketamine|ketamine|mesh-list
101966288|NCT02267980|Sevoflurane|sevoflurane|mesh-list
101966289|NCT02267980|Analgesics|analgesics|mesh-ancestor
101966290|NCT02267980|Sensory System Agents|sensory system agents|mesh-ancestor
101966291|NCT02267980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101966292|NCT02267980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966293|NCT02267980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101966294|NCT02267980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101966295|NCT02267980|Anesthetics, General|anesthetics, general|mesh-ancestor
101966296|NCT02267980|Anesthetics|anesthetics|mesh-ancestor
101966297|NCT02267980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101966298|NCT02267980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101966299|NCT02267980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101966300|NCT02267980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101966301|NCT02267980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966302|NCT02267980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101966303|NCT02267980|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101966304|NCT01224262|Vaccines|vaccines|mesh-list
101966305|NCT01224262|Immunologic Factors|immunologic factors|mesh-ancestor
101966306|NCT01224262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966307|NCT01222702|Vancomycin|vancomycin|mesh-list
101966308|NCT01222702|Oxazolidinones|oxazolidinones|mesh-list
101966309|NCT01222702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101966310|NCT01222702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101966311|NCT01222702|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101966312|NCT01222702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966313|NCT01222702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966314|NCT01204762|Entecavir|entecavir|mesh-list
101966315|NCT01204762|Antiviral Agents|antiviral agents|mesh-ancestor
101971053|NCT04915755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971054|NCT04915755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971055|NCT04914897|Pembrolizumab|pembrolizumab|mesh-list
101971056|NCT04914897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101971057|NCT04914897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971058|NCT04914897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101971059|NCT04914897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971060|NCT04897321|Cyclophosphamide|cyclophosphamide|mesh-list
101971061|NCT04897321|Fludarabine|fludarabine|mesh-list
101971062|NCT04897321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101971063|NCT04897321|Immunologic Factors|immunologic factors|mesh-ancestor
101966316|NCT01204762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101966318|NCT02236078|Antitubercular Agents|antitubercular agents|mesh-ancestor
101966319|NCT02236078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101966320|NCT02236078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101966321|NCT02236078|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101966322|NCT02236078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101966323|NCT02236078|Antimetabolites|antimetabolites|mesh-ancestor
101966324|NCT02236078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966325|NCT02236078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101966326|NCT01198834|Etodolac|etodolac|mesh-list
101966327|NCT01198834|Lidocaine|lidocaine|mesh-list
101966328|NCT01198834|Anesthetics, Local|anesthetics, local|mesh-ancestor
101966329|NCT01198834|Anesthetics|anesthetics|mesh-ancestor
101966330|NCT01198834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101966331|NCT01198834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966332|NCT01198834|Sensory System Agents|sensory system agents|mesh-ancestor
101966333|NCT01198834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101966334|NCT01198834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101966335|NCT01198834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101966336|NCT01198834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101966337|NCT01198834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101966338|NCT01198834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966339|NCT01198834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101966340|NCT01198834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101966341|NCT01198834|Analgesics|analgesics|mesh-ancestor
101966342|NCT01198834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101966343|NCT01198834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101966344|NCT01198834|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101966345|NCT01198834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101966346|NCT01198834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966347|NCT01193140|Temozolomide|temozolomide|mesh-list
101966348|NCT01193140|Veliparib|veliparib|mesh-list
101966349|NCT01193140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101966350|NCT01193140|Alkylating Agents|alkylating agents|mesh-ancestor
101966351|NCT01193140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966352|NCT01193140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101966353|NCT01193140|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101966354|NCT01193140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966355|NCT01189396|Albuterol|albuterol|mesh-list
101966356|NCT01189396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101966357|NCT01189396|Autonomic Agents|autonomic agents|mesh-ancestor
101966358|NCT01189396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101966359|NCT01189396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966360|NCT01189396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101966361|NCT01189396|Respiratory System Agents|respiratory system agents|mesh-ancestor
101966362|NCT01189396|Tocolytic Agents|tocolytic agents|mesh-ancestor
101966363|NCT01189396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101966364|NCT01189396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101966365|NCT01189396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101971064|NCT04897321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971065|NCT04897321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101971066|NCT04897321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101971067|NCT04897321|Alkylating Agents|alkylating agents|mesh-ancestor
101305827|NCT02022293|Atorvastatin|atorvastatin|mesh-list
101966366|NCT01189396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101966367|NCT01189396|Adrenergic Agents|adrenergic agents|mesh-ancestor
101966368|NCT01189396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101966369|NCT01189396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966370|NCT05626972|Tenecteplase|tenecteplase|mesh-list
101966371|NCT05626972|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101966372|NCT05626972|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101966373|NCT05626972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966374|NCT01174732|Albuterol|albuterol|mesh-list
101966375|NCT01174732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101966376|NCT01174732|Autonomic Agents|autonomic agents|mesh-ancestor
101966377|NCT01174732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101966378|NCT01174732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966379|NCT01174732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101966380|NCT01174732|Respiratory System Agents|respiratory system agents|mesh-ancestor
101966381|NCT01174732|Tocolytic Agents|tocolytic agents|mesh-ancestor
101966382|NCT01174732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101966383|NCT01174732|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101966384|NCT01174732|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101966385|NCT01174732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101966386|NCT01174732|Adrenergic Agents|adrenergic agents|mesh-ancestor
101966387|NCT01174732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101966388|NCT01174732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966389|NCT01076764|Heparin|heparin|mesh-list
101966390|NCT01076764|Calcium heparin|calcium heparin|mesh-list
101966391|NCT01076764|Otamixaban|otamixaban|mesh-list
101966392|NCT01076764|Eptifibatide|eptifibatide|mesh-list
101966393|NCT01076764|Anticoagulants|anticoagulants|mesh-ancestor
101966394|NCT01076764|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101966395|NCT01076764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101966396|NCT01076764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966397|NCT01076764|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101966398|NCT01076764|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101966399|NCT01076764|Antithrombins|antithrombins|mesh-ancestor
101966400|NCT01076764|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101966401|NCT01076764|Protease Inhibitors|protease inhibitors|mesh-ancestor
101966402|NCT01076764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966403|NCT02269072|Anastrozole|anastrozole|mesh-list
101966404|NCT02269072|Leuprolide|leuprolide|mesh-list
101966405|NCT02269072|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101966406|NCT02269072|Testosterone|testosterone|mesh-list
101966407|NCT02269072|Androgens|androgens|mesh-ancestor
101966408|NCT02269072|Hormones|hormones|mesh-ancestor
101966409|NCT02269072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101966410|NCT02269072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966411|NCT02269072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101966412|NCT02269072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101966413|NCT02269072|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101966414|NCT02269072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101966415|NCT02269072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966416|NCT02269072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966417|NCT02269072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101966418|NCT02269072|Hormone Antagonists|hormone antagonists|mesh-ancestor
101966419|NCT02269072|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101966420|NCT02269072|Fertility Agents|fertility agents|mesh-ancestor
101966421|NCT02269072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101966422|NCT02269072|Natriuretic Agents|natriuretic agents|mesh-ancestor
101966424|NCT01071850|Ipragliflozin|ipragliflozin|mesh-list
101966425|NCT01071850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101966426|NCT01071850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966427|NCT01071850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101966428|NCT01071850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966429|NCT02269228|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
101966430|NCT02269228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101966431|NCT01037062|Entecavir|entecavir|mesh-list
101971068|NCT04897321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971069|NCT04897321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971070|NCT04897321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101971071|NCT04889664|Ketamine|ketamine|mesh-list
101971072|NCT04889664|Analgesics|analgesics|mesh-ancestor
101971073|NCT04889664|Sensory System Agents|sensory system agents|mesh-ancestor
101971074|NCT04889664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101971075|NCT04889664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971076|NCT04889664|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101971077|NCT04889664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101971078|NCT04889664|Anesthetics, General|anesthetics, general|mesh-ancestor
101971079|NCT04889664|Anesthetics|anesthetics|mesh-ancestor
101971080|NCT04889664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101971081|NCT04889664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101971082|NCT04889664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101971083|NCT04889664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101971084|NCT04889664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971085|NCT04879823|Acetaminophen|acetaminophen|mesh-list
101971086|NCT04879823|Dexamethasone|dexamethasone|mesh-list
101971087|NCT04879823|Ibuprofen|ibuprofen|mesh-list
101971088|NCT04879823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101971089|NCT04879823|Antiemetics|antiemetics|mesh-ancestor
101971090|NCT04879823|Autonomic Agents|autonomic agents|mesh-ancestor
101971091|NCT04879823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101971092|NCT04879823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305835|NCT02022358|Leucovorin|leucovorin|mesh-list
101966432|NCT01037062|Antiviral Agents|antiviral agents|mesh-ancestor
101966433|NCT01037062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101966434|NCT01167166|ON 01910|on 01910|mesh-list
101966435|NCT01167166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101966436|NCT01167166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101966437|NCT01167166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330896|NCT00032968|Naloxone|naloxone|mesh-list
101966438|NCT01167166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966439|NCT01035502|Idarubicin|idarubicin|mesh-list
101966440|NCT01035502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101966441|NCT01035502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101966442|NCT01035502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101966443|NCT01035502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101966444|NCT01035502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966445|NCT01035502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966446|NCT01030432|Ribavirin|ribavirin|mesh-list
101966447|NCT01030432|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101966448|NCT01030432|Interferon-alpha|interferon-alpha|mesh-list
101966449|NCT01030432|Asunaprevir|asunaprevir|mesh-list
101966450|NCT01030432|Antimetabolites|antimetabolites|mesh-ancestor
101966451|NCT01030432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966452|NCT01030432|Antiviral Agents|antiviral agents|mesh-ancestor
101693217|NCT00657774|Hormones|hormones|mesh-ancestor
101966453|NCT01030432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101971093|NCT04879823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101971095|NCT04879823|Hormones|hormones|mesh-ancestor
101966454|NCT01030432|Immunologic Factors|immunologic factors|mesh-ancestor
101966455|NCT01030432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966456|NCT01030432|Protease Inhibitors|protease inhibitors|mesh-ancestor
101966457|NCT01030432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966459|NCT02269462|Nevirapine|nevirapine|mesh-list
101966460|NCT02269462|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101966461|NCT02269462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101966462|NCT02269462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966463|NCT02269462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966464|NCT02269462|Antiviral Agents|antiviral agents|mesh-ancestor
101966465|NCT02269462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101966466|NCT02269462|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101966467|NCT02269462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101330925|NCT00033163|Tenofovir|tenofovir|mesh-list
101966468|NCT02269462|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101966469|NCT02269462|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101966470|NCT02269462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101330932|NCT00033163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966471|NCT02269462|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101966472|NCT02269462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101966473|NCT02269462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101966474|NCT02261506|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101966475|NCT02261506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101966476|NCT02261506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101966477|NCT02261506|Antitubercular Agents|antitubercular agents|mesh-ancestor
101966478|NCT02269540|Acetylcysteine|acetylcysteine|mesh-list
101966480|NCT02269540|Citalopram|citalopram|mesh-list
101966481|NCT02269540|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101336799|NCT00059761|Irinotecan|irinotecan|mesh-list
101966482|NCT02269540|Antiviral Agents|antiviral agents|mesh-ancestor
101966483|NCT02269540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101966484|NCT02269540|Expectorants|expectorants|mesh-ancestor
101966485|NCT02269540|Respiratory System Agents|respiratory system agents|mesh-ancestor
101966486|NCT02269540|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101966487|NCT02269540|Antioxidants|antioxidants|mesh-ancestor
101966488|NCT02269540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966489|NCT02269540|Protective Agents|protective agents|mesh-ancestor
101966490|NCT02269540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966491|NCT02269540|Antidotes|antidotes|mesh-ancestor
101966492|NCT02269540|Antidepressive Agents|antidepressive agents|mesh-ancestor
101966493|NCT02269540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101330951|NCT00000620|Rosiglitazone|rosiglitazone|mesh-list
101966494|NCT02269540|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101966495|NCT02269540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101966496|NCT02269540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101966497|NCT02269540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101966498|NCT02269540|Serotonin Agents|serotonin agents|mesh-ancestor
101966499|NCT02269540|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101966500|NCT01023880|Delanzomib|delanzomib|mesh-list
101966501|NCT01023880|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
101966502|NCT01023880|Protease Inhibitors|protease inhibitors|mesh-ancestor
101966503|NCT01023880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966504|NCT01023880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966505|NCT02650804|Coenzyme Q10|coenzyme q10|mesh-list
101966506|NCT02650804|Gemcitabine|gemcitabine|mesh-list
101966507|NCT02650804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101966508|NCT02650804|Antimetabolites|antimetabolites|mesh-ancestor
101693234|NCT02789969|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101966509|NCT02650804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966510|NCT02650804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101966511|NCT02650804|Vitamins|vitamins|mesh-ancestor
101966512|NCT02650804|Micronutrients|micronutrients|mesh-ancestor
101966513|NCT02650804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966514|NCT02269696|Metoprolol|metoprolol|mesh-list
101966515|NCT02269696|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101966516|NCT02269696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101966517|NCT02269696|Sympatholytics|sympatholytics|mesh-ancestor
101966518|NCT02269696|Autonomic Agents|autonomic agents|mesh-ancestor
101966519|NCT02269696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101966520|NCT02269696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330985|NCT00000620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101971096|NCT04879823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101966521|NCT02269696|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101966522|NCT02269696|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101966523|NCT02269696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101337627|NCT00065923|Topiramate|topiramate|mesh-list
101966524|NCT02269696|Adrenergic Agents|adrenergic agents|mesh-ancestor
101966525|NCT02269696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101966526|NCT02269696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966527|NCT03135184|Coal Tar|coal tar|mesh-list
101966528|NCT03135184|Keratolytic Agents|keratolytic agents|mesh-ancestor
101966529|NCT03135184|Dermatologic Agents|dermatologic agents|mesh-ancestor
101966530|NCT05613400|Simvastatin|simvastatin|mesh-list
101966531|NCT05613400|Ezetimibe|ezetimibe|mesh-list
101966532|NCT05613400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101966533|NCT05613400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101966534|NCT05613400|Antimetabolites|antimetabolites|mesh-ancestor
101966535|NCT05613400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966536|NCT05613400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101966537|NCT05613400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101966538|NCT05613400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966539|NCT02261662|Ribavirin|ribavirin|mesh-list
101966540|NCT02261662|Betamethasone|betamethasone|mesh-list
101966541|NCT02261662|Antimetabolites|antimetabolites|mesh-ancestor
101966542|NCT02261662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966543|NCT02261662|Antiviral Agents|antiviral agents|mesh-ancestor
101966544|NCT02261662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101966545|NCT02261662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101966546|NCT02261662|Glucocorticoids|glucocorticoids|mesh-ancestor
101686322|NCT00618228|Balsalazide|balsalazide|mesh-list
101966547|NCT02261662|Hormones|hormones|mesh-ancestor
101966548|NCT02261662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101966549|NCT02261662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966550|NCT02261662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101966551|NCT02261662|Respiratory System Agents|respiratory system agents|mesh-ancestor
101966553|NCT02261896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101966554|NCT02261896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101966555|NCT02261896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101966556|NCT02261896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101966557|NCT02261896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966558|NCT02261896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966559|NCT02261896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350571|NCT03759938|Rivaroxaban|rivaroxaban|mesh-list
101966560|NCT02261896|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101966561|NCT02261896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101966562|NCT00035555|Cyclosporine|cyclosporine|mesh-list
101966563|NCT00035555|Mycophenolic Acid|mycophenolic acid|mesh-list
101966564|NCT00035555|Abatacept|abatacept|mesh-list
101966565|NCT00035555|Cyclosporins|cyclosporins|mesh-list
101966566|NCT00035555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966567|NCT00035555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331031|NCT00033319|Folic Acid|folic acid|mesh-list
101966568|NCT00035555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101966569|NCT00035555|Immunologic Factors|immunologic factors|mesh-ancestor
101966570|NCT00035555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966571|NCT00035555|Antifungal Agents|antifungal agents|mesh-ancestor
101966572|NCT00035555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101966573|NCT00035555|Dermatologic Agents|dermatologic agents|mesh-ancestor
101966574|NCT00035555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101966575|NCT00035555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101966576|NCT00035555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101966577|NCT00035555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101966578|NCT00035555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101966579|NCT00035555|Antitubercular Agents|antitubercular agents|mesh-ancestor
101966580|NCT00035555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101966581|NCT00035555|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101966582|NCT00035555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101966584|NCT01093157|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101966585|NCT01093157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101966586|NCT01093157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966587|NCT01093235|Cyclophosphamide|cyclophosphamide|mesh-list
101966588|NCT01093235|Bevacizumab|bevacizumab|mesh-list
101966590|NCT01093235|Fluorouracil|fluorouracil|mesh-list
101966591|NCT01093235|Epirubicin|epirubicin|mesh-list
101966592|NCT01093235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101971097|NCT04879823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101971098|NCT04879823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971099|NCT04879823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101971100|NCT04879823|Analgesics|analgesics|mesh-ancestor
101971101|NCT04879823|Sensory System Agents|sensory system agents|mesh-ancestor
101305867|NCT02022488|Midazolam|midazolam|mesh-list
101966593|NCT01093235|Immunologic Factors|immunologic factors|mesh-ancestor
101966594|NCT01093235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966595|NCT01093235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101966596|NCT01093235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101966597|NCT01093235|Alkylating Agents|alkylating agents|mesh-ancestor
101966598|NCT01093235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966599|NCT01093235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101966600|NCT01093235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101966601|NCT01093235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101966602|NCT01093235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101966603|NCT01093235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101966604|NCT01093235|Growth Substances|growth substances|mesh-ancestor
101966605|NCT01093235|Growth Inhibitors|growth inhibitors|mesh-ancestor
101966606|NCT01093235|Tubulin Modulators|tubulin modulators|mesh-ancestor
101966607|NCT01093235|Antimitotic Agents|antimitotic agents|mesh-ancestor
101966608|NCT01093235|Mitosis Modulators|mitosis modulators|mesh-ancestor
101966609|NCT01093235|Antimetabolites|antimetabolites|mesh-ancestor
101966610|NCT01093235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101966611|NCT01093235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101693266|NCT00655512|Analgesics|analgesics|mesh-ancestor
101966612|NCT01093235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101966613|NCT01093235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101966614|NCT01093235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966615|NCT01097681|Ipragliflozin|ipragliflozin|mesh-list
101331076|NCT00033436|Niacin|niacin|mesh-list
101966616|NCT01097681|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101966617|NCT01097681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966618|NCT01097681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101966619|NCT01097681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966620|NCT01088009|Lamivudine|lamivudine|mesh-list
101966621|NCT01088009|Adefovir|adefovir|mesh-list
101966622|NCT01088009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101966623|NCT01088009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101966624|NCT01088009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966625|NCT01088009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966626|NCT01088009|Antiviral Agents|antiviral agents|mesh-ancestor
101966627|NCT01088009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101966628|NCT01088009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101331099|NCT00033553|Gemcitabine|gemcitabine|mesh-list
101966629|NCT01088009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101966631|NCT03894046|Colistin|colistin|mesh-list
101966632|NCT03894046|Sulbactam|sulbactam|mesh-list
101966633|NCT03894046|Durlobactam|durlobactam|mesh-list
101966635|NCT03894046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101966636|NCT03894046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101966637|NCT03894046|Protease Inhibitors|protease inhibitors|mesh-ancestor
101966638|NCT03894046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966639|NCT03894046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966640|NCT03894046|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101331108|NCT00033592|Bupropion|bupropion|mesh-list
101966641|NCT04475614|Vitamin B Complex|vitamin b complex|mesh-list
101966642|NCT04475614|Vitamins|vitamins|mesh-ancestor
101966643|NCT04475614|Micronutrients|micronutrients|mesh-ancestor
101966644|NCT04475614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966645|NCT01143064|Progesterone|progesterone|mesh-list
101966646|NCT01143064|Progestins|progestins|mesh-ancestor
101966647|NCT01143064|Hormones|hormones|mesh-ancestor
101966648|NCT01143064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101966649|NCT01143064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966650|NCT00033371|Eflornithine|eflornithine|mesh-list
101966651|NCT00033371|Celecoxib|celecoxib|mesh-list
101966652|NCT00033371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101966653|NCT00033371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101966654|NCT00033371|Analgesics|analgesics|mesh-ancestor
101966655|NCT00033371|Sensory System Agents|sensory system agents|mesh-ancestor
101966656|NCT00033371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101971102|NCT04879823|Antipyretics|antipyretics|mesh-ancestor
101971103|NCT04879823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101971104|NCT04879823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101966657|NCT00033371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966658|NCT00033371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101966659|NCT00033371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101966660|NCT00033371|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101966661|NCT00033371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101966662|NCT00033371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966663|NCT00033371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966664|NCT00033371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101966665|NCT00033371|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101966666|NCT00033371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101966667|NCT00033371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101966668|NCT00033371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101966669|NCT00033371|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
101966670|NCT01001338|Allopurinol|allopurinol|mesh-list
101966671|NCT01001338|Lesinurad|lesinurad|mesh-list
101966672|NCT01001338|Antimetabolites|antimetabolites|mesh-ancestor
101966673|NCT01001338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966674|NCT01001338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966675|NCT01001338|Gout Suppressants|gout suppressants|mesh-ancestor
101966676|NCT01001338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101966677|NCT01001338|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101966678|NCT01001338|Antioxidants|antioxidants|mesh-ancestor
101966679|NCT01001338|Protective Agents|protective agents|mesh-ancestor
101966680|NCT01001338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966681|NCT01001338|Uricosuric Agents|uricosuric agents|mesh-ancestor
101966682|NCT03952715|Ibuprofen|ibuprofen|mesh-list
101966683|NCT03952715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101966684|NCT03952715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101966685|NCT03952715|Analgesics|analgesics|mesh-ancestor
101339779|NCT00390260|Antipyretics|antipyretics|mesh-ancestor
101966686|NCT03952715|Sensory System Agents|sensory system agents|mesh-ancestor
101966687|NCT03952715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101966688|NCT03952715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966689|NCT03952715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101966690|NCT03952715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101966691|NCT03952715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101966692|NCT03952715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966693|NCT03952715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966695|NCT01137526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101966696|NCT01137526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331163|NCT00000641|Azithromycin|azithromycin|mesh-list
101966697|NCT01137526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686465|NCT02845349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101966698|NCT01137526|Cholinergic Agents|cholinergic agents|mesh-ancestor
101966699|NCT01137526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101331173|NCT00000641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966700|NCT01137526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966701|NCT01137526|Nootropic Agents|nootropic agents|mesh-ancestor
101966702|NCT00993382|Amiodarone|amiodarone|mesh-list
101966703|NCT00993382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101966704|NCT00993382|Vasodilator Agents|vasodilator agents|mesh-ancestor
101966705|NCT00993382|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101966706|NCT00993382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101966707|NCT00993382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966708|NCT00993382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101966709|NCT00993382|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101966710|NCT00993382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101966711|NCT00993382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966712|NCT00993382|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101966713|NCT00993382|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101966714|NCT00993382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101966715|NCT00081731|Candesartan cilexetil|candesartan cilexetil|mesh-list
101966716|NCT00081731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101966717|NCT00081731|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101966718|NCT00081731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101331186|NCT00000641|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101971105|NCT04879823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101971106|NCT04879823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101971107|NCT04879823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966719|NCT00081731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966721|NCT05628610|Carboplatin|carboplatin|mesh-list
101966722|NCT05628610|Tislelizumab|tislelizumab|mesh-list
101966723|NCT05628610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101966724|NCT05628610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101966725|NCT05628610|Tubulin Modulators|tubulin modulators|mesh-ancestor
101331197|NCT02971423|Imipenem|imipenem|mesh-list
101966726|NCT05628610|Antimitotic Agents|antimitotic agents|mesh-ancestor
101693301|NCT02634528|Insulin, Isophane|insulin, isophane|mesh-list
101966727|NCT05628610|Mitosis Modulators|mitosis modulators|mesh-ancestor
101966728|NCT05628610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966729|NCT05628610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101966730|NCT00079937|Fluticasone|fluticasone|mesh-list
101966731|NCT00079937|Omalizumab|omalizumab|mesh-list
101966732|NCT00079937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101966733|NCT00079937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101966734|NCT00079937|Autonomic Agents|autonomic agents|mesh-ancestor
101966735|NCT00079937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101966736|NCT00079937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966737|NCT00079937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101966738|NCT00079937|Respiratory System Agents|respiratory system agents|mesh-ancestor
101966739|NCT00079937|Dermatologic Agents|dermatologic agents|mesh-ancestor
101966740|NCT00079937|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101966741|NCT00909610|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101340717|NCT03844412|Lidocaine|lidocaine|mesh-list
101966742|NCT00909610|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101966743|NCT00909610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101966744|NCT03961607|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101966745|NCT03961607|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101966746|NCT03961607|Dermatologic Agents|dermatologic agents|mesh-ancestor
101966747|NCT03126110|Nivolumab|nivolumab|mesh-list
101966748|NCT03126110|Ipilimumab|ipilimumab|mesh-list
101966749|NCT03126110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101966750|NCT03126110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101966751|NCT03126110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101331215|NCT00389090|Alkylating Agents|alkylating agents|mesh-ancestor
101966752|NCT03126110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966754|NCT00908128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101966755|NCT00908128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101966756|NCT00908128|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101966757|NCT00908128|Antitubercular Agents|antitubercular agents|mesh-ancestor
101966758|NCT00908128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101966759|NCT00908128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101966760|NCT00908128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966761|NCT00908128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966762|NCT00906334|ON 01910|on 01910|mesh-list
101966763|NCT00906334|Glycine|glycine|mesh-list
101966764|NCT00906334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101966765|NCT00906334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101966766|NCT00906334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966767|NCT00906334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966768|NCT00906334|Glycine Agents|glycine agents|mesh-ancestor
101966769|NCT00906334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101966770|NCT00906334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966771|NCT00905164|Topiramate|topiramate|mesh-list
101966772|NCT00905164|Anticonvulsants|anticonvulsants|mesh-ancestor
101966773|NCT00905164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101331245|NCT00034138|Oregovomab|oregovomab|mesh-list
101966774|NCT00905164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966775|NCT00978016|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
101966777|NCT00978016|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101966778|NCT00978016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966779|NCT00978016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966780|NCT00978016|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101966781|NCT00978016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966782|NCT00978016|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101966783|NCT00978016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101966784|NCT00978016|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101966785|NCT00978016|GABA Agonists|gaba agonists|mesh-ancestor
101971108|NCT04879524|Botulinum Toxins|botulinum toxins|mesh-list
101971109|NCT04879524|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101971110|NCT04879524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101966787|NCT00978016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101966788|NCT01129648|Allopurinol|allopurinol|mesh-list
101966789|NCT01129648|Antimetabolites|antimetabolites|mesh-ancestor
101966790|NCT01129648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966791|NCT01129648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966792|NCT01129648|Gout Suppressants|gout suppressants|mesh-ancestor
101966793|NCT01129648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101966794|NCT01129648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101966795|NCT01129648|Antioxidants|antioxidants|mesh-ancestor
101966796|NCT01129648|Protective Agents|protective agents|mesh-ancestor
101966797|NCT01129648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966798|NCT04438720|Nifedipine|nifedipine|mesh-list
101966799|NCT04438720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101966800|NCT04438720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101966801|NCT04438720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966802|NCT04438720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101331270|NCT00389129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966803|NCT04438720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966804|NCT04438720|Vasodilator Agents|vasodilator agents|mesh-ancestor
101966806|NCT04438720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101966807|NCT05464810|Letrozole|letrozole|mesh-list
101966808|NCT05464810|Simvastatin|simvastatin|mesh-list
101966809|NCT05464810|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101966810|NCT05464810|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101966811|NCT05464810|Antimetabolites|antimetabolites|mesh-ancestor
101966812|NCT05464810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966813|NCT05464810|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101966814|NCT05464810|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101966815|NCT05464810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966816|NCT05464810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101966817|NCT05464810|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101966818|NCT05464810|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101966819|NCT05464810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101966820|NCT05464810|Hormone Antagonists|hormone antagonists|mesh-ancestor
101966821|NCT05464810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101966822|NCT05464810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966823|NCT03176966|Vitamin E|vitamin e|mesh-list
101966824|NCT03176966|Ropinirole|ropinirole|mesh-list
101966825|NCT03176966|Vitamins|vitamins|mesh-ancestor
101966826|NCT03176966|Micronutrients|micronutrients|mesh-ancestor
101966827|NCT03176966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966828|NCT03176966|Antioxidants|antioxidants|mesh-ancestor
101966829|NCT03176966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966830|NCT03176966|Protective Agents|protective agents|mesh-ancestor
101966831|NCT03176966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101966832|NCT03176966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101966833|NCT03176966|Dopamine Agonists|dopamine agonists|mesh-ancestor
101966834|NCT03176966|Dopamine Agents|dopamine agents|mesh-ancestor
101966835|NCT03176966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101966837|NCT03209570|Dermatologic Agents|dermatologic agents|mesh-ancestor
101966838|NCT03209570|Sunscreening Agents|sunscreening agents|mesh-ancestor
101966839|NCT03209570|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101966840|NCT03209570|Protective Agents|protective agents|mesh-ancestor
101966841|NCT03209570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966842|NCT04405102|Ozanimod|ozanimod|mesh-list
101966843|NCT04405102|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101966844|NCT04405102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966845|NCT04405102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101966846|NCT04405102|Immunologic Factors|immunologic factors|mesh-ancestor
101966847|NCT04405102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966848|NCT03209492|Leuprolide|leuprolide|mesh-list
101966849|NCT03209492|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101966850|NCT03209492|Fertility Agents|fertility agents|mesh-ancestor
101966851|NCT03209492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101966852|NCT03209492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966853|NCT03209492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101966854|NCT03209492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101966855|NCT00894868|Vildagliptin|vildagliptin|mesh-list
101971111|NCT04879524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966856|NCT00894868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101331320|NCT00000671|Zidovudine|zidovudine|mesh-list
101966857|NCT00894868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966858|NCT00894868|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101966859|NCT00894868|Protease Inhibitors|protease inhibitors|mesh-ancestor
101966860|NCT00894868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966861|NCT00894868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966862|NCT01122784|Vaccines|vaccines|mesh-list
101966863|NCT01122784|Immunologic Factors|immunologic factors|mesh-ancestor
101966864|NCT01122784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966865|NCT03208244|Antiviral Agents|antiviral agents|mesh-list
101966866|NCT03208244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101966867|NCT01088165|Adalimumab|adalimumab|mesh-list
101966868|NCT01088165|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101966869|NCT01088165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101966870|NCT01088165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101966871|NCT00892762|Travoprost|travoprost|mesh-list
101966872|NCT00892762|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101966873|NCT00892762|Latanoprost|latanoprost|mesh-list
101331332|NCT02971540|Tramadol|tramadol|mesh-list
101966874|NCT00892762|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101966875|NCT00892762|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101966876|NCT00890968|Triamcinolone|triamcinolone|mesh-list
101966877|NCT00890968|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101966878|NCT00890968|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101966879|NCT00890968|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101966880|NCT00890968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101966881|NCT00890968|Glucocorticoids|glucocorticoids|mesh-ancestor
101966882|NCT00890968|Hormones|hormones|mesh-ancestor
101331352|NCT00034489|Antimetabolites|antimetabolites|mesh-ancestor
101966883|NCT00890968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101966884|NCT00890968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966885|NCT00890968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101966886|NCT00890968|Immunologic Factors|immunologic factors|mesh-ancestor
101966887|NCT00890968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966888|NCT00890968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966889|NCT01098383|Acetylcholine|acetylcholine|mesh-list
101966890|NCT01098383|Donepezil|donepezil|mesh-list
101966891|NCT01098383|Choline|choline|mesh-list
101966892|NCT01098383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101966893|NCT01098383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966894|NCT01098383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966895|NCT01098383|Cholinergic Agents|cholinergic agents|mesh-ancestor
101966896|NCT01098383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101966897|NCT01098383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966898|NCT01098383|Nootropic Agents|nootropic agents|mesh-ancestor
101966899|NCT01098383|Lipotropic Agents|lipotropic agents|mesh-ancestor
101966900|NCT01098383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101966901|NCT01098383|Antimetabolites|antimetabolites|mesh-ancestor
101966902|NCT01098383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101966903|NCT01098383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101966904|NCT01098383|Vasodilator Agents|vasodilator agents|mesh-ancestor
101966905|NCT01098383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101966906|NCT00890890|BMS 708163|bms 708163|mesh-list
101966907|NCT00890890|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101966908|NCT00890890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966909|NCT00890890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966911|NCT03175172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101966912|NCT03175172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101966913|NCT03175172|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101966914|NCT03175172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966915|NCT00961090|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101966916|NCT00961090|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101966917|NCT00961090|Dermatologic Agents|dermatologic agents|mesh-ancestor
101966919|NCT01088477|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101966920|NCT01088477|Estradiol|estradiol|mesh-list
101966921|NCT01088477|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101966922|NCT01088477|Estrogens|estrogens|mesh-ancestor
101966924|NCT01088477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101331396|NCT00014040|Autonomic Agents|autonomic agents|mesh-ancestor
101966925|NCT01088477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971113|NCT04879524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101971114|NCT04879524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971115|NCT04844918|Tirzepatide|tirzepatide|mesh-list
101966926|NCT01088477|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101966927|NCT01088477|Contraceptive Agents|contraceptive agents|mesh-ancestor
101966928|NCT01088477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101966929|NCT01088477|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101966930|NCT01088555|Sodium thiosulfate|sodium thiosulfate|mesh-list
101966931|NCT01088555|Antidotes|antidotes|mesh-ancestor
101966932|NCT01088555|Protective Agents|protective agents|mesh-ancestor
101966933|NCT01088555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966935|NCT01088555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966936|NCT01088555|Antitubercular Agents|antitubercular agents|mesh-ancestor
101966937|NCT01088555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101966938|NCT01088555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101966939|NCT01088555|Chelating Agents|chelating agents|mesh-ancestor
101966940|NCT01088555|Sequestering Agents|sequestering agents|mesh-ancestor
101966941|NCT04474210|JNJ-56136379|jnj-56136379|mesh-list
101966942|NCT04474210|Antiviral Agents|antiviral agents|mesh-ancestor
101966943|NCT04474210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101966945|NCT00078767|Antidepressive Agents|antidepressive agents|mesh-ancestor
101331414|NCT00034528|Hormones|hormones|mesh-ancestor
101966946|NCT00078767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101966947|NCT00078767|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101966948|NCT00078767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101966949|NCT00078767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101966950|NCT00078767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966951|NCT00078767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101966952|NCT00078767|Serotonin Agents|serotonin agents|mesh-ancestor
101966953|NCT00078767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966954|NCT04474288|Antibodies|antibodies|mesh-list
101966955|NCT04474288|Immunologic Factors|immunologic factors|mesh-ancestor
101966956|NCT04474288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966957|NCT00078377|Modafinil|modafinil|mesh-list
101966958|NCT00078377|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101966959|NCT00078377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966960|NCT00078377|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101966961|NCT00078377|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101966962|NCT00078377|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101966963|NCT00078377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966964|NCT01107496|Viloxazine|viloxazine|mesh-list
101966965|NCT01107496|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101966966|NCT01107496|Antidepressive Agents|antidepressive agents|mesh-ancestor
101966967|NCT01107496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101966968|NCT01107496|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101966969|NCT01107496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101966970|NCT01107496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101966971|NCT01107496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966972|NCT01107496|Adrenergic Agents|adrenergic agents|mesh-ancestor
101966973|NCT01107496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101966974|NCT01107496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966975|NCT00886600|Losartan|losartan|mesh-list
101966976|NCT00886600|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101966977|NCT00886600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101966979|NCT00886600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101966980|NCT00886600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101966981|NCT00886600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966982|NCT00886600|Diuretics|diuretics|mesh-ancestor
101966983|NCT00886600|Natriuretic Agents|natriuretic agents|mesh-ancestor
101966984|NCT00886600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966985|NCT00886600|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101966986|NCT00886600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101966987|NCT02591654|Pembrolizumab|pembrolizumab|mesh-list
101966988|NCT02591654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101966989|NCT02591654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101966990|NCT02591654|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101966991|NCT02591654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966992|NCT03134872|Carboplatin|carboplatin|mesh-list
101966993|NCT03134872|Pemetrexed|pemetrexed|mesh-list
101971116|NCT04844918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101971117|NCT04844918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971118|NCT04844918|Incretins|incretins|mesh-ancestor
101971120|NCT04844918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101971121|NCT04826354|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101971122|NCT04826354|Ezetimibe|ezetimibe|mesh-list
101971123|NCT04826354|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101971124|NCT04826354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101971125|NCT04826354|Antimetabolites|antimetabolites|mesh-ancestor
101971126|NCT04826354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971127|NCT04826354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101971128|NCT04826354|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101971129|NCT04826354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101971130|NCT04824794|Daratumumab|daratumumab|mesh-list
101971131|NCT04824794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971132|NCT04790903|Prednisone|prednisone|mesh-list
101971133|NCT04790903|Cyclophosphamide|cyclophosphamide|mesh-list
101971134|NCT04790903|Rituximab|rituximab|mesh-list
101971135|NCT04790903|Doxorubicin|doxorubicin|mesh-list
101971136|NCT04790903|Venetoclax|venetoclax|mesh-list
101971137|NCT04790903|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
101686758|NCT03711318|Naloxone|naloxone|mesh-list
101966994|NCT03134872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101966995|NCT03134872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966996|NCT03134872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101966997|NCT03134872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101966998|NCT03134872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101966999|NCT03952481|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101967000|NCT03952481|Lifitegrast|lifitegrast|mesh-list
101967001|NCT03952481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101967002|NCT05135312|Etanercept|etanercept|mesh-list
101967003|NCT05135312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101967004|NCT05135312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101967005|NCT05135312|Analgesics|analgesics|mesh-ancestor
101967006|NCT05135312|Sensory System Agents|sensory system agents|mesh-ancestor
101967007|NCT05135312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101967008|NCT05135312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967009|NCT05135312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101967010|NCT05135312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101967011|NCT05135312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101967012|NCT05135312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101967013|NCT05135312|Immunologic Factors|immunologic factors|mesh-ancestor
101967014|NCT00881452|Citric Acid|citric acid|mesh-list
101967015|NCT00881452|Anticoagulants|anticoagulants|mesh-ancestor
101967016|NCT00881452|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101967017|NCT00881452|Chelating Agents|chelating agents|mesh-ancestor
101967018|NCT00881452|Sequestering Agents|sequestering agents|mesh-ancestor
101967019|NCT00881452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967020|NCT03952325|Pembrolizumab|pembrolizumab|mesh-list
101967022|NCT03952325|Atezolizumab|atezolizumab|mesh-list
101967023|NCT03952325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101967024|NCT03952325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101967025|NCT03952325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101967026|NCT03952325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967027|NCT00948142|Linezolid|linezolid|mesh-list
101967028|NCT00948142|Fusidic Acid|fusidic acid|mesh-list
101971138|NCT04790903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101971139|NCT04790903|Immunologic Factors|immunologic factors|mesh-ancestor
101971140|NCT04790903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971141|NCT04790903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101971142|NCT04790903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101971143|NCT04790903|Alkylating Agents|alkylating agents|mesh-ancestor
101971144|NCT04790903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971145|NCT04790903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971146|NCT04790903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101971147|NCT04790903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101971148|NCT04790903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101971149|NCT04790903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101971150|NCT04790903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101971151|NCT04790903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101971152|NCT04790903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101971153|NCT04790903|Glucocorticoids|glucocorticoids|mesh-ancestor
101971154|NCT04790903|Hormones|hormones|mesh-ancestor
101971155|NCT04790903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101971156|NCT04790903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101971157|NCT04790903|Immunoconjugates|immunoconjugates|mesh-ancestor
101971158|NCT04781998|Liraglutide|liraglutide|mesh-list
101971159|NCT04781998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101971160|NCT04781998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971161|NCT04781998|Incretins|incretins|mesh-ancestor
101971162|NCT04781998|Hormones|hormones|mesh-ancestor
101967029|NCT00948142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101967030|NCT00948142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101967031|NCT00948142|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101967032|NCT00948142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101967033|NCT00948142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967034|NCT00947518|Chlorhexidine|chlorhexidine|mesh-list
101967035|NCT00947518|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101967036|NCT00947518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101967037|NCT00947518|Disinfectants|disinfectants|mesh-ancestor
101967038|NCT00945802|Ciprofloxacin|ciprofloxacin|mesh-list
101967039|NCT00945802|Dexamethasone|dexamethasone|mesh-list
101967040|NCT00945802|Dexamethasone acetate|dexamethasone acetate|mesh-list
101967041|NCT00945802|BB 1101|bb 1101|mesh-list
101967042|NCT00945802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101967043|NCT00945802|Antiemetics|antiemetics|mesh-ancestor
101967044|NCT00945802|Autonomic Agents|autonomic agents|mesh-ancestor
101967045|NCT00945802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101967046|NCT00945802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967047|NCT00945802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101967048|NCT00945802|Glucocorticoids|glucocorticoids|mesh-ancestor
101967049|NCT00945802|Hormones|hormones|mesh-ancestor
101967050|NCT00945802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101967051|NCT00945802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101967052|NCT00945802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971163|NCT04781998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101971164|NCT04770610|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101971165|NCT04770610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101971166|NCT04708613|Corticosterone|corticosterone|mesh-list
101971167|NCT04708613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101971168|NCT04677387|Naloxone|naloxone|mesh-list
101971169|NCT04677387|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101971170|NCT04677387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971171|NCT04677387|Sensory System Agents|sensory system agents|mesh-ancestor
101971172|NCT04677387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101971173|NCT04664738|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101971174|NCT04664738|Hemostatics|hemostatics|mesh-ancestor
101971175|NCT04664738|Coagulants|coagulants|mesh-ancestor
101971176|NCT04663347|Cytarabine|cytarabine|mesh-list
101971177|NCT04663347|Dexamethasone|dexamethasone|mesh-list
101971178|NCT04663347|Prednisone|prednisone|mesh-list
101971179|NCT04663347|Cyclophosphamide|cyclophosphamide|mesh-list
101971180|NCT04663347|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101971181|NCT04663347|Ifosfamide|ifosfamide|mesh-list
101971182|NCT04663347|Rituximab|rituximab|mesh-list
101971183|NCT04663347|Carboplatin|carboplatin|mesh-list
101971184|NCT04663347|Gemcitabine|gemcitabine|mesh-list
101971185|NCT04663347|Doxorubicin|doxorubicin|mesh-list
101971186|NCT04663347|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101971187|NCT04663347|Oxaliplatin|oxaliplatin|mesh-list
101967053|NCT00945802|Protease Inhibitors|protease inhibitors|mesh-ancestor
101967054|NCT00945802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101967055|NCT00945802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967056|NCT00945802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101967057|NCT00945802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101967058|NCT00945802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101967059|NCT00945802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101967060|NCT00945802|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101967061|NCT00945802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101967062|NCT01105624|Azithromycin|azithromycin|mesh-list
101967063|NCT01105624|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101967064|NCT01105624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101967065|NCT01105624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101967066|NCT01105624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101967067|NCT01102660|Naproxen|naproxen|mesh-list
101967068|NCT01102660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101686832|NCT02686710|Propofol|propofol|mesh-list
101331537|NCT00000689|Hormones|hormones|mesh-ancestor
101967069|NCT01102660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101967070|NCT01102660|Analgesics|analgesics|mesh-ancestor
101967071|NCT01102660|Sensory System Agents|sensory system agents|mesh-ancestor
101967072|NCT01102660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101967073|NCT01102660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967074|NCT01102660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101967075|NCT01102660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101967076|NCT01102660|Gout Suppressants|gout suppressants|mesh-ancestor
101967077|NCT01102660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101967078|NCT01102660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101967079|NCT01102660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967080|NCT03135106|Itraconazole|itraconazole|mesh-list
101971188|NCT04663347|Etoposide|etoposide|mesh-list
101971189|NCT04663347|Vincristine|vincristine|mesh-list
101971190|NCT04663347|Lenalidomide|lenalidomide|mesh-list
101971191|NCT04663347|Etoposide phosphate|etoposide phosphate|mesh-list
101574941|NCT01028391|Hormones|hormones|mesh-ancestor
101690936|NCT00654576|Olanzapine|olanzapine|mesh-list
101971192|NCT04663347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101971193|NCT04663347|Immunologic Factors|immunologic factors|mesh-ancestor
101971194|NCT04663347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971195|NCT04663347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101971196|NCT04663347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101971197|NCT04663347|Alkylating Agents|alkylating agents|mesh-ancestor
101971198|NCT04663347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971199|NCT04663347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101305966|NCT02022930|Hormones|hormones|mesh-ancestor
101967081|NCT03135106|Fluconazole|fluconazole|mesh-list
101967082|NCT03135106|Antifungal Agents|antifungal agents|mesh-ancestor
101967083|NCT03135106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101967084|NCT03135106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101967085|NCT03135106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101967086|NCT03135106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101967087|NCT03135106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967088|NCT03135106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101967090|NCT03135106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101967091|NCT03135106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967092|NCT03135106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101967093|NCT03135106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101967094|NCT03135106|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101967096|NCT00872014|Trebananib|trebananib|mesh-list
101967097|NCT00872014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101967098|NCT00872014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101331578|NCT00014235|Cyclosporins|cyclosporins|mesh-list
101967099|NCT00872014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101967100|NCT00872014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967101|NCT00872014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101967102|NCT00872014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101967103|NCT00872014|Growth Substances|growth substances|mesh-ancestor
101967104|NCT00872014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967105|NCT00872014|Growth Inhibitors|growth inhibitors|mesh-ancestor
101967106|NCT00871936|Metformin|metformin|mesh-list
101967107|NCT00871936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101967108|NCT00871936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967109|NCT00870688|Valproic Acid|valproic acid|mesh-list
101967110|NCT00870688|Anticonvulsants|anticonvulsants|mesh-ancestor
101967111|NCT00870688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101967112|NCT00870688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967113|NCT00870688|GABA Agents|gaba agents|mesh-ancestor
101967114|NCT00870688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101967115|NCT00870688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967116|NCT00870688|Antimanic Agents|antimanic agents|mesh-ancestor
101967117|NCT00870688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101967118|NCT00870688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101967119|NCT00870688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101967120|NCT00870454|Pregabalin|pregabalin|mesh-list
101967121|NCT00870454|Analgesics|analgesics|mesh-ancestor
101967122|NCT00870454|Sensory System Agents|sensory system agents|mesh-ancestor
101967123|NCT00870454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101967124|NCT00870454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967125|NCT00870454|Anticonvulsants|anticonvulsants|mesh-ancestor
101967126|NCT00870454|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101971200|NCT04663347|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101971201|NCT04663347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101971202|NCT04663347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101971203|NCT04663347|Antiemetics|antiemetics|mesh-ancestor
101971204|NCT04663347|Autonomic Agents|autonomic agents|mesh-ancestor
101971205|NCT04663347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101971206|NCT04663347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101971207|NCT04663347|Glucocorticoids|glucocorticoids|mesh-ancestor
101971208|NCT04663347|Hormones|hormones|mesh-ancestor
101971209|NCT04663347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101971210|NCT04663347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101971211|NCT04663347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101971212|NCT04663347|Antimetabolites|antimetabolites|mesh-ancestor
101971213|NCT04663347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101971214|NCT04663347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101971215|NCT04663347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101971216|NCT04663347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101971217|NCT04663347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101971218|NCT04663347|Antiviral Agents|antiviral agents|mesh-ancestor
101971219|NCT04663347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101971220|NCT04663347|Tubulin Modulators|tubulin modulators|mesh-ancestor
101971221|NCT04663347|Antimitotic Agents|antimitotic agents|mesh-ancestor
101971222|NCT04663347|Mitosis Modulators|mitosis modulators|mesh-ancestor
101971223|NCT04663347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101971224|NCT04663347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101971225|NCT04663347|Growth Substances|growth substances|mesh-ancestor
101971226|NCT04663347|Growth Inhibitors|growth inhibitors|mesh-ancestor
101971227|NCT04623541|Prednisone|prednisone|mesh-list
101971228|NCT04623541|Cyclophosphamide|cyclophosphamide|mesh-list
101971229|NCT04623541|Rituximab|rituximab|mesh-list
101971230|NCT04623541|Doxorubicin|doxorubicin|mesh-list
101971231|NCT04623541|Vincristine|vincristine|mesh-list
101971232|NCT04623541|Lenalidomide|lenalidomide|mesh-list
101971233|NCT04623541|Venetoclax|venetoclax|mesh-list
101305973|NCT02023021|Paclitaxel|paclitaxel|mesh-list
101967127|NCT00870454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101967128|NCT00870454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967129|NCT00870454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101967130|NCT00870454|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101967131|NCT00870454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101967132|NCT00870454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101967133|NCT00870454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101971234|NCT04623541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101971235|NCT04623541|Immunologic Factors|immunologic factors|mesh-ancestor
101971236|NCT04623541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971237|NCT04623541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101971238|NCT04623541|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101971239|NCT04623541|Alkylating Agents|alkylating agents|mesh-ancestor
101971240|NCT04623541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971241|NCT04623541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971242|NCT04623541|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101971243|NCT04623541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101971244|NCT04623541|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101971245|NCT04623541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101971246|NCT04623541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101971247|NCT04623541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101971248|NCT04623541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101971249|NCT04623541|Glucocorticoids|glucocorticoids|mesh-ancestor
101971250|NCT04623541|Hormones|hormones|mesh-ancestor
101971251|NCT04623541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101971252|NCT04623541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101971253|NCT04623541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101971254|NCT04623541|Tubulin Modulators|tubulin modulators|mesh-ancestor
101971255|NCT04623541|Antimitotic Agents|antimitotic agents|mesh-ancestor
101971256|NCT04623541|Mitosis Modulators|mitosis modulators|mesh-ancestor
101971257|NCT04623541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101971258|NCT04623541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101971259|NCT04623541|Growth Substances|growth substances|mesh-ancestor
101971260|NCT04623541|Growth Inhibitors|growth inhibitors|mesh-ancestor
101971261|NCT04601402|Avelumab|avelumab|mesh-list
101306023|NCT02023359|Everolimus|everolimus|mesh-list
101967134|NCT05096962|Antibodies|antibodies|mesh-list
101967135|NCT05096962|Immunologic Factors|immunologic factors|mesh-ancestor
101967136|NCT05096962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967137|NCT00869128|Melatonin|melatonin|mesh-list
101967138|NCT00869128|Antioxidants|antioxidants|mesh-ancestor
101967139|NCT00869128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331612|NCT00000716|Antiviral Agents|antiviral agents|mesh-ancestor
101967140|NCT00869128|Protective Agents|protective agents|mesh-ancestor
101967141|NCT00869128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967142|NCT00869128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101967143|NCT00945646|Dexamethasone|dexamethasone|mesh-list
101967144|NCT00945646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101967145|NCT00945646|Antiemetics|antiemetics|mesh-ancestor
101967146|NCT00945646|Autonomic Agents|autonomic agents|mesh-ancestor
101967147|NCT00945646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101971262|NCT04601402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101971263|NCT04601402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101967148|NCT00945646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967149|NCT00945646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101967150|NCT00945646|Glucocorticoids|glucocorticoids|mesh-ancestor
101967152|NCT00945646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101967153|NCT00945646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101693451|NCT00964561|Ciprofloxacin|ciprofloxacin|mesh-list
101967154|NCT00945646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101967155|NCT00077675|Vancomycin|vancomycin|mesh-list
101967156|NCT00077675|Penicillins|penicillins|mesh-list
101967157|NCT00077675|Telavancin|telavancin|mesh-list
101967158|NCT00077675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101331648|NCT00000719|Zidovudine|zidovudine|mesh-list
101967159|NCT00077675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101967160|NCT00934180|Ondansetron|ondansetron|mesh-list
101967161|NCT00934180|Antiemetics|antiemetics|mesh-ancestor
101967162|NCT00934180|Autonomic Agents|autonomic agents|mesh-ancestor
101967163|NCT00934180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101967164|NCT00934180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967165|NCT00934180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101967166|NCT00934180|Antipruritics|antipruritics|mesh-ancestor
101967167|NCT00934180|Dermatologic Agents|dermatologic agents|mesh-ancestor
101967168|NCT00934180|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101967169|NCT00934180|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101967170|NCT00934180|Serotonin Agents|serotonin agents|mesh-ancestor
101967171|NCT00934180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101967172|NCT00934180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967173|NCT02576444|Olaparib|olaparib|mesh-list
101967174|NCT02576444|Adavosertib|adavosertib|mesh-list
101967175|NCT02576444|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101967177|NCT02576444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967178|NCT02576444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101967179|NCT00929968|Fluticasone|fluticasone|mesh-list
101967180|NCT00929968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101967181|NCT00929968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101967182|NCT00929968|Autonomic Agents|autonomic agents|mesh-ancestor
101967183|NCT00929968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101967184|NCT00929968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967185|NCT00929968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101967186|NCT00929968|Respiratory System Agents|respiratory system agents|mesh-ancestor
101967187|NCT00929968|Dermatologic Agents|dermatologic agents|mesh-ancestor
101343956|NCT00016133|Vitamins|vitamins|mesh-ancestor
101967188|NCT00929968|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101967189|NCT03957083|Oxytocin|oxytocin|mesh-list
101967190|NCT03957083|Oxytocics|oxytocics|mesh-ancestor
101967191|NCT03957083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101967192|NCT03957083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967193|NCT04945616|Aspirin|aspirin|mesh-list
101967194|NCT04945616|Clopidogrel|clopidogrel|mesh-list
101967195|NCT04945616|Ticagrelor|ticagrelor|mesh-list
101967196|NCT04945616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101967197|NCT04945616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101967198|NCT04945616|Analgesics|analgesics|mesh-ancestor
101967199|NCT04945616|Sensory System Agents|sensory system agents|mesh-ancestor
101967200|NCT04945616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101967201|NCT04945616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967202|NCT04945616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101331683|NCT00035113|Epothilone B|epothilone b|mesh-list
101967203|NCT04945616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101967204|NCT04945616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101693473|NCT00880620|Carbidopa|carbidopa|mesh-list
101967205|NCT04945616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101967206|NCT04945616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967207|NCT04945616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101967208|NCT04945616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101967209|NCT04945616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101967210|NCT04945616|Antipyretics|antipyretics|mesh-ancestor
101967211|NCT04945616|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101967212|NCT04945616|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101967213|NCT04945616|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101967214|NCT04945616|Purinergic Agents|purinergic agents|mesh-ancestor
101686982|NCT00619034|Analgesics|analgesics|mesh-ancestor
101967215|NCT04945616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101967216|NCT04473820|Lidocaine|lidocaine|mesh-list
101967217|NCT04473820|Prilocaine|prilocaine|mesh-list
101331699|NCT00035152|Tubulin Modulators|tubulin modulators|mesh-ancestor
101971265|NCT04584255|Dostarlimab|dostarlimab|mesh-list
101971266|NCT04584255|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101971267|NCT04584255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101971268|NCT04584255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971269|NCT04584255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101967219|NCT04473820|Anesthetics, Local|anesthetics, local|mesh-ancestor
101967220|NCT04473820|Anesthetics|anesthetics|mesh-ancestor
101967221|NCT04473820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101967222|NCT04473820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967223|NCT04473820|Sensory System Agents|sensory system agents|mesh-ancestor
101967224|NCT04473820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101967225|NCT04473820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101967226|NCT04473820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101967227|NCT04473820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101967228|NCT04473820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101967229|NCT04473820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967230|NCT04473820|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
101967231|NCT05064332|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101967232|NCT05064332|Contraceptive Agents|contraceptive agents|mesh-list
101967233|NCT05064332|Contraceptives, Oral|contraceptives, oral|mesh-list
101967234|NCT05064332|Estradiol|estradiol|mesh-list
101967235|NCT05064332|Estrogens|estrogens|mesh-ancestor
101967236|NCT05064332|Hormones|hormones|mesh-ancestor
101967237|NCT05064332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101967238|NCT05064332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967239|NCT05064332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101967240|NCT05064332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101967241|NCT05064332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101967242|NCT05064332|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101967243|NCT00855712|Cardioplegic Solutions|cardioplegic solutions|mesh-list
101967244|NCT00855712|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101967245|NCT00850174|Oxcarbazepine|oxcarbazepine|mesh-list
101967246|NCT00850174|Anticonvulsants|anticonvulsants|mesh-ancestor
101967247|NCT00850174|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101967248|NCT00850174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101967249|NCT00850174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101967250|NCT00850174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967251|NCT00850174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101967252|NCT00850174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101967253|NCT00849862|Levetiracetam|levetiracetam|mesh-list
101967254|NCT00849862|Anticonvulsants|anticonvulsants|mesh-ancestor
101967255|NCT00849862|Nootropic Agents|nootropic agents|mesh-ancestor
101967256|NCT00077207|Carboplatin|carboplatin|mesh-list
101967257|NCT00077207|Vincristine|vincristine|mesh-list
101967258|NCT00077207|Temozolomide|temozolomide|mesh-list
101967259|NCT00077207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101967260|NCT00077207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101967261|NCT00077207|Tubulin Modulators|tubulin modulators|mesh-ancestor
101967262|NCT00077207|Antimitotic Agents|antimitotic agents|mesh-ancestor
101967263|NCT00077207|Mitosis Modulators|mitosis modulators|mesh-ancestor
101967264|NCT00077207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967265|NCT00077207|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101967266|NCT00077207|Alkylating Agents|alkylating agents|mesh-ancestor
101967267|NCT01099085|Simvastatin|simvastatin|mesh-list
101967268|NCT01099085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101967269|NCT01099085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101967270|NCT01099085|Antimetabolites|antimetabolites|mesh-ancestor
101967271|NCT01099085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967272|NCT01099085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101967273|NCT01099085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101967274|NCT01099085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101967275|NCT03206918|Zanubrutinib|zanubrutinib|mesh-list
101967276|NCT03206918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101967277|NCT03206918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101967278|NCT03206918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101967279|NCT03206918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691009|NCT00681135|Olaflur|olaflur|mesh-list
101971270|NCT04569032|Prednisone|prednisone|mesh-list
101971271|NCT04569032|Cyclophosphamide|cyclophosphamide|mesh-list
101971272|NCT04569032|Doxorubicin|doxorubicin|mesh-list
101971273|NCT04569032|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101971274|NCT04569032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101967280|NCT05095064|Irinotecan|irinotecan|mesh-list
101967281|NCT05095064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101967282|NCT05095064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101967283|NCT05095064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101967284|NCT05095064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967285|NCT05095064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101967286|NCT03169244|Bupropion|bupropion|mesh-list
101967287|NCT03169244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101967288|NCT03169244|Antidepressive Agents|antidepressive agents|mesh-ancestor
101967289|NCT03169244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101967290|NCT03169244|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101967291|NCT03169244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101967292|NCT03169244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101967293|NCT03169244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967295|NCT03169244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101967296|NCT03169244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967297|NCT03169244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101967298|NCT03169244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101967299|NCT03169244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101967300|NCT02486042|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101967301|NCT02486042|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101967302|NCT02486042|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101967303|NCT02486042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101967304|NCT00920764|Atrasentan|atrasentan|mesh-list
101967305|NCT00920764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101967306|NCT00920764|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101967307|NCT00920764|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101967308|NCT00920764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967310|NCT05376046|Hemostatics|hemostatics|mesh-ancestor
101967311|NCT05376046|Coagulants|coagulants|mesh-ancestor
101967312|NCT03034304|Carboplatin|carboplatin|mesh-list
101967313|NCT03034304|Gemcitabine|gemcitabine|mesh-list
101967314|NCT03034304|Doxorubicin|doxorubicin|mesh-list
101967315|NCT03034304|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101967316|NCT03034304|Ifosfamide|ifosfamide|mesh-list
101967317|NCT03034304|Antibodies|antibodies|mesh-list
101967318|NCT03034304|Immunologic Factors|immunologic factors|mesh-ancestor
101967319|NCT03034304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967320|NCT03034304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101967321|NCT03034304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101967322|NCT03034304|Antimetabolites|antimetabolites|mesh-ancestor
101967323|NCT03034304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967324|NCT03034304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101967325|NCT03034304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101967326|NCT03034304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101967327|NCT03034304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101967328|NCT03034304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101967329|NCT03034304|Alkylating Agents|alkylating agents|mesh-ancestor
101967330|NCT00914602|Levodopa|levodopa|mesh-list
101967331|NCT00914602|Carbidopa|carbidopa|mesh-list
101967332|NCT00914602|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101967333|NCT00914602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101967334|NCT00914602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101967335|NCT00914602|Dopamine Agents|dopamine agents|mesh-ancestor
101967336|NCT00914602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101967337|NCT00914602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967338|NCT00914602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967339|NCT00914602|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101967340|NCT00914602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101967341|NCT00914602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101967342|NCT00914602|Immunologic Factors|immunologic factors|mesh-ancestor
101967343|NCT00914602|Dopamine Agonists|dopamine agonists|mesh-ancestor
101967344|NCT00914290|Baclofen|baclofen|mesh-list
101967345|NCT00914290|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101971275|NCT04569032|Immunologic Factors|immunologic factors|mesh-ancestor
101971276|NCT04569032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971277|NCT04569032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101184228|NCT03835728|Ocrelizumab|ocrelizumab|mesh-list
101967346|NCT00914290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967347|NCT00914290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101967348|NCT00914290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101967349|NCT00914290|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101967350|NCT00914290|GABA Agonists|gaba agonists|mesh-ancestor
101967351|NCT00914290|GABA Agents|gaba agents|mesh-ancestor
101967352|NCT00914290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101967353|NCT00914290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967354|NCT00057941|Fulvestrant|fulvestrant|mesh-list
101331850|NCT00000755|Zidovudine|zidovudine|mesh-list
101967356|NCT00057941|Gefitinib|gefitinib|mesh-list
101967357|NCT00057941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101967358|NCT00057941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101967359|NCT00057941|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101967360|NCT00057941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101967361|NCT00057941|Hormone Antagonists|hormone antagonists|mesh-ancestor
101967362|NCT00057941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101967363|NCT00057941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693522|NCT00881868|Clobetasol|clobetasol|mesh-list
101967364|NCT00057941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101967365|NCT00057941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101967366|NCT00057941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967367|NCT00057941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101967368|NCT00057941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101967369|NCT03005522|Dexamethasone|dexamethasone|mesh-list
101967370|NCT03005522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101967371|NCT03005522|Antiemetics|antiemetics|mesh-ancestor
101967372|NCT03005522|Autonomic Agents|autonomic agents|mesh-ancestor
101967373|NCT03005522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101967374|NCT03005522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967375|NCT03005522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101967376|NCT03005522|Glucocorticoids|glucocorticoids|mesh-ancestor
101967377|NCT03005522|Hormones|hormones|mesh-ancestor
101967378|NCT03005522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101967379|NCT03005522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101967380|NCT03005522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101967381|NCT02998736|Tadalafil|tadalafil|mesh-list
101967382|NCT02998736|Vasodilator Agents|vasodilator agents|mesh-ancestor
101967383|NCT02998736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101967384|NCT02998736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101967385|NCT02998736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101967386|NCT02998736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967387|NCT02998736|Urological Agents|urological agents|mesh-ancestor
101967388|NCT00075881|Bortezomib|bortezomib|mesh-list
101967389|NCT00075881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101967390|NCT00838630|Cilostazol|cilostazol|mesh-list
101967391|NCT00838630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101967392|NCT00838630|Autonomic Agents|autonomic agents|mesh-ancestor
101967393|NCT00838630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101967394|NCT00838630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967395|NCT00838630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101967396|NCT00838630|Respiratory System Agents|respiratory system agents|mesh-ancestor
101967397|NCT00838630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101967398|NCT00838630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101967399|NCT00838630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967400|NCT00838630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101967401|NCT00838630|Vasodilator Agents|vasodilator agents|mesh-ancestor
101967402|NCT00838630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101967403|NCT00838630|Protective Agents|protective agents|mesh-ancestor
101967404|NCT00838630|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101967405|NCT00838630|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101331879|NCT00014547|BBR 3464|bbr 3464|mesh-list
101967406|NCT00838630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101967407|NCT02996474|Pembrolizumab|pembrolizumab|mesh-list
101967408|NCT02996474|Decitabine|decitabine|mesh-list
101967409|NCT02996474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101967410|NCT02996474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101967411|NCT02996474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101971278|NCT04569032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101971279|NCT04569032|Alkylating Agents|alkylating agents|mesh-ancestor
101971280|NCT04569032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971281|NCT04569032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971282|NCT04569032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101971283|NCT04569032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101971284|NCT04569032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101971285|NCT04569032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101971286|NCT04569032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101971287|NCT04569032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101971288|NCT04569032|Glucocorticoids|glucocorticoids|mesh-ancestor
101971289|NCT04569032|Hormones|hormones|mesh-ancestor
101971290|NCT04569032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101971291|NCT04569032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101971292|NCT04569032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101971293|NCT04569032|Immunotoxins|immunotoxins|mesh-ancestor
101971294|NCT04569032|Immunoconjugates|immunoconjugates|mesh-ancestor
101971295|NCT04562896|Carbon Fiber|carbon fiber|mesh-list
101971296|NCT04562896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101971297|NCT04562896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101971298|NCT04562246|Antibodies|antibodies|mesh-list
101971299|NCT04562246|Immunologic Factors|immunologic factors|mesh-ancestor
101971300|NCT04562246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971301|NCT04560595|Caffeine|caffeine|mesh-list
101971302|NCT04560595|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101971303|NCT04560595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971304|NCT04560595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101971305|NCT04560595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101971306|NCT04560595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971307|NCT04560595|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101971308|NCT04560595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101971309|NCT04560595|Purinergic Agents|purinergic agents|mesh-ancestor
101971310|NCT04560595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101971311|NCT04545710|Osimertinib|osimertinib|mesh-list
101306044|NCT02023424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101306045|NCT02023450|Ritonavir|ritonavir|mesh-list
101971312|NCT04545710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971313|NCT04545710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101967412|NCT02996474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967413|NCT02996474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101967414|NCT02996474|Antimetabolites|antimetabolites|mesh-ancestor
101967415|NCT02996474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101967416|NCT00821002|Latanoprost|latanoprost|mesh-list
101967417|NCT00821002|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101967418|NCT00821002|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101967419|NCT00820924|Lapatinib|lapatinib|mesh-list
101967420|NCT00820924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101967421|NCT00820924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101967422|NCT00820924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101967423|NCT00820924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967424|NCT00820300|Latanoprost|latanoprost|mesh-list
101967425|NCT00820300|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101967426|NCT00820300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101967427|NCT00814372|Metformin|metformin|mesh-list
101967428|NCT00814372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101967429|NCT00814372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967430|NCT03134638|Carboplatin|carboplatin|mesh-list
101967431|NCT03134638|Fulvestrant|fulvestrant|mesh-list
101967432|NCT03134638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101967433|NCT03134638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101967434|NCT03134638|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101967435|NCT03134638|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101967436|NCT03134638|Hormone Antagonists|hormone antagonists|mesh-ancestor
101967437|NCT03134638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101967438|NCT03134638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687218|NCT02685306|Paclitaxel|paclitaxel|mesh-list
101967439|NCT03205046|Acalabrutinib|acalabrutinib|mesh-list
101967440|NCT03205046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101967441|NCT04855526|Dronabinol|dronabinol|mesh-list
101967442|NCT04855526|Hallucinogens|hallucinogens|mesh-ancestor
101967443|NCT04855526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967444|NCT04855526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101331943|NCT00035971|Alendronate|alendronate|mesh-list
101967445|NCT04855526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101967446|NCT04855526|Analgesics|analgesics|mesh-ancestor
101967447|NCT04855526|Sensory System Agents|sensory system agents|mesh-ancestor
101967448|NCT04855526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101967449|NCT04855526|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101967450|NCT04855526|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101967451|NCT04855526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101967452|NCT04855526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967453|NCT04855526|Hormones|hormones|mesh-ancestor
101967454|NCT04855526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101967455|NCT03204812|Durvalumab|durvalumab|mesh-list
101967456|NCT03204812|Ipilimumab|ipilimumab|mesh-list
101967457|NCT03204812|Tremelimumab|tremelimumab|mesh-list
101967458|NCT03204812|Immunoglobulins|immunoglobulins|mesh-list
101967460|NCT03204812|Immunoglobulin G|immunoglobulin g|mesh-list
101967461|NCT03204812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101967462|NCT03204812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101967463|NCT03204812|Immunologic Factors|immunologic factors|mesh-ancestor
101967464|NCT03204812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967465|NCT03204812|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101967466|NCT03204812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967467|NCT02339090|Hormones|hormones|mesh-list
101967468|NCT02339090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101967469|NCT02339090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967470|NCT05442008|Erenumab|erenumab|mesh-list
101967471|NCT05442008|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
101967472|NCT05442008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967473|NCT05442008|Analgesics|analgesics|mesh-ancestor
101967474|NCT05442008|Sensory System Agents|sensory system agents|mesh-ancestor
101967475|NCT05442008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101967476|NCT05442008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967477|NCT03524092|Mirikizumab|mirikizumab|mesh-list
101967478|NCT03524092|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101967479|NCT03524092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101967480|NCT03524092|Analgesics|analgesics|mesh-ancestor
101971314|NCT04545710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101971315|NCT04545710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967481|NCT03524092|Sensory System Agents|sensory system agents|mesh-ancestor
101967482|NCT03524092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101967483|NCT03524092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967484|NCT03524092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101967485|NCT03524092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101967486|NCT03524092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101967487|NCT03524092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101967489|NCT03331562|Pembrolizumab|pembrolizumab|mesh-list
101967490|NCT03331562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101967491|NCT03331562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101967492|NCT03331562|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101967493|NCT03331562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967494|NCT03331562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101967495|NCT03331562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967496|NCT03331562|Vitamins|vitamins|mesh-ancestor
101967497|NCT03331562|Micronutrients|micronutrients|mesh-ancestor
101967498|NCT03331562|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101967499|NCT00814294|Insulin|insulin|mesh-list
101967500|NCT00814294|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101967501|NCT00814294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101967502|NCT00814294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967503|NCT02038634|Betamethasone|betamethasone|mesh-list
101967504|NCT02038634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101967505|NCT02038634|Glucocorticoids|glucocorticoids|mesh-ancestor
101967506|NCT02038634|Hormones|hormones|mesh-ancestor
101967507|NCT02038634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101967508|NCT02038634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967509|NCT02038634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101967510|NCT02038634|Respiratory System Agents|respiratory system agents|mesh-ancestor
101967511|NCT00808288|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101687284|NCT02680548|Antiemetics|antiemetics|mesh-ancestor
101967512|NCT00808288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101967513|NCT00808288|Autonomic Agents|autonomic agents|mesh-ancestor
101967514|NCT00808288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101967515|NCT00808288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967516|NCT00808288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101967517|NCT00808288|Respiratory System Agents|respiratory system agents|mesh-ancestor
101967518|NCT00808288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101967519|NCT00808288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101967520|NCT00808288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101967521|NCT00808288|Adrenergic Agents|adrenergic agents|mesh-ancestor
101967522|NCT00808288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101967523|NCT00808288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967525|NCT03636308|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101967526|NCT03636308|Gemcitabine|gemcitabine|mesh-list
101967527|NCT03636308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101967528|NCT03636308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101967529|NCT03636308|Tubulin Modulators|tubulin modulators|mesh-ancestor
101967530|NCT03636308|Antimitotic Agents|antimitotic agents|mesh-ancestor
101967531|NCT03636308|Mitosis Modulators|mitosis modulators|mesh-ancestor
101967532|NCT03636308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967533|NCT03636308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101967534|NCT03636308|Antimetabolites|antimetabolites|mesh-ancestor
101967535|NCT00836056|Clindamycin|clindamycin|mesh-list
101967536|NCT00836056|Clindamycin palmitate|clindamycin palmitate|mesh-list
101967537|NCT00836056|Clindamycin phosphate|clindamycin phosphate|mesh-list
101967538|NCT00836056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101967539|NCT00836056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101967540|NCT00836056|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101967541|NCT00836056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101967542|NCT00836056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967543|NCT00835666|Finasteride|finasteride|mesh-list
101967544|NCT00835666|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101967545|NCT00835666|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101967546|NCT00835666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101967547|NCT00835666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967548|NCT00835666|Hormone Antagonists|hormone antagonists|mesh-ancestor
101971316|NCT04539938|Trastuzumab|trastuzumab|mesh-list
101971317|NCT04539938|Tucatinib|tucatinib|mesh-list
101971318|NCT04539938|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
101971319|NCT04539938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101967549|NCT00835666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101967550|NCT00835666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967551|NCT00835666|Urological Agents|urological agents|mesh-ancestor
101967552|NCT00835588|Pantoprazole|pantoprazole|mesh-list
101967553|NCT00835588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101967554|NCT00835588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101967555|NCT00835588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101967556|NCT00835588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101967557|NCT00835588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967558|NCT00713518|Ranibizumab|ranibizumab|mesh-list
101967559|NCT00713518|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101967560|NCT00713518|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101967562|NCT00713518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967563|NCT00713518|Growth Inhibitors|growth inhibitors|mesh-ancestor
101967564|NCT00713518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101967565|NCT04468958|Immunoglobulins|immunoglobulins|mesh-list
101967566|NCT04468958|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101967567|NCT04468958|Immunologic Factors|immunologic factors|mesh-ancestor
101967568|NCT04468958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967569|NCT00708292|Dexamethasone|dexamethasone|mesh-list
101967570|NCT00708292|Bortezomib|bortezomib|mesh-list
101967571|NCT00708292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101967572|NCT00708292|Antiemetics|antiemetics|mesh-ancestor
101967573|NCT00708292|Autonomic Agents|autonomic agents|mesh-ancestor
101967574|NCT00708292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101967575|NCT00708292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967576|NCT00708292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101967577|NCT00708292|Glucocorticoids|glucocorticoids|mesh-ancestor
101967579|NCT00708292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101967580|NCT00708292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101967581|NCT00708292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101967582|NCT00790660|Ipragliflozin|ipragliflozin|mesh-list
101967583|NCT00790660|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101967584|NCT00790660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967585|NCT00790660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101967586|NCT00790660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967587|NCT01330082|Photosensitizing Agents|photosensitizing agents|mesh-list
101967588|NCT01330082|Dermatologic Agents|dermatologic agents|mesh-ancestor
101967590|NCT00835354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101967591|NCT00835354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101967592|NCT00698230|Metformin|metformin|mesh-list
101967593|NCT00698230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101967594|NCT00698230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967595|NCT01330238|Zoledronic Acid|zoledronic acid|mesh-list
101967596|NCT01330238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101967597|NCT01330238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967598|NCT01330472|Alprazolam|alprazolam|mesh-list
101967599|NCT01330472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101967600|NCT01330472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101967601|NCT01330472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967602|NCT01330472|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101967603|NCT01330472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101967604|NCT01330472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101967605|NCT01330472|GABA Modulators|gaba modulators|mesh-ancestor
101967606|NCT01330472|GABA Agents|gaba agents|mesh-ancestor
101967607|NCT01330472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101967608|NCT01330472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967609|NCT00835276|Fexofenadine|fexofenadine|mesh-list
101967610|NCT00835276|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101967611|NCT00835276|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101967612|NCT00835276|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101967613|NCT00835276|Histamine Antagonists|histamine antagonists|mesh-ancestor
101967614|NCT00835276|Histamine Agents|histamine agents|mesh-ancestor
101967615|NCT00835276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101967616|NCT00835276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967617|NCT00835276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971320|NCT04539938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971321|NCT04539938|Immunoconjugates|immunoconjugates|mesh-ancestor
101971322|NCT04539938|Immunologic Factors|immunologic factors|mesh-ancestor
101306088|NCT02023684|Anesthetics|anesthetics|mesh-ancestor
101967618|NCT03344536|Fulvestrant|fulvestrant|mesh-list
101967619|NCT03344536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101967620|NCT03344536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101967621|NCT03344536|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101967622|NCT03344536|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101967623|NCT03344536|Hormone Antagonists|hormone antagonists|mesh-ancestor
101967624|NCT03344536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101967625|NCT03344536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967627|NCT01759238|Capecitabine|capecitabine|mesh-list
101967628|NCT01759238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101967629|NCT01759238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101967630|NCT01759238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101967631|NCT01759238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101967633|NCT01759238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345962|NCT00025428|Etoposide|etoposide|mesh-list
101967634|NCT01759238|Growth Inhibitors|growth inhibitors|mesh-ancestor
101693580|NCT05300282|Gemcitabine|gemcitabine|mesh-list
101967635|NCT01759238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101967636|NCT01759238|Antimetabolites|antimetabolites|mesh-ancestor
101967637|NCT01759238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967638|NCT00835042|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101967640|NCT00835042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101967641|NCT00835042|Diuretics|diuretics|mesh-ancestor
101967642|NCT00835042|Natriuretic Agents|natriuretic agents|mesh-ancestor
101967643|NCT00835042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967644|NCT00835042|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101967645|NCT00835042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101967646|NCT00835042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332155|NCT00036790|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101967647|NCT00835042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101967648|NCT00835042|Protease Inhibitors|protease inhibitors|mesh-ancestor
101967649|NCT00835042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101967650|NCT00834964|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101967651|NCT00834964|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101967652|NCT00834964|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101967653|NCT00834964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101967654|NCT00834964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967655|NCT00834964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101967656|NCT00834964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967657|NCT00834964|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101967658|NCT00834964|Antidepressive Agents|antidepressive agents|mesh-ancestor
101967659|NCT00834964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101967661|NCT03070522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101967662|NCT03070522|Glucocorticoids|glucocorticoids|mesh-ancestor
101967663|NCT03070522|Hormones|hormones|mesh-ancestor
101967664|NCT03070522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101332176|NCT00036868|Methotrexate|methotrexate|mesh-list
101967665|NCT03070522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967666|NCT03070522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101967667|NCT03070522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101967668|NCT00834574|Cefdinir|cefdinir|mesh-list
101967669|NCT00834574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101967670|NCT00834574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101967671|NCT04879966|Infliximab|infliximab|mesh-list
101967672|NCT04879966|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101967673|NCT04879966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101967674|NCT04879966|Dermatologic Agents|dermatologic agents|mesh-ancestor
101967675|NCT04879966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101967676|NCT04879966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101967677|NCT00834418|Leflunomide|leflunomide|mesh-list
101967678|NCT00834418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101967679|NCT00834418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967680|NCT00834418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101967681|NCT00834418|Immunologic Factors|immunologic factors|mesh-ancestor
101967682|NCT00834418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967683|NCT04621318|Denosumab|denosumab|mesh-list
101971323|NCT04539938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967684|NCT04621318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101332200|NCT00036946|Growth Substances|growth substances|mesh-ancestor
101967685|NCT04621318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967686|NCT00834340|Glimepiride|glimepiride|mesh-list
101967687|NCT00834340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101967688|NCT00834340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101967689|NCT00834340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967690|NCT00834340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101967691|NCT00834340|Immunologic Factors|immunologic factors|mesh-ancestor
101967692|NCT00683722|Remestemcel-l|remestemcel-l|mesh-list
101967693|NCT00683722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101967694|NCT00683722|Antiviral Agents|antiviral agents|mesh-ancestor
101967695|NCT00683722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101967696|NCT04473274|Pioglitazone|pioglitazone|mesh-list
101967697|NCT04473274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101967698|NCT04473274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967700|NCT00679588|Semuloparin|semuloparin|mesh-list
101967701|NCT00679588|Enoxaparin sodium|enoxaparin sodium|mesh-list
101967702|NCT00679588|Anticoagulants|anticoagulants|mesh-ancestor
101967703|NCT00679588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101967704|NCT00679588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101967705|NCT00679588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967706|NCT00151996|Guanfacine|guanfacine|mesh-list
101967707|NCT00151996|Methylphenidate|methylphenidate|mesh-list
101332221|NCT00037063|Vitamin E|vitamin e|mesh-list
101967708|NCT00151996|Amphetamine|amphetamine|mesh-list
101967709|NCT00151996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101967710|NCT00151996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967711|NCT00151996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101967712|NCT00151996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101967713|NCT00151996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101967714|NCT00151996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967715|NCT00151996|Dopamine Agents|dopamine agents|mesh-ancestor
101332233|NCT00000869|Nevirapine|nevirapine|mesh-list
101967717|NCT00151996|Sympathomimetics|sympathomimetics|mesh-ancestor
101967718|NCT00151996|Autonomic Agents|autonomic agents|mesh-ancestor
101967719|NCT00151996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101967720|NCT00151996|Adrenergic Agents|adrenergic agents|mesh-ancestor
101967721|NCT00151996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101967722|NCT00151996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101967723|NCT00151996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101967724|NCT00151996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101967725|NCT00151996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101967726|NCT00830206|Azithromycin|azithromycin|mesh-list
101967727|NCT00830206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101967728|NCT00830206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101967730|NCT00829504|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101967731|NCT00829504|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101967732|NCT00829504|Dopamine Agonists|dopamine agonists|mesh-ancestor
101967733|NCT00829504|Dopamine Agents|dopamine agents|mesh-ancestor
101967734|NCT00829504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101967735|NCT00829504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967736|NCT00829504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967738|NCT00829426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101967739|NCT00829426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101967740|NCT00829426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967741|NCT00829426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101967742|NCT00829426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101967743|NCT00829426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101967744|NCT00829426|GABA Modulators|gaba modulators|mesh-ancestor
101967745|NCT00829426|GABA Agents|gaba agents|mesh-ancestor
101967746|NCT00829426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101967747|NCT00829426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967748|NCT00152464|Levocetirizine|levocetirizine|mesh-list
101967749|NCT00152464|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101967750|NCT00152464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101967751|NCT00152464|Histamine Antagonists|histamine antagonists|mesh-ancestor
101967752|NCT00152464|Histamine Agents|histamine agents|mesh-ancestor
101967753|NCT00152464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101967754|NCT00152464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967755|NCT00152464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967756|NCT04472806|Endostar protein|endostar protein|mesh-list
101967757|NCT04472806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101306091|NCT02023684|Sensory System Agents|sensory system agents|mesh-ancestor
101967758|NCT04472806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101967759|NCT04472806|Growth Substances|growth substances|mesh-ancestor
101967760|NCT04472806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967761|NCT04472806|Growth Inhibitors|growth inhibitors|mesh-ancestor
101967762|NCT04472806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101967763|NCT00674440|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
101967764|NCT00674440|Dopamine Agents|dopamine agents|mesh-ancestor
101967765|NCT00674440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101967766|NCT00674440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967767|NCT00674440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967768|NCT01858948|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101967769|NCT01858948|Antidepressive Agents|antidepressive agents|mesh-ancestor
101967770|NCT01858948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101967771|NCT01858948|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101967772|NCT01858948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101967773|NCT01858948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101967774|NCT01858948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967775|NCT00770848|Prednisone|prednisone|mesh-list
101967776|NCT00770848|Mitoxantrone|mitoxantrone|mesh-list
101967778|NCT00770848|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101967779|NCT00770848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101967780|NCT00770848|Glucocorticoids|glucocorticoids|mesh-ancestor
101967781|NCT00770848|Hormones|hormones|mesh-ancestor
101332299|NCT00037219|Anidulafungin|anidulafungin|mesh-list
101967782|NCT00770848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101967783|NCT00770848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967784|NCT00770848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101967785|NCT00770848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101967786|NCT00770848|Analgesics|analgesics|mesh-ancestor
101967787|NCT00770848|Sensory System Agents|sensory system agents|mesh-ancestor
101967788|NCT00770848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101967789|NCT00770848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101967790|NCT00770848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101967791|NCT00770848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101967792|NCT00770848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967793|NCT00770848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101967794|NCT00770848|Immunologic Factors|immunologic factors|mesh-ancestor
101967795|NCT00672412|Lamivudine|lamivudine|mesh-list
101967796|NCT00672412|Zidovudine|zidovudine|mesh-list
101967797|NCT00672412|Nevirapine|nevirapine|mesh-list
101967798|NCT00672412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101967799|NCT00672412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101967800|NCT00672412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101967801|NCT00672412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967802|NCT00672412|Antiviral Agents|antiviral agents|mesh-ancestor
101967803|NCT00672412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101967804|NCT00672412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101967805|NCT00672412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101967807|NCT00672412|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101967808|NCT00672412|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101967809|NCT01315262|Sildenafil Citrate|sildenafil citrate|mesh-list
101967810|NCT01315262|Vasodilator Agents|vasodilator agents|mesh-ancestor
101967811|NCT01315262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101967812|NCT01315262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101967813|NCT01315262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101967814|NCT01315262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967815|NCT01315262|Urological Agents|urological agents|mesh-ancestor
101967816|NCT03197324|Bexagliflozin|bexagliflozin|mesh-list
101967818|NCT03197324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101967819|NCT03197324|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101967820|NCT03197324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101967821|NCT03197324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967822|NCT03197324|Protective Agents|protective agents|mesh-ancestor
101967823|NCT03197324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967824|NCT03197324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101693604|NCT02793011|Hormones|hormones|mesh-ancestor
101967825|NCT01330706|Polihexanide|polihexanide|mesh-list
101967826|NCT01330706|Disinfectants|disinfectants|mesh-ancestor
101967827|NCT01330706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101967828|NCT01156220|Furosemide|furosemide|mesh-list
101967829|NCT01156220|Diuretics|diuretics|mesh-ancestor
101967830|NCT01156220|Natriuretic Agents|natriuretic agents|mesh-ancestor
101967831|NCT01156220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971325|NCT04539938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101967832|NCT01156220|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101967833|NCT01156220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101967834|NCT01156220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967835|NCT03192488|Cetirizine|cetirizine|mesh-list
101967836|NCT03192488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101967837|NCT03192488|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101967838|NCT03192488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101967839|NCT03192488|Histamine Antagonists|histamine antagonists|mesh-ancestor
101967840|NCT03192488|Histamine Agents|histamine agents|mesh-ancestor
101967841|NCT03192488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101967842|NCT03192488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967843|NCT03192488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967844|NCT01642004|Docetaxel|docetaxel|mesh-list
101967845|NCT01642004|Nivolumab|nivolumab|mesh-list
101967846|NCT01642004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101967847|NCT01642004|Tubulin Modulators|tubulin modulators|mesh-ancestor
101967848|NCT01642004|Antimitotic Agents|antimitotic agents|mesh-ancestor
101967849|NCT01642004|Mitosis Modulators|mitosis modulators|mesh-ancestor
101967850|NCT01642004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967851|NCT01642004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101967852|NCT01642004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101967854|NCT03907826|Antibodies, Blocking|antibodies, blocking|mesh-list
101967855|NCT03907826|Immunologic Factors|immunologic factors|mesh-ancestor
101967856|NCT03907826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967857|NCT00042289|Ritonavir|ritonavir|mesh-list
101967858|NCT00042289|Lopinavir|lopinavir|mesh-list
101967859|NCT00042289|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101967861|NCT00042289|Nelfinavir|nelfinavir|mesh-list
101967862|NCT00042289|Indinavir|indinavir|mesh-list
101967863|NCT00042289|Fosamprenavir|fosamprenavir|mesh-list
101967864|NCT00042289|Amprenavir|amprenavir|mesh-list
101967865|NCT00042289|Tenofovir|tenofovir|mesh-list
101967866|NCT00042289|Emtricitabine|emtricitabine|mesh-list
101967867|NCT00042289|Raltegravir Potassium|raltegravir potassium|mesh-list
101967868|NCT00042289|Nevirapine|nevirapine|mesh-list
101967869|NCT00042289|Dolutegravir|dolutegravir|mesh-list
101967870|NCT00042289|Maraviroc|maraviroc|mesh-list
101967871|NCT00042289|Abacavir|abacavir|mesh-list
101967872|NCT00042289|Didanosine|didanosine|mesh-list
101967873|NCT00042289|Cobicistat|cobicistat|mesh-list
101967874|NCT00042289|Rilpivirine|rilpivirine|mesh-list
101967875|NCT00042289|Tipranavir|tipranavir|mesh-list
101967876|NCT00042289|Elvitegravir|elvitegravir|mesh-list
101967877|NCT00042289|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
101967878|NCT00042289|Moxifloxacin|moxifloxacin|mesh-list
101967879|NCT00042289|Efavirenz|efavirenz|mesh-list
101967880|NCT00042289|Rifampin|rifampin|mesh-list
101967882|NCT00042289|Linezolid|linezolid|mesh-list
101967883|NCT00042289|Cycloserine|cycloserine|mesh-list
101967884|NCT00042289|Amikacin|amikacin|mesh-list
101967885|NCT00042289|Pyrazinamide|pyrazinamide|mesh-list
101967886|NCT00042289|Ethambutol|ethambutol|mesh-list
101967887|NCT00042289|Bedaquiline|bedaquiline|mesh-list
101967888|NCT00042289|Etravirine|etravirine|mesh-list
101967889|NCT00042289|Clofazimine|clofazimine|mesh-list
101967890|NCT00042289|Ofloxacin|ofloxacin|mesh-list
101967891|NCT00042289|Aminosalicylic Acid|aminosalicylic acid|mesh-list
101967892|NCT00042289|Ethionamide|ethionamide|mesh-list
101967893|NCT00042289|Kanamycin|kanamycin|mesh-list
101967894|NCT00042289|Prothionamide|prothionamide|mesh-list
101967895|NCT00042289|Capreomycin|capreomycin|mesh-list
101967896|NCT00042289|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101967897|NCT00042289|Etonogestrel|etonogestrel|mesh-list
101967898|NCT00042289|Estradiol|estradiol|mesh-list
101967899|NCT00042289|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101967900|NCT00042289|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101967901|NCT00042289|Protease Inhibitors|protease inhibitors|mesh-ancestor
101332408|NCT00038077|Metoprolol|metoprolol|mesh-list
101967902|NCT00042289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101967903|NCT00042289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967904|NCT00042289|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101967905|NCT00042289|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101967906|NCT00042289|Antiviral Agents|antiviral agents|mesh-ancestor
101967907|NCT00042289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101967908|NCT00042289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101967909|NCT00042289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101967910|NCT00042289|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101332418|NCT00038077|Adrenergic Agents|adrenergic agents|mesh-ancestor
101967911|NCT00042289|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101971326|NCT04539938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967912|NCT00042289|Estrogens|estrogens|mesh-ancestor
101967913|NCT00042289|Hormones|hormones|mesh-ancestor
101967914|NCT00042289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101332424|NCT00038116|Autonomic Agents|autonomic agents|mesh-ancestor
101967915|NCT00042289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967916|NCT00042289|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101967917|NCT00042289|Contraceptive Agents|contraceptive agents|mesh-ancestor
101967918|NCT00042289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101967919|NCT00042289|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101967920|NCT00042289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101967921|NCT00042289|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101967922|NCT00042289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101967923|NCT00042289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101967924|NCT00042289|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101967925|NCT00042289|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101967926|NCT00042289|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101967927|NCT00042289|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101967928|NCT00042289|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101967929|NCT00042289|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101967930|NCT00042289|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101967931|NCT00042289|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101967932|NCT00042289|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101967933|NCT00042289|Antitubercular Agents|antitubercular agents|mesh-ancestor
101967934|NCT00042289|Leprostatic Agents|leprostatic agents|mesh-ancestor
101967935|NCT00042289|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101967936|NCT00042289|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101967937|NCT00042289|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101967938|NCT00042289|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101967939|NCT00042289|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101967940|NCT00042289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101967941|NCT00042289|Antimetabolites|antimetabolites|mesh-ancestor
101332452|NCT00000926|Nonoxynol|nonoxynol|mesh-list
101967942|NCT00042289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101967943|NCT00042289|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101967944|NCT00042289|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101967945|NCT00042289|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101967946|NCT00042289|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101967947|NCT00042289|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101967948|NCT00042289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101967949|NCT00042289|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101967951|NCT00039871|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101967952|NCT00039871|Interferon-alpha|interferon-alpha|mesh-list
101967954|NCT00039871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967955|NCT00039871|Antiviral Agents|antiviral agents|mesh-ancestor
101967956|NCT00039871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101967957|NCT00039871|Immunologic Factors|immunologic factors|mesh-ancestor
101967958|NCT00039871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967959|NCT01096693|Substance P|substance p|mesh-list
101967960|NCT01096693|Neurokinin A|neurokinin a|mesh-list
101967961|NCT01096693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101967962|NCT01096693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967963|NCT01096693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967964|NCT00015457|Amlodipine|amlodipine|mesh-list
101332473|NCT00000941|Simvastatin|simvastatin|mesh-list
101967965|NCT00015457|Botulinum Toxins|botulinum toxins|mesh-list
101967966|NCT00015457|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101967967|NCT00015457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101967968|NCT00015457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967969|NCT00015457|Cholinergic Agents|cholinergic agents|mesh-ancestor
101967970|NCT00015457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101967971|NCT00015457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967972|NCT00015457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101967973|NCT00015457|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101967974|NCT00015457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101967975|NCT00015457|Vasodilator Agents|vasodilator agents|mesh-ancestor
101967976|NCT03564470|Dasatinib|dasatinib|mesh-list
101967977|NCT03564470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101967978|NCT03564470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101967979|NCT03564470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101332494|NCT00014937|Ritonavir|ritonavir|mesh-list
101971327|NCT04538950|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
101971328|NCT04538950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971329|NCT04530981|Repaglinide|repaglinide|mesh-list
101971330|NCT04530981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101967980|NCT03564470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967981|NCT03191396|Liraglutide|liraglutide|mesh-list
101967982|NCT03191396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101967983|NCT03191396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967984|NCT03191396|Incretins|incretins|mesh-ancestor
101967985|NCT03191396|Hormones|hormones|mesh-ancestor
101967986|NCT03191396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101967987|NCT03509636|Fluzoparib|fluzoparib|mesh-list
101967988|NCT03509636|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101967989|NCT03509636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101967990|NCT03509636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967991|NCT03509636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101967992|NCT01333670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101967993|NCT00007345|Romidepsin|romidepsin|mesh-list
101967994|NCT00007345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101967995|NCT00007345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101967996|NCT00007345|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101967997|NCT00007345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101967998|NCT00007345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967999|NCT01584271|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101968000|NCT01584271|Carbamide Peroxide|carbamide peroxide|mesh-list
101968001|NCT01584271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101968002|NCT01584271|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101968003|NCT00031447|Acyclovir|acyclovir|mesh-list
101968004|NCT00031447|Antiviral Agents|antiviral agents|mesh-ancestor
101968005|NCT00031447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101968006|NCT00006721|Prednisone|prednisone|mesh-list
101968007|NCT00006721|Cyclophosphamide|cyclophosphamide|mesh-list
101968009|NCT00006721|Doxorubicin|doxorubicin|mesh-list
101968010|NCT00006721|Vincristine|vincristine|mesh-list
101968011|NCT00006721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101968012|NCT00006721|Immunologic Factors|immunologic factors|mesh-ancestor
101968013|NCT00006721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968014|NCT00006721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101349985|NCT05215730|Copper|copper|mesh-list
101968015|NCT00006721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101968016|NCT00006721|Alkylating Agents|alkylating agents|mesh-ancestor
101968017|NCT00006721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968018|NCT00006721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101968019|NCT00006721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101968020|NCT00006721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101968021|NCT00006721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101968022|NCT00006721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101968023|NCT00006721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101968024|NCT00006721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101968025|NCT00006721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101968026|NCT00006721|Glucocorticoids|glucocorticoids|mesh-ancestor
101968027|NCT00006721|Hormones|hormones|mesh-ancestor
101968028|NCT00006721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101968029|NCT00006721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101968030|NCT00006721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101968031|NCT00006721|Tubulin Modulators|tubulin modulators|mesh-ancestor
101968032|NCT00006721|Antimitotic Agents|antimitotic agents|mesh-ancestor
101968033|NCT00006721|Mitosis Modulators|mitosis modulators|mesh-ancestor
101968035|NCT00006289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101968036|NCT00006289|Immunologic Factors|immunologic factors|mesh-ancestor
101968037|NCT00006289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968038|NCT00006289|Analgesics|analgesics|mesh-ancestor
101687811|NCT00894647|Imiquimod|imiquimod|mesh-list
101350231|NCT04634838|Copper|copper|mesh-list
101968039|NCT00006289|Sensory System Agents|sensory system agents|mesh-ancestor
101968040|NCT00006289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101968041|NCT00006289|Anticonvulsants|anticonvulsants|mesh-ancestor
101968042|NCT05625841|Propolis|propolis|mesh-list
101968043|NCT05625841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101968044|NCT01103401|Tobramycin|tobramycin|mesh-list
101968045|NCT01103401|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
101968046|NCT01103401|Dexamethasone|dexamethasone|mesh-list
101971331|NCT04530981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971332|NCT04526899|Cemiplimab|cemiplimab|mesh-list
101971333|NCT04526899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101971334|NCT04526899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101968047|NCT01103401|Dexamethasone acetate|dexamethasone acetate|mesh-list
101968048|NCT01103401|Ketorolac|ketorolac|mesh-list
101968049|NCT01103401|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101968050|NCT01103401|BB 1101|bb 1101|mesh-list
101968051|NCT01103401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101350358|NCT04321993|Remdesivir|remdesivir|mesh-list
101968052|NCT01103401|Antiemetics|antiemetics|mesh-ancestor
101968053|NCT01103401|Autonomic Agents|autonomic agents|mesh-ancestor
101968054|NCT01103401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101968055|NCT01103401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968056|NCT01103401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101968057|NCT01103401|Glucocorticoids|glucocorticoids|mesh-ancestor
101968058|NCT01103401|Hormones|hormones|mesh-ancestor
101968059|NCT01103401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101968060|NCT01103401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101968061|NCT01103401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101968062|NCT01103401|Protease Inhibitors|protease inhibitors|mesh-ancestor
101968063|NCT01103401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101968064|NCT01103401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968065|NCT01103401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101968066|NCT01103401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101968067|NCT01103401|Analgesics|analgesics|mesh-ancestor
101968068|NCT01103401|Sensory System Agents|sensory system agents|mesh-ancestor
101968069|NCT01103401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101968070|NCT01103401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101968071|NCT01103401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101968072|NCT01103401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101968073|NCT01103401|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101332571|NCT00396721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101968074|NCT01103401|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101968075|NCT00005047|Doxorubicin|doxorubicin|mesh-list
101968076|NCT00005047|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101968077|NCT00005047|Methotrexate|methotrexate|mesh-list
101968078|NCT00005047|Vinblastine|vinblastine|mesh-list
101968079|NCT00005047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101968080|NCT00005047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101968081|NCT00005047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101968082|NCT00005047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101968083|NCT00005047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101968084|NCT00005047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968085|NCT00005047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101968086|NCT00005047|Abortifacient Agents|abortifacient agents|mesh-ancestor
101968087|NCT00005047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101968088|NCT00005047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968089|NCT00005047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101968090|NCT00005047|Antimetabolites|antimetabolites|mesh-ancestor
101968091|NCT00005047|Dermatologic Agents|dermatologic agents|mesh-ancestor
101332590|NCT00015054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101332594|NCT00015132|Sertraline|sertraline|mesh-list
101968092|NCT00005047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101968093|NCT00005047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101968094|NCT00005047|Immunologic Factors|immunologic factors|mesh-ancestor
101968095|NCT00005047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101968096|NCT00005047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101968097|NCT00005047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101968098|NCT00005047|Tubulin Modulators|tubulin modulators|mesh-ancestor
101968099|NCT00005047|Antimitotic Agents|antimitotic agents|mesh-ancestor
101968100|NCT00005047|Mitosis Modulators|mitosis modulators|mesh-ancestor
101968101|NCT01103635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101968102|NCT01103635|Ipilimumab|ipilimumab|mesh-list
101968103|NCT01103635|Tremelimumab|tremelimumab|mesh-list
101968104|NCT01103635|Antibodies|antibodies|mesh-list
101968105|NCT01103635|Immunoglobulins|immunoglobulins|mesh-list
101968106|NCT01103635|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101968107|NCT01103635|Immunologic Factors|immunologic factors|mesh-ancestor
101968108|NCT01103635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968109|NCT01103635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101968110|NCT01103635|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101971335|NCT04520178|Carbidopa|carbidopa|mesh-list
101971336|NCT04520178|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
101971337|NCT04520178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101971338|NCT04520178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101968111|NCT01103635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968112|NCT03949075|Enalapril|enalapril|mesh-list
101968113|NCT03949075|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101968114|NCT03949075|Protease Inhibitors|protease inhibitors|mesh-ancestor
101968115|NCT03949075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101968116|NCT03949075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968117|NCT03949075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101968118|NCT01101529|Aprepitant|aprepitant|mesh-list
101968119|NCT01101529|Antiemetics|antiemetics|mesh-ancestor
101968120|NCT01101529|Autonomic Agents|autonomic agents|mesh-ancestor
101968121|NCT01101529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101968122|NCT01101529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968123|NCT01101529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101968124|NCT01101529|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101968125|NCT01101529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101332626|NCT00015171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968126|NCT01101529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968128|NCT01100125|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101968129|NCT01100125|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101968130|NCT01100125|Insulin, Long-Acting|insulin, long-acting|mesh-list
101968131|NCT01100125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101968132|NCT01100125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968133|NCT01100125|Incretins|incretins|mesh-ancestor
101968134|NCT01100125|Hormones|hormones|mesh-ancestor
101968135|NCT01100125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101968136|NCT01100125|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101968137|NCT01100125|Protease Inhibitors|protease inhibitors|mesh-ancestor
101968138|NCT01100125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101968139|NCT01100125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968140|NCT01100203|Eplerenone|eplerenone|mesh-list
101968141|NCT01100203|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101968142|NCT01100203|Hormone Antagonists|hormone antagonists|mesh-ancestor
101968143|NCT01100203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101968144|NCT01100203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968145|NCT01100203|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101968146|NCT01100203|Diuretics|diuretics|mesh-ancestor
101968147|NCT01100203|Natriuretic Agents|natriuretic agents|mesh-ancestor
101968148|NCT01100203|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101968149|NCT03948685|Carvedilol|carvedilol|mesh-list
101968150|NCT03948685|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101968152|NCT03948685|Adrenergic Agents|adrenergic agents|mesh-ancestor
101968153|NCT03948685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101968154|NCT03948685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968155|NCT03948685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968156|NCT03948685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101968157|NCT03948685|Antioxidants|antioxidants|mesh-ancestor
101968158|NCT03948685|Protective Agents|protective agents|mesh-ancestor
101968159|NCT03948685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101968160|NCT03948685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101968161|NCT03948685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101968162|NCT03948685|Vasodilator Agents|vasodilator agents|mesh-ancestor
101968163|NCT03948685|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101968164|NCT03948685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101968166|NCT01585051|Vitamins|vitamins|mesh-ancestor
101968167|NCT01585051|Micronutrients|micronutrients|mesh-ancestor
101968168|NCT01585051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968169|NCT01585051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101968170|NCT01103791|Docetaxel|docetaxel|mesh-list
101968171|NCT01103791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101968172|NCT01103791|Tubulin Modulators|tubulin modulators|mesh-ancestor
101968173|NCT01103791|Antimitotic Agents|antimitotic agents|mesh-ancestor
101968174|NCT01103791|Mitosis Modulators|mitosis modulators|mesh-ancestor
101968175|NCT01103791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968176|NCT03800173|Galidesivir|galidesivir|mesh-list
101968177|NCT03800173|Antiviral Agents|antiviral agents|mesh-ancestor
101693686|NCT05277038|Clonidine|clonidine|mesh-list
101968178|NCT03800173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101971339|NCT04520178|Dopamine Agents|dopamine agents|mesh-ancestor
101971340|NCT04520178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101968179|NCT00003631|Cytarabine|cytarabine|mesh-list
101968180|NCT00003631|Cyclophosphamide|cyclophosphamide|mesh-list
101968182|NCT00003631|Ifosfamide|ifosfamide|mesh-list
101968183|NCT00003631|Carmustine|carmustine|mesh-list
101968184|NCT00003631|Carboplatin|carboplatin|mesh-list
101968185|NCT00003631|Etoposide|etoposide|mesh-list
101968186|NCT00003631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101968187|NCT00003631|Immunologic Factors|immunologic factors|mesh-ancestor
101332684|NCT00015288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101968188|NCT00003631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968189|NCT00003631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101968190|NCT00003631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101968192|NCT00003631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968193|NCT00003631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101968194|NCT00003631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101968195|NCT00003631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101968196|NCT00003631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101968197|NCT00003631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101968199|NCT00003631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101968200|NCT00003631|Antimetabolites|antimetabolites|mesh-ancestor
101968201|NCT00003631|Antiviral Agents|antiviral agents|mesh-ancestor
101968202|NCT00003631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101968203|NCT01101685|Escitalopram|escitalopram|mesh-list
101968204|NCT01101685|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101968205|NCT01101685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101968206|NCT01101685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101332707|NCT00000998|Vitamins|vitamins|mesh-ancestor
101968207|NCT01101685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968208|NCT01101685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101968209|NCT01101685|Serotonin Agents|serotonin agents|mesh-ancestor
101968210|NCT01101685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968211|NCT00030901|Selenium|selenium|mesh-list
101351772|NCT03625388|Dasatinib|dasatinib|mesh-list
101968212|NCT00030901|Antioxidants|antioxidants|mesh-ancestor
101968213|NCT00030901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968214|NCT00030901|Protective Agents|protective agents|mesh-ancestor
101968215|NCT00030901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968216|NCT00030901|Trace Elements|trace elements|mesh-ancestor
101968217|NCT00030901|Micronutrients|micronutrients|mesh-ancestor
101968218|NCT01104259|Vinorelbine|vinorelbine|mesh-list
101968219|NCT01104259|Veliparib|veliparib|mesh-list
101968220|NCT01104259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101968221|NCT01104259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101968222|NCT01104259|Tubulin Modulators|tubulin modulators|mesh-ancestor
101968223|NCT01104259|Antimitotic Agents|antimitotic agents|mesh-ancestor
101968224|NCT01104259|Mitosis Modulators|mitosis modulators|mesh-ancestor
101968225|NCT01104259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968226|NCT01104259|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101968227|NCT01104259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101968228|NCT01104337|Acetaminophen|acetaminophen|mesh-list
101968229|NCT01104337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101968230|NCT01104337|Analgesics|analgesics|mesh-ancestor
101968231|NCT01104337|Sensory System Agents|sensory system agents|mesh-ancestor
101968232|NCT01104337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101968233|NCT01104337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968234|NCT01104337|Antipyretics|antipyretics|mesh-ancestor
101968235|NCT01100359|Carboplatin|carboplatin|mesh-list
101968236|NCT01100359|Doxorubicin|doxorubicin|mesh-list
101968237|NCT01100359|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101968238|NCT01100359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101968239|NCT01100359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101968240|NCT01100359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101968241|NCT01100359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101968242|NCT01100359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101968243|NCT01100359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968244|NCT00003199|Tamoxifen|tamoxifen|mesh-list
101968245|NCT00003199|Aldesleukin|aldesleukin|mesh-list
101968246|NCT00003199|Melphalan|melphalan|mesh-list
101968247|NCT00003199|Busulfan|busulfan|mesh-list
101968248|NCT00003199|Thiotepa|thiotepa|mesh-list
101968249|NCT00003199|Interleukin-2|interleukin-2|mesh-list
101968250|NCT00003199|Sargramostim|sargramostim|mesh-list
101968251|NCT00003199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968252|NCT00003199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101971341|NCT04520178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968253|NCT00003199|Alkylating Agents|alkylating agents|mesh-ancestor
101968254|NCT00003199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101968255|NCT00003199|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101968256|NCT00003199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101968257|NCT00003199|Immunologic Factors|immunologic factors|mesh-ancestor
101968258|NCT00003199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968259|NCT00003199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101968260|NCT00003199|Analgesics|analgesics|mesh-ancestor
101968261|NCT00003199|Sensory System Agents|sensory system agents|mesh-ancestor
101688043|NCT02672202|Dopamine Agents|dopamine agents|mesh-ancestor
101968262|NCT00003199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101332753|NCT00001004|Interferons|interferons|mesh-list
101968263|NCT00003199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101968264|NCT00003199|Hormone Antagonists|hormone antagonists|mesh-ancestor
101968265|NCT00003199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101968266|NCT00003199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101968267|NCT00003199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101968268|NCT00003199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101968269|NCT00003199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101968271|NCT00003199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101968272|NCT00003199|Antiviral Agents|antiviral agents|mesh-ancestor
101968273|NCT00003199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101968274|NCT01327261|Levodopa|levodopa|mesh-list
101968275|NCT01327261|Benserazide|benserazide|mesh-list
101968276|NCT01327261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101332773|NCT00396760|Protease Inhibitors|protease inhibitors|mesh-ancestor
101968277|NCT01327261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101968278|NCT01327261|Dopamine Agents|dopamine agents|mesh-ancestor
101968279|NCT01327261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101968280|NCT01327261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968281|NCT01327261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968282|NCT01327261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101968283|NCT01101919|Tofacitinib|tofacitinib|mesh-list
101968284|NCT01101919|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101968285|NCT01101919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101968286|NCT01101919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101968287|NCT01101919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968288|NCT03951415|Durvalumab|durvalumab|mesh-list
101968289|NCT03951415|Olaparib|olaparib|mesh-list
101968290|NCT03951415|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
101968291|NCT03951415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101968292|NCT03951415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101968293|NCT03951415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101968294|NCT03951415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968295|NCT00001849|Edetic Acid|edetic acid|mesh-list
101968296|NCT00001849|Pentetic Acid|pentetic acid|mesh-list
101968297|NCT00001849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968298|NCT00001849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968299|NCT00001849|Antidotes|antidotes|mesh-ancestor
101968300|NCT00001849|Protective Agents|protective agents|mesh-ancestor
101968301|NCT00001849|Chelating Agents|chelating agents|mesh-ancestor
101968302|NCT00001849|Sequestering Agents|sequestering agents|mesh-ancestor
101968303|NCT00001849|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101968304|NCT00001849|Anticoagulants|anticoagulants|mesh-ancestor
101968305|NCT00001849|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101968306|NCT01104571|Trastuzumab|trastuzumab|mesh-list
101968307|NCT01104571|Lapatinib|lapatinib|mesh-list
101968308|NCT01104571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101968309|NCT01104571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101968310|NCT01104571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101968311|NCT01104571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101968312|NCT01104571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968314|NCT01104649|Anticonvulsants|anticonvulsants|mesh-ancestor
101968315|NCT01104649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101968316|NCT01104649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101968317|NCT01104649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101968318|NCT01104649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968319|NCT01104649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968320|NCT01104649|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101971342|NCT04520178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971343|NCT04520178|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101971344|NCT04520178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101968321|NCT01104649|Protective Agents|protective agents|mesh-ancestor
101968323|NCT01327729|Interferon-alpha|interferon-alpha|mesh-list
101968324|NCT01327729|Interferon alpha-2|interferon alpha-2|mesh-list
101968325|NCT01327729|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101968326|NCT01327729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101968327|NCT01327729|Antiviral Agents|antiviral agents|mesh-ancestor
101968328|NCT01327729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101968329|NCT01327729|Immunologic Factors|immunologic factors|mesh-ancestor
101968330|NCT01327729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968332|NCT01342952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101968333|NCT01104883|Iodine|iodine|mesh-list
101693752|NCT00960739|Topotecan|topotecan|mesh-list
101968334|NCT01104883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101968335|NCT01104883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101968336|NCT01104883|Trace Elements|trace elements|mesh-ancestor
101968337|NCT01104883|Micronutrients|micronutrients|mesh-ancestor
101968338|NCT01104883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968339|NCT01104961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101968340|NCT04371380|Rilpivirine|rilpivirine|mesh-list
101968342|NCT04371380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101968343|NCT04371380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101968344|NCT04371380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101968345|NCT04371380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968346|NCT04371380|Antiviral Agents|antiviral agents|mesh-ancestor
101968347|NCT04371380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101968348|NCT04371380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101968349|NCT04371380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101968350|NCT04371380|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101968351|NCT04371380|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101968352|NCT01341080|Varenicline|varenicline|mesh-list
101968353|NCT01341080|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101332861|NCT04680442|Immunotoxins|immunotoxins|mesh-ancestor
101968355|NCT01341080|Cholinergic Agents|cholinergic agents|mesh-ancestor
101968356|NCT01341080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101968357|NCT01341080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968358|NCT01341080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968359|NCT01333982|Amoxicillin|amoxicillin|mesh-list
101968360|NCT01333982|Gentamicins|gentamicins|mesh-list
101968361|NCT01333982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101968362|NCT01333982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101968363|NCT01333982|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101968364|NCT01333982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101968365|NCT01333982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968367|NCT01334060|Immunologic Factors|immunologic factors|mesh-ancestor
101968368|NCT01334060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968369|NCT04130828|Ferrous fumarate|ferrous fumarate|mesh-list
101968370|NCT04130828|Trace Elements|trace elements|mesh-ancestor
101968371|NCT04130828|Micronutrients|micronutrients|mesh-ancestor
101968372|NCT04130828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968373|NCT01332344|Fluticasone|fluticasone|mesh-list
101968374|NCT01332344|Xhance|xhance|mesh-list
101968375|NCT01332344|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101332878|NCT00001040|Zidovudine|zidovudine|mesh-list
101968376|NCT01332344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101968377|NCT01332344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101968379|NCT01332344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101968380|NCT01332344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968381|NCT01332344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101968382|NCT01332344|Respiratory System Agents|respiratory system agents|mesh-ancestor
101968383|NCT01332344|Dermatologic Agents|dermatologic agents|mesh-ancestor
101968384|NCT01332344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101968385|NCT01332344|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101968386|NCT01332344|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101968387|NCT01332344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101968388|NCT01332344|Adrenergic Agents|adrenergic agents|mesh-ancestor
101968393|NCT01332422|Fluticasone|fluticasone|mesh-list
101968394|NCT01332422|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101968395|NCT01332422|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101351115|NCT05715073|Caffeine|caffeine|mesh-list
101968396|NCT01332422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101968397|NCT01332422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101968398|NCT01332422|Autonomic Agents|autonomic agents|mesh-ancestor
101306112|NCT02023710|Growth Inhibitors|growth inhibitors|mesh-ancestor
101968399|NCT01332422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101968400|NCT01332422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968401|NCT01332422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101968402|NCT01332422|Respiratory System Agents|respiratory system agents|mesh-ancestor
101968403|NCT01332422|Dermatologic Agents|dermatologic agents|mesh-ancestor
101968404|NCT01332422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101968405|NCT01332422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101968406|NCT01332422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101968407|NCT01332422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101968408|NCT01332422|Adrenergic Agents|adrenergic agents|mesh-ancestor
101968409|NCT01332422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101968410|NCT01332422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968411|NCT01332422|Glucocorticoids|glucocorticoids|mesh-ancestor
101968412|NCT01332422|Hormones|hormones|mesh-ancestor
101968413|NCT01332422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101968414|NCT01332422|Sympathomimetics|sympathomimetics|mesh-ancestor
101968415|NCT03162224|Durvalumab|durvalumab|mesh-list
101968416|NCT03162224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101968417|NCT03162224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101968418|NCT00904046|Pioglitazone|pioglitazone|mesh-list
101968419|NCT00904046|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
101968420|NCT00904046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101968421|NCT00904046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968422|NCT01332734|Magnesium Sulfate|magnesium sulfate|mesh-list
101968423|NCT01332734|Analgesics|analgesics|mesh-ancestor
101968424|NCT01332734|Sensory System Agents|sensory system agents|mesh-ancestor
101968425|NCT01332734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101968426|NCT01332734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968427|NCT01332734|Anesthetics|anesthetics|mesh-ancestor
101968428|NCT01332734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101354026|NCT00024986|Tenofovir|tenofovir|mesh-list
101968429|NCT01332734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101968430|NCT01332734|Anticonvulsants|anticonvulsants|mesh-ancestor
101968431|NCT01332734|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101968432|NCT01332734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101968433|NCT01332734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968434|NCT01332734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101968435|NCT01332734|Tocolytic Agents|tocolytic agents|mesh-ancestor
101968436|NCT01332734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101693780|NCT04175522|Immunoglobulin G|immunoglobulin g|mesh-list
101968438|NCT03326492|Immunologic Factors|immunologic factors|mesh-ancestor
101968439|NCT03326492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968440|NCT01524536|Prednisone|prednisone|mesh-list
101968441|NCT01524536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101968442|NCT01524536|Glucocorticoids|glucocorticoids|mesh-ancestor
101968443|NCT01524536|Hormones|hormones|mesh-ancestor
101968444|NCT01524536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101968445|NCT01524536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968446|NCT01524536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101968447|NCT01524536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101968448|NCT00533468|Lidocaine|lidocaine|mesh-list
101968449|NCT00533468|Anesthetics, Local|anesthetics, local|mesh-ancestor
101968450|NCT00533468|Anesthetics|anesthetics|mesh-ancestor
101332952|NCT00001073|Isotretinoin|isotretinoin|mesh-list
101968451|NCT00533468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101968452|NCT00533468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968453|NCT00533468|Sensory System Agents|sensory system agents|mesh-ancestor
101968454|NCT00533468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101968455|NCT00533468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101968456|NCT00533468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101968457|NCT00533468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101968458|NCT00533468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101968459|NCT00533468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968460|NCT01333124|Gemcitabine|gemcitabine|mesh-list
101968461|NCT01333124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101968462|NCT01333124|Antimetabolites|antimetabolites|mesh-ancestor
101968463|NCT01333124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968464|NCT01333124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101968465|NCT03035630|Sunitinib|sunitinib|mesh-list
101968466|NCT03035630|Avelumab|avelumab|mesh-list
101968467|NCT03035630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101968468|NCT03035630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101968469|NCT03035630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101306113|NCT02023840|Metronidazole|metronidazole|mesh-list
101968470|NCT03035630|Growth Substances|growth substances|mesh-ancestor
101968471|NCT03035630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968472|NCT03035630|Growth Inhibitors|growth inhibitors|mesh-ancestor
101332977|NCT00015951|Immunologic Factors|immunologic factors|mesh-ancestor
101968473|NCT03035630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101968474|NCT03035630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101968475|NCT03035630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968476|NCT03035630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101968478|NCT00004124|Goserelin|goserelin|mesh-list
101968479|NCT00004124|Mitoxantrone|mitoxantrone|mesh-list
101968480|NCT00004124|Bicalutamide|bicalutamide|mesh-list
101968481|NCT00004124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101968482|NCT00004124|Glucocorticoids|glucocorticoids|mesh-ancestor
101968483|NCT00004124|Hormones|hormones|mesh-ancestor
101968484|NCT00004124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101968485|NCT00004124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968486|NCT00004124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101968487|NCT00004124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101968488|NCT00004124|Analgesics|analgesics|mesh-ancestor
101688252|NCT00646854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101968489|NCT00004124|Sensory System Agents|sensory system agents|mesh-ancestor
101968490|NCT00004124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101968491|NCT00004124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101968492|NCT00004124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101968493|NCT00004124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101968494|NCT00004124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968495|NCT00004124|Androgen Antagonists|androgen antagonists|mesh-ancestor
101968496|NCT00004124|Hormone Antagonists|hormone antagonists|mesh-ancestor
101968497|NCT01333358|Alemtuzumab|alemtuzumab|mesh-list
101968498|NCT01333358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101968499|NCT01333358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101968500|NCT01334684|Metformin|metformin|mesh-list
101968501|NCT01334684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101968502|NCT01334684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968503|NCT01334762|Letrozole|letrozole|mesh-list
101968504|NCT01334762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101968505|NCT01334762|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101968506|NCT01334762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101968507|NCT01334762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101968508|NCT01334762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968509|NCT01334762|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101968510|NCT01334762|Hormone Antagonists|hormone antagonists|mesh-ancestor
101968511|NCT01334762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101968512|NCT01334762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968513|NCT00383552|Mometasone Furoate|mometasone furoate|mesh-list
101968514|NCT00383552|Formoterol Fumarate|formoterol fumarate|mesh-list
101968515|NCT00383552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101968516|NCT00383552|Autonomic Agents|autonomic agents|mesh-ancestor
101968517|NCT00383552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101968518|NCT00383552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968519|NCT00383552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101968520|NCT00383552|Respiratory System Agents|respiratory system agents|mesh-ancestor
101968521|NCT00383552|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101968522|NCT00383552|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101968523|NCT00383552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101968524|NCT00383552|Adrenergic Agents|adrenergic agents|mesh-ancestor
101968525|NCT00383552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101968526|NCT00383552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968527|NCT00383552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101968528|NCT00383552|Dermatologic Agents|dermatologic agents|mesh-ancestor
101968529|NCT00383552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101968531|NCT01335074|Sorafenib|sorafenib|mesh-list
101968532|NCT01335074|Temsirolimus|temsirolimus|mesh-list
101968533|NCT01335074|MTOR Inhibitors|mtor inhibitors|mesh-list
101968534|NCT01335074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101968535|NCT01335074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101968536|NCT01335074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101968537|NCT01335074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968538|NCT01335074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101968539|NCT01335074|Immunologic Factors|immunologic factors|mesh-ancestor
101968540|NCT01335074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968541|NCT01335074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101971345|NCT04520178|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101971346|NCT04520178|Antidepressive Agents|antidepressive agents|mesh-ancestor
101971347|NCT04520178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101971348|NCT04432584|Eculizumab|eculizumab|mesh-list
101968542|NCT01335074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101968543|NCT01335074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101968544|NCT01335074|Antifungal Agents|antifungal agents|mesh-ancestor
101968545|NCT01337492|Sorafenib|sorafenib|mesh-list
101968546|NCT01337492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101968547|NCT01337492|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101968548|NCT01337492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101968549|NCT01337492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968550|NCT01337570|Dapivirine|dapivirine|mesh-list
101968551|NCT01337570|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101968552|NCT01337570|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101968553|NCT01337570|Antiviral Agents|antiviral agents|mesh-ancestor
101968554|NCT01337570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101968555|NCT01337804|Omeprazole|omeprazole|mesh-list
101968556|NCT01337804|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
101968557|NCT01337804|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101968558|NCT01337804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101968559|NCT01337804|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101968561|NCT01337804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968562|NCT01776424|Aspirin|aspirin|mesh-list
101968563|NCT01776424|Pantoprazole|pantoprazole|mesh-list
101968564|NCT01776424|Rivaroxaban|rivaroxaban|mesh-list
101693816|NCT00885378|Metformin|metformin|mesh-list
101968565|NCT01776424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101968566|NCT01776424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101968567|NCT01776424|Analgesics|analgesics|mesh-ancestor
101968569|NCT01776424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101968570|NCT01776424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968571|NCT01776424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101968572|NCT01776424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101968573|NCT01776424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101968574|NCT01776424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101968575|NCT01776424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968576|NCT01776424|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101968577|NCT01776424|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101968578|NCT01776424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101968580|NCT01776424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101968581|NCT01776424|Antithrombins|antithrombins|mesh-ancestor
101968582|NCT01776424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101968583|NCT01776424|Protease Inhibitors|protease inhibitors|mesh-ancestor
101968584|NCT01776424|Anticoagulants|anticoagulants|mesh-ancestor
101968585|NCT01776424|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101968586|NCT01776424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101968587|NCT01776424|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101968588|NCT00642148|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101968589|NCT00642148|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101968590|NCT00642148|Autonomic Agents|autonomic agents|mesh-ancestor
101968591|NCT00642148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101968592|NCT00642148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968593|NCT00642148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101968594|NCT00642148|Respiratory System Agents|respiratory system agents|mesh-ancestor
101968596|NCT00642148|Hormones|hormones|mesh-ancestor
101333111|NCT00016302|Cytarabine|cytarabine|mesh-list
101968597|NCT00642148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101968598|NCT00642148|Sympathomimetics|sympathomimetics|mesh-ancestor
101968599|NCT00629980|Azithromycin|azithromycin|mesh-list
101968600|NCT00629980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101968601|NCT00629980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101968602|NCT00629590|Azithromycin|azithromycin|mesh-list
101968603|NCT00629590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101968604|NCT00629590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101968606|NCT00626704|Conatumumab|conatumumab|mesh-list
101968607|NCT00626704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101968608|NCT00626704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101968609|NCT00626704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101968610|NCT00626704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101968611|NCT00626704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101971349|NCT04432584|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101968612|NCT00626704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968613|NCT00626704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101968614|NCT00765700|Ketoprofen|ketoprofen|mesh-list
101968615|NCT00765700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101968616|NCT00765700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101968617|NCT00765700|Analgesics|analgesics|mesh-ancestor
101968618|NCT00765700|Sensory System Agents|sensory system agents|mesh-ancestor
101968619|NCT00765700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101968620|NCT00765700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968621|NCT00765700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101355674|NCT00058461|Antiviral Agents|antiviral agents|mesh-ancestor
101968622|NCT00765700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101968623|NCT00765700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101968624|NCT00765700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101968625|NCT00765700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968626|NCT02280694|Celecoxib|celecoxib|mesh-list
101968627|NCT02280694|Cyclophosphamide|cyclophosphamide|mesh-list
101968628|NCT02280694|Capecitabine|capecitabine|mesh-list
101968629|NCT02280694|Methotrexate|methotrexate|mesh-list
101968630|NCT02280694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101968631|NCT02280694|Immunologic Factors|immunologic factors|mesh-ancestor
101968632|NCT02280694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968634|NCT02280694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101968635|NCT02280694|Alkylating Agents|alkylating agents|mesh-ancestor
101968636|NCT02280694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968637|NCT02280694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101968638|NCT02280694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101968639|NCT02280694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101968640|NCT02280694|Antimetabolites|antimetabolites|mesh-ancestor
101968641|NCT02280694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101968642|NCT02280694|Abortifacient Agents|abortifacient agents|mesh-ancestor
101968643|NCT02280694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101968644|NCT02280694|Dermatologic Agents|dermatologic agents|mesh-ancestor
101968645|NCT02280694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101968646|NCT02280694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101968647|NCT02280694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101968648|NCT02280694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101968649|NCT02280694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101968650|NCT02280694|Analgesics|analgesics|mesh-ancestor
101968651|NCT02280694|Sensory System Agents|sensory system agents|mesh-ancestor
101968652|NCT02280694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101968653|NCT02280694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101968654|NCT02280694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101968655|NCT02280694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101968656|NCT02280772|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
101968658|NCT02280772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101968659|NCT02280850|Nitroglycerin|nitroglycerin|mesh-list
101968660|NCT02280850|Vasodilator Agents|vasodilator agents|mesh-ancestor
101968661|NCT02281006|Sodium thiosulfate|sodium thiosulfate|mesh-list
101968662|NCT02281006|Antidotes|antidotes|mesh-ancestor
101968663|NCT02281006|Protective Agents|protective agents|mesh-ancestor
101968664|NCT02281006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968665|NCT02281006|Antioxidants|antioxidants|mesh-ancestor
101968666|NCT02281006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968667|NCT02281006|Antitubercular Agents|antitubercular agents|mesh-ancestor
101968668|NCT02281006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101968669|NCT02281006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101968670|NCT02281006|Chelating Agents|chelating agents|mesh-ancestor
101968671|NCT02281006|Sequestering Agents|sequestering agents|mesh-ancestor
101968672|NCT00758290|Triclosan|triclosan|mesh-list
101968673|NCT00758290|Fluorides|fluorides|mesh-list
101968674|NCT00758290|Cariostatic Agents|cariostatic agents|mesh-ancestor
101968675|NCT00758290|Protective Agents|protective agents|mesh-ancestor
101333188|NCT00016341|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101968676|NCT00758290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968678|NCT00758290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101968679|NCT00758290|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101968680|NCT00758290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101968681|NCT00758290|Antimetabolites|antimetabolites|mesh-ancestor
101968682|NCT00758290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968683|NCT00758290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101968684|NCT03799627|Epoetin Alfa|epoetin alfa|mesh-list
101968685|NCT03799627|Glycine|glycine|mesh-list
101971350|NCT04432584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101971351|NCT04432584|Immunologic Factors|immunologic factors|mesh-ancestor
101306120|NCT02023853|Metronidazole|metronidazole|mesh-list
101968686|NCT03799627|Hematinics|hematinics|mesh-ancestor
101968687|NCT03799627|Glycine Agents|glycine agents|mesh-ancestor
101968688|NCT03799627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101968689|NCT03799627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968690|NCT03799627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968691|NCT02274142|Methamphetamine|methamphetamine|mesh-list
101968692|NCT02274142|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101968693|NCT02274142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968694|NCT02274142|Sympathomimetics|sympathomimetics|mesh-ancestor
101356503|NCT02971397|Cytarabine|cytarabine|mesh-list
101968695|NCT02274142|Autonomic Agents|autonomic agents|mesh-ancestor
101968696|NCT02274142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101968697|NCT02274142|Dopamine Agents|dopamine agents|mesh-ancestor
101968698|NCT02274142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101968699|NCT02274142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968701|NCT02274142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101968702|NCT02274142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101968703|NCT02274142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101968704|NCT02274142|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101968705|NCT00752050|Botulinum Toxins|botulinum toxins|mesh-list
101968706|NCT00752050|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101968707|NCT00752050|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101968708|NCT00752050|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101968709|NCT00752050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101968710|NCT00752050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968711|NCT00752050|Cholinergic Agents|cholinergic agents|mesh-ancestor
101968712|NCT00752050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101688482|NCT00647868|Hormones|hormones|mesh-ancestor
101968713|NCT00752050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333232|NCT00001202|Deslorelin|deslorelin|mesh-list
101968715|NCT00752050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101968716|NCT02276014|Beta Carotene|beta carotene|mesh-list
101968717|NCT02276014|Carotenoids|carotenoids|mesh-list
101356917|NCT00063024|Calcium|calcium|mesh-list
101968719|NCT02276014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968720|NCT02276014|Protective Agents|protective agents|mesh-ancestor
101968721|NCT02276014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968723|NCT02276014|Vitamins|vitamins|mesh-ancestor
101968724|NCT02276014|Micronutrients|micronutrients|mesh-ancestor
101968725|NCT01102387|Octenidine|octenidine|mesh-list
101968726|NCT01102387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101968727|NCT01102387|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101968728|NCT02277808|Amikacin|amikacin|mesh-list
101968729|NCT02277808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101968730|NCT02277808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101968731|NCT02281240|Oprelvekin|oprelvekin|mesh-list
101968733|NCT02281240|Anticoagulants|anticoagulants|mesh-ancestor
101968734|NCT02281240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101968735|NCT02281240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101968736|NCT02281240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968737|NCT02281240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101968738|NCT01102465|Losartan|losartan|mesh-list
101968739|NCT01102465|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101968740|NCT01102465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101968741|NCT01102465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101968742|NCT01102465|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101968743|NCT01102465|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101968744|NCT01102465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968745|NCT01102465|Diuretics|diuretics|mesh-ancestor
101968746|NCT01102465|Natriuretic Agents|natriuretic agents|mesh-ancestor
101357281|NCT00065169|Analgesics|analgesics|mesh-ancestor
101968747|NCT01102465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968748|NCT01102465|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101968749|NCT01102465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101968750|NCT01105819|Chlorhexidine|chlorhexidine|mesh-list
101968751|NCT01105819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101968752|NCT01105819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101968753|NCT01105819|Disinfectants|disinfectants|mesh-ancestor
101968754|NCT00749632|Mandelic Acids|mandelic acids|mesh-list
101968755|NCT00749632|Oxybutynin|oxybutynin|mesh-list
101971352|NCT04432584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971353|NCT04430738|Leucovorin|leucovorin|mesh-list
101971354|NCT04430738|Pembrolizumab|pembrolizumab|mesh-list
101968756|NCT00749632|Parasympatholytics|parasympatholytics|mesh-ancestor
101968757|NCT00749632|Autonomic Agents|autonomic agents|mesh-ancestor
101968758|NCT00749632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101968759|NCT00749632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968760|NCT00749632|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101333272|NCT01156545|Antimetabolites|antimetabolites|mesh-ancestor
101968761|NCT00749632|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101968762|NCT00749632|Cholinergic Agents|cholinergic agents|mesh-ancestor
101968763|NCT00749632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101968764|NCT00749632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968765|NCT00749632|Urological Agents|urological agents|mesh-ancestor
101968766|NCT00749632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101968767|NCT00749632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101968768|NCT01105273|Cyclophosphamide|cyclophosphamide|mesh-list
101968769|NCT01105273|Fludarabine|fludarabine|mesh-list
101357573|NCT00070122|Antidotes|antidotes|mesh-ancestor
101968770|NCT01105273|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101968771|NCT01105273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101968772|NCT01105273|Immunologic Factors|immunologic factors|mesh-ancestor
101968773|NCT01105273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968774|NCT01105273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101968775|NCT01105273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101333291|NCT02347111|Sotalol|sotalol|mesh-list
101968776|NCT01105273|Alkylating Agents|alkylating agents|mesh-ancestor
101968777|NCT01105273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968778|NCT01105273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101968779|NCT01105273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101968780|NCT05215327|Vaccines|vaccines|mesh-list
101968781|NCT05215327|Immunologic Factors|immunologic factors|mesh-ancestor
101968782|NCT05215327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968783|NCT00743938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101968784|NCT00743938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101968785|NCT00743938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101968786|NCT00743938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101968787|NCT00743938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688569|NCT00648258|Naproxen|naproxen|mesh-list
101968788|NCT01105351|Folic Acid|folic acid|mesh-list
101968789|NCT01105351|Vitamin B Complex|vitamin b complex|mesh-list
101968790|NCT01105351|Hematinics|hematinics|mesh-ancestor
101968791|NCT01105351|Vitamins|vitamins|mesh-ancestor
101968792|NCT01105351|Micronutrients|micronutrients|mesh-ancestor
101968793|NCT01105351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968794|NCT00662506|Deoxyglucose|deoxyglucose|mesh-list
101968795|NCT00662506|Temozolomide|temozolomide|mesh-list
101968797|NCT00662506|Maleic acid|maleic acid|mesh-list
101968798|NCT00662506|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101968799|NCT00662506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101968800|NCT00662506|Alkylating Agents|alkylating agents|mesh-ancestor
101968801|NCT00662506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968802|NCT00662506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101968803|NCT00662506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101968804|NCT00662506|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101968805|NCT00662506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101968806|NCT00662506|Antimetabolites|antimetabolites|mesh-ancestor
101968807|NCT00662506|Antiviral Agents|antiviral agents|mesh-ancestor
101333318|NCT00001280|Hormone Antagonists|hormone antagonists|mesh-ancestor
101968808|NCT00662506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101968809|NCT03947125|Buprenorphine|buprenorphine|mesh-list
101968810|NCT03947125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101968811|NCT03947125|Narcotics|narcotics|mesh-ancestor
101968812|NCT03947125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101968813|NCT03947125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968814|NCT03947125|Analgesics|analgesics|mesh-ancestor
101968815|NCT03947125|Sensory System Agents|sensory system agents|mesh-ancestor
101968816|NCT03947125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101968817|NCT03947125|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101968818|NCT00658762|Paroxetine|paroxetine|mesh-list
101333332|NCT00016887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968820|NCT00658762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101968821|NCT00658762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101968822|NCT00658762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971355|NCT04430738|Trastuzumab|trastuzumab|mesh-list
101971356|NCT04430738|Fluorouracil|fluorouracil|mesh-list
101971357|NCT04430738|Capecitabine|capecitabine|mesh-list
101971358|NCT04430738|Oxaliplatin|oxaliplatin|mesh-list
101971359|NCT04430738|Tucatinib|tucatinib|mesh-list
101968823|NCT00658762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101968824|NCT00658762|Serotonin Agents|serotonin agents|mesh-ancestor
101968825|NCT00658762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968826|NCT00658762|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101968827|NCT00658762|Antidepressive Agents|antidepressive agents|mesh-ancestor
101968828|NCT00658762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101968829|NCT00658762|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101968830|NCT00658762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101968831|NCT00658762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101968832|NCT00658372|Paroxetine|paroxetine|mesh-list
101968833|NCT00658372|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101968834|NCT00658372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101968835|NCT00658372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101968836|NCT00658372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968837|NCT00658372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101968838|NCT00658372|Serotonin Agents|serotonin agents|mesh-ancestor
101968839|NCT00658372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968840|NCT00658372|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101968841|NCT00658372|Antidepressive Agents|antidepressive agents|mesh-ancestor
101968842|NCT00658372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101968843|NCT00658372|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101968844|NCT00658372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101968845|NCT00658372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101968846|NCT03946657|Anesthetics|anesthetics|mesh-list
101968847|NCT03946657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
101968848|NCT03946657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101968849|NCT03946657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968850|NCT03946657|Anesthetics, General|anesthetics, general|mesh-ancestor
101333361|NCT00038389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101968851|NCT00616798|Antipsychotic Agents|antipsychotic agents|mesh-list
101968852|NCT00616798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101968853|NCT00616798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101968854|NCT00616798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333371|NCT00038506|Zidovudine|zidovudine|mesh-list
101968855|NCT00616798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101968857|NCT01106053|Antioxidants|antioxidants|mesh-ancestor
101968858|NCT01106053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968859|NCT01106053|Protective Agents|protective agents|mesh-ancestor
101968860|NCT01106053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968861|NCT01106053|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101968862|NCT01106053|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101968863|NCT01106053|Dopamine Agonists|dopamine agonists|mesh-ancestor
101968864|NCT01106053|Dopamine Agents|dopamine agents|mesh-ancestor
101968865|NCT01106053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101968866|NCT00616330|Clindamycin|clindamycin|mesh-list
101968867|NCT00616330|Clindamycin palmitate|clindamycin palmitate|mesh-list
101968868|NCT00616330|Clindamycin phosphate|clindamycin phosphate|mesh-list
101968869|NCT00616330|Butoconazole|butoconazole|mesh-list
101968870|NCT00616330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101968871|NCT00616330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101968872|NCT00616330|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101968873|NCT00616330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101968874|NCT00616330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968875|NCT00616330|Antifungal Agents|antifungal agents|mesh-ancestor
101968876|NCT00612820|Fluticasone|fluticasone|mesh-list
101968877|NCT00612820|Xhance|xhance|mesh-list
101968878|NCT00612820|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
101968879|NCT00612820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101968880|NCT00612820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101968881|NCT00612820|Autonomic Agents|autonomic agents|mesh-ancestor
101968882|NCT00612820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101968883|NCT00612820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968884|NCT00612820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101968885|NCT00612820|Respiratory System Agents|respiratory system agents|mesh-ancestor
101971360|NCT04430738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101971361|NCT04430738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971362|NCT04430738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101971363|NCT04430738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971364|NCT04430738|Antimetabolites|antimetabolites|mesh-ancestor
101968886|NCT00612820|Dermatologic Agents|dermatologic agents|mesh-ancestor
101968887|NCT00612820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101968888|NCT00612820|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101968889|NCT00612820|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101968890|NCT00612820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101968891|NCT00612820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968893|NCT00612742|Androgens|androgens|mesh-ancestor
101968894|NCT00612742|Hormones|hormones|mesh-ancestor
101693919|NCT05238649|Immunologic Factors|immunologic factors|mesh-ancestor
101968895|NCT00612742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101968896|NCT00612742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968897|NCT05016895|Azithromycin|azithromycin|mesh-list
101968899|NCT05016895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101968900|NCT01106131|Pioglitazone|pioglitazone|mesh-list
101968901|NCT01106131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101968902|NCT01106131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968903|NCT00612118|Azelastine|azelastine|mesh-list
101968904|NCT00612118|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
101968905|NCT00612118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101968906|NCT00612118|Autonomic Agents|autonomic agents|mesh-ancestor
101968907|NCT00612118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101968908|NCT00612118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363022|NCT00079638|Niacin|niacin|mesh-list
101968909|NCT00612118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101968910|NCT00612118|Respiratory System Agents|respiratory system agents|mesh-ancestor
101968911|NCT00612118|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101968912|NCT00612118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101333426|NCT00038896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101968913|NCT00612118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968914|NCT00612118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101968915|NCT00612118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101968916|NCT00612118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101968917|NCT00612118|Histamine Antagonists|histamine antagonists|mesh-ancestor
101968919|NCT00612118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101968920|NCT00612118|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101968921|NCT00612118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101968922|NCT00743002|Metformin|metformin|mesh-list
101968923|NCT00743002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101968924|NCT00743002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968925|NCT03944863|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101333428|NCT00038896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101968926|NCT03944863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101968927|NCT01102699|Lenograstim|lenograstim|mesh-list
101968928|NCT01102699|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101968929|NCT01102699|Immunologic Factors|immunologic factors|mesh-ancestor
101968930|NCT01102699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968931|NCT00603616|Rifaximin|rifaximin|mesh-list
101968932|NCT00603616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101968933|NCT00603616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101968934|NCT00603616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101968938|NCT02280070|Oxaliplatin|oxaliplatin|mesh-list
101968939|NCT02280070|Antibodies|antibodies|mesh-list
101968940|NCT02280070|Immunoglobulins|immunoglobulins|mesh-list
101968941|NCT02280070|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
101968942|NCT02280070|Immunologic Factors|immunologic factors|mesh-ancestor
101968943|NCT02280070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968944|NCT02280070|Antimetabolites|antimetabolites|mesh-ancestor
101968945|NCT02280070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968947|NCT02280070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101968948|NCT02280070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101968949|NCT02280070|Antidotes|antidotes|mesh-ancestor
101968950|NCT02280070|Protective Agents|protective agents|mesh-ancestor
101968951|NCT02280070|Vitamin B Complex|vitamin b complex|mesh-ancestor
101968952|NCT02280070|Vitamins|vitamins|mesh-ancestor
101971365|NCT04430738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101971366|NCT04430738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101971367|NCT04430738|Immunologic Factors|immunologic factors|mesh-ancestor
101971368|NCT04430738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971370|NCT04430738|Protective Agents|protective agents|mesh-ancestor
101971371|NCT04430738|Vitamin B Complex|vitamin b complex|mesh-ancestor
101971372|NCT04430738|Vitamins|vitamins|mesh-ancestor
101971373|NCT04430738|Micronutrients|micronutrients|mesh-ancestor
101971374|NCT04430738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101971375|NCT04430738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101971376|NCT04418427|Aflibercept|aflibercept|mesh-list
101971377|NCT04418427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101971378|NCT04418427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101971379|NCT04418427|Growth Substances|growth substances|mesh-ancestor
101971380|NCT04418427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971381|NCT04418427|Growth Inhibitors|growth inhibitors|mesh-ancestor
101971382|NCT04418427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971383|NCT04416165|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101306135|NCT02023931|Sulforaphane|sulforaphane|mesh-list
101968953|NCT02280070|Micronutrients|micronutrients|mesh-ancestor
101968954|NCT01108783|Desloratadine|desloratadine|mesh-list
101968955|NCT01108783|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101968956|NCT01108783|Cholinergic Agents|cholinergic agents|mesh-ancestor
101968957|NCT01108783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101968958|NCT01108783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968959|NCT01108783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968960|NCT01108783|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101968961|NCT01108783|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101968962|NCT01108783|Histamine Antagonists|histamine antagonists|mesh-ancestor
101333472|NCT00001304|Hormones|hormones|mesh-list
101968963|NCT01108783|Histamine Agents|histamine agents|mesh-ancestor
101968964|NCT02743780|MGV354|mgv354|mesh-list
101968965|NCT02743780|Enzyme Activators|enzyme activators|mesh-ancestor
101968966|NCT02743780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968967|NCT02280148|Propofol|propofol|mesh-list
101968968|NCT02280148|Anesthetics|anesthetics|mesh-ancestor
101363621|NCT00047021|Cytarabine|cytarabine|mesh-list
101968969|NCT02280148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101968970|NCT02280148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968971|NCT02280148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101968972|NCT02280148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101968973|NCT02280148|Anesthetics, General|anesthetics, general|mesh-ancestor
101968974|NCT00602602|Bevacizumab|bevacizumab|mesh-list
101968975|NCT00602602|Gemcitabine|gemcitabine|mesh-list
101968976|NCT00602602|Fluorouracil|fluorouracil|mesh-list
101968977|NCT00602602|Oxaliplatin|oxaliplatin|mesh-list
101968978|NCT00602602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101968979|NCT00602602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101968980|NCT00602602|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101968981|NCT00602602|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101968982|NCT00602602|Growth Substances|growth substances|mesh-ancestor
101968983|NCT00602602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968984|NCT00602602|Growth Inhibitors|growth inhibitors|mesh-ancestor
101968985|NCT00602602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101968986|NCT00602602|Antimetabolites|antimetabolites|mesh-ancestor
101968987|NCT00602602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971384|NCT04416165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101971385|NCT04416165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101968988|NCT00602602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101968989|NCT00602602|Immunologic Factors|immunologic factors|mesh-ancestor
101968990|NCT04177654|Albendazole|albendazole|mesh-list
101968991|NCT04177654|Mebendazole|mebendazole|mesh-list
101968992|NCT04177654|Benzimidazole|benzimidazole|mesh-list
101968993|NCT04177654|Anthelmintics|anthelmintics|mesh-ancestor
101968994|NCT04177654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101693946|NCT05367089|Fluconazole|fluconazole|mesh-list
101968995|NCT04177654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101968996|NCT04177654|Anticestodal Agents|anticestodal agents|mesh-ancestor
101968997|NCT04177654|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101968998|NCT04177654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101968999|NCT04177654|Tubulin Modulators|tubulin modulators|mesh-ancestor
101969000|NCT04177654|Antimitotic Agents|antimitotic agents|mesh-ancestor
101969001|NCT04177654|Mitosis Modulators|mitosis modulators|mesh-ancestor
101969002|NCT04177654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969003|NCT04177654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101969004|NCT04177654|Antinematodal Agents|antinematodal agents|mesh-ancestor
101969005|NCT02281396|Vaccines|vaccines|mesh-list
101969006|NCT02281396|Immunologic Factors|immunologic factors|mesh-ancestor
101969007|NCT02281396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969008|NCT04471480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101969009|NCT04471480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969010|NCT04471480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101969011|NCT04471480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101969013|NCT02880956|Nootropic Agents|nootropic agents|mesh-ancestor
101969014|NCT01111513|Analgesics|analgesics|mesh-list
101969015|NCT01111513|Ropivacaine|ropivacaine|mesh-list
101969016|NCT01111513|Anesthetics, Local|anesthetics, local|mesh-ancestor
101969017|NCT01111513|Anesthetics|anesthetics|mesh-ancestor
101969018|NCT01111513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101969019|NCT01111513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969020|NCT01111513|Sensory System Agents|sensory system agents|mesh-ancestor
101969021|NCT01111513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101969022|NCT01111591|Celecoxib|celecoxib|mesh-list
101969023|NCT01111591|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
101969024|NCT01111591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101969025|NCT01111591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101969026|NCT01111591|Analgesics|analgesics|mesh-ancestor
101969027|NCT01111591|Sensory System Agents|sensory system agents|mesh-ancestor
101969028|NCT01111591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101969029|NCT01111591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969030|NCT01111591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101969031|NCT01111591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101969032|NCT01111591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101969033|NCT01111591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101969034|NCT01111591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969035|NCT01111669|Tranexamic Acid|tranexamic acid|mesh-list
101969036|NCT01111669|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101969037|NCT01111669|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101969038|NCT01111669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969039|NCT01111669|Hemostatics|hemostatics|mesh-ancestor
101969040|NCT01111669|Coagulants|coagulants|mesh-ancestor
101969041|NCT01108939|Antimalarials|antimalarials|mesh-list
101969042|NCT01108939|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101969043|NCT01108939|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101333532|NCT00039481|Dexrazoxane|dexrazoxane|mesh-list
101969044|NCT01108939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101969045|NCT00654706|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101969046|NCT00654706|Sertindole|sertindole|mesh-list
101969047|NCT00654706|Antidepressive Agents|antidepressive agents|mesh-ancestor
101969048|NCT00654706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101969049|NCT00654706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101969050|NCT00654706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101969051|NCT00654706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101969052|NCT00654706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969053|NCT03944473|Neostigmine|neostigmine|mesh-list
101969054|NCT03944473|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101969055|NCT03944473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101969056|NCT03944473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969057|NCT03944473|Cholinergic Agents|cholinergic agents|mesh-ancestor
101969058|NCT03944473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101971387|NCT04415944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971388|NCT04398368|Gemcitabine|gemcitabine|mesh-list
101971389|NCT04398368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101969059|NCT03944473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969060|NCT03944473|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101969061|NCT03944473|Autonomic Agents|autonomic agents|mesh-ancestor
101969062|NCT03944473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101969063|NCT03944317|Azithromycin|azithromycin|mesh-list
101969064|NCT03944317|Pyrimethamine|pyrimethamine|mesh-list
101969065|NCT03944317|Sulfadoxine|sulfadoxine|mesh-list
101969066|NCT03944317|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101969067|NCT03944317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101969068|NCT03944317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101969069|NCT03944317|Antimalarials|antimalarials|mesh-ancestor
101969070|NCT03944317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101969071|NCT03944317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101969072|NCT03944317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101969073|NCT03944317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101969074|NCT03944317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969075|NCT03944317|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101969076|NCT02280538|Hyaluronic Acid|hyaluronic acid|mesh-list
101969077|NCT02280538|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101969078|NCT02280538|Immunologic Factors|immunologic factors|mesh-ancestor
101969079|NCT02280538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969080|NCT02280538|Viscosupplements|viscosupplements|mesh-ancestor
101969081|NCT02280538|Protective Agents|protective agents|mesh-ancestor
101969082|NCT01111747|Mitogens|mitogens|mesh-list
101969083|NCT01111747|Mitosis Modulators|mitosis modulators|mesh-ancestor
101969084|NCT01111747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969085|NCT02281708|Cisplatin|cisplatin|mesh-list
101969086|NCT02281708|Vinorelbine|vinorelbine|mesh-list
101969087|NCT02281708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101969088|NCT02281708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101969089|NCT02281708|Tubulin Modulators|tubulin modulators|mesh-ancestor
101969090|NCT02281708|Antimitotic Agents|antimitotic agents|mesh-ancestor
101969091|NCT02281708|Mitosis Modulators|mitosis modulators|mesh-ancestor
101969092|NCT02281708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969093|NCT01111903|Lenalidomide|lenalidomide|mesh-list
101969094|NCT01111903|Immunologic Factors|immunologic factors|mesh-ancestor
101969095|NCT01111903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969096|NCT01111903|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101969097|NCT01111903|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101969098|NCT01111903|Growth Substances|growth substances|mesh-ancestor
101969099|NCT01111903|Growth Inhibitors|growth inhibitors|mesh-ancestor
101969100|NCT01111903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101969101|NCT02280616|Budesonide|budesonide|mesh-list
101969102|NCT02280616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101969103|NCT02280616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101969104|NCT02280616|Autonomic Agents|autonomic agents|mesh-ancestor
101969105|NCT02280616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101969106|NCT02280616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969107|NCT02280616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101969108|NCT02280616|Respiratory System Agents|respiratory system agents|mesh-ancestor
101969109|NCT02280616|Glucocorticoids|glucocorticoids|mesh-ancestor
101969110|NCT02280616|Hormones|hormones|mesh-ancestor
101969111|NCT02280616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101969112|NCT01111981|Clobetasol|clobetasol|mesh-list
101969113|NCT01111981|Emollients|emollients|mesh-list
101969114|NCT01111981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101969115|NCT01111981|Glucocorticoids|glucocorticoids|mesh-ancestor
101969116|NCT01111981|Hormones|hormones|mesh-ancestor
101969117|NCT01111981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101969118|NCT01111981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969119|NCT01111981|Dermatologic Agents|dermatologic agents|mesh-ancestor
101969120|NCT02283424|Carboplatin|carboplatin|mesh-list
101969121|NCT02283424|Docetaxel|docetaxel|mesh-list
101969122|NCT02283424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101693964|NCT02791919|Cytarabine|cytarabine|mesh-list
101969123|NCT02283424|Tubulin Modulators|tubulin modulators|mesh-ancestor
101969124|NCT02283424|Antimitotic Agents|antimitotic agents|mesh-ancestor
101969125|NCT02283424|Mitosis Modulators|mitosis modulators|mesh-ancestor
101969126|NCT02283424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969127|NCT03942601|Sirolimus|sirolimus|mesh-list
101971391|NCT04398368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971392|NCT04398368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971393|NCT04378959|Lidocaine|lidocaine|mesh-list
101969128|NCT03942601|Dexamethasone|dexamethasone|mesh-list
101969129|NCT03942601|Dexamethasone acetate|dexamethasone acetate|mesh-list
101969130|NCT03942601|Temsirolimus|temsirolimus|mesh-list
101969131|NCT03942601|MTOR Inhibitors|mtor inhibitors|mesh-list
101969132|NCT03942601|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101969133|NCT03942601|BB 1101|bb 1101|mesh-list
101969134|NCT03942601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101969135|NCT03942601|Antiemetics|antiemetics|mesh-ancestor
101969136|NCT03942601|Autonomic Agents|autonomic agents|mesh-ancestor
101969137|NCT03942601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101969138|NCT03942601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969139|NCT03942601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101969140|NCT03942601|Glucocorticoids|glucocorticoids|mesh-ancestor
101969141|NCT03942601|Hormones|hormones|mesh-ancestor
101969142|NCT03942601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101969143|NCT03942601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101969144|NCT03942601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101969145|NCT03942601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101969146|NCT03942601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101969147|NCT03942601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969148|NCT03942601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101969149|NCT03942601|Immunologic Factors|immunologic factors|mesh-ancestor
101969150|NCT03942601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101969151|NCT03942601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101969152|NCT03942601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101969153|NCT03942601|Antifungal Agents|antifungal agents|mesh-ancestor
101333657|NCT00040066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101969154|NCT03942601|Protease Inhibitors|protease inhibitors|mesh-ancestor
101969155|NCT00598312|Leuprolide|leuprolide|mesh-list
101969156|NCT00598312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101969157|NCT00598312|Fertility Agents|fertility agents|mesh-ancestor
101969158|NCT00598312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101969159|NCT00598312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333666|NCT00040066|Dopamine Agents|dopamine agents|mesh-ancestor
101969160|NCT00598312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101969161|NCT00598312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101969163|NCT00595426|Anticoagulants|anticoagulants|mesh-ancestor
101969164|NCT01112137|Clopidogrel|clopidogrel|mesh-list
101969165|NCT01112137|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101969166|NCT01112137|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101969167|NCT01112137|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101969168|NCT01112137|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101969169|NCT01112137|Purinergic Agents|purinergic agents|mesh-ancestor
101969170|NCT01112137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101969171|NCT01112137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969172|NCT01112137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333671|NCT00040105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101969173|NCT02282098|Colchicine|colchicine|mesh-list
101969174|NCT02282098|Gout Suppressants|gout suppressants|mesh-ancestor
101969175|NCT02282098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101969176|NCT02282098|Tubulin Modulators|tubulin modulators|mesh-ancestor
101969177|NCT02282098|Antimitotic Agents|antimitotic agents|mesh-ancestor
101969178|NCT02282098|Mitosis Modulators|mitosis modulators|mesh-ancestor
101333686|NCT00040183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101969179|NCT02282098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969180|NCT02282098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101969181|NCT01208935|Nicotine|nicotine|mesh-list
101969182|NCT01208935|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101969183|NCT01208935|Autonomic Agents|autonomic agents|mesh-ancestor
101969184|NCT01208935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101969185|NCT01208935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969186|NCT01208935|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101969187|NCT01208935|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101969188|NCT01208935|Cholinergic Agents|cholinergic agents|mesh-ancestor
101333690|NCT00040261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101969190|NCT01208935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969191|NCT00584974|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101969192|NCT00584974|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101969193|NCT00584974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101969194|NCT00584974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101333700|NCT00040378|Vitamins|vitamins|mesh-list
101969195|NCT00584974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969196|NCT00584974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101969197|NCT00584974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969198|NCT00584974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101333712|NCT00017199|Bortezomib|bortezomib|mesh-list
101969199|NCT00584974|Antidepressive Agents|antidepressive agents|mesh-ancestor
101969200|NCT00584974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101969201|NCT01107067|Testosterone|testosterone|mesh-list
101969202|NCT01107067|Androgens|androgens|mesh-ancestor
101969203|NCT01107067|Hormones|hormones|mesh-ancestor
101969204|NCT01107067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101969205|NCT01107067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969206|NCT02282176|Azithromycin|azithromycin|mesh-list
101969207|NCT02282176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101969208|NCT02282176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101969209|NCT00580216|Biotin|biotin|mesh-list
101969211|NCT00580216|Idraparinux|idraparinux|mesh-list
101969212|NCT00580216|Idrabiotaparinux|idrabiotaparinux|mesh-list
101969213|NCT00580216|Anticoagulants|anticoagulants|mesh-ancestor
101969214|NCT00580216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101969215|NCT00580216|Antithrombins|antithrombins|mesh-ancestor
101969216|NCT00580216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101969217|NCT00580216|Protease Inhibitors|protease inhibitors|mesh-ancestor
101969218|NCT00580216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101969219|NCT00580216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969220|NCT00580216|Vitamin B Complex|vitamin b complex|mesh-ancestor
101969221|NCT00580216|Vitamins|vitamins|mesh-ancestor
101969222|NCT00580216|Micronutrients|micronutrients|mesh-ancestor
101969223|NCT00580216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969224|NCT01107145|Artesunate|artesunate|mesh-list
101969225|NCT01107145|Chloroquine|chloroquine|mesh-list
101969226|NCT01107145|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
101969227|NCT01107145|Lumefantrine|lumefantrine|mesh-list
101969228|NCT01107145|Artemether|artemether|mesh-list
101969229|NCT01107145|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101969230|NCT01107145|Mefloquine|mefloquine|mesh-list
101969231|NCT01107145|Antimalarials|antimalarials|mesh-ancestor
101969232|NCT01107145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101969233|NCT01107145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101969234|NCT01107145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101969235|NCT01107145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101969236|NCT01107145|Antiviral Agents|antiviral agents|mesh-ancestor
101969237|NCT01107145|Schistosomicides|schistosomicides|mesh-ancestor
101969238|NCT01107145|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101969239|NCT01107145|Anthelmintics|anthelmintics|mesh-ancestor
101969240|NCT01107145|Amebicides|amebicides|mesh-ancestor
101969241|NCT01107145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101333731|NCT00040651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101969242|NCT01107145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101969243|NCT01107145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101969245|NCT01107145|Sensory System Agents|sensory system agents|mesh-ancestor
101969246|NCT01107145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101969247|NCT01107145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364741|NCT00405808|Hormones|hormones|mesh-ancestor
101969248|NCT01107145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101969249|NCT01107145|Filaricides|filaricides|mesh-ancestor
101969250|NCT01107145|Antinematodal Agents|antinematodal agents|mesh-ancestor
101969251|NCT03944005|Anesthetics|anesthetics|mesh-list
101969252|NCT03944005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101969253|NCT03944005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969254|NCT01209403|Insulin|insulin|mesh-list
101969255|NCT01209403|Insulin Aspart|insulin aspart|mesh-list
101969256|NCT01209403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101969257|NCT01209403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969258|NCT01112215|Mycophenolic Acid|mycophenolic acid|mesh-list
101969259|NCT01112215|Azathioprine|azathioprine|mesh-list
101969260|NCT01112215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101969261|NCT01112215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101969262|NCT01112215|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101969263|NCT01112215|Antitubercular Agents|antitubercular agents|mesh-ancestor
101969264|NCT01112215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101969265|NCT01112215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101969266|NCT01112215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101971395|NCT04378959|Anesthetics|anesthetics|mesh-ancestor
101971396|NCT04378959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101971397|NCT04378959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971398|NCT04378959|Sensory System Agents|sensory system agents|mesh-ancestor
101971399|NCT04378959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101971400|NCT04378959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101971401|NCT04378959|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101971402|NCT04378959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101971403|NCT04378959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101969267|NCT01112215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969268|NCT01112215|Antimetabolites|antimetabolites|mesh-ancestor
101969269|NCT01112215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101969270|NCT01112215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101969271|NCT01112215|Immunologic Factors|immunologic factors|mesh-ancestor
101969272|NCT01112215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969273|NCT01112215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101969274|NCT01107223|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101969275|NCT01107223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101969276|NCT01107223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101969277|NCT01107223|Antitubercular Agents|antitubercular agents|mesh-ancestor
101969278|NCT02286388|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101969279|NCT02286388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101969280|NCT02286544|Atorvastatin|atorvastatin|mesh-list
101969282|NCT02286544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101969283|NCT02286544|Antimetabolites|antimetabolites|mesh-ancestor
101969284|NCT02286544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969285|NCT02286544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101969286|NCT02286544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101969287|NCT02286544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101969288|NCT01338116|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101969289|NCT01338116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101969290|NCT00384904|Ritonavir|ritonavir|mesh-list
101969291|NCT00384904|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101969292|NCT00384904|Tenofovir|tenofovir|mesh-list
101969293|NCT00384904|Famotidine|famotidine|mesh-list
101333806|NCT00017277|Epoetin Alfa|epoetin alfa|mesh-list
101969294|NCT00384904|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101969295|NCT00384904|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101969297|NCT00384904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101969298|NCT00384904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101969299|NCT00384904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101969300|NCT00384904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101969301|NCT00384904|Antiviral Agents|antiviral agents|mesh-ancestor
101969302|NCT00384904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101969303|NCT00384904|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101969304|NCT00384904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101969305|NCT00384904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101969306|NCT00384904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101969307|NCT00384904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101969308|NCT00384904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101969309|NCT00384904|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101969310|NCT00384904|Histamine Antagonists|histamine antagonists|mesh-ancestor
101969311|NCT00384904|Histamine Agents|histamine agents|mesh-ancestor
101969312|NCT00384904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101969313|NCT00384904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969314|NCT01335386|Glycerol|glycerol|mesh-list
101969315|NCT01335386|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101333820|NCT00041236|Exatecan|exatecan|mesh-list
101969316|NCT01335386|Protective Agents|protective agents|mesh-ancestor
101969317|NCT01335386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101969318|NCT00383578|Metformin|metformin|mesh-list
101969319|NCT00383578|Vildagliptin|vildagliptin|mesh-list
102032869|NCT03648554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101971404|NCT04378959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971405|NCT04340193|Nivolumab|nivolumab|mesh-list
101971406|NCT04340193|Ipilimumab|ipilimumab|mesh-list
101971407|NCT04340193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101971408|NCT04340193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971409|NCT04340193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101971410|NCT04340193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971411|NCT04310930|Azithromycin|azithromycin|mesh-list
101971412|NCT04310930|Moxifloxacin|moxifloxacin|mesh-list
101971413|NCT04310930|Clarithromycin|clarithromycin|mesh-list
101971414|NCT04310930|Doxycycline|doxycycline|mesh-list
101691162|NCT04208516|Anesthetics|anesthetics|mesh-ancestor
101971415|NCT04310930|Linezolid|linezolid|mesh-list
101971416|NCT04310930|Imipenem|imipenem|mesh-list
101971417|NCT04310930|Amikacin|amikacin|mesh-list
101971418|NCT04310930|Ethambutol|ethambutol|mesh-list
101971419|NCT04310930|Rifabutin|rifabutin|mesh-list
101971420|NCT04310930|Tigecycline|tigecycline|mesh-list
101971421|NCT04310930|Bedaquiline|bedaquiline|mesh-list
101971423|NCT04310930|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101971424|NCT04310930|Cefoxitin|cefoxitin|mesh-list
101971425|NCT04310930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101971426|NCT04310930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101971427|NCT04310930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101971428|NCT04310930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102032870|NCT03648554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334364|NCT00043888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102033104|NCT01373463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033105|NCT01373463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101694023|NCT04158102|Bupivacaine|bupivacaine|mesh-list
102033106|NCT01373463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102033107|NCT04573647|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102033108|NCT04573647|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102033110|NCT03113409|Buprenorphine|buprenorphine|mesh-list
102033111|NCT03113409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102033112|NCT03113409|Narcotics|narcotics|mesh-ancestor
102033113|NCT03113409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102033114|NCT03113409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033115|NCT03113409|Analgesics|analgesics|mesh-ancestor
102033116|NCT03113409|Sensory System Agents|sensory system agents|mesh-ancestor
102033117|NCT03113409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102033118|NCT03113409|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102033119|NCT03113409|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102033120|NCT05193747|Anesthetics|anesthetics|mesh-list
102033121|NCT05193747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102033122|NCT05193747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033123|NCT03634293|Alirocumab|alirocumab|mesh-list
102033124|NCT03634293|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102033125|NCT03634293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102033126|NCT03634293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102033127|NCT03634293|Antimetabolites|antimetabolites|mesh-ancestor
102033128|NCT03634293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033519|NCT05200299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033520|NCT05200299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101971429|NCT04310930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101971430|NCT04310930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971431|NCT04310930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971432|NCT04310930|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101971433|NCT04310930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102033521|NCT05200299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033659|NCT03632733|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102033660|NCT03632733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102033661|NCT03632733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102033662|NCT03632733|Hormone Antagonists|hormone antagonists|mesh-ancestor
102033663|NCT03632733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102033664|NCT03632733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033665|NCT03632733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102033666|NCT03632733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102033667|NCT05074485|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102033668|NCT05074485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102033669|NCT03259425|Nivolumab|nivolumab|mesh-list
102033670|NCT03259425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102033734|NCT03477162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033736|NCT03461952|Ipilimumab|ipilimumab|mesh-list
102033737|NCT03461952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102033738|NCT03461952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033739|NCT03461952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102033740|NCT03461952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033741|NCT03619824|Gemcitabine|gemcitabine|mesh-list
102033742|NCT03619824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033743|NCT03619824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102033744|NCT03619824|Antimetabolites|antimetabolites|mesh-ancestor
101335228|NCT00048373|Etanercept|etanercept|mesh-list
102034373|NCT04661137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102034374|NCT04661137|Immunologic Factors|immunologic factors|mesh-ancestor
102034375|NCT04661137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102034376|NCT04661137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102034377|NCT04661137|Growth Substances|growth substances|mesh-ancestor
102034378|NCT04661137|Growth Inhibitors|growth inhibitors|mesh-ancestor
102034379|NCT03274687|Androgens|androgens|mesh-list
102034380|NCT03274687|Hormones|hormones|mesh-ancestor
102034381|NCT03274687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102034382|NCT03274687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034383|NCT02542956|Bupivacaine|bupivacaine|mesh-list
102034384|NCT02542956|Anesthetics, Local|anesthetics, local|mesh-ancestor
102034385|NCT02542956|Anesthetics|anesthetics|mesh-ancestor
102034386|NCT02542956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102034387|NCT02542956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034388|NCT02542956|Sensory System Agents|sensory system agents|mesh-ancestor
102034389|NCT02542956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102034390|NCT03274453|Ketamine|ketamine|mesh-list
102034391|NCT03274453|Analgesics|analgesics|mesh-ancestor
102034392|NCT03274453|Sensory System Agents|sensory system agents|mesh-ancestor
102034393|NCT03274453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102034394|NCT03274453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034395|NCT03274453|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102034396|NCT03274453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102034397|NCT03274453|Anesthetics, General|anesthetics, general|mesh-ancestor
102034398|NCT03274453|Anesthetics|anesthetics|mesh-ancestor
102034399|NCT03274453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102034400|NCT03274453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102034401|NCT03274453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102034402|NCT03274453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102034403|NCT03274453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034404|NCT02313870|Clobetasol|clobetasol|mesh-list
102034405|NCT02313870|Methotrexate|methotrexate|mesh-list
102034406|NCT02313870|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102034407|NCT02313870|Abortifacient Agents|abortifacient agents|mesh-ancestor
102034419|NCT02313870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102034420|NCT02313870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101971434|NCT04310930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101971435|NCT04310930|Antimalarials|antimalarials|mesh-ancestor
101971436|NCT04310930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101971437|NCT04310930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101971438|NCT04310930|Antitubercular Agents|antitubercular agents|mesh-ancestor
101971439|NCT04310930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101971440|NCT04310930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101971441|NCT04310930|Leprostatic Agents|leprostatic agents|mesh-ancestor
101971442|NCT04310930|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101971443|NCT04297995|Carboplatin|carboplatin|mesh-list
101971444|NCT04297995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971445|NCT04224688|Rozanolixizumab|rozanolixizumab|mesh-list
101971446|NCT04224688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101306203|NCT02024308|Cytarabine|cytarabine|mesh-list
102034421|NCT02313870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102034422|NCT02313870|Glucocorticoids|glucocorticoids|mesh-ancestor
102034423|NCT02313870|Hormones|hormones|mesh-ancestor
102034424|NCT02313870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102034425|NCT01942122|Mefenamic Acid|mefenamic acid|mesh-list
102034426|NCT01942122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102034427|NCT01942122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102034428|NCT01942122|Analgesics|analgesics|mesh-ancestor
102034429|NCT01942122|Sensory System Agents|sensory system agents|mesh-ancestor
102034430|NCT01942122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102034431|NCT01942122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034432|NCT01942122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102034433|NCT01942122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102034434|NCT01942122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102034435|NCT01942122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102034436|NCT01942122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034437|NCT04327999|Lubricant Eye Drops|lubricant eye drops|mesh-list
102034438|NCT04327999|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102034439|NCT04327999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102034440|NCT02236806|Ramipril|ramipril|mesh-list
102034441|NCT02236806|Bisoprolol|bisoprolol|mesh-list
102034442|NCT02236806|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102034443|NCT02236806|Protease Inhibitors|protease inhibitors|mesh-ancestor
102034444|NCT02236806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102034445|NCT02236806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034446|NCT02236806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102034447|NCT02236806|Sympatholytics|sympatholytics|mesh-ancestor
102034448|NCT02236806|Autonomic Agents|autonomic agents|mesh-ancestor
102034449|NCT02236806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102034450|NCT02236806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034451|NCT02236806|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102034452|NCT02236806|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102034453|NCT02236806|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102034454|NCT02236806|Adrenergic Agents|adrenergic agents|mesh-ancestor
102034455|NCT02236806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102034456|NCT01578954|Lenalidomide|lenalidomide|mesh-list
102034457|NCT01578954|Immunologic Factors|immunologic factors|mesh-ancestor
102034458|NCT01578954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034459|NCT01578954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102034460|NCT01578954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102034461|NCT01578954|Growth Substances|growth substances|mesh-ancestor
102034462|NCT01578954|Growth Inhibitors|growth inhibitors|mesh-ancestor
102034463|NCT01578954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102034464|NCT00659646|Levofloxacin|levofloxacin|mesh-list
102034465|NCT00659646|Ofloxacin|ofloxacin|mesh-list
102034466|NCT00659646|Gentamicins|gentamicins|mesh-list
102034467|NCT00659646|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102034468|NCT00659646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101971447|NCT04224688|Immunologic Factors|immunologic factors|mesh-ancestor
101971448|NCT04224688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034469|NCT00659646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101335926|NCT00053131|Analgesics|analgesics|mesh-ancestor
102034488|NCT03054870|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102034489|NCT03054870|Anesthetics, General|anesthetics, general|mesh-ancestor
102034491|NCT03054870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102034492|NCT03054870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034493|NCT03414047|Prexasertib|prexasertib|mesh-list
102034494|NCT03414047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102034495|NCT03414047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102034496|NCT03414047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034497|NCT05448677|Bevacizumab|bevacizumab|mesh-list
102034498|NCT05448677|Atezolizumab|atezolizumab|mesh-list
102034499|NCT05448677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102034500|NCT05448677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102034501|NCT05448677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102034502|NCT05448677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102034503|NCT05448677|Growth Substances|growth substances|mesh-ancestor
102034504|NCT05448677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034505|NCT05448677|Growth Inhibitors|growth inhibitors|mesh-ancestor
102034506|NCT05448677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102034507|NCT05448677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034508|NCT05222646|Metoclopramide|metoclopramide|mesh-list
102034509|NCT05222646|Antiemetics|antiemetics|mesh-ancestor
102034510|NCT05222646|Autonomic Agents|autonomic agents|mesh-ancestor
102034511|NCT05222646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102034512|NCT05222646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034513|NCT05222646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102034514|NCT05222646|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102034515|NCT05222646|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102034516|NCT05222646|Dopamine Agents|dopamine agents|mesh-ancestor
102034517|NCT05222646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102034518|NCT05222646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034519|NCT05222334|Bupivacaine|bupivacaine|mesh-list
102034520|NCT05222334|Anesthetics, Local|anesthetics, local|mesh-ancestor
102034521|NCT05222334|Anesthetics|anesthetics|mesh-ancestor
102034522|NCT05222334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102034523|NCT05222334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034532|NCT04434300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102034533|NCT04434300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102034534|NCT04315896|Hydroxychloroquine|hydroxychloroquine|mesh-list
102034535|NCT04315896|Antimalarials|antimalarials|mesh-ancestor
102034536|NCT04315896|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102034537|NCT04315896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102034538|NCT04315896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102034539|NCT04315896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102034540|NCT04315896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034541|NCT04315896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102034542|NCT05178654|Nirmatrelvir|nirmatrelvir|mesh-list
102034543|NCT05178654|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102034544|NCT05178654|Protease Inhibitors|protease inhibitors|mesh-ancestor
102034545|NCT05178654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102034546|NCT05178654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034547|NCT05178654|Antiviral Agents|antiviral agents|mesh-ancestor
102034548|NCT05178654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102034549|NCT04108962|Benralizumab|benralizumab|mesh-list
102034550|NCT04108962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102034551|NCT04108962|Respiratory System Agents|respiratory system agents|mesh-ancestor
102034552|NCT04865796|Lactoferrin|lactoferrin|mesh-list
102034553|NCT04865796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102034554|NCT04811118|Docetaxel|docetaxel|mesh-list
102034555|NCT04811118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102034556|NCT04811118|Tubulin Modulators|tubulin modulators|mesh-ancestor
102034557|NCT04811118|Antimitotic Agents|antimitotic agents|mesh-ancestor
102034558|NCT04811118|Mitosis Modulators|mitosis modulators|mesh-ancestor
102034559|NCT04811118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034560|NCT05221164|Aspirin|aspirin|mesh-list
102034561|NCT05221164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102034562|NCT05221164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102034563|NCT05221164|Analgesics|analgesics|mesh-ancestor
102034564|NCT05221164|Sensory System Agents|sensory system agents|mesh-ancestor
102034565|NCT05221164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101971450|NCT04204122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101971451|NCT04204122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101971452|NCT04204122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102034566|NCT05221164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034567|NCT05221164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102034568|NCT05221164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102034569|NCT05221164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102034570|NCT05221164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102034571|NCT05221164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034572|NCT05221164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102034573|NCT05221164|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102034574|NCT05221164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102034575|NCT05221164|Antipyretics|antipyretics|mesh-ancestor
102034576|NCT03627546|Sofosbuvir|sofosbuvir|mesh-list
102034577|NCT03627546|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102034578|NCT03627546|Velpatasvir|velpatasvir|mesh-list
102034579|NCT03627546|Antiviral Agents|antiviral agents|mesh-ancestor
102034580|NCT03627546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102034581|NCT04620798|Antibodies|antibodies|mesh-list
102034582|NCT04620798|Immunologic Factors|immunologic factors|mesh-ancestor
102034583|NCT04620798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034584|NCT05220228|Prucalopride|prucalopride|mesh-list
102034585|NCT05220228|Laxatives|laxatives|mesh-ancestor
102034586|NCT05220228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102034587|NCT05220228|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
102034588|NCT05220228|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102034589|NCT05220228|Serotonin Agents|serotonin agents|mesh-ancestor
102034590|NCT05220228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102034591|NCT05220228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034592|NCT05220228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034619|NCT03052764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034620|NCT03052764|Cholinergic Agents|cholinergic agents|mesh-ancestor
102034621|NCT03052764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102034622|NCT03052764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034623|NCT03052764|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102034624|NCT03052764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102034625|NCT05197374|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102034626|NCT05197374|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102034627|NCT05197374|Estradiol|estradiol|mesh-list
102034628|NCT05197374|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102034629|NCT05197374|Estrogens|estrogens|mesh-ancestor
102034630|NCT05197374|Hormones|hormones|mesh-ancestor
102034631|NCT05197374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102034632|NCT05197374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034633|NCT05197374|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102034634|NCT05197374|Contraceptive Agents|contraceptive agents|mesh-ancestor
102034635|NCT05197374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102034636|NCT05197374|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102034637|NCT02951819|Dexamethasone|dexamethasone|mesh-list
102034638|NCT02951819|Cyclophosphamide|cyclophosphamide|mesh-list
102034639|NCT02951819|Bortezomib|bortezomib|mesh-list
102034640|NCT02951819|Daratumumab|daratumumab|mesh-list
102034657|NCT02951819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102034658|NCT02951819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102034660|NCT05191290|Calcium heparin|calcium heparin|mesh-list
102034661|NCT05191290|Citric Acid|citric acid|mesh-list
102034662|NCT05191290|Sodium Citrate|sodium citrate|mesh-list
102034663|NCT05191290|Anticoagulants|anticoagulants|mesh-ancestor
102034664|NCT05191290|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102034665|NCT05191290|Chelating Agents|chelating agents|mesh-ancestor
102034666|NCT05191290|Sequestering Agents|sequestering agents|mesh-ancestor
102034667|NCT05191290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034668|NCT05191290|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102034669|NCT05191290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102034670|NCT05627544|Anesthetics|anesthetics|mesh-list
102034671|NCT05627544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102034672|NCT05627544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034673|NCT05189028|Gemcitabine|gemcitabine|mesh-list
102034674|NCT05189028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102034675|NCT05189028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101971453|NCT04204122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101971454|NCT04204122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101971455|NCT04204122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971456|NCT04204122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971457|NCT04200456|Rozanolixizumab|rozanolixizumab|mesh-list
101971458|NCT04200456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101971459|NCT04200456|Immunologic Factors|immunologic factors|mesh-ancestor
101971460|NCT04200456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971461|NCT04196413|Cyclophosphamide|cyclophosphamide|mesh-list
101971462|NCT04196413|Fludarabine|fludarabine|mesh-list
101971463|NCT04196413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101971464|NCT04196413|Immunologic Factors|immunologic factors|mesh-ancestor
101971465|NCT04196413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971466|NCT04196413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101971467|NCT04196413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101971468|NCT04196413|Alkylating Agents|alkylating agents|mesh-ancestor
101971469|NCT04196413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971470|NCT04196413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971471|NCT04196413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101971472|NCT04164732|Valsartan|valsartan|mesh-list
101971473|NCT04164732|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101971474|NCT04164732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101694077|NCT00961753|Analgesics|analgesics|mesh-ancestor
101971475|NCT04164732|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101971476|NCT04164732|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101971477|NCT04164732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971478|NCT04126135|Nicotine|nicotine|mesh-list
101971479|NCT04126135|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101971480|NCT04126135|Autonomic Agents|autonomic agents|mesh-ancestor
102034676|NCT05189028|Antimetabolites|antimetabolites|mesh-ancestor
102034677|NCT05189028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034678|NCT03383783|Listerine|listerine|mesh-list
102034679|NCT03383783|Fluorides|fluorides|mesh-list
102034680|NCT03383783|Sodium Fluoride|sodium fluoride|mesh-list
102034681|NCT03383783|Cariostatic Agents|cariostatic agents|mesh-ancestor
102034682|NCT03383783|Protective Agents|protective agents|mesh-ancestor
102034683|NCT03383783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034684|NCT03383783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102034685|NCT03383783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102034686|NCT03627390|Molybdenum|molybdenum|mesh-list
102034687|NCT03627390|Trace Elements|trace elements|mesh-ancestor
102034688|NCT03627390|Micronutrients|micronutrients|mesh-ancestor
102034689|NCT03627390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034690|NCT03709745|Ranibizumab|ranibizumab|mesh-list
102034691|NCT03709745|Aflibercept|aflibercept|mesh-list
102034692|NCT03709745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101971481|NCT04126135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101971482|NCT04126135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971483|NCT04126135|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101971484|NCT04126135|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101971485|NCT04126135|Cholinergic Agents|cholinergic agents|mesh-ancestor
101971486|NCT04126135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101971487|NCT04126135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971488|NCT04117932|Ustekinumab|ustekinumab|mesh-list
101971489|NCT04117932|Dermatologic Agents|dermatologic agents|mesh-ancestor
101971490|NCT04047628|Alemtuzumab|alemtuzumab|mesh-list
101971491|NCT04047628|Ofatumumab|ofatumumab|mesh-list
101971492|NCT04047628|Cladribine|cladribine|mesh-list
101691231|NCT00681525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101971493|NCT04047628|Ocrelizumab|ocrelizumab|mesh-list
101971494|NCT04047628|Natalizumab|natalizumab|mesh-list
101971495|NCT04047628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101971496|NCT04047628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971498|NCT04047628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971499|NCT04047628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101971500|NCT04033354|Paclitaxel|paclitaxel|mesh-list
101971501|NCT04033354|Carboplatin|carboplatin|mesh-list
101971502|NCT04033354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101971503|NCT04033354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971504|NCT04033354|Tubulin Modulators|tubulin modulators|mesh-ancestor
102034693|NCT03709745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102034694|NCT03709745|Growth Substances|growth substances|mesh-ancestor
102034695|NCT03709745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034696|NCT03709745|Growth Inhibitors|growth inhibitors|mesh-ancestor
102034697|NCT03709745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102034698|NCT05570526|Melatonin|melatonin|mesh-list
102034699|NCT05570526|Antioxidants|antioxidants|mesh-ancestor
101336162|NCT00054808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102034717|NCT03334721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102034718|NCT03334721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102034719|NCT03334721|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102034720|NCT03334721|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102034721|NCT03334721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102034722|NCT03334721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034723|NCT03334721|Antimanic Agents|antimanic agents|mesh-ancestor
102034724|NCT05706402|Acetylcysteine|acetylcysteine|mesh-list
102034725|NCT05706402|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102034726|NCT05706402|Antiviral Agents|antiviral agents|mesh-ancestor
102034727|NCT05706402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102034728|NCT05706402|Expectorants|expectorants|mesh-ancestor
102034729|NCT05706402|Respiratory System Agents|respiratory system agents|mesh-ancestor
102034730|NCT05706402|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102034731|NCT05706402|Antioxidants|antioxidants|mesh-ancestor
102034732|NCT05706402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034733|NCT05706402|Protective Agents|protective agents|mesh-ancestor
102034734|NCT05706402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034735|NCT05706402|Antidotes|antidotes|mesh-ancestor
102034736|NCT05706090|Fentanyl|fentanyl|mesh-list
102034737|NCT05706090|Anesthetics|anesthetics|mesh-ancestor
101971505|NCT04033354|Antimitotic Agents|antimitotic agents|mesh-ancestor
101971506|NCT04033354|Mitosis Modulators|mitosis modulators|mesh-ancestor
101971507|NCT04033354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971508|NCT03953131|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
101971509|NCT03953131|Chelating Agents|chelating agents|mesh-ancestor
101971510|NCT03953131|Sequestering Agents|sequestering agents|mesh-ancestor
102034738|NCT05706090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102034739|NCT05706090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034740|NCT05706090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102034741|NCT05706090|Narcotics|narcotics|mesh-ancestor
102034742|NCT05706090|Analgesics|analgesics|mesh-ancestor
102034743|NCT05706090|Sensory System Agents|sensory system agents|mesh-ancestor
102034744|NCT05706090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102034745|NCT05706090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102034746|NCT05706090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102034747|NCT05706090|Anesthetics, General|anesthetics, general|mesh-ancestor
102034748|NCT03380429|Albuterol|albuterol|mesh-list
102034749|NCT03380429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102034750|NCT03380429|Autonomic Agents|autonomic agents|mesh-ancestor
102034751|NCT03380429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102034752|NCT03380429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034753|NCT03380429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102034754|NCT03380429|Respiratory System Agents|respiratory system agents|mesh-ancestor
102034755|NCT03380429|Tocolytic Agents|tocolytic agents|mesh-ancestor
102034756|NCT03380429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101336231|NCT05527704|Albuterol|albuterol|mesh-list
102034770|NCT05096442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034772|NCT01313143|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102034773|NCT01313143|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102034774|NCT01313143|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102034775|NCT01313143|Adrenergic Agents|adrenergic agents|mesh-ancestor
102034776|NCT01313143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102034777|NCT01313143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034778|NCT01313143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034779|NCT05071794|Propofol|propofol|mesh-list
102034780|NCT05071794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102034781|NCT05071794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102034782|NCT05071794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034783|NCT05071794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102034784|NCT05071794|Anesthetics, General|anesthetics, general|mesh-ancestor
102034785|NCT05071794|Anesthetics|anesthetics|mesh-ancestor
102034786|NCT03280537|Omalizumab|omalizumab|mesh-list
102034787|NCT03280537|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102034788|NCT03280537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102034789|NCT03280537|Respiratory System Agents|respiratory system agents|mesh-ancestor
102034790|NCT05618730|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102034791|NCT05618730|Lubricant Eye Drops|lubricant eye drops|mesh-list
102034792|NCT05618730|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102034793|NCT05029050|Clonidine|clonidine|mesh-list
102034794|NCT05029050|Dexmedetomidine|dexmedetomidine|mesh-list
102034795|NCT05029050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102034796|NCT05029050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102034797|NCT05029050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034798|NCT05029050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102034799|NCT05029050|Analgesics|analgesics|mesh-ancestor
102034800|NCT05029050|Sensory System Agents|sensory system agents|mesh-ancestor
102034801|NCT05029050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102034802|NCT05029050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102034803|NCT05029050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102034804|NCT05029050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102034805|NCT05029050|Adrenergic Agents|adrenergic agents|mesh-ancestor
102034806|NCT05029050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102034807|NCT05029050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034808|NCT05029050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102034809|NCT05029050|Sympatholytics|sympatholytics|mesh-ancestor
102034810|NCT05029050|Autonomic Agents|autonomic agents|mesh-ancestor
102034811|NCT04690231|Etoposide|etoposide|mesh-list
102034812|NCT04690231|Etoposide phosphate|etoposide phosphate|mesh-list
101971511|NCT03953131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971512|NCT03952403|Bevacizumab|bevacizumab|mesh-list
101971513|NCT03952403|Carboplatin|carboplatin|mesh-list
101971514|NCT03952403|Pemetrexed|pemetrexed|mesh-list
101971515|NCT03952403|Antibodies|antibodies|mesh-list
101971516|NCT03952403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101971517|NCT03952403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971518|NCT03952403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101971519|NCT03952403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101971520|NCT03952403|Growth Substances|growth substances|mesh-ancestor
101971521|NCT03952403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971522|NCT03952403|Growth Inhibitors|growth inhibitors|mesh-ancestor
101306280|NCT02024633|Gemcitabine|gemcitabine|mesh-list
102034813|NCT04690231|Apatinib|apatinib|mesh-list
102034814|NCT04690231|Ifosfamide|ifosfamide|mesh-list
102034815|NCT04690231|Isophosphamide mustard|isophosphamide mustard|mesh-list
102034816|NCT04690231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101336280|NCT00055549|Lorazepam|lorazepam|mesh-list
102034838|NCT04234945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102034839|NCT04234945|Antimalarials|antimalarials|mesh-ancestor
102034840|NCT04234945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102034841|NCT04234945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102034842|NCT03316807|Vaccines|vaccines|mesh-list
102034843|NCT03316807|Immunologic Factors|immunologic factors|mesh-ancestor
102034844|NCT03316807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034845|NCT03379259|Tislelizumab|tislelizumab|mesh-list
102034846|NCT03379259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102034847|NCT03379259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102034848|NCT03328897|Omalizumab|omalizumab|mesh-list
102034849|NCT03328897|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102034850|NCT03328897|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102034851|NCT03328897|Respiratory System Agents|respiratory system agents|mesh-ancestor
102034852|NCT04918758|Sucralfate|sucralfate|mesh-list
102034853|NCT04918758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102034854|NCT04918758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102034855|NCT03378635|Glucagon|glucagon|mesh-list
102034856|NCT03378635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102034857|NCT03378635|Hormones|hormones|mesh-ancestor
102034858|NCT03378635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102034859|NCT03378635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034860|NCT01182727|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
102034861|NCT01182727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102034862|NCT01182727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102034863|NCT01182727|Analgesics|analgesics|mesh-ancestor
102034864|NCT01182727|Sensory System Agents|sensory system agents|mesh-ancestor
102034865|NCT01182727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102034866|NCT01182727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034867|NCT01182727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102034868|NCT01182727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102034869|NCT03334409|Vitamins|vitamins|mesh-list
102034894|NCT05230368|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102034896|NCT03046446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102034897|NCT03046446|Glucocorticoids|glucocorticoids|mesh-ancestor
102034898|NCT03046446|Hormones|hormones|mesh-ancestor
102034899|NCT03046446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102034900|NCT03046446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034901|NCT03046446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102034902|NCT03046446|Immunologic Factors|immunologic factors|mesh-ancestor
102034903|NCT03051217|Certolizumab Pegol|certolizumab pegol|mesh-list
102034904|NCT03051217|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102034905|NCT03051217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102034906|NCT03051217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102034907|NCT03051217|Immunologic Factors|immunologic factors|mesh-ancestor
102034908|NCT03051217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971524|NCT03952403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102034909|NCT03051217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102034910|NCT05035303|Epinephrine|epinephrine|mesh-list
102034911|NCT05035303|Norepinephrine|norepinephrine|mesh-list
102034912|NCT05035303|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102034913|NCT05035303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102034914|NCT05035303|Adrenergic Agents|adrenergic agents|mesh-ancestor
102034915|NCT05035303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102034916|NCT05035303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034917|NCT05035303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034918|NCT05035303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102034919|NCT05035303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102034920|NCT05035303|Autonomic Agents|autonomic agents|mesh-ancestor
101336390|NCT00056095|Cyclosporins|cyclosporins|mesh-list
102034935|NCT03262441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102034936|NCT03262441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102034937|NCT03262441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102034938|NCT03262441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034939|NCT04580394|Oxybutynin|oxybutynin|mesh-list
102034940|NCT04580394|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102034941|NCT04580394|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102034942|NCT04580394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102034943|NCT04580394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102034944|NCT04580394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034945|NCT04580394|Adrenergic Agents|adrenergic agents|mesh-ancestor
102034946|NCT04580394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102034947|NCT04580394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034948|NCT04580394|Parasympatholytics|parasympatholytics|mesh-ancestor
102034949|NCT04580394|Autonomic Agents|autonomic agents|mesh-ancestor
102034950|NCT04580394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102034951|NCT04580394|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102034952|NCT04580394|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102034953|NCT04580394|Cholinergic Agents|cholinergic agents|mesh-ancestor
102034954|NCT04580394|Urological Agents|urological agents|mesh-ancestor
102034956|NCT01343082|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102034957|NCT04385173|Temozolomide|temozolomide|mesh-list
102034958|NCT04385173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102034959|NCT04385173|Alkylating Agents|alkylating agents|mesh-ancestor
102034960|NCT04385173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034961|NCT04385173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102034962|NCT03707249|Ferric Compounds|ferric compounds|mesh-list
102034963|NCT03707249|Hematinics|hematinics|mesh-ancestor
102034964|NCT05682911|Simvastatin|simvastatin|mesh-list
102034965|NCT05682911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102034966|NCT05682911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102034967|NCT05682911|Antimetabolites|antimetabolites|mesh-ancestor
101694126|NCT00660036|Analgesics|analgesics|mesh-ancestor
102034968|NCT05682911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034969|NCT05682911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102034970|NCT05682911|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102034971|NCT05682911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102034972|NCT04625088|Atropine|atropine|mesh-list
102034973|NCT04625088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102034974|NCT04625088|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102034975|NCT04625088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102034976|NCT04625088|Autonomic Agents|autonomic agents|mesh-ancestor
102034977|NCT04625088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102034978|NCT04625088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034979|NCT04625088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102034980|NCT04625088|Respiratory System Agents|respiratory system agents|mesh-ancestor
102034981|NCT04625088|Mydriatics|mydriatics|mesh-ancestor
102035013|NCT03259555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035014|NCT03259555|Dopamine Agonists|dopamine agonists|mesh-ancestor
102035015|NCT03259555|Dopamine Agents|dopamine agents|mesh-ancestor
102035016|NCT03257995|Maleic acid|maleic acid|mesh-list
102035017|NCT03257995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102035018|NCT03257995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035019|NCT03049488|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102035020|NCT03049488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102035021|NCT03049488|Immunologic Factors|immunologic factors|mesh-ancestor
102035022|NCT03049488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035023|NCT03049488|Antacids|antacids|mesh-ancestor
102035044|NCT04446390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971525|NCT03952403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971526|NCT03952403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101971527|NCT03952403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101971529|NCT03918278|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101971530|NCT03918278|Carboplatin|carboplatin|mesh-list
101971531|NCT03918278|Gemcitabine|gemcitabine|mesh-list
101971532|NCT03918278|Pembrolizumab|pembrolizumab|mesh-list
101971533|NCT03918278|Pemetrexed|pemetrexed|mesh-list
101971534|NCT03918278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101971535|NCT03918278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102035045|NCT04446390|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102035046|NCT04446390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102035048|NCT02338921|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102035049|NCT02338921|Dapagliflozin|dapagliflozin|mesh-list
102035050|NCT02338921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102035051|NCT02338921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035052|NCT02338921|Incretins|incretins|mesh-ancestor
102035053|NCT02338921|Hormones|hormones|mesh-ancestor
102035054|NCT02338921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102035055|NCT02338921|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102035056|NCT02338921|Protease Inhibitors|protease inhibitors|mesh-ancestor
102035057|NCT02338921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102035058|NCT02338921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035059|NCT02338921|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102035060|NCT01313845|Amantadine|amantadine|mesh-list
102035061|NCT01313845|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102035062|NCT01313845|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102035063|NCT01313845|Antiviral Agents|antiviral agents|mesh-ancestor
102035064|NCT01313845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102035065|NCT01313845|Dopamine Agents|dopamine agents|mesh-ancestor
102035066|NCT01313845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102035067|NCT01313845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035068|NCT01313845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035069|NCT01313845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102035070|NCT01313845|Analgesics|analgesics|mesh-ancestor
102035071|NCT01313845|Sensory System Agents|sensory system agents|mesh-ancestor
102035072|NCT01313845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102035073|NCT04400058|gamma-Globulins|gamma-globulins|mesh-list
102035074|NCT04400058|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102035091|NCT04173247|Dermatologic Agents|dermatologic agents|mesh-ancestor
102035092|NCT03196986|Bevacizumab|bevacizumab|mesh-list
102035093|NCT03196986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102035094|NCT03196986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102035095|NCT03196986|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102035096|NCT03196986|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102035097|NCT03196986|Growth Substances|growth substances|mesh-ancestor
102035098|NCT03196986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035099|NCT03196986|Growth Inhibitors|growth inhibitors|mesh-ancestor
102035100|NCT04051632|Insulin|insulin|mesh-list
102035101|NCT04051632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102035102|NCT04051632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035103|NCT04423237|Deferasirox|deferasirox|mesh-list
102035104|NCT04423237|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102035105|NCT04423237|Chelating Agents|chelating agents|mesh-ancestor
102035106|NCT04423237|Sequestering Agents|sequestering agents|mesh-ancestor
102035107|NCT04423237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035108|NCT03043560|Ezogabine|ezogabine|mesh-list
102035109|NCT03043560|Anticonvulsants|anticonvulsants|mesh-ancestor
102035110|NCT03043560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102035111|NCT03043560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035112|NCT02145403|Tacrolimus|tacrolimus|mesh-list
102035113|NCT02145403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102035114|NCT02145403|Immunologic Factors|immunologic factors|mesh-ancestor
101971536|NCT03918278|Tubulin Modulators|tubulin modulators|mesh-ancestor
101971537|NCT03918278|Antimitotic Agents|antimitotic agents|mesh-ancestor
101971538|NCT03918278|Mitosis Modulators|mitosis modulators|mesh-ancestor
101971539|NCT03918278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035115|NCT02145403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035116|NCT02145403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102035117|NCT02145403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102035118|NCT02145403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035119|NCT02899988|Mirikizumab|mirikizumab|mesh-list
102035120|NCT02899988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102035121|NCT02899988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102035122|NCT02899988|Analgesics|analgesics|mesh-ancestor
102035123|NCT02899988|Sensory System Agents|sensory system agents|mesh-ancestor
102035124|NCT02899988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102035125|NCT02899988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035126|NCT02899988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102035127|NCT02899988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102035128|NCT02899988|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102035129|NCT02899988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102035130|NCT03646526|Amitriptyline|amitriptyline|mesh-list
102035131|NCT03646526|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102035132|NCT03646526|Antidepressive Agents|antidepressive agents|mesh-ancestor
102035133|NCT03646526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102035147|NCT03646370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102035148|NCT03646370|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102035149|NCT03646370|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102035150|NCT03646370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102035151|NCT03646370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035152|NCT03646370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102035153|NCT03646370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102035154|NCT03646292|Pioglitazone|pioglitazone|mesh-list
102035155|NCT03646292|Empagliflozin|empagliflozin|mesh-list
102035156|NCT03646292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102035157|NCT03646292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035158|NCT03646292|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102035159|NCT03646292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035160|NCT03345407|Albuterol|albuterol|mesh-list
102035161|NCT03345407|Nemiralisib|nemiralisib|mesh-list
102035162|NCT03345407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102035163|NCT03345407|Autonomic Agents|autonomic agents|mesh-ancestor
102035164|NCT03345407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102035165|NCT03345407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035166|NCT03345407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102035167|NCT03345407|Respiratory System Agents|respiratory system agents|mesh-ancestor
102035168|NCT03345407|Tocolytic Agents|tocolytic agents|mesh-ancestor
102035169|NCT03345407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102035170|NCT03345407|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102035171|NCT03345407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102035172|NCT03345407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102035173|NCT03345407|Adrenergic Agents|adrenergic agents|mesh-ancestor
102035174|NCT03345407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102035175|NCT03345407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754948|NCT02569320|Antiemetics|antiemetics|mesh-ancestor
102035176|NCT03345407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102035177|NCT03345407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102035178|NCT02537418|Durvalumab|durvalumab|mesh-list
102035179|NCT02537418|Tremelimumab|tremelimumab|mesh-list
102035180|NCT02537418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102035181|NCT02537418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102035182|NCT03626298|Niacinamide|niacinamide|mesh-list
102035183|NCT03626298|Niacin|niacin|mesh-list
102035184|NCT03626298|Nicotinic Acids|nicotinic acids|mesh-list
102035185|NCT03626298|Adapalene|adapalene|mesh-list
102035186|NCT03626298|Vitamin B Complex|vitamin b complex|mesh-ancestor
102035187|NCT03626298|Vitamins|vitamins|mesh-ancestor
102035188|NCT03626298|Micronutrients|micronutrients|mesh-ancestor
102035189|NCT03626298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035190|NCT03626298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102035191|NCT03626298|Antimetabolites|antimetabolites|mesh-ancestor
102035192|NCT03626298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035193|NCT03626298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101971540|NCT03918278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101971542|NCT03918278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101971543|NCT03918278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101971544|NCT03918278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101971545|NCT03918278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101971546|NCT03918278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101971547|NCT03904251|Cytarabine|cytarabine|mesh-list
101971548|NCT03904251|Daunorubicin|daunorubicin|mesh-list
101971549|NCT03904251|Gemtuzumab|gemtuzumab|mesh-list
101971550|NCT03904251|Calicheamicins|calicheamicins|mesh-list
101971551|NCT03904251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101971552|NCT03904251|Antimetabolites|antimetabolites|mesh-ancestor
101971553|NCT03904251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971554|NCT03904251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971555|NCT03904251|Antiviral Agents|antiviral agents|mesh-ancestor
101971556|NCT03904251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101971557|NCT03904251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101971558|NCT03904251|Immunologic Factors|immunologic factors|mesh-ancestor
101971559|NCT03904251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971560|NCT03904251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101336650|NCT00058201|Fluorouracil|fluorouracil|mesh-list
102035217|NCT02298348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102035218|NCT02298348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102035219|NCT02298348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102035220|NCT02298348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102035221|NCT02298348|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102035222|NCT02298348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102035224|NCT03240133|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102035225|NCT03240133|Protease Inhibitors|protease inhibitors|mesh-ancestor
102035226|NCT03240133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102035227|NCT03240133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035228|NCT03814356|Methylphenidate|methylphenidate|mesh-list
102035229|NCT03814356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101694155|NCT00966745|Protective Agents|protective agents|mesh-ancestor
102035230|NCT03814356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035231|NCT03814356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102035232|NCT03814356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102035233|NCT03814356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102035234|NCT03814356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035235|NCT03814356|Dopamine Agents|dopamine agents|mesh-ancestor
102035236|NCT03814356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102035237|NCT03707171|Liraglutide|liraglutide|mesh-list
102035238|NCT03707171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102035239|NCT03707171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035240|NCT03707171|Incretins|incretins|mesh-ancestor
102035241|NCT03707171|Hormones|hormones|mesh-ancestor
102035242|NCT03707171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102035243|NCT02030964|Eflornithine|eflornithine|mesh-list
102035244|NCT02030964|Celecoxib|celecoxib|mesh-list
102035264|NCT02030964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102035265|NCT02030964|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102035266|NCT02030964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102035267|NCT02030964|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101971572|NCT03748784|Aflibercept|aflibercept|mesh-list
102035268|NCT02030964|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102035269|NCT02030964|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102035270|NCT02030964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102035271|NCT02030964|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
102035272|NCT03372083|Deferasirox|deferasirox|mesh-list
102035273|NCT03372083|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102035274|NCT03372083|Chelating Agents|chelating agents|mesh-ancestor
102035275|NCT03372083|Sequestering Agents|sequestering agents|mesh-ancestor
102035276|NCT03372083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035278|NCT03044886|Vitamins|vitamins|mesh-ancestor
102035279|NCT03044886|Micronutrients|micronutrients|mesh-ancestor
102035280|NCT03044886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035281|NCT03044886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102035282|NCT02961764|Dalbavancin|dalbavancin|mesh-list
102035283|NCT02961764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102035284|NCT02961764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102035285|NCT03371459|Albuterol|albuterol|mesh-list
102035286|NCT03371459|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102035287|NCT03371459|Autonomic Agents|autonomic agents|mesh-ancestor
102035288|NCT03371459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102035289|NCT03371459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035290|NCT03371459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102035291|NCT03371459|Respiratory System Agents|respiratory system agents|mesh-ancestor
102035292|NCT03371459|Tocolytic Agents|tocolytic agents|mesh-ancestor
102035293|NCT03371459|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102035294|NCT03371459|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102035295|NCT03371459|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102035296|NCT03371459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102035297|NCT03371459|Adrenergic Agents|adrenergic agents|mesh-ancestor
102035298|NCT03371459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101336763|NCT05223582|Glucocorticoids|glucocorticoids|mesh-ancestor
102035299|NCT03371459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035301|NCT03371381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102035302|NCT03371381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102035303|NCT03371381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102035304|NCT03371381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035305|NCT03044730|Pembrolizumab|pembrolizumab|mesh-list
102035306|NCT03044730|Capecitabine|capecitabine|mesh-list
102035307|NCT03044730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102035308|NCT03044730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102035309|NCT03044730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102035310|NCT03044730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035311|NCT03044730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102035312|NCT03044730|Antimetabolites|antimetabolites|mesh-ancestor
102035313|NCT03738852|Insulin|insulin|mesh-list
102035314|NCT03738852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102035315|NCT03738852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035316|NCT02961374|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102035317|NCT02961374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102035318|NCT02961374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101971573|NCT03748784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101971574|NCT03748784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101971575|NCT03748784|Growth Substances|growth substances|mesh-ancestor
101971576|NCT03748784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971577|NCT03748784|Growth Inhibitors|growth inhibitors|mesh-ancestor
101971578|NCT03748784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971579|NCT03727776|Hormones|hormones|mesh-list
101971580|NCT03727776|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101306333|NCT02024984|Fertility Agents|fertility agents|mesh-ancestor
102035319|NCT02961374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102035320|NCT02961374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035321|NCT04783233|Chitosan|chitosan|mesh-list
102035322|NCT04783233|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
102035323|NCT04783233|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102035324|NCT04783233|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102035325|NCT04783233|Antimetabolites|antimetabolites|mesh-ancestor
102035326|NCT04783233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035327|NCT04783233|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102035328|NCT04783233|Chelating Agents|chelating agents|mesh-ancestor
102035329|NCT04783233|Sequestering Agents|sequestering agents|mesh-ancestor
102035330|NCT04783233|Hemostatics|hemostatics|mesh-ancestor
102035331|NCT04783233|Coagulants|coagulants|mesh-ancestor
102035332|NCT04777539|Natalizumab|natalizumab|mesh-list
102035333|NCT04777539|Immunologic Factors|immunologic factors|mesh-ancestor
102035334|NCT04777539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035335|NCT04664829|Capecitabine|capecitabine|mesh-list
102035336|NCT04664829|Bexarotene|bexarotene|mesh-list
102035337|NCT04664829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102035338|NCT04664829|Antimetabolites|antimetabolites|mesh-ancestor
102035339|NCT04664829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035340|NCT04664829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102035341|NCT02951429|Pirfenidone|pirfenidone|mesh-list
102035342|NCT02951429|Sildenafil Citrate|sildenafil citrate|mesh-list
102035343|NCT02951429|Vasodilator Agents|vasodilator agents|mesh-ancestor
102035344|NCT02951429|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102035345|NCT02951429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102035346|NCT02951429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102035347|NCT02951429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035348|NCT02951429|Urological Agents|urological agents|mesh-ancestor
102035349|NCT02951429|Analgesics|analgesics|mesh-ancestor
102035350|NCT02951429|Sensory System Agents|sensory system agents|mesh-ancestor
102035351|NCT02951429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102035352|NCT02951429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035353|NCT02951429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102035354|NCT02951429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102035355|NCT02951429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102035356|NCT02951429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102035357|NCT02951429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102035358|NCT04622709|Furosemide|furosemide|mesh-list
102035359|NCT04622709|Diuretics|diuretics|mesh-list
102035360|NCT04622709|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
102035361|NCT04622709|Natriuretic Agents|natriuretic agents|mesh-ancestor
102035362|NCT04622709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035363|NCT04622709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102035364|NCT04622709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035365|NCT05214807|Chitosan|chitosan|mesh-list
102035366|NCT05214807|Hylan|hylan|mesh-list
102035367|NCT05214807|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102035368|NCT05214807|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102035369|NCT05214807|Antimetabolites|antimetabolites|mesh-ancestor
101694167|NCT02668796|Estradiol|estradiol|mesh-list
102035370|NCT05214807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035371|NCT05214807|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102035372|NCT05214807|Chelating Agents|chelating agents|mesh-ancestor
102035396|NCT03343067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102035397|NCT03343067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102035398|NCT03343067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101971581|NCT03727776|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
101971582|NCT03727776|beta-Endorphin|beta-endorphin|mesh-list
101971583|NCT03727776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101971584|NCT03727776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971585|NCT03727776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101971586|NCT03727776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971587|NCT03701711|Lenalidomide|lenalidomide|mesh-list
101971588|NCT03701711|Immunologic Factors|immunologic factors|mesh-ancestor
101306341|NCT02025023|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102035399|NCT05205525|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102035400|NCT05205525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102035401|NCT05205525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102035404|NCT04707183|Anesthetics, Local|anesthetics, local|mesh-ancestor
102035405|NCT04707183|Anesthetics|anesthetics|mesh-ancestor
102035406|NCT04707183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102035407|NCT04707183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035408|NCT04707183|Sensory System Agents|sensory system agents|mesh-ancestor
102035409|NCT04707183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102035410|NCT04707183|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102035411|NCT04707183|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102035412|NCT04707183|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102035413|NCT04707183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102035414|NCT04707183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035415|NCT04703205|Ivermectin|ivermectin|mesh-list
102035416|NCT04703205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102035417|NCT04703205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102035418|NCT03706781|Cetylpyridinium|cetylpyridinium|mesh-list
102035419|NCT03706781|Benzydamine|benzydamine|mesh-list
102035420|NCT03706781|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102035421|NCT03706781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102035422|NCT03706781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102035423|NCT03706703|Carboplatin|carboplatin|mesh-list
102035424|NCT03706703|Docetaxel|docetaxel|mesh-list
102035425|NCT03706703|Pemetrexed|pemetrexed|mesh-list
102035426|NCT03706703|Endostar protein|endostar protein|mesh-list
102035474|NCT04608903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035475|NCT04608903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102035476|NCT05681975|Antibodies|antibodies|mesh-list
102035477|NCT05681975|Immunoglobulins|immunoglobulins|mesh-list
102035478|NCT05681975|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102035479|NCT05681975|Immunoglobulin G|immunoglobulin g|mesh-list
102035480|NCT05681975|Immunologic Factors|immunologic factors|mesh-ancestor
102035481|NCT05681975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035482|NCT05216744|Doxycycline|doxycycline|mesh-list
102035483|NCT05216744|Ceftriaxone|ceftriaxone|mesh-list
102035484|NCT05216744|Cefixime|cefixime|mesh-list
102035485|NCT05216744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102035486|NCT05216744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102035487|NCT05216744|Antimalarials|antimalarials|mesh-ancestor
102035488|NCT05216744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102035489|NCT05216744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102035490|NCT05681897|Minoxidil|minoxidil|mesh-list
102035491|NCT05681897|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102035492|NCT05681897|Vasodilator Agents|vasodilator agents|mesh-ancestor
102035493|NCT01345058|Lacosamide|lacosamide|mesh-list
102035494|NCT01345058|Levetiracetam|levetiracetam|mesh-list
102035495|NCT01345058|Anticonvulsants|anticonvulsants|mesh-ancestor
102035496|NCT01345058|Nootropic Agents|nootropic agents|mesh-ancestor
102035497|NCT01345058|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102035498|NCT01345058|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102035499|NCT01345058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102035500|NCT01345058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035501|NCT01345292|Listerine|listerine|mesh-list
102035502|NCT01345292|Fluorides|fluorides|mesh-list
102035503|NCT01345292|Sodium Fluoride|sodium fluoride|mesh-list
102035504|NCT01345292|Cariostatic Agents|cariostatic agents|mesh-ancestor
102035505|NCT01345292|Protective Agents|protective agents|mesh-ancestor
101971589|NCT03701711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971590|NCT03701711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101971591|NCT03701711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101971592|NCT03701711|Growth Substances|growth substances|mesh-ancestor
101971593|NCT03701711|Growth Inhibitors|growth inhibitors|mesh-ancestor
101971594|NCT03701711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971595|NCT03654274|Norethindrone|norethindrone|mesh-list
101971596|NCT03654274|Norethindrone Acetate|norethindrone acetate|mesh-list
101971597|NCT03654274|Estradiol|estradiol|mesh-list
101971598|NCT03654274|Relugolix|relugolix|mesh-list
101971599|NCT03654274|Estrogens|estrogens|mesh-ancestor
101971600|NCT03654274|Hormones|hormones|mesh-ancestor
101971601|NCT03654274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101971602|NCT03654274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971603|NCT03654274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101971604|NCT03654274|Contraceptive Agents|contraceptive agents|mesh-ancestor
101971605|NCT03654274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102035506|NCT01345292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035507|NCT01345292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102035508|NCT01345292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102035509|NCT03340961|Doxycycline|doxycycline|mesh-list
102035510|NCT03340961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102035511|NCT03340961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102035512|NCT03340961|Antimalarials|antimalarials|mesh-ancestor
102035513|NCT03340961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102035514|NCT03340961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102035515|NCT03708341|Melatonin|melatonin|mesh-list
102035516|NCT03708341|Antioxidants|antioxidants|mesh-ancestor
102035517|NCT03708341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035518|NCT03708341|Protective Agents|protective agents|mesh-ancestor
102035519|NCT03708341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035520|NCT03708341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102035521|NCT03643874|Albuterol|albuterol|mesh-list
102035522|NCT03643874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102035523|NCT03643874|Autonomic Agents|autonomic agents|mesh-ancestor
102035524|NCT03643874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102035525|NCT03643874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035556|NCT01068704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035557|NCT01068704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102035559|NCT03339401|Antiviral Agents|antiviral agents|mesh-ancestor
102035560|NCT03339401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102035561|NCT05179525|Risperidone|risperidone|mesh-list
102035562|NCT05179525|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102035563|NCT05179525|Serotonin Agents|serotonin agents|mesh-ancestor
102035564|NCT05179525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102035565|NCT05179525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035566|NCT05179525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035582|NCT01344824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102035583|NCT01344824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102035584|NCT01344824|Growth Substances|growth substances|mesh-ancestor
102035585|NCT01344824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035586|NCT01344824|Growth Inhibitors|growth inhibitors|mesh-ancestor
102035587|NCT01344824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102035588|NCT01344824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035589|NCT01344824|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102035590|NCT01344824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102035591|NCT01344824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101971606|NCT03654274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101971607|NCT03654274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101971608|NCT03654274|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102035592|NCT01311947|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102035593|NCT01311947|Antiviral Agents|antiviral agents|mesh-ancestor
102035594|NCT01311947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102035595|NCT05137496|Methylprednisolone|methylprednisolone|mesh-list
102035596|NCT05137496|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102035597|NCT05137496|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102035599|NCT05137496|Prednisolone acetate|prednisolone acetate|mesh-list
102035600|NCT05137496|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102035601|NCT05137496|Prednisolone phosphate|prednisolone phosphate|mesh-list
102035602|NCT05137496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102035603|NCT05137496|Antiemetics|antiemetics|mesh-ancestor
102035604|NCT05137496|Autonomic Agents|autonomic agents|mesh-ancestor
102035605|NCT05137496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102035606|NCT05137496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035607|NCT05137496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102035608|NCT05137496|Glucocorticoids|glucocorticoids|mesh-ancestor
102035610|NCT05137496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102035611|NCT05137496|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102035612|NCT05137496|Protective Agents|protective agents|mesh-ancestor
102035613|NCT05137496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102035614|NCT05137496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102035615|NCT03339245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102035616|NCT02959892|Amphetamine|amphetamine|mesh-list
102035617|NCT02959892|Naxagolide|naxagolide|mesh-list
102035618|NCT02959892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102035619|NCT02959892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035620|NCT02959892|Sympathomimetics|sympathomimetics|mesh-ancestor
102035621|NCT02959892|Autonomic Agents|autonomic agents|mesh-ancestor
102035622|NCT02959892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102035623|NCT02959892|Dopamine Agents|dopamine agents|mesh-ancestor
102035624|NCT02959892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102035625|NCT02959892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035626|NCT02959892|Adrenergic Agents|adrenergic agents|mesh-ancestor
102035627|NCT02959892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102035643|NCT01661400|Leprostatic Agents|leprostatic agents|mesh-ancestor
102035644|NCT01661400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102035645|NCT01661400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102035646|NCT01661400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102035647|NCT01661400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102035648|NCT01661400|Growth Substances|growth substances|mesh-ancestor
102035649|NCT01661400|Growth Inhibitors|growth inhibitors|mesh-ancestor
102035650|NCT05158166|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102035651|NCT05158166|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102035652|NCT05158166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102035653|NCT05158166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102035654|NCT05158166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035655|NCT05158166|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102035656|NCT05158166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102035657|NCT05158166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035658|NCT05158166|Cholinergic Agents|cholinergic agents|mesh-ancestor
102035659|NCT05158166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102035660|NCT03368807|Insulin Lispro|insulin lispro|mesh-list
102035661|NCT03368807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102035662|NCT03368807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035663|NCT05179213|Azacitidine|azacitidine|mesh-list
102035664|NCT05179213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102035665|NCT05179213|Antimetabolites|antimetabolites|mesh-ancestor
102035666|NCT05179213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035667|NCT05179213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102035668|NCT05179213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102035669|NCT03338855|Dapagliflozin|dapagliflozin|mesh-list
102035670|NCT03338855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102035671|NCT03338855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035672|NCT03338855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102035673|NCT03338855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035674|NCT03367793|Metronidazole|metronidazole|mesh-list
102035675|NCT03367793|Methamphetamine|methamphetamine|mesh-list
101971609|NCT03654274|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101971610|NCT03654274|Androgen Antagonists|androgen antagonists|mesh-ancestor
102035676|NCT03367793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102035677|NCT03367793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035678|NCT03367793|Sympathomimetics|sympathomimetics|mesh-ancestor
102035679|NCT03367793|Autonomic Agents|autonomic agents|mesh-ancestor
102035680|NCT03367793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102035681|NCT03367793|Dopamine Agents|dopamine agents|mesh-ancestor
102035682|NCT03367793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102035683|NCT03367793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035684|NCT03367793|Adrenergic Agents|adrenergic agents|mesh-ancestor
102035685|NCT03367793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101337145|NCT05219825|Psychotropic Drugs|psychotropic drugs|mesh-list
102035722|NCT03995641|Anesthetics, Local|anesthetics, local|mesh-ancestor
102035723|NCT03995641|Anesthetics|anesthetics|mesh-ancestor
102035724|NCT03995641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102035725|NCT03995641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035726|NCT03995641|Sensory System Agents|sensory system agents|mesh-ancestor
102035727|NCT03995641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102035728|NCT03995641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102035729|NCT03995641|Glucocorticoids|glucocorticoids|mesh-ancestor
102035731|NCT03995641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102035732|NCT03995641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102035733|NCT03995641|Immunologic Factors|immunologic factors|mesh-ancestor
102035734|NCT03532555|Zinc|zinc|mesh-list
102035735|NCT03532555|Trace Elements|trace elements|mesh-ancestor
102035736|NCT03532555|Micronutrients|micronutrients|mesh-ancestor
102035737|NCT03532555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035738|NCT03993457|Bupropion|bupropion|mesh-list
102035739|NCT03993457|Escitalopram|escitalopram|mesh-list
102035740|NCT03993457|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102035741|NCT03993457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102035742|NCT03993457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102035743|NCT03993457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035744|NCT03993457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102035745|NCT03993457|Serotonin Agents|serotonin agents|mesh-ancestor
102035746|NCT03993457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035747|NCT03993457|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102035748|NCT03993457|Antidepressive Agents|antidepressive agents|mesh-ancestor
102035749|NCT03993457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102035750|NCT03993457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102035751|NCT03993457|Dopamine Agents|dopamine agents|mesh-ancestor
102035752|NCT03993457|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102035753|NCT03993457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102035754|NCT03993457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102035755|NCT04677439|Flumatinib|flumatinib|mesh-list
102035756|NCT04677439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102035757|NCT04677439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101337214|NCT00062023|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102035812|NCT03707795|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102035813|NCT03707795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102035814|NCT03707795|Glucocorticoids|glucocorticoids|mesh-ancestor
102035815|NCT03707795|Hormones|hormones|mesh-ancestor
102035816|NCT03707795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102035817|NCT03707795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035818|NCT03707795|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102035819|NCT03707795|Respiratory System Agents|respiratory system agents|mesh-ancestor
102035820|NCT03707795|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102035821|NCT03707795|Autonomic Agents|autonomic agents|mesh-ancestor
102035822|NCT03707795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102035823|NCT03042312|177Lu-PSMA-617|177lu-psma-617|mesh-list
102035824|NCT03042312|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102035825|NCT03042312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035826|NCT05171231|Hemostatics|hemostatics|mesh-list
102035827|NCT05171231|Coagulants|coagulants|mesh-ancestor
102035828|NCT05692986|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102035829|NCT05692986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102035830|NCT03360071|Immunomodulating Agents|immunomodulating agents|mesh-list
102035831|NCT03360071|Immunologic Factors|immunologic factors|mesh-list
102035832|NCT03360071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035833|NCT05058924|Aspirin|aspirin|mesh-list
102035834|NCT05058924|Heparin|heparin|mesh-list
101971611|NCT03654274|Hormone Antagonists|hormone antagonists|mesh-ancestor
101971612|NCT03635021|Bevacizumab|bevacizumab|mesh-list
101971613|NCT03635021|Panitumumab|panitumumab|mesh-list
101971614|NCT03635021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101187588|NCT00002676|Antiemetics|antiemetics|mesh-ancestor
102035835|NCT05058924|Calcium heparin|calcium heparin|mesh-list
102035836|NCT05058924|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102035837|NCT05058924|Tinzaparin|tinzaparin|mesh-list
102035838|NCT05058924|Dalteparin|dalteparin|mesh-list
102035839|NCT05058924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102035840|NCT05058924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102035841|NCT05058924|Analgesics|analgesics|mesh-ancestor
102035842|NCT05058924|Sensory System Agents|sensory system agents|mesh-ancestor
102035843|NCT05058924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102035844|NCT05058924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035845|NCT05058924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102035863|NCT05681429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102035865|NCT05681429|Sensory System Agents|sensory system agents|mesh-ancestor
102035866|NCT05681429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102035867|NCT05681429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102035868|NCT05681429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102035869|NCT05681429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102035870|NCT05681429|Adrenergic Agents|adrenergic agents|mesh-ancestor
102035871|NCT05681429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102035872|NCT05681429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035873|NCT05681429|Antipyretics|antipyretics|mesh-ancestor
102035874|NCT05681429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102035875|NCT05681429|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102035876|NCT05681429|Anesthetics, General|anesthetics, general|mesh-ancestor
102035877|NCT05681429|Anesthetics|anesthetics|mesh-ancestor
102035878|NCT05681429|Anesthetics, Local|anesthetics, local|mesh-ancestor
102035879|NCT05681429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101694236|NCT00966901|Autonomic Agents|autonomic agents|mesh-ancestor
102035880|NCT05681429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102035881|NCT05681429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102035882|NCT05681429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102035883|NCT05681429|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102035884|NCT05681429|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102035885|NCT05681429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102035886|NCT05681429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102035887|NCT05681429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102035888|NCT05681429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102035889|NCT05024760|Chlorhexidine|chlorhexidine|mesh-list
102035890|NCT05024760|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102035891|NCT05024760|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102035892|NCT05024760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102035893|NCT05024760|Disinfectants|disinfectants|mesh-ancestor
102035894|NCT02949011|Oseltamivir|oseltamivir|mesh-list
102035895|NCT02949011|Baloxavir|baloxavir|mesh-list
102035896|NCT02949011|Antiviral Agents|antiviral agents|mesh-ancestor
102035897|NCT02949011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102035898|NCT02949011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102035899|NCT02949011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035900|NCT03705533|Telmisartan|telmisartan|mesh-list
102035901|NCT03705533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102035902|NCT03705533|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102035915|NCT03357341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102035916|NCT03357341|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102035917|NCT03357341|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102035918|NCT03357341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102035919|NCT03357341|Adrenergic Agents|adrenergic agents|mesh-ancestor
102035920|NCT03357341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102035921|NCT03357341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035922|NCT05177237|Endostar protein|endostar protein|mesh-list
102035923|NCT05177237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102035924|NCT05177237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101755694|NCT00864838|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102035925|NCT05177237|Growth Substances|growth substances|mesh-ancestor
102035926|NCT05177237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035927|NCT05177237|Growth Inhibitors|growth inhibitors|mesh-ancestor
102035928|NCT05177237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971615|NCT03635021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971616|NCT03635021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102035930|NCT05176925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102035931|NCT05176925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102035932|NCT05175131|Mebeverine|mebeverine|mesh-list
102035933|NCT05175131|Simethicone|simethicone|mesh-list
102035934|NCT05175131|Alverine|alverine|mesh-list
102035935|NCT05175131|Antifoaming Agents|antifoaming agents|mesh-ancestor
102035936|NCT05175131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035937|NCT05175131|Emollients|emollients|mesh-ancestor
102035938|NCT05175131|Dermatologic Agents|dermatologic agents|mesh-ancestor
102035939|NCT05175131|Anticonvulsants|anticonvulsants|mesh-ancestor
102035940|NCT05175131|Parasympatholytics|parasympatholytics|mesh-ancestor
102035941|NCT05175131|Autonomic Agents|autonomic agents|mesh-ancestor
102035942|NCT05175131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102035943|NCT05175131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035944|NCT04507373|Simvastatin|simvastatin|mesh-list
102035945|NCT04507373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102035946|NCT04507373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102035947|NCT04507373|Antimetabolites|antimetabolites|mesh-ancestor
102035948|NCT04507373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035949|NCT04507373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102035950|NCT04507373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102035951|NCT04507373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102035952|NCT01312337|Gefitinib|gefitinib|mesh-list
102035953|NCT01312337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102035954|NCT01312337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102035955|NCT01312337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102035956|NCT01312337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035957|NCT05229653|Ketamine|ketamine|mesh-list
102035958|NCT05229653|Analgesics|analgesics|mesh-ancestor
102035959|NCT05229653|Sensory System Agents|sensory system agents|mesh-ancestor
102035960|NCT05229653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102035961|NCT05229653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035962|NCT05229653|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102035963|NCT05229653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102035964|NCT05229653|Anesthetics, General|anesthetics, general|mesh-ancestor
102035965|NCT05229653|Anesthetics|anesthetics|mesh-ancestor
102035995|NCT05283954|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102035996|NCT05283954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102035997|NCT05283954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102035998|NCT05283954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102035999|NCT05283954|Serotonin Agents|serotonin agents|mesh-ancestor
102036000|NCT05283954|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102036001|NCT05283954|Antidepressive Agents|antidepressive agents|mesh-ancestor
102036002|NCT05283954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102036003|NCT05283954|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102036004|NCT05283954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102036005|NCT05283954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102036006|NCT05283954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102036007|NCT05283954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102036020|NCT01312415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036022|NCT01312415|Sensory System Agents|sensory system agents|mesh-ancestor
102036023|NCT01312415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102036024|NCT01312415|Anesthetics, Local|anesthetics, local|mesh-ancestor
102036025|NCT01312415|Anesthetics|anesthetics|mesh-ancestor
102036026|NCT03036852|Sofosbuvir|sofosbuvir|mesh-list
102036027|NCT03036852|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102036028|NCT03036852|Velpatasvir|velpatasvir|mesh-list
102036029|NCT03036852|Antiviral Agents|antiviral agents|mesh-ancestor
102036030|NCT03036852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102036031|NCT01312493|Panitumumab|panitumumab|mesh-list
102036032|NCT01312493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102036033|NCT01312493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102036034|NCT04313244|Vaccines|vaccines|mesh-list
102036035|NCT04313244|Immunologic Factors|immunologic factors|mesh-ancestor
102036036|NCT04313244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036037|NCT05309694|Copper|copper|mesh-list
102036038|NCT05309694|Contraceptive Agents|contraceptive agents|mesh-list
102036039|NCT05309694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102036040|NCT05309694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036041|NCT05309694|Trace Elements|trace elements|mesh-ancestor
102036042|NCT05309694|Micronutrients|micronutrients|mesh-ancestor
102036043|NCT05268510|Pembrolizumab|pembrolizumab|mesh-list
101971617|NCT03635021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101971618|NCT03635021|Growth Substances|growth substances|mesh-ancestor
101971619|NCT03635021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971620|NCT03635021|Growth Inhibitors|growth inhibitors|mesh-ancestor
101971621|NCT03551964|Ticagrelor|ticagrelor|mesh-list
102036044|NCT05268510|Olaparib|olaparib|mesh-list
102036045|NCT05268510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102036046|NCT05268510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102036047|NCT05268510|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102036048|NCT05268510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036049|NCT05268510|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102036050|NCT05268510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102036051|NCT05438303|Celecoxib|celecoxib|mesh-list
102036052|NCT05438303|Midazolam|midazolam|mesh-list
102036053|NCT05438303|Omeprazole|omeprazole|mesh-list
102036054|NCT05438303|Dabigatran|dabigatran|mesh-list
102036055|NCT05438303|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102036056|NCT05438303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102036057|NCT05438303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102036058|NCT05438303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036059|NCT05438303|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102036060|NCT05438303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102036061|NCT05438303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102036062|NCT05438303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102036063|NCT05438303|Anesthetics, General|anesthetics, general|mesh-ancestor
102036064|NCT05438303|Anesthetics|anesthetics|mesh-ancestor
102036065|NCT05438303|GABA Modulators|gaba modulators|mesh-ancestor
102036066|NCT05438303|GABA Agents|gaba agents|mesh-ancestor
102036067|NCT05438303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102036068|NCT05438303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036069|NCT05438303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102036070|NCT05438303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102036071|NCT05438303|Analgesics|analgesics|mesh-ancestor
102036072|NCT05438303|Sensory System Agents|sensory system agents|mesh-ancestor
102036073|NCT05438303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102036093|NCT04956809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036095|NCT04735913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102036096|NCT04735913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102036097|NCT04735913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102036098|NCT04735913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036099|NCT04735913|Hormone Antagonists|hormone antagonists|mesh-ancestor
102036100|NCT04735913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102036101|NCT04735913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036102|NCT04735913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102036103|NCT04906889|Lidocaine|lidocaine|mesh-list
102036104|NCT04906889|Dexmedetomidine|dexmedetomidine|mesh-list
102036105|NCT04906889|Remifentanil|remifentanil|mesh-list
102036106|NCT04906889|Anesthetics, Local|anesthetics, local|mesh-ancestor
102036107|NCT04906889|Anesthetics|anesthetics|mesh-ancestor
102036108|NCT04906889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102036109|NCT04906889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036110|NCT04906889|Sensory System Agents|sensory system agents|mesh-ancestor
102036111|NCT04906889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102036112|NCT04906889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102036113|NCT04906889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102036114|NCT04906889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102036115|NCT04906889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102036116|NCT04906889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036117|NCT04906889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102036118|NCT04906889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102036119|NCT04906889|Analgesics|analgesics|mesh-ancestor
102036120|NCT04906889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102036121|NCT04906889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102036122|NCT04906889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102036123|NCT04906889|Adrenergic Agents|adrenergic agents|mesh-ancestor
102036124|NCT04906889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102036125|NCT04906889|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102036135|NCT02948777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102036136|NCT02948777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101971622|NCT03551964|Cangrelor|cangrelor|mesh-list
101971623|NCT03551964|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101971624|NCT03551964|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101306383|NCT02025348|Metoprolol|metoprolol|mesh-list
102036137|NCT04868747|Lidocaine|lidocaine|mesh-list
102036138|NCT04868747|Anesthetics, Local|anesthetics, local|mesh-ancestor
102036139|NCT04868747|Anesthetics|anesthetics|mesh-ancestor
102036140|NCT04868747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102036141|NCT04868747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036142|NCT04868747|Sensory System Agents|sensory system agents|mesh-ancestor
102036143|NCT04868747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102036144|NCT04868747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102036145|NCT04868747|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102036146|NCT04868747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102036147|NCT04868747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102036148|NCT04868747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036149|NCT05330273|Efavirenz|efavirenz|mesh-list
101755925|NCT04039126|Iodine|iodine|mesh-list
102036150|NCT05330273|Lumefantrine|lumefantrine|mesh-list
102036151|NCT05330273|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102036152|NCT05330273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102036153|NCT05330273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102036154|NCT05330273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036155|NCT05330273|Antiviral Agents|antiviral agents|mesh-ancestor
102036156|NCT05330273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102036157|NCT05330273|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102036158|NCT05330273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102036159|NCT05330273|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102036160|NCT05330273|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102036161|NCT05330273|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102036162|NCT05330273|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102036163|NCT05330273|Antimalarials|antimalarials|mesh-ancestor
102036164|NCT05330273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102036165|NCT05330273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102036166|NCT05329259|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102036167|NCT05329259|Immunologic Factors|immunologic factors|mesh-ancestor
102036168|NCT05329259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036169|NCT04533737|Brodalumab|brodalumab|mesh-list
102036170|NCT04533737|Dermatologic Agents|dermatologic agents|mesh-ancestor
102036171|NCT05254847|Capecitabine|capecitabine|mesh-list
102036172|NCT05254847|Lenvatinib|lenvatinib|mesh-list
102036173|NCT05254847|Tislelizumab|tislelizumab|mesh-list
102036174|NCT05254847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102036175|NCT05254847|Antimetabolites|antimetabolites|mesh-ancestor
102036176|NCT05254847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036177|NCT05254847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102036178|NCT05254847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102036179|NCT05254847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102036180|NCT05254847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102036181|NCT05249699|Isoniazid|isoniazid|mesh-list
102036182|NCT05249699|Antitubercular Agents|antitubercular agents|mesh-list
102036183|NCT05249699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102036184|NCT05249699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102036185|NCT05249699|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102036186|NCT05249699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102036187|NCT05249699|Antimetabolites|antimetabolites|mesh-ancestor
102036188|NCT05249699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036189|NCT05249699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102036190|NCT04751669|Trace Elements|trace elements|mesh-list
102036207|NCT04731233|Mitosis Modulators|mitosis modulators|mesh-ancestor
102036209|NCT04695977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102036210|NCT04695977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102036211|NCT04695977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102036212|NCT04695977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036213|NCT03093155|Bevacizumab|bevacizumab|mesh-list
102036214|NCT03093155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102036215|NCT03093155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102036216|NCT03093155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102036217|NCT03093155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102036218|NCT03093155|Growth Substances|growth substances|mesh-ancestor
101971625|NCT03551964|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101971626|NCT03551964|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101971627|NCT03551964|Purinergic Agents|purinergic agents|mesh-ancestor
101401162|NCT04092179|Venetoclax|venetoclax|mesh-list
102036219|NCT03093155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036220|NCT03093155|Growth Inhibitors|growth inhibitors|mesh-ancestor
102036221|NCT03324581|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102036222|NCT03324581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101755997|NCT00736866|Antidotes|antidotes|mesh-ancestor
102036223|NCT03324581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102036224|NCT03324581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102036225|NCT03324581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036226|NCT03324581|Adrenergic Agents|adrenergic agents|mesh-ancestor
102036227|NCT03324581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102036228|NCT03324581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036230|NCT03629873|Cyclophosphamide|cyclophosphamide|mesh-list
102036231|NCT03629873|Carmustine|carmustine|mesh-list
102036232|NCT03629873|Etoposide|etoposide|mesh-list
102036233|NCT03629873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102036234|NCT03629873|Immunologic Factors|immunologic factors|mesh-ancestor
102036235|NCT03629873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036236|NCT03629873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102036237|NCT03629873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102036238|NCT03629873|Alkylating Agents|alkylating agents|mesh-ancestor
102036239|NCT03629873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036240|NCT03629873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102036241|NCT03629873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102036242|NCT03629873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102036243|NCT03629873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102036244|NCT03629873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102036245|NCT03629873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102036246|NCT03629873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101337718|NCT00389987|Tazobactam|tazobactam|mesh-list
102036271|NCT02864147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102036272|NCT02864147|Interferon Inducers|interferon inducers|mesh-ancestor
102036273|NCT04258631|Hydromorphone|hydromorphone|mesh-list
102036274|NCT04258631|Bupivacaine|bupivacaine|mesh-list
102036275|NCT04258631|Anesthetics, Local|anesthetics, local|mesh-ancestor
102036276|NCT04258631|Anesthetics|anesthetics|mesh-ancestor
102036277|NCT04258631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102036278|NCT04258631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036279|NCT04258631|Sensory System Agents|sensory system agents|mesh-ancestor
102036280|NCT04258631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102036281|NCT04258631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102036282|NCT04258631|Narcotics|narcotics|mesh-ancestor
102036283|NCT04258631|Analgesics|analgesics|mesh-ancestor
102036284|NCT02931695|Hormones|hormones|mesh-list
102036285|NCT02931695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102036286|NCT02931695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036287|NCT03638063|Adenosine|adenosine|mesh-list
102036288|NCT03638063|Capsaicin|capsaicin|mesh-list
102036289|NCT03638063|Antipruritics|antipruritics|mesh-ancestor
102036290|NCT03638063|Dermatologic Agents|dermatologic agents|mesh-ancestor
102036291|NCT03638063|Sensory System Agents|sensory system agents|mesh-ancestor
102036292|NCT03638063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102036293|NCT03638063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036294|NCT03638063|Analgesics|analgesics|mesh-ancestor
102036295|NCT03638063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102036296|NCT03638063|Vasodilator Agents|vasodilator agents|mesh-ancestor
102036297|NCT03638063|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102036315|NCT04869371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102036316|NCT04869371|Luteolytic Agents|luteolytic agents|mesh-ancestor
102036317|NCT04869371|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102036318|NCT04869371|Contraceptive Agents|contraceptive agents|mesh-ancestor
102036319|NCT04869371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102036320|NCT04869371|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102036321|NCT02710331|Ethanol|ethanol|mesh-list
102036322|NCT02710331|Dronabinol|dronabinol|mesh-list
102036323|NCT02710331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102036324|NCT02710331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102036325|NCT02710331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101971629|NCT03551964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971630|NCT03551964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971631|NCT03533283|Atezolizumab|atezolizumab|mesh-list
101971632|NCT03533283|Obinutuzumab|obinutuzumab|mesh-list
101971633|NCT03533283|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
101971634|NCT03533283|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101971635|NCT03533283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971636|NCT03533283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102036326|NCT02710331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036327|NCT02710331|Hallucinogens|hallucinogens|mesh-ancestor
102036328|NCT02710331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102036329|NCT02710331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102036330|NCT02710331|Analgesics|analgesics|mesh-ancestor
102036331|NCT02710331|Sensory System Agents|sensory system agents|mesh-ancestor
102036332|NCT02710331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102036333|NCT02710331|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102036334|NCT02710331|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102036335|NCT02710331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102036336|NCT02710331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036337|NCT02710331|Hormones|hormones|mesh-ancestor
102036338|NCT02710331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102036339|NCT03320057|Mifepristone|mifepristone|mesh-list
102036340|NCT03320057|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102036341|NCT03320057|Abortifacient Agents|abortifacient agents|mesh-ancestor
102036342|NCT03320057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102036343|NCT03320057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036344|NCT03320057|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102036345|NCT03320057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102036346|NCT03320057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102036347|NCT03320057|Contraceptive Agents|contraceptive agents|mesh-ancestor
102036348|NCT03320057|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102036349|NCT03320057|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102036350|NCT03320057|Hormone Antagonists|hormone antagonists|mesh-ancestor
102036351|NCT03320057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102036352|NCT03320057|Luteolytic Agents|luteolytic agents|mesh-ancestor
102036353|NCT03320057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101337822|NCT00399022|Analgesics|analgesics|mesh-ancestor
102036371|NCT04741139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102036372|NCT04741139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102036373|NCT04741139|Histamine Antagonists|histamine antagonists|mesh-ancestor
102036374|NCT04741139|Histamine Agents|histamine agents|mesh-ancestor
102036375|NCT04741139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102036376|NCT04741139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036377|NCT04741139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102036378|NCT04741139|Antipruritics|antipruritics|mesh-ancestor
102036379|NCT04741139|Dermatologic Agents|dermatologic agents|mesh-ancestor
102036408|NCT04853147|Dexamethasone|dexamethasone|mesh-list
102036409|NCT04853147|Dexamethasone acetate|dexamethasone acetate|mesh-list
102036410|NCT04853147|Palonosetron|palonosetron|mesh-list
102036411|NCT04853147|Fosaprepitant|fosaprepitant|mesh-list
102036412|NCT04853147|Aprepitant|aprepitant|mesh-list
102036413|NCT04853147|BB 1101|bb 1101|mesh-list
102036414|NCT04853147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102036426|NCT04853147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102036427|NCT04853147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036428|NCT04853147|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102036429|NCT04853147|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102036430|NCT04853147|Serotonin Agents|serotonin agents|mesh-ancestor
102036431|NCT04853147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102036432|NCT04853147|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102036433|NCT03473561|Racecadotril|racecadotril|mesh-list
102036434|NCT03473561|Antidiarrheals|antidiarrheals|mesh-ancestor
101971637|NCT03533283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971638|NCT03533283|Immunoconjugates|immunoconjugates|mesh-ancestor
101971639|NCT03533283|Immunologic Factors|immunologic factors|mesh-ancestor
101971640|NCT03533283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971641|NCT03449108|Aldesleukin|aldesleukin|mesh-list
101971642|NCT03449108|Cyclophosphamide|cyclophosphamide|mesh-list
101971643|NCT03449108|Nivolumab|nivolumab|mesh-list
101971644|NCT03449108|Fludarabine|fludarabine|mesh-list
102036435|NCT03473561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102036436|NCT03473561|Protease Inhibitors|protease inhibitors|mesh-ancestor
102036437|NCT03473561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102036438|NCT03473561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036439|NCT04689347|Leucovorin|leucovorin|mesh-list
101756218|NCT00737256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102036440|NCT04689347|Bevacizumab|bevacizumab|mesh-list
102036441|NCT04689347|Fluorouracil|fluorouracil|mesh-list
102036442|NCT04689347|Irinotecan|irinotecan|mesh-list
102036443|NCT04689347|Temozolomide|temozolomide|mesh-list
102036444|NCT04689347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102036445|NCT04689347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102036446|NCT04689347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102036447|NCT04689347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102036448|NCT04689347|Growth Substances|growth substances|mesh-ancestor
102036449|NCT04689347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036450|NCT04689347|Growth Inhibitors|growth inhibitors|mesh-ancestor
102036451|NCT04689347|Antimetabolites|antimetabolites|mesh-ancestor
102036452|NCT04689347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036453|NCT04689347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102036454|NCT04689347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102036455|NCT04689347|Immunologic Factors|immunologic factors|mesh-ancestor
102036456|NCT04689347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102036457|NCT04689347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102036458|NCT04689347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102036460|NCT04689347|Protective Agents|protective agents|mesh-ancestor
102036461|NCT04689347|Vitamin B Complex|vitamin b complex|mesh-ancestor
102036462|NCT04689347|Vitamins|vitamins|mesh-ancestor
102036463|NCT04689347|Micronutrients|micronutrients|mesh-ancestor
102036464|NCT04689347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102036465|NCT04689347|Alkylating Agents|alkylating agents|mesh-ancestor
102036466|NCT03313037|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102036467|NCT03313037|Immunologic Factors|immunologic factors|mesh-ancestor
102036468|NCT03313037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036469|NCT01268579|Ribavirin|ribavirin|mesh-list
102036470|NCT01268579|Antimetabolites|antimetabolites|mesh-ancestor
102036471|NCT01268579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036472|NCT01268579|Antiviral Agents|antiviral agents|mesh-ancestor
102036473|NCT01268579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102036474|NCT02420795|TIC10 compound|tic10 compound|mesh-list
102036475|NCT02420795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102036476|NCT02384759|Aflibercept|aflibercept|mesh-list
102036477|NCT02384759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102036478|NCT02384759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102036495|NCT03332771|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
102036497|NCT03332771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036498|NCT03332771|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102036499|NCT03332771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102036500|NCT03332771|Immunologic Factors|immunologic factors|mesh-ancestor
102036501|NCT03332771|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102036502|NCT03332771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036503|NCT03625830|Paclitaxel|paclitaxel|mesh-list
102036504|NCT03625830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102036505|NCT03625830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102036506|NCT03625830|Tubulin Modulators|tubulin modulators|mesh-ancestor
102036507|NCT03625830|Antimitotic Agents|antimitotic agents|mesh-ancestor
102036508|NCT03625830|Mitosis Modulators|mitosis modulators|mesh-ancestor
102036509|NCT03625830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036510|NCT04108104|Cyproheptadine|cyproheptadine|mesh-list
102036511|NCT04108104|Prazosin|prazosin|mesh-list
101971645|NCT03449108|Ipilimumab|ipilimumab|mesh-list
101971646|NCT03449108|Interleukin-2|interleukin-2|mesh-list
101971647|NCT03449108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101971648|NCT03449108|Immunologic Factors|immunologic factors|mesh-ancestor
101971649|NCT03449108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971650|NCT03449108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101971651|NCT03449108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101971652|NCT03449108|Alkylating Agents|alkylating agents|mesh-ancestor
101971653|NCT03449108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971654|NCT03449108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971655|NCT03449108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101971656|NCT03449108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101971657|NCT03449108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101971658|NCT03449108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101971659|NCT03449108|Analgesics|analgesics|mesh-ancestor
101971660|NCT03449108|Sensory System Agents|sensory system agents|mesh-ancestor
101971661|NCT03449108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101971662|NCT03449108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101971663|NCT03449108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101971664|NCT03449108|Antiviral Agents|antiviral agents|mesh-ancestor
101971665|NCT03449108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101306416|NCT02025465|Metoprolol|metoprolol|mesh-list
102036512|NCT04108104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102036513|NCT04108104|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102036514|NCT04108104|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102036515|NCT04108104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102036516|NCT04108104|Adrenergic Agents|adrenergic agents|mesh-ancestor
102036517|NCT04108104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102036518|NCT04108104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036519|NCT04108104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036520|NCT04108104|Antipruritics|antipruritics|mesh-ancestor
102036521|NCT04108104|Dermatologic Agents|dermatologic agents|mesh-ancestor
102036522|NCT04108104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102036523|NCT04108104|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102036524|NCT04108104|Histamine Antagonists|histamine antagonists|mesh-ancestor
102036525|NCT04108104|Histamine Agents|histamine agents|mesh-ancestor
102036526|NCT04108104|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102036527|NCT04108104|Serotonin Agents|serotonin agents|mesh-ancestor
102036528|NCT04108104|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102036529|NCT05304468|Cisplatin|cisplatin|mesh-list
102036530|NCT05304468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102036531|NCT04731480|Propofol|propofol|mesh-list
102036532|NCT04731480|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102036533|NCT04731480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102036534|NCT04731480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337996|NCT02966587|Durvalumab|durvalumab|mesh-list
102036552|NCT03035916|Anesthetics|anesthetics|mesh-list
102036553|NCT03035916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102036554|NCT03035916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036555|NCT01702571|Trastuzumab|trastuzumab|mesh-list
102036556|NCT01702571|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102036557|NCT01702571|Maytansine|maytansine|mesh-list
102036558|NCT01702571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101971667|NCT03448042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101971668|NCT03448042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102036559|NCT01702571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102036560|NCT01702571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102036561|NCT01702571|Tubulin Modulators|tubulin modulators|mesh-ancestor
102036562|NCT01702571|Antimitotic Agents|antimitotic agents|mesh-ancestor
102036563|NCT01702571|Mitosis Modulators|mitosis modulators|mesh-ancestor
102036564|NCT01702571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036565|NCT01702571|Immunotoxins|immunotoxins|mesh-ancestor
102036566|NCT01702571|Immunoconjugates|immunoconjugates|mesh-ancestor
102036567|NCT01702571|Immunologic Factors|immunologic factors|mesh-ancestor
102036568|NCT01702571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036569|NCT01578239|Octreotide|octreotide|mesh-list
102036570|NCT01578239|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102036571|NCT01578239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102036572|NCT01578239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102036573|NCT01578239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102036574|NCT01578239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102036575|NCT01578239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036576|NCT05274893|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102036577|NCT05274893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102036578|NCT03231709|Alogliptin|alogliptin|mesh-list
102036579|NCT03231709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102036580|NCT03231709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036581|NCT03231709|Incretins|incretins|mesh-ancestor
102036582|NCT03231709|Hormones|hormones|mesh-ancestor
102036583|NCT03231709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102036584|NCT03231709|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102036585|NCT03231709|Protease Inhibitors|protease inhibitors|mesh-ancestor
102036586|NCT03231709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102036587|NCT03231709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036588|NCT01220531|Cyclosporine|cyclosporine|mesh-list
102036589|NCT01220531|Mycophenolic Acid|mycophenolic acid|mesh-list
102036590|NCT01220531|Methylprednisolone|methylprednisolone|mesh-list
102036591|NCT01220531|Prednisolone|prednisolone|mesh-list
102036592|NCT01220531|Tacrolimus|tacrolimus|mesh-list
102036593|NCT01220531|Cyclosporins|cyclosporins|mesh-list
102036594|NCT01220531|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101338049|NCT00070174|Busulfan|busulfan|mesh-list
102036608|NCT01220531|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102036609|NCT01220531|Antitubercular Agents|antitubercular agents|mesh-ancestor
102036610|NCT01220531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102036611|NCT01220531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102036613|NCT01220531|Autonomic Agents|autonomic agents|mesh-ancestor
102036614|NCT01220531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102036615|NCT01220531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102036616|NCT01220531|Glucocorticoids|glucocorticoids|mesh-ancestor
102036617|NCT01220531|Hormones|hormones|mesh-ancestor
102036618|NCT01220531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102036619|NCT01220531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102036620|NCT01220531|Protective Agents|protective agents|mesh-ancestor
102036621|NCT01220531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102036622|NCT05255471|Olaparib|olaparib|mesh-list
102036623|NCT05255471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102036624|NCT05255471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102036625|NCT05255471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036626|NCT05255471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102036627|NCT03241927|Pembrolizumab|pembrolizumab|mesh-list
102036628|NCT03241927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102036629|NCT03241927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102036630|NCT03241927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102036631|NCT03241927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036632|NCT02941523|Carboplatin|carboplatin|mesh-list
102036633|NCT02941523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102036634|NCT03666143|Tislelizumab|tislelizumab|mesh-list
102036635|NCT03666143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102036636|NCT03666143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102036637|NCT00360425|Moxifloxacin|moxifloxacin|mesh-list
102036638|NCT00360425|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102036639|NCT00360425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102036640|NCT00360425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101971669|NCT03417882|Pembrolizumab|pembrolizumab|mesh-list
101971670|NCT03417882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101971671|NCT03417882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971672|NCT03417882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101188201|NCT03745170|Capecitabine|capecitabine|mesh-list
102036641|NCT00360425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102036642|NCT00360425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102036643|NCT00360425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102036644|NCT00360425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036645|NCT00360425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102036646|NCT00360425|Hematinics|hematinics|mesh-ancestor
102036647|NCT00360425|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102036648|NCT00360425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102036649|NCT02938585|Factor VIII|factor viii|mesh-list
102036650|NCT02938585|Coagulants|coagulants|mesh-ancestor
102036651|NCT00233597|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102036652|NCT00233597|Hematinics|hematinics|mesh-ancestor
102036653|NCT00233597|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102036654|NCT00233597|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102036655|NCT04282811|Venetoclax|venetoclax|mesh-list
102036670|NCT03620825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102036671|NCT03620825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036672|NCT03620825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102036673|NCT03620825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102036674|NCT03620825|Gout Suppressants|gout suppressants|mesh-ancestor
102036675|NCT03620825|Tocolytic Agents|tocolytic agents|mesh-ancestor
102036676|NCT03620825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102036677|NCT03620825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102036678|NCT03620825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102036679|NCT03620825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036680|NCT03527537|Insulin|insulin|mesh-list
102036681|NCT03527537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102036682|NCT03527537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036683|NCT01496118|Panobinostat|panobinostat|mesh-list
102036684|NCT01496118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102036685|NCT01496118|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102036686|NCT01496118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102036687|NCT01496118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036688|NCT05014776|Pembrolizumab|pembrolizumab|mesh-list
102036689|NCT05014776|Ipilimumab|ipilimumab|mesh-list
102036690|NCT05014776|Tadalafil|tadalafil|mesh-list
102036691|NCT05014776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102036692|NCT05014776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102036693|NCT05014776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102036694|NCT05014776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036695|NCT05014776|Vasodilator Agents|vasodilator agents|mesh-ancestor
102036696|NCT05014776|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102036697|NCT05014776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102036698|NCT05014776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102036699|NCT05014776|Urological Agents|urological agents|mesh-ancestor
102036700|NCT03329573|Paroxetine|paroxetine|mesh-list
102036701|NCT03329573|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102036702|NCT03329573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102036703|NCT03329573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102036704|NCT03329573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036705|NCT03329573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102036706|NCT03329573|Serotonin Agents|serotonin agents|mesh-ancestor
102036707|NCT03329573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036708|NCT03329573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102036709|NCT03329573|Antidepressive Agents|antidepressive agents|mesh-ancestor
102036710|NCT03329573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102036711|NCT03329573|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102036712|NCT03329573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102036713|NCT03329573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102036714|NCT00492349|Varenicline|varenicline|mesh-list
102036734|NCT04235855|Hematinics|hematinics|mesh-ancestor
102036735|NCT03328325|Vaccines|vaccines|mesh-list
102036736|NCT03328325|Immunologic Factors|immunologic factors|mesh-ancestor
102036737|NCT03328325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036738|NCT03476603|Irbesartan|irbesartan|mesh-list
101971673|NCT03417882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971674|NCT03367741|Nivolumab|nivolumab|mesh-list
101971675|NCT03367741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101306434|NCT02025491|Amphotericin B|amphotericin b|mesh-list
102036739|NCT03476603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102036740|NCT03476603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102036741|NCT03476603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102036742|NCT03476603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036743|NCT03476525|Fluoxetine|fluoxetine|mesh-list
102036744|NCT03476525|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102036745|NCT03476525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102036746|NCT03476525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102036747|NCT03476525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036748|NCT03476525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102036749|NCT03476525|Serotonin Agents|serotonin agents|mesh-ancestor
102036750|NCT03476525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036751|NCT03476525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102036752|NCT03476525|Antidepressive Agents|antidepressive agents|mesh-ancestor
102036753|NCT03476525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102036754|NCT03476525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102036755|NCT03476525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102036756|NCT03476525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102036757|NCT05039489|Antipsychotic Agents|antipsychotic agents|mesh-list
102036758|NCT05039489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102036759|NCT05039489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102036760|NCT05039489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036761|NCT05039489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102036762|NCT03665545|Poly I-C|poly i-c|mesh-list
102036763|NCT03665545|Pembrolizumab|pembrolizumab|mesh-list
102036764|NCT03665545|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102036765|NCT03665545|Poly ICLC|poly iclc|mesh-list
102036766|NCT03665545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102036780|NCT03305081|Contraceptive Agents|contraceptive agents|mesh-ancestor
102036781|NCT03305081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102036782|NCT03305081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036783|NCT03305081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102036784|NCT03305081|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102036785|NCT03305081|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102036786|NCT03305081|Trace Elements|trace elements|mesh-ancestor
102036787|NCT03305081|Micronutrients|micronutrients|mesh-ancestor
102036789|NCT04079881|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102036790|NCT04079881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102036791|NCT04079881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036792|NCT03223909|Hyaluronic Acid|hyaluronic acid|mesh-list
102036793|NCT03223909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102036794|NCT03223909|Immunologic Factors|immunologic factors|mesh-ancestor
102036795|NCT03223909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036796|NCT03223909|Viscosupplements|viscosupplements|mesh-ancestor
102036797|NCT03223909|Protective Agents|protective agents|mesh-ancestor
102036798|NCT03733925|Golimumab|golimumab|mesh-list
102036799|NCT03733925|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102036800|NCT03733925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102036801|NCT03733925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102036802|NCT03733925|Immunologic Factors|immunologic factors|mesh-ancestor
102036803|NCT03733925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036804|NCT03649711|Aspirin|aspirin|mesh-list
102036805|NCT03649711|Clopidogrel|clopidogrel|mesh-list
102036806|NCT03649711|Ticagrelor|ticagrelor|mesh-list
102036807|NCT03649711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102036808|NCT03649711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102036809|NCT03649711|Analgesics|analgesics|mesh-ancestor
102036810|NCT03649711|Sensory System Agents|sensory system agents|mesh-ancestor
102036811|NCT03649711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102036812|NCT03649711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036813|NCT03649711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102036814|NCT03649711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102036815|NCT03649711|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102036816|NCT03649711|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102036817|NCT03649711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971677|NCT03367741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101971678|NCT03367741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971679|NCT03330457|Betrixaban|betrixaban|mesh-list
101971680|NCT03330457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101971681|NCT03330457|Antithrombins|antithrombins|mesh-ancestor
102036818|NCT03649711|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102036819|NCT03649711|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102036820|NCT03649711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102036821|NCT03649711|Antipyretics|antipyretics|mesh-ancestor
102036822|NCT03649711|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102036823|NCT03649711|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102036825|NCT03649711|Purinergic Agents|purinergic agents|mesh-ancestor
102036826|NCT03649711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102036827|NCT03897673|Iron|iron|mesh-list
102036828|NCT03897673|Trace Elements|trace elements|mesh-ancestor
102036829|NCT03897673|Micronutrients|micronutrients|mesh-ancestor
102036830|NCT03897673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036851|NCT03271151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102036852|NCT03271151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036853|NCT03271151|Analgesics|analgesics|mesh-ancestor
102036854|NCT03271151|Sensory System Agents|sensory system agents|mesh-ancestor
102036855|NCT03271151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102036856|NCT03271151|Antidepressive Agents|antidepressive agents|mesh-ancestor
102036857|NCT03271151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102036858|NCT03271151|Dopamine Agents|dopamine agents|mesh-ancestor
102036859|NCT03301649|Ivermectin|ivermectin|mesh-list
102036860|NCT03301649|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102036861|NCT03301649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102036862|NCT01144416|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102036863|NCT01144416|Hormones|hormones|mesh-ancestor
102036864|NCT01144416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102036865|NCT01144416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036866|NCT00335777|Dihydroergotamine|dihydroergotamine|mesh-list
102036867|NCT00335777|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102036868|NCT00335777|Dopamine Agonists|dopamine agonists|mesh-ancestor
102036869|NCT00335777|Dopamine Agents|dopamine agents|mesh-ancestor
102036870|NCT00335777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102036871|NCT00335777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036872|NCT00335777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036873|NCT00335777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102036874|NCT00335777|Analgesics|analgesics|mesh-ancestor
102036875|NCT00335777|Sensory System Agents|sensory system agents|mesh-ancestor
102036876|NCT00335777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102036877|NCT03764137|Panitumumab|panitumumab|mesh-list
102036878|NCT03764137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102036879|NCT03764137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102036880|NCT02889809|Fluticasone|fluticasone|mesh-list
102036881|NCT02889809|Xhance|xhance|mesh-list
102036882|NCT02889809|Montelukast|montelukast|mesh-list
102036883|NCT02889809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102036884|NCT02889809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102036901|NCT03625518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102036902|NCT03625518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036903|NCT00972738|Loratadine|loratadine|mesh-list
102036904|NCT00972738|Montelukast|montelukast|mesh-list
102036905|NCT00972738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102036906|NCT00972738|Respiratory System Agents|respiratory system agents|mesh-ancestor
102036907|NCT00972738|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102036908|NCT00972738|Hormone Antagonists|hormone antagonists|mesh-ancestor
102036909|NCT00972738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102036910|NCT00972738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036911|NCT00972738|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102036912|NCT00972738|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102036913|NCT00972738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036914|NCT00972738|Antipruritics|antipruritics|mesh-ancestor
102036915|NCT00972738|Dermatologic Agents|dermatologic agents|mesh-ancestor
102036916|NCT00972738|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102036917|NCT00972738|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102036918|NCT00972738|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102036919|NCT00972738|Histamine Antagonists|histamine antagonists|mesh-ancestor
102036920|NCT00972738|Histamine Agents|histamine agents|mesh-ancestor
102036921|NCT00972738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102036922|NCT03452839|Meropenem|meropenem|mesh-list
102036923|NCT03452839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102036924|NCT03452839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102036925|NCT04701281|Capecitabine|capecitabine|mesh-list
102036926|NCT04701281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102036927|NCT04701281|Antimetabolites|antimetabolites|mesh-ancestor
102036928|NCT04701281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036929|NCT04701281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102036930|NCT03882918|Gaboxadol|gaboxadol|mesh-list
102036931|NCT03882918|Analgesics|analgesics|mesh-ancestor
102036932|NCT03882918|Sensory System Agents|sensory system agents|mesh-ancestor
102036933|NCT03882918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102036934|NCT03882918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036935|NCT03882918|Anticonvulsants|anticonvulsants|mesh-ancestor
102036936|NCT03882918|GABA Agonists|gaba agonists|mesh-ancestor
102036937|NCT03882918|GABA Agents|gaba agents|mesh-ancestor
102036938|NCT03882918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102036939|NCT03882918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036998|NCT02316834|Talazoparib|talazoparib|mesh-list
102036999|NCT02316834|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102037000|NCT02316834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102037001|NCT02316834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037002|NCT02316834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037003|NCT02879136|Methylphenidate|methylphenidate|mesh-list
102037004|NCT02879136|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102037005|NCT02879136|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102037006|NCT02879136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037007|NCT02879136|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102037008|NCT02879136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102037009|NCT02879136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102037010|NCT02879136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037011|NCT02879136|Dopamine Agents|dopamine agents|mesh-ancestor
102037012|NCT02879136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102037013|NCT02879136|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102037014|NCT02879136|Adrenergic Agents|adrenergic agents|mesh-ancestor
102037015|NCT00250458|Rizatriptan|rizatriptan|mesh-list
102037016|NCT00250458|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101338501|NCT00072670|Trabectedin|trabectedin|mesh-list
102037017|NCT00250458|Serotonin Agents|serotonin agents|mesh-ancestor
102037018|NCT00250458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102037019|NCT00250458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037020|NCT00250458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037022|NCT01965132|Infliximab|infliximab|mesh-list
102037023|NCT01965132|Golimumab|golimumab|mesh-list
102037024|NCT01965132|Etanercept|etanercept|mesh-list
102037025|NCT01965132|Abatacept|abatacept|mesh-list
102037026|NCT01965132|Upadacitinib|upadacitinib|mesh-list
102037027|NCT01965132|Ustekinumab|ustekinumab|mesh-list
102037028|NCT01965132|Ixekizumab|ixekizumab|mesh-list
102037029|NCT01965132|Tofacitinib|tofacitinib|mesh-list
102037030|NCT01965132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102037031|NCT01965132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037032|NCT01965132|Immunologic Factors|immunologic factors|mesh-ancestor
102037033|NCT01965132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037034|NCT01965132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102037035|NCT01965132|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102037036|NCT01965132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102037037|NCT01965132|Dermatologic Agents|dermatologic agents|mesh-ancestor
102037038|NCT01965132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102037039|NCT01965132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102037040|NCT01965132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102037041|NCT01965132|Analgesics|analgesics|mesh-ancestor
101756824|NCT00813735|Dexetimide|dexetimide|mesh-list
102037042|NCT01965132|Sensory System Agents|sensory system agents|mesh-ancestor
102037043|NCT01965132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102037044|NCT01965132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102037045|NCT01965132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102037046|NCT01965132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037047|NCT01965132|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102037048|NCT01965132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101971682|NCT03330457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101971683|NCT03330457|Protease Inhibitors|protease inhibitors|mesh-ancestor
101971684|NCT03330457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102037049|NCT01965132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102037051|NCT01667133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037052|NCT01667133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102037053|NCT01667133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102037054|NCT01667133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037055|NCT01498770|Olanzapine|olanzapine|mesh-list
102037056|NCT01498770|Risperidone|risperidone|mesh-list
102037057|NCT01498770|Aripiprazole|aripiprazole|mesh-list
102037058|NCT01498770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102037059|NCT01498770|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102037060|NCT01498770|Ziprasidone|ziprasidone|mesh-list
102037061|NCT01498770|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102037062|NCT01498770|Clozapine|clozapine|mesh-list
102037063|NCT01498770|Asenapine|asenapine|mesh-list
102037064|NCT01498770|Amisulpride|amisulpride|mesh-list
102037065|NCT01498770|Iloperidone|iloperidone|mesh-list
102037066|NCT01498770|Sertindole|sertindole|mesh-list
102037067|NCT01498770|Zotepine|zotepine|mesh-list
102037068|NCT01498770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102037069|NCT01498770|Serotonin Agents|serotonin agents|mesh-ancestor
102037070|NCT01498770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102037071|NCT01498770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037072|NCT01498770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037073|NCT01498770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102037074|NCT01498770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102037075|NCT01498770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102037076|NCT01498770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102037077|NCT01498770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102037078|NCT01498770|Dopamine Agents|dopamine agents|mesh-ancestor
102037079|NCT01498770|Antiemetics|antiemetics|mesh-ancestor
102037080|NCT01498770|Autonomic Agents|autonomic agents|mesh-ancestor
102037081|NCT01498770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102037082|NCT01498770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102037083|NCT01498770|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102037084|NCT01498770|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102037085|NCT01498770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102037086|NCT01498770|Antidepressive Agents|antidepressive agents|mesh-ancestor
102037087|NCT01498770|Dopamine Agonists|dopamine agonists|mesh-ancestor
102037088|NCT01498770|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102037089|NCT01498770|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102037090|NCT01498770|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102037091|NCT01498770|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102037092|NCT01498770|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101338545|NCT04834349|Pembrolizumab|pembrolizumab|mesh-list
102037103|NCT00140946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102037104|NCT00140946|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102037105|NCT00140946|Hormone Antagonists|hormone antagonists|mesh-ancestor
102037106|NCT00140946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102037107|NCT00140946|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102037108|NCT00140946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102037109|NCT00095004|Rizatriptan|rizatriptan|mesh-list
102037110|NCT00095004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102037111|NCT00095004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037112|NCT00095004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037113|NCT00095004|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102037114|NCT00095004|Serotonin Agents|serotonin agents|mesh-ancestor
102037115|NCT00967746|Etonogestrel|etonogestrel|mesh-list
102037116|NCT00967746|Desogestrel|desogestrel|mesh-list
102037117|NCT00967746|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102037118|NCT00967746|Contraceptive Agents|contraceptive agents|mesh-ancestor
102037119|NCT00967746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102037120|NCT00967746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037121|NCT00967746|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102037122|NCT00967746|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102037123|NCT00967746|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102037124|NCT00967746|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102037125|NCT00967746|Progestins|progestins|mesh-ancestor
102037126|NCT00967746|Hormones|hormones|mesh-ancestor
102037127|NCT00967746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101971685|NCT03330457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971686|NCT03330457|Anticoagulants|anticoagulants|mesh-ancestor
101401883|NCT00127257|Anesthetics|anesthetics|mesh-ancestor
102037128|NCT00092118|Montelukast|montelukast|mesh-list
102037129|NCT00092118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102037130|NCT00092118|Respiratory System Agents|respiratory system agents|mesh-ancestor
102037131|NCT00092118|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102037132|NCT00092118|Hormone Antagonists|hormone antagonists|mesh-ancestor
102037133|NCT00092118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102037134|NCT00092118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037135|NCT00092118|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102037136|NCT00092118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102037137|NCT00092118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037138|NCT00920634|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102037139|NCT00920634|Hormones|hormones|mesh-ancestor
102037140|NCT00920634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102037141|NCT00920634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037142|NCT00092040|Alendronate|alendronate|mesh-list
102037143|NCT00092040|Risedronic Acid|risedronic acid|mesh-list
102037144|NCT00092040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037145|NCT00092040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037146|NCT00092040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102037147|NCT00092040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102037148|NCT00092040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102037149|NCT00092040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102037150|NCT05224128|Imatinib Mesylate|imatinib mesylate|mesh-list
102037151|NCT05224128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037152|NCT05224128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102037160|NCT05416827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037161|NCT05416827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102037162|NCT05416827|Glucocorticoids|glucocorticoids|mesh-ancestor
102037163|NCT05416827|Hormones|hormones|mesh-ancestor
102037164|NCT05416827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102037165|NCT05416827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102037166|NCT05416827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037167|NCT04961619|Trametinib|trametinib|mesh-list
102037168|NCT04961619|Dabrafenib|dabrafenib|mesh-list
102037169|NCT04961619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037170|NCT04961619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102037171|NCT04961619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102037172|NCT04961619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037173|NCT05076513|Niraparib|niraparib|mesh-list
102037174|NCT05076513|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102037175|NCT05076513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102037176|NCT05076513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037177|NCT05076513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037178|NCT04979910|Ixekizumab|ixekizumab|mesh-list
102037179|NCT04979910|Dermatologic Agents|dermatologic agents|mesh-ancestor
102037180|NCT05418465|Dapagliflozin|dapagliflozin|mesh-list
102037181|NCT05418465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102037182|NCT05418465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037183|NCT05418465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102037184|NCT05418465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037185|NCT03261167|Botulinum Toxins|botulinum toxins|mesh-list
102037186|NCT03261167|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102037187|NCT03261167|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102037188|NCT03261167|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102037189|NCT03261167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102037190|NCT03261167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037191|NCT03261167|Cholinergic Agents|cholinergic agents|mesh-ancestor
102037192|NCT03261167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102037193|NCT03261167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037194|NCT03261167|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102037195|NCT03261167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102037196|NCT05391126|Irinotecan|irinotecan|mesh-list
102037197|NCT05391126|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102037198|NCT05391126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102037199|NCT05391126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101971687|NCT03286556|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101971688|NCT03286556|Autoantibodies|autoantibodies|mesh-list
101971689|NCT03286556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101971690|NCT03286556|Immunologic Factors|immunologic factors|mesh-ancestor
101971691|NCT03286556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971692|NCT03264131|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101971693|NCT03264131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101971694|NCT03264131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971695|NCT03264131|Immunotoxins|immunotoxins|mesh-ancestor
101971696|NCT03264131|Immunoconjugates|immunoconjugates|mesh-ancestor
101306452|NCT02025712|Everolimus|everolimus|mesh-list
102037200|NCT05391126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037201|NCT05391126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037202|NCT05418309|Paclitaxel|paclitaxel|mesh-list
102037203|NCT05418309|Tislelizumab|tislelizumab|mesh-list
102037204|NCT05418309|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102037205|NCT05418309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037206|NCT05418309|Tubulin Modulators|tubulin modulators|mesh-ancestor
102037207|NCT05418309|Antimitotic Agents|antimitotic agents|mesh-ancestor
102037208|NCT05418309|Mitosis Modulators|mitosis modulators|mesh-ancestor
102037209|NCT05418309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037210|NCT05418309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102037211|NCT05137548|Tenofovir|tenofovir|mesh-list
102037212|NCT05137548|Antiviral Agents|antiviral agents|mesh-ancestor
102037213|NCT05137548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102037214|NCT05137548|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102037215|NCT05137548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102037216|NCT05137548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102037217|NCT05137548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037218|NCT05137548|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102037227|NCT05044611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037228|NCT05044611|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
102037229|NCT05044611|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102037230|NCT05091294|Anesthetics|anesthetics|mesh-list
102037231|NCT05091294|Anesthetics, Local|anesthetics, local|mesh-list
102037232|NCT05091294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102037233|NCT05091294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037234|NCT05091294|Sensory System Agents|sensory system agents|mesh-ancestor
102037235|NCT05091294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102037236|NCT05320926|Aspirin|aspirin|mesh-list
102037237|NCT05320926|Clopidogrel|clopidogrel|mesh-list
102037238|NCT05320926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102037239|NCT05320926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102037240|NCT05320926|Analgesics|analgesics|mesh-ancestor
102037241|NCT05320926|Sensory System Agents|sensory system agents|mesh-ancestor
102037242|NCT05320926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102037243|NCT05320926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037244|NCT05320926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102037245|NCT05320926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102037246|NCT05320926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102037247|NCT05320926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102037248|NCT05320926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037249|NCT05320926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102037250|NCT05320926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102037251|NCT05320926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102037252|NCT05320926|Antipyretics|antipyretics|mesh-ancestor
102037253|NCT05320926|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102037254|NCT05320926|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102037255|NCT05320926|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102037256|NCT05320926|Purinergic Agents|purinergic agents|mesh-ancestor
102037257|NCT05320926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102037258|NCT05296512|Pembrolizumab|pembrolizumab|mesh-list
102037259|NCT05296512|Lenvatinib|lenvatinib|mesh-list
101757045|NCT00884884|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101971697|NCT03264131|Immunologic Factors|immunologic factors|mesh-ancestor
101971698|NCT03264131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971699|NCT03194893|Crizotinib|crizotinib|mesh-list
101971700|NCT03194893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037260|NCT05296512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102037261|NCT05296512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037262|NCT05296512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102037263|NCT05296512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037264|NCT05296512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102037265|NCT05296512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102037266|NCT05417997|Clarithromycin|clarithromycin|mesh-list
102037267|NCT05417997|Ceftriaxone|ceftriaxone|mesh-list
102037268|NCT05417997|Favipiravir|favipiravir|mesh-list
102037269|NCT05417997|Methylprednisolone|methylprednisolone|mesh-list
102037270|NCT05417997|Enoxaparin|enoxaparin|mesh-list
102037271|NCT05417997|Lansoprazole|lansoprazole|mesh-list
102037272|NCT05417997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102037273|NCT05417997|Antiemetics|antiemetics|mesh-ancestor
102037274|NCT05417997|Autonomic Agents|autonomic agents|mesh-ancestor
102037275|NCT05417997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102037276|NCT05417997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037277|NCT05417997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102037278|NCT05417997|Glucocorticoids|glucocorticoids|mesh-ancestor
102037279|NCT05417997|Hormones|hormones|mesh-ancestor
102037280|NCT05417997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102037281|NCT05417997|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102037282|NCT05417997|Protective Agents|protective agents|mesh-ancestor
102037283|NCT05417997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102037284|NCT05417997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102037288|NCT05417997|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102037289|NCT05417997|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102037291|NCT05417997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102037292|NCT05417997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102037293|NCT05417997|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102037294|NCT05417997|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102037295|NCT05417997|Antiviral Agents|antiviral agents|mesh-ancestor
102037296|NCT03856788|Bupivacaine|bupivacaine|mesh-list
102037297|NCT03856788|Anesthetics, Local|anesthetics, local|mesh-ancestor
102037298|NCT03856788|Anesthetics|anesthetics|mesh-ancestor
102037299|NCT03856788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102037300|NCT03856788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037301|NCT03856788|Sensory System Agents|sensory system agents|mesh-ancestor
102037302|NCT03856788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102037303|NCT03242759|Pirfenidone|pirfenidone|mesh-list
102037304|NCT03242759|Nintedanib|nintedanib|mesh-list
102037305|NCT03242759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037306|NCT03242759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102037307|NCT03242759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102037308|NCT03242759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037309|NCT03242759|Analgesics|analgesics|mesh-ancestor
102037310|NCT03242759|Sensory System Agents|sensory system agents|mesh-ancestor
102037311|NCT03242759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102037312|NCT03242759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037313|NCT03242759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102037314|NCT03242759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102037315|NCT03242759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102037316|NCT03242759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102037317|NCT03625050|Celecoxib|celecoxib|mesh-list
102037318|NCT03625050|Esomeprazole|esomeprazole|mesh-list
102037319|NCT03625050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102037320|NCT03625050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102037321|NCT03625050|Analgesics|analgesics|mesh-ancestor
102037322|NCT03625050|Sensory System Agents|sensory system agents|mesh-ancestor
102037323|NCT03625050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102037324|NCT03625050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037325|NCT03625050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102037326|NCT03625050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102037327|NCT03625050|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102037328|NCT03625050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102037329|NCT03625050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102037330|NCT03625050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971701|NCT03194893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101971702|NCT03194893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101971703|NCT03194893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971704|NCT03154359|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102037331|NCT03625050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102037332|NCT03625050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102037333|NCT03625050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102037334|NCT03257813|Timolol|timolol|mesh-list
102037335|NCT03257813|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102037336|NCT03257813|Dorzolamide|dorzolamide|mesh-list
102037337|NCT03257813|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102037338|NCT03257813|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102037339|NCT03257813|Adrenergic Agents|adrenergic agents|mesh-ancestor
102037340|NCT03257813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102037341|NCT03257813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037342|NCT03257813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037343|NCT03257813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102037344|NCT03257813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102037345|NCT03257813|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102037346|NCT03257813|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102037347|NCT03257813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102037348|NCT03257813|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102037349|NCT03257813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102037350|NCT03210259|Adalimumab|adalimumab|mesh-list
102037351|NCT03210259|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102037352|NCT03210259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102037353|NCT03210259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102037354|NCT04319757|Cyclophosphamide|cyclophosphamide|mesh-list
102037374|NCT02496611|Hormones|hormones|mesh-ancestor
102037375|NCT02496611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102037376|NCT03636295|Warfarin|warfarin|mesh-list
102037377|NCT03636295|Anticoagulants|anticoagulants|mesh-ancestor
102037378|NCT03237481|Bupivacaine|bupivacaine|mesh-list
102037379|NCT03237481|Anesthetics, Local|anesthetics, local|mesh-ancestor
102037380|NCT03237481|Anesthetics|anesthetics|mesh-ancestor
102037381|NCT03237481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102037382|NCT03237481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037383|NCT03237481|Sensory System Agents|sensory system agents|mesh-ancestor
102037384|NCT03237481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102037385|NCT03704220|Warfarin|warfarin|mesh-list
102037386|NCT03704220|Anticoagulants|anticoagulants|mesh-ancestor
102037387|NCT03222349|Diazepam|diazepam|mesh-list
102037388|NCT03222349|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102037389|NCT03222349|Anticonvulsants|anticonvulsants|mesh-ancestor
102037390|NCT03222349|Antiemetics|antiemetics|mesh-ancestor
102037391|NCT03222349|Autonomic Agents|autonomic agents|mesh-ancestor
102037392|NCT03222349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102037393|NCT03222349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037394|NCT03222349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102037395|NCT03222349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102037396|NCT03222349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102037397|NCT03222349|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102037398|NCT03222349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102037399|NCT03222349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102037400|NCT03222349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102037401|NCT03222349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102037402|NCT03222349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102037403|NCT03222349|Anesthetics, General|anesthetics, general|mesh-ancestor
102037404|NCT03222349|Anesthetics|anesthetics|mesh-ancestor
102037405|NCT03222349|GABA Modulators|gaba modulators|mesh-ancestor
102037406|NCT03222349|GABA Agents|gaba agents|mesh-ancestor
102037407|NCT03222349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102037408|NCT03222349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037409|NCT02927925|Daratumumab|daratumumab|mesh-list
102037410|NCT02927925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037411|NCT03208933|Pirfenidone|pirfenidone|mesh-list
102037412|NCT03208933|Analgesics|analgesics|mesh-ancestor
102037413|NCT03208933|Sensory System Agents|sensory system agents|mesh-ancestor
102037427|NCT02499120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037428|NCT01568307|Antidepressive Agents|antidepressive agents|mesh-list
102037429|NCT01568307|Serotonin|serotonin|mesh-list
102037430|NCT01568307|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
101971705|NCT03154359|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101971706|NCT03154359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101971707|NCT03154359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101306464|NCT02025712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102037431|NCT01568307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102037432|NCT01568307|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102037433|NCT01568307|Serotonin Agents|serotonin agents|mesh-ancestor
102037434|NCT01568307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101694426|NCT00645398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037435|NCT01568307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037436|NCT01568307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037437|NCT01568307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102037438|NCT01568307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102037439|NCT02415036|Melphalan|melphalan|mesh-list
102037440|NCT02415036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102037441|NCT02415036|Alkylating Agents|alkylating agents|mesh-ancestor
102037442|NCT02415036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037443|NCT02415036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037444|NCT02415036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102037445|NCT02415036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102037446|NCT02415036|Immunologic Factors|immunologic factors|mesh-ancestor
102037447|NCT02415036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037448|NCT04752267|Clevudine|clevudine|mesh-list
102037449|NCT04752267|Antiviral Agents|antiviral agents|mesh-ancestor
102037450|NCT04752267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102037451|NCT02117700|Acetylcysteine|acetylcysteine|mesh-list
102037452|NCT02117700|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102037453|NCT02117700|Antiviral Agents|antiviral agents|mesh-ancestor
102037454|NCT02117700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102037455|NCT02117700|Expectorants|expectorants|mesh-ancestor
102037456|NCT02117700|Respiratory System Agents|respiratory system agents|mesh-ancestor
102037457|NCT02117700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102037458|NCT02117700|Antioxidants|antioxidants|mesh-ancestor
102037459|NCT02117700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037460|NCT02117700|Protective Agents|protective agents|mesh-ancestor
102037461|NCT02117700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037462|NCT02117700|Antidotes|antidotes|mesh-ancestor
102037463|NCT02932579|Acetaminophen|acetaminophen|mesh-list
102037464|NCT02932579|Ibuprofen|ibuprofen|mesh-list
102037465|NCT02932579|Oxycodone|oxycodone|mesh-list
102037466|NCT02932579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102037467|NCT02932579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102037468|NCT02932579|Analgesics|analgesics|mesh-ancestor
102037469|NCT02932579|Sensory System Agents|sensory system agents|mesh-ancestor
102037470|NCT02932579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102037471|NCT02932579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037472|NCT02932579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102037473|NCT02932579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102037474|NCT02932579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102037499|NCT03207451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102037500|NCT03207451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102037501|NCT03207451|Antipyretics|antipyretics|mesh-ancestor
102037502|NCT03207451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102037503|NCT03207451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102037504|NCT03207451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102037505|NCT03207451|Purinergic Agents|purinergic agents|mesh-ancestor
102037506|NCT03207451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102037507|NCT05089123|Vaccines|vaccines|mesh-list
102037508|NCT05089123|Immunologic Factors|immunologic factors|mesh-ancestor
102037509|NCT05089123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037510|NCT02361125|Methylphenidate|methylphenidate|mesh-list
101694450|NCT00660582|Leucovorin|leucovorin|mesh-list
102037511|NCT02361125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102037512|NCT02361125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037513|NCT02361125|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102037514|NCT02361125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102037515|NCT02361125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102037516|NCT02361125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037517|NCT02361125|Dopamine Agents|dopamine agents|mesh-ancestor
102037518|NCT02361125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102037519|NCT03701256|Atracurium|atracurium|mesh-list
102037520|NCT03701256|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101971708|NCT03154359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971709|NCT03154359|Adrenergic Agents|adrenergic agents|mesh-ancestor
101306467|NCT02025803|Capecitabine|capecitabine|mesh-list
102037521|NCT03701256|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102037522|NCT03701256|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102037523|NCT03701256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102037524|NCT03701256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037525|NCT03701256|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102037541|NCT04780581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102037542|NCT04780581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037543|NCT04780581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102037544|NCT04780581|Glucocorticoids|glucocorticoids|mesh-ancestor
102037545|NCT04780581|Hormones|hormones|mesh-ancestor
102037546|NCT04780581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102037547|NCT04780581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102037548|NCT04780581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037549|NCT04780581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102037550|NCT04780581|Protective Agents|protective agents|mesh-ancestor
102037551|NCT01526135|Gemcitabine|gemcitabine|mesh-list
102037552|NCT01526135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102037553|NCT01526135|Antimetabolites|antimetabolites|mesh-ancestor
102037554|NCT01526135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037555|NCT01526135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037556|NCT05417139|Immunomodulating Agents|immunomodulating agents|mesh-list
102037557|NCT05417139|Immunologic Factors|immunologic factors|mesh-ancestor
102037558|NCT05417139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037559|NCT03701022|Apatinib|apatinib|mesh-list
102037560|NCT03701022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037561|NCT03701022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102037563|NCT03701022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037564|NCT04221165|Analgesics, Opioid|analgesics, opioid|mesh-list
102037565|NCT04221165|Narcotics|narcotics|mesh-ancestor
102037566|NCT04221165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102037567|NCT04221165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037568|NCT04221165|Analgesics|analgesics|mesh-ancestor
102037569|NCT04221165|Sensory System Agents|sensory system agents|mesh-ancestor
102037570|NCT04221165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102037571|NCT03255629|Glucagon|glucagon|mesh-list
102037572|NCT03255629|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102037573|NCT03255629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102037574|NCT03255629|Hormones|hormones|mesh-ancestor
102037575|NCT03255629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102037576|NCT03255629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037577|NCT03255629|Incretins|incretins|mesh-ancestor
102037578|NCT01143779|Telbivudine|telbivudine|mesh-list
102037579|NCT01143779|Antiviral Agents|antiviral agents|mesh-ancestor
102037580|NCT01143779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102037581|NCT01143779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102037582|NCT01143779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102037583|NCT01143779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037584|NCT03703596|Docetaxel|docetaxel|mesh-list
102037585|NCT03703596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037586|NCT03703596|Tubulin Modulators|tubulin modulators|mesh-ancestor
102037607|NCT04614909|Pamiparib|pamiparib|mesh-list
102037608|NCT04614909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102037609|NCT04614909|Alkylating Agents|alkylating agents|mesh-ancestor
102037610|NCT04614909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037611|NCT04614909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037612|NCT04614909|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102037613|NCT04614909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102037614|NCT04613271|Azithromycin|azithromycin|mesh-list
102037615|NCT04613271|Favipiravir|favipiravir|mesh-list
102037616|NCT04613271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102037617|NCT04613271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102037618|NCT04613271|Antiviral Agents|antiviral agents|mesh-ancestor
102037619|NCT03094611|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
102037620|NCT03094611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102037621|NCT03094611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037622|NCT03094611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102037623|NCT03094611|Immunotoxins|immunotoxins|mesh-ancestor
102037624|NCT03094611|Immunoconjugates|immunoconjugates|mesh-ancestor
101306468|NCT02025803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101971710|NCT03154359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101971711|NCT03154359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971712|NCT03152318|Cyclophosphamide|cyclophosphamide|mesh-list
101971713|NCT03152318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101971714|NCT03152318|Immunologic Factors|immunologic factors|mesh-ancestor
101971715|NCT03152318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971716|NCT03152318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101971717|NCT03152318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102037625|NCT03094611|Immunologic Factors|immunologic factors|mesh-ancestor
102037626|NCT03094611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037627|NCT03631953|Trametinib|trametinib|mesh-list
102037628|NCT03631953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037629|NCT03631953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102037630|NCT03631953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102037631|NCT03631953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037632|NCT01030575|Inositol|inositol|mesh-list
101757453|NCT01038505|Sirolimus|sirolimus|mesh-list
102037633|NCT01030575|Vitamin B Complex|vitamin b complex|mesh-ancestor
102037634|NCT01030575|Vitamins|vitamins|mesh-ancestor
102037635|NCT01030575|Micronutrients|micronutrients|mesh-ancestor
102037636|NCT01030575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037637|NCT04215471|Antibodies|antibodies|mesh-list
102037638|NCT04215471|Immunoglobulins|immunoglobulins|mesh-list
102037639|NCT04215471|Immunologic Factors|immunologic factors|mesh-ancestor
102037640|NCT04215471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037641|NCT04066023|Zolmitriptan|zolmitriptan|mesh-list
102037642|NCT04066023|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102037653|NCT02932267|Adapalene|adapalene|mesh-list
102037654|NCT02932267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102037655|NCT02932267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102037656|NCT02932267|Analgesics|analgesics|mesh-ancestor
102037657|NCT02932267|Sensory System Agents|sensory system agents|mesh-ancestor
102037658|NCT02932267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102037659|NCT02932267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037660|NCT02932267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102037661|NCT02932267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102037662|NCT02932267|Dermatologic Agents|dermatologic agents|mesh-ancestor
102037663|NCT03217591|Praliciguat|praliciguat|mesh-list
102037664|NCT03217591|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102037665|NCT03217591|Enzyme Activators|enzyme activators|mesh-ancestor
102037666|NCT03217591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037667|NCT03217591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102037668|NCT03697824|Cyclophosphamide|cyclophosphamide|mesh-list
102037669|NCT03697824|Pembrolizumab|pembrolizumab|mesh-list
102037670|NCT03697824|Fludarabine|fludarabine|mesh-list
102037671|NCT03697824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102037672|NCT03697824|Immunologic Factors|immunologic factors|mesh-ancestor
102037673|NCT03697824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037674|NCT03697824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102037675|NCT03697824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102037676|NCT03697824|Alkylating Agents|alkylating agents|mesh-ancestor
102037677|NCT03697824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037678|NCT03697824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037679|NCT03697824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102037680|NCT03697824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102037681|NCT03697824|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102037682|NCT03702894|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102037683|NCT03702894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102037684|NCT03702894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102037685|NCT03702894|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102037686|NCT03702894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102037687|NCT03702894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037688|NCT03697746|Acetaminophen|acetaminophen|mesh-list
102037689|NCT03697746|Ibuprofen|ibuprofen|mesh-list
102037690|NCT03697746|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
101971718|NCT03152318|Alkylating Agents|alkylating agents|mesh-ancestor
101694535|NCT00657384|Hemostatics|hemostatics|mesh-ancestor
101971719|NCT03152318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306477|NCT02025855|Analgesics|analgesics|mesh-ancestor
102037691|NCT03697746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102037692|NCT03697746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102037693|NCT03697746|Analgesics|analgesics|mesh-ancestor
102037694|NCT03697746|Sensory System Agents|sensory system agents|mesh-ancestor
102037695|NCT03697746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102037696|NCT03697746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037697|NCT03697746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102037698|NCT03697746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102037699|NCT03697746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102037700|NCT03697746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102037701|NCT03697746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037702|NCT03697746|Antipyretics|antipyretics|mesh-ancestor
102037703|NCT03697668|Piperaquine|piperaquine|mesh-list
102037704|NCT03697668|Artenimol|artenimol|mesh-list
102037716|NCT03702738|Antiviral Agents|antiviral agents|mesh-ancestor
102037717|NCT03702738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102037718|NCT03702738|Expectorants|expectorants|mesh-ancestor
102037719|NCT03702738|Respiratory System Agents|respiratory system agents|mesh-ancestor
102037720|NCT03702738|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102037721|NCT03702738|Antioxidants|antioxidants|mesh-ancestor
102037722|NCT03702738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037723|NCT03702738|Protective Agents|protective agents|mesh-ancestor
102037724|NCT03702738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037725|NCT03702738|Antidotes|antidotes|mesh-ancestor
102037726|NCT03702582|Warfarin|warfarin|mesh-list
102037727|NCT03702582|Rivaroxaban|rivaroxaban|mesh-list
102037728|NCT03702582|Anticoagulants|anticoagulants|mesh-ancestor
102037729|NCT03702582|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102037730|NCT03702582|Antithrombins|antithrombins|mesh-ancestor
102037731|NCT03702582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102037732|NCT03702582|Protease Inhibitors|protease inhibitors|mesh-ancestor
102037733|NCT03702582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102037734|NCT03702582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037735|NCT03697044|Irinotecan|irinotecan|mesh-list
102037736|NCT03697044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102037737|NCT03697044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102037738|NCT03697044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102037739|NCT03697044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037740|NCT03697044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037741|NCT03699774|Firuglipel|firuglipel|mesh-list
102037742|NCT03699774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102037743|NCT03699774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102037744|NCT03699774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102037745|NCT03699774|Antimetabolites|antimetabolites|mesh-ancestor
102037746|NCT03699774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037747|NCT03699774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102037748|NCT03699774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102037749|NCT03699774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102037750|NCT03699774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102037751|NCT03699774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037752|NCT03699696|Propofol|propofol|mesh-list
102037753|NCT03699696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102037754|NCT03699696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102037755|NCT03699696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037756|NCT03699696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102037757|NCT03699696|Anesthetics, General|anesthetics, general|mesh-ancestor
102037758|NCT03699696|Anesthetics|anesthetics|mesh-ancestor
102037759|NCT03702426|Norfloxacin|norfloxacin|mesh-list
102037760|NCT03702426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102037761|NCT03702426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102037762|NCT03702426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102037763|NCT03702426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102037764|NCT03702426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101694542|NCT00646880|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102037765|NCT03702426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037766|NCT03702426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037767|NCT03702426|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102037768|NCT03702426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102037785|NCT05378763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971720|NCT03152318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971721|NCT03152318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101971722|NCT03115424|Liraglutide|liraglutide|mesh-list
101971723|NCT03115424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101971724|NCT03115424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971725|NCT03115424|Incretins|incretins|mesh-ancestor
102037787|NCT02937571|Lenalidomide|lenalidomide|mesh-list
102037788|NCT02937571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102037789|NCT02937571|Antiemetics|antiemetics|mesh-ancestor
102037790|NCT02937571|Autonomic Agents|autonomic agents|mesh-ancestor
102037791|NCT02937571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102037792|NCT02937571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037793|NCT02937571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102037794|NCT02937571|Glucocorticoids|glucocorticoids|mesh-ancestor
102037795|NCT02937571|Hormones|hormones|mesh-ancestor
102037796|NCT02937571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102037797|NCT02937571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102037798|NCT02937571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037799|NCT02937571|Immunologic Factors|immunologic factors|mesh-ancestor
102037800|NCT02937571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102037801|NCT02937571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102037802|NCT02937571|Growth Substances|growth substances|mesh-ancestor
102037803|NCT02937571|Growth Inhibitors|growth inhibitors|mesh-ancestor
102037804|NCT03201211|Vaccines|vaccines|mesh-list
102037805|NCT03201211|Immunologic Factors|immunologic factors|mesh-ancestor
102037806|NCT03201211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037807|NCT04472949|Carboplatin|carboplatin|mesh-list
102037808|NCT04472949|Etoposide|etoposide|mesh-list
102037809|NCT04472949|Durvalumab|durvalumab|mesh-list
102037810|NCT04472949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037811|NCT04472949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102037812|NCT04472949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102037813|NCT04472949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102037814|NCT04472949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102037815|NCT04472949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037816|NCT04472949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102037817|NCT03696186|Phenobarbital|phenobarbital|mesh-list
102037818|NCT03696186|Anticonvulsants|anticonvulsants|mesh-ancestor
102037819|NCT03696186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102037820|NCT03696186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102037821|NCT03696186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037822|NCT03696186|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102037823|NCT03696186|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102037824|NCT03696186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102037825|NCT03696186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037826|NCT03696186|GABA Modulators|gaba modulators|mesh-ancestor
102037838|NCT03698916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102037839|NCT03698916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102037840|NCT03698916|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102037841|NCT03698916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102037842|NCT03698916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102037843|NCT03698916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037844|NCT03336333|Rituximab|rituximab|mesh-list
102037845|NCT03336333|Venetoclax|venetoclax|mesh-list
102037846|NCT03336333|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102037847|NCT03336333|Zanubrutinib|zanubrutinib|mesh-list
102037848|NCT03336333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102037849|NCT03336333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037850|NCT03336333|Immunologic Factors|immunologic factors|mesh-ancestor
102037851|NCT03336333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037852|NCT03336333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102037853|NCT03336333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102037854|NCT03336333|Alkylating Agents|alkylating agents|mesh-ancestor
102037855|NCT03336333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037856|NCT03336333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101757640|NCT00818415|Analgesics|analgesics|mesh-ancestor
102037857|NCT03336333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102037858|NCT03695952|Pembrolizumab|pembrolizumab|mesh-list
102037860|NCT03695952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101971726|NCT03115424|Hormones|hormones|mesh-ancestor
101971727|NCT03115424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101971728|NCT03083704|Enoxaparin|enoxaparin|mesh-list
101971729|NCT03083704|Rivaroxaban|rivaroxaban|mesh-list
101971730|NCT03083704|Apixaban|apixaban|mesh-list
102037861|NCT03695952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102037862|NCT03695952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037863|NCT03695952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037864|NCT03695640|Magnesium Sulfate|magnesium sulfate|mesh-list
102037865|NCT03695640|Analgesics|analgesics|mesh-ancestor
102037866|NCT03695640|Sensory System Agents|sensory system agents|mesh-ancestor
102037867|NCT03695640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102037868|NCT03695640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037869|NCT03695640|Anesthetics|anesthetics|mesh-ancestor
102037870|NCT03695640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102037871|NCT03695640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102037872|NCT03695640|Anticonvulsants|anticonvulsants|mesh-ancestor
102037873|NCT03695640|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102037874|NCT03695640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102037875|NCT03695640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037876|NCT03695640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102037877|NCT03695640|Tocolytic Agents|tocolytic agents|mesh-ancestor
102037878|NCT03695640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102037879|NCT03698682|Levofloxacin|levofloxacin|mesh-list
102037880|NCT03698682|Ofloxacin|ofloxacin|mesh-list
102037881|NCT03698682|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102037882|NCT03698682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102037883|NCT03698682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102037884|NCT03698682|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102037885|NCT03698682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102037886|NCT03698682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102037887|NCT03698682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037888|NCT03698682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037900|NCT05598567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102037901|NCT05598567|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102037902|NCT05598567|Anesthetics, General|anesthetics, general|mesh-ancestor
102037903|NCT03701880|Bisoprolol|bisoprolol|mesh-list
102037904|NCT03701880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102037905|NCT03701880|Sympatholytics|sympatholytics|mesh-ancestor
102037906|NCT03701880|Autonomic Agents|autonomic agents|mesh-ancestor
102037907|NCT03701880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102037908|NCT03701880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037909|NCT03701880|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102037910|NCT03701880|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102037911|NCT03701880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102037912|NCT03701880|Adrenergic Agents|adrenergic agents|mesh-ancestor
102037913|NCT03701880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102037914|NCT03701880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037915|NCT03692754|Calcium, Dietary|calcium, dietary|mesh-list
102037916|NCT03692754|Dexamethasone|dexamethasone|mesh-list
102037917|NCT03692754|Atorvastatin|atorvastatin|mesh-list
102037918|NCT03692754|Calcium|calcium|mesh-list
102037919|NCT03692754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102037920|NCT03692754|Antiemetics|antiemetics|mesh-ancestor
102037921|NCT03692754|Autonomic Agents|autonomic agents|mesh-ancestor
102037922|NCT03692754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102037923|NCT03692754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037924|NCT03692754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102037925|NCT03692754|Glucocorticoids|glucocorticoids|mesh-ancestor
102037926|NCT03692754|Hormones|hormones|mesh-ancestor
102037927|NCT03692754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102037928|NCT03692754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102037929|NCT03692754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037930|NCT03692754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102037931|NCT03692754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102037932|NCT03692754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102037933|NCT03692754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102037934|NCT03692754|Antimetabolites|antimetabolites|mesh-ancestor
102037935|NCT03692754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971732|NCT03083704|Enoxaparin sodium|enoxaparin sodium|mesh-list
101971733|NCT03083704|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101971734|NCT03083704|Antithrombins|antithrombins|mesh-ancestor
101971735|NCT03083704|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101971736|NCT03083704|Protease Inhibitors|protease inhibitors|mesh-ancestor
101971737|NCT03083704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101971738|NCT03083704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971739|NCT03083704|Anticoagulants|anticoagulants|mesh-ancestor
102037936|NCT03692754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102037937|NCT03692754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102037938|NCT03692754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102037939|NCT04224558|Acetaminophen|acetaminophen|mesh-list
102037940|NCT04224558|Diphenhydramine|diphenhydramine|mesh-list
102037941|NCT04224558|Promethazine|promethazine|mesh-list
102037942|NCT04224558|Methylprednisolone|methylprednisolone|mesh-list
102037943|NCT04224558|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102037944|NCT04224558|Cyclophosphamide|cyclophosphamide|mesh-list
102037945|NCT04224558|Fludarabine|fludarabine|mesh-list
102037946|NCT04224558|Thymoglobulin|thymoglobulin|mesh-list
102037947|NCT04224558|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102037948|NCT04224558|Immunoglobulins|immunoglobulins|mesh-list
102037949|NCT04224558|Antibodies|antibodies|mesh-list
102037950|NCT04224558|gamma-Globulins|gamma-globulins|mesh-list
102037951|NCT04224558|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102037964|NCT04224558|Sensory System Agents|sensory system agents|mesh-ancestor
102037965|NCT04224558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102037966|NCT04224558|Antipyretics|antipyretics|mesh-ancestor
102037967|NCT04224558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102037968|NCT04224558|Antiemetics|antiemetics|mesh-ancestor
102037969|NCT04224558|Autonomic Agents|autonomic agents|mesh-ancestor
102037970|NCT04224558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102037971|NCT04224558|Glucocorticoids|glucocorticoids|mesh-ancestor
102037972|NCT04224558|Hormones|hormones|mesh-ancestor
102037973|NCT04224558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102037974|NCT04224558|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102037975|NCT04224558|Protective Agents|protective agents|mesh-ancestor
102037976|NCT04224558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102037977|NCT04224558|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102037978|NCT04224558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102037979|NCT04224558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102037980|NCT04224558|Anesthetics, Local|anesthetics, local|mesh-ancestor
102037981|NCT04224558|Anesthetics|anesthetics|mesh-ancestor
102037982|NCT04224558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102037983|NCT04224558|Histamine Antagonists|histamine antagonists|mesh-ancestor
102037984|NCT04224558|Histamine Agents|histamine agents|mesh-ancestor
102037985|NCT04224558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102037986|NCT04224558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102037987|NCT04224558|Antipruritics|antipruritics|mesh-ancestor
102037988|NCT04224558|Dermatologic Agents|dermatologic agents|mesh-ancestor
102037989|NCT05598411|Methylprednisolone|methylprednisolone|mesh-list
102037990|NCT05598411|Glucocorticoids|glucocorticoids|mesh-list
102037991|NCT05598411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102037992|NCT05598411|Antiemetics|antiemetics|mesh-ancestor
102037993|NCT05598411|Autonomic Agents|autonomic agents|mesh-ancestor
102037994|NCT05598411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102037995|NCT05598411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037996|NCT05598411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102037997|NCT05598411|Hormones|hormones|mesh-ancestor
102037998|NCT05598411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102037999|NCT05598411|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102038000|NCT05598411|Protective Agents|protective agents|mesh-ancestor
102038001|NCT03688230|Cetuximab|cetuximab|mesh-list
102038002|NCT03688230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102038003|NCT03688230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102038004|NCT03694236|Durvalumab|durvalumab|mesh-list
102038005|NCT03694236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102038006|NCT03694236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102038007|NCT03692286|Calcium, Dietary|calcium, dietary|mesh-list
102038008|NCT03692286|Calcium|calcium|mesh-list
101971740|NCT03083704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101971741|NCT03083704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101971742|NCT03059940|Nicotine|nicotine|mesh-list
101971743|NCT03059940|Carbon Monoxide|carbon monoxide|mesh-list
101971744|NCT03059940|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101971745|NCT03059940|Autonomic Agents|autonomic agents|mesh-ancestor
101971746|NCT03059940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102038009|NCT03692286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102038010|NCT03692286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038011|NCT03692286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102038012|NCT03694080|Calcium|calcium|mesh-list
102038013|NCT03694080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102038014|NCT03694080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038032|NCT03691818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102038033|NCT03691818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038034|NCT03691818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102038035|NCT03691818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102038036|NCT03691818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102038037|NCT03691818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102038038|NCT03691818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038039|NCT03687606|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102038040|NCT03687606|Menotropins|menotropins|mesh-list
102038041|NCT03687606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102038042|NCT03687606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038043|NCT03687606|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102038044|NCT03687606|Fertility Agents|fertility agents|mesh-ancestor
102038045|NCT04059978|Remifentanil|remifentanil|mesh-list
102038046|NCT04059978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102038047|NCT04059978|Narcotics|narcotics|mesh-ancestor
102038048|NCT04059978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102038049|NCT04059978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038050|NCT04059978|Analgesics|analgesics|mesh-ancestor
102038051|NCT04059978|Sensory System Agents|sensory system agents|mesh-ancestor
102038052|NCT04059978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102038053|NCT03199963|Tamoxifen|tamoxifen|mesh-list
102038054|NCT03199963|Afimoxifene|afimoxifene|mesh-list
102038055|NCT03199963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102038056|NCT03199963|Hormone Antagonists|hormone antagonists|mesh-ancestor
102038057|NCT03199963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102038058|NCT03199963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038059|NCT03199963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102038060|NCT03199963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102038061|NCT03199963|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102038062|NCT03199963|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102038063|NCT03199963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102038064|NCT03636685|Paclitaxel|paclitaxel|mesh-list
102038065|NCT03636685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102038066|NCT03636685|Carboplatin|carboplatin|mesh-list
102038067|NCT03636685|Pemetrexed|pemetrexed|mesh-list
102038068|NCT03636685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102038069|NCT03636685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102038070|NCT03636685|Tubulin Modulators|tubulin modulators|mesh-ancestor
102038071|NCT03636685|Antimitotic Agents|antimitotic agents|mesh-ancestor
102038072|NCT03636685|Mitosis Modulators|mitosis modulators|mesh-ancestor
102038073|NCT03636685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038092|NCT03883581|Dextromethorphan|dextromethorphan|mesh-list
102038093|NCT03883581|Antitussive Agents|antitussive agents|mesh-ancestor
102038094|NCT03883581|Respiratory System Agents|respiratory system agents|mesh-ancestor
102038095|NCT03883581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102038096|NCT03883581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102038097|NCT03883581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102038098|NCT03883581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038099|NCT03883581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038100|NCT03883581|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102038101|NCT03883581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102038102|NCT03883581|Adrenergic Agents|adrenergic agents|mesh-ancestor
102038103|NCT03883581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101971747|NCT03059940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971748|NCT03059940|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101971749|NCT03059940|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101971750|NCT03059940|Cholinergic Agents|cholinergic agents|mesh-ancestor
102038104|NCT03883581|Antimalarials|antimalarials|mesh-ancestor
102038105|NCT03883581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102038106|NCT03883581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102038107|NCT03883581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102038108|NCT03883581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102038109|NCT03883581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102038110|NCT03883581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102038111|NCT03883581|Cholinergic Agents|cholinergic agents|mesh-ancestor
102038112|NCT03883581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102038113|NCT03883581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102038114|NCT03883581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102038115|NCT03883581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102038116|NCT03883581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102038117|NCT03824535|Deoxyglucose|deoxyglucose|mesh-list
102038118|NCT03824535|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102038119|NCT03824535|Fluorides|fluorides|mesh-list
102038120|NCT03824535|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101694613|NCT00973687|Dexamethasone|dexamethasone|mesh-list
102038121|NCT03824535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038122|NCT03824535|Cariostatic Agents|cariostatic agents|mesh-ancestor
102038123|NCT03824535|Protective Agents|protective agents|mesh-ancestor
102038124|NCT03824535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038125|NCT03824535|Antimetabolites|antimetabolites|mesh-ancestor
102038126|NCT03824535|Antiviral Agents|antiviral agents|mesh-ancestor
102038127|NCT03824535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102038128|NCT03113643|Azacitidine|azacitidine|mesh-list
102038129|NCT03113643|Venetoclax|venetoclax|mesh-list
102038130|NCT03113643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102038131|NCT03113643|Antimetabolites|antimetabolites|mesh-ancestor
102038132|NCT03113643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038145|NCT05598255|Autonomic Agents|autonomic agents|mesh-ancestor
102038146|NCT05598255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102038147|NCT05598255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038148|NCT05598255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102038149|NCT05598255|Glucocorticoids|glucocorticoids|mesh-ancestor
102038151|NCT05598255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102038152|NCT05598255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102038153|NCT05598255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101757939|NCT00627393|Antiemetics|antiemetics|mesh-ancestor
102038154|NCT05598255|Anesthetics, Local|anesthetics, local|mesh-ancestor
102038155|NCT05598255|Anesthetics|anesthetics|mesh-ancestor
102038156|NCT05598255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102038157|NCT05598255|Sensory System Agents|sensory system agents|mesh-ancestor
102038158|NCT04733235|Progesterone|progesterone|mesh-list
102038159|NCT04733235|Hormones|hormones|mesh-ancestor
102038160|NCT04733235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102038161|NCT04733235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038162|NCT04733235|Progestins|progestins|mesh-ancestor
102038163|NCT05598177|Dexmedetomidine|dexmedetomidine|mesh-list
102038164|NCT05598177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102038165|NCT05598177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102038166|NCT05598177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038167|NCT05598177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102038168|NCT05598177|Analgesics|analgesics|mesh-ancestor
102038169|NCT05598177|Sensory System Agents|sensory system agents|mesh-ancestor
102038170|NCT05598177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102038171|NCT05598177|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102038172|NCT05598177|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102038173|NCT05598177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102038174|NCT05598177|Adrenergic Agents|adrenergic agents|mesh-ancestor
102038175|NCT05598177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102038176|NCT05598177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038177|NCT03740529|Rituximab|rituximab|mesh-list
102038178|NCT03740529|Venetoclax|venetoclax|mesh-list
102038179|NCT03740529|Pirtobrutinib|pirtobrutinib|mesh-list
102038180|NCT03740529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102038181|NCT03740529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102038182|NCT03740529|Immunologic Factors|immunologic factors|mesh-ancestor
101971751|NCT03059940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101971752|NCT03059940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971753|NCT03059940|Antimetabolites|antimetabolites|mesh-ancestor
101971754|NCT03059940|Gasotransmitters|gasotransmitters|mesh-ancestor
101971755|NCT03033914|Doxorubicin|doxorubicin|mesh-list
102038183|NCT03740529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038184|NCT03740529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102038185|NCT03740529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102038186|NCT03740529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102038187|NCT03740529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038188|NCT03029208|Darbepoetin alfa|darbepoetin alfa|mesh-list
102038189|NCT03029208|Hematinics|hematinics|mesh-ancestor
102038190|NCT05212623|Vaccines|vaccines|mesh-list
102038191|NCT05212623|Immunologic Factors|immunologic factors|mesh-ancestor
102038192|NCT05212623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038193|NCT03693222|Morphine|morphine|mesh-list
102038194|NCT03693222|Tramadol|tramadol|mesh-list
102038195|NCT03693222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102038208|NCT03631641|Nivolumab|nivolumab|mesh-list
102038209|NCT03631641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102038210|NCT03631641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102038211|NCT03631641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102038212|NCT03631641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038213|NCT03631875|Ketamine|ketamine|mesh-list
102038214|NCT03631875|Propofol|propofol|mesh-list
102038215|NCT03631875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102038216|NCT03631875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102038217|NCT03631875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038218|NCT03631875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102038219|NCT03631875|Anesthetics, General|anesthetics, general|mesh-ancestor
102038220|NCT03631875|Anesthetics|anesthetics|mesh-ancestor
102038221|NCT03631875|Analgesics|analgesics|mesh-ancestor
102038222|NCT03631875|Sensory System Agents|sensory system agents|mesh-ancestor
102038223|NCT03631875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102038224|NCT03631875|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102038225|NCT03631875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102038226|NCT03631875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102038227|NCT03631875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102038228|NCT03631875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038229|NCT03631563|Immunosuppressive Agents|immunosuppressive agents|mesh-list
102038230|NCT03631563|Immunologic Factors|immunologic factors|mesh-ancestor
102038231|NCT03631563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038232|NCT03158805|Liraglutide|liraglutide|mesh-list
102038233|NCT03158805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102038234|NCT03158805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038235|NCT03158805|Incretins|incretins|mesh-ancestor
102038237|NCT03158805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102038238|NCT03197935|Paclitaxel|paclitaxel|mesh-list
102038239|NCT03197935|Cyclophosphamide|cyclophosphamide|mesh-list
102038240|NCT03197935|Doxorubicin|doxorubicin|mesh-list
102038241|NCT03197935|Atezolizumab|atezolizumab|mesh-list
102038242|NCT03197935|Antibodies|antibodies|mesh-list
102038243|NCT03197935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102038244|NCT03197935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102038245|NCT03197935|Tubulin Modulators|tubulin modulators|mesh-ancestor
102038246|NCT03197935|Antimitotic Agents|antimitotic agents|mesh-ancestor
102038247|NCT03197935|Mitosis Modulators|mitosis modulators|mesh-ancestor
102038248|NCT03197935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038249|NCT03197935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102038250|NCT03197935|Immunologic Factors|immunologic factors|mesh-ancestor
102038251|NCT03197935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038252|NCT03197935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102038253|NCT03197935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102038254|NCT03197935|Alkylating Agents|alkylating agents|mesh-ancestor
102038255|NCT03197935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102038256|NCT03197935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102038257|NCT03197935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102038258|NCT03197935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102038259|NCT03197935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102038265|NCT05597709|Insulin|insulin|mesh-list
102038266|NCT05597709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101971756|NCT03033914|Bleomycin|bleomycin|mesh-list
101971757|NCT03033914|Nivolumab|nivolumab|mesh-list
101971758|NCT03033914|Dacarbazine|dacarbazine|mesh-list
102038267|NCT05597709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038268|NCT02917629|Pioglitazone|pioglitazone|mesh-list
102038269|NCT02917629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102038270|NCT02917629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038271|NCT05417841|Insulin|insulin|mesh-list
102038272|NCT05417841|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102038273|NCT05417841|Insulin Aspart|insulin aspart|mesh-list
102038274|NCT05417841|Insulin, Long-Acting|insulin, long-acting|mesh-list
102038275|NCT05417841|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101694639|NCT02785601|Trazodone|trazodone|mesh-list
102038276|NCT05417841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102038277|NCT05417841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038278|NCT03691038|Pregabalin|pregabalin|mesh-list
102038279|NCT03691038|Analgesics|analgesics|mesh-ancestor
102038280|NCT03691038|Sensory System Agents|sensory system agents|mesh-ancestor
102038281|NCT03691038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102038282|NCT03691038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038283|NCT03691038|Anticonvulsants|anticonvulsants|mesh-ancestor
102038284|NCT03691038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102038285|NCT03691038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102038286|NCT03691038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038287|NCT03691038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102038288|NCT03691038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102038289|NCT03691038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102038290|NCT03691038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102038291|NCT03691038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102038292|NCT02927847|Nicotine|nicotine|mesh-list
102038293|NCT02927847|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102038294|NCT02927847|Autonomic Agents|autonomic agents|mesh-ancestor
102038295|NCT02927847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102038296|NCT02927847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038297|NCT02927847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102038298|NCT02927847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102038299|NCT02927847|Cholinergic Agents|cholinergic agents|mesh-ancestor
102038300|NCT02927847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102038301|NCT02927847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038302|NCT03682692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102038303|NCT03682692|Protease Inhibitors|protease inhibitors|mesh-ancestor
102038304|NCT03682692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102038305|NCT03682692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038306|NCT02886585|Pembrolizumab|pembrolizumab|mesh-list
101758088|NCT00822393|Busulfan|busulfan|mesh-list
102038307|NCT02886585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102038308|NCT02886585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102038309|NCT02886585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102038310|NCT02886585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038311|NCT01568853|Norepinephrine|norepinephrine|mesh-list
102038312|NCT01568853|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102038313|NCT01568853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102038314|NCT01568853|Adrenergic Agents|adrenergic agents|mesh-ancestor
102038315|NCT01568853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102038316|NCT01568853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038317|NCT01568853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038318|NCT01568853|Sympathomimetics|sympathomimetics|mesh-ancestor
102038319|NCT01568853|Autonomic Agents|autonomic agents|mesh-ancestor
102038320|NCT01568853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102038321|NCT01568853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102038322|NCT02960438|Quetmolimab|quetmolimab|mesh-list
102038323|NCT02960438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102038324|NCT03926052|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102038325|NCT03926052|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102038326|NCT03926052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038327|NCT03926052|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102038340|NCT05411991|Anticonvulsants|anticonvulsants|mesh-ancestor
102038341|NCT05411991|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102038342|NCT05411991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102038343|NCT05411991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038344|NCT05411991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101694644|NCT02785601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102038345|NCT05411991|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101971760|NCT03033914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102038346|NCT05411991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102038347|NCT03690414|Atropine|atropine|mesh-list
102038348|NCT03690414|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102038349|NCT03690414|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102038350|NCT03690414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102038351|NCT03690414|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102038352|NCT03690414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102038353|NCT03690414|Autonomic Agents|autonomic agents|mesh-ancestor
102038354|NCT03690414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102038355|NCT03690414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038356|NCT03690414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102038357|NCT03690414|Respiratory System Agents|respiratory system agents|mesh-ancestor
102038358|NCT03690414|Mydriatics|mydriatics|mesh-ancestor
102038359|NCT03690414|Parasympatholytics|parasympatholytics|mesh-ancestor
102038360|NCT03690414|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102038361|NCT03690414|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102038362|NCT03690414|Cholinergic Agents|cholinergic agents|mesh-ancestor
102038363|NCT03690414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102038364|NCT03690414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038365|NCT02959970|Dapsone|dapsone|mesh-list
102038366|NCT02959970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102038367|NCT02959970|Antimalarials|antimalarials|mesh-ancestor
102038368|NCT02959970|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102038369|NCT02959970|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102038370|NCT02959970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102038371|NCT02959970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102038372|NCT02959970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038373|NCT02959970|Leprostatic Agents|leprostatic agents|mesh-ancestor
102038374|NCT02959970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102038375|NCT03681990|Ethanol|ethanol|mesh-list
102038376|NCT03681990|Chlorhexidine|chlorhexidine|mesh-list
102038377|NCT03681990|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102038378|NCT03681990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102038379|NCT03681990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102038380|NCT03681990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102038381|NCT03681990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038382|NCT03681990|Disinfectants|disinfectants|mesh-ancestor
102038383|NCT03681990|Dermatologic Agents|dermatologic agents|mesh-ancestor
102038384|NCT02740335|Protein C|protein c|mesh-list
102038385|NCT02740335|Protein S|protein s|mesh-list
102038386|NCT02740335|Thrombin|thrombin|mesh-list
102038387|NCT02740335|Hemostatics|hemostatics|mesh-ancestor
102038388|NCT02740335|Coagulants|coagulants|mesh-ancestor
102038389|NCT02740335|Anticoagulants|anticoagulants|mesh-ancestor
102038390|NCT02740335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102038391|NCT02740335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102038406|NCT01568931|Keratolytic Agents|keratolytic agents|mesh-ancestor
102038407|NCT01568931|Dermatologic Agents|dermatologic agents|mesh-ancestor
102038408|NCT04800367|Denosumab|denosumab|mesh-list
102038409|NCT04800367|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102038410|NCT04800367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038411|NCT03713658|Risperidone|risperidone|mesh-list
102038412|NCT03713658|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102038413|NCT03713658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102038414|NCT03713658|Serotonin Agents|serotonin agents|mesh-ancestor
102038415|NCT03713658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102038416|NCT03713658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038417|NCT03713658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038418|NCT03713658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102038419|NCT03713658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102038420|NCT03713658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102038421|NCT03713658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102038422|NCT03713658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102038423|NCT03713658|Dopamine Agents|dopamine agents|mesh-ancestor
102038424|NCT03713658|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102038425|NCT03713658|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102038426|NCT05475717|Alprostadil|alprostadil|mesh-list
102038427|NCT05475717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102038428|NCT05475717|Vasodilator Agents|vasodilator agents|mesh-ancestor
102038429|NCT05475717|Urological Agents|urological agents|mesh-ancestor
102038430|NCT05133687|Bupivacaine|bupivacaine|mesh-list
102038431|NCT05133687|Anesthetics, Local|anesthetics, local|mesh-ancestor
102038432|NCT05133687|Anesthetics|anesthetics|mesh-ancestor
102038433|NCT05133687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101971761|NCT03033914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971762|NCT03033914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101971763|NCT03033914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101971765|NCT03033914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038434|NCT05133687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038435|NCT05133687|Sensory System Agents|sensory system agents|mesh-ancestor
102038436|NCT05133687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102038437|NCT03685032|Dexamethasone|dexamethasone|mesh-list
102038438|NCT03685032|Ondansetron|ondansetron|mesh-list
102038439|NCT03685032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102038440|NCT03685032|Antiemetics|antiemetics|mesh-ancestor
102038441|NCT03685032|Autonomic Agents|autonomic agents|mesh-ancestor
102038442|NCT03685032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102038443|NCT03685032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038444|NCT03685032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102038445|NCT03685032|Glucocorticoids|glucocorticoids|mesh-ancestor
102038446|NCT03685032|Hormones|hormones|mesh-ancestor
102038447|NCT03685032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102038448|NCT03685032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102038449|NCT03685032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102038450|NCT03685032|Antipruritics|antipruritics|mesh-ancestor
102038477|NCT05451771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102038478|NCT05451771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038479|NCT05451771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102038480|NCT05451771|Glucocorticoids|glucocorticoids|mesh-ancestor
102038481|NCT05451771|Hormones|hormones|mesh-ancestor
102038482|NCT05451771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102038483|NCT05451771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102038484|NCT05451771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102038485|NCT05451771|Protease Inhibitors|protease inhibitors|mesh-ancestor
102038486|NCT05451771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102038487|NCT05451771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038488|NCT05451771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102038489|NCT05451771|Alkylating Agents|alkylating agents|mesh-ancestor
102038490|NCT05451771|Immunologic Factors|immunologic factors|mesh-ancestor
102038491|NCT05451771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102038492|NCT05451771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102038493|NCT05451771|Growth Substances|growth substances|mesh-ancestor
102038494|NCT05451771|Growth Inhibitors|growth inhibitors|mesh-ancestor
102038495|NCT03680976|CXA-10|cxa-10|mesh-list
102038496|NCT03680976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102038497|NCT05387343|Vaccines|vaccines|mesh-list
102038498|NCT05387343|Immunologic Factors|immunologic factors|mesh-ancestor
102038499|NCT05387343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038500|NCT04220775|Atezolizumab|atezolizumab|mesh-list
102038501|NCT04220775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102038502|NCT04220775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038503|NCT04220775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102038508|NCT01381887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102038509|NCT01381887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038510|NCT04877379|Ceftibuten|ceftibuten|mesh-list
102038511|NCT04877379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102038512|NCT04877379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102038513|NCT01382745|Nimotuzumab|nimotuzumab|mesh-list
102038514|NCT01382745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102038515|NCT01382745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102038516|NCT03684330|Vitamin D|vitamin d|mesh-list
102038517|NCT03684330|Vitamins|vitamins|mesh-ancestor
102038518|NCT03684330|Micronutrients|micronutrients|mesh-ancestor
101694666|NCT00660894|Micronutrients|micronutrients|mesh-ancestor
102038519|NCT03684330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038520|NCT03684330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102038521|NCT03503370|Chlorhexidine|chlorhexidine|mesh-list
102038522|NCT03503370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102038523|NCT03503370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102038524|NCT03503370|Disinfectants|disinfectants|mesh-ancestor
102038525|NCT01381809|Epoetin Alfa|epoetin alfa|mesh-list
102038526|NCT01381809|Hematinics|hematinics|mesh-ancestor
102038527|NCT03677466|Tenecteplase|tenecteplase|mesh-list
102038528|NCT03677466|Streptokinase|streptokinase|mesh-list
101971766|NCT03033914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101971767|NCT03033914|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101971768|NCT03033914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101306512|NCT02025998|Ibudilast|ibudilast|mesh-list
102038529|NCT03677466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102038530|NCT03677466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102038531|NCT03677466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038532|NCT03447132|Fulvestrant|fulvestrant|mesh-list
102038533|NCT03447132|Goserelin|goserelin|mesh-list
102038534|NCT03447132|Palbociclib|palbociclib|mesh-list
102038535|NCT03447132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102038536|NCT03447132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102038537|NCT03447132|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102038538|NCT03447132|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102038539|NCT03447132|Hormone Antagonists|hormone antagonists|mesh-ancestor
102038540|NCT03447132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102038541|NCT03447132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038542|NCT03447132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102038543|NCT03447132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102038544|NCT03447132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038545|NCT04133623|Ibuprofen|ibuprofen|mesh-list
102038546|NCT04133623|Ketorolac|ketorolac|mesh-list
102038547|NCT04133623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102038548|NCT04133623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102038549|NCT04133623|Analgesics|analgesics|mesh-ancestor
102038550|NCT04133623|Sensory System Agents|sensory system agents|mesh-ancestor
102038551|NCT04133623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102038552|NCT04133623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038553|NCT04133623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102038554|NCT04133623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102038555|NCT04133623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102038556|NCT04133623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102038557|NCT04133623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038558|NCT03188185|Naltrexone|naltrexone|mesh-list
102038559|NCT03188185|Buprenorphine|buprenorphine|mesh-list
102038560|NCT03188185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102038561|NCT03188185|Narcotics|narcotics|mesh-ancestor
102038562|NCT03188185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102038563|NCT03188185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038564|NCT03188185|Analgesics|analgesics|mesh-ancestor
102038565|NCT03188185|Sensory System Agents|sensory system agents|mesh-ancestor
102038566|NCT03188185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102038567|NCT03188185|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102038568|NCT03188185|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102038569|NCT03679182|Olanzapine|olanzapine|mesh-list
102038570|NCT03679182|Antiemetics|antiemetics|mesh-ancestor
102038571|NCT03679182|Autonomic Agents|autonomic agents|mesh-ancestor
102038572|NCT03679182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102038573|NCT03679182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038574|NCT03679182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102038575|NCT03679182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102038606|NCT03193333|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102038607|NCT03193333|Adrenergic Agents|adrenergic agents|mesh-ancestor
102038608|NCT03193333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102038609|NCT03193333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038610|NCT03193333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038611|NCT03193333|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102038612|NCT03193333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102038613|NCT03193333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102038614|NCT03193333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102038615|NCT03193333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102038616|NCT03193333|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102038634|NCT03573648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102038635|NCT03026088|Bisoprolol|bisoprolol|mesh-list
102038636|NCT03026088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102038637|NCT03026088|Sympatholytics|sympatholytics|mesh-ancestor
102038638|NCT03026088|Autonomic Agents|autonomic agents|mesh-ancestor
102038639|NCT03026088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102038640|NCT03026088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971769|NCT03033914|Alkylating Agents|alkylating agents|mesh-ancestor
101971770|NCT03033914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101971771|NCT03033914|Tubulin Modulators|tubulin modulators|mesh-ancestor
101403173|NCT04705402|Mannitol|mannitol|mesh-list
102038641|NCT03026088|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102038642|NCT03026088|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102038643|NCT03026088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102038644|NCT03026088|Adrenergic Agents|adrenergic agents|mesh-ancestor
102038645|NCT03026088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102038646|NCT03026088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038647|NCT03678792|Morphine|morphine|mesh-list
102038648|NCT03678792|Buprenorphine|buprenorphine|mesh-list
102038649|NCT03678792|Tramadol|tramadol|mesh-list
102038650|NCT03678792|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102038651|NCT03678792|Naloxone|naloxone|mesh-list
102038652|NCT03678792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102038653|NCT03678792|Narcotics|narcotics|mesh-ancestor
102038654|NCT03678792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102038655|NCT03678792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038656|NCT03678792|Analgesics|analgesics|mesh-ancestor
102038657|NCT03678792|Sensory System Agents|sensory system agents|mesh-ancestor
102038658|NCT03678792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102038659|NCT03678792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102038660|NCT03678480|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102038661|NCT03678480|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102038662|NCT03678480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102038663|NCT03181789|Interleukin-12|interleukin-12|mesh-list
102038664|NCT03181789|Vaccines|vaccines|mesh-list
102038665|NCT03181789|Immunologic Factors|immunologic factors|mesh-ancestor
102038666|NCT03181789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038667|NCT03181789|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102038668|NCT03181789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102038669|NCT03181789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102038670|NCT03181789|Growth Substances|growth substances|mesh-ancestor
102038671|NCT03181789|Growth Inhibitors|growth inhibitors|mesh-ancestor
102038672|NCT03181789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102038673|NCT03678090|Plasminogen|plasminogen|mesh-list
102038674|NCT03678090|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102038675|NCT03678090|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102038688|NCT03676140|Ivermectin|ivermectin|mesh-list
102038689|NCT03676140|Albendazole|albendazole|mesh-list
102038690|NCT03676140|Diethylcarbamazine|diethylcarbamazine|mesh-list
102038691|NCT03676140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102038692|NCT03676140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102038693|NCT03676140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102038694|NCT03676140|Anthelmintics|anthelmintics|mesh-ancestor
102038695|NCT03676140|Anticestodal Agents|anticestodal agents|mesh-ancestor
102038696|NCT03676140|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102038697|NCT03676140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102038698|NCT03676140|Tubulin Modulators|tubulin modulators|mesh-ancestor
102038699|NCT03676140|Antimitotic Agents|antimitotic agents|mesh-ancestor
102038700|NCT03676140|Mitosis Modulators|mitosis modulators|mesh-ancestor
102038701|NCT03676140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038702|NCT03676140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102038703|NCT03676140|Filaricides|filaricides|mesh-ancestor
102038704|NCT03676140|Antinematodal Agents|antinematodal agents|mesh-ancestor
102038705|NCT03676140|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
102038706|NCT03676140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102038707|NCT03504774|Immunomodulating Agents|immunomodulating agents|mesh-list
102038708|NCT03504774|Immunologic Factors|immunologic factors|mesh-ancestor
102038709|NCT03504774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038710|NCT04059198|Tenofovir|tenofovir|mesh-list
102038711|NCT04059198|Antiviral Agents|antiviral agents|mesh-ancestor
102038712|NCT04059198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102038713|NCT04059198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102038714|NCT04059198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102038715|NCT04059198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102038716|NCT04059198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038717|NCT04059198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102038718|NCT04059198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102038719|NCT04058964|Pembrolizumab|pembrolizumab|mesh-list
102038720|NCT04058964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102038721|NCT04058964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971772|NCT03033914|Antimitotic Agents|antimitotic agents|mesh-ancestor
101971773|NCT03033914|Mitosis Modulators|mitosis modulators|mesh-ancestor
102038722|NCT04058964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102038723|NCT04058964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038724|NCT03246906|Cyclosporine|cyclosporine|mesh-list
102038725|NCT03246906|Sirolimus|sirolimus|mesh-list
102038726|NCT03246906|Mycophenolic Acid|mycophenolic acid|mesh-list
102038727|NCT03246906|Cyclophosphamide|cyclophosphamide|mesh-list
102038728|NCT03246906|Cyclosporins|cyclosporins|mesh-list
102038729|NCT03246906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102038730|NCT03246906|Immunologic Factors|immunologic factors|mesh-ancestor
102038731|NCT03246906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038732|NCT03246906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102038733|NCT03246906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102038734|NCT03246906|Alkylating Agents|alkylating agents|mesh-ancestor
102038735|NCT03246906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038736|NCT03246906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102038737|NCT03246906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101340205|NCT00136045|Rotigotine|rotigotine|mesh-list
102038756|NCT03671538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102038757|NCT03671538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102038759|NCT05420467|Docetaxel|docetaxel|mesh-list
102038760|NCT05420467|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102038761|NCT05420467|Cyclophosphamide|cyclophosphamide|mesh-list
102038762|NCT05420467|Carboplatin|carboplatin|mesh-list
102038763|NCT05420467|Trastuzumab|trastuzumab|mesh-list
102038764|NCT05420467|Epirubicin|epirubicin|mesh-list
102038765|NCT05420467|Pertuzumab|pertuzumab|mesh-list
102038766|NCT05420467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102038767|NCT05420467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102038768|NCT05420467|Tubulin Modulators|tubulin modulators|mesh-ancestor
102038769|NCT05420467|Antimitotic Agents|antimitotic agents|mesh-ancestor
102038770|NCT05420467|Mitosis Modulators|mitosis modulators|mesh-ancestor
102038771|NCT05420467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038772|NCT05420467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102038773|NCT05420467|Immunologic Factors|immunologic factors|mesh-ancestor
102038774|NCT05420467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038775|NCT05420467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102038776|NCT05420467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102038777|NCT05420467|Alkylating Agents|alkylating agents|mesh-ancestor
102038778|NCT05420467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102038779|NCT05420467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102038780|NCT05420467|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102038781|NCT05420467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102038782|NCT05420467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102038783|NCT05420467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102038784|NCT03022578|Lomustine|lomustine|mesh-list
102038785|NCT03022578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102038786|NCT03022578|Alkylating Agents|alkylating agents|mesh-ancestor
102038787|NCT03022578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038788|NCT03022578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102038789|NCT03671070|Epinephrine|epinephrine|mesh-list
102038790|NCT03671070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102038791|NCT03671070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102038792|NCT03671070|Adrenergic Agents|adrenergic agents|mesh-ancestor
102038793|NCT03671070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102038794|NCT03671070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340265|NCT00136747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102038806|NCT03670758|Anticoagulants|anticoagulants|mesh-ancestor
102038807|NCT03674658|Propafenone|propafenone|mesh-list
102038808|NCT03674658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102038809|NCT03674658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102038810|NCT03674658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102038811|NCT03674658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102038812|NCT03674658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038813|NCT03623256|Fentanyl|fentanyl|mesh-list
102038814|NCT03623256|Bupivacaine|bupivacaine|mesh-list
102038815|NCT03623256|Anesthetics, Local|anesthetics, local|mesh-ancestor
102038816|NCT03623256|Anesthetics|anesthetics|mesh-ancestor
102038817|NCT03623256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102038818|NCT03623256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038819|NCT03623256|Sensory System Agents|sensory system agents|mesh-ancestor
102038820|NCT03623256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101971775|NCT03010358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102038821|NCT03623256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102038822|NCT03623256|Narcotics|narcotics|mesh-ancestor
102038823|NCT03623256|Analgesics|analgesics|mesh-ancestor
102038824|NCT03623256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102038825|NCT03623256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102038826|NCT03623256|Anesthetics, General|anesthetics, general|mesh-ancestor
102038827|NCT03082014|Losartan|losartan|mesh-list
102038828|NCT03082014|Atenolol|atenolol|mesh-list
102038829|NCT03082014|Amlodipine|amlodipine|mesh-list
102038830|NCT03082014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102038831|NCT03082014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102038832|NCT03082014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102038833|NCT03082014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038834|NCT03082014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102038835|NCT03082014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038836|NCT03082014|Vasodilator Agents|vasodilator agents|mesh-ancestor
102038838|NCT03082014|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102038839|NCT03082014|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102038840|NCT03082014|Sympatholytics|sympatholytics|mesh-ancestor
102038841|NCT03082014|Autonomic Agents|autonomic agents|mesh-ancestor
102038842|NCT03082014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102038843|NCT03082014|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102038844|NCT03082014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102038845|NCT03082014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102038846|NCT03082014|Adrenergic Agents|adrenergic agents|mesh-ancestor
102038847|NCT03082014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102038848|NCT03670212|Hydrocortisone|hydrocortisone|mesh-list
102038849|NCT03670212|Yohimbine|yohimbine|mesh-list
102038850|NCT03670212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102038851|NCT03670212|Mydriatics|mydriatics|mesh-ancestor
102038852|NCT03670212|Autonomic Agents|autonomic agents|mesh-ancestor
102038853|NCT03670212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102038854|NCT03670212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038855|NCT03670212|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102038856|NCT03670212|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102038857|NCT03670212|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102038858|NCT03670212|Adrenergic Agents|adrenergic agents|mesh-ancestor
102038859|NCT03670212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101340320|NCT03968822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102038876|NCT05263921|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102038877|NCT05263921|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102038878|NCT05263921|Antiviral Agents|antiviral agents|mesh-ancestor
102038879|NCT05263921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102038880|NCT05263921|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102038881|NCT05263921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102038882|NCT03673332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102038883|NCT03673332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038884|NCT03673332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102038885|NCT03673332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102038886|NCT03048084|Levetiracetam|levetiracetam|mesh-list
102038887|NCT03048084|Valproic Acid|valproic acid|mesh-list
102038888|NCT03048084|Anticonvulsants|anticonvulsants|mesh-ancestor
102038889|NCT03048084|Nootropic Agents|nootropic agents|mesh-ancestor
102038890|NCT03048084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102038891|NCT03048084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038892|NCT03048084|GABA Agents|gaba agents|mesh-ancestor
102038893|NCT03048084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102038894|NCT03048084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038895|NCT03048084|Antimanic Agents|antimanic agents|mesh-ancestor
102038896|NCT03048084|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102038897|NCT03048084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102038898|NCT03048084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102038899|NCT02329860|Apatinib|apatinib|mesh-list
102038900|NCT02329860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102038901|NCT02329860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102038902|NCT02329860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102038903|NCT02329860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038904|NCT02251548|Cyclophosphamide|cyclophosphamide|mesh-list
102038905|NCT02251548|Rituximab|rituximab|mesh-list
102038906|NCT02251548|Fludarabine|fludarabine|mesh-list
102038907|NCT02251548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102038910|NCT02251548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102038911|NCT02251548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102038912|NCT02251548|Alkylating Agents|alkylating agents|mesh-ancestor
102038913|NCT02251548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038914|NCT02251548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102038915|NCT02251548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102038916|NCT02251548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102038933|NCT02224872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102038934|NCT02224872|Alkylating Agents|alkylating agents|mesh-ancestor
102038935|NCT02224872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038936|NCT02224872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102038937|NCT02224872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102038938|NCT02224872|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102038939|NCT02224872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102038940|NCT02224872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102038941|NCT02224872|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102038942|NCT02224872|Antitubercular Agents|antitubercular agents|mesh-ancestor
102038943|NCT02224872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102038944|NCT02224872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102038945|NCT02187198|Buprenorphine|buprenorphine|mesh-list
102038947|NCT02187198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102038948|NCT02187198|Narcotics|narcotics|mesh-ancestor
102038949|NCT02187198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102038950|NCT02187198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038951|NCT02187198|Analgesics|analgesics|mesh-ancestor
102038952|NCT02187198|Sensory System Agents|sensory system agents|mesh-ancestor
102038953|NCT02187198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102038954|NCT02187198|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102038955|NCT04969705|Dexmedetomidine|dexmedetomidine|mesh-list
102038956|NCT04969705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102038957|NCT04969705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102038958|NCT04969705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038959|NCT04969705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102038960|NCT04969705|Analgesics|analgesics|mesh-ancestor
102038961|NCT04969705|Sensory System Agents|sensory system agents|mesh-ancestor
102038962|NCT04969705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102038963|NCT04969705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102038964|NCT04969705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102038965|NCT04969705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102038966|NCT04969705|Adrenergic Agents|adrenergic agents|mesh-ancestor
102038967|NCT04969705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102038968|NCT04969705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038969|NCT03676374|Prucalopride|prucalopride|mesh-list
102038970|NCT03676374|Laxatives|laxatives|mesh-ancestor
102038971|NCT03676374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102038972|NCT03676374|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101971789|NCT02596100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101971790|NCT02596100|Antithrombins|antithrombins|mesh-ancestor
101306533|NCT02026050|Glucocorticoids|glucocorticoids|mesh-ancestor
102038973|NCT03676374|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102038974|NCT03676374|Serotonin Agents|serotonin agents|mesh-ancestor
102038975|NCT03676374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102038976|NCT03676374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038986|NCT01829958|Glucocorticoids|glucocorticoids|mesh-ancestor
102038987|NCT01829958|Hormones|hormones|mesh-ancestor
102038988|NCT01829958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102038989|NCT01829958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102038990|NCT03021642|Tepotinib|tepotinib|mesh-list
102038991|NCT03021642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102038992|NCT01374984|Immunoglobulins|immunoglobulins|mesh-list
102038993|NCT01374984|gamma-Globulins|gamma-globulins|mesh-list
102038994|NCT01374984|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102038995|NCT01374984|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102038996|NCT01374984|Immunologic Factors|immunologic factors|mesh-ancestor
102038997|NCT01374984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038998|NCT00867048|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102038999|NCT00867048|Antiviral Agents|antiviral agents|mesh-ancestor
102039000|NCT00867048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102039001|NCT03023046|Prednisone|prednisone|mesh-list
102039002|NCT03023046|Cortisone|cortisone|mesh-list
102039003|NCT03023046|Cyclophosphamide|cyclophosphamide|mesh-list
102039004|NCT03023046|Rituximab|rituximab|mesh-list
102039005|NCT03023046|Doxorubicin|doxorubicin|mesh-list
102039006|NCT03023046|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102039007|NCT03023046|Etoposide|etoposide|mesh-list
102039008|NCT03023046|Vincristine|vincristine|mesh-list
102039009|NCT03023046|Etoposide phosphate|etoposide phosphate|mesh-list
102039010|NCT03023046|Imatinib Mesylate|imatinib mesylate|mesh-list
102039011|NCT03023046|Daunorubicin|daunorubicin|mesh-list
102039012|NCT03023046|Dasatinib|dasatinib|mesh-list
102039013|NCT03023046|Podophyllotoxin|podophyllotoxin|mesh-list
102039014|NCT03023046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102039015|NCT03023046|Antibodies|antibodies|mesh-list
102039016|NCT03023046|Immunoglobulins|immunoglobulins|mesh-list
102039017|NCT03023046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102039018|NCT03023046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102039019|NCT03023046|Immunologic Factors|immunologic factors|mesh-ancestor
102039020|NCT03023046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039021|NCT03023046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102039022|NCT03023046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102039023|NCT03023046|Alkylating Agents|alkylating agents|mesh-ancestor
102039024|NCT03023046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039025|NCT03023046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102039026|NCT03023046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102039027|NCT03023046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102039028|NCT03023046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102039029|NCT03023046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102039030|NCT03023046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102039031|NCT03023046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102039032|NCT03023046|Glucocorticoids|glucocorticoids|mesh-ancestor
102039033|NCT03023046|Hormones|hormones|mesh-ancestor
102039034|NCT03023046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102039035|NCT03023046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102039036|NCT03023046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102039037|NCT03023046|Tubulin Modulators|tubulin modulators|mesh-ancestor
102039038|NCT03023046|Antimitotic Agents|antimitotic agents|mesh-ancestor
102039039|NCT03023046|Mitosis Modulators|mitosis modulators|mesh-ancestor
102039040|NCT03023046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102039041|NCT03023046|Keratolytic Agents|keratolytic agents|mesh-ancestor
102039042|NCT03023046|Dermatologic Agents|dermatologic agents|mesh-ancestor
102039043|NCT03668262|Atracurium|atracurium|mesh-list
102039044|NCT03668262|Cisatracurium|cisatracurium|mesh-list
102039067|NCT03668964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102039068|NCT03668964|Antioxidants|antioxidants|mesh-ancestor
102039069|NCT03668964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039070|NCT03668964|Protective Agents|protective agents|mesh-ancestor
102039071|NCT03668964|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102039072|NCT03668964|Dermatologic Agents|dermatologic agents|mesh-ancestor
101971791|NCT02596100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101971792|NCT02596100|Protease Inhibitors|protease inhibitors|mesh-ancestor
101971793|NCT02596100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101971794|NCT02596100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971795|NCT02596100|Anticoagulants|anticoagulants|mesh-ancestor
102039074|NCT03668730|Fluorouracil|fluorouracil|mesh-list
102039075|NCT03668730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102039076|NCT03668730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102039077|NCT03668730|Tubulin Modulators|tubulin modulators|mesh-ancestor
102039078|NCT03668730|Antimitotic Agents|antimitotic agents|mesh-ancestor
102039079|NCT03668730|Mitosis Modulators|mitosis modulators|mesh-ancestor
102039080|NCT03668730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039081|NCT03668730|Antimetabolites|antimetabolites|mesh-ancestor
102039082|NCT03668730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102039083|NCT03668730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102039084|NCT03668730|Immunologic Factors|immunologic factors|mesh-ancestor
102039085|NCT03668730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039086|NCT03021018|Lorazepam|lorazepam|mesh-list
102039087|NCT03021018|Brivaracetam|brivaracetam|mesh-list
102039088|NCT03021018|Anticonvulsants|anticonvulsants|mesh-ancestor
102039089|NCT03021018|Antiemetics|antiemetics|mesh-ancestor
102039090|NCT03021018|Autonomic Agents|autonomic agents|mesh-ancestor
102039091|NCT03021018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102039092|NCT03021018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039093|NCT03021018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102039094|NCT03021018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102039095|NCT03021018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102039096|NCT03021018|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102039097|NCT03021018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102039108|NCT02509507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039109|NCT03175549|Apremilast|apremilast|mesh-list
102039110|NCT03175549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102039111|NCT03175549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102039112|NCT03175549|Analgesics|analgesics|mesh-ancestor
102039113|NCT03175549|Sensory System Agents|sensory system agents|mesh-ancestor
102039114|NCT03175549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102039115|NCT03175549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039116|NCT03175549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102039117|NCT03175549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102039118|NCT03175549|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102039119|NCT03175549|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102039120|NCT03175549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102039121|NCT03175549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039122|NCT01314937|Mebendazole|mebendazole|mesh-list
102039123|NCT01314937|Piperazine|piperazine|mesh-list
102039124|NCT01314937|Piperazine citrate|piperazine citrate|mesh-list
102039125|NCT01314937|DMP 777|dmp 777|mesh-list
102039126|NCT01314937|Antinematodal Agents|antinematodal agents|mesh-ancestor
102039127|NCT01314937|Anthelmintics|anthelmintics|mesh-ancestor
102039128|NCT01314937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102039129|NCT01314937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102039130|NCT01314937|Tubulin Modulators|tubulin modulators|mesh-ancestor
102039131|NCT01314937|Antimitotic Agents|antimitotic agents|mesh-ancestor
102039132|NCT01314937|Mitosis Modulators|mitosis modulators|mesh-ancestor
102039133|NCT01314937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039134|NCT01314937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102039135|NCT01314937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102039136|NCT04718155|Atorvastatin|atorvastatin|mesh-list
102039137|NCT04718155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102039138|NCT04718155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102039139|NCT04718155|Antimetabolites|antimetabolites|mesh-ancestor
101694856|NCT00879996|Buprenorphine|buprenorphine|mesh-list
102039140|NCT04718155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039141|NCT04718155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102039142|NCT04718155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102039143|NCT04718155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102039144|NCT04668859|Midodrine|midodrine|mesh-list
102039145|NCT04668859|Sympathomimetics|sympathomimetics|mesh-ancestor
102039146|NCT04668859|Autonomic Agents|autonomic agents|mesh-ancestor
102039147|NCT04668859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102039148|NCT04668859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971796|NCT02319837|Leuprolide|leuprolide|mesh-list
101971797|NCT02319837|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101971798|NCT02319837|Fertility Agents|fertility agents|mesh-ancestor
101971799|NCT02319837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101306542|NCT02026219|Ticagrelor|ticagrelor|mesh-list
102039149|NCT04668859|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102039150|NCT04668859|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102039151|NCT04668859|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102039152|NCT04668859|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102039153|NCT04668859|Adrenergic Agents|adrenergic agents|mesh-ancestor
102039154|NCT04668859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102039155|NCT04668859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039156|NCT02924688|Fluticasone|fluticasone|mesh-list
102039157|NCT02924688|Albuterol|albuterol|mesh-list
102039158|NCT02924688|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102039159|NCT02924688|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102039160|NCT02924688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102039161|NCT02924688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102039162|NCT02924688|Autonomic Agents|autonomic agents|mesh-ancestor
102039187|NCT03668418|Epirubicin|epirubicin|mesh-list
102039188|NCT03668418|Taxane|taxane|mesh-list
102039189|NCT03668418|Antimetabolites|antimetabolites|mesh-list
102039190|NCT03668418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102039191|NCT03668418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102039192|NCT03668418|Tubulin Modulators|tubulin modulators|mesh-ancestor
102039193|NCT03668418|Antimitotic Agents|antimitotic agents|mesh-ancestor
102039194|NCT03668418|Mitosis Modulators|mitosis modulators|mesh-ancestor
102039195|NCT03668418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039196|NCT03668418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102039197|NCT03668418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102039198|NCT03668418|Immunologic Factors|immunologic factors|mesh-ancestor
102039199|NCT03668418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039200|NCT03668418|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102039201|NCT03668418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102039202|NCT03668418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102039203|NCT03668418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102039204|NCT03668418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102039205|NCT03011892|Triamcinolone|triamcinolone|mesh-list
102039206|NCT03011892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102039207|NCT03011892|Glucocorticoids|glucocorticoids|mesh-ancestor
102039208|NCT03011892|Hormones|hormones|mesh-ancestor
102039209|NCT03011892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102039210|NCT03011892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039211|NCT02125513|Paclitaxel|paclitaxel|mesh-list
102039212|NCT02125513|Carboplatin|carboplatin|mesh-list
102039213|NCT02125513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102039214|NCT02125513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102039227|NCT03666546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039228|NCT03666546|Sympathomimetics|sympathomimetics|mesh-ancestor
102039229|NCT03666546|Autonomic Agents|autonomic agents|mesh-ancestor
102039230|NCT03666546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102039231|NCT03666546|Dopamine Agents|dopamine agents|mesh-ancestor
102039232|NCT03666546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102039233|NCT03666546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039234|NCT03666546|Adrenergic Agents|adrenergic agents|mesh-ancestor
102039235|NCT03666546|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102039236|NCT03666546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102039237|NCT03666546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102039238|NCT03666546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102039239|NCT03012828|Moxidectin|moxidectin|mesh-list
102039240|NCT03012828|Anthelmintics|anthelmintics|mesh-ancestor
102039241|NCT03012828|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102039242|NCT03012828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102039243|NCT03012828|Antinematodal Agents|antinematodal agents|mesh-ancestor
102039244|NCT03666390|Midazolam|midazolam|mesh-list
102039245|NCT03666390|Ketamine|ketamine|mesh-list
102039246|NCT03666390|Analgesics|analgesics|mesh-ancestor
102039247|NCT03666390|Sensory System Agents|sensory system agents|mesh-ancestor
102039248|NCT03666390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102039249|NCT03666390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039250|NCT03666390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102039251|NCT03666390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101971800|NCT02319837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971801|NCT02319837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101971802|NCT02319837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971803|NCT02169310|Raclopride|raclopride|mesh-list
101971804|NCT02169310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101971805|NCT02169310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101971806|NCT02169310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102039252|NCT03666390|Anesthetics, General|anesthetics, general|mesh-ancestor
102039253|NCT03666390|Anesthetics|anesthetics|mesh-ancestor
102039254|NCT03666390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102039255|NCT03666390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102039256|NCT03666390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102039257|NCT03666390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102039258|NCT03666390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039259|NCT03666390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102039260|NCT03666390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102039261|NCT03666390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102039262|NCT03666390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102039263|NCT03666390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102039264|NCT03666390|GABA Modulators|gaba modulators|mesh-ancestor
102039265|NCT03666390|GABA Agents|gaba agents|mesh-ancestor
102039266|NCT03003390|Enoxaparin|enoxaparin|mesh-list
102039267|NCT03003390|Anticoagulants|anticoagulants|mesh-ancestor
102039268|NCT03003390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102039269|NCT03003390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102039270|NCT03003390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039271|NCT03003000|Ibuprofen|ibuprofen|mesh-list
102039272|NCT03003000|Caffeine|caffeine|mesh-list
102039273|NCT03003000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102039274|NCT03003000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102039275|NCT03003000|Analgesics|analgesics|mesh-ancestor
102039276|NCT03003000|Sensory System Agents|sensory system agents|mesh-ancestor
102039277|NCT03003000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102039278|NCT03003000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039288|NCT03003000|Purinergic Agents|purinergic agents|mesh-ancestor
102039289|NCT03003000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102039290|NCT03665766|Cycloserine|cycloserine|mesh-list
102039291|NCT03665766|Tacrolimus|tacrolimus|mesh-list
102039292|NCT03665766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102039293|NCT03665766|Immunologic Factors|immunologic factors|mesh-ancestor
102039294|NCT03665766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039295|NCT03665766|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102039296|NCT03665766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102039297|NCT03665766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039298|NCT03665766|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102039299|NCT03665766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102039300|NCT03665766|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102039301|NCT03665766|Antitubercular Agents|antitubercular agents|mesh-ancestor
102039302|NCT03665766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102039303|NCT03665766|Antimetabolites|antimetabolites|mesh-ancestor
102039309|NCT03637361|Methadone|methadone|mesh-list
102039310|NCT03637361|D-methadone|d-methadone|mesh-list
102039311|NCT03637361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102039312|NCT03637361|Narcotics|narcotics|mesh-ancestor
102039313|NCT03637361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102039314|NCT03637361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039315|NCT03637361|Analgesics|analgesics|mesh-ancestor
102039316|NCT03637361|Sensory System Agents|sensory system agents|mesh-ancestor
102039317|NCT03637361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102039318|NCT03637361|Antitussive Agents|antitussive agents|mesh-ancestor
102039319|NCT03637361|Respiratory System Agents|respiratory system agents|mesh-ancestor
102039320|NCT03637361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102039321|NCT00038675|Imatinib Mesylate|imatinib mesylate|mesh-list
102039322|NCT00038675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102039323|NCT00038675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102039324|NCT00038675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102039325|NCT00038675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039326|NCT03254459|Morphine|morphine|mesh-list
102039327|NCT03254459|Oxycodone|oxycodone|mesh-list
101971807|NCT02169310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971808|NCT02169310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101306552|NCT02026310|Glimepiride|glimepiride|mesh-list
102039328|NCT03254459|Buprenorphine|buprenorphine|mesh-list
102039329|NCT03254459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102039330|NCT03254459|Narcotics|narcotics|mesh-ancestor
102039331|NCT03254459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102039332|NCT03254459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039333|NCT03254459|Analgesics|analgesics|mesh-ancestor
102039334|NCT03254459|Sensory System Agents|sensory system agents|mesh-ancestor
102039335|NCT03254459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102039336|NCT03254459|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102039337|NCT03620591|Lidocaine|lidocaine|mesh-list
102039338|NCT03620591|Anesthetics, Local|anesthetics, local|mesh-ancestor
102039339|NCT03620591|Anesthetics|anesthetics|mesh-ancestor
102039340|NCT03620591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102039341|NCT03620591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039342|NCT03620591|Sensory System Agents|sensory system agents|mesh-ancestor
102039343|NCT03620591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102039360|NCT05178953|Protective Agents|protective agents|mesh-ancestor
102039361|NCT05178953|Vasodilator Agents|vasodilator agents|mesh-ancestor
102039362|NCT05178953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102039363|NCT05178953|Antioxidants|antioxidants|mesh-ancestor
102039364|NCT05178953|Astringents|astringents|mesh-ancestor
102039365|NCT05178953|Dermatologic Agents|dermatologic agents|mesh-ancestor
102039366|NCT02736617|Obinutuzumab|obinutuzumab|mesh-list
102039367|NCT02736617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102039368|NCT02736617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102039370|NCT03251963|Enoxaparin sodium|enoxaparin sodium|mesh-list
102039371|NCT03251963|Anticoagulants|anticoagulants|mesh-ancestor
102039372|NCT03251963|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102039373|NCT03251963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102039374|NCT03251963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039375|NCT03287219|Methylene Blue|methylene blue|mesh-list
102039376|NCT03287219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102039377|NCT03287219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039378|NCT03286751|Insulin Lispro|insulin lispro|mesh-list
102039379|NCT03286751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102039380|NCT03286751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039381|NCT05572229|Lenalidomide|lenalidomide|mesh-list
102039382|NCT05572229|Daratumumab|daratumumab|mesh-list
102039383|NCT05572229|Immunologic Factors|immunologic factors|mesh-ancestor
102039384|NCT05572229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039385|NCT05572229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102039386|NCT05572229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102039387|NCT05572229|Growth Substances|growth substances|mesh-ancestor
102039388|NCT05572229|Growth Inhibitors|growth inhibitors|mesh-ancestor
102039389|NCT05572229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102039390|NCT03249935|Azithromycin|azithromycin|mesh-list
102039391|NCT03249935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102039392|NCT03249935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102039393|NCT03622073|Misoprostol|misoprostol|mesh-list
102039394|NCT03622073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102039395|NCT03622073|Abortifacient Agents|abortifacient agents|mesh-ancestor
102039396|NCT03622073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102039397|NCT03622073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039398|NCT03622073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102039399|NCT03622073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102039400|NCT03622073|Oxytocics|oxytocics|mesh-ancestor
102039401|NCT03000348|Cysteamine|cysteamine|mesh-list
102039402|NCT03000348|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
102039414|NCT03492918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102039415|NCT03492918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039417|NCT03247673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102039418|NCT03247673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102039419|NCT03247673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102039420|NCT03247673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102039421|NCT03247673|Growth Substances|growth substances|mesh-ancestor
102039422|NCT03247673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039423|NCT03247673|Growth Inhibitors|growth inhibitors|mesh-ancestor
102039424|NCT03665610|Ozanimod|ozanimod|mesh-list
102039425|NCT03665610|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102039426|NCT03665610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971809|NCT02169310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101971810|NCT02169310|Dopamine Agents|dopamine agents|mesh-ancestor
101971811|NCT02169310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102039427|NCT03665610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102039428|NCT03665610|Immunologic Factors|immunologic factors|mesh-ancestor
102039429|NCT03665610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039430|NCT03664908|Antibodies|antibodies|mesh-list
102039431|NCT03664908|Immunologic Factors|immunologic factors|mesh-ancestor
102039432|NCT03664908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039433|NCT03665454|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102039434|NCT03665454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102039435|NCT03665454|Immunologic Factors|immunologic factors|mesh-ancestor
102039436|NCT03665454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039437|NCT03665454|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102039438|NCT03665454|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102039439|NCT03665454|Dopamine Agonists|dopamine agonists|mesh-ancestor
102039440|NCT03665454|Dopamine Agents|dopamine agents|mesh-ancestor
102039441|NCT03665454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101759213|NCT00825045|Dopamine Agents|dopamine agents|mesh-ancestor
102039442|NCT03665454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039443|NCT03664440|Nevirapine|nevirapine|mesh-list
102039444|NCT03664440|Rilpivirine|rilpivirine|mesh-list
102039445|NCT03664440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102039446|NCT03664440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102039447|NCT03664440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102039448|NCT03664440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039449|NCT03664440|Antiviral Agents|antiviral agents|mesh-ancestor
102039450|NCT03664440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102039451|NCT03664440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102039452|NCT03664440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102039453|NCT03664440|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102039454|NCT03664440|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102039455|NCT03664596|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102039456|NCT03664596|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102039457|NCT03664596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102039458|NCT03282227|Oxazolidinones|oxazolidinones|mesh-list
102039459|NCT03282227|Zolmitriptan|zolmitriptan|mesh-list
102039460|NCT03282227|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102039461|NCT03282227|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102039462|NCT03282227|Serotonin Agents|serotonin agents|mesh-ancestor
102039475|NCT03240575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102039477|NCT03240575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102039478|NCT03240575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694966|NCT00647660|Sympatholytics|sympatholytics|mesh-ancestor
102039479|NCT03240575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102039480|NCT03240575|Respiratory System Agents|respiratory system agents|mesh-ancestor
102039481|NCT03240575|Dermatologic Agents|dermatologic agents|mesh-ancestor
102039482|NCT03240575|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102039483|NCT03240575|Parasympatholytics|parasympatholytics|mesh-ancestor
102039484|NCT03240575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102039485|NCT03240575|Cholinergic Agents|cholinergic agents|mesh-ancestor
102039486|NCT03240575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102039487|NCT03240575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039488|NCT03240575|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102039489|NCT03240575|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102039490|NCT03240575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102039491|NCT03240575|Adrenergic Agents|adrenergic agents|mesh-ancestor
102039492|NCT04034225|Pembrolizumab|pembrolizumab|mesh-list
102039493|NCT04034225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102039494|NCT04034225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102039495|NCT04034225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102039496|NCT04034225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039497|NCT03690947|Ranibizumab|ranibizumab|mesh-list
102039498|NCT03690947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102039499|NCT03690947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102039500|NCT03690947|Growth Substances|growth substances|mesh-ancestor
102039501|NCT03690947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039502|NCT03690947|Growth Inhibitors|growth inhibitors|mesh-ancestor
102039503|NCT03690947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102039504|NCT02999178|Nintedanib|nintedanib|mesh-list
102039505|NCT02999178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102039506|NCT02999178|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102039507|NCT02999178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101971812|NCT02169310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971813|NCT02141438|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
101971814|NCT02141438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102039508|NCT02999178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039509|NCT02999100|Oxytocin|oxytocin|mesh-list
102039510|NCT02999100|Oxytocics|oxytocics|mesh-ancestor
102039511|NCT02999100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102039512|NCT02999100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039513|NCT02749370|Etanercept|etanercept|mesh-list
102039514|NCT02749370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102039515|NCT02749370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102039516|NCT02749370|Analgesics|analgesics|mesh-ancestor
102039517|NCT02749370|Sensory System Agents|sensory system agents|mesh-ancestor
102039518|NCT02749370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102039519|NCT02749370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039520|NCT02749370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102039521|NCT02749370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102039522|NCT02749370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102039523|NCT02749370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102039524|NCT02749370|Immunologic Factors|immunologic factors|mesh-ancestor
102039525|NCT03618758|Paclitaxel|paclitaxel|mesh-list
102039533|NCT03617900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102039535|NCT03617900|Sensory System Agents|sensory system agents|mesh-ancestor
102039536|NCT03617900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102039537|NCT03617900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039538|NCT03617900|Antipyretics|antipyretics|mesh-ancestor
102039539|NCT05384366|Paclitaxel|paclitaxel|mesh-list
102039540|NCT05384366|Carboplatin|carboplatin|mesh-list
102039541|NCT05384366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102039542|NCT05384366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102039543|NCT05384366|Tubulin Modulators|tubulin modulators|mesh-ancestor
102039544|NCT05384366|Antimitotic Agents|antimitotic agents|mesh-ancestor
102039545|NCT05384366|Mitosis Modulators|mitosis modulators|mesh-ancestor
102039546|NCT05384366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039547|NCT03616808|Hemostatics|hemostatics|mesh-list
102039548|NCT03616808|Coagulants|coagulants|mesh-ancestor
102039549|NCT03617510|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
102039550|NCT03617510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102039551|NCT03617510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102039552|NCT03617510|Analgesics|analgesics|mesh-ancestor
102039553|NCT03617510|Sensory System Agents|sensory system agents|mesh-ancestor
102039554|NCT03617510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102039555|NCT03617510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039556|NCT03617510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102039557|NCT03617510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102039558|NCT03617432|Prednisone|prednisone|mesh-list
102039559|NCT03617432|Cyclophosphamide|cyclophosphamide|mesh-list
102039560|NCT03617432|Doxorubicin|doxorubicin|mesh-list
102039561|NCT03617432|Etoposide|etoposide|mesh-list
102039562|NCT03617432|Vincristine|vincristine|mesh-list
102039563|NCT03617432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102039564|NCT03617432|Immunologic Factors|immunologic factors|mesh-ancestor
102039565|NCT03617432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039566|NCT03617432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102039567|NCT03617432|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102039568|NCT03617432|Alkylating Agents|alkylating agents|mesh-ancestor
102039569|NCT03617432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039570|NCT03617432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102039571|NCT03617432|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102039572|NCT03617432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102039573|NCT03617432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102039574|NCT03617432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102039575|NCT03617432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102039576|NCT03617432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102039577|NCT03617432|Glucocorticoids|glucocorticoids|mesh-ancestor
102039578|NCT03617432|Hormones|hormones|mesh-ancestor
102039579|NCT03617432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102039580|NCT03617432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102039581|NCT03617432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102039582|NCT03617432|Tubulin Modulators|tubulin modulators|mesh-ancestor
101971816|NCT01802632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971817|NCT01802632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101971818|NCT01802632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101971819|NCT01802632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039583|NCT03617432|Antimitotic Agents|antimitotic agents|mesh-ancestor
102039584|NCT03617432|Mitosis Modulators|mitosis modulators|mesh-ancestor
102039585|NCT02996682|Ribavirin|ribavirin|mesh-list
102039586|NCT02996682|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102039587|NCT02996682|Antimetabolites|antimetabolites|mesh-ancestor
102039588|NCT02996682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039589|NCT02996682|Antiviral Agents|antiviral agents|mesh-ancestor
102039590|NCT02996682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102039591|NCT02873702|Lansoprazole|lansoprazole|mesh-list
102039592|NCT02873702|Dexlansoprazole|dexlansoprazole|mesh-list
102039593|NCT02873702|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102039604|NCT03616262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102039605|NCT03616262|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102039606|NCT03616262|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102039607|NCT03616262|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102039608|NCT03616262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102039609|NCT03616262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039611|NCT03615950|Vitamins|vitamins|mesh-ancestor
102039612|NCT03615950|Micronutrients|micronutrients|mesh-ancestor
102039613|NCT03615950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039614|NCT03615950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102039615|NCT02911116|Ustekinumab|ustekinumab|mesh-list
102039616|NCT02911116|Dermatologic Agents|dermatologic agents|mesh-ancestor
102039617|NCT03664050|Letrozole|letrozole|mesh-list
102039618|NCT03664050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102039619|NCT03664050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102039620|NCT03664050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102039621|NCT03664050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102039622|NCT03664050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039623|NCT03664050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102039624|NCT03664050|Hormone Antagonists|hormone antagonists|mesh-ancestor
102039625|NCT03664050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102039626|NCT03664050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039627|NCT04055844|Decitabine|decitabine|mesh-list
102039628|NCT04055844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102039629|NCT04055844|Antimetabolites|antimetabolites|mesh-ancestor
102039630|NCT04055844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039631|NCT04055844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102039632|NCT04055844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102039633|NCT04055688|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102039634|NCT04055688|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102039635|NCT04055688|Dermatologic Agents|dermatologic agents|mesh-ancestor
102039636|NCT04054284|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102039637|NCT04054284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039638|NCT04494438|Rituximab|rituximab|mesh-list
102039639|NCT04494438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102039640|NCT04494438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102039641|NCT04494438|Immunologic Factors|immunologic factors|mesh-ancestor
102039642|NCT04494438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039643|NCT04494438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102039644|NCT04057482|Dequalinium|dequalinium|mesh-list
102039645|NCT04057482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102039646|NCT04057482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102039647|NCT03662412|Sirolimus|sirolimus|mesh-list
102039648|NCT03662412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102039649|NCT03662412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102039650|NCT03662412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102039651|NCT03662412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102039652|NCT03662412|Antifungal Agents|antifungal agents|mesh-ancestor
102039653|NCT03662412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102039654|NCT03662412|Immunologic Factors|immunologic factors|mesh-ancestor
102039655|NCT03662412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039656|NCT02870972|Berotralstat|berotralstat|mesh-list
102039657|NCT02870972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102039658|NCT02870972|Protease Inhibitors|protease inhibitors|mesh-ancestor
102039668|NCT03662958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101971820|NCT01782352|Vitamin D|vitamin d|mesh-list
101971821|NCT01782352|Ergocalciferols|ergocalciferols|mesh-list
101971822|NCT01782352|Cholecalciferol|cholecalciferol|mesh-list
101971823|NCT01782352|Vitamins|vitamins|mesh-list
101971824|NCT01782352|Micronutrients|micronutrients|mesh-ancestor
102039669|NCT03662958|Fertility Agents|fertility agents|mesh-ancestor
102039670|NCT03662958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102039671|NCT03662958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039672|NCT03662958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102039673|NCT03662958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102039674|NCT03231371|Adenosine|adenosine|mesh-list
102039675|NCT03231371|Analgesics|analgesics|mesh-ancestor
102039676|NCT03231371|Sensory System Agents|sensory system agents|mesh-ancestor
102039677|NCT03231371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102039678|NCT03231371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039679|NCT03231371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102039680|NCT03231371|Vasodilator Agents|vasodilator agents|mesh-ancestor
102039681|NCT03231371|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102039682|NCT03231371|Purinergic Agonists|purinergic agonists|mesh-ancestor
102039683|NCT03231371|Purinergic Agents|purinergic agents|mesh-ancestor
102039684|NCT03231371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102039685|NCT03231371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039686|NCT03663114|Lenvatinib|lenvatinib|mesh-list
102039687|NCT03663114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102039688|NCT03663114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102039689|NCT03663114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102039690|NCT03663114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039691|NCT03526679|Lenvatinib|lenvatinib|mesh-list
102039692|NCT03526679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102039693|NCT03526679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102039694|NCT03526679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102039695|NCT03526679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039696|NCT04057326|Pancreatin|pancreatin|mesh-list
102039697|NCT04057326|Pancrelipase|pancrelipase|mesh-list
102039698|NCT04057326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102039699|NCT02870348|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
102039700|NCT02870348|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102039701|NCT02870348|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102039702|NCT02870348|Protease Inhibitors|protease inhibitors|mesh-ancestor
102039703|NCT02870348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102039704|NCT02870348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039705|NCT05384210|Gabapentin|gabapentin|mesh-list
102039706|NCT05384210|Milnacipran|milnacipran|mesh-list
102039707|NCT05384210|Levomilnacipran|levomilnacipran|mesh-list
102039708|NCT05384210|Analgesics|analgesics|mesh-ancestor
102039709|NCT05384210|Sensory System Agents|sensory system agents|mesh-ancestor
102039710|NCT05384210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102039711|NCT05384210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039712|NCT05384210|Anticonvulsants|anticonvulsants|mesh-ancestor
102039713|NCT05384210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102039714|NCT05384210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102039715|NCT05384210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102039716|NCT05384210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102039717|NCT05384210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102039718|NCT05384210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102039719|NCT05384210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102039720|NCT05384210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039721|NCT05384210|Antimanic Agents|antimanic agents|mesh-ancestor
102039722|NCT05384210|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102039723|NCT05384210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102039724|NCT05384210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102039742|NCT01068912|Favipiravir|favipiravir|mesh-list
102039743|NCT01068912|Antiviral Agents|antiviral agents|mesh-ancestor
102039744|NCT01068912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102039746|NCT04056702|Elexacaftor|elexacaftor|mesh-list
102039747|NCT04056702|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102039748|NCT04056702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102039749|NCT04056702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039750|NCT03662100|Mirikizumab|mirikizumab|mesh-list
102039751|NCT03662100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102039752|NCT03662100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101971825|NCT01782352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971826|NCT01782352|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101971827|NCT01782352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101971828|NCT01765868|Betrixaban|betrixaban|mesh-list
102039753|NCT03662100|Analgesics|analgesics|mesh-ancestor
102039754|NCT03662100|Sensory System Agents|sensory system agents|mesh-ancestor
102039755|NCT03662100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102039756|NCT03662100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039757|NCT03662100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102039758|NCT03662100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102039759|NCT03662100|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102039760|NCT03662100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102039761|NCT03612440|Dexmedetomidine|dexmedetomidine|mesh-list
102039762|NCT03612440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102039763|NCT03612440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102039764|NCT03612440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039765|NCT03612440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102039766|NCT03612440|Analgesics|analgesics|mesh-ancestor
102039767|NCT03612440|Sensory System Agents|sensory system agents|mesh-ancestor
102039768|NCT03612440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102039769|NCT03612440|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102039770|NCT03612440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102039771|NCT03612440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102039772|NCT03612440|Adrenergic Agents|adrenergic agents|mesh-ancestor
101695070|NCT00647816|Propranolol|propranolol|mesh-list
102039773|NCT03612440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102039774|NCT03612440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039775|NCT03662724|Venetoclax|venetoclax|mesh-list
102039776|NCT03662724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102039777|NCT03662568|Ritonavir|ritonavir|mesh-list
102039778|NCT03662568|Tenofovir|tenofovir|mesh-list
102039779|NCT03662568|Entecavir|entecavir|mesh-list
102039780|NCT03662568|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102039781|NCT03662568|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102039782|NCT03662568|Protease Inhibitors|protease inhibitors|mesh-ancestor
102039783|NCT03662568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102039784|NCT03662568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039785|NCT03662568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102039786|NCT03662568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102039832|NCT03611426|Coagulants|coagulants|mesh-ancestor
102039833|NCT03658746|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102039834|NCT03658746|Amoxicillin|amoxicillin|mesh-list
102039835|NCT03658746|Metronidazole|metronidazole|mesh-list
102039836|NCT03658746|Clarithromycin|clarithromycin|mesh-list
102039837|NCT03658746|Levofloxacin|levofloxacin|mesh-list
102039838|NCT03658746|Ofloxacin|ofloxacin|mesh-list
102039839|NCT03658746|Tetracycline|tetracycline|mesh-list
102039840|NCT03658746|Tinidazole|tinidazole|mesh-list
102039841|NCT03658746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102039842|NCT03658746|Furazolidone|furazolidone|mesh-list
102039843|NCT03658746|Bismuth|bismuth|mesh-list
102039844|NCT03658746|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
102039845|NCT03658746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102039846|NCT03658746|Antitubercular Agents|antitubercular agents|mesh-ancestor
102039847|NCT03658746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102039848|NCT03658746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102039849|NCT03658746|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102039850|NCT03658746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102039851|NCT03658746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039852|NCT03658746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102039853|NCT03658746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102039854|NCT03658746|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102039855|NCT03658746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102039856|NCT03658746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102039857|NCT03658746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102039858|NCT03658746|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102039859|NCT03658746|Antacids|antacids|mesh-ancestor
102039860|NCT03658746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102039861|NCT03658746|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102039862|NCT03658746|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
102039863|NCT03658746|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102039864|NCT03658746|Alkylating Agents|alkylating agents|mesh-ancestor
102039865|NCT02990910|Analgesics, Opioid|analgesics, opioid|mesh-list
102039866|NCT02990910|Narcotics|narcotics|mesh-ancestor
101971829|NCT01765868|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101971830|NCT01765868|Antithrombins|antithrombins|mesh-ancestor
101971831|NCT01765868|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101971832|NCT01765868|Protease Inhibitors|protease inhibitors|mesh-ancestor
101971833|NCT01765868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102039867|NCT02990910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102039868|NCT02990910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039869|NCT02990910|Analgesics|analgesics|mesh-ancestor
102039870|NCT02990910|Sensory System Agents|sensory system agents|mesh-ancestor
102039871|NCT02990910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102039872|NCT04056000|Caffeine|caffeine|mesh-list
102039873|NCT04056000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102039874|NCT04056000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039875|NCT04056000|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102039876|NCT04056000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102039877|NCT04056000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039878|NCT04056000|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102039879|NCT04056000|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102039880|NCT04056000|Purinergic Agents|purinergic agents|mesh-ancestor
102039881|NCT04056000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102039882|NCT03611348|Latanoprost|latanoprost|mesh-list
102039883|NCT03611348|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102039911|NCT02033096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039912|NCT03658590|Dexamethasone|dexamethasone|mesh-list
102039913|NCT03658590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102039914|NCT03658590|Antiemetics|antiemetics|mesh-ancestor
102039915|NCT03658590|Autonomic Agents|autonomic agents|mesh-ancestor
102039916|NCT03658590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102039917|NCT03658590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039918|NCT03658590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102039919|NCT03658590|Glucocorticoids|glucocorticoids|mesh-ancestor
102039920|NCT03658590|Hormones|hormones|mesh-ancestor
102039921|NCT03658590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102039922|NCT03658590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102039923|NCT03658590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102039924|NCT03428945|Hydroxychloroquine|hydroxychloroquine|mesh-list
102039925|NCT03428945|Antimalarials|antimalarials|mesh-ancestor
102039926|NCT03428945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102039927|NCT03428945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102039928|NCT03428945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102039929|NCT03428945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101341398|NCT00143728|Antiviral Agents|antiviral agents|mesh-ancestor
102039947|NCT03941093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039948|NCT03941093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102039950|NCT03941093|Antidotes|antidotes|mesh-ancestor
102039951|NCT03941093|Protective Agents|protective agents|mesh-ancestor
102039952|NCT03941093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039953|NCT03941093|Vitamin B Complex|vitamin b complex|mesh-ancestor
102039954|NCT03941093|Vitamins|vitamins|mesh-ancestor
102039955|NCT03941093|Micronutrients|micronutrients|mesh-ancestor
102039956|NCT03941093|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102039957|NCT03941093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102039958|NCT03941093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102039959|NCT03941093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102039960|NCT03941093|Immunologic Factors|immunologic factors|mesh-ancestor
102039961|NCT02033408|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102039962|NCT02033408|Amoxicillin|amoxicillin|mesh-list
102039963|NCT02033408|Metronidazole|metronidazole|mesh-list
102039964|NCT02033408|Vancomycin|vancomycin|mesh-list
102039965|NCT02033408|Doxycycline|doxycycline|mesh-list
102039966|NCT02033408|Ciprofloxacin|ciprofloxacin|mesh-list
101759725|NCT00903214|Riluzole|riluzole|mesh-list
102039967|NCT02033408|Gentamicins|gentamicins|mesh-list
102039968|NCT02033408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102039969|NCT02033408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102039970|NCT02033408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102039971|NCT02033408|Antimalarials|antimalarials|mesh-ancestor
102039972|NCT02033408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102039973|NCT02033408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102039974|NCT02033408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102039975|NCT02033408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039976|NCT02033408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971834|NCT01765868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971835|NCT01765868|Anticoagulants|anticoagulants|mesh-ancestor
101971836|NCT01641718|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101971837|NCT01641718|Hemostatics|hemostatics|mesh-ancestor
102039977|NCT02033408|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102039978|NCT02033408|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102039979|NCT02033408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102039980|NCT03610880|Yimitasvir|yimitasvir|mesh-list
102039981|NCT03610880|Antiviral Agents|antiviral agents|mesh-ancestor
102039982|NCT03610880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102039983|NCT02097121|Botulinum Toxins|botulinum toxins|mesh-list
102039984|NCT02097121|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102039985|NCT02097121|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102039986|NCT02097121|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102039987|NCT02097121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102039988|NCT02097121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039989|NCT02097121|Cholinergic Agents|cholinergic agents|mesh-ancestor
102039990|NCT02097121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102040007|NCT02560298|Mitosis Modulators|mitosis modulators|mesh-ancestor
102040008|NCT02560298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040009|NCT02560298|Antimetabolites|antimetabolites|mesh-ancestor
102040010|NCT02560298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102040011|NCT02560298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102040012|NCT02560298|Immunologic Factors|immunologic factors|mesh-ancestor
102040013|NCT02560298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040014|NCT01330615|Lidocaine|lidocaine|mesh-list
102040015|NCT01330615|Prilocaine|prilocaine|mesh-list
102040016|NCT01330615|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
102040017|NCT01330615|Anesthetics, Local|anesthetics, local|mesh-ancestor
102040018|NCT01330615|Anesthetics|anesthetics|mesh-ancestor
102040019|NCT01330615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102040020|NCT01330615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040021|NCT01330615|Sensory System Agents|sensory system agents|mesh-ancestor
102040022|NCT01330615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102040023|NCT01330615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102040024|NCT01330615|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102040025|NCT01330615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102040026|NCT01330615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102040027|NCT01330615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040028|NCT01330615|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
102040029|NCT05034029|Metformin|metformin|mesh-list
102040030|NCT05034029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102040031|NCT05034029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040032|NCT03237065|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
102040033|NCT03237065|Hematinics|hematinics|mesh-ancestor
102040034|NCT03620461|Gemcitabine|gemcitabine|mesh-list
102040035|NCT03620461|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102040036|NCT03620461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102040037|NCT03620461|Antimetabolites|antimetabolites|mesh-ancestor
102040038|NCT03620461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040039|NCT03620461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102040040|NCT01314781|Solifenacin Succinate|solifenacin succinate|mesh-list
102040041|NCT01314781|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102040042|NCT01314781|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102040043|NCT01314781|Cholinergic Agents|cholinergic agents|mesh-ancestor
102040044|NCT01314781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101759799|NCT00903994|Ketoprofen|ketoprofen|mesh-list
102040045|NCT01314781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040046|NCT01314781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040047|NCT01314781|Urological Agents|urological agents|mesh-ancestor
102040048|NCT01330693|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101341503|NCT00404716|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102040077|NCT05186623|Tofacitinib|tofacitinib|mesh-list
102040078|NCT05186623|Dermatologic Agents|dermatologic agents|mesh-ancestor
102040079|NCT05186623|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102040080|NCT05186623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102040081|NCT05186623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102040082|NCT05186623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040083|NCT05186623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102040084|NCT04602845|Flurbiprofen|flurbiprofen|mesh-list
101971838|NCT01641718|Coagulants|coagulants|mesh-ancestor
101971839|NCT01481974|Treprostinil|treprostinil|mesh-list
101971840|NCT01481974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101971841|NCT00968799|Cisplatin|cisplatin|mesh-list
101971842|NCT00968799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971843|NCT00751231|Clopidogrel|clopidogrel|mesh-list
102040085|NCT04602845|Fentanyl|fentanyl|mesh-list
102040086|NCT04602845|Midazolam|midazolam|mesh-list
102040087|NCT04602845|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102040088|NCT04602845|Narcotics|narcotics|mesh-ancestor
102040089|NCT04602845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102040090|NCT04602845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040091|NCT04602845|Analgesics|analgesics|mesh-ancestor
102040092|NCT04602845|Sensory System Agents|sensory system agents|mesh-ancestor
102040093|NCT04602845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102040094|NCT04602845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102040112|NCT04966325|Moxifloxacin|moxifloxacin|mesh-list
102040113|NCT04966325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102040114|NCT04966325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102040115|NCT04966325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102040116|NCT04966325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102040117|NCT04966325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102040118|NCT04966325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040119|NCT04966325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102040120|NCT03168919|Temozolomide|temozolomide|mesh-list
102040121|NCT03168919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102040122|NCT03168919|Alkylating Agents|alkylating agents|mesh-ancestor
102040123|NCT03168919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040124|NCT03168919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102040125|NCT03205163|Factor VIII|factor viii|mesh-list
102040126|NCT03205163|Coagulants|coagulants|mesh-ancestor
102040127|NCT03638947|Povidone-Iodine|povidone-iodine|mesh-list
102040128|NCT03638947|Povidone|povidone|mesh-list
102040129|NCT03638947|Plasma Substitutes|plasma substitutes|mesh-ancestor
102040130|NCT03638947|Blood Substitutes|blood substitutes|mesh-ancestor
102040131|NCT03638947|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102040132|NCT03638947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102040133|NCT03502681|Avelumab|avelumab|mesh-list
102040134|NCT03502681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102040135|NCT03502681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102040136|NCT04938817|Pembrolizumab|pembrolizumab|mesh-list
102040137|NCT04938817|Lenvatinib|lenvatinib|mesh-list
102040138|NCT04938817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102040139|NCT04938817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102040140|NCT04938817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102040141|NCT04938817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040142|NCT04938817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102040143|NCT04938817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102040144|NCT00788671|Levonorgestrel|levonorgestrel|mesh-list
102040145|NCT00788671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102040146|NCT00788671|Contraceptive Agents|contraceptive agents|mesh-ancestor
102040147|NCT00788671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102040148|NCT00788671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040149|NCT00788671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102040150|NCT00788671|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102040151|NCT00788671|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102040152|NCT03636373|Triamcinolone|triamcinolone|mesh-list
101341617|NCT01807455|Lidocaine|lidocaine|mesh-list
102040204|NCT02887183|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102040205|NCT02887183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102040206|NCT02887183|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102040207|NCT02887183|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102040208|NCT02887183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040209|NCT03660306|Analgesics, Opioid|analgesics, opioid|mesh-list
102040210|NCT03660306|Anesthetics|anesthetics|mesh-list
102040211|NCT03660306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102040212|NCT03660306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040213|NCT03660306|Narcotics|narcotics|mesh-ancestor
102040214|NCT03660306|Analgesics|analgesics|mesh-ancestor
102040215|NCT03660306|Sensory System Agents|sensory system agents|mesh-ancestor
102040216|NCT03660306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101971844|NCT00751231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102040217|NCT01067352|Hormones|hormones|mesh-list
102040218|NCT01067352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102040219|NCT01067352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040220|NCT02920242|Rifaximin|rifaximin|mesh-list
102040221|NCT02920242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102040222|NCT02920242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102040223|NCT02920242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102040224|NCT02985996|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102040225|NCT02985996|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102040226|NCT02985996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102040227|NCT02985996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102040228|NCT02985996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102040229|NCT02985996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040230|NCT02985996|Antiviral Agents|antiviral agents|mesh-ancestor
102040231|NCT02985996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102040232|NCT02985996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102040233|NCT02985996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102040234|NCT03203447|Triamcinolone|triamcinolone|mesh-list
102040235|NCT03203447|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102040236|NCT03203447|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102040237|NCT03203447|Bevacizumab|bevacizumab|mesh-list
102040238|NCT03203447|Ranibizumab|ranibizumab|mesh-list
102040239|NCT03203447|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102040240|NCT03203447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102040241|NCT03203447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102040242|NCT03203447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102040266|NCT03202511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102040267|NCT03202511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102040268|NCT03202511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040269|NCT03202511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102040270|NCT03202511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102040271|NCT03202511|Uricosuric Agents|uricosuric agents|mesh-ancestor
102040272|NCT03202511|Gout Suppressants|gout suppressants|mesh-ancestor
102040273|NCT03202511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102040274|NCT03637049|Midazolam|midazolam|mesh-list
102040275|NCT03637049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102040276|NCT03637049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102040277|NCT03637049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102040278|NCT03637049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040279|NCT03637049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102040280|NCT03637049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102040281|NCT03637049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102040282|NCT03637049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102040283|NCT03637049|Anesthetics, General|anesthetics, general|mesh-ancestor
102040284|NCT03637049|Anesthetics|anesthetics|mesh-ancestor
102040285|NCT03637049|GABA Modulators|gaba modulators|mesh-ancestor
102040286|NCT03637049|GABA Agents|gaba agents|mesh-ancestor
102040287|NCT03637049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102040288|NCT03637049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040289|NCT03636971|Mannitol|mannitol|mesh-list
102040290|NCT03636971|Sorbitol|sorbitol|mesh-list
102040291|NCT03636971|Hyaluronic Acid|hyaluronic acid|mesh-list
102040292|NCT03636971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102040293|NCT03636971|Immunologic Factors|immunologic factors|mesh-ancestor
102040294|NCT03636971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040309|NCT03657966|Gemcitabine|gemcitabine|mesh-list
102040310|NCT03657966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102040311|NCT03657966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102040312|NCT03657966|Tubulin Modulators|tubulin modulators|mesh-ancestor
102040313|NCT03657966|Antimitotic Agents|antimitotic agents|mesh-ancestor
102040314|NCT03657966|Mitosis Modulators|mitosis modulators|mesh-ancestor
102040315|NCT03657966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040316|NCT03657966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102040317|NCT03657966|Antimetabolites|antimetabolites|mesh-ancestor
102040318|NCT03659292|Anesthetics|anesthetics|mesh-list
102040319|NCT03659292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102040320|NCT03659292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040321|NCT03659058|Colchicine|colchicine|mesh-list
102040322|NCT03659058|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102040323|NCT03659058|Antioxidants|antioxidants|mesh-list
101971845|NCT00751231|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101971846|NCT00751231|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101971847|NCT00751231|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102040325|NCT03659058|Gout Suppressants|gout suppressants|mesh-ancestor
102040326|NCT03659058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102040327|NCT03659058|Tubulin Modulators|tubulin modulators|mesh-ancestor
102040328|NCT03659058|Antimitotic Agents|antimitotic agents|mesh-ancestor
102040329|NCT03659058|Mitosis Modulators|mitosis modulators|mesh-ancestor
102040330|NCT03659058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040331|NCT03659058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102040332|NCT03659058|Protective Agents|protective agents|mesh-ancestor
102040333|NCT03659058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040334|NCT03659058|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102040335|NCT03659058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102040336|NCT03635905|Gabapentin|gabapentin|mesh-list
102040337|NCT03635905|Analgesics|analgesics|mesh-ancestor
102040338|NCT03635905|Sensory System Agents|sensory system agents|mesh-ancestor
101760097|NCT00926926|Oxybutynin|oxybutynin|mesh-list
102040339|NCT03635905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102040340|NCT03635905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040341|NCT03635905|Anticonvulsants|anticonvulsants|mesh-ancestor
102040342|NCT03635905|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102040343|NCT03635905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102040344|NCT03635905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102040345|NCT03635905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102040346|NCT03635905|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102040347|NCT03635905|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102040348|NCT03635905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102040349|NCT03635905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040350|NCT03635905|Antimanic Agents|antimanic agents|mesh-ancestor
102040351|NCT02960113|Scopolamine|scopolamine|mesh-list
102040352|NCT02960113|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102040353|NCT02960113|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102040354|NCT02960113|Antiemetics|antiemetics|mesh-ancestor
102040355|NCT02960113|Autonomic Agents|autonomic agents|mesh-ancestor
102040356|NCT02960113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101341813|NCT01806753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102040390|NCT03657420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102040391|NCT03657420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102040392|NCT03657420|Growth Substances|growth substances|mesh-ancestor
102040393|NCT03657420|Growth Inhibitors|growth inhibitors|mesh-ancestor
102040394|NCT02984982|Anticoagulants|anticoagulants|mesh-list
102040395|NCT02984982|Atorvastatin|atorvastatin|mesh-list
102040396|NCT02984982|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102040397|NCT02984982|Ezetimibe|ezetimibe|mesh-list
102040398|NCT02984982|Alirocumab|alirocumab|mesh-list
102040411|NCT03656484|Metronidazole|metronidazole|mesh-list
102040412|NCT03656484|Tetracycline|tetracycline|mesh-list
102040413|NCT03656484|Melatonin|melatonin|mesh-list
102040414|NCT03656484|Hyaluronic Acid|hyaluronic acid|mesh-list
102040415|NCT03656484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102040416|NCT03656484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102040417|NCT03656484|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102040418|NCT03656484|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102040419|NCT03656484|Antioxidants|antioxidants|mesh-ancestor
102040420|NCT03656484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040421|NCT03656484|Protective Agents|protective agents|mesh-ancestor
102040422|NCT03656484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040423|NCT03656484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102040424|NCT03656484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102040425|NCT03656484|Immunologic Factors|immunologic factors|mesh-ancestor
102040426|NCT03656484|Viscosupplements|viscosupplements|mesh-ancestor
102040427|NCT03656484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102040428|NCT03656484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102040429|NCT04309578|Capecitabine|capecitabine|mesh-list
102040430|NCT04309578|Trastuzumab|trastuzumab|mesh-list
102040431|NCT04309578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102040432|NCT04309578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102040433|NCT04309578|Antimetabolites|antimetabolites|mesh-ancestor
102040434|NCT04309578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040435|NCT04309578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102040436|NCT03656952|Moxifloxacin|moxifloxacin|mesh-list
102040437|NCT03656952|PF-06700841|pf-06700841|mesh-list
101971848|NCT00751231|Purinergic Agents|purinergic agents|mesh-ancestor
101971849|NCT00751231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101306592|NCT02026518|Cholecalciferol|cholecalciferol|mesh-list
102040438|NCT03656952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102040439|NCT03656952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102040440|NCT03656952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102040441|NCT03656952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102040442|NCT03656952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102040443|NCT03656952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040444|NCT03656952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102040445|NCT03656952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102040446|NCT02981472|Vitamin K|vitamin k|mesh-list
102040447|NCT02981472|Heparin|heparin|mesh-list
102040448|NCT02981472|Enoxaparin|enoxaparin|mesh-list
102040449|NCT02981472|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102040450|NCT02981472|Tinzaparin|tinzaparin|mesh-list
102040451|NCT02981472|Dalteparin|dalteparin|mesh-list
102040452|NCT02981472|Warfarin|warfarin|mesh-list
102040453|NCT02981472|Apixaban|apixaban|mesh-list
102040454|NCT02981472|Vitamins|vitamins|mesh-ancestor
102040455|NCT02981472|Micronutrients|micronutrients|mesh-ancestor
102040456|NCT02981472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040457|NCT02981472|Anticoagulants|anticoagulants|mesh-ancestor
102040458|NCT02981472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102040459|NCT02981472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102040460|NCT02981472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040461|NCT02981472|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102040462|NCT02981472|Antithrombins|antithrombins|mesh-ancestor
102040463|NCT02981472|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101341914|NCT04846855|Anesthetics|anesthetics|mesh-list
102040482|NCT03656094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102040483|NCT03656094|Tubulin Modulators|tubulin modulators|mesh-ancestor
102040484|NCT03656094|Antimitotic Agents|antimitotic agents|mesh-ancestor
102040485|NCT03656094|Mitosis Modulators|mitosis modulators|mesh-ancestor
102040486|NCT03656094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695172|NCT02624505|Albuterol|albuterol|mesh-list
102040487|NCT03656094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102040488|NCT03656094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102040489|NCT03656094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102040490|NCT03656094|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102040491|NCT03656094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102040492|NCT03656094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102040494|NCT04298034|Nifedipine|nifedipine|mesh-list
102040495|NCT04298034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102040496|NCT04298034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102040497|NCT04298034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040498|NCT04298034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102040499|NCT04298034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040500|NCT04298034|Vasodilator Agents|vasodilator agents|mesh-ancestor
102040501|NCT04298034|Tocolytic Agents|tocolytic agents|mesh-ancestor
102040502|NCT04298034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102040503|NCT04298034|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102040504|NCT04298034|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102040505|NCT04298034|Adrenergic Agents|adrenergic agents|mesh-ancestor
102040506|NCT04298034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102040507|NCT04298034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102040508|NCT04298034|Sympathomimetics|sympathomimetics|mesh-ancestor
102040509|NCT04298034|Autonomic Agents|autonomic agents|mesh-ancestor
102040510|NCT04298034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102040511|NCT04298034|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102040512|NCT04298034|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102040513|NCT02982720|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102040514|NCT02982720|Pembrolizumab|pembrolizumab|mesh-list
102040515|NCT02982720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102040516|NCT02982720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102040517|NCT02982720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102040518|NCT02982720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040519|NCT02982720|Antiviral Agents|antiviral agents|mesh-ancestor
102040520|NCT02982720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102040521|NCT00849667|Carboplatin|carboplatin|mesh-list
102040547|NCT02924389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040549|NCT02924389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102040550|NCT02924389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101418642|NCT00138983|Vitamin D|vitamin d|mesh-list
102040551|NCT02924389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102040552|NCT02924389|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102040553|NCT02924389|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102040554|NCT01315093|Heparin|heparin|mesh-list
102040555|NCT01315093|Calcium heparin|calcium heparin|mesh-list
102040556|NCT01315093|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102040557|NCT01315093|Tinzaparin|tinzaparin|mesh-list
102040558|NCT01315093|Dalteparin|dalteparin|mesh-list
102040559|NCT01315093|Anticoagulants|anticoagulants|mesh-ancestor
102040560|NCT01315093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102040561|NCT01315093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102040562|NCT01315093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040563|NCT01331707|Everolimus|everolimus|mesh-list
102040564|NCT01331707|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102040565|NCT01331707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102040566|NCT01331707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102040567|NCT01331707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040568|NCT01331707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102040569|NCT01331707|Immunologic Factors|immunologic factors|mesh-ancestor
102040570|NCT01331707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040584|NCT03662711|Bronchodilator Agents|bronchodilator agents|mesh-list
102040585|NCT03662711|Olodaterol|olodaterol|mesh-list
102040586|NCT03662711|Autonomic Agents|autonomic agents|mesh-ancestor
101695173|NCT02624505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102040587|NCT03662711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102040588|NCT03662711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040589|NCT03662711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102040590|NCT03662711|Respiratory System Agents|respiratory system agents|mesh-ancestor
102040591|NCT02923531|Nivolumab|nivolumab|mesh-list
102040592|NCT02923531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102040593|NCT02923531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102040594|NCT02923531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102040595|NCT02923531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040596|NCT02934503|Carboplatin|carboplatin|mesh-list
102040597|NCT02934503|Pembrolizumab|pembrolizumab|mesh-list
102040598|NCT02934503|Etoposide|etoposide|mesh-list
102040599|NCT02934503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102040600|NCT02934503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102040601|NCT02934503|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102040602|NCT02934503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040603|NCT02934503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102040604|NCT02934503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102040605|NCT02934503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102040606|NCT02934503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102040607|NCT04563247|Antibodies|antibodies|mesh-list
102040608|NCT04563247|Immunologic Factors|immunologic factors|mesh-ancestor
102040609|NCT04563247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040610|NCT01314209|Dexmedetomidine|dexmedetomidine|mesh-list
102040611|NCT01314209|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102040612|NCT01314209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102040613|NCT01314209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040614|NCT01314209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102040615|NCT01314209|Analgesics|analgesics|mesh-ancestor
102040616|NCT01314209|Sensory System Agents|sensory system agents|mesh-ancestor
102040617|NCT01314209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102040618|NCT01314209|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102040619|NCT01314209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102040620|NCT01314209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102040621|NCT01314209|Adrenergic Agents|adrenergic agents|mesh-ancestor
102040622|NCT01314209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102040623|NCT01314209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040624|NCT05431075|Amoxicillin|amoxicillin|mesh-list
102040625|NCT05431075|Tetracycline|tetracycline|mesh-list
102040626|NCT05431075|Potassium Citrate|potassium citrate|mesh-list
102040627|NCT05431075|Esomeprazole|esomeprazole|mesh-list
102040628|NCT05431075|Bismuth|bismuth|mesh-list
102040629|NCT05431075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040630|NCT05431075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102040631|NCT05431075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102040645|NCT03636659|Amebicides|amebicides|mesh-ancestor
102040646|NCT03636659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102040647|NCT03636659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102040648|NCT03636659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102040649|NCT03636659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102040650|NCT03636659|Antifungal Agents|antifungal agents|mesh-ancestor
102040651|NCT04892173|Cetuximab|cetuximab|mesh-list
101971850|NCT00751231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971851|NCT00751231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040652|NCT04892173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102040653|NCT04892173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102040654|NCT03198767|Licogliflozin|licogliflozin|mesh-list
102040655|NCT03198767|Calcium Carbonate|calcium carbonate|mesh-list
102040656|NCT03198767|Psyllium|psyllium|mesh-list
102040657|NCT03198767|Calcium|calcium|mesh-list
102040658|NCT03198767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102040659|NCT03198767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040660|NCT03198767|Antacids|antacids|mesh-ancestor
102040661|NCT03198767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040662|NCT03198767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102040663|NCT03198767|Cathartics|cathartics|mesh-ancestor
102040664|NCT03198767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102040665|NCT03198767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102040666|NCT03162055|Glycopyrrolate|glycopyrrolate|mesh-list
102040667|NCT03162055|Formoterol Fumarate|formoterol fumarate|mesh-list
102040668|NCT03162055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102040669|NCT03162055|Autonomic Agents|autonomic agents|mesh-ancestor
102040670|NCT03162055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102040671|NCT03162055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040672|NCT03162055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102040673|NCT03162055|Respiratory System Agents|respiratory system agents|mesh-ancestor
102040674|NCT03162055|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102040675|NCT03162055|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102040676|NCT03162055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102040677|NCT03162055|Adrenergic Agents|adrenergic agents|mesh-ancestor
102040678|NCT03162055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102040679|NCT03162055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040680|NCT03162055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102040681|NCT03162055|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102040682|NCT03162055|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102040683|NCT03162055|Cholinergic Agents|cholinergic agents|mesh-ancestor
102040684|NCT01331785|Midodrine|midodrine|mesh-list
102040685|NCT01331785|Sympathomimetics|sympathomimetics|mesh-ancestor
102040686|NCT01331785|Autonomic Agents|autonomic agents|mesh-ancestor
102040687|NCT01331785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102040688|NCT01331785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040689|NCT01331785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102040690|NCT01331785|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102040691|NCT01331785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102040692|NCT01331785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102040693|NCT01331785|Adrenergic Agents|adrenergic agents|mesh-ancestor
102040694|NCT01331785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102040695|NCT01331785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040710|NCT01384227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102040712|NCT01382511|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102040713|NCT01382511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102040714|NCT01382511|Antimetabolites|antimetabolites|mesh-ancestor
102040715|NCT01382511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040716|NCT01382511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102040717|NCT01382511|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102040718|NCT01382511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102040719|NCT03684447|Propofol|propofol|mesh-list
101760464|NCT01049347|Analgesics|analgesics|mesh-ancestor
102040720|NCT03684447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102040721|NCT03684447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102040722|NCT03684447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040723|NCT03684447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102040724|NCT03684447|Anesthetics, General|anesthetics, general|mesh-ancestor
102040725|NCT03684447|Anesthetics|anesthetics|mesh-ancestor
102040726|NCT04505059|Anesthetics|anesthetics|mesh-list
102040727|NCT04505059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102040728|NCT04505059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040729|NCT01314599|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102040730|NCT04217135|Hydralazine|hydralazine|mesh-list
102040731|NCT04217135|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102040732|NCT04217135|Vasodilator Agents|vasodilator agents|mesh-ancestor
102040733|NCT01337401|Cediranib|cediranib|mesh-list
102040734|NCT01337401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102040735|NCT01337401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101971853|NCT00332956|Immunologic Factors|immunologic factors|mesh-ancestor
101971854|NCT00332956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040736|NCT01337401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102040737|NCT01337401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040738|NCT04178603|Insulin|insulin|mesh-list
102040739|NCT04178603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102040740|NCT04178603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040741|NCT01333891|Nitroprusside|nitroprusside|mesh-list
102040742|NCT01333891|Phenylephrine|phenylephrine|mesh-list
102040743|NCT01333891|Oxymetazoline|oxymetazoline|mesh-list
102040744|NCT01333891|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102040745|NCT01333891|Mydriatics|mydriatics|mesh-ancestor
102040746|NCT01333891|Autonomic Agents|autonomic agents|mesh-ancestor
102040747|NCT01333891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102040748|NCT01333891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040749|NCT01333891|Sympathomimetics|sympathomimetics|mesh-ancestor
102040750|NCT01333891|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102040751|NCT01333891|Nasal Decongestants|nasal decongestants|mesh-ancestor
102040752|NCT01333891|Respiratory System Agents|respiratory system agents|mesh-ancestor
102040753|NCT01333891|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102040754|NCT01333891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102040755|NCT01333891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102040774|NCT04853875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102040775|NCT04853875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040776|NCT04853875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102040777|NCT04853875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102040778|NCT04853875|Antacids|antacids|mesh-ancestor
102040779|NCT04853875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102040780|NCT04853875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102040781|NCT03196973|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101695217|NCT02784821|Gentamicins|gentamicins|mesh-list
102040782|NCT03196973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102040783|NCT03196973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102040784|NCT03196973|Antitubercular Agents|antitubercular agents|mesh-ancestor
102040785|NCT03196505|Bupivacaine|bupivacaine|mesh-list
102040786|NCT03196505|Anesthetics, Local|anesthetics, local|mesh-ancestor
102040787|NCT03196505|Anesthetics|anesthetics|mesh-ancestor
102040788|NCT03196505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102040789|NCT03196505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040790|NCT03196505|Sensory System Agents|sensory system agents|mesh-ancestor
102040791|NCT03196505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102040792|NCT01334047|Vaccines|vaccines|mesh-list
102040793|NCT01334047|Immunologic Factors|immunologic factors|mesh-ancestor
102040794|NCT01334047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040795|NCT01337557|Bepotastine besilate|bepotastine besilate|mesh-list
102040796|NCT01337557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101760543|NCT00391807|Estradiol|estradiol|mesh-list
102040797|NCT03196349|Warfarin|warfarin|mesh-list
102040798|NCT03196349|Rivaroxaban|rivaroxaban|mesh-list
102040799|NCT03196349|Apixaban|apixaban|mesh-list
102040800|NCT03196349|Anticoagulants|anticoagulants|mesh-ancestor
102040801|NCT03196349|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102040802|NCT03196349|Antithrombins|antithrombins|mesh-ancestor
102040803|NCT03196349|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102040804|NCT03196349|Protease Inhibitors|protease inhibitors|mesh-ancestor
102040805|NCT03196349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102040806|NCT03196349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040807|NCT01331941|Paclitaxel|paclitaxel|mesh-list
102040808|NCT01331941|Trebananib|trebananib|mesh-list
102040809|NCT01331941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102040810|NCT01331941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102040811|NCT01331941|Tubulin Modulators|tubulin modulators|mesh-ancestor
102040812|NCT01331941|Antimitotic Agents|antimitotic agents|mesh-ancestor
102040813|NCT01331941|Mitosis Modulators|mitosis modulators|mesh-ancestor
102040814|NCT01331941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040829|NCT01337791|Antiviral Agents|antiviral agents|mesh-ancestor
102040830|NCT01337791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102040831|NCT01337791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102040832|NCT01337791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102040833|NCT01337791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040835|NCT01334203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102040836|NCT01334203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102040837|NCT01334203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971856|NCT00324220|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101971857|NCT00324220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101971858|NCT00324220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418869|NCT00404261|Hormones|hormones|mesh-ancestor
102040838|NCT03085797|Mometasone Furoate|mometasone furoate|mesh-list
102040839|NCT03085797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102040840|NCT03085797|Dermatologic Agents|dermatologic agents|mesh-ancestor
102040841|NCT03085797|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102040842|NCT01569165|Fluorides|fluorides|mesh-list
102040843|NCT01569165|Fluorides, Topical|fluorides, topical|mesh-list
102040844|NCT01569165|Cariostatic Agents|cariostatic agents|mesh-ancestor
102040845|NCT01569165|Protective Agents|protective agents|mesh-ancestor
102040846|NCT01569165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040847|NCT04259749|Menthol|menthol|mesh-list
102040848|NCT04259749|Antipruritics|antipruritics|mesh-ancestor
102040849|NCT04259749|Dermatologic Agents|dermatologic agents|mesh-ancestor
102040850|NCT02535091|Cenobamate|cenobamate|mesh-list
102040851|NCT02535091|Anticonvulsants|anticonvulsants|mesh-ancestor
102040852|NCT01382277|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102040853|NCT01382277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102040854|NCT01382277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102040855|NCT01382277|Antimetabolites|antimetabolites|mesh-ancestor
102040856|NCT01382277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040857|NCT01382277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102040858|NCT01382277|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102040859|NCT01382277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102040860|NCT01382199|Lactoferrin|lactoferrin|mesh-list
102040861|NCT01382199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102040862|NCT01381497|Naproxen|naproxen|mesh-list
102040863|NCT01381497|Sumatriptan|sumatriptan|mesh-list
102040864|NCT01381497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102040865|NCT01381497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102040866|NCT01381497|Analgesics|analgesics|mesh-ancestor
102040867|NCT01381497|Sensory System Agents|sensory system agents|mesh-ancestor
102040868|NCT01381497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102040869|NCT01381497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040870|NCT01381497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102040871|NCT01381497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102040872|NCT01381497|Gout Suppressants|gout suppressants|mesh-ancestor
102040873|NCT01381497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102040874|NCT01381497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101760612|NCT00828087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102040875|NCT01381497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040877|NCT01381497|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102040896|NCT03635827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040897|NCT01338103|Rituximab|rituximab|mesh-list
102040898|NCT01338103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102040899|NCT01338103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102040900|NCT01338103|Immunologic Factors|immunologic factors|mesh-ancestor
102040901|NCT01338103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040902|NCT01338103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102040903|NCT03369665|Cladribine|cladribine|mesh-list
102040904|NCT03369665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102040905|NCT03369665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102040906|NCT03369665|Immunologic Factors|immunologic factors|mesh-ancestor
102040907|NCT03369665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040908|NCT03621761|Modafinil|modafinil|mesh-list
102040909|NCT03621761|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102040910|NCT03621761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040911|NCT03621761|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102040912|NCT03621761|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102040913|NCT03621761|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102040914|NCT03621761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040915|NCT03318861|Cyclophosphamide|cyclophosphamide|mesh-list
102040916|NCT03318861|Fludarabine|fludarabine|mesh-list
102040917|NCT03318861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102040918|NCT03318861|Immunologic Factors|immunologic factors|mesh-ancestor
102040919|NCT03318861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040920|NCT03318861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102040921|NCT03318861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101971859|NCT02287792|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101971860|NCT02287792|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101971861|NCT02287792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971862|NCT00417118|Escitalopram|escitalopram|mesh-list
102040922|NCT03318861|Alkylating Agents|alkylating agents|mesh-ancestor
102040923|NCT03318861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040924|NCT03318861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102040925|NCT03318861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102040927|NCT03084315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102040928|NCT03084315|Autonomic Agents|autonomic agents|mesh-ancestor
102040929|NCT03084315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102040930|NCT03084315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040931|NCT03084315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102040932|NCT03084315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102040933|NCT03084315|Cholinergic Agents|cholinergic agents|mesh-ancestor
102040950|NCT03187301|Dopamine Agonists|dopamine agonists|mesh-ancestor
102040951|NCT03187301|Dopamine Agents|dopamine agents|mesh-ancestor
102040952|NCT03187301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102040953|NCT01381185|Aspirin|aspirin|mesh-list
102040954|NCT01381185|Clopidogrel|clopidogrel|mesh-list
102040955|NCT01381185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102040956|NCT01381185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102040957|NCT01381185|Analgesics|analgesics|mesh-ancestor
102040958|NCT01381185|Sensory System Agents|sensory system agents|mesh-ancestor
102040959|NCT01381185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102040960|NCT01381185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040961|NCT01381185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102040962|NCT01381185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102040963|NCT01381185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102040964|NCT01381185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102040965|NCT01381185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040966|NCT01381185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102040967|NCT01381185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102040968|NCT01381185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102040969|NCT01381185|Antipyretics|antipyretics|mesh-ancestor
102040970|NCT01381185|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102040971|NCT01381185|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102040972|NCT01381185|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102040973|NCT01381185|Purinergic Agents|purinergic agents|mesh-ancestor
102040974|NCT01381185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102040975|NCT02946047|Ixazomib|ixazomib|mesh-list
102040976|NCT02946047|Glycine|glycine|mesh-list
102040977|NCT02946047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102040978|NCT02946047|Protease Inhibitors|protease inhibitors|mesh-ancestor
102040979|NCT02946047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102040980|NCT02946047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040981|NCT02946047|Glycine Agents|glycine agents|mesh-ancestor
102040982|NCT02946047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102040983|NCT02946047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040984|NCT05421897|Cyclophosphamide|cyclophosphamide|mesh-list
102040985|NCT05421897|Temozolomide|temozolomide|mesh-list
102040986|NCT05421897|Irinotecan|irinotecan|mesh-list
102040987|NCT05421897|Topotecan|topotecan|mesh-list
102040988|NCT05421897|Dinutuximab|dinutuximab|mesh-list
102040989|NCT05421897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102040990|NCT05421897|Immunologic Factors|immunologic factors|mesh-ancestor
102040991|NCT05421897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040992|NCT05421897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102040993|NCT05421897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102040994|NCT05421897|Alkylating Agents|alkylating agents|mesh-ancestor
102041005|NCT03077919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041006|NCT03077919|Sensory System Agents|sensory system agents|mesh-ancestor
102041007|NCT03077919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102041008|NCT01380951|Telbivudine|telbivudine|mesh-list
102041009|NCT01380951|Antiviral Agents|antiviral agents|mesh-ancestor
102041010|NCT01380951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102041011|NCT01380951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102041012|NCT01380951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102041013|NCT01380951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041014|NCT01377597|Ranibizumab|ranibizumab|mesh-list
102041015|NCT01377597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101971863|NCT00417118|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101695261|NCT04230083|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101971864|NCT00417118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101971865|NCT00417118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101971866|NCT00417118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971867|NCT00417118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102041016|NCT01377597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102041017|NCT01377597|Growth Substances|growth substances|mesh-ancestor
102041018|NCT01377597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041019|NCT01377597|Growth Inhibitors|growth inhibitors|mesh-ancestor
102041020|NCT01377597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102041021|NCT03204695|Clopidogrel|clopidogrel|mesh-list
102041022|NCT03204695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102041023|NCT03204695|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102041024|NCT03204695|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102041025|NCT03204695|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102041026|NCT03204695|Purinergic Agents|purinergic agents|mesh-ancestor
102041027|NCT03204695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102041028|NCT03204695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041029|NCT03204695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041031|NCT03287375|Doxorubicin|doxorubicin|mesh-list
102041032|NCT03287375|Oxaliplatin|oxaliplatin|mesh-list
102041033|NCT03287375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102041034|NCT03287375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102041035|NCT03287375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102041036|NCT03287375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102041037|NCT03287375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102041038|NCT03287375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041039|NCT03881059|Ustekinumab|ustekinumab|mesh-list
102041040|NCT03881059|Deucravacitinib|deucravacitinib|mesh-list
102041041|NCT03881059|Dermatologic Agents|dermatologic agents|mesh-ancestor
102041042|NCT03881059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102041043|NCT03881059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102041044|NCT03881059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041045|NCT01338337|Azacitidine|azacitidine|mesh-list
102041046|NCT01338337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102041047|NCT01338337|Antimetabolites|antimetabolites|mesh-ancestor
102041048|NCT01338337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041049|NCT01338337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102041050|NCT01338337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102041051|NCT03083847|Chloroquine|chloroquine|mesh-list
102041052|NCT03083847|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
102041053|NCT03083847|Pyrimethamine|pyrimethamine|mesh-list
102041054|NCT03083847|Amebicides|amebicides|mesh-ancestor
102041055|NCT03083847|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102041056|NCT03083847|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102041057|NCT03083847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102041058|NCT03083847|Antimalarials|antimalarials|mesh-ancestor
102041059|NCT03083847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102041107|NCT03609086|Melatonin|melatonin|mesh-list
102041108|NCT03609086|Antioxidants|antioxidants|mesh-ancestor
102041109|NCT03609086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041110|NCT03609086|Protective Agents|protective agents|mesh-ancestor
102041111|NCT03609086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041112|NCT03609086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102041113|NCT00730717|Adalimumab|adalimumab|mesh-list
102041114|NCT00730717|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102041115|NCT00730717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102041116|NCT00730717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102041117|NCT01332409|Fluticasone|fluticasone|mesh-list
102041118|NCT01332409|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102041119|NCT01332409|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102041120|NCT01332409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102041121|NCT01332409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102041122|NCT01332409|Autonomic Agents|autonomic agents|mesh-ancestor
102041123|NCT01332409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101695280|NCT00645866|Antimetabolites|antimetabolites|mesh-ancestor
102041124|NCT01332409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041125|NCT01332409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101971869|NCT00417118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971870|NCT02883452|Infliximab|infliximab|mesh-list
101971871|NCT02883452|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101971872|NCT02883452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101419092|NCT00140582|Rituximab|rituximab|mesh-list
102041126|NCT01332409|Respiratory System Agents|respiratory system agents|mesh-ancestor
102041127|NCT01332409|Dermatologic Agents|dermatologic agents|mesh-ancestor
102041128|NCT01332409|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102041129|NCT01332409|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102041130|NCT01332409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102041131|NCT01332409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102041132|NCT01332409|Adrenergic Agents|adrenergic agents|mesh-ancestor
102041133|NCT01332409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102041134|NCT01332409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041135|NCT01332409|Glucocorticoids|glucocorticoids|mesh-ancestor
102041136|NCT01332409|Hormones|hormones|mesh-ancestor
102041137|NCT01332409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102041138|NCT01332409|Sympathomimetics|sympathomimetics|mesh-ancestor
102041139|NCT03181451|Ferric maltol|ferric maltol|mesh-list
102041140|NCT03181451|Hematinics|hematinics|mesh-ancestor
102041141|NCT03495973|Ustekinumab|ustekinumab|mesh-list
102041142|NCT03495973|Dermatologic Agents|dermatologic agents|mesh-ancestor
102041156|NCT00480805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102041157|NCT00480805|Protease Inhibitors|protease inhibitors|mesh-ancestor
102041158|NCT00480805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102041159|NCT00406783|Desloratadine|desloratadine|mesh-list
102041160|NCT00406783|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102041161|NCT00406783|Cholinergic Agents|cholinergic agents|mesh-ancestor
102041162|NCT00406783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102041163|NCT00406783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041164|NCT00406783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041165|NCT00406783|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102041166|NCT00406783|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102041167|NCT00406783|Histamine Antagonists|histamine antagonists|mesh-ancestor
102041168|NCT00406783|Histamine Agents|histamine agents|mesh-ancestor
102041169|NCT03179891|Diazepam|diazepam|mesh-list
102041170|NCT03179891|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102041171|NCT03179891|Anticonvulsants|anticonvulsants|mesh-ancestor
102041172|NCT03179891|Antiemetics|antiemetics|mesh-ancestor
102041173|NCT03179891|Autonomic Agents|autonomic agents|mesh-ancestor
102041174|NCT03179891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102041175|NCT03179891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041176|NCT03179891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102041177|NCT03179891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102041178|NCT03179891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102041179|NCT03179891|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102041180|NCT03179891|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102041181|NCT03179891|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102041182|NCT03179891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102041183|NCT03179891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102041184|NCT03179891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102041185|NCT03179891|Anesthetics, General|anesthetics, general|mesh-ancestor
102041186|NCT03179891|Anesthetics|anesthetics|mesh-ancestor
102041187|NCT03179891|GABA Modulators|gaba modulators|mesh-ancestor
102041188|NCT03179891|GABA Agents|gaba agents|mesh-ancestor
102041189|NCT03179891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102041190|NCT03179891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041191|NCT01334671|Atorvastatin|atorvastatin|mesh-list
102041192|NCT01334671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102041193|NCT01334671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102041194|NCT01334671|Antimetabolites|antimetabolites|mesh-ancestor
102041195|NCT01334671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041196|NCT01334671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102041197|NCT01334671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101695288|NCT05221151|Analgesics|analgesics|mesh-ancestor
102041198|NCT01334671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102041199|NCT01332565|Dolutegravir|dolutegravir|mesh-list
102041200|NCT01332565|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102041201|NCT01332565|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102041202|NCT01332565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101971874|NCT02883452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101342657|NCT00010322|Hormone Antagonists|hormone antagonists|mesh-ancestor
102041221|NCT02736227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102041222|NCT01334905|Mirabegron|mirabegron|mesh-list
102041223|NCT01334905|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102041224|NCT01334905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102041225|NCT01334905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102041226|NCT01334905|Adrenergic Agents|adrenergic agents|mesh-ancestor
102041227|NCT01334905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102041228|NCT01334905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041229|NCT01334905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041230|NCT01334905|Urological Agents|urological agents|mesh-ancestor
102041231|NCT01335139|Immunomodulating Agents|immunomodulating agents|mesh-list
102041232|NCT01335139|Immunologic Factors|immunologic factors|mesh-list
102041233|NCT01335139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041234|NCT05030129|Vitamin B 6|vitamin b 6|mesh-list
102041235|NCT05030129|Pyridoxal|pyridoxal|mesh-list
102041236|NCT05030129|Pyridoxine|pyridoxine|mesh-list
102041237|NCT05030129|Ergoloid Mesylates|ergoloid mesylates|mesh-list
102041238|NCT05030129|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
102041239|NCT05030129|Dihydroergotoxine|dihydroergotoxine|mesh-list
102041240|NCT05030129|Vitamins|vitamins|mesh-ancestor
102041241|NCT05030129|Micronutrients|micronutrients|mesh-ancestor
102041242|NCT05030129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041243|NCT05030129|Vitamin B Complex|vitamin b complex|mesh-ancestor
102041244|NCT05030129|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102041245|NCT05030129|Antidepressive Agents|antidepressive agents|mesh-ancestor
102041246|NCT05030129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102041247|NCT05030129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102041248|NCT05030129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102041249|NCT05030129|Adrenergic Agents|adrenergic agents|mesh-ancestor
102041250|NCT05030129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102041251|NCT05030129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041253|NCT05030129|Nootropic Agents|nootropic agents|mesh-ancestor
102041254|NCT05030129|Dopamine Agonists|dopamine agonists|mesh-ancestor
102041255|NCT05030129|Dopamine Agents|dopamine agents|mesh-ancestor
102041256|NCT01339039|Plerixafor|plerixafor|mesh-list
102041257|NCT01339039|Bevacizumab|bevacizumab|mesh-list
102041258|NCT01339039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102041259|NCT01339039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102041260|NCT01339039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102041275|NCT03176459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102041277|NCT01332955|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102041278|NCT01332955|Antimetabolites|antimetabolites|mesh-ancestor
102041279|NCT01332955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041280|NCT01332955|Antiviral Agents|antiviral agents|mesh-ancestor
102041281|NCT01332955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102041282|NCT05224895|Anesthetics|anesthetics|mesh-list
102041283|NCT05224895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102041284|NCT05224895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041285|NCT01335373|Metronidazole|metronidazole|mesh-list
102041286|NCT01335373|Miconazole|miconazole|mesh-list
102041287|NCT01335373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102041288|NCT01335373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102041289|NCT01335373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102041290|NCT01335373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102041291|NCT01335373|Antifungal Agents|antifungal agents|mesh-ancestor
102041292|NCT01335373|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102041293|NCT01335373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102041294|NCT01335373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102041295|NCT01335373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041296|NCT01335373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102041297|NCT01335373|Hormone Antagonists|hormone antagonists|mesh-ancestor
102041298|NCT01335373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102041299|NCT01335373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041300|NCT01335373|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102041301|NCT01335373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102041302|NCT01333267|Hormones|hormones|mesh-list
102041303|NCT01333267|Anabolic Androgenic Steroids|anabolic androgenic steroids|mesh-list
102041304|NCT01333267|Testosterone Congeners|testosterone congeners|mesh-list
102041305|NCT01333267|Parathyroid Hormone|parathyroid hormone|mesh-list
102041306|NCT01333267|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
101971875|NCT02883452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101971877|NCT00508066|Anesthetics, Local|anesthetics, local|mesh-ancestor
101971878|NCT00508066|Anesthetics|anesthetics|mesh-ancestor
101971879|NCT00508066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102041307|NCT01333267|Anabolic Agents|anabolic agents|mesh-list
102041308|NCT01333267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102041309|NCT01333267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041310|NCT01333267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102041311|NCT01333267|Performance-Enhancing Substances|performance-enhancing substances|mesh-ancestor
102041312|NCT01335529|Interferons|interferons|mesh-list
102041313|NCT01335529|Ribavirin|ribavirin|mesh-list
102041314|NCT01335529|Interferon-alpha|interferon-alpha|mesh-list
102041315|NCT01335529|Interferon alpha-2|interferon alpha-2|mesh-list
102041316|NCT01335529|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102041317|NCT01335529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102041318|NCT01335529|Antiviral Agents|antiviral agents|mesh-ancestor
102041319|NCT01335529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102041320|NCT01335529|Antimetabolites|antimetabolites|mesh-ancestor
102041329|NCT00308347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041330|NCT02186834|Dexamethasone|dexamethasone|mesh-list
102041331|NCT02186834|Doxorubicin|doxorubicin|mesh-list
102041332|NCT02186834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102041333|NCT02186834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102041334|NCT02186834|Antiemetics|antiemetics|mesh-ancestor
102041335|NCT02186834|Autonomic Agents|autonomic agents|mesh-ancestor
102041336|NCT02186834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102041337|NCT02186834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041338|NCT02186834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102041339|NCT02186834|Glucocorticoids|glucocorticoids|mesh-ancestor
102041340|NCT02186834|Hormones|hormones|mesh-ancestor
102041341|NCT02186834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102041342|NCT02186834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102041343|NCT02186834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102041344|NCT02186834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102041345|NCT02186834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102041346|NCT02186834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102041347|NCT02186834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102041348|NCT02186834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041349|NCT04335890|Vaccines|vaccines|mesh-list
102041350|NCT04335890|Immunologic Factors|immunologic factors|mesh-ancestor
102041351|NCT04335890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041352|NCT01379157|Imipenem|imipenem|mesh-list
102041353|NCT01379157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102041354|NCT01379157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102041355|NCT01538966|Octreotide|octreotide|mesh-list
102041356|NCT01538966|Lanreotide|lanreotide|mesh-list
102041357|NCT01538966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102041358|NCT01538966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102041359|NCT01538966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102041360|NCT01377285|Pentoxifylline|pentoxifylline|mesh-list
102041361|NCT01377285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
102041362|NCT01377285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102041363|NCT01377285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102041364|NCT01377285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041365|NCT01377285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102041366|NCT01377285|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102041367|NCT01377285|Protective Agents|protective agents|mesh-ancestor
102041368|NCT01377285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041369|NCT01377285|Vasodilator Agents|vasodilator agents|mesh-ancestor
102041370|NCT01377285|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102041371|NCT01377285|Antioxidants|antioxidants|mesh-ancestor
102041372|NCT02905266|Nivolumab|nivolumab|mesh-list
102041373|NCT02905266|Ipilimumab|ipilimumab|mesh-list
102041374|NCT02905266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102041375|NCT02905266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102041376|NCT02905266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102041377|NCT02905266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041378|NCT01380717|Calcium Channel Blockers|calcium channel blockers|mesh-list
102041379|NCT01380717|Calcium|calcium|mesh-list
102041380|NCT01380717|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102041381|NCT01380717|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101971880|NCT00508066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971881|NCT00508066|Sensory System Agents|sensory system agents|mesh-ancestor
101971882|NCT00508066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102041382|NCT01380717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102041383|NCT01380717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041403|NCT03080493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102041404|NCT03080493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102041405|NCT03080493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102041406|NCT03080493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102041407|NCT03080493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041408|NCT03080493|Anticonvulsants|anticonvulsants|mesh-ancestor
102041409|NCT03080493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102041410|NCT03080493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102041411|NCT03080493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102041412|NCT03080493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102041413|NCT03080493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102041414|NCT03080493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102041415|NCT03080493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102041416|NCT03080493|Antimanic Agents|antimanic agents|mesh-ancestor
102041417|NCT03080493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102041418|NCT03080493|Narcotics|narcotics|mesh-ancestor
102041419|NCT03080493|Antitussive Agents|antitussive agents|mesh-ancestor
102041420|NCT03080493|Respiratory System Agents|respiratory system agents|mesh-ancestor
102041421|NCT03080493|Laxatives|laxatives|mesh-ancestor
102041422|NCT03080493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102041423|NCT02906007|Bedaquiline|bedaquiline|mesh-list
102041424|NCT02906007|Antitubercular Agents|antitubercular agents|mesh-ancestor
102041425|NCT02906007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102041426|NCT02906007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102041427|NCT01339910|Vidarabine|vidarabine|mesh-list
102041428|NCT01339910|Cyclophosphamide|cyclophosphamide|mesh-list
102041429|NCT01339910|Melphalan|melphalan|mesh-list
102041430|NCT01339910|Busulfan|busulfan|mesh-list
102041431|NCT01339910|Fludarabine|fludarabine|mesh-list
102041432|NCT01339910|Fludarabine phosphate|fludarabine phosphate|mesh-list
102041433|NCT01339910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102041434|NCT01339910|Immunologic Factors|immunologic factors|mesh-ancestor
102041435|NCT01339910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041436|NCT01339910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102041437|NCT01339910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102041438|NCT01339910|Alkylating Agents|alkylating agents|mesh-ancestor
102041439|NCT01339910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041440|NCT01339910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342899|NCT00847314|Testosterone|testosterone|mesh-list
102041457|NCT03655392|Antioxidants|antioxidants|mesh-ancestor
102041458|NCT03655392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041459|NCT03655392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102041460|NCT03655392|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102041461|NCT03655392|Vasodilator Agents|vasodilator agents|mesh-ancestor
102041462|NCT03655392|Gasotransmitters|gasotransmitters|mesh-ancestor
102041463|NCT03655392|Protective Agents|protective agents|mesh-ancestor
102041464|NCT03608618|Cyclophosphamide|cyclophosphamide|mesh-list
102041465|NCT03608618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102041466|NCT03608618|Immunologic Factors|immunologic factors|mesh-ancestor
102041467|NCT03608618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041468|NCT03608618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102041469|NCT03608618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102041470|NCT03608618|Alkylating Agents|alkylating agents|mesh-ancestor
102041471|NCT03608618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041472|NCT03608618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102041473|NCT03608618|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102041474|NCT04203290|Bupivacaine|bupivacaine|mesh-list
102041475|NCT04203290|Sevoflurane|sevoflurane|mesh-list
102041476|NCT04203290|Anesthetics, Local|anesthetics, local|mesh-ancestor
102041477|NCT04203290|Anesthetics|anesthetics|mesh-ancestor
102041478|NCT04203290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102041479|NCT04203290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041480|NCT04203290|Sensory System Agents|sensory system agents|mesh-ancestor
102041481|NCT04203290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102041482|NCT04203290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102041483|NCT04203290|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102041484|NCT04203290|Anesthetics, General|anesthetics, general|mesh-ancestor
101971883|NCT01336010|Ribavirin|ribavirin|mesh-list
101971884|NCT01336010|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101971885|NCT01336010|Antimetabolites|antimetabolites|mesh-ancestor
101333860|NCT00017394|Vinorelbine|vinorelbine|mesh-list
102041485|NCT02981082|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102041486|NCT02981082|Dermatologic Agents|dermatologic agents|mesh-ancestor
102041487|NCT02981082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102041488|NCT02981082|Immunologic Factors|immunologic factors|mesh-ancestor
102041489|NCT02981082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041490|NCT03654612|Apatinib|apatinib|mesh-list
102041491|NCT03654612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102041492|NCT03654612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102041493|NCT03654612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102041494|NCT03654612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041495|NCT01066104|Omalizumab|omalizumab|mesh-list
102041496|NCT01066104|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102041497|NCT01066104|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102041498|NCT01066104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101342951|NCT00012194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102041510|NCT03608306|Dopamine Agents|dopamine agents|mesh-ancestor
102041511|NCT03608306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101695343|NCT02783183|Anticonvulsants|anticonvulsants|mesh-ancestor
102041512|NCT03608306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041513|NCT03608306|Adrenergic Agents|adrenergic agents|mesh-ancestor
102041514|NCT03608306|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102041515|NCT03608306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102041516|NCT03608306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102041517|NCT03608306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102041518|NCT03654144|Dienogest|dienogest|mesh-list
102041519|NCT03654144|Contraceptive Agents|contraceptive agents|mesh-list
102041520|NCT03654144|Contraceptives, Oral|contraceptives, oral|mesh-list
102041521|NCT03654144|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
102041522|NCT03654144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102041523|NCT03654144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041524|NCT03654144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102041525|NCT03654144|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102041526|NCT03654144|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102041527|NCT03654144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102041528|NCT03654144|Hormone Antagonists|hormone antagonists|mesh-ancestor
102041529|NCT03654144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102041530|NCT03654144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102041531|NCT03654144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102041532|NCT02591615|Paclitaxel|paclitaxel|mesh-list
102041533|NCT02591615|Carboplatin|carboplatin|mesh-list
102041534|NCT02591615|Pembrolizumab|pembrolizumab|mesh-list
102041535|NCT02591615|Pemetrexed|pemetrexed|mesh-list
102041536|NCT02591615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102041537|NCT02591615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102041538|NCT02591615|Tubulin Modulators|tubulin modulators|mesh-ancestor
102041539|NCT02591615|Antimitotic Agents|antimitotic agents|mesh-ancestor
102041540|NCT02591615|Mitosis Modulators|mitosis modulators|mesh-ancestor
102041541|NCT02591615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041542|NCT02591615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102041543|NCT02591615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102041544|NCT02591615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102041545|NCT02591615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102041546|NCT02591615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102041547|NCT03077607|Itraconazole|itraconazole|mesh-list
101761288|NCT00743886|Mitosis Modulators|mitosis modulators|mesh-ancestor
102041548|NCT03077607|Rifampin|rifampin|mesh-list
102041549|NCT03077607|Talazoparib|talazoparib|mesh-list
102041550|NCT03077607|Antifungal Agents|antifungal agents|mesh-ancestor
102041551|NCT03077607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102041552|NCT03077607|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102041553|NCT03077607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102041554|NCT03077607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102041555|NCT03077607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041556|NCT03077607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102041557|NCT03077607|Hormone Antagonists|hormone antagonists|mesh-ancestor
102041558|NCT03077607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101343012|NCT00846885|Serotonin Agents|serotonin agents|mesh-ancestor
102041571|NCT03077607|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101971886|NCT01336010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971887|NCT01336010|Antiviral Agents|antiviral agents|mesh-ancestor
101971888|NCT01336010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101971890|NCT02207504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102041572|NCT03077607|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102041573|NCT03077607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102041574|NCT04215588|Hemostatics|hemostatics|mesh-list
102041575|NCT04215588|Coagulants|coagulants|mesh-ancestor
102041576|NCT01377051|Maleic acid|maleic acid|mesh-list
102041577|NCT01377051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102041578|NCT01377051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041579|NCT03217175|Glucagon|glucagon|mesh-list
102041580|NCT03217175|Pancrelipase|pancrelipase|mesh-list
102041581|NCT03217175|Pancreatin|pancreatin|mesh-list
102041582|NCT03217175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041583|NCT03217175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102041584|NCT03217175|Hormones|hormones|mesh-ancestor
102041585|NCT03217175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102041586|NCT01379079|Aspirin|aspirin|mesh-list
102041587|NCT01379079|Calcium, Dietary|calcium, dietary|mesh-list
102041588|NCT01379079|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
102041589|NCT01379079|Carbaspirin calcium|carbaspirin calcium|mesh-list
102041590|NCT01379079|Calcium|calcium|mesh-list
102041591|NCT01379079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102041592|NCT01379079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041593|NCT01379079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102041594|NCT01379079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102041595|NCT01379079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102041596|NCT01379079|Analgesics|analgesics|mesh-ancestor
102041597|NCT01379079|Sensory System Agents|sensory system agents|mesh-ancestor
102041598|NCT01379079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102041599|NCT01379079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102041600|NCT01379079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102041601|NCT01379079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102041602|NCT01379079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102041603|NCT01379079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041604|NCT01379079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102041605|NCT01379079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102041606|NCT01379079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102041607|NCT01379079|Antipyretics|antipyretics|mesh-ancestor
102041608|NCT02034968|Nimotuzumab|nimotuzumab|mesh-list
102041609|NCT02034968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102041610|NCT02034968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102041611|NCT01379001|Scopolamine|scopolamine|mesh-list
102041612|NCT01379001|Donepezil|donepezil|mesh-list
102041613|NCT01379001|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102041614|NCT01379001|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102041615|NCT01379001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102041616|NCT01379001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041617|NCT01379001|Cholinergic Agents|cholinergic agents|mesh-ancestor
101343077|NCT00846690|Lidocaine|lidocaine|mesh-list
102041632|NCT03172325|Adalimumab|adalimumab|mesh-list
102041633|NCT03172325|Methotrexate|methotrexate|mesh-list
102041634|NCT03172325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102041635|NCT03172325|Abortifacient Agents|abortifacient agents|mesh-ancestor
102041636|NCT03172325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102041637|NCT03172325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041638|NCT03172325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102041639|NCT03172325|Antimetabolites|antimetabolites|mesh-ancestor
102041640|NCT03172325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041641|NCT03172325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102041642|NCT03172325|Dermatologic Agents|dermatologic agents|mesh-ancestor
102041643|NCT03172325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102041644|NCT03172325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102041645|NCT03172325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102041646|NCT03172325|Immunologic Factors|immunologic factors|mesh-ancestor
102041647|NCT03172325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102041648|NCT03172325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102041649|NCT03172325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101971891|NCT02207504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101971892|NCT02207504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101971893|NCT02207504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971894|NCT01342016|Prednisone|prednisone|mesh-list
102041650|NCT03172325|Glucocorticoids|glucocorticoids|mesh-ancestor
102041651|NCT03172325|Hormones|hormones|mesh-ancestor
102041652|NCT03172325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102041653|NCT03172325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102041654|NCT03172325|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102041655|NCT03172325|Hematinics|hematinics|mesh-ancestor
102041656|NCT03172325|Vitamin B Complex|vitamin b complex|mesh-ancestor
102041657|NCT03172325|Vitamins|vitamins|mesh-ancestor
102041658|NCT03172325|Micronutrients|micronutrients|mesh-ancestor
102041659|NCT03653520|Diazepam|diazepam|mesh-list
102041660|NCT03653520|Tramadol|tramadol|mesh-list
102041661|NCT03653520|Ondansetron|ondansetron|mesh-list
102041662|NCT03653520|Antiemetics|antiemetics|mesh-ancestor
102041663|NCT03653520|Autonomic Agents|autonomic agents|mesh-ancestor
102041664|NCT03653520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102041665|NCT03653520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041666|NCT03653520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102041667|NCT03653520|Antipruritics|antipruritics|mesh-ancestor
102041668|NCT03653520|Dermatologic Agents|dermatologic agents|mesh-ancestor
102041669|NCT03653520|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102041670|NCT03653520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102041671|NCT03653520|Serotonin Agents|serotonin agents|mesh-ancestor
102041672|NCT03653520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102041673|NCT03653520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041674|NCT03653520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102041675|NCT03653520|Narcotics|narcotics|mesh-ancestor
102041676|NCT03653520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102041677|NCT03653520|Analgesics|analgesics|mesh-ancestor
102041678|NCT03653520|Sensory System Agents|sensory system agents|mesh-ancestor
102041679|NCT03653520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102041680|NCT03653520|Anticonvulsants|anticonvulsants|mesh-ancestor
102041681|NCT03653520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102041697|NCT01208090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041698|NCT01380483|Doxycycline|doxycycline|mesh-list
102041699|NCT01380483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102041700|NCT01380483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102041701|NCT01380483|Antimalarials|antimalarials|mesh-ancestor
102041702|NCT01380483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102041703|NCT01380483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102041704|NCT02745392|Zolmitriptan|zolmitriptan|mesh-list
102041705|NCT02745392|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102041706|NCT02745392|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102041707|NCT02745392|Serotonin Agents|serotonin agents|mesh-ancestor
102041708|NCT02745392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102041709|NCT02745392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041710|NCT02745392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041711|NCT01378845|Bosentan|bosentan|mesh-list
102041712|NCT01378845|Alprostadil|alprostadil|mesh-list
102041713|NCT01378845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102041714|NCT01378845|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102041715|NCT01378845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041716|NCT01378845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102041717|NCT01378845|Vasodilator Agents|vasodilator agents|mesh-ancestor
102041718|NCT01378845|Urological Agents|urological agents|mesh-ancestor
102041719|NCT04884399|Ranibizumab|ranibizumab|mesh-list
102041720|NCT04884399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102041721|NCT04884399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102041722|NCT04884399|Growth Substances|growth substances|mesh-ancestor
102041723|NCT04884399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041724|NCT04884399|Growth Inhibitors|growth inhibitors|mesh-ancestor
102041725|NCT04884399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102041726|NCT04904549|Vaccines|vaccines|mesh-list
102041727|NCT04904549|Immunologic Factors|immunologic factors|mesh-ancestor
102041728|NCT04904549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041729|NCT03607916|Morphine|morphine|mesh-list
102041730|NCT03607916|Prilocaine|prilocaine|mesh-list
102041731|NCT03607916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102041732|NCT03607916|Narcotics|narcotics|mesh-ancestor
101695373|NCT00693381|Antiemetics|antiemetics|mesh-ancestor
102041733|NCT03607916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101971895|NCT01342016|Tacrolimus|tacrolimus|mesh-list
101971896|NCT01342016|Leflunomide|leflunomide|mesh-list
101971897|NCT01342016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101971898|NCT01342016|Glucocorticoids|glucocorticoids|mesh-ancestor
101971899|NCT01342016|Hormones|hormones|mesh-ancestor
102041734|NCT03607916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041735|NCT03607916|Analgesics|analgesics|mesh-ancestor
102041736|NCT03607916|Sensory System Agents|sensory system agents|mesh-ancestor
102041737|NCT03607916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102041738|NCT03607916|Anesthetics, Local|anesthetics, local|mesh-ancestor
102041739|NCT03607916|Anesthetics|anesthetics|mesh-ancestor
102041740|NCT01141712|Cytarabine|cytarabine|mesh-list
102041741|NCT01141712|Etoposide|etoposide|mesh-list
102041742|NCT01141712|Melphalan|melphalan|mesh-list
102041743|NCT01141712|Carmustine|carmustine|mesh-list
101343192|NCT00845988|Dopamine Agonists|dopamine agonists|mesh-ancestor
102041755|NCT01141712|Immunologic Factors|immunologic factors|mesh-ancestor
102041756|NCT01141712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041757|NCT01141712|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102041758|NCT01141712|Alkylating Agents|alkylating agents|mesh-ancestor
102041759|NCT01141712|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102041760|NCT02034890|Hyaluronic Acid|hyaluronic acid|mesh-list
102041761|NCT02034890|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102041762|NCT02034890|Immunologic Factors|immunologic factors|mesh-ancestor
102041763|NCT02034890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041764|NCT02034890|Viscosupplements|viscosupplements|mesh-ancestor
102041765|NCT02034890|Protective Agents|protective agents|mesh-ancestor
102041766|NCT02015351|Bevacizumab|bevacizumab|mesh-list
102041767|NCT02015351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102041768|NCT02015351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102041769|NCT02015351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102041770|NCT02015351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101761513|NCT00841581|Ranibizumab|ranibizumab|mesh-list
102041771|NCT02015351|Growth Substances|growth substances|mesh-ancestor
102041772|NCT02015351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041773|NCT02015351|Growth Inhibitors|growth inhibitors|mesh-ancestor
102041774|NCT03604796|Acetaminophen|acetaminophen|mesh-list
102041775|NCT03604796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102041776|NCT03604796|Analgesics|analgesics|mesh-ancestor
102041777|NCT03604796|Sensory System Agents|sensory system agents|mesh-ancestor
102041778|NCT03604796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102041779|NCT03604796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041780|NCT03604796|Antipyretics|antipyretics|mesh-ancestor
102041781|NCT02237534|Calcium Carbonate|calcium carbonate|mesh-list
102041782|NCT02237534|Calcium|calcium|mesh-list
102041783|NCT02237534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102041784|NCT02237534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041785|NCT02237534|Antacids|antacids|mesh-ancestor
102041786|NCT02237534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041787|NCT02237534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102041788|NCT03606902|Fentanyl|fentanyl|mesh-list
102041789|NCT03606902|Bupivacaine|bupivacaine|mesh-list
102041790|NCT03606902|Anesthetics, Local|anesthetics, local|mesh-ancestor
102041791|NCT03606902|Anesthetics|anesthetics|mesh-ancestor
102041792|NCT03606902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101695389|NCT02663960|Chelating Agents|chelating agents|mesh-ancestor
102041793|NCT03606902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041794|NCT03606902|Sensory System Agents|sensory system agents|mesh-ancestor
102041795|NCT03606902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102041796|NCT03606902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102041797|NCT03606902|Narcotics|narcotics|mesh-ancestor
102041798|NCT03606902|Analgesics|analgesics|mesh-ancestor
102041799|NCT03606902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102041800|NCT03606902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102041801|NCT03606902|Anesthetics, General|anesthetics, general|mesh-ancestor
102041802|NCT03602378|Hydrocortisone|hydrocortisone|mesh-list
102041803|NCT03602378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102041804|NCT03606824|Pitavastatin|pitavastatin|mesh-list
102041805|NCT03606824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102041806|NCT03606824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102041818|NCT03604016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041820|NCT03604016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102041821|NCT01064622|Hydrocortisone|hydrocortisone|mesh-list
102041822|NCT01064622|Gemcitabine|gemcitabine|mesh-list
102041823|NCT01064622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102041824|NCT01064622|Antimetabolites|antimetabolites|mesh-ancestor
101971900|NCT01342016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101971901|NCT01342016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971902|NCT01342016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102041825|NCT01064622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041826|NCT01064622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102041827|NCT01064622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102041828|NCT01063764|Levetiracetam|levetiracetam|mesh-list
102041829|NCT01063764|Anticonvulsants|anticonvulsants|mesh-ancestor
102041830|NCT01063764|Nootropic Agents|nootropic agents|mesh-ancestor
102041831|NCT04053972|Lenvatinib|lenvatinib|mesh-list
102041832|NCT04053972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102041833|NCT04053972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102041834|NCT04053972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102041835|NCT04053972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041836|NCT01380249|Bromides|bromides|mesh-list
102041837|NCT01380249|Anticonvulsants|anticonvulsants|mesh-ancestor
102041838|NCT04054518|Durvalumab|durvalumab|mesh-list
102041839|NCT04054518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102041840|NCT04054518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102041841|NCT03652896|Liver Extracts|liver extracts|mesh-list
102041842|NCT03652896|Hematinics|hematinics|mesh-ancestor
102041843|NCT04565847|Albuterol|albuterol|mesh-list
102041844|NCT04565847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102041845|NCT04565847|Autonomic Agents|autonomic agents|mesh-ancestor
102041846|NCT04565847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101761587|NCT00844233|Irinotecan|irinotecan|mesh-list
102041847|NCT04565847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041848|NCT04565847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102041849|NCT04565847|Respiratory System Agents|respiratory system agents|mesh-ancestor
102041850|NCT04565847|Tocolytic Agents|tocolytic agents|mesh-ancestor
102041851|NCT04565847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102041852|NCT04565847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102041853|NCT04565847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102041854|NCT04565847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102041855|NCT04565847|Adrenergic Agents|adrenergic agents|mesh-ancestor
102041856|NCT04565847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102041857|NCT04565847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041858|NCT03075891|Doxycycline|doxycycline|mesh-list
102041859|NCT03075891|Ivermectin|ivermectin|mesh-list
102041860|NCT03075891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102041861|NCT03075891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102041862|NCT03075891|Antimalarials|antimalarials|mesh-ancestor
102041863|NCT03075891|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102041864|NCT03075891|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102041865|NCT02013167|Blinatumomab|blinatumomab|mesh-list
102041866|NCT02013167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102041867|NCT01378533|Paclitaxel|paclitaxel|mesh-list
102041868|NCT01378533|Cyclophosphamide|cyclophosphamide|mesh-list
102041869|NCT01378533|Carboplatin|carboplatin|mesh-list
102041870|NCT01378533|Epirubicin|epirubicin|mesh-list
101343316|NCT00276705|Cyclophosphamide|cyclophosphamide|mesh-list
102041882|NCT01378533|Alkylating Agents|alkylating agents|mesh-ancestor
102041883|NCT01378533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102041884|NCT01378533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102041885|NCT01378533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102041886|NCT01378533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102041887|NCT01378533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102041888|NCT02630199|Paclitaxel|paclitaxel|mesh-list
102041889|NCT02630199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102041890|NCT02630199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102041891|NCT02630199|Tubulin Modulators|tubulin modulators|mesh-ancestor
102041892|NCT02630199|Antimitotic Agents|antimitotic agents|mesh-ancestor
102041893|NCT02630199|Mitosis Modulators|mitosis modulators|mesh-ancestor
102041894|NCT02630199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041895|NCT02588781|Pemetrexed|pemetrexed|mesh-list
102041896|NCT02588781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102041897|NCT02588781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102041898|NCT02588781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041899|NCT02588781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102041900|NCT02588781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102041901|NCT01063062|Methotrexate|methotrexate|mesh-list
101971903|NCT01342016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971904|NCT01342016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101971905|NCT01342016|Immunologic Factors|immunologic factors|mesh-ancestor
101419733|NCT00141986|Vitamin D|vitamin d|mesh-list
102041902|NCT01063062|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102041903|NCT01063062|Abortifacient Agents|abortifacient agents|mesh-ancestor
102041904|NCT01063062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102041905|NCT01063062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041906|NCT01063062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102041907|NCT01063062|Antimetabolites|antimetabolites|mesh-ancestor
102041908|NCT01063062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041909|NCT01063062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102041910|NCT01063062|Dermatologic Agents|dermatologic agents|mesh-ancestor
102041911|NCT01063062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102041912|NCT01063062|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102041913|NCT01063062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102041914|NCT01063062|Immunologic Factors|immunologic factors|mesh-ancestor
102041915|NCT01063062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102041916|NCT01063062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102041917|NCT01314989|Cyproheptadine|cyproheptadine|mesh-list
102041918|NCT01314989|Antipruritics|antipruritics|mesh-ancestor
102041919|NCT01314989|Dermatologic Agents|dermatologic agents|mesh-ancestor
102041920|NCT01314989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102041921|NCT01314989|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102041922|NCT01314989|Histamine Antagonists|histamine antagonists|mesh-ancestor
102041923|NCT01314989|Histamine Agents|histamine agents|mesh-ancestor
102041924|NCT01314989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102041925|NCT01314989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041926|NCT01314989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041927|NCT01314989|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102041928|NCT01314989|Serotonin Agents|serotonin agents|mesh-ancestor
102041929|NCT01314989|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102041930|NCT04483115|Tadalafil|tadalafil|mesh-list
102041931|NCT04483115|Vasodilator Agents|vasodilator agents|mesh-ancestor
102041932|NCT04483115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102041958|NCT02973048|Anesthetics, Local|anesthetics, local|mesh-ancestor
102041959|NCT02973048|Anesthetics|anesthetics|mesh-ancestor
102041960|NCT02973048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102041961|NCT02973048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041962|NCT02973048|Sensory System Agents|sensory system agents|mesh-ancestor
102041963|NCT02973048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102041964|NCT04054206|Ibudilast|ibudilast|mesh-list
102041965|NCT04054206|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102041966|NCT04054206|Autonomic Agents|autonomic agents|mesh-ancestor
102041967|NCT04054206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102041968|NCT04054206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041969|NCT04054206|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102041970|NCT04054206|Respiratory System Agents|respiratory system agents|mesh-ancestor
102041971|NCT04054206|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102041972|NCT04054206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102041973|NCT04054206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041974|NCT04054206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102041975|NCT04054206|Vasodilator Agents|vasodilator agents|mesh-ancestor
102041976|NCT03603938|Losartan|losartan|mesh-list
102041977|NCT03603938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102041978|NCT03603938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102041979|NCT03603938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102041980|NCT03603938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102041981|NCT03603938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041982|NCT03652116|Meperidine|meperidine|mesh-list
102042019|NCT01380015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102042020|NCT01380015|Analgesics|analgesics|mesh-ancestor
102042021|NCT01380015|Sensory System Agents|sensory system agents|mesh-ancestor
102042034|NCT03603626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042035|NCT03603626|Analgesics|analgesics|mesh-ancestor
102042036|NCT03603626|Sensory System Agents|sensory system agents|mesh-ancestor
102042037|NCT03603626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102042038|NCT03603626|Anticonvulsants|anticonvulsants|mesh-ancestor
102042039|NCT03603626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102042040|NCT03603626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101971906|NCT01342016|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101971907|NCT01342016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101971908|NCT01342016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971909|NCT01336166|Vaccines|vaccines|mesh-list
101971910|NCT01336166|Immunologic Factors|immunologic factors|mesh-ancestor
102042041|NCT03603626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042042|NCT03603626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102042043|NCT03603626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102042044|NCT03603626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102042045|NCT03603626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102042046|NCT03603626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102042047|NCT01765218|Topiramate|topiramate|mesh-list
102042048|NCT01765218|Anticonvulsants|anticonvulsants|mesh-ancestor
102042049|NCT01765218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102042050|NCT01765218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042051|NCT02972502|Diphenhydramine|diphenhydramine|mesh-list
102042052|NCT02972502|Promethazine|promethazine|mesh-list
102042053|NCT02972502|Haloperidol|haloperidol|mesh-list
102042054|NCT02972502|Metoclopramide|metoclopramide|mesh-list
102042055|NCT02972502|Haloperidol decanoate|haloperidol decanoate|mesh-list
102042056|NCT02972502|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102042057|NCT02972502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102042058|NCT02972502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102042059|NCT02972502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042060|NCT02972502|Anesthetics, Local|anesthetics, local|mesh-ancestor
102042061|NCT02972502|Anesthetics|anesthetics|mesh-ancestor
102042062|NCT02972502|Sensory System Agents|sensory system agents|mesh-ancestor
102042063|NCT02972502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102042064|NCT02972502|Antiemetics|antiemetics|mesh-ancestor
102042065|NCT02972502|Autonomic Agents|autonomic agents|mesh-ancestor
102042066|NCT02972502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102042067|NCT02972502|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102042068|NCT02972502|Histamine Antagonists|histamine antagonists|mesh-ancestor
102042069|NCT02972502|Histamine Agents|histamine agents|mesh-ancestor
102042070|NCT02972502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102042071|NCT02972502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042072|NCT02972502|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102042073|NCT02972502|Antipruritics|antipruritics|mesh-ancestor
102042074|NCT02972502|Dermatologic Agents|dermatologic agents|mesh-ancestor
102042075|NCT02972502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102042076|NCT02972502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102042077|NCT02972502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102042078|NCT02972502|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102042079|NCT02972502|Dopamine Agents|dopamine agents|mesh-ancestor
102042080|NCT02972502|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102042081|NCT02972502|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102042082|NCT03606590|Sorafenib|sorafenib|mesh-list
102042083|NCT03606590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102042084|NCT03606590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102042085|NCT03606590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102042098|NCT03603548|Immunologic Factors|immunologic factors|mesh-ancestor
102042099|NCT03603548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042100|NCT03603548|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102042101|NCT03603548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102042102|NCT03603548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042103|NCT03954782|Nintedanib|nintedanib|mesh-list
102042104|NCT03954782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102042105|NCT03954782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102042106|NCT03954782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102042107|NCT03954782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042108|NCT03651726|Palmidrol|palmidrol|mesh-list
102042109|NCT03651726|Dronabinol|dronabinol|mesh-list
102042110|NCT03651726|Hallucinogens|hallucinogens|mesh-ancestor
102042111|NCT03651726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042112|NCT03651726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102042113|NCT03651726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102042114|NCT03651726|Analgesics|analgesics|mesh-ancestor
102042115|NCT03651726|Sensory System Agents|sensory system agents|mesh-ancestor
102042116|NCT03651726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102042117|NCT03651726|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102042118|NCT03651726|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101971911|NCT01336166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971912|NCT04470310|Pioglitazone|pioglitazone|mesh-list
101419891|NCT04511923|Heparin|heparin|mesh-list
102042119|NCT03651726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102042120|NCT03651726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042121|NCT03651726|Hormones|hormones|mesh-ancestor
102042122|NCT03651726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102042123|NCT03651726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102042124|NCT03651726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102042125|NCT03651726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102042126|NCT03651726|Antiviral Agents|antiviral agents|mesh-ancestor
102042127|NCT03651726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102042128|NCT00107250|Paclitaxel|paclitaxel|mesh-list
102042129|NCT00107250|Carboplatin|carboplatin|mesh-list
102042130|NCT00107250|Capecitabine|capecitabine|mesh-list
102042131|NCT00107250|Cediranib|cediranib|mesh-list
102042132|NCT00107250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102042133|NCT00107250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102042134|NCT00107250|Tubulin Modulators|tubulin modulators|mesh-ancestor
102042135|NCT00107250|Antimitotic Agents|antimitotic agents|mesh-ancestor
102042136|NCT00107250|Mitosis Modulators|mitosis modulators|mesh-ancestor
102042137|NCT00107250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042138|NCT00107250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102042139|NCT00107250|Antimetabolites|antimetabolites|mesh-ancestor
102042140|NCT00107250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102042141|NCT00107250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102042142|NCT03167411|Exenatide|exenatide|mesh-list
102042143|NCT03167411|Bexagliflozin|bexagliflozin|mesh-list
102042144|NCT03167411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102042145|NCT03167411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042146|NCT03167411|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102042147|NCT03167411|Incretins|incretins|mesh-ancestor
102042148|NCT03167411|Hormones|hormones|mesh-ancestor
102042157|NCT05461833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102042159|NCT05461833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102042160|NCT05461833|Parasympatholytics|parasympatholytics|mesh-ancestor
102042161|NCT05461833|Autonomic Agents|autonomic agents|mesh-ancestor
102042162|NCT05461833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102042163|NCT05461833|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102042164|NCT05461833|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102042165|NCT05461833|Cholinergic Agents|cholinergic agents|mesh-ancestor
102042166|NCT05461833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102042167|NCT01560585|Isotretinoin|isotretinoin|mesh-list
102042168|NCT01560585|Dermatologic Agents|dermatologic agents|mesh-ancestor
102042169|NCT01376427|Dexamethasone|dexamethasone|mesh-list
102042170|NCT01376427|Methotrexate|methotrexate|mesh-list
102042171|NCT01376427|Vincristine|vincristine|mesh-list
102042172|NCT01376427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102042173|NCT01376427|Antiemetics|antiemetics|mesh-ancestor
102042174|NCT01376427|Autonomic Agents|autonomic agents|mesh-ancestor
102042175|NCT01376427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102042176|NCT01376427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042177|NCT01376427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102042178|NCT01376427|Glucocorticoids|glucocorticoids|mesh-ancestor
102042179|NCT01376427|Hormones|hormones|mesh-ancestor
102042180|NCT01376427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102042181|NCT01376427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102042182|NCT01376427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102042183|NCT01376427|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102042184|NCT01376427|Abortifacient Agents|abortifacient agents|mesh-ancestor
102042185|NCT01376427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102042186|NCT01376427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102042187|NCT01376427|Antimetabolites|antimetabolites|mesh-ancestor
102042188|NCT01376427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042189|NCT01376427|Dermatologic Agents|dermatologic agents|mesh-ancestor
102042190|NCT01376427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102042191|NCT01376427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102042192|NCT01376427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102042193|NCT01376427|Immunologic Factors|immunologic factors|mesh-ancestor
102042194|NCT01376427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102042195|NCT01376427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102042196|NCT01376427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102042197|NCT01376427|Tubulin Modulators|tubulin modulators|mesh-ancestor
101971913|NCT04470310|Glimepiride|glimepiride|mesh-list
101971914|NCT04470310|Alogliptin|alogliptin|mesh-list
102042198|NCT01376427|Antimitotic Agents|antimitotic agents|mesh-ancestor
102042199|NCT01376427|Mitosis Modulators|mitosis modulators|mesh-ancestor
102042200|NCT03075501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
102042201|NCT03075501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042202|NCT03075501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102042203|NCT05462535|Losartan|losartan|mesh-list
102042204|NCT05462535|Amlodipine|amlodipine|mesh-list
102042205|NCT05462535|Chlorthalidone|chlorthalidone|mesh-list
102042206|NCT05462535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102042207|NCT05462535|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102042208|NCT05462535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102042209|NCT05462535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042210|NCT05462535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102042211|NCT05462535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042212|NCT05462535|Vasodilator Agents|vasodilator agents|mesh-ancestor
102042227|NCT05764317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102042229|NCT05764317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102042230|NCT05764317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102042231|NCT05764317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102042232|NCT05764317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102042233|NCT05764317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042234|NCT05764317|Vasodilator Agents|vasodilator agents|mesh-ancestor
102042235|NCT05764317|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102042236|NCT05764317|Protease Inhibitors|protease inhibitors|mesh-ancestor
102042237|NCT05461365|Insulin|insulin|mesh-list
102042238|NCT05461365|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102042239|NCT05461365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102042240|NCT05461365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042241|NCT03602846|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102042242|NCT03602846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042243|NCT02317991|Paclitaxel|paclitaxel|mesh-list
102042244|NCT02317991|Ramucirumab|ramucirumab|mesh-list
102042245|NCT02317991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102042246|NCT02317991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102042247|NCT02317991|Tubulin Modulators|tubulin modulators|mesh-ancestor
102042248|NCT02317991|Antimitotic Agents|antimitotic agents|mesh-ancestor
102042249|NCT02317991|Mitosis Modulators|mitosis modulators|mesh-ancestor
102042250|NCT02317991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042251|NCT03602690|Ritonavir|ritonavir|mesh-list
102042252|NCT03602690|Darunavir|darunavir|mesh-list
102042253|NCT03602690|Dolutegravir|dolutegravir|mesh-list
102042254|NCT03602690|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102042255|NCT03602690|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102042256|NCT03602690|Protease Inhibitors|protease inhibitors|mesh-ancestor
102042257|NCT03602690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102042258|NCT03602690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042259|NCT03602690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102042260|NCT03602690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102042261|NCT03602690|Antiviral Agents|antiviral agents|mesh-ancestor
102042262|NCT03602690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102042263|NCT03602690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102042264|NCT03602690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102042265|NCT03602690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102042266|NCT03602690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102042267|NCT01379547|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102042268|NCT01379547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102042269|NCT02978495|Paclitaxel|paclitaxel|mesh-list
102042270|NCT02978495|Cyclophosphamide|cyclophosphamide|mesh-list
102042271|NCT02978495|Carboplatin|carboplatin|mesh-list
102042272|NCT02978495|Doxorubicin|doxorubicin|mesh-list
101343724|NCT00275184|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102042289|NCT02978495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102042290|NCT02237690|Doxorubicin|doxorubicin|mesh-list
102042291|NCT02237690|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102042292|NCT02237690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102042293|NCT02237690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102042294|NCT02237690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102042295|NCT02237690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102042296|NCT02237690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102042297|NCT02237690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042298|NCT04788017|Ziresovir|ziresovir|mesh-list
102042299|NCT04788017|Antiviral Agents|antiviral agents|mesh-ancestor
102042300|NCT04788017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102042301|NCT03600974|Domperidone|domperidone|mesh-list
102042302|NCT03600974|Citalopram|citalopram|mesh-list
102042303|NCT03600974|Esomeprazole|esomeprazole|mesh-list
102042304|NCT03600974|Omeprazole|omeprazole|mesh-list
102042305|NCT03600974|Rabeprazole|rabeprazole|mesh-list
102042306|NCT03600974|Pantoprazole|pantoprazole|mesh-list
102042307|NCT03600974|Lansoprazole|lansoprazole|mesh-list
102042308|NCT03600974|Mosapride|mosapride|mesh-list
102042309|NCT03600974|Neurotransmitter Agents|neurotransmitter agents|mesh-list
102042310|NCT03600974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102042311|NCT03600974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102042312|NCT03600974|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102042313|NCT03600974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102042314|NCT03600974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042315|NCT03600974|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102042316|NCT03600974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102042317|NCT03600974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102042318|NCT03600974|Serotonin Agents|serotonin agents|mesh-ancestor
102042319|NCT03600974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042320|NCT03600974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102042321|NCT03600974|Antidepressive Agents|antidepressive agents|mesh-ancestor
102042322|NCT03600974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102042323|NCT03600974|Autonomic Agents|autonomic agents|mesh-ancestor
102042324|NCT03600974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102042325|NCT03600974|Antiemetics|antiemetics|mesh-ancestor
102042326|NCT03600974|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102042327|NCT03600974|Dopamine Agents|dopamine agents|mesh-ancestor
102042328|NCT03600974|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102042329|NCT03075267|Budesonide|budesonide|mesh-list
102042330|NCT03075267|Glycopyrrolate|glycopyrrolate|mesh-list
101343798|NCT00275106|Antidotes|antidotes|mesh-ancestor
102042351|NCT03075267|Cholinergic Agents|cholinergic agents|mesh-ancestor
102042352|NCT03600506|Dexmedetomidine|dexmedetomidine|mesh-list
102042353|NCT03600506|Sympatholytics|sympatholytics|mesh-list
102042354|NCT03600506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102042355|NCT03600506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102042356|NCT03600506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042357|NCT03600506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102042358|NCT03600506|Analgesics|analgesics|mesh-ancestor
102042359|NCT03600506|Sensory System Agents|sensory system agents|mesh-ancestor
102042360|NCT03600506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102042361|NCT03600506|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102042362|NCT03600506|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102042363|NCT03600506|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102042364|NCT03600506|Adrenergic Agents|adrenergic agents|mesh-ancestor
102042365|NCT03600506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102042366|NCT03600506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042367|NCT03600506|Autonomic Agents|autonomic agents|mesh-ancestor
102042369|NCT03074331|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102042370|NCT03074331|Velpatasvir|velpatasvir|mesh-list
102042371|NCT03074331|Antiviral Agents|antiviral agents|mesh-ancestor
102042372|NCT03074331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102042373|NCT02237924|Endostar protein|endostar protein|mesh-list
102042374|NCT02237924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102042375|NCT02237924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102042376|NCT02237924|Growth Substances|growth substances|mesh-ancestor
102042377|NCT02237924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042378|NCT02237924|Growth Inhibitors|growth inhibitors|mesh-ancestor
102042379|NCT02237924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102042381|NCT03825302|Methacholine Chloride|methacholine chloride|mesh-list
102042382|NCT03825302|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102042383|NCT03825302|Diuretics|diuretics|mesh-ancestor
102042384|NCT03825302|Natriuretic Agents|natriuretic agents|mesh-ancestor
102042396|NCT03825302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042398|NCT02238392|Analgesics|analgesics|mesh-ancestor
102042399|NCT02238392|Sensory System Agents|sensory system agents|mesh-ancestor
102042400|NCT02238392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102042401|NCT02238392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042402|NCT02238392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102042403|NCT02238392|Vasodilator Agents|vasodilator agents|mesh-ancestor
102042404|NCT02238392|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102042405|NCT02238392|Purinergic Agonists|purinergic agonists|mesh-ancestor
102042406|NCT02238392|Purinergic Agents|purinergic agents|mesh-ancestor
102042407|NCT02238392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102042408|NCT02238392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971916|NCT04470310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042409|NCT02260193|Glycine|glycine|mesh-list
102042410|NCT02260193|Glycine Agents|glycine agents|mesh-ancestor
102042411|NCT02260193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102042412|NCT02260193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042413|NCT02260193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042414|NCT02849678|Lidocaine|lidocaine|mesh-list
102042415|NCT02849678|Ropivacaine|ropivacaine|mesh-list
102042416|NCT02849678|Anesthetics, Local|anesthetics, local|mesh-ancestor
102042417|NCT02849678|Anesthetics|anesthetics|mesh-ancestor
102042418|NCT02849678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102042419|NCT02849678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042420|NCT02849678|Sensory System Agents|sensory system agents|mesh-ancestor
102042421|NCT02849678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102042422|NCT02849678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102042423|NCT02849678|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102042424|NCT02849678|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102042425|NCT02849678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102042426|NCT02849678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042427|NCT04295577|Niraparib|niraparib|mesh-list
102042428|NCT04295577|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102042429|NCT04295577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102042430|NCT04295577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042431|NCT04295577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102042432|NCT02238158|Ipratropium|ipratropium|mesh-list
102042433|NCT02238158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102042434|NCT02238158|Autonomic Agents|autonomic agents|mesh-ancestor
102042435|NCT02238158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102042436|NCT02238158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042437|NCT02238158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102042438|NCT02238158|Respiratory System Agents|respiratory system agents|mesh-ancestor
102042439|NCT02238158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102042440|NCT02238158|Cholinergic Agents|cholinergic agents|mesh-ancestor
102042441|NCT02238158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102042442|NCT02238158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042443|NCT02238314|Ritonavir|ritonavir|mesh-list
102042444|NCT02238314|Tipranavir|tipranavir|mesh-list
102042445|NCT02238314|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
102042446|NCT02238314|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102042465|NCT02238470|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102042467|NCT02238470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102042468|NCT02238470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042469|NCT03586934|Acetaminophen|acetaminophen|mesh-list
102042470|NCT03586934|Celecoxib|celecoxib|mesh-list
102042471|NCT03586934|Ketorolac|ketorolac|mesh-list
102042472|NCT03586934|Meloxicam|meloxicam|mesh-list
102042473|NCT03586934|Morphine|morphine|mesh-list
102042474|NCT03586934|Oxycodone|oxycodone|mesh-list
102042475|NCT03586934|Tramadol|tramadol|mesh-list
102042476|NCT03586934|Hydrocodone|hydrocodone|mesh-list
102042477|NCT03586934|Ropivacaine|ropivacaine|mesh-list
102042478|NCT03586934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102042479|NCT03586934|Narcotics|narcotics|mesh-ancestor
102042480|NCT03586934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102042481|NCT03586934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042482|NCT03586934|Analgesics|analgesics|mesh-ancestor
102042483|NCT03586934|Sensory System Agents|sensory system agents|mesh-ancestor
102042484|NCT03586934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102042485|NCT03586934|Anesthetics, Local|anesthetics, local|mesh-ancestor
102042486|NCT03586934|Anesthetics|anesthetics|mesh-ancestor
102042487|NCT03586934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102042488|NCT03586934|Antipyretics|antipyretics|mesh-ancestor
102042489|NCT03586934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102042490|NCT03586934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102042491|NCT03586934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102042492|NCT03586934|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102042493|NCT03586934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102042494|NCT03586934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102042495|NCT03586934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042496|NCT03586934|Antitussive Agents|antitussive agents|mesh-ancestor
102042497|NCT03586934|Respiratory System Agents|respiratory system agents|mesh-ancestor
102042498|NCT03586154|Ketamine|ketamine|mesh-list
102042499|NCT03586154|Bupivacaine|bupivacaine|mesh-list
102042500|NCT03586154|Anesthetics, Local|anesthetics, local|mesh-ancestor
101971917|NCT04470310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101971918|NCT04470310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101971919|NCT04470310|Immunologic Factors|immunologic factors|mesh-ancestor
101971920|NCT04470310|Incretins|incretins|mesh-ancestor
102042501|NCT03586154|Anesthetics|anesthetics|mesh-ancestor
102042502|NCT03586154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102042503|NCT03586154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042504|NCT03586154|Sensory System Agents|sensory system agents|mesh-ancestor
102042505|NCT03586154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102042506|NCT03586154|Analgesics|analgesics|mesh-ancestor
102042527|NCT01314833|Epirubicin|epirubicin|mesh-list
102042528|NCT01314833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102042529|NCT01314833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102042530|NCT01314833|Tubulin Modulators|tubulin modulators|mesh-ancestor
102042531|NCT01314833|Antimitotic Agents|antimitotic agents|mesh-ancestor
102042532|NCT01314833|Mitosis Modulators|mitosis modulators|mesh-ancestor
102042533|NCT01314833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042535|NCT01314833|Immunologic Factors|immunologic factors|mesh-ancestor
102042536|NCT01314833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042537|NCT01314833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102042538|NCT01314833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102042539|NCT01314833|Alkylating Agents|alkylating agents|mesh-ancestor
102042540|NCT01314833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102042541|NCT01314833|Antimetabolites|antimetabolites|mesh-ancestor
102042542|NCT01314833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102042543|NCT01314833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102042544|NCT01314833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102042545|NCT01314833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102042546|NCT01314833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102042547|NCT03579836|Gemcitabine|gemcitabine|mesh-list
102042548|NCT03579836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102042549|NCT03579836|Antimetabolites|antimetabolites|mesh-ancestor
102042550|NCT03579836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042551|NCT03579836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102042552|NCT02737826|Buprenorphine|buprenorphine|mesh-list
102042553|NCT02737826|Gabapentin|gabapentin|mesh-list
102042554|NCT02737826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102042555|NCT02737826|Narcotics|narcotics|mesh-ancestor
102042556|NCT02737826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102042557|NCT02737826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042558|NCT02737826|Analgesics|analgesics|mesh-ancestor
102042559|NCT02737826|Sensory System Agents|sensory system agents|mesh-ancestor
102042560|NCT02737826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102042561|NCT02737826|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102042562|NCT02737826|Anticonvulsants|anticonvulsants|mesh-ancestor
102042593|NCT03577652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102042594|NCT03577652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042595|NCT03577652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042597|NCT03620513|Phenylephrine|phenylephrine|mesh-list
102042598|NCT03620513|Oxymetazoline|oxymetazoline|mesh-list
102042599|NCT03620513|Nasal Decongestants|nasal decongestants|mesh-list
102042600|NCT03620513|Pseudoephedrine|pseudoephedrine|mesh-list
102042601|NCT03620513|Ephedrine|ephedrine|mesh-list
102042602|NCT03620513|Anesthetics|anesthetics|mesh-list
102042603|NCT03620513|Anesthetics, Local|anesthetics, local|mesh-ancestor
102042604|NCT03620513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102042605|NCT03620513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042606|NCT03620513|Sensory System Agents|sensory system agents|mesh-ancestor
102042624|NCT03620513|Protective Agents|protective agents|mesh-ancestor
102042625|NCT03620513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102042626|NCT03620513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102042627|NCT03620513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102042629|NCT03585062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102042630|NCT03585062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102042631|NCT03585062|Tubulin Modulators|tubulin modulators|mesh-ancestor
102042632|NCT03585062|Antimitotic Agents|antimitotic agents|mesh-ancestor
102042633|NCT03585062|Mitosis Modulators|mitosis modulators|mesh-ancestor
102042634|NCT03585062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042635|NCT03584360|Calcitriol|calcitriol|mesh-list
102042636|NCT03584360|Betamethasone|betamethasone|mesh-list
102042637|NCT03584360|Betamethasone Valerate|betamethasone valerate|mesh-list
102042638|NCT03584360|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101971921|NCT04470310|Hormones|hormones|mesh-ancestor
101971922|NCT04470310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101971923|NCT04470310|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101971924|NCT04470310|Protease Inhibitors|protease inhibitors|mesh-ancestor
101306658|NCT02026973|Anastrozole|anastrozole|mesh-list
102042639|NCT03584360|Betamethasone benzoate|betamethasone benzoate|mesh-list
102042640|NCT03584360|Calcipotriene|calcipotriene|mesh-list
102042641|NCT03584360|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102042642|NCT03584360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102042643|NCT03584360|Glucocorticoids|glucocorticoids|mesh-ancestor
102042644|NCT03584360|Hormones|hormones|mesh-ancestor
102042645|NCT03584360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102042646|NCT03584360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042647|NCT03584360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102042648|NCT03584360|Respiratory System Agents|respiratory system agents|mesh-ancestor
102042649|NCT03584360|Dermatologic Agents|dermatologic agents|mesh-ancestor
102042650|NCT03584360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102042651|NCT03584360|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102042652|NCT03584360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102042653|NCT03584360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042654|NCT03584360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102042655|NCT03584360|Vitamins|vitamins|mesh-ancestor
102042656|NCT03584360|Micronutrients|micronutrients|mesh-ancestor
102042657|NCT03584360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102042658|NCT05763771|Nicotine|nicotine|mesh-list
102042659|NCT05763771|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102042660|NCT05763771|Autonomic Agents|autonomic agents|mesh-ancestor
102042677|NCT01330901|Ustekinumab|ustekinumab|mesh-list
102042678|NCT01330901|Dermatologic Agents|dermatologic agents|mesh-ancestor
102042679|NCT02428647|Zinc|zinc|mesh-list
102042680|NCT02428647|Trace Elements|trace elements|mesh-ancestor
102042681|NCT02428647|Micronutrients|micronutrients|mesh-ancestor
102042682|NCT02428647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042683|NCT01071395|Amantadine|amantadine|mesh-list
102042684|NCT01071395|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102042685|NCT01071395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102042686|NCT01071395|Antiviral Agents|antiviral agents|mesh-ancestor
102042687|NCT01071395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102042688|NCT01071395|Dopamine Agents|dopamine agents|mesh-ancestor
102042689|NCT01071395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102042690|NCT01071395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042691|NCT01071395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042692|NCT01071395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102042693|NCT01071395|Analgesics|analgesics|mesh-ancestor
102042694|NCT01071395|Sensory System Agents|sensory system agents|mesh-ancestor
102042695|NCT01071395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102042696|NCT00335816|Leucovorin|leucovorin|mesh-list
102042697|NCT00335816|Fluorouracil|fluorouracil|mesh-list
102042698|NCT00335816|Oxaliplatin|oxaliplatin|mesh-list
102042699|NCT00335816|Calcium|calcium|mesh-list
102042700|NCT00335816|Levoleucovorin|levoleucovorin|mesh-list
102042701|NCT00335816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102042702|NCT00335816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042703|NCT00335816|Antimetabolites|antimetabolites|mesh-ancestor
102042704|NCT00335816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042705|NCT00335816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102042706|NCT00335816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102042707|NCT00335816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102042708|NCT00335816|Immunologic Factors|immunologic factors|mesh-ancestor
102042709|NCT00335816|Antidotes|antidotes|mesh-ancestor
102042710|NCT00335816|Protective Agents|protective agents|mesh-ancestor
102042711|NCT00335816|Vitamin B Complex|vitamin b complex|mesh-ancestor
102042712|NCT00335816|Vitamins|vitamins|mesh-ancestor
102042713|NCT00335816|Micronutrients|micronutrients|mesh-ancestor
102042714|NCT03577496|Peppermint oil|peppermint oil|mesh-list
102042715|NCT03577496|Antiemetics|antiemetics|mesh-ancestor
102042716|NCT03577496|Autonomic Agents|autonomic agents|mesh-ancestor
102042717|NCT03577496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102042718|NCT03577496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042719|NCT03577496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102042720|NCT03577496|Parasympatholytics|parasympatholytics|mesh-ancestor
102042745|NCT02238704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101941644|NCT03773133|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
101941645|NCT03773133|Chelating Agents|chelating agents|mesh-ancestor
101941646|NCT03773133|Sequestering Agents|sequestering agents|mesh-ancestor
102042747|NCT02238704|Micronutrients|micronutrients|mesh-ancestor
102042748|NCT02238704|Hematinics|hematinics|mesh-ancestor
102042749|NCT02238704|Vitamins|vitamins|mesh-ancestor
102042750|NCT01331135|Sirolimus|sirolimus|mesh-list
102042751|NCT01331135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102042752|NCT01331135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102042753|NCT01331135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102042754|NCT01331135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102042755|NCT01331135|Antifungal Agents|antifungal agents|mesh-ancestor
102042756|NCT01331135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102042757|NCT01331135|Immunologic Factors|immunologic factors|mesh-ancestor
102042758|NCT01331135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042759|NCT03577184|Metformin|metformin|mesh-list
102042760|NCT03577184|Vildagliptin|vildagliptin|mesh-list
102042761|NCT03577184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101695509|NCT04570436|Antimanic Agents|antimanic agents|mesh-ancestor
102042762|NCT03577184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042763|NCT03577184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102042764|NCT03577184|Protease Inhibitors|protease inhibitors|mesh-ancestor
102042765|NCT03577184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102042766|NCT03577184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042767|NCT02849171|Choline|choline|mesh-list
102042768|NCT02849171|Lipotropic Agents|lipotropic agents|mesh-ancestor
102042769|NCT02849171|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102042770|NCT02849171|Antimetabolites|antimetabolites|mesh-ancestor
102042771|NCT02849171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042772|NCT02849171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102042773|NCT02849171|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102042774|NCT02849171|Nootropic Agents|nootropic agents|mesh-ancestor
102042785|NCT01333709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102042786|NCT04869137|Pembrolizumab|pembrolizumab|mesh-list
102042787|NCT04869137|Lenvatinib|lenvatinib|mesh-list
102042788|NCT04869137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102042789|NCT04869137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102042790|NCT04869137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102042791|NCT04869137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042792|NCT04869137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102042793|NCT04869137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102042794|NCT00364637|Anesthetics|anesthetics|mesh-list
102042795|NCT00364637|Sevoflurane|sevoflurane|mesh-list
102042796|NCT00364637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102042797|NCT00364637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042798|NCT00364637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102042799|NCT00364637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102042800|NCT00364637|Anesthetics, General|anesthetics, general|mesh-ancestor
102042801|NCT00493961|Hormones|hormones|mesh-list
102042802|NCT00493961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102042803|NCT00493961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042804|NCT02903238|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102042805|NCT02903238|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102042806|NCT02903238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102042807|NCT02903238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102042808|NCT02903238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042809|NCT02903238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102042810|NCT02903238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042811|NCT02903238|Analgesics|analgesics|mesh-ancestor
102042812|NCT02903238|Sensory System Agents|sensory system agents|mesh-ancestor
102042813|NCT02903238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102042814|NCT02903238|Antidepressive Agents|antidepressive agents|mesh-ancestor
102042815|NCT02903238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102042816|NCT02903238|Dopamine Agents|dopamine agents|mesh-ancestor
102042817|NCT01329809|Molgramostim|molgramostim|mesh-list
102042818|NCT01329809|Sargramostim|sargramostim|mesh-list
102042819|NCT01329809|Immunologic Factors|immunologic factors|mesh-ancestor
102042820|NCT01329809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042821|NCT01329809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102042822|NCT02847260|Treprostinil|treprostinil|mesh-list
102042823|NCT02847260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102042824|NCT01331447|Exemestane|exemestane|mesh-list
101941647|NCT03773133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941648|NCT02969356|Botulinum Toxins|botulinum toxins|mesh-list
101941649|NCT02969356|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101941650|NCT02969356|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101420415|NCT00144326|Anticonvulsants|anticonvulsants|mesh-ancestor
102042825|NCT01331447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102042826|NCT01331447|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102042827|NCT01331447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102042828|NCT01331447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102042829|NCT01331447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042830|NCT01331447|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102042831|NCT01331447|Hormone Antagonists|hormone antagonists|mesh-ancestor
102042832|NCT01331447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102042833|NCT01331447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042834|NCT02968563|Obinutuzumab|obinutuzumab|mesh-list
102042835|NCT02968563|Idelalisib|idelalisib|mesh-list
102042836|NCT02968563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102042837|NCT02968563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102042838|NCT02968563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102042857|NCT01334177|Antibodies|antibodies|mesh-list
102042858|NCT01334177|Immunoglobulins|immunoglobulins|mesh-list
102042859|NCT01334177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102042860|NCT01334177|Immunologic Factors|immunologic factors|mesh-ancestor
102042861|NCT01334177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042862|NCT01334177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102042863|NCT04098393|Fludarabine|fludarabine|mesh-list
102042864|NCT04098393|Melphalan|melphalan|mesh-list
102042865|NCT04098393|Busulfan|busulfan|mesh-list
102042866|NCT04098393|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102042867|NCT04098393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102042868|NCT04098393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042869|NCT04098393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102042870|NCT04098393|Immunologic Factors|immunologic factors|mesh-ancestor
102042871|NCT04098393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042872|NCT04098393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102042873|NCT04098393|Alkylating Agents|alkylating agents|mesh-ancestor
102042874|NCT04098393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102042875|NCT05762523|Vaccines|vaccines|mesh-list
102042876|NCT05762523|Immunologic Factors|immunologic factors|mesh-ancestor
102042877|NCT05762523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042878|NCT02796261|Eflornithine|eflornithine|mesh-list
102042879|NCT02796261|Lomustine|lomustine|mesh-list
102042880|NCT02796261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102042881|NCT02796261|Alkylating Agents|alkylating agents|mesh-ancestor
102042882|NCT02796261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042883|NCT02796261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102042884|NCT02796261|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102042885|NCT02796261|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102042886|NCT02796261|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102042887|NCT02796261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102042888|NCT02796261|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
102042889|NCT02796261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102042890|NCT02904096|Lidocaine|lidocaine|mesh-list
102042891|NCT02904096|Anesthetics, Local|anesthetics, local|mesh-ancestor
102042892|NCT02904096|Anesthetics|anesthetics|mesh-ancestor
102042893|NCT02904096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102042894|NCT02904096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042908|NCT02586675|Tamoxifen|tamoxifen|mesh-list
102042909|NCT02586675|Goserelin|goserelin|mesh-list
102042910|NCT02586675|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102042911|NCT02586675|Hormone Antagonists|hormone antagonists|mesh-ancestor
102042912|NCT02586675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102042913|NCT02586675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042914|NCT02586675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102042915|NCT02586675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102042916|NCT02586675|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102042917|NCT02586675|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102042918|NCT02586675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102042919|NCT03648528|Cholecalciferol|cholecalciferol|mesh-list
102042920|NCT03648528|Vitamin D|vitamin d|mesh-list
101941651|NCT02969356|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101941652|NCT02969356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101420489|NCT00148083|Dopamine Agents|dopamine agents|mesh-ancestor
102042921|NCT03648528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102042922|NCT03648528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042923|NCT03648528|Vitamins|vitamins|mesh-ancestor
102042924|NCT03648528|Micronutrients|micronutrients|mesh-ancestor
102042925|NCT03648528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102042926|NCT03161405|Itraconazole|itraconazole|mesh-list
102042927|NCT03161405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102042928|NCT03161405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042929|NCT03161405|Antifungal Agents|antifungal agents|mesh-ancestor
102042930|NCT03161405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102042931|NCT03161405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102042932|NCT03161405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102042933|NCT03161405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102042934|NCT03161405|Hormone Antagonists|hormone antagonists|mesh-ancestor
102042935|NCT03161405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102042936|NCT03161405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042937|NCT03161405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102042938|NCT01813929|Metformin|metformin|mesh-list
102042939|NCT01813929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102042940|NCT01813929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042941|NCT01502085|Dexamethasone|dexamethasone|mesh-list
102042942|NCT01502085|Vorinostat|vorinostat|mesh-list
102042943|NCT01502085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102042944|NCT01502085|Antiemetics|antiemetics|mesh-ancestor
102042945|NCT01502085|Autonomic Agents|autonomic agents|mesh-ancestor
102042946|NCT01502085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102042947|NCT01502085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042948|NCT01502085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102042949|NCT01502085|Glucocorticoids|glucocorticoids|mesh-ancestor
102042950|NCT01502085|Hormones|hormones|mesh-ancestor
102042951|NCT01502085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102042952|NCT01502085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102042981|NCT02901054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102042982|NCT02901054|Antipruritics|antipruritics|mesh-ancestor
102042983|NCT02901054|Dermatologic Agents|dermatologic agents|mesh-ancestor
102042984|NCT02901054|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102042985|NCT02901054|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102042986|NCT02901054|Serotonin Agents|serotonin agents|mesh-ancestor
102042987|NCT02901054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102042988|NCT02901054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042990|NCT03647670|Abrocitinib|abrocitinib|mesh-list
102042991|NCT03647670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102042992|NCT03647670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102042993|NCT03647670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102042994|NCT03647670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042995|NCT03647670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102043015|NCT02966340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043017|NCT05284734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102043018|NCT05284734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043019|NCT03629379|Ustekinumab|ustekinumab|mesh-list
102043020|NCT03629379|Vedolizumab|vedolizumab|mesh-list
102043021|NCT03629379|Dermatologic Agents|dermatologic agents|mesh-ancestor
102043022|NCT03629379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102043023|NCT05055999|Atezolizumab|atezolizumab|mesh-list
102043024|NCT05055999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102043025|NCT05055999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043026|NCT05055999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102043027|NCT05055999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102043028|NCT05205837|Letrozole|letrozole|mesh-list
102043029|NCT05205837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102043030|NCT05205837|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102043031|NCT05205837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102043032|NCT05205837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102043033|NCT05205837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043034|NCT05205837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102043035|NCT05205837|Hormone Antagonists|hormone antagonists|mesh-ancestor
101941653|NCT02969356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941654|NCT02969356|Cholinergic Agents|cholinergic agents|mesh-ancestor
101941655|NCT02969356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102043036|NCT05205837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102043037|NCT05205837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043038|NCT05205603|Infliximab|infliximab|mesh-list
102043039|NCT05205603|Mesalamine|mesalamine|mesh-list
102043040|NCT05205603|Vedolizumab|vedolizumab|mesh-list
102043041|NCT05205603|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102043042|NCT05205603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102043043|NCT05205603|Dermatologic Agents|dermatologic agents|mesh-ancestor
102043044|NCT05205603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102043045|NCT05205603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102043046|NCT05205603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102043047|NCT05205603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102043048|NCT05205603|Analgesics|analgesics|mesh-ancestor
102043049|NCT05205603|Sensory System Agents|sensory system agents|mesh-ancestor
101344511|NCT00017654|Hormones|hormones|mesh-ancestor
102043065|NCT02550002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102043067|NCT03574376|Anesthetics, Local|anesthetics, local|mesh-ancestor
102043068|NCT03574376|Anesthetics|anesthetics|mesh-ancestor
102043069|NCT03574376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102043070|NCT03574376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043071|NCT03574376|Sensory System Agents|sensory system agents|mesh-ancestor
102043072|NCT03574376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102043073|NCT03576794|Prednisolone|prednisolone|mesh-list
102043074|NCT03576794|Leflunomide|leflunomide|mesh-list
102043075|NCT03576794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102043076|NCT03576794|Glucocorticoids|glucocorticoids|mesh-ancestor
102043077|NCT03576794|Hormones|hormones|mesh-ancestor
102043078|NCT03576794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102043079|NCT03576794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043080|NCT03576794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102043081|NCT03576794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102043082|NCT03576794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102043083|NCT03576794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043084|NCT03576794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102043085|NCT03576794|Immunologic Factors|immunologic factors|mesh-ancestor
102043086|NCT03578822|Aspirin|aspirin|mesh-list
102043087|NCT03578822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102043088|NCT03578822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102043089|NCT03578822|Analgesics|analgesics|mesh-ancestor
102043090|NCT03578822|Sensory System Agents|sensory system agents|mesh-ancestor
102043091|NCT03578822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102043092|NCT03578822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043093|NCT03578822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102043094|NCT03578822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102043095|NCT03578822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102043096|NCT03578822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102043097|NCT03578822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043098|NCT03578822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102043099|NCT03578822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102043100|NCT03578822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102043101|NCT03578822|Antipyretics|antipyretics|mesh-ancestor
102043102|NCT03576638|Levodopa|levodopa|mesh-list
102043103|NCT03576638|Carbidopa|carbidopa|mesh-list
102043104|NCT03576638|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102043105|NCT03576638|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102043106|NCT03576638|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102043107|NCT03576638|Dopamine Agents|dopamine agents|mesh-ancestor
102043122|NCT04284657|Sequestering Agents|sequestering agents|mesh-ancestor
102043123|NCT04284657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043124|NCT04284657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102043125|NCT04284657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102043126|NCT04284657|Antimetabolites|antimetabolites|mesh-ancestor
102043127|NCT04284657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102043128|NCT04284657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101762862|NCT00755898|Dopamine Agents|dopamine agents|mesh-ancestor
102043129|NCT04284657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102043130|NCT03574220|Pembrolizumab|pembrolizumab|mesh-list
102043131|NCT03574220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101941656|NCT02969356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306675|NCT02027064|Antiviral Agents|antiviral agents|mesh-ancestor
101695567|NCT00980239|Growth Substances|growth substances|mesh-ancestor
102043132|NCT03574220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102043133|NCT03574220|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102043134|NCT03574220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043135|NCT04876677|Beclomethasone|beclomethasone|mesh-list
102043136|NCT04876677|Glycopyrrolate|glycopyrrolate|mesh-list
102043137|NCT04876677|Formoterol Fumarate|formoterol fumarate|mesh-list
102043138|NCT04876677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102043139|NCT04876677|Autonomic Agents|autonomic agents|mesh-ancestor
102043140|NCT04876677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102043141|NCT04876677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043142|NCT04876677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102043143|NCT04876677|Respiratory System Agents|respiratory system agents|mesh-ancestor
102043144|NCT04876677|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102043145|NCT04876677|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102043146|NCT04876677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102043147|NCT04876677|Adrenergic Agents|adrenergic agents|mesh-ancestor
102043148|NCT04876677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102043149|NCT04876677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043150|NCT04876677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102043151|NCT04876677|Glucocorticoids|glucocorticoids|mesh-ancestor
102043152|NCT04876677|Hormones|hormones|mesh-ancestor
102043153|NCT04876677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102043154|NCT04876677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102043155|NCT04876677|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102043156|NCT04876677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102043157|NCT04876677|Cholinergic Agents|cholinergic agents|mesh-ancestor
102043158|NCT03578432|Everolimus|everolimus|mesh-list
102043159|NCT03578432|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102043160|NCT03578432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102043161|NCT03578432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102043162|NCT03578432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043163|NCT03578432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102043164|NCT03578432|Immunologic Factors|immunologic factors|mesh-ancestor
102043165|NCT03578432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043166|NCT03578432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102043183|NCT05204979|Misoprostol|misoprostol|mesh-list
102043184|NCT05204979|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102043185|NCT05204979|Abortifacient Agents|abortifacient agents|mesh-ancestor
102043186|NCT05204979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102043187|NCT05204979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043188|NCT05204979|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102043189|NCT05204979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102043190|NCT05204979|Oxytocics|oxytocics|mesh-ancestor
102043191|NCT03647514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102043192|NCT03647514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102043193|NCT02239952|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102043195|NCT02239952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102043196|NCT02239952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102043197|NCT02239952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102043198|NCT02239952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043199|NCT02239952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102043200|NCT02239952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102043201|NCT02239952|Growth Substances|growth substances|mesh-ancestor
101762935|NCT00854529|Growth Inhibitors|growth inhibitors|mesh-ancestor
102043202|NCT02239952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043203|NCT02239952|Growth Inhibitors|growth inhibitors|mesh-ancestor
102043204|NCT03647280|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102043205|NCT03647280|Epirubicin|epirubicin|mesh-list
102043206|NCT03647280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102043207|NCT03647280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043208|NCT03647280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102043209|NCT03647280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102043210|NCT03647280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102043211|NCT03647280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102043212|NCT03578042|Losartan|losartan|mesh-list
102043213|NCT03578042|Amlodipine|amlodipine|mesh-list
102043214|NCT03578042|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102043215|NCT03578042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101941658|NCT02969356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101941659|NCT03646006|Bupivacaine|bupivacaine|mesh-list
101941660|NCT03646006|Anesthetics, Local|anesthetics, local|mesh-ancestor
101941661|NCT03646006|Anesthetics|anesthetics|mesh-ancestor
102043216|NCT03578042|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102043217|NCT03578042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102043218|NCT03578042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043219|NCT03578042|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102043220|NCT03578042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043221|NCT03578042|Vasodilator Agents|vasodilator agents|mesh-ancestor
101344688|NCT00018954|Hormones|hormones|mesh-ancestor
102043241|NCT03574064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102043242|NCT03574064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043243|NCT03574064|Incretins|incretins|mesh-ancestor
102043244|NCT03573986|Bevacizumab|bevacizumab|mesh-list
102043245|NCT03573986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102043246|NCT03573986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102043247|NCT03573986|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102043248|NCT03573986|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102043249|NCT03573986|Growth Substances|growth substances|mesh-ancestor
102043250|NCT03573986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043251|NCT03573986|Growth Inhibitors|growth inhibitors|mesh-ancestor
102043252|NCT03959592|Carotenoids|carotenoids|mesh-list
102043253|NCT03959592|Antioxidants|antioxidants|mesh-ancestor
102043254|NCT03959592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043255|NCT03959592|Protective Agents|protective agents|mesh-ancestor
102043256|NCT03959592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043257|NCT04087395|Lidocaine|lidocaine|mesh-list
102043258|NCT04087395|Anesthetics|anesthetics|mesh-list
102043259|NCT04087395|Anesthetics, Local|anesthetics, local|mesh-ancestor
102043260|NCT04087395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102043261|NCT04087395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043262|NCT04087395|Sensory System Agents|sensory system agents|mesh-ancestor
102043263|NCT04087395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102043264|NCT04087395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102043265|NCT04087395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102043266|NCT04087395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102043267|NCT04087395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102043268|NCT04087395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043269|NCT03573596|Dasatinib|dasatinib|mesh-list
102043270|NCT03573596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102043271|NCT03573596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102043272|NCT03573596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102043273|NCT03573596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043274|NCT03621618|Dobutamine|dobutamine|mesh-list
102043275|NCT03621618|Norepinephrine|norepinephrine|mesh-list
101344736|NCT00019188|Growth Substances|growth substances|mesh-ancestor
102043296|NCT03944304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043298|NCT05204121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102043299|NCT05204121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102043300|NCT05204121|Antiviral Agents|antiviral agents|mesh-ancestor
102043301|NCT05204121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102043302|NCT01569945|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102043303|NCT01569945|Clomiphene|clomiphene|mesh-list
102043304|NCT01569945|Menotropins|menotropins|mesh-list
102043305|NCT01569945|Estradiol|estradiol|mesh-list
102043306|NCT01569945|Estrogens|estrogens|mesh-ancestor
102043307|NCT01569945|Hormones|hormones|mesh-ancestor
102043308|NCT01569945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102043309|NCT01569945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043310|NCT01569945|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102043311|NCT01569945|Contraceptive Agents|contraceptive agents|mesh-ancestor
102043312|NCT01569945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102043313|NCT01569945|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102043314|NCT01569945|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102043315|NCT01569945|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102043316|NCT01569945|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102043317|NCT01569945|Hormone Antagonists|hormone antagonists|mesh-ancestor
102043318|NCT01569945|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102043319|NCT01569945|Fertility Agents|fertility agents|mesh-ancestor
101941662|NCT03646006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101941663|NCT03646006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941664|NCT03646006|Sensory System Agents|sensory system agents|mesh-ancestor
101306683|NCT02027220|Dexamethasone|dexamethasone|mesh-list
102043320|NCT01569945|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102043321|NCT01569945|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102043322|NCT03645876|Capecitabine|capecitabine|mesh-list
102043323|NCT03645876|Oxaliplatin|oxaliplatin|mesh-list
102043324|NCT03645876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102043325|NCT03645876|Antimetabolites|antimetabolites|mesh-ancestor
102043326|NCT03645876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043327|NCT03645876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102043328|NCT02899728|Cisplatin|cisplatin|mesh-list
102043329|NCT02899728|Carboplatin|carboplatin|mesh-list
102043330|NCT02899728|Etoposide|etoposide|mesh-list
102043331|NCT02899728|Etoposide phosphate|etoposide phosphate|mesh-list
102043332|NCT02899728|Olaparib|olaparib|mesh-list
102043355|NCT03646266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102043356|NCT03646266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043358|NCT04052178|Antipruritics|antipruritics|mesh-ancestor
102043359|NCT04052178|Dermatologic Agents|dermatologic agents|mesh-ancestor
102043360|NCT04052178|Sensory System Agents|sensory system agents|mesh-ancestor
102043361|NCT04052178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102043362|NCT04052178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043363|NCT03645642|Midodrine|midodrine|mesh-list
102043364|NCT03645642|Diuretics|diuretics|mesh-list
102043365|NCT03645642|Natriuretic Agents|natriuretic agents|mesh-ancestor
102043366|NCT03645642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043367|NCT03645642|Sympathomimetics|sympathomimetics|mesh-ancestor
102043368|NCT03645642|Autonomic Agents|autonomic agents|mesh-ancestor
102043369|NCT03645642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102043370|NCT03645642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102043371|NCT03645642|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102043372|NCT03645642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101695597|NCT02781467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043373|NCT03645642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101695598|NCT02781467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102043374|NCT03645642|Adrenergic Agents|adrenergic agents|mesh-ancestor
102043375|NCT03645642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102043376|NCT03645642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043377|NCT03066609|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102043378|NCT03066609|Immunologic Factors|immunologic factors|mesh-ancestor
102043379|NCT03066609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043380|NCT03768492|Caffeine|caffeine|mesh-list
102043381|NCT03768492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102043382|NCT03768492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344847|NCT00019890|Sargramostim|sargramostim|mesh-list
102043391|NCT01345188|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102043392|NCT01345188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102043393|NCT01345188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043394|NCT03852459|Ibuprofen|ibuprofen|mesh-list
102043395|NCT03852459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102043396|NCT03852459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102043397|NCT03852459|Analgesics|analgesics|mesh-ancestor
102043398|NCT03852459|Sensory System Agents|sensory system agents|mesh-ancestor
102043399|NCT03852459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102043400|NCT03852459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043401|NCT03852459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102043402|NCT03852459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102043403|NCT03852459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102043404|NCT03852459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102043405|NCT03852459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043406|NCT03580902|Buprenorphine|buprenorphine|mesh-list
102043407|NCT03580902|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102043408|NCT03580902|Naloxone|naloxone|mesh-list
102043409|NCT03580902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102043410|NCT03580902|Narcotics|narcotics|mesh-ancestor
102043411|NCT03580902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102043412|NCT03580902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043413|NCT03580902|Analgesics|analgesics|mesh-ancestor
102043414|NCT03580902|Sensory System Agents|sensory system agents|mesh-ancestor
102043415|NCT03580902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102043416|NCT03580902|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101941665|NCT03646006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101941667|NCT03854344|Bupivacaine|bupivacaine|mesh-list
101941668|NCT03854344|Anesthetics, Local|anesthetics, local|mesh-ancestor
101941669|NCT03854344|Anesthetics|anesthetics|mesh-ancestor
102043417|NCT02896296|Buprenorphine|buprenorphine|mesh-list
102043418|NCT02896296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102043419|NCT02896296|Narcotics|narcotics|mesh-ancestor
102043420|NCT02896296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102043421|NCT02896296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043422|NCT02896296|Analgesics|analgesics|mesh-ancestor
102043423|NCT02896296|Sensory System Agents|sensory system agents|mesh-ancestor
102043424|NCT02896296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102043425|NCT02896296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102043426|NCT03644706|Potassium Citrate|potassium citrate|mesh-list
102043427|NCT03644706|Diuretics|diuretics|mesh-ancestor
102043428|NCT03644706|Natriuretic Agents|natriuretic agents|mesh-ancestor
102043429|NCT03644706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043430|NCT03644706|Expectorants|expectorants|mesh-ancestor
102043431|NCT03644706|Respiratory System Agents|respiratory system agents|mesh-ancestor
102043432|NCT03740919|Insulin|insulin|mesh-list
102043433|NCT03740919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102043434|NCT03740919|Insulin Glargine|insulin glargine|mesh-list
102043435|NCT03740919|Insulin Lispro|insulin lispro|mesh-list
102043436|NCT03740919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102043437|NCT03740919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043438|NCT01335685|Prednisone|prednisone|mesh-list
102043439|NCT01335685|Melphalan|melphalan|mesh-list
102043440|NCT01335685|Ixazomib|ixazomib|mesh-list
102043441|NCT01335685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102043442|NCT01335685|Glucocorticoids|glucocorticoids|mesh-ancestor
102043443|NCT01335685|Hormones|hormones|mesh-ancestor
102043444|NCT01335685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102043445|NCT01335685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043446|NCT01335685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102043447|NCT01335685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102043448|NCT01335685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102043449|NCT01335685|Alkylating Agents|alkylating agents|mesh-ancestor
101344897|NCT00020202|Romidepsin|romidepsin|mesh-list
102043461|NCT04462965|Alkylating Agents|alkylating agents|mesh-ancestor
102043462|NCT04462965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043463|NCT04462965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102043465|NCT01339663|Cyclophosphamide|cyclophosphamide|mesh-list
102043466|NCT01339663|Interleukin-2|interleukin-2|mesh-list
102043467|NCT01339663|Vaccines|vaccines|mesh-list
102043468|NCT01339663|Immunologic Factors|immunologic factors|mesh-ancestor
102043469|NCT01339663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043470|NCT01339663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102043471|NCT01339663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102043472|NCT01339663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102043473|NCT01339663|Alkylating Agents|alkylating agents|mesh-ancestor
102043474|NCT01339663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043475|NCT01339663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102043476|NCT01339663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102043477|NCT01339663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102043478|NCT01339663|Analgesics|analgesics|mesh-ancestor
102043479|NCT01339663|Sensory System Agents|sensory system agents|mesh-ancestor
102043480|NCT01339663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102043481|NCT01339663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102043482|NCT01339663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102043483|NCT01339663|Antiviral Agents|antiviral agents|mesh-ancestor
102043484|NCT01339663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102043485|NCT00092599|Ezetimibe|ezetimibe|mesh-list
102043486|NCT00092599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102043487|NCT00092599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102043488|NCT00092599|Antimetabolites|antimetabolites|mesh-ancestor
102043489|NCT00092599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043490|NCT00092599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102043491|NCT03737565|Tryptophan|tryptophan|mesh-list
102043492|NCT03737565|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102043493|NCT03737565|Antidepressive Agents|antidepressive agents|mesh-ancestor
102043494|NCT03737565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102043495|NCT02889133|Iron|iron|mesh-list
102043496|NCT02889133|Dextrans|dextrans|mesh-list
101941670|NCT03854344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102043497|NCT02889133|Iron-Dextran Complex|iron-dextran complex|mesh-list
102043498|NCT02889133|Trace Elements|trace elements|mesh-ancestor
102043499|NCT02889133|Micronutrients|micronutrients|mesh-ancestor
102043500|NCT02889133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043501|NCT02889133|Anticoagulants|anticoagulants|mesh-ancestor
102043502|NCT02889133|Plasma Substitutes|plasma substitutes|mesh-ancestor
102043503|NCT02889133|Blood Substitutes|blood substitutes|mesh-ancestor
102043504|NCT02889133|Hematinics|hematinics|mesh-ancestor
102043505|NCT01333423|Roscovitine|roscovitine|mesh-list
102043506|NCT01333423|Doxorubicin|doxorubicin|mesh-list
102043507|NCT01333423|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102043508|NCT01333423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102043509|NCT01333423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102043510|NCT01333423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102043511|NCT01333423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102043512|NCT01333423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102043513|NCT01333423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043514|NCT01333423|Antiviral Agents|antiviral agents|mesh-ancestor
102043527|NCT00092209|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102043528|NCT00092209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102043530|NCT01339741|Cholecalciferol|cholecalciferol|mesh-list
102043531|NCT01339741|Vitamins|vitamins|mesh-ancestor
102043532|NCT01339741|Micronutrients|micronutrients|mesh-ancestor
102043533|NCT01339741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043534|NCT01339741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102043535|NCT01339741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102043536|NCT00003777|Fluorouracil|fluorouracil|mesh-list
102043537|NCT00003777|Amifostine|amifostine|mesh-list
102043538|NCT00003777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102043539|NCT00003777|Antimetabolites|antimetabolites|mesh-ancestor
102043540|NCT00003777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043541|NCT00003777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102043542|NCT00003777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102043543|NCT00003777|Immunologic Factors|immunologic factors|mesh-ancestor
102043544|NCT00003777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043545|NCT00003777|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102043546|NCT00003777|Protective Agents|protective agents|mesh-ancestor
102043547|NCT01339819|Dabigatran|dabigatran|mesh-list
102043548|NCT01339819|Phenprocoumon|phenprocoumon|mesh-list
102043549|NCT01339819|Antithrombins|antithrombins|mesh-ancestor
102043550|NCT01339819|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102043551|NCT01339819|Protease Inhibitors|protease inhibitors|mesh-ancestor
102043552|NCT01339819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102043553|NCT01339819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043554|NCT01339819|Anticoagulants|anticoagulants|mesh-ancestor
102043555|NCT02963922|Liraglutide|liraglutide|mesh-list
102043556|NCT02963922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102043557|NCT02963922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043558|NCT02963922|Incretins|incretins|mesh-ancestor
102043559|NCT02963922|Hormones|hormones|mesh-ancestor
102043560|NCT02963922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102043561|NCT00090181|Diclofenac|diclofenac|mesh-list
102043562|NCT00090181|Etoricoxib|etoricoxib|mesh-list
102043563|NCT00090181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102043564|NCT00090181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102043565|NCT00090181|Analgesics|analgesics|mesh-ancestor
102043566|NCT00090181|Sensory System Agents|sensory system agents|mesh-ancestor
102043567|NCT00090181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102043568|NCT00090181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043569|NCT00090181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102043570|NCT00090181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102043571|NCT00090181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102043572|NCT00090181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102043573|NCT00090181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043574|NCT00090181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102043575|NCT03619785|Acetaminophen|acetaminophen|mesh-list
102043576|NCT03619785|Ibuprofen|ibuprofen|mesh-list
102043577|NCT03619785|Ketorolac|ketorolac|mesh-list
102043611|NCT03619785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102043612|NCT03619785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102043613|NCT03619785|Antimanic Agents|antimanic agents|mesh-ancestor
102043614|NCT03619785|Antitussive Agents|antitussive agents|mesh-ancestor
102043615|NCT03619785|Respiratory System Agents|respiratory system agents|mesh-ancestor
102043616|NCT02881567|Daclizumab|daclizumab|mesh-list
101941671|NCT03854344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941672|NCT03854344|Sensory System Agents|sensory system agents|mesh-ancestor
101941673|NCT03854344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101941674|NCT03854344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101941675|NCT03854344|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102043617|NCT02881567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102043618|NCT02881567|Immunologic Factors|immunologic factors|mesh-ancestor
102043619|NCT02881567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043620|NCT05184517|Cyclosporine|cyclosporine|mesh-list
102043621|NCT05184517|Cyclosporins|cyclosporins|mesh-list
102043636|NCT02962284|Prednisolone acetate|prednisolone acetate|mesh-list
102043637|NCT02962284|Abiraterone Acetate|abiraterone acetate|mesh-list
102043638|NCT02962284|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102043639|NCT02962284|Prednisolone phosphate|prednisolone phosphate|mesh-list
102043640|NCT02962284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102043642|NCT02962284|Autonomic Agents|autonomic agents|mesh-ancestor
102043643|NCT02962284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102043644|NCT02962284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043645|NCT02962284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102043646|NCT02962284|Glucocorticoids|glucocorticoids|mesh-ancestor
102043647|NCT02962284|Hormones|hormones|mesh-ancestor
102043648|NCT02962284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102043649|NCT02962284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102043650|NCT02962284|Protective Agents|protective agents|mesh-ancestor
102043651|NCT02962284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102043652|NCT02962284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102043653|NCT02962284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102043654|NCT02962284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102043655|NCT02962284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043656|NCT02962284|Hormone Antagonists|hormone antagonists|mesh-ancestor
102043657|NCT02962284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102043659|NCT03642600|Inositol|inositol|mesh-list
102043660|NCT03642600|Liraglutide|liraglutide|mesh-list
102043661|NCT03642600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102043662|NCT03642600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043663|NCT03642600|Incretins|incretins|mesh-ancestor
102043664|NCT03642600|Hormones|hormones|mesh-ancestor
102043665|NCT03642600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102043666|NCT03642600|Hematinics|hematinics|mesh-ancestor
102043667|NCT03642600|Vitamin B Complex|vitamin b complex|mesh-ancestor
102043668|NCT03642600|Vitamins|vitamins|mesh-ancestor
102043669|NCT03642600|Micronutrients|micronutrients|mesh-ancestor
102043670|NCT01069692|Ferric Compounds|ferric compounds|mesh-list
102043671|NCT01069692|Hematinics|hematinics|mesh-ancestor
102043672|NCT05183178|Ticagrelor|ticagrelor|mesh-list
102043673|NCT05183178|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102043674|NCT05183178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102043675|NCT05183178|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102043676|NCT05183178|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102043677|NCT05183178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102043678|NCT05183178|Purinergic Agents|purinergic agents|mesh-ancestor
102043679|NCT05183178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102043680|NCT05183178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043681|NCT05183178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043682|NCT03161093|Naproxen|naproxen|mesh-list
102043683|NCT03161093|Fasinumab|fasinumab|mesh-list
102043702|NCT03573284|Respiratory System Agents|respiratory system agents|mesh-ancestor
102043703|NCT03573284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102043704|NCT03573284|Antioxidants|antioxidants|mesh-ancestor
102043705|NCT03573284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043706|NCT03573284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102043707|NCT03573284|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102043708|NCT03573284|Vasodilator Agents|vasodilator agents|mesh-ancestor
102043709|NCT03573284|Gasotransmitters|gasotransmitters|mesh-ancestor
102043710|NCT03573284|Protective Agents|protective agents|mesh-ancestor
102043711|NCT03575780|Tirbanibulin|tirbanibulin|mesh-list
102043712|NCT03575780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102043713|NCT03575780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043715|NCT01334333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101941676|NCT03854344|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101941677|NCT03854344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101941678|NCT03854344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941680|NCT05284318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101941681|NCT03609424|Imatinib Mesylate|imatinib mesylate|mesh-list
101941682|NCT03609424|Spartalizumab|spartalizumab|mesh-list
101941683|NCT03609424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101941684|NCT03609424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101941685|NCT03609424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101941686|NCT03609424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941687|NCT03609424|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101941688|NCT03609424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101941689|NCT03645850|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101941690|NCT03645850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101941691|NCT03644446|Bisoprolol|bisoprolol|mesh-list
101941692|NCT03644446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101941693|NCT03644446|Sympatholytics|sympatholytics|mesh-ancestor
101306696|NCT02027220|Antiemetics|antiemetics|mesh-ancestor
102043716|NCT01334333|Immunologic Factors|immunologic factors|mesh-ancestor
102043717|NCT01334333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043718|NCT01334333|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102043719|NCT01334333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102043720|NCT01334333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043721|NCT03573050|Rivastigmine|rivastigmine|mesh-list
102043722|NCT03573050|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102043723|NCT03573050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102043724|NCT03573050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043725|NCT03573050|Cholinergic Agents|cholinergic agents|mesh-ancestor
102043726|NCT03573050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102043727|NCT03573050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043728|NCT03573050|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102043729|NCT03573050|Protective Agents|protective agents|mesh-ancestor
102043730|NCT03575312|Enrofloxacin|enrofloxacin|mesh-list
102043731|NCT03575312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102043732|NCT03575312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102043733|NCT02847494|Dexamethasone|dexamethasone|mesh-list
102043734|NCT02847494|Methylprednisolone|methylprednisolone|mesh-list
102043735|NCT02847494|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102043736|NCT02847494|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102043737|NCT02847494|Prednisolone|prednisolone|mesh-list
102043738|NCT02847494|Prednisolone acetate|prednisolone acetate|mesh-list
102043757|NCT02847494|Dopamine Agents|dopamine agents|mesh-ancestor
102043758|NCT02847494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102043759|NCT02847494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043760|NCT02554253|Ketamine|ketamine|mesh-list
102043761|NCT02554253|Propofol|propofol|mesh-list
102043762|NCT02554253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102043763|NCT02554253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102043764|NCT02554253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043765|NCT02554253|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102043766|NCT02554253|Anesthetics, General|anesthetics, general|mesh-ancestor
102043767|NCT02554253|Anesthetics|anesthetics|mesh-ancestor
102043768|NCT02554253|Analgesics|analgesics|mesh-ancestor
102043769|NCT02554253|Sensory System Agents|sensory system agents|mesh-ancestor
101941694|NCT03644446|Autonomic Agents|autonomic agents|mesh-ancestor
101941695|NCT03644446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101941696|NCT03644446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043770|NCT02554253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102043771|NCT02554253|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102043772|NCT02554253|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102043773|NCT02554253|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102043774|NCT02554253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102043775|NCT02554253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043776|NCT02239484|Tadalafil|tadalafil|mesh-list
102043777|NCT02239484|Tamsulosin|tamsulosin|mesh-list
102043778|NCT02239484|Vasodilator Agents|vasodilator agents|mesh-ancestor
102043779|NCT02239484|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102043780|NCT02239484|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102043781|NCT02239484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102043782|NCT02239484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043783|NCT02239484|Urological Agents|urological agents|mesh-ancestor
102043784|NCT02239484|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102043785|NCT02239484|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102043786|NCT02239484|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102043787|NCT02239484|Adrenergic Agents|adrenergic agents|mesh-ancestor
102043788|NCT02239484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102043789|NCT02239484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043790|NCT03575234|Cyclophosphamide|cyclophosphamide|mesh-list
102043791|NCT03575234|Nivolumab|nivolumab|mesh-list
102043792|NCT03575234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102043793|NCT03575234|Immunologic Factors|immunologic factors|mesh-ancestor
102043794|NCT03575234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043810|NCT04508855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043811|NCT03575078|Olaparib|olaparib|mesh-list
102043812|NCT03575078|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102043813|NCT03575078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102043814|NCT03575078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043815|NCT03575078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102043816|NCT03157583|Sunscreening Agents|sunscreening agents|mesh-list
102043817|NCT03157583|Glycerol|glycerol|mesh-list
102043818|NCT03157583|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102043819|NCT03157583|Protective Agents|protective agents|mesh-ancestor
102043820|NCT03157583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043821|NCT03157583|Dermatologic Agents|dermatologic agents|mesh-ancestor
102043822|NCT03157583|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102043823|NCT03570710|Tranexamic Acid|tranexamic acid|mesh-list
102043824|NCT03570710|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102043825|NCT03570710|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102043826|NCT03570710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043827|NCT03570710|Hemostatics|hemostatics|mesh-ancestor
102043828|NCT03570710|Coagulants|coagulants|mesh-ancestor
102043829|NCT01337765|Dactolisib|dactolisib|mesh-list
102043830|NCT01337765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102043831|NCT01307033|Losartan|losartan|mesh-list
102043832|NCT01307033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102043833|NCT01307033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102043834|NCT01307033|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102043835|NCT01307033|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102043836|NCT01307033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043837|NCT04475705|Propofol|propofol|mesh-list
102043838|NCT04475705|Sevoflurane|sevoflurane|mesh-list
102043839|NCT04475705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102043840|NCT04475705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102043841|NCT04475705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043842|NCT04475705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102043843|NCT04475705|Anesthetics, General|anesthetics, general|mesh-ancestor
102043844|NCT04475705|Anesthetics|anesthetics|mesh-ancestor
102043845|NCT04475705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102043846|NCT04475705|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102043847|NCT03158311|Fluticasone|fluticasone|mesh-list
102043848|NCT03158311|Tiotropium Bromide|tiotropium bromide|mesh-list
102043849|NCT03158311|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102043850|NCT03158311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102043851|NCT03158311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102043852|NCT03158311|Autonomic Agents|autonomic agents|mesh-ancestor
101941697|NCT03644446|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101941698|NCT03644446|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102043853|NCT03158311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102043868|NCT02244866|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102043869|NCT02244866|Hormones|hormones|mesh-ancestor
102043870|NCT02244866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102043871|NCT02244866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043872|NCT01334567|Tenofovir|tenofovir|mesh-list
102043873|NCT01334567|Antiviral Agents|antiviral agents|mesh-ancestor
102043874|NCT01334567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102043875|NCT01334567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102043876|NCT01334567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102043877|NCT01334567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102043878|NCT01334567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043879|NCT01334567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101763611|NCT02866136|Tubulin Modulators|tubulin modulators|mesh-ancestor
102043880|NCT01334567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102043881|NCT04398329|Bupivacaine|bupivacaine|mesh-list
102043882|NCT04398329|Anesthetics, Local|anesthetics, local|mesh-ancestor
102043883|NCT04398329|Anesthetics|anesthetics|mesh-ancestor
102043884|NCT04398329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102043885|NCT04398329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043886|NCT04398329|Sensory System Agents|sensory system agents|mesh-ancestor
102043887|NCT04398329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102043888|NCT00449111|Losartan|losartan|mesh-list
102043889|NCT00449111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102043890|NCT00449111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102043891|NCT00449111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102043892|NCT00449111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102043893|NCT00449111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043894|NCT03568916|Rivaroxaban|rivaroxaban|mesh-list
102043895|NCT03568916|Apixaban|apixaban|mesh-list
102043896|NCT03568916|Dabigatran|dabigatran|mesh-list
102043897|NCT03568916|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102043898|NCT03568916|Antithrombins|antithrombins|mesh-ancestor
102043899|NCT03568916|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102043900|NCT03568916|Protease Inhibitors|protease inhibitors|mesh-ancestor
102043901|NCT03568916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102043902|NCT03568916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043903|NCT03568916|Anticoagulants|anticoagulants|mesh-ancestor
102043904|NCT01334645|Arginine Vasopressin|arginine vasopressin|mesh-list
102043905|NCT01334645|Hemostatics|hemostatics|mesh-ancestor
102043906|NCT01334645|Coagulants|coagulants|mesh-ancestor
102043907|NCT01334645|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102043908|NCT01334645|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102043909|NCT01334645|Natriuretic Agents|natriuretic agents|mesh-ancestor
102043910|NCT01334645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043911|NCT03571490|Ropivacaine|ropivacaine|mesh-list
102043912|NCT03571490|Anesthetics, Local|anesthetics, local|mesh-ancestor
102043931|NCT01331993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043932|NCT01331993|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102043933|NCT01331993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102043934|NCT01331993|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102043935|NCT01338077|Omeprazole|omeprazole|mesh-list
102043936|NCT01338077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102043937|NCT01338077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102043938|NCT01338077|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102043939|NCT01338077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102043940|NCT01338077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043941|NCT03570320|Analgesics, Opioid|analgesics, opioid|mesh-list
102043942|NCT03570320|Narcotics|narcotics|mesh-ancestor
102043943|NCT03570320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102043944|NCT03570320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043945|NCT03570320|Analgesics|analgesics|mesh-ancestor
102043946|NCT03570320|Sensory System Agents|sensory system agents|mesh-ancestor
102043947|NCT03570320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102043948|NCT04266665|Dexmedetomidine|dexmedetomidine|mesh-list
102043949|NCT04266665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102043950|NCT04266665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102043951|NCT04266665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043952|NCT04266665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102043953|NCT04266665|Analgesics|analgesics|mesh-ancestor
101941699|NCT03644446|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101941700|NCT03644446|Adrenergic Agents|adrenergic agents|mesh-ancestor
101941701|NCT03644446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102043954|NCT04266665|Sensory System Agents|sensory system agents|mesh-ancestor
102043955|NCT04266665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102043956|NCT04266665|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102043957|NCT04266665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102043958|NCT04266665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102043959|NCT04266665|Adrenergic Agents|adrenergic agents|mesh-ancestor
102043960|NCT04266665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102043961|NCT04266665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043963|NCT03571100|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102043964|NCT03571100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102043965|NCT03571100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102043966|NCT03571100|Disinfectants|disinfectants|mesh-ancestor
102043967|NCT03571100|Dermatologic Agents|dermatologic agents|mesh-ancestor
102043968|NCT01338311|Albuterol|albuterol|mesh-list
102043981|NCT01338311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102043982|NCT01338311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043983|NCT01334879|Ranibizumab|ranibizumab|mesh-list
102043984|NCT01334879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102043985|NCT01334879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102043986|NCT01334879|Growth Substances|growth substances|mesh-ancestor
102043987|NCT01334879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043988|NCT01334879|Growth Inhibitors|growth inhibitors|mesh-ancestor
102043989|NCT01334879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102043990|NCT01315795|Lanreotide|lanreotide|mesh-list
102043991|NCT01315795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102043992|NCT03570164|Sevoflurane|sevoflurane|mesh-list
102043993|NCT03570164|Desflurane|desflurane|mesh-list
102043994|NCT03570164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102043995|NCT03570164|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102043996|NCT03570164|Anesthetics, General|anesthetics, general|mesh-ancestor
102043997|NCT03570164|Anesthetics|anesthetics|mesh-ancestor
102043998|NCT03570164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102043999|NCT03570164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044000|NCT01315951|Petrolatum|petrolatum|mesh-list
102044001|NCT01315951|Emollients|emollients|mesh-ancestor
102044002|NCT01315951|Dermatologic Agents|dermatologic agents|mesh-ancestor
102044003|NCT05184049|Vitamin B 12|vitamin b 12|mesh-list
102044004|NCT05184049|Epalrestat|epalrestat|mesh-list
102044005|NCT05184049|Vitamin B Complex|vitamin b complex|mesh-ancestor
102044006|NCT05184049|Vitamins|vitamins|mesh-ancestor
102044007|NCT05184049|Micronutrients|micronutrients|mesh-ancestor
102044008|NCT05184049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044009|NCT05184049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102044010|NCT05184049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044011|NCT01336543|Cisplatin|cisplatin|mesh-list
102044012|NCT01336543|Gemcitabine|gemcitabine|mesh-list
102044013|NCT01336543|Etoposide|etoposide|mesh-list
102044014|NCT01336543|Pemetrexed|pemetrexed|mesh-list
102044015|NCT01336543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102044016|NCT01336543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102044017|NCT01336543|Antimetabolites|antimetabolites|mesh-ancestor
102044018|NCT01336543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044019|NCT01336543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102044020|NCT01336543|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102044021|NCT01336543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102044022|NCT01336543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102044023|NCT01336543|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102044024|NCT01336543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102044025|NCT03568136|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102044026|NCT03568136|Immunologic Factors|immunologic factors|mesh-ancestor
102044027|NCT03568136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044028|NCT01336621|Ezogabine|ezogabine|mesh-list
102044029|NCT01336621|Anticonvulsants|anticonvulsants|mesh-ancestor
101763763|NCT00758004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102044030|NCT01336621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102044031|NCT01336621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044040|NCT00383435|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102044041|NCT00383435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102044042|NCT00383435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102044043|NCT00383435|Adrenergic Agents|adrenergic agents|mesh-ancestor
101941702|NCT03644446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941703|NCT02898454|Mometasone Furoate|mometasone furoate|mesh-list
101941704|NCT02898454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102044044|NCT00383435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102044045|NCT00383435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044046|NCT00383435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102044047|NCT00383435|Dermatologic Agents|dermatologic agents|mesh-ancestor
102044048|NCT00383435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102044049|NCT01340521|Clomiphene|clomiphene|mesh-list
102044050|NCT01340521|Enclomiphene|enclomiphene|mesh-list
102044051|NCT01340521|Zuclomiphene|zuclomiphene|mesh-list
102044052|NCT01340521|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102044053|NCT01340521|Hormone Antagonists|hormone antagonists|mesh-ancestor
102044054|NCT01340521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102044055|NCT01340521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044056|NCT01340521|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102044057|NCT01340521|Fertility Agents|fertility agents|mesh-ancestor
102044058|NCT01340521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102044059|NCT01340521|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102044060|NCT01340521|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102044061|NCT01340599|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
102044062|NCT01340599|Antioxidants|antioxidants|mesh-ancestor
102044063|NCT01340599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044064|NCT01340599|Protective Agents|protective agents|mesh-ancestor
102044065|NCT01340599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044066|NCT01340599|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
102044067|NCT01340599|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102044068|NCT01340599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102044069|NCT01340599|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102044070|NCT01335035|Deferasirox|deferasirox|mesh-list
102044071|NCT01335035|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102044072|NCT01335035|Chelating Agents|chelating agents|mesh-ancestor
102044073|NCT01335035|Sequestering Agents|sequestering agents|mesh-ancestor
102044074|NCT01335035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044075|NCT01340677|Canagliflozin|canagliflozin|mesh-list
102044076|NCT01340677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102044077|NCT01340677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044078|NCT01340677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102044079|NCT01340677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044080|NCT05163535|Elsulfavirine|elsulfavirine|mesh-list
102044081|NCT05163535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102044082|NCT05163535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102044083|NCT05163535|Antiviral Agents|antiviral agents|mesh-ancestor
102044084|NCT05163535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102044085|NCT01338389|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
102044086|NCT01338389|Nootropic Agents|nootropic agents|mesh-ancestor
102044087|NCT01340833|Dabrafenib|dabrafenib|mesh-list
102044088|NCT01340833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102044089|NCT01340833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102044090|NCT01340833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102044091|NCT01340833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044092|NCT01332383|Naratriptan|naratriptan|mesh-list
102044093|NCT01332383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102044094|NCT01332383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102044095|NCT01332383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102044096|NCT01332383|Serotonin Agents|serotonin agents|mesh-ancestor
102044097|NCT01332383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102044125|NCT01337323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102044126|NCT01337323|Respiratory System Agents|respiratory system agents|mesh-ancestor
102044127|NCT01337323|Dermatologic Agents|dermatologic agents|mesh-ancestor
102044128|NCT01337323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102044129|NCT03157037|Immunoglobulins|immunoglobulins|mesh-list
102044130|NCT03157037|Immunoglobulin G|immunoglobulin g|mesh-list
102044131|NCT03157037|Immunologic Factors|immunologic factors|mesh-ancestor
102044132|NCT03157037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044133|NCT04830943|Cerebrolysin|cerebrolysin|mesh-list
102044134|NCT04830943|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102044135|NCT04830943|Protective Agents|protective agents|mesh-ancestor
102044136|NCT04830943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044137|NCT04830943|Nootropic Agents|nootropic agents|mesh-ancestor
102044138|NCT04429321|Nivolumab|nivolumab|mesh-list
102044139|NCT04429321|Ipilimumab|ipilimumab|mesh-list
101941705|NCT02898454|Dermatologic Agents|dermatologic agents|mesh-ancestor
101941706|NCT02898454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101941707|NCT05283850|Calcium, Dietary|calcium, dietary|mesh-list
101941709|NCT05283850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102044140|NCT04429321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102044141|NCT04429321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102044142|NCT04429321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102044143|NCT04429321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044144|NCT03067610|Paclitaxel|paclitaxel|mesh-list
102044145|NCT03067610|Cisplatin|cisplatin|mesh-list
102044146|NCT03067610|Carboplatin|carboplatin|mesh-list
102044147|NCT03067610|Cetuximab|cetuximab|mesh-list
101345623|NCT00023751|Leucovorin|leucovorin|mesh-list
102044161|NCT00381485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102044162|NCT00381485|Respiratory System Agents|respiratory system agents|mesh-ancestor
102044163|NCT00381485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102044164|NCT00381485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102044165|NCT00381485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102044166|NCT00381485|Adrenergic Agents|adrenergic agents|mesh-ancestor
102044167|NCT00381485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102044168|NCT00381485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044169|NCT00381485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102044170|NCT00381485|Dermatologic Agents|dermatologic agents|mesh-ancestor
102044171|NCT00381485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102044172|NCT05182957|Lenalidomide|lenalidomide|mesh-list
102044173|NCT05182957|Azacitidine|azacitidine|mesh-list
102044174|NCT05182957|Antibodies|antibodies|mesh-list
102044175|NCT05182957|Immunoglobulins|immunoglobulins|mesh-list
102044176|NCT05182957|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102044177|NCT05182957|Immunologic Factors|immunologic factors|mesh-list
102044178|NCT05182957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044179|NCT05182957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102044180|NCT05182957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101763909|NCT00682890|Metformin|metformin|mesh-list
102044181|NCT05182957|Growth Substances|growth substances|mesh-ancestor
102044182|NCT05182957|Growth Inhibitors|growth inhibitors|mesh-ancestor
102044183|NCT05182957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102044184|NCT05182957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102044185|NCT05182957|Antimetabolites|antimetabolites|mesh-ancestor
102044186|NCT05182957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044187|NCT05182957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102044188|NCT00092651|Simvastatin|simvastatin|mesh-list
102044189|NCT00092651|Ezetimibe|ezetimibe|mesh-list
102044190|NCT00092651|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
102044191|NCT00092651|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102044192|NCT00092651|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102044193|NCT00092651|Antimetabolites|antimetabolites|mesh-ancestor
102044194|NCT00092651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044195|NCT00092651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102044196|NCT00092651|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102044197|NCT00092651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102044198|NCT04889599|Docetaxel|docetaxel|mesh-list
102044199|NCT04889599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102044200|NCT04889599|Tubulin Modulators|tubulin modulators|mesh-ancestor
102044201|NCT04889599|Antimitotic Agents|antimitotic agents|mesh-ancestor
102044202|NCT04889599|Mitosis Modulators|mitosis modulators|mesh-ancestor
102044203|NCT04889599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044204|NCT01342627|Sorafenib|sorafenib|mesh-list
102044205|NCT01342627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102044206|NCT01342627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102044207|NCT01342627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102044223|NCT01332617|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102044225|NCT01332617|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102044226|NCT01332617|Prednisolone phosphate|prednisolone phosphate|mesh-list
102044227|NCT01332617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102044228|NCT01332617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102044229|NCT01332617|Antiemetics|antiemetics|mesh-ancestor
102044230|NCT01332617|Autonomic Agents|autonomic agents|mesh-ancestor
102044231|NCT01332617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102044232|NCT01332617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044233|NCT01332617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101941710|NCT05283850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941711|NCT05283850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101941712|NCT03925779|Dexmedetomidine|dexmedetomidine|mesh-list
101422469|NCT00165633|Vitamins|vitamins|mesh-ancestor
102044234|NCT01332617|Glucocorticoids|glucocorticoids|mesh-ancestor
102044235|NCT01332617|Hormones|hormones|mesh-ancestor
102044236|NCT01332617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102044237|NCT01332617|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102044238|NCT01332617|Protective Agents|protective agents|mesh-ancestor
102044239|NCT01332617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102044240|NCT01332617|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102044241|NCT01332617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102044242|NCT01332617|Antimetabolites|antimetabolites|mesh-ancestor
102044243|NCT01332617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044244|NCT01332617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102044245|NCT01332617|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102044246|NCT01332617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102044247|NCT01332617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102044248|NCT01332617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102044249|NCT01332617|Analgesics|analgesics|mesh-ancestor
102044250|NCT01332617|Sensory System Agents|sensory system agents|mesh-ancestor
102044251|NCT01332617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102044252|NCT01332617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102044253|NCT01332617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102044254|NCT01332617|Alkylating Agents|alkylating agents|mesh-ancestor
102044255|NCT01332617|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102044256|NCT03569696|Nivolumab|nivolumab|mesh-list
102044257|NCT03569696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102044258|NCT03569696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102044259|NCT03569696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102044260|NCT03569696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044261|NCT00092573|Ezetimibe|ezetimibe|mesh-list
102044262|NCT00092573|Fenofibrate|fenofibrate|mesh-list
102044263|NCT00092573|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102044264|NCT00092573|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102044265|NCT00092573|Antimetabolites|antimetabolites|mesh-ancestor
102044266|NCT00092573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044267|NCT00092573|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102044268|NCT01342939|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102044296|NCT03379727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044297|NCT02247128|Aspirin|aspirin|mesh-list
102044298|NCT02247128|Clopidogrel|clopidogrel|mesh-list
102044299|NCT02247128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102044300|NCT02247128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102044301|NCT02247128|Analgesics|analgesics|mesh-ancestor
102044302|NCT02247128|Sensory System Agents|sensory system agents|mesh-ancestor
102044303|NCT02247128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102044304|NCT02247128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044305|NCT02247128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102044306|NCT02247128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102044307|NCT02247128|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102044308|NCT02247128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102044309|NCT02247128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044310|NCT02247128|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102044311|NCT02247128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102044312|NCT02247128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102044313|NCT02247128|Antipyretics|antipyretics|mesh-ancestor
102044314|NCT02247128|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101345796|NCT00024531|Atorvastatin|atorvastatin|mesh-list
102044330|NCT01344031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102044332|NCT01344031|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102044333|NCT01344031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102044334|NCT01344031|Hormone Antagonists|hormone antagonists|mesh-ancestor
102044335|NCT01344031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102044336|NCT01344031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044337|NCT01344031|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102044338|NCT01344031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102044339|NCT01344031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101941713|NCT03925779|Remifentanil|remifentanil|mesh-list
101941714|NCT03925779|Propofol|propofol|mesh-list
101941715|NCT03925779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101941716|NCT03925779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101941717|NCT03925779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941718|NCT03925779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101941719|NCT03925779|Analgesics|analgesics|mesh-ancestor
101306734|NCT02027337|Estrogens|estrogens|mesh-ancestor
102044340|NCT01344031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044342|NCT01332929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102044343|NCT01332929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102044344|NCT01332929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101695741|NCT05340803|Anesthetics|anesthetics|mesh-ancestor
102044345|NCT01332929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102044346|NCT01332929|Growth Substances|growth substances|mesh-ancestor
102044347|NCT01332929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044348|NCT01332929|Growth Inhibitors|growth inhibitors|mesh-ancestor
102044349|NCT03566966|Antiviral Agents|antiviral agents|mesh-list
102044350|NCT03566966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102044351|NCT02247986|Methylphenidate|methylphenidate|mesh-list
102044352|NCT02247986|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102044353|NCT02247986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044354|NCT02247986|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102044355|NCT02247986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102044356|NCT02247986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102044357|NCT02247986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044358|NCT02247986|Dopamine Agents|dopamine agents|mesh-ancestor
102044359|NCT02247986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102044360|NCT03567434|Ethanol|ethanol|mesh-list
102044361|NCT03567434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102044362|NCT03567434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102044363|NCT03567434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102044364|NCT03567434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044365|NCT05708534|Abatacept|abatacept|mesh-list
102044366|NCT05708534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102044367|NCT05708534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044368|NCT05708534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102044369|NCT05708534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102044380|NCT03000374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102044381|NCT03000374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102044382|NCT03000374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102044383|NCT03000374|Immunologic Factors|immunologic factors|mesh-ancestor
102044384|NCT03000374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044385|NCT03000374|Antidotes|antidotes|mesh-ancestor
102044386|NCT03000374|Protective Agents|protective agents|mesh-ancestor
102044387|NCT03000374|Vitamin B Complex|vitamin b complex|mesh-ancestor
102044388|NCT03000374|Vitamins|vitamins|mesh-ancestor
102044389|NCT03000374|Micronutrients|micronutrients|mesh-ancestor
102044390|NCT03000374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102044391|NCT03566576|Docetaxel|docetaxel|mesh-list
102044392|NCT03566576|Pemetrexed|pemetrexed|mesh-list
102044393|NCT03566576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102044394|NCT03566576|Tubulin Modulators|tubulin modulators|mesh-ancestor
102044395|NCT03566576|Antimitotic Agents|antimitotic agents|mesh-ancestor
102044396|NCT03566576|Mitosis Modulators|mitosis modulators|mesh-ancestor
102044397|NCT03566576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044398|NCT03566576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102044399|NCT03566576|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102044400|NCT03566576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102044401|NCT04377997|Heparin|heparin|mesh-list
102044402|NCT04377997|Calcium heparin|calcium heparin|mesh-list
102044403|NCT04377997|Enoxaparin|enoxaparin|mesh-list
102044404|NCT04377997|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102044405|NCT04377997|Tinzaparin|tinzaparin|mesh-list
102044406|NCT04377997|Dalteparin|dalteparin|mesh-list
102044407|NCT04377997|Anticoagulants|anticoagulants|mesh-ancestor
102044408|NCT04377997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102044409|NCT04377997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101941720|NCT03925779|Sensory System Agents|sensory system agents|mesh-ancestor
101941721|NCT03925779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101941722|NCT03925779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101971925|NCT04470310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102044410|NCT04377997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044411|NCT01336049|Nimotuzumab|nimotuzumab|mesh-list
101695756|NCT04033172|Fulvestrant|fulvestrant|mesh-list
102044412|NCT01336049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102044413|NCT01336049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102044414|NCT04758949|Nivolumab|nivolumab|mesh-list
102044415|NCT04758949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102044416|NCT04758949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102044417|NCT04758949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102044418|NCT04758949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044419|NCT03566030|Tenofovir|tenofovir|mesh-list
102044420|NCT03566030|Antiviral Agents|antiviral agents|mesh-ancestor
102044421|NCT03566030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102044422|NCT03566030|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102044423|NCT03566030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102044424|NCT03566030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102044425|NCT03566030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044426|NCT03566030|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102044427|NCT03566030|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102044428|NCT01333085|Paclitaxel|paclitaxel|mesh-list
102044429|NCT01333085|Carboplatin|carboplatin|mesh-list
102044430|NCT01333085|Everolimus|everolimus|mesh-list
102044431|NCT01333085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102044432|NCT01333085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102044433|NCT01333085|Tubulin Modulators|tubulin modulators|mesh-ancestor
102044434|NCT01333085|Antimitotic Agents|antimitotic agents|mesh-ancestor
102044435|NCT01333085|Mitosis Modulators|mitosis modulators|mesh-ancestor
102044436|NCT01333085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044437|NCT01333085|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102044458|NCT04734535|Hemostatics|hemostatics|mesh-ancestor
102044459|NCT04734535|Coagulants|coagulants|mesh-ancestor
102044460|NCT03565406|Nivolumab|nivolumab|mesh-list
102044461|NCT03565406|Ipilimumab|ipilimumab|mesh-list
102044462|NCT03565406|Mocetinostat|mocetinostat|mesh-list
102044463|NCT03565406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102044464|NCT03565406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102044465|NCT03565406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102044466|NCT03565406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044467|NCT03565406|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102044468|NCT03565406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102044469|NCT04734379|Fasudil|fasudil|mesh-list
102044470|NCT04734379|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102044471|NCT04734379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102044472|NCT04734379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044473|NCT04734379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102044474|NCT04734379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044475|NCT04734379|Vasodilator Agents|vasodilator agents|mesh-ancestor
102044476|NCT04734379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102044477|NCT04734379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102044478|NCT01339871|Vorinostat|vorinostat|mesh-list
102044479|NCT01339871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102044480|NCT01339871|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102044481|NCT01339871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102044482|NCT01339871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044483|NCT04693429|Bepotastine besilate|bepotastine besilate|mesh-list
102044484|NCT04693429|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102044486|NCT03564704|Dexamethasone|dexamethasone|mesh-list
102044487|NCT03564704|Cyclophosphamide|cyclophosphamide|mesh-list
102044488|NCT03564704|Methotrexate|methotrexate|mesh-list
102044489|NCT03564704|Etoposide|etoposide|mesh-list
102044490|NCT03564704|Vincristine|vincristine|mesh-list
102044491|NCT03564704|Doxorubicin|doxorubicin|mesh-list
102044492|NCT03564704|Mercaptopurine|mercaptopurine|mesh-list
102044493|NCT03564704|Idarubicin|idarubicin|mesh-list
102044504|NCT03564704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102044505|NCT03564704|Antiemetics|antiemetics|mesh-ancestor
102044506|NCT03564704|Autonomic Agents|autonomic agents|mesh-ancestor
102044507|NCT03564704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102044508|NCT03564704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101941723|NCT03925779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101941724|NCT03925779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102044509|NCT03564704|Glucocorticoids|glucocorticoids|mesh-ancestor
102044510|NCT03564704|Hormones|hormones|mesh-ancestor
102044511|NCT03564704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102044512|NCT03564704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102044513|NCT03564704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102044514|NCT03564704|Abortifacient Agents|abortifacient agents|mesh-ancestor
102044515|NCT03564704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102044516|NCT03564704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102044517|NCT03564704|Antimetabolites|antimetabolites|mesh-ancestor
102044518|NCT03564704|Dermatologic Agents|dermatologic agents|mesh-ancestor
102044519|NCT03564704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102044520|NCT03564704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102044521|NCT03564704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102044522|NCT03564704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102044523|NCT03564704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102044524|NCT03564704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102044525|NCT03564704|Antiviral Agents|antiviral agents|mesh-ancestor
102044526|NCT03564704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102044527|NCT03564704|Tubulin Modulators|tubulin modulators|mesh-ancestor
102044528|NCT03564704|Antimitotic Agents|antimitotic agents|mesh-ancestor
102044529|NCT03564704|Mitosis Modulators|mitosis modulators|mesh-ancestor
102044530|NCT03564704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102044531|NCT03564548|Morphine|morphine|mesh-list
102044532|NCT03564548|Oxycodone|oxycodone|mesh-list
102044533|NCT03564548|Hydromorphone|hydromorphone|mesh-list
102044534|NCT03564548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102044535|NCT03564548|Narcotics|narcotics|mesh-ancestor
102044536|NCT03564548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102044537|NCT03564548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044538|NCT03564548|Analgesics|analgesics|mesh-ancestor
102044539|NCT03564548|Sensory System Agents|sensory system agents|mesh-ancestor
102044540|NCT03564548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102044541|NCT05353010|Tacrolimus|tacrolimus|mesh-list
102044542|NCT05353010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102044543|NCT05353010|Immunologic Factors|immunologic factors|mesh-ancestor
102044544|NCT05353010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044545|NCT05353010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102044546|NCT05353010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102044547|NCT05353010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044548|NCT05352854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102044549|NCT05352854|Pilocarpine|pilocarpine|mesh-list
102044550|NCT05352854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102044551|NCT05352854|Miotics|miotics|mesh-ancestor
102044552|NCT05352854|Autonomic Agents|autonomic agents|mesh-ancestor
102044553|NCT05352854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102044554|NCT05352854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044555|NCT05352854|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102044556|NCT05352854|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102044557|NCT05352854|Cholinergic Agents|cholinergic agents|mesh-ancestor
102044558|NCT05352854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102044569|NCT01841177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044570|NCT02838134|Rocuronium|rocuronium|mesh-list
102044571|NCT02838134|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102044572|NCT02838134|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102044573|NCT02838134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102044574|NCT02838134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102044575|NCT02838134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044576|NCT03150589|Ranibizumab|ranibizumab|mesh-list
102044577|NCT03150589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102044578|NCT03150589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102044579|NCT03150589|Growth Substances|growth substances|mesh-ancestor
102044580|NCT03150589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044581|NCT03150589|Growth Inhibitors|growth inhibitors|mesh-ancestor
102044582|NCT03150589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102044583|NCT05708300|Vaccines|vaccines|mesh-list
102044584|NCT05708300|Immunologic Factors|immunologic factors|mesh-ancestor
102044585|NCT05708300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044586|NCT05340452|Clarithromycin|clarithromycin|mesh-list
102044587|NCT05340452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102044588|NCT05340452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102044589|NCT05340452|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102044590|NCT05340452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101941725|NCT03925779|Adrenergic Agents|adrenergic agents|mesh-ancestor
101941726|NCT03925779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101306745|NCT02027363|Capecitabine|capecitabine|mesh-list
102044591|NCT05340452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044592|NCT05340452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102044593|NCT05340452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102044594|NCT03145207|Lidocaine|lidocaine|mesh-list
102044595|NCT03145207|Anesthetics, Local|anesthetics, local|mesh-ancestor
102044596|NCT03145207|Anesthetics|anesthetics|mesh-ancestor
102044597|NCT03145207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102044598|NCT03145207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044599|NCT03145207|Sensory System Agents|sensory system agents|mesh-ancestor
102044600|NCT03145207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102044601|NCT03145207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102044602|NCT03145207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102044603|NCT03145207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102044604|NCT03145207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102044605|NCT03145207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044606|NCT02836652|Aspirin|aspirin|mesh-list
102044607|NCT02836652|Warfarin|warfarin|mesh-list
102044608|NCT02836652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102044609|NCT02836652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102044610|NCT02836652|Analgesics|analgesics|mesh-ancestor
102044611|NCT02836652|Sensory System Agents|sensory system agents|mesh-ancestor
102044612|NCT02836652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102044613|NCT02836652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044614|NCT02836652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102044615|NCT02836652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102044616|NCT02836652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102044617|NCT02836652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102044618|NCT02836652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044619|NCT02836652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101346081|NCT00025779|Adrenergic Agents|adrenergic agents|mesh-ancestor
102044640|NCT04044781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101695797|NCT00976105|Zolpidem|zolpidem|mesh-list
102044641|NCT04044781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102044642|NCT04044781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044644|NCT01345279|Topotecan|topotecan|mesh-list
102044645|NCT01345279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102044646|NCT01345279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102044647|NCT01345279|Tubulin Modulators|tubulin modulators|mesh-ancestor
102044648|NCT01345279|Antimitotic Agents|antimitotic agents|mesh-ancestor
102044649|NCT01345279|Mitosis Modulators|mitosis modulators|mesh-ancestor
102044650|NCT01345279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044651|NCT01345279|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102044652|NCT01345279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102044653|NCT01345279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102044654|NCT02833844|Evolocumab|evolocumab|mesh-list
102044655|NCT02833844|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102044656|NCT02833844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102044657|NCT02833844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102044658|NCT02833844|Antimetabolites|antimetabolites|mesh-ancestor
102044659|NCT02833844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044660|NCT02833844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102044661|NCT02833844|Protease Inhibitors|protease inhibitors|mesh-ancestor
102044662|NCT02833844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102044663|NCT02833844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102044664|NCT01345357|Gemcitabine|gemcitabine|mesh-list
102044665|NCT01345357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102044666|NCT01345357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102044667|NCT01345357|Antimetabolites|antimetabolites|mesh-ancestor
102044668|NCT01345357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044669|NCT01333631|Valproic Acid|valproic acid|mesh-list
102044670|NCT01333631|Anticonvulsants|anticonvulsants|mesh-ancestor
102044671|NCT01333631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102044672|NCT01333631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044673|NCT01333631|GABA Agents|gaba agents|mesh-ancestor
102044702|NCT01341782|Dermatologic Agents|dermatologic agents|mesh-ancestor
102044703|NCT01341782|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102044704|NCT01341782|Protective Agents|protective agents|mesh-ancestor
102044705|NCT01341782|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101941727|NCT03925779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941728|NCT03925779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101941729|NCT03925779|Anesthetics, General|anesthetics, general|mesh-ancestor
102044706|NCT01341782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102044707|NCT01341782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044708|NCT01341782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102044710|NCT02250157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102044711|NCT02250157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102044712|NCT02250157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102044713|NCT02250157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044714|NCT02250157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102044715|NCT05063149|Broncho-Vaxom|broncho-vaxom|mesh-list
102044716|NCT05063149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102044717|NCT05063149|Immunologic Factors|immunologic factors|mesh-ancestor
102044718|NCT05063149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044719|NCT03564158|Moxifloxacin|moxifloxacin|mesh-list
102044735|NCT02677298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044737|NCT02677298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102044738|NCT02677298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044739|NCT02677298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102044740|NCT02677298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102044741|NCT01345981|Lidocaine|lidocaine|mesh-list
102044742|NCT01345981|Anesthetics, Local|anesthetics, local|mesh-ancestor
102044743|NCT01345981|Anesthetics|anesthetics|mesh-ancestor
102044744|NCT01345981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102044745|NCT01345981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044746|NCT01345981|Sensory System Agents|sensory system agents|mesh-ancestor
102044747|NCT01345981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102044748|NCT01345981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102044749|NCT01345981|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102044750|NCT01345981|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102044751|NCT01345981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102044752|NCT01345981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044753|NCT00871351|Atorvastatin|atorvastatin|mesh-list
102044754|NCT00871351|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102044755|NCT00871351|Ezetimibe|ezetimibe|mesh-list
102044756|NCT00871351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102044757|NCT00871351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102044758|NCT00871351|Antimetabolites|antimetabolites|mesh-ancestor
102044759|NCT00871351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044760|NCT00871351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102044761|NCT00871351|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102044762|NCT00871351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102044763|NCT04920331|Erenumab|erenumab|mesh-list
102044764|NCT04920331|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
102044765|NCT04920331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044766|NCT04920331|Analgesics|analgesics|mesh-ancestor
102044767|NCT04920331|Sensory System Agents|sensory system agents|mesh-ancestor
102044768|NCT04920331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102044769|NCT04920331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044770|NCT02745080|Adalimumab|adalimumab|mesh-list
102044771|NCT02745080|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102044772|NCT02745080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102044773|NCT02745080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102044774|NCT01346137|Meloxicam|meloxicam|mesh-list
102044775|NCT01346137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102044776|NCT01346137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102044808|NCT02834390|Daunorubicin|daunorubicin|mesh-list
102044809|NCT02834390|Idarubicin|idarubicin|mesh-list
102044810|NCT02834390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102044811|NCT02834390|Antimetabolites|antimetabolites|mesh-ancestor
102044812|NCT02834390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044813|NCT02834390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102044814|NCT02834390|Antiviral Agents|antiviral agents|mesh-ancestor
102044815|NCT02834390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102044816|NCT02834390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102044817|NCT02834390|Immunologic Factors|immunologic factors|mesh-ancestor
102044818|NCT02834390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941730|NCT03925779|Anesthetics|anesthetics|mesh-ancestor
101941731|NCT03925779|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101941732|NCT03925779|Narcotics|narcotics|mesh-ancestor
101941733|NCT05283694|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102044819|NCT02834390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102044820|NCT02834390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102044839|NCT01356602|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102044840|NCT01356602|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102044841|NCT01356602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102044842|NCT01356602|Glucocorticoids|glucocorticoids|mesh-ancestor
102044843|NCT01356602|Hormones|hormones|mesh-ancestor
102044844|NCT01356602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102044845|NCT01356602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044846|NCT01356602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102044847|NCT01356602|Immunologic Factors|immunologic factors|mesh-ancestor
102044848|NCT01356602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102044849|NCT01356602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044850|NCT01347853|Ketorolac|ketorolac|mesh-list
102044851|NCT01347853|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102044852|NCT01347853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102044853|NCT01347853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102044854|NCT01347853|Analgesics|analgesics|mesh-ancestor
102044855|NCT01347853|Sensory System Agents|sensory system agents|mesh-ancestor
102044856|NCT01347853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102044857|NCT01347853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044858|NCT01347853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102044859|NCT01347853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102044860|NCT01347853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102044861|NCT01347853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102044862|NCT01347853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044864|NCT01346917|Anesthetics, Local|anesthetics, local|mesh-ancestor
102044865|NCT01346917|Anesthetics|anesthetics|mesh-ancestor
102044866|NCT01346917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102044867|NCT01346917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044868|NCT01346917|Sensory System Agents|sensory system agents|mesh-ancestor
102044869|NCT01346917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102044870|NCT01346917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102044871|NCT01346917|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102044872|NCT01346917|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102044873|NCT01346917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102044874|NCT01346917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044875|NCT01348009|Cisplatin|cisplatin|mesh-list
102044876|NCT01348009|Capecitabine|capecitabine|mesh-list
102044877|NCT01348009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102044878|NCT01348009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102044891|NCT01348243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044893|NCT01348243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102044894|NCT01348243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102044895|NCT01348243|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102044896|NCT01348243|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102044897|NCT01348243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102044898|NCT01348243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044899|NCT01348243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102044900|NCT01348321|Levamisole|levamisole|mesh-list
102044901|NCT01348321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102044902|NCT01348321|Immunologic Factors|immunologic factors|mesh-ancestor
102044903|NCT01348321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044904|NCT01348321|Antinematodal Agents|antinematodal agents|mesh-ancestor
102044905|NCT01348321|Anthelmintics|anthelmintics|mesh-ancestor
102044906|NCT01348321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101695920|NCT02665208|Nicotine|nicotine|mesh-list
102044907|NCT01348321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102044908|NCT01348321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102044909|NCT03772951|Clozapine|clozapine|mesh-list
102044910|NCT03772951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102044911|NCT03772951|Serotonin Agents|serotonin agents|mesh-ancestor
102044912|NCT03772951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102044913|NCT03772951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044914|NCT03772951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044915|NCT03772951|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102044916|NCT03772951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101941735|NCT05283694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941736|NCT03925701|Metformin|metformin|mesh-list
101941737|NCT03925701|Vildagliptin|vildagliptin|mesh-list
101423011|NCT02950441|Niacin|niacin|mesh-list
102044917|NCT03772951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102044918|NCT03772951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102044919|NCT03772951|GABA Antagonists|gaba antagonists|mesh-ancestor
102044920|NCT03772951|GABA Agents|gaba agents|mesh-ancestor
102044921|NCT01343329|Propranolol|propranolol|mesh-list
102044922|NCT01343329|Esmolol|esmolol|mesh-list
102044923|NCT01343329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102044924|NCT01343329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102044925|NCT01343329|Adrenergic Agents|adrenergic agents|mesh-ancestor
102044926|NCT01343329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102044927|NCT01343329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044928|NCT01343329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044929|NCT01343329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102044930|NCT01343329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102044931|NCT01343329|Vasodilator Agents|vasodilator agents|mesh-ancestor
102044932|NCT01343329|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102044933|NCT01317589|Fentanyl|fentanyl|mesh-list
102044934|NCT01317589|Methadone|methadone|mesh-list
102044935|NCT01317589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102044936|NCT01317589|Narcotics|narcotics|mesh-ancestor
102044937|NCT01317589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102044938|NCT01317589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044939|NCT01317589|Analgesics|analgesics|mesh-ancestor
102044940|NCT01317589|Sensory System Agents|sensory system agents|mesh-ancestor
102044958|NCT02829944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044959|NCT02829944|Sensory System Agents|sensory system agents|mesh-ancestor
102044960|NCT02829944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102044961|NCT02829944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102044962|NCT02829944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102044963|NCT02829944|Analgesics|analgesics|mesh-ancestor
102044964|NCT02829944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102044965|NCT02829944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102044966|NCT02829944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102044967|NCT02829944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102044968|NCT02829944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044969|NCT04014530|Pembrolizumab|pembrolizumab|mesh-list
102044970|NCT04014530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102044971|NCT04014530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102044972|NCT04014530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102044973|NCT04014530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044974|NCT03563534|Fluorides|fluorides|mesh-list
102044975|NCT03563534|Cariostatic Agents|cariostatic agents|mesh-ancestor
102044976|NCT03563534|Protective Agents|protective agents|mesh-ancestor
102044977|NCT03563534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044978|NCT03563144|Leucovorin|leucovorin|mesh-list
102044979|NCT03563144|Paclitaxel|paclitaxel|mesh-list
102044980|NCT03563144|Cyclophosphamide|cyclophosphamide|mesh-list
102044981|NCT03563144|Bevacizumab|bevacizumab|mesh-list
102044982|NCT03563144|Gemcitabine|gemcitabine|mesh-list
102044983|NCT03563144|Fluorouracil|fluorouracil|mesh-list
102044984|NCT03563144|Capecitabine|capecitabine|mesh-list
102044985|NCT03563144|Oxaliplatin|oxaliplatin|mesh-list
102044986|NCT03563144|Avelumab|avelumab|mesh-list
102044987|NCT03563144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102044988|NCT03563144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102044989|NCT03563144|Tubulin Modulators|tubulin modulators|mesh-ancestor
102044990|NCT03563144|Antimitotic Agents|antimitotic agents|mesh-ancestor
102044991|NCT03563144|Mitosis Modulators|mitosis modulators|mesh-ancestor
102044992|NCT03563144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044993|NCT03563144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102044994|NCT03563144|Immunologic Factors|immunologic factors|mesh-ancestor
102044995|NCT03563144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044996|NCT03563144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102044997|NCT03563144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102044998|NCT03563144|Alkylating Agents|alkylating agents|mesh-ancestor
102044999|NCT03563144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102045018|NCT01338818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941738|NCT03925701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101941739|NCT03925701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306755|NCT02027454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102045020|NCT01338818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102045021|NCT05310110|Lidocaine|lidocaine|mesh-list
102045022|NCT05310110|Propofol|propofol|mesh-list
102045023|NCT05310110|Cisatracurium|cisatracurium|mesh-list
102045024|NCT05310110|Atracurium|atracurium|mesh-list
102045025|NCT05310110|Anesthetics, Local|anesthetics, local|mesh-ancestor
102045026|NCT05310110|Anesthetics|anesthetics|mesh-ancestor
102045027|NCT05310110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102045028|NCT05310110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045029|NCT05310110|Sensory System Agents|sensory system agents|mesh-ancestor
102045030|NCT05310110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102045031|NCT05310110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102045032|NCT05310110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102045033|NCT05310110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102045034|NCT05310110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102045035|NCT05310110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045036|NCT05310110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102045037|NCT05310110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102045038|NCT05310110|Anesthetics, General|anesthetics, general|mesh-ancestor
102045039|NCT05310110|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102045040|NCT05310110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102045041|NCT05310110|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102045042|NCT05310110|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102045043|NCT05310110|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102045044|NCT05310110|Cholinergic Agents|cholinergic agents|mesh-ancestor
102045045|NCT05310110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102045046|NCT02823470|Ivacaftor|ivacaftor|mesh-list
102045047|NCT02823470|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102045048|NCT02823470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102045049|NCT02823470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045050|NCT03562754|Heparin|heparin|mesh-list
102045051|NCT03562754|Anticoagulants|anticoagulants|mesh-ancestor
102045052|NCT03562754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045053|NCT03562754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101346530|NCT00028431|Ipilimumab|ipilimumab|mesh-list
102045071|NCT01371656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102045073|NCT04541888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102045074|NCT01354964|Vitamin D|vitamin d|mesh-list
102045075|NCT01354964|Ergocalciferols|ergocalciferols|mesh-list
102045076|NCT01354964|Cholecalciferol|cholecalciferol|mesh-list
102045077|NCT01354964|Vitamins|vitamins|mesh-list
102045079|NCT01354964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045080|NCT01354964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102045081|NCT01354964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102045082|NCT02259998|Dipyridamole|dipyridamole|mesh-list
102045083|NCT02259998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102045084|NCT02259998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102045085|NCT02259998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045086|NCT02259998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102045087|NCT02259998|Vasodilator Agents|vasodilator agents|mesh-ancestor
102045088|NCT02035904|Morphine|morphine|mesh-list
102045089|NCT02035904|Levobupivacaine|levobupivacaine|mesh-list
102045090|NCT02035904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102045091|NCT02035904|Narcotics|narcotics|mesh-ancestor
102045092|NCT02035904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102045093|NCT02035904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045094|NCT02035904|Analgesics|analgesics|mesh-ancestor
102045095|NCT02035904|Sensory System Agents|sensory system agents|mesh-ancestor
102045096|NCT02035904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102045097|NCT02035904|Anesthetics, Local|anesthetics, local|mesh-ancestor
102045098|NCT02035904|Anesthetics|anesthetics|mesh-ancestor
102045099|NCT04110080|Anesthetics|anesthetics|mesh-list
102045100|NCT04110080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102045101|NCT04110080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045102|NCT02035982|Rivastigmine|rivastigmine|mesh-list
102045103|NCT02035982|Donepezil|donepezil|mesh-list
102045104|NCT02035982|Galantamine|galantamine|mesh-list
102045105|NCT02035982|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
102045106|NCT02035982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101941740|NCT03925701|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101941741|NCT03925701|Protease Inhibitors|protease inhibitors|mesh-ancestor
101941742|NCT03925701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102045107|NCT02035982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045108|NCT02035982|Cholinergic Agents|cholinergic agents|mesh-ancestor
102045109|NCT02035982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102045110|NCT02035982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045111|NCT02035982|Nootropic Agents|nootropic agents|mesh-ancestor
102045125|NCT05707832|Antifungal Agents|antifungal agents|mesh-ancestor
102045126|NCT05707832|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102045127|NCT05707832|Protease Inhibitors|protease inhibitors|mesh-ancestor
102045128|NCT05707832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102045129|NCT05707832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045130|NCT05707832|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102045131|NCT05707832|Protective Agents|protective agents|mesh-ancestor
102045132|NCT05707832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045133|NCT05707832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102045134|NCT02822222|Magnesium citrate|magnesium citrate|mesh-list
102045135|NCT02822222|Cathartics|cathartics|mesh-ancestor
102045136|NCT02822222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102045137|NCT02821910|Metformin|metformin|mesh-list
102045138|NCT02821910|Empagliflozin|empagliflozin|mesh-list
102045139|NCT02821910|Linagliptin|linagliptin|mesh-list
102045140|NCT02821910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102045141|NCT02821910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045142|NCT02821910|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102045143|NCT02821910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045144|NCT02821910|Incretins|incretins|mesh-ancestor
102045145|NCT02821910|Hormones|hormones|mesh-ancestor
102045146|NCT02821910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102045147|NCT02821910|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102045148|NCT02821910|Protease Inhibitors|protease inhibitors|mesh-ancestor
102045149|NCT02821910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102045150|NCT03819452|Vitamin D|vitamin d|mesh-list
102045151|NCT03819452|Vitamins|vitamins|mesh-ancestor
102045152|NCT03819452|Micronutrients|micronutrients|mesh-ancestor
102045153|NCT03819452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045154|NCT03819452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102045156|NCT03138655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102045157|NCT05707520|Mycophenolic Acid|mycophenolic acid|mesh-list
102045158|NCT05707520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102045159|NCT05707520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102045160|NCT05707520|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102045161|NCT05707520|Antitubercular Agents|antitubercular agents|mesh-ancestor
102045162|NCT05707520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102045163|NCT05707520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102045164|NCT05707520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102045165|NCT05707520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045166|NCT04412785|Cyclosporine|cyclosporine|mesh-list
102045167|NCT04412785|Cyclosporins|cyclosporins|mesh-list
102045168|NCT04412785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102045169|NCT04412785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045170|NCT04412785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102045171|NCT04412785|Immunologic Factors|immunologic factors|mesh-ancestor
102045172|NCT04412785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045173|NCT04412785|Antifungal Agents|antifungal agents|mesh-ancestor
102045174|NCT04412785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102045175|NCT04412785|Dermatologic Agents|dermatologic agents|mesh-ancestor
101346639|NCT00028899|Cytarabine|cytarabine|mesh-list
102045191|NCT02819804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102045192|NCT02819804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102045193|NCT02819804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045194|NCT02819804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102045195|NCT02819804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102045196|NCT02819726|Rituximab|rituximab|mesh-list
102045197|NCT02819726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102045198|NCT02819726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102045199|NCT02819726|Immunologic Factors|immunologic factors|mesh-ancestor
102045200|NCT02819726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045201|NCT02819726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102045202|NCT02816138|Nicotine|nicotine|mesh-list
102045203|NCT02816138|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101941743|NCT03925701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045204|NCT02816138|Autonomic Agents|autonomic agents|mesh-ancestor
102045205|NCT02816138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102045206|NCT02816138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045207|NCT02816138|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102045208|NCT02816138|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102045209|NCT02816138|Cholinergic Agents|cholinergic agents|mesh-ancestor
102045210|NCT02816138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102045211|NCT02816138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045212|NCT02036060|Prednisone|prednisone|mesh-list
102045213|NCT02036060|Docetaxel|docetaxel|mesh-list
102045214|NCT02036060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102045215|NCT02036060|Tubulin Modulators|tubulin modulators|mesh-ancestor
102045216|NCT02036060|Antimitotic Agents|antimitotic agents|mesh-ancestor
102045217|NCT02036060|Mitosis Modulators|mitosis modulators|mesh-ancestor
102045218|NCT02036060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045219|NCT02036060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102045220|NCT02036060|Glucocorticoids|glucocorticoids|mesh-ancestor
102045221|NCT02036060|Hormones|hormones|mesh-ancestor
102045222|NCT02036060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102045223|NCT02036060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045224|NCT02036060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102045225|NCT02036528|Doxycycline|doxycycline|mesh-list
102045226|NCT02036528|Ciprofloxacin|ciprofloxacin|mesh-list
102045227|NCT02036528|Gentamicins|gentamicins|mesh-list
102045228|NCT02036528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102045229|NCT02036528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102045230|NCT02036528|Antimalarials|antimalarials|mesh-ancestor
102045231|NCT02036528|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102045232|NCT02036528|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102045233|NCT02036528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102045234|NCT02036528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102045235|NCT02036528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101346701|NCT00029523|Cytarabine|cytarabine|mesh-list
102045253|NCT03635125|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102045255|NCT03635125|Adrenergic Agents|adrenergic agents|mesh-ancestor
102045256|NCT03635125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102045257|NCT03635125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045258|NCT03635125|Vasodilator Agents|vasodilator agents|mesh-ancestor
102045259|NCT03635125|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102045260|NCT03635125|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102045261|NCT03635125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102045262|NCT01854385|Sumatriptan|sumatriptan|mesh-list
102045263|NCT01854385|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102045264|NCT01854385|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102045265|NCT01854385|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102045266|NCT01854385|Serotonin Agents|serotonin agents|mesh-ancestor
102045267|NCT01854385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102045268|NCT01854385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045269|NCT01854385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045270|NCT02047838|Hormones|hormones|mesh-list
102045271|NCT02047838|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102045272|NCT02047838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102045273|NCT02047838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045274|NCT01318681|Fluticasone|fluticasone|mesh-list
102045275|NCT01318681|Xhance|xhance|mesh-list
102045276|NCT01318681|Cetirizine|cetirizine|mesh-list
102045277|NCT01318681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102045278|NCT01318681|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102045279|NCT01318681|Autonomic Agents|autonomic agents|mesh-ancestor
102045280|NCT01318681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102045281|NCT01318681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045282|NCT01318681|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102045283|NCT01318681|Respiratory System Agents|respiratory system agents|mesh-ancestor
102045284|NCT01318681|Dermatologic Agents|dermatologic agents|mesh-ancestor
102045285|NCT01318681|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102045286|NCT01318681|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102045287|NCT01318681|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102045288|NCT01318681|Histamine Antagonists|histamine antagonists|mesh-ancestor
102045289|NCT01318681|Histamine Agents|histamine agents|mesh-ancestor
102045290|NCT01318681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102045301|NCT03604159|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101941745|NCT01224717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101941746|NCT01224717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941747|NCT01224717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101941748|NCT03925233|Tamoxifen|tamoxifen|mesh-list
101941749|NCT03925233|Toremifene|toremifene|mesh-list
101941750|NCT03925233|Vinorelbine|vinorelbine|mesh-list
101941751|NCT03925233|Cyclophosphamide|cyclophosphamide|mesh-list
101941752|NCT03925233|Bevacizumab|bevacizumab|mesh-list
101941753|NCT03925233|Carboplatin|carboplatin|mesh-list
101941754|NCT03925233|Gemcitabine|gemcitabine|mesh-list
101941755|NCT03925233|Doxorubicin|doxorubicin|mesh-list
101941756|NCT03925233|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101941757|NCT03925233|Fluorouracil|fluorouracil|mesh-list
101941758|NCT03925233|Capecitabine|capecitabine|mesh-list
101941759|NCT03925233|Methotrexate|methotrexate|mesh-list
101941760|NCT03925233|Trastuzumab|trastuzumab|mesh-list
101941761|NCT03925233|Letrozole|letrozole|mesh-list
101941762|NCT03925233|Apatinib|apatinib|mesh-list
101941763|NCT03925233|Epirubicin|epirubicin|mesh-list
101941764|NCT03925233|Fulvestrant|fulvestrant|mesh-list
101941765|NCT03925233|Olaparib|olaparib|mesh-list
101941766|NCT03925233|Anastrozole|anastrozole|mesh-list
101941767|NCT03925233|Exemestane|exemestane|mesh-list
101941768|NCT03925233|Endostatins|endostatins|mesh-list
101765030|NCT00878865|Alprazolam|alprazolam|mesh-list
102045302|NCT03686930|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102045303|NCT01353235|Prednisolone|prednisolone|mesh-list
102045304|NCT01353235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102045305|NCT01353235|Glucocorticoids|glucocorticoids|mesh-ancestor
102045306|NCT01353235|Hormones|hormones|mesh-ancestor
102045307|NCT01353235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102045308|NCT01353235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045309|NCT01353235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102045310|NCT01353235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102045311|NCT02048228|Clopidogrel|clopidogrel|mesh-list
102045312|NCT02048228|Ticagrelor|ticagrelor|mesh-list
102045313|NCT02048228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102045314|NCT02048228|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102045315|NCT02048228|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102045316|NCT02048228|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102045317|NCT02048228|Purinergic Agents|purinergic agents|mesh-ancestor
102045318|NCT02048228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102045319|NCT02048228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045320|NCT02048228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045321|NCT03046927|Vitamin D|vitamin d|mesh-list
102045322|NCT03046927|Ergocalciferols|ergocalciferols|mesh-list
102045323|NCT03046927|Vitamins|vitamins|mesh-ancestor
102045324|NCT03046927|Micronutrients|micronutrients|mesh-ancestor
102045325|NCT03046927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045326|NCT03046927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102045327|NCT03046927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102045328|NCT01349257|Formoterol Fumarate|formoterol fumarate|mesh-list
102045329|NCT01349257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102045330|NCT01349257|Autonomic Agents|autonomic agents|mesh-ancestor
102045331|NCT01349257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102045332|NCT01349257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045333|NCT01349257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102045334|NCT01349257|Respiratory System Agents|respiratory system agents|mesh-ancestor
102045335|NCT01349257|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101941769|NCT03925233|Pirarubicin|pirarubicin|mesh-list
101941770|NCT03925233|Citric Acid|citric acid|mesh-list
101941771|NCT03925233|Sodium Citrate|sodium citrate|mesh-list
101423389|NCT05709990|Vitamin D|vitamin d|mesh-list
102045336|NCT01349257|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102045337|NCT01349257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102045338|NCT01349257|Adrenergic Agents|adrenergic agents|mesh-ancestor
102045339|NCT01349257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102045340|NCT01349257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045341|NCT03589105|Ocrelizumab|ocrelizumab|mesh-list
102045342|NCT03589105|Immunologic Factors|immunologic factors|mesh-ancestor
102045343|NCT03589105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045344|NCT02048384|Metformin|metformin|mesh-list
102045345|NCT02048384|Sirolimus|sirolimus|mesh-list
102045346|NCT02048384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102045347|NCT02048384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045348|NCT02048384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102045349|NCT02048384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102045350|NCT02048384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102045351|NCT02048384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102045352|NCT02048384|Antifungal Agents|antifungal agents|mesh-ancestor
101346821|NCT00030420|Antimitotic Agents|antimitotic agents|mesh-ancestor
102045366|NCT03009487|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
102045368|NCT03009487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102045369|NCT03009487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102045370|NCT03009487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102045371|NCT03009487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045372|NCT03009487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102045373|NCT03009487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045374|NCT03009487|Vasodilator Agents|vasodilator agents|mesh-ancestor
101765117|NCT00879099|Timolol|timolol|mesh-list
102045376|NCT03009487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102045377|NCT03009487|Antimetabolites|antimetabolites|mesh-ancestor
102045378|NCT03009487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102045379|NCT03009487|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102045380|NCT03009487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102045381|NCT03009487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102045382|NCT03009487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102045383|NCT02048540|Bevacizumab|bevacizumab|mesh-list
102045384|NCT02048540|Docetaxel|docetaxel|mesh-list
102045385|NCT02048540|Oxaliplatin|oxaliplatin|mesh-list
102045386|NCT02048540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102045387|NCT02048540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102045388|NCT02048540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102045389|NCT02048540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102045390|NCT02048540|Growth Substances|growth substances|mesh-ancestor
102045391|NCT02048540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045392|NCT02048540|Growth Inhibitors|growth inhibitors|mesh-ancestor
102045393|NCT02048540|Tubulin Modulators|tubulin modulators|mesh-ancestor
102045394|NCT02048540|Antimitotic Agents|antimitotic agents|mesh-ancestor
102045395|NCT02048540|Mitosis Modulators|mitosis modulators|mesh-ancestor
102045396|NCT02048540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045397|NCT01353469|Insulin|insulin|mesh-list
102045398|NCT01353469|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102045399|NCT01353469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102045400|NCT01353469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045401|NCT03562130|Teduglutide|teduglutide|mesh-list
102045402|NCT03562130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102045403|NCT03562130|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102045404|NCT03562130|Protective Agents|protective agents|mesh-ancestor
102045405|NCT03562130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045406|NCT02050178|Paclitaxel|paclitaxel|mesh-list
102045407|NCT02050178|Gemcitabine|gemcitabine|mesh-list
102045408|NCT02050178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102045409|NCT02050178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102045410|NCT02050178|Tubulin Modulators|tubulin modulators|mesh-ancestor
102045411|NCT02050178|Antimitotic Agents|antimitotic agents|mesh-ancestor
102045412|NCT02050178|Mitosis Modulators|mitosis modulators|mesh-ancestor
101346884|NCT00030654|Ketoconazole|ketoconazole|mesh-list
102045437|NCT02048930|Glucocorticoids|glucocorticoids|mesh-ancestor
102045438|NCT02048930|Hormones|hormones|mesh-ancestor
102045439|NCT02048930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102045440|NCT02049320|Remifentanil|remifentanil|mesh-list
101941772|NCT03925233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101306770|NCT02027493|Antiviral Agents|antiviral agents|mesh-ancestor
102045441|NCT02049320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102045442|NCT02049320|Narcotics|narcotics|mesh-ancestor
102045443|NCT02049320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102045444|NCT02049320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045445|NCT02049320|Analgesics|analgesics|mesh-ancestor
102045446|NCT02049320|Sensory System Agents|sensory system agents|mesh-ancestor
102045447|NCT02049320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102045448|NCT02050724|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
102045449|NCT02050724|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102045450|NCT02050724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045451|NCT02050802|Moxifloxacin|moxifloxacin|mesh-list
102045452|NCT02050802|Macitentan|macitentan|mesh-list
102045453|NCT02050802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102045454|NCT02050802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102045455|NCT02050802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102045456|NCT02050802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102045457|NCT02050802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102045458|NCT02050802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045459|NCT02050802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102045460|NCT02050802|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
102045461|NCT02050802|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101346947|NCT03823274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102045485|NCT02050958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102045486|NCT02050958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102045487|NCT02050958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102045488|NCT02050958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045489|NCT02037464|Capsaicin|capsaicin|mesh-list
102045490|NCT02037464|Antipruritics|antipruritics|mesh-ancestor
102045491|NCT02037464|Dermatologic Agents|dermatologic agents|mesh-ancestor
102045492|NCT02037464|Sensory System Agents|sensory system agents|mesh-ancestor
102045493|NCT02037464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102045494|NCT02037464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045495|NCT01357603|Insulin Glargine|insulin glargine|mesh-list
102045496|NCT01357603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102045497|NCT01357603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045498|NCT02051894|Dobutamine|dobutamine|mesh-list
102045499|NCT02051894|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102045500|NCT02051894|Sympathomimetics|sympathomimetics|mesh-ancestor
102045501|NCT02051894|Autonomic Agents|autonomic agents|mesh-ancestor
102045502|NCT02051894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102045503|NCT02051894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045504|NCT02051894|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102045505|NCT02051894|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102045506|NCT02051894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102045507|NCT02051894|Adrenergic Agents|adrenergic agents|mesh-ancestor
102045508|NCT02051894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102045509|NCT02051894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045510|NCT02051894|Protective Agents|protective agents|mesh-ancestor
102045511|NCT01357681|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
102045512|NCT01357681|Antioxidants|antioxidants|mesh-ancestor
102045513|NCT01357681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045514|NCT01357681|Protective Agents|protective agents|mesh-ancestor
102045531|NCT03561740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102045533|NCT01357759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102045534|NCT01357759|Antiviral Agents|antiviral agents|mesh-ancestor
102045535|NCT01357759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102045536|NCT02052128|Onapristone|onapristone|mesh-list
102045537|NCT02052128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102045538|NCT02052128|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102045539|NCT02052128|Fertility Agents|fertility agents|mesh-ancestor
102045540|NCT02052128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102045541|NCT02052128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045542|NCT02052128|Hormone Antagonists|hormone antagonists|mesh-ancestor
102045543|NCT02052128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102045544|NCT01349413|Esomeprazole|esomeprazole|mesh-list
102045545|NCT01349413|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102045546|NCT01349413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102045547|NCT01349413|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102045548|NCT01349413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101306771|NCT02027493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101423540|NCT05375916|Analgesics|analgesics|mesh-ancestor
102045549|NCT01349413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045550|NCT01349647|Vaccines|vaccines|mesh-list
102045551|NCT01349647|Immunologic Factors|immunologic factors|mesh-ancestor
102045552|NCT01349647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045553|NCT02806232|Praziquantel|praziquantel|mesh-list
102045554|NCT02806232|Anthelmintics|anthelmintics|mesh-ancestor
102045555|NCT02806232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102045556|NCT02806232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102045557|NCT02908087|Liraglutide|liraglutide|mesh-list
102045558|NCT02908087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102045559|NCT02908087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045560|NCT02908087|Incretins|incretins|mesh-ancestor
102045561|NCT02908087|Hormones|hormones|mesh-ancestor
102045562|NCT02908087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102045563|NCT02053766|Dexmedetomidine|dexmedetomidine|mesh-list
102045564|NCT02053766|Propofol|propofol|mesh-list
102045565|NCT02053766|Sevoflurane|sevoflurane|mesh-list
102045566|NCT02053766|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102045567|NCT02053766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102045568|NCT02053766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045569|NCT02053766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102045570|NCT02053766|Analgesics|analgesics|mesh-ancestor
102045571|NCT02053766|Sensory System Agents|sensory system agents|mesh-ancestor
102045572|NCT02053766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102045573|NCT02053766|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102045592|NCT02053922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102045593|NCT02053922|Oxytocics|oxytocics|mesh-ancestor
102045594|NCT02054000|Tirofiban|tirofiban|mesh-list
102045595|NCT02054000|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102045596|NCT02054000|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102045597|NCT02054000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045598|NCT02054000|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102045599|NCT02054078|Bevacizumab|bevacizumab|mesh-list
102045600|NCT02054078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102045601|NCT02054078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102045602|NCT02054078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102045603|NCT02054078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102045604|NCT02054078|Growth Substances|growth substances|mesh-ancestor
102045605|NCT02054078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045606|NCT02054078|Growth Inhibitors|growth inhibitors|mesh-ancestor
102045607|NCT00392327|Vitamin A|vitamin a|mesh-list
102045608|NCT00392327|Cyclophosphamide|cyclophosphamide|mesh-list
102045609|NCT00392327|Cisplatin|cisplatin|mesh-list
102045610|NCT00392327|Carboplatin|carboplatin|mesh-list
102045611|NCT00392327|Vincristine|vincristine|mesh-list
102045612|NCT00392327|Tretinoin|tretinoin|mesh-list
102045613|NCT00392327|Isotretinoin|isotretinoin|mesh-list
102045614|NCT00392327|Lenograstim|lenograstim|mesh-list
102045615|NCT00392327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102045616|NCT00392327|Immunologic Factors|immunologic factors|mesh-ancestor
102045617|NCT00392327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045618|NCT00392327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102045619|NCT00392327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102045620|NCT00392327|Alkylating Agents|alkylating agents|mesh-ancestor
102045621|NCT00392327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045622|NCT00392327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102045623|NCT00392327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102045624|NCT00392327|Vitamins|vitamins|mesh-ancestor
102045625|NCT00392327|Micronutrients|micronutrients|mesh-ancestor
102045626|NCT00392327|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102045627|NCT00392327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102045628|NCT00392327|Tubulin Modulators|tubulin modulators|mesh-ancestor
102045629|NCT00392327|Antimitotic Agents|antimitotic agents|mesh-ancestor
102045630|NCT00392327|Mitosis Modulators|mitosis modulators|mesh-ancestor
102045631|NCT00392327|Keratolytic Agents|keratolytic agents|mesh-ancestor
102045632|NCT00392327|Dermatologic Agents|dermatologic agents|mesh-ancestor
102045645|NCT01336595|Triamcinolone|triamcinolone|mesh-list
102045646|NCT01336595|Trace Elements|trace elements|mesh-ancestor
102045647|NCT01336595|Micronutrients|micronutrients|mesh-ancestor
102045648|NCT01336595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045649|NCT01336595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102045650|NCT01336595|Glucocorticoids|glucocorticoids|mesh-ancestor
102045651|NCT01336595|Hormones|hormones|mesh-ancestor
102045652|NCT01336595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101941773|NCT03925233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101941774|NCT03925233|Tubulin Modulators|tubulin modulators|mesh-ancestor
101941775|NCT03925233|Antimitotic Agents|antimitotic agents|mesh-ancestor
101941776|NCT03925233|Mitosis Modulators|mitosis modulators|mesh-ancestor
101306772|NCT02027493|Antimetabolites|antimetabolites|mesh-ancestor
102045653|NCT01336751|Insulin|insulin|mesh-list
102045654|NCT01336751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102045655|NCT01336751|Insulin Glargine|insulin glargine|mesh-list
102045656|NCT01336751|Insulin Lispro|insulin lispro|mesh-list
102045657|NCT01336751|Protamines|protamines|mesh-list
102045658|NCT01336751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102045659|NCT01336751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045660|NCT01336751|Heparin Antagonists|heparin antagonists|mesh-ancestor
102045661|NCT01336751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045662|NCT01336751|Coagulants|coagulants|mesh-ancestor
102045663|NCT01336829|Rilpivirine|rilpivirine|mesh-list
102045664|NCT01336829|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102045665|NCT01336829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102045666|NCT01336829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102045667|NCT01336829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045668|NCT01336829|Antiviral Agents|antiviral agents|mesh-ancestor
102045669|NCT01336829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102045670|NCT01336829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102045671|NCT01336829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102045672|NCT02960490|Quetmolimab|quetmolimab|mesh-list
102045673|NCT02960490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102045674|NCT05184179|Olmesartan|olmesartan|mesh-list
102045675|NCT05184179|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
102045676|NCT05184179|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102045677|NCT05184179|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102045678|NCT05184179|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102045679|NCT05184179|Antimetabolites|antimetabolites|mesh-ancestor
102045680|NCT05184179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045681|NCT05184179|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102045682|NCT05184179|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102045683|NCT05184179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102045684|NCT05184179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102045685|NCT05184179|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102045686|NCT05184179|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102045687|NCT05163834|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102045688|NCT05163834|Immunologic Factors|immunologic factors|mesh-ancestor
102045689|NCT05163834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045691|NCT01065012|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102045692|NCT01065012|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102045693|NCT01065012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102045694|NCT01065012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045695|NCT01315691|Amikacin|amikacin|mesh-list
102045708|NCT02054468|Propofol|propofol|mesh-list
102045709|NCT02054468|Rocuronium|rocuronium|mesh-list
102045710|NCT02054468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102045711|NCT02054468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102045712|NCT02054468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045713|NCT02054468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102045714|NCT02054468|Anesthetics, General|anesthetics, general|mesh-ancestor
102045715|NCT02054468|Anesthetics|anesthetics|mesh-ancestor
102045716|NCT02054468|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102045717|NCT02054468|Narcotics|narcotics|mesh-ancestor
102045718|NCT02054468|Analgesics|analgesics|mesh-ancestor
102045719|NCT02054468|Sensory System Agents|sensory system agents|mesh-ancestor
102045720|NCT02054468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102045721|NCT02054468|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102045722|NCT02054468|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102045723|NCT02054468|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102045724|NCT03640650|Triamcinolone|triamcinolone|mesh-list
102045725|NCT03640650|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102045726|NCT03640650|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102045727|NCT03640650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102045728|NCT03640650|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102045729|NCT03640650|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102045730|NCT03640650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102045731|NCT03640650|Glucocorticoids|glucocorticoids|mesh-ancestor
102045732|NCT03640650|Hormones|hormones|mesh-ancestor
101941777|NCT03925233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941778|NCT03925233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101941779|NCT03925233|Immunologic Factors|immunologic factors|mesh-ancestor
101306776|NCT02027532|Vancomycin|vancomycin|mesh-list
102045733|NCT03640650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102045734|NCT03640650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045735|NCT03640650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102045736|NCT03640650|Immunologic Factors|immunologic factors|mesh-ancestor
102045737|NCT03640650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102045738|NCT03640650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045739|NCT05183555|Edotreotide|edotreotide|mesh-list
102045740|NCT05183555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102045741|NCT05183555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045742|NCT02052908|Naproxen|naproxen|mesh-list
102045743|NCT02052908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102045744|NCT02052908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102045745|NCT02052908|Analgesics|analgesics|mesh-ancestor
102045746|NCT02052908|Sensory System Agents|sensory system agents|mesh-ancestor
102045747|NCT02052908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102045748|NCT02052908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045749|NCT02052908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102045750|NCT02052908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102045751|NCT02052908|Gout Suppressants|gout suppressants|mesh-ancestor
102045752|NCT02052908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102045753|NCT02052908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102045754|NCT02052908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045755|NCT01336985|Irinotecan|irinotecan|mesh-list
102045756|NCT01336985|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102045757|NCT01336985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102045758|NCT01336985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101347222|NCT00031785|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102045776|NCT03635411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045777|NCT03635411|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102045778|NCT03635411|Vasodilator Agents|vasodilator agents|mesh-ancestor
102045779|NCT02748512|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
102045780|NCT02748512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102045781|NCT02748512|Glucocorticoids|glucocorticoids|mesh-ancestor
102045783|NCT02748512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102045784|NCT02748512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045785|NCT01341041|Chlorine dioxide|chlorine dioxide|mesh-list
102045786|NCT01341041|Dental Disinfectants|dental disinfectants|mesh-ancestor
102045787|NCT01341041|Disinfectants|disinfectants|mesh-ancestor
102045788|NCT01341041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102045789|NCT02053142|Acyclovir|acyclovir|mesh-list
102045790|NCT02053142|Antiviral Agents|antiviral agents|mesh-ancestor
102045791|NCT02053142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102045792|NCT01316549|Fludarabine|fludarabine|mesh-list
102045793|NCT01316549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102045794|NCT03439657|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102045795|NCT03439657|Immunologic Factors|immunologic factors|mesh-ancestor
102045796|NCT03439657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045797|NCT01341743|Entecavir|entecavir|mesh-list
102045798|NCT01341743|Adefovir|adefovir|mesh-list
102045799|NCT01341743|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
102045800|NCT01341743|Antiviral Agents|antiviral agents|mesh-ancestor
102045801|NCT01341743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102045802|NCT01341743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102045803|NCT01341743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102045804|NCT01341743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102045805|NCT01341743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045806|NCT01341275|Vaccines|vaccines|mesh-list
102045807|NCT01341275|Immunologic Factors|immunologic factors|mesh-ancestor
102045808|NCT01341275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045809|NCT01353937|Plerixafor|plerixafor|mesh-list
102045810|NCT01353937|Becaplermin|becaplermin|mesh-list
102045811|NCT01353937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102045812|NCT01353937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102045813|NCT01353937|Antiviral Agents|antiviral agents|mesh-ancestor
102045814|NCT01353937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102045815|NCT01353937|Anticoagulants|anticoagulants|mesh-ancestor
102045816|NCT01353937|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
101941780|NCT03925233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941781|NCT03925233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101941782|NCT03925233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101941783|NCT03925233|Alkylating Agents|alkylating agents|mesh-ancestor
102045817|NCT01353937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102045818|NCT01353937|Growth Substances|growth substances|mesh-ancestor
101347284|NCT03151616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102045839|NCT02054936|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102045840|NCT02054936|Antithrombins|antithrombins|mesh-ancestor
102045841|NCT02054936|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102045842|NCT02054936|Protease Inhibitors|protease inhibitors|mesh-ancestor
102045843|NCT02054936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102045844|NCT02054936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045846|NCT04782791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102045847|NCT04782791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102045848|NCT04782791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102045849|NCT04782791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045850|NCT01341353|Amiodarone|amiodarone|mesh-list
102045851|NCT01341353|Calcium Channel Blockers|calcium channel blockers|mesh-list
102045852|NCT01341353|Calcium|calcium|mesh-list
102045853|NCT01341353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102045854|NCT01341353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045855|NCT01341353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102045856|NCT01341353|Vasodilator Agents|vasodilator agents|mesh-ancestor
102045857|NCT01341353|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102045858|NCT01341353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102045859|NCT01341353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045860|NCT01341353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102045861|NCT01341353|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102045862|NCT01341353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102045863|NCT01341353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102045864|NCT01341353|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102045865|NCT01341353|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102045866|NCT01341353|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102045867|NCT02056106|Antidepressive Agents|antidepressive agents|mesh-list
102045868|NCT02056106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102045869|NCT02056184|Adalimumab|adalimumab|mesh-list
102045870|NCT02056184|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102045871|NCT02056184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102045890|NCT02055014|Incretins|incretins|mesh-ancestor
102045891|NCT02055014|Hormones|hormones|mesh-ancestor
102045892|NCT02055014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102045893|NCT02055170|Finasteride|finasteride|mesh-list
102045894|NCT02055170|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102045895|NCT02055170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102045896|NCT02055170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102045897|NCT02055170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045898|NCT02055170|Hormone Antagonists|hormone antagonists|mesh-ancestor
102045899|NCT02055170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102045900|NCT02055170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045901|NCT02055170|Urological Agents|urological agents|mesh-ancestor
102045902|NCT04490993|Epirubicin|epirubicin|mesh-list
102045903|NCT04490993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102045904|NCT04490993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102045905|NCT04490993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102045906|NCT04490993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102045907|NCT04490993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102045908|NCT04490993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045909|NCT02055482|Darbepoetin alfa|darbepoetin alfa|mesh-list
102045910|NCT02055482|Hematinics|hematinics|mesh-ancestor
102045911|NCT02059460|Terlipressin|terlipressin|mesh-list
102045912|NCT02059460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102045913|NCT02059460|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102045914|NCT02055716|Sulforaphane|sulforaphane|mesh-list
102045915|NCT02055716|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102045916|NCT02055716|Protective Agents|protective agents|mesh-ancestor
101941784|NCT03925233|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101306785|NCT02027753|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
102045917|NCT02055716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045918|NCT02055716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102045919|NCT04739735|Anesthetics|anesthetics|mesh-list
102045920|NCT04739735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102045921|NCT04739735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045922|NCT02059616|Amlodipine|amlodipine|mesh-list
102045923|NCT02059616|Candesartan|candesartan|mesh-list
102045924|NCT02059616|Candesartan cilexetil|candesartan cilexetil|mesh-list
102045925|NCT02059616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102045926|NCT02059616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102045927|NCT02059616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102045928|NCT02059616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045940|NCT02059694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102045941|NCT02059694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045942|NCT02059694|Sensory System Agents|sensory system agents|mesh-ancestor
102045943|NCT02059694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102045944|NCT02059694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102045945|NCT02059694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102045946|NCT02059694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102045947|NCT02059694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102045948|NCT02059694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045949|NCT02059694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102045950|NCT02059694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102045951|NCT02059694|Adrenergic Agents|adrenergic agents|mesh-ancestor
102045952|NCT02059694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102045953|NCT02059694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102045954|NCT02059694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102045955|NCT02059694|Autonomic Agents|autonomic agents|mesh-ancestor
102045956|NCT02059694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102045957|NCT02059694|Respiratory System Agents|respiratory system agents|mesh-ancestor
102045958|NCT02059694|Mydriatics|mydriatics|mesh-ancestor
102045959|NCT02059694|Sympathomimetics|sympathomimetics|mesh-ancestor
102045960|NCT02059694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102045961|NCT03146741|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
102045962|NCT03146741|Antiviral Agents|antiviral agents|mesh-ancestor
102045963|NCT03146741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102045964|NCT02056730|Calcium|calcium|mesh-list
102045965|NCT02056730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102045966|NCT02056730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045967|NCT05162573|177Lu-PSMA-617|177lu-psma-617|mesh-list
102045968|NCT05162573|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102045969|NCT05162573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045970|NCT01337219|Tobramycin|tobramycin|mesh-list
102045971|NCT01337219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102045972|NCT01337219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102045973|NCT03560804|Olmesartan|olmesartan|mesh-list
102045974|NCT03560804|Chlorthalidone|chlorthalidone|mesh-list
102045975|NCT03560804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102045976|NCT03560804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102045977|NCT03560804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102045978|NCT03560804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045979|NCT03560804|Diuretics|diuretics|mesh-ancestor
102045980|NCT03560804|Natriuretic Agents|natriuretic agents|mesh-ancestor
102045981|NCT03560804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045982|NCT03560804|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102045983|NCT03560804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102045984|NCT03150719|Ivacaftor|ivacaftor|mesh-list
102045985|NCT03150719|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102045986|NCT03150719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102045987|NCT03150719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045988|NCT02059772|Ranibizumab|ranibizumab|mesh-list
102045989|NCT02059772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102045990|NCT02059772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101347457|NCT00032838|Yohimbine|yohimbine|mesh-list
102046007|NCT01344083|Histamine Antagonists|histamine antagonists|mesh-ancestor
102046008|NCT01344083|Histamine Agents|histamine agents|mesh-ancestor
102046009|NCT01344083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102046010|NCT01344083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046011|NCT02059850|Cyclophosphamide|cyclophosphamide|mesh-list
101941785|NCT03925233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101941786|NCT03925233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101941787|NCT03925233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102046012|NCT02059850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102046014|NCT02059850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046015|NCT02059850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102046016|NCT02059850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102046017|NCT02059850|Alkylating Agents|alkylating agents|mesh-ancestor
102046018|NCT02059850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046019|NCT02059850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102046020|NCT02059850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102046022|NCT00982111|Necitumumab|necitumumab|mesh-list
102046023|NCT00982111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102046024|NCT00982111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102046025|NCT00982111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046026|NCT00982111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102046027|NCT00982111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102046028|NCT00982111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102046029|NCT02957682|Alirocumab|alirocumab|mesh-list
102046030|NCT02957682|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102046031|NCT02957682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102046032|NCT02957682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102046033|NCT02957682|Antimetabolites|antimetabolites|mesh-ancestor
102046034|NCT02957682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046035|NCT02957682|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102046036|NCT02957682|Protease Inhibitors|protease inhibitors|mesh-ancestor
102046037|NCT02957682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102046038|NCT02957682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102046039|NCT03057951|Empagliflozin|empagliflozin|mesh-list
102046040|NCT03057951|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102046041|NCT03057951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046042|NCT03057951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102046043|NCT03057951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046044|NCT02060318|Infliximab|infliximab|mesh-list
102046045|NCT02060318|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102046046|NCT02060318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102046062|NCT01350037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102046063|NCT01350037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046064|NCT01350037|Analgesics|analgesics|mesh-ancestor
102046065|NCT01350037|Sensory System Agents|sensory system agents|mesh-ancestor
102046066|NCT01350037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102046067|NCT01350037|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102046068|NCT01350037|Anesthetics, General|anesthetics, general|mesh-ancestor
102046069|NCT01350037|Anesthetics|anesthetics|mesh-ancestor
102046070|NCT02060006|Meloxicam|meloxicam|mesh-list
102046071|NCT02060006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
102046072|NCT02060006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102046073|NCT02060006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102046074|NCT02060006|Analgesics|analgesics|mesh-ancestor
102046075|NCT02060006|Sensory System Agents|sensory system agents|mesh-ancestor
102046076|NCT02060006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102046077|NCT02060006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046078|NCT02060006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102046079|NCT02060006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102046080|NCT02060006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102046081|NCT02060006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102046082|NCT02060006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046083|NCT03620435|Atezolizumab|atezolizumab|mesh-list
102046084|NCT03620435|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102046085|NCT03620435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046086|NCT03620435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102046087|NCT03620435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102046088|NCT01317017|Interferon-gamma|interferon-gamma|mesh-list
102046089|NCT01317017|Antiviral Agents|antiviral agents|mesh-ancestor
102046090|NCT01317017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102046091|NCT04686773|Vaccines|vaccines|mesh-list
102046092|NCT04686773|Immunologic Factors|immunologic factors|mesh-ancestor
102046093|NCT04686773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941788|NCT03925233|Growth Substances|growth substances|mesh-ancestor
101941789|NCT03925233|Growth Inhibitors|growth inhibitors|mesh-ancestor
101941790|NCT03925233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101941791|NCT03925233|Antimetabolites|antimetabolites|mesh-ancestor
101941792|NCT03925233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101941793|NCT03925233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101941794|NCT03925233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101941795|NCT03925233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101941796|NCT03925233|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101941797|NCT03925233|Abortifacient Agents|abortifacient agents|mesh-ancestor
101941798|NCT03925233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101941799|NCT03925233|Dermatologic Agents|dermatologic agents|mesh-ancestor
101941800|NCT03925233|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101941801|NCT03925233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101941802|NCT03925233|Anticoagulants|anticoagulants|mesh-ancestor
101941803|NCT03925233|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101941804|NCT03925233|Chelating Agents|chelating agents|mesh-ancestor
101941805|NCT03925233|Sequestering Agents|sequestering agents|mesh-ancestor
101306791|NCT02027792|Diclofenac|diclofenac|mesh-list
102046094|NCT02956278|Allopurinol|allopurinol|mesh-list
102046095|NCT02956278|Antimetabolites|antimetabolites|mesh-ancestor
102046096|NCT02956278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046097|NCT02956278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102046098|NCT02956278|Gout Suppressants|gout suppressants|mesh-ancestor
102046099|NCT02956278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102046100|NCT02956278|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102046101|NCT02956278|Antioxidants|antioxidants|mesh-ancestor
102046102|NCT02956278|Protective Agents|protective agents|mesh-ancestor
102046103|NCT02956278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046104|NCT02060396|Aspirin|aspirin|mesh-list
102046105|NCT02060396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102046106|NCT02060396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101347577|NCT00033306|Irinotecan|irinotecan|mesh-list
102046117|NCT02060396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102046118|NCT02060396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102046119|NCT02060396|Antipyretics|antipyretics|mesh-ancestor
102046120|NCT01358071|Doxorubicin|doxorubicin|mesh-list
102046121|NCT01358071|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102046122|NCT01358071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102046123|NCT01358071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102046124|NCT01358071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102046125|NCT01358071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102046126|NCT01358071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102046127|NCT01358071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046129|NCT02058212|Selenium|selenium|mesh-list
102046130|NCT02058212|Vitamins|vitamins|mesh-ancestor
102046131|NCT02058212|Micronutrients|micronutrients|mesh-ancestor
102046132|NCT02058212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046133|NCT02058212|Antioxidants|antioxidants|mesh-ancestor
102046134|NCT02058212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046135|NCT02058212|Protective Agents|protective agents|mesh-ancestor
102046136|NCT02058212|Trace Elements|trace elements|mesh-ancestor
102046137|NCT02058446|Amlodipine|amlodipine|mesh-list
102046138|NCT02058446|Valsartan|valsartan|mesh-list
102046139|NCT02058446|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
102046140|NCT02058446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101941806|NCT03925233|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101941807|NCT03925233|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101941808|NCT03925233|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102046141|NCT02058446|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102046142|NCT02058446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102046143|NCT02058446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046144|NCT02058446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102046145|NCT02058446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046146|NCT02058446|Vasodilator Agents|vasodilator agents|mesh-ancestor
102046147|NCT02058446|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102046148|NCT02058446|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102046149|NCT01354405|Lanreotide|lanreotide|mesh-list
102046150|NCT01354405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102046151|NCT03363035|Enoxaparin|enoxaparin|mesh-list
102046152|NCT03363035|Rivaroxaban|rivaroxaban|mesh-list
102046153|NCT03363035|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102046154|NCT03363035|Antithrombins|antithrombins|mesh-ancestor
101696246|NCT00972985|Modafinil|modafinil|mesh-list
102046155|NCT03363035|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102046156|NCT03363035|Protease Inhibitors|protease inhibitors|mesh-ancestor
102046157|NCT03363035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102046158|NCT03363035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046159|NCT03363035|Anticoagulants|anticoagulants|mesh-ancestor
102046160|NCT03363035|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102046161|NCT03363035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102046162|NCT02060552|Diacerein|diacerein|mesh-list
102046163|NCT02060552|Colchicine|colchicine|mesh-list
102046164|NCT02060552|Febuxostat|febuxostat|mesh-list
102046165|NCT02060552|Gout Suppressants|gout suppressants|mesh-ancestor
102046166|NCT02060552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102046167|NCT02060552|Tubulin Modulators|tubulin modulators|mesh-ancestor
102046168|NCT02060552|Antimitotic Agents|antimitotic agents|mesh-ancestor
102046169|NCT02060552|Mitosis Modulators|mitosis modulators|mesh-ancestor
102046170|NCT02060552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046171|NCT02060552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102046192|NCT02031744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046193|NCT04653389|Immunomodulating Agents|immunomodulating agents|mesh-list
102046194|NCT04653389|Immunologic Factors|immunologic factors|mesh-ancestor
102046195|NCT04653389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046196|NCT01344395|Ketorolac|ketorolac|mesh-list
102046197|NCT01344395|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102046198|NCT01344395|Ropivacaine|ropivacaine|mesh-list
102046199|NCT01344395|Anesthetics, Local|anesthetics, local|mesh-ancestor
102046200|NCT01344395|Anesthetics|anesthetics|mesh-ancestor
102046201|NCT01344395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102046202|NCT01344395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046203|NCT01344395|Sensory System Agents|sensory system agents|mesh-ancestor
102046204|NCT01344395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102046205|NCT01344395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102046206|NCT01344395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102046207|NCT01344395|Analgesics|analgesics|mesh-ancestor
102046208|NCT01344395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102046209|NCT01344395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102046210|NCT01344395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102046211|NCT01344395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102046212|NCT01344395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046213|NCT02291445|Peppermint oil|peppermint oil|mesh-list
102046214|NCT02291445|Antiemetics|antiemetics|mesh-ancestor
102046215|NCT02291445|Autonomic Agents|autonomic agents|mesh-ancestor
102046216|NCT02291445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102046217|NCT02291445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046218|NCT02291445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102046219|NCT02291445|Parasympatholytics|parasympatholytics|mesh-ancestor
102046220|NCT02062112|Laxatives|laxatives|mesh-list
102046221|NCT02062112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102046222|NCT01342289|Mycophenolic Acid|mycophenolic acid|mesh-list
102046223|NCT01342289|Cyclophosphamide|cyclophosphamide|mesh-list
102046224|NCT01342289|Fludarabine|fludarabine|mesh-list
102046225|NCT01342289|Tacrolimus|tacrolimus|mesh-list
102046226|NCT01342289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102046227|NCT01342289|Immunologic Factors|immunologic factors|mesh-ancestor
101347699|NCT02149823|Oxytocics|oxytocics|mesh-ancestor
102046238|NCT01342289|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102046239|NCT01342289|Antitubercular Agents|antitubercular agents|mesh-ancestor
102046240|NCT01342289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101941809|NCT03925233|Hormone Antagonists|hormone antagonists|mesh-ancestor
101941810|NCT03925233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101941811|NCT03925233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101424139|NCT03767218|Hormones|hormones|mesh-ancestor
102046241|NCT01342289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102046242|NCT02062190|Resveratrol|resveratrol|mesh-list
102046243|NCT02062190|Antioxidants|antioxidants|mesh-ancestor
102046244|NCT02062190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046245|NCT02062190|Protective Agents|protective agents|mesh-ancestor
102046246|NCT02062190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046247|NCT02062190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102046248|NCT02062190|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102046249|NCT01354483|Methylprednisolone|methylprednisolone|mesh-list
102046250|NCT01354483|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101696270|NCT00867087|Rituximab|rituximab|mesh-list
102046251|NCT01354483|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102046252|NCT01354483|Prednisolone|prednisolone|mesh-list
102046253|NCT01354483|Prednisolone acetate|prednisolone acetate|mesh-list
102046254|NCT01354483|Lithium Carbonate|lithium carbonate|mesh-list
102046255|NCT01354483|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102046256|NCT01354483|Prednisolone phosphate|prednisolone phosphate|mesh-list
102046257|NCT01354483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102046258|NCT01354483|Antiemetics|antiemetics|mesh-ancestor
102046259|NCT01354483|Autonomic Agents|autonomic agents|mesh-ancestor
102046260|NCT01354483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102046261|NCT01354483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046262|NCT01354483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102046263|NCT01354483|Glucocorticoids|glucocorticoids|mesh-ancestor
102046264|NCT01354483|Hormones|hormones|mesh-ancestor
102046265|NCT01354483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102046266|NCT01354483|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102046267|NCT01354483|Protective Agents|protective agents|mesh-ancestor
102046268|NCT01354483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102046269|NCT01354483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102046270|NCT01354483|Antidepressive Agents|antidepressive agents|mesh-ancestor
102046271|NCT01354483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102046272|NCT01354483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102046273|NCT01354483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046274|NCT01354483|Antimanic Agents|antimanic agents|mesh-ancestor
102046275|NCT01354483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102046276|NCT01354483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102046277|NCT03618264|Dexamethasone|dexamethasone|mesh-list
101766004|NCT05954910|Immunoconjugates|immunoconjugates|mesh-ancestor
102046279|NCT03618264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102046280|NCT03618264|Antiemetics|antiemetics|mesh-ancestor
102046281|NCT03618264|Autonomic Agents|autonomic agents|mesh-ancestor
102046282|NCT03618264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102046283|NCT03618264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046284|NCT03618264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102046285|NCT03618264|Glucocorticoids|glucocorticoids|mesh-ancestor
102046286|NCT03618264|Hormones|hormones|mesh-ancestor
102046287|NCT03618264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102046288|NCT03618264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102046289|NCT03618264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102046290|NCT03618264|Anesthetics, Local|anesthetics, local|mesh-ancestor
102046291|NCT03618264|Anesthetics|anesthetics|mesh-ancestor
102046305|NCT02060786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102046306|NCT02060786|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102046307|NCT02060786|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102046308|NCT02060786|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102046309|NCT02060786|Purinergic Agents|purinergic agents|mesh-ancestor
102046310|NCT02060786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102046311|NCT02060786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046312|NCT02060786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046313|NCT03153137|Macitentan|macitentan|mesh-list
101696287|NCT02778425|Hormones|hormones|mesh-ancestor
102046314|NCT03153137|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
102046315|NCT03153137|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102046316|NCT03153137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046317|NCT03153137|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
102046318|NCT03617484|Bortezomib|bortezomib|mesh-list
101941812|NCT03925233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101941813|NCT03925233|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102046319|NCT03617484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102046320|NCT01344473|Caseins|caseins|mesh-list
102046321|NCT01344473|Chelating Agents|chelating agents|mesh-ancestor
102046322|NCT01344473|Sequestering Agents|sequestering agents|mesh-ancestor
102046323|NCT01344473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046324|NCT03618108|Azithromycin|azithromycin|mesh-list
102046325|NCT03618108|Doxycycline|doxycycline|mesh-list
102046326|NCT03618108|Rifabutin|rifabutin|mesh-list
102046327|NCT03618108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102046328|NCT03618108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102046329|NCT03618108|Antimalarials|antimalarials|mesh-ancestor
102046330|NCT03618108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102046331|NCT03618108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102046332|NCT03618108|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102046333|NCT03618108|Antitubercular Agents|antitubercular agents|mesh-ancestor
102046334|NCT01342601|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102046335|NCT01342601|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102046336|NCT02236728|Pramipexole|pramipexole|mesh-list
102046337|NCT02236728|Antioxidants|antioxidants|mesh-ancestor
102046338|NCT02236728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046339|NCT02236728|Protective Agents|protective agents|mesh-ancestor
102046340|NCT02236728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046341|NCT02236728|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102046342|NCT02236728|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102046343|NCT02236728|Dopamine Agonists|dopamine agonists|mesh-ancestor
102046344|NCT02236728|Dopamine Agents|dopamine agents|mesh-ancestor
102046345|NCT02236728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102046346|NCT03136861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102046347|NCT03136861|Immunologic Factors|immunologic factors|mesh-ancestor
102046348|NCT03136861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046349|NCT01342679|Dasatinib|dasatinib|mesh-list
102046350|NCT01342679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102046351|NCT01342679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102046352|NCT01342679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101347819|NCT00034632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102046366|NCT03139279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102046367|NCT03139279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102046368|NCT03139279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046369|NCT03139279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102046370|NCT03139279|Analgesics|analgesics|mesh-ancestor
102046371|NCT03139279|Sensory System Agents|sensory system agents|mesh-ancestor
102046372|NCT03139279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102046373|NCT03139279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102046374|NCT03139279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102046375|NCT03139279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102046376|NCT03139279|Adrenergic Agents|adrenergic agents|mesh-ancestor
102046377|NCT03139279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102046378|NCT03139279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046379|NCT03139279|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102046380|NCT03139279|Anesthetics, General|anesthetics, general|mesh-ancestor
102046381|NCT03139279|Anesthetics|anesthetics|mesh-ancestor
102046382|NCT02562599|Raltitrexed|raltitrexed|mesh-list
102046383|NCT02562599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102046384|NCT02562599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102046385|NCT02562599|Antimetabolites|antimetabolites|mesh-ancestor
102046386|NCT02562599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046387|NCT02562599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102046388|NCT02562599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102046389|NCT03311958|Nivolumab|nivolumab|mesh-list
102046390|NCT03311958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102046391|NCT03311958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102046392|NCT03311958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102046393|NCT03311958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046394|NCT01370642|Ribavirin|ribavirin|mesh-list
102046395|NCT01370642|Antimetabolites|antimetabolites|mesh-ancestor
102046396|NCT01370642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046397|NCT01370642|Antiviral Agents|antiviral agents|mesh-ancestor
102046398|NCT01370642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102046399|NCT03138967|Glycopyrrolate|glycopyrrolate|mesh-list
102046400|NCT03138967|Bromides|bromides|mesh-list
101941814|NCT03925233|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101941815|NCT03925233|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101941816|NCT03925233|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101306813|NCT02027922|Cariostatic Agents|cariostatic agents|mesh-ancestor
102046402|NCT03138967|Neostigmine|neostigmine|mesh-list
102046403|NCT03138967|Anticonvulsants|anticonvulsants|mesh-ancestor
102046404|NCT03138967|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102046405|NCT03138967|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102046406|NCT03138967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102046407|NCT03138967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102046408|NCT03138967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046409|NCT03138967|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102046410|NCT03138967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102046411|NCT03138967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046412|NCT03138967|Cholinergic Agents|cholinergic agents|mesh-ancestor
102046413|NCT03138967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102046414|NCT03138967|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102046415|NCT03138967|Autonomic Agents|autonomic agents|mesh-ancestor
102046429|NCT01358383|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102046431|NCT01358383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046432|NCT01358383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102046433|NCT01358383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102046435|NCT01358383|Sensory System Agents|sensory system agents|mesh-ancestor
102046436|NCT01358383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102046437|NCT01358383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046438|NCT01358383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102046439|NCT01358383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102046440|NCT01358383|Gout Suppressants|gout suppressants|mesh-ancestor
102046441|NCT01358383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102046442|NCT03560336|Liraglutide|liraglutide|mesh-list
102046443|NCT03560336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102046444|NCT03560336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046445|NCT03560336|Incretins|incretins|mesh-ancestor
102046446|NCT03560336|Hormones|hormones|mesh-ancestor
102046447|NCT03560336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102046448|NCT03136159|Anti-Infective Agents|anti-infective agents|mesh-list
102046449|NCT03136159|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102046450|NCT03615768|Clindamycin|clindamycin|mesh-list
102046451|NCT03615768|Clindamycin palmitate|clindamycin palmitate|mesh-list
102046452|NCT03615768|Clindamycin phosphate|clindamycin phosphate|mesh-list
102046453|NCT03615768|Adapalene|adapalene|mesh-list
102046454|NCT03615768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102046455|NCT03615768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102046456|NCT03615768|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102046457|NCT03615768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102046458|NCT03615768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046459|NCT03615768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102046460|NCT03615768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102046461|NCT03615768|Analgesics|analgesics|mesh-ancestor
102046462|NCT03615768|Sensory System Agents|sensory system agents|mesh-ancestor
102046463|NCT03615768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102046464|NCT03615768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046465|NCT03615768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102046466|NCT03615768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102046467|NCT03615768|Dermatologic Agents|dermatologic agents|mesh-ancestor
102046468|NCT02061644|Anesthetics|anesthetics|mesh-list
102046469|NCT02061644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102046470|NCT02061644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046471|NCT03793400|Bevacizumab|bevacizumab|mesh-list
102046472|NCT03793400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102046473|NCT03793400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102046474|NCT03793400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102046475|NCT03793400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102046476|NCT03793400|Growth Substances|growth substances|mesh-ancestor
102046477|NCT03793400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046493|NCT01318369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102046494|NCT01318369|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102046495|NCT01318369|Anticonvulsants|anticonvulsants|mesh-ancestor
101941817|NCT03925233|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101941818|NCT01130805|Capecitabine|capecitabine|mesh-list
101941819|NCT01130805|Oxaliplatin|oxaliplatin|mesh-list
101941820|NCT01130805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101941821|NCT01130805|Antimetabolites|antimetabolites|mesh-ancestor
101941822|NCT01130805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941823|NCT01130805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102046496|NCT01318369|Antiemetics|antiemetics|mesh-ancestor
102046497|NCT01318369|Autonomic Agents|autonomic agents|mesh-ancestor
102046498|NCT01318369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102046499|NCT01318369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102046500|NCT01318369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102046501|NCT01318369|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102046502|NCT01318369|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102046503|NCT01318369|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102046504|NCT01318369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102046505|NCT01318369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102046506|NCT01318369|Anesthetics, General|anesthetics, general|mesh-ancestor
102046507|NCT01318369|Anesthetics|anesthetics|mesh-ancestor
102046508|NCT01318369|GABA Modulators|gaba modulators|mesh-ancestor
102046509|NCT01318369|GABA Agents|gaba agents|mesh-ancestor
102046510|NCT03479684|Warfarin|warfarin|mesh-list
102046511|NCT03479684|Anticoagulants|anticoagulants|mesh-ancestor
102046512|NCT03614052|Tamsulosin|tamsulosin|mesh-list
102046513|NCT03614052|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102046514|NCT03614052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102046515|NCT03614052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102046516|NCT03614052|Adrenergic Agents|adrenergic agents|mesh-ancestor
102046517|NCT03614052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102046518|NCT03614052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046519|NCT03614052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046520|NCT03614052|Urological Agents|urological agents|mesh-ancestor
102046521|NCT02062892|Sirolimus|sirolimus|mesh-list
102046522|NCT02062892|Everolimus|everolimus|mesh-list
102046523|NCT02062892|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102046524|NCT02062892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102046525|NCT02062892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102046526|NCT02062892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046527|NCT02062892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102046528|NCT02062892|Immunologic Factors|immunologic factors|mesh-ancestor
102046529|NCT02062892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046530|NCT02062892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102046531|NCT02062892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102046532|NCT02062892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102046533|NCT02062892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102046534|NCT02062892|Antifungal Agents|antifungal agents|mesh-ancestor
102046535|NCT02063360|Ritonavir|ritonavir|mesh-list
102046536|NCT02063360|Darunavir|darunavir|mesh-list
102046537|NCT02063360|Fostemsavir|fostemsavir|mesh-list
102046538|NCT02063360|Etravirine|etravirine|mesh-list
102046539|NCT02063360|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102046555|NCT03614832|Ticagrelor|ticagrelor|mesh-list
102046556|NCT03614832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102046557|NCT03614832|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102046558|NCT03614832|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102046559|NCT03614832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102046560|NCT03614832|Purinergic Agents|purinergic agents|mesh-ancestor
102046561|NCT03614832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102046562|NCT03614832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046563|NCT03614832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046564|NCT05210595|Clopidogrel|clopidogrel|mesh-list
102046565|NCT05210595|Ticagrelor|ticagrelor|mesh-list
102046566|NCT05210595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102046567|NCT05210595|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102046568|NCT05210595|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102046569|NCT05210595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102046570|NCT05210595|Purinergic Agents|purinergic agents|mesh-ancestor
102046571|NCT05210595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101941824|NCT01345162|Ketorolac|ketorolac|mesh-list
101941825|NCT01345162|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101941826|NCT01345162|Tramadol|tramadol|mesh-list
101941827|NCT01345162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101941828|NCT01345162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101941829|NCT01345162|Analgesics|analgesics|mesh-ancestor
101941830|NCT01345162|Sensory System Agents|sensory system agents|mesh-ancestor
101941831|NCT01345162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101941832|NCT01345162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046572|NCT05210595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046573|NCT05210595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046574|NCT02061800|Methylprednisolone|methylprednisolone|mesh-list
102046575|NCT02061800|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102046576|NCT02061800|Cyclophosphamide|cyclophosphamide|mesh-list
102046577|NCT02061800|Melphalan|melphalan|mesh-list
102046578|NCT02061800|Busulfan|busulfan|mesh-list
102046579|NCT02061800|Thiotepa|thiotepa|mesh-list
102046580|NCT02061800|Fludarabine|fludarabine|mesh-list
102046581|NCT02061800|Alemtuzumab|alemtuzumab|mesh-list
102046582|NCT02061800|Tacrolimus|tacrolimus|mesh-list
102046583|NCT02061800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102046584|NCT02061800|Immunologic Factors|immunologic factors|mesh-ancestor
102046585|NCT02061800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046586|NCT02061800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102046587|NCT02061800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102046588|NCT02061800|Alkylating Agents|alkylating agents|mesh-ancestor
102046589|NCT02061800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046590|NCT02061800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102046591|NCT02061800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102046592|NCT02061800|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102046593|NCT02061800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102046594|NCT02061800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102046595|NCT02061800|Antiemetics|antiemetics|mesh-ancestor
102046596|NCT02061800|Autonomic Agents|autonomic agents|mesh-ancestor
101348061|NCT00035607|Hematinics|hematinics|mesh-ancestor
102046615|NCT01986075|Amphetamine|amphetamine|mesh-list
102046617|NCT01986075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102046618|NCT01986075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046619|NCT01986075|Sympathomimetics|sympathomimetics|mesh-ancestor
102046620|NCT01986075|Autonomic Agents|autonomic agents|mesh-ancestor
102046621|NCT01986075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102046622|NCT01986075|Dopamine Agents|dopamine agents|mesh-ancestor
102046623|NCT01986075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102046624|NCT01986075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046625|NCT01986075|Adrenergic Agents|adrenergic agents|mesh-ancestor
102046626|NCT01986075|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102046627|NCT01986075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102046628|NCT01986075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102046629|NCT01986075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102046630|NCT02061878|Bexarotene|bexarotene|mesh-list
102046631|NCT02061878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102046632|NCT00394355|Fluticasone|fluticasone|mesh-list
102046633|NCT00394355|Xhance|xhance|mesh-list
102046634|NCT00394355|Mometasone Furoate|mometasone furoate|mesh-list
102046635|NCT00394355|Montelukast|montelukast|mesh-list
102046636|NCT00394355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102046637|NCT00394355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102046638|NCT00394355|Autonomic Agents|autonomic agents|mesh-ancestor
102046639|NCT00394355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102046640|NCT00394355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046641|NCT00394355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102046642|NCT00394355|Respiratory System Agents|respiratory system agents|mesh-ancestor
102046643|NCT00394355|Dermatologic Agents|dermatologic agents|mesh-ancestor
102046644|NCT00394355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102046645|NCT00394355|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102046646|NCT00394355|Hormone Antagonists|hormone antagonists|mesh-ancestor
101941833|NCT01345162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101941834|NCT01345162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101941835|NCT01345162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101941836|NCT01345162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102046647|NCT00394355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102046648|NCT00394355|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102046649|NCT00394355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102046650|NCT00394355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046662|NCT02796560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102046663|NCT01316081|Vitamins|vitamins|mesh-list
102046664|NCT01316081|Ascorbic Acid|ascorbic acid|mesh-list
102046665|NCT01316081|Vitamin E|vitamin e|mesh-list
102046666|NCT01316081|Tocopherols|tocopherols|mesh-list
102046667|NCT01316081|Tocotrienols|tocotrienols|mesh-list
102046668|NCT01316081|alpha-Tocopherol|alpha-tocopherol|mesh-list
102046669|NCT01316081|Micronutrients|micronutrients|mesh-ancestor
102046670|NCT01316081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046671|NCT01316081|Antioxidants|antioxidants|mesh-ancestor
102046672|NCT01316081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046673|NCT01316081|Protective Agents|protective agents|mesh-ancestor
102046674|NCT00958737|Leucovorin|leucovorin|mesh-list
102046675|NCT00958737|Fluorouracil|fluorouracil|mesh-list
102046676|NCT00958737|Capecitabine|capecitabine|mesh-list
102046677|NCT00958737|Oxaliplatin|oxaliplatin|mesh-list
102046678|NCT00958737|Calcium|calcium|mesh-list
102046679|NCT00958737|Levoleucovorin|levoleucovorin|mesh-list
102046680|NCT00958737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102046681|NCT00958737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046682|NCT00958737|Antimetabolites|antimetabolites|mesh-ancestor
102046683|NCT00958737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046684|NCT00958737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102046685|NCT00958737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102046686|NCT00958737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102046687|NCT00958737|Immunologic Factors|immunologic factors|mesh-ancestor
102046688|NCT00958737|Antidotes|antidotes|mesh-ancestor
102046689|NCT00958737|Protective Agents|protective agents|mesh-ancestor
102046690|NCT00958737|Vitamin B Complex|vitamin b complex|mesh-ancestor
102046691|NCT00958737|Vitamins|vitamins|mesh-ancestor
102046692|NCT00958737|Micronutrients|micronutrients|mesh-ancestor
102046693|NCT02062034|Vitamins|vitamins|mesh-list
102046694|NCT02062034|Vitamin E|vitamin e|mesh-list
102046695|NCT02062034|Coenzyme Q10|coenzyme q10|mesh-list
102046696|NCT02062034|Ubiquinone|ubiquinone|mesh-list
102046697|NCT02062034|Antioxidants|antioxidants|mesh-list
102046698|NCT02062034|Micronutrients|micronutrients|mesh-ancestor
102046699|NCT02062034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046700|NCT02062034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046701|NCT02062034|Protective Agents|protective agents|mesh-ancestor
102046702|NCT00344487|Ritonavir|ritonavir|mesh-list
102046703|NCT00344487|Lopinavir|lopinavir|mesh-list
102046704|NCT00344487|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102046705|NCT00344487|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102046706|NCT00344487|Protease Inhibitors|protease inhibitors|mesh-ancestor
102046707|NCT00344487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102046708|NCT00344487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046709|NCT00344487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102046710|NCT00344487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102046711|NCT00344487|Antiviral Agents|antiviral agents|mesh-ancestor
102046712|NCT00344487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102046713|NCT00344487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102046714|NCT00344487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102046715|NCT03789968|Tenofovir|tenofovir|mesh-list
102046716|NCT03789968|Emtricitabine|emtricitabine|mesh-list
102046717|NCT03789968|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
102046718|NCT03789968|Antiviral Agents|antiviral agents|mesh-ancestor
101348174|NCT01805531|Antithrombins|antithrombins|mesh-ancestor
102046730|NCT05089643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102046732|NCT02871492|Pritelivir|pritelivir|mesh-list
102046733|NCT02871492|Antiviral Agents|antiviral agents|mesh-ancestor
102046734|NCT02871492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102046735|NCT02871492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102046736|NCT02871492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046737|NCT03613974|Lidocaine|lidocaine|mesh-list
102046738|NCT03613974|Anesthetics, Local|anesthetics, local|mesh-ancestor
101941837|NCT01345162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046740|NCT03613974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102046741|NCT03613974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046742|NCT03613974|Sensory System Agents|sensory system agents|mesh-ancestor
102046743|NCT03613974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102046744|NCT03613974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102046745|NCT03613974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102046746|NCT03613974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102046747|NCT03613974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102046748|NCT03613974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046749|NCT01343225|Ritonavir|ritonavir|mesh-list
102046750|NCT01343225|Darunavir|darunavir|mesh-list
102046751|NCT01343225|Raltegravir Potassium|raltegravir potassium|mesh-list
102046752|NCT01343225|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102046753|NCT01343225|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102046754|NCT01343225|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102046755|NCT01343225|Protease Inhibitors|protease inhibitors|mesh-ancestor
102046756|NCT01343225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102046757|NCT01343225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046758|NCT01343225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102046759|NCT01343225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102046760|NCT01343225|Antiviral Agents|antiviral agents|mesh-ancestor
102046761|NCT01343225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102046762|NCT01343225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102046763|NCT01343225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102046764|NCT01343225|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102046765|NCT01343225|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102046766|NCT01343225|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102046767|NCT01343225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102046768|NCT05208879|Carotenoids|carotenoids|mesh-list
102046769|NCT05208879|Antioxidants|antioxidants|mesh-ancestor
102046770|NCT05208879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046771|NCT05208879|Protective Agents|protective agents|mesh-ancestor
102046772|NCT05208879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046773|NCT04739865|Psilocybin|psilocybin|mesh-list
102046774|NCT04739865|Hallucinogens|hallucinogens|mesh-ancestor
102046775|NCT04739865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046776|NCT04739865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102046777|NCT01370408|Dexamethasone|dexamethasone|mesh-list
102046791|NCT01370408|Antipruritics|antipruritics|mesh-ancestor
102046792|NCT01370408|Dermatologic Agents|dermatologic agents|mesh-ancestor
102046793|NCT01370408|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102046794|NCT01370408|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102046795|NCT01370408|Serotonin Agents|serotonin agents|mesh-ancestor
102046796|NCT01370408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102046797|NCT01370408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046798|NCT04769388|Carboplatin|carboplatin|mesh-list
102046799|NCT04769388|Pemetrexed|pemetrexed|mesh-list
102046800|NCT04769388|Osimertinib|osimertinib|mesh-list
102046801|NCT04769388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102046802|NCT04769388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102046803|NCT04769388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046804|NCT04769388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101766532|NCT05551104|Sympathomimetics|sympathomimetics|mesh-ancestor
102046805|NCT04769388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102046806|NCT04769388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102046807|NCT03294109|Bupivacaine|bupivacaine|mesh-list
102046808|NCT03294109|Anesthetics, Local|anesthetics, local|mesh-ancestor
102046809|NCT03294109|Anesthetics|anesthetics|mesh-ancestor
102046810|NCT03294109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102046811|NCT03294109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046812|NCT03294109|Sensory System Agents|sensory system agents|mesh-ancestor
102046813|NCT03294109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102046814|NCT01345643|Chrysarobin|chrysarobin|mesh-list
102046815|NCT01345643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102046816|NCT01345643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102046817|NCT01345643|Analgesics|analgesics|mesh-ancestor
102046818|NCT01345643|Sensory System Agents|sensory system agents|mesh-ancestor
102046819|NCT01345643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102046820|NCT01345643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941838|NCT01345162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101941839|NCT01345162|Narcotics|narcotics|mesh-ancestor
101941840|NCT01345162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101941841|NCT01131039|Bevacizumab|bevacizumab|mesh-list
101941842|NCT01131039|Gemcitabine|gemcitabine|mesh-list
102046821|NCT01345643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102046822|NCT01345643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102046823|NCT02065466|Paclitaxel|paclitaxel|mesh-list
102046824|NCT02065466|Bevacizumab|bevacizumab|mesh-list
102046825|NCT02065466|Temozolomide|temozolomide|mesh-list
102046826|NCT02065466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102046827|NCT02065466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102046828|NCT02065466|Tubulin Modulators|tubulin modulators|mesh-ancestor
102046829|NCT02065466|Antimitotic Agents|antimitotic agents|mesh-ancestor
102046830|NCT02065466|Mitosis Modulators|mitosis modulators|mesh-ancestor
102046831|NCT02065466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046832|NCT02065466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102046833|NCT02065466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102046834|NCT02065466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102046835|NCT02065466|Growth Substances|growth substances|mesh-ancestor
102046836|NCT02065466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046837|NCT02065466|Growth Inhibitors|growth inhibitors|mesh-ancestor
102046838|NCT02065466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102046858|NCT02064140|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102046859|NCT02064140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102046860|NCT02064140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102046861|NCT02064140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046862|NCT05190627|Loratadine|loratadine|mesh-list
102046863|NCT05190627|Sirolimus|sirolimus|mesh-list
102046864|NCT05190627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102046865|NCT05190627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102046866|NCT05190627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102046867|NCT05190627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102046868|NCT05190627|Antifungal Agents|antifungal agents|mesh-ancestor
102046869|NCT05190627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102046870|NCT05190627|Immunologic Factors|immunologic factors|mesh-ancestor
102046871|NCT05190627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046872|NCT05190627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046873|NCT05190627|Antipruritics|antipruritics|mesh-ancestor
102046874|NCT05190627|Dermatologic Agents|dermatologic agents|mesh-ancestor
102046875|NCT05190627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102046876|NCT05190627|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102046877|NCT05190627|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102046878|NCT05190627|Histamine Antagonists|histamine antagonists|mesh-ancestor
102046879|NCT05190627|Histamine Agents|histamine agents|mesh-ancestor
102046880|NCT05190627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102046881|NCT02064218|Antihypertensive Agents|antihypertensive agents|mesh-list
102046882|NCT01343303|Naproxen|naproxen|mesh-list
102046883|NCT01343303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102046884|NCT01343303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102046885|NCT01343303|Analgesics|analgesics|mesh-ancestor
102046886|NCT01343303|Sensory System Agents|sensory system agents|mesh-ancestor
102046887|NCT01343303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102046888|NCT01343303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046889|NCT01343303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102046890|NCT01343303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102046891|NCT01343303|Gout Suppressants|gout suppressants|mesh-ancestor
102046892|NCT01343303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102046893|NCT01343303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102046894|NCT01343303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046915|NCT02064374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102046916|NCT01355263|Vitamin A|vitamin a|mesh-list
102046917|NCT01355263|Vitamins|vitamins|mesh-ancestor
102046918|NCT01355263|Micronutrients|micronutrients|mesh-ancestor
102046919|NCT01355263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046920|NCT03613428|Prednisone|prednisone|mesh-list
102046921|NCT03613428|Vincristine|vincristine|mesh-list
102046922|NCT03613428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102046923|NCT03613428|Glucocorticoids|glucocorticoids|mesh-ancestor
102046924|NCT03613428|Hormones|hormones|mesh-ancestor
102046925|NCT03613428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101941843|NCT01131039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101941844|NCT01131039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102046926|NCT03613428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046927|NCT03613428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102046928|NCT03613428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102046929|NCT03613428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102046930|NCT03613428|Tubulin Modulators|tubulin modulators|mesh-ancestor
102046931|NCT03613428|Antimitotic Agents|antimitotic agents|mesh-ancestor
102046932|NCT03613428|Mitosis Modulators|mitosis modulators|mesh-ancestor
102046933|NCT03613428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046934|NCT02064530|Dexmedetomidine|dexmedetomidine|mesh-list
102046935|NCT02064530|Bupivacaine|bupivacaine|mesh-list
102046936|NCT02064530|Anesthetics, Local|anesthetics, local|mesh-ancestor
102046937|NCT02064530|Anesthetics|anesthetics|mesh-ancestor
102046938|NCT02064530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102046939|NCT02064530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046940|NCT02064530|Sensory System Agents|sensory system agents|mesh-ancestor
102046941|NCT02064530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102046942|NCT02064530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102046943|NCT02064530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102046944|NCT02064530|Analgesics|analgesics|mesh-ancestor
102046945|NCT02064530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102046946|NCT02064530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102046947|NCT02064530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102046948|NCT02064530|Adrenergic Agents|adrenergic agents|mesh-ancestor
102046949|NCT02064530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102046950|NCT02064530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046965|NCT01359085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102046966|NCT01359085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102046967|NCT01359085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102046968|NCT04322357|Prednisone|prednisone|mesh-list
102046969|NCT04322357|Glucocorticoids|glucocorticoids|mesh-list
102046970|NCT04322357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102046971|NCT04322357|Hormones|hormones|mesh-ancestor
102046972|NCT04322357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102046973|NCT04322357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046974|NCT04322357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102046975|NCT04322357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102046976|NCT01351285|Remifentanil|remifentanil|mesh-list
102046977|NCT01351285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102046978|NCT01351285|Narcotics|narcotics|mesh-ancestor
102046979|NCT01351285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102046980|NCT01351285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046981|NCT01351285|Analgesics|analgesics|mesh-ancestor
102046982|NCT01351285|Sensory System Agents|sensory system agents|mesh-ancestor
102046983|NCT01351285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102046984|NCT02032290|Clopidogrel|clopidogrel|mesh-list
102046985|NCT02032290|Ticagrelor|ticagrelor|mesh-list
102046986|NCT02032290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102046987|NCT02032290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102046988|NCT02032290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102046989|NCT02032290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102046990|NCT02032290|Purinergic Agents|purinergic agents|mesh-ancestor
102046991|NCT02032290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102046992|NCT02032290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046993|NCT02032290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046994|NCT03379428|Trastuzumab|trastuzumab|mesh-list
102046995|NCT03379428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102046996|NCT03379428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102046997|NCT03628131|Carboplatin|carboplatin|mesh-list
102046998|NCT03628131|Etoposide|etoposide|mesh-list
102046999|NCT03628131|Ifosfamide|ifosfamide|mesh-list
102047000|NCT03628131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101696477|NCT02623504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102047001|NCT03628131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102047002|NCT03628131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102047003|NCT03628131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102047004|NCT03628131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102047005|NCT03628131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047006|NCT03628131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102047007|NCT03628131|Alkylating Agents|alkylating agents|mesh-ancestor
101348466|NCT00037518|Cinacalcet|cinacalcet|mesh-list
101941845|NCT01131039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101941846|NCT01131039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102047026|NCT05095857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102047027|NCT05095857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102047028|NCT05095857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047030|NCT05095857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102047031|NCT01351519|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102047032|NCT01351519|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102047033|NCT01351519|Dermatologic Agents|dermatologic agents|mesh-ancestor
102047035|NCT03612492|Anesthetics, Local|anesthetics, local|mesh-list
102047036|NCT03612492|Anesthetics|anesthetics|mesh-list
102047037|NCT03612492|Esmolol|esmolol|mesh-list
102047038|NCT03612492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102047039|NCT03612492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047040|NCT03612492|Sensory System Agents|sensory system agents|mesh-ancestor
102047041|NCT03612492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102047042|NCT03612492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102047043|NCT03612492|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102047044|NCT03612492|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102047045|NCT03612492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102047046|NCT03612492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047047|NCT03612492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102047048|NCT03612492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102047049|NCT03612492|Adrenergic Agents|adrenergic agents|mesh-ancestor
102047050|NCT03612492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102047051|NCT03612492|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102047052|NCT01359163|Ethynodiol Diacetate|ethynodiol diacetate|mesh-list
102047053|NCT01359163|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102047054|NCT01359163|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102047055|NCT01359163|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102047056|NCT01359163|Contraceptive Agents|contraceptive agents|mesh-ancestor
102047057|NCT01359163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102047058|NCT01359163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047059|NCT01359163|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102047060|NCT01359163|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102047061|NCT03730337|Nivolumab|nivolumab|mesh-list
102047062|NCT03730337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102047087|NCT03612180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047088|NCT03612180|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102047089|NCT03612180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102047090|NCT03612180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102047091|NCT03612180|Adrenergic Agents|adrenergic agents|mesh-ancestor
102047092|NCT03612180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102047093|NCT03612180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047094|NCT04400799|Enoxaparin|enoxaparin|mesh-list
102047095|NCT04400799|Anticoagulants|anticoagulants|mesh-ancestor
102047096|NCT04400799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102047097|NCT04400799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102047098|NCT04400799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047099|NCT01359241|Insulin|insulin|mesh-list
102047100|NCT01359241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102047101|NCT01359241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047102|NCT02068196|Ipilimumab|ipilimumab|mesh-list
102047103|NCT02068196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102047104|NCT02068196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102047105|NCT02068196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102047106|NCT02068196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047107|NCT03142451|Minocycline|minocycline|mesh-list
102047108|NCT03142451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102047109|NCT03142451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102047110|NCT04065789|Dexamethasone|dexamethasone|mesh-list
102047111|NCT04065789|Lenalidomide|lenalidomide|mesh-list
102047112|NCT04065789|Daratumumab|daratumumab|mesh-list
102047113|NCT04065789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102047138|NCT02064842|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102047139|NCT02064842|Protease Inhibitors|protease inhibitors|mesh-ancestor
102047140|NCT02064842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102047141|NCT02064842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047142|NCT02064842|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102047143|NCT02064842|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101941847|NCT01131039|Growth Substances|growth substances|mesh-ancestor
101941848|NCT01131039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941849|NCT01131039|Growth Inhibitors|growth inhibitors|mesh-ancestor
102047144|NCT02064842|Antiviral Agents|antiviral agents|mesh-ancestor
102047145|NCT02064842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102047146|NCT02064842|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102047147|NCT02064842|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102047148|NCT04192266|Estradiol|estradiol|mesh-list
102047149|NCT04192266|Estrogens|estrogens|mesh-ancestor
102047150|NCT04192266|Hormones|hormones|mesh-ancestor
102047151|NCT04192266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102047152|NCT04192266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047153|NCT01370018|Protease Inhibitors|protease inhibitors|mesh-list
102047154|NCT01370018|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
102047155|NCT01370018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102047156|NCT01370018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047157|NCT01370018|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102047158|NCT01370018|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102047159|NCT01359397|Bevacizumab|bevacizumab|mesh-list
102047160|NCT01359397|Trastuzumab|trastuzumab|mesh-list
102047161|NCT01359397|Docetaxel|docetaxel|mesh-list
102047162|NCT01359397|Oxaliplatin|oxaliplatin|mesh-list
102047163|NCT01359397|Capecitabine|capecitabine|mesh-list
102047164|NCT01359397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102047180|NCT05250245|Cholinergic Agents|cholinergic agents|mesh-ancestor
102047181|NCT05250245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102047182|NCT05250245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047183|NCT05250245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047184|NCT05250245|Urological Agents|urological agents|mesh-ancestor
102047185|NCT01347983|Methotrexate|methotrexate|mesh-list
102047186|NCT01347983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102047187|NCT01347983|Abortifacient Agents|abortifacient agents|mesh-ancestor
102047188|NCT01347983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102047189|NCT01347983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047190|NCT01347983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102047191|NCT01347983|Antimetabolites|antimetabolites|mesh-ancestor
102047192|NCT01347983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047193|NCT01347983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102047194|NCT01347983|Dermatologic Agents|dermatologic agents|mesh-ancestor
102047195|NCT01347983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102047196|NCT01347983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102047197|NCT01347983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102047198|NCT01347983|Immunologic Factors|immunologic factors|mesh-ancestor
102047199|NCT01347983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102047200|NCT01347983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102047201|NCT05249933|Benzocaine|benzocaine|mesh-list
102047202|NCT05249933|Anesthetics, Local|anesthetics, local|mesh-ancestor
102047203|NCT05249933|Anesthetics|anesthetics|mesh-ancestor
102047204|NCT05249933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102047205|NCT05249933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047206|NCT05249933|Sensory System Agents|sensory system agents|mesh-ancestor
102047207|NCT05249933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102047208|NCT02032836|Iloprost|iloprost|mesh-list
102047209|NCT02032836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102047210|NCT02032836|Vasodilator Agents|vasodilator agents|mesh-ancestor
102047211|NCT02065076|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
102047212|NCT02065076|Chelating Agents|chelating agents|mesh-ancestor
102047213|NCT02065076|Sequestering Agents|sequestering agents|mesh-ancestor
102047214|NCT02065076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047215|NCT02465593|Fluorouracil|fluorouracil|mesh-list
102047216|NCT02465593|Capecitabine|capecitabine|mesh-list
102047217|NCT02465593|Antimetabolites|antimetabolites|mesh-ancestor
102047218|NCT02465593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047219|NCT02465593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102047220|NCT02465593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102047221|NCT02465593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102047222|NCT02465593|Immunologic Factors|immunologic factors|mesh-ancestor
102047223|NCT02465593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047254|NCT02826486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047256|NCT02826486|Protective Agents|protective agents|mesh-ancestor
101941850|NCT01131039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101941851|NCT01131039|Antimetabolites|antimetabolites|mesh-ancestor
101941852|NCT01131039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941853|NCT01229085|Salicylic Acid|salicylic acid|mesh-list
101941854|NCT01229085|Salicylates|salicylates|mesh-list
101941855|NCT01229085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102047257|NCT02826486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047258|NCT02826486|Vitamin B Complex|vitamin b complex|mesh-ancestor
102047259|NCT02826486|Vitamins|vitamins|mesh-ancestor
102047260|NCT02826486|Micronutrients|micronutrients|mesh-ancestor
102047261|NCT02825940|Gemcitabine|gemcitabine|mesh-list
102047262|NCT02825940|Atezolizumab|atezolizumab|mesh-list
102047263|NCT02825940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102047264|NCT02825940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102047265|NCT02825940|Antimetabolites|antimetabolites|mesh-ancestor
102047266|NCT02825940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348748|NCT00846677|Vitamin D|vitamin d|mesh-list
102047340|NCT01356121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102047341|NCT01356121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102047342|NCT01356121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102047343|NCT01356121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102047344|NCT01356121|GABA Modulators|gaba modulators|mesh-ancestor
102047345|NCT01356121|GABA Agents|gaba agents|mesh-ancestor
102047346|NCT01356121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102047347|NCT01356121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047348|NCT01336608|Fluticasone|fluticasone|mesh-list
102047357|NCT01336608|Dermatologic Agents|dermatologic agents|mesh-ancestor
102047358|NCT01336608|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102047359|NCT03628521|Carboplatin|carboplatin|mesh-list
102047360|NCT03628521|Gemcitabine|gemcitabine|mesh-list
102047361|NCT03628521|Pemetrexed|pemetrexed|mesh-list
102047362|NCT03628521|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102047363|NCT03628521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102047364|NCT03628521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102047365|NCT03628521|Antimetabolites|antimetabolites|mesh-ancestor
102047366|NCT03628521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047367|NCT03628521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102047368|NCT03628521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102047369|NCT03628521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102047370|NCT03628521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102047371|NCT05697003|Fluticasone|fluticasone|mesh-list
102047372|NCT05697003|Xhance|xhance|mesh-list
102047373|NCT05697003|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102047374|NCT05697003|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102047375|NCT05697003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102047376|NCT05697003|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102047377|NCT05697003|Autonomic Agents|autonomic agents|mesh-ancestor
102047378|NCT05697003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102047379|NCT05697003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047380|NCT05697003|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102047381|NCT05697003|Respiratory System Agents|respiratory system agents|mesh-ancestor
102047382|NCT05697003|Dermatologic Agents|dermatologic agents|mesh-ancestor
102047383|NCT05697003|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102047384|NCT05697003|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102047385|NCT05697003|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102047386|NCT05697003|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102047387|NCT05697003|Adrenergic Agents|adrenergic agents|mesh-ancestor
102047388|NCT05697003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102047389|NCT05697003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047390|NCT05697003|Glucocorticoids|glucocorticoids|mesh-ancestor
102047391|NCT05697003|Hormones|hormones|mesh-ancestor
102047392|NCT05697003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102047393|NCT05697003|Sympathomimetics|sympathomimetics|mesh-ancestor
102047394|NCT02069522|Carotenoids|carotenoids|mesh-list
102047395|NCT02069522|Antioxidants|antioxidants|mesh-ancestor
102047396|NCT02069522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047397|NCT02069522|Protective Agents|protective agents|mesh-ancestor
102047398|NCT02069522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047399|NCT01361425|Methyldopa|methyldopa|mesh-list
102047400|NCT01361425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101941856|NCT01229085|Antifungal Agents|antifungal agents|mesh-ancestor
101941857|NCT01229085|Keratolytic Agents|keratolytic agents|mesh-ancestor
101941858|NCT01229085|Dermatologic Agents|dermatologic agents|mesh-ancestor
101306853|NCT02028234|Omeprazole|omeprazole|mesh-list
102047401|NCT01361425|Sympatholytics|sympatholytics|mesh-ancestor
102047402|NCT01361425|Autonomic Agents|autonomic agents|mesh-ancestor
102047403|NCT01361425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102047404|NCT01361425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047405|NCT01361425|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102047406|NCT01361425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102047407|NCT01361425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102047408|NCT01361425|Adrenergic Agents|adrenergic agents|mesh-ancestor
102047409|NCT01361425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102047410|NCT01361425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047411|NCT01356355|Tolterodine Tartrate|tolterodine tartrate|mesh-list
102047412|NCT01356355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102047413|NCT01356355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102047414|NCT01356355|Cholinergic Agents|cholinergic agents|mesh-ancestor
102047415|NCT01356355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102047445|NCT01356511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102047446|NCT01356511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102047447|NCT02069990|Cholecalciferol|cholecalciferol|mesh-list
102047448|NCT02069990|Vitamin D|vitamin d|mesh-list
102047449|NCT02069990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102047450|NCT02069990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047451|NCT02069990|Vitamins|vitamins|mesh-ancestor
102047452|NCT02069990|Micronutrients|micronutrients|mesh-ancestor
102047453|NCT02069990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102047454|NCT05076409|Fluconazole|fluconazole|mesh-list
102047455|NCT05076409|BI 425809|bi 425809|mesh-list
102047456|NCT05076409|Antifungal Agents|antifungal agents|mesh-ancestor
102047457|NCT05076409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102047458|NCT05076409|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102047459|NCT05076409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102047460|NCT05076409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102047461|NCT05076409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047480|NCT01347593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102047482|NCT02072330|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102047483|NCT02072330|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
102047484|NCT02072330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102047485|NCT02072330|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102047486|NCT02072330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102047487|NCT02072330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047488|NCT02072330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102047489|NCT02072330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047490|NCT02072330|Vasodilator Agents|vasodilator agents|mesh-ancestor
102047491|NCT02072330|Diuretics|diuretics|mesh-ancestor
102047492|NCT02072330|Natriuretic Agents|natriuretic agents|mesh-ancestor
102047493|NCT02072330|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102047494|NCT02072330|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102047495|NCT02072330|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102047496|NCT02072408|Aflibercept|aflibercept|mesh-list
102047497|NCT02072408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102047498|NCT02072408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102047499|NCT02072408|Growth Substances|growth substances|mesh-ancestor
102047500|NCT02072408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047501|NCT02072408|Growth Inhibitors|growth inhibitors|mesh-ancestor
102047502|NCT02072408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102047503|NCT02070458|Cytarabine|cytarabine|mesh-list
102047504|NCT02070458|Etoposide|etoposide|mesh-list
102047505|NCT02070458|Mitoxantrone|mitoxantrone|mesh-list
102047506|NCT02070458|Etoposide phosphate|etoposide phosphate|mesh-list
102047507|NCT02070458|Ixazomib|ixazomib|mesh-list
102047508|NCT02070458|Glycine|glycine|mesh-list
102047509|NCT02070458|Proteasome Inhibitors|proteasome inhibitors|mesh-list
102047510|NCT02070458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102047511|NCT02070458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102047512|NCT02070458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102047513|NCT02070458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102047514|NCT02070458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102047533|NCT03131479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941859|NCT01229085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101941860|NCT01229085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101941861|NCT01229085|Analgesics|analgesics|mesh-ancestor
101941862|NCT01229085|Sensory System Agents|sensory system agents|mesh-ancestor
101941863|NCT01229085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101941864|NCT01229085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941865|NCT01229085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102047534|NCT02077010|Milrinone|milrinone|mesh-list
102047535|NCT02077010|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102047536|NCT02077010|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102047537|NCT02077010|Vasodilator Agents|vasodilator agents|mesh-ancestor
102047538|NCT02077010|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102047539|NCT02077010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102047540|NCT02077010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102047541|NCT02077010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047542|NCT02077010|Protective Agents|protective agents|mesh-ancestor
102047543|NCT02077010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047544|NCT01319461|Hyaluronic Acid|hyaluronic acid|mesh-list
102047545|NCT01319461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102047546|NCT01319461|Immunologic Factors|immunologic factors|mesh-ancestor
102047547|NCT01319461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047548|NCT01319461|Viscosupplements|viscosupplements|mesh-ancestor
102047549|NCT01319461|Protective Agents|protective agents|mesh-ancestor
102047550|NCT02072720|Bevacizumab|bevacizumab|mesh-list
102047551|NCT02072720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102047552|NCT02072720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102047553|NCT02072720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102047554|NCT02072720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102047556|NCT02072720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047557|NCT02072720|Growth Inhibitors|growth inhibitors|mesh-ancestor
102047558|NCT01356745|Nitrous Oxide|nitrous oxide|mesh-list
102047559|NCT01356745|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102047560|NCT01356745|Anesthetics, General|anesthetics, general|mesh-ancestor
102047561|NCT01356745|Anesthetics|anesthetics|mesh-ancestor
102047562|NCT01356745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102047563|NCT01356745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047564|NCT01356745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102047565|NCT01356745|Analgesics|analgesics|mesh-ancestor
102047566|NCT01356745|Sensory System Agents|sensory system agents|mesh-ancestor
102047567|NCT01356745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102047568|NCT02072798|Cefuroxime|cefuroxime|mesh-list
102047569|NCT02072798|Cefuroxime axetil|cefuroxime axetil|mesh-list
102047570|NCT02072798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101349034|NCT00276068|Lidocaine|lidocaine|mesh-list
102047582|NCT04252105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047583|NCT02077322|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
102047584|NCT02077322|Hemostatics|hemostatics|mesh-ancestor
102047585|NCT02077322|Coagulants|coagulants|mesh-ancestor
102047587|NCT02077400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102047588|NCT02077400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102047589|NCT02077478|Remifentanil|remifentanil|mesh-list
102047590|NCT02077478|Propofol|propofol|mesh-list
102047591|NCT02077478|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102047592|NCT02077478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102047593|NCT02077478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047594|NCT02077478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102047595|NCT02077478|Anesthetics, General|anesthetics, general|mesh-ancestor
102047596|NCT02077478|Anesthetics|anesthetics|mesh-ancestor
102047597|NCT02077478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102047598|NCT02077478|Narcotics|narcotics|mesh-ancestor
102047599|NCT02077478|Analgesics|analgesics|mesh-ancestor
102047600|NCT02077478|Sensory System Agents|sensory system agents|mesh-ancestor
102047601|NCT02077478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102047602|NCT02077556|Mycophenolic Acid|mycophenolic acid|mesh-list
102047603|NCT02077556|Methylprednisolone|methylprednisolone|mesh-list
102047604|NCT02077556|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102047605|NCT02077556|Prednisolone|prednisolone|mesh-list
102047606|NCT02077556|Everolimus|everolimus|mesh-list
102047607|NCT02077556|Tacrolimus|tacrolimus|mesh-list
102047608|NCT02077556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101941866|NCT01229085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101941867|NCT01229085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101941868|NCT01229085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101941869|NCT01229085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047609|NCT02077556|Immunologic Factors|immunologic factors|mesh-ancestor
102047610|NCT02077556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047611|NCT02077556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102047612|NCT02077556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102047613|NCT02077556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047614|NCT02077556|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102047615|NCT02077556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102047616|NCT02077556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102047617|NCT02077556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102047618|NCT02077556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102047619|NCT02077556|Antitubercular Agents|antitubercular agents|mesh-ancestor
102047620|NCT02077556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102047621|NCT02077556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102047622|NCT02077556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102047623|NCT02077556|Antiemetics|antiemetics|mesh-ancestor
102047624|NCT02077556|Autonomic Agents|autonomic agents|mesh-ancestor
102047625|NCT02077556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102047626|NCT02077556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102047627|NCT02077556|Glucocorticoids|glucocorticoids|mesh-ancestor
102047628|NCT02077556|Hormones|hormones|mesh-ancestor
102047629|NCT02077556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102047630|NCT02077556|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102047631|NCT02077556|Protective Agents|protective agents|mesh-ancestor
102047632|NCT02077556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102047633|NCT02930941|Tranexamic Acid|tranexamic acid|mesh-list
102047634|NCT02930941|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101696617|NCT00982891|Morphine|morphine|mesh-list
102047635|NCT02930941|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102047643|NCT02077634|Hormones|hormones|mesh-ancestor
102047644|NCT02077634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102047645|NCT02077634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047646|NCT02077634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102047647|NCT02077634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102047648|NCT02077634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102047649|NCT02077634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102047650|NCT02077634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047651|NCT02077634|Hormone Antagonists|hormone antagonists|mesh-ancestor
102047652|NCT02077634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102047653|NCT01365403|Carbamazepine|carbamazepine|mesh-list
102047654|NCT01365403|Anticonvulsants|anticonvulsants|mesh-ancestor
102047655|NCT01365403|Antimanic Agents|antimanic agents|mesh-ancestor
102047656|NCT01365403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102047657|NCT01365403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102047658|NCT01365403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047659|NCT01365403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102047660|NCT01365403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102047661|NCT01365403|Analgesics|analgesics|mesh-ancestor
102047662|NCT01365403|Sensory System Agents|sensory system agents|mesh-ancestor
102047663|NCT01365403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102047664|NCT01365403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102047665|NCT01365403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102047666|NCT01365403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047667|NCT01365403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102047668|NCT01365403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102047669|NCT01352663|Insulin|insulin|mesh-list
102047670|NCT01352663|Insulin Glargine|insulin glargine|mesh-list
102047671|NCT01352663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102047672|NCT01352663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047673|NCT01362361|Nintedanib|nintedanib|mesh-list
102047674|NCT01362361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102047675|NCT01362361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102047676|NCT01362361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102047677|NCT01362361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047678|NCT02077712|Dexmedetomidine|dexmedetomidine|mesh-list
102047679|NCT02077712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101941871|NCT03921645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101941872|NCT03643666|Dexamethasone|dexamethasone|mesh-list
101941873|NCT03643666|Magnesium Sulfate|magnesium sulfate|mesh-list
101941874|NCT03643666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101941875|NCT03643666|Antiemetics|antiemetics|mesh-ancestor
101425255|NCT00521950|Mercaptopurine|mercaptopurine|mesh-list
102047680|NCT02077712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102047681|NCT02077712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047682|NCT02077712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102047683|NCT02077712|Analgesics|analgesics|mesh-ancestor
102047684|NCT02077712|Sensory System Agents|sensory system agents|mesh-ancestor
102047685|NCT02077712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102047686|NCT02077712|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102047687|NCT02077712|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102047688|NCT02077712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102047689|NCT02077712|Adrenergic Agents|adrenergic agents|mesh-ancestor
102047690|NCT02077712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102047691|NCT02077712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047692|NCT02073734|Dexamethasone|dexamethasone|mesh-list
102047693|NCT02073734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102047694|NCT02073734|Antiemetics|antiemetics|mesh-ancestor
102047695|NCT02073734|Autonomic Agents|autonomic agents|mesh-ancestor
102047696|NCT02073734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102047697|NCT02073734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047698|NCT02073734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102047699|NCT02073734|Glucocorticoids|glucocorticoids|mesh-ancestor
102047700|NCT02073734|Hormones|hormones|mesh-ancestor
102047701|NCT02073734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102047702|NCT02073734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102047712|NCT02071004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102047713|NCT02071004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102047714|NCT02071004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102047715|NCT02071004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047716|NCT02071004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102047717|NCT02071004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102047718|NCT02071004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102047719|NCT02071004|Antipyretics|antipyretics|mesh-ancestor
102047720|NCT02071160|Melatonin|melatonin|mesh-list
102047721|NCT02071160|Antioxidants|antioxidants|mesh-ancestor
102047722|NCT02071160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047723|NCT02071160|Protective Agents|protective agents|mesh-ancestor
102047724|NCT02071160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047725|NCT02071160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102047726|NCT03131713|Acetaminophen|acetaminophen|mesh-list
102047727|NCT03131713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102047728|NCT03131713|Analgesics|analgesics|mesh-ancestor
102047729|NCT03131713|Sensory System Agents|sensory system agents|mesh-ancestor
102047730|NCT03131713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102047731|NCT03131713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047732|NCT03131713|Antipyretics|antipyretics|mesh-ancestor
102047733|NCT03514121|Pembrolizumab|pembrolizumab|mesh-list
102047734|NCT03514121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102047735|NCT03514121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102047736|NCT03514121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102047737|NCT03514121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047738|NCT02930005|Meclofenamic Acid|meclofenamic acid|mesh-list
102047739|NCT02930005|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
102047740|NCT02930005|Anticoagulants|anticoagulants|mesh-ancestor
102047741|NCT02930005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102047742|NCT02930005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102047743|NCT02930005|Analgesics|analgesics|mesh-ancestor
102047744|NCT02930005|Sensory System Agents|sensory system agents|mesh-ancestor
102047745|NCT02930005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102047746|NCT02930005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047747|NCT02930005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102047748|NCT02930005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102047749|NCT02930005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101941876|NCT03643666|Autonomic Agents|autonomic agents|mesh-ancestor
101941877|NCT03643666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101941878|NCT03643666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941879|NCT03643666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101941880|NCT03643666|Glucocorticoids|glucocorticoids|mesh-ancestor
101941881|NCT03643666|Hormones|hormones|mesh-ancestor
101306869|NCT02028312|Lubricant Eye Drops|lubricant eye drops|mesh-list
102047750|NCT02930005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102047751|NCT02930005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047752|NCT01349387|Metformin|metformin|mesh-list
102047753|NCT01349387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102047754|NCT01349387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047755|NCT04905173|Amyl Nitrite|amyl nitrite|mesh-list
102047756|NCT04905173|Vasodilator Agents|vasodilator agents|mesh-ancestor
102047757|NCT01361269|Clindamycin|clindamycin|mesh-list
102047758|NCT01361269|Clindamycin palmitate|clindamycin palmitate|mesh-list
102047759|NCT01361269|Clindamycin phosphate|clindamycin phosphate|mesh-list
102047760|NCT01361269|Fosmidomycin|fosmidomycin|mesh-list
102047761|NCT01361269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102047762|NCT01361269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102047763|NCT01361269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102047764|NCT01361269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102047765|NCT01361269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047766|NCT01353209|Letrozole|letrozole|mesh-list
102047771|NCT01353209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047772|NCT01353209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102047773|NCT01353209|Hormone Antagonists|hormone antagonists|mesh-ancestor
102047774|NCT01353209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102047775|NCT01353209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047777|NCT03637491|Talazoparib|talazoparib|mesh-list
102047778|NCT03637491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102047779|NCT03637491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102047780|NCT03637491|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102047781|NCT03637491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102047782|NCT03637491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047783|NCT01363063|Ketorolac|ketorolac|mesh-list
102047784|NCT01363063|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102047785|NCT01363063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102047786|NCT01363063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102047787|NCT01363063|Analgesics|analgesics|mesh-ancestor
102047788|NCT01363063|Sensory System Agents|sensory system agents|mesh-ancestor
102047789|NCT01363063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102047790|NCT01363063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047791|NCT01363063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102047792|NCT01363063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102047793|NCT01363063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102047794|NCT01363063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102047795|NCT01363063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047796|NCT04550455|Cladribine|cladribine|mesh-list
102047797|NCT04550455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102047798|NCT04550455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102047799|NCT04550455|Immunologic Factors|immunologic factors|mesh-ancestor
102047800|NCT04550455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047801|NCT01349699|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102047802|NCT01349699|Deferasirox|deferasirox|mesh-list
102047803|NCT01349699|Hematinics|hematinics|mesh-ancestor
102047804|NCT01349699|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102047805|NCT01349699|Chelating Agents|chelating agents|mesh-ancestor
102047806|NCT01349699|Sequestering Agents|sequestering agents|mesh-ancestor
102047807|NCT01349699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047808|NCT01370161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102047809|NCT01370161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102047810|NCT01370161|Adrenergic Agents|adrenergic agents|mesh-ancestor
102047811|NCT01370161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101696726|NCT00973219|Interferon-alpha|interferon-alpha|mesh-list
102047812|NCT01370161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047813|NCT01370161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047814|NCT03628443|Mitogens|mitogens|mesh-list
101941882|NCT03643666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101941883|NCT03643666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102047815|NCT03628443|Mitosis Modulators|mitosis modulators|mesh-ancestor
102047816|NCT03628443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047817|NCT01365871|Anesthetics|anesthetics|mesh-list
102047818|NCT01365871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102047819|NCT01365871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047820|NCT01349777|Clopidogrel|clopidogrel|mesh-list
102047821|NCT01349777|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102047822|NCT01349777|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102047823|NCT01349777|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102047824|NCT01349777|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102047825|NCT01349777|Purinergic Agents|purinergic agents|mesh-ancestor
102047826|NCT01349777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102047827|NCT01349777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047828|NCT01349777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047829|NCT03446157|Cetuximab|cetuximab|mesh-list
102047830|NCT03446157|Palbociclib|palbociclib|mesh-list
102047831|NCT03446157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102047832|NCT03446157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102047833|NCT03446157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102047834|NCT03446157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102047847|NCT04700007|Sensory System Agents|sensory system agents|mesh-ancestor
102047848|NCT04700007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102047849|NCT04700007|Antipruritics|antipruritics|mesh-ancestor
102047850|NCT04700007|Dermatologic Agents|dermatologic agents|mesh-ancestor
102047851|NCT04700007|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102047852|NCT04700007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102047853|NCT04700007|Anesthetics, Local|anesthetics, local|mesh-ancestor
102047854|NCT04700007|Anesthetics|anesthetics|mesh-ancestor
102047855|NCT04700007|Antiemetics|antiemetics|mesh-ancestor
102047856|NCT04700007|Autonomic Agents|autonomic agents|mesh-ancestor
102047857|NCT04700007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102047858|NCT04700007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102047859|NCT04700007|Histamine Agents|histamine agents|mesh-ancestor
102047860|NCT04700007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102047861|NCT04700007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047862|NCT04700007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102047863|NCT04700007|Histamine Agonists|histamine agonists|mesh-ancestor
102047864|NCT01349855|Insulin Glargine|insulin glargine|mesh-list
102047865|NCT01349855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102047866|NCT01349855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047867|NCT01318655|Naloxegol|naloxegol|mesh-list
102047868|NCT01318655|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102047869|NCT01318655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047870|NCT01318655|Sensory System Agents|sensory system agents|mesh-ancestor
102047871|NCT01318655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102047872|NCT01353599|Mometasone Furoate|mometasone furoate|mesh-list
102047873|NCT01353599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102047874|NCT01353599|Dermatologic Agents|dermatologic agents|mesh-ancestor
102047875|NCT01353599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102047876|NCT02961881|Blinatumomab|blinatumomab|mesh-list
102047877|NCT02961881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102047878|NCT03334539|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102047879|NCT03334539|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102047880|NCT01350089|Ethanol|ethanol|mesh-list
102047881|NCT01350089|Caffeine|caffeine|mesh-list
102047882|NCT01350089|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102047883|NCT01350089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102047884|NCT01350089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102047885|NCT01350089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047886|NCT01350089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102047887|NCT01350089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102047888|NCT01350089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102047889|NCT01350089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047890|NCT01350089|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102047891|NCT01350089|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102047892|NCT01350089|Purinergic Agents|purinergic agents|mesh-ancestor
102047893|NCT01350089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102047894|NCT03137303|Albuterol|albuterol|mesh-list
102047895|NCT03137303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101941884|NCT03643666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101941886|NCT03643666|Sensory System Agents|sensory system agents|mesh-ancestor
102047896|NCT03137303|Autonomic Agents|autonomic agents|mesh-ancestor
102047897|NCT03137303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102047898|NCT03137303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047899|NCT03137303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101349356|NCT00130325|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102047907|NCT03137303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102047908|NCT03137303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047909|NCT03296553|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102047910|NCT03296553|Valganciclovir|valganciclovir|mesh-list
102047911|NCT03296553|Antiviral Agents|antiviral agents|mesh-ancestor
102047912|NCT03296553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102047913|NCT01363375|Carbon Fiber|carbon fiber|mesh-list
102047914|NCT01363375|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102047915|NCT01363375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102047916|NCT01370707|Metformin|metformin|mesh-list
102047917|NCT01370707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102047918|NCT01370707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047919|NCT01363531|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102047920|NCT01363531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102047921|NCT01363609|Insulin Glargine|insulin glargine|mesh-list
102047922|NCT01363609|Liraglutide|liraglutide|mesh-list
102047923|NCT01363609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102047924|NCT01363609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047925|NCT01363609|Incretins|incretins|mesh-ancestor
102047926|NCT01363609|Hormones|hormones|mesh-ancestor
102047927|NCT01363609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102047928|NCT03060447|Vesatolimod|vesatolimod|mesh-list
102047929|NCT03060447|Antiviral Agents|antiviral agents|mesh-ancestor
102047930|NCT03060447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102047931|NCT04623567|Metformin|metformin|mesh-list
102047932|NCT04623567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102047933|NCT04623567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047934|NCT01712789|Dexamethasone|dexamethasone|mesh-list
102047935|NCT01712789|Pomalidomide|pomalidomide|mesh-list
102047936|NCT01712789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102047937|NCT01712789|Antiemetics|antiemetics|mesh-ancestor
102047938|NCT01712789|Autonomic Agents|autonomic agents|mesh-ancestor
102047939|NCT01712789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102047940|NCT01712789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047941|NCT01712789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102047942|NCT01712789|Glucocorticoids|glucocorticoids|mesh-ancestor
102047943|NCT01712789|Hormones|hormones|mesh-ancestor
102047944|NCT01712789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102047945|NCT01712789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102047946|NCT01712789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102047947|NCT01712789|Immunologic Factors|immunologic factors|mesh-ancestor
102047948|NCT01712789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102047949|NCT01712789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102047950|NCT01712789|Growth Substances|growth substances|mesh-ancestor
102047951|NCT01712789|Growth Inhibitors|growth inhibitors|mesh-ancestor
102047952|NCT01350323|Bevacizumab|bevacizumab|mesh-list
102047953|NCT01350323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102047954|NCT01350323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102047955|NCT01350323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102047956|NCT01350323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102047957|NCT01350323|Growth Substances|growth substances|mesh-ancestor
102047958|NCT01350323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047959|NCT01350323|Growth Inhibitors|growth inhibitors|mesh-ancestor
102047960|NCT03074318|Avelumab|avelumab|mesh-list
102047961|NCT03074318|Trabectedin|trabectedin|mesh-list
102047962|NCT03074318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102047963|NCT03074318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102047964|NCT03074318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102047965|NCT03074318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102047966|NCT03074318|Alkylating Agents|alkylating agents|mesh-ancestor
102047967|NCT03074318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047968|NCT03074318|Immunologic Factors|immunologic factors|mesh-ancestor
102047986|NCT02074280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102047987|NCT02074280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102047988|NCT02077946|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102047989|NCT02077946|Liraglutide|liraglutide|mesh-list
101941887|NCT03643666|Anesthetics|anesthetics|mesh-ancestor
101941888|NCT03643666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101941889|NCT03643666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101941890|NCT03643666|Anticonvulsants|anticonvulsants|mesh-ancestor
102047990|NCT02077946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102047991|NCT02077946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047992|NCT02077946|Incretins|incretins|mesh-ancestor
102047993|NCT02077946|Hormones|hormones|mesh-ancestor
102047994|NCT02077946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102047995|NCT02077946|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102047996|NCT02077946|Protease Inhibitors|protease inhibitors|mesh-ancestor
102047997|NCT02077946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102047998|NCT02077946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047999|NCT03559790|Tenofovir|tenofovir|mesh-list
102048000|NCT03559790|Antiviral Agents|antiviral agents|mesh-ancestor
102048001|NCT03559790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102048002|NCT03559790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102048003|NCT03559790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102048004|NCT03559790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101767752|NCT02364089|Mydriatics|mydriatics|mesh-ancestor
102048005|NCT03559790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048006|NCT03559790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102048007|NCT03559790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102048009|NCT02079974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102048010|NCT02079974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102048011|NCT02079974|Antimetabolites|antimetabolites|mesh-ancestor
102048012|NCT02079974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048013|NCT02079974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102048014|NCT02079974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102048015|NCT02079974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102048016|NCT01353755|Immunomodulating Agents|immunomodulating agents|mesh-list
102048017|NCT01353755|Immunologic Factors|immunologic factors|mesh-ancestor
102048018|NCT01353755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048019|NCT01317953|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
102048020|NCT01317953|Antioxidants|antioxidants|mesh-ancestor
102048021|NCT01317953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048022|NCT01317953|Protective Agents|protective agents|mesh-ancestor
102048023|NCT01317953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048024|NCT01317953|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
102048025|NCT01317953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102048031|NCT02078336|Lorazepam|lorazepam|mesh-list
102048032|NCT02078336|Biperiden|biperiden|mesh-list
102048033|NCT02078336|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102048034|NCT02078336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102048035|NCT02078336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102048036|NCT02078336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048037|NCT02078336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102048038|NCT02078336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102048039|NCT02078336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102048040|NCT02078336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102048041|NCT02078336|Anesthetics, General|anesthetics, general|mesh-ancestor
102048042|NCT02078336|Anesthetics|anesthetics|mesh-ancestor
102048043|NCT02078336|GABA Modulators|gaba modulators|mesh-ancestor
102048044|NCT02078336|GABA Agents|gaba agents|mesh-ancestor
102048045|NCT02078336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102048046|NCT02078336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048047|NCT02078336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102048048|NCT02078336|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102048049|NCT02078336|Autonomic Agents|autonomic agents|mesh-ancestor
102048050|NCT02078336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102048051|NCT02078336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102048052|NCT02078336|Respiratory System Agents|respiratory system agents|mesh-ancestor
102048053|NCT02078336|Mydriatics|mydriatics|mesh-ancestor
102048054|NCT02078336|Parasympatholytics|parasympatholytics|mesh-ancestor
102048055|NCT02078336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102048056|NCT02078336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102048057|NCT02078336|Cholinergic Agents|cholinergic agents|mesh-ancestor
102048058|NCT02078336|Anticonvulsants|anticonvulsants|mesh-ancestor
102048059|NCT02078336|Antiemetics|antiemetics|mesh-ancestor
102048060|NCT02078336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102048061|NCT02078336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101941891|NCT03643666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101941892|NCT03643666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101306882|NCT02028416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102048062|NCT02078336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102048063|NCT02078336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102048064|NCT02078336|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102048065|NCT02078336|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102048066|NCT02078336|Dopamine Agents|dopamine agents|mesh-ancestor
102048067|NCT01353833|Aldesleukin|aldesleukin|mesh-list
102048068|NCT01353833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102048069|NCT01353833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102048070|NCT01353833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102048071|NCT01353833|Antiviral Agents|antiviral agents|mesh-ancestor
102048072|NCT01353833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102048073|NCT03353675|Nivolumab|nivolumab|mesh-list
102048074|NCT03353675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102048075|NCT03353675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102048076|NCT03353675|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102048077|NCT03353675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048078|NCT01350713|Povidone-Iodine|povidone-iodine|mesh-list
102048079|NCT01350713|Povidone|povidone|mesh-list
102048080|NCT01350713|Plasma Substitutes|plasma substitutes|mesh-ancestor
102048081|NCT01350713|Blood Substitutes|blood substitutes|mesh-ancestor
102048082|NCT01350713|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102048083|NCT01350713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102048084|NCT02075294|Entecavir|entecavir|mesh-list
102048085|NCT02075294|Adefovir|adefovir|mesh-list
102048086|NCT02075294|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
102048087|NCT02075294|Antiviral Agents|antiviral agents|mesh-ancestor
102048088|NCT02075294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102048089|NCT02075294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102048090|NCT02075294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102048091|NCT02075294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102048092|NCT02075294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048093|NCT01357967|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102048094|NCT01357967|Antidepressive Agents|antidepressive agents|mesh-ancestor
102048095|NCT01357967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102048096|NCT01357967|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102048097|NCT01357967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102048098|NCT01357967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102048099|NCT01357967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048110|NCT02075528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048112|NCT02075528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102048113|NCT02075528|Dopamine Agents|dopamine agents|mesh-ancestor
102048114|NCT02078648|Poly I-C|poly i-c|mesh-list
102048115|NCT02078648|Bevacizumab|bevacizumab|mesh-list
102048116|NCT02078648|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102048117|NCT02078648|Poly ICLC|poly iclc|mesh-list
102048118|NCT02078648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102048119|NCT02078648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102048120|NCT02078648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101696856|NCT00582556|Leuprolide|leuprolide|mesh-list
102048121|NCT02078648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102048122|NCT02078648|Growth Substances|growth substances|mesh-ancestor
102048123|NCT02078648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048124|NCT02078648|Growth Inhibitors|growth inhibitors|mesh-ancestor
102048125|NCT02078648|Interferon Inducers|interferon inducers|mesh-ancestor
102048126|NCT02078648|Immunologic Factors|immunologic factors|mesh-ancestor
102048127|NCT02078648|Antiviral Agents|antiviral agents|mesh-ancestor
102048128|NCT02078648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102048129|NCT02078648|Laxatives|laxatives|mesh-ancestor
102048130|NCT02078648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102048131|NCT01358045|Calcitriol|calcitriol|mesh-list
102048132|NCT01358045|Diclofenac|diclofenac|mesh-list
102048133|NCT01358045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102048134|NCT01358045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102048135|NCT01358045|Analgesics|analgesics|mesh-ancestor
102048136|NCT01358045|Sensory System Agents|sensory system agents|mesh-ancestor
102048137|NCT01358045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102048138|NCT01358045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048139|NCT01358045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102048140|NCT01358045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102048141|NCT01358045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102048142|NCT01358045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101941893|NCT03643666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306884|NCT02028429|Vasodilator Agents|vasodilator agents|mesh-ancestor
102048143|NCT01358045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048144|NCT01358045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102048145|NCT01358045|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102048146|NCT01358045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102048147|NCT01358045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102048148|NCT01358045|Vitamins|vitamins|mesh-ancestor
102048149|NCT01358045|Micronutrients|micronutrients|mesh-ancestor
102048150|NCT01358045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102048151|NCT02076230|Phosphoramide Mustards|phosphoramide mustards|mesh-list
102048152|NCT02076230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102048153|NCT02076230|Alkylating Agents|alkylating agents|mesh-ancestor
101767898|NCT04017741|Lidocaine|lidocaine|mesh-list
102048154|NCT02076230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048155|NCT02076230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102048156|NCT01357811|Digoxin|digoxin|mesh-list
102048157|NCT01357811|Eliglustat|eliglustat|mesh-list
102048158|NCT01357811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102048159|NCT01357811|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102048160|NCT01357811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102048161|NCT01357811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048162|NCT01357811|Protective Agents|protective agents|mesh-ancestor
102048166|NCT04300985|Anesthetics|anesthetics|mesh-list
102048167|NCT04300985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102048168|NCT04300985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048169|NCT04300985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102048170|NCT04300985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102048171|NCT04300985|Analgesics|analgesics|mesh-ancestor
102048172|NCT04300985|Sensory System Agents|sensory system agents|mesh-ancestor
102048173|NCT04300985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102048174|NCT04300985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102048175|NCT04300985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102048176|NCT04300985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102048177|NCT04300985|Adrenergic Agents|adrenergic agents|mesh-ancestor
102048178|NCT04300985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101696863|NCT00582556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102048179|NCT04300985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048180|NCT04300985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102048181|NCT04300985|Anticonvulsants|anticonvulsants|mesh-ancestor
102048182|NCT04300985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102048183|NCT04300985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102048184|NCT04300985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102048185|NCT04300985|Tocolytic Agents|tocolytic agents|mesh-ancestor
102048186|NCT04300985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102048188|NCT02079194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102048189|NCT02079194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102048190|NCT02079194|Analgesics|analgesics|mesh-ancestor
102048191|NCT02079194|Sensory System Agents|sensory system agents|mesh-ancestor
102048192|NCT02079194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102048193|NCT02079194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048194|NCT02079194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102048195|NCT02079194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102048196|NCT02079194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102048197|NCT02079194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102048198|NCT02079194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048199|NCT02079194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102048200|NCT02079194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102048201|NCT02079194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102048202|NCT02079194|Antipyretics|antipyretics|mesh-ancestor
102048203|NCT01351493|Nitric Oxide|nitric oxide|mesh-list
102048204|NCT01351493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102048205|NCT01351493|Autonomic Agents|autonomic agents|mesh-ancestor
102048206|NCT01351493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102048207|NCT01351493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048208|NCT01351493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102048209|NCT01351493|Respiratory System Agents|respiratory system agents|mesh-ancestor
102048210|NCT01351493|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102048211|NCT01351493|Antioxidants|antioxidants|mesh-ancestor
102048212|NCT01351493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048213|NCT01351493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101941894|NCT03643666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101941895|NCT03643666|Tocolytic Agents|tocolytic agents|mesh-ancestor
101425805|NCT03156452|Prednisolone|prednisolone|mesh-list
102048214|NCT01351493|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102048215|NCT01351493|Vasodilator Agents|vasodilator agents|mesh-ancestor
102048216|NCT01351493|Gasotransmitters|gasotransmitters|mesh-ancestor
102048217|NCT01351493|Protective Agents|protective agents|mesh-ancestor
102048218|NCT01318187|Acetaminophen|acetaminophen|mesh-list
102048219|NCT01318187|Morphine|morphine|mesh-list
102048220|NCT01318187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102048221|NCT01318187|Narcotics|narcotics|mesh-ancestor
102048222|NCT01318187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102048223|NCT01318187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048224|NCT01318187|Analgesics|analgesics|mesh-ancestor
102048225|NCT01318187|Sensory System Agents|sensory system agents|mesh-ancestor
102048226|NCT01318187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102048227|NCT01318187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102048228|NCT01318187|Antipyretics|antipyretics|mesh-ancestor
102048229|NCT01358435|Insulin|insulin|mesh-list
102048230|NCT01358435|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102048231|NCT01358435|Insulin, Isophane|insulin, isophane|mesh-list
102048232|NCT01358435|Isophane Insulin, Human|isophane insulin, human|mesh-list
102048233|NCT01358435|Isophane insulin, beef|isophane insulin, beef|mesh-list
102048234|NCT01358435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102048237|NCT01318265|Antifungal Agents|antifungal agents|mesh-ancestor
102048238|NCT01318265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102048239|NCT01318265|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102048240|NCT01318265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102048241|NCT01318265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102048242|NCT01318265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048243|NCT01318265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102048244|NCT01318265|Hormone Antagonists|hormone antagonists|mesh-ancestor
102048245|NCT01318265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102048246|NCT01318265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048247|NCT01318265|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102048248|NCT01354457|Epratuzumab|epratuzumab|mesh-list
102048249|NCT01354457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102048250|NCT01354457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102048252|NCT02079350|Plasma Substitutes|plasma substitutes|mesh-ancestor
102048253|NCT02079350|Blood Substitutes|blood substitutes|mesh-ancestor
102048254|NCT03062540|Cyclobenzaprine|cyclobenzaprine|mesh-list
102048255|NCT03062540|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102048256|NCT03062540|Antidepressive Agents|antidepressive agents|mesh-ancestor
102048257|NCT03062540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102048258|NCT03062540|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102048259|NCT03062540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048260|NCT03062540|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102048261|NCT03062540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102048262|NCT03062540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102048263|NCT03062540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102048264|NCT03060980|Empagliflozin|empagliflozin|mesh-list
102048265|NCT03060980|Glimepiride|glimepiride|mesh-list
102048266|NCT03060980|Exenatide|exenatide|mesh-list
102048267|NCT03060980|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102048268|NCT03060980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048269|NCT03060980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102048270|NCT03060980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048271|NCT03060980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102048272|NCT03060980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102048273|NCT03060980|Immunologic Factors|immunologic factors|mesh-ancestor
102048274|NCT03060980|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102048275|NCT03060980|Incretins|incretins|mesh-ancestor
102048276|NCT03060980|Hormones|hormones|mesh-ancestor
102048277|NCT03060980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102048278|NCT01358591|Calcium Carbonate|calcium carbonate|mesh-list
102048279|NCT01358591|Calcium|calcium|mesh-list
102048280|NCT01358591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102048281|NCT01358591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048282|NCT01358591|Antacids|antacids|mesh-ancestor
102048283|NCT01358591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048284|NCT01358591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102048285|NCT02081144|Nicotine|nicotine|mesh-list
101941896|NCT03643666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101941897|NCT03643588|Hyaluronic Acid|hyaluronic acid|mesh-list
101941898|NCT03643588|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101941899|NCT03643588|Immunologic Factors|immunologic factors|mesh-ancestor
101941900|NCT03643588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941901|NCT03643588|Viscosupplements|viscosupplements|mesh-ancestor
101941902|NCT03643588|Protective Agents|protective agents|mesh-ancestor
101941903|NCT01224951|Beclomethasone|beclomethasone|mesh-list
102048286|NCT02081144|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102048287|NCT02081144|Autonomic Agents|autonomic agents|mesh-ancestor
102048288|NCT02081144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102048289|NCT02081144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048290|NCT02081144|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102048291|NCT02081144|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102048292|NCT02081144|Cholinergic Agents|cholinergic agents|mesh-ancestor
102048293|NCT02081144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102048294|NCT02081144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048295|NCT02083328|Mannitol|mannitol|mesh-list
102048296|NCT02083328|Caffeine|caffeine|mesh-list
102048297|NCT02083328|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102048298|NCT02083328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048299|NCT02083328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102048300|NCT02083328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102048301|NCT02083328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048302|NCT02083328|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102048303|NCT02083328|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102048304|NCT02083328|Purinergic Agents|purinergic agents|mesh-ancestor
102048305|NCT02083328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102048307|NCT02083328|Diuretics|diuretics|mesh-ancestor
102048310|NCT02079506|Candesartan cilexetil|candesartan cilexetil|mesh-list
102048311|NCT02079506|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102048312|NCT02079506|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102048313|NCT02079506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102048314|NCT02079506|Antimetabolites|antimetabolites|mesh-ancestor
102048315|NCT02079506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048316|NCT02079506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102048317|NCT02079506|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102048318|NCT02079506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102048319|NCT02079506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102048320|NCT02079506|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102048321|NCT02079506|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102048323|NCT02940548|Nifedipine|nifedipine|mesh-list
102048324|NCT02940548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102048325|NCT02940548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102048326|NCT02940548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102048327|NCT02940548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048328|NCT02940548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102048329|NCT02940548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696903|NCT00985855|Etoposide|etoposide|mesh-list
102048330|NCT02940548|Vasodilator Agents|vasodilator agents|mesh-ancestor
102048331|NCT02940548|Tocolytic Agents|tocolytic agents|mesh-ancestor
102048332|NCT02940548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102048333|NCT01366183|Paclitaxel|paclitaxel|mesh-list
102048334|NCT01366183|Carboplatin|carboplatin|mesh-list
102048335|NCT01366183|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102048336|NCT01366183|Lenograstim|lenograstim|mesh-list
102048337|NCT01366183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102048338|NCT01366183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102048339|NCT01366183|Tubulin Modulators|tubulin modulators|mesh-ancestor
102048340|NCT01366183|Antimitotic Agents|antimitotic agents|mesh-ancestor
102048341|NCT01366183|Mitosis Modulators|mitosis modulators|mesh-ancestor
102048342|NCT01366183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048343|NCT01366183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102048344|NCT01366183|Immunologic Factors|immunologic factors|mesh-ancestor
102048345|NCT01366183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048346|NCT03134183|Misoprostol|misoprostol|mesh-list
102048347|NCT03134183|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101941904|NCT01224951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101941905|NCT01224951|Glucocorticoids|glucocorticoids|mesh-ancestor
101941906|NCT01224951|Hormones|hormones|mesh-ancestor
101941907|NCT01224951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102048348|NCT03134183|Abortifacient Agents|abortifacient agents|mesh-ancestor
102048349|NCT03134183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102048350|NCT03134183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048351|NCT03134183|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102048352|NCT03134183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102048353|NCT03134183|Oxytocics|oxytocics|mesh-ancestor
102048354|NCT02083484|Pembrolizumab|pembrolizumab|mesh-list
102048355|NCT02083484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102048356|NCT02083484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102048357|NCT02083484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102048358|NCT02083484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048359|NCT01354613|Amlodipine|amlodipine|mesh-list
102048360|NCT01354613|Dobutamine|dobutamine|mesh-list
102048361|NCT01354613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102048362|NCT01354613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102048363|NCT01354613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102048364|NCT01354613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048365|NCT01354613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102048366|NCT01354613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048367|NCT01354613|Vasodilator Agents|vasodilator agents|mesh-ancestor
102048368|NCT01354613|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102048369|NCT01354613|Sympathomimetics|sympathomimetics|mesh-ancestor
102048370|NCT01354613|Autonomic Agents|autonomic agents|mesh-ancestor
102048371|NCT01354613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102048372|NCT01354613|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102048373|NCT01354613|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102048374|NCT01354613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102048375|NCT01354613|Adrenergic Agents|adrenergic agents|mesh-ancestor
102048376|NCT01354613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102048377|NCT01354613|Protective Agents|protective agents|mesh-ancestor
102048378|NCT02083640|Palbociclib|palbociclib|mesh-list
102048380|NCT02083640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102048384|NCT01352039|Calcium heparin|calcium heparin|mesh-list
102048385|NCT01352039|Anticoagulants|anticoagulants|mesh-ancestor
102048386|NCT01352039|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102048387|NCT01352039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102048388|NCT01352039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048389|NCT04419337|Metformin|metformin|mesh-list
102048390|NCT04419337|Pioglitazone|pioglitazone|mesh-list
102048391|NCT04419337|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102048392|NCT04419337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102048393|NCT04419337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048394|NCT04419337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048395|NCT01359059|Pregabalin|pregabalin|mesh-list
102048396|NCT01359059|Analgesics|analgesics|mesh-ancestor
102048397|NCT01359059|Sensory System Agents|sensory system agents|mesh-ancestor
102048398|NCT01359059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102048399|NCT01359059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048400|NCT01359059|Anticonvulsants|anticonvulsants|mesh-ancestor
102048401|NCT01359059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102048402|NCT01359059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102048403|NCT01359059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048404|NCT01359059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102048405|NCT01359059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102048406|NCT01359059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102048407|NCT01359059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102048408|NCT01359059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102048409|NCT05189093|Antibodies|antibodies|mesh-list
102048410|NCT05189093|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102048411|NCT05189093|Immunologic Factors|immunologic factors|mesh-ancestor
102048412|NCT05189093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048413|NCT01371331|Tacrolimus|tacrolimus|mesh-list
102048414|NCT01371331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102048415|NCT01371331|Immunologic Factors|immunologic factors|mesh-ancestor
102048416|NCT01371331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048417|NCT01371331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101941908|NCT01224951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941909|NCT01224951|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101941910|NCT01224951|Respiratory System Agents|respiratory system agents|mesh-ancestor
101941911|NCT03641404|Ergothioneine|ergothioneine|mesh-list
101941912|NCT03641404|Antioxidants|antioxidants|mesh-ancestor
101306897|NCT02028507|Palbociclib|palbociclib|mesh-list
102048418|NCT01371331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102048419|NCT01371331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048420|NCT01366339|Methylnaltrexone|methylnaltrexone|mesh-list
102048421|NCT01366339|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102048422|NCT01366339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048423|NCT01366339|Sensory System Agents|sensory system agents|mesh-ancestor
102048424|NCT01366339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102048425|NCT03133793|Coenzyme Q10|coenzyme q10|mesh-list
102048426|NCT03133793|Vitamins|vitamins|mesh-ancestor
102048427|NCT03133793|Micronutrients|micronutrients|mesh-ancestor
102048428|NCT03133793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048429|NCT03133481|Ropivacaine|ropivacaine|mesh-list
102048430|NCT03133481|Anesthetics, Local|anesthetics, local|mesh-ancestor
102048431|NCT03133481|Anesthetics|anesthetics|mesh-ancestor
102048432|NCT03133481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102048433|NCT03133481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048434|NCT03133481|Sensory System Agents|sensory system agents|mesh-ancestor
102048435|NCT03133481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102048436|NCT01366651|Doripenem|doripenem|mesh-list
102048437|NCT01366651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102048438|NCT01366651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102048439|NCT05124509|Vaccines|vaccines|mesh-list
102048440|NCT05124509|Immunologic Factors|immunologic factors|mesh-ancestor
102048441|NCT05124509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048442|NCT02864316|Nivolumab|nivolumab|mesh-list
102048443|NCT02864316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102048444|NCT02864316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102048445|NCT02864316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102048446|NCT02864316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048447|NCT03941509|Anti-Infective Agents|anti-infective agents|mesh-list
102048448|NCT03941509|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102048449|NCT01361399|Aspirin|aspirin|mesh-list
102048450|NCT01361399|Lidocaine|lidocaine|mesh-list
102048451|NCT01361399|Anesthetics, Local|anesthetics, local|mesh-ancestor
102048452|NCT01361399|Anesthetics|anesthetics|mesh-ancestor
102048453|NCT01361399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102048462|NCT01361399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102048464|NCT01361399|Analgesics|analgesics|mesh-ancestor
102048465|NCT01361399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102048466|NCT01361399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102048467|NCT01361399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102048468|NCT01361399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102048469|NCT01361399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102048470|NCT01361399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102048471|NCT01361399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102048472|NCT01361399|Antipyretics|antipyretics|mesh-ancestor
102048473|NCT02862600|Perhexiline|perhexiline|mesh-list
102048474|NCT02862600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102048475|NCT02862600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102048476|NCT02862600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048477|NCT02862600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102048478|NCT02862600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048479|NCT02862600|Vasodilator Agents|vasodilator agents|mesh-ancestor
102048480|NCT01354925|Insulin|insulin|mesh-list
102048481|NCT01354925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102048482|NCT01354925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048483|NCT03556345|Trastuzumab|trastuzumab|mesh-list
102048484|NCT03556345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102048485|NCT03556345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102048486|NCT03610230|Iron|iron|mesh-list
102048487|NCT03610230|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102048488|NCT03610230|Ferric Compounds|ferric compounds|mesh-list
102048489|NCT03610230|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
102048490|NCT03610230|Trace Elements|trace elements|mesh-ancestor
102048491|NCT03610230|Micronutrients|micronutrients|mesh-ancestor
101941913|NCT03641404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941914|NCT03641404|Protective Agents|protective agents|mesh-ancestor
101941915|NCT03641404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941916|NCT01131741|Epinephrine|epinephrine|mesh-list
102048492|NCT03610230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048493|NCT03610230|Hematinics|hematinics|mesh-ancestor
102048494|NCT01359605|Varespladib methyl|varespladib methyl|mesh-list
102048495|NCT01359605|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
102048496|NCT01359605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102048497|NCT01359605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048498|NCT05188859|Pemetrexed|pemetrexed|mesh-list
102048499|NCT05188859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102048500|NCT05188859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102048501|NCT05188859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048502|NCT05188859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102048503|NCT05188859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102048504|NCT02033538|Paclitaxel|paclitaxel|mesh-list
102048505|NCT02033538|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102048506|NCT02033538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102048507|NCT02033538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102048508|NCT02033538|Tubulin Modulators|tubulin modulators|mesh-ancestor
102048509|NCT02033538|Antimitotic Agents|antimitotic agents|mesh-ancestor
102048510|NCT02033538|Mitosis Modulators|mitosis modulators|mesh-ancestor
102048511|NCT02033538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048512|NCT02792192|Atezolizumab|atezolizumab|mesh-list
102048513|NCT02792192|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102048514|NCT02792192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048515|NCT02792192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102048516|NCT02792192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102048530|NCT01361789|Dexamethasone acetate|dexamethasone acetate|mesh-list
102048531|NCT01361789|Etoricoxib|etoricoxib|mesh-list
102048532|NCT01361789|Parecoxib|parecoxib|mesh-list
102048533|NCT01361789|Valdecoxib|valdecoxib|mesh-list
102048534|NCT01361789|BB 1101|bb 1101|mesh-list
102048535|NCT01361789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102048536|NCT01361789|Antiemetics|antiemetics|mesh-ancestor
102048537|NCT01361789|Autonomic Agents|autonomic agents|mesh-ancestor
102048538|NCT01361789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102048539|NCT01361789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048540|NCT01361789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102048541|NCT01361789|Glucocorticoids|glucocorticoids|mesh-ancestor
102048542|NCT01361789|Hormones|hormones|mesh-ancestor
102048543|NCT01361789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102048544|NCT01361789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102048545|NCT01361789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102048546|NCT01361789|Protease Inhibitors|protease inhibitors|mesh-ancestor
102048547|NCT01361789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102048548|NCT01361789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048549|NCT01361789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102048550|NCT01361789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102048551|NCT01361789|Analgesics|analgesics|mesh-ancestor
102048552|NCT01361789|Sensory System Agents|sensory system agents|mesh-ancestor
102048553|NCT01361789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102048554|NCT01361789|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102048555|NCT01361789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102048556|NCT02964507|Fulvestrant|fulvestrant|mesh-list
102048557|NCT02964507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102048558|NCT02964507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102048559|NCT02964507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102048560|NCT02964507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102048561|NCT02964507|Hormone Antagonists|hormone antagonists|mesh-ancestor
102048562|NCT02964507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102048563|NCT02964507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048564|NCT02083874|Cannabidiol|cannabidiol|mesh-list
102048565|NCT02083874|Anticonvulsants|anticonvulsants|mesh-ancestor
102048566|NCT05188781|Pembrolizumab|pembrolizumab|mesh-list
102048567|NCT05188781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102048568|NCT05188781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102048569|NCT05188781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101941917|NCT01131741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101941918|NCT01131741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102048570|NCT05188781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048571|NCT03634735|Thiamine|thiamine|mesh-list
102048572|NCT03634735|Vitamins|vitamins|mesh-ancestor
102048573|NCT03634735|Micronutrients|micronutrients|mesh-ancestor
102048574|NCT03634735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048575|NCT03634735|Vitamin B Complex|vitamin b complex|mesh-ancestor
102048576|NCT02084342|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
102048589|NCT01371487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102048590|NCT01371487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048591|NCT02084420|Pantoprazole|pantoprazole|mesh-list
102048592|NCT02084420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102048593|NCT02084420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102048594|NCT02084420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102048595|NCT02084420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102048596|NCT02084420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048597|NCT01367431|Xanthohumol|xanthohumol|mesh-list
102048598|NCT01367431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102048599|NCT01367431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102048600|NCT01367431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102048601|NCT01367431|Growth Substances|growth substances|mesh-ancestor
102048602|NCT01367431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048603|NCT01367431|Growth Inhibitors|growth inhibitors|mesh-ancestor
102048604|NCT01367509|Methylnaltrexone|methylnaltrexone|mesh-list
102048605|NCT01367509|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102048606|NCT01367509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048607|NCT01367509|Sensory System Agents|sensory system agents|mesh-ancestor
102048608|NCT01367509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102048609|NCT01364701|Sildenafil Citrate|sildenafil citrate|mesh-list
102048610|NCT01364701|Tadalafil|tadalafil|mesh-list
102048611|NCT01364701|Vasodilator Agents|vasodilator agents|mesh-ancestor
102048612|NCT01364701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102048613|NCT01364701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102048614|NCT01364701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102048615|NCT01364701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048616|NCT01364701|Urological Agents|urological agents|mesh-ancestor
102048617|NCT02440464|Fludarabine|fludarabine|mesh-list
102048618|NCT02440464|Bortezomib|bortezomib|mesh-list
102048619|NCT02440464|Melphalan|melphalan|mesh-list
102048620|NCT02440464|Ixazomib|ixazomib|mesh-list
102048621|NCT02440464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102048622|NCT02440464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048623|NCT02440464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102048624|NCT02440464|Immunologic Factors|immunologic factors|mesh-ancestor
102048625|NCT02440464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048626|NCT02440464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102048627|NCT02440464|Alkylating Agents|alkylating agents|mesh-ancestor
102048628|NCT02440464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102048629|NCT02440464|Protease Inhibitors|protease inhibitors|mesh-ancestor
102048630|NCT02440464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102048631|NCT01367587|Methylnaltrexone|methylnaltrexone|mesh-list
102048632|NCT01367587|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102048633|NCT01367587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048634|NCT01367587|Sensory System Agents|sensory system agents|mesh-ancestor
102048635|NCT01367587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102048636|NCT02088398|Ricolinostat|ricolinostat|mesh-list
102048637|NCT02088398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102048638|NCT02088398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101350093|NCT04902911|Antibodies|antibodies|mesh-list
102048651|NCT02084576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102048653|NCT02084576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048654|NCT03131453|Umibecestat|umibecestat|mesh-list
102048655|NCT03131453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102048656|NCT03131453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048657|NCT02084654|Exenatide|exenatide|mesh-list
102048658|NCT02084654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102048659|NCT02084654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048660|NCT02084654|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102048661|NCT02084654|Incretins|incretins|mesh-ancestor
102048662|NCT02084654|Hormones|hormones|mesh-ancestor
102048663|NCT02084654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102048664|NCT01367743|Epinephrine|epinephrine|mesh-list
102048665|NCT01367743|Norepinephrine|norepinephrine|mesh-list
101941919|NCT01131741|Adrenergic Agents|adrenergic agents|mesh-ancestor
101941920|NCT01131741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101941921|NCT01131741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941922|NCT01131741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048666|NCT01367743|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
102048667|NCT01367743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102048668|NCT01367743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102048669|NCT01367743|Adrenergic Agents|adrenergic agents|mesh-ancestor
102048670|NCT01367743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102048671|NCT01367743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048672|NCT01367743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048673|NCT01367743|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102048674|NCT01367743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102048675|NCT01367743|Autonomic Agents|autonomic agents|mesh-ancestor
102048676|NCT01367743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102048677|NCT01367743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102048678|NCT01367743|Respiratory System Agents|respiratory system agents|mesh-ancestor
102048679|NCT01367743|Mydriatics|mydriatics|mesh-ancestor
102048680|NCT01367743|Sympathomimetics|sympathomimetics|mesh-ancestor
102048682|NCT02084732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102048683|NCT02084732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102048684|NCT02084732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102048685|NCT02084732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048686|NCT02780401|Vaccines|vaccines|mesh-list
102048687|NCT02780401|Sargramostim|sargramostim|mesh-list
102048688|NCT02780401|Immunologic Factors|immunologic factors|mesh-ancestor
102048689|NCT02780401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048690|NCT02533232|Minocycline|minocycline|mesh-list
102048691|NCT02533232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102048692|NCT02533232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102048693|NCT02673151|Edetic Acid|edetic acid|mesh-list
102048694|NCT02673151|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102048695|NCT02673151|Chelating Agents|chelating agents|mesh-ancestor
102048696|NCT02673151|Sequestering Agents|sequestering agents|mesh-ancestor
102048697|NCT02673151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048698|NCT02673151|Anticoagulants|anticoagulants|mesh-ancestor
102048699|NCT02673151|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102048700|NCT02673151|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101350153|NCT04846348|Histamine Agents|histamine agents|mesh-ancestor
102048711|NCT05042947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048712|NCT05042947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102048713|NCT05042947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048715|NCT02082236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102048716|NCT02082236|Narcotics|narcotics|mesh-ancestor
102048717|NCT02082236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102048718|NCT02082236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048719|NCT02082236|Analgesics|analgesics|mesh-ancestor
102048720|NCT02082236|Sensory System Agents|sensory system agents|mesh-ancestor
102048721|NCT02082236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102048722|NCT02082236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102048723|NCT02082236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102048724|NCT02082236|Anesthetics, General|anesthetics, general|mesh-ancestor
102048725|NCT02082236|Anesthetics|anesthetics|mesh-ancestor
102048726|NCT03557996|Listerine|listerine|mesh-list
102048727|NCT03557996|Fluorides|fluorides|mesh-list
102048728|NCT03557996|Sodium Fluoride|sodium fluoride|mesh-list
102048729|NCT03557996|Fluorides, Topical|fluorides, topical|mesh-list
102048730|NCT03557996|Cariostatic Agents|cariostatic agents|mesh-ancestor
102048731|NCT03557996|Protective Agents|protective agents|mesh-ancestor
102048732|NCT03557996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048733|NCT03557996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102048734|NCT03557996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102048735|NCT02296801|Letrozole|letrozole|mesh-list
102048736|NCT02296801|Palbociclib|palbociclib|mesh-list
102048737|NCT02296801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102048738|NCT02296801|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102048739|NCT02296801|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102048740|NCT02296801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102048741|NCT02296801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048742|NCT02296801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102048743|NCT02296801|Hormone Antagonists|hormone antagonists|mesh-ancestor
101941923|NCT01131741|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101941924|NCT01131741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101426318|NCT00528385|Diuretics|diuretics|mesh-ancestor
102048744|NCT02296801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102048745|NCT02296801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048746|NCT02296801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102048747|NCT02859324|Nivolumab|nivolumab|mesh-list
102048748|NCT02859324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102048749|NCT02859324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102048750|NCT02859324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102048751|NCT02859324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697141|NCT00988897|Vitamins|vitamins|mesh-ancestor
101768482|NCT00890253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102048752|NCT02085590|Vaccines|vaccines|mesh-list
102048753|NCT02085590|BCG Vaccine|bcg vaccine|mesh-list
102048754|NCT02085590|Immunologic Factors|immunologic factors|mesh-ancestor
102048755|NCT02085590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048756|NCT02085590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102048757|NCT02143063|Cocaine|cocaine|mesh-list
102048758|NCT02143063|Anesthetics, Local|anesthetics, local|mesh-ancestor
102048759|NCT02143063|Anesthetics|anesthetics|mesh-ancestor
102048760|NCT02143063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102048761|NCT02143063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048762|NCT02143063|Sensory System Agents|sensory system agents|mesh-ancestor
102048763|NCT02143063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102048768|NCT02143063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048769|NCT02143063|Dopamine Agents|dopamine agents|mesh-ancestor
102048770|NCT02143063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102048771|NCT02088866|Lidocaine|lidocaine|mesh-list
102048772|NCT02088866|Anesthetics, Local|anesthetics, local|mesh-ancestor
102048773|NCT02088866|Anesthetics|anesthetics|mesh-ancestor
102048774|NCT02088866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102048775|NCT02088866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048776|NCT02088866|Sensory System Agents|sensory system agents|mesh-ancestor
102048777|NCT02088866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102048778|NCT02088866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102048779|NCT02088866|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102048780|NCT02088866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102048781|NCT02088866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102048782|NCT02088866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048783|NCT02859246|Guaifenesin|guaifenesin|mesh-list
102048784|NCT02859246|Expectorants|expectorants|mesh-ancestor
102048785|NCT02859246|Respiratory System Agents|respiratory system agents|mesh-ancestor
102048786|NCT02088944|Infliximab|infliximab|mesh-list
102048787|NCT02088944|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102048788|NCT02088944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102048789|NCT02088944|Dermatologic Agents|dermatologic agents|mesh-ancestor
102048790|NCT02088944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102048791|NCT02088944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102048792|NCT02073097|Acyclovir|acyclovir|mesh-list
102048793|NCT02073097|Prednisone|prednisone|mesh-list
102048794|NCT02073097|Cyclophosphamide|cyclophosphamide|mesh-list
102048795|NCT02073097|Rituximab|rituximab|mesh-list
102048796|NCT02073097|Doxorubicin|doxorubicin|mesh-list
102048797|NCT02073097|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102048798|NCT02073097|Vincristine|vincristine|mesh-list
102048799|NCT02073097|Lenograstim|lenograstim|mesh-list
102048800|NCT02073097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102048801|NCT02073097|Immunologic Factors|immunologic factors|mesh-ancestor
102048802|NCT02073097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048803|NCT02073097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102048804|NCT02073097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102048805|NCT02073097|Alkylating Agents|alkylating agents|mesh-ancestor
102048806|NCT02073097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048807|NCT02073097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102048808|NCT02073097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102048809|NCT02073097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102048810|NCT02073097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102048811|NCT02073097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102048812|NCT02073097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102048813|NCT02073097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101941926|NCT01131741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101941927|NCT01131741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101941928|NCT01131741|Respiratory System Agents|respiratory system agents|mesh-ancestor
101941930|NCT01131741|Sympathomimetics|sympathomimetics|mesh-ancestor
101941931|NCT01131741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102048814|NCT02073097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102048815|NCT02073097|Glucocorticoids|glucocorticoids|mesh-ancestor
102048816|NCT02073097|Hormones|hormones|mesh-ancestor
102048817|NCT02073097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102048818|NCT02073097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102048819|NCT02073097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102048820|NCT02073097|Tubulin Modulators|tubulin modulators|mesh-ancestor
102048821|NCT02073097|Antimitotic Agents|antimitotic agents|mesh-ancestor
102048822|NCT02073097|Mitosis Modulators|mitosis modulators|mesh-ancestor
102048823|NCT02073097|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102048824|NCT02073097|Antiviral Agents|antiviral agents|mesh-ancestor
102048825|NCT02073097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102048826|NCT02921997|Vaccines|vaccines|mesh-list
102048827|NCT02921997|Immunologic Factors|immunologic factors|mesh-ancestor
102048828|NCT02921997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048830|NCT02791490|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102048831|NCT02791490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102048832|NCT02791490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048833|NCT02791490|Incretins|incretins|mesh-ancestor
102048834|NCT02791490|Hormones|hormones|mesh-ancestor
101350290|NCT04584112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102048845|NCT02085824|Enoxaparin|enoxaparin|mesh-list
102048846|NCT02085824|Rivaroxaban|rivaroxaban|mesh-list
102048847|NCT02085824|Dabigatran|dabigatran|mesh-list
102048848|NCT02085824|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102048849|NCT02085824|Antithrombins|antithrombins|mesh-ancestor
102048850|NCT02085824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102048851|NCT02085824|Protease Inhibitors|protease inhibitors|mesh-ancestor
102048852|NCT02085824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102048853|NCT02085824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048854|NCT02085824|Anticoagulants|anticoagulants|mesh-ancestor
102048855|NCT02085824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102048856|NCT02085824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102048857|NCT01368445|Azelastine|azelastine|mesh-list
102048858|NCT01368445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102048859|NCT01368445|Autonomic Agents|autonomic agents|mesh-ancestor
102048860|NCT01368445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102048861|NCT01368445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048862|NCT01368445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102048863|NCT01368445|Respiratory System Agents|respiratory system agents|mesh-ancestor
102048864|NCT01368445|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
102048865|NCT01368445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102048866|NCT01368445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048867|NCT01368445|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102048868|NCT01368445|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102048869|NCT01368445|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102048870|NCT01368445|Histamine Antagonists|histamine antagonists|mesh-ancestor
102048871|NCT01368445|Histamine Agents|histamine agents|mesh-ancestor
102048872|NCT01368445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102048873|NCT02085902|Ropivacaine|ropivacaine|mesh-list
102048874|NCT02085902|Anesthetics, Local|anesthetics, local|mesh-ancestor
102048875|NCT02085902|Anesthetics|anesthetics|mesh-ancestor
102048876|NCT02085902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102048877|NCT02085902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048878|NCT02085902|Sensory System Agents|sensory system agents|mesh-ancestor
102048879|NCT02085902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102048880|NCT01368757|Lenalidomide|lenalidomide|mesh-list
102048881|NCT01368757|Immunologic Factors|immunologic factors|mesh-ancestor
102048882|NCT01368757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048883|NCT01368757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102048884|NCT01368757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102048885|NCT01368757|Growth Substances|growth substances|mesh-ancestor
102048886|NCT01368757|Growth Inhibitors|growth inhibitors|mesh-ancestor
102048887|NCT01368757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102048888|NCT02086292|Lidocaine|lidocaine|mesh-list
101941932|NCT03919851|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101941933|NCT03919851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101941934|NCT03921567|Lidocaine|lidocaine|mesh-list
101941935|NCT03921567|Ketamine|ketamine|mesh-list
101941936|NCT03921567|Anesthetics, Local|anesthetics, local|mesh-ancestor
101941937|NCT03921567|Anesthetics|anesthetics|mesh-ancestor
101306919|NCT02028598|Citric Acid|citric acid|mesh-list
102048889|NCT02086292|Anesthetics, Local|anesthetics, local|mesh-ancestor
102048890|NCT02086292|Anesthetics|anesthetics|mesh-ancestor
102048891|NCT02086292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102048892|NCT02086292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048893|NCT02086292|Sensory System Agents|sensory system agents|mesh-ancestor
102048894|NCT02086292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102048895|NCT02086292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101350360|NCT04321993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102048909|NCT02425644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102048910|NCT02425644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102048911|NCT02425644|Immunologic Factors|immunologic factors|mesh-ancestor
102048912|NCT02425644|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102048913|NCT02425644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048914|NCT02184741|Immunoglobulins|immunoglobulins|mesh-list
102048915|NCT02184741|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102048916|NCT02184741|gamma-Globulins|gamma-globulins|mesh-list
102048917|NCT02184741|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102048918|NCT02184741|Immunologic Factors|immunologic factors|mesh-ancestor
102048919|NCT02184741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048920|NCT02086526|Metformin|metformin|mesh-list
102048921|NCT02086526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102048922|NCT02086526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048923|NCT04180995|Axitinib|axitinib|mesh-list
102048924|NCT04180995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102048925|NCT04180995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102048926|NCT04180995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102048927|NCT04180995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048928|NCT02089178|Remifentanil|remifentanil|mesh-list
102048929|NCT02089178|Anesthetics|anesthetics|mesh-list
102048930|NCT02089178|Propofol|propofol|mesh-list
102048931|NCT02089178|Sevoflurane|sevoflurane|mesh-list
102048932|NCT02089178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102048933|NCT02089178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048934|NCT02089178|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102048935|NCT02089178|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102048936|NCT02089178|Anesthetics, General|anesthetics, general|mesh-ancestor
102048937|NCT02089178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102048938|NCT02089178|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102048939|NCT02089178|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102048940|NCT02089178|Narcotics|narcotics|mesh-ancestor
102048941|NCT02089178|Analgesics|analgesics|mesh-ancestor
102048942|NCT02089178|Sensory System Agents|sensory system agents|mesh-ancestor
102048943|NCT02089178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102048944|NCT02089256|Liraglutide|liraglutide|mesh-list
102048945|NCT02089256|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102048946|NCT02089256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048947|NCT02089256|Incretins|incretins|mesh-ancestor
102048948|NCT02089256|Hormones|hormones|mesh-ancestor
102048949|NCT02089256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102048950|NCT02861664|Fluorides|fluorides|mesh-list
102048951|NCT02861664|Tin Fluorides|tin fluorides|mesh-list
102048952|NCT02861664|Fluorophosphate|fluorophosphate|mesh-list
102048953|NCT02861664|Cariostatic Agents|cariostatic agents|mesh-ancestor
102048954|NCT02861664|Protective Agents|protective agents|mesh-ancestor
102048955|NCT02861664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048956|NCT02086838|Dextrans|dextrans|mesh-list
102048957|NCT02086838|Iron-Dextran Complex|iron-dextran complex|mesh-list
102048966|NCT02236962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102048968|NCT02236962|Autonomic Agents|autonomic agents|mesh-ancestor
102048969|NCT02236962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102048970|NCT02236962|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102048971|NCT02236962|Adrenergic Agents|adrenergic agents|mesh-ancestor
102048972|NCT02236962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102048973|NCT02236962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941938|NCT03921567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102048975|NCT04431375|Antiviral Agents|antiviral agents|mesh-ancestor
102048976|NCT04431375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102048977|NCT04431375|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102048978|NCT04431375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102048979|NCT04431375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102048980|NCT04431375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048981|NCT04431375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102048982|NCT04431375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102048983|NCT02086994|Misoprostol|misoprostol|mesh-list
102048984|NCT02086994|Carbetocin|carbetocin|mesh-list
102048985|NCT02086994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102048986|NCT02086994|Abortifacient Agents|abortifacient agents|mesh-ancestor
102048987|NCT02086994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102048988|NCT02086994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048989|NCT02086994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102048990|NCT02086994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102048991|NCT02086994|Oxytocics|oxytocics|mesh-ancestor
102048992|NCT05664711|Bupivacaine|bupivacaine|mesh-list
102048993|NCT05664711|Anesthetics, Local|anesthetics, local|mesh-ancestor
102048994|NCT05664711|Anesthetics|anesthetics|mesh-ancestor
102048995|NCT05664711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102048996|NCT05664711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048997|NCT05664711|Sensory System Agents|sensory system agents|mesh-ancestor
102048998|NCT05664711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102048999|NCT02089568|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102049000|NCT02089568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102049001|NCT02089568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102049002|NCT02089568|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102049003|NCT02089568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102049004|NCT02089568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049005|NCT03284853|Latanoprost|latanoprost|mesh-list
102049006|NCT03284853|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102049007|NCT03284853|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102049008|NCT02087384|Vaccines|vaccines|mesh-list
102049009|NCT02087384|Immunologic Factors|immunologic factors|mesh-ancestor
102049010|NCT02087384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049011|NCT02087462|Vitamins|vitamins|mesh-list
102049012|NCT02087462|Thiamine|thiamine|mesh-list
102049013|NCT02087462|Vitamin B Complex|vitamin b complex|mesh-list
102049014|NCT02087462|Diclofenac|diclofenac|mesh-list
102049015|NCT02087462|Micronutrients|micronutrients|mesh-ancestor
102049016|NCT02087462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049017|NCT02087462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102049018|NCT02087462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102049019|NCT02087462|Analgesics|analgesics|mesh-ancestor
102049020|NCT02087462|Sensory System Agents|sensory system agents|mesh-ancestor
102049021|NCT02087462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102049022|NCT02087462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102049023|NCT02087462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102049024|NCT02087462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102049025|NCT02087462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101350487|NCT04134936|Lenalidomide|lenalidomide|mesh-list
102049031|NCT02087540|Antimetabolites|antimetabolites|mesh-ancestor
102049032|NCT02087540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049033|NCT02087540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102049034|NCT02087540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102049035|NCT02087540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102049036|NCT02087540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102049037|NCT02087540|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102049038|NCT02087540|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102049039|NCT03055221|Treprostinil|treprostinil|mesh-list
102049040|NCT03055221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102049041|NCT03206463|Dronabinol|dronabinol|mesh-list
102049042|NCT03206463|Hallucinogens|hallucinogens|mesh-ancestor
102049043|NCT03206463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049044|NCT03206463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102049045|NCT03206463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102049046|NCT03206463|Analgesics|analgesics|mesh-ancestor
102049047|NCT03206463|Sensory System Agents|sensory system agents|mesh-ancestor
102049048|NCT03206463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102049049|NCT03206463|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102049050|NCT03206463|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101941939|NCT03921567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941940|NCT03921567|Sensory System Agents|sensory system agents|mesh-ancestor
101941941|NCT03921567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101941942|NCT03921567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101426619|NCT00169026|Serotonin Agents|serotonin agents|mesh-ancestor
102049051|NCT03206463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102049052|NCT03206463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049053|NCT03206463|Hormones|hormones|mesh-ancestor
102049054|NCT03206463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102049055|NCT02091674|Hyaluronic Acid|hyaluronic acid|mesh-list
102049056|NCT02091674|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102049057|NCT02091674|Immunologic Factors|immunologic factors|mesh-ancestor
102049058|NCT02091674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049059|NCT02091674|Viscosupplements|viscosupplements|mesh-ancestor
102049060|NCT02091674|Protective Agents|protective agents|mesh-ancestor
102049061|NCT01218555|Lenalidomide|lenalidomide|mesh-list
102049062|NCT01218555|Everolimus|everolimus|mesh-list
102049063|NCT01218555|Immunologic Factors|immunologic factors|mesh-ancestor
102049064|NCT01218555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049065|NCT01218555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102049066|NCT01218555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102049067|NCT01218555|Growth Substances|growth substances|mesh-ancestor
102049068|NCT01218555|Growth Inhibitors|growth inhibitors|mesh-ancestor
102049069|NCT01218555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102049070|NCT01218555|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102049071|NCT01218555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102049072|NCT01218555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102049073|NCT01218555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049074|NCT01218555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102049075|NCT02091830|Acetaminophen|acetaminophen|mesh-list
102049076|NCT02091830|Cortisone|cortisone|mesh-list
102049077|NCT02091830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102049078|NCT02091830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
102049079|NCT02091830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102049080|NCT02091830|Analgesics|analgesics|mesh-ancestor
102049081|NCT02091830|Sensory System Agents|sensory system agents|mesh-ancestor
102049082|NCT02091830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102049083|NCT02091830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049084|NCT02091830|Antipyretics|antipyretics|mesh-ancestor
102049085|NCT02091830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102049086|NCT01111305|Diethylcarbamazine|diethylcarbamazine|mesh-list
102049087|NCT01111305|Reslizumab|reslizumab|mesh-list
102049088|NCT01111305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102049089|NCT01111305|Respiratory System Agents|respiratory system agents|mesh-ancestor
102049090|NCT01111305|Filaricides|filaricides|mesh-ancestor
102049091|NCT01111305|Antinematodal Agents|antinematodal agents|mesh-ancestor
102049092|NCT01111305|Anthelmintics|anthelmintics|mesh-ancestor
102049093|NCT01111305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102049094|NCT01111305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102049095|NCT01111305|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
102049104|NCT03752307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102049105|NCT03752307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049106|NCT03752307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102049107|NCT03752307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102049108|NCT03752307|Antiemetics|antiemetics|mesh-ancestor
102049109|NCT03752307|Autonomic Agents|autonomic agents|mesh-ancestor
102049110|NCT03752307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102049111|NCT03752307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102049112|NCT03752307|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102049113|NCT03752307|Protective Agents|protective agents|mesh-ancestor
102049114|NCT03752307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102049115|NCT03752307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102049116|NCT03752307|Adrenergic Agents|adrenergic agents|mesh-ancestor
102049117|NCT03752307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102049118|NCT03752307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049119|NCT03752307|Sympathomimetics|sympathomimetics|mesh-ancestor
102049120|NCT03752307|Vasodilator Agents|vasodilator agents|mesh-ancestor
102049121|NCT03752307|Tocolytic Agents|tocolytic agents|mesh-ancestor
102049122|NCT03752307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102049123|NCT00792831|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
101941943|NCT03921567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101941944|NCT03921567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101941945|NCT03921567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101941946|NCT03921567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941947|NCT03921567|Analgesics|analgesics|mesh-ancestor
101426692|NCT00169143|Rituximab|rituximab|mesh-list
102049124|NCT00792831|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102049125|NCT00792831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102049126|NCT00792831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049127|NCT00496431|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
101697233|NCT00649922|Adalimumab|adalimumab|mesh-list
102049128|NCT00496431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
102049129|NCT00496431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102049130|NCT00496431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049131|NCT02091908|Lactitol|lactitol|mesh-list
102049132|NCT02091908|Vaccines|vaccines|mesh-list
102049133|NCT02091908|Immunologic Factors|immunologic factors|mesh-ancestor
102049134|NCT02091908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049135|NCT02091908|Cathartics|cathartics|mesh-ancestor
102049136|NCT02091908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102049137|NCT03627897|Bupivacaine|bupivacaine|mesh-list
102049138|NCT03627897|Anesthetics, Local|anesthetics, local|mesh-ancestor
102049139|NCT03627897|Anesthetics|anesthetics|mesh-ancestor
102049140|NCT03627897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102049141|NCT03627897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049142|NCT03627897|Sensory System Agents|sensory system agents|mesh-ancestor
102049143|NCT03627897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102049144|NCT01372111|Cisplatin|cisplatin|mesh-list
102049145|NCT01372111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102049146|NCT03125941|Dexamethasone|dexamethasone|mesh-list
102049147|NCT03125941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102049148|NCT03125941|Antiemetics|antiemetics|mesh-ancestor
102049149|NCT03125941|Autonomic Agents|autonomic agents|mesh-ancestor
102049150|NCT03125941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102049151|NCT03125941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049152|NCT03125941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102049153|NCT03125941|Glucocorticoids|glucocorticoids|mesh-ancestor
102049154|NCT03125941|Hormones|hormones|mesh-ancestor
102049155|NCT03125941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102049156|NCT03125941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102049157|NCT03125941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102049158|NCT02092142|Vaccines|vaccines|mesh-list
102049159|NCT02092142|Immunologic Factors|immunologic factors|mesh-ancestor
102049160|NCT02092142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049161|NCT02095886|BMS-955176|bms-955176|mesh-list
102049162|NCT02095886|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102049163|NCT02095886|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102049164|NCT02095886|Antiviral Agents|antiviral agents|mesh-ancestor
102049192|NCT03125395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102049193|NCT03125395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049194|NCT01369303|Tenofovir|tenofovir|mesh-list
102049195|NCT01369303|Antiviral Agents|antiviral agents|mesh-ancestor
102049196|NCT01369303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102049197|NCT01369303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102049198|NCT01369303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102049199|NCT01369303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102049200|NCT01369303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049201|NCT01369303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102049202|NCT01369303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102049203|NCT02092532|Aflibercept|aflibercept|mesh-list
102049204|NCT02092532|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102049205|NCT02092532|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102049206|NCT02092532|Growth Substances|growth substances|mesh-ancestor
102049207|NCT02092532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049209|NCT02092532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102049210|NCT02092766|Artesunate|artesunate|mesh-list
102049211|NCT02092766|Quinine|quinine|mesh-list
102049212|NCT02092766|Antimalarials|antimalarials|mesh-ancestor
102049213|NCT02092766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102049214|NCT02092766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101941948|NCT03921567|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101941949|NCT03921567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101697243|NCT00986557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101941951|NCT03921567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101941952|NCT03921567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101941953|NCT03921567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101941954|NCT01229241|Anesthetics|anesthetics|mesh-list
101941955|NCT01229241|Anesthetics, Local|anesthetics, local|mesh-list
101941956|NCT01229241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101941957|NCT01229241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306933|NCT02028598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102049215|NCT02092766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102049216|NCT02092766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350704|NCT03098225|Hormones|hormones|mesh-ancestor
102049219|NCT02092766|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102049220|NCT02092766|Anthelmintics|anthelmintics|mesh-ancestor
102049221|NCT02092766|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102049222|NCT02092766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049223|NCT02092766|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102049224|NCT02092766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102049225|NCT02092766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102049227|NCT02092766|Sensory System Agents|sensory system agents|mesh-ancestor
102049228|NCT02090348|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102049229|NCT02090348|Dermatologic Agents|dermatologic agents|mesh-ancestor
102049230|NCT02090348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102049231|NCT02090348|Immunologic Factors|immunologic factors|mesh-ancestor
102049232|NCT02090348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049233|NCT02721069|Diazepam|diazepam|mesh-list
102049234|NCT02721069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102049235|NCT02721069|Anticonvulsants|anticonvulsants|mesh-ancestor
102049236|NCT02721069|Antiemetics|antiemetics|mesh-ancestor
102049237|NCT02721069|Autonomic Agents|autonomic agents|mesh-ancestor
102049238|NCT02721069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102049239|NCT02721069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049240|NCT02721069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102049241|NCT02721069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102049242|NCT02721069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102049243|NCT02721069|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102049244|NCT02721069|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102049245|NCT02721069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102049246|NCT02721069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102049247|NCT02721069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102049248|NCT02721069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102049249|NCT02721069|Anesthetics, General|anesthetics, general|mesh-ancestor
102049250|NCT02721069|Anesthetics|anesthetics|mesh-ancestor
102049251|NCT02721069|GABA Modulators|gaba modulators|mesh-ancestor
102049252|NCT02721069|GABA Agents|gaba agents|mesh-ancestor
102049253|NCT02721069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102049254|NCT02721069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049255|NCT02093000|Bevacizumab|bevacizumab|mesh-list
102049256|NCT02093000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102049257|NCT02093000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102049258|NCT02093000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102049259|NCT02093000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102049260|NCT02093000|Growth Substances|growth substances|mesh-ancestor
102049261|NCT02093000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049262|NCT02093000|Growth Inhibitors|growth inhibitors|mesh-ancestor
102049263|NCT00261807|Daptomycin|daptomycin|mesh-list
102049264|NCT00261807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102049265|NCT00261807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102049266|NCT02090504|Sodium Oxybate|sodium oxybate|mesh-list
102049267|NCT02090504|Oxazepam|oxazepam|mesh-list
102049268|NCT02090504|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102049269|NCT02090504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102049270|NCT02090504|Anesthetics, General|anesthetics, general|mesh-ancestor
101941958|NCT01229241|Sensory System Agents|sensory system agents|mesh-ancestor
101941959|NCT01229241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101941960|NCT05252884|Calcium, Dietary|calcium, dietary|mesh-list
102049271|NCT02090504|Anesthetics|anesthetics|mesh-ancestor
102049272|NCT02090504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101261384|NCT01749475|Midazolam|midazolam|mesh-list
102049273|NCT02090504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049274|NCT02090504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102049275|NCT02090504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102049276|NCT02090504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102049277|NCT02090504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102049278|NCT02090504|GABA Modulators|gaba modulators|mesh-ancestor
102049279|NCT02090504|GABA Agents|gaba agents|mesh-ancestor
102049280|NCT02090504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102049281|NCT02090504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049282|NCT01567059|Cytarabine|cytarabine|mesh-list
102049283|NCT01567059|Decitabine|decitabine|mesh-list
102049284|NCT01567059|Azacitidine|azacitidine|mesh-list
102049285|NCT01567059|Tosedostat|tosedostat|mesh-list
102049286|NCT01567059|Glycine|glycine|mesh-list
102049287|NCT01567059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102049288|NCT01567059|Antimetabolites|antimetabolites|mesh-ancestor
102049289|NCT01567059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049290|NCT01567059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102049291|NCT01567059|Antiviral Agents|antiviral agents|mesh-ancestor
102049292|NCT01567059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102049294|NCT01567059|Immunologic Factors|immunologic factors|mesh-ancestor
102049295|NCT01567059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049296|NCT01567059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102049298|NCT01567059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102049299|NCT02090738|Amoxicillin|amoxicillin|mesh-list
102049300|NCT02090738|Clarithromycin|clarithromycin|mesh-list
102049301|NCT02090738|Acetazolamide|acetazolamide|mesh-list
102049302|NCT02090738|Esomeprazole|esomeprazole|mesh-list
102049303|NCT02090738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102049304|NCT02090738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102049305|NCT02090738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102049306|NCT02090738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102049307|NCT02090738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102049308|NCT02090738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102049309|NCT02090738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049310|NCT02090738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102049311|NCT02090738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102049312|NCT02090738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102049313|NCT02090738|Anticonvulsants|anticonvulsants|mesh-ancestor
102049314|NCT02090738|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102049315|NCT02090738|Diuretics|diuretics|mesh-ancestor
102049316|NCT02090738|Natriuretic Agents|natriuretic agents|mesh-ancestor
102049317|NCT02090738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049318|NCT02096510|Hydrocortisone|hydrocortisone|mesh-list
102049319|NCT02096510|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102049320|NCT02096510|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102049321|NCT02096510|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102049322|NCT02096510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102049323|NCT03441555|Venetoclax|venetoclax|mesh-list
102049324|NCT03441555|Alvocidib|alvocidib|mesh-list
102049325|NCT03441555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102049326|NCT03441555|Growth Inhibitors|growth inhibitors|mesh-ancestor
102049327|NCT03441555|Growth Substances|growth substances|mesh-ancestor
102049328|NCT03441555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049329|NCT03441555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102049330|NCT03441555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102049331|NCT03441555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049332|NCT02093780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102049333|NCT03346239|Escitalopram|escitalopram|mesh-list
102049334|NCT03346239|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102049335|NCT03346239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102049336|NCT03346239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102049337|NCT03346239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049338|NCT03346239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102049339|NCT03346239|Serotonin Agents|serotonin agents|mesh-ancestor
102049340|NCT03346239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049341|NCT05218161|Dexmedetomidine|dexmedetomidine|mesh-list
102049342|NCT05218161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101941961|NCT05252884|Calcitriol|calcitriol|mesh-list
101941962|NCT05252884|Calcium Carbonate|calcium carbonate|mesh-list
101941963|NCT05252884|Calcium|calcium|mesh-list
101941964|NCT05252884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102049343|NCT05218161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102049344|NCT05218161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049345|NCT05218161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102049346|NCT05218161|Analgesics|analgesics|mesh-ancestor
102049347|NCT05218161|Sensory System Agents|sensory system agents|mesh-ancestor
102049348|NCT05218161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102049349|NCT05218161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102049350|NCT05218161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102049351|NCT05218161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102049352|NCT05218161|Adrenergic Agents|adrenergic agents|mesh-ancestor
102049353|NCT05218161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102049354|NCT05218161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049355|NCT02861586|Vaccines|vaccines|mesh-list
102049356|NCT02861586|Immunologic Factors|immunologic factors|mesh-ancestor
102049357|NCT02861586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049358|NCT02099240|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102049359|NCT02099240|Amoxicillin|amoxicillin|mesh-list
102049360|NCT02099240|Azithromycin|azithromycin|mesh-list
102049361|NCT02099240|Moxifloxacin|moxifloxacin|mesh-list
102049362|NCT02099240|Vancomycin|vancomycin|mesh-list
102049363|NCT02099240|Clarithromycin|clarithromycin|mesh-list
102049364|NCT02099240|Doxycycline|doxycycline|mesh-list
102049365|NCT02099240|Ciprofloxacin|ciprofloxacin|mesh-list
102049366|NCT02099240|Levofloxacin|levofloxacin|mesh-list
102049367|NCT02099240|Ofloxacin|ofloxacin|mesh-list
102049376|NCT02099240|Ceftriaxone|ceftriaxone|mesh-list
102049377|NCT02099240|Tazobactam|tazobactam|mesh-list
102049378|NCT02099240|Linezolid|linezolid|mesh-list
102049379|NCT02099240|Cycloserine|cycloserine|mesh-list
102049380|NCT02099240|Piperacillin|piperacillin|mesh-list
102049381|NCT02099240|Metronidazole|metronidazole|mesh-list
102049382|NCT02099240|Penicillins|penicillins|mesh-list
102049383|NCT02099240|Imipenem|imipenem|mesh-list
102049384|NCT02099240|Amikacin|amikacin|mesh-list
102049385|NCT02099240|Pyrazinamide|pyrazinamide|mesh-list
102049386|NCT02099240|Erythromycin|erythromycin|mesh-list
102049387|NCT02099240|Erythromycin Estolate|erythromycin estolate|mesh-list
102049388|NCT02099240|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
102049389|NCT02099240|Erythromycin stearate|erythromycin stearate|mesh-list
102049390|NCT02099240|Ceftazidime|ceftazidime|mesh-list
102049391|NCT02099240|Colistin|colistin|mesh-list
102049392|NCT02099240|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102049393|NCT02099240|Clavulanic Acids|clavulanic acids|mesh-list
102049394|NCT02099240|Clavulanic Acid|clavulanic acid|mesh-list
102049395|NCT02099240|Ampicillin|ampicillin|mesh-list
102049396|NCT02099240|Mupirocin|mupirocin|mesh-list
102049397|NCT02099240|Rifabutin|rifabutin|mesh-list
102049398|NCT02099240|Cefepime|cefepime|mesh-list
102049399|NCT02099240|Rifapentine|rifapentine|mesh-list
102049400|NCT02099240|Cefuroxime|cefuroxime|mesh-list
102049401|NCT02099240|Cefuroxime axetil|cefuroxime axetil|mesh-list
102049402|NCT02099240|Fosfomycin|fosfomycin|mesh-list
102049403|NCT02099240|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102049404|NCT02099240|Paromomycin|paromomycin|mesh-list
102049405|NCT02099240|Nitrofurantoin|nitrofurantoin|mesh-list
102049406|NCT02099240|Aztreonam|aztreonam|mesh-list
102049407|NCT02099240|Polymyxins|polymyxins|mesh-list
102049408|NCT02099240|Neomycin|neomycin|mesh-list
102049409|NCT02099240|Bacitracin|bacitracin|mesh-list
102049410|NCT02099240|Sulbactam|sulbactam|mesh-list
102049411|NCT02099240|Cefotaxime|cefotaxime|mesh-list
102049412|NCT02099240|Cefoxitin|cefoxitin|mesh-list
102049413|NCT02099240|Gatifloxacin|gatifloxacin|mesh-list
102049414|NCT02099240|Sulfadiazine|sulfadiazine|mesh-list
102049415|NCT02099240|Polymyxin B|polymyxin b|mesh-list
102049416|NCT02099240|Cefixime|cefixime|mesh-list
102049417|NCT02099240|Cefdinir|cefdinir|mesh-list
102049418|NCT02099240|Penicillin G|penicillin g|mesh-list
101697280|NCT00649454|Metformin|metformin|mesh-list
102049419|NCT02099240|Penicillin G Benzathine|penicillin g benzathine|mesh-list
102049420|NCT02099240|Penicillin G Procaine|penicillin g procaine|mesh-list
102049421|NCT02099240|Norfloxacin|norfloxacin|mesh-list
102049422|NCT02099240|Cloxacillin|cloxacillin|mesh-list
102049423|NCT02099240|Cefprozil|cefprozil|mesh-list
102049424|NCT02099240|Cephalosporins|cephalosporins|mesh-list
102049425|NCT02099240|Oxacillin|oxacillin|mesh-list
102049426|NCT02099240|Nafcillin|nafcillin|mesh-list
102049427|NCT02099240|Streptomycin|streptomycin|mesh-list
102049428|NCT02099240|Methenamine hippurate|methenamine hippurate|mesh-list
102049429|NCT02099240|Methenamine mandelate|methenamine mandelate|mesh-list
102049430|NCT02099240|Ticarcillin|ticarcillin|mesh-list
102049431|NCT02099240|Dicloxacillin|dicloxacillin|mesh-list
101941965|NCT05252884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941966|NCT05252884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101941968|NCT05252884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049432|NCT02099240|Sultamicillin|sultamicillin|mesh-list
102049433|NCT02099240|Cefpodoxime|cefpodoxime|mesh-list
102049434|NCT02099240|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
102049435|NCT02099240|Ceftizoxime|ceftizoxime|mesh-list
102049436|NCT02099240|Ethionamide|ethionamide|mesh-list
102049437|NCT02099240|Cefoperazone|cefoperazone|mesh-list
102049438|NCT02099240|Kanamycin|kanamycin|mesh-list
102049439|NCT02099240|Penicillin V|penicillin v|mesh-list
102049440|NCT02099240|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
102049441|NCT02099240|Ceftibuten|ceftibuten|mesh-list
102049442|NCT02099240|Lincomycin|lincomycin|mesh-list
102049443|NCT02099240|Cefotetan|cefotetan|mesh-list
102049444|NCT02099240|Dirithromycin|dirithromycin|mesh-list
102049445|NCT02099240|Cefaclor|cefaclor|mesh-list
102049446|NCT02099240|Demeclocycline|demeclocycline|mesh-list
102049447|NCT02099240|Tobramycin|tobramycin|mesh-list
102049448|NCT02099240|Capreomycin|capreomycin|mesh-list
102049449|NCT02099240|Mafenide|mafenide|mesh-list
102049450|NCT02099240|Chloramphenicol|chloramphenicol|mesh-list
102049451|NCT02099240|Chloramphenicol succinate|chloramphenicol succinate|mesh-list
102049452|NCT02099240|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
102049453|NCT02099240|Oxytetracycline|oxytetracycline|mesh-list
102049460|NCT02099240|Methicillin|methicillin|mesh-list
102049461|NCT02099240|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102049462|NCT02099240|Spectinomycin|spectinomycin|mesh-list
102049463|NCT02099240|Dalfopristin|dalfopristin|mesh-list
102049464|NCT02099240|Chlortetracycline|chlortetracycline|mesh-list
102049465|NCT02099240|Tetracycline|tetracycline|mesh-list
102049466|NCT02099240|Methacycline|methacycline|mesh-list
102049467|NCT02099240|Sparfloxacin|sparfloxacin|mesh-list
102049468|NCT02099240|Fluoroquinolones|fluoroquinolones|mesh-list
102049469|NCT02099240|Nalidixic Acid|nalidixic acid|mesh-list
102049470|NCT02099240|Lomefloxacin|lomefloxacin|mesh-list
102049471|NCT02099240|Grepafloxacin|grepafloxacin|mesh-list
102049473|NCT02099240|Cefmetazole|cefmetazole|mesh-list
102049474|NCT02099240|Cefonicid|cefonicid|mesh-list
102049475|NCT02099240|Cefamandole nafate|cefamandole nafate|mesh-list
102049476|NCT02099240|Cefamandole|cefamandole|mesh-list
102049477|NCT02099240|Benzathine benzylpenicillin, procaine benzylpenicillin, drug combination|benzathine benzylpenicillin, procaine benzylpenicillin, drug combination|mesh-list
102049478|NCT02099240|Mezlocillin|mezlocillin|mesh-list
102049479|NCT02099240|Carbenicillin indanyl|carbenicillin indanyl|mesh-list
102049480|NCT02099240|Carbenicillin|carbenicillin|mesh-list
102049481|NCT02099240|Bacampicillin|bacampicillin|mesh-list
102049482|NCT02099240|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102049483|NCT02099240|Sulfamethoxazole|sulfamethoxazole|mesh-list
102049484|NCT02099240|Sulfasalazine|sulfasalazine|mesh-list
102049485|NCT02099240|Silver Sulfadiazine|silver sulfadiazine|mesh-list
102049486|NCT02099240|Methenamine|methenamine|mesh-list
102049487|NCT02099240|Sulperazone|sulperazone|mesh-list
102049488|NCT02099240|Sulfisoxazole|sulfisoxazole|mesh-list
102049489|NCT02099240|Cinoxacin|cinoxacin|mesh-list
102049490|NCT02099240|Trimethoprim|trimethoprim|mesh-list
102049491|NCT02099240|Nitrofurazone|nitrofurazone|mesh-list
102049492|NCT02099240|Sulfamethizole|sulfamethizole|mesh-list
102049493|NCT02099240|Procaine|procaine|mesh-list
102049494|NCT02099240|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102049495|NCT02099240|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102049496|NCT02099240|Cilastatin|cilastatin|mesh-list
102049497|NCT02099240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102049498|NCT02099240|Antitubercular Agents|antitubercular agents|mesh-ancestor
102049499|NCT02099240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102049500|NCT02099240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102049501|NCT02099240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102049502|NCT02099240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049503|NCT02099240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102049504|NCT02099240|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102049505|NCT02099240|Contraceptive Agents|contraceptive agents|mesh-ancestor
102049506|NCT02099240|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102049507|NCT02099240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049508|NCT02099240|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102049509|NCT02099240|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102049510|NCT02099240|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102049511|NCT02099240|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102049512|NCT02099240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101941970|NCT05252884|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101941971|NCT05252884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101941972|NCT05252884|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101941973|NCT05252884|Vitamins|vitamins|mesh-ancestor
102049513|NCT02099240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102049514|NCT02099240|Antimalarials|antimalarials|mesh-ancestor
102049515|NCT02099240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102049516|NCT02099240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102049517|NCT02099240|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102049518|NCT02099240|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102049519|NCT02099240|Leprostatic Agents|leprostatic agents|mesh-ancestor
102049520|NCT02099240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102049521|NCT02099240|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102049522|NCT02099240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102049523|NCT02099240|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102049524|NCT02099240|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102049525|NCT02099240|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102049526|NCT02099240|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102049527|NCT02099240|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102049543|NCT02099240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102049544|NCT02099240|Coccidiostats|coccidiostats|mesh-ancestor
102049545|NCT02099240|Anesthetics, Local|anesthetics, local|mesh-ancestor
102049546|NCT02099240|Anesthetics|anesthetics|mesh-ancestor
102049547|NCT02099240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102049548|NCT02099240|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102049549|NCT02099240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102049550|NCT02099240|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102049551|NCT02099240|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102049552|NCT02099240|Dermatologic Agents|dermatologic agents|mesh-ancestor
102049553|NCT02245230|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
102049554|NCT02245230|Trimethaphan|trimethaphan|mesh-list
102049555|NCT02245230|Phenylephrine|phenylephrine|mesh-list
102049556|NCT02245230|Oxymetazoline|oxymetazoline|mesh-list
102049557|NCT02245230|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
102049558|NCT02245230|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102049559|NCT02245230|Mydriatics|mydriatics|mesh-ancestor
102049560|NCT02245230|Autonomic Agents|autonomic agents|mesh-ancestor
102049561|NCT02245230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102049562|NCT02245230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049563|NCT02245230|Sympathomimetics|sympathomimetics|mesh-ancestor
102049564|NCT02245230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102049565|NCT02245230|Nasal Decongestants|nasal decongestants|mesh-ancestor
102049566|NCT02245230|Respiratory System Agents|respiratory system agents|mesh-ancestor
102049567|NCT02245230|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102049568|NCT02245230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102049569|NCT02245230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102049570|NCT02245230|Adrenergic Agents|adrenergic agents|mesh-ancestor
102049571|NCT02245230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102049572|NCT02245230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049573|NCT02245230|Protective Agents|protective agents|mesh-ancestor
102049574|NCT02245230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102049575|NCT02245230|Vasodilator Agents|vasodilator agents|mesh-ancestor
102049576|NCT02245230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102049577|NCT02245230|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
102049578|NCT02245230|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102049579|NCT02245230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102049580|NCT02245230|Cholinergic Agents|cholinergic agents|mesh-ancestor
102049581|NCT05215743|Acetylcysteine|acetylcysteine|mesh-list
102049582|NCT05215743|Antioxidants|antioxidants|mesh-list
102049583|NCT05215743|Deferoxamine|deferoxamine|mesh-list
102049584|NCT05215743|Antiviral Agents|antiviral agents|mesh-ancestor
102049585|NCT05215743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102049586|NCT05215743|Expectorants|expectorants|mesh-ancestor
102049587|NCT05215743|Respiratory System Agents|respiratory system agents|mesh-ancestor
102049588|NCT05215743|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102049589|NCT05215743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049590|NCT05215743|Protective Agents|protective agents|mesh-ancestor
102049595|NCT05215743|Sequestering Agents|sequestering agents|mesh-ancestor
102049596|NCT02099396|Gemcitabine|gemcitabine|mesh-list
102049597|NCT02099396|Docetaxel|docetaxel|mesh-list
101941974|NCT05252884|Micronutrients|micronutrients|mesh-ancestor
101941975|NCT03921177|Micronutrients|micronutrients|mesh-list
101941976|NCT03921177|Trace Elements|trace elements|mesh-list
101941977|NCT03921177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941978|NCT01229319|Imiquimod|imiquimod|mesh-list
101941979|NCT01229319|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101941980|NCT01229319|Immunologic Factors|immunologic factors|mesh-ancestor
102049598|NCT02099396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102049599|NCT02099396|Antimetabolites|antimetabolites|mesh-ancestor
102049600|NCT02099396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049601|NCT02099396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102049602|NCT02099396|Tubulin Modulators|tubulin modulators|mesh-ancestor
102049603|NCT02099396|Antimitotic Agents|antimitotic agents|mesh-ancestor
102049604|NCT02099396|Mitosis Modulators|mitosis modulators|mesh-ancestor
102049605|NCT05215665|Lenvatinib|lenvatinib|mesh-list
102049606|NCT05215665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102049607|NCT05215665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102049608|NCT05215665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102049609|NCT05215665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049610|NCT02099474|Raltegravir Potassium|raltegravir potassium|mesh-list
102049611|NCT02099474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102049613|NCT02099474|Antiviral Agents|antiviral agents|mesh-ancestor
102049614|NCT02099474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102049615|NCT02099474|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102049616|NCT02099474|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102049617|NCT02099474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102049618|NCT02099474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049619|NCT05217069|Leucovorin|leucovorin|mesh-list
102049620|NCT05217069|Folic Acid|folic acid|mesh-list
102049621|NCT05217069|Irinotecan|irinotecan|mesh-list
102049622|NCT05217069|Cetuximab|cetuximab|mesh-list
102049623|NCT05217069|Avelumab|avelumab|mesh-list
102049624|NCT05217069|Levoleucovorin|levoleucovorin|mesh-list
102049625|NCT05217069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102049626|NCT05217069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102049627|NCT05217069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102049628|NCT05217069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049629|NCT05217069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102049630|NCT05217069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102049631|NCT05217069|Antidotes|antidotes|mesh-ancestor
102049632|NCT05217069|Protective Agents|protective agents|mesh-ancestor
102049633|NCT05217069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049634|NCT05217069|Vitamin B Complex|vitamin b complex|mesh-ancestor
102049635|NCT05217069|Vitamins|vitamins|mesh-ancestor
102049636|NCT05217069|Micronutrients|micronutrients|mesh-ancestor
102049637|NCT05217069|Hematinics|hematinics|mesh-ancestor
102049638|NCT02065635|Propofol|propofol|mesh-list
102049639|NCT02065635|Sevoflurane|sevoflurane|mesh-list
102049640|NCT02065635|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102049641|NCT02065635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102049642|NCT02065635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049643|NCT02065635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102049644|NCT02065635|Anesthetics, General|anesthetics, general|mesh-ancestor
102049645|NCT02065635|Anesthetics|anesthetics|mesh-ancestor
102049646|NCT02065635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102049647|NCT02065635|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102049648|NCT03628053|Blinatumomab|blinatumomab|mesh-list
102049649|NCT03628053|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
102049650|NCT03628053|Tisagenlecleucel|tisagenlecleucel|mesh-list
102049651|NCT03628053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102049652|NCT03628053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102049653|NCT03628053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102049654|NCT03628053|Immunotoxins|immunotoxins|mesh-ancestor
102049655|NCT03628053|Immunoconjugates|immunoconjugates|mesh-ancestor
102049656|NCT03628053|Immunologic Factors|immunologic factors|mesh-ancestor
102049657|NCT03628053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049658|NCT02100176|Dopamine|dopamine|mesh-list
102049659|NCT02100176|Rotigotine|rotigotine|mesh-list
102049660|NCT02100176|Dopamine Agonists|dopamine agonists|mesh-list
102049661|NCT02100176|Dopamine Agents|dopamine agents|mesh-ancestor
102049662|NCT02100176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102049663|NCT02100176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941981|NCT01229319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941982|NCT01229319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101941983|NCT01229319|Interferon Inducers|interferon inducers|mesh-ancestor
101941984|NCT03921099|Ascorbic Acid|ascorbic acid|mesh-list
101941985|NCT03921099|Vitamins|vitamins|mesh-ancestor
102049664|NCT02100176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049665|NCT02100176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102049666|NCT02100176|Sympathomimetics|sympathomimetics|mesh-ancestor
102049672|NCT05189145|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102049673|NCT05189145|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102049674|NCT05189145|Hormones|hormones|mesh-list
102049675|NCT05189145|Estradiol|estradiol|mesh-list
102049676|NCT05189145|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102049677|NCT05189145|Progesterone|progesterone|mesh-list
102049678|NCT05189145|Dydrogesterone|dydrogesterone|mesh-list
102049679|NCT05189145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102049680|NCT05189145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049681|NCT05189145|Estrogens|estrogens|mesh-ancestor
102049682|NCT05189145|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102049683|NCT05189145|Contraceptive Agents|contraceptive agents|mesh-ancestor
102049684|NCT05189145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102049685|NCT05189145|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102049686|NCT05189145|Progestins|progestins|mesh-ancestor
102049687|NCT04967079|Trametinib|trametinib|mesh-list
102049688|NCT04967079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102049689|NCT04967079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102049690|NCT04967079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102049691|NCT04967079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049692|NCT03556592|Metoprolol|metoprolol|mesh-list
102049693|NCT03556592|Midazolam|midazolam|mesh-list
102049694|NCT03556592|Caffeine|caffeine|mesh-list
102049695|NCT03556592|Omeprazole|omeprazole|mesh-list
102049696|NCT03556592|Warfarin|warfarin|mesh-list
102049697|NCT03556592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102049698|NCT03556592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102049699|NCT03556592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102049700|NCT03556592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049701|NCT03556592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102049702|NCT03556592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102049703|NCT03556592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102049704|NCT03556592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102049705|NCT03556592|Anesthetics, General|anesthetics, general|mesh-ancestor
102049706|NCT03556592|Anesthetics|anesthetics|mesh-ancestor
102049707|NCT03556592|GABA Modulators|gaba modulators|mesh-ancestor
102049708|NCT03556592|GABA Agents|gaba agents|mesh-ancestor
102049709|NCT03556592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102049710|NCT03556592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049711|NCT03556592|Anticoagulants|anticoagulants|mesh-ancestor
102049712|NCT03556592|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102049713|NCT03556592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102049714|NCT03556592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102049715|NCT03556592|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102049716|NCT03556592|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102049717|NCT03556592|Purinergic Agents|purinergic agents|mesh-ancestor
102049718|NCT03556592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102049719|NCT03556592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102049720|NCT03556592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102049721|NCT03556592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102049722|NCT03556592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102049723|NCT03556592|Sympatholytics|sympatholytics|mesh-ancestor
102049724|NCT03556592|Autonomic Agents|autonomic agents|mesh-ancestor
102049725|NCT03556592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102049726|NCT03556592|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102049727|NCT03556592|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102049728|NCT03556592|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102049729|NCT03556592|Adrenergic Agents|adrenergic agents|mesh-ancestor
102049730|NCT04964193|Cyproterone Acetate|cyproterone acetate|mesh-list
102049731|NCT04964193|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102049732|NCT04964193|Cyproterone|cyproterone|mesh-list
102049733|NCT04964193|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
102049734|NCT04964193|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102049735|NCT04964193|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101941986|NCT03921099|Micronutrients|micronutrients|mesh-ancestor
101941987|NCT03921099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941988|NCT03921099|Antioxidants|antioxidants|mesh-ancestor
101941989|NCT03921099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306965|NCT02028819|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102049736|NCT04964193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102049737|NCT04964193|Contraceptive Agents|contraceptive agents|mesh-ancestor
102049738|NCT04964193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101351166|NCT05637606|Etilefrine|etilefrine|mesh-list
102049755|NCT02095418|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102049756|NCT02095418|Antitubercular Agents|antitubercular agents|mesh-ancestor
102049757|NCT02095418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102049758|NCT02095418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102049759|NCT02095418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101697327|NCT02766803|Protective Agents|protective agents|mesh-ancestor
102049760|NCT02095418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049762|NCT04865497|Immunologic Factors|immunologic factors|mesh-ancestor
102049763|NCT04865497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049764|NCT05665725|Siltuximab|siltuximab|mesh-list
102049765|NCT05665725|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102049766|NCT05665725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102049767|NCT05665725|Immunologic Factors|immunologic factors|mesh-ancestor
102049768|NCT05665725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049769|NCT02098148|Xenon|xenon|mesh-list
102049770|NCT02098148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102049771|NCT02098148|Anesthetics, General|anesthetics, general|mesh-ancestor
102049772|NCT02098148|Anesthetics|anesthetics|mesh-ancestor
102049773|NCT02098148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102049774|NCT02098148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049775|NCT05168527|Paclitaxel|paclitaxel|mesh-list
102049776|NCT05168527|Gemcitabine|gemcitabine|mesh-list
102049777|NCT05168527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102049778|NCT05168527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102049779|NCT05168527|Tubulin Modulators|tubulin modulators|mesh-ancestor
102049780|NCT05168527|Antimitotic Agents|antimitotic agents|mesh-ancestor
102049781|NCT05168527|Mitosis Modulators|mitosis modulators|mesh-ancestor
102049782|NCT05168527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049783|NCT05168527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102049784|NCT05168527|Antimetabolites|antimetabolites|mesh-ancestor
102049785|NCT02098460|Cilostazol|cilostazol|mesh-list
102049786|NCT02098460|Atorvastatin|atorvastatin|mesh-list
102049787|NCT02098460|Probucol|probucol|mesh-list
102049788|NCT02098460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102049789|NCT02098460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102049790|NCT02098460|Antimetabolites|antimetabolites|mesh-ancestor
102049791|NCT02098460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049792|NCT02098460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102049793|NCT02098460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102049794|NCT02098460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102049795|NCT02098460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102049796|NCT02098460|Autonomic Agents|autonomic agents|mesh-ancestor
102049797|NCT02098460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102049802|NCT02098460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102049803|NCT02098460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102049804|NCT02098460|Vasodilator Agents|vasodilator agents|mesh-ancestor
102049805|NCT02098460|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102049806|NCT02098460|Protective Agents|protective agents|mesh-ancestor
102049807|NCT02098460|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102049808|NCT02098460|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102049809|NCT02098460|Antioxidants|antioxidants|mesh-ancestor
102049810|NCT02095574|Venetoclax|venetoclax|mesh-list
102049811|NCT02095574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102049814|NCT02095730|Vitamins|vitamins|mesh-list
102049815|NCT02095730|Riboflavin|riboflavin|mesh-list
102049816|NCT02095730|Vitamin B Complex|vitamin b complex|mesh-list
102049817|NCT02095730|Micronutrients|micronutrients|mesh-ancestor
102049818|NCT02095730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049819|NCT02095730|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102049820|NCT02095730|Dermatologic Agents|dermatologic agents|mesh-ancestor
102049821|NCT02102438|Paclitaxel|paclitaxel|mesh-list
102049822|NCT02102438|Carboplatin|carboplatin|mesh-list
102049823|NCT02102438|Trastuzumab|trastuzumab|mesh-list
102049824|NCT02102438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101941990|NCT03921099|Protective Agents|protective agents|mesh-ancestor
101941991|NCT02962648|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
101941992|NCT02962648|Hematinics|hematinics|mesh-ancestor
102049825|NCT02102438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102049826|NCT02102438|Tubulin Modulators|tubulin modulators|mesh-ancestor
102049827|NCT02102438|Antimitotic Agents|antimitotic agents|mesh-ancestor
102049828|NCT02102438|Mitosis Modulators|mitosis modulators|mesh-ancestor
102049829|NCT02102438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049830|NCT02102438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102049831|NCT02098616|Asunaprevir|asunaprevir|mesh-list
102049832|NCT02098616|Protease Inhibitors|protease inhibitors|mesh-ancestor
102049833|NCT02098616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102049834|NCT02098616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049835|NCT02102516|Ketorolac|ketorolac|mesh-list
102049836|NCT02102516|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102049837|NCT02102516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102049838|NCT02102516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102049839|NCT02102516|Analgesics|analgesics|mesh-ancestor
102049840|NCT02102516|Sensory System Agents|sensory system agents|mesh-ancestor
102049841|NCT02102516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102049842|NCT02102516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049843|NCT02102516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102049844|NCT02102516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102049845|NCT02102516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102049846|NCT02102516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102049847|NCT02102516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049848|NCT02106182|Silodosin|silodosin|mesh-list
102049849|NCT02106182|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102049850|NCT02106182|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102049851|NCT02106182|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102049852|NCT02106182|Adrenergic Agents|adrenergic agents|mesh-ancestor
102049853|NCT02106182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102049854|NCT02106182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049855|NCT02106182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049856|NCT02106182|Urological Agents|urological agents|mesh-ancestor
102049857|NCT01369693|Lobeline|lobeline|mesh-list
102049858|NCT01369693|Nicotine|nicotine|mesh-list
102049859|NCT01369693|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102049860|NCT01369693|Autonomic Agents|autonomic agents|mesh-ancestor
102049861|NCT01369693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102049862|NCT01369693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049863|NCT01369693|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102049864|NCT01369693|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102049865|NCT01369693|Cholinergic Agents|cholinergic agents|mesh-ancestor
102049866|NCT01369693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102049867|NCT01369693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049868|NCT01369693|Respiratory System Agents|respiratory system agents|mesh-ancestor
102049869|NCT02102594|Bortezomib|bortezomib|mesh-list
102049870|NCT02102594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102049871|NCT02102672|Trimetazidine|trimetazidine|mesh-list
102049891|NCT03121261|Anesthetics, Local|anesthetics, local|mesh-ancestor
102049892|NCT03121261|Anesthetics|anesthetics|mesh-ancestor
102049893|NCT03121261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102049894|NCT04249323|Prednisone|prednisone|mesh-list
102049895|NCT04249323|Cortisone|cortisone|mesh-list
102049896|NCT04249323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102049897|NCT04249323|Glucocorticoids|glucocorticoids|mesh-ancestor
102049898|NCT04249323|Hormones|hormones|mesh-ancestor
102049899|NCT04249323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102049900|NCT04249323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049901|NCT04249323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102049902|NCT04249323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102049903|NCT04227327|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102049904|NCT04227327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102049905|NCT04227327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102049906|NCT04227327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049907|NCT04227327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102049908|NCT04227327|Hormone Antagonists|hormone antagonists|mesh-ancestor
102049909|NCT04227327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102049910|NCT04227327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049911|NCT02102828|Aspirin|aspirin|mesh-list
101941994|NCT03920631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101941995|NCT03920631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102049912|NCT02102828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102049913|NCT02102828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102049914|NCT02102828|Analgesics|analgesics|mesh-ancestor
102049915|NCT02102828|Sensory System Agents|sensory system agents|mesh-ancestor
102049916|NCT02102828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102049917|NCT02102828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049918|NCT02102828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102049919|NCT02102828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102049920|NCT02102828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102049921|NCT02102828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102049922|NCT02102828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049923|NCT02102828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102049924|NCT02102828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101697408|NCT02655614|Midazolam|midazolam|mesh-list
102049925|NCT02102828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102049926|NCT02102828|Antipyretics|antipyretics|mesh-ancestor
102049927|NCT01372423|Lubiprostone|lubiprostone|mesh-list
102049934|NCT02106650|Hydroxocobalamin|hydroxocobalamin|mesh-list
102049936|NCT02106650|Micronutrients|micronutrients|mesh-ancestor
102049937|NCT02106650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049938|NCT02106650|Antidotes|antidotes|mesh-ancestor
102049939|NCT02106650|Protective Agents|protective agents|mesh-ancestor
102049940|NCT02106650|Vitamin B Complex|vitamin b complex|mesh-ancestor
102049941|NCT02106650|Hematinics|hematinics|mesh-ancestor
102049942|NCT05221437|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102049943|NCT05221437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102049944|NCT01376011|Quercetin|quercetin|mesh-list
102049945|NCT01376011|Antioxidants|antioxidants|mesh-ancestor
102049946|NCT01376011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049947|NCT01376011|Protective Agents|protective agents|mesh-ancestor
102049948|NCT01376011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049949|NCT04033107|Ascorbic Acid|ascorbic acid|mesh-list
102049950|NCT04033107|Metformin|metformin|mesh-list
102049951|NCT04033107|Vitamins|vitamins|mesh-ancestor
102049952|NCT04033107|Micronutrients|micronutrients|mesh-ancestor
102049953|NCT04033107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049954|NCT04033107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102049955|NCT04033107|Antioxidants|antioxidants|mesh-ancestor
102049956|NCT04033107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049957|NCT04033107|Protective Agents|protective agents|mesh-ancestor
102049958|NCT02106806|Zinc|zinc|mesh-list
102049959|NCT02106806|Zinc Sulfate|zinc sulfate|mesh-list
102049960|NCT02106806|Trace Elements|trace elements|mesh-ancestor
102049961|NCT02106806|Micronutrients|micronutrients|mesh-ancestor
102049962|NCT02106806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049963|NCT02106806|Astringents|astringents|mesh-ancestor
102049964|NCT02106806|Dermatologic Agents|dermatologic agents|mesh-ancestor
102049965|NCT02966119|Aspirin|aspirin|mesh-list
102049966|NCT02966119|Clopidogrel|clopidogrel|mesh-list
102049967|NCT02966119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102049968|NCT02966119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102049969|NCT02966119|Analgesics|analgesics|mesh-ancestor
102049970|NCT02966119|Sensory System Agents|sensory system agents|mesh-ancestor
102049971|NCT02966119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102049972|NCT02966119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049973|NCT02966119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102049974|NCT02966119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102049975|NCT02966119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102049976|NCT02966119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102049977|NCT02966119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049978|NCT02966119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102049979|NCT02966119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102049980|NCT02966119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102049981|NCT02966119|Antipyretics|antipyretics|mesh-ancestor
102049982|NCT02966119|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102049983|NCT02966119|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102049984|NCT02966119|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102049985|NCT02966119|Purinergic Agents|purinergic agents|mesh-ancestor
102049986|NCT02966119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102049987|NCT02101892|Amitriptyline|amitriptyline|mesh-list
102049988|NCT02101892|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102049989|NCT02101892|Antidepressive Agents|antidepressive agents|mesh-ancestor
101941997|NCT03920631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941998|NCT03930069|Vasopressins|vasopressins|mesh-list
101941999|NCT03930069|Arginine Vasopressin|arginine vasopressin|mesh-list
101942000|NCT03930069|Misoprostol|misoprostol|mesh-list
102049990|NCT02101892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102049991|NCT02101892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102049992|NCT02101892|Analgesics|analgesics|mesh-ancestor
102049993|NCT02101892|Sensory System Agents|sensory system agents|mesh-ancestor
101697430|NCT02655614|Purinergic Agents|purinergic agents|mesh-ancestor
102049994|NCT02101892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102049995|NCT02101892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049996|NCT02101892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102049997|NCT02101892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102049998|NCT02101892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102050002|NCT03634111|Morphine|morphine|mesh-list
102050003|NCT03634111|Ropivacaine|ropivacaine|mesh-list
102050004|NCT03634111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102050005|NCT03634111|Narcotics|narcotics|mesh-ancestor
102050006|NCT03634111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102050007|NCT03634111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050008|NCT03634111|Analgesics|analgesics|mesh-ancestor
102050009|NCT03634111|Sensory System Agents|sensory system agents|mesh-ancestor
102050010|NCT03634111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102050011|NCT03634111|Anesthetics, Local|anesthetics, local|mesh-ancestor
102050012|NCT03634111|Anesthetics|anesthetics|mesh-ancestor
102050013|NCT02102048|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102050014|NCT02102048|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102050015|NCT02102048|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102050016|NCT02102048|Protease Inhibitors|protease inhibitors|mesh-ancestor
102050017|NCT02102048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102050018|NCT02102048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050019|NCT02102048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102050020|NCT02102048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102050021|NCT02102048|Antiviral Agents|antiviral agents|mesh-ancestor
102050022|NCT02102048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102050023|NCT03118297|Ulipristal acetate|ulipristal acetate|mesh-list
102050024|NCT03118297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102050025|NCT03118297|Contraceptive Agents|contraceptive agents|mesh-ancestor
102050026|NCT03118297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102050027|NCT03118297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050028|NCT03118297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102050029|NCT02250794|Insulin|insulin|mesh-list
102050030|NCT02250794|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102050031|NCT02250794|Metformin|metformin|mesh-list
102050032|NCT02250794|Insulin Glargine|insulin glargine|mesh-list
102050033|NCT02250794|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102050034|NCT02250794|Insulin Lispro|insulin lispro|mesh-list
102050035|NCT02250794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102050036|NCT02250794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050037|NCT02250794|Incretins|incretins|mesh-ancestor
102050038|NCT02250794|Hormones|hormones|mesh-ancestor
102050039|NCT02250794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102050040|NCT02250794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102050041|NCT02250794|Protease Inhibitors|protease inhibitors|mesh-ancestor
102050042|NCT02250794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102050043|NCT02250794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050044|NCT02103374|Terbutaline|terbutaline|mesh-list
102050045|NCT02103374|Ipratropium|ipratropium|mesh-list
102050046|NCT02103374|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102050047|NCT02103374|Autonomic Agents|autonomic agents|mesh-ancestor
102050048|NCT02103374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102050049|NCT02103374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050050|NCT02103374|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102050051|NCT02103374|Respiratory System Agents|respiratory system agents|mesh-ancestor
102050052|NCT02103374|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102050053|NCT02103374|Cholinergic Agents|cholinergic agents|mesh-ancestor
102050054|NCT02103374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102050055|NCT02103374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050056|NCT02103374|Sympathomimetics|sympathomimetics|mesh-ancestor
102050057|NCT02103374|Tocolytic Agents|tocolytic agents|mesh-ancestor
102050058|NCT02103374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101942001|NCT03930069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101942002|NCT03930069|Abortifacient Agents|abortifacient agents|mesh-ancestor
101942003|NCT03930069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101942004|NCT03930069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306982|NCT02028923|Morphine|morphine|mesh-list
102050059|NCT02103374|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102050060|NCT02103374|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102050061|NCT02103374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102050062|NCT02103374|Adrenergic Agents|adrenergic agents|mesh-ancestor
102050063|NCT05707221|Chlorhexidine|chlorhexidine|mesh-list
102050064|NCT05707221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102050065|NCT05707221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102050066|NCT05707221|Disinfectants|disinfectants|mesh-ancestor
102050067|NCT03117361|Dexamethasone|dexamethasone|mesh-list
102050068|NCT03117361|Bortezomib|bortezomib|mesh-list
102050069|NCT03117361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102050070|NCT03117361|Antiemetics|antiemetics|mesh-ancestor
102050071|NCT03117361|Autonomic Agents|autonomic agents|mesh-ancestor
101769771|NCT00901875|Naloxone|naloxone|mesh-list
102050085|NCT03053427|Anticonvulsants|anticonvulsants|mesh-ancestor
102050086|NCT03053427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102050087|NCT03053427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102050088|NCT03053427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102050089|NCT03053427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102050090|NCT03053427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102050091|NCT03053427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102050092|NCT03053427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102050093|NCT03053427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050094|NCT03053427|Antimanic Agents|antimanic agents|mesh-ancestor
102050095|NCT02107118|Complement Factor H|complement factor h|mesh-list
102050096|NCT02107118|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102050097|NCT02107118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102050098|NCT02107118|Immunologic Factors|immunologic factors|mesh-ancestor
102050099|NCT02107118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050100|NCT05081089|Lumefantrine|lumefantrine|mesh-list
102050101|NCT05081089|Artemether|artemether|mesh-list
102050102|NCT05081089|Pyrimethamine|pyrimethamine|mesh-list
102050103|NCT05081089|Primaquine|primaquine|mesh-list
102050104|NCT05081089|Sulfadoxine|sulfadoxine|mesh-list
102050105|NCT05081089|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102050106|NCT05081089|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
102050107|NCT05081089|Amodiaquine|amodiaquine|mesh-list
102050108|NCT05081089|Tafenoquine|tafenoquine|mesh-list
102050109|NCT05081089|Antimalarials|antimalarials|mesh-ancestor
102050110|NCT05081089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102050111|NCT05081089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102050112|NCT05081089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102050113|NCT05081089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102050114|NCT05081089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102050115|NCT05081089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050116|NCT05081089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102050117|NCT03555032|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
102050118|NCT03555032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102050119|NCT03555032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102050120|NCT03554408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102050121|NCT03554408|Antibodies|antibodies|mesh-list
102050122|NCT03554408|Immunoglobulins|immunoglobulins|mesh-list
102050123|NCT03554408|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102050124|NCT03554408|Immunologic Factors|immunologic factors|mesh-ancestor
102050125|NCT03554408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050126|NCT03554408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102050127|NCT02103686|Pregabalin|pregabalin|mesh-list
102050128|NCT02103686|Analgesics|analgesics|mesh-ancestor
102050129|NCT02103686|Sensory System Agents|sensory system agents|mesh-ancestor
102050130|NCT02103686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102050131|NCT02103686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050132|NCT02103686|Anticonvulsants|anticonvulsants|mesh-ancestor
102050133|NCT02103686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102050149|NCT02103764|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102050150|NCT02103764|Contraceptive Agents|contraceptive agents|mesh-ancestor
102050151|NCT02103764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102050152|NCT02103764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942005|NCT03930069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101942006|NCT03930069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102050153|NCT02103764|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102050154|NCT02103764|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102050155|NCT02103764|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102050156|NCT02103764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102050157|NCT02103764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102050158|NCT02103764|Progestins|progestins|mesh-ancestor
102050160|NCT02103764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102050161|NCT02110316|Voriconazole|voriconazole|mesh-list
102050162|NCT02110316|Antifungal Agents|antifungal agents|mesh-ancestor
102050163|NCT02110316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102050164|NCT02110316|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102050165|NCT02110316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102050166|NCT02110316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102050167|NCT02110316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050168|NCT02110316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102050169|NCT02110316|Hormone Antagonists|hormone antagonists|mesh-ancestor
102050170|NCT02110316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102050171|NCT02110316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050172|NCT02110316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102050173|NCT05625087|Fulvestrant|fulvestrant|mesh-list
102050174|NCT05625087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102050175|NCT05625087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102050176|NCT05625087|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102050177|NCT05625087|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102050178|NCT05625087|Hormone Antagonists|hormone antagonists|mesh-ancestor
102050179|NCT05625087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102050180|NCT05625087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050181|NCT02110394|Rituximab|rituximab|mesh-list
102050182|NCT02110394|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102050183|NCT02110394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102050184|NCT02110394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102050185|NCT02110394|Immunologic Factors|immunologic factors|mesh-ancestor
102050186|NCT02110394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050187|NCT02110394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102050188|NCT02110394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102050189|NCT02110394|Alkylating Agents|alkylating agents|mesh-ancestor
102050206|NCT02103998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102050207|NCT02103998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102050208|NCT02103998|Trace Elements|trace elements|mesh-ancestor
102050209|NCT02103998|Micronutrients|micronutrients|mesh-ancestor
102050210|NCT01941589|Methylprednisolone|methylprednisolone|mesh-list
102050211|NCT01941589|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102050212|NCT01941589|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102050213|NCT01941589|Prednisolone|prednisolone|mesh-list
102050214|NCT01941589|Prednisolone acetate|prednisolone acetate|mesh-list
102050215|NCT01941589|Hydrocortisone|hydrocortisone|mesh-list
102050216|NCT01941589|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102050217|NCT01941589|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102050218|NCT01941589|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102050220|NCT01941589|Prednisolone phosphate|prednisolone phosphate|mesh-list
102050221|NCT01941589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102050222|NCT01941589|Antiemetics|antiemetics|mesh-ancestor
102050223|NCT01941589|Autonomic Agents|autonomic agents|mesh-ancestor
102050224|NCT01941589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102050225|NCT01941589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050226|NCT01941589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102050227|NCT01941589|Glucocorticoids|glucocorticoids|mesh-ancestor
102050228|NCT01941589|Hormones|hormones|mesh-ancestor
102050229|NCT01941589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102050230|NCT01941589|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102050231|NCT01941589|Protective Agents|protective agents|mesh-ancestor
102050232|NCT01941589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102050233|NCT01941589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102050234|NCT01845649|Estradiol|estradiol|mesh-list
102050235|NCT01845649|Estrogens|estrogens|mesh-ancestor
102050236|NCT01845649|Hormones|hormones|mesh-ancestor
102050237|NCT01845649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102050238|NCT01845649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050239|NCT01345929|Levofloxacin|levofloxacin|mesh-list
101942007|NCT03930069|Oxytocics|oxytocics|mesh-ancestor
101942008|NCT03930069|Hemostatics|hemostatics|mesh-ancestor
101942009|NCT03930069|Coagulants|coagulants|mesh-ancestor
102050240|NCT01345929|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102050241|NCT01345929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102050242|NCT01345929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102050243|NCT01345929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102050244|NCT01345929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102050245|NCT01345929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101351687|NCT04189107|Dexamethasone acetate|dexamethasone acetate|mesh-list
102050263|NCT02250872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102050264|NCT02110784|Piperaquine|piperaquine|mesh-list
102050265|NCT02110784|Artenimol|artenimol|mesh-list
102050266|NCT02110784|Antimalarials|antimalarials|mesh-ancestor
102050267|NCT02110784|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102050268|NCT02110784|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102050269|NCT02110784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102050270|NCT04988425|Methylprednisolone|methylprednisolone|mesh-list
102050271|NCT04988425|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102050272|NCT04988425|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102050273|NCT04988425|Prednisolone|prednisolone|mesh-list
102050274|NCT04988425|Prednisolone acetate|prednisolone acetate|mesh-list
102050275|NCT04988425|Antibodies|antibodies|mesh-list
102050276|NCT04988425|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102050277|NCT04988425|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102050278|NCT04988425|Prednisolone phosphate|prednisolone phosphate|mesh-list
102050279|NCT04988425|Immunologic Factors|immunologic factors|mesh-ancestor
102050280|NCT04988425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050281|NCT04988425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102050282|NCT04988425|Antiemetics|antiemetics|mesh-ancestor
102050283|NCT04988425|Autonomic Agents|autonomic agents|mesh-ancestor
102050284|NCT04988425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102050285|NCT04988425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102050286|NCT04988425|Glucocorticoids|glucocorticoids|mesh-ancestor
102050287|NCT04988425|Hormones|hormones|mesh-ancestor
102050288|NCT04988425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102050289|NCT04988425|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102050290|NCT04988425|Protective Agents|protective agents|mesh-ancestor
102050291|NCT04988425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102050292|NCT04988425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102050293|NCT01343901|Bevacizumab|bevacizumab|mesh-list
102050294|NCT01343901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102050295|NCT01343901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102050296|NCT01343901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102050297|NCT01343901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102050298|NCT01343901|Growth Substances|growth substances|mesh-ancestor
102050299|NCT01343901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050300|NCT01343901|Growth Inhibitors|growth inhibitors|mesh-ancestor
102050302|NCT05617521|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101351744|NCT03844997|Palbociclib|palbociclib|mesh-list
102050323|NCT02104700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102050324|NCT02104778|Dexamethasone|dexamethasone|mesh-list
102050325|NCT02104778|Epinephrine|epinephrine|mesh-list
102050326|NCT02104778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102050327|NCT02104778|Antiemetics|antiemetics|mesh-ancestor
102050328|NCT02104778|Autonomic Agents|autonomic agents|mesh-ancestor
102050329|NCT02104778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102050330|NCT02104778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050331|NCT02104778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102050332|NCT02104778|Glucocorticoids|glucocorticoids|mesh-ancestor
102050333|NCT02104778|Hormones|hormones|mesh-ancestor
102050334|NCT02104778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102050335|NCT02104778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102050336|NCT02104778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102050337|NCT02104778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102050338|NCT02104778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102050339|NCT02104778|Adrenergic Agents|adrenergic agents|mesh-ancestor
102050340|NCT02104778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102050341|NCT02104778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050342|NCT02104778|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102050343|NCT02104778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102050344|NCT02104778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102050345|NCT02104778|Respiratory System Agents|respiratory system agents|mesh-ancestor
102050346|NCT02104778|Mydriatics|mydriatics|mesh-ancestor
101942010|NCT03930069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101942011|NCT03930069|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101942012|NCT03930069|Natriuretic Agents|natriuretic agents|mesh-ancestor
101942013|NCT01132443|Clindamycin|clindamycin|mesh-list
101942014|NCT01132443|Clindamycin palmitate|clindamycin palmitate|mesh-list
102050347|NCT02104778|Sympathomimetics|sympathomimetics|mesh-ancestor
102050348|NCT02104778|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102050349|NCT02108366|Oseltamivir|oseltamivir|mesh-list
102050351|NCT02108366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102050352|NCT02108366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102050353|NCT02108366|Analgesics|analgesics|mesh-ancestor
102050354|NCT02108366|Sensory System Agents|sensory system agents|mesh-ancestor
102050355|NCT02108366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101351799|NCT03589729|Immunotoxins|immunotoxins|mesh-ancestor
102050365|NCT05706207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102050366|NCT05706207|Antibodies|antibodies|mesh-list
102050367|NCT05706207|Immunoglobulins|immunoglobulins|mesh-list
102050368|NCT05706207|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102050369|NCT05706207|Immunologic Factors|immunologic factors|mesh-ancestor
102050370|NCT05706207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050371|NCT05706207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102050372|NCT02105090|Anesthetics|anesthetics|mesh-list
102050373|NCT02105090|Anesthetics, Local|anesthetics, local|mesh-list
102050374|NCT02105090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102050375|NCT02105090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050376|NCT02105090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102050377|NCT02105090|Sensory System Agents|sensory system agents|mesh-ancestor
102050378|NCT03553628|Chlorhexidine|chlorhexidine|mesh-list
102050379|NCT03553628|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102050380|NCT03553628|Propolis|propolis|mesh-list
102050381|NCT03553628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102050382|NCT03553628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102050383|NCT03553628|Disinfectants|disinfectants|mesh-ancestor
102050384|NCT03553628|Dermatologic Agents|dermatologic agents|mesh-ancestor
102050385|NCT02112032|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102050386|NCT02112032|Pembrolizumab|pembrolizumab|mesh-list
102050387|NCT02112032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102050388|NCT02112032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102050389|NCT02112032|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102050390|NCT02112032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050391|NCT02112032|Antiviral Agents|antiviral agents|mesh-ancestor
102050392|NCT02112032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102050393|NCT01343823|Ecallantide|ecallantide|mesh-list
102050394|NCT01343823|Analgesics|analgesics|mesh-ancestor
102050395|NCT01343823|Sensory System Agents|sensory system agents|mesh-ancestor
102050396|NCT01343823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102050397|NCT01343823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050398|NCT01343823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102050399|NCT01343823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102050400|NCT01343823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102050401|NCT01343823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102050402|NCT02251184|Aspirin|aspirin|mesh-list
102050403|NCT02251184|Dipyridamole|dipyridamole|mesh-list
102050404|NCT02251184|Lansoprazole|lansoprazole|mesh-list
102050405|NCT02251184|Dexlansoprazole|dexlansoprazole|mesh-list
102050406|NCT02251184|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
102050407|NCT02251184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102050408|NCT02251184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102050409|NCT02251184|Analgesics|analgesics|mesh-ancestor
102050410|NCT02251184|Sensory System Agents|sensory system agents|mesh-ancestor
102050411|NCT02251184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102050412|NCT02251184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050413|NCT02251184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102050414|NCT02251184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102050415|NCT02251184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102050416|NCT02251184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102050417|NCT02251184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050418|NCT02251184|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102050419|NCT02251184|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102050420|NCT02251184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102050423|NCT02251184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101942015|NCT01132443|Clindamycin phosphate|clindamycin phosphate|mesh-list
101942016|NCT01132443|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101942017|NCT01132443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101942018|NCT01132443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101942019|NCT01132443|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101427851|NCT00175890|Levetiracetam|levetiracetam|mesh-list
102050424|NCT02251184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102050425|NCT02251184|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102050426|NCT02251184|Vasodilator Agents|vasodilator agents|mesh-ancestor
102050428|NCT02108756|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102050429|NCT02108756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102050430|NCT02108756|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102050431|NCT02108756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102050432|NCT02108756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050433|NCT05547399|Zanubrutinib|zanubrutinib|mesh-list
102050434|NCT05547399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102050435|NCT05547399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102050436|NCT05547399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102050437|NCT05547399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770126|NCT04034823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102050438|NCT01318083|Glimepiride|glimepiride|mesh-list
102050439|NCT01318083|Alogliptin|alogliptin|mesh-list
102050440|NCT01318083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102050441|NCT01318083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102050442|NCT01318083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050443|NCT01318083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102050444|NCT01318083|Immunologic Factors|immunologic factors|mesh-ancestor
102050445|NCT01318083|Incretins|incretins|mesh-ancestor
102050446|NCT01318083|Hormones|hormones|mesh-ancestor
102050447|NCT01318083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102050448|NCT01318083|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102050449|NCT01318083|Protease Inhibitors|protease inhibitors|mesh-ancestor
102050450|NCT01318083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102050451|NCT01318083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050452|NCT05545137|Fosfomycin|fosfomycin|mesh-list
102050453|NCT05545137|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
102050454|NCT05545137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102050455|NCT05545137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102050456|NCT05545137|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102050457|NCT02105714|Formaldehyde|formaldehyde|mesh-list
102050458|NCT02105714|Disinfectants|disinfectants|mesh-ancestor
102050459|NCT02105714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102050460|NCT02105792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102050461|NCT02105792|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
102050462|NCT02105792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050463|NCT02105792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102050464|NCT02105792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050465|NCT02105792|Protease Inhibitors|protease inhibitors|mesh-ancestor
102050466|NCT02105792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102050467|NCT03817515|Sirolimus|sirolimus|mesh-list
102050468|NCT03817515|Temsirolimus|temsirolimus|mesh-list
102050469|NCT03817515|MTOR Inhibitors|mtor inhibitors|mesh-list
102050470|NCT03817515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102050471|NCT03817515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102050472|NCT03817515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102050473|NCT03817515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102050474|NCT03817515|Antifungal Agents|antifungal agents|mesh-ancestor
102050475|NCT03817515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102050476|NCT03817515|Immunologic Factors|immunologic factors|mesh-ancestor
102050477|NCT03817515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050478|NCT03817515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102050479|NCT03817515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102050480|NCT03817515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050481|NCT02105870|Abciximab|abciximab|mesh-list
102050482|NCT02105870|Anticoagulants|anticoagulants|mesh-ancestor
102050483|NCT02105870|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102050484|NCT02112422|Dexamethasone|dexamethasone|mesh-list
102050485|NCT02112422|Dexamethasone acetate|dexamethasone acetate|mesh-list
102050486|NCT02112422|BB 1101|bb 1101|mesh-list
102050487|NCT02112422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101942020|NCT01132443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101942021|NCT01132443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050489|NCT02112422|Autonomic Agents|autonomic agents|mesh-ancestor
102050490|NCT02112422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102050491|NCT02112422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050492|NCT02112422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102050493|NCT02112422|Glucocorticoids|glucocorticoids|mesh-ancestor
102050508|NCT02109614|Vitamins|vitamins|mesh-ancestor
102050509|NCT02109614|Micronutrients|micronutrients|mesh-ancestor
102050510|NCT02109614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050511|NCT02106104|Glimepiride|glimepiride|mesh-list
102050512|NCT02106104|Linagliptin|linagliptin|mesh-list
102050513|NCT02106104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102050514|NCT02106104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101770203|NCT04035135|Immunoglobulins|immunoglobulins|mesh-list
102050515|NCT02106104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050516|NCT02106104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102050517|NCT02106104|Immunologic Factors|immunologic factors|mesh-ancestor
102050519|NCT02106104|Hormones|hormones|mesh-ancestor
102050520|NCT02106104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102050521|NCT02106104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102050522|NCT02106104|Protease Inhibitors|protease inhibitors|mesh-ancestor
102050523|NCT02106104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102050524|NCT02106104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050525|NCT01376323|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102050526|NCT01376323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102050527|NCT01376323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050528|NCT01376323|Incretins|incretins|mesh-ancestor
102050529|NCT01376323|Hormones|hormones|mesh-ancestor
102050530|NCT01376323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102050531|NCT01376323|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102050532|NCT01376323|Protease Inhibitors|protease inhibitors|mesh-ancestor
102050533|NCT01376323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102050534|NCT01376323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050535|NCT02113904|Adalimumab|adalimumab|mesh-list
102050536|NCT02113904|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102050537|NCT02113904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102050538|NCT02113904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102050539|NCT05432115|Amoxicillin|amoxicillin|mesh-list
102050540|NCT05432115|Tetracycline|tetracycline|mesh-list
102050541|NCT05432115|Esomeprazole|esomeprazole|mesh-list
102050542|NCT05432115|Bismuth|bismuth|mesh-list
102050543|NCT05432115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102050544|NCT05432115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102050545|NCT05432115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102050546|NCT05432115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102050547|NCT05432115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102050548|NCT05432115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102050549|NCT05432115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050550|NCT05432115|Antacids|antacids|mesh-ancestor
102050551|NCT05432115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102050552|NCT02114528|Amiodarone|amiodarone|mesh-list
102050553|NCT02114528|Sotalol|sotalol|mesh-list
101351996|NCT02571179|Anesthetics|anesthetics|mesh-ancestor
102050560|NCT02114528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050561|NCT02114528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102050562|NCT02114528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102050563|NCT02114528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102050564|NCT02114528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102050565|NCT02114528|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102050566|NCT02114528|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102050567|NCT02114528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102050568|NCT02114528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102050569|NCT02114528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102050570|NCT02114528|Adrenergic Agents|adrenergic agents|mesh-ancestor
102050571|NCT02114528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102050572|NCT02114528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050573|NCT02114528|Sympatholytics|sympatholytics|mesh-ancestor
102050574|NCT02114528|Autonomic Agents|autonomic agents|mesh-ancestor
102050575|NCT02114528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102050576|NCT02114528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101942023|NCT01132521|Urinastatin|urinastatin|mesh-list
101942024|NCT01132521|Trypsin Inhibitors|trypsin inhibitors|mesh-list
101942025|NCT01132521|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101942026|NCT01132521|Protease Inhibitors|protease inhibitors|mesh-ancestor
101942027|NCT01132521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101306998|NCT02029105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102050577|NCT02113202|Bevacizumab|bevacizumab|mesh-list
102050578|NCT02113202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102050579|NCT02113202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102050580|NCT02113202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102050581|NCT02113202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102050582|NCT02113202|Growth Substances|growth substances|mesh-ancestor
102050583|NCT02113202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050584|NCT02113202|Growth Inhibitors|growth inhibitors|mesh-ancestor
102050585|NCT01376401|Prednisone|prednisone|mesh-list
102050586|NCT01376401|Bortezomib|bortezomib|mesh-list
102050587|NCT01376401|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102050588|NCT01376401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102050589|NCT01376401|Glucocorticoids|glucocorticoids|mesh-ancestor
102050590|NCT01376401|Hormones|hormones|mesh-ancestor
102050591|NCT01376401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102050592|NCT01376401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050593|NCT01376401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102050594|NCT01376401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102050595|NCT01376401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102050596|NCT01376401|Alkylating Agents|alkylating agents|mesh-ancestor
102050597|NCT01376401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050598|NCT02119520|Atorvastatin|atorvastatin|mesh-list
102050599|NCT02119520|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102050600|NCT02119520|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102050601|NCT02119520|Antimetabolites|antimetabolites|mesh-ancestor
102050602|NCT02119520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050603|NCT02119520|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102050604|NCT02119520|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102050605|NCT02119520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102050606|NCT03961789|Analgesics, Opioid|analgesics, opioid|mesh-list
102050607|NCT03961789|Narcotics|narcotics|mesh-ancestor
102050608|NCT03961789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102050609|NCT03961789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050610|NCT03961789|Analgesics|analgesics|mesh-ancestor
102050611|NCT03961789|Sensory System Agents|sensory system agents|mesh-ancestor
102050612|NCT03961789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102050613|NCT04854343|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
102050614|NCT04854343|Protease Inhibitors|protease inhibitors|mesh-list
102050615|NCT04854343|Secretory Leukocyte Peptidase Inhibitor|secretory leukocyte peptidase inhibitor|mesh-list
102050616|NCT04854343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102050617|NCT04854343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050618|NCT04854343|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102050619|NCT04854343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102050620|NCT04854343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102050643|NCT03728179|Alkylating Agents|alkylating agents|mesh-ancestor
102050644|NCT03728179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050645|NCT03728179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102050646|NCT03728179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102050647|NCT03728179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102050648|NCT03728179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102050649|NCT03728179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102050650|NCT03728179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102050651|NCT03728179|Analgesics|analgesics|mesh-ancestor
102050652|NCT03728179|Sensory System Agents|sensory system agents|mesh-ancestor
102050653|NCT03728179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102050654|NCT03728179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102050655|NCT03728179|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102050656|NCT03728179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102050657|NCT03728179|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101942028|NCT01132521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942030|NCT01132599|Lipotropic Agents|lipotropic agents|mesh-ancestor
101942031|NCT01132599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102050658|NCT03728179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102050659|NCT03728179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102050660|NCT03728179|Antipyretics|antipyretics|mesh-ancestor
102050661|NCT03728179|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102050663|NCT01368536|Chlorthalidone|chlorthalidone|mesh-list
102050664|NCT01368536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101697679|NCT02765633|Purinergic Agents|purinergic agents|mesh-ancestor
102050665|NCT01368536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102050666|NCT01368536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102050667|NCT01368536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050668|NCT01368536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102050669|NCT01368536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050670|NCT01368536|Vasodilator Agents|vasodilator agents|mesh-ancestor
102050671|NCT01368536|Diuretics|diuretics|mesh-ancestor
102050672|NCT01368536|Natriuretic Agents|natriuretic agents|mesh-ancestor
102050673|NCT01368536|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102050674|NCT05103735|Dexmedetomidine|dexmedetomidine|mesh-list
102050675|NCT05103735|Remifentanil|remifentanil|mesh-list
102050688|NCT05103735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102050689|NCT05103735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050690|NCT05103735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102050691|NCT05103735|Anesthetics, General|anesthetics, general|mesh-ancestor
102050692|NCT05103735|Anesthetics|anesthetics|mesh-ancestor
102050693|NCT05103735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102050694|NCT05103735|Narcotics|narcotics|mesh-ancestor
102050695|NCT01319929|CB2 receptor agonist LY2828360|cb2 receptor agonist ly2828360|mesh-list
102050696|NCT01319929|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102050697|NCT01319929|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102050698|NCT01319929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102050699|NCT01319929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050700|NCT01319929|Hormones|hormones|mesh-ancestor
102050701|NCT01319929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102050702|NCT01319929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050703|NCT03633565|Prednisolone|prednisolone|mesh-list
102050704|NCT03633565|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102050705|NCT03633565|Methylprednisolone|methylprednisolone|mesh-list
102050706|NCT03633565|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102050707|NCT03633565|Prednisolone acetate|prednisolone acetate|mesh-list
102050708|NCT03633565|Sildenafil Citrate|sildenafil citrate|mesh-list
102050709|NCT03633565|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102050710|NCT03633565|Prednisolone phosphate|prednisolone phosphate|mesh-list
102050711|NCT03633565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
102050712|NCT03633565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102050713|NCT03633565|Glucocorticoids|glucocorticoids|mesh-ancestor
102050714|NCT03633565|Hormones|hormones|mesh-ancestor
102050715|NCT03633565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102050716|NCT03633565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050717|NCT03633565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102050718|NCT03633565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102050719|NCT03633565|Antiemetics|antiemetics|mesh-ancestor
102050720|NCT03633565|Autonomic Agents|autonomic agents|mesh-ancestor
102050721|NCT03633565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102050722|NCT03633565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102050723|NCT03633565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102050724|NCT03633565|Protective Agents|protective agents|mesh-ancestor
102050725|NCT03633565|Vasodilator Agents|vasodilator agents|mesh-ancestor
102050726|NCT03633565|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102050727|NCT03633565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102050728|NCT03633565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050729|NCT03633565|Urological Agents|urological agents|mesh-ancestor
102050730|NCT02120066|Plasminogen|plasminogen|mesh-list
102050731|NCT02120066|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102050732|NCT02120066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102050733|NCT02120066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102050734|NCT02120066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050735|NCT01373359|Misoprostol|misoprostol|mesh-list
102050736|NCT01373359|Oxytocin|oxytocin|mesh-list
101942033|NCT01132599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942034|NCT01132599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101942035|NCT01132599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102050737|NCT01373359|Oxytocics|oxytocics|mesh-ancestor
102050756|NCT04739995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050758|NCT04739995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102050759|NCT02120612|Naloxone|naloxone|mesh-list
102050760|NCT02120612|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102050761|NCT02120612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050762|NCT02120612|Sensory System Agents|sensory system agents|mesh-ancestor
102050763|NCT02120612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102050764|NCT02115152|Cyclophosphamide|cyclophosphamide|mesh-list
102050765|NCT02115152|Fluorouracil|fluorouracil|mesh-list
102050766|NCT02115152|Capecitabine|capecitabine|mesh-list
102050767|NCT02115152|Epirubicin|epirubicin|mesh-list
102050768|NCT02115152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102050769|NCT02115152|Immunologic Factors|immunologic factors|mesh-ancestor
102050770|NCT02115152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050771|NCT02115152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102050772|NCT02115152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102050773|NCT02115152|Alkylating Agents|alkylating agents|mesh-ancestor
102050774|NCT02115152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050775|NCT02115152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102050776|NCT02115152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102050777|NCT02115152|Antimetabolites|antimetabolites|mesh-ancestor
102050778|NCT02115152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102050779|NCT02115152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102050780|NCT02115152|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102050781|NCT02115152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102050782|NCT02115152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102050783|NCT02115464|Metformin|metformin|mesh-list
102050784|NCT02115464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102050785|NCT02115464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050786|NCT02858076|Aflibercept|aflibercept|mesh-list
102050787|NCT02858076|Endothelial Growth Factors|endothelial growth factors|mesh-list
102050788|NCT02858076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102050789|NCT02858076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102050790|NCT02858076|Growth Substances|growth substances|mesh-ancestor
102050791|NCT02858076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352245|NCT00019058|Antioxidants|antioxidants|mesh-ancestor
102050828|NCT02123654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050829|NCT02116010|Sulfadiazine|sulfadiazine|mesh-list
102050830|NCT02116010|Silver Sulfadiazine|silver sulfadiazine|mesh-list
102050831|NCT02116010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102050832|NCT02116010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102050833|NCT02116010|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102050834|NCT02116010|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102050835|NCT02116010|Coccidiostats|coccidiostats|mesh-ancestor
102050836|NCT02116010|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102050837|NCT03609294|Linagliptin|linagliptin|mesh-list
102050838|NCT03609294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102050839|NCT03609294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050840|NCT03609294|Incretins|incretins|mesh-ancestor
102050841|NCT03609294|Hormones|hormones|mesh-ancestor
102050842|NCT03609294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102050843|NCT03609294|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102050844|NCT03609294|Protease Inhibitors|protease inhibitors|mesh-ancestor
102050845|NCT03609294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102050846|NCT03609294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050847|NCT01917552|Capecitabine|capecitabine|mesh-list
102050848|NCT01917552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102050849|NCT01917552|Antimetabolites|antimetabolites|mesh-ancestor
102050850|NCT01917552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050851|NCT01917552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102050852|NCT01261728|Gemcitabine|gemcitabine|mesh-list
102050853|NCT01261728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102050854|NCT01261728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102050855|NCT01261728|Antimetabolites|antimetabolites|mesh-ancestor
102050856|NCT01261728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942036|NCT01132599|Nootropic Agents|nootropic agents|mesh-ancestor
101697705|NCT00581776|Hormones|hormones|mesh-ancestor
101942037|NCT03929835|Chlorophyllin|chlorophyllin|mesh-list
101942038|NCT03929835|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101942039|NCT03929835|Protective Agents|protective agents|mesh-ancestor
101942040|NCT03929835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050857|NCT02116400|Lithium Carbonate|lithium carbonate|mesh-list
102050858|NCT02116400|Antidepressive Agents|antidepressive agents|mesh-ancestor
102050859|NCT02116400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102050860|NCT02116400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102050861|NCT02116400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050862|NCT02116400|Antimanic Agents|antimanic agents|mesh-ancestor
102050863|NCT02116400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102050864|NCT02116400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102050865|NCT02116400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050867|NCT03119701|Interferon-beta|interferon-beta|mesh-list
102050868|NCT03119701|Interferon beta-1a|interferon beta-1a|mesh-list
102050869|NCT03119701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102050870|NCT03119701|Antiviral Agents|antiviral agents|mesh-ancestor
102050871|NCT03119701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102050872|NCT03119701|Immunologic Factors|immunologic factors|mesh-ancestor
102050873|NCT03119701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050874|NCT03119701|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102050875|NCT03717129|Tenofovir|tenofovir|mesh-list
102050876|NCT03717129|Emtricitabine|emtricitabine|mesh-list
102050877|NCT03717129|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102050878|NCT03717129|Cobicistat|cobicistat|mesh-list
102050879|NCT03717129|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
102050880|NCT03717129|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102050881|NCT03717129|Elvitegravir|elvitegravir|mesh-list
102050882|NCT03717129|Antiviral Agents|antiviral agents|mesh-ancestor
102050883|NCT03717129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102050884|NCT03717129|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102050885|NCT03717129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102050886|NCT03717129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102050887|NCT03717129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050888|NCT03717129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102050889|NCT03717129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102050890|NCT03717129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102050891|NCT03717129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102050892|NCT03717129|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102050893|NCT03627039|Metformin|metformin|mesh-list
102050894|NCT03627039|Dapagliflozin|dapagliflozin|mesh-list
102050895|NCT03627039|Empagliflozin|empagliflozin|mesh-list
102050896|NCT03627039|Canagliflozin|canagliflozin|mesh-list
102050901|NCT01374373|Epoetin Alfa|epoetin alfa|mesh-list
102050902|NCT01374373|Hematinics|hematinics|mesh-ancestor
102050903|NCT02116556|Rifaximin|rifaximin|mesh-list
102050904|NCT02116556|Prednisone|prednisone|mesh-list
102050905|NCT02116556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102050906|NCT02116556|Glucocorticoids|glucocorticoids|mesh-ancestor
102050907|NCT02116556|Hormones|hormones|mesh-ancestor
102050908|NCT02116556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102050909|NCT02116556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050910|NCT02116556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102050911|NCT02116556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102050912|NCT02116556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102050913|NCT02116556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101697718|NCT00662454|Levonorgestrel|levonorgestrel|mesh-list
102050914|NCT02116556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102050915|NCT03634345|Fluconazole|fluconazole|mesh-list
102050916|NCT03634345|Fluvoxamine|fluvoxamine|mesh-list
102050917|NCT03634345|Abrocitinib|abrocitinib|mesh-list
102050918|NCT03634345|Antifungal Agents|antifungal agents|mesh-ancestor
102050919|NCT03634345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102050920|NCT03634345|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102050921|NCT03634345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102050922|NCT03634345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102050923|NCT03634345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050924|NCT03634345|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102050925|NCT03634345|Hormone Antagonists|hormone antagonists|mesh-ancestor
101942041|NCT01132677|Methylprednisolone|methylprednisolone|mesh-list
101942042|NCT01132677|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101428276|NCT05786612|Laxatives|laxatives|mesh-ancestor
102050926|NCT03634345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102050927|NCT03634345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050928|NCT03634345|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102050929|NCT03634345|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102050930|NCT03634345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101770650|NCT00906867|Miotics|miotics|mesh-ancestor
102050931|NCT03634345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102050932|NCT03634345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102050933|NCT03634345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102050934|NCT03634345|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102050935|NCT03634345|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102050936|NCT03634345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102050937|NCT03634345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102050938|NCT03634345|Serotonin Agents|serotonin agents|mesh-ancestor
102050939|NCT03634345|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102050940|NCT03634345|Antidepressive Agents|antidepressive agents|mesh-ancestor
102050941|NCT03634345|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102050942|NCT03634345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102050943|NCT03553238|Cytarabine|cytarabine|mesh-list
102050944|NCT03553238|Dexamethasone|dexamethasone|mesh-list
102050945|NCT03553238|Cyclophosphamide|cyclophosphamide|mesh-list
102050946|NCT03553238|Methotrexate|methotrexate|mesh-list
102050947|NCT03553238|Etoposide|etoposide|mesh-list
102050948|NCT03553238|Vincristine|vincristine|mesh-list
102050949|NCT03553238|Doxorubicin|doxorubicin|mesh-list
102050950|NCT03553238|Mercaptopurine|mercaptopurine|mesh-list
102050951|NCT03553238|Idarubicin|idarubicin|mesh-list
102050952|NCT03553238|Pegaspargase|pegaspargase|mesh-list
102050953|NCT03553238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102050954|NCT03553238|Immunologic Factors|immunologic factors|mesh-ancestor
102050955|NCT03553238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050956|NCT03553238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102050957|NCT03553238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102050958|NCT03553238|Alkylating Agents|alkylating agents|mesh-ancestor
102050959|NCT03553238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050960|NCT03553238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102050961|NCT03553238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102050962|NCT03553238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102050963|NCT03553238|Antiemetics|antiemetics|mesh-ancestor
102050964|NCT03553238|Autonomic Agents|autonomic agents|mesh-ancestor
102050965|NCT03553238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102050970|NCT03553238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102050971|NCT03553238|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102050972|NCT03553238|Abortifacient Agents|abortifacient agents|mesh-ancestor
102050973|NCT03553238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102050974|NCT03553238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102050975|NCT03553238|Antimetabolites|antimetabolites|mesh-ancestor
102050976|NCT03553238|Dermatologic Agents|dermatologic agents|mesh-ancestor
102050977|NCT03553238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102050978|NCT03553238|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102050979|NCT03553238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102050980|NCT03553238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102050981|NCT03553238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102050982|NCT03553238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102050983|NCT03553238|Antiviral Agents|antiviral agents|mesh-ancestor
102050984|NCT03553238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102050985|NCT03553238|Tubulin Modulators|tubulin modulators|mesh-ancestor
102050986|NCT03553238|Antimitotic Agents|antimitotic agents|mesh-ancestor
102050987|NCT03553238|Mitosis Modulators|mitosis modulators|mesh-ancestor
102050988|NCT03553238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102050989|NCT04980027|Insulin Glargine|insulin glargine|mesh-list
102050990|NCT04980027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102050991|NCT04980027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050992|NCT01373593|Lidocaine|lidocaine|mesh-list
102050993|NCT01373593|Anesthetics, Local|anesthetics, local|mesh-ancestor
102050994|NCT01373593|Anesthetics|anesthetics|mesh-ancestor
102050995|NCT01373593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102050996|NCT01373593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050997|NCT01373593|Sensory System Agents|sensory system agents|mesh-ancestor
102050998|NCT01373593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101942043|NCT01132677|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101942044|NCT01132677|Prednisolone|prednisolone|mesh-list
101942045|NCT01132677|Prednisolone acetate|prednisolone acetate|mesh-list
102050999|NCT01373593|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102051000|NCT01373593|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102051001|NCT01373593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102051002|NCT01373593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102051003|NCT01373593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051004|NCT02116712|Saracatinib|saracatinib|mesh-list
102051005|NCT02116712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102051006|NCT02116712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102051007|NCT02116712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051008|NCT02116790|Naproxen|naproxen|mesh-list
102051009|NCT02116790|Levodopa|levodopa|mesh-list
102051010|NCT02116790|Carbidopa|carbidopa|mesh-list
102051011|NCT02116790|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102051012|NCT02116790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102051013|NCT02116790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102051014|NCT02116790|Analgesics|analgesics|mesh-ancestor
102051015|NCT02116790|Sensory System Agents|sensory system agents|mesh-ancestor
102051016|NCT02116790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102051017|NCT02116790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051018|NCT02116790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102051019|NCT02116790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102051020|NCT02116790|Gout Suppressants|gout suppressants|mesh-ancestor
102051021|NCT02116790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102051022|NCT02116790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102051023|NCT02116790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051024|NCT02116790|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102051025|NCT02116790|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102051026|NCT02116790|Dopamine Agents|dopamine agents|mesh-ancestor
102051027|NCT02116790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102051028|NCT02116790|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102051029|NCT02116790|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102051030|NCT02116790|Immunologic Factors|immunologic factors|mesh-ancestor
102051031|NCT02116790|Dopamine Agonists|dopamine agonists|mesh-ancestor
102051032|NCT02859961|Leronlimab|leronlimab|mesh-list
102051033|NCT02859961|HIV Antibodies|hiv antibodies|mesh-list
102051034|NCT02859961|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102051035|NCT02859961|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102051038|NCT02859961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102051039|NCT02859961|Antiviral Agents|antiviral agents|mesh-ancestor
102051040|NCT02859961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102051041|NCT02859961|Immunologic Factors|immunologic factors|mesh-ancestor
102051042|NCT02859961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051044|NCT02124200|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102051045|NCT02124200|Autonomic Agents|autonomic agents|mesh-ancestor
102051046|NCT02124200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102051047|NCT02124200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051048|NCT02124200|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102051049|NCT02124200|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102051050|NCT02124200|Cholinergic Agents|cholinergic agents|mesh-ancestor
102051051|NCT02124200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102051052|NCT02124200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051053|NCT02124278|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
102051054|NCT02124278|Respiratory System Agents|respiratory system agents|mesh-ancestor
102051055|NCT04503993|Antibodies|antibodies|mesh-list
102051056|NCT04503993|Immunoglobulins|immunoglobulins|mesh-list
102051057|NCT04503993|Immunologic Factors|immunologic factors|mesh-ancestor
102051058|NCT04503993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051059|NCT02116868|Antihypertensive Agents|antihypertensive agents|mesh-list
102051060|NCT02116868|Nicardipine|nicardipine|mesh-list
102051061|NCT02116868|Urapidil|urapidil|mesh-list
102051062|NCT02116868|Remifentanil|remifentanil|mesh-list
102051063|NCT02116868|Esmolol|esmolol|mesh-list
102051064|NCT02116868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102051065|NCT02116868|Narcotics|narcotics|mesh-ancestor
102051066|NCT02116868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102051067|NCT02116868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051068|NCT02116868|Analgesics|analgesics|mesh-ancestor
102051069|NCT02116868|Sensory System Agents|sensory system agents|mesh-ancestor
102051070|NCT02116868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101942046|NCT01132677|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101942047|NCT01132677|Prednisolone phosphate|prednisolone phosphate|mesh-list
101942048|NCT01132677|Hylan|hylan|mesh-list
101942049|NCT01132677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102051071|NCT02116868|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102051072|NCT02116868|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102051073|NCT02116868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102051074|NCT02116868|Adrenergic Agents|adrenergic agents|mesh-ancestor
102051075|NCT02116868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102051076|NCT02116868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051077|NCT02116868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102051078|NCT02116868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102051079|NCT02116868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102051080|NCT02116868|Vasodilator Agents|vasodilator agents|mesh-ancestor
102051081|NCT02116868|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102051082|NCT02116868|Serotonin Agents|serotonin agents|mesh-ancestor
102051083|NCT02116868|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102051084|NCT02116868|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102051085|NCT02679781|Midazolam|midazolam|mesh-list
102051086|NCT02679781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102051087|NCT02679781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102051088|NCT02679781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102051089|NCT02679781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051090|NCT02679781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102051091|NCT02679781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102051092|NCT02679781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102051093|NCT02679781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102051094|NCT02679781|Anesthetics, General|anesthetics, general|mesh-ancestor
102051095|NCT02679781|Anesthetics|anesthetics|mesh-ancestor
102051096|NCT02679781|GABA Modulators|gaba modulators|mesh-ancestor
102051097|NCT02679781|GABA Agents|gaba agents|mesh-ancestor
102051098|NCT02679781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102051099|NCT02679781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051100|NCT04373031|Pembrolizumab|pembrolizumab|mesh-list
102051101|NCT04373031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102051102|NCT04373031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102051103|NCT04373031|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102051104|NCT04373031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051105|NCT02624869|Evolocumab|evolocumab|mesh-list
102051106|NCT02624869|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102051107|NCT02624869|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102051120|NCT03553082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102051121|NCT03553082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102051122|NCT03553082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051123|NCT03553082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102051124|NCT03553082|Anesthetics, General|anesthetics, general|mesh-ancestor
102051125|NCT03553082|Anesthetics|anesthetics|mesh-ancestor
102051126|NCT03553082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102051127|NCT03553082|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102051128|NCT03318393|Heparin|heparin|mesh-list
102051129|NCT03318393|Calcium heparin|calcium heparin|mesh-list
102051130|NCT03318393|Bivalirudin|bivalirudin|mesh-list
102051131|NCT03318393|Anticoagulants|anticoagulants|mesh-ancestor
102051132|NCT03318393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102051133|NCT03318393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102051134|NCT03318393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051135|NCT03318393|Antithrombins|antithrombins|mesh-ancestor
102051136|NCT03318393|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102051137|NCT03318393|Protease Inhibitors|protease inhibitors|mesh-ancestor
102051138|NCT03318393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102051139|NCT03110029|Efinaconazole|efinaconazole|mesh-list
102051140|NCT03110029|Antifungal Agents|antifungal agents|mesh-ancestor
102051141|NCT03110029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102051142|NCT03552146|Dexmedetomidine|dexmedetomidine|mesh-list
102051143|NCT03552146|Propofol|propofol|mesh-list
102051144|NCT03552146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102051145|NCT03552146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102051146|NCT03552146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051147|NCT03552146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102051148|NCT03552146|Analgesics|analgesics|mesh-ancestor
102051149|NCT03552146|Sensory System Agents|sensory system agents|mesh-ancestor
102051150|NCT03552146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101942051|NCT01132677|Autonomic Agents|autonomic agents|mesh-ancestor
101942052|NCT01132677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101942053|NCT01132677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051151|NCT03552146|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102051152|NCT03552146|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102051153|NCT03552146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102051154|NCT03552146|Adrenergic Agents|adrenergic agents|mesh-ancestor
102051155|NCT03552146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102051156|NCT03552146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051157|NCT03552146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102051158|NCT03552146|Anesthetics, General|anesthetics, general|mesh-ancestor
102051159|NCT03552146|Anesthetics|anesthetics|mesh-ancestor
102051160|NCT01374763|Oxycodone|oxycodone|mesh-list
102051161|NCT01374763|Naloxone|naloxone|mesh-list
102051162|NCT01374763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102051163|NCT01374763|Narcotics|narcotics|mesh-ancestor
102051164|NCT01374763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102051165|NCT01374763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051166|NCT01374763|Analgesics|analgesics|mesh-ancestor
102051167|NCT01374763|Sensory System Agents|sensory system agents|mesh-ancestor
102051168|NCT01374763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102051169|NCT01374763|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102051170|NCT02747004|Tamoxifen|tamoxifen|mesh-list
102051171|NCT02747004|Loperamide|loperamide|mesh-list
102051172|NCT02747004|Antidiarrheals|antidiarrheals|mesh-list
102051173|NCT02747004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102051177|NCT02747004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102051178|NCT02747004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102051179|NCT02747004|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102051180|NCT02747004|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102051181|NCT02747004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102051182|NCT02747004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102051184|NCT04454515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102051185|NCT04454515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102051186|NCT04454515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051187|NCT04454515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102051188|NCT04454515|Analgesics|analgesics|mesh-ancestor
102051189|NCT04454515|Sensory System Agents|sensory system agents|mesh-ancestor
102051190|NCT04454515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102051191|NCT04454515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102051192|NCT04454515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102051193|NCT04454515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102051194|NCT04454515|Adrenergic Agents|adrenergic agents|mesh-ancestor
102051195|NCT04454515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102051196|NCT04454515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051197|NCT03608514|Terlipressin|terlipressin|mesh-list
102051198|NCT03608514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102051199|NCT03608514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102051200|NCT02117726|Midazolam|midazolam|mesh-list
102051201|NCT02117726|Dexmedetomidine|dexmedetomidine|mesh-list
102051202|NCT02117726|Propofol|propofol|mesh-list
102051203|NCT02117726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102051204|NCT02117726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102051205|NCT02117726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051206|NCT02117726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101575015|NCT01179516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575016|NCT01179516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101575017|NCT01179516|Serotonin Agents|serotonin agents|mesh-ancestor
101575018|NCT01179516|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101575019|NCT01179516|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101575020|NCT01179516|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101575021|NCT01179516|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101575022|NCT00635791|Sorafenib|sorafenib|mesh-list
101575023|NCT00635791|Vorinostat|vorinostat|mesh-list
101575024|NCT00635791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101575025|NCT00635791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101575026|NCT00635791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101575027|NCT00635791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575028|NCT00635791|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101575029|NCT02760121|Acetazolamide|acetazolamide|mesh-list
101942054|NCT01132677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101942056|NCT01132677|Hormones|hormones|mesh-ancestor
101942057|NCT01132677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101942058|NCT01132677|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101942059|NCT01132677|Protective Agents|protective agents|mesh-ancestor
101942060|NCT01132677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101942061|NCT01132677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101942062|NCT01132677|Viscosupplements|viscosupplements|mesh-ancestor
101942063|NCT02961790|Mandelic Acids|mandelic acids|mesh-list
101942064|NCT02961790|Oxybutynin|oxybutynin|mesh-list
101942065|NCT02961790|Parasympatholytics|parasympatholytics|mesh-ancestor
101942066|NCT02961790|Autonomic Agents|autonomic agents|mesh-ancestor
101942067|NCT02961790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101942068|NCT02961790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942069|NCT02961790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101942070|NCT02961790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101942071|NCT02961790|Cholinergic Agents|cholinergic agents|mesh-ancestor
101575030|NCT02760121|Methazolamide|methazolamide|mesh-list
101575031|NCT02760121|Anticonvulsants|anticonvulsants|mesh-ancestor
101575032|NCT02760121|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101575033|NCT02760121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101575034|NCT02760121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575035|NCT02760121|Diuretics|diuretics|mesh-ancestor
101575036|NCT02760121|Natriuretic Agents|natriuretic agents|mesh-ancestor
101575037|NCT02760121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575038|NCT05215873|Misoprostol|misoprostol|mesh-list
102051207|NCT02117726|Analgesics|analgesics|mesh-ancestor
101575039|NCT05215873|Oxytocin|oxytocin|mesh-list
102051208|NCT02117726|Sensory System Agents|sensory system agents|mesh-ancestor
102051209|NCT02117726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102051210|NCT02117726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102051211|NCT02117726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102051212|NCT02117726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102051213|NCT02117726|Adrenergic Agents|adrenergic agents|mesh-ancestor
102051214|NCT02117726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102051215|NCT02117726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051216|NCT02117726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102051217|NCT02117726|Anesthetics, General|anesthetics, general|mesh-ancestor
102051226|NCT02733432|Rezafungin|rezafungin|mesh-list
102051227|NCT02733432|Antifungal Agents|antifungal agents|mesh-ancestor
102051228|NCT02733432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102051229|NCT02733432|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101697821|NCT00650624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102051230|NCT02733432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102051231|NCT02733432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102051232|NCT02733432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051233|NCT02733432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102051234|NCT02733432|Hormone Antagonists|hormone antagonists|mesh-ancestor
102051235|NCT02733432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102051236|NCT02733432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051237|NCT02733432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102051238|NCT02733432|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102051239|NCT03634189|Cannabidiol|cannabidiol|mesh-list
102051240|NCT03634189|Anticonvulsants|anticonvulsants|mesh-ancestor
102051241|NCT03608046|Irinotecan|irinotecan|mesh-list
102051242|NCT03608046|Cetuximab|cetuximab|mesh-list
102051243|NCT03608046|Avelumab|avelumab|mesh-list
101942072|NCT02961790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101942073|NCT02961790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942074|NCT02961790|Urological Agents|urological agents|mesh-ancestor
101942075|NCT02961790|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102051244|NCT03608046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102051245|NCT03608046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102051246|NCT03608046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102051247|NCT03608046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051248|NCT03608046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102051249|NCT03608046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102051250|NCT02122484|Colchicine|colchicine|mesh-list
102051251|NCT02122484|Gout Suppressants|gout suppressants|mesh-ancestor
102051252|NCT02122484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102051253|NCT02122484|Tubulin Modulators|tubulin modulators|mesh-ancestor
102051254|NCT02122484|Antimitotic Agents|antimitotic agents|mesh-ancestor
102051255|NCT02122484|Mitosis Modulators|mitosis modulators|mesh-ancestor
102051256|NCT02122484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051257|NCT02122484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102051258|NCT03606018|Insulin|insulin|mesh-list
102051259|NCT03606018|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102051260|NCT03606018|Insulin Lispro|insulin lispro|mesh-list
102051261|NCT03606018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102051262|NCT03606018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051263|NCT01373749|Sildenafil Citrate|sildenafil citrate|mesh-list
102051264|NCT01373749|Vasodilator Agents|vasodilator agents|mesh-ancestor
102051265|NCT01373749|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102051266|NCT01373749|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102051267|NCT01373749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102051268|NCT01373749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051269|NCT01373749|Urological Agents|urological agents|mesh-ancestor
102051270|NCT04045795|Dexamethasone|dexamethasone|mesh-list
102051271|NCT04045795|Pomalidomide|pomalidomide|mesh-list
102051272|NCT04045795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102051273|NCT04045795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102051274|NCT04045795|Antiemetics|antiemetics|mesh-ancestor
102051275|NCT04045795|Autonomic Agents|autonomic agents|mesh-ancestor
102051276|NCT04045795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102051277|NCT04045795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051278|NCT04045795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102051279|NCT04045795|Glucocorticoids|glucocorticoids|mesh-ancestor
102051280|NCT04045795|Hormones|hormones|mesh-ancestor
102051281|NCT04045795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102051282|NCT04045795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102051284|NCT04045795|Immunologic Factors|immunologic factors|mesh-ancestor
102051285|NCT04045795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102051286|NCT04045795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102051287|NCT04045795|Growth Substances|growth substances|mesh-ancestor
102051288|NCT04045795|Growth Inhibitors|growth inhibitors|mesh-ancestor
102051289|NCT03605940|Methoxsalen|methoxsalen|mesh-list
102051294|NCT03607734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102051295|NCT02035488|Tobramycin|tobramycin|mesh-list
102051296|NCT02035488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102051297|NCT02035488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102051298|NCT03602430|Vitamin D|vitamin d|mesh-list
102051299|NCT03602430|Cholecalciferol|cholecalciferol|mesh-list
102051300|NCT03602430|Vitamins|vitamins|mesh-ancestor
102051301|NCT03602430|Micronutrients|micronutrients|mesh-ancestor
102051302|NCT03602430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051303|NCT03602430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102051304|NCT03602430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102051305|NCT02260544|Doxorubicin|doxorubicin|mesh-list
102051306|NCT02260544|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102051307|NCT02260544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102051308|NCT02260544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102051309|NCT02260544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102051310|NCT02260544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102051311|NCT02260544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102051312|NCT02260544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051313|NCT05470647|Interleukin-4|interleukin-4|mesh-list
102051314|NCT05470647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102051315|NCT05470647|Immunologic Factors|immunologic factors|mesh-ancestor
101942076|NCT02961790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101942077|NCT01225341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102051316|NCT05470647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051317|NCT05470647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102051318|NCT05470647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102051319|NCT04409665|Ketamine|ketamine|mesh-list
102051320|NCT04409665|Analgesics|analgesics|mesh-ancestor
102051321|NCT04409665|Sensory System Agents|sensory system agents|mesh-ancestor
102051322|NCT04409665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102051323|NCT04409665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051324|NCT04409665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102051325|NCT04409665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102051326|NCT04409665|Anesthetics, General|anesthetics, general|mesh-ancestor
102051327|NCT04409665|Anesthetics|anesthetics|mesh-ancestor
102051328|NCT04409665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102051329|NCT04409665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102051330|NCT04409665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102051331|NCT04409665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102051332|NCT04409665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051333|NCT02854800|Varenicline|varenicline|mesh-list
102051334|NCT02854800|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102051335|NCT02854800|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102051336|NCT02854800|Cholinergic Agents|cholinergic agents|mesh-ancestor
102051337|NCT02854800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102051338|NCT02854800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051339|NCT02854800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051340|NCT03552770|Bevacizumab|bevacizumab|mesh-list
102051341|NCT03552770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102051342|NCT03552770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102051343|NCT03552770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102051344|NCT03552770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102051345|NCT03552770|Growth Substances|growth substances|mesh-ancestor
102051346|NCT03552770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051347|NCT03552770|Growth Inhibitors|growth inhibitors|mesh-ancestor
102051348|NCT02127164|Sodium Hypochlorite|sodium hypochlorite|mesh-list
102051349|NCT02127164|Eusol|eusol|mesh-list
102051350|NCT02127164|Disinfectants|disinfectants|mesh-ancestor
102051351|NCT02127164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102051352|NCT02931539|Valganciclovir|valganciclovir|mesh-list
102051353|NCT02931539|Ganciclovir|ganciclovir|mesh-list
102051354|NCT02931539|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102051355|NCT02931539|Cidofovir|cidofovir|mesh-list
102051356|NCT02931539|Foscarnet|foscarnet|mesh-list
102051357|NCT02931539|Maribavir|maribavir|mesh-list
102051358|NCT02931539|Antiviral Agents|antiviral agents|mesh-ancestor
102051359|NCT02931539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102051360|NCT02931539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102051361|NCT02931539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102051362|NCT02931539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051366|NCT03602118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102051367|NCT03602118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102051368|NCT03602118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508127|NCT03459911|Losartan|losartan|mesh-list
102051369|NCT03602118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102051370|NCT03602118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102051371|NCT03602118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102051372|NCT03602118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051373|NCT03602118|GABA Modulators|gaba modulators|mesh-ancestor
102051374|NCT03602118|GABA Agents|gaba agents|mesh-ancestor
102051375|NCT03602118|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102051376|NCT03602118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102051377|NCT03602118|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102051378|NCT02125682|Atorvastatin|atorvastatin|mesh-list
102051379|NCT02125682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102051380|NCT02125682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102051381|NCT02125682|Antimetabolites|antimetabolites|mesh-ancestor
102051382|NCT02125682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051383|NCT02125682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102051384|NCT02125682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102051385|NCT02125682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102051386|NCT02546999|Botulinum Toxins|botulinum toxins|mesh-list
102051387|NCT02546999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102051388|NCT02546999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101942078|NCT01225341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101942079|NCT01225341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101942080|NCT01225341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101942081|NCT01225341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051389|NCT02546999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102051390|NCT02546999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051391|NCT02546999|Cholinergic Agents|cholinergic agents|mesh-ancestor
102051392|NCT02546999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102051393|NCT02546999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051394|NCT02546999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102051395|NCT02546999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102051396|NCT02131220|Tirofiban|tirofiban|mesh-list
102051397|NCT02131220|Saruplase|saruplase|mesh-list
102051398|NCT02131220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102051399|NCT02131220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102051400|NCT02131220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051401|NCT02131220|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102051402|NCT04042077|Vancomycin|vancomycin|mesh-list
102051403|NCT04042077|Tazobactam|tazobactam|mesh-list
102051404|NCT04042077|Linezolid|linezolid|mesh-list
102051405|NCT04042077|Piperacillin|piperacillin|mesh-list
102051406|NCT04042077|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102051407|NCT04042077|Tigecycline|tigecycline|mesh-list
102051408|NCT04042077|Delafloxacin|delafloxacin|mesh-list
102051409|NCT04042077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102051410|NCT04042077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102051411|NCT04042077|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102051412|NCT04042077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102051413|NCT04042077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051414|NCT04042077|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102051415|NCT03557359|Nivolumab|nivolumab|mesh-list
102051416|NCT03557359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102051417|NCT03557359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102051418|NCT03557359|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102051419|NCT03557359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051420|NCT02127320|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102051421|NCT02127320|Ezetimibe|ezetimibe|mesh-list
102051422|NCT02127320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102051423|NCT02127320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102051424|NCT02127320|Antimetabolites|antimetabolites|mesh-ancestor
102051425|NCT02127320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051426|NCT02127320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102051427|NCT02127320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102051428|NCT02127320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102051429|NCT03522415|Methotrexate|methotrexate|mesh-list
102051430|NCT03522415|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102051431|NCT03522415|Abortifacient Agents|abortifacient agents|mesh-ancestor
102051432|NCT03522415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101352913|NCT00021359|Dexamethasone|dexamethasone|mesh-list
102051436|NCT03522415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051437|NCT03522415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102051438|NCT03522415|Dermatologic Agents|dermatologic agents|mesh-ancestor
102051439|NCT03522415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102051440|NCT03522415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102051441|NCT03522415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102051442|NCT03522415|Immunologic Factors|immunologic factors|mesh-ancestor
102051443|NCT03522415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102051444|NCT03522415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102051445|NCT04226833|Entrectinib|entrectinib|mesh-list
102051446|NCT04226833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102051447|NCT04226833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102051448|NCT04226833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051449|NCT02131298|Itraconazole|itraconazole|mesh-list
102051450|NCT02131298|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
102051451|NCT02131298|Palbociclib|palbociclib|mesh-list
102051452|NCT02131298|Antifungal Agents|antifungal agents|mesh-ancestor
102051453|NCT02131298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102051454|NCT02131298|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102051455|NCT02131298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102051456|NCT02131298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101942083|NCT01225341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101942084|NCT01225341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942085|NCT01225341|Cholinergic Agents|cholinergic agents|mesh-ancestor
101307057|NCT02029482|Ponesimod|ponesimod|mesh-list
102051457|NCT02131298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051458|NCT02131298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102051459|NCT02131298|Hormone Antagonists|hormone antagonists|mesh-ancestor
102051460|NCT02131298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102051461|NCT02131298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051462|NCT02131298|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102051463|NCT02131298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102051464|NCT02131298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102051465|NCT01375387|Lacosamide|lacosamide|mesh-list
102051466|NCT01375387|Anticonvulsants|anticonvulsants|mesh-ancestor
102051467|NCT01375387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102051468|NCT01375387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102051469|NCT01375387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102051470|NCT01375387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051471|NCT02853318|Cyclophosphamide|cyclophosphamide|mesh-list
102051472|NCT02853318|Bevacizumab|bevacizumab|mesh-list
102051473|NCT02853318|Pembrolizumab|pembrolizumab|mesh-list
102051474|NCT02853318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102051475|NCT02853318|Antibodies|antibodies|mesh-list
102051476|NCT02853318|Immunoglobulins|immunoglobulins|mesh-list
102051477|NCT02853318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102051478|NCT02853318|Immunoglobulin G|immunoglobulin g|mesh-list
102051479|NCT02853318|Endothelial Growth Factors|endothelial growth factors|mesh-list
102051480|NCT02853318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102051481|NCT02853318|Immunologic Factors|immunologic factors|mesh-ancestor
102051482|NCT02853318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051483|NCT02853318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102051484|NCT02853318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102051485|NCT02853318|Alkylating Agents|alkylating agents|mesh-ancestor
102051486|NCT02853318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051487|NCT02853318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102051488|NCT02853318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102051489|NCT02853318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102051490|NCT02853318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102051491|NCT02853318|Growth Substances|growth substances|mesh-ancestor
102051492|NCT02853318|Growth Inhibitors|growth inhibitors|mesh-ancestor
102051493|NCT02853318|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102051494|NCT03626727|Sodium Oxybate|sodium oxybate|mesh-list
101697847|NCT02536352|Vitamins|vitamins|mesh-list
102051495|NCT03626727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102051496|NCT03626727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102051497|NCT03626727|Anesthetics, General|anesthetics, general|mesh-ancestor
102051498|NCT03626727|Anesthetics|anesthetics|mesh-ancestor
102051499|NCT03626727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102051500|NCT03626727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051501|NCT03604224|Canagliflozin|canagliflozin|mesh-list
102051502|NCT03604224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102051505|NCT03604224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051506|NCT02126384|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102051507|NCT02126384|Immunologic Factors|immunologic factors|mesh-ancestor
102051508|NCT02126384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051509|NCT02035410|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102051510|NCT02035410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102051511|NCT02035410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102051512|NCT02404155|Clozapine|clozapine|mesh-list
102051513|NCT02404155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102051514|NCT02404155|Serotonin Agents|serotonin agents|mesh-ancestor
102051515|NCT02404155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102051516|NCT02404155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051517|NCT02404155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051518|NCT02404155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102051519|NCT02404155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102051520|NCT02404155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101942086|NCT01225341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101942088|NCT03920553|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101942089|NCT03920553|Immunologic Factors|immunologic factors|mesh-ancestor
101942090|NCT03920553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942091|NCT03920553|Viscosupplements|viscosupplements|mesh-ancestor
101942092|NCT03920553|Protective Agents|protective agents|mesh-ancestor
101942093|NCT03643900|Indomethacin|indomethacin|mesh-list
101307060|NCT02029482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102051521|NCT02404155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102051522|NCT02404155|GABA Antagonists|gaba antagonists|mesh-ancestor
102051523|NCT02404155|GABA Agents|gaba agents|mesh-ancestor
102051524|NCT02127788|Micafungin|micafungin|mesh-list
102051525|NCT02127788|Antifungal Agents|antifungal agents|mesh-ancestor
102051526|NCT02127788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102051527|NCT02131688|Mitoxantrone|mitoxantrone|mesh-list
102051528|NCT02131688|Analgesics|analgesics|mesh-ancestor
102051529|NCT02131688|Sensory System Agents|sensory system agents|mesh-ancestor
102051530|NCT02131688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102051531|NCT02131688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051532|NCT02131688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102051533|NCT02131688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102051534|NCT02131688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102051535|NCT02131688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102051536|NCT02131688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051537|NCT02126462|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102051538|NCT02126462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102051539|NCT02126462|Immunologic Factors|immunologic factors|mesh-ancestor
102051540|NCT02126462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051541|NCT02126462|Antacids|antacids|mesh-ancestor
102051542|NCT02126462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051543|NCT02126462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102051544|NCT03113071|Decitabine|decitabine|mesh-list
102051545|NCT03113071|Digoxin|digoxin|mesh-list
102051546|NCT03113071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102051547|NCT03113071|Antimetabolites|antimetabolites|mesh-ancestor
102051548|NCT03113071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051549|NCT03113071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102051550|NCT03113071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102051551|NCT03113071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101697860|NCT00662844|Vitamin D|vitamin d|mesh-list
102051552|NCT03113071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102051553|NCT03113071|Protective Agents|protective agents|mesh-ancestor
102051554|NCT03113071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051555|NCT03050307|Lansoprazole|lansoprazole|mesh-list
102051556|NCT03050307|Dexlansoprazole|dexlansoprazole|mesh-list
102051557|NCT03050307|Bismuth|bismuth|mesh-list
102051558|NCT03050307|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102051559|NCT03050307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102051560|NCT03050307|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102051561|NCT03050307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102051562|NCT03050307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051563|NCT03050307|Antacids|antacids|mesh-ancestor
102051564|NCT02127866|Beclomethasone|beclomethasone|mesh-list
102051565|NCT02127866|Glycopyrrolate|glycopyrrolate|mesh-list
102051566|NCT02127866|Formoterol Fumarate|formoterol fumarate|mesh-list
102051567|NCT02127866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102051568|NCT02127866|Autonomic Agents|autonomic agents|mesh-ancestor
102051569|NCT02127866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102051570|NCT02127866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051571|NCT02127866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102051572|NCT02127866|Respiratory System Agents|respiratory system agents|mesh-ancestor
102051573|NCT02127866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102051574|NCT02127866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102051575|NCT02127866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102051579|NCT02127866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102051580|NCT02127866|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102051581|NCT02127866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102051582|NCT02127866|Cholinergic Agents|cholinergic agents|mesh-ancestor
102051583|NCT02127866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101942094|NCT03643900|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101942096|NCT03643900|Analgesics|analgesics|mesh-ancestor
101942097|NCT03643900|Sensory System Agents|sensory system agents|mesh-ancestor
101942098|NCT03643900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101942099|NCT03643900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942100|NCT03643900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101942101|NCT03643900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101942102|NCT03643900|Gout Suppressants|gout suppressants|mesh-ancestor
101942103|NCT03643900|Tocolytic Agents|tocolytic agents|mesh-ancestor
102051584|NCT02127866|Glucocorticoids|glucocorticoids|mesh-ancestor
102051585|NCT02127866|Hormones|hormones|mesh-ancestor
102051586|NCT02127866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102051587|NCT03550508|Antibodies|antibodies|mesh-list
102051588|NCT03550508|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102051589|NCT03550508|Immunologic Factors|immunologic factors|mesh-ancestor
102051590|NCT03550508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051591|NCT03607578|Sunscreening Agents|sunscreening agents|mesh-list
102051592|NCT03607578|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102051593|NCT03607578|Protective Agents|protective agents|mesh-ancestor
102051594|NCT03607578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051595|NCT03607578|Dermatologic Agents|dermatologic agents|mesh-ancestor
102051596|NCT05760079|Lactoferrin|lactoferrin|mesh-list
102051597|NCT05760079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102051598|NCT03603834|Leucovorin|leucovorin|mesh-list
102051599|NCT03603834|Fluorouracil|fluorouracil|mesh-list
102051600|NCT03603834|Oxaliplatin|oxaliplatin|mesh-list
102051601|NCT03603834|Irinotecan|irinotecan|mesh-list
102051602|NCT03603834|Antimetabolites|antimetabolites|mesh-ancestor
102051603|NCT03603834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051604|NCT03603834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102051605|NCT03603834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102051606|NCT03603834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102051607|NCT03603834|Immunologic Factors|immunologic factors|mesh-ancestor
102051608|NCT03603834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051609|NCT03603834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102051610|NCT03603834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102051611|NCT03603834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102051612|NCT03603834|Antidotes|antidotes|mesh-ancestor
102051613|NCT03603834|Protective Agents|protective agents|mesh-ancestor
102051614|NCT03603834|Vitamin B Complex|vitamin b complex|mesh-ancestor
102051615|NCT03603834|Vitamins|vitamins|mesh-ancestor
102051616|NCT03603834|Micronutrients|micronutrients|mesh-ancestor
102051617|NCT03601338|Bemiparin|bemiparin|mesh-list
102051618|NCT03601338|Anticoagulants|anticoagulants|mesh-ancestor
102051619|NCT02128022|Glyburide|glyburide|mesh-list
102051620|NCT02128022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102051621|NCT02128022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051622|NCT03256045|Dexamethasone|dexamethasone|mesh-list
102051623|NCT03256045|Dexamethasone acetate|dexamethasone acetate|mesh-list
102051624|NCT03256045|Panobinostat|panobinostat|mesh-list
102051625|NCT03256045|Ichthammol|ichthammol|mesh-list
102051626|NCT03256045|BB 1101|bb 1101|mesh-list
102051627|NCT03256045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102051628|NCT03256045|Antiemetics|antiemetics|mesh-ancestor
102051629|NCT03256045|Autonomic Agents|autonomic agents|mesh-ancestor
102051630|NCT03256045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102051631|NCT03256045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051632|NCT03256045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102051633|NCT03256045|Glucocorticoids|glucocorticoids|mesh-ancestor
102051634|NCT03256045|Hormones|hormones|mesh-ancestor
102051635|NCT03256045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102051636|NCT03256045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102051637|NCT03256045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102051638|NCT03256045|Protease Inhibitors|protease inhibitors|mesh-ancestor
102051639|NCT03256045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102051640|NCT03256045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051641|NCT03256045|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101942104|NCT03643900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101942105|NCT03643900|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102051642|NCT03256045|Dermatologic Agents|dermatologic agents|mesh-ancestor
102051643|NCT03603756|Paclitaxel|paclitaxel|mesh-list
102051644|NCT03603756|Irinotecan|irinotecan|mesh-list
102051645|NCT03603756|Apatinib|apatinib|mesh-list
102051646|NCT03603756|Nedaplatin|nedaplatin|mesh-list
102051647|NCT03603756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102051648|NCT03603756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102051649|NCT03603756|Tubulin Modulators|tubulin modulators|mesh-ancestor
102051654|NCT03603756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101771385|NCT01054105|Iloprost|iloprost|mesh-list
102051655|NCT03603756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102051656|NCT03603756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102051657|NCT02372409|Doxorubicin|doxorubicin|mesh-list
102051658|NCT02372409|Etoposide|etoposide|mesh-list
102051659|NCT02372409|Etoposide phosphate|etoposide phosphate|mesh-list
102051660|NCT02372409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102051661|NCT02372409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102051662|NCT02372409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102051663|NCT02372409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102051664|NCT02372409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102051665|NCT02372409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051666|NCT02372409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102051667|NCT03626259|Losartan|losartan|mesh-list
102051668|NCT03626259|Amlodipine|amlodipine|mesh-list
102051669|NCT03626259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102051670|NCT03626259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102051671|NCT03626259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102051672|NCT03626259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051673|NCT03626259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102051674|NCT03626259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051675|NCT03626259|Vasodilator Agents|vasodilator agents|mesh-ancestor
102051676|NCT03626259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102051677|NCT03626259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102051678|NCT03626259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102051679|NCT03601260|Allopurinol|allopurinol|mesh-list
102051680|NCT03601260|Antimetabolites|antimetabolites|mesh-ancestor
102051681|NCT03601260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051682|NCT03601260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102051683|NCT03601260|Gout Suppressants|gout suppressants|mesh-ancestor
102051684|NCT03601260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102051685|NCT03601260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102051686|NCT03601260|Antioxidants|antioxidants|mesh-ancestor
102051687|NCT03601260|Protective Agents|protective agents|mesh-ancestor
102051688|NCT03601260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051689|NCT05193253|Liver Extracts|liver extracts|mesh-list
102051690|NCT05193253|Hematinics|hematinics|mesh-ancestor
102051691|NCT02131922|Chlorhexidine|chlorhexidine|mesh-list
102051692|NCT02131922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102051693|NCT02131922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102051694|NCT02131922|Disinfectants|disinfectants|mesh-ancestor
102051695|NCT03600948|Sirolimus|sirolimus|mesh-list
102051696|NCT03600948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102051697|NCT03600948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102051698|NCT03600948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102051699|NCT03600948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102051700|NCT03600948|Antifungal Agents|antifungal agents|mesh-ancestor
102051701|NCT03600948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102051702|NCT03600948|Immunologic Factors|immunologic factors|mesh-ancestor
102051703|NCT03600948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051704|NCT02132000|Tamoxifen|tamoxifen|mesh-list
102051705|NCT02132000|Toremifene|toremifene|mesh-list
102051706|NCT02132000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102051707|NCT02132000|Hormone Antagonists|hormone antagonists|mesh-ancestor
102051708|NCT02132000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102051709|NCT02132000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051710|NCT02132000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102051711|NCT02132000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102051712|NCT02132000|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102051713|NCT02132000|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102051714|NCT02132000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102051715|NCT03118765|Bromides|bromides|mesh-list
102051716|NCT03118765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101942106|NCT03643900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101942107|NCT03643900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942109|NCT03919383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101942110|NCT03919383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101942111|NCT03919383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101942112|NCT03919383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051717|NCT03118765|Tiotropium Bromide|tiotropium bromide|mesh-list
102051718|NCT03118765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102051719|NCT03118765|Autonomic Agents|autonomic agents|mesh-ancestor
102051722|NCT03118765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102051723|NCT03118765|Respiratory System Agents|respiratory system agents|mesh-ancestor
102051724|NCT03118765|Parasympatholytics|parasympatholytics|mesh-ancestor
102051725|NCT03118765|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102051726|NCT03118765|Cholinergic Agents|cholinergic agents|mesh-ancestor
102051727|NCT03118765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102051728|NCT03118765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051729|NCT03118765|Anticonvulsants|anticonvulsants|mesh-ancestor
102051731|NCT02128100|Fluorouracil|fluorouracil|mesh-list
102051732|NCT02128100|Oxaliplatin|oxaliplatin|mesh-list
102051733|NCT02128100|Irinotecan|irinotecan|mesh-list
102051734|NCT02128100|Folfirinox|folfirinox|mesh-list
102051735|NCT02128100|Antimetabolites|antimetabolites|mesh-ancestor
102051736|NCT02128100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051737|NCT02128100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102051738|NCT02128100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102051739|NCT02128100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102051740|NCT02128100|Immunologic Factors|immunologic factors|mesh-ancestor
102051741|NCT02128100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051742|NCT02128100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102051743|NCT02128100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102051744|NCT02128100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102051745|NCT02128100|Antidotes|antidotes|mesh-ancestor
102051746|NCT02128100|Protective Agents|protective agents|mesh-ancestor
102051747|NCT02128100|Vitamin B Complex|vitamin b complex|mesh-ancestor
102051748|NCT02128100|Vitamins|vitamins|mesh-ancestor
102051749|NCT02128100|Micronutrients|micronutrients|mesh-ancestor
102051750|NCT03603366|Aspirin|aspirin|mesh-list
102051751|NCT03603366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102051752|NCT03603366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102051753|NCT03603366|Analgesics|analgesics|mesh-ancestor
102051754|NCT03603366|Sensory System Agents|sensory system agents|mesh-ancestor
102051755|NCT03603366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102051756|NCT03603366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051757|NCT03603366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102051758|NCT03603366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102051759|NCT03603366|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102051760|NCT03603366|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102051761|NCT03603366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051762|NCT03603366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102051763|NCT03603366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102051764|NCT03603366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102051765|NCT03603366|Antipyretics|antipyretics|mesh-ancestor
102051766|NCT02128178|Enoxaparin|enoxaparin|mesh-list
102051767|NCT02128178|Enoxaparin sodium|enoxaparin sodium|mesh-list
102051768|NCT02128178|Anticoagulants|anticoagulants|mesh-ancestor
102051769|NCT02128178|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102051770|NCT02128178|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102051771|NCT02128178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051772|NCT03600870|Midodrine|midodrine|mesh-list
102051773|NCT03600870|Sympathomimetics|sympathomimetics|mesh-ancestor
102051774|NCT03600870|Autonomic Agents|autonomic agents|mesh-ancestor
102051775|NCT03600870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102051776|NCT03600870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051777|NCT03600870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102051778|NCT03600870|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102051779|NCT03600870|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102051780|NCT03600870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102051781|NCT03600870|Adrenergic Agents|adrenergic agents|mesh-ancestor
101942113|NCT01131897|Levetiracetam|levetiracetam|mesh-list
101942114|NCT01131897|Anticonvulsants|anticonvulsants|mesh-ancestor
101942115|NCT01131897|Nootropic Agents|nootropic agents|mesh-ancestor
101942116|NCT01225419|Plerixafor|plerixafor|mesh-list
101942117|NCT01225419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101942118|NCT01225419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101942119|NCT01225419|Antiviral Agents|antiviral agents|mesh-ancestor
101942120|NCT01225419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101942121|NCT03919461|Etodolac|etodolac|mesh-list
101942122|NCT03919461|Propranolol|propranolol|mesh-list
101942123|NCT03919461|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101942124|NCT03919461|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101942125|NCT03919461|Adrenergic Agents|adrenergic agents|mesh-ancestor
102051782|NCT03600870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102051783|NCT03600870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051784|NCT02128334|Leuprolide|leuprolide|mesh-list
102051785|NCT02128334|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102051786|NCT02128334|Fertility Agents|fertility agents|mesh-ancestor
102051787|NCT02128334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102051788|NCT02128334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051789|NCT02128334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102051790|NCT02128334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102051791|NCT01375699|Doxorubicin|doxorubicin|mesh-list
102051792|NCT01375699|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102051793|NCT01375699|Sildenafil Citrate|sildenafil citrate|mesh-list
102051799|NCT01375699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051800|NCT01375699|Vasodilator Agents|vasodilator agents|mesh-ancestor
102051801|NCT01375699|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102051802|NCT01375699|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102051803|NCT01375699|Urological Agents|urological agents|mesh-ancestor
102051804|NCT01373983|Ziconotide|ziconotide|mesh-list
102051805|NCT01373983|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102051806|NCT01373983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102051807|NCT01373983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697892|NCT02650388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102051808|NCT01373983|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102051809|NCT01373983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051810|NCT01373983|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102051811|NCT01373983|Protective Agents|protective agents|mesh-ancestor
102051812|NCT01373983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102051813|NCT01373983|Analgesics|analgesics|mesh-ancestor
102051814|NCT01373983|Sensory System Agents|sensory system agents|mesh-ancestor
102051815|NCT01373983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102051816|NCT05173597|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102051817|NCT05173597|Hormones|hormones|mesh-ancestor
102051818|NCT05173597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102051819|NCT05173597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051820|NCT05812612|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102051821|NCT05812612|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102051822|NCT05812612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102051823|NCT05812521|Methylene Blue|methylene blue|mesh-list
102051824|NCT05812521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102051825|NCT05812521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051826|NCT05812430|Paclitaxel|paclitaxel|mesh-list
102051827|NCT05812430|Cisplatin|cisplatin|mesh-list
102051828|NCT05812430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102051829|NCT05812430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102051830|NCT05812430|Tubulin Modulators|tubulin modulators|mesh-ancestor
102051831|NCT05812430|Antimitotic Agents|antimitotic agents|mesh-ancestor
102051832|NCT05812430|Mitosis Modulators|mitosis modulators|mesh-ancestor
102051833|NCT05812430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051834|NCT05812404|Fexuprazan|fexuprazan|mesh-list
102051835|NCT05812404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102051836|NCT03607110|Fentanyl|fentanyl|mesh-list
102051837|NCT03607110|Ketamine|ketamine|mesh-list
102051838|NCT03607110|Analgesics|analgesics|mesh-ancestor
101942126|NCT03919461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101942127|NCT03919461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942128|NCT03919461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307089|NCT02029586|Antiviral Agents|antiviral agents|mesh-ancestor
102051839|NCT03607110|Sensory System Agents|sensory system agents|mesh-ancestor
102051840|NCT03607110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102051841|NCT03607110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051842|NCT03607110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102051843|NCT03607110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102051844|NCT03607110|Anesthetics, General|anesthetics, general|mesh-ancestor
102051845|NCT03607110|Anesthetics|anesthetics|mesh-ancestor
102051846|NCT03607110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102051847|NCT03607110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102051848|NCT03607110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102051849|NCT03607110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102051850|NCT03607110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051851|NCT03607110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102051852|NCT03607110|Narcotics|narcotics|mesh-ancestor
102051853|NCT03607110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102051854|NCT05811793|Bevacizumab|bevacizumab|mesh-list
102051855|NCT05811793|Tislelizumab|tislelizumab|mesh-list
102051856|NCT05811793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102051857|NCT05811793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102051858|NCT05811793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102051859|NCT05811793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102051860|NCT05811793|Growth Substances|growth substances|mesh-ancestor
102051861|NCT05811793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353349|NCT00050154|Tipifarnib|tipifarnib|mesh-list
102051863|NCT05811507|Testosterone|testosterone|mesh-list
102051864|NCT05811507|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
102051865|NCT05811507|Androgens|androgens|mesh-ancestor
102051866|NCT05811507|Hormones|hormones|mesh-ancestor
101697901|NCT00883740|Anticonvulsants|anticonvulsants|mesh-ancestor
102051867|NCT05811507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102051868|NCT05811507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051869|NCT05811507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102051870|NCT05811507|Immunologic Factors|immunologic factors|mesh-ancestor
102051871|NCT05811377|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102051872|NCT05811377|Hematinics|hematinics|mesh-ancestor
102051873|NCT05811377|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102051874|NCT05811377|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102051875|NCT05811221|Anesthetics|anesthetics|mesh-list
102051876|NCT05811221|Esketamine|esketamine|mesh-list
102051877|NCT05811221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102051878|NCT05811221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051879|NCT05811221|Antidepressive Agents|antidepressive agents|mesh-ancestor
102051880|NCT05811221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102051881|NCT05811000|Donepezil|donepezil|mesh-list
102051882|NCT05811000|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102051883|NCT05811000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102051884|NCT05811000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051885|NCT05811000|Cholinergic Agents|cholinergic agents|mesh-ancestor
102051886|NCT05811000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102051887|NCT05811000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051888|NCT05811000|Nootropic Agents|nootropic agents|mesh-ancestor
102051889|NCT05810909|Calcium Carbonate|calcium carbonate|mesh-list
102051891|NCT05810909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102051892|NCT05810909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051893|NCT05810909|Antacids|antacids|mesh-ancestor
102051894|NCT05810909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051895|NCT05810909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102051896|NCT05810350|Pemetrexed|pemetrexed|mesh-list
102051897|NCT05810350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102051898|NCT05810350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102051899|NCT05810350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051900|NCT05810350|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102051901|NCT05810350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102051902|NCT05807360|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102051903|NCT05807360|Hyaluronic Acid|hyaluronic acid|mesh-list
102051904|NCT05807360|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101942130|NCT03919461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101942131|NCT03919461|Vasodilator Agents|vasodilator agents|mesh-ancestor
101307092|NCT02029599|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102051905|NCT05807360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102051906|NCT05807360|Immunologic Factors|immunologic factors|mesh-ancestor
102051907|NCT05807360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051908|NCT05807360|Viscosupplements|viscosupplements|mesh-ancestor
102051909|NCT05807360|Protective Agents|protective agents|mesh-ancestor
102051910|NCT05803655|Oxymetazoline|oxymetazoline|mesh-list
102051911|NCT05803655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102051912|NCT05803655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102051913|NCT05803655|Adrenergic Agents|adrenergic agents|mesh-ancestor
102051914|NCT05803655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102051915|NCT05803655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051916|NCT05803655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051917|NCT05803655|Sympathomimetics|sympathomimetics|mesh-ancestor
102051918|NCT05803655|Autonomic Agents|autonomic agents|mesh-ancestor
102051919|NCT05803655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102051920|NCT05803655|Nasal Decongestants|nasal decongestants|mesh-ancestor
102051921|NCT05803655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102051922|NCT05803655|Respiratory System Agents|respiratory system agents|mesh-ancestor
102051923|NCT05801224|Nitric Oxide|nitric oxide|mesh-list
101697919|NCT02773199|Bupivacaine|bupivacaine|mesh-list
102051924|NCT05801224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102051925|NCT05801224|Autonomic Agents|autonomic agents|mesh-ancestor
102051926|NCT05801224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102051927|NCT05801224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051928|NCT05801224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102051929|NCT05801224|Respiratory System Agents|respiratory system agents|mesh-ancestor
102051930|NCT05801224|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102051931|NCT05801224|Antioxidants|antioxidants|mesh-ancestor
102051932|NCT05801224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051933|NCT05801224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102051934|NCT05801224|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102051935|NCT05801224|Vasodilator Agents|vasodilator agents|mesh-ancestor
102051936|NCT05801224|Gasotransmitters|gasotransmitters|mesh-ancestor
102051957|NCT05754853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102051959|NCT05747625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102051960|NCT05747625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102051961|NCT05742347|Protective Agents|protective agents|mesh-list
102051962|NCT05742347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051963|NCT05729932|Analgesics, Opioid|analgesics, opioid|mesh-list
102051964|NCT05729932|Narcotics|narcotics|mesh-ancestor
102051965|NCT05729932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102051966|NCT05729932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051967|NCT05729932|Analgesics|analgesics|mesh-ancestor
102051968|NCT05729932|Sensory System Agents|sensory system agents|mesh-ancestor
102051969|NCT05729932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102051970|NCT05708989|Dexmedetomidine|dexmedetomidine|mesh-list
102051971|NCT05708989|Ropivacaine|ropivacaine|mesh-list
102051972|NCT05708989|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102051973|NCT05708989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102051974|NCT05708989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051975|NCT05708989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102051976|NCT05708989|Analgesics|analgesics|mesh-ancestor
102051977|NCT05708989|Sensory System Agents|sensory system agents|mesh-ancestor
102051978|NCT05708989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102051979|NCT05708989|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102051980|NCT05708989|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102051981|NCT05708989|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102051982|NCT05708989|Adrenergic Agents|adrenergic agents|mesh-ancestor
102051983|NCT05708989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102051984|NCT05708989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051985|NCT05708989|Anesthetics, Local|anesthetics, local|mesh-ancestor
102051986|NCT05708989|Anesthetics|anesthetics|mesh-ancestor
102051987|NCT05705427|Tenofovir|tenofovir|mesh-list
102051988|NCT05705427|Vaccines|vaccines|mesh-list
102051989|NCT05705427|Immunologic Factors|immunologic factors|mesh-ancestor
102051990|NCT05705427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051991|NCT05705427|Antiviral Agents|antiviral agents|mesh-ancestor
101942132|NCT03919461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101942133|NCT03919461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102051992|NCT05705427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102051996|NCT05705427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051998|NCT05705427|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102051999|NCT05692869|Propranolol|propranolol|mesh-list
102052000|NCT05692869|Pseudoephedrine|pseudoephedrine|mesh-list
102052001|NCT05692869|Ephedrine|ephedrine|mesh-list
102052002|NCT05692869|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102052003|NCT05692869|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102052004|NCT05692869|Adrenergic Agents|adrenergic agents|mesh-ancestor
102052005|NCT05692869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102052006|NCT05692869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052007|NCT05692869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052008|NCT05692869|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102052009|NCT05692869|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102052010|NCT05692869|Vasodilator Agents|vasodilator agents|mesh-ancestor
102052011|NCT05692869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102052012|NCT05692869|Autonomic Agents|autonomic agents|mesh-ancestor
102052013|NCT05692869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102052014|NCT05692869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102052015|NCT05692869|Respiratory System Agents|respiratory system agents|mesh-ancestor
102052016|NCT05692869|Nasal Decongestants|nasal decongestants|mesh-ancestor
102052017|NCT05692869|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102052018|NCT05692869|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102052019|NCT05692869|Sympathomimetics|sympathomimetics|mesh-ancestor
102052020|NCT05655468|Dronedarone|dronedarone|mesh-list
102052021|NCT05655468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102052022|NCT05644353|Mirikizumab|mirikizumab|mesh-list
102052023|NCT05644353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102052024|NCT05644353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102052025|NCT05644353|Analgesics|analgesics|mesh-ancestor
102052026|NCT05644353|Sensory System Agents|sensory system agents|mesh-ancestor
102052027|NCT05644353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102052028|NCT05644353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052029|NCT05644353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102052030|NCT05644353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102052031|NCT05644353|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102052032|NCT05644353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102052033|NCT05563389|Atorvastatin|atorvastatin|mesh-list
101771760|NCT00539734|Growth Substances|growth substances|mesh-ancestor
102052034|NCT05563389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102052035|NCT05563389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102052036|NCT05563389|Antimetabolites|antimetabolites|mesh-ancestor
102052037|NCT05563389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052038|NCT05563389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102052039|NCT05563389|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102052040|NCT05563389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102052042|NCT05548660|Sensory System Agents|sensory system agents|mesh-ancestor
102052043|NCT05548660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102052044|NCT05548660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052045|NCT05539963|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102052046|NCT05539963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102052047|NCT05525273|Trametinib|trametinib|mesh-list
102052048|NCT05525273|Dabrafenib|dabrafenib|mesh-list
102052049|NCT05525273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102052050|NCT05525273|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102052051|NCT05525273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102052052|NCT05525273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052053|NCT05511766|Allopurinol|allopurinol|mesh-list
102052054|NCT05511766|Atorvastatin|atorvastatin|mesh-list
102052055|NCT05511766|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102052056|NCT05511766|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102052057|NCT05511766|Antimetabolites|antimetabolites|mesh-ancestor
102052058|NCT05511766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052059|NCT05511766|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102052060|NCT05511766|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102052061|NCT05511766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102052062|NCT05511766|Gout Suppressants|gout suppressants|mesh-ancestor
102052066|NCT05511766|Protective Agents|protective agents|mesh-ancestor
101942135|NCT03919461|Sensory System Agents|sensory system agents|mesh-ancestor
101942136|NCT03919461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101942137|NCT03919461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101942138|NCT03919461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101942139|NCT03919461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101942140|NCT03919461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102052067|NCT05511766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052068|NCT05476796|Trifluridine|trifluridine|mesh-list
102052069|NCT05476796|Oxaliplatin|oxaliplatin|mesh-list
102052070|NCT05476796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102052071|NCT05476796|Antimetabolites|antimetabolites|mesh-ancestor
102052072|NCT05476796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052073|NCT05476796|Antiviral Agents|antiviral agents|mesh-ancestor
102052074|NCT05476796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102052075|NCT05466734|Cilostazol|cilostazol|mesh-list
102052076|NCT05466734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101697936|NCT00656526|Lidocaine|lidocaine|mesh-list
102052077|NCT05466734|Autonomic Agents|autonomic agents|mesh-ancestor
102052078|NCT05466734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102052079|NCT05466734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052080|NCT05466734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102052081|NCT05466734|Respiratory System Agents|respiratory system agents|mesh-ancestor
102052082|NCT05466734|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102052083|NCT05466734|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102052084|NCT05466734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052085|NCT05466734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102052086|NCT05466734|Vasodilator Agents|vasodilator agents|mesh-ancestor
102052087|NCT05466734|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102052088|NCT05466734|Protective Agents|protective agents|mesh-ancestor
102052089|NCT05466734|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102052090|NCT05466734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102052091|NCT05466734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102052092|NCT05450029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102052093|NCT05450029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052094|NCT05450029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102052095|NCT05450029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102052096|NCT05420402|Propofol|propofol|mesh-list
102052097|NCT05420402|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102052098|NCT05420402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102052099|NCT05420402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052100|NCT05420402|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102052101|NCT05420402|Anesthetics, General|anesthetics, general|mesh-ancestor
102052102|NCT05420402|Anesthetics|anesthetics|mesh-ancestor
102052103|NCT05417087|Vortioxetine|vortioxetine|mesh-list
102052104|NCT05417087|Antidepressive Agents|antidepressive agents|mesh-ancestor
102052105|NCT05417087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102052106|NCT05417087|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102052107|NCT05417087|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102052108|NCT05417087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102052109|NCT05417087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052110|NCT05417087|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102052111|NCT05417087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102052112|NCT05417087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102052113|NCT05417087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052114|NCT05417087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102052115|NCT05417087|Serotonin Agents|serotonin agents|mesh-ancestor
102052116|NCT05417087|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102052117|NCT05417087|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102052118|NCT05417087|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102052119|NCT05417087|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102052120|NCT05416957|Vortioxetine|vortioxetine|mesh-list
102052121|NCT05416957|Antidepressive Agents|antidepressive agents|mesh-ancestor
102052122|NCT05416957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102052123|NCT05416957|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102052124|NCT05416957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102052125|NCT05416957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102052126|NCT05416957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942141|NCT03919461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101942142|NCT02528877|Sirolimus|sirolimus|mesh-list
101942143|NCT02528877|Fludarabine|fludarabine|mesh-list
102052127|NCT05416957|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102052128|NCT05416957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102052129|NCT05416957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102052130|NCT05416957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052131|NCT05416957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102052132|NCT05416957|Serotonin Agents|serotonin agents|mesh-ancestor
102052136|NCT05416957|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102052137|NCT05416762|Vortioxetine|vortioxetine|mesh-list
102052138|NCT05416762|Antidepressive Agents|antidepressive agents|mesh-ancestor
102052139|NCT05416762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102052140|NCT05416762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102052141|NCT05416762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102052142|NCT05416762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102052143|NCT05416762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052144|NCT05416762|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102052145|NCT05416762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102052146|NCT05416762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102052147|NCT05416762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052148|NCT05416762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102052149|NCT05416762|Serotonin Agents|serotonin agents|mesh-ancestor
102052150|NCT05416762|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102052151|NCT05416762|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102052152|NCT05416762|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102052153|NCT05416762|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102052155|NCT05383742|Isoniazid|isoniazid|mesh-list
102052156|NCT05383742|Linezolid|linezolid|mesh-list
102052157|NCT05383742|Pyrazinamide|pyrazinamide|mesh-list
102052158|NCT05383742|Ethambutol|ethambutol|mesh-list
102052159|NCT05383742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102052160|NCT05383742|Antitubercular Agents|antitubercular agents|mesh-ancestor
102052161|NCT05383742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102052162|NCT05383742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102052163|NCT05383742|Leprostatic Agents|leprostatic agents|mesh-ancestor
102052164|NCT05383742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102052165|NCT05383742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102052166|NCT05383742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052167|NCT05383742|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102052168|NCT05383742|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102052169|NCT05383742|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102052170|NCT05383742|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102052171|NCT05383742|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102052172|NCT05383742|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102052173|NCT05383742|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102052174|NCT05383742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102052175|NCT05383742|Antimetabolites|antimetabolites|mesh-ancestor
102052176|NCT05383742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102052177|NCT05383742|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102052178|NCT05365802|FAPI-46|fapi-46|mesh-list
102052179|NCT05365802|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102052180|NCT05365802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052181|NCT05358639|Olaparib|olaparib|mesh-list
102052182|NCT05358639|Navitoclax|navitoclax|mesh-list
102052183|NCT05358639|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102052184|NCT05358639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102052185|NCT05358639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052186|NCT05358639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102052187|NCT05330871|Vaccines|vaccines|mesh-list
102052188|NCT05330871|Immunologic Factors|immunologic factors|mesh-ancestor
102052189|NCT05330871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052190|NCT05327595|Midazolam|midazolam|mesh-list
102052191|NCT05327595|Atorvastatin|atorvastatin|mesh-list
102052192|NCT05327595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102052193|NCT05327595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102052194|NCT05327595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102052195|NCT05327595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052196|NCT05327595|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102052197|NCT05327595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102052198|NCT05327595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101942145|NCT02528877|Melphalan|melphalan|mesh-list
101942146|NCT02528877|Mechlorethamine|mechlorethamine|mesh-list
101942147|NCT02528877|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
101942148|NCT02528877|Tacrolimus|tacrolimus|mesh-list
101942149|NCT02528877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102052199|NCT05327595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102052200|NCT05327595|Anesthetics, General|anesthetics, general|mesh-ancestor
102052201|NCT05327595|Anesthetics|anesthetics|mesh-ancestor
102052202|NCT05327595|GABA Modulators|gaba modulators|mesh-ancestor
102052209|NCT05327595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102052210|NCT05327595|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102052211|NCT05327595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102052212|NCT05314153|Brexanolone|brexanolone|mesh-list
102052213|NCT05314153|Neurosteroids|neurosteroids|mesh-ancestor
102052214|NCT05314153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102052215|NCT05314153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052216|NCT05314153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052217|NCT05314153|GABA Modulators|gaba modulators|mesh-ancestor
102052218|NCT05314153|GABA Agents|gaba agents|mesh-ancestor
102052219|NCT05283408|Dexmedetomidine|dexmedetomidine|mesh-list
102052220|NCT05283408|Esketamine|esketamine|mesh-list
102052221|NCT05283408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102052222|NCT05283408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102052223|NCT05283408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052224|NCT05283408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102052225|NCT05283408|Analgesics|analgesics|mesh-ancestor
102052226|NCT05283408|Sensory System Agents|sensory system agents|mesh-ancestor
102052227|NCT05283408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102052228|NCT05283408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102052229|NCT05283408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102052230|NCT05283408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102052231|NCT05283408|Adrenergic Agents|adrenergic agents|mesh-ancestor
102052232|NCT05283408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102052233|NCT05283408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052234|NCT05283408|Antidepressive Agents|antidepressive agents|mesh-ancestor
102052235|NCT05283408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102052236|NCT05275400|Insulin|insulin|mesh-list
102052237|NCT05275400|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102052238|NCT05275400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102052239|NCT05275400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052240|NCT05240755|Cannabidiol|cannabidiol|mesh-list
102052241|NCT05240755|Anticonvulsants|anticonvulsants|mesh-ancestor
102052242|NCT05229315|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102052243|NCT05229315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052244|NCT05229315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102052245|NCT05229315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102052246|NCT05213143|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102052247|NCT05213143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102052248|NCT05213143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102052249|NCT05213143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102052250|NCT05213143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052251|NCT05213143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102052252|NCT05213143|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102052253|NCT05213143|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102052254|NCT05213143|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102052255|NCT05213143|Adrenergic Agents|adrenergic agents|mesh-ancestor
102052256|NCT05213143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102052257|NCT05213143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052258|NCT05213143|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102052259|NCT05213143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102052260|NCT05213143|Serotonin Agents|serotonin agents|mesh-ancestor
102052261|NCT05213143|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102052262|NCT05213143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102052263|NCT05213143|Dopamine Agents|dopamine agents|mesh-ancestor
102052264|NCT05208931|Mitogens|mitogens|mesh-list
102052265|NCT05208931|Endothelial Growth Factors|endothelial growth factors|mesh-list
102052266|NCT05208931|Mitosis Modulators|mitosis modulators|mesh-ancestor
102052267|NCT05208931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942150|NCT02528877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101942151|NCT02528877|Antimetabolites|antimetabolites|mesh-ancestor
101942152|NCT02528877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942153|NCT02528877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102052268|NCT05208931|Growth Substances|growth substances|mesh-ancestor
102052269|NCT05208931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052270|NCT05191862|Cilostazol|cilostazol|mesh-list
102052275|NCT05191862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102052276|NCT05191862|Respiratory System Agents|respiratory system agents|mesh-ancestor
102052277|NCT05191862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102052278|NCT05191862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102052279|NCT05191862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052280|NCT05191862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102052281|NCT05191862|Vasodilator Agents|vasodilator agents|mesh-ancestor
102052282|NCT05191862|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102052283|NCT05191862|Protective Agents|protective agents|mesh-ancestor
102052284|NCT05191862|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102052285|NCT05191862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102052286|NCT05191862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102052287|NCT05189704|Analgesics, Opioid|analgesics, opioid|mesh-list
102052288|NCT05189704|Narcotics|narcotics|mesh-ancestor
102052289|NCT05189704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102052290|NCT05189704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052291|NCT05189704|Analgesics|analgesics|mesh-ancestor
102052292|NCT05189704|Sensory System Agents|sensory system agents|mesh-ancestor
102052293|NCT05189704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102052294|NCT05179421|Oxytocin|oxytocin|mesh-list
102052295|NCT05179421|Oxytocics|oxytocics|mesh-ancestor
102052296|NCT05179421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102052297|NCT05179421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052298|NCT05100160|Gabapentin|gabapentin|mesh-list
102052299|NCT05100160|Analgesics|analgesics|mesh-ancestor
102052300|NCT05100160|Sensory System Agents|sensory system agents|mesh-ancestor
102052301|NCT05100160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102052302|NCT05100160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052303|NCT05100160|Anticonvulsants|anticonvulsants|mesh-ancestor
102052304|NCT05100160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102052305|NCT05100160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102052306|NCT05100160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102052307|NCT05100160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102052308|NCT05100160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102052309|NCT05100160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102052310|NCT05100160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102052311|NCT05100160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052312|NCT05100160|Antimanic Agents|antimanic agents|mesh-ancestor
102052313|NCT05052931|Paclitaxel|paclitaxel|mesh-list
102052314|NCT05052931|Oxaliplatin|oxaliplatin|mesh-list
102052315|NCT05052931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102052316|NCT05052931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102052317|NCT05052931|Tubulin Modulators|tubulin modulators|mesh-ancestor
102052318|NCT05052931|Antimitotic Agents|antimitotic agents|mesh-ancestor
102052319|NCT05052931|Mitosis Modulators|mitosis modulators|mesh-ancestor
102052320|NCT05052931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052321|NCT05052229|Nitric Oxide|nitric oxide|mesh-list
102052322|NCT05052229|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102052323|NCT05052229|Autonomic Agents|autonomic agents|mesh-ancestor
101697973|NCT00649688|Sympatholytics|sympatholytics|mesh-ancestor
102052324|NCT05052229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102052325|NCT05052229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052326|NCT05052229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102052327|NCT05052229|Respiratory System Agents|respiratory system agents|mesh-ancestor
102052328|NCT05052229|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102052329|NCT05052229|Antioxidants|antioxidants|mesh-ancestor
101772059|NCT00780780|Nepafenac|nepafenac|mesh-list
102052330|NCT05052229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052331|NCT05052229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102052332|NCT05052229|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102052333|NCT05052229|Vasodilator Agents|vasodilator agents|mesh-ancestor
102052334|NCT05052229|Gasotransmitters|gasotransmitters|mesh-ancestor
102052335|NCT05052229|Protective Agents|protective agents|mesh-ancestor
102052336|NCT05048212|Nivolumab|nivolumab|mesh-list
102052337|NCT05048212|Ipilimumab|ipilimumab|mesh-list
101942154|NCT02528877|Immunologic Factors|immunologic factors|mesh-ancestor
101942155|NCT02528877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942156|NCT02528877|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101942157|NCT02528877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102052338|NCT05048212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102052339|NCT05048212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353836|NCT00024440|Antimetabolites|antimetabolites|mesh-ancestor
102052345|NCT05037500|Antimetabolites|antimetabolites|mesh-ancestor
102052346|NCT05037500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052347|NCT05037500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102052348|NCT05037500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102052349|NCT05020769|Osimertinib|osimertinib|mesh-list
102052350|NCT05020769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102052351|NCT05020769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102052352|NCT05020769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102052353|NCT05020769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052354|NCT05002738|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102052355|NCT05002738|Desogestrel|desogestrel|mesh-list
102052356|NCT05002738|Estradiol|estradiol|mesh-list
102052357|NCT05002738|Estrogens|estrogens|mesh-ancestor
102052358|NCT05002738|Hormones|hormones|mesh-ancestor
102052359|NCT05002738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102052360|NCT05002738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052361|NCT05002738|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102052362|NCT05002738|Contraceptive Agents|contraceptive agents|mesh-ancestor
102052363|NCT05002738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102052364|NCT05002738|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102052365|NCT05002738|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102052366|NCT05002738|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102052367|NCT05002738|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102052368|NCT05002738|Progestins|progestins|mesh-ancestor
102052369|NCT04990284|Levodopa|levodopa|mesh-list
102052370|NCT04990284|Opicapone|opicapone|mesh-list
102052371|NCT04990284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102052372|NCT04990284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102052373|NCT04990284|Dopamine Agents|dopamine agents|mesh-ancestor
102052374|NCT04990284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102052375|NCT04990284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052376|NCT04990284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052377|NCT04990284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102052378|NCT04990284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102052379|NCT04955158|Dexmedetomidine|dexmedetomidine|mesh-list
102052380|NCT04955158|Ketamine|ketamine|mesh-list
102052381|NCT04955158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102052382|NCT04955158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102052383|NCT04955158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052384|NCT04955158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102052385|NCT04955158|Analgesics|analgesics|mesh-ancestor
102052386|NCT04955158|Sensory System Agents|sensory system agents|mesh-ancestor
102052387|NCT04955158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102052388|NCT04955158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102052389|NCT04955158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102052390|NCT04955158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102052391|NCT04955158|Adrenergic Agents|adrenergic agents|mesh-ancestor
102052392|NCT04955158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102052393|NCT04955158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052394|NCT04955158|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102052395|NCT04955158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102052396|NCT04955158|Anesthetics, General|anesthetics, general|mesh-ancestor
102052397|NCT04955158|Anesthetics|anesthetics|mesh-ancestor
102052398|NCT04955158|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102052399|NCT04955158|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102052400|NCT04928391|Dexmedetomidine|dexmedetomidine|mesh-list
102052401|NCT04928391|Nalbuphine|nalbuphine|mesh-list
102052402|NCT04928391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102052403|NCT04928391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102052404|NCT04928391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052405|NCT04928391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102052406|NCT04928391|Analgesics|analgesics|mesh-ancestor
102052407|NCT04928391|Sensory System Agents|sensory system agents|mesh-ancestor
102052412|NCT04928391|Adrenergic Agents|adrenergic agents|mesh-ancestor
101942158|NCT02528877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101942159|NCT02528877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101942160|NCT02528877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101942161|NCT02528877|Antifungal Agents|antifungal agents|mesh-ancestor
102052413|NCT04928391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102052414|NCT04928391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052415|NCT04928391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102052416|NCT04928391|Narcotics|narcotics|mesh-ancestor
102052417|NCT04928352|Bupivacaine|bupivacaine|mesh-list
102052418|NCT04928352|Anesthetics, Local|anesthetics, local|mesh-ancestor
102052419|NCT04928352|Anesthetics|anesthetics|mesh-ancestor
102052420|NCT04928352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102052421|NCT04928352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052422|NCT04928352|Sensory System Agents|sensory system agents|mesh-ancestor
102052423|NCT04928352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102052424|NCT04928300|Dexmedetomidine|dexmedetomidine|mesh-list
102052425|NCT04928300|Ketamine|ketamine|mesh-list
102052426|NCT04928300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102052427|NCT04928300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102052428|NCT04928300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052429|NCT04928300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102052430|NCT04928300|Analgesics|analgesics|mesh-ancestor
102052431|NCT04928300|Sensory System Agents|sensory system agents|mesh-ancestor
102052432|NCT04928300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102052433|NCT04928300|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102052434|NCT04928300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102052435|NCT04928300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102052436|NCT04928300|Adrenergic Agents|adrenergic agents|mesh-ancestor
102052437|NCT04928300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102052438|NCT04928300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052439|NCT04928300|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102052440|NCT04928300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102052441|NCT04928300|Anesthetics, General|anesthetics, general|mesh-ancestor
102052442|NCT04928300|Anesthetics|anesthetics|mesh-ancestor
102052443|NCT04928300|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102052444|NCT04928300|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102052445|NCT04910464|Tranexamic Acid|tranexamic acid|mesh-list
102052446|NCT04910464|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102052447|NCT04910464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102052448|NCT04910464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052449|NCT04910464|Hemostatics|hemostatics|mesh-ancestor
102052450|NCT04910464|Coagulants|coagulants|mesh-ancestor
102052451|NCT04905901|Tranexamic Acid|tranexamic acid|mesh-list
102052452|NCT04905901|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102052453|NCT04905901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102052454|NCT04905901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052455|NCT04905901|Hemostatics|hemostatics|mesh-ancestor
102052456|NCT04905901|Coagulants|coagulants|mesh-ancestor
102052457|NCT04901988|Nivolumab|nivolumab|mesh-list
102052458|NCT04901988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102052459|NCT04901988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102052460|NCT04901988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102052461|NCT04901988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052462|NCT04899687|Dextromethorphan|dextromethorphan|mesh-list
102052463|NCT04899687|Fluoxetine|fluoxetine|mesh-list
102052464|NCT04899687|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102052465|NCT04899687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102052466|NCT04899687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102052467|NCT04899687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052468|NCT04899687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102052469|NCT04899687|Serotonin Agents|serotonin agents|mesh-ancestor
102052470|NCT04899687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052471|NCT04899687|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102052472|NCT04899687|Antidepressive Agents|antidepressive agents|mesh-ancestor
102052473|NCT04899687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102052474|NCT04899687|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102052475|NCT04899687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102052479|NCT04899687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102052480|NCT04899687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101942162|NCT02528877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101942163|NCT02528877|Alkylating Agents|alkylating agents|mesh-ancestor
101942164|NCT02528877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101942165|NCT03918993|Tadalafil|tadalafil|mesh-list
101942166|NCT03918993|Vasodilator Agents|vasodilator agents|mesh-ancestor
101942167|NCT03918993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101942168|NCT03918993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101942169|NCT03918993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101942170|NCT03918993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942171|NCT03918993|Urological Agents|urological agents|mesh-ancestor
101942172|NCT03920475|Sertraline|sertraline|mesh-list
101307125|NCT02029625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102052481|NCT04823845|Adapalene|adapalene|mesh-list
102052482|NCT04823845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102052483|NCT04823845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102052484|NCT04823845|Analgesics|analgesics|mesh-ancestor
102052485|NCT04823845|Sensory System Agents|sensory system agents|mesh-ancestor
102052486|NCT04823845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102052487|NCT04823845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052488|NCT04823845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102052489|NCT04823845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102052490|NCT04823845|Dermatologic Agents|dermatologic agents|mesh-ancestor
102052491|NCT04792749|Metformin|metformin|mesh-list
102052492|NCT04792749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102052493|NCT04792749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052494|NCT04789070|Sirolimus|sirolimus|mesh-list
102052495|NCT04789070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102052496|NCT04789070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102052497|NCT04789070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102052498|NCT04789070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102052499|NCT04789070|Antifungal Agents|antifungal agents|mesh-ancestor
102052500|NCT04789070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102052501|NCT04789070|Immunologic Factors|immunologic factors|mesh-ancestor
102052502|NCT04789070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052503|NCT04756427|Citric Acid|citric acid|mesh-list
102052504|NCT04756427|Sodium Citrate|sodium citrate|mesh-list
102052505|NCT04756427|Anticoagulants|anticoagulants|mesh-list
102052506|NCT04756427|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102052507|NCT04756427|Chelating Agents|chelating agents|mesh-ancestor
102052508|NCT04756427|Sequestering Agents|sequestering agents|mesh-ancestor
102052509|NCT04756427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052510|NCT04722601|Azacitidine|azacitidine|mesh-list
102052511|NCT04722601|Venetoclax|venetoclax|mesh-list
102052512|NCT04722601|Obinutuzumab|obinutuzumab|mesh-list
102052514|NCT04722601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102052515|NCT04722601|Antimetabolites|antimetabolites|mesh-ancestor
101698012|NCT04223219|Analgesics|analgesics|mesh-ancestor
102052516|NCT04722601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052517|NCT04722601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102052518|NCT04722601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102052519|NCT04722601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102052520|NCT04692844|Propranolol|propranolol|mesh-list
102052521|NCT04692844|Primidone|primidone|mesh-list
102052522|NCT04692844|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102052523|NCT04692844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102052524|NCT04692844|Adrenergic Agents|adrenergic agents|mesh-ancestor
102052525|NCT04692844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102052526|NCT04692844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052527|NCT04692844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052528|NCT04692844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102052529|NCT04692844|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102052530|NCT04692844|Vasodilator Agents|vasodilator agents|mesh-ancestor
102052531|NCT04692844|Anticonvulsants|anticonvulsants|mesh-ancestor
102052532|NCT04692844|GABA Modulators|gaba modulators|mesh-ancestor
102052533|NCT04692844|GABA Agents|gaba agents|mesh-ancestor
102052534|NCT04657003|Tirzepatide|tirzepatide|mesh-list
101942173|NCT03920475|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101942174|NCT03920475|Antidepressive Agents|antidepressive agents|mesh-ancestor
101942175|NCT03920475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101942176|NCT03920475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102052535|NCT04657003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102052536|NCT04657003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052537|NCT04657003|Incretins|incretins|mesh-ancestor
102052538|NCT04657003|Hormones|hormones|mesh-ancestor
102052539|NCT04657003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102052540|NCT04624906|Rituximab|rituximab|mesh-list
102052541|NCT04624906|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102052542|NCT04624906|Acalabrutinib|acalabrutinib|mesh-list
102052543|NCT04624906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102052544|NCT04624906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102052545|NCT04624906|Immunologic Factors|immunologic factors|mesh-ancestor
102052546|NCT04624906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052547|NCT04624906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102052548|NCT04624906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102052549|NCT04624906|Alkylating Agents|alkylating agents|mesh-ancestor
102052558|NCT04546399|Dexamethasone acetate|dexamethasone acetate|mesh-list
102052559|NCT04546399|Hydrocortisone|hydrocortisone|mesh-list
102052560|NCT04546399|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102052561|NCT04546399|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102052562|NCT04546399|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102052563|NCT04546399|Cyclophosphamide|cyclophosphamide|mesh-list
102052564|NCT04546399|Nivolumab|nivolumab|mesh-list
102052565|NCT04546399|Methotrexate|methotrexate|mesh-list
102052566|NCT04546399|Etoposide|etoposide|mesh-list
102052567|NCT04546399|Vincristine|vincristine|mesh-list
102052568|NCT04546399|Etoposide phosphate|etoposide phosphate|mesh-list
102052569|NCT04546399|Asparaginase|asparaginase|mesh-list
102052570|NCT04546399|Mercaptopurine|mercaptopurine|mesh-list
102052571|NCT04546399|Podophyllotoxin|podophyllotoxin|mesh-list
102052572|NCT04546399|Pegaspargase|pegaspargase|mesh-list
102052573|NCT04546399|Thioguanine|thioguanine|mesh-list
102052574|NCT04546399|Blinatumomab|blinatumomab|mesh-list
102052575|NCT04546399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102052576|NCT04546399|Muromonab-CD3|muromonab-cd3|mesh-list
102052577|NCT04546399|Antibodies|antibodies|mesh-list
102052578|NCT04546399|Immunoglobulins|immunoglobulins|mesh-list
102052579|NCT04546399|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102052580|NCT04546399|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102052581|NCT04546399|BB 1101|bb 1101|mesh-list
102052582|NCT04546399|Calcium|calcium|mesh-list
102052583|NCT04546399|2-Aminopurine|2-aminopurine|mesh-list
102052584|NCT04546399|Levoleucovorin|levoleucovorin|mesh-list
102052585|NCT04546399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102052586|NCT04546399|Immunologic Factors|immunologic factors|mesh-ancestor
102052587|NCT04546399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052588|NCT04546399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102052589|NCT04546399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102052590|NCT04546399|Alkylating Agents|alkylating agents|mesh-ancestor
101698017|NCT04223219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102052591|NCT04546399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052592|NCT04546399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102052593|NCT04546399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102052594|NCT04546399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102052595|NCT04546399|Antiemetics|antiemetics|mesh-ancestor
102052596|NCT04546399|Autonomic Agents|autonomic agents|mesh-ancestor
102052597|NCT04546399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102052598|NCT04546399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102052599|NCT04546399|Glucocorticoids|glucocorticoids|mesh-ancestor
102052600|NCT04546399|Hormones|hormones|mesh-ancestor
102052601|NCT04546399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102052602|NCT04546399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102052603|NCT04546399|Protease Inhibitors|protease inhibitors|mesh-ancestor
102052604|NCT04546399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102052605|NCT04546399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102052606|NCT04546399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102052607|NCT04546399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102052608|NCT04546399|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102052609|NCT04546399|Abortifacient Agents|abortifacient agents|mesh-ancestor
102052610|NCT04546399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102052611|NCT04546399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102052612|NCT04546399|Antimetabolites|antimetabolites|mesh-ancestor
101942177|NCT03920475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101942178|NCT03920475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102052613|NCT04546399|Dermatologic Agents|dermatologic agents|mesh-ancestor
102052614|NCT04546399|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102052615|NCT04546399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102052616|NCT04546399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102052617|NCT04546399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102052618|NCT04546399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102052619|NCT04546399|Antiviral Agents|antiviral agents|mesh-ancestor
102052620|NCT04546399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102052621|NCT04546399|Antidotes|antidotes|mesh-ancestor
102052627|NCT04546399|Antimitotic Agents|antimitotic agents|mesh-ancestor
101772364|NCT04034199|Denosumab|denosumab|mesh-list
102052628|NCT04546399|Mitosis Modulators|mitosis modulators|mesh-ancestor
102052629|NCT04546399|Hematinics|hematinics|mesh-ancestor
102052630|NCT04546399|Keratolytic Agents|keratolytic agents|mesh-ancestor
102052631|NCT04540120|Dapansutrile|dapansutrile|mesh-list
102052632|NCT04540120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102052633|NCT04480086|Navitoclax|navitoclax|mesh-list
102052634|NCT04480086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102052635|NCT04476212|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102052636|NCT04476212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102052637|NCT04441138|Durvalumab|durvalumab|mesh-list
102052638|NCT04441138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102052639|NCT04441138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102052640|NCT04432688|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102052641|NCT04432688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102052642|NCT04432688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102052643|NCT04432688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102052644|NCT04432688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052645|NCT04432688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102052646|NCT04432688|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102052647|NCT04432688|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102052648|NCT04432688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102052649|NCT04432688|Adrenergic Agents|adrenergic agents|mesh-ancestor
102052650|NCT04432688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102052651|NCT04432688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052652|NCT04432688|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102052653|NCT04432688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102052654|NCT04432688|Serotonin Agents|serotonin agents|mesh-ancestor
102052655|NCT04432688|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102052656|NCT04432688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102052657|NCT04432688|Dopamine Agents|dopamine agents|mesh-ancestor
102052658|NCT04426825|Bevacizumab|bevacizumab|mesh-list
102052659|NCT04426825|Atezolizumab|atezolizumab|mesh-list
102052660|NCT04426825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102052661|NCT04426825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102052662|NCT04426825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102052663|NCT04426825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102052664|NCT04426825|Growth Substances|growth substances|mesh-ancestor
102052665|NCT04426825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052666|NCT04426825|Growth Inhibitors|growth inhibitors|mesh-ancestor
102052667|NCT04426825|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102052668|NCT04426825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052669|NCT04418479|Aspirin|aspirin|mesh-list
102052670|NCT04418479|Clopidogrel|clopidogrel|mesh-list
102052671|NCT04418479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102052672|NCT04418479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102052673|NCT04418479|Analgesics|analgesics|mesh-ancestor
102052674|NCT04418479|Sensory System Agents|sensory system agents|mesh-ancestor
102052675|NCT04418479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102052676|NCT04418479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052677|NCT04418479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102052678|NCT04418479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102052679|NCT04418479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102052680|NCT04418479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102052681|NCT04418479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052682|NCT04418479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102052683|NCT04418479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102052684|NCT04418479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102052685|NCT04418479|Antipyretics|antipyretics|mesh-ancestor
102052686|NCT04418479|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101942179|NCT03920475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942180|NCT03920475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101942181|NCT03920475|Serotonin Agents|serotonin agents|mesh-ancestor
102052687|NCT04418479|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102052688|NCT04418479|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102052689|NCT04418479|Purinergic Agents|purinergic agents|mesh-ancestor
102052690|NCT04418479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102052691|NCT04417998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102052704|NCT04262206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102052705|NCT04225117|Pembrolizumab|pembrolizumab|mesh-list
102052706|NCT04225117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102052707|NCT04225117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102052708|NCT04225117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102052709|NCT04225117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052710|NCT04181515|Hydrocortisone|hydrocortisone|mesh-list
102052711|NCT04181515|Yohimbine|yohimbine|mesh-list
102052712|NCT04181515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102052713|NCT04181515|Mydriatics|mydriatics|mesh-ancestor
102052714|NCT04181515|Autonomic Agents|autonomic agents|mesh-ancestor
102052715|NCT04181515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102052716|NCT04181515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052717|NCT04181515|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102052718|NCT04181515|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102052719|NCT04181515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102052720|NCT04181515|Adrenergic Agents|adrenergic agents|mesh-ancestor
102052721|NCT04181515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102052722|NCT04181515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052723|NCT04181515|Urological Agents|urological agents|mesh-ancestor
102052724|NCT04180969|Hydrocortisone|hydrocortisone|mesh-list
102052725|NCT04180969|Yohimbine|yohimbine|mesh-list
102052726|NCT04180969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102052727|NCT04180969|Mydriatics|mydriatics|mesh-ancestor
102052728|NCT04180969|Autonomic Agents|autonomic agents|mesh-ancestor
102052729|NCT04180969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102052730|NCT04180969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052731|NCT04180969|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102052732|NCT04180969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102052733|NCT04180969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102052734|NCT04180969|Adrenergic Agents|adrenergic agents|mesh-ancestor
102052735|NCT04180969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102052736|NCT04180969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052737|NCT04180969|Urological Agents|urological agents|mesh-ancestor
102052738|NCT04123470|Atezolizumab|atezolizumab|mesh-list
102052739|NCT04123470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102052740|NCT04123470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052741|NCT04123470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102052742|NCT04123470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102052743|NCT04083495|Cyclophosphamide|cyclophosphamide|mesh-list
102052744|NCT04083495|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102052745|NCT04083495|Fludarabine|fludarabine|mesh-list
102052746|NCT04083495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102052747|NCT04083495|Immunologic Factors|immunologic factors|mesh-ancestor
102052748|NCT04083495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052749|NCT04083495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102052750|NCT04083495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102052751|NCT04083495|Alkylating Agents|alkylating agents|mesh-ancestor
101354265|NCT00025454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102052766|NCT04080518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102052767|NCT04080518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052769|NCT04080518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052770|NCT04060108|Methamphetamine|methamphetamine|mesh-list
102052771|NCT04060108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102052772|NCT04060108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052773|NCT04060108|Sympathomimetics|sympathomimetics|mesh-ancestor
102052774|NCT04060108|Autonomic Agents|autonomic agents|mesh-ancestor
102052775|NCT04060108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102052776|NCT04060108|Dopamine Agents|dopamine agents|mesh-ancestor
102052777|NCT04060108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102052778|NCT04060108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942182|NCT03920475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942183|NCT03920475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101942184|NCT03920475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101772505|NCT00931437|Vitamins|vitamins|mesh-ancestor
102052779|NCT04060108|Adrenergic Agents|adrenergic agents|mesh-ancestor
102052780|NCT04060108|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102052781|NCT04060108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102052782|NCT04060108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102052783|NCT04060108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102052784|NCT04017598|Iron|iron|mesh-list
102052785|NCT04017598|Trace Elements|trace elements|mesh-ancestor
102052786|NCT04017598|Micronutrients|micronutrients|mesh-ancestor
102052787|NCT04017598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052788|NCT04014803|Aspirin|aspirin|mesh-list
102052789|NCT04014803|Clopidogrel|clopidogrel|mesh-list
102052790|NCT04014803|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102052791|NCT04014803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102052792|NCT04014803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102052793|NCT04014803|Analgesics|analgesics|mesh-ancestor
102052794|NCT04014803|Sensory System Agents|sensory system agents|mesh-ancestor
102052795|NCT04014803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102052796|NCT04014803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052797|NCT04014803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102052798|NCT04014803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102052799|NCT04014803|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102052800|NCT04014803|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102052801|NCT04014803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052802|NCT04014803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102052803|NCT04014803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102052804|NCT04014803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102052805|NCT04014803|Antipyretics|antipyretics|mesh-ancestor
102052806|NCT04014803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102052807|NCT04014803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102052808|NCT04014803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102052809|NCT04014803|Purinergic Agents|purinergic agents|mesh-ancestor
102052825|NCT03945903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052826|NCT03944876|Botulinum Toxins|botulinum toxins|mesh-list
102052827|NCT03944876|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102052828|NCT03944876|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102052829|NCT03944876|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102052830|NCT03944876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102052831|NCT03944876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052832|NCT03944876|Cholinergic Agents|cholinergic agents|mesh-ancestor
102052833|NCT03944876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102052834|NCT03944876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052835|NCT03944876|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102052836|NCT03944876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102052837|NCT03943589|Immunoglobulins|immunoglobulins|mesh-list
102052838|NCT03943589|Immunoglobulin G|immunoglobulin g|mesh-list
102052839|NCT03943589|Immunologic Factors|immunologic factors|mesh-ancestor
102052840|NCT03943589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052841|NCT03937219|Nivolumab|nivolumab|mesh-list
102052842|NCT03937219|Ipilimumab|ipilimumab|mesh-list
102052843|NCT03937219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102052844|NCT03937219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102052845|NCT03937219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102052846|NCT03937219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052847|NCT03934684|Dexamethasone|dexamethasone|mesh-list
102052848|NCT03934684|Dexamethasone acetate|dexamethasone acetate|mesh-list
102052849|NCT03934684|Lenalidomide|lenalidomide|mesh-list
102052850|NCT03934684|BB 1101|bb 1101|mesh-list
102052851|NCT03934684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102052852|NCT03934684|Antiemetics|antiemetics|mesh-ancestor
102052853|NCT03934684|Autonomic Agents|autonomic agents|mesh-ancestor
102052854|NCT03934684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102052855|NCT03934684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052856|NCT03934684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102052857|NCT03934684|Glucocorticoids|glucocorticoids|mesh-ancestor
102052858|NCT03934684|Hormones|hormones|mesh-ancestor
102052859|NCT03934684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101942185|NCT03920319|Bupropion|bupropion|mesh-list
101942186|NCT03920319|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101942187|NCT03920319|Antidepressive Agents|antidepressive agents|mesh-ancestor
102052860|NCT03934684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102052861|NCT03934684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102052862|NCT03934684|Protease Inhibitors|protease inhibitors|mesh-ancestor
102052863|NCT03934684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102052864|NCT03934684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052865|NCT03934684|Immunologic Factors|immunologic factors|mesh-ancestor
102052866|NCT03934684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102052867|NCT03934684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101354394|NCT00053976|Prednisolone|prednisolone|mesh-list
102052876|NCT03873805|Fludarabine phosphate|fludarabine phosphate|mesh-list
102052877|NCT03873805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102052878|NCT03873805|Immunologic Factors|immunologic factors|mesh-ancestor
102052879|NCT03873805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052880|NCT03873805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102052881|NCT03873805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102052882|NCT03873805|Alkylating Agents|alkylating agents|mesh-ancestor
102052883|NCT03873805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052884|NCT03873805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102052885|NCT03873805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102052886|NCT03873805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102052887|NCT03873805|Antimetabolites|antimetabolites|mesh-ancestor
102052888|NCT03873805|Antiviral Agents|antiviral agents|mesh-ancestor
102052889|NCT03873805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102052890|NCT03869268|Aspirin|aspirin|mesh-list
102052891|NCT03869268|Ticagrelor|ticagrelor|mesh-list
102052892|NCT03869268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102052893|NCT03869268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102052894|NCT03869268|Analgesics|analgesics|mesh-ancestor
102052895|NCT03869268|Sensory System Agents|sensory system agents|mesh-ancestor
102052896|NCT03869268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102052897|NCT03869268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052898|NCT03869268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102052899|NCT03869268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102052900|NCT03869268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102052901|NCT03869268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102052902|NCT03869268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052903|NCT03869268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102052904|NCT03869268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102052905|NCT03869268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102052906|NCT03869268|Antipyretics|antipyretics|mesh-ancestor
102052907|NCT03869268|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102052908|NCT03869268|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102052909|NCT03869268|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102052910|NCT03869268|Purinergic Agents|purinergic agents|mesh-ancestor
102052911|NCT03869268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102052912|NCT03843463|Dexetimide|dexetimide|mesh-list
102052913|NCT03843463|Citalopram|citalopram|mesh-list
102052914|NCT03843463|Escitalopram|escitalopram|mesh-list
102052915|NCT03843463|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102052916|NCT03843463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102052917|NCT03843463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102052918|NCT03843463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052919|NCT03843463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102052920|NCT03843463|Serotonin Agents|serotonin agents|mesh-ancestor
102052921|NCT03843463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052922|NCT03843463|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102052923|NCT03843463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102052924|NCT03843463|Parasympatholytics|parasympatholytics|mesh-ancestor
102052925|NCT03843463|Autonomic Agents|autonomic agents|mesh-ancestor
102052926|NCT03843463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101772656|NCT00782652|Nitric Oxide|nitric oxide|mesh-list
102052927|NCT03843463|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102052928|NCT03843463|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102052929|NCT03843463|Cholinergic Agents|cholinergic agents|mesh-ancestor
102052930|NCT03843463|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102052931|NCT03843463|Antidepressive Agents|antidepressive agents|mesh-ancestor
102052932|NCT03843463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102052933|NCT03660930|Sirolimus|sirolimus|mesh-list
101942188|NCT03920319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101942189|NCT03920319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101942190|NCT03920319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101942191|NCT03920319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101942192|NCT03920319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942193|NCT03920319|Dopamine Agents|dopamine agents|mesh-ancestor
101942194|NCT03920319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101942195|NCT03920319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942196|NCT03920319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101307152|NCT02029937|Proflavine|proflavine|mesh-list
102052934|NCT03660930|Temsirolimus|temsirolimus|mesh-list
102052935|NCT03660930|MTOR Inhibitors|mtor inhibitors|mesh-list
102052938|NCT03660930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102052939|NCT03660930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102052940|NCT03660930|Antifungal Agents|antifungal agents|mesh-ancestor
102052941|NCT03660930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102052942|NCT03660930|Immunologic Factors|immunologic factors|mesh-ancestor
102052943|NCT03660930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052944|NCT03660930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102052945|NCT03660930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102052946|NCT03660930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052948|NCT03643796|Ketamine|ketamine|mesh-list
102052949|NCT03643796|Remifentanil|remifentanil|mesh-list
102052950|NCT03643796|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102052951|NCT03643796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102052952|NCT03643796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052953|NCT03643796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102052954|NCT03643796|Analgesics|analgesics|mesh-ancestor
102052955|NCT03643796|Sensory System Agents|sensory system agents|mesh-ancestor
102052956|NCT03643796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102052957|NCT03643796|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102052958|NCT03643796|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102052959|NCT03643796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102052960|NCT03643796|Adrenergic Agents|adrenergic agents|mesh-ancestor
102052961|NCT03643796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102052962|NCT03643796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052963|NCT03643796|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102052964|NCT03643796|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102052965|NCT03643796|Anesthetics, General|anesthetics, general|mesh-ancestor
102052966|NCT03643796|Anesthetics|anesthetics|mesh-ancestor
102052967|NCT03643796|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102052968|NCT03643796|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102052969|NCT03643796|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102052970|NCT03643796|Narcotics|narcotics|mesh-ancestor
102052971|NCT03623854|Nivolumab|nivolumab|mesh-list
102052972|NCT03623854|Relatlimab|relatlimab|mesh-list
102052973|NCT03623854|Immunoglobulins|immunoglobulins|mesh-list
102052974|NCT03623854|Immunoglobulin G|immunoglobulin g|mesh-list
102052975|NCT03623854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102052976|NCT03623854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102052977|NCT03623854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102052978|NCT03623854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052979|NCT03623854|Immunologic Factors|immunologic factors|mesh-ancestor
102052980|NCT03623854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052981|NCT03584334|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102052982|NCT03584334|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102052983|NCT03584334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052984|NCT03530215|Antineoplastic Agents|antineoplastic agents|mesh-list
102052985|NCT03530215|Immunomodulating Agents|immunomodulating agents|mesh-list
102052986|NCT03530215|Immunologic Factors|immunologic factors|mesh-ancestor
102052987|NCT03530215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052988|NCT03475277|Ketamine|ketamine|mesh-list
102052989|NCT03475277|Analgesics|analgesics|mesh-ancestor
101942197|NCT03920319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101942198|NCT03920319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101942199|NCT03920397|Cholecalciferol|cholecalciferol|mesh-list
101430458|NCT00164775|Imipramine|imipramine|mesh-list
102052990|NCT03475277|Sensory System Agents|sensory system agents|mesh-ancestor
102052991|NCT03475277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102052992|NCT03475277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052993|NCT03475277|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102052994|NCT03475277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102052995|NCT03475277|Anesthetics, General|anesthetics, general|mesh-ancestor
102052996|NCT03475277|Anesthetics|anesthetics|mesh-ancestor
102052997|NCT03475277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102052998|NCT03475277|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102052999|NCT03475277|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102053000|NCT03475277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101772732|NCT00567567|Tubulin Modulators|tubulin modulators|mesh-ancestor
102053001|NCT03475277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053002|NCT03472274|Durvalumab|durvalumab|mesh-list
102053003|NCT03472274|Tremelimumab|tremelimumab|mesh-list
102053004|NCT03472274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102053005|NCT03472274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102053006|NCT03436433|Lacosamide|lacosamide|mesh-list
102053012|NCT03436433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102053013|NCT03436433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053014|NCT03415854|Paclitaxel|paclitaxel|mesh-list
102053015|NCT03415854|Cisplatin|cisplatin|mesh-list
102053016|NCT03415854|Gemcitabine|gemcitabine|mesh-list
102053017|NCT03415854|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102053018|NCT03415854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102053019|NCT03415854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102053020|NCT03415854|Tubulin Modulators|tubulin modulators|mesh-ancestor
102053021|NCT03415854|Antimitotic Agents|antimitotic agents|mesh-ancestor
102053022|NCT03415854|Mitosis Modulators|mitosis modulators|mesh-ancestor
102053023|NCT03415854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053024|NCT03415854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102053025|NCT03415854|Antimetabolites|antimetabolites|mesh-ancestor
102053026|NCT03405090|Fentanyl|fentanyl|mesh-list
102053027|NCT03405090|Bronchodilator Agents|bronchodilator agents|mesh-list
102053028|NCT03405090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102053029|NCT03405090|Narcotics|narcotics|mesh-ancestor
102053030|NCT03405090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102053031|NCT03405090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053032|NCT03405090|Analgesics|analgesics|mesh-ancestor
102053033|NCT03405090|Sensory System Agents|sensory system agents|mesh-ancestor
102053034|NCT03405090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102053035|NCT03405090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102053036|NCT03405090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102053037|NCT03405090|Anesthetics, General|anesthetics, general|mesh-ancestor
102053038|NCT03405090|Anesthetics|anesthetics|mesh-ancestor
102053039|NCT03405090|Autonomic Agents|autonomic agents|mesh-ancestor
102053040|NCT03405090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102053041|NCT03405090|Respiratory System Agents|respiratory system agents|mesh-ancestor
102053042|NCT03284307|Midazolam|midazolam|mesh-list
102053043|NCT03284307|Dexmedetomidine|dexmedetomidine|mesh-list
102053044|NCT03284307|Ketamine|ketamine|mesh-list
102053045|NCT03284307|Propofol|propofol|mesh-list
102053046|NCT03284307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102053047|NCT03284307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102053048|NCT03284307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053049|NCT03284307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102053050|NCT03284307|Analgesics|analgesics|mesh-ancestor
102053051|NCT03284307|Sensory System Agents|sensory system agents|mesh-ancestor
102053052|NCT03284307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102053053|NCT03284307|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102053054|NCT03284307|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102053055|NCT03284307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102053056|NCT03284307|Adrenergic Agents|adrenergic agents|mesh-ancestor
102053057|NCT03284307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102053058|NCT03284307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053059|NCT03284307|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102053060|NCT03284307|Anesthetics, General|anesthetics, general|mesh-ancestor
101942201|NCT03920397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101942202|NCT03920397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942204|NCT03920397|Micronutrients|micronutrients|mesh-ancestor
102053061|NCT03284307|Anesthetics|anesthetics|mesh-ancestor
102053062|NCT03284307|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102053063|NCT03284307|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102053064|NCT03284307|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102053065|NCT03284307|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102053066|NCT03284307|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102053067|NCT03284307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102053068|NCT03284307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102053069|NCT03284307|GABA Modulators|gaba modulators|mesh-ancestor
102053070|NCT03284307|GABA Agents|gaba agents|mesh-ancestor
102053071|NCT03279289|Leucovorin|leucovorin|mesh-list
102053072|NCT03279289|Folic Acid|folic acid|mesh-list
102053073|NCT03279289|Fluorouracil|fluorouracil|mesh-list
102053074|NCT03279289|Irinotecan|irinotecan|mesh-list
102053075|NCT03279289|Aflibercept|aflibercept|mesh-list
102053076|NCT03279289|Levoleucovorin|levoleucovorin|mesh-list
102053077|NCT03279289|Antimetabolites|antimetabolites|mesh-ancestor
102053078|NCT03279289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053079|NCT03279289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102053099|NCT03207867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053100|NCT03207867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102053101|NCT03207867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102053102|NCT03186456|Aspirin|aspirin|mesh-list
102053103|NCT03186456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102053104|NCT03186456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102053105|NCT03186456|Analgesics|analgesics|mesh-ancestor
102053106|NCT03186456|Sensory System Agents|sensory system agents|mesh-ancestor
102053107|NCT03186456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102053108|NCT03186456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053109|NCT03186456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102053110|NCT03186456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102053111|NCT03186456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102053112|NCT03186456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102053113|NCT03186456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053114|NCT03186456|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102053115|NCT03186456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102053116|NCT03186456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102053117|NCT03186456|Antipyretics|antipyretics|mesh-ancestor
102053118|NCT03184935|Decitabine|decitabine|mesh-list
102053119|NCT03184935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102053120|NCT03184935|Antimetabolites|antimetabolites|mesh-ancestor
102053121|NCT03184935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053122|NCT03184935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102053123|NCT03184935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102053124|NCT03176498|Aspirin|aspirin|mesh-list
102053125|NCT03176498|Atorvastatin|atorvastatin|mesh-list
102053126|NCT03176498|Calcium|calcium|mesh-list
102053127|NCT03176498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102053128|NCT03176498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053129|NCT03176498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102053130|NCT03176498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102053131|NCT03176498|Analgesics|analgesics|mesh-ancestor
102053132|NCT03176498|Sensory System Agents|sensory system agents|mesh-ancestor
102053133|NCT03176498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102053134|NCT03176498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102053135|NCT03176498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102053136|NCT03176498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102053147|NCT03176498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102053148|NCT03126591|Pembrolizumab|pembrolizumab|mesh-list
102053149|NCT03126591|Olaratumab|olaratumab|mesh-list
102053150|NCT03126591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102053151|NCT03126591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102053152|NCT03126591|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102053153|NCT03126591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053154|NCT03122197|Letrozole|letrozole|mesh-list
102053155|NCT03122197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102053156|NCT03122197|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102053157|NCT03122197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101942205|NCT03920397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101942206|NCT01131975|Lamotrigine|lamotrigine|mesh-list
101430571|NCT00164892|Analgesics|analgesics|mesh-ancestor
102053158|NCT03122197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102053159|NCT03122197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053160|NCT03122197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102053161|NCT03122197|Hormone Antagonists|hormone antagonists|mesh-ancestor
102053162|NCT03122197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102053163|NCT03122197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053165|NCT03085004|Paclitaxel|paclitaxel|mesh-list
102053166|NCT03085004|Gemcitabine|gemcitabine|mesh-list
102053167|NCT03085004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102053168|NCT03085004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102053169|NCT03085004|Tubulin Modulators|tubulin modulators|mesh-ancestor
102053170|NCT03085004|Antimitotic Agents|antimitotic agents|mesh-ancestor
102053171|NCT03085004|Mitosis Modulators|mitosis modulators|mesh-ancestor
102053172|NCT03085004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053173|NCT03085004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102053174|NCT03085004|Antimetabolites|antimetabolites|mesh-ancestor
102053175|NCT03085004|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102053176|NCT03085004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102053177|NCT03085004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102053178|NCT03085004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053179|NCT03059862|Tryptophan|tryptophan|mesh-list
102053180|NCT03059862|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102053181|NCT03059862|Antidepressive Agents|antidepressive agents|mesh-ancestor
102053182|NCT03059862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102053183|NCT03015844|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
102053184|NCT03015844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102053185|NCT03015844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102053186|NCT03015844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053187|NCT03015844|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102053188|NCT02949284|Prednisone|prednisone|mesh-list
102053189|NCT02949284|Cortisone|cortisone|mesh-list
102053190|NCT02949284|Abiraterone Acetate|abiraterone acetate|mesh-list
102053191|NCT02949284|Hormones|hormones|mesh-list
102053192|NCT02949284|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
102053193|NCT02949284|Androgens|androgens|mesh-list
102053194|NCT02949284|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
102053195|NCT02949284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102053196|NCT02949284|Glucocorticoids|glucocorticoids|mesh-ancestor
102053197|NCT02949284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102053198|NCT02949284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053199|NCT02949284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102053208|NCT02916862|Calcium|calcium|mesh-list
102053209|NCT02916862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102053210|NCT02916862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053211|NCT02916862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102053212|NCT02891447|Cisplatin|cisplatin|mesh-list
102053213|NCT02891447|Mitomycins|mitomycins|mesh-list
102053214|NCT02891447|Mitomycin|mitomycin|mesh-list
102053215|NCT02891447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102053216|NCT02891447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102053217|NCT02891447|Alkylating Agents|alkylating agents|mesh-ancestor
102053218|NCT02891447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053219|NCT02891447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102053220|NCT02891447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102053221|NCT02867761|Glycopyrrolate|glycopyrrolate|mesh-list
102053222|NCT02867761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102053223|NCT02867761|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102053224|NCT02867761|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102053225|NCT02867761|Cholinergic Agents|cholinergic agents|mesh-ancestor
102053226|NCT02867761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102053227|NCT02867761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053228|NCT02867761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053229|NCT02680626|Magnesium Sulfate|magnesium sulfate|mesh-list
102053230|NCT02680626|Ropivacaine|ropivacaine|mesh-list
102053231|NCT02680626|Anesthetics, Local|anesthetics, local|mesh-ancestor
102053232|NCT02680626|Anesthetics|anesthetics|mesh-ancestor
102053233|NCT02680626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102053234|NCT02680626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942208|NCT01131975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101430644|NCT04725422|Etanercept|etanercept|mesh-list
102053235|NCT02680626|Sensory System Agents|sensory system agents|mesh-ancestor
102053236|NCT02680626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102053237|NCT02680626|Analgesics|analgesics|mesh-ancestor
102053238|NCT02680626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102053239|NCT02680626|Anticonvulsants|anticonvulsants|mesh-ancestor
102053240|NCT02680626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102053241|NCT02680626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102053242|NCT02680626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053243|NCT02680626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102053244|NCT02680626|Tocolytic Agents|tocolytic agents|mesh-ancestor
102053245|NCT02680626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102053246|NCT02494583|Pembrolizumab|pembrolizumab|mesh-list
102053247|NCT02494583|Capecitabine|capecitabine|mesh-list
102053248|NCT02494583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102053249|NCT02494583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102053250|NCT02494583|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102053251|NCT02494583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053252|NCT02494583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102053253|NCT02494583|Antimetabolites|antimetabolites|mesh-ancestor
102053254|NCT02473042|Promethazine|promethazine|mesh-list
102053255|NCT02473042|Dexamethasone|dexamethasone|mesh-list
102053256|NCT02473042|Ondansetron|ondansetron|mesh-list
102053257|NCT02473042|Famotidine|famotidine|mesh-list
102053258|NCT02473042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102053259|NCT02473042|Antiemetics|antiemetics|mesh-ancestor
102053260|NCT02473042|Autonomic Agents|autonomic agents|mesh-ancestor
102053261|NCT02473042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102053262|NCT02473042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053263|NCT02473042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102053264|NCT02473042|Glucocorticoids|glucocorticoids|mesh-ancestor
102053265|NCT02473042|Hormones|hormones|mesh-ancestor
101354787|NCT00055770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102053288|NCT02359331|Bismuth|bismuth|mesh-list
102053289|NCT02359331|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
102053290|NCT02359331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102053291|NCT02359331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102053292|NCT02359331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102053293|NCT02359331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053294|NCT02359331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102053295|NCT02359331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102053296|NCT02359331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102053297|NCT02359331|Antacids|antacids|mesh-ancestor
102053298|NCT02359331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102053299|NCT02359331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102053300|NCT02322814|Paclitaxel|paclitaxel|mesh-list
102053301|NCT02322814|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102053302|NCT02322814|Atezolizumab|atezolizumab|mesh-list
102053303|NCT02322814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102053304|NCT02322814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102053306|NCT02322814|Antimitotic Agents|antimitotic agents|mesh-ancestor
102053307|NCT02322814|Mitosis Modulators|mitosis modulators|mesh-ancestor
102053308|NCT02322814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053309|NCT02322814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102053310|NCT02322814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102053311|NCT02057133|Tamoxifen|tamoxifen|mesh-list
102053312|NCT02057133|Trastuzumab|trastuzumab|mesh-list
102053313|NCT02057133|Pertuzumab|pertuzumab|mesh-list
102053314|NCT02057133|Everolimus|everolimus|mesh-list
102053315|NCT02057133|Letrozole|letrozole|mesh-list
102053316|NCT02057133|Fulvestrant|fulvestrant|mesh-list
102053317|NCT02057133|Anastrozole|anastrozole|mesh-list
102053318|NCT02057133|Exemestane|exemestane|mesh-list
102053319|NCT02057133|Loperamide|loperamide|mesh-list
102053320|NCT02057133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102053321|NCT02057133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102053325|NCT02057133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053327|NCT02057133|Immunologic Factors|immunologic factors|mesh-ancestor
102053328|NCT02057133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053329|NCT02057133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102053330|NCT02057133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102053331|NCT02057133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102053332|NCT02057133|Hormone Antagonists|hormone antagonists|mesh-ancestor
101942209|NCT01131975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101942210|NCT01131975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942211|NCT01131975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102053333|NCT02057133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102053334|NCT02057133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102053335|NCT02057133|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102053336|NCT02057133|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102053337|NCT02057133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102053338|NCT02057133|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102053339|NCT02057133|Antidiarrheals|antidiarrheals|mesh-ancestor
102053340|NCT02057133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102053341|NCT01894308|Testosterone|testosterone|mesh-list
102053342|NCT01894308|Androgens|androgens|mesh-ancestor
102053343|NCT01894308|Hormones|hormones|mesh-ancestor
102053344|NCT01894308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102053345|NCT01894308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053346|NCT01837862|Mebendazole|mebendazole|mesh-list
102053347|NCT01837862|Piperazine|piperazine|mesh-list
102053348|NCT01837862|Piperazine citrate|piperazine citrate|mesh-list
102053349|NCT01837862|Bevacizumab|bevacizumab|mesh-list
102053350|NCT01837862|Carboplatin|carboplatin|mesh-list
102053351|NCT01837862|Irinotecan|irinotecan|mesh-list
102053352|NCT01837862|Vincristine|vincristine|mesh-list
102053353|NCT01837862|Temozolomide|temozolomide|mesh-list
102053354|NCT01837862|DMP 777|dmp 777|mesh-list
102053355|NCT01837862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102053356|NCT01837862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102053357|NCT01837862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101698146|NCT02630160|Mydriatics|mydriatics|mesh-ancestor
102053358|NCT01837862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102053359|NCT01837862|Growth Substances|growth substances|mesh-ancestor
102053360|NCT01837862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053361|NCT01837862|Growth Inhibitors|growth inhibitors|mesh-ancestor
102053362|NCT01837862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102053363|NCT01837862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102053364|NCT01837862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102053365|NCT01837862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053366|NCT01837862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102053367|NCT01837862|Tubulin Modulators|tubulin modulators|mesh-ancestor
102053368|NCT01837862|Antimitotic Agents|antimitotic agents|mesh-ancestor
102053369|NCT01837862|Mitosis Modulators|mitosis modulators|mesh-ancestor
102053370|NCT01837862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102053371|NCT01837862|Alkylating Agents|alkylating agents|mesh-ancestor
102053372|NCT01837862|Antinematodal Agents|antinematodal agents|mesh-ancestor
102053373|NCT01837862|Anthelmintics|anthelmintics|mesh-ancestor
102053374|NCT01837862|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102053375|NCT01837862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102053376|NCT01675219|Mitomycins|mitomycins|mesh-list
102053377|NCT01675219|Mitomycin|mitomycin|mesh-list
101773107|NCT00932607|Immunologic Factors|immunologic factors|mesh-ancestor
102053378|NCT01675219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102053379|NCT01675219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102053380|NCT01675219|Alkylating Agents|alkylating agents|mesh-ancestor
102053381|NCT01675219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053382|NCT01675219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102053383|NCT01675219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102053384|NCT01590069|Aldesleukin|aldesleukin|mesh-list
102053385|NCT01590069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102053386|NCT01590069|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102053387|NCT01590069|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102053388|NCT01590069|Antiviral Agents|antiviral agents|mesh-ancestor
102053389|NCT01590069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102053390|NCT01529593|Metformin|metformin|mesh-list
102053391|NCT01529593|Sirolimus|sirolimus|mesh-list
102053392|NCT01529593|Temsirolimus|temsirolimus|mesh-list
102053393|NCT01529593|MTOR Inhibitors|mtor inhibitors|mesh-list
102053420|NCT01424982|Dexamethasone acetate|dexamethasone acetate|mesh-list
102053421|NCT01424982|Cortisone|cortisone|mesh-list
102053422|NCT01424982|Cyclophosphamide|cyclophosphamide|mesh-list
102053423|NCT01424982|Rituximab|rituximab|mesh-list
102053424|NCT01424982|Doxorubicin|doxorubicin|mesh-list
102053425|NCT01424982|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102053426|NCT01424982|Methotrexate|methotrexate|mesh-list
102053427|NCT01424982|Vincristine|vincristine|mesh-list
102053428|NCT01424982|Daunorubicin|daunorubicin|mesh-list
101942212|NCT01131975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942213|NCT01131975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102053429|NCT01424982|Ponatinib|ponatinib|mesh-list
102053430|NCT01424982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102053431|NCT01424982|Antibodies|antibodies|mesh-list
102053432|NCT01424982|Immunoglobulins|immunoglobulins|mesh-list
102053433|NCT01424982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102053434|NCT01424982|BB 1101|bb 1101|mesh-list
102053435|NCT01424982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102053436|NCT01424982|Immunologic Factors|immunologic factors|mesh-ancestor
102053437|NCT01424982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053438|NCT01424982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102053439|NCT01424982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102053440|NCT01424982|Alkylating Agents|alkylating agents|mesh-ancestor
102053441|NCT01424982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053442|NCT01424982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102053443|NCT01424982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102053444|NCT01424982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102053445|NCT01424982|Antiemetics|antiemetics|mesh-ancestor
102053451|NCT01424982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102053453|NCT01424982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102053454|NCT01424982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102053455|NCT01424982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102053456|NCT01424982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101773182|NCT00931203|Celecoxib|celecoxib|mesh-list
102053457|NCT01424982|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102053458|NCT01424982|Abortifacient Agents|abortifacient agents|mesh-ancestor
102053459|NCT01424982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102053460|NCT01424982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102053461|NCT01424982|Antimetabolites|antimetabolites|mesh-ancestor
102053462|NCT01424982|Dermatologic Agents|dermatologic agents|mesh-ancestor
102053463|NCT01424982|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102053464|NCT01424982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102053465|NCT01424982|Antiviral Agents|antiviral agents|mesh-ancestor
102053466|NCT01424982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102053467|NCT01424982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102053468|NCT01424982|Tubulin Modulators|tubulin modulators|mesh-ancestor
102053469|NCT01424982|Antimitotic Agents|antimitotic agents|mesh-ancestor
102053470|NCT01424982|Mitosis Modulators|mitosis modulators|mesh-ancestor
102053471|NCT01424982|Protease Inhibitors|protease inhibitors|mesh-ancestor
102053472|NCT01424982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102053473|NCT01333033|Leucovorin|leucovorin|mesh-list
102053474|NCT01333033|Paclitaxel|paclitaxel|mesh-list
102053475|NCT01333033|Carboplatin|carboplatin|mesh-list
102053476|NCT01333033|Fluorouracil|fluorouracil|mesh-list
102053477|NCT01333033|Oxaliplatin|oxaliplatin|mesh-list
102053478|NCT01333033|Calcium|calcium|mesh-list
102053479|NCT01333033|Levoleucovorin|levoleucovorin|mesh-list
102053480|NCT01333033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102053481|NCT01333033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102053482|NCT01333033|Tubulin Modulators|tubulin modulators|mesh-ancestor
102053483|NCT01333033|Antimitotic Agents|antimitotic agents|mesh-ancestor
102053484|NCT01333033|Mitosis Modulators|mitosis modulators|mesh-ancestor
102053485|NCT01333033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053486|NCT01333033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102053487|NCT01333033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053488|NCT01333033|Antimetabolites|antimetabolites|mesh-ancestor
102053489|NCT01333033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102053490|NCT01333033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102053491|NCT01333033|Immunologic Factors|immunologic factors|mesh-ancestor
102053492|NCT01333033|Antidotes|antidotes|mesh-ancestor
102053493|NCT01333033|Protective Agents|protective agents|mesh-ancestor
102053494|NCT01333033|Vitamin B Complex|vitamin b complex|mesh-ancestor
102053495|NCT01333033|Vitamins|vitamins|mesh-ancestor
102053496|NCT01333033|Micronutrients|micronutrients|mesh-ancestor
102053497|NCT01187199|Sirolimus|sirolimus|mesh-list
102053498|NCT01187199|Paclitaxel|paclitaxel|mesh-list
102053499|NCT01187199|Bevacizumab|bevacizumab|mesh-list
102053500|NCT01187199|Carboplatin|carboplatin|mesh-list
102053501|NCT01187199|Sorafenib|sorafenib|mesh-list
102053502|NCT01187199|Temsirolimus|temsirolimus|mesh-list
102053503|NCT01187199|MTOR Inhibitors|mtor inhibitors|mesh-list
102053504|NCT01187199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102053505|NCT01187199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102053506|NCT01187199|Tubulin Modulators|tubulin modulators|mesh-ancestor
102053507|NCT01187199|Antimitotic Agents|antimitotic agents|mesh-ancestor
101942214|NCT01131975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101942215|NCT01131975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101942216|NCT01131975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102053508|NCT01187199|Mitosis Modulators|mitosis modulators|mesh-ancestor
102053509|NCT01187199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053510|NCT01187199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102053511|NCT01187199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102053512|NCT01187199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102053513|NCT01187199|Growth Substances|growth substances|mesh-ancestor
102053514|NCT01187199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053515|NCT01187199|Growth Inhibitors|growth inhibitors|mesh-ancestor
101355028|NCT00056433|Hydroxyurea|hydroxyurea|mesh-list
102053529|NCT00778063|Analgesics|analgesics|mesh-ancestor
102053530|NCT00778063|Sensory System Agents|sensory system agents|mesh-ancestor
102053531|NCT00778063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102053532|NCT00778063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102053533|NCT00778063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102053534|NCT00778063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102053535|NCT00778063|Adrenergic Agents|adrenergic agents|mesh-ancestor
102053536|NCT00778063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102053537|NCT00778063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053538|NCT00547196|Cyclosporine|cyclosporine|mesh-list
102053539|NCT00547196|Mycophenolic Acid|mycophenolic acid|mesh-list
102053540|NCT00547196|Cyclophosphamide|cyclophosphamide|mesh-list
102053541|NCT00547196|Melphalan|melphalan|mesh-list
102053542|NCT00547196|Busulfan|busulfan|mesh-list
102053543|NCT00547196|Fludarabine|fludarabine|mesh-list
102053544|NCT00547196|Fludarabine phosphate|fludarabine phosphate|mesh-list
102053545|NCT00547196|Cyclosporins|cyclosporins|mesh-list
102053546|NCT00547196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102053547|NCT00547196|Immunologic Factors|immunologic factors|mesh-ancestor
102053548|NCT00547196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053549|NCT00547196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102053550|NCT00547196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102053551|NCT00547196|Alkylating Agents|alkylating agents|mesh-ancestor
102053552|NCT00547196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053553|NCT00547196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102053554|NCT00547196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102053555|NCT00547196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102053556|NCT00547196|Antimetabolites|antimetabolites|mesh-ancestor
102053557|NCT00547196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102053558|NCT00547196|Antifungal Agents|antifungal agents|mesh-ancestor
102053559|NCT00547196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102053560|NCT00547196|Dermatologic Agents|dermatologic agents|mesh-ancestor
102053561|NCT00547196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102053562|NCT00547196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102053563|NCT00547196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102053564|NCT00547196|Antitubercular Agents|antitubercular agents|mesh-ancestor
102053565|NCT00547196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102053566|NCT00330941|Lidocaine|lidocaine|mesh-list
102053567|NCT00330941|Anesthetics, Local|anesthetics, local|mesh-ancestor
102053568|NCT00330941|Anesthetics|anesthetics|mesh-ancestor
102053569|NCT00330941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102053570|NCT00330941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053571|NCT00330941|Sensory System Agents|sensory system agents|mesh-ancestor
102053572|NCT00330941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102053573|NCT00330941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102053574|NCT00330941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102053575|NCT00330941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102053576|NCT00330941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101355096|NCT00028886|Immunologic Factors|immunologic factors|mesh-ancestor
102053583|NCT03149107|Respiratory System Agents|respiratory system agents|mesh-ancestor
102053584|NCT03149107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102053585|NCT03149107|Antioxidants|antioxidants|mesh-ancestor
102053586|NCT03149107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053587|NCT03149107|Protective Agents|protective agents|mesh-ancestor
102053588|NCT03149107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053589|NCT03149107|Antidotes|antidotes|mesh-ancestor
102053590|NCT03135301|Metformin|metformin|mesh-list
102053591|NCT03135301|Letrozole|letrozole|mesh-list
102053592|NCT03135301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102053593|NCT03135301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942217|NCT01131975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101942218|NCT01231737|Prulifloxacin|prulifloxacin|mesh-list
101942219|NCT01231737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102053594|NCT03135301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102053595|NCT03135301|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102053596|NCT03135301|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102053597|NCT03135301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102053598|NCT03135301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053599|NCT03135301|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102053600|NCT03135301|Hormone Antagonists|hormone antagonists|mesh-ancestor
102053601|NCT03135301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102053602|NCT03602898|Cyclosporine|cyclosporine|mesh-list
102053603|NCT03602898|Cyclophosphamide|cyclophosphamide|mesh-list
102053604|NCT03602898|Busulfan|busulfan|mesh-list
102053605|NCT03602898|Methotrexate|methotrexate|mesh-list
102053606|NCT03602898|Fludarabine|fludarabine|mesh-list
102053607|NCT03602898|Fludarabine phosphate|fludarabine phosphate|mesh-list
102053608|NCT03602898|Tacrolimus|tacrolimus|mesh-list
102053609|NCT03602898|Cyclosporins|cyclosporins|mesh-list
102053610|NCT03602898|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102053611|NCT03602898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102053612|NCT03602898|Immunologic Factors|immunologic factors|mesh-ancestor
102053613|NCT03602898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053614|NCT03602898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102053615|NCT03602898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102053616|NCT03602898|Alkylating Agents|alkylating agents|mesh-ancestor
102053617|NCT03602898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053618|NCT03602898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102053619|NCT03602898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102053620|NCT03602898|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102053621|NCT03602898|Abortifacient Agents|abortifacient agents|mesh-ancestor
102053622|NCT03602898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102053623|NCT03602898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102053624|NCT03602898|Antimetabolites|antimetabolites|mesh-ancestor
102053625|NCT03602898|Dermatologic Agents|dermatologic agents|mesh-ancestor
102053626|NCT03602898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102053627|NCT03602898|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102053628|NCT03602898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102053629|NCT03602898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102053630|NCT03602898|Antifungal Agents|antifungal agents|mesh-ancestor
102053631|NCT03602898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102053633|NCT02983747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102053634|NCT02983747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102053635|NCT02983747|Analgesics|analgesics|mesh-ancestor
102053636|NCT02983747|Sensory System Agents|sensory system agents|mesh-ancestor
102053637|NCT02983747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102053638|NCT02983747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053639|NCT02983747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102053640|NCT02983747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102053641|NCT05759845|Topiramate|topiramate|mesh-list
102053642|NCT05759845|Amitriptyline|amitriptyline|mesh-list
102053643|NCT05759845|Anticonvulsants|anticonvulsants|mesh-ancestor
102053644|NCT05759845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102053645|NCT05759845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053646|NCT05759845|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102053647|NCT05759845|Antidepressive Agents|antidepressive agents|mesh-ancestor
102053654|NCT05759845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102053655|NCT05759845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102053656|NCT05759845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053658|NCT05759845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102053659|NCT03931291|Azacitidine|azacitidine|mesh-list
102053660|NCT03931291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102053661|NCT03931291|Antimetabolites|antimetabolites|mesh-ancestor
102053662|NCT03931291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053663|NCT03931291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102053664|NCT03931291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102053665|NCT00799110|Imiquimod|imiquimod|mesh-list
102053666|NCT00799110|Vaccines|vaccines|mesh-list
102053667|NCT00799110|Immunologic Factors|immunologic factors|mesh-ancestor
102053668|NCT00799110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053669|NCT00799110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102053670|NCT00799110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101942220|NCT01231737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101942221|NCT01231737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101942222|NCT01231737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101942223|NCT01231737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101307183|NCT02029950|Antimitotic Agents|antimitotic agents|mesh-ancestor
102053671|NCT00799110|Interferon Inducers|interferon inducers|mesh-ancestor
102053672|NCT05199727|Tadalafil|tadalafil|mesh-list
102053673|NCT05199727|Vasodilator Agents|vasodilator agents|mesh-ancestor
102053674|NCT05199727|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102053675|NCT05199727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102053676|NCT05199727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102053677|NCT05199727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053678|NCT05199727|Urological Agents|urological agents|mesh-ancestor
102053679|NCT02132234|Adalimumab|adalimumab|mesh-list
102053680|NCT02132234|Infliximab|infliximab|mesh-list
102053681|NCT02132234|Certolizumab Pegol|certolizumab pegol|mesh-list
102053682|NCT02132234|Etanercept|etanercept|mesh-list
102053683|NCT02132234|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102053684|NCT02132234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102053685|NCT02132234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102053686|NCT02132234|Dermatologic Agents|dermatologic agents|mesh-ancestor
102053687|NCT02132234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102053688|NCT02132234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102053689|NCT02132234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102053690|NCT02132234|Analgesics|analgesics|mesh-ancestor
102053691|NCT02132234|Sensory System Agents|sensory system agents|mesh-ancestor
102053692|NCT02132234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102053693|NCT02132234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053694|NCT02132234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102053695|NCT02132234|Immunologic Factors|immunologic factors|mesh-ancestor
102053696|NCT02132390|Toremifene|toremifene|mesh-list
102053697|NCT02132390|Goserelin|goserelin|mesh-list
102053698|NCT02132390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102053699|NCT02132390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102053700|NCT02132390|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102053701|NCT02132390|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102053702|NCT02132390|Hormone Antagonists|hormone antagonists|mesh-ancestor
102053703|NCT02132390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102053704|NCT02132390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053705|NCT02132390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102053706|NCT02128646|Ketorolac|ketorolac|mesh-list
102053707|NCT02128646|Bupivacaine|bupivacaine|mesh-list
102053708|NCT02128646|Anesthetics, Local|anesthetics, local|mesh-ancestor
102053709|NCT02128646|Anesthetics|anesthetics|mesh-ancestor
102053710|NCT02128646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102053711|NCT02128646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053712|NCT02128646|Sensory System Agents|sensory system agents|mesh-ancestor
102053713|NCT02128646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102053714|NCT02128646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102053715|NCT02128646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102053723|NCT05199103|Thymoglobulin|thymoglobulin|mesh-list
102053724|NCT05199103|Immunologic Factors|immunologic factors|mesh-ancestor
102053725|NCT05199103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053726|NCT05199103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102053727|NCT02132546|Chlorhexidine|chlorhexidine|mesh-list
102053728|NCT02132546|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102053729|NCT02132546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102053730|NCT02132546|Disinfectants|disinfectants|mesh-ancestor
102053732|NCT05198947|Permethrin|permethrin|mesh-list
102053733|NCT05198947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102053734|NCT05198947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102053735|NCT05198947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102053736|NCT05198947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053737|NCT01367834|Hormones|hormones|mesh-list
102053738|NCT01367834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102053739|NCT01367834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053740|NCT03106753|Bupivacaine|bupivacaine|mesh-list
102053741|NCT03106753|Terbutaline|terbutaline|mesh-list
102053742|NCT03106753|Anesthetics, Local|anesthetics, local|mesh-ancestor
102053743|NCT03106753|Anesthetics|anesthetics|mesh-ancestor
102053744|NCT03106753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101942224|NCT01231737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942225|NCT01231737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102053745|NCT03106753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053746|NCT03106753|Sensory System Agents|sensory system agents|mesh-ancestor
102053747|NCT03106753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102053748|NCT03106753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102053749|NCT03106753|Autonomic Agents|autonomic agents|mesh-ancestor
102053750|NCT03106753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102053751|NCT03106753|Respiratory System Agents|respiratory system agents|mesh-ancestor
102053752|NCT03106753|Sympathomimetics|sympathomimetics|mesh-ancestor
102053753|NCT03106753|Tocolytic Agents|tocolytic agents|mesh-ancestor
102053754|NCT03106753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102053755|NCT03106753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102053756|NCT03106753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102053757|NCT03106753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102053758|NCT03106753|Adrenergic Agents|adrenergic agents|mesh-ancestor
102053759|NCT03106753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102053760|NCT03106753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053762|NCT02133014|Antimetabolites|antimetabolites|mesh-ancestor
102053763|NCT02133014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053764|NCT02133014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102053765|NCT02133014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102053766|NCT02133014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102053767|NCT02133014|Immunologic Factors|immunologic factors|mesh-ancestor
102053768|NCT02133014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053769|NCT05759455|Vitamin D|vitamin d|mesh-list
102053770|NCT05759455|Vitamins|vitamins|mesh-ancestor
102053771|NCT05759455|Micronutrients|micronutrients|mesh-ancestor
102053772|NCT05759455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053773|NCT05759455|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102053774|NCT02129114|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102053775|NCT02129114|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102053776|NCT02129114|Estradiol|estradiol|mesh-list
102053777|NCT02129114|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102053778|NCT02129114|Estrogens|estrogens|mesh-ancestor
102053779|NCT02129114|Hormones|hormones|mesh-ancestor
102053780|NCT02129114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102053781|NCT02129114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053782|NCT02129114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102053783|NCT02129114|Contraceptive Agents|contraceptive agents|mesh-ancestor
102053789|NCT02136992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102053790|NCT02136992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053791|NCT02136992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102053793|NCT02136992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102053794|NCT02136992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102053795|NCT02136992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102053796|NCT02252978|Ciprofloxacin|ciprofloxacin|mesh-list
102053797|NCT02252978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102053798|NCT02252978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102053799|NCT02252978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102053800|NCT02252978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102053801|NCT02252978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102053802|NCT02252978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053803|NCT02252978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102053804|NCT02252978|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102053805|NCT02252978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102053806|NCT02129270|Lidocaine|lidocaine|mesh-list
102053807|NCT02129270|Anesthetics, Local|anesthetics, local|mesh-ancestor
102053808|NCT02129270|Anesthetics|anesthetics|mesh-ancestor
102053809|NCT02129270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102053810|NCT02129270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053811|NCT02129270|Sensory System Agents|sensory system agents|mesh-ancestor
102053812|NCT02129270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102053813|NCT02129270|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102053814|NCT02129270|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102053815|NCT02129270|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102053816|NCT02129270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102053817|NCT02129270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053818|NCT05370547|Cyclophosphamide|cyclophosphamide|mesh-list
101942226|NCT01128699|Bevacizumab|bevacizumab|mesh-list
101942227|NCT01128699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102053819|NCT05370547|Fludarabine|fludarabine|mesh-list
102053820|NCT05370547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102053821|NCT05370547|Immunologic Factors|immunologic factors|mesh-ancestor
102053822|NCT05370547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053823|NCT05370547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102053824|NCT05370547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102053825|NCT05370547|Alkylating Agents|alkylating agents|mesh-ancestor
102053826|NCT05370547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053827|NCT05370547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102053828|NCT05370547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102053829|NCT02133326|Acetaminophen|acetaminophen|mesh-list
102053830|NCT02133326|Ibuprofen|ibuprofen|mesh-list
102053831|NCT02133326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102053832|NCT02133326|Analgesics|analgesics|mesh-ancestor
102053833|NCT02133326|Sensory System Agents|sensory system agents|mesh-ancestor
102053834|NCT02133326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102053835|NCT02133326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053836|NCT02133326|Antipyretics|antipyretics|mesh-ancestor
102053837|NCT02133326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102053838|NCT02133326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102053839|NCT02133326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102053840|NCT02133326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102053841|NCT02133326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102053842|NCT02133326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053843|NCT02137616|Olanzapine|olanzapine|mesh-list
102053844|NCT02137616|Risperidone|risperidone|mesh-list
102053845|NCT02137616|Aripiprazole|aripiprazole|mesh-list
102053846|NCT02137616|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102053847|NCT02137616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102053848|NCT02137616|Serotonin Agents|serotonin agents|mesh-ancestor
102053849|NCT02137616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102053850|NCT02137616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053851|NCT02137616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053855|NCT02137616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102053856|NCT02137616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102053858|NCT02137616|Antiemetics|antiemetics|mesh-ancestor
102053859|NCT02137616|Autonomic Agents|autonomic agents|mesh-ancestor
102053860|NCT02137616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102053861|NCT02137616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102053862|NCT02137616|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102053863|NCT02137616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102053864|NCT02137616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102053865|NCT02137616|Antidepressive Agents|antidepressive agents|mesh-ancestor
102053866|NCT02137616|Dopamine Agonists|dopamine agonists|mesh-ancestor
102053867|NCT02137616|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102053868|NCT02137616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102053869|NCT02137616|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102053870|NCT02137616|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102053871|NCT02133638|Propofol|propofol|mesh-list
102053872|NCT02133638|Sevoflurane|sevoflurane|mesh-list
102053873|NCT02133638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102053874|NCT02133638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102053875|NCT02133638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053876|NCT02133638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102053877|NCT02133638|Anesthetics, General|anesthetics, general|mesh-ancestor
102053878|NCT02133638|Anesthetics|anesthetics|mesh-ancestor
102053879|NCT02133638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102053880|NCT02133638|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102053881|NCT02545283|Cytarabine|cytarabine|mesh-list
102053882|NCT02545283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102053883|NCT02545283|Antimetabolites|antimetabolites|mesh-ancestor
102053884|NCT02545283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053885|NCT02545283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102053886|NCT02545283|Antiviral Agents|antiviral agents|mesh-ancestor
102053887|NCT02545283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102053888|NCT02545283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102053889|NCT02545283|Immunologic Factors|immunologic factors|mesh-ancestor
102053890|NCT02545283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053891|NCT02137928|Carboplatin|carboplatin|mesh-list
102053892|NCT02137928|Etoposide|etoposide|mesh-list
102053893|NCT02137928|Etoposide phosphate|etoposide phosphate|mesh-list
101942228|NCT01128699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101431222|NCT00153725|Antipyretics|antipyretics|mesh-ancestor
102053894|NCT02137928|Vincristine|vincristine|mesh-list
102053895|NCT02137928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102053896|NCT02137928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102053897|NCT02137928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102053898|NCT02137928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102053899|NCT02137928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102053900|NCT02137928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053901|NCT02137928|Tubulin Modulators|tubulin modulators|mesh-ancestor
102053902|NCT02137928|Antimitotic Agents|antimitotic agents|mesh-ancestor
102053903|NCT02137928|Mitosis Modulators|mitosis modulators|mesh-ancestor
102053904|NCT02138084|Ritonavir|ritonavir|mesh-list
102053905|NCT02138084|Fostemsavir|fostemsavir|mesh-list
102053906|NCT02138084|Rifabutin|rifabutin|mesh-list
102053907|NCT02138084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102053908|NCT02138084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102053909|NCT02138084|Protease Inhibitors|protease inhibitors|mesh-ancestor
102053910|NCT02138084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101773633|NCT00688064|Analgesics|analgesics|mesh-ancestor
102053911|NCT02138084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053912|NCT02138084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102053913|NCT02138084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102053914|NCT02138084|Antiviral Agents|antiviral agents|mesh-ancestor
102053915|NCT02138084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102053916|NCT02138084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102053917|NCT02138084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102053918|NCT02138084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102053919|NCT02138084|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102053920|NCT02138084|Antitubercular Agents|antitubercular agents|mesh-ancestor
102053921|NCT02138084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101355432|NCT00030446|Carboplatin|carboplatin|mesh-list
102053954|NCT02138396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102053955|NCT02138396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053956|NCT02138396|Analgesics|analgesics|mesh-ancestor
102053957|NCT02138396|Sensory System Agents|sensory system agents|mesh-ancestor
102053958|NCT02138396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102053959|NCT02138396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102053960|NCT02138396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102053961|NCT02138396|Anesthetics, General|anesthetics, general|mesh-ancestor
102053962|NCT02138396|Anesthetics|anesthetics|mesh-ancestor
102053963|NCT02138396|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102053964|NCT02138396|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102053965|NCT04560881|Vaccines|vaccines|mesh-list
102053966|NCT04560881|Immunologic Factors|immunologic factors|mesh-ancestor
101355513|NCT00030719|Melphalan|melphalan|mesh-list
102053971|NCT02828761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053972|NCT02828761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102053973|NCT02875613|Avelumab|avelumab|mesh-list
102053974|NCT02875613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102053975|NCT02875613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102053976|NCT02815267|Minocycline|minocycline|mesh-list
102053977|NCT02815267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102053978|NCT02815267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102053979|NCT02130440|Resveratrol|resveratrol|mesh-list
102053980|NCT02130440|Antioxidants|antioxidants|mesh-ancestor
102053981|NCT02130440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053982|NCT02130440|Protective Agents|protective agents|mesh-ancestor
102053983|NCT02130440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053984|NCT02130440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102053985|NCT02130440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101575041|NCT05215873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102053986|NCT02138552|Octenidine|octenidine|mesh-list
102053987|NCT02138552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102053988|NCT02138552|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102053989|NCT02930837|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102053990|NCT02930837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102053991|NCT02930837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102053992|NCT02930837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053993|NCT02138708|Adenosine|adenosine|mesh-list
102053994|NCT02138708|Acetylcholine|acetylcholine|mesh-list
102053995|NCT02138708|Analgesics|analgesics|mesh-ancestor
102053996|NCT02138708|Sensory System Agents|sensory system agents|mesh-ancestor
102053997|NCT02138708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102053998|NCT02138708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942229|NCT01128699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101942230|NCT01128699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102053999|NCT02138708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102054000|NCT02138708|Vasodilator Agents|vasodilator agents|mesh-ancestor
102054001|NCT02138708|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102054002|NCT02138708|Purinergic Agonists|purinergic agonists|mesh-ancestor
102054003|NCT02138708|Purinergic Agents|purinergic agents|mesh-ancestor
102054004|NCT02138708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102054005|NCT02138708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054006|NCT02138708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102054007|NCT02138708|Cholinergic Agents|cholinergic agents|mesh-ancestor
102054008|NCT03633175|Progesterone|progesterone|mesh-list
102054009|NCT03633175|Progestins|progestins|mesh-ancestor
102054010|NCT03633175|Hormones|hormones|mesh-ancestor
102054011|NCT03633175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102054012|NCT03633175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054013|NCT02539693|Lidocaine|lidocaine|mesh-list
102054014|NCT02539693|Clonidine|clonidine|mesh-list
102054015|NCT02539693|Anesthetics, Local|anesthetics, local|mesh-ancestor
102054016|NCT02539693|Anesthetics|anesthetics|mesh-ancestor
102054017|NCT02539693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102054018|NCT02539693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054019|NCT02539693|Sensory System Agents|sensory system agents|mesh-ancestor
102054020|NCT02539693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102054021|NCT02539693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102054022|NCT02539693|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102054023|NCT02539693|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102054024|NCT02539693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102054025|NCT02539693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054026|NCT02539693|Analgesics|analgesics|mesh-ancestor
102054027|NCT02539693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102054028|NCT02539693|Sympatholytics|sympatholytics|mesh-ancestor
102054029|NCT02539693|Autonomic Agents|autonomic agents|mesh-ancestor
102054030|NCT02539693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102054031|NCT02539693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102054032|NCT02539693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102054033|NCT02539693|Adrenergic Agents|adrenergic agents|mesh-ancestor
102054034|NCT02539693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102054035|NCT05062135|Progesterone|progesterone|mesh-list
102054036|NCT05062135|Progestins|progestins|mesh-ancestor
102054062|NCT01354301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102054063|NCT01354301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102054065|NCT02134262|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102054066|NCT02134262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102054067|NCT02134262|Immunologic Factors|immunologic factors|mesh-ancestor
102054068|NCT02134262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054069|NCT02134262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102054070|NCT02134262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102054071|NCT02134262|Alkylating Agents|alkylating agents|mesh-ancestor
102054072|NCT02134262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054073|NCT02134262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102054074|NCT02134262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102054075|NCT01343277|Dacarbazine|dacarbazine|mesh-list
102054076|NCT01343277|Trabectedin|trabectedin|mesh-list
102054077|NCT01343277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102054078|NCT01343277|Alkylating Agents|alkylating agents|mesh-ancestor
102054079|NCT01343277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054080|NCT01343277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102054081|NCT04856293|Crizotinib|crizotinib|mesh-list
102054082|NCT04856293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102054083|NCT04856293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102054084|NCT04856293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102054085|NCT04856293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054086|NCT02253212|Carboplatin|carboplatin|mesh-list
102054091|NCT01355939|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102054093|NCT01355939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054094|NCT01356017|Amlodipine|amlodipine|mesh-list
102054095|NCT01356017|Telmisartan|telmisartan|mesh-list
102054096|NCT01356017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102054097|NCT01356017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102054098|NCT01356017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102054099|NCT01356017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942231|NCT01128699|Growth Substances|growth substances|mesh-ancestor
101942232|NCT01128699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942233|NCT01128699|Growth Inhibitors|growth inhibitors|mesh-ancestor
101942234|NCT01329627|Paclitaxel|paclitaxel|mesh-list
101942235|NCT01329627|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101942236|NCT01329627|Cyclophosphamide|cyclophosphamide|mesh-list
101942237|NCT01329627|Doxorubicin|doxorubicin|mesh-list
101942238|NCT01329627|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101942239|NCT01329627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101942240|NCT01329627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101942241|NCT01329627|Tubulin Modulators|tubulin modulators|mesh-ancestor
101942242|NCT01329627|Antimitotic Agents|antimitotic agents|mesh-ancestor
101942243|NCT01329627|Mitosis Modulators|mitosis modulators|mesh-ancestor
101942244|NCT01329627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942245|NCT01329627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101942246|NCT01329627|Immunologic Factors|immunologic factors|mesh-ancestor
101942247|NCT01329627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942248|NCT01329627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101942249|NCT01329627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101942250|NCT01329627|Alkylating Agents|alkylating agents|mesh-ancestor
101307198|NCT02031367|Immunologic Factors|immunologic factors|mesh-ancestor
102054100|NCT01356017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102054101|NCT01356017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054102|NCT01356017|Vasodilator Agents|vasodilator agents|mesh-ancestor
102054103|NCT01356017|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102054104|NCT01356017|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102054105|NCT02139098|Amitriptyline|amitriptyline|mesh-list
102054106|NCT02139098|Zolpidem|zolpidem|mesh-list
102054107|NCT02139098|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102054108|NCT02139098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102054109|NCT02139098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102054110|NCT02139098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054111|NCT02139098|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102054112|NCT02139098|GABA Agonists|gaba agonists|mesh-ancestor
102054113|NCT02139098|GABA Agents|gaba agents|mesh-ancestor
102054114|NCT02139098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102054115|NCT02139098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054116|NCT02139098|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102054117|NCT02139098|Antidepressive Agents|antidepressive agents|mesh-ancestor
102054118|NCT02139098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102054119|NCT02139098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102054120|NCT02139098|Analgesics|analgesics|mesh-ancestor
102054121|NCT02139098|Sensory System Agents|sensory system agents|mesh-ancestor
102054122|NCT02139098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102054123|NCT02139098|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102054124|NCT02139098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102054125|NCT02139098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102054126|NCT02139098|Adrenergic Agents|adrenergic agents|mesh-ancestor
102054127|NCT04498715|Zoledronic Acid|zoledronic acid|mesh-list
102054128|NCT04498715|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102054129|NCT04498715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054130|NCT02487979|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
102054131|NCT02487979|Immunoconjugates|immunoconjugates|mesh-list
101942251|NCT01329627|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101942252|NCT01329627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101942253|NCT01329627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101942254|NCT01329627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102054132|NCT02487979|Immunotoxins|immunotoxins|mesh-list
102054133|NCT02487979|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102054134|NCT02487979|Immunologic Factors|immunologic factors|mesh-ancestor
102054135|NCT02487979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054136|NCT02487979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102054137|NCT02487979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102054138|NCT02130830|Lidocaine|lidocaine|mesh-list
102054139|NCT02130830|Prilocaine|prilocaine|mesh-list
102054140|NCT02130830|Anesthetics, Local|anesthetics, local|mesh-ancestor
102054141|NCT02130830|Anesthetics|anesthetics|mesh-ancestor
102054142|NCT02130830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102054143|NCT02130830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054144|NCT02130830|Sensory System Agents|sensory system agents|mesh-ancestor
102054145|NCT02130830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102054146|NCT02130830|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102054147|NCT02130830|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102054148|NCT02130830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102054149|NCT02130830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102054150|NCT02130830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054151|NCT04471727|Atezolizumab|atezolizumab|mesh-list
102054152|NCT04471727|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102054153|NCT04471727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054154|NCT04471727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102054155|NCT04471727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102054168|NCT01363037|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102054169|NCT01363037|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102054170|NCT01363037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698253|NCT00541099|Bevacizumab|bevacizumab|mesh-list
102054171|NCT01363037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102054172|NCT01363037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102054173|NCT01363037|Antiviral Agents|antiviral agents|mesh-ancestor
102054174|NCT01363037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102054175|NCT01363037|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102054177|NCT01363115|Calcium|calcium|mesh-list
102054178|NCT01363115|Vitamins|vitamins|mesh-ancestor
102054179|NCT01363115|Micronutrients|micronutrients|mesh-ancestor
102054180|NCT01363115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054181|NCT01363115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102054182|NCT01363115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102054183|NCT01356329|Heparin|heparin|mesh-list
102054184|NCT01356329|Enoxaparin|enoxaparin|mesh-list
102054185|NCT01356329|Anticoagulants|anticoagulants|mesh-ancestor
102054186|NCT01356329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102054187|NCT01356329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102054188|NCT01356329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054189|NCT05579522|Hyaluronic Acid|hyaluronic acid|mesh-list
102054190|NCT05579522|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102054191|NCT05579522|Immunologic Factors|immunologic factors|mesh-ancestor
102054192|NCT05579522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054193|NCT05579522|Viscosupplements|viscosupplements|mesh-ancestor
102054194|NCT05579522|Protective Agents|protective agents|mesh-ancestor
102054195|NCT01356485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102054196|NCT01363193|Heparin|heparin|mesh-list
102054197|NCT01363193|Calcium heparin|calcium heparin|mesh-list
102054198|NCT01363193|Anticoagulants|anticoagulants|mesh-ancestor
102054199|NCT01363193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102054200|NCT01363193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102054201|NCT01363193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054202|NCT01319279|Hydrocodone|hydrocodone|mesh-list
102054203|NCT01319279|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102054204|NCT01319279|Narcotics|narcotics|mesh-ancestor
102054205|NCT01319279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102054206|NCT01319279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054207|NCT01319279|Analgesics|analgesics|mesh-ancestor
102054208|NCT01319279|Sensory System Agents|sensory system agents|mesh-ancestor
102054209|NCT01319279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102054210|NCT01319279|Antitussive Agents|antitussive agents|mesh-ancestor
102054211|NCT01319279|Respiratory System Agents|respiratory system agents|mesh-ancestor
101942255|NCT01329627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101942256|NCT03929211|Hydroxychloroquine|hydroxychloroquine|mesh-list
101942257|NCT03929211|Antimalarials|antimalarials|mesh-ancestor
101942258|NCT03929211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101942259|NCT03929211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101942260|NCT03929211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102054212|NCT01363271|Vancomycin|vancomycin|mesh-list
102054213|NCT01363271|Linezolid|linezolid|mesh-list
102054214|NCT01363271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102054215|NCT01363271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102054216|NCT01363271|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102054217|NCT01363271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102054218|NCT01363271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054219|NCT02134886|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102054220|NCT02134886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355736|NCT00058929|Treprostinil|treprostinil|mesh-list
102054223|NCT02134886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054225|NCT01360463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102054226|NCT01360463|Narcotics|narcotics|mesh-ancestor
102054227|NCT01360463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102054228|NCT01360463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054229|NCT01360463|Analgesics|analgesics|mesh-ancestor
102054230|NCT01360463|Sensory System Agents|sensory system agents|mesh-ancestor
102054231|NCT01360463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102054232|NCT01360463|Antitussive Agents|antitussive agents|mesh-ancestor
102054233|NCT01360463|Respiratory System Agents|respiratory system agents|mesh-ancestor
102054234|NCT01356641|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102054235|NCT01356641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102054236|NCT03103087|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102054237|NCT03103087|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101698270|NCT02575768|Adenosine|adenosine|mesh-list
102054238|NCT03103087|Norethindrone|norethindrone|mesh-list
102054239|NCT03103087|Norethindrone Acetate|norethindrone acetate|mesh-list
102054240|NCT03103087|Estradiol|estradiol|mesh-list
102054241|NCT03103087|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102054242|NCT03103087|Relugolix|relugolix|mesh-list
102054243|NCT03103087|Estrogens|estrogens|mesh-ancestor
102054244|NCT03103087|Hormones|hormones|mesh-ancestor
102054245|NCT03103087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102054246|NCT03103087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054247|NCT03103087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102054248|NCT03103087|Contraceptive Agents|contraceptive agents|mesh-ancestor
102054249|NCT03103087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102054250|NCT03103087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102054251|NCT03103087|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102054252|NCT03103087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102054253|NCT03103087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102054254|NCT03103087|Androgen Antagonists|androgen antagonists|mesh-ancestor
102054255|NCT03103087|Hormone Antagonists|hormone antagonists|mesh-ancestor
102054256|NCT05579288|Nitrous Oxide|nitrous oxide|mesh-list
102054257|NCT05579288|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102054258|NCT05579288|Anesthetics, General|anesthetics, general|mesh-ancestor
102054259|NCT05579288|Anesthetics|anesthetics|mesh-ancestor
102054260|NCT05579288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102054261|NCT05579288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054262|NCT05579288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102054263|NCT05579288|Analgesics|analgesics|mesh-ancestor
102054264|NCT05579288|Sensory System Agents|sensory system agents|mesh-ancestor
102054265|NCT05579288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102054266|NCT02134964|Dapansutrile|dapansutrile|mesh-list
102054267|NCT02134964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102054268|NCT01363583|Epoprostenol|epoprostenol|mesh-list
102054269|NCT01363583|Tezosentan|tezosentan|mesh-list
102054270|NCT01363583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102054271|NCT01363583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102054272|NCT01363583|Vasodilator Agents|vasodilator agents|mesh-ancestor
102054273|NCT02135120|Morphine|morphine|mesh-list
102054274|NCT02135120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102054275|NCT02135120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054276|NCT02135120|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102054277|NCT02135120|Narcotics|narcotics|mesh-ancestor
102054278|NCT02135120|Analgesics|analgesics|mesh-ancestor
102054279|NCT02135120|Sensory System Agents|sensory system agents|mesh-ancestor
101942261|NCT03929211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101942262|NCT03929211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942263|NCT03929211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101942265|NCT01132911|Vorinostat|vorinostat|mesh-list
101942266|NCT01132911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102054280|NCT02135120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102054281|NCT03131999|Imatinib Mesylate|imatinib mesylate|mesh-list
102054282|NCT03131999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102054283|NCT03131999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102054284|NCT03131999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102054285|NCT03131999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054286|NCT01319357|Saxagliptin|saxagliptin|mesh-list
102054287|NCT01319357|Incretins|incretins|mesh-ancestor
102054288|NCT01319357|Hormones|hormones|mesh-ancestor
102054289|NCT01319357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102054290|NCT01319357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054291|NCT01319357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102054292|NCT01319357|Protease Inhibitors|protease inhibitors|mesh-ancestor
102054293|NCT01319357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101355799|NCT00031577|Tubulin Modulators|tubulin modulators|mesh-ancestor
102054303|NCT02055053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054304|NCT02055053|Sensory System Agents|sensory system agents|mesh-ancestor
102054305|NCT02055053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102054306|NCT02303431|Edoxaban|edoxaban|mesh-list
102054307|NCT02303431|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102054308|NCT02303431|Antithrombins|antithrombins|mesh-ancestor
102054309|NCT02303431|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102054310|NCT02303431|Protease Inhibitors|protease inhibitors|mesh-ancestor
102054311|NCT02303431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101698276|NCT02575768|Vasodilator Agents|vasodilator agents|mesh-ancestor
102054312|NCT02303431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054313|NCT02303431|Anticoagulants|anticoagulants|mesh-ancestor
102054314|NCT02135510|Metoclopramide|metoclopramide|mesh-list
102054315|NCT02135510|Palonosetron|palonosetron|mesh-list
102054316|NCT02135510|Antiemetics|antiemetics|mesh-ancestor
102054317|NCT02135510|Autonomic Agents|autonomic agents|mesh-ancestor
102054318|NCT02135510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102054319|NCT02135510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054320|NCT02135510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102054321|NCT02135510|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102054322|NCT02135510|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102054323|NCT02135510|Dopamine Agents|dopamine agents|mesh-ancestor
102054324|NCT02135510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102054325|NCT02135510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054326|NCT02135510|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102054327|NCT02135510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102054328|NCT02135510|Serotonin Agents|serotonin agents|mesh-ancestor
102054329|NCT02004275|Dexamethasone|dexamethasone|mesh-list
102054330|NCT02004275|Pomalidomide|pomalidomide|mesh-list
102054331|NCT02004275|Ixazomib|ixazomib|mesh-list
102054332|NCT02004275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102054333|NCT02004275|Antiemetics|antiemetics|mesh-ancestor
102054334|NCT02004275|Autonomic Agents|autonomic agents|mesh-ancestor
102054335|NCT02004275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102054336|NCT02004275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054337|NCT02004275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102054338|NCT02004275|Glucocorticoids|glucocorticoids|mesh-ancestor
102054339|NCT02004275|Hormones|hormones|mesh-ancestor
102054340|NCT02004275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102054341|NCT02004275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102054342|NCT02004275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102054343|NCT02004275|Immunologic Factors|immunologic factors|mesh-ancestor
102054344|NCT02004275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102054345|NCT02004275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102054346|NCT02004275|Growth Substances|growth substances|mesh-ancestor
102054347|NCT02004275|Growth Inhibitors|growth inhibitors|mesh-ancestor
102054348|NCT02004275|Protease Inhibitors|protease inhibitors|mesh-ancestor
102054349|NCT02004275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102054350|NCT02004275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054351|NCT03548714|Ethanol|ethanol|mesh-list
102054352|NCT03548714|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101942267|NCT01132911|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101942268|NCT01132911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101942269|NCT01132911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942270|NCT01132989|Lenalidomide|lenalidomide|mesh-list
101942271|NCT01132989|Immunologic Factors|immunologic factors|mesh-ancestor
101942272|NCT01132989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942273|NCT01132989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101942274|NCT01132989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101942275|NCT01132989|Growth Substances|growth substances|mesh-ancestor
101942276|NCT01132989|Growth Inhibitors|growth inhibitors|mesh-ancestor
101942277|NCT01132989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101942278|NCT01225653|Latanoprost|latanoprost|mesh-list
101942279|NCT01225653|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101942280|NCT01225653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101942281|NCT01134861|Cisplatin|cisplatin|mesh-list
101942282|NCT01134861|Etoposide|etoposide|mesh-list
101942283|NCT01134861|Vinblastine|vinblastine|mesh-list
101942284|NCT01134861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101942285|NCT01134861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101942286|NCT01134861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101942287|NCT01134861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101942288|NCT01134861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101942289|NCT01134861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942290|NCT01134861|Tubulin Modulators|tubulin modulators|mesh-ancestor
101942291|NCT01134861|Antimitotic Agents|antimitotic agents|mesh-ancestor
101942292|NCT01134861|Mitosis Modulators|mitosis modulators|mesh-ancestor
101942293|NCT01133223|Plasminogen|plasminogen|mesh-list
101942294|NCT01133223|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101942295|NCT01133223|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101942296|NCT01133223|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102054353|NCT03548714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102054354|NCT03548714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102054355|NCT03548714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054356|NCT02135588|Plasminogen|plasminogen|mesh-list
102054357|NCT02135588|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102054358|NCT02135588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102054359|NCT02135588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101355876|NCT00031850|Goserelin|goserelin|mesh-list
102054373|NCT01363817|Antiemetics|antiemetics|mesh-ancestor
102054374|NCT01363817|Autonomic Agents|autonomic agents|mesh-ancestor
102054375|NCT01363817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102054376|NCT01363817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054377|NCT01363817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102054378|NCT01363817|Glucocorticoids|glucocorticoids|mesh-ancestor
102054379|NCT01363817|Hormones|hormones|mesh-ancestor
101942297|NCT01133223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942299|NCT01233219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101942300|NCT01233219|Narcotics|narcotics|mesh-ancestor
102054380|NCT01363817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102054381|NCT01363817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102054382|NCT01363817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102054383|NCT02140268|Midazolam|midazolam|mesh-list
102054384|NCT02140268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102054385|NCT02140268|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102054386|NCT02140268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102054387|NCT02140268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054388|NCT02140268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102054389|NCT02140268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102054390|NCT02140268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102054391|NCT02140268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102054392|NCT02140268|Anesthetics, General|anesthetics, general|mesh-ancestor
102054393|NCT02140268|Anesthetics|anesthetics|mesh-ancestor
102054394|NCT02140268|GABA Modulators|gaba modulators|mesh-ancestor
102054395|NCT02140268|GABA Agents|gaba agents|mesh-ancestor
102054396|NCT02140268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102054397|NCT02140268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054398|NCT05578352|Insulin|insulin|mesh-list
102054399|NCT05578352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102054400|NCT05578352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054401|NCT03602508|Solifenacin Succinate|solifenacin succinate|mesh-list
102054402|NCT03602508|Mirabegron|mirabegron|mesh-list
102054403|NCT03602508|Tolterodine Tartrate|tolterodine tartrate|mesh-list
102054404|NCT03602508|Fesoterodine|fesoterodine|mesh-list
102054405|NCT03602508|Oxybutynin|oxybutynin|mesh-list
102054406|NCT03602508|Darifenacin|darifenacin|mesh-list
102054407|NCT03602508|Propiverine|propiverine|mesh-list
102054408|NCT03602508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102054409|NCT03602508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102054410|NCT03602508|Cholinergic Agents|cholinergic agents|mesh-ancestor
102054411|NCT03602508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102054412|NCT03602508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054413|NCT03602508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054414|NCT03602508|Urological Agents|urological agents|mesh-ancestor
102054415|NCT03602508|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102054416|NCT03602508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102054417|NCT03602508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102054418|NCT03602508|Adrenergic Agents|adrenergic agents|mesh-ancestor
102054419|NCT03602508|Parasympatholytics|parasympatholytics|mesh-ancestor
102054420|NCT03602508|Autonomic Agents|autonomic agents|mesh-ancestor
102054421|NCT03602508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102054422|NCT03549728|Lenograstim|lenograstim|mesh-list
102054423|NCT03549728|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102054424|NCT03549728|Immunologic Factors|immunologic factors|mesh-ancestor
102054425|NCT03549728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054426|NCT01356797|Fentanyl|fentanyl|mesh-list
102054427|NCT01356797|Bupivacaine|bupivacaine|mesh-list
102054428|NCT01356797|Levobupivacaine|levobupivacaine|mesh-list
102054429|NCT01356797|Anesthetics, Local|anesthetics, local|mesh-ancestor
102054430|NCT01356797|Anesthetics|anesthetics|mesh-ancestor
102054431|NCT01356797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102054432|NCT01356797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054438|NCT01356797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102054439|NCT01356797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102054440|NCT01356797|Anesthetics, General|anesthetics, general|mesh-ancestor
102054442|NCT02238132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102054443|NCT02238132|Autonomic Agents|autonomic agents|mesh-ancestor
102054444|NCT02238132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102054445|NCT02238132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054446|NCT02238132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102054447|NCT02238132|Respiratory System Agents|respiratory system agents|mesh-ancestor
102054448|NCT02238132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102054449|NCT02238132|Cholinergic Agents|cholinergic agents|mesh-ancestor
102054450|NCT02238132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102054451|NCT02238132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054453|NCT05200429|Elexacaftor|elexacaftor|mesh-list
102054454|NCT05200429|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101942301|NCT01233219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101942302|NCT01233219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054455|NCT05200429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102054456|NCT05200429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054457|NCT05578196|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102054458|NCT02135822|Paclitaxel|paclitaxel|mesh-list
102054459|NCT02135822|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102054460|NCT02135822|Gemcitabine|gemcitabine|mesh-list
102054461|NCT02135822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102054462|NCT02135822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102054463|NCT02135822|Tubulin Modulators|tubulin modulators|mesh-ancestor
102054464|NCT02135822|Antimitotic Agents|antimitotic agents|mesh-ancestor
102054465|NCT02135822|Mitosis Modulators|mitosis modulators|mesh-ancestor
102054466|NCT02135822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054467|NCT02135822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102054468|NCT02135822|Antimetabolites|antimetabolites|mesh-ancestor
102054469|NCT02238210|Ipratropium|ipratropium|mesh-list
102054470|NCT02238210|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102054471|NCT02238210|Autonomic Agents|autonomic agents|mesh-ancestor
102054472|NCT02238210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102054473|NCT02238210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054474|NCT02238210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102054475|NCT02238210|Respiratory System Agents|respiratory system agents|mesh-ancestor
102054476|NCT02238210|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102054477|NCT02238210|Cholinergic Agents|cholinergic agents|mesh-ancestor
102054478|NCT02238210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102054479|NCT02238210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054480|NCT05739955|Disinfectants|disinfectants|mesh-list
102054481|NCT05739955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102054482|NCT02978456|Sirolimus|sirolimus|mesh-list
102054483|NCT02978456|Temsirolimus|temsirolimus|mesh-list
102054484|NCT02978456|MTOR Inhibitors|mtor inhibitors|mesh-list
102054485|NCT02978456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102054486|NCT02978456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102054487|NCT02978456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102054488|NCT02978456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102054489|NCT02978456|Antifungal Agents|antifungal agents|mesh-ancestor
102054490|NCT02978456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102054491|NCT02978456|Immunologic Factors|immunologic factors|mesh-ancestor
102054492|NCT02978456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054493|NCT02978456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102054494|NCT02978456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102054495|NCT02978456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054496|NCT05736913|Vaccines|vaccines|mesh-list
102054497|NCT05736913|Immunologic Factors|immunologic factors|mesh-ancestor
102054498|NCT05736913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054499|NCT03598452|Ganciclovir|ganciclovir|mesh-list
102054500|NCT03598452|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102054501|NCT03598452|Antiviral Agents|antiviral agents|mesh-ancestor
102054502|NCT03598452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102054503|NCT03598452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102054507|NCT03549026|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102054508|NCT03549026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102054509|NCT03549026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102054510|NCT03549026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054511|NCT03549026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102054512|NCT03549026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054513|NCT03549026|Analgesics|analgesics|mesh-ancestor
102054514|NCT03549026|Sensory System Agents|sensory system agents|mesh-ancestor
102054515|NCT03549026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102054516|NCT03549026|Antidepressive Agents|antidepressive agents|mesh-ancestor
102054517|NCT03549026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102054518|NCT03549026|Dopamine Agents|dopamine agents|mesh-ancestor
102054519|NCT03101371|Iodine|iodine|mesh-list
102054520|NCT03101371|Povidone-Iodine|povidone-iodine|mesh-list
102054521|NCT03101371|Povidone|povidone|mesh-list
102054522|NCT03101371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102054523|NCT03101371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102054524|NCT03101371|Trace Elements|trace elements|mesh-ancestor
102054525|NCT03101371|Micronutrients|micronutrients|mesh-ancestor
101942304|NCT01233219|Sensory System Agents|sensory system agents|mesh-ancestor
101942305|NCT01233219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101942306|NCT02960854|Nivolumab|nivolumab|mesh-list
101942307|NCT02960854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101942308|NCT02960854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101942309|NCT02960854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101942310|NCT02960854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054526|NCT03101371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054527|NCT03101371|Plasma Substitutes|plasma substitutes|mesh-ancestor
102054528|NCT03101371|Blood Substitutes|blood substitutes|mesh-ancestor
102054529|NCT03588078|Azacitidine|azacitidine|mesh-list
102054530|NCT03588078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102054531|NCT03588078|Antimetabolites|antimetabolites|mesh-ancestor
102054532|NCT03588078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054533|NCT03588078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102054534|NCT03588078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102054535|NCT02238366|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102054536|NCT02238366|Luteolytic Agents|luteolytic agents|mesh-ancestor
102054537|NCT02238366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102054538|NCT02238366|Contraceptive Agents|contraceptive agents|mesh-ancestor
102054539|NCT02238366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102054540|NCT02238366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054541|NCT02238366|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102054542|NCT02238366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102054543|NCT02238366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102054544|NCT05494190|Docetaxel|docetaxel|mesh-list
102054545|NCT05494190|Capecitabine|capecitabine|mesh-list
102054546|NCT05494190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102054547|NCT05494190|Tubulin Modulators|tubulin modulators|mesh-ancestor
102054548|NCT05494190|Antimitotic Agents|antimitotic agents|mesh-ancestor
102054549|NCT05494190|Mitosis Modulators|mitosis modulators|mesh-ancestor
102054550|NCT05494190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054551|NCT05494190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102054552|NCT05494190|Antimetabolites|antimetabolites|mesh-ancestor
102054553|NCT02850276|Bromides|bromides|mesh-list
102054554|NCT02850276|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
102054555|NCT02850276|Anticonvulsants|anticonvulsants|mesh-ancestor
102054556|NCT02850276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102054557|NCT02850276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102054558|NCT02850276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054559|NCT02850276|Cholinergic Agents|cholinergic agents|mesh-ancestor
102054560|NCT02850276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102054561|NCT02850276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054562|NCT04961593|Caspofungin|caspofungin|mesh-list
102054563|NCT04961593|Antifungal Agents|antifungal agents|mesh-ancestor
102054564|NCT04961593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102054565|NCT04961593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102054566|NCT04961593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054567|NCT03862170|Ciprofloxacin|ciprofloxacin|mesh-list
102054568|NCT03862170|Cefazolin|cefazolin|mesh-list
102054569|NCT03862170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102054570|NCT03862170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102054571|NCT03862170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102054572|NCT03862170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102054573|NCT03862170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102054574|NCT03862170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054579|NCT02140580|Respiratory System Agents|respiratory system agents|mesh-ancestor
102054580|NCT05577806|Dydrogesterone|dydrogesterone|mesh-list
102054581|NCT05577806|Progestins|progestins|mesh-ancestor
102054582|NCT05577806|Hormones|hormones|mesh-ancestor
102054583|NCT05577806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102054584|NCT05577806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054585|NCT03591276|Antineoplastic Agents|antineoplastic agents|mesh-list
102054586|NCT05465876|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
102054587|NCT05465876|Antiviral Agents|antiviral agents|mesh-ancestor
102054588|NCT05465876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102054589|NCT03548948|Iron|iron|mesh-list
101942311|NCT01133301|Naltrexone|naltrexone|mesh-list
101942312|NCT01133301|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101942313|NCT01133301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101942314|NCT01133301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054590|NCT03548948|Trace Elements|trace elements|mesh-ancestor
102054591|NCT03548948|Micronutrients|micronutrients|mesh-ancestor
102054592|NCT03548948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054593|NCT02238444|Aspirin|aspirin|mesh-list
102054594|NCT02238444|Heparin|heparin|mesh-list
102054595|NCT02238444|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102054596|NCT02238444|Tinzaparin|tinzaparin|mesh-list
102054597|NCT02238444|Dalteparin|dalteparin|mesh-list
102054598|NCT02238444|Dipyridamole|dipyridamole|mesh-list
102054599|NCT02238444|Warfarin|warfarin|mesh-list
102054600|NCT02238444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102054601|NCT02238444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102054602|NCT02238444|Analgesics|analgesics|mesh-ancestor
102054603|NCT02238444|Sensory System Agents|sensory system agents|mesh-ancestor
102054604|NCT02238444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102054605|NCT02238444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054606|NCT02238444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102054607|NCT02238444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102054608|NCT02238444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102054609|NCT02238444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102054610|NCT02238444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054611|NCT02238444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102054612|NCT02238444|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102054613|NCT02238444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102054614|NCT02238444|Antipyretics|antipyretics|mesh-ancestor
102054615|NCT02238444|Anticoagulants|anticoagulants|mesh-ancestor
102054616|NCT02238444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102054617|NCT02238444|Vasodilator Agents|vasodilator agents|mesh-ancestor
102054618|NCT03131687|Dulaglutide|dulaglutide|mesh-list
102054619|NCT03131687|Tirzepatide|tirzepatide|mesh-list
102054620|NCT03131687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102054621|NCT03131687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054622|NCT03131687|Incretins|incretins|mesh-ancestor
102054623|NCT03131687|Hormones|hormones|mesh-ancestor
102054624|NCT03131687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102054625|NCT03579888|Cyclophosphamide|cyclophosphamide|mesh-list
102054626|NCT03579888|Fludarabine|fludarabine|mesh-list
102054627|NCT03579888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102054628|NCT03579888|Immunologic Factors|immunologic factors|mesh-ancestor
102054629|NCT03579888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054630|NCT03579888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102054631|NCT03579888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102054632|NCT03579888|Alkylating Agents|alkylating agents|mesh-ancestor
102054633|NCT03579888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054634|NCT03579888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102054635|NCT03579888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102054636|NCT05344027|Mitotane|mitotane|mesh-list
102054637|NCT05344027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102054638|NCT05344027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102054639|NCT05430698|Antibodies|antibodies|mesh-list
102054640|NCT05430698|Immunologic Factors|immunologic factors|mesh-ancestor
102054641|NCT05430698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054642|NCT03585894|Ketorolac|ketorolac|mesh-list
102054643|NCT03585894|Sumatriptan|sumatriptan|mesh-list
102054644|NCT03585894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102054645|NCT03585894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102054646|NCT03585894|Analgesics|analgesics|mesh-ancestor
102054647|NCT03585894|Sensory System Agents|sensory system agents|mesh-ancestor
102054652|NCT03585894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102054653|NCT03585894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102054654|NCT03585894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054655|NCT03585894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102054656|NCT03585894|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102054657|NCT03585894|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102054658|NCT03585894|Serotonin Agents|serotonin agents|mesh-ancestor
102054659|NCT03585894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102054660|NCT04912921|Palmidrol|palmidrol|mesh-list
102054661|NCT04912921|Curcumin|curcumin|mesh-list
102054662|NCT04912921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102054663|NCT04912921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101942315|NCT01133301|Sensory System Agents|sensory system agents|mesh-ancestor
101942316|NCT01133301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101942317|NCT03918135|Acetaminophen|acetaminophen|mesh-list
101942318|NCT03918135|Ibuprofen|ibuprofen|mesh-list
101942319|NCT03918135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101662139|NCT00616759|Propofol|propofol|mesh-list
101942320|NCT03918135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101942321|NCT03918135|Analgesics|analgesics|mesh-ancestor
102054664|NCT04912921|Analgesics|analgesics|mesh-ancestor
102054665|NCT04912921|Sensory System Agents|sensory system agents|mesh-ancestor
102054666|NCT04912921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102054667|NCT04912921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054668|NCT04912921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102054669|NCT04912921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102054670|NCT04912921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102054671|NCT04912921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102054672|NCT04912921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054673|NCT04912921|Antiviral Agents|antiviral agents|mesh-ancestor
102054674|NCT04912921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102054675|NCT04912921|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102054676|NCT04912921|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102054677|NCT04912921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102054678|NCT04912921|Hormones|hormones|mesh-ancestor
102054679|NCT04912921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102054680|NCT05420324|Paclitaxel|paclitaxel|mesh-list
102054681|NCT05420324|Pembrolizumab|pembrolizumab|mesh-list
102054682|NCT05420324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102054683|NCT05420324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102054684|NCT05420324|Tubulin Modulators|tubulin modulators|mesh-ancestor
102054685|NCT05420324|Antimitotic Agents|antimitotic agents|mesh-ancestor
102054686|NCT05420324|Mitosis Modulators|mitosis modulators|mesh-ancestor
102054687|NCT05420324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054688|NCT05420324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102054689|NCT05420324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102054690|NCT02238288|Acetaminophen|acetaminophen|mesh-list
102054691|NCT02238288|Lidocaine|lidocaine|mesh-list
102054692|NCT02238288|Epinephrine|epinephrine|mesh-list
102054693|NCT02238288|Aminocaproic Acid|aminocaproic acid|mesh-list
102054694|NCT02238288|Anesthetics, Local|anesthetics, local|mesh-ancestor
102054695|NCT02238288|Anesthetics|anesthetics|mesh-ancestor
102054696|NCT02238288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101698323|NCT02577250|Anesthetics, General|anesthetics, general|mesh-ancestor
102054697|NCT02238288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054698|NCT02238288|Sensory System Agents|sensory system agents|mesh-ancestor
102054699|NCT02238288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102054700|NCT02238288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102054701|NCT02238288|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102054702|NCT02238288|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102054703|NCT02238288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102054704|NCT02238288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054705|NCT02238288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102054706|NCT02238288|Analgesics|analgesics|mesh-ancestor
102054707|NCT02238288|Antipyretics|antipyretics|mesh-ancestor
102054708|NCT02238288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102054709|NCT02238288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102054710|NCT02238288|Adrenergic Agents|adrenergic agents|mesh-ancestor
102054711|NCT02238288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102054712|NCT02238288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102054713|NCT02238288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102054714|NCT02238288|Autonomic Agents|autonomic agents|mesh-ancestor
102054715|NCT02238288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102054716|NCT02238288|Respiratory System Agents|respiratory system agents|mesh-ancestor
102054717|NCT02238288|Mydriatics|mydriatics|mesh-ancestor
102054721|NCT02238288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102054722|NCT02238288|Hemostatics|hemostatics|mesh-ancestor
102054723|NCT02238288|Coagulants|coagulants|mesh-ancestor
102054724|NCT01561040|Vitamin D|vitamin d|mesh-list
102054725|NCT01561040|Vitamin A|vitamin a|mesh-list
102054726|NCT01561040|Vitamins|vitamins|mesh-ancestor
102054727|NCT01561040|Micronutrients|micronutrients|mesh-ancestor
101942322|NCT03918135|Sensory System Agents|sensory system agents|mesh-ancestor
101942323|NCT03918135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101942324|NCT03918135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942325|NCT03918135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101307285|NCT02035709|Hydromorphone|hydromorphone|mesh-list
102054728|NCT01561040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054729|NCT01561040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102054730|NCT03590496|Calcium|calcium|mesh-list
102054731|NCT03590496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102054732|NCT03590496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054733|NCT05577260|Dexmedetomidine|dexmedetomidine|mesh-list
102054734|NCT05577260|Bupivacaine|bupivacaine|mesh-list
102054735|NCT05577260|Anesthetics, Local|anesthetics, local|mesh-ancestor
102054736|NCT05577260|Anesthetics|anesthetics|mesh-ancestor
102054737|NCT05577260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102054738|NCT05577260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054739|NCT05577260|Sensory System Agents|sensory system agents|mesh-ancestor
102054740|NCT05577260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102054741|NCT05577260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102054742|NCT05577260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102054743|NCT05577260|Analgesics|analgesics|mesh-ancestor
102054744|NCT05577260|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102054745|NCT05577260|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102054746|NCT05577260|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102054747|NCT05577260|Adrenergic Agents|adrenergic agents|mesh-ancestor
102054748|NCT05577260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102054749|NCT05577260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054750|NCT03760562|Glucocorticoids|glucocorticoids|mesh-list
102054751|NCT03760562|Hormones|hormones|mesh-ancestor
102054752|NCT03760562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102054753|NCT03760562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054754|NCT01357031|Amitriptyline|amitriptyline|mesh-list
102054755|NCT01357031|Melatonin|melatonin|mesh-list
102054756|NCT01357031|Antioxidants|antioxidants|mesh-ancestor
102054757|NCT01357031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054758|NCT01357031|Protective Agents|protective agents|mesh-ancestor
102054759|NCT01357031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054760|NCT01357031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102054761|NCT01357031|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102054762|NCT01357031|Antidepressive Agents|antidepressive agents|mesh-ancestor
102054763|NCT01357031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102054764|NCT01357031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102054765|NCT01357031|Analgesics|analgesics|mesh-ancestor
102054766|NCT01357031|Sensory System Agents|sensory system agents|mesh-ancestor
102054767|NCT01357031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102054768|NCT01357031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102054769|NCT01357031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102054770|NCT01357031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102054771|NCT01357031|Adrenergic Agents|adrenergic agents|mesh-ancestor
102054772|NCT01357031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102054773|NCT01357109|Bosentan|bosentan|mesh-list
102054774|NCT01357109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102054775|NCT01357109|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102054776|NCT01357109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054777|NCT02253446|Diclofenac|diclofenac|mesh-list
102054778|NCT02253446|Piroxicam|piroxicam|mesh-list
102054779|NCT02253446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102054780|NCT02253446|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102054781|NCT02253446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102054782|NCT02253446|Analgesics|analgesics|mesh-ancestor
102054783|NCT02253446|Sensory System Agents|sensory system agents|mesh-ancestor
102054784|NCT02253446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102054785|NCT02253446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054786|NCT02253446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102054787|NCT02253446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102054788|NCT02253446|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102054789|NCT02253446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101356296|NCT00033332|Immunologic Factors|immunologic factors|mesh-ancestor
101942326|NCT03918135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101942327|NCT03918135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102054808|NCT03585348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102054809|NCT03585348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054810|NCT05384678|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
102054811|NCT05384678|Hallucinogens|hallucinogens|mesh-ancestor
102054812|NCT05384678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054813|NCT05384678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102054814|NCT05384678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102054815|NCT05384678|Serotonin Agents|serotonin agents|mesh-ancestor
102054816|NCT05384678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102054817|NCT05384678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054818|NCT05384678|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101774543|NCT00352885|Escitalopram|escitalopram|mesh-list
102054820|NCT01563224|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102054821|NCT01563224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054822|NCT01563224|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102054823|NCT01563224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102054824|NCT01563224|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102054825|NCT01563224|GABA Agonists|gaba agonists|mesh-ancestor
102054826|NCT01563224|GABA Agents|gaba agents|mesh-ancestor
102054827|NCT01563224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102054828|NCT01563224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054829|NCT01369979|Imidacloprid|imidacloprid|mesh-list
102054830|NCT01369979|Cholinergic Agents|cholinergic agents|mesh-ancestor
102054831|NCT01369979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102054832|NCT01369979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054833|NCT01369979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054834|NCT03577860|Bupivacaine|bupivacaine|mesh-list
102054835|NCT03577860|Anesthetics, Local|anesthetics, local|mesh-ancestor
102054836|NCT03577860|Anesthetics|anesthetics|mesh-ancestor
102054837|NCT03577860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102054838|NCT03577860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054839|NCT03577860|Sensory System Agents|sensory system agents|mesh-ancestor
102054840|NCT03577860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102054841|NCT03577782|Vedolizumab|vedolizumab|mesh-list
102054842|NCT03577782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102054843|NCT03432065|Buspirone|buspirone|mesh-list
102054844|NCT03432065|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102054858|NCT03577626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054860|NCT03412799|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102054861|NCT03412799|Gemcitabine|gemcitabine|mesh-list
102054862|NCT03412799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102054863|NCT03412799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102054864|NCT03412799|Tubulin Modulators|tubulin modulators|mesh-ancestor
102054865|NCT03412799|Antimitotic Agents|antimitotic agents|mesh-ancestor
102054866|NCT03412799|Mitosis Modulators|mitosis modulators|mesh-ancestor
102054867|NCT03412799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054868|NCT03412799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102054869|NCT03412799|Antimetabolites|antimetabolites|mesh-ancestor
102054870|NCT03579732|Aspirin|aspirin|mesh-list
102054871|NCT03579732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102054872|NCT03579732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102054873|NCT03579732|Analgesics|analgesics|mesh-ancestor
102054874|NCT03579732|Sensory System Agents|sensory system agents|mesh-ancestor
102054875|NCT03579732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102054876|NCT03579732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054877|NCT03579732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102054878|NCT03579732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102054879|NCT03579732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102054880|NCT03579732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102054881|NCT03579732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054882|NCT03579732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102054883|NCT03579732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102054884|NCT03579732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102054885|NCT03579732|Antipyretics|antipyretics|mesh-ancestor
102054886|NCT02259816|Amlodipine|amlodipine|mesh-list
102054887|NCT02259816|Telmisartan|telmisartan|mesh-list
102054888|NCT02259816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102054889|NCT02259816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102054890|NCT02259816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102054891|NCT02259816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942328|NCT03918135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101942329|NCT03918135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942330|NCT03918135|Antipyretics|antipyretics|mesh-ancestor
101942331|NCT05480475|Dabigatran|dabigatran|mesh-list
102054892|NCT02259816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102054893|NCT02259816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054894|NCT02259816|Vasodilator Agents|vasodilator agents|mesh-ancestor
102054895|NCT02259816|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102054896|NCT02259816|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102054898|NCT01567735|Antiviral Agents|antiviral agents|mesh-ancestor
102054899|NCT01567735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102054900|NCT01567735|Protease Inhibitors|protease inhibitors|mesh-ancestor
102054901|NCT01567735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102054902|NCT01567735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054903|NCT04631471|Ibudilast|ibudilast|mesh-list
101356423|NCT00033722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102054908|NCT04631471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102054909|NCT04631471|Respiratory System Agents|respiratory system agents|mesh-ancestor
102054910|NCT04631471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102054911|NCT04631471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102054912|NCT04631471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054913|NCT04631471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102054914|NCT04631471|Vasodilator Agents|vasodilator agents|mesh-ancestor
102054915|NCT03577392|Capecitabine|capecitabine|mesh-list
102054916|NCT03577392|Oxaliplatin|oxaliplatin|mesh-list
102054917|NCT03577392|Endostatins|endostatins|mesh-list
102054918|NCT03577392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102054919|NCT03577392|Antimetabolites|antimetabolites|mesh-ancestor
102054920|NCT03577392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054921|NCT03577392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102054922|NCT03577392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102054923|NCT03577392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102054924|NCT03577392|Growth Substances|growth substances|mesh-ancestor
102054925|NCT03577392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054926|NCT03577392|Growth Inhibitors|growth inhibitors|mesh-ancestor
102054927|NCT03579576|Ribavirin|ribavirin|mesh-list
102054928|NCT03579576|Sofosbuvir|sofosbuvir|mesh-list
102054929|NCT03579576|Velpatasvir|velpatasvir|mesh-list
102054930|NCT03579576|Antimetabolites|antimetabolites|mesh-ancestor
102054931|NCT03579576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054932|NCT03579576|Antiviral Agents|antiviral agents|mesh-ancestor
102054933|NCT03579576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102054934|NCT01364519|Fluticasone|fluticasone|mesh-list
102054935|NCT01364519|Xhance|xhance|mesh-list
102054936|NCT01364519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102054937|NCT01364519|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102054938|NCT01364519|Autonomic Agents|autonomic agents|mesh-ancestor
102054939|NCT01364519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102054940|NCT01364519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054941|NCT01364519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102054942|NCT01364519|Respiratory System Agents|respiratory system agents|mesh-ancestor
102054943|NCT01364519|Dermatologic Agents|dermatologic agents|mesh-ancestor
102054944|NCT01364519|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102054945|NCT03577158|Insulin|insulin|mesh-list
102054946|NCT03577158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102054947|NCT03577158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054948|NCT02253914|Ritonavir|ritonavir|mesh-list
102054949|NCT02253914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102054950|NCT02253914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102054951|NCT02253914|Protease Inhibitors|protease inhibitors|mesh-ancestor
102054952|NCT02253914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102054953|NCT02253914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054954|NCT02253914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102054955|NCT02253914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102054956|NCT02253914|Antiviral Agents|antiviral agents|mesh-ancestor
102054957|NCT02253914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102054958|NCT02253914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102054959|NCT02253914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102054960|NCT01364675|Metformin|metformin|mesh-list
102054961|NCT01364675|Enalapril|enalapril|mesh-list
102054962|NCT01364675|Simvastatin|simvastatin|mesh-list
102054963|NCT01364675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101942332|NCT05480475|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101942333|NCT05480475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102054964|NCT01364675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054965|NCT01364675|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102054966|NCT01364675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102054967|NCT01364675|Antimetabolites|antimetabolites|mesh-ancestor
102054968|NCT01364675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054969|NCT01364675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102054970|NCT01364675|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102054971|NCT01364675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102054972|NCT01364675|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102054973|NCT01364675|Protease Inhibitors|protease inhibitors|mesh-ancestor
102054974|NCT01364675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102054975|NCT02253758|Propofol|propofol|mesh-list
102054981|NCT02253758|Anesthetics|anesthetics|mesh-ancestor
102054982|NCT03547232|Indomethacin|indomethacin|mesh-list
102054983|NCT03547232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102054984|NCT03547232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102054985|NCT03547232|Analgesics|analgesics|mesh-ancestor
102054986|NCT03547232|Sensory System Agents|sensory system agents|mesh-ancestor
102054987|NCT03547232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102054988|NCT03547232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054989|NCT03547232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102054990|NCT03547232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102054991|NCT03547232|Gout Suppressants|gout suppressants|mesh-ancestor
102054992|NCT03547232|Tocolytic Agents|tocolytic agents|mesh-ancestor
102054993|NCT03547232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102054994|NCT03547232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102054995|NCT03547232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102054996|NCT03547232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054997|NCT02250534|Nicotine|nicotine|mesh-list
102054998|NCT02250534|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102054999|NCT02250534|Autonomic Agents|autonomic agents|mesh-ancestor
102055000|NCT02250534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102055001|NCT02250534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055002|NCT02250534|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102055003|NCT02250534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102055004|NCT02250534|Cholinergic Agents|cholinergic agents|mesh-ancestor
102055005|NCT02250534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102055006|NCT02250534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055007|NCT01370135|Ranibizumab|ranibizumab|mesh-list
102055008|NCT01370135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102055009|NCT01370135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102055010|NCT01370135|Growth Substances|growth substances|mesh-ancestor
102055011|NCT01370135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055012|NCT01370135|Growth Inhibitors|growth inhibitors|mesh-ancestor
102055013|NCT01370135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102055014|NCT05266586|Ezetimibe|ezetimibe|mesh-list
102055015|NCT05266586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102055016|NCT05266586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102055017|NCT05266586|Antimetabolites|antimetabolites|mesh-ancestor
102055018|NCT05266586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055019|NCT05266586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102055020|NCT01370291|Risperidone|risperidone|mesh-list
102055021|NCT01370291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102055022|NCT01370291|Serotonin Agents|serotonin agents|mesh-ancestor
102055023|NCT01370291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102055024|NCT01370291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055025|NCT01370291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055026|NCT01370291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102055027|NCT01370291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102055028|NCT01370291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102055029|NCT01370291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102055030|NCT01370291|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102055031|NCT01370291|Dopamine Agents|dopamine agents|mesh-ancestor
102055032|NCT05575544|Morphine|morphine|mesh-list
102055033|NCT05575544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102055034|NCT05575544|Narcotics|narcotics|mesh-ancestor
102055035|NCT05575544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102055036|NCT05575544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055037|NCT05575544|Analgesics|analgesics|mesh-ancestor
102055038|NCT05575544|Sensory System Agents|sensory system agents|mesh-ancestor
102055039|NCT05575544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101942334|NCT05480475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101942335|NCT05480475|Antimetabolites|antimetabolites|mesh-ancestor
101307296|NCT02035891|Tubulin Modulators|tubulin modulators|mesh-ancestor
102055040|NCT05179772|Olanzapine|olanzapine|mesh-list
102055041|NCT05179772|Antiemetics|antiemetics|mesh-ancestor
101698378|NCT04153734|Pemetrexed|pemetrexed|mesh-list
102055042|NCT05179772|Autonomic Agents|autonomic agents|mesh-ancestor
102055043|NCT05179772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102055044|NCT05179772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055045|NCT05179772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102055054|NCT05179772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102055057|NCT01364987|Peficitinib|peficitinib|mesh-list
102055058|NCT01364987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102055059|NCT01364987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102055060|NCT01364987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102055061|NCT01364987|Antitubercular Agents|antitubercular agents|mesh-ancestor
102055062|NCT01364987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102055063|NCT01364987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102055064|NCT01364987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102055065|NCT01364987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055066|NCT01364987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102055067|NCT01364987|Immunologic Factors|immunologic factors|mesh-ancestor
102055068|NCT01364987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055069|NCT01365923|Dexmedetomidine|dexmedetomidine|mesh-list
102055070|NCT01365923|Remifentanil|remifentanil|mesh-list
102055071|NCT01365923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102055072|NCT01365923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102055073|NCT01365923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055074|NCT01365923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102055075|NCT01365923|Analgesics|analgesics|mesh-ancestor
102055076|NCT01365923|Sensory System Agents|sensory system agents|mesh-ancestor
102055077|NCT01365923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102055078|NCT01365923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102055079|NCT01365923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102055080|NCT01365923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102055081|NCT01365923|Adrenergic Agents|adrenergic agents|mesh-ancestor
102055082|NCT01365923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102055083|NCT01365923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055084|NCT01365923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102055085|NCT01365923|Narcotics|narcotics|mesh-ancestor
102055086|NCT01370915|Vitamins|vitamins|mesh-list
102055087|NCT01370915|Pregabalin|pregabalin|mesh-list
102055088|NCT01370915|Micronutrients|micronutrients|mesh-ancestor
102055089|NCT01370915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055090|NCT01370915|Analgesics|analgesics|mesh-ancestor
102055091|NCT01370915|Sensory System Agents|sensory system agents|mesh-ancestor
102055092|NCT01370915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102055093|NCT01370915|Anticonvulsants|anticonvulsants|mesh-ancestor
102055094|NCT01370915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102055095|NCT01370915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102055096|NCT01370915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055097|NCT01370915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102055098|NCT01370915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102055099|NCT01370915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102055100|NCT01370915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102055101|NCT01370915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102055102|NCT05574998|Paclitaxel|paclitaxel|mesh-list
102055103|NCT05574998|Cisplatin|cisplatin|mesh-list
102055104|NCT05574998|Carboplatin|carboplatin|mesh-list
102055105|NCT05574998|Pemetrexed|pemetrexed|mesh-list
102055106|NCT05574998|Endostar protein|endostar protein|mesh-list
102055107|NCT05574998|Endostatins|endostatins|mesh-list
102055108|NCT05574998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102055109|NCT05574998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102055110|NCT05574998|Tubulin Modulators|tubulin modulators|mesh-ancestor
102055111|NCT05574998|Antimitotic Agents|antimitotic agents|mesh-ancestor
102055122|NCT03547778|Misoprostol|misoprostol|mesh-list
102055123|NCT03547778|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102055124|NCT03547778|Abortifacient Agents|abortifacient agents|mesh-ancestor
102055125|NCT03547778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102055126|NCT03547778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055127|NCT03547778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102055128|NCT03547778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102055129|NCT03547778|Oxytocics|oxytocics|mesh-ancestor
102055130|NCT03547700|Ixazomib|ixazomib|mesh-list
102055131|NCT03547700|Romidepsin|romidepsin|mesh-list
101942336|NCT05480475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942337|NCT05480475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101942338|NCT05480475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101942339|NCT05480475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101942340|NCT05480475|Antithrombins|antithrombins|mesh-ancestor
101307301|NCT02035956|Vaccines|vaccines|mesh-list
102055132|NCT03547700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102055133|NCT03547700|Protease Inhibitors|protease inhibitors|mesh-ancestor
102055134|NCT03547700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102055135|NCT03547700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055136|NCT03547700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102055137|NCT03547700|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102055138|NCT02239458|Saxagliptin|saxagliptin|mesh-list
102055139|NCT02239458|Incretins|incretins|mesh-ancestor
102055140|NCT02239458|Hormones|hormones|mesh-ancestor
102055141|NCT02239458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102055142|NCT02239458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055143|NCT02239458|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102055144|NCT02239458|Protease Inhibitors|protease inhibitors|mesh-ancestor
102055145|NCT02239458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102055146|NCT02239458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055147|NCT02239458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102055148|NCT03578874|Capecitabine|capecitabine|mesh-list
102055149|NCT03578874|Oxaliplatin|oxaliplatin|mesh-list
102055150|NCT03578874|Sorafenib|sorafenib|mesh-list
102055151|NCT03578874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102055152|NCT03578874|Antimetabolites|antimetabolites|mesh-ancestor
102055153|NCT03578874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055154|NCT03578874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102055155|NCT03578874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102055156|NCT03578874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102055157|NCT01366001|Buprenorphine|buprenorphine|mesh-list
102055158|NCT01366001|ALKS-33|alks-33|mesh-list
102055159|NCT01366001|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102055160|NCT01366001|Narcotics|narcotics|mesh-ancestor
102055161|NCT01366001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102055162|NCT01366001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055163|NCT01366001|Analgesics|analgesics|mesh-ancestor
102055164|NCT01366001|Sensory System Agents|sensory system agents|mesh-ancestor
102055165|NCT01366001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102055166|NCT01366001|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102055167|NCT01365065|Vorinostat|vorinostat|mesh-list
102055168|NCT01365065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102055169|NCT01365065|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102055170|NCT01365065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102055171|NCT01365065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055172|NCT03576456|Alprazolam|alprazolam|mesh-list
102055173|NCT03576456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102055174|NCT03576456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102055175|NCT03576456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055190|NCT03576378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774906|NCT00343291|Cetuximab|cetuximab|mesh-list
102055192|NCT03576378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102055193|NCT03576378|Alkylating Agents|alkylating agents|mesh-ancestor
102055194|NCT03576378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055195|NCT03576378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102055196|NCT03576378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102055197|NCT03576378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102055198|NCT03576378|Glucocorticoids|glucocorticoids|mesh-ancestor
102055199|NCT03576378|Hormones|hormones|mesh-ancestor
102055200|NCT03576378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102055201|NCT03576378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102055202|NCT03576378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102055203|NCT03576378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102055204|NCT03576378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102055205|NCT03576378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102055206|NCT03576378|Analgesics|analgesics|mesh-ancestor
101942341|NCT05480475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101942342|NCT05480475|Protease Inhibitors|protease inhibitors|mesh-ancestor
101942343|NCT05480475|Anticoagulants|anticoagulants|mesh-ancestor
101942344|NCT03642184|Empagliflozin|empagliflozin|mesh-list
102055207|NCT03576378|Sensory System Agents|sensory system agents|mesh-ancestor
102055208|NCT03576378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102055209|NCT05572190|Hydrocodone|hydrocodone|mesh-list
102055210|NCT05572190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102055211|NCT05572190|Narcotics|narcotics|mesh-ancestor
102055212|NCT05572190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102055213|NCT05572190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055214|NCT05572190|Analgesics|analgesics|mesh-ancestor
102055215|NCT05572190|Sensory System Agents|sensory system agents|mesh-ancestor
102055216|NCT05572190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102055217|NCT05572190|Antitussive Agents|antitussive agents|mesh-ancestor
102055218|NCT05572190|Respiratory System Agents|respiratory system agents|mesh-ancestor
102055219|NCT01365221|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102055220|NCT01365221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102055221|NCT05567588|Pembrolizumab|pembrolizumab|mesh-list
102055222|NCT05567588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102055223|NCT05567588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102055224|NCT05567588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102055225|NCT05567588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055226|NCT03124199|Rifaximin|rifaximin|mesh-list
102055227|NCT03124199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102055228|NCT03124199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102055229|NCT03124199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102055230|NCT03578640|Grazoprevir|grazoprevir|mesh-list
102055231|NCT03578640|Antiviral Agents|antiviral agents|mesh-ancestor
102055232|NCT03578640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102055233|NCT04465916|Tenofovir|tenofovir|mesh-list
102055234|NCT04465916|Entecavir|entecavir|mesh-list
102055235|NCT04465916|Antiviral Agents|antiviral agents|mesh-ancestor
102055236|NCT04465916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102055237|NCT04465916|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102055252|NCT01366235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102055253|NCT01366235|Analgesics|analgesics|mesh-ancestor
102055254|NCT01366235|Sensory System Agents|sensory system agents|mesh-ancestor
102055255|NCT01366235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102055256|NCT01366235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055257|NCT01366235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102055258|NCT01366235|Filaricides|filaricides|mesh-ancestor
102055259|NCT01366235|Antinematodal Agents|antinematodal agents|mesh-ancestor
102055260|NCT01366235|Anthelmintics|anthelmintics|mesh-ancestor
102055261|NCT04871165|Immunoglobulins|immunoglobulins|mesh-list
102055262|NCT04871165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102055263|NCT04871165|Antibodies|antibodies|mesh-list
102055264|NCT04871165|Immunologic Factors|immunologic factors|mesh-ancestor
102055265|NCT04871165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055266|NCT04465760|Antibodies|antibodies|mesh-list
102055267|NCT04465760|Immunoglobulins|immunoglobulins|mesh-list
102055268|NCT04465760|Immunologic Factors|immunologic factors|mesh-ancestor
102055269|NCT04465760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055270|NCT04249739|Pembrolizumab|pembrolizumab|mesh-list
102055271|NCT04249739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102055272|NCT04249739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102055273|NCT04249739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102055274|NCT04249739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055275|NCT01366313|Acetaminophen|acetaminophen|mesh-list
102055276|NCT01366313|Morphine|morphine|mesh-list
102055277|NCT01366313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102055278|NCT01366313|Narcotics|narcotics|mesh-ancestor
102055279|NCT01366313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102055280|NCT01366313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055281|NCT01366313|Analgesics|analgesics|mesh-ancestor
102055282|NCT01366313|Sensory System Agents|sensory system agents|mesh-ancestor
102055283|NCT01366313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102055284|NCT01366313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102055285|NCT01366313|Antipyretics|antipyretics|mesh-ancestor
102055286|NCT05561738|Niacinamide|niacinamide|mesh-list
102055287|NCT05561738|Niacin|niacin|mesh-list
102055288|NCT05561738|Nicotinic Acids|nicotinic acids|mesh-list
102055289|NCT05561738|Vitamin B Complex|vitamin b complex|mesh-ancestor
102055290|NCT05561738|Vitamins|vitamins|mesh-ancestor
102055291|NCT05561738|Micronutrients|micronutrients|mesh-ancestor
101942345|NCT03642184|Linagliptin|linagliptin|mesh-list
101942346|NCT03642184|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101942347|NCT03642184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055292|NCT05561738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055293|NCT05561738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102055294|NCT05561738|Antimetabolites|antimetabolites|mesh-ancestor
102055295|NCT05561738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055296|NCT05561738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102055297|NCT05561738|Vasodilator Agents|vasodilator agents|mesh-ancestor
102055298|NCT02253524|Metoclopramide|metoclopramide|mesh-list
102055299|NCT02253524|Dimenhydrinate|dimenhydrinate|mesh-list
102055300|NCT02253524|Antiemetics|antiemetics|mesh-ancestor
101356825|NCT00062556|Vitamins|vitamins|mesh-ancestor
102055322|NCT03575520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102055323|NCT03575520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102055324|NCT03575520|Alkylating Agents|alkylating agents|mesh-ancestor
102055325|NCT03575520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055326|NCT03575520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102055327|NCT03575520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102055328|NCT03575520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102055329|NCT03575520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102055330|NCT03575520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102055331|NCT03575520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102055332|NCT01366391|Metformin|metformin|mesh-list
102055333|NCT01366391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102055334|NCT01366391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055335|NCT04408586|Topiramate|topiramate|mesh-list
102055336|NCT04408586|Phentermine|phentermine|mesh-list
102055337|NCT04408586|Anticonvulsants|anticonvulsants|mesh-ancestor
102055338|NCT04408586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102055339|NCT04408586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055340|NCT04408586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102055341|NCT04408586|Appetite Depressants|appetite depressants|mesh-ancestor
102055342|NCT04408586|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102055343|NCT04408586|Sympathomimetics|sympathomimetics|mesh-ancestor
102055344|NCT04408586|Autonomic Agents|autonomic agents|mesh-ancestor
102055345|NCT04408586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102055346|NCT04408586|Adrenergic Agents|adrenergic agents|mesh-ancestor
102055347|NCT04408586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102055348|NCT04408586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055349|NCT02239614|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102055350|NCT02239614|Aluminum sulfate|aluminum sulfate|mesh-list
102055351|NCT02239614|Immunologic Factors|immunologic factors|mesh-ancestor
102055352|NCT02239614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055353|NCT02239614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101356878|NCT00062673|Dopamine Agents|dopamine agents|mesh-ancestor
102055381|NCT02241018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102055382|NCT02241018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
102055383|NCT02241018|Immunologic Factors|immunologic factors|mesh-ancestor
102055384|NCT02241018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055385|NCT02241018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102055386|NCT02241018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055387|NCT04039022|Dextromethorphan|dextromethorphan|mesh-list
102055388|NCT04039022|Bupropion|bupropion|mesh-list
102055389|NCT04039022|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102055390|NCT04039022|Antidepressive Agents|antidepressive agents|mesh-ancestor
102055391|NCT04039022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102055392|NCT04039022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102055393|NCT04039022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102055394|NCT04039022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102055395|NCT04039022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055396|NCT04039022|Dopamine Agents|dopamine agents|mesh-ancestor
102055397|NCT04039022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102055398|NCT04039022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055399|NCT04039022|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102055400|NCT04039022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102055401|NCT04039022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102055404|NCT04039022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102055405|NCT04039022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102055406|NCT00109772|Lenalidomide|lenalidomide|mesh-list
102055407|NCT00109772|Immunologic Factors|immunologic factors|mesh-ancestor
101942348|NCT03642184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101942349|NCT03642184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942350|NCT03642184|Incretins|incretins|mesh-ancestor
102055408|NCT00109772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055409|NCT00109772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102055410|NCT00109772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102055411|NCT00109772|Growth Substances|growth substances|mesh-ancestor
102055412|NCT00109772|Growth Inhibitors|growth inhibitors|mesh-ancestor
102055413|NCT00109772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102055414|NCT03572010|Fesoterodine|fesoterodine|mesh-list
102055415|NCT03572010|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102055416|NCT03572010|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102055417|NCT03572010|Cholinergic Agents|cholinergic agents|mesh-ancestor
102055418|NCT03572010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102055419|NCT03572010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055420|NCT03572010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055421|NCT03572010|Urological Agents|urological agents|mesh-ancestor
102055422|NCT01560104|Paclitaxel|paclitaxel|mesh-list
102055423|NCT01560104|Carboplatin|carboplatin|mesh-list
102055424|NCT01560104|Veliparib|veliparib|mesh-list
102055425|NCT01560104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102055426|NCT01560104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102055427|NCT01560104|Tubulin Modulators|tubulin modulators|mesh-ancestor
102055428|NCT01560104|Antimitotic Agents|antimitotic agents|mesh-ancestor
102055429|NCT01560104|Mitosis Modulators|mitosis modulators|mesh-ancestor
102055430|NCT01560104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055431|NCT01560104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102055432|NCT01560104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102055433|NCT00101972|Antibodies|antibodies|mesh-list
102055434|NCT00101972|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102055435|NCT00101972|Immunologic Factors|immunologic factors|mesh-ancestor
102055436|NCT00101972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055437|NCT02245932|Resveratrol|resveratrol|mesh-list
102055438|NCT02245932|Antioxidants|antioxidants|mesh-ancestor
102055439|NCT02245932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055440|NCT02245932|Protective Agents|protective agents|mesh-ancestor
102055441|NCT02245932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055442|NCT02245932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102055443|NCT02245932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102055444|NCT03573102|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102055445|NCT03573102|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102055446|NCT03573102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055447|NCT03573102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055448|NCT03573102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102055449|NCT03573102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102055450|NCT03573102|Protease Inhibitors|protease inhibitors|mesh-ancestor
102055451|NCT03865706|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102055452|NCT03865706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102055453|NCT03865706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102055454|NCT03865706|Antitubercular Agents|antitubercular agents|mesh-ancestor
102055455|NCT04944368|Myeloma Proteins|myeloma proteins|mesh-list
102055456|NCT04944368|Paraproteins|paraproteins|mesh-list
102055457|NCT04944368|Immunologic Factors|immunologic factors|mesh-ancestor
102055458|NCT04944368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055459|NCT04260464|PF-06700841|pf-06700841|mesh-list
102055460|NCT04260464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102055461|NCT04260464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102055462|NCT04260464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055463|NCT03651518|Rituximab|rituximab|mesh-list
102055464|NCT03651518|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102055465|NCT03651518|Ustekinumab|ustekinumab|mesh-list
102055466|NCT03651518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102055467|NCT03651518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102055468|NCT03651518|Immunologic Factors|immunologic factors|mesh-ancestor
102055469|NCT03651518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055470|NCT03651518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102055471|NCT03651518|Dermatologic Agents|dermatologic agents|mesh-ancestor
102055472|NCT03546530|Interferons|interferons|mesh-list
102055473|NCT03546530|Resveratrol|resveratrol|mesh-list
102055474|NCT03546530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102055479|NCT03546530|Protective Agents|protective agents|mesh-ancestor
102055480|NCT03546530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942351|NCT03642184|Hormones|hormones|mesh-ancestor
101942352|NCT03642184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101307315|NCT02036255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102055481|NCT03546530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102055482|NCT03546530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102055483|NCT03568994|Cytarabine|cytarabine|mesh-list
102055484|NCT03568994|Atovaquone|atovaquone|mesh-list
102055485|NCT03568994|Etoposide|etoposide|mesh-list
102055486|NCT03568994|Daunorubicin|daunorubicin|mesh-list
102055487|NCT03568994|Gemtuzumab|gemtuzumab|mesh-list
102055488|NCT03568994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102055489|NCT03568994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102055490|NCT03568994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102055491|NCT03568994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102055492|NCT03568994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102055493|NCT03568994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055494|NCT03568994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102055495|NCT03568994|Antimetabolites|antimetabolites|mesh-ancestor
102055496|NCT03568994|Antiviral Agents|antiviral agents|mesh-ancestor
102055497|NCT03568994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101775204|NCT00324649|Lamivudine|lamivudine|mesh-list
102055498|NCT03568994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102055499|NCT03568994|Immunologic Factors|immunologic factors|mesh-ancestor
102055500|NCT03568994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055501|NCT03568994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102055502|NCT03568994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102055503|NCT03568994|Immunotoxins|immunotoxins|mesh-ancestor
102055504|NCT03568994|Immunoconjugates|immunoconjugates|mesh-ancestor
102055505|NCT03568994|Antimalarials|antimalarials|mesh-ancestor
102055506|NCT03568994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102055507|NCT03568994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102055508|NCT04203056|Aripiprazole|aripiprazole|mesh-list
102055509|NCT04203056|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
102055510|NCT04203056|Antidepressive Agents|antidepressive agents|mesh-ancestor
102055511|NCT04203056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102055512|NCT04203056|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102055513|NCT04203056|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102055514|NCT04203056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102055515|NCT04203056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055516|NCT04203056|Dopamine Agonists|dopamine agonists|mesh-ancestor
102055517|NCT04203056|Dopamine Agents|dopamine agents|mesh-ancestor
102055518|NCT04203056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102055519|NCT04203056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055520|NCT04203056|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102055521|NCT04203056|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102055522|NCT04203056|Serotonin Agents|serotonin agents|mesh-ancestor
102055523|NCT04203056|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102055524|NCT04203056|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102055525|NCT04203056|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102055526|NCT04203056|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102055527|NCT04894994|Ipilimumab|ipilimumab|mesh-list
102055528|NCT04894994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102055529|NCT04894994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102055530|NCT04894994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101698416|NCT00579982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055531|NCT04894994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055532|NCT01366547|Lamivudine|lamivudine|mesh-list
102055533|NCT01366547|Abacavir|abacavir|mesh-list
102055534|NCT01366547|Dideoxynucleosides|dideoxynucleosides|mesh-list
102055535|NCT01366547|Dolutegravir|dolutegravir|mesh-list
102055536|NCT01366547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102055537|NCT01366547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102055538|NCT01366547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102055539|NCT01366547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055540|NCT01366547|Antiviral Agents|antiviral agents|mesh-ancestor
102055541|NCT01366547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102055542|NCT01366547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102055543|NCT01366547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102055544|NCT01366547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102055545|NCT01366547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102055562|NCT04347239|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102055563|NCT04347239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055564|NCT04347239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101942353|NCT03642184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101942354|NCT03642184|Protease Inhibitors|protease inhibitors|mesh-ancestor
101942355|NCT03642184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101942356|NCT01137591|Acetaminophen|acetaminophen|mesh-list
101942357|NCT01137591|Acetylcysteine|acetylcysteine|mesh-list
101942358|NCT01137591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101942359|NCT01137591|Analgesics|analgesics|mesh-ancestor
101942360|NCT01137591|Sensory System Agents|sensory system agents|mesh-ancestor
102055565|NCT04347239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102055566|NCT04347239|Antiviral Agents|antiviral agents|mesh-ancestor
102055567|NCT04347239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102055568|NCT00109928|Methylprednisolone|methylprednisolone|mesh-list
102055569|NCT00109928|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102055570|NCT00109928|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102055571|NCT00109928|Prednisolone|prednisolone|mesh-list
102055572|NCT00109928|Prednisolone acetate|prednisolone acetate|mesh-list
102055573|NCT00109928|Gemcitabine|gemcitabine|mesh-list
102055574|NCT00109928|Etoposide|etoposide|mesh-list
102055575|NCT00109928|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102055576|NCT00109928|Prednisolone phosphate|prednisolone phosphate|mesh-list
102055577|NCT00109928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102055578|NCT00109928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102055579|NCT00109928|Antimetabolites|antimetabolites|mesh-ancestor
102055580|NCT00109928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055581|NCT00109928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102055582|NCT00109928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102055583|NCT00109928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102055584|NCT00109928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102055585|NCT00109928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102055586|NCT00109928|Antiemetics|antiemetics|mesh-ancestor
102055587|NCT00109928|Autonomic Agents|autonomic agents|mesh-ancestor
102055588|NCT00109928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102055589|NCT00109928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055590|NCT00109928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102055591|NCT00109928|Glucocorticoids|glucocorticoids|mesh-ancestor
102055592|NCT00109928|Hormones|hormones|mesh-ancestor
102055593|NCT00109928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102055594|NCT00109928|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102055595|NCT00109928|Protective Agents|protective agents|mesh-ancestor
102055596|NCT00109928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102055597|NCT02104310|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
102055598|NCT02104310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055599|NCT02104310|Dopamine Agents|dopamine agents|mesh-ancestor
102055600|NCT02104310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102055601|NCT02104310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055602|NCT00109850|Irinotecan|irinotecan|mesh-list
102055603|NCT00109850|Cetuximab|cetuximab|mesh-list
102055604|NCT00109850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102055606|NCT00109850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102055607|NCT00109850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102055608|NCT00109850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055609|NCT00109850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102055610|NCT03318770|Dasatinib|dasatinib|mesh-list
102055611|NCT03318770|Blinatumomab|blinatumomab|mesh-list
102055612|NCT03318770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102055613|NCT03318770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102055614|NCT03318770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102055615|NCT03318770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055616|NCT01065519|Umirolimus|umirolimus|mesh-list
102055617|NCT01065519|Everolimus|everolimus|mesh-list
102055618|NCT01065519|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102055619|NCT01065519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102055620|NCT01065519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102055621|NCT01065519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055622|NCT01065519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102055623|NCT01065519|Immunologic Factors|immunologic factors|mesh-ancestor
102055624|NCT01065519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055625|NCT01065519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101942361|NCT01137591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102055626|NCT01065519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102055627|NCT05493111|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102055628|NCT05493111|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102055630|NCT01810016|Ipilimumab|ipilimumab|mesh-list
102055631|NCT01810016|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102055632|NCT01810016|Vaccines|vaccines|mesh-list
102055633|NCT01810016|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
102055634|NCT01810016|Poly ICLC|poly iclc|mesh-list
102055635|NCT01810016|Immunologic Factors|immunologic factors|mesh-ancestor
102055636|NCT01810016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055637|NCT01810016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102055638|NCT01810016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102055639|NCT01810016|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102055640|NCT01810016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055641|NCT01810016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102055642|NCT01810016|Interferon Inducers|interferon inducers|mesh-ancestor
102055643|NCT01810016|Laxatives|laxatives|mesh-ancestor
102055644|NCT01810016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102055645|NCT01810016|Antiviral Agents|antiviral agents|mesh-ancestor
102055646|NCT01810016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101775360|NCT00944619|Insulin|insulin|mesh-list
102055647|NCT01722266|Liraglutide|liraglutide|mesh-list
102055648|NCT01722266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102055649|NCT01722266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055650|NCT01722266|Incretins|incretins|mesh-ancestor
102055651|NCT01722266|Hormones|hormones|mesh-ancestor
102055652|NCT01722266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102055653|NCT02254148|Metoprolol|metoprolol|mesh-list
102055654|NCT02254148|Digoxin|digoxin|mesh-list
102055655|NCT02254148|Midazolam|midazolam|mesh-list
102055656|NCT02254148|Caffeine|caffeine|mesh-list
102055657|NCT02254148|Omeprazole|omeprazole|mesh-list
102055658|NCT02254148|Warfarin|warfarin|mesh-list
102055659|NCT02254148|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102055660|NCT02254148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102055661|NCT02254148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102055662|NCT02254148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055663|NCT02254148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102055664|NCT02254148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102055665|NCT02254148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101698436|NCT02763059|Acetaminophen|acetaminophen|mesh-list
102055666|NCT02254148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102055667|NCT02254148|Anesthetics, General|anesthetics, general|mesh-ancestor
102055668|NCT02254148|Anesthetics|anesthetics|mesh-ancestor
102055669|NCT02254148|GABA Modulators|gaba modulators|mesh-ancestor
102055670|NCT02254148|GABA Agents|gaba agents|mesh-ancestor
102055671|NCT02254148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102055672|NCT02254148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055673|NCT02254148|Anticoagulants|anticoagulants|mesh-ancestor
102055674|NCT02254148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102055675|NCT02254148|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102055676|NCT02254148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102055677|NCT02254148|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102055678|NCT02254148|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102055679|NCT02254148|Purinergic Agents|purinergic agents|mesh-ancestor
102055680|NCT02254148|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102055689|NCT02254148|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102055690|NCT02254148|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102055691|NCT02254148|Adrenergic Agents|adrenergic agents|mesh-ancestor
102055692|NCT02254148|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102055693|NCT02254148|Protective Agents|protective agents|mesh-ancestor
102055694|NCT02842866|Vaccines|vaccines|mesh-list
102055695|NCT02842866|Immunologic Factors|immunologic factors|mesh-ancestor
102055696|NCT02842866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055697|NCT01316913|Bromides|bromides|mesh-list
102055698|NCT01316913|Tiotropium Bromide|tiotropium bromide|mesh-list
102055699|NCT01316913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102055700|NCT01316913|Autonomic Agents|autonomic agents|mesh-ancestor
102055701|NCT01316913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102055702|NCT01316913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055703|NCT01316913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102055704|NCT01316913|Respiratory System Agents|respiratory system agents|mesh-ancestor
102055705|NCT01316913|Parasympatholytics|parasympatholytics|mesh-ancestor
102055706|NCT01316913|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102055707|NCT01316913|Cholinergic Agents|cholinergic agents|mesh-ancestor
102055708|NCT01316913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101942362|NCT01137591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942363|NCT01137591|Antipyretics|antipyretics|mesh-ancestor
102055709|NCT01316913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055710|NCT01316913|Anticonvulsants|anticonvulsants|mesh-ancestor
102055711|NCT02875067|Pembrolizumab|pembrolizumab|mesh-list
102055712|NCT02875067|Lenalidomide|lenalidomide|mesh-list
102055713|NCT02875067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102055714|NCT02875067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102055715|NCT02875067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102055716|NCT02875067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055717|NCT02875067|Immunologic Factors|immunologic factors|mesh-ancestor
102055718|NCT02875067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055719|NCT02875067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102055720|NCT02875067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102055721|NCT02875067|Growth Substances|growth substances|mesh-ancestor
102055722|NCT02875067|Growth Inhibitors|growth inhibitors|mesh-ancestor
102055723|NCT03570294|Atosiban|atosiban|mesh-list
102055724|NCT03570294|Hormone Antagonists|hormone antagonists|mesh-ancestor
102055725|NCT03570294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102055726|NCT03570294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055727|NCT03570294|Tocolytic Agents|tocolytic agents|mesh-ancestor
102055728|NCT03570294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102055730|NCT02143622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102055731|NCT02143622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102055732|NCT02781506|Nivolumab|nivolumab|mesh-list
102055733|NCT02781506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102055734|NCT02781506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102055735|NCT02781506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102055736|NCT02781506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055737|NCT03571230|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102055738|NCT03571230|Amoxicillin|amoxicillin|mesh-list
102055739|NCT03571230|Metronidazole|metronidazole|mesh-list
102055740|NCT03571230|Clarithromycin|clarithromycin|mesh-list
102055741|NCT03571230|Levofloxacin|levofloxacin|mesh-list
102055742|NCT03571230|Tetracycline|tetracycline|mesh-list
102055743|NCT03571230|Tinidazole|tinidazole|mesh-list
102055744|NCT03571230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102055745|NCT03571230|Furazolidone|furazolidone|mesh-list
102055746|NCT03571230|Bismuth|bismuth|mesh-list
102055747|NCT03571230|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
102055748|NCT03571230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102055749|NCT03571230|Antitubercular Agents|antitubercular agents|mesh-ancestor
102055763|NCT03571230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102055764|NCT03571230|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102055765|NCT03571230|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
102055766|NCT03571230|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102055767|NCT03571230|Alkylating Agents|alkylating agents|mesh-ancestor
102055768|NCT03368963|Trifluridine|trifluridine|mesh-list
102055769|NCT03368963|Irinotecan|irinotecan|mesh-list
102055770|NCT03368963|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102055771|NCT03368963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102055772|NCT03368963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102055773|NCT03368963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055774|NCT03368963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102055775|NCT03368963|Antimetabolites|antimetabolites|mesh-ancestor
102055776|NCT03368963|Antiviral Agents|antiviral agents|mesh-ancestor
102055777|NCT03368963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102055778|NCT05489211|Leucovorin|leucovorin|mesh-list
102055779|NCT05489211|Prednisone|prednisone|mesh-list
102055780|NCT05489211|Prednisolone|prednisolone|mesh-list
102055781|NCT05489211|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102055782|NCT05489211|Methylprednisolone|methylprednisolone|mesh-list
102055783|NCT05489211|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102055784|NCT05489211|Prednisolone acetate|prednisolone acetate|mesh-list
102055785|NCT05489211|Bevacizumab|bevacizumab|mesh-list
102055786|NCT05489211|Durvalumab|durvalumab|mesh-list
102055787|NCT05489211|Carboplatin|carboplatin|mesh-list
102055788|NCT05489211|Fluorouracil|fluorouracil|mesh-list
102055789|NCT05489211|Capecitabine|capecitabine|mesh-list
102055790|NCT05489211|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102055791|NCT05489211|Prednisolone phosphate|prednisolone phosphate|mesh-list
102055792|NCT05489211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102055793|NCT05489211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102055794|NCT05489211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102055795|NCT05489211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102055796|NCT05489211|Growth Substances|growth substances|mesh-ancestor
101942364|NCT01137591|Antiviral Agents|antiviral agents|mesh-ancestor
101942365|NCT01137591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101942366|NCT01137591|Expectorants|expectorants|mesh-ancestor
101942367|NCT01137591|Respiratory System Agents|respiratory system agents|mesh-ancestor
101942368|NCT01137591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101942369|NCT01137591|Antioxidants|antioxidants|mesh-ancestor
101942370|NCT01137591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942371|NCT01137591|Protective Agents|protective agents|mesh-ancestor
101942372|NCT01133457|Finasteride|finasteride|mesh-list
101942373|NCT01133457|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102055797|NCT05489211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055798|NCT05489211|Growth Inhibitors|growth inhibitors|mesh-ancestor
101775530|NCT00537316|Infliximab|infliximab|mesh-list
102055799|NCT05489211|Antimetabolites|antimetabolites|mesh-ancestor
102055800|NCT05489211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055801|NCT05489211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102055802|NCT05489211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102055803|NCT05489211|Immunologic Factors|immunologic factors|mesh-ancestor
102055804|NCT05489211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102055805|NCT05489211|Glucocorticoids|glucocorticoids|mesh-ancestor
102055807|NCT05489211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102055808|NCT05489211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102055809|NCT05489211|Antidotes|antidotes|mesh-ancestor
102055810|NCT05489211|Protective Agents|protective agents|mesh-ancestor
102055811|NCT05489211|Vitamin B Complex|vitamin b complex|mesh-ancestor
102055829|NCT02254226|Adrenergic Agents|adrenergic agents|mesh-ancestor
102055830|NCT02254226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101698453|NCT02763059|Antipyretics|antipyretics|mesh-ancestor
102055831|NCT02254226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055832|NCT02143934|Chloroquine|chloroquine|mesh-list
102055833|NCT02143934|Lumefantrine|lumefantrine|mesh-list
102055834|NCT02143934|Artemether|artemether|mesh-list
102055835|NCT02143934|Primaquine|primaquine|mesh-list
102055836|NCT02143934|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102055837|NCT02143934|Amebicides|amebicides|mesh-ancestor
102055838|NCT02143934|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102055839|NCT02143934|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102055840|NCT02143934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102055841|NCT02143934|Antimalarials|antimalarials|mesh-ancestor
102055842|NCT02143934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102055843|NCT03096847|Letrozole|letrozole|mesh-list
102055844|NCT03096847|Goserelin|goserelin|mesh-list
102055845|NCT03096847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102055846|NCT03096847|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102055847|NCT03096847|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102055848|NCT03096847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102055849|NCT03096847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055850|NCT03096847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102055851|NCT03096847|Hormone Antagonists|hormone antagonists|mesh-ancestor
102055852|NCT03096847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102055853|NCT03096847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055854|NCT03096847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102055855|NCT03545516|Dexmedetomidine|dexmedetomidine|mesh-list
102055856|NCT03545516|Bupivacaine|bupivacaine|mesh-list
102055857|NCT03545516|Anesthetics, Local|anesthetics, local|mesh-ancestor
102055858|NCT03545516|Anesthetics|anesthetics|mesh-ancestor
102055859|NCT03545516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102055860|NCT03545516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055861|NCT03545516|Sensory System Agents|sensory system agents|mesh-ancestor
102055862|NCT03545516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102055863|NCT03545516|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102055864|NCT03545516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102055865|NCT03545516|Analgesics|analgesics|mesh-ancestor
102055866|NCT03545516|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102055867|NCT03545516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102055868|NCT03545516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102055869|NCT03545516|Adrenergic Agents|adrenergic agents|mesh-ancestor
101942374|NCT01133457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101942375|NCT01133457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102055870|NCT03545516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102055874|NCT04753879|Pembrolizumab|pembrolizumab|mesh-list
102055875|NCT04753879|Capecitabine|capecitabine|mesh-list
102055877|NCT04753879|Olaparib|olaparib|mesh-list
102055878|NCT04753879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102055879|NCT04753879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102055880|NCT04753879|Tubulin Modulators|tubulin modulators|mesh-ancestor
102055881|NCT04753879|Antimitotic Agents|antimitotic agents|mesh-ancestor
102055882|NCT04753879|Mitosis Modulators|mitosis modulators|mesh-ancestor
102055883|NCT04753879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055884|NCT04753879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102055885|NCT04753879|Antimetabolites|antimetabolites|mesh-ancestor
102055886|NCT04753879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102055887|NCT04753879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102055888|NCT04753879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102055889|NCT04753879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102055890|NCT04753879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102055891|NCT04753879|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102055892|NCT02846532|Aspirin|aspirin|mesh-list
102055893|NCT02846532|Rivaroxaban|rivaroxaban|mesh-list
102055894|NCT02846532|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102055895|NCT02846532|Antithrombins|antithrombins|mesh-ancestor
102055896|NCT02846532|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102055897|NCT02846532|Protease Inhibitors|protease inhibitors|mesh-ancestor
102055898|NCT02846532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102055899|NCT02846532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055900|NCT02846532|Anticoagulants|anticoagulants|mesh-ancestor
102055901|NCT02846532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102055902|NCT02846532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102055903|NCT02846532|Analgesics|analgesics|mesh-ancestor
102055904|NCT02846532|Sensory System Agents|sensory system agents|mesh-ancestor
102055905|NCT02846532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102055906|NCT02846532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055907|NCT02846532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102055908|NCT02846532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102055909|NCT02846532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102055910|NCT02846532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102055911|NCT02846532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102055912|NCT02846532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102055913|NCT02846532|Antipyretics|antipyretics|mesh-ancestor
102055914|NCT01371461|Paroxetine|paroxetine|mesh-list
102055915|NCT01371461|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102055916|NCT01371461|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102055917|NCT01371461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102055918|NCT01371461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055919|NCT01371461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102055920|NCT01371461|Serotonin Agents|serotonin agents|mesh-ancestor
102055921|NCT01371461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055922|NCT01371461|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102055923|NCT01371461|Antidepressive Agents|antidepressive agents|mesh-ancestor
102055924|NCT01371461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102055925|NCT01371461|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102055926|NCT01371461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102055927|NCT01371461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102055928|NCT05324423|Colchicine|colchicine|mesh-list
102055929|NCT05324423|Febuxostat|febuxostat|mesh-list
102055930|NCT05324423|Gout Suppressants|gout suppressants|mesh-ancestor
102055931|NCT05324423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102055932|NCT05324423|Tubulin Modulators|tubulin modulators|mesh-ancestor
102055933|NCT05324423|Antimitotic Agents|antimitotic agents|mesh-ancestor
102055934|NCT05324423|Mitosis Modulators|mitosis modulators|mesh-ancestor
102055935|NCT05324423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055936|NCT05324423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102055937|NCT04704219|Pembrolizumab|pembrolizumab|mesh-list
102055938|NCT04704219|Lenvatinib|lenvatinib|mesh-list
102055939|NCT04704219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102055940|NCT04704219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102055941|NCT04704219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101357448|NCT00069927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942376|NCT01133457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055949|NCT00842348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102055950|NCT00842348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775650|NCT00535288|Mirtazapine|mirtazapine|mesh-list
102055951|NCT02144246|Moxifloxacin|moxifloxacin|mesh-list
102055952|NCT02144246|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102055953|NCT02144246|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102055954|NCT02144246|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102055955|NCT02144246|Norgestimate|norgestimate|mesh-list
102055956|NCT02144246|Norgestrel|norgestrel|mesh-list
102055957|NCT02144246|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102055958|NCT02144246|Estradiol|estradiol|mesh-list
102055959|NCT02144246|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102055960|NCT02144246|Estrogens|estrogens|mesh-ancestor
102055961|NCT02144246|Hormones|hormones|mesh-ancestor
102055962|NCT02144246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102055963|NCT02144246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055964|NCT02144246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102055965|NCT02144246|Contraceptive Agents|contraceptive agents|mesh-ancestor
102055966|NCT02144246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102055967|NCT02144246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102055968|NCT02144246|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102055969|NCT02144246|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102055970|NCT02144246|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102055971|NCT02144246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102055972|NCT02144246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102055973|NCT02144246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102055974|NCT02144246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102055975|NCT02144246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102055976|NCT02144246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055977|NCT02144246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102055978|NCT02144246|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102055979|NCT03095521|Menthol|menthol|mesh-list
102055980|NCT03095521|Antipruritics|antipruritics|mesh-ancestor
102055981|NCT03095521|Dermatologic Agents|dermatologic agents|mesh-ancestor
102055982|NCT01372865|Mometasone Furoate|mometasone furoate|mesh-list
102055983|NCT01372865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102055984|NCT01372865|Dermatologic Agents|dermatologic agents|mesh-ancestor
102055985|NCT01372865|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102055986|NCT03569046|Antihypertensive Agents|antihypertensive agents|mesh-list
102055987|NCT03569046|Bupivacaine|bupivacaine|mesh-list
102055988|NCT03569046|Anesthetics, Local|anesthetics, local|mesh-list
102055989|NCT03569046|Anesthetics|anesthetics|mesh-list
102055990|NCT03569046|Anesthetics, General|anesthetics, general|mesh-list
102055991|NCT03569046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102055992|NCT03569046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055993|NCT03569046|Sensory System Agents|sensory system agents|mesh-ancestor
102055994|NCT03569046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102055995|NCT02935595|Ketamine|ketamine|mesh-list
102055996|NCT02935595|Analgesics|analgesics|mesh-ancestor
102055997|NCT02935595|Sensory System Agents|sensory system agents|mesh-ancestor
102055998|NCT02935595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102055999|NCT02935595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056000|NCT02935595|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102056001|NCT02935595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102056002|NCT02935595|Anesthetics, General|anesthetics, general|mesh-ancestor
102056003|NCT02935595|Anesthetics|anesthetics|mesh-ancestor
102056004|NCT02935595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102056005|NCT02935595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102056006|NCT02935595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102056007|NCT02935595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102056008|NCT02935595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056011|NCT02649673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102056012|NCT02649673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102056013|NCT02649673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056014|NCT02649673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102056016|NCT03568968|Niacin|niacin|mesh-list
102056017|NCT03568968|Nicotinic Acids|nicotinic acids|mesh-list
102056018|NCT03568968|Vitamin B Complex|vitamin b complex|mesh-ancestor
102056019|NCT03568968|Vitamins|vitamins|mesh-ancestor
102056020|NCT03568968|Micronutrients|micronutrients|mesh-ancestor
102056021|NCT03568968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942377|NCT01133457|Hormone Antagonists|hormone antagonists|mesh-ancestor
101942378|NCT01133457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101942379|NCT01133457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942380|NCT01133457|Urological Agents|urological agents|mesh-ancestor
102056022|NCT03568968|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102056023|NCT03568968|Antimetabolites|antimetabolites|mesh-ancestor
102056024|NCT03568968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056025|NCT03568968|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102056026|NCT03568968|Vasodilator Agents|vasodilator agents|mesh-ancestor
102056028|NCT02817347|Piperacillin|piperacillin|mesh-list
102056029|NCT02817347|Dexamethasone|dexamethasone|mesh-list
102056030|NCT02817347|Dexamethasone acetate|dexamethasone acetate|mesh-list
102056031|NCT02817347|BB 1101|bb 1101|mesh-list
102056032|NCT02817347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102056033|NCT02817347|Antiemetics|antiemetics|mesh-ancestor
102056034|NCT02817347|Autonomic Agents|autonomic agents|mesh-ancestor
102056035|NCT02817347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102056036|NCT02817347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056037|NCT02817347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102056038|NCT02817347|Glucocorticoids|glucocorticoids|mesh-ancestor
102056039|NCT02817347|Hormones|hormones|mesh-ancestor
102056040|NCT02817347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102056041|NCT02817347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102056042|NCT02817347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102056043|NCT02817347|Protease Inhibitors|protease inhibitors|mesh-ancestor
102056044|NCT02817347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102056045|NCT02817347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056046|NCT02817347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102056047|NCT02817347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102056048|NCT02817347|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102056049|NCT01373021|Fentanyl|fentanyl|mesh-list
102056050|NCT01373021|Dexmedetomidine|dexmedetomidine|mesh-list
102056051|NCT01373021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102056052|NCT01373021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102056053|NCT01373021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056054|NCT01373021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102056055|NCT01373021|Analgesics|analgesics|mesh-ancestor
102056056|NCT01373021|Sensory System Agents|sensory system agents|mesh-ancestor
102056057|NCT01373021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102056058|NCT01373021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102056059|NCT01373021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102056060|NCT01373021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102056061|NCT01373021|Adrenergic Agents|adrenergic agents|mesh-ancestor
102056062|NCT01373021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102056063|NCT01373021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056064|NCT01373021|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102056065|NCT01373021|Narcotics|narcotics|mesh-ancestor
102056066|NCT01373021|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102056067|NCT01373021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102056068|NCT01373021|Anesthetics, General|anesthetics, general|mesh-ancestor
102056069|NCT01373021|Anesthetics|anesthetics|mesh-ancestor
102056070|NCT02690558|Gemcitabine|gemcitabine|mesh-list
102056071|NCT02690558|Pembrolizumab|pembrolizumab|mesh-list
102056072|NCT02690558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102056073|NCT02690558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102056074|NCT02690558|Antimetabolites|antimetabolites|mesh-ancestor
102056075|NCT02690558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056076|NCT02690558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102056077|NCT02690558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102056078|NCT03568578|Entecavir|entecavir|mesh-list
102056079|NCT03568578|Antiviral Agents|antiviral agents|mesh-ancestor
102056080|NCT03568578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102056081|NCT01367483|Methylnaltrexone|methylnaltrexone|mesh-list
102056082|NCT01367483|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101357592|NCT00070200|Topotecan|topotecan|mesh-list
102056089|NCT05417035|Androgens|androgens|mesh-ancestor
102056090|NCT05417035|Hormones|hormones|mesh-ancestor
102056091|NCT05417035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102056092|NCT05417035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056093|NCT05708742|Bupivacaine|bupivacaine|mesh-list
101942381|NCT01135563|Sirolimus|sirolimus|mesh-list
101942382|NCT01135563|Vinblastine|vinblastine|mesh-list
101942383|NCT01135563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101942384|NCT01135563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101942385|NCT01135563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101942386|NCT01135563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101942387|NCT01135563|Antifungal Agents|antifungal agents|mesh-ancestor
101942388|NCT01135563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102056094|NCT05708742|Anesthetics, Local|anesthetics, local|mesh-list
102056095|NCT05708742|Anesthetics|anesthetics|mesh-list
102056096|NCT05708742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102056097|NCT05708742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056098|NCT05708742|Sensory System Agents|sensory system agents|mesh-ancestor
102056099|NCT05708742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101775798|NCT00575588|Metformin|metformin|mesh-list
102056100|NCT03095287|Factor VIII|factor viii|mesh-list
102056101|NCT03095287|Coagulants|coagulants|mesh-ancestor
102056102|NCT01335581|Tretinoin|tretinoin|mesh-list
102056103|NCT01335581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102056104|NCT01335581|Keratolytic Agents|keratolytic agents|mesh-ancestor
102056105|NCT01335581|Dermatologic Agents|dermatologic agents|mesh-ancestor
102056106|NCT05204563|Imipenem|imipenem|mesh-list
102056107|NCT05204563|Relebactam|relebactam|mesh-list
102056108|NCT05204563|Cilastatin|cilastatin|mesh-list
102056109|NCT05204563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102056110|NCT05204563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102056111|NCT05204563|Protease Inhibitors|protease inhibitors|mesh-ancestor
102056112|NCT05204563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102056113|NCT05204563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056114|NCT05204563|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102056115|NCT02140814|Niacinamide|niacinamide|mesh-list
102056117|NCT02140814|Nicotinic Acids|nicotinic acids|mesh-list
102056118|NCT02140814|Vitamins|vitamins|mesh-ancestor
102056119|NCT02140814|Micronutrients|micronutrients|mesh-ancestor
102056120|NCT02140814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056121|NCT02140814|Vitamin B Complex|vitamin b complex|mesh-ancestor
102056122|NCT02140814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102056123|NCT02140814|Antimetabolites|antimetabolites|mesh-ancestor
102056124|NCT02140814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056125|NCT02140814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102056126|NCT02140814|Vasodilator Agents|vasodilator agents|mesh-ancestor
102056127|NCT03015090|Theophylline|theophylline|mesh-list
102056128|NCT03015090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102056129|NCT03015090|Autonomic Agents|autonomic agents|mesh-ancestor
102056130|NCT03015090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102056131|NCT03015090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056132|NCT03015090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102056133|NCT03015090|Respiratory System Agents|respiratory system agents|mesh-ancestor
102056134|NCT03015090|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102056135|NCT03015090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102056136|NCT03015090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056137|NCT03015090|Vasodilator Agents|vasodilator agents|mesh-ancestor
102056138|NCT03015090|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102056139|NCT03015090|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102056140|NCT03015090|Purinergic Agents|purinergic agents|mesh-ancestor
102056141|NCT03015090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102056142|NCT02620748|Tranexamic Acid|tranexamic acid|mesh-list
102056143|NCT02620748|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102056144|NCT02620748|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102056145|NCT02620748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056146|NCT02620748|Hemostatics|hemostatics|mesh-ancestor
102056147|NCT02620748|Coagulants|coagulants|mesh-ancestor
102056148|NCT02144792|Verapamil|verapamil|mesh-list
102056149|NCT02144792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102056150|NCT02144792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102056151|NCT02144792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102056152|NCT02144792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056160|NCT03566394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056161|NCT03566394|Anticonvulsants|anticonvulsants|mesh-ancestor
101942389|NCT01135563|Immunologic Factors|immunologic factors|mesh-ancestor
101942390|NCT01135563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056162|NCT03566394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102056163|NCT03566394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102056164|NCT03566394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102056165|NCT03566394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102056166|NCT03566394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102056167|NCT03566394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102056168|NCT03566394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102056169|NCT03566394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056170|NCT03566394|Antimanic Agents|antimanic agents|mesh-ancestor
102056172|NCT00033293|Cortisone|cortisone|mesh-list
102056173|NCT00033293|Cyclophosphamide|cyclophosphamide|mesh-list
102056174|NCT00033293|Immunoglobulins|immunoglobulins|mesh-list
102056175|NCT00033293|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102056176|NCT00033293|Antibodies|antibodies|mesh-list
102056177|NCT00033293|gamma-Globulins|gamma-globulins|mesh-list
102056178|NCT00033293|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102056179|NCT00033293|Immunoglobulin G|immunoglobulin g|mesh-list
102056180|NCT00033293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102056181|NCT00033293|Immunologic Factors|immunologic factors|mesh-ancestor
102056182|NCT00033293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056183|NCT00033293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102056184|NCT00033293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102056185|NCT00033293|Alkylating Agents|alkylating agents|mesh-ancestor
101698482|NCT02696915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102056186|NCT00033293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056187|NCT00033293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102056188|NCT00033293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102056189|NCT00033293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102056190|NCT00033293|Glucocorticoids|glucocorticoids|mesh-ancestor
102056191|NCT00033293|Hormones|hormones|mesh-ancestor
102056192|NCT00033293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102056193|NCT00033293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102056194|NCT03566316|Amlodipine|amlodipine|mesh-list
102056195|NCT03566316|Telmisartan|telmisartan|mesh-list
102056196|NCT03566316|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
102056197|NCT03566316|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102056198|NCT03566316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102056199|NCT03566316|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102056200|NCT03566316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102056201|NCT03566316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056202|NCT03566316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102056203|NCT03566316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056204|NCT03566316|Vasodilator Agents|vasodilator agents|mesh-ancestor
102056205|NCT03566316|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102056206|NCT03566316|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102056207|NCT03566316|Antimetabolites|antimetabolites|mesh-ancestor
102056208|NCT03566316|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102056209|NCT03566316|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102056210|NCT03566316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102056211|NCT03566316|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102056212|NCT03566316|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102056213|NCT02145104|Valsartan|valsartan|mesh-list
102056214|NCT02145104|Cilnidipine|cilnidipine|mesh-list
102056215|NCT02145104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102056216|NCT02145104|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102056217|NCT02145104|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102056218|NCT02145104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357741|NCT00066612|Irinotecan|irinotecan|mesh-list
102056221|NCT02145104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102056222|NCT02145104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056223|NCT02145338|Trimethoprim|trimethoprim|mesh-list
102056224|NCT02145338|Nitrofurantoin|nitrofurantoin|mesh-list
102056225|NCT02145338|Cephalexin|cephalexin|mesh-list
102056226|NCT02145338|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102056227|NCT02145338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102056228|NCT02145338|Antimalarials|antimalarials|mesh-ancestor
102056229|NCT02145338|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102056230|NCT02145338|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102056231|NCT02145338|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102056232|NCT02145338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101942391|NCT01135563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942392|NCT01135563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101942393|NCT01135563|Tubulin Modulators|tubulin modulators|mesh-ancestor
102056233|NCT02145338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056234|NCT02145338|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102056235|NCT02145338|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102056236|NCT02145338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102056237|NCT02145338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102056238|NCT03565536|Sorafenib|sorafenib|mesh-list
102056239|NCT03565536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102056240|NCT03565536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102056241|NCT03565536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102056242|NCT03565536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056243|NCT03565458|Dapagliflozin|dapagliflozin|mesh-list
102056244|NCT03565458|Empagliflozin|empagliflozin|mesh-list
102056245|NCT03565458|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102056246|NCT03565458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056247|NCT03565458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102056248|NCT03565458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056249|NCT03565302|Terbutaline|terbutaline|mesh-list
102056250|NCT03565302|Formoterol Fumarate|formoterol fumarate|mesh-list
102056251|NCT03565302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102056252|NCT03565302|Autonomic Agents|autonomic agents|mesh-ancestor
102056253|NCT03565302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102056254|NCT03565302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056255|NCT03565302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102056256|NCT03565302|Respiratory System Agents|respiratory system agents|mesh-ancestor
102056257|NCT03565302|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102056258|NCT03565302|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102056259|NCT03565302|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102056260|NCT03565302|Adrenergic Agents|adrenergic agents|mesh-ancestor
102056261|NCT03565302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102056262|NCT03565302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056263|NCT03565302|Sympathomimetics|sympathomimetics|mesh-ancestor
102056264|NCT03565302|Tocolytic Agents|tocolytic agents|mesh-ancestor
102056265|NCT03565302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102056267|NCT05193227|Bupivacaine|bupivacaine|mesh-list
102056268|NCT05193227|Anesthetics, Local|anesthetics, local|mesh-ancestor
102056269|NCT05193227|Anesthetics|anesthetics|mesh-ancestor
102056270|NCT05193227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102056271|NCT05193227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056272|NCT05193227|Sensory System Agents|sensory system agents|mesh-ancestor
102056273|NCT05193227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102056274|NCT05193227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102056275|NCT05193227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102056276|NCT05193227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102056277|NCT05193227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102056278|NCT05193227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056279|NCT01372007|Lanreotide|lanreotide|mesh-list
102056280|NCT01372007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102056281|NCT01373411|Ticagrelor|ticagrelor|mesh-list
102056282|NCT01373411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102056283|NCT01373411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102056284|NCT01373411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102056285|NCT01373411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102056286|NCT01373411|Purinergic Agents|purinergic agents|mesh-ancestor
102056287|NCT01373411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102056288|NCT01373411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056289|NCT01373411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056302|NCT05354076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102056303|NCT05354076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102056304|NCT05354076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056305|NCT05192681|Docetaxel|docetaxel|mesh-list
102056306|NCT05192681|Tislelizumab|tislelizumab|mesh-list
102056307|NCT05192681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102056308|NCT05192681|Tubulin Modulators|tubulin modulators|mesh-ancestor
102056309|NCT05192681|Antimitotic Agents|antimitotic agents|mesh-ancestor
102056310|NCT05192681|Mitosis Modulators|mitosis modulators|mesh-ancestor
101942394|NCT01135563|Antimitotic Agents|antimitotic agents|mesh-ancestor
101942395|NCT01135563|Mitosis Modulators|mitosis modulators|mesh-ancestor
101942396|NCT03641950|Botulinum Toxins|botulinum toxins|mesh-list
102056311|NCT05192681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056312|NCT05192681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102056313|NCT05192213|Thiamine|thiamine|mesh-list
102056314|NCT05192213|Hydrocortisone|hydrocortisone|mesh-list
102056315|NCT05192213|Vitamins|vitamins|mesh-ancestor
102056316|NCT05192213|Micronutrients|micronutrients|mesh-ancestor
102056317|NCT05192213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056318|NCT05192213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102056319|NCT05192213|Vitamin B Complex|vitamin b complex|mesh-ancestor
102056320|NCT02039674|Paclitaxel|paclitaxel|mesh-list
102056321|NCT02039674|Bevacizumab|bevacizumab|mesh-list
102056322|NCT02039674|Carboplatin|carboplatin|mesh-list
102056323|NCT02039674|Pembrolizumab|pembrolizumab|mesh-list
102056324|NCT02039674|Pemetrexed|pemetrexed|mesh-list
102056325|NCT02039674|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102056326|NCT02039674|Ipilimumab|ipilimumab|mesh-list
102056327|NCT02039674|Gefitinib|gefitinib|mesh-list
102056328|NCT02039674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102056329|NCT02039674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102056330|NCT02039674|Tubulin Modulators|tubulin modulators|mesh-ancestor
102056331|NCT02039674|Antimitotic Agents|antimitotic agents|mesh-ancestor
102056332|NCT02039674|Mitosis Modulators|mitosis modulators|mesh-ancestor
102056333|NCT02039674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056334|NCT02039674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102056335|NCT02039674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102056336|NCT02039674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102056337|NCT02039674|Growth Substances|growth substances|mesh-ancestor
102056338|NCT02039674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056339|NCT02039674|Growth Inhibitors|growth inhibitors|mesh-ancestor
102056340|NCT02039674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102056341|NCT02039674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102056342|NCT02039674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102056343|NCT02039674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102056344|NCT02039674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102056345|NCT03099187|Pirfenidone|pirfenidone|mesh-list
102056346|NCT03099187|Analgesics|analgesics|mesh-ancestor
102056347|NCT03099187|Sensory System Agents|sensory system agents|mesh-ancestor
102056348|NCT03099187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102056349|NCT03099187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056350|NCT03099187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102056351|NCT03099187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102056352|NCT03099187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102056353|NCT03099187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102056354|NCT03099187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102056370|NCT04544267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056371|NCT04895488|Vortioxetine|vortioxetine|mesh-list
102056372|NCT04895488|Antipsychotic Agents|antipsychotic agents|mesh-list
102056373|NCT04895488|Antidepressive Agents|antidepressive agents|mesh-ancestor
102056374|NCT04895488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102056375|NCT04895488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102056376|NCT04895488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102056377|NCT04895488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102056378|NCT04895488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056379|NCT04895488|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102056380|NCT04895488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102056381|NCT04895488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102056382|NCT04895488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056383|NCT04895488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102056384|NCT04895488|Serotonin Agents|serotonin agents|mesh-ancestor
102056385|NCT04895488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102056386|NCT04895488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102056387|NCT04895488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102056388|NCT04895488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102056389|NCT04342715|Paromomycin|paromomycin|mesh-list
102056390|NCT04342715|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
102056391|NCT04342715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102056392|NCT04342715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102056393|NCT04342715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102056394|NCT04342715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102056395|NCT04342715|Schistosomicides|schistosomicides|mesh-ancestor
101942397|NCT03641950|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101942398|NCT03641950|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101942399|NCT03641950|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101942400|NCT03641950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102056396|NCT04342715|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102056397|NCT04342715|Anthelmintics|anthelmintics|mesh-ancestor
102056398|NCT01373333|Amifampridine|amifampridine|mesh-list
102056399|NCT01373333|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102056400|NCT01373333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102056401|NCT01373333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056402|NCT01373333|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102056403|NCT01373333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102056404|NCT01373333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056405|NCT01368341|Amoxicillin|amoxicillin|mesh-list
102056406|NCT01368341|Doxycycline|doxycycline|mesh-list
102056407|NCT01368341|Penicillin V|penicillin v|mesh-list
102056408|NCT01368341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102056409|NCT01368341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102056410|NCT01368341|Antimalarials|antimalarials|mesh-ancestor
102056411|NCT01368341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102056412|NCT01368341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102056413|NCT01368419|Endostar protein|endostar protein|mesh-list
102056424|NCT04639219|Immunoconjugates|immunoconjugates|mesh-ancestor
102056425|NCT04639219|Immunologic Factors|immunologic factors|mesh-ancestor
102056426|NCT04639219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056427|NCT04455100|Itraconazole|itraconazole|mesh-list
102056428|NCT04455100|Antifungal Agents|antifungal agents|mesh-ancestor
102056429|NCT04455100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102056430|NCT04455100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102056431|NCT04455100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102056432|NCT04455100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102056433|NCT04455100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056434|NCT04455100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102056435|NCT04455100|Hormone Antagonists|hormone antagonists|mesh-ancestor
102056436|NCT04455100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102056437|NCT04455100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056438|NCT04455100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102056439|NCT04439578|Rifampin|rifampin|mesh-list
102056440|NCT04439578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102056441|NCT04439578|Antitubercular Agents|antitubercular agents|mesh-ancestor
102056442|NCT04439578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102056443|NCT04439578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102056444|NCT04439578|Leprostatic Agents|leprostatic agents|mesh-ancestor
102056445|NCT04439578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102056446|NCT04439578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102056447|NCT04439578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056448|NCT04439578|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102056449|NCT04439578|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102056450|NCT04439578|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102056451|NCT04439578|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102056452|NCT04439578|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102056453|NCT04439578|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102056454|NCT03110848|Methylprednisolone|methylprednisolone|mesh-list
102056455|NCT03110848|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102056456|NCT03110848|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102056457|NCT03110848|Prednisolone|prednisolone|mesh-list
102056458|NCT03110848|Prednisolone acetate|prednisolone acetate|mesh-list
102056459|NCT03110848|Atorvastatin|atorvastatin|mesh-list
102056460|NCT03110848|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102056461|NCT03110848|Prednisolone phosphate|prednisolone phosphate|mesh-list
102056462|NCT03110848|Glucocorticoids|glucocorticoids|mesh-list
102056463|NCT03110848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102056464|NCT03110848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102056465|NCT03110848|Antimetabolites|antimetabolites|mesh-ancestor
102056466|NCT03110848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056467|NCT03110848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102056468|NCT03110848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102056469|NCT03110848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102056470|NCT03110848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101942401|NCT03641950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942402|NCT03641950|Cholinergic Agents|cholinergic agents|mesh-ancestor
101942403|NCT03641950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101307366|NCT02040142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102056471|NCT03110848|Antiemetics|antiemetics|mesh-ancestor
102056472|NCT03110848|Autonomic Agents|autonomic agents|mesh-ancestor
102056473|NCT03110848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102056474|NCT03110848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056475|NCT03110848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102056476|NCT03110848|Hormones|hormones|mesh-ancestor
102056489|NCT01368887|Calcipotriene|calcipotriene|mesh-list
102056490|NCT01368887|Vitamin B Complex|vitamin b complex|mesh-ancestor
102056491|NCT01368887|Vitamins|vitamins|mesh-ancestor
102056492|NCT01368887|Micronutrients|micronutrients|mesh-ancestor
102056493|NCT01368887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056494|NCT01368887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102056495|NCT01368887|Antimetabolites|antimetabolites|mesh-ancestor
102056496|NCT01368887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056497|NCT01368887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102056498|NCT01368887|Vasodilator Agents|vasodilator agents|mesh-ancestor
102056499|NCT01368887|Dermatologic Agents|dermatologic agents|mesh-ancestor
102056500|NCT01369043|Vitamins|vitamins|mesh-list
102056501|NCT01369043|Vitamin E|vitamin e|mesh-list
102056502|NCT01369043|Micronutrients|micronutrients|mesh-ancestor
102056503|NCT01369043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056504|NCT01369043|Antioxidants|antioxidants|mesh-ancestor
102056505|NCT01369043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056506|NCT01369043|Protective Agents|protective agents|mesh-ancestor
102056507|NCT04477096|Emtricitabine|emtricitabine|mesh-list
102056508|NCT04477096|Antiviral Agents|antiviral agents|mesh-ancestor
102056509|NCT04477096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102056510|NCT04477096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102056511|NCT04477096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102056512|NCT04477096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102056513|NCT04477096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056514|NCT04477096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102056515|NCT04477096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102056516|NCT01369121|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
102056517|NCT01369121|Hormones|hormones|mesh-ancestor
102056518|NCT01369121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102056519|NCT01369121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056520|NCT03868150|Amiodarone|amiodarone|mesh-list
102056521|NCT03868150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102056522|NCT03868150|Vasodilator Agents|vasodilator agents|mesh-ancestor
102056523|NCT03868150|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102056524|NCT03868150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102056525|NCT03868150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056526|NCT03868150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102056527|NCT03868150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102056528|NCT03868150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102056529|NCT03868150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102056530|NCT03868150|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102056531|NCT03868150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102056532|NCT03868150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102056533|NCT03521687|Apremilast|apremilast|mesh-list
102056534|NCT03521687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102056535|NCT03521687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102056536|NCT03521687|Analgesics|analgesics|mesh-ancestor
102056537|NCT03521687|Sensory System Agents|sensory system agents|mesh-ancestor
102056568|NCT01319825|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102056569|NCT01319825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102056570|NCT01319825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102056571|NCT01319825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056572|NCT01319825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102056573|NCT01319825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056574|NCT01319825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102056575|NCT01319825|Analgesics|analgesics|mesh-ancestor
102056576|NCT01319825|Sensory System Agents|sensory system agents|mesh-ancestor
101942404|NCT03641950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942405|NCT03641950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102056577|NCT01319825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102056593|NCT02983006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056595|NCT03811756|Vitamins|vitamins|mesh-ancestor
102056596|NCT03811756|Micronutrients|micronutrients|mesh-ancestor
102056597|NCT03811756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056598|NCT03141268|Lactulose|lactulose|mesh-list
102056599|NCT03141268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102056600|NCT03316781|Adalimumab|adalimumab|mesh-list
102056601|NCT03316781|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102056602|NCT03316781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102056603|NCT03316781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102056604|NCT01319903|Antibodies|antibodies|mesh-list
102056605|NCT01319903|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102056606|NCT01319903|Immunologic Factors|immunologic factors|mesh-ancestor
102056607|NCT01319903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056608|NCT02839200|Zolpidem|zolpidem|mesh-list
102056609|NCT02839200|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102056610|NCT02839200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102056611|NCT02839200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102056612|NCT02839200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056613|NCT02839200|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102056614|NCT02839200|GABA Agonists|gaba agonists|mesh-ancestor
102056615|NCT02839200|GABA Agents|gaba agents|mesh-ancestor
102056616|NCT02839200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102056617|NCT02839200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056618|NCT01369667|Vitamin D|vitamin d|mesh-list
102056619|NCT01369667|Cholecalciferol|cholecalciferol|mesh-list
102056620|NCT01369667|Vitamins|vitamins|mesh-ancestor
102056621|NCT01369667|Micronutrients|micronutrients|mesh-ancestor
102056622|NCT01369667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056623|NCT01369667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102056624|NCT01369667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102056626|NCT03564912|Oxaliplatin|oxaliplatin|mesh-list
102056627|NCT03564912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102056628|NCT03564912|Antimetabolites|antimetabolites|mesh-ancestor
102056629|NCT03564912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056630|NCT03564912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102056631|NCT03551626|Trametinib|trametinib|mesh-list
102056632|NCT03551626|Dabrafenib|dabrafenib|mesh-list
102056633|NCT03551626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102056634|NCT03551626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102056635|NCT03551626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102056636|NCT03551626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056637|NCT05760053|Cisplatin|cisplatin|mesh-list
102056642|NCT05760053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102056643|NCT05760053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102056645|NCT05760053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056646|NCT03118739|Febuxostat|febuxostat|mesh-list
102056647|NCT03118739|Verinurad|verinurad|mesh-list
102056648|NCT03118739|Gout Suppressants|gout suppressants|mesh-ancestor
102056649|NCT03118739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102056650|NCT03181126|Venetoclax|venetoclax|mesh-list
102056651|NCT03181126|Navitoclax|navitoclax|mesh-list
102056652|NCT03181126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102056653|NCT05139875|Triamcinolone|triamcinolone|mesh-list
102056654|NCT05139875|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102056655|NCT05139875|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102056656|NCT05139875|Betamethasone|betamethasone|mesh-list
102056657|NCT05139875|Betamethasone Valerate|betamethasone valerate|mesh-list
102056658|NCT05139875|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102056659|NCT05139875|Betamethasone benzoate|betamethasone benzoate|mesh-list
102056660|NCT05139875|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
102056661|NCT05139875|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102056662|NCT05139875|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102056663|NCT05139875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102056664|NCT05139875|Glucocorticoids|glucocorticoids|mesh-ancestor
102056665|NCT05139875|Hormones|hormones|mesh-ancestor
102056666|NCT05139875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102056667|NCT05139875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056668|NCT05139875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102056669|NCT05139875|Immunologic Factors|immunologic factors|mesh-ancestor
102056670|NCT05139875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101942406|NCT03641950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101942407|NCT03764631|Empagliflozin|empagliflozin|mesh-list
101942408|NCT03764631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
102056671|NCT05139875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056672|NCT05139875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102056673|NCT05139875|Respiratory System Agents|respiratory system agents|mesh-ancestor
102056674|NCT03140410|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102056675|NCT03140410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102056676|NCT04799548|Tislelizumab|tislelizumab|mesh-list
102056677|NCT04799548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102056678|NCT04799548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102056679|NCT01375985|Radavirsen|radavirsen|mesh-list
102056680|NCT01375985|Antiviral Agents|antiviral agents|mesh-ancestor
102056681|NCT01375985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102056682|NCT05384821|Irinotecan|irinotecan|mesh-list
102056683|NCT05384821|Etoposide|etoposide|mesh-list
102056684|NCT05384821|Vincristine|vincristine|mesh-list
102056685|NCT05384821|Temozolomide|temozolomide|mesh-list
102056686|NCT05384821|Tretinoin|tretinoin|mesh-list
102056687|NCT05384821|Isotretinoin|isotretinoin|mesh-list
102056688|NCT05384821|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102056689|NCT05384821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102056690|NCT05384821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102056691|NCT05384821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056692|NCT05384821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102056693|NCT05384821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102056694|NCT05384821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102056695|NCT05384821|Tubulin Modulators|tubulin modulators|mesh-ancestor
102056696|NCT05384821|Antimitotic Agents|antimitotic agents|mesh-ancestor
102056697|NCT05384821|Mitosis Modulators|mitosis modulators|mesh-ancestor
102056698|NCT05384821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102056699|NCT05384821|Alkylating Agents|alkylating agents|mesh-ancestor
102056700|NCT05384821|Keratolytic Agents|keratolytic agents|mesh-ancestor
102056701|NCT05384821|Dermatologic Agents|dermatologic agents|mesh-ancestor
102056702|NCT02654080|Vaccines|vaccines|mesh-list
102056703|NCT02654080|Immunologic Factors|immunologic factors|mesh-ancestor
102056704|NCT02654080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056705|NCT05375305|Morphine|morphine|mesh-list
102056706|NCT05375305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102056707|NCT05375305|Narcotics|narcotics|mesh-ancestor
102056708|NCT05375305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102056709|NCT05375305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056710|NCT05375305|Analgesics|analgesics|mesh-ancestor
102056714|NCT03140332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102056715|NCT03140332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102056716|NCT03140332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102056717|NCT03140332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056718|NCT02835690|Pembrolizumab|pembrolizumab|mesh-list
102056719|NCT02835690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102056720|NCT02835690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102056721|NCT02835690|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102056722|NCT02835690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056723|NCT02832167|Nivolumab|nivolumab|mesh-list
102056724|NCT02832167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102056725|NCT02832167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102056726|NCT02832167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102056727|NCT02832167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056728|NCT04941040|Analgesics, Opioid|analgesics, opioid|mesh-list
102056729|NCT04941040|Anesthetics|anesthetics|mesh-list
102056730|NCT04941040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102056731|NCT04941040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056732|NCT04941040|Narcotics|narcotics|mesh-ancestor
102056733|NCT04941040|Analgesics|analgesics|mesh-ancestor
102056734|NCT04941040|Sensory System Agents|sensory system agents|mesh-ancestor
102056735|NCT04941040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102056736|NCT00913705|Carboplatin|carboplatin|mesh-list
102056737|NCT00913705|Paclitaxel|paclitaxel|mesh-list
102056738|NCT00913705|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102056739|NCT00913705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102056740|NCT00913705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102056741|NCT00913705|Tubulin Modulators|tubulin modulators|mesh-ancestor
102056742|NCT00913705|Antimitotic Agents|antimitotic agents|mesh-ancestor
102056743|NCT00913705|Mitosis Modulators|mitosis modulators|mesh-ancestor
101942409|NCT03764631|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101942410|NCT03764631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433912|NCT00159770|Dopamine Agents|dopamine agents|mesh-ancestor
102056744|NCT00913705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056745|NCT04934410|Midazolam|midazolam|mesh-list
102056746|NCT04934410|Etomidate|etomidate|mesh-list
102056747|NCT04934410|Sevoflurane|sevoflurane|mesh-list
102056748|NCT04934410|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102056749|NCT04934410|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102056750|NCT04934410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102056751|NCT04934410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056752|NCT04934410|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102056753|NCT04934410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102056754|NCT04934410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102056755|NCT04934410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102056756|NCT04934410|Anesthetics, General|anesthetics, general|mesh-ancestor
102056757|NCT04934410|Anesthetics|anesthetics|mesh-ancestor
102056758|NCT04934410|GABA Modulators|gaba modulators|mesh-ancestor
102056759|NCT04934410|GABA Agents|gaba agents|mesh-ancestor
102056760|NCT04934410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102056761|NCT04934410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056762|NCT04934410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102056763|NCT04934410|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102056764|NCT02787239|Rituximab|rituximab|mesh-list
102056765|NCT02787239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102056766|NCT02787239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102056767|NCT02787239|Immunologic Factors|immunologic factors|mesh-ancestor
102056768|NCT02787239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056769|NCT02787239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102056770|NCT03140956|Levodopa|levodopa|mesh-list
102056771|NCT03140956|Carbidopa|carbidopa|mesh-list
102056772|NCT03140956|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102056773|NCT03140956|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102056774|NCT03140956|Dopamine Agents|dopamine agents|mesh-ancestor
102056775|NCT03140956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102056776|NCT03140956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056777|NCT03140956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056778|NCT03140956|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102056780|NCT02681237|Olaparib|olaparib|mesh-list
102056781|NCT02681237|Cediranib|cediranib|mesh-list
102056782|NCT02681237|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102056783|NCT02681237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101358308|NCT00202852|Infliximab|infliximab|mesh-list
102056838|NCT02653963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102056839|NCT02653963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056840|NCT03097861|Lubiprostone|lubiprostone|mesh-list
102056841|NCT03097861|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102056842|NCT03097861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102056843|NCT03097861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056844|NCT03910673|Fosfomycin|fosfomycin|mesh-list
102056845|NCT03910673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102056846|NCT03910673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102056847|NCT01376141|Sumatriptan|sumatriptan|mesh-list
102056848|NCT01376141|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102056849|NCT01376141|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102056850|NCT01376141|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102056851|NCT01376141|Serotonin Agents|serotonin agents|mesh-ancestor
102056852|NCT01376141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102056853|NCT01376141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056854|NCT01376141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056856|NCT03642067|Relatlimab|relatlimab|mesh-list
102056857|NCT03642067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102056858|NCT03642067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102056859|NCT03642067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102056860|NCT03642067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056861|NCT01816139|Estradiol|estradiol|mesh-list
102056862|NCT01816139|Estrogens|estrogens|mesh-ancestor
102056863|NCT01816139|Hormones|hormones|mesh-ancestor
102056864|NCT01816139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102056865|NCT01816139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942411|NCT03764631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101942412|NCT03764631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056866|NCT04052776|Levodopa|levodopa|mesh-list
102056867|NCT04052776|Carbidopa|carbidopa|mesh-list
102056872|NCT04052776|Dopamine Agents|dopamine agents|mesh-ancestor
102056873|NCT04052776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102056874|NCT04052776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056875|NCT04052776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056876|NCT04052776|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102056877|NCT04052776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102056878|NCT04052776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102056879|NCT04052776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102056880|NCT04052776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102056881|NCT04052776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102056882|NCT04052776|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102056883|NCT04052776|Serotonin Agents|serotonin agents|mesh-ancestor
102056884|NCT04052776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102056885|NCT04052776|Immunologic Factors|immunologic factors|mesh-ancestor
102056886|NCT04052776|Dopamine Agonists|dopamine agonists|mesh-ancestor
102056887|NCT01374191|Botulinum Toxins|botulinum toxins|mesh-list
102056888|NCT01374191|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102056889|NCT01374191|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102056890|NCT01374191|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102056891|NCT01374191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102056892|NCT01374191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056893|NCT01374191|Cholinergic Agents|cholinergic agents|mesh-ancestor
102056894|NCT01374191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102056895|NCT01374191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056896|NCT01374191|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102056897|NCT01374191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102056898|NCT03764735|Benzalkonium Compounds|benzalkonium compounds|mesh-list
102056899|NCT03764735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102056900|NCT03764735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102056901|NCT05041673|Metformin|metformin|mesh-list
102056902|NCT05041673|Liraglutide|liraglutide|mesh-list
102056903|NCT05041673|Empagliflozin|empagliflozin|mesh-list
102056904|NCT05041673|Vildagliptin|vildagliptin|mesh-list
102056905|NCT05041673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102056906|NCT05041673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056907|NCT05041673|Incretins|incretins|mesh-ancestor
102056908|NCT05041673|Hormones|hormones|mesh-ancestor
102056909|NCT05041673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102056910|NCT05041673|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102056911|NCT05041673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056912|NCT05041673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102056913|NCT05041673|Protease Inhibitors|protease inhibitors|mesh-ancestor
102056914|NCT05041673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102056915|NCT03907540|Belumosudil|belumosudil|mesh-list
102056916|NCT03907540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102056917|NCT03907540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102056918|NCT03907540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776622|NCT00811200|Growth Substances|growth substances|mesh-ancestor
102056919|NCT05759429|Melatonin|melatonin|mesh-list
102056920|NCT05759429|Antioxidants|antioxidants|mesh-ancestor
102056921|NCT05759429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056923|NCT05759429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056924|NCT05759429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102056925|NCT04005209|Ketamine|ketamine|mesh-list
102056926|NCT04005209|Analgesics|analgesics|mesh-ancestor
102056927|NCT04005209|Sensory System Agents|sensory system agents|mesh-ancestor
102056928|NCT04005209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102056929|NCT04005209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056930|NCT04005209|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102056931|NCT04005209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102056932|NCT04005209|Anesthetics, General|anesthetics, general|mesh-ancestor
102056933|NCT04005209|Anesthetics|anesthetics|mesh-ancestor
102056934|NCT04005209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102056935|NCT04005209|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101698611|NCT00671424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102056936|NCT04005209|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102056937|NCT04005209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102056943|NCT02833350|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102056944|NCT02833350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101942413|NCT03764631|Protease Inhibitors|protease inhibitors|mesh-ancestor
101942414|NCT03764631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102056945|NCT02833350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102056946|NCT02833350|Hematinics|hematinics|mesh-ancestor
102056947|NCT02833350|Vitamin B Complex|vitamin b complex|mesh-ancestor
102056948|NCT02833350|Vitamins|vitamins|mesh-ancestor
102056949|NCT02833350|Micronutrients|micronutrients|mesh-ancestor
102056950|NCT02833350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056951|NCT03137134|Crizotinib|crizotinib|mesh-list
102056952|NCT03137134|Esomeprazole|esomeprazole|mesh-list
102056953|NCT03137134|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102056954|NCT03137134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102056955|NCT03137134|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102056956|NCT03137134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102056957|NCT03137134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056958|NCT03137134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102056959|NCT03137134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102056960|NCT03137368|Tamoxifen|tamoxifen|mesh-list
102056961|NCT03137368|Exemestane|exemestane|mesh-list
102056962|NCT03137368|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102056963|NCT03137368|Hormone Antagonists|hormone antagonists|mesh-ancestor
102056964|NCT03137368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102056965|NCT03137368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056966|NCT03137368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102056967|NCT03137368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102056968|NCT03137368|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102056969|NCT03137368|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102056970|NCT03137368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102056971|NCT03137368|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102056972|NCT03137368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102056973|NCT03137368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102056974|NCT03137368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056975|NCT03138616|Vitamin D|vitamin d|mesh-list
102056976|NCT03138616|Vitamins|vitamins|mesh-ancestor
102056977|NCT03138616|Micronutrients|micronutrients|mesh-ancestor
102056978|NCT03138616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056979|NCT03138616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102056980|NCT03137290|Neostigmine|neostigmine|mesh-list
102056981|NCT03137290|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102056982|NCT03137290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102056983|NCT03137290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056984|NCT03137290|Cholinergic Agents|cholinergic agents|mesh-ancestor
102056985|NCT03137290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102056986|NCT03137290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056987|NCT03137290|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102056988|NCT03137290|Autonomic Agents|autonomic agents|mesh-ancestor
102056989|NCT03137290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102056990|NCT03782818|Olaparib|olaparib|mesh-list
102056991|NCT03782818|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102056992|NCT03782818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102056993|NCT03782818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776697|NCT00766220|Irinotecan|irinotecan|mesh-list
102056994|NCT03782818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102056995|NCT05391724|Brincidofovir|brincidofovir|mesh-list
102056996|NCT05391724|Antiviral Agents|antiviral agents|mesh-ancestor
102056997|NCT05391724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102056998|NCT03355534|Dexmedetomidine|dexmedetomidine|mesh-list
102056999|NCT03355534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102057000|NCT03355534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102057001|NCT03355534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057002|NCT03355534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102057003|NCT03355534|Analgesics|analgesics|mesh-ancestor
102057004|NCT03355534|Sensory System Agents|sensory system agents|mesh-ancestor
102057005|NCT03355534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102057006|NCT03355534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101358539|NCT00204256|Hematinics|hematinics|mesh-ancestor
102057025|NCT05385562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057026|NCT05385562|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102057027|NCT05385562|Viscosupplements|viscosupplements|mesh-ancestor
102057028|NCT05385562|Protective Agents|protective agents|mesh-ancestor
102057029|NCT01343043|Cyclophosphamide|cyclophosphamide|mesh-list
102057030|NCT01343043|Fludarabine|fludarabine|mesh-list
102057031|NCT01343043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102057032|NCT01343043|Immunologic Factors|immunologic factors|mesh-ancestor
101942415|NCT01135641|Cyclosporine|cyclosporine|mesh-list
101942416|NCT01135641|Rituximab|rituximab|mesh-list
101942417|NCT01135641|Cyclosporins|cyclosporins|mesh-list
102057033|NCT01343043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057034|NCT01343043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102057035|NCT01343043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102057036|NCT01343043|Alkylating Agents|alkylating agents|mesh-ancestor
102057037|NCT01343043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057038|NCT01343043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102057039|NCT01343043|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102057040|NCT03139708|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102057041|NCT03139708|Phenylephrine|phenylephrine|mesh-list
102057042|NCT03139708|Oxymetazoline|oxymetazoline|mesh-list
102057043|NCT03139708|Tropicamide|tropicamide|mesh-list
102057044|NCT03139708|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102057045|NCT03139708|Mydriatics|mydriatics|mesh-ancestor
102057046|NCT03139708|Autonomic Agents|autonomic agents|mesh-ancestor
102057047|NCT03139708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102057048|NCT03139708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057049|NCT03139708|Sympathomimetics|sympathomimetics|mesh-ancestor
102057050|NCT03139708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102057051|NCT03139708|Nasal Decongestants|nasal decongestants|mesh-ancestor
102057052|NCT03139708|Respiratory System Agents|respiratory system agents|mesh-ancestor
102057053|NCT03139708|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102057054|NCT03139708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102057055|NCT03139708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102057056|NCT03139708|Adrenergic Agents|adrenergic agents|mesh-ancestor
102057057|NCT03139708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102057058|NCT03139708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057059|NCT03139708|Protective Agents|protective agents|mesh-ancestor
102057060|NCT03139708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102057061|NCT03139708|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102057062|NCT03139708|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102057087|NCT03048747|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102057088|NCT03048747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057089|NCT03048747|Natriuretic Agents|natriuretic agents|mesh-ancestor
102057090|NCT03048747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057091|NCT05086822|Irinotecan|irinotecan|mesh-list
102057092|NCT05086822|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102057093|NCT05086822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102057094|NCT05086822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102057095|NCT05086822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057096|NCT05086822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102057097|NCT05354128|Fibrinolytic Agents|fibrinolytic agents|mesh-list
102057098|NCT05354128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101698635|NCT02757209|Xhance|xhance|mesh-list
102057099|NCT05354128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057100|NCT04051827|Midazolam|midazolam|mesh-list
102057101|NCT04051827|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102057102|NCT04051827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102057103|NCT04051827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102057104|NCT04051827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057105|NCT04051827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102057106|NCT04051827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102057107|NCT04051827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102057108|NCT04051827|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102057109|NCT04051827|Anesthetics, General|anesthetics, general|mesh-ancestor
102057110|NCT04051827|Anesthetics|anesthetics|mesh-ancestor
102057111|NCT04051827|GABA Modulators|gaba modulators|mesh-ancestor
102057112|NCT04051827|GABA Agents|gaba agents|mesh-ancestor
102057113|NCT04051827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102057114|NCT04051827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057567|NCT03563586|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102057568|NCT03563586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102057570|NCT05197062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102057571|NCT05197062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057572|NCT05197062|Sensory System Agents|sensory system agents|mesh-ancestor
102057573|NCT05197062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102057574|NCT05000736|Fulvestrant|fulvestrant|mesh-list
102057575|NCT05000736|Palbociclib|palbociclib|mesh-list
102057576|NCT05000736|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102057577|NCT05000736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102057578|NCT05000736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102057848|NCT05707572|Prednisolone phosphate|prednisolone phosphate|mesh-list
101942418|NCT01135641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101942419|NCT01135641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102057849|NCT05707572|Anesthetics, Local|anesthetics, local|mesh-ancestor
102057851|NCT05707572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102057852|NCT05707572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057853|NCT05707572|Sensory System Agents|sensory system agents|mesh-ancestor
102057854|NCT05707572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102057855|NCT05707572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102057856|NCT05707572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102057857|NCT05707572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102057858|NCT05707572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102057859|NCT05707572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057860|NCT05707572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102057861|NCT05707572|Antiemetics|antiemetics|mesh-ancestor
102057862|NCT05707572|Autonomic Agents|autonomic agents|mesh-ancestor
102057863|NCT05707572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102057864|NCT05707572|Glucocorticoids|glucocorticoids|mesh-ancestor
102060577|NCT01864018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060578|NCT01864018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102060579|NCT01864018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102060580|NCT01864018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102060581|NCT01864018|Antiemetics|antiemetics|mesh-ancestor
102060582|NCT01864018|Autonomic Agents|autonomic agents|mesh-ancestor
102060583|NCT01864018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102060584|NCT01864018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102060585|NCT01864018|Glucocorticoids|glucocorticoids|mesh-ancestor
102060586|NCT01864018|Hormones|hormones|mesh-ancestor
102060587|NCT01864018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102060588|NCT01864018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102060589|NCT01864018|Protease Inhibitors|protease inhibitors|mesh-ancestor
101780300|NCT03957590|Paclitaxel|paclitaxel|mesh-list
102060590|NCT01864018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102060591|NCT01864018|Dermatologic Agents|dermatologic agents|mesh-ancestor
102060592|NCT01864018|Glycine Agents|glycine agents|mesh-ancestor
102060593|NCT01864018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102060594|NCT01796197|Paclitaxel|paclitaxel|mesh-list
102060595|NCT01796197|Cyclophosphamide|cyclophosphamide|mesh-list
102060596|NCT01796197|Doxorubicin|doxorubicin|mesh-list
102060597|NCT01796197|Trastuzumab|trastuzumab|mesh-list
102060598|NCT01796197|Pertuzumab|pertuzumab|mesh-list
102060599|NCT01796197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102060621|NCT01712620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060622|NCT01712620|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102060623|NCT01712620|Diuretics|diuretics|mesh-ancestor
102060624|NCT01712620|Natriuretic Agents|natriuretic agents|mesh-ancestor
102060625|NCT01689766|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
102060626|NCT01689766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102060627|NCT01689766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060628|NCT01205048|Lidocaine|lidocaine|mesh-list
102060629|NCT01205048|Anesthetics, Local|anesthetics, local|mesh-ancestor
102060630|NCT01205048|Anesthetics|anesthetics|mesh-ancestor
102060631|NCT01205048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102060632|NCT01205048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060633|NCT01205048|Sensory System Agents|sensory system agents|mesh-ancestor
102060634|NCT01205048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102060635|NCT01205048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102060636|NCT01205048|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102060637|NCT01205048|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102060638|NCT01205048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102060639|NCT01205048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060640|NCT01052779|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102060641|NCT01052779|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102060642|NCT01052779|Hematinics|hematinics|mesh-ancestor
102060643|NCT01052779|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102060644|NCT01052779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102060645|NCT00785525|Lenograstim|lenograstim|mesh-list
102060646|NCT00785525|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102060647|NCT00785525|Immunologic Factors|immunologic factors|mesh-ancestor
102060648|NCT00785525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060649|NCT00591370|Temozolomide|temozolomide|mesh-list
102060661|NCT02782676|Immunologic Factors|immunologic factors|mesh-ancestor
101942420|NCT01135641|Immunologic Factors|immunologic factors|mesh-ancestor
101942421|NCT01135641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942422|NCT01135641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101942423|NCT01135641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102060662|NCT02782676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060663|NCT02782676|Viscosupplements|viscosupplements|mesh-ancestor
102060664|NCT02782676|Protective Agents|protective agents|mesh-ancestor
102060665|NCT03033095|Etanercept|etanercept|mesh-list
102060666|NCT03033095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102060667|NCT03033095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102060668|NCT03033095|Analgesics|analgesics|mesh-ancestor
102060669|NCT03033095|Sensory System Agents|sensory system agents|mesh-ancestor
102060670|NCT03033095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102060671|NCT03033095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060672|NCT03033095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102060673|NCT03033095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102060674|NCT03033095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102060675|NCT03033095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102060676|NCT03033095|Immunologic Factors|immunologic factors|mesh-ancestor
102060677|NCT02142920|Gedatolisib|gedatolisib|mesh-list
102060678|NCT02142920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102060679|NCT02142920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102060680|NCT02142920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060681|NCT01383785|Abciximab|abciximab|mesh-list
102060682|NCT01383785|Anticoagulants|anticoagulants|mesh-ancestor
102060683|NCT01383785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102060684|NCT02923739|Paclitaxel|paclitaxel|mesh-list
102060685|NCT02923739|Bevacizumab|bevacizumab|mesh-list
102060686|NCT02923739|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102060687|NCT02923739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102060688|NCT02923739|Endothelial Growth Factors|endothelial growth factors|mesh-list
102060689|NCT02923739|Antibodies|antibodies|mesh-list
102060690|NCT02923739|Immunoglobulins|immunoglobulins|mesh-list
102060691|NCT02923739|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102060692|NCT02923739|Immunoglobulin G|immunoglobulin g|mesh-list
101698655|NCT02757209|Adrenergic Agents|adrenergic agents|mesh-ancestor
102060693|NCT02923739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102060694|NCT02923739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102060695|NCT02923739|Tubulin Modulators|tubulin modulators|mesh-ancestor
102060696|NCT02923739|Antimitotic Agents|antimitotic agents|mesh-ancestor
102060697|NCT02923739|Mitosis Modulators|mitosis modulators|mesh-ancestor
102060698|NCT02923739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060699|NCT02923739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102060700|NCT02923739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102060701|NCT02923739|Growth Substances|growth substances|mesh-ancestor
102060702|NCT02923739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060703|NCT02923739|Growth Inhibitors|growth inhibitors|mesh-ancestor
102060704|NCT02923739|Immunologic Factors|immunologic factors|mesh-ancestor
102060705|NCT02146976|Propofol|propofol|mesh-list
102060706|NCT02146976|Sevoflurane|sevoflurane|mesh-list
102060707|NCT02146976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102060708|NCT02146976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102060709|NCT02146976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060710|NCT02146976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102060711|NCT02146976|Anesthetics, General|anesthetics, general|mesh-ancestor
102060712|NCT02146976|Anesthetics|anesthetics|mesh-ancestor
102060713|NCT02146976|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102060720|NCT02147054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060721|NCT00107978|Vancomycin|vancomycin|mesh-list
102060722|NCT00107978|Telavancin|telavancin|mesh-list
102060723|NCT00107978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102060724|NCT00107978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102060725|NCT02781818|Triamcinolone|triamcinolone|mesh-list
102060726|NCT02781818|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102060727|NCT02781818|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102060728|NCT02781818|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102060729|NCT02781818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102060730|NCT02781818|Glucocorticoids|glucocorticoids|mesh-ancestor
102060731|NCT02781818|Hormones|hormones|mesh-ancestor
102060732|NCT02781818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102060733|NCT02781818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060734|NCT02781818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102060735|NCT02781818|Immunologic Factors|immunologic factors|mesh-ancestor
102060736|NCT02781818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101942424|NCT01135641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942425|NCT01135641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101942426|NCT01135641|Antifungal Agents|antifungal agents|mesh-ancestor
101942427|NCT01135641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101942428|NCT01135641|Dermatologic Agents|dermatologic agents|mesh-ancestor
101434383|NCT00545935|Artesunate|artesunate|mesh-list
102060737|NCT02781818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060738|NCT02149628|Propofol|propofol|mesh-list
102060739|NCT02149628|Desflurane|desflurane|mesh-list
102060740|NCT02149628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102060741|NCT02149628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102060742|NCT02149628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060743|NCT02149628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102060744|NCT02149628|Anesthetics, General|anesthetics, general|mesh-ancestor
102060745|NCT02149628|Anesthetics|anesthetics|mesh-ancestor
102060746|NCT02149628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102060747|NCT02927873|Vaccines|vaccines|mesh-list
102060748|NCT02927873|Immunologic Factors|immunologic factors|mesh-ancestor
102060749|NCT02927873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060750|NCT02460419|Capecitabine|capecitabine|mesh-list
102060751|NCT02460419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102060752|NCT02460419|Antimetabolites|antimetabolites|mesh-ancestor
102060753|NCT02460419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060754|NCT02460419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102060755|NCT01568411|Itraconazole|itraconazole|mesh-list
102060756|NCT01568411|Antifungal Agents|antifungal agents|mesh-ancestor
102060757|NCT01568411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102060758|NCT01568411|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102060759|NCT01568411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102060760|NCT01568411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102060761|NCT01568411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060762|NCT01568411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102060763|NCT01568411|Hormone Antagonists|hormone antagonists|mesh-ancestor
102060764|NCT01568411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102060765|NCT01568411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060766|NCT01568411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102060767|NCT00142415|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
102060768|NCT00142415|Chelating Agents|chelating agents|mesh-ancestor
102060769|NCT00142415|Sequestering Agents|sequestering agents|mesh-ancestor
102060770|NCT00142415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060771|NCT03631901|Diazepam|diazepam|mesh-list
102060772|NCT03631901|Melatonin|melatonin|mesh-list
102060773|NCT03631901|Antioxidants|antioxidants|mesh-ancestor
102060774|NCT03631901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060775|NCT03631901|Protective Agents|protective agents|mesh-ancestor
102060776|NCT03631901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060777|NCT03631901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102060778|NCT03631901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102060779|NCT03631901|Anticonvulsants|anticonvulsants|mesh-ancestor
102060780|NCT03631901|Antiemetics|antiemetics|mesh-ancestor
102060781|NCT03631901|Autonomic Agents|autonomic agents|mesh-ancestor
102060788|NCT03631901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102060789|NCT03631901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102060790|NCT03631901|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102060791|NCT03631901|Anesthetics, General|anesthetics, general|mesh-ancestor
102060792|NCT03631901|Anesthetics|anesthetics|mesh-ancestor
102060793|NCT03631901|GABA Modulators|gaba modulators|mesh-ancestor
102060794|NCT03631901|GABA Agents|gaba agents|mesh-ancestor
102060795|NCT03631901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102060796|NCT01383395|Cilostazol|cilostazol|mesh-list
102060797|NCT01383395|Simvastatin|simvastatin|mesh-list
102060798|NCT01383395|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102060799|NCT01383395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102060800|NCT01383395|Antimetabolites|antimetabolites|mesh-ancestor
102060801|NCT01383395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060802|NCT01383395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102060803|NCT01383395|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102060804|NCT01383395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101942429|NCT01135641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101942430|NCT03640156|Oxytocin|oxytocin|mesh-list
101942431|NCT03640156|Oxytocics|oxytocics|mesh-ancestor
101942432|NCT03640156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101307392|NCT02040311|Topiramate|topiramate|mesh-list
102060805|NCT01383395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102060806|NCT01383395|Autonomic Agents|autonomic agents|mesh-ancestor
102060807|NCT01383395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102060808|NCT01383395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060809|NCT01383395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102060810|NCT01383395|Respiratory System Agents|respiratory system agents|mesh-ancestor
102060811|NCT01383395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102060812|NCT01383395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102060813|NCT01383395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102060814|NCT01383395|Vasodilator Agents|vasodilator agents|mesh-ancestor
102060815|NCT01383395|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102060816|NCT01383395|Protective Agents|protective agents|mesh-ancestor
102060817|NCT01383395|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102060818|NCT01383395|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102060820|NCT05084651|Lumefantrine|lumefantrine|mesh-list
102060821|NCT05084651|Antifungal Agents|antifungal agents|mesh-ancestor
102060822|NCT05084651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102060823|NCT05084651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102060824|NCT05084651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102060825|NCT05084651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102060826|NCT05084651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060827|NCT05084651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102060828|NCT05084651|Hormone Antagonists|hormone antagonists|mesh-ancestor
102060829|NCT05084651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102060830|NCT05084651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698668|NCT05338801|Menthol|menthol|mesh-list
102060831|NCT05084651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102060832|NCT05084651|Antimalarials|antimalarials|mesh-ancestor
102060833|NCT05084651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102060834|NCT05084651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102060835|NCT02781584|Firsocostat|firsocostat|mesh-list
102060836|NCT02781584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102060837|NCT02781584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060838|NCT02149706|Freund's Adjuvant|freund's adjuvant|mesh-list
102060839|NCT02149706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102060840|NCT02149706|Immunologic Factors|immunologic factors|mesh-ancestor
102060841|NCT02149706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060842|NCT02147678|Remifentanil|remifentanil|mesh-list
102060843|NCT02147678|Propofol|propofol|mesh-list
102060844|NCT02147678|Etomidate|etomidate|mesh-list
102060845|NCT02147678|Anesthetics|anesthetics|mesh-ancestor
102060846|NCT02147678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102060847|NCT02147678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060848|NCT02147678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102060849|NCT02147678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102060850|NCT02147678|Anesthetics, General|anesthetics, general|mesh-ancestor
102060851|NCT02147678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102060858|NCT02151344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060860|NCT02155634|Immunologic Factors|immunologic factors|mesh-ancestor
102060861|NCT02155634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060862|NCT02155634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102060863|NCT02155634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102060864|NCT02155634|Growth Substances|growth substances|mesh-ancestor
102060865|NCT02155634|Growth Inhibitors|growth inhibitors|mesh-ancestor
102060866|NCT02155634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102060867|NCT02151812|Paclitaxel|paclitaxel|mesh-list
102060868|NCT02151812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102060869|NCT02151812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102060870|NCT02151812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102060871|NCT02151812|Tubulin Modulators|tubulin modulators|mesh-ancestor
102060872|NCT02151812|Antimitotic Agents|antimitotic agents|mesh-ancestor
102060873|NCT02151812|Mitosis Modulators|mitosis modulators|mesh-ancestor
102060874|NCT02151812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060875|NCT02151968|Anesthetics|anesthetics|mesh-list
102060876|NCT02151968|Anesthetics, Local|anesthetics, local|mesh-list
102060877|NCT02151968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101942433|NCT03640156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942435|NCT01230723|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101942436|NCT01230723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101942437|NCT01230723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101307397|NCT02040350|Antidotes|antidotes|mesh-ancestor
102060878|NCT02151968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060879|NCT02151968|Sensory System Agents|sensory system agents|mesh-ancestor
102060880|NCT02151968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102060881|NCT02776670|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102060882|NCT02776670|Lubricant Eye Drops|lubricant eye drops|mesh-list
102060883|NCT02776670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102060884|NCT02255084|Menthol|menthol|mesh-list
102060885|NCT02255084|Antipruritics|antipruritics|mesh-ancestor
102060886|NCT02255084|Dermatologic Agents|dermatologic agents|mesh-ancestor
102060887|NCT02150330|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
102060888|NCT02150330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102060889|NCT02150330|Immunologic Factors|immunologic factors|mesh-ancestor
102060890|NCT02150330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060891|NCT02255162|Cytarabine|cytarabine|mesh-list
102060892|NCT02255162|Lenalidomide|lenalidomide|mesh-list
102060893|NCT02255162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102060894|NCT02255162|Antimetabolites|antimetabolites|mesh-ancestor
102060895|NCT02255162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060896|NCT02255162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102060897|NCT02255162|Antiviral Agents|antiviral agents|mesh-ancestor
102060898|NCT02255162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102060899|NCT02255162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102060900|NCT02255162|Immunologic Factors|immunologic factors|mesh-ancestor
102060901|NCT02255162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060902|NCT02255162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102060903|NCT02255162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102060904|NCT02255162|Growth Substances|growth substances|mesh-ancestor
102060905|NCT02255162|Growth Inhibitors|growth inhibitors|mesh-ancestor
102060907|NCT02152514|Morphine|morphine|mesh-list
102060908|NCT02152514|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102060909|NCT02152514|Narcotics|narcotics|mesh-ancestor
102060910|NCT02152514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102060911|NCT02152514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060912|NCT02152514|Analgesics|analgesics|mesh-ancestor
102060913|NCT02152514|Sensory System Agents|sensory system agents|mesh-ancestor
102060914|NCT02152514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102060915|NCT02152514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102060916|NCT02152514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102060917|NCT02152514|Anesthetics, General|anesthetics, general|mesh-ancestor
102060918|NCT02152514|Anesthetics|anesthetics|mesh-ancestor
102060919|NCT02261090|Pramipexole|pramipexole|mesh-list
102060920|NCT02261090|Antioxidants|antioxidants|mesh-ancestor
102060921|NCT02261090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060922|NCT02261090|Protective Agents|protective agents|mesh-ancestor
101362463|NCT00074841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102060947|NCT01307423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102060948|NCT01307423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102060949|NCT01307423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102060950|NCT01307423|Growth Substances|growth substances|mesh-ancestor
102060951|NCT01307423|Growth Inhibitors|growth inhibitors|mesh-ancestor
102060952|NCT01307423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102060953|NCT03543254|Botulinum Toxins|botulinum toxins|mesh-list
102060954|NCT03543254|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102060955|NCT03543254|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102060956|NCT03543254|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102060957|NCT03543254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102060958|NCT03543254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060959|NCT03543254|Cholinergic Agents|cholinergic agents|mesh-ancestor
102060960|NCT03543254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102060961|NCT03543254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060962|NCT03543254|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102060963|NCT03543254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102060964|NCT02156336|Ranolazine|ranolazine|mesh-list
102060965|NCT02156336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102060966|NCT02156336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101942438|NCT01230723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942439|NCT01230723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101942440|NCT01230723|Immunologic Factors|immunologic factors|mesh-ancestor
101942441|NCT01230723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942442|NCT01230723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101942443|NCT05401071|Rifapentine|rifapentine|mesh-list
101942444|NCT05401071|Rifampin|rifampin|mesh-list
101942445|NCT05401071|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101942446|NCT05401071|Antitubercular Agents|antitubercular agents|mesh-ancestor
101942447|NCT05401071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101942448|NCT05401071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101942449|NCT05401071|Leprostatic Agents|leprostatic agents|mesh-ancestor
101942450|NCT05401071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101698687|NCT02757365|Analgesics|analgesics|mesh-ancestor
102060967|NCT02156336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060968|NCT03542240|Curcumin|curcumin|mesh-list
102060969|NCT03542240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102060970|NCT03542240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102060971|NCT03542240|Analgesics|analgesics|mesh-ancestor
101362533|NCT04731740|Pembrolizumab|pembrolizumab|mesh-list
102060982|NCT00911183|Rituximab|rituximab|mesh-list
102060983|NCT00911183|Doxorubicin|doxorubicin|mesh-list
102060984|NCT00911183|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102060985|NCT00911183|Vincristine|vincristine|mesh-list
102060986|NCT00911183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102060987|NCT00911183|Immunologic Factors|immunologic factors|mesh-ancestor
102060988|NCT00911183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060989|NCT00911183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102060990|NCT00911183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102060991|NCT00911183|Alkylating Agents|alkylating agents|mesh-ancestor
102060992|NCT00911183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060993|NCT00911183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102060994|NCT00911183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102060995|NCT00911183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102060996|NCT00911183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102060997|NCT00911183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102060998|NCT00911183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102060999|NCT00911183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102061000|NCT00911183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102061001|NCT00911183|Glucocorticoids|glucocorticoids|mesh-ancestor
102061002|NCT00911183|Hormones|hormones|mesh-ancestor
102061003|NCT00911183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102061004|NCT00911183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102061005|NCT00911183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102061006|NCT00911183|Tubulin Modulators|tubulin modulators|mesh-ancestor
102061007|NCT00911183|Antimitotic Agents|antimitotic agents|mesh-ancestor
102061008|NCT00911183|Mitosis Modulators|mitosis modulators|mesh-ancestor
102061009|NCT03631121|Insulin Glargine|insulin glargine|mesh-list
102061010|NCT03631121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102061011|NCT03631121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061012|NCT02768792|Pembrolizumab|pembrolizumab|mesh-list
102061013|NCT02768792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102061014|NCT02768792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102061015|NCT02768792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102061016|NCT02768792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061017|NCT05420441|Chitosan|chitosan|mesh-list
102061018|NCT05420441|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102061019|NCT05420441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102061020|NCT05420441|Antimetabolites|antimetabolites|mesh-ancestor
102061021|NCT05420441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061022|NCT05420441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102061023|NCT05420441|Chelating Agents|chelating agents|mesh-ancestor
101942451|NCT05401071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101942452|NCT05401071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942453|NCT05401071|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102061024|NCT05420441|Sequestering Agents|sequestering agents|mesh-ancestor
102061025|NCT05420441|Hemostatics|hemostatics|mesh-ancestor
102061026|NCT05420441|Coagulants|coagulants|mesh-ancestor
102061027|NCT05598593|Cytarabine|cytarabine|mesh-list
102061028|NCT05598593|Fludarabine|fludarabine|mesh-list
102061029|NCT05598593|Busulfan|busulfan|mesh-list
102061030|NCT05598593|Thiotepa|thiotepa|mesh-list
102061031|NCT05598593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102061032|NCT05598593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102061033|NCT05598593|Antimetabolites|antimetabolites|mesh-ancestor
102061034|NCT05598593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061035|NCT05598593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102061036|NCT05598593|Immunologic Factors|immunologic factors|mesh-ancestor
102061044|NCT05337449|Cariostatic Agents|cariostatic agents|mesh-ancestor
102061045|NCT05337449|Protective Agents|protective agents|mesh-ancestor
102061046|NCT05337449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061047|NCT02150720|Tranexamic Acid|tranexamic acid|mesh-list
102061048|NCT02150720|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102061049|NCT02150720|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102061050|NCT02150720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101698698|NCT02757365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102061051|NCT02150720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061052|NCT02150720|Hemostatics|hemostatics|mesh-ancestor
102061053|NCT02150720|Coagulants|coagulants|mesh-ancestor
102061054|NCT02153060|Dexamethasone|dexamethasone|mesh-list
102061055|NCT02153060|Dexamethasone acetate|dexamethasone acetate|mesh-list
102061056|NCT02153060|BB 1101|bb 1101|mesh-list
102061057|NCT02153060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102061058|NCT02153060|Antiemetics|antiemetics|mesh-ancestor
102061059|NCT02153060|Autonomic Agents|autonomic agents|mesh-ancestor
102061060|NCT02153060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102061061|NCT02153060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061062|NCT02153060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102061063|NCT02153060|Glucocorticoids|glucocorticoids|mesh-ancestor
102061064|NCT02153060|Hormones|hormones|mesh-ancestor
102061065|NCT02153060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102061066|NCT02153060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102061067|NCT02153060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102061068|NCT02153060|Protease Inhibitors|protease inhibitors|mesh-ancestor
102061069|NCT02153060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102061070|NCT02153060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061071|NCT02156570|Ribavirin|ribavirin|mesh-list
102061072|NCT02156570|Sofosbuvir|sofosbuvir|mesh-list
102061073|NCT02156570|Antimetabolites|antimetabolites|mesh-ancestor
102061074|NCT02156570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061075|NCT02156570|Antiviral Agents|antiviral agents|mesh-ancestor
102061076|NCT02156570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102061077|NCT03087851|Zoledronic Acid|zoledronic acid|mesh-list
102061078|NCT03087851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102061079|NCT03087851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061080|NCT02156726|Cyclophosphamide|cyclophosphamide|mesh-list
102061081|NCT02156726|Fludarabine|fludarabine|mesh-list
102061082|NCT02156726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102061083|NCT02156726|Immunologic Factors|immunologic factors|mesh-ancestor
102061084|NCT02156726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061085|NCT02156726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102061086|NCT02156726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102061087|NCT02156726|Alkylating Agents|alkylating agents|mesh-ancestor
102061088|NCT02156726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061089|NCT02156726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102061090|NCT02156726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102061091|NCT02153450|Metformin|metformin|mesh-list
102061092|NCT02153450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102061093|NCT02153450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061094|NCT05598281|Sotorasib|sotorasib|mesh-list
102061095|NCT05598281|Digoxin|digoxin|mesh-list
102061096|NCT05598281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102061097|NCT05598281|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102061098|NCT05598281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102061099|NCT05598281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061100|NCT05598281|Protective Agents|protective agents|mesh-ancestor
101942454|NCT05401071|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101942455|NCT05401071|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101942456|NCT05401071|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101942457|NCT05401071|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102061101|NCT05598281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061102|NCT05598281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102061103|NCT05598281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102061104|NCT05598281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102061105|NCT03092375|Ribavirin|ribavirin|mesh-list
102061109|NCT03092375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102061111|NCT01995513|Prednisolone|prednisolone|mesh-list
102061112|NCT01995513|Abiraterone Acetate|abiraterone acetate|mesh-list
102061113|NCT01995513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102061114|NCT01995513|Glucocorticoids|glucocorticoids|mesh-ancestor
102061115|NCT01995513|Hormones|hormones|mesh-ancestor
102061116|NCT01995513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102061117|NCT01995513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061118|NCT01995513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102061119|NCT01995513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102061120|NCT01995513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102061121|NCT01995513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102061122|NCT01995513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061123|NCT01995513|Hormone Antagonists|hormone antagonists|mesh-ancestor
102061124|NCT01995513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102061125|NCT03180359|Vaccines|vaccines|mesh-list
102061126|NCT03180359|Immunologic Factors|immunologic factors|mesh-ancestor
102061127|NCT03180359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061128|NCT01304511|Ganirelix|ganirelix|mesh-list
102061129|NCT01304511|Hormone Antagonists|hormone antagonists|mesh-ancestor
102061130|NCT01304511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102061131|NCT01304511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061132|NCT04808973|Lamivudine|lamivudine|mesh-list
102061133|NCT04808973|Dolutegravir|dolutegravir|mesh-list
102061134|NCT04808973|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102061135|NCT04808973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102061136|NCT04808973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102061137|NCT04808973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061138|NCT04808973|Antiviral Agents|antiviral agents|mesh-ancestor
102061139|NCT04808973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102061140|NCT04808973|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102061141|NCT04808973|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102061142|NCT04808973|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102061143|NCT04808973|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102061144|NCT00103610|Plerixafor|plerixafor|mesh-list
102061145|NCT00103610|Lenograstim|lenograstim|mesh-list
102061146|NCT00103610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102061147|NCT00103610|Immunologic Factors|immunologic factors|mesh-ancestor
102061148|NCT00103610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061149|NCT00103610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102061150|NCT00103610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102061151|NCT00103610|Antiviral Agents|antiviral agents|mesh-ancestor
102061152|NCT00103610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102061153|NCT04871321|Paclitaxel|paclitaxel|mesh-list
102061154|NCT04871321|Gemcitabine|gemcitabine|mesh-list
102061155|NCT04871321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102061156|NCT04871321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102061157|NCT04871321|Tubulin Modulators|tubulin modulators|mesh-ancestor
102061158|NCT04871321|Antimitotic Agents|antimitotic agents|mesh-ancestor
102061159|NCT04871321|Mitosis Modulators|mitosis modulators|mesh-ancestor
102061160|NCT04871321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061161|NCT04871321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102061162|NCT04871321|Antimetabolites|antimetabolites|mesh-ancestor
102061163|NCT02156960|Denosumab|denosumab|mesh-list
102061164|NCT02156960|Teriparatide|teriparatide|mesh-list
102061165|NCT02156960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102061166|NCT02156960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061167|NCT02156960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102061168|NCT02153606|Glycerol|glycerol|mesh-list
102061169|NCT02153606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102061170|NCT02153606|Protective Agents|protective agents|mesh-ancestor
101942458|NCT05401071|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101942459|NCT01135953|Cycloserine|cycloserine|mesh-list
102061171|NCT02153606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061172|NCT02153762|Hydrocortisone|hydrocortisone|mesh-list
102061173|NCT02153762|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102061174|NCT02153762|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102061175|NCT02153762|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102061176|NCT02153762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102061177|NCT04687631|Bevacizumab|bevacizumab|mesh-list
102061184|NCT04687631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061185|NCT04687631|Growth Inhibitors|growth inhibitors|mesh-ancestor
102061186|NCT04833023|Olanzapine|olanzapine|mesh-list
102061187|NCT04833023|Antiemetics|antiemetics|mesh-ancestor
102061188|NCT04833023|Autonomic Agents|autonomic agents|mesh-ancestor
102061189|NCT04833023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102061190|NCT04833023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061191|NCT04833023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102061192|NCT04833023|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102061193|NCT04833023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102061194|NCT04833023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102061195|NCT04833023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102061196|NCT04833023|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102061197|NCT04833023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102061198|NCT04833023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102061199|NCT04833023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061200|NCT04833023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102061201|NCT04833023|Serotonin Agents|serotonin agents|mesh-ancestor
102061202|NCT03091439|Dalbavancin|dalbavancin|mesh-list
102061203|NCT03091439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102061204|NCT03091439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102061205|NCT03631823|Temozolomide|temozolomide|mesh-list
102061206|NCT03631823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102061207|NCT03631823|Alkylating Agents|alkylating agents|mesh-ancestor
102061208|NCT03631823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061209|NCT03631823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102061210|NCT02157272|Rivaroxaban|rivaroxaban|mesh-list
102061211|NCT02157272|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102061212|NCT02157272|Antithrombins|antithrombins|mesh-ancestor
102061213|NCT02157272|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102061214|NCT02157272|Protease Inhibitors|protease inhibitors|mesh-ancestor
102061215|NCT02157272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102061216|NCT02157272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061217|NCT02157272|Anticoagulants|anticoagulants|mesh-ancestor
102061218|NCT02154074|Dexmedetomidine|dexmedetomidine|mesh-list
102061219|NCT02154074|Isoflurane|isoflurane|mesh-list
102061220|NCT02154074|Anesthetics|anesthetics|mesh-ancestor
102061221|NCT02154074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102061222|NCT02154074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061223|NCT02154074|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102061224|NCT02154074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102061225|NCT02154074|Analgesics|analgesics|mesh-ancestor
102061226|NCT02154074|Sensory System Agents|sensory system agents|mesh-ancestor
102061227|NCT02154074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102061228|NCT02154074|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102061229|NCT02154074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102061230|NCT02154074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102061231|NCT02154074|Adrenergic Agents|adrenergic agents|mesh-ancestor
102061232|NCT02154074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102061233|NCT02154074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061234|NCT02154074|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102061235|NCT02154074|Anesthetics, General|anesthetics, general|mesh-ancestor
102061236|NCT05460455|Antibodies|antibodies|mesh-list
102061237|NCT05460455|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102061238|NCT05460455|Immunologic Factors|immunologic factors|mesh-ancestor
102061239|NCT05460455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061240|NCT03104413|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102061241|NCT03104413|Immunologic Factors|immunologic factors|mesh-ancestor
102061242|NCT03104413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061243|NCT01382147|Daunorubicin|daunorubicin|mesh-list
102061244|NCT01382147|Mitoxantrone|mitoxantrone|mesh-list
102061245|NCT01382147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101362793|NCT00045500|Prednisone|prednisone|mesh-list
102061266|NCT04429685|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101942460|NCT01135953|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101942461|NCT01135953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101434858|NCT00549289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102061267|NCT04429685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102061268|NCT04429685|Anesthetics, General|anesthetics, general|mesh-ancestor
102061269|NCT04429685|Anesthetics|anesthetics|mesh-ancestor
102061270|NCT04429685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101698721|NCT02757443|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102061271|NCT04429685|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102061273|NCT04429685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102061274|NCT04429685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061275|NCT01384279|Metformin|metformin|mesh-list
102061276|NCT01384279|Topiramate|topiramate|mesh-list
102061277|NCT01384279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102061278|NCT01384279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061279|NCT01384279|Anticonvulsants|anticonvulsants|mesh-ancestor
102061280|NCT01381601|Bevacizumab|bevacizumab|mesh-list
102061281|NCT01381601|Sunitinib|sunitinib|mesh-list
102061282|NCT01381601|Sorafenib|sorafenib|mesh-list
102061283|NCT01381601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102061284|NCT01381601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102061285|NCT01381601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102061286|NCT01381601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102061287|NCT01381601|Growth Substances|growth substances|mesh-ancestor
102061288|NCT01381601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061289|NCT01381601|Growth Inhibitors|growth inhibitors|mesh-ancestor
102061290|NCT01381601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102061291|NCT01381601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102061292|NCT01381601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061293|NCT02823353|Fenofibrate|fenofibrate|mesh-list
102061294|NCT02823353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102061295|NCT02823353|Antimetabolites|antimetabolites|mesh-ancestor
102061296|NCT02823353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061297|NCT02823353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102061298|NCT04509193|Warfarin|warfarin|mesh-list
102061299|NCT04509193|Rivaroxaban|rivaroxaban|mesh-list
102061300|NCT04509193|Anticoagulants|anticoagulants|mesh-ancestor
102061301|NCT04509193|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102061316|NCT02697383|Hormones|hormones|mesh-ancestor
102061317|NCT02697383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102061318|NCT02697383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102061319|NCT02697383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102061320|NCT02697383|Protease Inhibitors|protease inhibitors|mesh-ancestor
102061321|NCT02697383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102061322|NCT02697383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061323|NCT04173949|Ramipril|ramipril|mesh-list
102061324|NCT04173949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102061325|NCT04173949|Protease Inhibitors|protease inhibitors|mesh-ancestor
102061326|NCT04173949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102061327|NCT04173949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061328|NCT04173949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102061329|NCT05422001|Ketamine|ketamine|mesh-list
102061330|NCT05422001|Analgesics|analgesics|mesh-ancestor
102061331|NCT05422001|Sensory System Agents|sensory system agents|mesh-ancestor
102061332|NCT05422001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102061333|NCT05422001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061334|NCT05422001|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102061335|NCT05422001|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102061336|NCT05422001|Anesthetics, General|anesthetics, general|mesh-ancestor
102061337|NCT05422001|Anesthetics|anesthetics|mesh-ancestor
102061338|NCT05422001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102061339|NCT05422001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102061340|NCT05422001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102061341|NCT05422001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102061342|NCT05422001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061343|NCT01382017|Lacosamide|lacosamide|mesh-list
102061344|NCT01382017|Carbamazepine|carbamazepine|mesh-list
102061345|NCT01382017|Anticonvulsants|anticonvulsants|mesh-ancestor
101781043|NCT01067677|Diphenhydramine|diphenhydramine|mesh-list
102061346|NCT01382017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102061347|NCT01382017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102061348|NCT01382017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101356163|NCT00060684|Glucocorticoids|glucocorticoids|mesh-ancestor
101942462|NCT01135953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101942463|NCT01135953|Antitubercular Agents|antitubercular agents|mesh-ancestor
101942464|NCT01135953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101942466|NCT01135953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942467|NCT01136031|Paclitaxel|paclitaxel|mesh-list
102061349|NCT01382017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061350|NCT01382017|Antimanic Agents|antimanic agents|mesh-ancestor
102061351|NCT01382017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102061352|NCT01382017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102061353|NCT01382017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061354|NCT01382017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102061355|NCT01382017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102061356|NCT01382017|Analgesics|analgesics|mesh-ancestor
102061357|NCT01382017|Sensory System Agents|sensory system agents|mesh-ancestor
102061358|NCT01382017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102061359|NCT01382017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101362917|NCT00045773|Serotonin Agents|serotonin agents|mesh-ancestor
102061368|NCT01381523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061369|NCT01381523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102061370|NCT01381523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102061371|NCT01381523|Gout Suppressants|gout suppressants|mesh-ancestor
102061372|NCT01381523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102061373|NCT01381523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102061374|NCT01381523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061375|NCT01381523|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102061376|NCT01381523|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102061377|NCT01381523|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102061378|NCT01381523|Serotonin Agents|serotonin agents|mesh-ancestor
102061379|NCT01381523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102061380|NCT04233047|Fostemsavir|fostemsavir|mesh-list
102061381|NCT04233047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102061382|NCT04233047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102061383|NCT04233047|Antiviral Agents|antiviral agents|mesh-ancestor
102061384|NCT04233047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102061385|NCT04233047|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102061386|NCT04233047|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102061387|NCT04233047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061388|NCT01381445|Clobetasol|clobetasol|mesh-list
102061389|NCT01381445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102061390|NCT01381445|Glucocorticoids|glucocorticoids|mesh-ancestor
102061391|NCT01381445|Hormones|hormones|mesh-ancestor
102061392|NCT01381445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102061393|NCT01381445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061394|NCT03083639|Esomeprazole|esomeprazole|mesh-list
102061395|NCT03083639|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102061396|NCT03083639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102061397|NCT03083639|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102061398|NCT03083639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102061399|NCT03083639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061400|NCT02927431|Oseltamivir|oseltamivir|mesh-list
102061401|NCT02927431|Antiviral Agents|antiviral agents|mesh-ancestor
102061402|NCT02927431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102061403|NCT02927431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102061404|NCT02927431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061405|NCT05027893|Moxifloxacin|moxifloxacin|mesh-list
102061406|NCT05027893|Cefixime|cefixime|mesh-list
102061407|NCT05027893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102061408|NCT05027893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102061409|NCT05027893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102061410|NCT05027893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102061411|NCT05027893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102061412|NCT05027893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061413|NCT05027893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102061414|NCT04113083|Dehydrocholesterols|dehydrocholesterols|mesh-list
102061415|NCT04113083|Provitamins|provitamins|mesh-ancestor
102061416|NCT04113083|Vitamins|vitamins|mesh-ancestor
102061417|NCT04113083|Micronutrients|micronutrients|mesh-ancestor
101942469|NCT01136031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101942470|NCT01136031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101942471|NCT01136031|Tubulin Modulators|tubulin modulators|mesh-ancestor
102061418|NCT04113083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061419|NCT01381367|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102061421|NCT01381367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061422|NCT04989361|Hyaluronic Acid|hyaluronic acid|mesh-list
102061423|NCT04989361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102061424|NCT04989361|Immunologic Factors|immunologic factors|mesh-ancestor
102061425|NCT04989361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061426|NCT04989361|Viscosupplements|viscosupplements|mesh-ancestor
102061427|NCT04989361|Protective Agents|protective agents|mesh-ancestor
102061432|NCT04899193|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102061433|NCT04899193|Hormones|hormones|mesh-ancestor
102061434|NCT04899193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102061435|NCT04899193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061436|NCT01381705|Rituximab|rituximab|mesh-list
102061437|NCT01381705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102061438|NCT01381705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102061439|NCT01381705|Immunologic Factors|immunologic factors|mesh-ancestor
102061440|NCT01381705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061441|NCT01381705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102061442|NCT04401709|Gemcitabine|gemcitabine|mesh-list
102061443|NCT04401709|Capecitabine|capecitabine|mesh-list
102061444|NCT04401709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102061445|NCT04401709|Antimetabolites|antimetabolites|mesh-ancestor
102061446|NCT04401709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061447|NCT04401709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102061448|NCT04497987|Bamlanivimab|bamlanivimab|mesh-list
102061449|NCT04497987|Antiviral Agents|antiviral agents|mesh-ancestor
102061450|NCT04497987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102061451|NCT01381627|Dexmedetomidine|dexmedetomidine|mesh-list
102061452|NCT01381627|Remifentanil|remifentanil|mesh-list
102061453|NCT01381627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102061454|NCT01381627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102061455|NCT01381627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061456|NCT01381627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102061457|NCT01381627|Analgesics|analgesics|mesh-ancestor
102061458|NCT01381627|Sensory System Agents|sensory system agents|mesh-ancestor
102061459|NCT01381627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102061460|NCT01381627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102061461|NCT01381627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102061462|NCT01381627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102061463|NCT01381627|Adrenergic Agents|adrenergic agents|mesh-ancestor
102061464|NCT01381627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102061465|NCT01381627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061466|NCT01381627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102061467|NCT01381627|Narcotics|narcotics|mesh-ancestor
102061468|NCT00974571|Cetirizine|cetirizine|mesh-list
102061469|NCT00974571|Montelukast|montelukast|mesh-list
102061470|NCT00974571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101698748|NCT02536742|Palbociclib|palbociclib|mesh-list
102061471|NCT00974571|Respiratory System Agents|respiratory system agents|mesh-ancestor
102061472|NCT00974571|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102061473|NCT00974571|Hormone Antagonists|hormone antagonists|mesh-ancestor
102061474|NCT00974571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102061475|NCT00974571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061476|NCT00974571|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102061477|NCT00974571|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102061478|NCT00974571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061479|NCT00974571|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102061480|NCT00974571|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102061481|NCT00974571|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102061482|NCT00974571|Histamine Antagonists|histamine antagonists|mesh-ancestor
102061483|NCT00974571|Histamine Agents|histamine agents|mesh-ancestor
102061484|NCT00974571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102061485|NCT02766608|Budesonide|budesonide|mesh-list
102061486|NCT02766608|Formoterol Fumarate|formoterol fumarate|mesh-list
102061487|NCT02766608|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
102061488|NCT02766608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101942472|NCT01136031|Antimitotic Agents|antimitotic agents|mesh-ancestor
101942473|NCT01136031|Mitosis Modulators|mitosis modulators|mesh-ancestor
101942474|NCT01136031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061489|NCT02766608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102061490|NCT02766608|Autonomic Agents|autonomic agents|mesh-ancestor
102061491|NCT02766608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102061492|NCT02766608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061493|NCT02766608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102061494|NCT02766608|Respiratory System Agents|respiratory system agents|mesh-ancestor
102061495|NCT02766608|Glucocorticoids|glucocorticoids|mesh-ancestor
102061496|NCT02766608|Hormones|hormones|mesh-ancestor
102061513|NCT05082285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061514|NCT03317119|Trifluridine|trifluridine|mesh-list
102061515|NCT03317119|Trametinib|trametinib|mesh-list
102061516|NCT03317119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102061517|NCT03317119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102061518|NCT03317119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102061519|NCT03317119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061520|NCT03317119|Antimetabolites|antimetabolites|mesh-ancestor
102061521|NCT03317119|Antiviral Agents|antiviral agents|mesh-ancestor
102061522|NCT03317119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102061523|NCT04356495|Ciclesonide|ciclesonide|mesh-list
102061524|NCT04356495|Interferons|interferons|mesh-list
102061525|NCT04356495|Interferon-beta|interferon-beta|mesh-list
102061526|NCT04356495|Telmisartan|telmisartan|mesh-list
102061527|NCT04356495|Interferon beta-1b|interferon beta-1b|mesh-list
102061528|NCT04356495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061529|NCT04356495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102061530|NCT04356495|Antiviral Agents|antiviral agents|mesh-ancestor
102061531|NCT04356495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102061532|NCT04356495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102061533|NCT04356495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102061534|NCT04356495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102061535|NCT04356495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061536|NCT04356495|Glucocorticoids|glucocorticoids|mesh-ancestor
102061537|NCT04356495|Hormones|hormones|mesh-ancestor
102061538|NCT04356495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102061539|NCT04356495|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102061540|NCT04356495|Immunologic Factors|immunologic factors|mesh-ancestor
102061541|NCT04356495|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102061542|NCT05345249|Ropivacaine|ropivacaine|mesh-list
102061543|NCT05345249|Anesthetics, Local|anesthetics, local|mesh-ancestor
102061544|NCT05345249|Anesthetics|anesthetics|mesh-ancestor
102061545|NCT05345249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102061546|NCT05345249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061547|NCT05345249|Sensory System Agents|sensory system agents|mesh-ancestor
101514353|NCT01272193|Insulin|insulin|mesh-list
102061548|NCT05345249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102061549|NCT02154230|Calcium|calcium|mesh-list
102061550|NCT02154230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102061551|NCT02154230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061552|NCT04200963|Nivolumab|nivolumab|mesh-list
102061553|NCT04200963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102061554|NCT04200963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102061555|NCT04200963|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102061561|NCT02157428|GABA Modulators|gaba modulators|mesh-ancestor
102061562|NCT02157428|GABA Agents|gaba agents|mesh-ancestor
102061563|NCT02157428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102061564|NCT02157428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061565|NCT00960141|Loratadine|loratadine|mesh-list
102061566|NCT00960141|Montelukast|montelukast|mesh-list
102061567|NCT00960141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102061568|NCT00960141|Respiratory System Agents|respiratory system agents|mesh-ancestor
102061569|NCT00960141|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102061570|NCT00960141|Hormone Antagonists|hormone antagonists|mesh-ancestor
102061571|NCT00960141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102061572|NCT00960141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061573|NCT00960141|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102061574|NCT00960141|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102061575|NCT00960141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061576|NCT00960141|Antipruritics|antipruritics|mesh-ancestor
102061577|NCT00960141|Dermatologic Agents|dermatologic agents|mesh-ancestor
101942475|NCT01136031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101942476|NCT01136031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101942477|NCT01136031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101942478|NCT05400915|Paclitaxel|paclitaxel|mesh-list
101942479|NCT05400915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102061578|NCT00960141|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102061579|NCT00960141|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102061580|NCT00960141|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102061581|NCT00960141|Histamine Antagonists|histamine antagonists|mesh-ancestor
102061582|NCT00960141|Histamine Agents|histamine agents|mesh-ancestor
102061583|NCT00960141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102061584|NCT00759655|Factor VIII|factor viii|mesh-list
102061585|NCT00759655|Coagulants|coagulants|mesh-ancestor
102061586|NCT03918915|Atropine|atropine|mesh-list
102061587|NCT03918915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102061588|NCT03918915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102061589|NCT03918915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102061590|NCT03918915|Autonomic Agents|autonomic agents|mesh-ancestor
102061591|NCT03918915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102061592|NCT03918915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061593|NCT03918915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102061594|NCT03918915|Respiratory System Agents|respiratory system agents|mesh-ancestor
102061595|NCT03918915|Mydriatics|mydriatics|mesh-ancestor
102061596|NCT03918915|Parasympatholytics|parasympatholytics|mesh-ancestor
102061597|NCT03918915|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102061598|NCT03918915|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102061599|NCT03918915|Cholinergic Agents|cholinergic agents|mesh-ancestor
102061600|NCT03918915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102061601|NCT03918915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061602|NCT02255006|Glyburide|glyburide|mesh-list
102061603|NCT02255006|Celecoxib|celecoxib|mesh-list
102061604|NCT02255006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102061605|NCT02255006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102061606|NCT02255006|Analgesics|analgesics|mesh-ancestor
102061607|NCT02255006|Sensory System Agents|sensory system agents|mesh-ancestor
102061608|NCT02255006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102061609|NCT02255006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061610|NCT02255006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102061611|NCT02255006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101698773|NCT02756663|Antiemetics|antiemetics|mesh-ancestor
102061612|NCT02255006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102061613|NCT02255006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102061614|NCT02255006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102061615|NCT02255006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061616|NCT02255006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102061617|NCT03396471|Pembrolizumab|pembrolizumab|mesh-list
102061618|NCT03396471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102061619|NCT03396471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102061620|NCT03396471|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102061621|NCT03396471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061622|NCT00103142|Sargramostim|sargramostim|mesh-list
102061623|NCT00103142|Immunologic Factors|immunologic factors|mesh-ancestor
102061624|NCT00103142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061631|NCT00943683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061632|NCT00943683|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102061633|NCT00943683|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102061634|NCT00943683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061635|NCT03542006|Brinzolamide|brinzolamide|mesh-list
102061636|NCT03542006|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102061637|NCT03542006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102061638|NCT03542006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061639|NCT02154464|Acetaminophen|acetaminophen|mesh-list
102061640|NCT02154464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102061641|NCT02154464|Analgesics|analgesics|mesh-ancestor
102061642|NCT02154464|Sensory System Agents|sensory system agents|mesh-ancestor
102061643|NCT02154464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102061644|NCT02154464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061645|NCT02154464|Antipyretics|antipyretics|mesh-ancestor
102061646|NCT00911547|Beclomethasone|beclomethasone|mesh-list
102061647|NCT00911547|Montelukast|montelukast|mesh-list
101942480|NCT05400915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101942481|NCT05400915|Tubulin Modulators|tubulin modulators|mesh-ancestor
101942482|NCT05400915|Antimitotic Agents|antimitotic agents|mesh-ancestor
102061648|NCT00911547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102061649|NCT00911547|Respiratory System Agents|respiratory system agents|mesh-ancestor
102061650|NCT00911547|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102061651|NCT00911547|Hormone Antagonists|hormone antagonists|mesh-ancestor
102061652|NCT00911547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102061653|NCT00911547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061654|NCT00911547|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102061655|NCT00911547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102061656|NCT00911547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061657|NCT00911547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102061658|NCT00911547|Glucocorticoids|glucocorticoids|mesh-ancestor
102061659|NCT00911547|Hormones|hormones|mesh-ancestor
102061660|NCT02159690|Prednisone|prednisone|mesh-list
102061661|NCT02159690|Abiraterone Acetate|abiraterone acetate|mesh-list
102061662|NCT02159690|Dutasteride|dutasteride|mesh-list
102061663|NCT02159690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102061664|NCT02159690|Glucocorticoids|glucocorticoids|mesh-ancestor
102061665|NCT02159690|Hormones|hormones|mesh-ancestor
102061666|NCT02159690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102061667|NCT02159690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061668|NCT02159690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102061669|NCT02159690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102061670|NCT02159690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102061671|NCT02159690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102061672|NCT02159690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061673|NCT02159690|Hormone Antagonists|hormone antagonists|mesh-ancestor
102061674|NCT02159690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102061675|NCT02159690|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102061676|NCT02157818|Midazolam|midazolam|mesh-list
102061677|NCT02157818|Dexmedetomidine|dexmedetomidine|mesh-list
102061678|NCT02157818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102061679|NCT02157818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102061680|NCT02157818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061681|NCT02157818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102061682|NCT02157818|Analgesics|analgesics|mesh-ancestor
102061683|NCT02157818|Sensory System Agents|sensory system agents|mesh-ancestor
102061684|NCT02157818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102061685|NCT02157818|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102061686|NCT02157818|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102061687|NCT02157818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102061688|NCT02157818|Adrenergic Agents|adrenergic agents|mesh-ancestor
102061689|NCT02157818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102061690|NCT02157818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061711|NCT04326439|Gemtuzumab|gemtuzumab|mesh-list
102061712|NCT04326439|Calicheamicins|calicheamicins|mesh-list
102061713|NCT04326439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102061714|NCT04326439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102061715|NCT04326439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102061716|NCT04326439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102061717|NCT04326439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102061718|NCT04326439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061719|NCT04326439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102061720|NCT04326439|Antimetabolites|antimetabolites|mesh-ancestor
102061721|NCT04326439|Antiviral Agents|antiviral agents|mesh-ancestor
102061722|NCT04326439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102061723|NCT04326439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102061724|NCT04326439|Immunologic Factors|immunologic factors|mesh-ancestor
102061725|NCT04326439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061726|NCT04326439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102061727|NCT04326439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102061728|NCT04326439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102061729|NCT04326439|Immunotoxins|immunotoxins|mesh-ancestor
102061730|NCT04326439|Immunoconjugates|immunoconjugates|mesh-ancestor
102061731|NCT03541928|Valacyclovir|valacyclovir|mesh-list
102061732|NCT03541928|Leuprolide|leuprolide|mesh-list
102061733|NCT03541928|Bicalutamide|bicalutamide|mesh-list
102061734|NCT03541928|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102061735|NCT03541928|Fertility Agents|fertility agents|mesh-ancestor
101942484|NCT05400915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942485|NCT01137903|Amoxicillin|amoxicillin|mesh-list
101942486|NCT01137903|Ciprofloxacin|ciprofloxacin|mesh-list
101942487|NCT01137903|Clavulanic Acid|clavulanic acid|mesh-list
101942488|NCT01137903|Clavulanic Acids|clavulanic acids|mesh-list
101942489|NCT01137903|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101942490|NCT01137903|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101942491|NCT01137903|Trimethoprim|trimethoprim|mesh-list
101942492|NCT01137903|Sulfamethoxazole|sulfamethoxazole|mesh-list
101942493|NCT01137903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101942494|NCT01137903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101942495|NCT01137903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101942496|NCT01137903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101942497|NCT01137903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101942498|NCT01137903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942499|NCT01137903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101942500|NCT01137903|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101942501|NCT01137903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101942502|NCT01137903|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101942503|NCT01137903|Antimalarials|antimalarials|mesh-ancestor
101942504|NCT01137903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102061736|NCT03541928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102061737|NCT03541928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061738|NCT03541928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102061739|NCT03541928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102061740|NCT03541928|Androgen Antagonists|androgen antagonists|mesh-ancestor
102061741|NCT03541928|Hormone Antagonists|hormone antagonists|mesh-ancestor
101698791|NCT02654678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061742|NCT03541928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102061743|NCT03541928|Antiviral Agents|antiviral agents|mesh-ancestor
102061744|NCT03541928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102061745|NCT00145795|Ritonavir|ritonavir|mesh-list
102061746|NCT00145795|Lopinavir|lopinavir|mesh-list
102061747|NCT00145795|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102061748|NCT00145795|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102061749|NCT00145795|Protease Inhibitors|protease inhibitors|mesh-ancestor
102061758|NCT02771210|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102061759|NCT02771210|Immunologic Factors|immunologic factors|mesh-ancestor
102061760|NCT02771210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061761|NCT00898677|Sumatriptan|sumatriptan|mesh-list
102061762|NCT00898677|Rizatriptan|rizatriptan|mesh-list
102061763|NCT00898677|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102061764|NCT00898677|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102061765|NCT00898677|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102061766|NCT00898677|Serotonin Agents|serotonin agents|mesh-ancestor
102061767|NCT00898677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102061768|NCT00898677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061769|NCT00898677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061770|NCT01381393|Ibandronic Acid|ibandronic acid|mesh-list
102061771|NCT01381393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101942505|NCT01137903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101942506|NCT01137903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101942507|NCT01137903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101942508|NCT01137903|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101942509|NCT01137903|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101942510|NCT03739671|Vitamin D|vitamin d|mesh-list
101942511|NCT03739671|Ergocalciferols|ergocalciferols|mesh-list
101942512|NCT03739671|Cholecalciferol|cholecalciferol|mesh-list
101942513|NCT03739671|Vitamins|vitamins|mesh-list
102061772|NCT01381393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061773|NCT02154776|Letrozole|letrozole|mesh-list
102061774|NCT02154776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102061775|NCT02154776|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102061776|NCT02154776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102061777|NCT02154776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102061778|NCT02154776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061779|NCT02154776|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102061780|NCT02154776|Hormone Antagonists|hormone antagonists|mesh-ancestor
102061781|NCT02154776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102061782|NCT02154776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061783|NCT04967157|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
102061784|NCT04967157|Nootropic Agents|nootropic agents|mesh-ancestor
102061785|NCT03388749|Annamycin|annamycin|mesh-list
102061786|NCT03388749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102061787|NCT03388749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102061788|NCT02770820|Aldesleukin|aldesleukin|mesh-list
102061789|NCT02770820|Interleukin-2|interleukin-2|mesh-list
102061790|NCT02770820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102061791|NCT02770820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102061792|NCT02770820|Analgesics|analgesics|mesh-ancestor
102061794|NCT02770820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102061795|NCT02770820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061796|NCT02770820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102061797|NCT02770820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102061798|NCT02770820|Antiviral Agents|antiviral agents|mesh-ancestor
102061799|NCT02770820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102061800|NCT02154854|Tacrolimus|tacrolimus|mesh-list
102061801|NCT02154854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102061802|NCT02154854|Immunologic Factors|immunologic factors|mesh-ancestor
102061803|NCT02154854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061804|NCT02154854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102061805|NCT02154854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102061806|NCT02154854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061807|NCT02160080|Interferons|interferons|mesh-list
102061808|NCT02160080|Ribavirin|ribavirin|mesh-list
102061809|NCT02160080|Interferon-alpha|interferon-alpha|mesh-list
102061810|NCT02160080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102061811|NCT02160080|Antiviral Agents|antiviral agents|mesh-ancestor
102061812|NCT02160080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102061813|NCT02160080|Antimetabolites|antimetabolites|mesh-ancestor
102061814|NCT02160080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061815|NCT02160080|Immunologic Factors|immunologic factors|mesh-ancestor
102061816|NCT02160080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061820|NCT05422183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102061822|NCT05422183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061823|NCT02160158|Fesoterodine|fesoterodine|mesh-list
102061824|NCT02160158|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102061825|NCT02160158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102061826|NCT02160158|Cholinergic Agents|cholinergic agents|mesh-ancestor
102061827|NCT02160158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102061828|NCT02160158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061829|NCT02160158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061830|NCT02160158|Urological Agents|urological agents|mesh-ancestor
102061831|NCT02160236|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
102061832|NCT02160236|Tenoxicam|tenoxicam|mesh-list
102061833|NCT02160236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102061834|NCT02160236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102061835|NCT02160236|Analgesics|analgesics|mesh-ancestor
102061836|NCT02160236|Sensory System Agents|sensory system agents|mesh-ancestor
102061837|NCT02160236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102061838|NCT02160236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061839|NCT02160236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102061840|NCT02160236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102061841|NCT02160236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102061842|NCT02160236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102061843|NCT02160236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061844|NCT02154932|Misoprostol|misoprostol|mesh-list
102061845|NCT02154932|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102061846|NCT02154932|Abortifacient Agents|abortifacient agents|mesh-ancestor
102061847|NCT02154932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102061848|NCT02154932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061849|NCT02154932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102061850|NCT02154932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102061851|NCT02154932|Oxytocics|oxytocics|mesh-ancestor
102061852|NCT02158286|Acetaminophen|acetaminophen|mesh-list
102061853|NCT02158286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102061854|NCT02158286|Analgesics|analgesics|mesh-ancestor
102061855|NCT02158286|Sensory System Agents|sensory system agents|mesh-ancestor
101698815|NCT03912337|Erenumab|erenumab|mesh-list
102061856|NCT02158286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102061857|NCT02158286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061858|NCT02158286|Antipyretics|antipyretics|mesh-ancestor
102061859|NCT01377415|Bupivacaine|bupivacaine|mesh-list
102061860|NCT01377415|Anesthetics, Local|anesthetics, local|mesh-ancestor
102061861|NCT01377415|Anesthetics|anesthetics|mesh-ancestor
102061862|NCT01377415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102061863|NCT01377415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061864|NCT01377415|Sensory System Agents|sensory system agents|mesh-ancestor
102061865|NCT01377415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102061866|NCT02155088|Paclitaxel|paclitaxel|mesh-list
102061867|NCT02155088|Gemcitabine|gemcitabine|mesh-list
102061868|NCT02155088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102061869|NCT02155088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102061870|NCT02155088|Tubulin Modulators|tubulin modulators|mesh-ancestor
102061871|NCT02155088|Antimitotic Agents|antimitotic agents|mesh-ancestor
102061872|NCT02155088|Mitosis Modulators|mitosis modulators|mesh-ancestor
102061873|NCT02155088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061874|NCT02155088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102061875|NCT02155088|Antimetabolites|antimetabolites|mesh-ancestor
102061876|NCT02160548|Atropine|atropine|mesh-list
102061877|NCT02160548|Albuterol|albuterol|mesh-list
102061878|NCT02160548|Pralidoxime|pralidoxime|mesh-list
102061879|NCT02160548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102061880|NCT02160548|Autonomic Agents|autonomic agents|mesh-ancestor
102061881|NCT02160548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102061882|NCT02160548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061883|NCT02160548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102061884|NCT02160548|Respiratory System Agents|respiratory system agents|mesh-ancestor
102061885|NCT02160548|Tocolytic Agents|tocolytic agents|mesh-ancestor
102061886|NCT02160548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102061887|NCT02160548|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101363438|NCT00046748|Omalizumab|omalizumab|mesh-list
102061894|NCT02160548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102061895|NCT02160548|Mydriatics|mydriatics|mesh-ancestor
102061896|NCT02160548|Parasympatholytics|parasympatholytics|mesh-ancestor
102061897|NCT02160548|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102061898|NCT02160548|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102061899|NCT02160548|Cholinergic Agents|cholinergic agents|mesh-ancestor
102061900|NCT02160548|Antidotes|antidotes|mesh-ancestor
102061901|NCT02160548|Protective Agents|protective agents|mesh-ancestor
102061902|NCT02160548|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
102061903|NCT02160548|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
102061904|NCT02158598|Vitamin D|vitamin d|mesh-list
102061905|NCT02158598|Ergocalciferols|ergocalciferols|mesh-list
102061906|NCT02158598|Cholecalciferol|cholecalciferol|mesh-list
102061907|NCT02158598|Vitamins|vitamins|mesh-list
102061908|NCT02158598|Micronutrients|micronutrients|mesh-ancestor
102061909|NCT02158598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061910|NCT02158598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102061911|NCT02158598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102061912|NCT03082729|Apremilast|apremilast|mesh-list
102061913|NCT03082729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102061914|NCT03082729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102061915|NCT03082729|Analgesics|analgesics|mesh-ancestor
101942515|NCT03739671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942516|NCT03739671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101942517|NCT03739671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101942519|NCT01233453|Everolimus|everolimus|mesh-list
101942520|NCT01233453|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101942521|NCT01233453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101942522|NCT01233453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101942523|NCT01233453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942524|NCT01233453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101942525|NCT01233453|Immunologic Factors|immunologic factors|mesh-ancestor
101942526|NCT01233453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942527|NCT01233453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101942528|NCT01233453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101942529|NCT01133925|Sirolimus|sirolimus|mesh-list
101942530|NCT01133925|Paclitaxel|paclitaxel|mesh-list
101942531|NCT01133925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101942532|NCT01133925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101942533|NCT01133925|Tubulin Modulators|tubulin modulators|mesh-ancestor
101942534|NCT01133925|Antimitotic Agents|antimitotic agents|mesh-ancestor
101942535|NCT01133925|Mitosis Modulators|mitosis modulators|mesh-ancestor
101942536|NCT01133925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942537|NCT01133925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101942538|NCT01133925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101942539|NCT01133925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101942540|NCT01133925|Antifungal Agents|antifungal agents|mesh-ancestor
101942541|NCT01133925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101942542|NCT01133925|Immunologic Factors|immunologic factors|mesh-ancestor
101307479|NCT02040649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102061916|NCT03082729|Sensory System Agents|sensory system agents|mesh-ancestor
102061917|NCT03082729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102061918|NCT03082729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061919|NCT03082729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102061920|NCT03082729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102061921|NCT03082729|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102061922|NCT03082729|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102061923|NCT03082729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102061924|NCT03082729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061925|NCT02160704|Enclomiphene|enclomiphene|mesh-list
102061926|NCT02160704|Clomiphene|clomiphene|mesh-list
102061927|NCT02160704|Zuclomiphene|zuclomiphene|mesh-list
102061928|NCT02160704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102061929|NCT02160704|Hormone Antagonists|hormone antagonists|mesh-ancestor
102061930|NCT02160704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101942543|NCT01133925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942545|NCT01232439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942546|NCT01232439|Sensory System Agents|sensory system agents|mesh-ancestor
101942547|NCT01232439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101942548|NCT01232439|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101942549|NCT01138137|Acetylcysteine|acetylcysteine|mesh-list
101942550|NCT01138137|Paclitaxel|paclitaxel|mesh-list
101942551|NCT01138137|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102061931|NCT02160704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061932|NCT02160704|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102061933|NCT02160704|Fertility Agents|fertility agents|mesh-ancestor
102061934|NCT02160704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102061935|NCT02160704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102061936|NCT02160704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102061937|NCT03542552|Magnesium Sulfate|magnesium sulfate|mesh-list
102061938|NCT03542552|Nifedipine|nifedipine|mesh-list
102061939|NCT03542552|Analgesics|analgesics|mesh-ancestor
102061940|NCT03542552|Sensory System Agents|sensory system agents|mesh-ancestor
102061941|NCT03542552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102061942|NCT03542552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061943|NCT03542552|Anesthetics|anesthetics|mesh-ancestor
102061944|NCT03542552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102061945|NCT03542552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102061946|NCT03542552|Anticonvulsants|anticonvulsants|mesh-ancestor
102061947|NCT03542552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102061948|NCT03542552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102061949|NCT03542552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061950|NCT03542552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102061951|NCT03542552|Tocolytic Agents|tocolytic agents|mesh-ancestor
102061952|NCT03542552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102061953|NCT03542552|Vasodilator Agents|vasodilator agents|mesh-ancestor
102061955|NCT02155166|Lidocaine|lidocaine|mesh-list
102061956|NCT02155166|Anesthetics, Local|anesthetics, local|mesh-ancestor
102061957|NCT02155166|Anesthetics|anesthetics|mesh-ancestor
102061963|NCT02155166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102061964|NCT02155166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102061965|NCT02155166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102061966|NCT02155166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061967|NCT02155166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102061968|NCT02155166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102061969|NCT02155166|Analgesics|analgesics|mesh-ancestor
102061970|NCT02155166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102061971|NCT02155166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102061972|NCT02155166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102061973|NCT02155166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102061974|NCT00398931|Alendronate|alendronate|mesh-list
102061975|NCT00398931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061976|NCT00398931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102061977|NCT00920361|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102061978|NCT00920361|Hormones|hormones|mesh-ancestor
102061979|NCT00920361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102061980|NCT00920361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061981|NCT00651807|Etonogestrel|etonogestrel|mesh-list
102061982|NCT00651807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102061983|NCT00651807|Contraceptive Agents|contraceptive agents|mesh-ancestor
102061984|NCT00651807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102061985|NCT00651807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061986|NCT00651807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102061987|NCT03246529|Lenograstim|lenograstim|mesh-list
102061988|NCT03246529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102061989|NCT03246529|Immunologic Factors|immunologic factors|mesh-ancestor
102061990|NCT03246529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061991|NCT02158910|Donepezil|donepezil|mesh-list
102061992|NCT02158910|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102061993|NCT02158910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101942552|NCT01138137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102061994|NCT02158910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061995|NCT02158910|Cholinergic Agents|cholinergic agents|mesh-ancestor
102061996|NCT02158910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102061997|NCT02158910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061998|NCT02158910|Nootropic Agents|nootropic agents|mesh-ancestor
102061999|NCT03077659|Paclitaxel|paclitaxel|mesh-list
102062000|NCT03077659|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102062001|NCT03077659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102062002|NCT03077659|Tubulin Modulators|tubulin modulators|mesh-ancestor
102062003|NCT03077659|Antimitotic Agents|antimitotic agents|mesh-ancestor
102062004|NCT03077659|Mitosis Modulators|mitosis modulators|mesh-ancestor
102062005|NCT03077659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062006|NCT05052723|Pembrolizumab|pembrolizumab|mesh-list
102062007|NCT05052723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102062008|NCT05052723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102062009|NCT05052723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102062010|NCT05052723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062011|NCT02807883|Blinatumomab|blinatumomab|mesh-list
102062012|NCT02807883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102062013|NCT05563155|Dexamethasone|dexamethasone|mesh-list
102062014|NCT05563155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102062015|NCT05563155|Antiemetics|antiemetics|mesh-ancestor
102062016|NCT05563155|Autonomic Agents|autonomic agents|mesh-ancestor
102062017|NCT05563155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102062018|NCT05563155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062019|NCT05563155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102062020|NCT05563155|Glucocorticoids|glucocorticoids|mesh-ancestor
102062021|NCT05563155|Hormones|hormones|mesh-ancestor
102062022|NCT05563155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102062023|NCT05563155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102062024|NCT05563155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102062036|NCT00102440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102062037|NCT00102440|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102062038|NCT00102440|Antioxidants|antioxidants|mesh-ancestor
102062039|NCT00102440|Protective Agents|protective agents|mesh-ancestor
102062040|NCT00102440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062041|NCT05224167|Melatonin|melatonin|mesh-list
102062042|NCT05224167|Hydroxyzine|hydroxyzine|mesh-list
102062043|NCT05224167|Antioxidants|antioxidants|mesh-ancestor
102062044|NCT05224167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062045|NCT05224167|Protective Agents|protective agents|mesh-ancestor
102062046|NCT05224167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062047|NCT05224167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102062048|NCT05224167|Antipruritics|antipruritics|mesh-ancestor
102062049|NCT05224167|Dermatologic Agents|dermatologic agents|mesh-ancestor
102062050|NCT05224167|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102062051|NCT05224167|Histamine Antagonists|histamine antagonists|mesh-ancestor
102062052|NCT05224167|Histamine Agents|histamine agents|mesh-ancestor
102062053|NCT05224167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102062054|NCT01377259|Anesthetics|anesthetics|mesh-list
102062055|NCT01377259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102062056|NCT01377259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062057|NCT04994535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102062058|NCT04994535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102062059|NCT04994535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102062060|NCT04994535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102062061|NCT04994535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062062|NCT04994535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102062063|NCT04994535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102062064|NCT04994535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062065|NCT04994535|Cholinergic Agents|cholinergic agents|mesh-ancestor
102062066|NCT04994535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102062067|NCT03909607|Ketamine|ketamine|mesh-list
102062068|NCT03909607|Analgesics|analgesics|mesh-ancestor
102062069|NCT03909607|Sensory System Agents|sensory system agents|mesh-ancestor
102062070|NCT03909607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102062071|NCT03909607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062072|NCT03909607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102062073|NCT03909607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102062074|NCT03909607|Anesthetics, General|anesthetics, general|mesh-ancestor
102062075|NCT03909607|Anesthetics|anesthetics|mesh-ancestor
102062076|NCT03909607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101942553|NCT01138137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101942554|NCT01138137|Tubulin Modulators|tubulin modulators|mesh-ancestor
102062077|NCT03909607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102062078|NCT03909607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102062079|NCT03909607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102062080|NCT03909607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062081|NCT03902509|Pirfenidone|pirfenidone|mesh-list
102062082|NCT03902509|Analgesics|analgesics|mesh-ancestor
102062083|NCT03902509|Sensory System Agents|sensory system agents|mesh-ancestor
102062084|NCT03902509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102062085|NCT03902509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062086|NCT03902509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102062087|NCT03902509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102062092|NCT02166632|Anesthetics, Local|anesthetics, local|mesh-ancestor
102062094|NCT02166632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102062095|NCT02166632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062096|NCT02166632|Sensory System Agents|sensory system agents|mesh-ancestor
102062097|NCT02166632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102062098|NCT02161952|Pirfenidone|pirfenidone|mesh-list
102062099|NCT02161952|Analgesics|analgesics|mesh-ancestor
102062100|NCT02161952|Sensory System Agents|sensory system agents|mesh-ancestor
102062101|NCT02161952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102062102|NCT02161952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062103|NCT02161952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102062104|NCT02161952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102062105|NCT02161952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102062106|NCT02161952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102062107|NCT02161952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102062108|NCT04993677|Carboplatin|carboplatin|mesh-list
102062109|NCT04993677|Pembrolizumab|pembrolizumab|mesh-list
102062110|NCT04993677|Pemetrexed|pemetrexed|mesh-list
102062111|NCT04993677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102062112|NCT04993677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102062113|NCT04993677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102062114|NCT04993677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062115|NCT04993677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102062116|NCT04993677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102062117|NCT04993677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102062118|NCT05047731|Antihypertensive Agents|antihypertensive agents|mesh-list
102062119|NCT04795869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102062120|NCT04795869|Pembrolizumab|pembrolizumab|mesh-list
102062121|NCT04795869|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102062122|NCT04795869|Antibodies|antibodies|mesh-list
102062123|NCT04795869|Immunoglobulins|immunoglobulins|mesh-list
102062124|NCT04795869|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102062125|NCT04795869|Immunoconjugates|immunoconjugates|mesh-list
102062126|NCT04795869|Immunologic Factors|immunologic factors|mesh-ancestor
102062127|NCT04795869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062128|NCT04795869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102062129|NCT04795869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102062130|NCT04795869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062131|NCT04795869|Immunotoxins|immunotoxins|mesh-ancestor
102062132|NCT04050735|Ethanol|ethanol|mesh-list
102062133|NCT04050735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102062134|NCT04050735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102062135|NCT04050735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102062136|NCT04050735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062137|NCT04784559|Remdesivir|remdesivir|mesh-list
102062138|NCT04784559|Favipiravir|favipiravir|mesh-list
102062139|NCT04784559|Dexamethasone|dexamethasone|mesh-list
102062140|NCT04784559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102062141|NCT04784559|Antiemetics|antiemetics|mesh-ancestor
102062142|NCT04784559|Autonomic Agents|autonomic agents|mesh-ancestor
102062143|NCT04784559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102062144|NCT04784559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062145|NCT04784559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102062146|NCT04784559|Glucocorticoids|glucocorticoids|mesh-ancestor
102062147|NCT04784559|Hormones|hormones|mesh-ancestor
102062148|NCT04784559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102062149|NCT04784559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102062150|NCT04784559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102062151|NCT04784559|Antimetabolites|antimetabolites|mesh-ancestor
101942555|NCT01138137|Antimitotic Agents|antimitotic agents|mesh-ancestor
101942556|NCT01138137|Mitosis Modulators|mitosis modulators|mesh-ancestor
101942557|NCT01138137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942558|NCT01138137|Antiviral Agents|antiviral agents|mesh-ancestor
101942559|NCT01138137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101942560|NCT01138137|Expectorants|expectorants|mesh-ancestor
101942561|NCT01138137|Respiratory System Agents|respiratory system agents|mesh-ancestor
101942562|NCT01138137|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101942563|NCT01138137|Antioxidants|antioxidants|mesh-ancestor
101942564|NCT01138137|Protective Agents|protective agents|mesh-ancestor
101942565|NCT01138137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942566|NCT01138137|Antidotes|antidotes|mesh-ancestor
101942567|NCT01231113|Artesunate|artesunate|mesh-list
101942568|NCT01231113|Piperaquine|piperaquine|mesh-list
101942569|NCT01231113|Amodiaquine|amodiaquine|mesh-list
101942570|NCT01231113|Artenimol|artenimol|mesh-list
101307529|NCT02040883|Antiemetics|antiemetics|mesh-ancestor
102062152|NCT04784559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062153|NCT04784559|Antiviral Agents|antiviral agents|mesh-ancestor
102062154|NCT04784559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102062155|NCT03704181|Colchicine|colchicine|mesh-list
102062156|NCT03704181|Gout Suppressants|gout suppressants|mesh-ancestor
102062157|NCT03704181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102062158|NCT03704181|Tubulin Modulators|tubulin modulators|mesh-ancestor
102062159|NCT03704181|Antimitotic Agents|antimitotic agents|mesh-ancestor
102062166|NCT03625011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102062167|NCT03625011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062169|NCT03625011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102062170|NCT03625011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102062171|NCT03625011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102062172|NCT03625011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102062173|NCT03625011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102062174|NCT03625011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102062175|NCT03625011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102062176|NCT03625011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062177|NCT03625011|Antimanic Agents|antimanic agents|mesh-ancestor
102062178|NCT03625167|Petrolatum|petrolatum|mesh-list
102062179|NCT03625167|Emollients|emollients|mesh-ancestor
102062180|NCT03625167|Dermatologic Agents|dermatologic agents|mesh-ancestor
102062181|NCT04718727|Olanzapine|olanzapine|mesh-list
102062182|NCT04718727|Antiemetics|antiemetics|mesh-ancestor
102062183|NCT04718727|Autonomic Agents|autonomic agents|mesh-ancestor
102062184|NCT04718727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102062185|NCT04718727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062186|NCT04718727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102062187|NCT04718727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102062188|NCT04718727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102062189|NCT04718727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102062190|NCT04718727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102062191|NCT04718727|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102062192|NCT04718727|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102062193|NCT04718727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102062194|NCT04718727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062195|NCT04718727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102062196|NCT04718727|Serotonin Agents|serotonin agents|mesh-ancestor
102062197|NCT03701529|Anesthetics|anesthetics|mesh-list
102062198|NCT03701529|Propofol|propofol|mesh-list
102062199|NCT03701529|Sevoflurane|sevoflurane|mesh-list
102062200|NCT03701529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102062201|NCT03701529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062202|NCT03701529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101942571|NCT01231113|Antimalarials|antimalarials|mesh-ancestor
101942572|NCT01231113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101942573|NCT01231113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102062203|NCT03701529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102062204|NCT03701529|Anesthetics, General|anesthetics, general|mesh-ancestor
102062205|NCT03701529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102062206|NCT03701529|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102062207|NCT04535271|Gemcitabine|gemcitabine|mesh-list
102062208|NCT04535271|Dacarbazine|dacarbazine|mesh-list
102062209|NCT04535271|Trabectedin|trabectedin|mesh-list
102062210|NCT04535271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102062211|NCT04535271|Antimetabolites|antimetabolites|mesh-ancestor
102062212|NCT04535271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062213|NCT04535271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102062214|NCT04535271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102062215|NCT04535271|Alkylating Agents|alkylating agents|mesh-ancestor
102062216|NCT04553133|Letrozole|letrozole|mesh-list
102062217|NCT04553133|Fulvestrant|fulvestrant|mesh-list
102062218|NCT04553133|Palbociclib|palbociclib|mesh-list
102062219|NCT04553133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102062220|NCT04553133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102062221|NCT04553133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102062222|NCT04553133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102062223|NCT04553133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062224|NCT04553133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102062225|NCT04553133|Hormone Antagonists|hormone antagonists|mesh-ancestor
102062226|NCT04553133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102062227|NCT04553133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062230|NCT04553133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102062232|NCT03701451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102062233|NCT03701451|Antimetabolites|antimetabolites|mesh-ancestor
102062234|NCT03701451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062235|NCT03701451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102062236|NCT03701451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102062237|NCT03703089|Paclitaxel|paclitaxel|mesh-list
102062238|NCT03703089|Gemcitabine|gemcitabine|mesh-list
102062239|NCT03703089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102062240|NCT03703089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101781943|NCT00827580|Eniluracil|eniluracil|mesh-list
102062241|NCT03703089|Tubulin Modulators|tubulin modulators|mesh-ancestor
102062242|NCT03703089|Antimitotic Agents|antimitotic agents|mesh-ancestor
102062243|NCT03703089|Mitosis Modulators|mitosis modulators|mesh-ancestor
102062244|NCT03703089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062245|NCT03703089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102062246|NCT03703089|Antimetabolites|antimetabolites|mesh-ancestor
102062247|NCT02807844|Spartalizumab|spartalizumab|mesh-list
102062248|NCT02807844|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102062249|NCT02807844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062250|NCT02807844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102062251|NCT02807844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102062252|NCT02763566|Letrozole|letrozole|mesh-list
102062253|NCT02763566|Fulvestrant|fulvestrant|mesh-list
102062254|NCT02763566|Anastrozole|anastrozole|mesh-list
102062255|NCT02763566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102062256|NCT02763566|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102062257|NCT02763566|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102062258|NCT02763566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102062259|NCT02763566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062260|NCT02763566|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102062261|NCT02763566|Hormone Antagonists|hormone antagonists|mesh-ancestor
102062262|NCT02763566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102062263|NCT02763566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062264|NCT02763566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102062265|NCT02763566|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102062266|NCT03702855|Tetrabenazine|tetrabenazine|mesh-list
102062267|NCT03702855|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102062268|NCT03702855|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102062269|NCT03702855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102062270|NCT03702855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062271|NCT03702855|Adrenergic Agents|adrenergic agents|mesh-ancestor
102062272|NCT03702855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101942574|NCT01231113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101942575|NCT01231113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101942576|NCT01231113|Antiviral Agents|antiviral agents|mesh-ancestor
102062273|NCT03702855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062274|NCT02052180|Bupivacaine|bupivacaine|mesh-list
102062275|NCT02052180|Anesthetics, Local|anesthetics, local|mesh-ancestor
102062276|NCT02052180|Anesthetics|anesthetics|mesh-ancestor
102062277|NCT02052180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102062278|NCT02052180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062279|NCT02052180|Sensory System Agents|sensory system agents|mesh-ancestor
102062280|NCT02052180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102062281|NCT03561402|Teriflunomide|teriflunomide|mesh-list
102062282|NCT03561402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102062283|NCT03561402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102062284|NCT03561402|Analgesics|analgesics|mesh-ancestor
102062285|NCT03561402|Sensory System Agents|sensory system agents|mesh-ancestor
102062286|NCT03561402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102062287|NCT03561402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062288|NCT03561402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102062289|NCT03561402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102062290|NCT03561402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102062291|NCT03561402|Immunologic Factors|immunologic factors|mesh-ancestor
102062292|NCT04542135|Sulindac|sulindac|mesh-list
102062293|NCT04542135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102062294|NCT04542135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102062295|NCT04542135|Analgesics|analgesics|mesh-ancestor
102062296|NCT04542135|Sensory System Agents|sensory system agents|mesh-ancestor
101363855|NCT00080925|Cyclosporine|cyclosporine|mesh-list
102062318|NCT02052258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062319|NCT02053818|Sufentanil|sufentanil|mesh-list
102062320|NCT02053818|Remifentanil|remifentanil|mesh-list
102062321|NCT02053818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102062322|NCT02053818|Narcotics|narcotics|mesh-ancestor
102062323|NCT02053818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102062324|NCT02053818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062325|NCT02053818|Analgesics|analgesics|mesh-ancestor
102062326|NCT02053818|Sensory System Agents|sensory system agents|mesh-ancestor
102062327|NCT02053818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102062328|NCT02053818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102062329|NCT02053818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102062330|NCT02053818|Anesthetics, General|anesthetics, general|mesh-ancestor
102062331|NCT02053818|Anesthetics|anesthetics|mesh-ancestor
102062332|NCT03702387|Anesthetics|anesthetics|mesh-list
102062333|NCT03702387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102062334|NCT03702387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062335|NCT03031899|Tolonium Chloride|tolonium chloride|mesh-list
102062336|NCT03031899|Hemostatics|hemostatics|mesh-ancestor
102062337|NCT03031899|Coagulants|coagulants|mesh-ancestor
102062338|NCT03031899|Heparin Antagonists|heparin antagonists|mesh-ancestor
102062339|NCT03031899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062340|NCT03700905|Nivolumab|nivolumab|mesh-list
102062341|NCT03700905|Ipilimumab|ipilimumab|mesh-list
102062342|NCT03700905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102062343|NCT03700905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102062344|NCT03700905|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102062345|NCT03700905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062347|NCT03700749|Chlorhexidine|chlorhexidine|mesh-list
102062348|NCT03700749|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102062349|NCT03700749|Cadexomer iodine|cadexomer iodine|mesh-list
102062353|NCT03700749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102062354|NCT03700749|Disinfectants|disinfectants|mesh-ancestor
102062355|NCT03700749|Dermatologic Agents|dermatologic agents|mesh-ancestor
102062356|NCT03700749|Trace Elements|trace elements|mesh-ancestor
102062357|NCT03700749|Micronutrients|micronutrients|mesh-ancestor
102062358|NCT03700749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062359|NCT03700749|Plasma Substitutes|plasma substitutes|mesh-ancestor
102062360|NCT03700749|Blood Substitutes|blood substitutes|mesh-ancestor
102062361|NCT03086369|Paclitaxel|paclitaxel|mesh-list
102062362|NCT03086369|Gemcitabine|gemcitabine|mesh-list
102062363|NCT03086369|Olaratumab|olaratumab|mesh-list
102062364|NCT03086369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102062365|NCT03086369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102062366|NCT03086369|Tubulin Modulators|tubulin modulators|mesh-ancestor
102062367|NCT03086369|Antimitotic Agents|antimitotic agents|mesh-ancestor
102062368|NCT03086369|Mitosis Modulators|mitosis modulators|mesh-ancestor
101942577|NCT01231113|Schistosomicides|schistosomicides|mesh-ancestor
101942578|NCT01231113|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101942579|NCT01231113|Anthelmintics|anthelmintics|mesh-ancestor
101942580|NCT01136421|Magnesium Sulfate|magnesium sulfate|mesh-list
101942581|NCT01136421|Bromides|bromides|mesh-list
102062369|NCT03086369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062370|NCT03086369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102062371|NCT03086369|Antimetabolites|antimetabolites|mesh-ancestor
102062372|NCT00101582|Cisplatin|cisplatin|mesh-list
102062373|NCT00101582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102062374|NCT05326373|Fluorides|fluorides|mesh-list
102062375|NCT05326373|Tin Fluorides|tin fluorides|mesh-list
102062376|NCT05326373|Cariostatic Agents|cariostatic agents|mesh-ancestor
102062377|NCT05326373|Protective Agents|protective agents|mesh-ancestor
102062378|NCT05326373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062379|NCT02166944|Tamoxifen|tamoxifen|mesh-list
102062380|NCT02166944|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102062381|NCT02166944|Hormone Antagonists|hormone antagonists|mesh-ancestor
102062382|NCT02166944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102062383|NCT02166944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062384|NCT02166944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102062385|NCT02166944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102062386|NCT02166944|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102062387|NCT02166944|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102062388|NCT02166944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102062389|NCT03540836|Cortisone|cortisone|mesh-list
102062390|NCT03540836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102062391|NCT04211675|Irinotecan|irinotecan|mesh-list
102062392|NCT04211675|Temozolomide|temozolomide|mesh-list
102062393|NCT04211675|Dinutuximab|dinutuximab|mesh-list
102062394|NCT04211675|Sargramostim|sargramostim|mesh-list
102062395|NCT04211675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102062396|NCT04211675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102062397|NCT04211675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102062398|NCT04211675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062399|NCT04211675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102062400|NCT04211675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102062401|NCT04211675|Alkylating Agents|alkylating agents|mesh-ancestor
102062402|NCT04211675|Immunologic Factors|immunologic factors|mesh-ancestor
102062403|NCT04211675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062404|NCT02162264|Donepezil|donepezil|mesh-list
102062405|NCT02162264|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102062406|NCT02162264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102062407|NCT02162264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062408|NCT02162264|Cholinergic Agents|cholinergic agents|mesh-ancestor
102062409|NCT02162264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102062410|NCT02162264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062411|NCT02162264|Nootropic Agents|nootropic agents|mesh-ancestor
102062412|NCT03700515|Epoetin Alfa|epoetin alfa|mesh-list
102062413|NCT03700515|Hematinics|hematinics|mesh-ancestor
102062414|NCT04740008|Nicotine|nicotine|mesh-list
102062415|NCT04740008|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102062416|NCT04740008|Autonomic Agents|autonomic agents|mesh-ancestor
102062417|NCT04740008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102062418|NCT04740008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062419|NCT04740008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102062420|NCT04740008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102062421|NCT04740008|Cholinergic Agents|cholinergic agents|mesh-ancestor
102062422|NCT04740008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102062423|NCT04740008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062424|NCT03700359|Etoposide|etoposide|mesh-list
102062430|NCT03700359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062432|NCT02167178|Plasma Substitutes|plasma substitutes|mesh-ancestor
102062433|NCT02167178|Blood Substitutes|blood substitutes|mesh-ancestor
102062434|NCT03625089|Atorvastatin|atorvastatin|mesh-list
102062435|NCT03625089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102062436|NCT03625089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102062437|NCT03625089|Antimetabolites|antimetabolites|mesh-ancestor
102062438|NCT03625089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062439|NCT03625089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102062440|NCT03625089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101942582|NCT01136421|Ipratropium|ipratropium|mesh-list
101942583|NCT01136421|Anticonvulsants|anticonvulsants|mesh-ancestor
101942584|NCT01136421|Analgesics|analgesics|mesh-ancestor
101942585|NCT01136421|Sensory System Agents|sensory system agents|mesh-ancestor
101436012|NCT05693844|Paclitaxel|paclitaxel|mesh-list
102062441|NCT03625089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102062442|NCT01378949|Morphine|morphine|mesh-list
102062443|NCT01378949|Bupivacaine|bupivacaine|mesh-list
102062444|NCT01378949|Anesthetics, Local|anesthetics, local|mesh-ancestor
102062445|NCT01378949|Anesthetics|anesthetics|mesh-ancestor
102062446|NCT01378949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102062447|NCT01378949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062448|NCT01378949|Sensory System Agents|sensory system agents|mesh-ancestor
102062449|NCT01378949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102062450|NCT01378949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102062451|NCT01378949|Narcotics|narcotics|mesh-ancestor
102062452|NCT01378949|Analgesics|analgesics|mesh-ancestor
102062453|NCT01381055|Pentoxifylline|pentoxifylline|mesh-list
102062454|NCT01381055|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102062455|NCT01381055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102062456|NCT01381055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062457|NCT01381055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102062458|NCT01381055|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102062459|NCT01381055|Protective Agents|protective agents|mesh-ancestor
102062460|NCT01381055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062461|NCT01381055|Vasodilator Agents|vasodilator agents|mesh-ancestor
102062462|NCT01381055|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102062463|NCT01381055|Antioxidants|antioxidants|mesh-ancestor
102062464|NCT04649229|Aprepitant|aprepitant|mesh-list
102062465|NCT04649229|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102062466|NCT04649229|Antiemetics|antiemetics|mesh-ancestor
102062467|NCT04649229|Autonomic Agents|autonomic agents|mesh-ancestor
102062468|NCT04649229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102062469|NCT04649229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062470|NCT04649229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102062471|NCT04649229|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102062472|NCT04649229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102062473|NCT04649229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062474|NCT04649229|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102062475|NCT03122613|Curcumin|curcumin|mesh-list
102062476|NCT03122613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102062477|NCT03122613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102062478|NCT03122613|Analgesics|analgesics|mesh-ancestor
102062479|NCT03122613|Sensory System Agents|sensory system agents|mesh-ancestor
102062480|NCT03122613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102062481|NCT03122613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062482|NCT03122613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102062483|NCT03122613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102062484|NCT03122613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102062485|NCT03122613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102062486|NCT03122613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062487|NCT03540368|Tranexamic Acid|tranexamic acid|mesh-list
102062488|NCT03540368|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102062489|NCT03540368|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102062490|NCT03540368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062491|NCT03540368|Hemostatics|hemostatics|mesh-ancestor
102062492|NCT03540368|Coagulants|coagulants|mesh-ancestor
102062499|NCT02163980|Ropivacaine|ropivacaine|mesh-list
102062500|NCT02163980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102062501|NCT02163980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102062502|NCT02163980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062503|NCT02163980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102062504|NCT02163980|Analgesics|analgesics|mesh-ancestor
102062505|NCT02163980|Sensory System Agents|sensory system agents|mesh-ancestor
102062506|NCT02163980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102062507|NCT02163980|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102062508|NCT02163980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102062509|NCT02163980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102062510|NCT02163980|Adrenergic Agents|adrenergic agents|mesh-ancestor
102062511|NCT02163980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102062512|NCT02163980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942586|NCT01136421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101942587|NCT01136421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942588|NCT01136421|Anesthetics|anesthetics|mesh-ancestor
101942589|NCT01136421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102062513|NCT02163980|Anesthetics, Local|anesthetics, local|mesh-ancestor
102062514|NCT02163980|Anesthetics|anesthetics|mesh-ancestor
102062515|NCT02162888|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102062516|NCT02162888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102062517|NCT02162888|Alkylating Agents|alkylating agents|mesh-ancestor
102062518|NCT02162888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062519|NCT02162888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102062520|NCT01569035|Warfarin|warfarin|mesh-list
102062521|NCT01569035|Anticoagulants|anticoagulants|mesh-ancestor
102062522|NCT03841565|Dexamethasone|dexamethasone|mesh-list
102062523|NCT03841565|Dexamethasone acetate|dexamethasone acetate|mesh-list
102062524|NCT03841565|Daratumumab|daratumumab|mesh-list
102062525|NCT03841565|Pomalidomide|pomalidomide|mesh-list
102062526|NCT03841565|Ichthammol|ichthammol|mesh-list
102062527|NCT03841565|BB 1101|bb 1101|mesh-list
102062528|NCT03841565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102062529|NCT03841565|Antiemetics|antiemetics|mesh-ancestor
102062530|NCT03841565|Autonomic Agents|autonomic agents|mesh-ancestor
102062531|NCT03841565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102062532|NCT03841565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062533|NCT03841565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102062534|NCT03841565|Glucocorticoids|glucocorticoids|mesh-ancestor
102062535|NCT03841565|Hormones|hormones|mesh-ancestor
102062536|NCT03841565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102062537|NCT03841565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102062538|NCT03841565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102062539|NCT03841565|Protease Inhibitors|protease inhibitors|mesh-ancestor
102062540|NCT03841565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102062541|NCT03841565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062542|NCT03841565|Immunologic Factors|immunologic factors|mesh-ancestor
102062543|NCT03841565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102062544|NCT03841565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102062545|NCT03841565|Growth Substances|growth substances|mesh-ancestor
102062546|NCT03841565|Growth Inhibitors|growth inhibitors|mesh-ancestor
102062547|NCT03841565|Dermatologic Agents|dermatologic agents|mesh-ancestor
102062549|NCT02162966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102062550|NCT02162966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102062551|NCT01595321|Leucovorin|leucovorin|mesh-list
102062552|NCT01595321|Cyclophosphamide|cyclophosphamide|mesh-list
102062553|NCT01595321|Fluorouracil|fluorouracil|mesh-list
102062554|NCT01595321|Oxaliplatin|oxaliplatin|mesh-list
102062555|NCT01595321|Irinotecan|irinotecan|mesh-list
102062556|NCT01595321|Folfirinox|folfirinox|mesh-list
102062557|NCT01595321|Vaccines|vaccines|mesh-list
102062558|NCT01595321|Immunologic Factors|immunologic factors|mesh-ancestor
102062559|NCT01595321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062560|NCT01595321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102062561|NCT01595321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102062562|NCT01595321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102062563|NCT01595321|Alkylating Agents|alkylating agents|mesh-ancestor
102062564|NCT01595321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062570|NCT01595321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102062571|NCT01595321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102062573|NCT01595321|Protective Agents|protective agents|mesh-ancestor
102062574|NCT01595321|Vitamin B Complex|vitamin b complex|mesh-ancestor
102062575|NCT01595321|Vitamins|vitamins|mesh-ancestor
102062576|NCT01595321|Micronutrients|micronutrients|mesh-ancestor
102062577|NCT02164214|Etanercept|etanercept|mesh-list
102062578|NCT02164214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102062579|NCT02164214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102062580|NCT02164214|Analgesics|analgesics|mesh-ancestor
102062581|NCT02164214|Sensory System Agents|sensory system agents|mesh-ancestor
102062582|NCT02164214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102062583|NCT02164214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062584|NCT02164214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102062585|NCT02164214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102062586|NCT02164214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102062587|NCT02164214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102062588|NCT02164214|Immunologic Factors|immunologic factors|mesh-ancestor
102062589|NCT03722849|Adenosine|adenosine|mesh-list
101942590|NCT01136421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101942591|NCT01136421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102062591|NCT03722849|Antipruritics|antipruritics|mesh-ancestor
102062592|NCT03722849|Dermatologic Agents|dermatologic agents|mesh-ancestor
102062593|NCT03722849|Sensory System Agents|sensory system agents|mesh-ancestor
102062594|NCT03722849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102062595|NCT03722849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062596|NCT03722849|Analgesics|analgesics|mesh-ancestor
102062597|NCT03722849|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102062598|NCT03722849|Vasodilator Agents|vasodilator agents|mesh-ancestor
102062599|NCT03722849|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102062600|NCT03722849|Purinergic Agonists|purinergic agonists|mesh-ancestor
102062601|NCT03722849|Purinergic Agents|purinergic agents|mesh-ancestor
102062602|NCT03722849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102062603|NCT03722849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062604|NCT02170844|Dabigatran|dabigatran|mesh-list
102062605|NCT02170844|Antithrombins|antithrombins|mesh-ancestor
102062606|NCT02170844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102062607|NCT02170844|Protease Inhibitors|protease inhibitors|mesh-ancestor
102062608|NCT02170844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102062609|NCT02170844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062610|NCT02170844|Anticoagulants|anticoagulants|mesh-ancestor
102062611|NCT02170922|Dabigatran|dabigatran|mesh-list
102062612|NCT02170922|Antithrombins|antithrombins|mesh-ancestor
102062613|NCT02170922|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101699037|NCT00877890|Exenatide|exenatide|mesh-list
102062614|NCT02170922|Protease Inhibitors|protease inhibitors|mesh-ancestor
101782319|NCT00827814|Dutasteride|dutasteride|mesh-list
102062615|NCT02170922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102062616|NCT02170922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062617|NCT02170922|Anticoagulants|anticoagulants|mesh-ancestor
102062618|NCT02167958|Cyclophosphamide|cyclophosphamide|mesh-list
102062619|NCT02167958|Fludarabine|fludarabine|mesh-list
102062620|NCT02167958|Tacrolimus|tacrolimus|mesh-list
102062621|NCT02167958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102062622|NCT02167958|Immunologic Factors|immunologic factors|mesh-ancestor
102062623|NCT02167958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062624|NCT02167958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102062625|NCT02167958|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102062626|NCT02167958|Alkylating Agents|alkylating agents|mesh-ancestor
102062627|NCT02167958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062628|NCT02167958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102062629|NCT02167958|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102062630|NCT02167958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102062631|NCT02167958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102062632|NCT01384331|NuvaRing|nuvaring|mesh-list
102062633|NCT01384331|Desogestrel|desogestrel|mesh-list
102062634|NCT01384331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102062635|NCT01384331|Contraceptive Agents|contraceptive agents|mesh-ancestor
102062645|NCT03699423|Atropine|atropine|mesh-list
102062646|NCT03699423|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102062647|NCT03699423|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102062648|NCT03699423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102062649|NCT03699423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102062650|NCT03699423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102062651|NCT03699423|Autonomic Agents|autonomic agents|mesh-ancestor
102062652|NCT03699423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102062653|NCT03699423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062654|NCT03699423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102062655|NCT03699423|Respiratory System Agents|respiratory system agents|mesh-ancestor
102062656|NCT03699423|Mydriatics|mydriatics|mesh-ancestor
102062657|NCT03699423|Parasympatholytics|parasympatholytics|mesh-ancestor
102062658|NCT03699423|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102062659|NCT03699423|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102062660|NCT03699423|Cholinergic Agents|cholinergic agents|mesh-ancestor
102062661|NCT03699423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102062662|NCT03699423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062663|NCT02164448|Dexmedetomidine|dexmedetomidine|mesh-list
102062664|NCT02164448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102062665|NCT02164448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102062666|NCT02164448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062667|NCT02164448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102062668|NCT02164448|Analgesics|analgesics|mesh-ancestor
102062669|NCT02164448|Sensory System Agents|sensory system agents|mesh-ancestor
101942592|NCT01136421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101942593|NCT01136421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942594|NCT01136421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101942595|NCT01136421|Tocolytic Agents|tocolytic agents|mesh-ancestor
101942596|NCT01136421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101942597|NCT01136421|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102062670|NCT02164448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102062671|NCT02164448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102062672|NCT02164448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102062673|NCT02164448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102062674|NCT02164448|Adrenergic Agents|adrenergic agents|mesh-ancestor
102062675|NCT02164448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102062676|NCT02164448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062678|NCT03612713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102062679|NCT03612713|Narcotics|narcotics|mesh-ancestor
102062680|NCT03612713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102062681|NCT03612713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062682|NCT03612713|Analgesics|analgesics|mesh-ancestor
102062683|NCT03612713|Sensory System Agents|sensory system agents|mesh-ancestor
102062684|NCT03612713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102062685|NCT01380509|Metronidazole|metronidazole|mesh-list
102062686|NCT01380509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101699081|NCT02653742|Analgesics|analgesics|mesh-ancestor
102062687|NCT01380509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102062688|NCT01380509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102062689|NCT01380509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102062690|NCT01378715|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102062691|NCT01378715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102062692|NCT01378715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101782387|NCT00521014|Cytarabine|cytarabine|mesh-list
102062693|NCT01378715|Antimetabolites|antimetabolites|mesh-ancestor
102062694|NCT01378715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062695|NCT01378715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102062696|NCT01378715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102062697|NCT01378715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102062698|NCT00976131|Ubiquinone|ubiquinone|mesh-list
102062699|NCT00976131|Coenzyme Q10|coenzyme q10|mesh-list
102062709|NCT00976131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102062710|NCT00976131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102062711|NCT00976131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102062712|NCT00976131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102062713|NCT00976131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102062714|NCT00976131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102062715|NCT00976131|Micronutrients|micronutrients|mesh-ancestor
102062716|NCT00976131|Vitamins|vitamins|mesh-ancestor
102062717|NCT01384253|Trastuzumab|trastuzumab|mesh-list
102062718|NCT01384253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102062719|NCT01384253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102062720|NCT03631277|Calcium|calcium|mesh-list
102062721|NCT03631277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102062722|NCT03631277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062723|NCT02171000|Dabigatran|dabigatran|mesh-list
102062724|NCT02171000|Antithrombins|antithrombins|mesh-ancestor
102062725|NCT02171000|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102062726|NCT02171000|Protease Inhibitors|protease inhibitors|mesh-ancestor
102062727|NCT02171000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102062728|NCT02171000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062729|NCT02171000|Anticoagulants|anticoagulants|mesh-ancestor
102062730|NCT04841265|Vitamin D|vitamin d|mesh-list
102062731|NCT04841265|Cholecalciferol|cholecalciferol|mesh-list
102062732|NCT04841265|Vitamins|vitamins|mesh-ancestor
102062733|NCT04841265|Micronutrients|micronutrients|mesh-ancestor
102062734|NCT04841265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062735|NCT04841265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102062736|NCT04841265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102062737|NCT02164604|Ranibizumab|ranibizumab|mesh-list
102062738|NCT02164604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102062739|NCT02164604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101942598|NCT01136421|Autonomic Agents|autonomic agents|mesh-ancestor
101942599|NCT01136421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101436319|NCT04685980|Morphine|morphine|mesh-list
102062740|NCT02164604|Growth Substances|growth substances|mesh-ancestor
102062741|NCT02164604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062742|NCT02164604|Growth Inhibitors|growth inhibitors|mesh-ancestor
102062743|NCT02164604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102062744|NCT04380831|Cyclophosphamide|cyclophosphamide|mesh-list
102062745|NCT04380831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102062746|NCT04380831|Immunologic Factors|immunologic factors|mesh-ancestor
102062747|NCT04380831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062748|NCT04380831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102062749|NCT04380831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102062750|NCT04380831|Alkylating Agents|alkylating agents|mesh-ancestor
102062751|NCT04380831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062752|NCT04380831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102062753|NCT04380831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102062754|NCT04571645|Heparin|heparin|mesh-list
102062755|NCT04571645|Anticoagulants|anticoagulants|mesh-ancestor
102062756|NCT04571645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102062757|NCT04571645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102062758|NCT04571645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062759|NCT04050267|Nitrous Oxide|nitrous oxide|mesh-list
102062760|NCT04050267|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102062761|NCT04050267|Anesthetics, General|anesthetics, general|mesh-ancestor
102062762|NCT04050267|Anesthetics|anesthetics|mesh-ancestor
102062763|NCT04050267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102062764|NCT04050267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062765|NCT04050267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102062768|NCT04050267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102062769|NCT02759120|Doxycycline|doxycycline|mesh-list
102062770|NCT02759120|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102062771|NCT02759120|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102062772|NCT02759120|Anti-Infective Agents|anti-infective agents|mesh-list
102062773|NCT02759120|Antimalarials|antimalarials|mesh-ancestor
102062774|NCT02759120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102062775|NCT02759120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102062776|NCT02759120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102062777|NCT01569113|Levonorgestrel|levonorgestrel|mesh-list
102062778|NCT01569113|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102062779|NCT01569113|Ulipristal acetate|ulipristal acetate|mesh-list
102062780|NCT01569113|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
102062781|NCT01569113|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
102062782|NCT01569113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102062783|NCT01569113|Contraceptive Agents|contraceptive agents|mesh-ancestor
102062784|NCT01569113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102062785|NCT01569113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062786|NCT01569113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102062787|NCT01569113|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102062788|NCT01569113|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102062789|NCT01569113|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102062790|NCT01569113|Estrogens|estrogens|mesh-ancestor
102062792|NCT01569113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102062793|NCT01569113|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102062794|NCT01569113|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
102062795|NCT01569113|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102062796|NCT01569113|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102062797|NCT03699033|Paclitaxel|paclitaxel|mesh-list
102062798|NCT03699033|Carboplatin|carboplatin|mesh-list
102062799|NCT03699033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102062800|NCT03699033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102062801|NCT03699033|Tubulin Modulators|tubulin modulators|mesh-ancestor
102062802|NCT03699033|Antimitotic Agents|antimitotic agents|mesh-ancestor
102062803|NCT03699033|Mitosis Modulators|mitosis modulators|mesh-ancestor
102062804|NCT03699033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062805|NCT03697239|Ascorbic Acid|ascorbic acid|mesh-list
102062806|NCT03697239|Paclitaxel|paclitaxel|mesh-list
102062807|NCT03697239|Gemcitabine|gemcitabine|mesh-list
102062808|NCT03697239|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102062809|NCT03697239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102062810|NCT03697239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101942600|NCT01136421|Respiratory System Agents|respiratory system agents|mesh-ancestor
101942601|NCT01136421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101942602|NCT01136421|Cholinergic Agents|cholinergic agents|mesh-ancestor
101942603|NCT01136421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101942604|NCT01136499|Panobinostat|panobinostat|mesh-list
101942605|NCT01136499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101942606|NCT01136499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101942607|NCT01136499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101942608|NCT01136499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942609|NCT01231191|Acetaminophen|acetaminophen|mesh-list
101942610|NCT01231191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101942611|NCT01231191|Analgesics|analgesics|mesh-ancestor
102062811|NCT03697239|Tubulin Modulators|tubulin modulators|mesh-ancestor
102062812|NCT03697239|Antimitotic Agents|antimitotic agents|mesh-ancestor
102062813|NCT03697239|Mitosis Modulators|mitosis modulators|mesh-ancestor
102062814|NCT03697239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062815|NCT03697239|Vitamins|vitamins|mesh-ancestor
102062816|NCT03697239|Micronutrients|micronutrients|mesh-ancestor
102062817|NCT03697239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062818|NCT03697239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102062819|NCT03697239|Antimetabolites|antimetabolites|mesh-ancestor
102062820|NCT03697239|Antioxidants|antioxidants|mesh-ancestor
102062821|NCT03697239|Protective Agents|protective agents|mesh-ancestor
102062822|NCT01380431|Lisinopril|lisinopril|mesh-list
102062823|NCT01380431|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102062824|NCT01380431|Protease Inhibitors|protease inhibitors|mesh-ancestor
102062825|NCT01380431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102062826|NCT01380431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062827|NCT01380431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102062828|NCT01380431|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102062829|NCT01380431|Protective Agents|protective agents|mesh-ancestor
102062830|NCT01380431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062831|NCT03697161|Gaboxadol|gaboxadol|mesh-list
102062832|NCT03697161|Analgesics|analgesics|mesh-ancestor
102062833|NCT03697161|Sensory System Agents|sensory system agents|mesh-ancestor
102062834|NCT03697161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102062835|NCT03697161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062836|NCT03697161|Anticonvulsants|anticonvulsants|mesh-ancestor
102062837|NCT03697161|GABA Agonists|gaba agonists|mesh-ancestor
102062838|NCT03697161|GABA Agents|gaba agents|mesh-ancestor
102062845|NCT03164993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102062846|NCT03164993|Immunologic Factors|immunologic factors|mesh-ancestor
102062847|NCT03164993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062848|NCT03164993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102062849|NCT03164993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102062850|NCT03164993|Alkylating Agents|alkylating agents|mesh-ancestor
102062851|NCT03164993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062852|NCT03164993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102062853|NCT03164993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102062854|NCT03164993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102062855|NCT03164993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102062856|NCT03164993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102062857|NCT03164993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102062858|NCT03164993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102062859|NCT03164993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102062860|NCT02171156|Nintedanib|nintedanib|mesh-list
102062861|NCT02171156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102062862|NCT02171156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102062863|NCT02171156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102062864|NCT02171156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062865|NCT01380353|Diclofenac|diclofenac|mesh-list
102062866|NCT01380353|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
102062867|NCT01380353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101942612|NCT01231191|Sensory System Agents|sensory system agents|mesh-ancestor
101942613|NCT01231191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101942614|NCT01231191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942615|NCT01231191|Antipyretics|antipyretics|mesh-ancestor
101942616|NCT01138449|Vitamin A|vitamin a|mesh-list
101942617|NCT01138449|Vitamins|vitamins|mesh-ancestor
101942618|NCT01138449|Micronutrients|micronutrients|mesh-ancestor
101942619|NCT01138449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942620|NCT05402865|Denosumab|denosumab|mesh-list
101942621|NCT05402865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101942622|NCT05402865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942624|NCT01138605|Darunavir|darunavir|mesh-list
101942625|NCT01138605|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101942626|NCT01138605|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101307569|NCT02041143|Caseins|caseins|mesh-list
102062868|NCT01380353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102062869|NCT01380353|Analgesics|analgesics|mesh-ancestor
102062870|NCT01380353|Sensory System Agents|sensory system agents|mesh-ancestor
102062871|NCT01380353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102062872|NCT01380353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062873|NCT01380353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102062874|NCT01380353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102062875|NCT01380353|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102062876|NCT01380353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102062877|NCT01380353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062878|NCT02168426|Hyaluronic Acid|hyaluronic acid|mesh-list
102062879|NCT02168426|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102062880|NCT02168426|Immunologic Factors|immunologic factors|mesh-ancestor
102062881|NCT02168426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062882|NCT02168426|Viscosupplements|viscosupplements|mesh-ancestor
102062883|NCT02168426|Protective Agents|protective agents|mesh-ancestor
102062884|NCT01380275|Docetaxel|docetaxel|mesh-list
102062885|NCT01380275|Irinotecan|irinotecan|mesh-list
102062886|NCT01380275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102062887|NCT01380275|Tubulin Modulators|tubulin modulators|mesh-ancestor
102062888|NCT01380275|Antimitotic Agents|antimitotic agents|mesh-ancestor
102062889|NCT01380275|Mitosis Modulators|mitosis modulators|mesh-ancestor
102062890|NCT01380275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062891|NCT01380275|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102062892|NCT01380275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102062893|NCT01380275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102062894|NCT02171390|Methyltestosterone|methyltestosterone|mesh-list
102062895|NCT02171390|Testosterone|testosterone|mesh-list
102062896|NCT02171390|Testosterone undecanoate|testosterone undecanoate|mesh-list
102062897|NCT02171390|Testosterone enanthate|testosterone enanthate|mesh-list
102062898|NCT02171390|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102062899|NCT02171390|Androgens|androgens|mesh-ancestor
102062900|NCT02171390|Hormones|hormones|mesh-ancestor
102062901|NCT02171390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102062902|NCT02171390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062903|NCT02171390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102062904|NCT02171390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102062905|NCT02171390|Anabolic Agents|anabolic agents|mesh-ancestor
102062906|NCT01378481|Vorinostat|vorinostat|mesh-list
102062907|NCT01378481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102062911|NCT02171468|Dabigatran|dabigatran|mesh-list
102062912|NCT02171468|Antithrombins|antithrombins|mesh-ancestor
102062913|NCT02171468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102062914|NCT02171468|Protease Inhibitors|protease inhibitors|mesh-ancestor
102062915|NCT02171468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102062916|NCT02171468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062917|NCT02171468|Anticoagulants|anticoagulants|mesh-ancestor
102062918|NCT03502031|Losartan|losartan|mesh-list
101942627|NCT01138605|Protease Inhibitors|protease inhibitors|mesh-ancestor
101942628|NCT01138605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101942629|NCT01138605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062919|NCT03502031|Valsartan|valsartan|mesh-list
102062920|NCT03502031|Enalapril|enalapril|mesh-list
102062921|NCT03502031|Enalaprilat|enalaprilat|mesh-list
102062922|NCT03502031|Lisinopril|lisinopril|mesh-list
102062923|NCT03502031|Perindopril|perindopril|mesh-list
102062924|NCT03502031|Spironolactone|spironolactone|mesh-list
102062925|NCT03502031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102062926|NCT03502031|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102062927|NCT03502031|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101699174|NCT02576548|MEDI4276|medi4276|mesh-list
102062928|NCT03502031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062929|NCT03502031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102062930|NCT03502031|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102062931|NCT03502031|Hormone Antagonists|hormone antagonists|mesh-ancestor
102062932|NCT03502031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102062933|NCT03502031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062934|NCT03502031|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102062935|NCT03502031|Diuretics|diuretics|mesh-ancestor
102062936|NCT03502031|Natriuretic Agents|natriuretic agents|mesh-ancestor
102062937|NCT03502031|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102062938|NCT03502031|Protease Inhibitors|protease inhibitors|mesh-ancestor
102062939|NCT03502031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102062940|NCT03502031|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102062941|NCT03502031|Protective Agents|protective agents|mesh-ancestor
102062942|NCT02171546|Fexofenadine|fexofenadine|mesh-list
102062943|NCT02171546|Quinidine|quinidine|mesh-list
102062944|NCT02171546|Quinidine gluconate|quinidine gluconate|mesh-list
102062945|NCT02171546|Dabigatran|dabigatran|mesh-list
102062946|NCT02171546|Antithrombins|antithrombins|mesh-ancestor
102062947|NCT02171546|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102062948|NCT02171546|Protease Inhibitors|protease inhibitors|mesh-ancestor
102062949|NCT02171546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102062950|NCT02171546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062951|NCT02171546|Anticoagulants|anticoagulants|mesh-ancestor
102062952|NCT02171546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102062953|NCT02171546|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102062954|NCT02171546|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102062955|NCT02171546|Histamine Antagonists|histamine antagonists|mesh-ancestor
102062956|NCT02171546|Histamine Agents|histamine agents|mesh-ancestor
102062957|NCT02171546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102062958|NCT02171546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062959|NCT02171546|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102062960|NCT02171546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102062961|NCT02171546|Adrenergic Agents|adrenergic agents|mesh-ancestor
102062962|NCT02171546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102062963|NCT02171546|Antimalarials|antimalarials|mesh-ancestor
102062964|NCT02171546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102062965|NCT02171546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102062966|NCT02171546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102062967|NCT02171546|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102062968|NCT02171546|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102062969|NCT02171546|Cholinergic Agents|cholinergic agents|mesh-ancestor
102062970|NCT02171546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102062971|NCT02171546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102062972|NCT02171546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102062973|NCT02171546|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102062974|NCT02171546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102062975|NCT02171624|Quinidine|quinidine|mesh-list
102062976|NCT02171624|Dabigatran|dabigatran|mesh-list
102062977|NCT02171624|Antithrombins|antithrombins|mesh-ancestor
102062978|NCT02171624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102062979|NCT02171624|Protease Inhibitors|protease inhibitors|mesh-ancestor
102062983|NCT02171624|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102062984|NCT02171624|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102062986|NCT02171624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102062987|NCT02171624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062988|NCT02171624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102062989|NCT02171624|Antimalarials|antimalarials|mesh-ancestor
102062990|NCT02171624|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102062991|NCT02171624|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101942630|NCT01138605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101942631|NCT01138605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102062992|NCT02171624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102062993|NCT02171624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102062994|NCT02171624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102062995|NCT02171624|Cholinergic Agents|cholinergic agents|mesh-ancestor
102062996|NCT02171624|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102062997|NCT02171624|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102062998|NCT02171624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102062999|NCT02171624|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102063000|NCT02171624|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102063001|NCT03705351|Temozolomide|temozolomide|mesh-list
102063002|NCT03705351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102063003|NCT03705351|Alkylating Agents|alkylating agents|mesh-ancestor
102063004|NCT03705351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063005|NCT03705351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102063007|NCT03705195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102063008|NCT03705195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063009|NCT00101192|Cetuximab|cetuximab|mesh-list
102063010|NCT00101192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102063011|NCT00101192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102063012|NCT03688269|Dexamethasone|dexamethasone|mesh-list
102063013|NCT03688269|Ropivacaine|ropivacaine|mesh-list
102063014|NCT03688269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102063015|NCT03688269|Antiemetics|antiemetics|mesh-ancestor
102063016|NCT03688269|Autonomic Agents|autonomic agents|mesh-ancestor
102063017|NCT03688269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102063018|NCT03688269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063019|NCT03688269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102063020|NCT03688269|Glucocorticoids|glucocorticoids|mesh-ancestor
102063021|NCT03688269|Hormones|hormones|mesh-ancestor
102063022|NCT03688269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102063023|NCT03688269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102063024|NCT03688269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102063025|NCT03688269|Anesthetics, Local|anesthetics, local|mesh-ancestor
102063026|NCT03688269|Anesthetics|anesthetics|mesh-ancestor
102063027|NCT03688269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102063028|NCT03688269|Sensory System Agents|sensory system agents|mesh-ancestor
102063029|NCT03688191|Sirolimus|sirolimus|mesh-list
102063030|NCT03688191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102063031|NCT03688191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102063032|NCT03688191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102063033|NCT03688191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102063034|NCT03688191|Antifungal Agents|antifungal agents|mesh-ancestor
102063035|NCT03688191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102063036|NCT03688191|Immunologic Factors|immunologic factors|mesh-ancestor
102063037|NCT03688191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063038|NCT02164838|Axitinib|axitinib|mesh-list
102063039|NCT02164838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102063040|NCT02164838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102063041|NCT02164838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102063042|NCT02164838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063043|NCT02171702|Afatinib|afatinib|mesh-list
102063044|NCT02171702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102063045|NCT02171702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102063046|NCT02171702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102063047|NCT02171702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063048|NCT02171780|Olodaterol|olodaterol|mesh-list
102063049|NCT02171780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102063050|NCT02171780|Autonomic Agents|autonomic agents|mesh-ancestor
102063062|NCT02172014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063064|NCT02172014|Sensory System Agents|sensory system agents|mesh-ancestor
102063065|NCT02172014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102063066|NCT02172014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102063067|NCT02172014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102063068|NCT02172014|Anesthetics, General|anesthetics, general|mesh-ancestor
102063069|NCT02172014|Anesthetics|anesthetics|mesh-ancestor
102063070|NCT02172014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102063071|NCT02172014|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102063072|NCT02172014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102063073|NCT02172014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102063074|NCT02172014|GABA Modulators|gaba modulators|mesh-ancestor
101942635|NCT01138605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101942637|NCT01138683|Natriuretic Agents|natriuretic agents|mesh-ancestor
101942638|NCT01138683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942639|NCT04767243|Methamphetamine|methamphetamine|mesh-list
101942640|NCT04767243|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102063075|NCT02172014|GABA Agents|gaba agents|mesh-ancestor
102063076|NCT02172014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102063077|NCT02172014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063078|NCT02172014|Anticoagulants|anticoagulants|mesh-ancestor
102063079|NCT02172014|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102063080|NCT02172014|Chelating Agents|chelating agents|mesh-ancestor
102063081|NCT02172014|Sequestering Agents|sequestering agents|mesh-ancestor
102063082|NCT02172170|Empagliflozin|empagliflozin|mesh-list
102063083|NCT02172170|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102063084|NCT02172170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063085|NCT02172170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102063086|NCT02172170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063087|NCT02255942|Zinc|zinc|mesh-list
102063088|NCT02255942|Iron|iron|mesh-list
102063089|NCT02255942|Zinc Sulfate|zinc sulfate|mesh-list
102063090|NCT02255942|Zinc Oxide|zinc oxide|mesh-list
102063091|NCT02255942|Trace Elements|trace elements|mesh-ancestor
102063092|NCT02255942|Micronutrients|micronutrients|mesh-ancestor
102063093|NCT02255942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063094|NCT02255942|Astringents|astringents|mesh-ancestor
102063095|NCT02255942|Dermatologic Agents|dermatologic agents|mesh-ancestor
102063096|NCT02255942|Sunscreening Agents|sunscreening agents|mesh-ancestor
102063097|NCT02255942|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102063098|NCT02255942|Protective Agents|protective agents|mesh-ancestor
102063099|NCT03029247|Epoetin Alfa|epoetin alfa|mesh-list
102063100|NCT03029247|Hematinics|hematinics|mesh-ancestor
102063101|NCT03696459|Moxifloxacin|moxifloxacin|mesh-list
102063102|NCT03696459|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102063103|NCT03696459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102063104|NCT03696459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102063105|NCT03696459|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102063106|NCT03696459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102063107|NCT03696459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102063108|NCT03696459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063109|NCT03696459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102063110|NCT03696459|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102063111|NCT03696459|Contraceptive Agents|contraceptive agents|mesh-ancestor
102063112|NCT03696459|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102063113|NCT03696459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063114|NCT03696459|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102063115|NCT03696459|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102063116|NCT03696459|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102063126|NCT04327791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102063127|NCT04327791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063132|NCT03692013|Losartan|losartan|mesh-list
102063133|NCT03692013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102063134|NCT03692013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102063135|NCT03692013|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102063136|NCT03692013|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102063137|NCT03692013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063138|NCT03695835|Immunomodulating Agents|immunomodulating agents|mesh-list
102063139|NCT03695835|Immunologic Factors|immunologic factors|mesh-ancestor
101942641|NCT04767243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942643|NCT04767243|Autonomic Agents|autonomic agents|mesh-ancestor
101942644|NCT04767243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102063140|NCT03695835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063141|NCT03687255|Tazobactam|tazobactam|mesh-list
102063142|NCT03687255|Piperacillin|piperacillin|mesh-list
102063143|NCT03687255|Cefepime|cefepime|mesh-list
102063144|NCT03687255|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102063145|NCT03687255|Enmetazobactam|enmetazobactam|mesh-list
102063146|NCT03687255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102063147|NCT03687255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102063148|NCT03687255|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102063149|NCT03687255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102063150|NCT03687255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063151|NCT03691467|Hyaluronic Acid|hyaluronic acid|mesh-list
102063152|NCT03691467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102063153|NCT03691467|Immunologic Factors|immunologic factors|mesh-ancestor
102063154|NCT03691467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063155|NCT03691467|Viscosupplements|viscosupplements|mesh-ancestor
102063156|NCT03691467|Protective Agents|protective agents|mesh-ancestor
102063157|NCT02165774|Neurotransmitter Agents|neurotransmitter agents|mesh-list
102063158|NCT02165774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063159|NCT02165774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063161|NCT02165930|Oxycodone|oxycodone|mesh-list
102063162|NCT02165930|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102063163|NCT02165930|Narcotics|narcotics|mesh-ancestor
102063164|NCT02165930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102063165|NCT02165930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063166|NCT02165930|Analgesics|analgesics|mesh-ancestor
102063167|NCT02165930|Sensory System Agents|sensory system agents|mesh-ancestor
102063168|NCT02165930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102063169|NCT02165930|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102063170|NCT02165930|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102063171|NCT03694977|Spartalizumab|spartalizumab|mesh-list
102063172|NCT03694977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102063173|NCT03694977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063174|NCT03694977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102063175|NCT03694977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102063176|NCT02172248|Metformin|metformin|mesh-list
102063177|NCT02172248|Empagliflozin|empagliflozin|mesh-list
102063178|NCT02172248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102063179|NCT02172248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063180|NCT02172248|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102063181|NCT02172248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063182|NCT02172326|Tiotropium Bromide|tiotropium bromide|mesh-list
101364747|NCT00405847|Dexmedetomidine|dexmedetomidine|mesh-list
102063194|NCT02169596|Ticagrelor|ticagrelor|mesh-list
102063195|NCT02169596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102063196|NCT02169596|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102063197|NCT02169596|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102063198|NCT02169596|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102063199|NCT02169596|Purinergic Agents|purinergic agents|mesh-ancestor
102063200|NCT02169596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102063201|NCT02169596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063202|NCT02169596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063203|NCT02169752|Ambrisentan|ambrisentan|mesh-list
102063204|NCT02169752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102063205|NCT02172404|Ipratropium|ipratropium|mesh-list
102063206|NCT02172404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102063207|NCT02172404|Autonomic Agents|autonomic agents|mesh-ancestor
102063208|NCT02172404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102063209|NCT02172404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063210|NCT02172404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102063211|NCT02172404|Respiratory System Agents|respiratory system agents|mesh-ancestor
102063212|NCT02172404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102063213|NCT02172404|Cholinergic Agents|cholinergic agents|mesh-ancestor
102063214|NCT02172404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102063215|NCT02172404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063216|NCT00109538|Lonafarnib|lonafarnib|mesh-list
101942645|NCT04767243|Dopamine Agents|dopamine agents|mesh-ancestor
101942646|NCT04767243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101942647|NCT04767243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942648|NCT04767243|Adrenergic Agents|adrenergic agents|mesh-ancestor
102063217|NCT00109538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102063218|NCT00109538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063219|NCT02172482|Bromides|bromides|mesh-list
102063220|NCT02172482|Tiotropium Bromide|tiotropium bromide|mesh-list
102063221|NCT02172482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102063222|NCT02172482|Autonomic Agents|autonomic agents|mesh-ancestor
102063223|NCT02172482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102063224|NCT02172482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063225|NCT02172482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102063226|NCT02172482|Respiratory System Agents|respiratory system agents|mesh-ancestor
102063227|NCT02172482|Parasympatholytics|parasympatholytics|mesh-ancestor
102063228|NCT02172482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102063229|NCT02172482|Cholinergic Agents|cholinergic agents|mesh-ancestor
102063230|NCT02172482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102063231|NCT02172482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063232|NCT02172482|Anticonvulsants|anticonvulsants|mesh-ancestor
102063233|NCT02172560|Tiotropium Bromide|tiotropium bromide|mesh-list
102063234|NCT02172560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102063235|NCT02172560|Autonomic Agents|autonomic agents|mesh-ancestor
102063236|NCT02172560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102063237|NCT02172560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063238|NCT02172560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102063239|NCT02172560|Respiratory System Agents|respiratory system agents|mesh-ancestor
102063240|NCT02172560|Parasympatholytics|parasympatholytics|mesh-ancestor
102063241|NCT02172560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102063242|NCT02172560|Cholinergic Agents|cholinergic agents|mesh-ancestor
102063243|NCT02172560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101364809|NCT00148603|Respiratory System Agents|respiratory system agents|mesh-ancestor
102063252|NCT02166554|Viscosupplements|viscosupplements|mesh-ancestor
102063253|NCT02166554|Protective Agents|protective agents|mesh-ancestor
102063254|NCT02174666|Vitamin D|vitamin d|mesh-list
102063255|NCT02174666|Ergocalciferols|ergocalciferols|mesh-list
102063256|NCT02174666|Cholecalciferol|cholecalciferol|mesh-list
102063257|NCT02174666|Vitamins|vitamins|mesh-list
102063258|NCT02174666|Genistein|genistein|mesh-list
102063259|NCT02174666|Biochanin A|biochanin a|mesh-list
102063260|NCT02174666|Daidzein|daidzein|mesh-list
102063261|NCT02174666|Formononetin|formononetin|mesh-list
102063262|NCT02174666|Micronutrients|micronutrients|mesh-ancestor
102063263|NCT02174666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063264|NCT02174666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102063265|NCT02174666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102063266|NCT02174666|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102063267|NCT02174666|Protective Agents|protective agents|mesh-ancestor
102063268|NCT02174666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102063269|NCT02174666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102063270|NCT02174666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102063271|NCT02174666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063272|NCT02174666|Phytoestrogens|phytoestrogens|mesh-ancestor
102063273|NCT02174666|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102063274|NCT02174666|Estrogens|estrogens|mesh-ancestor
102063275|NCT02174666|Hormones|hormones|mesh-ancestor
102063276|NCT02174666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102063277|NCT03687021|Progesterone|progesterone|mesh-list
102063278|NCT03687021|Progestins|progestins|mesh-ancestor
102063279|NCT03687021|Hormones|hormones|mesh-ancestor
102063280|NCT03687021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102063281|NCT03687021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063282|NCT03691077|Ocrelizumab|ocrelizumab|mesh-list
102063283|NCT03691077|Immunologic Factors|immunologic factors|mesh-ancestor
102063284|NCT03691077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063285|NCT02172794|Tiotropium Bromide|tiotropium bromide|mesh-list
102063286|NCT02172794|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102063287|NCT02172794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102063288|NCT02172794|Autonomic Agents|autonomic agents|mesh-ancestor
102063289|NCT02172794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102063290|NCT02172794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063291|NCT02172794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101942649|NCT04767243|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101942650|NCT04767243|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101942651|NCT04767243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101942652|NCT04767243|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102063292|NCT02172794|Respiratory System Agents|respiratory system agents|mesh-ancestor
102063293|NCT02172794|Parasympatholytics|parasympatholytics|mesh-ancestor
102063294|NCT02172794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102063295|NCT02172794|Cholinergic Agents|cholinergic agents|mesh-ancestor
102063296|NCT02172794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102063297|NCT02172794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063298|NCT02172794|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102063299|NCT02172794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102063300|NCT02172794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102063301|NCT02172794|Adrenergic Agents|adrenergic agents|mesh-ancestor
102063302|NCT02174900|Lumefantrine|lumefantrine|mesh-list
102063304|NCT02174900|Primaquine|primaquine|mesh-list
102063305|NCT02174900|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102063306|NCT02174900|Antimalarials|antimalarials|mesh-ancestor
102063307|NCT02174900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102063308|NCT02174900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102063309|NCT02174900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102063310|NCT02170610|Pantoprazole|pantoprazole|mesh-list
102063311|NCT02170610|Dabigatran|dabigatran|mesh-list
102063312|NCT02170610|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102063321|NCT02173106|Cyclosporine|cyclosporine|mesh-list
102063322|NCT02173106|Cyclosporins|cyclosporins|mesh-list
102063323|NCT02173106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102063324|NCT02173106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063325|NCT02173106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102063326|NCT02173106|Immunologic Factors|immunologic factors|mesh-ancestor
102063327|NCT02173106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063328|NCT02173106|Antifungal Agents|antifungal agents|mesh-ancestor
102063329|NCT02173106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102063330|NCT02173106|Dermatologic Agents|dermatologic agents|mesh-ancestor
102063331|NCT02173106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102063332|NCT02173106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102063333|NCT03932721|Evolocumab|evolocumab|mesh-list
102063334|NCT03932721|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102063335|NCT03932721|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102063336|NCT03932721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102063337|NCT03932721|Antimetabolites|antimetabolites|mesh-ancestor
102063338|NCT03932721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063339|NCT03932721|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102063340|NCT03932721|Protease Inhibitors|protease inhibitors|mesh-ancestor
102063341|NCT03932721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102063342|NCT03932721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102063343|NCT00106340|Metformin|metformin|mesh-list
102063344|NCT00106340|Glimepiride|glimepiride|mesh-list
102063345|NCT00106340|Vildagliptin|vildagliptin|mesh-list
102063346|NCT00106340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102063347|NCT00106340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063348|NCT00106340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102063349|NCT00106340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102063350|NCT00106340|Immunologic Factors|immunologic factors|mesh-ancestor
102063351|NCT00106340|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102063352|NCT00106340|Protease Inhibitors|protease inhibitors|mesh-ancestor
102063353|NCT00106340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102063354|NCT00106340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063355|NCT03538496|Bupivacaine|bupivacaine|mesh-list
101699224|NCT02648048|Pirfenidone|pirfenidone|mesh-list
102063356|NCT03538496|Anesthetics, Local|anesthetics, local|mesh-ancestor
102063357|NCT03538496|Anesthetics|anesthetics|mesh-ancestor
102063358|NCT03538496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102063359|NCT03538496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063360|NCT03538496|Sensory System Agents|sensory system agents|mesh-ancestor
102063361|NCT03538496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102063362|NCT03686787|Tranexamic Acid|tranexamic acid|mesh-list
102063363|NCT03686787|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102063364|NCT03686787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102063365|NCT03686787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063366|NCT03686787|Hemostatics|hemostatics|mesh-ancestor
102063367|NCT03686787|Coagulants|coagulants|mesh-ancestor
101942653|NCT01138839|Dexamethasone|dexamethasone|mesh-list
101942654|NCT01138839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101942655|NCT01138839|Antiemetics|antiemetics|mesh-ancestor
101942656|NCT01138839|Autonomic Agents|autonomic agents|mesh-ancestor
101942657|NCT01138839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101942658|NCT01138839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942659|NCT01138839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101942660|NCT01138839|Glucocorticoids|glucocorticoids|mesh-ancestor
102063368|NCT03694587|Ibuprofen|ibuprofen|mesh-list
102063369|NCT03694587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102063370|NCT03694587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102063371|NCT03694587|Analgesics|analgesics|mesh-ancestor
102063372|NCT03694587|Sensory System Agents|sensory system agents|mesh-ancestor
102063373|NCT03694587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102063374|NCT03694587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063375|NCT03694587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102063376|NCT03694587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102063377|NCT03694587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102063378|NCT03694587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102063379|NCT03694587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063383|NCT02170766|Dabigatran|dabigatran|mesh-list
102063384|NCT02170766|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102063385|NCT02170766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102063386|NCT02170766|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102063387|NCT02170766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102063388|NCT02170766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063389|NCT02170766|Antithrombins|antithrombins|mesh-ancestor
102063390|NCT02170766|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102063391|NCT02170766|Protease Inhibitors|protease inhibitors|mesh-ancestor
102063392|NCT02170766|Anticoagulants|anticoagulants|mesh-ancestor
102063393|NCT04156659|Tisagenlecleucel|tisagenlecleucel|mesh-list
102063394|NCT04156659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102063395|NCT04156659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102063396|NCT03694119|Phenelzine|phenelzine|mesh-list
102063397|NCT03694119|Ozanimod|ozanimod|mesh-list
102063398|NCT03694119|Tyramine|tyramine|mesh-list
102063399|NCT03694119|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102063400|NCT03694119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063401|NCT03694119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102063402|NCT03694119|Immunologic Factors|immunologic factors|mesh-ancestor
102063403|NCT03694119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063404|NCT03694119|Antidepressive Agents|antidepressive agents|mesh-ancestor
102063405|NCT03694119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102063406|NCT03694119|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102063407|NCT03694119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102063408|NCT03694119|Sympathomimetics|sympathomimetics|mesh-ancestor
102063409|NCT03694119|Autonomic Agents|autonomic agents|mesh-ancestor
102063410|NCT03694119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102063411|NCT03694119|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102063412|NCT03694119|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102063413|NCT03694119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102063414|NCT03694119|Adrenergic Agents|adrenergic agents|mesh-ancestor
102063415|NCT03694119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102063416|NCT02178254|Fosfomycin|fosfomycin|mesh-list
102063417|NCT02178254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102063418|NCT02178254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102063419|NCT02173262|Ciprofloxacin|ciprofloxacin|mesh-list
102063420|NCT02173262|Lenograstim|lenograstim|mesh-list
102063421|NCT02173262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102063422|NCT02173262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102063423|NCT02173262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102063424|NCT02173262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102063425|NCT02173262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102063426|NCT02173262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063427|NCT02173262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102063428|NCT02173262|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102063429|NCT02173262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101942661|NCT01138839|Hormones|hormones|mesh-ancestor
101942662|NCT01138839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101437025|NCT00193362|Antimetabolites|antimetabolites|mesh-ancestor
102063430|NCT02173262|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102063431|NCT02173262|Immunologic Factors|immunologic factors|mesh-ancestor
102063432|NCT02173262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063433|NCT02173418|Ropivacaine|ropivacaine|mesh-list
102063434|NCT02173418|Anesthetics, Local|anesthetics, local|mesh-ancestor
102063435|NCT02173418|Anesthetics|anesthetics|mesh-ancestor
102063436|NCT02173418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102063437|NCT02173418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063438|NCT02173418|Sensory System Agents|sensory system agents|mesh-ancestor
102063439|NCT02173418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102063440|NCT03932331|Acalabrutinib|acalabrutinib|mesh-list
102063441|NCT03932331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102063442|NCT02178488|Cholecalciferol|cholecalciferol|mesh-list
102063443|NCT02178488|Vitamin D|vitamin d|mesh-list
102063444|NCT02178488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102063445|NCT02178488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063446|NCT02178488|Vitamins|vitamins|mesh-ancestor
101783155|NCT00622284|Hormones|hormones|mesh-ancestor
102063447|NCT02178488|Micronutrients|micronutrients|mesh-ancestor
102063448|NCT02178488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102063449|NCT02173652|Linagliptin|linagliptin|mesh-list
102063450|NCT02173652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102063451|NCT02173652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063460|NCT02173730|Dabigatran|dabigatran|mesh-list
102063461|NCT02173730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102063462|NCT02173730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102063463|NCT02173730|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102063464|NCT02173730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102063465|NCT02173730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063466|NCT02173730|Antithrombins|antithrombins|mesh-ancestor
102063467|NCT02173730|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102063468|NCT02173730|Protease Inhibitors|protease inhibitors|mesh-ancestor
102063469|NCT02173730|Anticoagulants|anticoagulants|mesh-ancestor
102063470|NCT02175446|Bevacizumab|bevacizumab|mesh-list
102063471|NCT02175446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102063472|NCT02175446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102063473|NCT02175446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102063474|NCT02175446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102063475|NCT02175446|Growth Substances|growth substances|mesh-ancestor
102063476|NCT02175446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063477|NCT02175446|Growth Inhibitors|growth inhibitors|mesh-ancestor
102063478|NCT02178644|Capecitabine|capecitabine|mesh-list
102063479|NCT02178644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102063480|NCT02178644|Antimetabolites|antimetabolites|mesh-ancestor
102063481|NCT02178644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063482|NCT02178644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102063483|NCT03686163|Mitogens|mitogens|mesh-list
102063484|NCT03686163|Mitosis Modulators|mitosis modulators|mesh-ancestor
102063485|NCT03686163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063486|NCT02173808|Levonorgestrel|levonorgestrel|mesh-list
102063487|NCT02173808|Levonorgestrel butanoate|levonorgestrel butanoate|mesh-list
102063488|NCT02173808|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102063489|NCT02173808|Contraceptive Agents|contraceptive agents|mesh-ancestor
102063490|NCT02173808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102063491|NCT02173808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063492|NCT02173808|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102063493|NCT02173808|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102063494|NCT02173808|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102063495|NCT02173808|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102063496|NCT02173886|Bupropion|bupropion|mesh-list
102063497|NCT02173886|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102063498|NCT02173886|Antidepressive Agents|antidepressive agents|mesh-ancestor
102063499|NCT02173886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102063500|NCT02173886|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102063501|NCT02173886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102063502|NCT02173886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102063503|NCT02173886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063504|NCT02173886|Dopamine Agents|dopamine agents|mesh-ancestor
101942663|NCT01138839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101942664|NCT01138839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101942665|NCT01234623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101942666|NCT01234623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102063505|NCT02173886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102063506|NCT02173886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063507|NCT02173886|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102063508|NCT02173886|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102063509|NCT02173886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102063510|NCT02173964|Pinaverium|pinaverium|mesh-list
102063511|NCT02173964|Bromides|bromides|mesh-list
102063512|NCT02173964|Anticonvulsants|anticonvulsants|mesh-ancestor
102063513|NCT02173964|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102063514|NCT02173964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102063515|NCT02173964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365074|NCT00150007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102063529|NCT02175602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063530|NCT02175602|Antidepressive Agents|antidepressive agents|mesh-ancestor
102063531|NCT02175602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102063532|NCT03686085|Dinoprostone|dinoprostone|mesh-list
102063533|NCT03686085|Oxytocics|oxytocics|mesh-ancestor
102063534|NCT03686085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102063535|NCT03686085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063536|NCT03693885|Oxytocin|oxytocin|mesh-list
102063537|NCT03693885|Oxytocics|oxytocics|mesh-ancestor
102063538|NCT03693885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102063539|NCT03693885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063540|NCT02174120|Propofol|propofol|mesh-list
102063541|NCT02174120|Etomidate|etomidate|mesh-list
102063542|NCT02174120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102063543|NCT02174120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102063544|NCT02174120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063545|NCT02174120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102063546|NCT02174120|Anesthetics, General|anesthetics, general|mesh-ancestor
102063547|NCT02174120|Anesthetics|anesthetics|mesh-ancestor
102063548|NCT02175914|Erythromycin|erythromycin|mesh-list
102063549|NCT02175914|Erythromycin Estolate|erythromycin estolate|mesh-list
102063550|NCT02175914|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
102063551|NCT02175914|Erythromycin stearate|erythromycin stearate|mesh-list
102063552|NCT02175914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102063553|NCT02175914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102063554|NCT02175914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102063555|NCT02175914|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102063556|NCT02175914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102063557|NCT02175914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063558|NCT02753816|Tranexamic Acid|tranexamic acid|mesh-list
102063559|NCT02753816|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102063560|NCT02753816|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102063561|NCT02753816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063562|NCT02753816|Hemostatics|hemostatics|mesh-ancestor
102063563|NCT02753816|Coagulants|coagulants|mesh-ancestor
102063564|NCT02179034|Menthol|menthol|mesh-list
102063565|NCT02179034|Nicotine|nicotine|mesh-list
102063566|NCT02179034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102063567|NCT02179034|Autonomic Agents|autonomic agents|mesh-ancestor
102063568|NCT02179034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102063569|NCT02179034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063570|NCT02179034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102063571|NCT02179034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102063572|NCT02179034|Cholinergic Agents|cholinergic agents|mesh-ancestor
102063573|NCT02179034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102063574|NCT02179034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063575|NCT02179034|Antipruritics|antipruritics|mesh-ancestor
102063576|NCT02179034|Dermatologic Agents|dermatologic agents|mesh-ancestor
102063577|NCT02174588|Midazolam|midazolam|mesh-list
102063587|NCT02174588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102063588|NCT02174588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102063589|NCT02174588|GABA Modulators|gaba modulators|mesh-ancestor
102063590|NCT02174588|GABA Agents|gaba agents|mesh-ancestor
102063591|NCT02174588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102063592|NCT02174588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063593|NCT03693573|Bevacizumab|bevacizumab|mesh-list
102063594|NCT03693573|Atezolizumab|atezolizumab|mesh-list
101942668|NCT01234701|Hematinics|hematinics|mesh-ancestor
101942669|NCT05280717|Sotrovimab|sotrovimab|mesh-list
101942670|NCT05280717|Antiviral Agents|antiviral agents|mesh-ancestor
101942671|NCT05280717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102063595|NCT03693573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102063596|NCT03693573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102063597|NCT03693573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102063598|NCT03693573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102063599|NCT03693573|Growth Substances|growth substances|mesh-ancestor
102063600|NCT03693573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063601|NCT03693573|Growth Inhibitors|growth inhibitors|mesh-ancestor
102063602|NCT03693573|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102063603|NCT03693573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063604|NCT02176304|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102063605|NCT02176304|Methylprednisolone|methylprednisolone|mesh-list
102063606|NCT02176304|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102063607|NCT02176304|Prednisolone|prednisolone|mesh-list
102063608|NCT02176304|Prednisolone acetate|prednisolone acetate|mesh-list
102063610|NCT02176304|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102063611|NCT02176304|Prednisolone phosphate|prednisolone phosphate|mesh-list
102063612|NCT02176304|Anesthetics, Local|anesthetics, local|mesh-ancestor
102063613|NCT02176304|Anesthetics|anesthetics|mesh-ancestor
102063614|NCT02176304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102063615|NCT02176304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063616|NCT02176304|Sensory System Agents|sensory system agents|mesh-ancestor
102063617|NCT02176304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102063618|NCT02176304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102063619|NCT02176304|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102063620|NCT02176304|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102063621|NCT02176304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102063622|NCT02176304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063623|NCT02176304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102063624|NCT02176304|Antiemetics|antiemetics|mesh-ancestor
102063625|NCT02176304|Autonomic Agents|autonomic agents|mesh-ancestor
102063626|NCT02176304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102063627|NCT02176304|Glucocorticoids|glucocorticoids|mesh-ancestor
102063628|NCT02176304|Hormones|hormones|mesh-ancestor
102063629|NCT02176304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101699259|NCT02576314|Sofosbuvir|sofosbuvir|mesh-list
102063630|NCT02176304|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102063631|NCT02176304|Protective Agents|protective agents|mesh-ancestor
102063632|NCT02176304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102063633|NCT02176304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102063634|NCT02176460|Colchicine|colchicine|mesh-list
102063635|NCT02176460|Gout Suppressants|gout suppressants|mesh-ancestor
102063636|NCT02176460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102063637|NCT02176460|Tubulin Modulators|tubulin modulators|mesh-ancestor
102063638|NCT02176460|Antimitotic Agents|antimitotic agents|mesh-ancestor
102063639|NCT02176460|Mitosis Modulators|mitosis modulators|mesh-ancestor
102063640|NCT02176460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063641|NCT02176460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102063642|NCT02256254|Simvastatin|simvastatin|mesh-list
102063643|NCT02256254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102063648|NCT02256254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102063649|NCT02256254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102063650|NCT02182076|Nintedanib|nintedanib|mesh-list
102063651|NCT02182076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102063652|NCT02182076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102063653|NCT02182076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102063654|NCT02182076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063655|NCT02179268|Sertraline|sertraline|mesh-list
102063656|NCT02179268|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102063657|NCT02179268|Citalopram|citalopram|mesh-list
102063658|NCT02179268|Reboxetine|reboxetine|mesh-list
102063659|NCT02179268|Antidepressive Agents|antidepressive agents|mesh-ancestor
102063660|NCT02179268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102063661|NCT02179268|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102063662|NCT02179268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102063663|NCT02179268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102063664|NCT02179268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942673|NCT04721613|Antioxidants|antioxidants|mesh-ancestor
101942674|NCT04721613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063665|NCT02179268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102063666|NCT02179268|Serotonin Agents|serotonin agents|mesh-ancestor
102063667|NCT02179268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063668|NCT02179268|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102063669|NCT02179268|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102063670|NCT02179268|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102063671|NCT02179268|Adrenergic Agents|adrenergic agents|mesh-ancestor
102063672|NCT02182154|Nintedanib|nintedanib|mesh-list
102063673|NCT02182154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102063674|NCT02182154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102063675|NCT02182154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102063676|NCT02182154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063677|NCT02182232|Paclitaxel|paclitaxel|mesh-list
102063678|NCT02182232|Carboplatin|carboplatin|mesh-list
102063679|NCT02182232|Nintedanib|nintedanib|mesh-list
102063680|NCT02182232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102063681|NCT02182232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102063682|NCT02182232|Tubulin Modulators|tubulin modulators|mesh-ancestor
102063683|NCT02182232|Antimitotic Agents|antimitotic agents|mesh-ancestor
102063684|NCT02182232|Mitosis Modulators|mitosis modulators|mesh-ancestor
102063685|NCT02182232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063686|NCT02182232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102063687|NCT02182232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102063688|NCT02182310|Moxifloxacin|moxifloxacin|mesh-list
102063689|NCT02182310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102063690|NCT02182310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102063691|NCT02182310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102063692|NCT02182310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102063693|NCT02182310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102063694|NCT02182310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063695|NCT02182310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102063696|NCT02176850|Telmisartan|telmisartan|mesh-list
102063697|NCT02176850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102063698|NCT02176850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102063699|NCT02176850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102063700|NCT02176850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063701|NCT03537326|Budesonide|budesonide|mesh-list
102063702|NCT03537326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102063703|NCT03537326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102063704|NCT03537326|Autonomic Agents|autonomic agents|mesh-ancestor
102063705|NCT03537326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102063706|NCT03537326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063707|NCT03537326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102063708|NCT03537326|Respiratory System Agents|respiratory system agents|mesh-ancestor
102063709|NCT03537326|Glucocorticoids|glucocorticoids|mesh-ancestor
102063710|NCT03537326|Hormones|hormones|mesh-ancestor
102063711|NCT03537326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102063712|NCT02182544|Ketotifen|ketotifen|mesh-list
102063725|NCT02179658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102063726|NCT02179658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102063727|NCT02177318|Bromides|bromides|mesh-list
102063728|NCT02177318|Tiotropium Bromide|tiotropium bromide|mesh-list
102063729|NCT02177318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102063730|NCT02177318|Autonomic Agents|autonomic agents|mesh-ancestor
102063731|NCT02177318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102063732|NCT02177318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063733|NCT02177318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102063734|NCT02177318|Respiratory System Agents|respiratory system agents|mesh-ancestor
102063735|NCT02177318|Parasympatholytics|parasympatholytics|mesh-ancestor
102063736|NCT02177318|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102063737|NCT02177318|Cholinergic Agents|cholinergic agents|mesh-ancestor
102063738|NCT02177318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102063739|NCT02177318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063740|NCT02177318|Anticonvulsants|anticonvulsants|mesh-ancestor
102063741|NCT02177396|Valsartan|valsartan|mesh-list
102063742|NCT02177396|Telmisartan|telmisartan|mesh-list
102063743|NCT02177396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102063744|NCT02177396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101942675|NCT04721613|Protective Agents|protective agents|mesh-ancestor
101942676|NCT04721613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307617|NCT02041481|Leucovorin|leucovorin|mesh-list
102063745|NCT02177396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102063746|NCT02177396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063747|NCT02030054|Atorvastatin|atorvastatin|mesh-list
102063748|NCT02030054|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102063749|NCT02030054|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102063750|NCT02030054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102063751|NCT02030054|Antimetabolites|antimetabolites|mesh-ancestor
102063752|NCT02030054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063753|NCT02030054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102063754|NCT02030054|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102063755|NCT02030054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102063756|NCT02182622|Prednisone|prednisone|mesh-list
102063757|NCT02182622|Docetaxel|docetaxel|mesh-list
102063758|NCT02182622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102063759|NCT02182622|Tubulin Modulators|tubulin modulators|mesh-ancestor
102063760|NCT02182622|Antimitotic Agents|antimitotic agents|mesh-ancestor
102063761|NCT02182622|Mitosis Modulators|mitosis modulators|mesh-ancestor
102063762|NCT02182622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063763|NCT02182622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102063764|NCT02182622|Glucocorticoids|glucocorticoids|mesh-ancestor
102063765|NCT02182622|Hormones|hormones|mesh-ancestor
102063766|NCT02182622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102063767|NCT02182622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063768|NCT02182622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102063769|NCT02182700|Bromides|bromides|mesh-list
102063770|NCT02182700|Albuterol|albuterol|mesh-list
102063771|NCT02182700|Ipratropium|ipratropium|mesh-list
102063772|NCT02182700|Anticonvulsants|anticonvulsants|mesh-ancestor
102063773|NCT02182700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102063774|NCT02182700|Autonomic Agents|autonomic agents|mesh-ancestor
102063775|NCT02182700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102063776|NCT02182700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063781|NCT02182700|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102063782|NCT02182700|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102063783|NCT02182700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102063784|NCT02182700|Adrenergic Agents|adrenergic agents|mesh-ancestor
102063785|NCT02182700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102063786|NCT02182700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063787|NCT02182700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102063788|NCT02182700|Cholinergic Agents|cholinergic agents|mesh-ancestor
102063790|NCT02182778|Gemcitabine|gemcitabine|mesh-list
102063791|NCT02182778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102063792|NCT02182778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102063793|NCT02182778|Antimetabolites|antimetabolites|mesh-ancestor
102063794|NCT02182778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063795|NCT03688971|Ketoconazole|ketoconazole|mesh-list
102063796|NCT03688971|Antifungal Agents|antifungal agents|mesh-ancestor
102063797|NCT03688971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102063798|NCT03688971|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102063799|NCT03688971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102063800|NCT03688971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102063801|NCT03688971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063802|NCT03688971|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102063803|NCT03688971|Hormone Antagonists|hormone antagonists|mesh-ancestor
102063804|NCT03688971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102063805|NCT03688971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063806|NCT03688971|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102063807|NCT02179814|Diphenhydramine|diphenhydramine|mesh-list
102063808|NCT02179814|Promethazine|promethazine|mesh-list
102063809|NCT02179814|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102063810|NCT02179814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102063811|NCT02179814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102063812|NCT02179814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063813|NCT02179814|Anesthetics, Local|anesthetics, local|mesh-ancestor
102063814|NCT02179814|Anesthetics|anesthetics|mesh-ancestor
102063815|NCT02179814|Sensory System Agents|sensory system agents|mesh-ancestor
102063816|NCT02179814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101942677|NCT04721613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101942678|NCT05275179|Posaconazole|posaconazole|mesh-list
101942679|NCT05275179|Antifungal Agents|antifungal agents|mesh-ancestor
102063817|NCT02179814|Antiemetics|antiemetics|mesh-ancestor
102063818|NCT02179814|Autonomic Agents|autonomic agents|mesh-ancestor
102063819|NCT02179814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102063820|NCT02179814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102063821|NCT02179814|Histamine Antagonists|histamine antagonists|mesh-ancestor
102063822|NCT02179814|Histamine Agents|histamine agents|mesh-ancestor
102063823|NCT02179814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102063824|NCT02179814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063825|NCT02179814|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102063826|NCT02179814|Antipruritics|antipruritics|mesh-ancestor
102063827|NCT02179814|Dermatologic Agents|dermatologic agents|mesh-ancestor
102063828|NCT02179970|Plerixafor|plerixafor|mesh-list
102063829|NCT02179970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102063830|NCT02179970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102063831|NCT02179970|Antiviral Agents|antiviral agents|mesh-ancestor
102063832|NCT02179970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102063833|NCT03537950|Cannabidiol|cannabidiol|mesh-list
102063834|NCT03537950|Anticonvulsants|anticonvulsants|mesh-ancestor
102063835|NCT02182856|Bromides|bromides|mesh-list
102063836|NCT02182856|Albuterol|albuterol|mesh-list
102063837|NCT02182856|Ipratropium|ipratropium|mesh-list
102063838|NCT02182856|Anticonvulsants|anticonvulsants|mesh-ancestor
102063839|NCT02182856|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102063840|NCT02182856|Autonomic Agents|autonomic agents|mesh-ancestor
102063841|NCT02182856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102063842|NCT02182856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063843|NCT02182856|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102063844|NCT02182856|Respiratory System Agents|respiratory system agents|mesh-ancestor
102063845|NCT02182856|Tocolytic Agents|tocolytic agents|mesh-ancestor
102063846|NCT02182856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102063847|NCT02182856|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102063863|NCT02183012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102063864|NCT02183012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102063865|NCT02183012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102063866|NCT02183012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063868|NCT02180048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102063869|NCT02180048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063870|NCT02180048|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102063871|NCT02180048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102063872|NCT02180048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063873|NCT02180048|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102063874|NCT02180048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102063875|NCT02180048|Purinergic Agents|purinergic agents|mesh-ancestor
102063876|NCT02180048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102063877|NCT03688659|Vancomycin|vancomycin|mesh-list
102063878|NCT03688659|Gentamicins|gentamicins|mesh-list
102063879|NCT03688659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102063880|NCT03688659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102063881|NCT03688659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102063882|NCT03688659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102063883|NCT03688659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063884|NCT03683043|Leuprolide|leuprolide|mesh-list
102063885|NCT03683043|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101699334|NCT00652730|Buspirone|buspirone|mesh-list
102063886|NCT03683043|Fertility Agents|fertility agents|mesh-ancestor
102063887|NCT03683043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102063888|NCT03683043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063889|NCT03683043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102063890|NCT03683043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102063891|NCT02180204|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102063892|NCT02180204|Tenecteplase|tenecteplase|mesh-list
102063893|NCT02180204|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102063894|NCT02180204|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102063895|NCT02180204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063897|NCT02183090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102063898|NCT02183090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102063899|NCT02183090|Analgesics|analgesics|mesh-ancestor
102063900|NCT02183090|Sensory System Agents|sensory system agents|mesh-ancestor
102063901|NCT02183090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102063902|NCT02183090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942680|NCT05275179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101942681|NCT05275179|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101942682|NCT05275179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102063903|NCT02183090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102063904|NCT02183090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102063905|NCT02183090|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102063910|NCT02177552|Docetaxel|docetaxel|mesh-list
102063911|NCT02177552|Capecitabine|capecitabine|mesh-list
102063912|NCT02177552|Oxaliplatin|oxaliplatin|mesh-list
102063913|NCT02177552|Epirubicin|epirubicin|mesh-list
102063914|NCT02177552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102063915|NCT02177552|Tubulin Modulators|tubulin modulators|mesh-ancestor
102063916|NCT02177552|Antimitotic Agents|antimitotic agents|mesh-ancestor
102063917|NCT02177552|Mitosis Modulators|mitosis modulators|mesh-ancestor
102063918|NCT02177552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063919|NCT02177552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102063920|NCT02177552|Antimetabolites|antimetabolites|mesh-ancestor
102063921|NCT02177552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102063922|NCT02177552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102063923|NCT02177552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102063924|NCT02177552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102063925|NCT03682653|Azithromycin|azithromycin|mesh-list
102063926|NCT03682653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102063927|NCT03682653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102063928|NCT03684993|Chlorhexidine|chlorhexidine|mesh-list
102063929|NCT03684993|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102063930|NCT03684993|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102063931|NCT03684993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102063932|NCT03684993|Disinfectants|disinfectants|mesh-ancestor
102063933|NCT03684993|Dermatologic Agents|dermatologic agents|mesh-ancestor
102063934|NCT04062279|Autoantibodies|autoantibodies|mesh-list
102063935|NCT04062279|Immunologic Factors|immunologic factors|mesh-ancestor
102063936|NCT04062279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063937|NCT02183168|Indomethacin|indomethacin|mesh-list
102063938|NCT02183168|Meloxicam|meloxicam|mesh-list
102063939|NCT02183168|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102063940|NCT02183168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102063941|NCT02183168|Analgesics|analgesics|mesh-ancestor
102063942|NCT02183168|Sensory System Agents|sensory system agents|mesh-ancestor
102063943|NCT02183168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102063944|NCT02183168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063945|NCT02183168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102063946|NCT02183168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102063947|NCT02183168|Gout Suppressants|gout suppressants|mesh-ancestor
102063948|NCT02183168|Tocolytic Agents|tocolytic agents|mesh-ancestor
102063949|NCT02183168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102063950|NCT02183168|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102063951|NCT02183168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102063952|NCT02183168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063953|NCT02183168|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102063954|NCT02183246|Porfiromycin|porfiromycin|mesh-list
102063955|NCT02183246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102063956|NCT02183246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102063957|NCT02183324|Linagliptin|linagliptin|mesh-list
102063958|NCT02183324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102063959|NCT02183324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063960|NCT02183324|Incretins|incretins|mesh-ancestor
102063961|NCT02183324|Hormones|hormones|mesh-ancestor
102063962|NCT02183324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102063963|NCT02183324|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102063964|NCT02183324|Protease Inhibitors|protease inhibitors|mesh-ancestor
102063965|NCT02183324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102063966|NCT02183324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063967|NCT02183402|Linagliptin|linagliptin|mesh-list
101783666|NCT00267865|Vitamins|vitamins|mesh-ancestor
102063968|NCT02183402|Digoxin|digoxin|mesh-list
102063969|NCT02183402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102063970|NCT02183402|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102063971|NCT02183402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102063972|NCT02183402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063973|NCT02183402|Protective Agents|protective agents|mesh-ancestor
102063974|NCT02183402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063975|NCT02183402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102063976|NCT02183402|Incretins|incretins|mesh-ancestor
101942683|NCT05275179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101942684|NCT05275179|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101942685|NCT05275179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101942686|NCT05275179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102063977|NCT02183402|Hormones|hormones|mesh-ancestor
102063985|NCT02183480|Hormones|hormones|mesh-ancestor
102063986|NCT02183480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102063987|NCT02183480|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102063988|NCT02183480|Protease Inhibitors|protease inhibitors|mesh-ancestor
102063989|NCT02183480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102063990|NCT02183480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063991|NCT05141864|Lidocaine|lidocaine|mesh-list
102063992|NCT05141864|Anesthetics, Local|anesthetics, local|mesh-ancestor
102063993|NCT05141864|Anesthetics|anesthetics|mesh-ancestor
102063994|NCT05141864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102063995|NCT05141864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063996|NCT05141864|Sensory System Agents|sensory system agents|mesh-ancestor
102063997|NCT05141864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101699359|NCT00635531|Alprazolam|alprazolam|mesh-list
102063998|NCT05141864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102063999|NCT05141864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102064000|NCT05141864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102064001|NCT05141864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102064002|NCT05141864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064003|NCT02180516|Meloxicam|meloxicam|mesh-list
102064004|NCT02180516|Etodolac|etodolac|mesh-list
102064005|NCT02180516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
102064006|NCT02180516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102064007|NCT02180516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102064008|NCT02180516|Analgesics|analgesics|mesh-ancestor
102064009|NCT02180516|Sensory System Agents|sensory system agents|mesh-ancestor
102064010|NCT02180516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102064011|NCT02180516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064012|NCT02180516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102064013|NCT02180516|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102064014|NCT02180516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102064015|NCT02180516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102064016|NCT02180516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064017|NCT02183636|Pioglitazone|pioglitazone|mesh-list
102064018|NCT02183636|Linagliptin|linagliptin|mesh-list
102064019|NCT02183636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102064020|NCT02183636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064021|NCT02183636|Incretins|incretins|mesh-ancestor
102064022|NCT02183636|Hormones|hormones|mesh-ancestor
102064023|NCT02183636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102064024|NCT02183636|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102064025|NCT02183636|Protease Inhibitors|protease inhibitors|mesh-ancestor
102064026|NCT02183636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102064027|NCT02183636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064028|NCT02183948|Oxytocin|oxytocin|mesh-list
102064029|NCT02183948|Oxytocics|oxytocics|mesh-ancestor
102064030|NCT02183948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102064031|NCT02183948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064032|NCT02184104|Caffeine|caffeine|mesh-list
102064033|NCT02184104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102064034|NCT02184104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064035|NCT02184104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102064036|NCT02184104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102064037|NCT02184104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064038|NCT02184104|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102064039|NCT02184104|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102064040|NCT02184104|Purinergic Agents|purinergic agents|mesh-ancestor
102064041|NCT02184104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102064042|NCT02184260|Dipyrone|dipyrone|mesh-list
102064051|NCT02184260|Antipyretics|antipyretics|mesh-ancestor
102064052|NCT03813147|Cytarabine|cytarabine|mesh-list
102064053|NCT03813147|Hydrocortisone|hydrocortisone|mesh-list
102064054|NCT03813147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102064055|NCT03813147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102064056|NCT03813147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101942687|NCT05275179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942688|NCT05275179|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101942689|NCT05275179|Hormone Antagonists|hormone antagonists|mesh-ancestor
102064057|NCT03813147|Methotrexate|methotrexate|mesh-list
102064058|NCT03813147|Fludarabine phosphate|fludarabine phosphate|mesh-list
102064059|NCT03813147|Azacitidine|azacitidine|mesh-list
102064060|NCT03813147|Fludarabine|fludarabine|mesh-list
102064061|NCT03813147|Enzyme Inhibitors|enzyme inhibitors|mesh-list
102064062|NCT03813147|Pevonedistat|pevonedistat|mesh-list
102064063|NCT03813147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102064064|NCT03813147|Abortifacient Agents|abortifacient agents|mesh-ancestor
102064065|NCT03813147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102064066|NCT03813147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064067|NCT03813147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102064068|NCT03813147|Antimetabolites|antimetabolites|mesh-ancestor
102064069|NCT03813147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064070|NCT03813147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102064071|NCT03813147|Dermatologic Agents|dermatologic agents|mesh-ancestor
102064072|NCT03813147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102064073|NCT03813147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102064074|NCT03813147|Immunologic Factors|immunologic factors|mesh-ancestor
102064075|NCT03813147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102064076|NCT03813147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102064077|NCT03813147|Antiviral Agents|antiviral agents|mesh-ancestor
102064078|NCT03813147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102064079|NCT03813147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102064080|NCT03684837|Vitamin D|vitamin d|mesh-list
102064081|NCT03684837|Vitamins|vitamins|mesh-ancestor
102064082|NCT03684837|Micronutrients|micronutrients|mesh-ancestor
102064083|NCT03684837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064084|NCT03684837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102064085|NCT03810417|Digoxin|digoxin|mesh-list
102064086|NCT03810417|Antibodies|antibodies|mesh-list
102064087|NCT03810417|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
102064088|NCT03810417|Immunologic Factors|immunologic factors|mesh-ancestor
102064089|NCT03810417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064090|NCT03810417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102064091|NCT03810417|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102064092|NCT03810417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102064093|NCT03810417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064094|NCT03810417|Protective Agents|protective agents|mesh-ancestor
102064095|NCT03808155|Tamsulosin|tamsulosin|mesh-list
102064096|NCT03808155|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102064097|NCT03808155|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102064098|NCT03808155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102064099|NCT03808155|Adrenergic Agents|adrenergic agents|mesh-ancestor
102064100|NCT03808155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102064101|NCT03808155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064102|NCT03808155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064103|NCT03808155|Urological Agents|urological agents|mesh-ancestor
102064104|NCT02752958|Fluorides|fluorides|mesh-list
102064105|NCT02752958|Tin Fluorides|tin fluorides|mesh-list
102064106|NCT02752958|Cariostatic Agents|cariostatic agents|mesh-ancestor
102064107|NCT02752958|Protective Agents|protective agents|mesh-ancestor
102064108|NCT02752958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064109|NCT02181218|Dexamethasone|dexamethasone|mesh-list
102064110|NCT02181218|Dexamethasone acetate|dexamethasone acetate|mesh-list
102064114|NCT02181218|BB 1101|bb 1101|mesh-list
102064115|NCT02181218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102064116|NCT02181218|Antiemetics|antiemetics|mesh-ancestor
102064117|NCT02181218|Autonomic Agents|autonomic agents|mesh-ancestor
102064118|NCT02181218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102064119|NCT02181218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064120|NCT02181218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102064121|NCT02181218|Glucocorticoids|glucocorticoids|mesh-ancestor
102064122|NCT02181218|Hormones|hormones|mesh-ancestor
102064123|NCT02181218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102064124|NCT02181218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102064125|NCT02181218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102064126|NCT02181218|Protease Inhibitors|protease inhibitors|mesh-ancestor
102064127|NCT02181218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102064128|NCT02181218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942690|NCT05275179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102064129|NCT02181218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102064130|NCT02181218|Antimetabolites|antimetabolites|mesh-ancestor
102064131|NCT02181218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102064132|NCT02181218|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102064133|NCT03536234|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102064134|NCT03536234|Luteolytic Agents|luteolytic agents|mesh-ancestor
102064135|NCT03536234|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102064136|NCT03536234|Contraceptive Agents|contraceptive agents|mesh-ancestor
102064137|NCT03536234|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102064138|NCT03536234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064139|NCT03536234|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102064140|NCT03536234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102064141|NCT03536234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102064142|NCT03682497|Spironolactone|spironolactone|mesh-list
102064143|NCT03682497|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102064144|NCT03682497|Hormone Antagonists|hormone antagonists|mesh-ancestor
102064145|NCT03682497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102064146|NCT03682497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064147|NCT03682497|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102064148|NCT03682497|Diuretics|diuretics|mesh-ancestor
102064149|NCT03682497|Natriuretic Agents|natriuretic agents|mesh-ancestor
102064150|NCT02185898|Menthol|menthol|mesh-list
102064151|NCT02185898|Nicotine|nicotine|mesh-list
102064152|NCT02185898|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102064153|NCT02185898|Autonomic Agents|autonomic agents|mesh-ancestor
102064154|NCT02185898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102064155|NCT02185898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064156|NCT02185898|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102064157|NCT02185898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102064158|NCT02185898|Cholinergic Agents|cholinergic agents|mesh-ancestor
102064159|NCT02185898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102064160|NCT02185898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064161|NCT02185898|Antipruritics|antipruritics|mesh-ancestor
102064162|NCT02185898|Dermatologic Agents|dermatologic agents|mesh-ancestor
102064163|NCT02805660|Durvalumab|durvalumab|mesh-list
102064164|NCT02805660|Mocetinostat|mocetinostat|mesh-list
102064165|NCT02805660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102064166|NCT02805660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102064167|NCT02805660|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102064168|NCT02805660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102064169|NCT02805660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064170|NCT02186132|Atropine|atropine|mesh-list
102064171|NCT02186132|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102064172|NCT02186132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102064173|NCT02186132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102064174|NCT02186132|Autonomic Agents|autonomic agents|mesh-ancestor
102064175|NCT02186132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102064176|NCT02186132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064177|NCT02186132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102064178|NCT02186132|Respiratory System Agents|respiratory system agents|mesh-ancestor
102064179|NCT02186132|Mydriatics|mydriatics|mesh-ancestor
102064180|NCT02186132|Parasympatholytics|parasympatholytics|mesh-ancestor
102064181|NCT02186132|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102064182|NCT02186132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101365737|NCT00152620|Glucocorticoids|glucocorticoids|mesh-ancestor
102064189|NCT03536780|Antimetabolites|antimetabolites|mesh-ancestor
102064190|NCT03536780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064191|NCT03536780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102064192|NCT03536780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102064194|NCT02052336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102064195|NCT02052336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102064196|NCT02052336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102064197|NCT02052336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102064198|NCT02052336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064199|NCT02052336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102064200|NCT02052336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102064201|NCT02181920|Dipyrone|dipyrone|mesh-list
102064202|NCT02181920|Diclofenac|diclofenac|mesh-list
102064203|NCT02181920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102064204|NCT02181920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102064205|NCT02181920|Analgesics|analgesics|mesh-ancestor
101942691|NCT05275179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942692|NCT01139151|Cytarabine|cytarabine|mesh-list
102064206|NCT02181920|Sensory System Agents|sensory system agents|mesh-ancestor
102064207|NCT02181920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102064208|NCT02181920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064209|NCT02181920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102064210|NCT02181920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102064211|NCT02181920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102064212|NCT02181920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102064213|NCT02181920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064214|NCT02181920|Antipyretics|antipyretics|mesh-ancestor
102064215|NCT02185118|Sevoflurane|sevoflurane|mesh-list
102064216|NCT02185118|Isoflurane|isoflurane|mesh-list
102064217|NCT02185118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102064218|NCT02185118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102064219|NCT02185118|Anesthetics, General|anesthetics, general|mesh-ancestor
102064220|NCT02185118|Anesthetics|anesthetics|mesh-ancestor
102064221|NCT02185118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102064222|NCT02185118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064223|NCT02186366|Buspirone|buspirone|mesh-list
102064224|NCT02186366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102064225|NCT02186366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102064226|NCT02186366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102064227|NCT02186366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064228|NCT02186366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102064229|NCT02186366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102064230|NCT02186366|Serotonin Agents|serotonin agents|mesh-ancestor
102064231|NCT02186366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102064232|NCT02186366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064233|NCT02053974|Spironolactone|spironolactone|mesh-list
102064234|NCT02053974|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102064235|NCT02053974|Hormone Antagonists|hormone antagonists|mesh-ancestor
102064236|NCT02053974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102064237|NCT02053974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064238|NCT02053974|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102064239|NCT02053974|Diuretics|diuretics|mesh-ancestor
102064240|NCT02053974|Natriuretic Agents|natriuretic agents|mesh-ancestor
102064241|NCT02185196|Vitamin D|vitamin d|mesh-list
102064242|NCT02185196|Cholecalciferol|cholecalciferol|mesh-list
102064243|NCT02185196|Vitamins|vitamins|mesh-ancestor
102064244|NCT02185196|Micronutrients|micronutrients|mesh-ancestor
102064245|NCT02185196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064246|NCT02185196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102064247|NCT02185196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102064248|NCT02052492|Vitamin D|vitamin d|mesh-list
102064249|NCT02052492|Vitamins|vitamins|mesh-ancestor
102064250|NCT02052492|Micronutrients|micronutrients|mesh-ancestor
102064257|NCT02181998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102064258|NCT02181998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102064259|NCT02181998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064260|NCT02054052|Bevacizumab|bevacizumab|mesh-list
102064261|NCT02054052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102064262|NCT02054052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102064263|NCT02054052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102064264|NCT02054052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102064265|NCT02054052|Growth Substances|growth substances|mesh-ancestor
102064266|NCT02054052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064267|NCT02054052|Growth Inhibitors|growth inhibitors|mesh-ancestor
102064268|NCT02185352|Cisplatin|cisplatin|mesh-list
102064269|NCT02185352|Etoposide|etoposide|mesh-list
101783968|NCT00842556|Dapagliflozin|dapagliflozin|mesh-list
102064270|NCT02185352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102064271|NCT02185352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102064272|NCT02185352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102064273|NCT02185352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102064274|NCT02185352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102064275|NCT02185352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064276|NCT02186600|Vitamin D|vitamin d|mesh-list
102064277|NCT02186600|Cholecalciferol|cholecalciferol|mesh-list
102064278|NCT02186600|Risedronic Acid|risedronic acid|mesh-list
102064279|NCT02186600|Calcium Carbonate|calcium carbonate|mesh-list
102064280|NCT02186600|Calcium|calcium|mesh-list
102064281|NCT02186600|Vitamins|vitamins|mesh-ancestor
102064282|NCT02186600|Micronutrients|micronutrients|mesh-ancestor
101942693|NCT01139151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101942694|NCT01139151|Antimetabolites|antimetabolites|mesh-ancestor
101942695|NCT01139151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942696|NCT01139151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102064283|NCT02186600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064284|NCT02186600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102064285|NCT02186600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102064286|NCT02186600|Antacids|antacids|mesh-ancestor
102064287|NCT02186600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064288|NCT02186600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102064289|NCT02186600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102064290|NCT02186600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102064291|NCT02052726|Vaccines|vaccines|mesh-list
102064292|NCT02052726|Immunologic Factors|immunologic factors|mesh-ancestor
102064293|NCT02052726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064294|NCT02185430|Dexmedetomidine|dexmedetomidine|mesh-list
102064295|NCT02185430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102064296|NCT02185430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102064297|NCT02185430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064298|NCT02185430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102064299|NCT02185430|Analgesics|analgesics|mesh-ancestor
102064300|NCT02185430|Sensory System Agents|sensory system agents|mesh-ancestor
102064301|NCT02185430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102064302|NCT02185430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102064303|NCT02185430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102064304|NCT02185430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102064305|NCT02185430|Adrenergic Agents|adrenergic agents|mesh-ancestor
102064306|NCT02185430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102064307|NCT02185430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064308|NCT03536390|Methylphenidate|methylphenidate|mesh-list
102064309|NCT03536390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102064310|NCT03536390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064311|NCT03536390|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102064312|NCT03536390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102064313|NCT03536390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102064314|NCT03536390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064315|NCT03536390|Dopamine Agents|dopamine agents|mesh-ancestor
102064316|NCT03536390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102064317|NCT03561870|Olaparib|olaparib|mesh-list
102064318|NCT03561870|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102064332|NCT05657028|Anesthetics, Local|anesthetics, local|mesh-ancestor
102064333|NCT05657028|Anesthetics|anesthetics|mesh-ancestor
102064334|NCT05657028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102064335|NCT05657028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064336|NCT05657028|Sensory System Agents|sensory system agents|mesh-ancestor
102064337|NCT05657028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102064338|NCT05657028|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102064339|NCT05657028|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102064340|NCT05657028|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102064341|NCT05657028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102064342|NCT05657028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064343|NCT05657028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102064344|NCT05657028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102064345|NCT05657028|Analgesics|analgesics|mesh-ancestor
102064346|NCT05657028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102064347|NCT05657028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102064348|NCT05657028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102064349|NCT05657028|Adrenergic Agents|adrenergic agents|mesh-ancestor
102064350|NCT05657028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102064351|NCT02187068|Dexmedetomidine|dexmedetomidine|mesh-list
102064352|NCT02187068|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102064353|NCT02187068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102064354|NCT02187068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064355|NCT02187068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102064356|NCT02187068|Analgesics|analgesics|mesh-ancestor
102064357|NCT02187068|Sensory System Agents|sensory system agents|mesh-ancestor
102064358|NCT02187068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101942697|NCT01139151|Antiviral Agents|antiviral agents|mesh-ancestor
101942698|NCT01139151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101942699|NCT01139151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101942700|NCT01139151|Immunologic Factors|immunologic factors|mesh-ancestor
101942701|NCT01139151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942703|NCT01234857|Exemestane|exemestane|mesh-list
101942704|NCT01234857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101942705|NCT01234857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101942706|NCT01234857|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101942707|NCT01234857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101942708|NCT01234857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101942709|NCT01234857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064359|NCT02187068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102064360|NCT02187068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102064361|NCT02187068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102064362|NCT02187068|Adrenergic Agents|adrenergic agents|mesh-ancestor
102064363|NCT02187068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102064364|NCT02187068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064365|NCT02054442|Methotrexate|methotrexate|mesh-list
102064366|NCT02054442|Cetuximab|cetuximab|mesh-list
102064367|NCT02054442|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102064368|NCT02054442|Abortifacient Agents|abortifacient agents|mesh-ancestor
102064369|NCT02054442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102064370|NCT02054442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064371|NCT02054442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102064372|NCT02054442|Antimetabolites|antimetabolites|mesh-ancestor
102064373|NCT02054442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064374|NCT02054442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102064375|NCT02054442|Dermatologic Agents|dermatologic agents|mesh-ancestor
102064376|NCT02054442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102064377|NCT02054442|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102064378|NCT02054442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102064379|NCT02054442|Immunologic Factors|immunologic factors|mesh-ancestor
102064385|NCT02054676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102064386|NCT02054676|Analgesics|analgesics|mesh-ancestor
102064387|NCT02054676|Sensory System Agents|sensory system agents|mesh-ancestor
102064388|NCT02054676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102064389|NCT02054676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064390|NCT02054676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102064391|NCT02054676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102064392|NCT02054676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102064393|NCT02054676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102064394|NCT02054676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064395|NCT02256956|Amitriptyline|amitriptyline|mesh-list
102064396|NCT02256956|Tolterodine Tartrate|tolterodine tartrate|mesh-list
102064397|NCT02256956|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102064398|NCT02256956|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102064399|NCT02256956|Cholinergic Agents|cholinergic agents|mesh-ancestor
102064400|NCT02256956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102064401|NCT02256956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064402|NCT02256956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064403|NCT02256956|Urological Agents|urological agents|mesh-ancestor
102064404|NCT02256956|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102064405|NCT02256956|Antidepressive Agents|antidepressive agents|mesh-ancestor
102064406|NCT02256956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102064407|NCT02256956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102064408|NCT02256956|Analgesics|analgesics|mesh-ancestor
102064409|NCT02256956|Sensory System Agents|sensory system agents|mesh-ancestor
102064410|NCT02256956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102064411|NCT02256956|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102064412|NCT02256956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101942710|NCT01234857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101942711|NCT01234857|Hormone Antagonists|hormone antagonists|mesh-ancestor
101942712|NCT01234857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101942713|NCT01234857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942714|NCT01234857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101942715|NCT01234857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101942716|NCT01234857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101942717|NCT01234857|Antifungal Agents|antifungal agents|mesh-ancestor
101942718|NCT01234857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101942719|NCT01234857|Immunologic Factors|immunologic factors|mesh-ancestor
101942720|NCT01233843|Carboplatin|carboplatin|mesh-list
101942721|NCT01233843|Fluorouracil|fluorouracil|mesh-list
101942722|NCT01233843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101942723|NCT01233843|Antimetabolites|antimetabolites|mesh-ancestor
102064413|NCT02256956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102064414|NCT02256956|Adrenergic Agents|adrenergic agents|mesh-ancestor
102064415|NCT02187536|Telmisartan|telmisartan|mesh-list
102064416|NCT02187536|Simvastatin|simvastatin|mesh-list
102064417|NCT02187536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102064418|NCT02187536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102064419|NCT02187536|Antimetabolites|antimetabolites|mesh-ancestor
102064420|NCT02187536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064421|NCT02187536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102064422|NCT02187536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102064423|NCT02187536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102064424|NCT02187536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102064425|NCT02187536|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102064426|NCT02187536|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102064428|NCT02256722|Bisoprolol|bisoprolol|mesh-list
102064429|NCT02256722|Acipimox|acipimox|mesh-list
102064430|NCT02256722|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102064431|NCT02256722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102064432|NCT02256722|Autonomic Agents|autonomic agents|mesh-ancestor
102064433|NCT02256722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102064434|NCT02256722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064435|NCT02256722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102064436|NCT02256722|Respiratory System Agents|respiratory system agents|mesh-ancestor
102064437|NCT02256722|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102064438|NCT02256722|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102064439|NCT02256722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102064440|NCT02256722|Adrenergic Agents|adrenergic agents|mesh-ancestor
102064441|NCT02256722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102064442|NCT02256722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064443|NCT02256722|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102064444|NCT02256722|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102064445|NCT02256722|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102064446|NCT02256722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102064447|NCT02256722|Vasodilator Agents|vasodilator agents|mesh-ancestor
102064448|NCT02256722|Sympatholytics|sympatholytics|mesh-ancestor
102064451|NCT02256722|Antimetabolites|antimetabolites|mesh-ancestor
102064452|NCT02256722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102064453|NCT02193620|Nalbuphine|nalbuphine|mesh-list
102064454|NCT02193620|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102064455|NCT02193620|Narcotics|narcotics|mesh-ancestor
102064456|NCT02193620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102064457|NCT02193620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064458|NCT02193620|Analgesics|analgesics|mesh-ancestor
102064459|NCT02193620|Sensory System Agents|sensory system agents|mesh-ancestor
101699430|NCT02768207|Vemurafenib|vemurafenib|mesh-list
102064460|NCT02193620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102064461|NCT02187614|Acetaminophen|acetaminophen|mesh-list
102064462|NCT02187614|Diclofenac|diclofenac|mesh-list
101942724|NCT01233843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942725|NCT01233843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101942726|NCT01233843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101942727|NCT01233843|Immunologic Factors|immunologic factors|mesh-ancestor
101942728|NCT01233843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942729|NCT01234935|Gemcitabine|gemcitabine|mesh-list
101942730|NCT01234935|Dasatinib|dasatinib|mesh-list
101942731|NCT01234935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101942732|NCT01234935|Antimetabolites|antimetabolites|mesh-ancestor
101942733|NCT01234935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064463|NCT02187614|Morphine|morphine|mesh-list
102064464|NCT02187614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102064465|NCT02187614|Narcotics|narcotics|mesh-ancestor
102064466|NCT02187614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102064467|NCT02187614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064468|NCT02187614|Analgesics|analgesics|mesh-ancestor
102064469|NCT02187614|Sensory System Agents|sensory system agents|mesh-ancestor
102064470|NCT02187614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102064471|NCT02187614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102064472|NCT02187614|Antipyretics|antipyretics|mesh-ancestor
102064473|NCT02187614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102064474|NCT02187614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102064475|NCT02187614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102064476|NCT02187614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102064477|NCT02187614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102064478|NCT02187614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064479|NCT02030678|Irinotecan|irinotecan|mesh-list
102064480|NCT02030678|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102064481|NCT02030678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102064482|NCT02030678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102064483|NCT02030678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064484|NCT02030678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102064485|NCT02054988|Caffeine|caffeine|mesh-list
102064486|NCT02054988|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102064487|NCT02054988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064488|NCT02054988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102064489|NCT02054988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102064490|NCT02054988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064491|NCT02054988|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102064492|NCT02054988|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102064493|NCT02054988|Purinergic Agents|purinergic agents|mesh-ancestor
102064494|NCT02054988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102064495|NCT02191124|Mirtazapine|mirtazapine|mesh-list
102064496|NCT02191124|Paroxetine|paroxetine|mesh-list
102064497|NCT02191124|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102064498|NCT02191124|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102064499|NCT02191124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102064500|NCT02191124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064501|NCT02191124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102064502|NCT02191124|Serotonin Agents|serotonin agents|mesh-ancestor
102064503|NCT02191124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064504|NCT02191124|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102064505|NCT02191124|Antidepressive Agents|antidepressive agents|mesh-ancestor
102064506|NCT02191124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102064507|NCT02191124|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102064508|NCT02191124|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102064509|NCT02191124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102064510|NCT02191124|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102064511|NCT02191124|Histamine Antagonists|histamine antagonists|mesh-ancestor
102064512|NCT02191124|Histamine Agents|histamine agents|mesh-ancestor
102064513|NCT02191124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101699439|NCT02653196|Melphalan|melphalan|mesh-list
102064514|NCT02191124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101942734|NCT01234935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101942735|NCT01234935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101942736|NCT01234935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101942738|NCT03674541|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
101942739|NCT03674541|Anticonvulsants|anticonvulsants|mesh-ancestor
101942740|NCT03674541|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101942741|NCT03674541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101307676|NCT02042482|Coenzyme Q10|coenzyme q10|mesh-list
102064515|NCT02191124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102064516|NCT02191124|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102064517|NCT02191124|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102064518|NCT02191124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102064519|NCT02191124|Adrenergic Agents|adrenergic agents|mesh-ancestor
102064531|NCT02193698|Glucocorticoids|glucocorticoids|mesh-ancestor
102064533|NCT02193698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102064534|NCT02193698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102064535|NCT02193698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102064536|NCT02193698|Immunologic Factors|immunologic factors|mesh-ancestor
102064537|NCT02193698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102064538|NCT02193698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102064539|NCT02193698|Growth Substances|growth substances|mesh-ancestor
102064540|NCT02193698|Growth Inhibitors|growth inhibitors|mesh-ancestor
102064541|NCT02191202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
102064542|NCT02191202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102064543|NCT02191202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102064544|NCT02191202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064545|NCT02191202|Antiviral Agents|antiviral agents|mesh-ancestor
102064546|NCT02191202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102064547|NCT02055300|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
102064548|NCT02055300|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102064549|NCT02055300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102064550|NCT02055300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102064551|NCT02055300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064552|NCT02055300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102064553|NCT02055300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064554|NCT02055300|Antidepressive Agents|antidepressive agents|mesh-ancestor
102064555|NCT02055300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102064556|NCT02191280|Quercetin|quercetin|mesh-list
102064557|NCT02191280|Antioxidants|antioxidants|mesh-ancestor
102064558|NCT02191280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064559|NCT02191280|Protective Agents|protective agents|mesh-ancestor
102064560|NCT02191280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064561|NCT02055378|Atropine|atropine|mesh-list
102064562|NCT02055378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102064563|NCT02055378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102064564|NCT02055378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102064565|NCT02055378|Autonomic Agents|autonomic agents|mesh-ancestor
102064566|NCT02055378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102064567|NCT02055378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064568|NCT02055378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102064569|NCT02055378|Respiratory System Agents|respiratory system agents|mesh-ancestor
102064570|NCT02055378|Mydriatics|mydriatics|mesh-ancestor
102064571|NCT02055378|Parasympatholytics|parasympatholytics|mesh-ancestor
102064572|NCT02055378|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102064573|NCT02055378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102064574|NCT02055378|Cholinergic Agents|cholinergic agents|mesh-ancestor
102064575|NCT02055378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102064576|NCT02055378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064577|NCT04558190|Ubiquinone|ubiquinone|mesh-list
102064578|NCT04558190|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102064579|NCT04558190|Albuterol|albuterol|mesh-list
102064580|NCT04558190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102064581|NCT04558190|Autonomic Agents|autonomic agents|mesh-ancestor
102064585|NCT04558190|Respiratory System Agents|respiratory system agents|mesh-ancestor
101942742|NCT03674541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942744|NCT03674541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101942745|NCT03674541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942746|NCT01235013|Maraviroc|maraviroc|mesh-list
101942747|NCT01235013|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102064586|NCT04558190|Tocolytic Agents|tocolytic agents|mesh-ancestor
102064587|NCT04558190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102064588|NCT04558190|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102064589|NCT04558190|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102064590|NCT04558190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102064591|NCT04558190|Adrenergic Agents|adrenergic agents|mesh-ancestor
102064592|NCT04558190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102064593|NCT04558190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064594|NCT04558190|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102064595|NCT04558190|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102064596|NCT04558190|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102064597|NCT04558190|Micronutrients|micronutrients|mesh-ancestor
102064607|NCT03676959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102064608|NCT03676959|Antibodies|antibodies|mesh-list
102064609|NCT03676959|Immunoglobulins|immunoglobulins|mesh-list
102064610|NCT03676959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102064611|NCT03676959|Immunologic Factors|immunologic factors|mesh-ancestor
102064612|NCT03676959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064613|NCT03676959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102064614|NCT03755973|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102064615|NCT03755973|Hormones|hormones|mesh-ancestor
102064616|NCT03755973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102064617|NCT03755973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064618|NCT02056938|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102064619|NCT02056938|Basiliximab|basiliximab|mesh-list
102064620|NCT02056938|Immunologic Factors|immunologic factors|mesh-ancestor
102064621|NCT02056938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064622|NCT02056938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102064623|NCT02191670|Tenecteplase|tenecteplase|mesh-list
102064624|NCT02191670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102064625|NCT02191670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102064626|NCT02191670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064627|NCT02057094|Caseins|caseins|mesh-list
102064628|NCT02057094|Chelating Agents|chelating agents|mesh-ancestor
102064629|NCT02057094|Sequestering Agents|sequestering agents|mesh-ancestor
102064630|NCT02057094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064631|NCT02917941|Dexamethasone|dexamethasone|mesh-list
102064632|NCT02917941|Lenalidomide|lenalidomide|mesh-list
102064633|NCT02917941|Ixazomib|ixazomib|mesh-list
102064634|NCT02917941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102064635|NCT02917941|Antiemetics|antiemetics|mesh-ancestor
102064636|NCT02917941|Autonomic Agents|autonomic agents|mesh-ancestor
102064637|NCT02917941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102064638|NCT02917941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064639|NCT02917941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102064640|NCT02917941|Glucocorticoids|glucocorticoids|mesh-ancestor
102064641|NCT02917941|Hormones|hormones|mesh-ancestor
102064642|NCT02917941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102064643|NCT02917941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102064644|NCT02917941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102064645|NCT02917941|Immunologic Factors|immunologic factors|mesh-ancestor
102064646|NCT02917941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102064647|NCT02917941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102064648|NCT02917941|Growth Substances|growth substances|mesh-ancestor
101942748|NCT01235013|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101942749|NCT01235013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942750|NCT01235013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101942751|NCT01235013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101942752|NCT01235013|Antiviral Agents|antiviral agents|mesh-ancestor
101942753|NCT01235013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101307691|NCT02042573|Serotonin Agents|serotonin agents|mesh-ancestor
102064649|NCT02917941|Growth Inhibitors|growth inhibitors|mesh-ancestor
102064650|NCT02917941|Protease Inhibitors|protease inhibitors|mesh-ancestor
102064651|NCT02917941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102064652|NCT02917941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064657|NCT02191748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102064658|NCT02191748|Glucocorticoids|glucocorticoids|mesh-ancestor
102064659|NCT02191748|Hormones|hormones|mesh-ancestor
102064660|NCT02191748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102064661|NCT02191748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064662|NCT02191826|Tolcapone|tolcapone|mesh-list
102064663|NCT02191826|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102064664|NCT02191826|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102064665|NCT02191826|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102064666|NCT02191826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102064667|NCT02191826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064668|NCT01333956|Pregabalin|pregabalin|mesh-list
102064669|NCT01333956|Analgesics|analgesics|mesh-ancestor
102064670|NCT01333956|Sensory System Agents|sensory system agents|mesh-ancestor
102064671|NCT01333956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102064672|NCT01333956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064673|NCT01333956|Anticonvulsants|anticonvulsants|mesh-ancestor
102064674|NCT01333956|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102064675|NCT01333956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102064676|NCT01333956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064677|NCT01333956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102064678|NCT01333956|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102064679|NCT01333956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102064680|NCT01333956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102064681|NCT01333956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102064682|NCT02057328|Telmisartan|telmisartan|mesh-list
102064683|NCT02057328|Nebivolol|nebivolol|mesh-list
102064684|NCT02057328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102064685|NCT02057328|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102064686|NCT02057328|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102064687|NCT02057328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064688|NCT02057328|Vasodilator Agents|vasodilator agents|mesh-ancestor
102064689|NCT02057328|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102064690|NCT02057328|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102064691|NCT02057328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102064692|NCT02057328|Adrenergic Agents|adrenergic agents|mesh-ancestor
102064693|NCT02057328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102064694|NCT02057328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064695|NCT02057484|Tacrolimus|tacrolimus|mesh-list
102064696|NCT02057484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102064697|NCT02057484|Immunologic Factors|immunologic factors|mesh-ancestor
102064698|NCT02057484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064699|NCT02057484|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102064700|NCT02057484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102064701|NCT02057484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064702|NCT02192060|Triclosan|triclosan|mesh-list
102064703|NCT02192060|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102064704|NCT02192060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102064705|NCT02192060|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102064706|NCT02192060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102064707|NCT02192060|Antimetabolites|antimetabolites|mesh-ancestor
102064708|NCT02192060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064709|NCT02192060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101784431|NCT00973713|Everolimus|everolimus|mesh-list
102064710|NCT02188394|Bupivacaine|bupivacaine|mesh-list
101942754|NCT01235013|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101942755|NCT01236495|Morphine|morphine|mesh-list
101942756|NCT01236495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101942757|NCT01236495|Narcotics|narcotics|mesh-ancestor
102064711|NCT02188394|Anesthetics|anesthetics|mesh-list
102064712|NCT02188394|Anesthetics, Local|anesthetics, local|mesh-ancestor
102064713|NCT02188394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102064714|NCT02188394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064715|NCT02188394|Sensory System Agents|sensory system agents|mesh-ancestor
102064716|NCT02188394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102064717|NCT01333722|Acetaminophen|acetaminophen|mesh-list
102064718|NCT01333722|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
102064719|NCT01333722|Hydrocodone|hydrocodone|mesh-list
102064720|NCT01333722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102064721|NCT01333722|Analgesics|analgesics|mesh-ancestor
102064729|NCT01333722|Antitussive Agents|antitussive agents|mesh-ancestor
102064730|NCT01333722|Respiratory System Agents|respiratory system agents|mesh-ancestor
102064731|NCT01333722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102064732|NCT01333722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102064733|NCT01333722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102064734|NCT02188472|Trimethoprim|trimethoprim|mesh-list
102064735|NCT02188472|Penicillins|penicillins|mesh-list
102064736|NCT02188472|Penicillin V|penicillin v|mesh-list
102064737|NCT02188472|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102064738|NCT02188472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102064739|NCT02188472|Antimalarials|antimalarials|mesh-ancestor
102064740|NCT02188472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102064741|NCT02188472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102064742|NCT02188472|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102064743|NCT02188472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102064744|NCT02188472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064745|NCT02188472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102064746|NCT02188472|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102064747|NCT02188472|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102064748|NCT02188472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102064749|NCT02188550|Everolimus|everolimus|mesh-list
102064750|NCT02188550|Letrozole|letrozole|mesh-list
102064751|NCT02188550|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102064752|NCT02188550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102064753|NCT02188550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102064754|NCT02188550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064755|NCT02188550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102064756|NCT02188550|Immunologic Factors|immunologic factors|mesh-ancestor
102064757|NCT02188550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064758|NCT02188550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102064759|NCT02188550|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102064760|NCT02188550|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102064761|NCT02188550|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102064762|NCT02188550|Hormone Antagonists|hormone antagonists|mesh-ancestor
102064763|NCT02188550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102064764|NCT02059590|Isavuconazole|isavuconazole|mesh-list
102064765|NCT02059590|Antifungal Agents|antifungal agents|mesh-ancestor
102064766|NCT02059590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102064767|NCT02057796|Efavirenz|efavirenz|mesh-list
102064768|NCT02057796|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102064769|NCT02057796|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102064770|NCT02057796|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
102064771|NCT02057796|Rifampin|rifampin|mesh-list
102064772|NCT02057796|Isoniazid|isoniazid|mesh-list
102064773|NCT02057796|Pyrazinamide|pyrazinamide|mesh-list
102064774|NCT02057796|Ethambutol|ethambutol|mesh-list
102064775|NCT02057796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102064776|NCT02057796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102064777|NCT02057796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102064778|NCT02057796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064779|NCT02057796|Antiviral Agents|antiviral agents|mesh-ancestor
102064780|NCT02057796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102064781|NCT02057796|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102064782|NCT02057796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101784495|NCT00857376|Vitamin B Complex|vitamin b complex|mesh-ancestor
101942758|NCT01236495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101942759|NCT01236495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942760|NCT01236495|Analgesics|analgesics|mesh-ancestor
101942761|NCT01236495|Sensory System Agents|sensory system agents|mesh-ancestor
101942762|NCT01236495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101942763|NCT01143129|Dexamethasone|dexamethasone|mesh-list
101942764|NCT01143129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101942765|NCT01143129|Antiemetics|antiemetics|mesh-ancestor
101942766|NCT01143129|Autonomic Agents|autonomic agents|mesh-ancestor
102064783|NCT02057796|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102064784|NCT02057796|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102064785|NCT02057796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102064786|NCT02057796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102064800|NCT02192450|Insulin|insulin|mesh-list
102064801|NCT02192450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102064802|NCT02192450|Insulin Aspart|insulin aspart|mesh-list
102064803|NCT02192450|Insulin, Long-Acting|insulin, long-acting|mesh-list
102064804|NCT02192450|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102064805|NCT02192450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102064806|NCT02192450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064807|NCT03284385|Adavosertib|adavosertib|mesh-list
102064808|NCT03284385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102064809|NCT03284385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064810|NCT03560856|Fulvestrant|fulvestrant|mesh-list
102064811|NCT03560856|Palbociclib|palbociclib|mesh-list
102064812|NCT03560856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102064813|NCT03560856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102064814|NCT03560856|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102064815|NCT03560856|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102064816|NCT03560856|Hormone Antagonists|hormone antagonists|mesh-ancestor
102064817|NCT03560856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102064818|NCT03560856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064819|NCT03560856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102064820|NCT03560856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102064821|NCT03560856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064822|NCT03676413|Fluticasone|fluticasone|mesh-list
102064824|NCT03676413|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102064825|NCT03676413|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102064826|NCT03676413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102064827|NCT03676413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102064828|NCT03676413|Autonomic Agents|autonomic agents|mesh-ancestor
102064829|NCT03676413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102064830|NCT03676413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064831|NCT03676413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102064832|NCT03676413|Respiratory System Agents|respiratory system agents|mesh-ancestor
102064833|NCT03676413|Dermatologic Agents|dermatologic agents|mesh-ancestor
102064834|NCT03676413|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102064835|NCT03676413|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102064836|NCT03676413|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102064837|NCT03676413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102064838|NCT03676413|Adrenergic Agents|adrenergic agents|mesh-ancestor
102064839|NCT03676413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102064840|NCT03676413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064841|NCT03676413|Glucocorticoids|glucocorticoids|mesh-ancestor
102064842|NCT03676413|Hormones|hormones|mesh-ancestor
102064843|NCT03676413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102064844|NCT03676413|Sympathomimetics|sympathomimetics|mesh-ancestor
102064845|NCT03676335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101366428|NCT00154414|Liraglutide|liraglutide|mesh-list
102064860|NCT01370694|Tubulin Modulators|tubulin modulators|mesh-ancestor
102064861|NCT01370694|Antimitotic Agents|antimitotic agents|mesh-ancestor
102064862|NCT01370694|Mitosis Modulators|mitosis modulators|mesh-ancestor
102064863|NCT01370694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101942767|NCT01143129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101662588|NCT02792400|Empagliflozin|empagliflozin|mesh-list
101942768|NCT01143129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064864|NCT01370694|Glucocorticoids|glucocorticoids|mesh-ancestor
102064865|NCT01370694|Hormones|hormones|mesh-ancestor
102064866|NCT01370694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102064867|NCT01370694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102064868|NCT02256878|Amitriptyline|amitriptyline|mesh-list
102064869|NCT02256878|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102064870|NCT02256878|Antidepressive Agents|antidepressive agents|mesh-ancestor
102064871|NCT02256878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102064872|NCT02256878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102064873|NCT02256878|Analgesics|analgesics|mesh-ancestor
102064874|NCT02256878|Sensory System Agents|sensory system agents|mesh-ancestor
102064875|NCT02256878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102064876|NCT02256878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064877|NCT02256878|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102064878|NCT02256878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102064879|NCT02256878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102064880|NCT02256878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064881|NCT02256878|Adrenergic Agents|adrenergic agents|mesh-ancestor
102064882|NCT02256878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102064883|NCT02058186|Vitamin D|vitamin d|mesh-list
102064884|NCT02058186|Vitamins|vitamins|mesh-ancestor
102064885|NCT02058186|Micronutrients|micronutrients|mesh-ancestor
102064886|NCT02058186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064887|NCT02058186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102064888|NCT03676023|Tranexamic Acid|tranexamic acid|mesh-list
102064889|NCT03676023|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102064890|NCT03676023|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102064891|NCT03676023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064892|NCT03676023|Hemostatics|hemostatics|mesh-ancestor
102064893|NCT03676023|Coagulants|coagulants|mesh-ancestor
102064894|NCT02260206|Colchicine|colchicine|mesh-list
102064895|NCT02260206|Gout Suppressants|gout suppressants|mesh-ancestor
102064896|NCT02260206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102064897|NCT02260206|Tubulin Modulators|tubulin modulators|mesh-ancestor
102064898|NCT02260206|Antimitotic Agents|antimitotic agents|mesh-ancestor
102064899|NCT02260206|Mitosis Modulators|mitosis modulators|mesh-ancestor
102064900|NCT02260206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064901|NCT02260206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102064902|NCT02058576|Tamsulosin|tamsulosin|mesh-list
102064903|NCT02058576|Dutasteride|dutasteride|mesh-list
102064904|NCT02058576|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102064918|NCT03535220|Protease Inhibitors|protease inhibitors|mesh-list
102064919|NCT03535220|Proteasome Inhibitors|proteasome inhibitors|mesh-list
102064920|NCT03535220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102064921|NCT03535220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064922|NCT03535220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102064923|NCT03535220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102064924|NCT03535220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102064925|NCT03535220|Antiviral Agents|antiviral agents|mesh-ancestor
102064926|NCT03535220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102064927|NCT02189720|Amifampridine|amifampridine|mesh-list
102064928|NCT02189720|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102064929|NCT02189720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102064930|NCT02189720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064931|NCT02189720|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102064932|NCT02189720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102064933|NCT02189720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064935|NCT03675555|Mirtazapine|mirtazapine|mesh-list
102064936|NCT03675555|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102064937|NCT03675555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102064938|NCT03675555|Antiemetics|antiemetics|mesh-ancestor
102064939|NCT03675555|Autonomic Agents|autonomic agents|mesh-ancestor
102064940|NCT03675555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102064941|NCT03675555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064942|NCT03675555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102064943|NCT03675555|Glucocorticoids|glucocorticoids|mesh-ancestor
102064944|NCT03675555|Hormones|hormones|mesh-ancestor
102064945|NCT03675555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101942769|NCT01143129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101942770|NCT01143129|Glucocorticoids|glucocorticoids|mesh-ancestor
101942771|NCT01143129|Hormones|hormones|mesh-ancestor
101942772|NCT01143129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101942773|NCT01143129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101307713|NCT02042690|Dexamethasone|dexamethasone|mesh-list
102064946|NCT03675555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102064947|NCT03675555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102064948|NCT03675555|Antidepressive Agents|antidepressive agents|mesh-ancestor
102064949|NCT03675555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102064950|NCT03675555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102064951|NCT03675555|Histamine Antagonists|histamine antagonists|mesh-ancestor
102064952|NCT03675555|Histamine Agents|histamine agents|mesh-ancestor
102064953|NCT03675555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102064954|NCT03675555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064955|NCT03675555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102064956|NCT03675555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102064957|NCT03675555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102064958|NCT03675555|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102064959|NCT03675555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102064960|NCT03675555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102064961|NCT03675555|Adrenergic Agents|adrenergic agents|mesh-ancestor
102064962|NCT03675555|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102064963|NCT03675555|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102064974|NCT02194166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064975|NCT02194166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102064976|NCT02194322|Olcegepant|olcegepant|mesh-list
102064977|NCT02194322|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
102064978|NCT02194322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064979|NCT02194322|Analgesics|analgesics|mesh-ancestor
102064980|NCT02194322|Sensory System Agents|sensory system agents|mesh-ancestor
102064981|NCT02194322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102064982|NCT02194322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064983|NCT02193308|Amlodipine|amlodipine|mesh-list
102064984|NCT02193308|Telmisartan|telmisartan|mesh-list
102064985|NCT02193308|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
102064986|NCT02193308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102064987|NCT02193308|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102064988|NCT02193308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102064989|NCT02193308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064990|NCT02193308|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102064991|NCT02193308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064992|NCT02193308|Vasodilator Agents|vasodilator agents|mesh-ancestor
102064993|NCT02193308|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102064994|NCT02193308|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102064995|NCT02060604|Ketorolac|ketorolac|mesh-list
102064996|NCT02060604|Ranibizumab|ranibizumab|mesh-list
102064997|NCT02060604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102064998|NCT02060604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102064999|NCT02060604|Growth Substances|growth substances|mesh-ancestor
102065000|NCT02060604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065001|NCT02060604|Growth Inhibitors|growth inhibitors|mesh-ancestor
102065002|NCT02060604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102065003|NCT02060604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102065004|NCT02060604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102065006|NCT02060604|Sensory System Agents|sensory system agents|mesh-ancestor
102065007|NCT02060604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102065008|NCT02060604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102065009|NCT02060604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102065010|NCT02060604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102065011|NCT02060604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102065012|NCT02060604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065013|NCT03679455|Obinutuzumab|obinutuzumab|mesh-list
102065014|NCT03679455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102065015|NCT03679455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101942774|NCT01143129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101942775|NCT01139463|Haloperidol|haloperidol|mesh-list
101942776|NCT01139463|Olanzapine|olanzapine|mesh-list
101942777|NCT01139463|Haloperidol decanoate|haloperidol decanoate|mesh-list
102065016|NCT03315143|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
102065017|NCT03315143|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102065018|NCT03315143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065019|NCT03315143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102065020|NCT03315143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065021|NCT02194556|Gemcitabine|gemcitabine|mesh-list
102065022|NCT02194556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102065023|NCT02194556|Antimetabolites|antimetabolites|mesh-ancestor
102065024|NCT02194556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065025|NCT02194556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102065030|NCT02060916|PAZ320|paz320|mesh-list
102065031|NCT02060916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102065032|NCT02060916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065033|NCT02797080|Interferons|interferons|mesh-list
102065034|NCT02797080|Interferon-gamma|interferon-gamma|mesh-list
102065035|NCT02797080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102065036|NCT02797080|Antiviral Agents|antiviral agents|mesh-ancestor
102065037|NCT02797080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102065038|NCT02196194|Tiotropium Bromide|tiotropium bromide|mesh-list
102065039|NCT02196194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102065040|NCT02196194|Autonomic Agents|autonomic agents|mesh-ancestor
102065041|NCT02196194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102065042|NCT02196194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065043|NCT02196194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102065044|NCT02196194|Respiratory System Agents|respiratory system agents|mesh-ancestor
102065045|NCT02196194|Parasympatholytics|parasympatholytics|mesh-ancestor
102065046|NCT02196194|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102065047|NCT02196194|Cholinergic Agents|cholinergic agents|mesh-ancestor
102065048|NCT02196194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102065049|NCT02196194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065050|NCT02915835|Riociguat|riociguat|mesh-list
102065051|NCT02915835|Enzyme Activators|enzyme activators|mesh-ancestor
102065052|NCT02915835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065053|NCT01370616|Amoxicillin|amoxicillin|mesh-list
102065054|NCT01370616|Tazobactam|tazobactam|mesh-list
102065055|NCT01370616|Piperacillin|piperacillin|mesh-list
102065056|NCT01370616|Ertapenem|ertapenem|mesh-list
102065057|NCT01370616|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102065058|NCT01370616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102065059|NCT01370616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102065060|NCT01370616|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102065061|NCT01370616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102065062|NCT01370616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065063|NCT02688881|Sirolimus|sirolimus|mesh-list
102065064|NCT02688881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102065065|NCT02688881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102065066|NCT02688881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102065067|NCT02688881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102065068|NCT02688881|Antifungal Agents|antifungal agents|mesh-ancestor
102065069|NCT02688881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102065070|NCT02688881|Immunologic Factors|immunologic factors|mesh-ancestor
102065071|NCT02688881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065072|NCT03560310|Ticagrelor|ticagrelor|mesh-list
102065073|NCT03560310|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102065074|NCT03560310|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102065075|NCT03560310|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102065076|NCT03560310|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102065077|NCT03560310|Purinergic Agents|purinergic agents|mesh-ancestor
102065078|NCT03560310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102065079|NCT03560310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065080|NCT03560310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065081|NCT02197286|Vitamin D|vitamin d|mesh-list
102065082|NCT02197286|Ergocalciferols|ergocalciferols|mesh-list
102065083|NCT02197286|Cholecalciferol|cholecalciferol|mesh-list
102065084|NCT02197286|Vitamins|vitamins|mesh-list
102065085|NCT02197286|Micronutrients|micronutrients|mesh-ancestor
102065086|NCT02197286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942778|NCT01139463|Antiemetics|antiemetics|mesh-ancestor
101942779|NCT01139463|Autonomic Agents|autonomic agents|mesh-ancestor
101942780|NCT01139463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101942781|NCT01139463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942782|NCT01139463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101942783|NCT01139463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101942784|NCT01139463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101942785|NCT01139463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101942786|NCT01139463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101942787|NCT01139463|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101307721|NCT02042690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102065087|NCT02197286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102065088|NCT02197286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102065089|NCT02197442|Valsartan|valsartan|mesh-list
102065090|NCT02197442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102065091|NCT02197442|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102065092|NCT02197442|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102065093|NCT02197442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065094|NCT03534674|Vitamin D|vitamin d|mesh-list
102065095|NCT03534674|Cholecalciferol|cholecalciferol|mesh-list
102065096|NCT03534674|Vitamins|vitamins|mesh-ancestor
102065097|NCT03534674|Micronutrients|micronutrients|mesh-ancestor
102065098|NCT03534674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065118|NCT02916927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102065119|NCT02916927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102065120|NCT02916927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102065121|NCT02916927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065122|NCT02197598|Nalmefene|nalmefene|mesh-list
102065123|NCT02197598|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102065124|NCT02197598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065125|NCT02197598|Sensory System Agents|sensory system agents|mesh-ancestor
102065126|NCT02197598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102065127|NCT02196662|Mesalamine|mesalamine|mesh-list
102065128|NCT02196662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102065129|NCT02196662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102065130|NCT02196662|Analgesics|analgesics|mesh-ancestor
102065131|NCT02196662|Sensory System Agents|sensory system agents|mesh-ancestor
102065132|NCT02196662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102065133|NCT02196662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065134|NCT02196662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102065135|NCT02196662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102065136|NCT02195180|Leucovorin|leucovorin|mesh-list
102065137|NCT02195180|Gemcitabine|gemcitabine|mesh-list
102065138|NCT02195180|Fluorouracil|fluorouracil|mesh-list
102065139|NCT02195180|Oxaliplatin|oxaliplatin|mesh-list
102065140|NCT02195180|Asparaginase|asparaginase|mesh-list
102065141|NCT02195180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102065142|NCT02195180|Antimetabolites|antimetabolites|mesh-ancestor
102065143|NCT02195180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065144|NCT02195180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102065145|NCT02195180|Antidotes|antidotes|mesh-ancestor
102065146|NCT02195180|Protective Agents|protective agents|mesh-ancestor
102065147|NCT02195180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065148|NCT02195180|Vitamin B Complex|vitamin b complex|mesh-ancestor
102065149|NCT02195180|Vitamins|vitamins|mesh-ancestor
102065150|NCT02195180|Micronutrients|micronutrients|mesh-ancestor
102065151|NCT02195180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102065152|NCT02195180|Immunologic Factors|immunologic factors|mesh-ancestor
102065154|NCT03623529|Giapreza|giapreza|mesh-list
102065155|NCT03623529|Angiotensinogen|angiotensinogen|mesh-list
101366748|NCT00158548|Amebicides|amebicides|mesh-ancestor
102065162|NCT02197676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102065163|NCT02916693|Mirabegron|mirabegron|mesh-list
102065164|NCT02916693|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102065165|NCT02916693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101942788|NCT01139463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101942789|NCT01139463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101942790|NCT01139463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065167|NCT02916693|Adrenergic Agents|adrenergic agents|mesh-ancestor
102065168|NCT02916693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102065169|NCT02916693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065170|NCT02916693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065171|NCT02916693|Urological Agents|urological agents|mesh-ancestor
102065172|NCT02195336|Paclitaxel|paclitaxel|mesh-list
102065173|NCT02195336|Bevacizumab|bevacizumab|mesh-list
102065174|NCT02195336|Carboplatin|carboplatin|mesh-list
102065175|NCT02195336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102065176|NCT02195336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102065177|NCT02195336|Tubulin Modulators|tubulin modulators|mesh-ancestor
102065178|NCT02195336|Antimitotic Agents|antimitotic agents|mesh-ancestor
102065179|NCT02195336|Mitosis Modulators|mitosis modulators|mesh-ancestor
102065180|NCT02195336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065181|NCT02195336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102065182|NCT02195336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102065183|NCT02195336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102065184|NCT02195336|Growth Substances|growth substances|mesh-ancestor
102065185|NCT02195336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065186|NCT02195336|Growth Inhibitors|growth inhibitors|mesh-ancestor
102065187|NCT03679065|Acetaminophen|acetaminophen|mesh-list
102065188|NCT03679065|Dexamethasone|dexamethasone|mesh-list
102065189|NCT03679065|Dexamethasone acetate|dexamethasone acetate|mesh-list
102065190|NCT03679065|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102065191|NCT03679065|BB 1101|bb 1101|mesh-list
102065192|NCT03679065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102065193|NCT03679065|Antiemetics|antiemetics|mesh-ancestor
102065194|NCT03679065|Autonomic Agents|autonomic agents|mesh-ancestor
102065195|NCT03679065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102065196|NCT03679065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065197|NCT03679065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102065198|NCT03679065|Glucocorticoids|glucocorticoids|mesh-ancestor
102065199|NCT03679065|Hormones|hormones|mesh-ancestor
102065200|NCT03679065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102065201|NCT03679065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102065202|NCT03679065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102065203|NCT03679065|Protease Inhibitors|protease inhibitors|mesh-ancestor
102065204|NCT03679065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102065205|NCT03679065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065206|NCT03679065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102065207|NCT03679065|Analgesics|analgesics|mesh-ancestor
102065208|NCT03679065|Sensory System Agents|sensory system agents|mesh-ancestor
102065209|NCT03679065|Antipyretics|antipyretics|mesh-ancestor
102065210|NCT02196740|Metronidazole|metronidazole|mesh-list
102065211|NCT02196740|Ciprofloxacin|ciprofloxacin|mesh-list
102065212|NCT02196740|Clindamycin|clindamycin|mesh-list
102065213|NCT02196740|Clindamycin palmitate|clindamycin palmitate|mesh-list
102065214|NCT02196740|Clindamycin phosphate|clindamycin phosphate|mesh-list
102065215|NCT02196740|Gatifloxacin|gatifloxacin|mesh-list
102065216|NCT02196740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102065217|NCT02196740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102065218|NCT02196740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102065219|NCT02196740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102065220|NCT02196740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102065221|NCT02196740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102065222|NCT02196740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102065223|NCT02196740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065224|NCT02196740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366807|NCT00051896|Dopamine Agents|dopamine agents|mesh-ancestor
102065240|NCT03678987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102065241|NCT03678987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102065242|NCT03678987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065243|NCT02919345|Dapagliflozin|dapagliflozin|mesh-list
102065244|NCT02919345|Glyburide|glyburide|mesh-list
102065245|NCT02919345|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102065246|NCT02919345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065247|NCT02919345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101942791|NCT01139463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101942792|NCT01139463|Serotonin Agents|serotonin agents|mesh-ancestor
101942793|NCT01139463|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102065248|NCT02919345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065250|NCT02195804|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
102065251|NCT02195804|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102065252|NCT02195804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102065253|NCT02195804|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102065254|NCT02195804|Histamine Antagonists|histamine antagonists|mesh-ancestor
102065255|NCT02195804|Histamine Agents|histamine agents|mesh-ancestor
102065256|NCT02195804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102065257|NCT02195804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699565|NCT02572492|Hormones|hormones|mesh-ancestor
102065258|NCT02195804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065259|NCT03672435|Proxymetacaine|proxymetacaine|mesh-list
102065260|NCT03672435|Anesthetics, Local|anesthetics, local|mesh-ancestor
102065261|NCT03672435|Anesthetics|anesthetics|mesh-ancestor
102065262|NCT03672435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102065263|NCT03672435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065264|NCT03672435|Sensory System Agents|sensory system agents|mesh-ancestor
102065265|NCT03672435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102065266|NCT03674463|Immunomodulating Agents|immunomodulating agents|mesh-list
102065267|NCT03674463|Immunologic Factors|immunologic factors|mesh-ancestor
102065268|NCT03674463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065269|NCT03674385|Vitamin E|vitamin e|mesh-list
102065270|NCT03674385|Metformin|metformin|mesh-list
102065271|NCT03674385|Clomiphene|clomiphene|mesh-list
102065272|NCT03674385|Enclomiphene|enclomiphene|mesh-list
102065273|NCT03674385|Zuclomiphene|zuclomiphene|mesh-list
102065274|NCT03674385|Vitamins|vitamins|mesh-ancestor
102065275|NCT03674385|Micronutrients|micronutrients|mesh-ancestor
102065276|NCT03674385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065277|NCT03674385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102065278|NCT03674385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065279|NCT03674385|Antioxidants|antioxidants|mesh-ancestor
102065280|NCT03674385|Protective Agents|protective agents|mesh-ancestor
102065281|NCT03674385|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102065282|NCT03674385|Hormone Antagonists|hormone antagonists|mesh-ancestor
102065283|NCT03674385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102065284|NCT03674385|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102065300|NCT02574455|Mitosis Modulators|mitosis modulators|mesh-ancestor
102065301|NCT02574455|Immunoconjugates|immunoconjugates|mesh-ancestor
102065302|NCT02574455|Immunologic Factors|immunologic factors|mesh-ancestor
102065303|NCT02574455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065304|NCT02197988|Fentanyl|fentanyl|mesh-list
102065305|NCT02197988|Bupivacaine|bupivacaine|mesh-list
102065306|NCT02197988|Anesthetics, Local|anesthetics, local|mesh-ancestor
102065307|NCT02197988|Anesthetics|anesthetics|mesh-ancestor
102065308|NCT02197988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102065309|NCT02197988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065310|NCT02197988|Sensory System Agents|sensory system agents|mesh-ancestor
102065311|NCT02197988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102065312|NCT02197988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102065313|NCT02197988|Narcotics|narcotics|mesh-ancestor
102065314|NCT02197988|Analgesics|analgesics|mesh-ancestor
102065315|NCT02197988|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102065316|NCT02197988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102065317|NCT02197988|Anesthetics, General|anesthetics, general|mesh-ancestor
102065318|NCT03672357|Liver Extracts|liver extracts|mesh-list
102065319|NCT03672357|Hematinics|hematinics|mesh-ancestor
102065320|NCT02201030|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102065321|NCT02201030|Immunologic Factors|immunologic factors|mesh-ancestor
102065322|NCT02201030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065323|NCT03674073|Vaccines|vaccines|mesh-list
102065324|NCT03674073|Immunologic Factors|immunologic factors|mesh-ancestor
102065325|NCT03674073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065326|NCT03673995|Inositol|inositol|mesh-list
102065327|NCT03673995|Vitamin B Complex|vitamin b complex|mesh-ancestor
102065328|NCT03673995|Vitamins|vitamins|mesh-ancestor
102065329|NCT03673995|Micronutrients|micronutrients|mesh-ancestor
102065330|NCT03673995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065331|NCT01378091|Prednisone|prednisone|mesh-list
102065332|NCT01378091|Docetaxel|docetaxel|mesh-list
102065333|NCT01378091|Lenalidomide|lenalidomide|mesh-list
102065334|NCT01378091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102065335|NCT01378091|Tubulin Modulators|tubulin modulators|mesh-ancestor
101942794|NCT01139463|Dopamine Agents|dopamine agents|mesh-ancestor
101942795|NCT01139463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101942796|NCT03640468|Lidocaine|lidocaine|mesh-list
101942797|NCT03640468|Midazolam|midazolam|mesh-list
101942798|NCT03640468|Ketamine|ketamine|mesh-list
102065336|NCT01378091|Antimitotic Agents|antimitotic agents|mesh-ancestor
102065337|NCT01378091|Mitosis Modulators|mitosis modulators|mesh-ancestor
102065338|NCT01378091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065339|NCT01378091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102065340|NCT01378091|Glucocorticoids|glucocorticoids|mesh-ancestor
102065341|NCT01378091|Hormones|hormones|mesh-ancestor
102065342|NCT01378091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102065343|NCT01378091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065344|NCT01378091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102065345|NCT01378091|Immunologic Factors|immunologic factors|mesh-ancestor
102065346|NCT01378091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102065356|NCT02063568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065358|NCT02257502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102065359|NCT02257502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102065360|NCT02257502|Growth Substances|growth substances|mesh-ancestor
102065361|NCT02257502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065362|NCT02257502|Growth Inhibitors|growth inhibitors|mesh-ancestor
102065363|NCT02257502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102065364|NCT02907099|Pembrolizumab|pembrolizumab|mesh-list
102065365|NCT02907099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102065366|NCT02907099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102065367|NCT02907099|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102065368|NCT02907099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065369|NCT02450123|Sunitinib|sunitinib|mesh-list
102065370|NCT02450123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102065371|NCT02450123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102065372|NCT02450123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102065373|NCT02450123|Growth Substances|growth substances|mesh-ancestor
102065374|NCT02450123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065375|NCT02450123|Growth Inhibitors|growth inhibitors|mesh-ancestor
102065376|NCT02450123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101785096|NCT02555852|Bismuth|bismuth|mesh-list
102065377|NCT02450123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102065378|NCT02450123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065379|NCT02063802|Metformin|metformin|mesh-list
102065380|NCT02063802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102065381|NCT02063802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065382|NCT03672045|Carbetocin|carbetocin|mesh-list
102065383|NCT03672045|Oxytocics|oxytocics|mesh-ancestor
102065384|NCT03672045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102065385|NCT03672045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065386|NCT02198300|Clopidogrel|clopidogrel|mesh-list
102065387|NCT02198300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102065388|NCT02198300|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102065389|NCT02198300|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102065390|NCT02198300|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102065391|NCT02198300|Purinergic Agents|purinergic agents|mesh-ancestor
102065392|NCT02198300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102065393|NCT02198300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065394|NCT02198300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065395|NCT03560232|Clindamycin|clindamycin|mesh-list
102065396|NCT03560232|Gentamicins|gentamicins|mesh-list
102065397|NCT03560232|Cefazolin|cefazolin|mesh-list
102065398|NCT03560232|Ceftriaxone|ceftriaxone|mesh-list
102065399|NCT03560232|Tazobactam|tazobactam|mesh-list
102065400|NCT03560232|Piperacillin|piperacillin|mesh-list
102065401|NCT03560232|Ampicillin|ampicillin|mesh-list
102065402|NCT03560232|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102065403|NCT03560232|Sulbactam|sulbactam|mesh-list
102065404|NCT03560232|Sultamicillin|sultamicillin|mesh-list
102065405|NCT03560232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102065406|NCT03560232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102065407|NCT03560232|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101518066|NCT00550992|Antiviral Agents|antiviral agents|mesh-ancestor
102065408|NCT03560232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102065409|NCT03560232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065410|NCT03560232|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102065411|NCT02201342|Udenafil|udenafil|mesh-list
101942799|NCT03640468|Anesthetics, Local|anesthetics, local|mesh-ancestor
101942800|NCT03640468|Anesthetics|anesthetics|mesh-ancestor
101942801|NCT03640468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101942802|NCT03640468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942803|NCT03640468|Sensory System Agents|sensory system agents|mesh-ancestor
101942804|NCT03640468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101942805|NCT03640468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101942806|NCT03640468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101942807|NCT03640468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101942808|NCT03640468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101942809|NCT03640468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942810|NCT03640468|Analgesics|analgesics|mesh-ancestor
101942811|NCT03640468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101942812|NCT03640468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101942813|NCT03640468|Anesthetics, General|anesthetics, general|mesh-ancestor
101366997|NCT00160186|Pancreatin|pancreatin|mesh-list
102065430|NCT02198378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102065431|NCT02198378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065432|NCT02198378|Analgesics|analgesics|mesh-ancestor
102065433|NCT02198378|Sensory System Agents|sensory system agents|mesh-ancestor
102065434|NCT02198378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102065435|NCT02198378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102065436|NCT02198378|Antipyretics|antipyretics|mesh-ancestor
102065437|NCT02198378|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
102065438|NCT02198378|Anesthetics|anesthetics|mesh-ancestor
102065439|NCT02063100|Losartan|losartan|mesh-list
102065440|NCT02063100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102065441|NCT02063100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102065442|NCT02063100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102065443|NCT02063100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102065444|NCT02063100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065445|NCT02198846|Insulin|insulin|mesh-list
102065446|NCT02198846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102065447|NCT02198846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065448|NCT02198924|Celecoxib|celecoxib|mesh-list
102065449|NCT02198924|Parecoxib|parecoxib|mesh-list
102065450|NCT02198924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102065451|NCT02198924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102065452|NCT02198924|Analgesics|analgesics|mesh-ancestor
102065453|NCT02198924|Sensory System Agents|sensory system agents|mesh-ancestor
102065454|NCT02198924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102065455|NCT02198924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065456|NCT02198924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102065457|NCT02198924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102065458|NCT02198924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102065459|NCT02198924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102065460|NCT02198924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102065461|NCT02198924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065462|NCT05462093|Liver Extracts|liver extracts|mesh-list
102065463|NCT05462093|Hematinics|hematinics|mesh-ancestor
102065464|NCT02064348|Moxifloxacin|moxifloxacin|mesh-list
102065465|NCT02064348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102065466|NCT02064348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102065467|NCT02064348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102065468|NCT02064348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102065469|NCT02064348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102065470|NCT02064348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065478|NCT02064504|Xhance|xhance|mesh-list
101942814|NCT03640468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101942815|NCT03640468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101942816|NCT03640468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101942817|NCT03640468|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102065479|NCT02064504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102065480|NCT02064504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102065481|NCT02064504|Autonomic Agents|autonomic agents|mesh-ancestor
102065482|NCT02064504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102065483|NCT02064504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065484|NCT02064504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102065485|NCT02064504|Respiratory System Agents|respiratory system agents|mesh-ancestor
102065486|NCT02064504|Dermatologic Agents|dermatologic agents|mesh-ancestor
102065487|NCT02064504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102065488|NCT02067936|Remifentanil|remifentanil|mesh-list
102065489|NCT02067936|Propofol|propofol|mesh-list
102065490|NCT02067936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102065491|NCT02067936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102065492|NCT02067936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065493|NCT02067936|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102065494|NCT02067936|Anesthetics, General|anesthetics, general|mesh-ancestor
102065495|NCT02067936|Anesthetics|anesthetics|mesh-ancestor
102065496|NCT02067936|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102065497|NCT02067936|Narcotics|narcotics|mesh-ancestor
102065498|NCT02067936|Analgesics|analgesics|mesh-ancestor
102065499|NCT02067936|Sensory System Agents|sensory system agents|mesh-ancestor
102065500|NCT02067936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102065501|NCT01377545|Anesthetics|anesthetics|mesh-list
102065502|NCT01377545|Anesthetics, Local|anesthetics, local|mesh-list
102065503|NCT01377545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102065504|NCT01377545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065505|NCT01377545|Sensory System Agents|sensory system agents|mesh-ancestor
102065506|NCT01377545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102065507|NCT01379807|Docetaxel|docetaxel|mesh-list
102065508|NCT01379807|Panitumumab|panitumumab|mesh-list
102065509|NCT01379807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102065510|NCT01379807|Tubulin Modulators|tubulin modulators|mesh-ancestor
102065511|NCT01379807|Antimitotic Agents|antimitotic agents|mesh-ancestor
102065512|NCT01379807|Mitosis Modulators|mitosis modulators|mesh-ancestor
102065513|NCT01379807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065514|NCT01379807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102065515|NCT02202512|Naproxen|naproxen|mesh-list
102065516|NCT02202512|Cimetidine|cimetidine|mesh-list
102065517|NCT02202512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102065518|NCT02202512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102065519|NCT02202512|Analgesics|analgesics|mesh-ancestor
102065520|NCT02202512|Sensory System Agents|sensory system agents|mesh-ancestor
102065521|NCT02202512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102065522|NCT02202512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065523|NCT02202512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102065524|NCT02202512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102065525|NCT02202512|Gout Suppressants|gout suppressants|mesh-ancestor
102065526|NCT02202512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102065527|NCT02202512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102065528|NCT02202512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065529|NCT02202512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102065530|NCT02202512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101785248|NCT00863460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102065531|NCT02202512|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102065532|NCT02202512|Histamine Antagonists|histamine antagonists|mesh-ancestor
102065534|NCT02202512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102065535|NCT02202512|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102065536|NCT02202512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102065537|NCT02065752|Metformin|metformin|mesh-list
102065538|NCT02065752|Canagliflozin|canagliflozin|mesh-list
102065539|NCT02065752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102065543|NCT02206490|Naltrexone|naltrexone|mesh-list
102065544|NCT02206490|Dextromethorphan|dextromethorphan|mesh-list
102065545|NCT02206490|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102065546|NCT02206490|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102065547|NCT02206490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065548|NCT02206490|Sensory System Agents|sensory system agents|mesh-ancestor
102065549|NCT02206490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101942818|NCT03640468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102065550|NCT02206490|Antitussive Agents|antitussive agents|mesh-ancestor
101699604|NCT04330690|Infliximab|infliximab|mesh-list
102065551|NCT02206490|Respiratory System Agents|respiratory system agents|mesh-ancestor
102065552|NCT02206490|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102065553|NCT02206490|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102065554|NCT02206490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102065555|NCT02206490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065556|NCT02068170|Azithromycin|azithromycin|mesh-list
102065557|NCT02068170|Moxifloxacin|moxifloxacin|mesh-list
102065558|NCT02068170|Clarithromycin|clarithromycin|mesh-list
102065559|NCT02068170|Levofloxacin|levofloxacin|mesh-list
102065560|NCT02068170|Erythromycin|erythromycin|mesh-list
102065561|NCT02068170|Erythromycin Estolate|erythromycin estolate|mesh-list
102065562|NCT02068170|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
102065563|NCT02068170|Erythromycin stearate|erythromycin stearate|mesh-list
102065564|NCT02068170|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102065565|NCT02068170|Itraconazole|itraconazole|mesh-list
102065566|NCT02068170|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
102065567|NCT02068170|Fluconazole|fluconazole|mesh-list
102065568|NCT02068170|Ketoconazole|ketoconazole|mesh-list
102065569|NCT02068170|Voriconazole|voriconazole|mesh-list
102065570|NCT02068170|Sunitinib|sunitinib|mesh-list
102065571|NCT02068170|Methadone|methadone|mesh-list
102065572|NCT02068170|Haloperidol|haloperidol|mesh-list
102065573|NCT02068170|Haloperidol decanoate|haloperidol decanoate|mesh-list
102065574|NCT02068170|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102065575|NCT02068170|Tacrolimus|tacrolimus|mesh-list
102065576|NCT02068170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102065577|NCT02068170|Immunologic Factors|immunologic factors|mesh-ancestor
102065578|NCT02068170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065579|NCT02068170|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102065580|NCT02068170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102065581|NCT02068170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065582|NCT02068170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102065583|NCT02068170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102065584|NCT02068170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102065585|NCT02068170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102065586|NCT02068170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102065587|NCT02068170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102065588|NCT02068170|Contraceptive Agents|contraceptive agents|mesh-ancestor
102065589|NCT02068170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102065590|NCT02068170|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102065591|NCT02068170|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102065592|NCT02068170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102065593|NCT02068170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102065594|NCT02068170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102065595|NCT02068170|Growth Substances|growth substances|mesh-ancestor
102065596|NCT02068170|Growth Inhibitors|growth inhibitors|mesh-ancestor
102065597|NCT02068170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102065598|NCT02068170|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102065599|NCT02068170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102065600|NCT02068170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102065601|NCT02068170|Antifungal Agents|antifungal agents|mesh-ancestor
102065602|NCT02068170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102065603|NCT02068170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102065604|NCT02068170|Hormone Antagonists|hormone antagonists|mesh-ancestor
102065605|NCT02068170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102065606|NCT02068170|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102065607|NCT02068170|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102065608|NCT02068170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102065609|NCT02068170|Narcotics|narcotics|mesh-ancestor
102065617|NCT02068170|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102065619|NCT02068170|Autonomic Agents|autonomic agents|mesh-ancestor
102065620|NCT02068170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102065621|NCT02068170|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102065622|NCT02068170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102065623|NCT02068170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102065624|NCT02068170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102065625|NCT02068170|Dopamine Agents|dopamine agents|mesh-ancestor
102065626|NCT02068170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102065627|NCT02068170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102065628|NCT02068170|Antimalarials|antimalarials|mesh-ancestor
102065629|NCT02068170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102065630|NCT02068170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102065631|NCT05545020|Chromium|chromium|mesh-list
101942819|NCT03640468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101942820|NCT03640468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101307751|NCT02042742|Antioxidants|antioxidants|mesh-ancestor
102065632|NCT05545020|Trace Elements|trace elements|mesh-ancestor
102065633|NCT05545020|Micronutrients|micronutrients|mesh-ancestor
102065634|NCT05545020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065635|NCT02206568|Insulin Lispro|insulin lispro|mesh-list
102065636|NCT02206568|Insulin, Short-Acting|insulin, short-acting|mesh-list
102065637|NCT02206568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102065638|NCT02206568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065639|NCT02206646|Tenecteplase|tenecteplase|mesh-list
102065640|NCT02206646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102065641|NCT02206646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102065642|NCT02206646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065643|NCT02419417|Nivolumab|nivolumab|mesh-list
102065644|NCT02419417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102065645|NCT02419417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102065646|NCT02419417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102065647|NCT02419417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065648|NCT02068404|Nifedipine|nifedipine|mesh-list
102065649|NCT02068404|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102065650|NCT02068404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102065651|NCT02068404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065652|NCT02068404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102065653|NCT02068404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065654|NCT02068404|Vasodilator Agents|vasodilator agents|mesh-ancestor
102065655|NCT02068404|Tocolytic Agents|tocolytic agents|mesh-ancestor
102065656|NCT02068404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102065657|NCT02068482|Rifaximin|rifaximin|mesh-list
102065658|NCT02068482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102065659|NCT02068482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102065660|NCT02068482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102065661|NCT02206802|Minoxidil|minoxidil|mesh-list
102065662|NCT02206802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102065663|NCT02206802|Vasodilator Agents|vasodilator agents|mesh-ancestor
102065664|NCT02065986|Tenofovir|tenofovir|mesh-list
102065665|NCT02065986|Emtricitabine|emtricitabine|mesh-list
102065666|NCT02065986|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102065667|NCT02065986|Antiviral Agents|antiviral agents|mesh-ancestor
102065668|NCT02065986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102065669|NCT02065986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102065670|NCT02065986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102065671|NCT02065986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102065672|NCT02065986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065673|NCT02065986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102065674|NCT02065986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102065675|NCT02068560|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
102065676|NCT02068560|Hemostatics|hemostatics|mesh-ancestor
102065690|NCT01377025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065692|NCT02342275|Atenolol|atenolol|mesh-list
102065693|NCT02342275|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102065694|NCT02342275|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102065695|NCT02342275|Adrenergic Agents|adrenergic agents|mesh-ancestor
102065696|NCT02342275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102065697|NCT02342275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065698|NCT02342275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065699|NCT02342275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102065700|NCT02342275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102065701|NCT02342275|Vasodilator Agents|vasodilator agents|mesh-ancestor
102065702|NCT02342275|Sympatholytics|sympatholytics|mesh-ancestor
102065703|NCT02342275|Autonomic Agents|autonomic agents|mesh-ancestor
102065704|NCT02342275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102065705|NCT02342275|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102065706|NCT01827553|Gemcitabine|gemcitabine|mesh-list
102065707|NCT01827553|Folfirinox|folfirinox|mesh-list
102065708|NCT01827553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102065709|NCT01827553|Antimetabolites|antimetabolites|mesh-ancestor
102065710|NCT01827553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065711|NCT01827553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102065712|NCT02207348|Liraglutide|liraglutide|mesh-list
102065713|NCT02207348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101942821|NCT03640468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101942822|NCT03640468|GABA Modulators|gaba modulators|mesh-ancestor
101942823|NCT03640468|GABA Agents|gaba agents|mesh-ancestor
101942824|NCT03640390|Magnesium Sulfate|magnesium sulfate|mesh-list
101942825|NCT03640390|Dexmedetomidine|dexmedetomidine|mesh-list
101942826|NCT03640390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101942827|NCT03640390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101942828|NCT03640390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942829|NCT03640390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101942830|NCT03640390|Analgesics|analgesics|mesh-ancestor
101942831|NCT03640390|Sensory System Agents|sensory system agents|mesh-ancestor
102065714|NCT02207348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065715|NCT02207348|Incretins|incretins|mesh-ancestor
102065717|NCT02207348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102065718|NCT02066454|Apixaban|apixaban|mesh-list
102065719|NCT02066454|Anticoagulants|anticoagulants|mesh-list
102065720|NCT02066454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102065721|NCT02066454|Antithrombins|antithrombins|mesh-ancestor
102065722|NCT02066454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102065723|NCT02066454|Protease Inhibitors|protease inhibitors|mesh-ancestor
102065724|NCT02066454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102065725|NCT02066454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065726|NCT02207426|Tobramycin|tobramycin|mesh-list
102065727|NCT02207426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102065728|NCT02207426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102065729|NCT00777491|Cisplatin|cisplatin|mesh-list
102065730|NCT00777491|Gemcitabine|gemcitabine|mesh-list
102065731|NCT00777491|Fluorouracil|fluorouracil|mesh-list
102065732|NCT00777491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102065733|NCT00777491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102065734|NCT00777491|Antimetabolites|antimetabolites|mesh-ancestor
102065735|NCT00777491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065736|NCT00777491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102065737|NCT00777491|Immunologic Factors|immunologic factors|mesh-ancestor
102065738|NCT00777491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065739|NCT02199392|Lenvatinib|lenvatinib|mesh-list
102065753|NCT03559920|Anesthetics|anesthetics|mesh-list
102065754|NCT03559920|Sevoflurane|sevoflurane|mesh-list
102065755|NCT03559920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102065756|NCT03559920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102065757|NCT03559920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065758|NCT03559920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102065759|NCT03559920|Anesthetics, General|anesthetics, general|mesh-ancestor
102065760|NCT03559920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101699636|NCT00672360|Folic Acid|folic acid|mesh-list
102065761|NCT03559920|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102065762|NCT02203760|Gemcitabine|gemcitabine|mesh-list
102065763|NCT02203760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102065764|NCT02203760|Antimetabolites|antimetabolites|mesh-ancestor
102065765|NCT02203760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065766|NCT02203760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102065767|NCT03703271|Methotrexate|methotrexate|mesh-list
102065768|NCT03703271|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102065769|NCT03703271|Abortifacient Agents|abortifacient agents|mesh-ancestor
102065770|NCT03703271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102065771|NCT03703271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065772|NCT03703271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102065773|NCT03703271|Antimetabolites|antimetabolites|mesh-ancestor
102065774|NCT03703271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065775|NCT03703271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102065776|NCT03703271|Dermatologic Agents|dermatologic agents|mesh-ancestor
102065777|NCT03703271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102065778|NCT03703271|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102065779|NCT03703271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102065780|NCT03703271|Immunologic Factors|immunologic factors|mesh-ancestor
101942833|NCT03640390|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101942834|NCT03640390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102065781|NCT03703271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102065782|NCT03703271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102065783|NCT03532802|Metoprolol|metoprolol|mesh-list
102065784|NCT03532802|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102065785|NCT03532802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102065786|NCT03532802|Sympatholytics|sympatholytics|mesh-ancestor
102065787|NCT03532802|Autonomic Agents|autonomic agents|mesh-ancestor
102065788|NCT03532802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102065789|NCT03532802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065790|NCT03532802|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102065791|NCT03532802|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102065792|NCT03532802|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102065793|NCT03532802|Adrenergic Agents|adrenergic agents|mesh-ancestor
102065794|NCT03532802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102065795|NCT03532802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065796|NCT03430531|Lidocaine|lidocaine|mesh-list
102065797|NCT03430531|Anesthetics, Local|anesthetics, local|mesh-ancestor
102065798|NCT03430531|Anesthetics|anesthetics|mesh-ancestor
102065799|NCT03430531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102065800|NCT03430531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065804|NCT03430531|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102065805|NCT03430531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102065806|NCT03430531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102065807|NCT03430531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065808|NCT02066532|Trastuzumab|trastuzumab|mesh-list
102065809|NCT02066532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102065810|NCT02066532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102065811|NCT05763329|Lemborexant|lemborexant|mesh-list
102065812|NCT05763329|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102065813|NCT05763329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102065814|NCT05763329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065815|NCT05763329|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102065816|NCT05763329|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102065817|NCT05763329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102065818|NCT05763329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065819|NCT04088513|Aspirin|aspirin|mesh-list
102065820|NCT04088513|Clopidogrel|clopidogrel|mesh-list
102065821|NCT04088513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102065822|NCT04088513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102065823|NCT04088513|Analgesics|analgesics|mesh-ancestor
102065824|NCT04088513|Sensory System Agents|sensory system agents|mesh-ancestor
102065825|NCT04088513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102065826|NCT04088513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065827|NCT04088513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102065828|NCT04088513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102065829|NCT04088513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101785553|NCT00787436|Sympatholytics|sympatholytics|mesh-ancestor
102065830|NCT04088513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102065831|NCT04088513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065832|NCT04088513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102065833|NCT04088513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102065834|NCT04088513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102065836|NCT04088513|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102065837|NCT04088513|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102065838|NCT04088513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102065839|NCT04088513|Purinergic Agents|purinergic agents|mesh-ancestor
102065840|NCT04088513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102065841|NCT02207660|Fluorouracil|fluorouracil|mesh-list
102065842|NCT02207660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102065843|NCT02207660|Antimetabolites|antimetabolites|mesh-ancestor
102065844|NCT02207660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065845|NCT02207660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102065846|NCT02207660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102065847|NCT02207660|Immunologic Factors|immunologic factors|mesh-ancestor
102065848|NCT02207660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942835|NCT03640390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101942836|NCT03640390|Adrenergic Agents|adrenergic agents|mesh-ancestor
101942837|NCT03640390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101942838|NCT03640390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942839|NCT03640390|Anesthetics|anesthetics|mesh-ancestor
101942840|NCT03640390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101942841|NCT03640390|Anticonvulsants|anticonvulsants|mesh-ancestor
101942842|NCT03640390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101942843|NCT03640390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101942844|NCT03640390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101942845|NCT03640390|Tocolytic Agents|tocolytic agents|mesh-ancestor
101942846|NCT03640390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101942847|NCT03618472|Metformin|metformin|mesh-list
101942848|NCT03618472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101942849|NCT03618472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942850|NCT00001984|Alemtuzumab|alemtuzumab|mesh-list
101942851|NCT00001984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101942852|NCT00001984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101942853|NCT03618316|Cimetidine|cimetidine|mesh-list
101942854|NCT03618316|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101942855|NCT03618316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101942856|NCT03618316|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102065849|NCT02069340|Zoledronic Acid|zoledronic acid|mesh-list
102065850|NCT02069340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102065851|NCT02069340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065852|NCT02069418|Alovudine|alovudine|mesh-list
102065853|NCT02069418|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102065854|NCT02069418|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102065855|NCT02069418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065856|NCT02069418|Antiviral Agents|antiviral agents|mesh-ancestor
102065857|NCT02069418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102065858|NCT02208128|Bevacizumab|bevacizumab|mesh-list
102065859|NCT02208128|Sunitinib|sunitinib|mesh-list
102065860|NCT02208128|Everolimus|everolimus|mesh-list
102065861|NCT02208128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102065862|NCT02208128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102065863|NCT02208128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102065864|NCT02208128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102065865|NCT02208128|Growth Substances|growth substances|mesh-ancestor
102065866|NCT02208128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065867|NCT02208128|Growth Inhibitors|growth inhibitors|mesh-ancestor
102065868|NCT02208128|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102065869|NCT02208128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101367454|NCT00162721|Doxorubicin|doxorubicin|mesh-list
102065875|NCT02066610|Selenious Acid|selenious acid|mesh-list
102065876|NCT02066610|Sodium Selenite|sodium selenite|mesh-list
102065877|NCT02066610|Selenic Acid|selenic acid|mesh-list
102065878|NCT02066610|Antioxidants|antioxidants|mesh-ancestor
102065879|NCT02066610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065880|NCT02066610|Protective Agents|protective agents|mesh-ancestor
102065881|NCT02066610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065882|NCT02066610|Trace Elements|trace elements|mesh-ancestor
102065883|NCT02066610|Micronutrients|micronutrients|mesh-ancestor
102065884|NCT03077711|Trimethoprim|trimethoprim|mesh-list
102065885|NCT03077711|Methenamine|methenamine|mesh-list
101942857|NCT03618316|Histamine Antagonists|histamine antagonists|mesh-ancestor
101942858|NCT03618316|Histamine Agents|histamine agents|mesh-ancestor
101942859|NCT03618316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101307768|NCT02043054|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102065886|NCT03077711|Methenamine hippurate|methenamine hippurate|mesh-list
102065887|NCT03077711|Methenamine mandelate|methenamine mandelate|mesh-list
102065888|NCT03077711|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102065889|NCT03077711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102065890|NCT03077711|Antimalarials|antimalarials|mesh-ancestor
102065891|NCT03077711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102065892|NCT03077711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102065893|NCT03077711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102065894|NCT03077711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102065895|NCT03077711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065896|NCT03077711|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102065897|NCT03077711|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102065898|NCT03077711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102065899|NCT03077711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102065901|NCT04374019|Ivermectin|ivermectin|mesh-list
102065902|NCT04374019|Camostat|camostat|mesh-list
102065903|NCT04374019|Antimalarials|antimalarials|mesh-ancestor
102065904|NCT04374019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102065905|NCT04374019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102065906|NCT04374019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102065907|NCT04374019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102065908|NCT04374019|Antiviral Agents|antiviral agents|mesh-ancestor
102065909|NCT04374019|Schistosomicides|schistosomicides|mesh-ancestor
102065910|NCT04374019|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102065911|NCT04374019|Anthelmintics|anthelmintics|mesh-ancestor
102065912|NCT04374019|Protease Inhibitors|protease inhibitors|mesh-ancestor
102065913|NCT04374019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102065914|NCT04374019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065915|NCT04374019|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102065916|NCT04374019|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102065917|NCT02069808|Leuprolide|leuprolide|mesh-list
102065918|NCT02069808|Menotropins|menotropins|mesh-list
102065919|NCT02069808|Ganirelix|ganirelix|mesh-list
102065920|NCT02069808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102065921|NCT02069808|Fertility Agents|fertility agents|mesh-ancestor
102065922|NCT02069808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102065923|NCT02069808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065924|NCT02069808|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102065925|NCT02069808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102065926|NCT02069808|Hormone Antagonists|hormone antagonists|mesh-ancestor
102065927|NCT02069808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102065928|NCT03673605|Warfarin|warfarin|mesh-list
102065929|NCT03673605|Rivaroxaban|rivaroxaban|mesh-list
102065930|NCT03673605|Anticoagulants|anticoagulants|mesh-ancestor
102065931|NCT03673605|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102065932|NCT03673605|Antithrombins|antithrombins|mesh-ancestor
102065933|NCT03673605|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102065934|NCT03673605|Protease Inhibitors|protease inhibitors|mesh-ancestor
102065935|NCT03673605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102065936|NCT03673605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065937|NCT02069886|Deferasirox|deferasirox|mesh-list
102065938|NCT02069886|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102065939|NCT02069886|Chelating Agents|chelating agents|mesh-ancestor
102065940|NCT02069886|Sequestering Agents|sequestering agents|mesh-ancestor
102065941|NCT02069886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065942|NCT04311463|Paroxetine|paroxetine|mesh-list
102065946|NCT04311463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065947|NCT04311463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102065948|NCT04311463|Serotonin Agents|serotonin agents|mesh-ancestor
102065949|NCT04311463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065950|NCT04311463|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102065951|NCT04311463|Antidepressive Agents|antidepressive agents|mesh-ancestor
102065952|NCT04311463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102065953|NCT04311463|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102065954|NCT04311463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102065955|NCT04311463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102065956|NCT02065128|Capsaicin|capsaicin|mesh-list
101942860|NCT03618316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942861|NCT03618316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065957|NCT02065128|Antipruritics|antipruritics|mesh-ancestor
102065958|NCT02065128|Dermatologic Agents|dermatologic agents|mesh-ancestor
102065959|NCT02065128|Sensory System Agents|sensory system agents|mesh-ancestor
102065960|NCT02065128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102065961|NCT02065128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065962|NCT03677895|Hyaluronic Acid|hyaluronic acid|mesh-list
102065963|NCT03677895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102065964|NCT03677895|Immunologic Factors|immunologic factors|mesh-ancestor
102065965|NCT03677895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065966|NCT03677895|Viscosupplements|viscosupplements|mesh-ancestor
102065967|NCT03677895|Protective Agents|protective agents|mesh-ancestor
102065968|NCT04295005|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102065969|NCT04295005|Empagliflozin|empagliflozin|mesh-list
102065970|NCT04295005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102065971|NCT04295005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065972|NCT04295005|Incretins|incretins|mesh-ancestor
102065973|NCT04295005|Hormones|hormones|mesh-ancestor
102065974|NCT04295005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102065975|NCT04295005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102065976|NCT04295005|Protease Inhibitors|protease inhibitors|mesh-ancestor
102065977|NCT04295005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102065978|NCT04295005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065979|NCT04295005|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102065980|NCT03174353|Lanreotide|lanreotide|mesh-list
102065981|NCT03174353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102065982|NCT05214235|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102065983|NCT05214235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065984|NCT03054363|Letrozole|letrozole|mesh-list
102065985|NCT03054363|Palbociclib|palbociclib|mesh-list
102065986|NCT03054363|Tucatinib|tucatinib|mesh-list
102065987|NCT03054363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102065988|NCT03054363|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102065989|NCT03054363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102065990|NCT03054363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102065991|NCT03054363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065992|NCT03054363|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102065993|NCT03054363|Hormone Antagonists|hormone antagonists|mesh-ancestor
102065994|NCT03054363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102065995|NCT03054363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065996|NCT03054363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102065997|NCT04080947|Montelukast|montelukast|mesh-list
102065998|NCT04080947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102065999|NCT04080947|Respiratory System Agents|respiratory system agents|mesh-ancestor
102066000|NCT04080947|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102066001|NCT04080947|Hormone Antagonists|hormone antagonists|mesh-ancestor
102066002|NCT04080947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102066003|NCT04080947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066004|NCT04080947|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102066005|NCT04080947|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102066006|NCT04080947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066007|NCT02066688|Calcium, Dietary|calcium, dietary|mesh-list
102066008|NCT02066688|Vitamin D|vitamin d|mesh-list
102066009|NCT02066688|Folic Acid|folic acid|mesh-list
102066010|NCT02066688|Vitamin B Complex|vitamin b complex|mesh-list
102066011|NCT02066688|Calcium|calcium|mesh-list
102066012|NCT02066688|Vitamins|vitamins|mesh-ancestor
102066017|NCT02066688|Hematinics|hematinics|mesh-ancestor
102066018|NCT03671733|Liraglutide|liraglutide|mesh-list
102066019|NCT03671733|Exenatide|exenatide|mesh-list
102066020|NCT03671733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102066021|NCT03671733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066022|NCT03671733|Incretins|incretins|mesh-ancestor
102066023|NCT03671733|Hormones|hormones|mesh-ancestor
102066024|NCT03671733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102066025|NCT03671733|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102066026|NCT03119363|Methamphetamine|methamphetamine|mesh-list
102066027|NCT03119363|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102066028|NCT03119363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066029|NCT03119363|Sympathomimetics|sympathomimetics|mesh-ancestor
102066030|NCT03119363|Autonomic Agents|autonomic agents|mesh-ancestor
101942862|NCT03618316|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101942863|NCT03618316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101942864|NCT03618316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101942865|NCT03445533|Ipilimumab|ipilimumab|mesh-list
101942866|NCT03445533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101942867|NCT03445533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102066031|NCT03119363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102066032|NCT03119363|Dopamine Agents|dopamine agents|mesh-ancestor
102066033|NCT03119363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102066034|NCT03119363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066035|NCT03119363|Adrenergic Agents|adrenergic agents|mesh-ancestor
102066036|NCT03119363|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102066037|NCT03119363|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102066038|NCT03119363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101699712|NCT04469699|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102066039|NCT03119363|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102066040|NCT04059081|Obinutuzumab|obinutuzumab|mesh-list
102066041|NCT04059081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102066042|NCT04059081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102066043|NCT03671655|Paclitaxel|paclitaxel|mesh-list
102066044|NCT03671655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102066045|NCT03671655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102066046|NCT03671655|Tubulin Modulators|tubulin modulators|mesh-ancestor
102066047|NCT03671655|Antimitotic Agents|antimitotic agents|mesh-ancestor
102066048|NCT03671655|Mitosis Modulators|mitosis modulators|mesh-ancestor
102066049|NCT03671655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066050|NCT02200094|Telmisartan|telmisartan|mesh-list
102066051|NCT02200094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102066052|NCT02200094|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102066053|NCT02200094|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102066054|NCT02200094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066055|NCT01370538|Esomeprazole|esomeprazole|mesh-list
102066056|NCT01370538|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102066057|NCT01370538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102066058|NCT01370538|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102066059|NCT01370538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102066060|NCT01370538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066061|NCT03248297|Amoxicillin|amoxicillin|mesh-list
102066062|NCT03248297|Azithromycin|azithromycin|mesh-list
102066063|NCT03248297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102066064|NCT03248297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102066065|NCT02208596|Pentazocine|pentazocine|mesh-list
102066066|NCT02208596|Propofol|propofol|mesh-list
102066067|NCT02208596|Etomidate|etomidate|mesh-list
102066068|NCT02208596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102066069|NCT02208596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102066070|NCT02208596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066071|NCT02208596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102066072|NCT02208596|Anesthetics, General|anesthetics, general|mesh-ancestor
102066073|NCT02208596|Anesthetics|anesthetics|mesh-ancestor
102066074|NCT02208596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102066075|NCT02208596|Narcotics|narcotics|mesh-ancestor
102066076|NCT02208596|Analgesics|analgesics|mesh-ancestor
102066077|NCT02208596|Sensory System Agents|sensory system agents|mesh-ancestor
102066078|NCT02208596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102066079|NCT02208596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102066080|NCT02208596|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102066081|NCT02070120|Mitomycins|mitomycins|mesh-list
102066082|NCT02070120|Mitomycin|mitomycin|mesh-list
102066083|NCT02070120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102066086|NCT02070120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066087|NCT02070120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102066088|NCT02070120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102066090|NCT02200172|Antioxidants|antioxidants|mesh-ancestor
102066091|NCT02200172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066092|NCT02200172|Protective Agents|protective agents|mesh-ancestor
102066093|NCT02200172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066094|NCT02200172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102066095|NCT03673137|Gemcitabine|gemcitabine|mesh-list
101942868|NCT03445533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101307774|NCT02043171|Cholecalciferol|cholecalciferol|mesh-list
102066096|NCT03673137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102066097|NCT03673137|Antimetabolites|antimetabolites|mesh-ancestor
102066098|NCT03673137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066099|NCT03673137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102066100|NCT02066844|Betamethasone|betamethasone|mesh-list
102066101|NCT02066844|Betamethasone Valerate|betamethasone valerate|mesh-list
102066102|NCT02066844|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102066103|NCT02066844|Betamethasone benzoate|betamethasone benzoate|mesh-list
102066104|NCT02066844|Lidocaine|lidocaine|mesh-list
102066105|NCT02066844|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102066106|NCT02066844|Anesthetics, Local|anesthetics, local|mesh-ancestor
102066107|NCT02066844|Anesthetics|anesthetics|mesh-ancestor
102066108|NCT02066844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102066109|NCT02066844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066110|NCT02066844|Sensory System Agents|sensory system agents|mesh-ancestor
102066111|NCT02066844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102066112|NCT02066844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102066113|NCT02066844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102066114|NCT02066844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102066115|NCT02066844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102066116|NCT02066844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066117|NCT02066844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102066118|NCT02066844|Glucocorticoids|glucocorticoids|mesh-ancestor
102066119|NCT02066844|Hormones|hormones|mesh-ancestor
102066120|NCT02066844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102066121|NCT02066844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102066122|NCT02066844|Respiratory System Agents|respiratory system agents|mesh-ancestor
102066123|NCT03669783|Dactinomycin|dactinomycin|mesh-list
102066124|NCT03669783|Carboplatin|carboplatin|mesh-list
102066125|NCT03669783|Doxorubicin|doxorubicin|mesh-list
102066126|NCT03669783|Etoposide|etoposide|mesh-list
102066127|NCT03669783|Vincristine|vincristine|mesh-list
102066128|NCT03669783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102066129|NCT03669783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101785856|NCT00284089|Ranibizumab|ranibizumab|mesh-list
102066130|NCT03669783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102066131|NCT03669783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102066132|NCT03669783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102066133|NCT03669783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066134|NCT03669783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102066135|NCT03669783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102066136|NCT03669783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102066137|NCT03669783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102066138|NCT03669783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102066139|NCT03669783|Tubulin Modulators|tubulin modulators|mesh-ancestor
102066140|NCT03669783|Antimitotic Agents|antimitotic agents|mesh-ancestor
102066141|NCT03669783|Mitosis Modulators|mitosis modulators|mesh-ancestor
102066142|NCT02067078|Dexamethasone|dexamethasone|mesh-list
102066143|NCT02067078|Dexamethasone acetate|dexamethasone acetate|mesh-list
102066144|NCT02067078|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102066145|NCT02067078|Clonidine|clonidine|mesh-list
102066146|NCT02067078|Epinephrine|epinephrine|mesh-list
102066147|NCT02067078|Racepinephrine|racepinephrine|mesh-list
102066148|NCT02067078|Ropivacaine|ropivacaine|mesh-list
102066149|NCT02067078|Bupivacaine|bupivacaine|mesh-list
102066150|NCT02067078|Epinephryl borate|epinephryl borate|mesh-list
102066151|NCT02067078|BB 1101|bb 1101|mesh-list
102066152|NCT02067078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102066153|NCT02067078|Antiemetics|antiemetics|mesh-ancestor
102066154|NCT02067078|Autonomic Agents|autonomic agents|mesh-ancestor
102066155|NCT02067078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101367736|NCT00053612|Vitamin A|vitamin a|mesh-list
102066168|NCT02067078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102066169|NCT02067078|Sensory System Agents|sensory system agents|mesh-ancestor
102066170|NCT02067078|Analgesics|analgesics|mesh-ancestor
102066171|NCT02067078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102066172|NCT02067078|Sympatholytics|sympatholytics|mesh-ancestor
102066173|NCT02067078|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102066174|NCT02067078|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102066175|NCT02067078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102066176|NCT02067078|Adrenergic Agents|adrenergic agents|mesh-ancestor
102066177|NCT02067078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102066178|NCT02067078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101942869|NCT03445533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942870|NCT01336972|Tolvaptan|tolvaptan|mesh-list
101307776|NCT02043171|Micronutrients|micronutrients|mesh-ancestor
102066179|NCT02067078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102066180|NCT02067078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102066181|NCT02067078|Respiratory System Agents|respiratory system agents|mesh-ancestor
102066182|NCT02067078|Mydriatics|mydriatics|mesh-ancestor
102066183|NCT02067078|Sympathomimetics|sympathomimetics|mesh-ancestor
102066184|NCT02067078|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102066185|NCT02067078|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102066186|NCT02067078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102066187|NCT02067078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102066188|NCT02067078|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102066189|NCT05461235|Pembrolizumab|pembrolizumab|mesh-list
102066190|NCT05461235|Nivolumab|nivolumab|mesh-list
102066191|NCT05461235|Tislelizumab|tislelizumab|mesh-list
102066192|NCT05461235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102066193|NCT05461235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102066194|NCT05461235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102066195|NCT05461235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066196|NCT02070198|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102066197|NCT02070198|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
102066198|NCT02070198|Hormones|hormones|mesh-ancestor
102066199|NCT02070198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102066200|NCT02070198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066201|NCT02070198|Luteolytic Agents|luteolytic agents|mesh-ancestor
102066202|NCT02070198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102066203|NCT02070198|Contraceptive Agents|contraceptive agents|mesh-ancestor
102066204|NCT02070198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102066205|NCT02070198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101785925|NCT00282919|Amebicides|amebicides|mesh-ancestor
102066206|NCT02070198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102066207|NCT02070198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102066208|NCT02918201|Tranexamic Acid|tranexamic acid|mesh-list
102066209|NCT02918201|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102066210|NCT02918201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102066211|NCT02918201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066212|NCT02918201|Hemostatics|hemostatics|mesh-ancestor
102066213|NCT02918201|Coagulants|coagulants|mesh-ancestor
102066214|NCT02200406|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
102066215|NCT02200406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102066220|NCT02200406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066221|NCT02200406|Antidepressive Agents|antidepressive agents|mesh-ancestor
102066222|NCT02200406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102066223|NCT02204852|Iloprost|iloprost|mesh-list
102066224|NCT02204852|Eptifibatide|eptifibatide|mesh-list
102066225|NCT02204852|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102066226|NCT02204852|Vasodilator Agents|vasodilator agents|mesh-ancestor
102066227|NCT02070510|Lisinopril|lisinopril|mesh-list
102066228|NCT02070510|Warfarin|warfarin|mesh-list
102066229|NCT02070510|Anticoagulants|anticoagulants|mesh-ancestor
102066230|NCT02070510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102066231|NCT02070510|Protease Inhibitors|protease inhibitors|mesh-ancestor
102066232|NCT02070510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102066233|NCT02070510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066234|NCT02070510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102066235|NCT02070510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102066236|NCT02070510|Protective Agents|protective agents|mesh-ancestor
101699741|NCT02695745|Dermatologic Agents|dermatologic agents|mesh-ancestor
102066237|NCT02070510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066238|NCT02200562|Ipilimumab|ipilimumab|mesh-list
102066239|NCT02200562|Dabrafenib|dabrafenib|mesh-list
102066240|NCT02200562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102066241|NCT02200562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102066242|NCT02200562|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102066243|NCT02200562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066244|NCT02200562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102066245|NCT02200562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102066246|NCT02200640|Losartan|losartan|mesh-list
102066247|NCT02200640|Telmisartan|telmisartan|mesh-list
102066248|NCT02200640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102066249|NCT02200640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102066250|NCT02200640|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101942871|NCT01336972|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101942872|NCT01336972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942873|NCT01336972|Natriuretic Agents|natriuretic agents|mesh-ancestor
102066251|NCT02200640|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102066252|NCT02200640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066253|NCT02200718|Freund's Adjuvant|freund's adjuvant|mesh-list
102066254|NCT02200718|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102066255|NCT02200718|Immunologic Factors|immunologic factors|mesh-ancestor
102066256|NCT02200718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066257|NCT02208986|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102066258|NCT02208986|Luteolytic Agents|luteolytic agents|mesh-ancestor
102066259|NCT02208986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102066260|NCT02208986|Contraceptive Agents|contraceptive agents|mesh-ancestor
102066261|NCT02208986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102066262|NCT02208986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066263|NCT02208986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102066264|NCT02208986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102066265|NCT02208986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102066266|NCT02067780|Levofloxacin|levofloxacin|mesh-list
102066267|NCT02067780|Ofloxacin|ofloxacin|mesh-list
102066268|NCT02067780|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102066269|NCT02067780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102066270|NCT02067780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102066271|NCT02067780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102066272|NCT02067780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102066273|NCT02067780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102066274|NCT02067780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066275|NCT02067780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102066276|NCT02067780|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102066277|NCT02067780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102066278|NCT02205164|Aprepitant|aprepitant|mesh-list
102066279|NCT02205164|Palonosetron|palonosetron|mesh-list
102066280|NCT02205164|Antiemetics|antiemetics|mesh-ancestor
102066281|NCT02205164|Autonomic Agents|autonomic agents|mesh-ancestor
102066282|NCT02205164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102066283|NCT02205164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066284|NCT02205164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102066293|NCT02071212|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102066294|NCT02071212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102066295|NCT02071212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102066296|NCT02071212|Purinergic Agents|purinergic agents|mesh-ancestor
102066297|NCT02071212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102066298|NCT02071212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066299|NCT02071212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066300|NCT02072382|Metformin|metformin|mesh-list
102066301|NCT02072382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101699750|NCT00990067|Analgesics|analgesics|mesh-ancestor
102066302|NCT02072382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066303|NCT02205242|Azithromycin|azithromycin|mesh-list
102066304|NCT02205242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102066305|NCT02205242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102066306|NCT02071368|Metformin|metformin|mesh-list
102066307|NCT02071368|Canagliflozin|canagliflozin|mesh-list
102066308|NCT02071368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102066309|NCT02071368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066310|NCT02071368|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102066311|NCT02071368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066312|NCT03402841|Olaparib|olaparib|mesh-list
102066313|NCT03402841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102066314|NCT03402841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102066315|NCT03402841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066316|NCT03402841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102066317|NCT02205398|Cetuximab|cetuximab|mesh-list
102066318|NCT02205398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102066319|NCT02205398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102066320|NCT04130659|Omeprazole|omeprazole|mesh-list
102066321|NCT04130659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102066322|NCT04130659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102066323|NCT04130659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102066324|NCT04130659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101942874|NCT01336972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942876|NCT03537508|Immunologic Factors|immunologic factors|mesh-ancestor
101942877|NCT03537508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942878|NCT03618082|Desflurane|desflurane|mesh-list
101942879|NCT03618082|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101942880|NCT03618082|Anesthetics, General|anesthetics, general|mesh-ancestor
101942881|NCT03618082|Anesthetics|anesthetics|mesh-ancestor
101942882|NCT03618082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101942883|NCT03618082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942884|NCT01236651|Drotaverin|drotaverin|mesh-list
101942885|NCT01236651|Meperidine|meperidine|mesh-list
101942886|NCT01236651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101942887|NCT01236651|Narcotics|narcotics|mesh-ancestor
101942888|NCT01236651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101942889|NCT01236651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942890|NCT01236651|Analgesics|analgesics|mesh-ancestor
101942891|NCT01236651|Sensory System Agents|sensory system agents|mesh-ancestor
101942892|NCT01236651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102066325|NCT04130659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066326|NCT02220608|Bortezomib|bortezomib|mesh-list
102066327|NCT02220608|Lenograstim|lenograstim|mesh-list
102066328|NCT02220608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102066329|NCT02220608|Immunologic Factors|immunologic factors|mesh-ancestor
102066330|NCT02220608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066331|NCT02220608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102066332|NCT03630367|Dexamethasone|dexamethasone|mesh-list
102066333|NCT03630367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102066334|NCT03630367|Antiemetics|antiemetics|mesh-ancestor
102066335|NCT03630367|Autonomic Agents|autonomic agents|mesh-ancestor
102066336|NCT03630367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102066337|NCT03630367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066338|NCT03630367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102066339|NCT03630367|Glucocorticoids|glucocorticoids|mesh-ancestor
102066340|NCT03630367|Hormones|hormones|mesh-ancestor
102066341|NCT03630367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102066342|NCT03630367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102066343|NCT03630367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102066344|NCT02258282|Etanercept|etanercept|mesh-list
102066345|NCT02258282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102066346|NCT02258282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102066347|NCT02258282|Analgesics|analgesics|mesh-ancestor
102066348|NCT02258282|Sensory System Agents|sensory system agents|mesh-ancestor
102066349|NCT02258282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102066350|NCT02258282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367949|NCT00165334|Cetuximab|cetuximab|mesh-list
102066369|NCT02076594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102066370|NCT02076594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102066372|NCT04175509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102066373|NCT04175509|Analgesics|analgesics|mesh-ancestor
102066374|NCT04175509|Sensory System Agents|sensory system agents|mesh-ancestor
102066375|NCT04175509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102066376|NCT04175509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066377|NCT04175509|Antipyretics|antipyretics|mesh-ancestor
102066378|NCT02220842|Atezolizumab|atezolizumab|mesh-list
102066379|NCT02220842|Obinutuzumab|obinutuzumab|mesh-list
102066380|NCT02220842|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102066381|NCT02220842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942893|NCT01236651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101942895|NCT01236651|Autonomic Agents|autonomic agents|mesh-ancestor
101942896|NCT01236651|Vasodilator Agents|vasodilator agents|mesh-ancestor
102066382|NCT02220842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102066383|NCT02220842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102066384|NCT02205554|Tramadol|tramadol|mesh-list
102066385|NCT02205554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102066386|NCT02205554|Narcotics|narcotics|mesh-ancestor
102066387|NCT02205554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102066388|NCT02205554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066389|NCT02205554|Analgesics|analgesics|mesh-ancestor
102066390|NCT02205554|Sensory System Agents|sensory system agents|mesh-ancestor
102066391|NCT02205554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102066392|NCT02076750|Vitamin D|vitamin d|mesh-list
102066393|NCT02076750|Cholecalciferol|cholecalciferol|mesh-list
102066394|NCT02076750|Vitamins|vitamins|mesh-ancestor
102066395|NCT02076750|Micronutrients|micronutrients|mesh-ancestor
102066396|NCT02076750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066397|NCT02076750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102066398|NCT02076750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102066399|NCT05262608|Olaparib|olaparib|mesh-list
102066400|NCT05262608|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102066401|NCT05262608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102066402|NCT05262608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066403|NCT05262608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102066404|NCT01380457|Dronabinol|dronabinol|mesh-list
102066405|NCT01380457|Hallucinogens|hallucinogens|mesh-ancestor
102066406|NCT01380457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066407|NCT01380457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102066441|NCT02221154|Micronutrients|micronutrients|mesh-ancestor
102066442|NCT02221154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066443|NCT02073084|Moxifloxacin|moxifloxacin|mesh-list
102066444|NCT02073084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102066445|NCT02073084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102066446|NCT02073084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102066447|NCT02073084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102066448|NCT02073084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102066449|NCT02073084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066450|NCT02073084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102066451|NCT03787849|Anesthetics|anesthetics|mesh-list
102066452|NCT03787849|Propofol|propofol|mesh-list
102066453|NCT03787849|Sevoflurane|sevoflurane|mesh-list
102066454|NCT03787849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102066455|NCT03787849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066456|NCT03787849|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102066457|NCT03787849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102066458|NCT03787849|Anesthetics, General|anesthetics, general|mesh-ancestor
102066459|NCT03787849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102066460|NCT03787849|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102066461|NCT03777319|Prednisolone|prednisolone|mesh-list
102066462|NCT03777319|Spironolactone|spironolactone|mesh-list
102066463|NCT03777319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102066464|NCT03777319|Glucocorticoids|glucocorticoids|mesh-ancestor
102066465|NCT03777319|Hormones|hormones|mesh-ancestor
102066466|NCT03777319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102066467|NCT03777319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066468|NCT03777319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102066469|NCT03777319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102066470|NCT03777319|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102066471|NCT03777319|Hormone Antagonists|hormone antagonists|mesh-ancestor
102066472|NCT03777319|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102066473|NCT03777319|Diuretics|diuretics|mesh-ancestor
102066474|NCT03777319|Natriuretic Agents|natriuretic agents|mesh-ancestor
102066475|NCT03671265|Apatinib|apatinib|mesh-list
102066476|NCT03671265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102066477|NCT03671265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102066478|NCT03671265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102066479|NCT03671265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066480|NCT02881957|Vitamin D|vitamin d|mesh-list
102066481|NCT02881957|Cholecalciferol|cholecalciferol|mesh-list
102066482|NCT02881957|Vitamins|vitamins|mesh-ancestor
102066483|NCT02881957|Micronutrients|micronutrients|mesh-ancestor
101942898|NCT04484025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101942899|NCT04484025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101942900|NCT04484025|Analgesics|analgesics|mesh-ancestor
101942901|NCT04484025|Sensory System Agents|sensory system agents|mesh-ancestor
101942902|NCT04484025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101942903|NCT04484025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066484|NCT02881957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066485|NCT02881957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102066486|NCT02881957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102066487|NCT02206022|Remifentanil|remifentanil|mesh-list
102066488|NCT02206022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102066489|NCT02206022|Narcotics|narcotics|mesh-ancestor
102066490|NCT02206022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102066491|NCT02206022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066492|NCT02206022|Analgesics|analgesics|mesh-ancestor
102066493|NCT02206022|Sensory System Agents|sensory system agents|mesh-ancestor
102066494|NCT02206022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102066495|NCT02073552|Ascorbic Acid|ascorbic acid|mesh-list
102066496|NCT02073552|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
102066497|NCT02073552|Antioxidants|antioxidants|mesh-ancestor
102066498|NCT02073552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066499|NCT02073552|Protective Agents|protective agents|mesh-ancestor
102066500|NCT02073552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066501|NCT02073552|Vitamins|vitamins|mesh-ancestor
102066502|NCT02073552|Micronutrients|micronutrients|mesh-ancestor
102066503|NCT02073552|Laxatives|laxatives|mesh-ancestor
102066504|NCT02073552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102066505|NCT02210156|Micronutrients|micronutrients|mesh-list
102066509|NCT02080026|Atovaquone|atovaquone|mesh-list
102066510|NCT02080026|Proguanil|proguanil|mesh-list
102066511|NCT02080026|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
102066512|NCT02080026|Amebicides|amebicides|mesh-ancestor
102066513|NCT02080026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102066514|NCT02080026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102066515|NCT02080026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102066516|NCT02080026|Antimalarials|antimalarials|mesh-ancestor
102066517|NCT02080026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102066518|NCT02080026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102066519|NCT02080026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102066520|NCT02080026|Analgesics|analgesics|mesh-ancestor
102066521|NCT02080026|Sensory System Agents|sensory system agents|mesh-ancestor
102066522|NCT02080026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102066523|NCT02080026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066524|NCT02080026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102066525|NCT02080026|Filaricides|filaricides|mesh-ancestor
102066526|NCT02080026|Antinematodal Agents|antinematodal agents|mesh-ancestor
102066527|NCT02080026|Anthelmintics|anthelmintics|mesh-ancestor
102066528|NCT02080026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102066529|NCT02080026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066530|NCT02080026|Antimetabolites|antimetabolites|mesh-ancestor
102066531|NCT02206178|Acetaminophen|acetaminophen|mesh-list
102066532|NCT02206178|Acetylcysteine|acetylcysteine|mesh-list
102066533|NCT02206178|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102066534|NCT02206178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102066535|NCT02206178|Analgesics|analgesics|mesh-ancestor
102066536|NCT02206178|Sensory System Agents|sensory system agents|mesh-ancestor
102066537|NCT02206178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102066538|NCT02206178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066539|NCT02206178|Antipyretics|antipyretics|mesh-ancestor
102066540|NCT02206178|Antiviral Agents|antiviral agents|mesh-ancestor
102066541|NCT02206178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102066542|NCT02206178|Expectorants|expectorants|mesh-ancestor
102066543|NCT02206178|Respiratory System Agents|respiratory system agents|mesh-ancestor
102066544|NCT02206178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102066545|NCT02206178|Antioxidants|antioxidants|mesh-ancestor
102066546|NCT02206178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066547|NCT02206178|Protective Agents|protective agents|mesh-ancestor
102066548|NCT02206178|Antidotes|antidotes|mesh-ancestor
102066549|NCT02080104|Oxytocin|oxytocin|mesh-list
102066550|NCT02080104|Oxytocics|oxytocics|mesh-ancestor
101942904|NCT04484025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101942905|NCT04484025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101942906|NCT04484025|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102066551|NCT02080104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102066552|NCT02080104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066553|NCT02211326|Warfarin|warfarin|mesh-list
102066554|NCT02211326|Anticoagulants|anticoagulants|mesh-ancestor
102066555|NCT02691793|Sunitinib|sunitinib|mesh-list
102066556|NCT02691793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102066557|NCT02691793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102066558|NCT02691793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102066559|NCT02691793|Growth Substances|growth substances|mesh-ancestor
102066560|NCT02691793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066561|NCT02691793|Growth Inhibitors|growth inhibitors|mesh-ancestor
102066562|NCT02691793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102066563|NCT02691793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102066564|NCT02691793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066565|NCT02221622|Pregnanolone|pregnanolone|mesh-list
102066566|NCT02221622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102066567|NCT02221622|Anesthetics|anesthetics|mesh-ancestor
102066568|NCT02221622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102066569|NCT02221622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066570|NCT02080182|Acetylcysteine|acetylcysteine|mesh-list
102066571|NCT02080182|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102066572|NCT02080182|Antiviral Agents|antiviral agents|mesh-ancestor
101699808|NCT00539305|Androgens|androgens|mesh-ancestor
102066573|NCT02080182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102066574|NCT02080182|Expectorants|expectorants|mesh-ancestor
102066575|NCT02080182|Respiratory System Agents|respiratory system agents|mesh-ancestor
102066576|NCT02080182|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102066577|NCT02080182|Antioxidants|antioxidants|mesh-ancestor
102066578|NCT02080182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066579|NCT02080182|Protective Agents|protective agents|mesh-ancestor
101368168|NCT00166816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102066586|NCT02750930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066588|NCT02080416|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102066589|NCT02080416|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102066590|NCT02080416|Protease Inhibitors|protease inhibitors|mesh-ancestor
102066591|NCT02080416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102066592|NCT02080416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066593|NCT02080416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102066594|NCT02080416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102066595|NCT02080416|Antiviral Agents|antiviral agents|mesh-ancestor
102066596|NCT02080416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102066597|NCT02080494|Tranexamic Acid|tranexamic acid|mesh-list
102066598|NCT02080494|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102066599|NCT02080494|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102066600|NCT02080494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066601|NCT02080494|Hemostatics|hemostatics|mesh-ancestor
102066602|NCT02080494|Coagulants|coagulants|mesh-ancestor
102066603|NCT02213744|Gemcitabine|gemcitabine|mesh-list
102066604|NCT02213744|Capecitabine|capecitabine|mesh-list
102066605|NCT02213744|Trastuzumab|trastuzumab|mesh-list
102066606|NCT02213744|Vinorelbine|vinorelbine|mesh-list
102066607|NCT02213744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102066608|NCT02213744|Antimetabolites|antimetabolites|mesh-ancestor
102066609|NCT02213744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066610|NCT02213744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102066611|NCT02213744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102066612|NCT02213744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102066613|NCT02213744|Tubulin Modulators|tubulin modulators|mesh-ancestor
102066614|NCT02213744|Antimitotic Agents|antimitotic agents|mesh-ancestor
102066615|NCT02213744|Mitosis Modulators|mitosis modulators|mesh-ancestor
102066616|NCT01378741|Dexmedetomidine|dexmedetomidine|mesh-list
102066617|NCT01378741|Propofol|propofol|mesh-list
102066618|NCT01378741|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102066619|NCT01378741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102066620|NCT01378741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066621|NCT01378741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102066622|NCT01378741|Analgesics|analgesics|mesh-ancestor
102066623|NCT01378741|Sensory System Agents|sensory system agents|mesh-ancestor
102066624|NCT01378741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102066625|NCT01378741|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102066626|NCT01378741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101942907|NCT04484025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101942908|NCT04484025|Antioxidants|antioxidants|mesh-ancestor
101942909|NCT04484025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942910|NCT04484025|Protective Agents|protective agents|mesh-ancestor
102066627|NCT01378741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102066628|NCT01378741|Adrenergic Agents|adrenergic agents|mesh-ancestor
101699832|NCT00990223|Eplerenone|eplerenone|mesh-list
102066629|NCT01378741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102066630|NCT01378741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066631|NCT01378741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102066632|NCT01378741|Anesthetics, General|anesthetics, general|mesh-ancestor
102066633|NCT01378741|Anesthetics|anesthetics|mesh-ancestor
102066634|NCT02461849|Imatinib Mesylate|imatinib mesylate|mesh-list
102066635|NCT02461849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102066636|NCT02461849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102066637|NCT02461849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102066638|NCT02461849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066639|NCT02225054|Dexmedetomidine|dexmedetomidine|mesh-list
102066640|NCT02225054|Ropivacaine|ropivacaine|mesh-list
102066641|NCT02225054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102066642|NCT02225054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102066643|NCT02225054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066644|NCT02225054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102066645|NCT02225054|Analgesics|analgesics|mesh-ancestor
102066646|NCT02225054|Sensory System Agents|sensory system agents|mesh-ancestor
102066647|NCT02225054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101368242|NCT00054587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102066657|NCT02080728|Anesthetics, Local|anesthetics, local|mesh-ancestor
102066658|NCT02080728|Anesthetics|anesthetics|mesh-ancestor
101786371|NCT00662558|Celecoxib|celecoxib|mesh-list
102066659|NCT02080728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102066660|NCT02080728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066661|NCT02080728|Sensory System Agents|sensory system agents|mesh-ancestor
102066662|NCT02080728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102066663|NCT03078907|Selexipag|selexipag|mesh-list
102066664|NCT03078907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102066665|NCT02225210|Fentanyl|fentanyl|mesh-list
102066666|NCT02225210|Midazolam|midazolam|mesh-list
102066667|NCT02225210|Dexmedetomidine|dexmedetomidine|mesh-list
102066668|NCT02225210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102066669|NCT02225210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102066670|NCT02225210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066671|NCT02225210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102066672|NCT02225210|Analgesics|analgesics|mesh-ancestor
102066673|NCT02225210|Sensory System Agents|sensory system agents|mesh-ancestor
102066674|NCT02225210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102066675|NCT02225210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102066676|NCT02225210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102066677|NCT02225210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102066678|NCT02225210|Adrenergic Agents|adrenergic agents|mesh-ancestor
102066679|NCT02225210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102066680|NCT02225210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066681|NCT02225210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102066682|NCT02225210|Narcotics|narcotics|mesh-ancestor
102066683|NCT02225210|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102066684|NCT02225210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102066685|NCT02225210|Anesthetics, General|anesthetics, general|mesh-ancestor
102066686|NCT02225210|Anesthetics|anesthetics|mesh-ancestor
102066687|NCT02225210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102066688|NCT02225210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102066689|NCT02225210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102066690|NCT02225210|GABA Modulators|gaba modulators|mesh-ancestor
102066691|NCT02225210|GABA Agents|gaba agents|mesh-ancestor
102066692|NCT02217020|Oxaliplatin|oxaliplatin|mesh-list
102066693|NCT02217020|Irinotecan|irinotecan|mesh-list
102066694|NCT02217020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102066695|NCT02217020|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102066696|NCT02217020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102066697|NCT02217020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102066698|NCT02217020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066699|NCT03249714|Ofatumumab|ofatumumab|mesh-list
102066700|NCT03249714|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102066701|NCT03249714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102066702|NCT03249714|Immunologic Factors|immunologic factors|mesh-ancestor
101942911|NCT04484025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101942912|NCT04484025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101942913|NCT04484025|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101942915|NCT01064518|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101942916|NCT01064518|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101942917|NCT01064518|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101942918|NCT01064518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101942919|NCT01064518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942920|NCT01064518|Cholinergic Agents|cholinergic agents|mesh-ancestor
101942921|NCT01064518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101942922|NCT01064518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942923|NCT01064518|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101942924|NCT01064518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101942925|NCT03616288|Thiamine|thiamine|mesh-list
101942926|NCT03616288|Vitamin B Complex|vitamin b complex|mesh-ancestor
102066703|NCT03249714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066704|NCT02222168|BI 409306|bi 409306|mesh-list
102066705|NCT02222168|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102066706|NCT02222168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102066707|NCT02222168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066708|NCT02925117|Upadacitinib|upadacitinib|mesh-list
102066709|NCT02925117|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102066710|NCT02925117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102066711|NCT02925117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102066712|NCT02925117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066713|NCT02925117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102066727|NCT02225756|Dermatologic Agents|dermatologic agents|mesh-ancestor
102066728|NCT02225756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102066729|NCT02225756|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102066730|NCT02225834|Atorvastatin|atorvastatin|mesh-list
102066731|NCT02225834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102066732|NCT02225834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102066733|NCT02225834|Antimetabolites|antimetabolites|mesh-ancestor
102066734|NCT02225834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066735|NCT02225834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102066736|NCT02225834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102066738|NCT02077998|Oxaliplatin|oxaliplatin|mesh-list
102066739|NCT02077998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102066740|NCT02222324|Moxifloxacin|moxifloxacin|mesh-list
102066741|NCT02222324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102066742|NCT02222324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102066743|NCT02222324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102066744|NCT02222324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102066745|NCT02222324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102066746|NCT02222324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066747|NCT02222324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102066748|NCT02074800|Siltuximab|siltuximab|mesh-list
102066749|NCT02074800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102066750|NCT02074800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102066751|NCT02074800|Immunologic Factors|immunologic factors|mesh-ancestor
102066752|NCT02074800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066753|NCT04504045|Metformin|metformin|mesh-list
102066754|NCT04504045|Efavirenz|efavirenz|mesh-list
102066755|NCT04504045|Losartan|losartan|mesh-list
102066756|NCT04504045|Metoprolol|metoprolol|mesh-list
102066757|NCT04504045|Midazolam|midazolam|mesh-list
102066758|NCT04504045|Caffeine|caffeine|mesh-list
102066759|NCT04504045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101942927|NCT03616288|Vitamins|vitamins|mesh-ancestor
101942928|NCT03616288|Micronutrients|micronutrients|mesh-ancestor
101942929|NCT03616288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942930|NCT02873338|Cytarabine|cytarabine|mesh-list
102066760|NCT04504045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066761|NCT04504045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102066762|NCT04504045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102066763|NCT04504045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102066764|NCT04504045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102066765|NCT04504045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102066766|NCT04504045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102066767|NCT04504045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102066768|NCT04504045|Anesthetics, General|anesthetics, general|mesh-ancestor
102066769|NCT04504045|Anesthetics|anesthetics|mesh-ancestor
102066770|NCT04504045|GABA Modulators|gaba modulators|mesh-ancestor
102066771|NCT04504045|GABA Agents|gaba agents|mesh-ancestor
102066772|NCT04504045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102066773|NCT04504045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066774|NCT04504045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102066775|NCT04504045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102066776|NCT04504045|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102066777|NCT04504045|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101368379|NCT00407407|Carboplatin|carboplatin|mesh-list
102066782|NCT04504045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102066783|NCT04504045|Purinergic Agents|purinergic agents|mesh-ancestor
102066784|NCT04504045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102066785|NCT04504045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102066786|NCT04504045|Antiviral Agents|antiviral agents|mesh-ancestor
102066787|NCT04504045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102066788|NCT04504045|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102066789|NCT04504045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102066790|NCT04504045|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102066791|NCT04504045|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102066792|NCT04504045|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102066793|NCT04504045|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102066794|NCT04504045|Sympatholytics|sympatholytics|mesh-ancestor
102066795|NCT04504045|Autonomic Agents|autonomic agents|mesh-ancestor
102066796|NCT04504045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102066797|NCT04504045|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102066798|NCT04504045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102066799|NCT04504045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102066800|NCT04504045|Adrenergic Agents|adrenergic agents|mesh-ancestor
102066802|NCT03283488|Megestrol Acetate|megestrol acetate|mesh-list
102066803|NCT03283488|Mirtazapine|mirtazapine|mesh-list
102066804|NCT03283488|Antidepressive Agents|antidepressive agents|mesh-ancestor
102066805|NCT03283488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102066806|NCT03283488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102066807|NCT03283488|Histamine Antagonists|histamine antagonists|mesh-ancestor
102066808|NCT03283488|Histamine Agents|histamine agents|mesh-ancestor
102066809|NCT03283488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101786527|NCT00789308|Cyclosporine|cyclosporine|mesh-list
102066810|NCT03283488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699874|NCT00715858|Doxycycline|doxycycline|mesh-list
102066811|NCT03283488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066812|NCT03283488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102066813|NCT03283488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102066814|NCT03283488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102066815|NCT03283488|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102066816|NCT03283488|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102066817|NCT03283488|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102066818|NCT03283488|Adrenergic Agents|adrenergic agents|mesh-ancestor
102066819|NCT03283488|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102066820|NCT03283488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102066821|NCT03283488|Serotonin Agents|serotonin agents|mesh-ancestor
102066822|NCT03283488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102066823|NCT03283488|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102066824|NCT03283488|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102066825|NCT03283488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102066826|NCT03283488|Contraceptive Agents|contraceptive agents|mesh-ancestor
102066827|NCT03283488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102066828|NCT03283488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101942932|NCT02873338|Heparin|heparin|mesh-list
101942933|NCT02873338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102066829|NCT03283488|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102066830|NCT03283488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102066831|NCT03283488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102066832|NCT03283488|Appetite Stimulants|appetite stimulants|mesh-ancestor
102066833|NCT03283488|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102066834|NCT02258204|Ketamine|ketamine|mesh-list
102066835|NCT02258204|Analgesics|analgesics|mesh-ancestor
102066836|NCT02258204|Sensory System Agents|sensory system agents|mesh-ancestor
102066837|NCT02258204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102066838|NCT02258204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066839|NCT02258204|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102066840|NCT02258204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102066841|NCT02258204|Anesthetics, General|anesthetics, general|mesh-ancestor
102066842|NCT02258204|Anesthetics|anesthetics|mesh-ancestor
102066843|NCT02258204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101368437|NCT04731948|Hematinics|hematinics|mesh-ancestor
102066862|NCT02220218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102066863|NCT02220218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066864|NCT02220218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102066865|NCT02220218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066866|NCT02222480|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102066867|NCT02222480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102066868|NCT02222480|Diuretics|diuretics|mesh-ancestor
102066869|NCT02222480|Natriuretic Agents|natriuretic agents|mesh-ancestor
102066870|NCT02222480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066871|NCT02222480|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102066872|NCT02222480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102066873|NCT02222480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066874|NCT03670875|Curcumin|curcumin|mesh-list
102066875|NCT03670875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102066876|NCT03670875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102066877|NCT03670875|Analgesics|analgesics|mesh-ancestor
102066878|NCT03670875|Sensory System Agents|sensory system agents|mesh-ancestor
102066879|NCT03670875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102066880|NCT03670875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786603|NCT00727415|Antimetabolites|antimetabolites|mesh-ancestor
102066881|NCT03670875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102066882|NCT03670875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101699893|NCT02643680|Chlorhexidine|chlorhexidine|mesh-list
102066883|NCT03670875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102066884|NCT03670875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102066885|NCT03670875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066886|NCT01379677|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
102066887|NCT01379677|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102066888|NCT01379677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066889|NCT02220296|Insulin|insulin|mesh-list
102066890|NCT02220296|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102066891|NCT02220296|Insulin Glargine|insulin glargine|mesh-list
102066892|NCT02220296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102066893|NCT02220296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066894|NCT02074878|Sunitinib|sunitinib|mesh-list
102066895|NCT02074878|Crizotinib|crizotinib|mesh-list
102066896|NCT02074878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102066897|NCT02074878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101368508|NCT00169000|Docetaxel|docetaxel|mesh-list
102066918|NCT02628405|Rituximab|rituximab|mesh-list
102066919|NCT02628405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102066920|NCT02628405|Carboplatin|carboplatin|mesh-list
102066921|NCT02628405|Etoposide|etoposide|mesh-list
102066922|NCT02628405|Lenalidomide|lenalidomide|mesh-list
102066923|NCT02628405|Etoposide phosphate|etoposide phosphate|mesh-list
102066924|NCT02628405|Ifosfamide|ifosfamide|mesh-list
102066925|NCT02628405|Isophosphamide mustard|isophosphamide mustard|mesh-list
102066926|NCT02628405|Podophyllotoxin|podophyllotoxin|mesh-list
102066927|NCT02628405|Antibodies|antibodies|mesh-list
102066928|NCT02628405|Immunoglobulins|immunoglobulins|mesh-list
102066929|NCT02628405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102066930|NCT02628405|Immunologic Factors|immunologic factors|mesh-ancestor
102066931|NCT02628405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066932|NCT02628405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102066933|NCT02628405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102066934|NCT02628405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101942934|NCT02873338|Antimetabolites|antimetabolites|mesh-ancestor
101942935|NCT02873338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942936|NCT02873338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101942937|NCT02873338|Antiviral Agents|antiviral agents|mesh-ancestor
101942938|NCT02873338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102066935|NCT02628405|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102066936|NCT02628405|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102066937|NCT02628405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102066938|NCT02628405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066939|NCT02628405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102066940|NCT02628405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102066941|NCT02628405|Growth Substances|growth substances|mesh-ancestor
102066942|NCT02628405|Growth Inhibitors|growth inhibitors|mesh-ancestor
102066943|NCT02628405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102066944|NCT02628405|Alkylating Agents|alkylating agents|mesh-ancestor
102066945|NCT02628405|Keratolytic Agents|keratolytic agents|mesh-ancestor
102066946|NCT02628405|Dermatologic Agents|dermatologic agents|mesh-ancestor
102066947|NCT02628405|Tubulin Modulators|tubulin modulators|mesh-ancestor
102066948|NCT02628405|Antimitotic Agents|antimitotic agents|mesh-ancestor
102066949|NCT02628405|Mitosis Modulators|mitosis modulators|mesh-ancestor
102066950|NCT02220530|Fentanyl|fentanyl|mesh-list
102066951|NCT02220530|Midazolam|midazolam|mesh-list
102066952|NCT02220530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102066953|NCT02220530|Narcotics|narcotics|mesh-ancestor
102066969|NCT02220530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102066970|NCT02220530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066972|NCT02078232|Pancreatin|pancreatin|mesh-list
102066973|NCT02078232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102066974|NCT02075034|ON 01910|on 01910|mesh-list
102066975|NCT02075034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102066976|NCT02075034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102066977|NCT02075034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102066978|NCT02075034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066979|NCT02567175|Domperidone|domperidone|mesh-list
102066980|NCT02567175|Antiemetics|antiemetics|mesh-ancestor
102066981|NCT02567175|Autonomic Agents|autonomic agents|mesh-ancestor
102066982|NCT02567175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102066983|NCT02567175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066984|NCT02567175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102066985|NCT02567175|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102066986|NCT02567175|Dopamine Agents|dopamine agents|mesh-ancestor
102066987|NCT02567175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102066988|NCT02567175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066989|NCT02078388|Doxorubicin|doxorubicin|mesh-list
102066990|NCT02078388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102066991|NCT02078388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102066992|NCT02078388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102066993|NCT02078388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102066994|NCT02078388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102066995|NCT02078388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066996|NCT02222636|Fentanyl|fentanyl|mesh-list
102066997|NCT02222636|Dexmedetomidine|dexmedetomidine|mesh-list
102066998|NCT02222636|Anesthetics|anesthetics|mesh-list
102066999|NCT02222636|Sevoflurane|sevoflurane|mesh-list
102067000|NCT02222636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102067001|NCT02222636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067002|NCT02222636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102067003|NCT02222636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102067004|NCT02222636|Analgesics|analgesics|mesh-ancestor
102067005|NCT02222636|Sensory System Agents|sensory system agents|mesh-ancestor
102067006|NCT02222636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102067007|NCT02222636|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102067008|NCT02222636|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102067009|NCT02222636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102067010|NCT02222636|Adrenergic Agents|adrenergic agents|mesh-ancestor
102067011|NCT02222636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102067012|NCT02222636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067013|NCT02222636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102067014|NCT02222636|Narcotics|narcotics|mesh-ancestor
102067015|NCT02222636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101942939|NCT02873338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101942941|NCT02873338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942942|NCT02873338|Anticoagulants|anticoagulants|mesh-ancestor
101942943|NCT02873338|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102067022|NCT04058145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102067023|NCT04058145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102067024|NCT04058145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102067025|NCT04058145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067026|NCT04058145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102067027|NCT04058145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102067028|NCT04058145|Antiviral Agents|antiviral agents|mesh-ancestor
102067029|NCT04058145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102067030|NCT02230982|Nintedanib|nintedanib|mesh-list
101786757|NCT00977223|Aprepitant|aprepitant|mesh-list
102067031|NCT02230982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102067032|NCT02230982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102067034|NCT02230982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067035|NCT02075112|Genistein|genistein|mesh-list
102067036|NCT02075112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102067037|NCT02075112|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102067038|NCT02075112|Protective Agents|protective agents|mesh-ancestor
102067039|NCT02075112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067040|NCT02075112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102067041|NCT02075112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102067042|NCT02075112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067043|NCT02075112|Phytoestrogens|phytoestrogens|mesh-ancestor
102067044|NCT02075112|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102067045|NCT02075112|Estrogens|estrogens|mesh-ancestor
102067046|NCT02075112|Hormones|hormones|mesh-ancestor
102067047|NCT02075112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102067048|NCT02223026|Metformin|metformin|mesh-list
102067049|NCT02223026|Linagliptin|linagliptin|mesh-list
102067050|NCT02223026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102067051|NCT02223026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067052|NCT02223026|Incretins|incretins|mesh-ancestor
102067053|NCT02223026|Hormones|hormones|mesh-ancestor
102067054|NCT02223026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102067055|NCT02223026|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102067056|NCT02223026|Protease Inhibitors|protease inhibitors|mesh-ancestor
102067057|NCT02223026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102067058|NCT02223026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067059|NCT02075268|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102067060|NCT02075268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102067061|NCT02477384|Propranolol|propranolol|mesh-list
102067062|NCT02477384|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102067063|NCT02477384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102067064|NCT02477384|Adrenergic Agents|adrenergic agents|mesh-ancestor
102067065|NCT02477384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102067066|NCT02477384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067067|NCT02477384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067068|NCT02477384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102067069|NCT02477384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102067070|NCT02477384|Vasodilator Agents|vasodilator agents|mesh-ancestor
102067071|NCT02231294|Pramipexole|pramipexole|mesh-list
102067072|NCT02231294|Antioxidants|antioxidants|mesh-ancestor
102067073|NCT02231294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067074|NCT02231294|Protective Agents|protective agents|mesh-ancestor
102067075|NCT02231294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067076|NCT02231294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102067077|NCT02231294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102067078|NCT02231294|Dopamine Agonists|dopamine agonists|mesh-ancestor
102067079|NCT02231294|Dopamine Agents|dopamine agents|mesh-ancestor
102067080|NCT02231294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102067081|NCT02223416|Teriparatide|teriparatide|mesh-list
102067082|NCT02223416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102067083|NCT02223416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067084|NCT02223416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102067104|NCT02082054|Nasal Decongestants|nasal decongestants|mesh-ancestor
101942944|NCT02873338|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101942945|NCT02873338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101942946|NCT02873338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101942947|NCT02873338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101942948|NCT02873338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101942949|NCT03616132|Sirolimus|sirolimus|mesh-list
101942950|NCT03616132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101942951|NCT03616132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101942952|NCT03616132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101942953|NCT03616132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101942954|NCT03616132|Antifungal Agents|antifungal agents|mesh-ancestor
101942955|NCT03616132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102067105|NCT02082054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101786822|NCT00879918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102067106|NCT02082054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102067107|NCT02082054|Sympathomimetics|sympathomimetics|mesh-ancestor
102067108|NCT02082054|Adrenergic Agents|adrenergic agents|mesh-ancestor
102067109|NCT02082054|Antipruritics|antipruritics|mesh-ancestor
102067110|NCT02082054|Dermatologic Agents|dermatologic agents|mesh-ancestor
102067111|NCT02082054|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102067112|NCT02082054|Histamine Antagonists|histamine antagonists|mesh-ancestor
102067113|NCT02082054|Histamine Agents|histamine agents|mesh-ancestor
102067114|NCT02082054|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102067115|NCT02231372|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
102067116|NCT02231372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102067117|NCT02231372|Autonomic Agents|autonomic agents|mesh-ancestor
102067118|NCT02231372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102067119|NCT02231372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067120|NCT02231372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102067121|NCT02231372|Respiratory System Agents|respiratory system agents|mesh-ancestor
102067122|NCT02884544|Dextroamphetamine|dextroamphetamine|mesh-list
102067123|NCT02884544|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102067124|NCT02884544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067125|NCT02884544|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102067126|NCT02884544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102067127|NCT02884544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102067128|NCT02884544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067129|NCT02884544|Dopamine Agents|dopamine agents|mesh-ancestor
102067130|NCT02884544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102067131|NCT02226926|Aspirin|aspirin|mesh-list
102067132|NCT02226926|Dipyridamole|dipyridamole|mesh-list
102067133|NCT02226926|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
102067134|NCT02226926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102067135|NCT02226926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102067136|NCT02226926|Analgesics|analgesics|mesh-ancestor
102067137|NCT02226926|Sensory System Agents|sensory system agents|mesh-ancestor
102067138|NCT02226926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101368752|NCT00170833|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102067151|NCT02924883|Trastuzumab|trastuzumab|mesh-list
102067152|NCT02924883|Atezolizumab|atezolizumab|mesh-list
102067153|NCT02924883|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102067154|NCT02924883|Maytansine|maytansine|mesh-list
102067155|NCT02924883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102067156|NCT02924883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102067157|NCT02924883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102067158|NCT02924883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067159|NCT02924883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102067160|NCT02924883|Tubulin Modulators|tubulin modulators|mesh-ancestor
102067161|NCT02924883|Antimitotic Agents|antimitotic agents|mesh-ancestor
102067162|NCT02924883|Mitosis Modulators|mitosis modulators|mesh-ancestor
102067163|NCT02924883|Immunotoxins|immunotoxins|mesh-ancestor
102067164|NCT02924883|Immunoconjugates|immunoconjugates|mesh-ancestor
102067165|NCT02924883|Immunologic Factors|immunologic factors|mesh-ancestor
101942957|NCT03616132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942958|NCT02872012|Lidocaine|lidocaine|mesh-list
101942959|NCT02872012|Anesthetics, Local|anesthetics, local|mesh-ancestor
101942960|NCT02872012|Anesthetics|anesthetics|mesh-ancestor
102067166|NCT02924883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067167|NCT02075970|Epoetin Alfa|epoetin alfa|mesh-list
102067168|NCT02075970|Hematinics|hematinics|mesh-ancestor
102067169|NCT02231450|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
102067170|NCT02231450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102067171|NCT02231450|Serotonin Agents|serotonin agents|mesh-ancestor
102067172|NCT02231450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102067173|NCT02231450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067174|NCT02231450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067175|NCT05764057|Dapagliflozin|dapagliflozin|mesh-list
102067176|NCT05764057|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102067177|NCT05764057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067178|NCT05764057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102067179|NCT05764057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067180|NCT02227082|Olaparib|olaparib|mesh-list
102067181|NCT02227082|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102067182|NCT02227082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102067183|NCT02227082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067184|NCT02227082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102067185|NCT01369680|Ketamine|ketamine|mesh-list
102067186|NCT01369680|Analgesics|analgesics|mesh-ancestor
102067187|NCT01369680|Sensory System Agents|sensory system agents|mesh-ancestor
102067188|NCT01369680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102067189|NCT01369680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067190|NCT01369680|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102067191|NCT01369680|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102067192|NCT01369680|Anesthetics, General|anesthetics, general|mesh-ancestor
102067193|NCT01369680|Anesthetics|anesthetics|mesh-ancestor
102067194|NCT01369680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102067195|NCT01369680|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102067196|NCT01369680|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102067197|NCT01369680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102067198|NCT01369680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067204|NCT03670095|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102067205|NCT03670095|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102067206|NCT03670095|Dopamine Agents|dopamine agents|mesh-ancestor
102067207|NCT03670095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102067208|NCT03670095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067209|NCT03670095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067210|NCT03670095|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102067211|NCT03670095|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102067212|NCT01378039|Budesonide|budesonide|mesh-list
102067213|NCT01378039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102067214|NCT01378039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102067215|NCT01378039|Autonomic Agents|autonomic agents|mesh-ancestor
102067216|NCT01378039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102067217|NCT01378039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067218|NCT01378039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102067219|NCT01378039|Respiratory System Agents|respiratory system agents|mesh-ancestor
102067220|NCT01378039|Glucocorticoids|glucocorticoids|mesh-ancestor
102067221|NCT01378039|Hormones|hormones|mesh-ancestor
102067222|NCT01378039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102067223|NCT01377961|Lycopene|lycopene|mesh-list
102067224|NCT01377961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102067225|NCT01377961|Antioxidants|antioxidants|mesh-ancestor
102067226|NCT01377961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067227|NCT01377961|Protective Agents|protective agents|mesh-ancestor
102067228|NCT01377961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067229|NCT01377961|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102067230|NCT01377961|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102067231|NCT01377961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102067232|NCT03558750|Rituximab|rituximab|mesh-list
102067233|NCT03558750|Nivolumab|nivolumab|mesh-list
101942961|NCT02872012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101307864|NCT02043977|Anesthetics|anesthetics|mesh-ancestor
102067234|NCT03558750|Lenalidomide|lenalidomide|mesh-list
102067235|NCT03558750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102067236|NCT03558750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102067237|NCT03558750|Immunologic Factors|immunologic factors|mesh-ancestor
102067238|NCT03558750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067239|NCT03558750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102067240|NCT03558750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102067241|NCT03558750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067242|NCT03558750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102067243|NCT03558750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102067244|NCT03558750|Growth Substances|growth substances|mesh-ancestor
102067245|NCT03558750|Growth Inhibitors|growth inhibitors|mesh-ancestor
102067246|NCT03559140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102067247|NCT02751320|Citric Acid|citric acid|mesh-list
102067248|NCT02751320|Sodium Citrate|sodium citrate|mesh-list
102067249|NCT02751320|Anticoagulants|anticoagulants|mesh-ancestor
102067250|NCT02751320|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102067251|NCT02751320|Chelating Agents|chelating agents|mesh-ancestor
102067252|NCT02751320|Sequestering Agents|sequestering agents|mesh-ancestor
102067253|NCT02751320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067254|NCT04093219|Acetaminophen|acetaminophen|mesh-list
102067255|NCT04093219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102067256|NCT04093219|Analgesics|analgesics|mesh-ancestor
102067257|NCT04093219|Sensory System Agents|sensory system agents|mesh-ancestor
102067258|NCT04093219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102067259|NCT04093219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067260|NCT04093219|Antipyretics|antipyretics|mesh-ancestor
102067261|NCT03559764|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
102067262|NCT03559764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102067263|NCT03559764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102067264|NCT04931641|Ferrous fumarate|ferrous fumarate|mesh-list
102067265|NCT04931641|Trace Elements|trace elements|mesh-ancestor
102067266|NCT04931641|Micronutrients|micronutrients|mesh-ancestor
102067267|NCT04931641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067268|NCT02083536|Docetaxel|docetaxel|mesh-list
102067269|NCT02083536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102067270|NCT02083536|Tubulin Modulators|tubulin modulators|mesh-ancestor
102067281|NCT02231606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102067282|NCT02231606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067283|NCT02231606|Adrenergic Agents|adrenergic agents|mesh-ancestor
102067284|NCT02231606|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102067285|NCT02231606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102067286|NCT02231606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102067287|NCT02231606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102067289|NCT02083692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102067290|NCT02083692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067291|NCT02227550|Vitamin K|vitamin k|mesh-list
102067292|NCT02227550|Warfarin|warfarin|mesh-list
102067293|NCT02227550|Apixaban|apixaban|mesh-list
102067294|NCT02227550|Phenprocoumon|phenprocoumon|mesh-list
102067295|NCT02227550|Fluindione|fluindione|mesh-list
102067296|NCT02227550|Vitamins|vitamins|mesh-ancestor
102067297|NCT02227550|Micronutrients|micronutrients|mesh-ancestor
102067298|NCT02227550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067299|NCT02227550|Anticoagulants|anticoagulants|mesh-ancestor
102067300|NCT02227550|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102067301|NCT02227550|Antithrombins|antithrombins|mesh-ancestor
102067302|NCT02227550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102067303|NCT02227550|Protease Inhibitors|protease inhibitors|mesh-ancestor
102067304|NCT02227550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102067305|NCT02227550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067306|NCT02227550|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102067307|NCT02227550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102067308|NCT02227550|Hemostatics|hemostatics|mesh-ancestor
102067309|NCT02227550|Coagulants|coagulants|mesh-ancestor
102067310|NCT02206035|Methotrexate|methotrexate|mesh-list
102067311|NCT02206035|Tacrolimus|tacrolimus|mesh-list
102067312|NCT02206035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102067313|NCT02206035|Abortifacient Agents|abortifacient agents|mesh-ancestor
102067314|NCT02206035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102067315|NCT02206035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067316|NCT02206035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102067317|NCT02206035|Antimetabolites|antimetabolites|mesh-ancestor
101942962|NCT02872012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101942963|NCT02872012|Sensory System Agents|sensory system agents|mesh-ancestor
101942964|NCT02872012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101942965|NCT02872012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102067318|NCT02206035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067319|NCT02206035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102067320|NCT02206035|Dermatologic Agents|dermatologic agents|mesh-ancestor
102067321|NCT02206035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102067322|NCT02206035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102067323|NCT02206035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102067324|NCT02206035|Immunologic Factors|immunologic factors|mesh-ancestor
102067325|NCT02206035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102067326|NCT02206035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102067327|NCT02206035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102067329|NCT02258828|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102067330|NCT02258828|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102067331|NCT02258828|Dopamine Agents|dopamine agents|mesh-ancestor
102067332|NCT02258828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102067333|NCT02258828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067334|NCT02258828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067335|NCT02258828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102067338|NCT02083068|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
102067339|NCT02083068|Immunologic Factors|immunologic factors|mesh-ancestor
102067340|NCT02083068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067341|NCT02083068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102067342|NCT02228252|Caseins|caseins|mesh-list
102067343|NCT02228252|Chelating Agents|chelating agents|mesh-ancestor
102067344|NCT02228252|Sequestering Agents|sequestering agents|mesh-ancestor
102067345|NCT02228252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067346|NCT02070549|Trametinib|trametinib|mesh-list
102067347|NCT02070549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102067348|NCT02070549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102067349|NCT02070549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102067350|NCT02070549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067351|NCT02591953|Methylprednisolone|methylprednisolone|mesh-list
102067352|NCT02591953|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102067353|NCT02591953|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102067354|NCT02591953|Prednisolone|prednisolone|mesh-list
102067355|NCT02591953|Prednisolone acetate|prednisolone acetate|mesh-list
102067356|NCT02591953|Lidocaine|lidocaine|mesh-list
102067357|NCT02591953|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102067358|NCT02591953|Prednisolone phosphate|prednisolone phosphate|mesh-list
102067359|NCT02591953|Anesthetics, Local|anesthetics, local|mesh-ancestor
102067360|NCT02591953|Anesthetics|anesthetics|mesh-ancestor
102067361|NCT02591953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102067362|NCT02591953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067363|NCT02591953|Sensory System Agents|sensory system agents|mesh-ancestor
102067364|NCT02591953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102067365|NCT02591953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102067366|NCT02591953|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102067367|NCT02591953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102067368|NCT02591953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102067369|NCT02591953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067370|NCT02591953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102067371|NCT02591953|Antiemetics|antiemetics|mesh-ancestor
102067372|NCT02591953|Autonomic Agents|autonomic agents|mesh-ancestor
102067373|NCT02591953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102067374|NCT02591953|Glucocorticoids|glucocorticoids|mesh-ancestor
102067375|NCT02591953|Hormones|hormones|mesh-ancestor
102067376|NCT02591953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102067377|NCT02591953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102067378|NCT02591953|Protective Agents|protective agents|mesh-ancestor
102067379|NCT02591953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102067380|NCT02591953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102067381|NCT02223884|Carboplatin|carboplatin|mesh-list
102067382|NCT02223884|Docetaxel|docetaxel|mesh-list
102067383|NCT02223884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102067384|NCT02223884|Tubulin Modulators|tubulin modulators|mesh-ancestor
102067385|NCT02223884|Antimitotic Agents|antimitotic agents|mesh-ancestor
101942966|NCT02872012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101942967|NCT02872012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101942968|NCT02872012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101307872|NCT02044120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102067386|NCT02223884|Mitosis Modulators|mitosis modulators|mesh-ancestor
102067387|NCT02223884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067388|NCT02079480|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
102067389|NCT02079480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102067390|NCT02079480|Immunologic Factors|immunologic factors|mesh-ancestor
102067391|NCT02079480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067392|NCT02569489|Paclitaxel|paclitaxel|mesh-list
102067393|NCT02569489|Trastuzumab|trastuzumab|mesh-list
102067394|NCT02569489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102067395|NCT02569489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102067396|NCT02569489|Tubulin Modulators|tubulin modulators|mesh-ancestor
102067397|NCT02569489|Antimitotic Agents|antimitotic agents|mesh-ancestor
102067398|NCT02569489|Mitosis Modulators|mitosis modulators|mesh-ancestor
102067399|NCT02569489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067400|NCT02569489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102067401|NCT02079558|Oxytocin|oxytocin|mesh-list
102067402|NCT02079558|Carbetocin|carbetocin|mesh-list
102067403|NCT02079558|Oxytocics|oxytocics|mesh-ancestor
102067404|NCT02079558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102067405|NCT02079558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067406|NCT04057755|Botulinum Toxins|botulinum toxins|mesh-list
102067407|NCT04057755|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102067408|NCT04057755|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102067409|NCT04057755|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102067414|NCT04057755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067415|NCT04057755|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102067416|NCT04057755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102067417|NCT03669003|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
102067418|NCT03669003|Hemostatics|hemostatics|mesh-ancestor
102067419|NCT03669003|Coagulants|coagulants|mesh-ancestor
102067420|NCT04313959|Dexamethasone|dexamethasone|mesh-list
102067421|NCT04313959|Ropivacaine|ropivacaine|mesh-list
102067422|NCT04313959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102067423|NCT04313959|Antiemetics|antiemetics|mesh-ancestor
102067424|NCT04313959|Autonomic Agents|autonomic agents|mesh-ancestor
102067425|NCT04313959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102067426|NCT04313959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067427|NCT04313959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102067428|NCT04313959|Glucocorticoids|glucocorticoids|mesh-ancestor
102067429|NCT04313959|Hormones|hormones|mesh-ancestor
102067430|NCT04313959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102067431|NCT04313959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102067432|NCT04313959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102067433|NCT04313959|Anesthetics, Local|anesthetics, local|mesh-ancestor
102067434|NCT04313959|Anesthetics|anesthetics|mesh-ancestor
102067435|NCT04313959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102067436|NCT04313959|Sensory System Agents|sensory system agents|mesh-ancestor
102067437|NCT03073213|Ixekizumab|ixekizumab|mesh-list
102067438|NCT03073213|Dermatologic Agents|dermatologic agents|mesh-ancestor
102067439|NCT03070483|Vitamin D|vitamin d|mesh-list
102067440|NCT03070483|Cholecalciferol|cholecalciferol|mesh-list
102067441|NCT03070483|Vitamins|vitamins|mesh-ancestor
102067442|NCT03070483|Micronutrients|micronutrients|mesh-ancestor
102067443|NCT03070483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067444|NCT03070483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102067445|NCT03070483|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102067446|NCT05763667|Bupivacaine|bupivacaine|mesh-list
102067447|NCT05763667|Anesthetics, Local|anesthetics, local|mesh-ancestor
102067448|NCT05763667|Anesthetics|anesthetics|mesh-ancestor
102067449|NCT05763667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102067450|NCT05763667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067451|NCT05763667|Sensory System Agents|sensory system agents|mesh-ancestor
102067452|NCT05763667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102067453|NCT04107727|Cytarabine|cytarabine|mesh-list
102067454|NCT04107727|Idarubicin|idarubicin|mesh-list
102067455|NCT04107727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102067456|NCT04107727|Antimetabolites|antimetabolites|mesh-ancestor
102067457|NCT04107727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942969|NCT02872012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307874|NCT02044120|Alkylating Agents|alkylating agents|mesh-ancestor
102067458|NCT04107727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102067459|NCT04107727|Antiviral Agents|antiviral agents|mesh-ancestor
102067460|NCT04107727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102067461|NCT04107727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102067462|NCT04107727|Immunologic Factors|immunologic factors|mesh-ancestor
102067463|NCT04107727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067464|NCT04107727|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102067465|NCT04107727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102067466|NCT04107727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102067467|NCT04107727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102067468|NCT01074151|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102067469|NCT01074151|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102067470|NCT01074151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102067471|NCT01074151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102067472|NCT01074151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067473|NCT01074151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102067474|NCT01074151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067475|NCT01074151|Analgesics|analgesics|mesh-ancestor
102067476|NCT01074151|Sensory System Agents|sensory system agents|mesh-ancestor
102067477|NCT01074151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102067478|NCT01074151|Antidepressive Agents|antidepressive agents|mesh-ancestor
102067479|NCT01074151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102067499|NCT02786329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102067500|NCT02786329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102067501|NCT02786329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102067502|NCT02786329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067503|NCT02786329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102067504|NCT02786329|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102067505|NCT02786329|Anesthetics, General|anesthetics, general|mesh-ancestor
102067511|NCT05761327|Curcumin|curcumin|mesh-list
102067512|NCT05761327|Resveratrol|resveratrol|mesh-list
102067513|NCT05761327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102067514|NCT05761327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102067515|NCT05761327|Analgesics|analgesics|mesh-ancestor
102067516|NCT05761327|Sensory System Agents|sensory system agents|mesh-ancestor
102067517|NCT05761327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102067518|NCT05761327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067519|NCT05761327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102067520|NCT05761327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102067521|NCT05761327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102067522|NCT05761327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102067523|NCT05761327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067524|NCT05761327|Antioxidants|antioxidants|mesh-ancestor
101700120|NCT02642900|Nystatin|nystatin|mesh-list
102067525|NCT05761327|Protective Agents|protective agents|mesh-ancestor
102067526|NCT05761327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102067527|NCT02231762|Temozolomide|temozolomide|mesh-list
102067528|NCT02231762|Lanreotide|lanreotide|mesh-list
102067529|NCT02231762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102067530|NCT02231762|Alkylating Agents|alkylating agents|mesh-ancestor
102067531|NCT02231762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067532|NCT02231762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102067533|NCT01191957|Cyclophosphamide|cyclophosphamide|mesh-list
102067534|NCT01191957|Busulfan|busulfan|mesh-list
102067535|NCT01191957|Fludarabine|fludarabine|mesh-list
102067536|NCT01191957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102067537|NCT01191957|Immunologic Factors|immunologic factors|mesh-ancestor
102067538|NCT01191957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067539|NCT01191957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102067540|NCT01191957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102067541|NCT01191957|Alkylating Agents|alkylating agents|mesh-ancestor
102067542|NCT01191957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067543|NCT01191957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102067544|NCT01191957|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102067545|NCT01050855|Busulfan|busulfan|mesh-list
102067546|NCT01050855|Alemtuzumab|alemtuzumab|mesh-list
102067547|NCT01050855|Alkylating Agents|alkylating agents|mesh-ancestor
101942971|NCT03617224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101942972|NCT03617224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101942973|NCT03617224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101307875|NCT02044120|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102067548|NCT01050855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067549|NCT01050855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102067559|NCT04459286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102067560|NCT04459286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102067561|NCT04459286|Protease Inhibitors|protease inhibitors|mesh-ancestor
102067562|NCT04459286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102067563|NCT04459286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067564|NCT04459286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102067565|NCT04459286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102067566|NCT04459286|Antiviral Agents|antiviral agents|mesh-ancestor
102067567|NCT04459286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102067568|NCT04459286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102067569|NCT04459286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102067570|NCT04459286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102067572|NCT00744081|Mitoxantrone|mitoxantrone|mesh-list
102067573|NCT00744081|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102067574|NCT00744081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102067575|NCT00744081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102067576|NCT00744081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067577|NCT00744081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102067578|NCT00744081|Analgesics|analgesics|mesh-ancestor
102067579|NCT00744081|Sensory System Agents|sensory system agents|mesh-ancestor
102067580|NCT00744081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102067581|NCT00744081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067582|NCT00744081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102067583|NCT02229266|Cytarabine|cytarabine|mesh-list
102067584|NCT02229266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102067585|NCT02229266|Antimetabolites|antimetabolites|mesh-ancestor
102067586|NCT02229266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067587|NCT02229266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102067588|NCT02229266|Antiviral Agents|antiviral agents|mesh-ancestor
102067589|NCT02229266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102067590|NCT02229266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102067591|NCT02229266|Immunologic Factors|immunologic factors|mesh-ancestor
102067592|NCT02229266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067593|NCT02224040|Azithromycin|azithromycin|mesh-list
102067594|NCT02224040|Ceftriaxone|ceftriaxone|mesh-list
102067595|NCT02224040|Cefixime|cefixime|mesh-list
102067596|NCT02224040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102067597|NCT02224040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102067598|NCT04448834|Vincristine|vincristine|mesh-list
102067599|NCT04448834|Blinatumomab|blinatumomab|mesh-list
102067600|NCT04448834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102067601|NCT04448834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102067602|NCT04448834|Tubulin Modulators|tubulin modulators|mesh-ancestor
102067603|NCT04448834|Antimitotic Agents|antimitotic agents|mesh-ancestor
102067604|NCT04448834|Mitosis Modulators|mitosis modulators|mesh-ancestor
102067605|NCT04448834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067609|NCT02232308|Lisinopril|lisinopril|mesh-list
102067610|NCT02232308|Nizatidine|nizatidine|mesh-list
102067611|NCT02232308|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102067612|NCT02232308|Protease Inhibitors|protease inhibitors|mesh-ancestor
102067613|NCT02232308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102067614|NCT02232308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067615|NCT02232308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102067616|NCT02232308|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102067617|NCT02232308|Protective Agents|protective agents|mesh-ancestor
102067618|NCT02232308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067619|NCT02232308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101369216|NCT00174304|Atorvastatin|atorvastatin|mesh-list
102067626|NCT02232386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102067627|NCT02232386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101787348|NCT00982215|Antipyretics|antipyretics|mesh-ancestor
102067628|NCT02232386|Immunologic Factors|immunologic factors|mesh-ancestor
101942974|NCT03617224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942975|NCT03615430|Anesthetics|anesthetics|mesh-list
101942976|NCT03615430|Anesthetics, Local|anesthetics, local|mesh-list
101942977|NCT03615430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101942978|NCT03615430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307881|NCT02044146|Clopidogrel|clopidogrel|mesh-list
102067629|NCT02232386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067630|NCT02232386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102067631|NCT02229734|Androgens|androgens|mesh-list
102067632|NCT02229734|Hormones|hormones|mesh-ancestor
102067633|NCT02229734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102067634|NCT02229734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067635|NCT04333160|Hylan|hylan|mesh-list
102067636|NCT04333160|Viscosupplements|viscosupplements|mesh-ancestor
102067637|NCT04333160|Protective Agents|protective agents|mesh-ancestor
102067638|NCT04333160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067639|NCT02258906|Urinastatin|urinastatin|mesh-list
102067640|NCT02258906|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102067641|NCT02258906|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102067642|NCT02258906|Protease Inhibitors|protease inhibitors|mesh-ancestor
102067643|NCT02258906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102067644|NCT02258906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067645|NCT02229812|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102067646|NCT02229812|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102067647|NCT02229812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102067648|NCT02229812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067649|NCT04222712|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102067650|NCT04222712|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102067651|NCT02229890|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102067652|NCT02229890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102067653|NCT02229890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102067654|NCT02229890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067655|NCT02230046|Abiraterone Acetate|abiraterone acetate|mesh-list
102067656|NCT02230046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102067657|NCT02230046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102067658|NCT02230046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102067659|NCT02230046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067660|NCT02230046|Hormone Antagonists|hormone antagonists|mesh-ancestor
102067661|NCT02230046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102067662|NCT02230046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067663|NCT02230046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102067664|NCT03068455|Nivolumab|nivolumab|mesh-list
102067665|NCT03068455|Ipilimumab|ipilimumab|mesh-list
102067666|NCT03068455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102067667|NCT03068455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102067668|NCT03068455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102067669|NCT03068455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067670|NCT03646994|Crizotinib|crizotinib|mesh-list
102067671|NCT03646994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102067672|NCT03646994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102067673|NCT03646994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102067674|NCT03646994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067675|NCT04207736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102067676|NCT04207736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102067677|NCT02232932|Capecitabine|capecitabine|mesh-list
102067678|NCT02232932|Liver Extracts|liver extracts|mesh-list
102067679|NCT02232932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102067680|NCT02232932|Antimetabolites|antimetabolites|mesh-ancestor
102067681|NCT02232932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067682|NCT02232932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102067683|NCT02232932|Hematinics|hematinics|mesh-ancestor
102067684|NCT02230358|Anesthetics|anesthetics|mesh-list
102067685|NCT02230358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102067686|NCT02230358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067693|NCT04049864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102067694|NCT04049864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101942979|NCT03615430|Sensory System Agents|sensory system agents|mesh-ancestor
101942980|NCT03615430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101942981|NCT01344226|Loteprednol Etabonate|loteprednol etabonate|mesh-list
101942982|NCT01344226|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102067695|NCT04049864|Growth Substances|growth substances|mesh-ancestor
102067696|NCT04049864|Growth Inhibitors|growth inhibitors|mesh-ancestor
102067697|NCT04049864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102067698|NCT03475706|Solabegron|solabegron|mesh-list
102067699|NCT03475706|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102067700|NCT03475706|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102067701|NCT03475706|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101787424|NCT00655850|Antimetabolites|antimetabolites|mesh-ancestor
102067702|NCT03475706|Adrenergic Agents|adrenergic agents|mesh-ancestor
102067703|NCT03475706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102067704|NCT03475706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067705|NCT03475706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067706|NCT02234492|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102067707|NCT02234492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102067708|NCT02234492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102067709|NCT02234492|Antimetabolites|antimetabolites|mesh-ancestor
102067710|NCT02234492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067711|NCT02234492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102067712|NCT02234492|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102067713|NCT02234492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102067714|NCT03928184|Lorecivivint|lorecivivint|mesh-list
102067715|NCT03928184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102067716|NCT02259374|Ropivacaine|ropivacaine|mesh-list
102067717|NCT02259374|Anesthetics, Local|anesthetics, local|mesh-ancestor
102067718|NCT02259374|Anesthetics|anesthetics|mesh-ancestor
102067719|NCT02259374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102067720|NCT02259374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700399|NCT00678756|Ketoconazole|ketoconazole|mesh-list
102067721|NCT02259374|Sensory System Agents|sensory system agents|mesh-ancestor
102067722|NCT02259374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102067723|NCT04921982|Propranolol|propranolol|mesh-list
102067724|NCT04921982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102067725|NCT04921982|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102067726|NCT04921982|Adrenergic Agents|adrenergic agents|mesh-ancestor
102067727|NCT04921982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102067728|NCT04921982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067729|NCT04921982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067730|NCT04921982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102067731|NCT04921982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102067732|NCT04921982|Vasodilator Agents|vasodilator agents|mesh-ancestor
102067733|NCT04874324|Levonadifloxacin|levonadifloxacin|mesh-list
102067734|NCT04874324|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102067735|NCT04874324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102067736|NCT04874324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067737|NCT04874324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102067738|NCT04874324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102067739|NCT04866056|Azacitidine|azacitidine|mesh-list
102067740|NCT04866056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102067741|NCT04866056|Antimetabolites|antimetabolites|mesh-ancestor
102067742|NCT04866056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067743|NCT04866056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102067744|NCT04866056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102067745|NCT03911102|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101700587|NCT05590117|Leucovorin|leucovorin|mesh-list
102067746|NCT03911102|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102067747|NCT03911102|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102067748|NCT03911102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102067749|NCT03911102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067750|NCT03911102|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102067751|NCT03911102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102067752|NCT03911102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067753|NCT03911102|Cholinergic Agents|cholinergic agents|mesh-ancestor
102067773|NCT03881852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787494|NCT00586157|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102067774|NCT03881852|Adrenergic Agents|adrenergic agents|mesh-ancestor
102067775|NCT03881852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101942983|NCT01344226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101358130|NCT02358187|Poly ICLC|poly iclc|mesh-list
101942984|NCT01344226|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101942985|NCT03615196|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101942986|NCT03615196|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102067776|NCT03881852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067778|NCT03818828|Cadexomer iodine|cadexomer iodine|mesh-list
102067779|NCT03818828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102067780|NCT03818828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102067781|NCT03818828|Trace Elements|trace elements|mesh-ancestor
102067782|NCT03818828|Micronutrients|micronutrients|mesh-ancestor
102067783|NCT03818828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067784|NCT02804282|Furosemide|furosemide|mesh-list
102067785|NCT02804282|Diuretics|diuretics|mesh-ancestor
102067786|NCT02804282|Natriuretic Agents|natriuretic agents|mesh-ancestor
102067787|NCT02804282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067788|NCT02804282|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102067789|NCT02804282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102067790|NCT02804282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067791|NCT02233244|Midazolam|midazolam|mesh-list
102067792|NCT02233244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101700775|NCT02744339|Riociguat|riociguat|mesh-list
102067793|NCT02233244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102067794|NCT02233244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102067795|NCT02233244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067796|NCT02233244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102067797|NCT02233244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102067798|NCT02233244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102067799|NCT02233244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102067800|NCT02233244|Anesthetics, General|anesthetics, general|mesh-ancestor
102067801|NCT02233244|Anesthetics|anesthetics|mesh-ancestor
102067802|NCT02233244|GABA Modulators|gaba modulators|mesh-ancestor
102067803|NCT02233244|GABA Agents|gaba agents|mesh-ancestor
102067804|NCT02233244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102067805|NCT02233244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067806|NCT02259530|Psychotropic Drugs|psychotropic drugs|mesh-list
102067807|NCT02234882|Fostemsavir|fostemsavir|mesh-list
102067808|NCT02234882|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102067821|NCT02234882|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102067822|NCT03729362|Miglustat|miglustat|mesh-list
102067823|NCT03729362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102067824|NCT03729362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067825|NCT03729362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102067826|NCT03729362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102067827|NCT03729362|Antiviral Agents|antiviral agents|mesh-ancestor
102067828|NCT03729362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102067829|NCT03729362|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102067830|NCT03729362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102067831|NCT03729362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067832|NCT03727022|Lorecivivint|lorecivivint|mesh-list
102067833|NCT03727022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102067834|NCT02233322|Ferrous gluconate|ferrous gluconate|mesh-list
102067835|NCT02233322|Hematinics|hematinics|mesh-ancestor
102067836|NCT02233400|Acetaminophen|acetaminophen|mesh-list
102067837|NCT02233400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102067838|NCT02233400|Analgesics|analgesics|mesh-ancestor
102067839|NCT02233400|Sensory System Agents|sensory system agents|mesh-ancestor
102067840|NCT02233400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102067841|NCT02233400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067842|NCT02233400|Antipyretics|antipyretics|mesh-ancestor
102067843|NCT03067441|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
102067844|NCT03067441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102067845|NCT03067441|Antimetabolites|antimetabolites|mesh-ancestor
102067846|NCT03067441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067847|NCT03067441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102067848|NCT03067441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102067849|NCT03067441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102067850|NCT03067441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067851|NCT02235194|Chromium|chromium|mesh-list
102067852|NCT02235194|Picolinic acid|picolinic acid|mesh-list
102067853|NCT02235194|Trace Elements|trace elements|mesh-ancestor
102067854|NCT02235194|Micronutrients|micronutrients|mesh-ancestor
102067855|NCT02235194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067856|NCT02235194|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101942988|NCT04837768|Progestins|progestins|mesh-ancestor
101942989|NCT04837768|Hormones|hormones|mesh-ancestor
101942990|NCT04837768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101942991|NCT04837768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067857|NCT02235194|Chelating Agents|chelating agents|mesh-ancestor
102067858|NCT02235194|Sequestering Agents|sequestering agents|mesh-ancestor
102067859|NCT02235194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067860|NCT03684278|Infliximab|infliximab|mesh-list
102067861|NCT03684278|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102067862|NCT03684278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102067863|NCT03684278|Dermatologic Agents|dermatologic agents|mesh-ancestor
102067864|NCT03684278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102067865|NCT03684278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102067866|NCT02726659|Celecoxib|celecoxib|mesh-list
102067867|NCT02726659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102067868|NCT02726659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102067869|NCT02726659|Analgesics|analgesics|mesh-ancestor
102067870|NCT02726659|Sensory System Agents|sensory system agents|mesh-ancestor
102067871|NCT02726659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102067884|NCT04446962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102067885|NCT04446962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102067886|NCT04446962|Growth Substances|growth substances|mesh-ancestor
102067887|NCT04446962|Growth Inhibitors|growth inhibitors|mesh-ancestor
102067888|NCT04446962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102067889|NCT03951961|Midostaurin|midostaurin|mesh-list
102067890|NCT03951961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102067891|NCT03951961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102067892|NCT03951961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102067893|NCT03951961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067894|NCT02232542|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102067895|NCT02232542|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102067896|NCT02232542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102067897|NCT02232542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102067898|NCT02232542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067899|NCT02232542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102067900|NCT02232542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067901|NCT02232542|Analgesics|analgesics|mesh-ancestor
102067902|NCT02232542|Sensory System Agents|sensory system agents|mesh-ancestor
102067903|NCT02232542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102067904|NCT02232542|Antidepressive Agents|antidepressive agents|mesh-ancestor
102067905|NCT02232542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102067906|NCT02232542|Dopamine Agents|dopamine agents|mesh-ancestor
102067907|NCT02600923|Letrozole|letrozole|mesh-list
102067908|NCT02600923|Palbociclib|palbociclib|mesh-list
102067909|NCT02600923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102067910|NCT02600923|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102067911|NCT02600923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102067912|NCT02600923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102067913|NCT02600923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067914|NCT02600923|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102067915|NCT02600923|Hormone Antagonists|hormone antagonists|mesh-ancestor
102067916|NCT02600923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102067917|NCT02600923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067918|NCT02600923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102067919|NCT02232776|Losartan|losartan|mesh-list
102067920|NCT02232776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102067921|NCT02232776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102067922|NCT02232776|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102067923|NCT02232776|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102067924|NCT02232776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067926|NCT03847519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102067927|NCT03847519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102067928|NCT03847519|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102067929|NCT03847519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067930|NCT02235428|Bromides|bromides|mesh-list
102067931|NCT02235428|Albuterol|albuterol|mesh-list
101369551|NCT00176020|Niacin|niacin|mesh-list
102067937|NCT02235428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067938|NCT02235428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102067939|NCT02235428|Respiratory System Agents|respiratory system agents|mesh-ancestor
102067940|NCT02235428|Tocolytic Agents|tocolytic agents|mesh-ancestor
102067941|NCT02235428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102067942|NCT02235428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102067943|NCT02235428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102067944|NCT02235428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102067945|NCT02235428|Adrenergic Agents|adrenergic agents|mesh-ancestor
102067946|NCT02235428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102067947|NCT02235428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067948|NCT02235428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102067949|NCT02235428|Cholinergic Agents|cholinergic agents|mesh-ancestor
102067950|NCT03070171|Dabigatran|dabigatran|mesh-list
102067951|NCT03070171|Antithrombins|antithrombins|mesh-ancestor
102067952|NCT03070171|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102067953|NCT03070171|Protease Inhibitors|protease inhibitors|mesh-ancestor
102067954|NCT03070171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102067955|NCT03070171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067956|NCT03070171|Anticoagulants|anticoagulants|mesh-ancestor
102067957|NCT02262572|Telmisartan|telmisartan|mesh-list
102067958|NCT02262572|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102067959|NCT02262572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102067960|NCT02262572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102067961|NCT02262572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102067962|NCT02262572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067963|NCT02262572|Diuretics|diuretics|mesh-ancestor
102067964|NCT02262572|Natriuretic Agents|natriuretic agents|mesh-ancestor
102067965|NCT02262572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067966|NCT02262572|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102067967|NCT02262572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102067968|NCT02235584|Dexamethasone|dexamethasone|mesh-list
102067969|NCT02235584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102067970|NCT02235584|Antiemetics|antiemetics|mesh-ancestor
102067971|NCT02235584|Autonomic Agents|autonomic agents|mesh-ancestor
102067972|NCT02235584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102067973|NCT02235584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067974|NCT02235584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102067975|NCT02235584|Glucocorticoids|glucocorticoids|mesh-ancestor
102067976|NCT02235584|Hormones|hormones|mesh-ancestor
102067977|NCT02235584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102067978|NCT02235584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102067979|NCT02235584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102067980|NCT02235662|Tenofovir|tenofovir|mesh-list
102067981|NCT02235662|Levonorgestrel|levonorgestrel|mesh-list
102067982|NCT02235662|Antiviral Agents|antiviral agents|mesh-ancestor
102067983|NCT02235662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102067984|NCT02235662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102067985|NCT02235662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102067986|NCT02235662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102067987|NCT02235662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067988|NCT02235662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102067989|NCT02235662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101701097|NCT02741219|Narcotics|narcotics|mesh-ancestor
102067990|NCT02235662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102067991|NCT02235662|Contraceptive Agents|contraceptive agents|mesh-ancestor
102067992|NCT02235662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102067993|NCT02235662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067994|NCT02235662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102067995|NCT02235662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102067996|NCT02235662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102067998|NCT02262650|Clopidogrel|clopidogrel|mesh-list
102067999|NCT02262650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102068000|NCT02262650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102068001|NCT02262650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102068018|NCT02233556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102068019|NCT02233556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068020|NCT02233556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068021|NCT02233556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102068022|NCT02233556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102068023|NCT04240288|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102068024|NCT04240288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101662811|NCT02787018|Dexmedetomidine|dexmedetomidine|mesh-list
101942994|NCT02869438|Respiratory System Agents|respiratory system agents|mesh-ancestor
102068025|NCT04240288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102068026|NCT04240288|Antitubercular Agents|antitubercular agents|mesh-ancestor
102068028|NCT02236052|Immunologic Factors|immunologic factors|mesh-ancestor
102068029|NCT02236052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068030|NCT04908592|Dexamethasone|dexamethasone|mesh-list
102068031|NCT04908592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102068032|NCT04908592|Antiemetics|antiemetics|mesh-ancestor
102068033|NCT04908592|Autonomic Agents|autonomic agents|mesh-ancestor
102068034|NCT04908592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102068035|NCT04908592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068036|NCT04908592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102068037|NCT04908592|Glucocorticoids|glucocorticoids|mesh-ancestor
102068038|NCT04908592|Hormones|hormones|mesh-ancestor
102068039|NCT04908592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102068040|NCT04908592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102068041|NCT04908592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102068042|NCT04759768|Naltrexone|naltrexone|mesh-list
102068043|NCT04759768|Nalmefene|nalmefene|mesh-list
102068044|NCT04759768|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102068045|NCT04759768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068046|NCT04759768|Sensory System Agents|sensory system agents|mesh-ancestor
102068047|NCT04759768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102068048|NCT04759768|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102068049|NCT02564744|Rituximab|rituximab|mesh-list
102068050|NCT02564744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102068051|NCT02564744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102068052|NCT02564744|Immunologic Factors|immunologic factors|mesh-ancestor
102068053|NCT02564744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068054|NCT02564744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102068055|NCT05759767|Tamsulosin|tamsulosin|mesh-list
102068056|NCT05759767|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102068057|NCT05759767|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102068058|NCT05759767|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102068059|NCT05759767|Adrenergic Agents|adrenergic agents|mesh-ancestor
102068066|NCT02750306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102068067|NCT02750306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102068068|NCT02750306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787791|NCT00799214|Metronidazole|metronidazole|mesh-list
102068069|NCT02750306|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102068070|NCT02750306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102068071|NCT02750306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068072|NCT03845140|Praziquantel|praziquantel|mesh-list
102068073|NCT03845140|Anthelmintics|anthelmintics|mesh-ancestor
102068074|NCT03845140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102068075|NCT03845140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102068076|NCT01816165|Acipimox|acipimox|mesh-list
102068077|NCT01816165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102068078|NCT01816165|Antimetabolites|antimetabolites|mesh-ancestor
102068079|NCT01816165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068080|NCT01816165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102068081|NCT04476680|Vitamin D|vitamin d|mesh-list
102068082|NCT04476680|Vitamins|vitamins|mesh-ancestor
102068083|NCT04476680|Micronutrients|micronutrients|mesh-ancestor
102068084|NCT04476680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068085|NCT04476680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102068086|NCT04952350|Atorvastatin|atorvastatin|mesh-list
102068087|NCT04952350|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102068088|NCT04952350|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102068089|NCT04952350|Antimetabolites|antimetabolites|mesh-ancestor
102068090|NCT04952350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068091|NCT04952350|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102068092|NCT04952350|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102068093|NCT04952350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102068094|NCT05376202|Cetuximab|cetuximab|mesh-list
102068095|NCT05376202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102068096|NCT05376202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102068097|NCT04812808|Bazedoxifene|bazedoxifene|mesh-list
102068098|NCT04812808|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102068099|NCT04812808|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102068100|NCT04812808|Hormone Antagonists|hormone antagonists|mesh-ancestor
102068101|NCT04812808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101942996|NCT02868892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101942997|NCT02868892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102068102|NCT04812808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068103|NCT04812808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102068104|NCT04788550|Listerine|listerine|mesh-list
102068105|NCT04788550|Fluorides|fluorides|mesh-list
102068106|NCT04788550|Sodium Fluoride|sodium fluoride|mesh-list
102068107|NCT04788550|Fluorides, Topical|fluorides, topical|mesh-list
102068108|NCT04788550|Cariostatic Agents|cariostatic agents|mesh-ancestor
102068109|NCT04788550|Protective Agents|protective agents|mesh-ancestor
102068110|NCT04788550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068111|NCT04788550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102068112|NCT04788550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102068113|NCT01677988|Folfirinox|folfirinox|mesh-list
102068114|NCT01677988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102068115|NCT02233790|Clopidogrel|clopidogrel|mesh-list
102068116|NCT02233790|Ticagrelor|ticagrelor|mesh-list
102068117|NCT02233790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102068118|NCT02233790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102068119|NCT02233790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102068120|NCT02233790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102068121|NCT02233790|Purinergic Agents|purinergic agents|mesh-ancestor
101701133|NCT00991783|Digoxin|digoxin|mesh-list
102068122|NCT02233790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102068123|NCT02233790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068124|NCT02233790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068125|NCT02547818|Ibuprofen|ibuprofen|mesh-list
102068126|NCT02547818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102068131|NCT02547818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068132|NCT02547818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102068134|NCT02547818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102068135|NCT02547818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102068136|NCT02547818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068137|NCT04539808|Calcium, Dietary|calcium, dietary|mesh-list
102068138|NCT04539808|Leucovorin|leucovorin|mesh-list
102068139|NCT04539808|Folic Acid|folic acid|mesh-list
102068140|NCT04539808|Fluorouracil|fluorouracil|mesh-list
102068141|NCT04539808|Capecitabine|capecitabine|mesh-list
102068142|NCT04539808|Oxaliplatin|oxaliplatin|mesh-list
102068143|NCT04539808|Irinotecan|irinotecan|mesh-list
102068144|NCT04539808|Camptothecin|camptothecin|mesh-list
102068145|NCT04539808|Losartan|losartan|mesh-list
102068146|NCT04539808|Calcium|calcium|mesh-list
102068147|NCT04539808|Levoleucovorin|levoleucovorin|mesh-list
102068148|NCT04539808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102068149|NCT04539808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068150|NCT04539808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102068151|NCT04539808|Antimetabolites|antimetabolites|mesh-ancestor
102068152|NCT04539808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068153|NCT04539808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102068154|NCT04539808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102068155|NCT04539808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102068156|NCT04539808|Immunologic Factors|immunologic factors|mesh-ancestor
102068157|NCT04539808|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102068158|NCT04539808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102068159|NCT04539808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102068160|NCT04539808|Antidotes|antidotes|mesh-ancestor
102068161|NCT04539808|Protective Agents|protective agents|mesh-ancestor
102068162|NCT04539808|Vitamin B Complex|vitamin b complex|mesh-ancestor
102068163|NCT04539808|Vitamins|vitamins|mesh-ancestor
102068164|NCT04539808|Micronutrients|micronutrients|mesh-ancestor
102068165|NCT04539808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102068166|NCT04539808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102068167|NCT04539808|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102068168|NCT04539808|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102068169|NCT04539808|Hematinics|hematinics|mesh-ancestor
102068170|NCT04539808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102068171|NCT02520076|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
102068172|NCT02520076|Protein C Inhibitor|protein c inhibitor|mesh-list
102068173|NCT02520076|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102068174|NCT02520076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102068175|NCT02520076|Protease Inhibitors|protease inhibitors|mesh-ancestor
102068176|NCT02520076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102068177|NCT02520076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068178|NCT03752918|Niacin|niacin|mesh-list
101942998|NCT02868892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101942999|NCT02868892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101441829|NCT00553618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102068179|NCT03752918|Nicotinic Acids|nicotinic acids|mesh-list
102068180|NCT03752918|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
102068181|NCT03752918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102068182|NCT03752918|Antimetabolites|antimetabolites|mesh-ancestor
102068183|NCT03752918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068184|NCT03752918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102068185|NCT03752918|Vasodilator Agents|vasodilator agents|mesh-ancestor
102068186|NCT03752918|Vitamin B Complex|vitamin b complex|mesh-ancestor
102068187|NCT03752918|Vitamins|vitamins|mesh-ancestor
102068188|NCT03752918|Micronutrients|micronutrients|mesh-ancestor
102068189|NCT03752918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068190|NCT03752918|Hallucinogens|hallucinogens|mesh-ancestor
102068191|NCT03752918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102068192|NCT03752918|Serotonin Agents|serotonin agents|mesh-ancestor
102068193|NCT03752918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102068194|NCT03752918|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102068195|NCT03752918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102068196|NCT03752918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102068197|NCT03752918|Adrenergic Agents|adrenergic agents|mesh-ancestor
102068198|NCT04259320|Propolis|propolis|mesh-list
102068199|NCT04259320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102068213|NCT02263196|Blood Substitutes|blood substitutes|mesh-ancestor
102068214|NCT05160506|Hydrocortisone|hydrocortisone|mesh-list
102068215|NCT05160506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102068216|NCT02926573|Gabapentin|gabapentin|mesh-list
102068217|NCT02926573|Analgesics|analgesics|mesh-ancestor
102068218|NCT02926573|Sensory System Agents|sensory system agents|mesh-ancestor
102068219|NCT02926573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102068220|NCT02926573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068221|NCT02926573|Anticonvulsants|anticonvulsants|mesh-ancestor
102068222|NCT02926573|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102068223|NCT02926573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102068224|NCT02926573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102068225|NCT02926573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102068226|NCT02926573|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102068227|NCT02926573|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102068228|NCT02926573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102068229|NCT02926573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068230|NCT02926573|Antimanic Agents|antimanic agents|mesh-ancestor
102068232|NCT04477018|Chelating Agents|chelating agents|mesh-list
102068233|NCT04477018|Micronutrients|micronutrients|mesh-ancestor
102068234|NCT04477018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068235|NCT04477018|Trace Elements|trace elements|mesh-ancestor
102068236|NCT04477018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068237|NCT04477018|Sequestering Agents|sequestering agents|mesh-ancestor
102068238|NCT00158860|Valacyclovir|valacyclovir|mesh-list
102068239|NCT00158860|Antiviral Agents|antiviral agents|mesh-ancestor
102068240|NCT00158860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102068241|NCT02490488|Gemcitabine|gemcitabine|mesh-list
102068242|NCT02490488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102068243|NCT02490488|Antimetabolites|antimetabolites|mesh-ancestor
102068244|NCT02490488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068245|NCT02490488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102068246|NCT02471222|Amantadine|amantadine|mesh-list
102068247|NCT02471222|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102068248|NCT02471222|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102068249|NCT02471222|Antiviral Agents|antiviral agents|mesh-ancestor
102068250|NCT02471222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102068251|NCT02471222|Dopamine Agents|dopamine agents|mesh-ancestor
102068252|NCT02471222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102068253|NCT02471222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068254|NCT02471222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068255|NCT02471222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102068256|NCT02471222|Analgesics|analgesics|mesh-ancestor
102068257|NCT02471222|Sensory System Agents|sensory system agents|mesh-ancestor
102068258|NCT02471222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102068259|NCT03136120|Bromides|bromides|mesh-list
102068260|NCT03136120|Ipratropium|ipratropium|mesh-list
102068261|NCT03136120|Anticonvulsants|anticonvulsants|mesh-ancestor
102068262|NCT03136120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101943000|NCT02868892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101943001|NCT03613558|Dexmedetomidine|dexmedetomidine|mesh-list
102068263|NCT03136120|Autonomic Agents|autonomic agents|mesh-ancestor
102068264|NCT03136120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102068269|NCT03136120|Cholinergic Agents|cholinergic agents|mesh-ancestor
102068270|NCT03136120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102068271|NCT03136120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068273|NCT01625234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102068274|NCT01625234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102068275|NCT01625234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102068276|NCT01625234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068277|NCT02264834|Sufentanil|sufentanil|mesh-list
102068278|NCT02264834|Dsuvia|dsuvia|mesh-list
102068279|NCT02264834|Levobupivacaine|levobupivacaine|mesh-list
102068280|NCT02264834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102068281|NCT02264834|Narcotics|narcotics|mesh-ancestor
102068282|NCT02264834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102068283|NCT02264834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068284|NCT02264834|Analgesics|analgesics|mesh-ancestor
102068285|NCT02264834|Sensory System Agents|sensory system agents|mesh-ancestor
102068286|NCT02264834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102068287|NCT02264834|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102068288|NCT02264834|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102068289|NCT02264834|Anesthetics, General|anesthetics, general|mesh-ancestor
102068290|NCT02264834|Anesthetics|anesthetics|mesh-ancestor
102068291|NCT02264834|Anesthetics, Local|anesthetics, local|mesh-ancestor
102068292|NCT05762419|Etoposide|etoposide|mesh-list
102068293|NCT05762419|Etoposide phosphate|etoposide phosphate|mesh-list
102068294|NCT05762419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102068295|NCT05762419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102068296|NCT05762419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102068297|NCT05762419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102068298|NCT05762419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102068299|NCT05762419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068300|NCT02264912|Clopidogrel|clopidogrel|mesh-list
102068301|NCT02264912|Ticagrelor|ticagrelor|mesh-list
102068302|NCT02264912|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102068303|NCT02264912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
102068304|NCT02264912|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102068305|NCT02264912|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102068306|NCT02264912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102068307|NCT02264912|Purinergic Agents|purinergic agents|mesh-ancestor
102068308|NCT02264912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102068309|NCT02264912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068310|NCT02264912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068311|NCT02263352|Carotenoids|carotenoids|mesh-list
102068312|NCT02263352|Antioxidants|antioxidants|mesh-ancestor
102068313|NCT02263352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068314|NCT02263352|Protective Agents|protective agents|mesh-ancestor
102068315|NCT02263352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068316|NCT01435226|Ribavirin|ribavirin|mesh-list
102068317|NCT01435226|Ledipasvir|ledipasvir|mesh-list
102068318|NCT01435226|Antimetabolites|antimetabolites|mesh-ancestor
102068319|NCT01435226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068320|NCT01435226|Antiviral Agents|antiviral agents|mesh-ancestor
102068321|NCT01435226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102068322|NCT01679002|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
102068323|NCT01679002|Oxcarbazepine|oxcarbazepine|mesh-list
102068324|NCT01679002|Anticonvulsants|anticonvulsants|mesh-ancestor
102068325|NCT01679002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102068326|NCT01679002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102068327|NCT01679002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102068328|NCT01679002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068329|NCT01679002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102068330|NCT01679002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102068331|NCT04409509|Antibodies|antibodies|mesh-list
102068332|NCT04409509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102068333|NCT04409509|Immunologic Factors|immunologic factors|mesh-ancestor
101369905|NCT00179062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102068350|NCT02265068|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102068352|NCT02265068|Purinergic Agents|purinergic agents|mesh-ancestor
102068353|NCT02265068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101943002|NCT03613558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101943003|NCT03613558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101943004|NCT03613558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307906|NCT02044250|Aspirin|aspirin|mesh-list
102068354|NCT02265068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068355|NCT02265068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068356|NCT02262416|Leuprolide|leuprolide|mesh-list
102068357|NCT02262416|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102068358|NCT02262416|Fertility Agents|fertility agents|mesh-ancestor
102068359|NCT02262416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102068360|NCT02262416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068361|NCT02262416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102068362|NCT02262416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102068363|NCT01577654|Folic Acid|folic acid|mesh-list
102068364|NCT01577654|Docetaxel|docetaxel|mesh-list
102068365|NCT01577654|Vinca Alkaloids|vinca alkaloids|mesh-list
102068366|NCT01577654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102068367|NCT01577654|Tubulin Modulators|tubulin modulators|mesh-ancestor
102068368|NCT01577654|Antimitotic Agents|antimitotic agents|mesh-ancestor
102068369|NCT01577654|Mitosis Modulators|mitosis modulators|mesh-ancestor
102068370|NCT01577654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068371|NCT01577654|Hematinics|hematinics|mesh-ancestor
102068372|NCT01577654|Vitamin B Complex|vitamin b complex|mesh-ancestor
102068373|NCT01577654|Vitamins|vitamins|mesh-ancestor
102068374|NCT01577654|Micronutrients|micronutrients|mesh-ancestor
102068375|NCT01577654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068376|NCT01423058|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
102068377|NCT01423058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102068378|NCT01423058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102068379|NCT01423058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068380|NCT04413292|BIRC5 protein, human|birc5 protein, human|mesh-list
102068381|NCT04413292|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
102068382|NCT04413292|Protease Inhibitors|protease inhibitors|mesh-ancestor
102068383|NCT04413292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102068384|NCT04413292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068385|NCT01418222|Leucovorin|leucovorin|mesh-list
102068386|NCT01418222|Bevacizumab|bevacizumab|mesh-list
102068387|NCT01418222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102068388|NCT01418222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102068389|NCT01418222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102068390|NCT01418222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102068391|NCT01418222|Growth Substances|growth substances|mesh-ancestor
102068394|NCT01418222|Antidotes|antidotes|mesh-ancestor
102068395|NCT01418222|Protective Agents|protective agents|mesh-ancestor
102068396|NCT01418222|Vitamin B Complex|vitamin b complex|mesh-ancestor
102068397|NCT01418222|Vitamins|vitamins|mesh-ancestor
102068398|NCT01418222|Micronutrients|micronutrients|mesh-ancestor
102068410|NCT01256762|Paclitaxel|paclitaxel|mesh-list
102068411|NCT01256762|Bevacizumab|bevacizumab|mesh-list
102068412|NCT01256762|Imetelstat|imetelstat|mesh-list
102068413|NCT01256762|Motesanib diphosphate|motesanib diphosphate|mesh-list
102068414|NCT01256762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102068415|NCT01256762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102068416|NCT01256762|Tubulin Modulators|tubulin modulators|mesh-ancestor
102068417|NCT01256762|Antimitotic Agents|antimitotic agents|mesh-ancestor
102068418|NCT01256762|Mitosis Modulators|mitosis modulators|mesh-ancestor
102068419|NCT01256762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068420|NCT01256762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102068421|NCT01256762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102068422|NCT01256762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101943005|NCT03613558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101943006|NCT03613558|Analgesics|analgesics|mesh-ancestor
102068423|NCT01256762|Growth Substances|growth substances|mesh-ancestor
102068424|NCT01256762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068425|NCT01256762|Growth Inhibitors|growth inhibitors|mesh-ancestor
102068426|NCT01256762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102068427|NCT01256762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102068428|NCT01252628|Cetuximab|cetuximab|mesh-list
102068429|NCT01252628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102068430|NCT01252628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102068431|NCT01236638|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
102068432|NCT01236638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102068433|NCT01236638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102068434|NCT01236638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068435|NCT04349371|Chloroquine|chloroquine|mesh-list
102068436|NCT04349371|Amebicides|amebicides|mesh-ancestor
102068437|NCT04349371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102068438|NCT04349371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102068439|NCT04349371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102068440|NCT04349371|Antimalarials|antimalarials|mesh-ancestor
102068441|NCT04349371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102068442|NCT01410188|Latanoprost|latanoprost|mesh-list
102068443|NCT01410188|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102068444|NCT01410188|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102068445|NCT01408082|Azithromycin|azithromycin|mesh-list
102068446|NCT01408082|Dexamethasone|dexamethasone|mesh-list
102068447|NCT01408082|Dexamethasone acetate|dexamethasone acetate|mesh-list
102068448|NCT01408082|BB 1101|bb 1101|mesh-list
102068449|NCT01408082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102068450|NCT01408082|Antiemetics|antiemetics|mesh-ancestor
102068451|NCT01408082|Autonomic Agents|autonomic agents|mesh-ancestor
102068452|NCT01408082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102068453|NCT01408082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068454|NCT01408082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102068455|NCT01408082|Glucocorticoids|glucocorticoids|mesh-ancestor
102068456|NCT01408082|Hormones|hormones|mesh-ancestor
102068457|NCT01408082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102068458|NCT01408082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102068459|NCT01408082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102068460|NCT01408082|Protease Inhibitors|protease inhibitors|mesh-ancestor
102068461|NCT01408082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102068462|NCT01408082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068463|NCT01408082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102068464|NCT01408082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102068465|NCT03071263|Spironolactone|spironolactone|mesh-list
102068473|NCT05200663|Tamoxifen|tamoxifen|mesh-list
102068474|NCT05200663|Vitamin E|vitamin e|mesh-list
102068475|NCT05200663|Vitamins|vitamins|mesh-ancestor
102068476|NCT05200663|Micronutrients|micronutrients|mesh-ancestor
102068477|NCT05200663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068478|NCT05200663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102068479|NCT05200663|Hormone Antagonists|hormone antagonists|mesh-ancestor
102068480|NCT05200663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102068481|NCT05200663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102068482|NCT05200663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102068483|NCT05200663|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102068484|NCT05200663|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102068485|NCT05200663|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102068486|NCT05200663|Antioxidants|antioxidants|mesh-ancestor
102068487|NCT05200663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068488|NCT05200663|Protective Agents|protective agents|mesh-ancestor
102068489|NCT02268422|Buprenorphine|buprenorphine|mesh-list
102068490|NCT02268422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102068491|NCT02268422|Narcotics|narcotics|mesh-ancestor
102068492|NCT02268422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102068493|NCT02268422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068494|NCT02268422|Analgesics|analgesics|mesh-ancestor
102068495|NCT02268422|Sensory System Agents|sensory system agents|mesh-ancestor
102068496|NCT02268422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102068497|NCT02268422|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102068498|NCT01522196|Varespladib methyl|varespladib methyl|mesh-list
102068499|NCT01522196|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
102068500|NCT01522196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101943008|NCT03613558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101943009|NCT03613558|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102068501|NCT01522196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068502|NCT05049343|Ketamine|ketamine|mesh-list
102068503|NCT05049343|Analgesics|analgesics|mesh-ancestor
102068504|NCT05049343|Sensory System Agents|sensory system agents|mesh-ancestor
102068505|NCT05049343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102068506|NCT05049343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068507|NCT05049343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102068508|NCT05049343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102068509|NCT05049343|Anesthetics, General|anesthetics, general|mesh-ancestor
102068510|NCT05049343|Anesthetics|anesthetics|mesh-ancestor
102068511|NCT05049343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102068512|NCT05049343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102068513|NCT05049343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102068514|NCT05049343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102068515|NCT05049343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068516|NCT01569919|Folic Acid|folic acid|mesh-list
102068517|NCT01569919|Vitamin B 12|vitamin b 12|mesh-list
102068518|NCT01569919|Dexamethasone|dexamethasone|mesh-list
102068519|NCT01569919|Pemetrexed|pemetrexed|mesh-list
102068520|NCT01569919|Vitamins|vitamins|mesh-ancestor
102068521|NCT01569919|Micronutrients|micronutrients|mesh-ancestor
102068522|NCT01569919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788247|NCT00731549|Serotonin Agents|serotonin agents|mesh-ancestor
102068523|NCT01569919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102068524|NCT01569919|Antiemetics|antiemetics|mesh-ancestor
102068525|NCT01569919|Autonomic Agents|autonomic agents|mesh-ancestor
102068526|NCT01569919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102068527|NCT01569919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102068528|NCT01569919|Glucocorticoids|glucocorticoids|mesh-ancestor
102068529|NCT01569919|Hormones|hormones|mesh-ancestor
102068530|NCT01569919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102068531|NCT01569919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102068549|NCT04069585|Sensory System Agents|sensory system agents|mesh-ancestor
102068550|NCT04069585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102068551|NCT04069585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102068552|NCT04069585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102068553|NCT04069585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102068554|NCT04069585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102068555|NCT04069585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068556|NCT00157196|Cyclophosphamide|cyclophosphamide|mesh-list
102068557|NCT00157196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102068558|NCT00157196|Immunologic Factors|immunologic factors|mesh-ancestor
102068559|NCT00157196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068560|NCT00157196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102068561|NCT00157196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102068562|NCT00157196|Alkylating Agents|alkylating agents|mesh-ancestor
102068563|NCT00157196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068564|NCT00157196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102068565|NCT00157196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102068566|NCT02265770|Cyclophosphamide|cyclophosphamide|mesh-list
102068567|NCT02265770|Cisplatin|cisplatin|mesh-list
102068568|NCT02265770|Carboplatin|carboplatin|mesh-list
102068569|NCT02265770|Methotrexate|methotrexate|mesh-list
102068570|NCT02265770|Etoposide|etoposide|mesh-list
102068571|NCT02265770|Etoposide phosphate|etoposide phosphate|mesh-list
102068572|NCT02265770|Vincristine|vincristine|mesh-list
102068573|NCT02265770|Valproic Acid|valproic acid|mesh-list
102068574|NCT02265770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102068575|NCT02265770|Immunologic Factors|immunologic factors|mesh-ancestor
102068576|NCT02265770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068577|NCT02265770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102068578|NCT02265770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102068579|NCT02265770|Alkylating Agents|alkylating agents|mesh-ancestor
102068580|NCT02265770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068581|NCT02265770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102068582|NCT02265770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102068583|NCT02265770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102068584|NCT02265770|Abortifacient Agents|abortifacient agents|mesh-ancestor
101943011|NCT03613558|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101943012|NCT03613558|Adrenergic Agents|adrenergic agents|mesh-ancestor
101943013|NCT03613558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102068585|NCT02265770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102068586|NCT02265770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102068587|NCT02265770|Antimetabolites|antimetabolites|mesh-ancestor
102068606|NCT03066193|Dronabinol|dronabinol|mesh-list
102068607|NCT03066193|Hallucinogens|hallucinogens|mesh-ancestor
102068608|NCT03066193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068609|NCT03066193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102068610|NCT03066193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102068611|NCT03066193|Analgesics|analgesics|mesh-ancestor
102068612|NCT03066193|Sensory System Agents|sensory system agents|mesh-ancestor
102068613|NCT03066193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102068614|NCT03066193|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102068615|NCT03066193|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102068616|NCT03066193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102068617|NCT03066193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068618|NCT03066193|Hormones|hormones|mesh-ancestor
102068619|NCT03066193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102068620|NCT03066193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102068621|NCT03066193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102068622|NCT03066193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102068623|NCT03066193|Antiviral Agents|antiviral agents|mesh-ancestor
102068624|NCT03066193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102068625|NCT02263976|Bromides|bromides|mesh-list
102068626|NCT02263976|Tiotropium Bromide|tiotropium bromide|mesh-list
102068627|NCT02263976|Methacholine Chloride|methacholine chloride|mesh-list
102068628|NCT02263976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102068629|NCT02263976|Autonomic Agents|autonomic agents|mesh-ancestor
102068630|NCT02263976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102068631|NCT02263976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068632|NCT02263976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102068633|NCT02263976|Respiratory System Agents|respiratory system agents|mesh-ancestor
102068634|NCT02263976|Parasympatholytics|parasympatholytics|mesh-ancestor
102068635|NCT02263976|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102068636|NCT02263976|Cholinergic Agents|cholinergic agents|mesh-ancestor
102068637|NCT02263976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102068638|NCT02263976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068639|NCT02263976|Anticonvulsants|anticonvulsants|mesh-ancestor
102068640|NCT02263976|Miotics|miotics|mesh-ancestor
102068641|NCT02263976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102068642|NCT02263976|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
102068643|NCT02263976|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102068644|NCT02263976|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102068645|NCT01382654|Azelastine|azelastine|mesh-list
102068646|NCT01382654|Epinastine|epinastine|mesh-list
101370228|NCT00182221|Fibrin fragment D|fibrin fragment d|mesh-list
102068664|NCT01378676|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102068665|NCT01378676|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102068666|NCT01378676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102068667|NCT01378676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068668|NCT01378676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068669|NCT01378676|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102068670|NCT01378676|Protective Agents|protective agents|mesh-ancestor
102068671|NCT01377662|Methylphenidate|methylphenidate|mesh-list
102068672|NCT01377662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102068673|NCT01377662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068674|NCT01377662|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102068675|NCT01377662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102068676|NCT01377662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102068677|NCT01377662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068678|NCT01377662|Dopamine Agents|dopamine agents|mesh-ancestor
102068679|NCT01377662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102068681|NCT01371578|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102068682|NCT01371578|Ledipasvir|ledipasvir|mesh-list
102068683|NCT01371578|Antimetabolites|antimetabolites|mesh-ancestor
102068684|NCT01371578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068685|NCT01371578|Antiviral Agents|antiviral agents|mesh-ancestor
101943014|NCT03613558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068686|NCT01371578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102068687|NCT01225640|Oxazolidinones|oxazolidinones|mesh-list
102068688|NCT01225640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101701249|NCT04003207|Hormones|hormones|mesh-list
102068689|NCT01225640|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102068690|NCT01225640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102068691|NCT01225640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068692|NCT01498328|Bevacizumab|bevacizumab|mesh-list
102068693|NCT01498328|Rindopepimut|rindopepimut|mesh-list
102068694|NCT01498328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102068695|NCT01498328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102068696|NCT01498328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102068697|NCT01498328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102068698|NCT01498328|Growth Substances|growth substances|mesh-ancestor
102068699|NCT01498328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068700|NCT01498328|Growth Inhibitors|growth inhibitors|mesh-ancestor
102068701|NCT01497704|Apatinib|apatinib|mesh-list
102068702|NCT01497704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101370287|NCT00182572|Analgesics|analgesics|mesh-ancestor
102068708|NCT02266160|Anesthetics|anesthetics|mesh-ancestor
102068709|NCT02266160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102068710|NCT02266160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068711|NCT02266160|Sensory System Agents|sensory system agents|mesh-ancestor
102068712|NCT02266160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102068713|NCT02266160|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
102068714|NCT03911713|Ivacaftor|ivacaftor|mesh-list
102068715|NCT03911713|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102068716|NCT03911713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102068717|NCT03911713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068718|NCT02264132|Pramipexole|pramipexole|mesh-list
102068719|NCT02264132|Antioxidants|antioxidants|mesh-ancestor
102068720|NCT02264132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068721|NCT02264132|Protective Agents|protective agents|mesh-ancestor
102068722|NCT02264132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068723|NCT02264132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102068724|NCT02264132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102068725|NCT02264132|Dopamine Agonists|dopamine agonists|mesh-ancestor
102068726|NCT02264132|Dopamine Agents|dopamine agents|mesh-ancestor
102068727|NCT02264132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102068728|NCT01192880|Antipsychotic Agents|antipsychotic agents|mesh-list
102068729|NCT01192880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102068730|NCT01192880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102068731|NCT01192880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068732|NCT01192880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102068733|NCT04540744|Tadalafil|tadalafil|mesh-list
102068734|NCT04540744|Macitentan|macitentan|mesh-list
102068735|NCT04540744|Vasodilator Agents|vasodilator agents|mesh-ancestor
102068736|NCT04540744|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102068737|NCT04540744|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102068738|NCT04540744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102068739|NCT04540744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068740|NCT04540744|Urological Agents|urological agents|mesh-ancestor
102068741|NCT04540744|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
102068742|NCT04540744|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102068743|NCT04540744|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
102068744|NCT05375734|Tislelizumab|tislelizumab|mesh-list
102068745|NCT05375734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102068746|NCT05375734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102068747|NCT01489046|Tenofovir|tenofovir|mesh-list
102068748|NCT01489046|Lamivudine|lamivudine|mesh-list
102068749|NCT01489046|Efavirenz|efavirenz|mesh-list
102068750|NCT01489046|Antiviral Agents|antiviral agents|mesh-ancestor
102068751|NCT01489046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102068752|NCT01489046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102068753|NCT01489046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102068754|NCT01489046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102068755|NCT01489046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068756|NCT01489046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102068757|NCT01489046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102068758|NCT01489046|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102068759|NCT01489046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102068760|NCT01489046|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101943016|NCT03613168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101943017|NCT03613168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102068761|NCT01489046|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102068762|NCT01489046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102068763|NCT01489046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102068764|NCT01180634|Levofloxacin|levofloxacin|mesh-list
102068765|NCT01180634|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102068766|NCT01180634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102068767|NCT01180634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102068768|NCT01180634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102068769|NCT01180634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102068782|NCT02268968|Sensory System Agents|sensory system agents|mesh-ancestor
102068783|NCT02268968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102068784|NCT02268968|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102068785|NCT02268968|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102068786|NCT02268968|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102068787|NCT02268968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102068788|NCT02268968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068789|NCT01359566|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
102068790|NCT01359566|Baclofen|baclofen|mesh-list
102068791|NCT01359566|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102068792|NCT01359566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068793|NCT01359566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102068794|NCT01359566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102068795|NCT01359566|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102068796|NCT01359566|GABA Agonists|gaba agonists|mesh-ancestor
102068797|NCT01359566|GABA Agents|gaba agents|mesh-ancestor
102068798|NCT01359566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102068799|NCT01359566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068800|NCT04885816|Sirolimus|sirolimus|mesh-list
102068801|NCT04885816|Everolimus|everolimus|mesh-list
102068802|NCT04885816|MTOR Inhibitors|mtor inhibitors|mesh-list
102068803|NCT04885816|Temsirolimus|temsirolimus|mesh-list
102068804|NCT04885816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102068805|NCT04885816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102068806|NCT04885816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068807|NCT04885816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102068808|NCT04885816|Immunologic Factors|immunologic factors|mesh-ancestor
102068809|NCT04885816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068810|NCT04885816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102068811|NCT04885816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102068812|NCT04885816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102068813|NCT04885816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102068814|NCT04885816|Antifungal Agents|antifungal agents|mesh-ancestor
102068815|NCT04865614|Sevoflurane|sevoflurane|mesh-list
102068816|NCT04865614|Etomidate|etomidate|mesh-list
102068817|NCT04865614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102068818|NCT04865614|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102068819|NCT04865614|Anesthetics, General|anesthetics, general|mesh-ancestor
102068820|NCT04865614|Anesthetics|anesthetics|mesh-ancestor
102068821|NCT04865614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102068822|NCT04865614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068823|NCT04865614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102068824|NCT04865614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102068825|NCT02269046|Simvastatin|simvastatin|mesh-list
102068826|NCT02269046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102068827|NCT02269046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102068828|NCT02269046|Antimetabolites|antimetabolites|mesh-ancestor
102068829|NCT02269046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068830|NCT02269046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101370414|NCT02965248|Antidotes|antidotes|mesh-ancestor
102068854|NCT04691128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102068855|NCT04691128|Anesthetics, General|anesthetics, general|mesh-ancestor
102068856|NCT04691128|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102068857|NCT04207918|Nimotuzumab|nimotuzumab|mesh-list
102068858|NCT04207918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102068859|NCT04207918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102068860|NCT02269202|Midazolam|midazolam|mesh-list
102068861|NCT02269202|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102068862|NCT02269202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102068863|NCT02269202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101943018|NCT01141881|Bevacizumab|bevacizumab|mesh-list
101943019|NCT01141881|Plasminogen|plasminogen|mesh-list
101943020|NCT01141881|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102068864|NCT02269202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068865|NCT02269202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102068866|NCT02269202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102068867|NCT02269202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102068868|NCT02269202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102068869|NCT02269202|Anesthetics, General|anesthetics, general|mesh-ancestor
102068870|NCT02269202|Anesthetics|anesthetics|mesh-ancestor
102068871|NCT02269202|GABA Modulators|gaba modulators|mesh-ancestor
102068872|NCT02269202|GABA Agents|gaba agents|mesh-ancestor
102068873|NCT02269202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102068874|NCT02269202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068875|NCT03614923|Mometasone Furoate|mometasone furoate|mesh-list
102068876|NCT03614923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102068877|NCT03614923|Dermatologic Agents|dermatologic agents|mesh-ancestor
102068878|NCT03614923|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102068879|NCT01353248|Ribavirin|ribavirin|mesh-list
102068880|NCT01353248|Ledipasvir|ledipasvir|mesh-list
102068881|NCT01353248|Antimetabolites|antimetabolites|mesh-ancestor
102068882|NCT01353248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068883|NCT01353248|Antiviral Agents|antiviral agents|mesh-ancestor
102068884|NCT01353248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102068885|NCT05095636|Apatinib|apatinib|mesh-list
102068913|NCT01170650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068914|NCT04533646|Insulin|insulin|mesh-list
102068915|NCT04533646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102068916|NCT04533646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068917|NCT01168310|Fluticasone|fluticasone|mesh-list
102068918|NCT01168310|Xhance|xhance|mesh-list
102068919|NCT01168310|Formoterol Fumarate|formoterol fumarate|mesh-list
102068920|NCT01168310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102068921|NCT01168310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102068922|NCT01168310|Autonomic Agents|autonomic agents|mesh-ancestor
102068923|NCT01168310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102068924|NCT01168310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068925|NCT01168310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102068926|NCT01168310|Respiratory System Agents|respiratory system agents|mesh-ancestor
101701300|NCT00686010|Dalcetrapib|dalcetrapib|mesh-list
102068927|NCT01168310|Dermatologic Agents|dermatologic agents|mesh-ancestor
102068928|NCT01168310|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102068929|NCT01168310|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102068930|NCT01168310|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102068931|NCT01168310|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102068932|NCT01168310|Adrenergic Agents|adrenergic agents|mesh-ancestor
102068933|NCT01168310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101370529|NCT00184561|Insulin Aspart|insulin aspart|mesh-list
102068942|NCT02269358|Abortifacient Agents|abortifacient agents|mesh-ancestor
102068943|NCT02269358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102068944|NCT02269358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068945|NCT02269358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102068946|NCT02269358|Antimetabolites|antimetabolites|mesh-ancestor
102068947|NCT02269358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068948|NCT02269358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102068949|NCT02269358|Dermatologic Agents|dermatologic agents|mesh-ancestor
102068950|NCT02269358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102068951|NCT02269358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102068952|NCT02269358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102068953|NCT02269358|Immunologic Factors|immunologic factors|mesh-ancestor
102068954|NCT02269358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102068955|NCT02269358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102068957|NCT04504240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102068958|NCT04504240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102068959|NCT04504240|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102068960|NCT04504240|Histamine Antagonists|histamine antagonists|mesh-ancestor
102068961|NCT04504240|Histamine Agents|histamine agents|mesh-ancestor
102068962|NCT04504240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102068963|NCT04504240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068964|NCT04504240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068965|NCT02088060|Cannabidiol|cannabidiol|mesh-list
102068966|NCT02088060|Olanzapine|olanzapine|mesh-list
102068967|NCT02088060|Antiemetics|antiemetics|mesh-ancestor
102068968|NCT02088060|Autonomic Agents|autonomic agents|mesh-ancestor
102068969|NCT02088060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101943021|NCT01141881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101943022|NCT01141881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102068970|NCT02088060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068971|NCT02088060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102068972|NCT02088060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102068973|NCT02088060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102068974|NCT02088060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102068975|NCT02088060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102068976|NCT02088060|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102068977|NCT02088060|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102068978|NCT02088060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102068979|NCT02088060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068980|NCT02088060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102068981|NCT02088060|Serotonin Agents|serotonin agents|mesh-ancestor
102068982|NCT02088060|Anticonvulsants|anticonvulsants|mesh-ancestor
102068983|NCT02264522|Dialysis Solutions|dialysis solutions|mesh-list
102068984|NCT02264522|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102068986|NCT02269514|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102068987|NCT02269514|Autonomic Agents|autonomic agents|mesh-ancestor
102068988|NCT02269514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102068989|NCT02269514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068990|NCT02269514|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102068991|NCT02269514|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102068992|NCT02269514|Cholinergic Agents|cholinergic agents|mesh-ancestor
101701312|NCT03823300|Aflibercept|aflibercept|mesh-list
102068993|NCT02269514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102068994|NCT02269514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068995|NCT01332812|Dexamethasone|dexamethasone|mesh-list
102068996|NCT01332812|Dexamethasone acetate|dexamethasone acetate|mesh-list
102068997|NCT01332812|BB 1101|bb 1101|mesh-list
102068998|NCT01332812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102069000|NCT01332812|Autonomic Agents|autonomic agents|mesh-ancestor
102069001|NCT01332812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102069002|NCT01332812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069003|NCT01332812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102069004|NCT01332812|Glucocorticoids|glucocorticoids|mesh-ancestor
102069005|NCT01332812|Hormones|hormones|mesh-ancestor
102069006|NCT01332812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102069007|NCT01332812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102069008|NCT01332812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069009|NCT01332812|Protease Inhibitors|protease inhibitors|mesh-ancestor
102069010|NCT01332812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102069011|NCT01332812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069012|NCT03408652|Zoledronic Acid|zoledronic acid|mesh-list
102069013|NCT03408652|Denosumab|denosumab|mesh-list
102069014|NCT03408652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102069015|NCT03408652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069016|NCT01332656|Paclitaxel|paclitaxel|mesh-list
102069017|NCT01332656|Carboplatin|carboplatin|mesh-list
102069018|NCT01332656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102069019|NCT01332656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069020|NCT01332656|Tubulin Modulators|tubulin modulators|mesh-ancestor
102069021|NCT01332656|Antimitotic Agents|antimitotic agents|mesh-ancestor
102069022|NCT01332656|Mitosis Modulators|mitosis modulators|mesh-ancestor
102069023|NCT01332656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069024|NCT02084472|Petrolatum|petrolatum|mesh-list
102069025|NCT02084472|Glycerol|glycerol|mesh-list
102069026|NCT02084472|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102069027|NCT02084472|Protective Agents|protective agents|mesh-ancestor
102069028|NCT02084472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069029|NCT02084472|Emollients|emollients|mesh-ancestor
102069030|NCT02084472|Dermatologic Agents|dermatologic agents|mesh-ancestor
102069031|NCT02266784|Nicotine|nicotine|mesh-list
102069032|NCT02266784|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102069033|NCT02266784|Autonomic Agents|autonomic agents|mesh-ancestor
102069034|NCT02266784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102069035|NCT02266784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069036|NCT02266784|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102069037|NCT02266784|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102069038|NCT02266784|Cholinergic Agents|cholinergic agents|mesh-ancestor
102069039|NCT02266784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102069040|NCT02266784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069041|NCT02090790|Dexamethasone|dexamethasone|mesh-list
101943023|NCT01141881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102069042|NCT02090790|Dexamethasone acetate|dexamethasone acetate|mesh-list
102069043|NCT02090790|BB 1101|bb 1101|mesh-list
102069044|NCT02090790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102069045|NCT02090790|Antiemetics|antiemetics|mesh-ancestor
102069047|NCT02090790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102069048|NCT02090790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069049|NCT02090790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102069050|NCT02090790|Glucocorticoids|glucocorticoids|mesh-ancestor
102069051|NCT02090790|Hormones|hormones|mesh-ancestor
102069052|NCT02090790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102069053|NCT02090790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102069054|NCT02090790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069055|NCT02090790|Protease Inhibitors|protease inhibitors|mesh-ancestor
102069056|NCT02090790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102069057|NCT02090790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069058|NCT02084550|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
102069059|NCT02084550|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102069060|NCT02084550|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102069061|NCT01443728|Vitamin D|vitamin d|mesh-list
102069062|NCT01443728|Ergocalciferols|ergocalciferols|mesh-list
102069063|NCT01443728|Cholecalciferol|cholecalciferol|mesh-list
102069064|NCT01443728|Vitamins|vitamins|mesh-list
102069065|NCT01443728|Micronutrients|micronutrients|mesh-ancestor
102069066|NCT01443728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069067|NCT01443728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102069068|NCT01443728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102069069|NCT01324466|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
102069070|NCT01324466|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
102069071|NCT01324466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102069072|NCT01324466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069073|NCT01312454|Travoprost|travoprost|mesh-list
102069101|NCT03557112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102069103|NCT01300208|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102069104|NCT01300208|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102069105|NCT01300208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102069106|NCT01300208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069107|NCT02085018|Omeprazole|omeprazole|mesh-list
102069108|NCT02085018|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102069109|NCT02085018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102069110|NCT02085018|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102069111|NCT02085018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102069112|NCT02085018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069113|NCT02091336|Metformin|metformin|mesh-list
102069114|NCT02091336|Glyburide|glyburide|mesh-list
102069115|NCT02091336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102069116|NCT02091336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069117|NCT01442090|Everolimus|everolimus|mesh-list
102069118|NCT01442090|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102069119|NCT01442090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102069120|NCT01442090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101370728|NCT00185419|Hormones|hormones|mesh-ancestor
102069127|NCT04475042|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102069128|NCT04475042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069129|NCT04475042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102069130|NCT04475042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069132|NCT02088450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102069133|NCT02088450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102069134|NCT02088450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102069135|NCT02088450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069136|NCT02088450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102069137|NCT02088450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069138|NCT02088450|Vasodilator Agents|vasodilator agents|mesh-ancestor
102069139|NCT03688828|Amoxicillin|amoxicillin|mesh-list
102069140|NCT03688828|Clarithromycin|clarithromycin|mesh-list
102069141|NCT03688828|Potassium Citrate|potassium citrate|mesh-list
102069142|NCT03688828|Esomeprazole|esomeprazole|mesh-list
102069143|NCT03688828|Bismuth|bismuth|mesh-list
102069144|NCT03688828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069145|NCT03688828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102069146|NCT03688828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102069147|NCT03688828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101943024|NCT01141881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101943025|NCT01141881|Growth Substances|growth substances|mesh-ancestor
101943026|NCT01141881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943027|NCT01141881|Growth Inhibitors|growth inhibitors|mesh-ancestor
102069148|NCT03688828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102069149|NCT03688828|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102069150|NCT03688828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102069151|NCT03688828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102069152|NCT03688828|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102069153|NCT03688828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102069154|NCT03688828|Antacids|antacids|mesh-ancestor
102069155|NCT03688828|Diuretics|diuretics|mesh-ancestor
102069156|NCT03688828|Natriuretic Agents|natriuretic agents|mesh-ancestor
102069157|NCT03688828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069158|NCT03688828|Expectorants|expectorants|mesh-ancestor
102069159|NCT03688828|Respiratory System Agents|respiratory system agents|mesh-ancestor
102069160|NCT02091492|Teriparatide|teriparatide|mesh-list
102069161|NCT02091492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102069162|NCT02091492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069163|NCT02091492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102069164|NCT02266940|DS-1971a|ds-1971a|mesh-list
102069165|NCT02266940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102069166|NCT02266940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102069167|NCT02266940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102069168|NCT02266940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069169|NCT03981952|Vaccines|vaccines|mesh-list
102069170|NCT03981952|Immunologic Factors|immunologic factors|mesh-ancestor
102069171|NCT03981952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069172|NCT04475120|Lactoferrin|lactoferrin|mesh-list
102069173|NCT04475120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102069174|NCT02088528|Mitomycins|mitomycins|mesh-list
102069175|NCT02088528|Mitomycin|mitomycin|mesh-list
102069176|NCT02088528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102069177|NCT02088528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069178|NCT02088528|Alkylating Agents|alkylating agents|mesh-ancestor
102069179|NCT02088528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069180|NCT02088528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102069181|NCT02088528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102069182|NCT03634150|Doxorubicin|doxorubicin|mesh-list
102069183|NCT03634150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102069184|NCT03634150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069185|NCT03634150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102069186|NCT03634150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102069187|NCT03634150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102069200|NCT02272166|Anesthetics, General|anesthetics, general|mesh-ancestor
102069202|NCT02272166|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102069203|NCT02272166|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102069204|NCT02088684|Fulvestrant|fulvestrant|mesh-list
102069205|NCT02088684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102069206|NCT02088684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069207|NCT02088684|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102069208|NCT02088684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102069209|NCT02088684|Hormone Antagonists|hormone antagonists|mesh-ancestor
102069210|NCT02088684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102069211|NCT02088684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069212|NCT01137968|Bevacizumab|bevacizumab|mesh-list
102069213|NCT01137968|Imetelstat|imetelstat|mesh-list
102069214|NCT01137968|Motesanib diphosphate|motesanib diphosphate|mesh-list
102069215|NCT01137968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102069216|NCT01137968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069217|NCT01137968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102069218|NCT01137968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102069219|NCT01137968|Growth Substances|growth substances|mesh-ancestor
102069220|NCT01137968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069221|NCT01137968|Growth Inhibitors|growth inhibitors|mesh-ancestor
102069222|NCT01137968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102069223|NCT01137968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069224|NCT01137968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102069225|NCT01133990|Leucovorin|leucovorin|mesh-list
102069226|NCT01133990|Bevacizumab|bevacizumab|mesh-list
101943028|NCT01141881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101943029|NCT01141881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101943030|NCT01141881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069227|NCT01133990|Fluorouracil|fluorouracil|mesh-list
102069228|NCT01133990|Irinotecan|irinotecan|mesh-list
102069229|NCT01133990|Calcium|calcium|mesh-list
102069230|NCT01133990|Levoleucovorin|levoleucovorin|mesh-list
102069231|NCT01133990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102069232|NCT01133990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069233|NCT01133990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102069234|NCT01133990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102069235|NCT01133990|Growth Substances|growth substances|mesh-ancestor
102069236|NCT01133990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069237|NCT01133990|Growth Inhibitors|growth inhibitors|mesh-ancestor
102069238|NCT01133990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102069239|NCT01133990|Antimetabolites|antimetabolites|mesh-ancestor
102069240|NCT01133990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069241|NCT01133990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102069242|NCT01133990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102069243|NCT01133990|Immunologic Factors|immunologic factors|mesh-ancestor
102069244|NCT01133990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102069245|NCT01133990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102069246|NCT01133990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102069247|NCT01133990|Antidotes|antidotes|mesh-ancestor
102069248|NCT01133990|Protective Agents|protective agents|mesh-ancestor
102069261|NCT02936596|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102069262|NCT02936596|Immunosuppressive Agents|immunosuppressive agents|mesh-list
102069263|NCT02936596|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102069264|NCT02936596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102069265|NCT02936596|Immunologic Factors|immunologic factors|mesh-ancestor
102069266|NCT02936596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789007|NCT00642746|Irinotecan|irinotecan|mesh-list
102069268|NCT02398396|Cathartics|cathartics|mesh-ancestor
102069269|NCT02398396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102069270|NCT05628584|Metformin|metformin|mesh-list
102069271|NCT05628584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102069272|NCT05628584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069273|NCT02088918|Metformin|metformin|mesh-list
102069274|NCT02088918|Nateglinide|nateglinide|mesh-list
102069275|NCT02088918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102069276|NCT02088918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069277|NCT02419378|Alemtuzumab|alemtuzumab|mesh-list
102069278|NCT02419378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102069279|NCT02419378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069280|NCT02092428|Adenosine|adenosine|mesh-list
102069281|NCT02092428|Regadenoson|regadenoson|mesh-list
102069282|NCT02092428|Analgesics|analgesics|mesh-ancestor
102069283|NCT02092428|Sensory System Agents|sensory system agents|mesh-ancestor
102069284|NCT02092428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102069285|NCT02092428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069286|NCT02092428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102069287|NCT02092428|Vasodilator Agents|vasodilator agents|mesh-ancestor
102069288|NCT02092428|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102069289|NCT02092428|Purinergic Agonists|purinergic agonists|mesh-ancestor
102069290|NCT02092428|Purinergic Agents|purinergic agents|mesh-ancestor
102069291|NCT02092428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102069292|NCT02092428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069293|NCT02092428|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
102069294|NCT02783404|Amoxicillin|amoxicillin|mesh-list
102069295|NCT02783404|Clavulanic Acid|clavulanic acid|mesh-list
102069296|NCT02783404|Clavulanic Acids|clavulanic acids|mesh-list
102069297|NCT02783404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102069298|NCT02783404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102069299|NCT02783404|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102069300|NCT02783404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102069301|NCT02783404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069302|NCT01097018|Capecitabine|capecitabine|mesh-list
102069303|NCT01097018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102069304|NCT01097018|Antimetabolites|antimetabolites|mesh-ancestor
102069305|NCT01097018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069306|NCT01097018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069307|NCT01096862|Peficitinib|peficitinib|mesh-list
102069308|NCT01096862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101943031|NCT04707430|Progesterone|progesterone|mesh-list
101943032|NCT04707430|Progestins|progestins|mesh-ancestor
101943034|NCT04707430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102069309|NCT01096862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069310|NCT01096862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102069311|NCT01096862|Immunologic Factors|immunologic factors|mesh-ancestor
102069312|NCT01096862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069325|NCT02092506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102069326|NCT01092104|Cenicriviroc|cenicriviroc|mesh-list
102069327|NCT01092104|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102069328|NCT01092104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069329|NCT01092104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102069330|NCT01092104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102069331|NCT01092104|Antiviral Agents|antiviral agents|mesh-ancestor
102069332|NCT01092104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102069333|NCT01128530|Linezolid|linezolid|mesh-list
102069334|NCT01128530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102069335|NCT01128530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102069336|NCT01128530|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102069337|NCT01128530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102069338|NCT01128530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069339|NCT02086032|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102069340|NCT02086032|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102069341|NCT02086032|Estradiol|estradiol|mesh-list
102069342|NCT02086032|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102069343|NCT02086032|Estrogens|estrogens|mesh-list
102069344|NCT02086032|Progesterone|progesterone|mesh-list
102069345|NCT02086032|Dydrogesterone|dydrogesterone|mesh-list
102069346|NCT02086032|Hormones|hormones|mesh-ancestor
102069347|NCT02086032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102069348|NCT02086032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069349|NCT02086032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102069350|NCT02086032|Contraceptive Agents|contraceptive agents|mesh-ancestor
102069351|NCT02086032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102069352|NCT02086032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102069353|NCT02086032|Progestins|progestins|mesh-ancestor
102069354|NCT02092818|Riociguat|riociguat|mesh-list
102069355|NCT02092818|Enzyme Activators|enzyme activators|mesh-ancestor
102069356|NCT02092818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069357|NCT02086188|Mirabegron|mirabegron|mesh-list
102069358|NCT02086188|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102069359|NCT02086188|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102069360|NCT02086188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102069361|NCT02086188|Adrenergic Agents|adrenergic agents|mesh-ancestor
102069362|NCT02086188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102069363|NCT02086188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069364|NCT02086188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069365|NCT02086188|Urological Agents|urological agents|mesh-ancestor
102069366|NCT02267408|Warfarin|warfarin|mesh-list
102069367|NCT02267408|Anticoagulants|anticoagulants|mesh-ancestor
102069368|NCT02092896|Liraglutide|liraglutide|mesh-list
102069369|NCT02092896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102069370|NCT02092896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069371|NCT02092896|Incretins|incretins|mesh-ancestor
102069372|NCT02092896|Hormones|hormones|mesh-ancestor
102069373|NCT02092896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102069374|NCT02092974|Citalopram|citalopram|mesh-list
102069375|NCT02092974|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101370961|NCT00187447|Analgesics|analgesics|mesh-ancestor
102069377|NCT02092974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102069378|NCT02092974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069379|NCT02092974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102069380|NCT02092974|Serotonin Agents|serotonin agents|mesh-ancestor
102069381|NCT02092974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069382|NCT02092974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102069383|NCT02092974|Antidepressive Agents|antidepressive agents|mesh-ancestor
102069384|NCT02092974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102069385|NCT05097508|Bromides|bromides|mesh-list
102069386|NCT05097508|Rocuronium|rocuronium|mesh-list
102069387|NCT05097508|Atracurium|atracurium|mesh-list
102069388|NCT05097508|Anticonvulsants|anticonvulsants|mesh-ancestor
101943035|NCT04707430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943036|NCT03611920|Tetracycline|tetracycline|mesh-list
101943037|NCT03611920|Dexamethasone|dexamethasone|mesh-list
101943038|NCT03611920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101943039|NCT03611920|Antiemetics|antiemetics|mesh-ancestor
101943040|NCT03611920|Autonomic Agents|autonomic agents|mesh-ancestor
102069389|NCT05097508|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102069390|NCT05097508|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102069391|NCT05097508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102069392|NCT05097508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102069393|NCT05097508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069394|NCT05097508|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102069395|NCT05097508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102069396|NCT05097508|Cholinergic Agents|cholinergic agents|mesh-ancestor
102069397|NCT05097508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102069398|NCT05097508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069400|NCT02089308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102069401|NCT02089308|Autonomic Agents|autonomic agents|mesh-ancestor
102069402|NCT02089308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102069403|NCT02089308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069404|NCT02089308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102069405|NCT02089308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102069406|NCT02089308|Cholinergic Agents|cholinergic agents|mesh-ancestor
102069407|NCT02089308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102069408|NCT02089308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069409|NCT00153920|Bortezomib|bortezomib|mesh-list
102069410|NCT00153920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069411|NCT05095714|Liver Extracts|liver extracts|mesh-list
102069412|NCT05095714|Hematinics|hematinics|mesh-ancestor
102069413|NCT02660242|Glucagon|glucagon|mesh-list
102069414|NCT02660242|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102069415|NCT02660242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069416|NCT02660242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102069417|NCT02660242|Hormones|hormones|mesh-ancestor
102069418|NCT02660242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102069419|NCT02660242|Incretins|incretins|mesh-ancestor
102069420|NCT02089386|Tamoxifen|tamoxifen|mesh-list
102069421|NCT02089386|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102069422|NCT02089386|Hormone Antagonists|hormone antagonists|mesh-ancestor
102069423|NCT02089386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102069424|NCT02089386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069425|NCT02089386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102069426|NCT02089386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069427|NCT02089386|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102069428|NCT02089386|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102069429|NCT02089386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102069430|NCT05628038|Capecitabine|capecitabine|mesh-list
102069431|NCT05628038|Oxaliplatin|oxaliplatin|mesh-list
102069432|NCT05628038|Antibodies|antibodies|mesh-list
102069433|NCT05628038|Immunologic Factors|immunologic factors|mesh-ancestor
102069434|NCT05628038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069435|NCT05628038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102069436|NCT05628038|Antimetabolites|antimetabolites|mesh-ancestor
102069437|NCT05628038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069438|NCT05628038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069439|NCT03557580|Isosorbide|isosorbide|mesh-list
102069440|NCT03557580|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
102069441|NCT03557580|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
102069442|NCT03557580|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102069443|NCT03557580|Diuretics|diuretics|mesh-ancestor
102069444|NCT03557580|Natriuretic Agents|natriuretic agents|mesh-ancestor
102069445|NCT03557580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069446|NCT03557580|Vasodilator Agents|vasodilator agents|mesh-ancestor
102069447|NCT03557580|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102069448|NCT03557580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069453|NCT01295060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102069454|NCT01295060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102069455|NCT01295060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069456|NCT02086656|Bevacizumab|bevacizumab|mesh-list
101943041|NCT03611920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101943042|NCT03611920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307942|NCT02044601|Carboplatin|carboplatin|mesh-list
102069457|NCT02086656|Capecitabine|capecitabine|mesh-list
102069458|NCT02086656|Oxaliplatin|oxaliplatin|mesh-list
102069459|NCT02086656|Irinotecan|irinotecan|mesh-list
102069460|NCT02086656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102069461|NCT02086656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069462|NCT02086656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102069463|NCT02086656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102069464|NCT02086656|Growth Substances|growth substances|mesh-ancestor
102069465|NCT02086656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069466|NCT02086656|Growth Inhibitors|growth inhibitors|mesh-ancestor
102069467|NCT02086656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102069468|NCT02086656|Antimetabolites|antimetabolites|mesh-ancestor
102069469|NCT02086656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069470|NCT02086656|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102069471|NCT02086656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102069472|NCT02086656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102069473|NCT01294202|Imatinib Mesylate|imatinib mesylate|mesh-list
102069474|NCT01294202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069475|NCT01294202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102069476|NCT01294202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102069477|NCT01294202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069478|NCT01071902|Moxifloxacin|moxifloxacin|mesh-list
102069479|NCT01071902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102069480|NCT01071902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102069481|NCT01071902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102069482|NCT01071902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102069483|NCT01071902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102069484|NCT01071902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102069485|NCT01071902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069486|NCT01071902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069487|NCT01126970|Orlistat|orlistat|mesh-list
102069488|NCT01126970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102069489|NCT01126970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069490|NCT01126970|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102069491|NCT01126970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102069492|NCT03557424|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
102069493|NCT03557424|Cathartics|cathartics|mesh-ancestor
102069494|NCT03557424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102069495|NCT05057572|Carvedilol|carvedilol|mesh-list
102069496|NCT05057572|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102069497|NCT05057572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102069498|NCT05057572|Adrenergic Agents|adrenergic agents|mesh-ancestor
102069499|NCT05057572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102069500|NCT05057572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069501|NCT05057572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069502|NCT05057572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102069503|NCT05057572|Antioxidants|antioxidants|mesh-ancestor
102069504|NCT05057572|Protective Agents|protective agents|mesh-ancestor
102069505|NCT05057572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102069506|NCT05057572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102069507|NCT05057572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102069508|NCT05057572|Vasodilator Agents|vasodilator agents|mesh-ancestor
102069509|NCT05057572|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102069510|NCT05057572|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102069511|NCT02093598|Sirolimus|sirolimus|mesh-list
102069512|NCT02093598|Temsirolimus|temsirolimus|mesh-list
102069513|NCT02093598|MTOR Inhibitors|mtor inhibitors|mesh-list
102069514|NCT02093598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102069515|NCT02093598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102069516|NCT02093598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069517|NCT02093598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102069518|NCT02093598|Immunologic Factors|immunologic factors|mesh-ancestor
101371099|NCT00188266|Cisplatin|cisplatin|mesh-list
102069529|NCT01124552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102069530|NCT01124552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069531|NCT01124552|Cholinergic Agents|cholinergic agents|mesh-ancestor
102069532|NCT01124552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102069533|NCT01124552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943043|NCT03611920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101943044|NCT03611920|Glucocorticoids|glucocorticoids|mesh-ancestor
101943045|NCT03611920|Hormones|hormones|mesh-ancestor
101943046|NCT03611920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102069534|NCT01124552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102069535|NCT01124552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102069536|NCT02087202|Magnesium Sulfate|magnesium sulfate|mesh-list
102069537|NCT02087202|Ketamine|ketamine|mesh-list
102069538|NCT02087202|Analgesics|analgesics|mesh-ancestor
102069539|NCT02087202|Sensory System Agents|sensory system agents|mesh-ancestor
102069540|NCT02087202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102069541|NCT02087202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069542|NCT02087202|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102069543|NCT02087202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102069544|NCT02087202|Anesthetics, General|anesthetics, general|mesh-ancestor
102069545|NCT02087202|Anesthetics|anesthetics|mesh-ancestor
102069546|NCT02087202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102069547|NCT02087202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102069548|NCT02087202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102069549|NCT02087202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102069550|NCT02087202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069551|NCT02087202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102069552|NCT02087202|Anticonvulsants|anticonvulsants|mesh-ancestor
102069553|NCT02087202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102069554|NCT02087202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102069555|NCT02087202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102069556|NCT02087202|Tocolytic Agents|tocolytic agents|mesh-ancestor
102069557|NCT02087202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102069558|NCT01283594|Levodopa|levodopa|mesh-list
102069559|NCT01283594|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102069560|NCT01283594|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102069561|NCT01283594|Dopamine Agents|dopamine agents|mesh-ancestor
102069562|NCT01283594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102069563|NCT01283594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069564|NCT01283594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069565|NCT01281254|Trebananib|trebananib|mesh-list
102069566|NCT01281254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102069567|NCT01281254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102069568|NCT01281254|Growth Substances|growth substances|mesh-ancestor
102069569|NCT01281254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069570|NCT01281254|Growth Inhibitors|growth inhibitors|mesh-ancestor
102069571|NCT01281254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069573|NCT05104138|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102069574|NCT05104138|Hormone Antagonists|hormone antagonists|mesh-ancestor
102069575|NCT05104138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102069576|NCT05104138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069577|NCT05104138|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102069578|NCT05104138|Diuretics|diuretics|mesh-ancestor
102069579|NCT05104138|Natriuretic Agents|natriuretic agents|mesh-ancestor
102069580|NCT05104138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102069581|NCT03072043|Azacitidine|azacitidine|mesh-list
102069582|NCT03072043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102069618|NCT05624840|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
102069623|NCT05624840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069624|NCT05624840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102069625|NCT05624840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102069626|NCT05624840|Antiviral Agents|antiviral agents|mesh-ancestor
102069627|NCT05624840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102069628|NCT05624840|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102069629|NCT05624840|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102069630|NCT02093910|Dexamethasone|dexamethasone|mesh-list
102069631|NCT02093910|Bortezomib|bortezomib|mesh-list
102069632|NCT02093910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102069633|NCT02093910|Antiemetics|antiemetics|mesh-ancestor
102069634|NCT02093910|Autonomic Agents|autonomic agents|mesh-ancestor
102069635|NCT02093910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102069636|NCT02093910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069637|NCT02093910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102069638|NCT02093910|Glucocorticoids|glucocorticoids|mesh-ancestor
101943047|NCT03611920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101943048|NCT03611920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101943049|NCT03611920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101943050|NCT03611920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101943051|NCT03611920|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101943052|NCT03611920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101943053|NCT03611920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943054|NCT03611530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102069639|NCT02093910|Hormones|hormones|mesh-ancestor
102069640|NCT02093910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102069641|NCT02093910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102069642|NCT02093910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069644|NCT04437160|Epirubicin|epirubicin|mesh-list
102069645|NCT04437160|Pirarubicin|pirarubicin|mesh-list
102069646|NCT04437160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102069647|NCT04437160|Immunologic Factors|immunologic factors|mesh-ancestor
102069648|NCT04437160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069649|NCT04437160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102069650|NCT04437160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102069651|NCT04437160|Alkylating Agents|alkylating agents|mesh-ancestor
102069652|NCT04437160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069653|NCT04437160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069654|NCT04437160|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102069655|NCT04437160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102069656|NCT04437160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102069657|NCT04437160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102069658|NCT04437160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102069659|NCT02089932|Dexmedetomidine|dexmedetomidine|mesh-list
102069660|NCT02089932|Bupivacaine|bupivacaine|mesh-list
102069661|NCT02089932|Anesthetics, Local|anesthetics, local|mesh-ancestor
102069662|NCT02089932|Anesthetics|anesthetics|mesh-ancestor
102069663|NCT02089932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102069664|NCT02089932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069665|NCT02089932|Sensory System Agents|sensory system agents|mesh-ancestor
102069666|NCT02089932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102069667|NCT02089932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102069668|NCT02089932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102069669|NCT02089932|Analgesics|analgesics|mesh-ancestor
102069670|NCT02089932|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102069671|NCT02089932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102069672|NCT02089932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102069673|NCT02089932|Adrenergic Agents|adrenergic agents|mesh-ancestor
102069674|NCT02089932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102069675|NCT02089932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069676|NCT01037036|Latanoprost|latanoprost|mesh-list
102069677|NCT01037036|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102069678|NCT01037036|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102069679|NCT05204641|Rifaximin|rifaximin|mesh-list
102069680|NCT05204641|Levodopa|levodopa|mesh-list
102069681|NCT05204641|Benserazide|benserazide|mesh-list
102069682|NCT05204641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102069683|NCT05204641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102069684|NCT05204641|Dopamine Agents|dopamine agents|mesh-ancestor
102069685|NCT05204641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102069686|NCT05204641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069687|NCT05204641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069688|NCT05204641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102069689|NCT05204641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102069690|NCT05204641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102069702|NCT02094066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069703|NCT02094066|Hemostatics|hemostatics|mesh-ancestor
102069704|NCT02094066|Coagulants|coagulants|mesh-ancestor
102069705|NCT01033292|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102069707|NCT01033292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101943055|NCT03611530|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101943056|NCT02936752|Pembrolizumab|pembrolizumab|mesh-list
101943057|NCT02936752|Entinostat|entinostat|mesh-list
101943058|NCT02936752|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
101943059|NCT02936752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102069708|NCT01033292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069709|NCT01033292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069710|NCT03068767|Vitamin D|vitamin d|mesh-list
102069711|NCT03068767|Vitamins|vitamins|mesh-ancestor
102069712|NCT03068767|Micronutrients|micronutrients|mesh-ancestor
102069713|NCT03068767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069714|NCT03068767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102069715|NCT02267720|Salicylic Acid|salicylic acid|mesh-list
102069716|NCT02267720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102069717|NCT02267720|Antifungal Agents|antifungal agents|mesh-ancestor
102069718|NCT02267720|Keratolytic Agents|keratolytic agents|mesh-ancestor
102069719|NCT02267720|Dermatologic Agents|dermatologic agents|mesh-ancestor
102069720|NCT05204329|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102069721|NCT05204329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102069723|NCT01110902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102069724|NCT01110902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102069725|NCT01110902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069726|NCT05204173|Paclitaxel|paclitaxel|mesh-list
102069727|NCT05204173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102069728|NCT05204173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069729|NCT05204173|Tubulin Modulators|tubulin modulators|mesh-ancestor
102069730|NCT05204173|Antimitotic Agents|antimitotic agents|mesh-ancestor
102069731|NCT05204173|Mitosis Modulators|mitosis modulators|mesh-ancestor
102069732|NCT05204173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069733|NCT01025648|Epinephrine|epinephrine|mesh-list
102069734|NCT01025648|Racepinephrine|racepinephrine|mesh-list
102069735|NCT01025648|Epinephryl borate|epinephryl borate|mesh-list
102069736|NCT01025648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102069737|NCT01025648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102069738|NCT01025648|Adrenergic Agents|adrenergic agents|mesh-ancestor
102069739|NCT01025648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102069740|NCT01025648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069741|NCT01025648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069742|NCT01025648|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102069743|NCT01025648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102069744|NCT01025648|Autonomic Agents|autonomic agents|mesh-ancestor
102069745|NCT01025648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102069746|NCT01025648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102069747|NCT01025648|Respiratory System Agents|respiratory system agents|mesh-ancestor
102069748|NCT01025648|Mydriatics|mydriatics|mesh-ancestor
102069749|NCT01025648|Sympathomimetics|sympathomimetics|mesh-ancestor
102069750|NCT01025648|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102069751|NCT01110746|Insulin|insulin|mesh-list
102069752|NCT01110746|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102069753|NCT01110746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102069754|NCT01110746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069755|NCT05622968|Dinoprostone|dinoprostone|mesh-list
102069756|NCT05622968|Oxytocics|oxytocics|mesh-ancestor
102069757|NCT05622968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102069758|NCT05622968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069804|NCT05617508|Micronutrients|micronutrients|mesh-ancestor
102069805|NCT05617508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069806|NCT05617508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102069807|NCT05617508|Antimetabolites|antimetabolites|mesh-ancestor
102069808|NCT05617508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069809|NCT05617508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102069810|NCT05617508|Vasodilator Agents|vasodilator agents|mesh-ancestor
102069811|NCT03018249|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102069812|NCT03018249|Entinostat|entinostat|mesh-list
102069813|NCT03018249|Medroxyprogesterone|medroxyprogesterone|mesh-list
102069814|NCT03018249|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
102069815|NCT03018249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102069816|NCT03018249|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102069817|NCT03018249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102069818|NCT03018249|Contraceptive Agents|contraceptive agents|mesh-ancestor
102069819|NCT03018249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101943060|NCT02936752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101943061|NCT02936752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101943062|NCT02936752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943063|NCT02936752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102069820|NCT03018249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069821|NCT03018249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102069822|NCT03018249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102069823|NCT03018249|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102069824|NCT03018249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102069825|NCT03018249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069826|NCT03018249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102069827|NCT03018249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069828|NCT05380154|Botulinum Toxins|botulinum toxins|mesh-list
102069829|NCT05380154|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102069830|NCT05380154|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102069831|NCT05380154|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102069832|NCT05380154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102069833|NCT05380154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069834|NCT05380154|Cholinergic Agents|cholinergic agents|mesh-ancestor
102069835|NCT05380154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102069836|NCT05380154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069837|NCT05380154|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102069838|NCT05380154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102069839|NCT05374252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102069840|NCT05374252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069841|NCT05374252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102069842|NCT05374252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069843|NCT04602975|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102069844|NCT04602975|Vaccines|vaccines|mesh-list
102069845|NCT04602975|Immunologic Factors|immunologic factors|mesh-ancestor
102069846|NCT04602975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069847|NCT04602975|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102069848|NCT04602975|Antacids|antacids|mesh-ancestor
102069849|NCT04602975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069850|NCT04602975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102069851|NCT00905606|Topiramate|topiramate|mesh-list
102069852|NCT00905606|Anticonvulsants|anticonvulsants|mesh-ancestor
102069853|NCT00905606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102069854|NCT00905606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069855|NCT03017235|Picosulfate sodium|picosulfate sodium|mesh-list
102069856|NCT03017235|Magnesium Oxide|magnesium oxide|mesh-list
102069857|NCT03017235|Sodium Citrate|sodium citrate|mesh-list
102069858|NCT03017235|Citric Acid|citric acid|mesh-list
102069859|NCT03017235|Anticoagulants|anticoagulants|mesh-ancestor
102069860|NCT03017235|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102069861|NCT03017235|Chelating Agents|chelating agents|mesh-ancestor
102069880|NCT03667677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102069881|NCT03667677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069882|NCT03667677|Vasodilator Agents|vasodilator agents|mesh-ancestor
102069883|NCT03667677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102069884|NCT03667677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102069885|NCT03667677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102069886|NCT03667677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102069887|NCT03667677|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102069888|NCT03667677|Serotonin Agents|serotonin agents|mesh-ancestor
102069889|NCT03667677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102069890|NCT04176718|Dexamethasone|dexamethasone|mesh-list
102069891|NCT04176718|Daratumumab|daratumumab|mesh-list
102069892|NCT04176718|Pomalidomide|pomalidomide|mesh-list
102069893|NCT04176718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102069894|NCT04176718|Antiemetics|antiemetics|mesh-ancestor
102069895|NCT04176718|Autonomic Agents|autonomic agents|mesh-ancestor
102069896|NCT04176718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102069897|NCT04176718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069898|NCT04176718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102069899|NCT04176718|Glucocorticoids|glucocorticoids|mesh-ancestor
102069900|NCT04176718|Hormones|hormones|mesh-ancestor
102069901|NCT04176718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102069902|NCT04176718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101943064|NCT05383534|Propofol|propofol|mesh-list
101943065|NCT05383534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101943066|NCT05383534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101307967|NCT02044952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102069903|NCT04176718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069904|NCT04176718|Immunologic Factors|immunologic factors|mesh-ancestor
102069905|NCT04176718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102069906|NCT04176718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102069907|NCT04176718|Growth Substances|growth substances|mesh-ancestor
102069908|NCT04176718|Growth Inhibitors|growth inhibitors|mesh-ancestor
102069909|NCT02880371|Pembrolizumab|pembrolizumab|mesh-list
102069910|NCT02880371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102069911|NCT02880371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069912|NCT02880371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102069913|NCT02880371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069914|NCT00813956|Carboplatin|carboplatin|mesh-list
102069915|NCT00813956|Gemcitabine|gemcitabine|mesh-list
102069916|NCT00813956|Iniparib|iniparib|mesh-list
101371505|NCT00190567|Analgesics|analgesics|mesh-ancestor
102069933|NCT01002248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102069934|NCT01002248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102069935|NCT01002248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069937|NCT02837029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102069938|NCT02837029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069939|NCT02837029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102069940|NCT02837029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069941|NCT03667131|Enalapril|enalapril|mesh-list
102069942|NCT03667131|Enalaprilat|enalaprilat|mesh-list
102069943|NCT03667131|Enzyme Inhibitors|enzyme inhibitors|mesh-list
102069944|NCT03667131|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102069945|NCT03667131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069946|NCT03667131|Protease Inhibitors|protease inhibitors|mesh-ancestor
102069947|NCT03667131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102069948|NCT04532710|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102069949|NCT04532710|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102069950|NCT01377155|Insulin Detemir|insulin detemir|mesh-list
102069951|NCT01377155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102069952|NCT01377155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069953|NCT04976374|Dexmedetomidine|dexmedetomidine|mesh-list
102069954|NCT04976374|Gabapentin|gabapentin|mesh-list
102069955|NCT04976374|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102069956|NCT04976374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102069957|NCT04976374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069958|NCT04976374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102069959|NCT04976374|Analgesics|analgesics|mesh-ancestor
102069960|NCT04976374|Sensory System Agents|sensory system agents|mesh-ancestor
102069961|NCT04976374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102069962|NCT04976374|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102069963|NCT04976374|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102069964|NCT04976374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102069965|NCT04976374|Adrenergic Agents|adrenergic agents|mesh-ancestor
102069966|NCT04976374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102069967|NCT04976374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069968|NCT04976374|Anticonvulsants|anticonvulsants|mesh-ancestor
102069969|NCT04976374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102069970|NCT04976374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102069971|NCT04976374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102069972|NCT04976374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102069973|NCT04976374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101371559|NCT00190840|Pemetrexed|pemetrexed|mesh-list
101943067|NCT05383534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943068|NCT05383534|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102069992|NCT00894530|Azithromycin|azithromycin|mesh-list
102069993|NCT00894530|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102069994|NCT00894530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102069995|NCT00894530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102069996|NCT00894530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102069997|NCT01376999|Hormones|hormones|mesh-list
102069998|NCT01376999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102069999|NCT01376999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070000|NCT00892970|Azithromycin|azithromycin|mesh-list
102070001|NCT00892970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102070002|NCT00892970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102070003|NCT00892970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102070004|NCT00892970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102070005|NCT05340257|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102070006|NCT05340257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102070007|NCT05340257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102070008|NCT05340257|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102070009|NCT05340257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102070010|NCT05340257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070011|NCT02201381|Metformin|metformin|mesh-list
102070012|NCT02201381|Doxycycline|doxycycline|mesh-list
102070013|NCT02201381|Mebendazole|mebendazole|mesh-list
102070014|NCT02201381|Atorvastatin|atorvastatin|mesh-list
102070015|NCT02201381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102070016|NCT02201381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070017|NCT02201381|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102070018|NCT02201381|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102070019|NCT02201381|Antimetabolites|antimetabolites|mesh-ancestor
102070020|NCT02201381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070021|NCT02201381|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102070022|NCT02201381|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102070023|NCT02201381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102070024|NCT02201381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102070025|NCT02201381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102070026|NCT02201381|Antimalarials|antimalarials|mesh-ancestor
102070027|NCT02201381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102070028|NCT02201381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102070029|NCT02201381|Antinematodal Agents|antinematodal agents|mesh-ancestor
102070030|NCT02201381|Anthelmintics|anthelmintics|mesh-ancestor
102070031|NCT02201381|Tubulin Modulators|tubulin modulators|mesh-ancestor
102070032|NCT02201381|Antimitotic Agents|antimitotic agents|mesh-ancestor
102070033|NCT02201381|Mitosis Modulators|mitosis modulators|mesh-ancestor
102070034|NCT02201381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102070036|NCT00803114|Narcotics|narcotics|mesh-list
102070037|NCT00803114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102070038|NCT00803114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102070039|NCT00803114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070040|NCT00803114|Analgesics|analgesics|mesh-ancestor
102070041|NCT00803114|Sensory System Agents|sensory system agents|mesh-ancestor
102070042|NCT00803114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102070070|NCT02162849|Cholinergic Agents|cholinergic agents|mesh-ancestor
102070071|NCT02162849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102070072|NCT02162849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070074|NCT02914275|Immunologic Factors|immunologic factors|mesh-ancestor
102070075|NCT02914275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070076|NCT01941875|Progesterone|progesterone|mesh-list
102070077|NCT01941875|Progestins|progestins|mesh-ancestor
102070078|NCT01941875|Hormones|hormones|mesh-ancestor
102070079|NCT01941875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102070080|NCT01941875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070081|NCT05508074|Riluzole|riluzole|mesh-list
102070082|NCT05508074|Anticonvulsants|anticonvulsants|mesh-ancestor
102070083|NCT05508074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102070084|NCT05508074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102070085|NCT05508074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102070086|NCT05508074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943072|NCT01235325|Vitamin K 1|vitamin k 1|mesh-list
101943073|NCT01235325|Vitamins|vitamins|mesh-ancestor
101943074|NCT01235325|Micronutrients|micronutrients|mesh-ancestor
101307972|NCT02044952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102070087|NCT05508074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070088|NCT05508074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102070089|NCT05508074|Protective Agents|protective agents|mesh-ancestor
102070090|NCT01814657|Lidocaine|lidocaine|mesh-list
102070091|NCT01814657|Anesthetics, Local|anesthetics, local|mesh-ancestor
102070101|NCT01814657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070102|NCT01773395|Methotrexate|methotrexate|mesh-list
102070103|NCT01773395|Fludarabine|fludarabine|mesh-list
102070104|NCT01773395|Busulfan|busulfan|mesh-list
102070105|NCT01773395|Tacrolimus|tacrolimus|mesh-list
102070106|NCT01773395|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102070107|NCT01773395|Abortifacient Agents|abortifacient agents|mesh-ancestor
102070108|NCT01773395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102070109|NCT01773395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070110|NCT01773395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102070111|NCT01773395|Antimetabolites|antimetabolites|mesh-ancestor
102070112|NCT01773395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070113|NCT01773395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102070114|NCT01773395|Dermatologic Agents|dermatologic agents|mesh-ancestor
102070115|NCT01773395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101701539|NCT02737709|Paclitaxel|paclitaxel|mesh-list
102070116|NCT01773395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102070117|NCT01773395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102070118|NCT01773395|Immunologic Factors|immunologic factors|mesh-ancestor
102070119|NCT01773395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102070120|NCT01773395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102070121|NCT01773395|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102070122|NCT01773395|Alkylating Agents|alkylating agents|mesh-ancestor
102070123|NCT01773395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102070124|NCT01773395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102070125|NCT01000922|Insulin|insulin|mesh-list
102070126|NCT01000922|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102070127|NCT01000922|Insulin Glargine|insulin glargine|mesh-list
102070128|NCT01000922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102070129|NCT01000922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070130|NCT04559217|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
102070131|NCT04559217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070132|NCT03666195|Titanium dioxide|titanium dioxide|mesh-list
102070133|NCT03666195|Sunscreening Agents|sunscreening agents|mesh-ancestor
102070134|NCT03666195|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102070135|NCT03666195|Protective Agents|protective agents|mesh-ancestor
102070136|NCT03666195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070137|NCT03666195|Dermatologic Agents|dermatologic agents|mesh-ancestor
102070138|NCT03666195|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102070139|NCT00889382|Paclitaxel|paclitaxel|mesh-list
102070140|NCT00889382|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102070141|NCT00889382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102070142|NCT00889382|Tubulin Modulators|tubulin modulators|mesh-ancestor
102070143|NCT00889382|Antimitotic Agents|antimitotic agents|mesh-ancestor
102070144|NCT00889382|Mitosis Modulators|mitosis modulators|mesh-ancestor
102070145|NCT00889382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070146|NCT04059003|Taxane|taxane|mesh-list
102070147|NCT04059003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102070148|NCT05375188|Dexmedetomidine|dexmedetomidine|mesh-list
102070149|NCT05375188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102070150|NCT05375188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102070151|NCT05375188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070152|NCT05375188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102070153|NCT05375188|Analgesics|analgesics|mesh-ancestor
102070154|NCT05375188|Sensory System Agents|sensory system agents|mesh-ancestor
102070155|NCT05375188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101371730|NCT00191893|Teriparatide|teriparatide|mesh-list
102070172|NCT04437004|Fenfluramine|fenfluramine|mesh-list
102070173|NCT04437004|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102070174|NCT04437004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102070175|NCT04437004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102070176|NCT04437004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070177|NCT04437004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101943075|NCT01235325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943076|NCT01235325|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101943077|NCT01235325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102070178|NCT04437004|Serotonin Agents|serotonin agents|mesh-ancestor
102070179|NCT04437004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070180|NCT00992732|Valganciclovir|valganciclovir|mesh-list
102070181|NCT00992732|Ganciclovir|ganciclovir|mesh-list
102070182|NCT00992732|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102070183|NCT00992732|Arginine butyrate|arginine butyrate|mesh-list
102070184|NCT00992732|Antiviral Agents|antiviral agents|mesh-ancestor
102070185|NCT00992732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101701540|NCT02737709|Carboplatin|carboplatin|mesh-list
102070186|NCT00992732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102070187|NCT00992732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102070188|NCT00992732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070189|NCT00992732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102070190|NCT00884234|Botulinum Toxins|botulinum toxins|mesh-list
102070191|NCT00884234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102070192|NCT00884234|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102070193|NCT00884234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102070194|NCT00884234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102070195|NCT00884234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070196|NCT00884234|Cholinergic Agents|cholinergic agents|mesh-ancestor
102070197|NCT00884234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102070198|NCT00884234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070199|NCT00884234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102070200|NCT00884234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102070202|NCT03006393|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102070203|NCT03006393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102070204|NCT03006393|Dermatologic Agents|dermatologic agents|mesh-ancestor
102070205|NCT03006393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102070206|NCT03006393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102070208|NCT00991172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102070209|NCT00991172|Analgesics|analgesics|mesh-ancestor
102070210|NCT00991172|Sensory System Agents|sensory system agents|mesh-ancestor
102070211|NCT00991172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102070212|NCT00991172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070213|NCT01383109|Pyronaridine|pyronaridine|mesh-list
102070236|NCT00880490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102070237|NCT00880490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070238|NCT00880490|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102070239|NCT00880490|Respiratory System Agents|respiratory system agents|mesh-ancestor
102070240|NCT00880490|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101789995|NCT00809042|Hydroxyurea|hydroxyurea|mesh-list
102070241|NCT00880490|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102070242|NCT00880490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102070243|NCT00880490|Adrenergic Agents|adrenergic agents|mesh-ancestor
102070244|NCT00880490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102070245|NCT00880490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070246|NCT05214157|Bupivacaine|bupivacaine|mesh-list
102070247|NCT05214157|Anesthetics, Local|anesthetics, local|mesh-ancestor
102070248|NCT05214157|Anesthetics|anesthetics|mesh-ancestor
102070249|NCT05214157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102070250|NCT05214157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070251|NCT05214157|Sensory System Agents|sensory system agents|mesh-ancestor
102070252|NCT05214157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102070253|NCT04549467|Tenofovir|tenofovir|mesh-list
102070254|NCT04549467|Lamivudine|lamivudine|mesh-list
102070255|NCT04549467|Emtricitabine|emtricitabine|mesh-list
102070256|NCT04549467|Dolutegravir|dolutegravir|mesh-list
102070257|NCT04549467|Antiviral Agents|antiviral agents|mesh-ancestor
102070258|NCT04549467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102070259|NCT04549467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102070260|NCT04549467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102070261|NCT04549467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102070262|NCT04549467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070263|NCT04549467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102070264|NCT04549467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102070286|NCT02632396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070288|NCT02632396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102070289|NCT05102422|Propofol|propofol|mesh-list
102070290|NCT05102422|Sevoflurane|sevoflurane|mesh-list
101943078|NCT01235325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943079|NCT01235325|Hemostatics|hemostatics|mesh-ancestor
101943080|NCT01235325|Coagulants|coagulants|mesh-ancestor
101943081|NCT01140009|Vaccines|vaccines|mesh-list
101443574|NCT00203580|Dalteparin|dalteparin|mesh-list
102070291|NCT05102422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102070292|NCT05102422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102070293|NCT05102422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070294|NCT05102422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102070295|NCT05102422|Anesthetics, General|anesthetics, general|mesh-ancestor
102070296|NCT05102422|Anesthetics|anesthetics|mesh-ancestor
102070297|NCT05102422|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102070298|NCT05102422|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102070299|NCT01088789|Cyclophosphamide|cyclophosphamide|mesh-list
102070300|NCT01088789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102070301|NCT01088789|Immunologic Factors|immunologic factors|mesh-ancestor
102070302|NCT01088789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070303|NCT01088789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102070304|NCT01088789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102070305|NCT01088789|Alkylating Agents|alkylating agents|mesh-ancestor
102070306|NCT01088789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070307|NCT01088789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102070308|NCT01088789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102070309|NCT03665181|Bismuth|bismuth|mesh-list
102070310|NCT03665181|Antacids|antacids|mesh-ancestor
102070311|NCT03665181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070312|NCT03665181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102070313|NCT05326906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102070314|NCT05326906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070315|NCT05326906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102070316|NCT05326906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102070324|NCT04044209|Nivolumab|nivolumab|mesh-list
102070325|NCT04044209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102070326|NCT04044209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102070327|NCT04044209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102070328|NCT04044209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070329|NCT03817463|Empagliflozin|empagliflozin|mesh-list
102070330|NCT03817463|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
102070331|NCT03817463|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102070332|NCT03817463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070333|NCT03817463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102070334|NCT03817463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070335|NCT03817463|Protease Inhibitors|protease inhibitors|mesh-ancestor
102070336|NCT03817463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102070337|NCT05207683|Antibodies|antibodies|mesh-list
102070338|NCT05207683|Antibodies, Antinuclear|antibodies, antinuclear|mesh-list
102070339|NCT05207683|Immunologic Factors|immunologic factors|mesh-ancestor
102070340|NCT05207683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070341|NCT03000075|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102070342|NCT03000075|Immunologic Factors|immunologic factors|mesh-ancestor
102070343|NCT03000075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070344|NCT05213065|Bupivacaine|bupivacaine|mesh-list
102070345|NCT05213065|Anesthetics, Local|anesthetics, local|mesh-ancestor
102070346|NCT05213065|Anesthetics|anesthetics|mesh-ancestor
102070347|NCT05213065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102070348|NCT05213065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070349|NCT05213065|Sensory System Agents|sensory system agents|mesh-ancestor
102070350|NCT05213065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102070351|NCT04578938|Ketamine|ketamine|mesh-list
102070352|NCT04578938|Analgesics|analgesics|mesh-ancestor
102070353|NCT04578938|Sensory System Agents|sensory system agents|mesh-ancestor
101701563|NCT00721240|Montelukast|montelukast|mesh-list
102070354|NCT04578938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102070355|NCT04578938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070356|NCT04578938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102070357|NCT04578938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102070358|NCT04578938|Anesthetics, General|anesthetics, general|mesh-ancestor
102070359|NCT04578938|Anesthetics|anesthetics|mesh-ancestor
102070360|NCT04578938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102070361|NCT04578938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101943082|NCT01140009|Immunologic Factors|immunologic factors|mesh-ancestor
101943083|NCT01140009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943084|NCT01235637|Sufentanil|sufentanil|mesh-list
101943085|NCT01235637|Alfentanil|alfentanil|mesh-list
101943086|NCT01235637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101943087|NCT01235637|Narcotics|narcotics|mesh-ancestor
102070362|NCT04578938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102070363|NCT04578938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102070364|NCT04578938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070365|NCT00969722|Tretinoin|tretinoin|mesh-list
102070366|NCT00969722|Molgramostim|molgramostim|mesh-list
102070367|NCT00969722|Isotretinoin|isotretinoin|mesh-list
102070368|NCT00969722|Sargramostim|sargramostim|mesh-list
102070369|NCT00969722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102070370|NCT00969722|Keratolytic Agents|keratolytic agents|mesh-ancestor
102070371|NCT00969722|Dermatologic Agents|dermatologic agents|mesh-ancestor
102070372|NCT00969722|Immunologic Factors|immunologic factors|mesh-ancestor
102070373|NCT00969722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070374|NCT05099614|Naloxone|naloxone|mesh-list
102070375|NCT05099614|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102070376|NCT05099614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070377|NCT05099614|Sensory System Agents|sensory system agents|mesh-ancestor
102070378|NCT05099614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102070379|NCT00968942|Botulinum Toxins|botulinum toxins|mesh-list
102070380|NCT00968942|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102070381|NCT00968942|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102070382|NCT00968942|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102070383|NCT00968942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102070384|NCT00968942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070394|NCT00869336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102070396|NCT02371889|Anticonvulsants|anticonvulsants|mesh-ancestor
102070397|NCT02371889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102070398|NCT02371889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070399|NCT00860288|Metformin|metformin|mesh-list
102070400|NCT00860288|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102070401|NCT00860288|Vildagliptin|vildagliptin|mesh-list
102070402|NCT00860288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102070403|NCT00860288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070404|NCT00860288|Incretins|incretins|mesh-ancestor
102070405|NCT00860288|Hormones|hormones|mesh-ancestor
102070406|NCT00860288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102070407|NCT00860288|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102070408|NCT00860288|Protease Inhibitors|protease inhibitors|mesh-ancestor
102070409|NCT00860288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102070410|NCT00860288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070411|NCT03630029|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102070412|NCT03630029|Hematinics|hematinics|mesh-ancestor
102070413|NCT05763953|Etripamil|etripamil|mesh-list
102070414|NCT05763953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102070415|NCT05763953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102070416|NCT05763953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070417|NCT05763953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102070418|NCT05763953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070419|NCT05212597|Losartan|losartan|mesh-list
102070420|NCT05212597|Amlodipine|amlodipine|mesh-list
102070421|NCT05212597|Valsartan|valsartan|mesh-list
102070422|NCT05212597|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102070423|NCT05212597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102070424|NCT05212597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102070425|NCT05212597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102070426|NCT05212597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070427|NCT05212597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102070428|NCT05212597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070429|NCT05212597|Vasodilator Agents|vasodilator agents|mesh-ancestor
102070430|NCT05212597|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102070431|NCT05212597|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102070432|NCT05212597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102070433|NCT02450812|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
102070434|NCT02450812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101943088|NCT01235637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101943089|NCT01235637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070435|NCT03629717|Vitamin D|vitamin d|mesh-list
102070436|NCT03629717|Denosumab|denosumab|mesh-list
102070437|NCT03629717|Calcium|calcium|mesh-list
102070438|NCT03629717|Vitamins|vitamins|mesh-ancestor
102070439|NCT03629717|Micronutrients|micronutrients|mesh-ancestor
102070440|NCT03629717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070441|NCT03629717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102070442|NCT03629717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102070443|NCT05108350|Metformin|metformin|mesh-list
102070444|NCT05108350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102070445|NCT05108350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070446|NCT00859430|Levetiracetam|levetiracetam|mesh-list
102070447|NCT00859430|Anticonvulsants|anticonvulsants|mesh-ancestor
102070448|NCT00859430|Nootropic Agents|nootropic agents|mesh-ancestor
102070449|NCT00855764|Paclitaxel|paclitaxel|mesh-list
102070450|NCT00855764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101372023|NCT00193921|Gemcitabine|gemcitabine|mesh-list
102070455|NCT00855764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070457|NCT00959036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102070458|NCT00959036|Abortifacient Agents|abortifacient agents|mesh-ancestor
102070459|NCT00959036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102070460|NCT00959036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070461|NCT00959036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102070462|NCT00959036|Antimetabolites|antimetabolites|mesh-ancestor
102070463|NCT00959036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070464|NCT00959036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102070465|NCT00959036|Dermatologic Agents|dermatologic agents|mesh-ancestor
102070466|NCT00959036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101790212|NCT02591771|Epinephrine|epinephrine|mesh-list
102070468|NCT00959036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102070469|NCT00959036|Immunologic Factors|immunologic factors|mesh-ancestor
102070470|NCT00959036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102070471|NCT00959036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102070472|NCT04129723|Tin Fluorides|tin fluorides|mesh-list
102070473|NCT04129723|Cariostatic Agents|cariostatic agents|mesh-ancestor
102070474|NCT04129723|Protective Agents|protective agents|mesh-ancestor
102070475|NCT04129723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070476|NCT04474262|Midodrine|midodrine|mesh-list
102070477|NCT04474262|Sympathomimetics|sympathomimetics|mesh-ancestor
102070478|NCT04474262|Autonomic Agents|autonomic agents|mesh-ancestor
102070479|NCT04474262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102070480|NCT04474262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070481|NCT04474262|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102070482|NCT04474262|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102070483|NCT04474262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102070484|NCT04474262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102070485|NCT04474262|Adrenergic Agents|adrenergic agents|mesh-ancestor
102070486|NCT04474262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102070487|NCT04474262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070488|NCT05211583|Progesterone|progesterone|mesh-list
102070489|NCT05211583|Progestins|progestins|mesh-ancestor
102070490|NCT05211583|Hormones|hormones|mesh-ancestor
102070491|NCT05211583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102070492|NCT05211583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070493|NCT04031599|Hormones|hormones|mesh-list
102070494|NCT04031599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070495|NCT04031599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102070496|NCT04724759|Lidocaine|lidocaine|mesh-list
102070497|NCT04724759|Dexmedetomidine|dexmedetomidine|mesh-list
102070498|NCT04724759|Ketamine|ketamine|mesh-list
102070499|NCT04724759|Anesthetics, Local|anesthetics, local|mesh-ancestor
102070500|NCT04724759|Anesthetics|anesthetics|mesh-ancestor
102070501|NCT04724759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102070502|NCT04724759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070503|NCT04724759|Sensory System Agents|sensory system agents|mesh-ancestor
102070504|NCT04724759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102070505|NCT04724759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102070506|NCT04724759|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102070507|NCT04724759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101943092|NCT01235637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101943093|NCT01235637|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101943094|NCT01235637|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101443832|NCT00199017|Cytarabine|cytarabine|mesh-list
102070508|NCT04724759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102070509|NCT04724759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070510|NCT04724759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102070511|NCT04724759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102070512|NCT04724759|Analgesics|analgesics|mesh-ancestor
102070513|NCT04724759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102070514|NCT04724759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102070515|NCT04724759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102070516|NCT04724759|Adrenergic Agents|adrenergic agents|mesh-ancestor
102070517|NCT04724759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102070518|NCT04724759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102070519|NCT04724759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102070526|NCT04019821|Insulin Lispro|insulin lispro|mesh-list
102070527|NCT04019821|Insulin glulisine|insulin glulisine|mesh-list
102070528|NCT04019821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102070529|NCT04019821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070530|NCT05186467|Magnesium Sulfate|magnesium sulfate|mesh-list
102070531|NCT05186467|Analgesics|analgesics|mesh-ancestor
102070532|NCT05186467|Sensory System Agents|sensory system agents|mesh-ancestor
102070533|NCT05186467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102070534|NCT05186467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070535|NCT05186467|Anesthetics|anesthetics|mesh-ancestor
102070536|NCT05186467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102070537|NCT05186467|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102070538|NCT05186467|Anticonvulsants|anticonvulsants|mesh-ancestor
102070539|NCT05186467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102070540|NCT05186467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102070541|NCT05186467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070542|NCT05186467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102070543|NCT05186467|Tocolytic Agents|tocolytic agents|mesh-ancestor
102070544|NCT05186467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102070545|NCT00771134|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102070546|NCT00771134|Antidepressive Agents|antidepressive agents|mesh-ancestor
102070547|NCT00771134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102070548|NCT00771134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102070549|NCT00771134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102070550|NCT00771134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102070551|NCT00771134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070552|NCT00768482|Buprenorphine|buprenorphine|mesh-list
102070553|NCT00768482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102070554|NCT00768482|Narcotics|narcotics|mesh-ancestor
102070555|NCT00768482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102070556|NCT00768482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070557|NCT00768482|Analgesics|analgesics|mesh-ancestor
102070558|NCT00768482|Sensory System Agents|sensory system agents|mesh-ancestor
102070559|NCT00768482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102070560|NCT00768482|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102070561|NCT00840866|Cefprozil|cefprozil|mesh-list
102070562|NCT00840866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102070563|NCT00840866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102070564|NCT05043116|Vitamin D|vitamin d|mesh-list
102070565|NCT05043116|Cholecalciferol|cholecalciferol|mesh-list
102070566|NCT05043116|Vitamins|vitamins|mesh-ancestor
102070567|NCT05043116|Micronutrients|micronutrients|mesh-ancestor
102070568|NCT05043116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070569|NCT05043116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102070570|NCT05043116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102070571|NCT00840632|Trandolapril|trandolapril|mesh-list
102070572|NCT00840632|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102070573|NCT00840632|Protease Inhibitors|protease inhibitors|mesh-ancestor
102070574|NCT00840632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102070575|NCT00840632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070576|NCT00840632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102070577|NCT00840476|Meloxicam|meloxicam|mesh-list
102070578|NCT00840476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101943095|NCT01235637|Anesthetics, General|anesthetics, general|mesh-ancestor
101943097|NCT01143831|Vitamins|vitamins|mesh-list
101943098|NCT01143831|Vitamin K|vitamin k|mesh-list
101943099|NCT01143831|Vitamin K 2|vitamin k 2|mesh-list
101943100|NCT01143831|Menatetrenone|menatetrenone|mesh-list
101943101|NCT01143831|Micronutrients|micronutrients|mesh-ancestor
101943102|NCT01143831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943103|NCT01143831|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101943104|NCT01143831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102070579|NCT00840476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102070580|NCT00840476|Analgesics|analgesics|mesh-ancestor
102070581|NCT00840476|Sensory System Agents|sensory system agents|mesh-ancestor
102070582|NCT00840476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102070583|NCT00840476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070584|NCT00840476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102070585|NCT00840476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102070586|NCT00840476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102070587|NCT00840476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102070588|NCT00840476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101372162|NCT02963116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102070593|NCT00765830|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102070594|NCT00765830|Protease Inhibitors|protease inhibitors|mesh-ancestor
102070595|NCT00765830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102070596|NCT00765830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070597|NCT03664869|Mitomycins|mitomycins|mesh-list
102070598|NCT03664869|Mitomycin|mitomycin|mesh-list
102070599|NCT03664869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102070600|NCT03664869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102070601|NCT03664869|Alkylating Agents|alkylating agents|mesh-ancestor
102070602|NCT03664869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070603|NCT03664869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102070604|NCT03664869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102070605|NCT00953420|Dexamethasone|dexamethasone|mesh-list
102070606|NCT00953420|Carboplatin|carboplatin|mesh-list
102070607|NCT00953420|Docetaxel|docetaxel|mesh-list
102070608|NCT00953420|Lenograstim|lenograstim|mesh-list
102070609|NCT00953420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102070610|NCT00953420|Antiemetics|antiemetics|mesh-ancestor
102070611|NCT00953420|Autonomic Agents|autonomic agents|mesh-ancestor
102070612|NCT00953420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102070613|NCT00953420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790363|NCT00895128|Dasatinib|dasatinib|mesh-list
102070614|NCT00953420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102070615|NCT00953420|Glucocorticoids|glucocorticoids|mesh-ancestor
102070616|NCT00953420|Hormones|hormones|mesh-ancestor
102070617|NCT00953420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102070618|NCT00953420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102070619|NCT00953420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102070620|NCT00953420|Tubulin Modulators|tubulin modulators|mesh-ancestor
102070621|NCT00953420|Antimitotic Agents|antimitotic agents|mesh-ancestor
102070622|NCT00953420|Mitosis Modulators|mitosis modulators|mesh-ancestor
102070623|NCT00953420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070624|NCT00953420|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102070625|NCT00953420|Immunologic Factors|immunologic factors|mesh-ancestor
102070626|NCT01602562|Valacyclovir|valacyclovir|mesh-list
102070627|NCT01602562|Antiviral Agents|antiviral agents|mesh-ancestor
102070628|NCT01602562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102070629|NCT01945775|Talazoparib|talazoparib|mesh-list
102070630|NCT01945775|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102070631|NCT01945775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102070632|NCT01945775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070633|NCT01945775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102070634|NCT00839930|Cilostazol|cilostazol|mesh-list
102070635|NCT00839930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102070636|NCT00839930|Autonomic Agents|autonomic agents|mesh-ancestor
102070637|NCT00839930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102070638|NCT00839930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943105|NCT01143831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943106|NCT01143831|Hemostatics|hemostatics|mesh-ancestor
101943107|NCT01143831|Coagulants|coagulants|mesh-ancestor
102070639|NCT00839930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102070640|NCT00839930|Respiratory System Agents|respiratory system agents|mesh-ancestor
102070641|NCT00839930|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102070642|NCT00839930|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102070643|NCT00839930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070644|NCT00839930|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102070645|NCT00839930|Vasodilator Agents|vasodilator agents|mesh-ancestor
102070646|NCT00839930|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102070647|NCT00839930|Protective Agents|protective agents|mesh-ancestor
102070648|NCT00839930|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102070649|NCT00839930|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102070650|NCT00839930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102070651|NCT00838136|Lamotrigine|lamotrigine|mesh-list
102070652|NCT00838136|Anticonvulsants|anticonvulsants|mesh-ancestor
102070653|NCT00838136|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102070654|NCT00838136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102070655|NCT00838136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070656|NCT00838136|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101372231|NCT00084240|Filaricides|filaricides|mesh-ancestor
102070665|NCT00944294|Analgesics|analgesics|mesh-ancestor
102070666|NCT00944294|Sensory System Agents|sensory system agents|mesh-ancestor
102070667|NCT00944294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102070668|NCT00944294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070669|NCT00944294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102070670|NCT00944294|Vasodilator Agents|vasodilator agents|mesh-ancestor
102070671|NCT00944294|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102070672|NCT00944294|Purinergic Agonists|purinergic agonists|mesh-ancestor
102070673|NCT00944294|Purinergic Agents|purinergic agents|mesh-ancestor
102070674|NCT00944294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102070675|NCT00944294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070676|NCT00758966|Naltrexone|naltrexone|mesh-list
102070677|NCT00758966|Fluoxetine|fluoxetine|mesh-list
102070678|NCT00758966|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102070679|NCT00758966|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102070680|NCT00758966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070681|NCT00758966|Sensory System Agents|sensory system agents|mesh-ancestor
102070682|NCT00758966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102070683|NCT00758966|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102070684|NCT00758966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102070685|NCT00758966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102070686|NCT00758966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070687|NCT00758966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102070688|NCT00758966|Serotonin Agents|serotonin agents|mesh-ancestor
102070689|NCT00758966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102070690|NCT00758966|Antidepressive Agents|antidepressive agents|mesh-ancestor
102070691|NCT00758966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102070692|NCT00758966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102070693|NCT00758966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102070694|NCT00758966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102070695|NCT03072719|Fluorides|fluorides|mesh-list
102070696|NCT03072719|Tin Fluorides|tin fluorides|mesh-list
102070697|NCT03072719|Fluorophosphate|fluorophosphate|mesh-list
102070698|NCT03072719|Cariostatic Agents|cariostatic agents|mesh-ancestor
102070699|NCT03072719|Protective Agents|protective agents|mesh-ancestor
102070700|NCT03072719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070701|NCT05106400|Lidocaine|lidocaine|mesh-list
102070702|NCT05106400|Menthol|menthol|mesh-list
102070703|NCT05106400|Anesthetics, Local|anesthetics, local|mesh-ancestor
102070704|NCT05106400|Anesthetics|anesthetics|mesh-ancestor
102070705|NCT05106400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102070706|NCT05106400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070707|NCT05106400|Sensory System Agents|sensory system agents|mesh-ancestor
102070708|NCT05106400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102070709|NCT05106400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102070710|NCT05106400|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102070711|NCT05106400|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102070712|NCT05106400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101943109|NCT04966299|Vasodilator Agents|vasodilator agents|mesh-ancestor
101943110|NCT01143987|Cinacalcet|cinacalcet|mesh-list
101943111|NCT01143987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102070713|NCT05106400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070714|NCT05106400|Antipruritics|antipruritics|mesh-ancestor
102070715|NCT05106400|Dermatologic Agents|dermatologic agents|mesh-ancestor
102070716|NCT00754988|Metformin|metformin|mesh-list
102070717|NCT00754988|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102070718|NCT00754988|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102070719|NCT00754988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102070720|NCT00754988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070721|NCT00754988|Incretins|incretins|mesh-ancestor
102070722|NCT00754988|Hormones|hormones|mesh-ancestor
102070723|NCT00754988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102070730|NCT01416935|Vasodilator Agents|vasodilator agents|mesh-ancestor
102070731|NCT01416935|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102070732|NCT01416935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102070733|NCT01416935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070734|NCT01416935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102070735|NCT01416935|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102070736|NCT01416935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102070737|NCT01416935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102070738|NCT01416935|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102070739|NCT01416935|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102070740|NCT01416935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102070741|NCT05012566|Botulinum Toxins|botulinum toxins|mesh-list
102070742|NCT05012566|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102070743|NCT05012566|Hyaluronic Acid|hyaluronic acid|mesh-list
102070744|NCT05012566|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102070745|NCT05012566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102070746|NCT05012566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070747|NCT05012566|Cholinergic Agents|cholinergic agents|mesh-ancestor
102070748|NCT05012566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102070749|NCT05012566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070750|NCT05012566|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102070751|NCT05012566|Immunologic Factors|immunologic factors|mesh-ancestor
102070752|NCT05012566|Viscosupplements|viscosupplements|mesh-ancestor
102070753|NCT05012566|Protective Agents|protective agents|mesh-ancestor
102070754|NCT05012566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102070755|NCT05012566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102070756|NCT05202665|Fluorides|fluorides|mesh-list
102070757|NCT05202665|Fluorides, Topical|fluorides, topical|mesh-list
102070758|NCT05202665|Cariostatic Agents|cariostatic agents|mesh-ancestor
102070759|NCT05202665|Protective Agents|protective agents|mesh-ancestor
102070760|NCT05202665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070761|NCT04438772|Anesthetics|anesthetics|mesh-list
101790506|NCT00900744|Tamoxifen|tamoxifen|mesh-list
102070762|NCT04438772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102070763|NCT04438772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070764|NCT04560634|Norepinephrine|norepinephrine|mesh-list
102070765|NCT04560634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102070766|NCT04560634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102070767|NCT04560634|Adrenergic Agents|adrenergic agents|mesh-ancestor
102070768|NCT04560634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102070769|NCT04560634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070770|NCT04560634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070771|NCT04560634|Sympathomimetics|sympathomimetics|mesh-ancestor
102070772|NCT04560634|Autonomic Agents|autonomic agents|mesh-ancestor
102070773|NCT04560634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102070774|NCT04560634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102070775|NCT00927914|Ranirestat|ranirestat|mesh-list
102070776|NCT00927914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102070777|NCT00927914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070778|NCT05261464|Metoprolol|metoprolol|mesh-list
102070779|NCT05261464|Diltiazem|diltiazem|mesh-list
102070780|NCT05261464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102070781|NCT05261464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102070782|NCT05261464|Sympatholytics|sympatholytics|mesh-ancestor
102070783|NCT05261464|Autonomic Agents|autonomic agents|mesh-ancestor
102070784|NCT05261464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101943112|NCT01143987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943113|NCT01143987|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101943114|NCT01143987|Hormone Antagonists|hormone antagonists|mesh-ancestor
101971926|NCT04470310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701658|NCT02732093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102070785|NCT05261464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070786|NCT05261464|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102070787|NCT05261464|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102070788|NCT05261464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102070789|NCT05261464|Adrenergic Agents|adrenergic agents|mesh-ancestor
102070794|NCT05261464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102070795|NCT05261464|Vasodilator Agents|vasodilator agents|mesh-ancestor
102070796|NCT05681377|Flumazenil|flumazenil|mesh-list
102070797|NCT05681377|Antidotes|antidotes|mesh-ancestor
102070798|NCT05681377|Protective Agents|protective agents|mesh-ancestor
102070799|NCT05681377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070800|NCT05681377|GABA Modulators|gaba modulators|mesh-ancestor
102070801|NCT05681377|GABA Agents|gaba agents|mesh-ancestor
102070802|NCT05681377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102070803|NCT05681377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070804|NCT00835796|Finasteride|finasteride|mesh-list
102070805|NCT00835796|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102070806|NCT00835796|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102070807|NCT00835796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102070808|NCT00835796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070809|NCT00835796|Hormone Antagonists|hormone antagonists|mesh-ancestor
102070810|NCT00835796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102070811|NCT00835796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070812|NCT00835796|Urological Agents|urological agents|mesh-ancestor
102070813|NCT05106712|Vitamin D|vitamin d|mesh-list
102070814|NCT05106712|Cholecalciferol|cholecalciferol|mesh-list
102070815|NCT05106712|Letrozole|letrozole|mesh-list
102070816|NCT05106712|Clomiphene|clomiphene|mesh-list
102070817|NCT05106712|Enclomiphene|enclomiphene|mesh-list
102070818|NCT05106712|Zuclomiphene|zuclomiphene|mesh-list
102070819|NCT05106712|Vitamins|vitamins|mesh-ancestor
102070820|NCT05106712|Micronutrients|micronutrients|mesh-ancestor
102070821|NCT05106712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070822|NCT05106712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102070823|NCT05106712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070824|NCT05106712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102070825|NCT05106712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102070826|NCT05106712|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102070827|NCT05106712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102070828|NCT05106712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102070829|NCT05106712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102070830|NCT05106712|Hormone Antagonists|hormone antagonists|mesh-ancestor
102070831|NCT05106712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102070832|NCT05106712|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102070833|NCT05106712|Fertility Agents|fertility agents|mesh-ancestor
102070834|NCT05106712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102070835|NCT05106712|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102070836|NCT05106712|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102070838|NCT05105698|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102070839|NCT05105698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
102070840|NCT05105698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070841|NCT05105698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102070842|NCT05105698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070843|NCT05105698|Protease Inhibitors|protease inhibitors|mesh-ancestor
102070844|NCT05105698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102070845|NCT00835640|Fexofenadine|fexofenadine|mesh-list
102070846|NCT00835640|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102070847|NCT00835640|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102070848|NCT00835640|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101701670|NCT00718354|Cisplatin|cisplatin|mesh-list
102070849|NCT00835640|Histamine Antagonists|histamine antagonists|mesh-ancestor
102070850|NCT00835640|Histamine Agents|histamine agents|mesh-ancestor
102070851|NCT00835640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102070852|NCT00835640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070853|NCT00835640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943115|NCT01143987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101943117|NCT01144065|Testosterone|testosterone|mesh-list
101943118|NCT01144065|Androgens|androgens|mesh-ancestor
101943119|NCT01144065|Hormones|hormones|mesh-ancestor
101943120|NCT01144065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101943121|NCT01144065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943122|NCT01144065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101943123|NCT01142505|Mannitol|mannitol|mesh-list
101943124|NCT01142505|Montelukast|montelukast|mesh-list
101943125|NCT01142505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101943126|NCT01142505|Respiratory System Agents|respiratory system agents|mesh-ancestor
101943127|NCT01142505|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102070854|NCT00752570|Trebananib|trebananib|mesh-list
102070855|NCT00752570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102070856|NCT00752570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102070857|NCT00752570|Growth Substances|growth substances|mesh-ancestor
102070858|NCT00752570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070866|NCT05083000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102070867|NCT00752258|Botulinum Toxins|botulinum toxins|mesh-list
102070868|NCT00752258|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102070869|NCT00752258|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102070870|NCT00752258|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102070871|NCT00752258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102070872|NCT00752258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070873|NCT00752258|Cholinergic Agents|cholinergic agents|mesh-ancestor
102070874|NCT00752258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102070875|NCT00752258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070876|NCT00752258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102070877|NCT00752258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102070878|NCT02942017|Brexanolone|brexanolone|mesh-list
102070879|NCT02942017|Neurosteroids|neurosteroids|mesh-ancestor
102070880|NCT02942017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102070881|NCT02942017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070882|NCT02942017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070883|NCT02942017|GABA Modulators|gaba modulators|mesh-ancestor
102070884|NCT02942017|GABA Agents|gaba agents|mesh-ancestor
102070885|NCT04447781|Citric Acid|citric acid|mesh-list
102070886|NCT04447781|Sodium Citrate|sodium citrate|mesh-list
102070887|NCT04447781|Anticoagulants|anticoagulants|mesh-ancestor
102070888|NCT04447781|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102070889|NCT04447781|Chelating Agents|chelating agents|mesh-ancestor
102070890|NCT04447781|Sequestering Agents|sequestering agents|mesh-ancestor
102070891|NCT04447781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070892|NCT04364776|Durvalumab|durvalumab|mesh-list
102070893|NCT04364776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102070894|NCT04364776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102070895|NCT00835484|Cefdinir|cefdinir|mesh-list
102070896|NCT00835484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102070897|NCT00835484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102070898|NCT00835406|Alendronate|alendronate|mesh-list
102070899|NCT00835406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102070900|NCT00835406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070901|NCT05202275|Olanzapine|olanzapine|mesh-list
102070902|NCT05202275|Aprepitant|aprepitant|mesh-list
102070903|NCT05202275|Palonosetron|palonosetron|mesh-list
102070904|NCT05202275|Antiemetics|antiemetics|mesh-ancestor
102070905|NCT05202275|Autonomic Agents|autonomic agents|mesh-ancestor
102070906|NCT05202275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102070907|NCT05202275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070908|NCT05202275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102070909|NCT05202275|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102070910|NCT05202275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101943128|NCT01142505|Hormone Antagonists|hormone antagonists|mesh-ancestor
101943129|NCT01142505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101943130|NCT01142505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070911|NCT05202275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102070913|NCT05202275|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102070914|NCT05202275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102070915|NCT05202275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102070916|NCT05202275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070917|NCT05202275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102070918|NCT05202275|Serotonin Agents|serotonin agents|mesh-ancestor
102070919|NCT05202275|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102070920|NCT05202275|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102070921|NCT05202275|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102070922|NCT04369937|Pembrolizumab|pembrolizumab|mesh-list
102070923|NCT04369937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102070924|NCT04369937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102070925|NCT04369937|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102070926|NCT04369937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070941|NCT00745316|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102070942|NCT00744926|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102070943|NCT00744926|Incretins|incretins|mesh-ancestor
102070944|NCT00744926|Hormones|hormones|mesh-ancestor
102070945|NCT00744926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102070946|NCT00744926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070947|NCT03838744|Olaparib|olaparib|mesh-list
102070948|NCT03838744|Trabectedin|trabectedin|mesh-list
102070949|NCT03838744|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102070950|NCT03838744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102070951|NCT03838744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070952|NCT03838744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102070953|NCT03838744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102070954|NCT03838744|Alkylating Agents|alkylating agents|mesh-ancestor
102070955|NCT05327348|Ascorbic Acid|ascorbic acid|mesh-list
102070956|NCT05327348|Antioxidants|antioxidants|mesh-ancestor
102070957|NCT05327348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070958|NCT05327348|Protective Agents|protective agents|mesh-ancestor
102070959|NCT05327348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070960|NCT05327348|Vitamins|vitamins|mesh-ancestor
102070961|NCT05327348|Micronutrients|micronutrients|mesh-ancestor
102070962|NCT04695106|Aspirin|aspirin|mesh-list
102070963|NCT04695106|Dabigatran|dabigatran|mesh-list
102070964|NCT04695106|Clopidogrel|clopidogrel|mesh-list
102070965|NCT04695106|Ticagrelor|ticagrelor|mesh-list
102070966|NCT04695106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102070967|NCT04695106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102070968|NCT04695106|Analgesics|analgesics|mesh-ancestor
102070969|NCT04695106|Sensory System Agents|sensory system agents|mesh-ancestor
102070970|NCT04695106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102070971|NCT04695106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070972|NCT04695106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102070973|NCT04695106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102070974|NCT04695106|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102070975|NCT04695106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102070976|NCT04695106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070977|NCT04695106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101701703|NCT04067986|Apatinib|apatinib|mesh-list
102070978|NCT04695106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102070979|NCT04695106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102070980|NCT04695106|Antipyretics|antipyretics|mesh-ancestor
102070981|NCT04695106|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102070982|NCT04695106|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102070983|NCT04695106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102070984|NCT04695106|Purinergic Agents|purinergic agents|mesh-ancestor
102070985|NCT04695106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102070986|NCT04695106|Antithrombins|antithrombins|mesh-ancestor
102070992|NCT04032665|Antithrombins|antithrombins|mesh-ancestor
102070993|NCT04032665|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102070994|NCT04032665|Protease Inhibitors|protease inhibitors|mesh-ancestor
102070995|NCT04032665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101943131|NCT01142505|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101943132|NCT01142505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101971927|NCT02083250|Fludarabine|fludarabine|mesh-list
102070996|NCT04032665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070997|NCT04032665|Anticoagulants|anticoagulants|mesh-ancestor
102070999|NCT03629639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102071000|NCT03629639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071001|NCT00835172|Glimepiride|glimepiride|mesh-list
102071002|NCT00835172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102071003|NCT00835172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102071004|NCT00835172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071005|NCT00835172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102071006|NCT00835172|Immunologic Factors|immunologic factors|mesh-ancestor
102071007|NCT04941755|Famotidine|famotidine|mesh-list
102071008|NCT04941755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102071009|NCT04941755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102071010|NCT04941755|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102071011|NCT04941755|Histamine Antagonists|histamine antagonists|mesh-ancestor
102071012|NCT04941755|Histamine Agents|histamine agents|mesh-ancestor
102071013|NCT04941755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102071014|NCT04941755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071015|NCT04941755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071016|NCT04921735|Cisatracurium|cisatracurium|mesh-list
102071017|NCT04921735|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102071018|NCT04921735|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102071019|NCT04921735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102071020|NCT04921735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071021|NCT01676116|Liraglutide|liraglutide|mesh-list
102071022|NCT01676116|Exenatide|exenatide|mesh-list
102071023|NCT01676116|Xultophy|xultophy|mesh-list
102071024|NCT01676116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102071025|NCT01676116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071026|NCT01676116|Incretins|incretins|mesh-ancestor
102071027|NCT01676116|Hormones|hormones|mesh-ancestor
102071028|NCT01676116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102071029|NCT01676116|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102071030|NCT05200793|Metformin|metformin|mesh-list
102071031|NCT05200793|Empagliflozin|empagliflozin|mesh-list
102071032|NCT05200793|Linagliptin|linagliptin|mesh-list
102071033|NCT05200793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102071034|NCT05200793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071035|NCT05200793|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102071036|NCT05200793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071037|NCT05200793|Incretins|incretins|mesh-ancestor
102071038|NCT05200793|Hormones|hormones|mesh-ancestor
102071039|NCT05200793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102071040|NCT05200793|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102071041|NCT05200793|Protease Inhibitors|protease inhibitors|mesh-ancestor
102071042|NCT05200793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102071043|NCT03383224|Nicotine|nicotine|mesh-list
102071044|NCT03383224|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102071045|NCT03383224|Autonomic Agents|autonomic agents|mesh-ancestor
102071046|NCT03383224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102071047|NCT03383224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071048|NCT03383224|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102071049|NCT03383224|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102071050|NCT03383224|Cholinergic Agents|cholinergic agents|mesh-ancestor
102071051|NCT03383224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102071052|NCT03383224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071053|NCT04699357|Atropine|atropine|mesh-list
102071054|NCT04699357|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102071055|NCT04699357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102071056|NCT04699357|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101790808|NCT00927654|Iloprost|iloprost|mesh-list
102071057|NCT04699357|Autonomic Agents|autonomic agents|mesh-ancestor
102071069|NCT03030118|Hydroxychloroquine|hydroxychloroquine|mesh-list
102071070|NCT03030118|Antimalarials|antimalarials|mesh-ancestor
102071071|NCT03030118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102071072|NCT03030118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102071073|NCT03030118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102071074|NCT03030118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102071075|NCT03030118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071076|NCT03030118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101943133|NCT01142505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071078|NCT05198531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102071079|NCT05198531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102071080|NCT05198531|Antimetabolites|antimetabolites|mesh-ancestor
102071081|NCT05198531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071082|NCT01869829|Antifungal Agents|antifungal agents|mesh-list
102071083|NCT01869829|Clotrimazole|clotrimazole|mesh-list
102071084|NCT01869829|Miconazole|miconazole|mesh-list
102071085|NCT01869829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102071086|NCT01869829|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102071087|NCT01869829|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102071088|NCT01869829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102071089|NCT01869829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102071090|NCT01869829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071091|NCT01869829|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102071092|NCT01869829|Hormone Antagonists|hormone antagonists|mesh-ancestor
102071093|NCT01869829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102071094|NCT01869829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071095|NCT01869829|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102071096|NCT01869829|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102071097|NCT02683018|Dronabinol|dronabinol|mesh-list
102071098|NCT02683018|Hallucinogens|hallucinogens|mesh-ancestor
102071099|NCT02683018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071100|NCT02683018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102071101|NCT02683018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102071102|NCT02683018|Analgesics|analgesics|mesh-ancestor
102071103|NCT02683018|Sensory System Agents|sensory system agents|mesh-ancestor
102071104|NCT02683018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102071105|NCT02683018|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102071106|NCT02683018|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102071107|NCT02683018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102071108|NCT02683018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071109|NCT02683018|Hormones|hormones|mesh-ancestor
102071110|NCT02683018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102071111|NCT03982576|Nicotine|nicotine|mesh-list
102071112|NCT03982576|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102071113|NCT03982576|Autonomic Agents|autonomic agents|mesh-ancestor
102071114|NCT03982576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102071115|NCT03982576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071116|NCT03982576|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102071117|NCT03982576|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101372702|NCT00084708|Glucocorticoids|glucocorticoids|mesh-ancestor
102071126|NCT02675842|Dronabinol|dronabinol|mesh-list
102071127|NCT02675842|Hallucinogens|hallucinogens|mesh-ancestor
102071128|NCT02675842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071129|NCT02675842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102071130|NCT02675842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102071131|NCT02675842|Analgesics|analgesics|mesh-ancestor
102071132|NCT02675842|Sensory System Agents|sensory system agents|mesh-ancestor
102071133|NCT02675842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102071134|NCT02675842|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102071135|NCT02675842|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102071136|NCT02675842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102071137|NCT02675842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071138|NCT02675842|Hormones|hormones|mesh-ancestor
102071139|NCT02675842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102071140|NCT04528108|Hemostatics|hemostatics|mesh-list
102071141|NCT04528108|Coagulants|coagulants|mesh-ancestor
102071142|NCT04251689|Mannitol|mannitol|mesh-list
102071143|NCT04251689|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102071144|NCT04251689|Diuretics|diuretics|mesh-ancestor
102071145|NCT04251689|Natriuretic Agents|natriuretic agents|mesh-ancestor
102071146|NCT04251689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071147|NCT04232423|Olanzapine|olanzapine|mesh-list
102071148|NCT04232423|Antiemetics|antiemetics|mesh-ancestor
102071149|NCT04232423|Autonomic Agents|autonomic agents|mesh-ancestor
102071150|NCT04232423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102071151|NCT04232423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071152|NCT04232423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102071153|NCT04232423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102071154|NCT04232423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101943134|NCT01142505|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101943135|NCT01142505|Diuretics|diuretics|mesh-ancestor
102071155|NCT04232423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102071156|NCT04232423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102071157|NCT04232423|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102071158|NCT04232423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102071159|NCT04232423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102071160|NCT04232423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071161|NCT04232423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102071162|NCT04232423|Serotonin Agents|serotonin agents|mesh-ancestor
102071163|NCT04178993|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102071164|NCT04178993|Methylphenidate|methylphenidate|mesh-list
102071165|NCT04178993|Methamphetamine|methamphetamine|mesh-list
102071166|NCT04178993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102071167|NCT04178993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071168|NCT04178993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102071169|NCT04178993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102071170|NCT04178993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102071171|NCT04178993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071172|NCT04178993|Dopamine Agents|dopamine agents|mesh-ancestor
102071173|NCT04178993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101701737|NCT02730845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102071174|NCT04178993|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102071175|NCT04178993|Analgesics|analgesics|mesh-ancestor
102071176|NCT04178993|Sensory System Agents|sensory system agents|mesh-ancestor
102071177|NCT04178993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102071178|NCT04178993|Antidepressive Agents|antidepressive agents|mesh-ancestor
102071179|NCT04178993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102071180|NCT04178993|Sympathomimetics|sympathomimetics|mesh-ancestor
102071181|NCT04178993|Autonomic Agents|autonomic agents|mesh-ancestor
102071182|NCT04178993|Adrenergic Agents|adrenergic agents|mesh-ancestor
102071186|NCT04436536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071187|NCT04436536|Sympathomimetics|sympathomimetics|mesh-ancestor
102071188|NCT04436536|Autonomic Agents|autonomic agents|mesh-ancestor
102071189|NCT04436536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102071190|NCT04436536|Dopamine Agents|dopamine agents|mesh-ancestor
102071191|NCT04436536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102071192|NCT04436536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071193|NCT04436536|Adrenergic Agents|adrenergic agents|mesh-ancestor
102071194|NCT04436536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102071195|NCT04436536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102071196|NCT04436536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102071197|NCT04436536|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102071198|NCT05762003|Interferons|interferons|mesh-list
102071199|NCT05762003|Teriflunomide|teriflunomide|mesh-list
102071201|NCT05762003|Alemtuzumab|alemtuzumab|mesh-list
102071202|NCT05762003|Ofatumumab|ofatumumab|mesh-list
102071203|NCT05762003|Cladribine|cladribine|mesh-list
102071204|NCT05762003|Glatiramer Acetate|glatiramer acetate|mesh-list
101575043|NCT05215873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102071205|NCT05762003|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102071206|NCT05762003|Ocrelizumab|ocrelizumab|mesh-list
102071207|NCT05762003|Natalizumab|natalizumab|mesh-list
102071208|NCT05762003|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102071209|NCT05762003|(T,G)-A-L|(t,g)-a-l|mesh-list
102071210|NCT05762003|Ponesimod|ponesimod|mesh-list
102071211|NCT05762003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102071212|NCT05762003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102071213|NCT05762003|Immunologic Factors|immunologic factors|mesh-ancestor
102071214|NCT05762003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071215|NCT05762003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102071216|NCT05762003|Antiviral Agents|antiviral agents|mesh-ancestor
102071217|NCT05762003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102071218|NCT05762003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102071219|NCT05762003|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102071220|NCT05762003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071221|NCT05762003|Dermatologic Agents|dermatologic agents|mesh-ancestor
102071222|NCT05762003|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102071223|NCT05762003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102071224|NCT05762003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102071225|NCT05762003|Analgesics|analgesics|mesh-ancestor
102071226|NCT05762003|Sensory System Agents|sensory system agents|mesh-ancestor
102071227|NCT05762003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101943136|NCT01142505|Natriuretic Agents|natriuretic agents|mesh-ancestor
101943137|NCT01236963|Listerine|listerine|mesh-list
101943138|NCT01236963|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102071228|NCT05762003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102071229|NCT04094012|Isoniazid|isoniazid|mesh-list
102071230|NCT04094012|Rifapentine|rifapentine|mesh-list
102071231|NCT04094012|Antitubercular Agents|antitubercular agents|mesh-ancestor
102071232|NCT04094012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102071233|NCT04094012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102071234|NCT04094012|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102071235|NCT04094012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102071236|NCT04094012|Antimetabolites|antimetabolites|mesh-ancestor
102071237|NCT04094012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071238|NCT04094012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101701753|NCT03579316|Olaparib|olaparib|mesh-list
102071239|NCT04094012|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102071240|NCT04094012|Leprostatic Agents|leprostatic agents|mesh-ancestor
102071241|NCT03679676|Omalizumab|omalizumab|mesh-list
102071242|NCT03679676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102071243|NCT03679676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102071244|NCT03679676|Respiratory System Agents|respiratory system agents|mesh-ancestor
102071245|NCT03001557|Lemborexant|lemborexant|mesh-list
102071246|NCT03001557|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102071247|NCT03001557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102071248|NCT03001557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071249|NCT03001557|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102071250|NCT03001557|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102071251|NCT03001557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102071252|NCT03001557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071253|NCT03134612|Lidocaine|lidocaine|mesh-list
102071254|NCT03134612|Ondansetron|ondansetron|mesh-list
102071261|NCT03134612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102071262|NCT03134612|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102071263|NCT03134612|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102071264|NCT03134612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102071265|NCT03134612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071266|NCT03134612|Antiemetics|antiemetics|mesh-ancestor
102071267|NCT03134612|Autonomic Agents|autonomic agents|mesh-ancestor
102071268|NCT03134612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102071269|NCT03134612|Antipruritics|antipruritics|mesh-ancestor
102071270|NCT03134612|Dermatologic Agents|dermatologic agents|mesh-ancestor
102071271|NCT03134612|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102071272|NCT03134612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102071273|NCT03134612|Serotonin Agents|serotonin agents|mesh-ancestor
102071274|NCT03134612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102071275|NCT00831662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102071276|NCT00831662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102071278|NCT04365985|Ketamine|ketamine|mesh-list
102071279|NCT04365985|Analgesics|analgesics|mesh-ancestor
102071280|NCT04365985|Sensory System Agents|sensory system agents|mesh-ancestor
102071281|NCT04365985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102071282|NCT04365985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071283|NCT04365985|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102071284|NCT04365985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102071285|NCT04365985|Anesthetics, General|anesthetics, general|mesh-ancestor
102071286|NCT04365985|Anesthetics|anesthetics|mesh-ancestor
102071287|NCT04365985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102071288|NCT04365985|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102071289|NCT04365985|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102071290|NCT04365985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102071291|NCT04365985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071292|NCT04365985|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102071293|NCT04365985|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102071294|NCT05111860|Bevacizumab|bevacizumab|mesh-list
102071295|NCT05111860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102071296|NCT05111860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102071297|NCT05111860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102071298|NCT05111860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102071299|NCT05111860|Growth Substances|growth substances|mesh-ancestor
102071300|NCT05111860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071301|NCT05111860|Growth Inhibitors|growth inhibitors|mesh-ancestor
102071302|NCT00830336|Azithromycin|azithromycin|mesh-list
102071303|NCT00830336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101943139|NCT01236963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101943140|NCT02908672|Atezolizumab|atezolizumab|mesh-list
101943141|NCT02908672|Vemurafenib|vemurafenib|mesh-list
101662969|NCT00869869|Melatonin|melatonin|mesh-list
101308035|NCT02045069|Ivermectin|ivermectin|mesh-list
102071304|NCT00830336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102071305|NCT00830258|Pravastatin|pravastatin|mesh-list
102071306|NCT00830258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101701759|NCT02730533|Esomeprazole|esomeprazole|mesh-list
102071307|NCT00830258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102071308|NCT00830258|Antimetabolites|antimetabolites|mesh-ancestor
102071309|NCT00830258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071310|NCT00830258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102071311|NCT00830258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102071312|NCT00830258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102071313|NCT00830102|Fluticasone|fluticasone|mesh-list
102071314|NCT00830102|Xhance|xhance|mesh-list
102071315|NCT00830102|Formoterol Fumarate|formoterol fumarate|mesh-list
102071316|NCT00830102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102071317|NCT00830102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102071318|NCT00830102|Autonomic Agents|autonomic agents|mesh-ancestor
102071319|NCT00830102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102071320|NCT00830102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071321|NCT00830102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102071322|NCT00830102|Respiratory System Agents|respiratory system agents|mesh-ancestor
102071336|NCT00830024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102071338|NCT00830024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102071339|NCT00830024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102071340|NCT00830024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102071341|NCT00830024|GABA Modulators|gaba modulators|mesh-ancestor
102071342|NCT00830024|GABA Agents|gaba agents|mesh-ancestor
102071343|NCT00830024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102071344|NCT00830024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071345|NCT00829868|Zaleplon|zaleplon|mesh-list
102071346|NCT00829868|Anticonvulsants|anticonvulsants|mesh-ancestor
102071347|NCT00829868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102071348|NCT00829868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102071349|NCT00829868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071350|NCT00829868|GABA Modulators|gaba modulators|mesh-ancestor
102071351|NCT00829868|GABA Agents|gaba agents|mesh-ancestor
102071352|NCT00829868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102071353|NCT00829868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071354|NCT00721760|Enoxaparin|enoxaparin|mesh-list
102071355|NCT00721760|Semuloparin|semuloparin|mesh-list
102071356|NCT00721760|Enoxaparin sodium|enoxaparin sodium|mesh-list
102071357|NCT00721760|Anticoagulants|anticoagulants|mesh-ancestor
102071358|NCT00721760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102071359|NCT00721760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102071360|NCT00721760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071361|NCT04491370|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
102071362|NCT04491370|Immunoconjugates|immunoconjugates|mesh-ancestor
102071363|NCT04491370|Immunologic Factors|immunologic factors|mesh-ancestor
102071364|NCT04491370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071365|NCT00829790|Doxycycline|doxycycline|mesh-list
102071366|NCT00829790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102071367|NCT00829790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102071368|NCT00829790|Antimalarials|antimalarials|mesh-ancestor
102071369|NCT00829790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102071370|NCT00829790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102071371|NCT03207815|Prednisone|prednisone|mesh-list
102071372|NCT03207815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101701775|NCT03214250|Paclitaxel|paclitaxel|mesh-list
102071373|NCT03207815|Glucocorticoids|glucocorticoids|mesh-ancestor
102071374|NCT03207815|Hormones|hormones|mesh-ancestor
102071375|NCT03207815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102071376|NCT03207815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071377|NCT03207815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102071378|NCT03207815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102071379|NCT02911935|Azithromycin|azithromycin|mesh-list
102071380|NCT02911935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102071381|NCT02911935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102071382|NCT05193487|Anesthetics|anesthetics|mesh-list
102071383|NCT05193487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102071384|NCT05193487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071391|NCT00829712|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
101943142|NCT02908672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101943143|NCT02908672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101943144|NCT02908672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071392|NCT00829712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102071393|NCT00829712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071394|NCT00829712|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102071395|NCT00829712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102071396|NCT00829712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102071397|NCT00829712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071398|NCT00829712|Dopamine Agents|dopamine agents|mesh-ancestor
102071399|NCT00829712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102071400|NCT05079802|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102071401|NCT05079802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102071403|NCT05079802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102071404|NCT05079802|Antitubercular Agents|antitubercular agents|mesh-ancestor
102071405|NCT05079802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102071406|NCT05079802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102071407|NCT05079802|Antimetabolites|antimetabolites|mesh-ancestor
102071408|NCT05079802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071409|NCT05079802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102071410|NCT05079802|Chelating Agents|chelating agents|mesh-ancestor
102071411|NCT05079802|Sequestering Agents|sequestering agents|mesh-ancestor
102071412|NCT05079802|Hemostatics|hemostatics|mesh-ancestor
102071413|NCT05079802|Coagulants|coagulants|mesh-ancestor
102071414|NCT05203055|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102071415|NCT05203055|Interferon-alpha|interferon-alpha|mesh-list
102071416|NCT05203055|Antiviral Agents|antiviral agents|mesh-ancestor
102071417|NCT05203055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102071418|NCT05203055|Immunologic Factors|immunologic factors|mesh-ancestor
102071419|NCT05203055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071420|NCT03899636|Folfirinox|folfirinox|mesh-list
102071421|NCT03899636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102071422|NCT03386942|Farletuzumab|farletuzumab|mesh-list
102071423|NCT03386942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102071424|NCT04910230|Niacinamide|niacinamide|mesh-list
102071425|NCT04910230|Niacin|niacin|mesh-list
102071426|NCT04910230|Nicotinic Acids|nicotinic acids|mesh-list
102071427|NCT04910230|Vitamin B Complex|vitamin b complex|mesh-ancestor
102071428|NCT04910230|Vitamins|vitamins|mesh-ancestor
102071429|NCT04910230|Micronutrients|micronutrients|mesh-ancestor
101791188|NCT00717197|Capecitabine|capecitabine|mesh-list
102071430|NCT04910230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071431|NCT04910230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102071432|NCT04910230|Antimetabolites|antimetabolites|mesh-ancestor
102071433|NCT04910230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071434|NCT04910230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102071435|NCT04910230|Vasodilator Agents|vasodilator agents|mesh-ancestor
102071436|NCT04995094|Pembrolizumab|pembrolizumab|mesh-list
102071437|NCT04995094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102071438|NCT04995094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102071439|NCT04995094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102071440|NCT04995094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071442|NCT05202821|Fluorides, Topical|fluorides, topical|mesh-list
102071443|NCT05202821|Cariostatic Agents|cariostatic agents|mesh-ancestor
102071444|NCT05202821|Protective Agents|protective agents|mesh-ancestor
102071445|NCT05202821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071446|NCT02560805|Losartan|losartan|mesh-list
102071447|NCT02560805|Atenolol|atenolol|mesh-list
102071448|NCT02560805|Nitroprusside|nitroprusside|mesh-list
102071449|NCT02560805|Phenylephrine|phenylephrine|mesh-list
102071450|NCT02560805|Oxymetazoline|oxymetazoline|mesh-list
102071451|NCT02560805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102071452|NCT02560805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102071453|NCT02560805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102071454|NCT02560805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101373036|NCT00200473|Nebivolol|nebivolol|mesh-list
102071463|NCT02560805|Nasal Decongestants|nasal decongestants|mesh-ancestor
102071464|NCT02560805|Respiratory System Agents|respiratory system agents|mesh-ancestor
102071465|NCT02560805|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102071466|NCT02560805|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102071467|NCT02560805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102071468|NCT02560805|Adrenergic Agents|adrenergic agents|mesh-ancestor
102071469|NCT02560805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101943145|NCT02908672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101943146|NCT02908672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102071470|NCT02560805|Protective Agents|protective agents|mesh-ancestor
102071471|NCT02560805|Sympatholytics|sympatholytics|mesh-ancestor
102071472|NCT02560805|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102071473|NCT02560805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102071474|NCT02560805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102071475|NCT02560805|Vasodilator Agents|vasodilator agents|mesh-ancestor
102071476|NCT02560805|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102071477|NCT04615936|Methylene Blue|methylene blue|mesh-list
102071478|NCT04615936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102071479|NCT04615936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071480|NCT03797222|Vitamin E|vitamin e|mesh-list
102071481|NCT03797222|Tocopherols|tocopherols|mesh-list
102071482|NCT03797222|alpha-Tocopherol|alpha-tocopherol|mesh-list
102071483|NCT03797222|Vitamins|vitamins|mesh-ancestor
102071484|NCT03797222|Micronutrients|micronutrients|mesh-ancestor
102071485|NCT03797222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071486|NCT03797222|Antioxidants|antioxidants|mesh-ancestor
102071487|NCT03797222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071488|NCT03797222|Protective Agents|protective agents|mesh-ancestor
102071489|NCT04471675|Docetaxel|docetaxel|mesh-list
102071490|NCT04471675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102071491|NCT04471675|Tubulin Modulators|tubulin modulators|mesh-ancestor
102071492|NCT04471675|Antimitotic Agents|antimitotic agents|mesh-ancestor
102071493|NCT04471675|Mitosis Modulators|mitosis modulators|mesh-ancestor
102071494|NCT04471675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071495|NCT04461028|Dexamethasone|dexamethasone|mesh-list
102071496|NCT04461028|Bupivacaine|bupivacaine|mesh-list
102071497|NCT04461028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102071498|NCT04461028|Antiemetics|antiemetics|mesh-ancestor
102071499|NCT04461028|Autonomic Agents|autonomic agents|mesh-ancestor
102071500|NCT04461028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102071501|NCT04461028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071502|NCT04461028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102071503|NCT04461028|Glucocorticoids|glucocorticoids|mesh-ancestor
102071504|NCT04461028|Hormones|hormones|mesh-ancestor
102071505|NCT04461028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102071506|NCT04461028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102071507|NCT04461028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102071508|NCT04461028|Anesthetics, Local|anesthetics, local|mesh-ancestor
102071509|NCT04461028|Anesthetics|anesthetics|mesh-ancestor
102071510|NCT04461028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102071511|NCT04461028|Sensory System Agents|sensory system agents|mesh-ancestor
102071512|NCT00716534|Paclitaxel|paclitaxel|mesh-list
102071513|NCT00716534|Carboplatin|carboplatin|mesh-list
102071514|NCT00716534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102071515|NCT00716534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102071516|NCT00716534|Tubulin Modulators|tubulin modulators|mesh-ancestor
102071517|NCT00716534|Antimitotic Agents|antimitotic agents|mesh-ancestor
102071518|NCT00716534|Mitosis Modulators|mitosis modulators|mesh-ancestor
102071519|NCT00716534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071520|NCT02283476|Gemcitabine|gemcitabine|mesh-list
102071521|NCT02283476|Endostar protein|endostar protein|mesh-list
102071522|NCT02283476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102071525|NCT02283476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071526|NCT02283476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102071527|NCT02283476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102071528|NCT02283476|Growth Substances|growth substances|mesh-ancestor
102071529|NCT02283476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071530|NCT02283476|Growth Inhibitors|growth inhibitors|mesh-ancestor
102071531|NCT05156879|Aspirin|aspirin|mesh-list
102071532|NCT05156879|Drospirenone|drospirenone|mesh-list
102071533|NCT05156879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102071534|NCT05156879|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
102071535|NCT05156879|Estradiol|estradiol|mesh-list
102071536|NCT05156879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102071537|NCT05156879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102071538|NCT05156879|Analgesics|analgesics|mesh-ancestor
102071539|NCT05156879|Sensory System Agents|sensory system agents|mesh-ancestor
102071540|NCT05156879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102071541|NCT05156879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071542|NCT05156879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102071543|NCT05156879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101943148|NCT02908672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943149|NCT02908672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101943150|NCT02908672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102071544|NCT05156879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102071545|NCT05156879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102071546|NCT05156879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071547|NCT05156879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102071548|NCT05156879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102071549|NCT05156879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102071550|NCT05156879|Antipyretics|antipyretics|mesh-ancestor
102071551|NCT05156879|Estrogens|estrogens|mesh-ancestor
102071552|NCT05156879|Hormones|hormones|mesh-ancestor
102071553|NCT05156879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102071554|NCT05156879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102071555|NCT05156879|Contraceptive Agents|contraceptive agents|mesh-ancestor
102071556|NCT05156879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102071557|NCT05156879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102071558|NCT05156879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102071559|NCT05156879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102071560|NCT05156879|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102071561|NCT05156879|Hormone Antagonists|hormone antagonists|mesh-ancestor
102071562|NCT05156879|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102071563|NCT05156879|Diuretics|diuretics|mesh-ancestor
101701822|NCT00653354|Valdecoxib|valdecoxib|mesh-list
102071564|NCT05156879|Natriuretic Agents|natriuretic agents|mesh-ancestor
102071565|NCT02283554|Metformin|metformin|mesh-list
102071566|NCT02283554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102071567|NCT02283554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071568|NCT00641732|Enoxaparin|enoxaparin|mesh-list
102071569|NCT00641732|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1H)-one|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1h)-one|mesh-list
102071570|NCT00641732|Anticoagulants|anticoagulants|mesh-ancestor
102071571|NCT00641732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102071572|NCT00641732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102071573|NCT00641732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071574|NCT00641732|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102071575|NCT00641732|Antithrombins|antithrombins|mesh-ancestor
102071576|NCT00641732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102071577|NCT00641732|Protease Inhibitors|protease inhibitors|mesh-ancestor
102071578|NCT00641732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102071579|NCT00790829|Nicotine|nicotine|mesh-list
102071580|NCT00790829|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102071581|NCT00790829|Autonomic Agents|autonomic agents|mesh-ancestor
102071582|NCT00790829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102071583|NCT00790829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071584|NCT00790829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102071585|NCT00790829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102071586|NCT00790829|Cholinergic Agents|cholinergic agents|mesh-ancestor
102071587|NCT00790829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102071588|NCT00790829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071589|NCT00640484|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102071590|NCT00640484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102071592|NCT00640484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102071593|NCT00640484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071594|NCT00640484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102071614|NCT03065933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102071615|NCT03065933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071616|NCT00630656|Talactoferrin alfa|talactoferrin alfa|mesh-list
102071617|NCT00630656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102071618|NCT04256629|Allopurinol|allopurinol|mesh-list
102071619|NCT04256629|Verinurad|verinurad|mesh-list
102071620|NCT04256629|Antimetabolites|antimetabolites|mesh-ancestor
102071621|NCT04256629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071622|NCT04256629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102071623|NCT04256629|Gout Suppressants|gout suppressants|mesh-ancestor
102071624|NCT04256629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102071625|NCT04256629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102071626|NCT04256629|Antioxidants|antioxidants|mesh-ancestor
102071627|NCT04256629|Protective Agents|protective agents|mesh-ancestor
102071628|NCT04256629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943151|NCT02572167|Nivolumab|nivolumab|mesh-list
101943152|NCT02572167|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101943153|NCT02572167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101943154|NCT02572167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101943155|NCT02572167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102071629|NCT05206721|Chlorhexidine|chlorhexidine|mesh-list
102071630|NCT05206721|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102071631|NCT05206721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102071632|NCT05206721|Disinfectants|disinfectants|mesh-ancestor
102071633|NCT00696332|alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid|alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid|mesh-list
101701833|NCT00653354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102071634|NCT00696332|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
102071635|NCT00696332|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102071636|NCT00696332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102071637|NCT00696332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071638|NCT00696332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071639|NCT05125523|Sirolimus|sirolimus|mesh-list
102071640|NCT05125523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102071641|NCT05125523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102071642|NCT05125523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102071643|NCT05125523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102071644|NCT05125523|Antifungal Agents|antifungal agents|mesh-ancestor
102071645|NCT05125523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102071646|NCT05125523|Immunologic Factors|immunologic factors|mesh-ancestor
102071647|NCT05125523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071648|NCT00625664|Gemcitabine|gemcitabine|mesh-list
102071649|NCT00625664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102071653|NCT02947165|Spartalizumab|spartalizumab|mesh-list
102071654|NCT02947165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102071655|NCT02947165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071656|NCT02947165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102071657|NCT02947165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102071658|NCT03629093|Anesthetics|anesthetics|mesh-list
102071659|NCT03629093|Anesthetics, General|anesthetics, general|mesh-list
102071660|NCT03629093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102071661|NCT03629093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071662|NCT02283710|Pentoxifylline|pentoxifylline|mesh-list
102071663|NCT02283710|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102071664|NCT02283710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102071665|NCT02283710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071666|NCT02283710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102071667|NCT02283710|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102071668|NCT02283710|Protective Agents|protective agents|mesh-ancestor
102071669|NCT02283710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071670|NCT02283710|Vasodilator Agents|vasodilator agents|mesh-ancestor
102071671|NCT02283710|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102071672|NCT02283710|Antioxidants|antioxidants|mesh-ancestor
102071673|NCT05055947|Atezolizumab|atezolizumab|mesh-list
102071674|NCT05055947|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102071675|NCT05055947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071676|NCT05055947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102071677|NCT05055947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102071678|NCT03943342|Venetoclax|venetoclax|mesh-list
102071679|NCT03943342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102071680|NCT00357565|Cyclosporine|cyclosporine|mesh-list
102071681|NCT00357565|Mycophenolic Acid|mycophenolic acid|mesh-list
102071682|NCT00357565|Fludarabine|fludarabine|mesh-list
102071683|NCT00357565|Fludarabine phosphate|fludarabine phosphate|mesh-list
102071684|NCT00357565|Melphalan|melphalan|mesh-list
102071685|NCT00357565|Busulfan|busulfan|mesh-list
102071686|NCT00357565|Cyclosporins|cyclosporins|mesh-list
102071687|NCT00357565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102071688|NCT00357565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102071689|NCT00357565|Antimetabolites|antimetabolites|mesh-ancestor
102071690|NCT00357565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071691|NCT00357565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102071692|NCT00357565|Immunologic Factors|immunologic factors|mesh-ancestor
102071693|NCT00357565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071694|NCT00357565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102071695|NCT00357565|Antifungal Agents|antifungal agents|mesh-ancestor
101943156|NCT02572167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943157|NCT02572167|Immunotoxins|immunotoxins|mesh-ancestor
101943158|NCT02572167|Immunoconjugates|immunoconjugates|mesh-ancestor
101943159|NCT02572167|Immunologic Factors|immunologic factors|mesh-ancestor
101943160|NCT02572167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071696|NCT00357565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102071697|NCT00357565|Dermatologic Agents|dermatologic agents|mesh-ancestor
102071698|NCT00357565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102071699|NCT00357565|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102071700|NCT00357565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102071701|NCT00357565|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102071702|NCT00357565|Antitubercular Agents|antitubercular agents|mesh-ancestor
102071703|NCT00357565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102071704|NCT00357565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102071705|NCT00357565|Alkylating Agents|alkylating agents|mesh-ancestor
102071706|NCT00357565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102071707|NCT00694928|Clindamycin|clindamycin|mesh-list
102071708|NCT00694928|Clindamycin palmitate|clindamycin palmitate|mesh-list
102071709|NCT00694928|Clindamycin phosphate|clindamycin phosphate|mesh-list
102071710|NCT00694928|Butoconazole|butoconazole|mesh-list
102071711|NCT00694928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102071712|NCT00694928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102071713|NCT00694928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102071714|NCT00694928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102071715|NCT00694928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071716|NCT00694928|Antifungal Agents|antifungal agents|mesh-ancestor
102071717|NCT03272464|Trametinib|trametinib|mesh-list
102071718|NCT03272464|Dabrafenib|dabrafenib|mesh-list
102071719|NCT03272464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102071720|NCT03272464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102071721|NCT03272464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102071735|NCT05116150|Grape Seed Extract|grape seed extract|mesh-list
102071736|NCT05116150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102071737|NCT05116150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102071738|NCT05116150|Antioxidants|antioxidants|mesh-ancestor
102071739|NCT05116150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071740|NCT05116150|Protective Agents|protective agents|mesh-ancestor
102071741|NCT05116150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071742|NCT00136903|Cyclosporine|cyclosporine|mesh-list
102071743|NCT00136903|Mycophenolic Acid|mycophenolic acid|mesh-list
102071744|NCT00136903|Remestemcel-l|remestemcel-l|mesh-list
102071745|NCT00136903|Prednisone|prednisone|mesh-list
102071746|NCT00136903|Methylprednisolone|methylprednisolone|mesh-list
102071747|NCT00136903|Tacrolimus|tacrolimus|mesh-list
102071748|NCT00136903|Cyclosporins|cyclosporins|mesh-list
102071749|NCT00136903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102071750|NCT00136903|Glucocorticoids|glucocorticoids|mesh-ancestor
102071751|NCT00136903|Hormones|hormones|mesh-ancestor
102071752|NCT00136903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102071753|NCT00136903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071754|NCT00136903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102071755|NCT00136903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102071756|NCT00136903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102071757|NCT00136903|Immunologic Factors|immunologic factors|mesh-ancestor
102071758|NCT00136903|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102071759|NCT00136903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102071760|NCT00136903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071761|NCT00136903|Antifungal Agents|antifungal agents|mesh-ancestor
102071762|NCT00136903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102071763|NCT00136903|Dermatologic Agents|dermatologic agents|mesh-ancestor
102071764|NCT00136903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102071765|NCT00136903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102071766|NCT00136903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102071767|NCT00136903|Antitubercular Agents|antitubercular agents|mesh-ancestor
102071768|NCT00136903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102071769|NCT00136903|Antiemetics|antiemetics|mesh-ancestor
102071770|NCT00136903|Autonomic Agents|autonomic agents|mesh-ancestor
102071771|NCT00136903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102071772|NCT00136903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102071773|NCT00136903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102071774|NCT00136903|Protective Agents|protective agents|mesh-ancestor
101943161|NCT01336738|Nicotinic Acids|nicotinic acids|mesh-list
101943162|NCT01336738|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101971928|NCT02083250|Fludarabine phosphate|fludarabine phosphate|mesh-list
102071775|NCT00136903|Antiviral Agents|antiviral agents|mesh-ancestor
102071776|NCT04917029|Dexmedetomidine|dexmedetomidine|mesh-list
102071777|NCT04917029|Bupivacaine|bupivacaine|mesh-list
101701859|NCT02694653|Antipyretics|antipyretics|mesh-ancestor
102071778|NCT04917029|Anesthetics, Local|anesthetics, local|mesh-ancestor
102071779|NCT04917029|Anesthetics|anesthetics|mesh-ancestor
102071780|NCT04917029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102071781|NCT04917029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071782|NCT04917029|Sensory System Agents|sensory system agents|mesh-ancestor
102071783|NCT04917029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102071803|NCT03632759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102071804|NCT03632759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102071805|NCT03632759|Immunologic Factors|immunologic factors|mesh-ancestor
101791559|NCT00926718|Remifentanil|remifentanil|mesh-list
102071807|NCT02953093|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102071808|NCT02953093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102071809|NCT02953093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071810|NCT02953093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102071811|NCT02953093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071812|NCT04518280|Capecitabine|capecitabine|mesh-list
102071813|NCT04518280|Oxaliplatin|oxaliplatin|mesh-list
102071814|NCT04518280|Antibodies|antibodies|mesh-list
102071815|NCT04518280|Immunologic Factors|immunologic factors|mesh-ancestor
102071816|NCT04518280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071817|NCT04518280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102071818|NCT04518280|Antimetabolites|antimetabolites|mesh-ancestor
102071819|NCT04518280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071820|NCT04518280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102071821|NCT00498836|Sorafenib|sorafenib|mesh-list
102071822|NCT00498836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102071823|NCT00498836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102071824|NCT00498836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102071825|NCT00498836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071826|NCT02283866|Desflurane|desflurane|mesh-list
102071827|NCT02283866|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102071828|NCT02283866|Anesthetics, General|anesthetics, general|mesh-ancestor
102071829|NCT02283866|Anesthetics|anesthetics|mesh-ancestor
102071830|NCT02283866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102071831|NCT02283866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071832|NCT04517110|Pregabalin|pregabalin|mesh-list
102071833|NCT04517110|Analgesics|analgesics|mesh-ancestor
102071834|NCT04517110|Sensory System Agents|sensory system agents|mesh-ancestor
102071835|NCT04517110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102071836|NCT04517110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071837|NCT04517110|Anticonvulsants|anticonvulsants|mesh-ancestor
102071838|NCT04517110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102071843|NCT04517110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102071844|NCT04517110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102071845|NCT04517110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102071846|NCT00498212|1018 oligonucleotide|1018 oligonucleotide|mesh-list
102071847|NCT00498212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102071848|NCT00498212|Immunologic Factors|immunologic factors|mesh-ancestor
102071849|NCT00498212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071851|NCT02281058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102071852|NCT02281058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071853|NCT02281058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102071854|NCT02281058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102071855|NCT02281058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102071856|NCT02281058|Immunologic Factors|immunologic factors|mesh-ancestor
102071857|NCT02281058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071858|NCT02281058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102071859|NCT02784262|Botulinum Toxins|botulinum toxins|mesh-list
102071860|NCT02784262|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102071861|NCT02784262|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102071862|NCT02784262|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102071863|NCT02784262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102071864|NCT02784262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071865|NCT02784262|Cholinergic Agents|cholinergic agents|mesh-ancestor
102071866|NCT02784262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101943163|NCT01336738|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
101943164|NCT01336738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101943165|NCT01336738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071867|NCT02784262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071868|NCT02784262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102071869|NCT02784262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102071871|NCT05205317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102071872|NCT05205317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071873|NCT00691964|Etanercept|etanercept|mesh-list
102071874|NCT00691964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102071875|NCT00691964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102071876|NCT00691964|Analgesics|analgesics|mesh-ancestor
102071877|NCT00691964|Sensory System Agents|sensory system agents|mesh-ancestor
102071878|NCT00691964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102071879|NCT00691964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071880|NCT00691964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102071881|NCT00691964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102071882|NCT00691964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102071883|NCT00691964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102071884|NCT00691964|Immunologic Factors|immunologic factors|mesh-ancestor
102071885|NCT04470908|Rifabutin|rifabutin|mesh-list
102071886|NCT04470908|Zanubrutinib|zanubrutinib|mesh-list
102071887|NCT04470908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102071888|NCT04470908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102071889|NCT04470908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102071890|NCT04470908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071891|NCT04470908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102071892|NCT04470908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102071893|NCT04470908|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102071894|NCT04470908|Antitubercular Agents|antitubercular agents|mesh-ancestor
102071895|NCT02281292|Ranibizumab|ranibizumab|mesh-list
102071896|NCT02281292|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102071897|NCT02281292|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102071898|NCT02281292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102071899|NCT02281292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102071900|NCT02281292|Growth Substances|growth substances|mesh-ancestor
102071901|NCT02281292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071902|NCT02281292|Growth Inhibitors|growth inhibitors|mesh-ancestor
102071903|NCT02281292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102071904|NCT03723772|Insulin|insulin|mesh-list
102071905|NCT03723772|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102071906|NCT03723772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101373487|NCT00061802|Serotonin Agents|serotonin agents|mesh-ancestor
102071918|NCT00491738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071919|NCT00491738|Growth Inhibitors|growth inhibitors|mesh-ancestor
102071920|NCT00491738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102071921|NCT00491738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102071922|NCT00491738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071923|NCT02281370|Cyclosporine|cyclosporine|mesh-list
102071924|NCT02281370|Cyclosporins|cyclosporins|mesh-list
102071925|NCT02281370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102071926|NCT02281370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071927|NCT02281370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102071928|NCT02281370|Immunologic Factors|immunologic factors|mesh-ancestor
102071929|NCT02281370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071930|NCT02281370|Antifungal Agents|antifungal agents|mesh-ancestor
102071931|NCT02281370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102071932|NCT02281370|Dermatologic Agents|dermatologic agents|mesh-ancestor
102071933|NCT02281370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102071934|NCT02281370|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102071935|NCT00680342|Silymarin|silymarin|mesh-list
102071936|NCT00680342|Antioxidants|antioxidants|mesh-ancestor
102071937|NCT00680342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071938|NCT00680342|Protective Agents|protective agents|mesh-ancestor
102071939|NCT00680342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071940|NCT04057365|Nivolumab|nivolumab|mesh-list
102071941|NCT04057365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102071942|NCT04057365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102071943|NCT04057365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101943166|NCT01336738|Incretins|incretins|mesh-ancestor
101943167|NCT01336738|Hormones|hormones|mesh-ancestor
101943168|NCT01336738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101943169|NCT01336738|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102071944|NCT04057365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071945|NCT00616148|Cenobamate|cenobamate|mesh-list
102071946|NCT00616148|Anticonvulsants|anticonvulsants|mesh-ancestor
102071947|NCT03622827|Endostar protein|endostar protein|mesh-list
102071948|NCT03622827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102071949|NCT03622827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102071950|NCT03622827|Growth Substances|growth substances|mesh-ancestor
102071951|NCT03622827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071952|NCT03622827|Growth Inhibitors|growth inhibitors|mesh-ancestor
102071953|NCT03622827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102071954|NCT00486512|Aspirin|aspirin|mesh-list
102071955|NCT00486512|Calcium, Dietary|calcium, dietary|mesh-list
102071956|NCT00486512|Calcitriol|calcitriol|mesh-list
102071957|NCT00486512|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
102071958|NCT00486512|Calcium Carbonate|calcium carbonate|mesh-list
102071959|NCT00486512|Calcium|calcium|mesh-list
102071960|NCT00486512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102071961|NCT00486512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071962|NCT00486512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102071963|NCT00486512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102071964|NCT00486512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102071965|NCT00486512|Analgesics|analgesics|mesh-ancestor
102071966|NCT00486512|Sensory System Agents|sensory system agents|mesh-ancestor
102071967|NCT00486512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102071968|NCT00486512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102071969|NCT00486512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102071970|NCT00486512|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101373556|NCT00223717|Metoprolol|metoprolol|mesh-list
102071989|NCT04057989|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102071990|NCT04057989|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102071991|NCT04057989|Anesthetics, General|anesthetics, general|mesh-ancestor
102071992|NCT04057989|Anesthetics|anesthetics|mesh-ancestor
102071993|NCT04057989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102071994|NCT04057989|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102071995|NCT04057989|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102071996|NCT04057989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102071997|NCT04057989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071998|NCT00486200|Valacyclovir|valacyclovir|mesh-list
102071999|NCT00486200|Antiviral Agents|antiviral agents|mesh-ancestor
101701904|NCT02729441|Ramipril|ramipril|mesh-list
102072000|NCT00486200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102072001|NCT00479258|Insulin|insulin|mesh-list
102072002|NCT00479258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102072003|NCT00479258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102072004|NCT00479258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072005|NCT00612170|Reboxetine|reboxetine|mesh-list
102072006|NCT00612170|Antidepressive Agents|antidepressive agents|mesh-ancestor
102072007|NCT00612170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102072008|NCT00612170|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102072009|NCT00612170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102072010|NCT00612170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102072011|NCT00612170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072012|NCT00612170|Adrenergic Agents|adrenergic agents|mesh-ancestor
102072013|NCT00612170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102072014|NCT00612170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072015|NCT05068336|Anesthetics|anesthetics|mesh-list
102072016|NCT05068336|Sevoflurane|sevoflurane|mesh-list
102072017|NCT05068336|Desflurane|desflurane|mesh-list
102072018|NCT05068336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102072019|NCT05068336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072020|NCT05068336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102072021|NCT05068336|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102072022|NCT05068336|Anesthetics, General|anesthetics, general|mesh-ancestor
102072023|NCT00607256|Reboxetine|reboxetine|mesh-list
102072024|NCT00607256|Antidepressive Agents|antidepressive agents|mesh-ancestor
102072025|NCT00607256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102072026|NCT00607256|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102072027|NCT00607256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101943170|NCT01336738|Protease Inhibitors|protease inhibitors|mesh-ancestor
101943171|NCT01336738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101943172|NCT01336738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072034|NCT02774590|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102072035|NCT02774590|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102072036|NCT02774590|Adrenergic Agents|adrenergic agents|mesh-ancestor
102072037|NCT02774590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102072038|NCT02774590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072039|NCT02774590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072040|NCT02774590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102072041|NCT02774590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102072042|NCT01069341|Ranibizumab|ranibizumab|mesh-list
102072043|NCT01069341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102072044|NCT01069341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102072045|NCT01069341|Growth Substances|growth substances|mesh-ancestor
102072046|NCT01069341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072047|NCT01069341|Growth Inhibitors|growth inhibitors|mesh-ancestor
102072048|NCT01069341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102072049|NCT00676832|Prednisolone|prednisolone|mesh-list
102072050|NCT00676832|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102072051|NCT00676832|Methylprednisolone|methylprednisolone|mesh-list
102072052|NCT00676832|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102072053|NCT00676832|Prednisolone acetate|prednisolone acetate|mesh-list
102072054|NCT00676832|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102072055|NCT00676832|Prednisolone phosphate|prednisolone phosphate|mesh-list
102072056|NCT00676832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102072057|NCT00676832|Glucocorticoids|glucocorticoids|mesh-ancestor
102072058|NCT00676832|Hormones|hormones|mesh-ancestor
102072059|NCT00676832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102072060|NCT00676832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072061|NCT00676832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102072062|NCT00676832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102072063|NCT00676832|Antiemetics|antiemetics|mesh-ancestor
102072064|NCT00676832|Autonomic Agents|autonomic agents|mesh-ancestor
102072065|NCT00676832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102072066|NCT00676832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102072067|NCT00676832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102072068|NCT00676832|Protective Agents|protective agents|mesh-ancestor
102072069|NCT01909414|Vaccines|vaccines|mesh-list
102072070|NCT01909414|Immunologic Factors|immunologic factors|mesh-ancestor
102072071|NCT01909414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072072|NCT00467402|Agomelatine|agomelatine|mesh-list
102072073|NCT00467402|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102072074|NCT00467402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102072075|NCT00467402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072076|NCT02996097|Triamcinolone|triamcinolone|mesh-list
102072077|NCT02996097|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102072078|NCT02996097|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102072079|NCT02996097|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102072080|NCT02996097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102072081|NCT02996097|Glucocorticoids|glucocorticoids|mesh-ancestor
102072082|NCT02996097|Hormones|hormones|mesh-ancestor
102072083|NCT02996097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102072084|NCT02996097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072085|NCT02996097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102072086|NCT02996097|Immunologic Factors|immunologic factors|mesh-ancestor
102072087|NCT02996097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102072088|NCT02996097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072089|NCT04054713|Acetic Acid|acetic acid|mesh-list
102072090|NCT04054713|Retinol acetate|retinol acetate|mesh-list
102072091|NCT04054713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102072092|NCT04054713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102072093|NCT04054713|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102072094|NCT04054713|Immunologic Factors|immunologic factors|mesh-ancestor
101373680|NCT00224185|Dimercaprol|dimercaprol|mesh-list
102072121|NCT03133832|Anthelmintics|anthelmintics|mesh-ancestor
102072122|NCT03133832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102072123|NCT03133832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102072124|NCT03663465|Antipsychotic Agents|antipsychotic agents|mesh-list
102072125|NCT03663465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102072126|NCT03663465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101943173|NCT01336738|Vitamin B Complex|vitamin b complex|mesh-ancestor
101943174|NCT01336738|Vitamins|vitamins|mesh-ancestor
101943175|NCT01336738|Micronutrients|micronutrients|mesh-ancestor
102072127|NCT03663465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072128|NCT03663465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102072129|NCT04161430|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102072130|NCT04161430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102072131|NCT04161430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072132|NCT04161430|Incretins|incretins|mesh-ancestor
102072133|NCT04161430|Hormones|hormones|mesh-ancestor
102072134|NCT04161430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102072135|NCT04161430|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102072136|NCT04161430|Protease Inhibitors|protease inhibitors|mesh-ancestor
102072137|NCT04161430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102072138|NCT04161430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072139|NCT00673478|Tiotropium Bromide|tiotropium bromide|mesh-list
102072140|NCT00673478|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102072141|NCT00673478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102072142|NCT00673478|Autonomic Agents|autonomic agents|mesh-ancestor
102072143|NCT00673478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101373755|NCT00062114|Rituximab|rituximab|mesh-list
102072149|NCT00673478|Cholinergic Agents|cholinergic agents|mesh-ancestor
102072150|NCT00673478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102072151|NCT00673478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072152|NCT00673478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102072153|NCT00673478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102072154|NCT00673478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102072155|NCT00673478|Adrenergic Agents|adrenergic agents|mesh-ancestor
102072157|NCT02203474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102072158|NCT02203474|Autonomic Agents|autonomic agents|mesh-ancestor
102072159|NCT02203474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102072160|NCT02203474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072161|NCT02203474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102072162|NCT02203474|Respiratory System Agents|respiratory system agents|mesh-ancestor
102072163|NCT02203474|Parasympatholytics|parasympatholytics|mesh-ancestor
102072164|NCT02203474|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102072165|NCT02203474|Cholinergic Agents|cholinergic agents|mesh-ancestor
102072166|NCT02203474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102072167|NCT02203474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072168|NCT04053699|Factor VIII|factor viii|mesh-list
102072169|NCT04053699|Coagulants|coagulants|mesh-ancestor
102072170|NCT04303000|Analgesics, Opioid|analgesics, opioid|mesh-list
102072171|NCT04303000|Naloxone|naloxone|mesh-list
102072172|NCT04303000|Narcotics|narcotics|mesh-ancestor
102072173|NCT04303000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102072174|NCT04303000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072175|NCT04303000|Analgesics|analgesics|mesh-ancestor
102072176|NCT04303000|Sensory System Agents|sensory system agents|mesh-ancestor
102072177|NCT04303000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102072178|NCT04303000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102072179|NCT00672386|Metformin|metformin|mesh-list
102072180|NCT00672386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102072181|NCT00672386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072182|NCT04056897|Teriflunomide|teriflunomide|mesh-list
102072183|NCT04056897|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102072185|NCT04056897|Analgesics|analgesics|mesh-ancestor
102072186|NCT04056897|Sensory System Agents|sensory system agents|mesh-ancestor
102072187|NCT04056897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102072188|NCT04056897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072189|NCT04056897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102072190|NCT04056897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102072191|NCT04056897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102072192|NCT04056897|Immunologic Factors|immunologic factors|mesh-ancestor
102072193|NCT02281682|Fluorouracil|fluorouracil|mesh-list
102072194|NCT02281682|Imiquimod|imiquimod|mesh-list
102072195|NCT02281682|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
102072196|NCT02281682|Antimetabolites|antimetabolites|mesh-ancestor
102072197|NCT02281682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072198|NCT02281682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102072199|NCT02281682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102072200|NCT02281682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102072201|NCT02281682|Immunologic Factors|immunologic factors|mesh-ancestor
102072202|NCT02281682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943176|NCT01140399|Dopamine|dopamine|mesh-list
101943177|NCT01140399|Furosemide|furosemide|mesh-list
101943178|NCT01140399|Diuretics|diuretics|mesh-ancestor
102072203|NCT02281682|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102072204|NCT02281682|Interferon Inducers|interferon inducers|mesh-ancestor
102072205|NCT02281682|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102072206|NCT02281682|Dermatologic Agents|dermatologic agents|mesh-ancestor
102072207|NCT04057053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102072208|NCT04057053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102072209|NCT04056975|Antibodies|antibodies|mesh-list
102072210|NCT04056975|Immunologic Factors|immunologic factors|mesh-ancestor
102072211|NCT04056975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072212|NCT02281916|Immunomodulating Agents|immunomodulating agents|mesh-list
102072213|NCT02281916|Immunologic Factors|immunologic factors|mesh-ancestor
102072214|NCT02281916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072220|NCT03662763|Adrenergic Agents|adrenergic agents|mesh-ancestor
102072221|NCT03662763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102072222|NCT03662763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072223|NCT03662763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072224|NCT00458978|Cediranib|cediranib|mesh-list
102072225|NCT00458978|Maleic acid|maleic acid|mesh-list
102072226|NCT00458978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102072227|NCT00458978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072228|NCT00458978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102072229|NCT00458978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102072230|NCT00458276|Tezosentan|tezosentan|mesh-list
102072231|NCT00458276|Vasodilator Agents|vasodilator agents|mesh-ancestor
102072232|NCT04520074|Cyclophosphamide|cyclophosphamide|mesh-list
102072233|NCT04520074|Carboplatin|carboplatin|mesh-list
102072234|NCT04520074|Etoposide|etoposide|mesh-list
102072235|NCT04520074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102072236|NCT04520074|Immunologic Factors|immunologic factors|mesh-ancestor
102072237|NCT04520074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072238|NCT04520074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102072239|NCT04520074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102072240|NCT04520074|Alkylating Agents|alkylating agents|mesh-ancestor
102072241|NCT04520074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072242|NCT04520074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102072243|NCT04520074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102072244|NCT04520074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102072245|NCT04520074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102072246|NCT04520074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102072247|NCT04520074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102072248|NCT00455156|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102072249|NCT00455156|ST 1435|st 1435|mesh-list
102072250|NCT00455156|Estradiol|estradiol|mesh-list
102072251|NCT00455156|Estrogens|estrogens|mesh-ancestor
102072252|NCT00455156|Hormones|hormones|mesh-ancestor
102072253|NCT00455156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102072254|NCT00455156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072255|NCT00455156|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102072256|NCT00455156|Contraceptive Agents|contraceptive agents|mesh-ancestor
102072257|NCT00455156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102072258|NCT00455156|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102072259|NCT00455156|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102072260|NCT00455156|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102072261|NCT03661515|Cytarabine|cytarabine|mesh-list
102072262|NCT03661515|Fludarabine|fludarabine|mesh-list
102072263|NCT03661515|Idarubicin|idarubicin|mesh-list
102072264|NCT03661515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102072265|NCT03661515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102072266|NCT03661515|Antimetabolites|antimetabolites|mesh-ancestor
102072267|NCT03661515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072268|NCT03661515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102072269|NCT03661515|Immunologic Factors|immunologic factors|mesh-ancestor
102072270|NCT03661515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072271|NCT03661515|Antiviral Agents|antiviral agents|mesh-ancestor
102072272|NCT03661515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102072273|NCT03661515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102072274|NCT03661515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102072275|NCT03661515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102072276|NCT03661515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102072277|NCT01624480|Modafinil|modafinil|mesh-list
102072278|NCT01624480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101943179|NCT01140399|Natriuretic Agents|natriuretic agents|mesh-ancestor
101971930|NCT02083250|Vorinostat|vorinostat|mesh-list
102072279|NCT01624480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072280|NCT01624480|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102072281|NCT01624480|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102072282|NCT01624480|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102072283|NCT01624480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373873|NCT00413179|Metformin|metformin|mesh-list
102072287|NCT00448058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102072288|NCT00448058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072289|NCT00448058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102072290|NCT00448058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072291|NCT00448058|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102072292|NCT00448058|Antidepressive Agents|antidepressive agents|mesh-ancestor
102072293|NCT00448058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102072295|NCT02284412|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102072296|NCT02284412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102072297|NCT02284412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072298|NCT02284412|Cholinergic Agents|cholinergic agents|mesh-ancestor
102072299|NCT02284412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102072300|NCT02284412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072301|NCT02284412|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102072302|NCT02284412|Autonomic Agents|autonomic agents|mesh-ancestor
102072303|NCT02284412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102072304|NCT02789020|Rasagiline|rasagiline|mesh-list
102072305|NCT02789020|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102072306|NCT02789020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102072307|NCT02789020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072308|NCT02789020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102072309|NCT02789020|Protective Agents|protective agents|mesh-ancestor
102072310|NCT02789020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072311|NCT02284490|Pemetrexed|pemetrexed|mesh-list
102072312|NCT02284490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102072313|NCT02284490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102072314|NCT02284490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072315|NCT02284490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102072316|NCT02284490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102072317|NCT02273570|Vitamin D|vitamin d|mesh-list
102072318|NCT02273570|Calcium|calcium|mesh-list
102072319|NCT02273570|Vitamins|vitamins|mesh-ancestor
102072320|NCT02273570|Micronutrients|micronutrients|mesh-ancestor
102072321|NCT02273570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072322|NCT02273570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102072323|NCT02273570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102072324|NCT02282150|Hydrocortisone|hydrocortisone|mesh-list
102072325|NCT02282150|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102072326|NCT02282150|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102072327|NCT02282150|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102072328|NCT02282150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102072329|NCT00579020|Moxifloxacin|moxifloxacin|mesh-list
102072330|NCT00579020|Dexamethasone|dexamethasone|mesh-list
102072331|NCT00579020|Dexamethasone acetate|dexamethasone acetate|mesh-list
102072332|NCT00579020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102072333|NCT00579020|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102072334|NCT00579020|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102072335|NCT00579020|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102072336|NCT00579020|BB 1101|bb 1101|mesh-list
102072337|NCT00579020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102072338|NCT00579020|Antiemetics|antiemetics|mesh-ancestor
102072339|NCT00579020|Autonomic Agents|autonomic agents|mesh-ancestor
102072340|NCT00579020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102072341|NCT00579020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072342|NCT00579020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102072343|NCT00579020|Glucocorticoids|glucocorticoids|mesh-ancestor
102072344|NCT00579020|Hormones|hormones|mesh-ancestor
102072345|NCT00579020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102072346|NCT00579020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102072347|NCT00579020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102072348|NCT00579020|Protease Inhibitors|protease inhibitors|mesh-ancestor
102072349|NCT00579020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102072350|NCT00579020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943180|NCT01140399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943181|NCT01140399|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102072351|NCT00579020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101373937|NCT00225238|Esomeprazole|esomeprazole|mesh-list
102072358|NCT00579020|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102072359|NCT00579020|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102072360|NCT00579020|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102072362|NCT04530604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102072363|NCT04530604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102072364|NCT04530604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072365|NCT04530604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102072366|NCT04169698|Denosumab|denosumab|mesh-list
102072367|NCT04169698|Alendronate|alendronate|mesh-list
102072368|NCT04169698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102072369|NCT04169698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072370|NCT04470752|Capsaicin|capsaicin|mesh-list
102072371|NCT04470752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102072372|NCT04470752|Antipruritics|antipruritics|mesh-ancestor
102072373|NCT04470752|Dermatologic Agents|dermatologic agents|mesh-ancestor
102072374|NCT04470752|Sensory System Agents|sensory system agents|mesh-ancestor
102072375|NCT04470752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102072376|NCT04470752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072377|NCT02273804|Topiramate|topiramate|mesh-list
102072378|NCT02273804|Anticonvulsants|anticonvulsants|mesh-ancestor
102072379|NCT02273804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102072380|NCT02273804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072381|NCT00578474|Ofloxacin|ofloxacin|mesh-list
102072382|NCT00578474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102072383|NCT00578474|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102072384|NCT00578474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102072385|NCT00578474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102072386|NCT00578474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102072387|NCT00578474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102072388|NCT00578474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102072389|NCT00578474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072390|NCT00578474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102072391|NCT00578474|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102072392|NCT00578474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102072393|NCT00577148|Rimonabant|rimonabant|mesh-list
102072394|NCT00577148|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102072395|NCT00577148|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
102072396|NCT00577148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102072397|NCT00577148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102072398|NCT00577148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072399|NCT00577148|Hormones|hormones|mesh-ancestor
102072400|NCT00577148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102072401|NCT00577148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072402|NCT03673228|Nicotine|nicotine|mesh-list
102072403|NCT03673228|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102072404|NCT03673228|Autonomic Agents|autonomic agents|mesh-ancestor
101701975|NCT00578344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102072405|NCT03673228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102072406|NCT03673228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072408|NCT03673228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102072409|NCT03673228|Cholinergic Agents|cholinergic agents|mesh-ancestor
102072410|NCT03673228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102072411|NCT03673228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072412|NCT05116462|Paclitaxel|paclitaxel|mesh-list
102072413|NCT05116462|Docetaxel|docetaxel|mesh-list
102072414|NCT05116462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102072415|NCT05116462|Carboplatin|carboplatin|mesh-list
102072416|NCT05116462|Gemcitabine|gemcitabine|mesh-list
102072417|NCT05116462|Pemetrexed|pemetrexed|mesh-list
102072418|NCT05116462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102072419|NCT05116462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102072420|NCT05116462|Tubulin Modulators|tubulin modulators|mesh-ancestor
102072423|NCT05116462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072424|NCT05116462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102072425|NCT05116462|Antimetabolites|antimetabolites|mesh-ancestor
102072426|NCT05116462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102072427|NCT05116462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102072428|NCT05116462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101943182|NCT01140399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101943183|NCT01140399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072429|NCT05116306|Hyaluronic Acid|hyaluronic acid|mesh-list
102072430|NCT05116306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102072431|NCT05116306|Immunologic Factors|immunologic factors|mesh-ancestor
102072432|NCT05116306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072433|NCT05116306|Viscosupplements|viscosupplements|mesh-ancestor
102072434|NCT05116306|Protective Agents|protective agents|mesh-ancestor
102072435|NCT00570986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102072436|NCT00570986|Immunologic Factors|immunologic factors|mesh-ancestor
102072437|NCT00570986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072438|NCT00570752|Atorvastatin|atorvastatin|mesh-list
102072439|NCT00570752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102072440|NCT00570752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102072441|NCT00570752|Antimetabolites|antimetabolites|mesh-ancestor
102072442|NCT00570752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072443|NCT00570752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102072444|NCT00570752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102072445|NCT00570752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102072446|NCT02282384|Oseltamivir|oseltamivir|mesh-list
102072447|NCT02282384|Calcium Carbonate|calcium carbonate|mesh-list
102072448|NCT02282384|Antiviral Agents|antiviral agents|mesh-ancestor
102072449|NCT02282384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102072450|NCT02282384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102072451|NCT02282384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072452|NCT02282384|Antacids|antacids|mesh-ancestor
102072453|NCT02282384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102072454|NCT02989389|Itraconazole|itraconazole|mesh-list
102072455|NCT02989389|Antifungal Agents|antifungal agents|mesh-ancestor
102072456|NCT02989389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102072457|NCT02989389|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102072458|NCT02989389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102072459|NCT02989389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102072460|NCT02989389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072461|NCT02989389|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102072462|NCT02989389|Hormone Antagonists|hormone antagonists|mesh-ancestor
102072463|NCT02989389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102072464|NCT02989389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072465|NCT02989389|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102072466|NCT02653300|Insulin|insulin|mesh-list
102072467|NCT02653300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102072468|NCT02653300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072469|NCT00436670|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102072470|NCT00436670|Immunologic Factors|immunologic factors|mesh-ancestor
102072471|NCT00436670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072472|NCT03187509|Torsemide|torsemide|mesh-list
102072473|NCT03187509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102072474|NCT03187509|Diuretics|diuretics|mesh-ancestor
102072475|NCT03187509|Natriuretic Agents|natriuretic agents|mesh-ancestor
102072476|NCT03187509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072477|NCT03187509|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101575045|NCT05215873|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102072478|NCT03187509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102072479|NCT03187509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072480|NCT00430508|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102072482|NCT00430508|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
102072483|NCT00430508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102072484|NCT00430508|Diuretics|diuretics|mesh-ancestor
102072485|NCT00430508|Natriuretic Agents|natriuretic agents|mesh-ancestor
102072486|NCT00430508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072487|NCT00430508|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102072488|NCT00430508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102072489|NCT00430508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072490|NCT00430508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101374074|NCT00225862|Ropinirole|ropinirole|mesh-list
102072497|NCT04221880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102072498|NCT04221880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072499|NCT04221880|Sensory System Agents|sensory system agents|mesh-ancestor
102072500|NCT04221880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101943184|NCT01140399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101943185|NCT01140399|Sympathomimetics|sympathomimetics|mesh-ancestor
101943186|NCT01140399|Autonomic Agents|autonomic agents|mesh-ancestor
101943187|NCT01140399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101943188|NCT01140399|Dopamine Agents|dopamine agents|mesh-ancestor
102072501|NCT04221880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102072502|NCT04221880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102072503|NCT04221880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102072504|NCT04221880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102072505|NCT04221880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072506|NCT04055415|Bronchodilator Agents|bronchodilator agents|mesh-list
102072507|NCT04055415|Expectorants|expectorants|mesh-list
102072508|NCT04055415|Autonomic Agents|autonomic agents|mesh-ancestor
102072509|NCT04055415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102072510|NCT04055415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072511|NCT04055415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102072512|NCT04055415|Respiratory System Agents|respiratory system agents|mesh-ancestor
102072513|NCT00427856|Rituximab|rituximab|mesh-list
102072514|NCT00427856|Obatoclax|obatoclax|mesh-list
102072515|NCT00427856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102072516|NCT00427856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102072517|NCT00427856|Immunologic Factors|immunologic factors|mesh-ancestor
102072518|NCT00427856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072519|NCT00427856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102072520|NCT00427856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102072521|NCT00427856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072522|NCT00427154|Insulin|insulin|mesh-list
102072523|NCT00427154|Metformin|metformin|mesh-list
102072524|NCT00427154|Glimepiride|glimepiride|mesh-list
102072525|NCT00427154|Rosiglitazone|rosiglitazone|mesh-list
102072526|NCT00427154|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102072527|NCT00427154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102072528|NCT00427154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072529|NCT00427154|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102072530|NCT00427154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102072531|NCT00427154|Immunologic Factors|immunologic factors|mesh-ancestor
102072532|NCT02988219|Epinephrine|epinephrine|mesh-list
102072533|NCT02988219|Fentanyl|fentanyl|mesh-list
102072534|NCT02988219|Bupivacaine|bupivacaine|mesh-list
102072535|NCT02988219|Anesthetics|anesthetics|mesh-list
102072536|NCT02988219|Anesthetics, Local|anesthetics, local|mesh-ancestor
102072537|NCT02988219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102072538|NCT02988219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072539|NCT02988219|Sensory System Agents|sensory system agents|mesh-ancestor
102072540|NCT02988219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102072541|NCT02988219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102072542|NCT02988219|Narcotics|narcotics|mesh-ancestor
102072543|NCT02988219|Analgesics|analgesics|mesh-ancestor
102072544|NCT02988219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102072545|NCT02988219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102072546|NCT02988219|Anesthetics, General|anesthetics, general|mesh-ancestor
102072547|NCT02988219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102072548|NCT02988219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102072549|NCT02988219|Adrenergic Agents|adrenergic agents|mesh-ancestor
102072550|NCT02988219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102072551|NCT02988219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072552|NCT02988219|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102072553|NCT02988219|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102072554|NCT02988219|Autonomic Agents|autonomic agents|mesh-ancestor
102072555|NCT02988219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102072556|NCT02988219|Respiratory System Agents|respiratory system agents|mesh-ancestor
102072557|NCT02988219|Mydriatics|mydriatics|mesh-ancestor
102072558|NCT02988219|Sympathomimetics|sympathomimetics|mesh-ancestor
102072559|NCT02988219|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102072560|NCT01346059|Vancomycin|vancomycin|mesh-list
102072561|NCT01346059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102072562|NCT01346059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102072587|NCT02277938|Analgesics|analgesics|mesh-ancestor
102072588|NCT02277938|Sensory System Agents|sensory system agents|mesh-ancestor
102072589|NCT02277938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102072590|NCT00415142|Escitalopram|escitalopram|mesh-list
102072591|NCT00415142|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101943189|NCT01140399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101943190|NCT01140399|Protective Agents|protective agents|mesh-ancestor
101943191|NCT02410317|Morphine|morphine|mesh-list
101943192|NCT02410317|Ropivacaine|ropivacaine|mesh-list
101943193|NCT02410317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101943194|NCT02410317|Narcotics|narcotics|mesh-ancestor
101943195|NCT02410317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101943196|NCT02410317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072592|NCT00415142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102072593|NCT00415142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102072594|NCT00415142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072595|NCT00415142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102072596|NCT00415142|Serotonin Agents|serotonin agents|mesh-ancestor
102072597|NCT00415142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702024|NCT00723424|Digoxin|digoxin|mesh-list
102072598|NCT03661125|Saracatinib|saracatinib|mesh-list
102072599|NCT03661125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102072600|NCT03661125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102072601|NCT03661125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072602|NCT00413114|Obatoclax|obatoclax|mesh-list
102072603|NCT00413114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102072604|NCT00413114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072605|NCT03016013|Methotrexate|methotrexate|mesh-list
102072606|NCT03016013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102072607|NCT03016013|Abortifacient Agents|abortifacient agents|mesh-ancestor
102072608|NCT03016013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102072609|NCT03016013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072610|NCT03016013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102072611|NCT03016013|Antimetabolites|antimetabolites|mesh-ancestor
101374219|NCT00062660|Antiviral Agents|antiviral agents|mesh-ancestor
102072628|NCT01318915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102072629|NCT01318915|Immunologic Factors|immunologic factors|mesh-ancestor
102072630|NCT01318915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072631|NCT01318915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102072632|NCT01318915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102072633|NCT01318915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102072634|NCT01318915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102072635|NCT01318915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072636|NCT01318915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102072637|NCT01318915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102072638|NCT01318915|Antitubercular Agents|antitubercular agents|mesh-ancestor
102072639|NCT01318915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102072640|NCT01318915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102072641|NCT01318915|Antifungal Agents|antifungal agents|mesh-ancestor
102072642|NCT04688177|Nicotine|nicotine|mesh-list
102072643|NCT04688177|Carbon Monoxide|carbon monoxide|mesh-list
102072644|NCT04688177|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102072645|NCT04688177|Autonomic Agents|autonomic agents|mesh-ancestor
102072646|NCT04688177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102072647|NCT04688177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072648|NCT04688177|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102072649|NCT04688177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102072650|NCT04688177|Cholinergic Agents|cholinergic agents|mesh-ancestor
102072651|NCT04688177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102072652|NCT04688177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072653|NCT04688177|Antimetabolites|antimetabolites|mesh-ancestor
102072654|NCT04688177|Gasotransmitters|gasotransmitters|mesh-ancestor
102072655|NCT04675294|Pembrolizumab|pembrolizumab|mesh-list
102072656|NCT04675294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102072657|NCT04675294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102072658|NCT04675294|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102072659|NCT04675294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072660|NCT00411242|Agomelatine|agomelatine|mesh-list
102072661|NCT00411242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102072662|NCT00411242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102072663|NCT00411242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072664|NCT05203913|Paclitaxel|paclitaxel|mesh-list
102072665|NCT05203913|Nivolumab|nivolumab|mesh-list
102072666|NCT05203913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102072667|NCT05203913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102072668|NCT05203913|Tubulin Modulators|tubulin modulators|mesh-ancestor
102072669|NCT05203913|Antimitotic Agents|antimitotic agents|mesh-ancestor
102072670|NCT05203913|Mitosis Modulators|mitosis modulators|mesh-ancestor
101374269|NCT00062699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102072680|NCT00402428|Antiviral Agents|antiviral agents|mesh-ancestor
102072681|NCT00402428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102072682|NCT00402428|Antimetabolites|antimetabolites|mesh-ancestor
102072683|NCT00402428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072684|NCT00402428|Immunologic Factors|immunologic factors|mesh-ancestor
102072685|NCT00402428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072686|NCT05120206|Chlorhexidine|chlorhexidine|mesh-list
102072687|NCT05120206|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102072688|NCT05120206|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102072689|NCT05120206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102072690|NCT05120206|Disinfectants|disinfectants|mesh-ancestor
102072691|NCT05120206|Dermatologic Agents|dermatologic agents|mesh-ancestor
102072692|NCT03660267|Caffeine|caffeine|mesh-list
102072693|NCT03660267|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102072694|NCT03660267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072695|NCT03660267|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102072696|NCT03660267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102072697|NCT03660267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072698|NCT03660267|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102072699|NCT03660267|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102072700|NCT03660267|Purinergic Agents|purinergic agents|mesh-ancestor
102072701|NCT03660267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102072702|NCT03950245|Glucagon|glucagon|mesh-list
102072703|NCT03950245|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102072704|NCT03950245|Incretins|incretins|mesh-ancestor
102072705|NCT03950245|Hormones|hormones|mesh-ancestor
102072706|NCT03950245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102072707|NCT03950245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072708|NCT03950245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102072709|NCT00401570|Gemcitabine|gemcitabine|mesh-list
102072710|NCT00401570|Volociximab|volociximab|mesh-list
102072711|NCT00401570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102072712|NCT00401570|Antimetabolites|antimetabolites|mesh-ancestor
102072713|NCT00401570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072714|NCT00401570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102072715|NCT00401570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102072716|NCT00401570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102072717|NCT00401570|Growth Substances|growth substances|mesh-ancestor
102072718|NCT00401570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072719|NCT00401570|Growth Inhibitors|growth inhibitors|mesh-ancestor
102072720|NCT04056741|Pulmonary Surfactants|pulmonary surfactants|mesh-list
102072721|NCT04056741|Respiratory System Agents|respiratory system agents|mesh-ancestor
102072722|NCT05193565|Mycophenolic Acid|mycophenolic acid|mesh-list
102072723|NCT05193565|Sirolimus|sirolimus|mesh-list
102072724|NCT05193565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102072725|NCT05193565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102072726|NCT05193565|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102072727|NCT05193565|Antitubercular Agents|antitubercular agents|mesh-ancestor
102072728|NCT05193565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102072729|NCT05193565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102072730|NCT05193565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102072731|NCT05193565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072732|NCT05193565|Antifungal Agents|antifungal agents|mesh-ancestor
102072733|NCT05193565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102072734|NCT05193565|Immunologic Factors|immunologic factors|mesh-ancestor
102072735|NCT05193565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072736|NCT04471922|Rabeprazole|rabeprazole|mesh-list
102072756|NCT02285036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072757|NCT00543374|Remestemcel-l|remestemcel-l|mesh-list
102072758|NCT00543374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102072759|NCT00543374|Antiviral Agents|antiviral agents|mesh-ancestor
102072760|NCT00543374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102072761|NCT02926937|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
102072762|NCT02926937|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102072763|NCT02926937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072764|NCT02926937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102072765|NCT02926937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072766|NCT05229796|Empagliflozin|empagliflozin|mesh-list
102072767|NCT05229796|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102072768|NCT05229796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072769|NCT05229796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102072770|NCT05229796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072771|NCT04189588|Diphenhydramine|diphenhydramine|mesh-list
102072772|NCT04189588|Promethazine|promethazine|mesh-list
102072773|NCT04189588|Cetirizine|cetirizine|mesh-list
102072774|NCT04189588|Paclitaxel|paclitaxel|mesh-list
102072775|NCT04189588|Rituximab|rituximab|mesh-list
102072776|NCT04189588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102072777|NCT04189588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102072778|NCT04189588|Tubulin Modulators|tubulin modulators|mesh-ancestor
102072779|NCT04189588|Antimitotic Agents|antimitotic agents|mesh-ancestor
102072780|NCT04189588|Mitosis Modulators|mitosis modulators|mesh-ancestor
102072781|NCT04189588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072782|NCT04189588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102072783|NCT04189588|Immunologic Factors|immunologic factors|mesh-ancestor
102072784|NCT04189588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072785|NCT04189588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102072786|NCT04189588|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102072787|NCT04189588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102072788|NCT04189588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102072789|NCT04189588|Anesthetics, Local|anesthetics, local|mesh-ancestor
102072790|NCT04189588|Anesthetics|anesthetics|mesh-ancestor
102072791|NCT04189588|Sensory System Agents|sensory system agents|mesh-ancestor
102072806|NCT00151892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102072807|NCT00151892|Analgesics|analgesics|mesh-ancestor
102072808|NCT00151892|Sensory System Agents|sensory system agents|mesh-ancestor
102072809|NCT00151892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102072810|NCT00151892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072811|NCT00151892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102072812|NCT00151892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102072813|NCT02740127|Dexamethasone|dexamethasone|mesh-list
102072814|NCT02740127|Clonidine|clonidine|mesh-list
102072815|NCT02740127|Epinephrine|epinephrine|mesh-list
102072816|NCT02740127|Propofol|propofol|mesh-list
102072817|NCT02740127|Ropivacaine|ropivacaine|mesh-list
102072818|NCT02740127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102072819|NCT02740127|Antiemetics|antiemetics|mesh-ancestor
102072820|NCT02740127|Autonomic Agents|autonomic agents|mesh-ancestor
102072821|NCT02740127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102072822|NCT02740127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072823|NCT02740127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102072824|NCT02740127|Glucocorticoids|glucocorticoids|mesh-ancestor
102072825|NCT02740127|Hormones|hormones|mesh-ancestor
102072826|NCT02740127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102072827|NCT02740127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102072828|NCT02740127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102072829|NCT02740127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072830|NCT02740127|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102072831|NCT02740127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102072832|NCT02740127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102072833|NCT02740127|Anesthetics, General|anesthetics, general|mesh-ancestor
102072834|NCT02740127|Anesthetics|anesthetics|mesh-ancestor
102072835|NCT02740127|Anesthetics, Local|anesthetics, local|mesh-ancestor
102072836|NCT02740127|Sensory System Agents|sensory system agents|mesh-ancestor
102072837|NCT02740127|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102072838|NCT02740127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102072839|NCT02740127|Adrenergic Agents|adrenergic agents|mesh-ancestor
102072840|NCT02740127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102072841|NCT02740127|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102072842|NCT02740127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102072843|NCT02740127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102072844|NCT02740127|Respiratory System Agents|respiratory system agents|mesh-ancestor
102072845|NCT02740127|Mydriatics|mydriatics|mesh-ancestor
102072846|NCT02740127|Sympathomimetics|sympathomimetics|mesh-ancestor
102072847|NCT02740127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102072848|NCT02740127|Analgesics|analgesics|mesh-ancestor
102072849|NCT02740127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102072850|NCT02740127|Sympatholytics|sympatholytics|mesh-ancestor
102072851|NCT02740127|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102072852|NCT05008783|Capecitabine|capecitabine|mesh-list
101943199|NCT02410317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101943201|NCT02410317|Anesthetics|anesthetics|mesh-ancestor
102072853|NCT05008783|Oxaliplatin|oxaliplatin|mesh-list
102072854|NCT05008783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102072872|NCT00393068|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102072873|NCT00393068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102072874|NCT00393068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102072875|NCT00393068|Tubulin Modulators|tubulin modulators|mesh-ancestor
102072876|NCT00393068|Antimitotic Agents|antimitotic agents|mesh-ancestor
102072877|NCT00393068|Mitosis Modulators|mitosis modulators|mesh-ancestor
102072878|NCT00393068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072879|NCT00393068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102072880|NCT00393068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102072881|NCT00393068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102072882|NCT00393068|Growth Substances|growth substances|mesh-ancestor
102072883|NCT00393068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072884|NCT00393068|Growth Inhibitors|growth inhibitors|mesh-ancestor
102072886|NCT00393068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102072887|NCT00393068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102072888|NCT00393068|Immunologic Factors|immunologic factors|mesh-ancestor
102072889|NCT00393068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102072890|NCT00393068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102072891|NCT02280278|Immunomodulating Agents|immunomodulating agents|mesh-list
102072892|NCT02280278|Immunologic Factors|immunologic factors|mesh-ancestor
102072893|NCT02280278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072894|NCT04769401|Progesterone|progesterone|mesh-list
102072895|NCT04769401|Progestins|progestins|mesh-ancestor
102072896|NCT04769401|Hormones|hormones|mesh-ancestor
102072897|NCT04769401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102072898|NCT04769401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072899|NCT02094222|Glycerol|glycerol|mesh-list
102072900|NCT02094222|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102072901|NCT02094222|Protective Agents|protective agents|mesh-ancestor
102072902|NCT02094222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072903|NCT02280590|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102072904|NCT02280590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102072905|NCT02280590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102072906|NCT02280590|Antimetabolites|antimetabolites|mesh-ancestor
102072907|NCT02280590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072908|NCT02280590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102072909|NCT02280590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102072910|NCT02280590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102072911|NCT02090244|Teriparatide|teriparatide|mesh-list
101374513|NCT00228046|Adrenergic Agents|adrenergic agents|mesh-ancestor
102072913|NCT02090244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072914|NCT02090244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102072916|NCT02282774|Bupivacaine|bupivacaine|mesh-list
102072917|NCT02282774|Anesthetics, Local|anesthetics, local|mesh-ancestor
102072918|NCT02282774|Anesthetics|anesthetics|mesh-ancestor
102072919|NCT02282774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102072920|NCT02282774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072921|NCT02282774|Sensory System Agents|sensory system agents|mesh-ancestor
102072922|NCT02282774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102072923|NCT02282774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102072924|NCT02282774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102072925|NCT02282774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102072926|NCT02282774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102072927|NCT02282774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792674|NCT00537303|Insulin|insulin|mesh-list
102072928|NCT02090322|Bevacizumab|bevacizumab|mesh-list
102072929|NCT02090322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102072930|NCT02090322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102072931|NCT02090322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102072932|NCT02090322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102072933|NCT02090322|Growth Substances|growth substances|mesh-ancestor
102072934|NCT02090322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072935|NCT02090322|Growth Inhibitors|growth inhibitors|mesh-ancestor
102072936|NCT03658785|Aldesleukin|aldesleukin|mesh-list
102072937|NCT03658785|Cyclophosphamide|cyclophosphamide|mesh-list
102072938|NCT03658785|Fludarabine|fludarabine|mesh-list
101943202|NCT01237119|Liraglutide|liraglutide|mesh-list
101943203|NCT01237119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102072939|NCT03658785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102072940|NCT03658785|Immunologic Factors|immunologic factors|mesh-ancestor
102072941|NCT03658785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072942|NCT03658785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102072943|NCT03658785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102072944|NCT03658785|Alkylating Agents|alkylating agents|mesh-ancestor
102072945|NCT03658785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072946|NCT03658785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102072947|NCT03658785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102072948|NCT03658785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102072949|NCT03658785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102072950|NCT03658785|Antiviral Agents|antiviral agents|mesh-ancestor
102072951|NCT03658785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102072952|NCT02095782|Paclitaxel|paclitaxel|mesh-list
102072953|NCT02095782|Carboplatin|carboplatin|mesh-list
102072954|NCT02095782|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102072955|NCT02095782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102072956|NCT02095782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102072957|NCT02095782|Tubulin Modulators|tubulin modulators|mesh-ancestor
102072958|NCT02095782|Antimitotic Agents|antimitotic agents|mesh-ancestor
102072959|NCT02095782|Mitosis Modulators|mitosis modulators|mesh-ancestor
102072960|NCT02095782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072961|NCT02095782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102072962|NCT02095782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102072963|NCT02094378|Esketamine|esketamine|mesh-list
102072964|NCT02094378|Antidepressive Agents|antidepressive agents|mesh-ancestor
102072965|NCT02094378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102072966|NCT02285738|Aspirin|aspirin|mesh-list
102072967|NCT02285738|Simvastatin|simvastatin|mesh-list
102072968|NCT02285738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102072969|NCT02285738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102072970|NCT02285738|Analgesics|analgesics|mesh-ancestor
102072971|NCT02285738|Sensory System Agents|sensory system agents|mesh-ancestor
102072972|NCT02285738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102072973|NCT02285738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072974|NCT02285738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102072975|NCT02285738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102072976|NCT02285738|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102072977|NCT02285738|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102072978|NCT02285738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072979|NCT02285738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102072980|NCT02285738|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102072981|NCT02285738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102072982|NCT02285738|Antipyretics|antipyretics|mesh-ancestor
102072983|NCT02285738|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102073002|NCT03134846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102073003|NCT01068717|Metformin|metformin|mesh-list
102073004|NCT01068717|Saxagliptin|saxagliptin|mesh-list
102073005|NCT01068717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102073006|NCT01068717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073007|NCT01068717|Incretins|incretins|mesh-ancestor
102073008|NCT01068717|Hormones|hormones|mesh-ancestor
102073009|NCT01068717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102073010|NCT01068717|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102073011|NCT01068717|Protease Inhibitors|protease inhibitors|mesh-ancestor
102073012|NCT01068717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102073013|NCT01068717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073014|NCT02095938|Amisulpride|amisulpride|mesh-list
102073015|NCT02095938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102073016|NCT02095938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102073017|NCT02095938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102073018|NCT02095938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073019|NCT02095938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102073020|NCT02095938|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102073021|NCT02095938|Dopamine Agents|dopamine agents|mesh-ancestor
102073022|NCT02095938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102073023|NCT02095938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073024|NCT02095938|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102073025|NCT02095938|Antidepressive Agents|antidepressive agents|mesh-ancestor
102073026|NCT02285972|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
102073027|NCT02285972|Tenoxicam|tenoxicam|mesh-list
101943204|NCT01237119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943205|NCT01237119|Incretins|incretins|mesh-ancestor
101943206|NCT01237119|Hormones|hormones|mesh-ancestor
101943207|NCT01237119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101943208|NCT03760263|Tacrolimus|tacrolimus|mesh-list
101943209|NCT03760263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101943210|NCT03760263|Immunologic Factors|immunologic factors|mesh-ancestor
101943211|NCT03760263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943212|NCT03760263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101943213|NCT03760263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101943214|NCT03760263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073028|NCT02285972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102073029|NCT02285972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102073030|NCT02285972|Analgesics|analgesics|mesh-ancestor
102073031|NCT02285972|Sensory System Agents|sensory system agents|mesh-ancestor
102073032|NCT02285972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102073033|NCT02285972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073034|NCT02285972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102073035|NCT02285972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101374649|NCT00228904|Insulin|insulin|mesh-list
102073042|NCT02096094|Disinfectants|disinfectants|mesh-ancestor
102073043|NCT02921763|Dydrogesterone|dydrogesterone|mesh-list
102073044|NCT02921763|Progestins|progestins|mesh-ancestor
102073045|NCT02921763|Hormones|hormones|mesh-ancestor
102073046|NCT02921763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102073047|NCT02921763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073048|NCT03658473|Naproxen|naproxen|mesh-list
102073049|NCT03658473|Rabeprazole|rabeprazole|mesh-list
102073050|NCT03658473|Rebamipide|rebamipide|mesh-list
102073051|NCT03658473|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102073052|NCT03658473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102073053|NCT03658473|Analgesics|analgesics|mesh-ancestor
102073054|NCT03658473|Sensory System Agents|sensory system agents|mesh-ancestor
102073055|NCT03658473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102073056|NCT03658473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073057|NCT03658473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102073058|NCT03658473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102073059|NCT03658473|Gout Suppressants|gout suppressants|mesh-ancestor
102073060|NCT03658473|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102073061|NCT03658473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102073062|NCT03658473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073063|NCT03658473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102073064|NCT03658473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102073065|NCT03658473|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102073066|NCT03658473|Antioxidants|antioxidants|mesh-ancestor
102073067|NCT03658473|Protective Agents|protective agents|mesh-ancestor
102073068|NCT02096250|Ferrous fumarate|ferrous fumarate|mesh-list
102073069|NCT02096250|Edetic Acid|edetic acid|mesh-list
102073070|NCT02096250|Ferric Compounds|ferric compounds|mesh-list
102073071|NCT02096250|Fe(III)-EDTA|fe(iii)-edta|mesh-list
102073072|NCT02096250|Trace Elements|trace elements|mesh-ancestor
102073073|NCT02096250|Micronutrients|micronutrients|mesh-ancestor
102073074|NCT02096250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073075|NCT02096250|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102073076|NCT02096250|Chelating Agents|chelating agents|mesh-ancestor
102073077|NCT02096250|Sequestering Agents|sequestering agents|mesh-ancestor
102073078|NCT02096250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073079|NCT02096250|Anticoagulants|anticoagulants|mesh-ancestor
102073080|NCT02096250|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102073081|NCT02096250|Hematinics|hematinics|mesh-ancestor
102073082|NCT02096328|Murepavadin|murepavadin|mesh-list
102073083|NCT02096328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102073084|NCT02096328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102073085|NCT01318135|Metformin|metformin|mesh-list
102073086|NCT01318135|Glimepiride|glimepiride|mesh-list
102073087|NCT01318135|Alogliptin|alogliptin|mesh-list
101943216|NCT01237275|Fluoxetine|fluoxetine|mesh-list
101663039|NCT02784054|Melphalan|melphalan|mesh-list
101943217|NCT01237275|Paroxetine|paroxetine|mesh-list
101943218|NCT01237275|Antidepressive Agents|antidepressive agents|mesh-ancestor
101943219|NCT01237275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101943220|NCT01237275|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101943221|NCT01237275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101943222|NCT01237275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101943223|NCT01237275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943224|NCT01237275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101943225|NCT01237275|Serotonin Agents|serotonin agents|mesh-ancestor
101943226|NCT01237275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943227|NCT01237275|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102073088|NCT01318135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102073089|NCT01318135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073090|NCT01318135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102073091|NCT01318135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102073092|NCT01318135|Immunologic Factors|immunologic factors|mesh-ancestor
102073093|NCT01318135|Incretins|incretins|mesh-ancestor
102073094|NCT01318135|Hormones|hormones|mesh-ancestor
102073095|NCT01318135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102073096|NCT01318135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102073097|NCT01318135|Protease Inhibitors|protease inhibitors|mesh-ancestor
102073098|NCT01318135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102073099|NCT01318135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073100|NCT02094924|Candesartan|candesartan|mesh-list
102073101|NCT02094924|Candesartan cilexetil|candesartan cilexetil|mesh-list
102073102|NCT02094924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102073103|NCT02094924|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102073104|NCT02094924|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101374702|NCT00229333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102073108|NCT02286206|Serotonin Agents|serotonin agents|mesh-ancestor
102073109|NCT02286206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102073110|NCT02286206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073111|NCT02286206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073112|NCT02286206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102073113|NCT02286206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102073114|NCT02286206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102073115|NCT02286206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102073116|NCT02286206|GABA Antagonists|gaba antagonists|mesh-ancestor
102073117|NCT02286206|GABA Agents|gaba agents|mesh-ancestor
102073118|NCT03104283|Apatinib|apatinib|mesh-list
102073119|NCT03104283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102073120|NCT03104283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102073121|NCT03104283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102073122|NCT03104283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073123|NCT00529178|Pravastatin|pravastatin|mesh-list
102073124|NCT00529178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102073125|NCT00529178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102073126|NCT00529178|Antimetabolites|antimetabolites|mesh-ancestor
102073127|NCT00529178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073128|NCT00529178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102073129|NCT00529178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102073130|NCT00529178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102073131|NCT00382460|Pravastatin|pravastatin|mesh-list
102073132|NCT00382460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102073133|NCT00382460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102073134|NCT00382460|Antimetabolites|antimetabolites|mesh-ancestor
101943228|NCT01237275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101943229|NCT01237275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101943231|NCT01237977|Botulinum Toxins|botulinum toxins|mesh-list
102073135|NCT00382460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073136|NCT00382460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102073137|NCT00382460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102073138|NCT00382460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102073139|NCT00523250|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102073140|NCT00523250|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102073141|NCT02286596|Heparin|heparin|mesh-list
102073142|NCT02286596|Dextrans|dextrans|mesh-list
102073143|NCT02286596|Anticoagulants|anticoagulants|mesh-ancestor
102073144|NCT02286596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102073145|NCT02286596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102073146|NCT02286596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073147|NCT02286596|Plasma Substitutes|plasma substitutes|mesh-ancestor
102073148|NCT02286596|Blood Substitutes|blood substitutes|mesh-ancestor
102073149|NCT02098824|Methylphenidate|methylphenidate|mesh-list
102073150|NCT02098824|Galantamine|galantamine|mesh-list
102073151|NCT02098824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102073152|NCT02098824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073153|NCT02098824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102073154|NCT02098824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102073155|NCT02098824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102073156|NCT02098824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073157|NCT02098824|Dopamine Agents|dopamine agents|mesh-ancestor
102073158|NCT02098824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102073159|NCT02098824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102073160|NCT02098824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102073161|NCT02098824|Cholinergic Agents|cholinergic agents|mesh-ancestor
102073162|NCT02098824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102073163|NCT02098824|Autonomic Agents|autonomic agents|mesh-ancestor
102073164|NCT02098824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102073165|NCT02098824|Nootropic Agents|nootropic agents|mesh-ancestor
102073166|NCT03658317|Uric Acid|uric acid|mesh-list
102073167|NCT03658317|Antioxidants|antioxidants|mesh-ancestor
102073168|NCT03658317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073169|NCT03658317|Protective Agents|protective agents|mesh-ancestor
102073170|NCT03658317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073171|NCT02286752|Neostigmine|neostigmine|mesh-list
102073172|NCT02286752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102073173|NCT02286752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102073174|NCT02286752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073175|NCT02286752|Cholinergic Agents|cholinergic agents|mesh-ancestor
102073183|NCT04470050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102073184|NCT04470050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073185|NCT04470050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102073186|NCT04470050|Analgesics|analgesics|mesh-ancestor
102073187|NCT04470050|Sensory System Agents|sensory system agents|mesh-ancestor
101702095|NCT00686556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102073188|NCT04470050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102073189|NCT04470050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102073190|NCT04470050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102073191|NCT04470050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102073192|NCT04470050|Adrenergic Agents|adrenergic agents|mesh-ancestor
102073193|NCT04470050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102073194|NCT04470050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073195|NCT02095314|Vaccines|vaccines|mesh-list
102073196|NCT02095314|Immunologic Factors|immunologic factors|mesh-ancestor
102073197|NCT02095314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073198|NCT02098980|Vitamin D|vitamin d|mesh-list
102073199|NCT02098980|Vitamins|vitamins|mesh-ancestor
102073200|NCT02098980|Micronutrients|micronutrients|mesh-ancestor
102073201|NCT02098980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073202|NCT02098980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102073203|NCT00372944|Capecitabine|capecitabine|mesh-list
102073204|NCT00372944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102073205|NCT00372944|Antimetabolites|antimetabolites|mesh-ancestor
102073206|NCT00372944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943232|NCT01237977|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101943233|NCT01237977|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101943234|NCT01237977|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101943235|NCT01237977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102073207|NCT00372944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102073208|NCT02099136|Celecoxib|celecoxib|mesh-list
102073209|NCT02099136|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102073210|NCT02099136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102073211|NCT02099136|Analgesics|analgesics|mesh-ancestor
102073212|NCT02099136|Sensory System Agents|sensory system agents|mesh-ancestor
102073213|NCT02099136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102073214|NCT02099136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073215|NCT02099136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102073216|NCT02099136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102073217|NCT02099136|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102073218|NCT02099136|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102073219|NCT02099136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102073220|NCT02099136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073221|NCT00117650|Etoposide|etoposide|mesh-list
102073222|NCT00117650|Etoposide phosphate|etoposide phosphate|mesh-list
102073223|NCT00117650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102073224|NCT00117650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102073225|NCT00117650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102073226|NCT00117650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102073227|NCT00117650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102073228|NCT00117650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073229|NCT02095548|Lorecivivint|lorecivivint|mesh-list
102073230|NCT02095548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102073232|NCT00113438|Fosbretabulin|fosbretabulin|mesh-list
102073233|NCT00113438|Combretastatin|combretastatin|mesh-list
102073234|NCT00113438|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102073235|NCT00113438|Carboplatin|carboplatin|mesh-list
102073236|NCT00113438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102073237|NCT00113438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102073238|NCT00113438|Tubulin Modulators|tubulin modulators|mesh-ancestor
102073239|NCT00113438|Antimitotic Agents|antimitotic agents|mesh-ancestor
102073240|NCT00113438|Mitosis Modulators|mitosis modulators|mesh-ancestor
102073241|NCT00113438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073242|NCT04087408|Hormones|hormones|mesh-list
102073243|NCT04087408|Progesterone|progesterone|mesh-list
101374842|NCT00230035|Thymoglobulin|thymoglobulin|mesh-list
102073259|NCT02283242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073260|NCT02283242|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101702111|NCT04070482|Tenofovir|tenofovir|mesh-list
102073261|NCT02283242|Autonomic Agents|autonomic agents|mesh-ancestor
102073262|NCT02283242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102073263|NCT02283242|Nootropic Agents|nootropic agents|mesh-ancestor
102073264|NCT02283320|Docetaxel|docetaxel|mesh-list
102073265|NCT02283320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102073266|NCT02283320|Tubulin Modulators|tubulin modulators|mesh-ancestor
102073267|NCT02283320|Antimitotic Agents|antimitotic agents|mesh-ancestor
102073268|NCT02283320|Mitosis Modulators|mitosis modulators|mesh-ancestor
102073269|NCT02283320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073270|NCT03556098|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
102073271|NCT03556098|Hormones|hormones|mesh-list
102073272|NCT03556098|Incretins|incretins|mesh-list
102073273|NCT03556098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073274|NCT03556098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102073275|NCT03556098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102073276|NCT02286986|Cannabidiol|cannabidiol|mesh-list
102073277|NCT02286986|Anticonvulsants|anticonvulsants|mesh-ancestor
102073278|NCT04995874|Micronutrients|micronutrients|mesh-list
102073279|NCT04995874|Trace Elements|trace elements|mesh-list
102073280|NCT04995874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073281|NCT02287064|Immunoglobulins|immunoglobulins|mesh-list
102073282|NCT02287064|Antibodies|antibodies|mesh-list
102073283|NCT02287064|gamma-Globulins|gamma-globulins|mesh-list
102073284|NCT02287064|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102073285|NCT02287064|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102073286|NCT02287064|Immunologic Factors|immunologic factors|mesh-ancestor
102073287|NCT02287064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073288|NCT02095704|Acetaminophen|acetaminophen|mesh-list
102073289|NCT02095704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102073290|NCT02095704|Analgesics|analgesics|mesh-ancestor
102073291|NCT02095704|Sensory System Agents|sensory system agents|mesh-ancestor
102073292|NCT02095704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102073293|NCT02095704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073294|NCT02095704|Antipyretics|antipyretics|mesh-ancestor
102073295|NCT02099604|Vitamin D|vitamin d|mesh-list
102073296|NCT02099604|Interferons|interferons|mesh-list
102073297|NCT02099604|Ribavirin|ribavirin|mesh-list
102073298|NCT02099604|Interferon-alpha|interferon-alpha|mesh-list
102073299|NCT02099604|Interferon alpha-2|interferon alpha-2|mesh-list
102073300|NCT02099604|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102073301|NCT02099604|Vitamins|vitamins|mesh-ancestor
102073302|NCT02099604|Micronutrients|micronutrients|mesh-ancestor
102073303|NCT02099604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073304|NCT02099604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102073309|NCT02099604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073311|NCT02099916|Menotropins|menotropins|mesh-list
102073312|NCT02099916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073313|NCT02099916|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102073314|NCT02099916|Fertility Agents|fertility agents|mesh-ancestor
102073315|NCT02099916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102073316|NCT02102646|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102073317|NCT02102646|Luteolytic Agents|luteolytic agents|mesh-ancestor
102073318|NCT02102646|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102073319|NCT02102646|Contraceptive Agents|contraceptive agents|mesh-ancestor
102073320|NCT02102646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102073321|NCT02102646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073322|NCT02102646|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102073323|NCT02102646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102073324|NCT02102646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102073325|NCT00366704|Risperidone|risperidone|mesh-list
102073326|NCT00366704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102073327|NCT00366704|Serotonin Agents|serotonin agents|mesh-ancestor
102073328|NCT00366704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102073329|NCT00366704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073330|NCT00366704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073331|NCT00366704|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102073332|NCT00366704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102073333|NCT00366704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102073334|NCT00366704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102073335|NCT00366704|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102073336|NCT00366704|Dopamine Agents|dopamine agents|mesh-ancestor
102073337|NCT02097264|Adalimumab|adalimumab|mesh-list
102073338|NCT02097264|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102073339|NCT02097264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102073340|NCT02097264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102073341|NCT02097342|Linagliptin|linagliptin|mesh-list
102073342|NCT02097342|Voglibose|voglibose|mesh-list
102073343|NCT02097342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102073344|NCT02097342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073345|NCT02097342|Incretins|incretins|mesh-ancestor
102073346|NCT02097342|Hormones|hormones|mesh-ancestor
102073347|NCT02097342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102073348|NCT02097342|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102073349|NCT02097342|Protease Inhibitors|protease inhibitors|mesh-ancestor
102073350|NCT02097342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102073351|NCT02097342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073352|NCT02097342|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102073353|NCT04294498|Entecavir|entecavir|mesh-list
102073354|NCT04294498|Durvalumab|durvalumab|mesh-list
102073355|NCT04294498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102073356|NCT04294498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102073357|NCT04294498|Antiviral Agents|antiviral agents|mesh-ancestor
102073358|NCT04294498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102073359|NCT04059172|Ibuprofen|ibuprofen|mesh-list
102073360|NCT04059172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102073361|NCT04059172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102073362|NCT04059172|Analgesics|analgesics|mesh-ancestor
102073363|NCT04059172|Sensory System Agents|sensory system agents|mesh-ancestor
102073364|NCT04059172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102073365|NCT04059172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073366|NCT04059172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102073367|NCT04059172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102073368|NCT04059172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102073369|NCT04059172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101943236|NCT01237977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943237|NCT01237977|Cholinergic Agents|cholinergic agents|mesh-ancestor
102073370|NCT04059172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073372|NCT00359450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102073373|NCT03530462|Methylprednisolone|methylprednisolone|mesh-list
102073374|NCT03530462|Cyclophosphamide|cyclophosphamide|mesh-list
102073375|NCT03530462|Rituximab|rituximab|mesh-list
102073376|NCT03530462|Immunoglobulins|immunoglobulins|mesh-list
102073377|NCT03530462|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101702144|NCT00723502|Esomeprazole|esomeprazole|mesh-list
102073383|NCT03530462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073384|NCT03530462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102073385|NCT03530462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102073386|NCT03530462|Alkylating Agents|alkylating agents|mesh-ancestor
102073387|NCT03530462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073388|NCT03530462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102073389|NCT03530462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102073390|NCT03530462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102073391|NCT03530462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102073392|NCT03530462|Antiemetics|antiemetics|mesh-ancestor
102073393|NCT03530462|Autonomic Agents|autonomic agents|mesh-ancestor
102073394|NCT03530462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102073395|NCT03530462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102073396|NCT03530462|Glucocorticoids|glucocorticoids|mesh-ancestor
102073397|NCT03530462|Hormones|hormones|mesh-ancestor
102073398|NCT03530462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102073399|NCT03530462|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102073400|NCT03530462|Protective Agents|protective agents|mesh-ancestor
102073401|NCT02103192|Antioxidants|antioxidants|mesh-list
102073402|NCT02103192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073403|NCT02103192|Protective Agents|protective agents|mesh-ancestor
102073404|NCT02103192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073405|NCT02097810|Entrectinib|entrectinib|mesh-list
102073406|NCT02097810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102073407|NCT02097810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102073408|NCT02097810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073409|NCT02100462|Aspirin|aspirin|mesh-list
102073410|NCT02100462|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102073411|NCT02100462|Chlorthalidone|chlorthalidone|mesh-list
102073412|NCT02100462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102073413|NCT02100462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102073414|NCT02100462|Analgesics|analgesics|mesh-ancestor
102073415|NCT02100462|Sensory System Agents|sensory system agents|mesh-ancestor
102073416|NCT02100462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102073417|NCT02100462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073418|NCT02100462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102073419|NCT02100462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102073420|NCT02100462|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102073421|NCT02100462|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102073422|NCT02100462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073423|NCT02100462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102073424|NCT02100462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102073425|NCT02100462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102073426|NCT02100462|Antipyretics|antipyretics|mesh-ancestor
102073427|NCT02100462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102073428|NCT02100462|Diuretics|diuretics|mesh-ancestor
102073429|NCT02100462|Natriuretic Agents|natriuretic agents|mesh-ancestor
102073430|NCT02100462|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102073431|NCT02100462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102073432|NCT04507126|BCG Vaccine|bcg vaccine|mesh-list
102073433|NCT04507126|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102073434|NCT04507126|Immunologic Factors|immunologic factors|mesh-ancestor
102073435|NCT04507126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073436|NCT00150176|Asenapine|asenapine|mesh-list
102073437|NCT00150176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102073438|NCT00150176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102073439|NCT00150176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102073440|NCT00150176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073441|NCT00150176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102073442|NCT00961792|Diphenhydramine|diphenhydramine|mesh-list
102073443|NCT00961792|Promethazine|promethazine|mesh-list
102073444|NCT00961792|Ethanol|ethanol|mesh-list
102073445|NCT00961792|Caffeine|caffeine|mesh-list
101943238|NCT01237977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101943239|NCT01237977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943241|NCT01237977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101943242|NCT02033434|Ketamine|ketamine|mesh-list
102073446|NCT00961792|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102073447|NCT00961792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375043|NCT00063596|Vitamin A|vitamin a|mesh-list
102073475|NCT02100852|Obinutuzumab|obinutuzumab|mesh-list
102073476|NCT02100852|Chlorambucil|chlorambucil|mesh-list
102073477|NCT02100852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102073478|NCT02100852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102073479|NCT02100852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102073480|NCT02100852|Alkylating Agents|alkylating agents|mesh-ancestor
102073481|NCT02100852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073482|NCT00057980|Celecoxib|celecoxib|mesh-list
102073483|NCT00057980|Epirubicin|epirubicin|mesh-list
102073484|NCT00057980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102073485|NCT00057980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102073486|NCT00057980|Analgesics|analgesics|mesh-ancestor
102073487|NCT00057980|Sensory System Agents|sensory system agents|mesh-ancestor
102073488|NCT00057980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102073489|NCT00057980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073490|NCT00057980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102073491|NCT00057980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102073492|NCT00057980|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102073493|NCT00057980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102073494|NCT00057980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101375115|NCT00075933|Antiviral Agents|antiviral agents|mesh-ancestor
102073504|NCT02097966|Antimetabolites|antimetabolites|mesh-ancestor
102073505|NCT02097966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073506|NCT02097966|Antiviral Agents|antiviral agents|mesh-ancestor
102073507|NCT02097966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102073508|NCT00052598|Aldesleukin|aldesleukin|mesh-list
102073509|NCT00052598|Interleukin-2|interleukin-2|mesh-list
102073510|NCT00052598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102073511|NCT00052598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102073512|NCT00052598|Analgesics|analgesics|mesh-ancestor
102073513|NCT00052598|Sensory System Agents|sensory system agents|mesh-ancestor
102073514|NCT00052598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102073515|NCT00052598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073516|NCT00052598|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102073517|NCT00052598|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102073518|NCT00052598|Antiviral Agents|antiviral agents|mesh-ancestor
102073519|NCT00052598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102073520|NCT05037994|Prednisolone|prednisolone|mesh-list
102073521|NCT05037994|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102073522|NCT05037994|Methylprednisolone|methylprednisolone|mesh-list
102073523|NCT05037994|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102073524|NCT05037994|Prednisolone acetate|prednisolone acetate|mesh-list
102073525|NCT05037994|Gabapentin|gabapentin|mesh-list
102073526|NCT05037994|Bupivacaine|bupivacaine|mesh-list
102073527|NCT05037994|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102073528|NCT05037994|Prednisolone phosphate|prednisolone phosphate|mesh-list
102073529|NCT05037994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102073530|NCT05037994|Glucocorticoids|glucocorticoids|mesh-ancestor
102073531|NCT05037994|Hormones|hormones|mesh-ancestor
102073532|NCT05037994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102073533|NCT05037994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073534|NCT05037994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102073535|NCT05037994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102073536|NCT05037994|Antiemetics|antiemetics|mesh-ancestor
102073537|NCT05037994|Autonomic Agents|autonomic agents|mesh-ancestor
102073538|NCT05037994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102073539|NCT05037994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102073540|NCT05037994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102073541|NCT05037994|Protective Agents|protective agents|mesh-ancestor
102073542|NCT05037994|Analgesics|analgesics|mesh-ancestor
102073543|NCT05037994|Sensory System Agents|sensory system agents|mesh-ancestor
102073544|NCT05037994|Anticonvulsants|anticonvulsants|mesh-ancestor
102073545|NCT05037994|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102073546|NCT05037994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101943243|NCT02033434|Analgesics|analgesics|mesh-ancestor
101943244|NCT02033434|Sensory System Agents|sensory system agents|mesh-ancestor
101943245|NCT02033434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102073547|NCT05037994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102073548|NCT05037994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102073549|NCT05037994|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102073550|NCT05037994|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102073551|NCT05037994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102073552|NCT05037994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073553|NCT05037994|Antimanic Agents|antimanic agents|mesh-ancestor
102073554|NCT05037994|Anesthetics, Local|anesthetics, local|mesh-ancestor
102073555|NCT05037994|Anesthetics|anesthetics|mesh-ancestor
102073556|NCT00052520|Aldesleukin|aldesleukin|mesh-list
102073557|NCT00052520|Interleukin-2|interleukin-2|mesh-list
102073558|NCT00052520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102073559|NCT00052520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102073560|NCT00052520|Analgesics|analgesics|mesh-ancestor
102073561|NCT00052520|Sensory System Agents|sensory system agents|mesh-ancestor
102073562|NCT00052520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101375171|NCT00232492|Ketamine|ketamine|mesh-list
102073567|NCT00052520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102073569|NCT05036434|Lenvatinib|lenvatinib|mesh-list
102073570|NCT05036434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102073571|NCT05036434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102073572|NCT05036434|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102073573|NCT05036434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073574|NCT05036434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102073575|NCT05036434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102073576|NCT00051038|Entecavir|entecavir|mesh-list
102073577|NCT00051038|Antiviral Agents|antiviral agents|mesh-ancestor
102073578|NCT00051038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102073579|NCT05035186|Amoxicillin|amoxicillin|mesh-list
102073580|NCT05035186|Clarithromycin|clarithromycin|mesh-list
102073581|NCT05035186|Levofloxacin|levofloxacin|mesh-list
102073582|NCT05035186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102073583|NCT05035186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102073584|NCT05035186|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102073585|NCT05035186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102073586|NCT05035186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073587|NCT05035186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102073588|NCT05035186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102073589|NCT05035186|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102073590|NCT05035186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102073591|NCT05035186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102073592|NCT05035186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102073593|NCT05035186|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102073594|NCT01067469|Bevacizumab|bevacizumab|mesh-list
102073595|NCT01067469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102073596|NCT01067469|Lomustine|lomustine|mesh-list
102073597|NCT01067469|Antibodies|antibodies|mesh-list
102073598|NCT01067469|Immunoglobulins|immunoglobulins|mesh-list
102073599|NCT01067469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102073600|NCT01067469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102073601|NCT01067469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102073602|NCT01067469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102073603|NCT01067469|Growth Substances|growth substances|mesh-ancestor
102073604|NCT01067469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073605|NCT01067469|Growth Inhibitors|growth inhibitors|mesh-ancestor
102073606|NCT01067469|Immunologic Factors|immunologic factors|mesh-ancestor
101793350|NCT01011166|Ribavirin|ribavirin|mesh-list
102073607|NCT01067469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102073608|NCT01067469|Alkylating Agents|alkylating agents|mesh-ancestor
102073609|NCT01067469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073610|NCT00050102|Ipilimumab|ipilimumab|mesh-list
102073611|NCT00050102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102073612|NCT00050102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102073613|NCT00050102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102073614|NCT00050102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073615|NCT02103660|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102073616|NCT02103660|Contraceptive Agents|contraceptive agents|mesh-list
102073617|NCT02103660|Medroxyprogesterone|medroxyprogesterone|mesh-list
102073618|NCT02103660|Progestins|progestins|mesh-list
101943246|NCT02033434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943247|NCT02033434|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101943248|NCT02033434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101943249|NCT02033434|Anesthetics, General|anesthetics, general|mesh-ancestor
101943250|NCT02033434|Anesthetics|anesthetics|mesh-ancestor
101943251|NCT02033434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102073619|NCT02103660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102073620|NCT02103660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073621|NCT02103660|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102073622|NCT02103660|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102073623|NCT02103660|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102073624|NCT02103660|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102073625|NCT02103660|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102073626|NCT02103660|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102073627|NCT02103660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102073628|NCT02103660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102073629|NCT02103660|Hormones|hormones|mesh-ancestor
102073630|NCT02103660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102073631|NCT02788773|Durvalumab|durvalumab|mesh-list
102073659|NCT02985021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073661|NCT05714540|Ketamine|ketamine|mesh-list
102073662|NCT05714540|Analgesics|analgesics|mesh-ancestor
102073663|NCT05714540|Sensory System Agents|sensory system agents|mesh-ancestor
101525453|NCT03026517|Phenformin|phenformin|mesh-list
102073664|NCT05714540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102073665|NCT05714540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073666|NCT05714540|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102073667|NCT05714540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102073668|NCT05714540|Anesthetics, General|anesthetics, general|mesh-ancestor
102073669|NCT05714540|Anesthetics|anesthetics|mesh-ancestor
102073670|NCT05714540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102073671|NCT05714540|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102073672|NCT05714540|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102073673|NCT05714540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102073674|NCT05714540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073675|NCT05714540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102073676|NCT05714540|Anticonvulsants|anticonvulsants|mesh-ancestor
102073677|NCT05714540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102073678|NCT05714540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101375300|NCT02958566|Fentanyl|fentanyl|mesh-list
102073746|NCT03657381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102073747|NCT03657381|Immunologic Factors|immunologic factors|mesh-ancestor
102073748|NCT03657381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073750|NCT00005918|Efavirenz|efavirenz|mesh-list
102073751|NCT00005918|Stavudine|stavudine|mesh-list
102073752|NCT00005918|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102073753|NCT00005918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102073754|NCT00005918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102073755|NCT00005918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575046|NCT05215873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102073756|NCT00005918|Antiviral Agents|antiviral agents|mesh-ancestor
102073757|NCT00005918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102073758|NCT00005918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102076346|NCT05705635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076347|NCT05204550|Heparin|heparin|mesh-list
102076348|NCT05204550|Calcium heparin|calcium heparin|mesh-list
102076349|NCT05204550|Anticoagulants|anticoagulants|mesh-ancestor
102076350|NCT05204550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102076351|NCT05204550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102076352|NCT05204550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076353|NCT00085774|Albuterol|albuterol|mesh-list
102076354|NCT00085774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102076355|NCT00085774|Autonomic Agents|autonomic agents|mesh-ancestor
102076356|NCT00085774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102076357|NCT00085774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076358|NCT00085774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102076359|NCT00085774|Respiratory System Agents|respiratory system agents|mesh-ancestor
102076360|NCT00085774|Tocolytic Agents|tocolytic agents|mesh-ancestor
101943252|NCT02033434|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101943253|NCT02033434|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101943254|NCT02033434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102076361|NCT00085774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102076362|NCT00085774|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102076363|NCT00085774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102076364|NCT00085774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102076365|NCT00085774|Adrenergic Agents|adrenergic agents|mesh-ancestor
102076366|NCT00085774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102076367|NCT00085774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076368|NCT04491682|Megestrol|megestrol|mesh-list
102076369|NCT04491682|Megestrol Acetate|megestrol acetate|mesh-list
102076370|NCT04491682|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102076371|NCT04491682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102076372|NCT04491682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102076373|NCT04491682|Antimetabolites|antimetabolites|mesh-ancestor
102076374|NCT04491682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076375|NCT04491682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102076376|NCT04491682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102076377|NCT04491682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102076378|NCT04491682|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102076379|NCT04491682|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102076380|NCT04491682|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102076381|NCT04491682|Contraceptive Agents|contraceptive agents|mesh-ancestor
102076382|NCT04491682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102076383|NCT04491682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076384|NCT04491682|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102076385|NCT04491682|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102076386|NCT04491682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102076387|NCT04491682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102076388|NCT04491682|Appetite Stimulants|appetite stimulants|mesh-ancestor
101377994|NCT00249964|Tubulin Modulators|tubulin modulators|mesh-ancestor
102076412|NCT05193968|Tocolytic Agents|tocolytic agents|mesh-ancestor
102076413|NCT05193968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102076414|NCT05193968|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102076415|NCT05193968|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102076416|NCT02137356|Capecitabine|capecitabine|mesh-list
102076417|NCT02137356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102076418|NCT02137356|Antimetabolites|antimetabolites|mesh-ancestor
102076419|NCT02137356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076420|NCT02137356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102076421|NCT05137288|Atropine|atropine|mesh-list
102076422|NCT05137288|Ondansetron|ondansetron|mesh-list
102076423|NCT05137288|Bupivacaine|bupivacaine|mesh-list
102076424|NCT05137288|Anesthetics, Local|anesthetics, local|mesh-ancestor
102076425|NCT05137288|Anesthetics|anesthetics|mesh-ancestor
102076426|NCT05137288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102076427|NCT05137288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076428|NCT05137288|Sensory System Agents|sensory system agents|mesh-ancestor
102076429|NCT05137288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102076430|NCT05137288|Antiemetics|antiemetics|mesh-ancestor
102076431|NCT05137288|Autonomic Agents|autonomic agents|mesh-ancestor
102076432|NCT05137288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102076433|NCT05137288|Antipruritics|antipruritics|mesh-ancestor
102076434|NCT05137288|Dermatologic Agents|dermatologic agents|mesh-ancestor
102076435|NCT05137288|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102076436|NCT05137288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102076437|NCT05137288|Serotonin Agents|serotonin agents|mesh-ancestor
102076438|NCT05137288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102076439|NCT05137288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076440|NCT05137288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102076441|NCT05137288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102076444|NCT05137288|Respiratory System Agents|respiratory system agents|mesh-ancestor
102076445|NCT05137288|Mydriatics|mydriatics|mesh-ancestor
102076446|NCT05137288|Parasympatholytics|parasympatholytics|mesh-ancestor
102076447|NCT05137288|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102076448|NCT05137288|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102076449|NCT05137288|Cholinergic Agents|cholinergic agents|mesh-ancestor
102076450|NCT05135182|Metronidazole|metronidazole|mesh-list
101943255|NCT02033434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943256|NCT02033512|Hormones|hormones|mesh-list
101943257|NCT02033512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101943258|NCT02033512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076451|NCT05135182|Furazolidone|furazolidone|mesh-list
102076452|NCT05135182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102076453|NCT05135182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102076454|NCT05135182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102076455|NCT05135182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102076456|NCT05135182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102076457|NCT05135182|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102076458|NCT05135182|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
102076459|NCT05135182|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102076460|NCT05135182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102076461|NCT05135182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076462|NCT02137434|Calcium, Dietary|calcium, dietary|mesh-list
102076463|NCT02137434|Calcium|calcium|mesh-list
102076464|NCT02137434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102076465|NCT02137434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076466|NCT02137434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102076467|NCT02137668|Vancomycin|vancomycin|mesh-list
102076468|NCT02137668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102076469|NCT02137668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102076470|NCT04216472|Paclitaxel|paclitaxel|mesh-list
102076471|NCT04216472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102076472|NCT04216472|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
102076473|NCT04216472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102076474|NCT04216472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102076475|NCT04216472|Tubulin Modulators|tubulin modulators|mesh-ancestor
102076476|NCT04216472|Antimitotic Agents|antimitotic agents|mesh-ancestor
102076477|NCT04216472|Mitosis Modulators|mitosis modulators|mesh-ancestor
102076478|NCT04216472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076479|NCT04216472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102076480|NCT03522428|Vitamin B 12|vitamin b 12|mesh-list
102076481|NCT03522428|Hydroxocobalamin|hydroxocobalamin|mesh-list
102076482|NCT03522428|Vitamins|vitamins|mesh-ancestor
102076483|NCT03522428|Micronutrients|micronutrients|mesh-ancestor
102076484|NCT03522428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076485|NCT03522428|Vitamin B Complex|vitamin b complex|mesh-ancestor
102076486|NCT03522428|Hematinics|hematinics|mesh-ancestor
102076487|NCT05575999|Ketorolac|ketorolac|mesh-list
102076488|NCT05575999|Ketamine|ketamine|mesh-list
102076489|NCT05575999|Bupivacaine|bupivacaine|mesh-list
102076490|NCT05575999|Anesthetics, Local|anesthetics, local|mesh-ancestor
102076491|NCT05575999|Anesthetics|anesthetics|mesh-ancestor
102076492|NCT05575999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102076493|NCT05575999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076494|NCT05575999|Sensory System Agents|sensory system agents|mesh-ancestor
102076495|NCT05575999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102076496|NCT05575999|Analgesics|analgesics|mesh-ancestor
102076497|NCT05575999|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102076498|NCT05575999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102076499|NCT05575999|Anesthetics, General|anesthetics, general|mesh-ancestor
102076500|NCT05575999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102076501|NCT05575999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102076502|NCT05575999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102076503|NCT05575999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076504|NCT05575999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102076505|NCT05575999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102076506|NCT05575999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102076507|NCT05575999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102076508|NCT05575999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102076509|NCT05575999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102076510|NCT01062399|Everolimus|everolimus|mesh-list
102076511|NCT01062399|Temozolomide|temozolomide|mesh-list
102076512|NCT01062399|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102076513|NCT01062399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102076514|NCT01062399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102076515|NCT01062399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076519|NCT01062399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101943259|NCT02712112|Imatinib Mesylate|imatinib mesylate|mesh-list
101943260|NCT02712112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101943261|NCT02712112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101943262|NCT02712112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102076520|NCT01062399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102076521|NCT01062399|Alkylating Agents|alkylating agents|mesh-ancestor
102076522|NCT05136508|Propofol|propofol|mesh-list
102076523|NCT05136508|Sevoflurane|sevoflurane|mesh-list
102076524|NCT05136508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102076525|NCT05136508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102076526|NCT05136508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076527|NCT05136508|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102076528|NCT05136508|Anesthetics, General|anesthetics, general|mesh-ancestor
102076529|NCT05136508|Anesthetics|anesthetics|mesh-ancestor
102076530|NCT05136508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102076531|NCT05136508|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102076532|NCT02129322|Oxaliplatin|oxaliplatin|mesh-list
102076533|NCT02129322|Sorafenib|sorafenib|mesh-list
102076534|NCT02129322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102076535|NCT02129322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102076536|NCT02129322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102076537|NCT02129322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076538|NCT05125978|Dipyrone|dipyrone|mesh-list
102076539|NCT05125978|Tramadol|tramadol|mesh-list
102076540|NCT05125978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102076541|NCT05125978|Narcotics|narcotics|mesh-ancestor
102076542|NCT05125978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102076543|NCT05125978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076544|NCT05125978|Analgesics|analgesics|mesh-ancestor
102076545|NCT05125978|Sensory System Agents|sensory system agents|mesh-ancestor
102076546|NCT05125978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102076547|NCT05125978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102076548|NCT05125978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102076549|NCT05125978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102076550|NCT05125978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102076551|NCT05125978|Antipyretics|antipyretics|mesh-ancestor
102076552|NCT03767712|Antibodies|antibodies|mesh-list
102076553|NCT03767712|Antibodies, Antinuclear|antibodies, antinuclear|mesh-list
102076554|NCT03767712|Immunologic Factors|immunologic factors|mesh-ancestor
102076555|NCT03767712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076556|NCT05221411|Mycophenolic Acid|mycophenolic acid|mesh-list
102076557|NCT05221411|Tacrolimus|tacrolimus|mesh-list
102076558|NCT05221411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102076559|NCT05221411|Immunologic Factors|immunologic factors|mesh-ancestor
102076560|NCT05221411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076561|NCT05221411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102076562|NCT05221411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102076563|NCT05221411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076564|NCT05221411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102076565|NCT05221411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102076566|NCT05221411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102076567|NCT05221411|Antitubercular Agents|antitubercular agents|mesh-ancestor
102076568|NCT05221411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102076569|NCT05221411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102076570|NCT05306002|Antioxidants|antioxidants|mesh-list
102076571|NCT05306002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076572|NCT05306002|Protective Agents|protective agents|mesh-ancestor
102076573|NCT05306002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076574|NCT04346914|Carboplatin|carboplatin|mesh-list
102076575|NCT04346914|Etoposide|etoposide|mesh-list
102076576|NCT04346914|Antibodies|antibodies|mesh-list
102076577|NCT04346914|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102076578|NCT04346914|Immunologic Factors|immunologic factors|mesh-ancestor
102076579|NCT04346914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076580|NCT04346914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102076581|NCT04346914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102076582|NCT04346914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102076583|NCT04346914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102076584|NCT04346914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102076585|NCT04346914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076586|NCT02129400|Anesthetics|anesthetics|mesh-list
102076587|NCT02129400|Xenon|xenon|mesh-list
101971933|NCT02083250|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101971934|NCT02083250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102076588|NCT02129400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102076593|NCT05305768|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102076594|NCT05305768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102076595|NCT05305768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076596|NCT05305768|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102076597|NCT05305768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102076598|NCT05305768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076599|NCT05305768|Cholinergic Agents|cholinergic agents|mesh-ancestor
102076600|NCT05305768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102076601|NCT02133378|Hemostatics|hemostatics|mesh-list
102076602|NCT02133378|Coagulants|coagulants|mesh-ancestor
102076603|NCT04171622|Pembrolizumab|pembrolizumab|mesh-list
102076604|NCT04171622|Lenvatinib|lenvatinib|mesh-list
102076605|NCT04171622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102076606|NCT04171622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102076607|NCT04171622|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102076608|NCT04171622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076609|NCT04171622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102076610|NCT04171622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102076611|NCT05234580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102076612|NCT02138058|Topiramate|topiramate|mesh-list
102076613|NCT02138058|Anticonvulsants|anticonvulsants|mesh-ancestor
102076614|NCT02138058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102076615|NCT02138058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076616|NCT02129634|Paclitaxel|paclitaxel|mesh-list
102076617|NCT02129634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102076618|NCT02129634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102076619|NCT02129634|Tubulin Modulators|tubulin modulators|mesh-ancestor
102076620|NCT02129634|Antimitotic Agents|antimitotic agents|mesh-ancestor
102076621|NCT02129634|Mitosis Modulators|mitosis modulators|mesh-ancestor
102076622|NCT02129634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076623|NCT05174455|Niraparib|niraparib|mesh-list
102076624|NCT05174455|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102076625|NCT05174455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102076626|NCT05174455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076627|NCT05174455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102076628|NCT05162053|Clopidogrel|clopidogrel|mesh-list
102076629|NCT05162053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102076630|NCT05162053|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102076631|NCT05162053|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102076632|NCT05162053|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102076633|NCT05162053|Purinergic Agents|purinergic agents|mesh-ancestor
102076634|NCT05162053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102076635|NCT05162053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076636|NCT05162053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076637|NCT02138292|Trametinib|trametinib|mesh-list
102076638|NCT02138292|Digoxin|digoxin|mesh-list
102076639|NCT02138292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102076640|NCT02138292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102076641|NCT02138292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102076642|NCT02138292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076643|NCT02138292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102076644|NCT02138292|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102076645|NCT02138292|Protective Agents|protective agents|mesh-ancestor
102076646|NCT02138292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076647|NCT02133612|Paclitaxel|paclitaxel|mesh-list
102076648|NCT02133612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102076649|NCT02133612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102076650|NCT02133612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102076651|NCT02133612|Tubulin Modulators|tubulin modulators|mesh-ancestor
102076652|NCT02133612|Antimitotic Agents|antimitotic agents|mesh-ancestor
102076653|NCT02133612|Mitosis Modulators|mitosis modulators|mesh-ancestor
102076654|NCT02133612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076655|NCT03522194|Propofol|propofol|mesh-list
102076656|NCT03522194|Sevoflurane|sevoflurane|mesh-list
101702273|NCT02645864|Irinotecan|irinotecan|mesh-list
102076657|NCT03522194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101378248|NCT00068744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102076664|NCT03522194|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102076665|NCT04820686|Tenofovir|tenofovir|mesh-list
102076666|NCT04820686|Entecavir|entecavir|mesh-list
101943263|NCT02712112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943264|NCT02860546|Nivolumab|nivolumab|mesh-list
101943265|NCT02860546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102076667|NCT04820686|Antiviral Agents|antiviral agents|mesh-ancestor
102076668|NCT04820686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102076669|NCT04820686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102076670|NCT04820686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102076671|NCT04820686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102076672|NCT04820686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076673|NCT04820686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102076674|NCT04820686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102076675|NCT02260908|Enoxaparin|enoxaparin|mesh-list
102076676|NCT02260908|Anticoagulants|anticoagulants|mesh-ancestor
102076677|NCT02260908|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102076678|NCT02260908|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102076679|NCT02260908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076680|NCT02969655|Darbepoetin alfa|darbepoetin alfa|mesh-list
102076682|NCT02969655|Hematinics|hematinics|mesh-ancestor
102076683|NCT02969655|Glycine Agents|glycine agents|mesh-ancestor
102076684|NCT02969655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102076685|NCT02969655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076686|NCT02969655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076687|NCT04488874|Mannitol|mannitol|mesh-list
102076688|NCT04488874|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102076689|NCT04488874|Diuretics|diuretics|mesh-ancestor
102076690|NCT04488874|Natriuretic Agents|natriuretic agents|mesh-ancestor
102076691|NCT04488874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076692|NCT03651219|Irinotecan|irinotecan|mesh-list
102076693|NCT03651219|Apatinib|apatinib|mesh-list
102076694|NCT03651219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102076695|NCT03651219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102076696|NCT03651219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102076697|NCT03651219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076698|NCT03651219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102076699|NCT03651219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102076700|NCT02648698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102076701|NCT02648698|Levofloxacin|levofloxacin|mesh-list
102076702|NCT02648698|Tinidazole|tinidazole|mesh-list
102076703|NCT02648698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102076704|NCT02648698|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102076705|NCT02648698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102076706|NCT02648698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102076707|NCT02648698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102076708|NCT02648698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076709|NCT02648698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102076710|NCT02648698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102076711|NCT02648698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102076712|NCT02648698|Alkylating Agents|alkylating agents|mesh-ancestor
102076713|NCT02648698|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
102076714|NCT02648698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101702284|NCT02574130|Amikacin|amikacin|mesh-list
102076715|NCT02648698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102076716|NCT04059458|Calcium, Dietary|calcium, dietary|mesh-list
102076717|NCT04059458|Calcium|calcium|mesh-list
102076718|NCT04059458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102076719|NCT04059458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076720|NCT04059458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102076721|NCT05304598|Dexmedetomidine|dexmedetomidine|mesh-list
102076722|NCT05304598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102076723|NCT05304598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102076724|NCT05304598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076725|NCT05304598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102076726|NCT05304598|Analgesics|analgesics|mesh-ancestor
102076727|NCT05304598|Sensory System Agents|sensory system agents|mesh-ancestor
102076730|NCT05304598|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102076731|NCT05304598|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102076732|NCT05304598|Adrenergic Agents|adrenergic agents|mesh-ancestor
102076733|NCT05304598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102076734|NCT05304598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076736|NCT03524846|Ascorbic Acid|ascorbic acid|mesh-list
102076737|NCT03524846|Micronutrients|micronutrients|mesh-ancestor
102076738|NCT03524846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943266|NCT02860546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101943267|NCT02860546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101943268|NCT02860546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943269|NCT01982955|Carboplatin|carboplatin|mesh-list
101943270|NCT01982955|Pemetrexed|pemetrexed|mesh-list
101943271|NCT01982955|Gefitinib|gefitinib|mesh-list
101943272|NCT01982955|Tepotinib|tepotinib|mesh-list
101943273|NCT01982955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101943274|NCT01982955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101308157|NCT02046044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076739|NCT03524846|Antioxidants|antioxidants|mesh-ancestor
102076740|NCT03524846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076741|NCT03524846|Protective Agents|protective agents|mesh-ancestor
102076742|NCT05134558|Xenon|xenon|mesh-list
102076743|NCT05134558|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102076744|NCT05134558|Anesthetics, General|anesthetics, general|mesh-ancestor
102076745|NCT05134558|Anesthetics|anesthetics|mesh-ancestor
102076746|NCT05134558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102076747|NCT05134558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076748|NCT02970669|Valsartan|valsartan|mesh-list
102076749|NCT02970669|Enalapril|enalapril|mesh-list
102076750|NCT02970669|Enalaprilat|enalaprilat|mesh-list
102076751|NCT02970669|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102076752|NCT02970669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102076753|NCT02970669|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102076754|NCT02970669|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102076755|NCT02970669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076756|NCT02970669|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102076757|NCT02970669|Protease Inhibitors|protease inhibitors|mesh-ancestor
102076758|NCT02970669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102076759|NCT02134002|Disulfiram|disulfiram|mesh-list
102076760|NCT02134002|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102076761|NCT02134002|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
102076762|NCT02134002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102076763|NCT02134002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076764|NCT03650361|Adapalene|adapalene|mesh-list
101702304|NCT02726867|Anesthetics|anesthetics|mesh-ancestor
102076765|NCT03650361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102076766|NCT03650361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102076767|NCT03650361|Analgesics|analgesics|mesh-ancestor
102076768|NCT03650361|Sensory System Agents|sensory system agents|mesh-ancestor
102076769|NCT03650361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102076770|NCT03650361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076771|NCT03650361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102076772|NCT03650361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102076773|NCT03650361|Dermatologic Agents|dermatologic agents|mesh-ancestor
102076774|NCT02138994|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102076775|NCT02138994|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
102076776|NCT02138994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102076777|NCT02138994|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102076778|NCT05303818|Rivaroxaban|rivaroxaban|mesh-list
102076779|NCT05303818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102076780|NCT05303818|Antithrombins|antithrombins|mesh-ancestor
102076781|NCT05303818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102076782|NCT05303818|Protease Inhibitors|protease inhibitors|mesh-ancestor
102076783|NCT05303818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102076784|NCT05303818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076785|NCT05303818|Anticoagulants|anticoagulants|mesh-ancestor
102076786|NCT02902965|Dexamethasone|dexamethasone|mesh-list
102076787|NCT02902965|Bortezomib|bortezomib|mesh-list
102076788|NCT02902965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102076789|NCT02902965|Antiemetics|antiemetics|mesh-ancestor
102076790|NCT02902965|Autonomic Agents|autonomic agents|mesh-ancestor
102076791|NCT02902965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102076792|NCT02902965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943275|NCT01982955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308166|NCT02046187|Alkylating Agents|alkylating agents|mesh-ancestor
102076793|NCT02902965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102076794|NCT02902965|Glucocorticoids|glucocorticoids|mesh-ancestor
102076795|NCT02902965|Hormones|hormones|mesh-ancestor
102076796|NCT02902965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102076797|NCT02902965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102076798|NCT02902965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102076805|NCT02130414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076806|NCT02130414|Antifungal Agents|antifungal agents|mesh-ancestor
102076807|NCT02130414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102076808|NCT02130414|Dermatologic Agents|dermatologic agents|mesh-ancestor
102076809|NCT02130414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102076810|NCT02130414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102076811|NCT02902809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102076812|NCT02902809|Immunologic Factors|immunologic factors|mesh-ancestor
102076813|NCT02902809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076815|NCT02134470|Androgens|androgens|mesh-ancestor
102076816|NCT02134470|Hormones|hormones|mesh-ancestor
102076817|NCT02134470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102076818|NCT02134470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076819|NCT02134626|Simvastatin|simvastatin|mesh-list
102076820|NCT02134626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102076821|NCT02134626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102076822|NCT02134626|Antimetabolites|antimetabolites|mesh-ancestor
102076823|NCT02134626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076824|NCT02134626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102076825|NCT02134626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102076826|NCT02134626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102076827|NCT02969187|Bupivacaine|bupivacaine|mesh-list
102076828|NCT02969187|Anesthetics, Local|anesthetics, local|mesh-ancestor
102076829|NCT02969187|Anesthetics|anesthetics|mesh-ancestor
102076830|NCT02969187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102076831|NCT02969187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076832|NCT02969187|Sensory System Agents|sensory system agents|mesh-ancestor
102076833|NCT02969187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102076834|NCT02139618|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102076835|NCT02139618|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
102076836|NCT02139618|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102076837|NCT02139618|Dermatologic Agents|dermatologic agents|mesh-ancestor
102076838|NCT05285085|Atorvastatin|atorvastatin|mesh-list
102076839|NCT05285085|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102076840|NCT05285085|Simvastatin|simvastatin|mesh-list
102076841|NCT05285085|Pravastatin|pravastatin|mesh-list
102076842|NCT05285085|Pitavastatin|pitavastatin|mesh-list
102076844|NCT05285085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102076845|NCT05285085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102076846|NCT05285085|Antimetabolites|antimetabolites|mesh-ancestor
102076847|NCT05285085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076848|NCT05285085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102076849|NCT05285085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102076850|NCT05285085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102076851|NCT02139930|Nicotine|nicotine|mesh-list
102076852|NCT02139930|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102076853|NCT02139930|Autonomic Agents|autonomic agents|mesh-ancestor
102076854|NCT02139930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102076855|NCT02139930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076856|NCT02139930|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102076857|NCT02139930|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102076858|NCT02139930|Cholinergic Agents|cholinergic agents|mesh-ancestor
102076859|NCT02139930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102076860|NCT02139930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076861|NCT02130804|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
102076862|NCT02130804|Salicylates|salicylates|mesh-list
102076863|NCT02130804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102076864|NCT02130804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102076865|NCT02130804|Analgesics|analgesics|mesh-ancestor
102076866|NCT02130804|Sensory System Agents|sensory system agents|mesh-ancestor
102076867|NCT02130804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102076868|NCT02130804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943277|NCT01982955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101943278|NCT01982955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101943279|NCT01144533|Hyaluronic Acid|hyaluronic acid|mesh-list
101943280|NCT01144533|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101943281|NCT01144533|Immunologic Factors|immunologic factors|mesh-ancestor
102076929|NCT05373446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102076930|NCT04734028|Clopidogrel|clopidogrel|mesh-list
102076931|NCT04734028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076932|NCT04734028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076933|NCT04734028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102076934|NCT04734028|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102076935|NCT04734028|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102076936|NCT04734028|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102076937|NCT04734028|Purinergic Agents|purinergic agents|mesh-ancestor
102076943|NCT05285397|Hormones|hormones|mesh-ancestor
102076944|NCT05285397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102076945|NCT03050359|Lansoprazole|lansoprazole|mesh-list
102076946|NCT03050359|Dexlansoprazole|dexlansoprazole|mesh-list
102076947|NCT03050359|Bismuth|bismuth|mesh-list
102076948|NCT03050359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102076949|NCT03050359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102076950|NCT03050359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102076951|NCT03050359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102076952|NCT03050359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076953|NCT03050359|Antacids|antacids|mesh-ancestor
102076954|NCT02140242|Daunorubicin|daunorubicin|mesh-list
102076955|NCT02140242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102076956|NCT02140242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102076957|NCT02140242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102076958|NCT02140242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102076959|NCT02140242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102076960|NCT02140242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076961|NCT05302726|Estrogens|estrogens|mesh-list
102076962|NCT05302726|Hormones|hormones|mesh-ancestor
102076963|NCT05302726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102076964|NCT05302726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076965|NCT02253264|Rituximab|rituximab|mesh-list
102076966|NCT02253264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102076967|NCT02253264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102076968|NCT02253264|Immunologic Factors|immunologic factors|mesh-ancestor
102076969|NCT02253264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076970|NCT02253264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102076971|NCT03648333|Niacin|niacin|mesh-list
102076972|NCT03648333|Amlodipine|amlodipine|mesh-list
102076973|NCT03648333|Valsartan|valsartan|mesh-list
101796721|NCT05172401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102076974|NCT03648333|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
102076975|NCT03648333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102076976|NCT03648333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102076977|NCT03648333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102076978|NCT03648333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076979|NCT03648333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102076980|NCT03648333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076981|NCT03648333|Vasodilator Agents|vasodilator agents|mesh-ancestor
102076982|NCT03648333|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102076983|NCT03648333|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102076984|NCT03648333|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102076985|NCT03648333|Antimetabolites|antimetabolites|mesh-ancestor
102076986|NCT03648333|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102076987|NCT03648333|Vitamin B Complex|vitamin b complex|mesh-ancestor
102076989|NCT03648333|Micronutrients|micronutrients|mesh-ancestor
102076990|NCT02252796|Paclitaxel|paclitaxel|mesh-list
102076991|NCT02252796|Carboplatin|carboplatin|mesh-list
102076992|NCT02252796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102076993|NCT02252796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102076994|NCT02252796|Tubulin Modulators|tubulin modulators|mesh-ancestor
102076995|NCT02252796|Antimitotic Agents|antimitotic agents|mesh-ancestor
102076996|NCT02252796|Mitosis Modulators|mitosis modulators|mesh-ancestor
101943282|NCT01144533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943283|NCT01144533|Viscosupplements|viscosupplements|mesh-ancestor
101943284|NCT01144533|Protective Agents|protective agents|mesh-ancestor
102076997|NCT02252796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076998|NCT02785770|Moxifloxacin|moxifloxacin|mesh-list
102076999|NCT02785770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102077000|NCT02785770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102077001|NCT02785770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102077002|NCT02785770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102077003|NCT02785770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102077004|NCT02785770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077005|NCT02785770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102077006|NCT04166474|Dolutegravir|dolutegravir|mesh-list
102077007|NCT04166474|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102077008|NCT04166474|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102077010|NCT04166474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077012|NCT04166474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102077013|NCT04166474|Antiviral Agents|antiviral agents|mesh-ancestor
102077014|NCT04166474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102077015|NCT04660123|Bismuth|bismuth|mesh-list
102077016|NCT04660123|Antacids|antacids|mesh-ancestor
102077017|NCT04660123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077018|NCT04660123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102077019|NCT04530136|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
102077020|NCT04530136|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102077021|NCT04530136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102077022|NCT04530136|Immunologic Factors|immunologic factors|mesh-ancestor
102077023|NCT04530136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077024|NCT02965833|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102077025|NCT02965833|Contact Lens Solutions|contact lens solutions|mesh-list
102077026|NCT02965833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102077027|NCT02965833|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102077028|NCT02965833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102077029|NCT02965833|Disinfectants|disinfectants|mesh-ancestor
102077030|NCT05579418|Evolocumab|evolocumab|mesh-list
102077031|NCT05579418|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102077032|NCT05579418|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102077033|NCT05579418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102077034|NCT05579418|Antimetabolites|antimetabolites|mesh-ancestor
102077035|NCT05579418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077036|NCT05579418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102077037|NCT05579418|Protease Inhibitors|protease inhibitors|mesh-ancestor
102077038|NCT05579418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102077039|NCT05579418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102077040|NCT02968173|Palivizumab|palivizumab|mesh-list
102077041|NCT02968173|Antiviral Agents|antiviral agents|mesh-ancestor
102077042|NCT02968173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102077043|NCT02135640|Denosumab|denosumab|mesh-list
102077044|NCT02135640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102077045|NCT02135640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077046|NCT02784834|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102077047|NCT02784834|Dermatologic Agents|dermatologic agents|mesh-ancestor
102077048|NCT02784834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102077049|NCT02784834|Immunologic Factors|immunologic factors|mesh-ancestor
102077050|NCT02784834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077051|NCT02253342|Levonadifloxacin|levonadifloxacin|mesh-list
102077052|NCT02253342|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102077053|NCT02253342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102077054|NCT02253342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077055|NCT02253342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102077056|NCT02253342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102077058|NCT00495508|Artemether|artemether|mesh-list
102077059|NCT00495508|Quinine|quinine|mesh-list
102077060|NCT00495508|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102077061|NCT00495508|Antimalarials|antimalarials|mesh-ancestor
102077062|NCT00495508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102077063|NCT00495508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102077064|NCT00495508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102077065|NCT00495508|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102077066|NCT00495508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077067|NCT00495508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102077068|NCT00495508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101943286|NCT01238055|Sunitinib|sunitinib|mesh-list
101943287|NCT01238055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101943288|NCT01238055|Tubulin Modulators|tubulin modulators|mesh-ancestor
102077069|NCT00495508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102077070|NCT00495508|Analgesics|analgesics|mesh-ancestor
102077071|NCT00495508|Sensory System Agents|sensory system agents|mesh-ancestor
102077072|NCT01554046|Methylphenidate|methylphenidate|mesh-list
102077073|NCT01554046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102077074|NCT01554046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077075|NCT01554046|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102077076|NCT01554046|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102077077|NCT01554046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102077078|NCT01554046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077079|NCT01554046|Dopamine Agents|dopamine agents|mesh-ancestor
102077080|NCT01554046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102077081|NCT05284851|Vaccines|vaccines|mesh-list
102077082|NCT05284851|Immunologic Factors|immunologic factors|mesh-ancestor
102077083|NCT05284851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077088|NCT03049735|Estradiol|estradiol|mesh-list
102077089|NCT03049735|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102077090|NCT03049735|Relugolix|relugolix|mesh-list
102077091|NCT03049735|Estrogens|estrogens|mesh-ancestor
102077092|NCT03049735|Hormones|hormones|mesh-ancestor
102077093|NCT03049735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102077094|NCT03049735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077095|NCT03049735|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102077096|NCT03049735|Contraceptive Agents|contraceptive agents|mesh-ancestor
102077097|NCT03049735|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102077098|NCT03049735|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102077099|NCT03049735|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102077100|NCT03049735|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102077101|NCT03049735|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102077102|NCT03049735|Androgen Antagonists|androgen antagonists|mesh-ancestor
102077103|NCT03049735|Hormone Antagonists|hormone antagonists|mesh-ancestor
102077104|NCT04785638|Bupivacaine|bupivacaine|mesh-list
102077105|NCT04785638|Anesthetics, Local|anesthetics, local|mesh-ancestor
102077106|NCT04785638|Anesthetics|anesthetics|mesh-ancestor
102077107|NCT04785638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102077108|NCT04785638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077109|NCT04785638|Sensory System Agents|sensory system agents|mesh-ancestor
102077110|NCT04785638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102077111|NCT04762472|Montelukast|montelukast|mesh-list
102077112|NCT04762472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102077113|NCT04762472|Respiratory System Agents|respiratory system agents|mesh-ancestor
102077114|NCT04762472|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102077115|NCT04762472|Hormone Antagonists|hormone antagonists|mesh-ancestor
102077116|NCT04762472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102077117|NCT04762472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077118|NCT04762472|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102077119|NCT04762472|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102077120|NCT04762472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077121|NCT01295944|Bevacizumab|bevacizumab|mesh-list
102077122|NCT01295944|Carboplatin|carboplatin|mesh-list
102077123|NCT01295944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102077124|NCT01295944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102077125|NCT01295944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102077126|NCT01295944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102077127|NCT01295944|Growth Substances|growth substances|mesh-ancestor
102077128|NCT01295944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077129|NCT01295944|Growth Inhibitors|growth inhibitors|mesh-ancestor
102077130|NCT04742348|Levodopa|levodopa|mesh-list
102077131|NCT04742348|Carbidopa|carbidopa|mesh-list
102077132|NCT04742348|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102077133|NCT04742348|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102077134|NCT04742348|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102077135|NCT04742348|Dopamine Agents|dopamine agents|mesh-ancestor
102077136|NCT04742348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102077137|NCT04742348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077138|NCT04742348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943289|NCT01238055|Antimitotic Agents|antimitotic agents|mesh-ancestor
101943290|NCT01238055|Mitosis Modulators|mitosis modulators|mesh-ancestor
101943291|NCT01238055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943292|NCT01238055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102077139|NCT04742348|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102077140|NCT04742348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102077141|NCT04742348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102077142|NCT04742348|Immunologic Factors|immunologic factors|mesh-ancestor
102077143|NCT04742348|Dopamine Agonists|dopamine agonists|mesh-ancestor
102077144|NCT02140632|Methylprednisolone|methylprednisolone|mesh-list
102077145|NCT02140632|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102077146|NCT02140632|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102077147|NCT02140632|Prednisolone|prednisolone|mesh-list
102077148|NCT02140632|Prednisolone acetate|prednisolone acetate|mesh-list
102077149|NCT02140632|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102077150|NCT02140632|Prednisolone phosphate|prednisolone phosphate|mesh-list
102077151|NCT02140632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102077152|NCT02140632|Antiemetics|antiemetics|mesh-ancestor
102077153|NCT02140632|Autonomic Agents|autonomic agents|mesh-ancestor
102077154|NCT02140632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102077169|NCT05578404|Micronutrients|micronutrients|mesh-ancestor
102077170|NCT05578404|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102077172|NCT04848584|Immunologic Factors|immunologic factors|mesh-ancestor
102077173|NCT04848584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077174|NCT03521960|Buspirone|buspirone|mesh-list
102077175|NCT03521960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102077176|NCT03521960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102077177|NCT03521960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102077178|NCT03521960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077179|NCT03521960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102077180|NCT03521960|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102077181|NCT03521960|Serotonin Agents|serotonin agents|mesh-ancestor
102077182|NCT03521960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102077183|NCT03521960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077184|NCT05479578|Dexamethasone|dexamethasone|mesh-list
102077185|NCT05479578|Dexamethasone acetate|dexamethasone acetate|mesh-list
102077186|NCT05479578|Cyclophosphamide|cyclophosphamide|mesh-list
102077187|NCT05479578|Ichthammol|ichthammol|mesh-list
102077188|NCT05479578|BB 1101|bb 1101|mesh-list
102077189|NCT05479578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102077190|NCT05479578|Immunologic Factors|immunologic factors|mesh-ancestor
102077191|NCT05479578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077192|NCT05479578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102077193|NCT05479578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102077194|NCT05479578|Alkylating Agents|alkylating agents|mesh-ancestor
102077195|NCT05479578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077196|NCT05479578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102077197|NCT05479578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102077198|NCT05479578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102077199|NCT05479578|Antiemetics|antiemetics|mesh-ancestor
102077200|NCT05479578|Autonomic Agents|autonomic agents|mesh-ancestor
102077201|NCT05479578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102077202|NCT05479578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102077203|NCT05479578|Glucocorticoids|glucocorticoids|mesh-ancestor
102077204|NCT05479578|Hormones|hormones|mesh-ancestor
102077205|NCT05479578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102077206|NCT05479578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102077207|NCT05479578|Protease Inhibitors|protease inhibitors|mesh-ancestor
102077208|NCT05479578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102077209|NCT05479578|Dermatologic Agents|dermatologic agents|mesh-ancestor
102077210|NCT02899377|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
102077211|NCT02899377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077212|NCT02899377|Chelating Agents|chelating agents|mesh-ancestor
102077213|NCT02899377|Sequestering Agents|sequestering agents|mesh-ancestor
102077214|NCT05363462|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102077230|NCT03521726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077232|NCT03546426|Interleukin-2|interleukin-2|mesh-list
102077233|NCT03546426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102077234|NCT03546426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101943293|NCT01238055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101943294|NCT01238055|Growth Substances|growth substances|mesh-ancestor
101943295|NCT01238055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447728|NCT00425516|Cyclophosphamide|cyclophosphamide|mesh-list
102077235|NCT03546426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102077236|NCT03546426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077237|NCT03546426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102077238|NCT03546426|Analgesics|analgesics|mesh-ancestor
102077239|NCT03546426|Sensory System Agents|sensory system agents|mesh-ancestor
102077240|NCT03546426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102077241|NCT03546426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077242|NCT02897349|Linagliptin|linagliptin|mesh-list
102077243|NCT02897349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102077244|NCT02897349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077245|NCT02897349|Incretins|incretins|mesh-ancestor
102077246|NCT02897349|Hormones|hormones|mesh-ancestor
102077247|NCT02897349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102077248|NCT02897349|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102077249|NCT02897349|Protease Inhibitors|protease inhibitors|mesh-ancestor
102077250|NCT02897349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102077251|NCT02897349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077252|NCT03134378|Amoxicillin|amoxicillin|mesh-list
102077253|NCT03134378|Clarithromycin|clarithromycin|mesh-list
102077254|NCT03134378|Rabeprazole|rabeprazole|mesh-list
102077255|NCT03134378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102077256|NCT03134378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102077257|NCT03134378|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102077258|NCT03134378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102077259|NCT03134378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077260|NCT03134378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102077261|NCT03134378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102077262|NCT03134378|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102077263|NCT03134378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102077264|NCT03134378|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102077265|NCT05434104|Metronidazole|metronidazole|mesh-list
102077266|NCT05434104|Fluconazole|fluconazole|mesh-list
102077267|NCT05434104|Lactoferrin|lactoferrin|mesh-list
102077268|NCT05434104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102077269|NCT05434104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102077270|NCT05434104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102077271|NCT05434104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102077272|NCT05434104|Antifungal Agents|antifungal agents|mesh-ancestor
102077273|NCT05434104|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101378879|NCT00255541|Glyburide|glyburide|mesh-list
102077284|NCT00488072|Antidepressive Agents|antidepressive agents|mesh-ancestor
102077285|NCT00488072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102077286|NCT00488072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102077287|NCT00488072|Histamine Antagonists|histamine antagonists|mesh-ancestor
102077289|NCT00488072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102077290|NCT00488072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077291|NCT00488072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077292|NCT00488072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102077293|NCT00488072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102077294|NCT00488072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102077295|NCT00488072|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102077296|NCT00488072|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102077297|NCT00488072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102077298|NCT00488072|Adrenergic Agents|adrenergic agents|mesh-ancestor
102077299|NCT00488072|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102077300|NCT00488072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102077301|NCT00488072|Serotonin Agents|serotonin agents|mesh-ancestor
102077302|NCT00488072|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102077303|NCT03525704|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102077304|NCT03523832|Celecoxib|celecoxib|mesh-list
102077305|NCT03523832|Pregabalin|pregabalin|mesh-list
102077306|NCT03523832|Analgesics|analgesics|mesh-ancestor
102077307|NCT03523832|Sensory System Agents|sensory system agents|mesh-ancestor
102077308|NCT03523832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102077309|NCT03523832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077310|NCT03523832|Anticonvulsants|anticonvulsants|mesh-ancestor
101943296|NCT01238055|Growth Inhibitors|growth inhibitors|mesh-ancestor
101943297|NCT01238055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102077311|NCT03523832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102077312|NCT03523832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102077313|NCT03523832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077314|NCT03523832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102077315|NCT03523832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102077316|NCT03523832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102077317|NCT03523832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102077318|NCT03523832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102077319|NCT03523832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102077320|NCT03523832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102077321|NCT03523832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102077322|NCT03523832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102077323|NCT03523832|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102077324|NCT03523832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102077325|NCT03523832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102077327|NCT05577624|Sotorasib|sotorasib|mesh-list
102077328|NCT05577624|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102077329|NCT05577624|Antitubercular Agents|antitubercular agents|mesh-ancestor
102077330|NCT05577624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102077331|NCT05577624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102077332|NCT05577624|Leprostatic Agents|leprostatic agents|mesh-ancestor
102077333|NCT05577624|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102077345|NCT03294694|Fulvestrant|fulvestrant|mesh-list
102077346|NCT03294694|Spartalizumab|spartalizumab|mesh-list
102077347|NCT03294694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102077348|NCT03294694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102077349|NCT03294694|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102077350|NCT03294694|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102077351|NCT03294694|Hormone Antagonists|hormone antagonists|mesh-ancestor
102077352|NCT03294694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102077353|NCT03294694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077354|NCT03294694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102077355|NCT03294694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077356|NCT03294694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102077357|NCT03523754|Isosorbide|isosorbide|mesh-list
102077358|NCT03523754|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
102077359|NCT03523754|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
102077360|NCT03523754|Misoprostol|misoprostol|mesh-list
102077361|NCT03523754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102077362|NCT03523754|Abortifacient Agents|abortifacient agents|mesh-ancestor
102077363|NCT03523754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102077364|NCT03523754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077365|NCT03523754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102077366|NCT03523754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102077367|NCT03523754|Oxytocics|oxytocics|mesh-ancestor
102077368|NCT03523754|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102077369|NCT03523754|Diuretics|diuretics|mesh-ancestor
102077370|NCT03523754|Natriuretic Agents|natriuretic agents|mesh-ancestor
102077371|NCT03523754|Vasodilator Agents|vasodilator agents|mesh-ancestor
102077372|NCT03523754|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102077373|NCT03523754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077374|NCT04727034|Propofol|propofol|mesh-list
102077375|NCT04727034|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102077376|NCT04727034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102077377|NCT04727034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077378|NCT04727034|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102077379|NCT04727034|Anesthetics, General|anesthetics, general|mesh-ancestor
102077380|NCT04727034|Anesthetics|anesthetics|mesh-ancestor
102077381|NCT03644511|Sorafenib|sorafenib|mesh-list
102077382|NCT03644511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102077383|NCT03644511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102077384|NCT03644511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102077385|NCT03644511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077386|NCT03290560|Kallikreins|kallikreins|mesh-list
102077387|NCT03290560|Coagulants|coagulants|mesh-ancestor
102077388|NCT03290560|Fertility Agents, Male|fertility agents, male|mesh-ancestor
102077389|NCT03290560|Fertility Agents|fertility agents|mesh-ancestor
102077390|NCT03290560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102077391|NCT03290560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943298|NCT01238055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101943299|NCT01144923|Gabapentin|gabapentin|mesh-list
101943300|NCT01144923|Nortriptyline|nortriptyline|mesh-list
101943301|NCT01144923|Analgesics|analgesics|mesh-ancestor
101943302|NCT01144923|Sensory System Agents|sensory system agents|mesh-ancestor
101943303|NCT01144923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102077392|NCT01316419|Amlodipine|amlodipine|mesh-list
102077393|NCT01316419|Telmisartan|telmisartan|mesh-list
102077394|NCT01316419|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102077397|NCT01316419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077398|NCT01316419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102077399|NCT01316419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077401|NCT01316419|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102077402|NCT01316419|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102077403|NCT03547362|Caseins|caseins|mesh-list
102077404|NCT03547362|Chelating Agents|chelating agents|mesh-ancestor
102077405|NCT03547362|Sequestering Agents|sequestering agents|mesh-ancestor
102077406|NCT03547362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077407|NCT04258150|Nivolumab|nivolumab|mesh-list
102077408|NCT04258150|Ipilimumab|ipilimumab|mesh-list
102077409|NCT04258150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102077410|NCT04258150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102077411|NCT04258150|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102077412|NCT04258150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077413|NCT02854696|Insulin|insulin|mesh-list
102077414|NCT02854696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102077415|NCT02854696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077416|NCT02289248|Ketamine|ketamine|mesh-list
101702500|NCT02624856|Hormones|hormones|mesh-ancestor
102077417|NCT02289248|Analgesics|analgesics|mesh-ancestor
102077418|NCT02289248|Sensory System Agents|sensory system agents|mesh-ancestor
102077419|NCT02289248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102077420|NCT02289248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077421|NCT02289248|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102077422|NCT02289248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102077423|NCT02289248|Anesthetics, General|anesthetics, general|mesh-ancestor
102077424|NCT02289248|Anesthetics|anesthetics|mesh-ancestor
102077425|NCT02289248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102077426|NCT02289248|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102077427|NCT02289248|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102077428|NCT02289248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102077429|NCT02289248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077430|NCT02782468|Azacitidine|azacitidine|mesh-list
102077431|NCT02782468|Pevonedistat|pevonedistat|mesh-list
102077432|NCT02782468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102077433|NCT02782468|Antimetabolites|antimetabolites|mesh-ancestor
102077434|NCT02782468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077435|NCT02782468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102077436|NCT02782468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102077437|NCT02253420|Itraconazole|itraconazole|mesh-list
102077438|NCT02253420|Rifampin|rifampin|mesh-list
102077439|NCT02253420|Antifungal Agents|antifungal agents|mesh-ancestor
102077440|NCT02253420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102077441|NCT02253420|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102077442|NCT02253420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102077443|NCT02253420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102077444|NCT02253420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077445|NCT02253420|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102077446|NCT02253420|Hormone Antagonists|hormone antagonists|mesh-ancestor
102077447|NCT02253420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102077448|NCT02253420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077449|NCT02253420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102077450|NCT02253420|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102077451|NCT02253420|Antitubercular Agents|antitubercular agents|mesh-ancestor
102077452|NCT02253420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102077453|NCT02253420|Leprostatic Agents|leprostatic agents|mesh-ancestor
102077454|NCT02253420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102077455|NCT02253420|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101943304|NCT01144923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943305|NCT01144923|Anticonvulsants|anticonvulsants|mesh-ancestor
101943306|NCT01144923|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101943307|NCT01144923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101943308|NCT01144923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101943309|NCT01144923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101943310|NCT01144923|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101943311|NCT01144923|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101943312|NCT01144923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101943313|NCT01144923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943314|NCT01144923|Antimanic Agents|antimanic agents|mesh-ancestor
101943315|NCT01144923|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101943316|NCT01144923|Antidepressive Agents|antidepressive agents|mesh-ancestor
101943317|NCT01144923|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101943318|NCT01144923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101943319|NCT01144923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101943320|NCT01144923|Adrenergic Agents|adrenergic agents|mesh-ancestor
101943321|NCT01329783|Maraviroc|maraviroc|mesh-list
101943322|NCT01329783|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101943323|NCT01329783|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101943324|NCT01329783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943325|NCT01329783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101943326|NCT01329783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101943327|NCT01329783|Antiviral Agents|antiviral agents|mesh-ancestor
101943328|NCT01329783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101943329|NCT01329783|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102077456|NCT02253420|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102077457|NCT02253420|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102077458|NCT02253420|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102077459|NCT02253420|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102077460|NCT02253420|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102077461|NCT02028364|Everolimus|everolimus|mesh-list
102077462|NCT02028364|Exemestane|exemestane|mesh-list
102077463|NCT02028364|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102077468|NCT02028364|Immunologic Factors|immunologic factors|mesh-ancestor
102077469|NCT02028364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077470|NCT02028364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102077471|NCT02028364|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102077472|NCT02028364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102077473|NCT02028364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102077474|NCT02028364|Hormone Antagonists|hormone antagonists|mesh-ancestor
102077475|NCT02028364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102077476|NCT02897115|Adalimumab|adalimumab|mesh-list
102077477|NCT02897115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102077478|NCT02897115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101943331|NCT01238133|Carboplatin|carboplatin|mesh-list
101943332|NCT01238133|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101971935|NCT02083250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101971936|NCT02083250|Antimetabolites|antimetabolites|mesh-ancestor
102077479|NCT02897115|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102077480|NCT02897115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102077481|NCT02897115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102077482|NCT02897115|Analgesics|analgesics|mesh-ancestor
102077483|NCT02897115|Sensory System Agents|sensory system agents|mesh-ancestor
102077484|NCT02897115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102077485|NCT02897115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077486|NCT02289482|Ritonavir|ritonavir|mesh-list
102077487|NCT02289482|GSK-2838232|gsk-2838232|mesh-list
102077488|NCT02289482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102077489|NCT02289482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102077490|NCT02289482|Protease Inhibitors|protease inhibitors|mesh-ancestor
102077491|NCT02289482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102077492|NCT02289482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077493|NCT02289482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102077494|NCT02289482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102077495|NCT02289482|Antiviral Agents|antiviral agents|mesh-ancestor
102077496|NCT02289482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102077497|NCT02289482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102077498|NCT02289482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102077499|NCT05277636|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
102077500|NCT05277636|Hallucinogens|hallucinogens|mesh-ancestor
102077501|NCT05277636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077502|NCT05277636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102077503|NCT05277636|Serotonin Agents|serotonin agents|mesh-ancestor
101261651|NCT01751321|Incretins|incretins|mesh-ancestor
102077504|NCT05277636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102077505|NCT05277636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077506|NCT05277636|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102077507|NCT05277636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102077508|NCT05277636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102077509|NCT05277636|Adrenergic Agents|adrenergic agents|mesh-ancestor
102077510|NCT04030195|Cyclophosphamide|cyclophosphamide|mesh-list
102077511|NCT04030195|Fludarabine|fludarabine|mesh-list
102077512|NCT04030195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102077513|NCT04030195|Immunologic Factors|immunologic factors|mesh-ancestor
102077514|NCT04030195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077515|NCT04030195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102077516|NCT04030195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102077517|NCT04030195|Alkylating Agents|alkylating agents|mesh-ancestor
102077518|NCT04030195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077519|NCT04030195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102077520|NCT04030195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102077521|NCT02253966|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102077522|NCT02253966|Methylprednisolone|methylprednisolone|mesh-list
102077523|NCT02253966|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102077524|NCT02253966|Prednisolone|prednisolone|mesh-list
102077525|NCT02253966|Prednisolone acetate|prednisolone acetate|mesh-list
102077526|NCT02253966|Lidocaine|lidocaine|mesh-list
102077527|NCT02253966|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102077528|NCT02253966|Prednisolone phosphate|prednisolone phosphate|mesh-list
102077529|NCT02253966|Anesthetics, Local|anesthetics, local|mesh-ancestor
102077530|NCT02253966|Anesthetics|anesthetics|mesh-ancestor
102077531|NCT02253966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102077532|NCT02253966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077536|NCT02253966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102077537|NCT02253966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102077538|NCT02253966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102077539|NCT02253966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077540|NCT02253966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102077541|NCT02253966|Antiemetics|antiemetics|mesh-ancestor
102077542|NCT02253966|Autonomic Agents|autonomic agents|mesh-ancestor
102077543|NCT02253966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102077544|NCT02253966|Glucocorticoids|glucocorticoids|mesh-ancestor
102077545|NCT02253966|Hormones|hormones|mesh-ancestor
102077546|NCT02253966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101943333|NCT01238133|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
102077547|NCT02253966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102077548|NCT02253966|Protective Agents|protective agents|mesh-ancestor
102077549|NCT02253966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102077550|NCT02253966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102077551|NCT01673620|Loratadine|loratadine|mesh-list
102077552|NCT01673620|Montelukast|montelukast|mesh-list
102077553|NCT01673620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102077554|NCT01673620|Respiratory System Agents|respiratory system agents|mesh-ancestor
102077555|NCT01673620|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102077556|NCT01673620|Hormone Antagonists|hormone antagonists|mesh-ancestor
102077557|NCT01673620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102077558|NCT01673620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077559|NCT01673620|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102077560|NCT01673620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102077561|NCT01673620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077562|NCT01673620|Antipruritics|antipruritics|mesh-ancestor
101797328|NCT00201643|Dexamethasone|dexamethasone|mesh-list
102077563|NCT01673620|Dermatologic Agents|dermatologic agents|mesh-ancestor
102077564|NCT01673620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102077565|NCT01673620|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102077566|NCT01673620|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102077567|NCT01673620|Histamine Antagonists|histamine antagonists|mesh-ancestor
102077568|NCT01673620|Histamine Agents|histamine agents|mesh-ancestor
102077569|NCT01673620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102077570|NCT04671355|Fluticasone|fluticasone|mesh-list
102077571|NCT04671355|Xhance|xhance|mesh-list
102077572|NCT04671355|Beclomethasone|beclomethasone|mesh-list
102077573|NCT04671355|Glycopyrrolate|glycopyrrolate|mesh-list
102077574|NCT04671355|Formoterol Fumarate|formoterol fumarate|mesh-list
102077575|NCT04671355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102077576|NCT04671355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102077577|NCT04671355|Autonomic Agents|autonomic agents|mesh-ancestor
102077578|NCT04671355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102077579|NCT04671355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077580|NCT04671355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102077581|NCT04671355|Respiratory System Agents|respiratory system agents|mesh-ancestor
102077582|NCT04671355|Dermatologic Agents|dermatologic agents|mesh-ancestor
102077583|NCT04671355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102077584|NCT04671355|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102077585|NCT04671355|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102077586|NCT04671355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102077587|NCT04671355|Adrenergic Agents|adrenergic agents|mesh-ancestor
102077588|NCT04671355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102077589|NCT04671355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077590|NCT04671355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102077591|NCT04671355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102077592|NCT04671355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102077593|NCT04671355|Cholinergic Agents|cholinergic agents|mesh-ancestor
102077594|NCT04671355|Glucocorticoids|glucocorticoids|mesh-ancestor
102077595|NCT04671355|Hormones|hormones|mesh-ancestor
102077596|NCT04671355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102077597|NCT03521492|Vitamin D|vitamin d|mesh-list
102077598|NCT03521492|Calcium|calcium|mesh-list
102077599|NCT03521492|Parathyroid Hormone|parathyroid hormone|mesh-list
102077600|NCT03521492|Hormones|hormones|mesh-list
102077601|NCT03521492|Vitamins|vitamins|mesh-ancestor
102077602|NCT03521492|Micronutrients|micronutrients|mesh-ancestor
102077603|NCT03521492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077606|NCT03521492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102077607|NCT03521414|Sevoflurane|sevoflurane|mesh-list
102077608|NCT03521414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102077609|NCT03521414|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102077610|NCT03521414|Anesthetics, General|anesthetics, general|mesh-ancestor
102077611|NCT03521414|Anesthetics|anesthetics|mesh-ancestor
102077612|NCT03521414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102077613|NCT03521414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077614|NCT00432094|Paclitaxel|paclitaxel|mesh-list
102077615|NCT00432094|Etoposide|etoposide|mesh-list
102077616|NCT00432094|Carboplatin|carboplatin|mesh-list
102077617|NCT00432094|Ifosfamide|ifosfamide|mesh-list
102077618|NCT00432094|Thiotepa|thiotepa|mesh-list
102077619|NCT00432094|Mesna|mesna|mesh-list
101943334|NCT01238133|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
101943335|NCT01238133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101943336|NCT01238133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101943337|NCT01238133|Tubulin Modulators|tubulin modulators|mesh-ancestor
101943338|NCT01238133|Antimitotic Agents|antimitotic agents|mesh-ancestor
101943339|NCT01238133|Mitosis Modulators|mitosis modulators|mesh-ancestor
101943340|NCT01238133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943341|NCT01238133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101943342|NCT01145079|Sirolimus|sirolimus|mesh-list
101943343|NCT01145079|Everolimus|everolimus|mesh-list
101943344|NCT01145079|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101943345|NCT01145079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101943346|NCT01145079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101943347|NCT01145079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943348|NCT01145079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102077620|NCT00432094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102077621|NCT00432094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102077622|NCT00432094|Tubulin Modulators|tubulin modulators|mesh-ancestor
102077623|NCT00432094|Antimitotic Agents|antimitotic agents|mesh-ancestor
102077624|NCT00432094|Mitosis Modulators|mitosis modulators|mesh-ancestor
102077625|NCT00432094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077626|NCT00432094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102077627|NCT00432094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102077628|NCT00432094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102077629|NCT00432094|Immunologic Factors|immunologic factors|mesh-ancestor
102077630|NCT00432094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077631|NCT00432094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102077632|NCT00432094|Alkylating Agents|alkylating agents|mesh-ancestor
102077633|NCT00432094|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102077634|NCT00432094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102077635|NCT00432094|Protective Agents|protective agents|mesh-ancestor
102077636|NCT04562779|Naltrexone|naltrexone|mesh-list
102077637|NCT04562779|Ketamine|ketamine|mesh-list
102077638|NCT04562779|Analgesics|analgesics|mesh-ancestor
102077639|NCT04562779|Sensory System Agents|sensory system agents|mesh-ancestor
102077640|NCT04562779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102077641|NCT04562779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077642|NCT04562779|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102077643|NCT04562779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102077644|NCT04562779|Anesthetics, General|anesthetics, general|mesh-ancestor
102077645|NCT04562779|Anesthetics|anesthetics|mesh-ancestor
102077646|NCT04562779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102077647|NCT04562779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102077648|NCT04562779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102077649|NCT04562779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102077650|NCT04562779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077651|NCT04562779|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102077652|NCT04562779|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102077653|NCT03751761|Paclitaxel|paclitaxel|mesh-list
102077654|NCT03751761|Durvalumab|durvalumab|mesh-list
102077655|NCT03751761|Tremelimumab|tremelimumab|mesh-list
102077656|NCT03751761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102077657|NCT03751761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102077658|NCT03751761|Tubulin Modulators|tubulin modulators|mesh-ancestor
102077659|NCT03751761|Antimitotic Agents|antimitotic agents|mesh-ancestor
102077660|NCT03751761|Mitosis Modulators|mitosis modulators|mesh-ancestor
102077661|NCT03751761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077662|NCT03751761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101943349|NCT01145079|Immunologic Factors|immunologic factors|mesh-ancestor
102077663|NCT03644823|Atezolizumab|atezolizumab|mesh-list
102077664|NCT03644823|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102077665|NCT03644823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077666|NCT03644823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102077667|NCT03644823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102077668|NCT00072358|Carbamide Peroxide|carbamide peroxide|mesh-list
102077669|NCT00072358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102077670|NCT00072358|Irinotecan|irinotecan|mesh-list
102077671|NCT00072358|Temozolomide|temozolomide|mesh-list
102077672|NCT00072358|Molgramostim|molgramostim|mesh-list
102077673|NCT00072358|Isotretinoin|isotretinoin|mesh-list
102077674|NCT00072358|Antibodies|antibodies|mesh-list
102077675|NCT00072358|Immunoglobulins|immunoglobulins|mesh-list
102077676|NCT00072358|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102077677|NCT00072358|Sargramostim|sargramostim|mesh-list
102077683|NCT00072358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102077684|NCT00072358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102077685|NCT00072358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077686|NCT00072358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102077687|NCT00072358|Alkylating Agents|alkylating agents|mesh-ancestor
102077688|NCT00072358|Dermatologic Agents|dermatologic agents|mesh-ancestor
102077689|NCT00072358|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102077690|NCT00072358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102077691|NCT03104998|Ubiquinone|ubiquinone|mesh-list
102077692|NCT03104998|Coenzyme Q10|coenzyme q10|mesh-list
102077693|NCT03104998|Micronutrients|micronutrients|mesh-ancestor
102077694|NCT03104998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077695|NCT03104998|Vitamins|vitamins|mesh-ancestor
102077696|NCT03990766|Theophylline|theophylline|mesh-list
102077697|NCT03990766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102077698|NCT03990766|Autonomic Agents|autonomic agents|mesh-ancestor
102077699|NCT03990766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102077700|NCT03990766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077701|NCT03990766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102077702|NCT03990766|Respiratory System Agents|respiratory system agents|mesh-ancestor
102077703|NCT03990766|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102077704|NCT03990766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102077705|NCT03990766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077706|NCT03990766|Vasodilator Agents|vasodilator agents|mesh-ancestor
102077707|NCT03990766|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102077708|NCT03990766|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102077709|NCT03990766|Purinergic Agents|purinergic agents|mesh-ancestor
102077710|NCT03990766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102077711|NCT02294162|Ketamine|ketamine|mesh-list
102077712|NCT02294162|Analgesics|analgesics|mesh-ancestor
102077713|NCT02294162|Sensory System Agents|sensory system agents|mesh-ancestor
102077714|NCT02294162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102077715|NCT02294162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077716|NCT02294162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102077718|NCT02294162|Anesthetics, General|anesthetics, general|mesh-ancestor
102077719|NCT02294162|Anesthetics|anesthetics|mesh-ancestor
102077720|NCT02294162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102077721|NCT02294162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102077722|NCT02294162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102077723|NCT02294162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102077724|NCT02294162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077725|NCT05176158|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
102077726|NCT05176158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102077727|NCT05176158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102077728|NCT05176158|Analgesics|analgesics|mesh-ancestor
102077729|NCT05176158|Sensory System Agents|sensory system agents|mesh-ancestor
102077730|NCT05176158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102077731|NCT05176158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077732|NCT05176158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102077733|NCT05176158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102077734|NCT02294240|Folic Acid|folic acid|mesh-list
102077735|NCT02294240|Hematinics|hematinics|mesh-ancestor
102077736|NCT02294240|Vitamin B Complex|vitamin b complex|mesh-ancestor
102077737|NCT02294240|Vitamins|vitamins|mesh-ancestor
102077738|NCT02294240|Micronutrients|micronutrients|mesh-ancestor
102077739|NCT02294240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077740|NCT04481724|Evening primrose oil|evening primrose oil|mesh-list
102077741|NCT04481724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101943350|NCT01145079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943351|NCT01145079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101943352|NCT01145079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101943353|NCT01145079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101943354|NCT01145079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101943355|NCT01145079|Antifungal Agents|antifungal agents|mesh-ancestor
101943356|NCT01146483|Pantoprazole|pantoprazole|mesh-list
101943357|NCT01146483|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101943358|NCT01146483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101943359|NCT01146483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101943360|NCT01146483|Antimetabolites|antimetabolites|mesh-ancestor
101943361|NCT01146483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077742|NCT04481724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102077743|NCT04481724|Analgesics|analgesics|mesh-ancestor
102077744|NCT04481724|Sensory System Agents|sensory system agents|mesh-ancestor
102077745|NCT04481724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102077746|NCT04481724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077747|NCT04481724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102077748|NCT04481724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102077751|NCT04481724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077752|NCT04481724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102077753|NCT04481724|Dermatologic Agents|dermatologic agents|mesh-ancestor
102077754|NCT02298218|Meloxicam|meloxicam|mesh-list
102077755|NCT02298218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102077756|NCT02298218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102077757|NCT02298218|Analgesics|analgesics|mesh-ancestor
102077758|NCT02298218|Sensory System Agents|sensory system agents|mesh-ancestor
102077759|NCT02298218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102077760|NCT02298218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077761|NCT02298218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102077762|NCT02298218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102077763|NCT02298218|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102077764|NCT02298218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102077765|NCT02298218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102077766|NCT02298218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077767|NCT03547830|Plerixafor|plerixafor|mesh-list
102077768|NCT03547830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102077769|NCT03547830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102077770|NCT03547830|Antiviral Agents|antiviral agents|mesh-ancestor
102077771|NCT03547830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102077772|NCT04390945|Capecitabine|capecitabine|mesh-list
102077773|NCT04390945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102077774|NCT04390945|Antimetabolites|antimetabolites|mesh-ancestor
102077775|NCT04390945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077776|NCT04390945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102077777|NCT03734809|Pembrolizumab|pembrolizumab|mesh-list
102077778|NCT03734809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102077779|NCT03734809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102077780|NCT03734809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102077781|NCT03734809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077782|NCT02291666|Tolbutamide|tolbutamide|mesh-list
102077783|NCT02291666|Midazolam|midazolam|mesh-list
102077784|NCT02291666|Dextromethorphan|dextromethorphan|mesh-list
102077785|NCT02291666|Caffeine|caffeine|mesh-list
102077786|NCT02291666|Chlorzoxazone|chlorzoxazone|mesh-list
102077787|NCT02291666|Bupropion|bupropion|mesh-list
102077788|NCT02291666|Omeprazole|omeprazole|mesh-list
102077789|NCT02291666|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102077790|NCT02291666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102077791|NCT02291666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102077792|NCT02291666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077793|NCT02291666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102077794|NCT02291666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101943362|NCT01146483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101943363|NCT01146483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101943364|NCT01146483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102077795|NCT02291666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102077796|NCT02291666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102077797|NCT02291666|Anesthetics, General|anesthetics, general|mesh-ancestor
102077798|NCT02291666|Anesthetics|anesthetics|mesh-ancestor
102077799|NCT02291666|GABA Modulators|gaba modulators|mesh-ancestor
102077800|NCT02291666|GABA Agents|gaba agents|mesh-ancestor
102077801|NCT02291666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102077802|NCT02291666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077803|NCT02291666|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102077804|NCT02291666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102077805|NCT02291666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102077806|NCT02291666|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102077807|NCT02291666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102077808|NCT02291666|Purinergic Agents|purinergic agents|mesh-ancestor
102077809|NCT02291666|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102077810|NCT02291666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102077811|NCT02291666|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102077812|NCT02291666|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102077813|NCT02291666|Antidepressive Agents|antidepressive agents|mesh-ancestor
102077814|NCT02291666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102077815|NCT02291666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102077816|NCT02291666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102077817|NCT02291666|Dopamine Agents|dopamine agents|mesh-ancestor
102077818|NCT02291666|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102077819|NCT02291666|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102077820|NCT02291666|Antitussive Agents|antitussive agents|mesh-ancestor
102077821|NCT02291666|Respiratory System Agents|respiratory system agents|mesh-ancestor
102077829|NCT03102658|Antifungal Agents|antifungal agents|mesh-ancestor
102077830|NCT03102658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102077831|NCT02646748|Pembrolizumab|pembrolizumab|mesh-list
102077832|NCT02646748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102077833|NCT02646748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102077834|NCT02646748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102077835|NCT02646748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077836|NCT03624985|Lidocaine|lidocaine|mesh-list
102077837|NCT03624985|Anesthetics, Local|anesthetics, local|mesh-ancestor
102077838|NCT03624985|Anesthetics|anesthetics|mesh-ancestor
102077839|NCT03624985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102077840|NCT03624985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077841|NCT03624985|Sensory System Agents|sensory system agents|mesh-ancestor
102077842|NCT03624985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102077843|NCT03624985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102077844|NCT03624985|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102077845|NCT03624985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102077846|NCT03624985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102077847|NCT03624985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077848|NCT03521024|Lithium Carbonate|lithium carbonate|mesh-list
102077849|NCT03521024|Ether|ether|mesh-list
102077850|NCT03521024|Antidepressive Agents|antidepressive agents|mesh-ancestor
102077851|NCT03521024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102077852|NCT03521024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102077853|NCT03521024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077854|NCT03521024|Antimanic Agents|antimanic agents|mesh-ancestor
102077855|NCT03521024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102077856|NCT03521024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102077857|NCT03521024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077858|NCT03521024|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102077859|NCT03521024|Anesthetics, General|anesthetics, general|mesh-ancestor
102077860|NCT03521024|Anesthetics|anesthetics|mesh-ancestor
102077861|NCT02294552|Mycophenolic Acid|mycophenolic acid|mesh-list
102077862|NCT02294552|Cyclophosphamide|cyclophosphamide|mesh-list
102077863|NCT02294552|Busulfan|busulfan|mesh-list
102077864|NCT02294552|Fludarabine|fludarabine|mesh-list
101797626|NCT03712904|Aflibercept|aflibercept|mesh-list
102077865|NCT02294552|Fludarabine phosphate|fludarabine phosphate|mesh-list
102077866|NCT02294552|Tacrolimus|tacrolimus|mesh-list
102077867|NCT02294552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101943365|NCT01146483|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101943366|NCT01146483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101943367|NCT01146483|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102077868|NCT02294552|Immunologic Factors|immunologic factors|mesh-ancestor
102077869|NCT02294552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077870|NCT02294552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102077871|NCT02294552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102077872|NCT02294552|Alkylating Agents|alkylating agents|mesh-ancestor
102077873|NCT02294552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077874|NCT02294552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102077875|NCT02294552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102077876|NCT02294552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102077877|NCT02294552|Antimetabolites|antimetabolites|mesh-ancestor
102077878|NCT02294552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102077879|NCT02294552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102077880|NCT02294552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102077881|NCT02294552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102077882|NCT02294552|Antitubercular Agents|antitubercular agents|mesh-ancestor
102077883|NCT02294552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102077884|NCT02294552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102077885|NCT05574036|Vitamin E|vitamin e|mesh-list
102077886|NCT05574036|Febuxostat|febuxostat|mesh-list
102077887|NCT05574036|Vitamins|vitamins|mesh-ancestor
102077888|NCT05574036|Micronutrients|micronutrients|mesh-ancestor
101379489|NCT00104988|Growth Inhibitors|growth inhibitors|mesh-ancestor
101702629|NCT03415828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102077891|NCT05574036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077893|NCT05574036|Gout Suppressants|gout suppressants|mesh-ancestor
102077894|NCT05574036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102077895|NCT03517982|Mycophenolic Acid|mycophenolic acid|mesh-list
102077896|NCT03517982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102077897|NCT03517982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102077898|NCT03517982|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102077899|NCT03517982|Antitubercular Agents|antitubercular agents|mesh-ancestor
102077900|NCT03517982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102077901|NCT03517982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102077902|NCT03517982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102077903|NCT03517982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077904|NCT03869944|Lamivudine|lamivudine|mesh-list
102077905|NCT03869944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102077906|NCT03869944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102077907|NCT03869944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102077908|NCT03869944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077909|NCT03869944|Antiviral Agents|antiviral agents|mesh-ancestor
102077910|NCT03869944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102077911|NCT03869944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102077912|NCT03869944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102077913|NCT03864094|Phenylephrine|phenylephrine|mesh-list
102077914|NCT03864094|Oxymetazoline|oxymetazoline|mesh-list
102077915|NCT03864094|Norepinephrine|norepinephrine|mesh-list
102077916|NCT03864094|Ephedrine|ephedrine|mesh-list
102077917|NCT03864094|Pseudoephedrine|pseudoephedrine|mesh-list
102077918|NCT03864094|Remifentanil|remifentanil|mesh-list
102077919|NCT03864094|Propofol|propofol|mesh-list
102077920|NCT03864094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102077921|NCT03864094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102077922|NCT03864094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077923|NCT03864094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102077924|NCT03864094|Anesthetics, General|anesthetics, general|mesh-ancestor
102077925|NCT03864094|Anesthetics|anesthetics|mesh-ancestor
102077926|NCT03864094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102077927|NCT03864094|Narcotics|narcotics|mesh-ancestor
102077928|NCT03864094|Analgesics|analgesics|mesh-ancestor
102077929|NCT03864094|Sensory System Agents|sensory system agents|mesh-ancestor
102077930|NCT03864094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102077931|NCT03864094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102077932|NCT03864094|Mydriatics|mydriatics|mesh-ancestor
102077933|NCT03864094|Autonomic Agents|autonomic agents|mesh-ancestor
102077934|NCT03864094|Sympathomimetics|sympathomimetics|mesh-ancestor
102077935|NCT03864094|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102077936|NCT03864094|Nasal Decongestants|nasal decongestants|mesh-ancestor
102077937|NCT03864094|Respiratory System Agents|respiratory system agents|mesh-ancestor
102077938|NCT03864094|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102077939|NCT03864094|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102077940|NCT03864094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101943368|NCT00396279|Vitamin D|vitamin d|mesh-list
101943369|NCT00396279|Denosumab|denosumab|mesh-list
101943370|NCT00396279|Calcium|calcium|mesh-list
101943371|NCT00396279|Vitamins|vitamins|mesh-ancestor
101943372|NCT00396279|Micronutrients|micronutrients|mesh-ancestor
101308260|NCT02046538|Antidotes|antidotes|mesh-ancestor
102077941|NCT03864094|Adrenergic Agents|adrenergic agents|mesh-ancestor
102077942|NCT03864094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102077943|NCT03864094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077944|NCT03864094|Protective Agents|protective agents|mesh-ancestor
102077945|NCT03864094|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102077946|NCT03864094|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102077947|NCT03864094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102077948|NCT05573802|Dexamethasone|dexamethasone|mesh-list
102077949|NCT05573802|Lenalidomide|lenalidomide|mesh-list
102077950|NCT05573802|Nirogacestat|nirogacestat|mesh-list
102077951|NCT05573802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102077952|NCT05573802|Antiemetics|antiemetics|mesh-ancestor
102077953|NCT05573802|Autonomic Agents|autonomic agents|mesh-ancestor
102077954|NCT05573802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102077955|NCT05573802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077956|NCT05573802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102077957|NCT05573802|Glucocorticoids|glucocorticoids|mesh-ancestor
102077958|NCT05573802|Hormones|hormones|mesh-ancestor
102077959|NCT05573802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102077960|NCT05573802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102077961|NCT05573802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102077962|NCT05573802|Immunologic Factors|immunologic factors|mesh-ancestor
102077965|NCT05573802|Growth Substances|growth substances|mesh-ancestor
102077966|NCT05573802|Growth Inhibitors|growth inhibitors|mesh-ancestor
102077967|NCT05573802|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
102077968|NCT05573802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102077969|NCT05573802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077970|NCT04435522|Maraviroc|maraviroc|mesh-list
102077971|NCT04435522|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102077972|NCT04435522|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102077973|NCT04435522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077974|NCT04435522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102077975|NCT04435522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102077976|NCT04435522|Antiviral Agents|antiviral agents|mesh-ancestor
102077977|NCT04435522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102077978|NCT04435522|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102077979|NCT03575325|Cytarabine|cytarabine|mesh-list
102077980|NCT03575325|Daunorubicin|daunorubicin|mesh-list
102077981|NCT03575325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102077982|NCT03575325|Antimetabolites|antimetabolites|mesh-ancestor
102077983|NCT03575325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077984|NCT03575325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102077985|NCT03575325|Antiviral Agents|antiviral agents|mesh-ancestor
102077986|NCT03575325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102077987|NCT03575325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102077988|NCT03575325|Immunologic Factors|immunologic factors|mesh-ancestor
102077989|NCT03575325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077990|NCT03575325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102077991|NCT03575325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102077992|NCT03575325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102077993|NCT03575325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102077994|NCT03843970|Bupivacaine|bupivacaine|mesh-list
102077995|NCT03843970|Levobupivacaine|levobupivacaine|mesh-list
102077996|NCT03843970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102077997|NCT03843970|Anesthetics, Local|anesthetics, local|mesh-ancestor
102077998|NCT03843970|Anesthetics|anesthetics|mesh-ancestor
102077999|NCT03843970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102078000|NCT03843970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078001|NCT03843970|Sensory System Agents|sensory system agents|mesh-ancestor
102078002|NCT03843970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102078003|NCT03043651|Treprostinil|treprostinil|mesh-list
102078004|NCT03043651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102078005|NCT04353024|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
102078006|NCT04353024|Hallucinogens|hallucinogens|mesh-ancestor
102078007|NCT04353024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078008|NCT04353024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101308265|NCT02046551|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101448556|NCT00188045|Vasodilator Agents|vasodilator agents|mesh-ancestor
102078009|NCT04353024|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102078010|NCT04353024|Serotonin Agents|serotonin agents|mesh-ancestor
102078011|NCT04353024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102078012|NCT04353024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078013|NCT04353024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102078014|NCT04465292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102078015|NCT04465292|Immunologic Factors|immunologic factors|mesh-ancestor
102078016|NCT04465292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078017|NCT02298530|Caffeine|caffeine|mesh-list
102078018|NCT02298530|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102078019|NCT02298530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078020|NCT02298530|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102078021|NCT02298530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102078022|NCT02298530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078023|NCT02298530|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102078024|NCT02298530|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102078025|NCT02298530|Purinergic Agents|purinergic agents|mesh-ancestor
102078026|NCT02298530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102078027|NCT05051436|Tadalafil|tadalafil|mesh-list
102078028|NCT05051436|Mirabegron|mirabegron|mesh-list
102078029|NCT05051436|Vasodilator Agents|vasodilator agents|mesh-ancestor
102078030|NCT05051436|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102078031|NCT05051436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102078032|NCT05051436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102078033|NCT05051436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078034|NCT05051436|Urological Agents|urological agents|mesh-ancestor
102078039|NCT05051436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102078040|NCT05051436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078041|NCT03644589|Pembrolizumab|pembrolizumab|mesh-list
102078042|NCT03644589|Immunoglobulins|immunoglobulins|mesh-list
102078043|NCT03644589|Immunoglobulin G|immunoglobulin g|mesh-list
102078044|NCT03644589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078045|NCT03644589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102078046|NCT03644589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102078047|NCT03644589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078048|NCT03644589|Immunologic Factors|immunologic factors|mesh-ancestor
102078049|NCT03644589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078050|NCT03514550|Propofol|propofol|mesh-list
102078051|NCT03514550|Sevoflurane|sevoflurane|mesh-list
102078052|NCT03514550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102078053|NCT03514550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102078054|NCT03514550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078055|NCT03514550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102078056|NCT03514550|Anesthetics, General|anesthetics, general|mesh-ancestor
102078057|NCT03514550|Anesthetics|anesthetics|mesh-ancestor
102078058|NCT03514550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102078059|NCT03514550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102078060|NCT04173988|Cyclophosphamide|cyclophosphamide|mesh-list
102078061|NCT04173988|Fludarabine|fludarabine|mesh-list
102078062|NCT04173988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102078063|NCT04173988|Immunologic Factors|immunologic factors|mesh-ancestor
102078064|NCT04173988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078065|NCT04173988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102078066|NCT04173988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102078067|NCT04173988|Alkylating Agents|alkylating agents|mesh-ancestor
102078068|NCT04173988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078069|NCT04173988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078070|NCT04173988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102078071|NCT01344759|Dexmedetomidine|dexmedetomidine|mesh-list
102078072|NCT01344759|Propofol|propofol|mesh-list
102078073|NCT01344759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102078074|NCT01344759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102078075|NCT01344759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078076|NCT01344759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102078077|NCT01344759|Analgesics|analgesics|mesh-ancestor
102078078|NCT01344759|Sensory System Agents|sensory system agents|mesh-ancestor
102078079|NCT01344759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102078080|NCT01344759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102078081|NCT01344759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102078082|NCT01344759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101702714|NCT00655616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101943373|NCT00396279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943374|NCT00396279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101943375|NCT00396279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101943376|NCT01238367|Factor VIII|factor viii|mesh-list
101448647|NCT00188669|Vitamin E|vitamin e|mesh-list
102078083|NCT01344759|Adrenergic Agents|adrenergic agents|mesh-ancestor
102078084|NCT01344759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102078085|NCT01344759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078086|NCT01344759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102078087|NCT01344759|Anesthetics, General|anesthetics, general|mesh-ancestor
102078088|NCT01344759|Anesthetics|anesthetics|mesh-ancestor
102078089|NCT05885386|Temozolomide|temozolomide|mesh-list
102078090|NCT05885386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102078091|NCT05885386|Alkylating Agents|alkylating agents|mesh-ancestor
102078092|NCT05885386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078093|NCT05885386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078094|NCT05885360|Istradefylline|istradefylline|mesh-list
102078095|NCT05885360|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
102078096|NCT05885360|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102078097|NCT05885360|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102078098|NCT05885360|Purinergic Agents|purinergic agents|mesh-ancestor
102078099|NCT05885360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102078100|NCT05885360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078101|NCT05885360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078102|NCT05885269|Clobetasol|clobetasol|mesh-list
102078103|NCT05885269|Tacrolimus|tacrolimus|mesh-list
101379701|NCT00071942|Metronidazole|metronidazole|mesh-list
102078122|NCT05884970|Autonomic Agents|autonomic agents|mesh-ancestor
102078123|NCT05884970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102078124|NCT05884970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078125|NCT05884970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102078126|NCT05884970|Respiratory System Agents|respiratory system agents|mesh-ancestor
102078127|NCT05884970|Tocolytic Agents|tocolytic agents|mesh-ancestor
102078128|NCT05884970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102078129|NCT05884970|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102078130|NCT05884970|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102078131|NCT05884970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102078132|NCT05884970|Adrenergic Agents|adrenergic agents|mesh-ancestor
102078133|NCT05884970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102078134|NCT05884970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078135|NCT05884957|Nitric Oxide|nitric oxide|mesh-list
102078136|NCT05884957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102078137|NCT05884957|Autonomic Agents|autonomic agents|mesh-ancestor
102078138|NCT05884957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102078139|NCT05884957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078140|NCT05884957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102078141|NCT05884957|Respiratory System Agents|respiratory system agents|mesh-ancestor
102078142|NCT05884957|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102078143|NCT05884957|Antioxidants|antioxidants|mesh-ancestor
102078144|NCT05884957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078145|NCT05884957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102078146|NCT05884957|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102078147|NCT05884957|Vasodilator Agents|vasodilator agents|mesh-ancestor
102078148|NCT05884957|Gasotransmitters|gasotransmitters|mesh-ancestor
102078149|NCT05884957|Protective Agents|protective agents|mesh-ancestor
102078150|NCT05884866|Dapagliflozin|dapagliflozin|mesh-list
102078151|NCT05884866|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102078152|NCT05884866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078153|NCT05884866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102078154|NCT05884866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078155|NCT05884671|Sulpiride|sulpiride|mesh-list
102078156|NCT05884671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102078157|NCT05884671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101527226|NCT03456882|RNS60|rns60|mesh-list
101379776|NCT00072059|Epoetin Alfa|epoetin alfa|mesh-list
102078165|NCT05884671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102078166|NCT05884671|Antidepressive Agents|antidepressive agents|mesh-ancestor
102078167|NCT05884502|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102078168|NCT05884502|Ezetimibe|ezetimibe|mesh-list
102078169|NCT05884502|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101943377|NCT01238367|Coagulants|coagulants|mesh-ancestor
101943378|NCT01347866|Irinotecan|irinotecan|mesh-list
101943379|NCT01347866|Gedatolisib|gedatolisib|mesh-list
101943380|NCT01347866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101943381|NCT01347866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101943382|NCT01347866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101943383|NCT01347866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943384|NCT01347866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101943385|NCT01347866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101943386|NCT01347710|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
102078170|NCT05884502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102078171|NCT05884502|Antimetabolites|antimetabolites|mesh-ancestor
102078172|NCT05884502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078173|NCT05884502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102078174|NCT05884502|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102078175|NCT05884502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102078176|NCT05884463|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102078177|NCT05884463|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102078178|NCT05884463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078179|NCT05884268|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102078180|NCT05884268|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102078181|NCT05884268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102078182|NCT05884268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102078183|NCT05884268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078184|NCT05884268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102078185|NCT05884268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078186|NCT05884268|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102078187|NCT05884268|Antidepressive Agents|antidepressive agents|mesh-ancestor
102078188|NCT05884268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102078189|NCT05884255|Octreotide|octreotide|mesh-list
102078190|NCT05884255|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102078191|NCT05884255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102078192|NCT05884255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102078193|NCT05884255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078194|NCT05884255|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102078195|NCT05884255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078196|NCT05884151|Tranexamic Acid|tranexamic acid|mesh-list
102078197|NCT05884151|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102078198|NCT05884151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102078199|NCT05884151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078200|NCT05884151|Hemostatics|hemostatics|mesh-ancestor
102078201|NCT05884151|Coagulants|coagulants|mesh-ancestor
102078202|NCT05883956|Azacitidine|azacitidine|mesh-list
102078203|NCT05883956|Decitabine|decitabine|mesh-list
102078204|NCT05883956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102078205|NCT05883956|Antimetabolites|antimetabolites|mesh-ancestor
102078206|NCT05883956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078207|NCT05883956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078208|NCT05883956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102078209|NCT05883891|Thrombin|thrombin|mesh-list
102078210|NCT05883891|Hemostatics|hemostatics|mesh-ancestor
102078211|NCT05883891|Coagulants|coagulants|mesh-ancestor
102078212|NCT05883865|Fenofibrate|fenofibrate|mesh-list
102078213|NCT05883865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102078214|NCT05883865|Antimetabolites|antimetabolites|mesh-ancestor
102078215|NCT05883865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078216|NCT05883865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102078217|NCT05883709|Lenalidomide|lenalidomide|mesh-list
102078218|NCT05883709|Immunologic Factors|immunologic factors|mesh-ancestor
102078219|NCT05883709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078220|NCT05883709|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102078221|NCT05883709|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102078222|NCT05883709|Growth Substances|growth substances|mesh-ancestor
102078226|NCT05883449|Fludarabine|fludarabine|mesh-list
101943387|NCT01347710|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
101943388|NCT01347710|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101943389|NCT01347710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943390|NCT05470868|Naphazoline|naphazoline|mesh-list
101943391|NCT05470868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101943392|NCT05470868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101943393|NCT05470868|Adrenergic Agents|adrenergic agents|mesh-ancestor
102078227|NCT05883449|Interleukin-2|interleukin-2|mesh-list
102078228|NCT05883449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102078229|NCT05883449|Immunologic Factors|immunologic factors|mesh-ancestor
102078230|NCT05883449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078231|NCT05883449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102078232|NCT05883449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102078233|NCT05883449|Alkylating Agents|alkylating agents|mesh-ancestor
102078234|NCT05883449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078235|NCT05883449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078236|NCT05883449|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102078237|NCT05883449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102078238|NCT05883449|Analgesics|analgesics|mesh-ancestor
102078239|NCT05883449|Sensory System Agents|sensory system agents|mesh-ancestor
102078240|NCT05883449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102078241|NCT05881720|Valsartan|valsartan|mesh-list
102078242|NCT05881720|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102078243|NCT05881720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102078244|NCT05881720|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102078245|NCT05881720|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102078246|NCT05881720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078247|NCT05873725|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102078248|NCT05873725|Hormones|hormones|mesh-ancestor
102078249|NCT05873725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102078250|NCT05873725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078251|NCT05860530|Olaparib|olaparib|mesh-list
102078252|NCT05860530|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102078253|NCT05860530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102078254|NCT05860530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078255|NCT05860530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078256|NCT05855798|Magnesium Sulfate|magnesium sulfate|mesh-list
102078257|NCT05855798|Ketamine|ketamine|mesh-list
102078258|NCT05855798|Bupivacaine|bupivacaine|mesh-list
102078259|NCT05855798|Anesthetics, Local|anesthetics, local|mesh-ancestor
102078260|NCT05855798|Anesthetics|anesthetics|mesh-ancestor
102078261|NCT05855798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102078262|NCT05855798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078263|NCT05855798|Sensory System Agents|sensory system agents|mesh-ancestor
102078264|NCT05855798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102078265|NCT05855798|Analgesics|analgesics|mesh-ancestor
102078266|NCT05855798|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102078267|NCT05855798|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102078268|NCT05855798|Anesthetics, General|anesthetics, general|mesh-ancestor
102078269|NCT05855798|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102078270|NCT05855798|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102078271|NCT05855798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102078272|NCT05855798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078273|NCT05855798|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102078274|NCT05855798|Anticonvulsants|anticonvulsants|mesh-ancestor
102078275|NCT05855798|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102078276|NCT05855798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102078277|NCT05855798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102078278|NCT05855798|Tocolytic Agents|tocolytic agents|mesh-ancestor
102078279|NCT05855798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102078280|NCT05833126|Bevacizumab|bevacizumab|mesh-list
102078281|NCT05833126|Atezolizumab|atezolizumab|mesh-list
102078282|NCT05833126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102078283|NCT05833126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078284|NCT05833126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101943394|NCT05470868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101448845|NCT00189566|Paclitaxel|paclitaxel|mesh-list
102078285|NCT05833126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102078286|NCT05833126|Growth Substances|growth substances|mesh-ancestor
102078287|NCT05833126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078288|NCT05833126|Growth Inhibitors|growth inhibitors|mesh-ancestor
102078289|NCT05833126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102078290|NCT05833126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078291|NCT05830799|Tolbutamide|tolbutamide|mesh-list
102078292|NCT05830799|Nintedanib|nintedanib|mesh-list
102078295|NCT05830799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102078296|NCT05830799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102078297|NCT05830799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102078298|NCT05830799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078300|NCT05830799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102078301|NCT05830799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102078302|NCT05830799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102078303|NCT05830799|Anesthetics, General|anesthetics, general|mesh-ancestor
102078304|NCT05830799|Anesthetics|anesthetics|mesh-ancestor
102078305|NCT05830799|GABA Modulators|gaba modulators|mesh-ancestor
102078306|NCT05830799|GABA Agents|gaba agents|mesh-ancestor
102078307|NCT05830799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102078308|NCT05830799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078309|NCT05830799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102078310|NCT05830799|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102078311|NCT05830799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102078312|NCT05830799|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102078313|NCT05830799|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102078314|NCT05830799|Purinergic Agents|purinergic agents|mesh-ancestor
102078315|NCT05830799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078316|NCT05830799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102078317|NCT05830799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102078318|NCT05827523|Cisplatin|cisplatin|mesh-list
102078319|NCT05827523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078320|NCT05798156|Rituximab|rituximab|mesh-list
102078321|NCT05798156|Obinutuzumab|obinutuzumab|mesh-list
102078322|NCT05798156|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
102078323|NCT05798156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102078324|NCT05798156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078325|NCT05798156|Immunologic Factors|immunologic factors|mesh-ancestor
102078326|NCT05798156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078327|NCT05798156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102078328|NCT05798156|Immunoconjugates|immunoconjugates|mesh-ancestor
102078329|NCT05731843|Ruzasvir|ruzasvir|mesh-list
102078330|NCT05731843|Antiviral Agents|antiviral agents|mesh-ancestor
102078331|NCT05731843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102078332|NCT05720949|Dexamethasone|dexamethasone|mesh-list
102078333|NCT05720949|Bupivacaine|bupivacaine|mesh-list
102078334|NCT05720949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102078335|NCT05720949|Antiemetics|antiemetics|mesh-ancestor
102078336|NCT05720949|Autonomic Agents|autonomic agents|mesh-ancestor
102078337|NCT05720949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102078338|NCT05720949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078339|NCT05720949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102078340|NCT05720949|Glucocorticoids|glucocorticoids|mesh-ancestor
102078341|NCT05720949|Hormones|hormones|mesh-ancestor
102078342|NCT05720949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102078343|NCT05720949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102078344|NCT05720949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078345|NCT05720949|Anesthetics, Local|anesthetics, local|mesh-ancestor
102078346|NCT05720949|Anesthetics|anesthetics|mesh-ancestor
102078347|NCT05720949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102078348|NCT05720949|Sensory System Agents|sensory system agents|mesh-ancestor
102078349|NCT05714631|Lidocaine|lidocaine|mesh-list
102078350|NCT05714631|Anesthetics, Local|anesthetics, local|mesh-ancestor
102078351|NCT05714631|Anesthetics|anesthetics|mesh-ancestor
102078352|NCT05714631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102078353|NCT05714631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078354|NCT05714631|Sensory System Agents|sensory system agents|mesh-ancestor
102078355|NCT05714631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102078356|NCT05714631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102078357|NCT05714631|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102078358|NCT05714631|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102078359|NCT05714631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101943395|NCT05470868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943396|NCT05470868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943397|NCT05470868|Nasal Decongestants|nasal decongestants|mesh-ancestor
102078360|NCT05714631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078361|NCT05676411|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102078362|NCT05676411|Dermatologic Agents|dermatologic agents|mesh-ancestor
102078363|NCT05650476|Talazoparib|talazoparib|mesh-list
102078364|NCT05650476|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102078365|NCT05650476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102078366|NCT05650476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078368|NCT05633563|Trimetazidine|trimetazidine|mesh-list
102078369|NCT05633563|Vasodilator Agents|vasodilator agents|mesh-ancestor
102078370|NCT05627271|Ofatumumab|ofatumumab|mesh-list
102078371|NCT05627271|Ocrelizumab|ocrelizumab|mesh-list
102078372|NCT05627271|Natalizumab|natalizumab|mesh-list
102078373|NCT05627271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078374|NCT05627271|Immunologic Factors|immunologic factors|mesh-ancestor
102078375|NCT05627271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078376|NCT05610735|Doxorubicin|doxorubicin|mesh-list
102078377|NCT05610735|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102078378|NCT05610735|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102078379|NCT05610735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078380|NCT05610735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102078381|NCT05610735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102078382|NCT05610735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102078383|NCT05610735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078384|NCT05593458|Oxaliplatin|oxaliplatin|mesh-list
102078385|NCT05593458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078386|NCT05571514|Calcium Carbonate|calcium carbonate|mesh-list
102078387|NCT05571514|Calcium|calcium|mesh-list
102078388|NCT05571514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102078389|NCT05571514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078391|NCT05571514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078392|NCT05571514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102078393|NCT05562713|Denatonium|denatonium|mesh-list
102078394|NCT05562713|Aversive Agents|aversive agents|mesh-ancestor
102078395|NCT05562713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078396|NCT05562713|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
102078397|NCT05562713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078398|NCT05562713|Sensory System Agents|sensory system agents|mesh-ancestor
102078399|NCT05562713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102078400|NCT05556720|Vaccines|vaccines|mesh-list
102078401|NCT05556720|Immunologic Factors|immunologic factors|mesh-ancestor
102078402|NCT05556720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078403|NCT05513391|Vaccines|vaccines|mesh-list
102078404|NCT05513391|Immunologic Factors|immunologic factors|mesh-ancestor
102078405|NCT05513391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078406|NCT05498766|Capecitabine|capecitabine|mesh-list
102078407|NCT05498766|Tegafur|tegafur|mesh-list
102078408|NCT05498766|Oxaliplatin|oxaliplatin|mesh-list
102078409|NCT05498766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102078410|NCT05498766|Antimetabolites|antimetabolites|mesh-ancestor
102078411|NCT05498766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078412|NCT05498766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078413|NCT05498389|Osimertinib|osimertinib|mesh-list
102078414|NCT05498389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078415|NCT05498389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102078416|NCT05498389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102078417|NCT05498389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078418|NCT05466578|Abrocitinib|abrocitinib|mesh-list
102078419|NCT05466578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102078420|NCT05466578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101702814|NCT00885482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102078421|NCT05466578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078422|NCT05351541|Zolpidem|zolpidem|mesh-list
102078423|NCT05351541|Modafinil|modafinil|mesh-list
102078424|NCT05351541|Psilocybin|psilocybin|mesh-list
102078425|NCT05351541|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
102078426|NCT05351541|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102078427|NCT05351541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078428|NCT05351541|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102078429|NCT05351541|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101943398|NCT05470868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101943399|NCT05470868|Respiratory System Agents|respiratory system agents|mesh-ancestor
101943400|NCT03485222|Empagliflozin|empagliflozin|mesh-list
101449008|NCT00213252|Hormones|hormones|mesh-ancestor
102078430|NCT05351541|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102078431|NCT05351541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078432|NCT05351541|Hallucinogens|hallucinogens|mesh-ancestor
102078433|NCT05351541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102078434|NCT05351541|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102078435|NCT05351541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102078436|NCT05351541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102078437|NCT05351541|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102078438|NCT05351541|GABA Agonists|gaba agonists|mesh-ancestor
102078439|NCT05351541|GABA Agents|gaba agents|mesh-ancestor
102078440|NCT05351541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102078441|NCT05351541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102078442|NCT05351541|Serotonin Agents|serotonin agents|mesh-ancestor
102078454|NCT05334056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102078455|NCT05334056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078456|NCT05334056|Dopamine Agents|dopamine agents|mesh-ancestor
102078457|NCT05334056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102078458|NCT05328414|Prednisolone|prednisolone|mesh-list
102078459|NCT05328414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102078460|NCT05328414|Glucocorticoids|glucocorticoids|mesh-ancestor
102078461|NCT05328414|Hormones|hormones|mesh-ancestor
102078462|NCT05328414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102078463|NCT05328414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078464|NCT05328414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102078465|NCT05328414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078466|NCT05320393|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102078467|NCT05320393|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102078468|NCT05320393|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102078469|NCT05320393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102078470|NCT05320393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078471|NCT05320393|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102078472|NCT05320393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102078473|NCT05320393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078474|NCT05320393|Cholinergic Agents|cholinergic agents|mesh-ancestor
102078475|NCT05320393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102078476|NCT05298085|Oxytocin|oxytocin|mesh-list
102078477|NCT05298085|Oxytocics|oxytocics|mesh-ancestor
102078478|NCT05298085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102078479|NCT05298085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078480|NCT05291598|Ketorolac|ketorolac|mesh-list
102078481|NCT05291598|Meloxicam|meloxicam|mesh-list
102078482|NCT05291598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102078483|NCT05291598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102078484|NCT05291598|Analgesics|analgesics|mesh-ancestor
102078485|NCT05291598|Sensory System Agents|sensory system agents|mesh-ancestor
102078486|NCT05291598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102078487|NCT05291598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078488|NCT05291598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102078489|NCT05291598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102078490|NCT05291598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102078491|NCT05291598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102078492|NCT05291598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078493|NCT05291598|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102078494|NCT05288153|Metformin|metformin|mesh-list
102078495|NCT05288153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102078496|NCT05288153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078497|NCT05255003|Enoxaparin|enoxaparin|mesh-list
102078498|NCT05255003|Dalteparin|dalteparin|mesh-list
102078499|NCT05255003|Tinzaparin|tinzaparin|mesh-list
102078500|NCT05255003|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102078501|NCT05255003|Anticoagulants|anticoagulants|mesh-ancestor
102078502|NCT05255003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102078503|NCT05255003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102078504|NCT05255003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078505|NCT05190432|Taxifolin|taxifolin|mesh-list
102078508|NCT05190432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078509|NCT05190432|Protective Agents|protective agents|mesh-ancestor
101943401|NCT03485222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101943402|NCT03485222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943403|NCT03485222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101943404|NCT03485222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943405|NCT01347554|Everolimus|everolimus|mesh-list
101943406|NCT01347554|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101943407|NCT01347554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101943408|NCT01347554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101943409|NCT01347554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943410|NCT01347554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101943411|NCT01347554|Immunologic Factors|immunologic factors|mesh-ancestor
102078510|NCT05190432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078511|NCT05190432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102078512|NCT05190432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102078513|NCT05190432|Analgesics|analgesics|mesh-ancestor
102078514|NCT05190432|Sensory System Agents|sensory system agents|mesh-ancestor
102078515|NCT05190432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102078516|NCT05190432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102078517|NCT05190432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102078518|NCT05171166|Leucovorin|leucovorin|mesh-list
102078519|NCT05171166|Fluorouracil|fluorouracil|mesh-list
102078520|NCT05171166|Oxaliplatin|oxaliplatin|mesh-list
102078521|NCT05171166|Chlorotrianisene|chlorotrianisene|mesh-list
102078522|NCT05171166|Antimetabolites|antimetabolites|mesh-ancestor
102078523|NCT05171166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078524|NCT05171166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102078525|NCT05171166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078526|NCT05171166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102078527|NCT05171166|Immunologic Factors|immunologic factors|mesh-ancestor
102078528|NCT05171166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078529|NCT05171166|Antidotes|antidotes|mesh-ancestor
102078530|NCT05171166|Protective Agents|protective agents|mesh-ancestor
102078531|NCT05171166|Vitamin B Complex|vitamin b complex|mesh-ancestor
102078532|NCT05171166|Vitamins|vitamins|mesh-ancestor
102078533|NCT05171166|Micronutrients|micronutrients|mesh-ancestor
102078534|NCT05171166|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102078535|NCT05171166|Estrogens|estrogens|mesh-ancestor
102078536|NCT05171166|Hormones|hormones|mesh-ancestor
102078537|NCT05171166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102078538|NCT05171166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102078539|NCT05150340|Immunoglobulins|immunoglobulins|mesh-list
102078540|NCT05150340|Immunologic Factors|immunologic factors|mesh-ancestor
102078541|NCT05150340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078542|NCT05123131|Dexamethasone|dexamethasone|mesh-list
102078543|NCT05123131|Lenalidomide|lenalidomide|mesh-list
102078544|NCT05123131|Bortezomib|bortezomib|mesh-list
102078545|NCT05123131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102078546|NCT05123131|Antiemetics|antiemetics|mesh-ancestor
102078547|NCT05123131|Autonomic Agents|autonomic agents|mesh-ancestor
102078548|NCT05123131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102078549|NCT05123131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078550|NCT05123131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102078551|NCT05123131|Glucocorticoids|glucocorticoids|mesh-ancestor
102078552|NCT05123131|Hormones|hormones|mesh-ancestor
102078553|NCT05123131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102078554|NCT05123131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102078555|NCT05123131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078556|NCT05123131|Immunologic Factors|immunologic factors|mesh-ancestor
102078557|NCT05123131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102078558|NCT05123131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102078559|NCT05123131|Growth Substances|growth substances|mesh-ancestor
102078560|NCT05123131|Growth Inhibitors|growth inhibitors|mesh-ancestor
102078561|NCT05102162|Meropenem|meropenem|mesh-list
102078562|NCT05102162|Tazobactam|tazobactam|mesh-list
102078563|NCT05102162|Piperacillin|piperacillin|mesh-list
101943412|NCT01347554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943413|NCT01347554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101943414|NCT05567354|Oxycodone|oxycodone|mesh-list
101308305|NCT02046720|Propofol|propofol|mesh-list
102078564|NCT05102162|Cefepime|cefepime|mesh-list
102078565|NCT05102162|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102078566|NCT05102162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102078567|NCT05102162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102078568|NCT05102162|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102078569|NCT05102162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102078570|NCT05102162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078571|NCT05101187|Amphotericin B|amphotericin b|mesh-list
102078572|NCT05101187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102078573|NCT05101187|Olorofim|olorofim|mesh-list
102078574|NCT05101187|Amebicides|amebicides|mesh-ancestor
102078575|NCT05101187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102078576|NCT05101187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102078577|NCT05101187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102078578|NCT05101187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102078579|NCT05101187|Antifungal Agents|antifungal agents|mesh-ancestor
102078580|NCT05065866|Azacitidine|azacitidine|mesh-list
102078581|NCT05065866|Cc-486|cc-486|mesh-list
102078582|NCT05065866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102078586|NCT05065866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102078587|NCT05024513|Fluorouracil|fluorouracil|mesh-list
102078588|NCT05024513|Oxaliplatin|oxaliplatin|mesh-list
102078589|NCT05024513|Antimetabolites|antimetabolites|mesh-ancestor
102078590|NCT05024513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078591|NCT05024513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102078592|NCT05024513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078593|NCT05024513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102078594|NCT05024513|Immunologic Factors|immunologic factors|mesh-ancestor
102078595|NCT05024513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078596|NCT05024045|Pirtobrutinib|pirtobrutinib|mesh-list
102078597|NCT05024045|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102078598|NCT05024045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102078599|NCT05024045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078600|NCT05000047|Silicon|silicon|mesh-list
102078601|NCT05000047|Trace Elements|trace elements|mesh-ancestor
102078602|NCT05000047|Micronutrients|micronutrients|mesh-ancestor
102078603|NCT05000047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078604|NCT04982848|Talazoparib|talazoparib|mesh-list
102078605|NCT04982848|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102078606|NCT04982848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102078607|NCT04982848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078608|NCT04982848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078609|NCT04982445|Cabotegravir, rilpivirine drug combination|cabotegravir, rilpivirine drug combination|mesh-list
102078610|NCT04982445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102078611|NCT04982445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102078612|NCT04982445|Antiviral Agents|antiviral agents|mesh-ancestor
102078613|NCT04982445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102078614|NCT04974047|Tislelizumab|tislelizumab|mesh-list
102078615|NCT04974047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102078616|NCT04974047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078617|NCT04934800|Cladribine|cladribine|mesh-list
102078618|NCT04934800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078619|NCT04934800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102078620|NCT04934800|Immunologic Factors|immunologic factors|mesh-ancestor
102078621|NCT04934800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078622|NCT04920942|Ivermectin|ivermectin|mesh-list
102078623|NCT04920942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102078624|NCT04920942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102078625|NCT04918186|Durvalumab|durvalumab|mesh-list
102078626|NCT04918186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102078627|NCT04918186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078628|NCT04821687|Opicapone|opicapone|mesh-list
102078629|NCT04821687|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
102078630|NCT04821687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102078631|NCT04821687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078632|NCT04821687|Dopamine Agents|dopamine agents|mesh-ancestor
102078633|NCT04821687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102078634|NCT04821687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078635|NCT04821687|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101943415|NCT05567354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101943416|NCT05567354|Narcotics|narcotics|mesh-ancestor
101943417|NCT05567354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101943418|NCT05567354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943419|NCT05567354|Analgesics|analgesics|mesh-ancestor
101943420|NCT05567354|Sensory System Agents|sensory system agents|mesh-ancestor
101308311|NCT02046720|Anesthetics|anesthetics|mesh-ancestor
102078636|NCT04821687|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102078637|NCT04821687|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102078638|NCT04764344|Haloperidol|haloperidol|mesh-list
102078639|NCT04764344|Ondansetron|ondansetron|mesh-list
102078640|NCT04764344|Haloperidol decanoate|haloperidol decanoate|mesh-list
102078641|NCT04764344|Antiemetics|antiemetics|mesh-ancestor
102078642|NCT04764344|Autonomic Agents|autonomic agents|mesh-ancestor
102078643|NCT04764344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102078644|NCT04764344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078645|NCT04764344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102078646|NCT04764344|Antipruritics|antipruritics|mesh-ancestor
102078647|NCT04764344|Dermatologic Agents|dermatologic agents|mesh-ancestor
102078648|NCT04764344|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102078649|NCT04764344|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102078650|NCT04764344|Serotonin Agents|serotonin agents|mesh-ancestor
102078651|NCT04764344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102078652|NCT04764344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078653|NCT04764344|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102078654|NCT04764344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102078662|NCT04738981|Basiliximab|basiliximab|mesh-list
102078663|NCT04738981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102078664|NCT04738981|Immunologic Factors|immunologic factors|mesh-ancestor
102078665|NCT04738981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078666|NCT04709185|Dexamethasone|dexamethasone|mesh-list
102078667|NCT04709185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102078668|NCT04709185|Antiemetics|antiemetics|mesh-ancestor
102078669|NCT04709185|Autonomic Agents|autonomic agents|mesh-ancestor
102078670|NCT04709185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102078671|NCT04709185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078672|NCT04709185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102078673|NCT04709185|Glucocorticoids|glucocorticoids|mesh-ancestor
102078674|NCT04709185|Hormones|hormones|mesh-ancestor
102078675|NCT04709185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102078676|NCT04709185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102078677|NCT04709185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078678|NCT04693156|Bupivacaine|bupivacaine|mesh-list
102078679|NCT04693156|Prilocaine|prilocaine|mesh-list
102078680|NCT04693156|Anesthetics, Local|anesthetics, local|mesh-ancestor
102078681|NCT04693156|Anesthetics|anesthetics|mesh-ancestor
102078682|NCT04693156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102078683|NCT04693156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078684|NCT04693156|Sensory System Agents|sensory system agents|mesh-ancestor
102078685|NCT04693156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102078686|NCT04685616|Doxorubicin|doxorubicin|mesh-list
102078687|NCT04685616|Bleomycin|bleomycin|mesh-list
101798454|NCT00191113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078688|NCT04685616|Dacarbazine|dacarbazine|mesh-list
102078689|NCT04685616|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102078690|NCT04685616|Vinblastine|vinblastine|mesh-list
102078691|NCT04685616|Mitogens|mitogens|mesh-list
102078692|NCT04685616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102078693|NCT04685616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078694|NCT04685616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102078695|NCT04685616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102078696|NCT04685616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102078697|NCT04685616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078698|NCT04685616|Mitosis Modulators|mitosis modulators|mesh-ancestor
102078699|NCT04685616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102078700|NCT04685616|Alkylating Agents|alkylating agents|mesh-ancestor
102078701|NCT04685616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102078702|NCT04685616|Immunotoxins|immunotoxins|mesh-ancestor
102078703|NCT04685616|Immunoconjugates|immunoconjugates|mesh-ancestor
102078704|NCT04685616|Immunologic Factors|immunologic factors|mesh-ancestor
101943421|NCT05567354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101943422|NCT03482882|Pimavanserin|pimavanserin|mesh-list
101943423|NCT03482882|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101943424|NCT03482882|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101943425|NCT03482882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101943426|NCT03482882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101943427|NCT03482882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101943428|NCT03482882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943429|NCT03482882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101943430|NCT03482882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101943431|NCT03482882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101943432|NCT03482882|Serotonin Agents|serotonin agents|mesh-ancestor
101943433|NCT03482882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101943434|NCT03482882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943435|NCT03480932|Interferons|interferons|mesh-list
101943436|NCT03480932|Interferon-alpha|interferon-alpha|mesh-list
101943437|NCT03480932|Interferon alpha-2|interferon alpha-2|mesh-list
101943438|NCT03480932|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101943439|NCT03480932|Sofosbuvir|sofosbuvir|mesh-list
101943440|NCT03480932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101943441|NCT03480932|Antiviral Agents|antiviral agents|mesh-ancestor
101943442|NCT03480932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101943443|NCT03480932|Immunologic Factors|immunologic factors|mesh-ancestor
101943444|NCT03480932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943445|NCT03387020|Everolimus|everolimus|mesh-list
101943446|NCT03387020|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101308319|NCT02046850|Rifampin|rifampin|mesh-list
102078705|NCT04685616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703039|NCT02724761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102078706|NCT04685616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102078707|NCT04685616|Tubulin Modulators|tubulin modulators|mesh-ancestor
102078708|NCT04685616|Antimitotic Agents|antimitotic agents|mesh-ancestor
102078709|NCT04504331|Tamoxifen|tamoxifen|mesh-list
102078710|NCT04504331|Infigratinib|infigratinib|mesh-list
102078711|NCT04504331|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102078712|NCT04504331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102078713|NCT04504331|Hormone Antagonists|hormone antagonists|mesh-ancestor
102078714|NCT04504331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102078715|NCT04504331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078716|NCT04504331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102078717|NCT04504331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078718|NCT04504331|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102078719|NCT04504331|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102078720|NCT04504331|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102078721|NCT04504331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102078722|NCT04504331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102078727|NCT04447911|Empagliflozin|empagliflozin|mesh-list
102078728|NCT04447911|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102078729|NCT04447911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943447|NCT03387020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101943448|NCT03387020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101943449|NCT03387020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703074|NCT02721173|Dermatologic Agents|dermatologic agents|mesh-ancestor
101943450|NCT03387020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101943451|NCT03387020|Immunologic Factors|immunologic factors|mesh-ancestor
101943452|NCT03387020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449364|NCT00221052|Diclofenac|diclofenac|mesh-list
102078730|NCT04447911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102078731|NCT04447911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078732|NCT04420195|Tacrolimus|tacrolimus|mesh-list
102078733|NCT04420195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102078734|NCT04420195|Immunologic Factors|immunologic factors|mesh-ancestor
102078735|NCT04420195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078736|NCT04420195|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102078737|NCT04420195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102078738|NCT04420195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078739|NCT04313985|Immunologic Factors|immunologic factors|mesh-list
102078740|NCT04313985|Immunomodulating Agents|immunomodulating agents|mesh-list
102078741|NCT04313985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078742|NCT04283578|Oxytocin|oxytocin|mesh-list
102078743|NCT04283578|Oxytocics|oxytocics|mesh-ancestor
102078744|NCT04283578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102078745|NCT04283578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078746|NCT04123873|Acetaminophen|acetaminophen|mesh-list
102078747|NCT04123873|Dexamethasone|dexamethasone|mesh-list
102078748|NCT04123873|Ibuprofen|ibuprofen|mesh-list
102078749|NCT04123873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102078750|NCT04123873|Antiemetics|antiemetics|mesh-ancestor
102078751|NCT04123873|Autonomic Agents|autonomic agents|mesh-ancestor
102078752|NCT04123873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102078753|NCT04123873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078754|NCT04123873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102078755|NCT04123873|Glucocorticoids|glucocorticoids|mesh-ancestor
102078756|NCT04123873|Hormones|hormones|mesh-ancestor
102078757|NCT04123873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102078758|NCT04123873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102078759|NCT04123873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078760|NCT04123873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102078761|NCT04123873|Analgesics|analgesics|mesh-ancestor
102078762|NCT04123873|Sensory System Agents|sensory system agents|mesh-ancestor
102078763|NCT04123873|Antipyretics|antipyretics|mesh-ancestor
102078764|NCT04123873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102078765|NCT04123873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102078766|NCT04123873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102078767|NCT04123873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102078768|NCT04123873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078770|NCT04116203|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102078771|NCT04116203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078772|NCT04106362|Cisplatin|cisplatin|mesh-list
102078773|NCT04106362|Cetuximab|cetuximab|mesh-list
102078774|NCT04106362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102078775|NCT04106362|Antibodies|antibodies|mesh-list
102078776|NCT04106362|Immunoglobulins|immunoglobulins|mesh-list
102078777|NCT04106362|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102078778|NCT04106362|Immunologic Factors|immunologic factors|mesh-ancestor
102078779|NCT04106362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078780|NCT04106362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078781|NCT04079088|Interferons|interferons|mesh-list
102078782|NCT04079088|Interferon-beta|interferon-beta|mesh-list
102078783|NCT04079088|Glatiramer Acetate|glatiramer acetate|mesh-list
102078784|NCT04079088|(T,G)-A-L|(t,g)-a-l|mesh-list
102078785|NCT04079088|Interferon beta-1b|interferon beta-1b|mesh-list
102078786|NCT04079088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078787|NCT04079088|Antiviral Agents|antiviral agents|mesh-ancestor
102078788|NCT04079088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102078789|NCT04079088|Immunologic Factors|immunologic factors|mesh-ancestor
102078790|NCT04079088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078791|NCT04079088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102078792|NCT04079088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102078793|NCT04079088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102078794|NCT04060030|Calcium, Dietary|calcium, dietary|mesh-list
102078796|NCT04060030|Calcium|calcium|mesh-list
102078820|NCT03819465|Gemcitabine|gemcitabine|mesh-list
102078821|NCT03819465|Pemetrexed|pemetrexed|mesh-list
102078822|NCT03819465|Durvalumab|durvalumab|mesh-list
102078823|NCT03819465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102078824|NCT03819465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078825|NCT03819465|Tubulin Modulators|tubulin modulators|mesh-ancestor
102078826|NCT03819465|Antimitotic Agents|antimitotic agents|mesh-ancestor
102078827|NCT03819465|Mitosis Modulators|mitosis modulators|mesh-ancestor
102078828|NCT03819465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078829|NCT03819465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102078830|NCT03819465|Antimetabolites|antimetabolites|mesh-ancestor
102078831|NCT03819465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102078832|NCT03819465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102078833|NCT03819465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102078834|NCT03819465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102078835|NCT03713424|Clavulanic Acids|clavulanic acids|mesh-list
102078836|NCT03713424|Clavulanic Acid|clavulanic acid|mesh-list
102078837|NCT03713424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102078838|NCT03713424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102078839|NCT03713424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102078840|NCT03713424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078841|NCT03713424|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101798625|NCT00944814|Zinc|zinc|mesh-list
102078842|NCT03637803|Pembrolizumab|pembrolizumab|mesh-list
102078843|NCT03637803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102078844|NCT03637803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078845|NCT03637803|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102078846|NCT03637803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078847|NCT03567720|Paclitaxel|paclitaxel|mesh-list
102078848|NCT03567720|Carboplatin|carboplatin|mesh-list
102078864|NCT03519906|Sympatholytics|sympatholytics|mesh-ancestor
102078865|NCT03519906|Autonomic Agents|autonomic agents|mesh-ancestor
102078866|NCT03519906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102078867|NCT03519906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078868|NCT03519906|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102078869|NCT03519906|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102078870|NCT03519906|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102078871|NCT03519906|Adrenergic Agents|adrenergic agents|mesh-ancestor
102078872|NCT03519906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102078873|NCT03519906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078874|NCT03519893|Losartan|losartan|mesh-list
102078875|NCT03519893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102078876|NCT03519893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102078877|NCT03519893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102078878|NCT03519893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102078879|NCT03519893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078880|NCT03519256|Nivolumab|nivolumab|mesh-list
102078881|NCT03519256|Linrodostat|linrodostat|mesh-list
102078882|NCT03519256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102078883|NCT03519256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078884|NCT03519256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102078885|NCT03519256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078886|NCT03519256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102078887|NCT03507608|Flutamide|flutamide|mesh-list
102078888|NCT03507608|Androgen Antagonists|androgen antagonists|mesh-ancestor
102078889|NCT03507608|Hormone Antagonists|hormone antagonists|mesh-ancestor
102078890|NCT03507608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102078891|NCT03507608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078892|NCT03507608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102078893|NCT03507608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078894|NCT03465579|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102078895|NCT03465579|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102078896|NCT03465579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078897|NCT03453528|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102078898|NCT03453528|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102078899|NCT03453528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078900|NCT03343054|Talazoparib|talazoparib|mesh-list
102078901|NCT03343054|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102078902|NCT03343054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101943453|NCT03387020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101943454|NCT03386474|Aflibercept|aflibercept|mesh-list
101943455|NCT03386474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101943456|NCT03386474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101943457|NCT03386474|Growth Substances|growth substances|mesh-ancestor
101449481|NCT00123383|Modafinil|modafinil|mesh-list
102078903|NCT03343054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078904|NCT03343054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078905|NCT03330847|Olaparib|olaparib|mesh-list
102078914|NCT03215927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102078915|NCT03215927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078916|NCT03215927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102078917|NCT03215927|Immunologic Factors|immunologic factors|mesh-ancestor
102078918|NCT03215927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078919|NCT03215927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102078921|NCT03073967|Pritelivir|pritelivir|mesh-list
102078922|NCT03073967|Antiviral Agents|antiviral agents|mesh-ancestor
102078923|NCT03073967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102078924|NCT03073967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102078925|NCT03073967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102078926|NCT03073967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102078927|NCT03073967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078928|NCT02999230|Listerine|listerine|mesh-list
102078929|NCT02999230|Fluorides|fluorides|mesh-list
102078930|NCT02999230|Sodium Fluoride|sodium fluoride|mesh-list
102078931|NCT02999230|Cariostatic Agents|cariostatic agents|mesh-ancestor
102078932|NCT02999230|Protective Agents|protective agents|mesh-ancestor
102078933|NCT02999230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078934|NCT02999230|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102078935|NCT02999230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102078936|NCT02941315|Captopril|captopril|mesh-list
102078937|NCT02941315|Spironolactone|spironolactone|mesh-list
102078938|NCT02941315|Furosemide|furosemide|mesh-list
102078939|NCT02941315|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102078940|NCT02941315|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102078941|NCT02941315|Hormone Antagonists|hormone antagonists|mesh-ancestor
102078942|NCT02941315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102078943|NCT02941315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078944|NCT02941315|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102078945|NCT02941315|Diuretics|diuretics|mesh-ancestor
102078946|NCT02941315|Natriuretic Agents|natriuretic agents|mesh-ancestor
102078947|NCT02941315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102078948|NCT02941315|Adrenergic Agents|adrenergic agents|mesh-ancestor
102078949|NCT02941315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102078950|NCT02941315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078951|NCT02941315|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102078952|NCT02941315|Protease Inhibitors|protease inhibitors|mesh-ancestor
102078953|NCT02941315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102078954|NCT02941315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102078955|NCT02941315|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102078956|NCT02941315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102078957|NCT02920229|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102078958|NCT02920229|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102078959|NCT02920229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078960|NCT02918721|Lidocaine|lidocaine|mesh-list
102078961|NCT02918721|Hyaluronic Acid|hyaluronic acid|mesh-list
102078962|NCT02918721|Anesthetics, Local|anesthetics, local|mesh-ancestor
102078963|NCT02918721|Anesthetics|anesthetics|mesh-ancestor
102078964|NCT02918721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102078965|NCT02918721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078966|NCT02918721|Sensory System Agents|sensory system agents|mesh-ancestor
102078967|NCT02918721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102078968|NCT02918721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102078969|NCT02918721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102078978|NCT02884180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102078979|NCT02884180|Antiemetics|antiemetics|mesh-ancestor
102078980|NCT02884180|Autonomic Agents|autonomic agents|mesh-ancestor
102078981|NCT02884180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101943458|NCT03386474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943459|NCT03386474|Growth Inhibitors|growth inhibitors|mesh-ancestor
101943460|NCT03386474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101943461|NCT03405818|Tavaborole|tavaborole|mesh-list
101308352|NCT02046915|Hormones|hormones|mesh-ancestor
102078982|NCT02884180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078983|NCT02884180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102078984|NCT02884180|Glucocorticoids|glucocorticoids|mesh-ancestor
102078985|NCT02884180|Hormones|hormones|mesh-ancestor
102078986|NCT02884180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102078987|NCT02884180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102078988|NCT02884180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078989|NCT02799602|Docetaxel|docetaxel|mesh-list
102078990|NCT02799602|Androgens|androgens|mesh-list
102078991|NCT02799602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078992|NCT02799602|Tubulin Modulators|tubulin modulators|mesh-ancestor
102078993|NCT02799602|Antimitotic Agents|antimitotic agents|mesh-ancestor
102078994|NCT02799602|Mitosis Modulators|mitosis modulators|mesh-ancestor
102078995|NCT02799602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078997|NCT02799602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102078998|NCT02799602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078999|NCT02770040|Infliximab|infliximab|mesh-list
102079000|NCT02770040|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102079001|NCT02770040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102079002|NCT02770040|Dermatologic Agents|dermatologic agents|mesh-ancestor
102079003|NCT02770040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102079004|NCT02770040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102079005|NCT02754297|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102079006|NCT02754297|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102079007|NCT02754297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079008|NCT02451423|Atezolizumab|atezolizumab|mesh-list
102079009|NCT02451423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102079010|NCT02451423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079011|NCT02451423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102079012|NCT02451423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102079013|NCT02291705|Tramadol|tramadol|mesh-list
102079014|NCT02291705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102079015|NCT02291705|Narcotics|narcotics|mesh-ancestor
102079016|NCT02291705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102079017|NCT02291705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079018|NCT02291705|Analgesics|analgesics|mesh-ancestor
102079019|NCT02291705|Sensory System Agents|sensory system agents|mesh-ancestor
102079020|NCT02291705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102079021|NCT02243709|Mifepristone|mifepristone|mesh-list
102079022|NCT02243709|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102079023|NCT02243709|Abortifacient Agents|abortifacient agents|mesh-ancestor
102079024|NCT02243709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102079025|NCT02243709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079026|NCT02243709|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102079027|NCT02243709|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102079028|NCT02243709|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102079029|NCT02243709|Contraceptive Agents|contraceptive agents|mesh-ancestor
102079030|NCT02243709|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102079031|NCT02243709|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102079032|NCT02243709|Hormone Antagonists|hormone antagonists|mesh-ancestor
102079033|NCT02243709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102079034|NCT02243709|Luteolytic Agents|luteolytic agents|mesh-ancestor
102079035|NCT02243709|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102079047|NCT02027935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079048|NCT02027935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102079049|NCT02027935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102079050|NCT02027935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102079051|NCT02027935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102079052|NCT02027935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102079054|NCT02027935|Sensory System Agents|sensory system agents|mesh-ancestor
102079055|NCT02027935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102079056|NCT02027935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102079057|NCT02027935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101943462|NCT03405818|Antifungal Agents|antifungal agents|mesh-ancestor
101943463|NCT03405818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102079058|NCT02027935|Antiviral Agents|antiviral agents|mesh-ancestor
102079059|NCT02027935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102079061|NCT01969578|Carboplatin|carboplatin|mesh-list
102079062|NCT01969578|Doxorubicin|doxorubicin|mesh-list
102079063|NCT01969578|Bicalutamide|bicalutamide|mesh-list
102079064|NCT01969578|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102079065|NCT01969578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102079066|NCT01969578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102079067|NCT01969578|Tubulin Modulators|tubulin modulators|mesh-ancestor
102079068|NCT01969578|Antimitotic Agents|antimitotic agents|mesh-ancestor
102079069|NCT01969578|Mitosis Modulators|mitosis modulators|mesh-ancestor
102079070|NCT01969578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079071|NCT01969578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102079072|NCT01969578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102079073|NCT01969578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102079074|NCT01969578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102079075|NCT01969578|Androgen Antagonists|androgen antagonists|mesh-ancestor
102079076|NCT01969578|Hormone Antagonists|hormone antagonists|mesh-ancestor
102079077|NCT01969578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102079078|NCT01969578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079079|NCT01969578|Luteolytic Agents|luteolytic agents|mesh-ancestor
102079080|NCT01969578|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102079081|NCT01969578|Contraceptive Agents|contraceptive agents|mesh-ancestor
102079082|NCT01969578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102079083|NCT01969578|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102079084|NCT01969578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102079086|NCT01896011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102079087|NCT01896011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079088|NCT01896011|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102079089|NCT01891396|Hyaluronic Acid|hyaluronic acid|mesh-list
102079090|NCT01891396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102079091|NCT01891396|Immunologic Factors|immunologic factors|mesh-ancestor
102079092|NCT01891396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079093|NCT01891396|Viscosupplements|viscosupplements|mesh-ancestor
102079094|NCT01891396|Protective Agents|protective agents|mesh-ancestor
102079095|NCT01746225|Paclitaxel|paclitaxel|mesh-list
102079096|NCT01746225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102079097|NCT01746225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102079098|NCT01746225|Tubulin Modulators|tubulin modulators|mesh-ancestor
102079099|NCT01746225|Antimitotic Agents|antimitotic agents|mesh-ancestor
102079100|NCT01746225|Mitosis Modulators|mitosis modulators|mesh-ancestor
102079117|NCT01650545|Sirolimus|sirolimus|mesh-list
102079118|NCT01650545|Tacrolimus|tacrolimus|mesh-list
102079119|NCT01650545|Cyclosporins|cyclosporins|mesh-list
102079120|NCT01650545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102079121|NCT01650545|Immunologic Factors|immunologic factors|mesh-ancestor
102079122|NCT01650545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079123|NCT01650545|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102079124|NCT01650545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102079125|NCT01650545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079126|NCT01650545|Antifungal Agents|antifungal agents|mesh-ancestor
102079127|NCT01650545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102079128|NCT01650545|Dermatologic Agents|dermatologic agents|mesh-ancestor
102079129|NCT01650545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102079130|NCT01650545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102079131|NCT01650545|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102079132|NCT01650545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102079133|NCT01191008|Timolol|timolol|mesh-list
102079134|NCT01191008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102079135|NCT01191008|Latanoprost|latanoprost|mesh-list
102079136|NCT01191008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102079137|NCT01191008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798901|NCT00527397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102079138|NCT01191008|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102079139|NCT01191008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102079140|NCT01191008|Adrenergic Agents|adrenergic agents|mesh-ancestor
102079141|NCT01191008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102079142|NCT01191008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079143|NCT01191008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102079144|NCT01191008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102079145|NCT01155232|Teriparatide|teriparatide|mesh-list
101943464|NCT03403634|Interferons|interferons|mesh-list
101943465|NCT03403634|Interferon-alpha|interferon-alpha|mesh-list
101943466|NCT03403634|Interferon alpha-2|interferon alpha-2|mesh-list
102079146|NCT01155232|Parathyroid Hormone|parathyroid hormone|mesh-list
102079147|NCT01155232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079148|NCT01155232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102079149|NCT01155232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102079150|NCT00821587|Cyclosporine|cyclosporine|mesh-list
102079151|NCT00821587|Tacrolimus|tacrolimus|mesh-list
102079152|NCT00821587|Cyclosporins|cyclosporins|mesh-list
102079153|NCT00821587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102079154|NCT00821587|Immunologic Factors|immunologic factors|mesh-ancestor
102079155|NCT00821587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079156|NCT00821587|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102079157|NCT00821587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102079158|NCT00821587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079171|NCT00751829|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102079172|NCT00751829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102079173|NCT00751829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079174|NCT00751829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102079175|NCT00751829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102079177|NCT00751829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102079178|NCT00751829|Vasodilator Agents|vasodilator agents|mesh-ancestor
102079179|NCT00645801|Lubiprostone|lubiprostone|mesh-list
102079180|NCT00645801|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102079181|NCT00645801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102079182|NCT00645801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079183|NCT00424099|Methylphenidate|methylphenidate|mesh-list
102079184|NCT00424099|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101703318|NCT02723981|Antithrombins|antithrombins|mesh-ancestor
102079185|NCT00424099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079186|NCT00424099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102079187|NCT00424099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102079188|NCT00424099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102079189|NCT00424099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079190|NCT00424099|Dopamine Agents|dopamine agents|mesh-ancestor
102079191|NCT00424099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102079192|NCT00382213|Olmesartan|olmesartan|mesh-list
102079193|NCT00382213|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
102079194|NCT00382213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102079195|NCT00382213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102079196|NCT00382213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102079197|NCT00382213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079198|NCT00176267|Paclitaxel|paclitaxel|mesh-list
102079199|NCT00176267|Carboplatin|carboplatin|mesh-list
102079200|NCT00176267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102079201|NCT00176267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102079202|NCT00176267|Tubulin Modulators|tubulin modulators|mesh-ancestor
102079203|NCT00176267|Antimitotic Agents|antimitotic agents|mesh-ancestor
102079204|NCT00176267|Mitosis Modulators|mitosis modulators|mesh-ancestor
102079205|NCT00176267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079206|NCT02298764|Psychotropic Drugs|psychotropic drugs|mesh-list
102079207|NCT02298920|Zoliflodacin|zoliflodacin|mesh-list
102079208|NCT02298920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102079209|NCT02298920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102079210|NCT02298920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102079211|NCT02298920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079212|NCT02298920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102079213|NCT03517748|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102079214|NCT03517748|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102079215|NCT03517670|Milrinone|milrinone|mesh-list
102079216|NCT03517670|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102079217|NCT03517670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102079218|NCT03517670|Vasodilator Agents|vasodilator agents|mesh-ancestor
102079219|NCT03517670|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102079231|NCT00109668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102079232|NCT00109668|Glucocorticoids|glucocorticoids|mesh-ancestor
102079234|NCT00109668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102079235|NCT00109668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079236|NCT00109668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101943468|NCT03403634|Celecoxib|celecoxib|mesh-list
102079237|NCT00109668|Respiratory System Agents|respiratory system agents|mesh-ancestor
102079238|NCT03104140|Ketamine|ketamine|mesh-list
102079239|NCT03104140|Thiopental|thiopental|mesh-list
102079240|NCT03104140|Analgesics|analgesics|mesh-ancestor
102079241|NCT03104140|Sensory System Agents|sensory system agents|mesh-ancestor
102079242|NCT03104140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102079243|NCT03104140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079244|NCT03104140|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102079245|NCT03104140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102079246|NCT03104140|Anesthetics, General|anesthetics, general|mesh-ancestor
102079247|NCT03104140|Anesthetics|anesthetics|mesh-ancestor
102079248|NCT03104140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102079249|NCT03104140|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102079250|NCT03104140|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102079251|NCT03104140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102079252|NCT03104140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079253|NCT03104140|Anticonvulsants|anticonvulsants|mesh-ancestor
102079254|NCT03104140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102079255|NCT03104140|GABA Modulators|gaba modulators|mesh-ancestor
102079256|NCT03104140|GABA Agents|gaba agents|mesh-ancestor
102079257|NCT03520478|Bicalutamide|bicalutamide|mesh-list
102079258|NCT03520478|Androgen Antagonists|androgen antagonists|mesh-ancestor
102079259|NCT03520478|Hormone Antagonists|hormone antagonists|mesh-ancestor
102079260|NCT03520478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102079261|NCT03520478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079262|NCT03520478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102079263|NCT00102648|Temozolomide|temozolomide|mesh-list
102079264|NCT00102648|Lonafarnib|lonafarnib|mesh-list
102079265|NCT00102648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102079266|NCT00102648|Alkylating Agents|alkylating agents|mesh-ancestor
102079267|NCT00102648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079268|NCT00102648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102079269|NCT00102648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102079270|NCT03290287|Bromides|bromides|mesh-list
102079271|NCT03290287|Anticonvulsants|anticonvulsants|mesh-ancestor
102079272|NCT02253888|Ritonavir|ritonavir|mesh-list
102079273|NCT02253888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102079274|NCT02253888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102079275|NCT02253888|Protease Inhibitors|protease inhibitors|mesh-ancestor
102079276|NCT02253888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102079277|NCT02253888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079278|NCT02253888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102079279|NCT02253888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102079280|NCT02253888|Antiviral Agents|antiviral agents|mesh-ancestor
102079281|NCT02253888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102079284|NCT05430802|Pemetrexed|pemetrexed|mesh-list
102079285|NCT05430802|Aflutinib|aflutinib|mesh-list
102079286|NCT05430802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102079287|NCT05430802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102079288|NCT05430802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079289|NCT05430802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102079290|NCT05430802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102079291|NCT05430802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102079292|NCT05524038|Dexamethasone|dexamethasone|mesh-list
102079293|NCT05524038|Dexamethasone acetate|dexamethasone acetate|mesh-list
102079294|NCT05524038|Bupivacaine|bupivacaine|mesh-list
102079295|NCT05524038|BB 1101|bb 1101|mesh-list
102079296|NCT05524038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102079297|NCT05524038|Antiemetics|antiemetics|mesh-ancestor
102079298|NCT05524038|Autonomic Agents|autonomic agents|mesh-ancestor
102079299|NCT05524038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102079300|NCT05524038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079301|NCT05524038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102079302|NCT05524038|Glucocorticoids|glucocorticoids|mesh-ancestor
102079303|NCT05524038|Hormones|hormones|mesh-ancestor
102079304|NCT05524038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101703360|NCT00726700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102079305|NCT05524038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102079306|NCT05524038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102079307|NCT05524038|Protease Inhibitors|protease inhibitors|mesh-ancestor
102079308|NCT05524038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102079309|NCT05524038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079310|NCT05524038|Anesthetics, Local|anesthetics, local|mesh-ancestor
102079311|NCT05524038|Anesthetics|anesthetics|mesh-ancestor
101943469|NCT03403634|Benzenesulfonamide|benzenesulfonamide|mesh-list
101943470|NCT03403634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101943471|NCT03403634|Antiviral Agents|antiviral agents|mesh-ancestor
101943472|NCT03403634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101943473|NCT03403634|Immunologic Factors|immunologic factors|mesh-ancestor
101943474|NCT03403634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079312|NCT05524038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102079313|NCT05524038|Sensory System Agents|sensory system agents|mesh-ancestor
102079314|NCT03240835|Docetaxel|docetaxel|mesh-list
102079315|NCT03240835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102079316|NCT03240835|Tubulin Modulators|tubulin modulators|mesh-ancestor
102079317|NCT03240835|Antimitotic Agents|antimitotic agents|mesh-ancestor
102079318|NCT03240835|Mitosis Modulators|mitosis modulators|mesh-ancestor
102079319|NCT03240835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079320|NCT04118868|Pembrolizumab|pembrolizumab|mesh-list
102079321|NCT04118868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102079322|NCT04118868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102079323|NCT04118868|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102079324|NCT04118868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079325|NCT04900350|Azacitidine|azacitidine|mesh-list
102079326|NCT04900350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102079327|NCT04900350|Antimetabolites|antimetabolites|mesh-ancestor
102079328|NCT04900350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079329|NCT04900350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102079330|NCT04900350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102079331|NCT02292290|Pioglitazone|pioglitazone|mesh-list
102079332|NCT02292290|Liraglutide|liraglutide|mesh-list
102079333|NCT02292290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102079334|NCT02292290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079335|NCT02292290|Incretins|incretins|mesh-ancestor
102079336|NCT02292290|Hormones|hormones|mesh-ancestor
102079337|NCT02292290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102079338|NCT02299232|Dexmedetomidine|dexmedetomidine|mesh-list
102079339|NCT02299232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102079340|NCT02299232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102079341|NCT02299232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079342|NCT02299232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102079343|NCT02299232|Analgesics|analgesics|mesh-ancestor
102079344|NCT02299232|Sensory System Agents|sensory system agents|mesh-ancestor
102079345|NCT02299232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102079346|NCT02299232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102079347|NCT02299232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102079348|NCT02299232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102079349|NCT02299232|Adrenergic Agents|adrenergic agents|mesh-ancestor
102079350|NCT02299232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102079351|NCT02299232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079352|NCT02963493|Dexamethasone|dexamethasone|mesh-list
102079353|NCT02963493|Melphalan|melphalan|mesh-list
102079368|NCT02963493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102079369|NCT02963493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102079370|NCT02963493|Immunologic Factors|immunologic factors|mesh-ancestor
102079372|NCT02299310|Perindopril|perindopril|mesh-list
102079373|NCT02299310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102079374|NCT02299310|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102079375|NCT02299310|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102079376|NCT02299310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079377|NCT02299310|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102079378|NCT02299310|Protease Inhibitors|protease inhibitors|mesh-ancestor
102079379|NCT02299310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102079380|NCT03519776|Progesterone|progesterone|mesh-list
102079381|NCT03519776|Progestins|progestins|mesh-ancestor
102079382|NCT03519776|Hormones|hormones|mesh-ancestor
102079383|NCT03519776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102079384|NCT03519776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079385|NCT02295566|Nitric Oxide|nitric oxide|mesh-list
102079386|NCT02295566|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102079387|NCT02295566|Autonomic Agents|autonomic agents|mesh-ancestor
102079388|NCT02295566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101943475|NCT03403634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101943476|NCT03403634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102079389|NCT02295566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079390|NCT02295566|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102079391|NCT02295566|Respiratory System Agents|respiratory system agents|mesh-ancestor
102079392|NCT02295566|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102079393|NCT02295566|Antioxidants|antioxidants|mesh-ancestor
102079394|NCT02295566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079395|NCT02295566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102079396|NCT02295566|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102079397|NCT02295566|Vasodilator Agents|vasodilator agents|mesh-ancestor
102079398|NCT02295566|Gasotransmitters|gasotransmitters|mesh-ancestor
102079399|NCT02295566|Protective Agents|protective agents|mesh-ancestor
102079400|NCT05283681|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102079401|NCT05283681|Immunologic Factors|immunologic factors|mesh-ancestor
102079402|NCT05283681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079403|NCT03513458|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102079404|NCT03513458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102079405|NCT03738397|Upadacitinib|upadacitinib|mesh-list
102079406|NCT03738397|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102079407|NCT03738397|Immunologic Factors|immunologic factors|mesh-ancestor
102079408|NCT03738397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079409|NCT03738397|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102079410|NCT03738397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102079411|NCT03738397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102079418|NCT03643497|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102079419|NCT03643497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102079420|NCT03643497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079421|NCT03519542|Sunitinib|sunitinib|mesh-list
102079422|NCT03519542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102079423|NCT03519542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102079424|NCT03519542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102079425|NCT03519542|Growth Substances|growth substances|mesh-ancestor
102079426|NCT03519542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079427|NCT03519542|Growth Inhibitors|growth inhibitors|mesh-ancestor
102079428|NCT03519542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102079429|NCT03519542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102079430|NCT03519542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079431|NCT03516500|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102079432|NCT03516500|Hematinics|hematinics|mesh-ancestor
102079433|NCT02293148|Moxifloxacin|moxifloxacin|mesh-list
102079434|NCT02293148|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102079435|NCT02293148|Glycine|glycine|mesh-list
102079436|NCT02293148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102079437|NCT02293148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102079438|NCT02293148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102079439|NCT02293148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102079440|NCT02293148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102079441|NCT02293148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079442|NCT02293148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102079443|NCT02293148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102079444|NCT02293148|Contraceptive Agents|contraceptive agents|mesh-ancestor
102079445|NCT02293148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102079446|NCT02293148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079447|NCT02293148|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102079448|NCT02293148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102079449|NCT02293148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102079450|NCT02293148|Glycine Agents|glycine agents|mesh-ancestor
102079451|NCT02293148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102079452|NCT03519152|Diclofenac|diclofenac|mesh-list
102079453|NCT03519152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102079454|NCT03519152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102079455|NCT03519152|Analgesics|analgesics|mesh-ancestor
102079456|NCT03519152|Sensory System Agents|sensory system agents|mesh-ancestor
102079457|NCT03519152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102079458|NCT03519152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079459|NCT03519152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102079460|NCT03519152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102079461|NCT03519152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102079462|NCT03519152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101943478|NCT03403634|Sensory System Agents|sensory system agents|mesh-ancestor
101943479|NCT03403634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101943480|NCT03403634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101943481|NCT03403634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101943482|NCT03403634|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101308367|NCT02047019|Candesartan|candesartan|mesh-list
102079463|NCT03519152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079464|NCT02959983|Eluxadoline|eluxadoline|mesh-list
102079465|NCT02959983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102079466|NCT03516188|Antacids|antacids|mesh-list
102079467|NCT03516188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079468|NCT03516188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102079469|NCT03512990|Bupivacaine|bupivacaine|mesh-list
102079470|NCT03512990|Anesthetics, Local|anesthetics, local|mesh-ancestor
102079471|NCT03512990|Anesthetics|anesthetics|mesh-ancestor
102079472|NCT03512990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102079473|NCT03512990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079474|NCT03512990|Sensory System Agents|sensory system agents|mesh-ancestor
102079475|NCT03512990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102079476|NCT03512834|Paclitaxel|paclitaxel|mesh-list
102079477|NCT03512834|Avelumab|avelumab|mesh-list
102079478|NCT03512834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102079479|NCT03512834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101381091|NCT00107523|Idarubicin|idarubicin|mesh-list
102079484|NCT03512834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102079485|NCT03640221|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102079487|NCT03640221|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102079488|NCT03640221|Antihypertensive Agents|antihypertensive agents|mesh-list
102079489|NCT03640221|Diuretics|diuretics|mesh-ancestor
102079490|NCT03640221|Natriuretic Agents|natriuretic agents|mesh-ancestor
102079491|NCT03640221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079492|NCT03640221|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102079493|NCT03640221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102079494|NCT03640221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079495|NCT03640221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102079496|NCT03518528|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102079497|NCT03518528|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102079498|NCT03518528|Estradiol|estradiol|mesh-list
102079499|NCT03518528|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102079500|NCT03518528|Estrogens|estrogens|mesh-ancestor
102079501|NCT03518528|Hormones|hormones|mesh-ancestor
102079502|NCT03518528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102079503|NCT03518528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079504|NCT03518528|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102079505|NCT03518528|Contraceptive Agents|contraceptive agents|mesh-ancestor
102079506|NCT03518528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102079507|NCT03518528|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102079508|NCT03515798|Paclitaxel|paclitaxel|mesh-list
102079509|NCT03515798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102079510|NCT03515798|Cyclophosphamide|cyclophosphamide|mesh-list
101703466|NCT02636816|Carbetocin|carbetocin|mesh-list
102079511|NCT03515798|Pembrolizumab|pembrolizumab|mesh-list
102079512|NCT03515798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102079513|NCT03515798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102079514|NCT03515798|Tubulin Modulators|tubulin modulators|mesh-ancestor
102079515|NCT03515798|Antimitotic Agents|antimitotic agents|mesh-ancestor
102079516|NCT03515798|Mitosis Modulators|mitosis modulators|mesh-ancestor
102079517|NCT03515798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079518|NCT03515798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102079519|NCT03515798|Immunologic Factors|immunologic factors|mesh-ancestor
102079520|NCT03515798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079521|NCT03515798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102079522|NCT03515798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102079523|NCT03515798|Alkylating Agents|alkylating agents|mesh-ancestor
102079524|NCT03515798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102079525|NCT03515798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102079526|NCT03515798|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102079527|NCT03041701|Dasatinib|dasatinib|mesh-list
101943483|NCT03403634|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101943484|NCT03403634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101943485|NCT03403634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450052|NCT00215514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102079528|NCT03041701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079529|NCT03041701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102079530|NCT03041701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102079531|NCT03041701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102079532|NCT02293694|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102079533|NCT02293694|Medroxyprogesterone|medroxyprogesterone|mesh-list
102079534|NCT02293694|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102079535|NCT02293694|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102079536|NCT02293694|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102079537|NCT02293694|Contraceptive Agents|contraceptive agents|mesh-ancestor
102079538|NCT02293694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102079539|NCT02293694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079540|NCT02293694|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102079541|NCT02293694|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102079542|NCT02293694|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102079543|NCT02293694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102079544|NCT02293694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102079545|NCT02956629|Ribavirin|ribavirin|mesh-list
102079546|NCT02956629|Uprifosbuvir|uprifosbuvir|mesh-list
102079547|NCT02956629|Ruzasvir|ruzasvir|mesh-list
102079548|NCT02956629|Antimetabolites|antimetabolites|mesh-ancestor
102079554|NCT02297204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102079556|NCT02297204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079557|NCT02297204|Growth Inhibitors|growth inhibitors|mesh-ancestor
102079558|NCT02297204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102079559|NCT02294006|Metformin|metformin|mesh-list
102079560|NCT02294006|Everolimus|everolimus|mesh-list
102079561|NCT02294006|Octreotide|octreotide|mesh-list
102079562|NCT02294006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102079563|NCT02294006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079564|NCT02294006|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102079565|NCT02294006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102079566|NCT02294006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102079567|NCT02294006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079568|NCT02294006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102079569|NCT02294006|Immunologic Factors|immunologic factors|mesh-ancestor
102079570|NCT02294006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102079571|NCT02294006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102079572|NCT02294006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102079573|NCT02294084|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102079574|NCT02294084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102079575|NCT02294084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079576|NCT02294084|Incretins|incretins|mesh-ancestor
102079577|NCT02294084|Hormones|hormones|mesh-ancestor
102079578|NCT02294084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102079579|NCT02294084|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101799353|NCT00132691|Dermatologic Agents|dermatologic agents|mesh-ancestor
102079580|NCT02294084|Protease Inhibitors|protease inhibitors|mesh-ancestor
102079581|NCT02294084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102079582|NCT02294084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079584|NCT01597258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102079585|NCT01597258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102079586|NCT01597258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102079587|NCT01597258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079588|NCT02958267|Hyaluronic Acid|hyaluronic acid|mesh-list
102079589|NCT02958267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102079590|NCT02958267|Immunologic Factors|immunologic factors|mesh-ancestor
102079591|NCT02958267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079592|NCT02958267|Viscosupplements|viscosupplements|mesh-ancestor
102079593|NCT02958267|Protective Agents|protective agents|mesh-ancestor
102079594|NCT02302430|Oxytocin|oxytocin|mesh-list
102079595|NCT02302430|Oxytocics|oxytocics|mesh-ancestor
102079596|NCT02302430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102079597|NCT02302430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079598|NCT02300948|Folic Acid|folic acid|mesh-list
102079599|NCT02300948|Vitamin B Complex|vitamin b complex|mesh-list
102079600|NCT02300948|Hematinics|hematinics|mesh-ancestor
101943486|NCT03403634|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101943487|NCT02863354|Aflibercept|aflibercept|mesh-list
102079601|NCT02300948|Vitamins|vitamins|mesh-ancestor
102079602|NCT02300948|Micronutrients|micronutrients|mesh-ancestor
102079603|NCT02300948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079604|NCT02302508|Clopidogrel|clopidogrel|mesh-list
102079605|NCT02302508|Ticagrelor|ticagrelor|mesh-list
102079606|NCT02302508|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102079607|NCT02302508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102079608|NCT02302508|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102079609|NCT02302508|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102079610|NCT02302508|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102079611|NCT02302508|Purinergic Agents|purinergic agents|mesh-ancestor
102079612|NCT02302508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102079613|NCT02302508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079614|NCT02302508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079615|NCT02297594|Ziresovir|ziresovir|mesh-list
102079616|NCT02297594|Antiviral Agents|antiviral agents|mesh-ancestor
102079617|NCT02297594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102079618|NCT02301026|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
102079621|NCT01952574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102079622|NCT01952574|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
102079623|NCT01952574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079624|NCT01952574|Analgesics|analgesics|mesh-ancestor
102079625|NCT01952574|Sensory System Agents|sensory system agents|mesh-ancestor
102079626|NCT01952574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102079627|NCT01952574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079628|NCT01952574|Immunologic Factors|immunologic factors|mesh-ancestor
102079629|NCT02302586|Morphine|morphine|mesh-list
102079630|NCT02302586|Bupivacaine|bupivacaine|mesh-list
102079631|NCT02302586|Anesthetics, Local|anesthetics, local|mesh-ancestor
102079632|NCT02302586|Anesthetics|anesthetics|mesh-ancestor
102079633|NCT02302586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102079634|NCT02302586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079635|NCT02302586|Sensory System Agents|sensory system agents|mesh-ancestor
102079636|NCT02302586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102079637|NCT02302586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102079638|NCT02302586|Narcotics|narcotics|mesh-ancestor
102079639|NCT02302586|Analgesics|analgesics|mesh-ancestor
102079640|NCT04484272|Analgesics, Opioid|analgesics, opioid|mesh-list
102079641|NCT04484272|Narcotics|narcotics|mesh-ancestor
102079642|NCT04484272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102079643|NCT04484272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079644|NCT04484272|Analgesics|analgesics|mesh-ancestor
102079645|NCT04484272|Sensory System Agents|sensory system agents|mesh-ancestor
102079646|NCT04484272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102079647|NCT01551472|Vitamin E|vitamin e|mesh-list
102079648|NCT01551472|Vitamins|vitamins|mesh-ancestor
102079649|NCT01551472|Micronutrients|micronutrients|mesh-ancestor
102079650|NCT01551472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079651|NCT01551472|Antioxidants|antioxidants|mesh-ancestor
102079652|NCT01551472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079653|NCT01551472|Protective Agents|protective agents|mesh-ancestor
102079654|NCT02254044|Maytansine|maytansine|mesh-list
102079655|NCT02254044|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
102079656|NCT02254044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102079657|NCT02254044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102079658|NCT02254044|Tubulin Modulators|tubulin modulators|mesh-ancestor
102079659|NCT02254044|Antimitotic Agents|antimitotic agents|mesh-ancestor
102079660|NCT02254044|Mitosis Modulators|mitosis modulators|mesh-ancestor
102079661|NCT02254044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079662|NCT02254044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102079663|NCT02254044|Immunotoxins|immunotoxins|mesh-ancestor
102079664|NCT02254044|Immunoconjugates|immunoconjugates|mesh-ancestor
102079665|NCT02254044|Immunologic Factors|immunologic factors|mesh-ancestor
102079666|NCT02254044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079667|NCT02959437|Pembrolizumab|pembrolizumab|mesh-list
102079668|NCT02959437|Azacitidine|azacitidine|mesh-list
102079669|NCT02959437|INCB057643|incb057643|mesh-list
102079670|NCT02959437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102079671|NCT02959437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102079672|NCT02959437|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102079673|NCT02959437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079674|NCT02959437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101943488|NCT02863354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101943489|NCT02863354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102079675|NCT02959437|Antimetabolites|antimetabolites|mesh-ancestor
102079676|NCT02959437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102079677|NCT02297906|Ketorolac|ketorolac|mesh-list
102079678|NCT02297906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102079679|NCT02297906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102079680|NCT02297906|Analgesics|analgesics|mesh-ancestor
102079681|NCT02297906|Sensory System Agents|sensory system agents|mesh-ancestor
102079682|NCT02297906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102079683|NCT02297906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079684|NCT02297906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102079685|NCT02297906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102079686|NCT02297906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102079687|NCT02297906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102079688|NCT02297906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079689|NCT03511820|Amphotericin B|amphotericin b|mesh-list
102079690|NCT03511820|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102079691|NCT03511820|Amebicides|amebicides|mesh-ancestor
102079692|NCT03511820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102079693|NCT03511820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102079707|NCT02298062|Infliximab|infliximab|mesh-list
102079708|NCT02298062|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102079709|NCT02298062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102079710|NCT02298062|Dermatologic Agents|dermatologic agents|mesh-ancestor
102079711|NCT02298062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102079712|NCT02298062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102079713|NCT03515018|Imatinib Mesylate|imatinib mesylate|mesh-list
102079714|NCT03515018|Hydroxyurea|hydroxyurea|mesh-list
102079715|NCT03515018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102079716|NCT03515018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102079717|NCT03515018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102079718|NCT03515018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079719|NCT03515018|Antisickling Agents|antisickling agents|mesh-ancestor
102079720|NCT03515018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102079721|NCT03748966|Calcitriol|calcitriol|mesh-list
102079722|NCT03748966|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
102079723|NCT03748966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102079724|NCT03748966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079725|NCT03748966|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102079726|NCT03748966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102079727|NCT03748966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079728|NCT03748966|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102079729|NCT03748966|Vitamins|vitamins|mesh-ancestor
102079730|NCT03748966|Micronutrients|micronutrients|mesh-ancestor
102079731|NCT03748966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102079732|NCT05891249|Luspatercept|luspatercept|mesh-list
102079733|NCT05891249|Hematinics|hematinics|mesh-ancestor
102079734|NCT05891145|Midazolam|midazolam|mesh-list
102079735|NCT05891145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102079736|NCT05891145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102079737|NCT05891145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102079738|NCT05891145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079739|NCT05891145|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102079740|NCT05891145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102079741|NCT05891145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102079742|NCT05891145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102079743|NCT05891145|Anesthetics, General|anesthetics, general|mesh-ancestor
102079744|NCT05891145|Anesthetics|anesthetics|mesh-ancestor
102079745|NCT05891145|GABA Modulators|gaba modulators|mesh-ancestor
102079746|NCT05891145|GABA Agents|gaba agents|mesh-ancestor
102079747|NCT05891145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102079748|NCT05891145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079749|NCT05891132|Lidocaine|lidocaine|mesh-list
102079750|NCT05891132|Prilocaine|prilocaine|mesh-list
102079751|NCT05891132|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
102079752|NCT05891132|Anesthetics|anesthetics|mesh-list
102079753|NCT05891132|Anesthetics, Local|anesthetics, local|mesh-ancestor
102079754|NCT05891132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102079755|NCT05891132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079759|NCT05891132|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102079760|NCT05891132|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101943491|NCT02863354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943492|NCT02863354|Growth Inhibitors|growth inhibitors|mesh-ancestor
101943493|NCT02863354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101943494|NCT02859454|Avelumab|avelumab|mesh-list
101943495|NCT02859454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102079761|NCT05891132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102079762|NCT05891132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079763|NCT05891132|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
102079765|NCT05891119|Metoprolol|metoprolol|mesh-list
102079766|NCT05891119|Midazolam|midazolam|mesh-list
102079767|NCT05891119|Caffeine|caffeine|mesh-list
102079768|NCT05891119|Caffeine citrate|caffeine citrate|mesh-list
102079769|NCT05891119|Omeprazole|omeprazole|mesh-list
102079770|NCT05891119|Warfarin|warfarin|mesh-list
102079771|NCT05891119|Vitamins|vitamins|mesh-ancestor
102079772|NCT05891119|Micronutrients|micronutrients|mesh-ancestor
102079773|NCT05891119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079774|NCT05891119|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102079775|NCT05891119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102079776|NCT05891119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102079777|NCT05891119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102079778|NCT05891119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102079779|NCT05891119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102079780|NCT05891119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102079781|NCT05891119|Anesthetics, General|anesthetics, general|mesh-ancestor
102079782|NCT05891119|Anesthetics|anesthetics|mesh-ancestor
102079783|NCT05891119|GABA Modulators|gaba modulators|mesh-ancestor
102079784|NCT05891119|GABA Agents|gaba agents|mesh-ancestor
102079785|NCT05891119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102079786|NCT05891119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079787|NCT05891119|Anticoagulants|anticoagulants|mesh-ancestor
102079788|NCT05891119|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102079789|NCT05891119|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102079790|NCT05891119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102079791|NCT05891119|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102079792|NCT05891119|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102079793|NCT05891119|Purinergic Agents|purinergic agents|mesh-ancestor
102079794|NCT05891119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102079795|NCT05891119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102079796|NCT05891119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102079797|NCT05891119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102079798|NCT05891119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102079799|NCT05891119|Sympatholytics|sympatholytics|mesh-ancestor
102079800|NCT05891119|Autonomic Agents|autonomic agents|mesh-ancestor
102079801|NCT05891119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102079802|NCT05891119|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102079803|NCT05891119|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102079804|NCT05891119|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102079805|NCT05891119|Adrenergic Agents|adrenergic agents|mesh-ancestor
102079806|NCT05891119|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102079807|NCT05891119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102079808|NCT05891119|Hemostatics|hemostatics|mesh-ancestor
102079809|NCT05891119|Coagulants|coagulants|mesh-ancestor
102079810|NCT05891093|Tamoxifen|tamoxifen|mesh-list
102079811|NCT05891093|Toremifene|toremifene|mesh-list
102079812|NCT05891093|Letrozole|letrozole|mesh-list
102079813|NCT05891093|Anastrozole|anastrozole|mesh-list
102079814|NCT05891093|Exemestane|exemestane|mesh-list
102079815|NCT05891093|Fluzoparib|fluzoparib|mesh-list
102079816|NCT05891093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102079817|NCT05891093|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102079818|NCT05891093|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102079819|NCT05891093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102079820|NCT05891093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079821|NCT05891093|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102079822|NCT05891093|Hormone Antagonists|hormone antagonists|mesh-ancestor
102079823|NCT05891093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102079824|NCT05891093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079825|NCT05891093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102079826|NCT05891093|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102079827|NCT05891093|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102079828|NCT05891093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101943496|NCT02859454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101943497|NCT02862730|Pancrelipase|pancrelipase|mesh-list
101943498|NCT02862730|Pancreatin|pancreatin|mesh-list
101943499|NCT02862730|Hormones|hormones|mesh-list
101943500|NCT02862730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308381|NCT02047136|Histamine|histamine|mesh-list
102079839|NCT05891080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102079840|NCT05891080|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102079841|NCT05891080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102079842|NCT05890911|Dopamine|dopamine|mesh-list
102079843|NCT05890911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102079844|NCT05890911|Sympathomimetics|sympathomimetics|mesh-ancestor
102079845|NCT05890911|Autonomic Agents|autonomic agents|mesh-ancestor
102079846|NCT05890911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102079847|NCT05890911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079848|NCT05890911|Dopamine Agents|dopamine agents|mesh-ancestor
102079849|NCT05890911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102079850|NCT05890911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079851|NCT05890911|Protective Agents|protective agents|mesh-ancestor
102079852|NCT05890768|Risperidone|risperidone|mesh-list
101703593|NCT00693342|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
102079853|NCT05890768|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102079854|NCT05890768|Serotonin Agents|serotonin agents|mesh-ancestor
102079855|NCT05890768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102079856|NCT05890768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079857|NCT05890768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079858|NCT05890768|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102079859|NCT05890768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102079860|NCT05890768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102079861|NCT05890768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102079862|NCT05890768|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102079863|NCT05890768|Dopamine Agents|dopamine agents|mesh-ancestor
102079864|NCT05890703|Lidocaine|lidocaine|mesh-list
102079865|NCT05890703|Tetracaine|tetracaine|mesh-list
102079866|NCT05890703|Anesthetics, Local|anesthetics, local|mesh-ancestor
102079867|NCT05890703|Anesthetics|anesthetics|mesh-ancestor
102079868|NCT05890703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102079869|NCT05890703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079870|NCT05890703|Sensory System Agents|sensory system agents|mesh-ancestor
102079871|NCT05890703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102079872|NCT05890703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102079873|NCT05890703|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102079874|NCT05890703|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102079875|NCT05890703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102079876|NCT05890703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079877|NCT05890664|Colchicine|colchicine|mesh-list
102079878|NCT05890664|Gout Suppressants|gout suppressants|mesh-ancestor
102079879|NCT05890664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102079880|NCT05890664|Tubulin Modulators|tubulin modulators|mesh-ancestor
102079881|NCT05890664|Antimitotic Agents|antimitotic agents|mesh-ancestor
102079882|NCT05890664|Mitosis Modulators|mitosis modulators|mesh-ancestor
102079883|NCT05890664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079884|NCT05890664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102079885|NCT05890495|Lidocaine|lidocaine|mesh-list
102079886|NCT05890495|Anesthetics, Local|anesthetics, local|mesh-ancestor
102079887|NCT05890495|Anesthetics|anesthetics|mesh-ancestor
102079888|NCT05890495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102079889|NCT05890495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079890|NCT05890495|Sensory System Agents|sensory system agents|mesh-ancestor
102079891|NCT05890495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102079892|NCT05890495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101381508|NCT00274495|Antimetabolites|antimetabolites|mesh-ancestor
102079896|NCT05890495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079898|NCT05890287|Letrozole|letrozole|mesh-list
102079899|NCT05890287|Fulvestrant|fulvestrant|mesh-list
102079900|NCT05890287|Anastrozole|anastrozole|mesh-list
102079901|NCT05890287|Exemestane|exemestane|mesh-list
102079902|NCT05890287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102079903|NCT05890287|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102079904|NCT05890287|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102079905|NCT05890287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102079906|NCT05890287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943501|NCT02862730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102079907|NCT05890287|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102079908|NCT05890287|Hormone Antagonists|hormone antagonists|mesh-ancestor
102079909|NCT05890287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102079910|NCT05890287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079911|NCT05890287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102079912|NCT05890287|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102079913|NCT05890287|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102079914|NCT05890287|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102079915|NCT05890287|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102079916|NCT05890235|Tamsulosin|tamsulosin|mesh-list
102079917|NCT05890235|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102079918|NCT05890235|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102079919|NCT05890235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102079920|NCT05890235|Adrenergic Agents|adrenergic agents|mesh-ancestor
102079921|NCT05890235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102079922|NCT05890235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079923|NCT05890235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079924|NCT05890235|Urological Agents|urological agents|mesh-ancestor
102079925|NCT05887505|Vitamin D|vitamin d|mesh-list
102079926|NCT05887505|Vitamins|vitamins|mesh-ancestor
102079927|NCT05887505|Micronutrients|micronutrients|mesh-ancestor
102079928|NCT05887505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079929|NCT05887505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102079930|NCT05882162|Calcium|calcium|mesh-list
102079931|NCT05882162|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102079932|NCT05882162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079933|NCT05881486|Ondansetron|ondansetron|mesh-list
102079934|NCT05881486|Fosaprepitant|fosaprepitant|mesh-list
102079935|NCT05881486|Aprepitant|aprepitant|mesh-list
102079936|NCT05881486|Antiemetics|antiemetics|mesh-ancestor
102079937|NCT05881486|Autonomic Agents|autonomic agents|mesh-ancestor
102079938|NCT05881486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102079939|NCT05881486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079940|NCT05881486|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102079941|NCT05881486|Antipruritics|antipruritics|mesh-ancestor
102079942|NCT05881486|Dermatologic Agents|dermatologic agents|mesh-ancestor
102079943|NCT05881486|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102079944|NCT05881486|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102079945|NCT05881486|Serotonin Agents|serotonin agents|mesh-ancestor
102079946|NCT05881486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102079947|NCT05881486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079948|NCT05881486|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102079949|NCT05874570|Metronidazole|metronidazole|mesh-list
102079950|NCT05874570|Doxycycline|doxycycline|mesh-list
102079951|NCT05874570|Tetracycline|tetracycline|mesh-list
102079952|NCT05874570|Potassium Citrate|potassium citrate|mesh-list
102079953|NCT05874570|Esomeprazole|esomeprazole|mesh-list
102079954|NCT05874570|Bismuth|bismuth|mesh-list
102079955|NCT05874570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079956|NCT05874570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102079957|NCT05874570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101703638|NCT02723435|Midostaurin|midostaurin|mesh-list
102079958|NCT05874570|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102079959|NCT05874570|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102079960|NCT05874570|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102079961|NCT05874570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102079962|NCT05874570|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102079963|NCT05874570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102079967|NCT05874570|Diuretics|diuretics|mesh-ancestor
102079968|NCT05874570|Natriuretic Agents|natriuretic agents|mesh-ancestor
102079969|NCT05874570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079970|NCT05874570|Expectorants|expectorants|mesh-ancestor
102079971|NCT05874570|Respiratory System Agents|respiratory system agents|mesh-ancestor
102079972|NCT05826912|Minocycline|minocycline|mesh-list
102079973|NCT05826912|Candesartan|candesartan|mesh-list
102079974|NCT05826912|Candesartan cilexetil|candesartan cilexetil|mesh-list
102079975|NCT05826912|Atorvastatin|atorvastatin|mesh-list
102079976|NCT05826912|Calcium|calcium|mesh-list
102079977|NCT05826912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102079978|NCT05826912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079979|NCT05826912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102079980|NCT05826912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101943502|NCT02862730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101943503|NCT03609970|Vitamin D|vitamin d|mesh-list
101943504|NCT03609970|Vitamins|vitamins|mesh-ancestor
101943505|NCT03609970|Micronutrients|micronutrients|mesh-ancestor
101308387|NCT02047149|Zileuton|zileuton|mesh-list
102079981|NCT05826912|Antimetabolites|antimetabolites|mesh-ancestor
102079982|NCT05826912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079983|NCT05826912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102079984|NCT05826912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102079985|NCT05826912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102079986|NCT05826912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102079987|NCT05826912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102079988|NCT05826912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102079989|NCT05826912|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102079990|NCT05826912|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102079991|NCT05814042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102079992|NCT05810649|Hyaluronic Acid|hyaluronic acid|mesh-list
102079993|NCT05810649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102079994|NCT05810649|Immunologic Factors|immunologic factors|mesh-ancestor
102079995|NCT05810649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079996|NCT05810649|Viscosupplements|viscosupplements|mesh-ancestor
102079997|NCT05810649|Protective Agents|protective agents|mesh-ancestor
102079998|NCT05806060|Paclitaxel|paclitaxel|mesh-list
102079999|NCT05806060|Vinorelbine|vinorelbine|mesh-list
102080000|NCT05806060|Carboplatin|carboplatin|mesh-list
102080001|NCT05806060|Capecitabine|capecitabine|mesh-list
102080002|NCT05806060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102080003|NCT05806060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080004|NCT05806060|Tubulin Modulators|tubulin modulators|mesh-ancestor
102080005|NCT05806060|Antimitotic Agents|antimitotic agents|mesh-ancestor
102080006|NCT05806060|Mitosis Modulators|mitosis modulators|mesh-ancestor
102080007|NCT05806060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080008|NCT05806060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102080009|NCT05806060|Antimetabolites|antimetabolites|mesh-ancestor
102080010|NCT05770297|Propolis|propolis|mesh-list
102080011|NCT05770297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102080012|NCT05760378|Carboplatin|carboplatin|mesh-list
102080013|NCT05760378|Capecitabine|capecitabine|mesh-list
102080014|NCT05760378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080015|NCT05760378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102080016|NCT05760378|Antimetabolites|antimetabolites|mesh-ancestor
102080017|NCT05760378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080018|NCT05744635|Tacrolimus|tacrolimus|mesh-list
102080019|NCT05744635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102080020|NCT05744635|Immunologic Factors|immunologic factors|mesh-ancestor
101703664|NCT04116047|Durvalumab|durvalumab|mesh-list
102080021|NCT05744635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080022|NCT05744635|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102080023|NCT05744635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080024|NCT05744635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080025|NCT05733689|Paclitaxel|paclitaxel|mesh-list
102080026|NCT05733689|Docetaxel|docetaxel|mesh-list
102080027|NCT05733689|Carboplatin|carboplatin|mesh-list
102080028|NCT05733689|Pembrolizumab|pembrolizumab|mesh-list
102080029|NCT05733689|Nivolumab|nivolumab|mesh-list
102080030|NCT05733689|Irinotecan|irinotecan|mesh-list
102080031|NCT05733689|Folfirinox|folfirinox|mesh-list
102080032|NCT05733689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102080033|NCT05733689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080034|NCT05733689|Tubulin Modulators|tubulin modulators|mesh-ancestor
102080035|NCT05733689|Antimitotic Agents|antimitotic agents|mesh-ancestor
102080036|NCT05733689|Mitosis Modulators|mitosis modulators|mesh-ancestor
102080037|NCT05733689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080038|NCT05733689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102080061|NCT05610826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080062|NCT05608837|Dexamethasone|dexamethasone|mesh-list
102080063|NCT05608837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102080064|NCT05608837|Antiemetics|antiemetics|mesh-ancestor
102080065|NCT05608837|Autonomic Agents|autonomic agents|mesh-ancestor
102080066|NCT05608837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102080067|NCT05608837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080068|NCT05608837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102080069|NCT05608837|Glucocorticoids|glucocorticoids|mesh-ancestor
102080070|NCT05608837|Hormones|hormones|mesh-ancestor
101943506|NCT03609970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080071|NCT05608837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102080072|NCT05608837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102080073|NCT05608837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080074|NCT05555706|Paclitaxel|paclitaxel|mesh-list
102080075|NCT05555706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102080076|NCT05555706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080077|NCT05555706|Tubulin Modulators|tubulin modulators|mesh-ancestor
102080078|NCT05555706|Antimitotic Agents|antimitotic agents|mesh-ancestor
102080079|NCT05555706|Mitosis Modulators|mitosis modulators|mesh-ancestor
102080080|NCT05555706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080081|NCT05553132|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102080082|NCT05553132|Hemostatics|hemostatics|mesh-ancestor
102080083|NCT05553132|Coagulants|coagulants|mesh-ancestor
102080084|NCT05521880|Oritavancin|oritavancin|mesh-list
102080085|NCT05521880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102080086|NCT05521880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102080087|NCT05489887|Ceritinib|ceritinib|mesh-list
102080088|NCT05489887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080089|NCT05489887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102080090|NCT05489887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101381713|NCT00108576|GABA Agents|gaba agents|mesh-ancestor
102080129|NCT05271448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102080130|NCT05271448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101262757|NCT01758666|Levoleucovorin|levoleucovorin|mesh-list
102080131|NCT05271448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080132|NCT05271448|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102080133|NCT05271448|Protease Inhibitors|protease inhibitors|mesh-ancestor
102080134|NCT05271448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080135|NCT05254405|Brexanolone|brexanolone|mesh-list
102080136|NCT05254405|Neurosteroids|neurosteroids|mesh-ancestor
102080137|NCT05254405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102080138|NCT05254405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080139|NCT05254405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080140|NCT05254405|GABA Modulators|gaba modulators|mesh-ancestor
102080141|NCT05254405|GABA Agents|gaba agents|mesh-ancestor
102080142|NCT05223231|Antibodies|antibodies|mesh-list
102080143|NCT05223231|Immunoglobulins|immunoglobulins|mesh-list
102080144|NCT05223231|Immunologic Factors|immunologic factors|mesh-ancestor
102080145|NCT05223231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080146|NCT05215106|Durvalumab|durvalumab|mesh-list
102080147|NCT05215106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102080148|NCT05215106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080149|NCT05187182|Pembrolizumab|pembrolizumab|mesh-list
102080150|NCT05187182|Nivolumab|nivolumab|mesh-list
102080151|NCT05187182|Trastuzumab|trastuzumab|mesh-list
102080152|NCT05187182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102080153|NCT05187182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080154|NCT05187182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102080155|NCT05187182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080156|NCT05177731|Cytarabine|cytarabine|mesh-list
102080157|NCT05177731|Decitabine|decitabine|mesh-list
102080158|NCT05177731|Venetoclax|venetoclax|mesh-list
102080159|NCT05177731|Idarubicin|idarubicin|mesh-list
102080160|NCT05177731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102080161|NCT05177731|Antimetabolites|antimetabolites|mesh-ancestor
102080162|NCT05177731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080163|NCT05177731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080164|NCT05177731|Antiviral Agents|antiviral agents|mesh-ancestor
102080165|NCT05177731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102080166|NCT05177731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102080167|NCT05177731|Immunologic Factors|immunologic factors|mesh-ancestor
102080168|NCT05177731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080169|NCT05177731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080170|NCT05177731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102080171|NCT05177731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102080172|NCT05177731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102080173|NCT05156710|Rituximab|rituximab|mesh-list
102080174|NCT05156710|Tacrolimus|tacrolimus|mesh-list
102080175|NCT05156710|Immunoglobulins|immunoglobulins|mesh-list
102080176|NCT05156710|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102080177|NCT05156710|Antibodies|antibodies|mesh-list
102080178|NCT05156710|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102080179|NCT05156710|gamma-Globulins|gamma-globulins|mesh-list
102080180|NCT05156710|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102080181|NCT05156710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102080182|NCT05156710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101943507|NCT03609970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101943508|NCT03610282|Propofol|propofol|mesh-list
101943509|NCT03610282|Methylphenidate|methylphenidate|mesh-list
102080183|NCT05156710|Immunologic Factors|immunologic factors|mesh-ancestor
102080184|NCT05156710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080185|NCT05156710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102080186|NCT05156710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102080187|NCT05156710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102080188|NCT05156710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080189|NCT05156710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080190|NCT05110482|Oxytocin|oxytocin|mesh-list
102080191|NCT05110482|Carbetocin|carbetocin|mesh-list
102080192|NCT05110482|Oxytocics|oxytocics|mesh-ancestor
102080193|NCT05110482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102080194|NCT05110482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080195|NCT05054348|Pembrolizumab|pembrolizumab|mesh-list
102080196|NCT05054348|Cemiplimab|cemiplimab|mesh-list
102080197|NCT05054348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102080198|NCT05054348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080202|NCT05029960|Anticonvulsants|anticonvulsants|mesh-ancestor
102080203|NCT05005000|Triamcinolone|triamcinolone|mesh-list
102080204|NCT05005000|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102080205|NCT05005000|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102080206|NCT05005000|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102080207|NCT05005000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102080208|NCT05005000|Glucocorticoids|glucocorticoids|mesh-ancestor
102080209|NCT05005000|Hormones|hormones|mesh-ancestor
102080210|NCT05005000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102080211|NCT05005000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080212|NCT05005000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102080213|NCT05005000|Immunologic Factors|immunologic factors|mesh-ancestor
102080214|NCT05005000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080215|NCT05005000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080216|NCT04989946|Nivolumab|nivolumab|mesh-list
102080217|NCT04989946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102080218|NCT04989946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080219|NCT04989946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102080220|NCT04989946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080221|NCT04987996|Pembrolizumab|pembrolizumab|mesh-list
102080222|NCT04987996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102080223|NCT04987996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080224|NCT04987996|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102080225|NCT04987996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080226|NCT04916509|Fulvestrant|fulvestrant|mesh-list
102080227|NCT04916509|Palbociclib|palbociclib|mesh-list
102080228|NCT04916509|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102080229|NCT04916509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102080230|NCT04916509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080231|NCT04916509|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102080232|NCT04916509|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102080233|NCT04916509|Hormone Antagonists|hormone antagonists|mesh-ancestor
102080234|NCT04916509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102080235|NCT04916509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080236|NCT04916509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102080237|NCT04916509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080238|NCT04916509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080239|NCT04916509|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102080240|NCT04891770|Tenofovir|tenofovir|mesh-list
102080241|NCT04891770|Nivolumab|nivolumab|mesh-list
102080242|NCT04891770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102080243|NCT04891770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080244|NCT04891770|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102080245|NCT04891770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080246|NCT04891770|Antiviral Agents|antiviral agents|mesh-ancestor
102080247|NCT04891770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102080248|NCT04891770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102080249|NCT04891770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102080250|NCT04891770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080251|NCT04891770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102080252|NCT04891770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102080253|NCT04882774|Treprostinil|treprostinil|mesh-list
102080255|NCT04870125|Carbon Monoxide|carbon monoxide|mesh-list
102080256|NCT04870125|Antimetabolites|antimetabolites|mesh-ancestor
102080257|NCT04870125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080258|NCT04870125|Gasotransmitters|gasotransmitters|mesh-ancestor
102080259|NCT04870125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102080260|NCT04870125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080261|NCT04846920|Belzutifan|belzutifan|mesh-list
102080262|NCT04846920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080263|NCT04774406|Olaparib|olaparib|mesh-list
102080264|NCT04774406|Niraparib|niraparib|mesh-list
102080265|NCT04774406|Talazoparib|talazoparib|mesh-list
102080266|NCT04774406|Veliparib|veliparib|mesh-list
102080268|NCT04774406|Rucaparib|rucaparib|mesh-list
102080269|NCT04774406|Pamiparib|pamiparib|mesh-list
101381872|NCT00279253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102080276|NCT04759833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102080277|NCT04759833|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
102080278|NCT04759833|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102080279|NCT04759833|Serotonin Agents|serotonin agents|mesh-ancestor
102080280|NCT04759833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102080281|NCT04759833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080282|NCT04759833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080283|NCT04752813|Vitamin K|vitamin k|mesh-list
102080284|NCT04752813|Vitamin K 1|vitamin k 1|mesh-list
102080285|NCT04752813|Temozolomide|temozolomide|mesh-list
102080286|NCT04752813|Vitamins|vitamins|mesh-ancestor
102080287|NCT04752813|Micronutrients|micronutrients|mesh-ancestor
102080288|NCT04752813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080289|NCT04752813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102080290|NCT04752813|Alkylating Agents|alkylating agents|mesh-ancestor
102080291|NCT04752813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080292|NCT04752813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080293|NCT04752813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102080294|NCT04752813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102080295|NCT04752813|Hemostatics|hemostatics|mesh-ancestor
102080296|NCT04752813|Coagulants|coagulants|mesh-ancestor
102080297|NCT04735367|Letrozole|letrozole|mesh-list
102080298|NCT04735367|Palbociclib|palbociclib|mesh-list
102080299|NCT04735367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080300|NCT04735367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102080301|NCT04735367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102080302|NCT04735367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080303|NCT04735367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080304|NCT04735367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102080305|NCT04735367|Hormone Antagonists|hormone antagonists|mesh-ancestor
102080306|NCT04735367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102080307|NCT04735367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080308|NCT04735367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102080309|NCT04720963|Dexmedetomidine|dexmedetomidine|mesh-list
102080310|NCT04720963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102080311|NCT04720963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102080312|NCT04720963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080313|NCT04720963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102080314|NCT04720963|Analgesics|analgesics|mesh-ancestor
102080315|NCT04720963|Sensory System Agents|sensory system agents|mesh-ancestor
102080316|NCT04720963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102080317|NCT04720963|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102080318|NCT04720963|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102080319|NCT04720963|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102080320|NCT04720963|Adrenergic Agents|adrenergic agents|mesh-ancestor
102080321|NCT04720963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102080322|NCT04720963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080323|NCT04715113|Sildenafil Citrate|sildenafil citrate|mesh-list
102080324|NCT04715113|Vasodilator Agents|vasodilator agents|mesh-ancestor
102080325|NCT04715113|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102080326|NCT04715113|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102080327|NCT04715113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080328|NCT04715113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080329|NCT04715113|Urological Agents|urological agents|mesh-ancestor
102080330|NCT04713657|Propranolol|propranolol|mesh-list
102080331|NCT04713657|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102080332|NCT04713657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102080333|NCT04713657|Adrenergic Agents|adrenergic agents|mesh-ancestor
102080334|NCT04713657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101943510|NCT03610282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101943511|NCT03610282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101450814|NCT00125489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102080335|NCT04713657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080336|NCT04713657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080341|NCT04706546|Vasodilator Agents|vasodilator agents|mesh-ancestor
102080342|NCT04706546|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102080343|NCT04706546|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102080344|NCT04706546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080345|NCT04706546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080346|NCT04706546|Urological Agents|urological agents|mesh-ancestor
102080347|NCT04704440|Sildenafil Citrate|sildenafil citrate|mesh-list
102080348|NCT04704440|Vasodilator Agents|vasodilator agents|mesh-ancestor
102080349|NCT04704440|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102080350|NCT04704440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102080351|NCT04704440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080352|NCT04704440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080353|NCT04704440|Urological Agents|urological agents|mesh-ancestor
102080354|NCT04697862|Sildenafil Citrate|sildenafil citrate|mesh-list
102080355|NCT04697862|Vasodilator Agents|vasodilator agents|mesh-ancestor
102080356|NCT04697862|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102080357|NCT04697862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102080358|NCT04697862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080359|NCT04697862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080360|NCT04697862|Urological Agents|urological agents|mesh-ancestor
102080361|NCT04696029|Eflornithine|eflornithine|mesh-list
102080362|NCT04696029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080363|NCT04696029|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102080364|NCT04696029|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102080365|NCT04696029|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102080366|NCT04696029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102080367|NCT04696029|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
102080368|NCT04696029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080369|NCT04696029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080370|NCT04666610|Brivaracetam|brivaracetam|mesh-list
102080371|NCT04666610|Anticonvulsants|anticonvulsants|mesh-ancestor
102080372|NCT04652544|Vitamin D|vitamin d|mesh-list
102080373|NCT04652544|Cholecalciferol|cholecalciferol|mesh-list
102080374|NCT04652544|Vitamins|vitamins|mesh-ancestor
102080375|NCT04652544|Micronutrients|micronutrients|mesh-ancestor
102080376|NCT04652544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080377|NCT04652544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102080378|NCT04652544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102080379|NCT04640545|Axitinib|axitinib|mesh-list
102080380|NCT04640545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080381|NCT04640545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102080382|NCT04640545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080383|NCT04640545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080384|NCT04625699|Durvalumab|durvalumab|mesh-list
102080385|NCT04625699|Tremelimumab|tremelimumab|mesh-list
102080386|NCT04625699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102080387|NCT04625699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080388|NCT04613492|Durvalumab|durvalumab|mesh-list
102080389|NCT04613492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102080390|NCT04613492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080391|NCT04562467|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
102080392|NCT04562467|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102080393|NCT04562467|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102080394|NCT04510584|Bevacizumab|bevacizumab|mesh-list
102080395|NCT04510584|Atezolizumab|atezolizumab|mesh-list
102080396|NCT04510584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102080397|NCT04510584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080398|NCT04510584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102080399|NCT04510584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102080400|NCT04510584|Growth Substances|growth substances|mesh-ancestor
102080401|NCT04510584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080402|NCT04510584|Growth Inhibitors|growth inhibitors|mesh-ancestor
102080403|NCT04510584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102080404|NCT04510584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080405|NCT04500847|Emtricitabine|emtricitabine|mesh-list
101943512|NCT03610282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943513|NCT03610282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101943514|NCT03610282|Anesthetics, General|anesthetics, general|mesh-ancestor
102080406|NCT04500847|Antiviral Agents|antiviral agents|mesh-ancestor
102080407|NCT04500847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102080410|NCT04500847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080411|NCT04500847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080412|NCT04500847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102080413|NCT04500847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102080414|NCT04484532|Vaccines|vaccines|mesh-list
102080415|NCT04484532|Immunologic Factors|immunologic factors|mesh-ancestor
102080416|NCT04484532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080417|NCT04483583|Clopidogrel|clopidogrel|mesh-list
102080418|NCT04483583|Ticagrelor|ticagrelor|mesh-list
102080419|NCT04483583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102080420|NCT04483583|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102080421|NCT04483583|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102080422|NCT04483583|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102080423|NCT04483583|Purinergic Agents|purinergic agents|mesh-ancestor
102080424|NCT04483583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102080425|NCT04483583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080426|NCT04483583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080427|NCT04447989|Sildenafil Citrate|sildenafil citrate|mesh-list
102080428|NCT04447989|Vasodilator Agents|vasodilator agents|mesh-ancestor
102080429|NCT04447989|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102080430|NCT04447989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102080431|NCT04447989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080432|NCT04447989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080433|NCT04447989|Urological Agents|urological agents|mesh-ancestor
102080434|NCT04416750|Imatinib Mesylate|imatinib mesylate|mesh-list
102080435|NCT04416750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080436|NCT04416750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102080437|NCT04416750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101703810|NCT02722421|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102080438|NCT04416750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080439|NCT04382898|Cemiplimab|cemiplimab|mesh-list
102080440|NCT04382898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102080441|NCT04382898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080442|NCT04375527|Nivolumab|nivolumab|mesh-list
102080443|NCT04375527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102080444|NCT04375527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080445|NCT04375527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102080446|NCT04375527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080447|NCT04362488|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102080448|NCT04362488|Dermatologic Agents|dermatologic agents|mesh-ancestor
102080449|NCT04336189|Pyrimethamine|pyrimethamine|mesh-list
102080450|NCT04336189|Piperaquine|piperaquine|mesh-list
102080451|NCT04336189|Sulfadoxine|sulfadoxine|mesh-list
102080452|NCT04336189|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
102080453|NCT04336189|Artenimol|artenimol|mesh-list
102080454|NCT04336189|Antimalarials|antimalarials|mesh-ancestor
102080455|NCT04336189|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102080456|NCT04336189|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102080457|NCT04336189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102080458|NCT04336189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102080459|NCT04336189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080460|NCT04336189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080461|NCT04336189|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102080462|NCT04231877|Prednisone|prednisone|mesh-list
102080463|NCT04231877|Cortisone|cortisone|mesh-list
102080464|NCT04231877|Cyclophosphamide|cyclophosphamide|mesh-list
102080465|NCT04231877|Rituximab|rituximab|mesh-list
102080466|NCT04231877|Doxorubicin|doxorubicin|mesh-list
102080467|NCT04231877|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102080468|NCT04231877|Etoposide|etoposide|mesh-list
102080469|NCT04231877|Daunorubicin|daunorubicin|mesh-list
102080470|NCT04231877|Podophyllotoxin|podophyllotoxin|mesh-list
102080471|NCT04231877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102080472|NCT04231877|Antibodies|antibodies|mesh-list
102080473|NCT04231877|Immunoglobulins|immunoglobulins|mesh-list
102080474|NCT04231877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102080475|NCT04231877|Lenograstim|lenograstim|mesh-list
102080476|NCT04231877|Immunoconjugates|immunoconjugates|mesh-list
102080477|NCT04231877|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
102080478|NCT04231877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101943516|NCT03610282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101943517|NCT03610282|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102080479|NCT04231877|Immunologic Factors|immunologic factors|mesh-ancestor
102080480|NCT04231877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080481|NCT04231877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102080488|NCT04231877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102080489|NCT04231877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101800258|NCT00956436|Sorafenib|sorafenib|mesh-list
102080490|NCT04231877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080491|NCT04231877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102080492|NCT04231877|Glucocorticoids|glucocorticoids|mesh-ancestor
102080493|NCT04231877|Hormones|hormones|mesh-ancestor
102080494|NCT04231877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102080495|NCT04231877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102080496|NCT04231877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102080497|NCT04231877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102080498|NCT04231877|Keratolytic Agents|keratolytic agents|mesh-ancestor
102080499|NCT04231877|Dermatologic Agents|dermatologic agents|mesh-ancestor
102080500|NCT04231877|Tubulin Modulators|tubulin modulators|mesh-ancestor
102080501|NCT04231877|Antimitotic Agents|antimitotic agents|mesh-ancestor
102080502|NCT04231877|Mitosis Modulators|mitosis modulators|mesh-ancestor
102080503|NCT04218799|Chlorhexidine|chlorhexidine|mesh-list
102080504|NCT04218799|Mupirocin|mupirocin|mesh-list
102080505|NCT04218799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102080506|NCT04218799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102080507|NCT04218799|Disinfectants|disinfectants|mesh-ancestor
102080508|NCT04218799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102080509|NCT04218799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102080510|NCT04218799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080511|NCT04218799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080512|NCT04189445|Futibatinib|futibatinib|mesh-list
102080513|NCT04189445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080514|NCT04179032|Belimumab|belimumab|mesh-list
102080515|NCT04179032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102080516|NCT04179032|Immunologic Factors|immunologic factors|mesh-ancestor
102080517|NCT04179032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080518|NCT04143594|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
102080519|NCT04143594|Antiviral Agents|antiviral agents|mesh-ancestor
102080520|NCT04143594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102080521|NCT04143594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102080522|NCT04143594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102080523|NCT04143594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080524|NCT04143594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080525|NCT04143594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102080526|NCT04143594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102080527|NCT04026776|Allopurinol|allopurinol|mesh-list
102080528|NCT04026776|Antimetabolites|antimetabolites|mesh-ancestor
102080529|NCT04026776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080530|NCT04026776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080531|NCT04026776|Gout Suppressants|gout suppressants|mesh-ancestor
102080532|NCT04026776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101703872|NCT03903406|Dexamethasone|dexamethasone|mesh-list
102080533|NCT04026776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102080534|NCT04026776|Antioxidants|antioxidants|mesh-ancestor
102080535|NCT04026776|Protective Agents|protective agents|mesh-ancestor
102080536|NCT04026776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080537|NCT03871348|Cemiplimab|cemiplimab|mesh-list
102080538|NCT03871348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102080539|NCT03871348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080540|NCT03846427|Zanubrutinib|zanubrutinib|mesh-list
102080541|NCT03846427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080542|NCT03846427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102080543|NCT03846427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080544|NCT03846427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080545|NCT03831113|Buprenorphine|buprenorphine|mesh-list
102080546|NCT03831113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102080547|NCT03831113|Narcotics|narcotics|mesh-ancestor
102080548|NCT03831113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102080554|NCT03824561|Vedolizumab|vedolizumab|mesh-list
102080555|NCT03824561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102080556|NCT03821857|Corticosterone|corticosterone|mesh-list
102080557|NCT03821857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102080558|NCT04305236|Fulvestrant|fulvestrant|mesh-list
102080559|NCT04305236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102080560|NCT04305236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101943518|NCT03610282|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102080561|NCT04305236|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102080562|NCT04305236|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102080563|NCT04305236|Hormone Antagonists|hormone antagonists|mesh-ancestor
102080564|NCT04305236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102080565|NCT04305236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080566|NCT03774472|Hydroxychloroquine|hydroxychloroquine|mesh-list
102080568|NCT03774472|Palbociclib|palbociclib|mesh-list
102080569|NCT03774472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080570|NCT03774472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102080571|NCT03774472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102080572|NCT03774472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080573|NCT03774472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080574|NCT03774472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102080575|NCT03774472|Hormone Antagonists|hormone antagonists|mesh-ancestor
102080576|NCT03774472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102080577|NCT03774472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080578|NCT03774472|Antimalarials|antimalarials|mesh-ancestor
102080579|NCT03774472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102080580|NCT03774472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102080581|NCT03774472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102080582|NCT03774472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102080583|NCT03774472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102080584|NCT03727061|Carboplatin|carboplatin|mesh-list
102080585|NCT03727061|Pembrolizumab|pembrolizumab|mesh-list
102080586|NCT03727061|Fluorouracil|fluorouracil|mesh-list
102080587|NCT03727061|Nivolumab|nivolumab|mesh-list
102080588|NCT03727061|Cetuximab|cetuximab|mesh-list
102080589|NCT03727061|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
102080590|NCT03727061|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
102080591|NCT03727061|Trioxsalen|trioxsalen|mesh-list
102080592|NCT03727061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080593|NCT03727061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102080594|NCT03727061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102080595|NCT03727061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080596|NCT03727061|Antimetabolites|antimetabolites|mesh-ancestor
102080597|NCT03727061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102080598|NCT03727061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102080599|NCT03727061|Immunologic Factors|immunologic factors|mesh-ancestor
102080600|NCT03727061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080601|NCT03727061|Dermatologic Agents|dermatologic agents|mesh-ancestor
102080602|NCT03727061|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102080603|NCT03668340|Adavosertib|adavosertib|mesh-list
102080604|NCT03668340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080605|NCT03668340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080606|NCT03657160|Vedolizumab|vedolizumab|mesh-list
102080607|NCT03657160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102080608|NCT03508726|Ascorbic Acid|ascorbic acid|mesh-list
102080609|NCT03508726|Vitamins|vitamins|mesh-ancestor
102080610|NCT03508726|Micronutrients|micronutrients|mesh-ancestor
102080611|NCT03508726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080612|NCT03508726|Antioxidants|antioxidants|mesh-ancestor
102080613|NCT03508726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080614|NCT03508726|Protective Agents|protective agents|mesh-ancestor
102080615|NCT03404661|Secretin|secretin|mesh-list
102080616|NCT03404661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102080617|NCT03404661|Hormones|hormones|mesh-ancestor
102080618|NCT03404661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102080619|NCT03404661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080645|NCT03342196|Immunologic Factors|immunologic factors|mesh-ancestor
102080646|NCT03342196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080647|NCT03342196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102080648|NCT03342196|Alkylating Agents|alkylating agents|mesh-ancestor
102080649|NCT03342196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102080651|NCT03319537|Pevonedistat|pevonedistat|mesh-list
102080652|NCT03319537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080653|NCT03319537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080654|NCT03319537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080655|NCT03319537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102080656|NCT03319537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102080657|NCT03279692|Pembrolizumab|pembrolizumab|mesh-list
102080658|NCT03279692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101943519|NCT03610282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102080659|NCT03279692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101703922|NCT02704156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080660|NCT03279692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102080661|NCT03279692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080662|NCT03237780|Atezolizumab|atezolizumab|mesh-list
102080663|NCT03237780|Halichondrin B|halichondrin b|mesh-list
102080664|NCT03237780|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102080665|NCT03237780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102080666|NCT03237780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080667|NCT03237780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102080668|NCT03237780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080669|NCT03237780|Immunologic Factors|immunologic factors|mesh-ancestor
102080690|NCT03100786|Dexamethasone|dexamethasone|mesh-list
102080691|NCT03100786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102080692|NCT03100786|Antiemetics|antiemetics|mesh-ancestor
102080693|NCT03100786|Autonomic Agents|autonomic agents|mesh-ancestor
102080694|NCT03100786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102080695|NCT03100786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080696|NCT03100786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102080697|NCT03100786|Glucocorticoids|glucocorticoids|mesh-ancestor
102080699|NCT03100786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102080700|NCT03100786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102080701|NCT03100786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080702|NCT03043053|Oxytocin|oxytocin|mesh-list
102080703|NCT03043053|Oxytocics|oxytocics|mesh-ancestor
102080704|NCT03043053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102080705|NCT03043053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080706|NCT03025035|Pembrolizumab|pembrolizumab|mesh-list
102080707|NCT03025035|Olaparib|olaparib|mesh-list
102080708|NCT03025035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102080709|NCT03025035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080710|NCT03025035|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102080711|NCT03025035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080712|NCT03025035|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102080713|NCT03025035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080714|NCT03001882|Nivolumab|nivolumab|mesh-list
102080715|NCT03001882|Ipilimumab|ipilimumab|mesh-list
102080716|NCT03001882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102080717|NCT03001882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080718|NCT03001882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102080719|NCT03001882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080720|NCT02981966|Dapagliflozin|dapagliflozin|mesh-list
102080721|NCT02981966|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102080722|NCT02981966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080723|NCT02981966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102080724|NCT02981966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080725|NCT02932956|Cyclophosphamide|cyclophosphamide|mesh-list
102080726|NCT02932956|Fludarabine|fludarabine|mesh-list
102080727|NCT02932956|Fludarabine phosphate|fludarabine phosphate|mesh-list
102080728|NCT02932956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102080729|NCT02932956|Immunologic Factors|immunologic factors|mesh-ancestor
102080730|NCT02932956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080731|NCT02932956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102080732|NCT02932956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102080733|NCT02932956|Alkylating Agents|alkylating agents|mesh-ancestor
102080749|NCT02807467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080750|NCT02807467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102080751|NCT02807467|Analgesics|analgesics|mesh-ancestor
102080752|NCT02807467|Sensory System Agents|sensory system agents|mesh-ancestor
102080753|NCT02807467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102080754|NCT02807467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102080755|NCT02807467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102080756|NCT02807467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102080757|NCT02807467|Adrenergic Agents|adrenergic agents|mesh-ancestor
101943520|NCT03610282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943521|NCT03610282|Dopamine Agents|dopamine agents|mesh-ancestor
101451249|NCT00126308|Diuretics|diuretics|mesh-ancestor
102080758|NCT02807467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102080759|NCT02807467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080760|NCT02807467|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102080761|NCT02807467|Anesthetics, General|anesthetics, general|mesh-ancestor
102080762|NCT02807467|Anesthetics|anesthetics|mesh-ancestor
102080763|NCT02794428|Eflornithine|eflornithine|mesh-list
102080764|NCT02794428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080765|NCT02794428|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102080766|NCT02794428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102080767|NCT02794428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102080768|NCT02794428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102080769|NCT02794428|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
102080770|NCT02794428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080771|NCT02794428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080772|NCT02740179|Eplerenone|eplerenone|mesh-list
102080773|NCT02740179|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102080774|NCT02740179|Hormone Antagonists|hormone antagonists|mesh-ancestor
101703981|NCT00912756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102080775|NCT02740179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102080776|NCT02740179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080777|NCT02740179|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102080778|NCT02740179|Diuretics|diuretics|mesh-ancestor
102080779|NCT02740179|Natriuretic Agents|natriuretic agents|mesh-ancestor
102080780|NCT02740179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102080781|NCT02679144|Eflornithine|eflornithine|mesh-list
102080782|NCT02679144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080783|NCT02679144|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102080784|NCT02679144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102080785|NCT02679144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102080786|NCT02679144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102080787|NCT02679144|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
102080788|NCT02679144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080789|NCT02679144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080790|NCT02650986|Cyclophosphamide|cyclophosphamide|mesh-list
102080791|NCT02650986|Decitabine|decitabine|mesh-list
102080797|NCT02650986|Alkylating Agents|alkylating agents|mesh-ancestor
102080798|NCT02650986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080799|NCT02650986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080800|NCT02650986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102080801|NCT02650986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102080802|NCT02650986|Antimetabolites|antimetabolites|mesh-ancestor
102080803|NCT02650986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080804|NCT02619409|Bupivacaine|bupivacaine|mesh-list
102080805|NCT02619409|Anesthetics, Local|anesthetics, local|mesh-ancestor
102080806|NCT02619409|Anesthetics|anesthetics|mesh-ancestor
102080807|NCT02619409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102080808|NCT02619409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080809|NCT02619409|Sensory System Agents|sensory system agents|mesh-ancestor
102080810|NCT02619409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102080811|NCT02606045|Tranexamic Acid|tranexamic acid|mesh-list
102080812|NCT02606045|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102080813|NCT02606045|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102080814|NCT02606045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080815|NCT02606045|Hemostatics|hemostatics|mesh-ancestor
102080816|NCT02606045|Coagulants|coagulants|mesh-ancestor
102080817|NCT02603432|Avelumab|avelumab|mesh-list
102080818|NCT02603432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102080819|NCT02603432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102080820|NCT02603432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080821|NCT02603432|Immunologic Factors|immunologic factors|mesh-ancestor
102080822|NCT02603432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080823|NCT02582866|Lacosamide|lacosamide|mesh-list
102080824|NCT02582866|Anticonvulsants|anticonvulsants|mesh-ancestor
102080825|NCT02582866|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102080826|NCT02582866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102080827|NCT02582866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102080828|NCT02582866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080829|NCT02559778|Eflornithine|eflornithine|mesh-list
102080830|NCT02559778|Sorafenib|sorafenib|mesh-list
102080831|NCT02559778|Dasatinib|dasatinib|mesh-list
101308402|NCT02047149|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
102080832|NCT02559778|Vorinostat|vorinostat|mesh-list
102080833|NCT02559778|Ceritinib|ceritinib|mesh-list
102080834|NCT02559778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080835|NCT02559778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102080836|NCT02559778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080837|NCT02559778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080838|NCT02559778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102080839|NCT02559778|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102080840|NCT02559778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102080841|NCT02559778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102080842|NCT02559778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102080843|NCT02559778|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
102080844|NCT02465307|Hydrocortisone|hydrocortisone|mesh-list
102080845|NCT02465307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102080846|NCT02453373|Magnesium Sulfate|magnesium sulfate|mesh-list
102080847|NCT02453373|Plasminogen|plasminogen|mesh-list
102080848|NCT02453373|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102080849|NCT02453373|Propofol|propofol|mesh-list
102080850|NCT02453373|Etomidate|etomidate|mesh-list
102080851|NCT02453373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102080852|NCT02453373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102080853|NCT02453373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080854|NCT02453373|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102080855|NCT02453373|Anesthetics, General|anesthetics, general|mesh-ancestor
102080856|NCT02453373|Anesthetics|anesthetics|mesh-ancestor
102080857|NCT02453373|Analgesics|analgesics|mesh-ancestor
102080858|NCT02453373|Sensory System Agents|sensory system agents|mesh-ancestor
102080859|NCT02453373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102080860|NCT02453373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102080861|NCT02453373|Anticonvulsants|anticonvulsants|mesh-ancestor
102080862|NCT02453373|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102080866|NCT02453373|Tocolytic Agents|tocolytic agents|mesh-ancestor
102080867|NCT02453373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102080868|NCT02453373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102080869|NCT02453373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102080870|NCT02395666|Eflornithine|eflornithine|mesh-list
102080871|NCT02395666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080872|NCT02395666|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102080873|NCT02395666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102080874|NCT02395666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102080875|NCT02395666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102080876|NCT02395666|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
102080877|NCT02395666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080878|NCT02395666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080879|NCT02180867|Doxorubicin|doxorubicin|mesh-list
102080880|NCT02180867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102080881|NCT02180867|Daunorubicin|daunorubicin|mesh-list
102080882|NCT02180867|Ifosfamide|ifosfamide|mesh-list
102080883|NCT02180867|Isophosphamide mustard|isophosphamide mustard|mesh-list
102080884|NCT02180867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102080885|NCT02180867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080886|NCT02180867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102080887|NCT02180867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102080888|NCT02180867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080889|NCT02180867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080890|NCT02180867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102080891|NCT02180867|Alkylating Agents|alkylating agents|mesh-ancestor
102080892|NCT01734928|Thalidomide|thalidomide|mesh-list
102080893|NCT01734928|Dexamethasone|dexamethasone|mesh-list
102080894|NCT01734928|Bortezomib|bortezomib|mesh-list
102080895|NCT01734928|Pomalidomide|pomalidomide|mesh-list
102080896|NCT01734928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102080897|NCT01734928|Antiemetics|antiemetics|mesh-ancestor
102080898|NCT01734928|Autonomic Agents|autonomic agents|mesh-ancestor
102080899|NCT01734928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102080900|NCT01734928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080901|NCT01734928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102080902|NCT01734928|Glucocorticoids|glucocorticoids|mesh-ancestor
102080903|NCT01734928|Hormones|hormones|mesh-ancestor
102080904|NCT01734928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102080905|NCT01734928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102080906|NCT01734928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080907|NCT01734928|Immunologic Factors|immunologic factors|mesh-ancestor
102080908|NCT01734928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102080909|NCT01734928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101308403|NCT02047149|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102080910|NCT01734928|Growth Substances|growth substances|mesh-ancestor
102080911|NCT01734928|Growth Inhibitors|growth inhibitors|mesh-ancestor
102080912|NCT01734928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102080913|NCT01734928|Leprostatic Agents|leprostatic agents|mesh-ancestor
102080914|NCT01734928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102080915|NCT01734928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102080916|NCT01682616|Rituximab|rituximab|mesh-list
102080917|NCT01682616|Venetoclax|venetoclax|mesh-list
102080918|NCT01682616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102080919|NCT01682616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080920|NCT01682616|Immunologic Factors|immunologic factors|mesh-ancestor
102080921|NCT01682616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080922|NCT01682616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102080923|NCT01430572|Everolimus|everolimus|mesh-list
102080924|NCT01430572|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102080925|NCT01430572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102080926|NCT01430572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080927|NCT01430572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080928|NCT01430572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102080929|NCT01430572|Immunologic Factors|immunologic factors|mesh-ancestor
102080930|NCT01430572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080931|NCT01430572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080932|NCT00950430|Corticosterone|corticosterone|mesh-list
102080933|NCT00950430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102080934|NCT00909051|Acarbose|acarbose|mesh-list
102080937|NCT00909051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080938|NCT00909051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102080939|NCT00909051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080941|NCT00750841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080942|NCT00750841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101800703|NCT00947466|Buprenorphine|buprenorphine|mesh-list
102080943|NCT00750841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080944|NCT00750841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080945|NCT05015608|Carboplatin|carboplatin|mesh-list
102080946|NCT05015608|Pemetrexed|pemetrexed|mesh-list
102080947|NCT05015608|Osimertinib|osimertinib|mesh-list
102080948|NCT05015608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080949|NCT05015608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080950|NCT05015608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080951|NCT05015608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102080952|NCT05015608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102080953|NCT05015608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102080954|NCT03510416|Apatinib|apatinib|mesh-list
102080955|NCT03510416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080956|NCT03510416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102080957|NCT03510416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080958|NCT03510416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080959|NCT03510962|Chlorhexidine|chlorhexidine|mesh-list
102080960|NCT03510962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102080961|NCT03510962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102080962|NCT03510962|Disinfectants|disinfectants|mesh-ancestor
102080963|NCT02646124|Naproxen|naproxen|mesh-list
102080964|NCT02646124|Diazepam|diazepam|mesh-list
102080965|NCT02646124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102080966|NCT02646124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102080967|NCT02646124|Analgesics|analgesics|mesh-ancestor
102080968|NCT02646124|Sensory System Agents|sensory system agents|mesh-ancestor
101704100|NCT02716415|Protective Agents|protective agents|mesh-ancestor
102080969|NCT02646124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102080970|NCT02646124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080971|NCT02646124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102080972|NCT02646124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102080973|NCT02646124|Gout Suppressants|gout suppressants|mesh-ancestor
102080974|NCT02646124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102080975|NCT02646124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080976|NCT02646124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080977|NCT02646124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102080978|NCT02646124|Anticonvulsants|anticonvulsants|mesh-ancestor
102080979|NCT02646124|Antiemetics|antiemetics|mesh-ancestor
102080980|NCT02646124|Autonomic Agents|autonomic agents|mesh-ancestor
102080981|NCT02646124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102080982|NCT02646124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102080983|NCT02646124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102080984|NCT02646124|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102080985|NCT02646124|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101943523|NCT02862574|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
101943524|NCT02862574|Methotrexate|methotrexate|mesh-list
101943525|NCT02862574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101943526|NCT02862574|Abortifacient Agents|abortifacient agents|mesh-ancestor
101943527|NCT02862574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101943528|NCT02862574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943529|NCT02862574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101943530|NCT02862574|Antimetabolites|antimetabolites|mesh-ancestor
102080986|NCT02646124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102080987|NCT02646124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102080988|NCT02646124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102080989|NCT02646124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102080990|NCT02646124|Anesthetics, General|anesthetics, general|mesh-ancestor
102080991|NCT02646124|Anesthetics|anesthetics|mesh-ancestor
102080992|NCT02646124|GABA Modulators|gaba modulators|mesh-ancestor
102080993|NCT02646124|GABA Agents|gaba agents|mesh-ancestor
102080994|NCT02646124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102080995|NCT02306564|Cabergoline|cabergoline|mesh-list
102080996|NCT02306564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102080997|NCT02306564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102080998|NCT02306564|Dopamine Agonists|dopamine agonists|mesh-ancestor
102080999|NCT02306564|Dopamine Agents|dopamine agents|mesh-ancestor
102081000|NCT02306564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102081001|NCT02306564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081002|NCT02306564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081003|NCT02301494|Fluocinonide|fluocinonide|mesh-list
102081004|NCT02301494|Imiquimod|imiquimod|mesh-list
102081005|NCT02301494|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102081006|NCT02301494|Immunologic Factors|immunologic factors|mesh-ancestor
101382608|NCT00283621|Alkylating Agents|alkylating agents|mesh-ancestor
102081013|NCT02301494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102081014|NCT02301494|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102081015|NCT03101800|Azathioprine|azathioprine|mesh-list
102081016|NCT03101800|Allopurinol|allopurinol|mesh-list
102081017|NCT03101800|Antimetabolites|antimetabolites|mesh-ancestor
102081018|NCT03101800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081019|NCT03101800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102081020|NCT03101800|Gout Suppressants|gout suppressants|mesh-ancestor
102081021|NCT03101800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102081022|NCT03101800|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102081023|NCT03101800|Antioxidants|antioxidants|mesh-ancestor
102081024|NCT03101800|Protective Agents|protective agents|mesh-ancestor
102081025|NCT03101800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081026|NCT03101800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102081027|NCT03101800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102081028|NCT03101800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102081029|NCT03101800|Immunologic Factors|immunologic factors|mesh-ancestor
102081030|NCT03507842|Cytarabine|cytarabine|mesh-list
102081031|NCT03507842|Daunorubicin|daunorubicin|mesh-list
102081032|NCT03507842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102081033|NCT03507842|Antimetabolites|antimetabolites|mesh-ancestor
102081034|NCT03507842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081035|NCT03507842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102081036|NCT03507842|Antiviral Agents|antiviral agents|mesh-ancestor
102081037|NCT03507842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102081038|NCT03507842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102081039|NCT03507842|Immunologic Factors|immunologic factors|mesh-ancestor
102081040|NCT03507842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081041|NCT03507842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102081042|NCT03507842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102081043|NCT03507842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102081044|NCT03507842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102081045|NCT03132584|Cyclophosphamide|cyclophosphamide|mesh-list
102081046|NCT03132584|Alemtuzumab|alemtuzumab|mesh-list
102081047|NCT03132584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102081048|NCT03132584|Immunologic Factors|immunologic factors|mesh-ancestor
101943531|NCT02862574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943532|NCT02862574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101943533|NCT02862574|Dermatologic Agents|dermatologic agents|mesh-ancestor
101943534|NCT02862574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101943535|NCT02862574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101943536|NCT02862574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101943537|NCT02862574|Immunologic Factors|immunologic factors|mesh-ancestor
101943538|NCT02862574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101943539|NCT02862574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101943540|NCT02862574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101943541|NCT05383300|Oxytocin|oxytocin|mesh-list
101943542|NCT05383300|Oxytocics|oxytocics|mesh-ancestor
101943543|NCT05383300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102081049|NCT03132584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081050|NCT03132584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102081051|NCT03132584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102081052|NCT03132584|Alkylating Agents|alkylating agents|mesh-ancestor
102081053|NCT03132584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081054|NCT03132584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102081055|NCT03132584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102081056|NCT03132584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102081057|NCT03656926|Cyclosporine|cyclosporine|mesh-list
102081058|NCT03656926|Cyclosporins|cyclosporins|mesh-list
102081059|NCT03656926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102081060|NCT03656926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081061|NCT03656926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102081062|NCT03656926|Immunologic Factors|immunologic factors|mesh-ancestor
102081063|NCT03656926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081064|NCT03656926|Antifungal Agents|antifungal agents|mesh-ancestor
102081065|NCT03656926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102081066|NCT03656926|Dermatologic Agents|dermatologic agents|mesh-ancestor
102081067|NCT03656926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102081068|NCT03656926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102081069|NCT02301650|Tenofovir|tenofovir|mesh-list
102081070|NCT02301650|Lamivudine|lamivudine|mesh-list
102081071|NCT02301650|Telbivudine|telbivudine|mesh-list
102081072|NCT02301650|Antiviral Agents|antiviral agents|mesh-ancestor
102081073|NCT02301650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102081074|NCT02301650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102081075|NCT02301650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102081076|NCT02301650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102081078|NCT02301650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102081079|NCT02301650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102081080|NCT03510338|Sildenafil Citrate|sildenafil citrate|mesh-list
102081081|NCT03510338|Vasodilator Agents|vasodilator agents|mesh-ancestor
102081082|NCT03510338|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102081083|NCT03510338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102081084|NCT03510338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102081085|NCT03510338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081086|NCT03510338|Urological Agents|urological agents|mesh-ancestor
102081087|NCT02303366|Pembrolizumab|pembrolizumab|mesh-list
102081088|NCT02303366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102081089|NCT02303366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102081090|NCT02303366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102081091|NCT02303366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081092|NCT02301806|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102081093|NCT02301806|Glimepiride|glimepiride|mesh-list
102081094|NCT02301806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102081095|NCT02301806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081096|NCT02301806|Incretins|incretins|mesh-ancestor
102081097|NCT02301806|Hormones|hormones|mesh-ancestor
101943544|NCT05383300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943546|NCT03712046|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101943547|NCT03712046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943548|NCT02862106|Vaccines|vaccines|mesh-list
101943549|NCT02862106|Immunologic Factors|immunologic factors|mesh-ancestor
101943550|NCT02862106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943551|NCT03609892|Amoxicillin|amoxicillin|mesh-list
102081098|NCT02301806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102081099|NCT02301806|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102081100|NCT02301806|Protease Inhibitors|protease inhibitors|mesh-ancestor
102081101|NCT02301806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102081102|NCT02301806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081103|NCT02301806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102081104|NCT02301806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102081105|NCT02301806|Immunologic Factors|immunologic factors|mesh-ancestor
102081106|NCT03103204|Chlorhexidine|chlorhexidine|mesh-list
102081107|NCT03103204|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102081108|NCT03103204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102081109|NCT03103204|Disinfectants|disinfectants|mesh-ancestor
102081110|NCT02301962|Panitumumab|panitumumab|mesh-list
102081111|NCT02301962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102081112|NCT02301962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102081113|NCT03507374|Alirocumab|alirocumab|mesh-list
102081114|NCT03507374|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102081115|NCT03507374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102081116|NCT03507374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102081117|NCT03507374|Antimetabolites|antimetabolites|mesh-ancestor
102081118|NCT03507374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081119|NCT03507374|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102081120|NCT03507374|Protease Inhibitors|protease inhibitors|mesh-ancestor
102081121|NCT03507374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102081122|NCT03507374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102081123|NCT02639650|Dactinomycin|dactinomycin|mesh-list
102081124|NCT02639650|Paclitaxel|paclitaxel|mesh-list
102081125|NCT02639650|Etoposide|etoposide|mesh-list
102081126|NCT02639650|Vincristine|vincristine|mesh-list
102081127|NCT02639650|Cyclophosphamide|cyclophosphamide|mesh-list
102081128|NCT02639650|Carboplatin|carboplatin|mesh-list
102081129|NCT02639650|Methotrexate|methotrexate|mesh-list
102081130|NCT02639650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102081131|NCT02639650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102081132|NCT02639650|Tubulin Modulators|tubulin modulators|mesh-ancestor
102081133|NCT02639650|Antimitotic Agents|antimitotic agents|mesh-ancestor
102081134|NCT02639650|Mitosis Modulators|mitosis modulators|mesh-ancestor
102081135|NCT02639650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081136|NCT02639650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102081137|NCT02639650|Immunologic Factors|immunologic factors|mesh-ancestor
102081138|NCT02639650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081139|NCT02639650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102081140|NCT02639650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102081141|NCT02639650|Alkylating Agents|alkylating agents|mesh-ancestor
102081142|NCT02639650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102081143|NCT02639650|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102081144|NCT02639650|Abortifacient Agents|abortifacient agents|mesh-ancestor
102081145|NCT02639650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102081146|NCT02639650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102081147|NCT02639650|Antimetabolites|antimetabolites|mesh-ancestor
102081148|NCT02639650|Dermatologic Agents|dermatologic agents|mesh-ancestor
102081149|NCT02639650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102081150|NCT02639650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102081163|NCT02306798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102081164|NCT02306798|Analgesics|analgesics|mesh-ancestor
102081165|NCT02306798|Sensory System Agents|sensory system agents|mesh-ancestor
102081166|NCT02306798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102081167|NCT02306798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081168|NCT02306798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101943552|NCT03609892|Tetracycline|tetracycline|mesh-list
101943553|NCT03609892|Furazolidone|furazolidone|mesh-list
101943554|NCT03609892|Esomeprazole|esomeprazole|mesh-list
101943556|NCT03609892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101943557|NCT03609892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101943558|NCT03609892|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101943559|NCT03609892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102081169|NCT02306798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101800931|NCT00719693|Calcium, Dietary|calcium, dietary|mesh-list
102081170|NCT02306954|Aldesleukin|aldesleukin|mesh-list
102081171|NCT02306954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102081172|NCT02306954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102081173|NCT02306954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102081174|NCT02306954|Antiviral Agents|antiviral agents|mesh-ancestor
102081175|NCT02306954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102081176|NCT03509714|Ascorbic Acid|ascorbic acid|mesh-list
102081177|NCT03509714|Antioxidants|antioxidants|mesh-ancestor
102081178|NCT03509714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081179|NCT03509714|Protective Agents|protective agents|mesh-ancestor
102081180|NCT03509714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081181|NCT03509714|Vitamins|vitamins|mesh-ancestor
102081182|NCT03509714|Micronutrients|micronutrients|mesh-ancestor
102081183|NCT02302274|Flecainide|flecainide|mesh-list
102081184|NCT02302274|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102081185|NCT02302274|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102081186|NCT02302274|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102081187|NCT02302274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102081188|NCT02302274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081189|NCT02303600|Montelukast|montelukast|mesh-list
102081190|NCT02303600|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102081191|NCT02303600|Respiratory System Agents|respiratory system agents|mesh-ancestor
102081192|NCT02303600|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102081193|NCT02303600|Hormone Antagonists|hormone antagonists|mesh-ancestor
102081194|NCT02303600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102081195|NCT02303600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081196|NCT02303600|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102081197|NCT02303600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102081198|NCT02303600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081199|NCT04463342|Methamphetamine|methamphetamine|mesh-list
102081200|NCT04463342|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102081201|NCT04463342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081202|NCT04463342|Sympathomimetics|sympathomimetics|mesh-ancestor
102081203|NCT04463342|Autonomic Agents|autonomic agents|mesh-ancestor
102081204|NCT04463342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102081205|NCT04463342|Dopamine Agents|dopamine agents|mesh-ancestor
102081206|NCT04463342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102081207|NCT04463342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081208|NCT04463342|Adrenergic Agents|adrenergic agents|mesh-ancestor
102081209|NCT04463342|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101382823|NCT00285376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102081213|NCT02303912|Carboplatin|carboplatin|mesh-list
102081214|NCT02303912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102081215|NCT01597492|Belimumab|belimumab|mesh-list
102081216|NCT01597492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102081217|NCT01597492|Immunologic Factors|immunologic factors|mesh-ancestor
102081218|NCT01597492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081219|NCT04569994|Insulin|insulin|mesh-list
102081220|NCT04569994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102081221|NCT04569994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081222|NCT00109590|Ritonavir|ritonavir|mesh-list
102081223|NCT00109590|Lopinavir|lopinavir|mesh-list
102081224|NCT00109590|Zidovudine|zidovudine|mesh-list
102081225|NCT00109590|Nevirapine|nevirapine|mesh-list
102081226|NCT00109590|Didanosine|didanosine|mesh-list
102081227|NCT00109590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102081228|NCT00109590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102081229|NCT00109590|Protease Inhibitors|protease inhibitors|mesh-ancestor
102081230|NCT00109590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102081231|NCT00109590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943560|NCT03609892|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101943561|NCT03609892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101943562|NCT03609892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943563|NCT03609892|Antacids|antacids|mesh-ancestor
101943564|NCT03609892|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101943565|NCT03609892|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101943566|NCT03609892|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101943567|NCT03609892|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
101943568|NCT03609892|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101943569|NCT03609892|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101943570|NCT03609892|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102081232|NCT00109590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102081233|NCT00109590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102081234|NCT00109590|Antiviral Agents|antiviral agents|mesh-ancestor
102081235|NCT00109590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102081236|NCT00109590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102081237|NCT00109590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102081238|NCT00109590|Antimetabolites|antimetabolites|mesh-ancestor
102081239|NCT00109590|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102081240|NCT00109590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102081241|NCT00109590|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102081242|NCT00109590|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102081243|NCT03507062|Plasma-lyte 148|plasma-lyte 148|mesh-list
102081244|NCT03507062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102081245|NCT03507062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102081247|NCT05243446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102081248|NCT05243446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102081249|NCT05243446|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102081250|NCT05243446|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102081251|NCT05243446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081252|NCT02143362|Remifentanil|remifentanil|mesh-list
102081253|NCT02143362|Anesthetics|anesthetics|mesh-list
102081254|NCT02143362|Propofol|propofol|mesh-list
102081255|NCT02143362|Cisatracurium|cisatracurium|mesh-list
102081256|NCT02143362|Atracurium|atracurium|mesh-list
102081257|NCT02143362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102081258|NCT02143362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081259|NCT02143362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102081260|NCT02143362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102081261|NCT02143362|Anesthetics, General|anesthetics, general|mesh-ancestor
102081262|NCT02143362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102081263|NCT02143362|Narcotics|narcotics|mesh-ancestor
102081264|NCT02143362|Analgesics|analgesics|mesh-ancestor
102081265|NCT02143362|Sensory System Agents|sensory system agents|mesh-ancestor
102081266|NCT02143362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102081267|NCT02143362|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102081268|NCT02143362|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102081269|NCT02143362|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102081270|NCT02143362|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102081271|NCT02143362|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102081272|NCT02143362|Cholinergic Agents|cholinergic agents|mesh-ancestor
102081273|NCT02143362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102081274|NCT02143362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081275|NCT03509324|Insulin Lispro|insulin lispro|mesh-list
102081276|NCT03509324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102081277|NCT03509324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081278|NCT02143440|Insulin|insulin|mesh-list
102081279|NCT02143440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102081280|NCT02143440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081281|NCT02143518|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102081282|NCT02143518|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
102081283|NCT02143518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102081286|NCT02143518|Antacids|antacids|mesh-ancestor
101943571|NCT03609814|Fludarabine|fludarabine|mesh-list
101943572|NCT03609814|Clofarabine|clofarabine|mesh-list
101943573|NCT03609814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101943574|NCT03609814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101943575|NCT03609814|Antimetabolites|antimetabolites|mesh-ancestor
101943576|NCT03609814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943577|NCT02457598|Obinutuzumab|obinutuzumab|mesh-list
101943578|NCT02457598|Idelalisib|idelalisib|mesh-list
101943579|NCT02457598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101308456|NCT02047292|Autonomic Agents|autonomic agents|mesh-ancestor
102081287|NCT02143518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081288|NCT02143518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102081289|NCT03682770|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102081290|NCT03682770|Immunologic Factors|immunologic factors|mesh-ancestor
102081291|NCT03682770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081292|NCT03506828|Phenol|phenol|mesh-list
102081293|NCT03506828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102081294|NCT03506828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102081295|NCT03506828|Disinfectants|disinfectants|mesh-ancestor
102081296|NCT03506828|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102081297|NCT03506828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102081298|NCT00054964|Albuterol|albuterol|mesh-list
102081299|NCT00054964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102081300|NCT00054964|Autonomic Agents|autonomic agents|mesh-ancestor
102081301|NCT00054964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102081302|NCT00054964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081303|NCT00054964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102081304|NCT00054964|Respiratory System Agents|respiratory system agents|mesh-ancestor
102081305|NCT00054964|Tocolytic Agents|tocolytic agents|mesh-ancestor
102081306|NCT00054964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102081307|NCT00054964|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102081308|NCT00054964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102081309|NCT00054964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102081310|NCT00054964|Adrenergic Agents|adrenergic agents|mesh-ancestor
102081311|NCT00054964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102081312|NCT00054964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081313|NCT02781558|Sofosbuvir|sofosbuvir|mesh-list
102081314|NCT02781558|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102081315|NCT02781558|Velpatasvir|velpatasvir|mesh-list
102081316|NCT02781558|Antiviral Agents|antiviral agents|mesh-ancestor
102081317|NCT02781558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102081318|NCT05073640|Pentoxifylline|pentoxifylline|mesh-list
102081319|NCT05073640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102081320|NCT05073640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102081321|NCT05073640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081322|NCT05073640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102081323|NCT05073640|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102081324|NCT05073640|Protective Agents|protective agents|mesh-ancestor
102081325|NCT05073640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081326|NCT05073640|Vasodilator Agents|vasodilator agents|mesh-ancestor
102081327|NCT05073640|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102081328|NCT05073640|Antioxidants|antioxidants|mesh-ancestor
102081329|NCT05073094|Esmolol|esmolol|mesh-list
102081330|NCT05073094|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102081331|NCT05073094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102081332|NCT05073094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102081333|NCT05073094|Adrenergic Agents|adrenergic agents|mesh-ancestor
102081334|NCT05073094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102081335|NCT05073094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081336|NCT05073094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081337|NCT03509246|Doxorubicin|doxorubicin|mesh-list
102081338|NCT03509246|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102081339|NCT03509246|Bortezomib|bortezomib|mesh-list
102081340|NCT03509246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102081341|NCT03509246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101943580|NCT02457598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101943581|NCT02457598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101943582|NCT02457598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943583|NCT02859142|Nicotine|nicotine|mesh-list
101943584|NCT02859142|Varenicline|varenicline|mesh-list
101943585|NCT02859142|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101943586|NCT02859142|Autonomic Agents|autonomic agents|mesh-ancestor
101943587|NCT02859142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101943588|NCT02859142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663425|NCT00638118|Fexofenadine|fexofenadine|mesh-list
101943589|NCT02859142|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101943590|NCT02859142|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101943591|NCT02859142|Cholinergic Agents|cholinergic agents|mesh-ancestor
101943592|NCT02859142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101943593|NCT02859142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943595|NCT03351608|Glycopyrrolate|glycopyrrolate|mesh-list
101943596|NCT03351608|Neostigmine|neostigmine|mesh-list
102081342|NCT03509246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102081343|NCT03509246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102081344|NCT03509246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102081345|NCT03509246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081346|NCT03509168|Misoprostol|misoprostol|mesh-list
102081347|NCT03509168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102081348|NCT03509168|Abortifacient Agents|abortifacient agents|mesh-ancestor
102081349|NCT03509168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102081350|NCT03509168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081351|NCT03509168|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102081352|NCT03509168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102081353|NCT03509168|Oxytocics|oxytocics|mesh-ancestor
102081354|NCT05072938|Nizatidine|nizatidine|mesh-list
102081355|NCT05072938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102081356|NCT05072938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102081359|NCT05072938|Histamine Agents|histamine agents|mesh-ancestor
102081360|NCT05072938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102081361|NCT05072938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081362|NCT05072938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081363|NCT03041311|Carboplatin|carboplatin|mesh-list
102081364|NCT03041311|Etoposide|etoposide|mesh-list
102081365|NCT03041311|Atezolizumab|atezolizumab|mesh-list
102081366|NCT03041311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102081367|NCT03041311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102081368|NCT03041311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102081369|NCT03041311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102081370|NCT03041311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102081371|NCT03041311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081372|NCT03041311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102081373|NCT03041311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102081374|NCT05072860|Tranexamic Acid|tranexamic acid|mesh-list
102081375|NCT05072860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102081376|NCT05072860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102081377|NCT05072860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081378|NCT05072860|Hemostatics|hemostatics|mesh-ancestor
102081379|NCT05072860|Coagulants|coagulants|mesh-ancestor
102081380|NCT02311946|Palbociclib|palbociclib|mesh-list
102081381|NCT02311946|Rabeprazole|rabeprazole|mesh-list
102081382|NCT02311946|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
102081383|NCT02311946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102081384|NCT02311946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101943597|NCT03351608|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101943598|NCT03351608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101943599|NCT03351608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101943600|NCT03351608|Autonomic Agents|autonomic agents|mesh-ancestor
101943601|NCT03351608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101943602|NCT03351608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943603|NCT03351608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101943604|NCT03351608|Respiratory System Agents|respiratory system agents|mesh-ancestor
102081385|NCT02311946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102081386|NCT02311946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081387|NCT02311946|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102081388|NCT02311946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102081389|NCT04302766|Remdesivir|remdesivir|mesh-list
102081390|NCT04302766|Antimetabolites|antimetabolites|mesh-ancestor
102081391|NCT04302766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081392|NCT04302766|Antiviral Agents|antiviral agents|mesh-ancestor
102081393|NCT04302766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102081394|NCT02312102|Lenalidomide|lenalidomide|mesh-list
101801154|NCT00712439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102081395|NCT02312102|Bortezomib|bortezomib|mesh-list
102081396|NCT02312102|Immunologic Factors|immunologic factors|mesh-ancestor
102081397|NCT02312102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081398|NCT02312102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102081399|NCT02312102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102081400|NCT02312102|Growth Substances|growth substances|mesh-ancestor
102081401|NCT02312102|Growth Inhibitors|growth inhibitors|mesh-ancestor
102081402|NCT02312102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102081403|NCT05408221|Lenvatinib|lenvatinib|mesh-list
102081404|NCT05408221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102081405|NCT05408221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102081406|NCT05408221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102081407|NCT05408221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081408|NCT02307968|Insulin|insulin|mesh-list
102081409|NCT02307968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102081410|NCT02307968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081411|NCT02312180|Plasminogen|plasminogen|mesh-list
102081412|NCT02312180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102081413|NCT02312180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102081414|NCT02312180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081415|NCT03504566|Empagliflozin|empagliflozin|mesh-list
102081416|NCT03504566|Linagliptin|linagliptin|mesh-list
102081417|NCT03504566|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
102081418|NCT03504566|Telmisartan|telmisartan|mesh-list
102081419|NCT03504566|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102081420|NCT03504566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081421|NCT03504566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102081422|NCT03504566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081423|NCT03504566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102081424|NCT03504566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102081425|NCT03504566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102081426|NCT03504566|Incretins|incretins|mesh-ancestor
102081427|NCT03504566|Hormones|hormones|mesh-ancestor
101628306|NCT02590705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081431|NCT03504566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102081432|NCT03504566|Anticoagulants|anticoagulants|mesh-ancestor
102081433|NCT03504566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102081434|NCT03504566|Antimetabolites|antimetabolites|mesh-ancestor
102081435|NCT03504566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102081436|NCT03504566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102081437|NCT03504566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102081438|NCT05070520|Lumefantrine|lumefantrine|mesh-list
102081440|NCT05070520|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102081441|NCT05070520|Antimalarials|antimalarials|mesh-ancestor
102081442|NCT05070520|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102081443|NCT05070520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102081444|NCT05070520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102081445|NCT05070598|Paclitaxel|paclitaxel|mesh-list
101943606|NCT03351608|Parasympatholytics|parasympatholytics|mesh-ancestor
102081446|NCT05070598|Tegafur|tegafur|mesh-list
102081447|NCT05070598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102081448|NCT05070598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102081449|NCT05070598|Tubulin Modulators|tubulin modulators|mesh-ancestor
102081450|NCT05070598|Antimitotic Agents|antimitotic agents|mesh-ancestor
102081451|NCT05070598|Mitosis Modulators|mitosis modulators|mesh-ancestor
102081452|NCT05070598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081453|NCT05070598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102081454|NCT05070598|Antimetabolites|antimetabolites|mesh-ancestor
102081455|NCT03884452|Atorvastatin|atorvastatin|mesh-list
102081456|NCT03884452|Simvastatin|simvastatin|mesh-list
102081457|NCT03884452|Ezetimibe|ezetimibe|mesh-list
102081458|NCT03884452|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102081459|NCT03884452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102081460|NCT03884452|Antimetabolites|antimetabolites|mesh-ancestor
102081461|NCT03884452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081462|NCT03884452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102081463|NCT03884452|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102081464|NCT03884452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102081465|NCT03882892|Ezetimibe|ezetimibe|mesh-list
102081466|NCT03882892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102081467|NCT03882892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102081468|NCT03882892|Antimetabolites|antimetabolites|mesh-ancestor
102081469|NCT03882892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081470|NCT03882892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102081471|NCT02305160|Poractant alfa|poractant alfa|mesh-list
102081473|NCT02305160|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
102081474|NCT02305160|Respiratory System Agents|respiratory system agents|mesh-ancestor
102081475|NCT02305394|Ketamine|ketamine|mesh-list
102081476|NCT02305394|Propofol|propofol|mesh-list
102081477|NCT02305394|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102081478|NCT02305394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102081479|NCT02305394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081480|NCT02305394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102081481|NCT02305394|Anesthetics, General|anesthetics, general|mesh-ancestor
102081482|NCT02305394|Anesthetics|anesthetics|mesh-ancestor
102081483|NCT02305394|Analgesics|analgesics|mesh-ancestor
102081484|NCT02305394|Sensory System Agents|sensory system agents|mesh-ancestor
102081485|NCT02305394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102081486|NCT02305394|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102081487|NCT02305394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102081488|NCT02305394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102081489|NCT02305394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102081490|NCT02305394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081491|NCT05068960|Bupivacaine|bupivacaine|mesh-list
102081492|NCT05068960|Anesthetics, Local|anesthetics, local|mesh-ancestor
102081493|NCT05068960|Anesthetics|anesthetics|mesh-ancestor
102081494|NCT05068960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102081495|NCT05068960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081496|NCT05068960|Sensory System Agents|sensory system agents|mesh-ancestor
102081497|NCT05068960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102081498|NCT02305550|Nitric Oxide|nitric oxide|mesh-list
102081499|NCT02305550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101383104|NCT00286936|GABA Agents|gaba agents|mesh-ancestor
102081511|NCT02305550|Gasotransmitters|gasotransmitters|mesh-ancestor
102081512|NCT02305550|Protective Agents|protective agents|mesh-ancestor
102081513|NCT03506516|Ethanol|ethanol|mesh-list
102081514|NCT03506516|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102081515|NCT03506516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102081516|NCT03506516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102081517|NCT03506516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081518|NCT02312492|Palmitic Acid|palmitic acid|mesh-list
102081519|NCT02312492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102081520|NCT02312492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081521|NCT02643394|Acetaminophen|acetaminophen|mesh-list
102081522|NCT02643394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102081523|NCT02643394|Analgesics|analgesics|mesh-ancestor
102081524|NCT02643394|Sensory System Agents|sensory system agents|mesh-ancestor
102081525|NCT02643394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102081526|NCT02643394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081527|NCT02643394|Antipyretics|antipyretics|mesh-ancestor
102081528|NCT03101644|Darunavir|darunavir|mesh-list
102081529|NCT03101644|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101943607|NCT03351608|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101943608|NCT03351608|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101943609|NCT03351608|Cholinergic Agents|cholinergic agents|mesh-ancestor
101943610|NCT03351608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101943611|NCT03351608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943612|NCT03351608|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101308494|NCT00005829|Gemcitabine|gemcitabine|mesh-list
102081530|NCT03101644|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102081531|NCT03101644|Protease Inhibitors|protease inhibitors|mesh-ancestor
102081532|NCT03101644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102081533|NCT03101644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081534|NCT03101644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102081535|NCT03101644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102081536|NCT03101644|Antiviral Agents|antiviral agents|mesh-ancestor
102081537|NCT03101644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102081538|NCT03132272|Autoantibodies|autoantibodies|mesh-list
102081539|NCT03132272|Immunologic Factors|immunologic factors|mesh-ancestor
102081540|NCT03132272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081541|NCT03503786|Paclitaxel|paclitaxel|mesh-list
102081542|NCT03503786|Carboplatin|carboplatin|mesh-list
102081543|NCT03503786|Avelumab|avelumab|mesh-list
102081544|NCT03503786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102081545|NCT03503786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102081546|NCT03503786|Tubulin Modulators|tubulin modulators|mesh-ancestor
102081547|NCT03503786|Antimitotic Agents|antimitotic agents|mesh-ancestor
102081548|NCT03503786|Mitosis Modulators|mitosis modulators|mesh-ancestor
102081549|NCT03503786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081550|NCT03503786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102081551|NCT02308982|Immunoglobulins|immunoglobulins|mesh-list
102081552|NCT02308982|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102081553|NCT02308982|Antibodies|antibodies|mesh-list
102081554|NCT02308982|gamma-Globulins|gamma-globulins|mesh-list
102081555|NCT02308982|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102081556|NCT02308982|Immunologic Factors|immunologic factors|mesh-ancestor
102081557|NCT02308982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081558|NCT05515627|Atezolizumab|atezolizumab|mesh-list
102081559|NCT05515627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102081560|NCT05515627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081561|NCT05515627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101628308|NCT00720343|Lipotropic Agents|lipotropic agents|mesh-ancestor
102081585|NCT02305862|Antimetabolites|antimetabolites|mesh-ancestor
102081586|NCT02305862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081587|NCT02305862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102081588|NCT02305862|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102081589|NCT02305862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102081590|NCT02305940|Doxycycline|doxycycline|mesh-list
102081591|NCT02305940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102081592|NCT02305940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102081593|NCT02305940|Antimalarials|antimalarials|mesh-ancestor
102081594|NCT02305940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102081595|NCT02305940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102081597|NCT02312804|Carboplatin|carboplatin|mesh-list
102081598|NCT02312804|Infigratinib|infigratinib|mesh-list
102081599|NCT02312804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102081600|NCT02312804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102081601|NCT02312804|Tubulin Modulators|tubulin modulators|mesh-ancestor
102081602|NCT02312804|Antimitotic Agents|antimitotic agents|mesh-ancestor
102081603|NCT02312804|Mitosis Modulators|mitosis modulators|mesh-ancestor
102081604|NCT02312804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081605|NCT03099616|Propofol|propofol|mesh-list
102081606|NCT03099616|Desflurane|desflurane|mesh-list
102081607|NCT03099616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102081608|NCT03099616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102081609|NCT03099616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081610|NCT03099616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102081611|NCT03099616|Anesthetics, General|anesthetics, general|mesh-ancestor
102081612|NCT03099616|Anesthetics|anesthetics|mesh-ancestor
102081613|NCT03099616|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101943613|NCT03351608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101943614|NCT03351608|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101943615|NCT03382418|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101943616|NCT03382418|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102081614|NCT04463966|Tranexamic Acid|tranexamic acid|mesh-list
102081617|NCT04463966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081619|NCT04463966|Coagulants|coagulants|mesh-ancestor
102081620|NCT00794248|Fexofenadine|fexofenadine|mesh-list
102081621|NCT00794248|Desloratadine|desloratadine|mesh-list
102081622|NCT00794248|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101801384|NCT02539706|Rocuronium|rocuronium|mesh-list
102081623|NCT00794248|Cholinergic Agents|cholinergic agents|mesh-ancestor
102081624|NCT00794248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102081625|NCT00794248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081626|NCT00794248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081627|NCT00794248|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102081628|NCT00794248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102081629|NCT00794248|Histamine Antagonists|histamine antagonists|mesh-ancestor
102081630|NCT00794248|Histamine Agents|histamine agents|mesh-ancestor
102081631|NCT00794248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102081632|NCT02309450|Asunaprevir|asunaprevir|mesh-list
102081633|NCT02309450|Protease Inhibitors|protease inhibitors|mesh-ancestor
102081634|NCT02309450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102081635|NCT02309450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081637|NCT04475224|Mitosis Modulators|mitosis modulators|mesh-ancestor
102081638|NCT04475224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081639|NCT05370235|Afamelanotide|afamelanotide|mesh-list
102081640|NCT05370235|Dermatologic Agents|dermatologic agents|mesh-ancestor
102081641|NCT00353496|Lanreotide|lanreotide|mesh-list
102081642|NCT00353496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102081643|NCT00389896|Oxymetazoline|oxymetazoline|mesh-list
102081644|NCT00389896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102081645|NCT00389896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102081646|NCT00389896|Adrenergic Agents|adrenergic agents|mesh-ancestor
102081647|NCT00389896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102081648|NCT00389896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081649|NCT00389896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081650|NCT00389896|Sympathomimetics|sympathomimetics|mesh-ancestor
102081651|NCT00389896|Autonomic Agents|autonomic agents|mesh-ancestor
102081652|NCT00389896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102081653|NCT00389896|Nasal Decongestants|nasal decongestants|mesh-ancestor
102081654|NCT00389896|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102081655|NCT00389896|Respiratory System Agents|respiratory system agents|mesh-ancestor
102081656|NCT03388190|Leucovorin|leucovorin|mesh-list
102081657|NCT03388190|Fluorouracil|fluorouracil|mesh-list
102081658|NCT03388190|Oxaliplatin|oxaliplatin|mesh-list
102081659|NCT03388190|Nivolumab|nivolumab|mesh-list
102081660|NCT03388190|Levoleucovorin|levoleucovorin|mesh-list
102081661|NCT03388190|Antimetabolites|antimetabolites|mesh-ancestor
102081662|NCT03388190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081663|NCT03388190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102081664|NCT03388190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102081665|NCT03388190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102081666|NCT03388190|Immunologic Factors|immunologic factors|mesh-ancestor
102081667|NCT03388190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081668|NCT03388190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102081669|NCT03388190|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102081670|NCT03388190|Antidotes|antidotes|mesh-ancestor
102081671|NCT03388190|Protective Agents|protective agents|mesh-ancestor
102081672|NCT03388190|Vitamin B Complex|vitamin b complex|mesh-ancestor
102081673|NCT03388190|Vitamins|vitamins|mesh-ancestor
102081674|NCT03388190|Micronutrients|micronutrients|mesh-ancestor
102081675|NCT02313272|Bevacizumab|bevacizumab|mesh-list
102081676|NCT02313272|Pembrolizumab|pembrolizumab|mesh-list
102081677|NCT02313272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102081678|NCT02313272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102081679|NCT02313272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102081680|NCT02313272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102081681|NCT02313272|Growth Substances|growth substances|mesh-ancestor
102081682|NCT02313272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081683|NCT02313272|Growth Inhibitors|growth inhibitors|mesh-ancestor
102081684|NCT02313272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101943617|NCT03382418|Immunologic Factors|immunologic factors|mesh-ancestor
101704385|NCT02620800|Paclitaxel|paclitaxel|mesh-list
101943618|NCT03382418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943619|NCT03382418|Antacids|antacids|mesh-ancestor
102081685|NCT02313272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081686|NCT03473977|Benralizumab|benralizumab|mesh-list
102081687|NCT03473977|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101383291|NCT00111540|Incretins|incretins|mesh-ancestor
102081690|NCT01361464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102081692|NCT04051255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102081693|NCT04051255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102081694|NCT04051255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102081695|NCT04051255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102081696|NCT03505736|Adenosine|adenosine|mesh-list
102081697|NCT03505736|Regadenoson|regadenoson|mesh-list
102081698|NCT03505736|Analgesics|analgesics|mesh-ancestor
101801455|NCT04920149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102081699|NCT03505736|Sensory System Agents|sensory system agents|mesh-ancestor
102081700|NCT03505736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102081701|NCT03505736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081702|NCT03505736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102081703|NCT03505736|Vasodilator Agents|vasodilator agents|mesh-ancestor
102081704|NCT03505736|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102081705|NCT03505736|Purinergic Agonists|purinergic agonists|mesh-ancestor
102081706|NCT03505736|Purinergic Agents|purinergic agents|mesh-ancestor
102081707|NCT03505736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102081708|NCT03505736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081709|NCT03505736|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
102081710|NCT02316626|Progesterone|progesterone|mesh-list
102081711|NCT02316626|Progestins|progestins|mesh-ancestor
102081712|NCT02316626|Hormones|hormones|mesh-ancestor
102081713|NCT02316626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102081714|NCT02316626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081715|NCT03505502|Tranexamic Acid|tranexamic acid|mesh-list
102081716|NCT03505502|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102081717|NCT03505502|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102081718|NCT03505502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081719|NCT03505502|Hemostatics|hemostatics|mesh-ancestor
102081720|NCT03505502|Coagulants|coagulants|mesh-ancestor
102081721|NCT03977896|Carbon-11 methionine|carbon-11 methionine|mesh-list
102081722|NCT03977896|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102081723|NCT03977896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081724|NCT02316704|Tacrine|tacrine|mesh-list
102081725|NCT02316704|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102081726|NCT02316704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102081727|NCT02316704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081728|NCT02316704|Cholinergic Agents|cholinergic agents|mesh-ancestor
102081729|NCT02316704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102081730|NCT02316704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081731|NCT02316704|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102081732|NCT02316704|Autonomic Agents|autonomic agents|mesh-ancestor
102081733|NCT02316704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101704431|NCT04135014|GABA Agents|gaba agents|mesh-ancestor
102081734|NCT02316704|Nootropic Agents|nootropic agents|mesh-ancestor
102081735|NCT03501680|Insulin|insulin|mesh-list
102081736|NCT03501680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102081737|NCT03501680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081738|NCT02310074|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102081739|NCT02310074|Hormones|hormones|mesh-list
102081740|NCT02310074|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102081741|NCT02310074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102081742|NCT02310074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081743|NCT02310074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102081744|NCT02313584|Dabigatran|dabigatran|mesh-list
102081745|NCT02313584|Antithrombins|antithrombins|mesh-ancestor
102081746|NCT02313584|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102081747|NCT02313584|Protease Inhibitors|protease inhibitors|mesh-ancestor
102081748|NCT02313584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102081749|NCT02313584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081750|NCT02313584|Anticoagulants|anticoagulants|mesh-ancestor
102081751|NCT05063578|Lidocaine|lidocaine|mesh-list
102081752|NCT05063578|Anesthetics, Local|anesthetics, local|mesh-ancestor
102081753|NCT05063578|Anesthetics|anesthetics|mesh-ancestor
102081754|NCT05063578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102081755|NCT05063578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943620|NCT03382418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943621|NCT03382418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101943622|NCT03382262|Triamcinolone|triamcinolone|mesh-list
101943623|NCT03382262|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102081756|NCT05063578|Sensory System Agents|sensory system agents|mesh-ancestor
102081757|NCT05063578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102081758|NCT05063578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102081759|NCT05063578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102081778|NCT05063422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102081779|NCT05063422|Laxatives|laxatives|mesh-ancestor
102081780|NCT05063422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102081781|NCT03782350|Tranexamic Acid|tranexamic acid|mesh-list
102081782|NCT03782350|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102081783|NCT03782350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102081784|NCT03782350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081785|NCT03782350|Hemostatics|hemostatics|mesh-ancestor
102081786|NCT03782350|Coagulants|coagulants|mesh-ancestor
102081787|NCT03098680|Verapamil|verapamil|mesh-list
102081788|NCT03098680|Nicardipine|nicardipine|mesh-list
102081789|NCT03098680|Phentolamine|phentolamine|mesh-list
102081790|NCT03098680|Phenylephrine|phenylephrine|mesh-list
102081791|NCT03098680|Dobutamine|dobutamine|mesh-list
102081792|NCT03098680|Oxymetazoline|oxymetazoline|mesh-list
102081793|NCT03098680|Albuterol|albuterol|mesh-list
102081794|NCT03098680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102081795|NCT03098680|Autonomic Agents|autonomic agents|mesh-ancestor
102081796|NCT03098680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102081797|NCT03098680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081798|NCT03098680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102081799|NCT03098680|Respiratory System Agents|respiratory system agents|mesh-ancestor
102081800|NCT03098680|Tocolytic Agents|tocolytic agents|mesh-ancestor
102081801|NCT03098680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102081802|NCT03098680|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102081803|NCT03098680|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102081804|NCT03098680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102081805|NCT03098680|Adrenergic Agents|adrenergic agents|mesh-ancestor
102081806|NCT03098680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102081807|NCT03098680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081808|NCT03098680|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102081809|NCT03098680|Mydriatics|mydriatics|mesh-ancestor
102081810|NCT03098680|Sympathomimetics|sympathomimetics|mesh-ancestor
102081811|NCT03098680|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102081812|NCT03098680|Nasal Decongestants|nasal decongestants|mesh-ancestor
102081813|NCT03098680|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102081814|NCT03098680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102081815|NCT03098680|Protective Agents|protective agents|mesh-ancestor
102081816|NCT03098680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102081828|NCT03098368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102081829|NCT03098368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081830|NCT03098368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081832|NCT05062486|Resveratrol|resveratrol|mesh-list
102081833|NCT05062486|Quercetin|quercetin|mesh-list
102081834|NCT05062486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102081835|NCT05062486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102081836|NCT05062486|Analgesics|analgesics|mesh-ancestor
102081837|NCT05062486|Sensory System Agents|sensory system agents|mesh-ancestor
102081838|NCT05062486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102081839|NCT05062486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081840|NCT05062486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102081841|NCT05062486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102081842|NCT05062486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102081843|NCT05062486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102081844|NCT05062486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081845|NCT05062486|Antioxidants|antioxidants|mesh-ancestor
102081846|NCT05062486|Protective Agents|protective agents|mesh-ancestor
102081847|NCT05062486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101801616|NCT00894920|Biotin|biotin|mesh-list
102081848|NCT04474600|Propofol|propofol|mesh-list
102081849|NCT04474600|Desflurane|desflurane|mesh-list
102081850|NCT04474600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102081851|NCT04474600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102081852|NCT04474600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943624|NCT03382262|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101943625|NCT03382262|FX006|fx006|mesh-list
101943626|NCT03382262|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101943627|NCT03382262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101943628|NCT03382262|Glucocorticoids|glucocorticoids|mesh-ancestor
101943629|NCT03382262|Hormones|hormones|mesh-ancestor
101308510|NCT00005841|Freund's Adjuvant|freund's adjuvant|mesh-list
102081853|NCT04474600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102081854|NCT04474600|Anesthetics, General|anesthetics, general|mesh-ancestor
102081855|NCT04474600|Anesthetics|anesthetics|mesh-ancestor
102081856|NCT04474600|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102081857|NCT02314208|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
102081858|NCT02314208|Resveratrol|resveratrol|mesh-list
102081859|NCT02314208|Atorvastatin|atorvastatin|mesh-list
102081860|NCT02314208|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102081861|NCT02314208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102081862|NCT02314208|Antimetabolites|antimetabolites|mesh-ancestor
102081863|NCT02314208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081864|NCT02314208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102081865|NCT02314208|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102081866|NCT02314208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102081867|NCT02314208|Antioxidants|antioxidants|mesh-ancestor
102081868|NCT02314208|Protective Agents|protective agents|mesh-ancestor
102081869|NCT02314208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081870|NCT02314208|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102081871|NCT02314208|Cathartics|cathartics|mesh-ancestor
102081872|NCT02314208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102081873|NCT03100318|Dotinurad|dotinurad|mesh-list
102081874|NCT03100318|Benzbromarone|benzbromarone|mesh-list
102081875|NCT03100318|Uricosuric Agents|uricosuric agents|mesh-ancestor
102081876|NCT03100318|Gout Suppressants|gout suppressants|mesh-ancestor
102081877|NCT03100318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102081878|NCT02311010|Tacrolimus|tacrolimus|mesh-list
102081879|NCT02311010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101383491|NCT00078260|Pemetrexed|pemetrexed|mesh-list
102081884|NCT02311010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081885|NCT02314286|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102081886|NCT02314286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102081887|NCT02314286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102081888|NCT02314286|Antimetabolites|antimetabolites|mesh-ancestor
102081889|NCT02314286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081890|NCT02314286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102081891|NCT02314286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102081892|NCT02314286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102081893|NCT03132194|Dapsone|dapsone|mesh-list
102081894|NCT03132194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102081895|NCT03132194|Antimalarials|antimalarials|mesh-ancestor
102081896|NCT03132194|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102081897|NCT03132194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102081898|NCT03132194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102081899|NCT03132194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102081900|NCT03132194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081901|NCT03132194|Leprostatic Agents|leprostatic agents|mesh-ancestor
102081902|NCT03132194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102081903|NCT02311088|Caffeine|caffeine|mesh-list
102081904|NCT02311088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102081905|NCT02311088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081906|NCT02311088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102081907|NCT02311088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102081908|NCT02311088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081909|NCT02311088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102081910|NCT02311088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102081911|NCT02311088|Purinergic Agents|purinergic agents|mesh-ancestor
102081912|NCT02311088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102081913|NCT03501212|Anesthetics|anesthetics|mesh-list
102081914|NCT03501212|Anesthetics, Local|anesthetics, local|mesh-list
102081915|NCT03501212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101704500|NCT00994903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102081916|NCT03501212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081917|NCT03501212|Sensory System Agents|sensory system agents|mesh-ancestor
102081918|NCT03501212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101943630|NCT03382262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101943631|NCT03382262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943632|NCT03382262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101943633|NCT03382262|Immunologic Factors|immunologic factors|mesh-ancestor
102081919|NCT02317484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102081920|NCT02317484|Ipragliflozin|ipragliflozin|mesh-list
102081921|NCT02317484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801691|NCT03476369|Fentanyl|fentanyl|mesh-list
102081922|NCT02317484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102081923|NCT02317484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081925|NCT04435210|Nifedipine|nifedipine|mesh-list
102081926|NCT04435210|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102081927|NCT04435210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102081928|NCT04435210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081929|NCT04435210|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102081930|NCT04435210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081931|NCT04435210|Vasodilator Agents|vasodilator agents|mesh-ancestor
102081932|NCT04435210|Tocolytic Agents|tocolytic agents|mesh-ancestor
102081933|NCT04435210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102081934|NCT04435210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102081935|NCT03501056|Antibodies|antibodies|mesh-list
102081936|NCT03501056|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102081937|NCT03501056|Immunologic Factors|immunologic factors|mesh-ancestor
102081938|NCT03501056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081939|NCT03292146|Denosumab|denosumab|mesh-list
102081940|NCT03292146|Alendronate|alendronate|mesh-list
102081941|NCT03292146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102081942|NCT03292146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081943|NCT02144376|Psyllium|psyllium|mesh-list
102081944|NCT02144376|Cathartics|cathartics|mesh-ancestor
102081945|NCT02144376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102081946|NCT02314754|Misoprostol|misoprostol|mesh-list
102081947|NCT02314754|Mifepristone|mifepristone|mesh-list
102081948|NCT02314754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102081949|NCT02314754|Abortifacient Agents|abortifacient agents|mesh-ancestor
102081951|NCT02314754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081953|NCT02314754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102081954|NCT02314754|Oxytocics|oxytocics|mesh-ancestor
102081955|NCT02314754|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102081956|NCT02314754|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102081957|NCT02314754|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102081958|NCT02314754|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102081959|NCT02314754|Contraceptive Agents|contraceptive agents|mesh-ancestor
102081960|NCT02314754|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102081961|NCT02314754|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102081962|NCT02314754|Hormone Antagonists|hormone antagonists|mesh-ancestor
102081963|NCT02314754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102081964|NCT02314754|Luteolytic Agents|luteolytic agents|mesh-ancestor
102081965|NCT02314754|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102081966|NCT02314754|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102081967|NCT02317640|Testosterone|testosterone|mesh-list
102081968|NCT02317640|Androgens|androgens|mesh-ancestor
102081969|NCT02317640|Hormones|hormones|mesh-ancestor
102081970|NCT02317640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102081971|NCT02317640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081972|NCT02716948|Nivolumab|nivolumab|mesh-list
102081973|NCT02716948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102081974|NCT02716948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102081975|NCT02716948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102081976|NCT02716948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081977|NCT03500900|Vildagliptin|vildagliptin|mesh-list
102081978|NCT03500900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102081979|NCT03500900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081980|NCT03500900|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102081981|NCT03500900|Protease Inhibitors|protease inhibitors|mesh-ancestor
102081982|NCT03500900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102081983|NCT03500900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081984|NCT02144688|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101943634|NCT03382262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101943635|NCT03382262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943636|NCT02236936|Cetuximab|cetuximab|mesh-list
101943637|NCT02236936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101943638|NCT02236936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101943639|NCT03638960|Bupivacaine|bupivacaine|mesh-list
101943640|NCT03638960|Anesthetics, Local|anesthetics, local|mesh-ancestor
101943641|NCT03638960|Anesthetics|anesthetics|mesh-ancestor
101308518|NCT00005850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308520|NCT00005850|Antimetabolites|antimetabolites|mesh-ancestor
102081985|NCT02144688|Antiviral Agents|antiviral agents|mesh-ancestor
102081986|NCT02144688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102081987|NCT02141100|Thioguanine|thioguanine|mesh-list
102081988|NCT02141100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102081989|NCT02141100|Antimetabolites|antimetabolites|mesh-ancestor
102081990|NCT02141100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081991|NCT02141100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102081992|NCT02141178|Bupivacaine|bupivacaine|mesh-list
102081993|NCT02141178|Anesthetics, Local|anesthetics, local|mesh-ancestor
102081994|NCT02141178|Anesthetics|anesthetics|mesh-ancestor
102081995|NCT02141178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102081996|NCT02141178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081997|NCT02141178|Sensory System Agents|sensory system agents|mesh-ancestor
102081998|NCT02141178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102081999|NCT02141412|Dexmedetomidine|dexmedetomidine|mesh-list
102082000|NCT02141412|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102082001|NCT02141412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102082002|NCT02141412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082003|NCT02141412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102082004|NCT02141412|Analgesics|analgesics|mesh-ancestor
102082005|NCT02141412|Sensory System Agents|sensory system agents|mesh-ancestor
102082006|NCT02141412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102082007|NCT02141412|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102082008|NCT02141412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102082009|NCT02141412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102082010|NCT02141412|Adrenergic Agents|adrenergic agents|mesh-ancestor
101704540|NCT00994981|Anesthetics|anesthetics|mesh-ancestor
102082011|NCT02141412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102082012|NCT02141412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082013|NCT04463264|Nitazoxanide|nitazoxanide|mesh-list
102082014|NCT04463264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102082015|NCT04463264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102082016|NCT03210558|Testosterone|testosterone|mesh-list
102082017|NCT03210558|Androgens|androgens|mesh-ancestor
102082018|NCT03210558|Hormones|hormones|mesh-ancestor
102082019|NCT03210558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102082020|NCT03210558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082023|NCT05046262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082025|NCT05036824|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102082026|NCT05036824|Dalteparin|dalteparin|mesh-list
102082027|NCT05036824|Anticoagulants|anticoagulants|mesh-ancestor
102082028|NCT05036824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102082029|NCT05036824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102082030|NCT05036824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082031|NCT04462250|Analgesics, Opioid|analgesics, opioid|mesh-list
102082032|NCT04462250|Narcotics|narcotics|mesh-ancestor
102082033|NCT04462250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102082034|NCT04462250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082035|NCT04462250|Analgesics|analgesics|mesh-ancestor
102082036|NCT04462250|Sensory System Agents|sensory system agents|mesh-ancestor
102082037|NCT04462250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102082038|NCT02144766|Ropivacaine|ropivacaine|mesh-list
102082039|NCT02144766|Anesthetics, Local|anesthetics, local|mesh-ancestor
102082040|NCT02144766|Anesthetics|anesthetics|mesh-ancestor
102082041|NCT02144766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102082042|NCT02144766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943642|NCT03638960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101943643|NCT03638960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943644|NCT03638960|Sensory System Agents|sensory system agents|mesh-ancestor
101943645|NCT03638960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102082043|NCT02144766|Sensory System Agents|sensory system agents|mesh-ancestor
102082044|NCT02144766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102082045|NCT05045248|Apraclonidine|apraclonidine|mesh-list
102082046|NCT05045248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102082047|NCT05045248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102082048|NCT05045248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102082049|NCT05045248|Adrenergic Agents|adrenergic agents|mesh-ancestor
102082050|NCT05045248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102082051|NCT05045248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082052|NCT05045248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082053|NCT02144922|Pitavastatin|pitavastatin|mesh-list
102082054|NCT02144922|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102082055|NCT02144922|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102082056|NCT02144922|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102082057|NCT02144922|Antimetabolites|antimetabolites|mesh-ancestor
102082058|NCT02144922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082059|NCT02144922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102082060|NCT02144922|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102082061|NCT02261064|Amlodipine|amlodipine|mesh-list
102082062|NCT02261064|Telmisartan|telmisartan|mesh-list
102082063|NCT02261064|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
102082064|NCT02261064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102082065|NCT02261064|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102082066|NCT02261064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102082067|NCT02261064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801832|NCT00724529|Infliximab|infliximab|mesh-list
102082068|NCT02261064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102082069|NCT02261064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082070|NCT02261064|Vasodilator Agents|vasodilator agents|mesh-ancestor
102082071|NCT02261064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102082072|NCT02261064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102082073|NCT02955966|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102082074|NCT02955966|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102082075|NCT02955966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082076|NCT05035498|Phenylephrine|phenylephrine|mesh-list
102082077|NCT05035498|Oxymetazoline|oxymetazoline|mesh-list
102082078|NCT05035498|Norepinephrine|norepinephrine|mesh-list
102082079|NCT05035498|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
102082080|NCT05035498|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102082081|NCT05035498|Mydriatics|mydriatics|mesh-ancestor
102082082|NCT05035498|Autonomic Agents|autonomic agents|mesh-ancestor
102082083|NCT05035498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102082084|NCT05035498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082085|NCT05035498|Sympathomimetics|sympathomimetics|mesh-ancestor
102082086|NCT05035498|Nasal Decongestants|nasal decongestants|mesh-ancestor
102082087|NCT05035498|Respiratory System Agents|respiratory system agents|mesh-ancestor
102082088|NCT05035498|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102082089|NCT05035498|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102082090|NCT05035498|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102082091|NCT05035498|Adrenergic Agents|adrenergic agents|mesh-ancestor
102082093|NCT05035498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082095|NCT03498326|Celecoxib|celecoxib|mesh-list
102082096|NCT03498326|Gemcitabine|gemcitabine|mesh-list
102082097|NCT03498326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102082098|NCT03498326|Antimetabolites|antimetabolites|mesh-ancestor
102082099|NCT03498326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082100|NCT03498326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102082101|NCT03498326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102082102|NCT03498326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102082103|NCT03498326|Analgesics|analgesics|mesh-ancestor
102082104|NCT03498326|Sensory System Agents|sensory system agents|mesh-ancestor
102082105|NCT03498326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102082106|NCT03498326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943648|NCT02259790|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
101943649|NCT02259790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101452712|NCT00409994|Sirolimus|sirolimus|mesh-list
102082107|NCT03498326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102082108|NCT03498326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102082109|NCT03498326|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102082110|NCT03498326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102082111|NCT03498326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102082112|NCT03498248|Lenograstim|lenograstim|mesh-list
102082113|NCT03498248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102082114|NCT03498248|Immunologic Factors|immunologic factors|mesh-ancestor
102082115|NCT03498248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082116|NCT01360996|Contraceptive Agents|contraceptive agents|mesh-list
102082117|NCT01360996|Contraceptives, Oral|contraceptives, oral|mesh-list
102082118|NCT01360996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102082119|NCT01360996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082120|NCT01360996|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102082121|NCT03498170|Itraconazole|itraconazole|mesh-list
102082122|NCT03498170|Acumapimod|acumapimod|mesh-list
102082123|NCT03498170|Antifungal Agents|antifungal agents|mesh-ancestor
101704569|NCT01000441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102082124|NCT03498170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102082125|NCT03498170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102082126|NCT03498170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102082127|NCT03498170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102082128|NCT03498170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082129|NCT03498170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102082130|NCT03498170|Hormone Antagonists|hormone antagonists|mesh-ancestor
102082131|NCT03498170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102082132|NCT03498170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082133|NCT03498170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102082134|NCT03498170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102082135|NCT05055544|Fosfomycin|fosfomycin|mesh-list
102082136|NCT05055544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102082137|NCT05055544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102082138|NCT03498092|Dexmedetomidine|dexmedetomidine|mesh-list
102082139|NCT03498092|Bupivacaine|bupivacaine|mesh-list
102082140|NCT03498092|Anesthetics, Local|anesthetics, local|mesh-ancestor
102082141|NCT03498092|Anesthetics|anesthetics|mesh-ancestor
102082142|NCT03498092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102082143|NCT03498092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082144|NCT03498092|Sensory System Agents|sensory system agents|mesh-ancestor
102082145|NCT03498092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102082146|NCT03498092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102082147|NCT03498092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102082148|NCT03498092|Analgesics|analgesics|mesh-ancestor
102082149|NCT03498092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102082150|NCT03498092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102082151|NCT03498092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102082152|NCT03498092|Adrenergic Agents|adrenergic agents|mesh-ancestor
102082153|NCT03498092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102082154|NCT03498092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082155|NCT03500432|Lidocaine|lidocaine|mesh-list
102082156|NCT03500432|Anesthetics, Local|anesthetics, local|mesh-ancestor
102082157|NCT03500432|Anesthetics|anesthetics|mesh-ancestor
102082158|NCT03500432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102082159|NCT03500432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082160|NCT03500432|Sensory System Agents|sensory system agents|mesh-ancestor
102082161|NCT03500432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102082162|NCT03500432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101628309|NCT00720343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102082165|NCT03500432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102082166|NCT03500432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082167|NCT01951885|Mycophenolic Acid|mycophenolic acid|mesh-list
102082168|NCT01951885|Methotrexate|methotrexate|mesh-list
102082169|NCT01951885|Tacrolimus|tacrolimus|mesh-list
102082170|NCT01951885|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102082171|NCT01951885|Abortifacient Agents|abortifacient agents|mesh-ancestor
102082172|NCT01951885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102082173|NCT01951885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943650|NCT02259790|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101943651|NCT02259790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101943652|NCT02259790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943653|NCT02259790|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101943654|NCT02259790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943655|NCT02259790|Vasodilator Agents|vasodilator agents|mesh-ancestor
102082174|NCT01951885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102082175|NCT01951885|Antimetabolites|antimetabolites|mesh-ancestor
102082176|NCT01951885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082177|NCT01951885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102082178|NCT01951885|Dermatologic Agents|dermatologic agents|mesh-ancestor
102082179|NCT01951885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102082180|NCT01951885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102082181|NCT01951885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102082182|NCT01951885|Immunologic Factors|immunologic factors|mesh-ancestor
102082183|NCT01951885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102082184|NCT01951885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102082185|NCT01951885|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102082186|NCT01951885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102082187|NCT01951885|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102082188|NCT01951885|Antitubercular Agents|antitubercular agents|mesh-ancestor
102082189|NCT01951885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102082190|NCT01951885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102082191|NCT02315690|Piperaquine|piperaquine|mesh-list
102082192|NCT02315690|Artenimol|artenimol|mesh-list
102082193|NCT02315690|Antimalarials|antimalarials|mesh-ancestor
102082194|NCT02315690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102082195|NCT02315690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102082196|NCT02315690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102082197|NCT02639338|Sofosbuvir|sofosbuvir|mesh-list
102082198|NCT02639338|Velpatasvir|velpatasvir|mesh-list
102082199|NCT02639338|Antiviral Agents|antiviral agents|mesh-ancestor
102082200|NCT02639338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102082201|NCT01754857|Rituximab|rituximab|mesh-list
102082202|NCT01754857|Lenalidomide|lenalidomide|mesh-list
102082203|NCT01754857|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102082204|NCT01754857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102082205|NCT01754857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102082206|NCT01754857|Immunologic Factors|immunologic factors|mesh-ancestor
102082207|NCT01754857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082208|NCT01754857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102082209|NCT01754857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102082210|NCT01754857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102082211|NCT01754857|Growth Substances|growth substances|mesh-ancestor
102082212|NCT01754857|Growth Inhibitors|growth inhibitors|mesh-ancestor
102082213|NCT01754857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102082214|NCT01754857|Alkylating Agents|alkylating agents|mesh-ancestor
101801982|NCT02539316|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102082215|NCT01754857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082216|NCT03497702|Cyclophosphamide|cyclophosphamide|mesh-list
102082217|NCT03497702|Docetaxel|docetaxel|mesh-list
102082218|NCT03497702|Doxorubicin|doxorubicin|mesh-list
102082219|NCT03497702|Letrozole|letrozole|mesh-list
102082220|NCT03497702|Leuprolide|leuprolide|mesh-list
102082221|NCT03497702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102082222|NCT03497702|Immunologic Factors|immunologic factors|mesh-ancestor
102082223|NCT03497702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082224|NCT03497702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102082225|NCT03497702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102082226|NCT03497702|Alkylating Agents|alkylating agents|mesh-ancestor
102082227|NCT03497702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082228|NCT03497702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102082229|NCT03497702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102082230|NCT03497702|Tubulin Modulators|tubulin modulators|mesh-ancestor
102082231|NCT03497702|Antimitotic Agents|antimitotic agents|mesh-ancestor
102082232|NCT03497702|Mitosis Modulators|mitosis modulators|mesh-ancestor
102082233|NCT03497702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102082234|NCT03497702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101943656|NCT02259790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101452886|NCT00204776|Capecitabine|capecitabine|mesh-list
102082235|NCT03497702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102082238|NCT03497702|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102082239|NCT03497702|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102082240|NCT03497702|Hormone Antagonists|hormone antagonists|mesh-ancestor
102082241|NCT03497702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102082242|NCT03497702|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102082244|NCT03497702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102082245|NCT03497702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102082246|NCT02900352|Zonisamide|zonisamide|mesh-list
102082247|NCT02900352|Anticonvulsants|anticonvulsants|mesh-ancestor
102082248|NCT02900352|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102082249|NCT02900352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102082250|NCT02900352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082251|NCT02900352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102082252|NCT02900352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082253|NCT05034406|Lidocaine|lidocaine|mesh-list
102082254|NCT05034406|Levobupivacaine|levobupivacaine|mesh-list
102082255|NCT05034406|Anesthetics, Local|anesthetics, local|mesh-ancestor
102082256|NCT05034406|Anesthetics|anesthetics|mesh-ancestor
102082257|NCT05034406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102082258|NCT05034406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082259|NCT05034406|Sensory System Agents|sensory system agents|mesh-ancestor
102082260|NCT05034406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102082261|NCT05034406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102082262|NCT05034406|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102082263|NCT05034406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102082264|NCT05034406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102082265|NCT05034406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082266|NCT02254668|Mycophenolic Acid|mycophenolic acid|mesh-list
102082267|NCT02254668|Everolimus|everolimus|mesh-list
102082268|NCT02254668|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102082269|NCT02254668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102082270|NCT02254668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102082271|NCT02254668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082272|NCT02254668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102082273|NCT02254668|Immunologic Factors|immunologic factors|mesh-ancestor
102082274|NCT02254668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082275|NCT02254668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102082276|NCT02254668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102082277|NCT02254668|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102082278|NCT02254668|Antitubercular Agents|antitubercular agents|mesh-ancestor
102082279|NCT02254668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102082280|NCT02254668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102082281|NCT03095404|Lidocaine|lidocaine|mesh-list
102082282|NCT03095404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102082283|NCT03095404|Anesthetics, Local|anesthetics, local|mesh-ancestor
102082284|NCT03095404|Anesthetics|anesthetics|mesh-ancestor
102082285|NCT03095404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102082286|NCT03095404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082287|NCT03095404|Sensory System Agents|sensory system agents|mesh-ancestor
102082288|NCT03095404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102082289|NCT03095404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102082290|NCT03095404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102082291|NCT03095404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102082292|NCT03095404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102082293|NCT03095404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082294|NCT02145546|Amiodarone|amiodarone|mesh-list
102082295|NCT02145546|Sotalol|sotalol|mesh-list
102082296|NCT02145546|Propafenone|propafenone|mesh-list
102082297|NCT02145546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102082298|NCT02145546|Vasodilator Agents|vasodilator agents|mesh-ancestor
102082299|NCT02145546|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102082300|NCT02145546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102082301|NCT02145546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082302|NCT02145546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102082303|NCT02145546|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102082304|NCT02145546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102082305|NCT02145546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101943658|NCT02857270|Paclitaxel|paclitaxel|mesh-list
101943659|NCT02857270|Gemcitabine|gemcitabine|mesh-list
101943660|NCT02857270|Cetuximab|cetuximab|mesh-list
101943661|NCT02857270|Midazolam|midazolam|mesh-list
102082316|NCT02145546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102082317|NCT02145546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102082319|NCT03039673|Riluzole|riluzole|mesh-list
102082320|NCT03039673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102082321|NCT03039673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102082322|NCT03039673|Analgesics|analgesics|mesh-ancestor
102082323|NCT03039673|Sensory System Agents|sensory system agents|mesh-ancestor
102082324|NCT03039673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102082325|NCT03039673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082326|NCT03039673|Anticonvulsants|anticonvulsants|mesh-ancestor
102082327|NCT03039673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102082328|NCT03039673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102082329|NCT03039673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102082330|NCT03039673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082331|NCT03039673|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102082332|NCT03039673|Protective Agents|protective agents|mesh-ancestor
102082333|NCT02145624|Vaccines|vaccines|mesh-list
102082334|NCT02145624|Immunologic Factors|immunologic factors|mesh-ancestor
102082335|NCT02145624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082336|NCT02321384|Ritonavir|ritonavir|mesh-list
102082337|NCT02321384|Midazolam|midazolam|mesh-list
102082338|NCT02321384|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102082339|NCT02321384|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102082340|NCT02321384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102082341|NCT02321384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082342|NCT02321384|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102082343|NCT02321384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102082344|NCT02321384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102082345|NCT02321384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102082346|NCT02321384|Anesthetics, General|anesthetics, general|mesh-ancestor
102082347|NCT02321384|Anesthetics|anesthetics|mesh-ancestor
102082348|NCT02321384|GABA Modulators|gaba modulators|mesh-ancestor
102082349|NCT02321384|GABA Agents|gaba agents|mesh-ancestor
102082350|NCT02321384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102082351|NCT02321384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082352|NCT02321384|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102082353|NCT02321384|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102082354|NCT02321384|Protease Inhibitors|protease inhibitors|mesh-ancestor
102082355|NCT02321384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102082356|NCT02321384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102082357|NCT02321384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102082358|NCT02321384|Antiviral Agents|antiviral agents|mesh-ancestor
102082359|NCT02321384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102082360|NCT02321384|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102082361|NCT02321384|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101802130|NCT00725777|Artemether|artemether|mesh-list
102082362|NCT03095326|Zinc|zinc|mesh-list
102082363|NCT03095326|Zinc Sulfate|zinc sulfate|mesh-list
102082364|NCT03095326|Vaccines|vaccines|mesh-list
102082365|NCT03095326|Immunologic Factors|immunologic factors|mesh-ancestor
102082366|NCT03095326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082367|NCT03095326|Trace Elements|trace elements|mesh-ancestor
102082368|NCT03095326|Micronutrients|micronutrients|mesh-ancestor
102082369|NCT03095326|Astringents|astringents|mesh-ancestor
102082382|NCT03500120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082383|NCT03500120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102082384|NCT03500120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102082385|NCT02141958|Fenretinide|fenretinide|mesh-list
102082386|NCT02141958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102082387|NCT02141958|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102082388|NCT02141958|Protective Agents|protective agents|mesh-ancestor
102082389|NCT02141958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082390|NCT02142036|Trastuzumab|trastuzumab|mesh-list
102082391|NCT02142036|Cetuximab|cetuximab|mesh-list
102082392|NCT02142036|Panitumumab|panitumumab|mesh-list
102082393|NCT02142036|Everolimus|everolimus|mesh-list
102082394|NCT02142036|Sunitinib|sunitinib|mesh-list
102082395|NCT02142036|Dasatinib|dasatinib|mesh-list
102082396|NCT02142036|Lapatinib|lapatinib|mesh-list
102082397|NCT02142036|Gefitinib|gefitinib|mesh-list
102082398|NCT02142036|Temsirolimus|temsirolimus|mesh-list
101943662|NCT02857270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101943663|NCT02857270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101943664|NCT02857270|Tubulin Modulators|tubulin modulators|mesh-ancestor
102082399|NCT02142036|Afatinib|afatinib|mesh-list
102082400|NCT02142036|Vemurafenib|vemurafenib|mesh-list
102082401|NCT02142036|Dabrafenib|dabrafenib|mesh-list
102082402|NCT02142036|Crizotinib|crizotinib|mesh-list
102082403|NCT02142036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102082404|NCT02142036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102082405|NCT02142036|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102082406|NCT02142036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102082407|NCT02142036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102082408|NCT02142036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082409|NCT02142036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102082410|NCT02142036|Immunologic Factors|immunologic factors|mesh-ancestor
102082411|NCT02142036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082412|NCT02142036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102082413|NCT02142036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102082414|NCT02142036|Growth Substances|growth substances|mesh-ancestor
102082415|NCT02142036|Growth Inhibitors|growth inhibitors|mesh-ancestor
102082416|NCT05053594|Neostigmine|neostigmine|mesh-list
102082417|NCT05053594|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102082418|NCT05053594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102082419|NCT05053594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082420|NCT05053594|Cholinergic Agents|cholinergic agents|mesh-ancestor
102082421|NCT05053594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102082422|NCT05053594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082423|NCT05053594|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102082424|NCT05053594|Autonomic Agents|autonomic agents|mesh-ancestor
102082425|NCT05053594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102082426|NCT02318888|Icodextrin|icodextrin|mesh-list
102082427|NCT02318888|Dialysis Solutions|dialysis solutions|mesh-ancestor
102082428|NCT02318888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102082429|NCT02142192|Natalizumab|natalizumab|mesh-list
102082430|NCT02142192|Immunologic Factors|immunologic factors|mesh-ancestor
102082431|NCT02142192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082432|NCT02324582|Pembrolizumab|pembrolizumab|mesh-list
102082433|NCT02324582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102082434|NCT02324582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102082435|NCT02324582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102082448|NCT02777190|Oxytocics|oxytocics|mesh-ancestor
102082449|NCT03494426|Pregabalin|pregabalin|mesh-list
102082450|NCT03494426|Tramadol|tramadol|mesh-list
102082451|NCT03494426|Antidepressive Agents|antidepressive agents|mesh-list
102082452|NCT03494426|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
102082453|NCT03494426|Analgesics|analgesics|mesh-ancestor
102082454|NCT03494426|Sensory System Agents|sensory system agents|mesh-ancestor
102082455|NCT03494426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102082456|NCT03494426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082457|NCT03494426|Anticonvulsants|anticonvulsants|mesh-ancestor
102082458|NCT03494426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102082459|NCT03494426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102082460|NCT03494426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082461|NCT03494426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102082462|NCT03494426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102082463|NCT03494426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102082464|NCT03494426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102082465|NCT03494426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102082466|NCT03494426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102082467|NCT03494426|Narcotics|narcotics|mesh-ancestor
102082468|NCT02432209|Orlistat|orlistat|mesh-list
102082469|NCT02432209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102082470|NCT02432209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082471|NCT02432209|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102082472|NCT02432209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102082473|NCT00108732|Metronidazole|metronidazole|mesh-list
102082474|NCT00108732|Goserelin|goserelin|mesh-list
102082475|NCT00108732|Bicalutamide|bicalutamide|mesh-list
102082476|NCT00108732|Vaccines|vaccines|mesh-list
102082477|NCT00108732|Sargramostim|sargramostim|mesh-list
102082478|NCT00108732|Immunologic Factors|immunologic factors|mesh-ancestor
102082479|NCT00108732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082480|NCT00108732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102082481|NCT00108732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101943665|NCT02857270|Antimitotic Agents|antimitotic agents|mesh-ancestor
101943666|NCT02857270|Mitosis Modulators|mitosis modulators|mesh-ancestor
101943667|NCT02857270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082482|NCT00108732|Androgen Antagonists|androgen antagonists|mesh-ancestor
102082483|NCT00108732|Hormone Antagonists|hormone antagonists|mesh-ancestor
102082484|NCT00108732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102082485|NCT00108732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102082486|NCT00108732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102082487|NCT00108732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102082488|NCT00108732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102082490|NCT02319200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102082491|NCT02319200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082492|NCT02319278|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102082493|NCT02319278|Hematinics|hematinics|mesh-ancestor
102082494|NCT02319278|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102082495|NCT02319278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102082496|NCT02324738|Piperaquine|piperaquine|mesh-list
102082497|NCT02324738|Artenimol|artenimol|mesh-list
102082498|NCT02324738|Mefloquine|mefloquine|mesh-list
102082499|NCT02324738|Antimalarials|antimalarials|mesh-ancestor
102082500|NCT02324738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102082530|NCT02716038|Carboplatin|carboplatin|mesh-list
102082531|NCT02716038|Atezolizumab|atezolizumab|mesh-list
102082532|NCT02716038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102082533|NCT02716038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102082534|NCT02716038|Tubulin Modulators|tubulin modulators|mesh-ancestor
102082535|NCT02716038|Antimitotic Agents|antimitotic agents|mesh-ancestor
102082536|NCT02716038|Mitosis Modulators|mitosis modulators|mesh-ancestor
102082537|NCT02716038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082538|NCT02716038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102082539|NCT02716038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102082540|NCT02325050|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
102082541|NCT02325050|Antiviral Agents|antiviral agents|mesh-ancestor
102082542|NCT02325050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102082543|NCT03544710|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
102082544|NCT03544710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102082547|NCT02322008|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102082548|NCT02322008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102082549|NCT02322008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102082550|NCT02322008|Dermatologic Agents|dermatologic agents|mesh-ancestor
102082551|NCT02322008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102082553|NCT02647554|Trypsin Inhibitors|trypsin inhibitors|mesh-list
102082554|NCT02647554|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102082555|NCT02647554|Protease Inhibitors|protease inhibitors|mesh-ancestor
102082556|NCT02647554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102082557|NCT02647554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082558|NCT03499730|Midazolam|midazolam|mesh-list
102082559|NCT03499730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102082560|NCT03499730|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102082561|NCT03499730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102082562|NCT03499730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082563|NCT03499730|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102082564|NCT03499730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102082565|NCT03499730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102082566|NCT03499730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102082567|NCT03499730|Anesthetics, General|anesthetics, general|mesh-ancestor
102082568|NCT03499730|Anesthetics|anesthetics|mesh-ancestor
102082569|NCT03499730|GABA Modulators|gaba modulators|mesh-ancestor
102082570|NCT03499730|GABA Agents|gaba agents|mesh-ancestor
102082571|NCT03499730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102082572|NCT03499730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082573|NCT02143050|Metformin|metformin|mesh-list
102082574|NCT02143050|Trametinib|trametinib|mesh-list
102082575|NCT02143050|Dabrafenib|dabrafenib|mesh-list
102082576|NCT02143050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102082577|NCT02143050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082578|NCT02143050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102082579|NCT02143050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102082580|NCT02143050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102082581|NCT02143050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082582|NCT02325206|Dapagliflozin|dapagliflozin|mesh-list
101943668|NCT02857270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101943669|NCT02857270|Antimetabolites|antimetabolites|mesh-ancestor
101943670|NCT02857270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102082583|NCT02325206|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102082584|NCT02325206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082585|NCT02325206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102082586|NCT02325206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082587|NCT02325362|Miglustat|miglustat|mesh-list
102082588|NCT02325362|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
102082589|NCT02325362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102082590|NCT02325362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082591|NCT02325362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102082592|NCT02325362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102082593|NCT02325362|Antiviral Agents|antiviral agents|mesh-ancestor
102082594|NCT02325362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102082595|NCT02325362|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102082596|NCT02325362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102082597|NCT02325362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082598|NCT04462094|Ketamine|ketamine|mesh-list
102082599|NCT04462094|Anesthetics|anesthetics|mesh-ancestor
102082600|NCT04462094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102082601|NCT04462094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082602|NCT04462094|Analgesics|analgesics|mesh-ancestor
102082603|NCT04462094|Sensory System Agents|sensory system agents|mesh-ancestor
102082604|NCT04462094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102082605|NCT04462094|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102082606|NCT04462094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102082607|NCT04462094|Anesthetics, General|anesthetics, general|mesh-ancestor
102082608|NCT04462094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102082609|NCT04462094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102082610|NCT04462094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102082611|NCT04462094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082612|NCT02325440|Natalizumab|natalizumab|mesh-list
102082613|NCT02325440|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102082614|NCT02325440|Immunologic Factors|immunologic factors|mesh-ancestor
102082615|NCT02325440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082616|NCT02325440|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102082617|NCT02325440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082636|NCT03499106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082637|NCT03499106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102082638|NCT03499106|Hormone Antagonists|hormone antagonists|mesh-ancestor
102082639|NCT03499106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102082640|NCT03499106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082641|NCT03499106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102082642|NCT03499106|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102082643|NCT03499106|Enzyme Activators|enzyme activators|mesh-ancestor
102082644|NCT03499106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102082645|NCT02146638|Fentanyl|fentanyl|mesh-list
102082646|NCT02146638|Morphine|morphine|mesh-list
102082647|NCT02146638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102082648|NCT02146638|Narcotics|narcotics|mesh-ancestor
102082649|NCT02146638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102082650|NCT02146638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082651|NCT02146638|Analgesics|analgesics|mesh-ancestor
102082652|NCT02146638|Sensory System Agents|sensory system agents|mesh-ancestor
102082653|NCT02146638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102082654|NCT02146638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102082655|NCT02146638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102082656|NCT02146638|Anesthetics, General|anesthetics, general|mesh-ancestor
102082657|NCT02146638|Anesthetics|anesthetics|mesh-ancestor
102082658|NCT02320448|Cisplatin|cisplatin|mesh-list
102082659|NCT02320448|Doxorubicin|doxorubicin|mesh-list
102082660|NCT02320448|Oxaliplatin|oxaliplatin|mesh-list
102082661|NCT02320448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102082662|NCT02320448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102082663|NCT02320448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102082664|NCT02320448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102082665|NCT02320448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102082666|NCT02320448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082667|NCT02320604|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101943671|NCT02857270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101943672|NCT02857270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101943673|NCT02857270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943674|NCT02857270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101943675|NCT02857270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102082668|NCT02320604|Antifungal Agents|antifungal agents|mesh-ancestor
102082669|NCT02320604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102082670|NCT02320604|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102082671|NCT02320604|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102082672|NCT03493568|Dolutegravir|dolutegravir|mesh-list
102082673|NCT03493568|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102082674|NCT03493568|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102082675|NCT03493568|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102082676|NCT03493568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102082690|NCT01366638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102082692|NCT02147808|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102082693|NCT02147808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102082694|NCT02147808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102082695|NCT02147808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082696|NCT02147808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102082697|NCT02147808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102082698|NCT02147808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102082699|NCT02147808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102082700|NCT02147808|Anesthetics, General|anesthetics, general|mesh-ancestor
102082701|NCT02147808|Anesthetics|anesthetics|mesh-ancestor
102082702|NCT02147808|GABA Modulators|gaba modulators|mesh-ancestor
102082703|NCT02147808|GABA Agents|gaba agents|mesh-ancestor
102082704|NCT02147808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102082705|NCT02147808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082706|NCT03543072|Diphosphonates|diphosphonates|mesh-list
102082707|NCT03543072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102082708|NCT03543072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082709|NCT02147964|Ketoconazole|ketoconazole|mesh-list
102082710|NCT02147964|Methyltestosterone|methyltestosterone|mesh-list
102082711|NCT02147964|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102082712|NCT02147964|Testosterone|testosterone|mesh-list
102082713|NCT02147964|Testosterone undecanoate|testosterone undecanoate|mesh-list
102082714|NCT02147964|Testosterone enanthate|testosterone enanthate|mesh-list
102082715|NCT02147964|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102082716|NCT02147964|Dutasteride|dutasteride|mesh-list
102082717|NCT02147964|Acyline|acyline|mesh-list
102082718|NCT02147964|Androgens|androgens|mesh-ancestor
102082719|NCT02147964|Hormones|hormones|mesh-ancestor
102082720|NCT02147964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102082721|NCT02147964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082722|NCT02147964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102082723|NCT02147964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102082724|NCT02147964|Anabolic Agents|anabolic agents|mesh-ancestor
102082725|NCT02147964|Antifungal Agents|antifungal agents|mesh-ancestor
102082726|NCT02147964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102082727|NCT02147964|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102082728|NCT02147964|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102082729|NCT02147964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102082730|NCT02147964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082731|NCT02147964|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102082732|NCT02147964|Hormone Antagonists|hormone antagonists|mesh-ancestor
102082733|NCT02147964|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101704772|NCT02714231|Antiemetics|antiemetics|mesh-ancestor
102082734|NCT02147964|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102082735|NCT02147964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102082736|NCT02780700|Capecitabine|capecitabine|mesh-list
102082737|NCT02780700|Nintedanib|nintedanib|mesh-list
102082738|NCT02780700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102082739|NCT02780700|Antimetabolites|antimetabolites|mesh-ancestor
102082745|NCT02147262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102082746|NCT02147262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102082747|NCT02147262|Antimalarials|antimalarials|mesh-ancestor
102082748|NCT02147262|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102082749|NCT02147262|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102082750|NCT02447276|Fasinumab|fasinumab|mesh-list
102082751|NCT02447276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101943676|NCT02857270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101943677|NCT02857270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101943678|NCT02857270|Anesthetics, General|anesthetics, general|mesh-ancestor
101943679|NCT02857270|Anesthetics|anesthetics|mesh-ancestor
102082752|NCT02447276|Analgesics|analgesics|mesh-ancestor
102082753|NCT02447276|Sensory System Agents|sensory system agents|mesh-ancestor
102082754|NCT02447276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102082755|NCT02447276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082756|NCT05100134|Ceritinib|ceritinib|mesh-list
102082757|NCT05100134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102082758|NCT05100134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102082759|NCT05100134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102082760|NCT05100134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082761|NCT05079620|Amoxicillin|amoxicillin|mesh-list
102082762|NCT05079620|Vancomycin|vancomycin|mesh-list
102082763|NCT05079620|Levofloxacin|levofloxacin|mesh-list
102082764|NCT05079620|Ceftriaxone|ceftriaxone|mesh-list
102082765|NCT05079620|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102082766|NCT05079620|Clavulanic Acids|clavulanic acids|mesh-list
102082767|NCT05079620|Clavulanic Acid|clavulanic acid|mesh-list
102082768|NCT05079620|Cefepime|cefepime|mesh-list
102082769|NCT05079620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102082770|NCT05079620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102082771|NCT05079620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102082772|NCT05079620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102082773|NCT05079620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102082774|NCT05079620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102082775|NCT05079620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082776|NCT05079620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102082777|NCT05079620|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102082778|NCT05079620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102082779|NCT05079620|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102082780|NCT02323412|Amoxicillin|amoxicillin|mesh-list
102082781|NCT02323412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102082782|NCT02323412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102082783|NCT04537910|Bamlanivimab|bamlanivimab|mesh-list
102082784|NCT04537910|Antiviral Agents|antiviral agents|mesh-ancestor
102082785|NCT04537910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102082786|NCT03109730|Tenofovir|tenofovir|mesh-list
102082787|NCT03109730|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102082788|NCT03109730|Entecavir|entecavir|mesh-list
102082789|NCT03109730|Antiviral Agents|antiviral agents|mesh-ancestor
102082790|NCT03109730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102082791|NCT03109730|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102082792|NCT03109730|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102082793|NCT03109730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102082794|NCT03109730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082795|NCT03109730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102082796|NCT03109730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102082797|NCT03495206|Edaravone|edaravone|mesh-list
102082798|NCT03495206|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102082799|NCT03495206|Antioxidants|antioxidants|mesh-ancestor
102082800|NCT03495206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082801|NCT03495206|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102082802|NCT03495206|Protective Agents|protective agents|mesh-ancestor
102082803|NCT03495206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082804|NCT04223024|Nimotuzumab|nimotuzumab|mesh-list
102082805|NCT04223024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102082806|NCT04223024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102082807|NCT03491696|Metyrapone|metyrapone|mesh-list
102082808|NCT03491696|Antimetabolites|antimetabolites|mesh-ancestor
101628310|NCT00720343|Antimetabolites|antimetabolites|mesh-ancestor
102082813|NCT03492866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102082814|NCT03492866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102082815|NCT03492866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102082816|NCT03492866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082817|NCT03492710|Immunoglobulins|immunoglobulins|mesh-list
102082818|NCT03492710|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102082819|NCT03492710|Antibodies|antibodies|mesh-list
102082820|NCT03492710|Immunologic Factors|immunologic factors|mesh-ancestor
102082821|NCT03492710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082822|NCT03954938|Cocaine|cocaine|mesh-list
102082823|NCT03954938|Anesthetics, Local|anesthetics, local|mesh-ancestor
102082824|NCT03954938|Anesthetics|anesthetics|mesh-ancestor
101943680|NCT02857270|GABA Modulators|gaba modulators|mesh-ancestor
101943681|NCT02857270|GABA Agents|gaba agents|mesh-ancestor
101943682|NCT02857270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101943683|NCT02857270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101943684|NCT03609190|Ketamine|ketamine|mesh-list
101943685|NCT03609190|Analgesics|analgesics|mesh-ancestor
102082825|NCT03954938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102082826|NCT03954938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082827|NCT03954938|Sensory System Agents|sensory system agents|mesh-ancestor
102082828|NCT03954938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102082829|NCT03954938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102082830|NCT03954938|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102082831|NCT03954938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102082832|NCT03954938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102082833|NCT03954938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082834|NCT03954938|Dopamine Agents|dopamine agents|mesh-ancestor
102082835|NCT03954938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102082836|NCT02148120|Beclomethasone|beclomethasone|mesh-list
102082837|NCT02148120|Formoterol Fumarate|formoterol fumarate|mesh-list
102082838|NCT02148120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102082839|NCT02148120|Autonomic Agents|autonomic agents|mesh-ancestor
102082840|NCT02148120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102082841|NCT02148120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082842|NCT02148120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102082843|NCT02148120|Respiratory System Agents|respiratory system agents|mesh-ancestor
102082844|NCT02148120|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102082845|NCT02148120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102082846|NCT02148120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102082847|NCT02148120|Adrenergic Agents|adrenergic agents|mesh-ancestor
102082848|NCT02148120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102082849|NCT02148120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082850|NCT02148120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102082851|NCT02148120|Glucocorticoids|glucocorticoids|mesh-ancestor
102082852|NCT02148120|Hormones|hormones|mesh-ancestor
101704806|NCT05167513|Metformin|metformin|mesh-list
102082853|NCT02148120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102082854|NCT03492632|Hormones|hormones|mesh-list
102082855|NCT03492632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102082856|NCT03492632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082857|NCT02147574|Antidiarrheals|antidiarrheals|mesh-list
102082858|NCT02147574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102082859|NCT02147730|Anesthetics|anesthetics|mesh-list
102082860|NCT02147730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102082861|NCT02147730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082862|NCT02151630|Salicylic Acid|salicylic acid|mesh-list
102082863|NCT02151630|Salicylates|salicylates|mesh-list
102082864|NCT02151630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102082865|NCT02151630|Antifungal Agents|antifungal agents|mesh-ancestor
102082866|NCT02151630|Keratolytic Agents|keratolytic agents|mesh-ancestor
102082867|NCT02151630|Dermatologic Agents|dermatologic agents|mesh-ancestor
102082868|NCT02151630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102082869|NCT02151630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102082870|NCT02151630|Analgesics|analgesics|mesh-ancestor
102082871|NCT02151630|Sensory System Agents|sensory system agents|mesh-ancestor
102082872|NCT02151630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102082873|NCT02151630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082874|NCT02151630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102082875|NCT02151630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102082876|NCT02151630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102082877|NCT02151630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384497|NCT00086463|Iloprost|iloprost|mesh-list
102082890|NCT03490058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102082891|NCT03490058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082892|NCT03490058|Antiviral Agents|antiviral agents|mesh-ancestor
102082893|NCT03490058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102082894|NCT03490058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102082895|NCT03490058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102082896|NCT02148432|Dexmedetomidine|dexmedetomidine|mesh-list
102082897|NCT02148432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101943686|NCT03609190|Sensory System Agents|sensory system agents|mesh-ancestor
101943687|NCT03609190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101943688|NCT03609190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943689|NCT03609190|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102082898|NCT02148432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102082899|NCT02148432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082900|NCT02148432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102082901|NCT02148432|Analgesics|analgesics|mesh-ancestor
102082902|NCT02148432|Sensory System Agents|sensory system agents|mesh-ancestor
102082903|NCT02148432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102082904|NCT02148432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102082905|NCT02148432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102082906|NCT02148432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102082907|NCT02148432|Adrenergic Agents|adrenergic agents|mesh-ancestor
102082908|NCT02148432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102082909|NCT02148432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082910|NCT03756961|Lidocaine|lidocaine|mesh-list
102082911|NCT03756961|Dexmedetomidine|dexmedetomidine|mesh-list
102082912|NCT03756961|Remifentanil|remifentanil|mesh-list
102082913|NCT03756961|Oxycodone|oxycodone|mesh-list
102082914|NCT03756961|Propofol|propofol|mesh-list
102082915|NCT03756961|Desflurane|desflurane|mesh-list
102082916|NCT03756961|Esketamine|esketamine|mesh-list
102082917|NCT03756961|Anesthetics, Local|anesthetics, local|mesh-ancestor
102082918|NCT03756961|Anesthetics|anesthetics|mesh-ancestor
102082919|NCT03756961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102082920|NCT03756961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082921|NCT03756961|Sensory System Agents|sensory system agents|mesh-ancestor
102082922|NCT03756961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102082923|NCT03756961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102082924|NCT03756961|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102082925|NCT03756961|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102082926|NCT03756961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102082927|NCT03756961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082928|NCT03756961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102082929|NCT03756961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102082930|NCT03756961|Analgesics|analgesics|mesh-ancestor
102082931|NCT03756961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102082932|NCT03756961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102082933|NCT03756961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102082934|NCT03756961|Adrenergic Agents|adrenergic agents|mesh-ancestor
102082935|NCT03756961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102082936|NCT03756961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102082937|NCT03756961|Anesthetics, General|anesthetics, general|mesh-ancestor
102082958|NCT05033314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082959|NCT05033314|Anticoagulants|anticoagulants|mesh-ancestor
102082961|NCT03504423|Folic Acid|folic acid|mesh-list
102082962|NCT03504423|Oxaliplatin|oxaliplatin|mesh-list
102082963|NCT03504423|Irinotecan|irinotecan|mesh-list
102082964|NCT03504423|Folfirinox|folfirinox|mesh-list
102082965|NCT03504423|Levoleucovorin|levoleucovorin|mesh-list
101802742|NCT02538926|Hormones|hormones|mesh-ancestor
102082966|NCT03504423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102082967|NCT03504423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102082968|NCT03504423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102082969|NCT03504423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102082970|NCT03504423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082972|NCT03504423|Protective Agents|protective agents|mesh-ancestor
102082973|NCT03504423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082974|NCT03504423|Vitamin B Complex|vitamin b complex|mesh-ancestor
102082975|NCT03504423|Vitamins|vitamins|mesh-ancestor
102082976|NCT03504423|Micronutrients|micronutrients|mesh-ancestor
102082977|NCT03504423|Hematinics|hematinics|mesh-ancestor
102082978|NCT03097198|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102082979|NCT03097198|Tropicamide|tropicamide|mesh-list
102082980|NCT03097198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102082981|NCT03097198|Mydriatics|mydriatics|mesh-ancestor
102082982|NCT03097198|Autonomic Agents|autonomic agents|mesh-ancestor
102082983|NCT03097198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102082984|NCT03097198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082985|NCT03097198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102082986|NCT03097198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101943690|NCT03609190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102082987|NCT03097198|Cholinergic Agents|cholinergic agents|mesh-ancestor
102082988|NCT03097198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102082989|NCT03097198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082990|NCT02770248|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102082991|NCT02770248|Brinzolamide|brinzolamide|mesh-list
102082992|NCT02770248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102082993|NCT02770248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102082994|NCT02770248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102082995|NCT02770248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102082996|NCT02770248|Adrenergic Agents|adrenergic agents|mesh-ancestor
101285416|NCT01935310|Imiquimod|imiquimod|mesh-list
102083003|NCT03619005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102083004|NCT03619005|Immunologic Factors|immunologic factors|mesh-ancestor
102083005|NCT03619005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083006|NCT02686346|Etoposide|etoposide|mesh-list
102083007|NCT02686346|Ifosfamide|ifosfamide|mesh-list
102083008|NCT02686346|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102083009|NCT02686346|Carboplatin|carboplatin|mesh-list
102083010|NCT02686346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102083011|NCT02686346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102083012|NCT02686346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102083013|NCT02686346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102083014|NCT02686346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083015|NCT02686346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704867|NCT00998101|Carboplatin|carboplatin|mesh-list
102083016|NCT02686346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102083017|NCT02686346|Alkylating Agents|alkylating agents|mesh-ancestor
102083018|NCT02686346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102083019|NCT02686346|Immunotoxins|immunotoxins|mesh-ancestor
102083020|NCT02686346|Immunoconjugates|immunoconjugates|mesh-ancestor
102083021|NCT02686346|Immunologic Factors|immunologic factors|mesh-ancestor
102083022|NCT02686346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083023|NCT03489044|Levetiracetam|levetiracetam|mesh-list
102083024|NCT03489044|Anticonvulsants|anticonvulsants|mesh-ancestor
102083025|NCT03489044|Nootropic Agents|nootropic agents|mesh-ancestor
102083026|NCT01344369|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102083027|NCT01344369|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102083028|NCT01344369|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102083029|NCT01344369|Norethindrone|norethindrone|mesh-list
102083030|NCT01344369|Norethindrone Acetate|norethindrone acetate|mesh-list
102083031|NCT01344369|Estradiol|estradiol|mesh-list
102083032|NCT01344369|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102083033|NCT01344369|Estrogens|estrogens|mesh-ancestor
102083034|NCT01344369|Hormones|hormones|mesh-ancestor
102083035|NCT01344369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102083036|NCT01344369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083037|NCT01344369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102083038|NCT01344369|Contraceptive Agents|contraceptive agents|mesh-ancestor
102083039|NCT01344369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102083040|NCT01344369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102083041|NCT01344369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102083042|NCT01344369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102083043|NCT01344369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101802811|NCT04018703|Midazolam|midazolam|mesh-list
102083044|NCT03491072|Fentanyl|fentanyl|mesh-list
102083045|NCT03491072|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102083047|NCT03491072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102083048|NCT03491072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083049|NCT03491072|Analgesics|analgesics|mesh-ancestor
102083050|NCT03491072|Sensory System Agents|sensory system agents|mesh-ancestor
102083051|NCT03491072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102083052|NCT03491072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102083053|NCT03491072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102083054|NCT03491072|Anesthetics, General|anesthetics, general|mesh-ancestor
102083055|NCT03491072|Anesthetics|anesthetics|mesh-ancestor
102083056|NCT03503409|Ivosidenib|ivosidenib|mesh-list
102083057|NCT03503409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102083058|NCT03503409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083059|NCT03503409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083060|NCT03490994|Warfarin|warfarin|mesh-list
102083061|NCT03490994|Rivaroxaban|rivaroxaban|mesh-list
102083062|NCT03490994|Anticoagulants|anticoagulants|mesh-ancestor
102083063|NCT03490994|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102083064|NCT03490994|Antithrombins|antithrombins|mesh-ancestor
102083065|NCT03490994|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102083066|NCT03490994|Protease Inhibitors|protease inhibitors|mesh-ancestor
101943691|NCT03609190|Anesthetics, General|anesthetics, general|mesh-ancestor
101943692|NCT03609190|Anesthetics|anesthetics|mesh-ancestor
101943693|NCT03609190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101943694|NCT03609190|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101943695|NCT03609190|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101308575|NCT00005871|Rubitecan|rubitecan|mesh-list
102083067|NCT03490994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083068|NCT03490994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083069|NCT01360762|Pentamidine|pentamidine|mesh-list
102083070|NCT01360762|Antifungal Agents|antifungal agents|mesh-ancestor
102083071|NCT01360762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102083072|NCT01360762|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102083073|NCT01360762|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102083074|NCT01360762|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102083075|NCT04382924|Ifenprodil|ifenprodil|mesh-list
102083076|NCT04382924|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102083077|NCT04382924|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102083078|NCT04382924|Adrenergic Agents|adrenergic agents|mesh-ancestor
102083083|NCT04382924|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102083084|NCT04382924|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102083086|NCT00002601|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102083087|NCT00002601|Melphalan|melphalan|mesh-list
102083088|NCT00002601|Ifosfamide|ifosfamide|mesh-list
102083089|NCT00002601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102083090|NCT00002601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102083091|NCT00002601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102083092|NCT00002601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102083093|NCT00002601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083094|NCT00002601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083095|NCT00002601|Immunologic Factors|immunologic factors|mesh-ancestor
102083096|NCT00002601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083097|NCT00002601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102083098|NCT00002601|Alkylating Agents|alkylating agents|mesh-ancestor
102083099|NCT00002601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102083100|NCT00002601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102083101|NCT05033704|Plasma protein fraction|plasma protein fraction|mesh-list
102083102|NCT05033704|Plasma Substitutes|plasma substitutes|mesh-ancestor
102083103|NCT05033704|Blood Substitutes|blood substitutes|mesh-ancestor
102083104|NCT05693077|Vancomycin|vancomycin|mesh-list
102083105|NCT05693077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102083106|NCT05693077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102083107|NCT02031861|Nifedipine|nifedipine|mesh-list
102083108|NCT02031861|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102083109|NCT02031861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102083110|NCT02031861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083111|NCT02031861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102083112|NCT02031861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083113|NCT02031861|Vasodilator Agents|vasodilator agents|mesh-ancestor
102083114|NCT02031861|Tocolytic Agents|tocolytic agents|mesh-ancestor
102083115|NCT02031861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102083116|NCT03455439|Rivaroxaban|rivaroxaban|mesh-list
101802879|NCT00738569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083117|NCT03455439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102083118|NCT03455439|Antithrombins|antithrombins|mesh-ancestor
102083119|NCT03455439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102083120|NCT03455439|Protease Inhibitors|protease inhibitors|mesh-ancestor
102083121|NCT03455439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083122|NCT03455439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083123|NCT03455439|Anticoagulants|anticoagulants|mesh-ancestor
102083124|NCT02645474|Ropivacaine|ropivacaine|mesh-list
102083125|NCT02645474|Anesthetics, Local|anesthetics, local|mesh-ancestor
102083126|NCT02645474|Anesthetics|anesthetics|mesh-ancestor
102083127|NCT02645474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102083128|NCT02645474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083129|NCT02645474|Sensory System Agents|sensory system agents|mesh-ancestor
102083130|NCT02645474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102083131|NCT05052814|Chlorhexidine|chlorhexidine|mesh-list
102083132|NCT05052814|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102083133|NCT05052814|Root Canal Irrigants|root canal irrigants|mesh-list
102083134|NCT05052814|Calcium|calcium|mesh-list
101943696|NCT03609190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101943697|NCT03609190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943699|NCT02856880|Trace Elements|trace elements|mesh-ancestor
101943700|NCT02856880|Micronutrients|micronutrients|mesh-ancestor
101943701|NCT02856880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943702|NCT02856802|Sumatriptan|sumatriptan|mesh-list
102083135|NCT05052814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102083136|NCT05052814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083137|NCT05052814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102083138|NCT05052814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102083139|NCT05052814|Disinfectants|disinfectants|mesh-ancestor
102083140|NCT05052814|Dermatologic Agents|dermatologic agents|mesh-ancestor
102083141|NCT05052814|Dental Disinfectants|dental disinfectants|mesh-ancestor
102083142|NCT03615417|Anesthetics|anesthetics|mesh-list
102083143|NCT03615417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102083144|NCT03615417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083145|NCT02155530|Atorvastatin|atorvastatin|mesh-list
102083146|NCT02155530|Pravastatin|pravastatin|mesh-list
102083147|NCT02155530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102083152|NCT02155530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102083153|NCT02155530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083154|NCT05051956|Palbociclib|palbociclib|mesh-list
102083155|NCT05051956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102083156|NCT05051956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102083157|NCT05051956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083158|NCT05051956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083159|NCT02769624|Treprostinil|treprostinil|mesh-list
102083160|NCT02769624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102083161|NCT03543774|Simvastatin|simvastatin|mesh-list
102083162|NCT03543774|Ezetimibe|ezetimibe|mesh-list
102083163|NCT03543774|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
102083164|NCT03543774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102083165|NCT03543774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102083166|NCT03543774|Antimetabolites|antimetabolites|mesh-ancestor
102083167|NCT03543774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083168|NCT03543774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102083169|NCT03543774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102083170|NCT03543774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083171|NCT03261830|Clindamycin|clindamycin|mesh-list
102083172|NCT03261830|Clindamycin palmitate|clindamycin palmitate|mesh-list
102083173|NCT03261830|Clindamycin phosphate|clindamycin phosphate|mesh-list
102083174|NCT03261830|Cefazolin|cefazolin|mesh-list
102083175|NCT03261830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102083176|NCT03261830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102083177|NCT03261830|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102083178|NCT03261830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083179|NCT03261830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083180|NCT02152176|Morphine|morphine|mesh-list
102083181|NCT02152176|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102083182|NCT02152176|Narcotics|narcotics|mesh-ancestor
102083183|NCT02152176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102083184|NCT02152176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083185|NCT02152176|Analgesics|analgesics|mesh-ancestor
102083186|NCT02152176|Sensory System Agents|sensory system agents|mesh-ancestor
102083187|NCT02152176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102083188|NCT03617055|Cystatins|cystatins|mesh-list
102083189|NCT03617055|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
102083190|NCT03617055|Protease Inhibitors|protease inhibitors|mesh-ancestor
102083191|NCT03617055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083192|NCT03617055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083193|NCT03488888|Bupivacaine|bupivacaine|mesh-list
102083194|NCT03488888|Anesthetics, Local|anesthetics, local|mesh-ancestor
102083195|NCT03488888|Anesthetics|anesthetics|mesh-ancestor
102083196|NCT03488888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102083197|NCT03488888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083198|NCT03488888|Sensory System Agents|sensory system agents|mesh-ancestor
102083199|NCT03488888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101943703|NCT02856802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101943704|NCT02856802|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101943705|NCT02856802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101943706|NCT02856802|Serotonin Agents|serotonin agents|mesh-ancestor
102083200|NCT05031676|Analgesics, Opioid|analgesics, opioid|mesh-list
102083201|NCT05031676|Anesthetics|anesthetics|mesh-list
102083202|NCT05031676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102083203|NCT05031676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083204|NCT05031676|Narcotics|narcotics|mesh-ancestor
102083205|NCT05031676|Analgesics|analgesics|mesh-ancestor
102083206|NCT05031676|Sensory System Agents|sensory system agents|mesh-ancestor
102083207|NCT05031676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102083208|NCT03488810|Hormones|hormones|mesh-list
102083209|NCT03488810|Androgens|androgens|mesh-list
102083210|NCT03488810|Androgen Antagonists|androgen antagonists|mesh-list
102083211|NCT03488810|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
102083212|NCT03488810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102083213|NCT03488810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083214|NCT03488810|Hormone Antagonists|hormone antagonists|mesh-ancestor
102083215|NCT03492242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102083216|NCT03492242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384833|NCT00086970|Ifosfamide|ifosfamide|mesh-list
102083222|NCT03572283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102083223|NCT03572283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083224|NCT03572283|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102083225|NCT03572283|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102083226|NCT03572283|Cholinergic Agents|cholinergic agents|mesh-ancestor
102083227|NCT03572283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102083228|NCT03572283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083229|NCT02254824|Atorvastatin|atorvastatin|mesh-list
102083230|NCT02254824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102083231|NCT02254824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102083232|NCT02254824|Antimetabolites|antimetabolites|mesh-ancestor
102083233|NCT02254824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083234|NCT02254824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102083235|NCT02254824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102083236|NCT02254824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083237|NCT01525316|Lactoferrin|lactoferrin|mesh-list
102083238|NCT01525316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102083239|NCT01673386|Sunitinib|sunitinib|mesh-list
102083240|NCT01673386|Tivozanib|tivozanib|mesh-list
102083241|NCT01673386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102083242|NCT01673386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102083243|NCT01673386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102083244|NCT01673386|Growth Substances|growth substances|mesh-ancestor
102083245|NCT01673386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083246|NCT01673386|Growth Inhibitors|growth inhibitors|mesh-ancestor
102083247|NCT01673386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102083248|NCT01673386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083249|NCT01673386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083250|NCT00103740|Vitamin D|vitamin d|mesh-list
102083251|NCT00103740|Zoledronic Acid|zoledronic acid|mesh-list
102083252|NCT00103740|Risedronic Acid|risedronic acid|mesh-list
102083253|NCT00103740|Etidronic Acid|etidronic acid|mesh-list
102083254|NCT00103740|Calcium|calcium|mesh-list
102083255|NCT00103740|Vitamins|vitamins|mesh-ancestor
102083256|NCT00103740|Micronutrients|micronutrients|mesh-ancestor
102083257|NCT00103740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083258|NCT00103740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102083259|NCT00103740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102083260|NCT00103740|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102083261|NCT00103740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102083262|NCT00103740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083263|NCT03616509|Hormones|hormones|mesh-list
102083264|NCT03616509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102083265|NCT03616509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083266|NCT02869893|Secretin|secretin|mesh-list
102083267|NCT02869893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102083268|NCT02869893|Hormones|hormones|mesh-ancestor
102083269|NCT02869893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101943707|NCT02856802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101943708|NCT02856802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943709|NCT02856802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083270|NCT02869893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083272|NCT02152332|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102083273|NCT02152332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102083274|NCT02152332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102083275|NCT02152332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102083276|NCT02152332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102083277|NCT02152332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083278|NCT02152332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083279|NCT02152332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102083280|NCT02152332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102083281|NCT02152332|Contraceptive Agents|contraceptive agents|mesh-ancestor
102083282|NCT02152332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102083283|NCT02152332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083284|NCT02152332|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101384907|NCT00306319|Moxifloxacin|moxifloxacin|mesh-list
102083289|NCT03617289|Magnesium Sulfate|magnesium sulfate|mesh-list
102083290|NCT03617289|Analgesics|analgesics|mesh-ancestor
102083291|NCT03617289|Sensory System Agents|sensory system agents|mesh-ancestor
102083292|NCT03617289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102083293|NCT03617289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083294|NCT03617289|Anesthetics|anesthetics|mesh-ancestor
102083295|NCT03617289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102083296|NCT03617289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102083297|NCT03617289|Anticonvulsants|anticonvulsants|mesh-ancestor
102083298|NCT03617289|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102083299|NCT03617289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102083300|NCT03617289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083301|NCT03617289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102083302|NCT03617289|Tocolytic Agents|tocolytic agents|mesh-ancestor
102083303|NCT03617289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102083304|NCT02152410|Morphine|morphine|mesh-list
102083305|NCT02152410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102083306|NCT02152410|Narcotics|narcotics|mesh-ancestor
102083307|NCT02152410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102083308|NCT02152410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083309|NCT02152410|Analgesics|analgesics|mesh-ancestor
102083310|NCT02152410|Sensory System Agents|sensory system agents|mesh-ancestor
102083311|NCT02152410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102083312|NCT05043688|Paclitaxel|paclitaxel|mesh-list
102083313|NCT05043688|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102083314|NCT05043688|Carboplatin|carboplatin|mesh-list
102083315|NCT05043688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102083316|NCT05043688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102083317|NCT05043688|Tubulin Modulators|tubulin modulators|mesh-ancestor
102083318|NCT05043688|Antimitotic Agents|antimitotic agents|mesh-ancestor
102083319|NCT05043688|Mitosis Modulators|mitosis modulators|mesh-ancestor
102083320|NCT05043688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083321|NCT03614715|Interferons|interferons|mesh-list
102083322|NCT03614715|Interferon-beta|interferon-beta|mesh-list
102083323|NCT03614715|Interferon beta-1a|interferon beta-1a|mesh-list
102083324|NCT03614715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102083325|NCT03614715|Antiviral Agents|antiviral agents|mesh-ancestor
102083326|NCT03614715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102083327|NCT03614715|Immunologic Factors|immunologic factors|mesh-ancestor
102083328|NCT03614715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083329|NCT03614715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102083330|NCT00363038|Vitamins|vitamins|mesh-list
102083331|NCT00363038|Vitamin K|vitamin k|mesh-list
102083332|NCT00363038|Vitamin A|vitamin a|mesh-list
102083333|NCT00363038|Petrolatum|petrolatum|mesh-list
102083334|NCT00363038|Micronutrients|micronutrients|mesh-ancestor
102083335|NCT00363038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083336|NCT00363038|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101705095|NCT02636348|Vitamin D|vitamin d|mesh-list
102083337|NCT00363038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102083338|NCT00363038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083339|NCT00363038|Hemostatics|hemostatics|mesh-ancestor
102083340|NCT00363038|Coagulants|coagulants|mesh-ancestor
102083341|NCT00363038|Emollients|emollients|mesh-ancestor
101943710|NCT03381248|Hyaluronic Acid|hyaluronic acid|mesh-list
101943711|NCT03381248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101943712|NCT03381248|Immunologic Factors|immunologic factors|mesh-ancestor
101943713|NCT03381248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308592|NCT00005877|Rubitecan|rubitecan|mesh-list
102083342|NCT00363038|Dermatologic Agents|dermatologic agents|mesh-ancestor
102083343|NCT03489668|Metformin|metformin|mesh-list
102083344|NCT03489668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102083345|NCT03489668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083346|NCT02872311|Vaccines|vaccines|mesh-list
102083348|NCT02872311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083349|NCT03614403|Vitamin D|vitamin d|mesh-list
102083350|NCT03614403|Cholecalciferol|cholecalciferol|mesh-list
102083351|NCT03614403|Vitamins|vitamins|mesh-ancestor
102083352|NCT03614403|Micronutrients|micronutrients|mesh-ancestor
102083353|NCT03614403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083354|NCT03614403|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102083355|NCT03614403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102083356|NCT03488186|Lansoprazole|lansoprazole|mesh-list
102083357|NCT03488186|Dexlansoprazole|dexlansoprazole|mesh-list
102083358|NCT03488186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102083359|NCT03488186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102083360|NCT03488186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102083364|NCT05103644|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102083365|NCT05103644|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102083366|NCT05103644|Antimetabolites|antimetabolites|mesh-ancestor
102083367|NCT05103644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083368|NCT05103644|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102083369|NCT05103644|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102083370|NCT05103644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083371|NCT03887624|Ethosuximide|ethosuximide|mesh-list
102083372|NCT03887624|Escitalopram|escitalopram|mesh-list
102083373|NCT03887624|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102083374|NCT03887624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102083375|NCT03887624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102083376|NCT03887624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083377|NCT03887624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102083378|NCT03887624|Serotonin Agents|serotonin agents|mesh-ancestor
102083379|NCT03887624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083380|NCT03887624|Anticonvulsants|anticonvulsants|mesh-ancestor
102083381|NCT02446028|Insulin Lispro|insulin lispro|mesh-list
102083382|NCT02446028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102083383|NCT02446028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083384|NCT03485846|Ritonavir|ritonavir|mesh-list
102083385|NCT03485846|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102083386|NCT03485846|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102083387|NCT03485846|Protease Inhibitors|protease inhibitors|mesh-ancestor
102083388|NCT03485846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083389|NCT03485846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083390|NCT03485846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102083391|NCT03485846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102083392|NCT03485846|Antiviral Agents|antiviral agents|mesh-ancestor
102083393|NCT03485846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102083394|NCT03485846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102083395|NCT03485846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102083396|NCT02032095|Immunoglobulins|immunoglobulins|mesh-list
102083397|NCT02032095|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102083398|NCT02032095|gamma-Globulins|gamma-globulins|mesh-list
102083399|NCT02032095|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102083400|NCT02032095|Immunologic Factors|immunologic factors|mesh-ancestor
102083401|NCT02032095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083402|NCT03613857|Clopidogrel|clopidogrel|mesh-list
102083403|NCT03613857|Ticagrelor|ticagrelor|mesh-list
102083404|NCT03613857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102083405|NCT03613857|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102083406|NCT03613857|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102083407|NCT03613857|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102083408|NCT03613857|Purinergic Agents|purinergic agents|mesh-ancestor
102083409|NCT03613857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102083410|NCT03613857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943714|NCT03381248|Viscosupplements|viscosupplements|mesh-ancestor
101943715|NCT03381248|Protective Agents|protective agents|mesh-ancestor
101943716|NCT02024230|Warfarin|warfarin|mesh-list
101943717|NCT02024230|Rivaroxaban|rivaroxaban|mesh-list
102083411|NCT03613857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083412|NCT03613389|Vitamin E|vitamin e|mesh-list
102083413|NCT03613389|Vitamins|vitamins|mesh-ancestor
102083414|NCT03613389|Micronutrients|micronutrients|mesh-ancestor
102083415|NCT03613389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083416|NCT03613389|Antioxidants|antioxidants|mesh-ancestor
102083417|NCT03613389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083418|NCT03613389|Protective Agents|protective agents|mesh-ancestor
102083419|NCT03614013|Immunomodulating Agents|immunomodulating agents|mesh-list
102083420|NCT03614013|Immunologic Factors|immunologic factors|mesh-ancestor
102083422|NCT02259777|Amlodipine|amlodipine|mesh-list
102083423|NCT02259777|Telmisartan|telmisartan|mesh-list
102083424|NCT02259777|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
102083425|NCT02259777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102083426|NCT02259777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102083427|NCT02259777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102083428|NCT02259777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083429|NCT02259777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102083430|NCT02259777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385050|NCT00301951|Sargramostim|sargramostim|mesh-list
102083436|NCT03261375|Nifedipine|nifedipine|mesh-list
102083437|NCT03261375|Diuretics|diuretics|mesh-ancestor
102083438|NCT03261375|Natriuretic Agents|natriuretic agents|mesh-ancestor
102083439|NCT03261375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083440|NCT03261375|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102083441|NCT03261375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102083442|NCT03261375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083443|NCT03261375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102083444|NCT03261375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102083445|NCT03261375|Vasodilator Agents|vasodilator agents|mesh-ancestor
102083446|NCT03261375|Tocolytic Agents|tocolytic agents|mesh-ancestor
102083447|NCT03261375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102083448|NCT03613545|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102083449|NCT03613545|Rifaximin|rifaximin|mesh-list
102083450|NCT03613545|Antidepressive Agents|antidepressive agents|mesh-list
102083451|NCT03613545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102083452|NCT03613545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102083453|NCT03613545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102083454|NCT01361308|Paroxetine|paroxetine|mesh-list
102083455|NCT01361308|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102083456|NCT01361308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102083457|NCT01361308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102083458|NCT01361308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083459|NCT01361308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102083460|NCT01361308|Serotonin Agents|serotonin agents|mesh-ancestor
102083461|NCT01361308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083462|NCT01361308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102083463|NCT01361308|Antidepressive Agents|antidepressive agents|mesh-ancestor
102083464|NCT01361308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102083465|NCT01361308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102083466|NCT01361308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102083467|NCT01361308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083468|NCT05043142|Antibodies|antibodies|mesh-list
102083469|NCT05043142|Immunologic Factors|immunologic factors|mesh-ancestor
102083470|NCT05043142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083471|NCT03612297|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102083472|NCT03612297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102083473|NCT02872935|Glycopyrrolate|glycopyrrolate|mesh-list
102083474|NCT02872935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102083475|NCT02872935|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102083476|NCT02872935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102083477|NCT02872935|Cholinergic Agents|cholinergic agents|mesh-ancestor
102083478|NCT02872935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102083479|NCT02872935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083480|NCT02872935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083481|NCT00103662|Plerixafor|plerixafor|mesh-list
102083482|NCT00103662|Lenograstim|lenograstim|mesh-list
102083483|NCT00103662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101943719|NCT02024230|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101943720|NCT02024230|Antithrombins|antithrombins|mesh-ancestor
101943721|NCT02024230|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102083484|NCT00103662|Immunologic Factors|immunologic factors|mesh-ancestor
102083485|NCT00103662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083486|NCT00103662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102083487|NCT00103662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102083488|NCT00103662|Antiviral Agents|antiviral agents|mesh-ancestor
102083489|NCT00103662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102083490|NCT03612219|Apatinib|apatinib|mesh-list
102083491|NCT03612219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101705166|NCT02713139|Hormone Antagonists|hormone antagonists|mesh-ancestor
102083492|NCT03612219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102083493|NCT03612219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083494|NCT03612219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083495|NCT05030116|Domperidone|domperidone|mesh-list
102083496|NCT05030116|Antiemetics|antiemetics|mesh-ancestor
102083497|NCT05030116|Autonomic Agents|autonomic agents|mesh-ancestor
102083498|NCT05030116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102083499|NCT05030116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083555|NCT04667013|Vasodilator Agents|vasodilator agents|mesh-ancestor
102083557|NCT03611985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102083558|NCT03097900|Caffeine|caffeine|mesh-list
102083559|NCT03097900|Caffeine citrate|caffeine citrate|mesh-list
102083560|NCT03097900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083561|NCT03097900|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102083562|NCT03097900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083563|NCT03097900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102083564|NCT03097900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083565|NCT03097900|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102083566|NCT03097900|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102083567|NCT03097900|Purinergic Agents|purinergic agents|mesh-ancestor
101803327|NCT00514917|Docetaxel|docetaxel|mesh-list
102083568|NCT03097900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102083569|NCT00104676|Paclitaxel|paclitaxel|mesh-list
102083570|NCT00104676|Etoposide|etoposide|mesh-list
102083571|NCT00104676|Oxaliplatin|oxaliplatin|mesh-list
102083572|NCT00104676|Ifosfamide|ifosfamide|mesh-list
102083573|NCT00104676|Bleomycin|bleomycin|mesh-list
102083574|NCT00104676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102083575|NCT00104676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102083576|NCT00104676|Tubulin Modulators|tubulin modulators|mesh-ancestor
102083577|NCT00104676|Antimitotic Agents|antimitotic agents|mesh-ancestor
102083578|NCT00104676|Mitosis Modulators|mitosis modulators|mesh-ancestor
102083579|NCT00104676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083580|NCT00104676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102083581|NCT00104676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102083582|NCT00104676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083583|NCT00104676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102083584|NCT00104676|Alkylating Agents|alkylating agents|mesh-ancestor
102083585|NCT00104676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102083586|NCT00354835|Dactinomycin|dactinomycin|mesh-list
102083587|NCT00354835|Cactinomycin|cactinomycin|mesh-list
102083588|NCT00354835|Cyclophosphamide|cyclophosphamide|mesh-list
102083589|NCT00354835|Irinotecan|irinotecan|mesh-list
102083590|NCT00354835|Vincristine|vincristine|mesh-list
102083591|NCT00354835|Camptothecin|camptothecin|mesh-list
102083592|NCT00354835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102083593|NCT00354835|Immunologic Factors|immunologic factors|mesh-ancestor
102083594|NCT00354835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083595|NCT00354835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102083596|NCT00354835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102083597|NCT00354835|Alkylating Agents|alkylating agents|mesh-ancestor
102083598|NCT00354835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083599|NCT00354835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102083600|NCT00354835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102083601|NCT00354835|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102083602|NCT00354835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102083603|NCT00354835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083604|NCT00354835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102083605|NCT00354835|Tubulin Modulators|tubulin modulators|mesh-ancestor
102083606|NCT00354835|Antimitotic Agents|antimitotic agents|mesh-ancestor
102083607|NCT00354835|Mitosis Modulators|mitosis modulators|mesh-ancestor
101943722|NCT02024230|Protease Inhibitors|protease inhibitors|mesh-ancestor
101943723|NCT02024230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101943724|NCT02024230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943725|NCT03380390|Phenylephrine|phenylephrine|mesh-list
102083608|NCT00354835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101385231|NCT00081380|Valproic Acid|valproic acid|mesh-list
102083611|NCT00354835|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102083612|NCT00354835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102083613|NCT02768298|Enalapril|enalapril|mesh-list
102083614|NCT02768298|Enalaprilat|enalaprilat|mesh-list
102083615|NCT02768298|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102083616|NCT02768298|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102083617|NCT02768298|Protease Inhibitors|protease inhibitors|mesh-ancestor
102083618|NCT02768298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083619|NCT02768298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083620|NCT02768298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102083621|NCT02768298|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102083622|NCT05028322|Imiquimod|imiquimod|mesh-list
102083623|NCT05028322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102083624|NCT05028322|Immunologic Factors|immunologic factors|mesh-ancestor
102083625|NCT05028322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083626|NCT05028322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102083627|NCT05028322|Interferon Inducers|interferon inducers|mesh-ancestor
102083628|NCT03096340|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
102083629|NCT03096340|Irinotecan|irinotecan|mesh-list
102083630|NCT03096340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102083631|NCT03096340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102083632|NCT03096340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102083633|NCT03096340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102083634|NCT03096340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083635|NCT03096340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083636|NCT02152800|Valacyclovir|valacyclovir|mesh-list
102083637|NCT02152800|Antiviral Agents|antiviral agents|mesh-ancestor
102083638|NCT02152800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102083639|NCT02149758|Etoricoxib|etoricoxib|mesh-list
102083640|NCT02149758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102083641|NCT02149758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102083642|NCT02149758|Analgesics|analgesics|mesh-ancestor
102083643|NCT02149758|Sensory System Agents|sensory system agents|mesh-ancestor
102083644|NCT02149758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102083645|NCT02149758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083646|NCT02149758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102083647|NCT02149758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102083648|NCT02149758|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102083649|NCT02149758|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102083650|NCT02149758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083651|NCT02149758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083652|NCT03542214|Calcium|calcium|mesh-list
102083653|NCT03542214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102083654|NCT03542214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083655|NCT03094468|Terbinafine|terbinafine|mesh-list
102083656|NCT03094468|Antifungal Agents|antifungal agents|mesh-ancestor
102083657|NCT03094468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102083658|NCT03094468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083659|NCT03094468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083660|NCT03744546|Tilavonemab|tilavonemab|mesh-list
102083661|NCT03744546|Nootropic Agents|nootropic agents|mesh-ancestor
102083662|NCT02775864|Antipsychotic Agents|antipsychotic agents|mesh-list
102083663|NCT02775864|Antidepressive Agents|antidepressive agents|mesh-list
102083664|NCT02775864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102083665|NCT02775864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102083666|NCT02775864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102083667|NCT02775864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083668|NCT03095872|Petrolatum|petrolatum|mesh-list
102083669|NCT03095872|Emollients|emollients|mesh-ancestor
102083670|NCT03095872|Dermatologic Agents|dermatologic agents|mesh-ancestor
102083671|NCT03096184|Apatinib|apatinib|mesh-list
102083672|NCT03096184|Tegafur|tegafur|mesh-list
102083673|NCT03096184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102083674|NCT03096184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102083675|NCT03096184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101943726|NCT03380390|Oxymetazoline|oxymetazoline|mesh-list
101943727|NCT03380390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101943728|NCT03380390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102083676|NCT03096184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083677|NCT03096184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102083678|NCT03096184|Antimetabolites|antimetabolites|mesh-ancestor
102083679|NCT02157012|Tofacitinib|tofacitinib|mesh-list
102083680|NCT02157012|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102083681|NCT02157012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102083688|NCT03096028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083689|NCT03096028|Vitamin B Complex|vitamin b complex|mesh-ancestor
102083690|NCT03096028|Hematinics|hematinics|mesh-ancestor
102083691|NCT02149914|Rabeprazole|rabeprazole|mesh-list
102083692|NCT02149914|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
102083693|NCT02149914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102083694|NCT02149914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102083695|NCT02149914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083696|NCT02149914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083697|NCT02149992|Inositol|inositol|mesh-list
102083698|NCT02149992|Vitamin B Complex|vitamin b complex|mesh-ancestor
102083699|NCT02149992|Vitamins|vitamins|mesh-ancestor
102083700|NCT02149992|Micronutrients|micronutrients|mesh-ancestor
102083701|NCT02149992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083702|NCT04833582|Gemcitabine|gemcitabine|mesh-list
102083703|NCT04833582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102083704|NCT04833582|Antimetabolites|antimetabolites|mesh-ancestor
102083705|NCT04833582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083706|NCT04833582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102083707|NCT05041582|Citalopram|citalopram|mesh-list
102083708|NCT05041582|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102083709|NCT05041582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102083710|NCT05041582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102083711|NCT05041582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083712|NCT05041582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102083713|NCT05041582|Serotonin Agents|serotonin agents|mesh-ancestor
102083714|NCT05041582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083715|NCT05041582|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102083716|NCT05041582|Antidepressive Agents|antidepressive agents|mesh-ancestor
102083717|NCT05041582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102083718|NCT02150070|ASP2408|asp2408|mesh-list
101803476|NCT00448864|Ecallantide|ecallantide|mesh-list
102083720|NCT02150070|Immunologic Factors|immunologic factors|mesh-ancestor
102083721|NCT02150070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083726|NCT02153424|Apixaban|apixaban|mesh-list
102083727|NCT02153424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102083728|NCT02153424|Antithrombins|antithrombins|mesh-ancestor
102083729|NCT02153424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102083730|NCT02153424|Protease Inhibitors|protease inhibitors|mesh-ancestor
102083731|NCT02153424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083732|NCT02153424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083733|NCT02153424|Anticoagulants|anticoagulants|mesh-ancestor
102083734|NCT05027386|Irinotecan|irinotecan|mesh-list
102083735|NCT05027386|Temozolomide|temozolomide|mesh-list
102083736|NCT05027386|Apatinib|apatinib|mesh-list
102083737|NCT05027386|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102083738|NCT05027386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102083739|NCT05027386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083740|NCT05027386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083741|NCT05027386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102083742|NCT05027386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102083743|NCT05027386|Alkylating Agents|alkylating agents|mesh-ancestor
102083744|NCT05027386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102083745|NCT04434430|Gabapentin|gabapentin|mesh-list
102083746|NCT04434430|Analgesics|analgesics|mesh-ancestor
102083747|NCT04434430|Sensory System Agents|sensory system agents|mesh-ancestor
102083748|NCT04434430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102083749|NCT04434430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083750|NCT04434430|Anticonvulsants|anticonvulsants|mesh-ancestor
102083751|NCT04434430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101943729|NCT03380390|Adrenergic Agents|adrenergic agents|mesh-ancestor
101943730|NCT03380390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101705251|NCT02708693|Hormones|hormones|mesh-ancestor
101943731|NCT03380390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943732|NCT03380390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943733|NCT03380390|Sympathomimetics|sympathomimetics|mesh-ancestor
101385375|NCT00303589|Lactams|lactams|mesh-list
102083757|NCT04434430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102083758|NCT04434430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083759|NCT04434430|Antimanic Agents|antimanic agents|mesh-ancestor
102083760|NCT03094156|Resveratrol|resveratrol|mesh-list
102083761|NCT03094156|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
102083762|NCT03094156|Antioxidants|antioxidants|mesh-ancestor
102083763|NCT03094156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083764|NCT03094156|Protective Agents|protective agents|mesh-ancestor
102083765|NCT03094156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083766|NCT03094156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083767|NCT03094156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102083768|NCT03094156|Dopamine Agents|dopamine agents|mesh-ancestor
102083769|NCT03094156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102083770|NCT02964273|Tolvaptan|tolvaptan|mesh-list
102083771|NCT02964273|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102083772|NCT02964273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083773|NCT02964273|Natriuretic Agents|natriuretic agents|mesh-ancestor
102083774|NCT02964273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083775|NCT05040724|Ivermectin|ivermectin|mesh-list
102083776|NCT05040724|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102083777|NCT05040724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102083778|NCT03542058|Carvedilol|carvedilol|mesh-list
102083779|NCT03542058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102083780|NCT03542058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102083781|NCT03542058|Adrenergic Agents|adrenergic agents|mesh-ancestor
102083782|NCT03542058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102083783|NCT03542058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083784|NCT03542058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083785|NCT03542058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102083786|NCT03542058|Antioxidants|antioxidants|mesh-ancestor
102083787|NCT03542058|Protective Agents|protective agents|mesh-ancestor
102083788|NCT03542058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102083789|NCT03542058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102083790|NCT03542058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102083791|NCT03542058|Vasodilator Agents|vasodilator agents|mesh-ancestor
101803588|NCT02568839|Docetaxel|docetaxel|mesh-list
102083792|NCT03542058|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102083793|NCT03542058|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102083794|NCT03321513|Bevacizumab|bevacizumab|mesh-list
102083795|NCT03321513|Aflibercept|aflibercept|mesh-list
102083796|NCT03321513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102083797|NCT03321513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102083798|NCT03321513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102083799|NCT03321513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102083800|NCT03321513|Growth Substances|growth substances|mesh-ancestor
102083801|NCT03321513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083802|NCT03321513|Growth Inhibitors|growth inhibitors|mesh-ancestor
102083803|NCT02032797|Progesterone|progesterone|mesh-list
102083804|NCT02032797|Progestins|progestins|mesh-ancestor
102083805|NCT02032797|Hormones|hormones|mesh-ancestor
102083806|NCT02032797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102083807|NCT02032797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083808|NCT05024266|Paclitaxel|paclitaxel|mesh-list
102083809|NCT05024266|Carboplatin|carboplatin|mesh-list
102083810|NCT05024266|Tislelizumab|tislelizumab|mesh-list
102083811|NCT05024266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102083812|NCT05024266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102083813|NCT05024266|Tubulin Modulators|tubulin modulators|mesh-ancestor
102083814|NCT05024266|Antimitotic Agents|antimitotic agents|mesh-ancestor
102083815|NCT05024266|Mitosis Modulators|mitosis modulators|mesh-ancestor
102083816|NCT05024266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083817|NCT05024266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102083818|NCT02773368|Insulin|insulin|mesh-list
101943734|NCT03380390|Autonomic Agents|autonomic agents|mesh-ancestor
101943735|NCT03380390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101943736|NCT03380390|Nasal Decongestants|nasal decongestants|mesh-ancestor
101943737|NCT03380390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101943738|NCT03380390|Respiratory System Agents|respiratory system agents|mesh-ancestor
101943739|NCT03380390|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101943740|NCT03380390|Mydriatics|mydriatics|mesh-ancestor
101943741|NCT03380390|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101943742|NCT03380390|Protective Agents|protective agents|mesh-ancestor
101943743|NCT01935778|Docetaxel|docetaxel|mesh-list
101943744|NCT01935778|Capecitabine|capecitabine|mesh-list
101943745|NCT01935778|Oxaliplatin|oxaliplatin|mesh-list
101943746|NCT01935778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101943747|NCT01935778|Tubulin Modulators|tubulin modulators|mesh-ancestor
101943748|NCT01935778|Antimitotic Agents|antimitotic agents|mesh-ancestor
101385441|NCT00303940|Carboplatin|carboplatin|mesh-list
102083821|NCT02773368|Liraglutide|liraglutide|mesh-list
102083822|NCT02773368|Xultophy|xultophy|mesh-list
102083823|NCT02773368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102083824|NCT02773368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083825|NCT02773368|Incretins|incretins|mesh-ancestor
102083826|NCT02773368|Hormones|hormones|mesh-ancestor
102083827|NCT02773368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102083828|NCT02153658|Chlorhexidine|chlorhexidine|mesh-list
102083829|NCT02153658|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102083830|NCT02153658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102083831|NCT02153658|Disinfectants|disinfectants|mesh-ancestor
102083832|NCT02157558|Fexofenadine|fexofenadine|mesh-list
102083833|NCT02157558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102083834|NCT02157558|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102083835|NCT02157558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102083836|NCT02157558|Histamine Antagonists|histamine antagonists|mesh-ancestor
102083837|NCT02157558|Histamine Agents|histamine agents|mesh-ancestor
102083838|NCT02157558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102083839|NCT02157558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083840|NCT02157558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083841|NCT05018182|Leucovorin|leucovorin|mesh-list
102083842|NCT05018182|Folic Acid|folic acid|mesh-list
102083843|NCT05018182|Fluorouracil|fluorouracil|mesh-list
102083844|NCT05018182|Capecitabine|capecitabine|mesh-list
102083845|NCT05018182|Oxaliplatin|oxaliplatin|mesh-list
102083846|NCT05018182|Irinotecan|irinotecan|mesh-list
102083847|NCT05018182|Levoleucovorin|levoleucovorin|mesh-list
101705309|NCT02635802|GABA Agents|gaba agents|mesh-ancestor
102083848|NCT05018182|Antimetabolites|antimetabolites|mesh-ancestor
102083849|NCT05018182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083850|NCT05018182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102083851|NCT05018182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102083852|NCT05018182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102083853|NCT05018182|Immunologic Factors|immunologic factors|mesh-ancestor
102083854|NCT05018182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083855|NCT05018182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102083856|NCT05018182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102083857|NCT05018182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083858|NCT05018182|Antidotes|antidotes|mesh-ancestor
102083859|NCT05018182|Protective Agents|protective agents|mesh-ancestor
102083860|NCT05018182|Vitamin B Complex|vitamin b complex|mesh-ancestor
102083861|NCT05018182|Vitamins|vitamins|mesh-ancestor
102083862|NCT05018182|Micronutrients|micronutrients|mesh-ancestor
102083863|NCT05018182|Hematinics|hematinics|mesh-ancestor
102083864|NCT01336569|Timolol|timolol|mesh-list
102083865|NCT01336569|Travoprost|travoprost|mesh-list
101803627|NCT00736931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102083866|NCT01336569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083867|NCT01336569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102083868|NCT01336569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101943750|NCT01935778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943751|NCT01935778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101943752|NCT01935778|Antimetabolites|antimetabolites|mesh-ancestor
101943753|NCT02034292|Aspirin|aspirin|mesh-list
101943754|NCT02034292|Clopidogrel|clopidogrel|mesh-list
101943755|NCT02034292|APD791|apd791|mesh-list
101943756|NCT02034292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101308626|NCT00005889|Glucagon|glucagon|mesh-list
102083869|NCT01336569|Adrenergic Agents|adrenergic agents|mesh-ancestor
102083870|NCT01336569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102083871|NCT01336569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083872|NCT01336569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102083873|NCT01336569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102083874|NCT03092986|Paclitaxel|paclitaxel|mesh-list
102083875|NCT03092986|Vinblastine|vinblastine|mesh-list
102083876|NCT03092986|Carboplatin|carboplatin|mesh-list
102083877|NCT03092986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102083878|NCT03092986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102083879|NCT03092986|Tubulin Modulators|tubulin modulators|mesh-ancestor
102083880|NCT03092986|Antimitotic Agents|antimitotic agents|mesh-ancestor
102083881|NCT03092986|Mitosis Modulators|mitosis modulators|mesh-ancestor
102083882|NCT03092986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083883|NCT03092908|Acetic Acid|acetic acid|mesh-list
102083884|NCT03092908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102083885|NCT03092908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102083886|NCT03543306|Trametinib|trametinib|mesh-list
102083887|NCT03543306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102083888|NCT03543306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102083889|NCT03543306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083890|NCT03543306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083891|NCT02157792|Carboplatin|carboplatin|mesh-list
102083892|NCT02157792|Gemcitabine|gemcitabine|mesh-list
102083893|NCT02157792|Irinotecan|irinotecan|mesh-list
102083894|NCT02157792|Etoposide|etoposide|mesh-list
102083895|NCT02157792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102083898|NCT02157792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083900|NCT02157792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102083901|NCT02157792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083902|NCT02157792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102083903|NCT02157792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102083904|NCT05023408|Bleomycin|bleomycin|mesh-list
102083905|NCT05023408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102083906|NCT05023408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102083907|NCT02772978|Tolcapone|tolcapone|mesh-list
102083908|NCT02772978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102083909|NCT02772978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102083910|NCT02772978|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102083911|NCT02772978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083912|NCT02772978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083913|NCT03090490|Antipsychotic Agents|antipsychotic agents|mesh-list
102083914|NCT03090490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102083915|NCT03090490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102083916|NCT03090490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083917|NCT03090490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102083918|NCT05164549|Buprenorphine|buprenorphine|mesh-list
102083919|NCT05164549|Methadone|methadone|mesh-list
102083920|NCT05164549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102083921|NCT05164549|Narcotics|narcotics|mesh-ancestor
102083922|NCT05164549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102083923|NCT05164549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083924|NCT05164549|Analgesics|analgesics|mesh-ancestor
102083925|NCT05164549|Sensory System Agents|sensory system agents|mesh-ancestor
102083926|NCT05164549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102083927|NCT05164549|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102083928|NCT05164549|Antitussive Agents|antitussive agents|mesh-ancestor
102083929|NCT05164549|Respiratory System Agents|respiratory system agents|mesh-ancestor
102083930|NCT00104052|Ribavirin|ribavirin|mesh-list
101943757|NCT02034292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101943758|NCT02034292|Analgesics|analgesics|mesh-ancestor
101943759|NCT02034292|Sensory System Agents|sensory system agents|mesh-ancestor
102083931|NCT00104052|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102083932|NCT00104052|Interferon-alpha|interferon-alpha|mesh-list
102083933|NCT00104052|Antimetabolites|antimetabolites|mesh-ancestor
102083934|NCT00104052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083935|NCT00104052|Antiviral Agents|antiviral agents|mesh-ancestor
102083936|NCT00104052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102083937|NCT00104052|Immunologic Factors|immunologic factors|mesh-ancestor
102083938|NCT00104052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083939|NCT05038072|Triamcinolone|triamcinolone|mesh-list
102083940|NCT05038072|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101803702|NCT00931736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102083941|NCT05038072|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102083942|NCT05038072|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102083943|NCT05038072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102083944|NCT05038072|Glucocorticoids|glucocorticoids|mesh-ancestor
102083945|NCT05038072|Hormones|hormones|mesh-ancestor
102083946|NCT05038072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102083947|NCT05038072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083948|NCT05038072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102083949|NCT05038072|Immunologic Factors|immunologic factors|mesh-ancestor
102083950|NCT05038072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083951|NCT05038072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083952|NCT02777970|Acetaminophen|acetaminophen|mesh-list
102083953|NCT02777970|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
102083954|NCT02777970|Tramadol|tramadol|mesh-list
101705326|NCT00657410|Hormones|hormones|mesh-ancestor
102083955|NCT02777970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102083956|NCT02777970|Analgesics|analgesics|mesh-ancestor
102083957|NCT02777970|Sensory System Agents|sensory system agents|mesh-ancestor
102083958|NCT02777970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102083959|NCT02777970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083960|NCT02777970|Antipyretics|antipyretics|mesh-ancestor
102083961|NCT02777970|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102083962|NCT02777970|Narcotics|narcotics|mesh-ancestor
102083963|NCT02777970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102083964|NCT02777970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102083965|NCT02777970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102083966|NCT02777970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102083968|NCT02150616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102083969|NCT02150616|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102083970|NCT02150616|Anesthetics, General|anesthetics, general|mesh-ancestor
102083971|NCT02150616|Anesthetics|anesthetics|mesh-ancestor
102083972|NCT02150616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102083973|NCT02150616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083974|NCT01336023|Insulin|insulin|mesh-list
102083975|NCT01336023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102083976|NCT01336023|Liraglutide|liraglutide|mesh-list
102083977|NCT01336023|Insulin, Long-Acting|insulin, long-acting|mesh-list
102083978|NCT01336023|Xultophy|xultophy|mesh-list
102083979|NCT01336023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102083980|NCT01336023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083981|NCT01336023|Incretins|incretins|mesh-ancestor
102083982|NCT01336023|Hormones|hormones|mesh-ancestor
102083983|NCT01336023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102083984|NCT02255292|Cannabidiol|cannabidiol|mesh-list
102083985|NCT02255292|Anticonvulsants|anticonvulsants|mesh-ancestor
102083986|NCT03092206|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
102083987|NCT03092206|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102083988|NCT03092206|Antiviral Agents|antiviral agents|mesh-ancestor
102083989|NCT03092206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102083990|NCT03092206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102083991|NCT03092206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102083992|NCT03092206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083993|NCT03092206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083994|NCT03092206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102083995|NCT03092206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102083996|NCT02254980|Vitamin E|vitamin e|mesh-list
102083997|NCT02254980|Vitamins|vitamins|mesh-ancestor
102083998|NCT02254980|Micronutrients|micronutrients|mesh-ancestor
102083999|NCT02254980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943760|NCT02034292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101943761|NCT02034292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084000|NCT02254980|Antioxidants|antioxidants|mesh-ancestor
102084001|NCT02254980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084002|NCT02254980|Protective Agents|protective agents|mesh-ancestor
102084004|NCT05281003|Pembrolizumab|pembrolizumab|mesh-list
102084005|NCT05281003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102084006|NCT05281003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102084007|NCT05281003|Tubulin Modulators|tubulin modulators|mesh-ancestor
102084008|NCT05281003|Antimitotic Agents|antimitotic agents|mesh-ancestor
102084009|NCT05281003|Mitosis Modulators|mitosis modulators|mesh-ancestor
102084010|NCT05281003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084011|NCT05281003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102084012|NCT05281003|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102084013|NCT02158182|Rifaximin|rifaximin|mesh-list
102084014|NCT02158182|Lactulose|lactulose|mesh-list
102084015|NCT02158182|N-Methylaspartate|n-methylaspartate|mesh-list
102084016|NCT02158182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102084017|NCT02158182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102084018|NCT02158182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102084019|NCT02158182|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
102084020|NCT02158182|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102084021|NCT02158182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102084022|NCT02158182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084023|NCT02158182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084024|NCT02033187|Chlorhexidine|chlorhexidine|mesh-list
102084025|NCT02033187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102084026|NCT02033187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102084027|NCT02033187|Disinfectants|disinfectants|mesh-ancestor
102084029|NCT02154360|Antiemetics|antiemetics|mesh-ancestor
102084030|NCT02154360|Autonomic Agents|autonomic agents|mesh-ancestor
102084031|NCT02154360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102084032|NCT02154360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084033|NCT02154360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102084034|NCT02154360|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102084035|NCT02154360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102084036|NCT02154360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084037|NCT02033031|Bevacizumab|bevacizumab|mesh-list
102084038|NCT02033031|Ranibizumab|ranibizumab|mesh-list
102084039|NCT02033031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102084040|NCT02033031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102084041|NCT02033031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102084045|NCT02033031|Growth Inhibitors|growth inhibitors|mesh-ancestor
102084046|NCT05034367|Mannitol|mannitol|mesh-list
102084047|NCT05034367|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102084048|NCT05034367|Diuretics|diuretics|mesh-ancestor
102084049|NCT05034367|Natriuretic Agents|natriuretic agents|mesh-ancestor
102084050|NCT05034367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084051|NCT02150928|Asparaginase|asparaginase|mesh-list
102084052|NCT02150928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102084053|NCT03611049|Vitamin D|vitamin d|mesh-list
102084054|NCT03611049|Ergocalciferols|ergocalciferols|mesh-list
102084055|NCT03611049|Cholecalciferol|cholecalciferol|mesh-list
102084056|NCT03611049|Vitamins|vitamins|mesh-list
102084057|NCT03611049|Micronutrients|micronutrients|mesh-ancestor
102084058|NCT03611049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084059|NCT03611049|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102084060|NCT03611049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102084061|NCT03610893|Dexamethasone|dexamethasone|mesh-list
102084062|NCT03610893|Dexmedetomidine|dexmedetomidine|mesh-list
102084063|NCT03610893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102084064|NCT03610893|Antiemetics|antiemetics|mesh-ancestor
102084065|NCT03610893|Autonomic Agents|autonomic agents|mesh-ancestor
102084066|NCT03610893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102084067|NCT03610893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084068|NCT03610893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102084069|NCT03610893|Glucocorticoids|glucocorticoids|mesh-ancestor
102084070|NCT03610893|Hormones|hormones|mesh-ancestor
102084071|NCT03610893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102084072|NCT03610893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102084073|NCT03610893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102084074|NCT03610893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101943762|NCT02034292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101943764|NCT02034292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101454571|NCT04570345|Antipyretics|antipyretics|mesh-ancestor
102084075|NCT03610893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102084076|NCT03610893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102084077|NCT03610893|Analgesics|analgesics|mesh-ancestor
102084078|NCT03610893|Sensory System Agents|sensory system agents|mesh-ancestor
102084079|NCT03610893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102084080|NCT03610893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102084081|NCT03610893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102084082|NCT03610893|Adrenergic Agents|adrenergic agents|mesh-ancestor
102084083|NCT03610893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102084084|NCT03610893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084085|NCT04737109|Ipatasertib|ipatasertib|mesh-list
102084086|NCT04737109|Androgens|androgens|mesh-list
102084087|NCT04737109|Hormones|hormones|mesh-ancestor
102084088|NCT04737109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102084089|NCT04737109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084090|NCT04737109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102084091|NCT04737109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102084092|NCT04737109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102084093|NCT04737109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084094|NCT02154438|Ketamine|ketamine|mesh-list
102084095|NCT02154438|Analgesics|analgesics|mesh-ancestor
102084096|NCT02154438|Sensory System Agents|sensory system agents|mesh-ancestor
102084097|NCT02154438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102084098|NCT02154438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084099|NCT02154438|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102084100|NCT02154438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102084101|NCT02154438|Anesthetics, General|anesthetics, general|mesh-ancestor
102084102|NCT02154438|Anesthetics|anesthetics|mesh-ancestor
102084103|NCT02154438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102084104|NCT02154438|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102084105|NCT02154438|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102084106|NCT02154438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102084107|NCT02154438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084108|NCT02520921|Aspirin|aspirin|mesh-list
102084109|NCT02520921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102084110|NCT02520921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102084111|NCT02520921|Analgesics|analgesics|mesh-ancestor
102084112|NCT02520921|Sensory System Agents|sensory system agents|mesh-ancestor
102084113|NCT02520921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102084117|NCT02520921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102084118|NCT02520921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102084119|NCT02520921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084120|NCT02520921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102084121|NCT02520921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102084122|NCT02520921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102084123|NCT02520921|Antipyretics|antipyretics|mesh-ancestor
102084124|NCT02154594|Chlorhexidine|chlorhexidine|mesh-list
102084125|NCT02154594|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102084126|NCT02154594|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102084127|NCT02154594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102084128|NCT02154594|Disinfectants|disinfectants|mesh-ancestor
102084129|NCT02154594|Dermatologic Agents|dermatologic agents|mesh-ancestor
102084130|NCT03610347|Paclitaxel|paclitaxel|mesh-list
102084131|NCT03610347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102084132|NCT03610347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102084133|NCT03610347|Tubulin Modulators|tubulin modulators|mesh-ancestor
102084134|NCT03610347|Antimitotic Agents|antimitotic agents|mesh-ancestor
102084135|NCT03610347|Mitosis Modulators|mitosis modulators|mesh-ancestor
102084136|NCT03610347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084137|NCT01518517|Asparaginase|asparaginase|mesh-list
102084138|NCT01518517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102084139|NCT02863575|Ibuprofen|ibuprofen|mesh-list
102084140|NCT02863575|Caffeine|caffeine|mesh-list
102084141|NCT02863575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102084142|NCT02863575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102084143|NCT02863575|Analgesics|analgesics|mesh-ancestor
102084144|NCT02863575|Sensory System Agents|sensory system agents|mesh-ancestor
101943765|NCT02034292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101943766|NCT02034292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308644|NCT00005898|Cyclosporine|cyclosporine|mesh-list
102084145|NCT02863575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102084146|NCT02863575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084147|NCT02863575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102084148|NCT02863575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102084149|NCT02863575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102084150|NCT02863575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102084151|NCT02863575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084152|NCT02863575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102084153|NCT02863575|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102084154|NCT02863575|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102084155|NCT02863575|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102084156|NCT02863575|Purinergic Agents|purinergic agents|mesh-ancestor
102084157|NCT02863575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102084158|NCT05021770|Thiotepa|thiotepa|mesh-list
102084159|NCT05021770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102084160|NCT05021770|Alkylating Agents|alkylating agents|mesh-ancestor
102084161|NCT05021770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084162|NCT05021770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102084163|NCT05021770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102084164|NCT05021770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102084165|NCT05021770|Immunologic Factors|immunologic factors|mesh-ancestor
102084166|NCT05021770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084167|NCT05230303|Caffeine|caffeine|mesh-list
102084168|NCT05230303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102084169|NCT05230303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084170|NCT05230303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102084171|NCT05230303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102084172|NCT05230303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084173|NCT05230303|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102084174|NCT05230303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102084175|NCT05230303|Purinergic Agents|purinergic agents|mesh-ancestor
102084176|NCT05230303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102084177|NCT04287790|Naltrexone|naltrexone|mesh-list
102084178|NCT04287790|Disulfiram|disulfiram|mesh-list
102084179|NCT04287790|Acamprosate|acamprosate|mesh-list
102084180|NCT04287790|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102084181|NCT04287790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102084182|NCT04287790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084183|NCT04287790|Sensory System Agents|sensory system agents|mesh-ancestor
102084184|NCT04287790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102084188|NCT03723967|Paclitaxel|paclitaxel|mesh-list
102084189|NCT03723967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102084190|NCT03723967|Carboplatin|carboplatin|mesh-list
102084191|NCT03723967|Durvalumab|durvalumab|mesh-list
102084192|NCT03723967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102084193|NCT03723967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102084194|NCT03723967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102084195|NCT03723967|Tubulin Modulators|tubulin modulators|mesh-ancestor
102084196|NCT03723967|Antimitotic Agents|antimitotic agents|mesh-ancestor
102084197|NCT03723967|Mitosis Modulators|mitosis modulators|mesh-ancestor
102084198|NCT03723967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084199|NCT03723967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102084200|NCT03723967|Immunologic Factors|immunologic factors|mesh-ancestor
102084201|NCT03723967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084202|NCT05008666|Azacitidine|azacitidine|mesh-list
102084203|NCT05008666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102084204|NCT05008666|Antimetabolites|antimetabolites|mesh-ancestor
102084205|NCT05008666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084206|NCT05008666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102084207|NCT05008666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102084208|NCT03659461|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102084209|NCT03659461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102084210|NCT03659461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084211|NCT03659461|Incretins|incretins|mesh-ancestor
102084212|NCT03659461|Hormones|hormones|mesh-ancestor
102084213|NCT03659461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102084214|NCT03659461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101943767|NCT02034292|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101943768|NCT02034292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102084215|NCT03659461|Protease Inhibitors|protease inhibitors|mesh-ancestor
102084216|NCT03659461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102084217|NCT03659461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084218|NCT01227187|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
102084219|NCT01227187|Protein C|protein c|mesh-list
102084220|NCT01227187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102084221|NCT01227187|Anticoagulants|anticoagulants|mesh-ancestor
102084222|NCT01227187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102084223|NCT01227187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102084224|NCT01227187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084225|NCT03088072|Aspirin|aspirin|mesh-list
102084226|NCT03088072|Warfarin|warfarin|mesh-list
102084227|NCT03088072|Edoxaban|edoxaban|mesh-list
102084228|NCT03088072|Clopidogrel|clopidogrel|mesh-list
102084229|NCT03088072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102084230|NCT03088072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102084231|NCT03088072|Analgesics|analgesics|mesh-ancestor
102084232|NCT03088072|Sensory System Agents|sensory system agents|mesh-ancestor
102084233|NCT03088072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102084234|NCT03088072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084235|NCT03088072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102084236|NCT03088072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102084237|NCT03088072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102084238|NCT03088072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102084239|NCT03088072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084240|NCT03088072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102084241|NCT03088072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102084242|NCT03088072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102084243|NCT03088072|Antipyretics|antipyretics|mesh-ancestor
102084244|NCT03088072|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102084245|NCT03088072|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102084246|NCT03088072|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102084247|NCT03088072|Purinergic Agents|purinergic agents|mesh-ancestor
102084248|NCT03088072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102084249|NCT03088072|Anticoagulants|anticoagulants|mesh-ancestor
102084250|NCT03088072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102084251|NCT03088072|Antithrombins|antithrombins|mesh-ancestor
102084252|NCT03088072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102084253|NCT03088072|Protease Inhibitors|protease inhibitors|mesh-ancestor
102084254|NCT01077817|Alendronate|alendronate|mesh-list
102084255|NCT01077817|Risedronic Acid|risedronic acid|mesh-list
102084260|NCT01077817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084261|NCT01077817|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101705400|NCT04459871|Hemostatics|hemostatics|mesh-ancestor
102084262|NCT01077817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102084263|NCT01077817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084264|NCT01077817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102084265|NCT01077817|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102084266|NCT01077817|Hormone Antagonists|hormone antagonists|mesh-ancestor
102084267|NCT01077817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102084268|NCT01077817|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102084269|NCT01077817|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102084270|NCT02638012|Hemostatics|hemostatics|mesh-list
102084271|NCT02638012|Coagulants|coagulants|mesh-ancestor
102084272|NCT05014906|Minocycline|minocycline|mesh-list
102084273|NCT05014906|Azelaic acid|azelaic acid|mesh-list
102084274|NCT05014906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102084275|NCT05014906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102084276|NCT05014906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102084277|NCT05014906|Dermatologic Agents|dermatologic agents|mesh-ancestor
102084278|NCT00103506|Doxorubicin|doxorubicin|mesh-list
102084279|NCT00103506|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102084281|NCT00103506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102084282|NCT00103506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102084283|NCT00103506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102084284|NCT00103506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102084285|NCT00103506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102084286|NCT00103506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084287|NCT02151240|Acyclovir|acyclovir|mesh-list
102084288|NCT02151240|Foscarnet|foscarnet|mesh-list
101943770|NCT02034292|Antipyretics|antipyretics|mesh-ancestor
101943771|NCT02034292|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101308649|NCT00005898|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102084289|NCT02151240|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
102084290|NCT02151240|Antiviral Agents|antiviral agents|mesh-ancestor
102084291|NCT02151240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102084292|NCT02151240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102084293|NCT02151240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102084294|NCT02151240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102084295|NCT02151240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084296|NCT02159196|Acetylcysteine|acetylcysteine|mesh-list
102084297|NCT02159196|Albuterol|albuterol|mesh-list
102084298|NCT02159196|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102084299|NCT02159196|Antiviral Agents|antiviral agents|mesh-ancestor
102084300|NCT02159196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102084301|NCT02159196|Expectorants|expectorants|mesh-ancestor
102084302|NCT02159196|Respiratory System Agents|respiratory system agents|mesh-ancestor
102084303|NCT02159196|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102084304|NCT02159196|Antioxidants|antioxidants|mesh-ancestor
102084305|NCT02159196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084306|NCT02159196|Protective Agents|protective agents|mesh-ancestor
102084307|NCT02159196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084308|NCT02159196|Antidotes|antidotes|mesh-ancestor
102084309|NCT02159196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102084310|NCT02159196|Autonomic Agents|autonomic agents|mesh-ancestor
102084311|NCT02159196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102084312|NCT02159196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102084313|NCT02159196|Tocolytic Agents|tocolytic agents|mesh-ancestor
102084314|NCT02159196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102084315|NCT02159196|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102084316|NCT02159196|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102084317|NCT02159196|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102084318|NCT02159196|Adrenergic Agents|adrenergic agents|mesh-ancestor
102084319|NCT02159196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102084320|NCT02765490|Simeprevir|simeprevir|mesh-list
102084321|NCT02765490|Odalasvir|odalasvir|mesh-list
102084322|NCT02765490|Antiviral Agents|antiviral agents|mesh-ancestor
102084323|NCT02765490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102084324|NCT02765490|Protease Inhibitors|protease inhibitors|mesh-ancestor
102084325|NCT02765490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102084326|NCT02765490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385946|NCT00120783|Lamivudine|lamivudine|mesh-list
102084349|NCT02863419|Incretins|incretins|mesh-ancestor
102084351|NCT02863419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102084352|NCT03541668|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102084353|NCT03541668|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102084354|NCT03541668|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102084355|NCT03541668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084356|NCT04961632|Tamoxifen|tamoxifen|mesh-list
102084357|NCT04961632|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102084358|NCT04961632|Hormone Antagonists|hormone antagonists|mesh-ancestor
102084359|NCT04961632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102084360|NCT04961632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084361|NCT04961632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102084362|NCT04961632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102084363|NCT04961632|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102084364|NCT04961632|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102084365|NCT04961632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102084366|NCT02155374|Insulin|insulin|mesh-list
102084367|NCT02155374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102084368|NCT02155374|Insulin, Short-Acting|insulin, short-acting|mesh-list
102084369|NCT02155374|Antineoplastic Agents|antineoplastic agents|mesh-list
102084370|NCT02155374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102084371|NCT02155374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084372|NCT04434118|Antirheumatic Agents|antirheumatic agents|mesh-list
102084373|NCT02765100|Minocycline|minocycline|mesh-list
102084374|NCT02765100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102084375|NCT02765100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102084376|NCT03091894|Dexmedetomidine|dexmedetomidine|mesh-list
102084377|NCT03091894|Propofol|propofol|mesh-list
101386021|NCT05446142|Rabeprazole|rabeprazole|mesh-list
102084379|NCT03091894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101943772|NCT02034292|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101943773|NCT02034292|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101943774|NCT02034292|Purinergic Agents|purinergic agents|mesh-ancestor
101943775|NCT02034292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101308653|NCT00005898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102084380|NCT03091894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084381|NCT03091894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102084382|NCT03091894|Analgesics|analgesics|mesh-ancestor
102084383|NCT03091894|Sensory System Agents|sensory system agents|mesh-ancestor
102084384|NCT03091894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102084385|NCT03091894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102084386|NCT03091894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102084387|NCT03091894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102084388|NCT03091894|Adrenergic Agents|adrenergic agents|mesh-ancestor
102084389|NCT03091894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102084390|NCT03091894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084391|NCT03091894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102084392|NCT03091894|Anesthetics, General|anesthetics, general|mesh-ancestor
102084393|NCT03091894|Anesthetics|anesthetics|mesh-ancestor
102084394|NCT05014594|Dapagliflozin|dapagliflozin|mesh-list
102084395|NCT05014594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102084396|NCT05014594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084397|NCT05014594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102084398|NCT05014594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084399|NCT02761980|Acetaminophen|acetaminophen|mesh-list
102084400|NCT02761980|Ibuprofen|ibuprofen|mesh-list
102084401|NCT02761980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102084402|NCT02761980|Analgesics|analgesics|mesh-ancestor
102084403|NCT02761980|Sensory System Agents|sensory system agents|mesh-ancestor
102084404|NCT02761980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102084405|NCT02761980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084406|NCT02761980|Antipyretics|antipyretics|mesh-ancestor
102084407|NCT02761980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102084408|NCT02761980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102084409|NCT02761980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102084410|NCT02761980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102084411|NCT02761980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102084412|NCT02761980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084413|NCT05007340|Dimercaprol|dimercaprol|mesh-list
102084414|NCT05007340|Chelating Agents|chelating agents|mesh-ancestor
102084415|NCT05007340|Sequestering Agents|sequestering agents|mesh-ancestor
102084416|NCT05007340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084417|NCT05014048|Vitamin D|vitamin d|mesh-list
102084418|NCT05014048|Cholecalciferol|cholecalciferol|mesh-list
102084419|NCT05014048|Vitamins|vitamins|mesh-ancestor
102084420|NCT05014048|Micronutrients|micronutrients|mesh-ancestor
102084421|NCT05014048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084422|NCT05014048|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102084423|NCT05014048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102084424|NCT02163174|Pentoxifylline|pentoxifylline|mesh-list
102084425|NCT02163174|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102084426|NCT02163174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102084427|NCT02163174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084428|NCT02163174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102084429|NCT02163174|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102084430|NCT02163174|Protective Agents|protective agents|mesh-ancestor
102084431|NCT02163174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084432|NCT02163174|Vasodilator Agents|vasodilator agents|mesh-ancestor
102084433|NCT02163174|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102084434|NCT02163174|Antioxidants|antioxidants|mesh-ancestor
102084435|NCT01744912|Lenalidomide|lenalidomide|mesh-list
102084436|NCT01744912|Immunologic Factors|immunologic factors|mesh-ancestor
102084437|NCT01744912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084438|NCT01744912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102084439|NCT01744912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102084440|NCT01744912|Growth Substances|growth substances|mesh-ancestor
102084441|NCT01744912|Growth Inhibitors|growth inhibitors|mesh-ancestor
102084442|NCT01744912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102084443|NCT03540810|Hydroxychloroquine|hydroxychloroquine|mesh-list
101943776|NCT02034292|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101943777|NCT02034292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101943778|NCT02034292|Serotonin Agents|serotonin agents|mesh-ancestor
101943779|NCT01758328|Fludarabine|fludarabine|mesh-list
101943780|NCT01758328|Melphalan|melphalan|mesh-list
101943781|NCT01758328|Busulfan|busulfan|mesh-list
102084444|NCT03540810|Antimalarials|antimalarials|mesh-ancestor
102084445|NCT03540810|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102084446|NCT03540810|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102084447|NCT03540810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102084448|NCT03540810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102084449|NCT03540810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084450|NCT03540810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102084451|NCT02159820|Paclitaxel|paclitaxel|mesh-list
102084455|NCT02159820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102084456|NCT02159820|Tubulin Modulators|tubulin modulators|mesh-ancestor
102084457|NCT02159820|Antimitotic Agents|antimitotic agents|mesh-ancestor
102084458|NCT02159820|Mitosis Modulators|mitosis modulators|mesh-ancestor
102084459|NCT02159820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705439|NCT01006057|Insulin|insulin|mesh-list
102084460|NCT02159820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102084461|NCT02159820|Antimetabolites|antimetabolites|mesh-ancestor
102084462|NCT02159820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102084464|NCT02862171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102084465|NCT02862171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102084466|NCT02862171|Antiviral Agents|antiviral agents|mesh-ancestor
102084467|NCT02862171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102084468|NCT05013112|Metformin|metformin|mesh-list
102084469|NCT05013112|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102084471|NCT05013112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084472|NCT05013112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084473|NCT05013034|Basiliximab|basiliximab|mesh-list
102084474|NCT05013034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102084475|NCT05013034|Immunologic Factors|immunologic factors|mesh-ancestor
102084476|NCT05013034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084477|NCT02638948|Methotrexate|methotrexate|mesh-list
102084478|NCT02638948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102084479|NCT02638948|Abortifacient Agents|abortifacient agents|mesh-ancestor
102084480|NCT02638948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102084481|NCT02638948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084482|NCT02638948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102084483|NCT02638948|Antimetabolites|antimetabolites|mesh-ancestor
102084484|NCT02638948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084485|NCT02638948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102084486|NCT02638948|Dermatologic Agents|dermatologic agents|mesh-ancestor
102084487|NCT02638948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102084488|NCT02638948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102084489|NCT02638948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102084490|NCT02638948|Immunologic Factors|immunologic factors|mesh-ancestor
102084491|NCT02638948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102084492|NCT02638948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102084493|NCT03091426|Antimicrobial Cationic Peptides|antimicrobial cationic peptides|mesh-list
102084494|NCT03091426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102084495|NCT04465864|Dexamethasone|dexamethasone|mesh-list
102084496|NCT04465864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102084497|NCT04465864|Antiemetics|antiemetics|mesh-ancestor
102084498|NCT04465864|Autonomic Agents|autonomic agents|mesh-ancestor
102084499|NCT04465864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102084500|NCT04465864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084501|NCT04465864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102084502|NCT04465864|Glucocorticoids|glucocorticoids|mesh-ancestor
102084503|NCT04465864|Hormones|hormones|mesh-ancestor
102084504|NCT04465864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102084505|NCT04465864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102084506|NCT04465864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102084507|NCT03091504|Albuterol|albuterol|mesh-list
102084508|NCT03091504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102084509|NCT03091504|Autonomic Agents|autonomic agents|mesh-ancestor
102084510|NCT03091504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102084511|NCT03091504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084512|NCT03091504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101943782|NCT01758328|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101943783|NCT01758328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101943784|NCT01758328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943785|NCT01758328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101943786|NCT01758328|Immunologic Factors|immunologic factors|mesh-ancestor
101943787|NCT01758328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943788|NCT01758328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101943789|NCT01758328|Alkylating Agents|alkylating agents|mesh-ancestor
101943790|NCT01758328|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101943791|NCT04125550|Propofol|propofol|mesh-list
101455043|NCT05427721|Thymol|thymol|mesh-list
102084513|NCT03091504|Respiratory System Agents|respiratory system agents|mesh-ancestor
102084514|NCT03091504|Tocolytic Agents|tocolytic agents|mesh-ancestor
102084515|NCT03091504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102084516|NCT03091504|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102084517|NCT03091504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102084518|NCT03091504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102084519|NCT03091504|Adrenergic Agents|adrenergic agents|mesh-ancestor
102084520|NCT03091504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102084521|NCT03091504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084522|NCT05019586|Amoxicillin|amoxicillin|mesh-list
102084523|NCT05019586|Clarithromycin|clarithromycin|mesh-list
101386150|NCT00309205|Dapivirine|dapivirine|mesh-list
102084528|NCT05019586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102084529|NCT05019586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084530|NCT05019586|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102084531|NCT05019586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102084532|NCT05019586|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102084533|NCT05019586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102084534|NCT05019586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102084535|NCT05019586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102084536|NCT05019586|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102084537|NCT03081676|Glimepiride|glimepiride|mesh-list
102084538|NCT03081676|Glucagon|glucagon|mesh-list
102084539|NCT03081676|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
102084540|NCT03081676|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102084541|NCT03081676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102084542|NCT03081676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102084543|NCT03081676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084545|NCT03081676|Immunologic Factors|immunologic factors|mesh-ancestor
102084546|NCT03081676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102084547|NCT03081676|Hormones|hormones|mesh-ancestor
102084548|NCT03081676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102084549|NCT03081676|Incretins|incretins|mesh-ancestor
102084550|NCT05013268|Paclitaxel|paclitaxel|mesh-list
102084551|NCT05013268|Docetaxel|docetaxel|mesh-list
102084552|NCT05013268|Carboplatin|carboplatin|mesh-list
102084553|NCT05013268|Tislelizumab|tislelizumab|mesh-list
102084554|NCT05013268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102084555|NCT05013268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102084556|NCT05013268|Tubulin Modulators|tubulin modulators|mesh-ancestor
102084557|NCT05013268|Antimitotic Agents|antimitotic agents|mesh-ancestor
102084558|NCT05013268|Mitosis Modulators|mitosis modulators|mesh-ancestor
102084559|NCT05013268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084560|NCT05013268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102084561|NCT00102960|Ritonavir|ritonavir|mesh-list
102084562|NCT00102960|Lopinavir|lopinavir|mesh-list
102084563|NCT00102960|Lamivudine|lamivudine|mesh-list
102084564|NCT00102960|Zidovudine|zidovudine|mesh-list
102084565|NCT00102960|Nevirapine|nevirapine|mesh-list
102084566|NCT00102960|Abacavir|abacavir|mesh-list
102084567|NCT00102960|Didanosine|didanosine|mesh-list
102084568|NCT00102960|Efavirenz|efavirenz|mesh-list
102084569|NCT00102960|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102084570|NCT00102960|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102084571|NCT00102960|Protease Inhibitors|protease inhibitors|mesh-ancestor
101943792|NCT04125550|Sevoflurane|sevoflurane|mesh-list
101455082|NCT00211679|Cholinergic Agents|cholinergic agents|mesh-ancestor
102084572|NCT00102960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102084573|NCT00102960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084574|NCT00102960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102084575|NCT00102960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102084576|NCT00102960|Antiviral Agents|antiviral agents|mesh-ancestor
102084577|NCT00102960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102084578|NCT00102960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102084579|NCT00102960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102084580|NCT00102960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102084581|NCT00102960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102084582|NCT00102960|Antimetabolites|antimetabolites|mesh-ancestor
102084583|NCT00102960|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102084584|NCT00102960|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102084585|NCT00102960|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102084586|NCT00102960|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102084587|NCT00102960|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102084588|NCT02858895|Interleukin-4|interleukin-4|mesh-list
102084589|NCT02858895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102084590|NCT02858895|Immunologic Factors|immunologic factors|mesh-ancestor
102084591|NCT02858895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084592|NCT02858895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102084593|NCT02858895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102084594|NCT05018962|Paclitaxel|paclitaxel|mesh-list
102084595|NCT05018962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102084596|NCT05018962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102084600|NCT05018962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084602|NCT02160054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102084603|NCT02160054|Immunologic Factors|immunologic factors|mesh-ancestor
102084604|NCT02160054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084605|NCT02160054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102084606|NCT02160054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102084607|NCT02160054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084608|NCT03609489|Capecitabine|capecitabine|mesh-list
102084609|NCT03609489|Apatinib|apatinib|mesh-list
102084610|NCT03609489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102084611|NCT03609489|Antimetabolites|antimetabolites|mesh-ancestor
102084612|NCT03609489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084613|NCT03609489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102084614|NCT03609489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102084615|NCT03609489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102084616|NCT02033967|Milrinone|milrinone|mesh-list
102084617|NCT02033967|Vasodilator Agents|vasodilator agents|mesh-list
102084618|NCT02033967|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102084619|NCT02033967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102084620|NCT02033967|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101705475|NCT02710877|Anesthetics|anesthetics|mesh-ancestor
102084621|NCT02033967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102084622|NCT02033967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102084623|NCT02033967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084624|NCT02033967|Protective Agents|protective agents|mesh-ancestor
102084625|NCT02033967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084626|NCT02163330|Acetazolamide|acetazolamide|mesh-list
102084627|NCT02163330|Anticonvulsants|anticonvulsants|mesh-ancestor
102084628|NCT02163330|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102084629|NCT02163330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102084630|NCT02163330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084631|NCT02163330|Diuretics|diuretics|mesh-ancestor
102084632|NCT02163330|Natriuretic Agents|natriuretic agents|mesh-ancestor
102084633|NCT02163330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084634|NCT03610035|Immunoglobulins|immunoglobulins|mesh-list
102084635|NCT03610035|Immunoglobulin G|immunoglobulin g|mesh-list
102084636|NCT03610035|Immunologic Factors|immunologic factors|mesh-ancestor
102084637|NCT03610035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084638|NCT02160132|Methylprednisolone|methylprednisolone|mesh-list
102084639|NCT02160132|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102084640|NCT02160132|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102084641|NCT02160132|Prednisolone|prednisolone|mesh-list
102084642|NCT02160132|Prednisolone acetate|prednisolone acetate|mesh-list
102084643|NCT02160132|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102084644|NCT02160132|Prednisolone phosphate|prednisolone phosphate|mesh-list
102084645|NCT02160132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101943793|NCT04125550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101943794|NCT04125550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101943795|NCT04125550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943796|NCT04125550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101943797|NCT04125550|Anesthetics, General|anesthetics, general|mesh-ancestor
101943798|NCT04125550|Anesthetics|anesthetics|mesh-ancestor
101943799|NCT04125550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101943800|NCT04125550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101943801|NCT02237326|Acetic Acid|acetic acid|mesh-list
101943802|NCT02237326|Retinol acetate|retinol acetate|mesh-list
101943803|NCT02237326|Lugol's solution|lugol's solution|mesh-list
101943804|NCT02237326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101943805|NCT02237326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101943806|NCT02237326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101943807|NCT02237326|Immunologic Factors|immunologic factors|mesh-ancestor
101943808|NCT02237326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943809|NCT02237326|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102084646|NCT02160132|Antiemetics|antiemetics|mesh-ancestor
102084647|NCT02160132|Autonomic Agents|autonomic agents|mesh-ancestor
102084648|NCT02160132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102084649|NCT02160132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084650|NCT02160132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102084651|NCT02160132|Glucocorticoids|glucocorticoids|mesh-ancestor
102084652|NCT02160132|Hormones|hormones|mesh-ancestor
102084653|NCT02160132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102084654|NCT02160132|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102084655|NCT02160132|Protective Agents|protective agents|mesh-ancestor
102084656|NCT02160132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102084657|NCT02160132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102084658|NCT02034201|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102084659|NCT02034201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102084660|NCT02034201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084661|NCT02034201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102084662|NCT02034201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102084663|NCT02034201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102084664|NCT02034201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084665|NCT02034201|Dopamine Agents|dopamine agents|mesh-ancestor
102084666|NCT02034201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102084669|NCT02637856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084670|NCT02858037|Dapivirine|dapivirine|mesh-list
102084671|NCT02858037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102084672|NCT02858037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102084673|NCT02858037|Antiviral Agents|antiviral agents|mesh-ancestor
102084674|NCT02858037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102084675|NCT01755975|Lenalidomide|lenalidomide|mesh-list
102084676|NCT01755975|Romidepsin|romidepsin|mesh-list
102084677|NCT01755975|Immunologic Factors|immunologic factors|mesh-ancestor
102084678|NCT01755975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084679|NCT01755975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102084680|NCT01755975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102084681|NCT01755975|Growth Substances|growth substances|mesh-ancestor
102084682|NCT01755975|Growth Inhibitors|growth inhibitors|mesh-ancestor
102084683|NCT01755975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102084684|NCT01755975|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102084685|NCT01755975|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102084686|NCT01755975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102084687|NCT01755975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943810|NCT02237326|Protective Agents|protective agents|mesh-ancestor
101943811|NCT02237326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101943812|NCT02237326|Hemostatics|hemostatics|mesh-ancestor
101943813|NCT02237326|Coagulants|coagulants|mesh-ancestor
101943814|NCT02034604|Tamsulosin|tamsulosin|mesh-list
101943815|NCT02034604|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101943816|NCT02034604|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101943817|NCT02034604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101943818|NCT02034604|Adrenergic Agents|adrenergic agents|mesh-ancestor
101943819|NCT02034604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101308692|NCT00386529|Antipyretics|antipyretics|mesh-ancestor
102084688|NCT01541709|Imatinib Mesylate|imatinib mesylate|mesh-list
102084689|NCT01541709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102084690|NCT01541709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102084691|NCT01541709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102084692|NCT01541709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084693|NCT04266340|Midazolam|midazolam|mesh-list
102084694|NCT04266340|Dexmedetomidine|dexmedetomidine|mesh-list
102084695|NCT04266340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102084696|NCT04266340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102084697|NCT04266340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084698|NCT04266340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102084699|NCT04266340|Analgesics|analgesics|mesh-ancestor
102084700|NCT04266340|Sensory System Agents|sensory system agents|mesh-ancestor
102084701|NCT04266340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102084702|NCT04266340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102084703|NCT04266340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102084704|NCT04266340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102084705|NCT04266340|Adrenergic Agents|adrenergic agents|mesh-ancestor
102084706|NCT04266340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102084707|NCT04266340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084708|NCT04266340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102084709|NCT04266340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102084710|NCT04266340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102084711|NCT04266340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102084712|NCT04266340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102084713|NCT04266340|Anesthetics, General|anesthetics, general|mesh-ancestor
102084714|NCT04266340|Anesthetics|anesthetics|mesh-ancestor
102084715|NCT04266340|GABA Modulators|gaba modulators|mesh-ancestor
102084716|NCT04266340|GABA Agents|gaba agents|mesh-ancestor
102084717|NCT02856555|Firsocostat|firsocostat|mesh-list
102084718|NCT02856555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102084719|NCT02856555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084720|NCT03609099|Moxifloxacin|moxifloxacin|mesh-list
102084721|NCT03609099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102084722|NCT03609099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102084723|NCT03609099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102084724|NCT03609099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102084725|NCT03609099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102084726|NCT03609099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084727|NCT03609099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102084728|NCT05000086|Diphosphonates|diphosphonates|mesh-list
102084729|NCT05000086|Methylene diphosphonate|methylene diphosphonate|mesh-list
102084730|NCT05000086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102084731|NCT05000086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084732|NCT01242267|Thalidomide|thalidomide|mesh-list
102084733|NCT01242267|Bortezomib|bortezomib|mesh-list
102084734|NCT01242267|Melphalan|melphalan|mesh-list
102084735|NCT01242267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102084736|NCT01242267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102084737|NCT01242267|Alkylating Agents|alkylating agents|mesh-ancestor
102084738|NCT01242267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084739|NCT01242267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102084740|NCT01242267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102084744|NCT01242267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101943820|NCT02034604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943821|NCT02034604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943822|NCT02034604|Urological Agents|urological agents|mesh-ancestor
101943823|NCT03608098|Oxymetazoline|oxymetazoline|mesh-list
101943824|NCT03608098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101943825|NCT03608098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101943826|NCT03608098|Adrenergic Agents|adrenergic agents|mesh-ancestor
101943827|NCT03608098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101943828|NCT03608098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943829|NCT03608098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943830|NCT03608098|Sympathomimetics|sympathomimetics|mesh-ancestor
101943831|NCT03608098|Autonomic Agents|autonomic agents|mesh-ancestor
101943832|NCT03608098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101943833|NCT03608098|Nasal Decongestants|nasal decongestants|mesh-ancestor
101943834|NCT03608098|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101943835|NCT03608098|Respiratory System Agents|respiratory system agents|mesh-ancestor
102084745|NCT01242267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102084746|NCT01242267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102084747|NCT01242267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102084748|NCT01242267|Growth Substances|growth substances|mesh-ancestor
102084749|NCT01242267|Growth Inhibitors|growth inhibitors|mesh-ancestor
102084750|NCT02637232|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102084751|NCT02637232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102084752|NCT02637232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102084753|NCT02637232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102084754|NCT02637232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102084755|NCT02637232|Adrenergic Agents|adrenergic agents|mesh-ancestor
102084756|NCT02637232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102084757|NCT02637232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084758|NCT02637232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084759|NCT02635984|Olanzapine|olanzapine|mesh-list
102084760|NCT02635984|Antiemetics|antiemetics|mesh-ancestor
102084761|NCT02635984|Autonomic Agents|autonomic agents|mesh-ancestor
102084762|NCT02635984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102084763|NCT02635984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084764|NCT02635984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102084765|NCT02635984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102084766|NCT02635984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102084767|NCT02635984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102084768|NCT02635984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102084769|NCT02635984|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102084770|NCT02635984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102084771|NCT02635984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102084772|NCT02635984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084773|NCT02635984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102084774|NCT02635984|Serotonin Agents|serotonin agents|mesh-ancestor
102084775|NCT03073408|Propofol|propofol|mesh-list
102084776|NCT03073408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102084777|NCT03073408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102084778|NCT03073408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084779|NCT03073408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102084780|NCT03073408|Anesthetics, General|anesthetics, general|mesh-ancestor
102084781|NCT03073408|Anesthetics|anesthetics|mesh-ancestor
102084782|NCT04993222|Amphotericin B|amphotericin b|mesh-list
102084783|NCT04993222|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102084784|NCT04993222|Amebicides|amebicides|mesh-ancestor
102084785|NCT04993222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101943836|NCT02035072|Gemcitabine|gemcitabine|mesh-list
101943837|NCT02035072|Oxaliplatin|oxaliplatin|mesh-list
101943838|NCT02035072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101943839|NCT02035072|Antimetabolites|antimetabolites|mesh-ancestor
101943840|NCT02035072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943841|NCT02035072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101943842|NCT00358215|Darbepoetin alfa|darbepoetin alfa|mesh-list
101943843|NCT00358215|Hematinics|hematinics|mesh-ancestor
101943844|NCT03605758|Ivermectin|ivermectin|mesh-list
102084786|NCT04993222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102084787|NCT04993222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102084788|NCT04993222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102084789|NCT04993222|Antifungal Agents|antifungal agents|mesh-ancestor
102084790|NCT03076762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102084791|NCT03076762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102084792|NCT03076762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102084793|NCT03076762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102084794|NCT03076762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084795|NCT03076762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102084796|NCT03076762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102084797|NCT03076762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084798|NCT03076762|Cholinergic Agents|cholinergic agents|mesh-ancestor
102084799|NCT03076762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102084800|NCT02747043|Rituximab|rituximab|mesh-list
102084801|NCT02747043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102084802|NCT02747043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102084803|NCT02747043|Immunologic Factors|immunologic factors|mesh-ancestor
102084804|NCT02747043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084805|NCT02747043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102084806|NCT05004142|Letrozole|letrozole|mesh-list
102084807|NCT05004142|Fulvestrant|fulvestrant|mesh-list
102084808|NCT05004142|Goserelin|goserelin|mesh-list
102084809|NCT05004142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102084810|NCT05004142|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102084811|NCT05004142|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102084812|NCT05004142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102084816|NCT05004142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102084817|NCT05004142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084818|NCT05004142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102084819|NCT05004142|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102084820|NCT03076684|Allopurinol|allopurinol|mesh-list
102084821|NCT03076684|Antimetabolites|antimetabolites|mesh-ancestor
102084822|NCT03076684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084823|NCT03076684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102084824|NCT03076684|Gout Suppressants|gout suppressants|mesh-ancestor
102084825|NCT03076684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102084826|NCT03076684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102084827|NCT03076684|Antioxidants|antioxidants|mesh-ancestor
102084828|NCT03076684|Protective Agents|protective agents|mesh-ancestor
102084829|NCT03076684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084830|NCT04999930|Tiotropium Bromide|tiotropium bromide|mesh-list
102084831|NCT04999930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102084832|NCT04999930|Autonomic Agents|autonomic agents|mesh-ancestor
102084833|NCT04999930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102084834|NCT04999930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084835|NCT04999930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102084836|NCT04999930|Respiratory System Agents|respiratory system agents|mesh-ancestor
102084837|NCT04999930|Parasympatholytics|parasympatholytics|mesh-ancestor
102084838|NCT04999930|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102084839|NCT04999930|Cholinergic Agents|cholinergic agents|mesh-ancestor
102084840|NCT04999930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102084841|NCT04999930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084842|NCT03607851|Lacosamide|lacosamide|mesh-list
102084843|NCT03607851|Anticonvulsants|anticonvulsants|mesh-ancestor
102084844|NCT03607851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102084845|NCT03607851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101943845|NCT03605758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101943846|NCT03605758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101943847|NCT03605056|Dexamethasone|dexamethasone|mesh-list
101943848|NCT03605056|Lenalidomide|lenalidomide|mesh-list
101943849|NCT03605056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101943850|NCT03605056|Antiemetics|antiemetics|mesh-ancestor
101943851|NCT03605056|Autonomic Agents|autonomic agents|mesh-ancestor
101943852|NCT03605056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101943853|NCT03605056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943854|NCT03605056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101943855|NCT03605056|Glucocorticoids|glucocorticoids|mesh-ancestor
101943856|NCT03605056|Hormones|hormones|mesh-ancestor
102084846|NCT03607851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102084847|NCT03607851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084848|NCT04999540|Fulvestrant|fulvestrant|mesh-list
102084849|NCT04999540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102084850|NCT04999540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102084851|NCT04999540|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102084852|NCT04999540|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102084853|NCT04999540|Hormone Antagonists|hormone antagonists|mesh-ancestor
102084854|NCT04999540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102084855|NCT04999540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084856|NCT03608007|Ensartinib|ensartinib|mesh-list
102084857|NCT03608007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102084858|NCT03608007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102084859|NCT03608007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102084860|NCT03608007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084861|NCT02637076|Sodium Oxybate|sodium oxybate|mesh-list
102084862|NCT02637076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102084863|NCT02637076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102084864|NCT02637076|Anesthetics, General|anesthetics, general|mesh-ancestor
102084865|NCT02637076|Anesthetics|anesthetics|mesh-ancestor
102084866|NCT02637076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102084867|NCT02637076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084868|NCT03075358|Lidocaine|lidocaine|mesh-list
102084869|NCT03075358|Anesthetics, Local|anesthetics, local|mesh-ancestor
102084870|NCT03075358|Anesthetics|anesthetics|mesh-ancestor
102084871|NCT03075358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102084872|NCT03075358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084873|NCT03075358|Sensory System Agents|sensory system agents|mesh-ancestor
102084874|NCT03075358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102084875|NCT03075358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102084876|NCT03075358|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102084877|NCT03075358|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102084878|NCT03075358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102084879|NCT03075358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084880|NCT05003596|Methylprednisolone|methylprednisolone|mesh-list
102084881|NCT05003596|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102084888|NCT05003596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102084889|NCT05003596|Antiemetics|antiemetics|mesh-ancestor
102084890|NCT05003596|Autonomic Agents|autonomic agents|mesh-ancestor
102084891|NCT05003596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102084892|NCT05003596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084893|NCT05003596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102084894|NCT05003596|Glucocorticoids|glucocorticoids|mesh-ancestor
102084896|NCT05003596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102084897|NCT05003596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102084898|NCT05003596|Protective Agents|protective agents|mesh-ancestor
102084899|NCT05003596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102084900|NCT05003596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102084901|NCT05003596|Analgesics|analgesics|mesh-ancestor
102084902|NCT05003596|Sensory System Agents|sensory system agents|mesh-ancestor
101943857|NCT03605056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101308735|NCT00005940|Iodine|iodine|mesh-list
102084903|NCT05003596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102084904|NCT02854527|Metformin|metformin|mesh-list
102084905|NCT02854527|Digoxin|digoxin|mesh-list
102084906|NCT02854527|Furosemide|furosemide|mesh-list
102084907|NCT02854527|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102084908|NCT02854527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102084909|NCT02854527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084910|NCT02854527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102084911|NCT02854527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102084912|NCT02854527|Antimetabolites|antimetabolites|mesh-ancestor
102084913|NCT02854527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084914|NCT02854527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102084915|NCT02854527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102084916|NCT02854527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102084917|NCT02854527|Diuretics|diuretics|mesh-ancestor
102084918|NCT02854527|Natriuretic Agents|natriuretic agents|mesh-ancestor
101705578|NCT00870870|Gemcitabine|gemcitabine|mesh-list
102084919|NCT02854527|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102084920|NCT02854527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102084921|NCT02854527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102084922|NCT02854527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102084923|NCT02854527|Protective Agents|protective agents|mesh-ancestor
102084924|NCT04433572|Sirolimus|sirolimus|mesh-list
102084925|NCT04433572|Temsirolimus|temsirolimus|mesh-list
102084926|NCT04433572|MTOR Inhibitors|mtor inhibitors|mesh-list
102084927|NCT04433572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102084928|NCT04433572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102084929|NCT04433572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084930|NCT04433572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102084931|NCT04433572|Immunologic Factors|immunologic factors|mesh-ancestor
102084932|NCT04433572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084933|NCT04433572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102084934|NCT04433572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102084935|NCT04433572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102084936|NCT04433572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102084937|NCT04433572|Antifungal Agents|antifungal agents|mesh-ancestor
102084938|NCT03073018|Fosinopril|fosinopril|mesh-list
102084939|NCT03073018|Pravastatin|pravastatin|mesh-list
102084940|NCT03073018|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102084941|NCT03073018|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102084942|NCT03073018|Antimetabolites|antimetabolites|mesh-ancestor
102084943|NCT03073018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084944|NCT03073018|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102084945|NCT03073018|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102084946|NCT03073018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102084947|NCT03073018|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102084948|NCT03073018|Protease Inhibitors|protease inhibitors|mesh-ancestor
102084949|NCT03073018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102084950|NCT03608241|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101386578|NCT00089037|Tacrolimus|tacrolimus|mesh-list
102084956|NCT03608241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102084958|NCT03608241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102084959|NCT03608241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102084960|NCT03608241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102084961|NCT03608241|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102084962|NCT03606057|Moxifloxacin|moxifloxacin|mesh-list
102084963|NCT03606057|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102084964|NCT03606057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102084965|NCT03606057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102084966|NCT03606057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102084967|NCT03606057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102084968|NCT03606057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102084969|NCT03606057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084970|NCT03606057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102084971|NCT03606057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102084972|NCT03606057|Contraceptive Agents|contraceptive agents|mesh-ancestor
102084973|NCT03606057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102084974|NCT03606057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084975|NCT03606057|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102084976|NCT03606057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101943858|NCT03605056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101943859|NCT03605056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101943860|NCT03605056|Immunologic Factors|immunologic factors|mesh-ancestor
101943861|NCT03605056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101943862|NCT03605056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101943863|NCT03605056|Growth Substances|growth substances|mesh-ancestor
101943864|NCT03605056|Growth Inhibitors|growth inhibitors|mesh-ancestor
101943865|NCT01002742|Mycophenolic Acid|mycophenolic acid|mesh-list
101943866|NCT01002742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101943867|NCT01002742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102084977|NCT03606057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102084978|NCT03607383|Red yeast rice|red yeast rice|mesh-list
102084979|NCT03607383|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101705596|NCT04120636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102084980|NCT03607383|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102084981|NCT03607383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102084982|NCT03607383|Antimetabolites|antimetabolites|mesh-ancestor
102084983|NCT03607383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084984|NCT03607383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102084985|NCT03607383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102084986|NCT03607227|Levobupivacaine|levobupivacaine|mesh-list
102084987|NCT03607227|Anesthetics, Local|anesthetics, local|mesh-ancestor
102084988|NCT03607227|Anesthetics|anesthetics|mesh-ancestor
101804754|NCT05324891|Narcotics|narcotics|mesh-ancestor
102084989|NCT03607227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102084990|NCT03607227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084991|NCT03607227|Sensory System Agents|sensory system agents|mesh-ancestor
102084992|NCT03607227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102084994|NCT03607149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102084995|NCT03607149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102084996|NCT03607149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084997|NCT03607149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102084998|NCT03607149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102084999|NCT04998838|Tenofovir|tenofovir|mesh-list
102085000|NCT04998838|Immunoglobulins|immunoglobulins|mesh-list
102085001|NCT04998838|Antibodies|antibodies|mesh-list
102085002|NCT04998838|gamma-Globulins|gamma-globulins|mesh-list
102085003|NCT04998838|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102085004|NCT04998838|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102085005|NCT04998838|Antiviral Agents|antiviral agents|mesh-ancestor
102085006|NCT04998838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102085007|NCT04998838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102085008|NCT04998838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102085009|NCT04998838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102085010|NCT04998838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085011|NCT04998838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102085012|NCT04998838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102085013|NCT04998838|Immunologic Factors|immunologic factors|mesh-ancestor
102085014|NCT04998838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085015|NCT03607071|Prednisolone|prednisolone|mesh-list
102085016|NCT03607071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102085017|NCT03607071|Glucocorticoids|glucocorticoids|mesh-ancestor
102085018|NCT03607071|Hormones|hormones|mesh-ancestor
101386648|NCT00121524|Epinephrine|epinephrine|mesh-list
102085029|NCT02035215|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102085031|NCT03605589|Pembrolizumab|pembrolizumab|mesh-list
102085032|NCT03605589|Blinatumomab|blinatumomab|mesh-list
102085033|NCT03605589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102085034|NCT03605589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102085035|NCT03605589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102085036|NCT03605589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085037|NCT05002270|Cetuximab|cetuximab|mesh-list
102085038|NCT05002270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102085039|NCT05002270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102085040|NCT05002036|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101943868|NCT01002742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101943869|NCT01002742|Antitubercular Agents|antitubercular agents|mesh-ancestor
101943870|NCT01002742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101943871|NCT01002742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101943872|NCT01002742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101943873|NCT01002742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943874|NCT03604744|Psilocybin|psilocybin|mesh-list
101943875|NCT03604744|Hallucinogens|hallucinogens|mesh-ancestor
101943876|NCT03604744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943877|NCT03604744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101943878|NCT03604354|Pregabalin|pregabalin|mesh-list
101943879|NCT03604354|Tapentadol|tapentadol|mesh-list
101943880|NCT03604354|Analgesics|analgesics|mesh-ancestor
101943881|NCT03604354|Sensory System Agents|sensory system agents|mesh-ancestor
101943882|NCT03604354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101943883|NCT03604354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943884|NCT03604354|Anticonvulsants|anticonvulsants|mesh-ancestor
101943885|NCT03604354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101943886|NCT03604354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101943887|NCT03604354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943888|NCT03604354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101943889|NCT03604354|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101663732|NCT05339646|Ritonavir|ritonavir|mesh-list
101943890|NCT03604354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101943891|NCT03604354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101943892|NCT03604354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101943893|NCT03604354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101943895|NCT03604354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101943896|NCT03604354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101943897|NCT03604354|Adrenergic Agents|adrenergic agents|mesh-ancestor
101943898|NCT03604354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101943899|NCT03603418|Dexamethasone|dexamethasone|mesh-list
101943900|NCT03603418|Dexamethasone acetate|dexamethasone acetate|mesh-list
101943901|NCT03603418|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101943902|NCT03603418|BB 1101|bb 1101|mesh-list
101943903|NCT03603418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101308776|NCT00005946|Etoposide|etoposide|mesh-list
102085041|NCT05002036|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101943904|NCT03603418|Antiemetics|antiemetics|mesh-ancestor
101943905|NCT03603418|Autonomic Agents|autonomic agents|mesh-ancestor
101943906|NCT03603418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101943907|NCT03603418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943908|NCT03603418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102085042|NCT03074968|Benzydamine|benzydamine|mesh-list
102085043|NCT03074968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102085044|NCT04991584|Amoxicillin|amoxicillin|mesh-list
102085045|NCT04991584|Levofloxacin|levofloxacin|mesh-list
102085046|NCT04991584|Tetracycline|tetracycline|mesh-list
102085047|NCT04991584|Furazolidone|furazolidone|mesh-list
102085048|NCT04991584|Esomeprazole|esomeprazole|mesh-list
102085049|NCT04991584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102085050|NCT04991584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102085051|NCT04991584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102085052|NCT04991584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102085053|NCT04991584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102085054|NCT04991584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102085055|NCT04991584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085056|NCT04991584|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102085057|NCT04991584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102085058|NCT04991584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102085059|NCT04991584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102085060|NCT04991584|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102085061|NCT04991584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102085062|NCT04991584|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102085063|NCT04991584|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102085064|NCT04991584|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
102085065|NCT04991584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102085066|NCT04991584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102085067|NCT04991584|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102085069|NCT05001412|Etoposide|etoposide|mesh-list
102085070|NCT05001412|Apatinib|apatinib|mesh-list
102085071|NCT05001412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102085072|NCT05001412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102085073|NCT05001412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102085074|NCT05001412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102085075|NCT05001412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102085076|NCT05001412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085077|NCT05001412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102085078|NCT04991896|Metoprolol|metoprolol|mesh-list
102085079|NCT04991896|Sotalol|sotalol|mesh-list
102085080|NCT04991896|Flecainide|flecainide|mesh-list
102085081|NCT04991896|Bisoprolol|bisoprolol|mesh-list
102085082|NCT04991896|Betaxolol|betaxolol|mesh-list
102085087|NCT04991896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102085088|NCT04991896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085089|NCT04991896|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102085090|NCT04991896|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102085091|NCT04991896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102085092|NCT04991896|Adrenergic Agents|adrenergic agents|mesh-ancestor
102085093|NCT04991896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102085094|NCT04991896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085095|NCT04991896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102085096|NCT04991896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102085097|NCT04991896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102085098|NCT03072394|Lidocaine|lidocaine|mesh-list
102085099|NCT03072394|Anesthetics, Local|anesthetics, local|mesh-list
102085100|NCT03072394|Anesthetics|anesthetics|mesh-list
102085101|NCT03072394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102085102|NCT03072394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085103|NCT03072394|Sensory System Agents|sensory system agents|mesh-ancestor
102085104|NCT03072394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102085105|NCT03072394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102085106|NCT03072394|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102085107|NCT03072394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102085108|NCT03072394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102085109|NCT03072394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085110|NCT03072082|Aspirin|aspirin|mesh-list
102085111|NCT03072082|Metoprolol|metoprolol|mesh-list
101943909|NCT03603418|Glucocorticoids|glucocorticoids|mesh-ancestor
101943910|NCT03603418|Hormones|hormones|mesh-ancestor
101943911|NCT03603418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102085112|NCT03072082|Isosorbide|isosorbide|mesh-list
102085113|NCT03072082|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
102085114|NCT03072082|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
102085115|NCT03072082|Trimetazidine|trimetazidine|mesh-list
102085116|NCT03072082|Clopidogrel|clopidogrel|mesh-list
102085117|NCT03072082|Atorvastatin|atorvastatin|mesh-list
102085118|NCT03072082|Calcium|calcium|mesh-list
102085119|NCT03072082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102085120|NCT03072082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085121|NCT03072082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102085122|NCT03072082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102085123|NCT03072082|Analgesics|analgesics|mesh-ancestor
102085124|NCT03072082|Sensory System Agents|sensory system agents|mesh-ancestor
102085125|NCT03072082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102085126|NCT03072082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102085127|NCT03072082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102085128|NCT03072082|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102085129|NCT03072082|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102085130|NCT03072082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085131|NCT03072082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101705634|NCT02709863|Anesthetics|anesthetics|mesh-ancestor
102085132|NCT03072082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102085133|NCT03072082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102085134|NCT03072082|Antipyretics|antipyretics|mesh-ancestor
102085135|NCT03072082|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102085136|NCT03072082|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102085137|NCT03072082|Antimetabolites|antimetabolites|mesh-ancestor
101804914|NCT00694109|Mipomersen|mipomersen|mesh-list
102085139|NCT03072082|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102085140|NCT03072082|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102085141|NCT03072082|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102085142|NCT03072082|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102085143|NCT03072082|Purinergic Agents|purinergic agents|mesh-ancestor
102085144|NCT03072082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102085145|NCT03072082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102085146|NCT03072082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102085147|NCT03072082|Sympatholytics|sympatholytics|mesh-ancestor
102085148|NCT03072082|Autonomic Agents|autonomic agents|mesh-ancestor
102085149|NCT03072082|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102085150|NCT03072082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102085151|NCT03072082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102085152|NCT03072082|Adrenergic Agents|adrenergic agents|mesh-ancestor
102085159|NCT04934020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102085160|NCT04934020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102085161|NCT04934020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102085162|NCT04934020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102085163|NCT04904614|Letermovir|letermovir|mesh-list
102085164|NCT04904614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102085165|NCT04904614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102085166|NCT04904614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085167|NCT04904614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102085168|NCT04904614|Antiviral Agents|antiviral agents|mesh-ancestor
102085169|NCT04904614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102085170|NCT04987450|Prednisone|prednisone|mesh-list
102085171|NCT04987450|Methylprednisolone|methylprednisolone|mesh-list
102085172|NCT04987450|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102085173|NCT04987450|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102085174|NCT04987450|Prednisolone|prednisolone|mesh-list
102085175|NCT04987450|Prednisolone acetate|prednisolone acetate|mesh-list
102085176|NCT04987450|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102085177|NCT04987450|Prednisolone phosphate|prednisolone phosphate|mesh-list
102085178|NCT04987450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102085179|NCT04987450|Glucocorticoids|glucocorticoids|mesh-ancestor
102085180|NCT04987450|Hormones|hormones|mesh-ancestor
102085181|NCT04987450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102085182|NCT04987450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085183|NCT04987450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102085184|NCT04987450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102085185|NCT04987450|Antiemetics|antiemetics|mesh-ancestor
102085186|NCT04987450|Autonomic Agents|autonomic agents|mesh-ancestor
101943912|NCT03603418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101943913|NCT03603418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101943914|NCT03603418|Protease Inhibitors|protease inhibitors|mesh-ancestor
101943915|NCT03603418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101943916|NCT03603418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943917|NCT02034838|Ritonavir|ritonavir|mesh-list
101943918|NCT02034838|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101943919|NCT02034838|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101943920|NCT02034838|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101943921|NCT02034838|Protease Inhibitors|protease inhibitors|mesh-ancestor
101943922|NCT02034838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101705640|NCT03877237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101943923|NCT02034838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943924|NCT02034838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101943925|NCT02034838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101943926|NCT02034838|Antiviral Agents|antiviral agents|mesh-ancestor
101943927|NCT02034838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101943928|NCT02034838|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101943929|NCT02034838|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101943930|NCT02852434|Lidocaine|lidocaine|mesh-list
101943931|NCT02852434|Anesthetics, Local|anesthetics, local|mesh-ancestor
101943932|NCT02852434|Anesthetics|anesthetics|mesh-ancestor
102085187|NCT04987450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102085188|NCT04987450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102085189|NCT04987450|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102085190|NCT04987450|Protective Agents|protective agents|mesh-ancestor
102085191|NCT03074578|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102085192|NCT03074578|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
102085193|NCT03074578|beta-Endorphin|beta-endorphin|mesh-list
102085194|NCT03074578|Hormones|hormones|mesh-ancestor
102085195|NCT03074578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102085196|NCT03074578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085197|NCT03074578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102085198|NCT03074578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085199|NCT04991194|Zamicastat|zamicastat|mesh-list
102085200|NCT04991194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102085201|NCT04991194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085202|NCT02853435|Gepotidacin|gepotidacin|mesh-list
102085203|NCT02853435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102085204|NCT02853435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102085205|NCT02853435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085206|NCT02853435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102085207|NCT03071770|Ivosidenib|ivosidenib|mesh-list
102085208|NCT03071770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102085209|NCT03071770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102085210|NCT03071770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085211|NCT04986982|Opicapone|opicapone|mesh-list
102085212|NCT04986982|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102085214|NCT04986982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085215|NCT04986982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102085216|NCT04986982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102085217|NCT04996498|Oxytocin|oxytocin|mesh-list
102085218|NCT04996498|Oxytocics|oxytocics|mesh-ancestor
101943933|NCT02852434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101943934|NCT02852434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943935|NCT02852434|Sensory System Agents|sensory system agents|mesh-ancestor
101943936|NCT02852434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101943937|NCT02852434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101943938|NCT02852434|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102085219|NCT04996498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102085220|NCT04996498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085221|NCT03074344|Hyaluronic Acid|hyaluronic acid|mesh-list
102085222|NCT03074344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102085223|NCT03074344|Immunologic Factors|immunologic factors|mesh-ancestor
102085228|NCT03605511|Immunologic Factors|immunologic factors|mesh-ancestor
102085229|NCT03605511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085230|NCT02035371|Insulin|insulin|mesh-list
102085231|NCT02035371|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102085232|NCT02035371|Insulin Aspart|insulin aspart|mesh-list
102085233|NCT02035371|Insulin, Long-Acting|insulin, long-acting|mesh-list
102085234|NCT02035371|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102085235|NCT02035371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102085236|NCT02035371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085237|NCT03069820|Docetaxel|docetaxel|mesh-list
102085238|NCT03069820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102085239|NCT03069820|Tubulin Modulators|tubulin modulators|mesh-ancestor
102085240|NCT03069820|Antimitotic Agents|antimitotic agents|mesh-ancestor
102085241|NCT03069820|Mitosis Modulators|mitosis modulators|mesh-ancestor
102085242|NCT03069820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085243|NCT03605433|Rivaroxaban|rivaroxaban|mesh-list
102085244|NCT03605433|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102085245|NCT03605433|Antithrombins|antithrombins|mesh-ancestor
102085246|NCT03605433|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102085247|NCT03605433|Protease Inhibitors|protease inhibitors|mesh-ancestor
102085248|NCT03605433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102085249|NCT03605433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085250|NCT03605433|Anticoagulants|anticoagulants|mesh-ancestor
102085251|NCT03071302|Tissue Inhibitor of Metalloproteinase-3|tissue inhibitor of metalloproteinase-3|mesh-list
102085252|NCT03071302|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
102085253|NCT03071302|Protease Inhibitors|protease inhibitors|mesh-ancestor
102085254|NCT03071302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102085255|NCT03071302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085256|NCT03270501|Golimumab|golimumab|mesh-list
102085257|NCT03270501|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102085258|NCT03270501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102085259|NCT03270501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102085260|NCT03270501|Immunologic Factors|immunologic factors|mesh-ancestor
102085261|NCT03270501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085262|NCT03606681|Calcium, Dietary|calcium, dietary|mesh-list
102085263|NCT03606681|Calcium|calcium|mesh-list
102085264|NCT03606681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102085265|NCT03606681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085266|NCT03606681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102085267|NCT03071380|Rivaroxaban|rivaroxaban|mesh-list
102085268|NCT03071380|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102085269|NCT03071380|Antithrombins|antithrombins|mesh-ancestor
102085270|NCT03071380|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102085271|NCT03071380|Protease Inhibitors|protease inhibitors|mesh-ancestor
102085272|NCT03071380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102085273|NCT03071380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085274|NCT03071380|Anticoagulants|anticoagulants|mesh-ancestor
102085275|NCT03605199|Denosumab|denosumab|mesh-list
102085276|NCT03605199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102085277|NCT03605199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085278|NCT03606369|Ondansetron|ondansetron|mesh-list
102085279|NCT03606369|Palonosetron|palonosetron|mesh-list
102085280|NCT03606369|Antiemetics|antiemetics|mesh-ancestor
102085281|NCT03606369|Autonomic Agents|autonomic agents|mesh-ancestor
102085282|NCT03606369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102085283|NCT03606369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943939|NCT02852434|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101943940|NCT02852434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101308822|NCT00005961|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
102085284|NCT03606369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102085285|NCT03606369|Antipruritics|antipruritics|mesh-ancestor
102085286|NCT03606369|Dermatologic Agents|dermatologic agents|mesh-ancestor
102085287|NCT03606369|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102085288|NCT03606369|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102085289|NCT03606369|Serotonin Agents|serotonin agents|mesh-ancestor
102085290|NCT03606369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102085291|NCT03606369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085292|NCT02635204|Clobetasol|clobetasol|mesh-list
102085293|NCT02635204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102085294|NCT02635204|Glucocorticoids|glucocorticoids|mesh-ancestor
102085295|NCT02635204|Hormones|hormones|mesh-ancestor
102085297|NCT02635204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085299|NCT00102804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102085300|NCT00102804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102085301|NCT00102804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085302|NCT00102804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102085303|NCT00102804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102085304|NCT03038113|Immunomodulating Agents|immunomodulating agents|mesh-list
102085305|NCT03038113|Immunologic Factors|immunologic factors|mesh-ancestor
102085306|NCT03038113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085307|NCT02163720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102085308|NCT02163720|Doxorubicin|doxorubicin|mesh-list
102085309|NCT02163720|Trabectedin|trabectedin|mesh-list
102085310|NCT02163720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102085311|NCT02163720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102085312|NCT02163720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102085313|NCT02163720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102085314|NCT02163720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102085315|NCT02163720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085316|NCT02163720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102085317|NCT02163720|Alkylating Agents|alkylating agents|mesh-ancestor
102085318|NCT03487874|Ropivacaine|ropivacaine|mesh-list
102085319|NCT03487874|Anesthetics, Local|anesthetics, local|mesh-ancestor
102085320|NCT03487874|Anesthetics|anesthetics|mesh-ancestor
102085321|NCT03487874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102085322|NCT03487874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085323|NCT03487874|Sensory System Agents|sensory system agents|mesh-ancestor
102085324|NCT03487874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102085325|NCT04989400|Misoprostol|misoprostol|mesh-list
102085326|NCT04989400|Ulipristal acetate|ulipristal acetate|mesh-list
102085327|NCT04989400|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102085328|NCT04989400|Abortifacient Agents|abortifacient agents|mesh-ancestor
102085329|NCT04989400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102085330|NCT04989400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085331|NCT04989400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102085332|NCT04989400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102085333|NCT04989400|Oxytocics|oxytocics|mesh-ancestor
102085334|NCT04989400|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102085335|NCT04989400|Contraceptive Agents|contraceptive agents|mesh-ancestor
102085336|NCT04989400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102085337|NCT02163954|Clopidogrel|clopidogrel|mesh-list
102085338|NCT02163954|Ticagrelor|ticagrelor|mesh-list
102085339|NCT02163954|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102085340|NCT02163954|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102085341|NCT02163954|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102085342|NCT02163954|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102085343|NCT02163954|Purinergic Agents|purinergic agents|mesh-ancestor
102085344|NCT02163954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102085345|NCT02163954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085346|NCT02163954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085347|NCT04985656|Decitabine|decitabine|mesh-list
102085348|NCT04985656|Pevonedistat|pevonedistat|mesh-list
102085349|NCT04985656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102085350|NCT04985656|Antimetabolites|antimetabolites|mesh-ancestor
102085351|NCT04985656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085352|NCT04985656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102085353|NCT04985656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101943941|NCT02852434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943943|NCT03606928|Docetaxel|docetaxel|mesh-list
101943944|NCT03606928|Oxaliplatin|oxaliplatin|mesh-list
101943945|NCT03606928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101943946|NCT03606928|Tubulin Modulators|tubulin modulators|mesh-ancestor
101943947|NCT03606928|Antimitotic Agents|antimitotic agents|mesh-ancestor
101943948|NCT03606928|Mitosis Modulators|mitosis modulators|mesh-ancestor
102085354|NCT02164032|Insulin|insulin|mesh-list
102085355|NCT02164032|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102085356|NCT02164032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102085357|NCT02164032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085358|NCT04682288|Levofloxacin|levofloxacin|mesh-list
102085359|NCT04682288|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102085360|NCT04682288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102085361|NCT04682288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102085362|NCT04682288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102085363|NCT04682288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102085365|NCT04682288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085366|NCT04682288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102085367|NCT04682288|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102085371|NCT00968149|Respiratory System Agents|respiratory system agents|mesh-ancestor
102085372|NCT00968149|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102085373|NCT00968149|Hormone Antagonists|hormone antagonists|mesh-ancestor
102085374|NCT00968149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102085375|NCT00968149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085376|NCT00968149|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102085377|NCT00968149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102085378|NCT00968149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085379|NCT02164110|Vaccines|vaccines|mesh-list
102085380|NCT02164110|Immunologic Factors|immunologic factors|mesh-ancestor
102085381|NCT02164110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085382|NCT02167464|Coal Tar|coal tar|mesh-list
102085383|NCT02167464|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
102085384|NCT02167464|Keratolytic Agents|keratolytic agents|mesh-ancestor
102085385|NCT02167464|Dermatologic Agents|dermatologic agents|mesh-ancestor
102085386|NCT02167464|Hormone Antagonists|hormone antagonists|mesh-ancestor
102085387|NCT02167464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102085388|NCT02167464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085389|NCT02167464|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102085390|NCT02167464|Diuretics|diuretics|mesh-ancestor
102085391|NCT02167464|Natriuretic Agents|natriuretic agents|mesh-ancestor
102085392|NCT03485456|Tobramycin|tobramycin|mesh-list
102085393|NCT03485456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102085394|NCT03485456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102085395|NCT03487562|Amoxicillin|amoxicillin|mesh-list
102085396|NCT03487562|Clarithromycin|clarithromycin|mesh-list
102085397|NCT03487562|Lansoprazole|lansoprazole|mesh-list
102085398|NCT03487562|Dexlansoprazole|dexlansoprazole|mesh-list
102085399|NCT03487562|Fexuprazan|fexuprazan|mesh-list
102085400|NCT03487562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102085401|NCT03487562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102085402|NCT03487562|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102085403|NCT03487562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102085404|NCT03487562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085405|NCT03487562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102085406|NCT03487562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102085407|NCT03487562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102085408|NCT03487562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102085409|NCT03487562|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102085410|NCT02167620|Metformin|metformin|mesh-list
102085411|NCT02167620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102085412|NCT02167620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085413|NCT03485300|Warfarin|warfarin|mesh-list
102085414|NCT03485300|Anticoagulants|anticoagulants|mesh-ancestor
102085415|NCT00963469|Loratadine|loratadine|mesh-list
102085416|NCT00963469|Montelukast|montelukast|mesh-list
102085417|NCT00963469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101943949|NCT03606928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943950|NCT03606928|Antidotes|antidotes|mesh-ancestor
101943951|NCT03606928|Protective Agents|protective agents|mesh-ancestor
102085418|NCT00963469|Respiratory System Agents|respiratory system agents|mesh-ancestor
102085419|NCT00963469|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102085420|NCT00963469|Hormone Antagonists|hormone antagonists|mesh-ancestor
102085421|NCT00963469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102085422|NCT00963469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085423|NCT00963469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102085424|NCT00963469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102085425|NCT00963469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085426|NCT00963469|Antipruritics|antipruritics|mesh-ancestor
102085427|NCT00963469|Dermatologic Agents|dermatologic agents|mesh-ancestor
102085428|NCT00963469|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102085429|NCT00963469|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102085430|NCT00963469|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102085431|NCT00963469|Histamine Antagonists|histamine antagonists|mesh-ancestor
102085432|NCT00963469|Histamine Agents|histamine agents|mesh-ancestor
101805204|NCT01031368|Antiviral Agents|antiviral agents|mesh-ancestor
102085433|NCT00963469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102085434|NCT00897949|Rizatriptan|rizatriptan|mesh-list
102085435|NCT00897949|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102085436|NCT00897949|Serotonin Agents|serotonin agents|mesh-ancestor
102085437|NCT00897949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101387069|NCT00294853|Calcium|calcium|mesh-list
102085445|NCT03487406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102085446|NCT03487406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102085448|NCT03487406|Sensory System Agents|sensory system agents|mesh-ancestor
102085449|NCT03487406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102085450|NCT03487406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085451|NCT03487406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102085452|NCT03487406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102085453|NCT03487406|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102085454|NCT03487406|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102085455|NCT03487406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085456|NCT03487406|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102085457|NCT03487406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102085458|NCT03487406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102085459|NCT03487406|Antipyretics|antipyretics|mesh-ancestor
102085460|NCT03487406|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102085461|NCT03487406|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102085462|NCT03487406|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102085463|NCT03487406|Purinergic Agents|purinergic agents|mesh-ancestor
102085464|NCT03487406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102085465|NCT00725491|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102085466|NCT00725491|Ganirelix|ganirelix|mesh-list
102085467|NCT00725491|Luteolytic Agents|luteolytic agents|mesh-ancestor
102085468|NCT00725491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102085469|NCT00725491|Contraceptive Agents|contraceptive agents|mesh-ancestor
102085470|NCT00725491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102085471|NCT00725491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085472|NCT00725491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102085473|NCT00725491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102085474|NCT00725491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102085475|NCT00725491|Hormone Antagonists|hormone antagonists|mesh-ancestor
102085476|NCT00725491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102085477|NCT00724789|Ganirelix|ganirelix|mesh-list
102085478|NCT00724789|Hormone Antagonists|hormone antagonists|mesh-ancestor
102085479|NCT00724789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102085480|NCT00724789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085481|NCT00711607|Estradiol|estradiol|mesh-list
102085482|NCT00711607|Estrogens|estrogens|mesh-ancestor
102085483|NCT00711607|Hormones|hormones|mesh-ancestor
102085484|NCT00711607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102085485|NCT00711607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085486|NCT02164578|Aspirin|aspirin|mesh-list
102085487|NCT02164578|Rivaroxaban|rivaroxaban|mesh-list
102085488|NCT02164578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102085489|NCT02164578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101943952|NCT03606928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943953|NCT03606928|Vitamin B Complex|vitamin b complex|mesh-ancestor
101943954|NCT03606928|Vitamins|vitamins|mesh-ancestor
101943955|NCT03606928|Micronutrients|micronutrients|mesh-ancestor
101943956|NCT03602248|Methamphetamine|methamphetamine|mesh-list
101943957|NCT03602248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101943958|NCT03602248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943959|NCT03602248|Sympathomimetics|sympathomimetics|mesh-ancestor
102085490|NCT02164578|Analgesics|analgesics|mesh-ancestor
102085491|NCT02164578|Sensory System Agents|sensory system agents|mesh-ancestor
102085492|NCT02164578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102085493|NCT02164578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085494|NCT02164578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102085495|NCT02164578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102085496|NCT02164578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102085497|NCT02164578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102085498|NCT02164578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085499|NCT02164578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102085500|NCT02164578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102085501|NCT02164578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102085502|NCT02164578|Antipyretics|antipyretics|mesh-ancestor
102085503|NCT02164578|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102085511|NCT03893318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102085512|NCT03893318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085513|NCT03893318|Sensory System Agents|sensory system agents|mesh-ancestor
102085514|NCT03893318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102085515|NCT03893318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102085516|NCT03893318|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102085517|NCT03893318|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102085518|NCT03893318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102085519|NCT03893318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085520|NCT03625531|Letrozole|letrozole|mesh-list
102085521|NCT03625531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102085522|NCT03625531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102085523|NCT03625531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102085524|NCT03625531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102085525|NCT03625531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085526|NCT03625531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102085527|NCT03625531|Hormone Antagonists|hormone antagonists|mesh-ancestor
102085528|NCT03625531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102085529|NCT03625531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085530|NCT02167698|Methylprednisolone|methylprednisolone|mesh-list
102085531|NCT02167698|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102085532|NCT02167698|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102085533|NCT02167698|Prednisolone|prednisolone|mesh-list
102085534|NCT02167698|Prednisolone acetate|prednisolone acetate|mesh-list
102085535|NCT02167698|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102085536|NCT02167698|Prednisolone phosphate|prednisolone phosphate|mesh-list
102085537|NCT02167698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102085538|NCT02167698|Antiemetics|antiemetics|mesh-ancestor
102085539|NCT02167698|Autonomic Agents|autonomic agents|mesh-ancestor
102085540|NCT02167698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102085541|NCT02167698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085542|NCT02167698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102085543|NCT02167698|Glucocorticoids|glucocorticoids|mesh-ancestor
102085544|NCT02167698|Hormones|hormones|mesh-ancestor
102085545|NCT02167698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102085546|NCT02167698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102085547|NCT02167698|Protective Agents|protective agents|mesh-ancestor
102085548|NCT02167698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102085549|NCT02167698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102085550|NCT02634580|Ezetimibe|ezetimibe|mesh-list
102085551|NCT02634580|Evolocumab|evolocumab|mesh-list
102085552|NCT02634580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102085553|NCT02634580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102085554|NCT02634580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101943961|NCT03602248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101943962|NCT03602248|Dopamine Agents|dopamine agents|mesh-ancestor
102085555|NCT02634580|Antimetabolites|antimetabolites|mesh-ancestor
102085556|NCT02634580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085557|NCT02634580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102085558|NCT02634580|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102085559|NCT02634580|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102085560|NCT02634580|Protease Inhibitors|protease inhibitors|mesh-ancestor
102085561|NCT02634580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102085562|NCT02634580|Immunologic Factors|immunologic factors|mesh-ancestor
102085563|NCT02634580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085564|NCT00697255|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102085565|NCT00697255|Hormones|hormones|mesh-list
102085566|NCT00697255|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102085567|NCT00697255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102085568|NCT00697255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085569|NCT00697255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102085570|NCT02164734|Remifentanil|remifentanil|mesh-list
102085571|NCT02164734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102085572|NCT02164734|Narcotics|narcotics|mesh-ancestor
101387210|NCT00295945|Sensory System Agents|sensory system agents|mesh-ancestor
102085578|NCT00548912|Spironolactone|spironolactone|mesh-list
102085579|NCT00548912|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102085580|NCT00548912|Hormone Antagonists|hormone antagonists|mesh-ancestor
102085581|NCT00548912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102085582|NCT00548912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085583|NCT00548912|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102085585|NCT00548912|Natriuretic Agents|natriuretic agents|mesh-ancestor
102085586|NCT05002933|Insulin Glargine|insulin glargine|mesh-list
102085587|NCT05002933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102085588|NCT05002933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085589|NCT03071068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102085590|NCT03071068|Antibodies|antibodies|mesh-list
102085591|NCT03071068|Immunoglobulins|immunoglobulins|mesh-list
102085592|NCT03071068|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102085593|NCT03071068|Immunologic Factors|immunologic factors|mesh-ancestor
102085594|NCT03071068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085595|NCT03071068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102085596|NCT03487172|Mannitol|mannitol|mesh-list
102085597|NCT03487172|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102085598|NCT03487172|Diuretics|diuretics|mesh-ancestor
102085599|NCT03487172|Natriuretic Agents|natriuretic agents|mesh-ancestor
102085600|NCT03487172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085601|NCT04995016|Pembrolizumab|pembrolizumab|mesh-list
102085602|NCT04995016|Axitinib|axitinib|mesh-list
102085603|NCT04995016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102085604|NCT04995016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102085605|NCT04995016|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102085606|NCT04995016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085607|NCT04995016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102085608|NCT04995016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102085609|NCT04994860|Sildenafil Citrate|sildenafil citrate|mesh-list
102085610|NCT04994860|Zamicastat|zamicastat|mesh-list
102085611|NCT04994860|Vasodilator Agents|vasodilator agents|mesh-ancestor
102085612|NCT04994860|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102085613|NCT04994860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102085614|NCT04994860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102085615|NCT04994860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085616|NCT04994860|Urological Agents|urological agents|mesh-ancestor
102085617|NCT03481400|Calcitonin|calcitonin|mesh-list
102085618|NCT03481400|Salmon calcitonin|salmon calcitonin|mesh-list
102085619|NCT03481400|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
102085620|NCT03481400|Katacalcin|katacalcin|mesh-list
102085621|NCT03481400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102085622|NCT03481400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085623|NCT03481400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102085624|NCT03481400|Vasodilator Agents|vasodilator agents|mesh-ancestor
102085625|NCT02851407|Defibrotide|defibrotide|mesh-list
102085626|NCT02851407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102085627|NCT02851407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102085628|NCT02851407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943963|NCT03602248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101943964|NCT03602248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085629|NCT02851407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102085631|NCT02167854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102085632|NCT02167854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102085633|NCT02161614|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102085634|NCT02161614|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102085635|NCT02161614|Estradiol|estradiol|mesh-list
102085636|NCT02161614|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102085637|NCT02161614|Estrogens|estrogens|mesh-ancestor
102085638|NCT02161614|Hormones|hormones|mesh-ancestor
102085639|NCT02161614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102085640|NCT02161614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085641|NCT02161614|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102085642|NCT02161614|Contraceptive Agents|contraceptive agents|mesh-ancestor
102085645|NCT04994626|Rituximab|rituximab|mesh-list
102085646|NCT04994626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102085647|NCT04994626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102085648|NCT04994626|Immunologic Factors|immunologic factors|mesh-ancestor
102085649|NCT04994626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085650|NCT04994626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102085651|NCT02168010|Neurotropin|neurotropin|mesh-list
102085652|NCT02168010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102085653|NCT02168010|Immunologic Factors|immunologic factors|mesh-ancestor
102085654|NCT02168010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085655|NCT02168010|Analgesics|analgesics|mesh-ancestor
102085656|NCT02168010|Sensory System Agents|sensory system agents|mesh-ancestor
102085657|NCT02168010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102085658|NCT02168010|Anticonvulsants|anticonvulsants|mesh-ancestor
102085660|NCT04994314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085661|NCT04994314|Cariostatic Agents|cariostatic agents|mesh-ancestor
102085662|NCT04994314|Protective Agents|protective agents|mesh-ancestor
102085663|NCT02161692|Cyclophosphamide|cyclophosphamide|mesh-list
102085664|NCT02161692|Carboplatin|carboplatin|mesh-list
102085665|NCT02161692|Etoposide|etoposide|mesh-list
102085666|NCT02161692|Bleomycin|bleomycin|mesh-list
102085667|NCT02161692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102085668|NCT02161692|Immunologic Factors|immunologic factors|mesh-ancestor
102085669|NCT02161692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085670|NCT02161692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102085671|NCT02161692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102085672|NCT02161692|Alkylating Agents|alkylating agents|mesh-ancestor
102085673|NCT02161692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085674|NCT02161692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102085675|NCT02161692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102085676|NCT02161692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102085677|NCT02161692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102085678|NCT02161692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102085679|NCT02161692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102085680|NCT02161692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102085681|NCT02746575|Metoprolol|metoprolol|mesh-list
102085682|NCT02746575|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102085683|NCT02746575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102085684|NCT02746575|Sympatholytics|sympatholytics|mesh-ancestor
102085685|NCT02746575|Autonomic Agents|autonomic agents|mesh-ancestor
102085686|NCT02746575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102085687|NCT02746575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085688|NCT02746575|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102085689|NCT02746575|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102085690|NCT02746575|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102085691|NCT02746575|Adrenergic Agents|adrenergic agents|mesh-ancestor
102085692|NCT02746575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102085693|NCT02746575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085694|NCT02161770|Osimertinib|osimertinib|mesh-list
102085695|NCT02161770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102085696|NCT02161770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102085697|NCT02161770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102085698|NCT02161770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085699|NCT03604575|Insulin|insulin|mesh-list
102085700|NCT03604575|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102085701|NCT03604575|Insulin Lispro|insulin lispro|mesh-list
101943965|NCT03602248|Adrenergic Agents|adrenergic agents|mesh-ancestor
101943966|NCT03602248|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101943967|NCT03602248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101943968|NCT03602248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101943969|NCT03602248|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101943970|NCT03602638|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101943972|NCT03602638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101943973|NCT03602638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943974|NCT03602638|Incretins|incretins|mesh-ancestor
101943975|NCT03602638|Hormones|hormones|mesh-ancestor
101943976|NCT03602638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101943977|NCT03602638|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101943978|NCT03602638|Protease Inhibitors|protease inhibitors|mesh-ancestor
101943979|NCT03602638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101943980|NCT03602638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101943981|NCT03602638|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101943982|NCT02237560|Camphor|camphor|mesh-list
101943983|NCT02237560|Salicylates|salicylates|mesh-list
101943984|NCT02237560|Methyl salicylate|methyl salicylate|mesh-list
101943985|NCT02237560|Menthol|menthol|mesh-list
101943986|NCT02237560|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101943987|NCT02237560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101943988|NCT02237560|Antipruritics|antipruritics|mesh-ancestor
101943989|NCT02237560|Dermatologic Agents|dermatologic agents|mesh-ancestor
102085702|NCT03604575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102085703|NCT03604575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085704|NCT04988932|Nitric Oxide|nitric oxide|mesh-list
102085705|NCT04988932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102085706|NCT04988932|Autonomic Agents|autonomic agents|mesh-ancestor
102085707|NCT04988932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102085708|NCT04988932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085709|NCT04988932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102085710|NCT04988932|Respiratory System Agents|respiratory system agents|mesh-ancestor
102085711|NCT04988932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102085712|NCT04988932|Antioxidants|antioxidants|mesh-ancestor
102085713|NCT04988932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085714|NCT04988932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102085715|NCT04988932|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102085716|NCT04988932|Vasodilator Agents|vasodilator agents|mesh-ancestor
102085722|NCT03625466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085723|NCT03604419|Metformin|metformin|mesh-list
102085724|NCT03604419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102085725|NCT03604419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085726|NCT03484832|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
102085727|NCT03484832|Ethyl Chloride|ethyl chloride|mesh-list
102085728|NCT03484832|Anesthetics, Local|anesthetics, local|mesh-ancestor
102085729|NCT03484832|Anesthetics|anesthetics|mesh-ancestor
101805502|NCT00436618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102085730|NCT03484832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101943990|NCT02237560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101943991|NCT02237560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101943992|NCT02237560|Analgesics|analgesics|mesh-ancestor
101943993|NCT02237560|Sensory System Agents|sensory system agents|mesh-ancestor
102085731|NCT03484832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085732|NCT03484832|Sensory System Agents|sensory system agents|mesh-ancestor
102085733|NCT03484832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102085734|NCT03484832|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
102085735|NCT04985110|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102085736|NCT04985110|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102085737|NCT04985110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102085738|NCT04985110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102085739|NCT04985110|Antimalarials|antimalarials|mesh-ancestor
102085740|NCT04985110|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102085741|NCT04985110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102085742|NCT02164812|Moxifloxacin|moxifloxacin|mesh-list
102085743|NCT02164812|Efavirenz|efavirenz|mesh-list
102085744|NCT02164812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102085745|NCT02164812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102085746|NCT02164812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102085747|NCT02164812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102085748|NCT02164812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102085749|NCT02164812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085750|NCT02164812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102085751|NCT02164812|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102085752|NCT02164812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102085753|NCT02164812|Antiviral Agents|antiviral agents|mesh-ancestor
102085754|NCT02164812|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102085755|NCT02164812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102085756|NCT02164812|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102085757|NCT02164812|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102085758|NCT02164812|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102085759|NCT02164812|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102085760|NCT04988776|Bupivacaine|bupivacaine|mesh-list
102085761|NCT04988776|Anesthetics, Local|anesthetics, local|mesh-ancestor
102085762|NCT04988776|Anesthetics|anesthetics|mesh-ancestor
102085763|NCT04988776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102085764|NCT04988776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085765|NCT04988776|Sensory System Agents|sensory system agents|mesh-ancestor
102085766|NCT04988776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102085767|NCT02853123|Tiotropium Bromide|tiotropium bromide|mesh-list
102085768|NCT02853123|Olodaterol|olodaterol|mesh-list
102085769|NCT02853123|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102085770|NCT02853123|Autonomic Agents|autonomic agents|mesh-ancestor
102085771|NCT02853123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102085772|NCT02853123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085773|NCT02853123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102085774|NCT02853123|Respiratory System Agents|respiratory system agents|mesh-ancestor
102085775|NCT02853123|Parasympatholytics|parasympatholytics|mesh-ancestor
102085776|NCT02853123|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102085777|NCT02853123|Cholinergic Agents|cholinergic agents|mesh-ancestor
102085778|NCT02853123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102085779|NCT02853123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085780|NCT02255370|Curcumin|curcumin|mesh-list
102085781|NCT02255370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102085782|NCT02255370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102085783|NCT02255370|Analgesics|analgesics|mesh-ancestor
102085784|NCT02255370|Sensory System Agents|sensory system agents|mesh-ancestor
102085787|NCT02255370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102085788|NCT02255370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102085789|NCT02255370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102085790|NCT02255370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102085791|NCT02255370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085793|NCT04984408|Immunologic Factors|immunologic factors|mesh-ancestor
102085794|NCT04984408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085795|NCT03484754|Botulinum Toxins|botulinum toxins|mesh-list
102085796|NCT03484754|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102085797|NCT03484754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101943994|NCT02237560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101943995|NCT02237560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101943996|NCT02237560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102085798|NCT03484754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085799|NCT03484754|Cholinergic Agents|cholinergic agents|mesh-ancestor
102085800|NCT03484754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102085801|NCT03484754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085802|NCT04459676|Mitogens|mitogens|mesh-list
102085803|NCT04459676|Mitosis Modulators|mitosis modulators|mesh-ancestor
102085804|NCT04459676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085805|NCT02164890|Micafungin|micafungin|mesh-list
102085806|NCT02164890|Antifungal Agents|antifungal agents|mesh-ancestor
102085807|NCT02164890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102085808|NCT02634346|Olanzapine|olanzapine|mesh-list
102085809|NCT02634346|Antiemetics|antiemetics|mesh-ancestor
102085810|NCT02634346|Autonomic Agents|autonomic agents|mesh-ancestor
102085811|NCT02634346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102085812|NCT02634346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085813|NCT02634346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102085814|NCT02634346|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102085815|NCT02634346|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102085816|NCT02634346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102085817|NCT02634346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102085818|NCT02634346|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102085819|NCT02634346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102085820|NCT02634346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102085821|NCT02634346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085822|NCT02634346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102085823|NCT02634346|Serotonin Agents|serotonin agents|mesh-ancestor
102085824|NCT02168634|Botulinum Toxins|botulinum toxins|mesh-list
102085825|NCT02168634|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102085826|NCT02168634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102085827|NCT02168634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085828|NCT02168634|Cholinergic Agents|cholinergic agents|mesh-ancestor
102085829|NCT02168634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102085830|NCT02168634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085831|NCT00812240|Imatinib Mesylate|imatinib mesylate|mesh-list
102085832|NCT00812240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102085833|NCT00812240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102085834|NCT00812240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102085835|NCT00812240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085836|NCT02165046|Budesonide|budesonide|mesh-list
102085837|NCT02165046|Procaterol|procaterol|mesh-list
102085838|NCT02165046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102085839|NCT02165046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102085840|NCT02165046|Autonomic Agents|autonomic agents|mesh-ancestor
102085841|NCT02165046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102085842|NCT02165046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085843|NCT02165046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102085844|NCT02165046|Respiratory System Agents|respiratory system agents|mesh-ancestor
102085845|NCT02165046|Glucocorticoids|glucocorticoids|mesh-ancestor
102085846|NCT02165046|Hormones|hormones|mesh-ancestor
102085847|NCT02165046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102085848|NCT02165046|Sympathomimetics|sympathomimetics|mesh-ancestor
102085849|NCT02165046|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102085850|NCT02165046|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102085851|NCT02165046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102085852|NCT02165046|Adrenergic Agents|adrenergic agents|mesh-ancestor
102085853|NCT02165046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102085854|NCT02165046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085858|NCT03070678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085859|NCT03070678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102085860|NCT03070678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085861|NCT03070678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102085862|NCT03070678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102085863|NCT03070678|Analgesics|analgesics|mesh-ancestor
102085864|NCT03070678|Sensory System Agents|sensory system agents|mesh-ancestor
101943997|NCT02237560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101943998|NCT02237560|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101943999|NCT02237560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101308882|NCT00005970|Alkylating Agents|alkylating agents|mesh-ancestor
102085865|NCT03070678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102085866|NCT03070678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102085867|NCT03070678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102085868|NCT03070678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102085869|NCT03070678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102085870|NCT00101166|Vaccines|vaccines|mesh-list
102085871|NCT00101166|Immunologic Factors|immunologic factors|mesh-ancestor
102085872|NCT00101166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805653|NCT01034020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102085873|NCT04994236|Leucovorin|leucovorin|mesh-list
102085874|NCT04994236|Fluorouracil|fluorouracil|mesh-list
102085875|NCT04994236|Oxaliplatin|oxaliplatin|mesh-list
102085876|NCT04994236|Antimetabolites|antimetabolites|mesh-ancestor
102085877|NCT04994236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085878|NCT04994236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102085879|NCT04994236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102085880|NCT04994236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102085881|NCT04994236|Immunologic Factors|immunologic factors|mesh-ancestor
102085882|NCT04994236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085883|NCT04994236|Antidotes|antidotes|mesh-ancestor
102085884|NCT04994236|Protective Agents|protective agents|mesh-ancestor
102085885|NCT04994236|Vitamin B Complex|vitamin b complex|mesh-ancestor
102085886|NCT04994236|Vitamins|vitamins|mesh-ancestor
102085887|NCT04994236|Micronutrients|micronutrients|mesh-ancestor
102085888|NCT03601611|Prednisolone|prednisolone|mesh-list
102085889|NCT03601611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102085890|NCT03601611|Glucocorticoids|glucocorticoids|mesh-ancestor
102085891|NCT03601611|Hormones|hormones|mesh-ancestor
102085892|NCT03601611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102085893|NCT03601611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085894|NCT03601611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102085895|NCT03601611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102085896|NCT03597945|Lidocaine|lidocaine|mesh-list
102085897|NCT03597945|Magnesium Sulfate|magnesium sulfate|mesh-list
102085898|NCT03597945|Epinephrine|epinephrine|mesh-list
102085899|NCT03597945|Anesthetics, Local|anesthetics, local|mesh-ancestor
102085900|NCT03597945|Anesthetics|anesthetics|mesh-ancestor
102085901|NCT03597945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102085902|NCT03597945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085903|NCT03597945|Sensory System Agents|sensory system agents|mesh-ancestor
102085904|NCT03597945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102085905|NCT03597945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102085906|NCT03597945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102085907|NCT03597945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102085908|NCT03597945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102085909|NCT03597945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085910|NCT03597945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102085911|NCT03597945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102085912|NCT03597945|Adrenergic Agents|adrenergic agents|mesh-ancestor
102085913|NCT03597945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102085914|NCT03597945|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102085915|NCT03597945|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102085916|NCT03597945|Autonomic Agents|autonomic agents|mesh-ancestor
102085917|NCT03597945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102085918|NCT03597945|Respiratory System Agents|respiratory system agents|mesh-ancestor
102085919|NCT03597945|Mydriatics|mydriatics|mesh-ancestor
102085920|NCT03597945|Sympathomimetics|sympathomimetics|mesh-ancestor
102085921|NCT03597945|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102085922|NCT03597945|Analgesics|analgesics|mesh-ancestor
102085923|NCT03597945|Anticonvulsants|anticonvulsants|mesh-ancestor
102085925|NCT03597945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102085926|NCT03597945|Tocolytic Agents|tocolytic agents|mesh-ancestor
102085927|NCT03597945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102085928|NCT03601533|Phenol|phenol|mesh-list
102085929|NCT03601533|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102085930|NCT03601533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102085931|NCT03601533|Disinfectants|disinfectants|mesh-ancestor
102085932|NCT03601533|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102085933|NCT03601533|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101944000|NCT02237560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944001|NCT03601624|Dexamethasone|dexamethasone|mesh-list
101944002|NCT03601624|Cyclophosphamide|cyclophosphamide|mesh-list
101944003|NCT03601624|Pomalidomide|pomalidomide|mesh-list
101944004|NCT03601624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101944005|NCT03601624|Immunologic Factors|immunologic factors|mesh-ancestor
102085935|NCT03486626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102085936|NCT03486626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085937|NCT04983550|Doxorubicin|doxorubicin|mesh-list
102085938|NCT04983550|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102085939|NCT04983550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102085940|NCT04983550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102085941|NCT04983550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102085942|NCT04983550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102085943|NCT04983550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102085944|NCT04983550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085945|NCT02255682|Simvastatin|simvastatin|mesh-list
102085946|NCT02255682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102085947|NCT02255682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102085948|NCT02255682|Antimetabolites|antimetabolites|mesh-ancestor
102085949|NCT02255682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085950|NCT02255682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102085951|NCT02255682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102085952|NCT02255682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102085953|NCT05153486|Ethanol|ethanol|mesh-list
102085954|NCT05153486|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102085955|NCT05153486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102085956|NCT05153486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102085957|NCT05153486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085958|NCT03136263|Oxytocin|oxytocin|mesh-list
102085959|NCT03136263|Oxytocics|oxytocics|mesh-ancestor
102085960|NCT03136263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102085961|NCT03136263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085962|NCT03486548|Dexamethasone|dexamethasone|mesh-list
102085963|NCT03486548|Lidocaine|lidocaine|mesh-list
102085964|NCT03486548|Bupivacaine|bupivacaine|mesh-list
102085965|NCT03486548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102085966|NCT03486548|Antiemetics|antiemetics|mesh-ancestor
102085967|NCT03486548|Autonomic Agents|autonomic agents|mesh-ancestor
102085968|NCT03486548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102085969|NCT03486548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085970|NCT03486548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102085971|NCT03486548|Glucocorticoids|glucocorticoids|mesh-ancestor
102085972|NCT03486548|Hormones|hormones|mesh-ancestor
102085973|NCT03486548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102085974|NCT03486548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102085975|NCT03486548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102085976|NCT03486548|Anesthetics, Local|anesthetics, local|mesh-ancestor
102085977|NCT03486548|Anesthetics|anesthetics|mesh-ancestor
102085978|NCT03486548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102085979|NCT03486548|Sensory System Agents|sensory system agents|mesh-ancestor
102085980|NCT03486548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102085981|NCT03486548|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102085982|NCT03486548|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102085983|NCT03486548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102085984|NCT03486548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085985|NCT04983160|Allopurinol|allopurinol|mesh-list
102085986|NCT04983160|Antimetabolites|antimetabolites|mesh-ancestor
102085987|NCT04983160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085988|NCT04983160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102085989|NCT04983160|Gout Suppressants|gout suppressants|mesh-ancestor
102085990|NCT04983160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102085991|NCT04983160|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102085992|NCT04983160|Antioxidants|antioxidants|mesh-ancestor
102085993|NCT04983160|Protective Agents|protective agents|mesh-ancestor
102085994|NCT04983160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085995|NCT02759016|BI 836826|bi 836826|mesh-list
102085996|NCT02759016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101944006|NCT03601624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944007|NCT03601624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101944008|NCT03601624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101775409|NCT03988075|Acetaminophen|acetaminophen|mesh-list
102085997|NCT02759016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102085998|NCT05379166|Azacitidine|azacitidine|mesh-list
102086000|NCT05379166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102086001|NCT05379166|Antimetabolites|antimetabolites|mesh-ancestor
102086002|NCT05379166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086003|NCT05379166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102086004|NCT05379166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102086005|NCT02852967|Belumosudil|belumosudil|mesh-list
102086006|NCT02852967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102086007|NCT02852967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102086008|NCT02852967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086009|NCT03593044|Atropine|atropine|mesh-list
102086010|NCT03593044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101705811|NCT00727870|Glycerol|glycerol|mesh-list
102086011|NCT03593044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102086012|NCT03593044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102086013|NCT03593044|Autonomic Agents|autonomic agents|mesh-ancestor
102086014|NCT03593044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102086015|NCT03593044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086016|NCT03593044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102086017|NCT03593044|Respiratory System Agents|respiratory system agents|mesh-ancestor
102086018|NCT03593044|Mydriatics|mydriatics|mesh-ancestor
102086019|NCT03593044|Parasympatholytics|parasympatholytics|mesh-ancestor
102086020|NCT03593044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102086021|NCT03593044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102086022|NCT03593044|Cholinergic Agents|cholinergic agents|mesh-ancestor
102086023|NCT03593044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102086024|NCT03593044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086026|NCT03597087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102086027|NCT03597087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086028|NCT03603327|Antiviral Agents|antiviral agents|mesh-list
102086029|NCT03603327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102086030|NCT03596775|Dexmedetomidine|dexmedetomidine|mesh-list
102086031|NCT03596775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102086032|NCT03596775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102086033|NCT03596775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086034|NCT03596775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102086035|NCT03596775|Analgesics|analgesics|mesh-ancestor
102086036|NCT03596775|Sensory System Agents|sensory system agents|mesh-ancestor
102086037|NCT03596775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102086038|NCT03596775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102086039|NCT03596775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102086040|NCT03596775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102086041|NCT03596775|Adrenergic Agents|adrenergic agents|mesh-ancestor
102086042|NCT03596775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102086043|NCT03596775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086044|NCT03066466|Methotrexate|methotrexate|mesh-list
102086045|NCT03066466|Atorvastatin|atorvastatin|mesh-list
102086046|NCT03066466|Tacrolimus|tacrolimus|mesh-list
102086047|NCT03066466|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102086048|NCT03066466|Abortifacient Agents|abortifacient agents|mesh-ancestor
102086049|NCT03066466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102086050|NCT03066466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086051|NCT03066466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102086052|NCT03066466|Antimetabolites|antimetabolites|mesh-ancestor
102086053|NCT03066466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086054|NCT03066466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102086055|NCT03066466|Dermatologic Agents|dermatologic agents|mesh-ancestor
102086056|NCT03066466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102086057|NCT03066466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102086058|NCT03066466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102086059|NCT03066466|Immunologic Factors|immunologic factors|mesh-ancestor
102086060|NCT03066466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102086061|NCT03066466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102086062|NCT03066466|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102086063|NCT03066466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102086064|NCT03066466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101944009|NCT03601624|Alkylating Agents|alkylating agents|mesh-ancestor
101944010|NCT03601624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775477|NCT00322621|Analgesics|analgesics|mesh-ancestor
102086065|NCT03066466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102086066|NCT03066466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102086067|NCT03603249|Trimetazidine|trimetazidine|mesh-list
102086068|NCT03603249|Vasodilator Agents|vasodilator agents|mesh-ancestor
102086069|NCT03068260|Acetaminophen|acetaminophen|mesh-list
102086070|NCT03068260|Ibuprofen|ibuprofen|mesh-list
102086071|NCT03068260|Morphine|morphine|mesh-list
102086072|NCT03068260|Ropivacaine|ropivacaine|mesh-list
102086073|NCT03068260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102086080|NCT03068260|Anesthetics, Local|anesthetics, local|mesh-ancestor
102086081|NCT03068260|Anesthetics|anesthetics|mesh-ancestor
102086082|NCT03068260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102086083|NCT03068260|Antipyretics|antipyretics|mesh-ancestor
102086084|NCT03068260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102086085|NCT03068260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102086086|NCT03068260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102086087|NCT03068260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102086088|NCT03068260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102086089|NCT03068260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086090|NCT02237859|Vancomycin|vancomycin|mesh-list
102086091|NCT02237859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102086092|NCT02237859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102086093|NCT03594825|Valsartan|valsartan|mesh-list
102086094|NCT03594825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102086095|NCT03594825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102086096|NCT03594825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102086097|NCT03594825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086098|NCT02162550|Exenatide|exenatide|mesh-list
102086099|NCT02162550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102086100|NCT02162550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086101|NCT02162550|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102086102|NCT02162550|Incretins|incretins|mesh-ancestor
102086103|NCT02162550|Hormones|hormones|mesh-ancestor
102086104|NCT02162550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102086105|NCT03600831|Docetaxel|docetaxel|mesh-list
102086106|NCT03600831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102086107|NCT03600831|Tubulin Modulators|tubulin modulators|mesh-ancestor
102086108|NCT03600831|Antimitotic Agents|antimitotic agents|mesh-ancestor
102086109|NCT03600831|Mitosis Modulators|mitosis modulators|mesh-ancestor
102086110|NCT03600831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086111|NCT02852265|Contraceptive Agents|contraceptive agents|mesh-list
102086112|NCT02852265|Etonogestrel|etonogestrel|mesh-list
102086113|NCT02852265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102086114|NCT02852265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086115|NCT02852265|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102086116|NCT02852265|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102086117|NCT02162784|Budesonide|budesonide|mesh-list
102086118|NCT02162784|Albuterol|albuterol|mesh-list
102086119|NCT02162784|Procaterol|procaterol|mesh-list
102086120|NCT02162784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102086121|NCT02162784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102086122|NCT02162784|Autonomic Agents|autonomic agents|mesh-ancestor
102086123|NCT02162784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102086124|NCT02162784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086125|NCT02162784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102086126|NCT02162784|Respiratory System Agents|respiratory system agents|mesh-ancestor
102086127|NCT02162784|Glucocorticoids|glucocorticoids|mesh-ancestor
102086128|NCT02162784|Hormones|hormones|mesh-ancestor
102086129|NCT02162784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102086130|NCT02162784|Tocolytic Agents|tocolytic agents|mesh-ancestor
102086131|NCT02162784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102086132|NCT02162784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102086133|NCT02162784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102086134|NCT02162784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102086135|NCT02162784|Adrenergic Agents|adrenergic agents|mesh-ancestor
102086136|NCT02162784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102086137|NCT02162784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086138|NCT02162784|Sympathomimetics|sympathomimetics|mesh-ancestor
102086139|NCT03539718|Taurolidine|taurolidine|mesh-list
102086140|NCT03539718|Heparin|heparin|mesh-list
101944011|NCT03601624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101944012|NCT03601624|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101944013|NCT03601624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101944014|NCT03601624|Antiemetics|antiemetics|mesh-ancestor
101944015|NCT03601624|Autonomic Agents|autonomic agents|mesh-ancestor
101775551|NCT00655980|Folic Acid|folic acid|mesh-list
102086141|NCT03539718|Calcium heparin|calcium heparin|mesh-list
102086142|NCT03539718|Anticoagulants|anticoagulants|mesh-ancestor
102086143|NCT03539718|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102086145|NCT03539718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086146|NCT03539718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102086147|NCT03539718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102086148|NCT03539718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102086149|NCT02166450|Nystatin|nystatin|mesh-list
102086150|NCT02166450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102086151|NCT02166450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102086152|NCT02166450|Antifungal Agents|antifungal agents|mesh-ancestor
102086153|NCT02166450|Ionophores|ionophores|mesh-ancestor
102086154|NCT02166450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102086155|NCT02166450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086156|NCT03600363|Metformin|metformin|mesh-list
102086157|NCT03600363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102086158|NCT03600363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086159|NCT03600129|Ropivacaine|ropivacaine|mesh-list
102086160|NCT03600129|Anesthetics, Local|anesthetics, local|mesh-ancestor
102086161|NCT03600129|Anesthetics|anesthetics|mesh-ancestor
102086162|NCT03600129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102086163|NCT03600129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086164|NCT03600129|Sensory System Agents|sensory system agents|mesh-ancestor
102086165|NCT03600129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102086166|NCT02169570|Calcium, Dietary|calcium, dietary|mesh-list
102086167|NCT02169570|Vitamin D|vitamin d|mesh-list
102086168|NCT02169570|Ergocalciferols|ergocalciferols|mesh-list
102086169|NCT02169570|Cholecalciferol|cholecalciferol|mesh-list
102086170|NCT02169570|Vitamins|vitamins|mesh-list
102086171|NCT02169570|Calcium|calcium|mesh-list
102086172|NCT02169570|Micronutrients|micronutrients|mesh-ancestor
102086173|NCT02169570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086174|NCT02169570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102086175|NCT02169570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102086176|NCT02169648|Ranibizumab|ranibizumab|mesh-list
102086177|NCT02169648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102086178|NCT02169648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102086179|NCT02169648|Growth Substances|growth substances|mesh-ancestor
102086180|NCT02169648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086181|NCT02169648|Growth Inhibitors|growth inhibitors|mesh-ancestor
102086182|NCT02169648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102086183|NCT03594591|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102086184|NCT03594591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086185|NCT02170896|Pantoprazole|pantoprazole|mesh-list
102086186|NCT02170896|Dabigatran|dabigatran|mesh-list
102086187|NCT02170896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102086188|NCT02170896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102086189|NCT02170896|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102086190|NCT02170896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102086191|NCT02170896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086192|NCT02170896|Antithrombins|antithrombins|mesh-ancestor
102086193|NCT02170896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102086194|NCT02170896|Protease Inhibitors|protease inhibitors|mesh-ancestor
102086195|NCT02170896|Anticoagulants|anticoagulants|mesh-ancestor
102086196|NCT03594513|Dipyrone|dipyrone|mesh-list
102086197|NCT03594513|Chlorhexidine|chlorhexidine|mesh-list
102086198|NCT03594513|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102086199|NCT03594513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102086200|NCT03594513|Disinfectants|disinfectants|mesh-ancestor
102086201|NCT03594513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102086202|NCT03594513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102086203|NCT03594513|Analgesics|analgesics|mesh-ancestor
102086204|NCT03594513|Sensory System Agents|sensory system agents|mesh-ancestor
102086205|NCT03594513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102086206|NCT03594513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086207|NCT03594513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101944016|NCT03601624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101944017|NCT03601624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101944018|NCT03601624|Glucocorticoids|glucocorticoids|mesh-ancestor
102086208|NCT03594513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102086209|NCT03594513|Antipyretics|antipyretics|mesh-ancestor
102086210|NCT02633800|Carboplatin|carboplatin|mesh-list
102086211|NCT02633800|Cetuximab|cetuximab|mesh-list
102086212|NCT02633800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102086213|NCT02633800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102086214|NCT02169804|Enclomiphene|enclomiphene|mesh-list
102086215|NCT02169804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102086216|NCT02169804|Hormone Antagonists|hormone antagonists|mesh-ancestor
102086217|NCT02169804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102086218|NCT02169804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086219|NCT02169804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102086223|NCT02169804|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102086225|NCT02170974|Antithrombins|antithrombins|mesh-ancestor
102086226|NCT02170974|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102086227|NCT02170974|Protease Inhibitors|protease inhibitors|mesh-ancestor
102086228|NCT02170974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102086229|NCT02170974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086230|NCT02170974|Anticoagulants|anticoagulants|mesh-ancestor
102086231|NCT02174718|Vitamin D|vitamin d|mesh-list
102086232|NCT02174718|Cholecalciferol|cholecalciferol|mesh-list
102086233|NCT02174718|Vitamins|vitamins|mesh-ancestor
102086234|NCT02174718|Micronutrients|micronutrients|mesh-ancestor
102086235|NCT02174718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086236|NCT02174718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102086237|NCT02174718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102086238|NCT02238171|Ipratropium|ipratropium|mesh-list
102086239|NCT02238171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102086240|NCT02238171|Autonomic Agents|autonomic agents|mesh-ancestor
102086241|NCT02238171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102086242|NCT02238171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086243|NCT02238171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102086244|NCT02238171|Respiratory System Agents|respiratory system agents|mesh-ancestor
102086245|NCT02238171|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102086246|NCT02238171|Cholinergic Agents|cholinergic agents|mesh-ancestor
102086247|NCT02238171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102086248|NCT02238171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086249|NCT02169882|Rifampin|rifampin|mesh-list
102086250|NCT02169882|Dexamethasone|dexamethasone|mesh-list
102086251|NCT02169882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101806031|NCT00693017|Zonisamide|zonisamide|mesh-list
102086252|NCT02169882|Antiemetics|antiemetics|mesh-ancestor
102086253|NCT02169882|Autonomic Agents|autonomic agents|mesh-ancestor
102086254|NCT02169882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102086255|NCT02169882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086256|NCT02169882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102086257|NCT02169882|Glucocorticoids|glucocorticoids|mesh-ancestor
102086258|NCT02169882|Hormones|hormones|mesh-ancestor
102086259|NCT02169882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102086260|NCT02169882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102086261|NCT02169882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102086262|NCT02169882|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102086263|NCT02169882|Antitubercular Agents|antitubercular agents|mesh-ancestor
102086264|NCT02169882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102086265|NCT02169882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102086266|NCT02169882|Leprostatic Agents|leprostatic agents|mesh-ancestor
102086267|NCT02169882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102086268|NCT02169882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102086269|NCT02169882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086270|NCT02169882|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102086271|NCT02169882|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102086272|NCT02169882|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102086273|NCT02169882|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102086274|NCT02169882|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102086275|NCT02169882|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102086276|NCT03602547|Vorolanib|vorolanib|mesh-list
102086277|NCT03602547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102086278|NCT03602547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101944019|NCT03601624|Hormones|hormones|mesh-ancestor
102086279|NCT03602547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086280|NCT03602469|Bupivacaine|bupivacaine|mesh-list
102086281|NCT03602469|Propofol|propofol|mesh-list
102086282|NCT03602469|Sevoflurane|sevoflurane|mesh-list
102086283|NCT03602469|Rocuronium|rocuronium|mesh-list
102086284|NCT03602469|Anesthetics, Local|anesthetics, local|mesh-ancestor
102086285|NCT03602469|Anesthetics|anesthetics|mesh-ancestor
102086286|NCT03602469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102086287|NCT03602469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086288|NCT03602469|Sensory System Agents|sensory system agents|mesh-ancestor
102086289|NCT03602469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102086295|NCT03602469|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102086296|NCT03602469|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102086297|NCT03602469|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102086298|NCT02170038|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
102086299|NCT02170038|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
102086300|NCT02170038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102086301|NCT02170038|Contraceptive Agents|contraceptive agents|mesh-ancestor
102086302|NCT02170038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102086303|NCT02170038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086304|NCT02170038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102086305|NCT02170038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102086306|NCT02170038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102086307|NCT02170038|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102086308|NCT02170038|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102086309|NCT02170038|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
102086310|NCT02170038|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102086311|NCT02170038|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102086313|NCT05001373|Immunologic Factors|immunologic factors|mesh-ancestor
102086314|NCT05001373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086315|NCT02171052|Digoxin|digoxin|mesh-list
102086316|NCT02171052|Dabigatran|dabigatran|mesh-list
102086317|NCT02171052|Antithrombins|antithrombins|mesh-ancestor
102086318|NCT02171052|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102086319|NCT02171052|Protease Inhibitors|protease inhibitors|mesh-ancestor
102086320|NCT02171052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102086321|NCT02171052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086322|NCT02171052|Anticoagulants|anticoagulants|mesh-ancestor
102086323|NCT02171052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102086324|NCT02171052|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102086325|NCT02171052|Protective Agents|protective agents|mesh-ancestor
102086326|NCT02171052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086327|NCT03591549|Fulvestrant|fulvestrant|mesh-list
102086328|NCT03591549|Goserelin|goserelin|mesh-list
102086329|NCT03591549|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102086330|NCT03591549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102086331|NCT03591549|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102086332|NCT03591549|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102086333|NCT03591549|Hormone Antagonists|hormone antagonists|mesh-ancestor
101705867|NCT04942067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102086334|NCT03591549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102086335|NCT03591549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086336|NCT02261220|Durvalumab|durvalumab|mesh-list
102086337|NCT02261220|Tremelimumab|tremelimumab|mesh-list
102086338|NCT02261220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102086339|NCT02261220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102086340|NCT02237937|Amitriptyline|amitriptyline|mesh-list
102086341|NCT02237937|Citalopram|citalopram|mesh-list
102086342|NCT02237937|Paroxetine|paroxetine|mesh-list
102086343|NCT02237937|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102086344|NCT02237937|Sertraline|sertraline|mesh-list
102086345|NCT02237937|Nortriptyline|nortriptyline|mesh-list
102086346|NCT02237937|Trimipramine|trimipramine|mesh-list
102086347|NCT02237937|Escitalopram|escitalopram|mesh-list
102086348|NCT02237937|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102086349|NCT02237937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102086350|NCT02237937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102086351|NCT02237937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086352|NCT02237937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102086353|NCT02237937|Serotonin Agents|serotonin agents|mesh-ancestor
102086354|NCT02237937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086355|NCT02237937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102086356|NCT02237937|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101944020|NCT03601624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101775763|NCT00309907|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102086357|NCT02237937|Antidepressive Agents|antidepressive agents|mesh-ancestor
102086362|NCT02237937|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102086364|NCT02237937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102086365|NCT02237937|Analgesics|analgesics|mesh-ancestor
102086366|NCT02237937|Sensory System Agents|sensory system agents|mesh-ancestor
102086367|NCT02237937|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102086368|NCT02237937|Adrenergic Agents|adrenergic agents|mesh-ancestor
102086369|NCT02170116|Dabigatran|dabigatran|mesh-list
102086370|NCT02170116|Antithrombins|antithrombins|mesh-ancestor
102086371|NCT02170116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102086372|NCT02170116|Protease Inhibitors|protease inhibitors|mesh-ancestor
102086373|NCT02170116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102086374|NCT02170116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086375|NCT02170116|Anticoagulants|anticoagulants|mesh-ancestor
102086376|NCT03035227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
102086377|NCT03539562|Promethazine|promethazine|mesh-list
102086378|NCT03539562|Diphenhydramine|diphenhydramine|mesh-list
102086379|NCT03539562|Morphine|morphine|mesh-list
102086380|NCT03539562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102086381|NCT03539562|Narcotics|narcotics|mesh-ancestor
102086382|NCT03539562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102086383|NCT03539562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086384|NCT03539562|Analgesics|analgesics|mesh-ancestor
102086385|NCT03539562|Sensory System Agents|sensory system agents|mesh-ancestor
102086386|NCT03539562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102086387|NCT03539562|Antipruritics|antipruritics|mesh-ancestor
102086388|NCT03539562|Dermatologic Agents|dermatologic agents|mesh-ancestor
102086389|NCT03539562|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102086390|NCT03539562|Histamine Antagonists|histamine antagonists|mesh-ancestor
102086391|NCT03539562|Histamine Agents|histamine agents|mesh-ancestor
102086392|NCT03539562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102086393|NCT03539562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086394|NCT03539562|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102086395|NCT03539562|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102086396|NCT03539562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102086397|NCT03539562|Anesthetics, Local|anesthetics, local|mesh-ancestor
102086398|NCT03539562|Anesthetics|anesthetics|mesh-ancestor
102086399|NCT03539562|Antiemetics|antiemetics|mesh-ancestor
102086400|NCT03539562|Autonomic Agents|autonomic agents|mesh-ancestor
102086401|NCT03539562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101705874|NCT01007773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102086413|NCT03590769|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102086414|NCT03590769|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102086415|NCT03590769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086416|NCT00394069|Montelukast|montelukast|mesh-list
102086417|NCT00394069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102086418|NCT00394069|Respiratory System Agents|respiratory system agents|mesh-ancestor
102086419|NCT00394069|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102086420|NCT00394069|Hormone Antagonists|hormone antagonists|mesh-ancestor
102086421|NCT00394069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102086422|NCT00394069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086423|NCT00394069|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102086424|NCT00394069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102086425|NCT00394069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086426|NCT03598959|Tofacitinib|tofacitinib|mesh-list
102086427|NCT03598959|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102086436|NCT02238717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086437|NCT02238717|Anticonvulsants|anticonvulsants|mesh-ancestor
102086438|NCT02238717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102086439|NCT02238717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101944021|NCT03601624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101944022|NCT03601624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101944023|NCT03601624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101944024|NCT03601624|Growth Substances|growth substances|mesh-ancestor
101944025|NCT03601624|Growth Inhibitors|growth inhibitors|mesh-ancestor
102086440|NCT02238717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086441|NCT02238717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102086442|NCT02238717|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102086443|NCT02238717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102086444|NCT02238717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102086445|NCT02238717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102086446|NCT02238717|GABA Modulators|gaba modulators|mesh-ancestor
102086447|NCT02238717|GABA Agents|gaba agents|mesh-ancestor
102086448|NCT02238717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102086449|NCT05266066|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102086450|NCT05266066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102086451|NCT05266066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102086452|NCT05266066|Antitubercular Agents|antitubercular agents|mesh-ancestor
102086453|NCT03470311|Benralizumab|benralizumab|mesh-list
102086454|NCT03470311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102086455|NCT03470311|Respiratory System Agents|respiratory system agents|mesh-ancestor
102086456|NCT03580005|Methylphenidate|methylphenidate|mesh-list
102086457|NCT03580005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102086458|NCT03580005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086459|NCT03580005|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102086460|NCT03580005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102086461|NCT03580005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102086462|NCT03580005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086463|NCT03580005|Dopamine Agents|dopamine agents|mesh-ancestor
102086464|NCT03580005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102086465|NCT03579927|Cytarabine|cytarabine|mesh-list
102086466|NCT03579927|Rituximab|rituximab|mesh-list
102086467|NCT03579927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102086468|NCT03579927|Etoposide|etoposide|mesh-list
102086469|NCT03579927|Etoposide phosphate|etoposide phosphate|mesh-list
102086470|NCT03579927|Melphalan|melphalan|mesh-list
102086471|NCT03579927|Mechlorethamine|mechlorethamine|mesh-list
102086472|NCT03579927|Carmustine|carmustine|mesh-list
102086473|NCT03579927|Podophyllotoxin|podophyllotoxin|mesh-list
101806259|NCT03463265|Alkylating Agents|alkylating agents|mesh-ancestor
102086474|NCT03579927|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102086475|NCT03579927|Antibodies|antibodies|mesh-list
102086476|NCT03579927|Immunoglobulins|immunoglobulins|mesh-list
102086477|NCT03579927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102086478|NCT03579927|Lenograstim|lenograstim|mesh-list
102086479|NCT03579927|Immunologic Factors|immunologic factors|mesh-ancestor
102086480|NCT03579927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086481|NCT03579927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102086482|NCT03579927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102086483|NCT03579927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102086484|NCT03579927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102086485|NCT03579927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102086486|NCT03579927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102086487|NCT03579927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086488|NCT03579927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102086489|NCT03579927|Antimetabolites|antimetabolites|mesh-ancestor
102086490|NCT03579927|Antiviral Agents|antiviral agents|mesh-ancestor
102086491|NCT03579927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102086492|NCT03579927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102086493|NCT03579927|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101388142|NCT06001047|Betahistine|betahistine|mesh-list
102086500|NCT03579927|Antimitotic Agents|antimitotic agents|mesh-ancestor
102086501|NCT03579927|Mitosis Modulators|mitosis modulators|mesh-ancestor
102086502|NCT03587025|Amitriptyline|amitriptyline|mesh-list
102086503|NCT03587025|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102086504|NCT03587025|Antidepressive Agents|antidepressive agents|mesh-ancestor
102086505|NCT03587025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102086506|NCT03587025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102086507|NCT03587025|Analgesics|analgesics|mesh-ancestor
102086508|NCT03587025|Sensory System Agents|sensory system agents|mesh-ancestor
102086509|NCT03587025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101944026|NCT03899428|Sorafenib|sorafenib|mesh-list
101944027|NCT03899428|Durvalumab|durvalumab|mesh-list
101944028|NCT03899428|Lenvatinib|lenvatinib|mesh-list
101944029|NCT03899428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102086510|NCT03587025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086511|NCT03587025|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102086512|NCT03587025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102086513|NCT03587025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102086514|NCT03587025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086515|NCT03587025|Adrenergic Agents|adrenergic agents|mesh-ancestor
102086516|NCT03587025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102086517|NCT02171208|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102086518|NCT02171208|Dermatologic Agents|dermatologic agents|mesh-ancestor
102086519|NCT02171208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102086520|NCT02171208|Immunologic Factors|immunologic factors|mesh-ancestor
102086521|NCT02171208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086522|NCT00140881|Montelukast|montelukast|mesh-list
102086523|NCT00140881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102086524|NCT00140881|Respiratory System Agents|respiratory system agents|mesh-ancestor
102086525|NCT00140881|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102086526|NCT00140881|Hormone Antagonists|hormone antagonists|mesh-ancestor
102086527|NCT00140881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102086528|NCT00140881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086529|NCT00140881|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102086530|NCT00140881|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102086531|NCT00140881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086532|NCT02848833|Empagliflozin|empagliflozin|mesh-list
102086533|NCT02848833|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102086534|NCT02848833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086535|NCT02848833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102086536|NCT02848833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086537|NCT03539328|Paclitaxel|paclitaxel|mesh-list
102086538|NCT03539328|Gemcitabine|gemcitabine|mesh-list
102086539|NCT03539328|Doxorubicin|doxorubicin|mesh-list
102086540|NCT03539328|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102086541|NCT03539328|Pembrolizumab|pembrolizumab|mesh-list
102086542|NCT03539328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102086543|NCT03539328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102086544|NCT03539328|Tubulin Modulators|tubulin modulators|mesh-ancestor
102086545|NCT03539328|Antimitotic Agents|antimitotic agents|mesh-ancestor
102086546|NCT03539328|Mitosis Modulators|mitosis modulators|mesh-ancestor
102086547|NCT03539328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086548|NCT03539328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102086550|NCT03539328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102086551|NCT03539328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102086552|NCT03539328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102086553|NCT03539328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102086554|NCT03539328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102086555|NCT03539328|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102086556|NCT00111709|Rizatriptan|rizatriptan|mesh-list
102086557|NCT00111709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102086558|NCT00111709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086559|NCT00111709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086560|NCT00111709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102086561|NCT00111709|Serotonin Agents|serotonin agents|mesh-ancestor
102086567|NCT02171442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086568|NCT02171442|Anticoagulants|anticoagulants|mesh-ancestor
102086569|NCT02035527|Docetaxel|docetaxel|mesh-list
102086570|NCT02035527|Sorafenib|sorafenib|mesh-list
102086571|NCT02035527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102086572|NCT02035527|Tubulin Modulators|tubulin modulators|mesh-ancestor
102086573|NCT02035527|Antimitotic Agents|antimitotic agents|mesh-ancestor
102086574|NCT02035527|Mitosis Modulators|mitosis modulators|mesh-ancestor
102086575|NCT02035527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086576|NCT02035527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102086577|NCT02035527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102086578|NCT00092131|Montelukast|montelukast|mesh-list
102086579|NCT00092131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102086580|NCT00092131|Respiratory System Agents|respiratory system agents|mesh-ancestor
102086581|NCT00092131|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101944030|NCT03899428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101944031|NCT03899428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775977|NCT00759824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102086582|NCT00092131|Hormone Antagonists|hormone antagonists|mesh-ancestor
102086583|NCT00092131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102086584|NCT00092131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086585|NCT00092131|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102086586|NCT00092131|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102086587|NCT00092131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086588|NCT02170584|Dabigatran|dabigatran|mesh-list
102086589|NCT02170584|Antithrombins|antithrombins|mesh-ancestor
102086590|NCT02170584|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102086591|NCT02170584|Protease Inhibitors|protease inhibitors|mesh-ancestor
102086592|NCT02170584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102086593|NCT02170584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086594|NCT02170584|Anticoagulants|anticoagulants|mesh-ancestor
102086595|NCT03577977|Interferons|interferons|mesh-list
102086596|NCT03577977|Interferon-beta|interferon-beta|mesh-list
102086597|NCT03577977|Interferon beta-1b|interferon beta-1b|mesh-list
102086598|NCT03577977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102086599|NCT03577977|Antiviral Agents|antiviral agents|mesh-ancestor
102086600|NCT03577977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102086601|NCT03577977|Immunologic Factors|immunologic factors|mesh-ancestor
102086602|NCT03577977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086603|NCT03577977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102086604|NCT02668783|Ibuprofen|ibuprofen|mesh-list
102086605|NCT02668783|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102086606|NCT02668783|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102086607|NCT02668783|Etonogestrel|etonogestrel|mesh-list
102086608|NCT02668783|Estradiol|estradiol|mesh-list
102086609|NCT02668783|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102086610|NCT02668783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102086611|NCT02668783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102086612|NCT02668783|Analgesics|analgesics|mesh-ancestor
102086613|NCT02668783|Sensory System Agents|sensory system agents|mesh-ancestor
102086614|NCT02668783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102086615|NCT02668783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086616|NCT02668783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102086617|NCT02668783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102086618|NCT02668783|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102086619|NCT02668783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102086620|NCT02668783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086621|NCT02668783|Estrogens|estrogens|mesh-ancestor
102086622|NCT02668783|Hormones|hormones|mesh-ancestor
101806404|NCT00923663|Lenalidomide|lenalidomide|mesh-list
102086623|NCT02668783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102086624|NCT02668783|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102086625|NCT02668783|Contraceptive Agents|contraceptive agents|mesh-ancestor
102086626|NCT02668783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102086627|NCT02668783|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102086628|NCT05010304|Amoxicillin|amoxicillin|mesh-list
102086629|NCT05010304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102086630|NCT05010304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102086631|NCT03577899|Aflibercept|aflibercept|mesh-list
102086638|NCT02175342|Tiotropium Bromide|tiotropium bromide|mesh-list
102086639|NCT02175342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102086640|NCT02175342|Autonomic Agents|autonomic agents|mesh-ancestor
102086641|NCT02175342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102086642|NCT02175342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086643|NCT02175342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102086644|NCT02175342|Respiratory System Agents|respiratory system agents|mesh-ancestor
102086645|NCT02175342|Parasympatholytics|parasympatholytics|mesh-ancestor
102086646|NCT02175342|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102086647|NCT02175342|Cholinergic Agents|cholinergic agents|mesh-ancestor
102086648|NCT02175342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102086649|NCT02175342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086650|NCT02171520|Dabigatran|dabigatran|mesh-list
102086651|NCT02171520|Antithrombins|antithrombins|mesh-ancestor
102086652|NCT02171520|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102086653|NCT02171520|Protease Inhibitors|protease inhibitors|mesh-ancestor
102086654|NCT02171520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102086655|NCT02171520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944032|NCT03899428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944033|NCT03899428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101944034|NCT02238418|Cholecalciferol|cholecalciferol|mesh-list
102086656|NCT02171520|Anticoagulants|anticoagulants|mesh-ancestor
102086657|NCT00092053|Ibandronic Acid|ibandronic acid|mesh-list
102086658|NCT00092053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102086659|NCT00092053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086661|NCT00101010|Cyclophosphamide|cyclophosphamide|mesh-list
102086662|NCT00101010|Rituximab|rituximab|mesh-list
102086663|NCT00101010|Doxorubicin|doxorubicin|mesh-list
102086664|NCT00101010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102086665|NCT00101010|Vincristine|vincristine|mesh-list
102086666|NCT00101010|Lenograstim|lenograstim|mesh-list
102086667|NCT00101010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102086668|NCT00101010|Immunologic Factors|immunologic factors|mesh-ancestor
102086669|NCT00101010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086670|NCT00101010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102086671|NCT00101010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102086672|NCT00101010|Alkylating Agents|alkylating agents|mesh-ancestor
102086673|NCT00101010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086674|NCT00101010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102086675|NCT00101010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102086676|NCT00101010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102086677|NCT00101010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102086678|NCT00101010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102086679|NCT00101010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102086680|NCT00101010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102086681|NCT00101010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102086682|NCT00101010|Glucocorticoids|glucocorticoids|mesh-ancestor
102086683|NCT00101010|Hormones|hormones|mesh-ancestor
102086684|NCT00101010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102086685|NCT00101010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102086686|NCT00101010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102086687|NCT00101010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102086688|NCT00101010|Tubulin Modulators|tubulin modulators|mesh-ancestor
102086689|NCT00101010|Antimitotic Agents|antimitotic agents|mesh-ancestor
102086690|NCT00101010|Mitosis Modulators|mitosis modulators|mesh-ancestor
102086691|NCT03539172|Apatinib|apatinib|mesh-list
102086692|NCT03539172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102086693|NCT03539172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102086694|NCT03539172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101806490|NCT00948272|Vaccines|vaccines|mesh-list
102086695|NCT03539172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086696|NCT03209401|Carboplatin|carboplatin|mesh-list
102086698|NCT03209401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102086699|NCT03209401|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102086700|NCT03209401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102086706|NCT04859764|Betamethasone|betamethasone|mesh-list
102086707|NCT04859764|Bupivacaine|bupivacaine|mesh-list
102086708|NCT04859764|Anesthetics, Local|anesthetics, local|mesh-ancestor
102086709|NCT04859764|Anesthetics|anesthetics|mesh-ancestor
102086710|NCT04859764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102086711|NCT04859764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086712|NCT04859764|Sensory System Agents|sensory system agents|mesh-ancestor
102086713|NCT04859764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102086714|NCT04859764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102086715|NCT04859764|Glucocorticoids|glucocorticoids|mesh-ancestor
102086716|NCT04859764|Hormones|hormones|mesh-ancestor
102086717|NCT04859764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102086718|NCT04859764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102086719|NCT04859764|Respiratory System Agents|respiratory system agents|mesh-ancestor
102086720|NCT02170740|Pantoprazole|pantoprazole|mesh-list
102086721|NCT02170740|Dabigatran|dabigatran|mesh-list
102086722|NCT02170740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102086723|NCT02170740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102086724|NCT02170740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102086725|NCT02170740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102086726|NCT02170740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086727|NCT02170740|Antithrombins|antithrombins|mesh-ancestor
102086728|NCT02170740|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102086729|NCT02170740|Protease Inhibitors|protease inhibitors|mesh-ancestor
101944035|NCT02238418|Vitamin D|vitamin d|mesh-list
101944036|NCT02238418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101944037|NCT02238418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944038|NCT02238418|Vitamins|vitamins|mesh-ancestor
101944039|NCT02238418|Micronutrients|micronutrients|mesh-ancestor
101944040|NCT02238418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101944041|NCT02850016|Romidepsin|romidepsin|mesh-list
101944042|NCT02850016|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
101944043|NCT02850016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101944044|NCT02850016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101705932|NCT02615262|Dexamethasone|dexamethasone|mesh-list
101944045|NCT02850016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101944046|NCT02850016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944047|NCT02849704|Pancrelipase|pancrelipase|mesh-list
101944048|NCT02849704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101944050|NCT03600766|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101944051|NCT03600766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101944052|NCT03600766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101944053|NCT03600766|Adrenergic Agents|adrenergic agents|mesh-ancestor
101944054|NCT03600766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101944055|NCT03600766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944056|NCT03600766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944057|NCT03600766|Urological Agents|urological agents|mesh-ancestor
101944058|NCT03600454|Anesthetics|anesthetics|mesh-list
101944059|NCT03600454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101944060|NCT03600454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944061|NCT03594604|Contraceptive Agents|contraceptive agents|mesh-list
102086730|NCT02170740|Anticoagulants|anticoagulants|mesh-ancestor
102086731|NCT02848599|Morphine|morphine|mesh-list
102086732|NCT02848599|Levobupivacaine|levobupivacaine|mesh-list
102086733|NCT02848599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102086734|NCT02848599|Narcotics|narcotics|mesh-ancestor
102086735|NCT02848599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102086736|NCT02848599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086737|NCT02848599|Analgesics|analgesics|mesh-ancestor
102086738|NCT02848599|Sensory System Agents|sensory system agents|mesh-ancestor
102086739|NCT02848599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102086740|NCT02848599|Anesthetics, Local|anesthetics, local|mesh-ancestor
102086741|NCT02848599|Anesthetics|anesthetics|mesh-ancestor
102086742|NCT02171598|Dabigatran|dabigatran|mesh-list
102086743|NCT02171598|Clopidogrel|clopidogrel|mesh-list
102086744|NCT02171598|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102086745|NCT02171598|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102086746|NCT02171598|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102086747|NCT02171598|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102086748|NCT02171598|Purinergic Agents|purinergic agents|mesh-ancestor
102086749|NCT02171598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102086750|NCT02171598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086751|NCT02171598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086752|NCT02171598|Antithrombins|antithrombins|mesh-ancestor
101944063|NCT03594604|Norethindrone Acetate|norethindrone acetate|mesh-list
101944064|NCT03594604|Contraceptives, Oral|contraceptives, oral|mesh-list
101433616|NCT00540787|Sympatholytics|sympatholytics|mesh-ancestor
102086753|NCT02171598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102086754|NCT02171598|Protease Inhibitors|protease inhibitors|mesh-ancestor
102086755|NCT02171598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102086756|NCT02171598|Anticoagulants|anticoagulants|mesh-ancestor
102086757|NCT03068962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
102086758|NCT03068962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102086759|NCT02171676|Docetaxel|docetaxel|mesh-list
102086760|NCT02171676|Afatinib|afatinib|mesh-list
102086761|NCT02171676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102086762|NCT02171676|Tubulin Modulators|tubulin modulators|mesh-ancestor
102086763|NCT02171676|Antimitotic Agents|antimitotic agents|mesh-ancestor
102086764|NCT02171676|Mitosis Modulators|mitosis modulators|mesh-ancestor
102086765|NCT02171676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086766|NCT02171676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102086767|NCT02171676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102086768|NCT03577743|Bevacizumab|bevacizumab|mesh-list
102086769|NCT03577743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102086770|NCT03577743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102086771|NCT03577743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102086782|NCT04794790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086784|NCT04794790|Sensory System Agents|sensory system agents|mesh-ancestor
102086785|NCT04794790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102086786|NCT04794790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102086787|NCT02171754|Ritonavir|ritonavir|mesh-list
102086788|NCT02171754|Afatinib|afatinib|mesh-list
102086789|NCT02171754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101705943|NCT02615262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102086790|NCT02171754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102086791|NCT02171754|Protease Inhibitors|protease inhibitors|mesh-ancestor
102086792|NCT02171754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102086793|NCT02171754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086794|NCT02171754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102086795|NCT02171754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102086796|NCT02171754|Antiviral Agents|antiviral agents|mesh-ancestor
102086797|NCT02171754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102086798|NCT02171754|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102086799|NCT02171754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102086800|NCT02171754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102086801|NCT02171754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102086802|NCT02171832|Olodaterol|olodaterol|mesh-list
102086803|NCT02171832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102086804|NCT02171832|Autonomic Agents|autonomic agents|mesh-ancestor
102086805|NCT02171832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102086806|NCT02171832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086807|NCT02171832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102086808|NCT02171832|Respiratory System Agents|respiratory system agents|mesh-ancestor
102086809|NCT02171910|Doxapram|doxapram|mesh-list
102086810|NCT02171910|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102086811|NCT02171910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086812|NCT02171910|Respiratory System Agents|respiratory system agents|mesh-ancestor
102086813|NCT02178306|Telmisartan|telmisartan|mesh-list
102086814|NCT02178306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102086815|NCT02178306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102086816|NCT02178306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102086817|NCT02178306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086818|NCT05729386|Metformin|metformin|mesh-list
102086819|NCT05729386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102086820|NCT05729386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086821|NCT05729308|Anesthetics|anesthetics|mesh-list
102086822|NCT05729308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102086823|NCT05729308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086824|NCT00778999|Desogestrel|desogestrel|mesh-list
102086825|NCT00778999|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102086826|NCT00778999|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102086827|NCT00778999|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102086828|NCT00778999|Contraceptive Agents|contraceptive agents|mesh-ancestor
102086829|NCT00778999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102086830|NCT00778999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086831|NCT00778999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101944065|NCT03594604|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
101944066|NCT03594604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101944067|NCT03594604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944068|NCT03594604|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101944069|NCT03594604|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101944070|NCT03594604|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102086832|NCT00778999|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102086833|NCT00778999|Progestins|progestins|mesh-ancestor
102086838|NCT02171988|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
102086839|NCT02171988|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102086840|NCT02171988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102086841|NCT02171988|Adrenergic Agents|adrenergic agents|mesh-ancestor
102086842|NCT02171988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102086843|NCT02171988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086844|NCT02171988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086845|NCT02171988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102086846|NCT02171988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102086847|NCT02171988|Vasodilator Agents|vasodilator agents|mesh-ancestor
102086848|NCT02171988|Sympatholytics|sympatholytics|mesh-ancestor
102086849|NCT02171988|Autonomic Agents|autonomic agents|mesh-ancestor
102086850|NCT02171988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102086851|NCT02171988|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102086852|NCT02171988|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102086853|NCT02171988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102086854|NCT02171988|Cholinergic Agents|cholinergic agents|mesh-ancestor
102086855|NCT00725413|Etonogestrel|etonogestrel|mesh-list
102086856|NCT00725413|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102086857|NCT00725413|Contraceptive Agents|contraceptive agents|mesh-ancestor
102086858|NCT00725413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102086859|NCT00725413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086860|NCT00725413|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102086861|NCT00103038|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102086862|NCT00103038|Hematinics|hematinics|mesh-ancestor
102086863|NCT00103038|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102086864|NCT00103038|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102086865|NCT00620035|Etonogestrel|etonogestrel|mesh-list
102086866|NCT00620035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102086867|NCT00620035|Contraceptive Agents|contraceptive agents|mesh-ancestor
102086868|NCT00620035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102086869|NCT00620035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086870|NCT00620035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102086871|NCT02175888|Iron|iron|mesh-list
102086872|NCT02175888|Trace Elements|trace elements|mesh-ancestor
102086873|NCT02175888|Micronutrients|micronutrients|mesh-ancestor
102086874|NCT02175888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086875|NCT05577637|Tacrolimus|tacrolimus|mesh-list
102086876|NCT05577637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102086877|NCT05577637|Immunologic Factors|immunologic factors|mesh-ancestor
102086878|NCT05577637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086879|NCT05577637|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102086880|NCT05577637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102086881|NCT05577637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086882|NCT02176044|Nitroprusside|nitroprusside|mesh-list
102086883|NCT02176044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102086884|NCT02176044|Vasodilator Agents|vasodilator agents|mesh-ancestor
102086885|NCT02176044|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102086886|NCT02176044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086887|NCT02176122|Meropenem|meropenem|mesh-list
102086888|NCT02176122|Tazobactam|tazobactam|mesh-list
102086889|NCT02176122|Piperacillin|piperacillin|mesh-list
102086890|NCT02176122|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102086891|NCT02176122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102086892|NCT02176122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102086893|NCT02176122|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102086894|NCT02176122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102086895|NCT02176122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944071|NCT03594604|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101944073|NCT02689258|Anesthetics, Local|anesthetics, local|mesh-ancestor
101944074|NCT02689258|Anesthetics|anesthetics|mesh-ancestor
102086896|NCT04887064|Sotorasib|sotorasib|mesh-list
102086897|NCT04887064|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102086898|NCT04887064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086899|NCT04887064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102086900|NCT04887064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102086901|NCT02967757|Liraglutide|liraglutide|mesh-list
102086902|NCT02967757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102086903|NCT02967757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086904|NCT02967757|Incretins|incretins|mesh-ancestor
102086909|NCT02261298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102086910|NCT02261298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102086911|NCT02261298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086913|NCT02176200|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
102086914|NCT02176200|Ipratropium|ipratropium|mesh-list
102086915|NCT02176200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102086916|NCT02176200|Autonomic Agents|autonomic agents|mesh-ancestor
102086917|NCT02176200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102086918|NCT02176200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086919|NCT02176200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101705960|NCT02624388|Genistein|genistein|mesh-list
102086920|NCT02176200|Respiratory System Agents|respiratory system agents|mesh-ancestor
102086921|NCT02176200|Sympathomimetics|sympathomimetics|mesh-ancestor
102086922|NCT02176200|Tocolytic Agents|tocolytic agents|mesh-ancestor
102086923|NCT02176200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102086924|NCT02176200|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102086925|NCT02176200|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102086926|NCT02176200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102086927|NCT02176200|Adrenergic Agents|adrenergic agents|mesh-ancestor
102086928|NCT02176200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102086929|NCT02176200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086930|NCT02176200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102086931|NCT02176200|Cholinergic Agents|cholinergic agents|mesh-ancestor
102086932|NCT03537612|Clonidine|clonidine|mesh-list
102086933|NCT03537612|Morphine|morphine|mesh-list
102086934|NCT03537612|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102086935|NCT03537612|Narcotics|narcotics|mesh-ancestor
102086936|NCT03537612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102086937|NCT03537612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086938|NCT03537612|Analgesics|analgesics|mesh-ancestor
102086939|NCT03537612|Sensory System Agents|sensory system agents|mesh-ancestor
102086940|NCT03537612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102086941|NCT03537612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102086942|NCT03537612|Sympatholytics|sympatholytics|mesh-ancestor
102086943|NCT03537612|Autonomic Agents|autonomic agents|mesh-ancestor
102086944|NCT03537612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102086945|NCT03537612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102086946|NCT03537612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102086947|NCT03537612|Adrenergic Agents|adrenergic agents|mesh-ancestor
102086948|NCT03537612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102086949|NCT03537612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086950|NCT00336063|Azacitidine|azacitidine|mesh-list
102086951|NCT00336063|Vorinostat|vorinostat|mesh-list
102086952|NCT00336063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102086953|NCT00336063|Antimetabolites|antimetabolites|mesh-ancestor
102086954|NCT00336063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086955|NCT00336063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102086956|NCT00336063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102086957|NCT00336063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102086958|NCT02172144|Moxifloxacin|moxifloxacin|mesh-list
102086959|NCT02172144|Olodaterol|olodaterol|mesh-list
102086960|NCT02172144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102086961|NCT02172144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102086962|NCT02172144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102086963|NCT02172144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102086964|NCT02172144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102086965|NCT02172144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086966|NCT02172144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102086967|NCT02172144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944076|NCT02689258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944077|NCT02689258|Sensory System Agents|sensory system agents|mesh-ancestor
101944078|NCT02689258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102086968|NCT02172144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102086969|NCT02172144|Autonomic Agents|autonomic agents|mesh-ancestor
102086970|NCT02172144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102086971|NCT02172144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102086972|NCT02172144|Respiratory System Agents|respiratory system agents|mesh-ancestor
102086973|NCT05729074|Pimecrolimus|pimecrolimus|mesh-list
102086974|NCT05729074|Varespladib methyl|varespladib methyl|mesh-list
102086989|NCT05729074|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
102086990|NCT02176512|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102086991|NCT02176512|Telmisartan|telmisartan|mesh-list
102086992|NCT02176512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102086993|NCT02176512|Diuretics|diuretics|mesh-ancestor
102086994|NCT02176512|Natriuretic Agents|natriuretic agents|mesh-ancestor
102086995|NCT02176512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806781|NCT00963534|Rituximab|rituximab|mesh-list
102086996|NCT02176512|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102086997|NCT02176512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102086998|NCT02176512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086999|NCT02176512|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102087000|NCT02176512|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102087002|NCT03537534|Anesthetics, Local|anesthetics, local|mesh-ancestor
102087003|NCT03537534|Anesthetics|anesthetics|mesh-ancestor
102087004|NCT03537534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102087005|NCT03537534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087006|NCT03537534|Sensory System Agents|sensory system agents|mesh-ancestor
102087007|NCT03537534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102087008|NCT03537534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102087009|NCT03537534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102087010|NCT03537534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102087011|NCT03537534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102087012|NCT03537534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087013|NCT03068650|Rindopepimut|rindopepimut|mesh-list
102087014|NCT03068650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102087015|NCT03068650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102087016|NCT04646005|Cemiplimab|cemiplimab|mesh-list
102087017|NCT04646005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102087018|NCT04646005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102087019|NCT02757768|Tamsulosin|tamsulosin|mesh-list
102087020|NCT02757768|Mirabegron|mirabegron|mesh-list
102087021|NCT02757768|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102087022|NCT02757768|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102087023|NCT02757768|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102087024|NCT02757768|Adrenergic Agents|adrenergic agents|mesh-ancestor
102087025|NCT02757768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102087026|NCT02757768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087027|NCT02757768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087028|NCT02757768|Urological Agents|urological agents|mesh-ancestor
102087029|NCT02757768|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102087030|NCT02757768|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102087031|NCT02757768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102087032|NCT03066076|Propylthiouracil|propylthiouracil|mesh-list
102087035|NCT03066076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087036|NCT03066076|Hormone Antagonists|hormone antagonists|mesh-ancestor
102087037|NCT03066076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102087038|NCT03066076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087039|NCT05225077|Dapagliflozin|dapagliflozin|mesh-list
102087040|NCT05225077|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102087041|NCT05225077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087042|NCT05225077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102087043|NCT05225077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087044|NCT03067792|Leucovorin|leucovorin|mesh-list
102087045|NCT03067792|Docetaxel|docetaxel|mesh-list
102087046|NCT03067792|Fluorouracil|fluorouracil|mesh-list
102087047|NCT03067792|Irinotecan|irinotecan|mesh-list
101944080|NCT02238184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101944081|NCT02238184|Autonomic Agents|autonomic agents|mesh-ancestor
101944082|NCT02238184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101944083|NCT02238184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776451|NCT00672620|Vortioxetine|vortioxetine|mesh-list
102087048|NCT03067792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102087049|NCT03067792|Tubulin Modulators|tubulin modulators|mesh-ancestor
102087050|NCT03067792|Antimitotic Agents|antimitotic agents|mesh-ancestor
102087051|NCT03067792|Mitosis Modulators|mitosis modulators|mesh-ancestor
102087052|NCT03067792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087053|NCT03067792|Antimetabolites|antimetabolites|mesh-ancestor
102087054|NCT03067792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102087055|NCT03067792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102087056|NCT03067792|Immunologic Factors|immunologic factors|mesh-ancestor
102087057|NCT03067792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087058|NCT03067792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102087059|NCT03067792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102087060|NCT03067792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102087061|NCT03067792|Antidotes|antidotes|mesh-ancestor
102087062|NCT03067792|Protective Agents|protective agents|mesh-ancestor
101705970|NCT02624388|Estrogens|estrogens|mesh-ancestor
102087063|NCT03067792|Vitamin B Complex|vitamin b complex|mesh-ancestor
102087064|NCT03067792|Vitamins|vitamins|mesh-ancestor
102087065|NCT03067792|Micronutrients|micronutrients|mesh-ancestor
102087066|NCT05224999|Nivolumab|nivolumab|mesh-list
102087067|NCT05224999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102087068|NCT05224999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102087069|NCT05224999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102087070|NCT05224999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087071|NCT03066154|Ritonavir|ritonavir|mesh-list
102087072|NCT03066154|Docetaxel|docetaxel|mesh-list
102087073|NCT03066154|Androgens|androgens|mesh-list
102087074|NCT03066154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102087075|NCT03066154|Tubulin Modulators|tubulin modulators|mesh-ancestor
102087076|NCT03066154|Antimitotic Agents|antimitotic agents|mesh-ancestor
102087077|NCT03066154|Mitosis Modulators|mitosis modulators|mesh-ancestor
102087078|NCT03066154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087079|NCT03066154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102087080|NCT03066154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102087081|NCT03066154|Protease Inhibitors|protease inhibitors|mesh-ancestor
102087082|NCT03066154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102087083|NCT03066154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102087084|NCT03066154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102087085|NCT03066154|Antiviral Agents|antiviral agents|mesh-ancestor
102087086|NCT03066154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102087087|NCT03066154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102087088|NCT03066154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102087089|NCT03066154|Hormones|hormones|mesh-ancestor
102087090|NCT03066154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102087091|NCT03066154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087092|NCT05224687|Daptomycin|daptomycin|mesh-list
102087093|NCT05224687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102087094|NCT05224687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102087095|NCT02753946|Tazobactam|tazobactam|mesh-list
102087096|NCT02753946|Piperacillin|piperacillin|mesh-list
102087097|NCT02753946|Fosfomycin|fosfomycin|mesh-list
102087098|NCT02753946|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102087099|NCT02753946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102087100|NCT02753946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102087101|NCT02753946|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102087102|NCT02753946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102087103|NCT02753946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087104|NCT00431431|Tibolone|tibolone|mesh-list
102087105|NCT00431431|Androgen Antagonists|androgen antagonists|mesh-ancestor
102087106|NCT00431431|Hormone Antagonists|hormone antagonists|mesh-ancestor
102087110|NCT00431431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102087111|NCT00431431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102087112|NCT00431431|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102087113|NCT00431431|Anabolic Agents|anabolic agents|mesh-ancestor
102087115|NCT02172222|Linagliptin|linagliptin|mesh-list
102087116|NCT02172222|Empagliflozin|empagliflozin|mesh-list
101944084|NCT02238184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101944085|NCT02238184|Respiratory System Agents|respiratory system agents|mesh-ancestor
101944086|NCT02238184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101944087|NCT02238184|Cholinergic Agents|cholinergic agents|mesh-ancestor
101944088|NCT02238184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101944089|NCT02238184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944090|NCT03592498|Sulfadiazine|sulfadiazine|mesh-list
101944091|NCT03592498|Silver Sulfadiazine|silver sulfadiazine|mesh-list
101944092|NCT03592498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101944093|NCT03592498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101944094|NCT03592498|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101944095|NCT03592498|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102087117|NCT02172222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102087118|NCT02172222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087119|NCT02172222|Incretins|incretins|mesh-ancestor
102087120|NCT02172222|Hormones|hormones|mesh-ancestor
101705976|NCT00727948|Analgesics|analgesics|mesh-ancestor
102087121|NCT02172222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102087122|NCT02172222|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102087123|NCT02172222|Protease Inhibitors|protease inhibitors|mesh-ancestor
102087124|NCT02172222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102087125|NCT02172222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087126|NCT02172222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102087127|NCT03625219|Prednisone|prednisone|mesh-list
102087128|NCT03625219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102087129|NCT03625219|Glucocorticoids|glucocorticoids|mesh-ancestor
102087130|NCT03625219|Hormones|hormones|mesh-ancestor
102087131|NCT03625219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102087132|NCT03625219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087133|NCT03625219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102087134|NCT03625219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102087135|NCT03065842|Contraceptive Agents|contraceptive agents|mesh-list
102087136|NCT03065842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102087137|NCT03065842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087138|NCT02179008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102087139|NCT02179008|Latanoprost|latanoprost|mesh-list
102087140|NCT02179008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102087141|NCT02172300|Tiotropium Bromide|tiotropium bromide|mesh-list
102087142|NCT02172300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102087143|NCT02172300|Autonomic Agents|autonomic agents|mesh-ancestor
102087144|NCT02172300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102087145|NCT02172300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087146|NCT02172300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102087147|NCT02172300|Respiratory System Agents|respiratory system agents|mesh-ancestor
102087148|NCT02172300|Parasympatholytics|parasympatholytics|mesh-ancestor
102087149|NCT02172300|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102087150|NCT02172300|Cholinergic Agents|cholinergic agents|mesh-ancestor
102087151|NCT02172300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102087152|NCT02172300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087153|NCT05223907|Propofol|propofol|mesh-list
102087154|NCT05223907|Etomidate|etomidate|mesh-list
102087155|NCT05223907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102087156|NCT05223907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102087157|NCT05223907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087158|NCT05223907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102087159|NCT05223907|Anesthetics, General|anesthetics, general|mesh-ancestor
102087160|NCT05223907|Anesthetics|anesthetics|mesh-ancestor
102087161|NCT03065998|Baclofen|baclofen|mesh-list
102087162|NCT03065998|Opipramol|opipramol|mesh-list
102087163|NCT03065998|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102087164|NCT03065998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087165|NCT03065998|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102087166|NCT03065998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102087167|NCT03065998|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101944096|NCT03592498|Coccidiostats|coccidiostats|mesh-ancestor
101944097|NCT03592498|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102087168|NCT03065998|GABA Agonists|gaba agonists|mesh-ancestor
102087169|NCT03065998|GABA Agents|gaba agents|mesh-ancestor
102087170|NCT03065998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102087171|NCT03065998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087172|NCT03065998|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102087173|NCT03065998|Antidepressive Agents|antidepressive agents|mesh-ancestor
102087174|NCT03065998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102087175|NCT03065998|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102087176|NCT03065998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102087182|NCT02172378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102087183|NCT02172378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087184|NCT02172378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102087185|NCT02172378|Respiratory System Agents|respiratory system agents|mesh-ancestor
102087186|NCT02172378|Parasympatholytics|parasympatholytics|mesh-ancestor
102087187|NCT02172378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102087188|NCT02172378|Cholinergic Agents|cholinergic agents|mesh-ancestor
102087189|NCT02172378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102087190|NCT02172378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087191|NCT05728528|Factor VIII|factor viii|mesh-list
102087192|NCT05728528|Coagulants|coagulants|mesh-ancestor
102087193|NCT02256228|Ropivacaine|ropivacaine|mesh-list
102087194|NCT02256228|Anesthetics, Local|anesthetics, local|mesh-ancestor
102087195|NCT02256228|Anesthetics|anesthetics|mesh-ancestor
102087196|NCT02256228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102087197|NCT02256228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087198|NCT02256228|Sensory System Agents|sensory system agents|mesh-ancestor
102087199|NCT02256228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102087200|NCT03067168|Bupivacaine|bupivacaine|mesh-list
102087201|NCT03067168|Anesthetics, Local|anesthetics, local|mesh-ancestor
102087202|NCT03067168|Anesthetics|anesthetics|mesh-ancestor
102087203|NCT03067168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102087204|NCT03067168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087205|NCT03067168|Sensory System Agents|sensory system agents|mesh-ancestor
102087206|NCT03067168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102087207|NCT04774237|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102087208|NCT04774237|Carbachol|carbachol|mesh-list
102087209|NCT04774237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102087210|NCT04774237|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102087211|NCT04774237|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102087212|NCT04774237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102087213|NCT04774237|Adrenergic Agents|adrenergic agents|mesh-ancestor
102087214|NCT04774237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102087215|NCT04774237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087216|NCT04774237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087217|NCT04774237|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102087218|NCT04774237|Miotics|miotics|mesh-ancestor
102087219|NCT04774237|Autonomic Agents|autonomic agents|mesh-ancestor
102087220|NCT04774237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102087221|NCT04774237|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102087222|NCT04774237|Cholinergic Agents|cholinergic agents|mesh-ancestor
102087223|NCT04774237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102087224|NCT04774237|Analgesics|analgesics|mesh-ancestor
102087225|NCT04774237|Sensory System Agents|sensory system agents|mesh-ancestor
102087226|NCT04774237|Protective Agents|protective agents|mesh-ancestor
102087227|NCT02172456|Tiotropium Bromide|tiotropium bromide|mesh-list
102087228|NCT02172456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102087229|NCT02172456|Autonomic Agents|autonomic agents|mesh-ancestor
102087230|NCT02172456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102087231|NCT02172456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087232|NCT02172456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102087233|NCT02172456|Respiratory System Agents|respiratory system agents|mesh-ancestor
102087234|NCT02172456|Parasympatholytics|parasympatholytics|mesh-ancestor
102087235|NCT02172456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102087236|NCT02172456|Cholinergic Agents|cholinergic agents|mesh-ancestor
102087237|NCT02172456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102087238|NCT02172456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087239|NCT02172534|Bromides|bromides|mesh-list
102087240|NCT02172534|Tiotropium Bromide|tiotropium bromide|mesh-list
102087241|NCT02172534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102087242|NCT02172534|Autonomic Agents|autonomic agents|mesh-ancestor
101944099|NCT03600064|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101944100|NCT03600064|Abortifacient Agents|abortifacient agents|mesh-ancestor
101944101|NCT03600064|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101776654|NCT00766064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102087243|NCT02172534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102087244|NCT02172534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087245|NCT02172534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102087246|NCT02172534|Respiratory System Agents|respiratory system agents|mesh-ancestor
102087247|NCT02172534|Parasympatholytics|parasympatholytics|mesh-ancestor
102087252|NCT02172534|Anticonvulsants|anticonvulsants|mesh-ancestor
102087253|NCT04713631|Artesunate|artesunate|mesh-list
102087254|NCT04713631|Curcumin|curcumin|mesh-list
102087255|NCT04713631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102087256|NCT04713631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102087257|NCT04713631|Analgesics|analgesics|mesh-ancestor
102087258|NCT04713631|Sensory System Agents|sensory system agents|mesh-ancestor
102087259|NCT04713631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102087260|NCT04713631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087261|NCT04713631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102087262|NCT04713631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102087263|NCT04713631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102087264|NCT04713631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102087265|NCT04713631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087266|NCT04713631|Antimalarials|antimalarials|mesh-ancestor
102087267|NCT04713631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102087268|NCT04713631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102087269|NCT04713631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102087270|NCT04713631|Antiviral Agents|antiviral agents|mesh-ancestor
102087271|NCT04713631|Schistosomicides|schistosomicides|mesh-ancestor
102087272|NCT04713631|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102087273|NCT04713631|Anthelmintics|anthelmintics|mesh-ancestor
102087274|NCT04459078|Apatinib|apatinib|mesh-list
102087275|NCT04459078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102087276|NCT04459078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102087277|NCT04459078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102087278|NCT04459078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102087279|NCT04459078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087280|NCT04459078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102087281|NCT02756832|Alogliptin|alogliptin|mesh-list
102087282|NCT02756832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102087283|NCT02756832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087284|NCT02756832|Incretins|incretins|mesh-ancestor
102087285|NCT02756832|Hormones|hormones|mesh-ancestor
102087286|NCT02756832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102087287|NCT02756832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102087288|NCT02756832|Protease Inhibitors|protease inhibitors|mesh-ancestor
102087289|NCT02756832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102087290|NCT02756832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087291|NCT00108810|Ketoprofen|ketoprofen|mesh-list
102087292|NCT00108810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102087293|NCT00108810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102087294|NCT00108810|Analgesics|analgesics|mesh-ancestor
102087295|NCT00108810|Sensory System Agents|sensory system agents|mesh-ancestor
102087296|NCT00108810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102087297|NCT00108810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087298|NCT00108810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102087299|NCT00108810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102087300|NCT00108810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102087301|NCT00108810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102087302|NCT00108810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087303|NCT04448392|Valacyclovir|valacyclovir|mesh-list
102087304|NCT04448392|Antiviral Agents|antiviral agents|mesh-ancestor
102087305|NCT04448392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102087306|NCT05588284|Rivaroxaban|rivaroxaban|mesh-list
102087307|NCT05588284|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102087308|NCT05588284|Antithrombins|antithrombins|mesh-ancestor
102087309|NCT05588284|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102087310|NCT05588284|Protease Inhibitors|protease inhibitors|mesh-ancestor
102087311|NCT05588284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102087312|NCT05588284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087313|NCT05588284|Anticoagulants|anticoagulants|mesh-ancestor
101944102|NCT03600064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944103|NCT03600064|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101944104|NCT03600064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101944105|NCT03600064|Oxytocics|oxytocics|mesh-ancestor
101944106|NCT02721082|Nicotine|nicotine|mesh-list
101944107|NCT02721082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101944108|NCT02721082|Autonomic Agents|autonomic agents|mesh-ancestor
101944109|NCT02721082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101944110|NCT02721082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944111|NCT02721082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101944112|NCT02721082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102087315|NCT02256150|Cyclophosphamide|cyclophosphamide|mesh-list
102087316|NCT02256150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102087317|NCT02256150|Immunologic Factors|immunologic factors|mesh-ancestor
102087318|NCT02256150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087319|NCT02256150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102087324|NCT02256150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102087325|NCT02256150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102087326|NCT02256150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102087328|NCT02256150|Sensory System Agents|sensory system agents|mesh-ancestor
102087329|NCT02256150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102087330|NCT02256150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102087331|NCT02256150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102087332|NCT02256150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102087333|NCT02256150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102087334|NCT02256150|Antimalarials|antimalarials|mesh-ancestor
102087335|NCT02256150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102087336|NCT02256150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102087337|NCT02256150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102087338|NCT02177370|Fenoterol|fenoterol|mesh-list
102087339|NCT02177370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102087340|NCT02177370|Autonomic Agents|autonomic agents|mesh-ancestor
102087341|NCT02177370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102087342|NCT02177370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087343|NCT02177370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102087344|NCT02177370|Respiratory System Agents|respiratory system agents|mesh-ancestor
102087345|NCT02177370|Sympathomimetics|sympathomimetics|mesh-ancestor
102087346|NCT02177370|Tocolytic Agents|tocolytic agents|mesh-ancestor
102087347|NCT02177370|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102087348|NCT02177370|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102087349|NCT02177370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102087350|NCT02177370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102087351|NCT02177370|Adrenergic Agents|adrenergic agents|mesh-ancestor
102087352|NCT02177370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102087353|NCT02177370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087354|NCT03538704|Metformin|metformin|mesh-list
102087355|NCT03538704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102087356|NCT03538704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087357|NCT02172768|Micafungin|micafungin|mesh-list
102087358|NCT02172768|Antifungal Agents|antifungal agents|mesh-ancestor
102087359|NCT02172768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102087360|NCT02172846|Paclitaxel|paclitaxel|mesh-list
102087361|NCT02172846|Carboplatin|carboplatin|mesh-list
102087362|NCT02172846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102087363|NCT02172846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102087364|NCT02172846|Tubulin Modulators|tubulin modulators|mesh-ancestor
102087365|NCT02172846|Antimitotic Agents|antimitotic agents|mesh-ancestor
102087366|NCT02172846|Mitosis Modulators|mitosis modulators|mesh-ancestor
102087367|NCT02172846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087368|NCT00106626|Pemetrexed|pemetrexed|mesh-list
102087369|NCT00106626|Vorinostat|vorinostat|mesh-list
102087370|NCT00106626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102087371|NCT00106626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102087372|NCT00106626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087373|NCT00106626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101944113|NCT02721082|Cholinergic Agents|cholinergic agents|mesh-ancestor
101944114|NCT02721082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101944115|NCT02721082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944116|NCT02238106|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101944117|NCT02238106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101944118|NCT02238106|Autonomic Agents|autonomic agents|mesh-ancestor
102087374|NCT00106626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102087375|NCT00106626|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102087376|NCT02177448|Enalapril|enalapril|mesh-list
102087377|NCT02177448|Enalaprilat|enalaprilat|mesh-list
102087378|NCT02177448|Telmisartan|telmisartan|mesh-list
102087379|NCT02177448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102087380|NCT02177448|Protease Inhibitors|protease inhibitors|mesh-ancestor
102087381|NCT02177448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102087382|NCT02177448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087383|NCT02177448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102087384|NCT02177448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102087385|NCT02177448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102087386|NCT03537144|Acetaminophen|acetaminophen|mesh-list
102087387|NCT03537144|Indomethacin|indomethacin|mesh-list
102087388|NCT03537144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102087389|NCT03537144|Analgesics|analgesics|mesh-ancestor
102087397|NCT03537144|Gout Suppressants|gout suppressants|mesh-ancestor
102087398|NCT03537144|Tocolytic Agents|tocolytic agents|mesh-ancestor
102087399|NCT03537144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102087400|NCT03537144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102087401|NCT03537144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102087402|NCT03537144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087403|NCT03065764|Pembrolizumab|pembrolizumab|mesh-list
102087404|NCT03065764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102087405|NCT03065764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102087406|NCT03065764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102087407|NCT03065764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087408|NCT02755818|Heparin|heparin|mesh-list
102087409|NCT02755818|Calcium heparin|calcium heparin|mesh-list
102087410|NCT02755818|Anticoagulants|anticoagulants|mesh-ancestor
102087411|NCT02755818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102087412|NCT02755818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102087413|NCT02755818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087414|NCT02177760|Sirolimus|sirolimus|mesh-list
102087415|NCT02177760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102087416|NCT02177760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102087417|NCT02177760|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102087418|NCT02177760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102087419|NCT02177760|Antifungal Agents|antifungal agents|mesh-ancestor
102087420|NCT02177760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102087421|NCT02177760|Immunologic Factors|immunologic factors|mesh-ancestor
102087422|NCT02177760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087423|NCT02173782|Fenoterol|fenoterol|mesh-list
102087424|NCT02173782|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
102087425|NCT02173782|Ipratropium|ipratropium|mesh-list
102087426|NCT02173782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102087427|NCT02173782|Autonomic Agents|autonomic agents|mesh-ancestor
102087428|NCT02173782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102087429|NCT02173782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087430|NCT02173782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102087431|NCT02173782|Respiratory System Agents|respiratory system agents|mesh-ancestor
102087432|NCT02173782|Sympathomimetics|sympathomimetics|mesh-ancestor
102087433|NCT02173782|Tocolytic Agents|tocolytic agents|mesh-ancestor
102087434|NCT02173782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102087435|NCT02173782|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102087436|NCT02173782|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102087437|NCT02173782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102087438|NCT02173782|Adrenergic Agents|adrenergic agents|mesh-ancestor
102087439|NCT02173782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102087440|NCT02173782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087441|NCT02173782|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102087442|NCT02173782|Cholinergic Agents|cholinergic agents|mesh-ancestor
101944119|NCT02238106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101944120|NCT02238106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944121|NCT02238106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101944122|NCT02238106|Respiratory System Agents|respiratory system agents|mesh-ancestor
101776857|NCT00814008|Insulin|insulin|mesh-list
102087443|NCT05717374|Dexamethasone|dexamethasone|mesh-list
102087444|NCT05717374|Dexamethasone acetate|dexamethasone acetate|mesh-list
102087445|NCT05717374|Methylprednisolone|methylprednisolone|mesh-list
102087446|NCT05717374|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102087447|NCT05717374|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102087448|NCT05717374|Prednisolone|prednisolone|mesh-list
102087449|NCT05717374|Prednisolone acetate|prednisolone acetate|mesh-list
102087450|NCT05717374|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102087451|NCT05717374|Prednisolone phosphate|prednisolone phosphate|mesh-list
102087452|NCT05717374|BB 1101|bb 1101|mesh-list
102087453|NCT05717374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102087454|NCT05717374|Antiemetics|antiemetics|mesh-ancestor
102087455|NCT05717374|Autonomic Agents|autonomic agents|mesh-ancestor
102087456|NCT05717374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102087457|NCT05717374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087468|NCT05717374|Protective Agents|protective agents|mesh-ancestor
102087469|NCT03537768|Levonorgestrel|levonorgestrel|mesh-list
102087470|NCT03537768|Ulipristal acetate|ulipristal acetate|mesh-list
102087471|NCT03537768|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102087472|NCT03537768|Contraceptive Agents|contraceptive agents|mesh-ancestor
102087473|NCT03537768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102087474|NCT03537768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087475|NCT03537768|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102087476|NCT03537768|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102087477|NCT03537768|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102087478|NCT02174094|Clobazam|clobazam|mesh-list
102087479|NCT02174094|Anticonvulsants|anticonvulsants|mesh-ancestor
102087480|NCT02174094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102087481|NCT02174094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102087482|NCT02174094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102087483|NCT02174094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087484|NCT02174094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102087485|NCT02174094|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102087486|NCT02174094|GABA Agonists|gaba agonists|mesh-ancestor
102087487|NCT02174094|GABA Agents|gaba agents|mesh-ancestor
102087488|NCT02174094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102087489|NCT02174094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087490|NCT02174172|Interferons|interferons|mesh-list
102087491|NCT02174172|Interferon-alpha|interferon-alpha|mesh-list
102087492|NCT02174172|Interferon alpha-2|interferon alpha-2|mesh-list
102087493|NCT02174172|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102087494|NCT02174172|Bevacizumab|bevacizumab|mesh-list
102087495|NCT02174172|Ipilimumab|ipilimumab|mesh-list
102087496|NCT02174172|Atezolizumab|atezolizumab|mesh-list
102087497|NCT02174172|Obinutuzumab|obinutuzumab|mesh-list
102087498|NCT02174172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102087499|NCT02174172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102087500|NCT02174172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102087501|NCT02174172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102087502|NCT02174172|Growth Substances|growth substances|mesh-ancestor
102087503|NCT02174172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087504|NCT02174172|Growth Inhibitors|growth inhibitors|mesh-ancestor
102087505|NCT02174172|Antiviral Agents|antiviral agents|mesh-ancestor
102087506|NCT02174172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102087507|NCT02174172|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102087508|NCT02174172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087509|NCT02174172|Immunologic Factors|immunologic factors|mesh-ancestor
102087510|NCT02180334|Acetaminophen|acetaminophen|mesh-list
102087511|NCT02180334|Linagliptin|linagliptin|mesh-list
102087512|NCT02180334|Mosapride|mosapride|mesh-list
102087513|NCT02180334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102087514|NCT02180334|Analgesics|analgesics|mesh-ancestor
102087515|NCT02180334|Sensory System Agents|sensory system agents|mesh-ancestor
102087516|NCT02180334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102087517|NCT02180334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087518|NCT02180334|Antipyretics|antipyretics|mesh-ancestor
102087519|NCT02180334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087520|NCT02180334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101944123|NCT02238106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101944124|NCT02238106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101944125|NCT02238106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102087522|NCT02180334|Hormones|hormones|mesh-ancestor
102087523|NCT02180334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102087530|NCT02180334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102087531|NCT02174250|Rifampin|rifampin|mesh-list
102087532|NCT02174250|Istradefylline|istradefylline|mesh-list
102087533|NCT02174250|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102087534|NCT02174250|Antitubercular Agents|antitubercular agents|mesh-ancestor
102087535|NCT02174250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102087536|NCT02174250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102087537|NCT02174250|Leprostatic Agents|leprostatic agents|mesh-ancestor
102087538|NCT02174250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102087539|NCT02174250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102087540|NCT02174250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087541|NCT02174250|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102087542|NCT02174250|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102087543|NCT02174250|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102087544|NCT02174250|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102087545|NCT02174250|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102087546|NCT02174250|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102087547|NCT02174250|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
102087548|NCT02174250|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102087549|NCT02174250|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102087550|NCT02174250|Purinergic Agents|purinergic agents|mesh-ancestor
102087551|NCT02174250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102087552|NCT02174250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087553|NCT02174328|Aspirin|aspirin|mesh-list
102087554|NCT02174328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102087555|NCT02174328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102087556|NCT02174328|Analgesics|analgesics|mesh-ancestor
102087557|NCT02174328|Sensory System Agents|sensory system agents|mesh-ancestor
102087558|NCT02174328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102087559|NCT02174328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087560|NCT02174328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102087561|NCT02174328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102087562|NCT02174328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102087563|NCT02174328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102087564|NCT02174328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087565|NCT02174328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102087566|NCT02174328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102087567|NCT02174328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102087568|NCT02174328|Antipyretics|antipyretics|mesh-ancestor
102087569|NCT02177994|Ceftriaxone|ceftriaxone|mesh-list
102087570|NCT02177994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102087571|NCT02177994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102087572|NCT02755116|Olanzapine|olanzapine|mesh-list
102087573|NCT02755116|Antiemetics|antiemetics|mesh-ancestor
102087574|NCT02755116|Autonomic Agents|autonomic agents|mesh-ancestor
102087575|NCT02755116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102087576|NCT02755116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087577|NCT02755116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102087578|NCT02755116|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102087579|NCT02755116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102087580|NCT02755116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102087581|NCT02755116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102087582|NCT02755116|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102087583|NCT02755116|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102087584|NCT02755116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102087585|NCT02755116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087586|NCT02755116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102087587|NCT02755116|Serotonin Agents|serotonin agents|mesh-ancestor
102087588|NCT02178150|Magnesium Oxide|magnesium oxide|mesh-list
102087589|NCT02178150|Antacids|antacids|mesh-ancestor
101389258|NCT05896566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102087594|NCT04411030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102087595|NCT04411030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102087596|NCT04411030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101944127|NCT02238106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101776999|NCT00560391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102087597|NCT04411030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087598|NCT04411030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102087599|NCT04411030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102087600|NCT04411030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102087601|NCT04411030|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102087602|NCT04411030|Anesthetics, General|anesthetics, general|mesh-ancestor
102087603|NCT04411030|Anesthetics|anesthetics|mesh-ancestor
102087604|NCT04411030|GABA Modulators|gaba modulators|mesh-ancestor
102087605|NCT04411030|GABA Agents|gaba agents|mesh-ancestor
102087606|NCT04411030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102087607|NCT04411030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087608|NCT04411030|Antifungal Agents|antifungal agents|mesh-ancestor
102087609|NCT04411030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102087610|NCT04411030|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102087611|NCT04411030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102087612|NCT04411030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102087613|NCT04411030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102087614|NCT04411030|Hormone Antagonists|hormone antagonists|mesh-ancestor
102087615|NCT04411030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102087616|NCT04411030|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102087617|NCT04437654|Apixaban|apixaban|mesh-list
102087618|NCT04437654|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102087619|NCT04437654|Antithrombins|antithrombins|mesh-ancestor
102087620|NCT04437654|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102087621|NCT04437654|Protease Inhibitors|protease inhibitors|mesh-ancestor
102087622|NCT04437654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102087623|NCT04437654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087624|NCT04437654|Anticoagulants|anticoagulants|mesh-ancestor
102087625|NCT02185638|Appetite Depressants|appetite depressants|mesh-list
102087626|NCT02185638|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102087627|NCT02185716|Levobupivacaine|levobupivacaine|mesh-list
102087628|NCT02185716|Anesthetics, Local|anesthetics, local|mesh-ancestor
102087629|NCT02185716|Anesthetics|anesthetics|mesh-ancestor
102087630|NCT02185716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102087631|NCT02185716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087632|NCT02185716|Sensory System Agents|sensory system agents|mesh-ancestor
102087633|NCT02185716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102087634|NCT02182050|Nintedanib|nintedanib|mesh-list
102087635|NCT02182050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102087636|NCT02182050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102087637|NCT02182050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102087638|NCT02182050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087639|NCT02182128|Nintedanib|nintedanib|mesh-list
102087640|NCT02182128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102087641|NCT02182128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102087642|NCT02182128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102087643|NCT02182128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087644|NCT02182206|Nintedanib|nintedanib|mesh-list
102087645|NCT02182206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102087646|NCT02182206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102087647|NCT02182206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102087648|NCT02182206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087649|NCT03963544|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102087650|NCT03963544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102087651|NCT03963544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102087652|NCT03963544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087653|NCT02180568|Ethiodized Oil|ethiodized oil|mesh-list
102087654|NCT02180568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102087655|NCT02657889|Pembrolizumab|pembrolizumab|mesh-list
102087656|NCT02657889|Niraparib|niraparib|mesh-list
102087657|NCT02657889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102087658|NCT02657889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102087659|NCT02657889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102087661|NCT02657889|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102087662|NCT02657889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102087663|NCT03536208|Warfarin|warfarin|mesh-list
102087664|NCT03536208|Anticoagulants|anticoagulants|mesh-ancestor
102087665|NCT03034915|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101944128|NCT02238106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087666|NCT03034915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102087667|NCT03034915|Autonomic Agents|autonomic agents|mesh-ancestor
102087668|NCT03034915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102087669|NCT03034915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087670|NCT03034915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102087671|NCT03034915|Respiratory System Agents|respiratory system agents|mesh-ancestor
102087672|NCT03034915|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102087673|NCT03034915|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102087674|NCT03034915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102087675|NCT03034915|Adrenergic Agents|adrenergic agents|mesh-ancestor
102087676|NCT03034915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102087677|NCT03034915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087679|NCT02631538|Belimumab|belimumab|mesh-list
102087680|NCT02631538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102087681|NCT02631538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102087682|NCT02631538|Immunologic Factors|immunologic factors|mesh-ancestor
102087683|NCT02631538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087684|NCT02631538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102087685|NCT02631538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102087686|NCT03578679|Ivermectin|ivermectin|mesh-list
102087687|NCT03578679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102087688|NCT03578679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102087689|NCT04930783|Nivolumab|nivolumab|mesh-list
102087690|NCT04930783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102087691|NCT04930783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102087692|NCT04930783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102087693|NCT04930783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087694|NCT05666206|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102087695|NCT05666206|Hemostatics|hemostatics|mesh-ancestor
102087696|NCT05666206|Coagulants|coagulants|mesh-ancestor
102087697|NCT05459701|Dapagliflozin|dapagliflozin|mesh-list
102087698|NCT05459701|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102087699|NCT05459701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087700|NCT05459701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102087701|NCT05459701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087702|NCT05459389|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102087703|NCT05459389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102087704|NCT02256462|Adalimumab|adalimumab|mesh-list
102087705|NCT02256462|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102087706|NCT02256462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102087707|NCT02256462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102087708|NCT02631148|Melatonin|melatonin|mesh-list
102087709|NCT02631148|Antioxidants|antioxidants|mesh-ancestor
102087710|NCT02631148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087711|NCT02631148|Protective Agents|protective agents|mesh-ancestor
102087712|NCT02631148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087713|NCT02631148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102087714|NCT02239107|Acetylcysteine|acetylcysteine|mesh-list
102087715|NCT02239107|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102087716|NCT02239107|Antiviral Agents|antiviral agents|mesh-ancestor
102087717|NCT02239107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102087718|NCT02239107|Expectorants|expectorants|mesh-ancestor
102087719|NCT02239107|Respiratory System Agents|respiratory system agents|mesh-ancestor
102087720|NCT02239107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102087721|NCT02239107|Antioxidants|antioxidants|mesh-ancestor
102087722|NCT02239107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087723|NCT02239107|Protective Agents|protective agents|mesh-ancestor
102087724|NCT02239107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087725|NCT02239107|Antidotes|antidotes|mesh-ancestor
102087726|NCT02182518|Pseudoephedrine|pseudoephedrine|mesh-list
102087727|NCT02182518|Ephedrine|ephedrine|mesh-list
102087728|NCT02182518|Epinastine|epinastine|mesh-list
102087729|NCT02182518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102087730|NCT02182518|Autonomic Agents|autonomic agents|mesh-ancestor
102087733|NCT02182518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102087734|NCT02182518|Respiratory System Agents|respiratory system agents|mesh-ancestor
102087735|NCT02182518|Nasal Decongestants|nasal decongestants|mesh-ancestor
102087736|NCT02182518|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102087737|NCT02182518|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102087738|NCT02182518|Sympathomimetics|sympathomimetics|mesh-ancestor
102087739|NCT02182518|Adrenergic Agents|adrenergic agents|mesh-ancestor
102087740|NCT02182518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101944130|NCT03577912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101944131|NCT03577912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944132|NCT02238262|Telmisartan|telmisartan|mesh-list
101944133|NCT02238262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102087741|NCT02182518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087742|NCT02182518|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102087743|NCT02182518|Histamine Antagonists|histamine antagonists|mesh-ancestor
102087745|NCT03881488|Pembrolizumab|pembrolizumab|mesh-list
102087746|NCT03881488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102087747|NCT03881488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102087748|NCT03881488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102087749|NCT03881488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087750|NCT05486182|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
102087751|NCT05486182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087752|NCT03574857|Metolazone|metolazone|mesh-list
102087753|NCT03574857|Chlorothiazide|chlorothiazide|mesh-list
102087754|NCT03574857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102087755|NCT03574857|Diuretics|diuretics|mesh-ancestor
102087756|NCT03574857|Natriuretic Agents|natriuretic agents|mesh-ancestor
102087757|NCT03574857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087758|NCT03574857|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102087759|NCT03574857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102087760|NCT03574857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087761|NCT02238639|Fibrin fragment D|fibrin fragment d|mesh-list
102087762|NCT02238639|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102087763|NCT02238639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101706081|NCT01366144|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102087764|NCT02238639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087765|NCT02238639|Hemostatics|hemostatics|mesh-ancestor
102087766|NCT02238639|Coagulants|coagulants|mesh-ancestor
102087767|NCT02186028|Vitamin D|vitamin d|mesh-list
102087768|NCT02186028|Vitamins|vitamins|mesh-ancestor
102087769|NCT02186028|Micronutrients|micronutrients|mesh-ancestor
102087770|NCT02186028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087771|NCT02186028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102087772|NCT02182596|Gemtuzumab|gemtuzumab|mesh-list
102087773|NCT02182596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102087774|NCT02182596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102087775|NCT02182596|Immunotoxins|immunotoxins|mesh-ancestor
102087776|NCT02182596|Immunoconjugates|immunoconjugates|mesh-ancestor
102087777|NCT02182596|Immunologic Factors|immunologic factors|mesh-ancestor
102087778|NCT02182596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087779|NCT03574701|Vitamin A|vitamin a|mesh-list
102087780|NCT03574701|Vitamins|vitamins|mesh-ancestor
102087781|NCT03574701|Micronutrients|micronutrients|mesh-ancestor
102087782|NCT03574701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087783|NCT02180880|Pregabalin|pregabalin|mesh-list
102087784|NCT02180880|Oxcarbazepine|oxcarbazepine|mesh-list
102087785|NCT02180880|Analgesics|analgesics|mesh-ancestor
102087786|NCT02180880|Sensory System Agents|sensory system agents|mesh-ancestor
102087787|NCT02180880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102087788|NCT02180880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087789|NCT02180880|Anticonvulsants|anticonvulsants|mesh-ancestor
102087790|NCT02180880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102087791|NCT02180880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102087792|NCT02180880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087793|NCT02180880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102087794|NCT02180880|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102087795|NCT02180880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102087796|NCT02180880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102087797|NCT02180880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102087798|NCT02180880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102087799|NCT02180880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102087800|NCT02180880|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102087801|NCT02180880|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102087802|NCT02186106|Cholecalciferol|cholecalciferol|mesh-list
102087803|NCT02186106|Vitamin D|vitamin d|mesh-list
102087808|NCT02186106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102087810|NCT03943147|Deucravacitinib|deucravacitinib|mesh-list
102087811|NCT03943147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101944134|NCT02238262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101944135|NCT02238262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101944136|NCT02238262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087812|NCT03943147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102087813|NCT03943147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102087814|NCT03943147|Antitubercular Agents|antitubercular agents|mesh-ancestor
102087815|NCT03943147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102087816|NCT03943147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102087817|NCT03943147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102087818|NCT03943147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087819|NCT03943147|Dermatologic Agents|dermatologic agents|mesh-ancestor
102087820|NCT03943147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102087822|NCT02182752|Ropivacaine|ropivacaine|mesh-list
102087823|NCT02182752|Anesthetics, Local|anesthetics, local|mesh-ancestor
102087824|NCT02182752|Anesthetics|anesthetics|mesh-ancestor
102087825|NCT02182752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102087826|NCT02182752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087827|NCT02182752|Sensory System Agents|sensory system agents|mesh-ancestor
102087828|NCT02182752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102087829|NCT02182752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102087830|NCT02182752|Narcotics|narcotics|mesh-ancestor
102087831|NCT02182752|Analgesics|analgesics|mesh-ancestor
102087832|NCT03536598|Amlodipine|amlodipine|mesh-list
102087833|NCT03536598|Valsartan|valsartan|mesh-list
102087834|NCT03536598|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102087835|NCT03536598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102087836|NCT03536598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102087837|NCT03536598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102087838|NCT03536598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087839|NCT03536598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102087840|NCT03536598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087841|NCT03536598|Vasodilator Agents|vasodilator agents|mesh-ancestor
102087842|NCT03536598|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102087843|NCT03536598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102087844|NCT03536598|Antimetabolites|antimetabolites|mesh-ancestor
102087845|NCT03536598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102087846|NCT03536598|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102087847|NCT03536598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102087848|NCT03536598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102087849|NCT03536598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102087850|NCT03576963|Nivolumab|nivolumab|mesh-list
102087851|NCT03576963|Guadecitabine|guadecitabine|mesh-list
102087852|NCT03576963|Azacitidine|azacitidine|mesh-list
102087853|NCT03576963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102087854|NCT03576963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102087855|NCT03576963|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102087856|NCT03576963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087857|NCT03576963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102087858|NCT03576963|Antimetabolites|antimetabolites|mesh-ancestor
102087859|NCT03576963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102087860|NCT02186496|Amlodipine|amlodipine|mesh-list
102087861|NCT02186496|Candesartan|candesartan|mesh-list
102087862|NCT02186496|Candesartan cilexetil|candesartan cilexetil|mesh-list
102087863|NCT02186496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102087864|NCT02186496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102087865|NCT02186496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102087866|NCT02186496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087867|NCT02186496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102087868|NCT02186496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087869|NCT02186496|Vasodilator Agents|vasodilator agents|mesh-ancestor
102087870|NCT02186496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102087871|NCT02186496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102087872|NCT05615194|Dexmedetomidine|dexmedetomidine|mesh-list
102087873|NCT05615194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102087881|NCT05615194|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102087882|NCT05615194|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102087883|NCT05615194|Adrenergic Agents|adrenergic agents|mesh-ancestor
102087884|NCT05615194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102087885|NCT05615194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944137|NCT03577834|Acetic Acid|acetic acid|mesh-list
101944138|NCT03577834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101944139|NCT03577834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101944141|NCT03707678|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102087886|NCT02186574|Tenofovir|tenofovir|mesh-list
102087887|NCT02186574|Antiviral Agents|antiviral agents|mesh-ancestor
102087888|NCT02186574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102087889|NCT02186574|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102087890|NCT02186574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102087892|NCT02186574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087893|NCT02186574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102087894|NCT02186574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102087895|NCT03066700|Hemostatics|hemostatics|mesh-list
102087896|NCT03066700|Coagulants|coagulants|mesh-ancestor
102087897|NCT03066544|Dexamethasone|dexamethasone|mesh-list
102087898|NCT03066544|Ketorolac|ketorolac|mesh-list
102087899|NCT03066544|Naratriptan|naratriptan|mesh-list
102087900|NCT03066544|Bupivacaine|bupivacaine|mesh-list
102087901|NCT03066544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102087902|NCT03066544|Antiemetics|antiemetics|mesh-ancestor
102087903|NCT03066544|Autonomic Agents|autonomic agents|mesh-ancestor
102087904|NCT03066544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102087905|NCT03066544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087906|NCT03066544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102087907|NCT03066544|Glucocorticoids|glucocorticoids|mesh-ancestor
102087908|NCT03066544|Hormones|hormones|mesh-ancestor
102087909|NCT03066544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102087910|NCT03066544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102087911|NCT03066544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102087912|NCT03066544|Anesthetics, Local|anesthetics, local|mesh-ancestor
102087913|NCT03066544|Anesthetics|anesthetics|mesh-ancestor
102087914|NCT03066544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102087915|NCT03066544|Sensory System Agents|sensory system agents|mesh-ancestor
102087916|NCT03066544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102087917|NCT03066544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102087918|NCT03066544|Analgesics|analgesics|mesh-ancestor
102087919|NCT03066544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102087920|NCT03066544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102087921|NCT03066544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102087922|NCT03066544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087923|NCT03066544|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102087924|NCT03066544|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102087925|NCT03066544|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102087926|NCT03066544|Serotonin Agents|serotonin agents|mesh-ancestor
102087927|NCT03066544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102087928|NCT03182179|Ondansetron|ondansetron|mesh-list
102087929|NCT03182179|Antiemetics|antiemetics|mesh-ancestor
102087930|NCT03182179|Autonomic Agents|autonomic agents|mesh-ancestor
102087931|NCT03182179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102087932|NCT03182179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087933|NCT03182179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102087934|NCT03182179|Antipruritics|antipruritics|mesh-ancestor
102087935|NCT03182179|Dermatologic Agents|dermatologic agents|mesh-ancestor
102087936|NCT03182179|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102087937|NCT03182179|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102087938|NCT03182179|Serotonin Agents|serotonin agents|mesh-ancestor
102087939|NCT03182179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102087940|NCT03182179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389615|NCT05826964|Hormones|hormones|mesh-ancestor
102087945|NCT03576651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102087946|NCT03576651|Growth Substances|growth substances|mesh-ancestor
102087947|NCT03576651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087948|NCT03576651|Growth Inhibitors|growth inhibitors|mesh-ancestor
102087950|NCT04116112|Hydralazine|hydralazine|mesh-list
102087951|NCT04116112|Nicardipine|nicardipine|mesh-list
102087952|NCT04116112|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102087953|NCT04116112|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102087954|NCT04116112|Adrenergic Agents|adrenergic agents|mesh-ancestor
102087955|NCT04116112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102087956|NCT04116112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087957|NCT04116112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087958|NCT04116112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101944142|NCT03707678|Autonomic Agents|autonomic agents|mesh-ancestor
101944143|NCT03707678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101944144|NCT03707678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944145|NCT03707678|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101777357|NCT00781391|Protease Inhibitors|protease inhibitors|mesh-ancestor
102087959|NCT04116112|Sympathomimetics|sympathomimetics|mesh-ancestor
102087960|NCT04116112|Autonomic Agents|autonomic agents|mesh-ancestor
102087961|NCT04116112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102087962|NCT04116112|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102087963|NCT04116112|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102087964|NCT04116112|Vasodilator Agents|vasodilator agents|mesh-ancestor
102087965|NCT04116112|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101706109|NCT00712270|Aripiprazole|aripiprazole|mesh-list
102087966|NCT04116112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102087967|NCT04116112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102087969|NCT03064906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102087970|NCT03034135|Copper|copper|mesh-list
102087971|NCT03034135|Temozolomide|temozolomide|mesh-list
102087972|NCT03034135|Disulfiram|disulfiram|mesh-list
102087973|NCT03034135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102087974|NCT03034135|Alkylating Agents|alkylating agents|mesh-ancestor
102087975|NCT03034135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087976|NCT03034135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102087977|NCT03034135|Trace Elements|trace elements|mesh-ancestor
102087978|NCT03034135|Micronutrients|micronutrients|mesh-ancestor
102087979|NCT03034135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087980|NCT03034135|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102087981|NCT03034135|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
102087982|NCT03034135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102087983|NCT02239731|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102087984|NCT02239731|Doxycycline|doxycycline|mesh-list
102087985|NCT02239731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102087986|NCT02239731|Antimalarials|antimalarials|mesh-ancestor
102087987|NCT02239731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102087988|NCT02239731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102087989|NCT03571815|Listerine|listerine|mesh-list
102087990|NCT03571815|Fluorides|fluorides|mesh-list
102087991|NCT03571815|Sodium Fluoride|sodium fluoride|mesh-list
102087992|NCT03571815|Fluorides, Topical|fluorides, topical|mesh-list
102087993|NCT03571815|Cariostatic Agents|cariostatic agents|mesh-ancestor
102087994|NCT03571815|Protective Agents|protective agents|mesh-ancestor
102087995|NCT03571815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087996|NCT03571815|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102087997|NCT03571815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102087998|NCT03571737|Ibuprofen|ibuprofen|mesh-list
102087999|NCT03571737|Lidocaine|lidocaine|mesh-list
102088000|NCT03571737|Anesthetics, Local|anesthetics, local|mesh-ancestor
102088001|NCT03571737|Anesthetics|anesthetics|mesh-ancestor
102088002|NCT03571737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102088003|NCT03571737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088004|NCT03571737|Sensory System Agents|sensory system agents|mesh-ancestor
102088005|NCT03571737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102088006|NCT03571737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102088007|NCT03571737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102088008|NCT03571737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102088009|NCT03571737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102088010|NCT03571737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088011|NCT03571737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102088012|NCT03571737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102088020|NCT03573999|Diuretics|diuretics|mesh-ancestor
102088021|NCT03573999|Natriuretic Agents|natriuretic agents|mesh-ancestor
102088022|NCT03573999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088023|NCT03063190|Vitamin D|vitamin d|mesh-list
102088024|NCT03063190|Vitamins|vitamins|mesh-ancestor
102088025|NCT03063190|Micronutrients|micronutrients|mesh-ancestor
102088026|NCT03063190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088027|NCT03063190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102088028|NCT03573687|Caseins|caseins|mesh-list
102088029|NCT03573687|Chelating Agents|chelating agents|mesh-ancestor
102088030|NCT03573687|Sequestering Agents|sequestering agents|mesh-ancestor
102088031|NCT03573687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088032|NCT01671280|Azithromycin|azithromycin|mesh-list
101944146|NCT03707678|Respiratory System Agents|respiratory system agents|mesh-ancestor
101944148|NCT03707678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101777429|NCT03982849|Silymarin|silymarin|mesh-list
102088033|NCT01671280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102088034|NCT01671280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102088035|NCT04904302|Nivolumab|nivolumab|mesh-list
102088036|NCT04904302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102088037|NCT04904302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102088038|NCT04904302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102088039|NCT04904302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088040|NCT03575637|Olanzapine|olanzapine|mesh-list
102088041|NCT03575637|Antiemetics|antiemetics|mesh-ancestor
102088042|NCT03575637|Autonomic Agents|autonomic agents|mesh-ancestor
102088043|NCT03575637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102088044|NCT03575637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088045|NCT03575637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102088046|NCT03575637|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102088047|NCT03575637|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102088048|NCT03575637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102088049|NCT03575637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102088050|NCT03575637|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102088051|NCT03575637|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102088052|NCT03575637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102088053|NCT03575637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088054|NCT03575637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102088055|NCT03575637|Serotonin Agents|serotonin agents|mesh-ancestor
102088056|NCT03062800|Thalidomide|thalidomide|mesh-list
102088057|NCT03062800|Carboplatin|carboplatin|mesh-list
102088058|NCT03062800|Pemetrexed|pemetrexed|mesh-list
102088059|NCT03062800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102088060|NCT03062800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102088061|NCT03062800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088062|NCT03062800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102088063|NCT03062800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102088064|NCT03062800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102088065|NCT03062800|Immunologic Factors|immunologic factors|mesh-ancestor
102088066|NCT03062800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088067|NCT03062800|Leprostatic Agents|leprostatic agents|mesh-ancestor
102088068|NCT03062800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102088069|NCT03062800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102088070|NCT03062800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102088071|NCT03062800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102088072|NCT03062800|Growth Substances|growth substances|mesh-ancestor
102088073|NCT03062800|Growth Inhibitors|growth inhibitors|mesh-ancestor
102088074|NCT05709015|Chlorhexidine|chlorhexidine|mesh-list
102088075|NCT05709015|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102088076|NCT05709015|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102088077|NCT05709015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102088078|NCT05709015|Disinfectants|disinfectants|mesh-ancestor
102088079|NCT05709015|Dermatologic Agents|dermatologic agents|mesh-ancestor
102088080|NCT03418779|Prednisolone|prednisolone|mesh-list
102088081|NCT03418779|Cyclophosphamide|cyclophosphamide|mesh-list
102088082|NCT03418779|Immunosuppressive Agents|immunosuppressive agents|mesh-list
102088098|NCT03573063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102088099|NCT03573063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088100|NCT03572829|Dexamethasone|dexamethasone|mesh-list
102088101|NCT03572829|Ondansetron|ondansetron|mesh-list
102088102|NCT03572829|Aprepitant|aprepitant|mesh-list
102088103|NCT03572829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102088104|NCT03572829|Antiemetics|antiemetics|mesh-ancestor
102088105|NCT03572829|Autonomic Agents|autonomic agents|mesh-ancestor
102088106|NCT03572829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102088107|NCT03572829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088108|NCT03572829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102088109|NCT03572829|Glucocorticoids|glucocorticoids|mesh-ancestor
102088110|NCT03572829|Hormones|hormones|mesh-ancestor
101706135|NCT03860597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102088111|NCT03572829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102088112|NCT03572829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102088113|NCT03572829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102088114|NCT03572829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944149|NCT03707678|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101944150|NCT03707678|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102088115|NCT03572829|Antipruritics|antipruritics|mesh-ancestor
102088116|NCT03572829|Dermatologic Agents|dermatologic agents|mesh-ancestor
102088117|NCT03572829|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102088118|NCT03572829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102088119|NCT03572829|Serotonin Agents|serotonin agents|mesh-ancestor
102088120|NCT03572829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102088121|NCT03572829|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102088122|NCT03575247|Glucocorticoids|glucocorticoids|mesh-list
102088123|NCT03575247|Hormones|hormones|mesh-ancestor
102088124|NCT03575247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102088125|NCT03575247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088126|NCT03704623|Acetaminophen|acetaminophen|mesh-list
102088127|NCT03704623|Parecoxib|parecoxib|mesh-list
102088128|NCT03704623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102088129|NCT03704623|Analgesics|analgesics|mesh-ancestor
102088130|NCT03704623|Sensory System Agents|sensory system agents|mesh-ancestor
102088131|NCT03704623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102088132|NCT03704623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088133|NCT03704623|Antipyretics|antipyretics|mesh-ancestor
102088134|NCT03704623|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102088135|NCT03704623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102088136|NCT03704623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102088137|NCT03704623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088138|NCT03704623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102088139|NCT03704623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102088140|NCT03704623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102088145|NCT03572517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102088146|NCT03572517|Narcotics|narcotics|mesh-ancestor
102088147|NCT03572517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102088148|NCT03572517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088149|NCT03572517|Analgesics|analgesics|mesh-ancestor
102088150|NCT03572517|Sensory System Agents|sensory system agents|mesh-ancestor
102088151|NCT03572517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102088152|NCT03570645|Dexamethasone|dexamethasone|mesh-list
102088153|NCT03570645|Dexmedetomidine|dexmedetomidine|mesh-list
102088154|NCT03570645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102088155|NCT03570645|Antiemetics|antiemetics|mesh-ancestor
102088156|NCT03570645|Autonomic Agents|autonomic agents|mesh-ancestor
102088157|NCT03570645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102088158|NCT03570645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088159|NCT03570645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102088160|NCT03570645|Glucocorticoids|glucocorticoids|mesh-ancestor
102088162|NCT03570645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102088163|NCT03570645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102088164|NCT03570645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102088165|NCT03570645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102088166|NCT03570645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102088167|NCT03570645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102088168|NCT03570645|Analgesics|analgesics|mesh-ancestor
102088169|NCT03570645|Sensory System Agents|sensory system agents|mesh-ancestor
102088170|NCT03570645|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102088171|NCT03570645|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102088172|NCT03570645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102088173|NCT03570645|Adrenergic Agents|adrenergic agents|mesh-ancestor
102088174|NCT03570645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102088175|NCT03570645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088176|NCT03940690|Bevacizumab|bevacizumab|mesh-list
102088177|NCT03940690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102088178|NCT03940690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102088179|NCT03940690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102088180|NCT03940690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102088181|NCT03940690|Growth Substances|growth substances|mesh-ancestor
102088182|NCT03940690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088183|NCT03940690|Growth Inhibitors|growth inhibitors|mesh-ancestor
102088184|NCT03567135|Temozolomide|temozolomide|mesh-list
102088185|NCT03567135|Apatinib|apatinib|mesh-list
102088186|NCT03567135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102088187|NCT03567135|Alkylating Agents|alkylating agents|mesh-ancestor
102088188|NCT03567135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944151|NCT03707678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101944152|NCT03707678|Adrenergic Agents|adrenergic agents|mesh-ancestor
101777570|NCT03646474|Hemostatics|hemostatics|mesh-ancestor
102088189|NCT03567135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807979|NCT00972426|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102088190|NCT03567135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102088191|NCT03567135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102088192|NCT03698383|Trastuzumab|trastuzumab|mesh-list
102088193|NCT03698383|Gedatolisib|gedatolisib|mesh-list
102088194|NCT03698383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102088195|NCT03698383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102088196|NCT03698383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102088197|NCT03698383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102088198|NCT03698383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088199|NCT04760782|Abaloparatide|abaloparatide|mesh-list
102088200|NCT04760782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102088201|NCT04760782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088202|NCT04740580|Acetylcysteine|acetylcysteine|mesh-list
102088203|NCT04740580|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102088204|NCT04740580|Glycine|glycine|mesh-list
102088205|NCT04740580|Antiviral Agents|antiviral agents|mesh-ancestor
102088206|NCT04740580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102088207|NCT04740580|Expectorants|expectorants|mesh-ancestor
102088208|NCT04740580|Respiratory System Agents|respiratory system agents|mesh-ancestor
102088209|NCT04740580|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102088210|NCT04740580|Antioxidants|antioxidants|mesh-ancestor
102088213|NCT04740580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088214|NCT04740580|Antidotes|antidotes|mesh-ancestor
102088215|NCT04740580|Glycine Agents|glycine agents|mesh-ancestor
102088216|NCT04740580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102088217|NCT03064282|Papaverine|papaverine|mesh-list
102088218|NCT03064282|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102088219|NCT03064282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102088220|NCT03064282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088221|NCT03064282|Vasodilator Agents|vasodilator agents|mesh-ancestor
102088222|NCT03064282|Urological Agents|urological agents|mesh-ancestor
102088223|NCT04679818|Fentanyl|fentanyl|mesh-list
102088224|NCT04679818|Analgesics, Opioid|analgesics, opioid|mesh-list
102088225|NCT04679818|Narcotics|narcotics|mesh-ancestor
102088226|NCT04679818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102088227|NCT04679818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088228|NCT04679818|Analgesics|analgesics|mesh-ancestor
102088229|NCT04679818|Sensory System Agents|sensory system agents|mesh-ancestor
102088230|NCT04679818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102088231|NCT04679818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102088232|NCT04679818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102088233|NCT04679818|Anesthetics, General|anesthetics, general|mesh-ancestor
102088234|NCT04679818|Anesthetics|anesthetics|mesh-ancestor
102088235|NCT03027609|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101706162|NCT05260619|Lenalidomide|lenalidomide|mesh-list
102088236|NCT03027609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102088237|NCT03063112|Ethanol|ethanol|mesh-list
102088238|NCT03063112|Lidocaine|lidocaine|mesh-list
102088239|NCT03063112|Anesthetics, Local|anesthetics, local|mesh-ancestor
102088240|NCT03063112|Anesthetics|anesthetics|mesh-ancestor
102088241|NCT03063112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102088242|NCT03063112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088243|NCT03063112|Sensory System Agents|sensory system agents|mesh-ancestor
102088244|NCT03063112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102088245|NCT03063112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102088246|NCT03063112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102088247|NCT03063112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102088248|NCT03063112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102088249|NCT03063112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088250|NCT03063112|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102088251|NCT03063112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102088252|NCT04767217|Lumefantrine|lumefantrine|mesh-list
102088253|NCT04767217|Artemether|artemether|mesh-list
102088254|NCT04767217|Piperaquine|piperaquine|mesh-list
102088255|NCT04767217|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102088256|NCT04767217|Artenimol|artenimol|mesh-list
102088257|NCT04767217|Antimalarials|antimalarials|mesh-ancestor
102088258|NCT04767217|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102088259|NCT04767217|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102088260|NCT04767217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102088261|NCT03701503|Hormones|hormones|mesh-list
101944153|NCT03707678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101944154|NCT03707678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944155|NCT03334448|Insulin Lispro|insulin lispro|mesh-list
101944156|NCT03334448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101944157|NCT03334448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944158|NCT04773002|Anesthetics|anesthetics|mesh-list
102088262|NCT03701503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102088263|NCT03701503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088264|NCT03704155|Botulinum Toxins|botulinum toxins|mesh-list
102088265|NCT03704155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102088266|NCT03704155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102088267|NCT03704155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102088268|NCT03704155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102088269|NCT03704155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088270|NCT03704155|Cholinergic Agents|cholinergic agents|mesh-ancestor
102088271|NCT03704155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102088272|NCT03704155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088273|NCT03704155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102088274|NCT03704155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102088275|NCT03698227|Doxorubicin|doxorubicin|mesh-list
102088276|NCT03698227|Dexrazoxane|dexrazoxane|mesh-list
102088277|NCT03698227|Razoxane|razoxane|mesh-list
102088278|NCT03698227|Olaratumab|olaratumab|mesh-list
102088279|NCT03698227|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102088280|NCT03698227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102088281|NCT03698227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102088282|NCT03698227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102088283|NCT03698227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101389969|NCT05688085|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102088289|NCT03698227|Mitosis Modulators|mitosis modulators|mesh-ancestor
102088290|NCT01342965|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102088291|NCT01342965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102088292|NCT01342965|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102088293|NCT01342965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102088294|NCT01342965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088296|NCT02181348|Vitamins|vitamins|mesh-ancestor
102088297|NCT02181348|Micronutrients|micronutrients|mesh-ancestor
102088298|NCT02181348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088299|NCT02181348|Antioxidants|antioxidants|mesh-ancestor
102088300|NCT02181348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088301|NCT02181348|Protective Agents|protective agents|mesh-ancestor
102088302|NCT02186886|Golimumab|golimumab|mesh-list
102088303|NCT02186886|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102088304|NCT02186886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102088305|NCT02186886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102088306|NCT02186886|Immunologic Factors|immunologic factors|mesh-ancestor
102088307|NCT02186886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088308|NCT03722680|Riluzole|riluzole|mesh-list
102088309|NCT03722680|Anticonvulsants|anticonvulsants|mesh-ancestor
102088310|NCT03722680|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102088311|NCT03722680|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102088312|NCT03722680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102088313|NCT03722680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088314|NCT03722680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088315|NCT03722680|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102088316|NCT03722680|Protective Agents|protective agents|mesh-ancestor
102088317|NCT02182986|Immunosuppressive Agents|immunosuppressive agents|mesh-list
102088318|NCT02182986|Immunologic Factors|immunologic factors|mesh-ancestor
102088319|NCT02182986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088320|NCT03536910|Arginine Vasopressin|arginine vasopressin|mesh-list
102088321|NCT03536910|Hemostatics|hemostatics|mesh-ancestor
102088322|NCT03536910|Coagulants|coagulants|mesh-ancestor
102088323|NCT03536910|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102088324|NCT03536910|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102088325|NCT03536910|Natriuretic Agents|natriuretic agents|mesh-ancestor
102088326|NCT03536910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088327|NCT04308174|Durvalumab|durvalumab|mesh-list
101944159|NCT04773002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101944160|NCT04773002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944161|NCT02849080|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102088328|NCT04308174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102088329|NCT04308174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102088331|NCT03697681|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102088332|NCT03697681|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102088333|NCT03697681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088334|NCT03697681|Hemostatics|hemostatics|mesh-ancestor
102088335|NCT03697681|Coagulants|coagulants|mesh-ancestor
102088336|NCT02187276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
102088337|NCT02187276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102088338|NCT02187276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088339|NCT02187276|Cholinergic Agents|cholinergic agents|mesh-ancestor
102088340|NCT02187276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102088341|NCT02187276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088343|NCT02683239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102088344|NCT02683239|Analgesics|analgesics|mesh-ancestor
102088345|NCT02683239|Sensory System Agents|sensory system agents|mesh-ancestor
102088346|NCT02683239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102088347|NCT02683239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088348|NCT02183064|Meloxicam|meloxicam|mesh-list
102088349|NCT02183064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102088350|NCT02183064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102088351|NCT02183064|Analgesics|analgesics|mesh-ancestor
102088352|NCT02183064|Sensory System Agents|sensory system agents|mesh-ancestor
102088353|NCT02183064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102088357|NCT02183064|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102088358|NCT02183064|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102088359|NCT02183064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102088360|NCT02183064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088361|NCT03704077|Paclitaxel|paclitaxel|mesh-list
102088362|NCT03704077|Nivolumab|nivolumab|mesh-list
102088363|NCT03704077|Ramucirumab|ramucirumab|mesh-list
102088364|NCT03704077|Relatlimab|relatlimab|mesh-list
102088365|NCT03704077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102088366|NCT03704077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102088367|NCT03704077|Tubulin Modulators|tubulin modulators|mesh-ancestor
102088368|NCT03704077|Antimitotic Agents|antimitotic agents|mesh-ancestor
102088369|NCT03704077|Mitosis Modulators|mitosis modulators|mesh-ancestor
102088370|NCT03704077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088371|NCT03704077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102088372|NCT03704077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102088373|NCT03618550|Gemcitabine|gemcitabine|mesh-list
102088374|NCT03618550|Doxorubicin|doxorubicin|mesh-list
102088375|NCT03618550|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102088376|NCT03618550|Pembrolizumab|pembrolizumab|mesh-list
102088377|NCT03618550|Vinorelbine|vinorelbine|mesh-list
102088378|NCT03618550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102088379|NCT03618550|Antimetabolites|antimetabolites|mesh-ancestor
102088380|NCT03618550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088381|NCT03618550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102088382|NCT03618550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102088383|NCT03618550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102088384|NCT03618550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102088385|NCT03618550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102088386|NCT03618550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102088387|NCT03618550|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102088388|NCT03618550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102088389|NCT03618550|Tubulin Modulators|tubulin modulators|mesh-ancestor
102088390|NCT03618550|Antimitotic Agents|antimitotic agents|mesh-ancestor
102088391|NCT03618550|Mitosis Modulators|mitosis modulators|mesh-ancestor
102088392|NCT02183142|Meloxicam|meloxicam|mesh-list
102088393|NCT02183142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102088394|NCT02183142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102088395|NCT02183142|Analgesics|analgesics|mesh-ancestor
102088396|NCT02183142|Sensory System Agents|sensory system agents|mesh-ancestor
102088397|NCT02183142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102088398|NCT02183142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088399|NCT02183142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101944162|NCT02849080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101944163|NCT02849080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088400|NCT02183142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102088401|NCT02183142|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102088402|NCT02183142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102088403|NCT02183142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102088404|NCT02183142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088405|NCT02183220|Aspirin|aspirin|mesh-list
102088406|NCT02183220|Dipyrone|dipyrone|mesh-list
102088407|NCT02183220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102088408|NCT02183220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102088409|NCT02183220|Analgesics|analgesics|mesh-ancestor
102088410|NCT02183220|Sensory System Agents|sensory system agents|mesh-ancestor
102088411|NCT02183220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102088412|NCT02183220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088413|NCT02183220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102088414|NCT02183220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102088415|NCT02183220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101808202|NCT00432172|Docetaxel|docetaxel|mesh-list
102088416|NCT02183220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102088417|NCT02183220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088418|NCT02183220|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102088419|NCT02183220|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102088420|NCT02183220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102088421|NCT02183220|Antipyretics|antipyretics|mesh-ancestor
102088423|NCT02187588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102088424|NCT02187588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102088425|NCT02187588|Analgesics|analgesics|mesh-ancestor
102088429|NCT02187588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102088430|NCT02187588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102088431|NCT02187588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102088432|NCT02187588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102088433|NCT02187588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088434|NCT05364489|Bevacizumab|bevacizumab|mesh-list
102088435|NCT05364489|Oxaliplatin|oxaliplatin|mesh-list
102088436|NCT05364489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102088437|NCT05364489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102088438|NCT05364489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102088439|NCT05364489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102088440|NCT05364489|Growth Substances|growth substances|mesh-ancestor
102088441|NCT05364489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088442|NCT05364489|Growth Inhibitors|growth inhibitors|mesh-ancestor
102088443|NCT02183298|Linagliptin|linagliptin|mesh-list
102088444|NCT02183298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102088445|NCT02183298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088446|NCT02183298|Incretins|incretins|mesh-ancestor
102088447|NCT02183298|Hormones|hormones|mesh-ancestor
102088448|NCT02183298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102088449|NCT02183298|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102088450|NCT02183298|Protease Inhibitors|protease inhibitors|mesh-ancestor
102088451|NCT02183298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102088452|NCT02183298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088453|NCT03697057|Anesthetics|anesthetics|mesh-list
102088454|NCT03697057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102088455|NCT03697057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088456|NCT02183376|Linagliptin|linagliptin|mesh-list
102088457|NCT02183376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102088458|NCT02183376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088459|NCT02183376|Incretins|incretins|mesh-ancestor
102088460|NCT02183376|Hormones|hormones|mesh-ancestor
102088461|NCT02183376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102088462|NCT02183376|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102088463|NCT02183376|Protease Inhibitors|protease inhibitors|mesh-ancestor
102088464|NCT02183376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102088465|NCT02183376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088466|NCT02187822|Taxane|taxane|mesh-list
102088467|NCT02187822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102088468|NCT03696901|Dalbavancin|dalbavancin|mesh-list
102088469|NCT03696901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102088470|NCT03696901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102088471|NCT02187900|Mycophenolic Acid|mycophenolic acid|mesh-list
102088472|NCT02187900|Cardiac Glycosides|cardiac glycosides|mesh-list
101944164|NCT02849080|Incretins|incretins|mesh-ancestor
101944165|NCT02849080|Hormones|hormones|mesh-ancestor
101944166|NCT02849080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101944167|NCT02849080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101944168|NCT02849080|Protease Inhibitors|protease inhibitors|mesh-ancestor
101944169|NCT02849080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101944170|NCT02849080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088473|NCT02187900|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102088474|NCT02187900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102088475|NCT02187900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102088476|NCT02187900|Antitubercular Agents|antitubercular agents|mesh-ancestor
102088477|NCT02187900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102088478|NCT02187900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102088479|NCT02187900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102088480|NCT02187900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088481|NCT02187900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102088482|NCT02187900|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102088483|NCT02187900|Protective Agents|protective agents|mesh-ancestor
102088484|NCT02187900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088485|NCT03062644|Celecoxib|celecoxib|mesh-list
102088486|NCT03062644|Tramadol|tramadol|mesh-list
102088487|NCT03062644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102088488|NCT03062644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101808286|NCT04082910|Infliximab|infliximab|mesh-list
102088489|NCT03062644|Analgesics|analgesics|mesh-ancestor
102088490|NCT03062644|Sensory System Agents|sensory system agents|mesh-ancestor
102088491|NCT03062644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102088492|NCT03062644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088493|NCT03062644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102088494|NCT03062644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102088495|NCT03062644|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102088501|NCT03062644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102088502|NCT02190318|Losartan|losartan|mesh-list
102088503|NCT02190318|Spironolactone|spironolactone|mesh-list
102088504|NCT02190318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102088505|NCT02190318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102088506|NCT02190318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102088507|NCT02190318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102088508|NCT02190318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088509|NCT02190318|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102088510|NCT02190318|Hormone Antagonists|hormone antagonists|mesh-ancestor
102088511|NCT02190318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102088512|NCT02190318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088513|NCT02190318|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102088514|NCT02190318|Diuretics|diuretics|mesh-ancestor
102088515|NCT02190318|Natriuretic Agents|natriuretic agents|mesh-ancestor
102088516|NCT04743661|Antipyretics|antipyretics|mesh-list
102088517|NCT04743661|Dexamethasone|dexamethasone|mesh-list
102088518|NCT04743661|Bevacizumab|bevacizumab|mesh-list
102088519|NCT04743661|Irinotecan|irinotecan|mesh-list
102088520|NCT04743661|Temozolomide|temozolomide|mesh-list
102088521|NCT04743661|Antiemetics|antiemetics|mesh-list
102088522|NCT04743661|Emetics|emetics|mesh-list
102088523|NCT04743661|Histamine Antagonists|histamine antagonists|mesh-list
102088524|NCT04743661|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
102088525|NCT04743661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102088526|NCT04743661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102088527|NCT04743661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102088528|NCT04743661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102088529|NCT04743661|Growth Substances|growth substances|mesh-ancestor
102088530|NCT04743661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088531|NCT04743661|Growth Inhibitors|growth inhibitors|mesh-ancestor
102088532|NCT04743661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102088533|NCT04743661|Autonomic Agents|autonomic agents|mesh-ancestor
102088534|NCT04743661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102088535|NCT04743661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102088536|NCT04743661|Glucocorticoids|glucocorticoids|mesh-ancestor
101944171|NCT03346070|Glycopyrrolate|glycopyrrolate|mesh-list
101944172|NCT03346070|Rocuronium|rocuronium|mesh-list
101944173|NCT03346070|Vecuronium Bromide|vecuronium bromide|mesh-list
101944174|NCT03346070|Neostigmine|neostigmine|mesh-list
101944175|NCT03346070|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102088537|NCT04743661|Hormones|hormones|mesh-ancestor
102088538|NCT04743661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102088539|NCT04743661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102088540|NCT04743661|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102088541|NCT04743661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102088542|NCT04743661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102088543|NCT04743661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088544|NCT04743661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102088545|NCT04743661|Alkylating Agents|alkylating agents|mesh-ancestor
102088546|NCT04743661|Histamine Agents|histamine agents|mesh-ancestor
102088547|NCT04743661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102088548|NCT02183532|Linagliptin|linagliptin|mesh-list
102088549|NCT02183532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102088550|NCT02183532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088551|NCT02183532|Incretins|incretins|mesh-ancestor
102088552|NCT02183532|Hormones|hormones|mesh-ancestor
102088553|NCT02183532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102088554|NCT02183532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102088555|NCT02183532|Protease Inhibitors|protease inhibitors|mesh-ancestor
102088556|NCT02183532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102088557|NCT02183532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088558|NCT03569631|BPN14770|bpn14770|mesh-list
102088559|NCT03569631|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102088560|NCT03569631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102088562|NCT03569631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088564|NCT02629822|Lamivudine|lamivudine|mesh-list
102088565|NCT02629822|Antiviral Agents|antiviral agents|mesh-ancestor
102088566|NCT02629822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102088567|NCT02629822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102088568|NCT02629822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102088569|NCT02629822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102088570|NCT02629822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088571|NCT02629822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102088572|NCT02629822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102088573|NCT03700801|Insulin|insulin|mesh-list
102088574|NCT03700801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102088575|NCT03700801|Metformin|metformin|mesh-list
102088576|NCT03700801|Dapagliflozin|dapagliflozin|mesh-list
102088577|NCT03700801|Insulin Aspart|insulin aspart|mesh-list
102088578|NCT03700801|Saxagliptin|saxagliptin|mesh-list
102088579|NCT03700801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102088580|NCT03700801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088581|NCT03700801|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102088582|NCT03700801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088583|NCT03700801|Incretins|incretins|mesh-ancestor
102088584|NCT03700801|Hormones|hormones|mesh-ancestor
102088585|NCT03700801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102088586|NCT03700801|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102088587|NCT03700801|Protease Inhibitors|protease inhibitors|mesh-ancestor
102088588|NCT03700801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102088589|NCT03700645|Allopurinol|allopurinol|mesh-list
102088590|NCT03700645|Antimetabolites|antimetabolites|mesh-ancestor
102088591|NCT03700645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088592|NCT03700645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102088593|NCT03700645|Gout Suppressants|gout suppressants|mesh-ancestor
102088594|NCT03700645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102088595|NCT03700645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102088596|NCT03700645|Antioxidants|antioxidants|mesh-ancestor
102088597|NCT03700645|Protective Agents|protective agents|mesh-ancestor
102088598|NCT03700645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088599|NCT04499053|Durvalumab|durvalumab|mesh-list
102088600|NCT04499053|Tremelimumab|tremelimumab|mesh-list
102088601|NCT04499053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102088602|NCT04499053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102088603|NCT03567681|Oxcarbazepine|oxcarbazepine|mesh-list
102088604|NCT03567681|Anticonvulsants|anticonvulsants|mesh-ancestor
101944176|NCT03346070|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101944177|NCT03346070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101944178|NCT03346070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101944179|NCT03346070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944180|NCT03346070|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101944181|NCT03346070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101944182|NCT03346070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944183|NCT03346070|Cholinergic Agents|cholinergic agents|mesh-ancestor
102088605|NCT03567681|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102088606|NCT03567681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102088607|NCT03567681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102088608|NCT03567681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088609|NCT03567681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102088610|NCT03567681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102088612|NCT03567447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102088613|NCT03567447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102088614|NCT03567369|Dexamethasone|dexamethasone|mesh-list
101706216|NCT00869778|Vaccines|vaccines|mesh-list
102088615|NCT03567369|Dexamethasone acetate|dexamethasone acetate|mesh-list
102088616|NCT03567369|BB 1101|bb 1101|mesh-list
102088617|NCT03567369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102088618|NCT03567369|Antiemetics|antiemetics|mesh-ancestor
102088619|NCT03567369|Autonomic Agents|autonomic agents|mesh-ancestor
102088620|NCT03567369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102088621|NCT03567369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088622|NCT03567369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102088623|NCT03567369|Glucocorticoids|glucocorticoids|mesh-ancestor
102088624|NCT03567369|Hormones|hormones|mesh-ancestor
102088625|NCT03567369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102088626|NCT03567369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102088627|NCT03567369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102088628|NCT03567369|Protease Inhibitors|protease inhibitors|mesh-ancestor
102088629|NCT03567369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102088630|NCT03567369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088631|NCT03397654|Pembrolizumab|pembrolizumab|mesh-list
102088635|NCT03397654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088636|NCT03266146|Methylprednisolone|methylprednisolone|mesh-list
101808424|NCT00981318|Maraviroc|maraviroc|mesh-list
102088637|NCT03266146|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102088638|NCT03266146|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102088640|NCT03266146|Prednisolone acetate|prednisolone acetate|mesh-list
102088641|NCT03266146|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102088642|NCT03266146|Prednisolone phosphate|prednisolone phosphate|mesh-list
102088643|NCT03266146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102088644|NCT03266146|Antiemetics|antiemetics|mesh-ancestor
102088645|NCT03266146|Autonomic Agents|autonomic agents|mesh-ancestor
102088646|NCT03266146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102088647|NCT03266146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088648|NCT03266146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102088649|NCT03266146|Glucocorticoids|glucocorticoids|mesh-ancestor
102088650|NCT03266146|Hormones|hormones|mesh-ancestor
102088651|NCT03266146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102088652|NCT03266146|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102088653|NCT03266146|Protective Agents|protective agents|mesh-ancestor
102088654|NCT03266146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102088655|NCT03266146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102088656|NCT03700489|Titanium dioxide|titanium dioxide|mesh-list
102088657|NCT03700489|Sunscreening Agents|sunscreening agents|mesh-ancestor
102088658|NCT03700489|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102088659|NCT03700489|Protective Agents|protective agents|mesh-ancestor
102088660|NCT03700489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088661|NCT03700489|Dermatologic Agents|dermatologic agents|mesh-ancestor
102088662|NCT03700489|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102088663|NCT02800941|Warfarin|warfarin|mesh-list
102088664|NCT02800941|Anticoagulants|anticoagulants|mesh-list
102088665|NCT02800941|Acenocoumarol|acenocoumarol|mesh-list
101778061|NCT00814944|Sirolimus|sirolimus|mesh-list
102088666|NCT02800941|Fluindione|fluindione|mesh-list
102088667|NCT03695887|Nitrous Oxide|nitrous oxide|mesh-list
102088668|NCT03695887|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102088669|NCT03695887|Anesthetics, General|anesthetics, general|mesh-ancestor
102088670|NCT03695887|Anesthetics|anesthetics|mesh-ancestor
102088671|NCT03695887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102088672|NCT03695887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088673|NCT03695887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102088674|NCT03695887|Analgesics|analgesics|mesh-ancestor
102088675|NCT03695887|Sensory System Agents|sensory system agents|mesh-ancestor
102088676|NCT03695887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102088677|NCT04432714|Prednisone|prednisone|mesh-list
102088678|NCT04432714|Cyclophosphamide|cyclophosphamide|mesh-list
102088679|NCT04432714|Rituximab|rituximab|mesh-list
102088680|NCT04432714|Doxorubicin|doxorubicin|mesh-list
102088681|NCT04432714|Etoposide|etoposide|mesh-list
102088682|NCT04432714|Vincristine|vincristine|mesh-list
102088683|NCT04432714|Lenalidomide|lenalidomide|mesh-list
102088684|NCT04432714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102088685|NCT04432714|Immunologic Factors|immunologic factors|mesh-ancestor
102088686|NCT04432714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088687|NCT04432714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101706219|NCT04159610|Glycopyrrolate|glycopyrrolate|mesh-list
102088688|NCT04432714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102088689|NCT04432714|Alkylating Agents|alkylating agents|mesh-ancestor
102088690|NCT04432714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088691|NCT04432714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102088692|NCT04432714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102088693|NCT04432714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102088694|NCT04432714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102088695|NCT04432714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102088696|NCT04432714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102088697|NCT04432714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102088698|NCT04432714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102088699|NCT04432714|Glucocorticoids|glucocorticoids|mesh-ancestor
102088700|NCT04432714|Hormones|hormones|mesh-ancestor
102088701|NCT04432714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102088702|NCT04432714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102088703|NCT04432714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102088704|NCT04432714|Tubulin Modulators|tubulin modulators|mesh-ancestor
102088712|NCT02752074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102088713|NCT02752074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102088714|NCT02752074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102088715|NCT02752074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088717|NCT03564795|Silver Sulfadiazine|silver sulfadiazine|mesh-list
102088718|NCT03564795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102088719|NCT03564795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102088720|NCT03564795|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102088721|NCT03564795|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102088722|NCT03564795|Coccidiostats|coccidiostats|mesh-ancestor
102088723|NCT03564795|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102088724|NCT03624595|Dexmedetomidine|dexmedetomidine|mesh-list
102088725|NCT03624595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102088726|NCT03624595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102088727|NCT03624595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088728|NCT03624595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102088729|NCT03624595|Analgesics|analgesics|mesh-ancestor
102088730|NCT03624595|Sensory System Agents|sensory system agents|mesh-ancestor
102088731|NCT03624595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102088732|NCT03624595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102088733|NCT03624595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102088734|NCT03624595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102088735|NCT03624595|Adrenergic Agents|adrenergic agents|mesh-ancestor
102088736|NCT03624595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102088737|NCT03624595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088738|NCT03063892|Tranexamic Acid|tranexamic acid|mesh-list
102088739|NCT03063892|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102088740|NCT03063892|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102088741|NCT03063892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088742|NCT03063892|Hemostatics|hemostatics|mesh-ancestor
102088743|NCT03063892|Coagulants|coagulants|mesh-ancestor
102088744|NCT03063580|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
102088745|NCT03063580|Rifampin|rifampin|mesh-list
101944184|NCT03346070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101944185|NCT03346070|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101944186|NCT03346070|Autonomic Agents|autonomic agents|mesh-ancestor
101944187|NCT03346070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102088746|NCT03063580|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102088747|NCT03063580|Antitubercular Agents|antitubercular agents|mesh-ancestor
102088748|NCT03063580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102088749|NCT03063580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102088750|NCT03063580|Leprostatic Agents|leprostatic agents|mesh-ancestor
102088751|NCT03063580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102088752|NCT03063580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102088753|NCT03063580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088754|NCT03063580|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102088755|NCT03063580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102088756|NCT03063580|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102088757|NCT03063580|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102088758|NCT03063580|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102088759|NCT03063580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102088760|NCT03063580|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102088761|NCT03063580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102088762|NCT03063580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088763|NCT05353101|Loteprednol Etabonate|loteprednol etabonate|mesh-list
102088764|NCT05353101|Cyclosporine|cyclosporine|mesh-list
102088765|NCT05353101|Tobramycin|tobramycin|mesh-list
102088766|NCT05353101|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102088767|NCT05353101|Cyclosporins|cyclosporins|mesh-list
102088768|NCT05353101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102088772|NCT05353101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088773|NCT05353101|Antifungal Agents|antifungal agents|mesh-ancestor
102088774|NCT05353101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102088775|NCT05353101|Dermatologic Agents|dermatologic agents|mesh-ancestor
102088776|NCT05353101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102088777|NCT05353101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102088778|NCT05353101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102088779|NCT05353101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102088780|NCT05353101|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102088782|NCT03700333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102088783|NCT03700333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102088784|NCT03700333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088785|NCT03700333|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102088786|NCT03700333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102088787|NCT03700177|Dexamethasone|dexamethasone|mesh-list
102088788|NCT03700177|Ropivacaine|ropivacaine|mesh-list
102088789|NCT03700177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102088790|NCT03700177|Antiemetics|antiemetics|mesh-ancestor
102088791|NCT03700177|Autonomic Agents|autonomic agents|mesh-ancestor
102088792|NCT03700177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102088793|NCT03700177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088794|NCT03700177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102088795|NCT03700177|Glucocorticoids|glucocorticoids|mesh-ancestor
102088796|NCT03700177|Hormones|hormones|mesh-ancestor
102088797|NCT03700177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102088798|NCT03700177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102088799|NCT03700177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102088800|NCT03700177|Anesthetics, Local|anesthetics, local|mesh-ancestor
102088801|NCT03700177|Anesthetics|anesthetics|mesh-ancestor
102088802|NCT03700177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102088803|NCT03700177|Sensory System Agents|sensory system agents|mesh-ancestor
102088804|NCT02183610|Linagliptin|linagliptin|mesh-list
102088805|NCT02183610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102088806|NCT02183610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102088807|NCT02183610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088808|NCT02183610|Incretins|incretins|mesh-ancestor
102088809|NCT02183610|Hormones|hormones|mesh-ancestor
102088810|NCT02183610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102088811|NCT02183610|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102088812|NCT02183610|Protease Inhibitors|protease inhibitors|mesh-ancestor
102088813|NCT02183610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102088814|NCT02183610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088815|NCT02183688|Acetaminophen|acetaminophen|mesh-list
102088816|NCT02183688|Caffeine|caffeine|mesh-list
101664019|NCT00611767|Anesthetics|anesthetics|mesh-ancestor
101944188|NCT03346070|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102088817|NCT02183688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102088818|NCT02183688|Analgesics|analgesics|mesh-ancestor
102088819|NCT02183688|Sensory System Agents|sensory system agents|mesh-ancestor
102088820|NCT02183688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102088821|NCT02183688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088822|NCT02183688|Antipyretics|antipyretics|mesh-ancestor
102088823|NCT02183688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102088824|NCT02183688|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102088825|NCT02183688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102088826|NCT02183688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363675|NCT00047099|Fluorouracil|fluorouracil|mesh-list
102088827|NCT02183688|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102088828|NCT02183688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102088829|NCT02183688|Purinergic Agents|purinergic agents|mesh-ancestor
102088830|NCT02183688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102088831|NCT02190708|Midazolam|midazolam|mesh-list
102088832|NCT02190708|Omeprazole|omeprazole|mesh-list
102088833|NCT02190708|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
102088834|NCT02190708|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102088835|NCT02190708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102088836|NCT02190708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102088837|NCT02190708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088838|NCT02190708|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102088839|NCT02190708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102088845|NCT02190708|GABA Agents|gaba agents|mesh-ancestor
102088846|NCT02190708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102088847|NCT02190708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088848|NCT02190708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102088849|NCT02190708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102088850|NCT02190708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102088851|NCT05338983|Anesthetics|anesthetics|mesh-list
102088852|NCT05338983|Mepivacaine|mepivacaine|mesh-list
102088853|NCT05338983|Anesthetics, Local|anesthetics, local|mesh-list
102088854|NCT05338983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102088855|NCT05338983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088856|NCT05338983|Sensory System Agents|sensory system agents|mesh-ancestor
102088857|NCT05338983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102088858|NCT03063658|Acetaminophen|acetaminophen|mesh-list
102088859|NCT03063658|Ibuprofen|ibuprofen|mesh-list
102088860|NCT03063658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102088861|NCT03063658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102088862|NCT03063658|Analgesics|analgesics|mesh-ancestor
102088863|NCT03063658|Sensory System Agents|sensory system agents|mesh-ancestor
102088864|NCT03063658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102088865|NCT03063658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088866|NCT03063658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102088867|NCT03063658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102088868|NCT03063658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102088869|NCT03063658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102088870|NCT03063658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088871|NCT03063658|Antipyretics|antipyretics|mesh-ancestor
102088872|NCT03695107|Nifedipine|nifedipine|mesh-list
102088873|NCT03695107|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102088874|NCT03695107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102088875|NCT03695107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088876|NCT03695107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102088877|NCT03695107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088878|NCT03695107|Vasodilator Agents|vasodilator agents|mesh-ancestor
102088879|NCT03695107|Tocolytic Agents|tocolytic agents|mesh-ancestor
102088880|NCT03695107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102088881|NCT02835339|Magnesium Sulfate|magnesium sulfate|mesh-list
102088882|NCT02835339|Analgesics|analgesics|mesh-ancestor
102088883|NCT02835339|Sensory System Agents|sensory system agents|mesh-ancestor
102088884|NCT02835339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102088885|NCT02835339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088886|NCT02835339|Anesthetics|anesthetics|mesh-ancestor
102088887|NCT02835339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102088888|NCT02835339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102088889|NCT02835339|Anticonvulsants|anticonvulsants|mesh-ancestor
102088890|NCT02835339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102088891|NCT02835339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101944189|NCT03346070|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101944190|NCT03346070|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101944192|NCT03590626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101944193|NCT03590626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944194|NCT02238340|Ketoprofen|ketoprofen|mesh-list
102088892|NCT02835339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706237|NCT04162028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102088893|NCT02835339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102088894|NCT02835339|Tocolytic Agents|tocolytic agents|mesh-ancestor
102088895|NCT02835339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102088896|NCT03695029|Tenofovir|tenofovir|mesh-list
102088897|NCT03695029|Antiviral Agents|antiviral agents|mesh-ancestor
102088898|NCT03695029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102088899|NCT03695029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102088900|NCT03695029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102088901|NCT03695029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102088902|NCT03695029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088903|NCT03695029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102088904|NCT03695029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102088905|NCT02259855|Interferons|interferons|mesh-list
102088906|NCT02259855|Ritonavir|ritonavir|mesh-list
102088907|NCT02259855|Ribavirin|ribavirin|mesh-list
102088908|NCT02259855|Tipranavir|tipranavir|mesh-list
102088909|NCT02259855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102088910|NCT02259855|Antiviral Agents|antiviral agents|mesh-ancestor
102088915|NCT02259855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102088916|NCT02259855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088917|NCT02259855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102088918|NCT02259855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102088919|NCT02259855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102088920|NCT02259855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102088921|NCT02259855|Antimetabolites|antimetabolites|mesh-ancestor
102088922|NCT03703063|Leucovorin|leucovorin|mesh-list
102088923|NCT03703063|Paclitaxel|paclitaxel|mesh-list
102088924|NCT03703063|Gemcitabine|gemcitabine|mesh-list
102088925|NCT03703063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102088926|NCT03703063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102088927|NCT03703063|Tubulin Modulators|tubulin modulators|mesh-ancestor
102088928|NCT03703063|Antimitotic Agents|antimitotic agents|mesh-ancestor
102088929|NCT03703063|Mitosis Modulators|mitosis modulators|mesh-ancestor
102088930|NCT03703063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088931|NCT03703063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102088932|NCT03703063|Antimetabolites|antimetabolites|mesh-ancestor
102088933|NCT03703063|Antidotes|antidotes|mesh-ancestor
102088934|NCT03703063|Protective Agents|protective agents|mesh-ancestor
102088935|NCT03703063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088936|NCT03703063|Vitamin B Complex|vitamin b complex|mesh-ancestor
102088938|NCT03703063|Micronutrients|micronutrients|mesh-ancestor
102088939|NCT03702985|Capecitabine|capecitabine|mesh-list
102088941|NCT03702985|Amifostine|amifostine|mesh-list
102088942|NCT03702985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102088943|NCT03702985|Antimetabolites|antimetabolites|mesh-ancestor
102088944|NCT03702985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088945|NCT03702985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102088946|NCT03702985|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102088947|NCT03702985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102088948|NCT03702985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102088949|NCT03702985|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102088950|NCT03702985|Protective Agents|protective agents|mesh-ancestor
102088951|NCT03702985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088952|NCT03064984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102088953|NCT03064984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102088954|NCT02184078|Nevirapine|nevirapine|mesh-list
102088955|NCT02184078|Rifabutin|rifabutin|mesh-list
102088956|NCT02184078|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102088957|NCT02184078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102088958|NCT02184078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102088959|NCT02184078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088960|NCT02184078|Antiviral Agents|antiviral agents|mesh-ancestor
102088961|NCT02184078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102088962|NCT02184078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102088963|NCT02184078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101944195|NCT02238340|Morphine|morphine|mesh-list
101944196|NCT02238340|Oxycodone|oxycodone|mesh-list
101944197|NCT02238340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101944198|NCT02238340|Narcotics|narcotics|mesh-ancestor
101944199|NCT02238340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101944200|NCT02238340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944201|NCT02238340|Analgesics|analgesics|mesh-ancestor
101706246|NCT00656786|Hemostatics|hemostatics|mesh-ancestor
101944202|NCT02238340|Sensory System Agents|sensory system agents|mesh-ancestor
101944203|NCT02238340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101944204|NCT02238340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101944205|NCT02238340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101944206|NCT02238340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101944207|NCT02238340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101944208|NCT02238340|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101944209|NCT02238340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101778353|NCT00815646|Vasodilator Agents|vasodilator agents|mesh-ancestor
102088964|NCT02184078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102088965|NCT02184078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102088966|NCT02184078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102088967|NCT02184078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102088968|NCT02184078|Antitubercular Agents|antitubercular agents|mesh-ancestor
102088969|NCT04323436|Spartalizumab|spartalizumab|mesh-list
102088970|NCT04323436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102088971|NCT04323436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088972|NCT04323436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102088973|NCT04323436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102088974|NCT03694873|Celecoxib|celecoxib|mesh-list
102088975|NCT03694873|Tramadol|tramadol|mesh-list
102088976|NCT03694873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102088977|NCT03694873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102088978|NCT03694873|Analgesics|analgesics|mesh-ancestor
102088979|NCT03694873|Sensory System Agents|sensory system agents|mesh-ancestor
102088980|NCT03694873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102088981|NCT03694873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088982|NCT03694873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102088983|NCT03694873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102088987|NCT03694873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088989|NCT03694873|Narcotics|narcotics|mesh-ancestor
102088990|NCT03694873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102088991|NCT02191020|Acitretin|acitretin|mesh-list
102088992|NCT02191020|Keratolytic Agents|keratolytic agents|mesh-ancestor
102088993|NCT02191020|Dermatologic Agents|dermatologic agents|mesh-ancestor
102088994|NCT04476199|Decitabine|decitabine|mesh-list
102088995|NCT04476199|Venetoclax|venetoclax|mesh-list
102088996|NCT04476199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102088997|NCT04476199|Antimetabolites|antimetabolites|mesh-ancestor
102088998|NCT04476199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088999|NCT04476199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102089000|NCT04476199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102089001|NCT02188368|Clarithromycin|clarithromycin|mesh-list
102089002|NCT02188368|Dexamethasone|dexamethasone|mesh-list
102089003|NCT02188368|Prednisone|prednisone|mesh-list
102089004|NCT02188368|Cyclophosphamide|cyclophosphamide|mesh-list
102089005|NCT02188368|Bortezomib|bortezomib|mesh-list
102089006|NCT02188368|Pomalidomide|pomalidomide|mesh-list
102089007|NCT02188368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102089008|NCT02188368|Immunologic Factors|immunologic factors|mesh-ancestor
102089009|NCT02188368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089010|NCT02188368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102089011|NCT02188368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102089012|NCT02188368|Alkylating Agents|alkylating agents|mesh-ancestor
101944210|NCT02238340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089013|NCT02188368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089014|NCT02188368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102089015|NCT02188368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102089016|NCT02188368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102089018|NCT02188368|Autonomic Agents|autonomic agents|mesh-ancestor
102089019|NCT02188368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102089020|NCT02188368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102089021|NCT02188368|Glucocorticoids|glucocorticoids|mesh-ancestor
102089022|NCT02188368|Hormones|hormones|mesh-ancestor
102089023|NCT02188368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102089024|NCT02188368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102089025|NCT02188368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102089026|NCT02188368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102089027|NCT02188368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102089028|NCT02188368|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102089029|NCT02188368|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102089030|NCT02188368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102089031|NCT02188368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102089032|NCT02188368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102089033|NCT02188368|Growth Substances|growth substances|mesh-ancestor
102089034|NCT02188368|Growth Inhibitors|growth inhibitors|mesh-ancestor
102089035|NCT02191176|Dextromethorphan|dextromethorphan|mesh-list
102089036|NCT02191176|Antitussive Agents|antitussive agents|mesh-ancestor
102089037|NCT02191176|Respiratory System Agents|respiratory system agents|mesh-ancestor
102089038|NCT02191176|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102089039|NCT02191176|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102089040|NCT02191176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102089041|NCT02191176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089042|NCT02191176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089043|NCT02184312|Nevirapine|nevirapine|mesh-list
102089044|NCT02184312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102089045|NCT02184312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102089046|NCT02184312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102089047|NCT02184312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089048|NCT02184312|Antiviral Agents|antiviral agents|mesh-ancestor
102089049|NCT02184312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102089050|NCT02184312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102089051|NCT02184312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102089052|NCT02184312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102089053|NCT02184312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102089054|NCT04301011|Pembrolizumab|pembrolizumab|mesh-list
101390737|NCT05401916|Ibuprofen|ibuprofen|mesh-list
102089065|NCT02191332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102089067|NCT02191332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102089068|NCT02191332|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102089069|NCT02191332|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102089070|NCT02256774|Ritonavir|ritonavir|mesh-list
102089071|NCT02256774|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
102089072|NCT02256774|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102089073|NCT02256774|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102089074|NCT02256774|Protease Inhibitors|protease inhibitors|mesh-ancestor
102089075|NCT02256774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102089076|NCT02256774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089077|NCT02256774|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102089078|NCT02256774|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102089079|NCT02256774|Antiviral Agents|antiviral agents|mesh-ancestor
102089080|NCT02256774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102089081|NCT02256774|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102089082|NCT02256774|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102089083|NCT02256774|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102089084|NCT02256774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102089085|NCT02189304|Budesonide|budesonide|mesh-list
102089086|NCT02189304|Glycopyrrolate|glycopyrrolate|mesh-list
102089087|NCT02189304|Formoterol Fumarate|formoterol fumarate|mesh-list
102089088|NCT02189304|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
102089089|NCT02189304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102089090|NCT02189304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102089091|NCT02189304|Autonomic Agents|autonomic agents|mesh-ancestor
102089092|NCT02189304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101944211|NCT03577132|Atezolizumab|atezolizumab|mesh-list
101944212|NCT03577132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101706264|NCT00734890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101944213|NCT03577132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778484|NCT00790244|Doxorubicin|doxorubicin|mesh-list
102089093|NCT02189304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089094|NCT02189304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102089095|NCT02189304|Respiratory System Agents|respiratory system agents|mesh-ancestor
102089096|NCT02189304|Glucocorticoids|glucocorticoids|mesh-ancestor
102089097|NCT02189304|Hormones|hormones|mesh-ancestor
102089098|NCT02189304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102089099|NCT02189304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102089100|NCT02189304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102089101|NCT02189304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102089102|NCT02189304|Adrenergic Agents|adrenergic agents|mesh-ancestor
102089103|NCT02189304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102089104|NCT02189304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089105|NCT02189304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102089106|NCT02189304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102089107|NCT02189304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102089108|NCT02189304|Cholinergic Agents|cholinergic agents|mesh-ancestor
102089109|NCT02184858|Lisinopril|lisinopril|mesh-list
102089110|NCT02184858|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102089111|NCT02184858|Protease Inhibitors|protease inhibitors|mesh-ancestor
102089112|NCT02184858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102089113|NCT02184858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089114|NCT02184858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102089119|NCT03535662|Antifungal Agents|antifungal agents|mesh-ancestor
102089120|NCT03535662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102089121|NCT03535662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102089122|NCT03535662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102089123|NCT03535662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102089124|NCT03535662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089125|NCT03535662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102089126|NCT03535662|Hormone Antagonists|hormone antagonists|mesh-ancestor
102089127|NCT03535662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102089128|NCT03535662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089129|NCT03535662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102089131|NCT03702205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102089132|NCT03702205|Lipotropic Agents|lipotropic agents|mesh-ancestor
102089133|NCT03702205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102089134|NCT03702205|Antimetabolites|antimetabolites|mesh-ancestor
102089135|NCT03702205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089136|NCT03702205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102089137|NCT03698851|Methamphetamine|methamphetamine|mesh-list
102089138|NCT03698851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102089139|NCT03698851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089140|NCT03698851|Sympathomimetics|sympathomimetics|mesh-ancestor
102089141|NCT03698851|Autonomic Agents|autonomic agents|mesh-ancestor
102089142|NCT03698851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102089143|NCT03698851|Dopamine Agents|dopamine agents|mesh-ancestor
102089144|NCT03698851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102089145|NCT03698851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089146|NCT03698851|Adrenergic Agents|adrenergic agents|mesh-ancestor
102089147|NCT03698851|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102089148|NCT03698851|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102089149|NCT03698851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102089150|NCT03698851|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102089151|NCT03125902|Paclitaxel|paclitaxel|mesh-list
102089152|NCT03125902|Atezolizumab|atezolizumab|mesh-list
102089153|NCT03125902|Antibodies|antibodies|mesh-list
102089154|NCT03125902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102089155|NCT03125902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102089156|NCT03125902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102089157|NCT03125902|Tubulin Modulators|tubulin modulators|mesh-ancestor
102089158|NCT03125902|Antimitotic Agents|antimitotic agents|mesh-ancestor
102089159|NCT03125902|Mitosis Modulators|mitosis modulators|mesh-ancestor
102089160|NCT03125902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089161|NCT03125902|Immunologic Factors|immunologic factors|mesh-ancestor
101944214|NCT03577132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101944215|NCT03577132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101944216|NCT05194124|alpha-MSH|alpha-msh|mesh-list
102089162|NCT03125902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089163|NCT03125902|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102089164|NCT03125902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102089165|NCT02189694|Hormones|hormones|mesh-list
102089166|NCT02189694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089167|NCT02189694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102089168|NCT02189772|Metadoxine|metadoxine|mesh-list
102089169|NCT02189772|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102089170|NCT02192424|Insulin|insulin|mesh-list
102089171|NCT02192424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102089172|NCT02192424|Metformin|metformin|mesh-list
102089173|NCT02192424|Insulin Glargine|insulin glargine|mesh-list
102089174|NCT02192424|Insulin Lispro|insulin lispro|mesh-list
102089175|NCT02192424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102089176|NCT02192424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089177|NCT04276597|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
102089178|NCT04276597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102089179|NCT04276597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089180|NCT02257008|Ritonavir|ritonavir|mesh-list
102089181|NCT02257008|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102089182|NCT02257008|Nelfinavir|nelfinavir|mesh-list
102089183|NCT02257008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102089184|NCT02257008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102089187|NCT02257008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089188|NCT02257008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102089189|NCT02257008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102089190|NCT02257008|Antiviral Agents|antiviral agents|mesh-ancestor
102089191|NCT02257008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102089192|NCT02257008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102089193|NCT02257008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102089194|NCT03693391|Fluorides|fluorides|mesh-list
102089195|NCT03693391|Cariostatic Agents|cariostatic agents|mesh-ancestor
102089196|NCT03693391|Protective Agents|protective agents|mesh-ancestor
102089197|NCT03693391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089198|NCT02193594|Oxaliplatin|oxaliplatin|mesh-list
102089199|NCT02193594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102089200|NCT02185326|Hormones|hormones|mesh-list
102089201|NCT02185326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102089202|NCT02185326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089203|NCT04412707|Dexamethasone|dexamethasone|mesh-list
102089204|NCT04412707|Melphalan|melphalan|mesh-list
102089205|NCT04412707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102089206|NCT04412707|Antiemetics|antiemetics|mesh-ancestor
102089207|NCT04412707|Autonomic Agents|autonomic agents|mesh-ancestor
102089208|NCT04412707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102089209|NCT04412707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089210|NCT04412707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102089211|NCT04412707|Glucocorticoids|glucocorticoids|mesh-ancestor
102089212|NCT04412707|Hormones|hormones|mesh-ancestor
102089213|NCT04412707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102089214|NCT04412707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102089215|NCT04412707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102089216|NCT04412707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102089217|NCT04412707|Alkylating Agents|alkylating agents|mesh-ancestor
102089218|NCT04412707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089219|NCT04412707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102089220|NCT04412707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102089221|NCT04412707|Immunologic Factors|immunologic factors|mesh-ancestor
102089222|NCT03698695|Mefloquine|mefloquine|mesh-list
102089223|NCT03698695|Donepezil|donepezil|mesh-list
102089224|NCT03698695|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102089225|NCT03698695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102089226|NCT03698695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089227|NCT03698695|Cholinergic Agents|cholinergic agents|mesh-ancestor
102089228|NCT03698695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102089229|NCT03698695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089230|NCT03698695|Nootropic Agents|nootropic agents|mesh-ancestor
102089231|NCT03698695|Antimalarials|antimalarials|mesh-ancestor
102089232|NCT03698695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102089233|NCT03698695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101944217|NCT05194124|Hormones|hormones|mesh-ancestor
101944218|NCT05194124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102089234|NCT03698695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102089235|NCT04729296|Golimumab|golimumab|mesh-list
102089236|NCT04729296|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102089237|NCT04729296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102089238|NCT04729296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102089239|NCT04729296|Immunologic Factors|immunologic factors|mesh-ancestor
102089240|NCT04729296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089241|NCT03698617|Propofol|propofol|mesh-list
102089242|NCT03698617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102089243|NCT03698617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102089244|NCT03698617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089245|NCT03698617|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102089246|NCT03698617|Anesthetics, General|anesthetics, general|mesh-ancestor
102089247|NCT03698617|Anesthetics|anesthetics|mesh-ancestor
102089248|NCT02194374|Cyclophosphamide|cyclophosphamide|mesh-list
102089249|NCT02194374|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102089250|NCT02194374|Rituximab|rituximab|mesh-list
102089251|NCT02194374|Fludarabine|fludarabine|mesh-list
102089252|NCT02194374|Fludarabine phosphate|fludarabine phosphate|mesh-list
102089253|NCT02194374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102089254|NCT02194374|Immunologic Factors|immunologic factors|mesh-ancestor
102089255|NCT02194374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089256|NCT02194374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102089257|NCT02194374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101390949|NCT05331664|Prednisolone|prednisolone|mesh-list
102089281|NCT02194686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089282|NCT02194686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102089283|NCT02194686|Respiratory System Agents|respiratory system agents|mesh-ancestor
102089284|NCT02194686|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102089285|NCT02194686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102089286|NCT02194686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089287|NCT02194686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102089288|NCT02194686|Vasodilator Agents|vasodilator agents|mesh-ancestor
102089289|NCT02194686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102089290|NCT02194686|Protective Agents|protective agents|mesh-ancestor
102089291|NCT02194686|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102089292|NCT02194686|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102089293|NCT02194686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102089295|NCT04622995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102089296|NCT04622995|Anticonvulsants|anticonvulsants|mesh-ancestor
102089297|NCT04622995|Antiemetics|antiemetics|mesh-ancestor
102089298|NCT04622995|Autonomic Agents|autonomic agents|mesh-ancestor
102089299|NCT04622995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102089300|NCT04622995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089301|NCT04622995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102089302|NCT04622995|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102089303|NCT04622995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101809096|NCT00424294|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102089304|NCT04622995|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102089305|NCT04622995|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102089309|NCT04622995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102089310|NCT04622995|Anesthetics, General|anesthetics, general|mesh-ancestor
102089312|NCT04622995|GABA Modulators|gaba modulators|mesh-ancestor
102089313|NCT04622995|GABA Agents|gaba agents|mesh-ancestor
102089314|NCT04622995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102089315|NCT04622995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089316|NCT01341639|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102089317|NCT01341639|Immunologic Factors|immunologic factors|mesh-ancestor
102089318|NCT01341639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089319|NCT02194764|Naltrexone|naltrexone|mesh-list
102089320|NCT02194764|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102089321|NCT02194764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102089322|NCT02194764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089323|NCT02194764|Sensory System Agents|sensory system agents|mesh-ancestor
102089324|NCT02194764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102089325|NCT02967640|Ketamine|ketamine|mesh-list
102089326|NCT02967640|Analgesics|analgesics|mesh-ancestor
102089327|NCT02967640|Sensory System Agents|sensory system agents|mesh-ancestor
102089328|NCT02967640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102089329|NCT02967640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089330|NCT02967640|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101944219|NCT05194124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944220|NCT02250664|Nicotine|nicotine|mesh-list
101944221|NCT02250664|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101944222|NCT02250664|Autonomic Agents|autonomic agents|mesh-ancestor
101944223|NCT02250664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101944224|NCT02250664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944225|NCT02250664|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101944226|NCT02250664|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101944227|NCT02250664|Cholinergic Agents|cholinergic agents|mesh-ancestor
101944228|NCT02250664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101944229|NCT02250664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089331|NCT02967640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102089332|NCT02967640|Anesthetics, General|anesthetics, general|mesh-ancestor
102089333|NCT02967640|Anesthetics|anesthetics|mesh-ancestor
102089334|NCT02967640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102089335|NCT02967640|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102089336|NCT02967640|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102089337|NCT02967640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102089338|NCT02967640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089339|NCT02194920|Parathyroid Hormone|parathyroid hormone|mesh-list
102089340|NCT02194920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102089341|NCT02194920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089342|NCT00005584|Prednisone|prednisone|mesh-list
102089343|NCT00005584|Epirubicin|epirubicin|mesh-list
102089344|NCT00005584|Bleomycin|bleomycin|mesh-list
102089345|NCT00005584|Vinblastine|vinblastine|mesh-list
102089346|NCT00005584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102089347|NCT00005584|Glucocorticoids|glucocorticoids|mesh-ancestor
102089348|NCT00005584|Hormones|hormones|mesh-ancestor
102089349|NCT00005584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102089350|NCT00005584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089351|NCT00005584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102089352|NCT00005584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102089353|NCT00005584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102089354|NCT00005584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102089355|NCT00005584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102089356|NCT00005584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102089357|NCT00005584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089358|NCT00005584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102089359|NCT00005584|Tubulin Modulators|tubulin modulators|mesh-ancestor
102089360|NCT00005584|Antimitotic Agents|antimitotic agents|mesh-ancestor
102089361|NCT00005584|Mitosis Modulators|mitosis modulators|mesh-ancestor
102089362|NCT02194218|Nevirapine|nevirapine|mesh-list
102089363|NCT02194218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102089364|NCT02194218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102089365|NCT02194218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102089366|NCT02194218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089367|NCT02194218|Antiviral Agents|antiviral agents|mesh-ancestor
102089368|NCT02194218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102089369|NCT02194218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102089370|NCT02194218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102089371|NCT02194218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102089372|NCT02194218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102089373|NCT02194296|Ambroxol|ambroxol|mesh-list
102089374|NCT02194296|Expectorants|expectorants|mesh-ancestor
102089375|NCT02194296|Respiratory System Agents|respiratory system agents|mesh-ancestor
102089377|NCT02197026|Viscosupplements|viscosupplements|mesh-ancestor
102089378|NCT02197026|Protective Agents|protective agents|mesh-ancestor
102089393|NCT02197182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102089394|NCT02197182|Trace Elements|trace elements|mesh-ancestor
102089395|NCT02197182|Micronutrients|micronutrients|mesh-ancestor
102089396|NCT02197182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089397|NCT02197260|Amoxicillin|amoxicillin|mesh-list
102089398|NCT02197260|Metronidazole|metronidazole|mesh-list
101944230|NCT02239276|Stiripentol|stiripentol|mesh-list
101944231|NCT02239276|Anticonvulsants|anticonvulsants|mesh-ancestor
101944232|NCT03576820|Lidocaine|lidocaine|mesh-list
101944233|NCT03576820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101944234|NCT03576820|Anesthetics, Local|anesthetics, local|mesh-ancestor
101944235|NCT03576820|Anesthetics|anesthetics|mesh-ancestor
101944236|NCT03576820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101944237|NCT03576820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944238|NCT03576820|Sensory System Agents|sensory system agents|mesh-ancestor
101944239|NCT03576820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101944240|NCT03576820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101944241|NCT03576820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101944242|NCT03576820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101778764|NCT00818298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102089399|NCT02197260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102089400|NCT02197260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102089401|NCT02197260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102089402|NCT02197260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102089403|NCT03687931|Dexamethasone|dexamethasone|mesh-list
102089404|NCT03687931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102089405|NCT03687931|Antiemetics|antiemetics|mesh-ancestor
102089406|NCT03687931|Autonomic Agents|autonomic agents|mesh-ancestor
102089407|NCT03687931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102089408|NCT03687931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089409|NCT03687931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102089410|NCT03687931|Glucocorticoids|glucocorticoids|mesh-ancestor
102089411|NCT03687931|Hormones|hormones|mesh-ancestor
102089412|NCT03687931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102089413|NCT03687931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102089414|NCT03687931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102089415|NCT03534024|Curcumin|curcumin|mesh-list
102089416|NCT03534024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102089417|NCT03534024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102089418|NCT03534024|Analgesics|analgesics|mesh-ancestor
102089419|NCT03534024|Sensory System Agents|sensory system agents|mesh-ancestor
102089420|NCT03534024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102089421|NCT03534024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089422|NCT03534024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102089423|NCT03534024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102089424|NCT03534024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102089425|NCT03534024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102089426|NCT03534024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089427|NCT02753686|Tamoxifen|tamoxifen|mesh-list
102089428|NCT02753686|Everolimus|everolimus|mesh-list
102089429|NCT02753686|Letrozole|letrozole|mesh-list
102089430|NCT02753686|Fulvestrant|fulvestrant|mesh-list
102089431|NCT02753686|Anastrozole|anastrozole|mesh-list
102089432|NCT02753686|Exemestane|exemestane|mesh-list
102089433|NCT02753686|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102089434|NCT02753686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102089435|NCT02753686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102089436|NCT02753686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089437|NCT02753686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102089438|NCT02753686|Immunologic Factors|immunologic factors|mesh-ancestor
102089439|NCT02753686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089440|NCT02753686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102089441|NCT02753686|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102089442|NCT02753686|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102089443|NCT02753686|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102089444|NCT02753686|Hormone Antagonists|hormone antagonists|mesh-ancestor
102089456|NCT04216927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101809243|NCT04004754|Miltefosine|miltefosine|mesh-list
102089457|NCT04216927|Respiratory System Agents|respiratory system agents|mesh-ancestor
101944243|NCT03576820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101944244|NCT03576820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944245|NCT03579082|Decitabine|decitabine|mesh-list
101944246|NCT03579082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101944247|NCT03579082|Antimetabolites|antimetabolites|mesh-ancestor
101944248|NCT03579082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944249|NCT03579082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101944250|NCT03579082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101944251|NCT03579004|Paclitaxel|paclitaxel|mesh-list
102089458|NCT04216927|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102089459|NCT04216927|Antioxidants|antioxidants|mesh-ancestor
102089460|NCT04216927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089461|NCT04216927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102089462|NCT04216927|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102089463|NCT04216927|Vasodilator Agents|vasodilator agents|mesh-ancestor
102089464|NCT04216927|Gasotransmitters|gasotransmitters|mesh-ancestor
102089465|NCT04216927|Protective Agents|protective agents|mesh-ancestor
102089466|NCT02329834|Furosemide|furosemide|mesh-list
102089467|NCT02329834|Diuretics|diuretics|mesh-ancestor
102089468|NCT02329834|Natriuretic Agents|natriuretic agents|mesh-ancestor
102089469|NCT02329834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089470|NCT02329834|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102089471|NCT02329834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102089472|NCT02329834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089473|NCT02195466|Ritonavir|ritonavir|mesh-list
102089474|NCT02195466|Tipranavir|tipranavir|mesh-list
102089475|NCT02195466|Fluconazole|fluconazole|mesh-list
102089476|NCT02195466|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102089477|NCT02195466|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102089478|NCT02195466|Protease Inhibitors|protease inhibitors|mesh-ancestor
102089479|NCT02195466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102089480|NCT02195466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089481|NCT02195466|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102089482|NCT02195466|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102089483|NCT02195466|Antiviral Agents|antiviral agents|mesh-ancestor
102089484|NCT02195466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102089485|NCT02195466|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102089486|NCT02195466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102089487|NCT02195466|Antifungal Agents|antifungal agents|mesh-ancestor
102089488|NCT02195466|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102089489|NCT02195466|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102089490|NCT02195466|Hormone Antagonists|hormone antagonists|mesh-ancestor
102089491|NCT02195466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102089492|NCT02195466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089493|NCT02195466|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102089494|NCT02195466|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102089495|NCT02195544|Hylan|hylan|mesh-list
102089496|NCT02195544|Viscosupplements|viscosupplements|mesh-ancestor
102089497|NCT02195544|Protective Agents|protective agents|mesh-ancestor
102089498|NCT02195544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089499|NCT02197494|Valsartan|valsartan|mesh-list
102089500|NCT02197494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102089501|NCT02197494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102089502|NCT02197494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102089503|NCT02197494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089511|NCT03692299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102089512|NCT02197650|Asparaginase|asparaginase|mesh-list
102089514|NCT02197650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102089515|NCT02650648|Cyclophosphamide|cyclophosphamide|mesh-list
102089516|NCT02650648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102089517|NCT02650648|Immunologic Factors|immunologic factors|mesh-ancestor
102089518|NCT02650648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089519|NCT02650648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102089520|NCT02650648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101944252|NCT03579004|Fluorouracil|fluorouracil|mesh-list
101944253|NCT03579004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101944254|NCT03579004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102089521|NCT02650648|Alkylating Agents|alkylating agents|mesh-ancestor
102089522|NCT02650648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089523|NCT02650648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102089524|NCT02650648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102089525|NCT03682939|Vaccines|vaccines|mesh-list
102089526|NCT03682939|Immunologic Factors|immunologic factors|mesh-ancestor
102089527|NCT03682939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089528|NCT02201992|Crizotinib|crizotinib|mesh-list
102089529|NCT02201992|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102089530|NCT02201992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102089531|NCT02201992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102089532|NCT02201992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102089533|NCT02201992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089534|NCT03534492|Durvalumab|durvalumab|mesh-list
102089535|NCT03534492|Olaparib|olaparib|mesh-list
102089536|NCT03534492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102089537|NCT03534492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102089538|NCT03534492|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102089539|NCT03534492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102089540|NCT03534492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089541|NCT03624283|Betahistine|betahistine|mesh-list
102089542|NCT03624283|Vasodilator Agents|vasodilator agents|mesh-ancestor
102089543|NCT03624283|Histamine Agonists|histamine agonists|mesh-ancestor
102089544|NCT03624283|Histamine Agents|histamine agents|mesh-ancestor
102089545|NCT03624283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102089546|NCT03624283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089547|NCT03624283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089548|NCT03687463|Decitabine|decitabine|mesh-list
102089549|NCT03687463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102089550|NCT03687463|Antimetabolites|antimetabolites|mesh-ancestor
102089551|NCT03687463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089552|NCT03687463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102089553|NCT03687463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102089554|NCT03692143|Alendronate|alendronate|mesh-list
102089555|NCT03692143|Teriparatide|teriparatide|mesh-list
102089556|NCT03692143|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102089557|NCT03692143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089558|NCT03692143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102089559|NCT02201004|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
102089560|NCT02201004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102089561|NCT02201004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089562|NCT02201004|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102089563|NCT02201004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089564|NCT02197884|Clarithromycin|clarithromycin|mesh-list
102089565|NCT02197884|Itraconazole|itraconazole|mesh-list
102089566|NCT02197884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102089567|NCT02197884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101391313|NCT05171777|Atezolizumab|atezolizumab|mesh-list
102089570|NCT02197884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089571|NCT02197884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102089572|NCT02197884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102089573|NCT02197884|Antifungal Agents|antifungal agents|mesh-ancestor
102089574|NCT02197884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102089575|NCT02197884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102089576|NCT02197884|Hormone Antagonists|hormone antagonists|mesh-ancestor
102089577|NCT02197884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102089578|NCT02197884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089579|NCT02201082|Amikacin|amikacin|mesh-list
102089580|NCT02201082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102089581|NCT02201082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102089582|NCT03687229|Insulin|insulin|mesh-list
102089583|NCT03687229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102089584|NCT03687229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089585|NCT05085054|Osimertinib|osimertinib|mesh-list
102089586|NCT05085054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101944255|NCT03579004|Tubulin Modulators|tubulin modulators|mesh-ancestor
101944256|NCT03579004|Antimitotic Agents|antimitotic agents|mesh-ancestor
101944257|NCT03579004|Mitosis Modulators|mitosis modulators|mesh-ancestor
101944258|NCT03579004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944259|NCT03579004|Antimetabolites|antimetabolites|mesh-ancestor
101944260|NCT03579004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101944261|NCT03579004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101944262|NCT03579004|Immunologic Factors|immunologic factors|mesh-ancestor
101944263|NCT03579004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944264|NCT03576508|Lidocaine|lidocaine|mesh-list
101944265|NCT03576508|Epinephrine|epinephrine|mesh-list
101944266|NCT03576508|Capsaicin|capsaicin|mesh-list
101944267|NCT03576508|Anesthetics, Local|anesthetics, local|mesh-ancestor
101944268|NCT03576508|Anesthetics|anesthetics|mesh-ancestor
101944269|NCT03576508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101944270|NCT03576508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944271|NCT03576508|Sensory System Agents|sensory system agents|mesh-ancestor
101944272|NCT03576508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101944273|NCT03576508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101944274|NCT03576508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101944275|NCT03576508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101944276|NCT03576508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101944277|NCT03576508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944278|NCT03576508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101944279|NCT03576508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101944280|NCT03576508|Adrenergic Agents|adrenergic agents|mesh-ancestor
102089587|NCT05085054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102089588|NCT05085054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102089589|NCT05085054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089590|NCT03969121|Palbociclib|palbociclib|mesh-list
102089591|NCT03969121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102089592|NCT03969121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102089593|NCT03969121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102089594|NCT03969121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089595|NCT02201238|Diclofenac|diclofenac|mesh-list
102089596|NCT02201238|Menthol|menthol|mesh-list
102089597|NCT02201238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102089598|NCT02201238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102089599|NCT02201238|Analgesics|analgesics|mesh-ancestor
102089600|NCT02201238|Sensory System Agents|sensory system agents|mesh-ancestor
102089601|NCT02201238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102089602|NCT02201238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089603|NCT02201238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102089605|NCT02201238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102089606|NCT02201238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102089607|NCT02201238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089608|NCT02201238|Antipruritics|antipruritics|mesh-ancestor
101944281|NCT03576508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101944282|NCT03576508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101944283|NCT03576508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101944284|NCT03576508|Autonomic Agents|autonomic agents|mesh-ancestor
101944285|NCT03576508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101944286|NCT03576508|Respiratory System Agents|respiratory system agents|mesh-ancestor
101944287|NCT03576508|Mydriatics|mydriatics|mesh-ancestor
101944288|NCT03576508|Sympathomimetics|sympathomimetics|mesh-ancestor
101944289|NCT03576508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101944290|NCT03576508|Antipruritics|antipruritics|mesh-ancestor
101944291|NCT03576508|Dermatologic Agents|dermatologic agents|mesh-ancestor
101944292|NCT02646982|Candesartan|candesartan|mesh-list
101944293|NCT02646982|Candesartan cilexetil|candesartan cilexetil|mesh-list
101944294|NCT02646982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101944295|NCT02646982|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101944296|NCT02646982|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101944297|NCT02646982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944298|NCT03576040|Edotreotide|edotreotide|mesh-list
101944299|NCT03576040|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101944300|NCT03576040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944301|NCT03574246|Chlorhexidine|chlorhexidine|mesh-list
101944302|NCT03574246|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101944303|NCT03574246|Benzydamine|benzydamine|mesh-list
101944304|NCT03574246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101944305|NCT03574246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101944306|NCT03574246|Disinfectants|disinfectants|mesh-ancestor
101944307|NCT03574246|Dermatologic Agents|dermatologic agents|mesh-ancestor
101944308|NCT03574246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101944310|NCT02239900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101944311|NCT02239900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101944326|NCT02229136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101944327|NCT02229136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944328|NCT02229136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101944329|NCT02229136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101944330|NCT02523898|Metformin|metformin|mesh-list
101944331|NCT02523898|Clomiphene|clomiphene|mesh-list
101944332|NCT02523898|Enclomiphene|enclomiphene|mesh-list
101944333|NCT02523898|Zuclomiphene|zuclomiphene|mesh-list
101944334|NCT02523898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101944335|NCT02523898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944336|NCT02523898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101944337|NCT02523898|Hormone Antagonists|hormone antagonists|mesh-ancestor
101944338|NCT02523898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101944339|NCT02523898|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102089609|NCT02201238|Dermatologic Agents|dermatologic agents|mesh-ancestor
102089610|NCT02257398|Moxifloxacin|moxifloxacin|mesh-list
102089611|NCT02257398|Gepotidacin|gepotidacin|mesh-list
102089612|NCT02257398|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102089613|NCT02257398|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102089614|NCT02257398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102089615|NCT02257398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102089616|NCT02257398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102089617|NCT02257398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102089618|NCT02257398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089619|NCT02257398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102089620|NCT02257398|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102089621|NCT02257398|Contraceptive Agents|contraceptive agents|mesh-ancestor
102089622|NCT02257398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102089623|NCT02257398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089624|NCT02257398|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102089625|NCT02257398|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102089626|NCT02257398|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102089627|NCT02201316|Mosapride|mosapride|mesh-list
102089628|NCT02201316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089629|NCT02201316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102089633|NCT02201316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089634|NCT02198820|Anesthetics|anesthetics|mesh-list
102089635|NCT02198820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102089636|NCT02198820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089637|NCT02257476|Dexamethasone|dexamethasone|mesh-list
102089638|NCT02257476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102089639|NCT02257476|Antiemetics|antiemetics|mesh-ancestor
102089640|NCT02257476|Autonomic Agents|autonomic agents|mesh-ancestor
102089641|NCT02257476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102089642|NCT02257476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089643|NCT02257476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102089644|NCT02257476|Glucocorticoids|glucocorticoids|mesh-ancestor
102089646|NCT02257476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102089647|NCT02257476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102089648|NCT02257476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102089649|NCT03946111|Naltrexone|naltrexone|mesh-list
102089650|NCT03946111|Bupropion|bupropion|mesh-list
102089651|NCT03946111|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102089652|NCT03946111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102089653|NCT03946111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089654|NCT03946111|Sensory System Agents|sensory system agents|mesh-ancestor
102089655|NCT03946111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102089656|NCT03946111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102089657|NCT03946111|Antidepressive Agents|antidepressive agents|mesh-ancestor
101944340|NCT02523898|Fertility Agents|fertility agents|mesh-ancestor
101944341|NCT02523898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101944342|NCT02523898|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101944343|NCT02523898|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101944344|NCT02845336|Celecoxib|celecoxib|mesh-list
101944345|NCT02845336|Lubricant Eye Drops|lubricant eye drops|mesh-list
101944346|NCT02845336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101944347|NCT02845336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101944348|NCT02845336|Analgesics|analgesics|mesh-ancestor
101944349|NCT02845336|Sensory System Agents|sensory system agents|mesh-ancestor
101944350|NCT02845336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101944351|NCT02845336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944352|NCT02845336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101944353|NCT02845336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101779103|NCT01004224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102089658|NCT03946111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102089659|NCT03946111|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102089660|NCT03946111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102089661|NCT03946111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102089662|NCT03946111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089663|NCT03946111|Dopamine Agents|dopamine agents|mesh-ancestor
102089664|NCT03946111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102089665|NCT03946111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102089666|NCT03946111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102089667|NCT03946111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102089668|NCT03943927|Metoprolol|metoprolol|mesh-list
102089669|NCT03943927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102089670|NCT03943927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102089671|NCT03943927|Sympatholytics|sympatholytics|mesh-ancestor
102089672|NCT03943927|Autonomic Agents|autonomic agents|mesh-ancestor
102089673|NCT03943927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101809468|NCT05914506|Xenon|xenon|mesh-list
102089674|NCT03943927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089675|NCT03943927|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102089676|NCT03943927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102089677|NCT03943927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102089678|NCT03943927|Adrenergic Agents|adrenergic agents|mesh-ancestor
102089679|NCT03943927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102089680|NCT03943927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089681|NCT03533166|Chlorhexidine|chlorhexidine|mesh-list
102089682|NCT03533166|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102089683|NCT03533166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102089684|NCT03533166|Disinfectants|disinfectants|mesh-ancestor
102089685|NCT03687073|Silybin|silybin|mesh-list
102089686|NCT03687073|Indole-3-carbinol|indole-3-carbinol|mesh-list
102089687|NCT03687073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102089688|NCT03687073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102089689|NCT03687073|Protective Agents|protective agents|mesh-ancestor
102089690|NCT03687073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089691|NCT03687073|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102089692|NCT03682471|Deoxycholic Acid|deoxycholic acid|mesh-list
102089693|NCT03682471|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102089694|NCT03682471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102089695|NCT02198352|Olcegepant|olcegepant|mesh-list
102089696|NCT02198352|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
102089697|NCT02198352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089698|NCT02198352|Analgesics|analgesics|mesh-ancestor
101391447|NCT05068791|Psilocybin|psilocybin|mesh-list
102089706|NCT02202564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101944354|NCT02845336|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101944355|NCT02845336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101944356|NCT02845336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101944357|NCT02845336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944358|NCT02845336|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101944359|NCT02845336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101944360|NCT02244502|Paclitaxel|paclitaxel|mesh-list
101944361|NCT02244502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101944362|NCT02244502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101944363|NCT02244502|Tubulin Modulators|tubulin modulators|mesh-ancestor
101944364|NCT02244502|Antimitotic Agents|antimitotic agents|mesh-ancestor
101944365|NCT02244502|Mitosis Modulators|mitosis modulators|mesh-ancestor
101944366|NCT02244502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944367|NCT03573622|Sarpogrelate|sarpogrelate|mesh-list
101779164|NCT01005472|Sunitinib|sunitinib|mesh-list
102089707|NCT02202564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102089708|NCT02202564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089709|NCT02198508|Deferasirox|deferasirox|mesh-list
102089710|NCT02198508|Deferiprone|deferiprone|mesh-list
102089711|NCT02198508|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102089712|NCT02198508|Chelating Agents|chelating agents|mesh-ancestor
102089713|NCT02198508|Sequestering Agents|sequestering agents|mesh-ancestor
102089714|NCT02198508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089715|NCT02202720|Sevoflurane|sevoflurane|mesh-list
101706371|NCT05011357|Sympathomimetics|sympathomimetics|mesh-ancestor
102089716|NCT02202720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102089717|NCT02202720|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102089718|NCT02202720|Anesthetics, General|anesthetics, general|mesh-ancestor
102089719|NCT02202720|Anesthetics|anesthetics|mesh-ancestor
102089720|NCT02202720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102089721|NCT02202720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089722|NCT02206308|Antibodies|antibodies|mesh-list
102089723|NCT02206308|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102089724|NCT02206308|Immunologic Factors|immunologic factors|mesh-ancestor
102089725|NCT02206308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089726|NCT03028129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102089727|NCT03028129|Isoniazid|isoniazid|mesh-list
102089728|NCT03028129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102089729|NCT03028129|Antitubercular Agents|antitubercular agents|mesh-ancestor
102089730|NCT03028129|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102089731|NCT03028129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102089732|NCT03028129|Antimetabolites|antimetabolites|mesh-ancestor
102089733|NCT03028129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089734|NCT03028129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102089735|NCT04059679|Aspirin|aspirin|mesh-list
102089736|NCT04059679|Rivaroxaban|rivaroxaban|mesh-list
102089737|NCT04059679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102089738|NCT04059679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102089739|NCT04059679|Analgesics|analgesics|mesh-ancestor
102089740|NCT04059679|Sensory System Agents|sensory system agents|mesh-ancestor
102089741|NCT04059679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102089742|NCT04059679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089743|NCT04059679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102089744|NCT04059679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102089745|NCT04059679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102089746|NCT04059679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102089747|NCT04059679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089748|NCT04059679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102089749|NCT04059679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102089750|NCT04059679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102089752|NCT04059679|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101944368|NCT03573622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101944369|NCT03573622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101944370|NCT03573622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944371|NCT03573622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101944372|NCT03573622|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101944373|NCT03573622|Serotonin Agents|serotonin agents|mesh-ancestor
101944374|NCT03573622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101944375|NCT03573622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944376|NCT02951156|Rituximab|rituximab|mesh-list
101944377|NCT02951156|Avelumab|avelumab|mesh-list
101944378|NCT02951156|Gemcitabine|gemcitabine|mesh-list
101944379|NCT02951156|Oxaliplatin|oxaliplatin|mesh-list
101944380|NCT02951156|Azacitidine|azacitidine|mesh-list
101944381|NCT02951156|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101944382|NCT02951156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101944383|NCT02951156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101944384|NCT02951156|Immunologic Factors|immunologic factors|mesh-ancestor
101944385|NCT02951156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944386|NCT02951156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101944387|NCT02951156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101944388|NCT02951156|Antimetabolites|antimetabolites|mesh-ancestor
101944389|NCT02951156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944390|NCT02951156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101944391|NCT02951156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101944392|NCT02951156|Alkylating Agents|alkylating agents|mesh-ancestor
101944393|NCT03571594|Octreotide|octreotide|mesh-list
101944394|NCT03571594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101944395|NCT03571594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102089753|NCT04059679|Antithrombins|antithrombins|mesh-ancestor
102089754|NCT04059679|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102089755|NCT04059679|Protease Inhibitors|protease inhibitors|mesh-ancestor
102089756|NCT04059679|Anticoagulants|anticoagulants|mesh-ancestor
102089757|NCT03533556|Caffeine|caffeine|mesh-list
102089758|NCT03533556|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102089759|NCT03533556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089760|NCT03533556|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102089761|NCT03533556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102089762|NCT03533556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089763|NCT03533556|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102089764|NCT03533556|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102089765|NCT03533556|Purinergic Agents|purinergic agents|mesh-ancestor
102089766|NCT03533556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102089767|NCT02206854|Flurbiprofen|flurbiprofen|mesh-list
102089772|NCT02206854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089773|NCT02206854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102089774|NCT02206854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102089775|NCT02206854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101944396|NCT03571594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101944397|NCT03571438|Sirolimus|sirolimus|mesh-list
101944398|NCT03571438|Sunitinib|sunitinib|mesh-list
101944399|NCT03571438|Temsirolimus|temsirolimus|mesh-list
101944400|NCT03571438|MTOR Inhibitors|mtor inhibitors|mesh-list
101944401|NCT03571438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101944402|NCT03571438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101944403|NCT03571438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101944404|NCT03571438|Growth Substances|growth substances|mesh-ancestor
101944405|NCT03571438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944406|NCT03571438|Growth Inhibitors|growth inhibitors|mesh-ancestor
101944407|NCT03571438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101944408|NCT03571438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101944409|NCT03571438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944410|NCT03571438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101944411|NCT03571438|Immunologic Factors|immunologic factors|mesh-ancestor
101944412|NCT03571438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101944413|NCT03571438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101944414|NCT03571438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101944415|NCT03571438|Antifungal Agents|antifungal agents|mesh-ancestor
101944417|NCT01874860|Clindamycin|clindamycin|mesh-list
101944418|NCT01874860|Clindamycin palmitate|clindamycin palmitate|mesh-list
101944419|NCT01874860|Clindamycin phosphate|clindamycin phosphate|mesh-list
101944420|NCT01874860|Hydrocortisone|hydrocortisone|mesh-list
101944421|NCT01874860|Methylprednisolone|methylprednisolone|mesh-list
101944422|NCT01874860|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101944423|NCT01874860|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101944424|NCT01874860|Prednisolone|prednisolone|mesh-list
101944425|NCT01874860|Prednisolone acetate|prednisolone acetate|mesh-list
101944426|NCT01874860|Sunscreening Agents|sunscreening agents|mesh-list
101944427|NCT01874860|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101944428|NCT01874860|Prednisolone phosphate|prednisolone phosphate|mesh-list
101944429|NCT01874860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101944430|NCT01874860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101944431|NCT01874860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101944432|NCT01874860|Antimalarials|antimalarials|mesh-ancestor
101944433|NCT01874860|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102089776|NCT02206854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101706410|NCT00735280|Heparin|heparin|mesh-list
102089777|NCT02206854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102089778|NCT02206854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102089779|NCT02206854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944434|NCT01874860|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101944435|NCT01874860|Antiemetics|antiemetics|mesh-ancestor
101944436|NCT01874860|Autonomic Agents|autonomic agents|mesh-ancestor
101944437|NCT01874860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101944438|NCT01874860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944439|NCT01874860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101944440|NCT01874860|Glucocorticoids|glucocorticoids|mesh-ancestor
101944441|NCT01874860|Hormones|hormones|mesh-ancestor
101944442|NCT01874860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101944443|NCT01874860|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101944444|NCT01874860|Protective Agents|protective agents|mesh-ancestor
101944445|NCT01874860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101944446|NCT01874860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101944447|NCT01874860|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101944448|NCT01874860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101944449|NCT01874860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944450|NCT01874860|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101944451|NCT01874860|Dermatologic Agents|dermatologic agents|mesh-ancestor
101944452|NCT03570346|Hemay005|hemay005|mesh-list
101944453|NCT03570346|Dermatologic Agents|dermatologic agents|mesh-ancestor
101944454|NCT03570346|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101944455|NCT03570346|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101944456|NCT03570346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102089780|NCT02206854|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
102089781|NCT03624205|Paclitaxel|paclitaxel|mesh-list
102089782|NCT03624205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102089783|NCT03624205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102089784|NCT03624205|Tubulin Modulators|tubulin modulators|mesh-ancestor
102089785|NCT03624205|Antimitotic Agents|antimitotic agents|mesh-ancestor
102089786|NCT03624205|Mitosis Modulators|mitosis modulators|mesh-ancestor
102089787|NCT03624205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089788|NCT02206932|Sofosbuvir|sofosbuvir|mesh-list
102089789|NCT02206932|Simeprevir|simeprevir|mesh-list
102089790|NCT02206932|Antiviral Agents|antiviral agents|mesh-ancestor
102089791|NCT02206932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102089792|NCT02206932|Protease Inhibitors|protease inhibitors|mesh-ancestor
102089793|NCT02206932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102089794|NCT02206932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089795|NCT02207010|Adavosertib|adavosertib|mesh-list
102089796|NCT02207010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102089797|NCT02207010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089798|NCT02203422|Cyclosporine|cyclosporine|mesh-list
102089799|NCT02203422|Cyclosporins|cyclosporins|mesh-list
102089800|NCT02203422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102089801|NCT02203422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089802|NCT02203422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102089803|NCT02203422|Immunologic Factors|immunologic factors|mesh-ancestor
102089804|NCT02203422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089805|NCT02203422|Antifungal Agents|antifungal agents|mesh-ancestor
102089806|NCT02203422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102089807|NCT02203422|Dermatologic Agents|dermatologic agents|mesh-ancestor
102089808|NCT02203422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101944457|NCT03570346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944458|NCT03571126|Olanzapine|olanzapine|mesh-list
101944459|NCT03571126|Antiemetics|antiemetics|mesh-ancestor
101944460|NCT03571126|Autonomic Agents|autonomic agents|mesh-ancestor
101944461|NCT03571126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101944462|NCT03571126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944463|NCT03571126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101944464|NCT03571126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101944465|NCT03571126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101944466|NCT03571126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101944467|NCT03571126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101944468|NCT03571126|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101944469|NCT03571126|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102089809|NCT02203422|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102089810|NCT03532854|Valsartan|valsartan|mesh-list
102089811|NCT03532854|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102089812|NCT03532854|Ezetimibe|ezetimibe|mesh-list
102089813|NCT03532854|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102089814|NCT03532854|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102089815|NCT03532854|Antimetabolites|antimetabolites|mesh-ancestor
102089816|NCT03532854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089817|NCT03532854|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102089818|NCT03532854|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102089819|NCT03532854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102089820|NCT03532854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102089821|NCT03532854|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102089822|NCT03532854|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102089823|NCT02203500|Telmisartan|telmisartan|mesh-list
102089824|NCT02203500|Lacidipine|lacidipine|mesh-list
102089825|NCT02203500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102089826|NCT02203500|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102089827|NCT02203500|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102089828|NCT02203500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089829|NCT02203500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102089830|NCT02203500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102089831|NCT02203500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102089832|NCT02203500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089833|NCT02203656|Methyltestosterone|methyltestosterone|mesh-list
102089834|NCT02203656|Testosterone|testosterone|mesh-list
102089835|NCT02203656|Testosterone undecanoate|testosterone undecanoate|mesh-list
102089836|NCT02203656|Testosterone enanthate|testosterone enanthate|mesh-list
102089837|NCT02203656|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102089840|NCT02203656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102089842|NCT02203656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102089843|NCT02203656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102089844|NCT02203656|Anabolic Agents|anabolic agents|mesh-ancestor
102089845|NCT04431388|Levobupivacaine|levobupivacaine|mesh-list
102089846|NCT04431388|Anesthetics, Local|anesthetics, local|mesh-ancestor
102089847|NCT04431388|Anesthetics|anesthetics|mesh-ancestor
102089848|NCT04431388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102089849|NCT04431388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089850|NCT04431388|Sensory System Agents|sensory system agents|mesh-ancestor
102089851|NCT04431388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102089852|NCT02199444|Sevelamer|sevelamer|mesh-list
102089853|NCT02199444|Chelating Agents|chelating agents|mesh-ancestor
102089854|NCT02199444|Sequestering Agents|sequestering agents|mesh-ancestor
102089855|NCT02199444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089856|NCT02199522|Propofol|propofol|mesh-list
102089857|NCT02199522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101944470|NCT03571126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101944471|NCT03571126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944472|NCT03571126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101944473|NCT03571126|Serotonin Agents|serotonin agents|mesh-ancestor
101944474|NCT03570112|Sofosbuvir|sofosbuvir|mesh-list
101944475|NCT03570112|Velpatasvir|velpatasvir|mesh-list
101944476|NCT03570112|Antiviral Agents|antiviral agents|mesh-ancestor
101944477|NCT03570112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101944478|NCT03572686|Dexamethasone|dexamethasone|mesh-list
101944479|NCT03572686|Dexamethasone acetate|dexamethasone acetate|mesh-list
101944480|NCT03572686|Ropivacaine|ropivacaine|mesh-list
101944481|NCT03572686|BB 1101|bb 1101|mesh-list
101944482|NCT03572686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101944483|NCT03572686|Antiemetics|antiemetics|mesh-ancestor
101944484|NCT03572686|Autonomic Agents|autonomic agents|mesh-ancestor
101944485|NCT03572686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101944486|NCT03572686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089858|NCT02199522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102089859|NCT02199522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089860|NCT02199522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102089861|NCT02199522|Anesthetics, General|anesthetics, general|mesh-ancestor
102089862|NCT02199522|Anesthetics|anesthetics|mesh-ancestor
102089863|NCT03532698|Aspirin|aspirin|mesh-list
102089864|NCT03532698|Osimertinib|osimertinib|mesh-list
102089865|NCT03532698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102089866|NCT03532698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102089867|NCT03532698|Analgesics|analgesics|mesh-ancestor
102089868|NCT03532698|Sensory System Agents|sensory system agents|mesh-ancestor
102089869|NCT03532698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102089870|NCT03532698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089871|NCT03532698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102089872|NCT03532698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102089873|NCT03532698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102089874|NCT03532698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102089875|NCT03532698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089876|NCT03532698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102089877|NCT03532698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102089878|NCT03532698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102089879|NCT03532698|Antipyretics|antipyretics|mesh-ancestor
102089880|NCT03532698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102089881|NCT03532698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102089882|NCT03690739|Paclitaxel|paclitaxel|mesh-list
102089883|NCT03690739|Bevacizumab|bevacizumab|mesh-list
102089884|NCT03690739|Carboplatin|carboplatin|mesh-list
102089885|NCT03690739|Gemcitabine|gemcitabine|mesh-list
102089886|NCT03690739|Trabectedin|trabectedin|mesh-list
102089887|NCT03690739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102089888|NCT03690739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102089889|NCT03690739|Tubulin Modulators|tubulin modulators|mesh-ancestor
102089890|NCT03690739|Antimitotic Agents|antimitotic agents|mesh-ancestor
102089891|NCT03690739|Mitosis Modulators|mitosis modulators|mesh-ancestor
102089892|NCT03690739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089893|NCT03690739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102089894|NCT03690739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102089895|NCT03690739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102089896|NCT03690739|Growth Substances|growth substances|mesh-ancestor
102089897|NCT03690739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089898|NCT03690739|Growth Inhibitors|growth inhibitors|mesh-ancestor
102089899|NCT03690739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102089900|NCT03690739|Antimetabolites|antimetabolites|mesh-ancestor
101944487|NCT03572686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101944488|NCT03572686|Glucocorticoids|glucocorticoids|mesh-ancestor
101944490|NCT03572686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102089901|NCT03690739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102089902|NCT03690739|Alkylating Agents|alkylating agents|mesh-ancestor
102089903|NCT02199678|Ketamine|ketamine|mesh-list
102089904|NCT02199678|Analgesics|analgesics|mesh-ancestor
102089905|NCT02199678|Sensory System Agents|sensory system agents|mesh-ancestor
102089906|NCT02199678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102089907|NCT02199678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089908|NCT02199678|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102089909|NCT02199678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102089910|NCT02199678|Anesthetics, General|anesthetics, general|mesh-ancestor
102089914|NCT02199678|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102089915|NCT02199678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102089916|NCT02199678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089917|NCT03681613|Pyrantel|pyrantel|mesh-list
102089918|NCT03681613|Pyrantel Pamoate|pyrantel pamoate|mesh-list
102089919|NCT03681613|Antinematodal Agents|antinematodal agents|mesh-ancestor
102089920|NCT03681613|Anthelmintics|anthelmintics|mesh-ancestor
102089921|NCT03681613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102089922|NCT03681613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102089923|NCT03681613|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
102089924|NCT03681613|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102089925|NCT03681613|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102089926|NCT03681613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102089927|NCT03681613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089928|NCT03690583|Zinc|zinc|mesh-list
102089929|NCT03690583|Zinc Sulfate|zinc sulfate|mesh-list
102089930|NCT03690583|Trace Elements|trace elements|mesh-ancestor
102089931|NCT03690583|Micronutrients|micronutrients|mesh-ancestor
102089932|NCT03690583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089933|NCT03690583|Astringents|astringents|mesh-ancestor
102089934|NCT03690583|Dermatologic Agents|dermatologic agents|mesh-ancestor
102089935|NCT01309672|Prednisone|prednisone|mesh-list
102089936|NCT01309672|Abiraterone Acetate|abiraterone acetate|mesh-list
102089937|NCT01309672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102089938|NCT01309672|Glucocorticoids|glucocorticoids|mesh-ancestor
102089939|NCT01309672|Hormones|hormones|mesh-ancestor
102089940|NCT01309672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102089941|NCT01309672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089942|NCT01309672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102089943|NCT01309672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102089944|NCT01309672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102089945|NCT01309672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102089946|NCT01309672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089947|NCT01309672|Hormone Antagonists|hormone antagonists|mesh-ancestor
102089948|NCT01309672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102089949|NCT03026257|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102089950|NCT03026257|Contact Lens Solutions|contact lens solutions|mesh-list
102089951|NCT03026257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102089952|NCT03026257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102089953|NCT03026257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102089954|NCT03026257|Disinfectants|disinfectants|mesh-ancestor
102089955|NCT02200146|Hydroxychloroquine|hydroxychloroquine|mesh-list
102089956|NCT02200146|Prednisone|prednisone|mesh-list
102089957|NCT02200146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102089958|NCT02200146|Glucocorticoids|glucocorticoids|mesh-ancestor
102089959|NCT02200146|Hormones|hormones|mesh-ancestor
102089960|NCT02200146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102089961|NCT02200146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089962|NCT02200146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102089963|NCT02200146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102089964|NCT02200146|Antimalarials|antimalarials|mesh-ancestor
102089965|NCT02200146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102089966|NCT02200146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102089967|NCT02200146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102089968|NCT02200146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102089969|NCT02200146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089970|NCT02200146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101944491|NCT03572686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101944492|NCT03572686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101944493|NCT03572686|Protease Inhibitors|protease inhibitors|mesh-ancestor
101944494|NCT03572686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101944495|NCT03572686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944496|NCT03572686|Anesthetics, Local|anesthetics, local|mesh-ancestor
101944497|NCT03572686|Anesthetics|anesthetics|mesh-ancestor
102089971|NCT02208492|Levetiracetam|levetiracetam|mesh-list
102089972|NCT02208492|Anticonvulsants|anticonvulsants|mesh-ancestor
102089973|NCT02208492|Nootropic Agents|nootropic agents|mesh-ancestor
102089974|NCT01933048|Vaccines|vaccines|mesh-list
102089975|NCT01933048|Immunologic Factors|immunologic factors|mesh-ancestor
102089976|NCT01933048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089977|NCT02208882|Midazolam|midazolam|mesh-list
102089978|NCT02208882|BMS-986120|bms-986120|mesh-list
102089979|NCT02208882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102089980|NCT02208882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102089981|NCT02208882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102089982|NCT02208882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089983|NCT02208882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102090001|NCT02204202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090004|NCT01886794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102090005|NCT01886794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090006|NCT02209350|Aspirin|aspirin|mesh-list
102090007|NCT02209350|Clopidogrel|clopidogrel|mesh-list
102090008|NCT02209350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102090009|NCT02209350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102090010|NCT02209350|Analgesics|analgesics|mesh-ancestor
102090011|NCT02209350|Sensory System Agents|sensory system agents|mesh-ancestor
102090012|NCT02209350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102090013|NCT02209350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090014|NCT02209350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102090015|NCT02209350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102090016|NCT02209350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102090017|NCT02209350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102090018|NCT02209350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090019|NCT02209350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102090020|NCT02209350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102090021|NCT02209350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102090022|NCT02209350|Antipyretics|antipyretics|mesh-ancestor
102090023|NCT02209350|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102090024|NCT02209350|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102090025|NCT02209350|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102090026|NCT02209350|Purinergic Agents|purinergic agents|mesh-ancestor
102090027|NCT02209350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102090028|NCT02209428|Temozolomide|temozolomide|mesh-list
102090029|NCT02209428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102090030|NCT02209428|Alkylating Agents|alkylating agents|mesh-ancestor
102090031|NCT02209428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090032|NCT02209428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102090033|NCT02200848|Rituximab|rituximab|mesh-list
102090034|NCT02200848|Lenalidomide|lenalidomide|mesh-list
102090035|NCT02200848|Glutarimide|glutarimide|mesh-list
102090036|NCT02200848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102090037|NCT02200848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102090038|NCT02200848|Immunologic Factors|immunologic factors|mesh-ancestor
102090039|NCT02200848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090048|NCT02751450|Fluorides|fluorides|mesh-list
102090049|NCT02751450|Tin Fluorides|tin fluorides|mesh-list
102090050|NCT02751450|Fluorophosphate|fluorophosphate|mesh-list
102090051|NCT02751450|Cariostatic Agents|cariostatic agents|mesh-ancestor
102090052|NCT02751450|Protective Agents|protective agents|mesh-ancestor
102090053|NCT02751450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090054|NCT02209740|Tenofovir|tenofovir|mesh-list
102090055|NCT02209740|Antiviral Agents|antiviral agents|mesh-ancestor
102090056|NCT02209740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102090057|NCT02209740|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102090058|NCT02209740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101944498|NCT03572686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101944499|NCT03572686|Sensory System Agents|sensory system agents|mesh-ancestor
101944500|NCT02523820|Fluticasone|fluticasone|mesh-list
101944501|NCT02523820|Xhance|xhance|mesh-list
101944502|NCT02523820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101944503|NCT02523820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101944504|NCT02523820|Autonomic Agents|autonomic agents|mesh-ancestor
101944505|NCT02523820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101944506|NCT02523820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944507|NCT02523820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102090059|NCT02209740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102090060|NCT02209740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706451|NCT00613145|Sorafenib|sorafenib|mesh-list
102090061|NCT02209740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102090062|NCT02209740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102090063|NCT02257788|Leronlimab|leronlimab|mesh-list
102090064|NCT02257788|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102090065|NCT02257788|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102090066|NCT02257788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090067|NCT02257788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102090068|NCT02257788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102090069|NCT02257788|Antiviral Agents|antiviral agents|mesh-ancestor
102090070|NCT02257788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102090071|NCT02220660|Olodaterol|olodaterol|mesh-list
102090072|NCT02220660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102090073|NCT02220660|Autonomic Agents|autonomic agents|mesh-ancestor
102090074|NCT02220660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102090075|NCT02220660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090076|NCT02220660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102090077|NCT02220660|Respiratory System Agents|respiratory system agents|mesh-ancestor
102090078|NCT01515748|Docetaxel|docetaxel|mesh-list
102090079|NCT01515748|Fluorouracil|fluorouracil|mesh-list
102090080|NCT01515748|Oxaliplatin|oxaliplatin|mesh-list
102090081|NCT01515748|Tegafur|tegafur|mesh-list
102090082|NCT01515748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102090083|NCT01515748|Tubulin Modulators|tubulin modulators|mesh-ancestor
102090084|NCT01515748|Antimitotic Agents|antimitotic agents|mesh-ancestor
102090085|NCT01515748|Mitosis Modulators|mitosis modulators|mesh-ancestor
102090086|NCT01515748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090087|NCT01515748|Antimetabolites|antimetabolites|mesh-ancestor
102090088|NCT01515748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102090089|NCT01515748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102090090|NCT01515748|Immunologic Factors|immunologic factors|mesh-ancestor
102090091|NCT01515748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090092|NCT04973722|Denosumab|denosumab|mesh-list
102090093|NCT04973722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102090094|NCT04973722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090095|NCT03284034|Deoxycholic Acid|deoxycholic acid|mesh-list
102090096|NCT03284034|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102090097|NCT03284034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102090098|NCT01358175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102090099|NCT01358175|Immunologic Factors|immunologic factors|mesh-ancestor
102090100|NCT01358175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090101|NCT02209974|Fluticasone|fluticasone|mesh-list
102090102|NCT02209974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102090103|NCT02209974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102090104|NCT02209974|Autonomic Agents|autonomic agents|mesh-ancestor
102090105|NCT02209974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102090106|NCT02209974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090107|NCT02209974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102090118|NCT03679897|Anesthetics|anesthetics|mesh-ancestor
101809917|NCT04865731|Esomeprazole|esomeprazole|mesh-list
102090119|NCT03679897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102090120|NCT03679897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090121|NCT03679897|Sensory System Agents|sensory system agents|mesh-ancestor
102090122|NCT03679897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102090123|NCT03060070|Dexmedetomidine|dexmedetomidine|mesh-list
102090124|NCT03060070|Ketamine|ketamine|mesh-list
101944508|NCT02523820|Respiratory System Agents|respiratory system agents|mesh-ancestor
101944509|NCT02523820|Dermatologic Agents|dermatologic agents|mesh-ancestor
101944510|NCT02523820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101944511|NCT03369704|Omalizumab|omalizumab|mesh-list
101944512|NCT03369704|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101944513|NCT03369704|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101944514|NCT03369704|Respiratory System Agents|respiratory system agents|mesh-ancestor
101944515|NCT03709160|Bumetanide|bumetanide|mesh-list
101944516|NCT03709160|Diuretics|diuretics|mesh-ancestor
101944517|NCT03709160|Natriuretic Agents|natriuretic agents|mesh-ancestor
101944518|NCT03709160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944519|NCT03709160|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101944520|NCT03709160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101944521|NCT03709160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944522|NCT05332496|Bevacizumab|bevacizumab|mesh-list
101944523|NCT05332496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101944524|NCT05332496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101944525|NCT05332496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101779688|NCT05773807|Anesthetics, General|anesthetics, general|mesh-ancestor
102090125|NCT03060070|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102090126|NCT03060070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102090127|NCT03060070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090128|NCT03060070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102090129|NCT03060070|Analgesics|analgesics|mesh-ancestor
102090130|NCT03060070|Sensory System Agents|sensory system agents|mesh-ancestor
102090131|NCT03060070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102090132|NCT03060070|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102090133|NCT03060070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102090134|NCT03060070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102090135|NCT03060070|Adrenergic Agents|adrenergic agents|mesh-ancestor
102090136|NCT03060070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102090137|NCT03060070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090138|NCT03060070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102090139|NCT03060070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102090140|NCT03060070|Anesthetics, General|anesthetics, general|mesh-ancestor
102090141|NCT03060070|Anesthetics|anesthetics|mesh-ancestor
102090142|NCT03060070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102090143|NCT03060070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102090144|NCT03683563|Citric Acid|citric acid|mesh-list
102090145|NCT03683563|Sodium Citrate|sodium citrate|mesh-list
102090146|NCT03683563|Anticoagulants|anticoagulants|mesh-ancestor
102090147|NCT03683563|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102090148|NCT03683563|Chelating Agents|chelating agents|mesh-ancestor
102090149|NCT03683563|Sequestering Agents|sequestering agents|mesh-ancestor
102090150|NCT03683563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090151|NCT03563625|Bupivacaine|bupivacaine|mesh-list
102090152|NCT03563625|Anesthetics, Local|anesthetics, local|mesh-ancestor
102090153|NCT03563625|Anesthetics|anesthetics|mesh-ancestor
102090154|NCT03563625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102090155|NCT03563625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090156|NCT03563625|Sensory System Agents|sensory system agents|mesh-ancestor
102090157|NCT03563625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102090158|NCT02832375|Fluorides|fluorides|mesh-list
102090159|NCT02832375|Tin Fluorides|tin fluorides|mesh-list
102090160|NCT02832375|Fluorophosphate|fluorophosphate|mesh-list
102090161|NCT02832375|Cariostatic Agents|cariostatic agents|mesh-ancestor
101944526|NCT05332496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101944527|NCT05332496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101944528|NCT05332496|Growth Substances|growth substances|mesh-ancestor
101944529|NCT05332496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944530|NCT05332496|Growth Inhibitors|growth inhibitors|mesh-ancestor
101944531|NCT05332496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944532|NCT03567304|Rilpivirine|rilpivirine|mesh-list
101944533|NCT03567304|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101944534|NCT03567304|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101944535|NCT03567304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101944536|NCT03567304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090162|NCT02832375|Protective Agents|protective agents|mesh-ancestor
102090163|NCT02832375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090164|NCT03683329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102090165|NCT03683329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102090166|NCT02218476|Coenzyme Q10|coenzyme q10|mesh-list
102090167|NCT02218476|Vitamins|vitamins|mesh-ancestor
102090168|NCT02218476|Micronutrients|micronutrients|mesh-ancestor
102090169|NCT02218476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090170|NCT02205996|Insulin|insulin|mesh-list
102090171|NCT02205996|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102090172|NCT02205996|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102090173|NCT02205996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090174|NCT02220036|Magnesium Oxide|magnesium oxide|mesh-list
102090181|NCT02220114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090182|NCT02220114|GABA Agents|gaba agents|mesh-ancestor
102090183|NCT02220114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102090184|NCT02220114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090185|NCT02221596|Vitamin D|vitamin d|mesh-list
102090186|NCT02221596|Vitamins|vitamins|mesh-ancestor
102090187|NCT02221596|Micronutrients|micronutrients|mesh-ancestor
102090188|NCT02221596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090189|NCT02221596|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102090190|NCT02221752|Folic Acid|folic acid|mesh-list
102090191|NCT02221752|Vitamin B Complex|vitamin b complex|mesh-list
102090192|NCT02221752|Hematinics|hematinics|mesh-ancestor
102090193|NCT02221752|Vitamins|vitamins|mesh-ancestor
102090194|NCT02221752|Micronutrients|micronutrients|mesh-ancestor
102090195|NCT02221752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090196|NCT04971382|Curcumin|curcumin|mesh-list
102090197|NCT04971382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102090198|NCT04971382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102090199|NCT04971382|Analgesics|analgesics|mesh-ancestor
102090200|NCT04971382|Sensory System Agents|sensory system agents|mesh-ancestor
101809991|NCT04653246|Dexamethasone|dexamethasone|mesh-list
102090201|NCT04971382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102090202|NCT04971382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090203|NCT04971382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102090204|NCT04971382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102090205|NCT04971382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102090206|NCT04971382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102090207|NCT04971382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090208|NCT02220348|Linaclotide|linaclotide|mesh-list
102090209|NCT02220348|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102090210|NCT02220348|Enzyme Activators|enzyme activators|mesh-ancestor
102090211|NCT02220348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090212|NCT02220348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102090213|NCT04151680|Rivaroxaban|rivaroxaban|mesh-list
102090214|NCT04151680|Apixaban|apixaban|mesh-list
102090215|NCT04151680|Edoxaban|edoxaban|mesh-list
102090216|NCT04151680|Dabigatran|dabigatran|mesh-list
102090217|NCT04151680|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102090218|NCT04151680|Antithrombins|antithrombins|mesh-ancestor
102090219|NCT04151680|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102090220|NCT04151680|Protease Inhibitors|protease inhibitors|mesh-ancestor
102090221|NCT04151680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102090222|NCT04151680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090223|NCT04151680|Anticoagulants|anticoagulants|mesh-ancestor
102090224|NCT02221830|Oxytocin|oxytocin|mesh-list
102090225|NCT02221830|Oxytocics|oxytocics|mesh-ancestor
102090226|NCT02221830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102090227|NCT02221830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090228|NCT02224950|Emollients|emollients|mesh-list
102090229|NCT02224950|Chitosan|chitosan|mesh-list
102090230|NCT02224950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102090231|NCT02224950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102090232|NCT02224950|Antimetabolites|antimetabolites|mesh-ancestor
102090233|NCT02224950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090234|NCT02224950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102090235|NCT02224950|Chelating Agents|chelating agents|mesh-ancestor
102090236|NCT02224950|Sequestering Agents|sequestering agents|mesh-ancestor
102090237|NCT02224950|Hemostatics|hemostatics|mesh-ancestor
102090238|NCT02224950|Coagulants|coagulants|mesh-ancestor
102090239|NCT02224950|Dermatologic Agents|dermatologic agents|mesh-ancestor
102090240|NCT03039114|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102090241|NCT03039114|Obinutuzumab|obinutuzumab|mesh-list
102090242|NCT03039114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102090243|NCT03039114|Alkylating Agents|alkylating agents|mesh-ancestor
102090244|NCT03039114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090245|NCT03039114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392031|NCT04884360|Olaparib|olaparib|mesh-list
102090249|NCT04970602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090250|NCT04970446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102090251|NCT04970446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102090252|NCT02831673|Tenofovir|tenofovir|mesh-list
102090253|NCT02831673|Lamivudine|lamivudine|mesh-list
102090254|NCT02831673|Emtricitabine|emtricitabine|mesh-list
102090255|NCT02831673|Dolutegravir|dolutegravir|mesh-list
102090256|NCT02831673|Antiviral Agents|antiviral agents|mesh-ancestor
102090257|NCT02831673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102090258|NCT02831673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102090259|NCT02831673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102090260|NCT02831673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102090261|NCT02831673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090262|NCT02831673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102090263|NCT02831673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102090264|NCT02831673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102090265|NCT02831673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102090266|NCT02220504|Antipsychotic Agents|antipsychotic agents|mesh-list
102090267|NCT02220504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102090268|NCT02220504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102090269|NCT02220504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090270|NCT02220504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102090271|NCT04962958|Leucovorin|leucovorin|mesh-list
102090272|NCT04962958|Fluorouracil|fluorouracil|mesh-list
102090273|NCT04962958|Oxaliplatin|oxaliplatin|mesh-list
102090274|NCT04962958|Antimetabolites|antimetabolites|mesh-ancestor
102090275|NCT04962958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090276|NCT04962958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102090277|NCT04962958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102090278|NCT04962958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102090279|NCT04962958|Immunologic Factors|immunologic factors|mesh-ancestor
102090280|NCT04962958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090281|NCT04962958|Antidotes|antidotes|mesh-ancestor
102090282|NCT04962958|Protective Agents|protective agents|mesh-ancestor
102090283|NCT04962958|Vitamin B Complex|vitamin b complex|mesh-ancestor
102090284|NCT04962958|Vitamins|vitamins|mesh-ancestor
102090285|NCT04962958|Micronutrients|micronutrients|mesh-ancestor
102090286|NCT02031510|Dexmedetomidine|dexmedetomidine|mesh-list
102090287|NCT02031510|Bupivacaine|bupivacaine|mesh-list
102090288|NCT02031510|Anesthetics, Local|anesthetics, local|mesh-ancestor
102090289|NCT02031510|Anesthetics|anesthetics|mesh-ancestor
102090290|NCT02031510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102090291|NCT02031510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090292|NCT02031510|Sensory System Agents|sensory system agents|mesh-ancestor
102090293|NCT02031510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102090294|NCT02031510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102090295|NCT02031510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102090296|NCT02031510|Analgesics|analgesics|mesh-ancestor
102090297|NCT02031510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102090298|NCT02031510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101944537|NCT03567304|Antiviral Agents|antiviral agents|mesh-ancestor
101944538|NCT03567304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101944539|NCT03567304|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101944540|NCT03567304|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101944541|NCT05356858|Zanubrutinib|zanubrutinib|mesh-list
101944542|NCT05356858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101944543|NCT05356858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101944544|NCT05356858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101944545|NCT05356858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944546|NCT03566914|Tadalafil|tadalafil|mesh-list
101944547|NCT03566914|Vasodilator Agents|vasodilator agents|mesh-ancestor
101944548|NCT03566914|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101944549|NCT03566914|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101944550|NCT03566914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101944551|NCT03566914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944552|NCT03566914|Urological Agents|urological agents|mesh-ancestor
101944553|NCT03366428|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
101944554|NCT03366428|Immunoconjugates|immunoconjugates|mesh-ancestor
101944555|NCT03366428|Immunologic Factors|immunologic factors|mesh-ancestor
101944556|NCT03366428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944557|NCT03709082|Trastuzumab|trastuzumab|mesh-list
101944558|NCT03709082|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101944559|NCT03709082|Letrozole|letrozole|mesh-list
101944560|NCT03709082|Palbociclib|palbociclib|mesh-list
101779894|NCT05335928|Abatacept|abatacept|mesh-list
102090299|NCT02031510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102090300|NCT02031510|Adrenergic Agents|adrenergic agents|mesh-ancestor
102090301|NCT02031510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102090302|NCT02031510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090303|NCT04961788|Antibodies|antibodies|mesh-list
102090304|NCT04961788|Immunologic Factors|immunologic factors|mesh-ancestor
102090305|NCT04961788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090306|NCT02222142|Anesthetics|anesthetics|mesh-list
102090307|NCT02222142|Isoflurane|isoflurane|mesh-list
102090308|NCT02222142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102090309|NCT02222142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090310|NCT02222142|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102090311|NCT02222142|Anesthetics, General|anesthetics, general|mesh-ancestor
102090312|NCT04426084|Antihypertensive Agents|antihypertensive agents|mesh-list
102090313|NCT04425382|Ritonavir|ritonavir|mesh-list
102090314|NCT04425382|Lopinavir|lopinavir|mesh-list
102090315|NCT04425382|Darunavir|darunavir|mesh-list
102090316|NCT04425382|Cobicistat|cobicistat|mesh-list
102090317|NCT04425382|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
102090318|NCT04425382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102090319|NCT04425382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102090320|NCT04425382|Protease Inhibitors|protease inhibitors|mesh-ancestor
102090326|NCT04425382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102090327|NCT04425382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102090328|NCT04425382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102090329|NCT03563937|Rivaroxaban|rivaroxaban|mesh-list
102090330|NCT03563937|Apixaban|apixaban|mesh-list
102090331|NCT03563937|Edoxaban|edoxaban|mesh-list
102090332|NCT03563937|Phenprocoumon|phenprocoumon|mesh-list
101944561|NCT03709082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101944562|NCT03709082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101944563|NCT03709082|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101944564|NCT03709082|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101944566|NCT03709082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944567|NCT03709082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102090333|NCT03563937|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102090334|NCT03563937|Antithrombins|antithrombins|mesh-ancestor
102090335|NCT03563937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102090336|NCT03563937|Protease Inhibitors|protease inhibitors|mesh-ancestor
102090337|NCT03563937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102090338|NCT03563937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090339|NCT03563937|Anticoagulants|anticoagulants|mesh-ancestor
102090340|NCT02231346|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
102090341|NCT02231346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102090342|NCT02231346|Autonomic Agents|autonomic agents|mesh-ancestor
102090343|NCT02231346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102090344|NCT02231346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090345|NCT02231346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102090346|NCT02231346|Respiratory System Agents|respiratory system agents|mesh-ancestor
102090347|NCT02225418|Ropivacaine|ropivacaine|mesh-list
102090348|NCT02225418|Anesthetics, Local|anesthetics, local|mesh-ancestor
102090349|NCT02225418|Anesthetics|anesthetics|mesh-ancestor
102090350|NCT02225418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102090351|NCT02225418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090352|NCT02225418|Sensory System Agents|sensory system agents|mesh-ancestor
102090353|NCT02225418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102090354|NCT02231424|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
102090355|NCT02231424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102090356|NCT02231424|Autonomic Agents|autonomic agents|mesh-ancestor
102090357|NCT02231424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102090358|NCT02231424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090359|NCT02231424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101706493|NCT00613457|Prednisone|prednisone|mesh-list
102090360|NCT02231424|Respiratory System Agents|respiratory system agents|mesh-ancestor
102090361|NCT05057130|Cisplatin|cisplatin|mesh-list
102090362|NCT05057130|Doxorubicin|doxorubicin|mesh-list
102090363|NCT05057130|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102090364|NCT05057130|Methotrexate|methotrexate|mesh-list
102090365|NCT05057130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102090366|NCT05057130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102090367|NCT05057130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102090368|NCT05057130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102090369|NCT05057130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102090370|NCT05057130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090371|NCT05057130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102090372|NCT05057130|Abortifacient Agents|abortifacient agents|mesh-ancestor
102090373|NCT05057130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102090374|NCT05057130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090375|NCT05057130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102090376|NCT05057130|Antimetabolites|antimetabolites|mesh-ancestor
102090377|NCT05057130|Dermatologic Agents|dermatologic agents|mesh-ancestor
102090378|NCT05057130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102090379|NCT05057130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102090380|NCT05057130|Immunologic Factors|immunologic factors|mesh-ancestor
102090381|NCT05057130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102090382|NCT05057130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102090383|NCT02222220|Metoclopramide|metoclopramide|mesh-list
102090384|NCT02222220|Antiemetics|antiemetics|mesh-ancestor
102090385|NCT02222220|Autonomic Agents|autonomic agents|mesh-ancestor
102090386|NCT02222220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102090387|NCT02222220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090388|NCT02222220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102090389|NCT02222220|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102090390|NCT02222220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102090406|NCT03677323|Sensory System Agents|sensory system agents|mesh-ancestor
102090407|NCT03677323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102090408|NCT03677323|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101944568|NCT03709082|Hormone Antagonists|hormone antagonists|mesh-ancestor
101944569|NCT03709082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101944570|NCT03709082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944571|NCT03709082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102090410|NCT03677323|Autonomic Agents|autonomic agents|mesh-ancestor
102090411|NCT03677323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102090412|NCT03677323|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102090413|NCT03677323|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102090414|NCT03677323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102090415|NCT03677323|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102090416|NCT03677323|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102090417|NCT03677323|Dopamine Agents|dopamine agents|mesh-ancestor
102090418|NCT03677323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102090419|NCT03677323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090420|NCT02225652|Paclitaxel|paclitaxel|mesh-list
102090421|NCT02225652|Cyclophosphamide|cyclophosphamide|mesh-list
102090422|NCT02225652|Fluorouracil|fluorouracil|mesh-list
102090423|NCT02225652|Epirubicin|epirubicin|mesh-list
102090424|NCT02225652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102090425|NCT02225652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102090426|NCT02225652|Tubulin Modulators|tubulin modulators|mesh-ancestor
102090427|NCT02225652|Antimitotic Agents|antimitotic agents|mesh-ancestor
102090428|NCT02225652|Mitosis Modulators|mitosis modulators|mesh-ancestor
102090429|NCT02225652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810217|NCT04100018|Prednisone|prednisone|mesh-list
102090430|NCT02225652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102090431|NCT02225652|Immunologic Factors|immunologic factors|mesh-ancestor
102090432|NCT02225652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090433|NCT02225652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102090434|NCT02225652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102090435|NCT02225652|Alkylating Agents|alkylating agents|mesh-ancestor
102090436|NCT02225652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101706499|NCT00613457|Vincristine|vincristine|mesh-list
102090437|NCT02225652|Antimetabolites|antimetabolites|mesh-ancestor
102090438|NCT02225652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102090439|NCT02225652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102090440|NCT02225652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102090441|NCT02225652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102090442|NCT02225652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102090443|NCT02222376|Pirfenidone|pirfenidone|mesh-list
102090444|NCT02222376|Analgesics|analgesics|mesh-ancestor
102090445|NCT02222376|Sensory System Agents|sensory system agents|mesh-ancestor
102090446|NCT02222376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102090447|NCT02222376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090448|NCT02222376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102090449|NCT02222376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102090450|NCT02222376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102090451|NCT02222376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101392220|NCT04768881|Pembrolizumab|pembrolizumab|mesh-list
102090468|NCT04542408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090470|NCT04542408|Antithrombins|antithrombins|mesh-ancestor
102090471|NCT04542408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102090472|NCT04542408|Protease Inhibitors|protease inhibitors|mesh-ancestor
102090473|NCT04542408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102090474|NCT03059134|Mirabegron|mirabegron|mesh-list
102090475|NCT03059134|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102090476|NCT03059134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102090477|NCT03059134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102090478|NCT03059134|Adrenergic Agents|adrenergic agents|mesh-ancestor
102090479|NCT03059134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102090480|NCT03059134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090481|NCT03059134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090482|NCT03059134|Urological Agents|urological agents|mesh-ancestor
102090483|NCT02928991|Vidarabine|vidarabine|mesh-list
102090484|NCT02928991|Fludarabine|fludarabine|mesh-list
102090485|NCT02928991|Fludarabine phosphate|fludarabine phosphate|mesh-list
102090486|NCT02928991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102090487|NCT02928991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102090488|NCT02928991|Antimetabolites|antimetabolites|mesh-ancestor
102090489|NCT02928991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944572|NCT03709082|Tubulin Modulators|tubulin modulators|mesh-ancestor
101944573|NCT03709082|Antimitotic Agents|antimitotic agents|mesh-ancestor
101944574|NCT03709082|Mitosis Modulators|mitosis modulators|mesh-ancestor
101944575|NCT03709082|Immunotoxins|immunotoxins|mesh-ancestor
101944576|NCT03709082|Immunoconjugates|immunoconjugates|mesh-ancestor
101944577|NCT03709082|Immunologic Factors|immunologic factors|mesh-ancestor
101944578|NCT02839876|Acetaminophen|acetaminophen|mesh-list
101944579|NCT02839876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101944580|NCT02839876|Analgesics|analgesics|mesh-ancestor
101944581|NCT02839876|Sensory System Agents|sensory system agents|mesh-ancestor
101944582|NCT02839876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101944583|NCT02839876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944584|NCT02839876|Antipyretics|antipyretics|mesh-ancestor
101944585|NCT01312064|Rituximab|rituximab|mesh-list
101944586|NCT01312064|Everolimus|everolimus|mesh-list
101944587|NCT01312064|Tacrolimus|tacrolimus|mesh-list
101944588|NCT01312064|Thymoglobulin|thymoglobulin|mesh-list
101944589|NCT01312064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101944590|NCT01312064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101944591|NCT01312064|Immunologic Factors|immunologic factors|mesh-ancestor
101944592|NCT01312064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944593|NCT01312064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101944594|NCT01312064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101944595|NCT01312064|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101944596|NCT01312064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101944597|NCT01312064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780083|NCT04830397|Timolol|timolol|mesh-list
102090490|NCT02928991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102090491|NCT02928991|Immunologic Factors|immunologic factors|mesh-ancestor
102090492|NCT02928991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090493|NCT02928991|Antiviral Agents|antiviral agents|mesh-ancestor
102090494|NCT02928991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102090495|NCT03554317|Nivolumab|nivolumab|mesh-list
102090496|NCT03554317|Methyltestosterone|methyltestosterone|mesh-list
102090497|NCT03554317|Testosterone|testosterone|mesh-list
102090498|NCT03554317|Testosterone undecanoate|testosterone undecanoate|mesh-list
102090499|NCT03554317|Testosterone enanthate|testosterone enanthate|mesh-list
102090500|NCT03554317|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102090501|NCT03554317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102090502|NCT03554317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102090503|NCT03554317|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102090504|NCT03554317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090505|NCT03554317|Androgens|androgens|mesh-ancestor
102090506|NCT03554317|Hormones|hormones|mesh-ancestor
102090507|NCT03554317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102090508|NCT03554317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090509|NCT03554317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102090510|NCT03554317|Anabolic Agents|anabolic agents|mesh-ancestor
102090511|NCT03623425|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102090512|NCT03623425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102090516|NCT04957420|Dopamine Agents|dopamine agents|mesh-ancestor
102090517|NCT04957420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101944598|NCT01312064|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101944599|NCT01312064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101944600|NCT05682716|Nitroglycerin|nitroglycerin|mesh-list
101944601|NCT05682716|Vasodilator Agents|vasodilator agents|mesh-ancestor
101944602|NCT03566134|Solifenacin Succinate|solifenacin succinate|mesh-list
101944603|NCT03566134|DA-8010|da-8010|mesh-list
101944604|NCT03566134|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101944605|NCT03566134|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101944606|NCT03566134|Cholinergic Agents|cholinergic agents|mesh-ancestor
101944607|NCT03566134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101944608|NCT03566134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944609|NCT03566134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944610|NCT03566134|Urological Agents|urological agents|mesh-ancestor
101944611|NCT03101722|Huperzine A|huperzine a|mesh-list
101780124|NCT04652076|Paclitaxel|paclitaxel|mesh-list
102090518|NCT04957420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090519|NCT04957420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090520|NCT03350035|Ganaxolone|ganaxolone|mesh-list
102090521|NCT03350035|Neurosteroids|neurosteroids|mesh-ancestor
102090522|NCT03350035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102090523|NCT03350035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090524|NCT03350035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090525|NCT03350035|GABA Modulators|gaba modulators|mesh-ancestor
102090526|NCT03350035|GABA Agents|gaba agents|mesh-ancestor
102090527|NCT02905188|Cyclophosphamide|cyclophosphamide|mesh-list
102090528|NCT02905188|Fludarabine|fludarabine|mesh-list
102090529|NCT02905188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102090530|NCT02905188|Immunologic Factors|immunologic factors|mesh-ancestor
102090531|NCT02905188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090532|NCT02905188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102090533|NCT02905188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102090534|NCT02905188|Alkylating Agents|alkylating agents|mesh-ancestor
102090535|NCT02905188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090536|NCT02905188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102090537|NCT02905188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102090538|NCT03676933|Hydrocortisone|hydrocortisone|mesh-list
102090539|NCT03676933|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
102090540|NCT03676933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102090541|NCT03676933|Dermatologic Agents|dermatologic agents|mesh-ancestor
102090542|NCT03671941|Ticagrelor|ticagrelor|mesh-list
102090543|NCT03671941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102090544|NCT03671941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102090545|NCT03671941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102090546|NCT03671941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102090547|NCT03671941|Purinergic Agents|purinergic agents|mesh-ancestor
102090548|NCT03671941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102090549|NCT03671941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090550|NCT03671941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090551|NCT03058900|Methotrexate|methotrexate|mesh-list
102090552|NCT03058900|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102090553|NCT03058900|Abortifacient Agents|abortifacient agents|mesh-ancestor
102090554|NCT03058900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102090555|NCT03058900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090556|NCT03058900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102090557|NCT03058900|Antimetabolites|antimetabolites|mesh-ancestor
102090558|NCT03058900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090559|NCT03058900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102090560|NCT03058900|Dermatologic Agents|dermatologic agents|mesh-ancestor
102090561|NCT03058900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102090562|NCT03058900|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101944612|NCT03101722|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
101944613|NCT03101722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101944614|NCT03101722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944615|NCT03101722|Cholinergic Agents|cholinergic agents|mesh-ancestor
101944616|NCT03101722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101944617|NCT03101722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944618|NCT03101722|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101944619|NCT03101722|Protective Agents|protective agents|mesh-ancestor
101944620|NCT03088852|Magnesium citrate|magnesium citrate|mesh-list
101944621|NCT03088852|Cathartics|cathartics|mesh-ancestor
101944622|NCT03088852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101944623|NCT03568474|Fluorides|fluorides|mesh-list
101944624|NCT03568474|Cariostatic Agents|cariostatic agents|mesh-ancestor
101944625|NCT03568474|Protective Agents|protective agents|mesh-ancestor
101944626|NCT03568474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944627|NCT03345836|Upadacitinib|upadacitinib|mesh-list
101944628|NCT03345836|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102090563|NCT03058900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102090564|NCT03058900|Immunologic Factors|immunologic factors|mesh-ancestor
102090565|NCT03058900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102090566|NCT03058900|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102090567|NCT02226510|Metformin|metformin|mesh-list
102090568|NCT02226510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102090569|NCT02226510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090570|NCT02225886|Ascorbic Acid|ascorbic acid|mesh-list
102090571|NCT02225886|Antioxidants|antioxidants|mesh-ancestor
102090572|NCT02225886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090573|NCT02225886|Protective Agents|protective agents|mesh-ancestor
102090574|NCT02225886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090575|NCT02225886|Vitamins|vitamins|mesh-ancestor
102090576|NCT02225886|Micronutrients|micronutrients|mesh-ancestor
102090577|NCT03671707|Nicotine|nicotine|mesh-list
102090578|NCT03671707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102090579|NCT03671707|Autonomic Agents|autonomic agents|mesh-ancestor
102090580|NCT03671707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102090581|NCT03671707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810364|NCT03552471|Rucaparib|rucaparib|mesh-list
102090582|NCT03671707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102090583|NCT03671707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102090588|NCT02226588|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102090589|NCT02226588|Abortifacient Agents|abortifacient agents|mesh-ancestor
102090590|NCT02226588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102090591|NCT02226588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090592|NCT02226588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102090593|NCT02226588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102090595|NCT03676621|Misoprostol|misoprostol|mesh-list
102090596|NCT03676621|Oxytocin|oxytocin|mesh-list
102090597|NCT03676621|Oxytocics|oxytocics|mesh-ancestor
102090598|NCT03676621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102090599|NCT03676621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090600|NCT03676621|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102090601|NCT03676621|Abortifacient Agents|abortifacient agents|mesh-ancestor
102090602|NCT03676621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102090603|NCT03676621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102090604|NCT03678649|Capecitabine|capecitabine|mesh-list
102090605|NCT03678649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102090606|NCT03678649|Antimetabolites|antimetabolites|mesh-ancestor
102090607|NCT03678649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090608|NCT03678649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102090609|NCT02845297|Pembrolizumab|pembrolizumab|mesh-list
101944629|NCT03345836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101944630|NCT03345836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101780237|NCT04207086|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102090610|NCT02845297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102090611|NCT02845297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102090612|NCT02845297|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102090613|NCT02845297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090614|NCT02232360|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102090615|NCT02232360|Fenofibrate|fenofibrate|mesh-list
102090616|NCT02232360|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102090617|NCT02232360|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102090618|NCT02232360|Antimetabolites|antimetabolites|mesh-ancestor
102090619|NCT02232360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090620|NCT02232360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102090621|NCT02232360|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102090622|NCT02232360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102090623|NCT02226978|Ritonavir|ritonavir|mesh-list
102090624|NCT02226978|Tipranavir|tipranavir|mesh-list
102090625|NCT02226978|Valacyclovir|valacyclovir|mesh-list
102090626|NCT02226978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102090627|NCT02226978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102090628|NCT02226978|Protease Inhibitors|protease inhibitors|mesh-ancestor
102090629|NCT02226978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102090630|NCT02226978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090631|NCT02226978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102090632|NCT02226978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102090633|NCT02226978|Antiviral Agents|antiviral agents|mesh-ancestor
102090634|NCT02226978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102090635|NCT02226978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102090636|NCT02226978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102090637|NCT02227056|Methylphenidate|methylphenidate|mesh-list
102090638|NCT02227056|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102090639|NCT02227056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090640|NCT02227056|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102090641|NCT02227056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102090642|NCT02227056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102090643|NCT02227056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090644|NCT02227056|Dopamine Agents|dopamine agents|mesh-ancestor
102090645|NCT02227056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102090646|NCT05708157|Histamine Antagonists|histamine antagonists|mesh-list
102090647|NCT05708157|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
102090648|NCT05708157|Histamine Agents|histamine agents|mesh-ancestor
102090649|NCT05708157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102090650|NCT05708157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090651|NCT05708157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090652|NCT03058744|Clobetasol|clobetasol|mesh-list
102090653|NCT03058744|Halobetasol|halobetasol|mesh-list
102090654|NCT03058744|Tazarotene|tazarotene|mesh-list
102090658|NCT03058744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102090659|NCT03058744|Glucocorticoids|glucocorticoids|mesh-ancestor
102090661|NCT03058744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101706543|NCT04131582|Linagliptin|linagliptin|mesh-list
102090662|NCT03058744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090663|NCT02734537|Cisplatin|cisplatin|mesh-list
102090664|NCT02734537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102090665|NCT03059056|Empagliflozin|empagliflozin|mesh-list
102090666|NCT03059056|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102090667|NCT03059056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090668|NCT03059056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102090669|NCT03059056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090670|NCT03058666|Calfactant|calfactant|mesh-list
102090671|NCT03058666|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
102090672|NCT03058666|Respiratory System Agents|respiratory system agents|mesh-ancestor
102090673|NCT02227212|Insulin|insulin|mesh-list
102090674|NCT02227212|Insulin Glargine|insulin glargine|mesh-list
102090675|NCT02227212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102090676|NCT02227212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090677|NCT00303849|Sodium thiosulfate|sodium thiosulfate|mesh-list
102090678|NCT00303849|Carboplatin|carboplatin|mesh-list
102090679|NCT00303849|Etoposide|etoposide|mesh-list
102090680|NCT00303849|Etoposide phosphate|etoposide phosphate|mesh-list
102090681|NCT00303849|Melphalan|melphalan|mesh-list
102090682|NCT00303849|Mechlorethamine|mechlorethamine|mesh-list
102090683|NCT00303849|Podophyllotoxin|podophyllotoxin|mesh-list
102090684|NCT00303849|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102090685|NCT00303849|Mannitol|mannitol|mesh-list
102090686|NCT00303849|Antidotes|antidotes|mesh-list
102090687|NCT00303849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102090688|NCT00303849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102090689|NCT00303849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102090690|NCT00303849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102090691|NCT00303849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102090692|NCT00303849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090693|NCT00303849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102090694|NCT00303849|Alkylating Agents|alkylating agents|mesh-ancestor
102090695|NCT00303849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102090696|NCT00303849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102090697|NCT00303849|Immunologic Factors|immunologic factors|mesh-ancestor
102090698|NCT00303849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090699|NCT00303849|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102090700|NCT00303849|Diuretics|diuretics|mesh-ancestor
102090701|NCT00303849|Natriuretic Agents|natriuretic agents|mesh-ancestor
102090702|NCT00303849|Keratolytic Agents|keratolytic agents|mesh-ancestor
102090703|NCT00303849|Dermatologic Agents|dermatologic agents|mesh-ancestor
102090704|NCT00303849|Tubulin Modulators|tubulin modulators|mesh-ancestor
102090705|NCT00303849|Antimitotic Agents|antimitotic agents|mesh-ancestor
102090706|NCT00303849|Mitosis Modulators|mitosis modulators|mesh-ancestor
102090707|NCT00303849|Protective Agents|protective agents|mesh-ancestor
102090708|NCT00303849|Antioxidants|antioxidants|mesh-ancestor
102090709|NCT00303849|Antitubercular Agents|antitubercular agents|mesh-ancestor
102090710|NCT00303849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102090711|NCT00303849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102090712|NCT00303849|Chelating Agents|chelating agents|mesh-ancestor
102090713|NCT00303849|Sequestering Agents|sequestering agents|mesh-ancestor
102090714|NCT04952272|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
102090715|NCT04952272|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102090716|NCT04952272|Immunologic Factors|immunologic factors|mesh-ancestor
102090717|NCT04952272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090718|NCT01355523|Melatonin|melatonin|mesh-list
102090719|NCT01355523|Antioxidants|antioxidants|mesh-ancestor
102090720|NCT01355523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090721|NCT01355523|Protective Agents|protective agents|mesh-ancestor
102090722|NCT01355523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090723|NCT01355523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102090724|NCT02227914|Sorafenib|sorafenib|mesh-list
102090725|NCT02227914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102090726|NCT02227914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102090727|NCT02227914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102090728|NCT02227914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090737|NCT04161456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102090738|NCT04161456|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102090739|NCT04161456|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102090740|NCT04161456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102090741|NCT04161456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090743|NCT02224014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102090744|NCT02224014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102090745|NCT02224014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090746|NCT03671161|Insulin|insulin|mesh-list
102090747|NCT03671161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102090748|NCT03671161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090749|NCT04950400|Apatinib|apatinib|mesh-list
102090750|NCT04950400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102090751|NCT04950400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102090752|NCT04950400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102090753|NCT04950400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090754|NCT04949932|Turmeric extract|turmeric extract|mesh-list
102090755|NCT04949932|Antioxidants|antioxidants|mesh-ancestor
102090756|NCT04949932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090757|NCT04949932|Protective Agents|protective agents|mesh-ancestor
102090758|NCT04949932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090759|NCT02826603|Ustekinumab|ustekinumab|mesh-list
102090760|NCT02826603|Dermatologic Agents|dermatologic agents|mesh-ancestor
102090761|NCT02224170|Dexamethasone|dexamethasone|mesh-list
102090762|NCT02224170|Lidocaine|lidocaine|mesh-list
102090763|NCT02224170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102090764|NCT02224170|Antiemetics|antiemetics|mesh-ancestor
101944631|NCT03345836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944632|NCT03345836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101944633|NCT03708926|Abaloparatide|abaloparatide|mesh-list
102090765|NCT02224170|Autonomic Agents|autonomic agents|mesh-ancestor
102090766|NCT02224170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102090767|NCT02224170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090768|NCT02224170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102090769|NCT02224170|Glucocorticoids|glucocorticoids|mesh-ancestor
102090770|NCT02224170|Hormones|hormones|mesh-ancestor
102090771|NCT02224170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102090772|NCT02224170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102090773|NCT02224170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102090774|NCT02224170|Anesthetics, Local|anesthetics, local|mesh-ancestor
102090775|NCT02224170|Anesthetics|anesthetics|mesh-ancestor
102090776|NCT02224170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102090777|NCT02224170|Sensory System Agents|sensory system agents|mesh-ancestor
102090778|NCT02224170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102090779|NCT02224170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102090780|NCT02224170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102090781|NCT02224170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102090782|NCT02224170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090792|NCT05956769|Tranexamic Acid|tranexamic acid|mesh-list
102090793|NCT05956769|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102090794|NCT05956769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102090795|NCT05956769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090796|NCT05956769|Hemostatics|hemostatics|mesh-ancestor
102090797|NCT05956769|Coagulants|coagulants|mesh-ancestor
102090798|NCT05956639|Androgen Antagonists|androgen antagonists|mesh-list
102090799|NCT05956639|Hormone Antagonists|hormone antagonists|mesh-ancestor
101392556|NCT04605731|Durvalumab|durvalumab|mesh-list
101392557|NCT04605731|Ipilimumab|ipilimumab|mesh-list
102090805|NCT05956600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102090806|NCT05956600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090808|NCT05956600|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102090809|NCT05956600|Dopamine Agents|dopamine agents|mesh-ancestor
102090810|NCT05956600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102090811|NCT05956600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090812|NCT05956600|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102090813|NCT05956600|Antidepressive Agents|antidepressive agents|mesh-ancestor
102090815|NCT05956561|Vitamins|vitamins|mesh-ancestor
102090816|NCT05956561|Micronutrients|micronutrients|mesh-ancestor
102090817|NCT05956561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090818|NCT05956561|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102090819|NCT05956522|Empagliflozin|empagliflozin|mesh-list
102090820|NCT05956522|Linagliptin|linagliptin|mesh-list
102090821|NCT05956522|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102090822|NCT05956522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090823|NCT05956522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102090824|NCT05956522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090825|NCT05956522|Incretins|incretins|mesh-ancestor
102090826|NCT05956522|Hormones|hormones|mesh-ancestor
102090827|NCT05956522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102090828|NCT05956522|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102090829|NCT05956522|Protease Inhibitors|protease inhibitors|mesh-ancestor
102090830|NCT05956522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102090831|NCT05956509|Botulinum Toxins|botulinum toxins|mesh-list
102090832|NCT05956509|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102090833|NCT05956509|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102090834|NCT05956509|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102090835|NCT05956509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102090836|NCT05956509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090837|NCT05956509|Cholinergic Agents|cholinergic agents|mesh-ancestor
102090838|NCT05956509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102090839|NCT05956509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090840|NCT05956509|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102090841|NCT05956509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102090842|NCT05956431|Simendan|simendan|mesh-list
102090843|NCT05956431|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102090844|NCT05956431|Vasodilator Agents|vasodilator agents|mesh-ancestor
102090845|NCT05956431|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101944634|NCT03708926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101944635|NCT03708926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944636|NCT03567928|Propofol|propofol|mesh-list
102090846|NCT05956431|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102090847|NCT05956431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102090848|NCT05956431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090849|NCT05956431|Protective Agents|protective agents|mesh-ancestor
102090850|NCT05956431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090851|NCT05956418|Citric Acid|citric acid|mesh-list
102090852|NCT05956418|Sodium Citrate|sodium citrate|mesh-list
102090853|NCT05956418|Anticoagulants|anticoagulants|mesh-ancestor
102090854|NCT05956418|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102090855|NCT05956418|Chelating Agents|chelating agents|mesh-ancestor
102090856|NCT05956418|Sequestering Agents|sequestering agents|mesh-ancestor
102090857|NCT05956418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090858|NCT05956275|Tramadol|tramadol|mesh-list
102090859|NCT05956275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102090860|NCT05956275|Narcotics|narcotics|mesh-ancestor
102090861|NCT05956275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102090862|NCT05956275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090863|NCT05956275|Analgesics|analgesics|mesh-ancestor
102090864|NCT05956275|Sensory System Agents|sensory system agents|mesh-ancestor
102090865|NCT05956275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102090866|NCT05956145|Colchicine|colchicine|mesh-list
102090867|NCT05956145|Gout Suppressants|gout suppressants|mesh-ancestor
102090868|NCT05956145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102090875|NCT05956041|Mogamulizumab|mogamulizumab|mesh-list
102090876|NCT05956041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102090877|NCT05956041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102090878|NCT05956041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101810665|NCT00202813|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102090879|NCT05956041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090880|NCT05955924|Niacinamide|niacinamide|mesh-list
102090882|NCT05955924|Nicotinic Acids|nicotinic acids|mesh-list
102090883|NCT05955924|Vitamin B Complex|vitamin b complex|mesh-ancestor
102090884|NCT05955924|Vitamins|vitamins|mesh-ancestor
102090885|NCT05955924|Micronutrients|micronutrients|mesh-ancestor
102090886|NCT05955924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090887|NCT05955924|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102090888|NCT05955924|Antimetabolites|antimetabolites|mesh-ancestor
102090889|NCT05955924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090890|NCT05955924|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102090891|NCT05955924|Vasodilator Agents|vasodilator agents|mesh-ancestor
102090892|NCT05955833|Trastuzumab|trastuzumab|mesh-list
102090893|NCT05955833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102090894|NCT05955833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102090895|NCT05955768|Lidocaine|lidocaine|mesh-list
102090896|NCT05955768|Anesthetics, Local|anesthetics, local|mesh-ancestor
102090897|NCT05955768|Anesthetics|anesthetics|mesh-ancestor
102090898|NCT05955768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102090899|NCT05955768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090900|NCT05955768|Sensory System Agents|sensory system agents|mesh-ancestor
102090901|NCT05955768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102090902|NCT05955768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102090903|NCT05955768|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102090904|NCT05955768|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102090905|NCT05955768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102090906|NCT05955768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090907|NCT05955677|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102090908|NCT05955677|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102090909|NCT05955677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090910|NCT05955313|Naltrexone|naltrexone|mesh-list
102090911|NCT05955313|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102090912|NCT05955313|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102090913|NCT05955313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090914|NCT05955313|Sensory System Agents|sensory system agents|mesh-ancestor
102090915|NCT05955313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102090916|NCT05955209|Disitamab vedotin|disitamab vedotin|mesh-list
102090917|NCT05955209|Immunoconjugates|immunoconjugates|mesh-ancestor
102090918|NCT05955209|Immunologic Factors|immunologic factors|mesh-ancestor
102090919|NCT05955209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090920|NCT05955170|Trastuzumab|trastuzumab|mesh-list
102090921|NCT05955170|Tucatinib|tucatinib|mesh-list
101944637|NCT03567928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101944638|NCT03567928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101664471|NCT02775006|Docetaxel|docetaxel|mesh-list
102090922|NCT05955170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102090923|NCT05955170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102090924|NCT05955170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102090925|NCT05955170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102090926|NCT05955170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090927|NCT05955157|Tegafur|tegafur|mesh-list
102090928|NCT05955157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102090929|NCT05955157|Antimetabolites|antimetabolites|mesh-ancestor
102090930|NCT05955157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090931|NCT05955157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102090932|NCT05952349|Metformin|metformin|mesh-list
102090933|NCT05952349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102090934|NCT05952349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090935|NCT05952310|Immunomodulating Agents|immunomodulating agents|mesh-list
102090936|NCT05952310|Immunologic Factors|immunologic factors|mesh-ancestor
101392703|NCT04528082|Analgesics|analgesics|mesh-ancestor
102090944|NCT05951504|Prednisolone phosphate|prednisolone phosphate|mesh-list
102090945|NCT05951504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102090946|NCT05951504|Antiemetics|antiemetics|mesh-ancestor
102090947|NCT05951504|Autonomic Agents|autonomic agents|mesh-ancestor
102090948|NCT05951504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102090949|NCT05951504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090950|NCT05951504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102090951|NCT05951504|Glucocorticoids|glucocorticoids|mesh-ancestor
102090952|NCT05951504|Hormones|hormones|mesh-ancestor
102090953|NCT05951504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102090955|NCT05951504|Protective Agents|protective agents|mesh-ancestor
102090956|NCT05951504|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102090957|NCT05951504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102090958|NCT05946200|Anesthetics|anesthetics|mesh-list
102090959|NCT05946200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102090960|NCT05946200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090961|NCT05925166|Triamcinolone|triamcinolone|mesh-list
102090962|NCT05925166|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102090963|NCT05925166|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102090964|NCT05925166|Etanercept|etanercept|mesh-list
102090965|NCT05925166|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102090966|NCT05925166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102090967|NCT05925166|Glucocorticoids|glucocorticoids|mesh-ancestor
102090968|NCT05925166|Hormones|hormones|mesh-ancestor
102090969|NCT05925166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102090970|NCT05925166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090971|NCT05925166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102090972|NCT05925166|Immunologic Factors|immunologic factors|mesh-ancestor
102090973|NCT05925166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102090974|NCT05925166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090975|NCT05925166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102090976|NCT05925166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102090977|NCT05925166|Analgesics|analgesics|mesh-ancestor
102090978|NCT05925166|Sensory System Agents|sensory system agents|mesh-ancestor
102090979|NCT05925166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102090980|NCT05925166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102090981|NCT05925166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102090982|NCT05914155|Rituximab|rituximab|mesh-list
102090983|NCT05914155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102090984|NCT05914155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102090985|NCT05914155|Immunologic Factors|immunologic factors|mesh-ancestor
102090986|NCT05914155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090987|NCT05914155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102090988|NCT05896293|Hormones|hormones|mesh-list
102090989|NCT05896293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102090990|NCT05896293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090991|NCT05881928|Lamotrigine|lamotrigine|mesh-list
102090992|NCT05881928|Valproic Acid|valproic acid|mesh-list
102090993|NCT05881928|Anticonvulsants|anticonvulsants|mesh-ancestor
102090994|NCT05881928|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102090995|NCT05881928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102090996|NCT05881928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944639|NCT03567928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944640|NCT03567928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101944641|NCT03567928|Anesthetics, General|anesthetics, general|mesh-ancestor
101944642|NCT03567928|Anesthetics|anesthetics|mesh-ancestor
101944643|NCT03565354|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
101944644|NCT03565354|Hematinics|hematinics|mesh-ancestor
102090997|NCT05881928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102090998|NCT05881928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090999|NCT05881928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102091000|NCT05881928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102091001|NCT05881928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102091002|NCT05881928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102091003|NCT05881928|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102091004|NCT05881928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102091031|NCT05826275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102091032|NCT05826275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102091033|NCT05826275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102091034|NCT05826275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091035|NCT05799079|Decitabine|decitabine|mesh-list
102091036|NCT05799079|Venetoclax|venetoclax|mesh-list
102091037|NCT05799079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102091038|NCT05799079|Antimetabolites|antimetabolites|mesh-ancestor
102091039|NCT05799079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091040|NCT05799079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102091041|NCT05799079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102091042|NCT05774249|Bupivacaine|bupivacaine|mesh-list
102091043|NCT05774249|Anesthetics, Local|anesthetics, local|mesh-ancestor
102091044|NCT05774249|Anesthetics|anesthetics|mesh-ancestor
102091045|NCT05774249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102091046|NCT05774249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091047|NCT05774249|Sensory System Agents|sensory system agents|mesh-ancestor
102091048|NCT05774249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102091049|NCT05773053|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102091050|NCT05773053|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102091051|NCT05773053|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101392837|NCT04434664|Adrenergic Agents|adrenergic agents|mesh-ancestor
102091061|NCT05767398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102091063|NCT05767398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091064|NCT05756166|Interferons|interferons|mesh-list
102091065|NCT05756166|Interferon-alpha|interferon-alpha|mesh-list
102091066|NCT05756166|Interferon alpha-2|interferon alpha-2|mesh-list
102091067|NCT05756166|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
102091068|NCT05756166|Celecoxib|celecoxib|mesh-list
102091069|NCT05756166|Pembrolizumab|pembrolizumab|mesh-list
102091070|NCT05756166|Benzenesulfonamide|benzenesulfonamide|mesh-list
102091071|NCT05756166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102091072|NCT05756166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102091073|NCT05756166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102091074|NCT05756166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091075|NCT05756166|Antiviral Agents|antiviral agents|mesh-ancestor
102091076|NCT05756166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102091077|NCT05756166|Immunologic Factors|immunologic factors|mesh-ancestor
102091078|NCT05756166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091079|NCT05756166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102091080|NCT05756166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102091081|NCT05756166|Analgesics|analgesics|mesh-ancestor
102091082|NCT05756166|Sensory System Agents|sensory system agents|mesh-ancestor
102091083|NCT05756166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102091084|NCT05756166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102091085|NCT05756166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102091086|NCT05756166|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102091087|NCT05756166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102091088|NCT05756166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102091089|NCT05756166|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102091090|NCT05742438|Lidocaine|lidocaine|mesh-list
102091091|NCT05742438|Dexmedetomidine|dexmedetomidine|mesh-list
102091092|NCT05742438|Morphine|morphine|mesh-list
102091093|NCT05742438|Anesthetics, Local|anesthetics, local|mesh-ancestor
102091094|NCT05742438|Anesthetics|anesthetics|mesh-ancestor
102091095|NCT05742438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101944645|NCT03363776|Nivolumab|nivolumab|mesh-list
101944646|NCT03363776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101944647|NCT03363776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102091096|NCT05742438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091097|NCT05742438|Sensory System Agents|sensory system agents|mesh-ancestor
102091098|NCT05742438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102091099|NCT05742438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102091100|NCT05742438|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102091101|NCT05742438|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101706602|NCT03580967|Vortioxetine|vortioxetine|mesh-list
102091102|NCT05742438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102091103|NCT05742438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091104|NCT05742438|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102091105|NCT05742438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102091107|NCT05742438|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102091108|NCT05742438|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102091109|NCT05742438|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102091110|NCT05742438|Adrenergic Agents|adrenergic agents|mesh-ancestor
102091111|NCT05742438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102091112|NCT05742438|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102091113|NCT05742438|Narcotics|narcotics|mesh-ancestor
102091114|NCT05732961|Luspatercept|luspatercept|mesh-list
102091115|NCT05732961|Hematinics|hematinics|mesh-ancestor
102091116|NCT05730751|Anesthetics|anesthetics|mesh-list
102091118|NCT05730751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091120|NCT05685225|Naltrexone|naltrexone|mesh-list
102091121|NCT05685225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102091122|NCT05685225|Analgesics|analgesics|mesh-ancestor
102091123|NCT05685225|Sensory System Agents|sensory system agents|mesh-ancestor
102091124|NCT05685225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102091125|NCT05685225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091126|NCT05685225|Antipyretics|antipyretics|mesh-ancestor
102091127|NCT05685225|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102091128|NCT05685225|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102091129|NCT05670743|Fluorides|fluorides|mesh-list
102091130|NCT05670743|Cariostatic Agents|cariostatic agents|mesh-ancestor
102091131|NCT05670743|Protective Agents|protective agents|mesh-ancestor
102091132|NCT05670743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091133|NCT05662319|Antithrombins|antithrombins|mesh-list
102091134|NCT05662319|Antithrombin III|antithrombin iii|mesh-list
102091135|NCT05662319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102091136|NCT05662319|Protease Inhibitors|protease inhibitors|mesh-ancestor
102091137|NCT05662319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102091138|NCT05662319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091139|NCT05662319|Anticoagulants|anticoagulants|mesh-ancestor
102091140|NCT05656248|Cytarabine|cytarabine|mesh-list
102091141|NCT05656248|Hydrocortisone|hydrocortisone|mesh-list
102091142|NCT05656248|Methotrexate|methotrexate|mesh-list
102091143|NCT05656248|Daunorubicin|daunorubicin|mesh-list
102091144|NCT05656248|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102091145|NCT05656248|Abortifacient Agents|abortifacient agents|mesh-ancestor
102091146|NCT05656248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102091147|NCT05656248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091148|NCT05656248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102091149|NCT05656248|Antimetabolites|antimetabolites|mesh-ancestor
102091150|NCT05656248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091151|NCT05656248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102091152|NCT05656248|Dermatologic Agents|dermatologic agents|mesh-ancestor
102091153|NCT05656248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102091154|NCT05656248|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102091155|NCT05656248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102091156|NCT05656248|Immunologic Factors|immunologic factors|mesh-ancestor
102091157|NCT05656248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102091158|NCT05656248|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102091159|NCT05656248|Antiviral Agents|antiviral agents|mesh-ancestor
102091160|NCT05656248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102091161|NCT05656248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102091162|NCT05656248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102091163|NCT05656248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102091164|NCT05656248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102091165|NCT05650008|Anesthetics|anesthetics|mesh-list
102091166|NCT05650008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102091167|NCT05650008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091168|NCT05634174|Mirabegron|mirabegron|mesh-list
101944648|NCT03363776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101944649|NCT03363776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091169|NCT05634174|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102091170|NCT05634174|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102091171|NCT05634174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102091172|NCT05634174|Adrenergic Agents|adrenergic agents|mesh-ancestor
102091173|NCT05634174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102091174|NCT05634174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091175|NCT05634174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810972|NCT00097981|Hormones|hormones|mesh-ancestor
102091176|NCT05634174|Urological Agents|urological agents|mesh-ancestor
102091177|NCT05619705|Benzocaine|benzocaine|mesh-list
102091178|NCT05619705|Anesthetics, Local|anesthetics, local|mesh-ancestor
102091179|NCT05619705|Anesthetics|anesthetics|mesh-ancestor
102091180|NCT05619705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102091181|NCT05619705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091182|NCT05619705|Sensory System Agents|sensory system agents|mesh-ancestor
102091183|NCT05619705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102091207|NCT05609565|Bupivacaine|bupivacaine|mesh-list
102091208|NCT05609565|Prilocaine|prilocaine|mesh-list
102091209|NCT05609565|Anesthetics|anesthetics|mesh-list
102091210|NCT05609565|Anesthetics, Local|anesthetics, local|mesh-ancestor
102091211|NCT05609565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102091212|NCT05609565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091213|NCT05609565|Sensory System Agents|sensory system agents|mesh-ancestor
102091214|NCT05609565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102091215|NCT05604859|Methylprednisolone|methylprednisolone|mesh-list
102091216|NCT05604859|Heparin|heparin|mesh-list
102091217|NCT05604859|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102091218|NCT05604859|Tinzaparin|tinzaparin|mesh-list
102091219|NCT05604859|Dalteparin|dalteparin|mesh-list
102091220|NCT05604859|Immunoglobulins|immunoglobulins|mesh-list
102091221|NCT05604859|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102091222|NCT05604859|gamma-Globulins|gamma-globulins|mesh-list
102091223|NCT05604859|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102091224|NCT05604859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102091225|NCT05604859|Antiemetics|antiemetics|mesh-ancestor
102091226|NCT05604859|Autonomic Agents|autonomic agents|mesh-ancestor
102091227|NCT05604859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102091228|NCT05604859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091229|NCT05604859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102091230|NCT05604859|Glucocorticoids|glucocorticoids|mesh-ancestor
102091231|NCT05604859|Hormones|hormones|mesh-ancestor
102091232|NCT05604859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102091233|NCT05604859|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102091234|NCT05604859|Protective Agents|protective agents|mesh-ancestor
102091235|NCT05604859|Anticoagulants|anticoagulants|mesh-ancestor
102091236|NCT05604859|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102091237|NCT05604859|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102091238|NCT05604859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091239|NCT05604859|Immunologic Factors|immunologic factors|mesh-ancestor
102091240|NCT05593328|Bevacizumab|bevacizumab|mesh-list
102091241|NCT05593328|Onvansertib|onvansertib|mesh-list
102091242|NCT05593328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102091243|NCT05593328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102091244|NCT05593328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102091245|NCT05593328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102091246|NCT05593328|Growth Substances|growth substances|mesh-ancestor
102091247|NCT05593328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091248|NCT05593328|Growth Inhibitors|growth inhibitors|mesh-ancestor
102091249|NCT05593328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101944650|NCT03565276|Tranexamic Acid|tranexamic acid|mesh-list
101944651|NCT03565276|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102091250|NCT05593328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102091251|NCT05593328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091252|NCT05590585|Emollients|emollients|mesh-list
102091253|NCT05590585|Dermatologic Agents|dermatologic agents|mesh-ancestor
102091254|NCT05590234|Dexmedetomidine|dexmedetomidine|mesh-list
102091255|NCT05590234|Bupivacaine|bupivacaine|mesh-list
102091256|NCT05590234|Anesthetics, Local|anesthetics, local|mesh-ancestor
102091257|NCT05590234|Anesthetics|anesthetics|mesh-ancestor
102091258|NCT05590234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102091259|NCT05590234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091269|NCT05590234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102091270|NCT05590234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091272|NCT05572749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102091273|NCT05572749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091274|NCT05540223|Sirolimus|sirolimus|mesh-list
102091275|NCT05540223|Everolimus|everolimus|mesh-list
102091276|NCT05540223|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102091277|NCT05540223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102091278|NCT05540223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102091279|NCT05540223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091280|NCT05540223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102091281|NCT05540223|Immunologic Factors|immunologic factors|mesh-ancestor
102091282|NCT05540223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091283|NCT05540223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102091284|NCT05540223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102091285|NCT05540223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102091286|NCT05540223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102091287|NCT05540223|Antifungal Agents|antifungal agents|mesh-ancestor
102091288|NCT05539027|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102091289|NCT05539027|N-Methylaspartate|n-methylaspartate|mesh-list
102091290|NCT05539027|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
102091291|NCT05539027|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102091292|NCT05539027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102091293|NCT05539027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091294|NCT05539027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091295|NCT05476172|Dienogest|dienogest|mesh-list
102091296|NCT05476172|Norethindrone|norethindrone|mesh-list
102091297|NCT05476172|Norethindrone Acetate|norethindrone acetate|mesh-list
102091298|NCT05476172|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102091299|NCT05476172|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102091300|NCT05476172|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102091301|NCT05476172|Contraceptive Agents|contraceptive agents|mesh-ancestor
102091302|NCT05476172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102091303|NCT05476172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091304|NCT05476172|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102091305|NCT05476172|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102091306|NCT05476172|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102091307|NCT05476172|Hormone Antagonists|hormone antagonists|mesh-ancestor
102091308|NCT05476172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102091309|NCT05476172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102091310|NCT05476172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102091311|NCT05432518|Everolimus|everolimus|mesh-list
102091312|NCT05432518|Dasatinib|dasatinib|mesh-list
102091313|NCT05432518|Olaparib|olaparib|mesh-list
102091314|NCT05432518|Palbociclib|palbociclib|mesh-list
102091315|NCT05432518|Afatinib|afatinib|mesh-list
102091316|NCT05432518|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102091317|NCT05432518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102091318|NCT05432518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102091319|NCT05432518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091320|NCT05432518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102091321|NCT05432518|Immunologic Factors|immunologic factors|mesh-ancestor
102091322|NCT05432518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091323|NCT05432518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393090|NCT04224493|Lenalidomide|lenalidomide|mesh-list
102091324|NCT05432518|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102091326|NCT05413096|Diclofenac|diclofenac|mesh-list
101706633|NCT00851799|Antiviral Agents|antiviral agents|mesh-ancestor
102091327|NCT05413096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102091328|NCT05413096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101811130|NCT00751127|Timolol|timolol|mesh-list
102091329|NCT05413096|Analgesics|analgesics|mesh-ancestor
101944652|NCT03565276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101944653|NCT03565276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944654|NCT03565276|Hemostatics|hemostatics|mesh-ancestor
102091330|NCT05413096|Sensory System Agents|sensory system agents|mesh-ancestor
102091331|NCT05413096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102091332|NCT05413096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091333|NCT05413096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102091334|NCT05413096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102091335|NCT05413096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102091336|NCT05413096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102091337|NCT05413096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091338|NCT05413096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102091339|NCT05393037|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102091340|NCT05393037|Immunologic Factors|immunologic factors|mesh-ancestor
102091341|NCT05393037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091342|NCT05391061|Abrocitinib|abrocitinib|mesh-list
102091343|NCT05391061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102091344|NCT05391061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102091345|NCT05391061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091346|NCT05388006|Durvalumab|durvalumab|mesh-list
102091347|NCT05388006|Venetoclax|venetoclax|mesh-list
102091348|NCT05388006|Acalabrutinib|acalabrutinib|mesh-list
102091349|NCT05388006|Immunoglobulins|immunoglobulins|mesh-list
102091350|NCT05388006|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102091351|NCT05388006|Immunoglobulin G|immunoglobulin g|mesh-list
102091352|NCT05388006|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102091353|NCT05388006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102091354|NCT05388006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102091355|NCT05388006|Immunologic Factors|immunologic factors|mesh-ancestor
102091356|NCT05388006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091357|NCT05388006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102091358|NCT05388006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102091359|NCT05388006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091360|NCT05375994|Adagrasib|adagrasib|mesh-list
102091361|NCT05375994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102091362|NCT05338320|Fentanyl|fentanyl|mesh-list
102091363|NCT05338320|Morphine|morphine|mesh-list
102091364|NCT05338320|Anesthetics|anesthetics|mesh-ancestor
102091365|NCT05338320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102091366|NCT05338320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091367|NCT05338320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102091368|NCT05338320|Narcotics|narcotics|mesh-ancestor
102091369|NCT05338320|Analgesics|analgesics|mesh-ancestor
102091370|NCT05338320|Sensory System Agents|sensory system agents|mesh-ancestor
102091371|NCT05338320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102091372|NCT05338320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102091373|NCT05338320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102091374|NCT05338320|Anesthetics, General|anesthetics, general|mesh-ancestor
102091375|NCT05337540|Hylan|hylan|mesh-list
102091376|NCT05337540|Viscosupplements|viscosupplements|mesh-ancestor
102091377|NCT05337540|Protective Agents|protective agents|mesh-ancestor
102091378|NCT05337540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091379|NCT05316129|Hormones|hormones|mesh-list
102091380|NCT05316129|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102091381|NCT05316129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102091382|NCT05316129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091383|NCT05303532|Durvalumab|durvalumab|mesh-list
102091384|NCT05303532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102091385|NCT05303532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102091396|NCT05279937|Lidocaine|lidocaine|mesh-list
102091397|NCT05279937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102091398|NCT05279937|Anesthetics, Local|anesthetics, local|mesh-ancestor
101780959|NCT00635154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102091405|NCT05279937|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102091406|NCT05279937|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102091407|NCT05279937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102091408|NCT05279937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091409|NCT05260073|Tirbanibulin|tirbanibulin|mesh-list
102091410|NCT05260073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102091411|NCT05260073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091412|NCT05249959|Cytarabine|cytarabine|mesh-list
102091413|NCT05249959|Rituximab|rituximab|mesh-list
102091414|NCT05249959|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
102091415|NCT05249959|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102091416|NCT05249959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102091417|NCT05249959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102091418|NCT05249959|Immunologic Factors|immunologic factors|mesh-ancestor
102091419|NCT05249959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091420|NCT05249959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102091421|NCT05249959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102091422|NCT05249959|Antimetabolites|antimetabolites|mesh-ancestor
102091423|NCT05249959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091424|NCT05249959|Antiviral Agents|antiviral agents|mesh-ancestor
102091425|NCT05249959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102091426|NCT05249959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102091427|NCT05249959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102091428|NCT05249959|Alkylating Agents|alkylating agents|mesh-ancestor
102091429|NCT05242874|Dexamethasone|dexamethasone|mesh-list
102091430|NCT05242874|Dexamethasone acetate|dexamethasone acetate|mesh-list
102091431|NCT05242874|Olanzapine|olanzapine|mesh-list
102091432|NCT05242874|Fosaprepitant|fosaprepitant|mesh-list
102091433|NCT05242874|Aprepitant|aprepitant|mesh-list
102091434|NCT05242874|Antiemetics|antiemetics|mesh-list
102091435|NCT05242874|Tropisetron|tropisetron|mesh-list
102091436|NCT05242874|BB 1101|bb 1101|mesh-list
102091437|NCT05242874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102091438|NCT05242874|Autonomic Agents|autonomic agents|mesh-ancestor
102091439|NCT05242874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102091440|NCT05242874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091441|NCT05242874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102091442|NCT05242874|Glucocorticoids|glucocorticoids|mesh-ancestor
102091443|NCT05242874|Hormones|hormones|mesh-ancestor
102091444|NCT05242874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102091445|NCT05242874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102091446|NCT05242874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102091447|NCT05242874|Protease Inhibitors|protease inhibitors|mesh-ancestor
102091448|NCT05242874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102091449|NCT05242874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091450|NCT05242874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102091451|NCT05242874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102091452|NCT05242874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102091453|NCT05242874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102091454|NCT05242874|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102091455|NCT05242874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102091456|NCT05242874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102091457|NCT05242874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102091458|NCT05242874|Serotonin Agents|serotonin agents|mesh-ancestor
102091459|NCT05242874|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102091460|NCT05242874|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102091461|NCT05242874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102091462|NCT05227001|Camphor|camphor|mesh-list
102091463|NCT05227001|Menthol|menthol|mesh-list
102091464|NCT05227001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102091465|NCT05227001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102091466|NCT05227001|Antipruritics|antipruritics|mesh-ancestor
102091474|NCT05226871|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102091475|NCT05226871|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102091476|NCT05226871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101706652|NCT00520975|Trastuzumab|trastuzumab|mesh-list
102091477|NCT05226871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091478|NCT05226871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101811271|NCT00490815|Hormones|hormones|mesh-ancestor
102091479|NCT05226871|Hormone Antagonists|hormone antagonists|mesh-ancestor
102091480|NCT05226871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102091481|NCT05226871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944656|NCT03564964|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1h-indole dimesylate monohydrate|mesh-list
101944657|NCT03564964|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101944658|NCT03564964|Serotonin Agents|serotonin agents|mesh-ancestor
101944659|NCT03564964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101944660|NCT03564964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944661|NCT03564964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944662|NCT03708848|Metronidazole|metronidazole|mesh-list
101944663|NCT03708848|Clarithromycin|clarithromycin|mesh-list
101944664|NCT03708848|Levofloxacin|levofloxacin|mesh-list
101944665|NCT03708848|Tetracycline|tetracycline|mesh-list
101944666|NCT03708848|Potassium Citrate|potassium citrate|mesh-list
101944667|NCT03708848|Esomeprazole|esomeprazole|mesh-list
101944668|NCT03708848|Bismuth|bismuth|mesh-list
101944669|NCT03708848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944670|NCT03708848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101944671|NCT03708848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101944672|NCT03708848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101944673|NCT03708848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101944674|NCT03708848|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101944675|NCT03708848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102091482|NCT05226871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102091483|NCT05226871|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102091484|NCT05226871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102091485|NCT05218733|Fentanyl|fentanyl|mesh-list
102091486|NCT05218733|Morphine|morphine|mesh-list
102091487|NCT05218733|Anesthetics|anesthetics|mesh-ancestor
102091488|NCT05218733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102091489|NCT05218733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091490|NCT05218733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102091491|NCT05218733|Narcotics|narcotics|mesh-ancestor
102091492|NCT05218733|Analgesics|analgesics|mesh-ancestor
102091493|NCT05218733|Sensory System Agents|sensory system agents|mesh-ancestor
102091494|NCT05218733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102091495|NCT05218733|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102091496|NCT05218733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102091497|NCT05218733|Anesthetics, General|anesthetics, general|mesh-ancestor
102091499|NCT05214287|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102091500|NCT05214287|Protective Agents|protective agents|mesh-ancestor
102091501|NCT05214287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091502|NCT05182931|Trametinib|trametinib|mesh-list
102091503|NCT05182931|Dabrafenib|dabrafenib|mesh-list
102091504|NCT05182931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102091505|NCT05182931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102091506|NCT05182931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102091507|NCT05182931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091508|NCT05154370|Immunoglobulins|immunoglobulins|mesh-list
102091509|NCT05154370|Immunologic Factors|immunologic factors|mesh-ancestor
102091510|NCT05154370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091511|NCT05128734|Temozolomide|temozolomide|mesh-list
102091512|NCT05128734|Olaparib|olaparib|mesh-list
102091513|NCT05128734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102091514|NCT05128734|Alkylating Agents|alkylating agents|mesh-ancestor
102091515|NCT05128734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091516|NCT05128734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101944676|NCT03708848|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101944677|NCT03708848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102091517|NCT05128734|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102091518|NCT05128734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102091520|NCT05126836|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102091521|NCT05126836|Autonomic Agents|autonomic agents|mesh-ancestor
102091522|NCT05126836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102091523|NCT05126836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091524|NCT05126836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102091525|NCT05126836|Respiratory System Agents|respiratory system agents|mesh-ancestor
102091526|NCT05126836|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102091527|NCT05126836|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102091528|NCT05126836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091529|NCT05126836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102091530|NCT05126836|Vasodilator Agents|vasodilator agents|mesh-ancestor
102091531|NCT05126836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102091532|NCT05126836|Protective Agents|protective agents|mesh-ancestor
102091533|NCT05126836|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102091534|NCT05126836|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102091535|NCT05126836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102091553|NCT05108688|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102091554|NCT05108688|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102091555|NCT05108688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102091557|NCT05108688|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102091558|NCT05108688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102091559|NCT05108688|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102091574|NCT05085002|Letrozole|letrozole|mesh-list
102091575|NCT05085002|Fulvestrant|fulvestrant|mesh-list
102091576|NCT05085002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102091577|NCT05085002|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102091578|NCT05085002|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102091579|NCT05085002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102091580|NCT05085002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091581|NCT05085002|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102091582|NCT05085002|Hormone Antagonists|hormone antagonists|mesh-ancestor
102091583|NCT05085002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102091584|NCT05085002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091585|NCT05085002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102091586|NCT05085002|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102091587|NCT05076617|Alprazolam|alprazolam|mesh-list
102091588|NCT05076617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102091589|NCT05076617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102091590|NCT05076617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091594|NCT05076617|GABA Modulators|gaba modulators|mesh-ancestor
102091595|NCT05076617|GABA Agents|gaba agents|mesh-ancestor
102091596|NCT05076617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102091597|NCT05076617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091598|NCT05050357|Norethindrone|norethindrone|mesh-list
102091599|NCT05050357|Norethindrone Acetate|norethindrone acetate|mesh-list
102091600|NCT05050357|Progestins|progestins|mesh-list
102091601|NCT05050357|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102091602|NCT05050357|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102091603|NCT05050357|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102091604|NCT05050357|Contraceptive Agents|contraceptive agents|mesh-ancestor
102091605|NCT05050357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102091606|NCT05050357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944678|NCT03708848|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101944679|NCT03708848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102091607|NCT05050357|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102091608|NCT05050357|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102091609|NCT05050357|Hormones|hormones|mesh-ancestor
102091610|NCT05050357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102091611|NCT05017571|Colchicine|colchicine|mesh-list
102091612|NCT05017571|Gout Suppressants|gout suppressants|mesh-ancestor
102091613|NCT05017571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102091614|NCT05017571|Tubulin Modulators|tubulin modulators|mesh-ancestor
102091615|NCT05017571|Antimitotic Agents|antimitotic agents|mesh-ancestor
102091616|NCT05017571|Mitosis Modulators|mitosis modulators|mesh-ancestor
102091617|NCT05017571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091618|NCT05017571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102091619|NCT05008809|Leucovorin|leucovorin|mesh-list
102091620|NCT05008809|Fluorouracil|fluorouracil|mesh-list
102091621|NCT05008809|Oxaliplatin|oxaliplatin|mesh-list
102091622|NCT05008809|Irinotecan|irinotecan|mesh-list
102091623|NCT05008809|Levoleucovorin|levoleucovorin|mesh-list
102091624|NCT05008809|Antimetabolites|antimetabolites|mesh-ancestor
102091625|NCT05008809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091626|NCT05008809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102091627|NCT05008809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102091628|NCT05008809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102091629|NCT05008809|Immunologic Factors|immunologic factors|mesh-ancestor
102091630|NCT05008809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091631|NCT05008809|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102091632|NCT05008809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102091633|NCT05008809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102091634|NCT05008809|Antidotes|antidotes|mesh-ancestor
102091635|NCT05008809|Protective Agents|protective agents|mesh-ancestor
102091636|NCT05008809|Vitamin B Complex|vitamin b complex|mesh-ancestor
102091638|NCT05008809|Micronutrients|micronutrients|mesh-ancestor
102091639|NCT04975334|Naloxone|naloxone|mesh-list
102091640|NCT04975334|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
102091641|NCT04975334|Hormones|hormones|mesh-ancestor
102091642|NCT04975334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102091643|NCT04975334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091644|NCT04975334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102091645|NCT04975334|Sensory System Agents|sensory system agents|mesh-ancestor
102091646|NCT04975334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102091647|NCT04964843|Acetylcysteine|acetylcysteine|mesh-list
102091648|NCT04964843|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102091649|NCT04964843|Antiviral Agents|antiviral agents|mesh-ancestor
102091650|NCT04964843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102091651|NCT04964843|Expectorants|expectorants|mesh-ancestor
102091652|NCT04964843|Respiratory System Agents|respiratory system agents|mesh-ancestor
102091653|NCT04964843|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102091654|NCT04964843|Antioxidants|antioxidants|mesh-ancestor
102091655|NCT04964843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091656|NCT04964843|Protective Agents|protective agents|mesh-ancestor
102091657|NCT04964843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091658|NCT04964843|Antidotes|antidotes|mesh-ancestor
102091659|NCT04946825|Nicotine|nicotine|mesh-list
102091660|NCT04946825|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102091661|NCT04946825|Autonomic Agents|autonomic agents|mesh-ancestor
102091662|NCT04946825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102091663|NCT04946825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091664|NCT04946825|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102091665|NCT04946825|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102091668|NCT04946825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091670|NCT04908579|Bupivacaine|bupivacaine|mesh-list
102091671|NCT04908579|Anesthetics, Local|anesthetics, local|mesh-ancestor
102091672|NCT04908579|Anesthetics|anesthetics|mesh-ancestor
102091673|NCT04908579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102091674|NCT04908579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091675|NCT04908579|Sensory System Agents|sensory system agents|mesh-ancestor
102091676|NCT04908579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102091677|NCT04908579|Analgesics|analgesics|mesh-ancestor
102091678|NCT04908579|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102091679|NCT04908579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102091680|NCT04908579|Anesthetics, General|anesthetics, general|mesh-ancestor
102091681|NCT04908579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101944680|NCT03708848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101706678|NCT00614159|Sensory System Agents|sensory system agents|mesh-ancestor
102091682|NCT04908579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102091683|NCT04908579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102091684|NCT04908579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091685|NCT04898387|Timolol|timolol|mesh-list
102091686|NCT04898387|Bimatoprost|bimatoprost|mesh-list
102091687|NCT04898387|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102091688|NCT04898387|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102091689|NCT04898387|Adrenergic Agents|adrenergic agents|mesh-ancestor
102091690|NCT04898387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102091691|NCT04898387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091692|NCT04898387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091693|NCT04898387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102091694|NCT04898387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102091695|NCT04860960|Betadex|betadex|mesh-list
102091696|NCT04860960|Sequestering Agents|sequestering agents|mesh-ancestor
102091697|NCT04860960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091698|NCT04848753|Paclitaxel|paclitaxel|mesh-list
102091699|NCT04848753|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102091700|NCT04848753|Cisplatin|cisplatin|mesh-list
101811491|NCT00482391|Paclitaxel|paclitaxel|mesh-list
102091701|NCT04848753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102091702|NCT04848753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102091703|NCT04848753|Tubulin Modulators|tubulin modulators|mesh-ancestor
102091704|NCT04848753|Antimitotic Agents|antimitotic agents|mesh-ancestor
102091705|NCT04848753|Mitosis Modulators|mitosis modulators|mesh-ancestor
102091706|NCT04848753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091707|NCT04823247|Interleukin-23|interleukin-23|mesh-list
102091708|NCT04823247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102091709|NCT04823247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102091710|NCT04823247|Growth Substances|growth substances|mesh-ancestor
102091711|NCT04823247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091712|NCT04823247|Growth Inhibitors|growth inhibitors|mesh-ancestor
102091713|NCT04823247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102091714|NCT04800822|Cetuximab|cetuximab|mesh-list
102091715|NCT04800822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102091716|NCT04800822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102091717|NCT04777994|Mitogens|mitogens|mesh-list
102091718|NCT04777994|Endothelial Growth Factors|endothelial growth factors|mesh-list
102091719|NCT04777994|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102091720|NCT04777994|Mitosis Modulators|mitosis modulators|mesh-ancestor
102091721|NCT04777994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091722|NCT04777994|Growth Substances|growth substances|mesh-ancestor
102091723|NCT04777994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091724|NCT04777994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102091725|NCT04777994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102091726|NCT04772222|Dexmedetomidine|dexmedetomidine|mesh-list
102091727|NCT04772222|Morphine|morphine|mesh-list
102091728|NCT04772222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102091729|NCT04772222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102091730|NCT04772222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091731|NCT04772222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102091732|NCT04772222|Analgesics|analgesics|mesh-ancestor
102091733|NCT04772222|Sensory System Agents|sensory system agents|mesh-ancestor
102091734|NCT04772222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102091735|NCT04772222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102091736|NCT04772222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102091768|NCT04677049|Antimetabolites|antimetabolites|mesh-ancestor
102091769|NCT04677049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091770|NCT04677049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102091771|NCT04677049|Vasodilator Agents|vasodilator agents|mesh-ancestor
102091772|NCT04648969|Hormones|hormones|mesh-list
102091773|NCT04648969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102091774|NCT04648969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091775|NCT04626141|Abaloparatide|abaloparatide|mesh-list
102091776|NCT04626141|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101706696|NCT04071119|Oxytocin|oxytocin|mesh-list
102091777|NCT04626141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091778|NCT04562129|Aldesleukin|aldesleukin|mesh-list
102091779|NCT04562129|Nivolumab|nivolumab|mesh-list
102091780|NCT04562129|Ipilimumab|ipilimumab|mesh-list
102091781|NCT04562129|Interleukin-2|interleukin-2|mesh-list
102091782|NCT04562129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102091783|NCT04562129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101944681|NCT03708848|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101944682|NCT03708848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101944683|NCT03708848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102091789|NCT04562129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102091790|NCT04562129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091791|NCT04562129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102091792|NCT04562129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102091793|NCT04562129|Antiviral Agents|antiviral agents|mesh-ancestor
102091794|NCT04562129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102091795|NCT04545866|Budesonide|budesonide|mesh-list
102091796|NCT04545866|Poractant alfa|poractant alfa|mesh-list
102091797|NCT04545866|Pulmonary Surfactants|pulmonary surfactants|mesh-list
102091798|NCT04545866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102091799|NCT04545866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102091800|NCT04545866|Autonomic Agents|autonomic agents|mesh-ancestor
102091801|NCT04545866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102091802|NCT04545866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091803|NCT04545866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102091804|NCT04545866|Respiratory System Agents|respiratory system agents|mesh-ancestor
102091805|NCT04545866|Glucocorticoids|glucocorticoids|mesh-ancestor
102091806|NCT04545866|Hormones|hormones|mesh-ancestor
102091807|NCT04545866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102091808|NCT04524000|Fulvestrant|fulvestrant|mesh-list
102091809|NCT04524000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102091810|NCT04524000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102091811|NCT04524000|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102091812|NCT04524000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102091813|NCT04524000|Hormone Antagonists|hormone antagonists|mesh-ancestor
102091814|NCT04524000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102091815|NCT04524000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091816|NCT04502849|Vitamin E|vitamin e|mesh-list
102091817|NCT04502849|Tocopherols|tocopherols|mesh-list
102091818|NCT04502849|alpha-Tocopherol|alpha-tocopherol|mesh-list
102091819|NCT04502849|Vitamins|vitamins|mesh-ancestor
102091820|NCT04502849|Micronutrients|micronutrients|mesh-ancestor
102091821|NCT04502849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091822|NCT04502849|Antioxidants|antioxidants|mesh-ancestor
102091823|NCT04502849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091824|NCT04502849|Protective Agents|protective agents|mesh-ancestor
102091825|NCT04417465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102091826|NCT04417465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091827|NCT04417465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102091828|NCT04417465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102091829|NCT04407442|Dexamethasone|dexamethasone|mesh-list
102091830|NCT04407442|Dexamethasone acetate|dexamethasone acetate|mesh-list
102091831|NCT04407442|Azacitidine|azacitidine|mesh-list
102091832|NCT04407442|Daratumumab|daratumumab|mesh-list
102091833|NCT04407442|Ichthammol|ichthammol|mesh-list
102091834|NCT04407442|BB 1101|bb 1101|mesh-list
102091835|NCT04407442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102091836|NCT04407442|Antiemetics|antiemetics|mesh-ancestor
102091837|NCT04407442|Autonomic Agents|autonomic agents|mesh-ancestor
102091838|NCT04407442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101706700|NCT02634476|Ethanol|ethanol|mesh-list
102091839|NCT04407442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091840|NCT04407442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102091841|NCT04407442|Glucocorticoids|glucocorticoids|mesh-ancestor
102091842|NCT04407442|Hormones|hormones|mesh-ancestor
102091843|NCT04407442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102091844|NCT04407442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102091845|NCT04407442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102091846|NCT04407442|Protease Inhibitors|protease inhibitors|mesh-ancestor
102091847|NCT04407442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102091848|NCT04407442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091849|NCT04407442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102091850|NCT04407442|Antimetabolites|antimetabolites|mesh-ancestor
102091851|NCT04407442|Dermatologic Agents|dermatologic agents|mesh-ancestor
102091852|NCT04348448|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102091853|NCT04348448|Immunologic Factors|immunologic factors|mesh-ancestor
102091856|NCT04345796|Carvedilol|carvedilol|mesh-list
102091857|NCT04345796|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101944684|NCT03708848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101944685|NCT03708848|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101944686|NCT03708848|Antacids|antacids|mesh-ancestor
101944687|NCT03708848|Diuretics|diuretics|mesh-ancestor
101944688|NCT03708848|Natriuretic Agents|natriuretic agents|mesh-ancestor
101944689|NCT03708848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944690|NCT03708848|Expectorants|expectorants|mesh-ancestor
102091858|NCT04345796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091859|NCT04345796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102091860|NCT04345796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091861|NCT04345796|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102091862|NCT04345796|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102091863|NCT04345796|Adrenergic Agents|adrenergic agents|mesh-ancestor
102091864|NCT04345796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102091865|NCT04345796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102091866|NCT04345796|Antioxidants|antioxidants|mesh-ancestor
102091867|NCT04345796|Protective Agents|protective agents|mesh-ancestor
102091868|NCT04345796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102091869|NCT04345796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102091870|NCT04345796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102091871|NCT04345796|Vasodilator Agents|vasodilator agents|mesh-ancestor
102091872|NCT04345796|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102091873|NCT04345796|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102091874|NCT04265612|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102091875|NCT04265612|Laxatives|laxatives|mesh-ancestor
102091876|NCT04265612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102091877|NCT04222088|Chloroquine|chloroquine|mesh-list
102091878|NCT04222088|Lumefantrine|lumefantrine|mesh-list
102091879|NCT04222088|Primaquine|primaquine|mesh-list
102091880|NCT04222088|Amebicides|amebicides|mesh-ancestor
102091881|NCT04222088|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102091882|NCT04222088|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102091883|NCT04222088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102091884|NCT04222088|Antimalarials|antimalarials|mesh-ancestor
102091885|NCT04222088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102091886|NCT04217694|Memantine|memantine|mesh-list
102091887|NCT04217694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102091888|NCT04217694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102091889|NCT04217694|Dopamine Agents|dopamine agents|mesh-ancestor
102091890|NCT04217694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102091891|NCT04217694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091892|NCT04217694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091893|NCT04217694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102091894|NCT04217694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102091895|NCT04198506|Tacrolimus|tacrolimus|mesh-list
102091896|NCT04198506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102091897|NCT04198506|Immunologic Factors|immunologic factors|mesh-ancestor
102091898|NCT04198506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091899|NCT04198506|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102091900|NCT04198506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102091901|NCT04198506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091902|NCT04192981|GDC-0084|gdc-0084|mesh-list
101706715|NCT00740194|Estradiol|estradiol|mesh-list
102091903|NCT04192981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102091904|NCT04192981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944698|NCT03564574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101944699|NCT03710330|Tranexamic Acid|tranexamic acid|mesh-list
101944700|NCT03710330|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101944701|NCT03710330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101944702|NCT03710330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944703|NCT03710330|Hemostatics|hemostatics|mesh-ancestor
101781449|NCT00820404|BLI-489|bli-489|mesh-list
102091920|NCT04026113|Linaclotide|linaclotide|mesh-list
102091921|NCT04026113|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102091922|NCT04026113|Enzyme Activators|enzyme activators|mesh-ancestor
102091923|NCT04026113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091924|NCT04026113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102091925|NCT04021043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102091928|NCT04021043|Antibodies|antibodies|mesh-list
102091929|NCT04021043|Immunoglobulins|immunoglobulins|mesh-list
102091930|NCT04021043|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102091931|NCT04021043|Immunologic Factors|immunologic factors|mesh-ancestor
102091932|NCT04021043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091933|NCT04021043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102091934|NCT04021043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102091935|NCT04021043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091943|NCT03981614|Trifluridine|trifluridine|mesh-list
102091944|NCT03981614|Palbociclib|palbociclib|mesh-list
102091945|NCT03981614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102091946|NCT03981614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102091947|NCT03981614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102091948|NCT03981614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091949|NCT03981614|Antimetabolites|antimetabolites|mesh-ancestor
102091950|NCT03981614|Antiviral Agents|antiviral agents|mesh-ancestor
102091951|NCT03981614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102091952|NCT03978520|Upadacitinib|upadacitinib|mesh-list
102091953|NCT03978520|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102091954|NCT03978520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102091955|NCT03978520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102091956|NCT03978520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091957|NCT03978520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102091958|NCT03941743|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102091959|NCT03941743|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102091960|NCT03941743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091961|NCT03941743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102091962|NCT03941743|Immunologic Factors|immunologic factors|mesh-ancestor
102091963|NCT03941743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091964|NCT03896685|Linezolid|linezolid|mesh-list
102091965|NCT03896685|Bedaquiline|bedaquiline|mesh-list
102091966|NCT03896685|Clofazimine|clofazimine|mesh-list
102091967|NCT03896685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101944704|NCT03710330|Coagulants|coagulants|mesh-ancestor
101944705|NCT03710252|Ritonavir|ritonavir|mesh-list
101944706|NCT03710252|Ribavirin|ribavirin|mesh-list
101944707|NCT03710252|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102091968|NCT03896685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102091969|NCT03896685|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102091970|NCT03896685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102091971|NCT03896685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091972|NCT03896685|Antitubercular Agents|antitubercular agents|mesh-ancestor
102091973|NCT03896685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102091974|NCT03896685|Leprostatic Agents|leprostatic agents|mesh-ancestor
102091975|NCT03874715|Insulin|insulin|mesh-list
102091976|NCT03874715|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102091977|NCT03874715|Insulin Glargine|insulin glargine|mesh-list
102091978|NCT03874715|Insulin Aspart|insulin aspart|mesh-list
102091979|NCT03874715|Insulin, Long-Acting|insulin, long-acting|mesh-list
102091980|NCT03874715|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102091981|NCT03874715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102091982|NCT03874715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091983|NCT03869996|Cytarabine|cytarabine|mesh-list
102091984|NCT03869996|Methotrexate|methotrexate|mesh-list
102091985|NCT03869996|Etoposide|etoposide|mesh-list
102091986|NCT03869996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102091987|NCT03869996|Antimetabolites|antimetabolites|mesh-ancestor
102091988|NCT03869996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091989|NCT03869996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102091990|NCT03869996|Antiviral Agents|antiviral agents|mesh-ancestor
102091991|NCT03869996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102091992|NCT03869996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102091993|NCT03869996|Immunologic Factors|immunologic factors|mesh-ancestor
102091994|NCT03869996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091995|NCT03869996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102091996|NCT03869996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102091997|NCT03869996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102091998|NCT03869996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102091999|NCT03869996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102092004|NCT03869996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102092005|NCT03869996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102092006|NCT03801863|Ropivacaine|ropivacaine|mesh-list
102092007|NCT03801863|Anesthetics, Local|anesthetics, local|mesh-ancestor
102092008|NCT03801863|Anesthetics|anesthetics|mesh-ancestor
102092009|NCT03801863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102092010|NCT03801863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092011|NCT03801863|Sensory System Agents|sensory system agents|mesh-ancestor
102092012|NCT03801863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102092013|NCT03692065|Apixaban|apixaban|mesh-list
102092014|NCT03692065|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102092015|NCT03692065|Antithrombins|antithrombins|mesh-ancestor
102092016|NCT03692065|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102092017|NCT03692065|Protease Inhibitors|protease inhibitors|mesh-ancestor
102092018|NCT03692065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102092019|NCT03692065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092020|NCT03692065|Anticoagulants|anticoagulants|mesh-ancestor
102092021|NCT03664037|Dexamethasone|dexamethasone|mesh-list
102092022|NCT03664037|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102092023|NCT03664037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102092024|NCT03664037|Antiemetics|antiemetics|mesh-ancestor
102092025|NCT03664037|Autonomic Agents|autonomic agents|mesh-ancestor
102092026|NCT03664037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102092027|NCT03664037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092028|NCT03664037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102092029|NCT03664037|Glucocorticoids|glucocorticoids|mesh-ancestor
102092030|NCT03664037|Hormones|hormones|mesh-ancestor
102092031|NCT03664037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102092032|NCT03664037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102092033|NCT03664037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092034|NCT03593473|Oxytocin|oxytocin|mesh-list
102092035|NCT03593473|Oxytocics|oxytocics|mesh-ancestor
102092036|NCT03593473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102092037|NCT03593473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092038|NCT03581487|Durvalumab|durvalumab|mesh-list
102092039|NCT03581487|Ipilimumab|ipilimumab|mesh-list
102092040|NCT03581487|Tremelimumab|tremelimumab|mesh-list
102092041|NCT03581487|Immunoglobulins|immunoglobulins|mesh-list
101944708|NCT03710252|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101944709|NCT03710252|Protease Inhibitors|protease inhibitors|mesh-ancestor
101944710|NCT03710252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101944711|NCT03710252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944712|NCT03710252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102092042|NCT03581487|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102092043|NCT03581487|Immunoglobulin G|immunoglobulin g|mesh-list
102092044|NCT03581487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102092045|NCT03581487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092046|NCT03581487|Immunologic Factors|immunologic factors|mesh-ancestor
102092047|NCT03581487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092048|NCT03581487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102092049|NCT03581487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092050|NCT03576547|Dexamethasone|dexamethasone|mesh-list
102092051|NCT03576547|Dexamethasone acetate|dexamethasone acetate|mesh-list
102092053|NCT03576547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102092054|NCT03576547|Venetoclax|venetoclax|mesh-list
102092055|NCT03576547|Ponatinib|ponatinib|mesh-list
102092056|NCT03576547|Antibodies|antibodies|mesh-list
102092057|NCT03576547|Immunoglobulins|immunoglobulins|mesh-list
102092058|NCT03576547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102092059|NCT03576547|BB 1101|bb 1101|mesh-list
102092060|NCT03576547|Immunologic Factors|immunologic factors|mesh-ancestor
102092061|NCT03576547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092062|NCT03576547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092063|NCT03576547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102092064|NCT03576547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102092065|NCT03576547|Antiemetics|antiemetics|mesh-ancestor
102092066|NCT03576547|Autonomic Agents|autonomic agents|mesh-ancestor
102092067|NCT03576547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102092068|NCT03576547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102092069|NCT03576547|Glucocorticoids|glucocorticoids|mesh-ancestor
102092070|NCT03576547|Hormones|hormones|mesh-ancestor
101628311|NCT00720343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092073|NCT03576547|Protease Inhibitors|protease inhibitors|mesh-ancestor
102092074|NCT03576547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102092075|NCT03576547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092076|NCT03576547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102092077|NCT03538457|Acetaminophen|acetaminophen|mesh-list
102092078|NCT03538457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102092079|NCT03538457|Analgesics|analgesics|mesh-ancestor
102092080|NCT03538457|Sensory System Agents|sensory system agents|mesh-ancestor
102092081|NCT03538457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102092082|NCT03538457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092083|NCT03538457|Antipyretics|antipyretics|mesh-ancestor
102092084|NCT03535376|Valsartan|valsartan|mesh-list
102092085|NCT03535376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102092086|NCT03535376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102092087|NCT03535376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102092088|NCT03535376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092089|NCT03521154|Osimertinib|osimertinib|mesh-list
102092090|NCT03521154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092091|NCT03521154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102092092|NCT03521154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102092093|NCT03521154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092094|NCT03485677|Eliglustat|eliglustat|mesh-list
102092095|NCT03485677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102092096|NCT03485677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092097|NCT03414502|Hydroxychloroquine|hydroxychloroquine|mesh-list
102092098|NCT03414502|Minocycline|minocycline|mesh-list
102092099|NCT03414502|Sulfasalazine|sulfasalazine|mesh-list
102092100|NCT03414502|Adalimumab|adalimumab|mesh-list
102092101|NCT03414502|Infliximab|infliximab|mesh-list
102092102|NCT03414502|Golimumab|golimumab|mesh-list
102092103|NCT03414502|Certolizumab Pegol|certolizumab pegol|mesh-list
102092104|NCT03414502|Etanercept|etanercept|mesh-list
102092105|NCT03414502|Rituximab|rituximab|mesh-list
102092106|NCT03414502|Abatacept|abatacept|mesh-list
102092107|NCT03414502|Methotrexate|methotrexate|mesh-list
102092108|NCT03414502|Azathioprine|azathioprine|mesh-list
102092109|NCT03414502|Leflunomide|leflunomide|mesh-list
102092110|NCT03414502|Tofacitinib|tofacitinib|mesh-list
101944713|NCT03710252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101944714|NCT03710252|Antiviral Agents|antiviral agents|mesh-ancestor
101944715|NCT03710252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101781648|NCT00777101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092111|NCT03414502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102092112|NCT03414502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092113|NCT03414502|Immunologic Factors|immunologic factors|mesh-ancestor
102092114|NCT03414502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092115|NCT03414502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102092116|NCT03414502|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102092117|NCT03414502|Abortifacient Agents|abortifacient agents|mesh-ancestor
102092118|NCT03414502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102092119|NCT03414502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102092120|NCT03414502|Antimetabolites|antimetabolites|mesh-ancestor
102092121|NCT03414502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092122|NCT03414502|Dermatologic Agents|dermatologic agents|mesh-ancestor
102092123|NCT03414502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102092124|NCT03414502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102092125|NCT03414502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102092126|NCT03414502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102092127|NCT03414502|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102092128|NCT03414502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102092129|NCT03414502|Antimalarials|antimalarials|mesh-ancestor
102092130|NCT03414502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102092131|NCT03414502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102092132|NCT03414502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102092133|NCT03414502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102092134|NCT03414502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102092135|NCT03414502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102092136|NCT03414502|Analgesics|analgesics|mesh-ancestor
102092137|NCT03414502|Sensory System Agents|sensory system agents|mesh-ancestor
102092138|NCT03414502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102092139|NCT03414502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102092140|NCT03414502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102092141|NCT03414502|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102092142|NCT03414502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102092143|NCT03402945|Vancomycin|vancomycin|mesh-list
102092145|NCT03402945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102092146|NCT03402945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102092147|NCT03391973|Pembrolizumab|pembrolizumab|mesh-list
102092148|NCT03391973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102092149|NCT03391973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092150|NCT03391973|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102092151|NCT03391973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092152|NCT03381183|Durvalumab|durvalumab|mesh-list
102092153|NCT03381183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102092154|NCT03381183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092155|NCT03361306|Elotuzumab|elotuzumab|mesh-list
102092156|NCT03361306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092157|NCT03336242|Cannabidiol|cannabidiol|mesh-list
102092158|NCT03336242|Anticonvulsants|anticonvulsants|mesh-ancestor
102092159|NCT03333395|Heparin|heparin|mesh-list
102092161|NCT03333395|Anticoagulants|anticoagulants|mesh-ancestor
102092162|NCT03333395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102092163|NCT03333395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102092164|NCT03333395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092165|NCT03333395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102092166|NCT03333395|Autonomic Agents|autonomic agents|mesh-ancestor
102092167|NCT03333395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102092168|NCT03333395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092169|NCT03333395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102092170|NCT03333395|Respiratory System Agents|respiratory system agents|mesh-ancestor
102092171|NCT03333395|Tocolytic Agents|tocolytic agents|mesh-ancestor
102092172|NCT03333395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102092173|NCT03333395|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102092174|NCT03333395|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102092175|NCT03333395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102092176|NCT03333395|Adrenergic Agents|adrenergic agents|mesh-ancestor
102092177|NCT03333395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102092178|NCT03328104|Cyclophosphamide|cyclophosphamide|mesh-list
102092179|NCT03328104|Etoposide|etoposide|mesh-list
101944716|NCT03710252|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101944717|NCT03710252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101944718|NCT03710252|Antimetabolites|antimetabolites|mesh-ancestor
101944719|NCT02838628|Tirbanibulin|tirbanibulin|mesh-list
102092180|NCT03328104|Everolimus|everolimus|mesh-list
102092181|NCT03328104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102092182|NCT03328104|Immunologic Factors|immunologic factors|mesh-ancestor
102092183|NCT03328104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092184|NCT03328104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102092185|NCT03328104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102092186|NCT03328104|Alkylating Agents|alkylating agents|mesh-ancestor
102092187|NCT03328104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092188|NCT03328104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092189|NCT03328104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102092190|NCT03328104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102092191|NCT03328104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102092192|NCT03328104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102092193|NCT03328104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102092194|NCT03328104|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102092195|NCT03328104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102092196|NCT03274258|Nivolumab|nivolumab|mesh-list
102092197|NCT03274258|Ipilimumab|ipilimumab|mesh-list
102092198|NCT03274258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102092199|NCT03274258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092200|NCT03274258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102092201|NCT03274258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092202|NCT03179904|Paclitaxel|paclitaxel|mesh-list
102092203|NCT03179904|Trastuzumab|trastuzumab|mesh-list
102092204|NCT03179904|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102092205|NCT03179904|Letrozole|letrozole|mesh-list
102092206|NCT03179904|Fulvestrant|fulvestrant|mesh-list
102092207|NCT03179904|Anastrozole|anastrozole|mesh-list
102092208|NCT03179904|Exemestane|exemestane|mesh-list
102092209|NCT03179904|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
102092210|NCT03179904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102092211|NCT03179904|Antibodies|antibodies|mesh-list
102092212|NCT03179904|Immunoglobulins|immunoglobulins|mesh-list
102092213|NCT03179904|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102092214|NCT03179904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102092215|NCT03179904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092216|NCT03179904|Tubulin Modulators|tubulin modulators|mesh-ancestor
102092217|NCT03179904|Antimitotic Agents|antimitotic agents|mesh-ancestor
102092218|NCT03179904|Mitosis Modulators|mitosis modulators|mesh-ancestor
102092219|NCT03179904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092220|NCT03179904|Immunologic Factors|immunologic factors|mesh-ancestor
102092224|NCT03179904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102092225|NCT03179904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102092226|NCT03179904|Hormone Antagonists|hormone antagonists|mesh-ancestor
102092227|NCT03179904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102092228|NCT03179904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102092229|NCT03179904|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102092230|NCT03161522|Fluorouracil|fluorouracil|mesh-list
102092231|NCT03161522|Capecitabine|capecitabine|mesh-list
102092232|NCT03161522|Antimetabolites|antimetabolites|mesh-ancestor
102092233|NCT03161522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092234|NCT03161522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102092235|NCT03161522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092236|NCT03161522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102092237|NCT03161522|Immunologic Factors|immunologic factors|mesh-ancestor
102092238|NCT03161522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092239|NCT03143153|Fluorouracil|fluorouracil|mesh-list
102092240|NCT03143153|Nivolumab|nivolumab|mesh-list
102092241|NCT03143153|Ipilimumab|ipilimumab|mesh-list
102092242|NCT03143153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092243|NCT03143153|Antimetabolites|antimetabolites|mesh-ancestor
102092244|NCT03143153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092245|NCT03143153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102092246|NCT03143153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102092247|NCT03143153|Immunologic Factors|immunologic factors|mesh-ancestor
102092248|NCT03143153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092249|NCT03143153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101944720|NCT02838628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101944721|NCT02838628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092250|NCT03143153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102092251|NCT03137771|Gemcitabine|gemcitabine|mesh-list
102092252|NCT03137771|Docetaxel|docetaxel|mesh-list
102092253|NCT03137771|Pembrolizumab|pembrolizumab|mesh-list
102092254|NCT03137771|Pemetrexed|pemetrexed|mesh-list
102092255|NCT03137771|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102092256|NCT03137771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102092257|NCT03137771|Antimetabolites|antimetabolites|mesh-ancestor
102092258|NCT03137771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092259|NCT03137771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092260|NCT03137771|Tubulin Modulators|tubulin modulators|mesh-ancestor
102092261|NCT03137771|Antimitotic Agents|antimitotic agents|mesh-ancestor
102092262|NCT03137771|Mitosis Modulators|mitosis modulators|mesh-ancestor
102092263|NCT03137771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102092264|NCT03137771|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102092265|NCT03137771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102092266|NCT03137771|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102092267|NCT03137771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102092268|NCT03137771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102092269|NCT03033225|Verteporfin|verteporfin|mesh-list
102092270|NCT03033225|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102092271|NCT03033225|Dermatologic Agents|dermatologic agents|mesh-ancestor
102092272|NCT02998528|Paclitaxel|paclitaxel|mesh-list
102092273|NCT02998528|Vinorelbine|vinorelbine|mesh-list
102092274|NCT02998528|Docetaxel|docetaxel|mesh-list
102092275|NCT02998528|Carboplatin|carboplatin|mesh-list
102092276|NCT02998528|Gemcitabine|gemcitabine|mesh-list
102092277|NCT02998528|Nivolumab|nivolumab|mesh-list
102092278|NCT02998528|Pemetrexed|pemetrexed|mesh-list
102092279|NCT02998528|Ipilimumab|ipilimumab|mesh-list
102092280|NCT02998528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102092281|NCT02998528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092282|NCT02998528|Tubulin Modulators|tubulin modulators|mesh-ancestor
102092283|NCT02998528|Antimitotic Agents|antimitotic agents|mesh-ancestor
102092284|NCT02998528|Mitosis Modulators|mitosis modulators|mesh-ancestor
102092285|NCT02998528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092286|NCT02998528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102092287|NCT02998528|Antimetabolites|antimetabolites|mesh-ancestor
102092288|NCT02998528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102092289|NCT02998528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102092290|NCT02998528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102092291|NCT02998528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102092292|NCT02998528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102092293|NCT02955758|Pembrolizumab|pembrolizumab|mesh-list
102092295|NCT02955758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092296|NCT02955758|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102092297|NCT02955758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092298|NCT02919449|Atezolizumab|atezolizumab|mesh-list
102092299|NCT02919449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102092300|NCT02919449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092301|NCT02919449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102092302|NCT02919449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092303|NCT02913482|Risdiplam|risdiplam|mesh-list
102092304|NCT02913482|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102092305|NCT02913482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102092306|NCT02913482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092307|NCT02904291|Amlodipine|amlodipine|mesh-list
102092308|NCT02904291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102092309|NCT02904291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102092310|NCT02904291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102092311|NCT02904291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092312|NCT02904291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102092313|NCT02904291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092314|NCT02904291|Vasodilator Agents|vasodilator agents|mesh-ancestor
102092315|NCT02891824|Bevacizumab|bevacizumab|mesh-list
102092316|NCT02891824|Atezolizumab|atezolizumab|mesh-list
102092317|NCT02891824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102092318|NCT02891824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092319|NCT02891824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102092320|NCT02891824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102092321|NCT02891824|Growth Substances|growth substances|mesh-ancestor
101944722|NCT03705884|Prednisolone|prednisolone|mesh-list
101944723|NCT03705884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101944724|NCT03705884|Glucocorticoids|glucocorticoids|mesh-ancestor
101944725|NCT03705884|Hormones|hormones|mesh-ancestor
101781858|NCT02548494|Insulin|insulin|mesh-list
102092322|NCT02891824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092323|NCT02891824|Growth Inhibitors|growth inhibitors|mesh-ancestor
102092324|NCT02891824|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102092325|NCT02891824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092326|NCT02796859|Siltuximab|siltuximab|mesh-list
102092327|NCT02796859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092328|NCT02769832|Paclitaxel|paclitaxel|mesh-list
102092329|NCT02769832|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102092330|NCT02769832|Gemcitabine|gemcitabine|mesh-list
102092331|NCT02769832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102092332|NCT02769832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092333|NCT02769832|Tubulin Modulators|tubulin modulators|mesh-ancestor
102092334|NCT02769832|Antimitotic Agents|antimitotic agents|mesh-ancestor
102092335|NCT02769832|Mitosis Modulators|mitosis modulators|mesh-ancestor
102092336|NCT02769832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092337|NCT02769832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102092338|NCT02769832|Antimetabolites|antimetabolites|mesh-ancestor
102092339|NCT02743494|Nivolumab|nivolumab|mesh-list
102092340|NCT02743494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102092341|NCT02743494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092342|NCT02743494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102092343|NCT02743494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092344|NCT02723994|Leucovorin|leucovorin|mesh-list
102092345|NCT02723994|Cytarabine|cytarabine|mesh-list
102092346|NCT02723994|Dexamethasone|dexamethasone|mesh-list
102092347|NCT02723994|Prednisone|prednisone|mesh-list
102092348|NCT02723994|Cyclophosphamide|cyclophosphamide|mesh-list
102092349|NCT02723994|Doxorubicin|doxorubicin|mesh-list
102092350|NCT02723994|Methotrexate|methotrexate|mesh-list
102092351|NCT02723994|Vincristine|vincristine|mesh-list
102092352|NCT02723994|Asparaginase|asparaginase|mesh-list
102092353|NCT02723994|Mercaptopurine|mercaptopurine|mesh-list
102092354|NCT02723994|Pegaspargase|pegaspargase|mesh-list
102092355|NCT02723994|Thioguanine|thioguanine|mesh-list
102092356|NCT02723994|Levoleucovorin|levoleucovorin|mesh-list
102092357|NCT02723994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102092358|NCT02723994|Immunologic Factors|immunologic factors|mesh-ancestor
102092359|NCT02723994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092360|NCT02723994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102092361|NCT02723994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102092362|NCT02723994|Alkylating Agents|alkylating agents|mesh-ancestor
102092363|NCT02723994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092364|NCT02723994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092365|NCT02723994|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102092366|NCT02723994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102092367|NCT02723994|Antiemetics|antiemetics|mesh-ancestor
102092381|NCT02723994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102092382|NCT02723994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102092383|NCT02723994|Antimetabolites|antimetabolites|mesh-ancestor
102092384|NCT02723994|Dermatologic Agents|dermatologic agents|mesh-ancestor
102092385|NCT02723994|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101812164|NCT00969176|Antipyretics|antipyretics|mesh-ancestor
102092386|NCT02723994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102092387|NCT02723994|Antiviral Agents|antiviral agents|mesh-ancestor
102092388|NCT02723994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102092389|NCT02723994|Antidotes|antidotes|mesh-ancestor
102092390|NCT02723994|Protective Agents|protective agents|mesh-ancestor
102092391|NCT02723994|Vitamin B Complex|vitamin b complex|mesh-ancestor
102092392|NCT02723994|Vitamins|vitamins|mesh-ancestor
102092393|NCT02723994|Micronutrients|micronutrients|mesh-ancestor
102092394|NCT02723994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102092395|NCT02723994|Tubulin Modulators|tubulin modulators|mesh-ancestor
102092396|NCT02723994|Antimitotic Agents|antimitotic agents|mesh-ancestor
102092397|NCT02723994|Mitosis Modulators|mitosis modulators|mesh-ancestor
102092398|NCT02706704|Adalimumab|adalimumab|mesh-list
102092399|NCT02706704|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102092400|NCT02706704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102092401|NCT02706704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102092402|NCT02697227|Nicotine|nicotine|mesh-list
102092403|NCT02697227|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102092404|NCT02697227|Autonomic Agents|autonomic agents|mesh-ancestor
101944726|NCT03705884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101944727|NCT03705884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781928|NCT04093271|Anesthetics, Local|anesthetics, local|mesh-ancestor
102092405|NCT02697227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102092406|NCT02697227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092407|NCT02697227|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102092408|NCT02697227|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102092409|NCT02697227|Cholinergic Agents|cholinergic agents|mesh-ancestor
102092410|NCT02697227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102092411|NCT02697227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092412|NCT02684006|Sunitinib|sunitinib|mesh-list
102092413|NCT02684006|Avelumab|avelumab|mesh-list
102092414|NCT02684006|Axitinib|axitinib|mesh-list
102092415|NCT02684006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092416|NCT02684006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102092417|NCT02684006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102092418|NCT02684006|Growth Substances|growth substances|mesh-ancestor
102092419|NCT02684006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092420|NCT02684006|Growth Inhibitors|growth inhibitors|mesh-ancestor
102092421|NCT02684006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102092422|NCT02684006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102092423|NCT02684006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092424|NCT02684006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102092425|NCT02547662|Dexamethasone|dexamethasone|mesh-list
102092426|NCT02547662|Dexamethasone acetate|dexamethasone acetate|mesh-list
102092427|NCT02547662|Pomalidomide|pomalidomide|mesh-list
102092428|NCT02547662|Ixazomib|ixazomib|mesh-list
102092429|NCT02547662|Ichthammol|ichthammol|mesh-list
102092443|NCT02547662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092445|NCT02547662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102092446|NCT02547662|Immunologic Factors|immunologic factors|mesh-ancestor
102092447|NCT02547662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102092448|NCT02547662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102092449|NCT02547662|Growth Substances|growth substances|mesh-ancestor
102092450|NCT02547662|Growth Inhibitors|growth inhibitors|mesh-ancestor
102092451|NCT02547662|Dermatologic Agents|dermatologic agents|mesh-ancestor
102092452|NCT02547662|Glycine Agents|glycine agents|mesh-ancestor
102092453|NCT02547662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102092454|NCT02326311|Imatinib Mesylate|imatinib mesylate|mesh-list
102092455|NCT02326311|Dasatinib|dasatinib|mesh-list
102092456|NCT02326311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092457|NCT02326311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102092458|NCT02326311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102092459|NCT02326311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092460|NCT02324543|Gemcitabine|gemcitabine|mesh-list
101812237|NCT05623410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092461|NCT02324543|Docetaxel|docetaxel|mesh-list
102092462|NCT02324543|Capecitabine|capecitabine|mesh-list
102092463|NCT02324543|Irinotecan|irinotecan|mesh-list
102092464|NCT02324543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092465|NCT02324543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102092466|NCT02324543|Antimetabolites|antimetabolites|mesh-ancestor
102092467|NCT02324543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092468|NCT02324543|Tubulin Modulators|tubulin modulators|mesh-ancestor
102092469|NCT02324543|Antimitotic Agents|antimitotic agents|mesh-ancestor
102092470|NCT02324543|Mitosis Modulators|mitosis modulators|mesh-ancestor
102092471|NCT02324543|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102092472|NCT02324543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102092473|NCT02324543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102092474|NCT02252172|Dexamethasone|dexamethasone|mesh-list
102092475|NCT02252172|Lenalidomide|lenalidomide|mesh-list
102092476|NCT02252172|Daratumumab|daratumumab|mesh-list
102092477|NCT02252172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102092478|NCT02252172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102092479|NCT02252172|Antiemetics|antiemetics|mesh-ancestor
102092480|NCT02252172|Autonomic Agents|autonomic agents|mesh-ancestor
102092481|NCT02252172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102092482|NCT02252172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092483|NCT02252172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102092484|NCT02252172|Glucocorticoids|glucocorticoids|mesh-ancestor
102092485|NCT02252172|Hormones|hormones|mesh-ancestor
102092486|NCT02252172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102092487|NCT02252172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101944733|NCT03359174|Dermatologic Agents|dermatologic agents|mesh-ancestor
101944734|NCT03564106|Methylprednisolone|methylprednisolone|mesh-list
101944735|NCT03564106|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101944736|NCT03564106|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101944737|NCT03564106|Prednisolone|prednisolone|mesh-list
101944738|NCT03564106|Prednisolone acetate|prednisolone acetate|mesh-list
102092488|NCT02252172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092489|NCT02252172|Immunologic Factors|immunologic factors|mesh-ancestor
102092490|NCT02252172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101394279|NCT03210662|Pembrolizumab|pembrolizumab|mesh-list
102092501|NCT02076009|Dexamethasone|dexamethasone|mesh-list
102092502|NCT02076009|Lenalidomide|lenalidomide|mesh-list
102092503|NCT02076009|Daratumumab|daratumumab|mesh-list
102092504|NCT02076009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102092505|NCT02076009|Antiemetics|antiemetics|mesh-ancestor
102092506|NCT02076009|Autonomic Agents|autonomic agents|mesh-ancestor
102092507|NCT02076009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102092508|NCT02076009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092509|NCT02076009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102092510|NCT02076009|Glucocorticoids|glucocorticoids|mesh-ancestor
102092511|NCT02076009|Hormones|hormones|mesh-ancestor
102092512|NCT02076009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102092513|NCT02076009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102092514|NCT02076009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092515|NCT02076009|Immunologic Factors|immunologic factors|mesh-ancestor
102092516|NCT02076009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102092517|NCT02076009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102092518|NCT02076009|Growth Substances|growth substances|mesh-ancestor
102092519|NCT02076009|Growth Inhibitors|growth inhibitors|mesh-ancestor
102092520|NCT02055638|SRX246|srx246|mesh-list
102092521|NCT02055638|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102092522|NCT02055638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092523|NCT02055638|Natriuretic Agents|natriuretic agents|mesh-ancestor
102092524|NCT02055638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092525|NCT02029443|Acalabrutinib|acalabrutinib|mesh-list
102092526|NCT02029443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092527|NCT01850524|Dexamethasone|dexamethasone|mesh-list
102092528|NCT01850524|Lenalidomide|lenalidomide|mesh-list
102092529|NCT01850524|Ixazomib|ixazomib|mesh-list
102092530|NCT01850524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102092531|NCT01850524|Antiemetics|antiemetics|mesh-ancestor
102092532|NCT01850524|Autonomic Agents|autonomic agents|mesh-ancestor
102092533|NCT01850524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102092534|NCT01850524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092535|NCT01850524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102092536|NCT01850524|Glucocorticoids|glucocorticoids|mesh-ancestor
102092537|NCT01850524|Hormones|hormones|mesh-ancestor
102092538|NCT01850524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102092539|NCT01850524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102092540|NCT01850524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092541|NCT01850524|Immunologic Factors|immunologic factors|mesh-ancestor
102092542|NCT01850524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102092543|NCT01850524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102092544|NCT01850524|Growth Substances|growth substances|mesh-ancestor
102092545|NCT01850524|Growth Inhibitors|growth inhibitors|mesh-ancestor
102092546|NCT01850524|Protease Inhibitors|protease inhibitors|mesh-ancestor
101944740|NCT03564106|Prednisolone phosphate|prednisolone phosphate|mesh-list
101944741|NCT03564106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101944742|NCT03564106|Antiemetics|antiemetics|mesh-ancestor
101944743|NCT03564106|Autonomic Agents|autonomic agents|mesh-ancestor
101782072|NCT04234360|Prednisone|prednisone|mesh-list
102092547|NCT01850524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102092548|NCT01850524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092549|NCT01664910|Rituximab|rituximab|mesh-list
102092550|NCT01664910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102092551|NCT01664910|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
102092552|NCT01664910|Methotrexate|methotrexate|mesh-list
102092553|NCT01664910|Fludarabine|fludarabine|mesh-list
102092554|NCT01664910|Fludarabine phosphate|fludarabine phosphate|mesh-list
102092555|NCT01664910|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102092556|NCT01664910|Antibodies|antibodies|mesh-list
102092557|NCT01664910|Immunoglobulins|immunoglobulins|mesh-list
102092558|NCT01664910|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102092559|NCT01664910|Tacrolimus|tacrolimus|mesh-list
102092560|NCT01664910|Thymoglobulin|thymoglobulin|mesh-list
102092561|NCT01664910|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102092562|NCT01664910|Immunologic Factors|immunologic factors|mesh-ancestor
102092563|NCT01664910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092567|NCT01664910|Abortifacient Agents|abortifacient agents|mesh-ancestor
102092568|NCT01664910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102092569|NCT01664910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102092570|NCT01664910|Antimetabolites|antimetabolites|mesh-ancestor
102092571|NCT01664910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092572|NCT01664910|Dermatologic Agents|dermatologic agents|mesh-ancestor
102092573|NCT01664910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102092574|NCT01664910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102092575|NCT01664910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102092576|NCT01664910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102092577|NCT01664910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102092578|NCT01664910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102092579|NCT01664910|Alkylating Agents|alkylating agents|mesh-ancestor
102092580|NCT01664910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102092581|NCT01664910|Immunotoxins|immunotoxins|mesh-ancestor
102092582|NCT01664910|Immunoconjugates|immunoconjugates|mesh-ancestor
102092583|NCT01594580|Anti-Infective Agents|anti-infective agents|mesh-list
102092584|NCT01594580|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102092585|NCT01550003|Certolizumab Pegol|certolizumab pegol|mesh-list
102092586|NCT01550003|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102092587|NCT01550003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102092588|NCT01550003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102092589|NCT01550003|Immunologic Factors|immunologic factors|mesh-ancestor
102092590|NCT01550003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092591|NCT01550003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102092592|NCT00764595|Imatinib Mesylate|imatinib mesylate|mesh-list
102092593|NCT00764595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092594|NCT00764595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102092595|NCT00764595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102092596|NCT00764595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092597|NCT00576979|Cyclophosphamide|cyclophosphamide|mesh-list
102092599|NCT00576979|Etoposide phosphate|etoposide phosphate|mesh-list
102092600|NCT00576979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102092601|NCT00576979|Immunologic Factors|immunologic factors|mesh-ancestor
102092602|NCT00576979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092603|NCT00576979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102092604|NCT00576979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102092605|NCT00576979|Alkylating Agents|alkylating agents|mesh-ancestor
102092606|NCT00576979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092607|NCT00576979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092608|NCT00576979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102092609|NCT00576979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102092610|NCT00576979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102092611|NCT00576979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102092612|NCT00576979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102092613|NCT00390793|Cytarabine|cytarabine|mesh-list
102092614|NCT00390793|Dexamethasone|dexamethasone|mesh-list
101812387|NCT00964964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102092615|NCT00390793|Prednisone|prednisone|mesh-list
101944744|NCT03564106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101944745|NCT03564106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944746|NCT03564106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101944747|NCT03564106|Glucocorticoids|glucocorticoids|mesh-ancestor
101944748|NCT03564106|Hormones|hormones|mesh-ancestor
101944749|NCT03564106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101782192|NCT02597699|Dsuvia|dsuvia|mesh-list
102092616|NCT00390793|Dexamethasone acetate|dexamethasone acetate|mesh-list
102092617|NCT00390793|Cortisone|cortisone|mesh-list
102092618|NCT00390793|Cyclophosphamide|cyclophosphamide|mesh-list
102092619|NCT00390793|Doxorubicin|doxorubicin|mesh-list
102092620|NCT00390793|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102092621|NCT00390793|Methotrexate|methotrexate|mesh-list
102092622|NCT00390793|Vincristine|vincristine|mesh-list
102092623|NCT00390793|Daunorubicin|daunorubicin|mesh-list
102092624|NCT00390793|Dasatinib|dasatinib|mesh-list
102092625|NCT00390793|BB 1101|bb 1101|mesh-list
102092626|NCT00390793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102092627|NCT00390793|Immunologic Factors|immunologic factors|mesh-ancestor
102092628|NCT00390793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092629|NCT00390793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102092630|NCT00390793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102092631|NCT00390793|Alkylating Agents|alkylating agents|mesh-ancestor
102092632|NCT00390793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092633|NCT00390793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092634|NCT00390793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102092635|NCT00390793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102092651|NCT00390793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102092652|NCT00390793|Antimetabolites|antimetabolites|mesh-ancestor
102092653|NCT00390793|Dermatologic Agents|dermatologic agents|mesh-ancestor
102092654|NCT00390793|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102092655|NCT00390793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102092656|NCT00390793|Antiviral Agents|antiviral agents|mesh-ancestor
102092657|NCT00390793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102092658|NCT00390793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102092659|NCT00390793|Tubulin Modulators|tubulin modulators|mesh-ancestor
102092660|NCT00390793|Antimitotic Agents|antimitotic agents|mesh-ancestor
102092661|NCT00390793|Mitosis Modulators|mitosis modulators|mesh-ancestor
102092662|NCT00390793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102092663|NCT00390793|Protease Inhibitors|protease inhibitors|mesh-ancestor
102092664|NCT03563235|Calcitriol|calcitriol|mesh-list
102092665|NCT03563235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102092666|NCT03563235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092667|NCT03563235|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102092668|NCT03563235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102092669|NCT03563235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092670|NCT03563235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102092671|NCT03563235|Vitamins|vitamins|mesh-ancestor
102092672|NCT03563235|Micronutrients|micronutrients|mesh-ancestor
102092673|NCT03563235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102092674|NCT01329900|Etoposide|etoposide|mesh-list
102092675|NCT01329900|Ifosfamide|ifosfamide|mesh-list
102092676|NCT01329900|Ofatumumab|ofatumumab|mesh-list
102092677|NCT01329900|Lenograstim|lenograstim|mesh-list
102092678|NCT01329900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102092679|NCT01329900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092680|NCT01329900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102092681|NCT01329900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102092682|NCT01329900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102092683|NCT01329900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092684|NCT01329900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102092685|NCT01329900|Alkylating Agents|alkylating agents|mesh-ancestor
102092686|NCT01329900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102092687|NCT01329900|Immunologic Factors|immunologic factors|mesh-ancestor
101812465|NCT00679211|Immunotoxins|immunotoxins|mesh-ancestor
102092688|NCT01329900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092689|NCT04948294|Pyrithione zinc|pyrithione zinc|mesh-list
102092690|NCT04948294|Keratolytic Agents|keratolytic agents|mesh-ancestor
102092691|NCT04948294|Dermatologic Agents|dermatologic agents|mesh-ancestor
102092692|NCT04948372|Terlipressin|terlipressin|mesh-list
101944750|NCT03564106|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101944751|NCT03564106|Protective Agents|protective agents|mesh-ancestor
101944752|NCT03564106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101944753|NCT03564106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101944755|NCT03710174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101944756|NCT03710174|Antifungal Agents|antifungal agents|mesh-ancestor
101944757|NCT03710174|Keratolytic Agents|keratolytic agents|mesh-ancestor
101944758|NCT03710174|Dermatologic Agents|dermatologic agents|mesh-ancestor
101944759|NCT00093015|Darbepoetin alfa|darbepoetin alfa|mesh-list
101944760|NCT00093015|Hematinics|hematinics|mesh-ancestor
101944761|NCT01145703|Vitamin D|vitamin d|mesh-list
101944762|NCT01145703|Ergocalciferols|ergocalciferols|mesh-list
101944763|NCT01145703|Cholecalciferol|cholecalciferol|mesh-list
101944764|NCT01145703|Vitamins|vitamins|mesh-list
101944765|NCT01145703|Micronutrients|micronutrients|mesh-ancestor
101944766|NCT01145703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944767|NCT01145703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101944768|NCT01145703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102092693|NCT04948372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102092705|NCT05059977|Immunologic Factors|immunologic factors|mesh-ancestor
102092706|NCT05059977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092707|NCT02228616|Lactulose|lactulose|mesh-list
102092708|NCT02228616|Prucalopride|prucalopride|mesh-list
102092709|NCT02228616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102092710|NCT02228616|Laxatives|laxatives|mesh-ancestor
102092711|NCT02228616|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
102092712|NCT02228616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102092713|NCT02228616|Serotonin Agents|serotonin agents|mesh-ancestor
102092714|NCT02228616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102092715|NCT02228616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092716|NCT02228616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092717|NCT03936894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102092718|NCT03936894|Immunologic Factors|immunologic factors|mesh-ancestor
102092719|NCT03936894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092720|NCT02228772|Cytarabine|cytarabine|mesh-list
102092721|NCT02228772|Cyclophosphamide|cyclophosphamide|mesh-list
102092722|NCT02228772|Doxorubicin|doxorubicin|mesh-list
102092723|NCT02228772|Methotrexate|methotrexate|mesh-list
102092724|NCT02228772|Vincristine|vincristine|mesh-list
102092725|NCT02228772|Mercaptopurine|mercaptopurine|mesh-list
102092726|NCT02228772|Ixazomib|ixazomib|mesh-list
102092727|NCT02228772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102092728|NCT02228772|Immunologic Factors|immunologic factors|mesh-ancestor
102092729|NCT02228772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092730|NCT02228772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102092731|NCT02228772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102092732|NCT02228772|Alkylating Agents|alkylating agents|mesh-ancestor
102092733|NCT02228772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092734|NCT02228772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092735|NCT02228772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102092736|NCT02228772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102092737|NCT02228772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102092738|NCT02228772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102092739|NCT02228772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102092740|NCT02228772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102092741|NCT02228772|Abortifacient Agents|abortifacient agents|mesh-ancestor
102092742|NCT02228772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102092743|NCT02228772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101944769|NCT05137587|Ketamine|ketamine|mesh-list
101944770|NCT05137587|Propofol|propofol|mesh-list
101944771|NCT05137587|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101782261|NCT04089605|Hormones|hormones|mesh-ancestor
102092744|NCT02228772|Antimetabolites|antimetabolites|mesh-ancestor
102092745|NCT02228772|Dermatologic Agents|dermatologic agents|mesh-ancestor
102092746|NCT02228772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102092747|NCT02228772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102092748|NCT02228772|Antiviral Agents|antiviral agents|mesh-ancestor
102092749|NCT02228772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102092750|NCT02228772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102092751|NCT02228772|Tubulin Modulators|tubulin modulators|mesh-ancestor
102092752|NCT02228772|Antimitotic Agents|antimitotic agents|mesh-ancestor
102092753|NCT02228772|Mitosis Modulators|mitosis modulators|mesh-ancestor
102092754|NCT02228772|Protease Inhibitors|protease inhibitors|mesh-ancestor
102092755|NCT03646968|Docetaxel|docetaxel|mesh-list
102092756|NCT03646968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092757|NCT03646968|Tubulin Modulators|tubulin modulators|mesh-ancestor
102092758|NCT03646968|Antimitotic Agents|antimitotic agents|mesh-ancestor
102092759|NCT03646968|Mitosis Modulators|mitosis modulators|mesh-ancestor
101394551|NCT02854436|Niraparib|niraparib|mesh-list
102092770|NCT03563001|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102092771|NCT03563001|Autonomic Agents|autonomic agents|mesh-ancestor
102092772|NCT03563001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102092773|NCT03563001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092774|NCT03563001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102092775|NCT03563001|Respiratory System Agents|respiratory system agents|mesh-ancestor
102092776|NCT03563001|Glucocorticoids|glucocorticoids|mesh-ancestor
102092777|NCT03563001|Hormones|hormones|mesh-ancestor
102092778|NCT03563001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102092779|NCT03563001|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102092780|NCT03563001|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102092781|NCT03563001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102092782|NCT03563001|Adrenergic Agents|adrenergic agents|mesh-ancestor
102092783|NCT03563001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102092784|NCT03563001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092785|NCT02228928|Capsaicin|capsaicin|mesh-list
102092786|NCT02228928|Antipruritics|antipruritics|mesh-ancestor
102092787|NCT02228928|Dermatologic Agents|dermatologic agents|mesh-ancestor
102092788|NCT02228928|Sensory System Agents|sensory system agents|mesh-ancestor
102092789|NCT02228928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102092790|NCT02228928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092791|NCT03888378|Minocycline|minocycline|mesh-list
102092792|NCT03888378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102092793|NCT03888378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102092794|NCT03603288|Idebenone|idebenone|mesh-list
102092795|NCT03603288|Antioxidants|antioxidants|mesh-ancestor
102092796|NCT03603288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092797|NCT03603288|Protective Agents|protective agents|mesh-ancestor
102092798|NCT03603288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092799|NCT03857646|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102092800|NCT03857646|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102092801|NCT03857646|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102092802|NCT03857646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102092803|NCT03844074|Bevacizumab|bevacizumab|mesh-list
102092804|NCT03844074|Ranibizumab|ranibizumab|mesh-list
102092805|NCT03844074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102092806|NCT03844074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092807|NCT03844074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102092808|NCT03844074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102092809|NCT03844074|Growth Substances|growth substances|mesh-ancestor
102092810|NCT03844074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092811|NCT03844074|Growth Inhibitors|growth inhibitors|mesh-ancestor
102092812|NCT02624986|Rituximab|rituximab|mesh-list
102092813|NCT02624986|Obinutuzumab|obinutuzumab|mesh-list
102092814|NCT02624986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102092815|NCT02624986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092816|NCT02624986|Immunologic Factors|immunologic factors|mesh-ancestor
102092817|NCT02624986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092818|NCT02624986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102092819|NCT04946734|Aspirin|aspirin|mesh-list
102092820|NCT04946734|Clopidogrel|clopidogrel|mesh-list
102092821|NCT04946734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102092822|NCT04946734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101944772|NCT05137587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101782328|NCT01068847|Verapamil|verapamil|mesh-list
102092823|NCT04946734|Analgesics|analgesics|mesh-ancestor
102092824|NCT04946734|Sensory System Agents|sensory system agents|mesh-ancestor
102092825|NCT04946734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102092838|NCT04946734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102092839|NCT04946734|Purinergic Agents|purinergic agents|mesh-ancestor
102092840|NCT04946734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102092841|NCT04945954|Cyclophosphamide|cyclophosphamide|mesh-list
102092842|NCT04945954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102092844|NCT04945954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092845|NCT04945954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102092846|NCT04945954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102092847|NCT04945954|Alkylating Agents|alkylating agents|mesh-ancestor
102092848|NCT04945954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092849|NCT04945954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092850|NCT04945954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102092851|NCT04945096|Cytarabine|cytarabine|mesh-list
102092852|NCT04945096|Acetylcysteine|acetylcysteine|mesh-list
102092853|NCT04945096|Cyclosporine|cyclosporine|mesh-list
102092854|NCT04945096|Cyclophosphamide|cyclophosphamide|mesh-list
102092855|NCT04945096|Busulfan|busulfan|mesh-list
102092856|NCT04945096|Semustine|semustine|mesh-list
102092857|NCT04945096|Decitabine|decitabine|mesh-list
102092858|NCT04945096|Cyclosporins|cyclosporins|mesh-list
102092859|NCT04945096|Thymoglobulin|thymoglobulin|mesh-list
102092860|NCT04945096|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102092861|NCT04945096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102092862|NCT04945096|Immunologic Factors|immunologic factors|mesh-ancestor
102092863|NCT04945096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092864|NCT04945096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102092865|NCT04945096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102092866|NCT04945096|Alkylating Agents|alkylating agents|mesh-ancestor
102092867|NCT04945096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092868|NCT04945096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092869|NCT04945096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102092870|NCT04945096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102092871|NCT04945096|Antimetabolites|antimetabolites|mesh-ancestor
102092872|NCT04945096|Antiviral Agents|antiviral agents|mesh-ancestor
102092873|NCT04945096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102092874|NCT04945096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102092875|NCT04945096|Antifungal Agents|antifungal agents|mesh-ancestor
102092876|NCT04945096|Dermatologic Agents|dermatologic agents|mesh-ancestor
102092877|NCT04945096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102092878|NCT04945096|Expectorants|expectorants|mesh-ancestor
102092879|NCT04945096|Respiratory System Agents|respiratory system agents|mesh-ancestor
102092880|NCT04945096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102092881|NCT04945096|Antioxidants|antioxidants|mesh-ancestor
102092882|NCT04945096|Protective Agents|protective agents|mesh-ancestor
102092883|NCT04944082|Ivermectin|ivermectin|mesh-list
102092884|NCT04944082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102092885|NCT04944082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102092886|NCT04943692|Metformin|metformin|mesh-list
102092887|NCT04943692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102092888|NCT04943692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092889|NCT02587598|Cytarabine|cytarabine|mesh-list
102092894|NCT02587598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092895|NCT02587598|Antiviral Agents|antiviral agents|mesh-ancestor
102092896|NCT02587598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102092897|NCT02587598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102092898|NCT02587598|Immunologic Factors|immunologic factors|mesh-ancestor
102092899|NCT02587598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092900|NCT02587598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102092901|NCT04943536|Bicalutamide|bicalutamide|mesh-list
102092902|NCT04943536|Androgen Antagonists|androgen antagonists|mesh-ancestor
102092903|NCT04943536|Hormone Antagonists|hormone antagonists|mesh-ancestor
102092904|NCT04943536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102092905|NCT04943536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092906|NCT04943536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092907|NCT04943146|Aspirin|aspirin|mesh-list
102092908|NCT04943146|Prednisone|prednisone|mesh-list
102092909|NCT04943146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102092910|NCT04943146|Glucocorticoids|glucocorticoids|mesh-ancestor
102092911|NCT04943146|Hormones|hormones|mesh-ancestor
102092912|NCT04943146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102092913|NCT04943146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944773|NCT05137587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944774|NCT05137587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101944775|NCT05137587|Anesthetics, General|anesthetics, general|mesh-ancestor
101944776|NCT05137587|Anesthetics|anesthetics|mesh-ancestor
102092914|NCT04943146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102092915|NCT04943146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092916|NCT04943146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102092917|NCT04943146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102092918|NCT04943146|Analgesics|analgesics|mesh-ancestor
102092919|NCT04943146|Sensory System Agents|sensory system agents|mesh-ancestor
102092920|NCT04943146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102092921|NCT04943146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102092922|NCT04943146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102092923|NCT04943146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102092924|NCT04943146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092925|NCT04943146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102092926|NCT04943146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102092927|NCT04943146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102092928|NCT04943146|Antipyretics|antipyretics|mesh-ancestor
102092930|NCT02485574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102092931|NCT02485574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092932|NCT04942834|Amiodarone|amiodarone|mesh-list
102092933|NCT04942834|Sotalol|sotalol|mesh-list
102092934|NCT04942834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
102092935|NCT04942834|Dronedarone|dronedarone|mesh-list
102092936|NCT04942834|Propafenone|propafenone|mesh-list
102092937|NCT04942834|Vasodilator Agents|vasodilator agents|mesh-ancestor
102092938|NCT04942834|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102092939|NCT04942834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102092940|NCT04942834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092941|NCT04942834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102092942|NCT04942834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102092943|NCT04942834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102092944|NCT04942834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102092945|NCT04942834|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102092946|NCT04942834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102092947|NCT04942834|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102092948|NCT04942834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102092949|NCT04942834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102092950|NCT04942834|Adrenergic Agents|adrenergic agents|mesh-ancestor
102092951|NCT04942834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102092952|NCT04942834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092953|NCT04942834|Sympatholytics|sympatholytics|mesh-ancestor
102092954|NCT04942834|Autonomic Agents|autonomic agents|mesh-ancestor
102092955|NCT04942834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102092956|NCT04942834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102092957|NCT04941976|Benzydamine|benzydamine|mesh-list
102092958|NCT04941976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102092959|NCT01291004|Drospirenone|drospirenone|mesh-list
102092971|NCT01291004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102092973|NCT01291004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102092974|NCT01291004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102092975|NCT01291004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102092976|NCT01291004|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102092977|NCT01291004|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102092978|NCT01291004|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102092979|NCT01291004|Hormone Antagonists|hormone antagonists|mesh-ancestor
102092980|NCT01291004|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102092981|NCT01291004|Diuretics|diuretics|mesh-ancestor
102092982|NCT01291004|Natriuretic Agents|natriuretic agents|mesh-ancestor
102092983|NCT01291004|Progestins|progestins|mesh-ancestor
102092984|NCT04941118|Anesthetics|anesthetics|mesh-list
102092985|NCT04941118|Anesthetics, Local|anesthetics, local|mesh-list
102092986|NCT04941118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102092987|NCT04941118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092988|NCT04941118|Sensory System Agents|sensory system agents|mesh-ancestor
102092989|NCT04941118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102092990|NCT03483818|Antiviral Agents|antiviral agents|mesh-list
101944778|NCT05137587|Sensory System Agents|sensory system agents|mesh-ancestor
101944779|NCT05137587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101944780|NCT05137587|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101944781|NCT05137587|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101944782|NCT05137587|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101944783|NCT05137587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101944784|NCT05137587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944785|NCT01145859|Rivaroxaban|rivaroxaban|mesh-list
102092991|NCT03483818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102092992|NCT00374660|Oxaliplatin|oxaliplatin|mesh-list
101812763|NCT05590572|Etoposide|etoposide|mesh-list
102092993|NCT00374660|Irofulven|irofulven|mesh-list
102092994|NCT00374660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092995|NCT00374660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102092996|NCT00374660|Alkylating Agents|alkylating agents|mesh-ancestor
102092997|NCT00374660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092999|NCT02624050|Methohexital|methohexital|mesh-list
102093000|NCT02624050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102093001|NCT02624050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102093002|NCT02624050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093003|NCT02624050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102093004|NCT02624050|Anesthetics, General|anesthetics, general|mesh-ancestor
102093005|NCT02624050|Anesthetics|anesthetics|mesh-ancestor
102093006|NCT03131882|Triamcinolone|triamcinolone|mesh-list
102093007|NCT03131882|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102093008|NCT03131882|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102093009|NCT03131882|Hyaluronic Acid|hyaluronic acid|mesh-list
102093010|NCT03131882|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102093011|NCT03131882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102093012|NCT03131882|Glucocorticoids|glucocorticoids|mesh-ancestor
102093013|NCT03131882|Hormones|hormones|mesh-ancestor
102093014|NCT03131882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102093015|NCT03131882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093016|NCT03131882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102093017|NCT03131882|Immunologic Factors|immunologic factors|mesh-ancestor
102093018|NCT03131882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102093019|NCT03131882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093020|NCT03131882|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102093021|NCT03131882|Viscosupplements|viscosupplements|mesh-ancestor
102093022|NCT03131882|Protective Agents|protective agents|mesh-ancestor
102093023|NCT03483350|Midazolam|midazolam|mesh-list
102093024|NCT03483350|Granisetron|granisetron|mesh-list
101394816|NCT02140255|Antiviral Agents|antiviral agents|mesh-ancestor
102093029|NCT03483350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102093030|NCT03483350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102093031|NCT03483350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102093032|NCT03483350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102093033|NCT03483350|Anesthetics, General|anesthetics, general|mesh-ancestor
102093035|NCT03483350|GABA Modulators|gaba modulators|mesh-ancestor
102093036|NCT03483350|GABA Agents|gaba agents|mesh-ancestor
102093037|NCT03483350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102093038|NCT03483350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093039|NCT03483350|Antiemetics|antiemetics|mesh-ancestor
102093040|NCT03483350|Autonomic Agents|autonomic agents|mesh-ancestor
102093041|NCT03483350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102093042|NCT03483350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102093043|NCT03483350|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102093044|NCT03483350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102093045|NCT03483350|Serotonin Agents|serotonin agents|mesh-ancestor
102093046|NCT03480308|Dexamethasone|dexamethasone|mesh-list
102093047|NCT03480308|Fentanyl|fentanyl|mesh-list
102093048|NCT03480308|Bupivacaine|bupivacaine|mesh-list
102093049|NCT03480308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102093050|NCT03480308|Antiemetics|antiemetics|mesh-ancestor
102093051|NCT03480308|Autonomic Agents|autonomic agents|mesh-ancestor
102093052|NCT03480308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101944786|NCT01145859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101944787|NCT01145859|Antithrombins|antithrombins|mesh-ancestor
101944788|NCT01145859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102093053|NCT03480308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093054|NCT03480308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102093055|NCT03480308|Glucocorticoids|glucocorticoids|mesh-ancestor
102093056|NCT03480308|Hormones|hormones|mesh-ancestor
102093057|NCT03480308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102093058|NCT03480308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102093059|NCT03480308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102093060|NCT03480308|Anesthetics, Local|anesthetics, local|mesh-ancestor
102093061|NCT03480308|Anesthetics|anesthetics|mesh-ancestor
102093062|NCT03480308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102093063|NCT03480308|Sensory System Agents|sensory system agents|mesh-ancestor
102093064|NCT03480308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102093065|NCT03480308|Narcotics|narcotics|mesh-ancestor
102093066|NCT03480308|Analgesics|analgesics|mesh-ancestor
102093067|NCT03480308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102093068|NCT03480308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102093069|NCT03480308|Anesthetics, General|anesthetics, general|mesh-ancestor
102093070|NCT05151614|Colchicine|colchicine|mesh-list
102093071|NCT05151614|Gout Suppressants|gout suppressants|mesh-ancestor
102093072|NCT05151614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102093073|NCT05151614|Tubulin Modulators|tubulin modulators|mesh-ancestor
102093074|NCT05151614|Antimitotic Agents|antimitotic agents|mesh-ancestor
102093075|NCT05151614|Mitosis Modulators|mitosis modulators|mesh-ancestor
102093076|NCT05151614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093077|NCT05151614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102093078|NCT04937140|Antibodies|antibodies|mesh-list
102093079|NCT04937140|Immunologic Factors|immunologic factors|mesh-ancestor
102093080|NCT04937140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093081|NCT03482960|Xenon|xenon|mesh-list
102093082|NCT03482960|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102093083|NCT03482960|Anesthetics, General|anesthetics, general|mesh-ancestor
102093084|NCT03482960|Anesthetics|anesthetics|mesh-ancestor
102093085|NCT03482960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102093086|NCT03482960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093087|NCT03479996|Bupivacaine|bupivacaine|mesh-list
102093088|NCT03479996|Anesthetics, Local|anesthetics, local|mesh-ancestor
102093089|NCT03479996|Anesthetics|anesthetics|mesh-ancestor
102093090|NCT03479996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102093091|NCT03479996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093092|NCT03479996|Sensory System Agents|sensory system agents|mesh-ancestor
102093093|NCT03479996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102093094|NCT04936282|Tacrolimus|tacrolimus|mesh-list
102093095|NCT04936282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102093096|NCT04936282|Immunologic Factors|immunologic factors|mesh-ancestor
101394881|NCT02043678|Prednisone|prednisone|mesh-list
102093118|NCT03479918|Prednisone|prednisone|mesh-list
102093119|NCT03479918|Cyclophosphamide|cyclophosphamide|mesh-list
102093120|NCT03479918|Doxorubicin|doxorubicin|mesh-list
102093121|NCT03479918|Etoposide|etoposide|mesh-list
102093122|NCT03479918|Vincristine|vincristine|mesh-list
102093123|NCT03479918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102093124|NCT03479918|Immunologic Factors|immunologic factors|mesh-ancestor
102093125|NCT03479918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093126|NCT03479918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102093127|NCT03479918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102093128|NCT03479918|Alkylating Agents|alkylating agents|mesh-ancestor
102093129|NCT03479918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093130|NCT03479918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102093131|NCT03479918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102093132|NCT03479918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102093133|NCT03479918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102093134|NCT03479918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102093135|NCT03479918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102093136|NCT03479918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102093137|NCT03479918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102093138|NCT03479918|Glucocorticoids|glucocorticoids|mesh-ancestor
102093139|NCT03479918|Hormones|hormones|mesh-ancestor
102093140|NCT03479918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102093141|NCT03479918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102093142|NCT03479918|Tubulin Modulators|tubulin modulators|mesh-ancestor
102093143|NCT03479918|Antimitotic Agents|antimitotic agents|mesh-ancestor
101944789|NCT01145859|Protease Inhibitors|protease inhibitors|mesh-ancestor
101944790|NCT01145859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102093144|NCT03479918|Mitosis Modulators|mitosis modulators|mesh-ancestor
102093145|NCT03486080|Lenograstim|lenograstim|mesh-list
102093146|NCT03486080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102093147|NCT03486080|Immunologic Factors|immunologic factors|mesh-ancestor
102093148|NCT03486080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093152|NCT03477344|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102093153|NCT03477344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102093154|NCT03477344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093155|NCT03477344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102093156|NCT03477344|Analgesics|analgesics|mesh-ancestor
102093157|NCT03477344|Sensory System Agents|sensory system agents|mesh-ancestor
102093158|NCT03477344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102093159|NCT03477344|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102093160|NCT03477344|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102093161|NCT03477344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102093162|NCT03477344|Adrenergic Agents|adrenergic agents|mesh-ancestor
102093163|NCT03477344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102093164|NCT03477344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093165|NCT04933864|Methylene Blue|methylene blue|mesh-list
102093166|NCT04933864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102093167|NCT04933864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093168|NCT03477266|Mosapride|mosapride|mesh-list
102093169|NCT03477266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102093170|NCT03477266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102093171|NCT03477266|Serotonin Agents|serotonin agents|mesh-ancestor
102093172|NCT03477266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102093173|NCT03477266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093174|NCT03477266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093175|NCT03479372|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102093176|NCT03479372|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102093177|NCT03131336|Fibrin Foam|fibrin foam|mesh-list
102093178|NCT03131336|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
102093179|NCT03131336|Hemostatics|hemostatics|mesh-ancestor
102093180|NCT03131336|Coagulants|coagulants|mesh-ancestor
102093181|NCT03482492|Acetaminophen|acetaminophen|mesh-list
102093182|NCT03482492|Tramadol|tramadol|mesh-list
102093183|NCT03482492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102093184|NCT03482492|Analgesics|analgesics|mesh-ancestor
102093185|NCT03482492|Sensory System Agents|sensory system agents|mesh-ancestor
102093186|NCT03482492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102093187|NCT03482492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093188|NCT03482492|Antipyretics|antipyretics|mesh-ancestor
102093189|NCT03482492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102093190|NCT03482492|Narcotics|narcotics|mesh-ancestor
102093191|NCT03482492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102093192|NCT03477110|Temozolomide|temozolomide|mesh-list
102093193|NCT03477110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102093194|NCT03477110|Alkylating Agents|alkylating agents|mesh-ancestor
102093195|NCT03477110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093196|NCT03477110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102093197|NCT03874286|Liver Extracts|liver extracts|mesh-list
102093198|NCT03874286|Hematinics|hematinics|mesh-ancestor
102093199|NCT05259098|Sufentanil|sufentanil|mesh-list
102093200|NCT05259098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102093201|NCT05259098|Narcotics|narcotics|mesh-ancestor
102093202|NCT05259098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102093203|NCT05259098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093204|NCT05259098|Analgesics|analgesics|mesh-ancestor
102093205|NCT05259098|Sensory System Agents|sensory system agents|mesh-ancestor
102093206|NCT05259098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102093207|NCT05259098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102093208|NCT05259098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102093209|NCT05259098|Anesthetics, General|anesthetics, general|mesh-ancestor
102093210|NCT05259098|Anesthetics|anesthetics|mesh-ancestor
102093211|NCT03482180|Atorvastatin|atorvastatin|mesh-list
102093212|NCT03482180|Calcium|calcium|mesh-list
102093213|NCT03482180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102093214|NCT03482180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093215|NCT03482180|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102093216|NCT03482180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102093217|NCT03482180|Antimetabolites|antimetabolites|mesh-ancestor
102093218|NCT03482180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944791|NCT01145859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944792|NCT01145859|Anticoagulants|anticoagulants|mesh-ancestor
101944793|NCT01250847|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101944794|NCT01250847|Antidepressive Agents|antidepressive agents|mesh-ancestor
101944795|NCT01250847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101944796|NCT01250847|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101944797|NCT01250847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101944798|NCT01250847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101944799|NCT01250847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944800|NCT03913455|Carboplatin|carboplatin|mesh-list
101944801|NCT03913455|Guadecitabine|guadecitabine|mesh-list
101944802|NCT03913455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102093219|NCT03482180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102093220|NCT03482180|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101395007|NCT01776840|Rituximab|rituximab|mesh-list
102093224|NCT04390646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102093225|NCT04390646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093227|NCT04294550|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102093228|NCT04294550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093229|NCT04294550|Sensory System Agents|sensory system agents|mesh-ancestor
102093230|NCT04294550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102093232|NCT03476564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102093233|NCT03476564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102093234|NCT03476564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093235|NCT03476564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102093236|NCT03476564|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102093237|NCT03476564|Protective Agents|protective agents|mesh-ancestor
102093238|NCT03476564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093239|NCT03476564|Vasodilator Agents|vasodilator agents|mesh-ancestor
102093240|NCT03476564|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102093241|NCT03476564|Antioxidants|antioxidants|mesh-ancestor
102093242|NCT05258474|Niacinamide|niacinamide|mesh-list
102093243|NCT05258474|Niacin|niacin|mesh-list
102093244|NCT05258474|Nicotinic Acids|nicotinic acids|mesh-list
102093245|NCT05258474|Vitamin B Complex|vitamin b complex|mesh-ancestor
102093246|NCT05258474|Vitamins|vitamins|mesh-ancestor
102093247|NCT05258474|Micronutrients|micronutrients|mesh-ancestor
102093248|NCT05258474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093249|NCT05258474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102093250|NCT05258474|Antimetabolites|antimetabolites|mesh-ancestor
102093251|NCT05258474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093252|NCT05258474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102093253|NCT05258474|Vasodilator Agents|vasodilator agents|mesh-ancestor
102093254|NCT03478436|Doxycycline|doxycycline|mesh-list
102093255|NCT03478436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102093256|NCT03478436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102093257|NCT03478436|Antimalarials|antimalarials|mesh-ancestor
102093258|NCT03478436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102093259|NCT03478436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102093260|NCT01338987|Alovudine|alovudine|mesh-list
102093261|NCT01338987|Cyclophosphamide|cyclophosphamide|mesh-list
102093262|NCT01338987|Busulfan|busulfan|mesh-list
102093263|NCT01338987|Methotrexate|methotrexate|mesh-list
102093264|NCT01338987|Fludarabine|fludarabine|mesh-list
102093265|NCT01338987|Leuprolide|leuprolide|mesh-list
102093266|NCT01338987|Tacrolimus|tacrolimus|mesh-list
102093267|NCT01338987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102093268|NCT01338987|Immunologic Factors|immunologic factors|mesh-ancestor
102093269|NCT01338987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093270|NCT01338987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102093271|NCT01338987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102093272|NCT01338987|Alkylating Agents|alkylating agents|mesh-ancestor
102093273|NCT01338987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093274|NCT01338987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101944803|NCT01238523|Calpastatin|calpastatin|mesh-list
101944804|NCT01238523|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
101944805|NCT01238523|Protease Inhibitors|protease inhibitors|mesh-ancestor
101944806|NCT01238523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101944807|NCT01238523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944808|NCT03708536|Bevacizumab|bevacizumab|mesh-list
102093275|NCT01338987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102093276|NCT01338987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102093277|NCT01338987|Abortifacient Agents|abortifacient agents|mesh-ancestor
102093278|NCT01338987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102093279|NCT01338987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102093280|NCT01338987|Antimetabolites|antimetabolites|mesh-ancestor
102093281|NCT01338987|Dermatologic Agents|dermatologic agents|mesh-ancestor
102093282|NCT01338987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102093283|NCT01338987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102093284|NCT01338987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102093285|NCT01338987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102093286|NCT01338987|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102093287|NCT01338987|Fertility Agents|fertility agents|mesh-ancestor
102093288|NCT01338987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102093289|NCT01338987|Antiviral Agents|antiviral agents|mesh-ancestor
102093290|NCT01338987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101395075|NCT01352962|Lenalidomide|lenalidomide|mesh-list
102093298|NCT04856007|Metformin|metformin|mesh-list
102093299|NCT04856007|Dapagliflozin|dapagliflozin|mesh-list
102093300|NCT04856007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102093301|NCT04856007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093302|NCT04856007|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102093303|NCT04856007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093304|NCT04736979|Amoxicillin|amoxicillin|mesh-list
102093305|NCT04736979|Clavulanic Acid|clavulanic acid|mesh-list
102093306|NCT04736979|Clavulanic Acids|clavulanic acids|mesh-list
102093307|NCT04736979|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102093308|NCT04736979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102093309|NCT04736979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102093310|NCT04736979|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102093311|NCT04736979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102093312|NCT04736979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093313|NCT03562923|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102093314|NCT03562923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102093315|NCT03562923|Autonomic Agents|autonomic agents|mesh-ancestor
102093316|NCT03562923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102093317|NCT03562923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093318|NCT03562923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102093319|NCT03562923|Respiratory System Agents|respiratory system agents|mesh-ancestor
102093320|NCT03562923|Glucocorticoids|glucocorticoids|mesh-ancestor
102093321|NCT03562923|Hormones|hormones|mesh-ancestor
102093322|NCT03562923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102093323|NCT03562923|Sympathomimetics|sympathomimetics|mesh-ancestor
102093324|NCT03593252|Metronidazole|metronidazole|mesh-list
102093325|NCT03593252|Cefazolin|cefazolin|mesh-list
102093326|NCT03593252|Neomycin|neomycin|mesh-list
101706978|NCT00849693|Fluoxetine|fluoxetine|mesh-list
102093327|NCT03593252|Picosulfate sodium|picosulfate sodium|mesh-list
102093328|NCT03593252|Magnesium Oxide|magnesium oxide|mesh-list
102093329|NCT03593252|Citric Acid|citric acid|mesh-list
102093330|NCT03593252|Sodium Citrate|sodium citrate|mesh-list
102093331|NCT03593252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102093332|NCT03593252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102093333|NCT03593252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102093334|NCT03593252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102093335|NCT03593252|Anticoagulants|anticoagulants|mesh-ancestor
102093336|NCT03593252|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102093337|NCT03593252|Chelating Agents|chelating agents|mesh-ancestor
102093338|NCT03593252|Sequestering Agents|sequestering agents|mesh-ancestor
102093339|NCT03593252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093340|NCT03593252|Cathartics|cathartics|mesh-ancestor
102093341|NCT03593252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101944809|NCT03708536|Capecitabine|capecitabine|mesh-list
101944810|NCT03708536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102093342|NCT03593252|Antacids|antacids|mesh-ancestor
102093343|NCT03593252|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102093344|NCT03593252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102093345|NCT03476174|Pembrolizumab|pembrolizumab|mesh-list
102093346|NCT03476174|Interleukin-2|interleukin-2|mesh-list
102093347|NCT03476174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102093348|NCT03476174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102093349|NCT03476174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102093350|NCT03476174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093351|NCT03476174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102093352|NCT03476174|Analgesics|analgesics|mesh-ancestor
102093353|NCT03476174|Sensory System Agents|sensory system agents|mesh-ancestor
102093354|NCT03476174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102093355|NCT03476174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093356|NCT02523638|Interferons|interferons|mesh-list
102093357|NCT02523638|Interferon-alpha|interferon-alpha|mesh-list
102093358|NCT02523638|Interferon alpha-2|interferon alpha-2|mesh-list
102093359|NCT02523638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102093360|NCT02523638|Antiviral Agents|antiviral agents|mesh-ancestor
102093361|NCT02523638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102093362|NCT02523638|Immunologic Factors|immunologic factors|mesh-ancestor
102093363|NCT02523638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093364|NCT05257148|Nebivolol|nebivolol|mesh-list
102093365|NCT05257148|Zofenopril|zofenopril|mesh-list
102093366|NCT05257148|Captopril|captopril|mesh-list
102093367|NCT05257148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102093368|NCT05257148|Vasodilator Agents|vasodilator agents|mesh-ancestor
102093369|NCT05257148|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102093375|NCT05257148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707013|NCT04865939|Gemcitabine|gemcitabine|mesh-list
102093376|NCT05257148|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102093377|NCT05257148|Protease Inhibitors|protease inhibitors|mesh-ancestor
102093378|NCT05257148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102093379|NCT03481790|Folic Acid|folic acid|mesh-list
102093380|NCT03481790|Lactoferrin|lactoferrin|mesh-list
102093381|NCT03481790|Vitamins|vitamins|mesh-ancestor
102093382|NCT03481790|Micronutrients|micronutrients|mesh-ancestor
102093383|NCT03481790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093384|NCT03481790|Hematinics|hematinics|mesh-ancestor
102093385|NCT03481790|Vitamin B Complex|vitamin b complex|mesh-ancestor
102093386|NCT03481790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102093387|NCT03475862|Oxycodone|oxycodone|mesh-list
102093388|NCT03475862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102093389|NCT03475862|Narcotics|narcotics|mesh-ancestor
102093390|NCT03475862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102093391|NCT03475862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093392|NCT03475862|Analgesics|analgesics|mesh-ancestor
102093393|NCT03475862|Sensory System Agents|sensory system agents|mesh-ancestor
102093394|NCT03475862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102093395|NCT03368066|Cosyntropin|cosyntropin|mesh-list
102093396|NCT03368066|Hormones|hormones|mesh-ancestor
102093397|NCT03368066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102093398|NCT03368066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093399|NCT03475628|Daratumumab|daratumumab|mesh-list
102093400|NCT03475628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102093401|NCT05195450|Tenofovir|tenofovir|mesh-list
102093402|NCT05195450|Antiviral Agents|antiviral agents|mesh-ancestor
102093403|NCT05195450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102093404|NCT05195450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102093405|NCT05195450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102093406|NCT05195450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102093407|NCT05195450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093408|NCT05195450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102093409|NCT05195450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102093410|NCT03477422|Meropenem|meropenem|mesh-list
102093411|NCT03477422|Ceftriaxone|ceftriaxone|mesh-list
102093412|NCT03477422|Sulbactam|sulbactam|mesh-list
102093413|NCT03477422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102093414|NCT03477422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102093415|NCT03477422|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102093416|NCT03477422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102093417|NCT03477422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093418|NCT01355289|Interferons|interferons|mesh-list
102093419|NCT01355289|Ribavirin|ribavirin|mesh-list
102093420|NCT01355289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101944811|NCT03708536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101944812|NCT03708536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101944813|NCT03708536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101944814|NCT03708536|Growth Substances|growth substances|mesh-ancestor
101944815|NCT03708536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944816|NCT03708536|Growth Inhibitors|growth inhibitors|mesh-ancestor
102093421|NCT01355289|Antiviral Agents|antiviral agents|mesh-ancestor
102093422|NCT01355289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102093423|NCT01355289|Antimetabolites|antimetabolites|mesh-ancestor
102093424|NCT01355289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093425|NCT03473210|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102093426|NCT03473210|Erythromycin|erythromycin|mesh-list
102093427|NCT03473210|Ampicillin|ampicillin|mesh-list
102093428|NCT03473210|Dexamethasone|dexamethasone|mesh-list
102093429|NCT03473210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102093430|NCT03473210|Antiemetics|antiemetics|mesh-ancestor
102093431|NCT03473210|Autonomic Agents|autonomic agents|mesh-ancestor
102093432|NCT03473210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101707041|NCT00706953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102093433|NCT03473210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093434|NCT03473210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102093435|NCT03473210|Glucocorticoids|glucocorticoids|mesh-ancestor
102093436|NCT03473210|Hormones|hormones|mesh-ancestor
102093437|NCT03473210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102093438|NCT03473210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102093439|NCT03473210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102093440|NCT03473210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101395221|NCT00585650|Etanercept|etanercept|mesh-list
102093452|NCT03475160|Chelating Agents|chelating agents|mesh-ancestor
102093453|NCT03475160|Sequestering Agents|sequestering agents|mesh-ancestor
102093454|NCT03475160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093455|NCT03475160|Vasodilator Agents|vasodilator agents|mesh-ancestor
102093456|NCT03475160|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102093457|NCT03475160|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102093458|NCT03475160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102093459|NCT03475160|Urological Agents|urological agents|mesh-ancestor
102093460|NCT00308516|Leucovorin|leucovorin|mesh-list
102093461|NCT00308516|Bevacizumab|bevacizumab|mesh-list
102093462|NCT00308516|Fluorouracil|fluorouracil|mesh-list
102093463|NCT00308516|Oxaliplatin|oxaliplatin|mesh-list
102093464|NCT00308516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102093465|NCT00308516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102093466|NCT00308516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102093467|NCT00308516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102093468|NCT00308516|Growth Substances|growth substances|mesh-ancestor
102093469|NCT00308516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093470|NCT00308516|Growth Inhibitors|growth inhibitors|mesh-ancestor
102093471|NCT00308516|Antimetabolites|antimetabolites|mesh-ancestor
102093472|NCT00308516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093473|NCT00308516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102093474|NCT00308516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102093475|NCT00308516|Immunologic Factors|immunologic factors|mesh-ancestor
102093476|NCT00308516|Antidotes|antidotes|mesh-ancestor
102093477|NCT00308516|Protective Agents|protective agents|mesh-ancestor
102093478|NCT00308516|Vitamin B Complex|vitamin b complex|mesh-ancestor
102093479|NCT00308516|Vitamins|vitamins|mesh-ancestor
102093480|NCT00308516|Micronutrients|micronutrients|mesh-ancestor
102093481|NCT05155592|Adalimumab|adalimumab|mesh-list
102093482|NCT05155592|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102093483|NCT05155592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102093484|NCT05155592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102093485|NCT03474614|Propranolol|propranolol|mesh-list
101707053|NCT03462017|Urological Agents|urological agents|mesh-ancestor
102093486|NCT03474614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102093487|NCT03474614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102093488|NCT03474614|Adrenergic Agents|adrenergic agents|mesh-ancestor
102093489|NCT03474614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102093490|NCT03474614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093491|NCT03474614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093492|NCT03474614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102093493|NCT03474614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102093494|NCT03474614|Vasodilator Agents|vasodilator agents|mesh-ancestor
101944817|NCT03708536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101782961|NCT00553605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102093495|NCT05155202|Antihypertensive Agents|antihypertensive agents|mesh-list
102093496|NCT02737358|Acetylcysteine|acetylcysteine|mesh-list
102093497|NCT02737358|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102093498|NCT02737358|Antiviral Agents|antiviral agents|mesh-ancestor
102093499|NCT02737358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102093500|NCT02737358|Expectorants|expectorants|mesh-ancestor
102093501|NCT02737358|Respiratory System Agents|respiratory system agents|mesh-ancestor
102093502|NCT02737358|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102093503|NCT02737358|Antioxidants|antioxidants|mesh-ancestor
102093504|NCT02737358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093505|NCT02737358|Protective Agents|protective agents|mesh-ancestor
102093506|NCT02737358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093507|NCT02737358|Antidotes|antidotes|mesh-ancestor
102093511|NCT05052710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102093512|NCT05052710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093513|NCT05052710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102093514|NCT05052710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102093515|NCT05052710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102093516|NCT05052710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102093517|NCT05052710|Anesthetics, General|anesthetics, general|mesh-ancestor
102093519|NCT05052710|GABA Modulators|gaba modulators|mesh-ancestor
102093520|NCT05052710|GABA Agents|gaba agents|mesh-ancestor
102093521|NCT05052710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102093522|NCT05052710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093523|NCT02866838|Tranexamic Acid|tranexamic acid|mesh-list
102093524|NCT02866838|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102093525|NCT02866838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102093526|NCT02866838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093527|NCT02866838|Hemostatics|hemostatics|mesh-ancestor
102093528|NCT02866838|Coagulants|coagulants|mesh-ancestor
102093529|NCT03474146|Chlorhexidine|chlorhexidine|mesh-list
102093530|NCT03474146|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102093531|NCT03474146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102093532|NCT03474146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102093533|NCT03474146|Disinfectants|disinfectants|mesh-ancestor
102093534|NCT03474146|Dermatologic Agents|dermatologic agents|mesh-ancestor
102093535|NCT01090154|Certolizumab Pegol|certolizumab pegol|mesh-list
102093536|NCT01090154|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102093537|NCT01090154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102093538|NCT01090154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102093539|NCT01090154|Immunologic Factors|immunologic factors|mesh-ancestor
102093540|NCT01090154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093541|NCT01090154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102093542|NCT01354431|Nivolumab|nivolumab|mesh-list
102093543|NCT01354431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102093544|NCT01354431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102093545|NCT01354431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102093546|NCT01354431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093547|NCT02736578|Cetuximab|cetuximab|mesh-list
102093548|NCT02736578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102093549|NCT02736578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102093550|NCT02478788|Amphetamine|amphetamine|mesh-list
102093551|NCT02478788|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102093552|NCT02478788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093553|NCT02478788|Sympathomimetics|sympathomimetics|mesh-ancestor
102093554|NCT02478788|Autonomic Agents|autonomic agents|mesh-ancestor
102093555|NCT02478788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102093556|NCT02478788|Dopamine Agents|dopamine agents|mesh-ancestor
102093557|NCT02478788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102093558|NCT02478788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093559|NCT02478788|Adrenergic Agents|adrenergic agents|mesh-ancestor
102093560|NCT02478788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102093561|NCT02478788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102093562|NCT02478788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102093563|NCT02478788|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102093564|NCT05157542|Paclitaxel|paclitaxel|mesh-list
102093565|NCT05157542|Durvalumab|durvalumab|mesh-list
102093566|NCT05157542|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102093567|NCT05157542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101944819|NCT03708536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944821|NCT03705728|Propofol|propofol|mesh-list
102093568|NCT05157542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102093569|NCT05157542|Tubulin Modulators|tubulin modulators|mesh-ancestor
102093570|NCT05157542|Antimitotic Agents|antimitotic agents|mesh-ancestor
102093571|NCT05157542|Mitosis Modulators|mitosis modulators|mesh-ancestor
102093572|NCT05157542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093573|NCT05157542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102093574|NCT03472976|Imiquimod|imiquimod|mesh-list
102093575|NCT03472976|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102093576|NCT03472976|Immunologic Factors|immunologic factors|mesh-ancestor
102093577|NCT03472976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093578|NCT03472976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102093579|NCT03472976|Interferon Inducers|interferon inducers|mesh-ancestor
102093581|NCT03473600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102093582|NCT03473600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102093583|NCT03473600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102093584|NCT03473600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102093585|NCT03473600|Glucocorticoids|glucocorticoids|mesh-ancestor
102093586|NCT03473600|Hormones|hormones|mesh-ancestor
102093587|NCT03473600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102093588|NCT03473600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093589|NCT03473600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102093590|NCT03473600|Immunologic Factors|immunologic factors|mesh-ancestor
102093591|NCT03473600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101707094|NCT00577408|Naltrexone|naltrexone|mesh-list
102093592|NCT03473600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093593|NCT04457648|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102093594|NCT04457648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102093595|NCT02622724|Interferons|interferons|mesh-list
102093596|NCT02622724|Interferon-beta|interferon-beta|mesh-list
102093597|NCT02622724|Interferon beta-1a|interferon beta-1a|mesh-list
102093598|NCT02622724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102093599|NCT02622724|Antiviral Agents|antiviral agents|mesh-ancestor
102093600|NCT02622724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102093601|NCT02622724|Immunologic Factors|immunologic factors|mesh-ancestor
102093602|NCT02622724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093603|NCT02622724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102093604|NCT01354353|Aripiprazole|aripiprazole|mesh-list
102093605|NCT01354353|Antidepressive Agents|antidepressive agents|mesh-ancestor
102093606|NCT01354353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102093607|NCT01354353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101813353|NCT00984152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102093608|NCT01354353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102093609|NCT01354353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102093610|NCT01354353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093611|NCT01354353|Dopamine Agonists|dopamine agonists|mesh-ancestor
102093612|NCT01354353|Dopamine Agents|dopamine agents|mesh-ancestor
102093613|NCT01354353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102093614|NCT01354353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093615|NCT01354353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102093616|NCT01354353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102093617|NCT01354353|Serotonin Agents|serotonin agents|mesh-ancestor
102093618|NCT01354353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102093619|NCT01354353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102093620|NCT01354353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102093621|NCT01354353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102093622|NCT04931524|Mitogens|mitogens|mesh-list
102093623|NCT04931524|Mitosis Modulators|mitosis modulators|mesh-ancestor
102093624|NCT04931524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093625|NCT03562611|Flurbiprofen|flurbiprofen|mesh-list
102093626|NCT03562611|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
102093627|NCT03562611|Nalbuphine|nalbuphine|mesh-list
102093628|NCT03562611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102093629|NCT03562611|Narcotics|narcotics|mesh-ancestor
102093630|NCT03562611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102093631|NCT03562611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093632|NCT03562611|Analgesics|analgesics|mesh-ancestor
102093633|NCT03562611|Sensory System Agents|sensory system agents|mesh-ancestor
102093634|NCT03562611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102093635|NCT03562611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102093636|NCT03562611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101944822|NCT03705728|Sevoflurane|sevoflurane|mesh-list
101944823|NCT03705728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101944824|NCT03705728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102093637|NCT03562611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102093638|NCT03562611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102093639|NCT03562611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102093640|NCT03562611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102093641|NCT03562611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093642|NCT03057574|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102093643|NCT03057574|Hormones|hormones|mesh-ancestor
102093644|NCT03057574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102093645|NCT03057574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093646|NCT03057028|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102093647|NCT03057028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102093648|NCT04929652|Irinotecan|irinotecan|mesh-list
102093649|NCT04929652|Molgramostim|molgramostim|mesh-list
102093650|NCT04929652|Sargramostim|sargramostim|mesh-list
102093651|NCT04929652|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102093652|NCT04929652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102093654|NCT04929652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093656|NCT04929652|Immunologic Factors|immunologic factors|mesh-ancestor
102093657|NCT04929652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093658|NCT01353963|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
102093659|NCT01353963|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102093660|NCT01353963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102093661|NCT01353963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102093662|NCT01353963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093663|NCT01353963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102093664|NCT01353963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093665|NCT01353963|Antidepressive Agents|antidepressive agents|mesh-ancestor
102093666|NCT01353963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102093667|NCT04927936|Vaccines|vaccines|mesh-list
102093668|NCT04927936|Immunologic Factors|immunologic factors|mesh-ancestor
102093669|NCT04927936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093670|NCT04167813|Ondansetron|ondansetron|mesh-list
102093671|NCT04167813|Antiemetics|antiemetics|mesh-ancestor
102093672|NCT04167813|Autonomic Agents|autonomic agents|mesh-ancestor
102093673|NCT04167813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102093674|NCT04167813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093675|NCT04167813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102093676|NCT04167813|Antipruritics|antipruritics|mesh-ancestor
102093677|NCT04167813|Dermatologic Agents|dermatologic agents|mesh-ancestor
102093678|NCT04167813|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102093679|NCT04167813|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102093680|NCT04167813|Serotonin Agents|serotonin agents|mesh-ancestor
102093681|NCT04167813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102093682|NCT04167813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093684|NCT03562533|Carboplatin|carboplatin|mesh-list
102093685|NCT03562533|Doxorubicin|doxorubicin|mesh-list
102093686|NCT03562533|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102093687|NCT03562533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102093688|NCT03562533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102093689|NCT03562533|Tubulin Modulators|tubulin modulators|mesh-ancestor
102093690|NCT03562533|Antimitotic Agents|antimitotic agents|mesh-ancestor
102093691|NCT03562533|Mitosis Modulators|mitosis modulators|mesh-ancestor
102093692|NCT03562533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093693|NCT03562533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102093694|NCT03562533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102093695|NCT03562533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102093696|NCT03562533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102093697|NCT04927858|Empagliflozin|empagliflozin|mesh-list
102093698|NCT04927858|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102093699|NCT04927858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093700|NCT04927858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102093701|NCT04927858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093702|NCT05707455|Chrysarobin|chrysarobin|mesh-list
102093703|NCT05707455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102093704|NCT05707455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102093705|NCT05707455|Analgesics|analgesics|mesh-ancestor
102093706|NCT05707455|Sensory System Agents|sensory system agents|mesh-ancestor
101944825|NCT03705728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944826|NCT03705728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101944827|NCT03705728|Anesthetics, General|anesthetics, general|mesh-ancestor
101944829|NCT03705728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102093707|NCT05707455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102093708|NCT05707455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093709|NCT05707455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102093710|NCT05707455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102093711|NCT04927000|Tofacitinib|tofacitinib|mesh-list
102093712|NCT04927000|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102093713|NCT04927000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102093714|NCT04927000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102093715|NCT04927000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093716|NCT04926532|Sorafenib|sorafenib|mesh-list
102093717|NCT04926532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102093718|NCT04926532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102093719|NCT04926532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102093720|NCT04926532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093721|NCT03842709|Pramipexole|pramipexole|mesh-list
102093722|NCT03842709|Antioxidants|antioxidants|mesh-ancestor
102093723|NCT03842709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093724|NCT03842709|Protective Agents|protective agents|mesh-ancestor
102093726|NCT03842709|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102093727|NCT03842709|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102093728|NCT03842709|Dopamine Agonists|dopamine agonists|mesh-ancestor
102093729|NCT03842709|Dopamine Agents|dopamine agents|mesh-ancestor
102093730|NCT03842709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102093731|NCT05707533|Cefoxitin|cefoxitin|mesh-list
102093732|NCT05707533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102093733|NCT05707533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102093734|NCT03056482|Haloperidol|haloperidol|mesh-list
102093735|NCT03056482|Ondansetron|ondansetron|mesh-list
102093736|NCT03056482|Haloperidol decanoate|haloperidol decanoate|mesh-list
102093737|NCT03056482|Antiemetics|antiemetics|mesh-ancestor
102093738|NCT03056482|Autonomic Agents|autonomic agents|mesh-ancestor
102093739|NCT03056482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102093740|NCT03056482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093741|NCT03056482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102093742|NCT03056482|Antipruritics|antipruritics|mesh-ancestor
102093743|NCT03056482|Dermatologic Agents|dermatologic agents|mesh-ancestor
102093744|NCT03056482|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102093745|NCT03056482|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102093746|NCT03056482|Serotonin Agents|serotonin agents|mesh-ancestor
102093747|NCT03056482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102093748|NCT03056482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093749|NCT03056482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102093750|NCT03056482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102093751|NCT03056482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102093752|NCT03056482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102093753|NCT03056482|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102093754|NCT03056482|Dopamine Agents|dopamine agents|mesh-ancestor
102093755|NCT03056482|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102093756|NCT02817555|Epoetin Alfa|epoetin alfa|mesh-list
102093757|NCT02817555|Darbepoetin alfa|darbepoetin alfa|mesh-list
102093758|NCT02817555|Hematinics|hematinics|mesh-ancestor
102093759|NCT04924192|Irinotecan|irinotecan|mesh-list
102093760|NCT04924192|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102093761|NCT04924192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102093762|NCT04924192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102093763|NCT04924192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093764|NCT04924192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102093765|NCT02036073|Epoetin Alfa|epoetin alfa|mesh-list
102093766|NCT02036073|Hematinics|hematinics|mesh-ancestor
102093767|NCT02036229|Ivermectin|ivermectin|mesh-list
102093768|NCT02036229|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102093769|NCT02036229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102093770|NCT04922008|Capecitabine|capecitabine|mesh-list
102093771|NCT04922008|Trastuzumab|trastuzumab|mesh-list
102093772|NCT04922008|Vinorelbine|vinorelbine|mesh-list
102093773|NCT04922008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102093774|NCT04922008|Antimetabolites|antimetabolites|mesh-ancestor
101944830|NCT03705728|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101944831|NCT03705728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101944832|NCT03705728|Narcotics|narcotics|mesh-ancestor
101944833|NCT03705728|Analgesics|analgesics|mesh-ancestor
101783247|NCT00961857|Incretins|incretins|mesh-ancestor
102093775|NCT04922008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093776|NCT04922008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102093777|NCT04922008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102093778|NCT04922008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102093779|NCT04922008|Tubulin Modulators|tubulin modulators|mesh-ancestor
102093780|NCT04922008|Antimitotic Agents|antimitotic agents|mesh-ancestor
102093781|NCT04922008|Mitosis Modulators|mitosis modulators|mesh-ancestor
102093782|NCT03056092|Ranibizumab|ranibizumab|mesh-list
102093783|NCT03056092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102093784|NCT03056092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102093785|NCT03056092|Growth Substances|growth substances|mesh-ancestor
102093786|NCT03056092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093787|NCT03056092|Growth Inhibitors|growth inhibitors|mesh-ancestor
102093788|NCT03056092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102093789|NCT04921306|Clenbuterol|clenbuterol|mesh-list
102093790|NCT04921306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102093791|NCT04921306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102093792|NCT04921306|Adrenergic Agents|adrenergic agents|mesh-ancestor
102093793|NCT04921306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101707199|NCT00526669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102093794|NCT04921306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093795|NCT04921306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093796|NCT04921306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102093797|NCT04921306|Autonomic Agents|autonomic agents|mesh-ancestor
102093798|NCT04921306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102093799|NCT04921306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101395581|NCT00122655|Antiviral Agents|antiviral agents|mesh-ancestor
102093806|NCT03056248|Lithium Carbonate|lithium carbonate|mesh-list
102093807|NCT03056248|Antidepressive Agents|antidepressive agents|mesh-ancestor
102093808|NCT03056248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102093809|NCT03056248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102093810|NCT03056248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093811|NCT03056248|Antimanic Agents|antimanic agents|mesh-ancestor
102093812|NCT03056248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102093813|NCT03056248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102093814|NCT03056248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093815|NCT04920604|Anesthetics|anesthetics|mesh-list
102093816|NCT04920604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102093817|NCT04920604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093818|NCT04920448|Acetylcysteine|acetylcysteine|mesh-list
102093819|NCT04920448|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102093820|NCT04920448|Antiviral Agents|antiviral agents|mesh-ancestor
102093821|NCT04920448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102093822|NCT04920448|Expectorants|expectorants|mesh-ancestor
102093823|NCT04920448|Respiratory System Agents|respiratory system agents|mesh-ancestor
102093824|NCT04920448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102093825|NCT04920448|Antioxidants|antioxidants|mesh-ancestor
102093826|NCT04920448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093827|NCT04920448|Protective Agents|protective agents|mesh-ancestor
102093828|NCT04920448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093829|NCT04920448|Antidotes|antidotes|mesh-ancestor
102093830|NCT04969354|Immunomodulating Agents|immunomodulating agents|mesh-list
102093831|NCT04969354|Immunologic Factors|immunologic factors|mesh-ancestor
102093832|NCT04969354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093835|NCT03061006|Anticoagulants|anticoagulants|mesh-ancestor
102093836|NCT03061006|Antithrombins|antithrombins|mesh-ancestor
102093837|NCT03061006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102093838|NCT03061006|Protease Inhibitors|protease inhibitors|mesh-ancestor
102093839|NCT03061006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102093840|NCT03061006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093841|NCT03060850|Abivertinib|abivertinib|mesh-list
102093842|NCT03060850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102093843|NCT03060850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102093844|NCT03060850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093845|NCT04432558|Acetaminophen|acetaminophen|mesh-list
102093846|NCT04432558|Diclofenac|diclofenac|mesh-list
102093847|NCT04432558|Tramadol|tramadol|mesh-list
101783318|NCT00547911|Carbidopa|carbidopa|mesh-list
102093848|NCT04432558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102093849|NCT04432558|Analgesics|analgesics|mesh-ancestor
102093850|NCT04432558|Sensory System Agents|sensory system agents|mesh-ancestor
102093851|NCT04432558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102093852|NCT04432558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093853|NCT04432558|Antipyretics|antipyretics|mesh-ancestor
101707216|NCT03640949|Coagulants|coagulants|mesh-ancestor
102093854|NCT04432558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102093855|NCT04432558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102093856|NCT04432558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102093857|NCT04432558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102093858|NCT04432558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102093859|NCT04432558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093860|NCT04432558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102093861|NCT04432558|Narcotics|narcotics|mesh-ancestor
102093862|NCT04432558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102093863|NCT04979650|Methylprednisolone|methylprednisolone|mesh-list
102093864|NCT04979650|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102093865|NCT04979650|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102093866|NCT04979650|Prednisolone|prednisolone|mesh-list
102093867|NCT04979650|Prednisolone acetate|prednisolone acetate|mesh-list
102093868|NCT04979650|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102093869|NCT04979650|Prednisolone phosphate|prednisolone phosphate|mesh-list
102093870|NCT04979650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102093871|NCT04979650|Antiemetics|antiemetics|mesh-ancestor
102093878|NCT04979650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102093879|NCT04979650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102093880|NCT04979650|Protective Agents|protective agents|mesh-ancestor
102093881|NCT04979650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102093882|NCT04979650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102093883|NCT04650152|Fenofibrate|fenofibrate|mesh-list
102093884|NCT04650152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102093885|NCT04650152|Antimetabolites|antimetabolites|mesh-ancestor
102093886|NCT04650152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093887|NCT04650152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102093888|NCT04967950|Methotrexate|methotrexate|mesh-list
102093889|NCT04967950|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102093890|NCT04967950|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102093891|NCT04967950|Abortifacient Agents|abortifacient agents|mesh-ancestor
102093892|NCT04967950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102093893|NCT04967950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093894|NCT04967950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102093895|NCT04967950|Antimetabolites|antimetabolites|mesh-ancestor
102093896|NCT04967950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093897|NCT04967950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102093898|NCT04967950|Dermatologic Agents|dermatologic agents|mesh-ancestor
102093899|NCT04967950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102093900|NCT04967950|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102093901|NCT04967950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102093902|NCT04967950|Immunologic Factors|immunologic factors|mesh-ancestor
102093903|NCT04967950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102093904|NCT04967950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102093905|NCT04967326|Carbamazepine|carbamazepine|mesh-list
102093906|NCT04967326|Phenytoin|phenytoin|mesh-list
102093907|NCT04967326|Valproic Acid|valproic acid|mesh-list
102093908|NCT04967326|Anticonvulsants|anticonvulsants|mesh-list
102093909|NCT04967326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102093910|NCT04967326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093911|NCT04967326|GABA Agents|gaba agents|mesh-ancestor
102093912|NCT04967326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102093913|NCT04967326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093914|NCT04967326|Antimanic Agents|antimanic agents|mesh-ancestor
102093915|NCT04967326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102093916|NCT04967326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102093917|NCT04967326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102093918|NCT04967326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102093919|NCT04967326|Analgesics|analgesics|mesh-ancestor
102093920|NCT04967326|Sensory System Agents|sensory system agents|mesh-ancestor
102093921|NCT04967326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102093922|NCT04967326|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102093923|NCT04967326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102093924|NCT04967326|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101944835|NCT03705728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101944837|NCT05177666|Trastuzumab|trastuzumab|mesh-list
101944838|NCT05177666|Pertuzumab|pertuzumab|mesh-list
101944839|NCT05177666|Vemurafenib|vemurafenib|mesh-list
102093925|NCT04967326|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102093926|NCT04967326|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102093927|NCT04967326|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102093928|NCT03062176|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102093929|NCT03062176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102093930|NCT02620384|Metolazone|metolazone|mesh-list
102093931|NCT02620384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102093932|NCT02620384|Diuretics|diuretics|mesh-ancestor
102093933|NCT02620384|Natriuretic Agents|natriuretic agents|mesh-ancestor
102093934|NCT02620384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093935|NCT02620384|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102093936|NCT02620384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102093937|NCT02620384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093938|NCT04918576|Tranexamic Acid|tranexamic acid|mesh-list
102093939|NCT04918576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102093943|NCT04918576|Coagulants|coagulants|mesh-ancestor
102093944|NCT03472508|Folic Acid|folic acid|mesh-list
102093945|NCT03472508|Vitamin B Complex|vitamin b complex|mesh-list
102093946|NCT03472508|Enalapril|enalapril|mesh-list
102093947|NCT03472508|Enalaprilat|enalaprilat|mesh-list
102093948|NCT03472508|Hematinics|hematinics|mesh-ancestor
102093949|NCT03472508|Vitamins|vitamins|mesh-ancestor
102093950|NCT03472508|Micronutrients|micronutrients|mesh-ancestor
102093951|NCT03472508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093952|NCT03472508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102093953|NCT03472508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093954|NCT03472508|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102093955|NCT03472508|Protease Inhibitors|protease inhibitors|mesh-ancestor
102093956|NCT03472508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102093957|NCT04966234|Posaconazole|posaconazole|mesh-list
102093958|NCT04966234|Antifungal Agents|antifungal agents|mesh-ancestor
102093959|NCT04966234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102093960|NCT04966234|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102093961|NCT04966234|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102093962|NCT04966234|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102093963|NCT04966234|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102093964|NCT04966234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102093965|NCT04966234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102093966|NCT04966234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093967|NCT04966234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102093968|NCT04966234|Hormone Antagonists|hormone antagonists|mesh-ancestor
102093969|NCT04966234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102093970|NCT04966234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093971|NCT03915860|Trifarotene|trifarotene|mesh-list
102093972|NCT03915860|Dermatologic Agents|dermatologic agents|mesh-ancestor
102093973|NCT04170998|Metformin|metformin|mesh-list
102093974|NCT04170998|Dapagliflozin|dapagliflozin|mesh-list
102093975|NCT04170998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102093976|NCT04170998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093977|NCT04170998|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102093978|NCT04170998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093979|NCT04965532|Anesthetics|anesthetics|mesh-list
102093980|NCT04965532|Propofol|propofol|mesh-list
102093981|NCT04965532|Sevoflurane|sevoflurane|mesh-list
102093982|NCT04965532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102093983|NCT04965532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093984|NCT04965532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102093985|NCT04965532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102093986|NCT04965532|Anesthetics, General|anesthetics, general|mesh-ancestor
102093987|NCT04965532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102093988|NCT04965532|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102093989|NCT03055546|Oxytocin|oxytocin|mesh-list
102093990|NCT03055546|Oxytocics|oxytocics|mesh-ancestor
102093991|NCT03055546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102093992|NCT03055546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093993|NCT04918264|Capecitabine|capecitabine|mesh-list
101707235|NCT00827775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101944840|NCT05177666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101944841|NCT05177666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101944842|NCT05177666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101944843|NCT05177666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102093994|NCT04918264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102093995|NCT04918264|Antimetabolites|antimetabolites|mesh-ancestor
102093996|NCT04918264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093997|NCT04918264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102093998|NCT04917718|Tacrolimus|tacrolimus|mesh-list
102093999|NCT04917718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102094000|NCT04917718|Immunologic Factors|immunologic factors|mesh-ancestor
102094001|NCT04917718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094002|NCT04917718|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102094003|NCT04917718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102094004|NCT04917718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094005|NCT06016556|Ritonavir|ritonavir|mesh-list
102094006|NCT06016556|Nirmatrelvir|nirmatrelvir|mesh-list
102094007|NCT06016556|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
102094008|NCT06016556|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102094009|NCT06016556|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102094010|NCT06016556|Protease Inhibitors|protease inhibitors|mesh-ancestor
102094011|NCT06016556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102094024|NCT06016530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094025|NCT06016530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102094027|NCT06016530|Hormones|hormones|mesh-ancestor
102094028|NCT06016530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102094029|NCT06016530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102094030|NCT06016530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102094031|NCT06016517|Adalimumab|adalimumab|mesh-list
102094032|NCT06016517|Upadacitinib|upadacitinib|mesh-list
102094033|NCT06016517|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102094034|NCT06016517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102094035|NCT06016517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102094036|NCT06016517|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102094037|NCT06016517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102094038|NCT06016517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102094039|NCT06016517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094040|NCT06016465|Dexamethasone|dexamethasone|mesh-list
102094041|NCT06016465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102094042|NCT06016465|Antiemetics|antiemetics|mesh-ancestor
102094043|NCT06016465|Autonomic Agents|autonomic agents|mesh-ancestor
102094044|NCT06016465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102094045|NCT06016465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094046|NCT06016465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102094047|NCT06016465|Glucocorticoids|glucocorticoids|mesh-ancestor
102094048|NCT06016465|Hormones|hormones|mesh-ancestor
102094049|NCT06016465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102094050|NCT06016465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102094051|NCT06016465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102094052|NCT06016452|Chlorophyllin|chlorophyllin|mesh-list
102094053|NCT06016452|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
102094054|NCT06016452|Protective Agents|protective agents|mesh-ancestor
102094055|NCT06016452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094056|NCT06016413|Paclitaxel|paclitaxel|mesh-list
102094057|NCT06016413|Carboplatin|carboplatin|mesh-list
102094058|NCT06016413|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102094059|NCT06016413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102094060|NCT06016413|Tubulin Modulators|tubulin modulators|mesh-ancestor
102094061|NCT06016413|Antimitotic Agents|antimitotic agents|mesh-ancestor
102094062|NCT06016413|Mitosis Modulators|mitosis modulators|mesh-ancestor
102094063|NCT06016413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094064|NCT06016400|Alfacalcidol|alfacalcidol|mesh-list
102094065|NCT06016400|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
102094066|NCT06016400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102094067|NCT06016400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094068|NCT06016400|Vitamins|vitamins|mesh-ancestor
102094069|NCT06016400|Micronutrients|micronutrients|mesh-ancestor
102094070|NCT06016387|Capecitabine|capecitabine|mesh-list
102094071|NCT06016387|Trastuzumab|trastuzumab|mesh-list
102094072|NCT06016387|Tucatinib|tucatinib|mesh-list
102094073|NCT06016387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101944844|NCT05177666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944845|NCT03342638|Methylprednisolone|methylprednisolone|mesh-list
101944846|NCT03342638|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101944847|NCT03342638|Cyclophosphamide|cyclophosphamide|mesh-list
102094074|NCT06016387|Antimetabolites|antimetabolites|mesh-ancestor
102094084|NCT06016270|Tubulin Modulators|tubulin modulators|mesh-ancestor
102094085|NCT06016270|Antimitotic Agents|antimitotic agents|mesh-ancestor
102094086|NCT06016270|Mitosis Modulators|mitosis modulators|mesh-ancestor
102094087|NCT06016270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094088|NCT06016218|Simvastatin|simvastatin|mesh-list
102094089|NCT06016218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102094090|NCT06016218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102094091|NCT06016218|Antimetabolites|antimetabolites|mesh-ancestor
102094092|NCT06016218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094093|NCT06016218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102094094|NCT06016218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102094095|NCT06016218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102094096|NCT06016205|Morphine|morphine|mesh-list
102094097|NCT06016205|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102094098|NCT06016205|Narcotics|narcotics|mesh-ancestor
102094099|NCT06016205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102094100|NCT06016205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094101|NCT06016205|Analgesics|analgesics|mesh-ancestor
102094102|NCT06016205|Sensory System Agents|sensory system agents|mesh-ancestor
102094103|NCT06016205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102094104|NCT06016088|Tobramycin|tobramycin|mesh-list
102094105|NCT06016088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102094106|NCT06016088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102094107|NCT06015880|Lenalidomide|lenalidomide|mesh-list
102094108|NCT06015880|Antibodies|antibodies|mesh-list
102094109|NCT06015880|Immunoglobulins|immunoglobulins|mesh-list
102094110|NCT06015880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102094111|NCT06015880|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102094112|NCT06015880|Immunoconjugates|immunoconjugates|mesh-list
102094113|NCT06015880|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
102094114|NCT06015880|Immunologic Factors|immunologic factors|mesh-ancestor
102094115|NCT06015880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094116|NCT06015880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102094117|NCT06015880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102094118|NCT06015880|Growth Substances|growth substances|mesh-ancestor
102094119|NCT06015880|Growth Inhibitors|growth inhibitors|mesh-ancestor
102094120|NCT06015880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102094121|NCT06015828|Lactoferrin|lactoferrin|mesh-list
102094122|NCT06015828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102094123|NCT06015750|Folic Acid|folic acid|mesh-list
102094124|NCT06015750|Rituximab|rituximab|mesh-list
102094125|NCT06015750|Methotrexate|methotrexate|mesh-list
102094126|NCT06015750|Bortezomib|bortezomib|mesh-list
102094127|NCT06015750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102094128|NCT06015750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102094129|NCT06015750|Immunologic Factors|immunologic factors|mesh-ancestor
102094130|NCT06015750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094131|NCT06015750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102094132|NCT06015750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102094133|NCT06015750|Abortifacient Agents|abortifacient agents|mesh-ancestor
102094134|NCT06015750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102094135|NCT06015750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102094136|NCT06015750|Antimetabolites|antimetabolites|mesh-ancestor
102094137|NCT06015750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094138|NCT06015750|Dermatologic Agents|dermatologic agents|mesh-ancestor
102094139|NCT06015750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102094140|NCT06015750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102094149|NCT06015724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102094150|NCT06015724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102094151|NCT06015724|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102094152|NCT06015724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094154|NCT06015659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102094155|NCT06015659|Antimetabolites|antimetabolites|mesh-ancestor
102094156|NCT06015659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094157|NCT06015659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102094158|NCT06015594|Metformin|metformin|mesh-list
101944848|NCT03342638|Thymoglobulin|thymoglobulin|mesh-list
101944849|NCT03342638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101944850|NCT03342638|Immunologic Factors|immunologic factors|mesh-ancestor
101944851|NCT03342638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944852|NCT03342638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101944853|NCT03342638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101944854|NCT03342638|Alkylating Agents|alkylating agents|mesh-ancestor
101944855|NCT03342638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944856|NCT03342638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101944857|NCT03342638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101944858|NCT03342638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101944859|NCT03342638|Antiemetics|antiemetics|mesh-ancestor
101944860|NCT03342638|Autonomic Agents|autonomic agents|mesh-ancestor
101944861|NCT03342638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101944862|NCT03342638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101944863|NCT03342638|Glucocorticoids|glucocorticoids|mesh-ancestor
101944864|NCT03342638|Hormones|hormones|mesh-ancestor
102094159|NCT06015594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102094160|NCT06015594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094161|NCT06015516|Minoxidil|minoxidil|mesh-list
102094162|NCT06015516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102094163|NCT06015516|Vasodilator Agents|vasodilator agents|mesh-ancestor
102094164|NCT06015490|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102094165|NCT06015477|Ticagrelor|ticagrelor|mesh-list
102094166|NCT06015477|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102094167|NCT06015477|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102094168|NCT06015477|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102094169|NCT06015477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102094170|NCT06015477|Purinergic Agents|purinergic agents|mesh-ancestor
102094171|NCT06015477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102094172|NCT06015477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094173|NCT06015477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094174|NCT06015373|Carvedilol|carvedilol|mesh-list
102094175|NCT06015373|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102094176|NCT06015373|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102094177|NCT06015373|Adrenergic Agents|adrenergic agents|mesh-ancestor
102094178|NCT06015373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102094179|NCT06015373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094180|NCT06015373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094181|NCT06015373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102094182|NCT06015373|Antioxidants|antioxidants|mesh-ancestor
102094183|NCT06015373|Protective Agents|protective agents|mesh-ancestor
102094184|NCT06015373|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102094185|NCT06015373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102094186|NCT06015373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102094187|NCT06015373|Vasodilator Agents|vasodilator agents|mesh-ancestor
102094188|NCT06015373|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102094189|NCT06015373|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102094190|NCT06015308|Vaccines|vaccines|mesh-list
102094191|NCT06015308|Immunologic Factors|immunologic factors|mesh-ancestor
102094192|NCT06015308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094193|NCT06015269|Vaccines|vaccines|mesh-list
102094194|NCT06015269|Immunologic Factors|immunologic factors|mesh-ancestor
102094195|NCT06015269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094196|NCT06015152|Tazarotene|tazarotene|mesh-list
102094197|NCT06015152|Dermatologic Agents|dermatologic agents|mesh-ancestor
102094198|NCT06015152|Keratolytic Agents|keratolytic agents|mesh-ancestor
102094199|NCT06015126|Vinorelbine|vinorelbine|mesh-list
101944865|NCT03342638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101944866|NCT03342638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101944867|NCT03342638|Protective Agents|protective agents|mesh-ancestor
102094200|NCT06015126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102094201|NCT06015126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102094202|NCT06015126|Tubulin Modulators|tubulin modulators|mesh-ancestor
102094203|NCT06015126|Antimitotic Agents|antimitotic agents|mesh-ancestor
102094204|NCT06015126|Mitosis Modulators|mitosis modulators|mesh-ancestor
102094205|NCT06015126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094206|NCT06015113|Disitamab vedotin|disitamab vedotin|mesh-list
102094207|NCT06015113|Immunoconjugates|immunoconjugates|mesh-ancestor
102094208|NCT06015113|Immunologic Factors|immunologic factors|mesh-ancestor
102094209|NCT06015113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094224|NCT06015022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094226|NCT06015022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094227|NCT06015022|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
102094228|NCT06015022|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102094229|NCT06015022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102094230|NCT06015022|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102094231|NCT06012669|Lactoferrin|lactoferrin|mesh-list
102094232|NCT06012669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102094233|NCT06003348|Potassium Citrate|potassium citrate|mesh-list
102094234|NCT06003348|Diuretics|diuretics|mesh-ancestor
102094235|NCT06003348|Natriuretic Agents|natriuretic agents|mesh-ancestor
102094236|NCT06003348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094237|NCT06003348|Expectorants|expectorants|mesh-ancestor
102094238|NCT06003348|Respiratory System Agents|respiratory system agents|mesh-ancestor
102094239|NCT05999773|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102094240|NCT05999773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094241|NCT05999773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102094242|NCT05999773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094248|NCT05996471|Cabotegravir|cabotegravir|mesh-list
102094249|NCT05996471|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102094250|NCT05996471|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102094251|NCT05996471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102094252|NCT05996471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094253|NCT05996471|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102094254|NCT05996471|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102094255|NCT05996471|Antiviral Agents|antiviral agents|mesh-ancestor
102094256|NCT05996471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102094257|NCT05995444|Moxifloxacin|moxifloxacin|mesh-list
102094258|NCT05995444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102094259|NCT05995444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102094260|NCT05995444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102094261|NCT05995444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102094262|NCT05995444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102094263|NCT05995444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094264|NCT05995444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102094284|NCT05933395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094285|NCT05933395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102094286|NCT05933395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102094287|NCT05933395|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102094288|NCT05933395|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102094289|NCT05933395|Hormone Antagonists|hormone antagonists|mesh-ancestor
102094290|NCT05933395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102094302|NCT05911295|Carboplatin|carboplatin|mesh-list
102094303|NCT05911295|Gemcitabine|gemcitabine|mesh-list
102094304|NCT05911295|Pembrolizumab|pembrolizumab|mesh-list
102094305|NCT05911295|Disitamab vedotin|disitamab vedotin|mesh-list
102094306|NCT05911295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102094307|NCT05911295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102094308|NCT05911295|Antimetabolites|antimetabolites|mesh-ancestor
102094309|NCT05911295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094310|NCT05911295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102094311|NCT05911295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102094312|NCT05911295|Immunoconjugates|immunoconjugates|mesh-ancestor
102094313|NCT05911295|Immunologic Factors|immunologic factors|mesh-ancestor
102094314|NCT05911295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094315|NCT05907980|Atezolizumab|atezolizumab|mesh-list
102094316|NCT05907980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101944868|NCT03342638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101944869|NCT01246323|Fentanyl|fentanyl|mesh-list
101944870|NCT01246323|Morphine|morphine|mesh-list
101944871|NCT01246323|Anesthetics|anesthetics|mesh-ancestor
102094317|NCT05907980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094318|NCT05907980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102094319|NCT05907980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102094373|NCT05888207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102094374|NCT05888207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102094375|NCT05888207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094376|NCT05888207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102094377|NCT05888207|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102094378|NCT05888207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102094379|NCT05888207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102094380|NCT05888207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094381|NCT05888207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102094382|NCT05888207|Serotonin Agents|serotonin agents|mesh-ancestor
102094383|NCT05888207|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102094384|NCT05888207|Antidepressive Agents|antidepressive agents|mesh-ancestor
102094385|NCT05888207|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102094386|NCT05888207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102094387|NCT05888207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102094388|NCT05888207|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102094389|NCT05887843|Mometasone Furoate|mometasone furoate|mesh-list
102094390|NCT05887843|Azelastine|azelastine|mesh-list
102094391|NCT05887843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102094392|NCT05887843|Dermatologic Agents|dermatologic agents|mesh-ancestor
102094393|NCT05887843|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102094394|NCT05887843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102094395|NCT05887843|Autonomic Agents|autonomic agents|mesh-ancestor
102094396|NCT05887843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102094407|NCT05887843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102094413|NCT05878405|Anti-Infective Agents|anti-infective agents|mesh-list
102094414|NCT05878405|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102094415|NCT05878405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102094416|NCT05878405|Analgesics|analgesics|mesh-list
102094417|NCT05878405|Methylene Blue|methylene blue|mesh-list
102094418|NCT05878405|Sensory System Agents|sensory system agents|mesh-ancestor
102094419|NCT05878405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102094420|NCT05878405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094421|NCT05878405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102094422|NCT05878405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094423|NCT05878093|Budesonide|budesonide|mesh-list
102094424|NCT05878093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102094425|NCT05878093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102094426|NCT05878093|Autonomic Agents|autonomic agents|mesh-ancestor
102094427|NCT05878093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102094428|NCT05878093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094429|NCT05878093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102094430|NCT05878093|Respiratory System Agents|respiratory system agents|mesh-ancestor
102094431|NCT05878093|Glucocorticoids|glucocorticoids|mesh-ancestor
102094432|NCT05878093|Hormones|hormones|mesh-ancestor
102094433|NCT05878093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102094434|NCT05866367|Insulin|insulin|mesh-list
102094435|NCT05866367|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102094436|NCT05866367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102094437|NCT05866367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094447|NCT05836272|Norepinephrine|norepinephrine|mesh-list
102094448|NCT05836272|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102094449|NCT05836272|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102094450|NCT05836272|Adrenergic Agents|adrenergic agents|mesh-ancestor
102094451|NCT05836272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102094452|NCT05836272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094453|NCT05836272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094454|NCT05836272|Sympathomimetics|sympathomimetics|mesh-ancestor
102094455|NCT05836272|Autonomic Agents|autonomic agents|mesh-ancestor
102094456|NCT05836272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102094457|NCT05836272|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102094458|NCT05822765|Epinephrine|epinephrine|mesh-list
102094459|NCT05822765|Racepinephrine|racepinephrine|mesh-list
102094460|NCT05822765|Epinephryl borate|epinephryl borate|mesh-list
101944872|NCT01246323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101944873|NCT01246323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094461|NCT05822765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102094462|NCT05822765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102094463|NCT05822765|Adrenergic Agents|adrenergic agents|mesh-ancestor
102094464|NCT05822765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102094465|NCT05822765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094494|NCT05784363|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102094495|NCT05784363|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102094496|NCT05784363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102094497|NCT05784363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094498|NCT05784363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102094499|NCT05784363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102094500|NCT05784363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094501|NCT05784363|Cholinergic Agents|cholinergic agents|mesh-ancestor
102094502|NCT05784363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102094503|NCT05782244|Sildenafil Citrate|sildenafil citrate|mesh-list
102094504|NCT05782244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094505|NCT05782244|Vasodilator Agents|vasodilator agents|mesh-ancestor
102094506|NCT05782244|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102094507|NCT05782244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102094508|NCT05782244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102094509|NCT05782244|Urological Agents|urological agents|mesh-ancestor
102094520|NCT05773066|Anesthetics, Local|anesthetics, local|mesh-ancestor
102094521|NCT05773066|Anesthetics|anesthetics|mesh-ancestor
101707310|NCT00518323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094522|NCT05773066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102094523|NCT05773066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094524|NCT05773066|Sensory System Agents|sensory system agents|mesh-ancestor
102094525|NCT05773066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102094526|NCT05773066|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102094527|NCT05773066|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102094528|NCT05773066|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102094529|NCT05773066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102094530|NCT05773066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094531|NCT05766514|Cytarabine|cytarabine|mesh-list
102094532|NCT05766514|Decitabine|decitabine|mesh-list
102094533|NCT05766514|Venetoclax|venetoclax|mesh-list
102094550|NCT05738135|Aminophylline|aminophylline|mesh-list
102094551|NCT05738135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102094552|NCT05738135|Autonomic Agents|autonomic agents|mesh-ancestor
102094553|NCT05738135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102094554|NCT05738135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094555|NCT05738135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102094556|NCT05738135|Respiratory System Agents|respiratory system agents|mesh-ancestor
102094557|NCT05738135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102094558|NCT05738135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102094559|NCT05738135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102094560|NCT05738135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094561|NCT05738135|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102094562|NCT05738135|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102094563|NCT05738135|Purinergic Agents|purinergic agents|mesh-ancestor
102094564|NCT05738135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102094565|NCT05738135|Protective Agents|protective agents|mesh-ancestor
102094566|NCT05718323|Niraparib|niraparib|mesh-list
102094567|NCT05718323|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102094568|NCT05718323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102094569|NCT05718323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094570|NCT05718323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102094586|NCT05712356|Paclitaxel|paclitaxel|mesh-list
102094587|NCT05712356|Docetaxel|docetaxel|mesh-list
102094588|NCT05712356|Gemcitabine|gemcitabine|mesh-list
102094589|NCT05712356|Durvalumab|durvalumab|mesh-list
102094590|NCT05712356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102094591|NCT05712356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102094592|NCT05712356|Tubulin Modulators|tubulin modulators|mesh-ancestor
102094593|NCT05712356|Antimitotic Agents|antimitotic agents|mesh-ancestor
102094594|NCT05712356|Mitosis Modulators|mitosis modulators|mesh-ancestor
102094595|NCT05712356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094596|NCT05712356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102094597|NCT05712356|Antimetabolites|antimetabolites|mesh-ancestor
101944874|NCT01246323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101944875|NCT01246323|Narcotics|narcotics|mesh-ancestor
102094598|NCT05712356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102094599|NCT05708625|Doxycycline|doxycycline|mesh-list
102094600|NCT05708625|Voriconazole|voriconazole|mesh-list
102094601|NCT05708625|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
102094602|NCT05708625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102094603|NCT05708625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102094604|NCT05708625|Antimalarials|antimalarials|mesh-ancestor
102094605|NCT05708625|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101396394|NCT02959957|Cefotaxime|cefotaxime|mesh-list
102094631|NCT05697276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102094632|NCT05697276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814411|NCT03026036|Dopamine Agents|dopamine agents|mesh-ancestor
102094656|NCT05690204|Gout Suppressants|gout suppressants|mesh-ancestor
102094657|NCT05690204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102094658|NCT05690204|Tubulin Modulators|tubulin modulators|mesh-ancestor
102094659|NCT05690204|Antimitotic Agents|antimitotic agents|mesh-ancestor
102094660|NCT05690204|Mitosis Modulators|mitosis modulators|mesh-ancestor
101707321|NCT00707421|Ketorolac|ketorolac|mesh-list
102094661|NCT05690204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094662|NCT05690204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102094663|NCT05689151|Abrocitinib|abrocitinib|mesh-list
102094664|NCT05689151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102094665|NCT05689151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102094666|NCT05689151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094667|NCT05672784|Acetaminophen|acetaminophen|mesh-list
102094668|NCT05672784|Meloxicam|meloxicam|mesh-list
102094669|NCT05672784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102094670|NCT05672784|Analgesics|analgesics|mesh-ancestor
102094671|NCT05672784|Sensory System Agents|sensory system agents|mesh-ancestor
102094672|NCT05672784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102094673|NCT05672784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094674|NCT05672784|Antipyretics|antipyretics|mesh-ancestor
102094698|NCT05669989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102094699|NCT05669989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102094700|NCT05669989|Growth Substances|growth substances|mesh-ancestor
102094701|NCT05669989|Growth Inhibitors|growth inhibitors|mesh-ancestor
102094702|NCT05669989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102094703|NCT05669664|Leuprolide|leuprolide|mesh-list
102094704|NCT05669664|Androgen Antagonists|androgen antagonists|mesh-list
102094705|NCT05669664|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102094706|NCT05669664|Fertility Agents|fertility agents|mesh-ancestor
102094707|NCT05669664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102094708|NCT05669664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094709|NCT05669664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102094710|NCT05669664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102094711|NCT05669664|Hormone Antagonists|hormone antagonists|mesh-ancestor
102094712|NCT05669664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102094713|NCT05669352|Pembrolizumab|pembrolizumab|mesh-list
102094714|NCT05669352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102094715|NCT05669352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102094716|NCT05669352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102094717|NCT05669352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094718|NCT05661253|Bupivacaine|bupivacaine|mesh-list
102094719|NCT05661253|Anesthetics, Local|anesthetics, local|mesh-ancestor
102094720|NCT05661253|Anesthetics|anesthetics|mesh-ancestor
102094721|NCT05661253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102094722|NCT05661253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094723|NCT05661253|Sensory System Agents|sensory system agents|mesh-ancestor
102094724|NCT05661253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102094725|NCT05660850|Mannitol|mannitol|mesh-list
102094757|NCT05617885|Goserelin|goserelin|mesh-list
102094758|NCT05617885|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
102094759|NCT05617885|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102094760|NCT05617885|Fertility Agents|fertility agents|mesh-ancestor
102094761|NCT05617885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102094762|NCT05617885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094763|NCT05617885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102094764|NCT05617885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102094765|NCT05617885|Hormones|hormones|mesh-ancestor
102094766|NCT05617885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102094767|NCT05617313|Pembrolizumab|pembrolizumab|mesh-list
102094768|NCT05617313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101944877|NCT01246323|Sensory System Agents|sensory system agents|mesh-ancestor
101783964|NCT00849342|Insulin Detemir|insulin detemir|mesh-list
102094769|NCT05617313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102094770|NCT05617313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102094771|NCT05617313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094772|NCT05615818|Gemcitabine|gemcitabine|mesh-list
102094773|NCT05615818|Trastuzumab|trastuzumab|mesh-list
102094774|NCT05615818|Niraparib|niraparib|mesh-list
102094775|NCT05615818|Ivosidenib|ivosidenib|mesh-list
102094776|NCT05615818|Futibatinib|futibatinib|mesh-list
102094777|NCT05615818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102094778|NCT05615818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102094779|NCT05615818|Antimetabolites|antimetabolites|mesh-ancestor
102094780|NCT05615818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094781|NCT05615818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102094782|NCT05615818|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102094783|NCT05615818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102094784|NCT05603832|Acetaminophen|acetaminophen|mesh-list
102094785|NCT05603832|Bupivacaine|bupivacaine|mesh-list
102094786|NCT05603832|Methocarbamol|methocarbamol|mesh-list
102094787|NCT05603832|Anesthetics, Local|anesthetics, local|mesh-ancestor
102094788|NCT05603832|Anesthetics|anesthetics|mesh-ancestor
102094789|NCT05603832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102094790|NCT05603832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094791|NCT05603832|Sensory System Agents|sensory system agents|mesh-ancestor
102094792|NCT05603832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102094793|NCT05603832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102094794|NCT05603832|Analgesics|analgesics|mesh-ancestor
102094795|NCT05603832|Antipyretics|antipyretics|mesh-ancestor
102094796|NCT05603832|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102094797|NCT05603832|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102094798|NCT05601492|Thalidomide|thalidomide|mesh-list
102094799|NCT05601492|Apremilast|apremilast|mesh-list
102094802|NCT05601492|Analgesics|analgesics|mesh-ancestor
102094803|NCT05601492|Sensory System Agents|sensory system agents|mesh-ancestor
102094804|NCT05601492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102094805|NCT05601492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094806|NCT05601492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102094807|NCT05601492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102094808|NCT05601492|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102094809|NCT05601492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102094810|NCT05601492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102094811|NCT05601492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094812|NCT05601492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102094813|NCT05601492|Immunologic Factors|immunologic factors|mesh-ancestor
102094814|NCT05601492|Leprostatic Agents|leprostatic agents|mesh-ancestor
102094815|NCT05601492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102094816|NCT05601492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102094817|NCT05601492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102094818|NCT05601492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102094819|NCT05601492|Growth Substances|growth substances|mesh-ancestor
102094820|NCT05601492|Growth Inhibitors|growth inhibitors|mesh-ancestor
102094821|NCT05601492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102094822|NCT05601271|Allopurinol|allopurinol|mesh-list
102094823|NCT05601271|Antimetabolites|antimetabolites|mesh-ancestor
102094824|NCT05601271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094825|NCT05601271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102094826|NCT05601271|Gout Suppressants|gout suppressants|mesh-ancestor
102094827|NCT05601271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102094828|NCT05601271|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102094829|NCT05601271|Antioxidants|antioxidants|mesh-ancestor
102094830|NCT05601271|Protective Agents|protective agents|mesh-ancestor
102094831|NCT05601271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094832|NCT05580562|TIC10 compound|tic10 compound|mesh-list
102094833|NCT05580562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102094834|NCT05567835|Leucovorin|leucovorin|mesh-list
102094835|NCT05567835|Docetaxel|docetaxel|mesh-list
102094836|NCT05567835|Fluorouracil|fluorouracil|mesh-list
102094837|NCT05567835|Oxaliplatin|oxaliplatin|mesh-list
102094838|NCT05567835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102094839|NCT05567835|Tubulin Modulators|tubulin modulators|mesh-ancestor
102094840|NCT05567835|Antimitotic Agents|antimitotic agents|mesh-ancestor
102094841|NCT05567835|Mitosis Modulators|mitosis modulators|mesh-ancestor
102094842|NCT05567835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944878|NCT01246323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101944879|NCT01246323|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102094843|NCT05567835|Antimetabolites|antimetabolites|mesh-ancestor
102094844|NCT05567835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102094845|NCT05567835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102094846|NCT05567835|Immunologic Factors|immunologic factors|mesh-ancestor
102094847|NCT05567835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094848|NCT05567835|Antidotes|antidotes|mesh-ancestor
102094849|NCT05567835|Protective Agents|protective agents|mesh-ancestor
102094850|NCT05567835|Vitamin B Complex|vitamin b complex|mesh-ancestor
102094851|NCT05567835|Vitamins|vitamins|mesh-ancestor
102094852|NCT05567835|Micronutrients|micronutrients|mesh-ancestor
102094853|NCT05565495|Hydromorphone|hydromorphone|mesh-list
102094854|NCT05565495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102094855|NCT05565495|Narcotics|narcotics|mesh-ancestor
102094856|NCT05565495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102094857|NCT05565495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094858|NCT05565495|Analgesics|analgesics|mesh-ancestor
102094859|NCT05565495|Sensory System Agents|sensory system agents|mesh-ancestor
102094860|NCT05565495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102094861|NCT05564403|Calcium, Dietary|calcium, dietary|mesh-list
102094862|NCT05564403|Leucovorin|leucovorin|mesh-list
102094863|NCT05564403|Folic Acid|folic acid|mesh-list
102094864|NCT05564403|Fluorouracil|fluorouracil|mesh-list
102094865|NCT05564403|Oxaliplatin|oxaliplatin|mesh-list
102094866|NCT05564403|Calcium|calcium|mesh-list
102094867|NCT05564403|Levoleucovorin|levoleucovorin|mesh-list
102094868|NCT05564403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102094869|NCT05564403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094870|NCT05564403|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102094871|NCT05564403|Antimetabolites|antimetabolites|mesh-ancestor
102094872|NCT05564403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094873|NCT05564403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102094878|NCT05564403|Protective Agents|protective agents|mesh-ancestor
102094879|NCT05564403|Vitamin B Complex|vitamin b complex|mesh-ancestor
102094880|NCT05564403|Vitamins|vitamins|mesh-ancestor
102094881|NCT05564403|Micronutrients|micronutrients|mesh-ancestor
102094882|NCT05564403|Hematinics|hematinics|mesh-ancestor
102094884|NCT05564377|Paclitaxel|paclitaxel|mesh-list
102094885|NCT05564377|Fluorouracil|fluorouracil|mesh-list
102094886|NCT05564377|Oxaliplatin|oxaliplatin|mesh-list
102094887|NCT05564377|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102094888|NCT05564377|Fulvestrant|fulvestrant|mesh-list
102094889|NCT05564377|Olaparib|olaparib|mesh-list
102094890|NCT05564377|Palbociclib|palbociclib|mesh-list
102094891|NCT05564377|Panitumumab|panitumumab|mesh-list
102094892|NCT05564377|Ipatasertib|ipatasertib|mesh-list
102094893|NCT05564377|Sotorasib|sotorasib|mesh-list
102094894|NCT05564377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102094895|NCT05564377|Antibodies|antibodies|mesh-list
102094896|NCT05564377|Immunoglobulins|immunoglobulins|mesh-list
102094897|NCT05564377|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102094898|NCT05564377|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
102094899|NCT05564377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102094900|NCT05564377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102094901|NCT05564377|Tubulin Modulators|tubulin modulators|mesh-ancestor
102094902|NCT05564377|Antimitotic Agents|antimitotic agents|mesh-ancestor
102094903|NCT05564377|Mitosis Modulators|mitosis modulators|mesh-ancestor
102094904|NCT05564377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094905|NCT05564377|Immunologic Factors|immunologic factors|mesh-ancestor
102094906|NCT05564377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094907|NCT05564377|Antimetabolites|antimetabolites|mesh-ancestor
102094908|NCT05564377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102094909|NCT05564377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102094910|NCT05564377|Antidotes|antidotes|mesh-ancestor
102094911|NCT05564377|Protective Agents|protective agents|mesh-ancestor
102094912|NCT05564377|Vitamin B Complex|vitamin b complex|mesh-ancestor
102094913|NCT05564377|Vitamins|vitamins|mesh-ancestor
102094914|NCT05564377|Micronutrients|micronutrients|mesh-ancestor
102094915|NCT05564377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102094916|NCT05564377|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102094917|NCT05564377|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102094918|NCT05564377|Hormone Antagonists|hormone antagonists|mesh-ancestor
102094919|NCT05564377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102094920|NCT05564377|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102094921|NCT05564377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102094922|NCT05564377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101944880|NCT01246323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101944881|NCT01246323|Anesthetics, General|anesthetics, general|mesh-ancestor
101944882|NCT05160363|Piperaquine|piperaquine|mesh-list
101944883|NCT05160363|Pyronaridine|pyronaridine|mesh-list
101944884|NCT05160363|Antimalarials|antimalarials|mesh-ancestor
101944885|NCT05160363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102094923|NCT05564377|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102094924|NCT05544929|Tislelizumab|tislelizumab|mesh-list
102094925|NCT05544929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102094926|NCT05544929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102094927|NCT05542394|Curcumin|curcumin|mesh-list
102094928|NCT05542394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102094929|NCT05542394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102094930|NCT05542394|Analgesics|analgesics|mesh-ancestor
102094931|NCT05542394|Sensory System Agents|sensory system agents|mesh-ancestor
102094932|NCT05542394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102094933|NCT05542394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094934|NCT05542394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102094935|NCT05542394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102094936|NCT05542394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102094937|NCT05542394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102094938|NCT05542394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094939|NCT05519579|Methotrexate|methotrexate|mesh-list
102094940|NCT05519579|Blinatumomab|blinatumomab|mesh-list
102094941|NCT05519579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102094942|NCT05519579|Abortifacient Agents|abortifacient agents|mesh-ancestor
102094943|NCT05519579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102094944|NCT05519579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094945|NCT05519579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102094946|NCT05519579|Antimetabolites|antimetabolites|mesh-ancestor
102094947|NCT05519579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094962|NCT05487235|Atezolizumab|atezolizumab|mesh-list
102094963|NCT05487235|Omeprazole|omeprazole|mesh-list
102094964|NCT05487235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102094965|NCT05487235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094966|NCT05487235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102094967|NCT05487235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102094968|NCT05487235|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102094969|NCT05487235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102094970|NCT05487235|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102094971|NCT05487235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102094972|NCT05470517|Ceftriaxone|ceftriaxone|mesh-list
102094973|NCT05470517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102094974|NCT05470517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102094975|NCT05445778|Bevacizumab|bevacizumab|mesh-list
102094976|NCT05445778|Maytansine|maytansine|mesh-list
102094977|NCT05445778|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
102094978|NCT05445778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102094979|NCT05445778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102094980|NCT05445778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102094981|NCT05445778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102094982|NCT05445778|Growth Substances|growth substances|mesh-ancestor
102094983|NCT05445778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094984|NCT05445778|Growth Inhibitors|growth inhibitors|mesh-ancestor
102094985|NCT05445778|Immunoconjugates|immunoconjugates|mesh-ancestor
102094986|NCT05445778|Immunologic Factors|immunologic factors|mesh-ancestor
102094987|NCT05445778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102094988|NCT05445778|Tubulin Modulators|tubulin modulators|mesh-ancestor
102094989|NCT05445778|Antimitotic Agents|antimitotic agents|mesh-ancestor
102094990|NCT05445778|Mitosis Modulators|mitosis modulators|mesh-ancestor
102094991|NCT05445778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094992|NCT05443555|Gabapentin|gabapentin|mesh-list
102094993|NCT05443555|Analgesics|analgesics|mesh-ancestor
102094994|NCT05443555|Sensory System Agents|sensory system agents|mesh-ancestor
102094995|NCT05443555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102094996|NCT05443555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094997|NCT05443555|Anticonvulsants|anticonvulsants|mesh-ancestor
102094998|NCT05443555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102094999|NCT05443555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102095000|NCT05443555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101944886|NCT05160363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101944887|NCT05160363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101944889|NCT05177276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101944890|NCT05177276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101784173|NCT00853866|Reboxetine|reboxetine|mesh-list
102095001|NCT05443555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102095002|NCT05443555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102095003|NCT05443555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102095004|NCT05443555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102095005|NCT05443555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095006|NCT05443555|Antimanic Agents|antimanic agents|mesh-ancestor
102095007|NCT05442216|Azacitidine|azacitidine|mesh-list
102095008|NCT05442216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102095009|NCT05442216|Antimetabolites|antimetabolites|mesh-ancestor
102095010|NCT05442216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095011|NCT05442216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095012|NCT05442216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102095013|NCT05417594|Temozolomide|temozolomide|mesh-list
102095014|NCT05417594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102095015|NCT05417594|Alkylating Agents|alkylating agents|mesh-ancestor
102095016|NCT05417594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095017|NCT05417594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095018|NCT05396833|Avelumab|avelumab|mesh-list
102095028|NCT05372588|Vaccines|vaccines|mesh-list
102095029|NCT05372588|Immunologic Factors|immunologic factors|mesh-ancestor
102095030|NCT05372588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095031|NCT05369832|Ozanimod|ozanimod|mesh-list
102095032|NCT05369832|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102095033|NCT05369832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095035|NCT05369832|Immunologic Factors|immunologic factors|mesh-ancestor
102095036|NCT05369832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095037|NCT05363267|Curcumin|curcumin|mesh-list
102095038|NCT05363267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102095039|NCT05363267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102095040|NCT05363267|Analgesics|analgesics|mesh-ancestor
102095041|NCT05363267|Sensory System Agents|sensory system agents|mesh-ancestor
102095042|NCT05363267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102095043|NCT05363267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095044|NCT05363267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102095045|NCT05363267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102095046|NCT05363267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095047|NCT05363267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102095048|NCT05363267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095049|NCT05360966|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102095050|NCT05360966|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102095051|NCT05353257|Carboplatin|carboplatin|mesh-list
102095052|NCT05353257|Etoposide|etoposide|mesh-list
102095053|NCT05353257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095054|NCT05353257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102095055|NCT05353257|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102095056|NCT05353257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102095057|NCT05353257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101707361|NCT00825825|Citalopram|citalopram|mesh-list
102095058|NCT05353257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095059|NCT05307705|Paclitaxel|paclitaxel|mesh-list
102095060|NCT05307705|Letrozole|letrozole|mesh-list
102095061|NCT05307705|Fulvestrant|fulvestrant|mesh-list
102095062|NCT05307705|Anastrozole|anastrozole|mesh-list
102095063|NCT05307705|Exemestane|exemestane|mesh-list
102095064|NCT05307705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102095065|NCT05307705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095066|NCT05307705|Tubulin Modulators|tubulin modulators|mesh-ancestor
102095067|NCT05307705|Antimitotic Agents|antimitotic agents|mesh-ancestor
102095068|NCT05307705|Mitosis Modulators|mitosis modulators|mesh-ancestor
102095069|NCT05307705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095070|NCT05307705|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102095071|NCT05307705|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102095072|NCT05307705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102095073|NCT05307705|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102095074|NCT05307705|Hormone Antagonists|hormone antagonists|mesh-ancestor
101944891|NCT05177276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101944892|NCT05177276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944893|NCT05177276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101784257|NCT00854256|Mitomycins|mitomycins|mesh-list
102095075|NCT05307705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102095076|NCT05307705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095077|NCT05307705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102095078|NCT05307705|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102095079|NCT05301842|Durvalumab|durvalumab|mesh-list
102095080|NCT05301842|Lenvatinib|lenvatinib|mesh-list
102095081|NCT05301842|Tremelimumab|tremelimumab|mesh-list
102095082|NCT05301842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102095083|NCT05301842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095084|NCT05301842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102095085|NCT05301842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102095086|NCT05301842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095107|NCT05286801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095108|NCT05286801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102095109|NCT05286801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095110|NCT05286801|Immunologic Factors|immunologic factors|mesh-ancestor
102095111|NCT05286801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095112|NCT05286801|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102095113|NCT05286801|Antimetabolites|antimetabolites|mesh-ancestor
102095114|NCT05286801|Antiviral Agents|antiviral agents|mesh-ancestor
102095115|NCT05286801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102095116|NCT05276492|Prednisone|prednisone|mesh-list
102095117|NCT05276492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102095118|NCT05276492|Glucocorticoids|glucocorticoids|mesh-ancestor
102095119|NCT05276492|Hormones|hormones|mesh-ancestor
102095120|NCT05276492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102095121|NCT05276492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095122|NCT05276492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102095123|NCT05276492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095124|NCT05267626|Aldesleukin|aldesleukin|mesh-list
102095125|NCT05267626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095126|NCT05267626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102095127|NCT05267626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102095128|NCT05267626|Antiviral Agents|antiviral agents|mesh-ancestor
102095129|NCT05267626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102095130|NCT05253651|Leucovorin|leucovorin|mesh-list
102095131|NCT05253651|Bevacizumab|bevacizumab|mesh-list
102095132|NCT05253651|Trastuzumab|trastuzumab|mesh-list
102095133|NCT05253651|Cetuximab|cetuximab|mesh-list
102095134|NCT05253651|Fluorouracil|fluorouracil|mesh-list
102095135|NCT05253651|Oxaliplatin|oxaliplatin|mesh-list
102095136|NCT05253651|Tucatinib|tucatinib|mesh-list
102095137|NCT05253651|Levoleucovorin|levoleucovorin|mesh-list
102095138|NCT05253651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102095139|NCT05253651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095140|NCT05253651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102095141|NCT05253651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101707374|NCT03802487|Charcoal|charcoal|mesh-list
102095142|NCT05253651|Growth Substances|growth substances|mesh-ancestor
102095143|NCT05253651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095144|NCT05253651|Growth Inhibitors|growth inhibitors|mesh-ancestor
102095145|NCT05253651|Antimetabolites|antimetabolites|mesh-ancestor
102095146|NCT05253651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095147|NCT05253651|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102095148|NCT05253651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102095149|NCT05253651|Immunologic Factors|immunologic factors|mesh-ancestor
102095150|NCT05253651|Antidotes|antidotes|mesh-ancestor
102095151|NCT05253651|Protective Agents|protective agents|mesh-ancestor
102095152|NCT05253651|Vitamin B Complex|vitamin b complex|mesh-ancestor
102095153|NCT05253651|Vitamins|vitamins|mesh-ancestor
102095154|NCT05253651|Micronutrients|micronutrients|mesh-ancestor
102095155|NCT05253651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102095156|NCT05253651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102095157|NCT05190315|Temozolomide|temozolomide|mesh-list
101944894|NCT02528175|Capecitabine|capecitabine|mesh-list
101944895|NCT02528175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101944896|NCT02528175|Antimetabolites|antimetabolites|mesh-ancestor
102095158|NCT05190315|Chlorpromazine|chlorpromazine|mesh-list
102095159|NCT05190315|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102095160|NCT05190315|Alkylating Agents|alkylating agents|mesh-ancestor
102095161|NCT05190315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095171|NCT05190315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102095172|NCT05190315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102095173|NCT05190315|Dopamine Agents|dopamine agents|mesh-ancestor
102095174|NCT05190315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102095175|NCT05143840|Niacinamide|niacinamide|mesh-list
102095176|NCT05143840|Imatinib Mesylate|imatinib mesylate|mesh-list
102095178|NCT05143840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095179|NCT05143840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102095180|NCT05143840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102095181|NCT05143840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095182|NCT05143840|Vitamin B Complex|vitamin b complex|mesh-ancestor
102095183|NCT05143840|Vitamins|vitamins|mesh-ancestor
101814934|NCT05357456|Epinephrine|epinephrine|mesh-list
102095184|NCT05143840|Micronutrients|micronutrients|mesh-ancestor
102095185|NCT05143840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095186|NCT05134974|Phentolamine|phentolamine|mesh-list
102095187|NCT05134974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102095188|NCT05134974|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102095189|NCT05134974|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102095190|NCT05134974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102095191|NCT05134974|Adrenergic Agents|adrenergic agents|mesh-ancestor
102095192|NCT05134974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102095193|NCT05134974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095194|NCT05134974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095195|NCT05134974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102095196|NCT05134922|Gedatolisib|gedatolisib|mesh-list
102095197|NCT05134922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102095198|NCT05134922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102095199|NCT05134922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095200|NCT05132582|Trastuzumab|trastuzumab|mesh-list
102095201|NCT05132582|Pertuzumab|pertuzumab|mesh-list
102095202|NCT05132582|Tucatinib|tucatinib|mesh-list
102095203|NCT05132582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102095204|NCT05132582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095205|NCT05132582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102095206|NCT05132582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102095207|NCT05132582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095208|NCT05109442|Atezolizumab|atezolizumab|mesh-list
102095209|NCT05109442|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102095210|NCT05109442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095211|NCT05109442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102095212|NCT05109442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095213|NCT05108870|Paclitaxel|paclitaxel|mesh-list
102095214|NCT05108870|Carboplatin|carboplatin|mesh-list
102095215|NCT05108870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102095216|NCT05108870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095217|NCT05108870|Tubulin Modulators|tubulin modulators|mesh-ancestor
102095218|NCT05108870|Antimitotic Agents|antimitotic agents|mesh-ancestor
102095219|NCT05108870|Mitosis Modulators|mitosis modulators|mesh-ancestor
102095220|NCT05108870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095221|NCT05099276|Tranexamic Acid|tranexamic acid|mesh-list
102095222|NCT05099276|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102095223|NCT05099276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102095224|NCT05099276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095225|NCT05099276|Hemostatics|hemostatics|mesh-ancestor
102095226|NCT05099276|Coagulants|coagulants|mesh-ancestor
102095246|NCT05070650|Respiratory System Agents|respiratory system agents|mesh-ancestor
102095247|NCT05070650|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102095248|NCT05070650|Antioxidants|antioxidants|mesh-ancestor
102095249|NCT05070650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095250|NCT05070650|Protective Agents|protective agents|mesh-ancestor
102095251|NCT05070650|Antidotes|antidotes|mesh-ancestor
102095252|NCT05070650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102095253|NCT05070650|Mydriatics|mydriatics|mesh-ancestor
102095254|NCT05070650|Autonomic Agents|autonomic agents|mesh-ancestor
102095255|NCT05070650|Sympathomimetics|sympathomimetics|mesh-ancestor
101944897|NCT02528175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944898|NCT02528175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095256|NCT05070650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102095257|NCT05070650|Nasal Decongestants|nasal decongestants|mesh-ancestor
102095258|NCT05070650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102095259|NCT05070650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102095260|NCT05070650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102095261|NCT05070650|Adrenergic Agents|adrenergic agents|mesh-ancestor
102095262|NCT05070650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102095263|NCT05047211|Dextrans|dextrans|mesh-list
102095264|NCT05047211|Iron-Dextran Complex|iron-dextran complex|mesh-list
102095265|NCT05047211|Anticoagulants|anticoagulants|mesh-ancestor
102095266|NCT05047211|Plasma Substitutes|plasma substitutes|mesh-ancestor
102095267|NCT05047211|Blood Substitutes|blood substitutes|mesh-ancestor
102095268|NCT05047211|Hematinics|hematinics|mesh-ancestor
102095269|NCT04956432|Allopurinol|allopurinol|mesh-list
102095270|NCT04956432|Antimetabolites|antimetabolites|mesh-ancestor
102095271|NCT04956432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095272|NCT04956432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102095273|NCT04956432|Gout Suppressants|gout suppressants|mesh-ancestor
102095274|NCT04956432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102095275|NCT04956432|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102095276|NCT04956432|Antioxidants|antioxidants|mesh-ancestor
102095277|NCT04956432|Protective Agents|protective agents|mesh-ancestor
102095278|NCT04956432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095279|NCT04928846|Docetaxel|docetaxel|mesh-list
102095280|NCT04928846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095281|NCT04928846|Tubulin Modulators|tubulin modulators|mesh-ancestor
102095282|NCT04928846|Antimitotic Agents|antimitotic agents|mesh-ancestor
102095283|NCT04928846|Mitosis Modulators|mitosis modulators|mesh-ancestor
102095284|NCT04928846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095308|NCT04903197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102095309|NCT04903197|Growth Substances|growth substances|mesh-ancestor
102095310|NCT04903197|Growth Inhibitors|growth inhibitors|mesh-ancestor
102095311|NCT04903197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095313|NCT04900038|Dolutegravir|dolutegravir|mesh-list
102095314|NCT04900038|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102095315|NCT04900038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102095316|NCT04900038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102095317|NCT04900038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095318|NCT04900038|Antiviral Agents|antiviral agents|mesh-ancestor
102095319|NCT04900038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102095320|NCT04900038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102095321|NCT04900038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102095322|NCT04900038|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102095323|NCT04900038|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102095324|NCT04895202|Siponimod|siponimod|mesh-list
102095325|NCT04895202|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102095326|NCT04895202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095327|NCT04895202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102095328|NCT04895202|Immunologic Factors|immunologic factors|mesh-ancestor
102095329|NCT04895202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815090|NCT01415882|Hormones|hormones|mesh-ancestor
102095340|NCT04845399|Factor VIII|factor viii|mesh-list
102095341|NCT04845399|Coagulants|coagulants|mesh-ancestor
102095342|NCT04826003|Obinutuzumab|obinutuzumab|mesh-list
102095343|NCT04826003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102095344|NCT04826003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095345|NCT04781322|Alirocumab|alirocumab|mesh-list
102095346|NCT04781322|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102095347|NCT04781322|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102095348|NCT04781322|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102095349|NCT04781322|Antimetabolites|antimetabolites|mesh-ancestor
102095350|NCT04781322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095351|NCT04781322|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102095352|NCT04781322|Protease Inhibitors|protease inhibitors|mesh-ancestor
102095365|NCT04766853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102095366|NCT04766853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102095367|NCT04766853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095368|NCT04766853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102095369|NCT04766853|Immunologic Factors|immunologic factors|mesh-ancestor
102095370|NCT04766853|Viscosupplements|viscosupplements|mesh-ancestor
101944899|NCT03708458|Acetylcysteine|acetylcysteine|mesh-list
101944900|NCT03708458|Indomethacin|indomethacin|mesh-list
101784461|NCT00973869|Analgesics|analgesics|mesh-ancestor
102095371|NCT04766853|Protective Agents|protective agents|mesh-ancestor
102095373|NCT04765059|Carboplatin|carboplatin|mesh-list
102095374|NCT04765059|Pemetrexed|pemetrexed|mesh-list
102095375|NCT04765059|Osimertinib|osimertinib|mesh-list
102095376|NCT04765059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095377|NCT04765059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102095378|NCT04765059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095379|NCT04765059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102095380|NCT04765059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102095381|NCT04765059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101397212|NCT00325546|Hormones|hormones|mesh-ancestor
102095460|NCT04736966|Immunologic Factors|immunologic factors|mesh-ancestor
102095461|NCT04736966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095462|NCT04732845|Cyclophosphamide|cyclophosphamide|mesh-list
102095463|NCT04732845|Fludarabine|fludarabine|mesh-list
102095464|NCT04732845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102095465|NCT04732845|Immunologic Factors|immunologic factors|mesh-ancestor
101707406|NCT00658970|Tirbanibulin|tirbanibulin|mesh-list
102095466|NCT04732845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095467|NCT04732845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102095468|NCT04732845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102095469|NCT04732845|Alkylating Agents|alkylating agents|mesh-ancestor
102095470|NCT04732845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095471|NCT04732845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095472|NCT04732845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102095473|NCT04708782|Treprostinil|treprostinil|mesh-list
102095474|NCT04708782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102095475|NCT04699188|Tislelizumab|tislelizumab|mesh-list
102095476|NCT04699188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102095477|NCT04699188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095478|NCT04697628|Gemcitabine|gemcitabine|mesh-list
102095479|NCT04697628|Irinotecan|irinotecan|mesh-list
102095480|NCT04697628|Pemetrexed|pemetrexed|mesh-list
102095481|NCT04697628|Topotecan|topotecan|mesh-list
102095482|NCT04697628|Vinorelbine|vinorelbine|mesh-list
102095483|NCT04697628|Tisotumab vedotin|tisotumab vedotin|mesh-list
102095484|NCT04697628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102095485|NCT04697628|Antimetabolites|antimetabolites|mesh-ancestor
102095486|NCT04697628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095487|NCT04697628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095488|NCT04697628|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101815241|NCT04694300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102095490|NCT04697628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102095491|NCT04697628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102095497|NCT04697628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102095499|NCT04693715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102095500|NCT04693715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102095501|NCT04693715|Analgesics|analgesics|mesh-ancestor
102095502|NCT04693715|Sensory System Agents|sensory system agents|mesh-ancestor
102095503|NCT04693715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102095504|NCT04693715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095505|NCT04693715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102095506|NCT04693715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102095507|NCT04693715|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102095508|NCT04671667|Cisplatin|cisplatin|mesh-list
102095509|NCT04671667|Carboplatin|carboplatin|mesh-list
102095510|NCT04671667|Pembrolizumab|pembrolizumab|mesh-list
102095511|NCT04671667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095512|NCT04671667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102095513|NCT04671667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102095514|NCT04671667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095515|NCT04657289|Ranibizumab|ranibizumab|mesh-list
102095516|NCT04657289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102095517|NCT04657289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102095518|NCT04657289|Growth Substances|growth substances|mesh-ancestor
102095519|NCT04657289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095520|NCT04657289|Growth Inhibitors|growth inhibitors|mesh-ancestor
102095521|NCT04657289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095522|NCT04617522|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
102095523|NCT04617522|Immunoconjugates|immunoconjugates|mesh-ancestor
102095524|NCT04617522|Immunologic Factors|immunologic factors|mesh-ancestor
102095525|NCT04617522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095526|NCT04616560|Trastuzumab|trastuzumab|mesh-list
101944901|NCT03708458|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101944902|NCT03708458|Antiviral Agents|antiviral agents|mesh-ancestor
101944903|NCT03708458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101944905|NCT03708458|Respiratory System Agents|respiratory system agents|mesh-ancestor
102095527|NCT04616560|Camptothecin|camptothecin|mesh-list
102095528|NCT04616560|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
102095529|NCT04616560|Immunoconjugates|immunoconjugates|mesh-list
102095530|NCT04616560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102095531|NCT04616560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095532|NCT04616560|Immunologic Factors|immunologic factors|mesh-ancestor
102095533|NCT04616560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095534|NCT04616560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102095535|NCT04616560|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102095536|NCT04616560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102095537|NCT04616560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102095538|NCT04616560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095539|NCT04614610|Lidocaine|lidocaine|mesh-list
102095540|NCT04614610|Anesthetics, Local|anesthetics, local|mesh-ancestor
102095541|NCT04614610|Anesthetics|anesthetics|mesh-ancestor
102095542|NCT04614610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102095543|NCT04614610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095544|NCT04614610|Sensory System Agents|sensory system agents|mesh-ancestor
102095545|NCT04614610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102095546|NCT04614610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102095547|NCT04614610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102095548|NCT04614610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102095549|NCT04614610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102095550|NCT04614610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095551|NCT04613453|Midazolam|midazolam|mesh-list
102095552|NCT04613453|Ketamine|ketamine|mesh-list
102095553|NCT04613453|Analgesics|analgesics|mesh-ancestor
102095554|NCT04613453|Sensory System Agents|sensory system agents|mesh-ancestor
102095555|NCT04613453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102095556|NCT04613453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095557|NCT04613453|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102095558|NCT04613453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102095559|NCT04613453|Anesthetics, General|anesthetics, general|mesh-ancestor
102095560|NCT04613453|Anesthetics|anesthetics|mesh-ancestor
101815354|NCT00772187|Fentanyl|fentanyl|mesh-list
102095562|NCT04613453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102095563|NCT04613453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102095564|NCT04613453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102095565|NCT04613453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095566|NCT04613453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102095567|NCT04613453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102095568|NCT04613453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102095569|NCT04613453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102095570|NCT04613453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102095572|NCT04613453|GABA Agents|gaba agents|mesh-ancestor
102095573|NCT04610866|Mitapivat|mitapivat|mesh-list
102095574|NCT04610866|Enzyme Activators|enzyme activators|mesh-ancestor
102095575|NCT04610866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095576|NCT04521478|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102095577|NCT04521478|Antidepressive Agents|antidepressive agents|mesh-ancestor
102095578|NCT04521478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102095579|NCT04521478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102095580|NCT04521478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102095581|NCT04521478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102095582|NCT04521478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095583|NCT04511234|Sirolimus|sirolimus|mesh-list
102095584|NCT04511234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102095585|NCT04511234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102095586|NCT04511234|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102095587|NCT04511234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095588|NCT04511234|Antifungal Agents|antifungal agents|mesh-ancestor
102095589|NCT04511234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102095590|NCT04511234|Immunologic Factors|immunologic factors|mesh-ancestor
102095591|NCT04511234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095592|NCT04499924|Paclitaxel|paclitaxel|mesh-list
102095593|NCT04499924|Trastuzumab|trastuzumab|mesh-list
101944906|NCT03708458|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101944907|NCT03708458|Antioxidants|antioxidants|mesh-ancestor
101944908|NCT03708458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944909|NCT03708458|Protective Agents|protective agents|mesh-ancestor
102095594|NCT04499924|Ramucirumab|ramucirumab|mesh-list
102095595|NCT04499924|Tucatinib|tucatinib|mesh-list
102095596|NCT04499924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102095597|NCT04499924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095598|NCT04499924|Tubulin Modulators|tubulin modulators|mesh-ancestor
102095599|NCT04499924|Antimitotic Agents|antimitotic agents|mesh-ancestor
102095600|NCT04499924|Mitosis Modulators|mitosis modulators|mesh-ancestor
102095601|NCT04499924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095602|NCT04499924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102095603|NCT04499924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102095604|NCT04499924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102095605|NCT04481555|Azithromycin|azithromycin|mesh-list
102095606|NCT04481555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102095607|NCT04481555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102095608|NCT04468230|Nicotine|nicotine|mesh-list
102095609|NCT04468230|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102095610|NCT04468230|Autonomic Agents|autonomic agents|mesh-ancestor
102095611|NCT04468230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102095612|NCT04468230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095613|NCT04468230|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102095614|NCT04468230|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102095615|NCT04468230|Cholinergic Agents|cholinergic agents|mesh-ancestor
102095616|NCT04468230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102095617|NCT04468230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095618|NCT04456387|Factor VIII|factor viii|mesh-list
102095619|NCT04456387|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
102095620|NCT04456387|Coagulants|coagulants|mesh-ancestor
102095621|NCT04456387|Immunologic Factors|immunologic factors|mesh-ancestor
102095622|NCT04456387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095623|NCT04439357|Trametinib|trametinib|mesh-list
102095624|NCT04439357|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
102095625|NCT04439357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095626|NCT04439357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102095627|NCT04439357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102095628|NCT04439357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095629|NCT04439357|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102095630|NCT04439357|Protective Agents|protective agents|mesh-ancestor
102095631|NCT04439357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095632|NCT04439357|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102095633|NCT04439357|Antioxidants|antioxidants|mesh-ancestor
102095634|NCT04404283|Rituximab|rituximab|mesh-list
102095635|NCT04404283|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102095655|NCT04402788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095656|NCT04390763|Paclitaxel|paclitaxel|mesh-list
102095657|NCT04390763|Gemcitabine|gemcitabine|mesh-list
102095658|NCT04390763|Spartalizumab|spartalizumab|mesh-list
102095659|NCT04390763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102095660|NCT04390763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095661|NCT04390763|Tubulin Modulators|tubulin modulators|mesh-ancestor
102095662|NCT04390763|Antimitotic Agents|antimitotic agents|mesh-ancestor
102095663|NCT04390763|Mitosis Modulators|mitosis modulators|mesh-ancestor
102095664|NCT04390763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095665|NCT04390763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102095666|NCT04390763|Antimetabolites|antimetabolites|mesh-ancestor
102095667|NCT04390763|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102095668|NCT04390763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102095669|NCT04388163|Gentian Violet|gentian violet|mesh-list
102095670|NCT04388163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102095671|NCT04388163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102095672|NCT04377555|Ocrelizumab|ocrelizumab|mesh-list
102095673|NCT04377555|Immunologic Factors|immunologic factors|mesh-ancestor
102095674|NCT04377555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095689|NCT04370587|Pembrolizumab|pembrolizumab|mesh-list
102095690|NCT04370587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101397496|NCT00093678|Celecoxib|celecoxib|mesh-list
102095707|NCT04368559|Hormone Antagonists|hormone antagonists|mesh-ancestor
101707442|NCT02617680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095708|NCT04368559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101944910|NCT03708458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944911|NCT03708458|Antidotes|antidotes|mesh-ancestor
101944912|NCT03708458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102095709|NCT04368559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095710|NCT04368559|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101815462|NCT00537056|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102095711|NCT04368559|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102095712|NCT04368559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102095713|NCT04368559|Antimalarials|antimalarials|mesh-ancestor
102095714|NCT04368559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102095715|NCT04368559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102095716|NCT04368559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102095717|NCT04368559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102095718|NCT04368559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102095719|NCT04368559|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102095720|NCT04368559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102095721|NCT04354012|Gentian Violet|gentian violet|mesh-list
102095722|NCT04354012|Methylene Blue|methylene blue|mesh-list
102095723|NCT04354012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102095724|NCT04354012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095725|NCT04354012|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102095726|NCT04354012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102095727|NCT04345913|Halichondrin B|halichondrin b|mesh-list
102095728|NCT04345913|Tubulin Modulators|tubulin modulators|mesh-ancestor
102095729|NCT04345913|Antimitotic Agents|antimitotic agents|mesh-ancestor
102095730|NCT04345913|Mitosis Modulators|mitosis modulators|mesh-ancestor
102095731|NCT04345913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095732|NCT04345913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095738|NCT04323956|Prednisone|prednisone|mesh-list
102095739|NCT04323956|Cortisone|cortisone|mesh-list
102095740|NCT04323956|Cyclophosphamide|cyclophosphamide|mesh-list
102095741|NCT04323956|Rituximab|rituximab|mesh-list
102095742|NCT04323956|Doxorubicin|doxorubicin|mesh-list
102095743|NCT04323956|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102095744|NCT04323956|Vincristine|vincristine|mesh-list
102095745|NCT04323956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102095746|NCT04323956|Antibodies|antibodies|mesh-list
102095747|NCT04323956|Immunoglobulins|immunoglobulins|mesh-list
102095757|NCT04323956|Alkylating Agents|alkylating agents|mesh-ancestor
102095758|NCT04323956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095759|NCT04323956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095760|NCT04323956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102095761|NCT04323956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101707455|NCT02617680|Anesthetics|anesthetics|mesh-ancestor
102095762|NCT04323956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102095763|NCT04323956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102095764|NCT04323956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102095765|NCT04323956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102095766|NCT04323956|Glucocorticoids|glucocorticoids|mesh-ancestor
102095767|NCT04323956|Hormones|hormones|mesh-ancestor
102095768|NCT04323956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102095769|NCT04323956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102095770|NCT04323956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102095771|NCT04323956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102095772|NCT04323956|Tubulin Modulators|tubulin modulators|mesh-ancestor
102095773|NCT04323956|Antimitotic Agents|antimitotic agents|mesh-ancestor
102095774|NCT04323956|Mitosis Modulators|mitosis modulators|mesh-ancestor
102095775|NCT04319198|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
102095776|NCT04319198|Immunoconjugates|immunoconjugates|mesh-ancestor
102095777|NCT04319198|Immunologic Factors|immunologic factors|mesh-ancestor
102095778|NCT04319198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095779|NCT04318938|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102095780|NCT04318938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102095781|NCT04318938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102095782|NCT04318938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095783|NCT04311723|Anesthetics|anesthetics|mesh-list
102095784|NCT04311723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102095785|NCT04311723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095786|NCT04311632|Mycophenolic Acid|mycophenolic acid|mesh-list
102095787|NCT04311632|Tacrolimus|tacrolimus|mesh-list
102095788|NCT04311632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102095789|NCT04311632|Immunologic Factors|immunologic factors|mesh-ancestor
102095790|NCT04311632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944914|NCT03708458|Analgesics|analgesics|mesh-ancestor
101944915|NCT03708458|Sensory System Agents|sensory system agents|mesh-ancestor
102095791|NCT04311632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102095792|NCT04311632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102095793|NCT04311632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095794|NCT04311632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102095795|NCT04311632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095796|NCT04311632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102095797|NCT04311632|Antitubercular Agents|antitubercular agents|mesh-ancestor
102095798|NCT04311632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102095799|NCT04311632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102095800|NCT04294160|Tislelizumab|tislelizumab|mesh-list
102095801|NCT04294160|Spartalizumab|spartalizumab|mesh-list
102095802|NCT04294160|Trametinib|trametinib|mesh-list
102095803|NCT04294160|Dabrafenib|dabrafenib|mesh-list
102095804|NCT04294160|Naporafenib|naporafenib|mesh-list
102095805|NCT04294160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102095806|NCT04294160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095807|NCT04294160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102095808|NCT04294160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102095809|NCT04294160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095810|NCT04294160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102095813|NCT04248569|Nivolumab|nivolumab|mesh-list
102095826|NCT04237649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102095827|NCT04237649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095828|NCT04237649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102095829|NCT04237649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095831|NCT04232358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102095832|NCT04232358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095833|NCT04223570|Protoporphyrin IX|protoporphyrin ix|mesh-list
102095834|NCT04223570|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102095835|NCT04223570|Dermatologic Agents|dermatologic agents|mesh-ancestor
102095836|NCT04209114|Nivolumab|nivolumab|mesh-list
102095837|NCT04209114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102095838|NCT04209114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095839|NCT04209114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102095840|NCT04209114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095841|NCT04208958|Vancomycin|vancomycin|mesh-list
102095842|NCT04208958|Nivolumab|nivolumab|mesh-list
101707484|NCT04158830|Antipyretics|antipyretics|mesh-ancestor
102095843|NCT04208958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102095844|NCT04208958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095845|NCT04208958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102095846|NCT04208958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095847|NCT04208958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102095848|NCT04208958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102095853|NCT04180488|Histamine Antagonists|histamine antagonists|mesh-list
102095854|NCT04180488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
102095855|NCT04180488|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
102095856|NCT04180488|Histamine Agents|histamine agents|mesh-ancestor
102095857|NCT04180488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102095858|NCT04180488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095859|NCT04180488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095860|NCT04154956|Docetaxel|docetaxel|mesh-list
102095861|NCT04154956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095862|NCT04154956|Tubulin Modulators|tubulin modulators|mesh-ancestor
102095863|NCT04154956|Antimitotic Agents|antimitotic agents|mesh-ancestor
102095864|NCT04154956|Mitosis Modulators|mitosis modulators|mesh-ancestor
102095865|NCT04154956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095866|NCT04144153|Analgesics, Opioid|analgesics, opioid|mesh-list
102095867|NCT04144153|Anesthetics|anesthetics|mesh-list
102095868|NCT04144153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102095869|NCT04144153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095870|NCT04144153|Narcotics|narcotics|mesh-ancestor
102095871|NCT04144153|Analgesics|analgesics|mesh-ancestor
102095872|NCT04144153|Sensory System Agents|sensory system agents|mesh-ancestor
102095873|NCT04144153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101944916|NCT03708458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101944917|NCT03708458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102095918|NCT04086745|Adalimumab|adalimumab|mesh-list
102095919|NCT04086745|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
102095920|NCT04086745|Etanercept|etanercept|mesh-list
102095921|NCT04086745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102095922|NCT04086745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102095923|NCT04086745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102095924|NCT04086745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102095925|NCT04086745|Analgesics|analgesics|mesh-ancestor
102095926|NCT04086745|Sensory System Agents|sensory system agents|mesh-ancestor
102095927|NCT04086745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102095928|NCT04086745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095929|NCT04086745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102095930|NCT04086745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102095931|NCT04086745|Immunologic Factors|immunologic factors|mesh-ancestor
101397735|NCT00093990|Tipifarnib|tipifarnib|mesh-list
102095943|NCT03944772|Necitumumab|necitumumab|mesh-list
102095944|NCT03944772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095945|NCT03944772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102095946|NCT03944772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102095947|NCT03944772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102095948|NCT03944772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102095949|NCT03944772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095950|NCT03944772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102095951|NCT03944772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102095952|NCT03944772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102095953|NCT03944772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102095954|NCT03940703|Osimertinib|osimertinib|mesh-list
102095955|NCT03940703|Tepotinib|tepotinib|mesh-list
102095956|NCT03940703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095957|NCT03940703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102095958|NCT03940703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102095959|NCT03940703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095960|NCT03921242|Metformin|metformin|mesh-list
102095961|NCT03921242|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
101707490|NCT02617758|Fentanyl|fentanyl|mesh-list
102095962|NCT03921242|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
102095963|NCT03921242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102095964|NCT03921242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095965|NCT03921242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095966|NCT03921242|Protease Inhibitors|protease inhibitors|mesh-ancestor
102095967|NCT03921242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102095968|NCT03920293|Ravulizumab|ravulizumab|mesh-list
102095969|NCT03920293|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102095970|NCT03920293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102095971|NCT03920293|Immunologic Factors|immunologic factors|mesh-ancestor
102095972|NCT03920293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095973|NCT03919071|Trametinib|trametinib|mesh-list
102095974|NCT03919071|Dabrafenib|dabrafenib|mesh-list
102095975|NCT03919071|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
102095976|NCT03919071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095977|NCT03919071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102095978|NCT03919071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102095979|NCT03919071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095980|NCT03919071|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102095981|NCT03919071|Protective Agents|protective agents|mesh-ancestor
102095982|NCT03919071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095983|NCT03919071|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102095984|NCT03919071|Antioxidants|antioxidants|mesh-ancestor
102095985|NCT03915769|Ozanimod|ozanimod|mesh-list
102095986|NCT03915769|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102095987|NCT03915769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095988|NCT03915769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102095989|NCT03915769|Immunologic Factors|immunologic factors|mesh-ancestor
102095990|NCT03915769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095991|NCT03910387|Paclitaxel|paclitaxel|mesh-list
102095992|NCT03910387|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102095993|NCT03910387|Gemcitabine|gemcitabine|mesh-list
102095994|NCT03910387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101944918|NCT03708458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101944919|NCT03708458|Gout Suppressants|gout suppressants|mesh-ancestor
101944920|NCT03708458|Tocolytic Agents|tocolytic agents|mesh-ancestor
101944921|NCT03708458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102095995|NCT03910387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095996|NCT03910387|Tubulin Modulators|tubulin modulators|mesh-ancestor
102095997|NCT03910387|Antimitotic Agents|antimitotic agents|mesh-ancestor
102095998|NCT03910387|Mitosis Modulators|mitosis modulators|mesh-ancestor
102096015|NCT03844815|Antimetabolites|antimetabolites|mesh-ancestor
102096016|NCT03844815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096017|NCT03844815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096018|NCT03844815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102096020|NCT03837899|Tremelimumab|tremelimumab|mesh-list
102096021|NCT03837899|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102096022|NCT03837899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102096023|NCT03837899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096024|NCT03837899|Immunologic Factors|immunologic factors|mesh-ancestor
102096025|NCT03837899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096026|NCT03820830|Palbociclib|palbociclib|mesh-list
102096027|NCT03820830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096028|NCT03820830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102096029|NCT03820830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102096030|NCT03820830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096031|NCT03767582|Nivolumab|nivolumab|mesh-list
102096032|NCT03767582|Vaccines|vaccines|mesh-list
102096033|NCT03767582|Immunologic Factors|immunologic factors|mesh-ancestor
102096034|NCT03767582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096035|NCT03767582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102096036|NCT03767582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096037|NCT03767582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102096038|NCT03767582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096048|NCT03727880|Pembrolizumab|pembrolizumab|mesh-list
102096049|NCT03727880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102096050|NCT03727880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096051|NCT03727880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102096052|NCT03727880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096059|NCT03638141|Durvalumab|durvalumab|mesh-list
102096060|NCT03638141|Ipilimumab|ipilimumab|mesh-list
102096061|NCT03638141|Tremelimumab|tremelimumab|mesh-list
102096062|NCT03638141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102096063|NCT03638141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102096064|NCT03638141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096072|NCT03602586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102096073|NCT03602586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096074|NCT03535272|Bismuth|bismuth|mesh-list
102096075|NCT03535272|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
102096076|NCT03535272|Antacids|antacids|mesh-ancestor
102096077|NCT03535272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096078|NCT03535272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102096079|NCT03535272|Antidiarrheals|antidiarrheals|mesh-ancestor
102096080|NCT03530189|Insulin|insulin|mesh-list
102096081|NCT03530189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102096082|NCT03530189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096083|NCT03507491|Paclitaxel|paclitaxel|mesh-list
102096084|NCT03507491|Gemcitabine|gemcitabine|mesh-list
102096085|NCT03507491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102096086|NCT03507491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096087|NCT03507491|Tubulin Modulators|tubulin modulators|mesh-ancestor
102096088|NCT03507491|Antimitotic Agents|antimitotic agents|mesh-ancestor
102096089|NCT03507491|Mitosis Modulators|mitosis modulators|mesh-ancestor
102096090|NCT03507491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096091|NCT03507491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102096092|NCT03507491|Antimetabolites|antimetabolites|mesh-ancestor
102096093|NCT03485209|Carboplatin|carboplatin|mesh-list
102096094|NCT03485209|Pembrolizumab|pembrolizumab|mesh-list
102096095|NCT03485209|Tisotumab vedotin|tisotumab vedotin|mesh-list
102096096|NCT03485209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096097|NCT03485209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102096098|NCT03485209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102096099|NCT03485209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096100|NCT03478956|Etrolizumab|etrolizumab|mesh-list
102096101|NCT03478956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101944922|NCT03708458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101944923|NCT03708458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101944924|NCT05625555|Midazolam|midazolam|mesh-list
102096102|NCT03478956|Immunologic Factors|immunologic factors|mesh-ancestor
102096103|NCT03478956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096104|NCT03434769|Cyclophosphamide|cyclophosphamide|mesh-list
102096105|NCT03434769|Fludarabine|fludarabine|mesh-list
102096106|NCT03434769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102096107|NCT03434769|Immunologic Factors|immunologic factors|mesh-ancestor
102096108|NCT03434769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096109|NCT03434769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102096110|NCT03434769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102096111|NCT03434769|Alkylating Agents|alkylating agents|mesh-ancestor
102096112|NCT03434769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096113|NCT03434769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096114|NCT03434769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102096115|NCT03412565|Dexamethasone|dexamethasone|mesh-list
102096116|NCT03412565|Prednisone|prednisone|mesh-list
102096117|NCT03412565|Lenalidomide|lenalidomide|mesh-list
102096118|NCT03412565|Bortezomib|bortezomib|mesh-list
102096119|NCT03412565|Melphalan|melphalan|mesh-list
102096120|NCT03412565|Daratumumab|daratumumab|mesh-list
102096121|NCT03412565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102096122|NCT03412565|Antiemetics|antiemetics|mesh-ancestor
102096123|NCT03412565|Autonomic Agents|autonomic agents|mesh-ancestor
101707504|NCT00737542|Anesthetics|anesthetics|mesh-ancestor
102096124|NCT03412565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102096125|NCT03412565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096126|NCT03412565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102096127|NCT03412565|Glucocorticoids|glucocorticoids|mesh-ancestor
102096128|NCT03412565|Hormones|hormones|mesh-ancestor
102096129|NCT03412565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102096130|NCT03412565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102096131|NCT03412565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096132|NCT03412565|Immunologic Factors|immunologic factors|mesh-ancestor
102096136|NCT03412565|Growth Inhibitors|growth inhibitors|mesh-ancestor
102096137|NCT03412565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102096138|NCT03412565|Alkylating Agents|alkylating agents|mesh-ancestor
102096139|NCT03412565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096140|NCT03412565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102096141|NCT03412565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102096142|NCT03331198|Venetoclax|venetoclax|mesh-list
102096143|NCT03331198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096144|NCT03326310|Azacitidine|azacitidine|mesh-list
102096145|NCT03326310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102096146|NCT03326310|Antimetabolites|antimetabolites|mesh-ancestor
102096147|NCT03326310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096148|NCT03326310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096149|NCT03326310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102096150|NCT03317496|Cisplatin|cisplatin|mesh-list
102096151|NCT03317496|Carboplatin|carboplatin|mesh-list
102096152|NCT03317496|Gemcitabine|gemcitabine|mesh-list
102096153|NCT03317496|Pemetrexed|pemetrexed|mesh-list
102096154|NCT03317496|Avelumab|avelumab|mesh-list
102096155|NCT03317496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102096156|NCT03317496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096157|NCT03317496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102096158|NCT03317496|Antimetabolites|antimetabolites|mesh-ancestor
102096159|NCT03317496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096160|NCT03317496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102096161|NCT03317496|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102096162|NCT03317496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102096163|NCT03317496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102096164|NCT03317496|Immunologic Factors|immunologic factors|mesh-ancestor
102096165|NCT03317496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096166|NCT03309878|Pembrolizumab|pembrolizumab|mesh-list
102096167|NCT03309878|Mogamulizumab|mogamulizumab|mesh-list
102096168|NCT03309878|Immunoglobulins|immunoglobulins|mesh-list
102096169|NCT03309878|Immunoglobulin G|immunoglobulin g|mesh-list
102096170|NCT03309878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102096171|NCT03309878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096172|NCT03309878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102096173|NCT03309878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096174|NCT03309878|Immunologic Factors|immunologic factors|mesh-ancestor
102096175|NCT03309878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944925|NCT05625555|Ketamine|ketamine|mesh-list
101944926|NCT05625555|Analgesics|analgesics|mesh-ancestor
101944927|NCT05625555|Sensory System Agents|sensory system agents|mesh-ancestor
101944928|NCT05625555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101944929|NCT05625555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944930|NCT05625555|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101944931|NCT05625555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101944932|NCT05625555|Anesthetics, General|anesthetics, general|mesh-ancestor
101944933|NCT05625555|Anesthetics|anesthetics|mesh-ancestor
102096176|NCT03301506|Seladelpar|seladelpar|mesh-list
102096177|NCT03301506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102096178|NCT03301506|Antimetabolites|antimetabolites|mesh-ancestor
102096179|NCT03301506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096180|NCT03301506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102096181|NCT03298945|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
102096182|NCT03298945|Laxatives|laxatives|mesh-ancestor
102096183|NCT03298945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102096184|NCT03274492|Prednisone|prednisone|mesh-list
102096185|NCT03274492|Cyclophosphamide|cyclophosphamide|mesh-list
102096186|NCT03274492|Rituximab|rituximab|mesh-list
102096187|NCT03274492|Doxorubicin|doxorubicin|mesh-list
102096188|NCT03274492|Vincristine|vincristine|mesh-list
102096189|NCT03274492|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102096190|NCT03274492|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
102096191|NCT03274492|Immunoconjugates|immunoconjugates|mesh-list
102096192|NCT03274492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102096193|NCT03274492|Immunologic Factors|immunologic factors|mesh-ancestor
102096194|NCT03274492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096195|NCT03274492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102096196|NCT03274492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102096197|NCT03274492|Alkylating Agents|alkylating agents|mesh-ancestor
102096198|NCT03274492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096199|NCT03274492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096200|NCT03274492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102096201|NCT03274492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102096202|NCT03274492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102096203|NCT03274492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102096204|NCT03274492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102096205|NCT03274492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102096211|NCT03274492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102096212|NCT03274492|Tubulin Modulators|tubulin modulators|mesh-ancestor
102096213|NCT03274492|Antimitotic Agents|antimitotic agents|mesh-ancestor
102096214|NCT03274492|Mitosis Modulators|mitosis modulators|mesh-ancestor
102096215|NCT03269136|Thalidomide|thalidomide|mesh-list
102096216|NCT03269136|Dexamethasone|dexamethasone|mesh-list
102096217|NCT03269136|Dexamethasone acetate|dexamethasone acetate|mesh-list
102096218|NCT03269136|Lenalidomide|lenalidomide|mesh-list
102096219|NCT03269136|Pomalidomide|pomalidomide|mesh-list
102096220|NCT03269136|Antibodies|antibodies|mesh-list
102096221|NCT03269136|Immunoglobulins|immunoglobulins|mesh-list
102096222|NCT03269136|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102096223|NCT03269136|BB 1101|bb 1101|mesh-list
102096224|NCT03269136|Immunologic Factors|immunologic factors|mesh-ancestor
102096225|NCT03269136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096226|NCT03269136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102096227|NCT03269136|Antiemetics|antiemetics|mesh-ancestor
102096228|NCT03269136|Autonomic Agents|autonomic agents|mesh-ancestor
102096229|NCT03269136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102096230|NCT03269136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102096231|NCT03269136|Glucocorticoids|glucocorticoids|mesh-ancestor
102096232|NCT03269136|Hormones|hormones|mesh-ancestor
102096233|NCT03269136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102096234|NCT03269136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102096235|NCT03269136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096236|NCT03269136|Protease Inhibitors|protease inhibitors|mesh-ancestor
102096237|NCT03269136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102096238|NCT03269136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096239|NCT03269136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102096240|NCT03269136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101944934|NCT05625555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101944935|NCT05625555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101944936|NCT05625555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101944937|NCT05625555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101944938|NCT05625555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944939|NCT05625555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101944940|NCT05625555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101944941|NCT05625555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101664768|NCT02767362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101944942|NCT05625555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101944943|NCT05625555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101944944|NCT05625555|GABA Modulators|gaba modulators|mesh-ancestor
102096241|NCT03269136|Growth Substances|growth substances|mesh-ancestor
102096242|NCT03269136|Growth Inhibitors|growth inhibitors|mesh-ancestor
102096243|NCT03269136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102096244|NCT03269136|Leprostatic Agents|leprostatic agents|mesh-ancestor
102096245|NCT03269136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102096246|NCT03269136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102096247|NCT03228667|Pembrolizumab|pembrolizumab|mesh-list
102096248|NCT03228667|Nivolumab|nivolumab|mesh-list
102096249|NCT03228667|Atezolizumab|atezolizumab|mesh-list
102096250|NCT03228667|Durvalumab|durvalumab|mesh-list
102096251|NCT03228667|Avelumab|avelumab|mesh-list
102096252|NCT03228667|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102096253|NCT03228667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102096254|NCT03228667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096255|NCT03228667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102096256|NCT03228667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096257|NCT03228667|Immunologic Factors|immunologic factors|mesh-ancestor
102096258|NCT03228667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096259|NCT03155620|Olaparib|olaparib|mesh-list
102096260|NCT03155620|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102096261|NCT03155620|Palbociclib|palbociclib|mesh-list
102096262|NCT03155620|Vemurafenib|vemurafenib|mesh-list
102096263|NCT03155620|Tipifarnib|tipifarnib|mesh-list
102096264|NCT03155620|Ensartinib|ensartinib|mesh-list
102096265|NCT03155620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102096266|NCT03155620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096267|NCT03155620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096268|NCT03155620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102096269|NCT03127215|Olaparib|olaparib|mesh-list
102096270|NCT03127215|Trabectedin|trabectedin|mesh-list
102096271|NCT03127215|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102096272|NCT03127215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102096273|NCT03127215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096274|NCT03127215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096275|NCT03127215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102096276|NCT03127215|Alkylating Agents|alkylating agents|mesh-ancestor
102096277|NCT03125811|Ethanol|ethanol|mesh-list
102096290|NCT03125811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102096291|NCT03125811|Serotonin Agents|serotonin agents|mesh-ancestor
102096292|NCT03125811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102096293|NCT03125811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096294|NCT03096782|Mycophenolic Acid|mycophenolic acid|mesh-list
102096295|NCT03096782|Cyclophosphamide|cyclophosphamide|mesh-list
102096297|NCT03096782|Busulfan|busulfan|mesh-list
102096298|NCT03096782|Mechlorethamine|mechlorethamine|mesh-list
102096299|NCT03096782|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102096300|NCT03096782|Rituximab|rituximab|mesh-list
102096301|NCT03096782|Fludarabine|fludarabine|mesh-list
102096302|NCT03096782|Clofarabine|clofarabine|mesh-list
102096303|NCT03096782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102096304|NCT03096782|Tacrolimus|tacrolimus|mesh-list
102096305|NCT03096782|Thymoglobulin|thymoglobulin|mesh-list
101944945|NCT05625555|GABA Agents|gaba agents|mesh-ancestor
101944946|NCT01251471|Escitalopram|escitalopram|mesh-list
101944947|NCT01251471|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101944948|NCT01251471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101944949|NCT01251471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101785165|NCT00786734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102096306|NCT03096782|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102096307|NCT03096782|Antibodies|antibodies|mesh-list
102096308|NCT03096782|Immunoglobulins|immunoglobulins|mesh-list
102096309|NCT03096782|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102096310|NCT03096782|Lenograstim|lenograstim|mesh-list
102096311|NCT03096782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102096312|NCT03096782|Immunologic Factors|immunologic factors|mesh-ancestor
102096313|NCT03096782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096314|NCT03096782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101816064|NCT02556593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102096315|NCT03096782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102096316|NCT03096782|Alkylating Agents|alkylating agents|mesh-ancestor
102096317|NCT03096782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096318|NCT03096782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096319|NCT03096782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102096320|NCT03096782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102096321|NCT03096782|Antimetabolites|antimetabolites|mesh-ancestor
102096322|NCT03096782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102096323|NCT03096782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102096324|NCT03096782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102096325|NCT03096782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102096326|NCT03096782|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102096327|NCT03096782|Antitubercular Agents|antitubercular agents|mesh-ancestor
102096328|NCT03096782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102096329|NCT03096782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102096370|NCT02921256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102096371|NCT02921256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096372|NCT02921256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102096373|NCT02921256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096374|NCT02921256|Antimetabolites|antimetabolites|mesh-ancestor
102096375|NCT02921256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102096376|NCT02921256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102096377|NCT02921256|Immunologic Factors|immunologic factors|mesh-ancestor
102096378|NCT02921256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096379|NCT02921256|Antidotes|antidotes|mesh-ancestor
102096380|NCT02921256|Protective Agents|protective agents|mesh-ancestor
102096381|NCT02921256|Vitamin B Complex|vitamin b complex|mesh-ancestor
102096382|NCT02921256|Vitamins|vitamins|mesh-ancestor
102096383|NCT02921256|Micronutrients|micronutrients|mesh-ancestor
102096384|NCT02921256|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102096385|NCT02921256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102096386|NCT02769962|Olaparib|olaparib|mesh-list
102096387|NCT02769962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102096388|NCT02769962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102096389|NCT02769962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096390|NCT02769962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096391|NCT02711826|Acetaminophen|acetaminophen|mesh-list
102096392|NCT02711826|Diphenhydramine|diphenhydramine|mesh-list
102096393|NCT02711826|Promethazine|promethazine|mesh-list
102096394|NCT02711826|Mycophenolic Acid|mycophenolic acid|mesh-list
102096395|NCT02711826|Everolimus|everolimus|mesh-list
102096396|NCT02711826|Tacrolimus|tacrolimus|mesh-list
102096397|NCT02711826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102096398|NCT02711826|Immunologic Factors|immunologic factors|mesh-ancestor
102096399|NCT02711826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096400|NCT02711826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102096402|NCT02711826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096403|NCT02711826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102096404|NCT02711826|Analgesics|analgesics|mesh-ancestor
102096405|NCT02711826|Sensory System Agents|sensory system agents|mesh-ancestor
102096406|NCT02711826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102096407|NCT02711826|Antipyretics|antipyretics|mesh-ancestor
102096408|NCT02711826|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102096409|NCT02711826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101944950|NCT01251471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944951|NCT01251471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101944952|NCT01251471|Serotonin Agents|serotonin agents|mesh-ancestor
101785236|NCT00960921|Hematinics|hematinics|mesh-ancestor
101398188|NCT00322114|Lycopene|lycopene|mesh-list
102096420|NCT02711826|Anesthetics|anesthetics|mesh-ancestor
102096421|NCT02711826|Antiemetics|antiemetics|mesh-ancestor
102096422|NCT02711826|Autonomic Agents|autonomic agents|mesh-ancestor
102096423|NCT02711826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102096424|NCT02711826|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102096425|NCT02711826|Histamine Antagonists|histamine antagonists|mesh-ancestor
102096426|NCT02711826|Histamine Agents|histamine agents|mesh-ancestor
102096427|NCT02711826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102096428|NCT02711826|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102096429|NCT02711826|Antipruritics|antipruritics|mesh-ancestor
102096430|NCT02711826|Dermatologic Agents|dermatologic agents|mesh-ancestor
102096431|NCT02700841|Melphalan|melphalan|mesh-list
102096432|NCT02700841|Mechlorethamine|mechlorethamine|mesh-list
102096433|NCT02700841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102096434|NCT02700841|Alkylating Agents|alkylating agents|mesh-ancestor
102096435|NCT02700841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096436|NCT02700841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096437|NCT02700841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102096438|NCT02700841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102096439|NCT02700841|Immunologic Factors|immunologic factors|mesh-ancestor
102096440|NCT02700841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096441|NCT02688985|Ocrelizumab|ocrelizumab|mesh-list
102096442|NCT02688985|Histamine Antagonists|histamine antagonists|mesh-list
102096443|NCT02688985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
102096444|NCT02688985|Immunologic Factors|immunologic factors|mesh-ancestor
102096445|NCT02688985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096446|NCT02688985|Histamine Agents|histamine agents|mesh-ancestor
102096447|NCT02688985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102096448|NCT02688985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096449|NCT02669186|Fentanyl|fentanyl|mesh-list
102096450|NCT02669186|Bupivacaine|bupivacaine|mesh-list
102096451|NCT02669186|Anesthetics, Local|anesthetics, local|mesh-ancestor
102096452|NCT02669186|Anesthetics|anesthetics|mesh-ancestor
102096453|NCT02669186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102096454|NCT02669186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096455|NCT02669186|Sensory System Agents|sensory system agents|mesh-ancestor
102096456|NCT02669186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102096457|NCT02669186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102096458|NCT02669186|Narcotics|narcotics|mesh-ancestor
102096459|NCT02669186|Analgesics|analgesics|mesh-ancestor
102096460|NCT02669186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102096461|NCT02669186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102096462|NCT02669186|Anesthetics, General|anesthetics, general|mesh-ancestor
102096463|NCT02621021|Aldesleukin|aldesleukin|mesh-list
102096464|NCT02621021|Cyclophosphamide|cyclophosphamide|mesh-list
102096465|NCT02621021|Pembrolizumab|pembrolizumab|mesh-list
102096466|NCT02621021|Fludarabine|fludarabine|mesh-list
102096467|NCT02621021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102096468|NCT02621021|Immunologic Factors|immunologic factors|mesh-ancestor
102096469|NCT02621021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096470|NCT02621021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102096471|NCT02621021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102096472|NCT02621021|Alkylating Agents|alkylating agents|mesh-ancestor
102096473|NCT02621021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096474|NCT02621021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101398260|NCT00094692|Mydriatics|mydriatics|mesh-ancestor
102096493|NCT02365766|Gemcitabine|gemcitabine|mesh-list
102096494|NCT02365766|Pembrolizumab|pembrolizumab|mesh-list
102096495|NCT02365766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096496|NCT02365766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102096497|NCT02365766|Antimetabolites|antimetabolites|mesh-ancestor
102096498|NCT02365766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096499|NCT02365766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102096500|NCT02365766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102096501|NCT02344290|Pitavastatin|pitavastatin|mesh-list
102096502|NCT02344290|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102096503|NCT02344290|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102096504|NCT02344290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101944953|NCT01251471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944954|NCT01247805|Sildenafil Citrate|sildenafil citrate|mesh-list
101944955|NCT01247805|Citric Acid|citric acid|mesh-list
101944956|NCT01247805|Sodium Citrate|sodium citrate|mesh-list
101944957|NCT01247805|Anticoagulants|anticoagulants|mesh-ancestor
101944958|NCT01247805|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101944959|NCT01247805|Chelating Agents|chelating agents|mesh-ancestor
101944960|NCT01247805|Sequestering Agents|sequestering agents|mesh-ancestor
101944961|NCT01247805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944962|NCT01247805|Vasodilator Agents|vasodilator agents|mesh-ancestor
101944963|NCT01247805|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101944964|NCT01247805|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101944965|NCT01247805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101944966|NCT01247805|Urological Agents|urological agents|mesh-ancestor
102096505|NCT02344290|Antimetabolites|antimetabolites|mesh-ancestor
102096506|NCT02344290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096507|NCT02344290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102096508|NCT02344290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102096510|NCT02317874|Carboplatin|carboplatin|mesh-list
102096511|NCT02317874|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102096512|NCT02317874|Talazoparib|talazoparib|mesh-list
102096513|NCT02317874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102096514|NCT02317874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096515|NCT02317874|Tubulin Modulators|tubulin modulators|mesh-ancestor
102096516|NCT02317874|Antimitotic Agents|antimitotic agents|mesh-ancestor
102096517|NCT02317874|Mitosis Modulators|mitosis modulators|mesh-ancestor
102096518|NCT02317874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096519|NCT02317874|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102096520|NCT02317874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102096521|NCT02221999|Paclitaxel|paclitaxel|mesh-list
102096522|NCT02221999|Letrozole|letrozole|mesh-list
102096523|NCT02221999|Hormones|hormones|mesh-list
102096524|NCT02221999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102096525|NCT02221999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096526|NCT02221999|Tubulin Modulators|tubulin modulators|mesh-ancestor
102096527|NCT02221999|Antimitotic Agents|antimitotic agents|mesh-ancestor
102096528|NCT02221999|Mitosis Modulators|mitosis modulators|mesh-ancestor
102096529|NCT02221999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096530|NCT02221999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102096531|NCT02221999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096562|NCT02143414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102096563|NCT02143414|Methotrexate|methotrexate|mesh-list
102096564|NCT02143414|Vincristine|vincristine|mesh-list
102096565|NCT02143414|Dasatinib|dasatinib|mesh-list
102096566|NCT02143414|Mercaptopurine|mercaptopurine|mesh-list
102096567|NCT02143414|Blinatumomab|blinatumomab|mesh-list
102096568|NCT02143414|Antibodies|antibodies|mesh-list
102096569|NCT02143414|Immunoglobulins|immunoglobulins|mesh-list
102096570|NCT02143414|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102096571|NCT02143414|Muromonab-CD3|muromonab-cd3|mesh-list
102096572|NCT02143414|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101707594|NCT04161560|Cetuximab|cetuximab|mesh-list
102096573|NCT02143414|Immunologic Factors|immunologic factors|mesh-ancestor
102096574|NCT02143414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096575|NCT02143414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096576|NCT02143414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102096577|NCT02143414|Glucocorticoids|glucocorticoids|mesh-ancestor
102096578|NCT02143414|Hormones|hormones|mesh-ancestor
102096579|NCT02143414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102096580|NCT02143414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102096584|NCT02143414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102096585|NCT02143414|Antimetabolites|antimetabolites|mesh-ancestor
102096586|NCT02143414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944968|NCT05631717|Interleukin-2|interleukin-2|mesh-list
101944969|NCT05631717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101944970|NCT05631717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102096587|NCT02143414|Dermatologic Agents|dermatologic agents|mesh-ancestor
102096588|NCT02143414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102096589|NCT02143414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102096590|NCT02143414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102096591|NCT02143414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102096592|NCT02143414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102096593|NCT02143414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102096594|NCT02143414|Tubulin Modulators|tubulin modulators|mesh-ancestor
102096595|NCT02143414|Antimitotic Agents|antimitotic agents|mesh-ancestor
102096596|NCT02143414|Mitosis Modulators|mitosis modulators|mesh-ancestor
102096597|NCT02143414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102096598|NCT02112916|Calcium, Dietary|calcium, dietary|mesh-list
102096600|NCT02112916|Folic Acid|folic acid|mesh-list
102096601|NCT02112916|Cytarabine|cytarabine|mesh-list
102096602|NCT02112916|Dexamethasone|dexamethasone|mesh-list
102096603|NCT02112916|Dexamethasone acetate|dexamethasone acetate|mesh-list
102096604|NCT02112916|Hydrocortisone|hydrocortisone|mesh-list
102096605|NCT02112916|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102096606|NCT02112916|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102096607|NCT02112916|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102096608|NCT02112916|Cyclophosphamide|cyclophosphamide|mesh-list
102096609|NCT02112916|Ifosfamide|ifosfamide|mesh-list
102096610|NCT02112916|Isophosphamide mustard|isophosphamide mustard|mesh-list
102096611|NCT02112916|Doxorubicin|doxorubicin|mesh-list
102096612|NCT02112916|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102096613|NCT02112916|Methotrexate|methotrexate|mesh-list
102096614|NCT02112916|Etoposide|etoposide|mesh-list
102096615|NCT02112916|Vincristine|vincristine|mesh-list
102096616|NCT02112916|Etoposide phosphate|etoposide phosphate|mesh-list
102096617|NCT02112916|Bortezomib|bortezomib|mesh-list
102096618|NCT02112916|Daunorubicin|daunorubicin|mesh-list
102096619|NCT02112916|Asparaginase|asparaginase|mesh-list
102096620|NCT02112916|Mercaptopurine|mercaptopurine|mesh-list
102096621|NCT02112916|Podophyllotoxin|podophyllotoxin|mesh-list
102096622|NCT02112916|Pegaspargase|pegaspargase|mesh-list
102096623|NCT02112916|Thioguanine|thioguanine|mesh-list
102096624|NCT02112916|BB 1101|bb 1101|mesh-list
102096625|NCT02112916|Calcium|calcium|mesh-list
102096626|NCT02112916|2-Aminopurine|2-aminopurine|mesh-list
102096627|NCT02112916|Levoleucovorin|levoleucovorin|mesh-list
102096628|NCT02112916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102096629|NCT02112916|Immunologic Factors|immunologic factors|mesh-ancestor
102096630|NCT02112916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096631|NCT02112916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102096632|NCT02112916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102096633|NCT02112916|Alkylating Agents|alkylating agents|mesh-ancestor
102096634|NCT02112916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096635|NCT02112916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096636|NCT02112916|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102096637|NCT02112916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102096638|NCT02112916|Antiemetics|antiemetics|mesh-ancestor
102096639|NCT02112916|Autonomic Agents|autonomic agents|mesh-ancestor
102096640|NCT02112916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102096641|NCT02112916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102096642|NCT02112916|Glucocorticoids|glucocorticoids|mesh-ancestor
102096643|NCT02112916|Hormones|hormones|mesh-ancestor
102096644|NCT02112916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102096645|NCT02112916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102096646|NCT02112916|Protease Inhibitors|protease inhibitors|mesh-ancestor
102096647|NCT02112916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102096648|NCT02112916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102096649|NCT02112916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102096650|NCT02112916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102096651|NCT02112916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102096652|NCT02112916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102096653|NCT02112916|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102096654|NCT02112916|Abortifacient Agents|abortifacient agents|mesh-ancestor
102096655|NCT02112916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102096668|NCT02112916|Micronutrients|micronutrients|mesh-ancestor
102096669|NCT02112916|Tubulin Modulators|tubulin modulators|mesh-ancestor
102096670|NCT02112916|Antimitotic Agents|antimitotic agents|mesh-ancestor
102096671|NCT02112916|Mitosis Modulators|mitosis modulators|mesh-ancestor
101944971|NCT05631717|Analgesics|analgesics|mesh-ancestor
101944972|NCT05631717|Sensory System Agents|sensory system agents|mesh-ancestor
101944973|NCT05631717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101944974|NCT05631717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944975|NCT05631717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101944976|NCT05631717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101944977|NCT05631717|Antiviral Agents|antiviral agents|mesh-ancestor
101944978|NCT05631717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101944979|NCT01147731|Warfarin|warfarin|mesh-list
101944980|NCT01147731|rGLP-1 protein|rglp-1 protein|mesh-list
101944981|NCT01147731|Anticoagulants|anticoagulants|mesh-ancestor
101944982|NCT01147731|Incretins|incretins|mesh-ancestor
102096672|NCT02112916|Hematinics|hematinics|mesh-ancestor
102096673|NCT02112916|Keratolytic Agents|keratolytic agents|mesh-ancestor
102096674|NCT01849562|Ribavirin|ribavirin|mesh-list
102096675|NCT01849562|Odalasvir|odalasvir|mesh-list
102096676|NCT01849562|Antimetabolites|antimetabolites|mesh-ancestor
102096677|NCT01849562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096678|NCT01849562|Antiviral Agents|antiviral agents|mesh-ancestor
102096679|NCT01849562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102096680|NCT01700179|Ribavirin|ribavirin|mesh-list
102096681|NCT01700179|Antimetabolites|antimetabolites|mesh-ancestor
102096682|NCT01700179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096683|NCT01700179|Antiviral Agents|antiviral agents|mesh-ancestor
102096684|NCT01700179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102096685|NCT01659606|Cyclosporine|cyclosporine|mesh-list
102096686|NCT01659606|Mycophenolic Acid|mycophenolic acid|mesh-list
102096687|NCT01659606|Fludarabine|fludarabine|mesh-list
102096688|NCT01659606|Alemtuzumab|alemtuzumab|mesh-list
102096689|NCT01659606|Tacrolimus|tacrolimus|mesh-list
102096690|NCT01659606|Cyclosporins|cyclosporins|mesh-list
102096691|NCT01659606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096692|NCT01659606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096693|NCT01659606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102096694|NCT01659606|Immunologic Factors|immunologic factors|mesh-ancestor
102096695|NCT01659606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096696|NCT01659606|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102096697|NCT01659606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102096698|NCT01659606|Antifungal Agents|antifungal agents|mesh-ancestor
102096699|NCT01659606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102096700|NCT01659606|Dermatologic Agents|dermatologic agents|mesh-ancestor
102096701|NCT01659606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102096702|NCT01659606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102096703|NCT01659606|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102096704|NCT01659606|Antitubercular Agents|antitubercular agents|mesh-ancestor
102096705|NCT01659606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102096706|NCT01659606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101816442|NCT00782405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102096707|NCT01543763|Abexinostat|abexinostat|mesh-list
102096708|NCT01543763|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102096709|NCT01543763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102096710|NCT01543763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096711|NCT01517100|Dronabinol|dronabinol|mesh-list
102096712|NCT01517100|Nabilone|nabilone|mesh-list
102096713|NCT01517100|Antiemetics|antiemetics|mesh-ancestor
102096714|NCT01517100|Autonomic Agents|autonomic agents|mesh-ancestor
102096715|NCT01517100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102096716|NCT01517100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096717|NCT01517100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102096718|NCT01517100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102096719|NCT01517100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101398494|NCT00087581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096725|NCT01517100|Sensory System Agents|sensory system agents|mesh-ancestor
102096726|NCT01517100|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102096727|NCT01517100|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102096728|NCT01517100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102096729|NCT01517100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944984|NCT01147731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101944985|NCT01147731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096731|NCT01517100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102096732|NCT01474200|Furosemide|furosemide|mesh-list
102096733|NCT01474200|Diuretics|diuretics|mesh-list
102096734|NCT01474200|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
102096735|NCT01474200|Natriuretic Agents|natriuretic agents|mesh-ancestor
102096736|NCT01474200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096737|NCT01474200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102096738|NCT01474200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096739|NCT01407263|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102096740|NCT01407263|Hemostatics|hemostatics|mesh-list
102096741|NCT01407263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102096742|NCT01407263|Coagulants|coagulants|mesh-ancestor
102096743|NCT01351103|Spartalizumab|spartalizumab|mesh-list
102096744|NCT01351103|LGK974|lgk974|mesh-list
102096745|NCT01351103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102096746|NCT01351103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096747|NCT01351103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102096748|NCT01351103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096749|NCT01351103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102096750|NCT01245179|Panobinostat|panobinostat|mesh-list
102096751|NCT01245179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096752|NCT01245179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102096753|NCT01245179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102096754|NCT01245179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096755|NCT00500123|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
102096756|NCT00500123|Protein C Inhibitor|protein c inhibitor|mesh-list
102096757|NCT00500123|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102096758|NCT00500123|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102096759|NCT00500123|Protease Inhibitors|protease inhibitors|mesh-ancestor
102096760|NCT00500123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102096761|NCT00500123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816671|NCT00783731|Anesthetics|anesthetics|mesh-ancestor
101816889|NCT00998972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817036|NCT01004900|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101817331|NCT00787007|Equol|equol|mesh-list
101817638|NCT00796835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101817789|NCT00798083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101817974|NCT00803465|Xhance|xhance|mesh-list
101818558|NCT00817661|Vitamin A|vitamin a|mesh-list
101818622|NCT00061945|Dexamethasone|dexamethasone|mesh-list
101819227|NCT00462345|Antimetabolites|antimetabolites|mesh-ancestor
101819537|NCT01049932|Rilpivirine|rilpivirine|mesh-list
101819614|NCT01023243|Antipyretics|antipyretics|mesh-ancestor
101819757|NCT00450801|Granisetron|granisetron|mesh-list
101819982|NCT00467649|Insulin Glargine|insulin glargine|mesh-list
101820075|NCT00467259|Hormones|hormones|mesh-ancestor
101820659|NCT05254548|GABA Agents|gaba agents|mesh-ancestor
101821407|NCT00376246|Ezetimibe|ezetimibe|mesh-list
101821856|NCT00826553|Analgesics|analgesics|mesh-ancestor
101822083|NCT05889143|Ezetimibe|ezetimibe|mesh-list
101822157|NCT05887778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101822906|NCT03866174|Niacin|niacin|mesh-list
101822983|NCT03685773|Vasodilator Agents|vasodilator agents|mesh-ancestor
101823142|NCT03039413|Copper|copper|mesh-list
101823386|NCT02386774|Benoxinate|benoxinate|mesh-list
101823443|NCT01082679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823677|NCT00824057|Anesthetics|anesthetics|mesh-ancestor
101824038|NCT00434967|Diuretics|diuretics|mesh-ancestor
101824160|NCT00356278|Alprazolam|alprazolam|mesh-list
101824264|NCT00828971|Amoxicillin|amoxicillin|mesh-list
101824339|NCT01056172|Ribavirin|ribavirin|mesh-list
101824864|NCT00842933|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101825091|NCT00853697|Testosterone|testosterone|mesh-list
101398557|NCT00087659|Zoledronic Acid|zoledronic acid|mesh-list
101827338|NCT05795647|Vitamin E|vitamin e|mesh-list
101827635|NCT05541471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101827785|NCT06014658|Antibodies|antibodies|mesh-list
101828091|NCT06008860|Histamine Agents|histamine agents|mesh-ancestor
101485958|NCT00346749|Xhance|xhance|mesh-list
101828762|NCT05308446|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101828988|NCT05059626|Bazedoxifene|bazedoxifene|mesh-list
101829604|NCT04062266|Venetoclax|venetoclax|mesh-list
101829887|NCT03214562|Venetoclax|venetoclax|mesh-list
101575049|NCT02759887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575050|NCT02750917|Etoricoxib|etoricoxib|mesh-list
101575051|NCT02750917|Lornoxicam|lornoxicam|mesh-list
101944986|NCT03912285|Losartan|losartan|mesh-list
101944987|NCT03912285|Amlodipine|amlodipine|mesh-list
101944988|NCT03912285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101944989|NCT03912285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101944990|NCT03912285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101944991|NCT03912285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101944992|NCT03912285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101944993|NCT03912285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101944994|NCT03912285|Vasodilator Agents|vasodilator agents|mesh-ancestor
101944995|NCT03912285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101944996|NCT03912285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101944997|NCT03912285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101944998|NCT01251627|Decitabine|decitabine|mesh-list
101944999|NCT01251627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101945000|NCT01251627|Antimetabolites|antimetabolites|mesh-ancestor
101785580|NCT00745901|Drospirenone|drospirenone|mesh-list
101575052|NCT02750917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101575053|NCT02750917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101575054|NCT02750917|Analgesics|analgesics|mesh-ancestor
101575055|NCT02750917|Sensory System Agents|sensory system agents|mesh-ancestor
101575056|NCT02750917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101575057|NCT02750917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575058|NCT02750917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101575059|NCT02750917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101575060|NCT02750917|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101575061|NCT02750917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101575062|NCT02750917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101550201|NCT00597857|Hydrocortisone|hydrocortisone|mesh-list
101550202|NCT00597857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101550203|NCT00627133|Levetiracetam|levetiracetam|mesh-list
101550204|NCT00627133|Anticonvulsants|anticonvulsants|mesh-ancestor
101550205|NCT00627133|Nootropic Agents|nootropic agents|mesh-ancestor
101550206|NCT00598013|Pioglitazone|pioglitazone|mesh-list
101550207|NCT00598013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101550208|NCT00598013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550209|NCT04303429|Capecitabine|capecitabine|mesh-list
101550210|NCT04303429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101550211|NCT04303429|Antimetabolites|antimetabolites|mesh-ancestor
101550212|NCT04303429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550213|NCT04303429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101550214|NCT00598091|Gemcitabine|gemcitabine|mesh-list
101550215|NCT00598091|Dasatinib|dasatinib|mesh-list
101550216|NCT00598091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101550217|NCT00598091|Antimetabolites|antimetabolites|mesh-ancestor
101550218|NCT00598091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550219|NCT00598091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101550220|NCT00598091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101550221|NCT00598091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101550222|NCT00623415|Flupirtine|flupirtine|mesh-list
101550223|NCT00623415|Analgesics|analgesics|mesh-ancestor
101550224|NCT00623415|Sensory System Agents|sensory system agents|mesh-ancestor
101550225|NCT00623415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101550226|NCT00623415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550227|NCT04326725|Hydroxychloroquine|hydroxychloroquine|mesh-list
101550228|NCT04326725|Antimalarials|antimalarials|mesh-ancestor
101550229|NCT04326725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101550230|NCT04326725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101550231|NCT04326725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101550232|NCT04326725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101945001|NCT01251627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945002|NCT01251627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101945003|NCT01251627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101945004|NCT01146093|Pravastatin|pravastatin|mesh-list
101945005|NCT01146093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101945006|NCT01146093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101945007|NCT01146093|Antimetabolites|antimetabolites|mesh-ancestor
101550233|NCT04326725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550234|NCT04326725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101550235|NCT01038427|Mometasone Furoate|mometasone furoate|mesh-list
101550236|NCT01038427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101550237|NCT01038427|Dermatologic Agents|dermatologic agents|mesh-ancestor
101550238|NCT01038427|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101550239|NCT00598169|Dexamethasone|dexamethasone|mesh-list
101550241|NCT00598169|Carboplatin|carboplatin|mesh-list
101550242|NCT00598169|Etoposide|etoposide|mesh-list
101550243|NCT00598169|Bortezomib|bortezomib|mesh-list
101550244|NCT00598169|Ifosfamide|ifosfamide|mesh-list
101550245|NCT00598169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101550253|NCT00598169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101550254|NCT00598169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101550255|NCT00598169|Glucocorticoids|glucocorticoids|mesh-ancestor
101550256|NCT00598169|Hormones|hormones|mesh-ancestor
101550257|NCT00598169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101550258|NCT00598169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101550259|NCT00598169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101550260|NCT00598169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101550261|NCT00598169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101550262|NCT00598169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101550263|NCT00598169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550264|NCT00598169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101550265|NCT00598169|Alkylating Agents|alkylating agents|mesh-ancestor
101550266|NCT00598247|Paclitaxel|paclitaxel|mesh-list
101550267|NCT00598247|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
101550268|NCT00598247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101550269|NCT00598247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101550270|NCT00598247|Tubulin Modulators|tubulin modulators|mesh-ancestor
101550271|NCT00598247|Antimitotic Agents|antimitotic agents|mesh-ancestor
101550272|NCT00598247|Mitosis Modulators|mitosis modulators|mesh-ancestor
101550273|NCT00598247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550274|NCT00598403|Ciprofloxacin|ciprofloxacin|mesh-list
101550275|NCT00598403|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
101550276|NCT00598403|Cefditoren|cefditoren|mesh-list
101512166|NCT02938286|Epinephrine|epinephrine|mesh-list
101550277|NCT00598403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101550278|NCT00598403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101550279|NCT00598403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101550280|NCT00598403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101550281|NCT00598403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101550282|NCT00598403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550283|NCT00598403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101550284|NCT00598403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101550285|NCT00598403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101550286|NCT00598637|Everolimus|everolimus|mesh-list
101550287|NCT00598637|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101550288|NCT00598637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101550289|NCT00598637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101550290|NCT00598637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550291|NCT00598637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101550292|NCT00598637|Immunologic Factors|immunologic factors|mesh-ancestor
101550293|NCT00598637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550294|NCT00598637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101550295|NCT00598715|Sirolimus|sirolimus|mesh-list
101550296|NCT00598715|Paclitaxel|paclitaxel|mesh-list
101550297|NCT00598715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101550298|NCT00598715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101550299|NCT00598715|Tubulin Modulators|tubulin modulators|mesh-ancestor
101550300|NCT00598715|Antimitotic Agents|antimitotic agents|mesh-ancestor
101945008|NCT01146093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785705|NCT00787826|Immunologic Factors|immunologic factors|mesh-ancestor
101550301|NCT00598715|Mitosis Modulators|mitosis modulators|mesh-ancestor
101550302|NCT00598715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550303|NCT00598715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101550304|NCT00598715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101550305|NCT00598715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101550306|NCT00598715|Antifungal Agents|antifungal agents|mesh-ancestor
101550307|NCT00598715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101550308|NCT00598715|Immunologic Factors|immunologic factors|mesh-ancestor
101550309|NCT00598715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550310|NCT00598793|Insulin|insulin|mesh-list
101550311|NCT00598793|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101550312|NCT00598793|Metformin|metformin|mesh-list
101550333|NCT00599417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101550334|NCT00599417|Immunologic Factors|immunologic factors|mesh-ancestor
101550335|NCT00599417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550336|NCT00599573|Ondansetron|ondansetron|mesh-list
101550337|NCT00599573|Antiemetics|antiemetics|mesh-ancestor
101550338|NCT00599573|Autonomic Agents|autonomic agents|mesh-ancestor
101550339|NCT00599573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101550340|NCT00599573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550341|NCT00599573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101550342|NCT00599573|Antipruritics|antipruritics|mesh-ancestor
101550343|NCT00599573|Dermatologic Agents|dermatologic agents|mesh-ancestor
101550344|NCT00599573|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101550345|NCT00599573|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101550346|NCT00599573|Serotonin Agents|serotonin agents|mesh-ancestor
101550347|NCT00599573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101550348|NCT00599573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550349|NCT00599651|Pulmonary Surfactants|pulmonary surfactants|mesh-list
101550350|NCT00599651|Respiratory System Agents|respiratory system agents|mesh-ancestor
101550351|NCT01048099|Trastuzumab|trastuzumab|mesh-list
101550353|NCT01048099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101550354|NCT01048099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101550355|NCT00599807|Vitamin D|vitamin d|mesh-list
101550356|NCT00599807|Cholecalciferol|cholecalciferol|mesh-list
101550357|NCT00599807|Vitamins|vitamins|mesh-ancestor
101550358|NCT00599807|Micronutrients|micronutrients|mesh-ancestor
101550359|NCT00599807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550360|NCT00599807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101550361|NCT00599807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101550362|NCT00599885|Valsartan|valsartan|mesh-list
101550363|NCT00599885|Telmisartan|telmisartan|mesh-list
101550364|NCT00599885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101550365|NCT00599885|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101550366|NCT00599885|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101550367|NCT00599885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550373|NCT01303965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550374|NCT01303965|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101550375|NCT01303965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101550376|NCT01303965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550377|NCT01303965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101550378|NCT01303965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101550379|NCT01303965|Growth Substances|growth substances|mesh-ancestor
101550380|NCT01303965|Growth Inhibitors|growth inhibitors|mesh-ancestor
101550381|NCT01303965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101550382|NCT01303965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101550383|NCT01303965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101550384|NCT01303965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101550385|NCT01303965|Antifungal Agents|antifungal agents|mesh-ancestor
101550386|NCT00600041|Pantoprazole|pantoprazole|mesh-list
101550387|NCT00600041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101550388|NCT00600041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101550389|NCT00600041|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101550390|NCT00600041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101550391|NCT00600041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550392|NCT01045993|Analgesics|analgesics|mesh-list
101550393|NCT01045993|Sensory System Agents|sensory system agents|mesh-ancestor
101550394|NCT01045993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101550395|NCT01045993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550396|NCT00600509|Levetiracetam|levetiracetam|mesh-list
101945009|NCT01146093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101945010|NCT01146093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101945011|NCT01146093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101945012|NCT02452983|Sertraline|sertraline|mesh-list
101945013|NCT02452983|Antidepressive Agents|antidepressive agents|mesh-ancestor
101785793|NCT00961467|Prednisone|prednisone|mesh-list
101550397|NCT00600509|Anticonvulsants|anticonvulsants|mesh-ancestor
101550398|NCT00600509|Nootropic Agents|nootropic agents|mesh-ancestor
101550399|NCT01326533|Hydroxychloroquine|hydroxychloroquine|mesh-list
101550400|NCT01326533|Antimalarials|antimalarials|mesh-ancestor
101550401|NCT01326533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101550402|NCT01326533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101550403|NCT01326533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101550404|NCT01326533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101550405|NCT01326533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550406|NCT01326533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101550407|NCT00600587|Carboplatin|carboplatin|mesh-list
101550408|NCT00600587|Gemcitabine|gemcitabine|mesh-list
101550409|NCT00600587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101550410|NCT00600587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101550411|NCT00600587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101550412|NCT00600587|Antimetabolites|antimetabolites|mesh-ancestor
101550413|NCT00600587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550414|NCT00600587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101550415|NCT00600587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101550416|NCT01045447|Insulin|insulin|mesh-list
101550417|NCT01045447|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101707669|NCT02633774|Apixaban|apixaban|mesh-list
101550418|NCT01045447|Insulin Glargine|insulin glargine|mesh-list
101550419|NCT01045447|Insulin Aspart|insulin aspart|mesh-list
101550420|NCT01045447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101550421|NCT01045447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550422|NCT00623207|Atropine|atropine|mesh-list
101550423|NCT00623207|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101550424|NCT00623207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101550425|NCT00623207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101550426|NCT00623207|Autonomic Agents|autonomic agents|mesh-ancestor
101550427|NCT00623207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101550428|NCT00623207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550429|NCT00623207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101550430|NCT00623207|Respiratory System Agents|respiratory system agents|mesh-ancestor
101550432|NCT00623207|Parasympatholytics|parasympatholytics|mesh-ancestor
101550433|NCT00623207|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101550434|NCT00623207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101550435|NCT00623207|Cholinergic Agents|cholinergic agents|mesh-ancestor
101550436|NCT00623207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101550437|NCT00623207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550438|NCT00600977|Doxorubicin|doxorubicin|mesh-list
101550439|NCT00600977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101550440|NCT00600977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101550441|NCT00600977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101550446|NCT00601211|Pilocarpine|pilocarpine|mesh-list
101550447|NCT00601211|Miotics|miotics|mesh-ancestor
101550448|NCT00601211|Autonomic Agents|autonomic agents|mesh-ancestor
101550449|NCT00601211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101550450|NCT00601211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550451|NCT00601211|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101550452|NCT00601211|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101550453|NCT00601211|Cholinergic Agents|cholinergic agents|mesh-ancestor
101550454|NCT00601211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101550455|NCT00601211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550456|NCT00601289|Temozolomide|temozolomide|mesh-list
101550457|NCT00601289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101550458|NCT00601289|Alkylating Agents|alkylating agents|mesh-ancestor
101550459|NCT00601289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550460|NCT00601289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101550461|NCT00601913|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101550462|NCT00601913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101550463|NCT00601913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101550464|NCT00601913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101550465|NCT00601913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945014|NCT02452983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101945015|NCT02452983|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101550467|NCT00601991|Endothelial Growth Factors|endothelial growth factors|mesh-list
101550468|NCT00601991|Growth Substances|growth substances|mesh-ancestor
101550469|NCT00601991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550470|NCT00601991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101550471|NCT00601991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101550472|NCT00601991|Growth Inhibitors|growth inhibitors|mesh-ancestor
101550473|NCT00601991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101550474|NCT01301391|Maleic acid|maleic acid|mesh-list
101550475|NCT01301391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101550476|NCT01301391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550477|NCT04325633|Naproxen|naproxen|mesh-list
101550478|NCT04325633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101550479|NCT04325633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101550480|NCT04325633|Analgesics|analgesics|mesh-ancestor
101550481|NCT04325633|Sensory System Agents|sensory system agents|mesh-ancestor
101550482|NCT04325633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101550483|NCT04325633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550484|NCT04325633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101550485|NCT04325633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101550486|NCT04325633|Gout Suppressants|gout suppressants|mesh-ancestor
101550487|NCT04325633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101550488|NCT04325633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101550489|NCT04325633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550490|NCT05643651|Aspirin|aspirin|mesh-list
101550491|NCT05643651|Vitamin K|vitamin k|mesh-list
101550492|NCT05643651|Warfarin|warfarin|mesh-list
101550493|NCT05643651|Rivaroxaban|rivaroxaban|mesh-list
101550494|NCT05643651|Clopidogrel|clopidogrel|mesh-list
101550495|NCT05643651|Vitamins|vitamins|mesh-ancestor
101550496|NCT05643651|Micronutrients|micronutrients|mesh-ancestor
101550497|NCT05643651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550498|NCT05643651|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101550499|NCT05643651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101550500|NCT05643651|Analgesics|analgesics|mesh-ancestor
101550501|NCT05643651|Sensory System Agents|sensory system agents|mesh-ancestor
101550502|NCT05643651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101550503|NCT05643651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101550504|NCT05643651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101550505|NCT05643651|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101550506|NCT05643651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101550507|NCT05643651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550508|NCT05643651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101550509|NCT05643651|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101550510|NCT05643651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101550511|NCT05643651|Antipyretics|antipyretics|mesh-ancestor
101550514|NCT05643651|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101550515|NCT05643651|Purinergic Agents|purinergic agents|mesh-ancestor
101550516|NCT05643651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101550518|NCT05643651|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101550519|NCT05643651|Antithrombins|antithrombins|mesh-ancestor
101550520|NCT05643651|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101550521|NCT05643651|Protease Inhibitors|protease inhibitors|mesh-ancestor
101550522|NCT05643651|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101550523|NCT05643651|Hemostatics|hemostatics|mesh-ancestor
101550524|NCT05643651|Coagulants|coagulants|mesh-ancestor
101550525|NCT01061359|Epirubicin|epirubicin|mesh-list
101550526|NCT01061359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101550527|NCT01061359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101550528|NCT01061359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101550529|NCT01061359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101550530|NCT01061359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101550531|NCT01061359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550532|NCT05643417|Bevacizumab|bevacizumab|mesh-list
101550533|NCT05643417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101550534|NCT05643417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101550535|NCT05643417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101550536|NCT05643417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101550537|NCT05643417|Growth Substances|growth substances|mesh-ancestor
101550538|NCT05643417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550539|NCT05643417|Growth Inhibitors|growth inhibitors|mesh-ancestor
101550540|NCT04303741|Apatinib|apatinib|mesh-list
101945016|NCT02452983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101664843|NCT00803049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101945017|NCT02452983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101945018|NCT02452983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550541|NCT04303741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101550542|NCT04303741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101550543|NCT04303741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101550544|NCT04303741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550545|NCT00626977|Clonidine|clonidine|mesh-list
101550546|NCT00626977|Ropivacaine|ropivacaine|mesh-list
101550547|NCT00626977|Anesthetics, Local|anesthetics, local|mesh-ancestor
101550548|NCT00626977|Anesthetics|anesthetics|mesh-ancestor
101550549|NCT00626977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101550550|NCT00626977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550551|NCT00626977|Sensory System Agents|sensory system agents|mesh-ancestor
101550552|NCT00626977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101550553|NCT00626977|Analgesics|analgesics|mesh-ancestor
101550554|NCT00626977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101550555|NCT00626977|Sympatholytics|sympatholytics|mesh-ancestor
101550556|NCT00626977|Autonomic Agents|autonomic agents|mesh-ancestor
101550557|NCT00626977|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101550558|NCT00626977|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101550559|NCT00626977|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101550560|NCT00626977|Adrenergic Agents|adrenergic agents|mesh-ancestor
101550561|NCT00626977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101550562|NCT00626977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550563|NCT04303819|Exenatide|exenatide|mesh-list
101550564|NCT04303819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101550565|NCT04303819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550566|NCT04303819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101550567|NCT04303819|Incretins|incretins|mesh-ancestor
101550568|NCT04303819|Hormones|hormones|mesh-ancestor
101550569|NCT04303819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101550570|NCT01301079|Ketamine|ketamine|mesh-list
101550571|NCT01301079|Analgesics|analgesics|mesh-ancestor
101550572|NCT01301079|Sensory System Agents|sensory system agents|mesh-ancestor
101550573|NCT01301079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101550574|NCT01301079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550575|NCT01301079|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101550576|NCT01301079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101550577|NCT01301079|Anesthetics, General|anesthetics, general|mesh-ancestor
101550578|NCT01301079|Anesthetics|anesthetics|mesh-ancestor
101550579|NCT01301079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101550580|NCT01301079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101550581|NCT01301079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101550582|NCT01301079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101550583|NCT01301079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550589|NCT05271721|Autonomic Agents|autonomic agents|mesh-ancestor
101550590|NCT05271721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101550591|NCT05271721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550592|NCT05271721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101550593|NCT05271721|Glucocorticoids|glucocorticoids|mesh-ancestor
101550594|NCT05271721|Hormones|hormones|mesh-ancestor
101550595|NCT05271721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101550596|NCT05271721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101550597|NCT05271721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101550598|NCT05271721|Protease Inhibitors|protease inhibitors|mesh-ancestor
101550599|NCT05271721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101550600|NCT05271721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550601|NCT01301001|Gabapentin|gabapentin|mesh-list
101550602|NCT01301001|Analgesics|analgesics|mesh-ancestor
101550603|NCT01301001|Sensory System Agents|sensory system agents|mesh-ancestor
101550604|NCT01301001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101550605|NCT01301001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550606|NCT01301001|Anticonvulsants|anticonvulsants|mesh-ancestor
101550607|NCT01301001|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101550608|NCT01301001|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101550609|NCT01301001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101945019|NCT02452983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101945020|NCT02452983|Serotonin Agents|serotonin agents|mesh-ancestor
101945021|NCT02452983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945022|NCT03911817|Midodrine|midodrine|mesh-list
101550610|NCT01301001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101707700|NCT00517933|Urological Agents|urological agents|mesh-ancestor
101550611|NCT01301001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101550612|NCT01301001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101550613|NCT01301001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101550614|NCT01301001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550615|NCT01301001|Antimanic Agents|antimanic agents|mesh-ancestor
101550616|NCT01035463|Cytarabine|cytarabine|mesh-list
101550617|NCT01035463|Rituximab|rituximab|mesh-list
101550618|NCT01035463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101550619|NCT01035463|Etoposide|etoposide|mesh-list
101550620|NCT01035463|Lenalidomide|lenalidomide|mesh-list
101550621|NCT01035463|Etoposide phosphate|etoposide phosphate|mesh-list
101550622|NCT01035463|Melphalan|melphalan|mesh-list
101550623|NCT01035463|Mechlorethamine|mechlorethamine|mesh-list
101550624|NCT01035463|Carmustine|carmustine|mesh-list
101550625|NCT01035463|Podophyllotoxin|podophyllotoxin|mesh-list
101550626|NCT01035463|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
101550627|NCT01035463|Antibodies|antibodies|mesh-list
101550628|NCT01035463|Immunoglobulins|immunoglobulins|mesh-list
101550629|NCT01035463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101550630|NCT01035463|Immunologic Factors|immunologic factors|mesh-ancestor
101550631|NCT01035463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550632|NCT01035463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101550633|NCT01035463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101550634|NCT01035463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101550635|NCT01035463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101550636|NCT01035463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101550637|NCT01035463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101550638|NCT01035463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550639|NCT01035463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101550640|NCT01035463|Antimetabolites|antimetabolites|mesh-ancestor
101550641|NCT01035463|Antiviral Agents|antiviral agents|mesh-ancestor
101550642|NCT01035463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101550643|NCT01035463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101550644|NCT01035463|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101550645|NCT01035463|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101550646|NCT01035463|Growth Substances|growth substances|mesh-ancestor
101550647|NCT01035463|Growth Inhibitors|growth inhibitors|mesh-ancestor
101550648|NCT01035463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101550649|NCT01035463|Alkylating Agents|alkylating agents|mesh-ancestor
101550650|NCT01035463|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101550651|NCT01035463|Keratolytic Agents|keratolytic agents|mesh-ancestor
101550652|NCT01035463|Dermatologic Agents|dermatologic agents|mesh-ancestor
101550653|NCT01035463|Tubulin Modulators|tubulin modulators|mesh-ancestor
101550654|NCT01035463|Antimitotic Agents|antimitotic agents|mesh-ancestor
101550655|NCT01035463|Mitosis Modulators|mitosis modulators|mesh-ancestor
101550656|NCT01300923|Acamprosate|acamprosate|mesh-list
101550659|NCT01300767|Disinfectants|disinfectants|mesh-ancestor
101550660|NCT01300767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101550662|NCT02890173|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101550663|NCT02890173|Hormone Antagonists|hormone antagonists|mesh-ancestor
101550664|NCT02890173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101550665|NCT02890173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550666|NCT02890173|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101550668|NCT02890173|Natriuretic Agents|natriuretic agents|mesh-ancestor
101550669|NCT02890173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101550670|NCT01300455|Suvorexant|suvorexant|mesh-list
101550671|NCT01300455|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101550672|NCT01300455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101550673|NCT01300455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101550674|NCT01300455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550675|NCT01300455|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
101550676|NCT01300455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101550677|NCT01300455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550678|NCT01101178|Oxycodone|oxycodone|mesh-list
101550679|NCT01101178|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101550680|NCT01101178|Narcotics|narcotics|mesh-ancestor
101550681|NCT01101178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101945023|NCT03911817|Sympathomimetics|sympathomimetics|mesh-ancestor
101945024|NCT03911817|Autonomic Agents|autonomic agents|mesh-ancestor
101945025|NCT03911817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101550682|NCT01101178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550683|NCT01101178|Analgesics|analgesics|mesh-ancestor
101550684|NCT01101178|Sensory System Agents|sensory system agents|mesh-ancestor
101550685|NCT01101178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101550686|NCT05637645|Bupivacaine|bupivacaine|mesh-list
101550687|NCT05637645|Anesthetics, Local|anesthetics, local|mesh-ancestor
101550688|NCT05637645|Anesthetics|anesthetics|mesh-ancestor
101550689|NCT05637645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101550690|NCT05637645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550691|NCT05637645|Sensory System Agents|sensory system agents|mesh-ancestor
101550692|NCT05637645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101550693|NCT01101022|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101550694|NCT01101022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101550695|NCT01101022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550696|NCT01101022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101550697|NCT01101022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101550698|NCT01101022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101550699|NCT01101022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550700|NCT01101022|Dopamine Agents|dopamine agents|mesh-ancestor
101550701|NCT01101022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101550702|NCT02879110|Sulforaphane|sulforaphane|mesh-list
101550703|NCT02879110|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101550704|NCT02879110|Protective Agents|protective agents|mesh-ancestor
101550705|NCT02879110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550706|NCT02879110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101550707|NCT04207515|Anesthetics|anesthetics|mesh-list
101550708|NCT04207515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101550709|NCT04207515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550710|NCT01100944|Cyclophosphamide|cyclophosphamide|mesh-list
101550711|NCT01100944|Doxorubicin|doxorubicin|mesh-list
101550712|NCT01100944|Belinostat|belinostat|mesh-list
101550713|NCT01100944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101550714|NCT01100944|Immunologic Factors|immunologic factors|mesh-ancestor
101550715|NCT01100944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550716|NCT01100944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101550717|NCT01100944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101550718|NCT01100944|Alkylating Agents|alkylating agents|mesh-ancestor
101550719|NCT01100944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550720|NCT01100944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101550721|NCT01100944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101550722|NCT01100944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101550723|NCT01100944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101550724|NCT01100944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101550725|NCT01100944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101550726|NCT01100944|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101550727|NCT01100320|Oxycodone|oxycodone|mesh-list
101550728|NCT01100320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101550729|NCT01100320|Narcotics|narcotics|mesh-ancestor
101550730|NCT01100320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101550736|NCT04309708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101707732|NCT04161404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101550737|NCT04309708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101550738|NCT04309708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101550739|NCT04309708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550740|NCT04309708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101550741|NCT04309708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550742|NCT04309708|Vasodilator Agents|vasodilator agents|mesh-ancestor
101550744|NCT01100086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101550745|NCT01100086|Narcotics|narcotics|mesh-ancestor
101550746|NCT01100086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101550747|NCT01100086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550748|NCT01100086|Analgesics|analgesics|mesh-ancestor
101550749|NCT01100086|Sensory System Agents|sensory system agents|mesh-ancestor
101550750|NCT01100086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101550751|NCT01297959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101550752|NCT00626080|Insulin|insulin|mesh-list
101550753|NCT00626080|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101550754|NCT00626080|Insulin Detemir|insulin detemir|mesh-list
101550755|NCT00626080|Isophane Insulin, Human|isophane insulin, human|mesh-list
101786140|NCT00801866|Growth Inhibitors|growth inhibitors|mesh-ancestor
101550756|NCT00626080|Insulin, Isophane|insulin, isophane|mesh-list
101550757|NCT00626080|Isophane insulin, beef|isophane insulin, beef|mesh-list
101550758|NCT00626080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101550759|NCT00626080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550760|NCT04309240|Rivaroxaban|rivaroxaban|mesh-list
101550761|NCT04309240|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101550762|NCT04309240|Antithrombins|antithrombins|mesh-ancestor
101550763|NCT04309240|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101550764|NCT04309240|Protease Inhibitors|protease inhibitors|mesh-ancestor
101550765|NCT04309240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101550766|NCT04309240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550767|NCT04309240|Anticoagulants|anticoagulants|mesh-ancestor
101550768|NCT01035229|Everolimus|everolimus|mesh-list
101550769|NCT01035229|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101550770|NCT01035229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101550771|NCT01035229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101550772|NCT01035229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550773|NCT01035229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101550774|NCT01035229|Immunologic Factors|immunologic factors|mesh-ancestor
101550775|NCT01035229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550776|NCT01035229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101550777|NCT01059799|Insulin|insulin|mesh-list
101550778|NCT01059799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101550779|NCT01059799|Insulin Glargine|insulin glargine|mesh-list
101550780|NCT01059799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101550781|NCT01059799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550782|NCT04301869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101550783|NCT04301869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101550784|NCT04301479|Hydrocortisone|hydrocortisone|mesh-list
101550785|NCT04301479|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101550786|NCT04301479|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101550787|NCT04301479|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101550788|NCT04301479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101550789|NCT01106092|Vaccines|vaccines|mesh-list
101550790|NCT01106092|Immunologic Factors|immunologic factors|mesh-ancestor
101550791|NCT01106092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550792|NCT04307290|Dexmedetomidine|dexmedetomidine|mesh-list
101550793|NCT04307290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101550794|NCT04307290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101550795|NCT04307290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550796|NCT04307290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101550797|NCT04307290|Analgesics|analgesics|mesh-ancestor
101550798|NCT04307290|Sensory System Agents|sensory system agents|mesh-ancestor
101707744|NCT04161404|Antiviral Agents|antiviral agents|mesh-ancestor
101550799|NCT04307290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101550800|NCT04307290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101550801|NCT04307290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101550802|NCT04307290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101550817|NCT01095094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101550818|NCT01095094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101550820|NCT01095094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101550821|NCT01095094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550822|NCT01095094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101550823|NCT01095094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101550824|NCT01095094|Antiviral Agents|antiviral agents|mesh-ancestor
101550825|NCT01095094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101550826|NCT01095094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101550827|NCT01095094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101550828|NCT00623285|Pregabalin|pregabalin|mesh-list
101550829|NCT00623285|Analgesics|analgesics|mesh-ancestor
101550830|NCT00623285|Sensory System Agents|sensory system agents|mesh-ancestor
101550831|NCT00623285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101550832|NCT00623285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550833|NCT00623285|Anticonvulsants|anticonvulsants|mesh-ancestor
101550834|NCT00623285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101550835|NCT00623285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101550836|NCT00623285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550837|NCT00623285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101550838|NCT00623285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101550839|NCT00623285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101550840|NCT00623285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101550841|NCT00623285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101550842|NCT01097044|Afamelanotide|afamelanotide|mesh-list
101550843|NCT01097044|Dermatologic Agents|dermatologic agents|mesh-ancestor
101945026|NCT03911817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945027|NCT03911817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101945028|NCT03911817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101945029|NCT03911817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101550844|NCT01322009|Acetylcysteine|acetylcysteine|mesh-list
101550845|NCT01322009|Probenecid|probenecid|mesh-list
101550846|NCT01322009|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101550847|NCT01322009|Antiviral Agents|antiviral agents|mesh-ancestor
101550848|NCT01322009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101550849|NCT01322009|Expectorants|expectorants|mesh-ancestor
101550850|NCT01322009|Respiratory System Agents|respiratory system agents|mesh-ancestor
101550851|NCT01322009|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101550852|NCT01322009|Antioxidants|antioxidants|mesh-ancestor
101550853|NCT01322009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550854|NCT01322009|Protective Agents|protective agents|mesh-ancestor
101550855|NCT01322009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550856|NCT01322009|Antidotes|antidotes|mesh-ancestor
101550857|NCT01322009|Uricosuric Agents|uricosuric agents|mesh-ancestor
101550858|NCT01322009|Gout Suppressants|gout suppressants|mesh-ancestor
101550859|NCT01322009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101550860|NCT01320683|Leucovorin|leucovorin|mesh-list
101550861|NCT01320683|Bevacizumab|bevacizumab|mesh-list
101550862|NCT01320683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101550863|NCT01320683|Fluorouracil|fluorouracil|mesh-list
101550864|NCT01320683|Oxaliplatin|oxaliplatin|mesh-list
101550865|NCT01320683|Irinotecan|irinotecan|mesh-list
101550878|NCT01320683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550879|NCT01320683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101550880|NCT01320683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101550881|NCT01320683|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101550882|NCT01320683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101512784|NCT04689971|Vitamins|vitamins|mesh-list
101550883|NCT01320683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101550885|NCT01320683|Protective Agents|protective agents|mesh-ancestor
101550887|NCT01320683|Vitamins|vitamins|mesh-ancestor
101550888|NCT01320683|Micronutrients|micronutrients|mesh-ancestor
101550889|NCT01320293|Adalimumab|adalimumab|mesh-list
101550890|NCT01320293|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101550891|NCT01320293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101550892|NCT01320293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101550893|NCT01318811|Heparin|heparin|mesh-list
101550894|NCT01318811|Calcium heparin|calcium heparin|mesh-list
101550895|NCT01318811|Anticoagulants|anticoagulants|mesh-ancestor
101550896|NCT01318811|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101550897|NCT01318811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101550898|NCT01318811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550899|NCT05644769|Lisinopril|lisinopril|mesh-list
101550900|NCT05644769|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101550901|NCT05644769|Protease Inhibitors|protease inhibitors|mesh-ancestor
101550902|NCT05644769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101550903|NCT05644769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550904|NCT05644769|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101550905|NCT05644769|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101550906|NCT05644769|Protective Agents|protective agents|mesh-ancestor
101550907|NCT05644769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550908|NCT05644691|Emollients|emollients|mesh-list
101550909|NCT05644691|Dermatologic Agents|dermatologic agents|mesh-ancestor
101550910|NCT01093846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101550911|NCT01093846|Immunologic Factors|immunologic factors|mesh-ancestor
101550912|NCT01093846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550913|NCT01093534|Solifenacin Succinate|solifenacin succinate|mesh-list
101550914|NCT01093534|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101550915|NCT01093534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101550916|NCT01093534|Cholinergic Agents|cholinergic agents|mesh-ancestor
101550917|NCT01093534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101550918|NCT01093534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550919|NCT01093534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550920|NCT01093534|Urological Agents|urological agents|mesh-ancestor
101550921|NCT01314911|Oseltamivir|oseltamivir|mesh-list
101550922|NCT01314911|Antiviral Agents|antiviral agents|mesh-ancestor
101550923|NCT01314911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101550924|NCT01314911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101550925|NCT01314911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945030|NCT03911817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101945031|NCT03911817|Adrenergic Agents|adrenergic agents|mesh-ancestor
101550926|NCT01093222|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101550927|NCT01093222|Sorafenib|sorafenib|mesh-list
101550928|NCT01093222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101550929|NCT01093222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101550930|NCT01093222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101550931|NCT01093222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550942|NCT02878018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101550943|NCT01313663|Pemetrexed|pemetrexed|mesh-list
101550944|NCT01313663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101550945|NCT01313663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101550946|NCT01313663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550947|NCT01313663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101550948|NCT01313663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101550949|NCT01092832|Voriconazole|voriconazole|mesh-list
101550950|NCT01092832|Antifungal Agents|antifungal agents|mesh-ancestor
101550951|NCT01092832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101550952|NCT01092832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101550953|NCT01092832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101550954|NCT01092832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101550955|NCT01092832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550956|NCT01092832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101550957|NCT01092832|Hormone Antagonists|hormone antagonists|mesh-ancestor
101550958|NCT01092832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101550959|NCT01092832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550960|NCT01092832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101550961|NCT02878564|Praziquantel|praziquantel|mesh-list
101550962|NCT02878564|Anthelmintics|anthelmintics|mesh-ancestor
101550963|NCT02878564|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101550964|NCT02878564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101550965|NCT04308070|Hemostatics|hemostatics|mesh-list
101550966|NCT04308070|Coagulants|coagulants|mesh-ancestor
101550967|NCT01313273|Ascorbic Acid|ascorbic acid|mesh-list
101550968|NCT01313273|Methyltestosterone|methyltestosterone|mesh-list
101550970|NCT01313273|Androgens|androgens|mesh-list
101550971|NCT01313273|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101550972|NCT01313273|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101550973|NCT01313273|Androgen Antagonists|androgen antagonists|mesh-list
101550974|NCT01313273|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
101550975|NCT01313273|Hormones|hormones|mesh-ancestor
101550976|NCT01313273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101550977|NCT01313273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550978|NCT01313273|Antioxidants|antioxidants|mesh-ancestor
101550979|NCT01313273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550980|NCT01313273|Protective Agents|protective agents|mesh-ancestor
101550981|NCT01313273|Vitamins|vitamins|mesh-ancestor
101550982|NCT01313273|Micronutrients|micronutrients|mesh-ancestor
101550983|NCT01313273|Estrogens|estrogens|mesh-ancestor
101550984|NCT01313273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101550985|NCT01313273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101550986|NCT01313273|Anabolic Agents|anabolic agents|mesh-ancestor
101550987|NCT01313273|Hormone Antagonists|hormone antagonists|mesh-ancestor
101550988|NCT01091974|Modafinil|modafinil|mesh-list
101550989|NCT01091974|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101550990|NCT01091974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550991|NCT01091974|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101550992|NCT01091974|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101550993|NCT01091974|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101399375|NCT04088604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101551024|NCT01312961|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101551026|NCT01312961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101551027|NCT01312961|Adrenergic Agents|adrenergic agents|mesh-ancestor
101551028|NCT01312961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101551029|NCT01312961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551030|NCT01312961|Tocolytic Agents|tocolytic agents|mesh-ancestor
101512935|NCT02924909|Paclitaxel|paclitaxel|mesh-list
101551031|NCT01312961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101551032|NCT01312961|Immunologic Factors|immunologic factors|mesh-ancestor
101551033|NCT01312961|Glucocorticoids|glucocorticoids|mesh-ancestor
101551034|NCT01312961|Hormones|hormones|mesh-ancestor
101551035|NCT01312961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101945032|NCT03911817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101945033|NCT03911817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945034|NCT01239849|Atorvastatin|atorvastatin|mesh-list
101945035|NCT01239849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101945036|NCT01239849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101945037|NCT01239849|Antimetabolites|antimetabolites|mesh-ancestor
101945038|NCT01239849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945039|NCT01239849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101945040|NCT01239849|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101945041|NCT01239849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101945042|NCT04896489|Hydrocortisone|hydrocortisone|mesh-list
101551039|NCT00626158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101551040|NCT00626158|Antimetabolites|antimetabolites|mesh-ancestor
101551041|NCT00626158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551042|NCT00626158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101551043|NCT01310777|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101551044|NCT01310777|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101551045|NCT01310777|Brinzolamide|brinzolamide|mesh-list
101551046|NCT01310777|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101551047|NCT01310777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101551048|NCT01310777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101551049|NCT01310777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101551050|NCT01310777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101551051|NCT01310777|Adrenergic Agents|adrenergic agents|mesh-ancestor
101551052|NCT01310777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101551053|NCT01310777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551054|NCT01310777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551055|NCT01310777|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101551056|NCT01310777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101551058|NCT01309997|Imatinib Mesylate|imatinib mesylate|mesh-list
101551059|NCT01309997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101551060|NCT01309997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101551061|NCT01309997|Immunologic Factors|immunologic factors|mesh-ancestor
101551062|NCT01309997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551063|NCT01309997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101551064|NCT01309997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101551065|NCT01309997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101551066|NCT01309997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551067|NCT01309841|Naloxegol|naloxegol|mesh-list
101551068|NCT01309841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101551069|NCT01309841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551070|NCT01309841|Sensory System Agents|sensory system agents|mesh-ancestor
101551071|NCT01309841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101551072|NCT01308749|Oxytocin|oxytocin|mesh-list
101551073|NCT01308749|Oxytocics|oxytocics|mesh-ancestor
101551074|NCT01308749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101551075|NCT01308749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551076|NCT01307891|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101551077|NCT01307891|Paclitaxel|paclitaxel|mesh-list
101551078|NCT01307891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101551079|NCT01307891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101707818|NCT02997605|Hormones|hormones|mesh-ancestor
101551080|NCT01307891|Tubulin Modulators|tubulin modulators|mesh-ancestor
101551081|NCT01307891|Antimitotic Agents|antimitotic agents|mesh-ancestor
101551082|NCT01307891|Mitosis Modulators|mitosis modulators|mesh-ancestor
101551083|NCT01307891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551084|NCT05644301|Minocycline|minocycline|mesh-list
101551085|NCT05644301|Celecoxib|celecoxib|mesh-list
101551086|NCT05644301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101551087|NCT05644301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101551088|NCT05644301|Analgesics|analgesics|mesh-ancestor
101551089|NCT05644301|Sensory System Agents|sensory system agents|mesh-ancestor
101551090|NCT05644301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101945043|NCT04896489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101945044|NCT01148043|Hydroxychloroquine|hydroxychloroquine|mesh-list
101945045|NCT01148043|Antimalarials|antimalarials|mesh-ancestor
101945046|NCT01148043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101945047|NCT01148043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101945048|NCT01148043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101945049|NCT01148043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101551091|NCT05644301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551092|NCT05644301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101551093|NCT05644301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101551094|NCT05644301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101551095|NCT05644301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101551096|NCT05644301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101551097|NCT05644301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551098|NCT05644301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101551099|NCT05644301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101551100|NCT02890745|Empagliflozin|empagliflozin|mesh-list
101551101|NCT02890745|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101551102|NCT02890745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551103|NCT02890745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101513014|NCT01287364|Hormones|hormones|mesh-ancestor
101551104|NCT02890745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551105|NCT01307579|Fluconazole|fluconazole|mesh-list
101551106|NCT01307579|Caspofungin|caspofungin|mesh-list
101551112|NCT01307579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551113|NCT01307579|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101551114|NCT01307579|Hormone Antagonists|hormone antagonists|mesh-ancestor
101551115|NCT01307579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101551116|NCT01307579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551117|NCT01307579|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101551118|NCT01307579|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101551119|NCT01057693|Pregabalin|pregabalin|mesh-list
101551120|NCT01057693|Analgesics|analgesics|mesh-ancestor
101551121|NCT01057693|Sensory System Agents|sensory system agents|mesh-ancestor
101551122|NCT01057693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101551123|NCT01057693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551124|NCT01057693|Anticonvulsants|anticonvulsants|mesh-ancestor
101551125|NCT01057693|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101551126|NCT01057693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101551127|NCT01057693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551128|NCT01057693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101551129|NCT01057693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101551130|NCT01057693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101551131|NCT01057693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101551132|NCT01057693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101551133|NCT04325009|Atorvastatin|atorvastatin|mesh-list
101551134|NCT04325009|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101707829|NCT00857454|Hormones|hormones|mesh-ancestor
101551135|NCT04325009|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101551136|NCT04325009|Antimetabolites|antimetabolites|mesh-ancestor
101551137|NCT04325009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551138|NCT04325009|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101551139|NCT04325009|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101551140|NCT04325009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101551141|NCT01034137|Methotrexate|methotrexate|mesh-list
101551142|NCT01034137|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101551143|NCT01034137|Abortifacient Agents|abortifacient agents|mesh-ancestor
101551144|NCT01034137|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101551145|NCT01034137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551146|NCT01034137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101551147|NCT01034137|Antimetabolites|antimetabolites|mesh-ancestor
101551148|NCT01034137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551149|NCT01034137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101551150|NCT01034137|Dermatologic Agents|dermatologic agents|mesh-ancestor
101551151|NCT01034137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101551152|NCT01034137|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101551153|NCT01034137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101945050|NCT01148043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945051|NCT01148043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101945052|NCT04880655|Bacitracin|bacitracin|mesh-list
101945053|NCT04880655|Petrolatum|petrolatum|mesh-list
101945054|NCT04880655|Emollients|emollients|mesh-ancestor
101551154|NCT01034137|Immunologic Factors|immunologic factors|mesh-ancestor
101551155|NCT01034137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101551156|NCT01034137|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101551157|NCT04302805|Thymoglobulin|thymoglobulin|mesh-list
101551158|NCT04302805|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101551159|NCT04302805|Immunologic Factors|immunologic factors|mesh-ancestor
101551160|NCT04302805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551161|NCT04302805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101551162|NCT01056289|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101551163|NCT01056289|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101551164|NCT01056289|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101551165|NCT01056289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101551166|NCT01056289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551167|NCT01056289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101551168|NCT01056289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551169|NCT01056289|Antidepressive Agents|antidepressive agents|mesh-ancestor
101551170|NCT01056289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101551171|NCT02875093|Cytarabine|cytarabine|mesh-list
101399561|NCT03191864|Fluticasone|fluticasone|mesh-list
101551187|NCT01033825|Autonomic Agents|autonomic agents|mesh-ancestor
101551188|NCT01033825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101551189|NCT01033825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551190|NCT01033825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101551191|NCT01033825|Glucocorticoids|glucocorticoids|mesh-ancestor
101551192|NCT01033825|Hormones|hormones|mesh-ancestor
101551193|NCT01033825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101551194|NCT01033825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101551195|NCT01033825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101551196|NCT01033825|Protease Inhibitors|protease inhibitors|mesh-ancestor
101551197|NCT01033825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101551198|NCT01033825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551199|NCT01033825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101551200|NCT01033747|Deferasirox|deferasirox|mesh-list
101551201|NCT01033747|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101551202|NCT01033747|Chelating Agents|chelating agents|mesh-ancestor
101551203|NCT01033747|Sequestering Agents|sequestering agents|mesh-ancestor
101551204|NCT01033747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551205|NCT02875015|Lidocaine|lidocaine|mesh-list
101551206|NCT02875015|Bupivacaine|bupivacaine|mesh-list
101551207|NCT02875015|Anesthetics, Local|anesthetics, local|mesh-ancestor
101551208|NCT02875015|Anesthetics|anesthetics|mesh-ancestor
101551209|NCT02875015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101551210|NCT02875015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551211|NCT02875015|Sensory System Agents|sensory system agents|mesh-ancestor
101551212|NCT02875015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101551213|NCT02875015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101551214|NCT02875015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101551215|NCT02875015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101551216|NCT02875015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101551217|NCT02875015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551218|NCT01091428|Paclitaxel|paclitaxel|mesh-list
101551219|NCT01091428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101551220|NCT01091428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101551221|NCT01091428|Tubulin Modulators|tubulin modulators|mesh-ancestor
101551222|NCT01091428|Antimitotic Agents|antimitotic agents|mesh-ancestor
101551223|NCT01091428|Mitosis Modulators|mitosis modulators|mesh-ancestor
101551224|NCT01091428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551225|NCT01096342|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
101551226|NCT01096342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101551227|NCT01096342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101551228|NCT01096342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399636|NCT02968810|Simvastatin|simvastatin|mesh-list
101551232|NCT01096186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101945055|NCT04880655|Dermatologic Agents|dermatologic agents|mesh-ancestor
101945056|NCT04880655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101945057|NCT04880655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101945058|NCT04880655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101945059|NCT04865835|Metformin|metformin|mesh-list
101551234|NCT01096186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551235|NCT01096186|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101551236|NCT01096186|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101551237|NCT01096186|Dopamine Agonists|dopamine agonists|mesh-ancestor
101551238|NCT01096186|Dopamine Agents|dopamine agents|mesh-ancestor
101551239|NCT01096186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101551240|NCT01096186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551241|NCT01096186|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101551242|NCT01096186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101551243|NCT01032889|Deoxycholic Acid|deoxycholic acid|mesh-list
101551244|NCT01032889|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101551245|NCT01032889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101551246|NCT01049503|Fluorides|fluorides|mesh-list
101551247|NCT01049503|Cariostatic Agents|cariostatic agents|mesh-ancestor
101551248|NCT01049503|Protective Agents|protective agents|mesh-ancestor
101513159|NCT02933853|Insulin|insulin|mesh-list
101551249|NCT01049503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551250|NCT04302649|Dialysis Solutions|dialysis solutions|mesh-list
101551251|NCT04302649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101551252|NCT04301557|Capecitabine|capecitabine|mesh-list
101551253|NCT04301557|Oxaliplatin|oxaliplatin|mesh-list
101551254|NCT04301557|Antibodies|antibodies|mesh-list
101551255|NCT04301557|Immunologic Factors|immunologic factors|mesh-ancestor
101551256|NCT04301557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551257|NCT04301557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101551258|NCT04301557|Antimetabolites|antimetabolites|mesh-ancestor
101551259|NCT04301557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551260|NCT04301557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101551261|NCT02874313|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101551262|NCT02874313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551263|NCT01029535|Hyaluronic Acid|hyaluronic acid|mesh-list
101551264|NCT01029535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101551265|NCT01029535|Immunologic Factors|immunologic factors|mesh-ancestor
101551266|NCT01029535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551267|NCT01029535|Viscosupplements|viscosupplements|mesh-ancestor
101551268|NCT01029535|Protective Agents|protective agents|mesh-ancestor
101551269|NCT04301323|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101551270|NCT04301323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101551271|NCT01028053|Flutemetamol|flutemetamol|mesh-list
101551272|NCT01028053|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101551273|NCT01028053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551274|NCT01023217|Lamivudine|lamivudine|mesh-list
101551275|NCT01023217|Adefovir|adefovir|mesh-list
101551276|NCT01023217|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101551277|NCT01023217|Entecavir|entecavir|mesh-list
101551278|NCT01023217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101551279|NCT01023217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101551280|NCT01023217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101551281|NCT01023217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551282|NCT01023217|Antiviral Agents|antiviral agents|mesh-ancestor
101551283|NCT01023217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101551284|NCT01023217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101551285|NCT01023217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101551286|NCT01095796|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101551287|NCT01095796|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101551288|NCT01095796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101551289|NCT01095796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101551290|NCT01095796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101551291|NCT01095796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551292|NCT01095796|Antiviral Agents|antiviral agents|mesh-ancestor
101551293|NCT01095796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101551294|NCT01095796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101551295|NCT01095796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101551296|NCT01023061|Prednisone|prednisone|mesh-list
101551297|NCT01023061|Leuprolide|leuprolide|mesh-list
101945061|NCT04865835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551298|NCT01023061|Goserelin|goserelin|mesh-list
101551299|NCT01023061|Abiraterone Acetate|abiraterone acetate|mesh-list
101551306|NCT01023061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101551307|NCT01023061|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101551308|NCT01023061|Fertility Agents|fertility agents|mesh-ancestor
101551309|NCT01023061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101551310|NCT01023061|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101551311|NCT01023061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101551312|NCT01023061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551313|NCT01023061|Hormone Antagonists|hormone antagonists|mesh-ancestor
101551314|NCT01023061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101551315|NCT01027897|Doripenem|doripenem|mesh-list
101551316|NCT01027897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101551317|NCT01027897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101551318|NCT01027351|Vaccines|vaccines|mesh-list
101551319|NCT01027351|Immunologic Factors|immunologic factors|mesh-ancestor
101551320|NCT01027351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551321|NCT05661045|Anesthetics|anesthetics|mesh-list
101551322|NCT05661045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101551323|NCT05661045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551324|NCT01294683|Niacin|niacin|mesh-list
101551325|NCT01294683|Niacinamide|niacinamide|mesh-list
101551326|NCT01294683|Nicotinic Acids|nicotinic acids|mesh-list
101551327|NCT01294683|Simvastatin|simvastatin|mesh-list
101551328|NCT01294683|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101551329|NCT01294683|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101551330|NCT01294683|Antimetabolites|antimetabolites|mesh-ancestor
101551331|NCT01294683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551332|NCT01294683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101551333|NCT01294683|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101551334|NCT01294683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101551335|NCT01294683|Vasodilator Agents|vasodilator agents|mesh-ancestor
101551336|NCT01294683|Vitamin B Complex|vitamin b complex|mesh-ancestor
101551337|NCT01294683|Vitamins|vitamins|mesh-ancestor
101551338|NCT01294683|Micronutrients|micronutrients|mesh-ancestor
101551339|NCT01294683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551340|NCT01294449|Cytarabine|cytarabine|mesh-list
101551341|NCT01294449|Dexamethasone|dexamethasone|mesh-list
101551342|NCT01294449|Methotrexate|methotrexate|mesh-list
101551343|NCT01294449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101551344|NCT01294449|Antimetabolites|antimetabolites|mesh-ancestor
101551345|NCT01294449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551346|NCT01294449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101551347|NCT01294449|Antiviral Agents|antiviral agents|mesh-ancestor
101551348|NCT01294449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101551349|NCT01294449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101551350|NCT01294449|Immunologic Factors|immunologic factors|mesh-ancestor
101551351|NCT01294449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551352|NCT01294449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101551353|NCT01294449|Antiemetics|antiemetics|mesh-ancestor
101551354|NCT01294449|Autonomic Agents|autonomic agents|mesh-ancestor
101551355|NCT01294449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101551356|NCT01294449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101551357|NCT01294449|Glucocorticoids|glucocorticoids|mesh-ancestor
101551358|NCT01294449|Hormones|hormones|mesh-ancestor
101551359|NCT01294449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101551360|NCT01294449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101551361|NCT01294449|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101551362|NCT01294449|Abortifacient Agents|abortifacient agents|mesh-ancestor
101551363|NCT01294449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101551364|NCT01294449|Dermatologic Agents|dermatologic agents|mesh-ancestor
101551365|NCT01294449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101551366|NCT01294449|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101551367|NCT01294449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101551368|NCT01294449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101551373|NCT01293123|Antiviral Agents|antiviral agents|mesh-ancestor
101551374|NCT01293123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101551375|NCT01293123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101551376|NCT01293123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101551377|NCT01293123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101551378|NCT01293123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551379|NCT01293123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101945062|NCT03911271|Atropine|atropine|mesh-list
101945063|NCT03911271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101945064|NCT03911271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101945065|NCT03911271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101945066|NCT03911271|Autonomic Agents|autonomic agents|mesh-ancestor
101551380|NCT01293123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101551381|NCT01293123|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101551382|NCT01293123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101551383|NCT01293123|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101551384|NCT01293123|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101551385|NCT01293123|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101551386|NCT01293123|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101551387|NCT01293123|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101551388|NCT01293123|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101551389|NCT01292187|Calcitonin|calcitonin|mesh-list
101551390|NCT01292187|Salmon calcitonin|salmon calcitonin|mesh-list
101551391|NCT01292187|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
101551392|NCT01292187|Katacalcin|katacalcin|mesh-list
101551393|NCT01292187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101551394|NCT01292187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551395|NCT01292187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101551396|NCT01292187|Vasodilator Agents|vasodilator agents|mesh-ancestor
101551397|NCT01026493|Temozolomide|temozolomide|mesh-list
101551398|NCT01026493|Veliparib|veliparib|mesh-list
101551399|NCT01026493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101551400|NCT01026493|Alkylating Agents|alkylating agents|mesh-ancestor
101551401|NCT01026493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551402|NCT01026493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101551403|NCT01026493|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101551404|NCT01026493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101551405|NCT01291173|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101551406|NCT01291173|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101551407|NCT01291173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551408|NCT01291173|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101551409|NCT01291173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101551410|NCT01291173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101551411|NCT01291173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551412|NCT01291173|Dopamine Agents|dopamine agents|mesh-ancestor
101551413|NCT01291173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101551414|NCT01291017|Palbociclib|palbociclib|mesh-list
101551415|NCT01291017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101551416|NCT01291017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101551417|NCT01291017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101551418|NCT01291017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551419|NCT01290315|Dextrans|dextrans|mesh-list
101551420|NCT01290315|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101551421|NCT01290315|Iron-Dextran Complex|iron-dextran complex|mesh-list
101551422|NCT01290315|Hematinics|hematinics|mesh-ancestor
101551423|NCT01290315|Anticoagulants|anticoagulants|mesh-ancestor
101551424|NCT01290315|Plasma Substitutes|plasma substitutes|mesh-ancestor
101551425|NCT01290315|Blood Substitutes|blood substitutes|mesh-ancestor
101551426|NCT01289847|gamma-Globulins|gamma-globulins|mesh-list
101551427|NCT01289847|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101551428|NCT01289847|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101551429|NCT01289847|Immunologic Factors|immunologic factors|mesh-ancestor
101551430|NCT01289847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551431|NCT01021813|Suvorexant|suvorexant|mesh-list
101551432|NCT01021813|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101551433|NCT01021813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101551434|NCT01021813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101551435|NCT01021813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551436|NCT01021813|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
101551437|NCT01021813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101551438|NCT01021813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551452|NCT01020877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101551453|NCT01020877|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101551454|NCT01020877|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101551455|NCT01020799|Escitalopram|escitalopram|mesh-list
101551456|NCT01020799|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101945067|NCT03911271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101945068|NCT03911271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945069|NCT03911271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101945070|NCT03911271|Respiratory System Agents|respiratory system agents|mesh-ancestor
101945072|NCT03911271|Parasympatholytics|parasympatholytics|mesh-ancestor
101551457|NCT01020799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101551458|NCT01020799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101551459|NCT01020799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551460|NCT01020799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101551461|NCT01020799|Serotonin Agents|serotonin agents|mesh-ancestor
101551462|NCT01020799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551463|NCT02872597|Dexamethasone|dexamethasone|mesh-list
101551464|NCT02872597|Prednisone|prednisone|mesh-list
101551465|NCT02872597|Methylprednisolone|methylprednisolone|mesh-list
101551466|NCT02872597|Prednisolone|prednisolone|mesh-list
101551467|NCT02872597|Albuterol|albuterol|mesh-list
101551468|NCT02872597|Ipratropium|ipratropium|mesh-list
101551469|NCT02872597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101551470|NCT02872597|Antiemetics|antiemetics|mesh-ancestor
101551471|NCT02872597|Autonomic Agents|autonomic agents|mesh-ancestor
101551472|NCT02872597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101513386|NCT01283386|Rituximab|rituximab|mesh-list
101551473|NCT02872597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551474|NCT02872597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101551476|NCT02872597|Hormones|hormones|mesh-ancestor
101551477|NCT02872597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101551478|NCT02872597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101551479|NCT02872597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101551480|NCT02872597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551481|NCT02872597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101551482|NCT02872597|Protective Agents|protective agents|mesh-ancestor
101551483|NCT02872597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101551484|NCT02872597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101551485|NCT02872597|Respiratory System Agents|respiratory system agents|mesh-ancestor
101551486|NCT02872597|Tocolytic Agents|tocolytic agents|mesh-ancestor
101551487|NCT02872597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101551488|NCT02872597|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101551489|NCT02872597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101551490|NCT02872597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101551491|NCT02872597|Adrenergic Agents|adrenergic agents|mesh-ancestor
101551492|NCT02872597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101551493|NCT02872597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101551494|NCT02872597|Cholinergic Agents|cholinergic agents|mesh-ancestor
101551495|NCT02873065|Amoxicillin|amoxicillin|mesh-list
101551496|NCT02873065|Clarithromycin|clarithromycin|mesh-list
101551497|NCT02873065|Potassium Citrate|potassium citrate|mesh-list
101551498|NCT02873065|Bismuth|bismuth|mesh-list
101551499|NCT02873065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551500|NCT02873065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101551501|NCT02873065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101551502|NCT02873065|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101551515|NCT00628225|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101551517|NCT00628225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101551518|NCT00628225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551519|NCT00628225|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101551520|NCT00628225|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101551521|NCT00628225|Cholinergic Agents|cholinergic agents|mesh-ancestor
101551522|NCT00628225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101551523|NCT00628225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551524|NCT00628225|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101551525|NCT00628225|Antidepressive Agents|antidepressive agents|mesh-ancestor
101551526|NCT00628225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101551527|NCT00628225|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101551528|NCT00628225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101551529|NCT00628225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101551530|NCT00628225|Dopamine Agents|dopamine agents|mesh-ancestor
101551531|NCT00628225|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101945073|NCT03911271|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101786844|NCT01565590|Anesthetics|anesthetics|mesh-ancestor
101551532|NCT00628225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101551533|NCT00628225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101551534|NCT01014013|Ceftriaxone|ceftriaxone|mesh-list
101551535|NCT01014013|Ertapenem|ertapenem|mesh-list
101551536|NCT01014013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101551537|NCT01014013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101551538|NCT01013701|Fluticasone|fluticasone|mesh-list
101551539|NCT01013701|Xhance|xhance|mesh-list
101551540|NCT01013701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101551541|NCT01013701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101551542|NCT01013701|Autonomic Agents|autonomic agents|mesh-ancestor
101551543|NCT01013701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101551544|NCT01013701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551545|NCT01013701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101551546|NCT01013701|Respiratory System Agents|respiratory system agents|mesh-ancestor
101513456|NCT02932644|Vitamin D|vitamin d|mesh-list
101551547|NCT01013701|Dermatologic Agents|dermatologic agents|mesh-ancestor
101551548|NCT01013701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101551549|NCT01020019|Lofexidine|lofexidine|mesh-list
101551550|NCT01020019|Dronabinol|dronabinol|mesh-list
101551551|NCT01020019|Hallucinogens|hallucinogens|mesh-ancestor
101551552|NCT01020019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551553|NCT01020019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101551554|NCT01020019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101551555|NCT01020019|Analgesics|analgesics|mesh-ancestor
101551556|NCT01020019|Sensory System Agents|sensory system agents|mesh-ancestor
101551557|NCT01020019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101551558|NCT01020019|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101551559|NCT01020019|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101551560|NCT01020019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101551561|NCT01020019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551562|NCT01020019|Hormones|hormones|mesh-ancestor
101551563|NCT01020019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101551564|NCT01020019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101399965|NCT05953142|Dobutamine|dobutamine|mesh-list
101551571|NCT00627835|Sorafenib|sorafenib|mesh-list
101551572|NCT00627835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101551573|NCT00627835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101551574|NCT00627835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101551575|NCT00627835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551576|NCT01019317|Cytarabine|cytarabine|mesh-list
101551577|NCT01019317|Fludarabine|fludarabine|mesh-list
101551578|NCT01019317|Fludarabine phosphate|fludarabine phosphate|mesh-list
101551579|NCT01019317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101551580|NCT01019317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101551581|NCT01019317|Antimetabolites|antimetabolites|mesh-ancestor
101551582|NCT01019317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551583|NCT01019317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101551584|NCT01019317|Immunologic Factors|immunologic factors|mesh-ancestor
101551585|NCT01019317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551586|NCT01019317|Antiviral Agents|antiviral agents|mesh-ancestor
101551587|NCT01019317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101551588|NCT02877238|Sevoflurane|sevoflurane|mesh-list
101551589|NCT02877238|Anesthetics|anesthetics|mesh-ancestor
101551590|NCT02877238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101551591|NCT02877238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551592|NCT02877238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101551593|NCT02877238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101551594|NCT02877238|Anesthetics, General|anesthetics, general|mesh-ancestor
101551595|NCT01288911|Bicalutamide|bicalutamide|mesh-list
101551596|NCT01288911|Androgen Antagonists|androgen antagonists|mesh-ancestor
101551597|NCT01288911|Hormone Antagonists|hormone antagonists|mesh-ancestor
101551598|NCT01288911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101551599|NCT01288911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551600|NCT01288911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101551601|NCT01288443|Atorvastatin|atorvastatin|mesh-list
101551602|NCT01288443|Alirocumab|alirocumab|mesh-list
101551603|NCT01288443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101551604|NCT01288443|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101551605|NCT01288443|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101551606|NCT01288443|Antimetabolites|antimetabolites|mesh-ancestor
101551607|NCT01288443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551608|NCT01288443|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101945074|NCT03911271|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101945075|NCT03911271|Cholinergic Agents|cholinergic agents|mesh-ancestor
101945076|NCT03911271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101551609|NCT01288443|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101551610|NCT01288443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101551611|NCT01288443|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101551612|NCT01288443|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101551613|NCT01288443|Protease Inhibitors|protease inhibitors|mesh-ancestor
101551614|NCT01288443|Immunologic Factors|immunologic factors|mesh-ancestor
101551615|NCT01288443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551616|NCT01288209|Ribavirin|ribavirin|mesh-list
101551617|NCT01288209|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101551618|NCT01288209|Simeprevir|simeprevir|mesh-list
101551619|NCT01288209|Antimetabolites|antimetabolites|mesh-ancestor
101551620|NCT01288209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551621|NCT01288209|Antiviral Agents|antiviral agents|mesh-ancestor
101551622|NCT01288209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101551623|NCT01288209|Protease Inhibitors|protease inhibitors|mesh-ancestor
101551624|NCT01288209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101551626|NCT01287195|Muromonab-CD3|muromonab-cd3|mesh-list
101551627|NCT01287195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101551628|NCT01287195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101551629|NCT01287195|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101551630|NCT01287195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101551631|NCT01287195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551632|NCT01287195|Immunologic Factors|immunologic factors|mesh-ancestor
101551633|NCT01287195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551634|NCT01287195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101551635|NCT01287117|Omalizumab|omalizumab|mesh-list
101551641|NCT01287039|Respiratory System Agents|respiratory system agents|mesh-ancestor
101551642|NCT05572203|Caseins|caseins|mesh-list
101551643|NCT05572203|Chelating Agents|chelating agents|mesh-ancestor
101551644|NCT05572203|Sequestering Agents|sequestering agents|mesh-ancestor
101551645|NCT05572203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551646|NCT01285401|Interferons|interferons|mesh-list
101551647|NCT01285401|Interferon-beta|interferon-beta|mesh-list
101551648|NCT01285401|Interferon beta-1a|interferon beta-1a|mesh-list
101551649|NCT01285401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101551650|NCT01285401|Antiviral Agents|antiviral agents|mesh-ancestor
101551651|NCT01285401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101551652|NCT01285401|Immunologic Factors|immunologic factors|mesh-ancestor
101551653|NCT01285401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551654|NCT01285401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101551655|NCT01285323|Reslizumab|reslizumab|mesh-list
101551656|NCT01285323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101551657|NCT01285323|Respiratory System Agents|respiratory system agents|mesh-ancestor
101551658|NCT01284621|Empagliflozin|empagliflozin|mesh-list
101551659|NCT01284621|Ramipril|ramipril|mesh-list
101551660|NCT01284621|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101551661|NCT01284621|Protease Inhibitors|protease inhibitors|mesh-ancestor
101551662|NCT01284621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101551663|NCT01284621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551664|NCT01284621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101551665|NCT01284621|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101551666|NCT01284621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101551667|NCT01284621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551668|NCT01283139|Sifalimumab|sifalimumab|mesh-list
101551669|NCT01283139|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101551670|NCT01283139|Immunologic Factors|immunologic factors|mesh-ancestor
101551671|NCT01283139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551672|NCT01281969|Immunoglobulins|immunoglobulins|mesh-list
101551673|NCT01281969|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101551674|NCT01281969|Antibodies|antibodies|mesh-list
101551675|NCT01281969|gamma-Globulins|gamma-globulins|mesh-list
101551676|NCT01281969|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101551677|NCT01281969|Immunologic Factors|immunologic factors|mesh-ancestor
101551678|NCT01281969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551679|NCT01281813|Ritonavir|ritonavir|mesh-list
101551680|NCT01281813|Darunavir|darunavir|mesh-list
101551681|NCT01281813|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101551682|NCT01281813|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101551683|NCT01281813|Protease Inhibitors|protease inhibitors|mesh-ancestor
101551684|NCT01281813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101551685|NCT01281813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945077|NCT03911271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551686|NCT01281813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101551687|NCT01281813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101551688|NCT01281813|Antiviral Agents|antiviral agents|mesh-ancestor
101551689|NCT01281813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101551690|NCT01281813|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101551691|NCT01281813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101551692|NCT01090414|Idelalisib|idelalisib|mesh-list
101551693|NCT01090414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101551694|NCT01090414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101551695|NCT01090414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551696|NCT01090102|Aminosalicylic Acid|aminosalicylic acid|mesh-list
101551697|NCT01090102|Mesalamine|mesalamine|mesh-list
101551698|NCT01090102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101551699|NCT01090102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101551700|NCT01090102|Analgesics|analgesics|mesh-ancestor
101551701|NCT01090102|Sensory System Agents|sensory system agents|mesh-ancestor
101551702|NCT01090102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101551703|NCT01090102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551704|NCT01090102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101551705|NCT01090102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101551706|NCT01090102|Antitubercular Agents|antitubercular agents|mesh-ancestor
101400091|NCT05951959|Acalabrutinib|acalabrutinib|mesh-list
101551720|NCT04306666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101551721|NCT04306666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551722|NCT01280955|Plerixafor|plerixafor|mesh-list
101551723|NCT01280955|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101551724|NCT01280955|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101551725|NCT01280955|Antiviral Agents|antiviral agents|mesh-ancestor
101551726|NCT01280955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101551727|NCT01280721|Tolvaptan|tolvaptan|mesh-list
101551728|NCT01280721|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101551729|NCT01280721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551730|NCT01280721|Natriuretic Agents|natriuretic agents|mesh-ancestor
101551731|NCT01280721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551732|NCT01087762|Certolizumab Pegol|certolizumab pegol|mesh-list
101551733|NCT01087762|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101551734|NCT01087762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101551735|NCT01087762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101551736|NCT01087762|Immunologic Factors|immunologic factors|mesh-ancestor
101551737|NCT01087762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551738|NCT01087762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101551739|NCT04306354|Oxytocin|oxytocin|mesh-list
101551740|NCT04306354|Oxytocics|oxytocics|mesh-ancestor
101551741|NCT04306354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101551742|NCT04306354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551743|NCT04306276|Dienogest|dienogest|mesh-list
101551744|NCT04306276|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101551745|NCT04306276|Contraceptive Agents|contraceptive agents|mesh-ancestor
101551746|NCT04306276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101551747|NCT04306276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551748|NCT04306276|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101551749|NCT04306276|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101551750|NCT04306276|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101551751|NCT04306276|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101551752|NCT04306276|Hormone Antagonists|hormone antagonists|mesh-ancestor
101551753|NCT04306276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101551754|NCT04306276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101551755|NCT04306276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101551756|NCT01078168|Acitretin|acitretin|mesh-list
101551757|NCT01078168|Keratolytic Agents|keratolytic agents|mesh-ancestor
101551758|NCT01078168|Dermatologic Agents|dermatologic agents|mesh-ancestor
101551759|NCT01086358|Naproxen|naproxen|mesh-list
101551760|NCT01086358|Sumatriptan|sumatriptan|mesh-list
101551761|NCT01086358|Naratriptan|naratriptan|mesh-list
101551762|NCT01086358|Zolmitriptan|zolmitriptan|mesh-list
101551763|NCT01086358|Rizatriptan|rizatriptan|mesh-list
101551764|NCT01086358|Eletriptan|eletriptan|mesh-list
101551765|NCT01086358|Almotriptan|almotriptan|mesh-list
101551766|NCT01086358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101551767|NCT01086358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101551768|NCT01086358|Analgesics|analgesics|mesh-ancestor
101551769|NCT01086358|Sensory System Agents|sensory system agents|mesh-ancestor
101551770|NCT01086358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101945078|NCT01248195|Olanzapine|olanzapine|mesh-list
101945079|NCT01248195|Clozapine|clozapine|mesh-list
101945080|NCT01248195|Amisulpride|amisulpride|mesh-list
101945081|NCT01248195|Antiemetics|antiemetics|mesh-ancestor
101551773|NCT01086358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101551774|NCT01086358|Gout Suppressants|gout suppressants|mesh-ancestor
101551775|NCT01086358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101551776|NCT01086358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101551777|NCT01086358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551778|NCT01086358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101551779|NCT01086358|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101551780|NCT01086358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101551781|NCT01086358|Serotonin Agents|serotonin agents|mesh-ancestor
101551782|NCT01086358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101551783|NCT01277601|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101551784|NCT01277601|Antiviral Agents|antiviral agents|mesh-ancestor
101551785|NCT01277601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101551786|NCT01277523|Tiotropium Bromide|tiotropium bromide|mesh-list
101551787|NCT01277523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101551788|NCT01277523|Autonomic Agents|autonomic agents|mesh-ancestor
101551789|NCT01277523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101551790|NCT01277523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551791|NCT01277523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101551792|NCT01277523|Respiratory System Agents|respiratory system agents|mesh-ancestor
101551793|NCT01277523|Parasympatholytics|parasympatholytics|mesh-ancestor
101551794|NCT01277523|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101551795|NCT01277523|Cholinergic Agents|cholinergic agents|mesh-ancestor
101551796|NCT01277523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101551797|NCT01277523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551798|NCT01081834|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101551799|NCT01081834|Canagliflozin|canagliflozin|mesh-list
101551800|NCT01081834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101551801|NCT01081834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551802|NCT01081834|Incretins|incretins|mesh-ancestor
101551803|NCT01081834|Hormones|hormones|mesh-ancestor
101707942|NCT03393611|Fludarabine|fludarabine|mesh-list
101551804|NCT01081834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101551805|NCT01081834|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101551806|NCT01081834|Protease Inhibitors|protease inhibitors|mesh-ancestor
101551807|NCT01081834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101551808|NCT01081834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551809|NCT01081834|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101551810|NCT01079962|Atenolol|atenolol|mesh-list
101551811|NCT01079962|Bisoprolol|bisoprolol|mesh-list
101551812|NCT01079962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101551813|NCT01079962|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101551814|NCT01079962|Sympatholytics|sympatholytics|mesh-ancestor
101551815|NCT01079962|Autonomic Agents|autonomic agents|mesh-ancestor
101551816|NCT01079962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101551817|NCT01079962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551818|NCT01079962|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101551819|NCT01079962|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101551820|NCT01079962|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101551821|NCT01079962|Adrenergic Agents|adrenergic agents|mesh-ancestor
101551822|NCT01079962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101551823|NCT01079962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551824|NCT01274637|Dalteparin|dalteparin|mesh-list
101551825|NCT01274637|Tinzaparin|tinzaparin|mesh-list
101551826|NCT01274637|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101551827|NCT01274637|Anticoagulants|anticoagulants|mesh-ancestor
101551828|NCT01274637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101551829|NCT01274637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101551830|NCT01274637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551831|NCT01079806|Entecavir|entecavir|mesh-list
101551832|NCT01079806|Antiviral Agents|antiviral agents|mesh-ancestor
101551833|NCT01079806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101551834|NCT02876770|Melatonin|melatonin|mesh-list
101551835|NCT02876770|Antioxidants|antioxidants|mesh-ancestor
101551836|NCT02876770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551837|NCT02876770|Protective Agents|protective agents|mesh-ancestor
101551838|NCT02876770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551839|NCT02876770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101551840|NCT01077622|Ofatumumab|ofatumumab|mesh-list
101551841|NCT01077622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101551842|NCT01313676|Fluticasone|fluticasone|mesh-list
101551843|NCT01313676|Xhance|xhance|mesh-list
101551855|NCT00623376|Antiemetics|antiemetics|mesh-ancestor
101551856|NCT00623376|Autonomic Agents|autonomic agents|mesh-ancestor
101551857|NCT00623376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101551858|NCT00623376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551859|NCT00623376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101551860|NCT00623376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101551861|NCT00623376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101551862|NCT00623376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101551863|NCT00623376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101551864|NCT00623376|Hallucinogens|hallucinogens|mesh-ancestor
101551865|NCT00623376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101551866|NCT00623376|Analgesics|analgesics|mesh-ancestor
101551867|NCT00623376|Sensory System Agents|sensory system agents|mesh-ancestor
101551868|NCT00623376|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101551869|NCT00623376|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101551870|NCT00623376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101551871|NCT00623376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551872|NCT00623376|Hormones|hormones|mesh-ancestor
101551873|NCT00623376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101551874|NCT01313286|Globalagliatin|globalagliatin|mesh-list
101551875|NCT01313286|Enzyme Activators|enzyme activators|mesh-ancestor
101551876|NCT01313286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551877|NCT01313208|Etanercept|etanercept|mesh-list
101551878|NCT01313208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101551879|NCT01313208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101551880|NCT01313208|Analgesics|analgesics|mesh-ancestor
101551881|NCT01313208|Sensory System Agents|sensory system agents|mesh-ancestor
101551882|NCT01313208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101551883|NCT01313208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551884|NCT01313208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101551885|NCT01313208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101551886|NCT01313208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101551887|NCT01313208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101551888|NCT01313208|Immunologic Factors|immunologic factors|mesh-ancestor
101551889|NCT01075984|Posaconazole|posaconazole|mesh-list
101551890|NCT01075984|Antifungal Agents|antifungal agents|mesh-ancestor
101551891|NCT01075984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101551892|NCT01075984|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101551893|NCT01075984|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101551894|NCT01075984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101551895|NCT01075984|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101551896|NCT01075984|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101551897|NCT01075984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101551898|NCT01075984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551899|NCT01075984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101551900|NCT01075984|Hormone Antagonists|hormone antagonists|mesh-ancestor
101551901|NCT01075984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101551902|NCT01075984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551903|NCT01024231|Nivolumab|nivolumab|mesh-list
101551904|NCT01024231|Ipilimumab|ipilimumab|mesh-list
101551905|NCT01024231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101551906|NCT01024231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101551907|NCT01024231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101551908|NCT01024231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551916|NCT01012999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101551917|NCT01012999|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101551918|NCT01012999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101551919|NCT01012999|Anesthetics, General|anesthetics, general|mesh-ancestor
101551921|NCT00637663|Lamivudine|lamivudine|mesh-list
101551922|NCT00637663|Entecavir|entecavir|mesh-list
101551923|NCT00637663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101551924|NCT00637663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101551925|NCT00637663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101551926|NCT00637663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551928|NCT00637663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101551929|NCT00637663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101551930|NCT00637663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101551931|NCT01016977|Nicotinic Acids|nicotinic acids|mesh-list
101551932|NCT01016977|Clindamycin|clindamycin|mesh-list
101551933|NCT01016977|Clindamycin palmitate|clindamycin palmitate|mesh-list
101551934|NCT01016977|Clindamycin phosphate|clindamycin phosphate|mesh-list
101707977|NCT02313389|Rituximab|rituximab|mesh-list
101945083|NCT01248195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101945084|NCT01248195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945085|NCT01248195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101945087|NCT01248195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101945088|NCT01248195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101945089|NCT01248195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101945090|NCT01248195|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101945091|NCT01248195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101945092|NCT01248195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101945093|NCT01248195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551935|NCT01016977|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101551936|NCT01016977|Tazarotene|tazarotene|mesh-list
101551937|NCT01016977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101551938|NCT01016977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101551939|NCT01016977|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101551940|NCT01016977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101551941|NCT01016977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551942|NCT01016977|Dermatologic Agents|dermatologic agents|mesh-ancestor
101551943|NCT01016977|Keratolytic Agents|keratolytic agents|mesh-ancestor
101551944|NCT01016977|Vitamin B Complex|vitamin b complex|mesh-ancestor
101551945|NCT01016977|Vitamins|vitamins|mesh-ancestor
101551946|NCT01016977|Micronutrients|micronutrients|mesh-ancestor
101551947|NCT01016977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551948|NCT02871661|Amitriptyline|amitriptyline|mesh-list
101551949|NCT02871661|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101551950|NCT02871661|Antidepressive Agents|antidepressive agents|mesh-ancestor
101551951|NCT02871661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101551952|NCT02871661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101551953|NCT02871661|Analgesics|analgesics|mesh-ancestor
101551954|NCT02871661|Sensory System Agents|sensory system agents|mesh-ancestor
101551955|NCT02871661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101551956|NCT02871661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551957|NCT02871661|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101551958|NCT02871661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101551959|NCT02871661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101551960|NCT02871661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551961|NCT02871661|Adrenergic Agents|adrenergic agents|mesh-ancestor
101551962|NCT02871661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101551963|NCT01012765|Tiotropium Bromide|tiotropium bromide|mesh-list
101551964|NCT01012765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101551965|NCT01012765|Autonomic Agents|autonomic agents|mesh-ancestor
101551966|NCT01012765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101551967|NCT01012765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551968|NCT01012765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101551969|NCT01012765|Respiratory System Agents|respiratory system agents|mesh-ancestor
101551970|NCT01012765|Parasympatholytics|parasympatholytics|mesh-ancestor
101551971|NCT01012765|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101551972|NCT01012765|Cholinergic Agents|cholinergic agents|mesh-ancestor
101551973|NCT01012765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101551974|NCT01012765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551975|NCT00628459|Micronutrients|micronutrients|mesh-list
101551976|NCT00628459|Trace Elements|trace elements|mesh-list
101551977|NCT00628459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551978|NCT00627913|Anesthetics|anesthetics|mesh-list
101551989|NCT01006291|Insulin, Long-Acting|insulin, long-acting|mesh-list
101551990|NCT01006291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101551991|NCT01006291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551992|NCT04296175|Paclitaxel|paclitaxel|mesh-list
101551993|NCT04296175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101551994|NCT04296175|Carboplatin|carboplatin|mesh-list
101551995|NCT04296175|Epirubicin|epirubicin|mesh-list
101945094|NCT01248195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101945095|NCT01248195|Serotonin Agents|serotonin agents|mesh-ancestor
101787267|NCT00881088|Protease Inhibitors|protease inhibitors|mesh-ancestor
101708001|NCT02632916|Zoledronic Acid|zoledronic acid|mesh-list
101551996|NCT04296175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101551997|NCT04296175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101551998|NCT04296175|Tubulin Modulators|tubulin modulators|mesh-ancestor
101551999|NCT04296175|Antimitotic Agents|antimitotic agents|mesh-ancestor
101552000|NCT04296175|Mitosis Modulators|mitosis modulators|mesh-ancestor
101552001|NCT04296175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552002|NCT04296175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101552003|NCT04296175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101552004|NCT04296175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101552005|NCT04296175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101552007|NCT02871349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101552008|NCT02871349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101552009|NCT02871349|Adrenergic Agents|adrenergic agents|mesh-ancestor
101552010|NCT02871349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101552011|NCT02871349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552012|NCT02871349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552013|NCT02871349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101552014|NCT02871349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101552015|NCT02871349|Vasodilator Agents|vasodilator agents|mesh-ancestor
101552017|NCT01012609|Cetuximab|cetuximab|mesh-list
101552018|NCT01012609|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101552019|NCT01012609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101552020|NCT01012609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101552021|NCT01012609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552022|NCT01012609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101552023|NCT01012609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101552024|NCT04297501|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101552025|NCT04297501|Antiviral Agents|antiviral agents|mesh-ancestor
101552026|NCT04297501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101552027|NCT01012219|Aspirin|aspirin|mesh-list
101552028|NCT01012219|Niacin|niacin|mesh-list
101552029|NCT01012219|Clopidogrel|clopidogrel|mesh-list
101552030|NCT01012219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101552031|NCT01012219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101552032|NCT01012219|Analgesics|analgesics|mesh-ancestor
101552033|NCT01012219|Sensory System Agents|sensory system agents|mesh-ancestor
101552034|NCT01012219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101552035|NCT01012219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552036|NCT01012219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101552037|NCT01012219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101552038|NCT01012219|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101552039|NCT01012219|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101552040|NCT01012219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552041|NCT01012219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101552042|NCT01012219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101552043|NCT01012219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101552048|NCT01012219|Purinergic Agents|purinergic agents|mesh-ancestor
101552049|NCT01012219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101552050|NCT01012219|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101552051|NCT01012219|Antimetabolites|antimetabolites|mesh-ancestor
101552052|NCT01012219|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101552053|NCT01012219|Vasodilator Agents|vasodilator agents|mesh-ancestor
101552054|NCT01012219|Vitamin B Complex|vitamin b complex|mesh-ancestor
101552055|NCT01012219|Vitamins|vitamins|mesh-ancestor
101552056|NCT01012219|Micronutrients|micronutrients|mesh-ancestor
101552057|NCT01011907|Varenicline|varenicline|mesh-list
101552058|NCT01011907|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101552059|NCT01011907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101552060|NCT01011907|Cholinergic Agents|cholinergic agents|mesh-ancestor
101552061|NCT01011907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101552062|NCT01011907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552063|NCT01011907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552064|NCT01011673|Ketorolac|ketorolac|mesh-list
101552065|NCT01011673|Metoclopramide|metoclopramide|mesh-list
101552066|NCT01011673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101552067|NCT01011673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101552068|NCT01011673|Analgesics|analgesics|mesh-ancestor
101552069|NCT01011673|Sensory System Agents|sensory system agents|mesh-ancestor
101552070|NCT01011673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101945096|NCT01248195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101945097|NCT01248195|GABA Antagonists|gaba antagonists|mesh-ancestor
101945098|NCT01248195|GABA Agents|gaba agents|mesh-ancestor
101945099|NCT01248195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101945100|NCT01248195|Dopamine Agents|dopamine agents|mesh-ancestor
101552071|NCT01011673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552072|NCT01011673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101513982|NCT05466149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101552073|NCT01011673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101552074|NCT01011673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101552075|NCT01011673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101552076|NCT01011673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552077|NCT01011673|Antiemetics|antiemetics|mesh-ancestor
101552078|NCT01011673|Autonomic Agents|autonomic agents|mesh-ancestor
101552079|NCT01011673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101552080|NCT01011673|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101552081|NCT01011673|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101552082|NCT01011673|Dopamine Agents|dopamine agents|mesh-ancestor
101552083|NCT01011673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101552084|NCT01311648|Factor VIII|factor viii|mesh-list
101552085|NCT01311648|Coagulants|coagulants|mesh-ancestor
101552086|NCT01011439|Maleic acid|maleic acid|mesh-list
101552087|NCT01011439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101552088|NCT01011439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552089|NCT04406857|Capecitabine|capecitabine|mesh-list
101552090|NCT04406857|Ropidoxuridine|ropidoxuridine|mesh-list
101552091|NCT04406857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101552092|NCT04406857|Antimetabolites|antimetabolites|mesh-ancestor
101552093|NCT04406857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552094|NCT04406857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101552095|NCT01311024|Vaccines|vaccines|mesh-list
101552096|NCT01311024|Immunologic Factors|immunologic factors|mesh-ancestor
101552097|NCT01311024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552098|NCT02871193|Dexamethasone|dexamethasone|mesh-list
101552099|NCT02871193|Ropivacaine|ropivacaine|mesh-list
101552100|NCT02871193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101552101|NCT02871193|Antiemetics|antiemetics|mesh-ancestor
101552102|NCT02871193|Autonomic Agents|autonomic agents|mesh-ancestor
101552103|NCT02871193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101552104|NCT02871193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552105|NCT02871193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101552106|NCT02871193|Glucocorticoids|glucocorticoids|mesh-ancestor
101552107|NCT02871193|Hormones|hormones|mesh-ancestor
101552108|NCT02871193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101552109|NCT02871193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101552110|NCT02871193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101552111|NCT02871193|Anesthetics, Local|anesthetics, local|mesh-ancestor
101552112|NCT02871193|Anesthetics|anesthetics|mesh-ancestor
101552113|NCT02871193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101552114|NCT02871193|Sensory System Agents|sensory system agents|mesh-ancestor
101552115|NCT01310868|Carmustine|carmustine|mesh-list
101552120|NCT01310868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552121|NCT01310868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101552122|NCT01310868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101552123|NCT01310868|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101552124|NCT01310868|Dermatologic Agents|dermatologic agents|mesh-ancestor
101552125|NCT01273155|Belinostat|belinostat|mesh-list
101552126|NCT01273155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101708021|NCT02131493|Gemcitabine|gemcitabine|mesh-list
101552127|NCT01273155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101552128|NCT01273155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101552129|NCT01273155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552130|NCT05557851|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
101552131|NCT05557851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101552132|NCT05557851|Alkylating Agents|alkylating agents|mesh-ancestor
101552133|NCT05557851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552134|NCT05557851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101552135|NCT01005901|Glycopyrrolate|glycopyrrolate|mesh-list
101552136|NCT01005901|Bromides|bromides|mesh-list
101552137|NCT01005901|Anticonvulsants|anticonvulsants|mesh-ancestor
101552138|NCT01005901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101552139|NCT01005901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101552140|NCT01005901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101787411|NCT00873834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101552141|NCT01005901|Cholinergic Agents|cholinergic agents|mesh-ancestor
101552142|NCT01005901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101552143|NCT01005901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552144|NCT01005901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552145|NCT02889549|Clopidogrel|clopidogrel|mesh-list
101552146|NCT02889549|Ticagrelor|ticagrelor|mesh-list
101552147|NCT02889549|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101552148|NCT02889549|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101552149|NCT02889549|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101552150|NCT02889549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101552151|NCT02889549|Purinergic Agents|purinergic agents|mesh-ancestor
101552152|NCT02889549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101552153|NCT02889549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552154|NCT02889549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552155|NCT05549037|Immunomodulating Agents|immunomodulating agents|mesh-list
101552156|NCT05549037|Immunologic Factors|immunologic factors|mesh-ancestor
101552157|NCT05549037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552158|NCT01309386|Morphine|morphine|mesh-list
101552159|NCT01309386|Tapentadol|tapentadol|mesh-list
101552160|NCT01309386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101552161|NCT01309386|Narcotics|narcotics|mesh-ancestor
101552162|NCT01309386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101552163|NCT01309386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552164|NCT01309386|Analgesics|analgesics|mesh-ancestor
101552165|NCT01309386|Sensory System Agents|sensory system agents|mesh-ancestor
101552166|NCT01309386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101552167|NCT01309386|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101552168|NCT01309386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101552169|NCT01309386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101552170|NCT01309386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552171|NCT01309386|Adrenergic Agents|adrenergic agents|mesh-ancestor
101552172|NCT01309386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101552173|NCT04295317|Capecitabine|capecitabine|mesh-list
101552174|NCT04295317|Antibodies|antibodies|mesh-list
101552175|NCT04295317|Antibodies, Blocking|antibodies, blocking|mesh-list
101552176|NCT04295317|Immunologic Factors|immunologic factors|mesh-ancestor
101552177|NCT04295317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552178|NCT04295317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101552179|NCT04295317|Antimetabolites|antimetabolites|mesh-ancestor
101552180|NCT04295317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552181|NCT04295317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101552182|NCT01266603|Aldesleukin|aldesleukin|mesh-list
101552183|NCT01266603|Interleukin-2|interleukin-2|mesh-list
101552184|NCT01266603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101552185|NCT01266603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101552189|NCT01266603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552190|NCT01266603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101552191|NCT01266603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101552192|NCT01266603|Antiviral Agents|antiviral agents|mesh-ancestor
101552193|NCT01266603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101552194|NCT04295551|Ritonavir|ritonavir|mesh-list
101552195|NCT04295551|Lopinavir|lopinavir|mesh-list
101552196|NCT04295551|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101552197|NCT04295551|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101552198|NCT04295551|Protease Inhibitors|protease inhibitors|mesh-ancestor
101552199|NCT04295551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101552200|NCT04295551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552201|NCT04295551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101552202|NCT04295551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101552203|NCT04295551|Antiviral Agents|antiviral agents|mesh-ancestor
101552204|NCT04295551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101552205|NCT04295551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101552206|NCT04295551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101552207|NCT01266291|Vigabatrin|vigabatrin|mesh-list
101552208|NCT01266291|Anticonvulsants|anticonvulsants|mesh-ancestor
101552209|NCT01266291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101552210|NCT01266291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552211|NCT01266291|GABA Agents|gaba agents|mesh-ancestor
101552212|NCT01266291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101552213|NCT01266291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552214|NCT01004263|Rizatriptan|rizatriptan|mesh-list
101552215|NCT01004263|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101945101|NCT01248195|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101787491|NCT00586157|Methylphenidate|methylphenidate|mesh-list
101552216|NCT01004263|Serotonin Agents|serotonin agents|mesh-ancestor
101552217|NCT01004263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101552218|NCT01004263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552219|NCT01004263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552220|NCT01265823|Adalimumab|adalimumab|mesh-list
101552221|NCT01265823|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101552222|NCT01265823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101552223|NCT01265823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101552224|NCT01004185|Aminosalicylic Acid|aminosalicylic acid|mesh-list
101552225|NCT01004185|Mesalamine|mesalamine|mesh-list
101552226|NCT01004185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101552227|NCT01004185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101552228|NCT01004185|Analgesics|analgesics|mesh-ancestor
101552229|NCT01004185|Sensory System Agents|sensory system agents|mesh-ancestor
101552230|NCT01004185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101552231|NCT01004185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552232|NCT01004185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101552233|NCT01004185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101552234|NCT01004185|Antitubercular Agents|antitubercular agents|mesh-ancestor
101552235|NCT01004185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101552236|NCT01004185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101552237|NCT01265511|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101552238|NCT01265511|Antiviral Agents|antiviral agents|mesh-ancestor
101552239|NCT01265511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101552240|NCT01264965|Acetaminophen|acetaminophen|mesh-list
101552241|NCT01264965|Oxycodone|oxycodone|mesh-list
101552242|NCT01264965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101552243|NCT01264965|Analgesics|analgesics|mesh-ancestor
101552244|NCT01264965|Sensory System Agents|sensory system agents|mesh-ancestor
101552245|NCT01264965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101552246|NCT01264965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552247|NCT01264965|Antipyretics|antipyretics|mesh-ancestor
101552248|NCT01264965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101552249|NCT01264965|Narcotics|narcotics|mesh-ancestor
101552250|NCT01264965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101552251|NCT01264887|Tapentadol|tapentadol|mesh-list
101552252|NCT01264887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101552253|NCT01264887|Narcotics|narcotics|mesh-ancestor
101552254|NCT01264887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101552255|NCT01264887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552256|NCT01264887|Analgesics|analgesics|mesh-ancestor
101552257|NCT01264887|Sensory System Agents|sensory system agents|mesh-ancestor
101552258|NCT01264887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101708041|NCT02632136|Bupivacaine|bupivacaine|mesh-list
101552259|NCT01264887|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101552271|NCT01011283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101552272|NCT01263483|Inositol|inositol|mesh-list
101552273|NCT01263483|Alogliptin|alogliptin|mesh-list
101552274|NCT01263483|Voglibose|voglibose|mesh-list
101552275|NCT01263483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101552276|NCT01263483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552277|NCT01263483|Incretins|incretins|mesh-ancestor
101552278|NCT01263483|Hormones|hormones|mesh-ancestor
101552279|NCT01263483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101552280|NCT01263483|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101552281|NCT01263483|Protease Inhibitors|protease inhibitors|mesh-ancestor
101552282|NCT01263483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101552283|NCT01263483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552284|NCT01263483|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101552285|NCT01263483|Vitamin B Complex|vitamin b complex|mesh-ancestor
101552286|NCT01263483|Vitamins|vitamins|mesh-ancestor
101552287|NCT01263483|Micronutrients|micronutrients|mesh-ancestor
101552288|NCT01011049|Vaccines|vaccines|mesh-list
101552289|NCT01011049|Immunologic Factors|immunologic factors|mesh-ancestor
101552290|NCT01011049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552291|NCT01263093|Clopidogrel|clopidogrel|mesh-list
101552292|NCT01263093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101552293|NCT01263093|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101552294|NCT01263093|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101552295|NCT01263093|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101552296|NCT01263093|Purinergic Agents|purinergic agents|mesh-ancestor
101552297|NCT01263093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101552298|NCT01263093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945102|NCT01248195|Antidepressive Agents|antidepressive agents|mesh-ancestor
101945103|NCT03910803|Brodalumab|brodalumab|mesh-list
101945104|NCT03910803|Dermatologic Agents|dermatologic agents|mesh-ancestor
101945105|NCT03910647|Pantoprazole|pantoprazole|mesh-list
101945106|NCT03910647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101552299|NCT01263093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552300|NCT01010971|Ciclesonide|ciclesonide|mesh-list
101552301|NCT01010971|Glucocorticoids|glucocorticoids|mesh-ancestor
101552302|NCT01010971|Hormones|hormones|mesh-ancestor
101552303|NCT01010971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101489675|NCT00338117|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101552304|NCT01010971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552305|NCT01010971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101552306|NCT01306656|Vitamin D|vitamin d|mesh-list
101552307|NCT01306656|Ergocalciferols|ergocalciferols|mesh-list
101552308|NCT01306656|Cholecalciferol|cholecalciferol|mesh-list
101552309|NCT01306656|Vitamins|vitamins|mesh-list
101552310|NCT01306656|Micronutrients|micronutrients|mesh-ancestor
101552311|NCT01306656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552312|NCT01306656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101552313|NCT01306656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101552314|NCT01003639|Aspirin|aspirin|mesh-list
101552315|NCT01003639|Acetaminophen|acetaminophen|mesh-list
101552316|NCT01003639|Ibuprofen|ibuprofen|mesh-list
101552317|NCT01003639|Naproxen|naproxen|mesh-list
101552318|NCT01003639|Acetazolamide|acetazolamide|mesh-list
101552319|NCT01003639|Codeine|codeine|mesh-list
101552320|NCT01003639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101552321|NCT01003639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101552322|NCT01003639|Analgesics|analgesics|mesh-ancestor
101400717|NCT05253833|Allopurinol|allopurinol|mesh-list
101552342|NCT01003639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101552344|NCT01003639|Respiratory System Agents|respiratory system agents|mesh-ancestor
101552345|NCT01003249|Baclofen|baclofen|mesh-list
101552346|NCT01003249|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101552347|NCT01003249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552348|NCT01003249|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101552349|NCT01003249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101552350|NCT01003249|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101552351|NCT01003249|GABA Agonists|gaba agonists|mesh-ancestor
101552352|NCT01003249|GABA Agents|gaba agents|mesh-ancestor
101552353|NCT01003249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101552354|NCT01003249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552355|NCT04297033|Lovastatin|lovastatin|mesh-list
101552356|NCT04297033|L 647318|l 647318|mesh-list
101552357|NCT04297033|Dihydromevinolin|dihydromevinolin|mesh-list
101552358|NCT04297033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101552359|NCT04297033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101552360|NCT04297033|Antimetabolites|antimetabolites|mesh-ancestor
101552361|NCT04297033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552362|NCT04297033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101552363|NCT04297033|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101552364|NCT04297033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101552365|NCT04294537|Anesthetics|anesthetics|mesh-list
101552366|NCT04294537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101552367|NCT04294537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552368|NCT04295629|Anesthetics|anesthetics|mesh-list
101552369|NCT04295629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101552370|NCT04295629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552371|NCT01306032|Cyclophosphamide|cyclophosphamide|mesh-list
101552372|NCT01306032|Veliparib|veliparib|mesh-list
101552373|NCT01306032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101552374|NCT01306032|Immunologic Factors|immunologic factors|mesh-ancestor
101552375|NCT01306032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552376|NCT01306032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101552377|NCT01306032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101552394|NCT01263015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101552395|NCT01263015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101552396|NCT01263015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101552397|NCT01263015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101552398|NCT01263015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101552399|NCT01263015|Antimetabolites|antimetabolites|mesh-ancestor
101552400|NCT04322955|Nivolumab|nivolumab|mesh-list
101552401|NCT04322955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101945107|NCT03910647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101945108|NCT03910647|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101945109|NCT03910647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101945110|NCT03910647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552402|NCT04322955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101552403|NCT04322955|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101552404|NCT04322955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552405|NCT04322175|Meloxicam|meloxicam|mesh-list
101552406|NCT04322175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101552407|NCT04322175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101552408|NCT04322175|Analgesics|analgesics|mesh-ancestor
101552409|NCT04322175|Sensory System Agents|sensory system agents|mesh-ancestor
101552410|NCT04322175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101552411|NCT04322175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552412|NCT04322175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101552413|NCT04322175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101552414|NCT04322175|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101552415|NCT04322175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101552416|NCT04322175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101552417|NCT04322175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552418|NCT04321785|Caffeine|caffeine|mesh-list
101552419|NCT04321785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101552420|NCT04321785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552421|NCT04321785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101552422|NCT04321785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101552423|NCT04321785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552424|NCT04321785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101552425|NCT04321785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101552426|NCT04321785|Purinergic Agents|purinergic agents|mesh-ancestor
101552427|NCT04321785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101552428|NCT01305408|Modafinil|modafinil|mesh-list
101552429|NCT01305408|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101552430|NCT01305408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552431|NCT01305408|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101552432|NCT01305408|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101552439|NCT01261611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101552440|NCT01261611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552441|NCT01261611|Cholinergic Agents|cholinergic agents|mesh-ancestor
101552442|NCT01261611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101552443|NCT01261611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552444|NCT01261611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101552445|NCT01261611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101552446|NCT04207125|Psychotropic Drugs|psychotropic drugs|mesh-list
101552447|NCT04320693|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
101552448|NCT04320693|Immunoconjugates|immunoconjugates|mesh-ancestor
101552449|NCT04320693|Immunologic Factors|immunologic factors|mesh-ancestor
101552450|NCT04320693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552452|NCT00624039|Miotics|miotics|mesh-ancestor
101552453|NCT00624039|Autonomic Agents|autonomic agents|mesh-ancestor
101552454|NCT00624039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101552455|NCT00624039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552456|NCT00624039|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101552457|NCT00624039|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101552458|NCT00624039|Cholinergic Agents|cholinergic agents|mesh-ancestor
101552459|NCT00624039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101552460|NCT00624039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552461|NCT01304706|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
101552462|NCT01304706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101552463|NCT01304706|Glucocorticoids|glucocorticoids|mesh-ancestor
101552464|NCT01304706|Hormones|hormones|mesh-ancestor
101552465|NCT01304706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101552466|NCT01304706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552467|NCT05661240|Docetaxel|docetaxel|mesh-list
101552468|NCT05661240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101552469|NCT05661240|Tubulin Modulators|tubulin modulators|mesh-ancestor
101552470|NCT05661240|Antimitotic Agents|antimitotic agents|mesh-ancestor
101552471|NCT05661240|Mitosis Modulators|mitosis modulators|mesh-ancestor
101552472|NCT05661240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945111|NCT03709940|Methylphenidate|methylphenidate|mesh-list
101945112|NCT03709940|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101945113|NCT03709940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945114|NCT03709940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101552473|NCT02889003|Pioglitazone|pioglitazone|mesh-list
101552474|NCT02889003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101552475|NCT02889003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552476|NCT01008553|Fentanyl|fentanyl|mesh-list
101552477|NCT01008553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101552478|NCT01008553|Narcotics|narcotics|mesh-ancestor
101552479|NCT01008553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101552480|NCT01008553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552481|NCT01008553|Analgesics|analgesics|mesh-ancestor
101552482|NCT01008553|Sensory System Agents|sensory system agents|mesh-ancestor
101552483|NCT01008553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101552484|NCT01008553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101552485|NCT01008553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101552486|NCT01008553|Anesthetics, General|anesthetics, general|mesh-ancestor
101552487|NCT01008553|Anesthetics|anesthetics|mesh-ancestor
101552492|NCT05141877|Anesthetics|anesthetics|mesh-list
101552493|NCT05141877|Propofol|propofol|mesh-list
101552494|NCT05141877|Sevoflurane|sevoflurane|mesh-list
101552495|NCT05141877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101552496|NCT05141877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552497|NCT05141877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101552498|NCT05141877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101552499|NCT05141877|Anesthetics, General|anesthetics, general|mesh-ancestor
101552500|NCT05141877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101552501|NCT05141877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101552502|NCT04901169|Angiotensin II|angiotensin ii|mesh-list
101552503|NCT04901169|Giapreza|giapreza|mesh-list
101552504|NCT04901169|Angiotensinogen|angiotensinogen|mesh-list
101552505|NCT04901169|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101552506|NCT04901169|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101552512|NCT04479267|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101552513|NCT04479267|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101552514|NCT04479267|Prednisolone|prednisolone|mesh-list
101552515|NCT04479267|Prednisolone acetate|prednisolone acetate|mesh-list
101552516|NCT04479267|Hydrocortisone|hydrocortisone|mesh-list
101552517|NCT04479267|Cortisone|cortisone|mesh-list
101552518|NCT04479267|Cyclophosphamide|cyclophosphamide|mesh-list
101552519|NCT04479267|Rituximab|rituximab|mesh-list
101552520|NCT04479267|Doxorubicin|doxorubicin|mesh-list
101552521|NCT04479267|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101552522|NCT04479267|Antibodies|antibodies|mesh-list
101552523|NCT04479267|Immunoglobulins|immunoglobulins|mesh-list
101552524|NCT04479267|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101552525|NCT04479267|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101552526|NCT04479267|Prednisolone phosphate|prednisolone phosphate|mesh-list
101552527|NCT04479267|Immunoconjugates|immunoconjugates|mesh-list
101552528|NCT04479267|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
101552529|NCT04479267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101552530|NCT04479267|Immunologic Factors|immunologic factors|mesh-ancestor
101552531|NCT04479267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552532|NCT04479267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101552533|NCT04479267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101552534|NCT04479267|Alkylating Agents|alkylating agents|mesh-ancestor
101552535|NCT04479267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552536|NCT04479267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101552537|NCT04479267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101552538|NCT04479267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101552539|NCT04479267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101552540|NCT04479267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101552541|NCT04479267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101552542|NCT04479267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101552543|NCT04479267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101552544|NCT04479267|Glucocorticoids|glucocorticoids|mesh-ancestor
101552545|NCT04479267|Hormones|hormones|mesh-ancestor
101552546|NCT04479267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101552547|NCT04479267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101552548|NCT04479267|Antiemetics|antiemetics|mesh-ancestor
101552549|NCT04479267|Autonomic Agents|autonomic agents|mesh-ancestor
101552550|NCT04479267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101945115|NCT03709940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101945116|NCT03709940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101552551|NCT04479267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101552552|NCT04479267|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101552553|NCT04479267|Protective Agents|protective agents|mesh-ancestor
101552554|NCT04439799|Methyltestosterone|methyltestosterone|mesh-list
101552555|NCT04439799|Testosterone|testosterone|mesh-list
101552556|NCT04439799|Testosterone undecanoate|testosterone undecanoate|mesh-list
101552557|NCT04439799|Testosterone enanthate|testosterone enanthate|mesh-list
101552558|NCT04439799|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101552559|NCT04439799|Androgens|androgens|mesh-ancestor
101552560|NCT04439799|Hormones|hormones|mesh-ancestor
101552561|NCT04439799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101552562|NCT04439799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552563|NCT04439799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101552564|NCT04439799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101552565|NCT04439799|Anabolic Agents|anabolic agents|mesh-ancestor
101552566|NCT04021017|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101552567|NCT04021017|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101552568|NCT04021017|Estradiol|estradiol|mesh-list
101552569|NCT04021017|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101552570|NCT04021017|Estrogens|estrogens|mesh-ancestor
101552571|NCT04021017|Hormones|hormones|mesh-ancestor
101552572|NCT04021017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101552573|NCT04021017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552574|NCT04021017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101552575|NCT04021017|Contraceptive Agents|contraceptive agents|mesh-ancestor
101552576|NCT04021017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101552577|NCT04021017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101552578|NCT03916185|Vaccines|vaccines|mesh-list
101552584|NCT03764553|Capecitabine|capecitabine|mesh-list
101552585|NCT03764553|Oxaliplatin|oxaliplatin|mesh-list
101552586|NCT03764553|Irinotecan|irinotecan|mesh-list
101552587|NCT03764553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101552588|NCT03764553|Antimetabolites|antimetabolites|mesh-ancestor
101552589|NCT03764553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552590|NCT03764553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101552591|NCT03764553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101552592|NCT03764553|Immunologic Factors|immunologic factors|mesh-ancestor
101552593|NCT03764553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708135|NCT00661076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101552594|NCT03764553|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101552595|NCT03764553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101552596|NCT03764553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101552597|NCT03764553|Antidotes|antidotes|mesh-ancestor
101552598|NCT03764553|Protective Agents|protective agents|mesh-ancestor
101552599|NCT03764553|Vitamin B Complex|vitamin b complex|mesh-ancestor
101552600|NCT03764553|Vitamins|vitamins|mesh-ancestor
101552601|NCT03764553|Micronutrients|micronutrients|mesh-ancestor
101552602|NCT04320225|Dexamethasone|dexamethasone|mesh-list
101552603|NCT04320225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101552604|NCT04320225|Antiemetics|antiemetics|mesh-ancestor
101552605|NCT04320225|Autonomic Agents|autonomic agents|mesh-ancestor
101552606|NCT04320225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101552607|NCT04320225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552608|NCT04320225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101552610|NCT04320225|Hormones|hormones|mesh-ancestor
101552611|NCT04320225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101552612|NCT04320225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101552613|NCT04320225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101552614|NCT03221751|Prazosin|prazosin|mesh-list
101552615|NCT03221751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101552616|NCT03221751|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101552617|NCT03221751|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101552618|NCT03221751|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101552619|NCT03221751|Adrenergic Agents|adrenergic agents|mesh-ancestor
101552620|NCT03221751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101552621|NCT03221751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552622|NCT03221751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552623|NCT03219177|Analgesics, Opioid|analgesics, opioid|mesh-list
101552624|NCT03219177|Narcotics|narcotics|mesh-ancestor
101552625|NCT03219177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101552626|NCT03219177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552627|NCT03219177|Analgesics|analgesics|mesh-ancestor
101945117|NCT03709940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945118|NCT03709940|Dopamine Agents|dopamine agents|mesh-ancestor
101552628|NCT03219177|Sensory System Agents|sensory system agents|mesh-ancestor
101552629|NCT03219177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101552630|NCT01302834|Cetuximab|cetuximab|mesh-list
101552631|NCT01302834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101552632|NCT01302834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101552633|NCT02866071|Ketamine|ketamine|mesh-list
101552634|NCT02866071|Analgesics|analgesics|mesh-ancestor
101552635|NCT02866071|Sensory System Agents|sensory system agents|mesh-ancestor
101552636|NCT02866071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101552637|NCT02866071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552638|NCT02866071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101552639|NCT02866071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101552640|NCT02866071|Anesthetics, General|anesthetics, general|mesh-ancestor
101552641|NCT02866071|Anesthetics|anesthetics|mesh-ancestor
101552642|NCT02866071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101552643|NCT02866071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101552644|NCT02866071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101552645|NCT02866071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101552646|NCT02866071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552647|NCT02890602|Prednisolone|prednisolone|mesh-list
101552648|NCT02890602|Cyclophosphamide|cyclophosphamide|mesh-list
101552649|NCT02890602|Vincristine|vincristine|mesh-list
101552650|NCT02890602|Darbepoetin alfa|darbepoetin alfa|mesh-list
101552651|NCT02890602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101552661|NCT02890602|Tubulin Modulators|tubulin modulators|mesh-ancestor
101552662|NCT02890602|Antimitotic Agents|antimitotic agents|mesh-ancestor
101552663|NCT02890602|Mitosis Modulators|mitosis modulators|mesh-ancestor
101552664|NCT02890602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101552665|NCT02890602|Glucocorticoids|glucocorticoids|mesh-ancestor
101552666|NCT02890602|Hormones|hormones|mesh-ancestor
101552667|NCT02890602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101552668|NCT02890602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101552669|NCT02890602|Hematinics|hematinics|mesh-ancestor
101552670|NCT01259115|Ketoconazole|ketoconazole|mesh-list
101552671|NCT01259115|Buprenorphine|buprenorphine|mesh-list
101552672|NCT01259115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101552673|NCT01259115|Narcotics|narcotics|mesh-ancestor
101552674|NCT01259115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101552675|NCT01259115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552676|NCT01259115|Analgesics|analgesics|mesh-ancestor
101552677|NCT01259115|Sensory System Agents|sensory system agents|mesh-ancestor
101552678|NCT01259115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101552679|NCT01259115|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101552680|NCT01259115|Antifungal Agents|antifungal agents|mesh-ancestor
101552681|NCT01259115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101552682|NCT01259115|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101552683|NCT01259115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101552684|NCT01259115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101552685|NCT01259115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552686|NCT01259115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101552687|NCT01259115|Hormone Antagonists|hormone antagonists|mesh-ancestor
101552688|NCT01259115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101552689|NCT01259115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101552690|NCT01302054|Fesoterodine|fesoterodine|mesh-list
101552691|NCT01302054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101552692|NCT01302054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101552693|NCT01302054|Cholinergic Agents|cholinergic agents|mesh-ancestor
101552694|NCT01302054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101552695|NCT01302054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552696|NCT01302054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552697|NCT01302054|Urological Agents|urological agents|mesh-ancestor
101552698|NCT05642910|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
101552699|NCT05642910|Antiviral Agents|antiviral agents|mesh-ancestor
101552700|NCT05642910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101552701|NCT01300650|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101552702|NCT01300650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101552703|NCT01300572|Cyclosporine|cyclosporine|mesh-list
101552704|NCT01300572|Mycophenolic Acid|mycophenolic acid|mesh-list
101552705|NCT01300572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101552706|NCT01300572|Fludarabine|fludarabine|mesh-list
101945119|NCT03709940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101945120|NCT03341312|Insulin Lispro|insulin lispro|mesh-list
101787924|NCT00874926|Factor VIII|factor viii|mesh-list
101552707|NCT01300572|Fludarabine phosphate|fludarabine phosphate|mesh-list
101552708|NCT01300572|Antibodies|antibodies|mesh-list
101552709|NCT01300572|Immunoglobulins|immunoglobulins|mesh-list
101552710|NCT01300572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101552711|NCT01300572|Cyclosporins|cyclosporins|mesh-list
101552712|NCT01300572|Immunologic Factors|immunologic factors|mesh-ancestor
101552713|NCT01300572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552714|NCT01300572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101552715|NCT01300572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101552724|NCT01300572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101552725|NCT01300572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101552726|NCT01300572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101552727|NCT01300572|Antitubercular Agents|antitubercular agents|mesh-ancestor
101552728|NCT01300572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101552730|NCT01077154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101552731|NCT01077154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552732|NCT01258101|Ribavirin|ribavirin|mesh-list
101552733|NCT01258101|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101552734|NCT01258101|Interferon-alpha|interferon-alpha|mesh-list
101552735|NCT01258101|Antimetabolites|antimetabolites|mesh-ancestor
101552736|NCT01258101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552737|NCT01258101|Antiviral Agents|antiviral agents|mesh-ancestor
101552738|NCT01258101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101552739|NCT01258101|Immunologic Factors|immunologic factors|mesh-ancestor
101552740|NCT01258101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552741|NCT05640804|Dasatinib|dasatinib|mesh-list
101552742|NCT05640804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101552743|NCT05640804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101552744|NCT05640804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101552745|NCT05640804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552746|NCT00623688|Imidacloprid|imidacloprid|mesh-list
101552747|NCT00623688|Cholinergic Agents|cholinergic agents|mesh-ancestor
101552748|NCT00623688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101552749|NCT00623688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552750|NCT00623688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552751|NCT01300260|Dulaglutide|dulaglutide|mesh-list
101552752|NCT01300260|Glucagon|glucagon|mesh-list
101552753|NCT01300260|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101552754|NCT01300260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101552755|NCT01300260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552756|NCT01300260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101552758|NCT01300260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101552759|NCT01300260|Incretins|incretins|mesh-ancestor
101552760|NCT01256385|Sirolimus|sirolimus|mesh-list
101552761|NCT01256385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101552762|NCT01256385|Cetuximab|cetuximab|mesh-list
101552763|NCT01256385|Temsirolimus|temsirolimus|mesh-list
101552764|NCT01256385|MTOR Inhibitors|mtor inhibitors|mesh-list
101552765|NCT01256385|Antibodies|antibodies|mesh-list
101552766|NCT01256385|Immunoglobulins|immunoglobulins|mesh-list
101552767|NCT01256385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101552768|NCT01256385|Immunologic Factors|immunologic factors|mesh-ancestor
101552769|NCT01256385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552770|NCT01256385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101552771|NCT01256385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101552772|NCT01256385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101552773|NCT01256385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101552774|NCT01256385|Antifungal Agents|antifungal agents|mesh-ancestor
101552775|NCT01256385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101552776|NCT01256385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101552777|NCT01256385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101552778|NCT01256385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552779|NCT00637182|Anastrozole|anastrozole|mesh-list
101552780|NCT00637182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101552781|NCT00637182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101552782|NCT00637182|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101552783|NCT00637182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101552794|NCT01298778|Sensory System Agents|sensory system agents|mesh-ancestor
101552795|NCT01298778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101552796|NCT01298778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552797|NCT01298778|Antipyretics|antipyretics|mesh-ancestor
101945122|NCT03341312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945123|NCT01147029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
101552798|NCT01298778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101552799|NCT01298778|Narcotics|narcotics|mesh-ancestor
101552800|NCT01298778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101552801|NCT01298700|Bimatoprost|bimatoprost|mesh-list
101552802|NCT01298700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101552803|NCT01298700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101552804|NCT01298700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101552805|NCT01297920|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101552806|NCT01297920|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101552807|NCT01297920|Brinzolamide|brinzolamide|mesh-list
101552808|NCT01297920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101552809|NCT01297920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101552810|NCT01297920|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101552811|NCT01297920|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101552812|NCT01297920|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101552813|NCT01297920|Adrenergic Agents|adrenergic agents|mesh-ancestor
101552814|NCT01297920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101552815|NCT01297920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552816|NCT01297920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552817|NCT01297920|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101552818|NCT01297920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101552819|NCT01255761|Certolizumab Pegol|certolizumab pegol|mesh-list
101552820|NCT01255761|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101552821|NCT01255761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101552822|NCT01255761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101552823|NCT01255761|Immunologic Factors|immunologic factors|mesh-ancestor
101552824|NCT01255761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552825|NCT01255761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101552826|NCT01297062|Exenatide|exenatide|mesh-list
101552827|NCT01297062|Moxifloxacin|moxifloxacin|mesh-list
101552828|NCT01297062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101552829|NCT01297062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101552830|NCT01297062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101552831|NCT01297062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101552832|NCT01297062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101552833|NCT01297062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552834|NCT01297062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101552835|NCT01297062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552836|NCT01297062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101552837|NCT01297062|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101552839|NCT01297062|Hormones|hormones|mesh-ancestor
101552840|NCT01297062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101552841|NCT01296672|Finasteride|finasteride|mesh-list
101552842|NCT01296672|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101552843|NCT01296672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101552844|NCT01296672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101552845|NCT01296672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552846|NCT01296672|Hormone Antagonists|hormone antagonists|mesh-ancestor
101552847|NCT01296672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101552851|NCT01254669|Immunologic Factors|immunologic factors|mesh-ancestor
101552852|NCT01254669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552853|NCT04324476|Bevacizumab|bevacizumab|mesh-list
101552854|NCT04324476|Capecitabine|capecitabine|mesh-list
101552855|NCT04324476|Oxaliplatin|oxaliplatin|mesh-list
101552856|NCT04324476|Irinotecan|irinotecan|mesh-list
101552857|NCT04324476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101552858|NCT04324476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101552859|NCT04324476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101552860|NCT04324476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101552861|NCT04324476|Growth Substances|growth substances|mesh-ancestor
101552862|NCT04324476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552863|NCT04324476|Growth Inhibitors|growth inhibitors|mesh-ancestor
101552864|NCT04324476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101552865|NCT04324476|Antimetabolites|antimetabolites|mesh-ancestor
101552866|NCT04324476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552867|NCT04324476|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101552868|NCT04324476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101552869|NCT04324476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101945124|NCT01147029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101945125|NCT01147029|Growth Substances|growth substances|mesh-ancestor
101945126|NCT01147029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945127|NCT01147029|Growth Inhibitors|growth inhibitors|mesh-ancestor
101788066|NCT00800150|Fludarabine|fludarabine|mesh-list
101552870|NCT01295814|Adalimumab|adalimumab|mesh-list
101552871|NCT01295814|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101552872|NCT01295814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101552873|NCT01295814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101552874|NCT01254045|Oxytocin|oxytocin|mesh-list
101552875|NCT01254045|Oxytocics|oxytocics|mesh-ancestor
101552876|NCT01254045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101552877|NCT01254045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552878|NCT01075282|Metformin|metformin|mesh-list
101552879|NCT01075282|Insulin Glargine|insulin glargine|mesh-list
101552880|NCT01075282|Glimepiride|glimepiride|mesh-list
101552881|NCT01075282|Dulaglutide|dulaglutide|mesh-list
101552882|NCT01075282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101552883|NCT01075282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552884|NCT01075282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101552885|NCT01075282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101552886|NCT01075282|Immunologic Factors|immunologic factors|mesh-ancestor
101552887|NCT04324086|Calcium, Dietary|calcium, dietary|mesh-list
101552888|NCT04324086|Calcium|calcium|mesh-list
101552889|NCT04324086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101552890|NCT04324086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552891|NCT04324086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101552892|NCT01295034|Vitamin D|vitamin d|mesh-list
101552893|NCT01295034|Ergocalciferols|ergocalciferols|mesh-list
101552894|NCT01295034|Cholecalciferol|cholecalciferol|mesh-list
101552895|NCT01295034|Vitamins|vitamins|mesh-list
101552896|NCT01295034|Micronutrients|micronutrients|mesh-ancestor
101552897|NCT01295034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552898|NCT01295034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101552899|NCT01295034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101552900|NCT01253421|Amisulpride|amisulpride|mesh-list
101552901|NCT01253421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101552902|NCT01253421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101552903|NCT01253421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101552904|NCT01253421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514824|NCT00595543|Diclofenac|diclofenac|mesh-list
101552905|NCT01253421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101552906|NCT01253421|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101552907|NCT01253421|Dopamine Agents|dopamine agents|mesh-ancestor
101552908|NCT01253421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101552909|NCT01253421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552910|NCT01253421|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101552911|NCT01253421|Antidepressive Agents|antidepressive agents|mesh-ancestor
101552912|NCT01077076|Omeprazole|omeprazole|mesh-list
101552913|NCT01077076|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
101552914|NCT01077076|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101552915|NCT01077076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101552916|NCT01077076|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101552917|NCT01077076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101552918|NCT01077076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552919|NCT02876224|Bevacizumab|bevacizumab|mesh-list
101552920|NCT02876224|Atezolizumab|atezolizumab|mesh-list
101552940|NCT01293006|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
101552941|NCT01293006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101552942|NCT01293006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552943|NCT01253187|Tetrahydrofolates|tetrahydrofolates|mesh-list
101552944|NCT01253187|Drospirenone|drospirenone|mesh-list
101552945|NCT01253187|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101552946|NCT01253187|Hormone Antagonists|hormone antagonists|mesh-ancestor
101552947|NCT01253187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101552948|NCT01253187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552949|NCT01253187|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101552950|NCT01253187|Diuretics|diuretics|mesh-ancestor
101552951|NCT01253187|Natriuretic Agents|natriuretic agents|mesh-ancestor
101552952|NCT01253187|Vitamin B Complex|vitamin b complex|mesh-ancestor
101552953|NCT01253187|Vitamins|vitamins|mesh-ancestor
101945128|NCT01147029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101945129|NCT01239459|Teriflunomide|teriflunomide|mesh-list
101945130|NCT01239459|Cholestyramine Resin|cholestyramine resin|mesh-list
101552954|NCT01253187|Micronutrients|micronutrients|mesh-ancestor
101552955|NCT01252563|Amlodipine|amlodipine|mesh-list
101552956|NCT01252563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101708227|NCT02631668|Hematinics|hematinics|mesh-ancestor
101552957|NCT01252563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101552958|NCT01252563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101552959|NCT01252563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552960|NCT01252563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101552961|NCT01252563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552962|NCT01252563|Vasodilator Agents|vasodilator agents|mesh-ancestor
101552963|NCT01292226|Cyclosporine|cyclosporine|mesh-list
101552964|NCT01292226|Mycophenolic Acid|mycophenolic acid|mesh-list
101552965|NCT01292226|Antibodies|antibodies|mesh-list
101552966|NCT01292226|Cyclosporins|cyclosporins|mesh-list
101552967|NCT01292226|Immunologic Factors|immunologic factors|mesh-ancestor
101552968|NCT01292226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552969|NCT01292226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101552970|NCT01292226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552971|NCT01292226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101552972|NCT01292226|Antifungal Agents|antifungal agents|mesh-ancestor
101552973|NCT01292226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101552974|NCT01292226|Dermatologic Agents|dermatologic agents|mesh-ancestor
101552984|NCT01075048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101552985|NCT01075048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101552986|NCT01075048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101552987|NCT01075048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552988|NCT01075048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101552989|NCT01075048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101552990|NCT01252251|Everolimus|everolimus|mesh-list
101552991|NCT01252251|Pasireotide|pasireotide|mesh-list
101552992|NCT01252251|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101552993|NCT01252251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101552994|NCT01252251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101552995|NCT01252251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552996|NCT01252251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101552997|NCT01252251|Immunologic Factors|immunologic factors|mesh-ancestor
101552998|NCT01252251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552999|NCT01252251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101553000|NCT01252251|Hormones|hormones|mesh-ancestor
101553001|NCT01252251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101553002|NCT02888301|Clofarabine|clofarabine|mesh-list
101553003|NCT02888301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101553004|NCT02888301|Antimetabolites|antimetabolites|mesh-ancestor
101553005|NCT02888301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553006|NCT02888301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101553007|NCT00624273|Sildenafil Citrate|sildenafil citrate|mesh-list
101553008|NCT00624273|Vasodilator Agents|vasodilator agents|mesh-ancestor
101553009|NCT00624273|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101553010|NCT00624273|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101553011|NCT00624273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101553012|NCT00624273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553013|NCT00624273|Urological Agents|urological agents|mesh-ancestor
101553014|NCT04305964|Silicon|silicon|mesh-list
101553015|NCT04305964|Trace Elements|trace elements|mesh-ancestor
101553016|NCT04305964|Micronutrients|micronutrients|mesh-ancestor
101553017|NCT04305964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553018|NCT04306042|Pembrolizumab|pembrolizumab|mesh-list
101553019|NCT04306042|Nivolumab|nivolumab|mesh-list
101553020|NCT04306042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101553021|NCT04306042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101553022|NCT04306042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101553023|NCT04306042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553024|NCT01074502|Apremilast|apremilast|mesh-list
101553025|NCT01074502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101553026|NCT01074502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101553027|NCT01074502|Analgesics|analgesics|mesh-ancestor
101553028|NCT01074502|Sensory System Agents|sensory system agents|mesh-ancestor
101553029|NCT01074502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101553030|NCT01074502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553031|NCT01074502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101945131|NCT01239459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101945132|NCT01239459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101945133|NCT01239459|Analgesics|analgesics|mesh-ancestor
101553032|NCT01074502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101553033|NCT01074502|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101553034|NCT01074502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101553035|NCT01074502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101553036|NCT01074502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553037|NCT04303312|Benzydamine|benzydamine|mesh-list
101401437|NCT02728388|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101553041|NCT01285908|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101553042|NCT01285908|Adrenergic Agents|adrenergic agents|mesh-ancestor
101553043|NCT01285908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101553044|NCT01285908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553045|NCT01285908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553046|NCT01285908|Sympathomimetics|sympathomimetics|mesh-ancestor
101553047|NCT01285908|Autonomic Agents|autonomic agents|mesh-ancestor
101553048|NCT01285908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101553049|NCT01285908|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101553050|NCT01074268|Insulin|insulin|mesh-list
101553051|NCT01074268|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101553052|NCT01074268|Insulin Aspart|insulin aspart|mesh-list
101553053|NCT01074268|Insulin Detemir|insulin detemir|mesh-list
101553054|NCT01074268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101553055|NCT01074268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553056|NCT01074190|Fentanyl|fentanyl|mesh-list
101553057|NCT01074190|Bupivacaine|bupivacaine|mesh-list
101553058|NCT01074190|Anesthetics, Local|anesthetics, local|mesh-ancestor
101553059|NCT01074190|Anesthetics|anesthetics|mesh-ancestor
101553060|NCT01074190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101553061|NCT01074190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553062|NCT01074190|Sensory System Agents|sensory system agents|mesh-ancestor
101553063|NCT01074190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101553064|NCT01074190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101553065|NCT01074190|Narcotics|narcotics|mesh-ancestor
101553066|NCT01074190|Analgesics|analgesics|mesh-ancestor
101553067|NCT01074190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101553068|NCT01074190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101553069|NCT01074190|Anesthetics, General|anesthetics, general|mesh-ancestor
101553070|NCT01073566|Insulin|insulin|mesh-list
101553071|NCT01073566|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101553072|NCT01073566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101553073|NCT01073566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553074|NCT01072396|Tiotropium Bromide|tiotropium bromide|mesh-list
101553075|NCT01072396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101553076|NCT01072396|Autonomic Agents|autonomic agents|mesh-ancestor
101553077|NCT01072396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101553078|NCT01072396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553079|NCT01072396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101553080|NCT01072396|Respiratory System Agents|respiratory system agents|mesh-ancestor
101553081|NCT01072396|Parasympatholytics|parasympatholytics|mesh-ancestor
101553082|NCT01072396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101553083|NCT01072396|Cholinergic Agents|cholinergic agents|mesh-ancestor
101553084|NCT01072396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101553085|NCT01072396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553086|NCT01045096|Dexlansoprazole|dexlansoprazole|mesh-list
101553087|NCT01045096|Lansoprazole|lansoprazole|mesh-list
101553088|NCT01045096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101553089|NCT01045096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101553090|NCT01045096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101553091|NCT01045096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101553092|NCT01045096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553093|NCT02876146|Albendazole|albendazole|mesh-list
101553094|NCT02876146|Benzimidazole|benzimidazole|mesh-list
101553095|NCT02876146|Anthelmintics|anthelmintics|mesh-ancestor
101553096|NCT02876146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101553097|NCT02876146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101553098|NCT02876146|Anticestodal Agents|anticestodal agents|mesh-ancestor
101553099|NCT02876146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101553100|NCT02876146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101553101|NCT02876146|Tubulin Modulators|tubulin modulators|mesh-ancestor
101553102|NCT02876146|Antimitotic Agents|antimitotic agents|mesh-ancestor
101553103|NCT02876146|Mitosis Modulators|mitosis modulators|mesh-ancestor
101553104|NCT02876146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945134|NCT01239459|Sensory System Agents|sensory system agents|mesh-ancestor
101553105|NCT02876146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101553106|NCT02874586|Immunosuppressive Agents|immunosuppressive agents|mesh-list
101553107|NCT02874586|Immunologic Factors|immunologic factors|mesh-ancestor
101553108|NCT02874586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553109|NCT02875756|Ivermectin|ivermectin|mesh-list
101553110|NCT02875756|Selamectin|selamectin|mesh-list
101553111|NCT02875756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101553112|NCT02875756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101553118|NCT02874820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101553119|NCT02874820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553120|NCT02874820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553121|NCT04305028|Aspirin|aspirin|mesh-list
101553122|NCT04305028|Rivaroxaban|rivaroxaban|mesh-list
101553123|NCT04305028|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101553124|NCT04305028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101553125|NCT04305028|Analgesics|analgesics|mesh-ancestor
101553126|NCT04305028|Sensory System Agents|sensory system agents|mesh-ancestor
101553127|NCT04305028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101553128|NCT04305028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553129|NCT04305028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101553130|NCT04305028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101553131|NCT04305028|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101553132|NCT04305028|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101553133|NCT04305028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553134|NCT04305028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101553135|NCT04305028|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101553136|NCT04305028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101553137|NCT04305028|Antipyretics|antipyretics|mesh-ancestor
101553138|NCT04305028|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101553139|NCT04305028|Antithrombins|antithrombins|mesh-ancestor
101553140|NCT04305028|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101553141|NCT04305028|Protease Inhibitors|protease inhibitors|mesh-ancestor
101553142|NCT04305028|Anticoagulants|anticoagulants|mesh-ancestor
101553143|NCT04304794|Antithyroid Agents|antithyroid agents|mesh-list
101553144|NCT04304794|Hormone Antagonists|hormone antagonists|mesh-ancestor
101553145|NCT04304794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101553146|NCT04304794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553147|NCT02874664|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
101553148|NCT02874664|Immunoconjugates|immunoconjugates|mesh-ancestor
101553149|NCT02874664|Immunologic Factors|immunologic factors|mesh-ancestor
101553150|NCT02874664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553151|NCT01284114|Renin Inhibitors|renin inhibitors|mesh-list
101553152|NCT01284114|Protease Inhibitors|protease inhibitors|mesh-ancestor
101553153|NCT01284114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101553154|NCT01284114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553155|NCT01283334|Carboplatin|carboplatin|mesh-list
101553156|NCT01283334|Cetuximab|cetuximab|mesh-list
101553157|NCT01283334|Everolimus|everolimus|mesh-list
101553158|NCT01283334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101553159|NCT01283334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101553160|NCT01283334|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101553161|NCT01283334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101553162|NCT01283334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101553163|NCT01283334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553164|NCT01283334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101553165|NCT01283334|Immunologic Factors|immunologic factors|mesh-ancestor
101553166|NCT01283334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553167|NCT04304716|Anesthetics|anesthetics|mesh-list
101553168|NCT04304716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101553169|NCT04304716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553170|NCT01282476|Rituximab|rituximab|mesh-list
101553171|NCT01282476|Panobinostat|panobinostat|mesh-list
101553172|NCT01282476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101553173|NCT01282476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101553174|NCT01282476|Immunologic Factors|immunologic factors|mesh-ancestor
101553175|NCT01282476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553176|NCT01282476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101553177|NCT01282476|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101553178|NCT01282476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101553179|NCT01282476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553180|NCT02889822|Alprostadil|alprostadil|mesh-list
101553181|NCT02889822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101553188|NCT01282164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101945135|NCT01239459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101945136|NCT01239459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945137|NCT01239459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101945138|NCT01239459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101945139|NCT01239459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101553189|NCT01282164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553190|NCT01282164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101553191|NCT01282164|Hormones|hormones|mesh-ancestor
101553192|NCT01282164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101553193|NCT01282164|Incretins|incretins|mesh-ancestor
101553194|NCT01250379|Bevacizumab|bevacizumab|mesh-list
101553195|NCT01250379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101553196|NCT01250379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101553197|NCT01250379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101553198|NCT01250379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101553199|NCT01250379|Growth Substances|growth substances|mesh-ancestor
101553200|NCT01250379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553201|NCT01250379|Growth Inhibitors|growth inhibitors|mesh-ancestor
101553202|NCT01072630|Modafinil|modafinil|mesh-list
101553203|NCT01072630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101553204|NCT01072630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553205|NCT01072630|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101553206|NCT01072630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101553207|NCT01072630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101553208|NCT01072630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553209|NCT04302532|Ubiquinone|ubiquinone|mesh-list
101553210|NCT04302532|Coenzyme Q10|coenzyme q10|mesh-list
101553211|NCT04302532|Clomiphene|clomiphene|mesh-list
101553212|NCT04302532|Enclomiphene|enclomiphene|mesh-list
101553213|NCT04302532|Zuclomiphene|zuclomiphene|mesh-list
101553214|NCT04302532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101553215|NCT04302532|Hormone Antagonists|hormone antagonists|mesh-ancestor
101553216|NCT04302532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101553217|NCT04302532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553218|NCT04302532|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101553219|NCT04302532|Fertility Agents|fertility agents|mesh-ancestor
101553220|NCT04302532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101553221|NCT04302532|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101553222|NCT04302532|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101553223|NCT04302532|Micronutrients|micronutrients|mesh-ancestor
101553224|NCT04302532|Vitamins|vitamins|mesh-ancestor
101553225|NCT01281306|Valsartan|valsartan|mesh-list
101553226|NCT01281306|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101553227|NCT01281306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101553228|NCT01281306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101553229|NCT01281306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101553230|NCT01281306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553231|NCT04304560|Dapagliflozin|dapagliflozin|mesh-list
101553232|NCT04304560|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101553233|NCT04304560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553234|NCT04304560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101553235|NCT04304560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553236|NCT04643470|Zanubrutinib|zanubrutinib|mesh-list
101553237|NCT04643470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101553238|NCT04643470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101553239|NCT04643470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101553240|NCT04643470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553241|NCT01250145|Teriparatide|teriparatide|mesh-list
101553242|NCT01250145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101553243|NCT01250145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553244|NCT01250145|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101553245|NCT04319601|Rituximab|rituximab|mesh-list
101553246|NCT04319601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101553247|NCT04319601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101553248|NCT04319601|Immunologic Factors|immunologic factors|mesh-ancestor
101553249|NCT04319601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553259|NCT04640896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101945140|NCT01239459|Immunologic Factors|immunologic factors|mesh-ancestor
101945141|NCT01239459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101945142|NCT01239459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101553260|NCT04640896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101553261|NCT04640896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101553262|NCT04640896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101553263|NCT04640896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553264|NCT01273818|Gentamicins|gentamicins|mesh-list
101553265|NCT01273818|Cefazolin|cefazolin|mesh-list
101553266|NCT01273818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101553267|NCT01273818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101553268|NCT01273818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101553269|NCT01273818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101553270|NCT01273818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553271|NCT01037218|Udenafil|udenafil|mesh-list
101553272|NCT01037218|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101553273|NCT01037218|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101553274|NCT01037218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101553275|NCT01037218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553276|NCT01038856|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101553277|NCT01038856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101553278|NCT01038856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101553280|NCT01038856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553281|NCT01269918|Dexmedetomidine|dexmedetomidine|mesh-list
101553283|NCT01269918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101553284|NCT01269918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101553285|NCT01269918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553286|NCT01269918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101553287|NCT01269918|Analgesics|analgesics|mesh-ancestor
101553288|NCT01269918|Sensory System Agents|sensory system agents|mesh-ancestor
101553289|NCT01269918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101553290|NCT01269918|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101553291|NCT01269918|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101553292|NCT01269918|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101553293|NCT01269918|Adrenergic Agents|adrenergic agents|mesh-ancestor
101553294|NCT01269918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101553295|NCT01269918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553296|NCT01269918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101553297|NCT01269918|Narcotics|narcotics|mesh-ancestor
101553298|NCT01036594|Ketoconazole|ketoconazole|mesh-list
101553299|NCT01036594|Dexamethasone|dexamethasone|mesh-list
101553300|NCT01036594|Dexamethasone acetate|dexamethasone acetate|mesh-list
101553301|NCT01036594|Hydrocortisone|hydrocortisone|mesh-list
101553302|NCT01036594|BB 1101|bb 1101|mesh-list
101553303|NCT01036594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101553304|NCT01036594|Antiemetics|antiemetics|mesh-ancestor
101553305|NCT01036594|Autonomic Agents|autonomic agents|mesh-ancestor
101553306|NCT01036594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101553307|NCT01036594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553308|NCT01036594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101553309|NCT01036594|Glucocorticoids|glucocorticoids|mesh-ancestor
101553310|NCT01036594|Hormones|hormones|mesh-ancestor
101553311|NCT01036594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101553312|NCT01036594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101553313|NCT01036594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101553314|NCT01036594|Protease Inhibitors|protease inhibitors|mesh-ancestor
101553315|NCT01036594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101553316|NCT01036594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553321|NCT01036594|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101553322|NCT01036594|Hormone Antagonists|hormone antagonists|mesh-ancestor
101553323|NCT01036594|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101553324|NCT04301908|Interferons|interferons|mesh-list
101553325|NCT04301908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101553326|NCT04301908|Antiviral Agents|antiviral agents|mesh-ancestor
101553327|NCT04301908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101553328|NCT04304248|Paclitaxel|paclitaxel|mesh-list
101553329|NCT04304248|Carboplatin|carboplatin|mesh-list
101553330|NCT04304248|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101553331|NCT04304248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101553332|NCT04304248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101553333|NCT04304248|Tubulin Modulators|tubulin modulators|mesh-ancestor
101945144|NCT01239459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945145|NCT01239459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101553334|NCT04304248|Antimitotic Agents|antimitotic agents|mesh-ancestor
101553335|NCT04304248|Mitosis Modulators|mitosis modulators|mesh-ancestor
101553336|NCT04304248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553337|NCT01268046|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101553338|NCT01268046|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101553339|NCT01268046|Estradiol|estradiol|mesh-list
101553340|NCT01268046|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101553341|NCT01268046|Estrogens|estrogens|mesh-list
101553342|NCT01268046|Hormones|hormones|mesh-ancestor
101553343|NCT01268046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101553344|NCT01268046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553345|NCT01268046|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101553346|NCT01268046|Contraceptive Agents|contraceptive agents|mesh-ancestor
101553347|NCT01268046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101553348|NCT01268046|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101553349|NCT04732000|Acetylcysteine|acetylcysteine|mesh-list
101553350|NCT04732000|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101553351|NCT04732000|Antiviral Agents|antiviral agents|mesh-ancestor
101553353|NCT04732000|Expectorants|expectorants|mesh-ancestor
101490721|NCT00455091|Lamivudine|lamivudine|mesh-list
101553354|NCT04732000|Respiratory System Agents|respiratory system agents|mesh-ancestor
101553355|NCT04732000|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101553357|NCT04732000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553358|NCT04732000|Protective Agents|protective agents|mesh-ancestor
101553359|NCT04732000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553360|NCT04732000|Antidotes|antidotes|mesh-ancestor
101553361|NCT01267266|Hydrocortisone|hydrocortisone|mesh-list
101553362|NCT01267266|Saracatinib|saracatinib|mesh-list
101553363|NCT01267266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101553364|NCT01267266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101553365|NCT01267266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101553366|NCT01267266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553367|NCT01034176|Levofloxacin|levofloxacin|mesh-list
101553368|NCT01034176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101553369|NCT01034176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101553370|NCT01034176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101553371|NCT01034176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101553372|NCT01034176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101553373|NCT01034176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101553374|NCT01034176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553375|NCT01034176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101553376|NCT01034176|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101553377|NCT01034176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101553378|NCT02889432|Melatonin|melatonin|mesh-list
101553379|NCT02889432|Antioxidants|antioxidants|mesh-ancestor
101553380|NCT02889432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553381|NCT02889432|Protective Agents|protective agents|mesh-ancestor
101553382|NCT02889432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553383|NCT02889432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101553384|NCT01033942|Tenofovir|tenofovir|mesh-list
101553385|NCT01033942|Emtricitabine|emtricitabine|mesh-list
101553386|NCT01033942|Antiviral Agents|antiviral agents|mesh-ancestor
101553387|NCT01033942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101553388|NCT01033942|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101553391|NCT01033942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553393|NCT01033942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101553394|NCT01062256|Phenylpropanolamine|phenylpropanolamine|mesh-list
101553395|NCT01062256|Guaifenesin|guaifenesin|mesh-list
101553396|NCT01062256|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
101553397|NCT01062256|Expectorants|expectorants|mesh-ancestor
101553398|NCT01062256|Respiratory System Agents|respiratory system agents|mesh-ancestor
101553399|NCT01062256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101553400|NCT01062256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101553401|NCT01062256|Adrenergic Agents|adrenergic agents|mesh-ancestor
101553402|NCT01062256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101553403|NCT01062256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553404|NCT01062256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945146|NCT03915561|Parecoxib|parecoxib|mesh-list
101945147|NCT03915561|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101945148|NCT03915561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101553405|NCT01062256|Appetite Depressants|appetite depressants|mesh-ancestor
101553406|NCT01062256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101553407|NCT01062256|Sympathomimetics|sympathomimetics|mesh-ancestor
101553408|NCT01062256|Autonomic Agents|autonomic agents|mesh-ancestor
101553409|NCT01062256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101553410|NCT01062256|Nasal Decongestants|nasal decongestants|mesh-ancestor
101553411|NCT01062256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101553412|NCT01029886|Liraglutide|liraglutide|mesh-list
101553413|NCT01029886|Exenatide|exenatide|mesh-list
101553414|NCT01029886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101553415|NCT01029886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553416|NCT01029886|Incretins|incretins|mesh-ancestor
101553417|NCT01029886|Hormones|hormones|mesh-ancestor
101553418|NCT01029886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101553419|NCT01029886|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101553420|NCT01244061|Varenicline|varenicline|mesh-list
101553421|NCT01244061|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101553422|NCT01244061|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101553423|NCT01244061|Cholinergic Agents|cholinergic agents|mesh-ancestor
101553424|NCT01244061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101708331|NCT02705729|Sympathomimetics|sympathomimetics|mesh-ancestor
101553425|NCT01244061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553426|NCT01244061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553427|NCT01243671|Adalimumab|adalimumab|mesh-list
101553428|NCT01243671|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101553429|NCT01243671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101553430|NCT01243671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101553431|NCT01240785|Metformin|metformin|mesh-list
101553432|NCT01240785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101553433|NCT01240785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553434|NCT01266876|Alirocumab|alirocumab|mesh-list
101553435|NCT01266876|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101553436|NCT01266876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101553437|NCT01266876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101553438|NCT01266876|Antimetabolites|antimetabolites|mesh-ancestor
101553439|NCT01266876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553440|NCT01266876|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101553441|NCT01266876|Protease Inhibitors|protease inhibitors|mesh-ancestor
101553442|NCT01266876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101553443|NCT01266876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101553444|NCT01033240|Sorafenib|sorafenib|mesh-list
101553445|NCT01033240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101553446|NCT01033240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101553447|NCT01033240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101553448|NCT01033240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553449|NCT01032382|Gentamicins|gentamicins|mesh-list
101553450|NCT01032382|Paromomycin|paromomycin|mesh-list
101553451|NCT01032382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101553452|NCT01032382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101553453|NCT01032382|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101553454|NCT01032382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101553455|NCT01032382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553456|NCT01032382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101553457|NCT01032382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101553458|NCT01029652|Triamcinolone|triamcinolone|mesh-list
101553459|NCT01029652|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101553460|NCT01029652|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101553461|NCT01029652|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101553466|NCT01029652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101553467|NCT01029652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553468|NCT01029652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101553469|NCT01029652|Immunologic Factors|immunologic factors|mesh-ancestor
101553470|NCT01029652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101553471|NCT01029652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553472|NCT01029340|Factor VIII|factor viii|mesh-list
101553473|NCT01029340|Coagulants|coagulants|mesh-ancestor
101553474|NCT01265550|Baclofen|baclofen|mesh-list
101553475|NCT01265550|Desipramine|desipramine|mesh-list
101553476|NCT01265550|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101553477|NCT01265550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553478|NCT01265550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101553479|NCT01265550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101945149|NCT03915561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101945150|NCT03915561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945151|NCT03915561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101945152|NCT03915561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101945153|NCT03915561|Analgesics|analgesics|mesh-ancestor
101945154|NCT03915561|Sensory System Agents|sensory system agents|mesh-ancestor
101708332|NCT02705729|Autonomic Agents|autonomic agents|mesh-ancestor
101945155|NCT03915561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101788649|NCT00884442|Vasodilator Agents|vasodilator agents|mesh-ancestor
101553480|NCT01265550|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101553481|NCT01265550|GABA Agonists|gaba agonists|mesh-ancestor
101553482|NCT01265550|GABA Agents|gaba agents|mesh-ancestor
101553483|NCT01265550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101553484|NCT01265550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553485|NCT01265550|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101553486|NCT01265550|Antidepressive Agents|antidepressive agents|mesh-ancestor
101553487|NCT01265550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101553488|NCT01265550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101553489|NCT01265550|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101553490|NCT01265550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101553491|NCT01265550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101553492|NCT01265550|Adrenergic Agents|adrenergic agents|mesh-ancestor
101553493|NCT01265394|Flutemetamol|flutemetamol|mesh-list
101553494|NCT01265394|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101553495|NCT01265394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553496|NCT01029262|Lenalidomide|lenalidomide|mesh-list
101553497|NCT01029262|Immunologic Factors|immunologic factors|mesh-ancestor
101553498|NCT01029262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553499|NCT01029262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101553500|NCT01029262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101515416|NCT01313884|Irinotecan|irinotecan|mesh-list
101553501|NCT01029262|Growth Substances|growth substances|mesh-ancestor
101553502|NCT01029262|Growth Inhibitors|growth inhibitors|mesh-ancestor
101553504|NCT01061710|Varenicline|varenicline|mesh-list
101553505|NCT01061710|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101553506|NCT01061710|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101553507|NCT01061710|Cholinergic Agents|cholinergic agents|mesh-ancestor
101553508|NCT01061710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101553509|NCT01061710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553510|NCT01061710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553511|NCT01028014|Pseudoephedrine|pseudoephedrine|mesh-list
101553512|NCT01028014|Ephedrine|ephedrine|mesh-list
101553513|NCT01028014|Cyclobenzaprine|cyclobenzaprine|mesh-list
101553514|NCT01028014|Imipramine|imipramine|mesh-list
101553515|NCT01028014|Tamsulosin|tamsulosin|mesh-list
101553516|NCT01028014|Solifenacin Succinate|solifenacin succinate|mesh-list
101553517|NCT01028014|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101553518|NCT01028014|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101553519|NCT01028014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101553520|NCT01028014|Adrenergic Agents|adrenergic agents|mesh-ancestor
101553521|NCT01028014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101553522|NCT01028014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553523|NCT01028014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553524|NCT01028014|Urological Agents|urological agents|mesh-ancestor
101553525|NCT01028014|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101553526|NCT01028014|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101553527|NCT01028014|Cholinergic Agents|cholinergic agents|mesh-ancestor
101553528|NCT01028014|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101553529|NCT01028014|Autonomic Agents|autonomic agents|mesh-ancestor
101553530|NCT01028014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101553531|NCT01028014|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101553532|NCT01028014|Respiratory System Agents|respiratory system agents|mesh-ancestor
101553533|NCT01028014|Nasal Decongestants|nasal decongestants|mesh-ancestor
101553541|NCT01028014|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101553542|NCT01028014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101553543|NCT01028014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101553544|NCT01028014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101945156|NCT03915561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945157|NCT03915561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101788726|NCT00891072|Paclitaxel|paclitaxel|mesh-list
101553545|NCT01028014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101553546|NCT01028014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101553547|NCT01264770|Adalimumab|adalimumab|mesh-list
101553548|NCT01264770|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101553549|NCT01264770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101553550|NCT01264770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101553551|NCT02873650|Dabrafenib|dabrafenib|mesh-list
101553552|NCT02873650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101553553|NCT02873650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101553554|NCT02873650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101553555|NCT02873650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553556|NCT01302080|Sertraline|sertraline|mesh-list
101553557|NCT01302080|Antidepressive Agents|antidepressive agents|mesh-ancestor
101553558|NCT01302080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101553559|NCT01302080|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101553560|NCT01302080|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101553561|NCT01302080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101553562|NCT01302080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553563|NCT01302080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101553564|NCT01302080|Serotonin Agents|serotonin agents|mesh-ancestor
101553565|NCT01302080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553566|NCT01032070|Etoposide|etoposide|mesh-list
101553567|NCT01032070|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101553568|NCT01032070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101553569|NCT01032070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101553570|NCT01032070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101515489|NCT05105061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553571|NCT01032070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101553572|NCT01032070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101553573|NCT01032070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553574|NCT01032070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101553576|NCT01237899|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101553577|NCT01237899|Hormone Antagonists|hormone antagonists|mesh-ancestor
101553578|NCT01237899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101553579|NCT01237899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553580|NCT01237899|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101553581|NCT01237899|Diuretics|diuretics|mesh-ancestor
101553582|NCT01237899|Natriuretic Agents|natriuretic agents|mesh-ancestor
101553583|NCT01237899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101553584|NCT01263444|Timolol|timolol|mesh-list
101553585|NCT01263444|Bimatoprost|bimatoprost|mesh-list
101553586|NCT01263444|Travoprost|travoprost|mesh-list
101553587|NCT01263444|Latanoprost|latanoprost|mesh-list
101553588|NCT01263444|Brinzolamide|brinzolamide|mesh-list
101553589|NCT01263444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101553590|NCT01263444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101553591|NCT01263444|Adrenergic Agents|adrenergic agents|mesh-ancestor
101553592|NCT01263444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101553593|NCT01263444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553594|NCT01263444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553595|NCT01263444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101553596|NCT01263444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101553597|NCT01263444|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101553598|NCT01263444|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101402002|NCT00334477|Tadalafil|tadalafil|mesh-list
101553604|NCT01031836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553606|NCT01237587|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101553607|NCT01237587|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101553608|NCT01237587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101553609|NCT01237587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553610|NCT01237587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101553611|NCT01237587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553612|NCT01237587|Analgesics|analgesics|mesh-ancestor
101553613|NCT01237587|Sensory System Agents|sensory system agents|mesh-ancestor
101553614|NCT01237587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101553615|NCT01237587|Antidepressive Agents|antidepressive agents|mesh-ancestor
101553616|NCT01237587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101945158|NCT03915561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101945160|NCT01148277|Midazolam|midazolam|mesh-list
101945161|NCT01148277|Propofol|propofol|mesh-list
101553617|NCT01237587|Dopamine Agents|dopamine agents|mesh-ancestor
101553618|NCT01031680|Dapagliflozin|dapagliflozin|mesh-list
101553619|NCT01031680|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101553620|NCT01031680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553621|NCT01031680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101553622|NCT01031680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553623|NCT01031446|Paclitaxel|paclitaxel|mesh-list
101553624|NCT01031446|Everolimus|everolimus|mesh-list
101553625|NCT01031446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101553626|NCT01031446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101553627|NCT01031446|Tubulin Modulators|tubulin modulators|mesh-ancestor
101553628|NCT01031446|Antimitotic Agents|antimitotic agents|mesh-ancestor
101553629|NCT01031446|Mitosis Modulators|mitosis modulators|mesh-ancestor
101553630|NCT01031446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553631|NCT01031446|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101553632|NCT01031446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101553633|NCT01031446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101553634|NCT01031446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101553635|NCT01031446|Immunologic Factors|immunologic factors|mesh-ancestor
101553636|NCT01031446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553637|NCT01030900|Prednisone|prednisone|mesh-list
101553638|NCT01030900|Cyclophosphamide|cyclophosphamide|mesh-list
101553639|NCT01030900|Rituximab|rituximab|mesh-list
101553640|NCT01030900|Doxorubicin|doxorubicin|mesh-list
101553641|NCT01030900|Etoposide|etoposide|mesh-list
101553642|NCT01030900|Vincristine|vincristine|mesh-list
101553643|NCT01030900|Alemtuzumab|alemtuzumab|mesh-list
101553644|NCT01030900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101553645|NCT01030900|Immunologic Factors|immunologic factors|mesh-ancestor
101553646|NCT01030900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553647|NCT01030900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101553648|NCT01030900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101553649|NCT01030900|Alkylating Agents|alkylating agents|mesh-ancestor
101553650|NCT01030900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553651|NCT01030900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101553652|NCT01030900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101553653|NCT01030900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101553654|NCT01030900|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101553655|NCT01030900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101553656|NCT01030900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101553657|NCT01030900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101553658|NCT01030900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101553659|NCT01030900|Glucocorticoids|glucocorticoids|mesh-ancestor
101553661|NCT01030900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101553662|NCT01030900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101553663|NCT01030900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101553664|NCT01030900|Tubulin Modulators|tubulin modulators|mesh-ancestor
101553665|NCT01030900|Antimitotic Agents|antimitotic agents|mesh-ancestor
101553666|NCT01030900|Mitosis Modulators|mitosis modulators|mesh-ancestor
101553667|NCT01030822|Vaccines|vaccines|mesh-list
101402068|NCT00334672|Autonomic Agents|autonomic agents|mesh-ancestor
101553671|NCT01026454|Valacyclovir|valacyclovir|mesh-list
101553672|NCT01026454|Acyclovir|acyclovir|mesh-list
101553673|NCT01026454|Antiviral Agents|antiviral agents|mesh-ancestor
101553674|NCT01026454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101553675|NCT01026220|Prednisone|prednisone|mesh-list
101553676|NCT01026220|Cyclophosphamide|cyclophosphamide|mesh-list
101553677|NCT01026220|Ifosfamide|ifosfamide|mesh-list
101553678|NCT01026220|Doxorubicin|doxorubicin|mesh-list
101553679|NCT01026220|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101553680|NCT01026220|Etoposide|etoposide|mesh-list
101553681|NCT01026220|Vincristine|vincristine|mesh-list
101553682|NCT01026220|Vinorelbine|vinorelbine|mesh-list
101553683|NCT01026220|Bleomycin|bleomycin|mesh-list
101553684|NCT01026220|Etoposide phosphate|etoposide phosphate|mesh-list
101553685|NCT01026220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101553686|NCT01026220|Immunologic Factors|immunologic factors|mesh-ancestor
101553687|NCT01026220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553688|NCT01026220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101553689|NCT01026220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101553690|NCT01026220|Alkylating Agents|alkylating agents|mesh-ancestor
101553691|NCT01026220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945162|NCT01148277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101945163|NCT01148277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101945164|NCT01148277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945165|NCT01148277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101553692|NCT01026220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101553693|NCT01026220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101553694|NCT01026220|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101553695|NCT01026220|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101553696|NCT01026220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101553697|NCT01026220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101553698|NCT01026220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101553699|NCT01026220|Glucocorticoids|glucocorticoids|mesh-ancestor
101553700|NCT01026220|Hormones|hormones|mesh-ancestor
101553701|NCT01026220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101553702|NCT01026220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101553703|NCT01026220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101553704|NCT01026220|Tubulin Modulators|tubulin modulators|mesh-ancestor
101553705|NCT01026220|Antimitotic Agents|antimitotic agents|mesh-ancestor
101553706|NCT01026220|Mitosis Modulators|mitosis modulators|mesh-ancestor
101553707|NCT01026142|Capecitabine|capecitabine|mesh-list
101553708|NCT01026142|Trastuzumab|trastuzumab|mesh-list
101553709|NCT01026142|Pertuzumab|pertuzumab|mesh-list
101553710|NCT01026142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101553711|NCT01026142|Antimetabolites|antimetabolites|mesh-ancestor
101553712|NCT01026142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553713|NCT01026142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101553714|NCT01026142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101553715|NCT01030666|Chlorhexidine|chlorhexidine|mesh-list
101553716|NCT01030666|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101553717|NCT01030666|Doxycycline|doxycycline|mesh-list
101553718|NCT01030666|Ibuprofen|ibuprofen|mesh-list
101553719|NCT01030666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101553720|NCT01030666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101553721|NCT01030666|Analgesics|analgesics|mesh-ancestor
101553722|NCT01030666|Sensory System Agents|sensory system agents|mesh-ancestor
101553723|NCT01030666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101553724|NCT01030666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553725|NCT01030666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101553726|NCT01030666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101553727|NCT01030666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101553728|NCT01030666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101553729|NCT01030666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553730|NCT01030666|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101553731|NCT01030666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101553732|NCT01030666|Disinfectants|disinfectants|mesh-ancestor
101553733|NCT01030666|Dermatologic Agents|dermatologic agents|mesh-ancestor
101553734|NCT01030666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101553735|NCT01030666|Antimalarials|antimalarials|mesh-ancestor
101553736|NCT01030666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101553737|NCT01030666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101553738|NCT01023256|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101553739|NCT01023256|Immunologic Factors|immunologic factors|mesh-ancestor
101553740|NCT01023256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553741|NCT01058668|Cariprazine|cariprazine|mesh-list
101553745|NCT01058668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553746|NCT01058668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101553747|NCT00623558|Docetaxel|docetaxel|mesh-list
101553748|NCT00623558|Cetuximab|cetuximab|mesh-list
101553749|NCT00623558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101553750|NCT00623558|Tubulin Modulators|tubulin modulators|mesh-ancestor
101553751|NCT00623558|Antimitotic Agents|antimitotic agents|mesh-ancestor
101553752|NCT00623558|Mitosis Modulators|mitosis modulators|mesh-ancestor
101553753|NCT00623558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553754|NCT00623558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101553755|NCT01301066|Pravastatin|pravastatin|mesh-list
101553756|NCT01301066|Pitavastatin|pitavastatin|mesh-list
101553757|NCT01301066|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101553758|NCT01301066|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101553759|NCT01301066|Antimetabolites|antimetabolites|mesh-ancestor
101553760|NCT01301066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553761|NCT01301066|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101945166|NCT01148277|Anesthetics, General|anesthetics, general|mesh-ancestor
101945167|NCT01148277|Anesthetics|anesthetics|mesh-ancestor
101945168|NCT01148277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101553762|NCT01301066|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101553763|NCT01301066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101553764|NCT01022398|Vitamin D|vitamin d|mesh-list
101553765|NCT01022398|Cholecalciferol|cholecalciferol|mesh-list
101553766|NCT01022398|Vitamins|vitamins|mesh-ancestor
101553767|NCT01022398|Micronutrients|micronutrients|mesh-ancestor
101553768|NCT01022398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553769|NCT01022398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101553770|NCT01022398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101553771|NCT05642624|Amphotericin B|amphotericin b|mesh-list
101553772|NCT05642624|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101553773|NCT05642624|Deoxycholic Acid|deoxycholic acid|mesh-list
101553774|NCT05642624|Amebicides|amebicides|mesh-ancestor
101553775|NCT05642624|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101553776|NCT05642624|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101553777|NCT05642624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101553778|NCT05642624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101553779|NCT05642624|Antifungal Agents|antifungal agents|mesh-ancestor
101553780|NCT05642624|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101553781|NCT05642624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101553782|NCT04324346|Paclitaxel|paclitaxel|mesh-list
101553783|NCT04324346|Docetaxel|docetaxel|mesh-list
101553784|NCT04324346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101553785|NCT04324346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101553786|NCT04324346|Tubulin Modulators|tubulin modulators|mesh-ancestor
101553787|NCT04324346|Antimitotic Agents|antimitotic agents|mesh-ancestor
101553788|NCT04324346|Mitosis Modulators|mitosis modulators|mesh-ancestor
101553789|NCT04324346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553790|NCT04300114|Fluzoparib|fluzoparib|mesh-list
101553791|NCT04300114|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101553792|NCT04300114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101553793|NCT04300114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553794|NCT04300114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101553795|NCT02890238|Sildenafil Citrate|sildenafil citrate|mesh-list
101553796|NCT02890238|Citric Acid|citric acid|mesh-list
101553797|NCT02890238|Sodium Citrate|sodium citrate|mesh-list
101515713|NCT04687566|Memantine|memantine|mesh-list
101553798|NCT02890238|Clomiphene|clomiphene|mesh-list
101553799|NCT02890238|Enclomiphene|enclomiphene|mesh-list
101553800|NCT02890238|Zuclomiphene|zuclomiphene|mesh-list
101553801|NCT02890238|Anticoagulants|anticoagulants|mesh-ancestor
101553802|NCT02890238|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101553803|NCT02890238|Chelating Agents|chelating agents|mesh-ancestor
101553804|NCT02890238|Sequestering Agents|sequestering agents|mesh-ancestor
101553805|NCT02890238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553806|NCT02890238|Vasodilator Agents|vasodilator agents|mesh-ancestor
101553807|NCT02890238|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101553808|NCT02890238|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101553809|NCT02890238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101553810|NCT02890238|Urological Agents|urological agents|mesh-ancestor
101553811|NCT02890238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101553812|NCT02890238|Hormone Antagonists|hormone antagonists|mesh-ancestor
101553813|NCT02890238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101553814|NCT02890238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553821|NCT00627796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101553822|NCT01299896|Bupropion|bupropion|mesh-list
101553823|NCT01299896|Nicotine|nicotine|mesh-list
101553824|NCT01299896|Varenicline|varenicline|mesh-list
101553825|NCT01299896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101553826|NCT01299896|Autonomic Agents|autonomic agents|mesh-ancestor
101553827|NCT01299896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101553828|NCT01299896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553829|NCT01299896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101553830|NCT01299896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101553831|NCT01299896|Cholinergic Agents|cholinergic agents|mesh-ancestor
101553832|NCT01299896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101553833|NCT01299896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553834|NCT01299896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101553835|NCT01299896|Antidepressive Agents|antidepressive agents|mesh-ancestor
101553836|NCT01299896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101553837|NCT01299896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101945169|NCT01148277|Narcotics|narcotics|mesh-ancestor
101945170|NCT01148277|Analgesics|analgesics|mesh-ancestor
101945171|NCT01148277|Sensory System Agents|sensory system agents|mesh-ancestor
101789005|NCT00642746|Fluorouracil|fluorouracil|mesh-list
101553838|NCT01299896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101553839|NCT01299896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101553840|NCT01299896|Dopamine Agents|dopamine agents|mesh-ancestor
101553841|NCT01299896|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101553842|NCT01299896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101553843|NCT01299896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101553844|NCT01299584|Remifentanil|remifentanil|mesh-list
101553845|NCT01299584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101553846|NCT01299584|Narcotics|narcotics|mesh-ancestor
101553847|NCT01299584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101553848|NCT01299584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553849|NCT01299584|Analgesics|analgesics|mesh-ancestor
101553850|NCT01299584|Sensory System Agents|sensory system agents|mesh-ancestor
101553851|NCT01299584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101553852|NCT01236573|Cyclophosphamide|cyclophosphamide|mesh-list
101553853|NCT01236573|Fludarabine|fludarabine|mesh-list
101553854|NCT01236573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101553855|NCT01236573|Immunologic Factors|immunologic factors|mesh-ancestor
101553856|NCT01236573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553857|NCT01236573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101553858|NCT01236573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101553859|NCT01236573|Alkylating Agents|alkylating agents|mesh-ancestor
101553860|NCT01236573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553861|NCT01236573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101553862|NCT01236573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101553863|NCT04323228|Antioxidants|antioxidants|mesh-list
101553864|NCT04323228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553865|NCT04323228|Protective Agents|protective agents|mesh-ancestor
101553866|NCT04323228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553867|NCT04322760|Lidocaine|lidocaine|mesh-list
101553868|NCT04322760|Dexmedetomidine|dexmedetomidine|mesh-list
101553869|NCT04322760|Bupivacaine|bupivacaine|mesh-list
101553870|NCT04322760|Anesthetics, Local|anesthetics, local|mesh-ancestor
101553871|NCT04322760|Anesthetics|anesthetics|mesh-ancestor
101553872|NCT04322760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101553873|NCT04322760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553874|NCT04322760|Sensory System Agents|sensory system agents|mesh-ancestor
101553875|NCT04322760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101553876|NCT04322760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101553877|NCT04322760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101553878|NCT04322760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101553879|NCT04322760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101553880|NCT04322760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553881|NCT04322760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101402285|NCT00343369|Cytarabine|cytarabine|mesh-list
101553886|NCT04322760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101553887|NCT04322760|Adrenergic Agents|adrenergic agents|mesh-ancestor
101553888|NCT04322760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101553890|NCT04322214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101553891|NCT04322214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101553892|NCT04322214|Antiviral Agents|antiviral agents|mesh-ancestor
101553893|NCT04322214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101553894|NCT04322214|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101553895|NCT04322214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101553896|NCT04322214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101553897|NCT04322214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553898|NCT01057810|Ipilimumab|ipilimumab|mesh-list
101553899|NCT01057810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101553900|NCT01057810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101553901|NCT01057810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101553902|NCT01057810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553903|NCT01262352|Ivacaftor|ivacaftor|mesh-list
101553904|NCT01262352|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101553905|NCT01262352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101553906|NCT01262352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553907|NCT01299272|Serotonin|serotonin|mesh-list
101945172|NCT01148277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101945173|NCT01148277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101945174|NCT01148277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101553908|NCT01299272|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
101553909|NCT01299272|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101553910|NCT01299272|Serotonin Agents|serotonin agents|mesh-ancestor
101553911|NCT01299272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101553912|NCT01299272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553913|NCT01299272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553914|NCT01299272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101553915|NCT01299272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101553916|NCT01299116|Contraceptive Agents|contraceptive agents|mesh-list
101553917|NCT01299116|Etonogestrel|etonogestrel|mesh-list
101553918|NCT01299116|Contraceptives, Oral|contraceptives, oral|mesh-list
101553919|NCT01299116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101553920|NCT01299116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553921|NCT01299116|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101553922|NCT01299116|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101553923|NCT04207398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101553924|NCT04207398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101553925|NCT04207398|Adrenergic Agents|adrenergic agents|mesh-ancestor
101553926|NCT04207398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101553927|NCT04207398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553928|NCT04207398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553929|NCT01299038|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101553930|NCT01299038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101553931|NCT01299038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101553932|NCT01299038|Antimetabolites|antimetabolites|mesh-ancestor
101553933|NCT01299038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553934|NCT01299038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101708407|NCT00738088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101553935|NCT01299038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101553936|NCT01299038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101553937|NCT04321278|Azithromycin|azithromycin|mesh-list
101553938|NCT04321278|Hydroxychloroquine|hydroxychloroquine|mesh-list
101553939|NCT04321278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101553940|NCT04321278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101553941|NCT04321278|Antimalarials|antimalarials|mesh-ancestor
101553942|NCT04321278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101553943|NCT04321278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101553944|NCT04321278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101553945|NCT04321278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553946|NCT04321278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101553947|NCT01261338|Sucrose polyester|sucrose polyester|mesh-list
101553948|NCT01261338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101553949|NCT01261338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101553952|NCT01261338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101553953|NCT01260948|Donepezil|donepezil|mesh-list
101553954|NCT01260948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101553955|NCT01260948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101553956|NCT01260948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553957|NCT01260948|Cholinergic Agents|cholinergic agents|mesh-ancestor
101553958|NCT01260948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101553959|NCT01260948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553960|NCT01260948|Nootropic Agents|nootropic agents|mesh-ancestor
101553961|NCT01025284|Lenograstim|lenograstim|mesh-list
101553962|NCT01025284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101553963|NCT01025284|Immunologic Factors|immunologic factors|mesh-ancestor
101553964|NCT01025284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553965|NCT02873026|Triamcinolone|triamcinolone|mesh-list
101553966|NCT02873026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101553967|NCT02873026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101553968|NCT02873026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101553969|NCT02873026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101553970|NCT02873026|Glucocorticoids|glucocorticoids|mesh-ancestor
101553971|NCT02873026|Hormones|hormones|mesh-ancestor
101553972|NCT02873026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101553973|NCT02873026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553974|NCT02873026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101553975|NCT02873026|Immunologic Factors|immunologic factors|mesh-ancestor
101553976|NCT02873026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101945175|NCT01148277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101945176|NCT01148277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101945177|NCT01148277|GABA Modulators|gaba modulators|mesh-ancestor
101945178|NCT01148277|GABA Agents|gaba agents|mesh-ancestor
101789151|NCT00815048|Atropine|atropine|mesh-list
101553977|NCT02873026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553978|NCT01056718|Nebivolol|nebivolol|mesh-list
101553979|NCT01056718|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101553980|NCT01056718|Vasodilator Agents|vasodilator agents|mesh-ancestor
101553981|NCT01056718|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101553982|NCT01056718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101553983|NCT01056718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101553984|NCT01056718|Adrenergic Agents|adrenergic agents|mesh-ancestor
101553985|NCT01056718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101553986|NCT01056718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553987|NCT01056718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553988|NCT01298570|Leucovorin|leucovorin|mesh-list
101553989|NCT01298570|Fluorouracil|fluorouracil|mesh-list
101553990|NCT01298570|Irinotecan|irinotecan|mesh-list
101553991|NCT01298570|Levoleucovorin|levoleucovorin|mesh-list
101553992|NCT01298570|Antimetabolites|antimetabolites|mesh-ancestor
101553993|NCT01298570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101553994|NCT01298570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101553995|NCT01298570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101553996|NCT01298570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101553997|NCT01298570|Immunologic Factors|immunologic factors|mesh-ancestor
101553998|NCT01298570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708419|NCT04152941|Olaparib|olaparib|mesh-list
101553999|NCT01298570|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101554000|NCT01298570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101554001|NCT01298570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101554002|NCT01298570|Antidotes|antidotes|mesh-ancestor
101554003|NCT01298570|Protective Agents|protective agents|mesh-ancestor
101554004|NCT01298570|Vitamin B Complex|vitamin b complex|mesh-ancestor
101554005|NCT01298570|Vitamins|vitamins|mesh-ancestor
101554006|NCT01298570|Micronutrients|micronutrients|mesh-ancestor
101554007|NCT01259856|Aspirin|aspirin|mesh-list
101554008|NCT01259856|Interferons|interferons|mesh-list
101554009|NCT01259856|Interferon-alpha|interferon-alpha|mesh-list
101554010|NCT01259856|Interferon alpha-2|interferon alpha-2|mesh-list
101554011|NCT01259856|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101554012|NCT01259856|Hydroxyurea|hydroxyurea|mesh-list
101554013|NCT01259856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101554014|NCT01259856|Antiviral Agents|antiviral agents|mesh-ancestor
101554015|NCT01259856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101554016|NCT01259856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101554017|NCT01259856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101554018|NCT01259856|Analgesics|analgesics|mesh-ancestor
101554019|NCT01259856|Sensory System Agents|sensory system agents|mesh-ancestor
101554020|NCT01259856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101554021|NCT01259856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554022|NCT01259856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101554023|NCT01259856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101554024|NCT01259856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101554025|NCT01259856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101554040|NCT01259466|Autonomic Agents|autonomic agents|mesh-ancestor
101554041|NCT01259466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101554042|NCT01259466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554043|NCT01259466|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101554044|NCT01259466|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101554045|NCT01259466|Cholinergic Agents|cholinergic agents|mesh-ancestor
101554046|NCT01259466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101554047|NCT01259466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554048|NCT01259388|Lithium Carbonate|lithium carbonate|mesh-list
101554049|NCT01259388|Antidepressive Agents|antidepressive agents|mesh-ancestor
101554050|NCT01259388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101554051|NCT01259388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101554052|NCT01259388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554053|NCT01259388|Antimanic Agents|antimanic agents|mesh-ancestor
101554054|NCT01259388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101554055|NCT01259388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101554056|NCT01259388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554057|NCT05525910|Ritonavir|ritonavir|mesh-list
101554058|NCT05525910|Nirmatrelvir|nirmatrelvir|mesh-list
101945179|NCT01148277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101945180|NCT01148277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945181|NCT03907371|Donepezil|donepezil|mesh-list
101945182|NCT03907371|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101945183|NCT03907371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101945184|NCT03907371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554059|NCT05525910|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
101554060|NCT05525910|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101554061|NCT05525910|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101554062|NCT05525910|Protease Inhibitors|protease inhibitors|mesh-ancestor
101554063|NCT05525910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101554064|NCT05525910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554065|NCT05525910|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101554066|NCT05525910|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101554067|NCT05525910|Antiviral Agents|antiviral agents|mesh-ancestor
101554068|NCT05525910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101554069|NCT05525910|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101554070|NCT05525910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101554071|NCT00624078|Antivenins|antivenins|mesh-list
101554072|NCT00624078|Immunologic Factors|immunologic factors|mesh-ancestor
101554073|NCT00624078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554074|NCT05286528|Imatinib Mesylate|imatinib mesylate|mesh-list
101554075|NCT05286528|Dasatinib|dasatinib|mesh-list
101554076|NCT05286528|Ponatinib|ponatinib|mesh-list
101554077|NCT05286528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101554078|NCT05286528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101554079|NCT05286528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101554080|NCT05286528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554081|NCT01297244|Tivozanib|tivozanib|mesh-list
101554082|NCT01297244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101554083|NCT01297244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101554084|NCT01297244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554127|NCT03377478|Antiviral Agents|antiviral agents|mesh-ancestor
101554128|NCT03377478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101554129|NCT03181932|Vancomycin|vancomycin|mesh-list
101554130|NCT03181932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101554131|NCT03181932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101554132|NCT02583672|Acetylcysteine|acetylcysteine|mesh-list
101554133|NCT02583672|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101554134|NCT02583672|Antiviral Agents|antiviral agents|mesh-ancestor
101554135|NCT02583672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101554136|NCT02583672|Expectorants|expectorants|mesh-ancestor
101554137|NCT02583672|Respiratory System Agents|respiratory system agents|mesh-ancestor
101554138|NCT02583672|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101554139|NCT02583672|Antioxidants|antioxidants|mesh-ancestor
101554140|NCT02583672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554141|NCT02583672|Protective Agents|protective agents|mesh-ancestor
101554142|NCT02583672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554143|NCT02583672|Antidotes|antidotes|mesh-ancestor
101554144|NCT02888730|Tobramycin|tobramycin|mesh-list
101554145|NCT02888730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101554146|NCT02888730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101554147|NCT01598298|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101554148|NCT01598298|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101402568|NCT00127998|Lumefantrine|lumefantrine|mesh-list
101554151|NCT01598298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554153|NCT01598298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554154|NCT01598298|Analgesics|analgesics|mesh-ancestor
101554155|NCT01598298|Sensory System Agents|sensory system agents|mesh-ancestor
101554156|NCT01598298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101554157|NCT01598298|Antidepressive Agents|antidepressive agents|mesh-ancestor
101554158|NCT01598298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101554159|NCT01598298|Dopamine Agents|dopamine agents|mesh-ancestor
101554160|NCT02888652|Clopidogrel|clopidogrel|mesh-list
101554161|NCT02888652|Ticagrelor|ticagrelor|mesh-list
101554162|NCT02888652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
101554163|NCT02888652|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101554164|NCT02888652|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101945185|NCT03907371|Cholinergic Agents|cholinergic agents|mesh-ancestor
101945186|NCT03907371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101945187|NCT03907371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945188|NCT03907371|Nootropic Agents|nootropic agents|mesh-ancestor
101945189|NCT03908619|Esomeprazole|esomeprazole|mesh-list
101554165|NCT02888652|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101554166|NCT02888652|Purinergic Agents|purinergic agents|mesh-ancestor
101554167|NCT02888652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101554168|NCT02888652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554169|NCT02888652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554170|NCT01235949|Acetaminophen|acetaminophen|mesh-list
101554171|NCT01235949|Ibuprofen|ibuprofen|mesh-list
101554172|NCT01235949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101554173|NCT01235949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101554174|NCT01235949|Analgesics|analgesics|mesh-ancestor
101554175|NCT01235949|Sensory System Agents|sensory system agents|mesh-ancestor
101554177|NCT01235949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554178|NCT01235949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101554179|NCT01235949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101554180|NCT01235949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101554181|NCT01235949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101554182|NCT01235949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554183|NCT01235949|Antipyretics|antipyretics|mesh-ancestor
101554184|NCT00691158|Pramlintide|pramlintide|mesh-list
101554185|NCT00691158|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
101554186|NCT00691158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101554187|NCT00691158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554188|NCT00691158|Appetite Depressants|appetite depressants|mesh-ancestor
101554189|NCT00691158|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101554190|NCT00691158|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
101554191|NCT00691158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554192|NCT01235793|Temozolomide|temozolomide|mesh-list
101554193|NCT01235793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101554194|NCT01235793|Alkylating Agents|alkylating agents|mesh-ancestor
101554195|NCT01235793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554196|NCT01235793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101554197|NCT05601648|Psilocybin|psilocybin|mesh-list
101554198|NCT05601648|Hallucinogens|hallucinogens|mesh-ancestor
101554199|NCT05601648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554200|NCT05601648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101554201|NCT01235715|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101554202|NCT01235715|Hemostatics|hemostatics|mesh-ancestor
101554203|NCT01235715|Coagulants|coagulants|mesh-ancestor
101554204|NCT01235403|Lacosamide|lacosamide|mesh-list
101554205|NCT01235403|Anticonvulsants|anticonvulsants|mesh-ancestor
101554206|NCT01235403|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101554207|NCT01235403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101554208|NCT01235403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101554209|NCT01235403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554210|NCT01024036|Siltuximab|siltuximab|mesh-list
101554211|NCT01024036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101554212|NCT01234467|Rituximab|rituximab|mesh-list
101554213|NCT01234467|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101554214|NCT01234467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101554215|NCT01234467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101554216|NCT01234467|Immunologic Factors|immunologic factors|mesh-ancestor
101554217|NCT01234467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554218|NCT01234467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101554219|NCT01234467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101554220|NCT01234467|Alkylating Agents|alkylating agents|mesh-ancestor
101554225|NCT01233999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101554226|NCT01233999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101554227|NCT01233999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554229|NCT01233999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101554230|NCT01233999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554231|NCT01233999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101554232|NCT01233999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101554233|NCT01233687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101554234|NCT01233687|Rilotumumab|rilotumumab|mesh-list
101554235|NCT01233687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101945190|NCT03908619|Omeprazole|omeprazole|mesh-list
101945191|NCT03908619|Rabeprazole|rabeprazole|mesh-list
101945192|NCT03908619|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101554236|NCT01233687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101554237|NCT01233687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101554238|NCT01233687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554239|NCT01233687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101554240|NCT01233609|Valproic Acid|valproic acid|mesh-list
101554241|NCT01233609|Anticonvulsants|anticonvulsants|mesh-ancestor
101554242|NCT01233609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101554243|NCT01233609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554244|NCT01233609|GABA Agents|gaba agents|mesh-ancestor
101554245|NCT01233609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101708445|NCT02704715|Anesthetics|anesthetics|mesh-list
101554246|NCT01233609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554247|NCT01233609|Antimanic Agents|antimanic agents|mesh-ancestor
101554248|NCT01233609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101554249|NCT01233609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101554251|NCT01232283|Apremilast|apremilast|mesh-list
101554252|NCT01232283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101554253|NCT01232283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101554254|NCT01232283|Analgesics|analgesics|mesh-ancestor
101554255|NCT01232283|Sensory System Agents|sensory system agents|mesh-ancestor
101554256|NCT01232283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101554257|NCT01232283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554258|NCT01232283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101554259|NCT01232283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101554260|NCT01232283|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101554261|NCT01232283|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101554262|NCT01232283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101554263|NCT01232283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554264|NCT01232127|Ritonavir|ritonavir|mesh-list
101554265|NCT01232127|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101554266|NCT01232127|Tenofovir|tenofovir|mesh-list
101554267|NCT01232127|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
101554268|NCT01232127|Famotidine|famotidine|mesh-list
101554269|NCT01232127|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101554270|NCT01232127|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101554271|NCT01232127|Protease Inhibitors|protease inhibitors|mesh-ancestor
101554272|NCT01232127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101554273|NCT01232127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554274|NCT01232127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101554275|NCT01232127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101554276|NCT01232127|Antiviral Agents|antiviral agents|mesh-ancestor
101554277|NCT01232127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101554278|NCT01232127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101554279|NCT01232127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101554280|NCT01232127|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101554281|NCT01232127|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101554282|NCT01232127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101554283|NCT01232127|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101554284|NCT01232127|Histamine Antagonists|histamine antagonists|mesh-ancestor
101554285|NCT01232127|Histamine Agents|histamine agents|mesh-ancestor
101554286|NCT01232127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101554287|NCT01232127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554288|NCT01258608|Sorafenib|sorafenib|mesh-list
101554289|NCT01258608|Mapatumumab|mapatumumab|mesh-list
101554290|NCT01258608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101554296|NCT01231659|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101554297|NCT01231659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101554298|NCT01231659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101554299|NCT01231659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554300|NCT01231659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101554301|NCT01231659|Immunologic Factors|immunologic factors|mesh-ancestor
101554302|NCT01231659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554303|NCT01231659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101554304|NCT01231659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101554305|NCT01231659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101554306|NCT01231659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101554307|NCT01231659|Hormone Antagonists|hormone antagonists|mesh-ancestor
101554308|NCT01231659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101554309|NCT02875288|Bupivacaine|bupivacaine|mesh-list
101554310|NCT02875288|Anesthetics, Local|anesthetics, local|mesh-ancestor
101554311|NCT02875288|Anesthetics|anesthetics|mesh-ancestor
101945193|NCT03908619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101945194|NCT03908619|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101945195|NCT03908619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101554312|NCT02875288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101554313|NCT02875288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554314|NCT02875288|Sensory System Agents|sensory system agents|mesh-ancestor
101554315|NCT02875288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101554316|NCT01054222|Fesoterodine|fesoterodine|mesh-list
101554317|NCT01054222|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101554318|NCT01054222|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101554319|NCT01054222|Cholinergic Agents|cholinergic agents|mesh-ancestor
101516232|NCT05329116|Lidocaine|lidocaine|mesh-list
101554320|NCT01054222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101554321|NCT01054222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554322|NCT01054222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554323|NCT01054222|Urological Agents|urological agents|mesh-ancestor
101554324|NCT01052428|Metoprolol|metoprolol|mesh-list
101554325|NCT01052428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101554326|NCT01052428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101554327|NCT01052428|Sympatholytics|sympatholytics|mesh-ancestor
101554328|NCT01052428|Autonomic Agents|autonomic agents|mesh-ancestor
101554329|NCT01052428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101554330|NCT01052428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554331|NCT01052428|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101554332|NCT01052428|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101554333|NCT01052428|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101554334|NCT01052428|Adrenergic Agents|adrenergic agents|mesh-ancestor
101554335|NCT01052428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101554336|NCT01052428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554337|NCT01052272|Allopurinol|allopurinol|mesh-list
101554338|NCT01052272|Candesartan|candesartan|mesh-list
101554339|NCT01052272|Candesartan cilexetil|candesartan cilexetil|mesh-list
101554341|NCT01052272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101554342|NCT01052272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101554343|NCT01052272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101554344|NCT01052272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554345|NCT01052272|Antimetabolites|antimetabolites|mesh-ancestor
101554346|NCT01052272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101554347|NCT01052272|Gout Suppressants|gout suppressants|mesh-ancestor
101554348|NCT01052272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101554349|NCT01052272|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101554350|NCT01052272|Antioxidants|antioxidants|mesh-ancestor
101554351|NCT01052272|Protective Agents|protective agents|mesh-ancestor
101708489|NCT00666302|Analgesics|analgesics|mesh-ancestor
101554352|NCT01052272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554353|NCT01052272|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101554354|NCT01052272|Protease Inhibitors|protease inhibitors|mesh-ancestor
101554355|NCT01257204|Interferons|interferons|mesh-list
101554356|NCT01257204|Ribavirin|ribavirin|mesh-list
101554357|NCT01257204|Interferon-alpha|interferon-alpha|mesh-list
101554358|NCT01257204|Interferon alpha-2|interferon alpha-2|mesh-list
101554359|NCT01257204|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101402770|NCT02959762|Vitamins|vitamins|mesh-list
101554366|NCT01257204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554367|NCT01231581|Gemcitabine|gemcitabine|mesh-list
101554368|NCT01231581|Trametinib|trametinib|mesh-list
101554369|NCT01231581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101554370|NCT01231581|Antimetabolites|antimetabolites|mesh-ancestor
101554371|NCT01231581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554372|NCT01231581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101554373|NCT01231581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101554374|NCT01231581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101554375|NCT01050634|Exemestane|exemestane|mesh-list
101554376|NCT01050634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101554377|NCT01050634|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101554378|NCT01050634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101554379|NCT01050634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101554380|NCT01050634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554381|NCT01050634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101554382|NCT01050634|Hormone Antagonists|hormone antagonists|mesh-ancestor
101554383|NCT01050634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101554384|NCT01050634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554385|NCT01020526|Pregabalin|pregabalin|mesh-list
101945196|NCT03908619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554387|NCT01020526|Sensory System Agents|sensory system agents|mesh-ancestor
101554388|NCT01020526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101554389|NCT01020526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554390|NCT01020526|Anticonvulsants|anticonvulsants|mesh-ancestor
101554391|NCT01020526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101554392|NCT01020526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101554393|NCT01020526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554394|NCT01020526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101554395|NCT01020526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101554396|NCT01020526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101554397|NCT01020526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101554398|NCT01020526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101554399|NCT01020448|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101554400|NCT01020448|Luteolytic Agents|luteolytic agents|mesh-ancestor
101554401|NCT01020448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101554402|NCT01020448|Contraceptive Agents|contraceptive agents|mesh-ancestor
101554403|NCT01020448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101554404|NCT01020448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554405|NCT01020448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101554406|NCT01020448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101554407|NCT01020448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101554408|NCT04286230|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101554409|NCT04286230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101554410|NCT04286230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101554411|NCT04286230|Antitubercular Agents|antitubercular agents|mesh-ancestor
101554412|NCT01256658|Lumefantrine|lumefantrine|mesh-list
101554414|NCT01256658|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101554415|NCT01256658|Antimalarials|antimalarials|mesh-ancestor
101554416|NCT01256658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101554417|NCT01256658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101554418|NCT01256658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101554419|NCT01256190|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101554420|NCT01256190|Fibrin Foam|fibrin foam|mesh-list
101554421|NCT01256190|Hemostatics|hemostatics|mesh-ancestor
101554422|NCT01256190|Coagulants|coagulants|mesh-ancestor
101554423|NCT02888574|Oxytocin|oxytocin|mesh-list
101554424|NCT02888574|Oxytocics|oxytocics|mesh-ancestor
101554425|NCT02888574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101554426|NCT02888574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554427|NCT01231503|Vaccines|vaccines|mesh-list
101554428|NCT01231503|Immunologic Factors|immunologic factors|mesh-ancestor
101554429|NCT01231503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554434|NCT01228071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554436|NCT04319289|Ergocalciferols|ergocalciferols|mesh-list
101554437|NCT04319289|Cholecalciferol|cholecalciferol|mesh-list
101554438|NCT04319289|Vitamins|vitamins|mesh-list
101554439|NCT04319289|Micronutrients|micronutrients|mesh-ancestor
101554440|NCT04319289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554441|NCT04319289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101554442|NCT04319289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101554443|NCT01008475|Irinotecan|irinotecan|mesh-list
101554444|NCT01008475|Cetuximab|cetuximab|mesh-list
101554445|NCT01008475|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101554446|NCT01008475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101554447|NCT01008475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101554448|NCT01008475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554449|NCT01008475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101554450|NCT01008475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101554451|NCT01226745|Ceralifimod|ceralifimod|mesh-list
101554452|NCT01226745|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101554453|NCT01226745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554454|NCT01226745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101554455|NCT01226745|Immunologic Factors|immunologic factors|mesh-ancestor
101554456|NCT01226745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554457|NCT01226511|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101554458|NCT01226511|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101554459|NCT01226511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101554460|NCT01226511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101554461|NCT01226511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945197|NCT01358734|Lenalidomide|lenalidomide|mesh-list
101945198|NCT01358734|Azacitidine|azacitidine|mesh-list
101554462|NCT01226511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101554463|NCT01226511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554464|NCT01226511|Analgesics|analgesics|mesh-ancestor
101554465|NCT01226511|Sensory System Agents|sensory system agents|mesh-ancestor
101554466|NCT01226511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101554467|NCT01226511|Antidepressive Agents|antidepressive agents|mesh-ancestor
101554468|NCT01226511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101554469|NCT01226511|Dopamine Agents|dopamine agents|mesh-ancestor
101554470|NCT01226043|Insulin Glargine|insulin glargine|mesh-list
101554471|NCT01226043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101554472|NCT01226043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554473|NCT01001377|Cetuximab|cetuximab|mesh-list
101554474|NCT01001377|Panitumumab|panitumumab|mesh-list
101554475|NCT01001377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101554476|NCT01001377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101554478|NCT01225887|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101554479|NCT01225887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101554480|NCT01225887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101554481|NCT01225887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101554482|NCT01225887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554483|NCT01296932|BI 836826|bi 836826|mesh-list
101554484|NCT01296932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101554485|NCT01296932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101554486|NCT01296698|Nicotine|nicotine|mesh-list
101554487|NCT01296698|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101554488|NCT01296698|Autonomic Agents|autonomic agents|mesh-ancestor
101554489|NCT01296698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101554490|NCT01296698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554491|NCT01296698|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101554492|NCT01296698|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101554493|NCT01296698|Cholinergic Agents|cholinergic agents|mesh-ancestor
101554494|NCT01296698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101554495|NCT01296698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554496|NCT01001221|Gemcitabine|gemcitabine|mesh-list
101554497|NCT01001221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101554498|NCT01001221|Antimetabolites|antimetabolites|mesh-ancestor
101554499|NCT01001221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554502|NCT01296152|Medroxyprogesterone|medroxyprogesterone|mesh-list
101554503|NCT01296152|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101554504|NCT01296152|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101554505|NCT01296152|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101554506|NCT01296152|Contraceptive Agents|contraceptive agents|mesh-ancestor
101554507|NCT01296152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101554508|NCT01296152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554509|NCT01296152|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101554510|NCT01296152|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101554511|NCT01296152|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101554512|NCT01296152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101554513|NCT01296152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101554514|NCT01002547|Vitamins|vitamins|mesh-list
101554515|NCT01002547|Vitamin E|vitamin e|mesh-list
101554516|NCT01002547|Tocopherols|tocopherols|mesh-list
101554517|NCT01002547|Tocotrienols|tocotrienols|mesh-list
101554518|NCT01002547|alpha-Tocopherol|alpha-tocopherol|mesh-list
101554519|NCT01002547|Pioglitazone|pioglitazone|mesh-list
101554520|NCT01002547|Micronutrients|micronutrients|mesh-ancestor
101554521|NCT01002547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554522|NCT01002547|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101554523|NCT01002547|Antioxidants|antioxidants|mesh-ancestor
101554524|NCT01002547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554525|NCT01002547|Protective Agents|protective agents|mesh-ancestor
101554526|NCT04295161|Abiraterone Acetate|abiraterone acetate|mesh-list
101554527|NCT04295161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101554528|NCT04295161|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101554529|NCT04295161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101554530|NCT04295161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554531|NCT04295161|Hormone Antagonists|hormone antagonists|mesh-ancestor
101554532|NCT04295161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101554533|NCT04295161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554534|NCT04295161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101554535|NCT04325659|Lofexidine|lofexidine|mesh-list
101945199|NCT01358734|Immunologic Factors|immunologic factors|mesh-ancestor
101945200|NCT01358734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945201|NCT01358734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101554536|NCT04325659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101554537|NCT04325659|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101554538|NCT04325659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554539|NCT04325659|Sensory System Agents|sensory system agents|mesh-ancestor
101554540|NCT04325659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101554541|NCT04325659|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101554542|NCT04325659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101554543|NCT04325659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101554544|NCT04325659|Adrenergic Agents|adrenergic agents|mesh-ancestor
101554545|NCT04325659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101554546|NCT04325659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554548|NCT01007149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101554549|NCT01007149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101554550|NCT01007149|Respiratory System Agents|respiratory system agents|mesh-ancestor
101554552|NCT04433767|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101554553|NCT04433767|Autonomic Agents|autonomic agents|mesh-ancestor
101554554|NCT04433767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101554555|NCT04433767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554556|NCT04433767|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101554557|NCT04433767|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101554558|NCT04433767|Cholinergic Agents|cholinergic agents|mesh-ancestor
101554559|NCT04433767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101554560|NCT04433767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554561|NCT00998335|Insulin|insulin|mesh-list
101554562|NCT00998335|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101554563|NCT00998335|Insulin Aspart|insulin aspart|mesh-list
101554564|NCT00998335|Insulin, Long-Acting|insulin, long-acting|mesh-list
101708509|NCT00856986|Metformin|metformin|mesh-list
101554565|NCT00998335|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101554566|NCT00998335|Insulin Detemir|insulin detemir|mesh-list
101554567|NCT00998335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101554568|NCT00998335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554569|NCT02871505|Penicillins|penicillins|mesh-list
101554570|NCT02871505|Penicillin G|penicillin g|mesh-list
101554571|NCT02871505|Penicillin G Benzathine|penicillin g benzathine|mesh-list
101554572|NCT02871505|Penicillin G Procaine|penicillin g procaine|mesh-list
101402975|NCT00346957|Growth Substances|growth substances|mesh-ancestor
101554580|NCT01294670|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101554581|NCT01294670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101554582|NCT01294670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554583|NCT01294670|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101554584|NCT01006603|Glimepiride|glimepiride|mesh-list
101554585|NCT01006603|Saxagliptin|saxagliptin|mesh-list
101554586|NCT01006603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101554587|NCT01006603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101554588|NCT01006603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554589|NCT01006603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101554590|NCT01006603|Immunologic Factors|immunologic factors|mesh-ancestor
101554591|NCT01006603|Incretins|incretins|mesh-ancestor
101554592|NCT01006603|Hormones|hormones|mesh-ancestor
101554593|NCT01006603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101554594|NCT01006603|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101554595|NCT01006603|Protease Inhibitors|protease inhibitors|mesh-ancestor
101554596|NCT01006603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101554597|NCT01006603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554598|NCT00997321|Ketamine|ketamine|mesh-list
101554599|NCT00997321|Propofol|propofol|mesh-list
101554600|NCT00997321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101554601|NCT00997321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101554602|NCT00997321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554603|NCT00997321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101554604|NCT00997321|Anesthetics, General|anesthetics, general|mesh-ancestor
101554605|NCT00997321|Anesthetics|anesthetics|mesh-ancestor
101554606|NCT00997321|Analgesics|analgesics|mesh-ancestor
101554607|NCT00997321|Sensory System Agents|sensory system agents|mesh-ancestor
101554608|NCT00997321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101554609|NCT00997321|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101554610|NCT00997321|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101554611|NCT00997321|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101945202|NCT01358734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101945203|NCT01358734|Growth Substances|growth substances|mesh-ancestor
101554612|NCT00997321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101554613|NCT00997321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554614|NCT01294592|Tamsulosin|tamsulosin|mesh-list
101554615|NCT01294592|Dutasteride|dutasteride|mesh-list
101554616|NCT01294592|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101554617|NCT01294592|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101554618|NCT01294592|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101554619|NCT01294592|Adrenergic Agents|adrenergic agents|mesh-ancestor
101554620|NCT01294592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101554621|NCT01294592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554622|NCT01294592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554623|NCT01294592|Urological Agents|urological agents|mesh-ancestor
101554624|NCT01294592|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101554625|NCT01294592|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101554626|NCT01294592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101554627|NCT01294592|Hormone Antagonists|hormone antagonists|mesh-ancestor
101554628|NCT01294592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101554629|NCT00997243|Azacitidine|azacitidine|mesh-list
101554630|NCT00997243|Lintuzumab|lintuzumab|mesh-list
101554631|NCT00997243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101554632|NCT00997243|Antimetabolites|antimetabolites|mesh-ancestor
101554633|NCT00997243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554634|NCT00997243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101708514|NCT00856986|Incretins|incretins|mesh-ancestor
101554635|NCT00997243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101554636|NCT00997243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101554637|NCT02869321|Fentanyl|fentanyl|mesh-list
101554638|NCT02869321|Morphine|morphine|mesh-list
101554639|NCT02869321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101554640|NCT02869321|Narcotics|narcotics|mesh-ancestor
101554647|NCT02869321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101554648|NCT02869321|Anesthetics, General|anesthetics, general|mesh-ancestor
101554649|NCT02869321|Anesthetics|anesthetics|mesh-ancestor
101554650|NCT01294436|Dapagliflozin|dapagliflozin|mesh-list
101554651|NCT01294436|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101554652|NCT01294436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554653|NCT01294436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101554654|NCT01294436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554655|NCT01294358|Gemcitabine|gemcitabine|mesh-list
101554656|NCT01294358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101554657|NCT01294358|Antimetabolites|antimetabolites|mesh-ancestor
101554658|NCT01294358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554659|NCT01294358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101554660|NCT01224639|Vaccines|vaccines|mesh-list
101554661|NCT01224639|Immunologic Factors|immunologic factors|mesh-ancestor
101554662|NCT01224639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554663|NCT01293968|Diphenhydramine|diphenhydramine|mesh-list
101554664|NCT01293968|Promethazine|promethazine|mesh-list
101554665|NCT01293968|Ibuprofen|ibuprofen|mesh-list
101554666|NCT01293968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101554667|NCT01293968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101554668|NCT01293968|Analgesics|analgesics|mesh-ancestor
101554669|NCT01293968|Sensory System Agents|sensory system agents|mesh-ancestor
101554670|NCT01293968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101554671|NCT01293968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554672|NCT01293968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101554673|NCT01293968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101554674|NCT01293968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101554675|NCT01293968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101554676|NCT01293968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554677|NCT01293968|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101554678|NCT01293968|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101554679|NCT01293968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101554680|NCT01293968|Anesthetics, Local|anesthetics, local|mesh-ancestor
101554681|NCT01293968|Anesthetics|anesthetics|mesh-ancestor
101554682|NCT01293968|Antiemetics|antiemetics|mesh-ancestor
101554683|NCT01293968|Autonomic Agents|autonomic agents|mesh-ancestor
101554684|NCT01293968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101554685|NCT01293968|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101554686|NCT01293968|Histamine Antagonists|histamine antagonists|mesh-ancestor
101554687|NCT01293968|Histamine Agents|histamine agents|mesh-ancestor
101554688|NCT01293968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101945204|NCT01358734|Growth Inhibitors|growth inhibitors|mesh-ancestor
101945205|NCT01358734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101945206|NCT01358734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101945207|NCT01358734|Antimetabolites|antimetabolites|mesh-ancestor
101789811|NCT00893256|Citalopram|citalopram|mesh-list
101554689|NCT01293968|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101554690|NCT01293968|Antipruritics|antipruritics|mesh-ancestor
101554691|NCT01293968|Dermatologic Agents|dermatologic agents|mesh-ancestor
101554692|NCT01293032|Tamoxifen|tamoxifen|mesh-list
101554693|NCT01293032|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101554694|NCT01293032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554695|NCT01293032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101554696|NCT01293032|Hormone Antagonists|hormone antagonists|mesh-ancestor
101554697|NCT01293032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101554698|NCT01293032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554699|NCT01293032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101554700|NCT01293032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101554701|NCT01293032|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101554702|NCT01293032|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101554703|NCT01293032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101554704|NCT01293032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101554705|NCT01293032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101554707|NCT01224171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101554708|NCT01223937|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101554709|NCT01223937|Hemostatics|hemostatics|mesh-ancestor
101554714|NCT01223235|Bevacizumab|bevacizumab|mesh-list
101554715|NCT01223235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101554716|NCT01223235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101554717|NCT01223235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101554718|NCT01223235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101554719|NCT01223235|Growth Substances|growth substances|mesh-ancestor
101554720|NCT01223235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554721|NCT01223235|Growth Inhibitors|growth inhibitors|mesh-ancestor
101554722|NCT00993967|Idebenone|idebenone|mesh-list
101554723|NCT00993967|Antioxidants|antioxidants|mesh-ancestor
101554724|NCT00993967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554725|NCT00993967|Protective Agents|protective agents|mesh-ancestor
101554726|NCT00993967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554727|NCT04204603|CKD-506|ckd-506|mesh-list
101554728|NCT04204603|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101554729|NCT04204603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101554730|NCT04204603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554731|NCT01222533|Tiotropium Bromide|tiotropium bromide|mesh-list
101554732|NCT01222533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101554733|NCT01222533|Autonomic Agents|autonomic agents|mesh-ancestor
101554734|NCT01222533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101554735|NCT01222533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554736|NCT01222533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101554737|NCT01222533|Respiratory System Agents|respiratory system agents|mesh-ancestor
101554738|NCT01222533|Parasympatholytics|parasympatholytics|mesh-ancestor
101554739|NCT01222533|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101554740|NCT01222533|Cholinergic Agents|cholinergic agents|mesh-ancestor
101554741|NCT01222533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101554742|NCT01222533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554743|NCT01221753|Carboplatin|carboplatin|mesh-list
101554744|NCT01221753|Docetaxel|docetaxel|mesh-list
101554745|NCT01221753|Fluorouracil|fluorouracil|mesh-list
101554746|NCT01221753|Cetuximab|cetuximab|mesh-list
101554747|NCT01221753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101554748|NCT01221753|Tubulin Modulators|tubulin modulators|mesh-ancestor
101554749|NCT01221753|Antimitotic Agents|antimitotic agents|mesh-ancestor
101554750|NCT01221753|Mitosis Modulators|mitosis modulators|mesh-ancestor
101554751|NCT01221753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554752|NCT01221753|Antimetabolites|antimetabolites|mesh-ancestor
101554753|NCT01221753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101554754|NCT01221753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101554755|NCT01221753|Immunologic Factors|immunologic factors|mesh-ancestor
101554756|NCT01221753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554757|NCT01221753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101554758|NCT02888223|Factor VIII|factor viii|mesh-list
101945208|NCT01358734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945209|NCT01358734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101945210|NCT03907215|Citalopram|citalopram|mesh-list
101789869|NCT00638690|Prednisone|prednisone|mesh-list
101554759|NCT02888223|Coagulants|coagulants|mesh-ancestor
101554760|NCT01014988|Zanamivir|zanamivir|mesh-list
101554761|NCT01014988|Antiviral Agents|antiviral agents|mesh-ancestor
101554762|NCT01014988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101554763|NCT01014988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101554764|NCT01014988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554765|NCT01019980|Acetaminophen|acetaminophen|mesh-list
101554766|NCT01019980|Diclofenac|diclofenac|mesh-list
101554767|NCT01019980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101554768|NCT01019980|Analgesics|analgesics|mesh-ancestor
101554769|NCT01019980|Sensory System Agents|sensory system agents|mesh-ancestor
101554770|NCT01019980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101554771|NCT01019980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554773|NCT01019980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101554774|NCT01019980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101554775|NCT01019980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101554776|NCT01019980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101554777|NCT01019980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101554778|NCT01019980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554780|NCT00993499|Afatinib|afatinib|mesh-list
101554781|NCT00993499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101554782|NCT00993499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101403189|NCT00426439|Artemether|artemether|mesh-list
101554791|NCT00993499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554793|NCT01014442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101554794|NCT01014442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101554795|NCT01014442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101554796|NCT01014442|Antitubercular Agents|antitubercular agents|mesh-ancestor
101554797|NCT01014442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101554798|NCT01014442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101554799|NCT01014442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101554800|NCT01014442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554801|NCT00996307|MF59 oil emulsion|mf59 oil emulsion|mesh-list
101554802|NCT00996307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101554803|NCT00996307|Immunologic Factors|immunologic factors|mesh-ancestor
101554804|NCT00996307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554805|NCT02869165|Estrogens|estrogens|mesh-list
101554806|NCT02869165|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101554807|NCT02869165|Hormones|hormones|mesh-ancestor
101554808|NCT02869165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101554809|NCT02869165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554810|NCT01219959|Icodextrin|icodextrin|mesh-list
101554811|NCT01219959|Dialysis Solutions|dialysis solutions|mesh-ancestor
101554812|NCT01219959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101554813|NCT00993421|Sibutramine|sibutramine|mesh-list
101554814|NCT00993421|Metoprolol|metoprolol|mesh-list
101554815|NCT00993421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101554816|NCT00993421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101554817|NCT00993421|Sympatholytics|sympatholytics|mesh-ancestor
101554818|NCT00993421|Autonomic Agents|autonomic agents|mesh-ancestor
101554819|NCT00993421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101554820|NCT00993421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554821|NCT00993421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101554822|NCT00993421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101554823|NCT00993421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101554824|NCT00993421|Adrenergic Agents|adrenergic agents|mesh-ancestor
101554825|NCT00993421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101554826|NCT00993421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554827|NCT00993421|Antidepressive Agents|antidepressive agents|mesh-ancestor
101554828|NCT00993421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101554829|NCT00993421|Appetite Depressants|appetite depressants|mesh-ancestor
101554830|NCT00993421|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101554831|NCT01014208|Rituximab|rituximab|mesh-list
101554832|NCT01014208|Ofatumumab|ofatumumab|mesh-list
101554833|NCT01014208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101554834|NCT01014208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101554835|NCT01014208|Immunologic Factors|immunologic factors|mesh-ancestor
101554836|NCT01014208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945211|NCT03907215|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101945212|NCT03907215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101789943|NCT00897312|Infliximab|infliximab|mesh-list
101554837|NCT01014208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101554838|NCT04205578|3-n-butylphthalide|3-n-butylphthalide|mesh-list
101554839|NCT04205578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101554840|NCT04205578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101554841|NCT04205578|Protective Agents|protective agents|mesh-ancestor
101554842|NCT04205578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554843|NCT00991939|Dexamethasone|dexamethasone|mesh-list
101554844|NCT00991939|Prednisone|prednisone|mesh-list
101516769|NCT00539331|Paclitaxel|paclitaxel|mesh-list
101554845|NCT00991939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101554846|NCT00991939|Antiemetics|antiemetics|mesh-ancestor
101554847|NCT00991939|Autonomic Agents|autonomic agents|mesh-ancestor
101403264|NCT00126360|Anastrozole|anastrozole|mesh-list
101554851|NCT00991939|Glucocorticoids|glucocorticoids|mesh-ancestor
101554852|NCT00991939|Hormones|hormones|mesh-ancestor
101554853|NCT00991939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101554854|NCT00991939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101554855|NCT00991939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101554856|NCT02868385|Praziquantel|praziquantel|mesh-list
101554857|NCT02868385|Anthelmintics|anthelmintics|mesh-ancestor
101554858|NCT02868385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101554859|NCT02868385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101554860|NCT00993265|Acetylcysteine|acetylcysteine|mesh-list
101554861|NCT00993265|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101554862|NCT00993265|Antiviral Agents|antiviral agents|mesh-ancestor
101554863|NCT00993265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101554864|NCT00993265|Expectorants|expectorants|mesh-ancestor
101554865|NCT00993265|Respiratory System Agents|respiratory system agents|mesh-ancestor
101554866|NCT00993265|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101554867|NCT00993265|Antioxidants|antioxidants|mesh-ancestor
101554868|NCT00993265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554869|NCT00993265|Protective Agents|protective agents|mesh-ancestor
101554870|NCT00993265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554871|NCT00993265|Antidotes|antidotes|mesh-ancestor
101554872|NCT00993031|Ritonavir|ritonavir|mesh-list
101554873|NCT00993031|Lopinavir|lopinavir|mesh-list
101554874|NCT00993031|Lamivudine|lamivudine|mesh-list
101554875|NCT00993031|Zidovudine|zidovudine|mesh-list
101554876|NCT00993031|Efavirenz|efavirenz|mesh-list
101554877|NCT00993031|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101554878|NCT00993031|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101554879|NCT00993031|Protease Inhibitors|protease inhibitors|mesh-ancestor
101554880|NCT00993031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101554881|NCT00993031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554882|NCT00993031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101554883|NCT00993031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101554884|NCT00993031|Antiviral Agents|antiviral agents|mesh-ancestor
101554885|NCT00993031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101708574|NCT05343299|Lidocaine|lidocaine|mesh-list
101554886|NCT00993031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101554887|NCT00993031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101554888|NCT00993031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101554889|NCT00993031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101554890|NCT00993031|Antimetabolites|antimetabolites|mesh-ancestor
101554891|NCT00993031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101554892|NCT00993031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101554893|NCT00993031|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101554894|NCT00993031|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101554895|NCT00993031|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101554896|NCT01010776|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101554897|NCT01010776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101554898|NCT01010776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101554899|NCT01010776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101554900|NCT01010776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554901|NCT01010776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101554902|NCT01010776|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101554903|NCT01010776|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101554904|NCT01010776|Serotonin Agents|serotonin agents|mesh-ancestor
101554905|NCT01010776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101554906|NCT01010776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554907|NCT01010776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101945213|NCT03907215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101945214|NCT03907215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945215|NCT03907215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101945217|NCT03907215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945218|NCT03907215|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101554908|NCT01010776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101554909|NCT01010776|Dopamine Agents|dopamine agents|mesh-ancestor
101554910|NCT04291729|Interferons|interferons|mesh-list
101554911|NCT04291729|Ritonavir|ritonavir|mesh-list
101554912|NCT04291729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101554913|NCT04291729|Antiviral Agents|antiviral agents|mesh-ancestor
101554914|NCT04291729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101554915|NCT04291729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101554916|NCT04291729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101554917|NCT04291729|Protease Inhibitors|protease inhibitors|mesh-ancestor
101554918|NCT04291729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101554923|NCT04291729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101554925|NCT02868931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101554926|NCT02868931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554927|NCT01018810|Interleukin-23|interleukin-23|mesh-list
101554928|NCT01018810|Antibodies|antibodies|mesh-list
101554929|NCT01018810|Immunoglobulins|immunoglobulins|mesh-list
101554930|NCT01018810|Immunologic Factors|immunologic factors|mesh-ancestor
101554931|NCT01018810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554932|NCT01018810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101554933|NCT01018810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101554934|NCT01018810|Growth Substances|growth substances|mesh-ancestor
101554935|NCT01018810|Growth Inhibitors|growth inhibitors|mesh-ancestor
101554936|NCT01018810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101554937|NCT02867917|Psyllium|psyllium|mesh-list
101554938|NCT02867917|Cathartics|cathartics|mesh-ancestor
101554939|NCT02867917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101554940|NCT01018732|Lactitol|lactitol|mesh-list
101554941|NCT01018732|Cathartics|cathartics|mesh-ancestor
101554942|NCT01018732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101554943|NCT01218867|Aldesleukin|aldesleukin|mesh-list
101554944|NCT01218867|Cyclophosphamide|cyclophosphamide|mesh-list
101554945|NCT01218867|Fludarabine|fludarabine|mesh-list
101554946|NCT01218867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101554947|NCT01218867|Immunologic Factors|immunologic factors|mesh-ancestor
101554948|NCT01218867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554949|NCT01218867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101554950|NCT01218867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101554951|NCT01218867|Alkylating Agents|alkylating agents|mesh-ancestor
101554952|NCT01218867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554953|NCT01218867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101554954|NCT01218867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101554955|NCT01218867|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101554956|NCT01218867|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101554957|NCT01218867|Antiviral Agents|antiviral agents|mesh-ancestor
101554958|NCT01218867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101554959|NCT01018264|Solifenacin Succinate|solifenacin succinate|mesh-list
101554960|NCT01018264|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101554961|NCT01018264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101554962|NCT01018264|Cholinergic Agents|cholinergic agents|mesh-ancestor
101554963|NCT01018264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101554964|NCT01018264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554965|NCT01018264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554966|NCT01018264|Urological Agents|urological agents|mesh-ancestor
101554967|NCT01018186|Fluticasone|fluticasone|mesh-list
101554968|NCT01018186|Xhance|xhance|mesh-list
101554969|NCT01018186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101554970|NCT01018186|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101554971|NCT01018186|Autonomic Agents|autonomic agents|mesh-ancestor
101554972|NCT01018186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101554973|NCT01018186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554974|NCT01018186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101554975|NCT01018186|Respiratory System Agents|respiratory system agents|mesh-ancestor
101554976|NCT01018186|Dermatologic Agents|dermatologic agents|mesh-ancestor
101945219|NCT03907215|Antidepressive Agents|antidepressive agents|mesh-ancestor
101945220|NCT03907215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101945221|NCT05335954|Norepinephrine|norepinephrine|mesh-list
101790095|NCT00988845|Indole-3-carbinol|indole-3-carbinol|mesh-list
101554977|NCT01018186|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101554978|NCT00992407|Risperidone|risperidone|mesh-list
101554979|NCT00992407|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101554980|NCT00992407|Serotonin Agents|serotonin agents|mesh-ancestor
101554981|NCT00992407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101554982|NCT00992407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554983|NCT00992407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554984|NCT00992407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101554985|NCT00992407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101554986|NCT00992407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101554987|NCT00992407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101554988|NCT00992407|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101554989|NCT00992407|Dopamine Agents|dopamine agents|mesh-ancestor
101554990|NCT00986245|Ropinirole|ropinirole|mesh-list
101554991|NCT00986245|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101555005|NCT00989833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555007|NCT00989833|Respiratory System Agents|respiratory system agents|mesh-ancestor
101555008|NCT00989833|Glucocorticoids|glucocorticoids|mesh-ancestor
101555009|NCT00989833|Hormones|hormones|mesh-ancestor
101555010|NCT00989833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101555011|NCT00989833|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101555012|NCT00989833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101555013|NCT00989833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101555014|NCT00989833|Adrenergic Agents|adrenergic agents|mesh-ancestor
101555015|NCT00989833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101555016|NCT00989833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555017|NCT00989833|Sympathomimetics|sympathomimetics|mesh-ancestor
101555018|NCT00989833|Tocolytic Agents|tocolytic agents|mesh-ancestor
101555019|NCT00989833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101555020|NCT04292119|Crizotinib|crizotinib|mesh-list
101555021|NCT04292119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101555022|NCT04292119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101555023|NCT04292119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101555024|NCT04292119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555025|NCT01218477|Dasatinib|dasatinib|mesh-list
101555026|NCT01218477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101555027|NCT01218477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101555028|NCT01218477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101555029|NCT01218477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555030|NCT01218009|Albuterol|albuterol|mesh-list
101555031|NCT01218009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101555032|NCT01218009|Autonomic Agents|autonomic agents|mesh-ancestor
101555033|NCT01218009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101555034|NCT01218009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555035|NCT01218009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101555036|NCT01218009|Respiratory System Agents|respiratory system agents|mesh-ancestor
101555037|NCT01218009|Tocolytic Agents|tocolytic agents|mesh-ancestor
101555038|NCT01218009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101555039|NCT01218009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101555040|NCT01218009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101555041|NCT01218009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101555042|NCT01218009|Adrenergic Agents|adrenergic agents|mesh-ancestor
101555043|NCT01218009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101555044|NCT01218009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555045|NCT02868151|Ascorbic Acid|ascorbic acid|mesh-list
101555046|NCT02868151|Vitamins|vitamins|mesh-ancestor
101555047|NCT02868151|Micronutrients|micronutrients|mesh-ancestor
101555048|NCT02868151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555049|NCT02868151|Antioxidants|antioxidants|mesh-ancestor
101555050|NCT02868151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555066|NCT01013740|Tubulin Modulators|tubulin modulators|mesh-ancestor
101555067|NCT01013740|Antimitotic Agents|antimitotic agents|mesh-ancestor
101555068|NCT01013740|Mitosis Modulators|mitosis modulators|mesh-ancestor
101555069|NCT01013740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101555070|NCT01013740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101555072|NCT01217073|Pioglitazone|pioglitazone|mesh-list
101555073|NCT01217073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101555074|NCT01217073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945222|NCT05335954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101945223|NCT05335954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101945224|NCT05335954|Adrenergic Agents|adrenergic agents|mesh-ancestor
101555076|NCT00985621|Tanezumab|tanezumab|mesh-list
101555077|NCT00985621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101555078|NCT00985621|Narcotics|narcotics|mesh-ancestor
101555079|NCT00985621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101555080|NCT00985621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555081|NCT00985621|Analgesics|analgesics|mesh-ancestor
101555082|NCT00985621|Sensory System Agents|sensory system agents|mesh-ancestor
101555083|NCT00985621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101555084|NCT01215981|Vaccines|vaccines|mesh-list
101555085|NCT01215981|Immunologic Factors|immunologic factors|mesh-ancestor
101555086|NCT01215981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555087|NCT01215435|Insulin|insulin|mesh-list
101555088|NCT01215435|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101555089|NCT01215435|Insulin Aspart|insulin aspart|mesh-list
101555090|NCT01215435|Insulin, Long-Acting|insulin, long-acting|mesh-list
101555091|NCT01215435|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101555092|NCT01215435|Biphasic Insulins|biphasic insulins|mesh-list
101555093|NCT01215435|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101555094|NCT01215435|Insulin, Isophane|insulin, isophane|mesh-list
101555095|NCT01215435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101555096|NCT01215435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555097|NCT01215357|Ecopipam|ecopipam|mesh-list
101555098|NCT01215357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101555099|NCT01215357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101708605|NCT02701673|Azacitidine|azacitidine|mesh-list
101555100|NCT01215357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101555101|NCT01215357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555102|NCT01215357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101555103|NCT01215357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101555104|NCT01215357|Dopamine Agents|dopamine agents|mesh-ancestor
101555105|NCT01215357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101555106|NCT01215357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555107|NCT01017874|Pemetrexed|pemetrexed|mesh-list
101555108|NCT01017874|Gefitinib|gefitinib|mesh-list
101555109|NCT01017874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101555110|NCT01017874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101555111|NCT01017874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403532|NCT00428311|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101555123|NCT00627952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555124|NCT00627952|Vasodilator Agents|vasodilator agents|mesh-ancestor
101555125|NCT00627952|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101555126|NCT00627952|Protease Inhibitors|protease inhibitors|mesh-ancestor
101555127|NCT00627952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101555129|NCT01009840|Busulfan|busulfan|mesh-list
101555130|NCT01009840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101555131|NCT01009840|Alkylating Agents|alkylating agents|mesh-ancestor
101555132|NCT01009840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555133|NCT01009840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101555134|NCT01009840|Immunologic Factors|immunologic factors|mesh-ancestor
101555135|NCT01009840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555136|NCT01009840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101555137|NCT01009840|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101555138|NCT04420936|Benzocaine|benzocaine|mesh-list
101555139|NCT04420936|Anesthetics, Local|anesthetics, local|mesh-ancestor
101555140|NCT04420936|Anesthetics|anesthetics|mesh-ancestor
101555141|NCT04420936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101555142|NCT04420936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555143|NCT04420936|Sensory System Agents|sensory system agents|mesh-ancestor
101555144|NCT04420936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101555145|NCT02872090|Glycopyrrolate|glycopyrrolate|mesh-list
101555146|NCT02872090|Tiotropium Bromide|tiotropium bromide|mesh-list
101555147|NCT02872090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101517060|NCT00547209|Anesthetics|anesthetics|mesh-ancestor
101555148|NCT02872090|Autonomic Agents|autonomic agents|mesh-ancestor
101555149|NCT02872090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101555150|NCT02872090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555151|NCT02872090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101555152|NCT02872090|Respiratory System Agents|respiratory system agents|mesh-ancestor
101555153|NCT02872090|Parasympatholytics|parasympatholytics|mesh-ancestor
101555154|NCT02872090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101945225|NCT05335954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101945226|NCT05335954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945227|NCT05335954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790227|NCT02591771|Mydriatics|mydriatics|mesh-ancestor
101555155|NCT02872090|Cholinergic Agents|cholinergic agents|mesh-ancestor
101555156|NCT02872090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101555157|NCT02872090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555158|NCT02872090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101555159|NCT02872090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101555161|NCT00982657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101555162|NCT00982657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101555163|NCT00982657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101555164|NCT00982657|Growth Substances|growth substances|mesh-ancestor
101555165|NCT00982657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555166|NCT00982657|Growth Inhibitors|growth inhibitors|mesh-ancestor
101555167|NCT00982657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101555168|NCT00982657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101555169|NCT00982657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555171|NCT02867839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101555172|NCT02867293|Anesthetics|anesthetics|mesh-list
101708615|NCT02701673|Alkylating Agents|alkylating agents|mesh-ancestor
101555173|NCT02867293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101555174|NCT02867293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555762|NCT01201785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101556044|NCT01307111|Misoprostol|misoprostol|mesh-list
101556045|NCT01307111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101556046|NCT01307111|Abortifacient Agents|abortifacient agents|mesh-ancestor
101556047|NCT01307111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101556048|NCT01307111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556049|NCT01307111|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101556050|NCT01307111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101556052|NCT01191801|Cytarabine|cytarabine|mesh-list
101556053|NCT01191801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101556054|NCT01191801|Antimetabolites|antimetabolites|mesh-ancestor
101556055|NCT01191801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556056|NCT01191801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101556057|NCT01191801|Antiviral Agents|antiviral agents|mesh-ancestor
101556058|NCT01191801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101556059|NCT01191801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101556060|NCT01191801|Immunologic Factors|immunologic factors|mesh-ancestor
101556061|NCT01191801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556062|NCT01306643|Idelalisib|idelalisib|mesh-list
101556063|NCT01306643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101556064|NCT01306643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101556065|NCT01306643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556066|NCT05656833|Cysteamine|cysteamine|mesh-list
101556067|NCT05656833|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
101556068|NCT05656833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556069|NCT01306331|Nonoxynol|nonoxynol|mesh-list
101556070|NCT01306331|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
101556319|NCT05927259|Parasympatholytics|parasympatholytics|mesh-ancestor
101556320|NCT05927259|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101556321|NCT05927259|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101556322|NCT05927259|Cholinergic Agents|cholinergic agents|mesh-ancestor
101556323|NCT05927259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101556489|NCT05920798|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101556490|NCT05920798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556517|NCT05835011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556518|NCT05835011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101556520|NCT05835011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101556521|NCT05798481|Acetylcysteine|acetylcysteine|mesh-list
101556522|NCT05798481|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101556523|NCT05798481|Antiviral Agents|antiviral agents|mesh-ancestor
101556524|NCT05798481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101556525|NCT05798481|Expectorants|expectorants|mesh-ancestor
101556526|NCT05798481|Respiratory System Agents|respiratory system agents|mesh-ancestor
101556527|NCT05798481|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101556528|NCT05798481|Antioxidants|antioxidants|mesh-ancestor
101556529|NCT05798481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945228|NCT05335954|Sympathomimetics|sympathomimetics|mesh-ancestor
101945229|NCT05335954|Autonomic Agents|autonomic agents|mesh-ancestor
101790298|NCT04035798|Dopamine Agents|dopamine agents|mesh-ancestor
101556530|NCT05798481|Protective Agents|protective agents|mesh-ancestor
101556531|NCT05798481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556532|NCT05798481|Antidotes|antidotes|mesh-ancestor
101556533|NCT05790486|Nicotine|nicotine|mesh-list
101556534|NCT05790486|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101556535|NCT05790486|Autonomic Agents|autonomic agents|mesh-ancestor
101556536|NCT05790486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101556537|NCT05790486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556538|NCT05790486|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101556539|NCT05790486|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101556540|NCT05790486|Cholinergic Agents|cholinergic agents|mesh-ancestor
101556541|NCT05790486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101405009|NCT00098384|Rifaximin|rifaximin|mesh-list
101556975|NCT04666038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556976|NCT04666038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101556977|NCT04666038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101556978|NCT04630158|Lubricant Eye Drops|lubricant eye drops|mesh-list
101556979|NCT04630158|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101556980|NCT04630158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101556981|NCT04617535|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
101556982|NCT04617535|Antiviral Agents|antiviral agents|mesh-ancestor
101556983|NCT04617535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101556984|NCT04613518|Deucravacitinib|deucravacitinib|mesh-list
101556985|NCT04613518|Dermatologic Agents|dermatologic agents|mesh-ancestor
101556986|NCT04613518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101556987|NCT04613518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101556988|NCT04613518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556990|NCT04592913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101556991|NCT04592913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101556992|NCT04511039|Trifluridine|trifluridine|mesh-list
101556993|NCT04511039|Talazoparib|talazoparib|mesh-list
101557129|NCT04207931|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101557130|NCT04170283|Tislelizumab|tislelizumab|mesh-list
101557131|NCT04170283|Zanubrutinib|zanubrutinib|mesh-list
101557132|NCT04170283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101557133|NCT04170283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557134|NCT04170283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101557135|NCT04170283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101557136|NCT04170283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557137|NCT04161755|Atezolizumab|atezolizumab|mesh-list
101557138|NCT04161755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101557139|NCT04161755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557140|NCT04161755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101557141|NCT04161755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557438|NCT02989584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101557439|NCT02989584|Antimetabolites|antimetabolites|mesh-ancestor
101628315|NCT00720109|Calcium, Dietary|calcium, dietary|mesh-list
101557561|NCT02538198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557562|NCT02506959|Gemcitabine|gemcitabine|mesh-list
101557563|NCT02506959|Melphalan|melphalan|mesh-list
101557564|NCT02506959|Busulfan|busulfan|mesh-list
101557565|NCT02506959|Mechlorethamine|mechlorethamine|mesh-list
101557566|NCT02506959|Panobinostat|panobinostat|mesh-list
101557567|NCT02506959|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
101406001|NCT00102674|Cangrelor|cangrelor|mesh-list
101557769|NCT01873326|Alkylating Agents|alkylating agents|mesh-ancestor
101557770|NCT01873326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101557771|NCT01867606|Immunoglobulins|immunoglobulins|mesh-list
101557772|NCT01867606|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101557773|NCT01867606|Antibodies|antibodies|mesh-list
101557774|NCT01867606|Immunologic Factors|immunologic factors|mesh-ancestor
101557775|NCT01867606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557776|NCT01864109|Cyclophosphamide|cyclophosphamide|mesh-list
101557777|NCT01864109|Temozolomide|temozolomide|mesh-list
101557778|NCT01864109|Ifosfamide|ifosfamide|mesh-list
101557779|NCT01864109|Doxorubicin|doxorubicin|mesh-list
101557780|NCT01864109|Irinotecan|irinotecan|mesh-list
101557782|NCT01864109|Vincristine|vincristine|mesh-list
101557783|NCT01864109|Dexrazoxane|dexrazoxane|mesh-list
101557784|NCT01864109|Razoxane|razoxane|mesh-list
101557785|NCT01864109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101557786|NCT01864109|Immunologic Factors|immunologic factors|mesh-ancestor
101557787|NCT01864109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557788|NCT01864109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101945230|NCT05335954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101557789|NCT01864109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101557790|NCT01864109|Alkylating Agents|alkylating agents|mesh-ancestor
101557791|NCT01864109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557792|NCT01864109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557793|NCT01864109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101557794|NCT01864109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101557795|NCT01864109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101557796|NCT01864109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101557797|NCT01864109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101557798|NCT01864109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101557799|NCT01864109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101558236|NCT01182207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101558237|NCT01182207|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101558238|NCT01182207|Hormone Antagonists|hormone antagonists|mesh-ancestor
101558239|NCT01182207|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101560797|NCT00605137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560798|NCT00606775|Carvedilol|carvedilol|mesh-list
101560799|NCT00606775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101560800|NCT00606775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101560801|NCT00606775|Adrenergic Agents|adrenergic agents|mesh-ancestor
101560802|NCT00606775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101560803|NCT00606775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560804|NCT00606775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560805|NCT00606775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101560806|NCT00606775|Antioxidants|antioxidants|mesh-ancestor
101560807|NCT00606775|Protective Agents|protective agents|mesh-ancestor
101560808|NCT00606775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101560809|NCT00606775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101560810|NCT00606775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101560811|NCT00606775|Vasodilator Agents|vasodilator agents|mesh-ancestor
101560812|NCT00606775|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101560813|NCT00606775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101560814|NCT00605371|Lamotrigine|lamotrigine|mesh-list
101560815|NCT00605371|Anticonvulsants|anticonvulsants|mesh-list
101560816|NCT00605371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101560817|NCT00605371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101560818|NCT00605371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560819|NCT00605371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101560820|NCT00605371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560821|NCT00605371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101560822|NCT00605371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101560823|NCT00605371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101560824|NCT00605371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101560825|NCT00605371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101560826|NCT01267994|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101560827|NCT01267994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101560828|NCT02850913|Doxycycline|doxycycline|mesh-list
101618632|NCT04203342|Ketoconazole|ketoconazole|mesh-list
101618633|NCT04203342|Antifungal Agents|antifungal agents|mesh-ancestor
101618634|NCT04203342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101618635|NCT04203342|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101618636|NCT04203342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101618637|NCT04203342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101618638|NCT04203342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618640|NCT04203342|Hormone Antagonists|hormone antagonists|mesh-ancestor
101618641|NCT04203342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101618642|NCT04203342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619006|NCT00833560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101619007|NCT00833560|Glucocorticoids|glucocorticoids|mesh-ancestor
101619008|NCT00833560|Hormones|hormones|mesh-ancestor
101619009|NCT00833560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101619010|NCT00833560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101619011|NCT04242927|Nicotinic Acids|nicotinic acids|mesh-list
101619013|NCT04242927|Niacinamide|niacinamide|mesh-list
101619014|NCT04242927|Vitamin B Complex|vitamin b complex|mesh-ancestor
101619015|NCT04242927|Vitamins|vitamins|mesh-ancestor
101619016|NCT04242927|Micronutrients|micronutrients|mesh-ancestor
101619017|NCT04242927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619018|NCT04242927|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101619019|NCT04242927|Antimetabolites|antimetabolites|mesh-ancestor
101945231|NCT05335954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101945232|NCT01250457|Timolol|timolol|mesh-list
101619020|NCT04242927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619021|NCT04242927|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101619022|NCT04242927|Vasodilator Agents|vasodilator agents|mesh-ancestor
101619023|NCT00887679|Escitalopram|escitalopram|mesh-list
101619024|NCT00887679|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101619025|NCT00887679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101619026|NCT00887679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101619027|NCT00887679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619028|NCT00887679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101619029|NCT00887679|Serotonin Agents|serotonin agents|mesh-ancestor
101619030|NCT00887679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619031|NCT04241523|Lenvatinib|lenvatinib|mesh-list
101619032|NCT04241523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101619033|NCT04241523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101619034|NCT04241523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101619035|NCT04241523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619036|NCT00833482|Ritonavir|ritonavir|mesh-list
101619037|NCT00833482|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101619038|NCT00833482|Voriconazole|voriconazole|mesh-list
101619039|NCT00833482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101619040|NCT00833482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101619041|NCT00833482|Protease Inhibitors|protease inhibitors|mesh-ancestor
101619042|NCT00833482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101619043|NCT00833482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619044|NCT00833482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101619045|NCT00833482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101619046|NCT00833482|Antiviral Agents|antiviral agents|mesh-ancestor
101619047|NCT00833482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101619048|NCT00833482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101619049|NCT00833482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101619050|NCT00833482|Antifungal Agents|antifungal agents|mesh-ancestor
101619051|NCT00833482|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101619053|NCT00833482|Hormone Antagonists|hormone antagonists|mesh-ancestor
101619054|NCT00833482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101619055|NCT00833482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619056|NCT00845182|Pioglitazone|pioglitazone|mesh-list
101619057|NCT00845182|Exenatide|exenatide|mesh-list
101619058|NCT00845182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101619059|NCT00845182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619060|NCT00845182|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101619061|NCT00845182|Incretins|incretins|mesh-ancestor
101619062|NCT00845182|Hormones|hormones|mesh-ancestor
101619063|NCT00845182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101619064|NCT00833248|Goserelin|goserelin|mesh-list
101619065|NCT00833248|Bicalutamide|bicalutamide|mesh-list
101619066|NCT00833248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101619067|NCT00833248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101619068|NCT00833248|Androgen Antagonists|androgen antagonists|mesh-ancestor
101619069|NCT00833248|Hormone Antagonists|hormone antagonists|mesh-ancestor
101619070|NCT00833248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101619071|NCT00833248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619072|NCT00702130|Pravastatin|pravastatin|mesh-list
101619073|NCT00702130|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101619074|NCT00702130|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101619075|NCT00702130|Antimetabolites|antimetabolites|mesh-ancestor
101619079|NCT00702130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101619080|NCT00823264|Charcoal|charcoal|mesh-list
101619081|NCT00823264|Antidotes|antidotes|mesh-ancestor
101619082|NCT00823264|Protective Agents|protective agents|mesh-ancestor
101619083|NCT00823264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619084|NCT04241211|Denosumab|denosumab|mesh-list
101619085|NCT04241211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101619086|NCT04241211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619087|NCT00702442|Droperidol|droperidol|mesh-list
101619088|NCT00702442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101619089|NCT00702442|Antiemetics|antiemetics|mesh-ancestor
101619090|NCT00702442|Autonomic Agents|autonomic agents|mesh-ancestor
101619091|NCT00702442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101619092|NCT00702442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619093|NCT00702442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101619094|NCT00702442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101945233|NCT01250457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101945234|NCT01250457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101945235|NCT01250457|Adrenergic Agents|adrenergic agents|mesh-ancestor
101619095|NCT00702442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101619096|NCT00702442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101619097|NCT00702442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101619098|NCT00702442|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101619099|NCT00702442|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101619100|NCT00702442|Dopamine Agents|dopamine agents|mesh-ancestor
101619101|NCT00702442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101619102|NCT00702442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619103|NCT02612272|Ketorolac|ketorolac|mesh-list
101619104|NCT02612272|Betamethasone|betamethasone|mesh-list
101619105|NCT02612272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101619106|NCT02612272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101619107|NCT02612272|Analgesics|analgesics|mesh-ancestor
101619108|NCT02612272|Sensory System Agents|sensory system agents|mesh-ancestor
101619109|NCT02612272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101619110|NCT02612272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619111|NCT02612272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101619112|NCT02612272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101619113|NCT02612272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101619114|NCT02612272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101619115|NCT02612272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619116|NCT02612272|Glucocorticoids|glucocorticoids|mesh-ancestor
101619117|NCT02612272|Hormones|hormones|mesh-ancestor
101619118|NCT02612272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101619119|NCT02612272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101619120|NCT02612272|Respiratory System Agents|respiratory system agents|mesh-ancestor
101619121|NCT00832624|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101619122|NCT00832624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101619123|NCT00832624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619124|NCT00832624|Incretins|incretins|mesh-ancestor
101619125|NCT00832624|Hormones|hormones|mesh-ancestor
101619126|NCT00832624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101619127|NCT00832624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101619128|NCT00832624|Protease Inhibitors|protease inhibitors|mesh-ancestor
101619129|NCT00832624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101619130|NCT00832624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619131|NCT00913120|Enoxaparin|enoxaparin|mesh-list
101619132|NCT00913120|Anticoagulants|anticoagulants|mesh-ancestor
101619133|NCT00913120|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101619134|NCT00913120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101619135|NCT00913120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619136|NCT00822172|Cilostazol|cilostazol|mesh-list
101619137|NCT00822172|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101619138|NCT00822172|Autonomic Agents|autonomic agents|mesh-ancestor
101619139|NCT00822172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101619140|NCT00822172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619141|NCT00822172|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101619142|NCT00822172|Respiratory System Agents|respiratory system agents|mesh-ancestor
101619143|NCT00822172|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101708670|NCT00506389|Histamine Agents|histamine agents|mesh-ancestor
101619144|NCT00822172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101417880|NCT00159081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101619152|NCT00822172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101619153|NCT00832000|Mexiletine|mexiletine|mesh-list
101619154|NCT00832000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101619155|NCT00832000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101619156|NCT00832000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101619157|NCT00832000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101619158|NCT00832000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619159|NCT04202952|Sofosbuvir|sofosbuvir|mesh-list
101619160|NCT04202952|Antiviral Agents|antiviral agents|mesh-ancestor
101619161|NCT04202952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101619162|NCT04054674|Salicylic Acid|salicylic acid|mesh-list
101619163|NCT04054674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101619164|NCT04054674|Antifungal Agents|antifungal agents|mesh-ancestor
101619165|NCT04054674|Keratolytic Agents|keratolytic agents|mesh-ancestor
101619166|NCT04054674|Dermatologic Agents|dermatologic agents|mesh-ancestor
101619167|NCT04166292|Lidocaine|lidocaine|mesh-list
101619168|NCT04166292|Anesthetics, Local|anesthetics, local|mesh-ancestor
101619169|NCT04166292|Anesthetics|anesthetics|mesh-ancestor
101945236|NCT01250457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101790588|NCT00629798|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101619170|NCT04166292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101619171|NCT04166292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619172|NCT04166292|Sensory System Agents|sensory system agents|mesh-ancestor
101619173|NCT04166292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101619174|NCT04166292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101619175|NCT04166292|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101619176|NCT04166292|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101619177|NCT04166292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101619178|NCT04166292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619179|NCT04099771|Ketamine|ketamine|mesh-list
101619180|NCT04099771|Analgesics|analgesics|mesh-ancestor
101619181|NCT04099771|Sensory System Agents|sensory system agents|mesh-ancestor
101619182|NCT04099771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101619183|NCT04099771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619184|NCT04099771|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101619185|NCT04099771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101619186|NCT04099771|Anesthetics, General|anesthetics, general|mesh-ancestor
101619187|NCT04099771|Anesthetics|anesthetics|mesh-ancestor
101619188|NCT04099771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101619189|NCT04099771|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101619190|NCT04099771|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101619191|NCT04099771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101619192|NCT04099771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619193|NCT00768469|Paclitaxel|paclitaxel|mesh-list
101619194|NCT00768469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101619195|NCT00768469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101619196|NCT00768469|Tubulin Modulators|tubulin modulators|mesh-ancestor
101619197|NCT00768469|Antimitotic Agents|antimitotic agents|mesh-ancestor
101619198|NCT00768469|Mitosis Modulators|mitosis modulators|mesh-ancestor
101619199|NCT00768469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619200|NCT02825121|Iodine|iodine|mesh-list
101619201|NCT02825121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101619202|NCT02825121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101619203|NCT02825121|Trace Elements|trace elements|mesh-ancestor
101619204|NCT02825121|Micronutrients|micronutrients|mesh-ancestor
101619205|NCT02825121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619206|NCT02825199|Caffeine|caffeine|mesh-list
101619207|NCT02825199|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101619208|NCT02825199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619209|NCT02825199|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101619210|NCT02825199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101619216|NCT02824965|Pembrolizumab|pembrolizumab|mesh-list
101619217|NCT02824965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101619218|NCT02824965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101619219|NCT02824965|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101619220|NCT02824965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619221|NCT00886743|Oprelvekin|oprelvekin|mesh-list
101619222|NCT00886743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101619223|NCT02826759|Insulin|insulin|mesh-list
101619224|NCT02826759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101619225|NCT02826759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619226|NCT02823951|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101619227|NCT02823951|Dermatologic Agents|dermatologic agents|mesh-ancestor
101619228|NCT02823951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101619229|NCT02823951|Immunologic Factors|immunologic factors|mesh-ancestor
101619230|NCT02823951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619231|NCT02826837|Bevacizumab|bevacizumab|mesh-list
101619232|NCT02826837|Cetuximab|cetuximab|mesh-list
101619233|NCT02826837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101619234|NCT02826837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101619235|NCT02826837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101619236|NCT02826837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101619237|NCT02826837|Growth Substances|growth substances|mesh-ancestor
101619238|NCT02826837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619239|NCT02826837|Growth Inhibitors|growth inhibitors|mesh-ancestor
101619240|NCT02822547|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101619241|NCT02822547|Antiviral Agents|antiviral agents|mesh-ancestor
101619242|NCT02822547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101619243|NCT02823483|Sunscreening Agents|sunscreening agents|mesh-list
101619244|NCT02823483|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101945237|NCT01250457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945238|NCT01250457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945239|NCT01250457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101945240|NCT01250457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101619245|NCT02823483|Protective Agents|protective agents|mesh-ancestor
101619246|NCT02823483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619247|NCT02823483|Dermatologic Agents|dermatologic agents|mesh-ancestor
101619248|NCT04848597|Paclitaxel|paclitaxel|mesh-list
101619249|NCT04848597|Antibodies|antibodies|mesh-list
101619250|NCT04848597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101619251|NCT04848597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101619252|NCT04848597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101619253|NCT04848597|Tubulin Modulators|tubulin modulators|mesh-ancestor
101619254|NCT04848597|Antimitotic Agents|antimitotic agents|mesh-ancestor
101619255|NCT04848597|Mitosis Modulators|mitosis modulators|mesh-ancestor
101619256|NCT04848597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619257|NCT04848597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619258|NCT04848597|Immunologic Factors|immunologic factors|mesh-ancestor
101619259|NCT05037045|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101619260|NCT05037045|Incretins|incretins|mesh-ancestor
101619261|NCT05037045|Hormones|hormones|mesh-ancestor
101619262|NCT05037045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101619263|NCT05037045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619264|NCT05660811|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
101619265|NCT02823405|Pembrolizumab|pembrolizumab|mesh-list
101619266|NCT02823405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101619267|NCT02823405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101619268|NCT02823405|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101619269|NCT02823405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619270|NCT02823249|Erythritol|erythritol|mesh-list
101619271|NCT02823249|Tryptophan|tryptophan|mesh-list
101619272|NCT02823249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101619273|NCT02823249|Antidepressive Agents|antidepressive agents|mesh-ancestor
101619274|NCT02823249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101619275|NCT02823249|Vasodilator Agents|vasodilator agents|mesh-ancestor
101619276|NCT00768079|Benralizumab|benralizumab|mesh-list
101619277|NCT00768079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101619278|NCT00768079|Respiratory System Agents|respiratory system agents|mesh-ancestor
101619279|NCT02603575|Caspofungin|caspofungin|mesh-list
101619280|NCT02603575|Sulfanilamide|sulfanilamide|mesh-list
101619302|NCT02601859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101619303|NCT02601859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619304|NCT02601859|Antimanic Agents|antimanic agents|mesh-ancestor
101619305|NCT02601859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101619306|NCT02601859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101619307|NCT02601859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619308|NCT02822157|Paclitaxel|paclitaxel|mesh-list
101619309|NCT02822157|Carboplatin|carboplatin|mesh-list
101619310|NCT02822157|Gemcitabine|gemcitabine|mesh-list
101619311|NCT02822157|Doxorubicin|doxorubicin|mesh-list
101619312|NCT02822157|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101619313|NCT02822157|Topotecan|topotecan|mesh-list
101619314|NCT02822157|Olaparib|olaparib|mesh-list
101619315|NCT02822157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101619316|NCT02822157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101619317|NCT02822157|Tubulin Modulators|tubulin modulators|mesh-ancestor
101619318|NCT02822157|Antimitotic Agents|antimitotic agents|mesh-ancestor
101619319|NCT02822157|Mitosis Modulators|mitosis modulators|mesh-ancestor
101619320|NCT02822157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619321|NCT02822157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101619322|NCT02822157|Antimetabolites|antimetabolites|mesh-ancestor
101619323|NCT02822157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101619324|NCT02822157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101619325|NCT02822157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101619326|NCT02822157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101619327|NCT02822157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101619328|NCT02822157|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101619329|NCT02822937|Triazolam|triazolam|mesh-list
101619330|NCT02822937|Methylphenidate|methylphenidate|mesh-list
101619331|NCT02822937|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101619332|NCT02822937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945242|NCT03902925|Ropivacaine|ropivacaine|mesh-list
101945243|NCT03902925|Anesthetics, Local|anesthetics, local|mesh-ancestor
101790732|NCT00927498|Cytarabine|cytarabine|mesh-list
101619333|NCT02822937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101619334|NCT02822937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101619356|NCT04200885|Hormones|hormones|mesh-ancestor
101619357|NCT04200885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101619358|NCT04200885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101619359|NCT04200885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101619360|NCT04200885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101619361|NCT04200885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101619362|NCT04200885|Analgesics|analgesics|mesh-ancestor
101619363|NCT04200885|Sensory System Agents|sensory system agents|mesh-ancestor
101619364|NCT04200885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101619365|NCT05659251|Paclitaxel|paclitaxel|mesh-list
101619366|NCT05659251|Carboplatin|carboplatin|mesh-list
101619367|NCT05659251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101619368|NCT05659251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101619369|NCT05659251|Tubulin Modulators|tubulin modulators|mesh-ancestor
101619370|NCT05659251|Antimitotic Agents|antimitotic agents|mesh-ancestor
101619371|NCT05659251|Mitosis Modulators|mitosis modulators|mesh-ancestor
101619372|NCT05659251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619373|NCT00766831|Hydromorphone|hydromorphone|mesh-list
101619374|NCT00766831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101619375|NCT00766831|Narcotics|narcotics|mesh-ancestor
101619376|NCT00766831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101619377|NCT00766831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619378|NCT00766831|Analgesics|analgesics|mesh-ancestor
101619379|NCT00766831|Sensory System Agents|sensory system agents|mesh-ancestor
101619380|NCT00766831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101619381|NCT02821689|Pirfenidone|pirfenidone|mesh-list
101619382|NCT02821689|Analgesics|analgesics|mesh-ancestor
101619383|NCT02821689|Sensory System Agents|sensory system agents|mesh-ancestor
101619384|NCT02821689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101619385|NCT02821689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619386|NCT02821689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101619387|NCT02821689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101619388|NCT02821689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101619405|NCT00766675|Sensory System Agents|sensory system agents|mesh-ancestor
101619406|NCT00766675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101619407|NCT00766675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619408|NCT00766675|Antipyretics|antipyretics|mesh-ancestor
101619409|NCT00766675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101619410|NCT00766675|Narcotics|narcotics|mesh-ancestor
101619411|NCT00766675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101619412|NCT02820441|Zopiclone|zopiclone|mesh-list
101619413|NCT02820441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101619414|NCT02820441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101619415|NCT02820441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619416|NCT02821377|Furosemide|furosemide|mesh-list
101619417|NCT02821377|Diuretics|diuretics|mesh-ancestor
101619418|NCT02821377|Natriuretic Agents|natriuretic agents|mesh-ancestor
101619419|NCT02821377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619420|NCT02821377|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101619421|NCT02821377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101619422|NCT02821377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619423|NCT02820987|Meropenem|meropenem|mesh-list
101619424|NCT02820987|Tazobactam|tazobactam|mesh-list
101619425|NCT02820987|Piperacillin|piperacillin|mesh-list
101619426|NCT02820987|Cefepime|cefepime|mesh-list
101619427|NCT02820987|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101619428|NCT02820987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101619429|NCT02820987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101619430|NCT02820987|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101619431|NCT02820987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101619432|NCT02820987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619433|NCT04052490|Salicylic Acid|salicylic acid|mesh-list
101619434|NCT04052490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101619435|NCT04052490|Antifungal Agents|antifungal agents|mesh-ancestor
101619436|NCT04052490|Keratolytic Agents|keratolytic agents|mesh-ancestor
101619437|NCT04052490|Dermatologic Agents|dermatologic agents|mesh-ancestor
101945245|NCT03902925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101790810|NCT00927654|Vasodilator Agents|vasodilator agents|mesh-ancestor
101619438|NCT00773383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101619439|NCT00773383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101619440|NCT00773383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101619441|NCT00773383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101619442|NCT00773383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619443|NCT02818881|Methamphetamine|methamphetamine|mesh-list
101619444|NCT02818881|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101619445|NCT02818881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619446|NCT02818881|Sympathomimetics|sympathomimetics|mesh-ancestor
101619447|NCT02818881|Autonomic Agents|autonomic agents|mesh-ancestor
101619448|NCT02818881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101619449|NCT02818881|Dopamine Agents|dopamine agents|mesh-ancestor
101619450|NCT02818881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101619451|NCT02818881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619456|NCT02818881|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101619458|NCT02818803|Miconazole|miconazole|mesh-list
101619459|NCT02818803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101619460|NCT02818803|Antifungal Agents|antifungal agents|mesh-ancestor
101619461|NCT02818803|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101619462|NCT02818803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101619463|NCT02818803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101619464|NCT02818803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619465|NCT02818803|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101619466|NCT02818803|Hormone Antagonists|hormone antagonists|mesh-ancestor
101619467|NCT02818803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101619468|NCT02818803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619469|NCT02818803|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101619470|NCT02818803|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101619471|NCT02818725|Cisplatin|cisplatin|mesh-list
101619472|NCT02818725|Doxorubicin|doxorubicin|mesh-list
101619473|NCT02818725|Methotrexate|methotrexate|mesh-list
101619474|NCT02818725|Panitumumab|panitumumab|mesh-list
101619475|NCT02818725|Vinblastine|vinblastine|mesh-list
101619476|NCT02818725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101619477|NCT02818725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101619478|NCT02818725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101619479|NCT02818725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101619480|NCT02818725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101619481|NCT02818725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619482|NCT02818725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101619483|NCT02818725|Abortifacient Agents|abortifacient agents|mesh-ancestor
101619484|NCT02818725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101619485|NCT02818725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619486|NCT02818725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101619487|NCT02818725|Antimetabolites|antimetabolites|mesh-ancestor
101619488|NCT02818725|Dermatologic Agents|dermatologic agents|mesh-ancestor
101619489|NCT02818725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101619490|NCT02818725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101619491|NCT02818725|Immunologic Factors|immunologic factors|mesh-ancestor
101619492|NCT02818725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101619493|NCT02818725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101619494|NCT02818725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101619495|NCT02818725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101619496|NCT02818725|Tubulin Modulators|tubulin modulators|mesh-ancestor
101619497|NCT02818725|Antimitotic Agents|antimitotic agents|mesh-ancestor
101619498|NCT02818725|Mitosis Modulators|mitosis modulators|mesh-ancestor
101619499|NCT02820051|Lidocaine|lidocaine|mesh-list
101619500|NCT02820051|Midazolam|midazolam|mesh-list
101619501|NCT02820051|Nalbuphine|nalbuphine|mesh-list
101619502|NCT02820051|Propofol|propofol|mesh-list
101619503|NCT02820051|Anesthetics, Local|anesthetics, local|mesh-ancestor
101619504|NCT02820051|Anesthetics|anesthetics|mesh-ancestor
101619505|NCT02820051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101619506|NCT02820051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619507|NCT02820051|Sensory System Agents|sensory system agents|mesh-ancestor
101619508|NCT02820051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101619509|NCT02820051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101619510|NCT02820051|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101619511|NCT02820051|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101945246|NCT03902925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945247|NCT03902925|Sensory System Agents|sensory system agents|mesh-ancestor
101945248|NCT03902925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101945249|NCT03902925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101790880|NCT01075711|Prednisone|prednisone|mesh-list
101619512|NCT02820051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101619513|NCT02820051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619514|NCT02820051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101619515|NCT02820051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101619516|NCT02820051|Anesthetics, General|anesthetics, general|mesh-ancestor
101619517|NCT02820051|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101619518|NCT02820051|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101619519|NCT02820051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101619520|NCT02820051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101619527|NCT02817243|Simvastatin|simvastatin|mesh-list
101619528|NCT02817243|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101619529|NCT02817243|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101619530|NCT02817243|Antimetabolites|antimetabolites|mesh-ancestor
101619531|NCT02817243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619532|NCT02817243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101619533|NCT02817243|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101619534|NCT02817243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101619535|NCT00766363|Rivastigmine|rivastigmine|mesh-list
101619536|NCT00766363|Donepezil|donepezil|mesh-list
101619537|NCT00766363|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101619538|NCT00766363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101619539|NCT00766363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619540|NCT00766363|Cholinergic Agents|cholinergic agents|mesh-ancestor
101619541|NCT00766363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101619542|NCT00766363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619544|NCT00766363|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101619545|NCT00766363|Protective Agents|protective agents|mesh-ancestor
101619546|NCT02636946|Bimatoprost|bimatoprost|mesh-list
101619547|NCT02636946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101619548|NCT02819661|Morphine|morphine|mesh-list
101619549|NCT02819661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101619550|NCT02819661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619551|NCT02819661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101619552|NCT02819661|Narcotics|narcotics|mesh-ancestor
101619553|NCT02819661|Analgesics|analgesics|mesh-ancestor
101619554|NCT02819661|Sensory System Agents|sensory system agents|mesh-ancestor
101619555|NCT02819661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101619556|NCT00765817|Exenatide|exenatide|mesh-list
101619557|NCT00765817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101619558|NCT00765817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619559|NCT00765817|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101619560|NCT00765817|Incretins|incretins|mesh-ancestor
101619561|NCT00765817|Hormones|hormones|mesh-ancestor
101619562|NCT00765817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101619563|NCT02818491|Dexamethasone|dexamethasone|mesh-list
101619564|NCT02818491|Dexamethasone acetate|dexamethasone acetate|mesh-list
101619565|NCT02818491|Ropivacaine|ropivacaine|mesh-list
101619566|NCT02818491|BB 1101|bb 1101|mesh-list
101619567|NCT02818491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101619568|NCT02818491|Antiemetics|antiemetics|mesh-ancestor
101619569|NCT02818491|Autonomic Agents|autonomic agents|mesh-ancestor
101619570|NCT02818491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101619571|NCT02818491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619572|NCT02818491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101619573|NCT02818491|Glucocorticoids|glucocorticoids|mesh-ancestor
101619574|NCT02818491|Hormones|hormones|mesh-ancestor
101276617|NCT01870648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101619575|NCT02818491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101619576|NCT02818491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101619577|NCT02818491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101619578|NCT02818491|Protease Inhibitors|protease inhibitors|mesh-ancestor
101619579|NCT02818491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101619580|NCT02818491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619581|NCT02818491|Anesthetics, Local|anesthetics, local|mesh-ancestor
101619582|NCT02818491|Anesthetics|anesthetics|mesh-ancestor
101619583|NCT02818491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101945250|NCT03902925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101619584|NCT02818491|Sensory System Agents|sensory system agents|mesh-ancestor
101619585|NCT02816853|Moxifloxacin|moxifloxacin|mesh-list
101619586|NCT02816853|Domperidone|domperidone|mesh-list
101619587|NCT02816853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101619588|NCT02816853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101619589|NCT02816853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101619590|NCT02816853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101619591|NCT02816853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101619592|NCT02816853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619596|NCT02816853|Autonomic Agents|autonomic agents|mesh-ancestor
101619597|NCT02816853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101619598|NCT02816853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101619599|NCT02816853|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101619600|NCT02816853|Dopamine Agents|dopamine agents|mesh-ancestor
101619601|NCT02816853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101619602|NCT00772603|Oxcarbazepine|oxcarbazepine|mesh-list
101619603|NCT00772603|Anticonvulsants|anticonvulsants|mesh-ancestor
101619604|NCT00772603|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101619605|NCT00772603|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101619606|NCT00772603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101619607|NCT00772603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619608|NCT00772603|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101619609|NCT00772603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101619610|NCT05658861|Caseins|caseins|mesh-list
101619611|NCT05658861|Chelating Agents|chelating agents|mesh-ancestor
101619612|NCT05658861|Sequestering Agents|sequestering agents|mesh-ancestor
101619613|NCT05658861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619614|NCT00772447|Vancomycin|vancomycin|mesh-list
101619615|NCT00772447|Daptomycin|daptomycin|mesh-list
101619616|NCT00772447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101619617|NCT00772447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101619619|NCT04238169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101619620|NCT04238169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101619621|NCT04238169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101619622|NCT04238169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101619623|NCT04238169|Growth Substances|growth substances|mesh-ancestor
101619624|NCT04238169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619625|NCT04238169|Growth Inhibitors|growth inhibitors|mesh-ancestor
101619626|NCT00831844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101619627|NCT00831844|Immunologic Factors|immunologic factors|mesh-ancestor
101619628|NCT00831844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619629|NCT00764881|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
101619630|NCT00764881|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
101619631|NCT00764881|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101619632|NCT00764881|Contraceptive Agents|contraceptive agents|mesh-ancestor
101619633|NCT00764881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101619634|NCT00764881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619635|NCT00764881|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101619636|NCT00764881|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101619637|NCT00764881|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101619638|NCT00764881|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101619639|NCT00764881|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101619640|NCT00764881|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
101619641|NCT00764881|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101619642|NCT00764881|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101619643|NCT00702676|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101619644|NCT00702676|Antidepressive Agents|antidepressive agents|mesh-ancestor
101619645|NCT00702676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101619646|NCT00702676|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101619647|NCT00702676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101619648|NCT00702676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101619649|NCT00702676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619650|NCT02817477|Ketamine|ketamine|mesh-list
101619651|NCT02817477|Morphine|morphine|mesh-list
101619652|NCT02817477|Analgesics|analgesics|mesh-ancestor
101619653|NCT02817477|Sensory System Agents|sensory system agents|mesh-ancestor
101619654|NCT02817477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101619655|NCT02817477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619656|NCT02817477|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101619657|NCT02817477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101619658|NCT02817477|Anesthetics, General|anesthetics, general|mesh-ancestor
101945251|NCT03902925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101945252|NCT03902925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101945253|NCT03902925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619659|NCT02817477|Anesthetics|anesthetics|mesh-ancestor
101619660|NCT02817477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101619661|NCT02817477|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101619662|NCT02817477|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101619663|NCT02817477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101619672|NCT04099069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619673|NCT02816151|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101619674|NCT02816151|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101619675|NCT02816151|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101619676|NCT02816151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101619677|NCT02816151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619678|NCT02816151|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101619679|NCT02816151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101708722|NCT00668096|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101619680|NCT02816151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619681|NCT02816151|Cholinergic Agents|cholinergic agents|mesh-ancestor
101619682|NCT02816151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101619683|NCT04101019|Lidocaine|lidocaine|mesh-list
101619684|NCT04101019|Anesthetics, Local|anesthetics, local|mesh-ancestor
101619685|NCT04101019|Anesthetics|anesthetics|mesh-ancestor
101619686|NCT04101019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101619687|NCT04101019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619688|NCT04101019|Sensory System Agents|sensory system agents|mesh-ancestor
101619689|NCT04101019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101619690|NCT04101019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101619691|NCT04101019|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101619692|NCT04101019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101619693|NCT04101019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101619694|NCT04101019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619696|NCT02817321|Ropivacaine|ropivacaine|mesh-list
101619697|NCT02817321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101619698|NCT02817321|Narcotics|narcotics|mesh-ancestor
101619699|NCT02817321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101619700|NCT02817321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619701|NCT02817321|Analgesics|analgesics|mesh-ancestor
101619702|NCT02817321|Sensory System Agents|sensory system agents|mesh-ancestor
101619703|NCT02817321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101619704|NCT02817321|Anesthetics, Local|anesthetics, local|mesh-ancestor
101619705|NCT02817321|Anesthetics|anesthetics|mesh-ancestor
101619706|NCT00844480|Zoledronic Acid|zoledronic acid|mesh-list
101619707|NCT00844480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101619708|NCT00844480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619709|NCT00771901|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
101619710|NCT00771901|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
101619711|NCT00771901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101619712|NCT00771901|Antiviral Agents|antiviral agents|mesh-ancestor
101619713|NCT00771901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101619714|NCT00771901|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101619715|NCT00771901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101619716|NCT00705562|Caseins|caseins|mesh-list
101619717|NCT00705562|Chelating Agents|chelating agents|mesh-ancestor
101619718|NCT00705562|Sequestering Agents|sequestering agents|mesh-ancestor
101619719|NCT00705562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619720|NCT00843856|Mycophenolic Acid|mycophenolic acid|mesh-list
101619721|NCT00843856|Tacrolimus|tacrolimus|mesh-list
101619722|NCT00843856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101619723|NCT00843856|Immunologic Factors|immunologic factors|mesh-ancestor
101619724|NCT00843856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619725|NCT00843856|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101619726|NCT00843856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101619727|NCT00843856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619728|NCT00843856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101619729|NCT00843856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101619730|NCT00843856|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101619740|NCT00705640|Freund's Adjuvant|freund's adjuvant|mesh-list
101619741|NCT00705640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101619742|NCT00705640|Immunologic Factors|immunologic factors|mesh-ancestor
101619743|NCT00705640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945254|NCT01250535|Warfarin|warfarin|mesh-list
101945255|NCT01250535|Lovastatin|lovastatin|mesh-list
101945256|NCT01250535|L 647318|l 647318|mesh-list
101945257|NCT01250535|Dihydromevinolin|dihydromevinolin|mesh-list
101945258|NCT01250535|Anticoagulants|anticoagulants|mesh-ancestor
101945259|NCT01250535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101619744|NCT00705796|Methyltestosterone|methyltestosterone|mesh-list
101619745|NCT00705796|Testosterone|testosterone|mesh-list
101619746|NCT00705796|Testosterone undecanoate|testosterone undecanoate|mesh-list
101619747|NCT00705796|Testosterone enanthate|testosterone enanthate|mesh-list
101619748|NCT00705796|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101619749|NCT00705796|Androgens|androgens|mesh-ancestor
101619750|NCT00705796|Hormones|hormones|mesh-ancestor
101619751|NCT00705796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101619752|NCT00705796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619753|NCT00705796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101619754|NCT00705796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101619755|NCT00705796|Anabolic Agents|anabolic agents|mesh-ancestor
101619756|NCT00843778|Certolizumab Pegol|certolizumab pegol|mesh-list
101619757|NCT00843778|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101619758|NCT00843778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101619759|NCT00843778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101619760|NCT00843778|Immunologic Factors|immunologic factors|mesh-ancestor
101619761|NCT00843778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619762|NCT00843778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101619763|NCT05631249|Sotorasib|sotorasib|mesh-list
101619764|NCT05631249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101619765|NCT05631249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619766|NCT05631249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101619767|NCT05631249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101619768|NCT05629923|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
101619769|NCT05629923|Antiviral Agents|antiviral agents|mesh-ancestor
101619770|NCT05629923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101619771|NCT00820222|Capecitabine|capecitabine|mesh-list
101619772|NCT00820222|Trastuzumab|trastuzumab|mesh-list
101619773|NCT00820222|Lapatinib|lapatinib|mesh-list
101619774|NCT00820222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101619775|NCT00820222|Antimetabolites|antimetabolites|mesh-ancestor
101619776|NCT00820222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619777|NCT00820222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101619778|NCT00820222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101619779|NCT00820222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101619780|NCT00820222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101619781|NCT02815449|Iron|iron|mesh-list
101619782|NCT02815449|Trace Elements|trace elements|mesh-ancestor
101619783|NCT02815449|Micronutrients|micronutrients|mesh-ancestor
101619784|NCT02815449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619785|NCT01039688|Antirheumatic Agents|antirheumatic agents|mesh-list
101619786|NCT01039688|Tofacitinib|tofacitinib|mesh-list
101619787|NCT01039688|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101619788|NCT01039688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101619789|NCT01039688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101619790|NCT01039688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619791|NCT02237508|Budesonide|budesonide|mesh-list
101619792|NCT02237508|Formoterol Fumarate|formoterol fumarate|mesh-list
101619793|NCT02237508|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101619794|NCT02237508|Charcoal|charcoal|mesh-list
101619795|NCT02237508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101619796|NCT02237508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101619802|NCT02237508|Glucocorticoids|glucocorticoids|mesh-ancestor
101619803|NCT02237508|Hormones|hormones|mesh-ancestor
101619804|NCT02237508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101619805|NCT02237508|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101619806|NCT02237508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101619807|NCT02237508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101619808|NCT02237508|Adrenergic Agents|adrenergic agents|mesh-ancestor
101619809|NCT02237508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101619810|NCT02237508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619811|NCT02237508|Antidotes|antidotes|mesh-ancestor
101619812|NCT02237508|Protective Agents|protective agents|mesh-ancestor
101619813|NCT02809755|Lidocaine|lidocaine|mesh-list
101619814|NCT02809755|Anesthetics, Local|anesthetics, local|mesh-ancestor
101945260|NCT01250535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101945261|NCT01250535|Antimetabolites|antimetabolites|mesh-ancestor
101945262|NCT01250535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791160|NCT00907452|Dexamethasone|dexamethasone|mesh-list
101619815|NCT02809755|Anesthetics|anesthetics|mesh-ancestor
101619816|NCT02809755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101619817|NCT02809755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619818|NCT02809755|Sensory System Agents|sensory system agents|mesh-ancestor
101619819|NCT02809755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101619820|NCT02809755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101619821|NCT02809755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101619822|NCT02809755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101619823|NCT02809755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101619824|NCT02809755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619825|NCT02812719|Salicylic Acid|salicylic acid|mesh-list
101619826|NCT02812719|Salicylates|salicylates|mesh-list
101619827|NCT02812719|Glycolic acid|glycolic acid|mesh-list
101619828|NCT02812719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101619829|NCT02812719|Antifungal Agents|antifungal agents|mesh-ancestor
101619830|NCT02812719|Keratolytic Agents|keratolytic agents|mesh-ancestor
101619831|NCT02812719|Dermatologic Agents|dermatologic agents|mesh-ancestor
101619832|NCT02812719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101619833|NCT02812719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101619834|NCT02812719|Analgesics|analgesics|mesh-ancestor
101619835|NCT02812719|Sensory System Agents|sensory system agents|mesh-ancestor
101619836|NCT02812719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101619837|NCT02812719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619838|NCT02812719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101619839|NCT02812719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101619840|NCT02812719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101619841|NCT02812719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101619842|NCT02812719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619843|NCT02876978|Cyclophosphamide|cyclophosphamide|mesh-list
101619844|NCT02876978|Fludarabine|fludarabine|mesh-list
101619845|NCT02876978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101619846|NCT02876978|Immunologic Factors|immunologic factors|mesh-ancestor
101619847|NCT02876978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619848|NCT02876978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101619849|NCT02876978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101619850|NCT02876978|Alkylating Agents|alkylating agents|mesh-ancestor
101619851|NCT02876978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619852|NCT02876978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101619853|NCT02876978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101619854|NCT00909480|Insulin|insulin|mesh-list
101619855|NCT00909480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101619856|NCT00909480|Insulin Glargine|insulin glargine|mesh-list
101619857|NCT00909480|Insulin Detemir|insulin detemir|mesh-list
101619858|NCT00909480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101619859|NCT00909480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619860|NCT05642715|Varenicline|varenicline|mesh-list
101619861|NCT05642715|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101619862|NCT05642715|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101619863|NCT05642715|Cholinergic Agents|cholinergic agents|mesh-ancestor
101619864|NCT05642715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101619865|NCT05642715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619870|NCT02874326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101619871|NCT02812641|Bevacizumab|bevacizumab|mesh-list
101619873|NCT02812641|Fluorouracil|fluorouracil|mesh-list
101619874|NCT02812641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101619875|NCT02812641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101619876|NCT02812641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101619877|NCT02812641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101619878|NCT02812641|Growth Substances|growth substances|mesh-ancestor
101619879|NCT02812641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619880|NCT02812641|Growth Inhibitors|growth inhibitors|mesh-ancestor
101619881|NCT02812641|Antimetabolites|antimetabolites|mesh-ancestor
101619882|NCT02812641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619883|NCT02812641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101619884|NCT02812641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101619885|NCT02812641|Immunologic Factors|immunologic factors|mesh-ancestor
101945263|NCT01250535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101945264|NCT01250535|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101619886|NCT01058096|Cariprazine|cariprazine|mesh-list
101619887|NCT01058096|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101619888|NCT01058096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101619889|NCT01058096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101619890|NCT01058096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619891|NCT01058096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101619892|NCT00626990|Temozolomide|temozolomide|mesh-list
101619893|NCT00626990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101619894|NCT00626990|Alkylating Agents|alkylating agents|mesh-ancestor
101619895|NCT00626990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619896|NCT00626990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101619897|NCT01057862|Naltrexone|naltrexone|mesh-list
101619898|NCT01057862|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101619899|NCT01057862|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101619900|NCT01057862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619901|NCT01057862|Sensory System Agents|sensory system agents|mesh-ancestor
101619902|NCT01057862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101619903|NCT01038128|Memantine|memantine|mesh-list
101619904|NCT01038128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101619905|NCT01038128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101619906|NCT01038128|Dopamine Agents|dopamine agents|mesh-ancestor
101619907|NCT01038128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101619908|NCT01038128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619909|NCT01038128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619910|NCT01038128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101619911|NCT01038128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101619912|NCT04303520|Cyclophosphamide|cyclophosphamide|mesh-list
101619913|NCT04303520|Fludarabine|fludarabine|mesh-list
101619914|NCT04303520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101619915|NCT04303520|Immunologic Factors|immunologic factors|mesh-ancestor
101619916|NCT04303520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619917|NCT04303520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101619918|NCT04303520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101619919|NCT04303520|Alkylating Agents|alkylating agents|mesh-ancestor
101619920|NCT04303520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619921|NCT04303520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101619922|NCT04303520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101619923|NCT02562378|Doxorubicin|doxorubicin|mesh-list
101619924|NCT02562378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101619925|NCT02562378|Trastuzumab|trastuzumab|mesh-list
101619926|NCT02562378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101619927|NCT02562378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101619928|NCT02562378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101619929|NCT02562378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101619930|NCT02562378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101619931|NCT02562378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619932|NCT02562378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101619933|NCT00842530|Vaccines|vaccines|mesh-list
101619934|NCT00842530|Immunologic Factors|immunologic factors|mesh-ancestor
101619935|NCT00842530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619938|NCT05580510|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101619939|NCT05580510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101619940|NCT05580510|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101619941|NCT05580510|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101619942|NCT05580510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619943|NCT05580510|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101619944|NCT05580510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101619945|NCT05580510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619946|NCT02811627|Memantine|memantine|mesh-list
101619947|NCT02811627|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101619948|NCT02811627|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101619949|NCT02811627|Dopamine Agents|dopamine agents|mesh-ancestor
101619950|NCT02811627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101619951|NCT02811627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619952|NCT02811627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945266|NCT02527941|Metronidazole|metronidazole|mesh-list
101945267|NCT02527941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101945268|NCT02527941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101945269|NCT02527941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101791314|NCT00929370|Glycine|glycine|mesh-list
101619953|NCT02811627|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101619954|NCT02811627|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101619955|NCT00634413|Budesonide|budesonide|mesh-list
101619956|NCT00634413|Theophylline|theophylline|mesh-list
101619957|NCT00634413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101619958|NCT00634413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101619959|NCT00634413|Autonomic Agents|autonomic agents|mesh-ancestor
101619960|NCT00634413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101619961|NCT00634413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619962|NCT00634413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101619963|NCT00634413|Respiratory System Agents|respiratory system agents|mesh-ancestor
101619964|NCT00634413|Glucocorticoids|glucocorticoids|mesh-ancestor
101619965|NCT00634413|Hormones|hormones|mesh-ancestor
101619966|NCT00634413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101619967|NCT00634413|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101619968|NCT00634413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101619969|NCT00634413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619970|NCT00634413|Vasodilator Agents|vasodilator agents|mesh-ancestor
101619971|NCT00634413|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101619972|NCT00634413|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101619973|NCT00634413|Purinergic Agents|purinergic agents|mesh-ancestor
101619974|NCT00634413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101619975|NCT02815059|Prednisone|prednisone|mesh-list
101619976|NCT02815059|Dasatinib|dasatinib|mesh-list
101619977|NCT02815059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101619978|NCT02815059|Glucocorticoids|glucocorticoids|mesh-ancestor
101619979|NCT02815059|Hormones|hormones|mesh-ancestor
101619980|NCT02815059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101619981|NCT02815059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619982|NCT02815059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101619983|NCT02815059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101619984|NCT02815059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101619985|NCT02815059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101619986|NCT02815059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619988|NCT00819910|Fenofibrate|fenofibrate|mesh-list
101619989|NCT00819910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101619990|NCT00819910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619991|NCT00819910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101619992|NCT00819910|Antimetabolites|antimetabolites|mesh-ancestor
101619993|NCT00819910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619994|NCT00819910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101619995|NCT02808117|Micronutrients|micronutrients|mesh-list
101619996|NCT02808117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619997|NCT04321395|Vigabatrin|vigabatrin|mesh-list
101619998|NCT04321395|Anticonvulsants|anticonvulsants|mesh-ancestor
101619999|NCT04321395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101620000|NCT04321395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620001|NCT04321395|GABA Agents|gaba agents|mesh-ancestor
101620002|NCT04321395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101620003|NCT04321395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620004|NCT02814669|Atezolizumab|atezolizumab|mesh-list
101620005|NCT02814669|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
101620006|NCT02814669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101620007|NCT02814669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620011|NCT02808741|Antifungal Agents|antifungal agents|mesh-ancestor
101620012|NCT02808741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101620013|NCT02807727|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101620014|NCT02807727|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101620015|NCT02807727|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101620016|NCT02807727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101620018|NCT02807415|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101620019|NCT02807415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101620020|NCT02807415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620021|NCT02804841|Vitamin D|vitamin d|mesh-list
101620022|NCT02804841|Ergocalciferols|ergocalciferols|mesh-list
101945270|NCT02527941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101945272|NCT03906669|Letrozole|letrozole|mesh-list
101620024|NCT02804841|Vitamins|vitamins|mesh-list
101620025|NCT02804841|Micronutrients|micronutrients|mesh-ancestor
101620026|NCT02804841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620027|NCT02804841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101620028|NCT02804841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101620029|NCT00634491|Acetazolamide|acetazolamide|mesh-list
101620030|NCT00634491|Anticonvulsants|anticonvulsants|mesh-ancestor
101620031|NCT00634491|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101620032|NCT00634491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101620033|NCT00634491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620034|NCT00634491|Diuretics|diuretics|mesh-ancestor
101620035|NCT00634491|Natriuretic Agents|natriuretic agents|mesh-ancestor
101620036|NCT00634491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620037|NCT02807103|Cyclophosphamide|cyclophosphamide|mesh-list
101620038|NCT02807103|Rituximab|rituximab|mesh-list
101620039|NCT02807103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101620040|NCT02807103|Immunologic Factors|immunologic factors|mesh-ancestor
101620041|NCT02807103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620042|NCT02807103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101620043|NCT02807103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101620044|NCT02807103|Alkylating Agents|alkylating agents|mesh-ancestor
101620045|NCT02807103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620046|NCT02807103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101620047|NCT02807103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101620048|NCT02807103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101620049|NCT02806791|Lenograstim|lenograstim|mesh-list
101620050|NCT02806791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101620051|NCT02806791|Immunologic Factors|immunologic factors|mesh-ancestor
101620052|NCT02806791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620053|NCT00830128|Pregabalin|pregabalin|mesh-list
101620054|NCT00830128|Analgesics|analgesics|mesh-ancestor
101620055|NCT00830128|Sensory System Agents|sensory system agents|mesh-ancestor
101620056|NCT00830128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101620057|NCT00830128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620058|NCT00830128|Anticonvulsants|anticonvulsants|mesh-ancestor
101620059|NCT00830128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101620060|NCT00830128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101620061|NCT00830128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620062|NCT00830128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101620063|NCT00830128|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101620064|NCT00830128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101620065|NCT00830128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101620066|NCT00830128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101620067|NCT05498103|Methazolamide|methazolamide|mesh-list
101620068|NCT05498103|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101620069|NCT05498103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101620070|NCT05498103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620071|NCT05498103|Diuretics|diuretics|mesh-ancestor
101620072|NCT05498103|Natriuretic Agents|natriuretic agents|mesh-ancestor
101620073|NCT05498103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620074|NCT00771667|Ustekinumab|ustekinumab|mesh-list
101620075|NCT00771667|Dermatologic Agents|dermatologic agents|mesh-ancestor
101620076|NCT03893175|Acetaminophen|acetaminophen|mesh-list
101620077|NCT03893175|Ibuprofen|ibuprofen|mesh-list
101620078|NCT03893175|Oxycodone|oxycodone|mesh-list
101620079|NCT03893175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101620080|NCT03893175|Analgesics|analgesics|mesh-ancestor
101620094|NCT04236453|Tenofovir|tenofovir|mesh-list
101620095|NCT04236453|Emtricitabine|emtricitabine|mesh-list
101620096|NCT04236453|Darunavir|darunavir|mesh-list
101277146|NCT05855746|Colchicine|colchicine|mesh-list
101620097|NCT04236453|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101620098|NCT04236453|Cobicistat|cobicistat|mesh-list
101620099|NCT04236453|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
101620100|NCT04236453|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
101620101|NCT04236453|Antiviral Agents|antiviral agents|mesh-ancestor
101620102|NCT04236453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101620103|NCT04236453|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101620104|NCT04236453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101620105|NCT04236453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101945273|NCT03906669|Progesterone|progesterone|mesh-list
101945274|NCT03906669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101945275|NCT03906669|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101945276|NCT03906669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101945277|NCT03906669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101791450|NCT04087967|Immunologic Factors|immunologic factors|mesh-ancestor
101620106|NCT04236453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620107|NCT04236453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101620108|NCT04236453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101620109|NCT04236453|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101620110|NCT04236453|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101620111|NCT04236453|Protease Inhibitors|protease inhibitors|mesh-ancestor
101620112|NCT04236453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101620113|NCT04236453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101620114|NCT02807571|Anesthetics|anesthetics|mesh-list
101620115|NCT02807571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101620116|NCT02807571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620117|NCT05333250|Modafinil|modafinil|mesh-list
101620118|NCT05333250|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101620119|NCT05333250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620120|NCT05333250|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101620121|NCT05333250|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101620122|NCT05333250|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101620123|NCT05333250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620124|NCT05461339|Ranibizumab|ranibizumab|mesh-list
101620125|NCT05461339|Antibodies|antibodies|mesh-list
101620126|NCT05461339|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101620127|NCT05461339|Immunologic Factors|immunologic factors|mesh-ancestor
101620128|NCT05461339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620129|NCT05461339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101620130|NCT05461339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101620131|NCT05461339|Growth Substances|growth substances|mesh-ancestor
101620132|NCT05461339|Growth Inhibitors|growth inhibitors|mesh-ancestor
101620133|NCT05461339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101620135|NCT03409848|Ipilimumab|ipilimumab|mesh-list
101620136|NCT03409848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101620137|NCT03409848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101620138|NCT03409848|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101620139|NCT03409848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620141|NCT00763555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101620142|NCT00763555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620143|NCT00763555|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101620144|NCT00763555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101620145|NCT00763555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620146|NCT00763555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101620147|NCT00763555|Vitamins|vitamins|mesh-ancestor
101620148|NCT00763555|Micronutrients|micronutrients|mesh-ancestor
101620149|NCT00763555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101620150|NCT02804373|Oxytocin|oxytocin|mesh-list
101620151|NCT02804373|Oxytocics|oxytocics|mesh-ancestor
101620152|NCT02804373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101620153|NCT02804373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620154|NCT00763321|Acetaminophen|acetaminophen|mesh-list
101620155|NCT00763321|Hydrocodone|hydrocodone|mesh-list
101620156|NCT00763321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101620157|NCT00763321|Analgesics|analgesics|mesh-ancestor
101620158|NCT00763321|Sensory System Agents|sensory system agents|mesh-ancestor
101620159|NCT00763321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101620160|NCT00763321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620161|NCT00763321|Antipyretics|antipyretics|mesh-ancestor
101620162|NCT00763321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101620163|NCT00763321|Narcotics|narcotics|mesh-ancestor
101620164|NCT00763321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101620165|NCT00763321|Antitussive Agents|antitussive agents|mesh-ancestor
101620166|NCT00763321|Respiratory System Agents|respiratory system agents|mesh-ancestor
101620167|NCT02799927|Calcium|calcium|mesh-list
101620168|NCT02799927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101620169|NCT02799927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945278|NCT03906669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945279|NCT03906669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101945280|NCT03906669|Hormone Antagonists|hormone antagonists|mesh-ancestor
101620172|NCT00770653|Glimepiride|glimepiride|mesh-list
101620173|NCT00770653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101620174|NCT00770653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620175|NCT00770653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101620176|NCT00770653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101620177|NCT00770653|Immunologic Factors|immunologic factors|mesh-ancestor
101620178|NCT02799615|Infliximab|infliximab|mesh-list
101620179|NCT02799615|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101620180|NCT02799615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101620181|NCT02799615|Dermatologic Agents|dermatologic agents|mesh-ancestor
101620182|NCT02799615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101620183|NCT02799615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101620184|NCT00819052|Nevirapine|nevirapine|mesh-list
101620185|NCT00819052|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101620186|NCT00819052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101620187|NCT00819052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101620188|NCT00819052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620189|NCT00819052|Antiviral Agents|antiviral agents|mesh-ancestor
101620190|NCT00819052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101620191|NCT00819052|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101620192|NCT00819052|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101620193|NCT00819052|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101620194|NCT00819052|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101620195|NCT00763009|Dipyridamole|dipyridamole|mesh-list
101620196|NCT00763009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101620197|NCT00763009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101620198|NCT00763009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620199|NCT00763009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101620200|NCT00763009|Vasodilator Agents|vasodilator agents|mesh-ancestor
101620201|NCT02799459|Anesthetics|anesthetics|mesh-list
101620202|NCT02799459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101620203|NCT02799459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620204|NCT05477589|Cyclophosphamide|cyclophosphamide|mesh-list
101620205|NCT05477589|Melphalan|melphalan|mesh-list
101620206|NCT05477589|Busulfan|busulfan|mesh-list
101620207|NCT05477589|Fludarabine|fludarabine|mesh-list
101620208|NCT05477589|Clofarabine|clofarabine|mesh-list
101620209|NCT05477589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101620210|NCT05477589|Immunologic Factors|immunologic factors|mesh-ancestor
101620212|NCT05477589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101620213|NCT05477589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101620214|NCT05477589|Alkylating Agents|alkylating agents|mesh-ancestor
101620215|NCT05477589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620216|NCT05477589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101418936|NCT04727021|Rivaroxaban|rivaroxaban|mesh-list
101620224|NCT00841672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620225|NCT00841672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101620226|NCT00841672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620227|NCT00841672|Vasodilator Agents|vasodilator agents|mesh-ancestor
101620229|NCT05549115|Clarithromycin|clarithromycin|mesh-list
101620230|NCT05549115|Levofloxacin|levofloxacin|mesh-list
101620231|NCT05549115|Ofloxacin|ofloxacin|mesh-list
101620232|NCT05549115|Furazolidone|furazolidone|mesh-list
101620233|NCT05549115|Bismuth|bismuth|mesh-list
101620234|NCT05549115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101620235|NCT05549115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101620236|NCT05549115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101620237|NCT05549115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101620238|NCT05549115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620239|NCT05549115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101620240|NCT05549115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101620241|NCT05549115|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101620242|NCT05549115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101620243|NCT05549115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101620244|NCT05549115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101277291|NCT05853965|Venetoclax|venetoclax|mesh-list
101620245|NCT05549115|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101620246|NCT05549115|Antacids|antacids|mesh-ancestor
101945281|NCT03906669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101945282|NCT03906669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945283|NCT03906669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101620247|NCT05549115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101620248|NCT05549115|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101620249|NCT05549115|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
101620250|NCT05549115|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101620251|NCT05549115|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101620252|NCT05549115|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101620253|NCT04236219|Rasburicase|rasburicase|mesh-list
101620254|NCT04236219|Gout Suppressants|gout suppressants|mesh-ancestor
101620255|NCT04236219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101620256|NCT00908232|Dexamethasone|dexamethasone|mesh-list
101620257|NCT00908232|Cyclophosphamide|cyclophosphamide|mesh-list
101620258|NCT00908232|Lenalidomide|lenalidomide|mesh-list
101620259|NCT00908232|Bortezomib|bortezomib|mesh-list
101620260|NCT00908232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101620261|NCT00908232|Immunologic Factors|immunologic factors|mesh-ancestor
101620262|NCT00908232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620263|NCT00908232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101620264|NCT00908232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101620265|NCT00908232|Alkylating Agents|alkylating agents|mesh-ancestor
101620266|NCT00908232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620267|NCT00908232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101620268|NCT00908232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101620269|NCT00908232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101620270|NCT00908232|Antiemetics|antiemetics|mesh-ancestor
101620271|NCT00908232|Autonomic Agents|autonomic agents|mesh-ancestor
101620272|NCT00908232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101620273|NCT00908232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101620274|NCT00908232|Glucocorticoids|glucocorticoids|mesh-ancestor
101620275|NCT00908232|Hormones|hormones|mesh-ancestor
101620276|NCT00908232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101620277|NCT00908232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101620278|NCT00908232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101620279|NCT00908232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101620280|NCT00908232|Growth Substances|growth substances|mesh-ancestor
101620281|NCT00908232|Growth Inhibitors|growth inhibitors|mesh-ancestor
101620282|NCT00770341|Vancomycin|vancomycin|mesh-list
101620283|NCT00770341|Daptomycin|daptomycin|mesh-list
101620284|NCT00770341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101620298|NCT05472753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101620299|NCT05472753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620301|NCT05472753|Protective Agents|protective agents|mesh-ancestor
101620302|NCT05472753|Trace Elements|trace elements|mesh-ancestor
101620303|NCT05472753|Micronutrients|micronutrients|mesh-ancestor
101620304|NCT05472753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101620305|NCT05472753|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101620306|NCT03396276|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101620307|NCT03396276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101620308|NCT03396276|Narcotics|narcotics|mesh-ancestor
101620309|NCT03396276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101620310|NCT03396276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620311|NCT03396276|Analgesics|analgesics|mesh-ancestor
101620312|NCT03396276|Sensory System Agents|sensory system agents|mesh-ancestor
101620313|NCT03396276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101620314|NCT03396276|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101620315|NCT02799147|Fludarabine|fludarabine|mesh-list
101620316|NCT02799147|Fludarabine phosphate|fludarabine phosphate|mesh-list
101620317|NCT02799147|Busulfan|busulfan|mesh-list
101620318|NCT02799147|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101620319|NCT02799147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101620320|NCT02799147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101620321|NCT02799147|Antimetabolites|antimetabolites|mesh-ancestor
101620322|NCT02799147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620323|NCT02799147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101620324|NCT02799147|Immunologic Factors|immunologic factors|mesh-ancestor
101620325|NCT02799147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620326|NCT02799147|Alkylating Agents|alkylating agents|mesh-ancestor
101620327|NCT02799147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101620328|NCT02799147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101945284|NCT03906669|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101945285|NCT03906669|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101945286|NCT03906669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101945287|NCT03906669|Progestins|progestins|mesh-ancestor
101945288|NCT03906669|Hormones|hormones|mesh-ancestor
101945289|NCT01254825|Ropivacaine|ropivacaine|mesh-list
101945290|NCT01254825|Anesthetics, Local|anesthetics, local|mesh-ancestor
101945291|NCT01254825|Anesthetics|anesthetics|mesh-ancestor
101945292|NCT01254825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101620330|NCT02798913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101620331|NCT02798913|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101620332|NCT02798913|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101620333|NCT02798913|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101620334|NCT02798913|Purinergic Agents|purinergic agents|mesh-ancestor
101620335|NCT02798913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101620336|NCT02798913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620337|NCT02798913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620338|NCT00762463|Celecoxib|celecoxib|mesh-list
101620339|NCT00762463|Diclofenac|diclofenac|mesh-list
101620340|NCT00762463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101620341|NCT00762463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101620342|NCT00762463|Analgesics|analgesics|mesh-ancestor
101620343|NCT00762463|Sensory System Agents|sensory system agents|mesh-ancestor
101620344|NCT00762463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101620345|NCT00762463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620346|NCT00762463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101620347|NCT00762463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101620348|NCT00762463|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101620349|NCT00762463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101620350|NCT00762463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101620351|NCT00762463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620358|NCT05511909|Lofexidine|lofexidine|mesh-list
101620359|NCT05511909|Buspirone|buspirone|mesh-list
101620361|NCT05511909|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101620362|NCT05511909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101620363|NCT05511909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620364|NCT05511909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101620365|NCT05511909|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101620366|NCT05511909|Serotonin Agents|serotonin agents|mesh-ancestor
101620379|NCT00906282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101620380|NCT00906282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101620381|NCT00906282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620382|NCT00906282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101620383|NCT00906282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101620384|NCT02798757|Dapagliflozin|dapagliflozin|mesh-list
101620385|NCT02798757|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101620386|NCT02798757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620387|NCT02798757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101620388|NCT02798757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620389|NCT02798367|Melatonin|melatonin|mesh-list
101620390|NCT02798367|Antioxidants|antioxidants|mesh-ancestor
101620391|NCT02798367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620392|NCT02798367|Protective Agents|protective agents|mesh-ancestor
101620393|NCT02798367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620394|NCT02798367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101620395|NCT00762229|Ezetimibe|ezetimibe|mesh-list
101620396|NCT00762229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101620397|NCT00762229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101620398|NCT00762229|Antimetabolites|antimetabolites|mesh-ancestor
101620399|NCT00762229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620400|NCT00762229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101620401|NCT00907374|Benazepril|benazepril|mesh-list
101620402|NCT00907374|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101620403|NCT00907374|Protease Inhibitors|protease inhibitors|mesh-ancestor
101620404|NCT00907374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101945293|NCT01254825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945294|NCT01254825|Sensory System Agents|sensory system agents|mesh-ancestor
101620405|NCT00907374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620406|NCT00907374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101620407|NCT02805231|Vitamin D|vitamin d|mesh-list
101620408|NCT02805231|Vitamins|vitamins|mesh-ancestor
101620409|NCT02805231|Micronutrients|micronutrients|mesh-ancestor
101620410|NCT02805231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620411|NCT02805231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101620412|NCT03230604|Z 350|z 350|mesh-list
101620413|NCT03230604|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101620414|NCT03230604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101620415|NCT03230604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101620416|NCT03230604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620417|NCT03230604|Hormone Antagonists|hormone antagonists|mesh-ancestor
101620418|NCT03230604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101620419|NCT03230604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620420|NCT02798055|Bosentan|bosentan|mesh-list
101620421|NCT02798055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101620422|NCT02798055|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101620423|NCT02798055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620424|NCT05331768|Terlipressin|terlipressin|mesh-list
101620425|NCT05331768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101620426|NCT05331768|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101620427|NCT04235439|Insulin Lispro|insulin lispro|mesh-list
101620439|NCT02640222|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101620440|NCT02640222|Protease Inhibitors|protease inhibitors|mesh-ancestor
101620441|NCT02640222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101620442|NCT02640222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620443|NCT02640222|Anticoagulants|anticoagulants|mesh-ancestor
101620444|NCT02640222|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101620445|NCT02640222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101620446|NCT02640222|Hemostatics|hemostatics|mesh-ancestor
101620447|NCT02640222|Coagulants|coagulants|mesh-ancestor
101620448|NCT00818662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101620449|NCT00818662|Immunoglobulins|immunoglobulins|mesh-list
101620450|NCT00818662|Antibodies|antibodies|mesh-list
101620451|NCT00818662|gamma-Globulins|gamma-globulins|mesh-list
101620452|NCT00818662|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101620453|NCT00818662|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101620454|NCT00818662|Immunoglobulin G|immunoglobulin g|mesh-list
101620455|NCT00818662|Immunologic Factors|immunologic factors|mesh-ancestor
101620456|NCT00818662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620457|NCT03983031|Rituximab|rituximab|mesh-list
101620458|NCT03983031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101620459|NCT03983031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101620460|NCT03983031|Immunologic Factors|immunologic factors|mesh-ancestor
101620461|NCT03983031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620462|NCT03983031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101620463|NCT00703066|Vaccines|vaccines|mesh-list
101620464|NCT00703066|Immunologic Factors|immunologic factors|mesh-ancestor
101620465|NCT00703066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620466|NCT00762073|Budesonide|budesonide|mesh-list
101277516|NCT05531994|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101620467|NCT00762073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101620468|NCT00762073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101620469|NCT00762073|Autonomic Agents|autonomic agents|mesh-ancestor
101620470|NCT00762073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101620471|NCT00762073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620472|NCT00762073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101620473|NCT00762073|Respiratory System Agents|respiratory system agents|mesh-ancestor
101620474|NCT00762073|Glucocorticoids|glucocorticoids|mesh-ancestor
101620475|NCT00762073|Hormones|hormones|mesh-ancestor
101620476|NCT00762073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101620477|NCT03847857|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101620478|NCT03847857|Hemostatics|hemostatics|mesh-ancestor
101620479|NCT03847857|Coagulants|coagulants|mesh-ancestor
101620480|NCT02630628|Mycophenolic Acid|mycophenolic acid|mesh-list
101620481|NCT02630628|Tacrolimus|tacrolimus|mesh-list
101620482|NCT02630628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101620483|NCT02630628|Immunologic Factors|immunologic factors|mesh-ancestor
101620484|NCT02630628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620485|NCT02630628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101620486|NCT02630628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101945295|NCT01254825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101945296|NCT03906123|3-n-butylphthalide|3-n-butylphthalide|mesh-list
101945297|NCT03906123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101945298|NCT03906123|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101945299|NCT03906123|Protective Agents|protective agents|mesh-ancestor
101620487|NCT02630628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620488|NCT02630628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101620489|NCT02630628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101620490|NCT02630628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101620491|NCT02630628|Antitubercular Agents|antitubercular agents|mesh-ancestor
101620492|NCT02630628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101620493|NCT02630628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101620494|NCT00913588|Fluoxetine|fluoxetine|mesh-list
101419210|NCT00504946|Hormones|hormones|mesh-ancestor
101620498|NCT00913588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620499|NCT00913588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101620501|NCT00913588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620502|NCT00913588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101620503|NCT00913588|Antidepressive Agents|antidepressive agents|mesh-ancestor
101620504|NCT00913588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101620505|NCT00913588|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101620506|NCT00913588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101620507|NCT00913588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101620509|NCT02797587|Varenicline|varenicline|mesh-list
101620510|NCT02797587|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101620511|NCT02797587|Autonomic Agents|autonomic agents|mesh-ancestor
101620512|NCT02797587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101620513|NCT02797587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620514|NCT02797587|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101620515|NCT02797587|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101620516|NCT02797587|Cholinergic Agents|cholinergic agents|mesh-ancestor
101620517|NCT02797587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101620518|NCT02797587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620519|NCT00761605|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101620520|NCT00761605|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101620521|NCT00761605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101620522|NCT00761605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101620523|NCT00761605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620524|NCT00761605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101620525|NCT00761605|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101620526|NCT00761605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101620527|NCT00761605|Serotonin Agents|serotonin agents|mesh-ancestor
101620528|NCT00761605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101620529|NCT00761605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620530|NCT00761605|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101620531|NCT00761605|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101620532|NCT00761605|Dopamine Agents|dopamine agents|mesh-ancestor
101620533|NCT00761527|Desloratadine|desloratadine|mesh-list
101620534|NCT00761527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101620535|NCT00761527|Cholinergic Agents|cholinergic agents|mesh-ancestor
101620536|NCT00761527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101620537|NCT00761527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620538|NCT00761527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620539|NCT00761527|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101620540|NCT00761527|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101620541|NCT00761527|Histamine Antagonists|histamine antagonists|mesh-ancestor
101620542|NCT00761527|Histamine Agents|histamine agents|mesh-ancestor
101620543|NCT00770029|Botulinum Toxins|botulinum toxins|mesh-list
101620544|NCT00770029|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101620545|NCT00770029|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101620546|NCT00770029|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
101620547|NCT00770029|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101620548|NCT00770029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101620549|NCT00770029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620550|NCT00770029|Cholinergic Agents|cholinergic agents|mesh-ancestor
101620551|NCT00770029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101620552|NCT00770029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945300|NCT03906123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945301|NCT01341652|Molgramostim|molgramostim|mesh-list
101945302|NCT01341652|Sargramostim|sargramostim|mesh-list
101620553|NCT00770029|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101620554|NCT00770029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101620556|NCT04235985|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101620557|NCT04235985|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101620558|NCT04235985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101620559|NCT04235985|Disinfectants|disinfectants|mesh-ancestor
101620560|NCT04235985|Dermatologic Agents|dermatologic agents|mesh-ancestor
101620561|NCT00769561|Salicylic Acid|salicylic acid|mesh-list
101620562|NCT00769561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101620563|NCT00769561|Antifungal Agents|antifungal agents|mesh-ancestor
101620564|NCT00769561|Keratolytic Agents|keratolytic agents|mesh-ancestor
101620567|NCT02797041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101620569|NCT02794779|Oxytocics|oxytocics|mesh-ancestor
101620570|NCT02794779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101620571|NCT02794779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620572|NCT00761215|Tedizolid phosphate|tedizolid phosphate|mesh-list
101620573|NCT00761215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101620574|NCT00761215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101620575|NCT05805098|Cytarabine|cytarabine|mesh-list
101620576|NCT05805098|Venetoclax|venetoclax|mesh-list
101620577|NCT05805098|Homoharringtonine|homoharringtonine|mesh-list
101620578|NCT05805098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101620579|NCT05805098|Antimetabolites|antimetabolites|mesh-ancestor
101620580|NCT05805098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620581|NCT05805098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101620582|NCT05805098|Antiviral Agents|antiviral agents|mesh-ancestor
101620583|NCT05805098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101620585|NCT05805098|Immunologic Factors|immunologic factors|mesh-ancestor
101620586|NCT05805098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620587|NCT05805098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101620588|NCT05805098|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101620589|NCT05805098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101620590|NCT05804903|Fexofenadine|fexofenadine|mesh-list
101620591|NCT05804903|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101620592|NCT05804903|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101620593|NCT05804903|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101620594|NCT05804903|Histamine Antagonists|histamine antagonists|mesh-ancestor
101620595|NCT05804903|Histamine Agents|histamine agents|mesh-ancestor
101620596|NCT05804903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101620597|NCT05804903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620598|NCT05804903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620599|NCT05804734|Vitamin K|vitamin k|mesh-list
101620600|NCT05804734|Anticoagulants|anticoagulants|mesh-list
101620601|NCT05804734|Vitamins|vitamins|mesh-ancestor
101620602|NCT05804734|Micronutrients|micronutrients|mesh-ancestor
101620603|NCT05804734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620604|NCT05804734|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101620605|NCT05804734|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101620606|NCT05804734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620607|NCT05804734|Hemostatics|hemostatics|mesh-ancestor
101620608|NCT05804734|Coagulants|coagulants|mesh-ancestor
101620609|NCT05804721|Aripiprazole|aripiprazole|mesh-list
101620610|NCT05804721|Antidepressive Agents|antidepressive agents|mesh-ancestor
101620611|NCT05804721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101620612|NCT05804721|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101620613|NCT05804721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101620614|NCT05804721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101620615|NCT05804721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620616|NCT05804721|Dopamine Agonists|dopamine agonists|mesh-ancestor
101620617|NCT05804721|Dopamine Agents|dopamine agents|mesh-ancestor
101620618|NCT05804721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101620619|NCT05804721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620620|NCT05804721|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101620621|NCT05804721|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101620622|NCT05804721|Serotonin Agents|serotonin agents|mesh-ancestor
101620623|NCT05804721|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101620624|NCT05804721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101620625|NCT05804721|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101620626|NCT05804721|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101620627|NCT05804630|Lidocaine|lidocaine|mesh-list
101620628|NCT05804630|Anesthetics|anesthetics|mesh-list
101945303|NCT01341652|Immunologic Factors|immunologic factors|mesh-ancestor
101945304|NCT01341652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945305|NCT01341652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101945306|NCT03563794|Insulin Lispro|insulin lispro|mesh-list
101945307|NCT03563794|Vildagliptin|vildagliptin|mesh-list
101620629|NCT05804630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101620630|NCT05804630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620631|NCT05804630|Anesthetics, Local|anesthetics, local|mesh-ancestor
101620632|NCT05804630|Sensory System Agents|sensory system agents|mesh-ancestor
101620633|NCT05804630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101620634|NCT05804630|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101620635|NCT05804630|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101620636|NCT05804630|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101620637|NCT05804630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101620638|NCT05804630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620642|NCT05804591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101620643|NCT05804591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620644|NCT05804591|Anticonvulsants|anticonvulsants|mesh-ancestor
101620645|NCT05804591|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101620646|NCT05804591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101620647|NCT05804591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620648|NCT05804591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101620649|NCT05804591|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101620650|NCT05804591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101620651|NCT05804591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101620652|NCT05804591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101620653|NCT05804370|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101620654|NCT05804370|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101620655|NCT05804370|Dermatologic Agents|dermatologic agents|mesh-ancestor
101620656|NCT05804305|Misoprostol|misoprostol|mesh-list
101620657|NCT05804305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101620658|NCT05804305|Abortifacient Agents|abortifacient agents|mesh-ancestor
101620659|NCT05804305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101620660|NCT05804305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620661|NCT05804305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101620662|NCT05804305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101620663|NCT05804305|Oxytocics|oxytocics|mesh-ancestor
101620665|NCT05803863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101620666|NCT05803863|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101620667|NCT05803863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101620668|NCT05803863|Autonomic Agents|autonomic agents|mesh-ancestor
101620669|NCT05803863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101620670|NCT05803863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620671|NCT05803863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101620672|NCT05803863|Respiratory System Agents|respiratory system agents|mesh-ancestor
101620673|NCT05803863|Mydriatics|mydriatics|mesh-ancestor
101620674|NCT05803863|Parasympatholytics|parasympatholytics|mesh-ancestor
101620675|NCT05803863|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101620676|NCT05803863|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101620677|NCT05803863|Cholinergic Agents|cholinergic agents|mesh-ancestor
101620678|NCT05803863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101620679|NCT05803863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620680|NCT05803811|Riboflavin|riboflavin|mesh-list
101620681|NCT05803811|Vitamin B Complex|vitamin b complex|mesh-ancestor
101620682|NCT05803811|Vitamins|vitamins|mesh-ancestor
101620683|NCT05803811|Micronutrients|micronutrients|mesh-ancestor
101620684|NCT05803811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620685|NCT05803811|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101620686|NCT05803811|Dermatologic Agents|dermatologic agents|mesh-ancestor
101620687|NCT05803746|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101620688|NCT05803746|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101620689|NCT05803746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620690|NCT05803642|Haloperidol|haloperidol|mesh-list
101620691|NCT05803642|Olanzapine|olanzapine|mesh-list
101620692|NCT05803642|Haloperidol decanoate|haloperidol decanoate|mesh-list
101620693|NCT05803642|Antiemetics|antiemetics|mesh-ancestor
101620694|NCT05803642|Autonomic Agents|autonomic agents|mesh-ancestor
101620695|NCT05803642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101620696|NCT05803642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945308|NCT03563794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101945309|NCT03563794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945310|NCT03563794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101945311|NCT03563794|Protease Inhibitors|protease inhibitors|mesh-ancestor
101945312|NCT03563794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101945313|NCT03563794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945314|NCT03905967|Lenvatinib|lenvatinib|mesh-list
101945315|NCT03905967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101945316|NCT03905967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101665146|NCT02766036|Propolis|propolis|mesh-list
101945318|NCT03905967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620697|NCT05803642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101620698|NCT05803642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101620699|NCT05803642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101620700|NCT05803642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101620701|NCT05803642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101620702|NCT05803642|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101620703|NCT05803642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101620704|NCT05803642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101620705|NCT05803642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620706|NCT05803642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101620707|NCT05803642|Serotonin Agents|serotonin agents|mesh-ancestor
101620708|NCT05803642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101620709|NCT05803642|Dopamine Agents|dopamine agents|mesh-ancestor
101620710|NCT05803642|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101620711|NCT05803590|Chlorhexidine|chlorhexidine|mesh-list
101620720|NCT05803096|Nitrous Oxide|nitrous oxide|mesh-list
101620721|NCT05803096|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101620722|NCT05803096|Anesthetics, General|anesthetics, general|mesh-ancestor
101620723|NCT05803096|Anesthetics|anesthetics|mesh-ancestor
101620724|NCT05803096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101620725|NCT05803096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620726|NCT05803096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101620727|NCT05803096|Analgesics|analgesics|mesh-ancestor
101620728|NCT05803096|Sensory System Agents|sensory system agents|mesh-ancestor
101620729|NCT05803096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101620736|NCT05803070|Cetirizine|cetirizine|mesh-list
101620737|NCT05803070|Betamethasone|betamethasone|mesh-list
101620738|NCT05803070|Betamethasone Valerate|betamethasone valerate|mesh-list
101620739|NCT05803070|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101620740|NCT05803070|Betamethasone benzoate|betamethasone benzoate|mesh-list
101620741|NCT05803070|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101620742|NCT05803070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101620743|NCT05803070|Glucocorticoids|glucocorticoids|mesh-ancestor
101620744|NCT05803070|Hormones|hormones|mesh-ancestor
101620745|NCT05803070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101620746|NCT05803070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620747|NCT05803070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101620748|NCT05803070|Respiratory System Agents|respiratory system agents|mesh-ancestor
101620749|NCT05803070|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101620750|NCT05803070|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101620751|NCT05803070|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101620752|NCT05803070|Histamine Antagonists|histamine antagonists|mesh-ancestor
101620753|NCT05803070|Histamine Agents|histamine agents|mesh-ancestor
101620754|NCT05803070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101620755|NCT05803070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620756|NCT05803031|Tea Tree Oil|tea tree oil|mesh-list
101620757|NCT05803031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101620758|NCT05803031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101620759|NCT05802992|Dexamethasone|dexamethasone|mesh-list
101620760|NCT05802992|Dexamethasone acetate|dexamethasone acetate|mesh-list
101620761|NCT05802992|Lenalidomide|lenalidomide|mesh-list
101620762|NCT05802992|Colchicine|colchicine|mesh-list
101620763|NCT05802992|BB 1101|bb 1101|mesh-list
101945319|NCT03563950|Rifampin|rifampin|mesh-list
101945320|NCT03563950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101945321|NCT03563950|Antitubercular Agents|antitubercular agents|mesh-ancestor
101945322|NCT03563950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101945323|NCT03563950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101945324|NCT03563950|Leprostatic Agents|leprostatic agents|mesh-ancestor
101945325|NCT03563950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101945326|NCT03563950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101945327|NCT03563950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945328|NCT03563950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101945329|NCT03563950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101945330|NCT03563950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101945331|NCT03563950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101792074|NCT00537771|Hormone Antagonists|hormone antagonists|mesh-ancestor
101620764|NCT05802992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101620765|NCT05802992|Antiemetics|antiemetics|mesh-ancestor
101620766|NCT05802992|Autonomic Agents|autonomic agents|mesh-ancestor
101620767|NCT05802992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101620768|NCT05802992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620769|NCT05802992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101620770|NCT05802992|Glucocorticoids|glucocorticoids|mesh-ancestor
101620772|NCT05802992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101620773|NCT05802992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101620774|NCT05802992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101620775|NCT05802992|Protease Inhibitors|protease inhibitors|mesh-ancestor
101620776|NCT05802992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101620777|NCT05802992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620778|NCT05802992|Immunologic Factors|immunologic factors|mesh-ancestor
101620779|NCT05802992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101620780|NCT05802992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101620781|NCT05802992|Growth Substances|growth substances|mesh-ancestor
101620782|NCT05802992|Growth Inhibitors|growth inhibitors|mesh-ancestor
101620783|NCT05802992|Gout Suppressants|gout suppressants|mesh-ancestor
101620784|NCT05802992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101620785|NCT05802992|Tubulin Modulators|tubulin modulators|mesh-ancestor
101620789|NCT05802888|Amoxicillin|amoxicillin|mesh-list
101620790|NCT05802888|Tetracycline|tetracycline|mesh-list
101620791|NCT05802888|Esomeprazole|esomeprazole|mesh-list
101620792|NCT05802888|Bismuth|bismuth|mesh-list
101620793|NCT05802888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101620794|NCT05802888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101620795|NCT05802888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101620796|NCT05802888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101620797|NCT05802888|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101620798|NCT05802888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101620799|NCT05802888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620800|NCT05802888|Antacids|antacids|mesh-ancestor
101620801|NCT05802888|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101620802|NCT05802862|Insulin|insulin|mesh-list
101620803|NCT05802862|Insulin Aspart|insulin aspart|mesh-list
101620804|NCT05802862|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101620805|NCT05802862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101620806|NCT05802862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620807|NCT05800574|Cisplatin|cisplatin|mesh-list
101620808|NCT05800574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101620809|NCT05776875|Bevacizumab|bevacizumab|mesh-list
101620810|NCT05776875|Atezolizumab|atezolizumab|mesh-list
101620811|NCT05776875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101620812|NCT05776875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101620813|NCT05776875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101945333|NCT03563950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101945334|NCT03905655|Nitazoxanide|nitazoxanide|mesh-list
101620814|NCT05776875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101620815|NCT05776875|Growth Substances|growth substances|mesh-ancestor
101620816|NCT05776875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620817|NCT05776875|Growth Inhibitors|growth inhibitors|mesh-ancestor
101620818|NCT05776875|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101620819|NCT05776875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620820|NCT05776290|Hyaluronic Acid|hyaluronic acid|mesh-list
101620821|NCT05776290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101620822|NCT05776290|Immunologic Factors|immunologic factors|mesh-ancestor
101620823|NCT05776290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620824|NCT05776290|Viscosupplements|viscosupplements|mesh-ancestor
101620825|NCT05776290|Protective Agents|protective agents|mesh-ancestor
101620826|NCT05768711|Venetoclax|venetoclax|mesh-list
101620827|NCT05768711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101620828|NCT05766670|Vancomycin|vancomycin|mesh-list
101620829|NCT05766670|Gentamicins|gentamicins|mesh-list
101620830|NCT05766670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101620831|NCT05766670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101620832|NCT05766670|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101620833|NCT05766670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101620834|NCT05766670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620835|NCT05765227|Hydrogen Peroxide|hydrogen peroxide|mesh-list
101620836|NCT05765227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101620837|NCT05765227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101620838|NCT05761444|Atorvastatin|atorvastatin|mesh-list
101620839|NCT05761444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101620840|NCT05761444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101620841|NCT05761444|Antimetabolites|antimetabolites|mesh-ancestor
101620842|NCT05761444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620843|NCT05761444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101708862|NCT02701517|Antimetabolites|antimetabolites|mesh-ancestor
101620844|NCT05761444|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101620845|NCT05761444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101620846|NCT05758948|Formaldehyde|formaldehyde|mesh-list
101620847|NCT05758948|Disinfectants|disinfectants|mesh-ancestor
101620848|NCT05758948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101620849|NCT05757791|Empagliflozin|empagliflozin|mesh-list
101620850|NCT05757791|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101620851|NCT05757791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620852|NCT05757791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101620853|NCT05757791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620854|NCT05752734|Dexamethasone|dexamethasone|mesh-list
101620855|NCT05752734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101620856|NCT05752734|Antiemetics|antiemetics|mesh-ancestor
101620857|NCT05752734|Autonomic Agents|autonomic agents|mesh-ancestor
101620858|NCT05752734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101620859|NCT05752734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620863|NCT05752734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101620865|NCT05752734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101620866|NCT05728775|Propofol|propofol|mesh-list
101620867|NCT05728775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101620868|NCT05728775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101620869|NCT05728775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620870|NCT05728775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101620871|NCT05728775|Anesthetics, General|anesthetics, general|mesh-ancestor
101620872|NCT05728775|Anesthetics|anesthetics|mesh-ancestor
101620873|NCT05715671|Esketamine|esketamine|mesh-list
101620874|NCT05715671|Antidepressive Agents|antidepressive agents|mesh-ancestor
101620875|NCT05715671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101620876|NCT05705089|Warfarin|warfarin|mesh-list
101620877|NCT05705089|Rivaroxaban|rivaroxaban|mesh-list
101620878|NCT05705089|Anticoagulants|anticoagulants|mesh-ancestor
101620879|NCT05705089|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101620880|NCT05705089|Antithrombins|antithrombins|mesh-ancestor
101620881|NCT05705089|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101620882|NCT05705089|Protease Inhibitors|protease inhibitors|mesh-ancestor
101620883|NCT05705089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101620884|NCT05705089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620885|NCT05701917|Heparin|heparin|mesh-list
101620886|NCT05701917|Calcium heparin|calcium heparin|mesh-list
101620894|NCT05701917|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101945336|NCT03905655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101945337|NCT03914235|Lidocaine|lidocaine|mesh-list
101945338|NCT03914235|Anesthetics, Local|anesthetics, local|mesh-ancestor
101945339|NCT03914235|Anesthetics|anesthetics|mesh-ancestor
101945340|NCT03914235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101945341|NCT03914235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945342|NCT03914235|Sensory System Agents|sensory system agents|mesh-ancestor
101945343|NCT03914235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101945344|NCT03914235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101945345|NCT03914235|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101945346|NCT03914235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101945347|NCT03914235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101945348|NCT03914235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620895|NCT05701917|Antithrombins|antithrombins|mesh-ancestor
101620896|NCT05701917|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101620897|NCT05701917|Protease Inhibitors|protease inhibitors|mesh-ancestor
101620898|NCT05701917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101620899|NCT05687721|Avelumab|avelumab|mesh-list
101620900|NCT05687721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101620901|NCT05687721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101620902|NCT05672901|Estradiol|estradiol|mesh-list
101620903|NCT05672901|Estrogens|estrogens|mesh-ancestor
101620904|NCT05672901|Hormones|hormones|mesh-ancestor
101620905|NCT05672901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101620906|NCT05672901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620907|NCT05671822|Capecitabine|capecitabine|mesh-list
101620908|NCT05671822|Oxaliplatin|oxaliplatin|mesh-list
101620909|NCT05671822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101620910|NCT05671822|Antimetabolites|antimetabolites|mesh-ancestor
101620911|NCT05671822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620912|NCT05671822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101620913|NCT05649540|Amoxicillin|amoxicillin|mesh-list
101620914|NCT05649540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101620915|NCT05649540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101620916|NCT05646693|Sertraline|sertraline|mesh-list
101620917|NCT05646693|Magnesium Oxide|magnesium oxide|mesh-list
101620918|NCT05646693|Antidepressive Agents|antidepressive agents|mesh-ancestor
101620919|NCT05646693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101620920|NCT05646693|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101620921|NCT05646693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101620922|NCT05646693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101620923|NCT05646693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620924|NCT05646693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101620925|NCT05646693|Serotonin Agents|serotonin agents|mesh-ancestor
101620926|NCT05646693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620927|NCT05646693|Antacids|antacids|mesh-ancestor
101620928|NCT05646693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101620929|NCT05624359|Ropivacaine|ropivacaine|mesh-list
101620930|NCT05624359|Anesthetics, Local|anesthetics, local|mesh-ancestor
101620931|NCT05624359|Anesthetics|anesthetics|mesh-ancestor
101620932|NCT05624359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101620933|NCT05624359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620934|NCT05624359|Sensory System Agents|sensory system agents|mesh-ancestor
101620935|NCT05624359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101620936|NCT05616624|Gemcitabine|gemcitabine|mesh-list
101620937|NCT05616624|Docetaxel|docetaxel|mesh-list
101620938|NCT05616624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101620939|NCT05616624|Antimetabolites|antimetabolites|mesh-ancestor
101419629|NCT00162591|Analgesics|analgesics|mesh-ancestor
101620942|NCT05616624|Tubulin Modulators|tubulin modulators|mesh-ancestor
101945349|NCT01148667|Caseins|caseins|mesh-list
101945350|NCT01148667|Chelating Agents|chelating agents|mesh-ancestor
101945351|NCT01148667|Sequestering Agents|sequestering agents|mesh-ancestor
101620943|NCT05616624|Antimitotic Agents|antimitotic agents|mesh-ancestor
101620944|NCT05616624|Mitosis Modulators|mitosis modulators|mesh-ancestor
101620945|NCT05601817|Tocopherols|tocopherols|mesh-list
101620946|NCT05601817|Vitamin E|vitamin e|mesh-list
101620947|NCT05601817|alpha-Tocopherol|alpha-tocopherol|mesh-list
101620948|NCT05601817|Antioxidants|antioxidants|mesh-ancestor
101620949|NCT05601817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620950|NCT05601817|Protective Agents|protective agents|mesh-ancestor
101620951|NCT05601817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620952|NCT05601817|Vitamins|vitamins|mesh-ancestor
101620953|NCT05601817|Micronutrients|micronutrients|mesh-ancestor
101620954|NCT05535023|Cemiplimab|cemiplimab|mesh-list
101620955|NCT05535023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101620956|NCT05535023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101708897|NCT00505921|Immunologic Factors|immunologic factors|mesh-ancestor
101620987|NCT05494593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101620988|NCT05494593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101620989|NCT05494593|Immunologic Factors|immunologic factors|mesh-ancestor
101620990|NCT05494593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620991|NCT05494593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101620992|NCT05494593|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101620993|NCT05494593|Abortifacient Agents|abortifacient agents|mesh-ancestor
101620994|NCT05494593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101620995|NCT05494593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101620996|NCT05494593|Antimetabolites|antimetabolites|mesh-ancestor
101620997|NCT05494593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620998|NCT05494593|Dermatologic Agents|dermatologic agents|mesh-ancestor
101620999|NCT05494593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101621000|NCT05494593|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101621001|NCT05494593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101621002|NCT05494593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101621003|NCT05484349|Clonidine|clonidine|mesh-list
101621004|NCT05484349|Tizanidine|tizanidine|mesh-list
101621005|NCT05484349|Analgesics|analgesics|mesh-ancestor
101621006|NCT05484349|Sensory System Agents|sensory system agents|mesh-ancestor
101621007|NCT05484349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101621008|NCT05484349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621009|NCT05484349|Anticonvulsants|anticonvulsants|mesh-ancestor
101621010|NCT05484349|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101621011|NCT05484349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101621012|NCT05484349|Parasympatholytics|parasympatholytics|mesh-ancestor
101621013|NCT05484349|Autonomic Agents|autonomic agents|mesh-ancestor
101621014|NCT05484349|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101621015|NCT05484349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101621016|NCT05484349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101621017|NCT05484349|Adrenergic Agents|adrenergic agents|mesh-ancestor
101621018|NCT05484349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101621019|NCT05484349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621020|NCT05484349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101621021|NCT05484349|Sympatholytics|sympatholytics|mesh-ancestor
101621022|NCT05470244|Analgesics|analgesics|mesh-list
101621023|NCT05470244|Sensory System Agents|sensory system agents|mesh-ancestor
101621024|NCT05470244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101621025|NCT05470244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621026|NCT05449548|Lenalidomide|lenalidomide|mesh-list
101621027|NCT05449548|Immunologic Factors|immunologic factors|mesh-ancestor
101621028|NCT05449548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621029|NCT05449548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101621030|NCT05449548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101621031|NCT05449548|Growth Substances|growth substances|mesh-ancestor
101621032|NCT05449548|Growth Inhibitors|growth inhibitors|mesh-ancestor
101621033|NCT05449548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621034|NCT05438264|Donepezil|donepezil|mesh-list
101621035|NCT05438264|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101621036|NCT05438264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101531946|NCT04601259|Antifungal Agents|antifungal agents|mesh-ancestor
101621037|NCT05438264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621039|NCT05438264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101621040|NCT05438264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621041|NCT05438264|Nootropic Agents|nootropic agents|mesh-ancestor
101621061|NCT05359861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101792338|NCT00833378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101621062|NCT05359861|Growth Substances|growth substances|mesh-ancestor
101621063|NCT05359861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621064|NCT05359861|Growth Inhibitors|growth inhibitors|mesh-ancestor
101621065|NCT05359861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101621066|NCT05359861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621067|NCT05355857|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101621068|NCT05355857|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101621069|NCT05355857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621071|NCT05350085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101621072|NCT05350085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101621073|NCT05350085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101621074|NCT05350085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621075|NCT05350085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101278124|NCT04018313|Omalizumab|omalizumab|mesh-list
101621086|NCT05313308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101621087|NCT05313308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101621088|NCT05313308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101621089|NCT05313308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621090|NCT05313308|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101621091|NCT05313308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101621092|NCT05313308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101621093|NCT05313308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101621094|NCT05313308|Anesthetics, General|anesthetics, general|mesh-ancestor
101621095|NCT05313308|Anesthetics|anesthetics|mesh-ancestor
101621096|NCT05313308|GABA Modulators|gaba modulators|mesh-ancestor
101621097|NCT05313308|GABA Agents|gaba agents|mesh-ancestor
101621098|NCT05313308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101621099|NCT05313308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621110|NCT05273359|Benralizumab|benralizumab|mesh-list
101621111|NCT05273359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101621112|NCT05273359|Respiratory System Agents|respiratory system agents|mesh-ancestor
101621113|NCT05226455|Azacitidine|azacitidine|mesh-list
101621114|NCT05226455|Venetoclax|venetoclax|mesh-list
101621115|NCT05226455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101621116|NCT05226455|Antimetabolites|antimetabolites|mesh-ancestor
101621117|NCT05226455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621126|NCT05163223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101621127|NCT05163223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621128|NCT05163223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101621129|NCT05163223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621130|NCT05163223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101621132|NCT05163223|Immunologic Factors|immunologic factors|mesh-ancestor
101621133|NCT05163223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621135|NCT05101122|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101621136|NCT05101122|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101621137|NCT05101122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101621138|NCT05101122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101621139|NCT05101122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621140|NCT05101122|Adrenergic Agents|adrenergic agents|mesh-ancestor
101621141|NCT05101122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101621142|NCT05101122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621143|NCT05101122|Hallucinogens|hallucinogens|mesh-ancestor
101621144|NCT05101122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101621145|NCT05101122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101621146|NCT05101122|Analgesics|analgesics|mesh-ancestor
101621147|NCT05101122|Sensory System Agents|sensory system agents|mesh-ancestor
101621148|NCT05101122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101621149|NCT05101122|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101621150|NCT05101122|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101621151|NCT05101122|Hormones|hormones|mesh-ancestor
101621152|NCT05101122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101621153|NCT05092945|Niacin|niacin|mesh-list
101621154|NCT05092945|Nicotinic Acids|nicotinic acids|mesh-list
101621155|NCT05092945|Niacinamide|niacinamide|mesh-list
101621156|NCT05092945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101621157|NCT05092945|Antimetabolites|antimetabolites|mesh-ancestor
101621158|NCT05092945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621159|NCT05092945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101621160|NCT05092945|Vasodilator Agents|vasodilator agents|mesh-ancestor
101621161|NCT05092945|Vitamin B Complex|vitamin b complex|mesh-ancestor
101621162|NCT05092945|Vitamins|vitamins|mesh-ancestor
101621163|NCT05092945|Micronutrients|micronutrients|mesh-ancestor
101945352|NCT01148667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945354|NCT01254123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101621164|NCT05092945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621165|NCT05087771|Naltrexone|naltrexone|mesh-list
101621166|NCT05087771|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101621167|NCT05087771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101621168|NCT05087771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621169|NCT05087771|Sensory System Agents|sensory system agents|mesh-ancestor
101621170|NCT05087771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101621171|NCT05084235|Empagliflozin|empagliflozin|mesh-list
101621172|NCT05084235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101621173|NCT05084235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621174|NCT05084235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101621175|NCT05084235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621176|NCT05082142|Tranexamic Acid|tranexamic acid|mesh-list
101621177|NCT05082142|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101621178|NCT05082142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101621179|NCT05082142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621180|NCT05082142|Hemostatics|hemostatics|mesh-ancestor
101621181|NCT05082142|Coagulants|coagulants|mesh-ancestor
101621182|NCT05061017|Cyclophosphamide|cyclophosphamide|mesh-list
101621183|NCT05061017|Nivolumab|nivolumab|mesh-list
101621184|NCT05061017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101621185|NCT05061017|Immunologic Factors|immunologic factors|mesh-ancestor
101419834|NCT00505882|Pramlintide|pramlintide|mesh-list
101621200|NCT05042973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101621201|NCT05042973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621202|NCT05030272|Nicotine|nicotine|mesh-list
101621203|NCT05030272|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101621204|NCT05030272|Autonomic Agents|autonomic agents|mesh-ancestor
101621205|NCT05030272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101621206|NCT05030272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621207|NCT05030272|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101621208|NCT05030272|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101621209|NCT05030272|Cholinergic Agents|cholinergic agents|mesh-ancestor
101621210|NCT05030272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101621211|NCT05030272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621212|NCT04976257|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101621213|NCT04976257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101621214|NCT04976257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621215|NCT04954365|Amisulpride|amisulpride|mesh-list
101621216|NCT04954365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101621217|NCT04954365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101621218|NCT04954365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101621219|NCT04954365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621220|NCT04954365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101621221|NCT04954365|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101621222|NCT04954365|Dopamine Agents|dopamine agents|mesh-ancestor
101621223|NCT04954365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101621224|NCT04954365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621225|NCT04954365|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101621226|NCT04954365|Antidepressive Agents|antidepressive agents|mesh-ancestor
101621228|NCT04952389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101621229|NCT04952389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101621230|NCT04952389|Autonomic Agents|autonomic agents|mesh-ancestor
101621231|NCT04952389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101621232|NCT04952389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621233|NCT04952389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101621234|NCT04952389|Respiratory System Agents|respiratory system agents|mesh-ancestor
101621235|NCT04952389|Glucocorticoids|glucocorticoids|mesh-ancestor
101621237|NCT04952389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101621238|NCT04920617|Cyclophosphamide|cyclophosphamide|mesh-list
101621239|NCT04920617|Pembrolizumab|pembrolizumab|mesh-list
101621240|NCT04920617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101621241|NCT04920617|Immunologic Factors|immunologic factors|mesh-ancestor
101621242|NCT04920617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621243|NCT04920617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101621244|NCT04920617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101621249|NCT04920617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101621250|NCT04920617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101945355|NCT01254123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945356|NCT01254123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101945357|NCT01254123|Incretins|incretins|mesh-ancestor
101945358|NCT01254123|Hormones|hormones|mesh-ancestor
101792483|NCT01156389|Pyronaridine|pyronaridine|mesh-list
101621251|NCT04860804|Aspirin|aspirin|mesh-list
101621252|NCT04860804|Ketamine|ketamine|mesh-list
101621253|NCT04860804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101621254|NCT04860804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101621255|NCT04860804|Analgesics|analgesics|mesh-ancestor
101621256|NCT04860804|Sensory System Agents|sensory system agents|mesh-ancestor
101621257|NCT04860804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101621258|NCT04860804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621259|NCT04860804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101621260|NCT04860804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101621261|NCT04860804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101621262|NCT04860804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101621263|NCT04860804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621264|NCT04860804|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101621265|NCT04860804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101621266|NCT04860804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101621267|NCT04860804|Antipyretics|antipyretics|mesh-ancestor
101621268|NCT04860804|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101621269|NCT04860804|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101621270|NCT04860804|Anesthetics, General|anesthetics, general|mesh-ancestor
101621271|NCT04860804|Anesthetics|anesthetics|mesh-ancestor
101621272|NCT04860804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101621273|NCT04860804|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101621274|NCT04860804|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101621275|NCT04860804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101621276|NCT04817345|Plerixafor|plerixafor|mesh-list
101621277|NCT04817345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101621278|NCT04817345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101621280|NCT04817345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101621281|NCT04764396|Heparin|heparin|mesh-list
101621282|NCT04764396|Calcium heparin|calcium heparin|mesh-list
101621283|NCT04764396|Anticoagulants|anticoagulants|mesh-ancestor
101621284|NCT04764396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101621285|NCT04764396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101621286|NCT04764396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621287|NCT04684589|Tadalafil|tadalafil|mesh-list
101621288|NCT04684589|Vasodilator Agents|vasodilator agents|mesh-ancestor
101621289|NCT04684589|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101621290|NCT04684589|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101621291|NCT04684589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101621292|NCT04684589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621293|NCT04684589|Urological Agents|urological agents|mesh-ancestor
101621294|NCT04609514|Nicotine|nicotine|mesh-list
101621295|NCT04609514|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101621296|NCT04609514|Autonomic Agents|autonomic agents|mesh-ancestor
101621297|NCT04609514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101621298|NCT04609514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278341|NCT03317158|Antimetabolites|antimetabolites|mesh-ancestor
101621299|NCT04609514|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101621300|NCT04609514|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101621301|NCT04609514|Cholinergic Agents|cholinergic agents|mesh-ancestor
101621302|NCT04609514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101621303|NCT04609514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621304|NCT04569461|Pembrolizumab|pembrolizumab|mesh-list
101621305|NCT04569461|Androgens|androgens|mesh-list
101621306|NCT04569461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101621307|NCT04569461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621308|NCT04569461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101621309|NCT04569461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621310|NCT04569461|Hormones|hormones|mesh-ancestor
101621311|NCT04569461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101621312|NCT04569461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621313|NCT04527289|Amantadine|amantadine|mesh-list
101621314|NCT04527289|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101621319|NCT04527289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101621320|NCT04527289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945365|NCT03898635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945367|NCT05116917|Ipilimumab|ipilimumab|mesh-list
101945368|NCT05116917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101945369|NCT05116917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101945370|NCT05116917|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101792557|NCT05589441|Tocolytic Agents|tocolytic agents|mesh-ancestor
101621321|NCT04527289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621322|NCT04527289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101621323|NCT04527289|Analgesics|analgesics|mesh-ancestor
101621324|NCT04527289|Sensory System Agents|sensory system agents|mesh-ancestor
101621325|NCT04527289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101621326|NCT04505735|Corticosterone|corticosterone|mesh-list
101621327|NCT04505735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101621328|NCT04460872|Methyltestosterone|methyltestosterone|mesh-list
101621329|NCT04460872|Testosterone|testosterone|mesh-list
101621330|NCT04460872|Testosterone undecanoate|testosterone undecanoate|mesh-list
101621331|NCT04460872|Testosterone enanthate|testosterone enanthate|mesh-list
101621332|NCT04460872|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101621333|NCT04460872|Androgens|androgens|mesh-ancestor
101621334|NCT04460872|Hormones|hormones|mesh-ancestor
101621335|NCT04460872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101621336|NCT04460872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621337|NCT04460872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101621338|NCT04460872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621339|NCT04460872|Anabolic Agents|anabolic agents|mesh-ancestor
101621340|NCT04446351|Dostarlimab|dostarlimab|mesh-list
101621341|NCT04446351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621349|NCT04422795|Ethyl Chloride|ethyl chloride|mesh-list
101621350|NCT04422795|Anesthetics, Local|anesthetics, local|mesh-ancestor
101621351|NCT04422795|Anesthetics|anesthetics|mesh-ancestor
101621352|NCT04422795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101621353|NCT04422795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621354|NCT04422795|Sensory System Agents|sensory system agents|mesh-ancestor
101621355|NCT04422795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101621357|NCT04413617|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101621358|NCT04413617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101621359|NCT04413617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101621360|NCT04413617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621361|NCT04408625|Sirolimus|sirolimus|mesh-list
101621362|NCT04408625|Prednisone|prednisone|mesh-list
101621363|NCT04408625|Methylprednisolone|methylprednisolone|mesh-list
101621364|NCT04408625|Rituximab|rituximab|mesh-list
101621365|NCT04408625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101621366|NCT04408625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621367|NCT04408625|Immunologic Factors|immunologic factors|mesh-ancestor
101621368|NCT04408625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621369|NCT04408625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101621370|NCT04408625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101945371|NCT05116917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945372|NCT02528019|Glimepiride|glimepiride|mesh-list
101945373|NCT02528019|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
101945374|NCT02528019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101945375|NCT02528019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101945376|NCT02528019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621371|NCT04408625|Glucocorticoids|glucocorticoids|mesh-ancestor
101621372|NCT04408625|Hormones|hormones|mesh-ancestor
101621373|NCT04408625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101621374|NCT04408625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101621375|NCT04408625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101621376|NCT04408625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101621377|NCT04408625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101621378|NCT04408625|Antifungal Agents|antifungal agents|mesh-ancestor
101621379|NCT04408625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101621380|NCT04408625|Antiemetics|antiemetics|mesh-ancestor
101621381|NCT04408625|Autonomic Agents|autonomic agents|mesh-ancestor
101621382|NCT04408625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101621383|NCT04408625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101621384|NCT04408625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101621385|NCT04408625|Protective Agents|protective agents|mesh-ancestor
101621386|NCT04218565|Golimumab|golimumab|mesh-list
101621387|NCT04218565|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101621392|NCT04193293|Pembrolizumab|pembrolizumab|mesh-list
101621393|NCT04193293|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101621394|NCT04193293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101621395|NCT04193293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621396|NCT04193293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621397|NCT04129502|Carboplatin|carboplatin|mesh-list
101621398|NCT04129502|Pemetrexed|pemetrexed|mesh-list
101621399|NCT04129502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621400|NCT04129502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101621401|NCT04129502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621402|NCT04129502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101621403|NCT04129502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101621404|NCT04093362|Gemcitabine|gemcitabine|mesh-list
101621405|NCT04093362|Futibatinib|futibatinib|mesh-list
101621406|NCT04093362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621407|NCT04093362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101621408|NCT04093362|Antimetabolites|antimetabolites|mesh-ancestor
101621409|NCT04093362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621410|NCT04060849|Ethanol|ethanol|mesh-list
101621411|NCT04060849|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101621412|NCT04060849|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101621413|NCT04060849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101621414|NCT04060849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101621415|NCT04060849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621416|NCT04055116|Lidocaine|lidocaine|mesh-list
101621417|NCT04055116|Anesthetics, Local|anesthetics, local|mesh-ancestor
101621418|NCT04055116|Anesthetics|anesthetics|mesh-ancestor
101621419|NCT04055116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101621420|NCT04055116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621421|NCT04055116|Sensory System Agents|sensory system agents|mesh-ancestor
101621422|NCT04055116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101621423|NCT04055116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101621424|NCT04055116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101621425|NCT04055116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101621426|NCT04055116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101621427|NCT04055116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621428|NCT04045028|Rituximab|rituximab|mesh-list
101621429|NCT04045028|Atezolizumab|atezolizumab|mesh-list
101621430|NCT04045028|Daratumumab|daratumumab|mesh-list
101621431|NCT04045028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101621432|NCT04045028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621433|NCT04045028|Immunologic Factors|immunologic factors|mesh-ancestor
101621434|NCT04045028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945377|NCT02528019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101945378|NCT02528019|Immunologic Factors|immunologic factors|mesh-ancestor
101945379|NCT02528019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621435|NCT04045028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101621436|NCT04045028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101621437|NCT04045028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621438|NCT03990623|Liver Extracts|liver extracts|mesh-list
101621439|NCT03990623|Hematinics|hematinics|mesh-ancestor
101621440|NCT03916328|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101621441|NCT03916328|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101621442|NCT03916328|Contraceptive Agents|contraceptive agents|mesh-ancestor
101621443|NCT03916328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101621444|NCT03916328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621445|NCT03916328|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101621446|NCT03916328|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101621447|NCT03916328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101621448|NCT03916328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621450|NCT03867500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101621451|NCT03867500|Antimetabolites|antimetabolites|mesh-ancestor
101621452|NCT03867500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621453|NCT03867500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101621454|NCT03867500|Vasodilator Agents|vasodilator agents|mesh-ancestor
101621455|NCT03867500|Vitamin B Complex|vitamin b complex|mesh-ancestor
101621456|NCT03867500|Vitamins|vitamins|mesh-ancestor
101420096|NCT00163371|Hormones|hormones|mesh-ancestor
101621459|NCT03839446|Etoposide|etoposide|mesh-list
101621460|NCT03839446|Mitoxantrone|mitoxantrone|mesh-list
101621461|NCT03839446|Gemtuzumab|gemtuzumab|mesh-list
101621462|NCT03839446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101621463|NCT03839446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621464|NCT03839446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101621465|NCT03839446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101621466|NCT03839446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101621467|NCT03839446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621468|NCT03839446|Analgesics|analgesics|mesh-ancestor
101621469|NCT03839446|Sensory System Agents|sensory system agents|mesh-ancestor
101621470|NCT03839446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101621471|NCT03839446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621472|NCT03839446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101621473|NCT03839446|Immunotoxins|immunotoxins|mesh-ancestor
101621474|NCT03839446|Immunoconjugates|immunoconjugates|mesh-ancestor
101621475|NCT03839446|Immunologic Factors|immunologic factors|mesh-ancestor
101621476|NCT03781986|Carboplatin|carboplatin|mesh-list
101621477|NCT03781986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621478|NCT03743402|Analgesics, Opioid|analgesics, opioid|mesh-list
101621479|NCT03743402|Narcotics|narcotics|mesh-ancestor
101621480|NCT03743402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101621481|NCT03743402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621482|NCT03743402|Analgesics|analgesics|mesh-ancestor
101621483|NCT03743402|Sensory System Agents|sensory system agents|mesh-ancestor
101621484|NCT03743402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101621485|NCT03735433|Aspirin|aspirin|mesh-list
101621486|NCT03735433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101621487|NCT03735433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101621488|NCT03735433|Analgesics|analgesics|mesh-ancestor
101621489|NCT03735433|Sensory System Agents|sensory system agents|mesh-ancestor
101621490|NCT03735433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101621491|NCT03735433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621492|NCT03735433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101621493|NCT03735433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101621494|NCT03735433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101621495|NCT03735433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101621496|NCT03735433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621497|NCT03735433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101621498|NCT03735433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101621499|NCT03735433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101621500|NCT03735433|Antipyretics|antipyretics|mesh-ancestor
101621501|NCT03729401|Aspirin|aspirin|mesh-list
101621502|NCT03729401|Clopidogrel|clopidogrel|mesh-list
101621503|NCT03729401|Ticagrelor|ticagrelor|mesh-list
101621504|NCT03729401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101621505|NCT03729401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101945380|NCT01255215|Nitric Oxide|nitric oxide|mesh-list
101945381|NCT01255215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101621506|NCT03729401|Analgesics|analgesics|mesh-ancestor
101621507|NCT03729401|Sensory System Agents|sensory system agents|mesh-ancestor
101708962|NCT02700893|Autonomic Agents|autonomic agents|mesh-ancestor
101621508|NCT03729401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101621509|NCT03729401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621510|NCT03729401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101621511|NCT03729401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101621512|NCT03729401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101621513|NCT03729401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101621514|NCT03729401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621515|NCT03729401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101621516|NCT03729401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101621517|NCT03729401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101621518|NCT03729401|Antipyretics|antipyretics|mesh-ancestor
101621519|NCT03729401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101621520|NCT03729401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101621521|NCT03729401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101621522|NCT03729401|Purinergic Agents|purinergic agents|mesh-ancestor
101621523|NCT03729401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101621525|NCT03562416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621526|NCT03562416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101621527|NCT03562416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101621528|NCT03562416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621529|NCT03512262|Abaloparatide|abaloparatide|mesh-list
101420169|NCT00163605|Thrombin|thrombin|mesh-list
101621532|NCT03512262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621533|NCT03512262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101621534|NCT03503058|Chloroquine|chloroquine|mesh-list
101621535|NCT03503058|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
101621536|NCT03503058|Amebicides|amebicides|mesh-ancestor
101621537|NCT03503058|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101621538|NCT03503058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101621539|NCT03503058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101621540|NCT03503058|Antimalarials|antimalarials|mesh-ancestor
101621541|NCT03503058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101621542|NCT03503058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101621543|NCT03503058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101621544|NCT03503058|Analgesics|analgesics|mesh-ancestor
101621545|NCT03503058|Sensory System Agents|sensory system agents|mesh-ancestor
101621546|NCT03503058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101621547|NCT03503058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621548|NCT03503058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101621549|NCT03503058|Filaricides|filaricides|mesh-ancestor
101621550|NCT03503058|Antinematodal Agents|antinematodal agents|mesh-ancestor
101621551|NCT03503058|Anthelmintics|anthelmintics|mesh-ancestor
101621552|NCT03396211|Nivolumab|nivolumab|mesh-list
101621553|NCT03396211|Apatinib|apatinib|mesh-list
101621554|NCT03396211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101621555|NCT03396211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621556|NCT03396211|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101621557|NCT03396211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621558|NCT03396211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101621559|NCT03396211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101621560|NCT03301896|Spartalizumab|spartalizumab|mesh-list
101621561|NCT03301896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101621562|NCT03301896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621563|NCT03301896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101621564|NCT03301896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621565|NCT03260322|Pembrolizumab|pembrolizumab|mesh-list
101621566|NCT03260322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101621567|NCT03260322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621568|NCT03260322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101621569|NCT03260322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621570|NCT03257761|Durvalumab|durvalumab|mesh-list
101621571|NCT03257761|Guadecitabine|guadecitabine|mesh-list
101621572|NCT03257761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101621573|NCT03257761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621574|NCT03218085|Tenofovir|tenofovir|mesh-list
101621575|NCT03218085|Emtricitabine|emtricitabine|mesh-list
101621576|NCT03218085|Antiviral Agents|antiviral agents|mesh-ancestor
101621577|NCT03218085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101945383|NCT01255215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101945384|NCT01255215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945385|NCT01255215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101621578|NCT03218085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101621579|NCT03218085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101621580|NCT03218085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101621581|NCT03218085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621582|NCT03218085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101621583|NCT03218085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101621584|NCT03197077|Contraceptive Agents|contraceptive agents|mesh-list
101621585|NCT03197077|Desogestrel|desogestrel|mesh-list
101621586|NCT03197077|Contraceptives, Oral|contraceptives, oral|mesh-list
101621587|NCT03197077|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
101621588|NCT03197077|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101621589|NCT03197077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101621590|NCT03197077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621591|NCT03197077|Hormones|hormones|mesh-ancestor
101621592|NCT03197077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101621593|NCT03197077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101621594|NCT03197077|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101621595|NCT03197077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101621596|NCT03197077|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101621597|NCT03197077|Progestins|progestins|mesh-ancestor
101621598|NCT03153280|Capecitabine|capecitabine|mesh-list
101621599|NCT03153280|Oxaliplatin|oxaliplatin|mesh-list
101621600|NCT03153280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101621601|NCT03153280|Antimetabolites|antimetabolites|mesh-ancestor
101621605|NCT03098836|Abiraterone Acetate|abiraterone acetate|mesh-list
101621606|NCT03098836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101621607|NCT03098836|Glucocorticoids|glucocorticoids|mesh-ancestor
101621608|NCT03098836|Hormones|hormones|mesh-ancestor
101621609|NCT03098836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101621610|NCT03098836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621611|NCT03098836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101621612|NCT03098836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621613|NCT03098836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101621614|NCT03098836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101621615|NCT03098836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621616|NCT03098836|Hormone Antagonists|hormone antagonists|mesh-ancestor
101621617|NCT03098836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101621618|NCT03078855|Vitamin D|vitamin d|mesh-list
101621619|NCT03078855|Cholecalciferol|cholecalciferol|mesh-list
101621620|NCT03078855|Rituximab|rituximab|mesh-list
101621621|NCT03078855|Vitamins|vitamins|mesh-ancestor
101621622|NCT03078855|Micronutrients|micronutrients|mesh-ancestor
101621623|NCT03078855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621624|NCT03078855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101621625|NCT03078855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621626|NCT03078855|Immunologic Factors|immunologic factors|mesh-ancestor
101621627|NCT03078855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101621628|NCT03078855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101621629|NCT03078855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101621630|NCT03007979|Letrozole|letrozole|mesh-list
101621631|NCT03007979|Fulvestrant|fulvestrant|mesh-list
101621632|NCT03007979|Palbociclib|palbociclib|mesh-list
101621633|NCT03007979|Goserelin|goserelin|mesh-list
101621634|NCT03007979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621635|NCT03007979|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101621636|NCT03007979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101621637|NCT03007979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101621638|NCT03007979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621639|NCT03007979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101621640|NCT03007979|Hormone Antagonists|hormone antagonists|mesh-ancestor
101621641|NCT03007979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101621642|NCT03007979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621643|NCT03007979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101621644|NCT03007979|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101621645|NCT03007979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101621646|NCT02912572|Avelumab|avelumab|mesh-list
101945386|NCT01255215|Respiratory System Agents|respiratory system agents|mesh-ancestor
101945387|NCT01255215|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101945388|NCT01255215|Antioxidants|antioxidants|mesh-ancestor
101945389|NCT01255215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945391|NCT01255215|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101945392|NCT01255215|Vasodilator Agents|vasodilator agents|mesh-ancestor
101945393|NCT01255215|Gasotransmitters|gasotransmitters|mesh-ancestor
101945394|NCT01255215|Protective Agents|protective agents|mesh-ancestor
101945395|NCT02527785|Oxaliplatin|oxaliplatin|mesh-list
101945396|NCT02527785|Irinotecan|irinotecan|mesh-list
101945397|NCT02527785|Tegafur|tegafur|mesh-list
101945398|NCT02527785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101945399|NCT02527785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101945400|NCT02527785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101945401|NCT02527785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101945402|NCT02527785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945403|NCT02527785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101945404|NCT02527785|Antimetabolites|antimetabolites|mesh-ancestor
101945405|NCT02527863|Tolvaptan|tolvaptan|mesh-list
101945406|NCT02527863|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101945407|NCT02527863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945408|NCT02527863|Natriuretic Agents|natriuretic agents|mesh-ancestor
101945409|NCT02527863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945410|NCT01256541|Lactulose|lactulose|mesh-list
101621647|NCT02912572|Axitinib|axitinib|mesh-list
101621648|NCT02912572|Talazoparib|talazoparib|mesh-list
101621649|NCT02912572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101621650|NCT02912572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621651|NCT02912572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101621652|NCT02912572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101621653|NCT02912572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621654|NCT02912572|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101621655|NCT02910414|Ethanol|ethanol|mesh-list
101621656|NCT02910414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101621657|NCT02910414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101621658|NCT02910414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101621659|NCT02910414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621660|NCT02867813|Evolocumab|evolocumab|mesh-list
101621661|NCT02867813|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101621662|NCT02867813|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101621663|NCT02867813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101621664|NCT02867813|Antimetabolites|antimetabolites|mesh-ancestor
101621665|NCT02867813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621666|NCT02867813|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101621667|NCT02867813|Protease Inhibitors|protease inhibitors|mesh-ancestor
101621668|NCT02867813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101621669|NCT02867813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101621670|NCT02845596|Cyclosporine|cyclosporine|mesh-list
101621671|NCT02845596|Cyclophosphamide|cyclophosphamide|mesh-list
101621672|NCT02845596|Methotrexate|methotrexate|mesh-list
101621673|NCT02845596|Fludarabine|fludarabine|mesh-list
101945411|NCT01256541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101945412|NCT03904719|Vorolanib|vorolanib|mesh-list
101621678|NCT02845596|Immunologic Factors|immunologic factors|mesh-ancestor
101621679|NCT02845596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621680|NCT02845596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101708986|NCT04213781|Analgesics|analgesics|mesh-ancestor
101621681|NCT02845596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101621682|NCT02845596|Alkylating Agents|alkylating agents|mesh-ancestor
101621683|NCT02845596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621684|NCT02845596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621685|NCT02845596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101621686|NCT02845596|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101621687|NCT02845596|Abortifacient Agents|abortifacient agents|mesh-ancestor
101621688|NCT02845596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101621689|NCT02845596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101621690|NCT02845596|Antimetabolites|antimetabolites|mesh-ancestor
101621691|NCT02845596|Dermatologic Agents|dermatologic agents|mesh-ancestor
101621692|NCT02845596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101621693|NCT02845596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101621694|NCT02845596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101621695|NCT02845596|Antifungal Agents|antifungal agents|mesh-ancestor
101621696|NCT02845596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101621697|NCT02845596|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101621698|NCT02737787|Nivolumab|nivolumab|mesh-list
101621699|NCT02737787|Vaccines|vaccines|mesh-list
101621700|NCT02737787|Immunologic Factors|immunologic factors|mesh-ancestor
101621701|NCT02737787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621702|NCT02737787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101621703|NCT02737787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621704|NCT02737787|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101621705|NCT02737787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621706|NCT02646839|Biotin|biotin|mesh-list
101621707|NCT02646839|Vitamin B Complex|vitamin b complex|mesh-ancestor
101621708|NCT02646839|Vitamins|vitamins|mesh-ancestor
101621709|NCT02646839|Micronutrients|micronutrients|mesh-ancestor
101621710|NCT02646839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621711|NCT02494570|Sirolimus|sirolimus|mesh-list
101621712|NCT02494570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101621713|NCT02494570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101621714|NCT02494570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101621715|NCT02494570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621716|NCT02494570|Antifungal Agents|antifungal agents|mesh-ancestor
101621717|NCT02494570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101621718|NCT02494570|Immunologic Factors|immunologic factors|mesh-ancestor
101621719|NCT02494570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621720|NCT02437071|Pembrolizumab|pembrolizumab|mesh-list
101621721|NCT02437071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101621722|NCT02437071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621723|NCT02437071|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101621724|NCT02437071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621725|NCT02341274|Tacrolimus|tacrolimus|mesh-list
101621726|NCT02341274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101621727|NCT02341274|Immunologic Factors|immunologic factors|mesh-ancestor
101621728|NCT02341274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621729|NCT02341274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101621730|NCT02341274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101621731|NCT02341274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621732|NCT02256865|Ketoconazole|ketoconazole|mesh-list
101621733|NCT02256865|Hydrocortisone|hydrocortisone|mesh-list
101621734|NCT02256865|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101621735|NCT02256865|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101621736|NCT02256865|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101621737|NCT02256865|Methyltestosterone|methyltestosterone|mesh-list
101621738|NCT02256865|Testosterone|testosterone|mesh-list
101621739|NCT02256865|Testosterone undecanoate|testosterone undecanoate|mesh-list
101621740|NCT02256865|Testosterone enanthate|testosterone enanthate|mesh-list
101621741|NCT02256865|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101621742|NCT02256865|Androgens|androgens|mesh-ancestor
101621743|NCT02256865|Hormones|hormones|mesh-ancestor
101621744|NCT02256865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101621745|NCT02256865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621752|NCT02256865|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101621753|NCT02256865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101621754|NCT02256865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101945414|NCT03904719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101621755|NCT02256865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621756|NCT02256865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101621757|NCT02256865|Hormone Antagonists|hormone antagonists|mesh-ancestor
101621758|NCT02256865|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101621759|NCT02231879|Plerixafor|plerixafor|mesh-list
101621760|NCT02231879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101621761|NCT02231879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101621762|NCT02231879|Antiviral Agents|antiviral agents|mesh-ancestor
101621763|NCT02231879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101621764|NCT01968460|Pramipexole|pramipexole|mesh-list
101621765|NCT01968460|Rasagiline|rasagiline|mesh-list
101621766|NCT01968460|Antioxidants|antioxidants|mesh-ancestor
101621767|NCT01968460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621768|NCT01968460|Protective Agents|protective agents|mesh-ancestor
101621769|NCT01968460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621770|NCT01968460|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101621771|NCT01968460|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101621772|NCT01968460|Dopamine Agonists|dopamine agonists|mesh-ancestor
101621773|NCT01968460|Dopamine Agents|dopamine agents|mesh-ancestor
101621774|NCT01968460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101621775|NCT01968460|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101621776|NCT01968460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101621777|NCT01968460|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101621778|NCT01906853|Vaccines|vaccines|mesh-list
101621779|NCT01906853|BCG Vaccine|bcg vaccine|mesh-list
101621780|NCT01906853|Immunologic Factors|immunologic factors|mesh-ancestor
101621781|NCT01906853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621782|NCT01906853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101621783|NCT01712490|Doxorubicin|doxorubicin|mesh-list
101621784|NCT01712490|Bleomycin|bleomycin|mesh-list
101621785|NCT01712490|Dacarbazine|dacarbazine|mesh-list
101621786|NCT01712490|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101621787|NCT01712490|Vinblastine|vinblastine|mesh-list
101621788|NCT01712490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101621789|NCT01712490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621790|NCT01712490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101621791|NCT01712490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101621792|NCT01712490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101621793|NCT01712490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621794|NCT01712490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101621795|NCT01712490|Alkylating Agents|alkylating agents|mesh-ancestor
101621796|NCT01712490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101621797|NCT01712490|Immunotoxins|immunotoxins|mesh-ancestor
101621798|NCT01712490|Immunoconjugates|immunoconjugates|mesh-ancestor
101621799|NCT01712490|Immunologic Factors|immunologic factors|mesh-ancestor
101621800|NCT01712490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621801|NCT01712490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101621802|NCT01712490|Tubulin Modulators|tubulin modulators|mesh-ancestor
101621804|NCT01712490|Mitosis Modulators|mitosis modulators|mesh-ancestor
101621805|NCT01527747|Saxagliptin|saxagliptin|mesh-list
101621806|NCT01527747|Incretins|incretins|mesh-ancestor
101621807|NCT01527747|Hormones|hormones|mesh-ancestor
101621808|NCT01527747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101621809|NCT01527747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621810|NCT01527747|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101621811|NCT01527747|Protease Inhibitors|protease inhibitors|mesh-ancestor
101621812|NCT01527747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101621813|NCT01527747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621814|NCT01527747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101621816|NCT01439802|Trace Elements|trace elements|mesh-ancestor
101621817|NCT01439802|Micronutrients|micronutrients|mesh-ancestor
101420783|NCT00507832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101420785|NCT00507832|Analgesics|analgesics|mesh-ancestor
101420786|NCT00507832|Sensory System Agents|sensory system agents|mesh-ancestor
101420787|NCT00507832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101622655|NCT02787447|Immunologic Factors|immunologic factors|mesh-ancestor
101622656|NCT02787447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622658|NCT00904722|Pidilizumab|pidilizumab|mesh-list
101622659|NCT00904722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101622660|NCT00904722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101622661|NCT00904722|Immunologic Factors|immunologic factors|mesh-ancestor
101622662|NCT00904722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945415|NCT03904719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945416|NCT01148901|Infliximab|infliximab|mesh-list
101945417|NCT01148901|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101945418|NCT01148901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101945419|NCT01148901|Dermatologic Agents|dermatologic agents|mesh-ancestor
101945420|NCT01148901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101945421|NCT01148901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101945422|NCT01150617|Insulin|insulin|mesh-list
101945423|NCT01150617|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101622663|NCT00904722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101622664|NCT02909361|Fulvestrant|fulvestrant|mesh-list
101622665|NCT02909361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101622666|NCT02909361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101622667|NCT02909361|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101622668|NCT02909361|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101622669|NCT02909361|Hormone Antagonists|hormone antagonists|mesh-ancestor
101622670|NCT02909361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101622671|NCT02909361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622672|NCT04301024|Nitrous Oxide|nitrous oxide|mesh-list
101622673|NCT04301024|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101622674|NCT04301024|Anesthetics, General|anesthetics, general|mesh-ancestor
101622675|NCT04301024|Anesthetics|anesthetics|mesh-ancestor
101622676|NCT04301024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101622677|NCT04301024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622678|NCT04301024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101622679|NCT04301024|Analgesics|analgesics|mesh-ancestor
101622680|NCT04301024|Sensory System Agents|sensory system agents|mesh-ancestor
101622681|NCT04301024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101622682|NCT01340430|Trastuzumab|trastuzumab|mesh-list
101622683|NCT01340430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101622684|NCT01340430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101622685|NCT01029782|Cefazolin|cefazolin|mesh-list
101622686|NCT01029782|Cephalexin|cephalexin|mesh-list
101622687|NCT01029782|Probenecid|probenecid|mesh-list
101622688|NCT01029782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101622689|NCT01029782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101622690|NCT01029782|Uricosuric Agents|uricosuric agents|mesh-ancestor
101622691|NCT01029782|Gout Suppressants|gout suppressants|mesh-ancestor
101622692|NCT01029782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101622693|NCT04232007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
101622694|NCT02901717|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101622697|NCT02901717|Antitubercular Agents|antitubercular agents|mesh-ancestor
101622699|NCT02849730|Analgesics|analgesics|mesh-list
101622700|NCT02849730|Ropivacaine|ropivacaine|mesh-list
101622701|NCT02849730|Anesthetics, Local|anesthetics, local|mesh-ancestor
101622702|NCT02849730|Anesthetics|anesthetics|mesh-ancestor
101622703|NCT02849730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101622704|NCT02849730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622705|NCT02849730|Sensory System Agents|sensory system agents|mesh-ancestor
101622706|NCT02849730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101622707|NCT02849730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101622708|NCT02849730|Narcotics|narcotics|mesh-ancestor
101622709|NCT02849730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101622710|NCT02849730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101622711|NCT02849730|Anesthetics, General|anesthetics, general|mesh-ancestor
101622712|NCT02849340|Immunomodulating Agents|immunomodulating agents|mesh-list
101622713|NCT02849340|Immunologic Factors|immunologic factors|mesh-ancestor
101622714|NCT02849340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622716|NCT03936192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101622717|NCT03936192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101622718|NCT03936192|Analgesics|analgesics|mesh-ancestor
101622719|NCT03936192|Sensory System Agents|sensory system agents|mesh-ancestor
101622720|NCT03936192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101622721|NCT03936192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622722|NCT03936192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101622723|NCT03936192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101622724|NCT03936192|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101622725|NCT03936192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101945424|NCT01150617|Insulin Glargine|insulin glargine|mesh-list
101945425|NCT01150617|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101945426|NCT01150617|Insulin, Short-Acting|insulin, short-acting|mesh-list
101945427|NCT01150617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945428|NCT01256619|Desogestrel|desogestrel|mesh-list
101945429|NCT01256619|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101945430|NCT01256619|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101622726|NCT03936192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101622727|NCT03936192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622728|NCT00930228|Flutamide|flutamide|mesh-list
101622729|NCT00930228|Androgen Antagonists|androgen antagonists|mesh-ancestor
101622730|NCT00930228|Hormone Antagonists|hormone antagonists|mesh-ancestor
101622731|NCT00930228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101622732|NCT00930228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622733|NCT00930228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101622734|NCT00930228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101622735|NCT05043870|Infliximab|infliximab|mesh-list
101622736|NCT05043870|Immunosuppressive Agents|immunosuppressive agents|mesh-list
101622737|NCT05043870|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101622738|NCT05043870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101622739|NCT05043870|Dermatologic Agents|dermatologic agents|mesh-ancestor
101622740|NCT05043870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101622741|NCT05043870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101622742|NCT05043870|Immunologic Factors|immunologic factors|mesh-ancestor
101622743|NCT05043870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622744|NCT01029704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
101622745|NCT01029704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622746|NCT01029704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101622747|NCT01029704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622748|NCT02786979|Aspirin|aspirin|mesh-list
101622749|NCT02786979|Beraprost|beraprost|mesh-list
101622750|NCT02786979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101622751|NCT02786979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101622752|NCT02786979|Analgesics|analgesics|mesh-ancestor
101622753|NCT02786979|Sensory System Agents|sensory system agents|mesh-ancestor
101622754|NCT02786979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101622755|NCT02786979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622756|NCT02786979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101622757|NCT02786979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101622758|NCT02786979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101622759|NCT02786979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101622760|NCT02786979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622761|NCT02786979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101622762|NCT02786979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101622763|NCT02786979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101622764|NCT02786979|Antipyretics|antipyretics|mesh-ancestor
101622765|NCT02786979|Vasodilator Agents|vasodilator agents|mesh-ancestor
101622766|NCT02689869|Obinutuzumab|obinutuzumab|mesh-list
101421407|NCT05350592|Sympathomimetics|sympathomimetics|mesh-ancestor
101622787|NCT02847000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622788|NCT02847000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101622789|NCT02847000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101622790|NCT02784327|Ropivacaine|ropivacaine|mesh-list
101622791|NCT02784327|Anesthetics, Local|anesthetics, local|mesh-ancestor
101622792|NCT02784327|Anesthetics|anesthetics|mesh-ancestor
101622793|NCT02784327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101622794|NCT02784327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709019|NCT00669656|Estrogens|estrogens|mesh-ancestor
101622795|NCT02784327|Sensory System Agents|sensory system agents|mesh-ancestor
101622796|NCT02784327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101622797|NCT02845050|Cisplatin|cisplatin|mesh-list
101622798|NCT02845050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101622799|NCT02690922|Dexamethasone|dexamethasone|mesh-list
101622800|NCT02690922|Prednisone|prednisone|mesh-list
101622801|NCT02690922|Methotrexate|methotrexate|mesh-list
101622802|NCT02690922|Dasatinib|dasatinib|mesh-list
101622803|NCT02690922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101622804|NCT02690922|Antiemetics|antiemetics|mesh-ancestor
101622805|NCT02690922|Autonomic Agents|autonomic agents|mesh-ancestor
101622806|NCT02690922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101945431|NCT01256619|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101945432|NCT01256619|Contraceptive Agents|contraceptive agents|mesh-ancestor
101945433|NCT01256619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101793245|NCT01010698|Acyclovir|acyclovir|mesh-list
101622807|NCT02690922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622808|NCT02690922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101622809|NCT02690922|Glucocorticoids|glucocorticoids|mesh-ancestor
101622810|NCT02690922|Hormones|hormones|mesh-ancestor
101622811|NCT02690922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101622812|NCT02690922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101622813|NCT02690922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101622814|NCT02690922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101622815|NCT02690922|Abortifacient Agents|abortifacient agents|mesh-ancestor
101622816|NCT02690922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101622817|NCT02690922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101622818|NCT02690922|Antimetabolites|antimetabolites|mesh-ancestor
101622819|NCT02690922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622820|NCT02690922|Dermatologic Agents|dermatologic agents|mesh-ancestor
101622821|NCT02690922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101622822|NCT02690922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101622848|NCT04202406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101622849|NCT04202406|Narcotics|narcotics|mesh-ancestor
101622850|NCT04202406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101622851|NCT04202406|Antitussive Agents|antitussive agents|mesh-ancestor
101622852|NCT04202406|Respiratory System Agents|respiratory system agents|mesh-ancestor
101622853|NCT02846766|Lenvatinib|lenvatinib|mesh-list
101622854|NCT02846766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101622855|NCT02846766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101622856|NCT02846766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101622857|NCT02846766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622858|NCT00839956|Bortezomib|bortezomib|mesh-list
101622859|NCT00839956|Vorinostat|vorinostat|mesh-list
101622860|NCT00839956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101622861|NCT00839956|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101622862|NCT00839956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775305|NCT00936195|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101622863|NCT00839956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622865|NCT00839800|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101622866|NCT00839800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101622867|NCT00839800|Respiratory System Agents|respiratory system agents|mesh-ancestor
101622868|NCT00839800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101622869|NCT00839800|Autonomic Agents|autonomic agents|mesh-ancestor
101622870|NCT00839800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101622871|NCT00839800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622872|NCT00839800|Sympathomimetics|sympathomimetics|mesh-ancestor
101622873|NCT00839800|Tocolytic Agents|tocolytic agents|mesh-ancestor
101622890|NCT00867321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101622891|NCT00867321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101622892|NCT00867321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622893|NCT00913666|Interferons|interferons|mesh-list
101622894|NCT00913666|Interferon-beta|interferon-beta|mesh-list
101622895|NCT00913666|Interferon beta-1a|interferon beta-1a|mesh-list
101622896|NCT00913666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101622897|NCT00913666|Antiviral Agents|antiviral agents|mesh-ancestor
101622898|NCT00913666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101622899|NCT00913666|Immunologic Factors|immunologic factors|mesh-ancestor
101622900|NCT00913666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622901|NCT00913666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101622902|NCT05756764|Liraglutide|liraglutide|mesh-list
101622904|NCT05756764|Phentermine|phentermine|mesh-list
101622905|NCT05756764|Glucagon|glucagon|mesh-list
101622906|NCT05756764|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101622907|NCT05756764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101622908|NCT05756764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622909|NCT05756764|Incretins|incretins|mesh-ancestor
101622910|NCT05756764|Hormones|hormones|mesh-ancestor
101622911|NCT05756764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101622912|NCT05756764|Anticonvulsants|anticonvulsants|mesh-ancestor
101622913|NCT05756764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101622914|NCT05756764|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101622915|NCT05756764|Appetite Depressants|appetite depressants|mesh-ancestor
101945434|NCT01256619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945435|NCT01256619|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101945436|NCT01256619|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101945438|NCT01256619|Hormones|hormones|mesh-ancestor
101945439|NCT01256619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101945440|NCT03898011|Lamotrigine|lamotrigine|mesh-list
101945441|NCT03898011|Anticonvulsants|anticonvulsants|mesh-ancestor
101945442|NCT03898011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101945443|NCT03898011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101945444|NCT03898011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945445|NCT03898011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101945446|NCT03898011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945447|NCT03898011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101945448|NCT03898011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101945449|NCT03898011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101945450|NCT03898011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101622916|NCT05756764|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101622917|NCT05756764|Sympathomimetics|sympathomimetics|mesh-ancestor
101622918|NCT05756764|Autonomic Agents|autonomic agents|mesh-ancestor
101622919|NCT05756764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101622920|NCT05756764|Adrenergic Agents|adrenergic agents|mesh-ancestor
101622921|NCT05756764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101622922|NCT05756764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622923|NCT05308095|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101622924|NCT05308095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622925|NCT02601157|Aspirin|aspirin|mesh-list
101622926|NCT02601157|Clopidogrel|clopidogrel|mesh-list
101622927|NCT02601157|Ticagrelor|ticagrelor|mesh-list
101622928|NCT02601157|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101622929|NCT02601157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101622930|NCT02601157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101622931|NCT02601157|Analgesics|analgesics|mesh-ancestor
101622932|NCT02601157|Sensory System Agents|sensory system agents|mesh-ancestor
101421587|NCT00472108|Dermatologic Agents|dermatologic agents|mesh-ancestor
101622946|NCT02601157|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101622947|NCT02601157|Purinergic Agents|purinergic agents|mesh-ancestor
101622948|NCT02601157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101622950|NCT02784717|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101622951|NCT02784717|Antithrombins|antithrombins|mesh-ancestor
101622952|NCT02784717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101622953|NCT02784717|Protease Inhibitors|protease inhibitors|mesh-ancestor
101622954|NCT02784717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101622955|NCT02784717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622956|NCT02784717|Anticoagulants|anticoagulants|mesh-ancestor
101622957|NCT00902304|Amlodipine|amlodipine|mesh-list
101622958|NCT00902304|Valsartan|valsartan|mesh-list
101622959|NCT00902304|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101622960|NCT00902304|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
101622961|NCT00902304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101622962|NCT00902304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101622963|NCT00902304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101622964|NCT00902304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622965|NCT00902304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101622966|NCT00902304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622967|NCT00902304|Vasodilator Agents|vasodilator agents|mesh-ancestor
101945451|NCT03898011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101945452|NCT01254513|Prednisone|prednisone|mesh-list
101945453|NCT01254513|Docetaxel|docetaxel|mesh-list
101945454|NCT01254513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101945455|NCT01254513|Tubulin Modulators|tubulin modulators|mesh-ancestor
101945456|NCT01254513|Antimitotic Agents|antimitotic agents|mesh-ancestor
101945457|NCT01254513|Mitosis Modulators|mitosis modulators|mesh-ancestor
101945458|NCT01254513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945459|NCT01254513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101945460|NCT01254513|Glucocorticoids|glucocorticoids|mesh-ancestor
101945461|NCT01254513|Hormones|hormones|mesh-ancestor
101945462|NCT01254513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101945463|NCT01254513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622968|NCT00902304|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101622969|NCT00902304|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101622970|NCT00902304|Diuretics|diuretics|mesh-ancestor
101622971|NCT00902304|Natriuretic Agents|natriuretic agents|mesh-ancestor
101622972|NCT00902304|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101622973|NCT02784795|Carboplatin|carboplatin|mesh-list
101622974|NCT02784795|Gemcitabine|gemcitabine|mesh-list
101622975|NCT02784795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101622976|NCT02784795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101622977|NCT02784795|Antimetabolites|antimetabolites|mesh-ancestor
101622978|NCT02784795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622979|NCT05282277|Raclopride|raclopride|mesh-list
101622980|NCT05282277|Estradiol|estradiol|mesh-list
101622981|NCT05282277|Progesterone|progesterone|mesh-list
101622982|NCT05282277|Estrogens|estrogens|mesh-ancestor
101622983|NCT05282277|Hormones|hormones|mesh-ancestor
101622984|NCT05282277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101622985|NCT05282277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622986|NCT05282277|Progestins|progestins|mesh-ancestor
101622987|NCT05282277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101622988|NCT05282277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101622989|NCT05282277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101622990|NCT05282277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101623002|NCT02848794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101623003|NCT02848794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623004|NCT02848794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101623005|NCT02848794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101623006|NCT04096027|Cabergoline|cabergoline|mesh-list
101623007|NCT04096027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101623008|NCT04096027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101623009|NCT04096027|Dopamine Agonists|dopamine agonists|mesh-ancestor
101623010|NCT04096027|Dopamine Agents|dopamine agents|mesh-ancestor
101623011|NCT04096027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101623012|NCT04096027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623013|NCT04096027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623015|NCT04216134|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101623016|NCT04216134|Chelating Agents|chelating agents|mesh-ancestor
101623017|NCT04216134|Sequestering Agents|sequestering agents|mesh-ancestor
101623018|NCT04216134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623019|NCT04216134|Anticoagulants|anticoagulants|mesh-ancestor
101623020|NCT04216134|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101623021|NCT04216134|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101623023|NCT00638079|Megestrol Acetate|megestrol acetate|mesh-list
101623024|NCT00638079|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101623025|NCT00638079|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101623026|NCT00638079|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101623027|NCT00638079|Contraceptive Agents|contraceptive agents|mesh-ancestor
101623028|NCT00638079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101623029|NCT00638079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945464|NCT01254513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101945465|NCT01254591|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101945466|NCT01254591|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101945467|NCT01254591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945468|NCT01149993|Mycophenolic Acid|mycophenolic acid|mesh-list
101623030|NCT00638079|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101623031|NCT00638079|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101623032|NCT00638079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101623033|NCT00638079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101623034|NCT00638079|Appetite Stimulants|appetite stimulants|mesh-ancestor
101623035|NCT00638079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101623036|NCT00759031|Listerine|listerine|mesh-list
101623037|NCT00759031|Triclosan|triclosan|mesh-list
101623038|NCT00759031|Fluorides|fluorides|mesh-list
101623039|NCT00759031|Sodium Fluoride|sodium fluoride|mesh-list
101623040|NCT00759031|Fluorophosphate|fluorophosphate|mesh-list
101623041|NCT00759031|Cariostatic Agents|cariostatic agents|mesh-ancestor
101623042|NCT00759031|Protective Agents|protective agents|mesh-ancestor
101623043|NCT00759031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623044|NCT00759031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101623045|NCT00759031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101623046|NCT00759031|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101623047|NCT00759031|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101623048|NCT00759031|Antimetabolites|antimetabolites|mesh-ancestor
101623049|NCT00759031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623050|NCT00759031|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101623051|NCT04197219|Pembrolizumab|pembrolizumab|mesh-list
101623052|NCT04197219|Axitinib|axitinib|mesh-list
101623053|NCT04197219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101623054|NCT04197219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101623055|NCT04197219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101623074|NCT02512497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623075|NCT02512497|Alkylating Agents|alkylating agents|mesh-ancestor
101623076|NCT02512497|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101623077|NCT02512497|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101623078|NCT02512497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101623079|NCT02512497|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101623080|NCT02512497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101623081|NCT00916669|Etoposide|etoposide|mesh-list
101623082|NCT00916669|Enoxaparin|enoxaparin|mesh-list
101623083|NCT00916669|Enoxaparin sodium|enoxaparin sodium|mesh-list
101623084|NCT00916669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101623085|NCT00916669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101623086|NCT00916669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101623087|NCT00916669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101623088|NCT00916669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101623089|NCT00916669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623090|NCT00916669|Anticoagulants|anticoagulants|mesh-ancestor
101623091|NCT00916669|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101623092|NCT00916669|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101623093|NCT02784015|Cyclophosphamide|cyclophosphamide|mesh-list
101623094|NCT02784015|Melphalan|melphalan|mesh-list
101623095|NCT02784015|Ifosfamide|ifosfamide|mesh-list
101623096|NCT02784015|Thiotepa|thiotepa|mesh-list
101623097|NCT02784015|Carboplatin|carboplatin|mesh-list
101623098|NCT02784015|Doxorubicin|doxorubicin|mesh-list
101623099|NCT02784015|Etoposide|etoposide|mesh-list
101623100|NCT02784015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101623101|NCT02784015|Immunologic Factors|immunologic factors|mesh-ancestor
101623102|NCT02784015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623103|NCT02784015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101623104|NCT02784015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101623105|NCT02784015|Alkylating Agents|alkylating agents|mesh-ancestor
101623106|NCT02784015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623107|NCT02784015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101623108|NCT02784015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101623109|NCT02784015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101623110|NCT02784015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101623111|NCT02784015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101623112|NCT02784015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101945471|NCT01149993|Immunologic Factors|immunologic factors|mesh-ancestor
101945472|NCT01149993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945473|NCT01149993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101945474|NCT01149993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101945475|NCT01149993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101945476|NCT01149993|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101945477|NCT01149993|Antitubercular Agents|antitubercular agents|mesh-ancestor
101945478|NCT01149993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101945479|NCT01149993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101945480|NCT01149993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101945481|NCT01149993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945482|NCT01255371|Lopinavir|lopinavir|mesh-list
101945483|NCT01255371|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101945484|NCT01255371|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101945485|NCT01255371|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101945486|NCT01255371|Protease Inhibitors|protease inhibitors|mesh-ancestor
101945487|NCT01255371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101945488|NCT01255371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945489|NCT01255371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101623113|NCT02784015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101623114|NCT02601235|Pyrilamine|pyrilamine|mesh-list
101623126|NCT02601235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101623127|NCT02601235|Nasal Decongestants|nasal decongestants|mesh-ancestor
101623128|NCT02601235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101623129|NCT02601235|Respiratory System Agents|respiratory system agents|mesh-ancestor
101623130|NCT02601235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101623131|NCT02601235|Mydriatics|mydriatics|mesh-ancestor
101623132|NCT02601235|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101623133|NCT02601235|Protective Agents|protective agents|mesh-ancestor
101623134|NCT02601235|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101623135|NCT02601235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101623136|NCT02601235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101623137|NCT02601235|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101623138|NCT02601235|Histamine Antagonists|histamine antagonists|mesh-ancestor
101623139|NCT02601235|Histamine Agents|histamine agents|mesh-ancestor
101623140|NCT02601235|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101623141|NCT02783937|Lenograstim|lenograstim|mesh-list
101623142|NCT02783937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101623143|NCT02783937|Immunologic Factors|immunologic factors|mesh-ancestor
101623144|NCT02783937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623145|NCT02846142|Levonorgestrel|levonorgestrel|mesh-list
101623146|NCT02846142|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101623147|NCT02846142|Estradiol|estradiol|mesh-list
101623148|NCT02846142|Estrogens|estrogens|mesh-ancestor
101623149|NCT02846142|Hormones|hormones|mesh-ancestor
101623150|NCT02846142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101623151|NCT02846142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623152|NCT02846142|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101623153|NCT02846142|Contraceptive Agents|contraceptive agents|mesh-ancestor
101623154|NCT02846142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101623155|NCT02846142|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101623156|NCT02846142|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101623157|NCT02846142|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101623158|NCT02846142|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101945490|NCT01255371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101945491|NCT01255371|Antiviral Agents|antiviral agents|mesh-ancestor
101945492|NCT01255371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101945493|NCT01255371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101709062|NCT01009567|Cabergoline|cabergoline|mesh-list
101945494|NCT01255371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101945495|NCT03903783|Ceftriaxone|ceftriaxone|mesh-list
101945496|NCT03903783|Cefotaxime|cefotaxime|mesh-list
101945497|NCT03903783|Cefoxitin|cefoxitin|mesh-list
101945498|NCT03903783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101945499|NCT03903783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101945500|NCT03899337|Prednisolone|prednisolone|mesh-list
101945501|NCT03899337|Cyclophosphamide|cyclophosphamide|mesh-list
101945502|NCT03899337|Rituximab|rituximab|mesh-list
101945503|NCT03899337|Doxorubicin|doxorubicin|mesh-list
101945504|NCT03899337|Vincristine|vincristine|mesh-list
101945505|NCT03899337|Acalabrutinib|acalabrutinib|mesh-list
101945506|NCT03899337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101945507|NCT03899337|Immunologic Factors|immunologic factors|mesh-ancestor
101945508|NCT03899337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623159|NCT00757783|Ritonavir|ritonavir|mesh-list
101623160|NCT00757783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101623161|NCT00757783|Darunavir|darunavir|mesh-list
101623162|NCT00757783|Tenofovir|tenofovir|mesh-list
101623163|NCT00757783|Emtricitabine|emtricitabine|mesh-list
101623164|NCT00757783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101623165|NCT00757783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101623166|NCT00757783|Protease Inhibitors|protease inhibitors|mesh-ancestor
101623167|NCT00757783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101623168|NCT00757783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623169|NCT00757783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101623170|NCT00757783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101623171|NCT00757783|Antiviral Agents|antiviral agents|mesh-ancestor
101623172|NCT00757783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101623173|NCT00757783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101623174|NCT00757783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101623175|NCT00757783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101623176|NCT00757783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101623177|NCT05242926|Docetaxel|docetaxel|mesh-list
101623178|NCT05242926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101623179|NCT05242926|Tubulin Modulators|tubulin modulators|mesh-ancestor
101623180|NCT05242926|Antimitotic Agents|antimitotic agents|mesh-ancestor
101623181|NCT05242926|Mitosis Modulators|mitosis modulators|mesh-ancestor
101623204|NCT02845908|Fluorouracil|fluorouracil|mesh-list
101623205|NCT02845908|Oxaliplatin|oxaliplatin|mesh-list
101623206|NCT02845908|Antimetabolites|antimetabolites|mesh-ancestor
101623207|NCT02845908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623208|NCT02845908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101623209|NCT02845908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101623210|NCT02845908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101623211|NCT02845908|Immunologic Factors|immunologic factors|mesh-ancestor
101623212|NCT02845908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623213|NCT02845908|Antidotes|antidotes|mesh-ancestor
101623214|NCT02845908|Protective Agents|protective agents|mesh-ancestor
101623215|NCT02845908|Vitamin B Complex|vitamin b complex|mesh-ancestor
101623216|NCT02845908|Vitamins|vitamins|mesh-ancestor
101623217|NCT02845908|Micronutrients|micronutrients|mesh-ancestor
101623218|NCT02784483|Atezolizumab|atezolizumab|mesh-list
101623219|NCT02784483|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101623220|NCT02784483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623221|NCT02784483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101623222|NCT02784483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101945509|NCT03899337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101945510|NCT03899337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101945511|NCT03899337|Alkylating Agents|alkylating agents|mesh-ancestor
101793603|NCT00618956|Milnacipran|milnacipran|mesh-list
101623223|NCT02784561|Cytarabine|cytarabine|mesh-list
101623224|NCT02784561|Fludarabine|fludarabine|mesh-list
101623225|NCT02784561|Fludarabine phosphate|fludarabine phosphate|mesh-list
101623226|NCT02784561|Busulfan|busulfan|mesh-list
101623227|NCT02784561|Thymoglobulin|thymoglobulin|mesh-list
101623228|NCT02784561|Lenograstim|lenograstim|mesh-list
101623229|NCT02784561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101623230|NCT02784561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101623231|NCT02784561|Antimetabolites|antimetabolites|mesh-ancestor
101623232|NCT02784561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623233|NCT02784561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101623251|NCT00757627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101623252|NCT00757627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101623253|NCT00757627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101709071|NCT00669812|Prednisolone|prednisolone|mesh-list
101623254|NCT00757627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623255|NCT02600455|Abatacept|abatacept|mesh-list
101623256|NCT02600455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101623257|NCT02600455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623258|NCT02600455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101623259|NCT02600455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101623260|NCT02600455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101623261|NCT02600455|Immunologic Factors|immunologic factors|mesh-ancestor
101623262|NCT02600455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623263|NCT02600455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101623264|NCT01023308|Dexamethasone|dexamethasone|mesh-list
101623265|NCT01023308|Bortezomib|bortezomib|mesh-list
101623266|NCT01023308|Panobinostat|panobinostat|mesh-list
101623267|NCT01023308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101623268|NCT01023308|Antiemetics|antiemetics|mesh-ancestor
101623269|NCT01023308|Autonomic Agents|autonomic agents|mesh-ancestor
101623270|NCT01023308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101623271|NCT01023308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623272|NCT01023308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101623273|NCT01023308|Glucocorticoids|glucocorticoids|mesh-ancestor
101623274|NCT01023308|Hormones|hormones|mesh-ancestor
101623275|NCT01023308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101623276|NCT01023308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101623277|NCT01023308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101623278|NCT01023308|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101623279|NCT01023308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101623280|NCT01023308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623281|NCT02781909|Ibuprofen|ibuprofen|mesh-list
101623282|NCT02781909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101623283|NCT02781909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101623284|NCT02781909|Analgesics|analgesics|mesh-ancestor
101623285|NCT02781909|Sensory System Agents|sensory system agents|mesh-ancestor
101623286|NCT02781909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101623287|NCT02781909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623288|NCT02781909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101623289|NCT02781909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101623301|NCT01022996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101623302|NCT02781597|Tranexamic Acid|tranexamic acid|mesh-list
101623303|NCT02781597|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101623304|NCT02781597|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101623305|NCT02781597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623306|NCT02781597|Hemostatics|hemostatics|mesh-ancestor
101623307|NCT02781597|Coagulants|coagulants|mesh-ancestor
101623308|NCT00757237|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101623309|NCT00757237|Tobramycin|tobramycin|mesh-list
101623310|NCT00757237|Aztreonam|aztreonam|mesh-list
101623311|NCT00757237|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101623312|NCT00757237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101623313|NCT00757237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101623314|NCT00757237|Antitubercular Agents|antitubercular agents|mesh-ancestor
101623315|NCT01029392|Vitamin D|vitamin d|mesh-list
101623316|NCT01029392|Cholecalciferol|cholecalciferol|mesh-list
101623317|NCT01029392|Vitamins|vitamins|mesh-ancestor
101623318|NCT01029392|Micronutrients|micronutrients|mesh-ancestor
101623319|NCT01029392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945512|NCT03899337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623320|NCT01029392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101623321|NCT01029392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101623322|NCT02781753|Interferons|interferons|mesh-list
101623323|NCT02781753|Interferon-alpha|interferon-alpha|mesh-list
101623324|NCT02781753|Interferon alpha-2|interferon alpha-2|mesh-list
101623325|NCT02781753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101623326|NCT02781753|Antiviral Agents|antiviral agents|mesh-ancestor
101623327|NCT02781753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101623328|NCT02781753|Immunologic Factors|immunologic factors|mesh-ancestor
101623329|NCT02781753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623330|NCT00903006|Dasatinib|dasatinib|mesh-list
101623331|NCT00903006|Fulvestrant|fulvestrant|mesh-list
101623332|NCT00903006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101623333|NCT00903006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101623334|NCT00903006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101623335|NCT00903006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623336|NCT00903006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101623337|NCT00903006|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101623338|NCT00903006|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101623339|NCT00903006|Hormone Antagonists|hormone antagonists|mesh-ancestor
101623340|NCT00903006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101623341|NCT00903006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623342|NCT04097899|Anti-Infective Agents|anti-infective agents|mesh-list
101623343|NCT04097899|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101623344|NCT02845986|Oxaliplatin|oxaliplatin|mesh-list
101623345|NCT02845986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101623346|NCT00839332|Gemcitabine|gemcitabine|mesh-list
101623347|NCT00839332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101623348|NCT00839332|Antimetabolites|antimetabolites|mesh-ancestor
101623349|NCT00839332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623350|NCT00839332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101623351|NCT04095169|Complement System Proteins|complement system proteins|mesh-list
101623352|NCT04095169|Complement C3|complement c3|mesh-list
101623353|NCT04095169|Complement C3d|complement c3d|mesh-list
101623362|NCT05241912|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101623363|NCT05241912|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101623364|NCT05241912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101623365|NCT05241912|Adrenergic Agents|adrenergic agents|mesh-ancestor
101623366|NCT05241912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101623367|NCT05241912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623368|NCT05241912|Protective Agents|protective agents|mesh-ancestor
101623369|NCT05217654|Dapagliflozin|dapagliflozin|mesh-list
101623370|NCT05217654|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101623371|NCT05217654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623372|NCT05217654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101623373|NCT05217654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623374|NCT04229355|Sorafenib|sorafenib|mesh-list
101623375|NCT04229355|Lenvatinib|lenvatinib|mesh-list
101623376|NCT04229355|Chlorotrianisene|chlorotrianisene|mesh-list
101623377|NCT04229355|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101623378|NCT04229355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101623379|NCT04229355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101623380|NCT04229355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101623381|NCT04229355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623382|NCT04229355|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101623383|NCT04229355|Estrogens|estrogens|mesh-ancestor
101623384|NCT04229355|Hormones|hormones|mesh-ancestor
101623385|NCT04229355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101623386|NCT04229355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623387|NCT04229355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101623388|NCT04229355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101623389|NCT02848170|Olmesartan|olmesartan|mesh-list
101623390|NCT02848170|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101623392|NCT02848170|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101623393|NCT02848170|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101623394|NCT02848170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623395|NCT04420884|Pembrolizumab|pembrolizumab|mesh-list
101623396|NCT04420884|Fluorouracil|fluorouracil|mesh-list
101623397|NCT04420884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101623398|NCT04420884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101945513|NCT03899337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101945514|NCT03899337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101945515|NCT03899337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101623399|NCT04420884|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101623400|NCT04420884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623401|NCT04420884|Antimetabolites|antimetabolites|mesh-ancestor
101623402|NCT04420884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101623403|NCT04420884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101623404|NCT04420884|Immunologic Factors|immunologic factors|mesh-ancestor
101623405|NCT04420884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623406|NCT05341401|Prednisolone|prednisolone|mesh-list
101623407|NCT05341401|Budesonide|budesonide|mesh-list
101623408|NCT05341401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101623409|NCT05341401|Glucocorticoids|glucocorticoids|mesh-ancestor
101623410|NCT05341401|Hormones|hormones|mesh-ancestor
101623411|NCT05341401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101623412|NCT05341401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623413|NCT05341401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101623414|NCT05341401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101623415|NCT05341401|Autonomic Agents|autonomic agents|mesh-ancestor
101623416|NCT05341401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101623417|NCT05341401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101623418|NCT05341401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101623419|NCT05341401|Respiratory System Agents|respiratory system agents|mesh-ancestor
101623433|NCT05078502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623434|NCT05078502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101623435|NCT05078502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101623436|NCT02844894|Dexmedetomidine|dexmedetomidine|mesh-list
101623437|NCT02844894|Esmolol|esmolol|mesh-list
101623438|NCT02844894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101623439|NCT02844894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101623440|NCT02844894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623441|NCT02844894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101623442|NCT02844894|Analgesics|analgesics|mesh-ancestor
101623443|NCT02844894|Sensory System Agents|sensory system agents|mesh-ancestor
101623444|NCT02844894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101623445|NCT02844894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101623446|NCT02844894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101623447|NCT02844894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101623448|NCT02844894|Adrenergic Agents|adrenergic agents|mesh-ancestor
101623449|NCT02844894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101623450|NCT02844894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623451|NCT02844894|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101623452|NCT02844894|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101623453|NCT02844894|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101623454|NCT04778904|Nivolumab|nivolumab|mesh-list
101623455|NCT04778904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101623456|NCT04778904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101623457|NCT04778904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101623458|NCT04778904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623459|NCT00634725|Gemcitabine|gemcitabine|mesh-list
101623460|NCT00634725|Capecitabine|capecitabine|mesh-list
101623461|NCT00634725|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101623462|NCT00634725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101623463|NCT00634725|Antimetabolites|antimetabolites|mesh-ancestor
101623464|NCT00634725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623465|NCT00634725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101623466|NCT00634725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101623467|NCT00634725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101623468|NCT05325489|Budesonide|budesonide|mesh-list
101623469|NCT05325489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101623470|NCT05325489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101623471|NCT05325489|Autonomic Agents|autonomic agents|mesh-ancestor
101623472|NCT05325489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101623473|NCT05325489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623474|NCT05325489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101623475|NCT05325489|Respiratory System Agents|respiratory system agents|mesh-ancestor
101623476|NCT05325489|Glucocorticoids|glucocorticoids|mesh-ancestor
101623477|NCT05325489|Hormones|hormones|mesh-ancestor
101945516|NCT03899337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101945517|NCT03899337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101945518|NCT03899337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101945519|NCT03899337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101945520|NCT03899337|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101945521|NCT03899337|Tubulin Modulators|tubulin modulators|mesh-ancestor
101945522|NCT03899337|Antimitotic Agents|antimitotic agents|mesh-ancestor
101945523|NCT03899337|Mitosis Modulators|mitosis modulators|mesh-ancestor
101945524|NCT03899337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101945525|NCT03899337|Glucocorticoids|glucocorticoids|mesh-ancestor
101945526|NCT03899337|Hormones|hormones|mesh-ancestor
101945527|NCT03899337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101945528|NCT03899337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101945529|NCT01586169|Azithromycin|azithromycin|mesh-list
101945530|NCT01586169|Ivermectin|ivermectin|mesh-list
101945531|NCT01586169|Albendazole|albendazole|mesh-list
101945532|NCT01586169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101945533|NCT01586169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101945534|NCT01586169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101945535|NCT01586169|Anthelmintics|anthelmintics|mesh-ancestor
101945536|NCT01586169|Anticestodal Agents|anticestodal agents|mesh-ancestor
101945537|NCT01586169|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101945538|NCT01586169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101945539|NCT01586169|Tubulin Modulators|tubulin modulators|mesh-ancestor
101623478|NCT05325489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101623479|NCT00902538|Amlodipine|amlodipine|mesh-list
101623480|NCT00902538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101623481|NCT00902538|Olmesartan|olmesartan|mesh-list
101623482|NCT00902538|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101623483|NCT00902538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101623484|NCT00902538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101422134|NCT00158652|Carboplatin|carboplatin|mesh-list
101623486|NCT00902538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623488|NCT00902538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623489|NCT00902538|Vasodilator Agents|vasodilator agents|mesh-ancestor
101623490|NCT00902538|Diuretics|diuretics|mesh-ancestor
101280529|NCT01887691|Eszopiclone|eszopiclone|mesh-list
101623491|NCT00902538|Natriuretic Agents|natriuretic agents|mesh-ancestor
101623492|NCT00902538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101623493|NCT00902538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101623494|NCT00902538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101623495|NCT02780505|Ascorbic Acid|ascorbic acid|mesh-list
101623496|NCT02780505|Vitamins|vitamins|mesh-ancestor
101623497|NCT02780505|Micronutrients|micronutrients|mesh-ancestor
101623498|NCT02780505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623499|NCT02780505|Antioxidants|antioxidants|mesh-ancestor
101623500|NCT02780505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623501|NCT02780505|Protective Agents|protective agents|mesh-ancestor
101623502|NCT02690844|Clonazepam|clonazepam|mesh-list
101623503|NCT02690844|Anticonvulsants|anticonvulsants|mesh-ancestor
101623504|NCT02690844|GABA Modulators|gaba modulators|mesh-ancestor
101623505|NCT02690844|GABA Agents|gaba agents|mesh-ancestor
101623506|NCT02690844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101945540|NCT01586169|Antimitotic Agents|antimitotic agents|mesh-ancestor
101945541|NCT01586169|Mitosis Modulators|mitosis modulators|mesh-ancestor
101793869|NCT00858182|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101623507|NCT02690844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623508|NCT02690844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623509|NCT04201860|Hemostatics|hemostatics|mesh-list
101623510|NCT04201860|Coagulants|coagulants|mesh-ancestor
101623511|NCT02847702|Naproxen|naproxen|mesh-list
101623512|NCT02847702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101623513|NCT02847702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101623514|NCT02847702|Analgesics|analgesics|mesh-ancestor
101623515|NCT02847702|Sensory System Agents|sensory system agents|mesh-ancestor
101623516|NCT02847702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101623517|NCT02847702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623518|NCT02847702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101623519|NCT02847702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101623520|NCT02847702|Gout Suppressants|gout suppressants|mesh-ancestor
101623521|NCT02847702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101623522|NCT02847702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101623523|NCT02847702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623524|NCT02779413|Insulin|insulin|mesh-list
101623525|NCT02779413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101623526|NCT02779413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623527|NCT04887402|Clomiphene|clomiphene|mesh-list
101623528|NCT04887402|Enclomiphene|enclomiphene|mesh-list
101623529|NCT04887402|Zuclomiphene|zuclomiphene|mesh-list
101623530|NCT04887402|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101623531|NCT04887402|Hormone Antagonists|hormone antagonists|mesh-ancestor
101623532|NCT04887402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101623533|NCT04887402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623534|NCT04887402|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101623535|NCT04887402|Fertility Agents|fertility agents|mesh-ancestor
101623536|NCT04887402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101623537|NCT04887402|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101623538|NCT04887402|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101623539|NCT04793568|Interferons|interferons|mesh-list
101623540|NCT04793568|Interferon-gamma|interferon-gamma|mesh-list
101623541|NCT04793568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101623542|NCT04793568|Antiviral Agents|antiviral agents|mesh-ancestor
101623543|NCT04793568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101623544|NCT01979211|Cetuximab|cetuximab|mesh-list
101623545|NCT01979211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101623546|NCT01979211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101623547|NCT05339217|Aldesleukin|aldesleukin|mesh-list
101623548|NCT05339217|Interleukin-2|interleukin-2|mesh-list
101623549|NCT05339217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101623550|NCT05339217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101623551|NCT05339217|Analgesics|analgesics|mesh-ancestor
101623552|NCT05339217|Sensory System Agents|sensory system agents|mesh-ancestor
101623553|NCT05339217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101623554|NCT05339217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623555|NCT05339217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101623556|NCT05339217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101623557|NCT05339217|Antiviral Agents|antiviral agents|mesh-ancestor
101623563|NCT04793490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101623564|NCT04793490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623566|NCT00779532|Moxifloxacin|moxifloxacin|mesh-list
101623567|NCT00779532|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101623569|NCT00779532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101623570|NCT00779532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101623571|NCT00779532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101623572|NCT00779532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101623573|NCT00779532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623574|NCT00779532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101623575|NCT00779532|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101623576|NCT00779532|Contraceptive Agents|contraceptive agents|mesh-ancestor
101623577|NCT00779532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101623578|NCT00779532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623579|NCT00779532|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101623580|NCT00779532|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101623581|NCT00779532|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101623582|NCT05319093|Ozanimod|ozanimod|mesh-list
101945542|NCT01586169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945543|NCT01586169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101623583|NCT05319093|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101623584|NCT05319093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623585|NCT05319093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101623586|NCT05319093|Immunologic Factors|immunologic factors|mesh-ancestor
101709114|NCT02697851|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101623587|NCT05319093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623588|NCT00752557|Calcium, Dietary|calcium, dietary|mesh-list
101623589|NCT00752557|Vitamin D|vitamin d|mesh-list
101623590|NCT00752557|Ergocalciferols|ergocalciferols|mesh-list
101623591|NCT00752557|Cholecalciferol|cholecalciferol|mesh-list
101623592|NCT00752557|Diphosphonates|diphosphonates|mesh-list
101623593|NCT00752557|Vitamins|vitamins|mesh-list
101623594|NCT00752557|Calcium|calcium|mesh-list
101623595|NCT00752557|Micronutrients|micronutrients|mesh-ancestor
101623596|NCT00752557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623597|NCT00752557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101623598|NCT00752557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101623599|NCT04570176|Epinephrine|epinephrine|mesh-list
101623600|NCT04570176|Racepinephrine|racepinephrine|mesh-list
101623601|NCT04570176|Epinephryl borate|epinephryl borate|mesh-list
101623602|NCT04570176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101623603|NCT04570176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101623604|NCT04570176|Adrenergic Agents|adrenergic agents|mesh-ancestor
101623605|NCT04570176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101623606|NCT04570176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623607|NCT04570176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623608|NCT04570176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101623609|NCT04570176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101623610|NCT04570176|Autonomic Agents|autonomic agents|mesh-ancestor
101623611|NCT04570176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101623612|NCT04570176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101623613|NCT04570176|Respiratory System Agents|respiratory system agents|mesh-ancestor
101623614|NCT04570176|Mydriatics|mydriatics|mesh-ancestor
101623615|NCT04570176|Sympathomimetics|sympathomimetics|mesh-ancestor
101623616|NCT04570176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101623617|NCT00751218|Cetirizine|cetirizine|mesh-list
101623619|NCT00751218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101623620|NCT00751218|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101623621|NCT00751218|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101623622|NCT00751218|Histamine Antagonists|histamine antagonists|mesh-ancestor
101623623|NCT00751218|Histamine Agents|histamine agents|mesh-ancestor
101623624|NCT00751218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101623625|NCT00751218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623626|NCT00751218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623627|NCT00751218|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101623628|NCT00751218|Cholinergic Agents|cholinergic agents|mesh-ancestor
101623629|NCT02779569|Decitabine|decitabine|mesh-list
101623633|NCT02779569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101623634|NCT02779569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101623636|NCT04095013|Dexmedetomidine|dexmedetomidine|mesh-list
101623637|NCT04095013|Bupivacaine|bupivacaine|mesh-list
101623638|NCT04095013|Anesthetics, Local|anesthetics, local|mesh-ancestor
101623639|NCT04095013|Anesthetics|anesthetics|mesh-ancestor
101623640|NCT04095013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101623641|NCT04095013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623642|NCT04095013|Sensory System Agents|sensory system agents|mesh-ancestor
101623643|NCT04095013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101623644|NCT04095013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101623645|NCT04095013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101623646|NCT04095013|Analgesics|analgesics|mesh-ancestor
101623647|NCT04095013|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101623648|NCT04095013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101623649|NCT04095013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101623650|NCT04095013|Adrenergic Agents|adrenergic agents|mesh-ancestor
101623651|NCT04095013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101623652|NCT04095013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623653|NCT04095013|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101623654|NCT04095013|Narcotics|narcotics|mesh-ancestor
101623655|NCT04095013|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101623656|NCT04095013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101623657|NCT04095013|Anesthetics, General|anesthetics, general|mesh-ancestor
101623658|NCT02779881|Caseins|caseins|mesh-list
101623659|NCT02779881|Chelating Agents|chelating agents|mesh-ancestor
101945545|NCT01256775|Nitroaspirin|nitroaspirin|mesh-list
101945546|NCT01256775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101945547|NCT01256775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101945548|NCT01256775|Analgesics|analgesics|mesh-ancestor
101945549|NCT01256775|Sensory System Agents|sensory system agents|mesh-ancestor
101945550|NCT01256775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101945551|NCT01256775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945552|NCT01256775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101945553|NCT01256775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101945554|NCT01256775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101945555|NCT01256775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101945556|NCT01256775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945557|NCT01256775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101945558|NCT01256775|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
101945559|NCT01256775|Protease Inhibitors|protease inhibitors|mesh-ancestor
101623660|NCT02779881|Sequestering Agents|sequestering agents|mesh-ancestor
101623661|NCT02779881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623662|NCT00651378|Atorvastatin|atorvastatin|mesh-list
101623663|NCT00651378|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101623664|NCT00651378|Ezetimibe|ezetimibe|mesh-list
101623665|NCT00651378|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101623666|NCT00651378|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101623667|NCT00651378|Antimetabolites|antimetabolites|mesh-ancestor
101623668|NCT00651378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623669|NCT00651378|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101623670|NCT00651378|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101623671|NCT00651378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101623672|NCT00747643|Varenicline|varenicline|mesh-list
101623673|NCT00747643|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101623674|NCT00747643|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101623675|NCT00747643|Cholinergic Agents|cholinergic agents|mesh-ancestor
101623676|NCT00747643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101623677|NCT00747643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623678|NCT00747643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623679|NCT00627692|Prucalopride|prucalopride|mesh-list
101623680|NCT00627692|Laxatives|laxatives|mesh-ancestor
101623681|NCT00627692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101623682|NCT00627692|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101623683|NCT00627692|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101623684|NCT00627692|Serotonin Agents|serotonin agents|mesh-ancestor
101623685|NCT00627692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101623686|NCT00627692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623687|NCT00627692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623688|NCT00634881|Alemtuzumab|alemtuzumab|mesh-list
101623689|NCT00634881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101623690|NCT00634881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101623691|NCT04301882|Interferons|interferons|mesh-list
101623692|NCT04301882|Ribavirin|ribavirin|mesh-list
101623693|NCT04301882|Antiviral Agents|antiviral agents|mesh-list
101623694|NCT04301882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101623695|NCT04301882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101623696|NCT04301882|Antimetabolites|antimetabolites|mesh-ancestor
101623697|NCT04301882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623698|NCT04300322|Progesterone|progesterone|mesh-list
101623699|NCT04300322|Progestins|progestins|mesh-ancestor
101623700|NCT04300322|Hormones|hormones|mesh-ancestor
101422337|NCT00158847|Respiratory System Agents|respiratory system agents|mesh-ancestor
101945560|NCT01256775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101945561|NCT01256775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101945562|NCT01256775|Antipyretics|antipyretics|mesh-ancestor
101623717|NCT00311844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623719|NCT00311844|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101623721|NCT00311844|Histamine Antagonists|histamine antagonists|mesh-ancestor
101623722|NCT00311844|Histamine Agents|histamine agents|mesh-ancestor
101623723|NCT02599675|Vitamin D|vitamin d|mesh-list
101623724|NCT02599675|Cholecalciferol|cholecalciferol|mesh-list
101623725|NCT02599675|Vitamins|vitamins|mesh-ancestor
101623726|NCT02599675|Micronutrients|micronutrients|mesh-ancestor
101623727|NCT02599675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623728|NCT02599675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101623729|NCT02599675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101623730|NCT02778789|Adalimumab|adalimumab|mesh-list
101623731|NCT02778789|Infliximab|infliximab|mesh-list
101623732|NCT02778789|Golimumab|golimumab|mesh-list
101623733|NCT02778789|Certolizumab Pegol|certolizumab pegol|mesh-list
101623734|NCT02778789|Etanercept|etanercept|mesh-list
101623735|NCT02778789|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101623736|NCT02778789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101623737|NCT02778789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101623738|NCT02778789|Dermatologic Agents|dermatologic agents|mesh-ancestor
101623739|NCT02778789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101623740|NCT02778789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101623741|NCT02778789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101623742|NCT02778789|Analgesics|analgesics|mesh-ancestor
101623743|NCT02778789|Sensory System Agents|sensory system agents|mesh-ancestor
101623744|NCT02778789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101623745|NCT02778789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623746|NCT02778789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101623747|NCT02778789|Immunologic Factors|immunologic factors|mesh-ancestor
101623748|NCT00212784|Olanzapine|olanzapine|mesh-list
101623749|NCT00212784|Asenapine|asenapine|mesh-list
101623750|NCT00212784|Antiemetics|antiemetics|mesh-ancestor
101623751|NCT00212784|Autonomic Agents|autonomic agents|mesh-ancestor
101623752|NCT00212784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101623753|NCT00212784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623754|NCT00212784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101623755|NCT00212784|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101623756|NCT00212784|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101623757|NCT00212784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101623758|NCT00212784|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101623759|NCT00212784|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101623760|NCT00212784|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101623761|NCT00212784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101623762|NCT00212784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623763|NCT00212784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101623764|NCT00212784|Serotonin Agents|serotonin agents|mesh-ancestor
101623765|NCT00751933|Vaccines|vaccines|mesh-list
101623766|NCT00751933|Immunologic Factors|immunologic factors|mesh-ancestor
101623767|NCT00751933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623768|NCT04092751|Ibrexafungerp|ibrexafungerp|mesh-list
101623769|NCT04092751|Antifungal Agents|antifungal agents|mesh-ancestor
101623770|NCT04092751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101623772|NCT02778945|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101623773|NCT02778945|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101623784|NCT02721342|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101623785|NCT02721342|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101623786|NCT02779101|Pembrolizumab|pembrolizumab|mesh-list
101623787|NCT02779101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101623788|NCT02779101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101623789|NCT02779101|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101623790|NCT02779101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623791|NCT02779959|Prochlorperazine|prochlorperazine|mesh-list
101623792|NCT02779959|Antiemetics|antiemetics|mesh-ancestor
101623793|NCT02779959|Autonomic Agents|autonomic agents|mesh-ancestor
101623794|NCT02779959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101623795|NCT02779959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623796|NCT02779959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101623797|NCT02779959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101623798|NCT02779959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101945563|NCT03899571|Oseltamivir|oseltamivir|mesh-list
101945564|NCT03899571|Antiviral Agents|antiviral agents|mesh-ancestor
101945565|NCT03899571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101945566|NCT03899571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101945567|NCT03899571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945568|NCT01257009|Atorvastatin|atorvastatin|mesh-list
101623799|NCT02779959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101623800|NCT02779959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101623801|NCT02779959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101623802|NCT02779959|Dopamine Agents|dopamine agents|mesh-ancestor
101623803|NCT02779959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101623804|NCT02779959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623805|NCT05335278|Nintedanib|nintedanib|mesh-list
101623806|NCT05335278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101623807|NCT05335278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101623808|NCT05335278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101623809|NCT05335278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623810|NCT00092898|Ezetimibe|ezetimibe|mesh-list
101623811|NCT00092898|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101623812|NCT00092898|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101623813|NCT00092898|Antimetabolites|antimetabolites|mesh-ancestor
101623814|NCT00092898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623815|NCT00092898|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101623816|NCT04094467|Leuprolide|leuprolide|mesh-list
101623817|NCT04094467|Cetrorelix|cetrorelix|mesh-list
101623818|NCT04094467|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101623819|NCT04094467|Fertility Agents|fertility agents|mesh-ancestor
101623820|NCT04094467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101623821|NCT04094467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623822|NCT04094467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101623823|NCT04094467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101623824|NCT04094467|Hormone Antagonists|hormone antagonists|mesh-ancestor
101623825|NCT04094467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101623826|NCT04987281|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101623827|NCT00092820|Ezetimibe|ezetimibe|mesh-list
101623828|NCT00092820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101623829|NCT00092820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101623830|NCT00092820|Antimetabolites|antimetabolites|mesh-ancestor
101623831|NCT00092820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623832|NCT00092820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101623833|NCT04228263|Aspirin|aspirin|mesh-list
101623834|NCT04228263|Folic Acid|folic acid|mesh-list
101623835|NCT04228263|Hydroxychloroquine|hydroxychloroquine|mesh-list
101623836|NCT04228263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101422475|NCT00510913|Tacrolimus|tacrolimus|mesh-list
101623847|NCT04228263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101623848|NCT04228263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101623849|NCT04228263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101623850|NCT04228263|Antipyretics|antipyretics|mesh-ancestor
101623851|NCT04228263|Antimalarials|antimalarials|mesh-ancestor
101623852|NCT04228263|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101623853|NCT04228263|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101623854|NCT04228263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101623855|NCT04228263|Hematinics|hematinics|mesh-ancestor
101623856|NCT04228263|Vitamin B Complex|vitamin b complex|mesh-ancestor
101623857|NCT04228263|Vitamins|vitamins|mesh-ancestor
101623858|NCT04228263|Micronutrients|micronutrients|mesh-ancestor
101623859|NCT00092742|Diclofenac|diclofenac|mesh-list
101623860|NCT00092742|Etoricoxib|etoricoxib|mesh-list
101623861|NCT00092742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101623862|NCT00092742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101623863|NCT00092742|Analgesics|analgesics|mesh-ancestor
101623864|NCT00092742|Sensory System Agents|sensory system agents|mesh-ancestor
101623865|NCT00092742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101623866|NCT00092742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623867|NCT00092742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101623868|NCT00092742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101623869|NCT00092742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101623870|NCT00092742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101623871|NCT00092742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623872|NCT00092742|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101945569|NCT01257009|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101945570|NCT01257009|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101945571|NCT01257009|Antimetabolites|antimetabolites|mesh-ancestor
101623873|NCT02844270|Sirolimus|sirolimus|mesh-list
101623874|NCT02844270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101623875|NCT02844270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101623876|NCT02844270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101623877|NCT02844270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101623878|NCT02844270|Antifungal Agents|antifungal agents|mesh-ancestor
101623879|NCT02844270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101623880|NCT02844270|Immunologic Factors|immunologic factors|mesh-ancestor
101623881|NCT02844270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623882|NCT00634959|Maraviroc|maraviroc|mesh-list
101623883|NCT00634959|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101623884|NCT00634959|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101623885|NCT00634959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623886|NCT00634959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101623887|NCT00634959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101623888|NCT00634959|Antiviral Agents|antiviral agents|mesh-ancestor
101623889|NCT00634959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101623890|NCT00634959|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101623891|NCT02598427|Trastuzumab|trastuzumab|mesh-list
101623892|NCT02598427|Pertuzumab|pertuzumab|mesh-list
101623893|NCT02598427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101623894|NCT02598427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101623895|NCT04092595|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101623896|NCT04092595|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101623897|NCT04092595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101623898|NCT04092595|Antimetabolites|antimetabolites|mesh-ancestor
101623899|NCT04092595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623900|NCT04092595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101623901|NCT04092595|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101623902|NCT04092595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101422539|NCT00511498|Sildenafil Citrate|sildenafil citrate|mesh-list
101623929|NCT01027754|Cholinergic Agents|cholinergic agents|mesh-ancestor
101623930|NCT01027754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101623931|NCT01027754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623932|NCT01027754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623933|NCT02773017|Dexmedetomidine|dexmedetomidine|mesh-list
101623934|NCT02773017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101623935|NCT02773017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101623936|NCT02773017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623937|NCT02773017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101623938|NCT02773017|Analgesics|analgesics|mesh-ancestor
101623939|NCT02773017|Sensory System Agents|sensory system agents|mesh-ancestor
101623940|NCT02773017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101623941|NCT02773017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101623942|NCT02773017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101623943|NCT02773017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101623944|NCT02773017|Adrenergic Agents|adrenergic agents|mesh-ancestor
101623945|NCT02773017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101623946|NCT02773017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623947|NCT02776059|Prednisolone|prednisolone|mesh-list
101623948|NCT02776059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101623949|NCT02776059|Glucocorticoids|glucocorticoids|mesh-ancestor
101623958|NCT00774930|Hormones|hormones|mesh-ancestor
101623959|NCT00774930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101623960|NCT00774930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623961|NCT02841774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101623962|NCT02841774|Pravastatin|pravastatin|mesh-list
101623963|NCT02841774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101623964|NCT02841774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101623965|NCT02841774|Antimetabolites|antimetabolites|mesh-ancestor
101623966|NCT02841774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623967|NCT02841774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101623968|NCT02841774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101623969|NCT02841774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101623970|NCT02772237|Riboflavin|riboflavin|mesh-list
101623971|NCT02772237|Vitamins|vitamins|mesh-ancestor
101623972|NCT02772237|Micronutrients|micronutrients|mesh-ancestor
101623973|NCT02772237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623974|NCT02772237|Vitamin B Complex|vitamin b complex|mesh-ancestor
101945572|NCT01257009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945573|NCT01257009|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101945574|NCT01257009|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101623975|NCT02772237|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101623976|NCT02772237|Dermatologic Agents|dermatologic agents|mesh-ancestor
101623977|NCT02841306|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101623978|NCT02841306|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101623979|NCT02841306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101623980|NCT01316250|Imatinib Mesylate|imatinib mesylate|mesh-list
101623981|NCT01316250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101623982|NCT01316250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101623983|NCT01316250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101623984|NCT01316250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623985|NCT02771925|Gabapentin|gabapentin|mesh-list
101623986|NCT02771925|Analgesics|analgesics|mesh-ancestor
101623987|NCT02771925|Sensory System Agents|sensory system agents|mesh-ancestor
101281084|NCT01894269|Lamivudine|lamivudine|mesh-list
101623988|NCT02771925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101623989|NCT02771925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623991|NCT02771925|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101623992|NCT02771925|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101623993|NCT02771925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101623994|NCT02771925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101623995|NCT02771925|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101623996|NCT02771925|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101623997|NCT02771925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101623998|NCT02771925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623999|NCT02771925|Antimanic Agents|antimanic agents|mesh-ancestor
101624000|NCT03205956|Levodopa|levodopa|mesh-list
101624001|NCT03205956|Carbidopa|carbidopa|mesh-list
101624002|NCT03205956|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101624003|NCT03205956|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101624004|NCT03205956|Dopamine Agents|dopamine agents|mesh-ancestor
101624005|NCT03205956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101624006|NCT03205956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624007|NCT03205956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624008|NCT03205956|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101624009|NCT03205956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101624010|NCT02840994|Pembrolizumab|pembrolizumab|mesh-list
101624011|NCT02840994|Nivolumab|nivolumab|mesh-list
101624012|NCT02840994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101624013|NCT02840994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101624014|NCT02840994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101624015|NCT02840994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624024|NCT02843802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624026|NCT02771379|Antioxidants|antioxidants|mesh-ancestor
101624027|NCT02771379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624028|NCT02771379|Protective Agents|protective agents|mesh-ancestor
101624029|NCT02771379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624030|NCT01026870|Mometasone Furoate|mometasone furoate|mesh-list
101624031|NCT01026870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101624032|NCT01026870|Dermatologic Agents|dermatologic agents|mesh-ancestor
101624033|NCT01026870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101624034|NCT02844114|Cisplatin|cisplatin|mesh-list
101624035|NCT02844114|Gemcitabine|gemcitabine|mesh-list
101624036|NCT02844114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101624037|NCT02844114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101624038|NCT02844114|Antimetabolites|antimetabolites|mesh-ancestor
101624039|NCT02844114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624040|NCT02696733|Cephalosporins|cephalosporins|mesh-list
101624041|NCT02696733|Lidocaine|lidocaine|mesh-list
101624042|NCT02696733|Anesthetics, Local|anesthetics, local|mesh-ancestor
101624043|NCT02696733|Anesthetics|anesthetics|mesh-ancestor
101624044|NCT02696733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101624045|NCT02696733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624046|NCT02696733|Sensory System Agents|sensory system agents|mesh-ancestor
101624047|NCT02696733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101624048|NCT02696733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101624049|NCT02696733|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101624050|NCT02696733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101945575|NCT01257009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101945577|NCT01255527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101945578|NCT01151787|Amitriptyline|amitriptyline|mesh-list
101945579|NCT01151787|Cyclobenzaprine|cyclobenzaprine|mesh-list
101945580|NCT01151787|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101945581|NCT01151787|Antidepressive Agents|antidepressive agents|mesh-ancestor
101945582|NCT01151787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101945583|NCT01151787|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101945584|NCT01151787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945585|NCT01151787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101945586|NCT01151787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101945587|NCT01151787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101945588|NCT01151787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101945589|NCT01151787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101945590|NCT01151787|Analgesics|analgesics|mesh-ancestor
101945591|NCT01151787|Sensory System Agents|sensory system agents|mesh-ancestor
101945592|NCT01151787|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101945593|NCT01151787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101945594|NCT01151787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101945595|NCT01151787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945596|NCT01151787|Adrenergic Agents|adrenergic agents|mesh-ancestor
101624051|NCT02696733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101624052|NCT02696733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624053|NCT02696733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101624054|NCT02696733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101624055|NCT00897390|Metformin|metformin|mesh-list
101624056|NCT00897390|Saxagliptin|saxagliptin|mesh-list
101624057|NCT00897390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101624058|NCT00897390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624059|NCT00897390|Incretins|incretins|mesh-ancestor
101624060|NCT00897390|Hormones|hormones|mesh-ancestor
101624061|NCT00897390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101624062|NCT00897390|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101624063|NCT00897390|Protease Inhibitors|protease inhibitors|mesh-ancestor
101624064|NCT00897390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101624065|NCT00897390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624066|NCT01034462|Milnacipran|milnacipran|mesh-list
101624067|NCT01034462|Levomilnacipran|levomilnacipran|mesh-list
101624068|NCT01034462|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101624069|NCT01034462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101624070|NCT01034462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101624071|NCT01034462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624072|NCT01034462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101624073|NCT01034462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624074|NCT01034462|Antidepressive Agents|antidepressive agents|mesh-ancestor
101624075|NCT01034462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101624076|NCT01034462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101624077|NCT01034462|Analgesics|analgesics|mesh-ancestor
101624078|NCT01034462|Sensory System Agents|sensory system agents|mesh-ancestor
101624079|NCT01034462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101945597|NCT01151787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101945598|NCT01151865|Dexmedetomidine|dexmedetomidine|mesh-list
101945599|NCT01151865|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101945600|NCT01151865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101945601|NCT01151865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945602|NCT01151865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101945603|NCT01151865|Analgesics|analgesics|mesh-ancestor
101945604|NCT01151865|Sensory System Agents|sensory system agents|mesh-ancestor
101945605|NCT01151865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101945606|NCT01151865|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101945607|NCT01151865|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101945608|NCT01151865|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101945609|NCT01151865|Adrenergic Agents|adrenergic agents|mesh-ancestor
101945610|NCT01151865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101945611|NCT01151865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945612|NCT03893097|Artesunate|artesunate|mesh-list
101945614|NCT03893097|Praziquantel|praziquantel|mesh-list
101945615|NCT03893097|Antimalarials|antimalarials|mesh-ancestor
101945616|NCT03893097|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101945617|NCT03893097|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101945618|NCT03893097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101945619|NCT03893097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101945620|NCT03893097|Antiviral Agents|antiviral agents|mesh-ancestor
101945621|NCT03893097|Schistosomicides|schistosomicides|mesh-ancestor
101945622|NCT03893097|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101945623|NCT03893097|Anthelmintics|anthelmintics|mesh-ancestor
101624080|NCT01033448|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101624081|NCT01033448|Antiviral Agents|antiviral agents|mesh-ancestor
101624083|NCT02873234|Antidepressive Agents|antidepressive agents|mesh-list
101624084|NCT02873234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101624085|NCT02774811|Bimatoprost|bimatoprost|mesh-list
101624086|NCT02774811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101624087|NCT00817050|Fluticasone|fluticasone|mesh-list
101624088|NCT00817050|Mometasone Furoate|mometasone furoate|mesh-list
101624089|NCT00817050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101624090|NCT00817050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101624091|NCT00817050|Autonomic Agents|autonomic agents|mesh-ancestor
101624092|NCT00817050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101624093|NCT00817050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624094|NCT00817050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101624095|NCT00817050|Respiratory System Agents|respiratory system agents|mesh-ancestor
101624096|NCT00817050|Dermatologic Agents|dermatologic agents|mesh-ancestor
101624097|NCT00817050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101624099|NCT04224831|Mitosis Modulators|mitosis modulators|mesh-ancestor
101624100|NCT04224831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624101|NCT00816972|Loratadine|loratadine|mesh-list
101624102|NCT00816972|Mandelic Acids|mandelic acids|mesh-list
101624103|NCT00816972|Oxybutynin|oxybutynin|mesh-list
101624104|NCT00816972|Desloratadine|desloratadine|mesh-list
101624105|NCT00816972|Parasympatholytics|parasympatholytics|mesh-ancestor
101624106|NCT00816972|Autonomic Agents|autonomic agents|mesh-ancestor
101624107|NCT00816972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101945624|NCT01258491|Nicotinic Acids|nicotinic acids|mesh-list
101945625|NCT01258491|Niacin|niacin|mesh-list
101945626|NCT01258491|Niacinamide|niacinamide|mesh-list
101624108|NCT00816972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624109|NCT00816972|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101624110|NCT00816972|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101624111|NCT00816972|Cholinergic Agents|cholinergic agents|mesh-ancestor
101624112|NCT00816972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101624113|NCT00816972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624114|NCT00816972|Urological Agents|urological agents|mesh-ancestor
101624115|NCT00816972|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101624116|NCT00816972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101624117|NCT00816972|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101624118|NCT00816972|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101624119|NCT00816972|Histamine Antagonists|histamine antagonists|mesh-ancestor
101624120|NCT00816972|Histamine Agents|histamine agents|mesh-ancestor
101624121|NCT00816972|Antipruritics|antipruritics|mesh-ancestor
101624122|NCT00816972|Dermatologic Agents|dermatologic agents|mesh-ancestor
101624123|NCT00816972|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101624124|NCT02774499|Methadone|methadone|mesh-list
101624125|NCT02774499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101624126|NCT02774499|Narcotics|narcotics|mesh-ancestor
101624127|NCT02774499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101624128|NCT02774499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624129|NCT02774499|Analgesics|analgesics|mesh-ancestor
101624130|NCT02774499|Sensory System Agents|sensory system agents|mesh-ancestor
101624131|NCT02774499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101624132|NCT02774499|Antitussive Agents|antitussive agents|mesh-ancestor
101624133|NCT02774499|Respiratory System Agents|respiratory system agents|mesh-ancestor
101624134|NCT02770443|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101624135|NCT02770443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101624136|NCT02770443|Adrenergic Agents|adrenergic agents|mesh-ancestor
101624137|NCT02770443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101624138|NCT02770443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624139|NCT02770443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624140|NCT02774187|Leucovorin|leucovorin|mesh-list
101624141|NCT02774187|Fluorouracil|fluorouracil|mesh-list
101624142|NCT02774187|Oxaliplatin|oxaliplatin|mesh-list
101624144|NCT02774187|Antimetabolites|antimetabolites|mesh-ancestor
101624145|NCT02774187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624146|NCT02774187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101624147|NCT02774187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101624148|NCT02774187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101624149|NCT02774187|Immunologic Factors|immunologic factors|mesh-ancestor
101624150|NCT02774187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624151|NCT02774187|Antidotes|antidotes|mesh-ancestor
101624152|NCT02774187|Protective Agents|protective agents|mesh-ancestor
101624153|NCT02774187|Vitamin B Complex|vitamin b complex|mesh-ancestor
101624154|NCT02774187|Vitamins|vitamins|mesh-ancestor
101624155|NCT02774187|Micronutrients|micronutrients|mesh-ancestor
101624156|NCT02774187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101624157|NCT02774187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101624158|NCT02773797|Dexmedetomidine|dexmedetomidine|mesh-list
101624161|NCT02773797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624162|NCT02773797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101624163|NCT02773797|Analgesics|analgesics|mesh-ancestor
101624164|NCT02773797|Sensory System Agents|sensory system agents|mesh-ancestor
101624165|NCT02773797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101624166|NCT02773797|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101624167|NCT02773797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101624168|NCT02773797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101624169|NCT02773797|Adrenergic Agents|adrenergic agents|mesh-ancestor
101624170|NCT02773797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101624171|NCT02773797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624172|NCT02773875|Pancrelipase|pancrelipase|mesh-list
101624173|NCT02773875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101624174|NCT02768961|Sofosbuvir|sofosbuvir|mesh-list
101624175|NCT02768961|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
101624176|NCT02768961|Ledipasvir|ledipasvir|mesh-list
101624177|NCT02768961|Antiviral Agents|antiviral agents|mesh-ancestor
101624178|NCT02768961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101624179|NCT02773641|Botulinum Toxins|botulinum toxins|mesh-list
101624180|NCT02773641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101624181|NCT02773641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101945627|NCT01258491|Vitamin B Complex|vitamin b complex|mesh-ancestor
101945628|NCT01258491|Vitamins|vitamins|mesh-ancestor
101945629|NCT01258491|Micronutrients|micronutrients|mesh-ancestor
101945630|NCT01258491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945631|NCT01258491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101945632|NCT01258491|Antimetabolites|antimetabolites|mesh-ancestor
101945633|NCT01258491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624182|NCT02773641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101624183|NCT02773641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101624184|NCT02773641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624185|NCT02773641|Cholinergic Agents|cholinergic agents|mesh-ancestor
101624186|NCT02773641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101624187|NCT02773641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624188|NCT02773641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101624189|NCT02773641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101624190|NCT02768805|Vaccines|vaccines|mesh-list
101624191|NCT02768805|Immunologic Factors|immunologic factors|mesh-ancestor
101624192|NCT02768805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709187|NCT00669890|Immunotoxins|immunotoxins|mesh-ancestor
101624193|NCT02773251|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101624194|NCT02773251|Hyaluronic Acid|hyaluronic acid|mesh-list
101624195|NCT02773251|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101624196|NCT02773251|Immunologic Factors|immunologic factors|mesh-ancestor
101624197|NCT02773251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624198|NCT02773251|Viscosupplements|viscosupplements|mesh-ancestor
101624199|NCT02773251|Protective Agents|protective agents|mesh-ancestor
101624200|NCT02773251|Laxatives|laxatives|mesh-ancestor
101624201|NCT02773251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101624202|NCT02768649|Risperidone|risperidone|mesh-list
101624203|NCT02768649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101624204|NCT02768649|Serotonin Agents|serotonin agents|mesh-ancestor
101624205|NCT02768649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101624206|NCT02768649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624207|NCT02768649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624208|NCT02768649|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101624209|NCT02768649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101624210|NCT02768649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101281279|NCT01900301|Autonomic Agents|autonomic agents|mesh-ancestor
101624211|NCT02768649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101624212|NCT02768649|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101624213|NCT02768649|Dopamine Agents|dopamine agents|mesh-ancestor
101624214|NCT02773407|Azithromycin|azithromycin|mesh-list
101624215|NCT02773407|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101624216|NCT02773407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101624217|NCT02773407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101624218|NCT02773407|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101624219|NCT02773407|Antimalarials|antimalarials|mesh-ancestor
101624220|NCT02773407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101624221|NCT02773407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101624222|NCT04224675|Atenolol|atenolol|mesh-list
101624223|NCT04224675|Captopril|captopril|mesh-list
101624224|NCT04224675|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101624225|NCT04224675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101624226|NCT04224675|Sympatholytics|sympatholytics|mesh-ancestor
101624227|NCT04224675|Autonomic Agents|autonomic agents|mesh-ancestor
101624228|NCT04224675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101624229|NCT04224675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624230|NCT04224675|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101624239|NCT02768493|Ropivacaine|ropivacaine|mesh-list
101624240|NCT02768493|Anesthetics, Local|anesthetics, local|mesh-ancestor
101624241|NCT02768493|Anesthetics|anesthetics|mesh-ancestor
101624242|NCT02768493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101624243|NCT02768493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624244|NCT02768493|Sensory System Agents|sensory system agents|mesh-ancestor
101624245|NCT02768493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101624246|NCT02768415|Apatinib|apatinib|mesh-list
101624247|NCT02768415|Vinorelbine|vinorelbine|mesh-list
101624248|NCT02768415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101624249|NCT02768415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101624250|NCT02768415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101945634|NCT01258491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101945635|NCT01258491|Vasodilator Agents|vasodilator agents|mesh-ancestor
101945636|NCT01257165|Ethanol|ethanol|mesh-list
101945637|NCT01257165|Zopiclone|zopiclone|mesh-list
101945638|NCT01257165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101945639|NCT01257165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101945640|NCT01257165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101945641|NCT01257165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945642|NCT01257165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101945643|NCT01151943|Anesthetics|anesthetics|mesh-list
101945644|NCT01151943|Anesthetics, Local|anesthetics, local|mesh-list
101945645|NCT01151943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101945646|NCT01151943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624251|NCT02768415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624252|NCT02768415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101624253|NCT02768415|Tubulin Modulators|tubulin modulators|mesh-ancestor
101624254|NCT02768415|Antimitotic Agents|antimitotic agents|mesh-ancestor
101624255|NCT02768415|Mitosis Modulators|mitosis modulators|mesh-ancestor
101624256|NCT02773095|Lactitol|lactitol|mesh-list
101624257|NCT02773095|Cathartics|cathartics|mesh-ancestor
101624258|NCT02773095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101624259|NCT02768337|Afatinib|afatinib|mesh-list
101624260|NCT02768337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101624261|NCT02768337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101624262|NCT02768337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101624263|NCT02768337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624264|NCT02768571|Cerebrolysin|cerebrolysin|mesh-list
101624265|NCT02768571|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101624266|NCT02768571|Protective Agents|protective agents|mesh-ancestor
101624267|NCT02768571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624268|NCT02768571|Nootropic Agents|nootropic agents|mesh-ancestor
101624269|NCT02767713|Dexamethasone|dexamethasone|mesh-list
101624270|NCT02767713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101624271|NCT02767713|Antiemetics|antiemetics|mesh-ancestor
101624272|NCT02767713|Autonomic Agents|autonomic agents|mesh-ancestor
101624273|NCT02767713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101624274|NCT02767713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624275|NCT02767713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101624276|NCT02767713|Glucocorticoids|glucocorticoids|mesh-ancestor
101624277|NCT02767713|Hormones|hormones|mesh-ancestor
101624278|NCT02767713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101624279|NCT02767713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101624280|NCT02767713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101624281|NCT02767245|Thiamine|thiamine|mesh-list
101624282|NCT02767245|Vitamins|vitamins|mesh-ancestor
101624283|NCT02767245|Micronutrients|micronutrients|mesh-ancestor
101624284|NCT02767245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624285|NCT02767245|Vitamin B Complex|vitamin b complex|mesh-ancestor
101624286|NCT02767401|Aspirin|aspirin|mesh-list
101624287|NCT02767401|Metoprolol|metoprolol|mesh-list
101624288|NCT02767401|Clopidogrel|clopidogrel|mesh-list
101624289|NCT02767401|Ticagrelor|ticagrelor|mesh-list
101624290|NCT02767401|Atorvastatin|atorvastatin|mesh-list
101624291|NCT02767401|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101624292|NCT02767401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101624293|NCT02767401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101624294|NCT02767401|Analgesics|analgesics|mesh-ancestor
101624295|NCT02767401|Sensory System Agents|sensory system agents|mesh-ancestor
101624296|NCT02767401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101624297|NCT02767401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624298|NCT02767401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101624310|NCT02767401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101624311|NCT02767401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101624312|NCT02767401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101945647|NCT01151943|Sensory System Agents|sensory system agents|mesh-ancestor
101945648|NCT01151943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101945649|NCT01256151|Alprazolam|alprazolam|mesh-list
101945650|NCT01256151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101945651|NCT01256151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101945652|NCT01256151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945653|NCT01256151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101945654|NCT01256151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101945655|NCT01256151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101945656|NCT01256151|GABA Modulators|gaba modulators|mesh-ancestor
101945657|NCT01256151|GABA Agents|gaba agents|mesh-ancestor
101945658|NCT01256151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101945659|NCT01256151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945660|NCT01259973|Haloperidol|haloperidol|mesh-list
101945661|NCT01259973|Risperidone|risperidone|mesh-list
101945662|NCT01259973|Haloperidol decanoate|haloperidol decanoate|mesh-list
101945663|NCT01259973|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101945664|NCT01259973|Serotonin Agents|serotonin agents|mesh-ancestor
101945665|NCT01259973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101945666|NCT01259973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945667|NCT01259973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945668|NCT01259973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101624313|NCT02767401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101624314|NCT02767401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101624315|NCT02767401|Purinergic Agents|purinergic agents|mesh-ancestor
101624316|NCT02767401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101709196|NCT02697929|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101624317|NCT02767401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101624318|NCT02767401|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101624319|NCT02767401|Sympatholytics|sympatholytics|mesh-ancestor
101624320|NCT02767401|Autonomic Agents|autonomic agents|mesh-ancestor
101624321|NCT02767401|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101624322|NCT02767401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101624323|NCT02767401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101624324|NCT02767401|Adrenergic Agents|adrenergic agents|mesh-ancestor
101624325|NCT02767479|Esomeprazole|esomeprazole|mesh-list
101624326|NCT02767479|Rabeprazole|rabeprazole|mesh-list
101624327|NCT02767479|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101624328|NCT02767479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101624329|NCT02767479|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101624330|NCT02767479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101624331|NCT02767479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624332|NCT02767635|Triamcinolone|triamcinolone|mesh-list
101624333|NCT02767635|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101624334|NCT02767635|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101624335|NCT02767635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101624336|NCT02767635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101624337|NCT02767635|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101624338|NCT02767635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101624339|NCT02767635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101624340|NCT02767635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624341|NCT02767635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101624342|NCT02767635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101624343|NCT02767635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945669|NCT01259973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101945670|NCT01259973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101945671|NCT01259973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101945672|NCT01259973|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101945674|NCT01259973|Antiemetics|antiemetics|mesh-ancestor
101945675|NCT01259973|Autonomic Agents|autonomic agents|mesh-ancestor
101945676|NCT01259973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101945677|NCT01259973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101945678|NCT01259973|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101945679|NCT01257243|Potassium iodate|potassium iodate|mesh-list
101945680|NCT01257243|Phenylpropanolamine|phenylpropanolamine|mesh-list
101945681|NCT01257243|Guaifenesin|guaifenesin|mesh-list
101945682|NCT01257243|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
101945683|NCT01257243|Expectorants|expectorants|mesh-ancestor
101794722|NCT05213481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101624344|NCT02767635|Cholinergic Agents|cholinergic agents|mesh-ancestor
101624345|NCT02767635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101624346|NCT02767635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101624347|NCT02767635|Glucocorticoids|glucocorticoids|mesh-ancestor
101624348|NCT02767635|Hormones|hormones|mesh-ancestor
101624349|NCT02767635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101624350|NCT02767635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101624351|NCT02767635|Immunologic Factors|immunologic factors|mesh-ancestor
101624352|NCT02767635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101624353|NCT04224441|Temozolomide|temozolomide|mesh-list
101624354|NCT04224441|Chlorpromazine|chlorpromazine|mesh-list
101624355|NCT04224441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101624356|NCT04224441|Alkylating Agents|alkylating agents|mesh-ancestor
101624357|NCT04224441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624358|NCT04224441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101624359|NCT04224441|Antiemetics|antiemetics|mesh-ancestor
101624360|NCT04224441|Autonomic Agents|autonomic agents|mesh-ancestor
101422995|NCT00516100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101624364|NCT04224441|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101624366|NCT04224441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101624367|NCT04224441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101624368|NCT04224441|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101624369|NCT04224441|Dopamine Agents|dopamine agents|mesh-ancestor
101624370|NCT04224441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101624372|NCT02767089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101624373|NCT02767089|Glucocorticoids|glucocorticoids|mesh-ancestor
101624374|NCT02767089|Hormones|hormones|mesh-ancestor
101624375|NCT02767089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101624376|NCT02767089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624377|NCT02767089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101624378|NCT02767089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101624379|NCT02766855|Cysteamine|cysteamine|mesh-list
101624380|NCT02766855|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
101624381|NCT02766855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624382|NCT02762643|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101624383|NCT02762643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101624384|NCT02762643|Hormone Antagonists|hormone antagonists|mesh-ancestor
101624385|NCT02762643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101624386|NCT02762643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624387|NCT02762643|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101624388|NCT02762643|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101624389|NCT02762643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101624390|NCT04224051|Metformin|metformin|mesh-list
101945684|NCT01257243|Respiratory System Agents|respiratory system agents|mesh-ancestor
101794783|NCT00867152|Ritonavir|ritonavir|mesh-list
101624391|NCT04224051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101624392|NCT04224051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624393|NCT02762253|Riboflavin|riboflavin|mesh-list
101624394|NCT02762253|Vitamin B Complex|vitamin b complex|mesh-ancestor
101624395|NCT02762253|Vitamins|vitamins|mesh-ancestor
101624396|NCT02762253|Micronutrients|micronutrients|mesh-ancestor
101624397|NCT02762253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624398|NCT02762253|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101624399|NCT02762253|Dermatologic Agents|dermatologic agents|mesh-ancestor
101624400|NCT00746941|Mefloquine|mefloquine|mesh-list
101624401|NCT00746941|Antimalarials|antimalarials|mesh-ancestor
101624402|NCT00746941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101624403|NCT00746941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101624404|NCT00746941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101624405|NCT04532463|Fluconazole|fluconazole|mesh-list
101624406|NCT04532463|Amphotericin B|amphotericin b|mesh-list
101624407|NCT04532463|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101624408|NCT04532463|Flucytosine|flucytosine|mesh-list
101624409|NCT04532463|Antifungal Agents|antifungal agents|mesh-ancestor
101624410|NCT04532463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101624411|NCT04532463|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101624412|NCT04532463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101624413|NCT04532463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101624414|NCT04532463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624415|NCT04532463|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101624416|NCT04532463|Hormone Antagonists|hormone antagonists|mesh-ancestor
101624417|NCT04532463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101624418|NCT04532463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624419|NCT04532463|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101624420|NCT04532463|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101624421|NCT04532463|Amebicides|amebicides|mesh-ancestor
101624422|NCT04532463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101624423|NCT04532463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101624424|NCT04532463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101624425|NCT04532463|Antimetabolites|antimetabolites|mesh-ancestor
101624426|NCT04091971|Ketamine|ketamine|mesh-list
101624427|NCT04091971|Analgesics|analgesics|mesh-ancestor
101624428|NCT04091971|Sensory System Agents|sensory system agents|mesh-ancestor
101624429|NCT04091971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101624430|NCT04091971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624431|NCT04091971|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101624432|NCT04091971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101423060|NCT00516802|Olaparib|olaparib|mesh-list
101624442|NCT04091815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624443|NCT00746785|Olanzapine|olanzapine|mesh-list
101624444|NCT00746785|Antiemetics|antiemetics|mesh-ancestor
101624445|NCT00746785|Autonomic Agents|autonomic agents|mesh-ancestor
101624446|NCT00746785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101624447|NCT00746785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624448|NCT00746785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101624449|NCT00746785|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101624450|NCT00746785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101624451|NCT00746785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101624452|NCT00746785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101624453|NCT00746785|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101624454|NCT00746785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101624455|NCT00746785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101624456|NCT00746785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624457|NCT00746785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101624458|NCT00746785|Serotonin Agents|serotonin agents|mesh-ancestor
101624459|NCT04090021|Amoxicillin|amoxicillin|mesh-list
101624460|NCT04090021|Metronidazole|metronidazole|mesh-list
101624461|NCT04090021|Clarithromycin|clarithromycin|mesh-list
101624462|NCT04090021|Levofloxacin|levofloxacin|mesh-list
101624463|NCT04090021|Rifabutin|rifabutin|mesh-list
101624464|NCT04090021|Esomeprazole|esomeprazole|mesh-list
101624465|NCT04090021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101624466|NCT04090021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101624467|NCT04090021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101624468|NCT04090021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101624469|NCT04090021|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101624470|NCT04090021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101624471|NCT04090021|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101624472|NCT04090021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101945685|NCT01257243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101945686|NCT01257243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101945687|NCT01257243|Adrenergic Agents|adrenergic agents|mesh-ancestor
101945688|NCT01257243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101945689|NCT01257243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945690|NCT01257243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624473|NCT04090021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624474|NCT04090021|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101624475|NCT04090021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101624476|NCT04090021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101624477|NCT04090021|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101624478|NCT04090021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101624479|NCT04090021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101624480|NCT04090021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101624481|NCT04090021|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101624482|NCT04090021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101624483|NCT04090021|Antitubercular Agents|antitubercular agents|mesh-ancestor
101624484|NCT04223973|Insulin|insulin|mesh-list
101624485|NCT04223973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101624486|NCT04223973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624487|NCT00750919|Mirtazapine|mirtazapine|mesh-list
101624488|NCT00750919|Antidepressive Agents|antidepressive agents|mesh-ancestor
101624489|NCT00750919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101624490|NCT00750919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101624491|NCT00750919|Histamine Antagonists|histamine antagonists|mesh-ancestor
101624492|NCT00750919|Histamine Agents|histamine agents|mesh-ancestor
101624493|NCT00750919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101624494|NCT00750919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624495|NCT00750919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624496|NCT00750919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101624497|NCT00750919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101423132|NCT05861063|Lidocaine|lidocaine|mesh-list
101624502|NCT00750919|Adrenergic Agents|adrenergic agents|mesh-ancestor
101624503|NCT00750919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101624504|NCT00750919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101624505|NCT00750919|Serotonin Agents|serotonin agents|mesh-ancestor
101624506|NCT00750919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101624508|NCT02761161|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101624509|NCT02761161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101624510|NCT02761161|Adrenergic Agents|adrenergic agents|mesh-ancestor
101624511|NCT02761161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101624512|NCT02761161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624513|NCT02761161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624514|NCT02761161|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101624515|NCT02761161|Histamine Antagonists|histamine antagonists|mesh-ancestor
101624516|NCT02761161|Histamine Agents|histamine agents|mesh-ancestor
101624517|NCT02761161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101624518|NCT02761161|Serotonin Agents|serotonin agents|mesh-ancestor
101624519|NCT02761161|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101624520|NCT02761161|Antidepressive Agents|antidepressive agents|mesh-ancestor
101624521|NCT02761161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101624522|NCT02761395|Deferasirox|deferasirox|mesh-list
101624523|NCT02761395|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101624524|NCT02761395|Chelating Agents|chelating agents|mesh-ancestor
101624525|NCT02761395|Sequestering Agents|sequestering agents|mesh-ancestor
101624526|NCT02761395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624527|NCT02761317|Bisacodyl|bisacodyl|mesh-list
101624528|NCT02761317|Cathartics|cathartics|mesh-ancestor
101624529|NCT02761317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101624530|NCT02761317|Laxatives|laxatives|mesh-ancestor
101624531|NCT00746551|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101624532|NCT00746551|Hematinics|hematinics|mesh-ancestor
101624533|NCT02696577|Aspirin|aspirin|mesh-list
101624534|NCT02696577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101624535|NCT02696577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101624536|NCT02696577|Analgesics|analgesics|mesh-ancestor
101624537|NCT02696577|Sensory System Agents|sensory system agents|mesh-ancestor
101945691|NCT01257243|Appetite Depressants|appetite depressants|mesh-ancestor
101945692|NCT01257243|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101945693|NCT01257243|Sympathomimetics|sympathomimetics|mesh-ancestor
101945694|NCT01257243|Autonomic Agents|autonomic agents|mesh-ancestor
101624538|NCT02696577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101624539|NCT02696577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624540|NCT02696577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101624541|NCT02696577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101624542|NCT02696577|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101624543|NCT02696577|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101624544|NCT02696577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624545|NCT02696577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101624546|NCT02696577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101624547|NCT02696577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101624548|NCT02696577|Antipyretics|antipyretics|mesh-ancestor
101624549|NCT04222491|Immunomodulating Agents|immunomodulating agents|mesh-list
101624550|NCT04222491|Immunologic Factors|immunologic factors|mesh-ancestor
101624551|NCT04222491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624552|NCT00750061|Lithium Carbonate|lithium carbonate|mesh-list
101624553|NCT00750061|Antidepressive Agents|antidepressive agents|mesh-ancestor
101624554|NCT00750061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101624555|NCT00750061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101624556|NCT00750061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624557|NCT00750061|Antimanic Agents|antimanic agents|mesh-ancestor
101624558|NCT00750061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101624559|NCT00750061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101624560|NCT00750061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624561|NCT04223739|Amiodarone|amiodarone|mesh-list
101624562|NCT04223739|Landiolol|landiolol|mesh-list
101624563|NCT04223739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101624564|NCT04223739|Vasodilator Agents|vasodilator agents|mesh-ancestor
101624565|NCT04223739|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101624566|NCT04223739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101423197|NCT05860153|Anesthetics|anesthetics|mesh-ancestor
101624571|NCT04223739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101624572|NCT04223739|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101624573|NCT04223739|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101624574|NCT04223739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101624575|NCT04223739|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101624576|NCT04223739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101624577|NCT04223739|Adrenergic Agents|adrenergic agents|mesh-ancestor
101624578|NCT04223739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101624579|NCT04223739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624580|NCT02765373|Letrozole|letrozole|mesh-list
101624581|NCT02765373|Anastrozole|anastrozole|mesh-list
101624582|NCT02765373|Exemestane|exemestane|mesh-list
101624583|NCT02765373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101624584|NCT02765373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101624585|NCT02765373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101624586|NCT02765373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101624587|NCT02765373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624588|NCT02765373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101624589|NCT02765373|Hormone Antagonists|hormone antagonists|mesh-ancestor
101709215|NCT02700347|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101624590|NCT02765373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101624591|NCT02765373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624592|NCT02765373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101624593|NCT02760615|Losartan|losartan|mesh-list
101624594|NCT02760615|Midazolam|midazolam|mesh-list
101624595|NCT02760615|Dextromethorphan|dextromethorphan|mesh-list
101624596|NCT02760615|Caffeine|caffeine|mesh-list
101624597|NCT02760615|Omeprazole|omeprazole|mesh-list
101624598|NCT02760615|Vedolizumab|vedolizumab|mesh-list
101624599|NCT02760615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101624600|NCT02760615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101624601|NCT02760615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101624602|NCT02760615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624603|NCT02760615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101624604|NCT02760615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101624605|NCT02760615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101624606|NCT02760615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101624607|NCT02760615|Anesthetics, General|anesthetics, general|mesh-ancestor
101624608|NCT02760615|Anesthetics|anesthetics|mesh-ancestor
101624609|NCT02760615|GABA Modulators|gaba modulators|mesh-ancestor
101945695|NCT01257243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101945696|NCT01257243|Nasal Decongestants|nasal decongestants|mesh-ancestor
101945697|NCT01257243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101945698|NCT01257243|Antifungal Agents|antifungal agents|mesh-ancestor
101945699|NCT01257243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101945701|NCT01258569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101624611|NCT02760615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101624612|NCT02760615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624613|NCT02760615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101624614|NCT02760615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101624615|NCT02760615|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101624616|NCT02760615|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101624617|NCT02760615|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101624618|NCT02760615|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101624619|NCT02760615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101624620|NCT02760615|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101624621|NCT02760615|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101624622|NCT02760615|Purinergic Agents|purinergic agents|mesh-ancestor
101624623|NCT02760615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101624624|NCT02760615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101624625|NCT02760615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101624626|NCT02760615|Antitussive Agents|antitussive agents|mesh-ancestor
101624627|NCT02760615|Respiratory System Agents|respiratory system agents|mesh-ancestor
101624628|NCT02760615|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101624629|NCT02760615|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101624630|NCT02760459|Dexamethasone|dexamethasone|mesh-list
101624631|NCT02760459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101624632|NCT02760459|Antiemetics|antiemetics|mesh-ancestor
101624633|NCT02760459|Autonomic Agents|autonomic agents|mesh-ancestor
101624634|NCT02760459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101624635|NCT02760459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624639|NCT02760459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101624640|NCT02760459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101624642|NCT02765217|Amoxicillin|amoxicillin|mesh-list
101624643|NCT02765217|Clavulanic Acids|clavulanic acids|mesh-list
101624644|NCT02765217|Clavulanic Acid|clavulanic acid|mesh-list
101624645|NCT02765217|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101624646|NCT02765217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101624647|NCT02765217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101624648|NCT02765217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101624649|NCT02765217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624650|NCT02765217|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101624651|NCT02760381|Acetic Acid|acetic acid|mesh-list
101624652|NCT02760381|Retinol acetate|retinol acetate|mesh-list
101624653|NCT02760381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101624654|NCT02760381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101624655|NCT02760381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101624656|NCT02760381|Immunologic Factors|immunologic factors|mesh-ancestor
101624657|NCT02760381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624658|NCT02760381|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101624659|NCT02760381|Protective Agents|protective agents|mesh-ancestor
101624660|NCT02760381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101624661|NCT02760225|Pembrolizumab|pembrolizumab|mesh-list
101624662|NCT02760225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101624663|NCT02760225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101624664|NCT02760225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101624665|NCT02760225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624666|NCT00744757|Decitabine|decitabine|mesh-list
101624667|NCT00744757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101624668|NCT00744757|Antimetabolites|antimetabolites|mesh-ancestor
101624669|NCT00744757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624670|NCT00744757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101624672|NCT00917527|Atorvastatin|atorvastatin|mesh-list
101624673|NCT00917527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101624674|NCT00917527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101624675|NCT00917527|Antimetabolites|antimetabolites|mesh-ancestor
101945702|NCT01257399|Mesalamine|mesalamine|mesh-list
101945703|NCT01257399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101945704|NCT01257399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101945705|NCT01257399|Analgesics|analgesics|mesh-ancestor
101624676|NCT00917527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624677|NCT00917527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101624678|NCT00917527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101624679|NCT00917527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101624680|NCT00745849|Esomeprazole|esomeprazole|mesh-list
101624681|NCT00745849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101624682|NCT00745849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101624683|NCT00745849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101624684|NCT00745849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101624685|NCT00745849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624686|NCT02759991|Vaccines|vaccines|mesh-list
101624687|NCT02759991|Immunologic Factors|immunologic factors|mesh-ancestor
101624688|NCT02759991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624689|NCT04112277|Morphine|morphine|mesh-list
101624690|NCT04112277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101624691|NCT04112277|Narcotics|narcotics|mesh-ancestor
101624692|NCT04112277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101624693|NCT04112277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624694|NCT04112277|Analgesics|analgesics|mesh-ancestor
101624695|NCT04112277|Sensory System Agents|sensory system agents|mesh-ancestor
101624696|NCT04112277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101624697|NCT00749203|Midazolam|midazolam|mesh-list
101624698|NCT00749203|Ketamine|ketamine|mesh-list
101624699|NCT00749203|Analgesics|analgesics|mesh-ancestor
101624700|NCT00749203|Sensory System Agents|sensory system agents|mesh-ancestor
101624701|NCT00749203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101624702|NCT00749203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624703|NCT00749203|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101624704|NCT00749203|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101624705|NCT00749203|Anesthetics, General|anesthetics, general|mesh-ancestor
101624706|NCT00749203|Anesthetics|anesthetics|mesh-ancestor
101624707|NCT00749203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101423341|NCT05749211|Niraparib|niraparib|mesh-list
101624712|NCT00749203|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101624713|NCT00749203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101624714|NCT00749203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101624715|NCT00749203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101624716|NCT00749203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101624718|NCT00749203|GABA Agents|gaba agents|mesh-ancestor
101624719|NCT02764515|Methotrexate|methotrexate|mesh-list
101624720|NCT02764515|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101624721|NCT02764515|Abortifacient Agents|abortifacient agents|mesh-ancestor
101624722|NCT02764515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101624723|NCT02764515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624724|NCT02764515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101624725|NCT02764515|Antimetabolites|antimetabolites|mesh-ancestor
101624726|NCT02764515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624727|NCT02764515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101624728|NCT02764515|Dermatologic Agents|dermatologic agents|mesh-ancestor
101624729|NCT02764515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101624730|NCT02764515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101624731|NCT02764515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101624732|NCT02764515|Immunologic Factors|immunologic factors|mesh-ancestor
101624733|NCT02764515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101624734|NCT02764515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101624735|NCT02764749|Phenol|phenol|mesh-list
101624736|NCT02764749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101624737|NCT02764749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101624738|NCT02764749|Disinfectants|disinfectants|mesh-ancestor
101624739|NCT02764749|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
101624740|NCT02764749|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101624741|NCT02764359|Vancomycin|vancomycin|mesh-list
101624742|NCT02764359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101624743|NCT02764359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101624744|NCT02764125|Levodopa|levodopa|mesh-list
101624745|NCT02764125|Carbidopa|carbidopa|mesh-list
101624746|NCT02764125|Entacapone|entacapone|mesh-list
101624747|NCT02764125|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101624748|NCT02764125|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101624749|NCT02764125|Dopamine Agents|dopamine agents|mesh-ancestor
101945706|NCT01257399|Sensory System Agents|sensory system agents|mesh-ancestor
101945707|NCT01257399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101795137|NCT00872924|Sumatriptan|sumatriptan|mesh-list
101624750|NCT02764125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101624751|NCT02764125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624752|NCT02764125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624753|NCT02764125|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101624754|NCT02764125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101624755|NCT02764125|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101624756|NCT02764281|Dexamethasone|dexamethasone|mesh-list
101624757|NCT02764281|Methotrexate|methotrexate|mesh-list
101624758|NCT02764281|Etoposide|etoposide|mesh-list
101624759|NCT02764281|Pegaspargase|pegaspargase|mesh-list
101624760|NCT02764281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101624761|NCT02764281|Antiemetics|antiemetics|mesh-ancestor
101624762|NCT02764281|Autonomic Agents|autonomic agents|mesh-ancestor
101624763|NCT02764281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101624764|NCT02764281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624765|NCT02764281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101624766|NCT02764281|Glucocorticoids|glucocorticoids|mesh-ancestor
101624767|NCT02764281|Hormones|hormones|mesh-ancestor
101624768|NCT02764281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101624769|NCT02764281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101624770|NCT02764281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101624771|NCT02764281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101624772|NCT02764281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624773|NCT02764281|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101624774|NCT02764281|Abortifacient Agents|abortifacient agents|mesh-ancestor
101624775|NCT02764281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101624776|NCT02764281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101624777|NCT02764281|Antimetabolites|antimetabolites|mesh-ancestor
101624782|NCT02764281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101624783|NCT02764281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101624784|NCT02764281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101624785|NCT02764281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101624786|NCT02764281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101624788|NCT02763969|Interferon-alpha|interferon-alpha|mesh-list
101624789|NCT02763969|Interferon alpha-2|interferon alpha-2|mesh-list
101624790|NCT02763969|Ustekinumab|ustekinumab|mesh-list
101624791|NCT02763969|Famotidine|famotidine|mesh-list
101624792|NCT02763969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101624793|NCT02763969|Antiviral Agents|antiviral agents|mesh-ancestor
101624794|NCT02763969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101624795|NCT02763969|Immunologic Factors|immunologic factors|mesh-ancestor
101624796|NCT02763969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624797|NCT02763969|Dermatologic Agents|dermatologic agents|mesh-ancestor
101624798|NCT02763969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101624799|NCT02763969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101624800|NCT02763969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101624801|NCT02763969|Histamine Antagonists|histamine antagonists|mesh-ancestor
101624802|NCT02763969|Histamine Agents|histamine agents|mesh-ancestor
101624803|NCT02763969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101624804|NCT02763969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624805|NCT04660929|Pembrolizumab|pembrolizumab|mesh-list
101624806|NCT04660929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101624807|NCT04660929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101624808|NCT04660929|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101624809|NCT04660929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624810|NCT02758587|Pembrolizumab|pembrolizumab|mesh-list
101624811|NCT02758587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101624812|NCT02758587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101624813|NCT02758587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101624814|NCT02758587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624815|NCT02758509|Interferons|interferons|mesh-list
101624816|NCT02758509|Ritonavir|ritonavir|mesh-list
101624817|NCT02758509|Ribavirin|ribavirin|mesh-list
101624818|NCT02758509|Interferon-alpha|interferon-alpha|mesh-list
101624819|NCT02758509|Interferon alpha-2|interferon alpha-2|mesh-list
101624821|NCT02758509|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101624822|NCT02758509|Ledipasvir|ledipasvir|mesh-list
101624823|NCT02758509|Simeprevir|simeprevir|mesh-list
101624824|NCT02758509|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
101945708|NCT01257399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945709|NCT01257399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101945710|NCT01257399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101945711|NCT01258959|Anesthetics|anesthetics|mesh-list
101945712|NCT01258959|Anesthetics, Local|anesthetics, local|mesh-list
101945713|NCT01258959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101624825|NCT02758509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101624826|NCT02758509|Antiviral Agents|antiviral agents|mesh-ancestor
101624827|NCT02758509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101624828|NCT02758509|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101624829|NCT02758509|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101624830|NCT02758509|Protease Inhibitors|protease inhibitors|mesh-ancestor
101624831|NCT02758509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101624832|NCT02758509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624833|NCT02758509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101624834|NCT02758509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101624835|NCT02758509|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101624836|NCT02758509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101624837|NCT02758509|Antimetabolites|antimetabolites|mesh-ancestor
101624838|NCT02758509|Immunologic Factors|immunologic factors|mesh-ancestor
101624839|NCT02758509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624840|NCT02762955|Adalimumab|adalimumab|mesh-list
101624841|NCT02762955|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101624842|NCT02762955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101624843|NCT02762955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101624844|NCT04191681|Valsartan|valsartan|mesh-list
101624845|NCT04191681|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101624846|NCT04191681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101709252|NCT00504829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101624847|NCT04191681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101624848|NCT04191681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101423481|NCT05494398|Antiviral Agents|antiviral agents|mesh-ancestor
101624859|NCT04479579|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101624860|NCT04479579|Antithrombins|antithrombins|mesh-ancestor
101624861|NCT04479579|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101624862|NCT04479579|Protease Inhibitors|protease inhibitors|mesh-ancestor
101624863|NCT04479579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101624864|NCT04479579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624865|NCT04479579|Anticoagulants|anticoagulants|mesh-ancestor
101624866|NCT02757495|Dexmedetomidine|dexmedetomidine|mesh-list
101624867|NCT02757495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101624868|NCT02757495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101624869|NCT02757495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624870|NCT02757495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101624871|NCT02757495|Analgesics|analgesics|mesh-ancestor
101624872|NCT02757495|Sensory System Agents|sensory system agents|mesh-ancestor
101624873|NCT02757495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101624874|NCT02757495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101624875|NCT02757495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101624876|NCT02757495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101624877|NCT02757495|Adrenergic Agents|adrenergic agents|mesh-ancestor
101624878|NCT02757495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101624879|NCT02757495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624880|NCT02757261|Salicylic Acid|salicylic acid|mesh-list
101624881|NCT02757261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101624882|NCT02757261|Antifungal Agents|antifungal agents|mesh-ancestor
101624883|NCT02757261|Keratolytic Agents|keratolytic agents|mesh-ancestor
101624884|NCT02757261|Dermatologic Agents|dermatologic agents|mesh-ancestor
101624885|NCT02752113|Metformin|metformin|mesh-list
101624886|NCT02752113|Empagliflozin|empagliflozin|mesh-list
101624887|NCT02752113|Linagliptin|linagliptin|mesh-list
101624888|NCT02752113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101624890|NCT02752113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101624891|NCT02752113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624892|NCT02752113|Incretins|incretins|mesh-ancestor
101624893|NCT02752113|Hormones|hormones|mesh-ancestor
101624894|NCT02752113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101624895|NCT02752113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101624896|NCT02752113|Protease Inhibitors|protease inhibitors|mesh-ancestor
101945714|NCT01258959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945715|NCT01258959|Sensory System Agents|sensory system agents|mesh-ancestor
101945716|NCT01258959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101945717|NCT01153659|Esomeprazole|esomeprazole|mesh-list
101624897|NCT02752113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101624898|NCT02756715|Propofol|propofol|mesh-list
101624899|NCT02756715|Desflurane|desflurane|mesh-list
101624900|NCT02756715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101624901|NCT02756715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101624902|NCT02756715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624903|NCT02756715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101624904|NCT02756715|Anesthetics, General|anesthetics, general|mesh-ancestor
101624905|NCT02756715|Anesthetics|anesthetics|mesh-ancestor
101624906|NCT02756715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101624907|NCT04221321|Atorvastatin|atorvastatin|mesh-list
101624908|NCT04221321|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101624909|NCT04221321|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101624910|NCT04221321|Antimetabolites|antimetabolites|mesh-ancestor
101624911|NCT04221321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624912|NCT04221321|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101624913|NCT04221321|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101624914|NCT04221321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101624919|NCT02755857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101624920|NCT02755857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101624921|NCT02755857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624922|NCT02755857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101624923|NCT02755857|Hormone Antagonists|hormone antagonists|mesh-ancestor
101624924|NCT02755857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101624925|NCT02755857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624926|NCT02755857|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101624927|NCT02755545|Salicylic Acid|salicylic acid|mesh-list
101624928|NCT02755545|Adapalene|adapalene|mesh-list
101624929|NCT02755545|Salicylates|salicylates|mesh-list
101624930|NCT02755545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101624931|NCT02755545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101624932|NCT02755545|Analgesics|analgesics|mesh-ancestor
101624933|NCT02755545|Sensory System Agents|sensory system agents|mesh-ancestor
101624934|NCT02755545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101624935|NCT02755545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624936|NCT02755545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101624937|NCT02755545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101624938|NCT02755545|Dermatologic Agents|dermatologic agents|mesh-ancestor
101624939|NCT02755545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101624940|NCT02755545|Antifungal Agents|antifungal agents|mesh-ancestor
101624941|NCT02755545|Keratolytic Agents|keratolytic agents|mesh-ancestor
101624942|NCT02755545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101624943|NCT02755545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101624944|NCT02755545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624945|NCT02695797|Prednisolone|prednisolone|mesh-list
101624946|NCT02695797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101624947|NCT02695797|Glucocorticoids|glucocorticoids|mesh-ancestor
101624948|NCT02695797|Hormones|hormones|mesh-ancestor
101624949|NCT02695797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101624950|NCT02695797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624951|NCT02695797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101624952|NCT02695797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101624953|NCT02755311|Cisplatin|cisplatin|mesh-list
101624954|NCT02755311|Carboplatin|carboplatin|mesh-list
101624955|NCT02755311|Fluorouracil|fluorouracil|mesh-list
101624956|NCT02755311|Epirubicin|epirubicin|mesh-list
101624957|NCT02755311|Ethiodized Oil|ethiodized oil|mesh-list
101624958|NCT02755311|Pirarubicin|pirarubicin|mesh-list
101624959|NCT02755311|Doxorubicin|doxorubicin|mesh-list
101624960|NCT02755311|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
101624961|NCT02755311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101624962|NCT02755311|Antimetabolites|antimetabolites|mesh-ancestor
101624963|NCT02755311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624964|NCT02755311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101624965|NCT02755311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101624966|NCT02755311|Immunologic Factors|immunologic factors|mesh-ancestor
101624967|NCT02755311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945719|NCT01153659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101945720|NCT01153659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101624968|NCT02755311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101624969|NCT02755311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101624970|NCT02755311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101624971|NCT02755311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101624972|NCT02755311|Hemostatics|hemostatics|mesh-ancestor
101624973|NCT02755311|Coagulants|coagulants|mesh-ancestor
101624974|NCT04554771|Paclitaxel|paclitaxel|mesh-list
101624975|NCT04554771|Carboplatin|carboplatin|mesh-list
101624976|NCT04554771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101624977|NCT04554771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101624978|NCT04554771|Tubulin Modulators|tubulin modulators|mesh-ancestor
101624979|NCT04554771|Antimitotic Agents|antimitotic agents|mesh-ancestor
101624980|NCT04554771|Mitosis Modulators|mitosis modulators|mesh-ancestor
101624981|NCT04554771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624982|NCT04358289|Anti-Infective Agents|anti-infective agents|mesh-list
101624983|NCT04358289|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101624984|NCT04090801|Ethanol|ethanol|mesh-list
101624985|NCT04090801|Minoxidil|minoxidil|mesh-list
101624986|NCT04090801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101624992|NCT04089631|Capecitabine|capecitabine|mesh-list
101624993|NCT04089631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101624994|NCT04089631|Antimetabolites|antimetabolites|mesh-ancestor
101624995|NCT04089631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624996|NCT04089631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101624997|NCT00917059|Bupropion|bupropion|mesh-list
101624998|NCT00917059|Escitalopram|escitalopram|mesh-list
101624999|NCT00917059|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101625000|NCT00917059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101625001|NCT00917059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101625002|NCT00917059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625003|NCT00917059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101625004|NCT00917059|Serotonin Agents|serotonin agents|mesh-ancestor
101625005|NCT00917059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625006|NCT00917059|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101625007|NCT00917059|Antidepressive Agents|antidepressive agents|mesh-ancestor
101625008|NCT00917059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101625009|NCT00917059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101625010|NCT00917059|Dopamine Agents|dopamine agents|mesh-ancestor
101625011|NCT00917059|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101625012|NCT00917059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101625013|NCT00917059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101625014|NCT02754687|Nandrolone Decanoate|nandrolone decanoate|mesh-list
101625015|NCT02754687|Nandrolone|nandrolone|mesh-list
101625016|NCT02754687|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
101625017|NCT02754687|Androgens|androgens|mesh-ancestor
101625018|NCT02754687|Hormones|hormones|mesh-ancestor
101625019|NCT02754687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101625020|NCT02754687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625021|NCT02754687|Anabolic Agents|anabolic agents|mesh-ancestor
101625022|NCT02754687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101625023|NCT05429775|Budesonide|budesonide|mesh-list
101625024|NCT05429775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101625025|NCT05429775|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101625026|NCT05429775|Autonomic Agents|autonomic agents|mesh-ancestor
101625027|NCT05429775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101625028|NCT05429775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625029|NCT05429775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101625030|NCT05429775|Respiratory System Agents|respiratory system agents|mesh-ancestor
101625031|NCT05429775|Glucocorticoids|glucocorticoids|mesh-ancestor
101625032|NCT05429775|Hormones|hormones|mesh-ancestor
101625033|NCT05429775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101625034|NCT04220073|Antibodies|antibodies|mesh-list
101625035|NCT04220073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101625036|NCT04220073|Immunologic Factors|immunologic factors|mesh-ancestor
101282108|NCT01905150|Antidotes|antidotes|mesh-ancestor
101625037|NCT04220073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625038|NCT05429151|Acyclovir|acyclovir|mesh-list
101625039|NCT05429151|Antiviral Agents|antiviral agents|mesh-ancestor
101625040|NCT05429151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101625041|NCT04219995|Methylprednisolone|methylprednisolone|mesh-list
101625042|NCT04219995|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101625043|NCT04219995|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101625045|NCT04219995|Prednisolone acetate|prednisolone acetate|mesh-list
101625046|NCT04219995|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101625047|NCT04219995|Prednisolone phosphate|prednisolone phosphate|mesh-list
101625048|NCT04219995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101625049|NCT04219995|Antiemetics|antiemetics|mesh-ancestor
101625050|NCT04219995|Autonomic Agents|autonomic agents|mesh-ancestor
101625051|NCT04219995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101625052|NCT04219995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625053|NCT04219995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101625054|NCT04219995|Glucocorticoids|glucocorticoids|mesh-ancestor
101625055|NCT04219995|Hormones|hormones|mesh-ancestor
101423690|NCT04849026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625062|NCT04544475|Estradiol|estradiol|mesh-list
101625063|NCT04544475|Hormones|hormones|mesh-ancestor
101625064|NCT04544475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101625065|NCT04544475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625066|NCT04200417|Mitomycins|mitomycins|mesh-list
101625067|NCT04200417|Mitomycin|mitomycin|mesh-list
101625068|NCT04200417|Ethiodized Oil|ethiodized oil|mesh-list
101625069|NCT04200417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101625070|NCT04200417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101625071|NCT04200417|Alkylating Agents|alkylating agents|mesh-ancestor
101625072|NCT04200417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625073|NCT04200417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101625074|NCT04200417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101625075|NCT02753205|Dexmedetomidine|dexmedetomidine|mesh-list
101625076|NCT02753205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101625077|NCT02753205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101625078|NCT02753205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625079|NCT02753205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101625080|NCT02753205|Analgesics|analgesics|mesh-ancestor
101625081|NCT02753205|Sensory System Agents|sensory system agents|mesh-ancestor
101625082|NCT02753205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101625083|NCT02753205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101625084|NCT02753205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101625085|NCT02753205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101625086|NCT02753205|Adrenergic Agents|adrenergic agents|mesh-ancestor
101625087|NCT02753205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101625088|NCT02753205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625089|NCT04188873|Varenicline|varenicline|mesh-list
101625090|NCT04188873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101625091|NCT04188873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625092|NCT04188873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625093|NCT04188873|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101625094|NCT04188873|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101625095|NCT04188873|Cholinergic Agents|cholinergic agents|mesh-ancestor
101625096|NCT02695641|Bevacizumab|bevacizumab|mesh-list
101625097|NCT02695641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101625098|NCT02695641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101625099|NCT02695641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101625100|NCT02695641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101625101|NCT02695641|Growth Substances|growth substances|mesh-ancestor
101625102|NCT02695641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625103|NCT02695641|Growth Inhibitors|growth inhibitors|mesh-ancestor
101625104|NCT02750475|Sunscreening Agents|sunscreening agents|mesh-list
101625105|NCT02750475|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101625106|NCT02750475|Protective Agents|protective agents|mesh-ancestor
101625107|NCT02750475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625108|NCT02750475|Dermatologic Agents|dermatologic agents|mesh-ancestor
101625109|NCT04217265|Letrozole|letrozole|mesh-list
101625110|NCT04217265|Misoprostol|misoprostol|mesh-list
101625111|NCT04217265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101282205|NCT01906242|Eusol|eusol|mesh-list
101625112|NCT04217265|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101625113|NCT04217265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101625114|NCT04217265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101625115|NCT04217265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625116|NCT04217265|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101625117|NCT04217265|Hormone Antagonists|hormone antagonists|mesh-ancestor
101625118|NCT04217265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101625119|NCT04217265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945722|NCT01153659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101625120|NCT04217265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101625121|NCT04217265|Abortifacient Agents|abortifacient agents|mesh-ancestor
101625127|NCT00635973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101625128|NCT00635973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101625129|NCT00635973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101625130|NCT00635973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625131|NCT02752971|Diclofenac|diclofenac|mesh-list
101625132|NCT02752971|Bupivacaine|bupivacaine|mesh-list
101625133|NCT02752971|Anesthetics, Local|anesthetics, local|mesh-ancestor
101625134|NCT02752971|Anesthetics|anesthetics|mesh-ancestor
101625135|NCT02752971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101625136|NCT02752971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625137|NCT02752971|Sensory System Agents|sensory system agents|mesh-ancestor
101625138|NCT02752971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101625139|NCT02752971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101625140|NCT02752971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101625141|NCT02752971|Analgesics|analgesics|mesh-ancestor
101625142|NCT02752971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101625143|NCT02752971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101625144|NCT02752971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101625145|NCT02752971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101625146|NCT02752971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625147|NCT02750163|Acetaminophen|acetaminophen|mesh-list
101625148|NCT02750163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101625149|NCT02750163|Analgesics|analgesics|mesh-ancestor
101625150|NCT02750163|Sensory System Agents|sensory system agents|mesh-ancestor
101625151|NCT02750163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101625152|NCT02750163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625153|NCT02750163|Antipyretics|antipyretics|mesh-ancestor
101625154|NCT04217421|Allopurinol|allopurinol|mesh-list
101625155|NCT04217421|Mannitol|mannitol|mesh-list
101625156|NCT04217421|Antimetabolites|antimetabolites|mesh-ancestor
101625157|NCT04217421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625158|NCT04217421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101625159|NCT04217421|Gout Suppressants|gout suppressants|mesh-ancestor
101625160|NCT04217421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101625161|NCT04217421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101625162|NCT04217421|Antioxidants|antioxidants|mesh-ancestor
101625163|NCT04217421|Protective Agents|protective agents|mesh-ancestor
101625164|NCT04217421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625165|NCT04217421|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101625166|NCT04217421|Diuretics|diuretics|mesh-ancestor
101625167|NCT04217421|Natriuretic Agents|natriuretic agents|mesh-ancestor
101625168|NCT04036929|Bazedoxifene|bazedoxifene|mesh-list
101625169|NCT04036929|Estrogens|estrogens|mesh-list
101625170|NCT04036929|Hormones|hormones|mesh-ancestor
101625171|NCT04036929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101625172|NCT04036929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625173|NCT04036929|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101625174|NCT04036929|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101625175|NCT04036929|Hormone Antagonists|hormone antagonists|mesh-ancestor
101625176|NCT04036929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101625177|NCT04281147|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
101625178|NCT04281147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101625179|NCT04218981|Antipsychotic Agents|antipsychotic agents|mesh-list
101625180|NCT04218981|Paroxetine|paroxetine|mesh-list
101625181|NCT04218981|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101625182|NCT04218981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101625183|NCT04218981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101625184|NCT04218981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282320|NCT01907165|Copper|copper|mesh-list
101625185|NCT04218981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101625186|NCT04218981|Serotonin Agents|serotonin agents|mesh-ancestor
101625187|NCT04218981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625188|NCT04218981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101625189|NCT04218981|Antidepressive Agents|antidepressive agents|mesh-ancestor
101625190|NCT04218981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101625191|NCT04218981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101625192|NCT04218981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101625206|NCT04218435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101945723|NCT01153659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945724|NCT01260129|Silodosin|silodosin|mesh-list
101945725|NCT01260129|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101625207|NCT04218435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101625208|NCT04218435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625210|NCT04138875|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101625211|NCT04138875|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101625212|NCT04138875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101625213|NCT04138875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101625214|NCT04138875|Immunologic Factors|immunologic factors|mesh-ancestor
101625215|NCT04138875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625216|NCT04138875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101625217|NCT04138875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101625218|NCT04138875|Alkylating Agents|alkylating agents|mesh-ancestor
101625219|NCT04138875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625220|NCT04138875|Immunotoxins|immunotoxins|mesh-ancestor
101625221|NCT04138875|Immunoconjugates|immunoconjugates|mesh-ancestor
101625222|NCT02748135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101625223|NCT02748135|Immunologic Factors|immunologic factors|mesh-ancestor
101625224|NCT02748135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625225|NCT02695563|Lactoferrin|lactoferrin|mesh-list
101625226|NCT02695563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101625227|NCT02747823|Bevacizumab|bevacizumab|mesh-list
101625228|NCT02747823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101625229|NCT02747823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101625230|NCT02747823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101625231|NCT02747823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101625232|NCT02747823|Growth Substances|growth substances|mesh-ancestor
101625233|NCT02747823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625234|NCT02747823|Growth Inhibitors|growth inhibitors|mesh-ancestor
101625235|NCT02747511|Haloperidol|haloperidol|mesh-list
101625236|NCT02747511|Haloperidol decanoate|haloperidol decanoate|mesh-list
101625237|NCT02747511|Antiemetics|antiemetics|mesh-ancestor
101625238|NCT02747511|Autonomic Agents|autonomic agents|mesh-ancestor
101625239|NCT02747511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101625240|NCT02747511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625241|NCT02747511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101625242|NCT02747511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101625243|NCT02747511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101625244|NCT02747511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101625245|NCT02747511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101625246|NCT02747511|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101625247|NCT02747511|Dopamine Agents|dopamine agents|mesh-ancestor
101625248|NCT02747511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101625249|NCT02747511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625250|NCT02747511|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101625251|NCT04217733|Ethosuximide|ethosuximide|mesh-list
101625252|NCT04217733|Mebeverine|mebeverine|mesh-list
101625253|NCT04217733|Alverine|alverine|mesh-list
101625254|NCT04217733|Anticonvulsants|anticonvulsants|mesh-ancestor
101625259|NCT00636285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101625260|NCT00636285|Immunologic Factors|immunologic factors|mesh-ancestor
101625261|NCT00636285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625262|NCT02746185|Heparin|heparin|mesh-list
101625263|NCT02746185|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101625264|NCT02746185|Tinzaparin|tinzaparin|mesh-list
101625265|NCT02746185|Dalteparin|dalteparin|mesh-list
101625266|NCT02746185|Rivaroxaban|rivaroxaban|mesh-list
101625267|NCT02746185|Anticoagulants|anticoagulants|mesh-ancestor
101625268|NCT02746185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101625269|NCT02746185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101625270|NCT02746185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625271|NCT02746185|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101625272|NCT02746185|Antithrombins|antithrombins|mesh-ancestor
101625273|NCT02746185|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101625274|NCT02746185|Protease Inhibitors|protease inhibitors|mesh-ancestor
101625275|NCT02746185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101625276|NCT02742051|Cyclophosphamide|cyclophosphamide|mesh-list
101625277|NCT02742051|Fluorouracil|fluorouracil|mesh-list
101625278|NCT02742051|Everolimus|everolimus|mesh-list
101625279|NCT02742051|Letrozole|letrozole|mesh-list
101625280|NCT02742051|Epirubicin|epirubicin|mesh-list
101625281|NCT02742051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101625282|NCT02742051|Immunologic Factors|immunologic factors|mesh-ancestor
101945726|NCT01260129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101625283|NCT02742051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625284|NCT02742051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101625285|NCT02742051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101625286|NCT02742051|Alkylating Agents|alkylating agents|mesh-ancestor
101625287|NCT02742051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625288|NCT02742051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101625289|NCT02742051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101625290|NCT02742051|Antimetabolites|antimetabolites|mesh-ancestor
101625291|NCT02742051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101625292|NCT02742051|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101625293|NCT02742051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101625294|NCT02742051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101625295|NCT02742051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101625296|NCT02742051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101625297|NCT02742051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101625298|NCT02742051|Hormone Antagonists|hormone antagonists|mesh-ancestor
101625299|NCT02742051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101625300|NCT02742051|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101625301|NCT02742051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101625302|NCT02742051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101625303|NCT02741817|Aspirin|aspirin|mesh-list
101625304|NCT02741817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101625305|NCT02741817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101625306|NCT02741817|Analgesics|analgesics|mesh-ancestor
101625307|NCT02741817|Sensory System Agents|sensory system agents|mesh-ancestor
101625308|NCT02741817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101625309|NCT02741817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625310|NCT02741817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101625311|NCT02741817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101625312|NCT02741817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101625313|NCT02741817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101625314|NCT02741817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625315|NCT02741817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101625316|NCT02741817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101625317|NCT02741817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101625318|NCT02741817|Antipyretics|antipyretics|mesh-ancestor
101625319|NCT02745873|Ascorbic Acid|ascorbic acid|mesh-list
101625320|NCT02745873|Vitamins|vitamins|mesh-ancestor
101625321|NCT02745873|Micronutrients|micronutrients|mesh-ancestor
101625322|NCT02745873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625323|NCT02745873|Antioxidants|antioxidants|mesh-ancestor
101625324|NCT02745873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625325|NCT02745873|Protective Agents|protective agents|mesh-ancestor
101625326|NCT02745639|Capecitabine|capecitabine|mesh-list
101625327|NCT02745639|Oxaliplatin|oxaliplatin|mesh-list
101625344|NCT02745717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101625345|NCT02745717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101625346|NCT02745561|Oxaliplatin|oxaliplatin|mesh-list
101625347|NCT02745561|Endostatins|endostatins|mesh-list
101625348|NCT02745561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101625349|NCT02745561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101625350|NCT02745561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101625351|NCT02745561|Growth Substances|growth substances|mesh-ancestor
101625352|NCT02745561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625353|NCT02745561|Growth Inhibitors|growth inhibitors|mesh-ancestor
101625354|NCT02741427|Carbamide Peroxide|carbamide peroxide|mesh-list
101625355|NCT02741427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101625356|NCT02741427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101625357|NCT02745093|Misoprostol|misoprostol|mesh-list
101625358|NCT02745093|Mifepristone|mifepristone|mesh-list
101625359|NCT02745093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101625360|NCT02745093|Abortifacient Agents|abortifacient agents|mesh-ancestor
101625361|NCT02745093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101625362|NCT02745093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625363|NCT02745093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101625364|NCT02745093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101625365|NCT02745093|Oxytocics|oxytocics|mesh-ancestor
101625366|NCT02745093|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101625367|NCT02745093|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101625368|NCT02745093|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101625369|NCT02745093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101625370|NCT02745093|Contraceptive Agents|contraceptive agents|mesh-ancestor
101625371|NCT02745093|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101945727|NCT01260129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101625372|NCT02745093|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101625373|NCT02745093|Hormone Antagonists|hormone antagonists|mesh-ancestor
101625374|NCT02745093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101625375|NCT02745093|Luteolytic Agents|luteolytic agents|mesh-ancestor
101625376|NCT02745093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101366756|NCT00158704|Antiviral Agents|antiviral agents|mesh-ancestor
101625377|NCT02745093|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101625378|NCT00839254|Vaccines|vaccines|mesh-list
101625379|NCT00839254|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101625380|NCT00839254|Immunologic Factors|immunologic factors|mesh-ancestor
101625381|NCT00839254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625382|NCT02741115|Udenafil|udenafil|mesh-list
101625383|NCT02741115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101424033|NCT04098081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101625389|NCT02740803|Sodium Fluoride|sodium fluoride|mesh-list
101625390|NCT02740803|Tin Fluorides|tin fluorides|mesh-list
101625391|NCT02740803|Fluorophosphate|fluorophosphate|mesh-list
101625392|NCT02740803|Cariostatic Agents|cariostatic agents|mesh-ancestor
101625393|NCT02740803|Protective Agents|protective agents|mesh-ancestor
101625394|NCT02740803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625395|NCT02740803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101625396|NCT02740803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101625397|NCT02740647|Amoxicillin|amoxicillin|mesh-list
101625398|NCT02740647|Clavulanic Acid|clavulanic acid|mesh-list
101625399|NCT02740647|Clavulanic Acids|clavulanic acids|mesh-list
101625400|NCT02740647|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101625401|NCT02740647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101625402|NCT02740647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101625403|NCT02740647|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101625404|NCT02740647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101625405|NCT02740647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625406|NCT03737253|Menotropins|menotropins|mesh-list
101625407|NCT03737253|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101282484|NCT01907984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101625408|NCT03737253|Hormones|hormones|mesh-ancestor
101625409|NCT03737253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101625410|NCT03737253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625411|NCT03737253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101625412|NCT03737253|Fertility Agents|fertility agents|mesh-ancestor
101625413|NCT03737253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101625414|NCT00812968|Lenalidomide|lenalidomide|mesh-list
101625415|NCT00812968|Immunologic Factors|immunologic factors|mesh-ancestor
101625416|NCT00812968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625417|NCT00812968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101625418|NCT00812968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101625419|NCT00812968|Growth Substances|growth substances|mesh-ancestor
101625420|NCT00812968|Growth Inhibitors|growth inhibitors|mesh-ancestor
101625421|NCT00812968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101625422|NCT02744703|Capecitabine|capecitabine|mesh-list
101625423|NCT02744703|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101625424|NCT02744703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101625425|NCT02744703|Antimetabolites|antimetabolites|mesh-ancestor
101625426|NCT02744703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625427|NCT02744703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101625428|NCT02744937|Aspirin|aspirin|mesh-list
101625429|NCT02744937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101625430|NCT02744937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101625431|NCT02744937|Analgesics|analgesics|mesh-ancestor
101625432|NCT02744937|Sensory System Agents|sensory system agents|mesh-ancestor
101625433|NCT02744937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101625434|NCT02744937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625435|NCT02744937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101625436|NCT02744937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101625437|NCT02744937|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101625438|NCT02744937|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101625439|NCT02744937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625440|NCT02744937|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101625441|NCT02744937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101625442|NCT02744937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101625443|NCT02744937|Antipyretics|antipyretics|mesh-ancestor
101625444|NCT02744625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
101625445|NCT02744625|Propofol|propofol|mesh-list
101625446|NCT02744625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101945728|NCT01260129|Adrenergic Agents|adrenergic agents|mesh-ancestor
101945729|NCT01260129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101795789|NCT02582177|Betamethasone benzoate|betamethasone benzoate|mesh-list
101625447|NCT02744625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101625448|NCT02744625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625449|NCT02744625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101625450|NCT02744625|Anesthetics, General|anesthetics, general|mesh-ancestor
101625451|NCT02744625|Anesthetics|anesthetics|mesh-ancestor
101625452|NCT02610556|Cisplatin|cisplatin|mesh-list
101625453|NCT02610556|Docetaxel|docetaxel|mesh-list
101625456|NCT02610556|Antimitotic Agents|antimitotic agents|mesh-ancestor
101625457|NCT02610556|Mitosis Modulators|mitosis modulators|mesh-ancestor
101625458|NCT02610556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625460|NCT02740101|Oxytocics|oxytocics|mesh-ancestor
101625461|NCT02740101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101625462|NCT02740101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625463|NCT02612116|Ticagrelor|ticagrelor|mesh-list
101625464|NCT02612116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101625465|NCT02612116|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101625466|NCT02612116|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101625467|NCT02612116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101625468|NCT02612116|Purinergic Agents|purinergic agents|mesh-ancestor
101625469|NCT02612116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101625470|NCT02612116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625471|NCT02612116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625472|NCT00813748|Omalizumab|omalizumab|mesh-list
101625473|NCT00813748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101625474|NCT00813748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101625475|NCT00813748|Respiratory System Agents|respiratory system agents|mesh-ancestor
101625476|NCT00813592|Pasireotide|pasireotide|mesh-list
101625477|NCT00813592|Hormones|hormones|mesh-ancestor
101625478|NCT00813592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101625479|NCT00813592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625480|NCT02739633|Paclitaxel|paclitaxel|mesh-list
101625481|NCT02739633|genexol-PM|genexol-pm|mesh-list
101625482|NCT02739633|Gemcitabine|gemcitabine|mesh-list
101625483|NCT02739633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101625484|NCT02739633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101625485|NCT02739633|Tubulin Modulators|tubulin modulators|mesh-ancestor
101625486|NCT02739633|Antimitotic Agents|antimitotic agents|mesh-ancestor
101625487|NCT02739633|Mitosis Modulators|mitosis modulators|mesh-ancestor
101625488|NCT02739633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625489|NCT02739633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101625490|NCT02739633|Antimetabolites|antimetabolites|mesh-ancestor
101625491|NCT02739477|Favipiravir|favipiravir|mesh-list
101625492|NCT02739477|Antiviral Agents|antiviral agents|mesh-ancestor
101625493|NCT02739477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101625494|NCT02739399|Phenylephrine|phenylephrine|mesh-list
101625495|NCT02739399|Oxymetazoline|oxymetazoline|mesh-list
101625496|NCT02739399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101625497|NCT02739399|Mydriatics|mydriatics|mesh-ancestor
101625498|NCT02739399|Autonomic Agents|autonomic agents|mesh-ancestor
101625499|NCT02739399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101625500|NCT02739399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625501|NCT02739399|Sympathomimetics|sympathomimetics|mesh-ancestor
101625502|NCT02739399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101625503|NCT02739399|Nasal Decongestants|nasal decongestants|mesh-ancestor
101625504|NCT02739399|Respiratory System Agents|respiratory system agents|mesh-ancestor
101625505|NCT02739399|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101625506|NCT02739399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101625507|NCT02739399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101625508|NCT02739399|Adrenergic Agents|adrenergic agents|mesh-ancestor
101625509|NCT02739399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101625510|NCT02739399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625511|NCT02739399|Protective Agents|protective agents|mesh-ancestor
101625512|NCT02743065|Doxorubicin|doxorubicin|mesh-list
101625513|NCT02743065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101625514|NCT02743065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101625515|NCT02743065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101625516|NCT02743065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101625517|NCT02743065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101625518|NCT02743065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625519|NCT02742909|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101945730|NCT01260129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945731|NCT01260129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945732|NCT01260129|Urological Agents|urological agents|mesh-ancestor
101625520|NCT02742909|Natriuretic Agents|natriuretic agents|mesh-ancestor
101625521|NCT02742909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625523|NCT02742675|Goserelin|goserelin|mesh-list
101625524|NCT02742675|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101625525|NCT02742675|Flutamide|flutamide|mesh-list
101625526|NCT02742675|Bicalutamide|bicalutamide|mesh-list
101625527|NCT02742675|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101625538|NCT02742675|Contraceptive Agents|contraceptive agents|mesh-ancestor
101625539|NCT02742675|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101625540|NCT00812812|Paroxetine|paroxetine|mesh-list
101625541|NCT00812812|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101625542|NCT00812812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101625543|NCT00812812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101625544|NCT00812812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625545|NCT00812812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101625546|NCT00812812|Serotonin Agents|serotonin agents|mesh-ancestor
101625547|NCT00812812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625548|NCT00812812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101625549|NCT00812812|Antidepressive Agents|antidepressive agents|mesh-ancestor
101625550|NCT00812812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101625551|NCT00812812|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101625552|NCT00812812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101625553|NCT00812812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101625554|NCT02742285|Lumefantrine|lumefantrine|mesh-list
101625555|NCT02742285|Artemether|artemether|mesh-list
101625556|NCT02742285|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101625557|NCT02742285|Antimalarials|antimalarials|mesh-ancestor
101625558|NCT02742285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101625559|NCT02742285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101625560|NCT02742285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101625561|NCT03673527|Tacrolimus|tacrolimus|mesh-list
101625562|NCT03673527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101625563|NCT03673527|Immunologic Factors|immunologic factors|mesh-ancestor
101625564|NCT03673527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625565|NCT03673527|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101625566|NCT03673527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101625567|NCT03673527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625568|NCT02738931|Lamivudine|lamivudine|mesh-list
101625569|NCT02738931|Dolutegravir|dolutegravir|mesh-list
101625570|NCT02738931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101625571|NCT02738931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101625572|NCT02738931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101625573|NCT02738931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625574|NCT02738931|Antiviral Agents|antiviral agents|mesh-ancestor
101625575|NCT02738931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101625576|NCT02738931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101625577|NCT02738931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101625578|NCT02738931|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101625579|NCT02738931|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101625580|NCT02738619|Vitamin D|vitamin d|mesh-list
101625581|NCT02738619|Ergocalciferols|ergocalciferols|mesh-list
101625582|NCT02738619|Cholecalciferol|cholecalciferol|mesh-list
101625583|NCT02738619|Vitamins|vitamins|mesh-list
101625584|NCT02738619|Micronutrients|micronutrients|mesh-ancestor
101625585|NCT02738619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625586|NCT02738619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101625587|NCT02738619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101625588|NCT04016116|Pembrolizumab|pembrolizumab|mesh-list
101625589|NCT04016116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101625590|NCT04016116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101625594|NCT02736591|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
101625595|NCT02736591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101709311|NCT02699645|Diuretics|diuretics|mesh-ancestor
101625596|NCT02736591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625598|NCT05757466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101625599|NCT05757466|Alkylating Agents|alkylating agents|mesh-ancestor
101625600|NCT05757466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945733|NCT01260285|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101945734|NCT01260285|Vasodilator Agents|vasodilator agents|mesh-ancestor
101795933|NCT05183139|Glucocorticoids|glucocorticoids|mesh-ancestor
101625601|NCT05757466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101625602|NCT02736513|Osimertinib|osimertinib|mesh-list
101625603|NCT02736513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101625604|NCT02736513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101625605|NCT02736513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101625606|NCT02736513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625607|NCT02736435|Leuprolide|leuprolide|mesh-list
101625608|NCT02736435|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101625609|NCT02736435|Fertility Agents|fertility agents|mesh-ancestor
101625610|NCT02736435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101625611|NCT02736435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625612|NCT02736435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101625613|NCT02736435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101625614|NCT02736279|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101625615|NCT02736279|Dermatologic Agents|dermatologic agents|mesh-ancestor
101625616|NCT02736279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101625617|NCT02736279|Immunologic Factors|immunologic factors|mesh-ancestor
101625618|NCT02736279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625619|NCT00748189|Ofatumumab|ofatumumab|mesh-list
101625620|NCT00748189|Chlorambucil|chlorambucil|mesh-list
101625621|NCT00748189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101625622|NCT00748189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101625623|NCT00748189|Alkylating Agents|alkylating agents|mesh-ancestor
101625624|NCT00748189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625625|NCT02609230|TIC10 compound|tic10 compound|mesh-list
101625626|NCT02609230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101625627|NCT00913822|Desipramine|desipramine|mesh-list
101625628|NCT00913822|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101625629|NCT00913822|Antidepressive Agents|antidepressive agents|mesh-ancestor
101625630|NCT00913822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101625631|NCT00913822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101625632|NCT00913822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625633|NCT00913822|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101282712|NCT01909856|Serotonin Agents|serotonin agents|mesh-ancestor
101625634|NCT00913822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101625635|NCT00913822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101625636|NCT00913822|Adrenergic Agents|adrenergic agents|mesh-ancestor
101625637|NCT00913822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101625638|NCT00913822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625640|NCT02736123|Ipilimumab|ipilimumab|mesh-list
101625641|NCT02736123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101625642|NCT02736123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101625643|NCT02736123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101625644|NCT02736123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625645|NCT00744055|Prazosin|prazosin|mesh-list
101625646|NCT00744055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101625647|NCT00744055|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101625648|NCT00744055|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101625649|NCT00744055|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101625650|NCT00744055|Adrenergic Agents|adrenergic agents|mesh-ancestor
101625651|NCT00744055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101625652|NCT00744055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625653|NCT00744055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625654|NCT02738073|Tranexamic Acid|tranexamic acid|mesh-list
101625655|NCT02738073|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101625656|NCT02738073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101625657|NCT02738073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625658|NCT02738073|Hemostatics|hemostatics|mesh-ancestor
101625663|NCT03967483|Analgesics|analgesics|mesh-ancestor
101625664|NCT03967483|Sensory System Agents|sensory system agents|mesh-ancestor
101625665|NCT03967483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101625666|NCT03967483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709314|NCT04152434|Erenumab|erenumab|mesh-list
101625667|NCT03967483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101625668|NCT03967483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101625669|NCT03967483|Gout Suppressants|gout suppressants|mesh-ancestor
101625670|NCT03967483|Tocolytic Agents|tocolytic agents|mesh-ancestor
101625671|NCT03967483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101625672|NCT03967483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101945735|NCT01260285|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101945736|NCT01260285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101945737|NCT01260285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101625673|NCT03967483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101625674|NCT03967483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625675|NCT00740779|Silodosin|silodosin|mesh-list
101625676|NCT00740779|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101625677|NCT00740779|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101625678|NCT00740779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101625679|NCT00740779|Adrenergic Agents|adrenergic agents|mesh-ancestor
101625680|NCT00740779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101625681|NCT00740779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625682|NCT00740779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625683|NCT00740779|Urological Agents|urological agents|mesh-ancestor
101625684|NCT00735475|Vaccines|vaccines|mesh-list
101625685|NCT00735475|Immunologic Factors|immunologic factors|mesh-ancestor
101625686|NCT00735475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625687|NCT01026818|Tadalafil|tadalafil|mesh-list
101625688|NCT01026818|Vasodilator Agents|vasodilator agents|mesh-ancestor
101625689|NCT01026818|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101625690|NCT01026818|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101625691|NCT01026818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101625692|NCT01026818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625693|NCT01026818|Urological Agents|urological agents|mesh-ancestor
101625694|NCT02593747|Loratadine|loratadine|mesh-list
101625695|NCT02593747|Antipruritics|antipruritics|mesh-ancestor
101625696|NCT02593747|Dermatologic Agents|dermatologic agents|mesh-ancestor
101625697|NCT02593747|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101625698|NCT02593747|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101625699|NCT02593747|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101625700|NCT02593747|Histamine Antagonists|histamine antagonists|mesh-ancestor
101625701|NCT02593747|Histamine Agents|histamine agents|mesh-ancestor
101625702|NCT02593747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101625703|NCT02593747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625704|NCT02593747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625705|NCT00743509|Sirolimus|sirolimus|mesh-list
101625706|NCT00743509|Cyclophosphamide|cyclophosphamide|mesh-list
101625707|NCT00743509|Temsirolimus|temsirolimus|mesh-list
101625708|NCT00743509|MTOR Inhibitors|mtor inhibitors|mesh-list
101625709|NCT00743509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101625710|NCT00743509|Immunologic Factors|immunologic factors|mesh-ancestor
101625711|NCT00743509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625712|NCT00743509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101625713|NCT00743509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101625714|NCT00743509|Alkylating Agents|alkylating agents|mesh-ancestor
101625715|NCT00743509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625716|NCT00743509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101625717|NCT00743509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101625718|NCT00743509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101625719|NCT00743509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101625720|NCT00743509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101625721|NCT00743509|Antifungal Agents|antifungal agents|mesh-ancestor
101625722|NCT00743509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101625723|NCT00743509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101625724|NCT00734929|Dexamethasone|dexamethasone|mesh-list
101625725|NCT00734929|Dexamethasone acetate|dexamethasone acetate|mesh-list
101625726|NCT00734929|Ondansetron|ondansetron|mesh-list
101625727|NCT00734929|Aprepitant|aprepitant|mesh-list
101625728|NCT00734929|BB 1101|bb 1101|mesh-list
101625729|NCT00734929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101625730|NCT00734929|Antiemetics|antiemetics|mesh-ancestor
101625738|NCT00734929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101625739|NCT00734929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101625740|NCT00734929|Protease Inhibitors|protease inhibitors|mesh-ancestor
101625741|NCT00734929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101625742|NCT00734929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625743|NCT00734929|Antipruritics|antipruritics|mesh-ancestor
101625744|NCT00734929|Dermatologic Agents|dermatologic agents|mesh-ancestor
101625745|NCT00734929|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101625746|NCT00734929|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101625747|NCT00734929|Serotonin Agents|serotonin agents|mesh-ancestor
101625748|NCT00734929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101945738|NCT01260285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945739|NCT01260285|Urological Agents|urological agents|mesh-ancestor
101945740|NCT03888729|Velpatasvir|velpatasvir|mesh-list
101796079|NCT01014520|Amitriptyline|amitriptyline|mesh-list
101625749|NCT00734929|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101625750|NCT00734851|Docetaxel|docetaxel|mesh-list
101625751|NCT00734851|Sunitinib|sunitinib|mesh-list
101625752|NCT00734851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101625753|NCT00734851|Tubulin Modulators|tubulin modulators|mesh-ancestor
101625754|NCT00734851|Antimitotic Agents|antimitotic agents|mesh-ancestor
101625755|NCT00734851|Mitosis Modulators|mitosis modulators|mesh-ancestor
101625756|NCT00734851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625757|NCT00734851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101625758|NCT00734851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101625759|NCT00734851|Growth Substances|growth substances|mesh-ancestor
101625760|NCT00734851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625761|NCT00734851|Growth Inhibitors|growth inhibitors|mesh-ancestor
101625762|NCT00734851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101625763|NCT00734851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101625764|NCT00734617|Nicotine|nicotine|mesh-list
101625765|NCT00734617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101625766|NCT00734617|Autonomic Agents|autonomic agents|mesh-ancestor
101625767|NCT00734617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101625768|NCT00734617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625769|NCT00734617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101625770|NCT00734617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101625771|NCT00734617|Cholinergic Agents|cholinergic agents|mesh-ancestor
101625772|NCT00734617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101625773|NCT00734617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625774|NCT00743431|Doxorubicin|doxorubicin|mesh-list
101625775|NCT00743431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101625776|NCT00743431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101625777|NCT00743431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101625778|NCT00743431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101625779|NCT00743431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101282865|NCT01910506|Verinurad|verinurad|mesh-list
101625780|NCT00743431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625781|NCT02737605|Moxifloxacin|moxifloxacin|mesh-list
101625782|NCT02737605|Esketamine|esketamine|mesh-list
101625783|NCT02737605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101625784|NCT02737605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101625785|NCT02737605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101625786|NCT02737605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101625788|NCT02737605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625789|NCT02737605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101625790|NCT02737605|Antidepressive Agents|antidepressive agents|mesh-ancestor
101625792|NCT02737371|Antifungal Agents|antifungal agents|mesh-list
101625793|NCT02737371|Clotrimazole|clotrimazole|mesh-list
101625794|NCT02737371|Miconazole|miconazole|mesh-list
101625795|NCT02737371|Olorofim|olorofim|mesh-list
101625796|NCT02737371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101625797|NCT02737371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101625798|NCT02737371|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101424435|NCT00516841|Growth Inhibitors|growth inhibitors|mesh-ancestor
101625807|NCT02737371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101625808|NCT02737527|Levobupivacaine|levobupivacaine|mesh-list
101625809|NCT02737527|Anesthetics, Local|anesthetics, local|mesh-ancestor
101625810|NCT02737527|Anesthetics|anesthetics|mesh-ancestor
101625811|NCT02737527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101625812|NCT02737527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625813|NCT02737527|Sensory System Agents|sensory system agents|mesh-ancestor
101625814|NCT02737527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101625815|NCT00734539|Fluconazole|fluconazole|mesh-list
101625816|NCT00734539|Antifungal Agents|antifungal agents|mesh-ancestor
101625817|NCT00734539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101625818|NCT00734539|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101625819|NCT00734539|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101625820|NCT00734539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101625821|NCT00734539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625822|NCT00734539|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101625823|NCT00734539|Hormone Antagonists|hormone antagonists|mesh-ancestor
101945741|NCT03888729|Antiviral Agents|antiviral agents|mesh-ancestor
101945742|NCT03888729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101945743|NCT01151241|Anesthetics|anesthetics|mesh-list
101945744|NCT01151241|Anesthetics, Local|anesthetics, local|mesh-list
101945745|NCT01151241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101625824|NCT00734539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101625825|NCT00734539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625826|NCT00734539|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101625827|NCT00734539|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101625828|NCT02737059|Codeine|codeine|mesh-list
101625829|NCT02737059|Naloxegol|naloxegol|mesh-list
101625830|NCT02737059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101625831|NCT02737059|Narcotics|narcotics|mesh-ancestor
101625832|NCT02737059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101625833|NCT02737059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625834|NCT02737059|Analgesics|analgesics|mesh-ancestor
101625835|NCT02737059|Sensory System Agents|sensory system agents|mesh-ancestor
101625836|NCT02737059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101625837|NCT02737059|Antitussive Agents|antitussive agents|mesh-ancestor
101625838|NCT02737059|Respiratory System Agents|respiratory system agents|mesh-ancestor
101625839|NCT02737059|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101625840|NCT02731911|Dexamethasone|dexamethasone|mesh-list
101625841|NCT02731911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101625842|NCT02731911|Antiemetics|antiemetics|mesh-ancestor
101625843|NCT02731911|Autonomic Agents|autonomic agents|mesh-ancestor
101625844|NCT02731911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101625845|NCT02731911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625846|NCT02731911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101625847|NCT02731911|Glucocorticoids|glucocorticoids|mesh-ancestor
101625848|NCT02731911|Hormones|hormones|mesh-ancestor
101625849|NCT02731911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101625850|NCT02731911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101625851|NCT02731911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101625852|NCT00734149|Prednisone|prednisone|mesh-list
101625853|NCT00734149|Bortezomib|bortezomib|mesh-list
101625854|NCT00734149|Melphalan|melphalan|mesh-list
101282931|NCT01910883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101625855|NCT00734149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101625856|NCT00734149|Glucocorticoids|glucocorticoids|mesh-ancestor
101625857|NCT00734149|Hormones|hormones|mesh-ancestor
101625858|NCT00734149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101625859|NCT00734149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625860|NCT00734149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101625888|NCT00743197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101625889|NCT00743197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101625890|NCT00743197|Antipyretics|antipyretics|mesh-ancestor
101625891|NCT00743197|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101625892|NCT00743197|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101625893|NCT00743197|Antimetabolites|antimetabolites|mesh-ancestor
101625894|NCT00743197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101625895|NCT00743197|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101625896|NCT00743197|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101625897|NCT00743197|Protease Inhibitors|protease inhibitors|mesh-ancestor
101625898|NCT00743197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101625899|NCT00743197|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101625900|NCT00743197|Protective Agents|protective agents|mesh-ancestor
101625901|NCT02731287|Timolol|timolol|mesh-list
101625902|NCT02731287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625903|NCT02731287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101625904|NCT02731287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101625905|NCT02731287|Adrenergic Agents|adrenergic agents|mesh-ancestor
101625906|NCT02731287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101625907|NCT02731287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424566|NCT00518479|Valsartan|valsartan|mesh-list
101625924|NCT02735343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625925|NCT02735343|Antiemetics|antiemetics|mesh-ancestor
101625926|NCT02735343|Autonomic Agents|autonomic agents|mesh-ancestor
101625927|NCT02735343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101625928|NCT02735343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101625930|NCT02735343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101625931|NCT02735343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101945746|NCT01151241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945747|NCT01151241|Sensory System Agents|sensory system agents|mesh-ancestor
101945748|NCT01151241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101945749|NCT02949362|Teduglutide|teduglutide|mesh-list
101945750|NCT02949362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101625932|NCT02735343|Dopamine Agents|dopamine agents|mesh-ancestor
101625933|NCT02730975|Abiraterone Acetate|abiraterone acetate|mesh-list
101625934|NCT02730975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101625935|NCT02730975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101625936|NCT02730975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101625937|NCT02730975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625938|NCT02730975|Hormone Antagonists|hormone antagonists|mesh-ancestor
101625939|NCT02730975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101625940|NCT02730975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625941|NCT02730975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101625942|NCT00734071|Vortioxetine|vortioxetine|mesh-list
101625943|NCT00734071|Antidepressive Agents|antidepressive agents|mesh-ancestor
101625944|NCT00734071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101625945|NCT00734071|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101625946|NCT00734071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101625947|NCT00734071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101625948|NCT00734071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625949|NCT00734071|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101625950|NCT00734071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101625951|NCT00734071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101625952|NCT00734071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625953|NCT00734071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101625954|NCT00734071|Serotonin Agents|serotonin agents|mesh-ancestor
101625955|NCT00734071|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101625956|NCT00734071|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101625957|NCT00734071|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101625958|NCT00734071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101625959|NCT03255915|Tenofovir|tenofovir|mesh-list
101625960|NCT03255915|Emtricitabine|emtricitabine|mesh-list
101625961|NCT03255915|Antiviral Agents|antiviral agents|mesh-ancestor
101625962|NCT03255915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101625963|NCT03255915|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101424613|NCT00518908|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101625967|NCT03255915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101625968|NCT03255915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101625969|NCT04188951|Pembrolizumab|pembrolizumab|mesh-list
101625970|NCT04188951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101625971|NCT04188951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101625972|NCT04188951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101625973|NCT04188951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625974|NCT00739297|Montelukast|montelukast|mesh-list
101625975|NCT00739297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101625976|NCT00739297|Respiratory System Agents|respiratory system agents|mesh-ancestor
101625977|NCT00739297|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101625978|NCT00739297|Hormone Antagonists|hormone antagonists|mesh-ancestor
101625979|NCT00739297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101625980|NCT00739297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625981|NCT00739297|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101625982|NCT00739297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101625983|NCT00739297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625984|NCT05430243|Empagliflozin|empagliflozin|mesh-list
101625985|NCT05430243|Diuretics|diuretics|mesh-list
101625986|NCT05430243|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101625987|NCT05430243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625988|NCT05430243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101625989|NCT05430243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625990|NCT05430243|Natriuretic Agents|natriuretic agents|mesh-ancestor
101625991|NCT02730117|Cephalosporins|cephalosporins|mesh-list
101625992|NCT02730117|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101625993|NCT02730117|Dobutamine|dobutamine|mesh-list
101625994|NCT02730117|Dopamine|dopamine|mesh-list
101945751|NCT02949362|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101945752|NCT02949362|Protective Agents|protective agents|mesh-ancestor
101796287|NCT03944915|Paclitaxel|paclitaxel|mesh-list
101625995|NCT02730117|Milrinone|milrinone|mesh-list
101625996|NCT02730117|Norepinephrine|norepinephrine|mesh-list
101625997|NCT02730117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
101625998|NCT02730117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101625999|NCT02730117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101626000|NCT02730117|Adrenergic Agents|adrenergic agents|mesh-ancestor
101626001|NCT02730117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101626002|NCT02730117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626003|NCT02730117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626004|NCT02730117|Sympathomimetics|sympathomimetics|mesh-ancestor
101626005|NCT02730117|Autonomic Agents|autonomic agents|mesh-ancestor
101626006|NCT02730117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101626007|NCT02730117|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101626008|NCT02730117|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101626009|NCT02730117|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101626010|NCT02730117|Protective Agents|protective agents|mesh-ancestor
101626011|NCT02730117|Dopamine Agents|dopamine agents|mesh-ancestor
101626012|NCT02730117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101626013|NCT02730117|Vasodilator Agents|vasodilator agents|mesh-ancestor
101626014|NCT02730117|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101626015|NCT02730117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101626016|NCT02730117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101626017|NCT02730117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101626019|NCT02595463|Anesthetics, Local|anesthetics, local|mesh-ancestor
101626021|NCT02595463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101626022|NCT02595463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626023|NCT02595463|Sensory System Agents|sensory system agents|mesh-ancestor
101626024|NCT02595463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101626025|NCT02595463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101626026|NCT02595463|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101626027|NCT02595463|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101626028|NCT02595463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101626029|NCT02595463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626030|NCT02593669|Dexamethasone|dexamethasone|mesh-list
101626031|NCT02593669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101626032|NCT02593669|Antiemetics|antiemetics|mesh-ancestor
101626033|NCT02593669|Autonomic Agents|autonomic agents|mesh-ancestor
101424671|NCT02949349|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101626048|NCT02729961|Immunoconjugates|immunoconjugates|mesh-list
101626049|NCT02729961|Immunologic Factors|immunologic factors|mesh-ancestor
101626050|NCT02729961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626051|NCT02729961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101626052|NCT02729961|Immunotoxins|immunotoxins|mesh-ancestor
101626053|NCT02729961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101626054|NCT02729961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101626055|NCT02729961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626056|NCT02735031|Exenatide|exenatide|mesh-list
101626057|NCT02735031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101626058|NCT02735031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626059|NCT02735031|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101626060|NCT02735031|Incretins|incretins|mesh-ancestor
101626061|NCT02735031|Hormones|hormones|mesh-ancestor
101626062|NCT02735031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101626063|NCT02595541|Milrinone|milrinone|mesh-list
101626064|NCT02595541|Sildenafil Citrate|sildenafil citrate|mesh-list
101626065|NCT02595541|Vasodilator Agents|vasodilator agents|mesh-ancestor
101626066|NCT02595541|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101626067|NCT02595541|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101626068|NCT02595541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101626069|NCT02595541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626070|NCT02595541|Urological Agents|urological agents|mesh-ancestor
101626071|NCT02595541|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101626072|NCT02595541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101626073|NCT02595541|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101626074|NCT02595541|Protective Agents|protective agents|mesh-ancestor
101626075|NCT02595541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626076|NCT00739063|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101626077|NCT00739063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101626078|NCT00739063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101945753|NCT02949362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945754|NCT03896217|Simvastatin|simvastatin|mesh-list
101945755|NCT03896217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101945756|NCT03896217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101626079|NCT00739063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101626080|NCT00739063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626081|NCT01026194|Pioglitazone|pioglitazone|mesh-list
101626082|NCT01026194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101626083|NCT01026194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626084|NCT02734875|Anticoagulants|anticoagulants|mesh-list
101626085|NCT04088461|Metformin|metformin|mesh-list
101626086|NCT04088461|Linagliptin|linagliptin|mesh-list
101626087|NCT04088461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101626088|NCT04088461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626089|NCT04088461|Incretins|incretins|mesh-ancestor
101626090|NCT04088461|Hormones|hormones|mesh-ancestor
101626091|NCT04088461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101626092|NCT04088461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101626093|NCT04088461|Protease Inhibitors|protease inhibitors|mesh-ancestor
101626094|NCT04088461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101626096|NCT00636519|Antitoxins|antitoxins|mesh-list
101626097|NCT00636519|Botulinum Antitoxin|botulinum antitoxin|mesh-list
101626098|NCT00636519|Immunologic Factors|immunologic factors|mesh-ancestor
101626099|NCT00636519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626100|NCT00811954|Ritonavir|ritonavir|mesh-list
101626101|NCT00811954|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101626102|NCT00811954|Darunavir|darunavir|mesh-list
101626103|NCT00811954|Tenofovir|tenofovir|mesh-list
101626104|NCT00811954|Emtricitabine|emtricitabine|mesh-list
101626105|NCT00811954|Raltegravir Potassium|raltegravir potassium|mesh-list
101626106|NCT00811954|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101626107|NCT00811954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101626108|NCT00811954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101626109|NCT00811954|Protease Inhibitors|protease inhibitors|mesh-ancestor
101626110|NCT00811954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101626111|NCT00811954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626112|NCT00811954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101626113|NCT00811954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101626114|NCT00811954|Antiviral Agents|antiviral agents|mesh-ancestor
101626115|NCT00811954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101626116|NCT00811954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101626117|NCT00811954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101626118|NCT00811954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101626119|NCT00811954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101626120|NCT00811954|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101626121|NCT00811954|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101626122|NCT00917839|Lamotrigine|lamotrigine|mesh-list
101626123|NCT00917839|Anticonvulsants|anticonvulsants|mesh-ancestor
101626124|NCT00917839|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101626125|NCT00917839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101626126|NCT00917839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626127|NCT00917839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101626128|NCT00917839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626129|NCT00917839|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101626130|NCT00917839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101626131|NCT00917839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101626132|NCT00917839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101626133|NCT00917839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101626134|NCT01032200|Modafinil|modafinil|mesh-list
101626135|NCT01032200|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101626136|NCT01032200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626137|NCT01032200|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101626138|NCT01032200|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101626139|NCT01032200|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101626140|NCT01032200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626141|NCT03345771|Anti-Infective Agents|anti-infective agents|mesh-list
101626142|NCT03345771|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101626143|NCT00586105|Sorafenib|sorafenib|mesh-list
101626144|NCT00586105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101626145|NCT00586105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101626146|NCT00586105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101945757|NCT03896217|Antimetabolites|antimetabolites|mesh-ancestor
101945758|NCT03896217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945759|NCT03896217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101945760|NCT03896217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101626147|NCT00586105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626149|NCT00743119|Hallucinogens|hallucinogens|mesh-ancestor
101626150|NCT00743119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626151|NCT00743119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101626152|NCT00743119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101626153|NCT00743119|Analgesics|analgesics|mesh-ancestor
101626154|NCT00743119|Sensory System Agents|sensory system agents|mesh-ancestor
101626155|NCT00743119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101626156|NCT00743119|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101626157|NCT00743119|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101626158|NCT00743119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101626159|NCT00743119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626160|NCT00743119|Hormones|hormones|mesh-ancestor
101626161|NCT00743119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101626162|NCT02610010|Cisplatin|cisplatin|mesh-list
101626163|NCT02610010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101626164|NCT02610088|Dapagliflozin|dapagliflozin|mesh-list
101626165|NCT02610088|Gliclazide|gliclazide|mesh-list
101626166|NCT02610088|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101626172|NCT02734407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101626173|NCT02734407|Growth Substances|growth substances|mesh-ancestor
101626174|NCT02734407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626175|NCT02734407|Growth Inhibitors|growth inhibitors|mesh-ancestor
101626176|NCT02734407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101626177|NCT02734173|Ritonavir|ritonavir|mesh-list
101626178|NCT02734173|Ribavirin|ribavirin|mesh-list
101626179|NCT02734173|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101626180|NCT02734173|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101626181|NCT02734173|Protease Inhibitors|protease inhibitors|mesh-ancestor
101626182|NCT02734173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101626183|NCT02734173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626184|NCT02734173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101626185|NCT02734173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101626186|NCT02734173|Antiviral Agents|antiviral agents|mesh-ancestor
101626187|NCT02734173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101626188|NCT02734173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101626189|NCT02734173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101626190|NCT02734173|Antimetabolites|antimetabolites|mesh-ancestor
101626191|NCT05297422|Ketamine|ketamine|mesh-list
101626192|NCT05297422|Ropivacaine|ropivacaine|mesh-list
101626193|NCT05297422|Analgesics|analgesics|mesh-ancestor
101626194|NCT05297422|Sensory System Agents|sensory system agents|mesh-ancestor
101626195|NCT05297422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101626196|NCT05297422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626197|NCT05297422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101626198|NCT05297422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101626199|NCT05297422|Anesthetics, General|anesthetics, general|mesh-ancestor
101626200|NCT05297422|Anesthetics|anesthetics|mesh-ancestor
101626201|NCT05297422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101626202|NCT05297422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101626203|NCT05297422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101626204|NCT05297422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101626205|NCT05297422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626206|NCT05297422|Anesthetics, Local|anesthetics, local|mesh-ancestor
101626207|NCT00813124|Fludarabine|fludarabine|mesh-list
101626208|NCT00813124|Fludarabine phosphate|fludarabine phosphate|mesh-list
101626209|NCT00813124|Azacitidine|azacitidine|mesh-list
101626210|NCT00813124|Busulfan|busulfan|mesh-list
101626211|NCT00813124|Thymoglobulin|thymoglobulin|mesh-list
101626212|NCT00813124|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101626213|NCT00813124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101626214|NCT00813124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101626215|NCT00813124|Antimetabolites|antimetabolites|mesh-ancestor
101626216|NCT00813124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626217|NCT00813124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101626218|NCT00813124|Immunologic Factors|immunologic factors|mesh-ancestor
101626219|NCT00813124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626220|NCT00813124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101626221|NCT00813124|Alkylating Agents|alkylating agents|mesh-ancestor
101626222|NCT00813124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101626223|NCT00813124|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101626224|NCT00733291|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101626225|NCT02728869|Vaccines|vaccines|mesh-list
101626226|NCT02728869|Immunologic Factors|immunologic factors|mesh-ancestor
101626227|NCT02728869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626228|NCT02594761|Trastuzumab|trastuzumab|mesh-list
101626229|NCT02594761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101626230|NCT02594761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101626231|NCT02728947|Rotigotine|rotigotine|mesh-list
101626232|NCT02728947|Dopamine Agonists|dopamine agonists|mesh-ancestor
101626233|NCT02728947|Dopamine Agents|dopamine agents|mesh-ancestor
101626234|NCT02728947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101626235|NCT02728947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626236|NCT02728947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626257|NCT02597257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626258|NCT02597257|Sensory System Agents|sensory system agents|mesh-ancestor
101626259|NCT02597257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101626260|NCT02597257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101626261|NCT02597257|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101626262|NCT02597257|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101626263|NCT02597257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101626264|NCT02597257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626266|NCT02596555|Antithrombins|antithrombins|mesh-ancestor
101626267|NCT02596555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101626268|NCT02596555|Protease Inhibitors|protease inhibitors|mesh-ancestor
101626269|NCT02596555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101626270|NCT02596555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626271|NCT02596555|Anticoagulants|anticoagulants|mesh-ancestor
101626272|NCT02733471|Lidocaine|lidocaine|mesh-list
101626273|NCT02733471|Anesthetics, Local|anesthetics, local|mesh-ancestor
101626274|NCT02733471|Anesthetics|anesthetics|mesh-ancestor
101626275|NCT02733471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101626276|NCT02733471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626277|NCT02733471|Sensory System Agents|sensory system agents|mesh-ancestor
101626278|NCT02733471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101626279|NCT02733471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101626280|NCT02733471|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101626281|NCT02733471|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101626282|NCT02733471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101626283|NCT02733471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626284|NCT02733237|Oxytocin|oxytocin|mesh-list
101626285|NCT02733237|Oxytocics|oxytocics|mesh-ancestor
101626286|NCT02733237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101626287|NCT02733237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626288|NCT04206813|Vaccines|vaccines|mesh-list
101626289|NCT04206813|Immunologic Factors|immunologic factors|mesh-ancestor
101626290|NCT04206813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626291|NCT02728323|Levobupivacaine|levobupivacaine|mesh-list
101424941|NCT04694092|Landiolol|landiolol|mesh-list
101626295|NCT02728323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626296|NCT02728323|Sensory System Agents|sensory system agents|mesh-ancestor
101626297|NCT02728323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101626298|NCT00811720|Nalmefene|nalmefene|mesh-list
101626299|NCT00811720|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101626300|NCT00811720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626302|NCT00811720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101626303|NCT04202679|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
101626304|NCT04202679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101626305|NCT04202679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626307|NCT00811642|Antifungal Agents|antifungal agents|mesh-ancestor
101626308|NCT00811642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101626309|NCT00811642|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101626310|NCT00811642|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101626311|NCT00811642|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101626312|NCT00811642|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101626313|NCT00811642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101626314|NCT00811642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101945761|NCT03896217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101945762|NCT05220410|Psilocybin|psilocybin|mesh-list
101945763|NCT05220410|Hallucinogens|hallucinogens|mesh-ancestor
101665595|NCT02760888|Narcotics|narcotics|mesh-ancestor
101945764|NCT05220410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626315|NCT00811642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626316|NCT00811642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101626317|NCT00811642|Hormone Antagonists|hormone antagonists|mesh-ancestor
101626318|NCT00811642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101626319|NCT00811642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626320|NCT02609152|Esmolol|esmolol|mesh-list
101626321|NCT02609152|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101709398|NCT01009801|Doxorubicin|doxorubicin|mesh-list
101626322|NCT02609152|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101626323|NCT02609152|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101626324|NCT02609152|Adrenergic Agents|adrenergic agents|mesh-ancestor
101626325|NCT02609152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101626326|NCT02609152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626327|NCT02609152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626328|NCT02733393|Lidocaine|lidocaine|mesh-list
101626329|NCT02733393|Anesthetics, Local|anesthetics, local|mesh-ancestor
101626330|NCT02733393|Anesthetics|anesthetics|mesh-ancestor
101626331|NCT02733393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101626332|NCT02733393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626333|NCT02733393|Sensory System Agents|sensory system agents|mesh-ancestor
101626334|NCT02733393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101626335|NCT02733393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101626336|NCT02733393|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101626337|NCT02733393|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101626338|NCT02733393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101626339|NCT02733393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626340|NCT00809926|Valsartan|valsartan|mesh-list
101626341|NCT00809926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101626342|NCT00809926|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101626343|NCT00809926|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101626344|NCT00809926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626345|NCT02728245|Dienogest|dienogest|mesh-list
101626346|NCT02728245|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101626347|NCT02728245|Contraceptive Agents|contraceptive agents|mesh-ancestor
101626348|NCT02728245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101626349|NCT02728245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626350|NCT02728245|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101626351|NCT02728245|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101626352|NCT02728245|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101626353|NCT02728245|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101626354|NCT02728245|Hormone Antagonists|hormone antagonists|mesh-ancestor
101626355|NCT02728245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101626356|NCT02728245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101626357|NCT02728245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101626358|NCT02690415|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101626359|NCT02690415|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101626360|NCT02690415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101626361|NCT02690415|Antitubercular Agents|antitubercular agents|mesh-ancestor
101626365|NCT05753722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101626366|NCT05753722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626368|NCT02727621|Propofol|propofol|mesh-list
101626369|NCT02727621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101626371|NCT02727621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626372|NCT02727621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101626373|NCT02727621|Analgesics|analgesics|mesh-ancestor
101626374|NCT02727621|Sensory System Agents|sensory system agents|mesh-ancestor
101626375|NCT02727621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101626377|NCT02727621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101626378|NCT02727621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101626379|NCT02727621|Adrenergic Agents|adrenergic agents|mesh-ancestor
101626380|NCT02727621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101626381|NCT02727621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945765|NCT05220410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101945766|NCT03892161|Ritonavir|ritonavir|mesh-list
101945767|NCT03892161|Darunavir|darunavir|mesh-list
101796692|NCT00880178|Niacin|niacin|mesh-list
101626382|NCT02727621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101626383|NCT02727621|Anesthetics, General|anesthetics, general|mesh-ancestor
101626384|NCT02727621|Anesthetics|anesthetics|mesh-ancestor
101626385|NCT02608606|Tacrolimus|tacrolimus|mesh-list
101626386|NCT02608606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101626387|NCT02608606|Immunologic Factors|immunologic factors|mesh-ancestor
101626388|NCT02608606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626389|NCT02608606|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101626390|NCT02608606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101626391|NCT02608606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626392|NCT02608918|BMS-955176|bms-955176|mesh-list
101626393|NCT02608918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101626394|NCT02608918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101626395|NCT02608918|Antiviral Agents|antiviral agents|mesh-ancestor
101626396|NCT02608918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101626397|NCT05755204|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101626398|NCT05755204|Cabotegravir|cabotegravir|mesh-list
101626399|NCT05755204|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101626400|NCT05755204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101626401|NCT05755204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101626402|NCT05755204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626403|NCT05755204|Antiviral Agents|antiviral agents|mesh-ancestor
101626404|NCT05755204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101626405|NCT05755204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101626406|NCT05755204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101626407|NCT05755204|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101626408|NCT05755204|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101626409|NCT02727309|Apatinib|apatinib|mesh-list
101626410|NCT02727309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101626411|NCT02727309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101626412|NCT02727309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101626413|NCT02727309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626414|NCT05755750|Genipin|genipin|mesh-list
101626415|NCT05755750|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101626416|NCT05755750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101626417|NCT02732067|Anesthetics|anesthetics|mesh-list
101626418|NCT02732067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101626419|NCT02732067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626420|NCT02609932|Interferons|interferons|mesh-list
101626421|NCT02609932|Interferon-gamma|interferon-gamma|mesh-list
101626422|NCT02609932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101626423|NCT02609932|Antiviral Agents|antiviral agents|mesh-ancestor
101626424|NCT02609932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101626425|NCT02726919|Clobazam|clobazam|mesh-list
101626426|NCT02726919|Anticonvulsants|anticonvulsants|mesh-ancestor
101626427|NCT02726919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101626428|NCT02726919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101626429|NCT02726919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101626430|NCT02726919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626431|NCT02726919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101626432|NCT02726919|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101626433|NCT02726919|GABA Agonists|gaba agonists|mesh-ancestor
101626434|NCT02726919|GABA Agents|gaba agents|mesh-ancestor
101626435|NCT02726919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101626438|NCT00590902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101626439|NCT00590902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101626441|NCT00590902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626442|NCT05753566|Androgens|androgens|mesh-list
101626443|NCT05753566|Hormones|hormones|mesh-ancestor
101626444|NCT05753566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101626445|NCT05753566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626446|NCT00590824|Interleukin-2|interleukin-2|mesh-list
101626447|NCT00590824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101626448|NCT00590824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101626449|NCT00590824|Analgesics|analgesics|mesh-ancestor
101626450|NCT00590824|Sensory System Agents|sensory system agents|mesh-ancestor
101626451|NCT00590824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101626452|NCT00590824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626453|NCT02720991|Misoprostol|misoprostol|mesh-list
101626454|NCT02720991|Mifepristone|mifepristone|mesh-list
101945769|NCT03892161|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101945770|NCT03892161|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101945771|NCT03892161|Protease Inhibitors|protease inhibitors|mesh-ancestor
101945772|NCT03892161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101945773|NCT03892161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945774|NCT03892161|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101945775|NCT03892161|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101945776|NCT03892161|Antiviral Agents|antiviral agents|mesh-ancestor
101626455|NCT02720991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101626456|NCT02720991|Abortifacient Agents|abortifacient agents|mesh-ancestor
101626457|NCT02720991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101626458|NCT02720991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626459|NCT02720991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101626460|NCT02720991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101626461|NCT02720991|Oxytocics|oxytocics|mesh-ancestor
101626462|NCT02720991|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101626463|NCT02720991|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101626464|NCT02720991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101626465|NCT02720991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101626466|NCT02720991|Contraceptive Agents|contraceptive agents|mesh-ancestor
101626467|NCT02720991|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101626468|NCT02720991|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101626469|NCT02720991|Hormone Antagonists|hormone antagonists|mesh-ancestor
101626470|NCT02720991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101626471|NCT02720991|Luteolytic Agents|luteolytic agents|mesh-ancestor
101626472|NCT02720991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101626473|NCT02720991|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101626474|NCT02720601|Capecitabine|capecitabine|mesh-list
101626476|NCT02720601|Camptothecin|camptothecin|mesh-list
101626477|NCT02720601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101626478|NCT02720601|Antimetabolites|antimetabolites|mesh-ancestor
101626479|NCT02720601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626480|NCT02720601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101626481|NCT02720601|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101626482|NCT02720601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101626483|NCT02720601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101626484|NCT02720601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101626485|NCT00590590|Diphenhydramine|diphenhydramine|mesh-list
101626486|NCT00590590|Promethazine|promethazine|mesh-list
101626487|NCT00590590|Lidocaine|lidocaine|mesh-list
101626488|NCT00590590|Anesthetics, Local|anesthetics, local|mesh-ancestor
101626489|NCT00590590|Anesthetics|anesthetics|mesh-ancestor
101626490|NCT00590590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101626491|NCT00590590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626492|NCT00590590|Sensory System Agents|sensory system agents|mesh-ancestor
101626493|NCT00590590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101626494|NCT00590590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101626495|NCT00590590|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101626496|NCT00590590|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101626497|NCT00590590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101626498|NCT00590590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626499|NCT00590590|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101626500|NCT00590590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101626501|NCT00590590|Antiemetics|antiemetics|mesh-ancestor
101626502|NCT00590590|Autonomic Agents|autonomic agents|mesh-ancestor
101626503|NCT00590590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101626504|NCT00590590|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101626505|NCT00590590|Histamine Antagonists|histamine antagonists|mesh-ancestor
101626506|NCT00590590|Histamine Agents|histamine agents|mesh-ancestor
101626509|NCT00590590|Antipruritics|antipruritics|mesh-ancestor
101626510|NCT00590590|Dermatologic Agents|dermatologic agents|mesh-ancestor
101626511|NCT02720367|Gemcitabine|gemcitabine|mesh-list
101626512|NCT02720367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101626513|NCT02720367|Antimetabolites|antimetabolites|mesh-ancestor
101945778|NCT03892161|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101945779|NCT03892161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101945780|NCT03892161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101796797|NCT01007019|Esomeprazole|esomeprazole|mesh-list
101626514|NCT02720367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626515|NCT02720367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101626516|NCT02693769|Fluticasone|fluticasone|mesh-list
101626517|NCT02693769|Xhance|xhance|mesh-list
101626518|NCT02693769|Glycopyrrolate|glycopyrrolate|mesh-list
101626519|NCT02693769|Bromides|bromides|mesh-list
101626520|NCT02693769|Formoterol Fumarate|formoterol fumarate|mesh-list
101626521|NCT02693769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101626522|NCT02693769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101626523|NCT02693769|Autonomic Agents|autonomic agents|mesh-ancestor
101626524|NCT02693769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101626525|NCT02693769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626526|NCT02693769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101626527|NCT02693769|Respiratory System Agents|respiratory system agents|mesh-ancestor
101626528|NCT02693769|Dermatologic Agents|dermatologic agents|mesh-ancestor
101626529|NCT02693769|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101626530|NCT02693769|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101626531|NCT02693769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101626532|NCT02693769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101626533|NCT02693769|Adrenergic Agents|adrenergic agents|mesh-ancestor
101626534|NCT02693769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101626535|NCT02693769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626536|NCT02693769|Anticonvulsants|anticonvulsants|mesh-ancestor
101626537|NCT02693769|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101626538|NCT02693769|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101626539|NCT02693769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101626540|NCT02693769|Cholinergic Agents|cholinergic agents|mesh-ancestor
101626541|NCT02725359|Tizanidine|tizanidine|mesh-list
101626542|NCT02725359|Bupivacaine|bupivacaine|mesh-list
101626543|NCT02725359|Anesthetics, Local|anesthetics, local|mesh-ancestor
101626544|NCT02725359|Anesthetics|anesthetics|mesh-ancestor
101626545|NCT02725359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101626546|NCT02725359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626547|NCT02725359|Sensory System Agents|sensory system agents|mesh-ancestor
101626548|NCT02725359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101626549|NCT02725359|Analgesics|analgesics|mesh-ancestor
101626550|NCT02725359|Anticonvulsants|anticonvulsants|mesh-ancestor
101626551|NCT02725359|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101626552|NCT02725359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101626553|NCT02725359|Parasympatholytics|parasympatholytics|mesh-ancestor
101626554|NCT02725359|Autonomic Agents|autonomic agents|mesh-ancestor
101626555|NCT02725359|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101626556|NCT02725359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101626557|NCT02725359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101626558|NCT02725359|Adrenergic Agents|adrenergic agents|mesh-ancestor
101626559|NCT02725359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101626560|NCT02725359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626561|NCT00731731|Temozolomide|temozolomide|mesh-list
101626562|NCT00731731|Vorinostat|vorinostat|mesh-list
101626563|NCT00731731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101626564|NCT00731731|Alkylating Agents|alkylating agents|mesh-ancestor
101626565|NCT00731731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626566|NCT00731731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101626567|NCT00731731|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101626568|NCT00731731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101626569|NCT02719431|Warfarin|warfarin|mesh-list
101626570|NCT02719431|Anticoagulants|anticoagulants|mesh-ancestor
101626571|NCT00806494|Fesoterodine|fesoterodine|mesh-list
101626572|NCT00806494|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101626573|NCT00806494|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101626574|NCT00806494|Cholinergic Agents|cholinergic agents|mesh-ancestor
101626575|NCT00806494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101626576|NCT00806494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626577|NCT00806494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626578|NCT00806494|Urological Agents|urological agents|mesh-ancestor
101626579|NCT00806416|Vitamin D|vitamin d|mesh-list
101945782|NCT03892161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101945783|NCT03892161|Leprostatic Agents|leprostatic agents|mesh-ancestor
101945784|NCT03892161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101796864|NCT04994223|Rivaroxaban|rivaroxaban|mesh-list
101626580|NCT00806416|Cholecalciferol|cholecalciferol|mesh-list
101626581|NCT00806416|Alendronate|alendronate|mesh-list
101626584|NCT00806416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626585|NCT00806416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101626586|NCT00806416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101626588|NCT00811252|Vortioxetine|vortioxetine|mesh-list
101626589|NCT00811252|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101626590|NCT00811252|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101626591|NCT00811252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101626592|NCT00811252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626593|NCT00811252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101626594|NCT00811252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626595|NCT00811252|Analgesics|analgesics|mesh-ancestor
101626596|NCT00811252|Sensory System Agents|sensory system agents|mesh-ancestor
101626597|NCT00811252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101626598|NCT00811252|Antidepressive Agents|antidepressive agents|mesh-ancestor
101626599|NCT00811252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101626601|NCT00811252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101626602|NCT00811252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101626603|NCT00811252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101626604|NCT00811252|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101626605|NCT00811252|Serotonin Agents|serotonin agents|mesh-ancestor
101626606|NCT00811252|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101626607|NCT00811252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101626608|NCT00811252|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101626609|NCT00811252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101626610|NCT02608996|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101626611|NCT02608996|Natriuretic Agents|natriuretic agents|mesh-ancestor
101626612|NCT02608996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626613|NCT00736957|Acetaminophen|acetaminophen|mesh-list
101626614|NCT00736957|Tramadol|tramadol|mesh-list
101626615|NCT00736957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101626616|NCT00736957|Analgesics|analgesics|mesh-ancestor
101626617|NCT00736957|Sensory System Agents|sensory system agents|mesh-ancestor
101626618|NCT00736957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101626619|NCT00736957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626620|NCT00736957|Antipyretics|antipyretics|mesh-ancestor
101626621|NCT00736957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101626622|NCT00736957|Narcotics|narcotics|mesh-ancestor
101626623|NCT00736957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101626624|NCT05294523|Rocuronium|rocuronium|mesh-list
101626625|NCT05294523|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101626626|NCT05294523|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101626627|NCT05294523|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101626628|NCT05294523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101626629|NCT05294523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626630|NCT00736879|Dapagliflozin|dapagliflozin|mesh-list
101626631|NCT00736879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101626632|NCT00736879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626633|NCT00736879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101626634|NCT00736879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626635|NCT02718261|Pantoprazole|pantoprazole|mesh-list
101626636|NCT02718261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101626637|NCT02718261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101626638|NCT02718261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101626639|NCT02718261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101626640|NCT02718261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626641|NCT00806260|Ethanol|ethanol|mesh-list
101626642|NCT00806260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101626643|NCT00806260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101626644|NCT00806260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101626645|NCT00806260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626646|NCT02718183|Hydrogen Peroxide|hydrogen peroxide|mesh-list
101945785|NCT03892161|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101945786|NCT03892161|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101945787|NCT03892161|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101945788|NCT03892161|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101626647|NCT02718183|Carbamide Peroxide|carbamide peroxide|mesh-list
101626648|NCT02718183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101626649|NCT02718183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101626650|NCT00811174|gamma-Globulins|gamma-globulins|mesh-list
101626651|NCT00811174|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101626652|NCT00811174|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101626653|NCT00811174|Immunologic Factors|immunologic factors|mesh-ancestor
101626676|NCT02717871|Prednisolone acetate|prednisolone acetate|mesh-list
101626677|NCT02717871|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101626678|NCT02717871|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101626679|NCT02717871|Prednisolone phosphate|prednisolone phosphate|mesh-list
101626680|NCT02717871|Cyclopentolate|cyclopentolate|mesh-list
101626682|NCT02717871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101626683|NCT02717871|Glucocorticoids|glucocorticoids|mesh-ancestor
101626684|NCT02717871|Hormones|hormones|mesh-ancestor
101626685|NCT02717871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101626686|NCT02717871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626687|NCT02717871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101626688|NCT02717871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101626689|NCT02717871|Antiemetics|antiemetics|mesh-ancestor
101626690|NCT02717871|Autonomic Agents|autonomic agents|mesh-ancestor
101626691|NCT02717871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101626692|NCT02717871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101626693|NCT02717871|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101626694|NCT02717871|Protective Agents|protective agents|mesh-ancestor
101626695|NCT02717871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101626696|NCT02717871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101626697|NCT02717871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101626698|NCT02717871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101626699|NCT02717871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101626700|NCT02717871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626701|NCT02717871|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101626702|NCT02717871|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101626703|NCT02717871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101626704|NCT02717871|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101626705|NCT02717871|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101626706|NCT02717871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101626707|NCT02717871|Parasympatholytics|parasympatholytics|mesh-ancestor
101626708|NCT02717871|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101626709|NCT02717871|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101626710|NCT02717871|Cholinergic Agents|cholinergic agents|mesh-ancestor
101425358|NCT00512668|Fertility Agents|fertility agents|mesh-ancestor
101626716|NCT02723253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626717|NCT02723253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101626718|NCT02723253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101626720|NCT00730405|Antifungal Agents|antifungal agents|mesh-ancestor
101626721|NCT00730405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101626722|NCT02594449|Benzalkonium Compounds|benzalkonium compounds|mesh-list
101626723|NCT02594449|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101626724|NCT02594449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101626725|NCT02722083|Chlorpheniramine|chlorpheniramine|mesh-list
101626726|NCT02722083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626727|NCT02722083|Antipruritics|antipruritics|mesh-ancestor
101626728|NCT02722083|Dermatologic Agents|dermatologic agents|mesh-ancestor
101626729|NCT02722083|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101626730|NCT02722083|Histamine Antagonists|histamine antagonists|mesh-ancestor
101626731|NCT02722083|Histamine Agents|histamine agents|mesh-ancestor
101626732|NCT02722083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101626733|NCT02722083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626734|NCT02722083|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101626735|NCT05201079|Fidaxomicin|fidaxomicin|mesh-list
101626736|NCT05201079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101626737|NCT05201079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101626738|NCT00736645|Selenium|selenium|mesh-list
101945789|NCT03892161|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101945790|NCT03892161|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101945791|NCT01154361|Cortisone|cortisone|mesh-list
101626739|NCT00736645|Finasteride|finasteride|mesh-list
101626740|NCT00736645|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101626741|NCT00736645|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101626742|NCT00736645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101626743|NCT00736645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626744|NCT00736645|Hormone Antagonists|hormone antagonists|mesh-ancestor
101626745|NCT00736645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101626746|NCT00736645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626747|NCT00736645|Urological Agents|urological agents|mesh-ancestor
101626748|NCT00736645|Antioxidants|antioxidants|mesh-ancestor
101626749|NCT00736645|Protective Agents|protective agents|mesh-ancestor
101626750|NCT00736645|Trace Elements|trace elements|mesh-ancestor
101626751|NCT00736645|Micronutrients|micronutrients|mesh-ancestor
101626752|NCT00736489|Formoterol Fumarate|formoterol fumarate|mesh-list
101626753|NCT00736489|AZD-3199|azd-3199|mesh-list
101626754|NCT00736489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101626755|NCT00736489|Autonomic Agents|autonomic agents|mesh-ancestor
101626756|NCT00736489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101626757|NCT00736489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626758|NCT00736489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101626759|NCT00736489|Respiratory System Agents|respiratory system agents|mesh-ancestor
101626760|NCT00736489|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101626761|NCT00736489|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101626762|NCT00736489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101626763|NCT00736489|Adrenergic Agents|adrenergic agents|mesh-ancestor
101626764|NCT00736489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101626765|NCT00736489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626766|NCT02716233|Pegaspargase|pegaspargase|mesh-list
101626767|NCT02716233|Asparaginase|asparaginase|mesh-list
101626768|NCT02716233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101626769|NCT01999569|Letrozole|letrozole|mesh-list
101626770|NCT01999569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101626771|NCT01999569|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101626772|NCT01999569|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101626773|NCT01999569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101626774|NCT01999569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626775|NCT01999569|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101626776|NCT01999569|Hormone Antagonists|hormone antagonists|mesh-ancestor
101626777|NCT01999569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101626778|NCT01999569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626779|NCT04087915|Evolocumab|evolocumab|mesh-list
101626780|NCT04087915|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101626788|NCT04087915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101626790|NCT02715687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101626791|NCT02715687|Vasodilator Agents|vasodilator agents|mesh-ancestor
101626792|NCT02715687|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101626793|NCT02715687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101626794|NCT02715687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626795|NCT02715687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101626796|NCT02715687|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101626797|NCT02715687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101626798|NCT02715687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101626799|NCT02715687|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101626800|NCT02715687|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101626801|NCT02715687|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101626802|NCT02715531|Leucovorin|leucovorin|mesh-list
101626803|NCT02715531|Paclitaxel|paclitaxel|mesh-list
101626804|NCT02715531|Bevacizumab|bevacizumab|mesh-list
101626805|NCT02715531|Gemcitabine|gemcitabine|mesh-list
101626806|NCT02715531|Capecitabine|capecitabine|mesh-list
101626807|NCT02715531|Oxaliplatin|oxaliplatin|mesh-list
101626808|NCT02715531|Atezolizumab|atezolizumab|mesh-list
101626809|NCT02715531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101626810|NCT02715531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101626811|NCT02715531|Tubulin Modulators|tubulin modulators|mesh-ancestor
101626812|NCT02715531|Antimitotic Agents|antimitotic agents|mesh-ancestor
101626813|NCT02715531|Mitosis Modulators|mitosis modulators|mesh-ancestor
101626814|NCT02715531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945793|NCT01154361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101945794|NCT01154361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101945795|NCT01154361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101945796|NCT01154361|Analgesics|analgesics|mesh-ancestor
101945797|NCT01154361|Sensory System Agents|sensory system agents|mesh-ancestor
101945798|NCT01154361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101945799|NCT01154361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945800|NCT01154361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101945801|NCT01154361|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
101797075|NCT00564486|Antipyretics|antipyretics|mesh-ancestor
101626815|NCT02715531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101626816|NCT02715531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101626817|NCT02715531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101626818|NCT02715531|Growth Substances|growth substances|mesh-ancestor
101626819|NCT02715531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283906|NCT01917045|Anesthetics|anesthetics|mesh-ancestor
101626820|NCT02715531|Growth Inhibitors|growth inhibitors|mesh-ancestor
101626821|NCT02715531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101626824|NCT02715531|Protective Agents|protective agents|mesh-ancestor
101626825|NCT02715531|Vitamin B Complex|vitamin b complex|mesh-ancestor
101626826|NCT02715531|Vitamins|vitamins|mesh-ancestor
101626827|NCT02715531|Micronutrients|micronutrients|mesh-ancestor
101626828|NCT02715531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101626829|NCT00811018|Sitaxsentan|sitaxsentan|mesh-list
101626830|NCT00811018|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101626831|NCT00811018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626832|NCT04037085|Ketamine|ketamine|mesh-list
101626833|NCT04037085|Analgesics|analgesics|mesh-ancestor
101626834|NCT04037085|Sensory System Agents|sensory system agents|mesh-ancestor
101626835|NCT04037085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101626836|NCT04037085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626837|NCT04037085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101626838|NCT04037085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101626839|NCT04037085|Anesthetics, General|anesthetics, general|mesh-ancestor
101626840|NCT04037085|Anesthetics|anesthetics|mesh-ancestor
101626841|NCT04037085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101626842|NCT04037085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101626843|NCT04037085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101626844|NCT04037085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101626845|NCT04037085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626846|NCT00914056|Lactulose|lactulose|mesh-list
101626847|NCT00914056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101626848|NCT00730171|Linaclotide|linaclotide|mesh-list
101626852|NCT00730171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101626854|NCT04787835|Anesthetics, Local|anesthetics, local|mesh-list
101626855|NCT04787835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101626856|NCT04787835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626857|NCT04787835|Sensory System Agents|sensory system agents|mesh-ancestor
101626858|NCT04787835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101626859|NCT00730015|Linaclotide|linaclotide|mesh-list
101626860|NCT00730015|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
101626861|NCT00730015|Enzyme Activators|enzyme activators|mesh-ancestor
101626862|NCT00730015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626863|NCT00730015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101626864|NCT00806026|Pregabalin|pregabalin|mesh-list
101626865|NCT00806026|Pramipexole|pramipexole|mesh-list
101626866|NCT00806026|Analgesics|analgesics|mesh-ancestor
101626867|NCT00806026|Sensory System Agents|sensory system agents|mesh-ancestor
101626868|NCT00806026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101626869|NCT00806026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626870|NCT00806026|Anticonvulsants|anticonvulsants|mesh-ancestor
101626871|NCT00806026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101626872|NCT00806026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101945802|NCT01154361|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
101945803|NCT01154361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945804|NCT01154361|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101797145|NCT00934830|Amoxicillin|amoxicillin|mesh-list
101626873|NCT00806026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626874|NCT00806026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101626875|NCT00806026|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101626876|NCT00806026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101626877|NCT00806026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101626878|NCT00806026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101626879|NCT00806026|Antioxidants|antioxidants|mesh-ancestor
101626880|NCT00806026|Protective Agents|protective agents|mesh-ancestor
101626881|NCT00806026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101626882|NCT00806026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101626883|NCT00806026|Dopamine Agonists|dopamine agonists|mesh-ancestor
101626884|NCT00806026|Dopamine Agents|dopamine agents|mesh-ancestor
101626885|NCT00806026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101626886|NCT04227093|Acetazolamide|acetazolamide|mesh-list
101626887|NCT04227093|Anticonvulsants|anticonvulsants|mesh-ancestor
101626888|NCT04227093|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101626889|NCT04227093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101626890|NCT04227093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626891|NCT04227093|Diuretics|diuretics|mesh-ancestor
101626892|NCT04227093|Natriuretic Agents|natriuretic agents|mesh-ancestor
101626893|NCT04227093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626894|NCT00805792|Donepezil|donepezil|mesh-list
101626895|NCT00805792|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101626896|NCT00805792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101626897|NCT00805792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626899|NCT00805792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101626900|NCT00805792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626901|NCT00805792|Nootropic Agents|nootropic agents|mesh-ancestor
101626902|NCT04777929|Progesterone|progesterone|mesh-list
101626903|NCT04777929|Estrogens|estrogens|mesh-list
101626904|NCT04777929|Progestins|progestins|mesh-ancestor
101626905|NCT04777929|Hormones|hormones|mesh-ancestor
101626906|NCT04777929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101626907|NCT04777929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626908|NCT00590044|Insulin|insulin|mesh-list
101626909|NCT00590044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101626910|NCT00590044|Insulin Glargine|insulin glargine|mesh-list
101626911|NCT00590044|Insulin, Isophane|insulin, isophane|mesh-list
101626912|NCT00590044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101626913|NCT00590044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626914|NCT02714361|Vitamin D|vitamin d|mesh-list
101626915|NCT02714361|Cholecalciferol|cholecalciferol|mesh-list
101626916|NCT02714361|Vitamins|vitamins|mesh-ancestor
101626917|NCT02714361|Micronutrients|micronutrients|mesh-ancestor
101626918|NCT02714361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626919|NCT02714361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101626920|NCT02714361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101626938|NCT02713893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101626940|NCT00729937|Clindamycin|clindamycin|mesh-list
101626941|NCT00729937|Clindamycin palmitate|clindamycin palmitate|mesh-list
101626942|NCT00729937|Clindamycin phosphate|clindamycin phosphate|mesh-list
101626943|NCT00729937|Cephalexin|cephalexin|mesh-list
101626944|NCT00729937|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101626945|NCT00729937|Trimethoprim|trimethoprim|mesh-list
101626946|NCT00729937|Sulfamethoxazole|sulfamethoxazole|mesh-list
101626947|NCT00729937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101626948|NCT00729937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101626949|NCT00729937|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101626950|NCT00729937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101626951|NCT00729937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626952|NCT00729937|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101626953|NCT00729937|Antimalarials|antimalarials|mesh-ancestor
101626954|NCT00729937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101626955|NCT00729937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101626956|NCT00729937|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101626957|NCT00729937|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101945805|NCT01154361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101945806|NCT01154361|Immunologic Factors|immunologic factors|mesh-ancestor
101945807|NCT01260519|Heparin|heparin|mesh-list
101626958|NCT00729937|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101626959|NCT00729937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101626960|NCT00729859|Methyltestosterone|methyltestosterone|mesh-list
101626961|NCT00729859|Anastrozole|anastrozole|mesh-list
101626962|NCT00729859|Testosterone|testosterone|mesh-list
101626963|NCT00729859|Testosterone undecanoate|testosterone undecanoate|mesh-list
101626964|NCT00729859|Testosterone enanthate|testosterone enanthate|mesh-list
101626965|NCT00729859|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101626966|NCT00729859|Acyline|acyline|mesh-list
101626967|NCT00729859|Androgens|androgens|mesh-ancestor
101626968|NCT00729859|Hormones|hormones|mesh-ancestor
101709444|NCT01009957|Everolimus|everolimus|mesh-list
101626969|NCT00729859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101626970|NCT00729859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626971|NCT00729859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101626972|NCT00729859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101626973|NCT00729859|Anabolic Agents|anabolic agents|mesh-ancestor
101626974|NCT00729859|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101626975|NCT00729859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101425616|NCT00168051|Factor VIII|factor viii|mesh-list
101626984|NCT00810394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626986|NCT00736333|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101626987|NCT00736333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101626988|NCT00736333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101626989|NCT00736333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101626990|NCT00736333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101626991|NCT00736333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101626992|NCT00736333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626993|NCT00736255|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101626994|NCT00736255|Dextroamphetamine|dextroamphetamine|mesh-list
101626995|NCT00736255|Nicotine|nicotine|mesh-list
101626996|NCT00736255|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101626997|NCT00736255|Autonomic Agents|autonomic agents|mesh-ancestor
101626998|NCT00736255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101626999|NCT00736255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627000|NCT00736255|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101627001|NCT00736255|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101627002|NCT00736255|Cholinergic Agents|cholinergic agents|mesh-ancestor
101627003|NCT00736255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101627004|NCT00736255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627005|NCT00736255|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101627006|NCT00736255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101627007|NCT00736255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101627008|NCT00736255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101627009|NCT00736255|Dopamine Agents|dopamine agents|mesh-ancestor
101627010|NCT00742183|Silver Sulfadiazine|silver sulfadiazine|mesh-list
101627011|NCT00742183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101627012|NCT00742183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101627013|NCT00808444|Vaccines|vaccines|mesh-list
101627014|NCT00808444|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101627015|NCT00808444|Immunologic Factors|immunologic factors|mesh-ancestor
101627016|NCT00808444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627017|NCT00914134|Levodopa|levodopa|mesh-list
101627018|NCT00914134|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101627019|NCT00914134|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101627020|NCT00914134|Dopamine Agents|dopamine agents|mesh-ancestor
101627021|NCT00914134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101627022|NCT00914134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627023|NCT00914134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627024|NCT05754736|Bevacizumab|bevacizumab|mesh-list
101627025|NCT05754736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101627026|NCT05754736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101627027|NCT05754736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101627028|NCT05754736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101627029|NCT05754736|Growth Substances|growth substances|mesh-ancestor
101627030|NCT05754736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627031|NCT05754736|Growth Inhibitors|growth inhibitors|mesh-ancestor
101627032|NCT00742027|Panobinostat|panobinostat|mesh-list
101627033|NCT00742027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101627034|NCT00742027|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101945808|NCT01260519|Calcium heparin|calcium heparin|mesh-list
101945809|NCT01260519|Anticoagulants|anticoagulants|mesh-ancestor
101627035|NCT00742027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101627036|NCT00742027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627037|NCT02609698|Aspirin|aspirin|mesh-list
101627038|NCT02609698|Clopidogrel|clopidogrel|mesh-list
101627039|NCT02609698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101627040|NCT02609698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101627043|NCT02609698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101284141|NCT01918254|Paclitaxel|paclitaxel|mesh-list
101627044|NCT02609698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627045|NCT02609698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101627046|NCT02609698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101627047|NCT02609698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101627048|NCT02609698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101627049|NCT02609698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627050|NCT02609698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101627051|NCT02609698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101627052|NCT02609698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101627053|NCT02609698|Antipyretics|antipyretics|mesh-ancestor
101627054|NCT02609698|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101627055|NCT02609698|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101627056|NCT02609698|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101627057|NCT02609698|Purinergic Agents|purinergic agents|mesh-ancestor
101627058|NCT02609698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101627059|NCT05750134|Pancrelipase|pancrelipase|mesh-list
101627060|NCT05750134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101627061|NCT05749822|Fenofibrate|fenofibrate|mesh-list
101627062|NCT05749822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101627063|NCT05749822|Antimetabolites|antimetabolites|mesh-ancestor
101627064|NCT05749822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627065|NCT05749822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101627066|NCT02713191|Fentanyl|fentanyl|mesh-list
101627067|NCT02713191|Midazolam|midazolam|mesh-list
101627068|NCT02713191|Dexmedetomidine|dexmedetomidine|mesh-list
101627069|NCT02713191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101627070|NCT02713191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101627071|NCT02713191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627072|NCT02713191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101627073|NCT02713191|Analgesics|analgesics|mesh-ancestor
101627074|NCT02713191|Sensory System Agents|sensory system agents|mesh-ancestor
101627075|NCT02713191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101627076|NCT02713191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101627077|NCT02713191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101627078|NCT02713191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101627079|NCT02713191|Adrenergic Agents|adrenergic agents|mesh-ancestor
101627080|NCT02713191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101627081|NCT02713191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627082|NCT02713191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101627083|NCT02713191|Narcotics|narcotics|mesh-ancestor
101627084|NCT02713191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101627085|NCT02713191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101627086|NCT02713191|Anesthetics, General|anesthetics, general|mesh-ancestor
101627087|NCT02713191|Anesthetics|anesthetics|mesh-ancestor
101627088|NCT02713191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101627089|NCT02713191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101627090|NCT02713191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101627091|NCT02713191|GABA Modulators|gaba modulators|mesh-ancestor
101627092|NCT02713191|GABA Agents|gaba agents|mesh-ancestor
101627093|NCT00611169|Tirofiban|tirofiban|mesh-list
101627094|NCT00611169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101627095|NCT00611169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101627096|NCT00611169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627097|NCT00611169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101627098|NCT05754502|Trastuzumab|trastuzumab|mesh-list
101627099|NCT05754502|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101627100|NCT05754502|Maytansine|maytansine|mesh-list
101627101|NCT05754502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101627102|NCT05754502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101627103|NCT05754502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101627104|NCT05754502|Tubulin Modulators|tubulin modulators|mesh-ancestor
101627105|NCT05754502|Antimitotic Agents|antimitotic agents|mesh-ancestor
101627106|NCT05754502|Mitosis Modulators|mitosis modulators|mesh-ancestor
101627107|NCT05754502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945810|NCT01260519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101945811|NCT01260519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101945812|NCT01260519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627108|NCT05754502|Immunotoxins|immunotoxins|mesh-ancestor
101627109|NCT05754502|Immunoconjugates|immunoconjugates|mesh-ancestor
101627110|NCT05754502|Immunologic Factors|immunologic factors|mesh-ancestor
101627111|NCT05754502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627112|NCT02712957|Naproxen|naproxen|mesh-list
101627113|NCT02712957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101627118|NCT02712957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627119|NCT02712957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101627120|NCT02712957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101627121|NCT02712957|Gout Suppressants|gout suppressants|mesh-ancestor
101627122|NCT02712957|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101627123|NCT02712957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101627124|NCT02712957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627125|NCT04226625|Propofol|propofol|mesh-list
101627126|NCT04226625|Desflurane|desflurane|mesh-list
101627127|NCT04226625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101627128|NCT04226625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101627129|NCT04226625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627130|NCT04226625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101627131|NCT04226625|Anesthetics, General|anesthetics, general|mesh-ancestor
101627132|NCT04226625|Anesthetics|anesthetics|mesh-ancestor
101627133|NCT04226625|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101627134|NCT02777619|Dexmedetomidine|dexmedetomidine|mesh-list
101627135|NCT02777619|Propofol|propofol|mesh-list
101627136|NCT02777619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101627137|NCT02777619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101627138|NCT02777619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627139|NCT02777619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101627140|NCT02777619|Analgesics|analgesics|mesh-ancestor
101627141|NCT02777619|Sensory System Agents|sensory system agents|mesh-ancestor
101627142|NCT02777619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101627143|NCT02777619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101627144|NCT02777619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101627145|NCT02777619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101627146|NCT02777619|Adrenergic Agents|adrenergic agents|mesh-ancestor
101627147|NCT02777619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101627148|NCT02777619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627149|NCT02777619|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101627150|NCT02777619|Anesthetics, General|anesthetics, general|mesh-ancestor
101627151|NCT02777619|Anesthetics|anesthetics|mesh-ancestor
101627152|NCT05754424|Insulin Aspart|insulin aspart|mesh-list
101627153|NCT05754424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101627154|NCT05754424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627155|NCT00636831|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101627156|NCT00636831|Cefazolin|cefazolin|mesh-list
101627157|NCT00636831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101627158|NCT04193631|Cannabidiol|cannabidiol|mesh-list
101627159|NCT04193631|Anticonvulsants|anticonvulsants|mesh-ancestor
101627160|NCT04856631|Cetuximab|cetuximab|mesh-list
101627161|NCT04856631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101627162|NCT04856631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101627163|NCT00808210|Methylprednisolone|methylprednisolone|mesh-list
101627164|NCT00808210|Infliximab|infliximab|mesh-list
101627165|NCT00808210|Methotrexate|methotrexate|mesh-list
101627166|NCT00808210|Ocrelizumab|ocrelizumab|mesh-list
101627167|NCT00808210|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101627168|NCT00808210|Abortifacient Agents|abortifacient agents|mesh-ancestor
101627169|NCT00808210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101627170|NCT00808210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627171|NCT00808210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101627172|NCT00808210|Antimetabolites|antimetabolites|mesh-ancestor
101627173|NCT00808210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627174|NCT00808210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101627175|NCT00808210|Dermatologic Agents|dermatologic agents|mesh-ancestor
101627176|NCT00808210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101627177|NCT00808210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101627178|NCT00808210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101627179|NCT00808210|Immunologic Factors|immunologic factors|mesh-ancestor
101627180|NCT00808210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101627181|NCT00808210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101945813|NCT03888183|Lubricant Eye Drops|lubricant eye drops|mesh-list
101945814|NCT03888183|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101945815|NCT03888183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101945817|NCT03891615|Osimertinib|osimertinib|mesh-list
101945818|NCT03891615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101945819|NCT03891615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101627182|NCT00808210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101627183|NCT00808210|Antiemetics|antiemetics|mesh-ancestor
101627184|NCT00808210|Autonomic Agents|autonomic agents|mesh-ancestor
101627185|NCT00808210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101425816|NCT03156452|Hormones|hormones|mesh-ancestor
101627191|NCT00808210|Protective Agents|protective agents|mesh-ancestor
101627192|NCT00808210|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101627193|NCT02777229|Tenofovir|tenofovir|mesh-list
101627194|NCT02777229|Lamivudine|lamivudine|mesh-list
101627195|NCT02777229|Efavirenz|efavirenz|mesh-list
101627196|NCT02777229|Dolutegravir|dolutegravir|mesh-list
101627197|NCT02777229|Antiviral Agents|antiviral agents|mesh-ancestor
101627198|NCT02777229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101627199|NCT02777229|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101627200|NCT02777229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101627201|NCT02777229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101627202|NCT02777229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627203|NCT02777229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101627204|NCT02777229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101627205|NCT02777229|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101627206|NCT02777229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101627207|NCT02777229|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101627208|NCT02777229|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101627209|NCT02777229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101627210|NCT02777229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101627211|NCT02777229|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101627212|NCT02777229|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101627213|NCT02712177|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101627214|NCT02712177|Immunologic Factors|immunologic factors|mesh-ancestor
101627215|NCT02712177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627216|NCT00635037|Bupivacaine|bupivacaine|mesh-list
101627217|NCT00635037|Anesthetics, Local|anesthetics, local|mesh-ancestor
101627218|NCT00635037|Anesthetics|anesthetics|mesh-ancestor
101627219|NCT00635037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101627220|NCT00635037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627221|NCT00635037|Sensory System Agents|sensory system agents|mesh-ancestor
101627222|NCT00635037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101627223|NCT02777151|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
101627224|NCT02777151|Atoltivimab|atoltivimab|mesh-list
101627225|NCT02777151|Antiviral Agents|antiviral agents|mesh-ancestor
101627226|NCT02777151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101627227|NCT02777073|Dapagliflozin|dapagliflozin|mesh-list
101627228|NCT02777073|Liraglutide|liraglutide|mesh-list
101627229|NCT02777073|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101627230|NCT02777073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627231|NCT02777073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101627232|NCT02777073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627233|NCT02777073|Incretins|incretins|mesh-ancestor
101627234|NCT02777073|Hormones|hormones|mesh-ancestor
101709478|NCT00510289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101627235|NCT02777073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101627236|NCT02711865|Antibodies|antibodies|mesh-list
101627237|NCT02711865|Immunologic Factors|immunologic factors|mesh-ancestor
101627238|NCT02711865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627239|NCT02711943|Levofloxacin|levofloxacin|mesh-list
101627240|NCT02711943|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101627241|NCT02711943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101627242|NCT02711943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101627243|NCT02711943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101627244|NCT02711943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101627245|NCT02711943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101627246|NCT02711943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797496|NCT00141271|Dopamine Agents|dopamine agents|mesh-ancestor
101627247|NCT02711943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101627248|NCT02711943|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101627249|NCT02711943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101627250|NCT02776761|Vaccines|vaccines|mesh-list
101627251|NCT02776761|Immunologic Factors|immunologic factors|mesh-ancestor
101627252|NCT02776761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627253|NCT00736099|Pioglitazone|pioglitazone|mesh-list
101627259|NCT04616547|Protective Agents|protective agents|mesh-ancestor
101627260|NCT04616547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627261|NCT04616547|Chelating Agents|chelating agents|mesh-ancestor
101627262|NCT04616547|Sequestering Agents|sequestering agents|mesh-ancestor
101627263|NCT04616547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627264|NCT04616547|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101627265|NCT04616547|Anticoagulants|anticoagulants|mesh-ancestor
101627266|NCT04616547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101627267|NCT02711241|Dipyrone|dipyrone|mesh-list
101627268|NCT02711241|Papaverine|papaverine|mesh-list
101627269|NCT02711241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101284358|NCT01919593|Disinfectants|disinfectants|mesh-ancestor
101627270|NCT02711241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101627271|NCT02711241|Analgesics|analgesics|mesh-ancestor
101627272|NCT02711241|Sensory System Agents|sensory system agents|mesh-ancestor
101627273|NCT02711241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101627274|NCT02711241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627275|NCT02711241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101627276|NCT02711241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101627277|NCT02711241|Antipyretics|antipyretics|mesh-ancestor
101627278|NCT02711241|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101627279|NCT02711241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101627280|NCT02711241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627281|NCT02711241|Vasodilator Agents|vasodilator agents|mesh-ancestor
101627282|NCT02711241|Urological Agents|urological agents|mesh-ancestor
101627283|NCT02711007|Apatinib|apatinib|mesh-list
101627284|NCT02711007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101627285|NCT02711007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101627286|NCT02711007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101627287|NCT02711007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627288|NCT02710539|Amlodipine|amlodipine|mesh-list
101627289|NCT02710539|Perindopril|perindopril|mesh-list
101627290|NCT02710539|Indapamide|indapamide|mesh-list
101627291|NCT02710539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101627292|NCT02710539|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101627293|NCT02710539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101627294|NCT02710539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627295|NCT02710539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101627296|NCT02710539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627297|NCT02710539|Vasodilator Agents|vasodilator agents|mesh-ancestor
101627298|NCT02710539|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101627299|NCT02710539|Protease Inhibitors|protease inhibitors|mesh-ancestor
101627300|NCT02710539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101627301|NCT02710539|Diuretics|diuretics|mesh-ancestor
101627302|NCT02710539|Natriuretic Agents|natriuretic agents|mesh-ancestor
101627303|NCT02710539|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101627304|NCT00735709|Vortioxetine|vortioxetine|mesh-list
101627305|NCT00735709|Antidepressive Agents|antidepressive agents|mesh-ancestor
101627306|NCT00735709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101627307|NCT00735709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101627308|NCT00735709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101627309|NCT00735709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101627310|NCT00735709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627311|NCT00735709|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101627312|NCT00735709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101627313|NCT00735709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101627314|NCT00735709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627315|NCT00735709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101627316|NCT00735709|Serotonin Agents|serotonin agents|mesh-ancestor
101627317|NCT00735709|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101627318|NCT00735709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101627319|NCT00735709|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101627320|NCT00735709|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101627321|NCT02776527|Apatinib|apatinib|mesh-list
101627322|NCT02776527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101945820|NCT03891615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945821|NCT03891615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101945822|NCT03891615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101945823|NCT02947022|Calcium, Dietary|calcium, dietary|mesh-list
101627324|NCT02776527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101627325|NCT02776527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627327|NCT00729157|Aflibercept|aflibercept|mesh-list
101627328|NCT00729157|Endothelial Growth Factors|endothelial growth factors|mesh-list
101627329|NCT00729157|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101627330|NCT00729157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101627331|NCT00729157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101627332|NCT00729157|Growth Substances|growth substances|mesh-ancestor
101627333|NCT00729157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627334|NCT00729157|Growth Inhibitors|growth inhibitors|mesh-ancestor
101627335|NCT00729157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101627336|NCT00729157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627337|NCT00729157|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101627338|NCT00729157|Antimetabolites|antimetabolites|mesh-ancestor
101627339|NCT00729157|Antiviral Agents|antiviral agents|mesh-ancestor
101627340|NCT00729157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101627341|NCT02710305|Lidocaine|lidocaine|mesh-list
101627342|NCT02710305|Scopolamine|scopolamine|mesh-list
101284434|NCT01921374|Vitamin B 12|vitamin b 12|mesh-list
101627344|NCT02710305|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101627345|NCT02710305|Anesthetics, Local|anesthetics, local|mesh-ancestor
101627346|NCT02710305|Anesthetics|anesthetics|mesh-ancestor
101627347|NCT02710305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101627348|NCT02710305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627349|NCT02710305|Sensory System Agents|sensory system agents|mesh-ancestor
101627350|NCT02710305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101627351|NCT02710305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101627352|NCT02710305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101627353|NCT02710305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101627354|NCT02710305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101627355|NCT02710305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627356|NCT02710305|Anticonvulsants|anticonvulsants|mesh-ancestor
101627357|NCT02710305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101627358|NCT02710305|Antiemetics|antiemetics|mesh-ancestor
101627359|NCT02710305|Autonomic Agents|autonomic agents|mesh-ancestor
101627360|NCT02710305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101627361|NCT02710305|Mydriatics|mydriatics|mesh-ancestor
101627362|NCT02710305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101627363|NCT02710305|Cholinergic Agents|cholinergic agents|mesh-ancestor
101627364|NCT02710305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101627365|NCT02710305|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101627366|NCT02710305|Parasympatholytics|parasympatholytics|mesh-ancestor
101627367|NCT02708511|Copper|copper|mesh-list
101627368|NCT02708511|Trace Elements|trace elements|mesh-ancestor
101709498|NCT01015339|Capecitabine|capecitabine|mesh-list
101627369|NCT02708511|Micronutrients|micronutrients|mesh-ancestor
101627370|NCT02708511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627371|NCT00728689|Tecovirimat|tecovirimat|mesh-list
101627372|NCT00728689|Antiviral Agents|antiviral agents|mesh-ancestor
101627373|NCT00728689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101627374|NCT02596243|Vaccines|vaccines|mesh-list
101627375|NCT02596243|Immunologic Factors|immunologic factors|mesh-ancestor
101627376|NCT02596243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627377|NCT02717091|Paclitaxel|paclitaxel|mesh-list
101627378|NCT02717091|Gemcitabine|gemcitabine|mesh-list
101627379|NCT02717091|Folfirinox|folfirinox|mesh-list
101627380|NCT02717091|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101627381|NCT02717091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101627382|NCT02717091|Tubulin Modulators|tubulin modulators|mesh-ancestor
101627383|NCT02717091|Antimitotic Agents|antimitotic agents|mesh-ancestor
101627384|NCT02717091|Mitosis Modulators|mitosis modulators|mesh-ancestor
101627385|NCT02717091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627386|NCT02717091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101627387|NCT02717091|Antimetabolites|antimetabolites|mesh-ancestor
101627388|NCT00726895|Quinine|quinine|mesh-list
101627389|NCT00726895|Antimalarials|antimalarials|mesh-ancestor
101627390|NCT00726895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101627391|NCT00726895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101627392|NCT00726895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101627393|NCT00726895|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101945825|NCT02947022|Edetic Acid|edetic acid|mesh-list
101945826|NCT02947022|Calcium|calcium|mesh-list
101945827|NCT02947022|Pentetic Acid|pentetic acid|mesh-list
101797647|NCT00141037|Glucocorticoids|glucocorticoids|mesh-ancestor
101627394|NCT00726895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627395|NCT00726895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101627396|NCT00726895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101627397|NCT00726895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101627398|NCT00726895|Analgesics|analgesics|mesh-ancestor
101627403|NCT02593201|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101627404|NCT02593201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101627405|NCT02593201|Antitubercular Agents|antitubercular agents|mesh-ancestor
101627406|NCT02707809|Dexmedetomidine|dexmedetomidine|mesh-list
101627407|NCT02707809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101627408|NCT02707809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101627409|NCT02707809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627410|NCT02707809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101627411|NCT02707809|Analgesics|analgesics|mesh-ancestor
101627412|NCT02707809|Sensory System Agents|sensory system agents|mesh-ancestor
101627413|NCT02707809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101627414|NCT02707809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101627415|NCT02707809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101627416|NCT02707809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101627417|NCT02707809|Adrenergic Agents|adrenergic agents|mesh-ancestor
101627418|NCT02707809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101304187|NCT02011750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101627419|NCT02707809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627421|NCT00585325|Anesthetics, Local|anesthetics, local|mesh-ancestor
101627422|NCT00585325|Anesthetics|anesthetics|mesh-ancestor
101627423|NCT00585325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101627424|NCT00585325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627425|NCT00585325|Sensory System Agents|sensory system agents|mesh-ancestor
101627426|NCT00585325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101627427|NCT00585325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101627428|NCT00585325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101627429|NCT00585325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101627430|NCT00585325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101627431|NCT00585325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627432|NCT02716857|Oxycodone|oxycodone|mesh-list
101627433|NCT02716857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101627434|NCT02716857|Narcotics|narcotics|mesh-ancestor
101627435|NCT02716857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101627436|NCT02716857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627437|NCT02716857|Analgesics|analgesics|mesh-ancestor
101627438|NCT02716857|Sensory System Agents|sensory system agents|mesh-ancestor
101627439|NCT02716857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101627440|NCT00917761|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101627441|NCT00917761|Interferon-alpha|interferon-alpha|mesh-list
101627442|NCT00917761|Entecavir|entecavir|mesh-list
101627443|NCT00917761|Antiviral Agents|antiviral agents|mesh-ancestor
101627444|NCT00917761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101627445|NCT00917761|Immunologic Factors|immunologic factors|mesh-ancestor
101627446|NCT00917761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627447|NCT02709603|Scopolamine|scopolamine|mesh-list
101627448|NCT02709603|Bromides|bromides|mesh-list
101627449|NCT02709603|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101627450|NCT02709603|Anticonvulsants|anticonvulsants|mesh-ancestor
101627451|NCT02709603|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101627452|NCT02709603|Antiemetics|antiemetics|mesh-ancestor
101627453|NCT02709603|Autonomic Agents|autonomic agents|mesh-ancestor
101627454|NCT02709603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101627455|NCT02709603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627456|NCT02709603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101627457|NCT02709603|Mydriatics|mydriatics|mesh-ancestor
101627458|NCT02709603|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101627459|NCT02709603|Cholinergic Agents|cholinergic agents|mesh-ancestor
101627460|NCT02709603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101627461|NCT02709603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627462|NCT02709603|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101627463|NCT02709603|Parasympatholytics|parasympatholytics|mesh-ancestor
101627464|NCT00611793|Bevacizumab|bevacizumab|mesh-list
101627465|NCT00611793|Vatalanib|vatalanib|mesh-list
101945828|NCT02947022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101945829|NCT02947022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945830|NCT02947022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101945831|NCT02947022|Trace Elements|trace elements|mesh-ancestor
101945832|NCT02947022|Micronutrients|micronutrients|mesh-ancestor
101945833|NCT02947022|Antidotes|antidotes|mesh-ancestor
101945834|NCT02947022|Protective Agents|protective agents|mesh-ancestor
101945835|NCT02947022|Chelating Agents|chelating agents|mesh-ancestor
101945836|NCT02947022|Sequestering Agents|sequestering agents|mesh-ancestor
101945837|NCT02947022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945838|NCT02947022|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101945840|NCT02947022|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101945841|NCT01259193|Zoledronic Acid|zoledronic acid|mesh-list
101627466|NCT00611793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101627467|NCT00611793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101627468|NCT00611793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101627469|NCT00611793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101627482|NCT00611871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627483|NCT00611871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101627484|NCT00611871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101627485|NCT00611871|Vasodilator Agents|vasodilator agents|mesh-ancestor
101627486|NCT02709525|Hyaluronic Acid|hyaluronic acid|mesh-list
101627487|NCT02709525|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101627488|NCT02709525|Immunologic Factors|immunologic factors|mesh-ancestor
101627489|NCT02709525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627490|NCT02709525|Viscosupplements|viscosupplements|mesh-ancestor
101627491|NCT02709525|Protective Agents|protective agents|mesh-ancestor
101627492|NCT05087589|Tofacitinib|tofacitinib|mesh-list
101627493|NCT05087589|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101627494|NCT05087589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101627495|NCT05087589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101627496|NCT05087589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627497|NCT00612651|Temozolomide|temozolomide|mesh-list
101627498|NCT00612651|Lonafarnib|lonafarnib|mesh-list
101627499|NCT00612651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101627500|NCT00612651|Alkylating Agents|alkylating agents|mesh-ancestor
101627501|NCT00612651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627502|NCT00612651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101627503|NCT00612651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101627504|NCT00918307|Varenicline|varenicline|mesh-list
101627505|NCT00918307|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101627506|NCT00918307|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101627507|NCT00918307|Cholinergic Agents|cholinergic agents|mesh-ancestor
101627508|NCT00918307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101709508|NCT05110313|Immunologic Factors|immunologic factors|mesh-ancestor
101627509|NCT00918307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627510|NCT00918307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627511|NCT00741013|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
101627512|NCT00741013|Protein C|protein c|mesh-list
101627513|NCT00741013|Lovastatin|lovastatin|mesh-list
101627514|NCT00741013|L 647318|l 647318|mesh-list
101627515|NCT00741013|Dihydromevinolin|dihydromevinolin|mesh-list
101627516|NCT00741013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101627517|NCT00741013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101627518|NCT00741013|Antimetabolites|antimetabolites|mesh-ancestor
101627519|NCT00741013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627520|NCT00741013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101627521|NCT00741013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101627522|NCT00741013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101627523|NCT00741013|Anticoagulants|anticoagulants|mesh-ancestor
101627524|NCT00741013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101627525|NCT00741013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101627526|NCT00741013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101945842|NCT01259193|Sorafenib|sorafenib|mesh-list
101945843|NCT01259193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797783|NCT00889148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101627527|NCT04087759|Bedaquiline|bedaquiline|mesh-list
101627528|NCT04087759|Diarylquinolines|diarylquinolines|mesh-list
101627529|NCT04087759|Antitubercular Agents|antitubercular agents|mesh-ancestor
101627530|NCT04087759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101627531|NCT04087759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101627532|NCT00740857|Ibuprofen|ibuprofen|mesh-list
101627545|NCT00808132|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101627547|NCT00808132|Estrogens|estrogens|mesh-list
101627548|NCT00808132|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101627549|NCT00808132|Hormones|hormones|mesh-ancestor
101627550|NCT00808132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101627551|NCT00808132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627552|NCT00808132|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101627553|NCT00808132|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101627554|NCT00808132|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101627555|NCT00808132|Contraceptive Agents|contraceptive agents|mesh-ancestor
101627556|NCT00808132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101627557|NCT00808132|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101627558|NCT00808132|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101627559|NCT00808132|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101627560|NCT00808132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101627561|NCT00808132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101627562|NCT00808132|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101627563|NCT00808132|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101627564|NCT00808132|Hormone Antagonists|hormone antagonists|mesh-ancestor
101627565|NCT00808132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101627566|NCT00727441|Cyclophosphamide|cyclophosphamide|mesh-list
101627567|NCT00727441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101627568|NCT00727441|Immunologic Factors|immunologic factors|mesh-ancestor
101627569|NCT00727441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627570|NCT00727441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101627571|NCT00727441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101627572|NCT00727441|Alkylating Agents|alkylating agents|mesh-ancestor
101627573|NCT00727441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627574|NCT00727441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101627575|NCT00727441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101627576|NCT00914368|Clopidogrel|clopidogrel|mesh-list
101627577|NCT00914368|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101627578|NCT00914368|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101627579|NCT00914368|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101627580|NCT00914368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101627581|NCT00914368|Purinergic Agents|purinergic agents|mesh-ancestor
101627582|NCT00914368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101627583|NCT00914368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627584|NCT00914368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627585|NCT02607982|Paclitaxel|paclitaxel|mesh-list
101627586|NCT02607982|Oxaliplatin|oxaliplatin|mesh-list
101627587|NCT02607982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101627588|NCT02607982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101627589|NCT02607982|Tubulin Modulators|tubulin modulators|mesh-ancestor
101627590|NCT02607982|Antimitotic Agents|antimitotic agents|mesh-ancestor
101627591|NCT02607982|Mitosis Modulators|mitosis modulators|mesh-ancestor
101627595|NCT02692989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627596|NCT03643276|Cytarabine|cytarabine|mesh-list
101627597|NCT03643276|Dexamethasone|dexamethasone|mesh-list
101627598|NCT03643276|Prednisone|prednisone|mesh-list
101627599|NCT03643276|Prednisolone|prednisolone|mesh-list
101627600|NCT03643276|Cyclophosphamide|cyclophosphamide|mesh-list
101627601|NCT03643276|Ifosfamide|ifosfamide|mesh-list
101627602|NCT03643276|Doxorubicin|doxorubicin|mesh-list
101627603|NCT03643276|Methotrexate|methotrexate|mesh-list
101627604|NCT03643276|Fludarabine|fludarabine|mesh-list
101627605|NCT03643276|Fludarabine phosphate|fludarabine phosphate|mesh-list
101627606|NCT03643276|Etoposide|etoposide|mesh-list
101627607|NCT03643276|Vincristine|vincristine|mesh-list
101627608|NCT03643276|Bortezomib|bortezomib|mesh-list
101627609|NCT03643276|Daunorubicin|daunorubicin|mesh-list
101627610|NCT03643276|Mercaptopurine|mercaptopurine|mesh-list
101627611|NCT03643276|Pegaspargase|pegaspargase|mesh-list
101627612|NCT03643276|Blinatumomab|blinatumomab|mesh-list
101627613|NCT03643276|Vindesine|vindesine|mesh-list
101627614|NCT03643276|Asparaginase|asparaginase|mesh-list
101945844|NCT01259193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101945846|NCT01259193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945847|NCT01259193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101945848|NCT01259193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627615|NCT03643276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101627616|NCT03643276|Immunologic Factors|immunologic factors|mesh-ancestor
101627617|NCT03643276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627618|NCT03643276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101627619|NCT03643276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101627620|NCT03643276|Alkylating Agents|alkylating agents|mesh-ancestor
101627621|NCT03643276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627622|NCT03643276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101627623|NCT03643276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101627624|NCT03643276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101627625|NCT03643276|Antiemetics|antiemetics|mesh-ancestor
101627626|NCT03643276|Autonomic Agents|autonomic agents|mesh-ancestor
101627627|NCT03643276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101627628|NCT03643276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101627629|NCT03643276|Glucocorticoids|glucocorticoids|mesh-ancestor
101627630|NCT03643276|Hormones|hormones|mesh-ancestor
101627631|NCT03643276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101627632|NCT03643276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101627633|NCT03643276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101627634|NCT03643276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101627635|NCT03643276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101627636|NCT03643276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101627637|NCT03643276|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101627638|NCT03643276|Abortifacient Agents|abortifacient agents|mesh-ancestor
101627639|NCT03643276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101627640|NCT03643276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101627641|NCT03643276|Antimetabolites|antimetabolites|mesh-ancestor
101627642|NCT03643276|Dermatologic Agents|dermatologic agents|mesh-ancestor
101627643|NCT03643276|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101627644|NCT03643276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101627645|NCT03643276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101627646|NCT03643276|Antiviral Agents|antiviral agents|mesh-ancestor
101627647|NCT03643276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101627648|NCT03643276|Tubulin Modulators|tubulin modulators|mesh-ancestor
101627649|NCT03643276|Antimitotic Agents|antimitotic agents|mesh-ancestor
101627650|NCT03643276|Mitosis Modulators|mitosis modulators|mesh-ancestor
101627651|NCT04882293|Atorvastatin|atorvastatin|mesh-list
101627652|NCT04882293|Fenofibrate|fenofibrate|mesh-list
101627653|NCT04882293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101627654|NCT04882293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101627655|NCT04882293|Antimetabolites|antimetabolites|mesh-ancestor
101627656|NCT04882293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627657|NCT04882293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101627658|NCT04882293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101627659|NCT04882293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101627660|NCT02608060|Epoetin Alfa|epoetin alfa|mesh-list
101627661|NCT02608060|Hematinics|hematinics|mesh-ancestor
101627662|NCT04085575|Tranexamic Acid|tranexamic acid|mesh-list
101627663|NCT04085575|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101627664|NCT04085575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101627665|NCT04085575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627666|NCT04085575|Hemostatics|hemostatics|mesh-ancestor
101627674|NCT00585169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627675|NCT00585169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101627677|NCT00807742|Nicotine|nicotine|mesh-list
101627678|NCT00807742|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101627679|NCT00807742|Autonomic Agents|autonomic agents|mesh-ancestor
101627680|NCT00807742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101627681|NCT00807742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627682|NCT00807742|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101627683|NCT00807742|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101627684|NCT00807742|Cholinergic Agents|cholinergic agents|mesh-ancestor
101627685|NCT00807742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101945850|NCT05182892|Dopamine Agonists|dopamine agonists|mesh-list
101945851|NCT05182892|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101945852|NCT05182892|Sympathomimetics|sympathomimetics|mesh-ancestor
101945853|NCT05182892|Autonomic Agents|autonomic agents|mesh-ancestor
101945854|NCT05182892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101945855|NCT05182892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945856|NCT05182892|Dopamine Agents|dopamine agents|mesh-ancestor
101945857|NCT05182892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101945858|NCT05182892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945859|NCT05182892|Protective Agents|protective agents|mesh-ancestor
101945860|NCT01312376|Cyclophosphamide|cyclophosphamide|mesh-list
101945861|NCT01312376|Bevacizumab|bevacizumab|mesh-list
101945862|NCT01312376|Fludarabine|fludarabine|mesh-list
101945863|NCT01312376|Vaccines|vaccines|mesh-list
101945864|NCT01312376|Immunologic Factors|immunologic factors|mesh-ancestor
101945865|NCT01312376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945866|NCT01312376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101945867|NCT01312376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101945868|NCT01312376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101627686|NCT00807742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627687|NCT04741815|Carbon Fiber|carbon fiber|mesh-list
101627688|NCT04741815|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101627689|NCT04741815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101627690|NCT05738434|Apatinib|apatinib|mesh-list
101627691|NCT05738434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101627692|NCT05738434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101627693|NCT05738434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101627694|NCT05738434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627695|NCT00803452|Azithromycin|azithromycin|mesh-list
101627696|NCT00803452|Doxycycline|doxycycline|mesh-list
101627697|NCT00803452|Minocycline|minocycline|mesh-list
101627698|NCT00803452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101627699|NCT00803452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101627700|NCT00803452|Antimalarials|antimalarials|mesh-ancestor
101627701|NCT00803452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101627702|NCT00803452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101627703|NCT04546113|Ropivacaine|ropivacaine|mesh-list
101627704|NCT04546113|Anesthetics, Local|anesthetics, local|mesh-ancestor
101627705|NCT04546113|Anesthetics|anesthetics|mesh-ancestor
101627706|NCT04546113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101627707|NCT04546113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627708|NCT04546113|Sensory System Agents|sensory system agents|mesh-ancestor
101627709|NCT04546113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101627710|NCT05737342|Red yeast rice|red yeast rice|mesh-list
101627711|NCT05737342|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101627712|NCT05737342|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101627713|NCT05737342|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101627714|NCT05737342|Antimetabolites|antimetabolites|mesh-ancestor
101627715|NCT05737342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627716|NCT05737342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101627717|NCT05737342|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101627718|NCT00914212|Sibutramine|sibutramine|mesh-list
101627719|NCT00914212|Antidepressive Agents|antidepressive agents|mesh-ancestor
101627720|NCT00914212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101627721|NCT00914212|Appetite Depressants|appetite depressants|mesh-ancestor
101627722|NCT00914212|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101627723|NCT04456023|Tisagenlecleucel|tisagenlecleucel|mesh-list
101945869|NCT01312376|Alkylating Agents|alkylating agents|mesh-ancestor
101945870|NCT01312376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945871|NCT01312376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101945872|NCT01312376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101945873|NCT01312376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101945874|NCT01312376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101945875|NCT01312376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101627724|NCT04456023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101627725|NCT04456023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101627726|NCT04188483|Selenium|selenium|mesh-list
101627727|NCT04188483|Antioxidants|antioxidants|mesh-ancestor
101627728|NCT04188483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627729|NCT04188483|Protective Agents|protective agents|mesh-ancestor
101627730|NCT04188483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627731|NCT04188483|Trace Elements|trace elements|mesh-ancestor
101627732|NCT04188483|Micronutrients|micronutrients|mesh-ancestor
101627733|NCT02693145|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101627734|NCT02693145|Antiviral Agents|antiviral agents|mesh-ancestor
101426361|NCT00528619|Carboplatin|carboplatin|mesh-list
101627739|NCT00717067|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101627740|NCT00717067|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101627741|NCT00717067|Protease Inhibitors|protease inhibitors|mesh-ancestor
101627742|NCT00717067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101627743|NCT00717067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627744|NCT00717067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101627745|NCT00717067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101627746|NCT00717067|Antiviral Agents|antiviral agents|mesh-ancestor
101627747|NCT00717067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101627748|NCT00717067|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101627749|NCT00717067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101627750|NCT00717067|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101627751|NCT00717067|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101627752|NCT00717067|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101627754|NCT05731960|Metoclopramide|metoclopramide|mesh-list
101627755|NCT05731960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101627756|NCT05731960|Antiemetics|antiemetics|mesh-ancestor
101627757|NCT05731960|Autonomic Agents|autonomic agents|mesh-ancestor
101627758|NCT05731960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101627759|NCT05731960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627760|NCT05731960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101627761|NCT05731960|Glucocorticoids|glucocorticoids|mesh-ancestor
101627762|NCT05731960|Hormones|hormones|mesh-ancestor
101627763|NCT05731960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101627764|NCT05731960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101627765|NCT05731960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101627766|NCT05731960|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101627767|NCT05731960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101627768|NCT05731960|Dopamine Agents|dopamine agents|mesh-ancestor
101627769|NCT05731960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101627770|NCT05731960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627771|NCT04393311|Urinastatin|urinastatin|mesh-list
101627772|NCT04393311|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101627773|NCT04393311|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101627774|NCT04393311|Protease Inhibitors|protease inhibitors|mesh-ancestor
101627775|NCT04393311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101627776|NCT04393311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627777|NCT02607436|Aspirin|aspirin|mesh-list
101627778|NCT02607436|Sarpogrelate|sarpogrelate|mesh-list
101627779|NCT02607436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101627780|NCT02607436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101627781|NCT02607436|Analgesics|analgesics|mesh-ancestor
101627782|NCT02607436|Sensory System Agents|sensory system agents|mesh-ancestor
101627783|NCT02607436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101627784|NCT02607436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627785|NCT02607436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101627786|NCT02607436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101945876|NCT01312376|Growth Substances|growth substances|mesh-ancestor
101945877|NCT01312376|Growth Inhibitors|growth inhibitors|mesh-ancestor
101945878|NCT01260675|Buprenorphine|buprenorphine|mesh-list
101945880|NCT01260675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101945881|NCT01260675|Narcotics|narcotics|mesh-ancestor
101945882|NCT01260675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101945883|NCT01260675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945884|NCT01260675|Analgesics|analgesics|mesh-ancestor
101945885|NCT01260675|Sensory System Agents|sensory system agents|mesh-ancestor
101627787|NCT02607436|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101627788|NCT02607436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101627789|NCT02607436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627790|NCT02607436|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101627791|NCT02607436|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101627792|NCT02607436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101627793|NCT02607436|Antipyretics|antipyretics|mesh-ancestor
101627794|NCT02607436|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101627795|NCT02607436|Serotonin Agents|serotonin agents|mesh-ancestor
101627796|NCT02607436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101627797|NCT02607592|Pemetrexed|pemetrexed|mesh-list
101627798|NCT02607592|Nedaplatin|nedaplatin|mesh-list
101627799|NCT02607592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101627801|NCT02607592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627802|NCT02607592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101627803|NCT02607592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101627804|NCT04356339|Interferons|interferons|mesh-list
101627805|NCT04356339|Interferon-beta|interferon-beta|mesh-list
101627806|NCT04356339|Interferon beta-1b|interferon beta-1b|mesh-list
101627807|NCT04356339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101627822|NCT04331145|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101627823|NCT04331145|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101627824|NCT04331145|Purinergic Agents|purinergic agents|mesh-ancestor
101627825|NCT04331145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101627826|NCT04331145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627827|NCT04331145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627828|NCT03460522|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
101627829|NCT03460522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101627830|NCT03460522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101627831|NCT03460522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101627832|NCT03460522|Immunotoxins|immunotoxins|mesh-ancestor
101627833|NCT03460522|Immunoconjugates|immunoconjugates|mesh-ancestor
101627834|NCT03460522|Immunologic Factors|immunologic factors|mesh-ancestor
101627835|NCT03460522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627836|NCT02605720|Piperaquine|piperaquine|mesh-list
101627837|NCT02605720|Artenimol|artenimol|mesh-list
101627838|NCT02605720|Antimalarials|antimalarials|mesh-ancestor
101627839|NCT02605720|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101627840|NCT02605720|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101627841|NCT02605720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101627842|NCT04188561|Hyaluronic Acid|hyaluronic acid|mesh-list
101627843|NCT04188561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101627844|NCT04188561|Immunologic Factors|immunologic factors|mesh-ancestor
101627845|NCT04188561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627846|NCT04188561|Viscosupplements|viscosupplements|mesh-ancestor
101627847|NCT04188561|Protective Agents|protective agents|mesh-ancestor
101627848|NCT00588952|Ketamine|ketamine|mesh-list
101627849|NCT00588952|Analgesics|analgesics|mesh-ancestor
101627850|NCT00588952|Sensory System Agents|sensory system agents|mesh-ancestor
101627851|NCT00588952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101627852|NCT00588952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627853|NCT00588952|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101627854|NCT00588952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101627855|NCT00588952|Anesthetics, General|anesthetics, general|mesh-ancestor
101627856|NCT00588952|Anesthetics|anesthetics|mesh-ancestor
101627857|NCT00588952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101627858|NCT00588952|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101945886|NCT01260675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101945888|NCT03887871|Tamsulosin|tamsulosin|mesh-list
101798115|NCT04430036|Antimetabolites|antimetabolites|mesh-ancestor
101627859|NCT00588952|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101627860|NCT00588952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101627861|NCT00588952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627862|NCT04885257|Methylphenidate|methylphenidate|mesh-list
101627863|NCT04885257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101627864|NCT04885257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627865|NCT04885257|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101627866|NCT04885257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101627867|NCT04885257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101426504|NCT00145301|Lumiracoxib|lumiracoxib|mesh-list
101627877|NCT00802360|Progesterone|progesterone|mesh-list
101627878|NCT00802360|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101627879|NCT00802360|Ganirelix|ganirelix|mesh-list
101627880|NCT00802360|Progestins|progestins|mesh-ancestor
101627881|NCT00802360|Hormones|hormones|mesh-ancestor
101627882|NCT00802360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101627883|NCT00802360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627884|NCT00802360|Hormone Antagonists|hormone antagonists|mesh-ancestor
101627885|NCT00802360|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101627886|NCT00802360|Fertility Agents|fertility agents|mesh-ancestor
101627887|NCT00802360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101627888|NCT04908423|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
101627889|NCT04908423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101627890|NCT04908423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101627891|NCT04908423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627892|NCT04908423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101627893|NCT04908423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101627894|NCT04908423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627895|NCT04908423|Cholinergic Agents|cholinergic agents|mesh-ancestor
101627896|NCT04908423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101627897|NCT04811625|Aspirin|aspirin|mesh-list
101627898|NCT04811625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101627899|NCT04811625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101627900|NCT04811625|Analgesics|analgesics|mesh-ancestor
101627901|NCT04811625|Sensory System Agents|sensory system agents|mesh-ancestor
101627902|NCT04811625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101627903|NCT04811625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627904|NCT04811625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101627905|NCT04811625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101627906|NCT04811625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101627907|NCT04811625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101627908|NCT04811625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627909|NCT04811625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101627910|NCT04811625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101627911|NCT04811625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101627912|NCT04811625|Antipyretics|antipyretics|mesh-ancestor
101627913|NCT02764593|Nivolumab|nivolumab|mesh-list
101627914|NCT02764593|Cetuximab|cetuximab|mesh-list
101627915|NCT02764593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101627916|NCT02764593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101627917|NCT02764593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101627918|NCT02764593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627919|NCT04028596|Acetaminophen|acetaminophen|mesh-list
101627920|NCT04028596|Nimodipine|nimodipine|mesh-list
101627921|NCT04028596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101627922|NCT04028596|Analgesics|analgesics|mesh-ancestor
101627923|NCT04028596|Sensory System Agents|sensory system agents|mesh-ancestor
101627924|NCT04028596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101627925|NCT04028596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627926|NCT04028596|Antipyretics|antipyretics|mesh-ancestor
101627927|NCT04028596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101627928|NCT04028596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101627929|NCT04028596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101627930|NCT04028596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709544|NCT04061824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101627931|NCT04028596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101945889|NCT03887871|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101945890|NCT03887871|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101627936|NCT01026038|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101627938|NCT01026038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627939|NCT02606266|Valganciclovir|valganciclovir|mesh-list
101627940|NCT02606266|Antiviral Agents|antiviral agents|mesh-ancestor
101627941|NCT02606266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101627942|NCT04115020|Naltrexone|naltrexone|mesh-list
101627943|NCT04115020|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101627944|NCT04115020|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101627945|NCT04115020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627946|NCT04115020|Sensory System Agents|sensory system agents|mesh-ancestor
101627947|NCT04115020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101627948|NCT02801266|Contraceptive Agents|contraceptive agents|mesh-list
101627949|NCT02801266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101627950|NCT02801266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627951|NCT03292666|Warfarin|warfarin|mesh-list
101627952|NCT03292666|Rivaroxaban|rivaroxaban|mesh-list
101627953|NCT03292666|Dabigatran|dabigatran|mesh-list
101627954|NCT03292666|Apixaban|apixaban|mesh-list
101627955|NCT03292666|Anticoagulants|anticoagulants|mesh-list
101627956|NCT03292666|Edoxaban|edoxaban|mesh-list
101627957|NCT03292666|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101627958|NCT03292666|Antithrombins|antithrombins|mesh-ancestor
101627959|NCT03292666|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101627960|NCT03292666|Protease Inhibitors|protease inhibitors|mesh-ancestor
101627961|NCT03292666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101627962|NCT03292666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627963|NCT02707653|Misoprostol|misoprostol|mesh-list
101627964|NCT02707653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101627965|NCT02707653|Abortifacient Agents|abortifacient agents|mesh-ancestor
101627966|NCT02707653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101627967|NCT02707653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627968|NCT02707653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101627969|NCT02707653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101627970|NCT02707653|Oxytocics|oxytocics|mesh-ancestor
101627971|NCT03901131|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101627972|NCT03901131|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101627973|NCT03901131|Norethindrone|norethindrone|mesh-list
101627974|NCT03901131|Norethindrone Acetate|norethindrone acetate|mesh-list
101627975|NCT03901131|Norethindrone enanthate|norethindrone enanthate|mesh-list
101627976|NCT03901131|Estradiol|estradiol|mesh-list
101627977|NCT03901131|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101627978|NCT03901131|Estrogens|estrogens|mesh-ancestor
101627979|NCT03901131|Hormones|hormones|mesh-ancestor
101627980|NCT03901131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101627981|NCT03901131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627982|NCT03901131|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101627983|NCT03901131|Contraceptive Agents|contraceptive agents|mesh-ancestor
101627984|NCT03901131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101627985|NCT03901131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101627986|NCT03901131|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101627987|NCT03901131|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101627988|NCT03901131|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101627989|NCT02607202|Paclitaxel|paclitaxel|mesh-list
101627990|NCT02607202|Carboplatin|carboplatin|mesh-list
101627991|NCT02607202|Gemcitabine|gemcitabine|mesh-list
101627992|NCT02607202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101627993|NCT02607202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101627994|NCT02607202|Tubulin Modulators|tubulin modulators|mesh-ancestor
101627995|NCT02607202|Antimitotic Agents|antimitotic agents|mesh-ancestor
101627996|NCT02607202|Mitosis Modulators|mitosis modulators|mesh-ancestor
101627997|NCT02607202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627998|NCT02607202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101627999|NCT02607202|Antimetabolites|antimetabolites|mesh-ancestor
101628000|NCT02731612|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
101628001|NCT02731612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101628002|NCT02731612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101628003|NCT02731612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101426624|NCT00145613|Antibodies|antibodies|mesh-list
101709552|NCT04212533|Vitamin D|vitamin d|mesh-list
101628007|NCT02731612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101628008|NCT02731612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101628009|NCT02731612|Adrenergic Agents|adrenergic agents|mesh-ancestor
101628010|NCT02731612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101945891|NCT03887871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101945892|NCT03887871|Adrenergic Agents|adrenergic agents|mesh-ancestor
101628011|NCT02731612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628012|NCT02731612|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101628013|NCT02731612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101628014|NCT02731612|Serotonin Agents|serotonin agents|mesh-ancestor
101628015|NCT02731612|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101628016|NCT02731612|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101628017|NCT02731612|Dopamine Agents|dopamine agents|mesh-ancestor
101628019|NCT04371393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101628020|NCT04371393|Antiviral Agents|antiviral agents|mesh-ancestor
101628021|NCT04371393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101628022|NCT00923182|Alemtuzumab|alemtuzumab|mesh-list
101285110|NCT01932931|Vitamin D|vitamin d|mesh-list
101628023|NCT00923182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101628024|NCT00923182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101628025|NCT03868839|Telmisartan|telmisartan|mesh-list
101628026|NCT03868839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101628027|NCT03868839|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101628028|NCT03868839|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101628029|NCT03868839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628030|NCT00589420|Docetaxel|docetaxel|mesh-list
101628031|NCT00589420|Sorafenib|sorafenib|mesh-list
101628032|NCT00589420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101628033|NCT00589420|Tubulin Modulators|tubulin modulators|mesh-ancestor
101628034|NCT00589420|Antimitotic Agents|antimitotic agents|mesh-ancestor
101628035|NCT00589420|Mitosis Modulators|mitosis modulators|mesh-ancestor
101628036|NCT00589420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628037|NCT00589420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101628038|NCT00589420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628039|NCT04114630|Erenumab|erenumab|mesh-list
101628040|NCT04114630|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
101628041|NCT04114630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628042|NCT04114630|Analgesics|analgesics|mesh-ancestor
101628043|NCT04114630|Sensory System Agents|sensory system agents|mesh-ancestor
101628044|NCT04114630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101628045|NCT04114630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628046|NCT00914524|Olmesartan|olmesartan|mesh-list
101628047|NCT00914524|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101628048|NCT00914524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101628049|NCT00914524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101628050|NCT00914524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101628051|NCT00914524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628052|NCT03787095|Cemiplimab|cemiplimab|mesh-list
101628053|NCT03787095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101628054|NCT03787095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101628055|NCT04103385|Risedronic Acid|risedronic acid|mesh-list
101628056|NCT04103385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101628057|NCT04103385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101628058|NCT04103385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628059|NCT04103385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101628060|NCT04103385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628061|NCT04103385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101628062|NCT00796978|Trastuzumab|trastuzumab|mesh-list
101628063|NCT00796978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101628064|NCT00796978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101628065|NCT03779295|Clindamycin|clindamycin|mesh-list
101628066|NCT03779295|Clindamycin palmitate|clindamycin palmitate|mesh-list
101628067|NCT03779295|Clindamycin phosphate|clindamycin phosphate|mesh-list
101628068|NCT03779295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101628069|NCT03779295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101628070|NCT03779295|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101628071|NCT03779295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101709555|NCT04212533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628072|NCT03779295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628075|NCT00613665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628076|NCT00923572|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
101628077|NCT00923572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101628078|NCT00923572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628079|NCT03746769|Gastrins|gastrins|mesh-list
101628080|NCT03746769|Hormones|hormones|mesh-ancestor
101945893|NCT03887871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101945894|NCT03887871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945895|NCT03887871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945897|NCT03708146|Zamicastat|zamicastat|mesh-list
101945898|NCT03708146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101798342|NCT00887042|Busulfan|busulfan|mesh-list
101628081|NCT03746769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101628082|NCT03746769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628083|NCT00796822|Pentoxifylline|pentoxifylline|mesh-list
101628084|NCT00796822|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101628085|NCT00796822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628086|NCT00796822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628087|NCT00796822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101628088|NCT00796822|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101628089|NCT00796822|Protective Agents|protective agents|mesh-ancestor
101628090|NCT00796822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628091|NCT00796822|Vasodilator Agents|vasodilator agents|mesh-ancestor
101628092|NCT00796822|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101628093|NCT00796822|Antioxidants|antioxidants|mesh-ancestor
101628094|NCT04007991|Ecopipam|ecopipam|mesh-list
101628095|NCT04007991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101628096|NCT04007991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101628097|NCT04007991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101628098|NCT04007991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628099|NCT04007991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101628100|NCT04007991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101628101|NCT04007991|Dopamine Agents|dopamine agents|mesh-ancestor
101628102|NCT04007991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101628103|NCT04007991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628105|NCT03822507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101628106|NCT03822507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628107|NCT03822507|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101628108|NCT03822507|Hormone Antagonists|hormone antagonists|mesh-ancestor
101628109|NCT03822507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101628110|NCT04301726|Tetrabenazine|tetrabenazine|mesh-list
101628111|NCT04301726|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101628112|NCT04301726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101628113|NCT04301726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101628114|NCT04301726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628115|NCT04301726|Adrenergic Agents|adrenergic agents|mesh-ancestor
101628116|NCT04301726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101628117|NCT04301726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628118|NCT00614679|Tigecycline|tigecycline|mesh-list
101628119|NCT00614679|Heparin|heparin|mesh-list
101628120|NCT00614679|Anticoagulants|anticoagulants|mesh-ancestor
101628121|NCT00614679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101628122|NCT00614679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101628123|NCT00614679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628124|NCT00614679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101628125|NCT00614679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101628126|NCT00614679|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101628127|NCT00614679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628128|NCT03760965|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
101628129|NCT03760965|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101628130|NCT03760965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628131|NCT03760965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101628132|NCT03760965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628133|NCT03703869|Insulin Glargine|insulin glargine|mesh-list
101628134|NCT03703869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101628135|NCT03703869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628136|NCT01024946|Everolimus|everolimus|mesh-list
101628137|NCT01024946|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101945899|NCT03708146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945900|NCT01260753|Fluticasone|fluticasone|mesh-list
101628138|NCT01024946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101628139|NCT01024946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628140|NCT01024946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628141|NCT01024946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101628142|NCT01024946|Immunologic Factors|immunologic factors|mesh-ancestor
101628149|NCT00627536|Mitogens|mitogens|mesh-list
101628150|NCT00627536|Mitosis Modulators|mitosis modulators|mesh-ancestor
101628151|NCT00627536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628152|NCT00724711|Tenofovir|tenofovir|mesh-list
101628153|NCT00724711|Lamivudine|lamivudine|mesh-list
101628154|NCT00724711|Emtricitabine|emtricitabine|mesh-list
101628155|NCT00724711|Abacavir|abacavir|mesh-list
101628156|NCT00724711|Antiviral Agents|antiviral agents|mesh-ancestor
101628157|NCT00724711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101628158|NCT00724711|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101628159|NCT00724711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101628160|NCT00724711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628161|NCT00724711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628163|NCT00724711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101628164|NCT00721279|Pramipexole|pramipexole|mesh-list
101628165|NCT00721279|Antioxidants|antioxidants|mesh-ancestor
101628166|NCT00721279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628167|NCT00721279|Protective Agents|protective agents|mesh-ancestor
101628168|NCT00721279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628169|NCT00721279|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101628170|NCT00721279|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101628171|NCT00721279|Dopamine Agonists|dopamine agonists|mesh-ancestor
101628172|NCT00721279|Dopamine Agents|dopamine agents|mesh-ancestor
101628173|NCT00721279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101628174|NCT01030952|Acarbose|acarbose|mesh-list
101628175|NCT01030952|Nateglinide|nateglinide|mesh-list
101628176|NCT01030952|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101628177|NCT01030952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628178|NCT01030952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628179|NCT01030952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101628180|NCT01030952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628181|NCT03611751|Apremilast|apremilast|mesh-list
101628182|NCT03611751|Deucravacitinib|deucravacitinib|mesh-list
101628183|NCT03611751|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101628184|NCT03611751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101628185|NCT03611751|Analgesics|analgesics|mesh-ancestor
101628186|NCT03611751|Sensory System Agents|sensory system agents|mesh-ancestor
101628187|NCT03611751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101628188|NCT03611751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628189|NCT03611751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101628190|NCT03611751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101628191|NCT03611751|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101628192|NCT03611751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101628193|NCT03611751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628194|NCT03611751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628195|NCT03611751|Dermatologic Agents|dermatologic agents|mesh-ancestor
101628196|NCT03611751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101628197|NCT00613743|Morphine|morphine|mesh-list
101628198|NCT00613743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101628199|NCT00613743|Narcotics|narcotics|mesh-ancestor
101628200|NCT00613743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101628201|NCT00613743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628202|NCT00613743|Analgesics|analgesics|mesh-ancestor
101628203|NCT00613743|Sensory System Agents|sensory system agents|mesh-ancestor
101628204|NCT00613743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101628205|NCT00614757|Acetylcysteine|acetylcysteine|mesh-list
101628206|NCT00614757|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101628207|NCT00614757|Antiviral Agents|antiviral agents|mesh-ancestor
101628208|NCT00614757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101628209|NCT00614757|Expectorants|expectorants|mesh-ancestor
101628210|NCT00614757|Respiratory System Agents|respiratory system agents|mesh-ancestor
101628211|NCT00614757|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101628212|NCT00614757|Antioxidants|antioxidants|mesh-ancestor
101426839|NCT00174681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628213|NCT00614757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628215|NCT00614757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945901|NCT01260753|Xhance|xhance|mesh-list
101945902|NCT01260753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101945903|NCT01260753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101945904|NCT01260753|Autonomic Agents|autonomic agents|mesh-ancestor
101945905|NCT01260753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101945906|NCT01260753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945907|NCT01260753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101945908|NCT01260753|Respiratory System Agents|respiratory system agents|mesh-ancestor
101945909|NCT01260753|Dermatologic Agents|dermatologic agents|mesh-ancestor
101945910|NCT01260753|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101945911|NCT03895671|Azacitidine|azacitidine|mesh-list
101945912|NCT03895671|Ponatinib|ponatinib|mesh-list
101945913|NCT03895671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101945914|NCT03895671|Antimetabolites|antimetabolites|mesh-ancestor
101945915|NCT03895671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945916|NCT03895671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101945917|NCT03895671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101945918|NCT03895671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101945919|NCT01152723|Nicotine|nicotine|mesh-list
101945920|NCT01152723|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101945921|NCT01152723|Autonomic Agents|autonomic agents|mesh-ancestor
101945922|NCT01152723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101945923|NCT01152723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945924|NCT01152723|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101945925|NCT01152723|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101945926|NCT01152723|Cholinergic Agents|cholinergic agents|mesh-ancestor
101945927|NCT01152723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101945928|NCT01152723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945929|NCT01261065|Carvedilol|carvedilol|mesh-list
101945930|NCT01261065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101945931|NCT01261065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101945932|NCT01261065|Adrenergic Agents|adrenergic agents|mesh-ancestor
101945933|NCT01261065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101945934|NCT01261065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945935|NCT01261065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945936|NCT01261065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101945937|NCT01261065|Antioxidants|antioxidants|mesh-ancestor
101945938|NCT01261065|Protective Agents|protective agents|mesh-ancestor
101945939|NCT01261065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101945940|NCT01261065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101945941|NCT01261065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101945942|NCT01261065|Vasodilator Agents|vasodilator agents|mesh-ancestor
101945943|NCT01261065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101945944|NCT01261065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101945945|NCT01257867|Lithium Carbonate|lithium carbonate|mesh-list
101945946|NCT01257867|Antidepressive Agents|antidepressive agents|mesh-ancestor
101945947|NCT01257867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101945948|NCT01257867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101945949|NCT01257867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945950|NCT01257867|Antimanic Agents|antimanic agents|mesh-ancestor
101945951|NCT01257867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101945952|NCT01257867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101945953|NCT01257867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945954|NCT03338972|Cyclophosphamide|cyclophosphamide|mesh-list
101945955|NCT03338972|Fludarabine|fludarabine|mesh-list
101945956|NCT03338972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101945957|NCT03338972|Immunologic Factors|immunologic factors|mesh-ancestor
101945958|NCT03338972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945959|NCT03338972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101945960|NCT03338972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101945961|NCT03338972|Alkylating Agents|alkylating agents|mesh-ancestor
101945962|NCT03338972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101945963|NCT03338972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101945964|NCT03338972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101945966|NCT01151397|Ribavirin|ribavirin|mesh-list
101945967|NCT01151397|Vitamins|vitamins|mesh-ancestor
101945975|NCT01152801|Everolimus|everolimus|mesh-list
101945983|NCT01152801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101945984|NCT03887169|Vitamin B 12|vitamin b 12|mesh-list
101945985|NCT03887169|Hydroxocobalamin|hydroxocobalamin|mesh-list
101945986|NCT03887169|Vitamins|vitamins|mesh-ancestor
101945987|NCT03887169|Micronutrients|micronutrients|mesh-ancestor
101945988|NCT03887169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945989|NCT03887169|Vitamin B Complex|vitamin b complex|mesh-ancestor
101945990|NCT03887169|Hematinics|hematinics|mesh-ancestor
101945991|NCT03886779|Nepafenac|nepafenac|mesh-list
101945992|NCT03886779|Bromfenac|bromfenac|mesh-list
101945993|NCT03886779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101945994|NCT03886779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101945995|NCT03886779|Analgesics|analgesics|mesh-ancestor
101945996|NCT03886779|Sensory System Agents|sensory system agents|mesh-ancestor
101945997|NCT03886779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101945998|NCT03886779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101945999|NCT03886779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101946000|NCT03886779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101946001|NCT03887013|Trimetazidine|trimetazidine|mesh-list
101946002|NCT03887013|Vasodilator Agents|vasodilator agents|mesh-ancestor
101946003|NCT01261299|Carboplatin|carboplatin|mesh-list
101628216|NCT00614757|Antidotes|antidotes|mesh-ancestor
101628217|NCT02692365|Manganese|manganese|mesh-list
101628218|NCT02692365|Trace Elements|trace elements|mesh-ancestor
101628219|NCT02692365|Micronutrients|micronutrients|mesh-ancestor
101628220|NCT02692365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628221|NCT03492099|Buprenorphine|buprenorphine|mesh-list
101628222|NCT03492099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101628223|NCT03492099|Narcotics|narcotics|mesh-ancestor
101628224|NCT03492099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101628225|NCT03492099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628226|NCT03492099|Analgesics|analgesics|mesh-ancestor
101628227|NCT03492099|Sensory System Agents|sensory system agents|mesh-ancestor
101628228|NCT03492099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101628229|NCT03492099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101628230|NCT03481959|Methylphenidate|methylphenidate|mesh-list
101628231|NCT03481959|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101628232|NCT03481959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628233|NCT03481959|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101628234|NCT03481959|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101628235|NCT03481959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101628236|NCT03481959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628237|NCT03481959|Dopamine Agents|dopamine agents|mesh-ancestor
101628238|NCT03481959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101628239|NCT03245229|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101628240|NCT03245229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101628241|NCT03245229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101628242|NCT03245229|Antimetabolites|antimetabolites|mesh-ancestor
101628243|NCT03245229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628244|NCT03245229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101628245|NCT03245229|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101628246|NCT03245229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628247|NCT03462069|Empagliflozin|empagliflozin|mesh-list
101628248|NCT03462069|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
101628249|NCT03462069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101946004|NCT01261299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101946005|NCT01154829|Aripiprazole|aripiprazole|mesh-list
101946006|NCT01154829|Amisulpride|amisulpride|mesh-list
101946007|NCT01154829|Antidepressive Agents|antidepressive agents|mesh-ancestor
101946008|NCT01154829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101946009|NCT01154829|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101946010|NCT01154829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101709582|NCT03997279|Amoxicillin|amoxicillin|mesh-list
101946011|NCT01154829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101946012|NCT01154829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946013|NCT01154829|Dopamine Agonists|dopamine agonists|mesh-ancestor
101946014|NCT01154829|Dopamine Agents|dopamine agents|mesh-ancestor
101946015|NCT01154829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101946016|NCT01154829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946017|NCT01154829|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101946018|NCT01154829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101946019|NCT01154829|Serotonin Agents|serotonin agents|mesh-ancestor
101946020|NCT01154829|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101946021|NCT01154829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101798600|NCT00560352|Glucocorticoids|glucocorticoids|mesh-ancestor
101628250|NCT03462069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628251|NCT03462069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101628252|NCT03462069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628253|NCT03414723|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
101628254|NCT03414723|Ramipril|ramipril|mesh-list
101628255|NCT03414723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101628256|NCT03414723|Protease Inhibitors|protease inhibitors|mesh-ancestor
101628257|NCT03414723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628258|NCT03414723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628259|NCT03414723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101628260|NCT03414723|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101628261|NCT03414723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101628262|NCT03414723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628263|NCT03387657|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
101628264|NCT03387657|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101628265|NCT03387657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101628266|NCT03387657|Diuretics|diuretics|mesh-ancestor
101628267|NCT03387657|Natriuretic Agents|natriuretic agents|mesh-ancestor
101628268|NCT03387657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628269|NCT03387657|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101628270|NCT03387657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101628271|NCT03387657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628272|NCT03387657|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101628273|NCT03387657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101628274|NCT00720499|Bromides|bromides|mesh-list
101628275|NCT00720499|Tiotropium Bromide|tiotropium bromide|mesh-list
101628276|NCT00720499|Olodaterol|olodaterol|mesh-list
101628277|NCT00720499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101628278|NCT00720499|Autonomic Agents|autonomic agents|mesh-ancestor
101628279|NCT00720499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101426908|NCT02942212|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101971998|NCT00313768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946022|NCT01154829|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101798665|NCT00896558|Midazolam|midazolam|mesh-list
101971999|NCT00313768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101972001|NCT00313768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101972002|NCT00313768|Growth Substances|growth substances|mesh-ancestor
101972003|NCT00313768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972004|NCT00313768|Growth Inhibitors|growth inhibitors|mesh-ancestor
101972005|NCT01339988|Cyclophosphamide|cyclophosphamide|mesh-list
101972006|NCT01339988|Busulfan|busulfan|mesh-list
101972007|NCT01339988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101972008|NCT01339988|Immunologic Factors|immunologic factors|mesh-ancestor
101972009|NCT01339988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972010|NCT01339988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101972011|NCT01339988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101972012|NCT01339988|Alkylating Agents|alkylating agents|mesh-ancestor
101972013|NCT01339988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972014|NCT01339988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101972015|NCT01339988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101972016|NCT00406588|Levodopa|levodopa|mesh-list
101972017|NCT00406588|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101972018|NCT00406588|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101972019|NCT00406588|Dopamine Agents|dopamine agents|mesh-ancestor
101972020|NCT00406588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101972021|NCT00406588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972022|NCT00406588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972023|NCT01342328|Dexmedetomidine|dexmedetomidine|mesh-list
101972024|NCT01342328|Propofol|propofol|mesh-list
101972025|NCT01342328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101972026|NCT01342328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101972027|NCT01342328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972028|NCT01342328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101972029|NCT01342328|Analgesics|analgesics|mesh-ancestor
101972030|NCT01342328|Sensory System Agents|sensory system agents|mesh-ancestor
101972031|NCT01342328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101972032|NCT01342328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101972033|NCT01342328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101972034|NCT01342328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101972035|NCT01342328|Adrenergic Agents|adrenergic agents|mesh-ancestor
101972036|NCT01342328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101972037|NCT01342328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972038|NCT01342328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101972039|NCT01342328|Anesthetics, General|anesthetics, general|mesh-ancestor
101972040|NCT01342328|Anesthetics|anesthetics|mesh-ancestor
101972041|NCT00313222|Bosentan|bosentan|mesh-list
101972042|NCT00313222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101972043|NCT00313222|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101972044|NCT00313222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972045|NCT05184530|Evolocumab|evolocumab|mesh-list
101972046|NCT05184530|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101972047|NCT05184530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101972048|NCT05184530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101972049|NCT05184530|Antimetabolites|antimetabolites|mesh-ancestor
101972057|NCT05184374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101972059|NCT05187494|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
101972060|NCT05187494|Anesthetics, Local|anesthetics, local|mesh-ancestor
101972061|NCT05187494|Anesthetics|anesthetics|mesh-ancestor
101972062|NCT05187494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101972063|NCT05187494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972064|NCT05187494|Sensory System Agents|sensory system agents|mesh-ancestor
101972065|NCT05187494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101972066|NCT05187494|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
101972067|NCT01342562|Anesthetics|anesthetics|mesh-list
101972068|NCT01342562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101972069|NCT01342562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972070|NCT00116116|Lamivudine|lamivudine|mesh-list
101972071|NCT00116116|Efavirenz|efavirenz|mesh-list
101972072|NCT00116116|Stavudine|stavudine|mesh-list
101972073|NCT00116116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101972074|NCT00116116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101972075|NCT00116116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101972076|NCT00116116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972077|NCT00116116|Antiviral Agents|antiviral agents|mesh-ancestor
101946023|NCT01154829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101946024|NCT01154829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101946025|NCT01153191|Gentamicins|gentamicins|mesh-list
101946026|NCT01153191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101946027|NCT01153191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101946028|NCT01153191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101946029|NCT01153191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101946030|NCT01153191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946031|NCT01259817|Aspirin|aspirin|mesh-list
101946032|NCT01259817|Interferons|interferons|mesh-list
101946033|NCT01259817|Interferon-alpha|interferon-alpha|mesh-list
101946034|NCT01259817|Interferon alpha-2|interferon alpha-2|mesh-list
101946035|NCT01259817|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101972078|NCT00116116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101972079|NCT00116116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101972080|NCT00116116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101972081|NCT00116116|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101972082|NCT00116116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101972083|NCT00116116|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101972084|NCT00116116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101972085|NCT00116116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101972086|NCT00116116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101972087|NCT00116116|Antimetabolites|antimetabolites|mesh-ancestor
101972088|NCT02287870|Lidocaine|lidocaine|mesh-list
101972089|NCT02287870|Chloroprocaine|chloroprocaine|mesh-list
101972090|NCT02287870|Procaine|procaine|mesh-list
101972091|NCT02287870|Anesthetics, Local|anesthetics, local|mesh-ancestor
101972092|NCT02287870|Anesthetics|anesthetics|mesh-ancestor
101691843|NCT02812199|Mydriatics|mydriatics|mesh-ancestor
101972093|NCT02287870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101972095|NCT02287870|Sensory System Agents|sensory system agents|mesh-ancestor
101972096|NCT02287870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101972097|NCT02287870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101972098|NCT02287870|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101972099|NCT02287870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101972100|NCT02287870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101972101|NCT02287870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972102|NCT01340456|Rifampin|rifampin|mesh-list
101972103|NCT01340456|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101972104|NCT01340456|Antitubercular Agents|antitubercular agents|mesh-ancestor
101972105|NCT01340456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101972106|NCT01340456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101972107|NCT01340456|Leprostatic Agents|leprostatic agents|mesh-ancestor
101972108|NCT01340456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101972109|NCT01340456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101972110|NCT01340456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972111|NCT01340456|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101972112|NCT01340456|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101972113|NCT01340456|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101972117|NCT00110422|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101972118|NCT00110422|Irbesartan|irbesartan|mesh-list
101972119|NCT00110422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101972120|NCT00110422|Diuretics|diuretics|mesh-ancestor
101972121|NCT00110422|Natriuretic Agents|natriuretic agents|mesh-ancestor
101972122|NCT00110422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972123|NCT00110422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101972124|NCT00110422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101972125|NCT00110422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972126|NCT00110422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101972127|NCT00110422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101972128|NCT00305656|Cediranib|cediranib|mesh-list
101946036|NCT01259817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101946037|NCT01259817|Antiviral Agents|antiviral agents|mesh-ancestor
101946038|NCT01259817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101946039|NCT01259817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101946040|NCT01259817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101946041|NCT01259817|Analgesics|analgesics|mesh-ancestor
101946042|NCT01259817|Sensory System Agents|sensory system agents|mesh-ancestor
101946043|NCT01259817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101972129|NCT00305656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101972130|NCT00305656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972131|NCT00305656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101972132|NCT00305656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101972133|NCT02284984|Rituximab|rituximab|mesh-list
101972134|NCT02284984|Belimumab|belimumab|mesh-list
101972135|NCT02284984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101972136|NCT02284984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101972137|NCT02284984|Immunologic Factors|immunologic factors|mesh-ancestor
101972138|NCT02284984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972139|NCT02284984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101972140|NCT02284984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101972141|NCT00305188|Leucovorin|leucovorin|mesh-list
101972142|NCT00305188|Fluorouracil|fluorouracil|mesh-list
101972143|NCT00305188|Oxaliplatin|oxaliplatin|mesh-list
101972144|NCT00305188|Xaliproden|xaliproden|mesh-list
101972145|NCT00305188|Antimetabolites|antimetabolites|mesh-ancestor
101972146|NCT00305188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972147|NCT00305188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101972148|NCT00305188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101972149|NCT00305188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101972150|NCT00305188|Immunologic Factors|immunologic factors|mesh-ancestor
101972151|NCT00305188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972152|NCT00305188|Antidotes|antidotes|mesh-ancestor
101972153|NCT00305188|Protective Agents|protective agents|mesh-ancestor
101972154|NCT00305188|Vitamin B Complex|vitamin b complex|mesh-ancestor
101972155|NCT00305188|Vitamins|vitamins|mesh-ancestor
101972156|NCT00305188|Micronutrients|micronutrients|mesh-ancestor
101972157|NCT00305188|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101972158|NCT00305188|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101972159|NCT00305188|Serotonin Agents|serotonin agents|mesh-ancestor
101972160|NCT00305188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101972161|NCT00297310|Tacrolimus|tacrolimus|mesh-list
101972162|NCT00297310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101972163|NCT00297310|Immunologic Factors|immunologic factors|mesh-ancestor
101972164|NCT00297310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972165|NCT00297310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101972166|NCT00297310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101972167|NCT00297310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972168|NCT00095290|Ramipril|ramipril|mesh-list
101972169|NCT00095290|Irbesartan|irbesartan|mesh-list
101972170|NCT00095290|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101972171|NCT00095290|Protease Inhibitors|protease inhibitors|mesh-ancestor
101972172|NCT00095290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101972173|NCT00095290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972174|NCT00095290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101972175|NCT00095290|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101972176|NCT00095290|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101972177|NCT01340846|Ketoconazole|ketoconazole|mesh-list
101972178|NCT01340846|Dabrafenib|dabrafenib|mesh-list
101972179|NCT01340846|Warfarin|warfarin|mesh-list
101972180|NCT01340846|Gemfibrozil|gemfibrozil|mesh-list
101972181|NCT01340846|Anticoagulants|anticoagulants|mesh-ancestor
101972182|NCT01340846|Antifungal Agents|antifungal agents|mesh-ancestor
101972183|NCT01340846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101972184|NCT01340846|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101972185|NCT01340846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101972195|NCT01340846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101972196|NCT01340846|Antimetabolites|antimetabolites|mesh-ancestor
101972197|NCT01340846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101946044|NCT01259817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946045|NCT01259817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101946046|NCT01259817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101946047|NCT01259817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101946048|NCT01259817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101946049|NCT01259817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946050|NCT01259817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101946051|NCT01259817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101946052|NCT01259817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101946053|NCT01259817|Antipyretics|antipyretics|mesh-ancestor
101946054|NCT01259817|Immunologic Factors|immunologic factors|mesh-ancestor
101946055|NCT01261689|Sufentanil|sufentanil|mesh-list
101946056|NCT01261689|Dsuvia|dsuvia|mesh-list
101946057|NCT01261689|Ropivacaine|ropivacaine|mesh-list
101946058|NCT01261689|Anesthetics, Local|anesthetics, local|mesh-ancestor
101946059|NCT01261689|Anesthetics|anesthetics|mesh-ancestor
101946060|NCT01261689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101946061|NCT01261689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946062|NCT01261689|Sensory System Agents|sensory system agents|mesh-ancestor
101972198|NCT01340846|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101972199|NCT01342874|Inositol|inositol|mesh-list
101972200|NCT01342874|Vitamin B Complex|vitamin b complex|mesh-ancestor
101972201|NCT01342874|Vitamins|vitamins|mesh-ancestor
101972202|NCT01342874|Micronutrients|micronutrients|mesh-ancestor
101972203|NCT01342874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972204|NCT01337258|Dutasteride|dutasteride|mesh-list
101972205|NCT01337258|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101972206|NCT01337258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101972207|NCT01337258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101972208|NCT01337258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972209|NCT01337258|Hormone Antagonists|hormone antagonists|mesh-ancestor
101972210|NCT01337258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101972211|NCT01337258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972212|NCT02603809|Lisinopril|lisinopril|mesh-list
101972213|NCT02603809|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101972214|NCT02603809|Protease Inhibitors|protease inhibitors|mesh-ancestor
101972215|NCT02603809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101972216|NCT02603809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972217|NCT02603809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101972218|NCT02603809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101972219|NCT02603809|Protective Agents|protective agents|mesh-ancestor
101972220|NCT02603809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972221|NCT01341158|Interferons|interferons|mesh-list
101972222|NCT01341158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101972223|NCT01341158|Antiviral Agents|antiviral agents|mesh-ancestor
101972224|NCT01341158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101972225|NCT00393952|Fluticasone|fluticasone|mesh-list
101972227|NCT00393952|Formoterol Fumarate|formoterol fumarate|mesh-list
101972228|NCT00393952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101972229|NCT00393952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101972230|NCT00393952|Autonomic Agents|autonomic agents|mesh-ancestor
101972231|NCT00393952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101972232|NCT00393952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972233|NCT00393952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101972234|NCT00393952|Respiratory System Agents|respiratory system agents|mesh-ancestor
101972235|NCT00393952|Dermatologic Agents|dermatologic agents|mesh-ancestor
101972236|NCT00393952|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101946063|NCT01261689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101946064|NCT01261689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101972237|NCT00393952|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101972238|NCT00393952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101972239|NCT00393952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101691973|NCT00640094|Melatonin|melatonin|mesh-list
101972240|NCT00393952|Adrenergic Agents|adrenergic agents|mesh-ancestor
101972241|NCT00393952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101972242|NCT00393952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972243|NCT02285374|Tenofovir|tenofovir|mesh-list
101972244|NCT02285374|Emtricitabine|emtricitabine|mesh-list
101972245|NCT02285374|Efavirenz|efavirenz|mesh-list
101972246|NCT02285374|Dolutegravir|dolutegravir|mesh-list
101972247|NCT02285374|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101972248|NCT02285374|Antiviral Agents|antiviral agents|mesh-ancestor
101972256|NCT02285374|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101972257|NCT02285374|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101972258|NCT02285374|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101972259|NCT02285374|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101972260|NCT02285374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101972261|NCT02285374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101972262|NCT02285374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101972263|NCT02285374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101972264|NCT01112449|Selenium|selenium|mesh-list
101972265|NCT01112449|Antioxidants|antioxidants|mesh-ancestor
101709616|NCT05323565|Dexmedetomidine|dexmedetomidine|mesh-list
101972266|NCT01112449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972267|NCT01112449|Protective Agents|protective agents|mesh-ancestor
101972268|NCT01112449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972269|NCT01112449|Trace Elements|trace elements|mesh-ancestor
101972270|NCT01112449|Micronutrients|micronutrients|mesh-ancestor
101972271|NCT01341392|Amlodipine|amlodipine|mesh-list
101972272|NCT01341392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101972273|NCT01341392|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101972274|NCT01341392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101972275|NCT01341392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972276|NCT01341392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101972277|NCT01341392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972278|NCT01341392|Vasodilator Agents|vasodilator agents|mesh-ancestor
101972279|NCT04390958|Paclitaxel|paclitaxel|mesh-list
101972280|NCT04390958|Capecitabine|capecitabine|mesh-list
101972281|NCT04390958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101972282|NCT04390958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101972283|NCT04390958|Tubulin Modulators|tubulin modulators|mesh-ancestor
101972284|NCT04390958|Antimitotic Agents|antimitotic agents|mesh-ancestor
101972285|NCT04390958|Mitosis Modulators|mitosis modulators|mesh-ancestor
101972286|NCT04390958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972287|NCT04390958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101972288|NCT04390958|Antimetabolites|antimetabolites|mesh-ancestor
101972289|NCT03943459|Atorvastatin|atorvastatin|mesh-list
101972290|NCT03943459|Quercetin|quercetin|mesh-list
101972291|NCT03943459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101972292|NCT03943459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101972293|NCT03943459|Antimetabolites|antimetabolites|mesh-ancestor
101972294|NCT03943459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972295|NCT03943459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101972296|NCT03943459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101972297|NCT03943459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101972298|NCT03943459|Antioxidants|antioxidants|mesh-ancestor
101972299|NCT03943459|Protective Agents|protective agents|mesh-ancestor
101972300|NCT03943459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972301|NCT04832438|Carboplatin|carboplatin|mesh-list
101972302|NCT04832438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101972303|NCT05182970|Metformin|metformin|mesh-list
101972304|NCT05182970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101972305|NCT05182970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972306|NCT01315886|Fentanyl|fentanyl|mesh-list
101972307|NCT01315886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101972308|NCT01315886|Narcotics|narcotics|mesh-ancestor
101972309|NCT01315886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101972310|NCT01315886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972311|NCT01315886|Analgesics|analgesics|mesh-ancestor
101946066|NCT01261689|Analgesics|analgesics|mesh-ancestor
101946067|NCT01261689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101946068|NCT01261689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101946069|NCT01261689|Anesthetics, General|anesthetics, general|mesh-ancestor
101946070|NCT01154907|Praziquantel|praziquantel|mesh-list
101946071|NCT01154907|Anthelmintics|anthelmintics|mesh-ancestor
101946072|NCT01154907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101972312|NCT01315886|Sensory System Agents|sensory system agents|mesh-ancestor
101972313|NCT01315886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101427247|NCT02943655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101972316|NCT01315886|Anesthetics, General|anesthetics, general|mesh-ancestor
101972317|NCT01315886|Anesthetics|anesthetics|mesh-ancestor
101972319|NCT00065728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101972320|NCT00065728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101972321|NCT00065728|Growth Substances|growth substances|mesh-ancestor
101972322|NCT00065728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972323|NCT00065728|Growth Inhibitors|growth inhibitors|mesh-ancestor
101972324|NCT00065728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101972325|NCT00064714|Exenatide|exenatide|mesh-list
101972326|NCT00064714|Daclizumab|daclizumab|mesh-list
101972327|NCT00064714|Immunosuppressive Agents|immunosuppressive agents|mesh-list
101972328|NCT00064714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101972329|NCT00064714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972330|NCT00064714|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101972331|NCT00064714|Incretins|incretins|mesh-ancestor
101972332|NCT00064714|Hormones|hormones|mesh-ancestor
101972333|NCT00064714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101972334|NCT00064714|Immunologic Factors|immunologic factors|mesh-ancestor
101972335|NCT01109485|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
101972336|NCT01109485|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101972337|NCT01109485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101972338|NCT01109485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101972339|NCT01109485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101972340|NCT01109485|Analgesics|analgesics|mesh-ancestor
101972341|NCT01109485|Sensory System Agents|sensory system agents|mesh-ancestor
101972342|NCT01109485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101972343|NCT01109485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972344|NCT01109485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101972345|NCT01109485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101972346|NCT01109485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101972347|NCT01109485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101972348|NCT01109485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101972349|NCT01109485|Histamine Antagonists|histamine antagonists|mesh-ancestor
101972350|NCT01109485|Histamine Agents|histamine agents|mesh-ancestor
101972351|NCT01109485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101972352|NCT01109485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972353|NCT00292396|Antibodies|antibodies|mesh-list
101972354|NCT00292396|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101972355|NCT00292396|Immunologic Factors|immunologic factors|mesh-ancestor
101972356|NCT00292396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972357|NCT03942289|Norepinephrine|norepinephrine|mesh-list
101972358|NCT03942289|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101972359|NCT03942289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101972360|NCT03942289|Adrenergic Agents|adrenergic agents|mesh-ancestor
101972361|NCT03942289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101972362|NCT03942289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972363|NCT03942289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972364|NCT03942289|Sympathomimetics|sympathomimetics|mesh-ancestor
101972365|NCT03942289|Autonomic Agents|autonomic agents|mesh-ancestor
101972366|NCT03942289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101972367|NCT03942289|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101972368|NCT00284128|Losartan|losartan|mesh-list
101972369|NCT00284128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101972370|NCT00284128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101972371|NCT00284128|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101972372|NCT00284128|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101972373|NCT00284128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972374|NCT00035542|Metformin|metformin|mesh-list
101972375|NCT00035542|Glyburide|glyburide|mesh-list
101972376|NCT00035542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101946073|NCT01154907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101946074|NCT01261923|Alitretinoin|alitretinoin|mesh-list
101946075|NCT01261923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101946076|NCT01261923|Dermatologic Agents|dermatologic agents|mesh-ancestor
101972377|NCT00035542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972378|NCT01209715|Fluticasone|fluticasone|mesh-list
101972379|NCT01209715|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101972380|NCT01209715|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101972381|NCT01209715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101972382|NCT01209715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101709632|NCT05323565|Analgesics|analgesics|mesh-ancestor
101972383|NCT01209715|Autonomic Agents|autonomic agents|mesh-ancestor
101972384|NCT01209715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101972385|NCT01209715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972386|NCT01209715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101972387|NCT01209715|Respiratory System Agents|respiratory system agents|mesh-ancestor
101972395|NCT01209715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972396|NCT01209715|Glucocorticoids|glucocorticoids|mesh-ancestor
101972397|NCT01209715|Hormones|hormones|mesh-ancestor
101972398|NCT01209715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101972399|NCT01209715|Sympathomimetics|sympathomimetics|mesh-ancestor
101972400|NCT03740893|Durvalumab|durvalumab|mesh-list
101972401|NCT03740893|Olaparib|olaparib|mesh-list
101972402|NCT03740893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101972403|NCT03740893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101972404|NCT03740893|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101972405|NCT03740893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101972406|NCT03740893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972407|NCT00005788|Aldesleukin|aldesleukin|mesh-list
101972408|NCT00005788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101972409|NCT00005788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101972410|NCT00005788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101972411|NCT00005788|Antiviral Agents|antiviral agents|mesh-ancestor
101972412|NCT00005788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101972413|NCT03945955|Melatonin|melatonin|mesh-list
101972414|NCT03945955|Antioxidants|antioxidants|mesh-ancestor
101972415|NCT03945955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972416|NCT03945955|Protective Agents|protective agents|mesh-ancestor
101972417|NCT03945955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972418|NCT03945955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101972419|NCT00005608|Leucovorin|leucovorin|mesh-list
101972420|NCT00005608|Tegafur|tegafur|mesh-list
101972421|NCT00005608|Calcium|calcium|mesh-list
101972422|NCT00005608|Levoleucovorin|levoleucovorin|mesh-list
101972423|NCT00005608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101972424|NCT00005608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972425|NCT00005608|Antidotes|antidotes|mesh-ancestor
101972426|NCT00005608|Protective Agents|protective agents|mesh-ancestor
101972427|NCT00005608|Vitamin B Complex|vitamin b complex|mesh-ancestor
101972428|NCT00005608|Vitamins|vitamins|mesh-ancestor
101972429|NCT00005608|Micronutrients|micronutrients|mesh-ancestor
101972430|NCT00005608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101972431|NCT00005608|Antimetabolites|antimetabolites|mesh-ancestor
101972432|NCT00005608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972433|NCT00005608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101972434|NCT02288338|Atorvastatin|atorvastatin|mesh-list
101972435|NCT02288338|Ezetimibe|ezetimibe|mesh-list
101972436|NCT02288338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101972437|NCT02288338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101972438|NCT02288338|Antimetabolites|antimetabolites|mesh-ancestor
101972439|NCT02288338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972440|NCT02288338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101972441|NCT02288338|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101972442|NCT02288338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101972443|NCT00388960|Etoposide|etoposide|mesh-list
101972444|NCT00388960|Amrubicin|amrubicin|mesh-list
101972445|NCT00388960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101972446|NCT00388960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101972447|NCT00388960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101972448|NCT00388960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101972449|NCT00388960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101709647|NCT00676286|Lipotropic Agents|lipotropic agents|mesh-ancestor
101972450|NCT00388960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972451|NCT03941899|Levobupivacaine|levobupivacaine|mesh-list
101946078|NCT01157247|Anesthetics|anesthetics|mesh-list
101946079|NCT01157247|Anesthetics, Local|anesthetics, local|mesh-list
101972452|NCT03941899|Anesthetics, Local|anesthetics, local|mesh-ancestor
101972453|NCT03941899|Anesthetics|anesthetics|mesh-ancestor
101972454|NCT03941899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101972460|NCT00004912|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101692199|NCT02682134|Glucocorticoids|glucocorticoids|mesh-ancestor
101972461|NCT00004912|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101972462|NCT00004912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101972463|NCT00004912|Contraceptive Agents|contraceptive agents|mesh-ancestor
101972464|NCT00004912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101972465|NCT00004912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972466|NCT00004912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101972467|NCT00004912|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101972468|NCT00004912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101972469|NCT00004912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101972470|NCT00004912|Appetite Stimulants|appetite stimulants|mesh-ancestor
101972471|NCT00004912|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101972472|NCT02529787|Dexlansoprazole|dexlansoprazole|mesh-list
101972473|NCT02529787|Lansoprazole|lansoprazole|mesh-list
101972474|NCT02529787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101972475|NCT02529787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101972476|NCT02529787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101972477|NCT02529787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101972478|NCT02529787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972479|NCT00267592|Temozolomide|temozolomide|mesh-list
101972480|NCT00267592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101972481|NCT00267592|Alkylating Agents|alkylating agents|mesh-ancestor
101972482|NCT00267592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972483|NCT00267592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101972484|NCT00267280|Atorvastatin|atorvastatin|mesh-list
101972485|NCT00267280|Simvastatin|simvastatin|mesh-list
101972486|NCT00267280|Torcetrapib|torcetrapib|mesh-list
101972487|NCT00267280|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101972488|NCT00267280|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101972489|NCT00267280|Antimetabolites|antimetabolites|mesh-ancestor
101972490|NCT00267280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972491|NCT00267280|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101972492|NCT00267280|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101972493|NCT00267280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101972494|NCT03530488|Lidocaine|lidocaine|mesh-list
101972495|NCT03530488|Anesthetics, Local|anesthetics, local|mesh-ancestor
101972496|NCT03530488|Anesthetics|anesthetics|mesh-ancestor
101972497|NCT03530488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101972498|NCT03530488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972499|NCT03530488|Sensory System Agents|sensory system agents|mesh-ancestor
101972500|NCT03530488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101972501|NCT03530488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101972502|NCT03530488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101972503|NCT03530488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101972504|NCT03530488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101972505|NCT03530488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972506|NCT00262990|Doxorubicin|doxorubicin|mesh-list
101972507|NCT00262990|Epothilone B|epothilone b|mesh-list
101972508|NCT00262990|Epothilones|epothilones|mesh-list
101972509|NCT00262990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101972510|NCT00262990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101972511|NCT00262990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101972512|NCT00262990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101972513|NCT00262990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101972514|NCT00262990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972515|NCT00262990|Tubulin Modulators|tubulin modulators|mesh-ancestor
101972516|NCT00262990|Antimitotic Agents|antimitotic agents|mesh-ancestor
101972517|NCT00262990|Mitosis Modulators|mitosis modulators|mesh-ancestor
101972518|NCT01110031|Ofatumumab|ofatumumab|mesh-list
101972519|NCT01110031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101709665|NCT00699894|Serotonin Agents|serotonin agents|mesh-ancestor
101972520|NCT02741596|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101972521|NCT02741596|Immunologic Factors|immunologic factors|mesh-ancestor
101972522|NCT02741596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972529|NCT01210339|Purinergic Agents|purinergic agents|mesh-ancestor
101972530|NCT01210339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101946080|NCT01157247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101946081|NCT01157247|Narcotics|narcotics|mesh-ancestor
101799209|NCT04073537|Paclitaxel|paclitaxel|mesh-list
101972531|NCT01210339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972532|NCT01210339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972533|NCT01210339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101972534|NCT01210339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101972535|NCT01210339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101692286|NCT03973177|Phenol|phenol|mesh-list
101972536|NCT01210339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101972537|NCT03684694|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
101972538|NCT03684694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101972539|NCT03684694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101972540|NCT03147248|Infliximab|infliximab|mesh-list
101972541|NCT03147248|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101972542|NCT03147248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101972543|NCT03147248|Dermatologic Agents|dermatologic agents|mesh-ancestor
101972544|NCT03147248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101972545|NCT03147248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101972546|NCT00250822|Gemcitabine|gemcitabine|mesh-list
101972547|NCT00250822|Oxaliplatin|oxaliplatin|mesh-list
101972548|NCT00250822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101972549|NCT00250822|Antimetabolites|antimetabolites|mesh-ancestor
101972550|NCT00250822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972551|NCT00250822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101972552|NCT00004096|Carboplatin|carboplatin|mesh-list
101972553|NCT00004096|Vinorelbine|vinorelbine|mesh-list
101972554|NCT00004096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101972555|NCT00004096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101972556|NCT00004096|Tubulin Modulators|tubulin modulators|mesh-ancestor
101972557|NCT00004096|Antimitotic Agents|antimitotic agents|mesh-ancestor
101972558|NCT00004096|Mitosis Modulators|mitosis modulators|mesh-ancestor
101972559|NCT00004096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972560|NCT00002224|Nelfinavir|nelfinavir|mesh-list
101972561|NCT00002224|Didanosine|didanosine|mesh-list
101972562|NCT00002224|Stavudine|stavudine|mesh-list
101972563|NCT00002224|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101972564|NCT00002224|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101972565|NCT00002224|Protease Inhibitors|protease inhibitors|mesh-ancestor
101972566|NCT00002224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101972567|NCT00002224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972568|NCT00002224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101972569|NCT00002224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101972570|NCT00002224|Antiviral Agents|antiviral agents|mesh-ancestor
101972571|NCT00002224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101972572|NCT00002224|Antimetabolites|antimetabolites|mesh-ancestor
101972573|NCT00002224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101972574|NCT00002224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101972575|NCT01207921|Lenalidomide|lenalidomide|mesh-list
101972576|NCT01207921|Immunologic Factors|immunologic factors|mesh-ancestor
101972577|NCT01207921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972578|NCT01207921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101972579|NCT01207921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101972580|NCT01207921|Growth Substances|growth substances|mesh-ancestor
101972581|NCT01207921|Growth Inhibitors|growth inhibitors|mesh-ancestor
101972582|NCT01207921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101972583|NCT01108393|Agomelatine|agomelatine|mesh-list
101972584|NCT01108393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101972585|NCT01108393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101972586|NCT01108393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972587|NCT01113229|Misoprostol|misoprostol|mesh-list
101972588|NCT01113229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101972589|NCT01113229|Abortifacient Agents|abortifacient agents|mesh-ancestor
101972590|NCT01113229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101427521|NCT00169845|Vitamin E|vitamin e|mesh-list
101972593|NCT01113229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101972594|NCT01113229|Oxytocics|oxytocics|mesh-ancestor
101972595|NCT03530176|Listerine|listerine|mesh-list
101972596|NCT03530176|Fluorides|fluorides|mesh-list
101972597|NCT03530176|Sodium Fluoride|sodium fluoride|mesh-list
101972598|NCT03530176|Cariostatic Agents|cariostatic agents|mesh-ancestor
101972599|NCT03530176|Protective Agents|protective agents|mesh-ancestor
101972600|NCT03530176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972601|NCT03530176|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101972602|NCT03530176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101946082|NCT01157247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101946083|NCT01157247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946084|NCT01157247|Analgesics|analgesics|mesh-ancestor
101972603|NCT03151304|Azacitidine|azacitidine|mesh-list
101972604|NCT03151304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101972605|NCT03151304|Antimetabolites|antimetabolites|mesh-ancestor
101972606|NCT03151304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972607|NCT03151304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101972608|NCT03151304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101972609|NCT03530020|Lithium Carbonate|lithium carbonate|mesh-list
101972610|NCT03530020|Antidepressive Agents|antidepressive agents|mesh-ancestor
101692355|NCT00601640|Eflornithine|eflornithine|mesh-list
101972611|NCT03530020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101972612|NCT03530020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101972613|NCT03530020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972614|NCT03530020|Antimanic Agents|antimanic agents|mesh-ancestor
101972615|NCT03530020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101972616|NCT03530020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101972617|NCT03530020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972618|NCT02288962|Cabergoline|cabergoline|mesh-list
101972619|NCT02288962|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101972620|NCT02288962|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101972621|NCT02288962|Dopamine Agonists|dopamine agonists|mesh-ancestor
101972622|NCT02288962|Dopamine Agents|dopamine agents|mesh-ancestor
101972623|NCT02288962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101972624|NCT02288962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972625|NCT02288962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972626|NCT03942991|Mepivacaine|mepivacaine|mesh-list
101972627|NCT03942991|Carticaine|carticaine|mesh-list
101972628|NCT03942991|Anesthetics, Local|anesthetics, local|mesh-ancestor
101972629|NCT03942991|Anesthetics|anesthetics|mesh-ancestor
101972630|NCT03942991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101972631|NCT03942991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972632|NCT03942991|Sensory System Agents|sensory system agents|mesh-ancestor
101972633|NCT03942991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101972634|NCT00162292|Methotrexate|methotrexate|mesh-list
101972635|NCT00162292|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101972636|NCT00162292|Abortifacient Agents|abortifacient agents|mesh-ancestor
101972637|NCT00162292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101972638|NCT00162292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972639|NCT00162292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101972640|NCT00162292|Antimetabolites|antimetabolites|mesh-ancestor
101972641|NCT00162292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972642|NCT00162292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101972643|NCT00162292|Dermatologic Agents|dermatologic agents|mesh-ancestor
101972644|NCT00162292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101972645|NCT00162292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101972646|NCT00162292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101972647|NCT00162292|Immunologic Factors|immunologic factors|mesh-ancestor
101972648|NCT00162292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101972649|NCT00162292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101972650|NCT00135382|Efavirenz|efavirenz|mesh-list
101972651|NCT00135382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101972652|NCT00135382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101972653|NCT00135382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101972654|NCT00135382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972655|NCT00135382|Antiviral Agents|antiviral agents|mesh-ancestor
101972656|NCT00135382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101972657|NCT00135382|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101972658|NCT00135382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101972659|NCT00135382|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101972660|NCT00135382|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101972661|NCT00135382|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101972664|NCT03531970|Dexamethasone acetate|dexamethasone acetate|mesh-list
101972666|NCT03531970|Epinephrine|epinephrine|mesh-list
101972667|NCT03531970|BB 1101|bb 1101|mesh-list
101972668|NCT03531970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101972669|NCT03531970|Antiemetics|antiemetics|mesh-ancestor
101972670|NCT03531970|Autonomic Agents|autonomic agents|mesh-ancestor
101972671|NCT03531970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101972672|NCT03531970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946085|NCT01157247|Sensory System Agents|sensory system agents|mesh-ancestor
101946086|NCT01157247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101946087|NCT01157247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101946088|NCT01157247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101972673|NCT03531970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101972674|NCT03531970|Glucocorticoids|glucocorticoids|mesh-ancestor
101972675|NCT03531970|Hormones|hormones|mesh-ancestor
101972676|NCT03531970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101972677|NCT03531970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101972678|NCT03531970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101972679|NCT03531970|Protease Inhibitors|protease inhibitors|mesh-ancestor
101972680|NCT03531970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101972681|NCT03531970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972682|NCT03531970|Anesthetics, Local|anesthetics, local|mesh-ancestor
101972683|NCT03531970|Anesthetics|anesthetics|mesh-ancestor
101972684|NCT03531970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101972685|NCT03531970|Sensory System Agents|sensory system agents|mesh-ancestor
101972686|NCT03531970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101972687|NCT03531970|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101972688|NCT03531970|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101972689|NCT03531970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101972690|NCT03531970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101972691|NCT03531970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101972692|NCT03531970|Adrenergic Agents|adrenergic agents|mesh-ancestor
101972693|NCT03531970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101972694|NCT03531970|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101972695|NCT03531970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101972696|NCT03531970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101972697|NCT03531970|Respiratory System Agents|respiratory system agents|mesh-ancestor
101972698|NCT03531970|Mydriatics|mydriatics|mesh-ancestor
101972699|NCT03531970|Sympathomimetics|sympathomimetics|mesh-ancestor
101972700|NCT03531970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101972701|NCT01211821|Metoprolol|metoprolol|mesh-list
101972702|NCT01211821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101972703|NCT01211821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101972704|NCT01211821|Sympatholytics|sympatholytics|mesh-ancestor
101972705|NCT01211821|Autonomic Agents|autonomic agents|mesh-ancestor
101972706|NCT01211821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101972707|NCT01211821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972708|NCT01211821|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101972709|NCT01211821|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101972710|NCT01211821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101972711|NCT01211821|Adrenergic Agents|adrenergic agents|mesh-ancestor
101972712|NCT01211821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101972713|NCT01211821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972714|NCT03527836|Lidocaine|lidocaine|mesh-list
101972715|NCT03527836|Bupivacaine|bupivacaine|mesh-list
101972716|NCT03527836|Anesthetics, Local|anesthetics, local|mesh-ancestor
101972717|NCT03527836|Anesthetics|anesthetics|mesh-ancestor
101972718|NCT03527836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101972719|NCT03527836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972720|NCT03527836|Sensory System Agents|sensory system agents|mesh-ancestor
101972721|NCT03527836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101972722|NCT03527836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101972723|NCT03527836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101972724|NCT03527836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101972725|NCT03527836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101972726|NCT03527836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972727|NCT05724862|Anesthetics|anesthetics|mesh-list
101972728|NCT05724862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101972729|NCT05724862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972730|NCT03940651|Anesthetics|anesthetics|mesh-list
101972731|NCT03940651|Anesthetics, General|anesthetics, general|mesh-list
101972732|NCT03940651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101972733|NCT03940651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972741|NCT01211275|Pemetrexed|pemetrexed|mesh-list
101972742|NCT01211275|Axitinib|axitinib|mesh-list
101972743|NCT01211275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101972744|NCT01211275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101946089|NCT01157247|Anesthetics, General|anesthetics, general|mesh-ancestor
101946091|NCT03881787|Antibodies|antibodies|mesh-list
101946092|NCT03881787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101946093|NCT03881787|Immunologic Factors|immunologic factors|mesh-ancestor
101972745|NCT01211275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972746|NCT01211275|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101972747|NCT01211275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101972748|NCT01211275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101972749|NCT03529084|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101972750|NCT03529084|Gefitinib|gefitinib|mesh-list
101972751|NCT03529084|Nazartinib|nazartinib|mesh-list
101972752|NCT03529084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101972753|NCT03529084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101972754|NCT03529084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101972755|NCT03529084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972756|NCT03942757|Bilirubin|bilirubin|mesh-list
101972757|NCT03942757|Antioxidants|antioxidants|mesh-ancestor
101972758|NCT03942757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692499|NCT00922532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101972760|NCT03942757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972761|NCT05724628|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101972762|NCT05724628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101972763|NCT01208701|Atorvastatin|atorvastatin|mesh-list
101972764|NCT01208701|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101972765|NCT01208701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101972766|NCT01208701|Antimetabolites|antimetabolites|mesh-ancestor
101972767|NCT01208701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972768|NCT01208701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101972769|NCT01208701|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101972770|NCT01208701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101972771|NCT03528772|Minoxidil|minoxidil|mesh-list
101972772|NCT03528772|Nitroglycerin|nitroglycerin|mesh-list
101972773|NCT03528772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101972774|NCT03528772|Vasodilator Agents|vasodilator agents|mesh-ancestor
101972775|NCT01316744|Ketamine|ketamine|mesh-list
101972776|NCT01316744|Analgesics|analgesics|mesh-ancestor
101972777|NCT01316744|Sensory System Agents|sensory system agents|mesh-ancestor
101972778|NCT01316744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101972779|NCT01316744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972780|NCT01316744|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101972781|NCT01316744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101972782|NCT01316744|Anesthetics, General|anesthetics, general|mesh-ancestor
101972783|NCT01316744|Anesthetics|anesthetics|mesh-ancestor
101972784|NCT01316744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101972785|NCT01316744|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101972786|NCT01316744|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101972787|NCT01316744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101972788|NCT01316744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972789|NCT01213381|Carboplatin|carboplatin|mesh-list
101972790|NCT01213381|Gemcitabine|gemcitabine|mesh-list
101972791|NCT01213381|Iniparib|iniparib|mesh-list
101972792|NCT01213381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101972793|NCT01213381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101972794|NCT01213381|Antimetabolites|antimetabolites|mesh-ancestor
101972795|NCT01213381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972796|NCT01213381|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101972797|NCT01213381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101972798|NCT01316978|Ibuprofen|ibuprofen|mesh-list
101972799|NCT01316978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101972800|NCT01316978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101972801|NCT01316978|Analgesics|analgesics|mesh-ancestor
101972811|NCT01317212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101972813|NCT05250752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101972814|NCT05250752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972815|NCT05250752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101972816|NCT05250752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972817|NCT01211509|Montelukast|montelukast|mesh-list
101972818|NCT01211509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101972819|NCT01211509|Respiratory System Agents|respiratory system agents|mesh-ancestor
101972820|NCT01211509|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101946094|NCT03881787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946095|NCT03881787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101946097|NCT01157481|Nifedipine|nifedipine|mesh-list
101972821|NCT01211509|Hormone Antagonists|hormone antagonists|mesh-ancestor
101972822|NCT01211509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101972823|NCT01211509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972824|NCT01211509|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101972825|NCT01211509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101972826|NCT01211509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972827|NCT05072600|Pembrolizumab|pembrolizumab|mesh-list
101972828|NCT05072600|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101972829|NCT05072600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101972830|NCT05072600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101972831|NCT05072600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972832|NCT04441528|Hyaluronic Acid|hyaluronic acid|mesh-list
101972833|NCT04441528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101972834|NCT04441528|Immunologic Factors|immunologic factors|mesh-ancestor
101972835|NCT04441528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972836|NCT04441528|Viscosupplements|viscosupplements|mesh-ancestor
101972837|NCT04441528|Protective Agents|protective agents|mesh-ancestor
101972838|NCT01344512|Ciprofloxacin|ciprofloxacin|mesh-list
101972839|NCT01344512|Ceftazidime|ceftazidime|mesh-list
101972840|NCT01344512|Voriconazole|voriconazole|mesh-list
101972841|NCT01344512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101972842|NCT01344512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101972843|NCT01344512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101972844|NCT01344512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101972845|NCT01344512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101972846|NCT01344512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972847|NCT01344512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101972848|NCT01344512|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101972849|NCT01344512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101972850|NCT01344512|Antifungal Agents|antifungal agents|mesh-ancestor
101972851|NCT01344512|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101972852|NCT01344512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101972853|NCT01344512|Hormone Antagonists|hormone antagonists|mesh-ancestor
101972854|NCT01344512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101972855|NCT01344512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972856|NCT01344512|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101972857|NCT05064488|Metformin|metformin|mesh-list
101972858|NCT05064488|Digoxin|digoxin|mesh-list
101972859|NCT05064488|Sumatriptan|sumatriptan|mesh-list
101972860|NCT05064488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101972861|NCT05064488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101972862|NCT05064488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972863|NCT05064488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101972871|NCT05064488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101972872|NCT05064488|Protective Agents|protective agents|mesh-ancestor
101972873|NCT05064488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101972874|NCT05064488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101972875|NCT05064488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101972876|NCT05064488|Serotonin Agents|serotonin agents|mesh-ancestor
101972877|NCT05064488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101972878|NCT01344590|Ethanol|ethanol|mesh-list
101972879|NCT01344590|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101972880|NCT01344590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101972881|NCT01344590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101972882|NCT01344590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972883|NCT01114087|Imatinib Mesylate|imatinib mesylate|mesh-list
101972884|NCT01114087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101972885|NCT01114087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101972886|NCT01114087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101972887|NCT01114087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972888|NCT01212133|Liraglutide|liraglutide|mesh-list
101972889|NCT01212133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101972890|NCT01212133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972891|NCT01212133|Incretins|incretins|mesh-ancestor
101972892|NCT01212133|Hormones|hormones|mesh-ancestor
101946098|NCT01157481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101946099|NCT01157481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101946100|NCT01157481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946101|NCT01157481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101799598|NCT02272049|Xenon|xenon|mesh-list
101972893|NCT01212133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101972894|NCT04269356|Magnesium Oxide|magnesium oxide|mesh-list
101972895|NCT04269356|Magnesium Hydroxide|magnesium hydroxide|mesh-list
101972896|NCT04269356|Antacids|antacids|mesh-ancestor
101972897|NCT04269356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972898|NCT04269356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101972902|NCT01118065|Everolimus|everolimus|mesh-list
101972903|NCT01118065|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101972904|NCT01118065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101972905|NCT01118065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101972906|NCT01118065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972907|NCT01118065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101972908|NCT01118065|Immunologic Factors|immunologic factors|mesh-ancestor
101972909|NCT01118065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972910|NCT01118065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101972911|NCT03528616|Propranolol|propranolol|mesh-list
101972912|NCT03528616|Digoxin|digoxin|mesh-list
101972913|NCT03528616|Adenosine|adenosine|mesh-list
101972914|NCT03528616|Amiodarone|amiodarone|mesh-list
101972915|NCT03528616|Flecainide|flecainide|mesh-list
101972916|NCT03528616|Procainamide|procainamide|mesh-list
101972917|NCT03528616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101972918|NCT03528616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101972919|NCT03528616|Adrenergic Agents|adrenergic agents|mesh-ancestor
101972920|NCT03528616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101972921|NCT03528616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972922|NCT03528616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972923|NCT03528616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101972924|NCT03528616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101972925|NCT03528616|Vasodilator Agents|vasodilator agents|mesh-ancestor
101972926|NCT03528616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101972927|NCT03528616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101972928|NCT03528616|Protective Agents|protective agents|mesh-ancestor
101972929|NCT03528616|Analgesics|analgesics|mesh-ancestor
101972930|NCT03528616|Sensory System Agents|sensory system agents|mesh-ancestor
101972931|NCT03528616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101972932|NCT03528616|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101972933|NCT03528616|Purinergic Agonists|purinergic agonists|mesh-ancestor
101427877|NCT02928601|Antipruritics|antipruritics|mesh-ancestor
101972942|NCT03528616|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101972943|NCT03528616|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101972944|NCT02529631|Orlistat|orlistat|mesh-list
101972945|NCT02529631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101972946|NCT02529631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972947|NCT02529631|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101972948|NCT02529631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101972949|NCT04469062|Mirikizumab|mirikizumab|mesh-list
101972950|NCT04469062|Vedolizumab|vedolizumab|mesh-list
101972951|NCT04469062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101972952|NCT04469062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101972953|NCT04469062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101972954|NCT04469062|Analgesics|analgesics|mesh-ancestor
101972955|NCT04469062|Sensory System Agents|sensory system agents|mesh-ancestor
101972956|NCT04469062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101972957|NCT04469062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972958|NCT04469062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101972959|NCT04469062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101709691|NCT00491179|Antiviral Agents|antiviral agents|mesh-ancestor
101972960|NCT04469062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101972961|NCT03528538|Fenugreek seed meal|fenugreek seed meal|mesh-list
101972962|NCT03528538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101972963|NCT03528538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972964|NCT03145766|Immunoglobulins|immunoglobulins|mesh-list
101972965|NCT03145766|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101972966|NCT03145766|Antibodies|antibodies|mesh-list
101972967|NCT03145766|Immunologic Factors|immunologic factors|mesh-ancestor
101946102|NCT01157481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946103|NCT01157481|Vasodilator Agents|vasodilator agents|mesh-ancestor
101946104|NCT01157481|Tocolytic Agents|tocolytic agents|mesh-ancestor
101946105|NCT01157481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101946106|NCT03894189|Theophylline|theophylline|mesh-list
101972968|NCT03145766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972970|NCT01115179|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101972971|NCT01115179|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101972972|NCT01115179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101972973|NCT01115179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972974|NCT01115179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101972975|NCT01115179|Anesthetics, General|anesthetics, general|mesh-ancestor
101972976|NCT01115179|Anesthetics|anesthetics|mesh-ancestor
101972977|NCT01115179|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101972978|NCT01115179|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101972979|NCT01115179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101972980|NCT04468438|Estrogens|estrogens|mesh-list
101972981|NCT04468438|Hormones|hormones|mesh-ancestor
101972982|NCT04468438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101972983|NCT04468438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972984|NCT04468282|Vigabatrin|vigabatrin|mesh-list
101972985|NCT04468282|Anticonvulsants|anticonvulsants|mesh-ancestor
101972986|NCT04468282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101972987|NCT04468282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972988|NCT04468282|GABA Agents|gaba agents|mesh-ancestor
101972989|NCT04468282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101972990|NCT04468282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972991|NCT01121731|Interferons|interferons|mesh-list
101972992|NCT01121731|Interferon alpha-2|interferon alpha-2|mesh-list
101972993|NCT01121731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101972994|NCT01121731|Antiviral Agents|antiviral agents|mesh-ancestor
101972995|NCT01121731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101972996|NCT01215799|Bafetinib|bafetinib|mesh-list
101972997|NCT01215799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101972998|NCT01215799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101427948|NCT02926885|Liver Extracts|liver extracts|mesh-list
101973006|NCT03527134|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101973007|NCT03527134|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101973008|NCT03527134|Antiviral Agents|antiviral agents|mesh-ancestor
101973009|NCT03527134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101973010|NCT03527134|Dopamine Agents|dopamine agents|mesh-ancestor
101973011|NCT03527134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101973012|NCT03527134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973013|NCT03527134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973014|NCT03527134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101973015|NCT03527134|Analgesics|analgesics|mesh-ancestor
101973016|NCT03527134|Sensory System Agents|sensory system agents|mesh-ancestor
101973017|NCT03527134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101973018|NCT01213693|Fluticasone|fluticasone|mesh-list
101973019|NCT01213693|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101973020|NCT01213693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101973021|NCT01213693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101973022|NCT01213693|Autonomic Agents|autonomic agents|mesh-ancestor
101973023|NCT01213693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101973024|NCT01213693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973025|NCT01213693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101973026|NCT01213693|Respiratory System Agents|respiratory system agents|mesh-ancestor
101973027|NCT01213693|Dermatologic Agents|dermatologic agents|mesh-ancestor
101973028|NCT01213693|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101973029|NCT01213693|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101973030|NCT01213693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101973031|NCT01213693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101973032|NCT01213693|Adrenergic Agents|adrenergic agents|mesh-ancestor
101973033|NCT01213693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101973034|NCT01213693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973035|NCT01213849|Fluticasone|fluticasone|mesh-list
101973036|NCT01213849|Xhance|xhance|mesh-list
101973037|NCT01213849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101973038|NCT01213849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101973039|NCT01213849|Autonomic Agents|autonomic agents|mesh-ancestor
101946107|NCT03894189|Doxapram|doxapram|mesh-list
101946108|NCT03894189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101946109|NCT03894189|Autonomic Agents|autonomic agents|mesh-ancestor
101946110|NCT03894189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101946111|NCT03894189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973040|NCT01213849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101973041|NCT01213849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973042|NCT01213849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101973043|NCT01213849|Respiratory System Agents|respiratory system agents|mesh-ancestor
101973044|NCT01213849|Dermatologic Agents|dermatologic agents|mesh-ancestor
101973045|NCT01213849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101973046|NCT01121809|Raltegravir Potassium|raltegravir potassium|mesh-list
101973047|NCT01121809|Etravirine|etravirine|mesh-list
101973048|NCT01121809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101973049|NCT01121809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101973050|NCT01121809|Antiviral Agents|antiviral agents|mesh-ancestor
101973051|NCT01121809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101973052|NCT01121809|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101973053|NCT01121809|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101973054|NCT01121809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101973055|NCT01121809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973056|NCT01121809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101973057|NCT01121809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101973059|NCT03937687|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101973060|NCT03937687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973061|NCT03937687|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101973062|NCT03937687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101973063|NCT03937687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973064|NCT03937687|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101973065|NCT03937687|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101973074|NCT05110144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101973075|NCT05110144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973076|NCT05110144|Analgesics|analgesics|mesh-ancestor
101973077|NCT05110144|Sensory System Agents|sensory system agents|mesh-ancestor
101973078|NCT05110144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101973079|NCT05110144|Antidepressive Agents|antidepressive agents|mesh-ancestor
101973080|NCT05110144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101973081|NCT05110144|Dopamine Agents|dopamine agents|mesh-ancestor
101973082|NCT05110144|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101973083|NCT05110144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101973084|NCT05110144|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101973085|NCT05110144|Adrenergic Agents|adrenergic agents|mesh-ancestor
101973086|NCT01212367|Interferons|interferons|mesh-list
101973087|NCT01212367|Interferon-alpha|interferon-alpha|mesh-list
101973088|NCT01212367|Interferon alpha-2|interferon alpha-2|mesh-list
101973089|NCT01212367|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
101973090|NCT01212367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101973091|NCT01212367|Antiviral Agents|antiviral agents|mesh-ancestor
101973092|NCT01212367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101973093|NCT01212367|Immunologic Factors|immunologic factors|mesh-ancestor
101973094|NCT01212367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973095|NCT01216111|Paclitaxel|paclitaxel|mesh-list
101973096|NCT01216111|Docetaxel|docetaxel|mesh-list
101973097|NCT01216111|Cyclophosphamide|cyclophosphamide|mesh-list
101973098|NCT01216111|Fluorouracil|fluorouracil|mesh-list
101973099|NCT01216111|Epirubicin|epirubicin|mesh-list
101973100|NCT01216111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101973101|NCT01216111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101973102|NCT01216111|Tubulin Modulators|tubulin modulators|mesh-ancestor
101973103|NCT01216111|Antimitotic Agents|antimitotic agents|mesh-ancestor
101973104|NCT01216111|Mitosis Modulators|mitosis modulators|mesh-ancestor
101973105|NCT01216111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973106|NCT01216111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101973107|NCT01216111|Immunologic Factors|immunologic factors|mesh-ancestor
101973108|NCT01216111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973109|NCT01216111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101973110|NCT01216111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101973111|NCT01216111|Alkylating Agents|alkylating agents|mesh-ancestor
101973112|NCT01216111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101973113|NCT01216111|Antimetabolites|antimetabolites|mesh-ancestor
101973114|NCT01216111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101946112|NCT03894189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101973115|NCT01216111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101973116|NCT01216111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101973117|NCT01216111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101973118|NCT01216111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101973119|NCT01216267|Lansoprazole|lansoprazole|mesh-list
101973120|NCT01216267|Dexlansoprazole|dexlansoprazole|mesh-list
101973121|NCT01216267|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101973122|NCT01216267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101973123|NCT01216267|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101973124|NCT01216267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101973125|NCT01216267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973126|NCT01216345|Gemcitabine|gemcitabine|mesh-list
101973127|NCT01216345|Oxaliplatin|oxaliplatin|mesh-list
101973128|NCT01216345|Cetuximab|cetuximab|mesh-list
101973129|NCT01216345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101973130|NCT01216345|Antimetabolites|antimetabolites|mesh-ancestor
101973131|NCT01216345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428082|NCT00170781|Analgesics|analgesics|mesh-ancestor
101973136|NCT01118533|Dermatologic Agents|dermatologic agents|mesh-ancestor
101973137|NCT01118611|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101973138|NCT01118611|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101973139|NCT01118611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973141|NCT01212523|Isoflurane|isoflurane|mesh-list
101973142|NCT01212523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101973143|NCT01212523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101973144|NCT01212523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973145|NCT01212523|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101973146|NCT01212523|Anesthetics, General|anesthetics, general|mesh-ancestor
101973147|NCT01212523|Anesthetics|anesthetics|mesh-ancestor
101973148|NCT01212523|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101973149|NCT01122121|Leuprolide|leuprolide|mesh-list
101973150|NCT01122121|Flutamide|flutamide|mesh-list
101973151|NCT01122121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101973152|NCT01122121|Fertility Agents|fertility agents|mesh-ancestor
101973153|NCT01122121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101973154|NCT01122121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973155|NCT01122121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101973156|NCT01122121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101973157|NCT01122121|Androgen Antagonists|androgen antagonists|mesh-ancestor
101973158|NCT01122121|Hormone Antagonists|hormone antagonists|mesh-ancestor
101973159|NCT01122121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101973160|NCT01115725|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101973161|NCT01115725|Hormones|hormones|mesh-ancestor
101973162|NCT01115725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101973163|NCT01115725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973164|NCT01122199|Everolimus|everolimus|mesh-list
101973165|NCT01122199|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101973166|NCT01122199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101973167|NCT01122199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101973168|NCT01122199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973169|NCT01122199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101973170|NCT01122199|Immunologic Factors|immunologic factors|mesh-ancestor
101973171|NCT01122199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973172|NCT01122199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101973173|NCT01118923|Magnesium Hydroxide|magnesium hydroxide|mesh-list
101973174|NCT01118923|Antacids|antacids|mesh-ancestor
101973175|NCT01118923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973176|NCT01118923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101973177|NCT01119079|Anesthetics|anesthetics|mesh-list
101973178|NCT01119079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101973179|NCT01119079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973180|NCT04503616|Cyclophosphamide|cyclophosphamide|mesh-list
101973181|NCT04503616|Abatacept|abatacept|mesh-list
101973182|NCT04503616|Tacrolimus|tacrolimus|mesh-list
101973183|NCT04503616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101973184|NCT04503616|Immunologic Factors|immunologic factors|mesh-ancestor
101973185|NCT04503616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973186|NCT04503616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101973187|NCT04503616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101973188|NCT04503616|Alkylating Agents|alkylating agents|mesh-ancestor
101973189|NCT04503616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946113|NCT03894189|Respiratory System Agents|respiratory system agents|mesh-ancestor
101946114|NCT03894189|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101946115|NCT03894189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101946116|NCT03894189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946117|NCT03894189|Vasodilator Agents|vasodilator agents|mesh-ancestor
101946118|NCT03894189|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101946119|NCT03894189|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101946120|NCT03894189|Purinergic Agents|purinergic agents|mesh-ancestor
101946121|NCT03894189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101946122|NCT03894189|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101946123|NCT03886311|Nivolumab|nivolumab|mesh-list
101946124|NCT03886311|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
101946125|NCT03886311|Trabectedin|trabectedin|mesh-list
101973190|NCT04503616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101973191|NCT04503616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101973192|NCT04503616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101973193|NCT04503616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101973194|NCT04503616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101973195|NCT04503616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101973196|NCT01119157|Vaccines|vaccines|mesh-list
101973197|NCT01119157|Immunologic Factors|immunologic factors|mesh-ancestor
101973198|NCT01119157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973199|NCT01120015|Diacerein|diacerein|mesh-list
101973200|NCT01120015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101973201|NCT01216579|Mannitol|mannitol|mesh-list
101973202|NCT01216579|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101973207|NCT03528070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101973208|NCT03528070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101973209|NCT03528070|Analgesics|analgesics|mesh-ancestor
101973210|NCT03528070|Sensory System Agents|sensory system agents|mesh-ancestor
101973211|NCT03528070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101973212|NCT03528070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973213|NCT03528070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101973214|NCT03528070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101973215|NCT03528070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101973216|NCT03528070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101973217|NCT03528070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973218|NCT03528070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101973219|NCT03528070|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101973220|NCT03528070|Histamine Antagonists|histamine antagonists|mesh-ancestor
101973221|NCT03528070|Histamine Agents|histamine agents|mesh-ancestor
101973222|NCT03528070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101973223|NCT03528070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101973224|NCT03528070|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101973225|NCT03935815|Ropivacaine|ropivacaine|mesh-list
101973226|NCT03935815|Anesthetics, Local|anesthetics, local|mesh-ancestor
101973227|NCT03935815|Anesthetics|anesthetics|mesh-ancestor
101973228|NCT03935815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101973229|NCT03935815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973230|NCT03935815|Sensory System Agents|sensory system agents|mesh-ancestor
101973231|NCT03935815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101973232|NCT01216657|Sunitinib|sunitinib|mesh-list
101973233|NCT01216657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101973234|NCT01216657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101973235|NCT01216657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101973236|NCT01216657|Growth Substances|growth substances|mesh-ancestor
101973237|NCT01216657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973238|NCT01216657|Growth Inhibitors|growth inhibitors|mesh-ancestor
101973239|NCT01216657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101973240|NCT01216657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101973241|NCT01216657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946126|NCT03886311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101946127|NCT03886311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101946128|NCT03886311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101973243|NCT04400188|Fluzoparib|fluzoparib|mesh-list
101973244|NCT04400188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101973245|NCT04400188|Alkylating Agents|alkylating agents|mesh-ancestor
101973246|NCT04400188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973247|NCT04400188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101973248|NCT04400188|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101973249|NCT04400188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101973250|NCT04163458|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101973251|NCT04163458|Menotropins|menotropins|mesh-list
101973252|NCT04163458|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101973253|NCT04163458|Fertility Agents|fertility agents|mesh-ancestor
101973254|NCT04163458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101973255|NCT04163458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973256|NCT01115959|Valproic Acid|valproic acid|mesh-list
101973257|NCT01115959|Anticonvulsants|anticonvulsants|mesh-ancestor
101973258|NCT01115959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101973259|NCT01115959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973260|NCT01115959|GABA Agents|gaba agents|mesh-ancestor
101973261|NCT01115959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101973262|NCT01115959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973263|NCT01115959|Antimanic Agents|antimanic agents|mesh-ancestor
101973264|NCT01115959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101973265|NCT01115959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101973266|NCT01115959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101973267|NCT03936907|Nabiximols|nabiximols|mesh-list
101973268|NCT03936907|Analgesics|analgesics|mesh-ancestor
101973269|NCT03936907|Sensory System Agents|sensory system agents|mesh-ancestor
101973270|NCT03936907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101973271|NCT03936907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973272|NCT01116115|Palmitic Acid|palmitic acid|mesh-list
101973273|NCT01116115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101973278|NCT01217203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101973279|NCT01217203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101973280|NCT01217203|Growth Substances|growth substances|mesh-ancestor
101973281|NCT01217203|Growth Inhibitors|growth inhibitors|mesh-ancestor
101973282|NCT01217203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101973283|NCT01120171|Cyclophosphamide|cyclophosphamide|mesh-list
101973284|NCT01120171|Doxorubicin|doxorubicin|mesh-list
101973285|NCT01120171|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101973286|NCT01120171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101973287|NCT01120171|Immunologic Factors|immunologic factors|mesh-ancestor
101973288|NCT01120171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973289|NCT01120171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101973290|NCT01120171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101973291|NCT01120171|Alkylating Agents|alkylating agents|mesh-ancestor
101973292|NCT01120171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973293|NCT01120171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101973294|NCT01120171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101973295|NCT01120171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101973296|NCT01120171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101973297|NCT01120171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101973298|NCT01120171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101973299|NCT01116193|Dexamethasone|dexamethasone|mesh-list
101973300|NCT01116193|Lenalidomide|lenalidomide|mesh-list
101973301|NCT01116193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101973302|NCT01116193|Antiemetics|antiemetics|mesh-ancestor
101973303|NCT01116193|Autonomic Agents|autonomic agents|mesh-ancestor
101973304|NCT01116193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101973305|NCT01116193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973306|NCT01116193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101973307|NCT01116193|Glucocorticoids|glucocorticoids|mesh-ancestor
101973308|NCT01116193|Hormones|hormones|mesh-ancestor
101973309|NCT01116193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101973310|NCT01116193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101973311|NCT01116193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101973312|NCT01116193|Immunologic Factors|immunologic factors|mesh-ancestor
101973313|NCT01116193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101973314|NCT01116193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101946129|NCT03886311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946130|NCT03886311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101946131|NCT03886311|Alkylating Agents|alkylating agents|mesh-ancestor
101973315|NCT01116193|Growth Substances|growth substances|mesh-ancestor
101973316|NCT01116193|Growth Inhibitors|growth inhibitors|mesh-ancestor
101973317|NCT01120327|Amlodipine|amlodipine|mesh-list
101973318|NCT01120327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101973319|NCT01120327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101973320|NCT01120327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101973321|NCT01120327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973322|NCT01120327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101973323|NCT01120327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973324|NCT01120327|Vasodilator Agents|vasodilator agents|mesh-ancestor
101973325|NCT01116271|Irinotecan|irinotecan|mesh-list
101973326|NCT01116271|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101973327|NCT01116271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101973328|NCT01116271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101973329|NCT01116271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973330|NCT01116271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101973331|NCT01217359|Interferons|interferons|mesh-list
101973332|NCT01217359|Interferon-alpha|interferon-alpha|mesh-list
101973333|NCT01217359|Interferon alpha-2|interferon alpha-2|mesh-list
101973334|NCT01217359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101973335|NCT01217359|Antiviral Agents|antiviral agents|mesh-ancestor
101973336|NCT01217359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101973337|NCT01217359|Immunologic Factors|immunologic factors|mesh-ancestor
101973338|NCT01217359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973339|NCT01212679|Mitogens|mitogens|mesh-list
101973340|NCT01212679|Mitosis Modulators|mitosis modulators|mesh-ancestor
101973341|NCT01212679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973342|NCT03193684|Empagliflozin|empagliflozin|mesh-list
101628280|NCT00720499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973345|NCT03193684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101973346|NCT03193684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973347|NCT01217671|Protease Inhibitors|protease inhibitors|mesh-list
101973348|NCT01217671|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
101973349|NCT01217671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101973350|NCT01217671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973351|NCT01217671|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101973352|NCT01217671|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101973353|NCT01116583|Gabapentin|gabapentin|mesh-list
101973354|NCT01116583|Analgesics|analgesics|mesh-ancestor
101973355|NCT01116583|Sensory System Agents|sensory system agents|mesh-ancestor
101973356|NCT01116583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101973357|NCT01116583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973359|NCT01116583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101973360|NCT01116583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101973361|NCT01116583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101973362|NCT01116583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101973363|NCT01116583|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101973364|NCT01116583|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101973365|NCT01116583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101973366|NCT01116583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973367|NCT01116583|Antimanic Agents|antimanic agents|mesh-ancestor
101973368|NCT03935347|Vidarabine|vidarabine|mesh-list
101973369|NCT03935347|Aldesleukin|aldesleukin|mesh-list
101973370|NCT03935347|Cyclophosphamide|cyclophosphamide|mesh-list
101973371|NCT03935347|Pembrolizumab|pembrolizumab|mesh-list
101973372|NCT03935347|Fludarabine|fludarabine|mesh-list
101973373|NCT03935347|Fludarabine phosphate|fludarabine phosphate|mesh-list
101973374|NCT03935347|Interleukin-2|interleukin-2|mesh-list
101973375|NCT03935347|Immunoglobulins|immunoglobulins|mesh-list
101973376|NCT03935347|Immunoglobulin G|immunoglobulin g|mesh-list
101973377|NCT03935347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101973378|NCT03935347|Immunologic Factors|immunologic factors|mesh-ancestor
101973379|NCT03935347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973380|NCT03935347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101973381|NCT03935347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101973382|NCT03935347|Alkylating Agents|alkylating agents|mesh-ancestor
101973383|NCT03935347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973384|NCT03935347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101946132|NCT01155453|Trametinib|trametinib|mesh-list
101946133|NCT01155453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101946134|NCT01155453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101946135|NCT01155453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101973385|NCT03935347|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101973386|NCT03935347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101973387|NCT03935347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101973388|NCT03935347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101973389|NCT03935347|Antimetabolites|antimetabolites|mesh-ancestor
101973390|NCT03935347|Antiviral Agents|antiviral agents|mesh-ancestor
101973391|NCT03935347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101973392|NCT03935347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101973393|NCT03935347|Analgesics|analgesics|mesh-ancestor
101973394|NCT03935347|Sensory System Agents|sensory system agents|mesh-ancestor
101973395|NCT03935347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101973396|NCT03935347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101973397|NCT03935347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101973398|NCT04467346|Temozolomide|temozolomide|mesh-list
101973399|NCT04467346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101973400|NCT04467346|Alkylating Agents|alkylating agents|mesh-ancestor
101973401|NCT04467346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973402|NCT04467346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101973403|NCT03939871|Vinorelbine|vinorelbine|mesh-list
101973404|NCT03939871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101973405|NCT03939871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101973406|NCT03939871|Tubulin Modulators|tubulin modulators|mesh-ancestor
101973407|NCT03939871|Antimitotic Agents|antimitotic agents|mesh-ancestor
101973408|NCT03939871|Mitosis Modulators|mitosis modulators|mesh-ancestor
101973409|NCT03939871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973410|NCT01122667|Anacetrapib|anacetrapib|mesh-list
101973411|NCT01122667|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101973412|NCT01122667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101973413|NCT01122667|Antimetabolites|antimetabolites|mesh-ancestor
101973414|NCT01122667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428351|NCT05785234|Narcotics|narcotics|mesh-ancestor
101973422|NCT01120561|Immunologic Factors|immunologic factors|mesh-ancestor
101973423|NCT01120561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973424|NCT01120561|Tubulin Modulators|tubulin modulators|mesh-ancestor
101973425|NCT01120561|Antimitotic Agents|antimitotic agents|mesh-ancestor
101973426|NCT01120561|Mitosis Modulators|mitosis modulators|mesh-ancestor
101973427|NCT01120561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973428|NCT01217125|Sirolimus|sirolimus|mesh-list
101973429|NCT01217125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101973431|NCT01217125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101973432|NCT01217125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101973433|NCT01217125|Antifungal Agents|antifungal agents|mesh-ancestor
101973434|NCT01217125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101973435|NCT01217125|Immunologic Factors|immunologic factors|mesh-ancestor
101973436|NCT01217125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973437|NCT03936517|Prednisolone|prednisolone|mesh-list
101973438|NCT03936517|Hydrocortisone|hydrocortisone|mesh-list
101973439|NCT03936517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101973440|NCT03936517|Glucocorticoids|glucocorticoids|mesh-ancestor
101973441|NCT03936517|Hormones|hormones|mesh-ancestor
101973442|NCT03936517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101973443|NCT03936517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709737|NCT00503581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101973444|NCT03936517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101973445|NCT03936517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101973446|NCT03635372|Sucralfate|sucralfate|mesh-list
101973447|NCT03635372|Hydrotalcite|hydrotalcite|mesh-list
101973448|NCT03635372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101973449|NCT03635372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101973450|NCT03635372|Antacids|antacids|mesh-ancestor
101973451|NCT03635372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973452|NCT01116817|Ritonavir|ritonavir|mesh-list
101973453|NCT01116817|Lopinavir|lopinavir|mesh-list
101973454|NCT01116817|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101973455|NCT01116817|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101973456|NCT01116817|Protease Inhibitors|protease inhibitors|mesh-ancestor
101973457|NCT01116817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101973458|NCT01116817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973459|NCT01116817|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101946136|NCT01155453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946137|NCT03886233|Immunosuppressive Agents|immunosuppressive agents|mesh-list
101946138|NCT03886233|Immunologic Factors|immunologic factors|mesh-ancestor
101946139|NCT03886233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973460|NCT01116817|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101973461|NCT01116817|Antiviral Agents|antiviral agents|mesh-ancestor
101973462|NCT01116817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101973463|NCT01116817|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101973464|NCT01116817|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101973465|NCT01120795|Interferons|interferons|mesh-list
101973466|NCT01120795|Ribavirin|ribavirin|mesh-list
101973467|NCT01120795|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101973468|NCT01120795|Interferon-alpha|interferon-alpha|mesh-list
101973469|NCT01120795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101973470|NCT01120795|Antiviral Agents|antiviral agents|mesh-ancestor
101973471|NCT01120795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101973472|NCT01120795|Antimetabolites|antimetabolites|mesh-ancestor
101973473|NCT01120795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973474|NCT01120795|Immunologic Factors|immunologic factors|mesh-ancestor
101973475|NCT01120795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973476|NCT04467892|Methylprednisolone|methylprednisolone|mesh-list
101973477|NCT04467892|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101973478|NCT04467892|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101973479|NCT04467892|Prednisolone|prednisolone|mesh-list
101973480|NCT04467892|Prednisolone acetate|prednisolone acetate|mesh-list
101973481|NCT04467892|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101973482|NCT04467892|Prednisolone phosphate|prednisolone phosphate|mesh-list
101973483|NCT04467892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101973484|NCT04467892|Antiemetics|antiemetics|mesh-ancestor
101973485|NCT04467892|Autonomic Agents|autonomic agents|mesh-ancestor
101428423|NCT05782712|Adenosine|adenosine|mesh-list
101973489|NCT04467892|Glucocorticoids|glucocorticoids|mesh-ancestor
101973491|NCT04467892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101973492|NCT04467892|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101973493|NCT04467892|Protective Agents|protective agents|mesh-ancestor
101973494|NCT04467892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101973495|NCT04467892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101973496|NCT01122979|Insulin|insulin|mesh-list
101973497|NCT01122979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101973498|NCT01122979|Insulin Glargine|insulin glargine|mesh-list
101973499|NCT01122979|Insulin glulisine|insulin glulisine|mesh-list
101973500|NCT01122979|Insulin, Isophane|insulin, isophane|mesh-list
101973501|NCT01122979|Isophane Insulin, Human|isophane insulin, human|mesh-list
101973502|NCT01122979|Isophane insulin, beef|isophane insulin, beef|mesh-list
101973503|NCT01122979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101973504|NCT01122979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973505|NCT04179110|Pembrolizumab|pembrolizumab|mesh-list
101973506|NCT04179110|Ramucirumab|ramucirumab|mesh-list
101973507|NCT04179110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101973508|NCT04179110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101973509|NCT04179110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101973510|NCT04179110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973511|NCT01123057|Riboflavin|riboflavin|mesh-list
101973512|NCT01123057|Vitamin B Complex|vitamin b complex|mesh-ancestor
101973513|NCT01123057|Vitamins|vitamins|mesh-ancestor
101973514|NCT01123057|Micronutrients|micronutrients|mesh-ancestor
101973515|NCT01123057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973516|NCT01123057|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101973517|NCT01123057|Dermatologic Agents|dermatologic agents|mesh-ancestor
101973518|NCT03524950|Dexmedetomidine|dexmedetomidine|mesh-list
101973519|NCT03524950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101973520|NCT03524950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101973521|NCT03524950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973522|NCT03524950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101973523|NCT03524950|Analgesics|analgesics|mesh-ancestor
101973524|NCT03524950|Sensory System Agents|sensory system agents|mesh-ancestor
101973525|NCT03524950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101973526|NCT03524950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101973527|NCT03524950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101973528|NCT03524950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101973529|NCT03524950|Adrenergic Agents|adrenergic agents|mesh-ancestor
101973530|NCT03524950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101946140|NCT03885219|Paclitaxel|paclitaxel|mesh-list
101946141|NCT03885219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101665967|NCT02762838|Hematinics|hematinics|mesh-ancestor
101946142|NCT03885219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101973531|NCT03524950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973532|NCT04714190|Paclitaxel|paclitaxel|mesh-list
101973533|NCT04714190|Irinotecan|irinotecan|mesh-list
101973534|NCT04714190|Apatinib|apatinib|mesh-list
101973535|NCT04714190|Trastuzumab|trastuzumab|mesh-list
101973536|NCT04714190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101973537|NCT04714190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101973538|NCT04714190|Tubulin Modulators|tubulin modulators|mesh-ancestor
101973539|NCT04714190|Antimitotic Agents|antimitotic agents|mesh-ancestor
101973540|NCT04714190|Mitosis Modulators|mitosis modulators|mesh-ancestor
101973541|NCT04714190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973542|NCT04714190|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101973543|NCT04714190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101973544|NCT04714190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101973545|NCT04714190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101973546|NCT04714190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101973547|NCT03524872|Analgesics|analgesics|mesh-list
101973548|NCT03524872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973549|NCT03524872|Sensory System Agents|sensory system agents|mesh-ancestor
101973550|NCT03524872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101973551|NCT04143724|Luspatercept|luspatercept|mesh-list
101973552|NCT04143724|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
101973553|NCT04143724|Hematinics|hematinics|mesh-ancestor
101973554|NCT04143724|Immunologic Factors|immunologic factors|mesh-ancestor
101973555|NCT04143724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973556|NCT01345370|Temozolomide|temozolomide|mesh-list
101973557|NCT01345370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101973560|NCT01345370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101973561|NCT04702802|Hyaluronic Acid|hyaluronic acid|mesh-list
101973562|NCT04702802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101973563|NCT04702802|Immunologic Factors|immunologic factors|mesh-ancestor
101973564|NCT04702802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973565|NCT04702802|Viscosupplements|viscosupplements|mesh-ancestor
101973566|NCT04702802|Protective Agents|protective agents|mesh-ancestor
101973567|NCT01214941|Itraconazole|itraconazole|mesh-list
101973568|NCT01214941|Ticlopidine|ticlopidine|mesh-list
101973569|NCT01214941|Antifungal Agents|antifungal agents|mesh-ancestor
101973570|NCT01214941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101973571|NCT01214941|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101973572|NCT01214941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101973573|NCT01214941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101973574|NCT01214941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973575|NCT01214941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101973576|NCT01214941|Hormone Antagonists|hormone antagonists|mesh-ancestor
101973577|NCT01214941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101973578|NCT01214941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973579|NCT01214941|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101693326|NCT00546481|Epoetin Alfa|epoetin alfa|mesh-list
101973580|NCT01214941|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101973581|NCT01214941|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101973582|NCT01214941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101973583|NCT01214941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101973584|NCT01214941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101973585|NCT01214941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101973586|NCT01214941|Purinergic Agents|purinergic agents|mesh-ancestor
101973587|NCT01214941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101973588|NCT01214941|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101973589|NCT05301634|Bupivacaine|bupivacaine|mesh-list
101973590|NCT05301634|Anesthetics, Local|anesthetics, local|mesh-ancestor
101973591|NCT05301634|Anesthetics|anesthetics|mesh-ancestor
101973592|NCT05301634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101973593|NCT05301634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973594|NCT05301634|Sensory System Agents|sensory system agents|mesh-ancestor
101973595|NCT05301634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101973596|NCT01328821|Pentoxifylline|pentoxifylline|mesh-list
101973597|NCT01328821|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101973598|NCT01328821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101946143|NCT03885219|Tubulin Modulators|tubulin modulators|mesh-ancestor
101946144|NCT03885219|Antimitotic Agents|antimitotic agents|mesh-ancestor
101946145|NCT03885219|Mitosis Modulators|mitosis modulators|mesh-ancestor
101946146|NCT03885219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800269|NCT00956436|Hematinics|hematinics|mesh-ancestor
101973599|NCT01328821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973600|NCT01328821|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101973601|NCT01328821|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101973602|NCT01328821|Protective Agents|protective agents|mesh-ancestor
101973603|NCT01328821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973604|NCT01328821|Vasodilator Agents|vasodilator agents|mesh-ancestor
101973605|NCT01328821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101973606|NCT01328821|Antioxidants|antioxidants|mesh-ancestor
101973607|NCT01345448|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101973608|NCT01345448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101973609|NCT01345448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101973610|NCT01345448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101973611|NCT01345448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101973612|NCT01345448|Adrenergic Agents|adrenergic agents|mesh-ancestor
101973613|NCT01345448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101973614|NCT01345448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973615|NCT01345448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973616|NCT04001894|Clopidogrel|clopidogrel|mesh-list
101973617|NCT04001894|Ticagrelor|ticagrelor|mesh-list
101973618|NCT04001894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101973619|NCT04001894|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101973620|NCT04001894|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101973621|NCT04001894|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101973622|NCT04001894|Purinergic Agents|purinergic agents|mesh-ancestor
101973623|NCT04001894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101973624|NCT04001894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973625|NCT04001894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973626|NCT04066114|Mycophenolic Acid|mycophenolic acid|mesh-list
101973631|NCT04066114|Abatacept|abatacept|mesh-list
101973632|NCT04066114|Thymoglobulin|thymoglobulin|mesh-list
101973633|NCT04066114|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101973634|NCT04066114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101973635|NCT04066114|Glucocorticoids|glucocorticoids|mesh-ancestor
101973636|NCT04066114|Hormones|hormones|mesh-ancestor
101973637|NCT04066114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101973638|NCT04066114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973639|NCT04066114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101973640|NCT04066114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101973641|NCT04066114|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101973642|NCT04066114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101973643|NCT04066114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101973644|NCT04066114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973645|NCT04066114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101973646|NCT04066114|Immunologic Factors|immunologic factors|mesh-ancestor
101973647|NCT04066114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101973648|NCT04066114|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101973649|NCT04066114|Antitubercular Agents|antitubercular agents|mesh-ancestor
101973650|NCT04066114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101973651|NCT04066114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101973652|NCT04066114|Antiemetics|antiemetics|mesh-ancestor
101973653|NCT04066114|Autonomic Agents|autonomic agents|mesh-ancestor
101973654|NCT04066114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101973655|NCT04066114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101973656|NCT04066114|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101973657|NCT04066114|Protective Agents|protective agents|mesh-ancestor
101973658|NCT04066114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101973659|NCT04066114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101973660|NCT04066114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101973661|NCT01212913|Insulin|insulin|mesh-list
101973662|NCT01212913|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101973663|NCT01212913|Insulin Glargine|insulin glargine|mesh-list
101973664|NCT01212913|Insulin Aspart|insulin aspart|mesh-list
101973665|NCT01212913|Insulin glulisine|insulin glulisine|mesh-list
101973666|NCT01212913|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101946148|NCT01157559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101946149|NCT01157559|Serotonin Agents|serotonin agents|mesh-ancestor
101800332|NCT03944044|Antipyretics|antipyretics|mesh-ancestor
101973667|NCT01212913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101973668|NCT01212913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973669|NCT01345604|Ropivacaine|ropivacaine|mesh-list
101973670|NCT01345604|Anesthetics, Local|anesthetics, local|mesh-ancestor
101973671|NCT01345604|Anesthetics|anesthetics|mesh-ancestor
101973672|NCT01345604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101973673|NCT01345604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973674|NCT01345604|Sensory System Agents|sensory system agents|mesh-ancestor
101973675|NCT01345604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101973677|NCT01218217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101973678|NCT01218217|Antitubercular Agents|antitubercular agents|mesh-ancestor
101973679|NCT01218217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101973680|NCT01218217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101973681|NCT01218217|Leprostatic Agents|leprostatic agents|mesh-ancestor
101973682|NCT01218217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101973683|NCT01218217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101973684|NCT01218217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973685|NCT01218217|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101973686|NCT01218217|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101973687|NCT01218217|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101973688|NCT01218217|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101973689|NCT01218217|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101973690|NCT01218217|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101973691|NCT03522532|Zinc|zinc|mesh-list
101973692|NCT03522532|Trace Elements|trace elements|mesh-ancestor
101973693|NCT03522532|Micronutrients|micronutrients|mesh-ancestor
101973694|NCT03522532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973695|NCT01215019|Mannitol|mannitol|mesh-list
101973696|NCT01215019|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101973697|NCT01215019|Diuretics|diuretics|mesh-ancestor
101973698|NCT01215019|Natriuretic Agents|natriuretic agents|mesh-ancestor
101973710|NCT03526276|Protective Agents|protective agents|mesh-ancestor
101973711|NCT03526276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973712|NCT04466254|Cetuximab|cetuximab|mesh-list
101973713|NCT04466254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101973714|NCT04466254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101973715|NCT04466176|Fluticasone|fluticasone|mesh-list
101973717|NCT04466176|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101973718|NCT04466176|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101973719|NCT04466176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101973720|NCT04466176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101973721|NCT04466176|Autonomic Agents|autonomic agents|mesh-ancestor
101973722|NCT04466176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101973723|NCT04466176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973724|NCT04466176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101973725|NCT04466176|Respiratory System Agents|respiratory system agents|mesh-ancestor
101973726|NCT04466176|Dermatologic Agents|dermatologic agents|mesh-ancestor
101973727|NCT04466176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101973728|NCT04466176|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101973729|NCT04466176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101973730|NCT04466176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101973731|NCT04466176|Adrenergic Agents|adrenergic agents|mesh-ancestor
101973732|NCT04466176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101973733|NCT04466176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973734|NCT04466176|Glucocorticoids|glucocorticoids|mesh-ancestor
101973735|NCT04466176|Hormones|hormones|mesh-ancestor
101973736|NCT04466176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101973737|NCT04466176|Sympathomimetics|sympathomimetics|mesh-ancestor
101973738|NCT01215409|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101973739|NCT01215409|Vasodilator Agents|vasodilator agents|mesh-ancestor
101973740|NCT01215409|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101973741|NCT01215409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101973742|NCT01215409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101973743|NCT01215409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973744|NCT01215409|Urological Agents|urological agents|mesh-ancestor
101973745|NCT03936205|Dexmedetomidine|dexmedetomidine|mesh-list
101973746|NCT03936205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101973747|NCT03936205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101946150|NCT01157559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101946151|NCT01157559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946152|NCT01157559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946154|NCT01157559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101800405|NCT00168805|Enoxaparin|enoxaparin|mesh-list
101973748|NCT03936205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973749|NCT03936205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101973750|NCT03936205|Analgesics|analgesics|mesh-ancestor
101973751|NCT03936205|Sensory System Agents|sensory system agents|mesh-ancestor
101973752|NCT03936205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101973753|NCT03936205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101973754|NCT03936205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101973755|NCT03936205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101973756|NCT03936205|Adrenergic Agents|adrenergic agents|mesh-ancestor
101973757|NCT03936205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101973758|NCT03936205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973759|NCT04674020|Erenumab|erenumab|mesh-list
101973760|NCT04674020|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
101973761|NCT04674020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973762|NCT04674020|Analgesics|analgesics|mesh-ancestor
101973766|NCT01123525|Adenosine|adenosine|mesh-list
101973767|NCT01123525|Analgesics|analgesics|mesh-ancestor
101973768|NCT01123525|Sensory System Agents|sensory system agents|mesh-ancestor
101973769|NCT01123525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101973770|NCT01123525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973771|NCT01123525|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101973772|NCT01123525|Vasodilator Agents|vasodilator agents|mesh-ancestor
101973773|NCT01123525|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101973774|NCT01123525|Purinergic Agonists|purinergic agonists|mesh-ancestor
101973775|NCT01123525|Purinergic Agents|purinergic agents|mesh-ancestor
101973776|NCT01123525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101709771|NCT00677300|Emtricitabine|emtricitabine|mesh-list
101973777|NCT01123525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973778|NCT01215565|Sunitinib|sunitinib|mesh-list
101973779|NCT01215565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101973780|NCT01215565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101973781|NCT01215565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101973782|NCT01215565|Growth Substances|growth substances|mesh-ancestor
101973783|NCT01215565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973784|NCT01215565|Growth Inhibitors|growth inhibitors|mesh-ancestor
101973785|NCT01215565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101973786|NCT01215565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101973787|NCT01215565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973788|NCT01121497|Physostigmine|physostigmine|mesh-list
101973789|NCT01121497|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101973790|NCT01121497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101973791|NCT01121497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973792|NCT01121497|Cholinergic Agents|cholinergic agents|mesh-ancestor
101973793|NCT01121497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101973794|NCT01121497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973795|NCT01121497|Miotics|miotics|mesh-ancestor
101973796|NCT01121497|Autonomic Agents|autonomic agents|mesh-ancestor
101973797|NCT01121497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101973798|NCT01213147|Clomiphene|clomiphene|mesh-list
101973799|NCT01213147|Enclomiphene|enclomiphene|mesh-list
101973800|NCT01213147|Zuclomiphene|zuclomiphene|mesh-list
101973801|NCT01213147|Buserelin|buserelin|mesh-list
101973802|NCT01213147|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101973803|NCT01213147|Hormone Antagonists|hormone antagonists|mesh-ancestor
101973804|NCT01213147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101973805|NCT01213147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973806|NCT01213147|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101973807|NCT01213147|Fertility Agents|fertility agents|mesh-ancestor
101973808|NCT01213147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101973809|NCT01213147|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101973810|NCT01213147|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101973811|NCT03143816|Insulin|insulin|mesh-list
101973812|NCT03143816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101946155|NCT01157559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101946156|NCT01157559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101946157|NCT01157559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101973813|NCT03143816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973814|NCT01117129|Rituximab|rituximab|mesh-list
101973815|NCT01117129|Methotrexate|methotrexate|mesh-list
101973816|NCT01117129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101973817|NCT01117129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101973818|NCT01117129|Immunologic Factors|immunologic factors|mesh-ancestor
101973819|NCT01117129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973820|NCT01117129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101973821|NCT01117129|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101973822|NCT01117129|Abortifacient Agents|abortifacient agents|mesh-ancestor
101973823|NCT01117129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101973824|NCT01117129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101973825|NCT01117129|Antimetabolites|antimetabolites|mesh-ancestor
101973826|NCT01117129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973827|NCT01117129|Dermatologic Agents|dermatologic agents|mesh-ancestor
101973828|NCT01117129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101973829|NCT01117129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101973830|NCT01117129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101973831|NCT01117129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101973832|NCT03133988|Margetuximab|margetuximab|mesh-list
101973833|NCT03133988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101973841|NCT03934411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101973842|NCT01218451|Vaccines|vaccines|mesh-list
101973843|NCT01218451|Immunologic Factors|immunologic factors|mesh-ancestor
101973844|NCT01218451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973845|NCT01346930|Macitentan|macitentan|mesh-list
101973846|NCT01346930|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101973847|NCT01346930|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101709789|NCT02628392|Firuglipel|firuglipel|mesh-list
101973848|NCT01346930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973849|NCT01346930|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
101973850|NCT01219153|Letrozole|letrozole|mesh-list
101973851|NCT01219153|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
101973852|NCT01219153|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101973853|NCT01219153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101973854|NCT01219153|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101973855|NCT01219153|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101973856|NCT01219153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101973857|NCT01219153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973858|NCT01219153|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101973859|NCT01219153|Hormone Antagonists|hormone antagonists|mesh-ancestor
101973860|NCT01219153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101973861|NCT01219153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973862|NCT01219153|Hormones|hormones|mesh-ancestor
101973863|NCT03526042|Losartan|losartan|mesh-list
101973864|NCT03526042|Enalapril|enalapril|mesh-list
101973865|NCT03526042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
101973866|NCT03526042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101973867|NCT03526042|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101973868|NCT03526042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101973869|NCT03526042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101973870|NCT03526042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101973871|NCT03526042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973872|NCT03526042|Protease Inhibitors|protease inhibitors|mesh-ancestor
101973873|NCT01124539|Camptothecin|camptothecin|mesh-list
101973874|NCT01124539|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
101973875|NCT01124539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101973876|NCT01124539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101973877|NCT01124539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101973878|NCT01124539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101973879|NCT01124539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101973880|NCT01124539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973882|NCT03781375|Methotrexate|methotrexate|mesh-list
101973883|NCT03781375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101973884|NCT03781375|Abortifacient Agents|abortifacient agents|mesh-ancestor
101973885|NCT03781375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101946159|NCT01263951|Everolimus|everolimus|mesh-list
101946160|NCT01263951|Sorafenib|sorafenib|mesh-list
101946161|NCT01263951|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101973886|NCT03781375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973887|NCT03781375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101973888|NCT03781375|Antimetabolites|antimetabolites|mesh-ancestor
101973889|NCT03781375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973890|NCT03781375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101973891|NCT03781375|Dermatologic Agents|dermatologic agents|mesh-ancestor
101973892|NCT03781375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101973893|NCT03781375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101973894|NCT03781375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101973895|NCT03781375|Immunologic Factors|immunologic factors|mesh-ancestor
101973896|NCT03781375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101973897|NCT03781375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101973898|NCT03781375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101428845|NCT04532918|Leprostatic Agents|leprostatic agents|mesh-ancestor
101973916|NCT01218529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973918|NCT03938467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101973919|NCT01218607|Bosentan|bosentan|mesh-list
101973920|NCT01218607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101973921|NCT01218607|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101973922|NCT01218607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973923|NCT03933787|Saxagliptin|saxagliptin|mesh-list
101973924|NCT03933787|Incretins|incretins|mesh-ancestor
101973925|NCT03933787|Hormones|hormones|mesh-ancestor
101973926|NCT03933787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101973927|NCT03933787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973928|NCT03933787|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101973929|NCT03933787|Protease Inhibitors|protease inhibitors|mesh-ancestor
101973930|NCT03933787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101973931|NCT03933787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973932|NCT03933787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101973933|NCT03934333|Budesonide|budesonide|mesh-list
101973934|NCT03934333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101973935|NCT03934333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101973936|NCT03934333|Autonomic Agents|autonomic agents|mesh-ancestor
101973937|NCT03934333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101973938|NCT03934333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973939|NCT03934333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101973940|NCT03934333|Respiratory System Agents|respiratory system agents|mesh-ancestor
101973941|NCT03934333|Glucocorticoids|glucocorticoids|mesh-ancestor
101973942|NCT03934333|Hormones|hormones|mesh-ancestor
101973943|NCT03934333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101973944|NCT01124227|Icodextrin|icodextrin|mesh-list
101973945|NCT01124227|Dialysis Solutions|dialysis solutions|mesh-ancestor
101973946|NCT01124227|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101973947|NCT03931915|Leuprolide|leuprolide|mesh-list
101973948|NCT03931915|Relugolix|relugolix|mesh-list
101693703|NCT00960349|Cisplatin|cisplatin|mesh-list
101973949|NCT03931915|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101973950|NCT03931915|Fertility Agents|fertility agents|mesh-ancestor
101973951|NCT03931915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101973952|NCT03931915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973953|NCT03931915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101973954|NCT03931915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101973969|NCT01124383|Rocuronium|rocuronium|mesh-list
101973970|NCT01124383|Anesthetics, Local|anesthetics, local|mesh-ancestor
101973971|NCT01124383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101973972|NCT01124383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973973|NCT01124383|Sensory System Agents|sensory system agents|mesh-ancestor
101973974|NCT01124383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101973975|NCT01124383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101973976|NCT01124383|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101973977|NCT01124383|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101973978|NCT01124383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101973979|NCT01124383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973980|NCT01124383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101973981|NCT01124383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101973982|NCT01124383|Anesthetics, General|anesthetics, general|mesh-ancestor
101946162|NCT01263951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101946163|NCT01263951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101946164|NCT01263951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973983|NCT01124383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101973984|NCT01124383|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101973985|NCT01124383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101973986|NCT01124383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101973987|NCT01124383|GABA Modulators|gaba modulators|mesh-ancestor
101973988|NCT01124383|GABA Agents|gaba agents|mesh-ancestor
101973989|NCT01124383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101973990|NCT01124383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101973991|NCT01124383|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101973992|NCT01124383|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101973993|NCT01124383|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101973994|NCT01124383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101973995|NCT01124383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101973996|NCT01124383|Narcotics|narcotics|mesh-ancestor
101973997|NCT01124383|Analgesics|analgesics|mesh-ancestor
101973998|NCT01124383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101973999|NCT01124383|Sympathomimetics|sympathomimetics|mesh-ancestor
101974000|NCT01124383|Autonomic Agents|autonomic agents|mesh-ancestor
101974001|NCT01124383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101974002|NCT01124383|Adrenergic Agents|adrenergic agents|mesh-ancestor
101974003|NCT01226017|Oxytocin|oxytocin|mesh-list
101974004|NCT01226017|Oxytocics|oxytocics|mesh-ancestor
101974005|NCT01226017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101974006|NCT01226017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974007|NCT01222819|Lenograstim|lenograstim|mesh-list
101974008|NCT01222819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101974009|NCT01222819|Immunologic Factors|immunologic factors|mesh-ancestor
101974010|NCT01222819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974011|NCT01222897|Valacyclovir|valacyclovir|mesh-list
101974012|NCT01222897|Antiviral Agents|antiviral agents|mesh-ancestor
101974013|NCT01222897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101974014|NCT03150056|Prednisone|prednisone|mesh-list
101974015|NCT03150056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101974016|NCT03150056|Glucocorticoids|glucocorticoids|mesh-ancestor
101974017|NCT03150056|Hormones|hormones|mesh-ancestor
101974018|NCT03150056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101428974|NCT04173585|Immunotoxins|immunotoxins|mesh-ancestor
101974024|NCT01329367|Protective Agents|protective agents|mesh-ancestor
101974025|NCT01329367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974027|NCT01222975|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101974028|NCT01222975|Serotonin Agents|serotonin agents|mesh-ancestor
101974029|NCT01222975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101974030|NCT01222975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974031|NCT01222975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974032|NCT01222975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101974033|NCT01222975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101974034|NCT01222975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101974035|NCT01222975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101974036|NCT01222975|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101974037|NCT01222975|Dopamine Agents|dopamine agents|mesh-ancestor
101974038|NCT01129063|Clopidogrel|clopidogrel|mesh-list
101974039|NCT01129063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101974040|NCT01129063|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101974041|NCT01129063|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101974042|NCT01129063|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101974043|NCT01129063|Purinergic Agents|purinergic agents|mesh-ancestor
101974044|NCT01129063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101974045|NCT01129063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974046|NCT01129063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974047|NCT01317368|Ropivacaine|ropivacaine|mesh-list
101974048|NCT01317368|Anesthetics, Local|anesthetics, local|mesh-ancestor
101974049|NCT01317368|Anesthetics|anesthetics|mesh-ancestor
101974050|NCT01317368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101974051|NCT01317368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974052|NCT01317368|Sensory System Agents|sensory system agents|mesh-ancestor
101974053|NCT01317368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101974054|NCT01219699|Fulvestrant|fulvestrant|mesh-list
101974055|NCT01219699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101974056|NCT01219699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101946165|NCT01263951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101946166|NCT01263951|Immunologic Factors|immunologic factors|mesh-ancestor
101974057|NCT01219699|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101974058|NCT01219699|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101974059|NCT01219699|Hormone Antagonists|hormone antagonists|mesh-ancestor
101974060|NCT01219699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101974061|NCT01219699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974062|NCT03933319|Doxorubicin|doxorubicin|mesh-list
101974063|NCT03933319|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101974064|NCT03933319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101974065|NCT03933319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974066|NCT03933319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101974067|NCT03933319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101974068|NCT03933319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101974069|NCT03933319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974070|NCT01223053|Ketoprofen|ketoprofen|mesh-list
101974071|NCT01223053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101974072|NCT01223053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101974073|NCT01223053|Analgesics|analgesics|mesh-ancestor
101974074|NCT01223053|Sensory System Agents|sensory system agents|mesh-ancestor
101974075|NCT01223053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101974076|NCT01223053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974077|NCT01223053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101974078|NCT01223053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101974079|NCT01223053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101974080|NCT01223053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101974081|NCT01223053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974082|NCT01223131|Insulin|insulin|mesh-list
101974083|NCT01223131|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101974084|NCT01223131|Insulin Glargine|insulin glargine|mesh-list
101974085|NCT01223131|Insulin, Isophane|insulin, isophane|mesh-list
101974086|NCT01223131|Isophane Insulin, Human|isophane insulin, human|mesh-list
101974093|NCT01125553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974095|NCT02640664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101974096|NCT02640664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101974097|NCT02640664|Growth Substances|growth substances|mesh-ancestor
101974098|NCT02640664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693861|NCT04099849|Zinc|zinc|mesh-list
101974099|NCT02640664|Growth Inhibitors|growth inhibitors|mesh-ancestor
101974100|NCT02640664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974101|NCT01317446|Fluorides|fluorides|mesh-list
101974102|NCT01317446|Tin Fluorides|tin fluorides|mesh-list
101974103|NCT01317446|Cariostatic Agents|cariostatic agents|mesh-ancestor
101974104|NCT01317446|Protective Agents|protective agents|mesh-ancestor
101974105|NCT01317446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974106|NCT02529241|Delpazolid|delpazolid|mesh-list
101974107|NCT02529241|Oxazolidinones|oxazolidinones|mesh-list
101974108|NCT02529241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101974109|NCT02529241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101974110|NCT02529241|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101974111|NCT02529241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101974112|NCT02529241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974113|NCT02456012|Esomeprazole|esomeprazole|mesh-list
101974114|NCT02456012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101974115|NCT02456012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101974116|NCT02456012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101974117|NCT02456012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101974118|NCT02456012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974119|NCT00812006|Rizatriptan|rizatriptan|mesh-list
101974120|NCT00812006|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101974121|NCT00812006|Serotonin Agents|serotonin agents|mesh-ancestor
101974122|NCT00812006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101974123|NCT00812006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974124|NCT00812006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974125|NCT03133234|Osimertinib|osimertinib|mesh-list
101974126|NCT03133234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974127|NCT03133234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101974128|NCT03133234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101974129|NCT03133234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974130|NCT01125787|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101974131|NCT01125787|Ofatumumab|ofatumumab|mesh-list
101974132|NCT01125787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101946167|NCT01263951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946168|NCT01263951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101946170|NCT01265433|Sargramostim|sargramostim|mesh-list
101946171|NCT01265433|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101974133|NCT01125787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101974134|NCT01125787|Alkylating Agents|alkylating agents|mesh-ancestor
101974135|NCT01125787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974136|NCT01125787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974137|NCT01125787|Immunologic Factors|immunologic factors|mesh-ancestor
101974138|NCT01125787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974139|NCT02457442|Remifentanil|remifentanil|mesh-list
101974140|NCT02457442|Propofol|propofol|mesh-list
101974141|NCT02457442|Sevoflurane|sevoflurane|mesh-list
101974142|NCT02457442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101974143|NCT02457442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101974144|NCT02457442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974145|NCT02457442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101974146|NCT02457442|Anesthetics, General|anesthetics, general|mesh-ancestor
101974147|NCT02457442|Anesthetics|anesthetics|mesh-ancestor
101974148|NCT02457442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101974149|NCT02457442|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101974150|NCT02457442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101974151|NCT02457442|Narcotics|narcotics|mesh-ancestor
101974152|NCT02457442|Analgesics|analgesics|mesh-ancestor
101974153|NCT02457442|Sensory System Agents|sensory system agents|mesh-ancestor
101974154|NCT02457442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101974155|NCT03132038|Nivolumab|nivolumab|mesh-list
101974160|NCT01129375|Omeprazole|omeprazole|mesh-list
101974161|NCT01129375|Clopidogrel|clopidogrel|mesh-list
101974162|NCT01129375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101974163|NCT01129375|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101974164|NCT01129375|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101974165|NCT01129375|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101974166|NCT01129375|Purinergic Agents|purinergic agents|mesh-ancestor
101974167|NCT01129375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101974168|NCT01129375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974169|NCT01129375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974170|NCT01129375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101974171|NCT01129375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101974172|NCT01129375|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101974173|NCT01129375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101974174|NCT01352702|Dabigatran|dabigatran|mesh-list
101974175|NCT01352702|Phenprocoumon|phenprocoumon|mesh-list
101974176|NCT01352702|Antithrombins|antithrombins|mesh-ancestor
101974177|NCT01352702|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101974178|NCT01352702|Protease Inhibitors|protease inhibitors|mesh-ancestor
101974179|NCT01352702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101974180|NCT01352702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974181|NCT01352702|Anticoagulants|anticoagulants|mesh-ancestor
101974182|NCT03525730|Pyrimethamine|pyrimethamine|mesh-list
101974183|NCT03525730|Valproic Acid|valproic acid|mesh-list
101974184|NCT03525730|Antimalarials|antimalarials|mesh-ancestor
101974185|NCT03525730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101974186|NCT03525730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101974187|NCT03525730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101974188|NCT03525730|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101974189|NCT03525730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101974190|NCT03525730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974191|NCT03525730|Anticonvulsants|anticonvulsants|mesh-ancestor
101974192|NCT03525730|GABA Agents|gaba agents|mesh-ancestor
101974193|NCT03525730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101974194|NCT03525730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974195|NCT03525730|Antimanic Agents|antimanic agents|mesh-ancestor
101974196|NCT03525730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101974197|NCT03525730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101974198|NCT03525730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101974199|NCT01223443|Paclitaxel|paclitaxel|mesh-list
101974200|NCT01223443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101974201|NCT01223443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974202|NCT01223443|Tubulin Modulators|tubulin modulators|mesh-ancestor
101974203|NCT01223443|Antimitotic Agents|antimitotic agents|mesh-ancestor
101946172|NCT01265433|Immunologic Factors|immunologic factors|mesh-ancestor
101946173|NCT01265433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974204|NCT01223443|Mitosis Modulators|mitosis modulators|mesh-ancestor
101974205|NCT01223443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974207|NCT03525652|Immunologic Factors|immunologic factors|mesh-ancestor
101974208|NCT03525652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974209|NCT02290054|Anesthetics|anesthetics|mesh-list
101974210|NCT02290054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101974211|NCT02290054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974212|NCT01347944|Lenalidomide|lenalidomide|mesh-list
101974213|NCT01347944|Immunologic Factors|immunologic factors|mesh-ancestor
101974214|NCT01347944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974215|NCT01347944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101974216|NCT01347944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101974217|NCT01347944|Growth Substances|growth substances|mesh-ancestor
101974218|NCT01347944|Growth Inhibitors|growth inhibitors|mesh-ancestor
101974219|NCT01347944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974220|NCT02290132|Thymoglobulin|thymoglobulin|mesh-list
101974221|NCT02290132|Immunologic Factors|immunologic factors|mesh-ancestor
101974222|NCT02290132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974223|NCT02290132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101974224|NCT01220245|Heparin|heparin|mesh-list
101974225|NCT01220245|Anticoagulants|anticoagulants|mesh-ancestor
101974226|NCT01220245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101974241|NCT03931135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101974242|NCT03931135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974243|NCT03931135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101974245|NCT03931135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101974246|NCT03931135|Analgesics|analgesics|mesh-ancestor
101693998|NCT00659412|Methotrexate|methotrexate|mesh-list
101974247|NCT03931135|Sensory System Agents|sensory system agents|mesh-ancestor
101974248|NCT03931135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101974249|NCT03931135|Histamine Antagonists|histamine antagonists|mesh-ancestor
101974250|NCT03931135|Histamine Agents|histamine agents|mesh-ancestor
101974251|NCT03931135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101974252|NCT03931135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974253|NCT01353170|Dialysis Solutions|dialysis solutions|mesh-list
101974254|NCT01353170|Calcium|calcium|mesh-list
101974255|NCT01353170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101974256|NCT01353170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974257|NCT01353170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101974258|NCT03620318|Crenolanib|crenolanib|mesh-list
101974259|NCT03620318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974260|NCT01125943|Bevacizumab|bevacizumab|mesh-list
101974261|NCT01125943|Nitroprusside|nitroprusside|mesh-list
101974262|NCT01125943|Acetylcholine|acetylcholine|mesh-list
101974263|NCT01125943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101974264|NCT01125943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974265|NCT01125943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101974266|NCT01125943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101974267|NCT01125943|Growth Substances|growth substances|mesh-ancestor
101974268|NCT01125943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974269|NCT01125943|Growth Inhibitors|growth inhibitors|mesh-ancestor
101974270|NCT01125943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101974271|NCT01125943|Vasodilator Agents|vasodilator agents|mesh-ancestor
101974272|NCT01125943|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101974273|NCT01125943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974274|NCT01125943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101974275|NCT01125943|Cholinergic Agents|cholinergic agents|mesh-ancestor
101974276|NCT01125943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101974277|NCT01223755|Sirolimus|sirolimus|mesh-list
101974278|NCT01223755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101974279|NCT01223755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101974280|NCT01223755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101974281|NCT01223755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974282|NCT01223755|Antifungal Agents|antifungal agents|mesh-ancestor
101974283|NCT01223755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101974284|NCT01223755|Immunologic Factors|immunologic factors|mesh-ancestor
101974285|NCT01223755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974286|NCT01126177|Interferons|interferons|mesh-list
101974287|NCT01126177|Interferon-beta|interferon-beta|mesh-list
101974296|NCT03680092|Methotrexate|methotrexate|mesh-list
101974297|NCT03680092|Abatacept|abatacept|mesh-list
101974298|NCT03680092|Tacrolimus|tacrolimus|mesh-list
101946174|NCT01265433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101946175|NCT01265433|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101974299|NCT03680092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101974300|NCT03680092|Immunologic Factors|immunologic factors|mesh-ancestor
101974301|NCT03680092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974302|NCT03680092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101974303|NCT03680092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101974304|NCT03680092|Alkylating Agents|alkylating agents|mesh-ancestor
101974305|NCT03680092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974306|NCT03680092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974307|NCT03680092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101974308|NCT03680092|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101974309|NCT03680092|Abortifacient Agents|abortifacient agents|mesh-ancestor
101974310|NCT03680092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101974311|NCT03680092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101974312|NCT03680092|Antimetabolites|antimetabolites|mesh-ancestor
101974313|NCT03680092|Dermatologic Agents|dermatologic agents|mesh-ancestor
101974314|NCT03680092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101974315|NCT03680092|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101974316|NCT03680092|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101974317|NCT03680092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101974318|NCT03680092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101974319|NCT03680092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101974321|NCT03671044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974322|NCT03671044|Tubulin Modulators|tubulin modulators|mesh-ancestor
101974323|NCT03671044|Antimitotic Agents|antimitotic agents|mesh-ancestor
101974324|NCT03671044|Mitosis Modulators|mitosis modulators|mesh-ancestor
101974325|NCT03671044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974326|NCT05790070|Betaine|betaine|mesh-list
101974327|NCT05790070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101974328|NCT05790070|Lipotropic Agents|lipotropic agents|mesh-ancestor
101974329|NCT05790070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101974330|NCT05790070|Antimetabolites|antimetabolites|mesh-ancestor
101974331|NCT05790070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974332|NCT05790070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101974333|NCT05789680|Parathyroid Hormone|parathyroid hormone|mesh-list
101974334|NCT05789680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101974335|NCT05789680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974336|NCT05789667|Lenvatinib|lenvatinib|mesh-list
101974337|NCT05789667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974338|NCT05789667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101974339|NCT05789667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101974340|NCT05789667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974341|NCT05789537|Protein C|protein c|mesh-list
101974342|NCT05789537|Anticoagulants|anticoagulants|mesh-ancestor
101974343|NCT05789537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101974344|NCT05789537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101974345|NCT05789537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974346|NCT05789342|Itraconazole|itraconazole|mesh-list
101974347|NCT05789342|Oseltamivir|oseltamivir|mesh-list
101974348|NCT05789342|Digoxin|digoxin|mesh-list
101974349|NCT05789342|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101974350|NCT05789342|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101974351|NCT05789342|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101974352|NCT05789342|Antimetabolites|antimetabolites|mesh-ancestor
101974353|NCT05789342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974354|NCT05789342|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101429312|NCT01711554|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101974367|NCT05789342|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101974368|NCT05789342|Protective Agents|protective agents|mesh-ancestor
101974370|NCT05789186|Fluoxetine|fluoxetine|mesh-list
101974371|NCT05789186|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101974372|NCT05789186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101974373|NCT05789186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101974374|NCT05789186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974375|NCT05789186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101974376|NCT05789186|Serotonin Agents|serotonin agents|mesh-ancestor
101974377|NCT05789186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974378|NCT05789186|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101974379|NCT05789186|Antidepressive Agents|antidepressive agents|mesh-ancestor
101946176|NCT01265589|Vitamin A|vitamin a|mesh-list
101946177|NCT01265589|Pulmonary Surfactants|pulmonary surfactants|mesh-list
101946178|NCT01265589|Vitamins|vitamins|mesh-ancestor
101946179|NCT01265589|Micronutrients|micronutrients|mesh-ancestor
101974380|NCT05789186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101974381|NCT05789186|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101974382|NCT05789186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101974383|NCT05789186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101974384|NCT05789043|Apatinib|apatinib|mesh-list
101974385|NCT05789043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974386|NCT05789043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101974387|NCT05789043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101974388|NCT05789043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974389|NCT05789030|Prednisone|prednisone|mesh-list
101974390|NCT05789030|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
101974391|NCT05789030|Betamethasone|betamethasone|mesh-list
101974392|NCT05789030|Leflunomide|leflunomide|mesh-list
101974393|NCT05789030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101974394|NCT05789030|Glucocorticoids|glucocorticoids|mesh-ancestor
101974395|NCT05789030|Hormones|hormones|mesh-ancestor
101974396|NCT05789030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101974397|NCT05789030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694144|NCT03102047|Durvalumab|durvalumab|mesh-list
101974398|NCT05789030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101974399|NCT05789030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974400|NCT05789030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101974401|NCT05789030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974402|NCT05789030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101974403|NCT05789030|Immunologic Factors|immunologic factors|mesh-ancestor
101974404|NCT05789030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101974405|NCT05789030|Respiratory System Agents|respiratory system agents|mesh-ancestor
101974406|NCT05789017|Mycophenolic Acid|mycophenolic acid|mesh-list
101974407|NCT05789017|Prednisone|prednisone|mesh-list
101974408|NCT05789017|Leflunomide|leflunomide|mesh-list
101974409|NCT05789017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101974410|NCT05789017|Glucocorticoids|glucocorticoids|mesh-ancestor
101974411|NCT05789017|Hormones|hormones|mesh-ancestor
101974422|NCT05789017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974423|NCT05789017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101974424|NCT05789017|Immunologic Factors|immunologic factors|mesh-ancestor
101974425|NCT05788991|Metronidazole|metronidazole|mesh-list
101974426|NCT05788991|Dequalinium|dequalinium|mesh-list
101974427|NCT05788991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101974428|NCT05788991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101974429|NCT05788991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101974430|NCT05788991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101974431|NCT05788991|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101974432|NCT05788913|Heparin|heparin|mesh-list
101974433|NCT05788913|Anticoagulants|anticoagulants|mesh-ancestor
101974434|NCT05788913|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101974435|NCT05788913|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101974436|NCT05788913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974437|NCT05788900|Heparin|heparin|mesh-list
101974438|NCT05788900|Anticoagulants|anticoagulants|mesh-ancestor
101974439|NCT05788900|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101974440|NCT05788900|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101974441|NCT05788900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974442|NCT05788835|Chlorotrianisene|chlorotrianisene|mesh-list
101974443|NCT05788835|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101974444|NCT05788835|Estrogens|estrogens|mesh-ancestor
101974445|NCT05788835|Hormones|hormones|mesh-ancestor
101974446|NCT05788835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101974447|NCT05788835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974448|NCT05788835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101974449|NCT05788835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974450|NCT05788705|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
101974451|NCT05788705|Boswellic acid|boswellic acid|mesh-list
101974452|NCT05788705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101974453|NCT05788705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101974454|NCT05788705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101974455|NCT05788705|Analgesics|analgesics|mesh-ancestor
101974456|NCT05788705|Sensory System Agents|sensory system agents|mesh-ancestor
101974457|NCT05788705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101946180|NCT01265589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946181|NCT01265589|Respiratory System Agents|respiratory system agents|mesh-ancestor
101946183|NCT01159587|Coagulants|coagulants|mesh-ancestor
101946184|NCT03885297|Liraglutide|liraglutide|mesh-list
101946185|NCT03885297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101974458|NCT05788705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974459|NCT05788705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101974460|NCT05788679|Azacitidine|azacitidine|mesh-list
101974461|NCT05788679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101974462|NCT05788679|Antimetabolites|antimetabolites|mesh-ancestor
101974463|NCT05788679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974464|NCT05788679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974465|NCT05788679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101974466|NCT05770544|Entrectinib|entrectinib|mesh-list
101974467|NCT05770544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101974468|NCT05770544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101974469|NCT05770544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974470|NCT05767086|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101974471|NCT05767086|Medroxyprogesterone|medroxyprogesterone|mesh-list
101974472|NCT05767086|Cetrorelix|cetrorelix|mesh-list
101974474|NCT05767086|Dydrogesterone|dydrogesterone|mesh-list
101974475|NCT05767086|Hormone Antagonists|hormone antagonists|mesh-list
101974479|NCT05767086|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101974480|NCT05767086|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101974481|NCT05767086|Contraceptive Agents|contraceptive agents|mesh-ancestor
101974482|NCT05767086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101974483|NCT05767086|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101974484|NCT05767086|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101974485|NCT05767086|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101974486|NCT05767086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101974487|NCT05767086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974488|NCT05767086|Progestins|progestins|mesh-ancestor
101974489|NCT05767086|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101974490|NCT05767086|Fertility Agents|fertility agents|mesh-ancestor
101974491|NCT05755282|Hand Sanitizers|hand sanitizers|mesh-list
101974492|NCT05755282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101974493|NCT05755282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101974494|NCT05755282|Disinfectants|disinfectants|mesh-ancestor
101974495|NCT05732077|Dopamine|dopamine|mesh-list
101974496|NCT05732077|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101974497|NCT05732077|Sympathomimetics|sympathomimetics|mesh-ancestor
101974498|NCT05732077|Autonomic Agents|autonomic agents|mesh-ancestor
101974499|NCT05732077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101974500|NCT05732077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974501|NCT05732077|Dopamine Agents|dopamine agents|mesh-ancestor
101974502|NCT05732077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101974503|NCT05732077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974504|NCT05732077|Protective Agents|protective agents|mesh-ancestor
101974505|NCT05722886|Trastuzumab|trastuzumab|mesh-list
101974506|NCT05722886|Atezolizumab|atezolizumab|mesh-list
101974507|NCT05722886|Pertuzumab|pertuzumab|mesh-list
101974508|NCT05722886|Vemurafenib|vemurafenib|mesh-list
101974509|NCT05722886|Entrectinib|entrectinib|mesh-list
101974510|NCT05722886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101974511|NCT05722886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974512|NCT05722886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101974513|NCT05722886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974514|NCT05722886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101974515|NCT05722886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101974516|NCT05702905|Metformin|metformin|mesh-list
101974517|NCT05702905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101974518|NCT05702905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974519|NCT05697471|Dienogest|dienogest|mesh-list
101974520|NCT05697471|Danazol|danazol|mesh-list
101974521|NCT05697471|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101974522|NCT05697471|Contraceptive Agents|contraceptive agents|mesh-ancestor
101974523|NCT05697471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101974524|NCT05697471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974525|NCT05697471|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101974526|NCT05697471|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101946186|NCT03885297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946187|NCT03885297|Incretins|incretins|mesh-ancestor
101946188|NCT03885297|Hormones|hormones|mesh-ancestor
101801123|NCT00451906|Growth Substances|growth substances|mesh-ancestor
101974527|NCT05697471|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101974528|NCT05697471|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101974529|NCT05697471|Hormone Antagonists|hormone antagonists|mesh-ancestor
101974530|NCT05697471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101974531|NCT05697471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101974532|NCT05697471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974533|NCT05697471|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101974534|NCT05670561|Sufentanil|sufentanil|mesh-list
101974535|NCT05670561|Esketamine|esketamine|mesh-list
101974536|NCT05670561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101974537|NCT05670561|Narcotics|narcotics|mesh-ancestor
101974538|NCT05670561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101974539|NCT05670561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974540|NCT05670561|Analgesics|analgesics|mesh-ancestor
101974541|NCT05670561|Sensory System Agents|sensory system agents|mesh-ancestor
101974542|NCT05670561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101974543|NCT05670561|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101974544|NCT05670561|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101974545|NCT05670561|Anesthetics, General|anesthetics, general|mesh-ancestor
101694296|NCT00967057|Antimetabolites|antimetabolites|mesh-ancestor
101429515|NCT00171093|Valsartan|valsartan|mesh-list
101974550|NCT05635877|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101974551|NCT05635877|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101974552|NCT05635877|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101974553|NCT05635877|Adrenergic Agents|adrenergic agents|mesh-ancestor
101974554|NCT05635877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101974555|NCT05635877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974556|NCT05635877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974558|NCT05629546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101974559|NCT05629546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974560|NCT05629546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101974561|NCT05629546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974562|NCT05596006|Domperidone|domperidone|mesh-list
101974563|NCT05596006|Antiemetics|antiemetics|mesh-ancestor
101974564|NCT05596006|Autonomic Agents|autonomic agents|mesh-ancestor
101974565|NCT05596006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101974566|NCT05596006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974567|NCT05596006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101974568|NCT05596006|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101974569|NCT05596006|Dopamine Agents|dopamine agents|mesh-ancestor
101974570|NCT05596006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101974571|NCT05596006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974572|NCT05587374|Gemcitabine|gemcitabine|mesh-list
101974573|NCT05587374|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101974574|NCT05587374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974575|NCT05587374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101974576|NCT05587374|Antimetabolites|antimetabolites|mesh-ancestor
101974577|NCT05587374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974578|NCT05587374|Immunologic Factors|immunologic factors|mesh-ancestor
101974579|NCT05587374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974580|NCT05586529|Cholecalciferol|cholecalciferol|mesh-list
101974581|NCT05586529|Vitamin D|vitamin d|mesh-list
101974582|NCT05586529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101974583|NCT05586529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974584|NCT05586529|Vitamins|vitamins|mesh-ancestor
101974585|NCT05586529|Micronutrients|micronutrients|mesh-ancestor
101974586|NCT05586529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101974587|NCT05558280|Dinutuximab|dinutuximab|mesh-list
101974588|NCT05558280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974589|NCT05555303|Amikacin|amikacin|mesh-list
101974590|NCT05555303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101974591|NCT05555303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101974592|NCT05549752|Amiodarone|amiodarone|mesh-list
101974593|NCT05549752|Flecainide|flecainide|mesh-list
101974594|NCT05549752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101974595|NCT05549752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101974596|NCT05549752|Vasodilator Agents|vasodilator agents|mesh-ancestor
101974597|NCT05549752|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101971937|NCT02083250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974598|NCT05549752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101974599|NCT05549752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974600|NCT05549752|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101974601|NCT05549752|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101974602|NCT05549752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101974603|NCT05549752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101974604|NCT05549752|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101974605|NCT05549752|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101974606|NCT05549752|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101974607|NCT05549752|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101974608|NCT05538091|Atezolizumab|atezolizumab|mesh-list
101974609|NCT05538091|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101974610|NCT05538091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974611|NCT05538091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101974612|NCT05538091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974613|NCT05515029|Cyclophosphamide|cyclophosphamide|mesh-list
101974615|NCT05515029|Vedolizumab|vedolizumab|mesh-list
101974619|NCT05515029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974620|NCT05515029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101974621|NCT05515029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101974622|NCT05515029|Alkylating Agents|alkylating agents|mesh-ancestor
101974623|NCT05515029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974624|NCT05515029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974625|NCT05515029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101974626|NCT05515029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101974627|NCT05515029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101974628|NCT05515029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101974629|NCT05515029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101974631|NCT05499832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101974632|NCT05499832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101974633|NCT05499832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974634|NCT05461456|Fexofenadine|fexofenadine|mesh-list
101974635|NCT05461456|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101974636|NCT05461456|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101974637|NCT05461456|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101974638|NCT05461456|Histamine Antagonists|histamine antagonists|mesh-ancestor
101974639|NCT05461456|Histamine Agents|histamine agents|mesh-ancestor
101974640|NCT05461456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101974641|NCT05461456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709879|NCT00855894|Pertuzumab|pertuzumab|mesh-list
101974642|NCT05461456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974643|NCT05441930|Levofloxacin|levofloxacin|mesh-list
101974644|NCT05441930|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101974645|NCT05441930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101974646|NCT05441930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101974647|NCT05441930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101974648|NCT05441930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101974649|NCT05441930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101974650|NCT05441930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974651|NCT05441930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974652|NCT05441930|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101974653|NCT05441930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101974654|NCT05394727|Insulin|insulin|mesh-list
101974655|NCT05394727|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101974656|NCT05394727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101974657|NCT05394727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974658|NCT05350501|Nivolumab|nivolumab|mesh-list
101974659|NCT05350501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101974660|NCT05350501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974661|NCT05350501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101974662|NCT05350501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974663|NCT05322512|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101974664|NCT05322512|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101974665|NCT05322512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974666|NCT05268926|Dapagliflozin|dapagliflozin|mesh-list
101974667|NCT05268926|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101974668|NCT05268926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946189|NCT03885297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101946190|NCT01159821|Paroxetine|paroxetine|mesh-list
101801266|NCT00115063|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101974669|NCT05268926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101974670|NCT05268926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974671|NCT05267366|Bevacizumab|bevacizumab|mesh-list
101974672|NCT05267366|Carboplatin|carboplatin|mesh-list
101974673|NCT05267366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101974674|NCT05267366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101974675|NCT05267366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974676|NCT05267366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101974677|NCT05267366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101974678|NCT05267366|Growth Substances|growth substances|mesh-ancestor
101974679|NCT05267366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974680|NCT05267366|Growth Inhibitors|growth inhibitors|mesh-ancestor
101974681|NCT05267366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974682|NCT05267288|Afatinib|afatinib|mesh-list
101974683|NCT05267288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974684|NCT05267288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101974685|NCT05267288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101974690|NCT05218629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974691|NCT05191667|Paclitaxel|paclitaxel|mesh-list
101974692|NCT05191667|Carboplatin|carboplatin|mesh-list
101974693|NCT05191667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101974694|NCT05191667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974695|NCT05191667|Tubulin Modulators|tubulin modulators|mesh-ancestor
101974696|NCT05191667|Antimitotic Agents|antimitotic agents|mesh-ancestor
101974697|NCT05191667|Mitosis Modulators|mitosis modulators|mesh-ancestor
101974698|NCT05191667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974699|NCT05112263|Cyclosporine|cyclosporine|mesh-list
101974700|NCT05112263|Cyclosporins|cyclosporins|mesh-list
101974701|NCT05112263|Tofacitinib|tofacitinib|mesh-list
101974702|NCT05112263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101974703|NCT05112263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974704|NCT05112263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101974705|NCT05112263|Immunologic Factors|immunologic factors|mesh-ancestor
101974706|NCT05112263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974707|NCT05112263|Antifungal Agents|antifungal agents|mesh-ancestor
101974708|NCT05112263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101974709|NCT05112263|Dermatologic Agents|dermatologic agents|mesh-ancestor
101974710|NCT05112263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101974711|NCT05112263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101974712|NCT05112263|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101974713|NCT05112263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101974714|NCT05104281|Osimertinib|osimertinib|mesh-list
101974715|NCT05104281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974716|NCT05104281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101974717|NCT05104281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101974718|NCT05104281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974719|NCT05084378|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101974720|NCT05084378|Chlorhexidine|chlorhexidine|mesh-list
101974721|NCT05084378|Povidone-Iodine|povidone-iodine|mesh-list
101974722|NCT05084378|Povidone|povidone|mesh-list
101974723|NCT05084378|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101974724|NCT05084378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101974725|NCT05084378|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101974726|NCT05084378|Disinfectants|disinfectants|mesh-ancestor
101974727|NCT05084378|Plasma Substitutes|plasma substitutes|mesh-ancestor
101974728|NCT05084378|Blood Substitutes|blood substitutes|mesh-ancestor
101974729|NCT05072249|Naloxone|naloxone|mesh-list
101974730|NCT05072249|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101974731|NCT05072249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974732|NCT05072249|Sensory System Agents|sensory system agents|mesh-ancestor
101974733|NCT05072249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101974734|NCT05048017|Pembrolizumab|pembrolizumab|mesh-list
101974735|NCT05048017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101974736|NCT05048017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101974737|NCT05048017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974738|NCT05048017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974739|NCT05040984|Solifenacin Succinate|solifenacin succinate|mesh-list
101974740|NCT05040984|Mirabegron|mirabegron|mesh-list
101974741|NCT05040984|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101974742|NCT05040984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101946191|NCT01159821|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101801338|NCT00443560|Sensory System Agents|sensory system agents|mesh-ancestor
101974743|NCT05040984|Cholinergic Agents|cholinergic agents|mesh-ancestor
101974744|NCT05040984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101974745|NCT05040984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974746|NCT05040984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974747|NCT05040984|Urological Agents|urological agents|mesh-ancestor
101974748|NCT05040984|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101974749|NCT05040984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101974750|NCT05040984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101974751|NCT05040984|Adrenergic Agents|adrenergic agents|mesh-ancestor
101974752|NCT05017272|Analgesics, Opioid|analgesics, opioid|mesh-list
101974753|NCT05017272|Narcotics|narcotics|mesh-ancestor
101974754|NCT05017272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101429733|NCT02912182|Hormones|hormones|mesh-ancestor
101974759|NCT04981912|Rituximab|rituximab|mesh-list
101974760|NCT04981912|Venetoclax|venetoclax|mesh-list
101974761|NCT04981912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101974762|NCT04981912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974763|NCT04981912|Immunologic Factors|immunologic factors|mesh-ancestor
101974764|NCT04981912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974765|NCT04981912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101974766|NCT04974879|Osimertinib|osimertinib|mesh-list
101974767|NCT04974879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101694521|NCT00967603|Sunitinib|sunitinib|mesh-list
101974768|NCT04974879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101974769|NCT04974879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101974770|NCT04974879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974771|NCT04933058|Acetaminophen|acetaminophen|mesh-list
101974772|NCT04933058|Fentanyl|fentanyl|mesh-list
101974773|NCT04933058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101974774|NCT04933058|Narcotics|narcotics|mesh-ancestor
101974775|NCT04933058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101974776|NCT04933058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974777|NCT04933058|Analgesics|analgesics|mesh-ancestor
101974778|NCT04933058|Sensory System Agents|sensory system agents|mesh-ancestor
101974779|NCT04933058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101974780|NCT04933058|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101974781|NCT04933058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101974782|NCT04933058|Anesthetics, General|anesthetics, general|mesh-ancestor
101974783|NCT04933058|Anesthetics|anesthetics|mesh-ancestor
101974784|NCT04933058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101974785|NCT04933058|Antipyretics|antipyretics|mesh-ancestor
101974786|NCT04918810|Docetaxel|docetaxel|mesh-list
101974787|NCT04918810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974788|NCT04918810|Tubulin Modulators|tubulin modulators|mesh-ancestor
101974789|NCT04918810|Antimitotic Agents|antimitotic agents|mesh-ancestor
101974790|NCT04918810|Mitosis Modulators|mitosis modulators|mesh-ancestor
101974791|NCT04918810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974792|NCT04894864|Analgesics, Opioid|analgesics, opioid|mesh-list
101974793|NCT04894864|Anesthetics|anesthetics|mesh-list
101974794|NCT04894864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101974795|NCT04894864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974796|NCT04894864|Narcotics|narcotics|mesh-ancestor
101974797|NCT04894864|Analgesics|analgesics|mesh-ancestor
101974798|NCT04894864|Sensory System Agents|sensory system agents|mesh-ancestor
101974799|NCT04894864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101974800|NCT04880395|Lamivudine|lamivudine|mesh-list
101974801|NCT04880395|Emtricitabine|emtricitabine|mesh-list
101974802|NCT04880395|Dolutegravir|dolutegravir|mesh-list
101974803|NCT04880395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101974804|NCT04880395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101974805|NCT04880395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101974806|NCT04880395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974807|NCT04880395|Antiviral Agents|antiviral agents|mesh-ancestor
101974808|NCT04880395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101974809|NCT04880395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101974810|NCT04880395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101974811|NCT04880395|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101974812|NCT04880395|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101974813|NCT04849013|Ketanserin|ketanserin|mesh-list
101974814|NCT04849013|Mescaline|mescaline|mesh-list
101974815|NCT04849013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101974816|NCT04849013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101974817|NCT04849013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101946192|NCT01159821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101946193|NCT01159821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101946194|NCT01159821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974818|NCT04849013|Serotonin Agents|serotonin agents|mesh-ancestor
101974819|NCT04849013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101974820|NCT04849013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974821|NCT04849013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974822|NCT04849013|Hallucinogens|hallucinogens|mesh-ancestor
101974823|NCT04849013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101974824|NCT04849013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101974825|NCT04808245|Atezolizumab|atezolizumab|mesh-list
101974826|NCT04808245|Imiquimod|imiquimod|mesh-list
101974827|NCT04808245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101974847|NCT04777071|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101974848|NCT04777071|Chelating Agents|chelating agents|mesh-ancestor
101974849|NCT04777071|Sequestering Agents|sequestering agents|mesh-ancestor
101974850|NCT04777071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974851|NCT04777071|Anticoagulants|anticoagulants|mesh-ancestor
101974852|NCT04777071|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101974853|NCT04777071|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101974854|NCT04747847|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101974855|NCT04747847|Atorvastatin|atorvastatin|mesh-list
101974856|NCT04747847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101974857|NCT04747847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101974858|NCT04747847|Antimetabolites|antimetabolites|mesh-ancestor
101974859|NCT04747847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974860|NCT04747847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101974861|NCT04747847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101974862|NCT04747847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101974863|NCT04747847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101974864|NCT04646837|Paclitaxel|paclitaxel|mesh-list
101974865|NCT04646837|Carboplatin|carboplatin|mesh-list
101974866|NCT04646837|Durvalumab|durvalumab|mesh-list
101974867|NCT04646837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101974868|NCT04646837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974869|NCT04646837|Tubulin Modulators|tubulin modulators|mesh-ancestor
101974870|NCT04646837|Antimitotic Agents|antimitotic agents|mesh-ancestor
101974871|NCT04646837|Mitosis Modulators|mitosis modulators|mesh-ancestor
101974872|NCT04646837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974873|NCT04646837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101974874|NCT04600167|Isoniazid|isoniazid|mesh-list
101974875|NCT04600167|Rifapentine|rifapentine|mesh-list
101974876|NCT04600167|Antitubercular Agents|antitubercular agents|mesh-ancestor
101974877|NCT04600167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101974878|NCT04600167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101974879|NCT04600167|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101974880|NCT04600167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101974881|NCT04600167|Antimetabolites|antimetabolites|mesh-ancestor
101974882|NCT04600167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974883|NCT04600167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101974884|NCT04600167|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101429857|NCT00164112|Levofloxacin|levofloxacin|mesh-list
101974901|NCT04489888|Pembrolizumab|pembrolizumab|mesh-list
101974902|NCT04489888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101974903|NCT04489888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974904|NCT04489888|Tubulin Modulators|tubulin modulators|mesh-ancestor
101974905|NCT04489888|Antimitotic Agents|antimitotic agents|mesh-ancestor
101974906|NCT04489888|Mitosis Modulators|mitosis modulators|mesh-ancestor
101974907|NCT04489888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974908|NCT04489888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101974909|NCT04489888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101974910|NCT04443309|Lenvatinib|lenvatinib|mesh-list
101974911|NCT04443309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974912|NCT04443309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101974913|NCT04443309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101974914|NCT04443309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974915|NCT04401800|Lenvatinib|lenvatinib|mesh-list
101974916|NCT04401800|Tislelizumab|tislelizumab|mesh-list
101974917|NCT04401800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974918|NCT04401800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101974919|NCT04401800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101946195|NCT01159821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101946196|NCT01159821|Serotonin Agents|serotonin agents|mesh-ancestor
101801485|NCT02573051|Isosorbide|isosorbide|mesh-list
101974920|NCT04401800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974921|NCT04401800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101974923|NCT04400110|Clavulanic Acids|clavulanic acids|mesh-list
101974924|NCT04400110|Clavulanic Acid|clavulanic acid|mesh-list
101974925|NCT04400110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101974926|NCT04400110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101974927|NCT04400110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101974928|NCT04400110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974929|NCT04400110|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101974930|NCT04387227|Carboplatin|carboplatin|mesh-list
101974931|NCT04387227|Pembrolizumab|pembrolizumab|mesh-list
101974932|NCT04387227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974933|NCT04387227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101974934|NCT04387227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101974935|NCT04387227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974936|NCT04368078|Lenvatinib|lenvatinib|mesh-list
101709911|NCT00855738|Analgesics|analgesics|mesh-ancestor
101974937|NCT04368078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974938|NCT04368078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101974939|NCT04368078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101974940|NCT04368078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974941|NCT04350463|Nivolumab|nivolumab|mesh-list
101974942|NCT04350463|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
101974943|NCT04350463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101974944|NCT04350463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974947|NCT04350463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101974948|NCT04347616|Aldesleukin|aldesleukin|mesh-list
101974949|NCT04347616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974950|NCT04347616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101974951|NCT04347616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101974952|NCT04347616|Antiviral Agents|antiviral agents|mesh-ancestor
101974953|NCT04347616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101974959|NCT04265950|Vaccines|vaccines|mesh-list
101974960|NCT04265950|Immunologic Factors|immunologic factors|mesh-ancestor
101974961|NCT04265950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974962|NCT04249778|Dapagliflozin|dapagliflozin|mesh-list
101974963|NCT04249778|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101974964|NCT04249778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974965|NCT04249778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101974966|NCT04249778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974967|NCT04247815|Methotrexate|methotrexate|mesh-list
101974968|NCT04247815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101974969|NCT04247815|Abortifacient Agents|abortifacient agents|mesh-ancestor
101974970|NCT04247815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101974971|NCT04247815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974972|NCT04247815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101974973|NCT04247815|Antimetabolites|antimetabolites|mesh-ancestor
101974974|NCT04247815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974975|NCT04247815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974976|NCT04247815|Dermatologic Agents|dermatologic agents|mesh-ancestor
101974977|NCT04247815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101974978|NCT04247815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101974979|NCT04247815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101974980|NCT04247815|Immunologic Factors|immunologic factors|mesh-ancestor
101974981|NCT04247815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101974982|NCT04247815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101974983|NCT04227522|Rucaparib|rucaparib|mesh-list
101974984|NCT04227522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101974985|NCT04227522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101974986|NCT04227522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974987|NCT04227522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974988|NCT04216953|Atezolizumab|atezolizumab|mesh-list
101974989|NCT04216953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101974990|NCT04216953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946197|NCT01159821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946198|NCT01159821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101946199|NCT01159821|Antidepressive Agents|antidepressive agents|mesh-ancestor
101946200|NCT01159821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101694744|NCT02787317|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101974991|NCT04216953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101974992|NCT04216953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974993|NCT04211168|Lenvatinib|lenvatinib|mesh-list
101974994|NCT04211168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974995|NCT04211168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101974996|NCT04211168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101974997|NCT04211168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974998|NCT04196257|Paclitaxel|paclitaxel|mesh-list
101974999|NCT04196257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101975000|NCT04196257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101975001|NCT04196257|Tubulin Modulators|tubulin modulators|mesh-ancestor
101975002|NCT04196257|Antimitotic Agents|antimitotic agents|mesh-ancestor
101975003|NCT04196257|Mitosis Modulators|mitosis modulators|mesh-ancestor
101975004|NCT04196257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975005|NCT04193553|Lenvatinib|lenvatinib|mesh-list
101975006|NCT04193553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101975007|NCT04193553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101975008|NCT04193553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101975009|NCT04193553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975010|NCT04188548|Trastuzumab|trastuzumab|mesh-list
101975011|NCT04188548|Pertuzumab|pertuzumab|mesh-list
101975012|NCT04188548|Everolimus|everolimus|mesh-list
101975013|NCT04188548|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101975014|NCT04188548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101975023|NCT04188548|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101975024|NCT04188548|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101975025|NCT04188548|Hormone Antagonists|hormone antagonists|mesh-ancestor
101975026|NCT04188548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101975027|NCT04183101|Enalapril|enalapril|mesh-list
101975028|NCT04183101|Enalaprilat|enalaprilat|mesh-list
101975029|NCT04183101|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101975030|NCT04183101|Protease Inhibitors|protease inhibitors|mesh-ancestor
101975031|NCT04183101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101975032|NCT04183101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975033|NCT04183101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101975034|NCT04155632|Acetylcysteine|acetylcysteine|mesh-list
101975035|NCT04155632|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101975036|NCT04155632|Antiviral Agents|antiviral agents|mesh-ancestor
101975037|NCT04155632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101975038|NCT04155632|Expectorants|expectorants|mesh-ancestor
101975039|NCT04155632|Respiratory System Agents|respiratory system agents|mesh-ancestor
101975040|NCT04155632|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101975041|NCT04155632|Antioxidants|antioxidants|mesh-ancestor
101975042|NCT04155632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975043|NCT04155632|Protective Agents|protective agents|mesh-ancestor
101975044|NCT04155632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975045|NCT04155632|Antidotes|antidotes|mesh-ancestor
101975046|NCT04088630|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101975047|NCT04088630|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101975048|NCT04088630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975049|NCT04088630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101975050|NCT04088630|Immunologic Factors|immunologic factors|mesh-ancestor
101975051|NCT04088630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975052|NCT04073134|Evolocumab|evolocumab|mesh-list
101975053|NCT04073134|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101975054|NCT04073134|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101975055|NCT04073134|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101975056|NCT04073134|Antimetabolites|antimetabolites|mesh-ancestor
101975057|NCT04073134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975058|NCT04073134|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101975059|NCT04073134|Protease Inhibitors|protease inhibitors|mesh-ancestor
101975060|NCT04073134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101975061|NCT04073134|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101975062|NCT04034485|Evolocumab|evolocumab|mesh-list
101975063|NCT04034485|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101946201|NCT01159821|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101946202|NCT01159821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101946203|NCT01159821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101946204|NCT03881319|Contraceptive Agents|contraceptive agents|mesh-list
101946205|NCT03881319|Contraceptives, Oral|contraceptives, oral|mesh-list
101946206|NCT03881319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101946207|NCT03881319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975064|NCT04034485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101975065|NCT04034485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101975066|NCT04034485|Antimetabolites|antimetabolites|mesh-ancestor
101975067|NCT04034485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975068|NCT04034485|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101975069|NCT04034485|Protease Inhibitors|protease inhibitors|mesh-ancestor
101975070|NCT04034485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101975071|NCT04034485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101975072|NCT04010071|Axitinib|axitinib|mesh-list
101975073|NCT04010071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101975074|NCT04010071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101975075|NCT04010071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101975076|NCT04010071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975077|NCT03988920|Sevelamer|sevelamer|mesh-list
101975078|NCT03988920|Chelating Agents|chelating agents|mesh-ancestor
101975079|NCT03988920|Sequestering Agents|sequestering agents|mesh-ancestor
101628281|NCT00720499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101975082|NCT03925402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101975083|NCT03925402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101975084|NCT03892577|Immunomodulating Agents|immunomodulating agents|mesh-list
101975085|NCT03892577|Immunologic Factors|immunologic factors|mesh-ancestor
101975086|NCT03892577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975087|NCT03875079|Pembrolizumab|pembrolizumab|mesh-list
101975088|NCT03875079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101975089|NCT03875079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101975090|NCT03875079|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101975091|NCT03875079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975092|NCT03866252|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
101975093|NCT03866252|Hallucinogens|hallucinogens|mesh-ancestor
101975094|NCT03866252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975095|NCT03866252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101975096|NCT03866252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101975097|NCT03866252|Serotonin Agents|serotonin agents|mesh-ancestor
101975098|NCT03866252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101975099|NCT03866252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975100|NCT03866252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101975101|NCT03769298|Tacrolimus|tacrolimus|mesh-list
101975102|NCT03769298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101975103|NCT03769298|Immunologic Factors|immunologic factors|mesh-ancestor
101975104|NCT03769298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975105|NCT03769298|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101975106|NCT03769298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101975107|NCT03769298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975108|NCT03688451|Rituximab|rituximab|mesh-list
101975109|NCT03688451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101975110|NCT03688451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101975111|NCT03688451|Immunologic Factors|immunologic factors|mesh-ancestor
101975112|NCT03688451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975113|NCT03688451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101975114|NCT03626064|Nicotine|nicotine|mesh-list
101975115|NCT03626064|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101975116|NCT03626064|Autonomic Agents|autonomic agents|mesh-ancestor
101975117|NCT03626064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101975118|NCT03626064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975119|NCT03626064|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101975120|NCT03626064|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101975121|NCT03626064|Cholinergic Agents|cholinergic agents|mesh-ancestor
101975122|NCT03626064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101975123|NCT03626064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975124|NCT03613532|Fludarabine|fludarabine|mesh-list
101946208|NCT03881319|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101946209|NCT03885141|Zolpidem|zolpidem|mesh-list
101946210|NCT03885141|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101975125|NCT03613532|Azacitidine|azacitidine|mesh-list
101975126|NCT03613532|Busulfan|busulfan|mesh-list
101975127|NCT03613532|Decitabine|decitabine|mesh-list
101975128|NCT03613532|Venetoclax|venetoclax|mesh-list
101975129|NCT03613532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101975130|NCT03613532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101975131|NCT03613532|Antimetabolites|antimetabolites|mesh-ancestor
101975132|NCT03613532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975133|NCT03613532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101975134|NCT03613532|Immunologic Factors|immunologic factors|mesh-ancestor
101975135|NCT03613532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975136|NCT03613532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101975137|NCT03613532|Alkylating Agents|alkylating agents|mesh-ancestor
101975138|NCT03613532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101975139|NCT03613532|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101975140|NCT03593018|Gemcitabine|gemcitabine|mesh-list
101975142|NCT03593018|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101975143|NCT03593018|Romidepsin|romidepsin|mesh-list
101975144|NCT03593018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101975145|NCT03593018|Antimetabolites|antimetabolites|mesh-ancestor
101975146|NCT03593018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975147|NCT03593018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101975148|NCT03593018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101975149|NCT03593018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101975150|NCT03593018|Alkylating Agents|alkylating agents|mesh-ancestor
101975151|NCT03593018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101975152|NCT03593018|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101975153|NCT03570099|Naloxone|naloxone|mesh-list
101975160|NCT03529396|Primaquine|primaquine|mesh-list
101975161|NCT03529396|Amebicides|amebicides|mesh-ancestor
101975162|NCT03529396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101975163|NCT03529396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101975164|NCT03529396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101975165|NCT03529396|Antimalarials|antimalarials|mesh-ancestor
101975166|NCT03529396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101975167|NCT03529396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101975168|NCT03529396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101975169|NCT03529396|Analgesics|analgesics|mesh-ancestor
101975170|NCT03529396|Sensory System Agents|sensory system agents|mesh-ancestor
101975171|NCT03529396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101709978|NCT00678236|Histamine Antagonists|histamine antagonists|mesh-ancestor
101975172|NCT03529396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975173|NCT03529396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101975174|NCT03529396|Filaricides|filaricides|mesh-ancestor
101975175|NCT03529396|Antinematodal Agents|antinematodal agents|mesh-ancestor
101975176|NCT03529396|Anthelmintics|anthelmintics|mesh-ancestor
101975177|NCT03436563|Atezolizumab|atezolizumab|mesh-list
101975178|NCT03436563|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101975179|NCT03436563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975180|NCT03436563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101975181|NCT03436563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101975182|NCT03426254|Talazoparib|talazoparib|mesh-list
101975183|NCT03426254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101975184|NCT03426254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101975185|NCT03426254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975186|NCT03426254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101975187|NCT03411031|Thalidomide|thalidomide|mesh-list
101975188|NCT03411031|Dexamethasone|dexamethasone|mesh-list
101975189|NCT03411031|Lenalidomide|lenalidomide|mesh-list
101975190|NCT03411031|Elotuzumab|elotuzumab|mesh-list
101975191|NCT03411031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101975192|NCT03411031|Antiemetics|antiemetics|mesh-ancestor
101975193|NCT03411031|Autonomic Agents|autonomic agents|mesh-ancestor
101975194|NCT03411031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101975195|NCT03411031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975196|NCT03411031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101975197|NCT03411031|Glucocorticoids|glucocorticoids|mesh-ancestor
101975198|NCT03411031|Hormones|hormones|mesh-ancestor
101975199|NCT03411031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101975200|NCT03411031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101975201|NCT03411031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101975202|NCT03411031|Immunologic Factors|immunologic factors|mesh-ancestor
101946211|NCT03885141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101975203|NCT03411031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101975204|NCT03411031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101975205|NCT03411031|Growth Substances|growth substances|mesh-ancestor
101975206|NCT03411031|Growth Inhibitors|growth inhibitors|mesh-ancestor
101975207|NCT03411031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101975208|NCT03411031|Leprostatic Agents|leprostatic agents|mesh-ancestor
101975209|NCT03411031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101975210|NCT03411031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101975211|NCT03358017|Zoledronic Acid|zoledronic acid|mesh-list
101975212|NCT03358017|Atorvastatin|atorvastatin|mesh-list
101975213|NCT03358017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101975214|NCT03358017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101975215|NCT03358017|Antimetabolites|antimetabolites|mesh-ancestor
101694969|NCT00647660|Diuretics|diuretics|mesh-ancestor
101975216|NCT03358017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975217|NCT03358017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101975218|NCT03358017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101975220|NCT03358017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101975221|NCT03358017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975223|NCT03289351|Piperacillin|piperacillin|mesh-list
101975228|NCT03289351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101975229|NCT03289351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975230|NCT03280667|Denosumab|denosumab|mesh-list
101975231|NCT03280667|Pembrolizumab|pembrolizumab|mesh-list
101975232|NCT03280667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101975233|NCT03280667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101975234|NCT03280667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101975235|NCT03280667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975236|NCT03280667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101975237|NCT03280667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975238|NCT03272347|Tenofovir|tenofovir|mesh-list
101975239|NCT03272347|Lamivudine|lamivudine|mesh-list
101975240|NCT03272347|Islatravir|islatravir|mesh-list
101975241|NCT03272347|Antiviral Agents|antiviral agents|mesh-ancestor
101975242|NCT03272347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101975243|NCT03272347|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101975244|NCT03272347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101975245|NCT03272347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101975246|NCT03272347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975247|NCT03272347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101975248|NCT03272347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101975249|NCT03251300|Mirabegron|mirabegron|mesh-list
101975250|NCT03251300|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101975251|NCT03251300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101975252|NCT03251300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101975253|NCT03251300|Adrenergic Agents|adrenergic agents|mesh-ancestor
101975254|NCT03251300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101975255|NCT03251300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975256|NCT03251300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975257|NCT03251300|Urological Agents|urological agents|mesh-ancestor
101975258|NCT03228693|Triamcinolone|triamcinolone|mesh-list
101975259|NCT03228693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101975260|NCT03228693|Glucocorticoids|glucocorticoids|mesh-ancestor
101975261|NCT03228693|Hormones|hormones|mesh-ancestor
101975262|NCT03228693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101975263|NCT03228693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975264|NCT03108690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101975265|NCT03108690|Meropenem|meropenem|mesh-list
101975266|NCT03108690|Tazobactam|tazobactam|mesh-list
101975267|NCT03108690|Piperacillin|piperacillin|mesh-list
101975268|NCT03108690|Ampicillin|ampicillin|mesh-list
101975269|NCT03108690|Cefuroxime|cefuroxime|mesh-list
101975270|NCT03108690|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101975271|NCT03108690|Lactams|lactams|mesh-list
101975272|NCT03108690|beta-Lactams|beta-lactams|mesh-list
101975273|NCT03108690|Penicillin G|penicillin g|mesh-list
101975274|NCT03108690|Dicloxacillin|dicloxacillin|mesh-list
101975275|NCT03108690|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101975276|NCT03108690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101975277|NCT03108690|Antitubercular Agents|antitubercular agents|mesh-ancestor
101975278|NCT03108690|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101975279|NCT03108690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101975280|NCT03108690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946212|NCT03885141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101946213|NCT03885141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946214|NCT03885141|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101801872|NCT01010451|Calcium|calcium|mesh-list
101975281|NCT03103152|Aspirin|aspirin|mesh-list
101975282|NCT03103152|Vitamin D|vitamin d|mesh-list
101975283|NCT03103152|Ergocalciferols|ergocalciferols|mesh-list
101975284|NCT03103152|Cholecalciferol|cholecalciferol|mesh-list
101975285|NCT03103152|Vitamins|vitamins|mesh-list
101975286|NCT03103152|Micronutrients|micronutrients|mesh-ancestor
101975287|NCT03103152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975288|NCT03103152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101975289|NCT03103152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101975290|NCT03103152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101975291|NCT03103152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101975292|NCT03103152|Analgesics|analgesics|mesh-ancestor
101975293|NCT03103152|Sensory System Agents|sensory system agents|mesh-ancestor
101975294|NCT03103152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101975295|NCT03103152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101975297|NCT03103152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101975298|NCT03103152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101975299|NCT03103152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975300|NCT03103152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101975301|NCT03103152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101975302|NCT03103152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101975303|NCT03103152|Antipyretics|antipyretics|mesh-ancestor
101975304|NCT02988297|RNS60|rns60|mesh-list
101975305|NCT02988297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101975306|NCT02988297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101975307|NCT02988297|Analgesics|analgesics|mesh-ancestor
101975308|NCT02988297|Sensory System Agents|sensory system agents|mesh-ancestor
101975309|NCT02988297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101975310|NCT02988297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975311|NCT02988297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101975312|NCT02988297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101975313|NCT02988297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101975314|NCT02937285|Interferons|interferons|mesh-list
101975315|NCT02937285|Interferon-beta|interferon-beta|mesh-list
101975316|NCT02937285|Interferon beta-1a|interferon beta-1a|mesh-list
101975317|NCT02937285|Mitoxantrone|mitoxantrone|mesh-list
101975318|NCT02937285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101975319|NCT02937285|Antiviral Agents|antiviral agents|mesh-ancestor
101975320|NCT02937285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101975321|NCT02937285|Analgesics|analgesics|mesh-ancestor
101975322|NCT02937285|Sensory System Agents|sensory system agents|mesh-ancestor
101975323|NCT02937285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101975324|NCT02937285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975325|NCT02937285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101975326|NCT02937285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101975327|NCT02937285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101975328|NCT02937285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975329|NCT02937285|Immunologic Factors|immunologic factors|mesh-ancestor
101975330|NCT02937285|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101975331|NCT02878785|Decitabine|decitabine|mesh-list
101975332|NCT02878785|Talazoparib|talazoparib|mesh-list
101975333|NCT02878785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101975334|NCT02878785|Antimetabolites|antimetabolites|mesh-ancestor
101975335|NCT02878785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975336|NCT02878785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101975337|NCT02878785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101975338|NCT02878785|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101975339|NCT02825576|Glycopyrrolate|glycopyrrolate|mesh-list
101975340|NCT02825576|Neostigmine|neostigmine|mesh-list
101975341|NCT02825576|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101975342|NCT02825576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101975343|NCT02825576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975344|NCT02825576|Cholinergic Agents|cholinergic agents|mesh-ancestor
101975345|NCT02825576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101975346|NCT02825576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975347|NCT02825576|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101975348|NCT02825576|Autonomic Agents|autonomic agents|mesh-ancestor
101975349|NCT02825576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101946215|NCT03885141|GABA Agonists|gaba agonists|mesh-ancestor
101946216|NCT03885141|GABA Agents|gaba agents|mesh-ancestor
101946217|NCT03885141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101801918|NCT00509925|Isophane insulin, beef|isophane insulin, beef|mesh-list
101975350|NCT02825576|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101975351|NCT02825576|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101975352|NCT02825576|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101975353|NCT02719613|Dexamethasone|dexamethasone|mesh-list
101975354|NCT02719613|Dexamethasone acetate|dexamethasone acetate|mesh-list
101975355|NCT02719613|Nivolumab|nivolumab|mesh-list
101975356|NCT02719613|Lenalidomide|lenalidomide|mesh-list
101975357|NCT02719613|Bortezomib|bortezomib|mesh-list
101975358|NCT02719613|Pomalidomide|pomalidomide|mesh-list
101975359|NCT02719613|Elotuzumab|elotuzumab|mesh-list
101975360|NCT02719613|BB 1101|bb 1101|mesh-list
101975361|NCT02719613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101975362|NCT02719613|Antiemetics|antiemetics|mesh-ancestor
101975363|NCT02719613|Autonomic Agents|autonomic agents|mesh-ancestor
101975364|NCT02719613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101975365|NCT02719613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975366|NCT02719613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101975367|NCT02719613|Glucocorticoids|glucocorticoids|mesh-ancestor
101975368|NCT02719613|Hormones|hormones|mesh-ancestor
101975369|NCT02719613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101975370|NCT02719613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101975371|NCT02719613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101975382|NCT02660645|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101975383|NCT02660645|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101975384|NCT02660645|Dermatologic Agents|dermatologic agents|mesh-ancestor
101975385|NCT02603887|Pembrolizumab|pembrolizumab|mesh-list
101975386|NCT02603887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101975387|NCT02603887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101975388|NCT02603887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101975389|NCT02603887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975390|NCT02315196|Paclitaxel|paclitaxel|mesh-list
101975391|NCT02315196|Carboplatin|carboplatin|mesh-list
101975392|NCT02315196|Doxorubicin|doxorubicin|mesh-list
101975393|NCT02315196|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101975394|NCT02315196|Epirubicin|epirubicin|mesh-list
101975395|NCT02315196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101975396|NCT02315196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101975397|NCT02315196|Tubulin Modulators|tubulin modulators|mesh-ancestor
101975398|NCT02315196|Antimitotic Agents|antimitotic agents|mesh-ancestor
101975399|NCT02315196|Mitosis Modulators|mitosis modulators|mesh-ancestor
101975400|NCT02315196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975401|NCT02315196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101975402|NCT02315196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101975403|NCT02315196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101975404|NCT02315196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101975405|NCT02179853|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101975406|NCT02179853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101975407|NCT01917877|Dexamethasone|dexamethasone|mesh-list
101975408|NCT01917877|Bevacizumab|bevacizumab|mesh-list
101975409|NCT01917877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101975410|NCT01917877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101975411|NCT01917877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101975412|NCT01917877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101975413|NCT01917877|Growth Substances|growth substances|mesh-ancestor
101975414|NCT01917877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975415|NCT01917877|Growth Inhibitors|growth inhibitors|mesh-ancestor
101975416|NCT01917877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101975417|NCT01917877|Antiemetics|antiemetics|mesh-ancestor
101975418|NCT01917877|Autonomic Agents|autonomic agents|mesh-ancestor
101975419|NCT01917877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101975420|NCT01917877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101975421|NCT01917877|Glucocorticoids|glucocorticoids|mesh-ancestor
101975422|NCT01917877|Hormones|hormones|mesh-ancestor
101975423|NCT01917877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101975424|NCT01917877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101975425|NCT01698840|Vitamin D|vitamin d|mesh-list
101975426|NCT01698840|Vitamins|vitamins|mesh-ancestor
101975427|NCT01698840|Micronutrients|micronutrients|mesh-ancestor
101975428|NCT01698840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975429|NCT01698840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101946218|NCT03885141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946219|NCT03879057|Antibodies|antibodies|mesh-list
101975430|NCT01570296|Gefitinib|gefitinib|mesh-list
101975431|NCT01570296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101975432|NCT01570296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101975433|NCT01570296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101975434|NCT01570296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975435|NCT01087619|Parathyroid Hormone|parathyroid hormone|mesh-list
101975438|NCT00496873|Cyclophosphamide|cyclophosphamide|mesh-list
101975439|NCT00496873|Rituximab|rituximab|mesh-list
101975440|NCT00496873|Pentostatin|pentostatin|mesh-list
101975441|NCT00496873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101695191|NCT02782481|Carbidopa|carbidopa|mesh-list
101975442|NCT00496873|Immunologic Factors|immunologic factors|mesh-ancestor
101975443|NCT00496873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975444|NCT00496873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101975445|NCT00496873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101975446|NCT00496873|Alkylating Agents|alkylating agents|mesh-ancestor
101975447|NCT00496873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975448|NCT00496873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101975449|NCT00496873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101975450|NCT00496873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101975451|NCT00496873|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
101975452|NCT00496873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101975453|NCT00492778|Cisplatin|cisplatin|mesh-list
101975454|NCT00492778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101975455|NCT03931369|Tolvaptan|tolvaptan|mesh-list
101975456|NCT03931369|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101975457|NCT03931369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975458|NCT03931369|Natriuretic Agents|natriuretic agents|mesh-ancestor
101975459|NCT03931369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975460|NCT00359216|Mometasone Furoate|mometasone furoate|mesh-list
101975461|NCT00359216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101975462|NCT00359216|Dermatologic Agents|dermatologic agents|mesh-ancestor
101975463|NCT00359216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101975464|NCT01239550|Insulin Detemir|insulin detemir|mesh-list
101975465|NCT01239550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101975466|NCT01239550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975467|NCT03721328|Vancomycin|vancomycin|mesh-list
101975468|NCT03721328|Tobramycin|tobramycin|mesh-list
101975469|NCT03721328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101975470|NCT03721328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101975471|NCT01220791|Progesterone|progesterone|mesh-list
101975472|NCT01220791|Progestins|progestins|mesh-ancestor
101975473|NCT01220791|Hormones|hormones|mesh-ancestor
101975474|NCT01220791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101975475|NCT01220791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975476|NCT01353482|Pemetrexed|pemetrexed|mesh-list
101975477|NCT01353482|Vorinostat|vorinostat|mesh-list
101975478|NCT01353482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101975479|NCT01353482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101975480|NCT01353482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975481|NCT01353482|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101975482|NCT01353482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101975483|NCT01353482|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101975484|NCT02291380|Botulinum Toxins|botulinum toxins|mesh-list
101975485|NCT02291380|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101975486|NCT02291380|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101975487|NCT02291380|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101710028|NCT00665522|Anesthetics, General|anesthetics, general|mesh-ancestor
101710029|NCT00665522|Anesthetics|anesthetics|mesh-ancestor
101710030|NCT00675272|Hydrocortisone|hydrocortisone|mesh-list
101710031|NCT00675272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101710032|NCT00678626|Docetaxel|docetaxel|mesh-list
101710033|NCT00678626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101710034|NCT00678626|Tubulin Modulators|tubulin modulators|mesh-ancestor
101710035|NCT00678626|Antimitotic Agents|antimitotic agents|mesh-ancestor
101710036|NCT00678626|Mitosis Modulators|mitosis modulators|mesh-ancestor
101710037|NCT00678626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710038|NCT00678704|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101710039|NCT00678704|Vasodilator Agents|vasodilator agents|mesh-ancestor
101975488|NCT02291380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101975489|NCT02291380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975490|NCT02291380|Cholinergic Agents|cholinergic agents|mesh-ancestor
101975491|NCT02291380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101975492|NCT02291380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975493|NCT02291380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101975494|NCT02291380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101975495|NCT01353716|Dolutegravir|dolutegravir|mesh-list
101975496|NCT01353716|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101975497|NCT01353716|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101975498|NCT01353716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101975499|NCT01353716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975500|NCT01353716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101975501|NCT01353716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101946220|NCT03879057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101946221|NCT03879057|Immunologic Factors|immunologic factors|mesh-ancestor
101975502|NCT01353716|Antiviral Agents|antiviral agents|mesh-ancestor
101975503|NCT01353716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101975504|NCT04481672|Magnesium Sulfate|magnesium sulfate|mesh-list
101975505|NCT04481672|Analgesics|analgesics|mesh-ancestor
101975506|NCT04481672|Sensory System Agents|sensory system agents|mesh-ancestor
101975507|NCT04481672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101975510|NCT04481672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101975511|NCT04481672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101975512|NCT04481672|Anticonvulsants|anticonvulsants|mesh-ancestor
101975513|NCT04481672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101975514|NCT04481672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101975515|NCT04481672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975516|NCT04481672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101975518|NCT04481672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101975519|NCT01224067|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101975520|NCT01224067|Antidepressive Agents|antidepressive agents|mesh-ancestor
101975521|NCT01224067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101975522|NCT01224067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101975523|NCT01224067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101975524|NCT01224067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101975525|NCT01224067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975526|NCT04465942|Paclitaxel|paclitaxel|mesh-list
101975527|NCT04465942|Pembrolizumab|pembrolizumab|mesh-list
101975528|NCT04465942|Nivolumab|nivolumab|mesh-list
101975529|NCT04465942|Pemetrexed|pemetrexed|mesh-list
101975530|NCT04465942|Atezolizumab|atezolizumab|mesh-list
101975531|NCT04465942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101975532|NCT04465942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101975533|NCT04465942|Tubulin Modulators|tubulin modulators|mesh-ancestor
101975534|NCT04465942|Antimitotic Agents|antimitotic agents|mesh-ancestor
101975535|NCT04465942|Mitosis Modulators|mitosis modulators|mesh-ancestor
101975536|NCT04465942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975537|NCT04465942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101975538|NCT04465942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101975539|NCT04465942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101975540|NCT04465942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101975541|NCT04465942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101975542|NCT01126645|Sorafenib|sorafenib|mesh-list
101975543|NCT01126645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101975544|NCT01126645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101975545|NCT01126645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101975546|NCT01126645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975547|NCT01343186|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101975548|NCT01343186|Interferon-alpha|interferon-alpha|mesh-list
101975549|NCT01343186|Antiviral Agents|antiviral agents|mesh-ancestor
101975550|NCT01343186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101975551|NCT01343186|Immunologic Factors|immunologic factors|mesh-ancestor
101975552|NCT01343186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975553|NCT01329289|Dexamethasone|dexamethasone|mesh-list
101975554|NCT01329289|Dexamethasone acetate|dexamethasone acetate|mesh-list
101975555|NCT01329289|Bortezomib|bortezomib|mesh-list
101975556|NCT01329289|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101975557|NCT01329289|Pasireotide|pasireotide|mesh-list
101975558|NCT01329289|BB 1101|bb 1101|mesh-list
101975559|NCT01329289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101975560|NCT01329289|Antiemetics|antiemetics|mesh-ancestor
101975561|NCT01329289|Autonomic Agents|autonomic agents|mesh-ancestor
101975562|NCT01329289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101975563|NCT01329289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975564|NCT01329289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101975565|NCT01329289|Glucocorticoids|glucocorticoids|mesh-ancestor
101975566|NCT01329289|Hormones|hormones|mesh-ancestor
101975567|NCT01329289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101975568|NCT01329289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101975569|NCT01329289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101975570|NCT01329289|Protease Inhibitors|protease inhibitors|mesh-ancestor
101975571|NCT01329289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101975572|NCT01329289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975573|NCT02291536|Dronabinol|dronabinol|mesh-list
101975574|NCT02291536|Cannabidiol|cannabidiol|mesh-list
101975575|NCT02291536|Anticonvulsants|anticonvulsants|mesh-ancestor
101975576|NCT02291536|Hallucinogens|hallucinogens|mesh-ancestor
101975577|NCT02291536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946222|NCT03879057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946224|NCT01266057|Hydroxychloroquine|hydroxychloroquine|mesh-list
101946225|NCT01266057|Vorinostat|vorinostat|mesh-list
101946226|NCT01266057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101975578|NCT02291536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101975579|NCT02291536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101975580|NCT02291536|Analgesics|analgesics|mesh-ancestor
101975581|NCT02291536|Sensory System Agents|sensory system agents|mesh-ancestor
101975582|NCT02291536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101975585|NCT02291536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101975586|NCT02291536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975587|NCT02291536|Hormones|hormones|mesh-ancestor
101975588|NCT02291536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101975589|NCT01317992|Ibudilast|ibudilast|mesh-list
101975590|NCT01317992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101975591|NCT01317992|Autonomic Agents|autonomic agents|mesh-ancestor
101975592|NCT01317992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101975593|NCT01317992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975594|NCT01317992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101975595|NCT01317992|Respiratory System Agents|respiratory system agents|mesh-ancestor
101975596|NCT01317992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101975597|NCT01317992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101975598|NCT01317992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975599|NCT01317992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101975600|NCT01317992|Vasodilator Agents|vasodilator agents|mesh-ancestor
101975601|NCT03635788|Rilpivirine|rilpivirine|mesh-list
101975602|NCT03635788|Cabotegravir|cabotegravir|mesh-list
101975603|NCT03635788|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101975604|NCT03635788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101975605|NCT03635788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101975606|NCT03635788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975607|NCT03635788|Antiviral Agents|antiviral agents|mesh-ancestor
101975608|NCT03635788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101975609|NCT03635788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101975610|NCT03635788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101975611|NCT03635788|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101975612|NCT03635788|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101975613|NCT01348412|Oxaliplatin|oxaliplatin|mesh-list
101975614|NCT01348412|Raltitrexed|raltitrexed|mesh-list
101975615|NCT01348412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101975616|NCT01348412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101975617|NCT01348412|Antimetabolites|antimetabolites|mesh-ancestor
101975618|NCT01348412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975619|NCT01348412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101975620|NCT01348412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101975621|NCT01353794|Sorafenib|sorafenib|mesh-list
101975622|NCT01353794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101975623|NCT01353794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101975624|NCT01353794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101975625|NCT01353794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975626|NCT01224301|Vaccines|vaccines|mesh-list
101975627|NCT01224301|Immunologic Factors|immunologic factors|mesh-ancestor
101975628|NCT01224301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975629|NCT01221025|Parecoxib|parecoxib|mesh-list
101975630|NCT01221025|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101975631|NCT01221025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101975632|NCT01221025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101975633|NCT01221025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975634|NCT01221025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101975635|NCT01221025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101975636|NCT01221025|Analgesics|analgesics|mesh-ancestor
101975637|NCT01221025|Sensory System Agents|sensory system agents|mesh-ancestor
101975638|NCT01221025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101975639|NCT01221025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975640|NCT01221025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101975641|NCT01221025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101975642|NCT03523390|Avelumab|avelumab|mesh-list
101975643|NCT03523390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101975644|NCT03523390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101946227|NCT01266057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101975645|NCT01221103|Dexamethasone|dexamethasone|mesh-list
101975646|NCT01221103|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101975647|NCT01221103|Ofatumumab|ofatumumab|mesh-list
101975648|NCT01221103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101975649|NCT01221103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101975650|NCT01221103|Antiemetics|antiemetics|mesh-ancestor
101975651|NCT01221103|Autonomic Agents|autonomic agents|mesh-ancestor
101975652|NCT01221103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101975653|NCT01221103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975654|NCT01221103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101975658|NCT01221103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101975659|NCT01221103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101975660|NCT01221103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101975662|NCT01221103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975663|NCT01221103|Immunologic Factors|immunologic factors|mesh-ancestor
101975664|NCT03706898|Sofosbuvir|sofosbuvir|mesh-list
101975665|NCT03706898|Dolutegravir|dolutegravir|mesh-list
101695416|NCT00648362|Immunologic Factors|immunologic factors|mesh-ancestor
101975666|NCT03706898|Elsulfavirine|elsulfavirine|mesh-list
101975667|NCT03706898|Antiviral Agents|antiviral agents|mesh-ancestor
101975668|NCT03706898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101975669|NCT03706898|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101975670|NCT03706898|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101975671|NCT03706898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101975672|NCT03706898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975673|NCT03706898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101975674|NCT03706898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101975675|NCT03927313|Aspirin|aspirin|mesh-list
101975676|NCT03927313|Rifampin|rifampin|mesh-list
101975677|NCT03927313|Linezolid|linezolid|mesh-list
101975678|NCT03927313|Dexamethasone|dexamethasone|mesh-list
101975679|NCT03927313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101975680|NCT03927313|Antiemetics|antiemetics|mesh-ancestor
101975681|NCT03927313|Autonomic Agents|autonomic agents|mesh-ancestor
101975682|NCT03927313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101975683|NCT03927313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975684|NCT03927313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101975685|NCT03927313|Glucocorticoids|glucocorticoids|mesh-ancestor
101975686|NCT03927313|Hormones|hormones|mesh-ancestor
101975687|NCT03927313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101975688|NCT03927313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101975689|NCT03927313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101975690|NCT03927313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101975691|NCT03927313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101975692|NCT03927313|Analgesics|analgesics|mesh-ancestor
101975693|NCT03927313|Sensory System Agents|sensory system agents|mesh-ancestor
101975694|NCT03927313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101975695|NCT03927313|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101975696|NCT03927313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101975697|NCT03927313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975698|NCT03927313|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101975699|NCT03927313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101975700|NCT03927313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101975701|NCT03927313|Antipyretics|antipyretics|mesh-ancestor
101975702|NCT03927313|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101975703|NCT03927313|Antitubercular Agents|antitubercular agents|mesh-ancestor
101975704|NCT03927313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101975705|NCT03927313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101975706|NCT03927313|Leprostatic Agents|leprostatic agents|mesh-ancestor
101975707|NCT03927313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101975708|NCT03927313|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101975709|NCT03927313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101975710|NCT03927313|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101975711|NCT03927313|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101975712|NCT03927313|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101975713|NCT03927313|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101975714|NCT03927313|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101975715|NCT01224457|Phenobarbital|phenobarbital|mesh-list
101975716|NCT01224457|Anticonvulsants|anticonvulsants|mesh-ancestor
101975717|NCT01224457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101975718|NCT01224457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101975719|NCT01224457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975720|NCT01224457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101946228|NCT01266057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101946229|NCT01266057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101946230|NCT01266057|Antifungal Agents|antifungal agents|mesh-ancestor
101946231|NCT01266057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101975721|NCT01224457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101975722|NCT01224457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101975723|NCT01224457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975726|NCT01224457|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101975727|NCT01224457|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101975728|NCT01224457|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101975729|NCT03133312|Chlorhexidine|chlorhexidine|mesh-list
101975730|NCT03133312|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101975731|NCT03133312|Povidone-Iodine|povidone-iodine|mesh-list
101975732|NCT03133312|Povidone|povidone|mesh-list
101975733|NCT03133312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101975734|NCT03133312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101975735|NCT03133312|Disinfectants|disinfectants|mesh-ancestor
101975736|NCT03133312|Dermatologic Agents|dermatologic agents|mesh-ancestor
101975737|NCT03133312|Plasma Substitutes|plasma substitutes|mesh-ancestor
101975738|NCT03133312|Blood Substitutes|blood substitutes|mesh-ancestor
101975739|NCT01318148|Caspofungin|caspofungin|mesh-list
101975740|NCT01318148|Antifungal Agents|antifungal agents|mesh-ancestor
101975741|NCT01318148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101975742|NCT01318148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101975743|NCT01318148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975744|NCT01354262|Vitamin D|vitamin d|mesh-list
101975745|NCT01354262|Ergocalciferols|ergocalciferols|mesh-list
101975746|NCT01354262|Cholecalciferol|cholecalciferol|mesh-list
101975747|NCT01354262|Vitamins|vitamins|mesh-list
101975748|NCT01354262|Micronutrients|micronutrients|mesh-ancestor
101975749|NCT01354262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975750|NCT01354262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101975751|NCT01354262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101975752|NCT01343498|Dactolisib|dactolisib|mesh-list
101975753|NCT01343498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101975754|NCT01221337|Heparin|heparin|mesh-list
101975755|NCT01221337|Anticoagulants|anticoagulants|mesh-ancestor
101975756|NCT01221337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101975757|NCT01221337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101975758|NCT01221337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975759|NCT01354418|Phenylephrine|phenylephrine|mesh-list
101975760|NCT01354418|Oxymetazoline|oxymetazoline|mesh-list
101975761|NCT01354418|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101975762|NCT01354418|Mydriatics|mydriatics|mesh-ancestor
101975763|NCT01354418|Autonomic Agents|autonomic agents|mesh-ancestor
101975764|NCT01354418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101975765|NCT01354418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975766|NCT01354418|Sympathomimetics|sympathomimetics|mesh-ancestor
101975767|NCT01354418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101975768|NCT01354418|Nasal Decongestants|nasal decongestants|mesh-ancestor
101975769|NCT01354418|Respiratory System Agents|respiratory system agents|mesh-ancestor
101975770|NCT01354418|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101975771|NCT01354418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101975772|NCT01354418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101975773|NCT01354418|Adrenergic Agents|adrenergic agents|mesh-ancestor
101975774|NCT01354418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101975775|NCT01354418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975776|NCT01354418|Protective Agents|protective agents|mesh-ancestor
101975777|NCT02818868|Apixaban|apixaban|mesh-list
101975778|NCT02818868|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101975779|NCT02818868|Antithrombins|antithrombins|mesh-ancestor
101975780|NCT02818868|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101975781|NCT02818868|Protease Inhibitors|protease inhibitors|mesh-ancestor
101975782|NCT02818868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101975783|NCT02818868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975784|NCT02818868|Anticoagulants|anticoagulants|mesh-ancestor
101975785|NCT01224535|Micronutrients|micronutrients|mesh-list
101975786|NCT01224535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975787|NCT02289274|Aceclofenac|aceclofenac|mesh-list
101975788|NCT02289274|Eperisone|eperisone|mesh-list
101975789|NCT02289274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101975790|NCT02289274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101975791|NCT02289274|Analgesics|analgesics|mesh-ancestor
101946232|NCT01266057|Immunologic Factors|immunologic factors|mesh-ancestor
101946233|NCT01266057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946234|NCT01266057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101946235|NCT01266057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946236|NCT01266057|Antimalarials|antimalarials|mesh-ancestor
101946237|NCT01266057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101975792|NCT02289274|Sensory System Agents|sensory system agents|mesh-ancestor
101975793|NCT02289274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101975794|NCT02289274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975795|NCT02289274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101975796|NCT02289274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101975797|NCT02289274|Anticonvulsants|anticonvulsants|mesh-ancestor
101975798|NCT02289274|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101975799|NCT02289274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101975802|NCT02289274|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101975803|NCT02289274|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101975804|NCT02289274|Parasympatholytics|parasympatholytics|mesh-ancestor
101975805|NCT02289274|Autonomic Agents|autonomic agents|mesh-ancestor
101975806|NCT02289274|Vasodilator Agents|vasodilator agents|mesh-ancestor
101975807|NCT01224613|Vaccines|vaccines|mesh-list
101975808|NCT01224613|Immunologic Factors|immunologic factors|mesh-ancestor
101975809|NCT01224613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975810|NCT03930433|Nebivolol|nebivolol|mesh-list
101975811|NCT03930433|Diltiazem|diltiazem|mesh-list
101975812|NCT03930433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101695566|NCT00980239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101975813|NCT03930433|Vasodilator Agents|vasodilator agents|mesh-ancestor
101975814|NCT03930433|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101975815|NCT03930433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101975816|NCT03930433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101975817|NCT03930433|Adrenergic Agents|adrenergic agents|mesh-ancestor
101975818|NCT03930433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101975819|NCT03930433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975820|NCT03930433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975821|NCT03930433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101975822|NCT03930433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101975823|NCT03930433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101975824|NCT01224769|Rituximab|rituximab|mesh-list
101975825|NCT01224769|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101975826|NCT01224769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101975827|NCT01224769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101975828|NCT01224769|Immunologic Factors|immunologic factors|mesh-ancestor
101975829|NCT01224769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975830|NCT01224769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101975831|NCT01224769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101975832|NCT01224769|Alkylating Agents|alkylating agents|mesh-ancestor
101975833|NCT01224769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975834|NCT02289430|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101975835|NCT02289430|Ezetimibe|ezetimibe|mesh-list
101975836|NCT02289430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101975837|NCT02289430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101975838|NCT02289430|Antimetabolites|antimetabolites|mesh-ancestor
101975839|NCT02289430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975840|NCT02289430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101975841|NCT02289430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101975842|NCT02289430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101975843|NCT01224847|Lidocaine|lidocaine|mesh-list
101975844|NCT01224847|Cocaine|cocaine|mesh-list
101975845|NCT01224847|Tetracaine|tetracaine|mesh-list
101975846|NCT01224847|Anesthetics, Local|anesthetics, local|mesh-ancestor
101975847|NCT01224847|Anesthetics|anesthetics|mesh-ancestor
101975848|NCT01224847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101975849|NCT01224847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975850|NCT01224847|Sensory System Agents|sensory system agents|mesh-ancestor
101975851|NCT01224847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101975852|NCT01224847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101975853|NCT01224847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101975854|NCT01224847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101946239|NCT01266057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101946240|NCT01266057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101946241|NCT01266213|Fulvestrant|fulvestrant|mesh-list
101946242|NCT01266213|Anastrozole|anastrozole|mesh-list
101975855|NCT01224847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101975856|NCT01224847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975857|NCT01224847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101975858|NCT01224847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101975859|NCT01224847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101975860|NCT01224847|Dopamine Agents|dopamine agents|mesh-ancestor
101975861|NCT01224847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101975862|NCT02289586|Fentanyl|fentanyl|mesh-list
101975863|NCT02289586|Midazolam|midazolam|mesh-list
101975864|NCT02289586|Remifentanil|remifentanil|mesh-list
101975865|NCT02289586|Dezocine|dezocine|mesh-list
101975866|NCT02289586|Propofol|propofol|mesh-list
101975867|NCT02289586|Rocuronium|rocuronium|mesh-list
101975868|NCT02289586|Anesthetics|anesthetics|mesh-ancestor
101975869|NCT02289586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101975870|NCT02289586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975873|NCT02289586|Anesthetics, General|anesthetics, general|mesh-ancestor
101975874|NCT02289586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101975875|NCT02289586|Narcotics|narcotics|mesh-ancestor
101975876|NCT02289586|Analgesics|analgesics|mesh-ancestor
101975877|NCT02289586|Sensory System Agents|sensory system agents|mesh-ancestor
101975878|NCT02289586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101975879|NCT02289586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101975880|NCT02289586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101975881|NCT02289586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101975882|NCT02289586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101975883|NCT02289586|GABA Modulators|gaba modulators|mesh-ancestor
101975884|NCT02289586|GABA Agents|gaba agents|mesh-ancestor
101975885|NCT02289586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101975886|NCT02289586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975887|NCT02289586|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101975888|NCT02289586|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101975889|NCT02289586|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101975890|NCT03740581|Insulin|insulin|mesh-list
101975891|NCT03740581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101975892|NCT03740581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975893|NCT03874897|Antibodies|antibodies|mesh-list
101975894|NCT03874897|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101975895|NCT03874897|Immunologic Factors|immunologic factors|mesh-ancestor
101975896|NCT03874897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975897|NCT01127035|Immunomodulating Agents|immunomodulating agents|mesh-list
101975898|NCT01127035|Immunologic Factors|immunologic factors|mesh-ancestor
101975899|NCT01127035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975900|NCT02294266|Ethanol|ethanol|mesh-list
101975901|NCT02294266|Methamphetamine|methamphetamine|mesh-list
101975902|NCT02294266|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101975903|NCT02294266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101975904|NCT02294266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101975905|NCT02294266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975906|NCT02294266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101975907|NCT02294266|Sympathomimetics|sympathomimetics|mesh-ancestor
101975908|NCT02294266|Autonomic Agents|autonomic agents|mesh-ancestor
101975909|NCT02294266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101975910|NCT02294266|Dopamine Agents|dopamine agents|mesh-ancestor
101975911|NCT02294266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101975912|NCT02294266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975913|NCT02294266|Adrenergic Agents|adrenergic agents|mesh-ancestor
101975914|NCT02294266|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101975915|NCT02294266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101975916|NCT02294266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101975917|NCT02294266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101975918|NCT02294344|Cyclophosphamide|cyclophosphamide|mesh-list
101975919|NCT02294344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101975920|NCT02294344|Immunologic Factors|immunologic factors|mesh-ancestor
101975921|NCT02294344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975922|NCT02294344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101975923|NCT02294344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101946243|NCT01266213|Goserelin|goserelin|mesh-list
101946244|NCT01266213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101946245|NCT01266213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101975924|NCT02294344|Alkylating Agents|alkylating agents|mesh-ancestor
101975925|NCT02294344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975926|NCT02294344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101975927|NCT02294344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101975928|NCT01130311|Vitamin D|vitamin d|mesh-list
101975929|NCT01130311|Cholecalciferol|cholecalciferol|mesh-list
101975930|NCT01130311|Vitamins|vitamins|mesh-ancestor
101975931|NCT01130311|Micronutrients|micronutrients|mesh-ancestor
101975932|NCT01130311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975933|NCT01130311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101975934|NCT01130311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101975935|NCT03926377|Clobetasol|clobetasol|mesh-list
101975936|NCT03926377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101975937|NCT03926377|Glucocorticoids|glucocorticoids|mesh-ancestor
101975938|NCT03926377|Hormones|hormones|mesh-ancestor
101975939|NCT03926377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101975940|NCT03926377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975941|NCT03132688|Propofol|propofol|mesh-list
101975942|NCT03132688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101975943|NCT03132688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101975948|NCT01227811|Darifenacin|darifenacin|mesh-list
101975949|NCT01227811|Muscarinic Antagonists|muscarinic antagonists|mesh-list
101975950|NCT01227811|Cholinergic Agents|cholinergic agents|mesh-list
101975951|NCT01227811|Cholinergic Antagonists|cholinergic antagonists|mesh-list
101975952|NCT01227811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101975953|NCT01227811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975954|NCT01227811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975955|NCT01227811|Urological Agents|urological agents|mesh-ancestor
101975956|NCT01225081|Pioglitazone|pioglitazone|mesh-list
101975957|NCT01225081|Ipragliflozin|ipragliflozin|mesh-list
101975958|NCT01225081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101975959|NCT01225081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975960|NCT01225081|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101975961|NCT01225081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975962|NCT02298166|Cytarabine|cytarabine|mesh-list
101975963|NCT02298166|Mitoxantrone|mitoxantrone|mesh-list
101975964|NCT02298166|Crenolanib|crenolanib|mesh-list
101975965|NCT02298166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101975966|NCT02298166|Antimetabolites|antimetabolites|mesh-ancestor
101975967|NCT02298166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975968|NCT02298166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101975969|NCT02298166|Antiviral Agents|antiviral agents|mesh-ancestor
101975970|NCT02298166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101975971|NCT02298166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101975972|NCT02298166|Immunologic Factors|immunologic factors|mesh-ancestor
101975973|NCT02298166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975974|NCT02298166|Analgesics|analgesics|mesh-ancestor
101975975|NCT02298166|Sensory System Agents|sensory system agents|mesh-ancestor
101975976|NCT02298166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101975977|NCT02298166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101975978|NCT02298166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101975979|NCT02298166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101975980|NCT01127269|Insulin Glargine|insulin glargine|mesh-list
101975981|NCT01127269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101975982|NCT01127269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975983|NCT01221883|Diazepam|diazepam|mesh-list
101975984|NCT01221883|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101975985|NCT01221883|Anticonvulsants|anticonvulsants|mesh-ancestor
101975986|NCT01221883|Antiemetics|antiemetics|mesh-ancestor
101975987|NCT01221883|Autonomic Agents|autonomic agents|mesh-ancestor
101975988|NCT01221883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101975989|NCT01221883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975990|NCT01221883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101975991|NCT01221883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101975992|NCT01221883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101975993|NCT01221883|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101975994|NCT01221883|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101975995|NCT01221883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101975996|NCT01221883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101975997|NCT01221883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101946246|NCT01266213|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101946247|NCT01266213|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101946248|NCT01266213|Hormone Antagonists|hormone antagonists|mesh-ancestor
101975998|NCT01221883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101975999|NCT01221883|Anesthetics, General|anesthetics, general|mesh-ancestor
101976000|NCT01221883|Anesthetics|anesthetics|mesh-ancestor
101976001|NCT01221883|GABA Modulators|gaba modulators|mesh-ancestor
101976002|NCT01221883|GABA Agents|gaba agents|mesh-ancestor
101976003|NCT01221883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101976004|NCT01221883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976005|NCT02294656|Triamcinolone|triamcinolone|mesh-list
101976006|NCT02294656|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101976007|NCT02294656|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101976008|NCT02294656|Ranibizumab|ranibizumab|mesh-list
101976009|NCT02294656|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101976010|NCT02294656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101976011|NCT02294656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101976012|NCT02294656|Growth Substances|growth substances|mesh-ancestor
101976013|NCT02294656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976014|NCT02294656|Growth Inhibitors|growth inhibitors|mesh-ancestor
101976015|NCT02294656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101976016|NCT02294656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101976022|NCT02294656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101976023|NCT02294656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976024|NCT01225237|Ramosetron|ramosetron|mesh-list
101976025|NCT01225237|Antiemetics|antiemetics|mesh-ancestor
101976026|NCT01225237|Autonomic Agents|autonomic agents|mesh-ancestor
101976027|NCT01225237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101976028|NCT01225237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976029|NCT01225237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101976030|NCT01225237|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101976031|NCT01225237|Serotonin Agents|serotonin agents|mesh-ancestor
101976032|NCT01225237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101976033|NCT01225237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976034|NCT03517930|Loratadine|loratadine|mesh-list
101976035|NCT03517930|Pseudoephedrine|pseudoephedrine|mesh-list
101976036|NCT03517930|Ephedrine|ephedrine|mesh-list
101976037|NCT03517930|Antipruritics|antipruritics|mesh-ancestor
101976038|NCT03517930|Dermatologic Agents|dermatologic agents|mesh-ancestor
101976039|NCT03517930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101976040|NCT03517930|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101976041|NCT03517930|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101976042|NCT03517930|Histamine Antagonists|histamine antagonists|mesh-ancestor
101976043|NCT03517930|Histamine Agents|histamine agents|mesh-ancestor
101976044|NCT03517930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101976045|NCT03517930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976046|NCT03517930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976047|NCT03517930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101976048|NCT03517930|Autonomic Agents|autonomic agents|mesh-ancestor
101976049|NCT03517930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101976050|NCT03517930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101976051|NCT03517930|Respiratory System Agents|respiratory system agents|mesh-ancestor
101976052|NCT03517930|Nasal Decongestants|nasal decongestants|mesh-ancestor
101976053|NCT03517930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101976054|NCT03517930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101976055|NCT03517930|Sympathomimetics|sympathomimetics|mesh-ancestor
101976056|NCT03517930|Adrenergic Agents|adrenergic agents|mesh-ancestor
101976057|NCT01130467|Methylphenidate|methylphenidate|mesh-list
101976058|NCT01130467|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101976059|NCT01130467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101976060|NCT01130467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976061|NCT01130467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101976062|NCT01130467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101976063|NCT01130467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101976064|NCT01130467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976065|NCT01130467|Dopamine Agents|dopamine agents|mesh-ancestor
101976066|NCT01130467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101976067|NCT01130467|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101976068|NCT01130467|Adrenergic Agents|adrenergic agents|mesh-ancestor
101976069|NCT02295046|Amlodipine|amlodipine|mesh-list
101976070|NCT02295046|Atorvastatin|atorvastatin|mesh-list
101976071|NCT02295046|Calcium|calcium|mesh-list
101710119|NCT03045341|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101946249|NCT01266213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101946250|NCT01266213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946251|NCT01266213|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101976072|NCT02295046|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101976073|NCT02295046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976074|NCT02295046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101976075|NCT02295046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101976076|NCT02295046|Antimetabolites|antimetabolites|mesh-ancestor
101976077|NCT02295046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976078|NCT02295046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101976079|NCT02295046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101976080|NCT02295046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101976081|NCT02295046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101976082|NCT02295046|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101976083|NCT02295046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101976084|NCT02295046|Vasodilator Agents|vasodilator agents|mesh-ancestor
101976085|NCT03517618|Leucovorin|leucovorin|mesh-list
101976091|NCT03517618|Micronutrients|micronutrients|mesh-ancestor
101976092|NCT02295124|Oxycodone|oxycodone|mesh-list
101976093|NCT02295124|Hydromorphone|hydromorphone|mesh-list
101976094|NCT02295124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101976095|NCT02295124|Narcotics|narcotics|mesh-ancestor
101976096|NCT02295124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101976097|NCT02295124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976098|NCT02295124|Analgesics|analgesics|mesh-ancestor
101976099|NCT02295124|Sensory System Agents|sensory system agents|mesh-ancestor
101976100|NCT02295124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101976101|NCT03925051|Denosumab|denosumab|mesh-list
101976102|NCT03925051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101976103|NCT03925051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976104|NCT03514576|Pasireotide|pasireotide|mesh-list
101976105|NCT03514576|Hormones|hormones|mesh-ancestor
101976106|NCT03514576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101976107|NCT03514576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976108|NCT02299024|Analgesics, Opioid|analgesics, opioid|mesh-list
101976109|NCT02299024|Narcotics|narcotics|mesh-ancestor
101976110|NCT02299024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101976111|NCT02299024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976112|NCT02299024|Analgesics|analgesics|mesh-ancestor
101976113|NCT02299024|Sensory System Agents|sensory system agents|mesh-ancestor
101976114|NCT02299024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101976115|NCT03929419|Insulin|insulin|mesh-list
101976116|NCT03929419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101976117|NCT03929419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695863|NCT00971815|Dexetimide|dexetimide|mesh-list
101976118|NCT01228279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101976120|NCT01228279|Dialysis Solutions|dialysis solutions|mesh-ancestor
101976121|NCT03514342|Ropivacaine|ropivacaine|mesh-list
101976122|NCT03514342|Anesthetics, Local|anesthetics, local|mesh-ancestor
101976123|NCT03514342|Anesthetics|anesthetics|mesh-ancestor
101976124|NCT03514342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101976125|NCT03514342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976126|NCT03514342|Sensory System Agents|sensory system agents|mesh-ancestor
101976127|NCT03514342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101976128|NCT01228045|Trastuzumab|trastuzumab|mesh-list
101976129|NCT01228045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101976130|NCT01228045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101976131|NCT03514030|Antibodies|antibodies|mesh-list
101976132|NCT03514030|Immunologic Factors|immunologic factors|mesh-ancestor
101976133|NCT03514030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976134|NCT03517462|Ivermectin|ivermectin|mesh-list
101976135|NCT03517462|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101976136|NCT03517462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101976137|NCT03929575|Calcium|calcium|mesh-list
101976138|NCT03929575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101976139|NCT03929575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976140|NCT02292472|Botulinum Toxins|botulinum toxins|mesh-list
101976141|NCT02292472|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101976142|NCT02292472|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101976143|NCT02292472|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101976144|NCT02292472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101946252|NCT01266213|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101946253|NCT01266213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101946254|NCT01266213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976145|NCT02292472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976146|NCT02292472|Cholinergic Agents|cholinergic agents|mesh-ancestor
101976147|NCT02292472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101976148|NCT02292472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976149|NCT02292472|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101976150|NCT02292472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101976151|NCT01131247|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101976152|NCT01131247|Ofatumumab|ofatumumab|mesh-list
101976153|NCT01131247|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101976154|NCT01131247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101976155|NCT01131247|Alkylating Agents|alkylating agents|mesh-ancestor
101976156|NCT01131247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431102|NCT00165399|Alkylating Agents|alkylating agents|mesh-ancestor
101976160|NCT03513874|Metformin|metformin|mesh-list
101976161|NCT03513874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101976162|NCT03513874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976163|NCT01228357|Milnacipran|milnacipran|mesh-list
101976164|NCT01228357|Mirtazapine|mirtazapine|mesh-list
101976165|NCT01228357|Sertraline|sertraline|mesh-list
101976166|NCT01228357|Fluoxetine|fluoxetine|mesh-list
101976167|NCT01228357|Paroxetine|paroxetine|mesh-list
101976168|NCT01228357|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101976169|NCT01228357|Nortriptyline|nortriptyline|mesh-list
101976170|NCT01228357|Antidepressive Agents|antidepressive agents|mesh-ancestor
101976171|NCT01228357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101976172|NCT01228357|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101976173|NCT01228357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101976174|NCT01228357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101976175|NCT01228357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976176|NCT01228357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101976177|NCT01228357|Serotonin Agents|serotonin agents|mesh-ancestor
101976178|NCT01228357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976179|NCT01228357|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101976180|NCT01228357|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101976181|NCT01228357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101976182|NCT01228357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101976183|NCT01228357|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101976184|NCT01228357|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101976185|NCT01228357|Histamine Antagonists|histamine antagonists|mesh-ancestor
101976186|NCT01228357|Histamine Agents|histamine agents|mesh-ancestor
101976187|NCT01228357|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101976188|NCT01228357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101976189|NCT01228357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101976190|NCT01228357|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101976191|NCT01228357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101976192|NCT01228357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101976193|NCT01228357|Adrenergic Agents|adrenergic agents|mesh-ancestor
101976194|NCT01228357|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101976195|NCT01228357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101976196|NCT01228357|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101976197|NCT01228357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101976198|NCT01228357|Analgesics|analgesics|mesh-ancestor
101976199|NCT01228357|Sensory System Agents|sensory system agents|mesh-ancestor
101976200|NCT01228357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101976201|NCT01228357|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101976202|NCT01228357|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101976203|NCT01130701|Capecitabine|capecitabine|mesh-list
101976204|NCT01130701|Panitumumab|panitumumab|mesh-list
101976205|NCT01130701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101976206|NCT01130701|Antimetabolites|antimetabolites|mesh-ancestor
101976207|NCT01130701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976208|NCT01130701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101976209|NCT01130701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101976210|NCT02292550|Ceritinib|ceritinib|mesh-list
101976211|NCT02292550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101976212|NCT02292550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101946255|NCT01262391|Solifenacin Succinate|solifenacin succinate|mesh-list
101946256|NCT01262391|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101946257|NCT01262391|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101946258|NCT01262391|Cholinergic Agents|cholinergic agents|mesh-ancestor
101946259|NCT01262391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101976213|NCT02292550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101976214|NCT02292550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976216|NCT03925285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101976217|NCT03925285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101976218|NCT03925285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101976219|NCT03925285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101976220|NCT03925285|Growth Substances|growth substances|mesh-ancestor
101976221|NCT03925285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976222|NCT03925285|Growth Inhibitors|growth inhibitors|mesh-ancestor
101976223|NCT04464694|Ranibizumab|ranibizumab|mesh-list
101976224|NCT04464694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101976225|NCT04464694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101976226|NCT04464694|Growth Substances|growth substances|mesh-ancestor
101431169|NCT00165516|Antidotes|antidotes|mesh-ancestor
101976231|NCT01130779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101976232|NCT01130779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101976234|NCT01130779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976235|NCT03513484|Azacitidine|azacitidine|mesh-list
101976236|NCT03513484|Nintedanib|nintedanib|mesh-list
101976237|NCT03513484|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101976238|NCT03513484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101976239|NCT03513484|Antimetabolites|antimetabolites|mesh-ancestor
101976240|NCT03513484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976241|NCT03513484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101976242|NCT03513484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101976243|NCT03513484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101976244|NCT03519724|Neostigmine|neostigmine|mesh-list
101976245|NCT03519724|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101976246|NCT03519724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101976247|NCT03519724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976248|NCT03519724|Cholinergic Agents|cholinergic agents|mesh-ancestor
101976249|NCT03519724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101976250|NCT03519724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976251|NCT03519724|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101976252|NCT03519724|Autonomic Agents|autonomic agents|mesh-ancestor
101976253|NCT03519724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101976254|NCT03920449|Botulinum Toxins|botulinum toxins|mesh-list
101976255|NCT03920449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101976256|NCT03920449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101976257|NCT03920449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976258|NCT03920449|Cholinergic Agents|cholinergic agents|mesh-ancestor
101976259|NCT03920449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101976260|NCT03920449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976261|NCT03920059|Mycophenolic Acid|mycophenolic acid|mesh-list
101976262|NCT03920059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101976263|NCT03920059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101976264|NCT03920059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101976265|NCT03920059|Antitubercular Agents|antitubercular agents|mesh-ancestor
101976266|NCT03920059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101976267|NCT03920059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101976268|NCT03920059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101976269|NCT03920059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976270|NCT01132027|Tacrolimus|tacrolimus|mesh-list
101976271|NCT01132027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101976272|NCT01132027|Immunologic Factors|immunologic factors|mesh-ancestor
101976273|NCT01132027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976274|NCT01132027|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101976275|NCT01132027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101976276|NCT01132027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976277|NCT03136484|Canagliflozin|canagliflozin|mesh-list
101976278|NCT03136484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101976279|NCT03136484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946260|NCT01262391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946261|NCT01262391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946262|NCT01262391|Urological Agents|urological agents|mesh-ancestor
101946263|NCT03880695|Doxorubicin|doxorubicin|mesh-list
101946264|NCT03880695|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101946265|NCT03880695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101976280|NCT03136484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101976281|NCT03136484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976282|NCT01132183|Valproic Acid|valproic acid|mesh-list
101976283|NCT01132183|Anticonvulsants|anticonvulsants|mesh-ancestor
101976284|NCT01132183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101976285|NCT01132183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976286|NCT01132183|GABA Agents|gaba agents|mesh-ancestor
101976287|NCT01132183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101976288|NCT01132183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976289|NCT01132183|Antimanic Agents|antimanic agents|mesh-ancestor
101976290|NCT01132183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101976291|NCT01132183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101976292|NCT01132183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101976293|NCT03923881|Cetuximab|cetuximab|mesh-list
101976294|NCT03923881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101976298|NCT02295748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101976299|NCT02295748|Immunologic Factors|immunologic factors|mesh-ancestor
101976300|NCT02295748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976302|NCT03923803|Salmon calcitonin|salmon calcitonin|mesh-list
101976303|NCT03923803|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
101976304|NCT03923803|Katacalcin|katacalcin|mesh-list
101976305|NCT03923803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101976306|NCT03923803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976307|NCT03923803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101976308|NCT03923803|Vasodilator Agents|vasodilator agents|mesh-ancestor
101976309|NCT02295826|Aspirin|aspirin|mesh-list
101976310|NCT02295826|Dabigatran|dabigatran|mesh-list
101976311|NCT02295826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101976312|NCT02295826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101976313|NCT02295826|Analgesics|analgesics|mesh-ancestor
101976314|NCT02295826|Sensory System Agents|sensory system agents|mesh-ancestor
101976315|NCT02295826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101976316|NCT02295826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976317|NCT02295826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101976318|NCT02295826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101976319|NCT02295826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101976320|NCT02295826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101976321|NCT02295826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976322|NCT02295826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101976323|NCT02295826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101976324|NCT02295826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101976325|NCT02295826|Antipyretics|antipyretics|mesh-ancestor
101976326|NCT02295826|Antithrombins|antithrombins|mesh-ancestor
101976327|NCT02295826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101976328|NCT02295826|Protease Inhibitors|protease inhibitors|mesh-ancestor
101976329|NCT02295826|Anticoagulants|anticoagulants|mesh-ancestor
101976330|NCT01348724|Naloxegol|naloxegol|mesh-list
101976331|NCT01348724|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101976332|NCT01348724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976333|NCT01348724|Sensory System Agents|sensory system agents|mesh-ancestor
101976334|NCT01348724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101976335|NCT03519022|Cocaine|cocaine|mesh-list
101976336|NCT03519022|Methylphenidate|methylphenidate|mesh-list
101976337|NCT03519022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101976338|NCT03519022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976339|NCT03519022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101976340|NCT03519022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101976341|NCT03519022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101976342|NCT03519022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976343|NCT03519022|Dopamine Agents|dopamine agents|mesh-ancestor
101976344|NCT03519022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101976345|NCT03519022|Anesthetics, Local|anesthetics, local|mesh-ancestor
101946267|NCT03880695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101946268|NCT03880695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101946269|NCT03880695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101971938|NCT02083250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101976346|NCT03519022|Anesthetics|anesthetics|mesh-ancestor
101976347|NCT03519022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101976348|NCT03519022|Sensory System Agents|sensory system agents|mesh-ancestor
101976349|NCT03519022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101976350|NCT03519022|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101976351|NCT03923257|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
101976352|NCT03923257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101976353|NCT03923257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976354|NCT03516526|Natalizumab|natalizumab|mesh-list
101976355|NCT03516526|Immunologic Factors|immunologic factors|mesh-ancestor
101976356|NCT03516526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976357|NCT02730416|Paclitaxel|paclitaxel|mesh-list
101976358|NCT02730416|Carboplatin|carboplatin|mesh-list
101976359|NCT02730416|Nintedanib|nintedanib|mesh-list
101976360|NCT02730416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101976361|NCT02730416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101976362|NCT02730416|Tubulin Modulators|tubulin modulators|mesh-ancestor
101976363|NCT02730416|Antimitotic Agents|antimitotic agents|mesh-ancestor
101976364|NCT02730416|Mitosis Modulators|mitosis modulators|mesh-ancestor
101976365|NCT02730416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976366|NCT02730416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101976376|NCT01348880|Vasodilator Agents|vasodilator agents|mesh-ancestor
101976377|NCT01348880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101976378|NCT01348880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101976379|NCT01348880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101976380|NCT01348880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976381|NCT01348880|Urological Agents|urological agents|mesh-ancestor
101976383|NCT03923179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101976384|NCT03923179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101976385|NCT03923179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101976386|NCT03923179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101976387|NCT03923179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101976388|NCT03923179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976389|NCT01318460|Simendan|simendan|mesh-list
101976390|NCT01318460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101976391|NCT01318460|Vasodilator Agents|vasodilator agents|mesh-ancestor
101976392|NCT01318460|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101976393|NCT01318460|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101976394|NCT01318460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101976395|NCT01318460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976396|NCT01318460|Protective Agents|protective agents|mesh-ancestor
101976397|NCT01318460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976398|NCT02299726|Spironolactone|spironolactone|mesh-list
101976399|NCT02299726|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101976400|NCT02299726|Hormone Antagonists|hormone antagonists|mesh-ancestor
101976401|NCT02299726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101976402|NCT02299726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976403|NCT02299726|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101976404|NCT02299726|Diuretics|diuretics|mesh-ancestor
101976405|NCT02299726|Natriuretic Agents|natriuretic agents|mesh-ancestor
101976406|NCT03647852|Methylprednisolone|methylprednisolone|mesh-list
101976407|NCT03647852|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101976408|NCT03647852|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101976409|NCT03647852|Prednisolone|prednisolone|mesh-list
101976410|NCT03647852|Prednisolone acetate|prednisolone acetate|mesh-list
101976411|NCT03647852|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101976412|NCT03647852|Prednisolone phosphate|prednisolone phosphate|mesh-list
101976413|NCT03647852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101976414|NCT03647852|Antiemetics|antiemetics|mesh-ancestor
101976415|NCT03647852|Autonomic Agents|autonomic agents|mesh-ancestor
101976416|NCT03647852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101976417|NCT03647852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976418|NCT03647852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101976419|NCT03647852|Glucocorticoids|glucocorticoids|mesh-ancestor
101946270|NCT03880695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946271|NCT01155765|Clopidogrel|clopidogrel|mesh-list
101802995|NCT03410043|Osimertinib|osimertinib|mesh-list
101976420|NCT03647852|Hormones|hormones|mesh-ancestor
101976421|NCT03647852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101976422|NCT03647852|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101976423|NCT03647852|Protective Agents|protective agents|mesh-ancestor
101976424|NCT03647852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101976425|NCT03647852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101976426|NCT01354886|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101976427|NCT01354886|Hormones|hormones|mesh-ancestor
101976428|NCT01354886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101976429|NCT01354886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976430|NCT02299882|Vancomycin|vancomycin|mesh-list
101976435|NCT01355120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101976436|NCT01355120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101976437|NCT01355120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976438|NCT02300038|Lidocaine|lidocaine|mesh-list
101976439|NCT02300038|Anesthetics, Local|anesthetics, local|mesh-ancestor
101976440|NCT02300038|Anesthetics|anesthetics|mesh-ancestor
101976441|NCT02300038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101976442|NCT02300038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976443|NCT02300038|Sensory System Agents|sensory system agents|mesh-ancestor
101976444|NCT02300038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101976445|NCT02300038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101976446|NCT02300038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101976447|NCT02300038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101976448|NCT02300038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101976449|NCT02300038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976450|NCT01355198|Acetylcysteine|acetylcysteine|mesh-list
101976451|NCT01355198|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101976452|NCT01355198|Glycine|glycine|mesh-list
101976453|NCT01355198|Antiviral Agents|antiviral agents|mesh-ancestor
101976454|NCT01355198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101976455|NCT01355198|Expectorants|expectorants|mesh-ancestor
101976456|NCT01355198|Respiratory System Agents|respiratory system agents|mesh-ancestor
101976457|NCT01355198|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101976458|NCT01355198|Antioxidants|antioxidants|mesh-ancestor
101976459|NCT01355198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976460|NCT01355198|Protective Agents|protective agents|mesh-ancestor
101710177|NCT02627222|Vitamin A|vitamin a|mesh-list
101976461|NCT01355198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976462|NCT01355198|Antidotes|antidotes|mesh-ancestor
101976463|NCT01355198|Glycine Agents|glycine agents|mesh-ancestor
101976464|NCT01355198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101976465|NCT01355276|Domperidone|domperidone|mesh-list
101976466|NCT01355276|Cinitapride|cinitapride|mesh-list
101976467|NCT01355276|Antiemetics|antiemetics|mesh-ancestor
101976468|NCT01355276|Autonomic Agents|autonomic agents|mesh-ancestor
101976469|NCT01355276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101976470|NCT01355276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976471|NCT01355276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101976472|NCT01355276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101976473|NCT01355276|Dopamine Agents|dopamine agents|mesh-ancestor
101976474|NCT01355276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101976475|NCT01355276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976476|NCT01355276|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101976477|NCT02589860|Melphalan|melphalan|mesh-list
101976478|NCT02589860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101976479|NCT02589860|Alkylating Agents|alkylating agents|mesh-ancestor
101976480|NCT02589860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976481|NCT02589860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101976482|NCT02589860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101976483|NCT02589860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101976484|NCT02589860|Immunologic Factors|immunologic factors|mesh-ancestor
101976485|NCT02589860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976486|NCT01355354|Digoxin|digoxin|mesh-list
101976487|NCT01355354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101976488|NCT01355354|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101976489|NCT01355354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101976490|NCT01355354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976491|NCT01355354|Protective Agents|protective agents|mesh-ancestor
101946272|NCT01155765|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101946273|NCT01155765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101946274|NCT01155765|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101946275|NCT01155765|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101946276|NCT01155765|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101946277|NCT01155765|Purinergic Agents|purinergic agents|mesh-ancestor
101946278|NCT01155765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101946279|NCT01155765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946280|NCT01155765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946281|NCT01264341|Sirolimus|sirolimus|mesh-list
101946282|NCT01264341|Bevacizumab|bevacizumab|mesh-list
101946283|NCT01264341|Temsirolimus|temsirolimus|mesh-list
101946284|NCT01264341|MTOR Inhibitors|mtor inhibitors|mesh-list
101946285|NCT01264341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101946286|NCT01264341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101946287|NCT01264341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101946288|NCT01264341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101946289|NCT01264341|Growth Substances|growth substances|mesh-ancestor
101946290|NCT01264341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946291|NCT01264341|Growth Inhibitors|growth inhibitors|mesh-ancestor
101946292|NCT01264341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101946293|NCT01264341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101946294|NCT01264341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946295|NCT01264341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101946296|NCT01264341|Immunologic Factors|immunologic factors|mesh-ancestor
101946297|NCT01264341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101946298|NCT01264341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101946299|NCT01264341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101946300|NCT01264341|Antifungal Agents|antifungal agents|mesh-ancestor
101946301|NCT01264497|Tesamorelin|tesamorelin|mesh-list
101946302|NCT01264497|Growth Substances|growth substances|mesh-ancestor
101803064|NCT01815359|Leucovorin|leucovorin|mesh-list
101976492|NCT01355354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976493|NCT03513172|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101976494|NCT03513172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101976495|NCT03513172|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101976496|NCT03513172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101976497|NCT03513172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101976498|NCT03513172|Adrenergic Agents|adrenergic agents|mesh-ancestor
101976499|NCT03513172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101976500|NCT03513172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976506|NCT01349270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101946303|NCT01264497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946304|NCT01157949|Thymoglobulin|thymoglobulin|mesh-list
101946305|NCT01157949|Immunologic Factors|immunologic factors|mesh-ancestor
101976507|NCT01349270|Glucocorticoids|glucocorticoids|mesh-ancestor
101976508|NCT01349270|Hormones|hormones|mesh-ancestor
101976509|NCT01349270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101976510|NCT01349270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976511|NCT01349270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101976512|NCT01349270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101976513|NCT01349270|Immunologic Factors|immunologic factors|mesh-ancestor
101976514|NCT01132417|Tigecycline|tigecycline|mesh-list
101976515|NCT01132417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101976516|NCT01132417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101976517|NCT01132417|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101976518|NCT01132417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101976519|NCT01132417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976520|NCT02300194|Morphine|morphine|mesh-list
101976521|NCT02300194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101976522|NCT02300194|Narcotics|narcotics|mesh-ancestor
101976523|NCT02300194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101976524|NCT02300194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976525|NCT02300194|Analgesics|analgesics|mesh-ancestor
101976526|NCT02300194|Sensory System Agents|sensory system agents|mesh-ancestor
101976527|NCT02300194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101976528|NCT01225705|Ritonavir|ritonavir|mesh-list
101976529|NCT01225705|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101976530|NCT01225705|Raltegravir Potassium|raltegravir potassium|mesh-list
101976531|NCT01225705|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101976532|NCT01225705|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101976533|NCT01225705|Protease Inhibitors|protease inhibitors|mesh-ancestor
101976534|NCT01225705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101976535|NCT01225705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976536|NCT01225705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101976537|NCT01225705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101976538|NCT01225705|Antiviral Agents|antiviral agents|mesh-ancestor
101976539|NCT01225705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101976540|NCT01225705|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101976541|NCT01225705|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101976542|NCT01225705|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101976543|NCT01225705|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101976544|NCT01128985|Canagliflozin|canagliflozin|mesh-list
101976545|NCT01128985|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101976546|NCT01128985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976547|NCT01128985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101976548|NCT01128985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976549|NCT03922555|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
101976550|NCT03922555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101976551|NCT03922555|Antimetabolites|antimetabolites|mesh-ancestor
101976552|NCT03922555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976553|NCT03922555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101976554|NCT03512860|Valproic Acid|valproic acid|mesh-list
101976555|NCT03512860|Anticonvulsants|anticonvulsants|mesh-ancestor
101976556|NCT03512860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101976557|NCT03512860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976558|NCT03512860|GABA Agents|gaba agents|mesh-ancestor
101976559|NCT03512860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101976560|NCT03512860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976561|NCT03512860|Antimanic Agents|antimanic agents|mesh-ancestor
101696317|NCT00545233|Pioglitazone|pioglitazone|mesh-list
101976562|NCT03512860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101976563|NCT03512860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101976564|NCT03512860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101976565|NCT01357694|Psychotropic Drugs|psychotropic drugs|mesh-list
101976566|NCT02528695|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101976567|NCT02528695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976569|NCT02296762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101976570|NCT02296762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101976571|NCT02296762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101431522|NCT02922166|SRX246|srx246|mesh-list
101976574|NCT02296762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101976575|NCT02296762|Immunologic Factors|immunologic factors|mesh-ancestor
101946306|NCT01157949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946307|NCT01157949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101946308|NCT01262469|Capecitabine|capecitabine|mesh-list
101946309|NCT01262469|Lapatinib|lapatinib|mesh-list
101976576|NCT02296762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976578|NCT01132573|Entinostat|entinostat|mesh-list
101976579|NCT01132573|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
101976580|NCT01132573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101976581|NCT01132573|Antimetabolites|antimetabolites|mesh-ancestor
101976582|NCT01132573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976583|NCT01132573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101976584|NCT01132573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101976585|NCT01131559|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101976586|NCT01131559|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101976587|NCT01131559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976588|NCT01131559|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101976589|NCT01131559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101976590|NCT01131559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101976591|NCT01131559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976592|NCT01131559|Dopamine Agents|dopamine agents|mesh-ancestor
101976593|NCT01131559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101976594|NCT03518320|Gemcitabine|gemcitabine|mesh-list
101976595|NCT03518320|Nivolumab|nivolumab|mesh-list
101976596|NCT03518320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101976597|NCT03518320|Antimetabolites|antimetabolites|mesh-ancestor
101976598|NCT03518320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976599|NCT03518320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101976600|NCT03518320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101976601|NCT03518320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101976602|NCT01134289|Bupivacaine|bupivacaine|mesh-list
101976603|NCT01134289|Levobupivacaine|levobupivacaine|mesh-list
101976604|NCT01134289|Anesthetics, Local|anesthetics, local|mesh-ancestor
101976605|NCT01134289|Anesthetics|anesthetics|mesh-ancestor
101976606|NCT01134289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101976607|NCT01134289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976608|NCT01134289|Sensory System Agents|sensory system agents|mesh-ancestor
101976609|NCT01134289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101976610|NCT02300350|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
101976611|NCT02300350|Digoxin|digoxin|mesh-list
101976612|NCT02300350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101976613|NCT02300350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101976614|NCT02300350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101976615|NCT02300350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976616|NCT02300350|Protective Agents|protective agents|mesh-ancestor
101976617|NCT02300350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976618|NCT02300350|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101976619|NCT02300350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101976620|NCT01349348|Tolvaptan|tolvaptan|mesh-list
101976621|NCT01349348|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101976622|NCT01349348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976623|NCT01349348|Natriuretic Agents|natriuretic agents|mesh-ancestor
101976624|NCT01349348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976625|NCT02300428|Ferrous fumarate|ferrous fumarate|mesh-list
101976626|NCT02300428|Ferrous gluconate|ferrous gluconate|mesh-list
101976627|NCT02300428|Trace Elements|trace elements|mesh-ancestor
101976628|NCT02300428|Micronutrients|micronutrients|mesh-ancestor
101976629|NCT02300428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976630|NCT02300428|Hematinics|hematinics|mesh-ancestor
101976631|NCT02293876|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101976632|NCT02293876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101976633|NCT02296996|Trametinib|trametinib|mesh-list
101976634|NCT02296996|Dabrafenib|dabrafenib|mesh-list
101976636|NCT02296996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101976637|NCT02296996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101976638|NCT02296996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976639|NCT01132729|Valacyclovir|valacyclovir|mesh-list
101976640|NCT01132729|Antiviral Agents|antiviral agents|mesh-ancestor
101976641|NCT01132729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101976642|NCT02294110|Anesthetics|anesthetics|mesh-list
101431600|NCT02920801|Metformin|metformin|mesh-list
101946310|NCT01262469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101946311|NCT01262469|Antimetabolites|antimetabolites|mesh-ancestor
101946312|NCT01262469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976646|NCT03512548|Antifungal Agents|antifungal agents|mesh-ancestor
101976647|NCT03512548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101976648|NCT03512548|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101976649|NCT03512548|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101976650|NCT03512548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101976651|NCT03512548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976652|NCT03512548|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101976653|NCT03512548|Hormone Antagonists|hormone antagonists|mesh-ancestor
101976654|NCT03512548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101976655|NCT03512548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976656|NCT03512548|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101976658|NCT03515668|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101976659|NCT03515668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976660|NCT03515668|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101976661|NCT03515668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101976662|NCT03515668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101976663|NCT03515668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976664|NCT03515668|Dopamine Agents|dopamine agents|mesh-ancestor
101976665|NCT03515668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101976667|NCT01356212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101976668|NCT01356212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101976669|NCT01356212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101976670|NCT01356212|Analgesics|analgesics|mesh-ancestor
101976671|NCT01356212|Sensory System Agents|sensory system agents|mesh-ancestor
101976672|NCT01356212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101976673|NCT01356212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976674|NCT01356212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101976675|NCT01356212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101976676|NCT01356212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101976677|NCT01356212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101710227|NCT00619541|Sorafenib|sorafenib|mesh-list
101976678|NCT01356212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976679|NCT02302378|Bupivacaine|bupivacaine|mesh-list
101976680|NCT02302378|Anesthetics, Local|anesthetics, local|mesh-ancestor
101976681|NCT02302378|Anesthetics|anesthetics|mesh-ancestor
101976682|NCT02302378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101976683|NCT02302378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976684|NCT02302378|Sensory System Agents|sensory system agents|mesh-ancestor
101976685|NCT02302378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101976686|NCT01356368|Docetaxel|docetaxel|mesh-list
101976687|NCT01356368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101976688|NCT01356368|Tubulin Modulators|tubulin modulators|mesh-ancestor
101976689|NCT01356368|Antimitotic Agents|antimitotic agents|mesh-ancestor
101976690|NCT01356368|Mitosis Modulators|mitosis modulators|mesh-ancestor
101976691|NCT01356368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976692|NCT02302456|Tranexamic Acid|tranexamic acid|mesh-list
101976693|NCT02302456|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101976694|NCT02302456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101976695|NCT02302456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976696|NCT02302456|Hemostatics|hemostatics|mesh-ancestor
101976697|NCT02302456|Coagulants|coagulants|mesh-ancestor
101976698|NCT01356524|Progesterone|progesterone|mesh-list
101976699|NCT01356524|Progestins|progestins|mesh-ancestor
101976700|NCT01356524|Hormones|hormones|mesh-ancestor
101976701|NCT01356524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101976702|NCT01356524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976703|NCT01232023|Indobufen|indobufen|mesh-list
101976704|NCT01232023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101976705|NCT01232023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101976706|NCT01232023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101976707|NCT01232023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976708|NCT01232023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101976709|NCT01232023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101976711|NCT01232023|Sensory System Agents|sensory system agents|mesh-ancestor
101976716|NCT02300740|Niacinamide|niacinamide|mesh-list
101946313|NCT01262469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101946314|NCT01262469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101946315|NCT01262469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101976717|NCT02300740|Niacin|niacin|mesh-list
101976718|NCT02300740|Nicotinic Acids|nicotinic acids|mesh-list
101976719|NCT02300740|Vitamin B Complex|vitamin b complex|mesh-ancestor
101976720|NCT02300740|Vitamins|vitamins|mesh-ancestor
101976721|NCT02300740|Micronutrients|micronutrients|mesh-ancestor
101976722|NCT02300740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976723|NCT02300740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101976724|NCT02300740|Antimetabolites|antimetabolites|mesh-ancestor
101976725|NCT02300740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976726|NCT02300740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101976727|NCT02300740|Vasodilator Agents|vasodilator agents|mesh-ancestor
101976728|NCT02300818|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101976729|NCT02300818|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101976730|NCT02297386|Testosterone|testosterone|mesh-list
101976731|NCT02297386|Dihydrotestosterone|dihydrotestosterone|mesh-list
101976732|NCT02297386|Androgens|androgens|mesh-ancestor
101976733|NCT02297386|Hormones|hormones|mesh-ancestor
101976734|NCT02297386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101976735|NCT02297386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976736|NCT04464616|Anesthetics|anesthetics|mesh-list
101976737|NCT04464616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101976738|NCT04464616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976739|NCT01356680|Prednisone|prednisone|mesh-list
101976740|NCT01356680|Cyclophosphamide|cyclophosphamide|mesh-list
101976741|NCT01356680|Dacarbazine|dacarbazine|mesh-list
101976742|NCT01356680|Etoposide|etoposide|mesh-list
101976743|NCT01356680|Vincristine|vincristine|mesh-list
101976744|NCT01356680|Doxorubicin|doxorubicin|mesh-list
101976745|NCT01356680|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101976746|NCT01356680|Bleomycin|bleomycin|mesh-list
101976747|NCT01356680|Vinblastine|vinblastine|mesh-list
101976748|NCT01356680|Procarbazine|procarbazine|mesh-list
101976749|NCT01356680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101976750|NCT01356680|Immunologic Factors|immunologic factors|mesh-ancestor
101976751|NCT01356680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976752|NCT01356680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101976753|NCT01356680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101976754|NCT01356680|Alkylating Agents|alkylating agents|mesh-ancestor
101976755|NCT01356680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976756|NCT01356680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101976757|NCT01356680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101976758|NCT01356680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101976759|NCT01356680|Glucocorticoids|glucocorticoids|mesh-ancestor
101976760|NCT01356680|Hormones|hormones|mesh-ancestor
101976761|NCT01356680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101976762|NCT01356680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101976763|NCT01356680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101976764|NCT01356680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101976765|NCT01356680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101976766|NCT01356680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101976767|NCT01356680|Tubulin Modulators|tubulin modulators|mesh-ancestor
101976768|NCT01356680|Antimitotic Agents|antimitotic agents|mesh-ancestor
101976769|NCT01356680|Mitosis Modulators|mitosis modulators|mesh-ancestor
101976770|NCT01356680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101976771|NCT04464850|Iron|iron|mesh-list
101976772|NCT04464850|Ferrous fumarate|ferrous fumarate|mesh-list
101976773|NCT04464850|Folic Acid|folic acid|mesh-list
101976774|NCT04464850|Trace Elements|trace elements|mesh-ancestor
101976775|NCT04464850|Micronutrients|micronutrients|mesh-ancestor
101976776|NCT04464850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976777|NCT04464850|Hematinics|hematinics|mesh-ancestor
101976778|NCT04464850|Vitamin B Complex|vitamin b complex|mesh-ancestor
101976779|NCT04464850|Vitamins|vitamins|mesh-ancestor
101976780|NCT01356758|Adalimumab|adalimumab|mesh-list
101976781|NCT01356758|Infliximab|infliximab|mesh-list
101976782|NCT01356758|Etanercept|etanercept|mesh-list
101696536|NCT02777411|Vaccines|vaccines|mesh-list
101976783|NCT01356758|Ustekinumab|ustekinumab|mesh-list
101976784|NCT01356758|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101976786|NCT01356758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101976787|NCT01356758|Dermatologic Agents|dermatologic agents|mesh-ancestor
101976792|NCT01356758|Sensory System Agents|sensory system agents|mesh-ancestor
101976793|NCT01356758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101976794|NCT01356758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946316|NCT01155921|Risperidone|risperidone|mesh-list
101946317|NCT01155921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101946318|NCT01155921|Serotonin Agents|serotonin agents|mesh-ancestor
101946319|NCT01155921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101946320|NCT01155921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946321|NCT01155921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803393|NCT00736541|Cystatins|cystatins|mesh-list
101976795|NCT01356758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101976796|NCT01356758|Immunologic Factors|immunologic factors|mesh-ancestor
101976797|NCT01134523|Paclitaxel|paclitaxel|mesh-list
101976798|NCT01134523|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101976799|NCT01134523|Epirubicin|epirubicin|mesh-list
101976800|NCT01134523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101976801|NCT01134523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101976802|NCT01134523|Tubulin Modulators|tubulin modulators|mesh-ancestor
101976803|NCT01134523|Antimitotic Agents|antimitotic agents|mesh-ancestor
101976804|NCT01134523|Mitosis Modulators|mitosis modulators|mesh-ancestor
101976805|NCT01134523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976806|NCT01134523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101976807|NCT01134523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101976808|NCT01134523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101976809|NCT01134523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101976810|NCT01349738|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101976811|NCT01349738|Ciprofloxacin|ciprofloxacin|mesh-list
101976812|NCT01349738|Levofloxacin|levofloxacin|mesh-list
101976813|NCT01349738|Ofloxacin|ofloxacin|mesh-list
101976814|NCT01349738|Gentamicins|gentamicins|mesh-list
101976815|NCT01349738|Cefazolin|cefazolin|mesh-list
101976816|NCT01349738|Tobramycin|tobramycin|mesh-list
101976817|NCT01349738|Ampicillin|ampicillin|mesh-list
101976818|NCT01349738|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101976819|NCT01349738|Nitrofurantoin|nitrofurantoin|mesh-list
101976820|NCT01349738|Sulbactam|sulbactam|mesh-list
101976821|NCT01349738|Trimethoprim|trimethoprim|mesh-list
101976822|NCT01349738|Sulfamethoxazole|sulfamethoxazole|mesh-list
101976823|NCT01349738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101976824|NCT01349738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101976825|NCT01349738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101976826|NCT01349738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101976827|NCT01349738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976828|NCT01349738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101976829|NCT01349738|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101976830|NCT01349738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101976831|NCT01349738|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101976832|NCT01349738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101976833|NCT01349738|Antimalarials|antimalarials|mesh-ancestor
101976834|NCT01349738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101976835|NCT01349738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101976836|NCT01349738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101976837|NCT01349738|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101976838|NCT01349738|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101976839|NCT01349738|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101976840|NCT02302768|Selenium|selenium|mesh-list
101976841|NCT02302768|Antioxidants|antioxidants|mesh-ancestor
101976842|NCT02302768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976843|NCT02302768|Protective Agents|protective agents|mesh-ancestor
101976844|NCT02302768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976845|NCT02302768|Trace Elements|trace elements|mesh-ancestor
101976846|NCT02302768|Micronutrients|micronutrients|mesh-ancestor
101976847|NCT03921775|Propofol|propofol|mesh-list
101976848|NCT03921775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101976849|NCT03921775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101976850|NCT03921775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976851|NCT03921775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101976852|NCT03921775|Anesthetics, General|anesthetics, general|mesh-ancestor
101976853|NCT03921775|Anesthetics|anesthetics|mesh-ancestor
101976854|NCT01356992|Enoxaparin|enoxaparin|mesh-list
101976855|NCT01356992|Anticoagulants|anticoagulants|mesh-ancestor
101976856|NCT01356992|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101976857|NCT01356992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101946322|NCT01155921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101946323|NCT01155921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101946324|NCT01155921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101946325|NCT01155921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101976858|NCT01356992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976859|NCT01350050|Carticaine|carticaine|mesh-list
101976860|NCT01350050|Anesthetics, Local|anesthetics, local|mesh-ancestor
101976866|NCT03918889|Midazolam|midazolam|mesh-list
101976867|NCT03918889|Dexmedetomidine|dexmedetomidine|mesh-list
101976868|NCT03918889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101976869|NCT03918889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101976870|NCT03918889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976871|NCT03918889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101976872|NCT03918889|Analgesics|analgesics|mesh-ancestor
101976873|NCT03918889|Sensory System Agents|sensory system agents|mesh-ancestor
101976874|NCT03918889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101976875|NCT03918889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101976876|NCT03918889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101976877|NCT03918889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101976878|NCT03918889|Adrenergic Agents|adrenergic agents|mesh-ancestor
101976879|NCT03918889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101976880|NCT03918889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976881|NCT03918889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101976882|NCT03918889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101976883|NCT03918889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101976884|NCT03918889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101976885|NCT03918889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101976886|NCT03918889|Anesthetics, General|anesthetics, general|mesh-ancestor
101976887|NCT03918889|Anesthetics|anesthetics|mesh-ancestor
101976888|NCT03918889|GABA Modulators|gaba modulators|mesh-ancestor
101976889|NCT03918889|GABA Agents|gaba agents|mesh-ancestor
101976890|NCT02297620|Ipragliflozin|ipragliflozin|mesh-list
101976891|NCT02297620|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101976892|NCT02297620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976893|NCT02297620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101976894|NCT02297620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976895|NCT03739801|Irinotecan|irinotecan|mesh-list
101976896|NCT03739801|Ramucirumab|ramucirumab|mesh-list
101976897|NCT03739801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101976898|NCT03739801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101976899|NCT03739801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101976900|NCT03739801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976901|NCT03739801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101976902|NCT03512236|Insulin Lispro|insulin lispro|mesh-list
101976903|NCT03512236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101976904|NCT03512236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976905|NCT02303002|Botulinum Toxins|botulinum toxins|mesh-list
101976906|NCT02303002|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101976907|NCT02303002|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101976908|NCT02303002|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101976909|NCT02303002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101976910|NCT02303002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976911|NCT02303002|Cholinergic Agents|cholinergic agents|mesh-ancestor
101976912|NCT02303002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101976913|NCT02303002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976914|NCT02303002|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101976915|NCT02303002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101976916|NCT02297854|Valganciclovir|valganciclovir|mesh-list
101976917|NCT02297854|Antiviral Agents|antiviral agents|mesh-ancestor
101976918|NCT02297854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101976919|NCT03511768|Octreotide|octreotide|mesh-list
101976920|NCT03511768|Al18F-NOTA-octreotide|al18f-nota-octreotide|mesh-list
101976921|NCT03511768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101976922|NCT03511768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101976923|NCT03511768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101976924|NCT03511768|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101976925|NCT03511768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976926|NCT01134991|Minocycline|minocycline|mesh-list
101976927|NCT01134991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101976928|NCT01134991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101976929|NCT03515200|Cytarabine|cytarabine|mesh-list
101976930|NCT03515200|Dexamethasone|dexamethasone|mesh-list
101946327|NCT01155921|Dopamine Agents|dopamine agents|mesh-ancestor
101946328|NCT03884127|Orlistat|orlistat|mesh-list
101946329|NCT03884127|Ezetimibe|ezetimibe|mesh-list
101946330|NCT03884127|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101976934|NCT03515200|Bortezomib|bortezomib|mesh-list
101976935|NCT03515200|Dasatinib|dasatinib|mesh-list
101976936|NCT03515200|Palbociclib|palbociclib|mesh-list
101976937|NCT03515200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101976938|NCT03515200|Antiemetics|antiemetics|mesh-ancestor
101976940|NCT03515200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101976941|NCT03515200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976942|NCT03515200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101976943|NCT03515200|Glucocorticoids|glucocorticoids|mesh-ancestor
101976944|NCT03515200|Hormones|hormones|mesh-ancestor
101976945|NCT03515200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101976946|NCT03515200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101976947|NCT03515200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101976948|NCT03515200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101976949|NCT03515200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101976950|NCT03515200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101976951|NCT03515200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101976952|NCT03515200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976953|NCT03515200|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101976954|NCT03515200|Abortifacient Agents|abortifacient agents|mesh-ancestor
101976955|NCT03515200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101710255|NCT00684866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101976956|NCT03515200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101976957|NCT03515200|Antimetabolites|antimetabolites|mesh-ancestor
101976958|NCT03515200|Dermatologic Agents|dermatologic agents|mesh-ancestor
101976959|NCT03515200|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101976960|NCT03515200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101976961|NCT03515200|Immunologic Factors|immunologic factors|mesh-ancestor
101976962|NCT03515200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101976963|NCT03515200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101976964|NCT03515200|Antiviral Agents|antiviral agents|mesh-ancestor
101976965|NCT03515200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101976966|NCT03515200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101976967|NCT03918265|Tacrolimus|tacrolimus|mesh-list
101976968|NCT03918265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101976969|NCT03918265|Immunologic Factors|immunologic factors|mesh-ancestor
101976970|NCT03918265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976971|NCT03918265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101976972|NCT03918265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101976973|NCT03918265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976974|NCT03920839|Paclitaxel|paclitaxel|mesh-list
101976975|NCT03920839|Carboplatin|carboplatin|mesh-list
101976976|NCT03920839|Gemcitabine|gemcitabine|mesh-list
101976977|NCT03920839|Pemetrexed|pemetrexed|mesh-list
101976978|NCT03920839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101976979|NCT03920839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101976980|NCT03920839|Tubulin Modulators|tubulin modulators|mesh-ancestor
101976981|NCT03920839|Antimitotic Agents|antimitotic agents|mesh-ancestor
101976982|NCT03920839|Mitosis Modulators|mitosis modulators|mesh-ancestor
101976983|NCT03920839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101976984|NCT03920839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101976985|NCT03920839|Antimetabolites|antimetabolites|mesh-ancestor
101976986|NCT03920839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101976987|NCT03920839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101976988|NCT03920839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101976989|NCT02301130|Durvalumab|durvalumab|mesh-list
101976990|NCT02301130|Tremelimumab|tremelimumab|mesh-list
101976991|NCT02301130|Mogamulizumab|mogamulizumab|mesh-list
101976992|NCT02301130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101976993|NCT02301130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101976994|NCT02301130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101976995|NCT02301130|Immunologic Factors|immunologic factors|mesh-ancestor
101976996|NCT02301130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976997|NCT03920605|Tenofovir|tenofovir|mesh-list
101976998|NCT03920605|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101976999|NCT03920605|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101977000|NCT03920605|Antiviral Agents|antiviral agents|mesh-ancestor
101977001|NCT03920605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101977002|NCT03920605|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101946331|NCT03884127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101946332|NCT03884127|Antimetabolites|antimetabolites|mesh-ancestor
101946333|NCT03884127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946334|NCT03884127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101946335|NCT03884127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101977003|NCT03920605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101977004|NCT03920605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101977005|NCT03920605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977011|NCT02298010|Oxaliplatin|oxaliplatin|mesh-list
101977012|NCT02298010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101977013|NCT02298010|Antimetabolites|antimetabolites|mesh-ancestor
101977014|NCT02298010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977016|NCT01229605|Cyclophosphamide|cyclophosphamide|mesh-list
101977018|NCT01229605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101977019|NCT01229605|Immunologic Factors|immunologic factors|mesh-ancestor
101977020|NCT01229605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977021|NCT01229605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101977022|NCT01229605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101977023|NCT01229605|Alkylating Agents|alkylating agents|mesh-ancestor
101977024|NCT01229605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977025|NCT01229605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101977026|NCT01229605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101977027|NCT01229605|Tubulin Modulators|tubulin modulators|mesh-ancestor
101977028|NCT01229605|Antimitotic Agents|antimitotic agents|mesh-ancestor
101977029|NCT01229605|Mitosis Modulators|mitosis modulators|mesh-ancestor
101977030|NCT01319006|Glycine|glycine|mesh-list
101977031|NCT01319006|Glycine Agents|glycine agents|mesh-ancestor
101977032|NCT01319006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101977033|NCT01319006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977034|NCT01319006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977035|NCT01358240|Econazole|econazole|mesh-list
101977036|NCT01358240|Antifungal Agents|antifungal agents|mesh-ancestor
101977037|NCT01358240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101977038|NCT01358240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101977039|NCT01358240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101977040|NCT01358240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101977041|NCT01358240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977042|NCT01358240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101977043|NCT01358240|Hormone Antagonists|hormone antagonists|mesh-ancestor
101977044|NCT01358240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101977045|NCT01358240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977046|NCT01131949|Lamotrigine|lamotrigine|mesh-list
101977047|NCT01131949|Anticonvulsants|anticonvulsants|mesh-ancestor
101977048|NCT01131949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101977049|NCT01131949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101977050|NCT01131949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977051|NCT01131949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101977052|NCT01131949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977053|NCT01131949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101977054|NCT01131949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101977055|NCT01131949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101977056|NCT01131949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101977057|NCT01131949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101977058|NCT03511222|Pembrolizumab|pembrolizumab|mesh-list
101977059|NCT03511222|Nivolumab|nivolumab|mesh-list
101977060|NCT03511222|Vorolanib|vorolanib|mesh-list
101977061|NCT03511222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101977062|NCT03511222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101977063|NCT03511222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101977064|NCT03511222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977065|NCT03511222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101977066|NCT03511222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101977067|NCT01230463|Ketorolac|ketorolac|mesh-list
101977068|NCT01230463|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101977069|NCT01230463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101977070|NCT01230463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101946336|NCT03884127|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101946337|NCT01158105|Bortezomib|bortezomib|mesh-list
101946338|NCT01158105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101946339|NCT03337490|Ivermectin|ivermectin|mesh-list
101946340|NCT03337490|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101977071|NCT01230463|Analgesics|analgesics|mesh-ancestor
101977072|NCT01230463|Sensory System Agents|sensory system agents|mesh-ancestor
101977073|NCT01230463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101977074|NCT01230463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977075|NCT01230463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101977076|NCT01230463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101977080|NCT01358396|Chrysarobin|chrysarobin|mesh-list
101977081|NCT01358396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101977082|NCT01358396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101977083|NCT01358396|Analgesics|analgesics|mesh-ancestor
101977084|NCT01358396|Sensory System Agents|sensory system agents|mesh-ancestor
101977085|NCT01358396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101977086|NCT01358396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977088|NCT01358396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101977089|NCT01135615|Calcium|calcium|mesh-list
101977090|NCT01135615|Sevelamer|sevelamer|mesh-list
101977091|NCT01135615|Calcium acetate|calcium acetate|mesh-list
101977092|NCT01135615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101977093|NCT01135615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977094|NCT01135615|Chelating Agents|chelating agents|mesh-ancestor
101977095|NCT01135615|Sequestering Agents|sequestering agents|mesh-ancestor
101977096|NCT01135615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977097|NCT01361516|Anesthetics|anesthetics|mesh-list
101977098|NCT01361516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101977099|NCT01361516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977100|NCT03920137|Nicotine|nicotine|mesh-list
101977101|NCT03920137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101977102|NCT03920137|Autonomic Agents|autonomic agents|mesh-ancestor
101977103|NCT03920137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101977104|NCT03920137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977105|NCT03920137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101977106|NCT03920137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101977107|NCT03920137|Cholinergic Agents|cholinergic agents|mesh-ancestor
101977108|NCT03920137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101977109|NCT03920137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977110|NCT03132610|Andrographolide|andrographolide|mesh-list
101977111|NCT03132610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101977112|NCT03132610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101977113|NCT03132610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101977114|NCT03132610|Analgesics|analgesics|mesh-ancestor
101977115|NCT03132610|Sensory System Agents|sensory system agents|mesh-ancestor
101977116|NCT03132610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101977117|NCT03132610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977118|NCT03132610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101977119|NCT03132610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101977120|NCT03132610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101977121|NCT03132610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101977122|NCT03132610|Antiviral Agents|antiviral agents|mesh-ancestor
101977123|NCT03132610|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101977124|NCT02298088|Clopidogrel|clopidogrel|mesh-list
101977125|NCT02298088|Ticagrelor|ticagrelor|mesh-list
101977126|NCT02298088|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101977127|NCT02298088|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101977128|NCT02298088|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101977129|NCT02298088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101977130|NCT02298088|Purinergic Agents|purinergic agents|mesh-ancestor
101977131|NCT02298088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101977132|NCT02298088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977133|NCT02298088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977134|NCT01133119|Bupivacaine|bupivacaine|mesh-list
101977135|NCT01133119|Anesthetics, Local|anesthetics, local|mesh-ancestor
101977136|NCT01133119|Anesthetics|anesthetics|mesh-ancestor
101977137|NCT01133119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101977138|NCT01133119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977139|NCT01133119|Sensory System Agents|sensory system agents|mesh-ancestor
101977140|NCT01133119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101946341|NCT03337490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101946342|NCT01158183|Interferons|interferons|mesh-list
101946343|NCT01158183|Interferon-beta|interferon-beta|mesh-list
101946344|NCT01158183|Interferon beta-1b|interferon beta-1b|mesh-list
101946345|NCT01158183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101946346|NCT01158183|Antiviral Agents|antiviral agents|mesh-ancestor
101946347|NCT01158183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101946348|NCT01158183|Immunologic Factors|immunologic factors|mesh-ancestor
101803758|NCT00737789|Mesalamine|mesalamine|mesh-list
101977141|NCT01230541|Udenafil|udenafil|mesh-list
101977142|NCT01230541|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101977143|NCT01230541|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101977144|NCT01230541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101977145|NCT01230541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977146|NCT01229761|Trimethoprim|trimethoprim|mesh-list
101977147|NCT01229761|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101977152|NCT01229761|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101977153|NCT01229761|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101977154|NCT01229761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101977155|NCT01229761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101977156|NCT01229761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977157|NCT01229761|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101977158|NCT01229761|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101977159|NCT01229761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101977160|NCT01229761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101977161|NCT01229839|Ethiodized Oil|ethiodized oil|mesh-list
101977162|NCT01229839|Antineoplastic Agents|antineoplastic agents|mesh-list
101977164|NCT03514810|Sertraline|sertraline|mesh-list
101977165|NCT03514810|Antidepressive Agents|antidepressive agents|mesh-ancestor
101977166|NCT03514810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101977167|NCT03514810|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101977168|NCT03514810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101977169|NCT03514810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101977170|NCT03514810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977171|NCT03514810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101977172|NCT03514810|Serotonin Agents|serotonin agents|mesh-ancestor
101977173|NCT03514810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977174|NCT03514810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101977175|NCT03514810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101977176|NCT03514810|Analgesics|analgesics|mesh-ancestor
101977177|NCT03514810|Sensory System Agents|sensory system agents|mesh-ancestor
101977178|NCT03514810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101977179|NCT03514810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101977180|NCT03514810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101977181|NCT03514810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101977182|NCT03514810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101977183|NCT02301676|Dexmedetomidine|dexmedetomidine|mesh-list
101977184|NCT02301676|Propofol|propofol|mesh-list
101977185|NCT02301676|Sevoflurane|sevoflurane|mesh-list
101977186|NCT02301676|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101977187|NCT02301676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101977188|NCT02301676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977189|NCT02301676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101977190|NCT02301676|Analgesics|analgesics|mesh-ancestor
101977191|NCT02301676|Sensory System Agents|sensory system agents|mesh-ancestor
101977192|NCT02301676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101977193|NCT02301676|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101977194|NCT02301676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101977195|NCT02301676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101977196|NCT02301676|Adrenergic Agents|adrenergic agents|mesh-ancestor
101977197|NCT02301676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101977198|NCT02301676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977199|NCT02301676|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101977200|NCT02301676|Anesthetics, General|anesthetics, general|mesh-ancestor
101977201|NCT02301676|Anesthetics|anesthetics|mesh-ancestor
101977202|NCT02301676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101946349|NCT01158183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946351|NCT01264575|Epinephrine|epinephrine|mesh-list
101946352|NCT01264575|Racepinephrine|racepinephrine|mesh-list
101946353|NCT01264575|Bupivacaine|bupivacaine|mesh-list
101946354|NCT01264575|Epinephryl borate|epinephryl borate|mesh-list
101946355|NCT01264575|Anesthetics, Local|anesthetics, local|mesh-ancestor
101946356|NCT01264575|Anesthetics|anesthetics|mesh-ancestor
101946357|NCT01264575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101946358|NCT01264575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946359|NCT01264575|Sensory System Agents|sensory system agents|mesh-ancestor
101946360|NCT01264575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101803816|NCT00936962|Vaccines|vaccines|mesh-list
101710286|NCT00680732|Vitamins|vitamins|mesh-ancestor
101977203|NCT02301676|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101977204|NCT01135771|Insulin|insulin|mesh-list
101977205|NCT01135771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101977206|NCT01135771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977207|NCT01133353|Tetrabenazine|tetrabenazine|mesh-list
101977208|NCT01133353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101977209|NCT01133353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101977210|NCT01133353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101977211|NCT01133353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977212|NCT01133353|Adrenergic Agents|adrenergic agents|mesh-ancestor
101977213|NCT01133353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101977214|NCT01133353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977215|NCT01135927|Insulin|insulin|mesh-list
101977216|NCT01135927|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101977217|NCT01135927|Insulin Detemir|insulin detemir|mesh-list
101977218|NCT01135927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101977234|NCT01136005|Vitamins|vitamins|mesh-ancestor
101977235|NCT01136005|Micronutrients|micronutrients|mesh-ancestor
101977236|NCT01136005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977237|NCT03509740|Acetaminophen|acetaminophen|mesh-list
101977238|NCT03509740|Tramadol|tramadol|mesh-list
101977239|NCT03509740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101977240|NCT03509740|Analgesics|analgesics|mesh-ancestor
101977241|NCT03509740|Sensory System Agents|sensory system agents|mesh-ancestor
101977242|NCT03509740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101977243|NCT03509740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977244|NCT03509740|Antipyretics|antipyretics|mesh-ancestor
101977245|NCT03509740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101977246|NCT03509740|Narcotics|narcotics|mesh-ancestor
101977247|NCT03509740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101977248|NCT03918187|Midazolam|midazolam|mesh-list
101977249|NCT03918187|Nalbuphine|nalbuphine|mesh-list
101977250|NCT03918187|Bupivacaine|bupivacaine|mesh-list
101977251|NCT03918187|Anesthetics, Local|anesthetics, local|mesh-ancestor
101977252|NCT03918187|Anesthetics|anesthetics|mesh-ancestor
101977253|NCT03918187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101977254|NCT03918187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977255|NCT03918187|Sensory System Agents|sensory system agents|mesh-ancestor
101977256|NCT03918187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101977257|NCT03918187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101977258|NCT03918187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101977259|NCT03918187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101977260|NCT03918187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101977261|NCT03918187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101977262|NCT03918187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101977263|NCT03918187|Anesthetics, General|anesthetics, general|mesh-ancestor
101977264|NCT03918187|GABA Modulators|gaba modulators|mesh-ancestor
101977265|NCT03918187|GABA Agents|gaba agents|mesh-ancestor
101977266|NCT03918187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101977267|NCT03918187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977268|NCT03918187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101977269|NCT03918187|Narcotics|narcotics|mesh-ancestor
101977270|NCT03918187|Analgesics|analgesics|mesh-ancestor
101946361|NCT01264575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101946362|NCT01264575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101946363|NCT01264575|Adrenergic Agents|adrenergic agents|mesh-ancestor
101946364|NCT01264575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101946365|NCT01264575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977272|NCT03507634|Fentanyl|fentanyl|mesh-list
101977273|NCT03507634|Dexmedetomidine|dexmedetomidine|mesh-list
101977274|NCT03507634|Remifentanil|remifentanil|mesh-list
101977275|NCT03507634|Analgesics, Opioid|analgesics, opioid|mesh-list
101977276|NCT03507634|Anesthetics|anesthetics|mesh-list
101977277|NCT03507634|Anesthetics, Local|anesthetics, local|mesh-ancestor
101977278|NCT03507634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101977279|NCT03507634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977280|NCT03507634|Sensory System Agents|sensory system agents|mesh-ancestor
101432243|NCT05470972|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101977287|NCT03507634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101710297|NCT00698932|Saxagliptin|saxagliptin|mesh-list
101977288|NCT03507634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101977289|NCT03507634|Analgesics|analgesics|mesh-ancestor
101977290|NCT03507634|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101977291|NCT03507634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101977292|NCT03507634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101977293|NCT03507634|Adrenergic Agents|adrenergic agents|mesh-ancestor
101977294|NCT03507634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101977295|NCT03507634|Narcotics|narcotics|mesh-ancestor
101977296|NCT03507634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101977297|NCT03507634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101977298|NCT03507634|Anesthetics, General|anesthetics, general|mesh-ancestor
101977299|NCT03507556|Metronidazole|metronidazole|mesh-list
101977300|NCT03507556|Ciprofloxacin|ciprofloxacin|mesh-list
101977301|NCT03507556|Minocycline|minocycline|mesh-list
101977302|NCT03507556|Zinc Oxide|zinc oxide|mesh-list
101977303|NCT03507556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101977304|NCT03507556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101977305|NCT03507556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101977306|NCT03507556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101977307|NCT03507556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101977308|NCT03507556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101977309|NCT03507556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101977310|NCT03507556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977311|NCT03507556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101977312|NCT03507556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101977313|NCT03507556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101977314|NCT03507556|Dermatologic Agents|dermatologic agents|mesh-ancestor
101977315|NCT03507556|Sunscreening Agents|sunscreening agents|mesh-ancestor
101977316|NCT03507556|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101977317|NCT03507556|Protective Agents|protective agents|mesh-ancestor
101977318|NCT03507556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977320|NCT01232257|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101977321|NCT01232257|Antiviral Agents|antiviral agents|mesh-ancestor
101977322|NCT01232257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101977323|NCT01232257|Expectorants|expectorants|mesh-ancestor
101977324|NCT01232257|Respiratory System Agents|respiratory system agents|mesh-ancestor
101977325|NCT01232257|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101977326|NCT01232257|Antioxidants|antioxidants|mesh-ancestor
101977327|NCT01232257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977328|NCT01232257|Protective Agents|protective agents|mesh-ancestor
101977329|NCT01232257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977330|NCT01232257|Antidotes|antidotes|mesh-ancestor
101977331|NCT03509662|Ascorbic Acid|ascorbic acid|mesh-list
101977332|NCT03509662|Thiamine|thiamine|mesh-list
101977333|NCT03509662|Vitamins|vitamins|mesh-ancestor
101977334|NCT03509662|Micronutrients|micronutrients|mesh-ancestor
101977335|NCT03509662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977336|NCT03509662|Antioxidants|antioxidants|mesh-ancestor
101977337|NCT03509662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977338|NCT03509662|Protective Agents|protective agents|mesh-ancestor
101977339|NCT03509662|Vitamin B Complex|vitamin b complex|mesh-ancestor
101697137|NCT00988897|Immunologic Factors|immunologic factors|mesh-ancestor
101977340|NCT03504982|Moxifloxacin|moxifloxacin|mesh-list
101977341|NCT03504982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101977342|NCT03504982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101666193|NCT00792909|Vaccines|vaccines|mesh-list
101946366|NCT01264575|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101977343|NCT03504982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101977344|NCT03504982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101977345|NCT03504982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101977346|NCT03504982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977347|NCT03504982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101977348|NCT01133431|Glimepiride|glimepiride|mesh-list
101432304|NCT00188955|Antifungal Agents|antifungal agents|mesh-ancestor
101977353|NCT01133431|Immunologic Factors|immunologic factors|mesh-ancestor
101977354|NCT05610007|Prilocaine|prilocaine|mesh-list
101977355|NCT05610007|Anesthetics, Local|anesthetics, local|mesh-ancestor
101977356|NCT05610007|Anesthetics|anesthetics|mesh-ancestor
101977357|NCT05610007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101977358|NCT05610007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977359|NCT05610007|Sensory System Agents|sensory system agents|mesh-ancestor
101977360|NCT05610007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101977361|NCT01232413|Ipragliflozin|ipragliflozin|mesh-list
101977362|NCT01232413|Moxifloxacin|moxifloxacin|mesh-list
101977363|NCT01232413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101977364|NCT01232413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101977365|NCT01232413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101977366|NCT01232413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101977367|NCT01232413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101977368|NCT01232413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977369|NCT01232413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101977370|NCT01232413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977371|NCT01232413|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101977372|NCT01232413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101977373|NCT02303782|Azacitidine|azacitidine|mesh-list
101977374|NCT02303782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101977375|NCT02303782|Antimetabolites|antimetabolites|mesh-ancestor
101977376|NCT02303782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977377|NCT02303782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101977378|NCT02303782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101977379|NCT01233505|Capecitabine|capecitabine|mesh-list
101977380|NCT01233505|Oxaliplatin|oxaliplatin|mesh-list
101977381|NCT01233505|Veliparib|veliparib|mesh-list
101977382|NCT01233505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101977383|NCT01233505|Antimetabolites|antimetabolites|mesh-ancestor
101977384|NCT01233505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977385|NCT01233505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101977386|NCT01233505|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101977387|NCT01233505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101977388|NCT04925180|Cyproterone Acetate|cyproterone acetate|mesh-list
101977389|NCT04925180|Cyproterone|cyproterone|mesh-list
101977390|NCT04925180|Androgen Antagonists|androgen antagonists|mesh-ancestor
101977391|NCT04925180|Hormone Antagonists|hormone antagonists|mesh-ancestor
101977392|NCT04925180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101977393|NCT04925180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977394|NCT04925180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101977395|NCT04925180|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101977396|NCT04925180|Contraceptive Agents|contraceptive agents|mesh-ancestor
101977397|NCT04925180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101977398|NCT01133509|Vaccines|vaccines|mesh-list
101977399|NCT01133509|Immunologic Factors|immunologic factors|mesh-ancestor
101977400|NCT01133509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977401|NCT02306902|Fenofibrate|fenofibrate|mesh-list
101977402|NCT02306902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101977403|NCT02306902|Antimetabolites|antimetabolites|mesh-ancestor
101977404|NCT02306902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977405|NCT02306902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101977406|NCT01230697|Sorafenib|sorafenib|mesh-list
101977407|NCT01230697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101977408|NCT01230697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101977409|NCT01230697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101977410|NCT01230697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977411|NCT01361984|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101977412|NCT01361984|Formoterol Fumarate|formoterol fumarate|mesh-list
101977413|NCT01361984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101977414|NCT01361984|Autonomic Agents|autonomic agents|mesh-ancestor
101977415|NCT01361984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101977416|NCT01361984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946367|NCT01264575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101946368|NCT01264575|Autonomic Agents|autonomic agents|mesh-ancestor
101804019|NCT00933452|Analgesics|analgesics|mesh-ancestor
101977417|NCT01361984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101977418|NCT01361984|Respiratory System Agents|respiratory system agents|mesh-ancestor
101977429|NCT01230775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101977431|NCT01136317|Rabeprazole|rabeprazole|mesh-list
101977432|NCT01136317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101977433|NCT01136317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101977434|NCT01136317|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101977435|NCT01136317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101977436|NCT01136317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977437|NCT03507244|Dexamethasone|dexamethasone|mesh-list
101977438|NCT03507244|Pemetrexed|pemetrexed|mesh-list
101977439|NCT03507244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101977440|NCT03507244|Antiemetics|antiemetics|mesh-ancestor
101977441|NCT03507244|Autonomic Agents|autonomic agents|mesh-ancestor
101977442|NCT03507244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101977443|NCT03507244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977444|NCT03507244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101977445|NCT03507244|Glucocorticoids|glucocorticoids|mesh-ancestor
101977446|NCT03507244|Hormones|hormones|mesh-ancestor
101977447|NCT03507244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101977448|NCT03507244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101977449|NCT03507244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101977450|NCT03507244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101977451|NCT03507244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977452|NCT03507244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101977453|NCT03507244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101977454|NCT01136395|Rituximab|rituximab|mesh-list
101977455|NCT01136395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101977456|NCT01136395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101977457|NCT01136395|Immunologic Factors|immunologic factors|mesh-ancestor
101977458|NCT01136395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977459|NCT01136395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101977460|NCT02304094|Methylprednisolone|methylprednisolone|mesh-list
101977461|NCT02304094|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101977462|NCT02304094|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101977463|NCT02304094|Prednisolone|prednisolone|mesh-list
101977464|NCT02304094|Prednisolone acetate|prednisolone acetate|mesh-list
101977465|NCT02304094|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101977466|NCT02304094|Prednisolone phosphate|prednisolone phosphate|mesh-list
101977467|NCT02304094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101977468|NCT02304094|Antiemetics|antiemetics|mesh-ancestor
101977469|NCT02304094|Autonomic Agents|autonomic agents|mesh-ancestor
101977470|NCT02304094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101977471|NCT02304094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977472|NCT02304094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101977473|NCT02304094|Glucocorticoids|glucocorticoids|mesh-ancestor
101977474|NCT02304094|Hormones|hormones|mesh-ancestor
101977475|NCT02304094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101977476|NCT02304094|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101977477|NCT02304094|Protective Agents|protective agents|mesh-ancestor
101977478|NCT02304094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101977479|NCT02304094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101977480|NCT03507166|Trastuzumab|trastuzumab|mesh-list
101977481|NCT03507166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101977482|NCT03507166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101977483|NCT01233583|Adalimumab|adalimumab|mesh-list
101977499|NCT01233583|Immunologic Factors|immunologic factors|mesh-ancestor
101977500|NCT01233583|Keratolytic Agents|keratolytic agents|mesh-ancestor
101977501|NCT02304250|Dexamethasone|dexamethasone|mesh-list
101977502|NCT02304250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101977503|NCT02304250|Antiemetics|antiemetics|mesh-ancestor
101977504|NCT02304250|Autonomic Agents|autonomic agents|mesh-ancestor
101977505|NCT02304250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101977506|NCT02304250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977507|NCT02304250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101977508|NCT02304250|Glucocorticoids|glucocorticoids|mesh-ancestor
101977509|NCT02304250|Hormones|hormones|mesh-ancestor
101977510|NCT02304250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101574942|NCT01028391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101946369|NCT01264575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101946370|NCT01264575|Respiratory System Agents|respiratory system agents|mesh-ancestor
101946371|NCT01264575|Mydriatics|mydriatics|mesh-ancestor
101946372|NCT01264575|Sympathomimetics|sympathomimetics|mesh-ancestor
101574943|NCT01028391|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101574944|NCT01028391|Protease Inhibitors|protease inhibitors|mesh-ancestor
101574945|NCT01028391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101574946|NCT01028391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574947|NCT01179672|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101574948|NCT01179672|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101574949|NCT01179672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101574950|NCT01179672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101574951|NCT01179672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574952|NCT01179672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101574953|NCT01179672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574954|NCT01179672|Analgesics|analgesics|mesh-ancestor
101574955|NCT01179672|Sensory System Agents|sensory system agents|mesh-ancestor
101574956|NCT01179672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101574957|NCT01179672|Antidepressive Agents|antidepressive agents|mesh-ancestor
101574958|NCT01179672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101574959|NCT01179672|Dopamine Agents|dopamine agents|mesh-ancestor
101574960|NCT04301349|Misoprostol|misoprostol|mesh-list
101574961|NCT04301349|Dinoprostone|dinoprostone|mesh-list
101574962|NCT04301349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101574963|NCT04301349|Abortifacient Agents|abortifacient agents|mesh-ancestor
101574964|NCT04301349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101574965|NCT04301349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574966|NCT04301349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101574967|NCT04301349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101574968|NCT04301349|Oxytocics|oxytocics|mesh-ancestor
101574969|NCT02753647|Prednisone|prednisone|mesh-list
101574970|NCT02753647|Cyclophosphamide|cyclophosphamide|mesh-list
101231862|NCT00713193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101574971|NCT02753647|Rituximab|rituximab|mesh-list
101574972|NCT02753647|Doxorubicin|doxorubicin|mesh-list
101574973|NCT02753647|Vincristine|vincristine|mesh-list
101574974|NCT02753647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101574975|NCT02753647|Immunologic Factors|immunologic factors|mesh-ancestor
101574981|NCT02753647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101574982|NCT02753647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101574983|NCT02753647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101574984|NCT02753647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101574985|NCT02753647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101574986|NCT02753647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101574987|NCT02753647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101574988|NCT02753647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101574990|NCT02753647|Hormones|hormones|mesh-ancestor
101574991|NCT02753647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101574992|NCT02753647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101977512|NCT02304250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101977513|NCT01136551|Huperzine A|huperzine a|mesh-list
101977514|NCT01136551|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101977515|NCT01136551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101977516|NCT01136551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977517|NCT01136551|Cholinergic Agents|cholinergic agents|mesh-ancestor
101977518|NCT01136551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101977519|NCT01136551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977520|NCT01136551|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101977521|NCT01136551|Protective Agents|protective agents|mesh-ancestor
101977522|NCT03132142|Cinnamaldehyde|cinnamaldehyde|mesh-list
101977523|NCT03132142|Capsaicin|capsaicin|mesh-list
101977524|NCT03132142|Menthol|menthol|mesh-list
101977525|NCT03132142|Antipruritics|antipruritics|mesh-ancestor
101977526|NCT03132142|Dermatologic Agents|dermatologic agents|mesh-ancestor
101710328|NCT00823719|Ofatumumab|ofatumumab|mesh-list
101977527|NCT03132142|Sensory System Agents|sensory system agents|mesh-ancestor
101977528|NCT03132142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101977529|NCT03132142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977530|NCT03132142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101977531|NCT03132142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101977532|NCT03132142|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101977533|NCT03132142|Protective Agents|protective agents|mesh-ancestor
101977534|NCT01232647|Vitamins|vitamins|mesh-list
101946374|NCT04992260|Vaccines|vaccines|mesh-list
101946375|NCT04992260|Immunologic Factors|immunologic factors|mesh-ancestor
101977535|NCT01232647|Vitamin K|vitamin k|mesh-list
101977536|NCT01232647|Vitamin K 2|vitamin k 2|mesh-list
101977537|NCT01232647|Vitamin K 1|vitamin k 1|mesh-list
101977538|NCT01232647|Menatetrenone|menatetrenone|mesh-list
101977539|NCT01232647|Micronutrients|micronutrients|mesh-ancestor
101977540|NCT01232647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977541|NCT01232647|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101977542|NCT01232647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101977543|NCT01232647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977544|NCT01232647|Hemostatics|hemostatics|mesh-ancestor
101977545|NCT01232647|Coagulants|coagulants|mesh-ancestor
101977546|NCT03917095|Mesalamine|mesalamine|mesh-list
101977547|NCT03917095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101977548|NCT03917095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101977549|NCT03917095|Analgesics|analgesics|mesh-ancestor
101977550|NCT03917095|Sensory System Agents|sensory system agents|mesh-ancestor
101977551|NCT03917095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101977552|NCT03917095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977553|NCT03917095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101977554|NCT03917095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101977555|NCT01133743|Thalidomide|thalidomide|mesh-list
101977556|NCT01133743|Dexamethasone|dexamethasone|mesh-list
101977557|NCT01133743|Lenalidomide|lenalidomide|mesh-list
101977558|NCT01133743|Immunomodulating Agents|immunomodulating agents|mesh-list
101977559|NCT01133743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101977560|NCT01133743|Antiemetics|antiemetics|mesh-ancestor
101977561|NCT01133743|Autonomic Agents|autonomic agents|mesh-ancestor
101977562|NCT01133743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101977563|NCT01133743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977564|NCT01133743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101977581|NCT01138423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101977582|NCT01138423|Diuretics|diuretics|mesh-ancestor
101977583|NCT01138423|Natriuretic Agents|natriuretic agents|mesh-ancestor
101697380|NCT04754815|Paclitaxel|paclitaxel|mesh-list
101977584|NCT01138423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977585|NCT01138423|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101977586|NCT01138423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101977587|NCT01138423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977588|NCT01136863|Felodipine|felodipine|mesh-list
101977589|NCT01136863|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101977590|NCT01136863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101977591|NCT01136863|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101977592|NCT01136863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101977593|NCT01136863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977594|NCT01136863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101977595|NCT01136863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977596|NCT01136863|Vasodilator Agents|vasodilator agents|mesh-ancestor
101977597|NCT03961516|Pancrelipase|pancrelipase|mesh-list
101977598|NCT03961516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101977599|NCT03508882|Botulinum Toxins|botulinum toxins|mesh-list
101977600|NCT03508882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101977601|NCT03508882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101977602|NCT03508882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101977603|NCT03508882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101977604|NCT03508882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977605|NCT03508882|Cholinergic Agents|cholinergic agents|mesh-ancestor
101977606|NCT03508882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101977607|NCT03508882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977608|NCT03508882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101977609|NCT03508882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101977610|NCT05553145|Antibodies|antibodies|mesh-list
101977611|NCT05553145|Autoantibodies|autoantibodies|mesh-list
101977612|NCT05553145|Immunologic Factors|immunologic factors|mesh-ancestor
101977613|NCT05553145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977614|NCT03504280|Cholecalciferol|cholecalciferol|mesh-list
101977615|NCT03504280|Vitamin D|vitamin d|mesh-list
101977616|NCT03504280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101977617|NCT03504280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977618|NCT03504280|Vitamins|vitamins|mesh-ancestor
101977619|NCT03504280|Micronutrients|micronutrients|mesh-ancestor
101977620|NCT03504280|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101946376|NCT04992260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946377|NCT01266681|Amiodarone|amiodarone|mesh-list
101946378|NCT01266681|Dronedarone|dronedarone|mesh-list
101946379|NCT01266681|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101977621|NCT03504202|Trimetazidine|trimetazidine|mesh-list
101977622|NCT03504202|Vasodilator Agents|vasodilator agents|mesh-ancestor
101977629|NCT01136941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977631|NCT01136941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101977632|NCT01136941|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101977633|NCT01136941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101977634|NCT01136941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977635|NCT01136941|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101977636|NCT01136941|Hormone Antagonists|hormone antagonists|mesh-ancestor
101977637|NCT01136941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101977638|NCT01232803|Tenofovir|tenofovir|mesh-list
101977639|NCT01232803|Antiviral Agents|antiviral agents|mesh-ancestor
101977640|NCT01232803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101977641|NCT01232803|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101977642|NCT01232803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101977643|NCT01232803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101977644|NCT01232803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977645|NCT01232803|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101977646|NCT01232803|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101977647|NCT03504046|Pancrelipase|pancrelipase|mesh-list
101977648|NCT03504046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101977649|NCT01139203|Lamivudine|lamivudine|mesh-list
101977650|NCT01139203|Adefovir|adefovir|mesh-list
101977651|NCT01139203|Entecavir|entecavir|mesh-list
101977652|NCT01139203|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101977653|NCT01139203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101977654|NCT01139203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101977655|NCT01139203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977656|NCT01139203|Antiviral Agents|antiviral agents|mesh-ancestor
101977657|NCT01139203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101977658|NCT01139203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101977659|NCT01139203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101977660|NCT05187715|Simvastatin|simvastatin|mesh-list
101977661|NCT05187715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101977662|NCT05187715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101977663|NCT05187715|Antimetabolites|antimetabolites|mesh-ancestor
101977664|NCT05187715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977665|NCT05187715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101977666|NCT05187715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101977667|NCT05187715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101977668|NCT02312440|Tranexamic Acid|tranexamic acid|mesh-list
101977669|NCT02312440|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101977670|NCT02312440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101977671|NCT02312440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977673|NCT02312440|Coagulants|coagulants|mesh-ancestor
101977674|NCT01137019|Everolimus|everolimus|mesh-list
101977675|NCT01137019|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101977676|NCT01137019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101977677|NCT01137019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101977678|NCT01137019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977679|NCT01137019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101977680|NCT01137019|Immunologic Factors|immunologic factors|mesh-ancestor
101977681|NCT01137019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977682|NCT01137019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101977683|NCT03508804|Lidocaine|lidocaine|mesh-list
101977684|NCT03508804|Prilocaine|prilocaine|mesh-list
101977685|NCT03508804|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
101977686|NCT03508804|Anesthetics, Local|anesthetics, local|mesh-ancestor
101977687|NCT03508804|Anesthetics|anesthetics|mesh-ancestor
101977688|NCT03508804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101977689|NCT03508804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977690|NCT03508804|Sensory System Agents|sensory system agents|mesh-ancestor
101432697|NCT00406796|Ranibizumab|ranibizumab|mesh-list
101977692|NCT03508804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101977693|NCT03508804|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101977694|NCT03508804|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101977695|NCT03508804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101946380|NCT01266681|Vasodilator Agents|vasodilator agents|mesh-ancestor
101946381|NCT01266681|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101946382|NCT01266681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101977696|NCT03508804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977697|NCT03508804|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
101977698|NCT01231165|Aspirin|aspirin|mesh-list
101977699|NCT01231165|Amiloride|amiloride|mesh-list
101977700|NCT01231165|Clopidogrel|clopidogrel|mesh-list
101977701|NCT01231165|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
101977702|NCT01231165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101977703|NCT01231165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101977704|NCT01231165|Analgesics|analgesics|mesh-ancestor
101977705|NCT01231165|Sensory System Agents|sensory system agents|mesh-ancestor
101977706|NCT01231165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101977707|NCT01231165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977708|NCT01231165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101977709|NCT01231165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101977710|NCT01231165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101977711|NCT01231165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101977712|NCT01231165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977713|NCT01231165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101977714|NCT01231165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101977715|NCT01231165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101977716|NCT01231165|Antipyretics|antipyretics|mesh-ancestor
101977717|NCT01231165|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101977718|NCT01231165|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101977719|NCT01231165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101977720|NCT01231165|Purinergic Agents|purinergic agents|mesh-ancestor
101977721|NCT01231165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101977722|NCT01231165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101977723|NCT01231165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101977724|NCT01231165|Antimetabolites|antimetabolites|mesh-ancestor
101977725|NCT01231165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101977726|NCT01231165|Diuretics|diuretics|mesh-ancestor
101977727|NCT01231165|Natriuretic Agents|natriuretic agents|mesh-ancestor
101977728|NCT01231165|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
101977729|NCT01231165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101977730|NCT01231165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101977731|NCT01231165|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101977732|NCT01231165|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101977733|NCT01231243|Hydrogen Peroxide|hydrogen peroxide|mesh-list
101977734|NCT01231243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101977735|NCT01231243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101977736|NCT03503890|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
101977737|NCT03503890|Immunoconjugates|immunoconjugates|mesh-ancestor
101977738|NCT03503890|Immunologic Factors|immunologic factors|mesh-ancestor
101977739|NCT03503890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977740|NCT01233895|Bortezomib|bortezomib|mesh-list
101977741|NCT01233895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101977742|NCT05221645|Rituximab|rituximab|mesh-list
101977743|NCT05221645|Pembrolizumab|pembrolizumab|mesh-list
101977744|NCT05221645|Carboplatin|carboplatin|mesh-list
101977745|NCT05221645|Etoposide|etoposide|mesh-list
101977746|NCT05221645|Ifosfamide|ifosfamide|mesh-list
101977747|NCT05221645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101977748|NCT05221645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101977749|NCT05221645|Immunologic Factors|immunologic factors|mesh-ancestor
101977750|NCT05221645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977751|NCT05221645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101977752|NCT05221645|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101977753|NCT05221645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977754|NCT05221645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101977755|NCT05221645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101977756|NCT05221645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101977757|NCT05221645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101977758|NCT05221645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101977759|NCT05221645|Alkylating Agents|alkylating agents|mesh-ancestor
101977760|NCT03506620|Ropivacaine|ropivacaine|mesh-list
101977761|NCT03506620|Anesthetics, Local|anesthetics, local|mesh-ancestor
101977762|NCT03506620|Anesthetics|anesthetics|mesh-ancestor
101977763|NCT03506620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101977768|NCT02305030|Warfarin|warfarin|mesh-list
101946383|NCT01266681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946384|NCT01266681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101946385|NCT01266681|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101946386|NCT01266681|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101946387|NCT01266681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101946388|NCT01266681|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101971939|NCT02083250|Immunologic Factors|immunologic factors|mesh-ancestor
101977769|NCT02305030|Anticoagulants|anticoagulants|mesh-ancestor
101977770|NCT02305030|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101977771|NCT02305030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101977772|NCT02305030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977773|NCT02305030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101977774|NCT02305030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101977775|NCT01139437|Vaccines|vaccines|mesh-list
101977776|NCT01139437|Immunologic Factors|immunologic factors|mesh-ancestor
101977777|NCT01139437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977778|NCT01137253|Trimethaphan|trimethaphan|mesh-list
101977779|NCT01137253|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
101977780|NCT01137253|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101977781|NCT01137253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101977782|NCT01137253|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
101977783|NCT01137253|Autonomic Agents|autonomic agents|mesh-ancestor
101977784|NCT01137253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101977785|NCT01137253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977786|NCT01137253|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101977787|NCT01137253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101977788|NCT01137253|Cholinergic Agents|cholinergic agents|mesh-ancestor
101977789|NCT01137253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101977790|NCT01137253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977791|NCT01137253|Vasodilator Agents|vasodilator agents|mesh-ancestor
101977792|NCT05493163|Fibrinolytic Agents|fibrinolytic agents|mesh-list
101977793|NCT05493163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101977794|NCT05493163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977795|NCT03506542|Mitomycins|mitomycins|mesh-list
101977796|NCT03506542|Mitomycin|mitomycin|mesh-list
101977797|NCT03506542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101977798|NCT03506542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101977799|NCT03506542|Alkylating Agents|alkylating agents|mesh-ancestor
101977800|NCT03506542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977801|NCT03506542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101977802|NCT03506542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101977803|NCT02305186|Pembrolizumab|pembrolizumab|mesh-list
101977804|NCT02305186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101977805|NCT02305186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101977806|NCT02305186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101977807|NCT02305186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977808|NCT02312908|Clonazepam|clonazepam|mesh-list
101977809|NCT02312908|Anticonvulsants|anticonvulsants|mesh-ancestor
101977810|NCT02312908|GABA Modulators|gaba modulators|mesh-ancestor
101977811|NCT02312908|GABA Agents|gaba agents|mesh-ancestor
101977812|NCT02312908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101977813|NCT02312908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977814|NCT02312908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977815|NCT02308930|Vitamin D|vitamin d|mesh-list
101977816|NCT02308930|Vitamins|vitamins|mesh-list
101977817|NCT02308930|Vitamin A|vitamin a|mesh-list
101977818|NCT02308930|Retinol palmitate|retinol palmitate|mesh-list
101977819|NCT02308930|Micronutrients|micronutrients|mesh-ancestor
101977820|NCT02308930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977821|NCT02308930|Antioxidants|antioxidants|mesh-ancestor
101977822|NCT02308930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977823|NCT02308930|Protective Agents|protective agents|mesh-ancestor
101977824|NCT02308930|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101977825|NCT02308930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101977826|NCT02308930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101977827|NCT01139671|Remifentanil|remifentanil|mesh-list
101946389|NCT01266681|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101946390|NCT01266681|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101946391|NCT03638648|Capecitabine|capecitabine|mesh-list
101804443|NCT00935246|Citalopram|citalopram|mesh-list
101977828|NCT01139671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101977829|NCT01139671|Narcotics|narcotics|mesh-ancestor
101977830|NCT01139671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101977831|NCT01139671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977832|NCT01139671|Analgesics|analgesics|mesh-ancestor
101977833|NCT01139671|Sensory System Agents|sensory system agents|mesh-ancestor
101977834|NCT01139671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101977843|NCT01234051|Docetaxel|docetaxel|mesh-list
101977844|NCT01234051|Oxaliplatin|oxaliplatin|mesh-list
101977845|NCT01234051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101977846|NCT01234051|Tubulin Modulators|tubulin modulators|mesh-ancestor
101977847|NCT01234051|Antimitotic Agents|antimitotic agents|mesh-ancestor
101977848|NCT01234051|Mitosis Modulators|mitosis modulators|mesh-ancestor
101977849|NCT01234051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977850|NCT03341962|Calcium|calcium|mesh-list
101977851|NCT03341962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101977852|NCT03341962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977853|NCT01234597|Insulin|insulin|mesh-list
101977854|NCT01234597|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101977855|NCT01234597|Insulin Glargine|insulin glargine|mesh-list
101977856|NCT01234597|Insulin glulisine|insulin glulisine|mesh-list
101977857|NCT01234597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101977858|NCT01234597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977859|NCT02313220|Dapagliflozin|dapagliflozin|mesh-list
101977860|NCT02313220|Exenatide|exenatide|mesh-list
101977861|NCT02313220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101977862|NCT02313220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977863|NCT02313220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101977864|NCT02313220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977865|NCT02313220|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101977866|NCT02313220|Incretins|incretins|mesh-ancestor
101977867|NCT02313220|Hormones|hormones|mesh-ancestor
101977868|NCT02313220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101977869|NCT02309320|Gontivimab|gontivimab|mesh-list
101977870|NCT02309320|Antiviral Agents|antiviral agents|mesh-ancestor
101977871|NCT02309320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101977872|NCT01139749|Salicylic Acid|salicylic acid|mesh-list
101977873|NCT01139749|Ciclopirox|ciclopirox|mesh-list
101977874|NCT01139749|Salicylates|salicylates|mesh-list
101977875|NCT01139749|Isotretinoin|isotretinoin|mesh-list
101977876|NCT01139749|Dermatologic Agents|dermatologic agents|mesh-ancestor
101977877|NCT01139749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101977878|NCT01139749|Antifungal Agents|antifungal agents|mesh-ancestor
101977879|NCT01139749|Keratolytic Agents|keratolytic agents|mesh-ancestor
101977880|NCT01139749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101977881|NCT01139749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101977882|NCT01139749|Analgesics|analgesics|mesh-ancestor
101977883|NCT01139749|Sensory System Agents|sensory system agents|mesh-ancestor
101977884|NCT01139749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101977885|NCT01139749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697685|NCT00581776|Rituximab|rituximab|mesh-list
101977886|NCT01139749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101977887|NCT01139749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101977888|NCT01139749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101977890|NCT01139749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977891|NCT02305810|Everolimus|everolimus|mesh-list
101977892|NCT02305810|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101977893|NCT02305810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101977894|NCT02305810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101977895|NCT02305810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977896|NCT02305810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101977897|NCT02305810|Immunologic Factors|immunologic factors|mesh-ancestor
101977898|NCT02305810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977899|NCT02305810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101977900|NCT01142869|Cetuximab|cetuximab|mesh-list
101977901|NCT01142869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101977902|NCT01142869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101977903|NCT01139905|Ritonavir|ritonavir|mesh-list
101977914|NCT01139905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101946392|NCT03638648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101977915|NCT01139905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101977916|NCT05044429|Lidocaine|lidocaine|mesh-list
101977917|NCT05044429|Anesthetics, Local|anesthetics, local|mesh-ancestor
101977918|NCT05044429|Anesthetics|anesthetics|mesh-ancestor
101977919|NCT05044429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101977920|NCT05044429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977921|NCT05044429|Sensory System Agents|sensory system agents|mesh-ancestor
101977922|NCT05044429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101710410|NCT00822237|Vaccines|vaccines|mesh-list
101977923|NCT05044429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101977924|NCT05044429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101977925|NCT05044429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101977926|NCT05044429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101977927|NCT05044429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977928|NCT02309554|Nonoxynol|nonoxynol|mesh-list
101977929|NCT02309554|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
101977930|NCT02309554|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
101977931|NCT02309554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977932|NCT02309554|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101977933|NCT02309554|Contraceptive Agents|contraceptive agents|mesh-ancestor
101977934|NCT02309554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101977935|NCT02309554|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101977936|NCT01143025|Ropivacaine|ropivacaine|mesh-list
101977937|NCT01143025|Anesthetics, Local|anesthetics, local|mesh-ancestor
101977938|NCT01143025|Anesthetics|anesthetics|mesh-ancestor
101977939|NCT01143025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101977940|NCT01143025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977941|NCT01143025|Sensory System Agents|sensory system agents|mesh-ancestor
101977942|NCT01143025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101977943|NCT03502642|Morphine|morphine|mesh-list
101977944|NCT03502642|Ropivacaine|ropivacaine|mesh-list
101977945|NCT03502642|Anesthetics|anesthetics|mesh-ancestor
101977946|NCT03502642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101977947|NCT03502642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977948|NCT03502642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101977949|NCT03502642|Narcotics|narcotics|mesh-ancestor
101977950|NCT03502642|Analgesics|analgesics|mesh-ancestor
101977951|NCT03502642|Sensory System Agents|sensory system agents|mesh-ancestor
101977952|NCT03502642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101977953|NCT03502642|Anesthetics, Local|anesthetics, local|mesh-ancestor
101977954|NCT02306278|Gabapentin|gabapentin|mesh-list
101977955|NCT02306278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977956|NCT02306278|Analgesics|analgesics|mesh-ancestor
101977957|NCT02306278|Sensory System Agents|sensory system agents|mesh-ancestor
101977958|NCT02306278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101977959|NCT02306278|Anticonvulsants|anticonvulsants|mesh-ancestor
101977960|NCT02306278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101977961|NCT02306278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101697758|NCT04225325|Dolutegravir|dolutegravir|mesh-list
101977962|NCT02306278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101977963|NCT02306278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101977964|NCT02306278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101977965|NCT02306278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101977966|NCT02306278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101977967|NCT02306278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977970|NCT01234129|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101977971|NCT01234129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977974|NCT02313922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101977975|NCT02313922|Abortifacient Agents|abortifacient agents|mesh-ancestor
101977976|NCT02313922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101977977|NCT02313922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977978|NCT02313922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101977979|NCT02313922|Antimetabolites|antimetabolites|mesh-ancestor
101977980|NCT02313922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977981|NCT02313922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101977982|NCT02313922|Dermatologic Agents|dermatologic agents|mesh-ancestor
101977983|NCT02313922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101977984|NCT02313922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101977985|NCT02313922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101977986|NCT02313922|Immunologic Factors|immunologic factors|mesh-ancestor
101977987|NCT02313922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101946394|NCT03638648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977988|NCT02313922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101977989|NCT02313922|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101977990|NCT02313922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101977991|NCT02313922|Analgesics|analgesics|mesh-ancestor
101977992|NCT02313922|Sensory System Agents|sensory system agents|mesh-ancestor
101977993|NCT02313922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101977994|NCT02313922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101977995|NCT02313922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101977996|NCT03627013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101977997|NCT03508102|Remifentanil|remifentanil|mesh-list
101977998|NCT03508102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101977999|NCT03508102|Narcotics|narcotics|mesh-ancestor
101978000|NCT03508102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101978001|NCT03508102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978002|NCT03508102|Analgesics|analgesics|mesh-ancestor
101978003|NCT03508102|Sensory System Agents|sensory system agents|mesh-ancestor
101978004|NCT03508102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101978005|NCT03505528|Paclitaxel|paclitaxel|mesh-list
101978006|NCT03505528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101978007|NCT03505528|Phenelzine|phenelzine|mesh-list
101978008|NCT03505528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101978009|NCT03505528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101978010|NCT03505528|Tubulin Modulators|tubulin modulators|mesh-ancestor
101978011|NCT03505528|Antimitotic Agents|antimitotic agents|mesh-ancestor
101978012|NCT03505528|Mitosis Modulators|mitosis modulators|mesh-ancestor
101978013|NCT03505528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978014|NCT03505528|Antidepressive Agents|antidepressive agents|mesh-ancestor
101978015|NCT03505528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101978016|NCT03505528|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101978017|NCT03505528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101978018|NCT01234285|Heparin|heparin|mesh-list
101978019|NCT01234285|Calcium heparin|calcium heparin|mesh-list
101978020|NCT01234285|Anticoagulants|anticoagulants|mesh-ancestor
101978021|NCT01234285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101978022|NCT01234285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101978023|NCT01234285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978024|NCT02314312|Cyclosporine|cyclosporine|mesh-list
101978025|NCT02314312|Prednisolone|prednisolone|mesh-list
101978026|NCT02314312|Everolimus|everolimus|mesh-list
101978027|NCT02314312|Cyclosporins|cyclosporins|mesh-list
101978028|NCT02314312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101978029|NCT02314312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978030|NCT02314312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101978031|NCT02314312|Immunologic Factors|immunologic factors|mesh-ancestor
101978032|NCT02314312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978033|NCT02314312|Antifungal Agents|antifungal agents|mesh-ancestor
101978034|NCT02314312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101978035|NCT02314312|Dermatologic Agents|dermatologic agents|mesh-ancestor
101978036|NCT02314312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101978037|NCT02314312|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101978039|NCT02314312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101978040|NCT02314312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101978041|NCT02314312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101978042|NCT02314312|Glucocorticoids|glucocorticoids|mesh-ancestor
101978043|NCT02314312|Hormones|hormones|mesh-ancestor
101978064|NCT02310490|Natriuretic Agents|natriuretic agents|mesh-ancestor
101978065|NCT02310490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978066|NCT02316496|Irinotecan|irinotecan|mesh-list
101978067|NCT02316496|Cetuximab|cetuximab|mesh-list
101978068|NCT02316496|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101978069|NCT02316496|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101978070|NCT02316496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101978071|NCT02316496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978072|NCT02316496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101978073|NCT02316496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101978074|NCT01140529|Dexmedetomidine|dexmedetomidine|mesh-list
101978075|NCT01140529|Haloperidol|haloperidol|mesh-list
101978076|NCT01140529|Haloperidol decanoate|haloperidol decanoate|mesh-list
101978077|NCT01140529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101978078|NCT01140529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101978079|NCT01140529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978080|NCT01140529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101978081|NCT01140529|Analgesics|analgesics|mesh-ancestor
101978082|NCT01140529|Sensory System Agents|sensory system agents|mesh-ancestor
101946395|NCT03638648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101946396|NCT01266759|NuvaRing|nuvaring|mesh-list
101946397|NCT01266759|Norethindrone|norethindrone|mesh-list
101946398|NCT01266759|Norethindrone Acetate|norethindrone acetate|mesh-list
101946399|NCT01266759|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101946400|NCT01266759|Contraceptive Agents|contraceptive agents|mesh-ancestor
101804672|NCT00921167|Irinotecan|irinotecan|mesh-list
101978083|NCT01140529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101978084|NCT01140529|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101978085|NCT01140529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101978086|NCT01140529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101978087|NCT01140529|Adrenergic Agents|adrenergic agents|mesh-ancestor
101978088|NCT01140529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101978089|NCT01140529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978090|NCT01140529|Antiemetics|antiemetics|mesh-ancestor
101978091|NCT01140529|Autonomic Agents|autonomic agents|mesh-ancestor
101978092|NCT01140529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101978093|NCT01140529|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101978094|NCT01140529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101978095|NCT01140529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101978096|NCT01140529|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101978097|NCT01140529|Dopamine Agents|dopamine agents|mesh-ancestor
101978098|NCT01140529|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101978099|NCT01141153|Aspirin|aspirin|mesh-list
101978119|NCT01141153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101978120|NCT01141153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101978122|NCT01141153|Anticoagulants|anticoagulants|mesh-ancestor
101978123|NCT01235143|Sevoflurane|sevoflurane|mesh-list
101978124|NCT01235143|Desflurane|desflurane|mesh-list
101978125|NCT01235143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101978126|NCT01235143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101978127|NCT01235143|Anesthetics, General|anesthetics, general|mesh-ancestor
101978128|NCT01235143|Anesthetics|anesthetics|mesh-ancestor
101978129|NCT01235143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101978130|NCT01235143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978131|NCT01238029|Capecitabine|capecitabine|mesh-list
101978132|NCT01238029|Vinorelbine|vinorelbine|mesh-list
101978133|NCT01238029|Lapatinib|lapatinib|mesh-list
101978134|NCT01238029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101978135|NCT01238029|Antimetabolites|antimetabolites|mesh-ancestor
101978136|NCT01238029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978137|NCT01238029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101978138|NCT01238029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101978139|NCT01238029|Tubulin Modulators|tubulin modulators|mesh-ancestor
101978140|NCT01238029|Antimitotic Agents|antimitotic agents|mesh-ancestor
101978141|NCT01238029|Mitosis Modulators|mitosis modulators|mesh-ancestor
101978142|NCT01238029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101978143|NCT01238029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101978144|NCT01235221|4-Aminopyridine|4-aminopyridine|mesh-list
101978145|NCT01235221|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101978146|NCT01235221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101978147|NCT01235221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978148|NCT03139604|Prednisone|prednisone|mesh-list
101978149|NCT03139604|Methylprednisolone|methylprednisolone|mesh-list
101978150|NCT03139604|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101978151|NCT03139604|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101978155|NCT03139604|Prednisolone phosphate|prednisolone phosphate|mesh-list
101978156|NCT03139604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101978157|NCT03139604|Glucocorticoids|glucocorticoids|mesh-ancestor
101978159|NCT03139604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101978160|NCT03139604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978161|NCT03139604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101978162|NCT03139604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101978163|NCT03139604|Antiemetics|antiemetics|mesh-ancestor
101978164|NCT03139604|Autonomic Agents|autonomic agents|mesh-ancestor
101978165|NCT03139604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101978166|NCT03139604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101978167|NCT03139604|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101978168|NCT03139604|Protective Agents|protective agents|mesh-ancestor
101978169|NCT01350596|Ibuprofen|ibuprofen|mesh-list
101946401|NCT01266759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101946402|NCT01266759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946403|NCT01266759|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101946404|NCT01266759|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101946405|NCT01266759|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101978170|NCT01350596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101978171|NCT01350596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101978172|NCT01350596|Analgesics|analgesics|mesh-ancestor
101978173|NCT01350596|Sensory System Agents|sensory system agents|mesh-ancestor
101978174|NCT01350596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101978175|NCT01350596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978176|NCT01350596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101978177|NCT01350596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101978178|NCT01350596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101978179|NCT01350596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101978180|NCT01350596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978181|NCT04462588|Metronidazole|metronidazole|mesh-list
101978182|NCT04462588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101978183|NCT04462588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101978184|NCT04462588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101978185|NCT04462588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101978186|NCT04462822|Fluticasone|fluticasone|mesh-list
101978188|NCT04462822|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101978189|NCT04462822|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101978190|NCT04462822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101978191|NCT04462822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101978192|NCT04462822|Autonomic Agents|autonomic agents|mesh-ancestor
101978193|NCT04462822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101978194|NCT04462822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978195|NCT04462822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101978196|NCT04462822|Respiratory System Agents|respiratory system agents|mesh-ancestor
101978197|NCT04462822|Dermatologic Agents|dermatologic agents|mesh-ancestor
101978198|NCT04462822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101978199|NCT04462822|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101978200|NCT04462822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101978201|NCT04462822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101978202|NCT04462822|Adrenergic Agents|adrenergic agents|mesh-ancestor
101978203|NCT04462822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101978204|NCT04462822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978205|NCT04462822|Glucocorticoids|glucocorticoids|mesh-ancestor
101978206|NCT04462822|Hormones|hormones|mesh-ancestor
101710461|NCT04150172|Rebamipide|rebamipide|mesh-list
101978207|NCT04462822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101978208|NCT04462822|Sympathomimetics|sympathomimetics|mesh-ancestor
101978209|NCT01362218|Aspirin|aspirin|mesh-list
101978210|NCT01362218|Ramipril|ramipril|mesh-list
101978211|NCT01362218|Simvastatin|simvastatin|mesh-list
101978212|NCT01362218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101978213|NCT01362218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101978214|NCT01362218|Antimetabolites|antimetabolites|mesh-ancestor
101978215|NCT01362218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978216|NCT01362218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101978217|NCT01362218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101978218|NCT01362218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101978219|NCT01362218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101978220|NCT01362218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101978221|NCT01362218|Analgesics|analgesics|mesh-ancestor
101978222|NCT01362218|Sensory System Agents|sensory system agents|mesh-ancestor
101978223|NCT01362218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101978239|NCT02316964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101978240|NCT02316964|Antimetabolites|antimetabolites|mesh-ancestor
101978241|NCT02316964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978242|NCT02316964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101978243|NCT02316964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101978244|NCT02316964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101978245|NCT02316964|Analgesics|analgesics|mesh-ancestor
101978246|NCT02316964|Sensory System Agents|sensory system agents|mesh-ancestor
101978247|NCT02316964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101946406|NCT01266759|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101946407|NCT03512223|Dexamethasone|dexamethasone|mesh-list
101946408|NCT03512223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101946409|NCT03512223|Antiemetics|antiemetics|mesh-ancestor
101946410|NCT03512223|Autonomic Agents|autonomic agents|mesh-ancestor
101946411|NCT03512223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101946412|NCT03512223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946413|NCT03512223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101946414|NCT03512223|Glucocorticoids|glucocorticoids|mesh-ancestor
101946415|NCT03512223|Hormones|hormones|mesh-ancestor
101946416|NCT03512223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101804799|NCT03848416|Dermatologic Agents|dermatologic agents|mesh-ancestor
101978248|NCT02316964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978249|NCT02316964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101978250|NCT02316964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101978251|NCT02316964|Antiviral Agents|antiviral agents|mesh-ancestor
101978252|NCT02316964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101978253|NCT02875340|Risperidone|risperidone|mesh-list
101978254|NCT02875340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101978255|NCT02875340|Serotonin Agents|serotonin agents|mesh-ancestor
101978256|NCT02875340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101978257|NCT02875340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978258|NCT02875340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978259|NCT02875340|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101978260|NCT02875340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101978261|NCT02875340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101978262|NCT02875340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101978263|NCT02875340|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101978264|NCT02875340|Dopamine Agents|dopamine agents|mesh-ancestor
101978266|NCT04462666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101978267|NCT04462666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101978268|NCT04462666|Analgesics|analgesics|mesh-ancestor
101978269|NCT04462666|Sensory System Agents|sensory system agents|mesh-ancestor
101978270|NCT04462666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101978271|NCT04462666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978272|NCT04462666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101978273|NCT04462666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101978274|NCT04462666|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101978275|NCT04462666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101978276|NCT04462666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101978277|NCT04462666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978278|NCT01359020|Acetaminophen|acetaminophen|mesh-list
101978279|NCT01359020|Dipyrone|dipyrone|mesh-list
101978280|NCT01359020|Ibuprofen|ibuprofen|mesh-list
101978281|NCT01359020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101978282|NCT01359020|Analgesics|analgesics|mesh-ancestor
101978283|NCT01359020|Sensory System Agents|sensory system agents|mesh-ancestor
101978284|NCT01359020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101978285|NCT01359020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978290|NCT01359020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101978292|NCT01359020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978293|NCT01359098|Ciprofloxacin|ciprofloxacin|mesh-list
101978294|NCT01359098|Dexamethasone|dexamethasone|mesh-list
101978295|NCT01359098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101978296|NCT01359098|Antiemetics|antiemetics|mesh-ancestor
101978297|NCT01359098|Autonomic Agents|autonomic agents|mesh-ancestor
101978298|NCT01359098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101978299|NCT01359098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978300|NCT01359098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101978301|NCT01359098|Glucocorticoids|glucocorticoids|mesh-ancestor
101978302|NCT01359098|Hormones|hormones|mesh-ancestor
101978303|NCT01359098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101978304|NCT01359098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101804865|NCT00561470|Antidotes|antidotes|mesh-ancestor
101978305|NCT01359098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101978306|NCT01359098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101978307|NCT01359098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978308|NCT01359098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101978309|NCT01359098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101978310|NCT01359098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101978311|NCT01359098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101978312|NCT01359098|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101978313|NCT01359098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101978314|NCT01319240|Insulin|insulin|mesh-list
101978315|NCT01319240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101978316|NCT01319240|Liraglutide|liraglutide|mesh-list
101978317|NCT01319240|Insulin, Long-Acting|insulin, long-acting|mesh-list
101978318|NCT01319240|Xultophy|xultophy|mesh-list
101978319|NCT01319240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101978320|NCT01319240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978321|NCT01319240|Incretins|incretins|mesh-ancestor
101978322|NCT01319240|Hormones|hormones|mesh-ancestor
101978323|NCT01319240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101978324|NCT04463056|Eculizumab|eculizumab|mesh-list
101978325|NCT04463056|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101978326|NCT04463056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101978327|NCT04463056|Immunologic Factors|immunologic factors|mesh-ancestor
101978328|NCT04463056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978329|NCT02315950|Botulinum Toxins|botulinum toxins|mesh-list
101978330|NCT02315950|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101978331|NCT02315950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101978332|NCT02315950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978333|NCT02315950|Cholinergic Agents|cholinergic agents|mesh-ancestor
101978334|NCT02315950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101978335|NCT02315950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978336|NCT03319316|Durvalumab|durvalumab|mesh-list
101978337|NCT03319316|Tremelimumab|tremelimumab|mesh-list
101978338|NCT03319316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101978339|NCT03319316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101978340|NCT02316028|Decitabine|decitabine|mesh-list
101978341|NCT02316028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101978342|NCT02316028|Antimetabolites|antimetabolites|mesh-ancestor
101978343|NCT02316028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978344|NCT02316028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101978345|NCT02316028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101978346|NCT01359488|Hormones|hormones|mesh-list
101978347|NCT01359488|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
101978348|NCT01359488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101978349|NCT01359488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978350|NCT01141465|Fluticasone|fluticasone|mesh-list
101978351|NCT01141465|Xhance|xhance|mesh-list
101978352|NCT01141465|Budesonide|budesonide|mesh-list
101978353|NCT01141465|Formoterol Fumarate|formoterol fumarate|mesh-list
101978354|NCT01141465|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101978355|NCT01141465|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101978360|NCT01141465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101978361|NCT01141465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978362|NCT01141465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101978363|NCT01141465|Respiratory System Agents|respiratory system agents|mesh-ancestor
101978365|NCT01141465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101978366|NCT01141465|Glucocorticoids|glucocorticoids|mesh-ancestor
101978367|NCT01141465|Hormones|hormones|mesh-ancestor
101978368|NCT01141465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101978369|NCT01141465|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101978370|NCT01141465|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101978371|NCT01141465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101978372|NCT01141465|Adrenergic Agents|adrenergic agents|mesh-ancestor
101978373|NCT01141465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101978374|NCT01141465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978375|NCT01141465|Sympathomimetics|sympathomimetics|mesh-ancestor
101978376|NCT01141543|Plerixafor|plerixafor|mesh-list
101978377|NCT01141543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101978378|NCT01141543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101978379|NCT01141543|Antiviral Agents|antiviral agents|mesh-ancestor
101978380|NCT01141543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101978381|NCT03300518|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101978382|NCT03300518|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101946417|NCT03512223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101946418|NCT03512223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101978383|NCT03300518|Estradiol|estradiol|mesh-list
101978384|NCT03300518|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101978385|NCT03300518|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101978386|NCT03300518|Ganirelix|ganirelix|mesh-list
101978387|NCT03300518|Estrogens|estrogens|mesh-ancestor
101978388|NCT03300518|Hormones|hormones|mesh-ancestor
101978389|NCT03300518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101978390|NCT03300518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978391|NCT03300518|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101978392|NCT03300518|Contraceptive Agents|contraceptive agents|mesh-ancestor
101978393|NCT03300518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101978394|NCT03300518|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101978395|NCT03300518|Hormone Antagonists|hormone antagonists|mesh-ancestor
101978396|NCT02317198|Clopidogrel|clopidogrel|mesh-list
101978397|NCT02317198|Ticagrelor|ticagrelor|mesh-list
101978398|NCT02317198|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101978399|NCT02317198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101978400|NCT02317198|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101978401|NCT02317198|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101978402|NCT02317198|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101978403|NCT02317198|Purinergic Agents|purinergic agents|mesh-ancestor
101978404|NCT02317198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101978405|NCT02317198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978406|NCT02317198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978407|NCT01359722|Acetylcysteine|acetylcysteine|mesh-list
101978408|NCT01359722|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101978409|NCT01359722|Antiviral Agents|antiviral agents|mesh-ancestor
101978410|NCT01359722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101978411|NCT01359722|Expectorants|expectorants|mesh-ancestor
101698207|NCT02763761|Prednisone|prednisone|mesh-list
101978412|NCT01359722|Respiratory System Agents|respiratory system agents|mesh-ancestor
101978414|NCT01359722|Antioxidants|antioxidants|mesh-ancestor
101710485|NCT02325011|Analgesics|analgesics|mesh-ancestor
101978415|NCT01359722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978416|NCT01359722|Protective Agents|protective agents|mesh-ancestor
101978417|NCT01359722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978418|NCT01359722|Antidotes|antidotes|mesh-ancestor
101978419|NCT01238185|Aspirin|aspirin|mesh-list
101978420|NCT01238185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101978421|NCT01238185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101978422|NCT01238185|Analgesics|analgesics|mesh-ancestor
101978423|NCT01238185|Sensory System Agents|sensory system agents|mesh-ancestor
101978424|NCT01238185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101978425|NCT01238185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978430|NCT01238185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978431|NCT01238185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101978432|NCT01238185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101978433|NCT01238185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101978435|NCT01143805|Tofacitinib|tofacitinib|mesh-list
101978436|NCT01143805|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101978437|NCT01143805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101978438|NCT01143805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101978439|NCT01143805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978440|NCT01362764|Abiraterone Acetate|abiraterone acetate|mesh-list
101978441|NCT01362764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101978442|NCT01362764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101978443|NCT01362764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101978444|NCT01362764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978445|NCT01362764|Hormone Antagonists|hormone antagonists|mesh-ancestor
101978446|NCT01362764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101978447|NCT01362764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978448|NCT01362764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101978449|NCT03498118|Bupivacaine|bupivacaine|mesh-list
101978450|NCT03498118|Anesthetics, Local|anesthetics, local|mesh-ancestor
101978451|NCT03498118|Anesthetics|anesthetics|mesh-ancestor
101978452|NCT03498118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101978453|NCT03498118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978454|NCT03498118|Sensory System Agents|sensory system agents|mesh-ancestor
101978455|NCT03498118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101978456|NCT05188742|Mirabegron|mirabegron|mesh-list
101946419|NCT03878667|Calcium, Dietary|calcium, dietary|mesh-list
101946420|NCT03878667|Calcium Carbonate|calcium carbonate|mesh-list
101946421|NCT03878667|Calcium|calcium|mesh-list
101978457|NCT05188742|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101978458|NCT05188742|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101978459|NCT05188742|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101978460|NCT05188742|Adrenergic Agents|adrenergic agents|mesh-ancestor
101978461|NCT05188742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101978462|NCT05188742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978463|NCT05188742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978464|NCT05188742|Urological Agents|urological agents|mesh-ancestor
101978465|NCT02324452|Fluorouracil|fluorouracil|mesh-list
101978466|NCT02324452|Capecitabine|capecitabine|mesh-list
101978467|NCT02324452|Antimetabolites|antimetabolites|mesh-ancestor
101978468|NCT02324452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978469|NCT02324452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101978470|NCT02324452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101978471|NCT02324452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101978472|NCT02324452|Immunologic Factors|immunologic factors|mesh-ancestor
101978473|NCT02324452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978474|NCT02321176|Resveratrol|resveratrol|mesh-list
101978475|NCT02321176|Antioxidants|antioxidants|mesh-ancestor
101978476|NCT02321176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978477|NCT02321176|Protective Agents|protective agents|mesh-ancestor
101978478|NCT02321176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978479|NCT02321176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101710495|NCT02325011|Hormones|hormones|mesh-ancestor
101978480|NCT02321176|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101978481|NCT01351298|Lidocaine|lidocaine|mesh-list
101978482|NCT01351298|Xylometazoline|xylometazoline|mesh-list
101978483|NCT01351298|Anesthetics, Local|anesthetics, local|mesh-ancestor
101978484|NCT01351298|Anesthetics|anesthetics|mesh-ancestor
101978485|NCT01351298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101978486|NCT01351298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978487|NCT01351298|Sensory System Agents|sensory system agents|mesh-ancestor
101978488|NCT01351298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101978489|NCT01351298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101978490|NCT01351298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101978491|NCT01351298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101978492|NCT01351298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101978493|NCT01351298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978497|NCT02324686|Vitamin K|vitamin k|mesh-list
101978498|NCT02324686|Vitamin K 1|vitamin k 1|mesh-list
101978499|NCT02324686|Vitamins|vitamins|mesh-ancestor
101978500|NCT02324686|Micronutrients|micronutrients|mesh-ancestor
101978501|NCT02324686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978502|NCT02324686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101978503|NCT02324686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101978504|NCT02324686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978505|NCT02324686|Hemostatics|hemostatics|mesh-ancestor
101978506|NCT02324686|Coagulants|coagulants|mesh-ancestor
101978507|NCT01360034|Indomethacin|indomethacin|mesh-list
101978508|NCT01360034|Nifedipine|nifedipine|mesh-list
101978509|NCT01360034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101978510|NCT01360034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101978511|NCT01360034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978512|NCT01360034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101978513|NCT01360034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978514|NCT01360034|Vasodilator Agents|vasodilator agents|mesh-ancestor
101978515|NCT01360034|Tocolytic Agents|tocolytic agents|mesh-ancestor
101978516|NCT01360034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101978517|NCT01360034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101978518|NCT01360034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101978519|NCT01360034|Analgesics|analgesics|mesh-ancestor
101978520|NCT01360034|Sensory System Agents|sensory system agents|mesh-ancestor
101978521|NCT01360034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101978522|NCT01360034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101978523|NCT01360034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101978524|NCT01360034|Gout Suppressants|gout suppressants|mesh-ancestor
101978525|NCT01360034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101978526|NCT01360034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101978527|NCT01363310|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101978528|NCT01363310|Escitalopram|escitalopram|mesh-list
101946422|NCT03878667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101978529|NCT01363310|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101978530|NCT01363310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101978531|NCT01363310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101978532|NCT01363310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978533|NCT01363310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101978534|NCT01363310|Serotonin Agents|serotonin agents|mesh-ancestor
101978535|NCT01363310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978536|NCT01363310|Antidepressive Agents|antidepressive agents|mesh-ancestor
101978537|NCT01363310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101978538|NCT01363310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101978539|NCT01363310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101978540|NCT01363310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101978541|NCT01363544|Methylphenidate|methylphenidate|mesh-list
101710502|NCT00577096|Etoposide|etoposide|mesh-list
101978542|NCT01363544|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101978543|NCT01363544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978544|NCT01363544|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101978545|NCT01363544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101978546|NCT01363544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101978547|NCT01363544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978548|NCT01363544|Dopamine Agents|dopamine agents|mesh-ancestor
101978549|NCT01363544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101978550|NCT03257618|Temozolomide|temozolomide|mesh-list
101978551|NCT03257618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101978552|NCT03257618|Alkylating Agents|alkylating agents|mesh-ancestor
101978553|NCT03257618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978554|NCT03257618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101978555|NCT01363778|Tivozanib|tivozanib|mesh-list
101698375|NCT04153734|Paclitaxel|paclitaxel|mesh-list
101978556|NCT01363778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101978557|NCT01363778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101978558|NCT01363778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978559|NCT04175834|Cetirizine|cetirizine|mesh-list
101978560|NCT04175834|Histamine Antagonists|histamine antagonists|mesh-list
101978561|NCT04175834|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
101978562|NCT04175834|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101978563|NCT04175834|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101978564|NCT04175834|Histamine Agents|histamine agents|mesh-ancestor
101978565|NCT04175834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101978581|NCT03500848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978582|NCT03500848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101978583|NCT03500848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101978584|NCT03500848|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101978585|NCT03500848|Antitubercular Agents|antitubercular agents|mesh-ancestor
101978586|NCT03500848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101978587|NCT03500848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101978589|NCT01360190|Fluoxetine|fluoxetine|mesh-list
101978590|NCT01360190|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101978591|NCT01360190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101978592|NCT01360190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101978593|NCT01360190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978594|NCT01360190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101978595|NCT01360190|Serotonin Agents|serotonin agents|mesh-ancestor
101978596|NCT01360190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978597|NCT01360190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101978598|NCT01360190|Antidepressive Agents|antidepressive agents|mesh-ancestor
101978599|NCT01360190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101978600|NCT01360190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101978601|NCT01360190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101978602|NCT01360190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101978603|NCT01363934|Darbepoetin alfa|darbepoetin alfa|mesh-list
101978604|NCT01363934|Hematinics|hematinics|mesh-ancestor
101978605|NCT03132376|Caseins|caseins|mesh-list
101978606|NCT03132376|Chelating Agents|chelating agents|mesh-ancestor
101978607|NCT03132376|Sequestering Agents|sequestering agents|mesh-ancestor
101978608|NCT03132376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978609|NCT01364012|Paclitaxel|paclitaxel|mesh-list
101978610|NCT01364012|Bevacizumab|bevacizumab|mesh-list
101978611|NCT01364012|Carboplatin|carboplatin|mesh-list
101978612|NCT01364012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101978613|NCT01364012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101946423|NCT03878667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978614|NCT01364012|Tubulin Modulators|tubulin modulators|mesh-ancestor
101978615|NCT01364012|Antimitotic Agents|antimitotic agents|mesh-ancestor
101978616|NCT01364012|Mitosis Modulators|mitosis modulators|mesh-ancestor
101978617|NCT01364012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710520|NCT00577096|Antiemetics|antiemetics|mesh-ancestor
101978618|NCT01364012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101978619|NCT01364012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101978620|NCT01364012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101978621|NCT01364012|Growth Substances|growth substances|mesh-ancestor
101978622|NCT01364012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978626|NCT02318056|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101978627|NCT02318056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101978628|NCT02318056|Laxatives|laxatives|mesh-ancestor
101978629|NCT02318056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101978630|NCT02318056|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101978632|NCT01360424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101978633|NCT01360424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978634|NCT01360424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101978635|NCT01364324|Antitubercular Agents|antitubercular agents|mesh-list
101978636|NCT01364324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101978637|NCT01364324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101978638|NCT01364402|Epoetin Alfa|epoetin alfa|mesh-list
101978639|NCT01364402|Hematinics|hematinics|mesh-ancestor
101978640|NCT03552380|Nivolumab|nivolumab|mesh-list
101978641|NCT03552380|Ipilimumab|ipilimumab|mesh-list
101978642|NCT03552380|Entinostat|entinostat|mesh-list
101978643|NCT03552380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101978644|NCT03552380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101978645|NCT03552380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101978646|NCT03552380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978647|NCT03552380|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101978648|NCT03552380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101978649|NCT02318290|Analgesics|analgesics|mesh-list
101978650|NCT02318290|Narcotics|narcotics|mesh-list
101978651|NCT02318290|Sensory System Agents|sensory system agents|mesh-ancestor
101978652|NCT02318290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101978653|NCT02318290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978654|NCT02318290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101978655|NCT03467360|Etoposide|etoposide|mesh-list
101978656|NCT03467360|Acetazolamide|acetazolamide|mesh-list
101978657|NCT03467360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101978658|NCT03467360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101978659|NCT03467360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101978660|NCT03467360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101978661|NCT03467360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101978662|NCT03467360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978663|NCT03467360|Anticonvulsants|anticonvulsants|mesh-ancestor
101978664|NCT03467360|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101978665|NCT03467360|Diuretics|diuretics|mesh-ancestor
101978666|NCT03467360|Natriuretic Agents|natriuretic agents|mesh-ancestor
101978667|NCT03467360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978668|NCT03452072|Timolol|timolol|mesh-list
101978669|NCT03452072|Petrolatum|petrolatum|mesh-list
101978670|NCT03452072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101978671|NCT03452072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101978672|NCT03452072|Adrenergic Agents|adrenergic agents|mesh-ancestor
101978673|NCT03452072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101978674|NCT03452072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978675|NCT03452072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978676|NCT03452072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101978677|NCT03452072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101978678|NCT03452072|Emollients|emollients|mesh-ancestor
101978679|NCT03452072|Dermatologic Agents|dermatologic agents|mesh-ancestor
101978680|NCT03433040|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
101978681|NCT03433040|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
101978682|NCT03433040|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101978683|NCT03433040|Hormone Antagonists|hormone antagonists|mesh-ancestor
101978684|NCT03433040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101978685|NCT03433040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978686|NCT03433040|Progestins|progestins|mesh-ancestor
101978687|NCT03433040|Hormones|hormones|mesh-ancestor
101978688|NCT02318446|Folic Acid|folic acid|mesh-list
101978689|NCT02318446|Hematinics|hematinics|mesh-ancestor
101946424|NCT03878667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101946425|NCT03878667|Antacids|antacids|mesh-ancestor
101946426|NCT03878667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946427|NCT03878667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101978690|NCT02318446|Vitamin B Complex|vitamin b complex|mesh-ancestor
101978691|NCT02318446|Vitamins|vitamins|mesh-ancestor
101978692|NCT02318446|Micronutrients|micronutrients|mesh-ancestor
101978693|NCT02318446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978694|NCT02325934|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101978695|NCT02325934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101978696|NCT02325934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101978699|NCT01360658|Immunoglobulins|immunoglobulins|mesh-list
101978700|NCT01360658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101978701|NCT01360658|Antibodies|antibodies|mesh-list
101978702|NCT01360658|gamma-Globulins|gamma-globulins|mesh-list
101978703|NCT01360658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101698506|NCT02758067|Risperidone|risperidone|mesh-list
101978704|NCT01360658|Immunologic Factors|immunologic factors|mesh-ancestor
101978705|NCT01360658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978706|NCT02318758|Ethanol|ethanol|mesh-list
101978707|NCT02318758|Treprostinil|treprostinil|mesh-list
101978708|NCT02318758|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101978709|NCT02318758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101978710|NCT02318758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101978711|NCT02318758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978712|NCT02318758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101978713|NCT02441686|Dexamethasone|dexamethasone|mesh-list
101978714|NCT02441686|Lenalidomide|lenalidomide|mesh-list
101978715|NCT02441686|Bortezomib|bortezomib|mesh-list
101978716|NCT02441686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101978717|NCT02441686|Antiemetics|antiemetics|mesh-ancestor
101978718|NCT02441686|Autonomic Agents|autonomic agents|mesh-ancestor
101978719|NCT02441686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101978720|NCT02441686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978721|NCT02441686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101978722|NCT02441686|Glucocorticoids|glucocorticoids|mesh-ancestor
101978723|NCT02441686|Hormones|hormones|mesh-ancestor
101978724|NCT02441686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101978725|NCT02441686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101978726|NCT02441686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101978727|NCT02441686|Immunologic Factors|immunologic factors|mesh-ancestor
101978728|NCT02441686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101978729|NCT02441686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101978730|NCT02441686|Growth Substances|growth substances|mesh-ancestor
101978731|NCT02441686|Growth Inhibitors|growth inhibitors|mesh-ancestor
101978732|NCT03500146|Cholinergic Antagonists|cholinergic antagonists|mesh-list
101978733|NCT03500146|Cholinergic Agents|cholinergic agents|mesh-ancestor
101978734|NCT03500146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101978735|NCT03500146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978736|NCT03500146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978737|NCT01352234|Aspirin|aspirin|mesh-list
101978738|NCT01352234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101978739|NCT01352234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101978740|NCT01352234|Analgesics|analgesics|mesh-ancestor
101978741|NCT01352234|Sensory System Agents|sensory system agents|mesh-ancestor
101978742|NCT01352234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101978743|NCT01352234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978744|NCT01352234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101978745|NCT01352234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101978746|NCT01352234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101978747|NCT01352234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101978748|NCT01352234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978749|NCT01352234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101978750|NCT01352234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101978751|NCT01352234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101978752|NCT01352234|Antipyretics|antipyretics|mesh-ancestor
101978753|NCT01364792|Valacyclovir|valacyclovir|mesh-list
101978754|NCT01364792|Antiviral Agents|antiviral agents|mesh-ancestor
101978755|NCT01364792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101978756|NCT02318836|Lofexidine|lofexidine|mesh-list
101978757|NCT02318836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101946429|NCT01264653|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101946430|NCT01264653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101946431|NCT01264653|Adrenergic Agents|adrenergic agents|mesh-ancestor
101946432|NCT01264653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101946433|NCT01264653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978758|NCT02318836|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101978759|NCT02318836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978760|NCT02318836|Sensory System Agents|sensory system agents|mesh-ancestor
101978761|NCT02318836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101978762|NCT02318836|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101978763|NCT02318836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101978764|NCT02318836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101978765|NCT02318836|Adrenergic Agents|adrenergic agents|mesh-ancestor
101978766|NCT02318836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101978767|NCT02318836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978768|NCT01352312|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101978769|NCT01352312|Ofatumumab|ofatumumab|mesh-list
101978773|NCT01352312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978774|NCT01352312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101978775|NCT01352312|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
101978776|NCT01352312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101978777|NCT02939209|Hydromorphone|hydromorphone|mesh-list
101978778|NCT02939209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101978779|NCT02939209|Narcotics|narcotics|mesh-ancestor
101978780|NCT02939209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101978781|NCT02939209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978782|NCT02939209|Analgesics|analgesics|mesh-ancestor
101978783|NCT02939209|Sensory System Agents|sensory system agents|mesh-ancestor
101978784|NCT02939209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101978785|NCT01141855|Varenicline|varenicline|mesh-list
101978786|NCT01141855|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101978787|NCT01141855|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101978788|NCT01141855|Cholinergic Agents|cholinergic agents|mesh-ancestor
101978789|NCT01141855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101978790|NCT01141855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978791|NCT01141855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978793|NCT01236859|Analgesics|analgesics|mesh-ancestor
101978794|NCT01236859|Sensory System Agents|sensory system agents|mesh-ancestor
101978795|NCT01236859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101978796|NCT01236859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978797|NCT01236859|Anticonvulsants|anticonvulsants|mesh-ancestor
101978798|NCT01236859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101978799|NCT01236859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101978800|NCT01236859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101978801|NCT01236859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101978802|NCT01236859|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101978803|NCT01236859|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101978804|NCT01236859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101978805|NCT01236859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978806|NCT01236859|Antimanic Agents|antimanic agents|mesh-ancestor
101978807|NCT01145365|Anesthetics|anesthetics|mesh-list
101978808|NCT01145365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101978809|NCT01145365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978810|NCT04967092|Anti-Allergic Agents|anti-allergic agents|mesh-list
101978811|NCT01365104|Deferoxamine|deferoxamine|mesh-list
101978812|NCT01365104|Siderophores|siderophores|mesh-ancestor
101978813|NCT01365104|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101978814|NCT01365104|Chelating Agents|chelating agents|mesh-ancestor
101978815|NCT01365104|Sequestering Agents|sequestering agents|mesh-ancestor
101978816|NCT01365104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978817|NCT03492970|Melatonin|melatonin|mesh-list
101978818|NCT03492970|Antioxidants|antioxidants|mesh-ancestor
101978819|NCT03492970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978820|NCT03492970|Protective Agents|protective agents|mesh-ancestor
101978821|NCT03492970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978822|NCT03492970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101978823|NCT01362374|Leucovorin|leucovorin|mesh-list
101946434|NCT01264653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946435|NCT01264653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101946436|NCT01264653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101946437|NCT01264653|Autonomic Agents|autonomic agents|mesh-ancestor
101978824|NCT01362374|Paclitaxel|paclitaxel|mesh-list
101978825|NCT01362374|Docetaxel|docetaxel|mesh-list
101978826|NCT01362374|Oxaliplatin|oxaliplatin|mesh-list
101978827|NCT01362374|Ipatasertib|ipatasertib|mesh-list
101978828|NCT01362374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101978829|NCT01362374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101978830|NCT01362374|Tubulin Modulators|tubulin modulators|mesh-ancestor
101978831|NCT01362374|Antimitotic Agents|antimitotic agents|mesh-ancestor
101978832|NCT01362374|Mitosis Modulators|mitosis modulators|mesh-ancestor
101978833|NCT01362374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978834|NCT01362374|Antidotes|antidotes|mesh-ancestor
101978835|NCT01362374|Protective Agents|protective agents|mesh-ancestor
101978836|NCT01362374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978837|NCT01362374|Vitamin B Complex|vitamin b complex|mesh-ancestor
101978838|NCT01362374|Vitamins|vitamins|mesh-ancestor
101978839|NCT01362374|Micronutrients|micronutrients|mesh-ancestor
101978840|NCT01362374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101978841|NCT01362374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101978842|NCT01142011|Belimumab|belimumab|mesh-list
101978847|NCT02319460|Hemostatics|hemostatics|mesh-ancestor
101978848|NCT02319460|Coagulants|coagulants|mesh-ancestor
101978849|NCT04722952|Cytarabine|cytarabine|mesh-list
101978850|NCT04722952|Azacitidine|azacitidine|mesh-list
101978851|NCT04722952|Homoharringtonine|homoharringtonine|mesh-list
101978852|NCT04722952|Visilizumab|visilizumab|mesh-list
101978853|NCT04722952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101978854|NCT04722952|Antimetabolites|antimetabolites|mesh-ancestor
101978855|NCT04722952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978856|NCT04722952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101978857|NCT04722952|Antiviral Agents|antiviral agents|mesh-ancestor
101978858|NCT04722952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101978859|NCT04722952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101978860|NCT04722952|Immunologic Factors|immunologic factors|mesh-ancestor
101978861|NCT04722952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978862|NCT04722952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101978863|NCT04722952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101978864|NCT04722952|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101978865|NCT01365260|Hyaluronic Acid|hyaluronic acid|mesh-list
101978866|NCT01365260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101978867|NCT01365260|Immunologic Factors|immunologic factors|mesh-ancestor
101978868|NCT01365260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978869|NCT01365260|Viscosupplements|viscosupplements|mesh-ancestor
101978870|NCT01365260|Protective Agents|protective agents|mesh-ancestor
101978871|NCT01235455|Interferons|interferons|mesh-list
101978872|NCT01235455|Interferon-beta|interferon-beta|mesh-list
101978873|NCT01235455|Interferon beta-1b|interferon beta-1b|mesh-list
101978874|NCT01235455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101978875|NCT01235455|Antiviral Agents|antiviral agents|mesh-ancestor
101978876|NCT01235455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101978877|NCT01235455|Immunologic Factors|immunologic factors|mesh-ancestor
101978878|NCT01235455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978879|NCT01235455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101978880|NCT01145677|Topiramate|topiramate|mesh-list
101978881|NCT01145677|Anticonvulsants|anticonvulsants|mesh-ancestor
101978882|NCT01145677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101978883|NCT01145677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978884|NCT02319616|Clobetasol|clobetasol|mesh-list
101978885|NCT02319616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101978886|NCT02319616|Glucocorticoids|glucocorticoids|mesh-ancestor
101978887|NCT02319616|Hormones|hormones|mesh-ancestor
101978888|NCT02319616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101978889|NCT02319616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978890|NCT01142245|Esomeprazole|esomeprazole|mesh-list
101978891|NCT01142245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101978892|NCT01142245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101710548|NCT02625506|Levobupivacaine|levobupivacaine|mesh-list
101978893|NCT01142245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101978894|NCT01142245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101978895|NCT01142245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978896|NCT02319772|Galidesivir|galidesivir|mesh-list
101978897|NCT02319772|Antiviral Agents|antiviral agents|mesh-ancestor
101978898|NCT02319772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101946438|NCT01264653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101946439|NCT01264653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101946440|NCT01264653|Respiratory System Agents|respiratory system agents|mesh-ancestor
101978899|NCT03499132|Anesthetics|anesthetics|mesh-list
101978900|NCT03499132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101978901|NCT03499132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978902|NCT01142401|Bortezomib|bortezomib|mesh-list
101978903|NCT01142401|Fulvestrant|fulvestrant|mesh-list
101978904|NCT01142401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101978905|NCT01142401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101978906|NCT01142401|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101978907|NCT01142401|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101978908|NCT01142401|Hormone Antagonists|hormone antagonists|mesh-ancestor
101978909|NCT01142401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101978910|NCT01142401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978911|NCT03498898|Adrenergic Agents|adrenergic agents|mesh-list
101978912|NCT03498898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101978913|NCT03498898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978914|NCT03498898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978915|NCT03498820|Remifentanil|remifentanil|mesh-list
101978919|NCT03498820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978920|NCT03498820|Analgesics|analgesics|mesh-ancestor
101978921|NCT03498820|Sensory System Agents|sensory system agents|mesh-ancestor
101978922|NCT03498820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101978923|NCT05158309|Capsaicin|capsaicin|mesh-list
101978924|NCT05158309|Antipruritics|antipruritics|mesh-ancestor
101978925|NCT05158309|Dermatologic Agents|dermatologic agents|mesh-ancestor
101978926|NCT05158309|Sensory System Agents|sensory system agents|mesh-ancestor
101978927|NCT05158309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101978928|NCT05158309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978929|NCT02320084|Nitisinone|nitisinone|mesh-list
101978930|NCT02320084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101978931|NCT02320084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978932|NCT02320240|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101978933|NCT02320240|Fluvoxamine|fluvoxamine|mesh-list
101978935|NCT02320240|Fluoxetine|fluoxetine|mesh-list
101978936|NCT02320240|Paroxetine|paroxetine|mesh-list
101978937|NCT02320240|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101978938|NCT02320240|Sertraline|sertraline|mesh-list
101978939|NCT02320240|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101978940|NCT02320240|Escitalopram|escitalopram|mesh-list
101978941|NCT02320240|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101978942|NCT02320240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101978943|NCT02320240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101978944|NCT02320240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978945|NCT02320240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101978946|NCT02320240|Serotonin Agents|serotonin agents|mesh-ancestor
101978947|NCT02320240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978948|NCT02320240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101978949|NCT02320240|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101978950|NCT02320240|Antidepressive Agents|antidepressive agents|mesh-ancestor
101978951|NCT02320240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101978952|NCT02320240|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101978953|NCT02320240|Analgesics|analgesics|mesh-ancestor
101978954|NCT02320240|Sensory System Agents|sensory system agents|mesh-ancestor
101978955|NCT02320240|Dopamine Agents|dopamine agents|mesh-ancestor
101978956|NCT02320240|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101978957|NCT02320240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101978958|NCT02320240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101978959|NCT02320240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101978960|NCT02320240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101978961|NCT02320240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101978962|NCT02320240|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101978963|NCT02320240|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101978964|NCT03492736|Melatonin|melatonin|mesh-list
101978965|NCT03492736|Antioxidants|antioxidants|mesh-ancestor
101978966|NCT03492736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978967|NCT03492736|Protective Agents|protective agents|mesh-ancestor
101978968|NCT03492736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978969|NCT03492736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101946441|NCT01264653|Mydriatics|mydriatics|mesh-ancestor
101946442|NCT01264653|Sympathomimetics|sympathomimetics|mesh-ancestor
101805563|NCT00949494|Hylan|hylan|mesh-list
101978970|NCT02320474|Aflibercept|aflibercept|mesh-list
101978971|NCT02320474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101978972|NCT02320474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101978973|NCT02320474|Growth Substances|growth substances|mesh-ancestor
101978974|NCT02320474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978975|NCT02320474|Growth Inhibitors|growth inhibitors|mesh-ancestor
101978976|NCT02320474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101978977|NCT03492580|Dapagliflozin|dapagliflozin|mesh-list
101978978|NCT03492580|Empagliflozin|empagliflozin|mesh-list
101978979|NCT03492580|Canagliflozin|canagliflozin|mesh-list
101978980|NCT03492580|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
101978981|NCT03492580|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101978982|NCT03492580|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
101978983|NCT03492580|Glucagon|glucagon|mesh-list
101978984|NCT03492580|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101978985|NCT03492580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978986|NCT03492580|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101978987|NCT03492580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978996|NCT01238965|Fluorouracil|fluorouracil|mesh-list
101978997|NCT01238965|Panobinostat|panobinostat|mesh-list
101978998|NCT01238965|Calcium|calcium|mesh-list
101978999|NCT01238965|Levoleucovorin|levoleucovorin|mesh-list
101979000|NCT01238965|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
101979001|NCT01238965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101979002|NCT01238965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979003|NCT01238965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101979004|NCT01238965|Antimetabolites|antimetabolites|mesh-ancestor
101979005|NCT01238965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979006|NCT01238965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101979007|NCT01238965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101979008|NCT01238965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101979009|NCT01238965|Immunologic Factors|immunologic factors|mesh-ancestor
101979010|NCT01238965|Antidotes|antidotes|mesh-ancestor
101979011|NCT01238965|Protective Agents|protective agents|mesh-ancestor
101979012|NCT01238965|Vitamin B Complex|vitamin b complex|mesh-ancestor
101979013|NCT01238965|Vitamins|vitamins|mesh-ancestor
101979014|NCT01238965|Micronutrients|micronutrients|mesh-ancestor
101979015|NCT01238965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101979016|NCT01142557|Interferons|interferons|mesh-list
101979017|NCT01142557|Interferon-beta|interferon-beta|mesh-list
101979018|NCT01142557|Interferon beta-1a|interferon beta-1a|mesh-list
101979019|NCT01142557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101979020|NCT01142557|Antiviral Agents|antiviral agents|mesh-ancestor
101979021|NCT01142557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101979022|NCT01142557|Immunologic Factors|immunologic factors|mesh-ancestor
101979023|NCT01142557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979024|NCT01142557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101979025|NCT04496908|Misoprostol|misoprostol|mesh-list
101979026|NCT04496908|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101979027|NCT04496908|Abortifacient Agents|abortifacient agents|mesh-ancestor
101979028|NCT04496908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101979029|NCT04496908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979030|NCT04496908|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101979031|NCT04496908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101979032|NCT04496908|Oxytocics|oxytocics|mesh-ancestor
101979033|NCT01144117|Epoetin Alfa|epoetin alfa|mesh-list
101979034|NCT01144117|Hematinics|hematinics|mesh-ancestor
101979035|NCT04371640|Sirolimus|sirolimus|mesh-list
101979036|NCT04371640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101979037|NCT04371640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101979038|NCT04371640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101979039|NCT04371640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101979040|NCT04371640|Antifungal Agents|antifungal agents|mesh-ancestor
101979041|NCT04371640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101979042|NCT04371640|Immunologic Factors|immunologic factors|mesh-ancestor
101979043|NCT04371640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979044|NCT04356196|Verapamil|verapamil|mesh-list
101979045|NCT04356196|Bisoprolol|bisoprolol|mesh-list
101979046|NCT04356196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101979047|NCT04356196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101979048|NCT04356196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101979049|NCT04356196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979050|NCT04356196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101946443|NCT01264653|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101946444|NCT01266837|Everolimus|everolimus|mesh-list
101946445|NCT01266837|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101805595|NCT02903680|Hormones|hormones|mesh-ancestor
101979051|NCT04356196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979052|NCT04356196|Vasodilator Agents|vasodilator agents|mesh-ancestor
101979053|NCT04356196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101979054|NCT04356196|Sympatholytics|sympatholytics|mesh-ancestor
101979055|NCT04356196|Autonomic Agents|autonomic agents|mesh-ancestor
101979056|NCT04356196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101979057|NCT04356196|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101979059|NCT04356196|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101979060|NCT04356196|Adrenergic Agents|adrenergic agents|mesh-ancestor
101979061|NCT04356196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101979062|NCT02115139|Ipilimumab|ipilimumab|mesh-list
101979063|NCT02115139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101979064|NCT02115139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101979065|NCT02115139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101979066|NCT02115139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979067|NCT02047981|Azithromycin|azithromycin|mesh-list
101979068|NCT02047981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101979069|NCT02047981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101979070|NCT04802356|Dexamethasone|dexamethasone|mesh-list
101979071|NCT04802356|Lenalidomide|lenalidomide|mesh-list
101979072|NCT04802356|Bortezomib|bortezomib|mesh-list
101979073|NCT04802356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101979074|NCT04802356|Antiemetics|antiemetics|mesh-ancestor
101979075|NCT04802356|Autonomic Agents|autonomic agents|mesh-ancestor
101979076|NCT04802356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101979077|NCT04802356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979078|NCT04802356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101979079|NCT04802356|Glucocorticoids|glucocorticoids|mesh-ancestor
101979080|NCT04802356|Hormones|hormones|mesh-ancestor
101979081|NCT04802356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101979082|NCT04802356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101979083|NCT04802356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101979084|NCT04802356|Immunologic Factors|immunologic factors|mesh-ancestor
101698878|NCT03912259|Emollients|emollients|mesh-list
101979085|NCT04802356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101979086|NCT04802356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101979087|NCT04802356|Growth Substances|growth substances|mesh-ancestor
101979088|NCT04802356|Growth Inhibitors|growth inhibitors|mesh-ancestor
101979089|NCT01142635|Bromides|bromides|mesh-list
101979090|NCT01142635|Rocuronium|rocuronium|mesh-list
101979091|NCT01142635|Anticonvulsants|anticonvulsants|mesh-ancestor
101979092|NCT01142635|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101979093|NCT01142635|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101979094|NCT01142635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101979095|NCT01142635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101979096|NCT01142635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979097|NCT01144195|Panitumumab|panitumumab|mesh-list
101979098|NCT01144195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101979099|NCT01144195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101979100|NCT05631769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
101979101|NCT02528383|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101979102|NCT02528383|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101979103|NCT02528383|Estradiol|estradiol|mesh-list
101979104|NCT02528383|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101979105|NCT02528383|Estrogens|estrogens|mesh-ancestor
101979106|NCT02528383|Hormones|hormones|mesh-ancestor
101979107|NCT02528383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101979108|NCT02528383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979109|NCT02528383|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101979110|NCT02528383|Contraceptive Agents|contraceptive agents|mesh-ancestor
101979111|NCT02528383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101979112|NCT02528383|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101979113|NCT01146067|Rivastigmine|rivastigmine|mesh-list
101979114|NCT01146067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101979115|NCT01146067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101979116|NCT01146067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979117|NCT01146067|Cholinergic Agents|cholinergic agents|mesh-ancestor
101979118|NCT01146067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101979119|NCT01146067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946446|NCT01266837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101946447|NCT01266837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101946448|NCT01266837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946449|NCT01266837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101805662|NCT01032304|Erdosteine|erdosteine|mesh-list
101979120|NCT01146067|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101979121|NCT01146067|Protective Agents|protective agents|mesh-ancestor
101979122|NCT01237249|Dexamethasone|dexamethasone|mesh-list
101979123|NCT01237249|Prednisone|prednisone|mesh-list
101979124|NCT01237249|Melphalan|melphalan|mesh-list
101979125|NCT01237249|Lenalidomide|lenalidomide|mesh-list
101979126|NCT01237249|Bortezomib|bortezomib|mesh-list
101979127|NCT01237249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101979128|NCT01237249|Antiemetics|antiemetics|mesh-ancestor
101979129|NCT01237249|Autonomic Agents|autonomic agents|mesh-ancestor
101979130|NCT01237249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101979131|NCT01237249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979132|NCT01237249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101979135|NCT01237249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101979136|NCT01237249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101979137|NCT01237249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101979138|NCT01237249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101979140|NCT01237249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979141|NCT01237249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101979142|NCT01237249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101979143|NCT01237249|Immunologic Factors|immunologic factors|mesh-ancestor
101979144|NCT01237249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101979145|NCT01237249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101979146|NCT01237249|Growth Substances|growth substances|mesh-ancestor
101979147|NCT01237249|Growth Inhibitors|growth inhibitors|mesh-ancestor
101979148|NCT03646162|Zuclomiphene|zuclomiphene|mesh-list
101979149|NCT03646162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101979150|NCT03646162|Hormone Antagonists|hormone antagonists|mesh-ancestor
101979151|NCT03646162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101979152|NCT03646162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979153|NCT03646162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101979154|NCT03646162|Fertility Agents|fertility agents|mesh-ancestor
101979155|NCT03646162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101979156|NCT03646162|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101979157|NCT03646162|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101979158|NCT01244347|Folic Acid|folic acid|mesh-list
101698951|NCT02629536|Antioxidants|antioxidants|mesh-ancestor
101979159|NCT01244347|Vitamin B Complex|vitamin b complex|mesh-list
101979160|NCT01244347|Hematinics|hematinics|mesh-ancestor
101979161|NCT01244347|Vitamins|vitamins|mesh-ancestor
101979162|NCT01244347|Micronutrients|micronutrients|mesh-ancestor
101979163|NCT01244347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979164|NCT01763827|Ezetimibe|ezetimibe|mesh-list
101979165|NCT01763827|Evolocumab|evolocumab|mesh-list
101979166|NCT01763827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101979167|NCT01763827|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101979168|NCT01763827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101979169|NCT01763827|Antimetabolites|antimetabolites|mesh-ancestor
101979170|NCT01763827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979171|NCT01763827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101979172|NCT01763827|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101979173|NCT01763827|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101979174|NCT01763827|Protease Inhibitors|protease inhibitors|mesh-ancestor
101979175|NCT01763827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101979176|NCT01763827|Immunologic Factors|immunologic factors|mesh-ancestor
101979177|NCT01763827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979178|NCT01146145|Ketamine|ketamine|mesh-list
101979179|NCT01146145|Morphine|morphine|mesh-list
101979180|NCT01146145|Analgesics|analgesics|mesh-ancestor
101979181|NCT01146145|Sensory System Agents|sensory system agents|mesh-ancestor
101979182|NCT01146145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101979183|NCT01146145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979184|NCT01146145|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101979185|NCT01146145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101979186|NCT01146145|Anesthetics, General|anesthetics, general|mesh-ancestor
101979187|NCT01146145|Anesthetics|anesthetics|mesh-ancestor
101979188|NCT01146145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101946450|NCT01266837|Immunologic Factors|immunologic factors|mesh-ancestor
101979189|NCT01146145|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101979190|NCT01146145|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101979191|NCT01146145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101979192|NCT01146145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979193|NCT01146145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101979194|NCT01146145|Narcotics|narcotics|mesh-ancestor
101979195|NCT01146535|Interferons|interferons|mesh-list
101979196|NCT01146535|Interferon-alpha|interferon-alpha|mesh-list
101979197|NCT01146535|Oseltamivir|oseltamivir|mesh-list
101979198|NCT01146535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101979199|NCT01146535|Antiviral Agents|antiviral agents|mesh-ancestor
101979200|NCT01146535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101979201|NCT01146535|Immunologic Factors|immunologic factors|mesh-ancestor
101979202|NCT01146535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979203|NCT01146535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101979204|NCT01146535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979205|NCT01732783|Panitumumab|panitumumab|mesh-list
101979210|NCT04355728|Anticoagulants|anticoagulants|mesh-ancestor
101979211|NCT04355728|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101979212|NCT04355728|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101979213|NCT04355728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979215|NCT01693783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101979216|NCT01693783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101979217|NCT01693783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101979218|NCT01693783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979219|NCT02528461|Sofosbuvir|sofosbuvir|mesh-list
101979220|NCT02528461|Liver Extracts|liver extracts|mesh-list
101979221|NCT02528461|Hematinics|hematinics|mesh-ancestor
101979222|NCT02528461|Antiviral Agents|antiviral agents|mesh-ancestor
101979223|NCT02528461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101979224|NCT01237483|Cetuximab|cetuximab|mesh-list
101979225|NCT01237483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101979226|NCT01237483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101979227|NCT01240213|Vitamin D|vitamin d|mesh-list
101979228|NCT01240213|Vitamins|vitamins|mesh-ancestor
101979229|NCT01240213|Micronutrients|micronutrients|mesh-ancestor
101979230|NCT01240213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979231|NCT01240213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101979232|NCT01375777|Ezetimibe|ezetimibe|mesh-list
101979233|NCT01375777|Evolocumab|evolocumab|mesh-list
101979234|NCT01375777|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101979235|NCT01375777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101979236|NCT01375777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101979237|NCT01375777|Antimetabolites|antimetabolites|mesh-ancestor
101979238|NCT01375777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979239|NCT01375777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101979240|NCT01375777|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101979241|NCT01375777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101979242|NCT01375777|Protease Inhibitors|protease inhibitors|mesh-ancestor
101979243|NCT01375777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101979244|NCT01375777|Immunologic Factors|immunologic factors|mesh-ancestor
101979245|NCT01375777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979246|NCT02431702|Haloperidol|haloperidol|mesh-list
101979247|NCT02431702|Olanzapine|olanzapine|mesh-list
101979248|NCT02431702|Risperidone|risperidone|mesh-list
101979249|NCT02431702|Aripiprazole|aripiprazole|mesh-list
101979250|NCT02431702|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101979251|NCT02431702|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101979252|NCT02431702|Haloperidol decanoate|haloperidol decanoate|mesh-list
101979253|NCT02431702|Perphenazine|perphenazine|mesh-list
101979254|NCT02431702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101979255|NCT02431702|Serotonin Agents|serotonin agents|mesh-ancestor
101979256|NCT02431702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101979257|NCT02431702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979258|NCT02431702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979259|NCT02431702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101979260|NCT02431702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101979261|NCT02431702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101979262|NCT02431702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101979263|NCT02431702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101979264|NCT02431702|Dopamine Agents|dopamine agents|mesh-ancestor
101979265|NCT02431702|Antiemetics|antiemetics|mesh-ancestor
101979266|NCT02431702|Autonomic Agents|autonomic agents|mesh-ancestor
101979267|NCT02431702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101979268|NCT02431702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101946451|NCT01266837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946452|NCT01266837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101946454|NCT01264731|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101946455|NCT01264731|Immunologic Factors|immunologic factors|mesh-ancestor
101979269|NCT02431702|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101979270|NCT02431702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101979271|NCT02431702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101979272|NCT02431702|Antidepressive Agents|antidepressive agents|mesh-ancestor
101979273|NCT02431702|Dopamine Agonists|dopamine agonists|mesh-ancestor
101979274|NCT02431702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101979275|NCT02431702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101979276|NCT02431702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101979277|NCT02431702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101979278|NCT02431702|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101979281|NCT01145209|Fludarabine phosphate|fludarabine phosphate|mesh-list
101979282|NCT01145209|Ofatumumab|ofatumumab|mesh-list
101979283|NCT01145209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101979284|NCT01145209|Immunologic Factors|immunologic factors|mesh-ancestor
101979285|NCT01145209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979286|NCT01145209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101979287|NCT01145209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101979288|NCT01145209|Alkylating Agents|alkylating agents|mesh-ancestor
101979289|NCT01145209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979290|NCT01145209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101979291|NCT01145209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101979292|NCT01145209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101979293|NCT01145209|Antimetabolites|antimetabolites|mesh-ancestor
101979294|NCT02086552|Lenalidomide|lenalidomide|mesh-list
101979295|NCT02086552|Immunologic Factors|immunologic factors|mesh-ancestor
101979296|NCT02086552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979297|NCT02086552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101979298|NCT02086552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101979299|NCT02086552|Growth Substances|growth substances|mesh-ancestor
101979300|NCT02086552|Growth Inhibitors|growth inhibitors|mesh-ancestor
101979301|NCT02086552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101979302|NCT02321878|Liraglutide|liraglutide|mesh-list
101979303|NCT02321878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101979304|NCT02321878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979305|NCT02321878|Incretins|incretins|mesh-ancestor
101979306|NCT02321878|Hormones|hormones|mesh-ancestor
101979307|NCT02321878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101979308|NCT03625141|Atezolizumab|atezolizumab|mesh-list
101979309|NCT03625141|Vemurafenib|vemurafenib|mesh-list
101979310|NCT03625141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101979311|NCT03625141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979312|NCT03625141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101979313|NCT03625141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101979314|NCT03625141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101979315|NCT03625141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101979317|NCT03491410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101979318|NCT03491410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101979319|NCT03491410|Analgesics|analgesics|mesh-ancestor
101979320|NCT03491410|Sensory System Agents|sensory system agents|mesh-ancestor
101979321|NCT03491410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101979322|NCT03491410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979323|NCT03491410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101979324|NCT03491410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101979325|NCT03491410|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101979326|NCT03491410|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101979327|NCT03491410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979328|NCT03491410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101979329|NCT03491410|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101979330|NCT03491410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101979331|NCT03491410|Antipyretics|antipyretics|mesh-ancestor
101979332|NCT00876031|Etoposide|etoposide|mesh-list
101979333|NCT00876031|Idarubicin|idarubicin|mesh-list
101979334|NCT00876031|Trofosfamide|trofosfamide|mesh-list
101979335|NCT00876031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101946456|NCT01264731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946457|NCT01264731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101805884|NCT00427960|Atorvastatin|atorvastatin|mesh-list
101979336|NCT00876031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101979337|NCT00876031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101979338|NCT00876031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101979339|NCT00876031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101979340|NCT00876031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979341|NCT00876031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101979342|NCT00876031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101979343|NCT00876031|Immunologic Factors|immunologic factors|mesh-ancestor
101979344|NCT00876031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979345|NCT00876031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101979346|NCT00876031|Alkylating Agents|alkylating agents|mesh-ancestor
101979347|NCT02322346|Levobupivacaine|levobupivacaine|mesh-list
101979348|NCT02322346|Anesthetics, Local|anesthetics, local|mesh-ancestor
101979349|NCT02322346|Anesthetics|anesthetics|mesh-ancestor
101979350|NCT02322346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101979351|NCT02322346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979352|NCT02322346|Sensory System Agents|sensory system agents|mesh-ancestor
101979356|NCT01146301|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101979357|NCT01146301|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101979358|NCT01146301|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101979359|NCT01146301|Purinergic Agents|purinergic agents|mesh-ancestor
101979360|NCT01146301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101979361|NCT01146301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979362|NCT01146301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979363|NCT00807859|Paclitaxel|paclitaxel|mesh-list
101710602|NCT00695110|Anabolic Agents|anabolic agents|mesh-ancestor
101979364|NCT00807859|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101979365|NCT00807859|Capecitabine|capecitabine|mesh-list
101979366|NCT00807859|Trastuzumab|trastuzumab|mesh-list
101979367|NCT00807859|Lapatinib|lapatinib|mesh-list
101979368|NCT00807859|Trebananib|trebananib|mesh-list
101979369|NCT00807859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101979370|NCT00807859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101979371|NCT00807859|Tubulin Modulators|tubulin modulators|mesh-ancestor
101979372|NCT00807859|Antimitotic Agents|antimitotic agents|mesh-ancestor
101979373|NCT00807859|Mitosis Modulators|mitosis modulators|mesh-ancestor
101979374|NCT00807859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979375|NCT00807859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101979376|NCT00807859|Antimetabolites|antimetabolites|mesh-ancestor
101979377|NCT00807859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101979378|NCT00807859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101979379|NCT00807859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101979380|NCT00807859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101979381|NCT00807859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101979382|NCT00807859|Growth Substances|growth substances|mesh-ancestor
101979383|NCT00807859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979384|NCT00807859|Growth Inhibitors|growth inhibitors|mesh-ancestor
101979385|NCT01246453|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101699175|NCT02576548|Immunoconjugates|immunoconjugates|mesh-ancestor
101979386|NCT01246453|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101979387|NCT01246453|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101979388|NCT01246453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979389|NCT03491098|Mometasone Furoate|mometasone furoate|mesh-list
101979390|NCT03491098|Prednisolone|prednisolone|mesh-list
101979391|NCT03491098|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101979392|NCT03491098|Methylprednisolone|methylprednisolone|mesh-list
101979393|NCT03491098|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101979394|NCT03491098|Prednisolone acetate|prednisolone acetate|mesh-list
101979395|NCT03491098|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101979396|NCT03491098|Prednisolone phosphate|prednisolone phosphate|mesh-list
101979397|NCT03491098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101979398|NCT03491098|Glucocorticoids|glucocorticoids|mesh-ancestor
101979399|NCT03491098|Hormones|hormones|mesh-ancestor
101979400|NCT03491098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101979401|NCT03491098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979402|NCT03491098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101979403|NCT03491098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101979404|NCT03491098|Antiemetics|antiemetics|mesh-ancestor
101979405|NCT03491098|Autonomic Agents|autonomic agents|mesh-ancestor
101946458|NCT01264731|Interferon Inducers|interferon inducers|mesh-ancestor
101946459|NCT03879837|Fluticasone|fluticasone|mesh-list
101946460|NCT03879837|Xhance|xhance|mesh-list
101946461|NCT03879837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101946462|NCT03879837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101979406|NCT03491098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101979407|NCT03491098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101979408|NCT03491098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101979409|NCT03491098|Protective Agents|protective agents|mesh-ancestor
101979410|NCT03491098|Dermatologic Agents|dermatologic agents|mesh-ancestor
101979411|NCT03491098|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101979412|NCT02322502|Propofol|propofol|mesh-list
101979413|NCT02322502|Sevoflurane|sevoflurane|mesh-list
101979414|NCT02322502|Desflurane|desflurane|mesh-list
101979415|NCT02322502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101979416|NCT02322502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101979417|NCT02322502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979418|NCT02322502|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101979419|NCT02322502|Anesthetics, General|anesthetics, general|mesh-ancestor
101979420|NCT02322502|Anesthetics|anesthetics|mesh-ancestor
101979421|NCT02322502|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101979422|NCT02322502|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101979423|NCT02322580|Etanercept|etanercept|mesh-list
101434415|NCT00160589|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101979429|NCT02322580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979430|NCT02322580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101196321|NCT01384682|Maraviroc|maraviroc|mesh-list
101979431|NCT02322580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101979432|NCT02322580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101979433|NCT02322580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101979434|NCT02322580|Immunologic Factors|immunologic factors|mesh-ancestor
101979435|NCT03190174|Sirolimus|sirolimus|mesh-list
101979436|NCT03190174|Nivolumab|nivolumab|mesh-list
101979437|NCT03190174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101979438|NCT03190174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101979439|NCT03190174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101979440|NCT03190174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979441|NCT03190174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101979442|NCT03190174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101979443|NCT03190174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101979444|NCT03190174|Antifungal Agents|antifungal agents|mesh-ancestor
101979445|NCT03190174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101979446|NCT03190174|Immunologic Factors|immunologic factors|mesh-ancestor
101979447|NCT03190174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979448|NCT03490708|Tranilast|tranilast|mesh-list
101979449|NCT03490708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101979450|NCT03490708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101979451|NCT03490708|Analgesics|analgesics|mesh-ancestor
101979452|NCT03490708|Sensory System Agents|sensory system agents|mesh-ancestor
101979453|NCT03490708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101979454|NCT03490708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979455|NCT03490708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101979456|NCT03490708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101979457|NCT03490708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101979458|NCT03490708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101979459|NCT03490708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979460|NCT03490708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101979461|NCT03490708|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101979462|NCT03490708|Histamine Antagonists|histamine antagonists|mesh-ancestor
101979463|NCT03490708|Histamine Agents|histamine agents|mesh-ancestor
101979464|NCT03490708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101979465|NCT03490708|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101979466|NCT03490708|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101979467|NCT00924326|Vidarabine|vidarabine|mesh-list
101979468|NCT00924326|Aldesleukin|aldesleukin|mesh-list
101979469|NCT00924326|Cyclophosphamide|cyclophosphamide|mesh-list
101979470|NCT00924326|Fludarabine|fludarabine|mesh-list
101979471|NCT00924326|Fludarabine phosphate|fludarabine phosphate|mesh-list
101979472|NCT00924326|Interleukin-2|interleukin-2|mesh-list
101979473|NCT00924326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101979474|NCT00924326|Immunologic Factors|immunologic factors|mesh-ancestor
101979475|NCT00924326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979476|NCT00924326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101946463|NCT03879837|Autonomic Agents|autonomic agents|mesh-ancestor
101806025|NCT03954834|Tirzepatide|tirzepatide|mesh-list
101979477|NCT00924326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101979478|NCT00924326|Alkylating Agents|alkylating agents|mesh-ancestor
101979479|NCT00924326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979480|NCT00924326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101979481|NCT00924326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101979482|NCT00924326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101979483|NCT00924326|Antimetabolites|antimetabolites|mesh-ancestor
101979484|NCT00924326|Antiviral Agents|antiviral agents|mesh-ancestor
101979485|NCT00924326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101979486|NCT00924326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101979487|NCT00924326|Analgesics|analgesics|mesh-ancestor
101979488|NCT00924326|Sensory System Agents|sensory system agents|mesh-ancestor
101979489|NCT00924326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101979490|NCT00924326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101979491|NCT00924326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101979492|NCT03496870|Levodopa|levodopa|mesh-list
101979493|NCT03496870|Carbidopa|carbidopa|mesh-list
101979497|NCT03496870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101979498|NCT03496870|Dopamine Agents|dopamine agents|mesh-ancestor
101979499|NCT03496870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101710617|NCT03264352|Vasodilator Agents|vasodilator agents|mesh-ancestor
101979500|NCT03496870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979501|NCT03496870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979502|NCT03496870|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101979503|NCT03496870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101979504|NCT03496870|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101979505|NCT03496870|Immunologic Factors|immunologic factors|mesh-ancestor
101979506|NCT03496870|Dopamine Agonists|dopamine agonists|mesh-ancestor
101979507|NCT03496870|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101979508|NCT01370096|Epoprostenol|epoprostenol|mesh-list
101979509|NCT01370096|Vasopressins|vasopressins|mesh-list
101979510|NCT01370096|Arginine Vasopressin|arginine vasopressin|mesh-list
101979511|NCT01370096|Tezosentan|tezosentan|mesh-list
101979512|NCT01370096|Hemostatics|hemostatics|mesh-ancestor
101979513|NCT01370096|Coagulants|coagulants|mesh-ancestor
101979514|NCT01370096|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101979515|NCT01370096|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101979516|NCT01370096|Natriuretic Agents|natriuretic agents|mesh-ancestor
101979517|NCT01370096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979518|NCT01370096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101979519|NCT01370096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101979520|NCT01370096|Vasodilator Agents|vasodilator agents|mesh-ancestor
101979521|NCT03131570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101979522|NCT03131570|Immunologic Factors|immunologic factors|mesh-ancestor
101979523|NCT03131570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979524|NCT01370876|Oxaliplatin|oxaliplatin|mesh-list
101979525|NCT01370876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101979526|NCT02875028|Vorapaxar|vorapaxar|mesh-list
101979527|NCT02875028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101979528|NCT01371344|Tacrolimus|tacrolimus|mesh-list
101979529|NCT01371344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101979530|NCT01371344|Immunologic Factors|immunologic factors|mesh-ancestor
101979531|NCT01371344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979532|NCT01371344|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101979533|NCT01371344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101979534|NCT01371344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699323|NCT02758769|Immunologic Factors|immunologic factors|mesh-ancestor
101979535|NCT03631004|Olanzapine|olanzapine|mesh-list
101979536|NCT03631004|Antiemetics|antiemetics|mesh-ancestor
101979537|NCT03631004|Autonomic Agents|autonomic agents|mesh-ancestor
101979538|NCT03631004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101979539|NCT03631004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979540|NCT03631004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101979541|NCT03631004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101979542|NCT03631004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101979543|NCT03631004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101979544|NCT03631004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101979545|NCT03631004|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101979546|NCT03631004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101979547|NCT03631004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101979548|NCT03631004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979549|NCT03631004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101979550|NCT03631004|Serotonin Agents|serotonin agents|mesh-ancestor
101946464|NCT03879837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101946465|NCT03879837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979552|NCT01366118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101979553|NCT00943618|Bupropion|bupropion|mesh-list
101979554|NCT00943618|Varenicline|varenicline|mesh-list
101979555|NCT00943618|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101979556|NCT00943618|Antidepressive Agents|antidepressive agents|mesh-ancestor
101979557|NCT00943618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101979558|NCT00943618|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101979559|NCT00943618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101979560|NCT00943618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101979561|NCT00943618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979562|NCT00943618|Dopamine Agents|dopamine agents|mesh-ancestor
101979563|NCT00943618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101979564|NCT00943618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979568|NCT00943618|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101979569|NCT00943618|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101979570|NCT00943618|Cholinergic Agents|cholinergic agents|mesh-ancestor
101979571|NCT01372670|Hydroxyzine|hydroxyzine|mesh-list
101979572|NCT01372670|Antipruritics|antipruritics|mesh-ancestor
101979573|NCT01372670|Dermatologic Agents|dermatologic agents|mesh-ancestor
101979574|NCT01372670|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101979575|NCT01372670|Histamine Antagonists|histamine antagonists|mesh-ancestor
101979576|NCT01372670|Histamine Agents|histamine agents|mesh-ancestor
101979577|NCT01372670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101979578|NCT01372670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979579|NCT01372670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979580|NCT02322658|Eszopiclone|eszopiclone|mesh-list
101979581|NCT02322658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101979582|NCT02322658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101979583|NCT02322658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979584|NCT04218656|Rivaroxaban|rivaroxaban|mesh-list
101979585|NCT04218656|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101979586|NCT04218656|Antithrombins|antithrombins|mesh-ancestor
101979587|NCT04218656|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101979588|NCT04218656|Protease Inhibitors|protease inhibitors|mesh-ancestor
101979589|NCT04218656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101979590|NCT04218656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979591|NCT04218656|Anticoagulants|anticoagulants|mesh-ancestor
101979592|NCT02710084|Oxytocin|oxytocin|mesh-list
101979593|NCT02710084|Oxytocics|oxytocics|mesh-ancestor
101979594|NCT02710084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101979595|NCT02710084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979596|NCT02849990|Prednisone|prednisone|mesh-list
101979597|NCT02849990|Cortisone|cortisone|mesh-list
101979598|NCT02849990|Indomethacin|indomethacin|mesh-list
101979599|NCT02849990|Abiraterone Acetate|abiraterone acetate|mesh-list
101979600|NCT02849990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101979601|NCT02849990|Glucocorticoids|glucocorticoids|mesh-ancestor
101979602|NCT02849990|Hormones|hormones|mesh-ancestor
101979603|NCT02849990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101979604|NCT02849990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979605|NCT02849990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101979606|NCT02849990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101979607|NCT02849990|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101979608|NCT02849990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101979609|NCT02849990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979610|NCT02849990|Hormone Antagonists|hormone antagonists|mesh-ancestor
101699409|NCT01563835|Fentanyl|fentanyl|mesh-list
101979611|NCT02849990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101979612|NCT02849990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101979613|NCT02849990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101979614|NCT02849990|Analgesics|analgesics|mesh-ancestor
101979615|NCT02849990|Sensory System Agents|sensory system agents|mesh-ancestor
101979616|NCT02849990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101979617|NCT02849990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101979618|NCT02849990|Gout Suppressants|gout suppressants|mesh-ancestor
101979619|NCT02849990|Tocolytic Agents|tocolytic agents|mesh-ancestor
101979620|NCT02849990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101979621|NCT02849990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101979622|NCT01366352|Methylnaltrexone|methylnaltrexone|mesh-list
101979623|NCT01366352|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101946466|NCT03879837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101946467|NCT03879837|Respiratory System Agents|respiratory system agents|mesh-ancestor
101946468|NCT03879837|Dermatologic Agents|dermatologic agents|mesh-ancestor
101946469|NCT03879837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101946470|NCT05308628|Complement C3|complement c3|mesh-list
101946471|NCT05308628|Immunologic Factors|immunologic factors|mesh-ancestor
101979624|NCT01366352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979625|NCT01366352|Sensory System Agents|sensory system agents|mesh-ancestor
101979626|NCT01366352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101979627|NCT03490396|Povidone|povidone|mesh-list
101979628|NCT03490396|Hyaluronic Acid|hyaluronic acid|mesh-list
101979629|NCT03490396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101979630|NCT03490396|Immunologic Factors|immunologic factors|mesh-ancestor
101979631|NCT03490396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979632|NCT03490396|Viscosupplements|viscosupplements|mesh-ancestor
101979633|NCT03490396|Protective Agents|protective agents|mesh-ancestor
101979634|NCT03490396|Plasma Substitutes|plasma substitutes|mesh-ancestor
101979635|NCT03490396|Blood Substitutes|blood substitutes|mesh-ancestor
101979636|NCT05136040|Bupivacaine|bupivacaine|mesh-list
101979665|NCT02017964|Alkylating Agents|alkylating agents|mesh-ancestor
101979666|NCT02017964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979667|NCT02017964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101979668|NCT02017964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101979669|NCT02017964|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101979670|NCT02017964|Abortifacient Agents|abortifacient agents|mesh-ancestor
101979671|NCT02017964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101979672|NCT02017964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101979673|NCT02017964|Antimetabolites|antimetabolites|mesh-ancestor
101979674|NCT02017964|Dermatologic Agents|dermatologic agents|mesh-ancestor
101979675|NCT02017964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101979676|NCT02017964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101979677|NCT02017964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101979678|NCT02017964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101979679|NCT02017964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101979680|NCT02017964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101979681|NCT02017964|Tubulin Modulators|tubulin modulators|mesh-ancestor
101979682|NCT02017964|Antimitotic Agents|antimitotic agents|mesh-ancestor
101979683|NCT02017964|Mitosis Modulators|mitosis modulators|mesh-ancestor
101979684|NCT02017964|Keratolytic Agents|keratolytic agents|mesh-ancestor
101979685|NCT05121298|Upadacitinib|upadacitinib|mesh-list
101979714|NCT01802086|Anesthetics, Local|anesthetics, local|mesh-ancestor
101979715|NCT01802086|Anesthetics|anesthetics|mesh-ancestor
101979716|NCT01802086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101979717|NCT01802086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979718|NCT01802086|Sensory System Agents|sensory system agents|mesh-ancestor
101979719|NCT01802086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101979720|NCT01802086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101979721|NCT01802086|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101979722|NCT01802086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101979723|NCT01802086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101979724|NCT01802086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979725|NCT01802086|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
101979727|NCT05347316|Gout Suppressants|gout suppressants|mesh-ancestor
101979728|NCT05347316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101979729|NCT05347316|Tubulin Modulators|tubulin modulators|mesh-ancestor
101979730|NCT05347316|Antimitotic Agents|antimitotic agents|mesh-ancestor
101979733|NCT05347316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101979734|NCT03495466|Anesthetics|anesthetics|mesh-list
101979735|NCT03495466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101979736|NCT03495466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979737|NCT01372826|Naloxegol|naloxegol|mesh-list
101979738|NCT01372826|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101979739|NCT01372826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979740|NCT01372826|Sensory System Agents|sensory system agents|mesh-ancestor
101979741|NCT01372826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101979742|NCT01371968|Alfentanil|alfentanil|mesh-list
101979743|NCT01371968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101979744|NCT01371968|Narcotics|narcotics|mesh-ancestor
101979745|NCT01371968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101946472|NCT05308628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946473|NCT01156077|Tedizolid phosphate|tedizolid phosphate|mesh-list
101946474|NCT01156077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101946475|NCT01156077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101946476|NCT01158729|Antithrombins|antithrombins|mesh-list
101946477|NCT01158729|Antithrombin III|antithrombin iii|mesh-list
101979746|NCT01371968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979747|NCT01371968|Analgesics|analgesics|mesh-ancestor
101979748|NCT01371968|Sensory System Agents|sensory system agents|mesh-ancestor
101979749|NCT01371968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101979750|NCT01371968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101979751|NCT01371968|Anesthetics, General|anesthetics, general|mesh-ancestor
101979752|NCT01371968|Anesthetics|anesthetics|mesh-ancestor
101979753|NCT04989322|Carboplatin|carboplatin|mesh-list
101979754|NCT04989322|Pembrolizumab|pembrolizumab|mesh-list
101979755|NCT04989322|Pemetrexed|pemetrexed|mesh-list
101979756|NCT04989322|Lenvatinib|lenvatinib|mesh-list
101979757|NCT04989322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101979758|NCT04989322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101979759|NCT04989322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101979760|NCT04989322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979761|NCT04989322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101979762|NCT04989322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101979763|NCT04989322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101979764|NCT04989322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101979765|NCT01367054|Metformin|metformin|mesh-list
101979766|NCT01367054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101979767|NCT01367054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979768|NCT03634514|Hormones|hormones|mesh-list
101979769|NCT03634514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101979770|NCT03634514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979771|NCT02323438|Menthol|menthol|mesh-list
101979772|NCT02323438|Nicotine|nicotine|mesh-list
101979773|NCT02323438|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101979774|NCT02323438|Autonomic Agents|autonomic agents|mesh-ancestor
101979775|NCT02323438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101979776|NCT02323438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979777|NCT02323438|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101979778|NCT02323438|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101979779|NCT02323438|Cholinergic Agents|cholinergic agents|mesh-ancestor
101979780|NCT02323438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101979781|NCT02323438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979782|NCT02323438|Antipruritics|antipruritics|mesh-ancestor
101979783|NCT02323438|Dermatologic Agents|dermatologic agents|mesh-ancestor
101979784|NCT01372904|Dexamethasone|dexamethasone|mesh-list
101979785|NCT01372904|Dexamethasone acetate|dexamethasone acetate|mesh-list
101979786|NCT01372904|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101979787|NCT01372904|BB 1101|bb 1101|mesh-list
101979788|NCT01372904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101979789|NCT01372904|Antiemetics|antiemetics|mesh-ancestor
101979790|NCT01372904|Autonomic Agents|autonomic agents|mesh-ancestor
101979791|NCT01372904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101979792|NCT01372904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979793|NCT01372904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101979794|NCT01372904|Glucocorticoids|glucocorticoids|mesh-ancestor
101979795|NCT01372904|Hormones|hormones|mesh-ancestor
101979796|NCT01372904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101979797|NCT01372904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101979798|NCT01372904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101979799|NCT01372904|Protease Inhibitors|protease inhibitors|mesh-ancestor
101979800|NCT01372904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101979801|NCT01372904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979802|NCT01372982|Letrozole|letrozole|mesh-list
101979803|NCT01372982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101979804|NCT01372982|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101979811|NCT01372982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979813|NCT02323516|Loperamide|loperamide|mesh-list
101979814|NCT02323516|Antidiarrheals|antidiarrheals|mesh-list
101979815|NCT02323516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101979816|NCT02323516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101979817|NCT02323516|Analgesics|analgesics|mesh-ancestor
101946478|NCT01158729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101946479|NCT01158729|Protease Inhibitors|protease inhibitors|mesh-ancestor
101946480|NCT01158729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101946481|NCT01158729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946482|NCT01158729|Anticoagulants|anticoagulants|mesh-ancestor
101979818|NCT02323516|Sensory System Agents|sensory system agents|mesh-ancestor
101979819|NCT02323516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101979820|NCT02323516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979821|NCT02323516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101979822|NCT02323516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101979823|NCT02323516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101979824|NCT02323516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101979825|NCT02323516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979826|NCT02323516|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101979827|NCT02323516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101979828|NCT02323516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101979829|NCT02323516|Antipyretics|antipyretics|mesh-ancestor
101979830|NCT02323516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101979831|NCT01367210|Maraviroc|maraviroc|mesh-list
101979832|NCT01367210|Darunavir|darunavir|mesh-list
101979833|NCT01367210|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101979834|NCT01367210|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101979835|NCT01367210|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101979836|NCT01367210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979837|NCT01367210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101979838|NCT01367210|Antiviral Agents|antiviral agents|mesh-ancestor
101979839|NCT01367210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101979840|NCT01367210|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101979841|NCT01367210|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101979842|NCT01367210|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101979843|NCT01367210|Protease Inhibitors|protease inhibitors|mesh-ancestor
101979844|NCT01367210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101979845|NCT02323594|Asunaprevir|asunaprevir|mesh-list
101979846|NCT02323594|Protease Inhibitors|protease inhibitors|mesh-ancestor
101979847|NCT02323594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101979848|NCT02323594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979849|NCT01372280|Galantamine|galantamine|mesh-list
101979850|NCT01372280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101979851|NCT01372280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101979852|NCT01372280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979853|NCT01372280|Cholinergic Agents|cholinergic agents|mesh-ancestor
101979854|NCT01372280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101979855|NCT01372280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979856|NCT01372280|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101979857|NCT01372280|Autonomic Agents|autonomic agents|mesh-ancestor
101979858|NCT01372280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101979859|NCT01372280|Nootropic Agents|nootropic agents|mesh-ancestor
101979860|NCT01373060|Ipragliflozin|ipragliflozin|mesh-list
101979861|NCT01373060|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101979862|NCT01373060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979863|NCT01373060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101979864|NCT01373060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979865|NCT04742140|Magnesium Sulfate|magnesium sulfate|mesh-list
101979866|NCT04742140|Analgesics|analgesics|mesh-ancestor
101979867|NCT04742140|Sensory System Agents|sensory system agents|mesh-ancestor
101979868|NCT04742140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101979869|NCT04742140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979870|NCT04742140|Anesthetics|anesthetics|mesh-ancestor
101434889|NCT00161447|Acyline|acyline|mesh-list
101979873|NCT04742140|Anticonvulsants|anticonvulsants|mesh-ancestor
101979874|NCT04742140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101710668|NCT00690560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101979875|NCT04742140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101979876|NCT04742140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979877|NCT04742140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101979878|NCT04742140|Tocolytic Agents|tocolytic agents|mesh-ancestor
101979879|NCT04742140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101979880|NCT04580992|Ajmaline|ajmaline|mesh-list
101979881|NCT04580992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101979882|NCT04580992|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101946483|NCT01262859|Bevacizumab|bevacizumab|mesh-list
101946484|NCT01262859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101946485|NCT01262859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101979883|NCT04580992|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101979884|NCT04580992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101979885|NCT04580992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979886|NCT04590274|Azithromycin|azithromycin|mesh-list
101979887|NCT04590274|Hydroxychloroquine|hydroxychloroquine|mesh-list
101979888|NCT04590274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101979889|NCT04590274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101979890|NCT04590274|Antimalarials|antimalarials|mesh-ancestor
101979891|NCT04590274|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101979892|NCT04590274|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101979893|NCT04590274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101979894|NCT04590274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979895|NCT04590274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101979896|NCT01367288|Zoledronic Acid|zoledronic acid|mesh-list
101979897|NCT01367288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101979898|NCT01367288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979899|NCT04455178|Indapamide|indapamide|mesh-list
101979900|NCT04455178|Spironolactone|spironolactone|mesh-list
101979901|NCT04455178|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101979902|NCT04455178|Hormone Antagonists|hormone antagonists|mesh-ancestor
101979903|NCT04455178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101979904|NCT04455178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979905|NCT04455178|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101979906|NCT04455178|Diuretics|diuretics|mesh-ancestor
101979907|NCT04455178|Natriuretic Agents|natriuretic agents|mesh-ancestor
101979908|NCT04455178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101979909|NCT04455178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101979910|NCT04455178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101979911|NCT04455178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979912|NCT01367522|Methylnaltrexone|methylnaltrexone|mesh-list
101979913|NCT01367522|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101979914|NCT01367522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979915|NCT01367522|Sensory System Agents|sensory system agents|mesh-ancestor
101979916|NCT01367522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101979917|NCT02446834|Metformin|metformin|mesh-list
101979918|NCT02446834|Acarbose|acarbose|mesh-list
101979919|NCT02446834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101979920|NCT02446834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979921|NCT02446834|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101979922|NCT02446834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101979923|NCT02446834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979924|NCT03489616|Pemetrexed|pemetrexed|mesh-list
101979925|NCT03489616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101979926|NCT03489616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101979927|NCT03489616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979928|NCT03489616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101979929|NCT03489616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101979930|NCT02323906|Sorafenib|sorafenib|mesh-list
101979931|NCT02323906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101979932|NCT02323906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101979933|NCT02323906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101979934|NCT02323906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979935|NCT03116828|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
101979936|NCT03116828|Anticonvulsants|anticonvulsants|mesh-ancestor
101979937|NCT03116828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101979938|NCT03116828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101979939|NCT03116828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101628282|NCT00720499|Respiratory System Agents|respiratory system agents|mesh-ancestor
101979945|NCT01319942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979946|NCT01373138|Pseudoephedrine|pseudoephedrine|mesh-list
101979948|NCT01373138|Desloratadine|desloratadine|mesh-list
101979949|NCT01373138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101979950|NCT01373138|Cholinergic Agents|cholinergic agents|mesh-ancestor
101979951|NCT01373138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101979952|NCT01373138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979953|NCT01373138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946486|NCT01262859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101946487|NCT01262859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101946488|NCT01262859|Growth Substances|growth substances|mesh-ancestor
101946489|NCT01262859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806451|NCT00962442|Antioxidants|antioxidants|mesh-ancestor
101979954|NCT01373138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101979955|NCT01373138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101979956|NCT01373138|Histamine Antagonists|histamine antagonists|mesh-ancestor
101979957|NCT01373138|Histamine Agents|histamine agents|mesh-ancestor
101979958|NCT01373138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101979959|NCT01373138|Autonomic Agents|autonomic agents|mesh-ancestor
101979960|NCT01373138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101979961|NCT01373138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101979962|NCT01373138|Respiratory System Agents|respiratory system agents|mesh-ancestor
101979963|NCT01373138|Nasal Decongestants|nasal decongestants|mesh-ancestor
101979964|NCT01373138|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101979965|NCT01373138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101979966|NCT01373138|Sympathomimetics|sympathomimetics|mesh-ancestor
101979967|NCT01373138|Adrenergic Agents|adrenergic agents|mesh-ancestor
101979968|NCT01373216|Exenatide|exenatide|mesh-list
101979969|NCT01373216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101979970|NCT01373216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979971|NCT01373216|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101979972|NCT01373216|Incretins|incretins|mesh-ancestor
101979973|NCT01373216|Hormones|hormones|mesh-ancestor
101979974|NCT01373216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101979975|NCT03487354|Misoprostol|misoprostol|mesh-list
101979976|NCT03487354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101979977|NCT03487354|Abortifacient Agents|abortifacient agents|mesh-ancestor
101979978|NCT03487354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101979979|NCT03487354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979980|NCT03487354|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101979981|NCT03487354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101979982|NCT03487354|Oxytocics|oxytocics|mesh-ancestor
101979983|NCT04461340|Sirolimus|sirolimus|mesh-list
101979984|NCT04461340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101979985|NCT04461340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101979986|NCT04461340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101979987|NCT04461340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101979988|NCT04461340|Antifungal Agents|antifungal agents|mesh-ancestor
101979989|NCT04461340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101979990|NCT04461340|Immunologic Factors|immunologic factors|mesh-ancestor
101979991|NCT04461340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979992|NCT05154968|Mannitol|mannitol|mesh-list
101979993|NCT05154968|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101979994|NCT05154968|Diuretics|diuretics|mesh-ancestor
101979995|NCT05154968|Natriuretic Agents|natriuretic agents|mesh-ancestor
101979996|NCT05154968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979997|NCT01373372|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
101979998|NCT01373372|Hormones|hormones|mesh-ancestor
101979999|NCT01373372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101980000|NCT01373372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980001|NCT04146142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101980002|NCT04146142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101980003|NCT02324296|Cisplatin|cisplatin|mesh-list
101980004|NCT02324296|Etoposide|etoposide|mesh-list
101980005|NCT02324296|Ifosfamide|ifosfamide|mesh-list
101980006|NCT02324296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101980007|NCT02324296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101980008|NCT02324296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101980009|NCT02324296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101980025|NCT02565914|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101980026|NCT02565914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101980027|NCT02565914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980028|NCT03881020|Fluorides|fluorides|mesh-list
101980029|NCT03881020|Cariostatic Agents|cariostatic agents|mesh-ancestor
101980030|NCT03881020|Protective Agents|protective agents|mesh-ancestor
101980031|NCT03881020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980032|NCT01367600|Methylnaltrexone|methylnaltrexone|mesh-list
101980033|NCT01367600|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101980034|NCT01367600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946490|NCT01262859|Growth Inhibitors|growth inhibitors|mesh-ancestor
101946491|NCT02527083|Ketamine|ketamine|mesh-list
101946492|NCT02527083|Remifentanil|remifentanil|mesh-list
101946493|NCT02527083|Propofol|propofol|mesh-list
101946494|NCT02527083|Sevoflurane|sevoflurane|mesh-list
101946495|NCT02527083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101946496|NCT02527083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101946497|NCT02527083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946498|NCT02527083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101806524|NCT00744185|Propranolol|propranolol|mesh-list
101980035|NCT01367600|Sensory System Agents|sensory system agents|mesh-ancestor
101980036|NCT01367600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101980037|NCT01367678|Chlorhexidine|chlorhexidine|mesh-list
101980038|NCT01367678|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101980039|NCT01367678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101980040|NCT01367678|Disinfectants|disinfectants|mesh-ancestor
101980041|NCT03487042|Bimatoprost|bimatoprost|mesh-list
101980042|NCT03487042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101980043|NCT03487042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101980044|NCT03487042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101980045|NCT03115294|Theophylline|theophylline|mesh-list
101980046|NCT03115294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101980047|NCT03115294|Autonomic Agents|autonomic agents|mesh-ancestor
101980048|NCT03115294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101980049|NCT03115294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980050|NCT03115294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101980051|NCT03115294|Respiratory System Agents|respiratory system agents|mesh-ancestor
101980052|NCT03115294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101980053|NCT03115294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101980054|NCT03115294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980055|NCT03115294|Vasodilator Agents|vasodilator agents|mesh-ancestor
101980056|NCT03115294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101980057|NCT03115294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101980058|NCT03115294|Purinergic Agents|purinergic agents|mesh-ancestor
101980059|NCT03115294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101980060|NCT01367756|Citalopram|citalopram|mesh-list
101980061|NCT01367756|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101980062|NCT01367756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101980063|NCT01367756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101980064|NCT01367756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980065|NCT01367756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101980066|NCT01367756|Serotonin Agents|serotonin agents|mesh-ancestor
101435075|NCT00551005|Etoposide|etoposide|mesh-list
101980070|NCT01367756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101980071|NCT04624958|Rituximab|rituximab|mesh-list
101980072|NCT04624958|Zanubrutinib|zanubrutinib|mesh-list
101980073|NCT04624958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101980074|NCT04624958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101980075|NCT04624958|Immunologic Factors|immunologic factors|mesh-ancestor
101980076|NCT04624958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980077|NCT04624958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101980078|NCT04624958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101980079|NCT04624958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101980080|NCT04624958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980081|NCT03485482|Bisoprolol|bisoprolol|mesh-list
101980082|NCT03485482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101980083|NCT03485482|Sympatholytics|sympatholytics|mesh-ancestor
101980084|NCT03485482|Autonomic Agents|autonomic agents|mesh-ancestor
101980085|NCT03485482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101980086|NCT03485482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980087|NCT03485482|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101980088|NCT03485482|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101980089|NCT03485482|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101980090|NCT03485482|Adrenergic Agents|adrenergic agents|mesh-ancestor
101980091|NCT03485482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101980092|NCT03485482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946499|NCT02527083|Anesthetics, General|anesthetics, general|mesh-ancestor
101946500|NCT02527083|Anesthetics|anesthetics|mesh-ancestor
101946501|NCT02527083|Analgesics|analgesics|mesh-ancestor
101946502|NCT02527083|Sensory System Agents|sensory system agents|mesh-ancestor
101980093|NCT02946424|Simvastatin|simvastatin|mesh-list
101980094|NCT02946424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101980095|NCT02946424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101980096|NCT02946424|Antimetabolites|antimetabolites|mesh-ancestor
101980097|NCT02946424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980098|NCT02946424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101980099|NCT02946424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101980100|NCT02946424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101980101|NCT00783536|Etanercept|etanercept|mesh-list
101980102|NCT00783536|Methotrexate|methotrexate|mesh-list
101980103|NCT00783536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101980104|NCT00783536|Abortifacient Agents|abortifacient agents|mesh-ancestor
101980105|NCT00783536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101980106|NCT00783536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980107|NCT00783536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101980108|NCT00783536|Antimetabolites|antimetabolites|mesh-ancestor
101980109|NCT00783536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980110|NCT00783536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101980111|NCT00783536|Dermatologic Agents|dermatologic agents|mesh-ancestor
101980112|NCT00783536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101980113|NCT00783536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101980114|NCT00783536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101980115|NCT00783536|Immunologic Factors|immunologic factors|mesh-ancestor
101980116|NCT00783536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101980117|NCT00783536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101980118|NCT00783536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101980119|NCT00783536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101980120|NCT00783536|Analgesics|analgesics|mesh-ancestor
101980121|NCT00783536|Sensory System Agents|sensory system agents|mesh-ancestor
101980122|NCT00783536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101980123|NCT00783536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101980124|NCT00783536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101980125|NCT01367912|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101980126|NCT01367912|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101980127|NCT01367912|Estradiol|estradiol|mesh-list
101980128|NCT01367912|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101980129|NCT01367912|Estrogens|estrogens|mesh-ancestor
101980130|NCT01367912|Hormones|hormones|mesh-ancestor
101980131|NCT01367912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101699924|NCT02647424|Letrozole|letrozole|mesh-list
101980132|NCT01367912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980133|NCT01367912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101980134|NCT01367912|Contraceptive Agents|contraceptive agents|mesh-ancestor
101980135|NCT01367912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101980150|NCT01373528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101980152|NCT01373528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101980153|NCT01373528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980154|NCT01373528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101980155|NCT01373528|Respiratory System Agents|respiratory system agents|mesh-ancestor
101980156|NCT01373528|Glucocorticoids|glucocorticoids|mesh-ancestor
101980157|NCT01373528|Hormones|hormones|mesh-ancestor
101980158|NCT01373528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101980159|NCT03634202|Capecitabine|capecitabine|mesh-list
101980160|NCT03634202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101980161|NCT03634202|Antimetabolites|antimetabolites|mesh-ancestor
101980162|NCT03634202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980163|NCT03634202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101980164|NCT05019560|Sevoflurane|sevoflurane|mesh-list
101980165|NCT05019560|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101980166|NCT05019560|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101980167|NCT05019560|Anesthetics, General|anesthetics, general|mesh-ancestor
101980168|NCT05019560|Anesthetics|anesthetics|mesh-ancestor
101980169|NCT05019560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101980170|NCT05019560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980171|NCT01373606|Terlipressin|terlipressin|mesh-list
101980172|NCT01373606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101980173|NCT01373606|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101946503|NCT02527083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101946504|NCT02527083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101946505|NCT02527083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101946506|NCT02527083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101946507|NCT02527083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101971940|NCT02083250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980174|NCT01367990|Norepinephrine|norepinephrine|mesh-list
101980175|NCT01367990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101980176|NCT01367990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101980177|NCT01367990|Adrenergic Agents|adrenergic agents|mesh-ancestor
101980178|NCT01367990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101980179|NCT01367990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980180|NCT01367990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980181|NCT01367990|Sympathomimetics|sympathomimetics|mesh-ancestor
101980182|NCT01367990|Autonomic Agents|autonomic agents|mesh-ancestor
101980183|NCT01367990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101980184|NCT01367990|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101980185|NCT03556358|Paclitaxel|paclitaxel|mesh-list
101980186|NCT03556358|Cyclophosphamide|cyclophosphamide|mesh-list
101980187|NCT03556358|Trastuzumab|trastuzumab|mesh-list
101980188|NCT03556358|Epirubicin|epirubicin|mesh-list
101980189|NCT03556358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101980190|NCT03556358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101980191|NCT03556358|Tubulin Modulators|tubulin modulators|mesh-ancestor
101980192|NCT03556358|Antimitotic Agents|antimitotic agents|mesh-ancestor
101980193|NCT03556358|Mitosis Modulators|mitosis modulators|mesh-ancestor
101980194|NCT03556358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980195|NCT03556358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101980205|NCT03556358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101980206|NCT03556358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101980208|NCT01374308|Interferon-alpha|interferon-alpha|mesh-list
101980209|NCT01374308|Interferon alpha-2|interferon alpha-2|mesh-list
101980210|NCT01374308|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101980211|NCT01374308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101980212|NCT01374308|Antiviral Agents|antiviral agents|mesh-ancestor
101710725|NCT00742846|Glucocorticoids|glucocorticoids|mesh-ancestor
101980213|NCT01374308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101980214|NCT01374308|Immunologic Factors|immunologic factors|mesh-ancestor
101980215|NCT01374308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980216|NCT01368068|Tibolone|tibolone|mesh-list
101980217|NCT01368068|Escitalopram|escitalopram|mesh-list
101980218|NCT01368068|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101980219|NCT01368068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101980220|NCT01368068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101980221|NCT01368068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980222|NCT01368068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101980223|NCT01368068|Serotonin Agents|serotonin agents|mesh-ancestor
101980224|NCT01368068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980225|NCT01368068|Androgen Antagonists|androgen antagonists|mesh-ancestor
101980226|NCT01368068|Hormone Antagonists|hormone antagonists|mesh-ancestor
101980227|NCT01368068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101980228|NCT01368068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101980229|NCT01368068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101980230|NCT01368068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101980231|NCT01368068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101980232|NCT01368068|Anabolic Agents|anabolic agents|mesh-ancestor
101980233|NCT01368068|Hormones|hormones|mesh-ancestor
101980234|NCT01373684|Tenofovir|tenofovir|mesh-list
101980235|NCT01373684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101980236|NCT01373684|Entecavir|entecavir|mesh-list
101980237|NCT01373684|Adefovir|adefovir|mesh-list
101980238|NCT01373684|Antiviral Agents|antiviral agents|mesh-ancestor
101980239|NCT01373684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101980240|NCT01373684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101980241|NCT01373684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101980242|NCT01373684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101980243|NCT01373684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980244|NCT01373684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101980245|NCT01373684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101980246|NCT04490018|Vaccines|vaccines|mesh-list
101946508|NCT02527083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946509|NCT02527083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101946510|NCT02527083|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101946511|NCT02527083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101980247|NCT04490018|Immunologic Factors|immunologic factors|mesh-ancestor
101980248|NCT04490018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980249|NCT02891798|Dexamethasone|dexamethasone|mesh-list
101980250|NCT02891798|Dexamethasone acetate|dexamethasone acetate|mesh-list
101980251|NCT02891798|Clonidine|clonidine|mesh-list
101980252|NCT02891798|Buprenorphine|buprenorphine|mesh-list
101980253|NCT02891798|Bupivacaine|bupivacaine|mesh-list
101980254|NCT02891798|BB 1101|bb 1101|mesh-list
101980255|NCT02891798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101980256|NCT02891798|Antiemetics|antiemetics|mesh-ancestor
101980257|NCT02891798|Autonomic Agents|autonomic agents|mesh-ancestor
101980258|NCT02891798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101980259|NCT02891798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980260|NCT02891798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101980261|NCT02891798|Glucocorticoids|glucocorticoids|mesh-ancestor
101980262|NCT02891798|Hormones|hormones|mesh-ancestor
101628283|NCT00720499|Parasympatholytics|parasympatholytics|mesh-ancestor
101980264|NCT02891798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101980265|NCT02891798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101980266|NCT02891798|Protease Inhibitors|protease inhibitors|mesh-ancestor
101980267|NCT02891798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101980268|NCT02891798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980269|NCT02891798|Anesthetics, Local|anesthetics, local|mesh-ancestor
101980270|NCT02891798|Anesthetics|anesthetics|mesh-ancestor
101980271|NCT02891798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101980272|NCT02891798|Sensory System Agents|sensory system agents|mesh-ancestor
101980273|NCT02891798|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101980274|NCT02891798|Narcotics|narcotics|mesh-ancestor
101980275|NCT02891798|Analgesics|analgesics|mesh-ancestor
101980276|NCT02891798|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101980277|NCT02891798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101980278|NCT02891798|Sympatholytics|sympatholytics|mesh-ancestor
101980279|NCT02891798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101980280|NCT02891798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101980281|NCT02891798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101980282|NCT02891798|Adrenergic Agents|adrenergic agents|mesh-ancestor
101980283|NCT02891798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101980284|NCT01374464|Levobupivacaine|levobupivacaine|mesh-list
101980285|NCT01374464|Anesthetics, Local|anesthetics, local|mesh-ancestor
101980286|NCT01374464|Anesthetics|anesthetics|mesh-ancestor
101980287|NCT01374464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101980288|NCT01374464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980289|NCT01374464|Sensory System Agents|sensory system agents|mesh-ancestor
101980290|NCT01374464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101980291|NCT01374620|Paclitaxel|paclitaxel|mesh-list
101980292|NCT01374620|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101980293|NCT01374620|Cyclophosphamide|cyclophosphamide|mesh-list
101980294|NCT01374620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101980295|NCT01374620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101980296|NCT01374620|Tubulin Modulators|tubulin modulators|mesh-ancestor
101980297|NCT01374620|Antimitotic Agents|antimitotic agents|mesh-ancestor
101980298|NCT01374620|Mitosis Modulators|mitosis modulators|mesh-ancestor
101980299|NCT01374620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980300|NCT01374620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101980301|NCT01374620|Immunologic Factors|immunologic factors|mesh-ancestor
101980302|NCT01374620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980303|NCT01374620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101980304|NCT01374620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101980305|NCT01374620|Alkylating Agents|alkylating agents|mesh-ancestor
101980306|NCT01374620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101980307|NCT01374698|Aspirin|aspirin|mesh-list
101980308|NCT01374698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101980309|NCT01374698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101980310|NCT01374698|Analgesics|analgesics|mesh-ancestor
101980311|NCT01374698|Sensory System Agents|sensory system agents|mesh-ancestor
101980312|NCT01374698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101980313|NCT01374698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980314|NCT01374698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101946513|NCT05156684|Zinc|zinc|mesh-list
101946514|NCT05156684|Pentoxifylline|pentoxifylline|mesh-list
101946515|NCT05156684|Zinc Sulfate|zinc sulfate|mesh-list
101980315|NCT01374698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101980316|NCT01374698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101980317|NCT01374698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101980318|NCT01374698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980319|NCT01374698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101980320|NCT01374698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101980321|NCT01374698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101980322|NCT01374698|Antipyretics|antipyretics|mesh-ancestor
101980323|NCT01368458|Antipsychotic Agents|antipsychotic agents|mesh-list
101980324|NCT01368458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101980325|NCT01368458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101980326|NCT01368458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980327|NCT01368458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101980328|NCT05197088|Tamsulosin|tamsulosin|mesh-list
101980329|NCT05197088|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101980330|NCT05197088|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101980331|NCT05197088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101980332|NCT05197088|Adrenergic Agents|adrenergic agents|mesh-ancestor
101980333|NCT05197088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101980334|NCT05197088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980339|NCT01368848|Bevacizumab|bevacizumab|mesh-list
101980340|NCT01368848|Docetaxel|docetaxel|mesh-list
101980341|NCT01368848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101980342|NCT01368848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101980343|NCT01368848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101980344|NCT01368848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101980345|NCT01368848|Growth Substances|growth substances|mesh-ancestor
101980346|NCT01368848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980347|NCT01368848|Growth Inhibitors|growth inhibitors|mesh-ancestor
101980348|NCT01368848|Tubulin Modulators|tubulin modulators|mesh-ancestor
101980349|NCT01368848|Antimitotic Agents|antimitotic agents|mesh-ancestor
101980350|NCT01368848|Mitosis Modulators|mitosis modulators|mesh-ancestor
101980351|NCT01368848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980352|NCT03604874|Oxytocin|oxytocin|mesh-list
101980353|NCT03604874|Oxytocics|oxytocics|mesh-ancestor
101980354|NCT03604874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101980355|NCT03604874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980356|NCT01369082|Cyclosporine|cyclosporine|mesh-list
101980357|NCT01369082|Sirolimus|sirolimus|mesh-list
101980358|NCT01369082|Mycophenolic Acid|mycophenolic acid|mesh-list
101980359|NCT01369082|Tacrolimus|tacrolimus|mesh-list
101980360|NCT01369082|Cyclosporins|cyclosporins|mesh-list
101980361|NCT01369082|Immunosuppressive Agents|immunosuppressive agents|mesh-list
101980362|NCT01369082|Immunologic Factors|immunologic factors|mesh-ancestor
101980363|NCT01369082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980364|NCT01369082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101980365|NCT01369082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101980366|NCT01369082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980367|NCT01369082|Antifungal Agents|antifungal agents|mesh-ancestor
101980368|NCT01369082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101980369|NCT01369082|Dermatologic Agents|dermatologic agents|mesh-ancestor
101980370|NCT01369082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101980371|NCT01369082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101980372|NCT01369082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101980373|NCT01369082|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101980374|NCT01369082|Antitubercular Agents|antitubercular agents|mesh-ancestor
101980375|NCT01369082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101980376|NCT03382730|Chlorhexidine|chlorhexidine|mesh-list
101980377|NCT03382730|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101980378|NCT03382730|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101980379|NCT03382730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101980380|NCT03382730|Disinfectants|disinfectants|mesh-ancestor
101980381|NCT03382730|Dermatologic Agents|dermatologic agents|mesh-ancestor
101980382|NCT03135262|Rituximab|rituximab|mesh-list
101980383|NCT03135262|Obinutuzumab|obinutuzumab|mesh-list
101980384|NCT03135262|Venetoclax|venetoclax|mesh-list
101980385|NCT03135262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101980386|NCT03135262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101980387|NCT03135262|Immunologic Factors|immunologic factors|mesh-ancestor
101980388|NCT03135262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946516|NCT05156684|Trace Elements|trace elements|mesh-ancestor
101946517|NCT05156684|Micronutrients|micronutrients|mesh-ancestor
101946518|NCT05156684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946519|NCT05156684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101946520|NCT05156684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101946521|NCT05156684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946522|NCT05156684|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101946523|NCT05156684|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101946524|NCT05156684|Protective Agents|protective agents|mesh-ancestor
101946525|NCT05156684|Vasodilator Agents|vasodilator agents|mesh-ancestor
101946526|NCT05156684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101946527|NCT05156684|Antioxidants|antioxidants|mesh-ancestor
101946528|NCT05156684|Astringents|astringents|mesh-ancestor
101946529|NCT05156684|Dermatologic Agents|dermatologic agents|mesh-ancestor
101946530|NCT03883347|Dexmedetomidine|dexmedetomidine|mesh-list
101946531|NCT03883347|Remifentanil|remifentanil|mesh-list
101946532|NCT03883347|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101946533|NCT03883347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101946534|NCT03883347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946535|NCT03883347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101946536|NCT03883347|Analgesics|analgesics|mesh-ancestor
101946537|NCT03883347|Sensory System Agents|sensory system agents|mesh-ancestor
101946538|NCT03883347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101946539|NCT03883347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101946540|NCT03883347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101980389|NCT03135262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101980390|NCT01375244|Lisinopril|lisinopril|mesh-list
101980391|NCT01375244|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101980392|NCT01375244|Protease Inhibitors|protease inhibitors|mesh-ancestor
101980393|NCT01375244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101980394|NCT01375244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980395|NCT01375244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101980396|NCT01375244|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101980397|NCT01375244|Protective Agents|protective agents|mesh-ancestor
101980398|NCT01375244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980399|NCT01375322|Amlodipine|amlodipine|mesh-list
101980400|NCT01375322|Valsartan|valsartan|mesh-list
101980401|NCT01375322|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101980402|NCT01375322|Benazepril|benazepril|mesh-list
101980403|NCT01375322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101980404|NCT01375322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101980405|NCT01375322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101980406|NCT01375322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980407|NCT01375322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101980410|NCT01375322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101980411|NCT01375322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101980412|NCT01375322|Diuretics|diuretics|mesh-ancestor
101980413|NCT01375322|Natriuretic Agents|natriuretic agents|mesh-ancestor
101980414|NCT01375322|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101946541|NCT03883347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101946542|NCT03883347|Adrenergic Agents|adrenergic agents|mesh-ancestor
101980415|NCT01375322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101980416|NCT01375322|Protease Inhibitors|protease inhibitors|mesh-ancestor
101980417|NCT01375322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101980418|NCT01369238|Pyranoprofen|pyranoprofen|mesh-list
101980419|NCT01369238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101980420|NCT01369238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101980421|NCT01369238|Analgesics|analgesics|mesh-ancestor
101980422|NCT01369238|Sensory System Agents|sensory system agents|mesh-ancestor
101980423|NCT01369238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101980424|NCT01369238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980425|NCT01369238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101980426|NCT01369238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101980427|NCT01369238|Gout Suppressants|gout suppressants|mesh-ancestor
101980429|NCT03485404|Folic Acid|folic acid|mesh-list
101980430|NCT03485404|Vitamin B 12|vitamin b 12|mesh-list
101980431|NCT03485404|Vitamin B Complex|vitamin b complex|mesh-list
101980432|NCT03485404|Micronutrients|micronutrients|mesh-ancestor
101980433|NCT03485404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980434|NCT03485404|Hematinics|hematinics|mesh-ancestor
101980435|NCT05195294|Lenvatinib|lenvatinib|mesh-list
101980436|NCT05195294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101980437|NCT05195294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101980438|NCT05195294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101980439|NCT05195294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980440|NCT03072628|Nicotine|nicotine|mesh-list
101980441|NCT03072628|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101980442|NCT03072628|Autonomic Agents|autonomic agents|mesh-ancestor
101980443|NCT03072628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101980444|NCT03072628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980445|NCT03072628|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101980446|NCT03072628|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101980447|NCT03072628|Cholinergic Agents|cholinergic agents|mesh-ancestor
101980448|NCT03072628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101980449|NCT03072628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980450|NCT05195060|Sotrovimab|sotrovimab|mesh-list
101980451|NCT05195060|Molnupiravir|molnupiravir|mesh-list
101980452|NCT05195060|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
101980453|NCT05195060|Antiviral Agents|antiviral agents|mesh-ancestor
101980454|NCT05195060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101980455|NCT03535194|Mirikizumab|mirikizumab|mesh-list
101980456|NCT03535194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101980457|NCT03535194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101980458|NCT03535194|Analgesics|analgesics|mesh-ancestor
101980459|NCT03535194|Sensory System Agents|sensory system agents|mesh-ancestor
101980460|NCT03535194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101980461|NCT03535194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980462|NCT03535194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101980463|NCT03535194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101980464|NCT03535194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101980465|NCT03535194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101980466|NCT03633812|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101980467|NCT03633812|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101980468|NCT03633812|Adrenergic Agents|adrenergic agents|mesh-ancestor
101980469|NCT03633812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101980470|NCT03633812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980471|NCT03633812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980472|NCT05194904|Ketorolac|ketorolac|mesh-list
101980473|NCT05194904|Dexmedetomidine|dexmedetomidine|mesh-list
101980474|NCT05194904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101980475|NCT05194904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101980476|NCT05194904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980477|NCT05194904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101980478|NCT05194904|Analgesics|analgesics|mesh-ancestor
101980479|NCT05194904|Sensory System Agents|sensory system agents|mesh-ancestor
101980480|NCT05194904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101980488|NCT05194904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101980489|NCT05194904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101980490|NCT05194904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101980491|NCT05194904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101980492|NCT01375400|Aspirin|aspirin|mesh-list
101980493|NCT01375400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101980494|NCT01375400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101946543|NCT03883347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101946544|NCT03883347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946545|NCT03883347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101946546|NCT03883347|Narcotics|narcotics|mesh-ancestor
101946547|NCT01159275|Lopinavir|lopinavir|mesh-list
101980495|NCT01375400|Analgesics|analgesics|mesh-ancestor
101980496|NCT01375400|Sensory System Agents|sensory system agents|mesh-ancestor
101980497|NCT01375400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101980498|NCT01375400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980499|NCT01375400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101980500|NCT01375400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101980501|NCT01375400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101980502|NCT01375400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101980503|NCT01375400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980504|NCT01375400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101980505|NCT01375400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101980506|NCT01375400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101980507|NCT01375400|Antipyretics|antipyretics|mesh-ancestor
101700296|NCT02573038|Aflibercept|aflibercept|mesh-list
101980508|NCT01319864|Plerixafor|plerixafor|mesh-list
101980509|NCT01319864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101980510|NCT01319864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101980511|NCT01319864|Antiviral Agents|antiviral agents|mesh-ancestor
101980512|NCT01319864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101980513|NCT05194046|Amoxicillin|amoxicillin|mesh-list
101980514|NCT05194046|Clarithromycin|clarithromycin|mesh-list
101980515|NCT05194046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101980516|NCT05194046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101980517|NCT05194046|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101980518|NCT05194046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101980519|NCT05194046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980520|NCT05194046|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101710763|NCT02622126|Atropine|atropine|mesh-list
101980521|NCT05194046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101980522|NCT01369472|Carvedilol|carvedilol|mesh-list
101980523|NCT01369472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101980524|NCT01369472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101980525|NCT01369472|Adrenergic Agents|adrenergic agents|mesh-ancestor
101980526|NCT01369472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101980527|NCT01369472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980528|NCT01369472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980529|NCT01369472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101980530|NCT01369472|Antioxidants|antioxidants|mesh-ancestor
101980531|NCT01369472|Protective Agents|protective agents|mesh-ancestor
101980532|NCT01369472|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101980533|NCT01369472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101980534|NCT01369472|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101980535|NCT01369472|Vasodilator Agents|vasodilator agents|mesh-ancestor
101980536|NCT01369472|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101980537|NCT01369472|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101980538|NCT03559530|Anti-Infective Agents|anti-infective agents|mesh-list
101980539|NCT03559530|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101980540|NCT05193734|Hemagglutinins|hemagglutinins|mesh-list
101980541|NCT05193734|Agglutinins|agglutinins|mesh-ancestor
101980542|NCT05193734|Immunologic Factors|immunologic factors|mesh-ancestor
101980543|NCT05193734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980544|NCT05193734|Coagulants|coagulants|mesh-ancestor
101980545|NCT01375556|Ethanol|ethanol|mesh-list
101435543|NCT03757585|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101980549|NCT01375556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980550|NCT03486496|Gefitinib|gefitinib|mesh-list
101980551|NCT03486496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101980552|NCT03486496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101980553|NCT03486496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101980554|NCT03486496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980555|NCT02091934|Dipivefrin|dipivefrin|mesh-list
101980556|NCT02091934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101980557|NCT02091934|Adrenergic Agents|adrenergic agents|mesh-ancestor
101980558|NCT02091934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101980559|NCT02091934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980560|NCT02091934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980561|NCT01375634|Midazolam|midazolam|mesh-list
101946548|NCT01159275|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101946549|NCT01159275|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101946550|NCT01159275|Protease Inhibitors|protease inhibitors|mesh-ancestor
101946551|NCT01159275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101971941|NCT02083250|Alkylating Agents|alkylating agents|mesh-ancestor
101980562|NCT01375634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101980563|NCT01375634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101980564|NCT01375634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101980565|NCT01375634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980566|NCT01375634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101980567|NCT01375634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101980568|NCT01375634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101980569|NCT01375634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101980570|NCT01375634|Anesthetics, General|anesthetics, general|mesh-ancestor
101980571|NCT01375634|Anesthetics|anesthetics|mesh-ancestor
101980572|NCT01375634|GABA Modulators|gaba modulators|mesh-ancestor
101980573|NCT01375634|GABA Agents|gaba agents|mesh-ancestor
101980574|NCT01375634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101980575|NCT01375634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980576|NCT05388448|Amoxicillin|amoxicillin|mesh-list
101980577|NCT05388448|Rifampin|rifampin|mesh-list
101980578|NCT05388448|Clavulanic Acids|clavulanic acids|mesh-list
101980579|NCT05388448|Clavulanic Acid|clavulanic acid|mesh-list
101700375|NCT04391855|Analgesics|analgesics|mesh-ancestor
101980580|NCT05388448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101980581|NCT05388448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101980582|NCT05388448|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101980583|NCT05388448|Antitubercular Agents|antitubercular agents|mesh-ancestor
101980584|NCT05388448|Leprostatic Agents|leprostatic agents|mesh-ancestor
101980585|NCT05388448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101980586|NCT05388448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101980587|NCT05388448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980588|NCT05388448|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101980589|NCT05388448|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101980590|NCT05388448|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101980591|NCT05388448|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101980592|NCT05388448|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101980593|NCT05388448|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101980594|NCT05388448|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101980595|NCT05108740|Everolimus|everolimus|mesh-list
101980596|NCT05108740|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101980597|NCT05108740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101980598|NCT05108740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101980599|NCT05108740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980600|NCT05108740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101980601|NCT05108740|Immunologic Factors|immunologic factors|mesh-ancestor
101980602|NCT05108740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980603|NCT05108740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101980604|NCT05105750|Aspirin|aspirin|mesh-list
101980605|NCT05105750|Indobufen|indobufen|mesh-list
101980606|NCT05105750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101980607|NCT05105750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101980608|NCT05105750|Analgesics|analgesics|mesh-ancestor
101980609|NCT05105750|Sensory System Agents|sensory system agents|mesh-ancestor
101980610|NCT05105750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101980611|NCT05105750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980612|NCT05105750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101980613|NCT05105750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101980614|NCT05105750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101980615|NCT05105750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101980631|NCT03485092|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101980632|NCT03485092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980633|NCT03485092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101980634|NCT03485092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980635|NCT03481582|Nitroglycerin|nitroglycerin|mesh-list
101980636|NCT03481582|Vasodilator Agents|vasodilator agents|mesh-ancestor
101980637|NCT01376102|Ibandronic Acid|ibandronic acid|mesh-list
101980638|NCT01376102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101980639|NCT01376102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980640|NCT05064800|Ritonavir|ritonavir|mesh-list
101946552|NCT01159275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980641|NCT05064800|Nirmatrelvir|nirmatrelvir|mesh-list
101980642|NCT05064800|Dabigatran|dabigatran|mesh-list
101980643|NCT05064800|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101980644|NCT05064800|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101980645|NCT05064800|Protease Inhibitors|protease inhibitors|mesh-ancestor
101980646|NCT05064800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101980647|NCT05064800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980648|NCT05064800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101980649|NCT05064800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101980650|NCT05064800|Antiviral Agents|antiviral agents|mesh-ancestor
101980651|NCT05064800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101980652|NCT05064800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101980653|NCT05064800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101980654|NCT05064800|Antithrombins|antithrombins|mesh-ancestor
101980655|NCT05064800|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101980656|NCT05064800|Anticoagulants|anticoagulants|mesh-ancestor
101980657|NCT01376180|Lamotrigine|lamotrigine|mesh-list
101980658|NCT01376180|Anticonvulsants|anticonvulsants|mesh-ancestor
101980659|NCT01376180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101980660|NCT01376180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101980661|NCT01376180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980662|NCT01376180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101980663|NCT01376180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980664|NCT01376180|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101980665|NCT01376180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101980666|NCT01376180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101980667|NCT01376180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101980668|NCT01376180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101980669|NCT03633734|Folfirinox|folfirinox|mesh-list
101980670|NCT03633734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101980671|NCT01376258|Finasteride|finasteride|mesh-list
101980672|NCT01376258|Dutasteride|dutasteride|mesh-list
101980673|NCT01376258|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101980674|NCT01376258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101980677|NCT01376258|Hormone Antagonists|hormone antagonists|mesh-ancestor
101980678|NCT01376258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101980679|NCT01376258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980680|NCT01376258|Urological Agents|urological agents|mesh-ancestor
101980681|NCT05151874|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101980682|NCT05151874|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101980683|NCT05151874|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101980684|NCT05151874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101980685|NCT05151874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980686|NCT05151874|Cholinergic Agents|cholinergic agents|mesh-ancestor
101980687|NCT05151874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101980688|NCT05151874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980689|NCT05151874|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101980690|NCT05151874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101980692|NCT03531840|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101980693|NCT03531840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101980694|NCT03531840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980695|NCT03531840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101980696|NCT05151796|Aspirin|aspirin|mesh-list
101980697|NCT05151796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101980698|NCT05151796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101980699|NCT05151796|Analgesics|analgesics|mesh-ancestor
101980700|NCT05151796|Sensory System Agents|sensory system agents|mesh-ancestor
101980701|NCT05151796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101980702|NCT05151796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980703|NCT05151796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101980704|NCT05151796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101980705|NCT05151796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101980706|NCT05151796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101980707|NCT05151796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980708|NCT05151796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101980709|NCT05151796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101980710|NCT05151796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101980711|NCT05151796|Antipyretics|antipyretics|mesh-ancestor
101980712|NCT04460092|Insulin|insulin|mesh-list
101980713|NCT04460092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101946553|NCT01159275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101946554|NCT01159275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101980714|NCT04460092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101980715|NCT04460092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980716|NCT03110900|Lorazepam|lorazepam|mesh-list
101980717|NCT03110900|Haloperidol|haloperidol|mesh-list
101980718|NCT03110900|Haloperidol decanoate|haloperidol decanoate|mesh-list
101980719|NCT03110900|Loxapine|loxapine|mesh-list
101980720|NCT03110900|Antiemetics|antiemetics|mesh-ancestor
101980721|NCT03110900|Autonomic Agents|autonomic agents|mesh-ancestor
101980722|NCT03110900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101980723|NCT03110900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980724|NCT03110900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101980725|NCT03110900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101980726|NCT03110900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101980727|NCT03110900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101980728|NCT03110900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101980729|NCT03110900|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101980730|NCT03110900|Dopamine Agents|dopamine agents|mesh-ancestor
101980731|NCT03110900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101980732|NCT03110900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980733|NCT03110900|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101980734|NCT03110900|Anticonvulsants|anticonvulsants|mesh-ancestor
101980735|NCT03110900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101980736|NCT03110900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101980737|NCT03110900|GABA Modulators|gaba modulators|mesh-ancestor
101980738|NCT03110900|GABA Agents|gaba agents|mesh-ancestor
101980739|NCT03486184|Cystatins|cystatins|mesh-list
101980740|NCT03486184|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
101980741|NCT03486184|Protease Inhibitors|protease inhibitors|mesh-ancestor
101980742|NCT03486184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101980743|NCT03486184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980744|NCT03109756|Gaboxadol|gaboxadol|mesh-list
101980745|NCT03109756|Analgesics|analgesics|mesh-ancestor
101980746|NCT03109756|Sensory System Agents|sensory system agents|mesh-ancestor
101980749|NCT03109756|Anticonvulsants|anticonvulsants|mesh-ancestor
101980750|NCT03109756|GABA Agonists|gaba agonists|mesh-ancestor
101980751|NCT03109756|GABA Agents|gaba agents|mesh-ancestor
101980752|NCT03109756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101980753|NCT03109756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980754|NCT03867734|Aztreonam|aztreonam|mesh-list
101980755|NCT03867734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101980756|NCT03867734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101980757|NCT05759546|Fulvestrant|fulvestrant|mesh-list
101980758|NCT05759546|Fluzoparib|fluzoparib|mesh-list
101980759|NCT05759546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101980760|NCT05759546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101980761|NCT05759546|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101980762|NCT05759546|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101980763|NCT05759546|Hormone Antagonists|hormone antagonists|mesh-ancestor
101980764|NCT05759546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101980765|NCT05759546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980766|NCT05759546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101980767|NCT05759546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101980768|NCT05759546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980769|NCT05151016|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101980770|NCT05151016|Mifepristone|mifepristone|mesh-list
101980771|NCT05151016|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101980772|NCT05151016|Abortifacient Agents|abortifacient agents|mesh-ancestor
101980773|NCT05151016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101980774|NCT05151016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980775|NCT05151016|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101980776|NCT05151016|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101980777|NCT05151016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101980778|NCT05151016|Contraceptive Agents|contraceptive agents|mesh-ancestor
101980779|NCT05151016|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101980780|NCT05151016|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101980781|NCT05151016|Hormone Antagonists|hormone antagonists|mesh-ancestor
101980782|NCT05151016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101980783|NCT05151016|Luteolytic Agents|luteolytic agents|mesh-ancestor
101980784|NCT05151016|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101980785|NCT05151016|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101980786|NCT05151016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101946555|NCT01159275|Antiviral Agents|antiviral agents|mesh-ancestor
101946556|NCT01159275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101946557|NCT01159275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101946558|NCT01159275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101946559|NCT01159353|Insulin|insulin|mesh-list
101980787|NCT05151016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101980788|NCT04459312|Antibodies|antibodies|mesh-list
101980789|NCT04459312|Immunologic Factors|immunologic factors|mesh-ancestor
101980790|NCT04459312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980791|NCT04871360|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101980792|NCT04871360|Laxatives|laxatives|mesh-ancestor
101980793|NCT04871360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101980794|NCT05153200|Adalimumab|adalimumab|mesh-list
101980795|NCT05153200|Upadacitinib|upadacitinib|mesh-list
101980796|NCT05153200|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101980797|NCT05153200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101980798|NCT05153200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101980799|NCT05153200|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101980800|NCT05153200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101980801|NCT05153200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101980802|NCT05153200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980803|NCT03481036|Antiviral Agents|antiviral agents|mesh-list
101700597|NCT05590117|Immunologic Factors|immunologic factors|mesh-ancestor
101980804|NCT03481036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101980806|NCT03477136|Vitamins|vitamins|mesh-ancestor
101980807|NCT03477136|Micronutrients|micronutrients|mesh-ancestor
101980808|NCT03477136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980809|NCT03477136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101980810|NCT03552068|Clonidine|clonidine|mesh-list
101980811|NCT03552068|Analgesics|analgesics|mesh-ancestor
101980812|NCT03552068|Sensory System Agents|sensory system agents|mesh-ancestor
101980813|NCT03552068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101980814|NCT03552068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980815|NCT03552068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101980816|NCT03552068|Sympatholytics|sympatholytics|mesh-ancestor
101980817|NCT03552068|Autonomic Agents|autonomic agents|mesh-ancestor
101435811|NCT00066040|Disinfectants|disinfectants|mesh-ancestor
101980827|NCT00702988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980828|NCT05759312|Metformin|metformin|mesh-list
101980829|NCT05759312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101980830|NCT05759312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980831|NCT03446456|Vasopressins|vasopressins|mesh-list
101980832|NCT03446456|Arginine Vasopressin|arginine vasopressin|mesh-list
101980833|NCT03446456|Hemostatics|hemostatics|mesh-ancestor
101980834|NCT03446456|Coagulants|coagulants|mesh-ancestor
101980835|NCT03446456|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101980836|NCT03446456|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101980837|NCT03446456|Natriuretic Agents|natriuretic agents|mesh-ancestor
101980838|NCT03446456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980839|NCT03396692|Morphine|morphine|mesh-list
101980840|NCT03396692|Ropivacaine|ropivacaine|mesh-list
101980841|NCT03396692|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101980842|NCT03396692|Narcotics|narcotics|mesh-ancestor
101980843|NCT03396692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101980844|NCT03396692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980845|NCT03396692|Analgesics|analgesics|mesh-ancestor
101980846|NCT03396692|Sensory System Agents|sensory system agents|mesh-ancestor
101980847|NCT03396692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101980848|NCT03396692|Anesthetics, Local|anesthetics, local|mesh-ancestor
101980849|NCT03396692|Anesthetics|anesthetics|mesh-ancestor
101980850|NCT03480958|Morphine|morphine|mesh-list
101980851|NCT03480958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101980852|NCT03480958|Narcotics|narcotics|mesh-ancestor
101980853|NCT03480958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101980854|NCT03480958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980855|NCT03480958|Analgesics|analgesics|mesh-ancestor
101980856|NCT03480958|Sensory System Agents|sensory system agents|mesh-ancestor
101980857|NCT03480958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101980858|NCT03495102|Dulaglutide|dulaglutide|mesh-list
101980859|NCT03495102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101980860|NCT03495102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980861|NCT04859608|Eculizumab|eculizumab|mesh-list
101980862|NCT04859608|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101980863|NCT04859608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101946560|NCT01159353|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101946561|NCT01159353|Insulin Aspart|insulin aspart|mesh-list
101946562|NCT01159353|Insulin glulisine|insulin glulisine|mesh-list
101946563|NCT01159353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101946564|NCT01159353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980864|NCT04859608|Immunologic Factors|immunologic factors|mesh-ancestor
101980865|NCT04859608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980867|NCT04754386|Immunologic Factors|immunologic factors|mesh-ancestor
101980868|NCT04754386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980869|NCT05198180|Hydrogen Peroxide|hydrogen peroxide|mesh-list
101980870|NCT05198180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101980871|NCT05198180|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101710799|NCT00685568|Analgesics|analgesics|mesh-ancestor
101980872|NCT05198180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101980873|NCT03253172|Potassium Citrate|potassium citrate|mesh-list
101980874|NCT03253172|Diuretics|diuretics|mesh-ancestor
101980875|NCT03253172|Natriuretic Agents|natriuretic agents|mesh-ancestor
101980876|NCT03253172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980877|NCT03253172|Expectorants|expectorants|mesh-ancestor
101980878|NCT03253172|Respiratory System Agents|respiratory system agents|mesh-ancestor
101980879|NCT03483376|Anti-Infective Agents|anti-infective agents|mesh-list
101980880|NCT03483376|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101980881|NCT03480646|Prednisone|prednisone|mesh-list
101980882|NCT03480646|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
101980888|NCT03480646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101980889|NCT03480646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101980890|NCT03480646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101980891|NCT03480646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980892|NCT03483142|Misoprostol|misoprostol|mesh-list
101980893|NCT03483142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101980894|NCT03483142|Abortifacient Agents|abortifacient agents|mesh-ancestor
101980895|NCT03483142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101980896|NCT03483142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980897|NCT03483142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101980898|NCT03483142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101980899|NCT03483142|Oxytocics|oxytocics|mesh-ancestor
101980901|NCT03726372|Rocuronium|rocuronium|mesh-list
101980902|NCT03726372|Anticonvulsants|anticonvulsants|mesh-ancestor
101980903|NCT03726372|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101980904|NCT03726372|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101980905|NCT03726372|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101980906|NCT03726372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101980907|NCT03726372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980908|NCT03104816|Acetaminophen|acetaminophen|mesh-list
101980909|NCT03104816|Hydromorphone|hydromorphone|mesh-list
101980910|NCT03104816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101980911|NCT03104816|Analgesics|analgesics|mesh-ancestor
101980912|NCT03104816|Sensory System Agents|sensory system agents|mesh-ancestor
101980913|NCT03104816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101980914|NCT03104816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980915|NCT03104816|Antipyretics|antipyretics|mesh-ancestor
101980916|NCT03104816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101980917|NCT03104816|Narcotics|narcotics|mesh-ancestor
101980918|NCT03104816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101980919|NCT04720976|Pembrolizumab|pembrolizumab|mesh-list
101980920|NCT04720976|Sotorasib|sotorasib|mesh-list
101980921|NCT04720976|Osimertinib|osimertinib|mesh-list
101980922|NCT04720976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101980923|NCT04720976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101980924|NCT04720976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101980925|NCT04720976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980926|NCT04720976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101980927|NCT04720976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101980928|NCT03480568|Alirocumab|alirocumab|mesh-list
101980929|NCT03480568|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101980930|NCT03480568|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101980931|NCT03480568|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101980932|NCT03480568|Antimetabolites|antimetabolites|mesh-ancestor
101980933|NCT03480568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980934|NCT03480568|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101946565|NCT02943668|Deferasirox|deferasirox|mesh-list
101946566|NCT02943668|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101980935|NCT03480568|Protease Inhibitors|protease inhibitors|mesh-ancestor
101980936|NCT03480568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101980937|NCT03480568|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101980938|NCT04707326|Lamivudine|lamivudine|mesh-list
101980939|NCT04707326|Dolutegravir|dolutegravir|mesh-list
101980940|NCT04707326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101980941|NCT04707326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101980942|NCT04707326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101980943|NCT04707326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980944|NCT04707326|Antiviral Agents|antiviral agents|mesh-ancestor
101980945|NCT04707326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101980946|NCT04707326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101980947|NCT04707326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101980948|NCT04707326|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101980949|NCT04707326|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101980950|NCT03559062|Ivacaftor|ivacaftor|mesh-list
101980951|NCT03559062|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101980952|NCT03559062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101980953|NCT03559062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980958|NCT05759000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980960|NCT03726216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101980961|NCT03726216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101980962|NCT00089791|Denosumab|denosumab|mesh-list
101980963|NCT00089791|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101980964|NCT00089791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980965|NCT02876510|Aldesleukin|aldesleukin|mesh-list
101980966|NCT02876510|Cyclophosphamide|cyclophosphamide|mesh-list
101980967|NCT02876510|Fludarabine|fludarabine|mesh-list
101980968|NCT02876510|Fludarabine phosphate|fludarabine phosphate|mesh-list
101980969|NCT02876510|Atezolizumab|atezolizumab|mesh-list
101980970|NCT02876510|Interleukin-2|interleukin-2|mesh-list
101980971|NCT02876510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101980972|NCT02876510|Immunologic Factors|immunologic factors|mesh-ancestor
101980973|NCT02876510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980974|NCT02876510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101980975|NCT02876510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101980976|NCT02876510|Alkylating Agents|alkylating agents|mesh-ancestor
101980977|NCT02876510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980978|NCT02876510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101980979|NCT02876510|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101980980|NCT02876510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101980981|NCT02876510|Antimetabolites|antimetabolites|mesh-ancestor
101980982|NCT02876510|Antiviral Agents|antiviral agents|mesh-ancestor
101980983|NCT02876510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101980984|NCT02876510|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101980985|NCT02876510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101980986|NCT02876510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101980987|NCT02876510|Analgesics|analgesics|mesh-ancestor
101980988|NCT02876510|Sensory System Agents|sensory system agents|mesh-ancestor
101980989|NCT02876510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101980990|NCT02876510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101980991|NCT02876510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101980992|NCT03380455|Cimetidine|cimetidine|mesh-list
101980993|NCT03380455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101980994|NCT03380455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101980995|NCT03380455|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101980996|NCT03380455|Histamine Antagonists|histamine antagonists|mesh-ancestor
101980997|NCT03380455|Histamine Agents|histamine agents|mesh-ancestor
101980998|NCT03380455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101980999|NCT03380455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981000|NCT03380455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981001|NCT03380455|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101981002|NCT03380455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101981003|NCT03380455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101981004|NCT02815280|Minocycline|minocycline|mesh-list
101981005|NCT02815280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101981006|NCT02815280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101981007|NCT03482752|Molgramostim|molgramostim|mesh-list
101981008|NCT03482752|Sargramostim|sargramostim|mesh-list
101981009|NCT03482752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101981010|NCT03482752|Immunologic Factors|immunologic factors|mesh-ancestor
101981011|NCT03482752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946567|NCT02943668|Chelating Agents|chelating agents|mesh-ancestor
101946568|NCT02943668|Sequestering Agents|sequestering agents|mesh-ancestor
101981012|NCT04729543|Azacitidine|azacitidine|mesh-list
101981013|NCT04729543|Interleukin-2|interleukin-2|mesh-list
101981014|NCT04729543|Valproic Acid|valproic acid|mesh-list
101981015|NCT04729543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101981016|NCT04729543|Antimetabolites|antimetabolites|mesh-ancestor
101710810|NCT02626208|Contraceptive Agents|contraceptive agents|mesh-list
101981017|NCT04729543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981018|NCT04729543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101981019|NCT04729543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101981020|NCT04729543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101981021|NCT04729543|Analgesics|analgesics|mesh-ancestor
101981022|NCT04729543|Sensory System Agents|sensory system agents|mesh-ancestor
101981023|NCT04729543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101436023|NCT05693844|Immunologic Factors|immunologic factors|mesh-ancestor
101981036|NCT01310712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981037|NCT01310712|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101981038|NCT01310712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101981039|NCT01310712|Cholinergic Agents|cholinergic agents|mesh-ancestor
101981040|NCT01310712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101981041|NCT01310712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981042|NCT01310712|Urological Agents|urological agents|mesh-ancestor
101981043|NCT02737930|Fluoxetine|fluoxetine|mesh-list
101981044|NCT02737930|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101981045|NCT02737930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101981046|NCT02737930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101981047|NCT02737930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981048|NCT02737930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101981049|NCT02737930|Serotonin Agents|serotonin agents|mesh-ancestor
101981050|NCT02737930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981051|NCT02737930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101981052|NCT02737930|Antidepressive Agents|antidepressive agents|mesh-ancestor
101981053|NCT02737930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101981054|NCT02737930|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101981055|NCT02737930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101981056|NCT02737930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101981057|NCT01242787|Entecavir|entecavir|mesh-list
101981058|NCT01242787|Antiviral Agents|antiviral agents|mesh-ancestor
101981059|NCT01242787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101981060|NCT03476356|Clomiphene|clomiphene|mesh-list
101981061|NCT03476356|Enclomiphene|enclomiphene|mesh-list
101981062|NCT03476356|Zuclomiphene|zuclomiphene|mesh-list
101981063|NCT03476356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101981064|NCT03476356|Hormone Antagonists|hormone antagonists|mesh-ancestor
101981065|NCT03476356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101981066|NCT03476356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981067|NCT03476356|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101981068|NCT03476356|Fertility Agents|fertility agents|mesh-ancestor
101981069|NCT03476356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101981070|NCT03476356|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101981071|NCT03476356|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101981072|NCT03723096|Pomalidomide|pomalidomide|mesh-list
101981073|NCT03723096|Immunologic Factors|immunologic factors|mesh-ancestor
101981074|NCT03723096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981075|NCT03723096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101981076|NCT03723096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101981077|NCT03723096|Growth Substances|growth substances|mesh-ancestor
101981078|NCT03723096|Growth Inhibitors|growth inhibitors|mesh-ancestor
101981079|NCT03723096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101981080|NCT02534012|Anesthetics|anesthetics|mesh-list
101981081|NCT02534012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101981082|NCT02534012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981083|NCT05626387|Mycophenolic Acid|mycophenolic acid|mesh-list
101981084|NCT05626387|Prednisolone|prednisolone|mesh-list
101981085|NCT05626387|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101981086|NCT05626387|Methylprednisolone|methylprednisolone|mesh-list
101981097|NCT05626387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101981098|NCT05626387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981099|NCT05626387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101981100|NCT05626387|Glucocorticoids|glucocorticoids|mesh-ancestor
101981102|NCT05626387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101981103|NCT05626387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946569|NCT02943668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946570|NCT01265199|Cytarabine|cytarabine|mesh-list
101946571|NCT01265199|Daunorubicin|daunorubicin|mesh-list
101946572|NCT01265199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101981104|NCT05626387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101981105|NCT05626387|Antiemetics|antiemetics|mesh-ancestor
101981106|NCT05626387|Autonomic Agents|autonomic agents|mesh-ancestor
101981107|NCT05626387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101981108|NCT05626387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101981109|NCT05626387|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101981110|NCT05626387|Protective Agents|protective agents|mesh-ancestor
101981111|NCT03722940|Magnesium Sulfate|magnesium sulfate|mesh-list
101981112|NCT03722940|Analgesics|analgesics|mesh-ancestor
101981113|NCT03722940|Sensory System Agents|sensory system agents|mesh-ancestor
101981114|NCT03722940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101981115|NCT03722940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981116|NCT03722940|Anesthetics|anesthetics|mesh-ancestor
101981117|NCT03722940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101981118|NCT03722940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101981119|NCT03722940|Anticonvulsants|anticonvulsants|mesh-ancestor
101981120|NCT03722940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101981121|NCT03722940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101981122|NCT03722940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981123|NCT03722940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101981124|NCT03722940|Tocolytic Agents|tocolytic agents|mesh-ancestor
101981125|NCT03722940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101981126|NCT01146925|Deferiprone|deferiprone|mesh-list
101981127|NCT01146925|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101981128|NCT01146925|Chelating Agents|chelating agents|mesh-ancestor
101981129|NCT01146925|Sequestering Agents|sequestering agents|mesh-ancestor
101981130|NCT01146925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981131|NCT04635254|Histamine|histamine|mesh-list
101981132|NCT04635254|Histamine Agonists|histamine agonists|mesh-ancestor
101981133|NCT04635254|Histamine Agents|histamine agents|mesh-ancestor
101981134|NCT04635254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101981135|NCT04635254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981136|NCT04635254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981137|NCT03476044|Selenium|selenium|mesh-list
101981138|NCT03476044|Antioxidants|antioxidants|mesh-ancestor
101981139|NCT03476044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981140|NCT03476044|Protective Agents|protective agents|mesh-ancestor
101981141|NCT03476044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981142|NCT03476044|Trace Elements|trace elements|mesh-ancestor
101981143|NCT03476044|Micronutrients|micronutrients|mesh-ancestor
101981144|NCT01250821|Menotropins|menotropins|mesh-list
101981145|NCT01250821|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101981146|NCT01250821|Fertility Agents|fertility agents|mesh-ancestor
101981147|NCT01250821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101981148|NCT01250821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981149|NCT03493698|Midazolam|midazolam|mesh-list
101436169|NCT05267873|Vortioxetine|vortioxetine|mesh-list
101710831|NCT00696540|Albuterol|albuterol|mesh-list
101981153|NCT03493698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981154|NCT03493698|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101981155|NCT03493698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101981156|NCT03493698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101981157|NCT03493698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101981158|NCT03493698|Anesthetics, General|anesthetics, general|mesh-ancestor
101981160|NCT03493698|GABA Modulators|gaba modulators|mesh-ancestor
101981161|NCT03493698|GABA Agents|gaba agents|mesh-ancestor
101981162|NCT03493698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101981163|NCT03493698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981164|NCT01148173|Ifosfamide|ifosfamide|mesh-list
101981165|NCT01148173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101981166|NCT01148173|Alkylating Agents|alkylating agents|mesh-ancestor
101981167|NCT01148173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981168|NCT01148173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101981169|NCT01898312|Mifepristone|mifepristone|mesh-list
101981170|NCT01898312|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101981171|NCT01898312|Abortifacient Agents|abortifacient agents|mesh-ancestor
101981172|NCT01898312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101981173|NCT01898312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946573|NCT01265199|Antimetabolites|antimetabolites|mesh-ancestor
101946574|NCT01265199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946575|NCT01265199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101946576|NCT01265199|Antiviral Agents|antiviral agents|mesh-ancestor
101946577|NCT01265199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101946578|NCT01265199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101946579|NCT01265199|Immunologic Factors|immunologic factors|mesh-ancestor
101946580|NCT01265199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946581|NCT01265199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101946582|NCT01265199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101946583|NCT01265199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101946584|NCT01265199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101946585|NCT01263171|Leucovorin|leucovorin|mesh-list
101981174|NCT01898312|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101981175|NCT01898312|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101981176|NCT01898312|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101981177|NCT01898312|Contraceptive Agents|contraceptive agents|mesh-ancestor
101981178|NCT01898312|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101981179|NCT01898312|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101981180|NCT01898312|Hormone Antagonists|hormone antagonists|mesh-ancestor
101981181|NCT01898312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101981182|NCT01898312|Luteolytic Agents|luteolytic agents|mesh-ancestor
101981183|NCT01898312|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101981184|NCT01898312|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101981185|NCT03528174|Pancrelipase|pancrelipase|mesh-list
101981186|NCT03528174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101981187|NCT05756660|Sodium thiosulfate|sodium thiosulfate|mesh-list
101981188|NCT05756660|Cisplatin|cisplatin|mesh-list
101981189|NCT05756660|Vorinostat|vorinostat|mesh-list
101981190|NCT05756660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101981191|NCT05756660|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101981192|NCT05756660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101981193|NCT05756660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981194|NCT05756660|Antidotes|antidotes|mesh-ancestor
101981195|NCT05756660|Protective Agents|protective agents|mesh-ancestor
101981196|NCT05756660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981197|NCT05756660|Antioxidants|antioxidants|mesh-ancestor
101981198|NCT05756660|Antitubercular Agents|antitubercular agents|mesh-ancestor
101981199|NCT05756660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101981200|NCT05756660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101981201|NCT05756660|Chelating Agents|chelating agents|mesh-ancestor
101981202|NCT05756660|Sequestering Agents|sequestering agents|mesh-ancestor
101981203|NCT03482440|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
101981204|NCT03482440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101981205|NCT03482440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101981206|NCT03482440|Analgesics|analgesics|mesh-ancestor
101981207|NCT03482440|Sensory System Agents|sensory system agents|mesh-ancestor
101981208|NCT03482440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101981209|NCT03482440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981210|NCT03482440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101981211|NCT03482440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101981212|NCT04638634|Immunoglobulins|immunoglobulins|mesh-list
101981213|NCT04638634|Immunologic Factors|immunologic factors|mesh-ancestor
101981214|NCT04638634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981215|NCT01253473|Budesonide|budesonide|mesh-list
101981216|NCT01253473|Albuterol|albuterol|mesh-list
101981217|NCT01253473|Formoterol Fumarate|formoterol fumarate|mesh-list
101981218|NCT01253473|Ipratropium|ipratropium|mesh-list
101981219|NCT01253473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101981220|NCT01253473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101981221|NCT01253473|Autonomic Agents|autonomic agents|mesh-ancestor
101981225|NCT01253473|Respiratory System Agents|respiratory system agents|mesh-ancestor
101981226|NCT01253473|Glucocorticoids|glucocorticoids|mesh-ancestor
101946587|NCT01263171|Oxaliplatin|oxaliplatin|mesh-list
101946588|NCT01263171|Calcium|calcium|mesh-list
101946589|NCT01263171|Levoleucovorin|levoleucovorin|mesh-list
101946590|NCT01263171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101946591|NCT01263171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946592|NCT01263171|Antimetabolites|antimetabolites|mesh-ancestor
101946593|NCT01263171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946594|NCT01263171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101946595|NCT01263171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101946596|NCT01263171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101946597|NCT01263171|Immunologic Factors|immunologic factors|mesh-ancestor
101946598|NCT01263171|Antidotes|antidotes|mesh-ancestor
101946599|NCT01263171|Protective Agents|protective agents|mesh-ancestor
101946600|NCT01263171|Vitamin B Complex|vitamin b complex|mesh-ancestor
101946601|NCT01263171|Vitamins|vitamins|mesh-ancestor
101946602|NCT01263171|Micronutrients|micronutrients|mesh-ancestor
101946603|NCT01156233|Anesthetics|anesthetics|mesh-list
101946604|NCT01156233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101946605|NCT01156233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946606|NCT03883269|Ethanol|ethanol|mesh-list
101946607|NCT03883269|Clindamycin|clindamycin|mesh-list
101946608|NCT03883269|Clindamycin palmitate|clindamycin palmitate|mesh-list
101946609|NCT03883269|Clindamycin phosphate|clindamycin phosphate|mesh-list
101946610|NCT03883269|Erythromycin|erythromycin|mesh-list
101946611|NCT03883269|Erythromycin Estolate|erythromycin estolate|mesh-list
101946612|NCT03883269|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101946613|NCT03883269|Erythromycin stearate|erythromycin stearate|mesh-list
101946614|NCT03883269|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101946615|NCT03883269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101946616|NCT03883269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101946617|NCT03883269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946618|NCT03883269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101946619|NCT03883269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101946620|NCT03883269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101946621|NCT03883269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946622|NCT03883269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101946627|NCT01267305|Calcium|calcium|mesh-list
101946628|NCT01267305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101946629|NCT01267305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946630|NCT01267305|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101946631|NCT01267305|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101946632|NCT01267305|Antithrombins|antithrombins|mesh-ancestor
101946633|NCT01267305|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101946634|NCT01267305|Protease Inhibitors|protease inhibitors|mesh-ancestor
101946635|NCT01267305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101946636|NCT01267305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946637|NCT01267305|Anticoagulants|anticoagulants|mesh-ancestor
101946638|NCT01267305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101946639|NCT01267305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101946640|NCT02891408|Fenofibrate|fenofibrate|mesh-list
101946641|NCT02891408|Firsocostat|firsocostat|mesh-list
101946642|NCT02891408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101946643|NCT02891408|Antimetabolites|antimetabolites|mesh-ancestor
101946644|NCT02891408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946645|NCT02891408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101946646|NCT02891408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101946647|NCT01160991|Olanzapine|olanzapine|mesh-list
101946648|NCT01160991|Amisulpride|amisulpride|mesh-list
101946649|NCT01160991|Antiemetics|antiemetics|mesh-ancestor
101946650|NCT01160991|Autonomic Agents|autonomic agents|mesh-ancestor
101946651|NCT01160991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101691681|NCT00683319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101981227|NCT01253473|Hormones|hormones|mesh-ancestor
101981228|NCT01253473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101981229|NCT01253473|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101981230|NCT01253473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101981231|NCT01253473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101981232|NCT01253473|Adrenergic Agents|adrenergic agents|mesh-ancestor
101981233|NCT01253473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101981234|NCT01253473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981235|NCT01253473|Tocolytic Agents|tocolytic agents|mesh-ancestor
101981236|NCT01253473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101981237|NCT01253473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101981238|NCT01253473|Cholinergic Agents|cholinergic agents|mesh-ancestor
101981239|NCT01883804|Methyldopa|methyldopa|mesh-list
101981240|NCT01883804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101981241|NCT01883804|Sympatholytics|sympatholytics|mesh-ancestor
101981242|NCT01883804|Autonomic Agents|autonomic agents|mesh-ancestor
101981243|NCT01883804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101981244|NCT01883804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981245|NCT01883804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101981246|NCT01883804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101981247|NCT01883804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101981248|NCT01883804|Adrenergic Agents|adrenergic agents|mesh-ancestor
101981249|NCT01883804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101981250|NCT01883804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946652|NCT01160991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946653|NCT01160991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101946654|NCT01160991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101946655|NCT01160991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101946656|NCT01160991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101946657|NCT01160991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101946658|NCT01160991|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101946659|NCT01160991|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101981251|NCT01247935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
101981252|NCT01247935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101981253|NCT01247935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981254|NCT03475810|Midazolam|midazolam|mesh-list
101981255|NCT03475810|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101981256|NCT03475810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101981257|NCT03475810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101981258|NCT03475810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981259|NCT03475810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101981260|NCT03475810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101981261|NCT03475810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101981262|NCT03475810|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101981263|NCT03475810|Anesthetics, General|anesthetics, general|mesh-ancestor
101981264|NCT03475810|Anesthetics|anesthetics|mesh-ancestor
101981265|NCT03475810|GABA Modulators|gaba modulators|mesh-ancestor
101981266|NCT03475810|GABA Agents|gaba agents|mesh-ancestor
101981267|NCT03475810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101981268|NCT03475810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981269|NCT03480100|Xylometazoline|xylometazoline|mesh-list
101981270|NCT03480100|Nasal Decongestants|nasal decongestants|mesh-ancestor
101981271|NCT03480100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101981272|NCT03480100|Respiratory System Agents|respiratory system agents|mesh-ancestor
101981273|NCT02348203|Aspirin|aspirin|mesh-list
101981274|NCT02348203|Zileuton|zileuton|mesh-list
101981275|NCT02348203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101981276|NCT02348203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101981277|NCT02348203|Analgesics|analgesics|mesh-ancestor
101981278|NCT02348203|Sensory System Agents|sensory system agents|mesh-ancestor
101981279|NCT02348203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101981280|NCT02348203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981281|NCT02348203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101981282|NCT02348203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101981283|NCT02348203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101981284|NCT02348203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101981285|NCT02348203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981286|NCT02348203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101981287|NCT02348203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101981288|NCT02348203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101981289|NCT02348203|Antipyretics|antipyretics|mesh-ancestor
101981290|NCT02348203|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101981291|NCT02348203|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101981292|NCT02348203|Hormone Antagonists|hormone antagonists|mesh-ancestor
101981296|NCT03493542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981297|NCT03482362|Vinorelbine|vinorelbine|mesh-list
101981298|NCT03482362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101981299|NCT03482362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101981300|NCT03482362|Tubulin Modulators|tubulin modulators|mesh-ancestor
101981301|NCT03482362|Antimitotic Agents|antimitotic agents|mesh-ancestor
101981302|NCT03482362|Mitosis Modulators|mitosis modulators|mesh-ancestor
101981303|NCT03482362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981304|NCT04500470|Ketoprofen|ketoprofen|mesh-list
101981305|NCT04500470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101981306|NCT04500470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101981307|NCT04500470|Analgesics|analgesics|mesh-ancestor
101981308|NCT04500470|Sensory System Agents|sensory system agents|mesh-ancestor
101981309|NCT04500470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101981310|NCT04500470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981311|NCT04500470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101946660|NCT01160991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101946661|NCT01160991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946662|NCT01160991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101465226|NCT02213653|Iron|iron|mesh-list
101981312|NCT04500470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101981313|NCT04500470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101981314|NCT04500470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101981315|NCT04500470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981316|NCT03493386|Glycine|glycine|mesh-list
101981317|NCT03493386|Glycine Agents|glycine agents|mesh-ancestor
101981318|NCT03493386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101981319|NCT03493386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981320|NCT03493386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981321|NCT04937816|Empagliflozin|empagliflozin|mesh-list
101981322|NCT04937816|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101981323|NCT04937816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981324|NCT04937816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101981325|NCT04937816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981326|NCT01366898|Methotrexate|methotrexate|mesh-list
101981327|NCT01366898|Idarubicin|idarubicin|mesh-list
101574993|NCT02753647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101981328|NCT01366898|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101981329|NCT01366898|Abortifacient Agents|abortifacient agents|mesh-ancestor
101981330|NCT01366898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101981331|NCT01366898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981332|NCT01366898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101981333|NCT01366898|Antimetabolites|antimetabolites|mesh-ancestor
101981334|NCT01366898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981335|NCT01366898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101981336|NCT01366898|Dermatologic Agents|dermatologic agents|mesh-ancestor
101981337|NCT01366898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101981338|NCT01366898|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101981339|NCT01366898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101981340|NCT01366898|Immunologic Factors|immunologic factors|mesh-ancestor
101981341|NCT01366898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101981342|NCT01366898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101981343|NCT01366898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101981344|NCT01366898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101981345|NCT01366898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101981346|NCT01248871|Sufentanil|sufentanil|mesh-list
101981347|NCT01248871|Remifentanil|remifentanil|mesh-list
101981349|NCT01248871|Propofol|propofol|mesh-list
101981350|NCT01248871|Sevoflurane|sevoflurane|mesh-list
101981351|NCT01248871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101981352|NCT01248871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101981353|NCT01248871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981354|NCT01248871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101981355|NCT01248871|Anesthetics, General|anesthetics, general|mesh-ancestor
101981356|NCT01248871|Anesthetics|anesthetics|mesh-ancestor
101981357|NCT01248871|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101981358|NCT01248871|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101981359|NCT01248871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101981360|NCT01248871|Narcotics|narcotics|mesh-ancestor
101981361|NCT01248871|Analgesics|analgesics|mesh-ancestor
101981362|NCT01248871|Sensory System Agents|sensory system agents|mesh-ancestor
101981365|NCT01251133|Vaccines|vaccines|mesh-list
101981366|NCT01251133|Immunologic Factors|immunologic factors|mesh-ancestor
101981367|NCT01251133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981368|NCT03720288|Acetazolamide|acetazolamide|mesh-list
101981369|NCT03720288|Anticonvulsants|anticonvulsants|mesh-ancestor
101981370|NCT03720288|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101981371|NCT03720288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101981372|NCT03720288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981373|NCT03720288|Diuretics|diuretics|mesh-ancestor
101981374|NCT03720288|Natriuretic Agents|natriuretic agents|mesh-ancestor
101981375|NCT03720288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981376|NCT03916393|Denatonium|denatonium|mesh-list
101981377|NCT03916393|Aversive Agents|aversive agents|mesh-ancestor
101981378|NCT03916393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981379|NCT03916393|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
101946663|NCT01160991|Serotonin Agents|serotonin agents|mesh-ancestor
101946664|NCT01160991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101946665|NCT01160991|Dopamine Agents|dopamine agents|mesh-ancestor
101946666|NCT01160991|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101946667|NCT01160991|Antidepressive Agents|antidepressive agents|mesh-ancestor
101946668|NCT05498480|Nivolumab|nivolumab|mesh-list
101946669|NCT05498480|Relatlimab|relatlimab|mesh-list
101946670|NCT05498480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101946671|NCT05498480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101946672|NCT05498480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101946673|NCT05498480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946674|NCT01161069|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1H)-one|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1h)-one|mesh-list
101946675|NCT01161069|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101981380|NCT03916393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981381|NCT03916393|Sensory System Agents|sensory system agents|mesh-ancestor
101981382|NCT03916393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101981383|NCT03907813|Bupivacaine|bupivacaine|mesh-list
101981384|NCT03907813|Anesthetics, Local|anesthetics, local|mesh-ancestor
101981385|NCT03907813|Anesthetics|anesthetics|mesh-ancestor
101981386|NCT03907813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101981387|NCT03907813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981388|NCT03907813|Sensory System Agents|sensory system agents|mesh-ancestor
101981389|NCT03907813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101981390|NCT00938912|Lacosamide|lacosamide|mesh-list
101981391|NCT00938912|Anticonvulsants|anticonvulsants|mesh-ancestor
101981392|NCT00938912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101981393|NCT00938912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101981394|NCT00938912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101981395|NCT00938912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981396|NCT01251211|Botulinum Toxins|botulinum toxins|mesh-list
101710877|NCT04138472|Lidocaine|lidocaine|mesh-list
101981397|NCT01251211|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101981398|NCT01251211|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101981399|NCT01251211|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101981400|NCT01251211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101981401|NCT01251211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981402|NCT01251211|Cholinergic Agents|cholinergic agents|mesh-ancestor
101981403|NCT01251211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101981404|NCT01251211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981405|NCT01251211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101981406|NCT01251211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101981408|NCT03473340|Analgesics|analgesics|mesh-ancestor
101981409|NCT03473340|Sensory System Agents|sensory system agents|mesh-ancestor
101981410|NCT03473340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101981411|NCT03473340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981412|NCT03473340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101981413|NCT03473340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101981414|NCT03473340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101981415|NCT03473340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101981416|NCT03473340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101981417|NCT01147705|Allopurinol|allopurinol|mesh-list
101981418|NCT01147705|Antimetabolites|antimetabolites|mesh-ancestor
101981419|NCT01147705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981420|NCT01147705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101981421|NCT01147705|Gout Suppressants|gout suppressants|mesh-ancestor
101981422|NCT01147705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101981423|NCT01147705|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101981424|NCT01147705|Antioxidants|antioxidants|mesh-ancestor
101946676|NCT01161069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101946677|NCT01161069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101946678|NCT01161069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946679|NCT01161147|Meloxicam|meloxicam|mesh-list
101981425|NCT01147705|Protective Agents|protective agents|mesh-ancestor
101981426|NCT01147705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981427|NCT03907111|Chitosan|chitosan|mesh-list
101981428|NCT03907111|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101981429|NCT03907111|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101981430|NCT03907111|Antimetabolites|antimetabolites|mesh-ancestor
101981431|NCT03907111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981432|NCT03907111|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101981433|NCT03907111|Chelating Agents|chelating agents|mesh-ancestor
101981434|NCT03907111|Sequestering Agents|sequestering agents|mesh-ancestor
101981435|NCT03907111|Hemostatics|hemostatics|mesh-ancestor
101981441|NCT03912727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981442|NCT03912727|Vitamin B Complex|vitamin b complex|mesh-ancestor
101981443|NCT03912727|Vitamins|vitamins|mesh-ancestor
101981444|NCT03912727|Micronutrients|micronutrients|mesh-ancestor
101981445|NCT03661567|Methylprednisolone|methylprednisolone|mesh-list
101981446|NCT03661567|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101981447|NCT03661567|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101981448|NCT03661567|Prednisolone|prednisolone|mesh-list
101981449|NCT03661567|Prednisolone acetate|prednisolone acetate|mesh-list
101981450|NCT03661567|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101981451|NCT03661567|Prednisolone phosphate|prednisolone phosphate|mesh-list
101981452|NCT03661567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101981453|NCT03661567|Antiemetics|antiemetics|mesh-ancestor
101981454|NCT03661567|Autonomic Agents|autonomic agents|mesh-ancestor
101981455|NCT03661567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101981456|NCT03661567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981457|NCT03661567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101981458|NCT03661567|Glucocorticoids|glucocorticoids|mesh-ancestor
101981459|NCT03661567|Hormones|hormones|mesh-ancestor
101981460|NCT03661567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101981461|NCT03661567|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101981462|NCT03661567|Protective Agents|protective agents|mesh-ancestor
101981463|NCT03661567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101981464|NCT03661567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101981465|NCT03739138|Pembrolizumab|pembrolizumab|mesh-list
101710881|NCT04138472|Anesthetics|anesthetics|mesh-ancestor
101981466|NCT03739138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101981467|NCT03739138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101981468|NCT03739138|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101981469|NCT03739138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981470|NCT03472326|GS-9131|gs-9131|mesh-list
101981471|NCT03472326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101981472|NCT03472326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981473|NCT03472326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101981474|NCT03472326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101981475|NCT03472326|Antiviral Agents|antiviral agents|mesh-ancestor
101981476|NCT03472326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101981477|NCT03472326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101701292|NCT00674310|Ropinirole|ropinirole|mesh-list
101981478|NCT03472326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101981479|NCT03472014|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
101981480|NCT03472014|Antiviral Agents|antiviral agents|mesh-ancestor
101981481|NCT03472014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101981482|NCT04182100|Aspirin|aspirin|mesh-list
101981483|NCT04182100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101981484|NCT04182100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101981485|NCT04182100|Analgesics|analgesics|mesh-ancestor
101981486|NCT04182100|Sensory System Agents|sensory system agents|mesh-ancestor
101981487|NCT04182100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101981488|NCT04182100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981489|NCT04182100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101981490|NCT04182100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101981491|NCT04182100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101981492|NCT04182100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101981493|NCT04182100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981494|NCT04182100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101946680|NCT01161147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101946681|NCT01161147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101946682|NCT01161147|Analgesics|analgesics|mesh-ancestor
101946683|NCT01161147|Sensory System Agents|sensory system agents|mesh-ancestor
101946684|NCT01161147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101946685|NCT01161147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946686|NCT01161147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101946687|NCT01161147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101946688|NCT01161147|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101946689|NCT01161147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101946690|NCT01161147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101946691|NCT01161147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981495|NCT04182100|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101981496|NCT04182100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101981497|NCT04182100|Antipyretics|antipyretics|mesh-ancestor
101981498|NCT03479320|Lidocaine|lidocaine|mesh-list
101981499|NCT03479320|Anesthetics, Local|anesthetics, local|mesh-ancestor
101981500|NCT03479320|Anesthetics|anesthetics|mesh-ancestor
101981501|NCT03479320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101981502|NCT03479320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981503|NCT03479320|Sensory System Agents|sensory system agents|mesh-ancestor
101981504|NCT03479320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101981507|NCT03479320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101981508|NCT03479320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101981509|NCT03479320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981511|NCT03912415|Bevacizumab|bevacizumab|mesh-list
101981512|NCT03912415|Carboplatin|carboplatin|mesh-list
101981513|NCT03912415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101981514|NCT03912415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101981515|NCT03912415|Tubulin Modulators|tubulin modulators|mesh-ancestor
101981516|NCT03912415|Antimitotic Agents|antimitotic agents|mesh-ancestor
101981517|NCT03912415|Mitosis Modulators|mitosis modulators|mesh-ancestor
101981518|NCT03912415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981519|NCT03912415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101981520|NCT03912415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101981521|NCT03912415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101981522|NCT03912415|Growth Substances|growth substances|mesh-ancestor
101981523|NCT03912415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981524|NCT03912415|Growth Inhibitors|growth inhibitors|mesh-ancestor
101981525|NCT03525834|Everolimus|everolimus|mesh-list
101981526|NCT03525834|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101981527|NCT03525834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101981528|NCT03525834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101981529|NCT03525834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981530|NCT03525834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101981531|NCT03525834|Immunologic Factors|immunologic factors|mesh-ancestor
101981532|NCT03525834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981533|NCT03525834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101981534|NCT00925652|Cyclophosphamide|cyclophosphamide|mesh-list
101981535|NCT00925652|Bevacizumab|bevacizumab|mesh-list
101981536|NCT00925652|Methotrexate|methotrexate|mesh-list
101981537|NCT00925652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101981538|NCT00925652|Immunologic Factors|immunologic factors|mesh-ancestor
101981539|NCT00925652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981540|NCT00925652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101981541|NCT00925652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101981542|NCT00925652|Alkylating Agents|alkylating agents|mesh-ancestor
101981543|NCT00925652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981544|NCT00925652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101946693|NCT01161927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101946694|NCT01161927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101946695|NCT01161927|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101946696|NCT01161927|Histamine Antagonists|histamine antagonists|mesh-ancestor
101946697|NCT01161927|Histamine Agents|histamine agents|mesh-ancestor
101946698|NCT01161927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101946699|NCT01161927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946700|NCT01161927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946701|NCT01267383|Sertraline|sertraline|mesh-list
101946702|NCT01267383|Antidepressive Agents|antidepressive agents|mesh-ancestor
101946703|NCT01267383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101946704|NCT01267383|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101946705|NCT01267383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101946706|NCT01267383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101946707|NCT01267383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946708|NCT01267383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101946709|NCT01267383|Serotonin Agents|serotonin agents|mesh-ancestor
101946710|NCT01267383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946711|NCT03283670|Nitrous Oxide|nitrous oxide|mesh-list
101946712|NCT03283670|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101946713|NCT03283670|Anesthetics, General|anesthetics, general|mesh-ancestor
101946714|NCT03283670|Anesthetics|anesthetics|mesh-ancestor
101946715|NCT03283670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101946716|NCT03283670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946717|NCT03283670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101946718|NCT03283670|Analgesics|analgesics|mesh-ancestor
101946719|NCT03283670|Sensory System Agents|sensory system agents|mesh-ancestor
101946720|NCT03283670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101946721|NCT03110432|Nicotinic Acids|nicotinic acids|mesh-list
101946722|NCT03110432|Niacin|niacin|mesh-list
101946723|NCT03110432|Ezetimibe|ezetimibe|mesh-list
101808119|NCT01033084|Sertraline|sertraline|mesh-list
101981545|NCT00925652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101981546|NCT00925652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101981547|NCT00925652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101981548|NCT00925652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101981549|NCT00925652|Growth Substances|growth substances|mesh-ancestor
101981550|NCT00925652|Growth Inhibitors|growth inhibitors|mesh-ancestor
101981551|NCT00925652|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101981552|NCT00925652|Abortifacient Agents|abortifacient agents|mesh-ancestor
101981553|NCT00925652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101981554|NCT00925652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101981555|NCT00925652|Antimetabolites|antimetabolites|mesh-ancestor
101946725|NCT03110432|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
101946726|NCT03110432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101946727|NCT03110432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101946728|NCT03110432|Antimetabolites|antimetabolites|mesh-ancestor
101946729|NCT03110432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946730|NCT03110432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101946731|NCT03110432|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101946732|NCT03110432|Protease Inhibitors|protease inhibitors|mesh-ancestor
101981556|NCT00925652|Dermatologic Agents|dermatologic agents|mesh-ancestor
101981557|NCT00925652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101981558|NCT00925652|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101981559|NCT00925652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101981560|NCT04872686|Povidone-Iodine|povidone-iodine|mesh-list
101981561|NCT04872686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101981562|NCT04872686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101981563|NCT03954106|Defibrotide|defibrotide|mesh-list
101981564|NCT03954106|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101981565|NCT03954106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101981566|NCT03954106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981567|NCT03954106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101981568|NCT03525444|Ivacaftor|ivacaftor|mesh-list
101981569|NCT03525444|Elexacaftor|elexacaftor|mesh-list
101981570|NCT03525444|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101981571|NCT03525444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101981572|NCT03525444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981573|NCT01251835|Rifampin|rifampin|mesh-list
101981574|NCT01251835|Sitaxsentan|sitaxsentan|mesh-list
101981575|NCT01251835|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101981587|NCT01251835|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101981588|NCT01251835|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101981589|NCT01251835|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101981590|NCT03632876|Vitamin A|vitamin a|mesh-list
101981591|NCT03632876|Retinol palmitate|retinol palmitate|mesh-list
101981592|NCT03632876|Antioxidants|antioxidants|mesh-ancestor
101981593|NCT03632876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981594|NCT03632876|Protective Agents|protective agents|mesh-ancestor
101981595|NCT03632876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981596|NCT03632876|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101981597|NCT03632876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101981598|NCT03632876|Vitamins|vitamins|mesh-ancestor
101981599|NCT03632876|Micronutrients|micronutrients|mesh-ancestor
101981600|NCT03914755|Tucatinib|tucatinib|mesh-list
101981601|NCT03914755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101981602|NCT03914755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101981603|NCT03914755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101981604|NCT03914755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981605|NCT03905317|Bevacizumab|bevacizumab|mesh-list
101981606|NCT03905317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101981607|NCT03905317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101710918|NCT00620789|Autonomic Agents|autonomic agents|mesh-ancestor
101981608|NCT03905317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101981609|NCT03905317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101981610|NCT03905317|Growth Substances|growth substances|mesh-ancestor
101981611|NCT03905317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981612|NCT03905317|Growth Inhibitors|growth inhibitors|mesh-ancestor
101981613|NCT03487848|Sofosbuvir|sofosbuvir|mesh-list
101981614|NCT03487848|Antiviral Agents|antiviral agents|mesh-ancestor
101981615|NCT03487848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101981616|NCT01251991|Psyllium|psyllium|mesh-list
101981617|NCT01251991|Calcium polycarbophil|calcium polycarbophil|mesh-list
101981618|NCT01251991|Cathartics|cathartics|mesh-ancestor
101981619|NCT01251991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101981620|NCT01251991|Antidiarrheals|antidiarrheals|mesh-ancestor
101981621|NCT04458454|Methocarbamol|methocarbamol|mesh-list
101981622|NCT04458454|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101981623|NCT04458454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981624|NCT04458454|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101946734|NCT03110432|Vitamin B Complex|vitamin b complex|mesh-ancestor
101946735|NCT03110432|Vitamins|vitamins|mesh-ancestor
101701428|NCT04137978|Diuretics|diuretics|mesh-ancestor
101981625|NCT04458454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101981626|NCT03914677|Mecamylamine|mecamylamine|mesh-list
101981627|NCT03914677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101981628|NCT03914677|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
101981629|NCT03914677|Autonomic Agents|autonomic agents|mesh-ancestor
101981630|NCT03914677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101981631|NCT03914677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981632|NCT03914677|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101981633|NCT03914677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101981634|NCT03914677|Cholinergic Agents|cholinergic agents|mesh-ancestor
101981635|NCT03914677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101981636|NCT03914677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981644|NCT03479086|Anticonvulsants|anticonvulsants|mesh-ancestor
101981645|NCT03479086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101981646|NCT01252069|Ulipristal acetate|ulipristal acetate|mesh-list
101981647|NCT01252069|Progestins|progestins|mesh-list
101981648|NCT01252069|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101981649|NCT01252069|Contraceptive Agents|contraceptive agents|mesh-ancestor
101981650|NCT01252069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101981651|NCT01252069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981652|NCT01252069|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101981653|NCT01252069|Hormones|hormones|mesh-ancestor
101981654|NCT01252069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101981655|NCT01252225|Lidocaine|lidocaine|mesh-list
101981656|NCT01252225|Anesthetics, Local|anesthetics, local|mesh-ancestor
101981657|NCT01252225|Anesthetics|anesthetics|mesh-ancestor
101981658|NCT01252225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101981659|NCT01252225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981660|NCT01252225|Sensory System Agents|sensory system agents|mesh-ancestor
101981661|NCT01252225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101981662|NCT01252225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101981663|NCT01252225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101981664|NCT01252225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101981665|NCT01252225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101981666|NCT01252225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981667|NCT04459702|Ritonavir|ritonavir|mesh-list
101981668|NCT04459702|Lopinavir|lopinavir|mesh-list
101981669|NCT04459702|Azithromycin|azithromycin|mesh-list
101981670|NCT04459702|Hydroxychloroquine|hydroxychloroquine|mesh-list
101981671|NCT04459702|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101981672|NCT04459702|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101981673|NCT04459702|Protease Inhibitors|protease inhibitors|mesh-ancestor
101981674|NCT04459702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101981675|NCT04459702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981676|NCT04459702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101981677|NCT04459702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101981678|NCT04459702|Antiviral Agents|antiviral agents|mesh-ancestor
101981679|NCT04459702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101981680|NCT04459702|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101981681|NCT04459702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101981682|NCT04459702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101981683|NCT04459702|Antimalarials|antimalarials|mesh-ancestor
101981684|NCT04459702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101981685|NCT04459702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101981686|NCT04459702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101981687|NCT03574792|Oxycodone|oxycodone|mesh-list
101981688|NCT03574792|Methadone|methadone|mesh-list
101981689|NCT03574792|Gabapentin|gabapentin|mesh-list
101981690|NCT03574792|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101981691|NCT03574792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101981692|NCT03574792|Narcotics|narcotics|mesh-ancestor
101981693|NCT03574792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101981694|NCT03574792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981695|NCT03574792|Analgesics|analgesics|mesh-ancestor
101981696|NCT03574792|Sensory System Agents|sensory system agents|mesh-ancestor
101981697|NCT03574792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101981698|NCT03574792|Anticonvulsants|anticonvulsants|mesh-ancestor
101701503|NCT00717808|Anticonvulsants|anticonvulsants|mesh-ancestor
101981699|NCT03574792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101981704|NCT03574792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101946736|NCT03110432|Micronutrients|micronutrients|mesh-ancestor
101946737|NCT03110432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946738|NCT03110432|Vasodilator Agents|vasodilator agents|mesh-ancestor
101946739|NCT03205358|Vaccines|vaccines|mesh-list
101946740|NCT03205358|Immunologic Factors|immunologic factors|mesh-ancestor
101946741|NCT03205358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946742|NCT01358578|Etanercept|etanercept|mesh-list
101946743|NCT01358578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101946744|NCT01358578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101946745|NCT01358578|Analgesics|analgesics|mesh-ancestor
101946746|NCT01358578|Sensory System Agents|sensory system agents|mesh-ancestor
101981705|NCT03574792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981706|NCT03574792|Antimanic Agents|antimanic agents|mesh-ancestor
101981707|NCT03574792|Antitussive Agents|antitussive agents|mesh-ancestor
101981708|NCT03574792|Respiratory System Agents|respiratory system agents|mesh-ancestor
101981709|NCT03574792|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101981710|NCT03574792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101981711|NCT03574792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101981712|NCT03574792|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101981713|NCT03574792|Antidepressive Agents|antidepressive agents|mesh-ancestor
101981714|NCT03904849|Cannabidiol|cannabidiol|mesh-list
101981715|NCT03904849|Anticonvulsants|anticonvulsants|mesh-ancestor
101981716|NCT01250743|Vitamins|vitamins|mesh-list
101981717|NCT01250743|Ascorbic Acid|ascorbic acid|mesh-list
101981718|NCT01250743|Micronutrients|micronutrients|mesh-ancestor
101981719|NCT01250743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981720|NCT01250743|Antioxidants|antioxidants|mesh-ancestor
101981721|NCT01250743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981722|NCT01250743|Protective Agents|protective agents|mesh-ancestor
101981723|NCT01254175|Vaccines|vaccines|mesh-list
101981724|NCT01254175|Immunologic Factors|immunologic factors|mesh-ancestor
101981725|NCT01254175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981726|NCT04377620|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
101981727|NCT04377620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101981728|NCT04377620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101981729|NCT04377620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981730|NCT03478540|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101981731|NCT03478540|Antiviral Agents|antiviral agents|mesh-ancestor
101981732|NCT03478540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101981733|NCT03903367|Fentanyl|fentanyl|mesh-list
101981734|NCT03903367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101981735|NCT03903367|Narcotics|narcotics|mesh-ancestor
101981736|NCT03903367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101981737|NCT03903367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981738|NCT03903367|Analgesics|analgesics|mesh-ancestor
101981739|NCT03903367|Sensory System Agents|sensory system agents|mesh-ancestor
101981740|NCT03903367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101981741|NCT03903367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101981742|NCT03903367|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101981743|NCT03903367|Anesthetics, General|anesthetics, general|mesh-ancestor
101981744|NCT03903367|Anesthetics|anesthetics|mesh-ancestor
101981745|NCT03486834|Vaccines|vaccines|mesh-list
101981746|NCT03486834|Immunologic Factors|immunologic factors|mesh-ancestor
101981747|NCT03486834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981748|NCT02523664|Hydrocortisone|hydrocortisone|mesh-list
101981749|NCT02523664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101981750|NCT03177460|Daratumumab|daratumumab|mesh-list
101981751|NCT03177460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101981752|NCT03717168|Hormones|hormones|mesh-list
101981753|NCT03717168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101981754|NCT03717168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981755|NCT00708448|Bevacizumab|bevacizumab|mesh-list
101981756|NCT00708448|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101981757|NCT00708448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101981758|NCT00708448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101946747|NCT01358578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101946748|NCT01358578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946749|NCT01358578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101946750|NCT01358578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101946751|NCT01358578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101946752|NCT01358578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101981759|NCT00708448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101981760|NCT00708448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101981761|NCT00708448|Growth Substances|growth substances|mesh-ancestor
101981762|NCT00708448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981763|NCT00708448|Growth Inhibitors|growth inhibitors|mesh-ancestor
101981764|NCT00708448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101981765|NCT00708448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101981766|NCT00708448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981767|NCT02892604|Insulin|insulin|mesh-list
101981768|NCT02892604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101981769|NCT02892604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981770|NCT03478306|Melatonin|melatonin|mesh-list
101981771|NCT03478306|Antioxidants|antioxidants|mesh-ancestor
101436785|NCT01527149|Antiemetics|antiemetics|mesh-ancestor
101981775|NCT03478306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101981777|NCT03103100|Bupivacaine|bupivacaine|mesh-list
101981778|NCT03103100|Anesthetics, Local|anesthetics, local|mesh-ancestor
101981779|NCT03103100|Anesthetics|anesthetics|mesh-ancestor
101981780|NCT03103100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101981781|NCT03103100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981782|NCT03103100|Sensory System Agents|sensory system agents|mesh-ancestor
101981783|NCT03103100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101981784|NCT03103100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101981785|NCT03103100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101981786|NCT03103100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101981787|NCT03103100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101981788|NCT03103100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981789|NCT03639168|Cisplatin|cisplatin|mesh-list
101981790|NCT03639168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101981791|NCT03131050|Scopolamine|scopolamine|mesh-list
101981792|NCT03131050|Escitalopram|escitalopram|mesh-list
101786972|NCT00981513|Vaccines|vaccines|mesh-list
101981793|NCT03131050|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101981794|NCT03131050|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101981795|NCT03131050|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101981796|NCT03131050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101981797|NCT03131050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981798|NCT03131050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101981799|NCT03131050|Serotonin Agents|serotonin agents|mesh-ancestor
101981800|NCT03131050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981801|NCT03131050|Parasympatholytics|parasympatholytics|mesh-ancestor
101981802|NCT03131050|Autonomic Agents|autonomic agents|mesh-ancestor
101981803|NCT03131050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101981804|NCT03131050|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101981805|NCT03131050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101981806|NCT03131050|Cholinergic Agents|cholinergic agents|mesh-ancestor
101981807|NCT03131050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101981808|NCT03131050|Antiemetics|antiemetics|mesh-ancestor
101981809|NCT03131050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101981810|NCT03131050|Mydriatics|mydriatics|mesh-ancestor
101981811|NCT03719820|Clopidogrel|clopidogrel|mesh-list
101981812|NCT03719820|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101981813|NCT03719820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981814|NCT03719820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981815|NCT03719820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101981816|NCT03719820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101981817|NCT03719820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101981818|NCT03719820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101981819|NCT03719820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101981820|NCT03719820|Purinergic Agents|purinergic agents|mesh-ancestor
101981821|NCT03719820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101981822|NCT03719820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101946753|NCT01358578|Immunologic Factors|immunologic factors|mesh-ancestor
101946754|NCT01161459|Prednisone|prednisone|mesh-list
101946755|NCT01161459|Tacrolimus|tacrolimus|mesh-list
101946756|NCT01161459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101808453|NCT00984984|Hormones|hormones|mesh-ancestor
101981823|NCT03719820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101981824|NCT03719820|Antimetabolites|antimetabolites|mesh-ancestor
101981825|NCT03719820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101981826|NCT03719820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101981827|NCT04206020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101981828|NCT04206020|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101981829|NCT03466086|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101981830|NCT03466086|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101981831|NCT01254799|Doxycycline|doxycycline|mesh-list
101981832|NCT01254799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101981833|NCT01254799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101981834|NCT01254799|Antimalarials|antimalarials|mesh-ancestor
101981835|NCT01254799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101981836|NCT01254799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101981837|NCT03718884|Mirikizumab|mirikizumab|mesh-list
101981838|NCT03718884|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101981839|NCT03718884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101981840|NCT03718884|Analgesics|analgesics|mesh-ancestor
101981841|NCT03718884|Sensory System Agents|sensory system agents|mesh-ancestor
101981842|NCT03718884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101981845|NCT03718884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101981846|NCT03718884|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101981847|NCT03718884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101981848|NCT03718806|Zoliflodacin|zoliflodacin|mesh-list
101981849|NCT03718806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101710959|NCT04271917|Ibuprofen|ibuprofen|mesh-list
101981850|NCT03718806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101981851|NCT03718806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101981852|NCT03718806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981853|NCT03718806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101981854|NCT03716856|Cyclophosphamide|cyclophosphamide|mesh-list
101981855|NCT03716856|Fludarabine|fludarabine|mesh-list
101981856|NCT03716856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101981857|NCT03716856|Immunologic Factors|immunologic factors|mesh-ancestor
101981858|NCT03716856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981859|NCT03716856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101981860|NCT03716856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101981861|NCT03716856|Alkylating Agents|alkylating agents|mesh-ancestor
101981862|NCT03716856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981863|NCT03716856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101981864|NCT03716856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101981865|NCT03910543|Tofacitinib|tofacitinib|mesh-list
101981866|NCT03910543|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101981867|NCT03910543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101981868|NCT03910543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101981869|NCT03910543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981870|NCT03101462|Vaccines|vaccines|mesh-list
101981871|NCT03101462|Immunologic Factors|immunologic factors|mesh-ancestor
101981872|NCT03101462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981873|NCT03904537|Antibodies|antibodies|mesh-list
101981874|NCT03904537|Immunologic Factors|immunologic factors|mesh-ancestor
101981875|NCT03904537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981876|NCT03904225|Tegafur|tegafur|mesh-list
101981877|NCT03904225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101981878|NCT03904225|Antimetabolites|antimetabolites|mesh-ancestor
101981879|NCT03904225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981880|NCT03904225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101981881|NCT03910231|Tolvaptan|tolvaptan|mesh-list
101981882|NCT03910231|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101981883|NCT03910231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981884|NCT03910231|Natriuretic Agents|natriuretic agents|mesh-ancestor
101981885|NCT03910231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981886|NCT01149109|Temozolomide|temozolomide|mesh-list
101981887|NCT01149109|Lomustine|lomustine|mesh-list
101981888|NCT01149109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101981889|NCT01149109|Alkylating Agents|alkylating agents|mesh-ancestor
101981890|NCT01149109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981891|NCT01149109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101946757|NCT01161459|Glucocorticoids|glucocorticoids|mesh-ancestor
101946758|NCT01161459|Hormones|hormones|mesh-ancestor
101946759|NCT01161459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101946760|NCT01161459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946761|NCT01161459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101946762|NCT01161459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101946763|NCT01161459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101808509|NCT00981786|Travoprost|travoprost|mesh-list
101981892|NCT05667415|Cisplatin|cisplatin|mesh-list
101981893|NCT05667415|Disulfiram|disulfiram|mesh-list
101981894|NCT05667415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101981895|NCT05667415|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101981896|NCT05667415|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
101981897|NCT05667415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101981898|NCT05667415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981899|NCT01586143|Acetaminophen|acetaminophen|mesh-list
101981900|NCT01586143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101981901|NCT01586143|Analgesics|analgesics|mesh-ancestor
101981902|NCT01586143|Sensory System Agents|sensory system agents|mesh-ancestor
101981903|NCT01586143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101981904|NCT01586143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981905|NCT01586143|Antipyretics|antipyretics|mesh-ancestor
101981906|NCT01256359|Docetaxel|docetaxel|mesh-list
101981907|NCT01256359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101710973|NCT04271917|Anticonvulsants|anticonvulsants|mesh-ancestor
101981908|NCT01256359|Tubulin Modulators|tubulin modulators|mesh-ancestor
101981909|NCT01256359|Antimitotic Agents|antimitotic agents|mesh-ancestor
101981910|NCT01256359|Mitosis Modulators|mitosis modulators|mesh-ancestor
101981911|NCT01256359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981912|NCT02527993|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101981913|NCT02527993|Liraglutide|liraglutide|mesh-list
101981914|NCT02527993|Acarbose|acarbose|mesh-list
101981915|NCT02527993|Verapamil|verapamil|mesh-list
101981921|NCT02527993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101981922|NCT02527993|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101574994|NCT02753647|Tubulin Modulators|tubulin modulators|mesh-ancestor
101981923|NCT02527993|Protease Inhibitors|protease inhibitors|mesh-ancestor
101981924|NCT02527993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101981925|NCT02527993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981926|NCT02527993|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101981927|NCT02527993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101981928|NCT02527993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101981929|NCT02527993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101981930|NCT02527993|Vasodilator Agents|vasodilator agents|mesh-ancestor
101981931|NCT02527993|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101981933|NCT04927052|Anesthetics, Local|anesthetics, local|mesh-ancestor
101981934|NCT04927052|Anesthetics|anesthetics|mesh-ancestor
101981935|NCT04927052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101981936|NCT04927052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981937|NCT04927052|Sensory System Agents|sensory system agents|mesh-ancestor
101981938|NCT04927052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101981939|NCT04927052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101981940|NCT04927052|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101981941|NCT04927052|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101981942|NCT04927052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101981943|NCT04927052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981944|NCT01149499|Valacyclovir|valacyclovir|mesh-list
101981945|NCT01149499|Antiviral Agents|antiviral agents|mesh-ancestor
101981946|NCT01149499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101981947|NCT03900871|Aspirin|aspirin|mesh-list
101981948|NCT03900871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101981949|NCT03900871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101981950|NCT03900871|Analgesics|analgesics|mesh-ancestor
101981951|NCT03900871|Sensory System Agents|sensory system agents|mesh-ancestor
101981952|NCT03900871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101981953|NCT03900871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981954|NCT03900871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101946764|NCT01161459|Immunologic Factors|immunologic factors|mesh-ancestor
101946765|NCT01161459|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101946766|NCT01161459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101946767|NCT01161459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946769|NCT03882489|Anesthetics, Local|anesthetics, local|mesh-ancestor
101946770|NCT03882489|Anesthetics|anesthetics|mesh-ancestor
101946771|NCT03882489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101946772|NCT03882489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946773|NCT03882489|Sensory System Agents|sensory system agents|mesh-ancestor
101946774|NCT03882489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101946775|NCT03882099|Vitamin D|vitamin d|mesh-list
101946776|NCT03882099|Vitamins|vitamins|mesh-ancestor
101946777|NCT03882099|Micronutrients|micronutrients|mesh-ancestor
101946778|NCT03882099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946779|NCT03882099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101946780|NCT01268163|Docetaxel|docetaxel|mesh-list
101946781|NCT01268163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101946782|NCT01268163|Tubulin Modulators|tubulin modulators|mesh-ancestor
101946783|NCT01268163|Antimitotic Agents|antimitotic agents|mesh-ancestor
101946784|NCT01268163|Mitosis Modulators|mitosis modulators|mesh-ancestor
101946785|NCT01268163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946786|NCT04745780|Inositol|inositol|mesh-list
101946787|NCT04745780|Vitamin B Complex|vitamin b complex|mesh-ancestor
101946788|NCT04745780|Vitamins|vitamins|mesh-ancestor
101981955|NCT03900871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101981956|NCT03900871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101710977|NCT00686114|Paclitaxel|paclitaxel|mesh-list
101981957|NCT03900871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101981958|NCT03900871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981959|NCT03900871|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101981960|NCT03900871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101981961|NCT03900871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101981962|NCT03900871|Antipyretics|antipyretics|mesh-ancestor
101981963|NCT01149577|Olanzapine|olanzapine|mesh-list
101981964|NCT01149577|Antiemetics|antiemetics|mesh-ancestor
101981965|NCT01149577|Autonomic Agents|autonomic agents|mesh-ancestor
101981966|NCT01149577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101981967|NCT01149577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981968|NCT01149577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101981969|NCT01149577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101981970|NCT01149577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101981971|NCT01149577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101981972|NCT01149577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101981973|NCT01149577|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101981974|NCT01149577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101981975|NCT01149577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101981976|NCT01149577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981977|NCT01149577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101981978|NCT01149577|Serotonin Agents|serotonin agents|mesh-ancestor
101981979|NCT03894007|Maytansine|maytansine|mesh-list
101981980|NCT03894007|Docetaxel|docetaxel|mesh-list
101981981|NCT03894007|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101946790|NCT04745780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946791|NCT02833948|Aspirin|aspirin|mesh-list
101946792|NCT02833948|Rivaroxaban|rivaroxaban|mesh-list
101946793|NCT02833948|Clopidogrel|clopidogrel|mesh-list
101981982|NCT03894007|Cyclophosphamide|cyclophosphamide|mesh-list
101981983|NCT03894007|Carboplatin|carboplatin|mesh-list
101981986|NCT03894007|Epirubicin|epirubicin|mesh-list
101981987|NCT03894007|Pertuzumab|pertuzumab|mesh-list
101981988|NCT03894007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101981989|NCT03894007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101981990|NCT03894007|Tubulin Modulators|tubulin modulators|mesh-ancestor
101981991|NCT03894007|Antimitotic Agents|antimitotic agents|mesh-ancestor
101981992|NCT03894007|Mitosis Modulators|mitosis modulators|mesh-ancestor
101981993|NCT03894007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981994|NCT03894007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101981995|NCT03894007|Immunologic Factors|immunologic factors|mesh-ancestor
101981996|NCT03894007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981997|NCT03894007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101981998|NCT03894007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101981999|NCT03894007|Alkylating Agents|alkylating agents|mesh-ancestor
101982000|NCT03894007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101982001|NCT03894007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101982002|NCT03894007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101982003|NCT03894007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101982004|NCT03894007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101982005|NCT03894007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101982006|NCT03894007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101982007|NCT03894007|Immunotoxins|immunotoxins|mesh-ancestor
101982008|NCT03894007|Immunoconjugates|immunoconjugates|mesh-ancestor
101982009|NCT01150747|Azithromycin|azithromycin|mesh-list
101982010|NCT01150747|Ceftriaxone|ceftriaxone|mesh-list
101982011|NCT01150747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101982012|NCT01150747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101982013|NCT03893695|Nivolumab|nivolumab|mesh-list
101982014|NCT03893695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101982015|NCT03893695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101982016|NCT03893695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101982017|NCT03893695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982018|NCT01258309|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
101982019|NCT01258309|Ketorolac|ketorolac|mesh-list
101982020|NCT01258309|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101982021|NCT01258309|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101982022|NCT01258309|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101982023|NCT01258309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101982024|NCT01258309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101982025|NCT01258309|Analgesics|analgesics|mesh-ancestor
101982026|NCT01258309|Sensory System Agents|sensory system agents|mesh-ancestor
101982027|NCT01258309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101982028|NCT01258309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982029|NCT01258309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101982030|NCT01258309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101982031|NCT01258309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101982032|NCT01258309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101982033|NCT01258309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982034|NCT01258309|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101982035|NCT01258309|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101982036|NCT01258309|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101982037|NCT01258309|Histamine Antagonists|histamine antagonists|mesh-ancestor
101982038|NCT01258309|Histamine Agents|histamine agents|mesh-ancestor
101982039|NCT01258309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101982040|NCT01256905|Modafinil|modafinil|mesh-list
101982041|NCT01256905|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101982042|NCT01256905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982043|NCT01256905|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101982044|NCT01256905|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101982045|NCT01256905|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101982046|NCT01256905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982047|NCT01586299|Acetaminophen|acetaminophen|mesh-list
101982048|NCT01586299|Ibuprofen|ibuprofen|mesh-list
101982049|NCT01586299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101946794|NCT02833948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101946795|NCT02833948|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101946796|NCT02833948|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101946797|NCT02833948|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101946798|NCT02833948|Purinergic Agents|purinergic agents|mesh-ancestor
101946799|NCT02833948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101946800|NCT02833948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946801|NCT02833948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946802|NCT02833948|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101946803|NCT02833948|Antithrombins|antithrombins|mesh-ancestor
101982050|NCT01586299|Analgesics|analgesics|mesh-ancestor
101982051|NCT01586299|Sensory System Agents|sensory system agents|mesh-ancestor
101982052|NCT01586299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101982053|NCT01586299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982054|NCT01586299|Antipyretics|antipyretics|mesh-ancestor
101982055|NCT01586299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101982056|NCT01586299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101982059|NCT01586299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101982060|NCT01586299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982061|NCT02874794|Valsartan|valsartan|mesh-list
101982062|NCT02874794|Enalapril|enalapril|mesh-list
101982063|NCT02874794|Enalaprilat|enalaprilat|mesh-list
101982064|NCT02874794|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101982065|NCT02874794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101982066|NCT02874794|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101982067|NCT02874794|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101982068|NCT02874794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982069|NCT02874794|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101982070|NCT02874794|Protease Inhibitors|protease inhibitors|mesh-ancestor
101982071|NCT02874794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101982072|NCT03102710|Lidocaine|lidocaine|mesh-list
101982073|NCT03102710|Capsaicin|capsaicin|mesh-list
101982074|NCT03102710|Anesthetics, Local|anesthetics, local|mesh-ancestor
101982075|NCT03102710|Anesthetics|anesthetics|mesh-ancestor
101982076|NCT03102710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101982077|NCT03102710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982078|NCT03102710|Sensory System Agents|sensory system agents|mesh-ancestor
101982079|NCT03102710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101982080|NCT03102710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101982081|NCT03102710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101982082|NCT03102710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101982083|NCT03102710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101982084|NCT03102710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982085|NCT03102710|Antipruritics|antipruritics|mesh-ancestor
101982086|NCT03102710|Dermatologic Agents|dermatologic agents|mesh-ancestor
101982087|NCT01149967|Dexetimide|dexetimide|mesh-list
101982088|NCT01149967|Citalopram|citalopram|mesh-list
101982089|NCT01149967|Escitalopram|escitalopram|mesh-list
101982090|NCT01149967|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101982091|NCT01149967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101982092|NCT01149967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101982093|NCT01149967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982094|NCT01149967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101982095|NCT01149967|Serotonin Agents|serotonin agents|mesh-ancestor
101982096|NCT01149967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982097|NCT01149967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101982098|NCT01149967|Antidepressive Agents|antidepressive agents|mesh-ancestor
101982099|NCT01149967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101982100|NCT01149967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101982101|NCT01149967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101982102|NCT01149967|Parasympatholytics|parasympatholytics|mesh-ancestor
101946804|NCT02833948|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101946805|NCT02833948|Protease Inhibitors|protease inhibitors|mesh-ancestor
101808757|NCT00982722|Vitamins|vitamins|mesh-ancestor
101982103|NCT01149967|Autonomic Agents|autonomic agents|mesh-ancestor
101982104|NCT01149967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101982105|NCT01149967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101982106|NCT01149967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101982107|NCT01149967|Cholinergic Agents|cholinergic agents|mesh-ancestor
101982108|NCT05505409|Pirfenidone|pirfenidone|mesh-list
101982109|NCT05505409|Glucocorticoids|glucocorticoids|mesh-list
101982110|NCT05505409|Immunosuppressive Agents|immunosuppressive agents|mesh-list
101982111|NCT05505409|Hormones|hormones|mesh-ancestor
101982112|NCT05505409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101982113|NCT05505409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982114|NCT05505409|Analgesics|analgesics|mesh-ancestor
101982115|NCT05505409|Sensory System Agents|sensory system agents|mesh-ancestor
101982116|NCT05505409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101982117|NCT05505409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101982118|NCT05505409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101982119|NCT05505409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101982120|NCT05505409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101982121|NCT05505409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101982122|NCT05505409|Immunologic Factors|immunologic factors|mesh-ancestor
101982123|NCT04770740|Vitamin K|vitamin k|mesh-list
101982124|NCT04770740|Vitamin K 2|vitamin k 2|mesh-list
101982125|NCT04770740|Menaquinone 7|menaquinone 7|mesh-list
101982126|NCT04770740|Vitamins|vitamins|mesh-ancestor
101982127|NCT04770740|Micronutrients|micronutrients|mesh-ancestor
101982128|NCT04770740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982149|NCT01258777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101982150|NCT01258777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101982151|NCT01258777|Immunologic Factors|immunologic factors|mesh-ancestor
101982152|NCT01258777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982153|NCT03896893|Emollients|emollients|mesh-list
101982154|NCT03896893|Dermatologic Agents|dermatologic agents|mesh-ancestor
101982155|NCT01257373|Cobalt|cobalt|mesh-list
101982156|NCT01257373|Chromium|chromium|mesh-list
101982157|NCT01257373|Sirolimus|sirolimus|mesh-list
101982158|NCT01257373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101982159|NCT01257373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101982160|NCT01257373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101982161|NCT01257373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101982162|NCT01257373|Antifungal Agents|antifungal agents|mesh-ancestor
101711002|NCT00698724|Antiemetics|antiemetics|mesh-ancestor
101982163|NCT01257373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101982164|NCT01257373|Immunologic Factors|immunologic factors|mesh-ancestor
101982165|NCT01257373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982166|NCT01257373|Trace Elements|trace elements|mesh-ancestor
101982167|NCT01257373|Micronutrients|micronutrients|mesh-ancestor
101982168|NCT03899233|Tranexamic Acid|tranexamic acid|mesh-list
101982169|NCT03899233|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101982170|NCT03899233|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101982171|NCT03899233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982172|NCT03899233|Hemostatics|hemostatics|mesh-ancestor
101982173|NCT03899233|Coagulants|coagulants|mesh-ancestor
101982174|NCT03101150|Vitamin D|vitamin d|mesh-list
101982175|NCT03101150|Ergocalciferols|ergocalciferols|mesh-list
101982176|NCT03101150|Cholecalciferol|cholecalciferol|mesh-list
101982177|NCT03101150|Vitamins|vitamins|mesh-list
101982178|NCT03101150|Micronutrients|micronutrients|mesh-ancestor
101982179|NCT03101150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982180|NCT03101150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101982181|NCT03101150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101982182|NCT03899077|Goserelin|goserelin|mesh-list
101437223|NCT00176280|Antiemetics|antiemetics|mesh-ancestor
101982185|NCT03899077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101982186|NCT03899077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101982187|NCT03899077|Luteolytic Agents|luteolytic agents|mesh-ancestor
101982188|NCT03899077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101982189|NCT03899077|Contraceptive Agents|contraceptive agents|mesh-ancestor
101982190|NCT03899077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101982191|NCT03899077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982192|NCT03899077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101982193|NCT03899077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101982195|NCT01255579|Fluticasone|fluticasone|mesh-list
101982196|NCT01255579|Beclomethasone|beclomethasone|mesh-list
101982197|NCT01255579|Formoterol Fumarate|formoterol fumarate|mesh-list
101946806|NCT02833948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101946807|NCT02833948|Anticoagulants|anticoagulants|mesh-ancestor
101946808|NCT02833948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101808832|NCT00977964|Caseins|caseins|mesh-list
101982198|NCT01255579|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101982199|NCT01255579|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101982200|NCT01255579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101982201|NCT01255579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101982202|NCT01255579|Autonomic Agents|autonomic agents|mesh-ancestor
101982203|NCT01255579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101982204|NCT01255579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982205|NCT01255579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101982206|NCT01255579|Respiratory System Agents|respiratory system agents|mesh-ancestor
101982207|NCT01255579|Dermatologic Agents|dermatologic agents|mesh-ancestor
101982208|NCT01255579|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101982209|NCT01255579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101982210|NCT01255579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101982211|NCT01255579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101982212|NCT01255579|Adrenergic Agents|adrenergic agents|mesh-ancestor
101982213|NCT01255579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101982214|NCT01255579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982215|NCT01255579|Glucocorticoids|glucocorticoids|mesh-ancestor
101982216|NCT01255579|Hormones|hormones|mesh-ancestor
101982217|NCT01255579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101574996|NCT02753647|Mitosis Modulators|mitosis modulators|mesh-ancestor
101982218|NCT01255579|Sympathomimetics|sympathomimetics|mesh-ancestor
101982219|NCT03101930|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101982220|NCT03101930|Liraglutide|liraglutide|mesh-list
101982221|NCT03101930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101982222|NCT03101930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982224|NCT03101930|Hormones|hormones|mesh-ancestor
101982225|NCT03101930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101982226|NCT03101930|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101982227|NCT03101930|Protease Inhibitors|protease inhibitors|mesh-ancestor
101982228|NCT03101930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101982229|NCT03101930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982230|NCT04239950|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
101982231|NCT04239950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101982232|NCT04239950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101982233|NCT05415254|Calcitriol|calcitriol|mesh-list
101982234|NCT05415254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101982235|NCT05415254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982236|NCT05415254|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101982237|NCT05415254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101982238|NCT05415254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982239|NCT05415254|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101982240|NCT05415254|Vitamins|vitamins|mesh-ancestor
101982241|NCT05415254|Micronutrients|micronutrients|mesh-ancestor
101982242|NCT05415254|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101982243|NCT01150201|Losartan|losartan|mesh-list
101982244|NCT01150201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101982245|NCT01150201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101982246|NCT01150201|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101982247|NCT01150201|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101982248|NCT01150201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982249|NCT01257451|Vildagliptin|vildagliptin|mesh-list
101982250|NCT01257451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101982251|NCT01257451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982252|NCT01257451|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101982253|NCT01257451|Protease Inhibitors|protease inhibitors|mesh-ancestor
101982257|NCT01257529|Analgesics|analgesics|mesh-ancestor
101982258|NCT01257529|Sensory System Agents|sensory system agents|mesh-ancestor
101982259|NCT01257529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101982260|NCT01257529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982261|NCT01257529|Anticonvulsants|anticonvulsants|mesh-ancestor
101982262|NCT01257529|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101982263|NCT01257529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101982264|NCT01257529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946810|NCT02833948|Analgesics|analgesics|mesh-ancestor
101982265|NCT01257529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101982266|NCT01257529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101982267|NCT01257529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101982268|NCT01257529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101982269|NCT01257529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101982270|NCT03896113|Celecoxib|celecoxib|mesh-list
101982271|NCT03896113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101982272|NCT03896113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101982273|NCT03896113|Analgesics|analgesics|mesh-ancestor
101982274|NCT03896113|Sensory System Agents|sensory system agents|mesh-ancestor
101982275|NCT03896113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101982276|NCT03896113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982277|NCT03896113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101982278|NCT03896113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101982279|NCT03896113|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101982280|NCT03896113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101982281|NCT03896113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101982282|NCT03896113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982283|NCT03100838|Nifedipine|nifedipine|mesh-list
101982284|NCT03100838|Omeprazole|omeprazole|mesh-list
101982285|NCT03100838|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
101982286|NCT03100838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101982287|NCT03100838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101982288|NCT03100838|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101982289|NCT03100838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101982290|NCT03100838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982291|NCT03100838|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101982292|NCT03100838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101982293|NCT03100838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101982294|NCT03100838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982295|NCT03100838|Vasodilator Agents|vasodilator agents|mesh-ancestor
101982296|NCT03100838|Tocolytic Agents|tocolytic agents|mesh-ancestor
101982297|NCT03100838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101982298|NCT01260025|Endostatins|endostatins|mesh-list
101982299|NCT01260025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101982300|NCT01260025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101982301|NCT01260025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101982302|NCT01260025|Growth Substances|growth substances|mesh-ancestor
101982303|NCT01260025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982304|NCT01260025|Growth Inhibitors|growth inhibitors|mesh-ancestor
101982305|NCT03984578|Pembrolizumab|pembrolizumab|mesh-list
101982306|NCT03984578|Capecitabine|capecitabine|mesh-list
101982307|NCT03984578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101982308|NCT03984578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101982309|NCT03984578|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101982310|NCT03984578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982311|NCT03984578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101982312|NCT03984578|Antimetabolites|antimetabolites|mesh-ancestor
101982313|NCT03892525|Atezolizumab|atezolizumab|mesh-list
101982314|NCT03892525|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101982315|NCT03892525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982316|NCT03892525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101982317|NCT03892525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101982318|NCT05418452|Metformin|metformin|mesh-list
101982319|NCT05418452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101982320|NCT05418452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982321|NCT01260103|Temozolomide|temozolomide|mesh-list
101982322|NCT01260103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101982323|NCT01260103|Alkylating Agents|alkylating agents|mesh-ancestor
101982327|NCT03480750|Doxorubicin|doxorubicin|mesh-list
101982328|NCT03480750|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101982329|NCT03480750|Trientine|trientine|mesh-list
101982330|NCT03480750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101982331|NCT03480750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101982332|NCT03480750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101982333|NCT03480750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101982334|NCT03480750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101982335|NCT03480750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982336|NCT03480750|Chelating Agents|chelating agents|mesh-ancestor
101982337|NCT03480750|Sequestering Agents|sequestering agents|mesh-ancestor
101946811|NCT02833948|Sensory System Agents|sensory system agents|mesh-ancestor
101946812|NCT02833948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101946813|NCT02833948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101946814|NCT02833948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101946815|NCT02833948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101946816|NCT02833948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101946817|NCT02833948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101946818|NCT02833948|Antipyretics|antipyretics|mesh-ancestor
101982338|NCT03892447|Ferulic acid|ferulic acid|mesh-list
101982339|NCT03892447|Dopamine|dopamine|mesh-list
101982340|NCT03892447|Alprostadil|alprostadil|mesh-list
101982341|NCT03892447|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101982342|NCT03892447|Sympathomimetics|sympathomimetics|mesh-ancestor
101982343|NCT03892447|Autonomic Agents|autonomic agents|mesh-ancestor
101982344|NCT03892447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101982345|NCT03892447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982346|NCT03892447|Dopamine Agents|dopamine agents|mesh-ancestor
101982347|NCT03892447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101982348|NCT03892447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982349|NCT03892447|Protective Agents|protective agents|mesh-ancestor
101982350|NCT03892447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101982351|NCT03892447|Vasodilator Agents|vasodilator agents|mesh-ancestor
101982352|NCT03892447|Urological Agents|urological agents|mesh-ancestor
101982353|NCT03892447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101982354|NCT03892447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101982355|NCT03892447|Analgesics|analgesics|mesh-ancestor
101982356|NCT03892447|Sensory System Agents|sensory system agents|mesh-ancestor
101982357|NCT03892447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101982358|NCT03892447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101982359|NCT03892447|Anticoagulants|anticoagulants|mesh-ancestor
101982360|NCT03892447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101982361|NCT03892447|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101982362|NCT03892447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101982363|NCT03892447|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101982364|NCT03892447|Antioxidants|antioxidants|mesh-ancestor
101982365|NCT03716700|Immunoglobulins|immunoglobulins|mesh-list
101982366|NCT03716700|gamma-Globulins|gamma-globulins|mesh-list
101982367|NCT03716700|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101982368|NCT03716700|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101982369|NCT03716700|Immunologic Factors|immunologic factors|mesh-ancestor
101982370|NCT03716700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982371|NCT05250596|Colchicine|colchicine|mesh-list
101982372|NCT05250596|Atorvastatin|atorvastatin|mesh-list
101982373|NCT05250596|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101982374|NCT05250596|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101982375|NCT05250596|Antimetabolites|antimetabolites|mesh-ancestor
101982376|NCT05250596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982377|NCT05250596|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101982378|NCT05250596|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101982379|NCT05250596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101982380|NCT05250596|Gout Suppressants|gout suppressants|mesh-ancestor
101982381|NCT05250596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101982382|NCT05250596|Tubulin Modulators|tubulin modulators|mesh-ancestor
101982383|NCT05250596|Antimitotic Agents|antimitotic agents|mesh-ancestor
101982384|NCT05250596|Mitosis Modulators|mitosis modulators|mesh-ancestor
101982385|NCT05250596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101982386|NCT04788914|Charcoal|charcoal|mesh-list
101982387|NCT04788914|Antidotes|antidotes|mesh-ancestor
101982388|NCT04788914|Protective Agents|protective agents|mesh-ancestor
101982389|NCT04788914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982390|NCT03716622|Clarithromycin|clarithromycin|mesh-list
101982391|NCT03716622|Furazolidone|furazolidone|mesh-list
101982392|NCT03716622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101982393|NCT03716622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101982394|NCT03716622|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101982395|NCT03716622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101982396|NCT03716622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982397|NCT03716622|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101982401|NCT03716622|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
101946819|NCT02527005|Azithromycin|azithromycin|mesh-list
101946820|NCT02527005|Pyrimethamine|pyrimethamine|mesh-list
101666639|NCT02754882|Paclitaxel|paclitaxel|mesh-list
101946821|NCT02527005|Sulfadoxine|sulfadoxine|mesh-list
101946822|NCT02527005|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101946823|NCT02527005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101946824|NCT02527005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101946825|NCT02527005|Antimalarials|antimalarials|mesh-ancestor
101982403|NCT03716622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101982404|NCT03716622|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101982405|NCT03892213|Benzonidazole|benzonidazole|mesh-list
101982406|NCT03892213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101982407|NCT03892213|Immunologic Factors|immunologic factors|mesh-ancestor
101982408|NCT03892213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982409|NCT03892213|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101982410|NCT03892213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101982411|NCT03892213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101982412|NCT03892213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101982413|NCT03412734|Chlorhexidine|chlorhexidine|mesh-list
101982414|NCT03412734|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101982415|NCT03412734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101982416|NCT03412734|Disinfectants|disinfectants|mesh-ancestor
101982417|NCT04881032|Temozolomide|temozolomide|mesh-list
101982418|NCT04881032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101982419|NCT04881032|Alkylating Agents|alkylating agents|mesh-ancestor
101982420|NCT04881032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982421|NCT04881032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101982422|NCT03891979|Metronidazole|metronidazole|mesh-list
101982423|NCT03891979|Ciprofloxacin|ciprofloxacin|mesh-list
101982424|NCT03891979|Pembrolizumab|pembrolizumab|mesh-list
101982425|NCT03891979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101982426|NCT03891979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101982427|NCT03891979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101982428|NCT03891979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982429|NCT03891979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101982430|NCT03891979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101982431|NCT03891979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101982432|NCT03891979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101982433|NCT03891979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101982434|NCT03891979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101982435|NCT03891979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101982436|NCT03891979|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101982437|NCT03891979|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101982438|NCT01260415|Oxaliplatin|oxaliplatin|mesh-list
101982439|NCT01260415|Panitumumab|panitumumab|mesh-list
101982440|NCT01260415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101982441|NCT01260415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101982442|NCT04608344|Atorvastatin|atorvastatin|mesh-list
101574997|NCT02872389|Sevoflurane|sevoflurane|mesh-list
101982443|NCT04608344|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101982444|NCT04608344|Pravastatin|pravastatin|mesh-list
101982445|NCT04608344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101982446|NCT04608344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101982447|NCT04608344|Antimetabolites|antimetabolites|mesh-ancestor
101982448|NCT04608344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982449|NCT04608344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101982450|NCT04608344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101982451|NCT04608344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101982452|NCT03891433|Meropenem|meropenem|mesh-list
101982453|NCT03891433|Tazobactam|tazobactam|mesh-list
101982454|NCT03891433|Piperacillin|piperacillin|mesh-list
101982455|NCT03891433|Ertapenem|ertapenem|mesh-list
101982456|NCT03891433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101982457|NCT03891433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101982458|NCT03891433|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101982459|NCT03891433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101982460|NCT03891433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982461|NCT03895411|Sotalol|sotalol|mesh-list
101982462|NCT03895411|Propafenone|propafenone|mesh-list
101982463|NCT03895411|Metoprolol|metoprolol|mesh-list
101946826|NCT02527005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101946827|NCT02527005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101946828|NCT02527005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101946829|NCT02527005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101946830|NCT02527005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946831|NCT02527005|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101946832|NCT01267695|Imatinib Mesylate|imatinib mesylate|mesh-list
101946833|NCT01267695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101946834|NCT01267695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101946835|NCT01267695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101946836|NCT01267695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946838|NCT02404688|Dronabinol|dronabinol|mesh-list
101946839|NCT02404688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101946840|NCT02404688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101946841|NCT02404688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101946842|NCT02404688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946843|NCT02404688|Hallucinogens|hallucinogens|mesh-ancestor
101982464|NCT03895411|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101982465|NCT03895411|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101982466|NCT03895411|Adrenergic Agents|adrenergic agents|mesh-ancestor
101982467|NCT03895411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101982468|NCT03895411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982476|NCT03895411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101982477|NCT03895411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101982478|NCT03895411|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101982479|NCT01259323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101982480|NCT01259323|Immunologic Factors|immunologic factors|mesh-ancestor
101982481|NCT01259323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982482|NCT03891277|Ferrous succinate|ferrous succinate|mesh-list
101982483|NCT03891277|Hematinics|hematinics|mesh-ancestor
101982484|NCT03888157|Liraglutide|liraglutide|mesh-list
101982485|NCT03888157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101982486|NCT03888157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982487|NCT03888157|Incretins|incretins|mesh-ancestor
101982488|NCT03888157|Hormones|hormones|mesh-ancestor
101982489|NCT03888157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101982490|NCT01154491|Epoetin Alfa|epoetin alfa|mesh-list
101982491|NCT01154491|Hematinics|hematinics|mesh-ancestor
101982492|NCT01260571|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101982493|NCT01260571|Dermatologic Agents|dermatologic agents|mesh-ancestor
101982494|NCT02527603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101982495|NCT02527603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101982496|NCT02527603|Analgesics|analgesics|mesh-ancestor
101982497|NCT02527603|Sensory System Agents|sensory system agents|mesh-ancestor
101982498|NCT02527603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101982499|NCT02527603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982500|NCT02527603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101982501|NCT02527603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101982502|NCT01259479|Satraplatin|satraplatin|mesh-list
101982503|NCT01259479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101982504|NCT01260727|Vaccines|vaccines|mesh-list
101982505|NCT01260727|Immunologic Factors|immunologic factors|mesh-ancestor
101982506|NCT01260727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982507|NCT03890809|Deucravacitinib|deucravacitinib|mesh-list
101982508|NCT03890809|Dermatologic Agents|dermatologic agents|mesh-ancestor
101982509|NCT03890809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101946844|NCT02404688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101946845|NCT02404688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101946846|NCT02404688|Analgesics|analgesics|mesh-ancestor
101946847|NCT02404688|Sensory System Agents|sensory system agents|mesh-ancestor
101946848|NCT02404688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101982510|NCT03890809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101982511|NCT03890809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982512|NCT03891121|Botulinum Toxins|botulinum toxins|mesh-list
101982513|NCT03891121|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101982514|NCT03891121|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101982515|NCT03891121|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101982516|NCT03891121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101982517|NCT03891121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982518|NCT03891121|Cholinergic Agents|cholinergic agents|mesh-ancestor
101982519|NCT03891121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101982520|NCT03891121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982521|NCT03891121|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101982522|NCT03891121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101982523|NCT01154569|Azithromycin|azithromycin|mesh-list
101982524|NCT01154569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101982525|NCT01154569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101982526|NCT03891043|Selenium|selenium|mesh-list
101982527|NCT03891043|Antioxidants|antioxidants|mesh-ancestor
101982528|NCT03891043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982529|NCT03891043|Protective Agents|protective agents|mesh-ancestor
101982530|NCT03891043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982531|NCT03891043|Trace Elements|trace elements|mesh-ancestor
101982532|NCT03891043|Micronutrients|micronutrients|mesh-ancestor
101982533|NCT03890341|Drospirenone|drospirenone|mesh-list
101982534|NCT03890341|Midazolam|midazolam|mesh-list
101982535|NCT03890341|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101982536|NCT03890341|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
101982540|NCT03890341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101982541|NCT03890341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982542|NCT03890341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101982543|NCT03890341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101982544|NCT03890341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101982545|NCT03890341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101982546|NCT03890341|Anesthetics, General|anesthetics, general|mesh-ancestor
101982547|NCT03890341|Anesthetics|anesthetics|mesh-ancestor
101982548|NCT03890341|GABA Modulators|gaba modulators|mesh-ancestor
101982549|NCT03890341|GABA Agents|gaba agents|mesh-ancestor
101982550|NCT03890341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101982551|NCT03890341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982552|NCT03890341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101982553|NCT03890341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101982554|NCT03890341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101982555|NCT03890341|Contraceptive Agents|contraceptive agents|mesh-ancestor
101982556|NCT03890341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101982557|NCT03890341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101982558|NCT03890341|Estrogens|estrogens|mesh-ancestor
101982559|NCT03890341|Hormones|hormones|mesh-ancestor
101982560|NCT03890341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101982561|NCT03890341|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101982562|NCT03890341|Hormone Antagonists|hormone antagonists|mesh-ancestor
101982563|NCT03890341|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101982564|NCT03890341|Diuretics|diuretics|mesh-ancestor
101982565|NCT03890341|Natriuretic Agents|natriuretic agents|mesh-ancestor
101982566|NCT03890341|Sequestering Agents|sequestering agents|mesh-ancestor
101982567|NCT01259557|Botulinum Toxins|botulinum toxins|mesh-list
101982568|NCT01259557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101982569|NCT01259557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101982570|NCT01259557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101982571|NCT01259557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101982572|NCT01259557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982573|NCT01259557|Cholinergic Agents|cholinergic agents|mesh-ancestor
101982574|NCT01259557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101982575|NCT01259557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982576|NCT01259557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101946849|NCT02404688|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101946850|NCT02404688|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101946851|NCT02404688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101946852|NCT02404688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946853|NCT02404688|Hormones|hormones|mesh-ancestor
101946854|NCT02404688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101946855|NCT04704518|Hyaluronic Acid|hyaluronic acid|mesh-list
101946856|NCT04704518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101946857|NCT04704518|Immunologic Factors|immunologic factors|mesh-ancestor
101946858|NCT04704518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946859|NCT04704518|Viscosupplements|viscosupplements|mesh-ancestor
101809227|NCT00091819|Vancomycin|vancomycin|mesh-list
101982577|NCT01259557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101982578|NCT03894085|Paroxetine|paroxetine|mesh-list
101982579|NCT03894085|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101982580|NCT03894085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101982581|NCT03894085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101982582|NCT03894085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982583|NCT03894085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101982584|NCT03894085|Serotonin Agents|serotonin agents|mesh-ancestor
101982585|NCT03894085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982586|NCT03894085|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101982587|NCT03894085|Antidepressive Agents|antidepressive agents|mesh-ancestor
101982588|NCT03894085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101982589|NCT03894085|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101982590|NCT03894085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101982591|NCT03894085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101982592|NCT01152931|Vitamins|vitamins|mesh-list
101982593|NCT01152931|Vitamin E|vitamin e|mesh-list
101982594|NCT01152931|Tocopherols|tocopherols|mesh-list
101982596|NCT01152931|alpha-Tocopherol|alpha-tocopherol|mesh-list
101982597|NCT01152931|Vitamin A|vitamin a|mesh-list
101982598|NCT01152931|Zinc|zinc|mesh-list
101982599|NCT01152931|Selenium|selenium|mesh-list
101982600|NCT01152931|Artesunate|artesunate|mesh-list
101982601|NCT01152931|Lumefantrine|lumefantrine|mesh-list
101982602|NCT01152931|Artemether|artemether|mesh-list
101982603|NCT01152931|Amodiaquine|amodiaquine|mesh-list
101982604|NCT01152931|Retinol palmitate|retinol palmitate|mesh-list
101982605|NCT01152931|Micronutrients|micronutrients|mesh-ancestor
101982606|NCT01152931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982607|NCT01152931|Trace Elements|trace elements|mesh-ancestor
101982608|NCT01152931|Antioxidants|antioxidants|mesh-ancestor
101982609|NCT01152931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982610|NCT01152931|Protective Agents|protective agents|mesh-ancestor
101982611|NCT01152931|Antimalarials|antimalarials|mesh-ancestor
101982618|NCT01152931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101982619|NCT01152931|Anthelmintics|anthelmintics|mesh-ancestor
101982620|NCT01152931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101982621|NCT01261117|Ibuprofen|ibuprofen|mesh-list
101982622|NCT01261117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101982623|NCT01261117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101982624|NCT01261117|Analgesics|analgesics|mesh-ancestor
101982625|NCT01261117|Sensory System Agents|sensory system agents|mesh-ancestor
101982626|NCT01261117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101982627|NCT01261117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982628|NCT01261117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101982629|NCT01261117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101982630|NCT01261117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101982631|NCT01261117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101982632|NCT01261117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982633|NCT03889717|Vitamin D|vitamin d|mesh-list
101982634|NCT03889717|Vitamins|vitamins|mesh-ancestor
101982635|NCT03889717|Micronutrients|micronutrients|mesh-ancestor
101946860|NCT04704518|Protective Agents|protective agents|mesh-ancestor
101946861|NCT02624102|Antidepressive Agents|antidepressive agents|mesh-list
101946862|NCT02624102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101946864|NCT01162941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101946865|NCT01162941|Glucocorticoids|glucocorticoids|mesh-ancestor
101946866|NCT01162941|Hormones|hormones|mesh-ancestor
101946867|NCT01162941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101946868|NCT01162941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946869|NCT01162941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101946870|NCT01162941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101946871|NCT00161044|Galantamine|galantamine|mesh-list
101946872|NCT00161044|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101809295|NCT05919550|Clozapine|clozapine|mesh-list
101982636|NCT03889717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982637|NCT03889717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101982638|NCT03885895|Tranexamic Acid|tranexamic acid|mesh-list
101982639|NCT03885895|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101982640|NCT03885895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101982641|NCT03885895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982642|NCT03885895|Hemostatics|hemostatics|mesh-ancestor
101982643|NCT03885895|Coagulants|coagulants|mesh-ancestor
101982644|NCT01154647|Citalopram|citalopram|mesh-list
101982645|NCT01154647|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101982646|NCT01154647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101982647|NCT01154647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101982648|NCT01154647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982649|NCT01154647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101982650|NCT01154647|Serotonin Agents|serotonin agents|mesh-ancestor
101982651|NCT01154647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982652|NCT01154647|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101982653|NCT01154647|Antidepressive Agents|antidepressive agents|mesh-ancestor
101982654|NCT01154647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101982655|NCT01153165|Citalopram|citalopram|mesh-list
101982656|NCT01153165|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101982657|NCT01153165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101982658|NCT01153165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101982659|NCT01153165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982660|NCT01153165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101982661|NCT01153165|Serotonin Agents|serotonin agents|mesh-ancestor
101982662|NCT01153165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982663|NCT01153165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101982664|NCT01153165|Antidepressive Agents|antidepressive agents|mesh-ancestor
101982665|NCT01153165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101982666|NCT01155505|Lenalidomide|lenalidomide|mesh-list
101982667|NCT01155505|Immunologic Factors|immunologic factors|mesh-ancestor
101982668|NCT01155505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982669|NCT01155505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101982670|NCT01155505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101982671|NCT01155505|Growth Substances|growth substances|mesh-ancestor
101982672|NCT01155505|Growth Inhibitors|growth inhibitors|mesh-ancestor
101982673|NCT01155505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101982674|NCT01153243|Vitamin D|vitamin d|mesh-list
101982675|NCT01153243|Ergocalciferols|ergocalciferols|mesh-list
101982676|NCT01153243|Vitamins|vitamins|mesh-ancestor
101982677|NCT01153243|Micronutrients|micronutrients|mesh-ancestor
101982678|NCT01153243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982679|NCT01153243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101437705|NCT00166478|Sulindac sulfone|sulindac sulfone|mesh-list
101982681|NCT03432858|Vancomycin|vancomycin|mesh-list
101982682|NCT03432858|Cefazolin|cefazolin|mesh-list
101946874|NCT00161044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946875|NCT00161044|Cholinergic Agents|cholinergic agents|mesh-ancestor
101946876|NCT00161044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101946877|NCT00161044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946878|NCT00161044|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101946879|NCT00161044|Autonomic Agents|autonomic agents|mesh-ancestor
101946880|NCT00161044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101946881|NCT00161044|Nootropic Agents|nootropic agents|mesh-ancestor
101946882|NCT01156779|Exenatide|exenatide|mesh-list
101946883|NCT01156779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101946884|NCT01156779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946885|NCT01156779|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101946886|NCT01156779|Incretins|incretins|mesh-ancestor
101946887|NCT01156779|Hormones|hormones|mesh-ancestor
101982683|NCT03432858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101982684|NCT03432858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101982685|NCT01154803|Micronutrients|micronutrients|mesh-list
101982686|NCT01154803|Trace Elements|trace elements|mesh-list
101982687|NCT01154803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982688|NCT03885427|Ketamine|ketamine|mesh-list
101982689|NCT03885427|Analgesics|analgesics|mesh-ancestor
101982690|NCT03885427|Sensory System Agents|sensory system agents|mesh-ancestor
101982691|NCT03885427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101982692|NCT03885427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982693|NCT03885427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101982694|NCT03885427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101982695|NCT03885427|Anesthetics, General|anesthetics, general|mesh-ancestor
101982696|NCT03885427|Anesthetics|anesthetics|mesh-ancestor
101982697|NCT03885427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101711097|NCT00621101|Sirolimus|sirolimus|mesh-list
101982698|NCT03885427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101982699|NCT03885427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101982700|NCT03885427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101982701|NCT03885427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982702|NCT03456960|Aspirin|aspirin|mesh-list
101982703|NCT03456960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101982704|NCT03456960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101982705|NCT03456960|Analgesics|analgesics|mesh-ancestor
101982706|NCT03456960|Sensory System Agents|sensory system agents|mesh-ancestor
101982707|NCT03456960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101982708|NCT03456960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982709|NCT03456960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101982710|NCT03456960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101982711|NCT03456960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101982712|NCT03456960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101982713|NCT03456960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982714|NCT03456960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101982715|NCT03456960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101982716|NCT03456960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101982717|NCT03456960|Antipyretics|antipyretics|mesh-ancestor
101982718|NCT03716388|Mesalamine|mesalamine|mesh-list
101982719|NCT03716388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101982720|NCT03716388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101982721|NCT03716388|Analgesics|analgesics|mesh-ancestor
101982722|NCT03716388|Sensory System Agents|sensory system agents|mesh-ancestor
101982723|NCT03716388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101982724|NCT03716388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982725|NCT03716388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101982726|NCT03716388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101982727|NCT01311336|Loratadine|loratadine|mesh-list
101946888|NCT01156779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101946889|NCT01156857|Ulipristal acetate|ulipristal acetate|mesh-list
101946890|NCT01156857|Progestins|progestins|mesh-list
101946891|NCT01156857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101946892|NCT01156857|Contraceptive Agents|contraceptive agents|mesh-ancestor
101946893|NCT01156857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101946894|NCT01156857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946895|NCT01156857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101946897|NCT01156857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101946898|NCT01269333|Fluvoxamine|fluvoxamine|mesh-list
101946899|NCT01269333|Omeprazole|omeprazole|mesh-list
101946900|NCT01269333|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101946901|NCT01269333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101946902|NCT01269333|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101946903|NCT01269333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101946904|NCT01269333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946905|NCT01269333|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101809422|NCT05918211|Udenafil|udenafil|mesh-list
101982728|NCT01311336|Antipruritics|antipruritics|mesh-ancestor
101982729|NCT01311336|Dermatologic Agents|dermatologic agents|mesh-ancestor
101982730|NCT01311336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101982731|NCT01311336|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101982732|NCT01311336|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101982733|NCT01311336|Histamine Antagonists|histamine antagonists|mesh-ancestor
101982734|NCT01311336|Histamine Agents|histamine agents|mesh-ancestor
101982735|NCT01311336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101982736|NCT01311336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982737|NCT01311336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982738|NCT03430986|Lidocaine|lidocaine|mesh-list
101982739|NCT03430986|Anesthetics, Local|anesthetics, local|mesh-ancestor
101982740|NCT03430986|Anesthetics|anesthetics|mesh-ancestor
101982741|NCT03430986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101982742|NCT03430986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982743|NCT03430986|Sensory System Agents|sensory system agents|mesh-ancestor
101982744|NCT03430986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101711100|NCT00621101|Ezetimibe|ezetimibe|mesh-list
101702554|NCT02725541|Immunotoxins|immunotoxins|mesh-ancestor
101982745|NCT03430986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101982746|NCT03430986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101982747|NCT03430986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101982748|NCT03430986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101982749|NCT03430986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982750|NCT01261741|Memantine|memantine|mesh-list
101982751|NCT01261741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101982764|NCT01157455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101982766|NCT01157455|Analgesics|analgesics|mesh-ancestor
101982767|NCT01157455|Sensory System Agents|sensory system agents|mesh-ancestor
101982768|NCT01157455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101982769|NCT01157455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982770|NCT01157455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101982771|NCT01157455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101982772|NCT01157455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101982773|NCT01157455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101982774|NCT01157455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982775|NCT01157455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101982776|NCT01157455|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101946907|NCT01269333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101946908|NCT01269333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946909|NCT01269333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101946910|NCT01269333|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101946911|NCT01269333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101946912|NCT01269333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101946913|NCT01269333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101946914|NCT01269333|Serotonin Agents|serotonin agents|mesh-ancestor
101946915|NCT01269333|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101946916|NCT01269333|Antidepressive Agents|antidepressive agents|mesh-ancestor
101982777|NCT01157455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101982778|NCT01157455|Antipyretics|antipyretics|mesh-ancestor
101982779|NCT01157455|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101982780|NCT01157455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101982781|NCT01157455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101982782|NCT01157455|Immunologic Factors|immunologic factors|mesh-ancestor
101982783|NCT01157455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101982784|NCT01157455|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101982785|NCT01157455|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101982786|NCT01157455|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101982787|NCT01157455|Purinergic Agents|purinergic agents|mesh-ancestor
101982788|NCT01157455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101982789|NCT01157455|Anticoagulants|anticoagulants|mesh-ancestor
101982790|NCT01157455|Antithrombins|antithrombins|mesh-ancestor
101982791|NCT01157455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101982792|NCT01157455|Protease Inhibitors|protease inhibitors|mesh-ancestor
101982793|NCT03713892|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
101982794|NCT03713892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101982795|NCT03713892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982796|NCT03884881|Meropenem|meropenem|mesh-list
101982797|NCT03884881|Imipenem|imipenem|mesh-list
101982798|NCT03884881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101982799|NCT03884881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101982800|NCT01154881|Insulin|insulin|mesh-list
101982801|NCT01154881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101982802|NCT01154881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982803|NCT03886441|Beclomethasone|beclomethasone|mesh-list
101982804|NCT03886441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101982805|NCT03886441|Glucocorticoids|glucocorticoids|mesh-ancestor
101982806|NCT03886441|Hormones|hormones|mesh-ancestor
101982807|NCT03886441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101982808|NCT03886441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982809|NCT03886441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101982810|NCT03886441|Respiratory System Agents|respiratory system agents|mesh-ancestor
101982811|NCT03713346|Caseins|caseins|mesh-list
101982812|NCT03713346|Chelating Agents|chelating agents|mesh-ancestor
101982813|NCT03713346|Sequestering Agents|sequestering agents|mesh-ancestor
101982814|NCT03713346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982822|NCT01154959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101982823|NCT01154959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101982824|NCT01154959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101982825|NCT01154959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982826|NCT01154959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101982827|NCT01154959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101982828|NCT01154959|Antitubercular Agents|antitubercular agents|mesh-ancestor
101982829|NCT01154959|Leprostatic Agents|leprostatic agents|mesh-ancestor
101982830|NCT01154959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101982831|NCT01154959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101982832|NCT01154959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101982833|NCT01154959|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101946917|NCT01269333|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101946918|NCT01269333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101946919|NCT01269333|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101971942|NCT02083250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101809536|NCT05879107|Immunologic Factors|immunologic factors|mesh-ancestor
101982834|NCT01154959|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101982835|NCT01154959|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101982836|NCT01154959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101982837|NCT01154959|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101982838|NCT01154959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101982839|NCT01154959|Antimetabolites|antimetabolites|mesh-ancestor
101982840|NCT01154959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101982841|NCT03881293|Lidocaine|lidocaine|mesh-list
101982842|NCT03881293|Anesthetics, Local|anesthetics, local|mesh-ancestor
101982843|NCT03881293|Anesthetics|anesthetics|mesh-ancestor
101982844|NCT03881293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101982845|NCT03881293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982846|NCT03881293|Sensory System Agents|sensory system agents|mesh-ancestor
101982847|NCT03881293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101982848|NCT03881293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101982849|NCT03881293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101982850|NCT03881293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101982851|NCT03881293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101982852|NCT03881293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982853|NCT01155037|Vaccines|vaccines|mesh-list
101982854|NCT01155037|Immunologic Factors|immunologic factors|mesh-ancestor
101982855|NCT01155037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982856|NCT01261897|Ropivacaine|ropivacaine|mesh-list
101982857|NCT01261897|Anesthetics, Local|anesthetics, local|mesh-ancestor
101982858|NCT01261897|Anesthetics|anesthetics|mesh-ancestor
101982859|NCT01261897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101982860|NCT01261897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982861|NCT01261897|Sensory System Agents|sensory system agents|mesh-ancestor
101982862|NCT01261897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101982863|NCT03448536|Acetaminophen|acetaminophen|mesh-list
101982864|NCT03448536|Naproxen|naproxen|mesh-list
101982865|NCT03448536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101982866|NCT03448536|Analgesics|analgesics|mesh-ancestor
101982867|NCT03448536|Sensory System Agents|sensory system agents|mesh-ancestor
101982868|NCT03448536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101982869|NCT03448536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982870|NCT03448536|Antipyretics|antipyretics|mesh-ancestor
101982871|NCT03448536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101982872|NCT03448536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101982873|NCT03448536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101982874|NCT03448536|Gout Suppressants|gout suppressants|mesh-ancestor
101982875|NCT03448536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101982876|NCT03448536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101982877|NCT03448536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982878|NCT01155115|Nitric Oxide|nitric oxide|mesh-list
101982879|NCT01155115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101982880|NCT01155115|Autonomic Agents|autonomic agents|mesh-ancestor
101982881|NCT01155115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101437907|NCT00177567|Olanzapine|olanzapine|mesh-list
101982887|NCT01155115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982888|NCT01155115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101982889|NCT01155115|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101982890|NCT01155115|Vasodilator Agents|vasodilator agents|mesh-ancestor
101982892|NCT01155115|Protective Agents|protective agents|mesh-ancestor
101982893|NCT03713190|Empagliflozin|empagliflozin|mesh-list
101982894|NCT03713190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101982895|NCT03713190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982896|NCT03713190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101982897|NCT03713190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982899|NCT03718182|Vitamin D|vitamin d|mesh-list
101982900|NCT03718182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101982901|NCT03718182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946920|NCT01269411|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
101946921|NCT01269411|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101946922|NCT01269411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101982902|NCT03718182|Vitamins|vitamins|mesh-ancestor
101982903|NCT03718182|Micronutrients|micronutrients|mesh-ancestor
101982904|NCT03718182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101982905|NCT03881449|Aripiprazole|aripiprazole|mesh-list
101982906|NCT03881449|Antidepressive Agents|antidepressive agents|mesh-ancestor
101982907|NCT03881449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101982908|NCT03881449|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101982909|NCT03881449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101982910|NCT03881449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101982911|NCT03881449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982912|NCT03881449|Dopamine Agonists|dopamine agonists|mesh-ancestor
101982913|NCT03881449|Dopamine Agents|dopamine agents|mesh-ancestor
101982914|NCT03881449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101982915|NCT03881449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982916|NCT03881449|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101982917|NCT03881449|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101982918|NCT03881449|Serotonin Agents|serotonin agents|mesh-ancestor
101982919|NCT03881449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101982920|NCT03881449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101982921|NCT03881449|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101982922|NCT03881449|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101982923|NCT03884491|Vortioxetine|vortioxetine|mesh-list
101982924|NCT03884491|Antidepressive Agents|antidepressive agents|mesh-ancestor
101982925|NCT03884491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101982926|NCT03884491|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101982927|NCT03884491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101982928|NCT03884491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101982929|NCT03884491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982930|NCT03884491|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101982931|NCT03884491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101982932|NCT03884491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101982933|NCT03884491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982934|NCT03884491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101982935|NCT03884491|Serotonin Agents|serotonin agents|mesh-ancestor
101982936|NCT03884491|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101982937|NCT03884491|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101982938|NCT03884491|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101982939|NCT03884491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101982940|NCT03712956|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101982941|NCT03712956|Doxorubicin|doxorubicin|mesh-list
101982942|NCT03712956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101982943|NCT03712956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101982944|NCT03712956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101982945|NCT03712956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101982946|NCT03712956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101982947|NCT03712956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982948|NCT03880981|Acetaminophen|acetaminophen|mesh-list
101982949|NCT03880981|Ibuprofen|ibuprofen|mesh-list
101982966|NCT03424044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101702776|NCT00675246|Hormones|hormones|mesh-ancestor
101982967|NCT03424044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982968|NCT03424044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101982969|NCT03880903|Albuterol|albuterol|mesh-list
101982970|NCT03880903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101982971|NCT03880903|Autonomic Agents|autonomic agents|mesh-ancestor
101982972|NCT03880903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101982973|NCT03880903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982974|NCT03880903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101982975|NCT03880903|Respiratory System Agents|respiratory system agents|mesh-ancestor
101982976|NCT03880903|Tocolytic Agents|tocolytic agents|mesh-ancestor
101982977|NCT03880903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101982978|NCT03880903|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101982979|NCT03880903|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101982980|NCT03880903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101946923|NCT01269411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982981|NCT03880903|Adrenergic Agents|adrenergic agents|mesh-ancestor
101982982|NCT03880903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101982983|NCT03880903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982984|NCT01155895|Amlodipine|amlodipine|mesh-list
101982985|NCT01155895|Benazepril|benazepril|mesh-list
101982986|NCT01155895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101982987|NCT01155895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101982988|NCT01155895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101982989|NCT01155895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982990|NCT01155895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101982991|NCT01155895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982992|NCT01155895|Vasodilator Agents|vasodilator agents|mesh-ancestor
101982993|NCT01155895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101982994|NCT01155895|Protease Inhibitors|protease inhibitors|mesh-ancestor
101982995|NCT01155895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101982996|NCT01265641|Moxifloxacin|moxifloxacin|mesh-list
101982997|NCT01265641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101982998|NCT01265641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101982999|NCT01265641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101983000|NCT01265641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101983001|NCT01265641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101983002|NCT01265641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983003|NCT01265641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101983004|NCT01589809|Niacinamide|niacinamide|mesh-list
101983006|NCT01589809|Nicotinic Acids|nicotinic acids|mesh-list
101983007|NCT01589809|Vitamins|vitamins|mesh-ancestor
101983008|NCT01589809|Micronutrients|micronutrients|mesh-ancestor
101983012|NCT01589809|Antimetabolites|antimetabolites|mesh-ancestor
101983013|NCT01589809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983014|NCT01589809|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101983015|NCT01589809|Vasodilator Agents|vasodilator agents|mesh-ancestor
101983016|NCT01264237|Etoricoxib|etoricoxib|mesh-list
101983017|NCT01264237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101983018|NCT01264237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101983019|NCT01264237|Analgesics|analgesics|mesh-ancestor
101983020|NCT01264237|Sensory System Agents|sensory system agents|mesh-ancestor
101983021|NCT01264237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101983022|NCT01264237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983023|NCT01264237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101983024|NCT01264237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101983025|NCT01264237|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101983026|NCT01264237|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101983027|NCT01264237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101983028|NCT01264237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983029|NCT03880825|Metformin|metformin|mesh-list
101983030|NCT03880825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101983031|NCT03880825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983032|NCT01159639|Clopidogrel|clopidogrel|mesh-list
101983033|NCT01159639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101983034|NCT01159639|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101983035|NCT01159639|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101983036|NCT01159639|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101983037|NCT01159639|Purinergic Agents|purinergic agents|mesh-ancestor
101983038|NCT01159639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101983039|NCT01159639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983040|NCT01159639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983041|NCT03880357|Betamethasone|betamethasone|mesh-list
101983042|NCT03880357|Betamethasone Valerate|betamethasone valerate|mesh-list
101983043|NCT03880357|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101983044|NCT03880357|Betamethasone benzoate|betamethasone benzoate|mesh-list
101983045|NCT03880357|Calcipotriene|calcipotriene|mesh-list
101983046|NCT03880357|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101983047|NCT03880357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101983048|NCT03880357|Glucocorticoids|glucocorticoids|mesh-ancestor
101983050|NCT03880357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101983051|NCT03880357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983052|NCT03880357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101983053|NCT03880357|Respiratory System Agents|respiratory system agents|mesh-ancestor
101983054|NCT03880357|Dermatologic Agents|dermatologic agents|mesh-ancestor
101983055|NCT01266031|Bevacizumab|bevacizumab|mesh-list
101946924|NCT03882255|Propranolol|propranolol|mesh-list
101946925|NCT03882255|Ponesimod|ponesimod|mesh-list
101946926|NCT03882255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101946927|NCT03882255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101946928|NCT03882255|Adrenergic Agents|adrenergic agents|mesh-ancestor
101983056|NCT01266031|Vorinostat|vorinostat|mesh-list
101983057|NCT01266031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101983058|NCT01266031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101983059|NCT01266031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101983060|NCT01266031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101983061|NCT01266031|Growth Substances|growth substances|mesh-ancestor
101983062|NCT01266031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983063|NCT01266031|Growth Inhibitors|growth inhibitors|mesh-ancestor
101983064|NCT01266031|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101983065|NCT01266031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101983066|NCT01266031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983067|NCT03880045|Vasopressins|vasopressins|mesh-list
101983068|NCT03880045|Arginine Vasopressin|arginine vasopressin|mesh-list
101983069|NCT03880045|Hemostatics|hemostatics|mesh-ancestor
101983070|NCT03880045|Coagulants|coagulants|mesh-ancestor
101983071|NCT03880045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101983072|NCT03880045|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101983073|NCT03880045|Natriuretic Agents|natriuretic agents|mesh-ancestor
101983074|NCT03880045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983075|NCT03879889|Nicotine|nicotine|mesh-list
101983076|NCT03879889|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101983077|NCT03879889|Autonomic Agents|autonomic agents|mesh-ancestor
101983078|NCT03879889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101983079|NCT03879889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983080|NCT03879889|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101983084|NCT03879889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983085|NCT01266187|Leucovorin|leucovorin|mesh-list
101983086|NCT01266187|Cetuximab|cetuximab|mesh-list
101983087|NCT01266187|Fluorouracil|fluorouracil|mesh-list
101983088|NCT01266187|Oxaliplatin|oxaliplatin|mesh-list
101983089|NCT01266187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101983090|NCT01266187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101983091|NCT01266187|Antimetabolites|antimetabolites|mesh-ancestor
101983092|NCT01266187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983093|NCT01266187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101983094|NCT01266187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101983095|NCT01266187|Immunologic Factors|immunologic factors|mesh-ancestor
101983096|NCT01266187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983097|NCT01266187|Antidotes|antidotes|mesh-ancestor
101983098|NCT01266187|Protective Agents|protective agents|mesh-ancestor
101983099|NCT01266187|Vitamin B Complex|vitamin b complex|mesh-ancestor
101983100|NCT01266187|Vitamins|vitamins|mesh-ancestor
101983101|NCT01266187|Micronutrients|micronutrients|mesh-ancestor
101983102|NCT01586533|Mesalamine|mesalamine|mesh-list
101983103|NCT01586533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101983104|NCT01586533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101983105|NCT01586533|Analgesics|analgesics|mesh-ancestor
101983106|NCT01586533|Sensory System Agents|sensory system agents|mesh-ancestor
101983107|NCT01586533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101983108|NCT01586533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983109|NCT01586533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101983110|NCT01586533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101983111|NCT03880123|Ixazomib|ixazomib|mesh-list
101983112|NCT03880123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101983113|NCT03880123|Protease Inhibitors|protease inhibitors|mesh-ancestor
101983114|NCT03880123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101983115|NCT03880123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983116|NCT01266499|Colistin|colistin|mesh-list
101983117|NCT01266499|Polymyxins|polymyxins|mesh-list
101983118|NCT01266499|Gentamicins|gentamicins|mesh-list
101983119|NCT01266499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101983120|NCT01266499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101983121|NCT01266499|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101983122|NCT01266499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101983123|NCT01266499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983124|NCT00075725|Calcium, Dietary|calcium, dietary|mesh-list
101983125|NCT00075725|Leucovorin|leucovorin|mesh-list
101983126|NCT00075725|Folic Acid|folic acid|mesh-list
101983127|NCT00075725|Cytarabine|cytarabine|mesh-list
101946929|NCT03882255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101946930|NCT03882255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946931|NCT03882255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983128|NCT00075725|Dexamethasone|dexamethasone|mesh-list
101983129|NCT00075725|Dexamethasone acetate|dexamethasone acetate|mesh-list
101983130|NCT00075725|Prednisone|prednisone|mesh-list
101983131|NCT00075725|Cortisone|cortisone|mesh-list
101983132|NCT00075725|Cyclophosphamide|cyclophosphamide|mesh-list
101983133|NCT00075725|Doxorubicin|doxorubicin|mesh-list
101983134|NCT00075725|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101983135|NCT00075725|Methotrexate|methotrexate|mesh-list
101983136|NCT00075725|Vincristine|vincristine|mesh-list
101983137|NCT00075725|Daunorubicin|daunorubicin|mesh-list
101983138|NCT00075725|Asparaginase|asparaginase|mesh-list
101983139|NCT00075725|Mercaptopurine|mercaptopurine|mesh-list
101983140|NCT00075725|Pegaspargase|pegaspargase|mesh-list
101983141|NCT00075725|Thioguanine|thioguanine|mesh-list
101983142|NCT00075725|BB 1101|bb 1101|mesh-list
101983143|NCT00075725|Calcium|calcium|mesh-list
101983144|NCT00075725|2-Aminopurine|2-aminopurine|mesh-list
101983145|NCT00075725|Levoleucovorin|levoleucovorin|mesh-list
101983146|NCT00075725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101983147|NCT00075725|Immunologic Factors|immunologic factors|mesh-ancestor
101983148|NCT00075725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983149|NCT00075725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101983150|NCT00075725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101983151|NCT00075725|Alkylating Agents|alkylating agents|mesh-ancestor
101983152|NCT00075725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983153|NCT00075725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101983154|NCT00075725|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101983155|NCT00075725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101983156|NCT00075725|Antiemetics|antiemetics|mesh-ancestor
101983157|NCT00075725|Autonomic Agents|autonomic agents|mesh-ancestor
101983158|NCT00075725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101983168|NCT00075725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101983169|NCT00075725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101983170|NCT00075725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101983171|NCT00075725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101983172|NCT00075725|Abortifacient Agents|abortifacient agents|mesh-ancestor
101983173|NCT00075725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101983174|NCT00075725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101983175|NCT00075725|Antimetabolites|antimetabolites|mesh-ancestor
101983176|NCT00075725|Dermatologic Agents|dermatologic agents|mesh-ancestor
101983177|NCT00075725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101983178|NCT00075725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101983179|NCT00075725|Antiviral Agents|antiviral agents|mesh-ancestor
101983180|NCT00075725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101983181|NCT00075725|Antidotes|antidotes|mesh-ancestor
101983182|NCT00075725|Protective Agents|protective agents|mesh-ancestor
101983183|NCT00075725|Vitamin B Complex|vitamin b complex|mesh-ancestor
101983184|NCT00075725|Vitamins|vitamins|mesh-ancestor
101983185|NCT00075725|Micronutrients|micronutrients|mesh-ancestor
101983186|NCT00075725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101983187|NCT00075725|Tubulin Modulators|tubulin modulators|mesh-ancestor
101983188|NCT00075725|Antimitotic Agents|antimitotic agents|mesh-ancestor
101983189|NCT00075725|Mitosis Modulators|mitosis modulators|mesh-ancestor
101983190|NCT00075725|Hematinics|hematinics|mesh-ancestor
101983191|NCT02953782|Cetuximab|cetuximab|mesh-list
101983192|NCT02953782|Magrolimab|magrolimab|mesh-list
101983193|NCT02953782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101983194|NCT02953782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101983195|NCT01264783|RNS60|rns60|mesh-list
101983196|NCT01264783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101983197|NCT01264783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101983198|NCT01264783|Analgesics|analgesics|mesh-ancestor
101983199|NCT01264783|Sensory System Agents|sensory system agents|mesh-ancestor
101983200|NCT01264783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101983201|NCT01264783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983202|NCT01264783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101983203|NCT01264783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101983204|NCT01264783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101983205|NCT01156129|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
101983206|NCT01156129|Antidiarrheals|antidiarrheals|mesh-ancestor
101983207|NCT01156129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101983208|NCT01160029|Nateglinide|nateglinide|mesh-list
101983209|NCT01160029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101946933|NCT03882255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101946934|NCT03882255|Vasodilator Agents|vasodilator agents|mesh-ancestor
101946935|NCT03882255|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101983210|NCT01160029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983211|NCT00057863|Paclitaxel|paclitaxel|mesh-list
101983212|NCT00057863|Oxaliplatin|oxaliplatin|mesh-list
101983213|NCT00057863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101983214|NCT00057863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101983215|NCT00057863|Tubulin Modulators|tubulin modulators|mesh-ancestor
101983216|NCT00057863|Antimitotic Agents|antimitotic agents|mesh-ancestor
101983217|NCT00057863|Mitosis Modulators|mitosis modulators|mesh-ancestor
101983218|NCT00057863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983219|NCT01266655|Baclofen|baclofen|mesh-list
101983220|NCT01266655|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101983221|NCT01266655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983222|NCT01266655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101983223|NCT01266655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101983224|NCT01266655|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101983225|NCT01266655|GABA Agonists|gaba agonists|mesh-ancestor
101983239|NCT00075023|Growth Inhibitors|growth inhibitors|mesh-ancestor
101983240|NCT00075023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101983242|NCT01100801|Oxaliplatin|oxaliplatin|mesh-list
101983243|NCT01100801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101983244|NCT01263145|Paclitaxel|paclitaxel|mesh-list
101983245|NCT01263145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101983246|NCT01263145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101983247|NCT01263145|Tubulin Modulators|tubulin modulators|mesh-ancestor
101983248|NCT01263145|Antimitotic Agents|antimitotic agents|mesh-ancestor
101983249|NCT01263145|Mitosis Modulators|mitosis modulators|mesh-ancestor
101983250|NCT01263145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983251|NCT03717558|Ivermectin|ivermectin|mesh-list
101983252|NCT03717558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101983253|NCT03717558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101983254|NCT00074711|Calcium, Dietary|calcium, dietary|mesh-list
101983255|NCT00074711|Calcium Carbonate|calcium carbonate|mesh-list
101983256|NCT00074711|Calcium|calcium|mesh-list
101983257|NCT00074711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101983258|NCT00074711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983259|NCT00074711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101983260|NCT00074711|Antacids|antacids|mesh-ancestor
101983261|NCT00074711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983262|NCT00074711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101983263|NCT03960905|Meropenem|meropenem|mesh-list
101983264|NCT03960905|Ceftazidime|ceftazidime|mesh-list
101983265|NCT03960905|Cefepime|cefepime|mesh-list
101983266|NCT03960905|Anti-Infective Agents|anti-infective agents|mesh-list
101983267|NCT03960905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101983268|NCT05619120|Mexiletine|mexiletine|mesh-list
101983269|NCT05619120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101983270|NCT05619120|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101983271|NCT05619120|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101703073|NCT02721173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101983272|NCT05619120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101983273|NCT05619120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983274|NCT01265017|Hydrocortisone|hydrocortisone|mesh-list
101983275|NCT01265017|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101983276|NCT01265017|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101983277|NCT01265017|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101983278|NCT01265017|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101983279|NCT01265017|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101983280|NCT01265017|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101983281|NCT01265017|Medroxyprogesterone|medroxyprogesterone|mesh-list
101983282|NCT01265017|Estradiol|estradiol|mesh-list
101983283|NCT01265017|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101983284|NCT01265017|Hormones|hormones|mesh-ancestor
101983285|NCT01265017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101983286|NCT01265017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983289|NCT01265017|Contraceptive Agents|contraceptive agents|mesh-ancestor
101983290|NCT01265017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101983291|NCT01265017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101946936|NCT03882255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101946937|NCT03882255|Immunologic Factors|immunologic factors|mesh-ancestor
101946938|NCT05433272|Vaccines|vaccines|mesh-list
101946939|NCT05433272|Immunologic Factors|immunologic factors|mesh-ancestor
101946940|NCT05433272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946941|NCT01268631|Pregabalin|pregabalin|mesh-list
101946942|NCT01268631|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101946943|NCT01268631|Analgesics|analgesics|mesh-ancestor
101946944|NCT01268631|Sensory System Agents|sensory system agents|mesh-ancestor
101946945|NCT01268631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101983292|NCT01265017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101983293|NCT01265017|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101983294|NCT01265017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101983295|NCT01265017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101983296|NCT01265017|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101983297|NCT01265017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101983298|NCT01265017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101983299|NCT03420300|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
101983301|NCT03420300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101983302|NCT03879811|Nivolumab|nivolumab|mesh-list
101983303|NCT03879811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101983304|NCT03879811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101983305|NCT03879811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101983306|NCT03879811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983307|NCT01158859|Pregabalin|pregabalin|mesh-list
101983308|NCT01158859|Analgesics|analgesics|mesh-ancestor
101983309|NCT01158859|Sensory System Agents|sensory system agents|mesh-ancestor
101983310|NCT01158859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101711166|NCT00700284|Dapivirine|dapivirine|mesh-list
101983311|NCT01158859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983312|NCT01158859|Anticonvulsants|anticonvulsants|mesh-ancestor
101983313|NCT01158859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101983314|NCT01158859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101983315|NCT01158859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983316|NCT01158859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101983317|NCT01158859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101983318|NCT01158859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101983319|NCT01158859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101983320|NCT01158859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101983321|NCT01100021|Doxazosin|doxazosin|mesh-list
101983322|NCT01100021|Tamsulosin|tamsulosin|mesh-list
101983323|NCT01100021|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101983324|NCT01100021|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101983325|NCT01100021|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101983326|NCT01100021|Adrenergic Agents|adrenergic agents|mesh-ancestor
101983327|NCT01100021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101983328|NCT01100021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983329|NCT01100021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983330|NCT01100021|Urological Agents|urological agents|mesh-ancestor
101983331|NCT01100021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101983332|NCT03407430|Pregabalin|pregabalin|mesh-list
101983333|NCT03407430|Analgesics|analgesics|mesh-ancestor
101983334|NCT03407430|Sensory System Agents|sensory system agents|mesh-ancestor
101983335|NCT03407430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101983336|NCT03407430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983337|NCT03407430|Anticonvulsants|anticonvulsants|mesh-ancestor
101983338|NCT03407430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101983339|NCT03407430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101983340|NCT03407430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983341|NCT03407430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101983342|NCT03407430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101983343|NCT03407430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101983344|NCT03407430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101983345|NCT03407430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101703150|NCT02720471|Sensory System Agents|sensory system agents|mesh-ancestor
101946946|NCT01268631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946947|NCT01268631|Anticonvulsants|anticonvulsants|mesh-ancestor
101946948|NCT01268631|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101946949|NCT01268631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101946950|NCT01268631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983347|NCT01266811|Dexamethasone acetate|dexamethasone acetate|mesh-list
101983348|NCT01266811|Bortezomib|bortezomib|mesh-list
101983349|NCT01266811|Siltuximab|siltuximab|mesh-list
101983350|NCT01266811|BB 1101|bb 1101|mesh-list
101983351|NCT01266811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101983352|NCT01266811|Antiemetics|antiemetics|mesh-ancestor
101983353|NCT01266811|Autonomic Agents|autonomic agents|mesh-ancestor
101983354|NCT01266811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101983355|NCT01266811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983356|NCT01266811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101983357|NCT01266811|Glucocorticoids|glucocorticoids|mesh-ancestor
101983358|NCT01266811|Hormones|hormones|mesh-ancestor
101983368|NCT03407118|Insulin Lispro|insulin lispro|mesh-list
101983369|NCT03407118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101983370|NCT03407118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983371|NCT01100177|Sunitinib|sunitinib|mesh-list
101983372|NCT01100177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101983373|NCT01100177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101983374|NCT01100177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101983375|NCT01100177|Growth Substances|growth substances|mesh-ancestor
101983376|NCT01100177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983377|NCT01100177|Growth Inhibitors|growth inhibitors|mesh-ancestor
101983378|NCT01100177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101983379|NCT01100177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101983380|NCT01100177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983381|NCT01100333|Hormones|hormones|mesh-list
101983382|NCT01100333|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101983383|NCT01100333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101983384|NCT01100333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983385|NCT01327235|Cisplatin|cisplatin|mesh-list
101983386|NCT01327235|Endostar protein|endostar protein|mesh-list
101983387|NCT01327235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101983388|NCT01327235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101983389|NCT01327235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101983390|NCT01327235|Growth Substances|growth substances|mesh-ancestor
101983391|NCT01327235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983392|NCT01327235|Growth Inhibitors|growth inhibitors|mesh-ancestor
101983393|NCT03406260|Lasmiditan|lasmiditan|mesh-list
101983394|NCT03406260|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101983395|NCT03406260|Serotonin Agents|serotonin agents|mesh-ancestor
101983396|NCT03406260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101983397|NCT03406260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983398|NCT03406260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983399|NCT01089179|Metformin|metformin|mesh-list
101983400|NCT01089179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101983401|NCT01089179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983402|NCT01160185|Paclitaxel|paclitaxel|mesh-list
101983403|NCT01160185|Topotecan|topotecan|mesh-list
101983404|NCT01160185|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101983405|NCT01160185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101983406|NCT01160185|Tubulin Modulators|tubulin modulators|mesh-ancestor
101983407|NCT01160185|Antimitotic Agents|antimitotic agents|mesh-ancestor
101983408|NCT01160185|Mitosis Modulators|mitosis modulators|mesh-ancestor
101983409|NCT01160185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983410|NCT01160185|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101983411|NCT01160185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101983412|NCT01160185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101983413|NCT03419364|Niacinamide|niacinamide|mesh-list
101983415|NCT03419364|Nicotinic Acids|nicotinic acids|mesh-list
101983416|NCT03419364|Vitamin B Complex|vitamin b complex|mesh-ancestor
101983417|NCT03419364|Vitamins|vitamins|mesh-ancestor
101983418|NCT03419364|Micronutrients|micronutrients|mesh-ancestor
101983419|NCT03419364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983420|NCT03419364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101983421|NCT03419364|Antimetabolites|antimetabolites|mesh-ancestor
101703230|NCT02639858|Docetaxel|docetaxel|mesh-list
101946951|NCT01268631|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101810102|NCT04484623|Dexamethasone|dexamethasone|mesh-list
101983422|NCT03419364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983426|NCT01265173|Ceftriaxone|ceftriaxone|mesh-list
101983427|NCT01265173|Cefotaxime|cefotaxime|mesh-list
101983428|NCT01265173|Cefoxitin|cefoxitin|mesh-list
101983429|NCT01265173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101983430|NCT01265173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101983431|NCT01265173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101983432|NCT01265173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101983433|NCT01265173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101983434|NCT01265173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983435|NCT01265173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101983436|NCT01265173|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101983437|NCT01265173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101983438|NCT01159327|Sorafenib|sorafenib|mesh-list
101983439|NCT01159327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101983440|NCT01159327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101983441|NCT01159327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101983442|NCT01159327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983443|NCT01160341|Methyltestosterone|methyltestosterone|mesh-list
101983444|NCT01160341|Testosterone|testosterone|mesh-list
101983445|NCT01160341|Testosterone undecanoate|testosterone undecanoate|mesh-list
101983446|NCT01160341|Testosterone enanthate|testosterone enanthate|mesh-list
101983447|NCT01160341|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101983448|NCT01160341|Androgens|androgens|mesh-ancestor
101983449|NCT01160341|Hormones|hormones|mesh-ancestor
101983450|NCT01160341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101983451|NCT01160341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983452|NCT01160341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101983453|NCT01160341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101983454|NCT01160341|Anabolic Agents|anabolic agents|mesh-ancestor
101983455|NCT03882775|Heparin|heparin|mesh-list
101983456|NCT03882775|Bivalirudin|bivalirudin|mesh-list
101983457|NCT03882775|Anticoagulants|anticoagulants|mesh-ancestor
101983458|NCT03882775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101983459|NCT03882775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101983460|NCT03882775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983461|NCT03882775|Antithrombins|antithrombins|mesh-ancestor
101983462|NCT03882775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101983463|NCT03882775|Protease Inhibitors|protease inhibitors|mesh-ancestor
101983464|NCT03882775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101983465|NCT03877705|Listerine|listerine|mesh-list
101983466|NCT03877705|Sodium Fluoride|sodium fluoride|mesh-list
101983467|NCT03877705|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101983468|NCT03877705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101983469|NCT03877705|Cariostatic Agents|cariostatic agents|mesh-ancestor
101983470|NCT03877705|Protective Agents|protective agents|mesh-ancestor
101983471|NCT03877705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983472|NCT01160419|Leucovorin|leucovorin|mesh-list
101983473|NCT01160419|Folic Acid|folic acid|mesh-list
101983474|NCT01160419|Docetaxel|docetaxel|mesh-list
101983475|NCT01160419|Oxaliplatin|oxaliplatin|mesh-list
101983476|NCT01160419|Levoleucovorin|levoleucovorin|mesh-list
101983477|NCT01160419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101983478|NCT01160419|Tubulin Modulators|tubulin modulators|mesh-ancestor
101983479|NCT01160419|Antimitotic Agents|antimitotic agents|mesh-ancestor
101983480|NCT01160419|Mitosis Modulators|mitosis modulators|mesh-ancestor
101983481|NCT01160419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983482|NCT01160419|Antidotes|antidotes|mesh-ancestor
101983483|NCT01160419|Protective Agents|protective agents|mesh-ancestor
101983484|NCT01160419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983485|NCT01160419|Vitamin B Complex|vitamin b complex|mesh-ancestor
101983486|NCT01160419|Vitamins|vitamins|mesh-ancestor
101983487|NCT01160419|Micronutrients|micronutrients|mesh-ancestor
101983488|NCT01160419|Hematinics|hematinics|mesh-ancestor
101983489|NCT02954172|Paclitaxel|paclitaxel|mesh-list
101983490|NCT02954172|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101983491|NCT02954172|Bevacizumab|bevacizumab|mesh-list
101983492|NCT02954172|Carboplatin|carboplatin|mesh-list
101983493|NCT02954172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101983494|NCT02954172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101983495|NCT02954172|Tubulin Modulators|tubulin modulators|mesh-ancestor
101983496|NCT02954172|Antimitotic Agents|antimitotic agents|mesh-ancestor
101983497|NCT02954172|Mitosis Modulators|mitosis modulators|mesh-ancestor
101983498|NCT02954172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946952|NCT01268631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101946953|NCT01268631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101946954|NCT01268631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101946955|NCT01268631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101946956|NCT01268631|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101946957|NCT01268631|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101946958|NCT01268631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101810174|NCT04201561|Selenious Acid|selenious acid|mesh-list
101983503|NCT02954172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983504|NCT02954172|Growth Inhibitors|growth inhibitors|mesh-ancestor
101983505|NCT01156519|Hydrocortisone|hydrocortisone|mesh-list
101983506|NCT01156519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101983507|NCT02953938|Ranibizumab|ranibizumab|mesh-list
101983508|NCT02953938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101983509|NCT02953938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101983510|NCT02953938|Growth Substances|growth substances|mesh-ancestor
101983511|NCT02953938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983512|NCT02953938|Growth Inhibitors|growth inhibitors|mesh-ancestor
101983513|NCT02953938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101983514|NCT01161667|Naratriptan|naratriptan|mesh-list
101983515|NCT01161667|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101983516|NCT01161667|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101983517|NCT01161667|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101983518|NCT01161667|Serotonin Agents|serotonin agents|mesh-ancestor
101983519|NCT01161667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101983520|NCT01161667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983521|NCT01161667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983523|NCT02526979|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101983524|NCT02526979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101983525|NCT02526979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101983526|NCT02526979|Adrenergic Agents|adrenergic agents|mesh-ancestor
101983527|NCT02526979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101983528|NCT02526979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983529|NCT02526979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983530|NCT02526979|Urological Agents|urological agents|mesh-ancestor
101983531|NCT03882541|Midazolam|midazolam|mesh-list
101983532|NCT03882541|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101983533|NCT03882541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101983534|NCT03882541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101983535|NCT03882541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983536|NCT03882541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101983537|NCT03882541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101983538|NCT03882541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101983539|NCT03882541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101983540|NCT03882541|Anesthetics, General|anesthetics, general|mesh-ancestor
101983541|NCT03882541|Anesthetics|anesthetics|mesh-ancestor
101983542|NCT03882541|GABA Modulators|gaba modulators|mesh-ancestor
101983543|NCT03882541|GABA Agents|gaba agents|mesh-ancestor
101983544|NCT03882541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101983545|NCT03882541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983546|NCT01267903|Vaccines|vaccines|mesh-list
101983547|NCT01267903|Immunologic Factors|immunologic factors|mesh-ancestor
101983548|NCT01267903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983549|NCT03576313|Ivermectin|ivermectin|mesh-list
101983550|NCT03576313|Piperaquine|piperaquine|mesh-list
101983551|NCT03576313|Artenimol|artenimol|mesh-list
101983552|NCT03576313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101983553|NCT03576313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101983554|NCT03576313|Antimalarials|antimalarials|mesh-ancestor
101983555|NCT03576313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101983556|NCT01161979|Zonisamide|zonisamide|mesh-list
101983557|NCT01161979|Anticonvulsants|anticonvulsants|mesh-ancestor
101983558|NCT01161979|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101983559|NCT01161979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101983560|NCT01161979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983561|NCT01161979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101946959|NCT01268631|Antidepressive Agents|antidepressive agents|mesh-ancestor
101946960|NCT01268631|Dopamine Agents|dopamine agents|mesh-ancestor
101983562|NCT01161979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983563|NCT01160731|Etoposide|etoposide|mesh-list
101983564|NCT01160731|Panobinostat|panobinostat|mesh-list
101983565|NCT01160731|Etoposide phosphate|etoposide phosphate|mesh-list
101983566|NCT01160731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101983567|NCT01160731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101983568|NCT01160731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101983569|NCT01160731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101703380|NCT02723903|Fluoxetine|fluoxetine|mesh-list
101983574|NCT01160965|Levobupivacaine|levobupivacaine|mesh-list
101983575|NCT01160965|Anesthetics, Local|anesthetics, local|mesh-ancestor
101983576|NCT01160965|Anesthetics|anesthetics|mesh-ancestor
101983577|NCT01160965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101983578|NCT01160965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983579|NCT01160965|Sensory System Agents|sensory system agents|mesh-ancestor
101983580|NCT01160965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101983581|NCT01156909|Rituximab|rituximab|mesh-list
101983582|NCT01156909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101983583|NCT01156909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101983584|NCT01156909|Immunologic Factors|immunologic factors|mesh-ancestor
101983585|NCT01156909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983586|NCT01156909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101983587|NCT01162603|Latanoprost|latanoprost|mesh-list
101983588|NCT01162603|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101983589|NCT01162603|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101983590|NCT03881995|Insulin Glargine|insulin glargine|mesh-list
101983591|NCT03881995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101983592|NCT03881995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983593|NCT02527213|Sodium thiosulfate|sodium thiosulfate|mesh-list
101983594|NCT02527213|Antidotes|antidotes|mesh-ancestor
101983595|NCT02527213|Protective Agents|protective agents|mesh-ancestor
101983596|NCT02527213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983597|NCT02527213|Antioxidants|antioxidants|mesh-ancestor
101983598|NCT02527213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983599|NCT02527213|Antitubercular Agents|antitubercular agents|mesh-ancestor
101983600|NCT02527213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101983601|NCT02527213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101983602|NCT02527213|Chelating Agents|chelating agents|mesh-ancestor
101983603|NCT02527213|Sequestering Agents|sequestering agents|mesh-ancestor
101983604|NCT01161277|Haloperidol|haloperidol|mesh-list
101983605|NCT01161277|Aripiprazole|aripiprazole|mesh-list
101983606|NCT01161277|Haloperidol decanoate|haloperidol decanoate|mesh-list
101983607|NCT01161277|Antidepressive Agents|antidepressive agents|mesh-ancestor
101983608|NCT01161277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101983609|NCT01161277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101983610|NCT01161277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101983611|NCT01161277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101983612|NCT01161277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983613|NCT01161277|Dopamine Agonists|dopamine agonists|mesh-ancestor
101983614|NCT01161277|Dopamine Agents|dopamine agents|mesh-ancestor
101983615|NCT01161277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101983616|NCT01161277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983617|NCT01161277|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101983618|NCT01161277|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101983619|NCT01161277|Serotonin Agents|serotonin agents|mesh-ancestor
101983620|NCT01161277|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101983621|NCT01161277|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101983622|NCT01161277|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101983623|NCT01161277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101983624|NCT01161277|Antiemetics|antiemetics|mesh-ancestor
101983625|NCT01161277|Autonomic Agents|autonomic agents|mesh-ancestor
101983626|NCT01161277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101983627|NCT01161277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101983628|NCT01161277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101983629|NCT01268215|Budesonide|budesonide|mesh-list
101983630|NCT01268215|Calfactant|calfactant|mesh-list
101983631|NCT01268215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101983632|NCT01268215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101983633|NCT01268215|Autonomic Agents|autonomic agents|mesh-ancestor
101983634|NCT01268215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101983635|NCT01268215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983636|NCT01268215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101983637|NCT01268215|Respiratory System Agents|respiratory system agents|mesh-ancestor
101946962|NCT05430230|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101946963|NCT05430230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101711211|NCT01010581|Antimetabolites|antimetabolites|mesh-ancestor
101946964|NCT05430230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101946965|NCT05430230|Analgesics|analgesics|mesh-ancestor
101946966|NCT05430230|Sensory System Agents|sensory system agents|mesh-ancestor
101946967|NCT05430230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101983638|NCT01268215|Glucocorticoids|glucocorticoids|mesh-ancestor
101983639|NCT01268215|Hormones|hormones|mesh-ancestor
101983640|NCT01268215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101983646|NCT01269307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983647|NCT01269307|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101983648|NCT01269307|Anesthetics, General|anesthetics, general|mesh-ancestor
101983649|NCT01269307|Anesthetics|anesthetics|mesh-ancestor
101983650|NCT01269307|Analgesics|analgesics|mesh-ancestor
101983651|NCT01269307|Sensory System Agents|sensory system agents|mesh-ancestor
101983652|NCT01269307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101983653|NCT01269307|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101983654|NCT01269307|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101983655|NCT01269307|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101983656|NCT01269307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101983657|NCT01269307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983658|NCT03874585|Nicotine|nicotine|mesh-list
101983659|NCT03874585|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101983660|NCT03874585|Autonomic Agents|autonomic agents|mesh-ancestor
101983661|NCT03874585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101983662|NCT03874585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983663|NCT03874585|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101983664|NCT03874585|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101983665|NCT03874585|Cholinergic Agents|cholinergic agents|mesh-ancestor
101983666|NCT03874585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101983667|NCT03874585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983668|NCT01268371|Everolimus|everolimus|mesh-list
101983669|NCT01268371|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101983670|NCT01268371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101983671|NCT01268371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101983672|NCT01268371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983673|NCT01268371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101983674|NCT01268371|Immunologic Factors|immunologic factors|mesh-ancestor
101983675|NCT01268371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983676|NCT01268371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101983677|NCT01267669|Somatostatin|somatostatin|mesh-list
101983678|NCT01267669|Hormones|hormones|mesh-ancestor
101983679|NCT01267669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101983680|NCT01267669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983681|NCT05666869|Esketamine|esketamine|mesh-list
101983682|NCT05666869|Antidepressive Agents|antidepressive agents|mesh-ancestor
101983683|NCT05666869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101983684|NCT01164943|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101983685|NCT01164943|Hormones|hormones|mesh-ancestor
101983686|NCT01164943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101983687|NCT01164943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983688|NCT01269541|Rifampin|rifampin|mesh-list
101983689|NCT01269541|Mupirocin|mupirocin|mesh-list
101983690|NCT01269541|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101983691|NCT01269541|Antitubercular Agents|antitubercular agents|mesh-ancestor
101983692|NCT01269541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101983693|NCT01269541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101983694|NCT01269541|Leprostatic Agents|leprostatic agents|mesh-ancestor
101983695|NCT01269541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101983696|NCT01269541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101983697|NCT01269541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983698|NCT01269541|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101983699|NCT01269541|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101983700|NCT01269541|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101983701|NCT01269541|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101946968|NCT05430230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946969|NCT05430230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101946970|NCT05430230|Gout Suppressants|gout suppressants|mesh-ancestor
101983702|NCT01269541|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101983703|NCT01269541|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101983704|NCT01269541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101983705|NCT03877003|Choline|choline|mesh-list
101983706|NCT03877003|Lipotropic Agents|lipotropic agents|mesh-ancestor
101983707|NCT03877003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101983708|NCT03877003|Antimetabolites|antimetabolites|mesh-ancestor
101628284|NCT00720499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101983714|NCT01280149|Neurokinin A|neurokinin a|mesh-list
101983715|NCT01280149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101983716|NCT01280149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983717|NCT01280149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983718|NCT01165255|Bupropion|bupropion|mesh-list
101983719|NCT01165255|Antidepressive Agents|antidepressive agents|mesh-list
101983720|NCT01165255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101983721|NCT01165255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101983722|NCT01165255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101983723|NCT01165255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101703528|NCT02625636|Incretins|incretins|mesh-ancestor
101983725|NCT01165255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983726|NCT01165255|Dopamine Agents|dopamine agents|mesh-ancestor
101983727|NCT01165255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101983728|NCT01165255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983729|NCT01165255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101983730|NCT01165255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101983731|NCT01165255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101983732|NCT01167049|Capecitabine|capecitabine|mesh-list
101983733|NCT01167049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101983734|NCT01167049|Antimetabolites|antimetabolites|mesh-ancestor
101983735|NCT01167049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983736|NCT01167049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101983737|NCT01311414|Urapidil|urapidil|mesh-list
101983738|NCT01311414|Theodrenaline|theodrenaline|mesh-list
101983739|NCT01311414|Cafedrine|cafedrine|mesh-list
101983740|NCT01311414|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101983741|NCT01311414|Vasodilator Agents|vasodilator agents|mesh-ancestor
101983742|NCT01311414|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101983743|NCT01311414|Serotonin Agents|serotonin agents|mesh-ancestor
101983744|NCT01311414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101983745|NCT01311414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983746|NCT01311414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983747|NCT01311414|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101983748|NCT01311414|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101983749|NCT01311414|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101983750|NCT01311414|Adrenergic Agents|adrenergic agents|mesh-ancestor
101983751|NCT03715296|Lenalidomide|lenalidomide|mesh-list
101983752|NCT03715296|Immunologic Factors|immunologic factors|mesh-ancestor
101983753|NCT03715296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983754|NCT03715296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101983755|NCT03715296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101983756|NCT03715296|Growth Substances|growth substances|mesh-ancestor
101983757|NCT03715296|Growth Inhibitors|growth inhibitors|mesh-ancestor
101983758|NCT03715296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101983759|NCT01347762|Nabilone|nabilone|mesh-list
101983760|NCT01347762|Antiemetics|antiemetics|mesh-ancestor
101983761|NCT01347762|Autonomic Agents|autonomic agents|mesh-ancestor
101711235|NCT01016041|Everolimus|everolimus|mesh-list
101983762|NCT01347762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101983763|NCT01347762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983764|NCT01347762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101983765|NCT01347762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101983766|NCT01347762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101983767|NCT01347762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101983768|NCT01347762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101983769|NCT03874273|Crizotinib|crizotinib|mesh-list
101983770|NCT03874273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101983771|NCT03874273|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101983772|NCT03874273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101983773|NCT03874273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983774|NCT05657652|Cytarabine|cytarabine|mesh-list
101946971|NCT05430230|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101946972|NCT05430230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101946973|NCT05430230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946975|NCT01268709|Nortriptyline|nortriptyline|mesh-list
101946976|NCT01268709|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101946977|NCT01268709|Antidepressive Agents|antidepressive agents|mesh-ancestor
101946978|NCT01268709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101946979|NCT01268709|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101946980|NCT01268709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101946981|NCT01268709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101946982|NCT01268709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101946983|NCT01268709|Adrenergic Agents|adrenergic agents|mesh-ancestor
101946984|NCT01268709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101946985|NCT01268709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946986|NCT01268709|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101946987|NCT01268709|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101946988|NCT01268709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101946989|NCT01268709|Histamine Antagonists|histamine antagonists|mesh-ancestor
101946990|NCT01268709|Histamine Agents|histamine agents|mesh-ancestor
101946991|NCT03881943|Aspirin|aspirin|mesh-list
101946992|NCT03881943|Ticagrelor|ticagrelor|mesh-list
101946993|NCT03881943|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101946994|NCT03881943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101946995|NCT03881943|Analgesics|analgesics|mesh-ancestor
101946996|NCT03881943|Sensory System Agents|sensory system agents|mesh-ancestor
101946997|NCT03881943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101946998|NCT03881943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101946999|NCT03881943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101947000|NCT03881943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101947001|NCT03881943|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101947002|NCT03881943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101947003|NCT03881943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947004|NCT03881943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101947006|NCT03881943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101947009|NCT03881943|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101947010|NCT03881943|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101947011|NCT03881943|Purinergic Agents|purinergic agents|mesh-ancestor
101947012|NCT03881943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101947013|NCT03760185|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101947014|NCT03760185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101947015|NCT03760185|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101947016|NCT03760185|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101947017|NCT03760185|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101947018|NCT03760185|Adrenergic Agents|adrenergic agents|mesh-ancestor
101947019|NCT03760185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101947020|NCT03760185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947021|NCT03760185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947022|NCT01164969|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101947023|NCT01164969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101947024|NCT04722848|Imatinib Mesylate|imatinib mesylate|mesh-list
101947025|NCT04722848|Blinatumomab|blinatumomab|mesh-list
101947026|NCT04722848|Ponatinib|ponatinib|mesh-list
101947027|NCT04722848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101947028|NCT04722848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101947029|NCT04722848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101947030|NCT04722848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810485|NCT03172975|Antacids|antacids|mesh-ancestor
101983775|NCT05657652|Venetoclax|venetoclax|mesh-list
101983776|NCT05657652|Cladribine|cladribine|mesh-list
101983777|NCT05657652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101983778|NCT05657652|Antimetabolites|antimetabolites|mesh-ancestor
101983782|NCT05657652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101983783|NCT05657652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101983784|NCT05657652|Immunologic Factors|immunologic factors|mesh-ancestor
101983785|NCT05657652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983786|NCT01167127|Oxycodone|oxycodone|mesh-list
101983787|NCT01167127|Naloxone|naloxone|mesh-list
101983788|NCT01167127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101983789|NCT01167127|Narcotics|narcotics|mesh-ancestor
101983790|NCT01167127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101983791|NCT01167127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983792|NCT01167127|Analgesics|analgesics|mesh-ancestor
101983793|NCT01167127|Sensory System Agents|sensory system agents|mesh-ancestor
101983794|NCT01167127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101983795|NCT01167127|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101983796|NCT01280305|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101983797|NCT01280305|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101983798|NCT01280305|Hormone Antagonists|hormone antagonists|mesh-ancestor
101983799|NCT01280305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101983800|NCT01280305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983801|NCT01280305|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101983802|NCT01280305|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101983803|NCT01280305|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101983804|NCT03872011|Vitamins|vitamins|mesh-list
101983805|NCT03872011|Ascorbic Acid|ascorbic acid|mesh-list
101983806|NCT03872011|Thiamine|thiamine|mesh-list
101983807|NCT03872011|Hydrocortisone|hydrocortisone|mesh-list
101947031|NCT01157013|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101947032|NCT01157013|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101947033|NCT01157013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947034|NCT01584466|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101947035|NCT01584466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101947036|NCT01584466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101947037|NCT01584466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101947038|NCT01584466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947039|NCT01584466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101947040|NCT01584466|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101947041|NCT01584466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101947043|NCT01584466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101947044|NCT01584466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947045|NCT01584466|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101947046|NCT01584466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101947047|NCT01584466|Dopamine Agents|dopamine agents|mesh-ancestor
101947048|NCT05363384|Metformin|metformin|mesh-list
101947049|NCT05363384|Alogliptin|alogliptin|mesh-list
101947050|NCT05363384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101947051|NCT05363384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947052|NCT05363384|Incretins|incretins|mesh-ancestor
101947053|NCT05363384|Hormones|hormones|mesh-ancestor
101983808|NCT03872011|Micronutrients|micronutrients|mesh-ancestor
101983809|NCT03872011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983810|NCT03872011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101983811|NCT03872011|Antioxidants|antioxidants|mesh-ancestor
101983812|NCT03872011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983813|NCT03872011|Protective Agents|protective agents|mesh-ancestor
101983814|NCT03872011|Vitamin B Complex|vitamin b complex|mesh-ancestor
101983815|NCT03438396|Tisotumab vedotin|tisotumab vedotin|mesh-list
101711256|NCT02696837|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101983816|NCT03438396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101983817|NCT03438396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101983818|NCT03876067|Cardioplegic Solutions|cardioplegic solutions|mesh-list
101983819|NCT03876067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101983820|NCT01163929|Paclitaxel|paclitaxel|mesh-list
101983821|NCT01163929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101983822|NCT01163929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101983823|NCT01163929|Tubulin Modulators|tubulin modulators|mesh-ancestor
101983824|NCT01163929|Antimitotic Agents|antimitotic agents|mesh-ancestor
101983825|NCT01163929|Mitosis Modulators|mitosis modulators|mesh-ancestor
101983826|NCT01163929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983827|NCT03871777|Chlorhexidine|chlorhexidine|mesh-list
101983828|NCT03871777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101983829|NCT03871777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101983830|NCT03871777|Disinfectants|disinfectants|mesh-ancestor
101983831|NCT00073307|Sorafenib|sorafenib|mesh-list
101983832|NCT00073307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101983833|NCT00073307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101983834|NCT00073307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101983835|NCT00073307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983836|NCT01270789|Liraglutide|liraglutide|mesh-list
101983837|NCT01270789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101947054|NCT05363384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101947055|NCT05363384|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101983838|NCT01270789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983839|NCT01270789|Incretins|incretins|mesh-ancestor
101983840|NCT01270789|Hormones|hormones|mesh-ancestor
101983841|NCT01270789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101983842|NCT01164085|Ketorolac|ketorolac|mesh-list
101983843|NCT01164085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101983844|NCT01164085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101983845|NCT01164085|Analgesics|analgesics|mesh-ancestor
101983846|NCT01164085|Sensory System Agents|sensory system agents|mesh-ancestor
101983847|NCT01164085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101983848|NCT01164085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983849|NCT01164085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101983850|NCT01164085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101983857|NCT01271179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101983858|NCT01271179|Analgesics|analgesics|mesh-ancestor
101983859|NCT01271179|Sensory System Agents|sensory system agents|mesh-ancestor
101983860|NCT01271179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101983861|NCT01271179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983862|NCT01271179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101983863|NCT01271179|Vasodilator Agents|vasodilator agents|mesh-ancestor
101983864|NCT01271179|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101983865|NCT01271179|Purinergic Agonists|purinergic agonists|mesh-ancestor
101983866|NCT01271179|Purinergic Agents|purinergic agents|mesh-ancestor
101983867|NCT01271179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101983868|NCT01271179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983869|NCT01271179|Antimetabolites|antimetabolites|mesh-ancestor
101983870|NCT01271179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101983871|NCT01271179|Gout Suppressants|gout suppressants|mesh-ancestor
101983872|NCT01271179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101703680|NCT00689598|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101983873|NCT01271179|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101983874|NCT01271179|Antioxidants|antioxidants|mesh-ancestor
101983875|NCT01271179|Protective Agents|protective agents|mesh-ancestor
101983876|NCT01271179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101983878|NCT03388164|Citalopram|citalopram|mesh-list
101983879|NCT03388164|Escitalopram|escitalopram|mesh-list
101983880|NCT03388164|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101983881|NCT03388164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101983882|NCT03388164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101983883|NCT03388164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983884|NCT03388164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101983885|NCT03388164|Serotonin Agents|serotonin agents|mesh-ancestor
101983886|NCT03388164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983887|NCT03388164|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101983888|NCT03388164|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101983889|NCT03388164|Parasympatholytics|parasympatholytics|mesh-ancestor
101983890|NCT03388164|Autonomic Agents|autonomic agents|mesh-ancestor
101983891|NCT03388164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101983892|NCT03388164|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101983893|NCT03388164|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101983894|NCT03388164|Cholinergic Agents|cholinergic agents|mesh-ancestor
101983895|NCT03388164|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101983896|NCT03388164|Antidepressive Agents|antidepressive agents|mesh-ancestor
101983897|NCT03388164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101983898|NCT01268761|Cetrorelix|cetrorelix|mesh-list
101983899|NCT01268761|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101983900|NCT01268761|Fertility Agents|fertility agents|mesh-ancestor
101983901|NCT01268761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101983902|NCT01268761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983903|NCT01268761|Hormone Antagonists|hormone antagonists|mesh-ancestor
101983904|NCT01268761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101983905|NCT01268839|Efavirenz|efavirenz|mesh-list
101983906|NCT01268839|Rilpivirine|rilpivirine|mesh-list
101983907|NCT01268839|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101983908|NCT01268839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101983909|NCT01268839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101983910|NCT01268839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983911|NCT01268839|Antiviral Agents|antiviral agents|mesh-ancestor
101983912|NCT01268839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101947057|NCT05363384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101947058|NCT05363384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947059|NCT01165125|Ketoconazole|ketoconazole|mesh-list
101810663|NCT00775476|Antidotes|antidotes|mesh-ancestor
101983913|NCT01268839|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101983914|NCT01268839|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101983915|NCT01268839|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101983916|NCT01268839|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101983917|NCT01268839|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101983918|NCT01268839|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101983935|NCT01165567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101983936|NCT01165567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101983938|NCT01165567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101983939|NCT01165567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983940|NCT03387462|Tenofovir|tenofovir|mesh-list
101983941|NCT03387462|Emtricitabine|emtricitabine|mesh-list
101983942|NCT03387462|Antiviral Agents|antiviral agents|mesh-ancestor
101983943|NCT03387462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101983944|NCT03387462|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101983945|NCT03387462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101983946|NCT03387462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101983947|NCT03387462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983948|NCT03387462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101983949|NCT03387462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101983951|NCT03756883|Xhance|xhance|mesh-list
101983952|NCT03756883|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101983953|NCT03756883|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101983954|NCT03756883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101983955|NCT03756883|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101983956|NCT03756883|Autonomic Agents|autonomic agents|mesh-ancestor
101983957|NCT03756883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101983958|NCT03756883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983959|NCT03756883|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101983960|NCT03756883|Respiratory System Agents|respiratory system agents|mesh-ancestor
101983961|NCT03756883|Dermatologic Agents|dermatologic agents|mesh-ancestor
101983962|NCT03756883|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101983963|NCT03756883|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101983964|NCT03756883|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101983965|NCT03756883|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101983966|NCT03756883|Adrenergic Agents|adrenergic agents|mesh-ancestor
101983967|NCT03756883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101983968|NCT03756883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983969|NCT03756883|Glucocorticoids|glucocorticoids|mesh-ancestor
101983970|NCT03756883|Hormones|hormones|mesh-ancestor
101983971|NCT03756883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101983972|NCT03756883|Sympathomimetics|sympathomimetics|mesh-ancestor
101983973|NCT01586611|Leucovorin|leucovorin|mesh-list
101983974|NCT01586611|Gemcitabine|gemcitabine|mesh-list
101983975|NCT01586611|Oxaliplatin|oxaliplatin|mesh-list
101983976|NCT01586611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101983977|NCT01586611|Antimetabolites|antimetabolites|mesh-ancestor
101628285|NCT00720499|Cholinergic Agents|cholinergic agents|mesh-ancestor
101983992|NCT03386448|Sensory System Agents|sensory system agents|mesh-ancestor
101983993|NCT03386448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101983994|NCT03386448|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101983996|NCT03386448|Autonomic Agents|autonomic agents|mesh-ancestor
101983997|NCT03386448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101983998|NCT03386448|Mydriatics|mydriatics|mesh-ancestor
101983999|NCT03386448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101984000|NCT03386448|Cholinergic Agents|cholinergic agents|mesh-ancestor
101984001|NCT03386448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101984002|NCT03386448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984003|NCT03386448|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101984004|NCT03386448|Parasympatholytics|parasympatholytics|mesh-ancestor
101984005|NCT01280929|Ranibizumab|ranibizumab|mesh-list
101984006|NCT01280929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101984007|NCT01280929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101984008|NCT01280929|Growth Substances|growth substances|mesh-ancestor
101947060|NCT01165125|Antifungal Agents|antifungal agents|mesh-ancestor
101947061|NCT01165125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101947062|NCT01165125|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101984009|NCT01280929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984010|NCT01280929|Growth Inhibitors|growth inhibitors|mesh-ancestor
101984011|NCT01280929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101984012|NCT01268917|Aspirin|aspirin|mesh-list
101984013|NCT01268917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101984014|NCT01268917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101984015|NCT01268917|Analgesics|analgesics|mesh-ancestor
101984016|NCT01268917|Sensory System Agents|sensory system agents|mesh-ancestor
101984017|NCT01268917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101984018|NCT01268917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984019|NCT01268917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101984020|NCT01268917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101984021|NCT01268917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101984022|NCT01268917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101984023|NCT01268917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984024|NCT01268917|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101984025|NCT01268917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101984026|NCT01268917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101984027|NCT01268917|Antipyretics|antipyretics|mesh-ancestor
101984028|NCT01281163|Lapatinib|lapatinib|mesh-list
101984029|NCT01281163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101984030|NCT01281163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101984031|NCT01281163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101984032|NCT01281163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984033|NCT01268995|Cyclosporine|cyclosporine|mesh-list
101984034|NCT01268995|Tacrolimus|tacrolimus|mesh-list
101984035|NCT01268995|Cyclosporins|cyclosporins|mesh-list
101984036|NCT01268995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101984037|NCT01268995|Immunologic Factors|immunologic factors|mesh-ancestor
101984038|NCT01268995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984039|NCT01268995|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101984044|NCT01268995|Dermatologic Agents|dermatologic agents|mesh-ancestor
101984045|NCT01268995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101984047|NCT00009737|Fluorouracil|fluorouracil|mesh-list
101984048|NCT00009737|Capecitabine|capecitabine|mesh-list
101984049|NCT00009737|Antimetabolites|antimetabolites|mesh-ancestor
101984050|NCT00009737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984051|NCT00009737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101984052|NCT00009737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101984053|NCT00009737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101984054|NCT00009737|Immunologic Factors|immunologic factors|mesh-ancestor
101984055|NCT00009737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984056|NCT00009737|Antidotes|antidotes|mesh-ancestor
101984057|NCT00009737|Protective Agents|protective agents|mesh-ancestor
101984058|NCT00009737|Vitamin B Complex|vitamin b complex|mesh-ancestor
101984059|NCT00009737|Vitamins|vitamins|mesh-ancestor
101984060|NCT00009737|Micronutrients|micronutrients|mesh-ancestor
101984061|NCT03711240|Leucovorin|leucovorin|mesh-list
101984062|NCT03711240|Bevacizumab|bevacizumab|mesh-list
101984063|NCT03711240|Oxaliplatin|oxaliplatin|mesh-list
101984064|NCT03711240|Irinotecan|irinotecan|mesh-list
101984065|NCT03711240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101984066|NCT03711240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101984067|NCT03711240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101984068|NCT03711240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101984069|NCT03711240|Growth Substances|growth substances|mesh-ancestor
101984070|NCT03711240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984071|NCT03711240|Growth Inhibitors|growth inhibitors|mesh-ancestor
101984072|NCT03711240|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101984073|NCT03711240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101984074|NCT03711240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101984075|NCT03711240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984076|NCT03711240|Antidotes|antidotes|mesh-ancestor
101984077|NCT03711240|Protective Agents|protective agents|mesh-ancestor
101984078|NCT03711240|Vitamin B Complex|vitamin b complex|mesh-ancestor
101984079|NCT03711240|Vitamins|vitamins|mesh-ancestor
101984080|NCT03711240|Micronutrients|micronutrients|mesh-ancestor
101984081|NCT01271881|Heparin|heparin|mesh-list
101984082|NCT01271881|Anticoagulants|anticoagulants|mesh-ancestor
101984083|NCT01271881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101984084|NCT01271881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101947063|NCT01165125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101947064|NCT01165125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101947065|NCT01165125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947066|NCT01165125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101947067|NCT01165125|Hormone Antagonists|hormone antagonists|mesh-ancestor
101971943|NCT02083250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101984085|NCT01271881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984086|NCT05459844|Octreotide|octreotide|mesh-list
101984087|NCT05459844|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
101984088|NCT05459844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101984089|NCT05459844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101984090|NCT05459844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101984091|NCT05459844|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101984092|NCT05459844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984093|NCT03874975|Vitamin D|vitamin d|mesh-list
101984094|NCT03874975|Vitamins|vitamins|mesh-ancestor
101984095|NCT03874975|Micronutrients|micronutrients|mesh-ancestor
101984096|NCT03874975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984097|NCT03874975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101984098|NCT01164709|Nelfinavir|nelfinavir|mesh-list
101984099|NCT01164709|Bortezomib|bortezomib|mesh-list
101984100|NCT01164709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101984101|NCT01164709|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101984102|NCT01164709|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101984103|NCT01164709|Protease Inhibitors|protease inhibitors|mesh-ancestor
101984104|NCT01164709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101984105|NCT01164709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984106|NCT01164709|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101984107|NCT01164709|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101984108|NCT01164709|Antiviral Agents|antiviral agents|mesh-ancestor
101984109|NCT01164709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101984110|NCT03960671|Midazolam|midazolam|mesh-list
101984111|NCT03960671|Diazepam|diazepam|mesh-list
101984112|NCT03960671|Propofol|propofol|mesh-list
101984113|NCT03960671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101984117|NCT03960671|Anesthetics, General|anesthetics, general|mesh-ancestor
101984118|NCT03960671|Anesthetics|anesthetics|mesh-ancestor
101984119|NCT03960671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101984120|NCT03960671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101984121|NCT03960671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101984122|NCT03960671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101984123|NCT03960671|GABA Modulators|gaba modulators|mesh-ancestor
101984124|NCT03960671|GABA Agents|gaba agents|mesh-ancestor
101984125|NCT03960671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101984126|NCT03960671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984127|NCT03960671|Anticonvulsants|anticonvulsants|mesh-ancestor
101984128|NCT03960671|Antiemetics|antiemetics|mesh-ancestor
101984129|NCT03960671|Autonomic Agents|autonomic agents|mesh-ancestor
101984130|NCT03960671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101984131|NCT03960671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101984132|NCT03960671|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101984133|NCT03960671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101984134|NCT01281553|Cisapride|cisapride|mesh-list
101984135|NCT01281553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101984136|NCT01281553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101984137|NCT01281553|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101984138|NCT01281553|Serotonin Agents|serotonin agents|mesh-ancestor
101984139|NCT01281553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101984140|NCT01281553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984141|NCT01281553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984142|NCT01164787|Trandolapril|trandolapril|mesh-list
101984143|NCT01164787|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101984144|NCT01164787|Protease Inhibitors|protease inhibitors|mesh-ancestor
101984145|NCT01164787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101984146|NCT01164787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984147|NCT01164787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101984148|NCT01269151|Ranibizumab|ranibizumab|mesh-list
101984149|NCT01269151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101984150|NCT01269151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101984151|NCT01269151|Growth Substances|growth substances|mesh-ancestor
101947068|NCT01165125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101984152|NCT01269151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984153|NCT01269151|Growth Inhibitors|growth inhibitors|mesh-ancestor
101984154|NCT01269151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101984155|NCT00028769|Paclitaxel|paclitaxel|mesh-list
101984156|NCT00028769|Etoposide|etoposide|mesh-list
101984157|NCT00028769|Leuprolide|leuprolide|mesh-list
101984158|NCT00028769|Goserelin|goserelin|mesh-list
101984159|NCT00028769|Bicalutamide|bicalutamide|mesh-list
101984160|NCT00028769|Flutamide|flutamide|mesh-list
101984161|NCT00028769|Estramustine|estramustine|mesh-list
101984162|NCT00028769|Nilutamide|nilutamide|mesh-list
101984163|NCT00028769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101984164|NCT00028769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101984165|NCT00028769|Tubulin Modulators|tubulin modulators|mesh-ancestor
101984166|NCT00028769|Antimitotic Agents|antimitotic agents|mesh-ancestor
101984167|NCT00028769|Mitosis Modulators|mitosis modulators|mesh-ancestor
101711301|NCT01014247|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101984168|NCT00028769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984169|NCT00028769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101984170|NCT00028769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101984171|NCT00028769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101984172|NCT00028769|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101984173|NCT00028769|Fertility Agents|fertility agents|mesh-ancestor
101984174|NCT00028769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101984175|NCT00028769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984176|NCT00028769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101984177|NCT00028769|Androgen Antagonists|androgen antagonists|mesh-ancestor
101984178|NCT00028769|Hormone Antagonists|hormone antagonists|mesh-ancestor
101984179|NCT00028769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101984180|NCT00028769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101984181|NCT00028769|Alkylating Agents|alkylating agents|mesh-ancestor
101984182|NCT01281787|Losartan|losartan|mesh-list
101984183|NCT01281787|Metoprolol|metoprolol|mesh-list
101984184|NCT01281787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101984185|NCT01281787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101984186|NCT01281787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101984191|NCT01281787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101984192|NCT01281787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984193|NCT01281787|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101984194|NCT01281787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101984195|NCT01281787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101984196|NCT01281787|Adrenergic Agents|adrenergic agents|mesh-ancestor
101984197|NCT01281787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101984198|NCT02953314|Ivacaftor|ivacaftor|mesh-list
101984199|NCT02953314|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101984200|NCT02953314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101984201|NCT02953314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984202|NCT00007475|Cyclophosphamide|cyclophosphamide|mesh-list
101984203|NCT00007475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101984204|NCT00007475|Immunologic Factors|immunologic factors|mesh-ancestor
101984205|NCT00007475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984206|NCT00007475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101984207|NCT00007475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101984208|NCT00007475|Alkylating Agents|alkylating agents|mesh-ancestor
101984209|NCT00007475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984210|NCT00007475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101984211|NCT00007475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101984212|NCT01273441|Amoxicillin|amoxicillin|mesh-list
101984213|NCT01273441|Metronidazole|metronidazole|mesh-list
101984214|NCT01273441|Clarithromycin|clarithromycin|mesh-list
101984215|NCT01273441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101984216|NCT01273441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101984217|NCT01273441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101984218|NCT01273441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101984219|NCT01273441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101984220|NCT01273441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101984221|NCT01273441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984222|NCT01273441|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101984223|NCT01273441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101984224|NCT03714360|Tranexamic Acid|tranexamic acid|mesh-list
101984225|NCT03714360|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101984226|NCT03714360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101947069|NCT01165125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984227|NCT03714360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984228|NCT03714360|Hemostatics|hemostatics|mesh-ancestor
101984229|NCT03714360|Coagulants|coagulants|mesh-ancestor
101984230|NCT01169857|Bortezomib|bortezomib|mesh-list
101984231|NCT01169857|Proteasome Inhibitors|proteasome inhibitors|mesh-list
101984232|NCT01169857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101984233|NCT01169857|Protease Inhibitors|protease inhibitors|mesh-ancestor
101984234|NCT01169857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101984235|NCT01169857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984236|NCT01169935|Dextrans|dextrans|mesh-list
101984237|NCT01169935|Anticoagulants|anticoagulants|mesh-ancestor
101984238|NCT01169935|Plasma Substitutes|plasma substitutes|mesh-ancestor
101984239|NCT01169935|Blood Substitutes|blood substitutes|mesh-ancestor
101984240|NCT01168063|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101984241|NCT01168063|Amoxicillin|amoxicillin|mesh-list
101984242|NCT01168063|Metronidazole|metronidazole|mesh-list
101984243|NCT01168063|Clarithromycin|clarithromycin|mesh-list
101984244|NCT01168063|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101984245|NCT01168063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101984246|NCT01168063|Antitubercular Agents|antitubercular agents|mesh-ancestor
101984247|NCT01168063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101984248|NCT01168063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101984249|NCT01168063|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101984250|NCT01168063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101984251|NCT01168063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704059|NCT00866307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101984252|NCT01168063|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101984253|NCT01168063|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101984254|NCT01166035|Lenalidomide|lenalidomide|mesh-list
101984255|NCT01166035|Cetuximab|cetuximab|mesh-list
101984268|NCT01281943|Sirolimus|sirolimus|mesh-list
101984269|NCT01281943|Doxorubicin|doxorubicin|mesh-list
101984270|NCT01281943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101984271|NCT01281943|Temsirolimus|temsirolimus|mesh-list
101984272|NCT01281943|MTOR Inhibitors|mtor inhibitors|mesh-list
101984273|NCT01281943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101984274|NCT01281943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101984275|NCT01281943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101984276|NCT01281943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101984277|NCT01281943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101984278|NCT01281943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984279|NCT01281943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101984280|NCT01281943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101984281|NCT01281943|Immunologic Factors|immunologic factors|mesh-ancestor
101984282|NCT01281943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984283|NCT01281943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101984284|NCT01281943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101984285|NCT01281943|Antifungal Agents|antifungal agents|mesh-ancestor
101984286|NCT03869047|Dexmedetomidine|dexmedetomidine|mesh-list
101984287|NCT03869047|Bupivacaine|bupivacaine|mesh-list
101984288|NCT03869047|Anesthetics, Local|anesthetics, local|mesh-ancestor
101984289|NCT03869047|Anesthetics|anesthetics|mesh-ancestor
101984290|NCT03869047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101984291|NCT03869047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984292|NCT03869047|Sensory System Agents|sensory system agents|mesh-ancestor
101984293|NCT03869047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101984294|NCT03869047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101984295|NCT03869047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101984296|NCT03869047|Analgesics|analgesics|mesh-ancestor
101984297|NCT03869047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101984298|NCT03869047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101984299|NCT03869047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101984300|NCT03869047|Adrenergic Agents|adrenergic agents|mesh-ancestor
101711338|NCT03854227|Docetaxel|docetaxel|mesh-list
101984301|NCT03869047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101984302|NCT03869047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984303|NCT01168531|Dexamethasone|dexamethasone|mesh-list
101984304|NCT01168531|Pregabalin|pregabalin|mesh-list
101984305|NCT01168531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101984306|NCT01168531|Antiemetics|antiemetics|mesh-ancestor
101984307|NCT01168531|Autonomic Agents|autonomic agents|mesh-ancestor
101984308|NCT01168531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101984309|NCT01168531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984310|NCT01168531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101984311|NCT01168531|Glucocorticoids|glucocorticoids|mesh-ancestor
101984312|NCT01168531|Hormones|hormones|mesh-ancestor
101947070|NCT01165125|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101947071|NCT01163799|Alefacept|alefacept|mesh-list
101947072|NCT01163799|Dermatologic Agents|dermatologic agents|mesh-ancestor
101947073|NCT01163799|Immunologic Factors|immunologic factors|mesh-ancestor
101947074|NCT01163799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984313|NCT01168531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101984314|NCT01168531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101984315|NCT01168531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101984316|NCT01168531|Analgesics|analgesics|mesh-ancestor
101984317|NCT01168531|Sensory System Agents|sensory system agents|mesh-ancestor
101984318|NCT01168531|Anticonvulsants|anticonvulsants|mesh-ancestor
101984319|NCT01168531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101984345|NCT01282333|Gemcitabine|gemcitabine|mesh-list
101984346|NCT01282333|Veliparib|veliparib|mesh-list
101984347|NCT01282333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101984348|NCT01282333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101984349|NCT01282333|Antimetabolites|antimetabolites|mesh-ancestor
101984350|NCT01282333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984351|NCT01282333|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101984352|NCT01282333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101984353|NCT01166425|Lithium Carbonate|lithium carbonate|mesh-list
101984354|NCT01166425|Antidepressive Agents|antidepressive agents|mesh-ancestor
101984355|NCT01166425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101984356|NCT01166425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101984357|NCT01166425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984358|NCT01166425|Antimanic Agents|antimanic agents|mesh-ancestor
101984359|NCT01166425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101984360|NCT01166425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101984361|NCT01166425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984362|NCT03868969|Fosfomycin|fosfomycin|mesh-list
101984363|NCT03868969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101984364|NCT03868969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101984365|NCT01311570|Buprenorphine|buprenorphine|mesh-list
101984366|NCT01311570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101984367|NCT01311570|Narcotics|narcotics|mesh-ancestor
101984368|NCT01311570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101984371|NCT01311570|Sensory System Agents|sensory system agents|mesh-ancestor
101984372|NCT01311570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101984373|NCT01311570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101984374|NCT01170325|Valproic Acid|valproic acid|mesh-list
101984375|NCT01170325|Anticonvulsants|anticonvulsants|mesh-ancestor
101984376|NCT01170325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101984377|NCT01170325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984378|NCT01170325|GABA Agents|gaba agents|mesh-ancestor
101984379|NCT01170325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101984380|NCT01170325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984381|NCT01170325|Antimanic Agents|antimanic agents|mesh-ancestor
101984382|NCT01170325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101984383|NCT01170325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101984384|NCT01170325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101984386|NCT05542446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101984387|NCT05542446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101984388|NCT03355326|Glycerol|glycerol|mesh-list
101984389|NCT03355326|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101984390|NCT03355326|Protective Agents|protective agents|mesh-ancestor
101711341|NCT03854227|Antimitotic Agents|antimitotic agents|mesh-ancestor
101984391|NCT03355326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984392|NCT01170637|Ibuprofen|ibuprofen|mesh-list
101984393|NCT01170637|Pseudoephedrine|pseudoephedrine|mesh-list
101984394|NCT01170637|Ephedrine|ephedrine|mesh-list
101984395|NCT01170637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101984396|NCT01170637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101984397|NCT01170637|Analgesics|analgesics|mesh-ancestor
101984398|NCT01170637|Sensory System Agents|sensory system agents|mesh-ancestor
101984399|NCT01170637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101984400|NCT01170637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984401|NCT01170637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101984402|NCT01170637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101704216|NCT02716259|Fluorides|fluorides|mesh-list
101984403|NCT01170637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101984404|NCT01170637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101984405|NCT01170637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947075|NCT02274662|Cyclosporine|cyclosporine|mesh-list
101947076|NCT02274662|Tacrolimus|tacrolimus|mesh-list
101947077|NCT02274662|Cyclosporins|cyclosporins|mesh-list
101947078|NCT02274662|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101947079|NCT02274662|Thymoglobulin|thymoglobulin|mesh-list
101947080|NCT02274662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101947081|NCT02274662|Immunologic Factors|immunologic factors|mesh-ancestor
101947082|NCT02274662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947083|NCT02274662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101947084|NCT02274662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101984406|NCT01170637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101984407|NCT01170637|Autonomic Agents|autonomic agents|mesh-ancestor
101984408|NCT01170637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101984409|NCT01170637|Respiratory System Agents|respiratory system agents|mesh-ancestor
101984410|NCT01170637|Nasal Decongestants|nasal decongestants|mesh-ancestor
101984411|NCT01170637|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101984412|NCT01170637|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101984413|NCT01170637|Sympathomimetics|sympathomimetics|mesh-ancestor
101984414|NCT01170637|Adrenergic Agents|adrenergic agents|mesh-ancestor
101984415|NCT01170637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101984416|NCT03873025|Pembrolizumab|pembrolizumab|mesh-list
101984417|NCT03873025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101984418|NCT03873025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101984419|NCT03873025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101984420|NCT03873025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984421|NCT02526745|Vaccines|vaccines|mesh-list
101984422|NCT02526745|Immunologic Factors|immunologic factors|mesh-ancestor
101984423|NCT02526745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984424|NCT01169389|Bupivacaine|bupivacaine|mesh-list
101984425|NCT01169389|Anesthetics, Local|anesthetics, local|mesh-ancestor
101984426|NCT01169389|Anesthetics|anesthetics|mesh-ancestor
101984427|NCT01169389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101984428|NCT01169389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984429|NCT01169389|Sensory System Agents|sensory system agents|mesh-ancestor
101984430|NCT01169389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101984431|NCT01170871|Pemetrexed|pemetrexed|mesh-list
101984432|NCT01170871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101984433|NCT01170871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101984434|NCT01170871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984435|NCT01170871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101984436|NCT01170871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101984437|NCT03868111|Sufentanil|sufentanil|mesh-list
101984438|NCT03868111|Remifentanil|remifentanil|mesh-list
101984439|NCT03868111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101984440|NCT03868111|Narcotics|narcotics|mesh-ancestor
101984441|NCT03868111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101984444|NCT03868111|Sensory System Agents|sensory system agents|mesh-ancestor
101984445|NCT03868111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101984446|NCT03868111|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101984447|NCT03868111|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101984448|NCT03868111|Anesthetics, General|anesthetics, general|mesh-ancestor
101984449|NCT03868111|Anesthetics|anesthetics|mesh-ancestor
101984450|NCT01282879|Itraconazole|itraconazole|mesh-list
101984451|NCT01282879|Antifungal Agents|antifungal agents|mesh-ancestor
101984452|NCT01282879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101984453|NCT01282879|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101984454|NCT01282879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101984455|NCT01282879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101984456|NCT01282879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984457|NCT01282879|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101984458|NCT01282879|Hormone Antagonists|hormone antagonists|mesh-ancestor
101984459|NCT01282879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101984460|NCT01282879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984461|NCT01282879|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101984462|NCT03868033|Zoledronic Acid|zoledronic acid|mesh-list
101984463|NCT03868033|Denosumab|denosumab|mesh-list
101947085|NCT02274662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947086|NCT02274662|Antifungal Agents|antifungal agents|mesh-ancestor
101947087|NCT02274662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101947088|NCT02274662|Dermatologic Agents|dermatologic agents|mesh-ancestor
101811167|NCT00751205|Vitamins|vitamins|mesh-ancestor
101984464|NCT03868033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101984465|NCT03868033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984466|NCT01166815|Zinc Sulfate|zinc sulfate|mesh-list
101984467|NCT01166815|Astringents|astringents|mesh-ancestor
101984468|NCT01166815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984469|NCT01166815|Dermatologic Agents|dermatologic agents|mesh-ancestor
101984470|NCT03751657|Insulin|insulin|mesh-list
101984471|NCT03751657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101984472|NCT03751657|Metformin|metformin|mesh-list
101984473|NCT03751657|Insulin Glargine|insulin glargine|mesh-list
101984474|NCT03751657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
101984475|NCT03751657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101704286|NCT02752841|Micronutrients|micronutrients|mesh-ancestor
101984476|NCT03751657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984478|NCT03751657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101984479|NCT03751657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984480|NCT03873415|Deucravacitinib|deucravacitinib|mesh-list
101984481|NCT03873415|Dermatologic Agents|dermatologic agents|mesh-ancestor
101984482|NCT03873415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101984483|NCT03873415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101984484|NCT03873415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984485|NCT00025259|Cytarabine|cytarabine|mesh-list
101984486|NCT00025259|Dexamethasone|dexamethasone|mesh-list
101984487|NCT00025259|Prednisone|prednisone|mesh-list
101984488|NCT00025259|Dexamethasone acetate|dexamethasone acetate|mesh-list
101984489|NCT00025259|Cortisone|cortisone|mesh-list
101984490|NCT00025259|Cyclophosphamide|cyclophosphamide|mesh-list
101984491|NCT00025259|Cisplatin|cisplatin|mesh-list
101984492|NCT00025259|Doxorubicin|doxorubicin|mesh-list
101984493|NCT00025259|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101984494|NCT00025259|Etoposide|etoposide|mesh-list
101984495|NCT00025259|Vincristine|vincristine|mesh-list
101984496|NCT00025259|Etoposide phosphate|etoposide phosphate|mesh-list
101984497|NCT00025259|Bleomycin|bleomycin|mesh-list
101984498|NCT00025259|Podophyllotoxin|podophyllotoxin|mesh-list
101984499|NCT00025259|Lenograstim|lenograstim|mesh-list
101984500|NCT00025259|BB 1101|bb 1101|mesh-list
101984501|NCT00025259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101984502|NCT00025259|Immunologic Factors|immunologic factors|mesh-ancestor
101984503|NCT00025259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984504|NCT00025259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101984505|NCT00025259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101984506|NCT00025259|Alkylating Agents|alkylating agents|mesh-ancestor
101984507|NCT00025259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984508|NCT00025259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101984509|NCT00025259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101984510|NCT00025259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101984511|NCT00025259|Antiemetics|antiemetics|mesh-ancestor
101984512|NCT00025259|Autonomic Agents|autonomic agents|mesh-ancestor
101984513|NCT00025259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101984514|NCT00025259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101984515|NCT00025259|Glucocorticoids|glucocorticoids|mesh-ancestor
101984516|NCT00025259|Hormones|hormones|mesh-ancestor
101984517|NCT00025259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101984522|NCT00025259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101984523|NCT00025259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101984524|NCT00025259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101984525|NCT00025259|Antimetabolites|antimetabolites|mesh-ancestor
101984526|NCT00025259|Antiviral Agents|antiviral agents|mesh-ancestor
101984527|NCT00025259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101984528|NCT00025259|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101984529|NCT00025259|Tubulin Modulators|tubulin modulators|mesh-ancestor
101984530|NCT00025259|Antimitotic Agents|antimitotic agents|mesh-ancestor
101984531|NCT00025259|Mitosis Modulators|mitosis modulators|mesh-ancestor
101984532|NCT00025259|Protease Inhibitors|protease inhibitors|mesh-ancestor
101984533|NCT00025259|Keratolytic Agents|keratolytic agents|mesh-ancestor
101984534|NCT00025259|Dermatologic Agents|dermatologic agents|mesh-ancestor
101984535|NCT01171651|Sorafenib|sorafenib|mesh-list
101984536|NCT01171651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101947089|NCT02274662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101984537|NCT01171651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101984538|NCT01171651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101984539|NCT01171651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984540|NCT03866629|Lifitegrast|lifitegrast|mesh-list
101984541|NCT03866629|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101984542|NCT03866629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101984543|NCT01280071|Aminophylline|aminophylline|mesh-list
101984544|NCT01280071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101984545|NCT01280071|Autonomic Agents|autonomic agents|mesh-ancestor
101984546|NCT01280071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101984547|NCT01280071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984548|NCT01280071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101984549|NCT01280071|Respiratory System Agents|respiratory system agents|mesh-ancestor
101984550|NCT01280071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101984551|NCT01280071|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101984552|NCT01280071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101984553|NCT01280071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984554|NCT01280071|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101984555|NCT01280071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101984556|NCT01280071|Purinergic Agents|purinergic agents|mesh-ancestor
101984557|NCT01280071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101984558|NCT01280071|Protective Agents|protective agents|mesh-ancestor
101984559|NCT02526199|Dexamethasone|dexamethasone|mesh-list
101984560|NCT02526199|Epinephrine|epinephrine|mesh-list
101984561|NCT02526199|Bupivacaine|bupivacaine|mesh-list
101984562|NCT02526199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101984563|NCT02526199|Antiemetics|antiemetics|mesh-ancestor
101984564|NCT02526199|Autonomic Agents|autonomic agents|mesh-ancestor
101984565|NCT02526199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101984566|NCT02526199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984567|NCT02526199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101984568|NCT02526199|Glucocorticoids|glucocorticoids|mesh-ancestor
101984569|NCT02526199|Hormones|hormones|mesh-ancestor
101984570|NCT02526199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101984571|NCT02526199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101984572|NCT02526199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101984573|NCT02526199|Anesthetics, Local|anesthetics, local|mesh-ancestor
101984574|NCT02526199|Anesthetics|anesthetics|mesh-ancestor
101984575|NCT02526199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101984576|NCT02526199|Sensory System Agents|sensory system agents|mesh-ancestor
101984577|NCT02526199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101984578|NCT02526199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101984579|NCT02526199|Adrenergic Agents|adrenergic agents|mesh-ancestor
101984580|NCT02526199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101984581|NCT02526199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984582|NCT02526199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101984583|NCT02526199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101984584|NCT02526199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101984585|NCT02526199|Respiratory System Agents|respiratory system agents|mesh-ancestor
101984586|NCT02526199|Mydriatics|mydriatics|mesh-ancestor
101984587|NCT02526199|Sympathomimetics|sympathomimetics|mesh-ancestor
101984588|NCT02526199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101984611|NCT03863977|Anesthetics, Local|anesthetics, local|mesh-ancestor
101984612|NCT03863977|Anesthetics|anesthetics|mesh-ancestor
101984613|NCT03863977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101984614|NCT03863977|Sensory System Agents|sensory system agents|mesh-ancestor
101984615|NCT01171807|Dexamethasone|dexamethasone|mesh-list
101984616|NCT01171807|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101984617|NCT01171807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101984618|NCT01171807|Antiemetics|antiemetics|mesh-ancestor
101984619|NCT01171807|Autonomic Agents|autonomic agents|mesh-ancestor
101984620|NCT01171807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101984621|NCT01171807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984622|NCT01171807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101984623|NCT01171807|Glucocorticoids|glucocorticoids|mesh-ancestor
101984624|NCT01171807|Hormones|hormones|mesh-ancestor
101984625|NCT01171807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101984626|NCT01171807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101704438|NCT00996697|Autonomic Agents|autonomic agents|mesh-ancestor
101984627|NCT01171807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101984628|NCT05445648|Tislelizumab|tislelizumab|mesh-list
101984629|NCT05445648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101984630|NCT05445648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101947090|NCT02891174|Acetaminophen|acetaminophen|mesh-list
101947091|NCT02891174|Ibuprofen|ibuprofen|mesh-list
101947092|NCT02891174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101947093|NCT02891174|Analgesics|analgesics|mesh-ancestor
101947094|NCT02891174|Sensory System Agents|sensory system agents|mesh-ancestor
101947095|NCT02891174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101947096|NCT02891174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984632|NCT01171885|Anesthetics, Local|anesthetics, local|mesh-ancestor
101984633|NCT01171885|Anesthetics|anesthetics|mesh-ancestor
101984634|NCT01171885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101984635|NCT01171885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984636|NCT01171885|Sensory System Agents|sensory system agents|mesh-ancestor
101984637|NCT01171885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101984638|NCT01286233|Metformin|metformin|mesh-list
101984639|NCT01286233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101984640|NCT01286233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984641|NCT01175161|Copper|copper|mesh-list
101984667|NCT00024167|Hormones|hormones|mesh-ancestor
101984668|NCT00024167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101984669|NCT00024167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101984670|NCT00024167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101984671|NCT00024167|Tubulin Modulators|tubulin modulators|mesh-ancestor
101984672|NCT00024167|Antimitotic Agents|antimitotic agents|mesh-ancestor
101984673|NCT00024167|Mitosis Modulators|mitosis modulators|mesh-ancestor
101984674|NCT00024167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984675|NCT00024167|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101984676|NCT00024167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101984677|NCT00024167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101984678|NCT00024167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101984679|NCT00024167|Antifungal Agents|antifungal agents|mesh-ancestor
101984680|NCT00024167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101984681|NCT00024167|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101984682|NCT00024167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101984683|NCT00024167|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101984684|NCT00024167|Hormone Antagonists|hormone antagonists|mesh-ancestor
101984685|NCT00024167|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101984686|NCT00024167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101984687|NCT00024167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101984688|NCT00024167|Alkylating Agents|alkylating agents|mesh-ancestor
101984689|NCT03867097|Iloprost|iloprost|mesh-list
101984690|NCT03867097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101984691|NCT03867097|Vasodilator Agents|vasodilator agents|mesh-ancestor
101984692|NCT00022763|Enfuvirtide|enfuvirtide|mesh-list
101984693|NCT00022763|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101984702|NCT01285141|Immunologic Factors|immunologic factors|mesh-ancestor
101984703|NCT01285141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984704|NCT01285141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101984705|NCT01285141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101984706|NCT01285141|Antiviral Agents|antiviral agents|mesh-ancestor
101984707|NCT01285141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101984708|NCT01285141|Interferon Inducers|interferon inducers|mesh-ancestor
101984709|NCT01285141|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101984710|NCT01285141|Protective Agents|protective agents|mesh-ancestor
101984711|NCT01285219|Lenograstim|lenograstim|mesh-list
101984712|NCT01285219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101984713|NCT01285219|Immunologic Factors|immunologic factors|mesh-ancestor
101984714|NCT01285219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984715|NCT01284439|Hyaluronic Acid|hyaluronic acid|mesh-list
101984716|NCT01284439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101984717|NCT01284439|Immunologic Factors|immunologic factors|mesh-ancestor
101984718|NCT01284439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984719|NCT01284439|Viscosupplements|viscosupplements|mesh-ancestor
101984720|NCT01284439|Protective Agents|protective agents|mesh-ancestor
101984721|NCT01172431|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101984722|NCT01172431|Indapamide|indapamide|mesh-list
101984723|NCT01172431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101984724|NCT01172431|Diuretics|diuretics|mesh-ancestor
101984725|NCT01172431|Natriuretic Agents|natriuretic agents|mesh-ancestor
101984726|NCT01172431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947097|NCT02891174|Antipyretics|antipyretics|mesh-ancestor
101947098|NCT02891174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101947099|NCT02891174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101984727|NCT01172431|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101984728|NCT01172431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101984729|NCT01172431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984730|NCT01172509|Baclofen|baclofen|mesh-list
101984731|NCT01172509|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101984732|NCT01172509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984733|NCT01172509|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101984734|NCT01172509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101984735|NCT01172509|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101984736|NCT01172509|GABA Agonists|gaba agonists|mesh-ancestor
101984737|NCT01172509|GABA Agents|gaba agents|mesh-ancestor
101984738|NCT01172509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101984739|NCT01172509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984740|NCT01089959|Esomeprazole|esomeprazole|mesh-list
101984741|NCT01089959|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101984742|NCT01089959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101984743|NCT01089959|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101984744|NCT01089959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101984745|NCT01089959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984746|NCT01090037|Epoprostenol|epoprostenol|mesh-list
101984747|NCT01090037|Beraprost|beraprost|mesh-list
101984748|NCT01090037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101984749|NCT01090037|Vasodilator Agents|vasodilator agents|mesh-ancestor
101984750|NCT01090037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101984751|NCT01285375|Curcumin|curcumin|mesh-list
101984752|NCT01285375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101984753|NCT01285375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101984754|NCT01285375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101984755|NCT01285375|Analgesics|analgesics|mesh-ancestor
101984756|NCT01285375|Sensory System Agents|sensory system agents|mesh-ancestor
101984757|NCT01285375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101984758|NCT01285375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984759|NCT01285375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101984777|NCT01178047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101984778|NCT01178047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984779|NCT01178047|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101984780|NCT01178047|Protective Agents|protective agents|mesh-ancestor
101984781|NCT01178047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984782|NCT01101113|Cinacalcet|cinacalcet|mesh-list
101984783|NCT01101113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101984784|NCT01101113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984785|NCT01101113|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101984786|NCT01101113|Hormone Antagonists|hormone antagonists|mesh-ancestor
101984787|NCT01101113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101984788|NCT01288261|Paclitaxel|paclitaxel|mesh-list
101984789|NCT01288261|Bavituximab|bavituximab|mesh-list
101984790|NCT01288261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101984791|NCT01288261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101984792|NCT01288261|Tubulin Modulators|tubulin modulators|mesh-ancestor
101984793|NCT01288261|Antimitotic Agents|antimitotic agents|mesh-ancestor
101984794|NCT01288261|Mitosis Modulators|mitosis modulators|mesh-ancestor
101984795|NCT01288261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984796|NCT01288261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101984797|NCT01174303|Insulin|insulin|mesh-list
101984798|NCT01174303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101984799|NCT01174303|Insulin Aspart|insulin aspart|mesh-list
101984800|NCT01174303|Insulin, Long-Acting|insulin, long-acting|mesh-list
101984801|NCT01174303|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101984802|NCT01174303|Biphasic Insulins|biphasic insulins|mesh-list
101984803|NCT01174303|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101984804|NCT01174303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101984805|NCT01174303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984806|NCT01285453|Vadimezan|vadimezan|mesh-list
101984807|NCT01285453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101984808|NCT01288339|Leucovorin|leucovorin|mesh-list
101984809|NCT01288339|Fluorouracil|fluorouracil|mesh-list
101984810|NCT01288339|Oxaliplatin|oxaliplatin|mesh-list
101984811|NCT01288339|Panitumumab|panitumumab|mesh-list
101947100|NCT02891174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101947101|NCT02891174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101947102|NCT02891174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101947103|NCT02891174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947104|NCT01280175|Charcoal|charcoal|mesh-list
101947105|NCT01280175|Antidotes|antidotes|mesh-ancestor
101947106|NCT01280175|Protective Agents|protective agents|mesh-ancestor
101947107|NCT01280175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947108|NCT01588431|Bevacizumab|bevacizumab|mesh-list
101947109|NCT01588431|Cetuximab|cetuximab|mesh-list
101947110|NCT01588431|Cisplatin|cisplatin|mesh-list
101947111|NCT01588431|Docetaxel|docetaxel|mesh-list
101947112|NCT01588431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101947113|NCT01588431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101984812|NCT01288339|Antimetabolites|antimetabolites|mesh-ancestor
101984813|NCT01288339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984814|NCT01288339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101984815|NCT01288339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101984823|NCT01288339|Micronutrients|micronutrients|mesh-ancestor
101984824|NCT01288339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101984825|NCT00006389|Bryostatin 1|bryostatin 1|mesh-list
101984826|NCT00006389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101984827|NCT00006389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101984828|NCT00006389|Immunologic Factors|immunologic factors|mesh-ancestor
101984829|NCT00006389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984830|NCT04965311|Botulinum Toxins|botulinum toxins|mesh-list
101984831|NCT04965311|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101984832|NCT04965311|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101984833|NCT04965311|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
101984834|NCT04965311|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101984835|NCT04965311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101984836|NCT04965311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984837|NCT04965311|Cholinergic Agents|cholinergic agents|mesh-ancestor
101984838|NCT04965311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101984839|NCT04965311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984840|NCT04965311|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101984841|NCT04965311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101984842|NCT01105481|Amisulpride|amisulpride|mesh-list
101984843|NCT01105481|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101984844|NCT01105481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101984845|NCT01105481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101984846|NCT01105481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984847|NCT01105481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101984848|NCT01105481|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101984849|NCT01105481|Dopamine Agents|dopamine agents|mesh-ancestor
101984850|NCT01105481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101984851|NCT01105481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984852|NCT01105481|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101704664|NCT01001143|Decitabine|decitabine|mesh-list
101984853|NCT01105481|Antidepressive Agents|antidepressive agents|mesh-ancestor
101984854|NCT01178203|Naproxen|naproxen|mesh-list
101984855|NCT01178203|Tramadol|tramadol|mesh-list
101984856|NCT01178203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101984857|NCT01178203|Narcotics|narcotics|mesh-ancestor
101984858|NCT01178203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101984859|NCT01178203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984860|NCT01178203|Analgesics|analgesics|mesh-ancestor
101984861|NCT01178203|Sensory System Agents|sensory system agents|mesh-ancestor
101984862|NCT01178203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101984863|NCT01178203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101984864|NCT01178203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101984865|NCT01178203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101947114|NCT01588431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101947115|NCT01588431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101947116|NCT01588431|Growth Substances|growth substances|mesh-ancestor
101947117|NCT01588431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947118|NCT01588431|Growth Inhibitors|growth inhibitors|mesh-ancestor
101947119|NCT01588431|Tubulin Modulators|tubulin modulators|mesh-ancestor
101984866|NCT01178203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101984867|NCT01178203|Gout Suppressants|gout suppressants|mesh-ancestor
101984868|NCT01178203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101984869|NCT01178203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101984870|NCT01178203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984871|NCT01286701|Terbinafine|terbinafine|mesh-list
101984872|NCT01286701|Antifungal Agents|antifungal agents|mesh-ancestor
101984873|NCT01286701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101984874|NCT01286701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101984875|NCT01286701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984876|NCT00006305|Biguanides|biguanides|mesh-list
101984877|NCT00006305|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
101984878|NCT00006305|Calcium Channel Blockers|calcium channel blockers|mesh-list
101984879|NCT00006305|Calcium|calcium|mesh-list
101984880|NCT00006305|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101984881|NCT00006305|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101984882|NCT00006305|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
101984883|NCT00006305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101984887|NCT00006305|Adrenergic Agents|adrenergic agents|mesh-ancestor
101984888|NCT00006305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101984889|NCT00006305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984890|NCT00006305|Protease Inhibitors|protease inhibitors|mesh-ancestor
101984891|NCT00006305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101984892|NCT00006305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101984893|NCT01284907|Vitamin D|vitamin d|mesh-list
101984894|NCT01284907|Cholecalciferol|cholecalciferol|mesh-list
101984895|NCT01284907|Vitamins|vitamins|mesh-ancestor
101984896|NCT01284907|Micronutrients|micronutrients|mesh-ancestor
101984897|NCT01284907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984898|NCT01284907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101984899|NCT01284907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101984900|NCT01286857|Silicon|silicon|mesh-list
101984901|NCT01286857|Trace Elements|trace elements|mesh-ancestor
101984902|NCT01286857|Micronutrients|micronutrients|mesh-ancestor
101984903|NCT01286857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984904|NCT01101269|Lisinopril|lisinopril|mesh-list
101984905|NCT01101269|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101984906|NCT01101269|Protease Inhibitors|protease inhibitors|mesh-ancestor
101711467|NCT00692120|Ergocalciferols|ergocalciferols|mesh-list
101984907|NCT01101269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101984908|NCT01101269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984909|NCT01101269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101984910|NCT01101269|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101984911|NCT01101269|Protective Agents|protective agents|mesh-ancestor
101984912|NCT01101269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984913|NCT01103375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101984914|NCT01103375|Isotretinoin|isotretinoin|mesh-list
101984915|NCT01103375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101984916|NCT01103375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101984917|NCT01103375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101984918|NCT01103375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984919|NCT01103375|Dermatologic Agents|dermatologic agents|mesh-ancestor
101984920|NCT03949049|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
101984921|NCT03949049|Nootropic Agents|nootropic agents|mesh-ancestor
101984922|NCT01288417|Raltegravir Potassium|raltegravir potassium|mesh-list
101984923|NCT01288417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101984924|NCT01288417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101984925|NCT01288417|Antiviral Agents|antiviral agents|mesh-ancestor
101984926|NCT01288417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101574999|NCT02872389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101984927|NCT01288417|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101984928|NCT01288417|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101984929|NCT01288417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101984930|NCT01288417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947120|NCT01588431|Antimitotic Agents|antimitotic agents|mesh-ancestor
101947121|NCT01588431|Mitosis Modulators|mitosis modulators|mesh-ancestor
101947122|NCT01588431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947123|NCT01583283|Dexamethasone|dexamethasone|mesh-list
101947124|NCT01583283|Lenalidomide|lenalidomide|mesh-list
101811591|NCT01324180|Metformin|metformin|mesh-list
101984931|NCT01285765|Rituximab|rituximab|mesh-list
101984932|NCT01285765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101984933|NCT01285765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101984934|NCT01285765|Immunologic Factors|immunologic factors|mesh-ancestor
101984935|NCT01285765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984936|NCT01285765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101984937|NCT03864913|Testosterone|testosterone|mesh-list
101984938|NCT03864913|Androgens|androgens|mesh-ancestor
101984939|NCT03864913|Hormones|hormones|mesh-ancestor
101984940|NCT03864913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101984941|NCT03864913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984942|NCT03865147|Acetaminophen|acetaminophen|mesh-list
101984943|NCT03865147|Cetrimonium|cetrimonium|mesh-list
101984944|NCT03865147|Ibuprofen|ibuprofen|mesh-list
101984945|NCT03865147|Lidocaine|lidocaine|mesh-list
101984946|NCT03865147|Epinephrine|epinephrine|mesh-list
101984947|NCT03865147|Racepinephrine|racepinephrine|mesh-list
101984948|NCT03865147|Bupivacaine|bupivacaine|mesh-list
101984949|NCT03865147|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
101984950|NCT03865147|Epinephryl borate|epinephryl borate|mesh-list
101984951|NCT03865147|Anesthetics, Local|anesthetics, local|mesh-ancestor
101984952|NCT03865147|Anesthetics|anesthetics|mesh-ancestor
101984953|NCT03865147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101984954|NCT03865147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984955|NCT03865147|Sensory System Agents|sensory system agents|mesh-ancestor
101984962|NCT03865147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101984963|NCT03865147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101984964|NCT03865147|Analgesics|analgesics|mesh-ancestor
101984965|NCT03865147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101984966|NCT03865147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101984967|NCT03865147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101984968|NCT03865147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101984969|NCT03865147|Antipyretics|antipyretics|mesh-ancestor
101984970|NCT03865147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101984971|NCT03865147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101984972|NCT03865147|Adrenergic Agents|adrenergic agents|mesh-ancestor
101984973|NCT03865147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101984974|NCT03865147|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101984975|NCT03865147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101984976|NCT03865147|Autonomic Agents|autonomic agents|mesh-ancestor
101984977|NCT03865147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101984978|NCT03865147|Respiratory System Agents|respiratory system agents|mesh-ancestor
101984979|NCT03865147|Mydriatics|mydriatics|mesh-ancestor
101984980|NCT03865147|Sympathomimetics|sympathomimetics|mesh-ancestor
101984981|NCT03865147|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101984982|NCT03865147|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
101984983|NCT03865147|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101984984|NCT03865147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101984985|NCT03722823|Tucatinib|tucatinib|mesh-list
101984986|NCT03722823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101984987|NCT03722823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101984988|NCT03722823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101984989|NCT03722823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984990|NCT03862651|Cangrelor|cangrelor|mesh-list
101984991|NCT03862651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101984992|NCT03862651|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101984993|NCT03862651|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101984994|NCT03862651|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101984995|NCT03862651|Purinergic Agents|purinergic agents|mesh-ancestor
101984996|NCT03862651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101984997|NCT03862651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984998|NCT03862651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984999|NCT03349710|Nivolumab|nivolumab|mesh-list
101985000|NCT03349710|Cetuximab|cetuximab|mesh-list
101985001|NCT03349710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101985002|NCT03349710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101947126|NCT01583283|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
101985003|NCT03349710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101985004|NCT03349710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985005|NCT01288495|Psyllium|psyllium|mesh-list
101985006|NCT01288495|Cathartics|cathartics|mesh-ancestor
101985007|NCT01288495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101985008|NCT01105793|Danazol|danazol|mesh-list
101985009|NCT01105793|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101985010|NCT01105793|Hormone Antagonists|hormone antagonists|mesh-ancestor
101985011|NCT01105793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101985012|NCT01105793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985013|NCT04934579|Rituximab|rituximab|mesh-list
101985014|NCT04934579|Methotrexate|methotrexate|mesh-list
101985015|NCT04934579|Lenalidomide|lenalidomide|mesh-list
101985016|NCT04934579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101985017|NCT04934579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101985018|NCT04934579|Immunologic Factors|immunologic factors|mesh-ancestor
101985019|NCT04934579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985020|NCT04934579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101985021|NCT04934579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101985022|NCT04934579|Abortifacient Agents|abortifacient agents|mesh-ancestor
101985038|NCT01103609|Warfarin|warfarin|mesh-list
101985039|NCT01103609|Anticoagulants|anticoagulants|mesh-ancestor
101985040|NCT03528369|Capsaicin|capsaicin|mesh-list
101985041|NCT03528369|Antipruritics|antipruritics|mesh-ancestor
101985042|NCT03528369|Dermatologic Agents|dermatologic agents|mesh-ancestor
101985043|NCT03528369|Sensory System Agents|sensory system agents|mesh-ancestor
101985044|NCT03528369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101985045|NCT03528369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985046|NCT01288573|Plerixafor|plerixafor|mesh-list
101985047|NCT01288573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101985048|NCT01288573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101985049|NCT01288573|Antiviral Agents|antiviral agents|mesh-ancestor
101985050|NCT01288573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101985051|NCT01174693|Clopidogrel|clopidogrel|mesh-list
101985052|NCT01174693|Triflusal|triflusal|mesh-list
101985053|NCT01174693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101985054|NCT01174693|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101985055|NCT01174693|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101985056|NCT01174693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101985057|NCT01174693|Purinergic Agents|purinergic agents|mesh-ancestor
101711490|NCT00819585|Immunologic Factors|immunologic factors|mesh-ancestor
101985058|NCT01174693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101985059|NCT01174693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985060|NCT01174693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985061|NCT00006011|Paclitaxel|paclitaxel|mesh-list
101985062|NCT00006011|Doxorubicin|doxorubicin|mesh-list
101985063|NCT00006011|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101985064|NCT00006011|Lenograstim|lenograstim|mesh-list
101985065|NCT00006011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101985066|NCT00006011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101985067|NCT00006011|Tubulin Modulators|tubulin modulators|mesh-ancestor
101985068|NCT00006011|Antimitotic Agents|antimitotic agents|mesh-ancestor
101985069|NCT00006011|Mitosis Modulators|mitosis modulators|mesh-ancestor
101985070|NCT00006011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985071|NCT00006011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101985072|NCT00006011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101985073|NCT00006011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101985074|NCT00006011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101985075|NCT00006011|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101985076|NCT00006011|Immunologic Factors|immunologic factors|mesh-ancestor
101985077|NCT00006011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985078|NCT01105871|Naloxone|naloxone|mesh-list
101985079|NCT01105871|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101985080|NCT01105871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985081|NCT01105871|Sensory System Agents|sensory system agents|mesh-ancestor
101985082|NCT01105871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101985088|NCT05625581|Cyclophosphamide|cyclophosphamide|mesh-list
101985089|NCT05625581|Tofacitinib|tofacitinib|mesh-list
101985090|NCT05625581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101985091|NCT05625581|Immunologic Factors|immunologic factors|mesh-ancestor
101985092|NCT05625581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985093|NCT05625581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101985094|NCT05625581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101985095|NCT05625581|Alkylating Agents|alkylating agents|mesh-ancestor
101947127|NCT01583283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101947128|NCT01583283|Antiemetics|antiemetics|mesh-ancestor
101947129|NCT01583283|Autonomic Agents|autonomic agents|mesh-ancestor
101811716|NCT01038388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101985096|NCT05625581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985097|NCT05625581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101985098|NCT05625581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101985099|NCT05625581|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101985100|NCT05625581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101985101|NCT05625581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101985102|NCT01176175|Progesterone|progesterone|mesh-list
101985103|NCT01176175|Progestins|progestins|mesh-ancestor
101985104|NCT01176175|Hormones|hormones|mesh-ancestor
101985105|NCT01176175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101985106|NCT01176175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985107|NCT05624099|Paclitaxel|paclitaxel|mesh-list
101985108|NCT05624099|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101985109|NCT05624099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101985110|NCT05624099|Tubulin Modulators|tubulin modulators|mesh-ancestor
101985111|NCT05624099|Antimitotic Agents|antimitotic agents|mesh-ancestor
101985112|NCT05624099|Mitosis Modulators|mitosis modulators|mesh-ancestor
101985113|NCT05624099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985114|NCT03864601|JNJ-56136379|jnj-56136379|mesh-list
101985115|NCT03864601|Antiviral Agents|antiviral agents|mesh-ancestor
101985116|NCT03864601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101985117|NCT03864523|Pioglitazone|pioglitazone|mesh-list
101985118|NCT03864523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101985119|NCT03864523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985120|NCT01174849|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101985121|NCT01174849|Immunologic Factors|immunologic factors|mesh-ancestor
101985122|NCT01174849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985123|NCT03583359|Lidocaine|lidocaine|mesh-list
101985124|NCT03583359|Anesthetics, Local|anesthetics, local|mesh-ancestor
101985125|NCT03583359|Anesthetics|anesthetics|mesh-ancestor
101985126|NCT03583359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101711496|NCT00687284|Insulin Detemir|insulin detemir|mesh-list
101985127|NCT03583359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985128|NCT03583359|Sensory System Agents|sensory system agents|mesh-ancestor
101985129|NCT03583359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101985130|NCT03583359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101985131|NCT03583359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101985132|NCT03583359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101985133|NCT03583359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101985134|NCT03583359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985135|NCT05619887|Fentanyl|fentanyl|mesh-list
101985136|NCT05619887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101985137|NCT05619887|Narcotics|narcotics|mesh-ancestor
101985138|NCT05619887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101985139|NCT05619887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985140|NCT05619887|Analgesics|analgesics|mesh-ancestor
101985141|NCT05619887|Sensory System Agents|sensory system agents|mesh-ancestor
101985142|NCT05619887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101985143|NCT05619887|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101985144|NCT05619887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101985145|NCT05619887|Anesthetics, General|anesthetics, general|mesh-ancestor
101985146|NCT05619887|Anesthetics|anesthetics|mesh-ancestor
101985147|NCT01174927|Heroin|heroin|mesh-list
101985148|NCT01174927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101985149|NCT01174927|Narcotics|narcotics|mesh-ancestor
101985150|NCT01174927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101985151|NCT01174927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985163|NCT03948737|Tocopherols|tocopherols|mesh-list
101985165|NCT03948737|Tocotrienols|tocotrienols|mesh-list
101985166|NCT03948737|alpha-Tocopherol|alpha-tocopherol|mesh-list
101985167|NCT03948737|Antioxidants|antioxidants|mesh-ancestor
101985168|NCT03948737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985169|NCT03948737|Protective Agents|protective agents|mesh-ancestor
101985170|NCT03948737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985171|NCT03948737|Vitamins|vitamins|mesh-ancestor
101985172|NCT03948737|Micronutrients|micronutrients|mesh-ancestor
101985173|NCT01287247|Botulinum Toxins|botulinum toxins|mesh-list
101985174|NCT01287247|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
101985175|NCT01287247|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101947130|NCT01583283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101947131|NCT01583283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947132|NCT01583283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101947133|NCT01583283|Glucocorticoids|glucocorticoids|mesh-ancestor
101947135|NCT01583283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101985176|NCT01287247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101985177|NCT01287247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985178|NCT01287247|Cholinergic Agents|cholinergic agents|mesh-ancestor
101985179|NCT01287247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101985180|NCT01287247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985181|NCT01287247|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101985182|NCT01287247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101985183|NCT01327859|Donepezil|donepezil|mesh-list
101985184|NCT01327859|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101985185|NCT01327859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101985186|NCT01327859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985187|NCT01327859|Cholinergic Agents|cholinergic agents|mesh-ancestor
101985188|NCT01327859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101985189|NCT01327859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985190|NCT01327859|Nootropic Agents|nootropic agents|mesh-ancestor
101985191|NCT01176409|Valacyclovir|valacyclovir|mesh-list
101985192|NCT01176409|Antiviral Agents|antiviral agents|mesh-ancestor
101985193|NCT01176409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101985194|NCT03480009|Oxycodone|oxycodone|mesh-list
101985195|NCT03480009|Dextromethorphan|dextromethorphan|mesh-list
101985196|NCT03480009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101985197|NCT03480009|Narcotics|narcotics|mesh-ancestor
101985198|NCT03480009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101985199|NCT03480009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985200|NCT03480009|Analgesics|analgesics|mesh-ancestor
101711499|NCT02358395|Sorafenib|sorafenib|mesh-list
101985201|NCT03480009|Sensory System Agents|sensory system agents|mesh-ancestor
101985202|NCT03480009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101985203|NCT03480009|Antitussive Agents|antitussive agents|mesh-ancestor
101985204|NCT03480009|Respiratory System Agents|respiratory system agents|mesh-ancestor
101985205|NCT03480009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101985206|NCT03480009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101985207|NCT03480009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101985208|NCT03480009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985209|NCT03859375|Disinfectants|disinfectants|mesh-list
101985210|NCT03859375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101985211|NCT01310751|Iloprost|iloprost|mesh-list
101985212|NCT01310751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101985213|NCT01310751|Vasodilator Agents|vasodilator agents|mesh-ancestor
101985214|NCT01180933|Folic Acid|folic acid|mesh-list
101985215|NCT01180933|Vitamin B Complex|vitamin b complex|mesh-list
101985216|NCT01180933|Hematinics|hematinics|mesh-ancestor
101985220|NCT03639363|Chlorhexidine|chlorhexidine|mesh-list
101985221|NCT03639363|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101985222|NCT03639363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101985223|NCT03639363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101985224|NCT03639363|Disinfectants|disinfectants|mesh-ancestor
101985225|NCT03639363|Dermatologic Agents|dermatologic agents|mesh-ancestor
101985226|NCT03859141|Vaccines|vaccines|mesh-list
101985227|NCT03859141|Immunologic Factors|immunologic factors|mesh-ancestor
101985228|NCT03859141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985229|NCT03859219|Rozanolixizumab|rozanolixizumab|mesh-list
101985230|NCT03859219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101985231|NCT03859219|Immunologic Factors|immunologic factors|mesh-ancestor
101985232|NCT03859219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985233|NCT03374358|Raltegravir Potassium|raltegravir potassium|mesh-list
101985234|NCT03374358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101985235|NCT03374358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101985236|NCT03374358|Antiviral Agents|antiviral agents|mesh-ancestor
101985237|NCT03374358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101985238|NCT03374358|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101985239|NCT03374358|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101985240|NCT03374358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101985241|NCT03374358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985242|NCT03711708|Sertraline|sertraline|mesh-list
101985243|NCT03711708|Antidepressive Agents|antidepressive agents|mesh-ancestor
101947136|NCT01583283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101947137|NCT01583283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101947138|NCT01583283|Immunologic Factors|immunologic factors|mesh-ancestor
101947139|NCT01583283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101947140|NCT01583283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101985244|NCT03711708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101985245|NCT03711708|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101985246|NCT03711708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101985247|NCT03711708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101985248|NCT03711708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985249|NCT03711708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101985250|NCT03711708|Serotonin Agents|serotonin agents|mesh-ancestor
101985251|NCT03711708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985253|NCT01179529|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101985254|NCT01179529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101985255|NCT01179529|Respiratory System Agents|respiratory system agents|mesh-ancestor
101985256|NCT00004859|Thalidomide|thalidomide|mesh-list
101985257|NCT00004859|Paclitaxel|paclitaxel|mesh-list
101985258|NCT00004859|Carboplatin|carboplatin|mesh-list
101985259|NCT00004859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101985260|NCT00004859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101985261|NCT00004859|Tubulin Modulators|tubulin modulators|mesh-ancestor
101985262|NCT00004859|Antimitotic Agents|antimitotic agents|mesh-ancestor
101985263|NCT00004859|Mitosis Modulators|mitosis modulators|mesh-ancestor
101985264|NCT00004859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985265|NCT00004859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101985266|NCT00004859|Immunologic Factors|immunologic factors|mesh-ancestor
101985267|NCT00004859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985268|NCT00004859|Leprostatic Agents|leprostatic agents|mesh-ancestor
101985269|NCT00004859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101985270|NCT00004859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101985271|NCT00004859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101197208|NCT01390051|Tinzaparin|tinzaparin|mesh-list
101985272|NCT00004859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101985273|NCT00004859|Growth Substances|growth substances|mesh-ancestor
101985274|NCT00004859|Growth Inhibitors|growth inhibitors|mesh-ancestor
101985275|NCT03348930|Tolcapone|tolcapone|mesh-list
101985276|NCT03348930|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101985277|NCT03348930|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101985278|NCT03348930|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101985279|NCT03348930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101985280|NCT03348930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985281|NCT03500211|Lidocaine|lidocaine|mesh-list
101985282|NCT03500211|Anesthetics, Local|anesthetics, local|mesh-ancestor
101985283|NCT03500211|Anesthetics|anesthetics|mesh-ancestor
101985284|NCT03500211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101985285|NCT03500211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985286|NCT03500211|Sensory System Agents|sensory system agents|mesh-ancestor
101985287|NCT03500211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101985288|NCT03500211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101985289|NCT03500211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101985316|NCT03478683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101985317|NCT03478683|Respiratory System Agents|respiratory system agents|mesh-ancestor
101985319|NCT03478683|Hormones|hormones|mesh-ancestor
101985320|NCT03478683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101985321|NCT03478683|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101985322|NCT03478683|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101985323|NCT03478683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101985324|NCT03478683|Adrenergic Agents|adrenergic agents|mesh-ancestor
101985325|NCT03478683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101985326|NCT03478683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985327|NCT03478683|Parasympatholytics|parasympatholytics|mesh-ancestor
101985328|NCT03478683|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101985329|NCT03478683|Cholinergic Agents|cholinergic agents|mesh-ancestor
101985330|NCT03478683|Tocolytic Agents|tocolytic agents|mesh-ancestor
101985331|NCT03478683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101985332|NCT04744883|Naloxone|naloxone|mesh-list
101985341|NCT01176799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101947141|NCT01583283|Growth Substances|growth substances|mesh-ancestor
101947142|NCT01583283|Growth Inhibitors|growth inhibitors|mesh-ancestor
101947143|NCT01583283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101811924|NCT00419926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101985342|NCT01176799|Immunologic Factors|immunologic factors|mesh-ancestor
101985343|NCT01176799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985344|NCT01176799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101985345|NCT01176799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101985346|NCT01176799|Alkylating Agents|alkylating agents|mesh-ancestor
101985347|NCT01176799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985348|NCT01176799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101985349|NCT01176799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101985350|NCT01176799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101985351|NCT01176799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101985352|NCT01176799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101985353|NCT01176799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101985354|NCT01176799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101985355|NCT01176799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101985356|NCT01176799|Growth Substances|growth substances|mesh-ancestor
101985357|NCT01176799|Growth Inhibitors|growth inhibitors|mesh-ancestor
101985358|NCT01176799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101985359|NCT03861403|Cyclophosphamide|cyclophosphamide|mesh-list
101985360|NCT03861403|Avelumab|avelumab|mesh-list
101985361|NCT03861403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101985362|NCT03861403|Immunologic Factors|immunologic factors|mesh-ancestor
101985363|NCT03861403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985364|NCT03861403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101985365|NCT03861403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101711508|NCT03928847|Antioxidants|antioxidants|mesh-ancestor
101985366|NCT03861403|Alkylating Agents|alkylating agents|mesh-ancestor
101985367|NCT03861403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985368|NCT03861403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101985369|NCT03861403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101985370|NCT03861403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101985371|NCT03477903|Metoclopramide|metoclopramide|mesh-list
101985372|NCT03477903|Antiemetics|antiemetics|mesh-ancestor
101985373|NCT03477903|Autonomic Agents|autonomic agents|mesh-ancestor
101985374|NCT03477903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101985375|NCT03477903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985376|NCT03477903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101985377|NCT03477903|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101985378|NCT03477903|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101985379|NCT03477903|Dopamine Agents|dopamine agents|mesh-ancestor
101985380|NCT03477903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101985381|NCT03477903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985382|NCT04728425|Immunoglobulins|immunoglobulins|mesh-list
101985383|NCT04728425|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101985384|NCT04728425|Antibodies|antibodies|mesh-list
101985385|NCT04728425|gamma-Globulins|gamma-globulins|mesh-list
101985386|NCT04728425|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101985387|NCT04728425|Immunoglobulin G|immunoglobulin g|mesh-list
101985388|NCT04728425|Immunologic Factors|immunologic factors|mesh-ancestor
101985389|NCT04728425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985390|NCT01181401|Cisplatin|cisplatin|mesh-list
101985391|NCT01181401|Docetaxel|docetaxel|mesh-list
101985392|NCT01181401|Cetuximab|cetuximab|mesh-list
101985393|NCT01181401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101985394|NCT01181401|Tubulin Modulators|tubulin modulators|mesh-ancestor
101985395|NCT01181401|Antimitotic Agents|antimitotic agents|mesh-ancestor
101985396|NCT01181401|Mitosis Modulators|mitosis modulators|mesh-ancestor
101985397|NCT01181401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985398|NCT01181401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101985399|NCT01287715|Etanercept|etanercept|mesh-list
101985400|NCT01287715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101985405|NCT01287715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985406|NCT01287715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101985407|NCT01287715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101985408|NCT01287715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101985409|NCT01287715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101985410|NCT01287715|Immunologic Factors|immunologic factors|mesh-ancestor
101985411|NCT03474081|Albuterol|albuterol|mesh-list
101985412|NCT03474081|Tiotropium Bromide|tiotropium bromide|mesh-list
101985413|NCT03474081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101947144|NCT01583283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947145|NCT02076620|Doxorubicin|doxorubicin|mesh-list
101947146|NCT02076620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101947147|NCT02076620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101985414|NCT03474081|Autonomic Agents|autonomic agents|mesh-ancestor
101985415|NCT03474081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101985416|NCT03474081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985417|NCT03474081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101985418|NCT03474081|Respiratory System Agents|respiratory system agents|mesh-ancestor
101985419|NCT03474081|Parasympatholytics|parasympatholytics|mesh-ancestor
101985420|NCT03474081|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101985421|NCT03474081|Cholinergic Agents|cholinergic agents|mesh-ancestor
101985422|NCT03474081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101985423|NCT03474081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985424|NCT03474081|Tocolytic Agents|tocolytic agents|mesh-ancestor
101985425|NCT03474081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101985426|NCT03474081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101985427|NCT03474081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101985428|NCT03474081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101985429|NCT03474081|Adrenergic Agents|adrenergic agents|mesh-ancestor
101985430|NCT03393000|Vitamin A|vitamin a|mesh-list
101985431|NCT03393000|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
101985432|NCT03393000|Antioxidants|antioxidants|mesh-ancestor
101985433|NCT03393000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711516|NCT02624726|Leucovorin|leucovorin|mesh-list
101985434|NCT03393000|Protective Agents|protective agents|mesh-ancestor
101985435|NCT03393000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985436|NCT03393000|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101985437|NCT03393000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101985438|NCT03393000|Vitamins|vitamins|mesh-ancestor
101985439|NCT03393000|Micronutrients|micronutrients|mesh-ancestor
101985440|NCT01311804|Parecoxib|parecoxib|mesh-list
101985441|NCT01311804|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101985442|NCT01311804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101985443|NCT01311804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101985444|NCT01311804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985445|NCT01311804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101985446|NCT01311804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101985447|NCT01311804|Analgesics|analgesics|mesh-ancestor
101985448|NCT01311804|Sensory System Agents|sensory system agents|mesh-ancestor
101985449|NCT01311804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101985450|NCT01311804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985451|NCT01311804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101705259|NCT02638922|Norethindrone|norethindrone|mesh-list
101985452|NCT01311804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101985453|NCT03370770|Osimertinib|osimertinib|mesh-list
101985454|NCT03370770|Afatinib|afatinib|mesh-list
101985455|NCT03370770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101985456|NCT03370770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101985457|NCT03370770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101985458|NCT03370770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985459|NCT01180075|Ritonavir|ritonavir|mesh-list
101985460|NCT01180075|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101985461|NCT01180075|Tenofovir|tenofovir|mesh-list
101985462|NCT01180075|Emtricitabine|emtricitabine|mesh-list
101985463|NCT01180075|Efavirenz|efavirenz|mesh-list
101985464|NCT01180075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101985465|NCT01180075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101985466|NCT01180075|Protease Inhibitors|protease inhibitors|mesh-ancestor
101985467|NCT01180075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101985468|NCT01180075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985469|NCT01180075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101985470|NCT01180075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101985471|NCT01180075|Antiviral Agents|antiviral agents|mesh-ancestor
101440542|NCT03914625|Prednisolone acetate|prednisolone acetate|mesh-list
101985478|NCT01180075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101985479|NCT01180075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101985480|NCT01180075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101985481|NCT01180075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101985482|NCT01311882|Zopiclone|zopiclone|mesh-list
101985483|NCT01311882|Suvorexant|suvorexant|mesh-list
101985484|NCT01311882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101947148|NCT02076620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101947149|NCT02076620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101947150|NCT02076620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101947151|NCT02076620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985485|NCT01311882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101985486|NCT01311882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985487|NCT01311882|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101985488|NCT01311882|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
101985489|NCT01311882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101985490|NCT01311882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985491|NCT01287793|Moxifloxacin|moxifloxacin|mesh-list
101985492|NCT01287793|Tigecycline|tigecycline|mesh-list
101985493|NCT01287793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101985494|NCT01287793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101985495|NCT01287793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101985496|NCT01287793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101985497|NCT01287793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101985498|NCT01287793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985499|NCT01287793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101985500|NCT01287793|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101985501|NCT03391284|Acetaminophen|acetaminophen|mesh-list
101985502|NCT03391284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101985503|NCT03391284|Analgesics|analgesics|mesh-ancestor
101985504|NCT03391284|Sensory System Agents|sensory system agents|mesh-ancestor
101985505|NCT03391284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101985506|NCT03391284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985507|NCT03391284|Antipyretics|antipyretics|mesh-ancestor
101985508|NCT01180153|Oxaliplatin|oxaliplatin|mesh-list
101985509|NCT01180153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101985510|NCT03719625|Norepinephrine|norepinephrine|mesh-list
101985511|NCT03719625|Ephedrine|ephedrine|mesh-list
101985512|NCT03719625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101985513|NCT03719625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101985514|NCT03719625|Adrenergic Agents|adrenergic agents|mesh-ancestor
101985515|NCT03719625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101985516|NCT03719625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985517|NCT03719625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985518|NCT03719625|Sympathomimetics|sympathomimetics|mesh-ancestor
101985519|NCT03719625|Autonomic Agents|autonomic agents|mesh-ancestor
101985520|NCT03719625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101985521|NCT03719625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101985522|NCT03719625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101985523|NCT01289743|Etanercept|etanercept|mesh-list
101985524|NCT01289743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101985525|NCT01289743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101705347|NCT01005433|Analgesics|analgesics|mesh-ancestor
101985526|NCT01289743|Analgesics|analgesics|mesh-ancestor
101985527|NCT01289743|Sensory System Agents|sensory system agents|mesh-ancestor
101985528|NCT01289743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101985529|NCT01289743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985530|NCT01289743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101985531|NCT01289743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101985532|NCT01289743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101985533|NCT01289743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101985534|NCT01289743|Immunologic Factors|immunologic factors|mesh-ancestor
101985535|NCT03390426|Anesthetics|anesthetics|mesh-list
101985536|NCT03390426|Mepivacaine|mepivacaine|mesh-list
101985537|NCT03390426|Anesthetics, Local|anesthetics, local|mesh-list
101985540|NCT03390426|Sensory System Agents|sensory system agents|mesh-ancestor
101985541|NCT03390426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101985542|NCT03472521|Gabapentin|gabapentin|mesh-list
101985543|NCT03472521|Analgesics|analgesics|mesh-ancestor
101985544|NCT03472521|Sensory System Agents|sensory system agents|mesh-ancestor
101985545|NCT03472521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101985546|NCT03472521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985547|NCT03472521|Anticonvulsants|anticonvulsants|mesh-ancestor
101985548|NCT03472521|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101985549|NCT03472521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101985550|NCT03472521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101985551|NCT03472521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101985552|NCT03472521|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101947152|NCT01270737|Daidzein|daidzein|mesh-list
101812141|NCT02559791|Reslizumab|reslizumab|mesh-list
101985553|NCT03472521|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101985554|NCT03472521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101985555|NCT03472521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985556|NCT03472521|Antimanic Agents|antimanic agents|mesh-ancestor
101985557|NCT02906020|Venglustat|venglustat|mesh-list
101985558|NCT02906020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101985559|NCT02906020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985560|NCT01177423|Anesthetics|anesthetics|mesh-list
101985561|NCT01177423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101985562|NCT01177423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985563|NCT01180231|Moxonidine|moxonidine|mesh-list
101985564|NCT01180231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101985565|NCT01177501|Topotecan|topotecan|mesh-list
101985566|NCT01177501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101985567|NCT01177501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101985568|NCT01177501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101985569|NCT01177501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985570|NCT01177501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101985571|NCT03478150|Zinc Oxide|zinc oxide|mesh-list
101985572|NCT03478150|Dermatologic Agents|dermatologic agents|mesh-ancestor
101985573|NCT03478150|Sunscreening Agents|sunscreening agents|mesh-ancestor
101985574|NCT03478150|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101985575|NCT03478150|Protective Agents|protective agents|mesh-ancestor
101985576|NCT03478150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985577|NCT03499353|Talazoparib|talazoparib|mesh-list
101985578|NCT03499353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101985579|NCT03499353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101985580|NCT03499353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985581|NCT03499353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101985582|NCT03368664|Interferons|interferons|mesh-list
101985583|NCT03368664|Acyclovir|acyclovir|mesh-list
101985584|NCT03368664|Interferon-beta|interferon-beta|mesh-list
101985585|NCT03368664|Methylprednisolone|methylprednisolone|mesh-list
101985586|NCT03368664|Prednisolone|prednisolone|mesh-list
101985587|NCT03368664|Alemtuzumab|alemtuzumab|mesh-list
101985588|NCT03368664|Glatiramer Acetate|glatiramer acetate|mesh-list
101985589|NCT03368664|Ranitidine|ranitidine|mesh-list
101985590|NCT03368664|(T,G)-A-L|(t,g)-a-l|mesh-list
101985591|NCT03368664|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
101985592|NCT03368664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101985593|NCT03368664|Antiviral Agents|antiviral agents|mesh-ancestor
101985594|NCT03368664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101985595|NCT03368664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101985596|NCT03368664|Antiemetics|antiemetics|mesh-ancestor
101985597|NCT03368664|Autonomic Agents|autonomic agents|mesh-ancestor
101985598|NCT03368664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101985599|NCT03368664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985600|NCT03368664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101705411|NCT01005979|Rituximab|rituximab|mesh-list
101985601|NCT03368664|Glucocorticoids|glucocorticoids|mesh-ancestor
101985602|NCT03368664|Hormones|hormones|mesh-ancestor
101985603|NCT03368664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101985604|NCT03368664|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101985605|NCT03368664|Protective Agents|protective agents|mesh-ancestor
101985606|NCT03368664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101985607|NCT03368664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101985608|NCT03368664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101985609|NCT03368664|Immunologic Factors|immunologic factors|mesh-ancestor
101985610|NCT03368664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101985620|NCT00004259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101985621|NCT00004259|Alkylating Agents|alkylating agents|mesh-ancestor
101985622|NCT00004259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985623|NCT00004259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101985625|NCT01177579|Trace Elements|trace elements|mesh-ancestor
101985626|NCT01177579|Micronutrients|micronutrients|mesh-ancestor
101985627|NCT01177579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985628|NCT03722355|Carmustine|carmustine|mesh-list
101985629|NCT03722355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101985630|NCT03722355|Alkylating Agents|alkylating agents|mesh-ancestor
101985631|NCT03722355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985632|NCT03722355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101985633|NCT03857815|Antibodies|antibodies|mesh-list
101985634|NCT03857815|Immunologic Factors|immunologic factors|mesh-ancestor
101947153|NCT01270737|Phytoestrogens|phytoestrogens|mesh-ancestor
101947154|NCT01270737|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101947155|NCT01270737|Estrogens|estrogens|mesh-ancestor
101947156|NCT01270737|Hormones|hormones|mesh-ancestor
101971944|NCT02083250|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101985635|NCT03857815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985636|NCT03365934|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101985637|NCT03365934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101985638|NCT04682405|Melphalan|melphalan|mesh-list
101985639|NCT04682405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101985640|NCT04682405|Alkylating Agents|alkylating agents|mesh-ancestor
101985641|NCT04682405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985642|NCT04682405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101985643|NCT04682405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101985644|NCT04682405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101985645|NCT04682405|Immunologic Factors|immunologic factors|mesh-ancestor
101985646|NCT04682405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985647|NCT03477994|Clonidine|clonidine|mesh-list
101985648|NCT03477994|Dexmedetomidine|dexmedetomidine|mesh-list
101985649|NCT03477994|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101985650|NCT03477994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101985651|NCT03477994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985652|NCT03477994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101985653|NCT03477994|Analgesics|analgesics|mesh-ancestor
101985654|NCT03477994|Sensory System Agents|sensory system agents|mesh-ancestor
101985655|NCT03477994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101985656|NCT03477994|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101985657|NCT03477994|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101985658|NCT03477994|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101985659|NCT03477994|Adrenergic Agents|adrenergic agents|mesh-ancestor
101985660|NCT03477994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101985661|NCT03477994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985662|NCT03477994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101985663|NCT03477994|Sympatholytics|sympatholytics|mesh-ancestor
101985664|NCT03477994|Autonomic Agents|autonomic agents|mesh-ancestor
101985665|NCT04668131|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101985666|NCT04668131|Lubricant Eye Drops|lubricant eye drops|mesh-list
101985667|NCT04668131|Hyaluronic Acid|hyaluronic acid|mesh-list
101985668|NCT04668131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101985669|NCT04668131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101985670|NCT04668131|Immunologic Factors|immunologic factors|mesh-ancestor
101985671|NCT04668131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985672|NCT04668131|Viscosupplements|viscosupplements|mesh-ancestor
101985673|NCT04668131|Protective Agents|protective agents|mesh-ancestor
101985674|NCT03857581|Olanzapine|olanzapine|mesh-list
101985675|NCT03857581|Clozapine|clozapine|mesh-list
101985676|NCT03857581|Antiemetics|antiemetics|mesh-ancestor
101985677|NCT03857581|Autonomic Agents|autonomic agents|mesh-ancestor
101985678|NCT03857581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101985683|NCT03857581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101985685|NCT03857581|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101985686|NCT03857581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101985687|NCT03857581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101985688|NCT03857581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985689|NCT03857581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101985690|NCT03857581|Serotonin Agents|serotonin agents|mesh-ancestor
101985691|NCT03857581|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101985692|NCT03857581|GABA Antagonists|gaba antagonists|mesh-ancestor
101985693|NCT03857581|GABA Agents|gaba agents|mesh-ancestor
101985694|NCT01103843|Clopidogrel|clopidogrel|mesh-list
101985695|NCT01103843|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101985696|NCT01103843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101985697|NCT01103843|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101985698|NCT01103843|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101985699|NCT01103843|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101985700|NCT01103843|Purinergic Agents|purinergic agents|mesh-ancestor
101985701|NCT01103843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101985702|NCT01103843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985703|NCT01103843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985704|NCT03738865|Glucagon|glucagon|mesh-list
101947157|NCT01270737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101947158|NCT01270737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711551|NCT00819039|Ondansetron|ondansetron|mesh-list
101985705|NCT03738865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101985706|NCT03738865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101985707|NCT03738865|Hormones|hormones|mesh-ancestor
101985708|NCT03738865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101985709|NCT03738865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985710|NCT03738865|Incretins|incretins|mesh-ancestor
101985711|NCT03524157|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101985712|NCT03524157|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101985713|NCT03524157|Hyaluronic Acid|hyaluronic acid|mesh-list
101985714|NCT03524157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101985715|NCT03524157|Immunologic Factors|immunologic factors|mesh-ancestor
101985716|NCT03524157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985717|NCT03524157|Viscosupplements|viscosupplements|mesh-ancestor
101985718|NCT03524157|Protective Agents|protective agents|mesh-ancestor
101985719|NCT03719391|Nicotine|nicotine|mesh-list
101985720|NCT03719391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101985721|NCT03719391|Autonomic Agents|autonomic agents|mesh-ancestor
101985722|NCT03719391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101985723|NCT03719391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985724|NCT03719391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101985725|NCT03719391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101985726|NCT03719391|Cholinergic Agents|cholinergic agents|mesh-ancestor
101985727|NCT03719391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101985728|NCT03719391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985729|NCT03468543|Memantine|memantine|mesh-list
101985730|NCT03468543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101985731|NCT03468543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101985732|NCT03468543|Dopamine Agents|dopamine agents|mesh-ancestor
101985733|NCT03468543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101985734|NCT03468543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985735|NCT03468543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985736|NCT03468543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101985737|NCT03468543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101985738|NCT03467763|Metformin|metformin|mesh-list
101985739|NCT03467763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101985740|NCT03467763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985741|NCT00004031|Prednisone|prednisone|mesh-list
101985742|NCT00004031|Cyclophosphamide|cyclophosphamide|mesh-list
101985743|NCT00004031|Carmustine|carmustine|mesh-list
101985744|NCT00004031|Rituximab|rituximab|mesh-list
101985745|NCT00004031|Doxorubicin|doxorubicin|mesh-list
101985746|NCT00004031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101985747|NCT00004031|Etoposide|etoposide|mesh-list
101985748|NCT00004031|Vincristine|vincristine|mesh-list
101985749|NCT00004031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101985753|NCT00004031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101985755|NCT00004031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985756|NCT00004031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101985757|NCT00004031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101985758|NCT00004031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101985759|NCT00004031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101985760|NCT00004031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101985761|NCT00004031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101985762|NCT00004031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101985763|NCT00004031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101985764|NCT00004031|Glucocorticoids|glucocorticoids|mesh-ancestor
101985765|NCT00004031|Hormones|hormones|mesh-ancestor
101985766|NCT00004031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101985767|NCT00004031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101985768|NCT00004031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101985769|NCT00004031|Tubulin Modulators|tubulin modulators|mesh-ancestor
101985770|NCT00004031|Antimitotic Agents|antimitotic agents|mesh-ancestor
101985771|NCT00004031|Mitosis Modulators|mitosis modulators|mesh-ancestor
101985772|NCT01184443|Olanzapine|olanzapine|mesh-list
101985773|NCT01184443|Antiemetics|antiemetics|mesh-ancestor
101985774|NCT01184443|Autonomic Agents|autonomic agents|mesh-ancestor
101985775|NCT01184443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101985776|NCT01184443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985777|NCT01184443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101985778|NCT01184443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101985779|NCT01184443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101947159|NCT01270815|Pregabalin|pregabalin|mesh-list
101947160|NCT01270815|Analgesics|analgesics|mesh-ancestor
101947161|NCT01270815|Sensory System Agents|sensory system agents|mesh-ancestor
101947162|NCT01270815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101947163|NCT01270815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947164|NCT01270815|Anticonvulsants|anticonvulsants|mesh-ancestor
101985780|NCT01184443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101985781|NCT01184443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101985782|NCT01184443|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101985783|NCT01184443|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101985784|NCT01184443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101985785|NCT01184443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985786|NCT01184443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101985787|NCT01184443|Serotonin Agents|serotonin agents|mesh-ancestor
101985788|NCT01180621|Vaccines|vaccines|mesh-list
101985789|NCT01180621|Immunologic Factors|immunologic factors|mesh-ancestor
101985790|NCT01180621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985791|NCT01290133|Vestipitant|vestipitant|mesh-list
101985792|NCT01290133|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101985793|NCT01290133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101985794|NCT01290133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985795|NCT01290133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985796|NCT03467217|Losartan|losartan|mesh-list
101985797|NCT03467217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101985798|NCT03467217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101985799|NCT03467217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101985800|NCT03467217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101985801|NCT03467217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985802|NCT00003875|Aldesleukin|aldesleukin|mesh-list
101985803|NCT00003875|Etoposide|etoposide|mesh-list
101985804|NCT00003875|Etoposide phosphate|etoposide phosphate|mesh-list
101985805|NCT00003875|Busulfan|busulfan|mesh-list
101985806|NCT00003875|Interleukin-2|interleukin-2|mesh-list
101985807|NCT00003875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101985808|NCT00003875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101985809|NCT00003875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101985810|NCT00003875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101985811|NCT00003875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101985812|NCT00003875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985813|NCT00003875|Alkylating Agents|alkylating agents|mesh-ancestor
101985814|NCT00003875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101985815|NCT00003875|Immunologic Factors|immunologic factors|mesh-ancestor
101985816|NCT00003875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440900|NCT03301220|Daratumumab|daratumumab|mesh-list
101985821|NCT00003875|Sensory System Agents|sensory system agents|mesh-ancestor
101985822|NCT00003875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101985824|NCT00003875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101985825|NCT00003875|Antiviral Agents|antiviral agents|mesh-ancestor
101985826|NCT00003875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101985827|NCT01327625|Azithromycin|azithromycin|mesh-list
101985828|NCT01327625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101985829|NCT01327625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101985830|NCT01290211|Ritonavir|ritonavir|mesh-list
101985831|NCT01290211|Fosamprenavir|fosamprenavir|mesh-list
101985832|NCT01290211|Maraviroc|maraviroc|mesh-list
101985833|NCT01290211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101985834|NCT01290211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101985835|NCT01290211|Protease Inhibitors|protease inhibitors|mesh-ancestor
101985836|NCT01290211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101985837|NCT01290211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985838|NCT01290211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101985839|NCT01290211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101985840|NCT01290211|Antiviral Agents|antiviral agents|mesh-ancestor
101985841|NCT01290211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101985842|NCT01290211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101985843|NCT01290211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101985844|NCT01290211|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101985845|NCT01290211|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101985846|NCT01290211|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101947165|NCT01270815|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101947166|NCT01270815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101947167|NCT01270815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947168|NCT01270815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101985847|NCT03720873|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101985849|NCT03720873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101985850|NCT03720873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101985851|NCT03720873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101985852|NCT03720873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985853|NCT01311960|Bevacizumab|bevacizumab|mesh-list
101985854|NCT01311960|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101985855|NCT01311960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101985856|NCT01311960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101985857|NCT01311960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101985858|NCT01311960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101985859|NCT01311960|Growth Substances|growth substances|mesh-ancestor
101985860|NCT01311960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985861|NCT01311960|Growth Inhibitors|growth inhibitors|mesh-ancestor
101985862|NCT01311960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101985863|NCT03709056|Propofol|propofol|mesh-list
101985864|NCT03709056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101985865|NCT03709056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101985866|NCT03709056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985867|NCT03709056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101985868|NCT03709056|Anesthetics, General|anesthetics, general|mesh-ancestor
101985869|NCT03709056|Anesthetics|anesthetics|mesh-ancestor
101985870|NCT05663307|Aspirin|aspirin|mesh-list
101985871|NCT05663307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101985872|NCT05663307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101985873|NCT05663307|Analgesics|analgesics|mesh-ancestor
101985874|NCT05663307|Sensory System Agents|sensory system agents|mesh-ancestor
101985875|NCT05663307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101985876|NCT05663307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985877|NCT05663307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101985878|NCT05663307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101985879|NCT05663307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101985880|NCT05663307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101985881|NCT05663307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985882|NCT05663307|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101985883|NCT05663307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101985884|NCT05663307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101985885|NCT05663307|Antipyretics|antipyretics|mesh-ancestor
101985886|NCT01106495|Simvastatin|simvastatin|mesh-list
101985887|NCT01106495|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101985893|NCT01106495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101985894|NCT01184833|Interferons|interferons|mesh-list
101985895|NCT01184833|Interferon-beta|interferon-beta|mesh-list
101985896|NCT01184833|Interferon beta-1b|interferon beta-1b|mesh-list
101985897|NCT01184833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101985898|NCT01184833|Antiviral Agents|antiviral agents|mesh-ancestor
101985899|NCT01184833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101363225|NCT00131326|Hylan|hylan|mesh-list
101985900|NCT01184833|Immunologic Factors|immunologic factors|mesh-ancestor
101985901|NCT01184833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985902|NCT01184833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101985903|NCT01184911|Pyrimethamine|pyrimethamine|mesh-list
101985904|NCT01184911|Sulfadoxine|sulfadoxine|mesh-list
101985905|NCT01184911|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101985906|NCT01184911|Antimalarials|antimalarials|mesh-ancestor
101985907|NCT01184911|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101985908|NCT01184911|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101985909|NCT01184911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101985910|NCT01184911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101985911|NCT01184911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101985912|NCT01184911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985913|NCT01184911|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101985914|NCT01185067|Grape Seed Extract|grape seed extract|mesh-list
101985915|NCT01185067|Resveratrol|resveratrol|mesh-list
101985916|NCT01185067|Antioxidants|antioxidants|mesh-list
101985917|NCT01185067|Quercetin|quercetin|mesh-list
101947169|NCT01270815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101947170|NCT01270815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101947171|NCT01270815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101947172|NCT01270815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101985918|NCT01185067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985919|NCT01185067|Protective Agents|protective agents|mesh-ancestor
101985920|NCT01185067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985921|NCT01185067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101985922|NCT01185067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101985923|NCT01185067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101985924|NCT01185067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101985925|NCT03364686|Biotin|biotin|mesh-list
101985926|NCT03364686|Vitamin B Complex|vitamin b complex|mesh-ancestor
101985927|NCT03364686|Vitamins|vitamins|mesh-ancestor
101985928|NCT03364686|Micronutrients|micronutrients|mesh-ancestor
101985929|NCT03364686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985930|NCT03437577|Tacrolimus|tacrolimus|mesh-list
101985931|NCT03437577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101985932|NCT03437577|Immunologic Factors|immunologic factors|mesh-ancestor
101985933|NCT03437577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985934|NCT03437577|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101985935|NCT03437577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101985936|NCT03437577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985937|NCT03336528|Insulin Glargine|insulin glargine|mesh-list
101985938|NCT03336528|Insulin Aspart|insulin aspart|mesh-list
101985939|NCT03336528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101985940|NCT03336528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985941|NCT03364608|Albuterol|albuterol|mesh-list
101985942|NCT03364608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101985943|NCT03364608|Autonomic Agents|autonomic agents|mesh-ancestor
101985944|NCT03364608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101985945|NCT03364608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985946|NCT03364608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101985947|NCT03364608|Respiratory System Agents|respiratory system agents|mesh-ancestor
101985948|NCT03364608|Tocolytic Agents|tocolytic agents|mesh-ancestor
101985949|NCT03364608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101985950|NCT03364608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101985951|NCT03364608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101985952|NCT03364608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101985953|NCT03364608|Adrenergic Agents|adrenergic agents|mesh-ancestor
101985954|NCT03364608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101985955|NCT03364608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985956|NCT03719157|Anesthetics|anesthetics|mesh-list
101985957|NCT03719157|Anesthetics, Local|anesthetics, local|mesh-list
101985966|NCT01185223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101985967|NCT01185223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101985968|NCT01185223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101985969|NCT01185223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985971|NCT03852979|Carboplatin|carboplatin|mesh-list
101985972|NCT03852979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101985973|NCT03852979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101985974|NCT03852979|Tubulin Modulators|tubulin modulators|mesh-ancestor
101985975|NCT03852979|Antimitotic Agents|antimitotic agents|mesh-ancestor
101575000|NCT02872389|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101985976|NCT03852979|Mitosis Modulators|mitosis modulators|mesh-ancestor
101711587|NCT00692510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101985977|NCT03852979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985978|NCT01188031|Alprazolam|alprazolam|mesh-list
101985979|NCT01188031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101985980|NCT01188031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101985981|NCT01188031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985982|NCT01188031|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101985983|NCT01188031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101985984|NCT01188031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101985985|NCT01188031|GABA Modulators|gaba modulators|mesh-ancestor
101985986|NCT01188031|GABA Agents|gaba agents|mesh-ancestor
101985987|NCT01188031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101985988|NCT01188031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985989|NCT01182883|Sirolimus|sirolimus|mesh-list
101985990|NCT01182883|Temsirolimus|temsirolimus|mesh-list
101985991|NCT01182883|MTOR Inhibitors|mtor inhibitors|mesh-list
101985992|NCT01182883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101985993|NCT01182883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101985994|NCT01182883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985995|NCT01182883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101985996|NCT01182883|Immunologic Factors|immunologic factors|mesh-ancestor
101985997|NCT01182883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985998|NCT01182883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101985999|NCT01182883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101986000|NCT01182883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101986001|NCT01182883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101986002|NCT01182883|Antifungal Agents|antifungal agents|mesh-ancestor
101986003|NCT01188265|Valproic Acid|valproic acid|mesh-list
101986004|NCT01188265|Dextromethorphan|dextromethorphan|mesh-list
101986005|NCT01188265|Antitussive Agents|antitussive agents|mesh-ancestor
101986006|NCT01188265|Respiratory System Agents|respiratory system agents|mesh-ancestor
101986007|NCT01188265|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101986008|NCT01188265|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101986009|NCT01188265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101986010|NCT01188265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986011|NCT01188265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986012|NCT01188265|Anticonvulsants|anticonvulsants|mesh-ancestor
101986013|NCT01188265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101986014|NCT01188265|GABA Agents|gaba agents|mesh-ancestor
101986015|NCT01188265|Antimanic Agents|antimanic agents|mesh-ancestor
101986016|NCT01188265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101986017|NCT01188265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101986018|NCT01188265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101986019|NCT01291069|Tadalafil|tadalafil|mesh-list
101986020|NCT01291069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986021|NCT01291069|Vasodilator Agents|vasodilator agents|mesh-ancestor
101986022|NCT01291069|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101986026|NCT00003869|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
101986027|NCT00003869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101986028|NCT00003869|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101986029|NCT00003869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101986030|NCT00003869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986031|NCT00003869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101986032|NCT00003869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986034|NCT01588639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101986035|NCT01588639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101986036|NCT01588639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986037|NCT02524639|Sirolimus|sirolimus|mesh-list
101986038|NCT02524639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101986039|NCT02524639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101986040|NCT02524639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101986041|NCT02524639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101986042|NCT02524639|Antifungal Agents|antifungal agents|mesh-ancestor
101986043|NCT02524639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101986044|NCT02524639|Immunologic Factors|immunologic factors|mesh-ancestor
101986045|NCT02524639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986046|NCT01185535|Anesthetics|anesthetics|mesh-list
101986047|NCT01185535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101986048|NCT01185535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986049|NCT00003659|Cyclophosphamide|cyclophosphamide|mesh-list
101986050|NCT00003659|Rituximab|rituximab|mesh-list
101986051|NCT00003659|Fludarabine|fludarabine|mesh-list
101986052|NCT00003659|Fludarabine phosphate|fludarabine phosphate|mesh-list
101986053|NCT00003659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101986054|NCT00003659|Immunologic Factors|immunologic factors|mesh-ancestor
101986055|NCT00003659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986056|NCT00003659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101986057|NCT00003659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101986058|NCT00003659|Alkylating Agents|alkylating agents|mesh-ancestor
101986059|NCT00003659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986060|NCT00003659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101986061|NCT00003659|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101986062|NCT00003659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101986063|NCT00003659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101986064|NCT00003659|Antimetabolites|antimetabolites|mesh-ancestor
101986065|NCT01101581|Epratuzumab|epratuzumab|mesh-list
101986066|NCT01101581|Veltuzumab|veltuzumab|mesh-list
101986067|NCT01101581|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
101986068|NCT01101581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101947173|NCT01751984|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
101947174|NCT01751984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101947175|NCT01751984|Antimetabolites|antimetabolites|mesh-ancestor
101947176|NCT01751984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947177|NCT01751984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101947178|NCT01751984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101947179|NCT01751984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101947180|NCT01751984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947181|NCT03330236|Anesthetics|anesthetics|mesh-list
101947182|NCT03330236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101947183|NCT03330236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947184|NCT01271361|Sirolimus|sirolimus|mesh-list
101947185|NCT01271361|Umirolimus|umirolimus|mesh-list
101986069|NCT01101581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101986070|NCT01101581|Chelating Agents|chelating agents|mesh-ancestor
101986071|NCT01101581|Sequestering Agents|sequestering agents|mesh-ancestor
101986072|NCT01101581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986073|NCT01183585|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101986074|NCT01183585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101986075|NCT01183585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101986076|NCT01183585|Antimetabolites|antimetabolites|mesh-ancestor
101986077|NCT01183585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986078|NCT01183585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101986079|NCT01183585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101986080|NCT01183585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101986081|NCT03494985|Muramidase|muramidase|mesh-list
101986082|NCT03494985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101986083|NCT01185769|Tocotrienols|tocotrienols|mesh-list
101986084|NCT01185769|Vitamin E|vitamin e|mesh-list
101986085|NCT01185769|Tocopherols|tocopherols|mesh-list
101986086|NCT01185769|Antioxidants|antioxidants|mesh-ancestor
101986087|NCT01185769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986088|NCT01185769|Protective Agents|protective agents|mesh-ancestor
101986089|NCT01185769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986090|NCT01185769|Vitamins|vitamins|mesh-ancestor
101986091|NCT01185769|Micronutrients|micronutrients|mesh-ancestor
101986092|NCT01185847|Gemcitabine|gemcitabine|mesh-list
101986093|NCT01185847|Pemetrexed|pemetrexed|mesh-list
101441184|NCT02339571|Nivolumab|nivolumab|mesh-list
101986101|NCT03720483|Acetylcysteine|acetylcysteine|mesh-list
101986102|NCT03720483|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101986103|NCT03720483|Antiviral Agents|antiviral agents|mesh-ancestor
101986104|NCT03720483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101986105|NCT03720483|Expectorants|expectorants|mesh-ancestor
101986106|NCT03720483|Respiratory System Agents|respiratory system agents|mesh-ancestor
101986107|NCT03720483|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101986108|NCT03720483|Antioxidants|antioxidants|mesh-ancestor
101986109|NCT03720483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986110|NCT03720483|Protective Agents|protective agents|mesh-ancestor
101986111|NCT03720483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986112|NCT03720483|Antidotes|antidotes|mesh-ancestor
101986113|NCT01183663|Leucovorin|leucovorin|mesh-list
101986114|NCT01183663|Sirolimus|sirolimus|mesh-list
101986115|NCT01183663|Bevacizumab|bevacizumab|mesh-list
101986116|NCT01183663|Lenalidomide|lenalidomide|mesh-list
101986117|NCT01183663|Fluorouracil|fluorouracil|mesh-list
101986118|NCT01183663|Oxaliplatin|oxaliplatin|mesh-list
101986119|NCT01183663|Sorafenib|sorafenib|mesh-list
101986120|NCT01183663|Temsirolimus|temsirolimus|mesh-list
101986121|NCT01183663|MTOR Inhibitors|mtor inhibitors|mesh-list
101986122|NCT01183663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101986123|NCT01183663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101986124|NCT01183663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101986125|NCT01183663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101986126|NCT01183663|Growth Substances|growth substances|mesh-ancestor
101947186|NCT01271361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101947187|NCT01271361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101667031|NCT00898417|Paclitaxel|paclitaxel|mesh-list
101947189|NCT01271361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947190|NCT01271361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101947191|NCT01271361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101947192|NCT01271361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101947193|NCT01271361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101947194|NCT01271361|Antifungal Agents|antifungal agents|mesh-ancestor
101947195|NCT03638726|Atropine|atropine|mesh-list
101947196|NCT03638726|Phenylephrine|phenylephrine|mesh-list
101947197|NCT03638726|Epinephrine|epinephrine|mesh-list
101947198|NCT03638726|Racepinephrine|racepinephrine|mesh-list
101947199|NCT03638726|Oxymetazoline|oxymetazoline|mesh-list
101947200|NCT03638726|Cyclopentolate|cyclopentolate|mesh-list
101947201|NCT03638726|Epinephryl borate|epinephryl borate|mesh-list
101947202|NCT03638726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101947203|NCT03638726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101986127|NCT01183663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986128|NCT01183663|Growth Inhibitors|growth inhibitors|mesh-ancestor
101986129|NCT01183663|Antimetabolites|antimetabolites|mesh-ancestor
101986130|NCT01183663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986131|NCT01183663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101986132|NCT01183663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101986133|NCT01183663|Immunologic Factors|immunologic factors|mesh-ancestor
101986134|NCT01183663|Antidotes|antidotes|mesh-ancestor
101986135|NCT01183663|Protective Agents|protective agents|mesh-ancestor
101986136|NCT01183663|Vitamin B Complex|vitamin b complex|mesh-ancestor
101986137|NCT01183663|Vitamins|vitamins|mesh-ancestor
101986138|NCT01183663|Micronutrients|micronutrients|mesh-ancestor
101986139|NCT01183663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101986140|NCT01183663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101986141|NCT01183663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101986142|NCT01183663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101986143|NCT01183663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101986144|NCT01183663|Antifungal Agents|antifungal agents|mesh-ancestor
101986145|NCT01291927|Pancrelipase|pancrelipase|mesh-list
101986146|NCT01291927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101986147|NCT03344172|Hydroxychloroquine|hydroxychloroquine|mesh-list
101986148|NCT03344172|Paclitaxel|paclitaxel|mesh-list
101986149|NCT03344172|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101986150|NCT03344172|Gemcitabine|gemcitabine|mesh-list
101986151|NCT03344172|Avelumab|avelumab|mesh-list
101986152|NCT03344172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101986153|NCT03344172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101986154|NCT03344172|Tubulin Modulators|tubulin modulators|mesh-ancestor
101986155|NCT03344172|Antimitotic Agents|antimitotic agents|mesh-ancestor
101986156|NCT03344172|Mitosis Modulators|mitosis modulators|mesh-ancestor
101711615|NCT02303795|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101986157|NCT03344172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986158|NCT03344172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101986159|NCT03344172|Antimetabolites|antimetabolites|mesh-ancestor
101986160|NCT03344172|Antimalarials|antimalarials|mesh-ancestor
101986161|NCT03344172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101986162|NCT03344172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101986163|NCT03344172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101986164|NCT03344172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101986167|NCT01188733|Octreotide|octreotide|mesh-list
101986168|NCT01188733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101986169|NCT01188733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101986170|NCT01188733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101986171|NCT01101659|Ketamine|ketamine|mesh-list
101986172|NCT01101659|Analgesics|analgesics|mesh-ancestor
101986173|NCT01101659|Sensory System Agents|sensory system agents|mesh-ancestor
101947204|NCT03638726|Adrenergic Agents|adrenergic agents|mesh-ancestor
101947205|NCT03638726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101947206|NCT03638726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947207|NCT03638726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986174|NCT01101659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101986175|NCT01101659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986176|NCT01101659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101986177|NCT01101659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101986178|NCT01101659|Anesthetics, General|anesthetics, general|mesh-ancestor
101986179|NCT01101659|Anesthetics|anesthetics|mesh-ancestor
101986180|NCT01101659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101986181|NCT01101659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101986182|NCT01101659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101986183|NCT01101659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101986184|NCT01101659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986185|NCT03855865|Vortioxetine|vortioxetine|mesh-list
101986186|NCT03855865|Antidepressive Agents|antidepressive agents|mesh-ancestor
101986187|NCT03855865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101986188|NCT03855865|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101986189|NCT03855865|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101986190|NCT03855865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101986191|NCT03855865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986192|NCT03855865|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101986193|NCT03855865|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101986194|NCT03855865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101986195|NCT03855865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986196|NCT03855865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101986197|NCT03855865|Serotonin Agents|serotonin agents|mesh-ancestor
101986198|NCT03855865|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101986199|NCT03855865|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101986200|NCT03855865|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101986201|NCT03855865|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101986202|NCT01290367|Hyaluronic Acid|hyaluronic acid|mesh-list
101986203|NCT01290367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101986204|NCT01290367|Immunologic Factors|immunologic factors|mesh-ancestor
101986205|NCT01290367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986206|NCT01290367|Viscosupplements|viscosupplements|mesh-ancestor
101986207|NCT01290367|Protective Agents|protective agents|mesh-ancestor
101986208|NCT03465891|Atezolizumab|atezolizumab|mesh-list
101986209|NCT03465891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101986210|NCT03465891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986211|NCT03465891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101986212|NCT03465891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101986213|NCT03363906|Dulaglutide|dulaglutide|mesh-list
101986214|NCT03363906|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
101986215|NCT03363906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101986216|NCT03363906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986217|NCT03363906|Immunologic Factors|immunologic factors|mesh-ancestor
101986218|NCT03948191|Methylene diphosphonate|methylene diphosphonate|mesh-list
101986219|NCT03948191|Methylprednisolone|methylprednisolone|mesh-list
101986220|NCT03948191|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101986221|NCT03948191|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101986222|NCT03948191|Prednisolone|prednisolone|mesh-list
101986223|NCT03948191|Prednisolone acetate|prednisolone acetate|mesh-list
101986224|NCT03948191|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101986225|NCT03948191|Prednisolone phosphate|prednisolone phosphate|mesh-list
101986226|NCT03948191|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
101986227|NCT03948191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101986228|NCT03948191|Antiemetics|antiemetics|mesh-ancestor
101986229|NCT03948191|Autonomic Agents|autonomic agents|mesh-ancestor
101986230|NCT03948191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101986231|NCT03948191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986232|NCT03948191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101986233|NCT03948191|Glucocorticoids|glucocorticoids|mesh-ancestor
101986234|NCT03948191|Hormones|hormones|mesh-ancestor
101986235|NCT03948191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101986244|NCT01292083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101947208|NCT03638726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101947209|NCT03638726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101947210|NCT03638726|Autonomic Agents|autonomic agents|mesh-ancestor
101947211|NCT03638726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101947212|NCT03638726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101986246|NCT01292083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986247|NCT01292083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101986248|NCT01292083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101986249|NCT01104467|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
101986250|NCT01104467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101986251|NCT01104467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101986252|NCT01104467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986253|NCT01292161|Silymarin|silymarin|mesh-list
101986254|NCT01292161|Antioxidants|antioxidants|mesh-ancestor
101986255|NCT01292161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986256|NCT01292161|Protective Agents|protective agents|mesh-ancestor
101986257|NCT01292161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986258|NCT01185925|Sildenafil Citrate|sildenafil citrate|mesh-list
101986259|NCT01185925|Vasodilator Agents|vasodilator agents|mesh-ancestor
101986260|NCT01185925|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101986261|NCT01185925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101986262|NCT01185925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101986263|NCT01185925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986264|NCT01185925|Urological Agents|urological agents|mesh-ancestor
101986265|NCT01188889|Imatinib Mesylate|imatinib mesylate|mesh-list
101986266|NCT01188889|Everolimus|everolimus|mesh-list
101986267|NCT01188889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101986268|NCT01188889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101986269|NCT01188889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101986270|NCT01188889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986271|NCT01188889|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101986272|NCT01188889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101986273|NCT01188889|Immunologic Factors|immunologic factors|mesh-ancestor
101986274|NCT01188889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986275|NCT01184287|Ranpirnase|ranpirnase|mesh-list
101986276|NCT01184287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101986277|NCT01184287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101986278|NCT01184287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101986279|NCT01184287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986280|NCT01107431|Chromium|chromium|mesh-list
101986281|NCT01107431|Trace Elements|trace elements|mesh-ancestor
101986282|NCT01107431|Micronutrients|micronutrients|mesh-ancestor
101986283|NCT01107431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986284|NCT01186159|Parecoxib|parecoxib|mesh-list
101986285|NCT01186159|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101986286|NCT01186159|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101986287|NCT01186159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101986288|NCT01186159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986289|NCT01186159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101986290|NCT01186159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101986291|NCT01186159|Analgesics|analgesics|mesh-ancestor
101986292|NCT01186159|Sensory System Agents|sensory system agents|mesh-ancestor
101986293|NCT01186159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101986294|NCT01186159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986295|NCT01186159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101986296|NCT01186159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101986297|NCT01107509|Everolimus|everolimus|mesh-list
101986298|NCT01107509|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101986299|NCT01107509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101986319|NCT01293643|Tetracycline|tetracycline|mesh-list
101986320|NCT01293643|Ketoconazole|ketoconazole|mesh-list
101986321|NCT01293643|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101986322|NCT01293643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101986323|NCT01293643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101986324|NCT01293643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101986325|NCT01293643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101986326|NCT01293643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986327|NCT01293643|Antifungal Agents|antifungal agents|mesh-ancestor
101986328|NCT01293643|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101947213|NCT03638726|Respiratory System Agents|respiratory system agents|mesh-ancestor
101947214|NCT03638726|Mydriatics|mydriatics|mesh-ancestor
101947215|NCT03638726|Sympathomimetics|sympathomimetics|mesh-ancestor
101947216|NCT03638726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101986329|NCT01293643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101986330|NCT01293643|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101986331|NCT01293643|Hormone Antagonists|hormone antagonists|mesh-ancestor
101986332|NCT01293643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101986333|NCT01293643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986334|NCT01293643|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101986335|NCT01293643|Amebicides|amebicides|mesh-ancestor
101986336|NCT01293643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101986337|NCT01293643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101986338|NCT01105013|Clotrimazole|clotrimazole|mesh-list
101986339|NCT01105013|Miconazole|miconazole|mesh-list
101986340|NCT01105013|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101986341|NCT01105013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101986342|NCT01105013|Antifungal Agents|antifungal agents|mesh-ancestor
101986343|NCT01105013|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101986344|NCT01105013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101986345|NCT01105013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101986346|NCT01105013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986347|NCT01105013|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101986348|NCT01105013|Hormone Antagonists|hormone antagonists|mesh-ancestor
101711650|NCT01014481|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101986349|NCT01105013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101706170|NCT00695682|Infliximab|infliximab|mesh-list
101986350|NCT01105013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986351|NCT01105013|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101986352|NCT01105013|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101986377|NCT01186471|Autonomic Agents|autonomic agents|mesh-ancestor
101986378|NCT01186471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101986379|NCT01186471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986380|NCT01186471|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101986381|NCT01186471|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101986382|NCT01186471|Cholinergic Agents|cholinergic agents|mesh-ancestor
101986383|NCT01186471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101986384|NCT01186471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986385|NCT01292551|Bosentan|bosentan|mesh-list
101986386|NCT01292551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101986387|NCT01292551|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101986388|NCT01292551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986389|NCT03854383|Isosorbide|isosorbide|mesh-list
101986390|NCT03854383|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
101986391|NCT03854383|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
101986392|NCT03854383|Misoprostol|misoprostol|mesh-list
101986393|NCT03854383|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101986394|NCT03854383|Abortifacient Agents|abortifacient agents|mesh-ancestor
101986395|NCT03854383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101986396|NCT03854383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986397|NCT03854383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101986398|NCT03854383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101986399|NCT03854383|Oxytocics|oxytocics|mesh-ancestor
101986400|NCT03854383|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101986401|NCT03854383|Diuretics|diuretics|mesh-ancestor
101986402|NCT03854383|Natriuretic Agents|natriuretic agents|mesh-ancestor
101986403|NCT03854383|Vasodilator Agents|vasodilator agents|mesh-ancestor
101986404|NCT03854383|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101986405|NCT03854383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986406|NCT03854617|Vinorelbine|vinorelbine|mesh-list
101986407|NCT03854617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101441555|NCT02902744|Hormones|hormones|mesh-ancestor
101986416|NCT01186549|Anesthetics, Local|anesthetics, local|mesh-ancestor
101986418|NCT01186549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101986419|NCT01186549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986420|NCT01186549|Sensory System Agents|sensory system agents|mesh-ancestor
101986421|NCT01186549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101986422|NCT01186549|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101986423|NCT01186549|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101986424|NCT01186549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101947217|NCT03638726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101947218|NCT03638726|Nasal Decongestants|nasal decongestants|mesh-ancestor
101947219|NCT03638726|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101812971|NCT00079183|Sirolimus|sirolimus|mesh-list
101575001|NCT02872389|Anesthetics, General|anesthetics, general|mesh-ancestor
101986425|NCT01186549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101986426|NCT01186549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986427|NCT01186549|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101986429|NCT01186549|Autonomic Agents|autonomic agents|mesh-ancestor
101986430|NCT01186549|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101986431|NCT01186549|Adrenergic Agents|adrenergic agents|mesh-ancestor
101986432|NCT01186549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101986433|NCT01186549|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101986434|NCT01186549|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101986435|NCT01186549|Respiratory System Agents|respiratory system agents|mesh-ancestor
101986436|NCT01186549|Nasal Decongestants|nasal decongestants|mesh-ancestor
101986437|NCT03851341|Metformin|metformin|mesh-list
101986438|NCT03851341|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101986439|NCT03851341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101986440|NCT03851341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986441|NCT03851341|Incretins|incretins|mesh-ancestor
101986442|NCT03851341|Hormones|hormones|mesh-ancestor
101711668|NCT00508027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101986443|NCT03851341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101986444|NCT03851341|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101986445|NCT03851341|Protease Inhibitors|protease inhibitors|mesh-ancestor
101986446|NCT03851341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101986447|NCT03851341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986448|NCT03362190|Ranibizumab|ranibizumab|mesh-list
101986449|NCT03362190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101986450|NCT03362190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101986451|NCT03362190|Growth Substances|growth substances|mesh-ancestor
101986452|NCT03362190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986453|NCT03362190|Growth Inhibitors|growth inhibitors|mesh-ancestor
101986454|NCT03362190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101986455|NCT01292785|Hormones|hormones|mesh-list
101986456|NCT01292785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101986457|NCT01292785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986458|NCT02323126|Nivolumab|nivolumab|mesh-list
101986459|NCT02323126|Nazartinib|nazartinib|mesh-list
101986460|NCT02323126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101986461|NCT02323126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101986462|NCT02323126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101986463|NCT02323126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986464|NCT01291459|Tenofovir|tenofovir|mesh-list
101986465|NCT01291459|Emtricitabine|emtricitabine|mesh-list
101986466|NCT01291459|Raltegravir Potassium|raltegravir potassium|mesh-list
101986467|NCT01291459|Maraviroc|maraviroc|mesh-list
101986468|NCT01291459|Antiviral Agents|antiviral agents|mesh-ancestor
101986469|NCT01291459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101986470|NCT01291459|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101986471|NCT01291459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101986472|NCT01291459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101986473|NCT01291459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986479|NCT01291459|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101986480|NCT01291459|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101986481|NCT00003377|Paclitaxel|paclitaxel|mesh-list
101986482|NCT00003377|Cisplatin|cisplatin|mesh-list
101986483|NCT00003377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101986484|NCT00003377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101986485|NCT00003377|Tubulin Modulators|tubulin modulators|mesh-ancestor
101986486|NCT00003377|Antimitotic Agents|antimitotic agents|mesh-ancestor
101986487|NCT00003377|Mitosis Modulators|mitosis modulators|mesh-ancestor
101986488|NCT00003377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986489|NCT01291537|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101986490|NCT01291537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101986491|NCT01291537|Immunologic Factors|immunologic factors|mesh-ancestor
101986492|NCT01291537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986493|NCT01291537|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101986494|NCT01291537|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101986495|NCT01291537|Dopamine Agonists|dopamine agonists|mesh-ancestor
101947220|NCT03638726|Protective Agents|protective agents|mesh-ancestor
101947221|NCT03638726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101947222|NCT03638726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101947223|NCT03638726|Parasympatholytics|parasympatholytics|mesh-ancestor
101986496|NCT01291537|Dopamine Agents|dopamine agents|mesh-ancestor
101986497|NCT01291537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101706323|NCT04246541|Ketorolac|ketorolac|mesh-list
101986498|NCT01291537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986500|NCT01328015|Cholinergic Antagonists|cholinergic antagonists|mesh-list
101986501|NCT01328015|Parasympatholytics|parasympatholytics|mesh-ancestor
101986502|NCT01328015|Autonomic Agents|autonomic agents|mesh-ancestor
101986503|NCT01328015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101986504|NCT01328015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986505|NCT01328015|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101986506|NCT01328015|Cholinergic Agents|cholinergic agents|mesh-ancestor
101986507|NCT01328015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101986508|NCT01328015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986509|NCT01328015|Urological Agents|urological agents|mesh-ancestor
101986510|NCT01101893|Raltegravir Potassium|raltegravir potassium|mesh-list
101986511|NCT01101893|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101986512|NCT01101893|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101986513|NCT01101893|Antiviral Agents|antiviral agents|mesh-ancestor
101986514|NCT01101893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101986515|NCT01101893|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101986516|NCT01101893|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101986517|NCT01101893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101986518|NCT01101893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986519|NCT01292863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101986520|NCT01292863|Dialysis Solutions|dialysis solutions|mesh-list
101986521|NCT00002651|Goserelin|goserelin|mesh-list
101986522|NCT00002651|Bicalutamide|bicalutamide|mesh-list
101986523|NCT00002651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101986524|NCT00002651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101986525|NCT00002651|Androgen Antagonists|androgen antagonists|mesh-ancestor
101986526|NCT00002651|Hormone Antagonists|hormone antagonists|mesh-ancestor
101986527|NCT00002651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101986528|NCT00002651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986529|NCT03853993|Vaccines|vaccines|mesh-list
101986530|NCT03853993|Immunologic Factors|immunologic factors|mesh-ancestor
101986531|NCT03853993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986532|NCT03473626|Alicaforsen|alicaforsen|mesh-list
101986533|NCT03473626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101986534|NCT03473626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101986535|NCT03473626|Immunologic Factors|immunologic factors|mesh-ancestor
101986536|NCT03473626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986537|NCT05154682|Acetaminophen|acetaminophen|mesh-list
101986538|NCT05154682|Naproxen|naproxen|mesh-list
101986539|NCT05154682|Oxycodone|oxycodone|mesh-list
101986540|NCT05154682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101986541|NCT05154682|Analgesics|analgesics|mesh-ancestor
101986542|NCT05154682|Sensory System Agents|sensory system agents|mesh-ancestor
101986543|NCT05154682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101986544|NCT05154682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986549|NCT05154682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101986550|NCT05154682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101986551|NCT05154682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101986552|NCT05154682|Gout Suppressants|gout suppressants|mesh-ancestor
101986553|NCT05154682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101986554|NCT05154682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101986555|NCT05154682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986556|NCT04312841|Acetic Acid|acetic acid|mesh-list
101986557|NCT04312841|Letermovir|letermovir|mesh-list
101986558|NCT04312841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101986559|NCT04312841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101986560|NCT04312841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101986561|NCT04312841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986562|NCT04312841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101986563|NCT04312841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101986564|NCT04312841|Antiviral Agents|antiviral agents|mesh-ancestor
101986565|NCT01294735|Temozolomide|temozolomide|mesh-list
101986566|NCT01294735|Niraparib|niraparib|mesh-list
101986567|NCT01294735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101947224|NCT03638726|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101947225|NCT03638726|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101947226|NCT03638726|Cholinergic Agents|cholinergic agents|mesh-ancestor
101947227|NCT01164189|Bevacizumab|bevacizumab|mesh-list
101947228|NCT01164189|Temozolomide|temozolomide|mesh-list
101947229|NCT01164189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101986568|NCT01294735|Alkylating Agents|alkylating agents|mesh-ancestor
101986569|NCT01294735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986570|NCT01294735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101986571|NCT01294735|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101575002|NCT02872389|Anesthetics|anesthetics|mesh-ancestor
101986572|NCT01294735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101986573|NCT03851263|Evolocumab|evolocumab|mesh-list
101986574|NCT03851263|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101986575|NCT03851263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101986576|NCT03851263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101986577|NCT03851263|Antimetabolites|antimetabolites|mesh-ancestor
101986578|NCT03851263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986579|NCT03851263|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101986580|NCT03851263|Protease Inhibitors|protease inhibitors|mesh-ancestor
101986581|NCT03851263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101986582|NCT03851263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101986583|NCT03849235|Glucagon|glucagon|mesh-list
101986584|NCT03849235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101986585|NCT03849235|Hormones|hormones|mesh-ancestor
101986586|NCT03849235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101986587|NCT03849235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986588|NCT03477448|Bleomycin|bleomycin|mesh-list
101986589|NCT03477448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101986590|NCT03477448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101986591|NCT01187485|Methyltestosterone|methyltestosterone|mesh-list
101986592|NCT01187485|Testosterone|testosterone|mesh-list
101986593|NCT01187485|Testosterone undecanoate|testosterone undecanoate|mesh-list
101986594|NCT01187485|Testosterone enanthate|testosterone enanthate|mesh-list
101986595|NCT01187485|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101986596|NCT01187485|Androgens|androgens|mesh-ancestor
101986597|NCT01187485|Hormones|hormones|mesh-ancestor
101986598|NCT01187485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101986599|NCT01187485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986600|NCT01187485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101986601|NCT01187485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101986602|NCT01187485|Anabolic Agents|anabolic agents|mesh-ancestor
101986603|NCT00002597|Leuprolide|leuprolide|mesh-list
101986604|NCT00002597|Goserelin|goserelin|mesh-list
101986605|NCT00002597|Flutamide|flutamide|mesh-list
101986606|NCT00002597|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101986607|NCT00002597|Fertility Agents|fertility agents|mesh-ancestor
101986608|NCT00002597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101986609|NCT00002597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986610|NCT00002597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101986611|NCT00002597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101986612|NCT00002597|Androgen Antagonists|androgen antagonists|mesh-ancestor
101986613|NCT00002597|Hormone Antagonists|hormone antagonists|mesh-ancestor
101986614|NCT00002597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101986615|NCT03853525|Petrolatum|petrolatum|mesh-list
101986620|NCT03716583|Antioxidants|antioxidants|mesh-ancestor
101986621|NCT03716583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986622|NCT03716583|Protective Agents|protective agents|mesh-ancestor
101986623|NCT03716583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986624|NCT03716583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101986625|NCT03716583|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101986626|NCT03716583|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101986627|NCT02738008|Tenofovir|tenofovir|mesh-list
101986628|NCT02738008|Entecavir|entecavir|mesh-list
101986629|NCT02738008|Histamine Antagonists|histamine antagonists|mesh-list
101986630|NCT02738008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
101986631|NCT02738008|Antiviral Agents|antiviral agents|mesh-ancestor
101986632|NCT02738008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101986633|NCT02738008|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101947230|NCT01164189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101947231|NCT01164189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101986634|NCT02738008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101986635|NCT02738008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101986636|NCT02738008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986637|NCT02738008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101986638|NCT02738008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101986639|NCT02738008|Histamine Agents|histamine agents|mesh-ancestor
101986640|NCT02738008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101986641|NCT02738008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986643|NCT03720249|Vitamin B 12|vitamin b 12|mesh-list
101986644|NCT03720249|Vitamin B 6|vitamin b 6|mesh-list
101986645|NCT03720249|Vitamin B Complex|vitamin b complex|mesh-list
101986646|NCT03720249|Betaine|betaine|mesh-list
101986647|NCT03720249|Micronutrients|micronutrients|mesh-ancestor
101986648|NCT03720249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986649|NCT03720249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101986650|NCT03720249|Lipotropic Agents|lipotropic agents|mesh-ancestor
101986651|NCT03720249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101986652|NCT03720249|Antimetabolites|antimetabolites|mesh-ancestor
101986653|NCT03720249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986654|NCT03720249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101986655|NCT01294969|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
101986656|NCT01294969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101986657|NCT01294969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101986658|NCT01294969|Analgesics|analgesics|mesh-ancestor
101986659|NCT01294969|Sensory System Agents|sensory system agents|mesh-ancestor
101986660|NCT01294969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101986661|NCT01294969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986662|NCT01294969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101986663|NCT01294969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101986664|NCT01294969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101986665|NCT01294969|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101986666|NCT01294969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101986667|NCT01294969|Histamine Antagonists|histamine antagonists|mesh-ancestor
101986668|NCT01294969|Histamine Agents|histamine agents|mesh-ancestor
101986669|NCT01294969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101986670|NCT01294969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986671|NCT03850561|Ubiquinone|ubiquinone|mesh-list
101986672|NCT03850561|Coenzyme Q10|coenzyme q10|mesh-list
101986673|NCT03850561|Micronutrients|micronutrients|mesh-ancestor
101986674|NCT03850561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986675|NCT03850561|Vitamins|vitamins|mesh-ancestor
101986676|NCT01190137|Cholecalciferol|cholecalciferol|mesh-list
101986677|NCT01190137|Vitamin D|vitamin d|mesh-list
101986678|NCT01190137|Ergocalciferols|ergocalciferols|mesh-list
101986679|NCT01190137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101986680|NCT01190137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986681|NCT01190137|Vitamins|vitamins|mesh-ancestor
101986682|NCT01190137|Micronutrients|micronutrients|mesh-ancestor
101986683|NCT01190137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101986684|NCT02529839|Cyclophosphamide|cyclophosphamide|mesh-list
101986685|NCT02529839|Fludarabine|fludarabine|mesh-list
101986686|NCT02529839|Alemtuzumab|alemtuzumab|mesh-list
101986687|NCT02529839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101986688|NCT02529839|Immunologic Factors|immunologic factors|mesh-ancestor
101986689|NCT02529839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986691|NCT02529839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101986692|NCT02529839|Alkylating Agents|alkylating agents|mesh-ancestor
101986693|NCT02529839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986694|NCT02529839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101986695|NCT02529839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101986696|NCT02529839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101986698|NCT03473314|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101986699|NCT03473314|Autonomic Agents|autonomic agents|mesh-ancestor
101986700|NCT03473314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101986701|NCT03473314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986702|NCT03473314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101986703|NCT03473314|Respiratory System Agents|respiratory system agents|mesh-ancestor
101986704|NCT03473314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101986705|NCT03473314|Antioxidants|antioxidants|mesh-ancestor
101986706|NCT03473314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947232|NCT01164189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101947234|NCT01164189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986707|NCT03473314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101986708|NCT03473314|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101986709|NCT03473314|Vasodilator Agents|vasodilator agents|mesh-ancestor
101986710|NCT03473314|Gasotransmitters|gasotransmitters|mesh-ancestor
101986711|NCT03473314|Protective Agents|protective agents|mesh-ancestor
101711698|NCT00681902|Lidocaine|lidocaine|mesh-list
101986712|NCT03945539|Itraconazole|itraconazole|mesh-list
101986713|NCT03945539|JNJ-56136379|jnj-56136379|mesh-list
101986714|NCT03945539|Antifungal Agents|antifungal agents|mesh-ancestor
101986715|NCT03945539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101986716|NCT03945539|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101986717|NCT03945539|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101986718|NCT03945539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101986719|NCT03945539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986720|NCT03945539|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101986721|NCT03945539|Hormone Antagonists|hormone antagonists|mesh-ancestor
101986722|NCT03945539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101706533|NCT00613457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101986723|NCT03945539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986724|NCT03945539|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101986725|NCT03945539|Antiviral Agents|antiviral agents|mesh-ancestor
101986726|NCT01190293|Efavirenz|efavirenz|mesh-list
101986727|NCT01190293|Maraviroc|maraviroc|mesh-list
101986728|NCT01190293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101986729|NCT01190293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101986730|NCT01190293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101986731|NCT01190293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986732|NCT01190293|Antiviral Agents|antiviral agents|mesh-ancestor
101986733|NCT01190293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101986734|NCT01190293|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101986735|NCT01190293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101986736|NCT01190293|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101986737|NCT01190293|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101986738|NCT01190293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101986739|NCT01190293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101986740|NCT01190293|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101986741|NCT01190293|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101986742|NCT01190293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101986743|NCT01190293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101986744|NCT01190293|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101986745|NCT03945227|Spartalizumab|spartalizumab|mesh-list
101986746|NCT03945227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101986747|NCT03945227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986748|NCT03945227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101986749|NCT03945227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101986750|NCT01108133|Dexamethasone|dexamethasone|mesh-list
101986751|NCT01108133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101986752|NCT01108133|Antiemetics|antiemetics|mesh-ancestor
101986753|NCT01108133|Autonomic Agents|autonomic agents|mesh-ancestor
101986754|NCT01108133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101986755|NCT01108133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986756|NCT01108133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101986757|NCT01108133|Glucocorticoids|glucocorticoids|mesh-ancestor
101986758|NCT01108133|Hormones|hormones|mesh-ancestor
101441858|NCT00408174|Analgesics|analgesics|mesh-ancestor
101986761|NCT01108133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101986763|NCT01108289|Oxytocics|oxytocics|mesh-ancestor
101986764|NCT01108289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101986765|NCT01108289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986766|NCT03947489|Sarpogrelate|sarpogrelate|mesh-list
101986767|NCT03947489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101986768|NCT03947489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101986769|NCT03947489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986770|NCT03947489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101986771|NCT03947489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101986772|NCT03947489|Serotonin Agents|serotonin agents|mesh-ancestor
101986773|NCT03947489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101986774|NCT03947489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947235|NCT01164189|Growth Inhibitors|growth inhibitors|mesh-ancestor
101947236|NCT01164189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101813328|NCT00983450|beta-Endorphin|beta-endorphin|mesh-list
101986775|NCT03947411|Oseltamivir|oseltamivir|mesh-list
101986776|NCT03947411|Antiviral Agents|antiviral agents|mesh-ancestor
101986777|NCT03947411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101986778|NCT03947411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101986779|NCT03947411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986780|NCT03257254|Polidocanol|polidocanol|mesh-list
101986781|NCT03257254|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
101986782|NCT03257254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101986783|NCT01327469|Albendazole|albendazole|mesh-list
101986784|NCT01327469|Mebendazole|mebendazole|mesh-list
101986785|NCT01327469|Piperazine|piperazine|mesh-list
101986786|NCT01327469|Piperazine citrate|piperazine citrate|mesh-list
101986787|NCT01327469|Pyrantel|pyrantel|mesh-list
101986788|NCT01327469|Oxantel|oxantel|mesh-list
101986789|NCT01327469|DMP 777|dmp 777|mesh-list
101986790|NCT01327469|Anthelmintics|anthelmintics|mesh-ancestor
101986791|NCT01327469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101986792|NCT01327469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101986793|NCT01327469|Anticestodal Agents|anticestodal agents|mesh-ancestor
101986794|NCT01327469|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101986795|NCT01327469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101986796|NCT01327469|Tubulin Modulators|tubulin modulators|mesh-ancestor
101986797|NCT01327469|Antimitotic Agents|antimitotic agents|mesh-ancestor
101986798|NCT01327469|Mitosis Modulators|mitosis modulators|mesh-ancestor
101986799|NCT01327469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986800|NCT01327469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101986801|NCT01327469|Antinematodal Agents|antinematodal agents|mesh-ancestor
101986802|NCT01327469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101986803|NCT01327469|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
101986804|NCT01327469|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101986805|NCT01327469|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101986806|NCT01327469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101986807|NCT01327469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986808|NCT03950141|Apatinib|apatinib|mesh-list
101986809|NCT03950141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101986810|NCT03950141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101986811|NCT03950141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101986812|NCT03950141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986813|NCT01108601|Ciprofloxacin|ciprofloxacin|mesh-list
101986814|NCT01108601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101986815|NCT01108601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101986816|NCT01108601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101986817|NCT01108601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101986818|NCT01108601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101986819|NCT01108601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986820|NCT01108601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101986821|NCT01108601|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101986822|NCT01108601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101986823|NCT03084718|Beclomethasone|beclomethasone|mesh-list
101986824|NCT03084718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101986825|NCT03084718|Glucocorticoids|glucocorticoids|mesh-ancestor
101986826|NCT03084718|Hormones|hormones|mesh-ancestor
101986827|NCT03084718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101986828|NCT03084718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986829|NCT03084718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101986830|NCT03084718|Respiratory System Agents|respiratory system agents|mesh-ancestor
101986845|NCT03944291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986847|NCT03944291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101986848|NCT03067571|Daratumumab|daratumumab|mesh-list
101986849|NCT03067571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101986850|NCT01102439|Aspirin|aspirin|mesh-list
101986851|NCT01102439|Clopidogrel|clopidogrel|mesh-list
101986852|NCT01102439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101986853|NCT01102439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101986854|NCT01102439|Analgesics|analgesics|mesh-ancestor
101986855|NCT01102439|Sensory System Agents|sensory system agents|mesh-ancestor
101986856|NCT01102439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101986857|NCT01102439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986858|NCT01102439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101986859|NCT01102439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101947237|NCT01164189|Alkylating Agents|alkylating agents|mesh-ancestor
101947238|NCT01164189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986860|NCT01102439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101986861|NCT01102439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101986862|NCT01102439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986863|NCT01102439|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101986864|NCT01102439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101986865|NCT01102439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101986866|NCT01102439|Antipyretics|antipyretics|mesh-ancestor
101986867|NCT01102439|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101986868|NCT01102439|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101986869|NCT01102439|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101706685|NCT05042531|Azacitidine|azacitidine|mesh-list
101986870|NCT01102439|Purinergic Agents|purinergic agents|mesh-ancestor
101986871|NCT01102439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101986872|NCT03949985|Hemostatics|hemostatics|mesh-list
101986873|NCT03949985|Contraceptive Agents|contraceptive agents|mesh-list
101986874|NCT03949985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101986875|NCT03949985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986876|NCT03949985|Coagulants|coagulants|mesh-ancestor
101986877|NCT01584791|Aspirin|aspirin|mesh-list
101986878|NCT01584791|Clopidogrel|clopidogrel|mesh-list
101986879|NCT01584791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101986880|NCT01584791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101986881|NCT01584791|Analgesics|analgesics|mesh-ancestor
101986882|NCT01584791|Sensory System Agents|sensory system agents|mesh-ancestor
101986883|NCT01584791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101986884|NCT01584791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986885|NCT01584791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101986886|NCT01584791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101986887|NCT01584791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101442009|NCT00196599|Antimetabolites|antimetabolites|mesh-ancestor
101986891|NCT01584791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101986893|NCT01584791|Antipyretics|antipyretics|mesh-ancestor
101986894|NCT01584791|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101986895|NCT01584791|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101986896|NCT01584791|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101986897|NCT01584791|Purinergic Agents|purinergic agents|mesh-ancestor
101986898|NCT01584791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101986899|NCT04285684|Ketamine|ketamine|mesh-list
101986900|NCT04285684|Analgesics|analgesics|mesh-ancestor
101986901|NCT04285684|Sensory System Agents|sensory system agents|mesh-ancestor
101986902|NCT04285684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101986903|NCT04285684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986904|NCT04285684|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101986905|NCT04285684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101986906|NCT04285684|Anesthetics, General|anesthetics, general|mesh-ancestor
101986907|NCT04285684|Anesthetics|anesthetics|mesh-ancestor
101986908|NCT04285684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101986909|NCT04285684|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101986910|NCT04285684|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101986911|NCT04285684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101986912|NCT04285684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986913|NCT01310985|Capecitabine|capecitabine|mesh-list
101986914|NCT01310985|Cetuximab|cetuximab|mesh-list
101986915|NCT01310985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101986916|NCT01310985|Antimetabolites|antimetabolites|mesh-ancestor
101986917|NCT01310985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986918|NCT01310985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101986919|NCT01310985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101986920|NCT03433677|Insulin Lispro|insulin lispro|mesh-list
101986921|NCT03433677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101986922|NCT03433677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986923|NCT02492711|Trastuzumab|trastuzumab|mesh-list
101986924|NCT02492711|Margetuximab|margetuximab|mesh-list
101986925|NCT02492711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101986926|NCT02492711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101986927|NCT03716427|Tolbutamide|tolbutamide|mesh-list
101986928|NCT03716427|Midazolam|midazolam|mesh-list
101986929|NCT03716427|Dextromethorphan|dextromethorphan|mesh-list
101986930|NCT03716427|Omeprazole|omeprazole|mesh-list
101986931|NCT03716427|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101947240|NCT01164267|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101947241|NCT01164267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101947242|NCT01164267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101947243|NCT01164267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947244|NCT01164267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101986932|NCT03716427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101986933|NCT03716427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101986934|NCT03716427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986935|NCT03716427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101986936|NCT03716427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101986937|NCT03716427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101986938|NCT03716427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101986939|NCT03716427|Anesthetics, General|anesthetics, general|mesh-ancestor
101986940|NCT03716427|Anesthetics|anesthetics|mesh-ancestor
101986941|NCT03716427|GABA Modulators|gaba modulators|mesh-ancestor
101986942|NCT03716427|GABA Agents|gaba agents|mesh-ancestor
101986943|NCT03716427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101986944|NCT03716427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986945|NCT03716427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101986946|NCT03716427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101986947|NCT03716427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101986948|NCT03716427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101986949|NCT03716427|Antitussive Agents|antitussive agents|mesh-ancestor
101986950|NCT03716427|Respiratory System Agents|respiratory system agents|mesh-ancestor
101986951|NCT03716427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101986952|NCT03716427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101986953|NCT03716427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101986954|NCT01147822|Sunitinib|sunitinib|mesh-list
101986955|NCT01147822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101986956|NCT01147822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101986957|NCT01147822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101986958|NCT01147822|Growth Substances|growth substances|mesh-ancestor
101986963|NCT01147822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986965|NCT03431337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101986966|NCT03431337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101986967|NCT01293097|Atorvastatin|atorvastatin|mesh-list
101986968|NCT01293097|Pravastatin|pravastatin|mesh-list
101986969|NCT01293097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101986970|NCT01293097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101986971|NCT01293097|Antimetabolites|antimetabolites|mesh-ancestor
101986972|NCT01293097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986973|NCT01293097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101986974|NCT01293097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101986975|NCT01293097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101986976|NCT03516292|Mitogens|mitogens|mesh-list
101986977|NCT03516292|Mitosis Modulators|mitosis modulators|mesh-ancestor
101986978|NCT03516292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986979|NCT01291615|Gemcitabine|gemcitabine|mesh-list
101986980|NCT01291615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101986981|NCT01291615|Antimetabolites|antimetabolites|mesh-ancestor
101986982|NCT01291615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986983|NCT01291615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101986984|NCT01295047|Atenolol|atenolol|mesh-list
101986985|NCT01295047|Verapamil|verapamil|mesh-list
101986986|NCT01295047|Perindopril|perindopril|mesh-list
101986987|NCT01295047|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101986988|NCT01295047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101986989|NCT01295047|Sympatholytics|sympatholytics|mesh-ancestor
101986990|NCT01295047|Autonomic Agents|autonomic agents|mesh-ancestor
101986991|NCT01295047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101986992|NCT01295047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986993|NCT01295047|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101986994|NCT01295047|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101986995|NCT01295047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101986996|NCT01295047|Adrenergic Agents|adrenergic agents|mesh-ancestor
101986997|NCT01295047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101986998|NCT01295047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986999|NCT01295047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101987000|NCT01295047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101947245|NCT01164267|Immunologic Factors|immunologic factors|mesh-ancestor
101947246|NCT01164267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947247|NCT01164267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101947248|NCT01164345|Plerixafor|plerixafor|mesh-list
101947249|NCT01164345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101947250|NCT01164345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101987001|NCT01295047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101987002|NCT01295047|Vasodilator Agents|vasodilator agents|mesh-ancestor
101987003|NCT01295047|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101987004|NCT01295047|Protease Inhibitors|protease inhibitors|mesh-ancestor
101987005|NCT01295047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101987006|NCT03472846|Teriparatide|teriparatide|mesh-list
101987007|NCT03472846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101987008|NCT03472846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987009|NCT03472846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101987010|NCT01190371|Artesunate|artesunate|mesh-list
101987011|NCT01190371|Antimalarials|antimalarials|mesh-ancestor
101987012|NCT01190371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101987013|NCT01190371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101987014|NCT01190371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101987015|NCT01190371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101987016|NCT01190371|Antiviral Agents|antiviral agents|mesh-ancestor
101987017|NCT01190371|Schistosomicides|schistosomicides|mesh-ancestor
101987018|NCT01190371|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101987019|NCT01190371|Anthelmintics|anthelmintics|mesh-ancestor
101987020|NCT05158426|Propofol|propofol|mesh-list
101987021|NCT05158426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101987022|NCT05158426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101987023|NCT05158426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987024|NCT05158426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101987025|NCT05158426|Anesthetics, General|anesthetics, general|mesh-ancestor
101987026|NCT05158426|Anesthetics|anesthetics|mesh-ancestor
101987027|NCT03853369|Nifekalant|nifekalant|mesh-list
101987028|NCT03853369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101987034|NCT05158348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987035|NCT05158348|Sensory System Agents|sensory system agents|mesh-ancestor
101987036|NCT05158348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101987037|NCT05158348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101987038|NCT05158348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101987039|NCT05158348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101987040|NCT05158348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101987041|NCT05158348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987042|NCT05158348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101987043|NCT05158348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101987044|NCT05158348|Analgesics|analgesics|mesh-ancestor
101987045|NCT05158348|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101987046|NCT05158348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101987047|NCT05158348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101987048|NCT05158348|Adrenergic Agents|adrenergic agents|mesh-ancestor
101987049|NCT05158348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101987050|NCT01187719|Phenytoin|phenytoin|mesh-list
101987051|NCT01187719|Anticonvulsants|anticonvulsants|mesh-ancestor
101987052|NCT01187719|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101987053|NCT01187719|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101987054|NCT01187719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101987055|NCT01187719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987056|NCT01187719|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101987057|NCT01187719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101987058|NCT01102595|Bevacizumab|bevacizumab|mesh-list
101987059|NCT01102595|Temozolomide|temozolomide|mesh-list
101987060|NCT01102595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101987061|NCT01102595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101987062|NCT01102595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101987063|NCT01102595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101987064|NCT01102595|Growth Substances|growth substances|mesh-ancestor
101987065|NCT01102595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987066|NCT01102595|Growth Inhibitors|growth inhibitors|mesh-ancestor
101987067|NCT01102595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101987068|NCT01102595|Alkylating Agents|alkylating agents|mesh-ancestor
101947252|NCT01164345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101947253|NCT02948582|Glycopyrrolate|glycopyrrolate|mesh-list
101947254|NCT02948582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101947255|NCT02948582|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101947256|NCT02948582|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101947257|NCT02948582|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101947258|NCT02948582|Cholinergic Agents|cholinergic agents|mesh-ancestor
101947259|NCT02948582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101947260|NCT02948582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947261|NCT02948582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947262|NCT02259868|Ritonavir|ritonavir|mesh-list
101947263|NCT02259868|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101947264|NCT02259868|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101947265|NCT02259868|Protease Inhibitors|protease inhibitors|mesh-ancestor
101987069|NCT01102595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987070|NCT03949517|Piperidine|piperidine|mesh-list
101987071|NCT03949517|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101987072|NCT03949517|Bombesin|bombesin|mesh-list
101987073|NCT03949517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987074|NCT03949517|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101987075|NCT03949517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101987076|NCT03949517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987077|NCT03949517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101987078|NCT03949517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101987079|NCT03949517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101987080|NCT03848611|Vorolanib|vorolanib|mesh-list
101987081|NCT03848611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101987082|NCT03848611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101987083|NCT03848611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987084|NCT01584947|Bupivacaine|bupivacaine|mesh-list
101987085|NCT01584947|Anesthetics, Local|anesthetics, local|mesh-ancestor
101987086|NCT01584947|Anesthetics|anesthetics|mesh-ancestor
101987087|NCT01584947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101987088|NCT01584947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987089|NCT01584947|Sensory System Agents|sensory system agents|mesh-ancestor
101987090|NCT01584947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101987091|NCT03848767|Insulin Lispro|insulin lispro|mesh-list
101987092|NCT03848767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101987093|NCT03848767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987094|NCT01109615|Gemcitabine|gemcitabine|mesh-list
101987096|NCT01109615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101987097|NCT01109615|Antimetabolites|antimetabolites|mesh-ancestor
101442203|NCT00409890|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101987102|NCT01109615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101987103|NCT01209065|Ritonavir|ritonavir|mesh-list
101987104|NCT01209065|Fosamprenavir|fosamprenavir|mesh-list
101987105|NCT01209065|Dolutegravir|dolutegravir|mesh-list
101987106|NCT01209065|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101987107|NCT01209065|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101987108|NCT01209065|Protease Inhibitors|protease inhibitors|mesh-ancestor
101987109|NCT01209065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101987110|NCT01209065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987111|NCT01209065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101987112|NCT01209065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101987113|NCT01209065|Antiviral Agents|antiviral agents|mesh-ancestor
101987114|NCT01209065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101987115|NCT01209065|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101987116|NCT01209065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101987117|NCT01209065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101947266|NCT02259868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101947267|NCT02259868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987118|NCT01209065|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101987119|NCT02782702|Botulinum Toxins|botulinum toxins|mesh-list
101987120|NCT02782702|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101987121|NCT02782702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101987122|NCT02782702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987123|NCT02782702|Cholinergic Agents|cholinergic agents|mesh-ancestor
101987124|NCT02782702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101987125|NCT02782702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987126|NCT01102673|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
101987127|NCT01102673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101987128|NCT01102673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987130|NCT03481725|Keratolytic Agents|keratolytic agents|mesh-ancestor
101987131|NCT03481725|Dermatologic Agents|dermatologic agents|mesh-ancestor
101987132|NCT03472456|Eugenol|eugenol|mesh-list
101987133|NCT03472456|Carticaine|carticaine|mesh-list
101987134|NCT03472456|Anesthetics, Local|anesthetics, local|mesh-ancestor
101987135|NCT03472456|Anesthetics|anesthetics|mesh-ancestor
101987136|NCT03472456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101987137|NCT03472456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987138|NCT03472456|Sensory System Agents|sensory system agents|mesh-ancestor
101987139|NCT03472456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101987140|NCT03472456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101987141|NCT01193881|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101987142|NCT01193881|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
101987143|NCT01193881|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
101987144|NCT01193881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101987145|NCT01193881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101987146|NCT01193881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101987147|NCT01193881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987148|NCT01194037|Interferons|interferons|mesh-list
101987149|NCT01194037|Interferon-alpha|interferon-alpha|mesh-list
101987150|NCT01194037|Interferon alpha-2|interferon alpha-2|mesh-list
101987151|NCT01194037|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101987152|NCT01194037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101987153|NCT01194037|Antiviral Agents|antiviral agents|mesh-ancestor
101987154|NCT01194037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101987155|NCT01194037|Immunologic Factors|immunologic factors|mesh-ancestor
101987156|NCT01194037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987157|NCT03480243|Erythromycin|erythromycin|mesh-list
101987158|NCT03480243|Erythromycin Estolate|erythromycin estolate|mesh-list
101987159|NCT03480243|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101987160|NCT03480243|Erythromycin stearate|erythromycin stearate|mesh-list
101987161|NCT03480243|Padsevonil|padsevonil|mesh-list
101987162|NCT03480243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101987163|NCT03480243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101987164|NCT03480243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101987165|NCT03480243|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101987169|NCT01109693|Mirtazapine|mirtazapine|mesh-list
101987170|NCT01109693|Sertraline|sertraline|mesh-list
101987171|NCT01109693|Antidepressive Agents|antidepressive agents|mesh-ancestor
101987172|NCT01109693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101987173|NCT01109693|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101987174|NCT01109693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101987175|NCT01109693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101987176|NCT01109693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987177|NCT01109693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101987178|NCT01109693|Serotonin Agents|serotonin agents|mesh-ancestor
101987179|NCT01109693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987180|NCT01109693|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101987181|NCT01109693|Histamine Antagonists|histamine antagonists|mesh-ancestor
101987182|NCT01109693|Histamine Agents|histamine agents|mesh-ancestor
101987183|NCT01109693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101987184|NCT01109693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101987185|NCT01109693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101987186|NCT01109693|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101987187|NCT01109693|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101947268|NCT02259868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101947269|NCT02259868|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101987188|NCT01109693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101987189|NCT01109693|Adrenergic Agents|adrenergic agents|mesh-ancestor
101987190|NCT01109693|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101987191|NCT01109693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101987192|NCT01109693|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101987193|NCT01190683|Calcium, Dietary|calcium, dietary|mesh-list
101987194|NCT01190683|Vitamin D|vitamin d|mesh-list
101987195|NCT01190683|Ergocalciferols|ergocalciferols|mesh-list
101987196|NCT01190683|Cholecalciferol|cholecalciferol|mesh-list
101987197|NCT01190683|Vitamins|vitamins|mesh-list
101987198|NCT01190683|Calcium Carbonate|calcium carbonate|mesh-list
101987199|NCT01190683|Calcium|calcium|mesh-list
101987200|NCT01190683|Micronutrients|micronutrients|mesh-ancestor
101987201|NCT01190683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987202|NCT01190683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101987203|NCT01190683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101987204|NCT01190683|Antacids|antacids|mesh-ancestor
101987205|NCT01190683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987206|NCT01190683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101987207|NCT01190761|Galantamine|galantamine|mesh-list
101987208|NCT01190761|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101987209|NCT01190761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101987210|NCT01190761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987211|NCT01190761|Cholinergic Agents|cholinergic agents|mesh-ancestor
101987212|NCT01190761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101987213|NCT01190761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987214|NCT01190761|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101987215|NCT01190761|Autonomic Agents|autonomic agents|mesh-ancestor
101987216|NCT01190761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101987217|NCT01190761|Nootropic Agents|nootropic agents|mesh-ancestor
101987218|NCT01209455|Acetaminophen|acetaminophen|mesh-list
101987219|NCT01209455|Chlorpheniramine|chlorpheniramine|mesh-list
101987220|NCT01209455|Ranitidine|ranitidine|mesh-list
101987221|NCT01209455|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
101987222|NCT01209455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101987223|NCT01209455|Analgesics|analgesics|mesh-ancestor
101987224|NCT01209455|Sensory System Agents|sensory system agents|mesh-ancestor
101987225|NCT01209455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101987226|NCT01209455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987227|NCT01209455|Antipyretics|antipyretics|mesh-ancestor
101987228|NCT01209455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101987229|NCT01209455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101987230|NCT01209455|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101987231|NCT01209455|Histamine Antagonists|histamine antagonists|mesh-ancestor
101987232|NCT01209455|Histamine Agents|histamine agents|mesh-ancestor
101987233|NCT01209455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101987234|NCT01209455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987235|NCT01209455|Antipruritics|antipruritics|mesh-ancestor
101987236|NCT01209455|Dermatologic Agents|dermatologic agents|mesh-ancestor
101442341|NCT00170729|Prednisolone|prednisolone|mesh-list
101987240|NCT01194115|Cephalexin|cephalexin|mesh-list
101987241|NCT01194115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101987242|NCT01194115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101987243|NCT01194115|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101987244|NCT01194115|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101987246|NCT01209533|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101987247|NCT01209533|Vasodilator Agents|vasodilator agents|mesh-ancestor
101987248|NCT03847363|Anesthetics|anesthetics|mesh-list
101987249|NCT03847363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101987250|NCT03847363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987251|NCT01207739|Hydroxychloroquine|hydroxychloroquine|mesh-list
101987252|NCT01207739|Doxycycline|doxycycline|mesh-list
101987253|NCT01207739|Clarithromycin|clarithromycin|mesh-list
101987254|NCT01207739|Antimalarials|antimalarials|mesh-ancestor
101987255|NCT01207739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101987256|NCT01207739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101987257|NCT01207739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101987258|NCT01207739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101987259|NCT01207739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987260|NCT01207739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101987261|NCT01207739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101987262|NCT01207739|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101987263|NCT01207739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101947270|NCT02259868|Antiviral Agents|antiviral agents|mesh-ancestor
101947271|NCT02259868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101947272|NCT02259868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101947273|NCT02259868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101947274|NCT01167231|Acarbose|acarbose|mesh-list
101947275|NCT01167231|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101987264|NCT01207739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101987265|NCT03941951|Anti-Infective Agents|anti-infective agents|mesh-list
101987266|NCT03941951|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101987267|NCT03847207|Pasireotide|pasireotide|mesh-list
101987268|NCT03847207|Hormones|hormones|mesh-ancestor
101987269|NCT03847207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101987270|NCT03847207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987271|NCT01192087|Cetuximab|cetuximab|mesh-list
101987272|NCT01192087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101987273|NCT01192087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101987274|NCT03942029|Fluconazole|fluconazole|mesh-list
101987275|NCT03942029|Antifungal Agents|antifungal agents|mesh-ancestor
101987276|NCT03942029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101987277|NCT03942029|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101987278|NCT03942029|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101987279|NCT03942029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101987280|NCT03942029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987281|NCT03942029|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101987282|NCT03942029|Hormone Antagonists|hormone antagonists|mesh-ancestor
101987283|NCT03942029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101987284|NCT03942029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987285|NCT03942029|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101987286|NCT03942029|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101987287|NCT03740945|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101987288|NCT03740945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101987289|NCT03740945|Immunologic Factors|immunologic factors|mesh-ancestor
101987290|NCT03740945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987291|NCT01192165|Paclitaxel|paclitaxel|mesh-list
101987292|NCT01192165|Docetaxel|docetaxel|mesh-list
101987293|NCT01192165|Carboplatin|carboplatin|mesh-list
101987294|NCT01192165|Pemetrexed|pemetrexed|mesh-list
101987295|NCT01192165|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101987296|NCT01192165|Trametinib|trametinib|mesh-list
101987297|NCT01192165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101987298|NCT01192165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101987299|NCT01192165|Tubulin Modulators|tubulin modulators|mesh-ancestor
101987300|NCT01192165|Antimitotic Agents|antimitotic agents|mesh-ancestor
101987301|NCT01192165|Mitosis Modulators|mitosis modulators|mesh-ancestor
101987302|NCT01192165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987303|NCT01192165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101987304|NCT01192165|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101987305|NCT01192165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101987306|NCT01192165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101987307|NCT01192243|Carboplatin|carboplatin|mesh-list
101987308|NCT01192243|Pemetrexed|pemetrexed|mesh-list
101987309|NCT01192243|Gefitinib|gefitinib|mesh-list
101711758|NCT01016665|Anastrozole|anastrozole|mesh-list
101987310|NCT01192243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101987318|NCT01209845|Sensory System Agents|sensory system agents|mesh-ancestor
101987319|NCT01209845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101987320|NCT01209845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987321|NCT01209845|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101987322|NCT01209845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101987323|NCT01209845|Anesthetics, General|anesthetics, general|mesh-ancestor
101987324|NCT01209845|Anesthetics|anesthetics|mesh-ancestor
101987325|NCT01209845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101987326|NCT01209845|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101987327|NCT01209845|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101987328|NCT01209845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101987329|NCT01209845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987330|NCT01112813|Lithium Carbonate|lithium carbonate|mesh-list
101987331|NCT01112813|Antidepressive Agents|antidepressive agents|mesh-ancestor
101987332|NCT01112813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101947276|NCT01167231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101947277|NCT01167231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947278|NCT01167231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101947279|NCT01167231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947280|NCT03871803|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101813890|NCT03742908|Cefazolin|cefazolin|mesh-list
101987333|NCT01112813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101987334|NCT01112813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987335|NCT01112813|Antimanic Agents|antimanic agents|mesh-ancestor
101987336|NCT01112813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101987337|NCT01112813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101987338|NCT01112813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987339|NCT01196767|Ropivacaine|ropivacaine|mesh-list
101987340|NCT01196767|Anesthetics, Local|anesthetics, local|mesh-ancestor
101987341|NCT01196767|Anesthetics|anesthetics|mesh-ancestor
101987342|NCT01196767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101987343|NCT01196767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987344|NCT01196767|Sensory System Agents|sensory system agents|mesh-ancestor
101987345|NCT01196767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101987346|NCT03451773|Gemcitabine|gemcitabine|mesh-list
101987347|NCT03451773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101987348|NCT03451773|Antimetabolites|antimetabolites|mesh-ancestor
101987349|NCT03451773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987350|NCT03451773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101987351|NCT01112891|Vitamin D|vitamin d|mesh-list
101987352|NCT01112891|Ergocalciferols|ergocalciferols|mesh-list
101987353|NCT01112891|Cholecalciferol|cholecalciferol|mesh-list
101987354|NCT01112891|Vitamins|vitamins|mesh-list
101987355|NCT01112891|Micronutrients|micronutrients|mesh-ancestor
101987356|NCT01112891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987357|NCT01112891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101987358|NCT01112891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101987359|NCT03847441|Vitamin D|vitamin d|mesh-list
101987360|NCT03847441|Cholecalciferol|cholecalciferol|mesh-list
101987361|NCT03847441|Calcipotriene|calcipotriene|mesh-list
101987362|NCT03847441|Vitamins|vitamins|mesh-ancestor
101987363|NCT03847441|Micronutrients|micronutrients|mesh-ancestor
101987364|NCT03847441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987365|NCT03847441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101987366|NCT03847441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101987367|NCT03847441|Dermatologic Agents|dermatologic agents|mesh-ancestor
101987368|NCT02529683|NuvaRing|nuvaring|mesh-list
101987369|NCT02529683|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101987370|NCT02529683|Contraceptive Agents|contraceptive agents|mesh-ancestor
101987371|NCT02529683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101987372|NCT02529683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987373|NCT05406895|Lidocaine|lidocaine|mesh-list
101987374|NCT05406895|Epinephrine|epinephrine|mesh-list
101987375|NCT05406895|Anesthetics, Local|anesthetics, local|mesh-ancestor
101987376|NCT05406895|Anesthetics|anesthetics|mesh-ancestor
101987377|NCT05406895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101987378|NCT05406895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987383|NCT05406895|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101987384|NCT05406895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101987385|NCT05406895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987386|NCT05406895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101987387|NCT05406895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101987388|NCT05406895|Adrenergic Agents|adrenergic agents|mesh-ancestor
101987389|NCT05406895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101987390|NCT05406895|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101987391|NCT05406895|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101987392|NCT05406895|Autonomic Agents|autonomic agents|mesh-ancestor
101987393|NCT05406895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101987394|NCT05406895|Respiratory System Agents|respiratory system agents|mesh-ancestor
101987395|NCT05406895|Mydriatics|mydriatics|mesh-ancestor
101987396|NCT05406895|Sympathomimetics|sympathomimetics|mesh-ancestor
101987397|NCT05406895|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101987398|NCT03425253|Lidocaine|lidocaine|mesh-list
101987399|NCT03425253|Anesthetics, Local|anesthetics, local|mesh-ancestor
101987400|NCT03425253|Anesthetics|anesthetics|mesh-ancestor
101947281|NCT03871803|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101947282|NCT03871803|Adrenergic Agents|adrenergic agents|mesh-ancestor
101947283|NCT03871803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101987401|NCT03425253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101987402|NCT03425253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987403|NCT03425253|Sensory System Agents|sensory system agents|mesh-ancestor
101987404|NCT03425253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101987405|NCT03425253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101987406|NCT03425253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101987407|NCT03425253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101987408|NCT03425253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101987409|NCT03425253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987410|NCT03941561|Tegafur|tegafur|mesh-list
101987411|NCT03941561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101987412|NCT03941561|Antimetabolites|antimetabolites|mesh-ancestor
101987413|NCT03941561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987414|NCT03941561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101987415|NCT05403229|Topiramate|topiramate|mesh-list
101987416|NCT05403229|Anticonvulsants|anticonvulsants|mesh-ancestor
101987417|NCT05403229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101987418|NCT05403229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987419|NCT03424239|Vitamin D|vitamin d|mesh-list
101987420|NCT03424239|Ergocalciferols|ergocalciferols|mesh-list
101987421|NCT03424239|Cholecalciferol|cholecalciferol|mesh-list
101987422|NCT03424239|Zoledronic Acid|zoledronic acid|mesh-list
101987423|NCT03424239|Vitamins|vitamins|mesh-list
101987424|NCT03424239|Micronutrients|micronutrients|mesh-ancestor
101987425|NCT03424239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987426|NCT03424239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101987427|NCT03424239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101987428|NCT03941795|Axitinib|axitinib|mesh-list
101987429|NCT03941795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101987430|NCT03941795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101987431|NCT03941795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101987432|NCT03941795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987433|NCT01197001|Losartan|losartan|mesh-list
101987434|NCT01197001|Amlodipine|amlodipine|mesh-list
101987435|NCT01197001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101987436|NCT01197001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101987437|NCT01197001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101987438|NCT01197001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987439|NCT01197001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101987440|NCT01197001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987441|NCT01197001|Vasodilator Agents|vasodilator agents|mesh-ancestor
101711769|NCT00681980|Valproic Acid|valproic acid|mesh-list
101987442|NCT01197001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101987443|NCT01197001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101987444|NCT01197001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101987445|NCT01113047|Amlodipine|amlodipine|mesh-list
101987446|NCT01113047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101987447|NCT01113047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101442548|NCT01330030|Selegiline|selegiline|mesh-list
101987462|NCT01210391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987463|NCT03846739|Oxytocin|oxytocin|mesh-list
101987464|NCT03846739|Oxytocics|oxytocics|mesh-ancestor
101575003|NCT02872389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101987465|NCT03846739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101987466|NCT03846739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987468|NCT03716115|Teduglutide|teduglutide|mesh-list
101987469|NCT03716115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101987470|NCT03716115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101987471|NCT03716115|Autonomic Agents|autonomic agents|mesh-ancestor
101987472|NCT03716115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101987473|NCT03716115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987474|NCT03716115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101987475|NCT03716115|Respiratory System Agents|respiratory system agents|mesh-ancestor
101987476|NCT03716115|Glucocorticoids|glucocorticoids|mesh-ancestor
101987477|NCT03716115|Hormones|hormones|mesh-ancestor
101987478|NCT03716115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101987479|NCT03716115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101987480|NCT03716115|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101987481|NCT03716115|Protective Agents|protective agents|mesh-ancestor
101971945|NCT02083250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101971947|NCT00412828|Immunoconjugates|immunoconjugates|mesh-ancestor
101971948|NCT00412828|Immunologic Factors|immunologic factors|mesh-ancestor
101971949|NCT00412828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101971950|NCT00412828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101971951|NCT00412828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971952|NCT00315640|Hydrocortisone|hydrocortisone|mesh-list
101971953|NCT00315640|Anecortave|anecortave|mesh-list
101971954|NCT00315640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101987482|NCT01113281|Vaccines|vaccines|mesh-list
101987483|NCT01113281|Immunologic Factors|immunologic factors|mesh-ancestor
101987484|NCT01113281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987485|NCT01295593|Cladribine|cladribine|mesh-list
101987486|NCT01295593|Valproic Acid|valproic acid|mesh-list
101987487|NCT01295593|Anticonvulsants|anticonvulsants|mesh-ancestor
101987488|NCT01295593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101987489|NCT01295593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987490|NCT01295593|GABA Agents|gaba agents|mesh-ancestor
101987491|NCT01295593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101987492|NCT01295593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987493|NCT01295593|Antimanic Agents|antimanic agents|mesh-ancestor
101987494|NCT01295593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101987495|NCT01295593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101987496|NCT01295593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101987497|NCT01295593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101987498|NCT01295593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101987499|NCT01295593|Immunologic Factors|immunologic factors|mesh-ancestor
101987500|NCT03845881|Oxycodone|oxycodone|mesh-list
101987501|NCT03845881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101987502|NCT03845881|Narcotics|narcotics|mesh-ancestor
101987503|NCT03845881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101987504|NCT03845881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987505|NCT03845881|Analgesics|analgesics|mesh-ancestor
101987506|NCT03845881|Sensory System Agents|sensory system agents|mesh-ancestor
101987507|NCT03845881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101987513|NCT01296997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987514|NCT01114841|Tazarotene|tazarotene|mesh-list
101987515|NCT01114841|Dermatologic Agents|dermatologic agents|mesh-ancestor
101987516|NCT01114841|Keratolytic Agents|keratolytic agents|mesh-ancestor
101987517|NCT01113437|Omalizumab|omalizumab|mesh-list
101987518|NCT01113437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101987519|NCT01113437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101987520|NCT01113437|Respiratory System Agents|respiratory system agents|mesh-ancestor
101987521|NCT01197235|Darbepoetin alfa|darbepoetin alfa|mesh-list
101987522|NCT01197235|Hematinics|hematinics|mesh-ancestor
101987523|NCT01192789|Amoxicillin|amoxicillin|mesh-list
101987524|NCT01192789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101987525|NCT01192789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101987526|NCT01211171|Telmisartan|telmisartan|mesh-list
101987527|NCT01211171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101987528|NCT01211171|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101987529|NCT01211171|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101987530|NCT01211171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987531|NCT03846973|Tranexamic Acid|tranexamic acid|mesh-list
101987532|NCT03846973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101987533|NCT03846973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101987534|NCT03846973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987535|NCT03846973|Hemostatics|hemostatics|mesh-ancestor
101707355|NCT03632213|Losartan|losartan|mesh-list
101987536|NCT03846973|Coagulants|coagulants|mesh-ancestor
101987537|NCT01113515|Esmolol|esmolol|mesh-list
101987538|NCT01113515|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101987539|NCT01113515|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101987540|NCT01113515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101987541|NCT01113515|Adrenergic Agents|adrenergic agents|mesh-ancestor
101987542|NCT01113515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101987543|NCT01113515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987544|NCT01113515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947284|NCT03871803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947285|NCT03871803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947286|NCT00135226|Aspirin|aspirin|mesh-list
101814102|NCT04126538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101987545|NCT01211327|Cyclosporine|cyclosporine|mesh-list
101987546|NCT01211327|Dexamethasone|dexamethasone|mesh-list
101987547|NCT01211327|Cyclosporins|cyclosporins|mesh-list
101987548|NCT01211327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101987549|NCT01211327|Antiemetics|antiemetics|mesh-ancestor
101987550|NCT01211327|Autonomic Agents|autonomic agents|mesh-ancestor
101987551|NCT01211327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101987552|NCT01211327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987553|NCT01211327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101987554|NCT01211327|Glucocorticoids|glucocorticoids|mesh-ancestor
101987555|NCT01211327|Hormones|hormones|mesh-ancestor
101987556|NCT01211327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101987557|NCT01211327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101987558|NCT01211327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101987559|NCT01211327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101987560|NCT01211327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987561|NCT01211327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101987562|NCT01211327|Immunologic Factors|immunologic factors|mesh-ancestor
101987563|NCT01211327|Antifungal Agents|antifungal agents|mesh-ancestor
101987564|NCT01211327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101711808|NCT00489853|Budesonide|budesonide|mesh-list
101987565|NCT01211327|Dermatologic Agents|dermatologic agents|mesh-ancestor
101987566|NCT01211327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101987567|NCT01211327|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101987568|NCT05601895|Sorafenib|sorafenib|mesh-list
101987569|NCT05601895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101987570|NCT05601895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101987571|NCT05601895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101987572|NCT05601895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987573|NCT01113671|Vitamin E|vitamin e|mesh-list
101987574|NCT01113671|Tocopherols|tocopherols|mesh-list
101987575|NCT01113671|alpha-Tocopherol|alpha-tocopherol|mesh-list
101987576|NCT01113671|Vitamins|vitamins|mesh-ancestor
101987577|NCT01113671|Micronutrients|micronutrients|mesh-ancestor
101987578|NCT01113671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987581|NCT01113671|Protective Agents|protective agents|mesh-ancestor
101987582|NCT03943043|Paclitaxel|paclitaxel|mesh-list
101987583|NCT03943043|Gemcitabine|gemcitabine|mesh-list
101987584|NCT03943043|Oxaliplatin|oxaliplatin|mesh-list
101987585|NCT03943043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101987586|NCT03943043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101987587|NCT03943043|Tubulin Modulators|tubulin modulators|mesh-ancestor
101987588|NCT03943043|Antimitotic Agents|antimitotic agents|mesh-ancestor
101987589|NCT03943043|Mitosis Modulators|mitosis modulators|mesh-ancestor
101987590|NCT03943043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987591|NCT03943043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101987592|NCT03943043|Antimetabolites|antimetabolites|mesh-ancestor
101987593|NCT01109927|Insulin|insulin|mesh-list
101987594|NCT01109927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101987595|NCT01109927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987596|NCT01211795|Ketoprofen|ketoprofen|mesh-list
101987597|NCT01211795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101987598|NCT01211795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101987599|NCT01211795|Analgesics|analgesics|mesh-ancestor
101987600|NCT01211795|Sensory System Agents|sensory system agents|mesh-ancestor
101987601|NCT01211795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101987602|NCT01211795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987603|NCT01211795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101987604|NCT01211795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101987605|NCT01211795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101987606|NCT01211795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101987607|NCT01211795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987608|NCT01193491|Geldanamycin|geldanamycin|mesh-list
101987609|NCT01193491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101987610|NCT01193491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101987611|NCT01193491|Antiviral Agents|antiviral agents|mesh-ancestor
101987612|NCT01193491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101987613|NCT01193491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101987614|NCT01193491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947287|NCT00135226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101947288|NCT00135226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101947289|NCT00135226|Analgesics|analgesics|mesh-ancestor
101814175|NCT05359874|Bevacizumab|bevacizumab|mesh-list
101987615|NCT01193491|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
101987616|NCT01193491|Protease Inhibitors|protease inhibitors|mesh-ancestor
101987618|NCT01110317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101987619|NCT01110317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101987620|NCT01110317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101987621|NCT01110317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987622|NCT01110317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101987623|NCT01110317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101987624|NCT01110317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101987625|NCT01110317|Serotonin Agents|serotonin agents|mesh-ancestor
101987626|NCT01110317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101987627|NCT01110317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987628|NCT01110317|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101987629|NCT01110317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101987630|NCT01110317|Dopamine Agents|dopamine agents|mesh-ancestor
101987631|NCT01208285|Ivacaftor|ivacaftor|mesh-list
101987632|NCT01208285|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101987633|NCT01208285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101711810|NCT00489853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101987634|NCT01208285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987635|NCT01208363|Fe(III)-EDTA|fe(iii)-edta|mesh-list
101987636|NCT01208363|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101987637|NCT01208363|Chelating Agents|chelating agents|mesh-ancestor
101987638|NCT01208363|Sequestering Agents|sequestering agents|mesh-ancestor
101987639|NCT01208363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987640|NCT01208441|Letrozole|letrozole|mesh-list
101987641|NCT01208441|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
101987642|NCT01208441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101987643|NCT01208441|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101987644|NCT01208441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101987645|NCT01208441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101987646|NCT01208441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987647|NCT01208441|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101987648|NCT01208441|Hormone Antagonists|hormone antagonists|mesh-ancestor
101987649|NCT01208441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101987652|NCT03718377|Anesthetics|anesthetics|mesh-list
101987653|NCT03718377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101987654|NCT03718377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987655|NCT01197469|Tadalafil|tadalafil|mesh-list
101987656|NCT01197469|Vasodilator Agents|vasodilator agents|mesh-ancestor
101987657|NCT01197469|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101987658|NCT01197469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101987659|NCT01197469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101987660|NCT01197469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987661|NCT01197469|Urological Agents|urological agents|mesh-ancestor
101987662|NCT01211561|Selenium|selenium|mesh-list
101987663|NCT01211561|Antioxidants|antioxidants|mesh-ancestor
101987664|NCT01211561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987665|NCT01211561|Protective Agents|protective agents|mesh-ancestor
101987666|NCT01211561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987667|NCT01211561|Trace Elements|trace elements|mesh-ancestor
101987668|NCT01211561|Micronutrients|micronutrients|mesh-ancestor
101987669|NCT01213355|Scopolamine|scopolamine|mesh-list
101987670|NCT01213355|Donepezil|donepezil|mesh-list
101987671|NCT01213355|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101987672|NCT01213355|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101987673|NCT01213355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101987674|NCT01213355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987675|NCT01213355|Cholinergic Agents|cholinergic agents|mesh-ancestor
101987676|NCT01213355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101987677|NCT01213355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987678|NCT01213355|Nootropic Agents|nootropic agents|mesh-ancestor
101987679|NCT01213355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101987680|NCT01213355|Antiemetics|antiemetics|mesh-ancestor
101987681|NCT01213355|Autonomic Agents|autonomic agents|mesh-ancestor
101987682|NCT01213355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101947290|NCT00135226|Sensory System Agents|sensory system agents|mesh-ancestor
101947291|NCT00135226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101947292|NCT00135226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987683|NCT01213355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101987684|NCT01213355|Mydriatics|mydriatics|mesh-ancestor
101711817|NCT00489853|Glucocorticoids|glucocorticoids|mesh-ancestor
101987685|NCT01213355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101987686|NCT01213355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101987687|NCT01213355|Parasympatholytics|parasympatholytics|mesh-ancestor
101987688|NCT03938363|Botulinum Toxins|botulinum toxins|mesh-list
101987689|NCT03938363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101987690|NCT03938363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101987691|NCT03938363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987692|NCT03938363|Cholinergic Agents|cholinergic agents|mesh-ancestor
101987693|NCT03938363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101987694|NCT03938363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987695|NCT03848065|Vaccines|vaccines|mesh-list
101987696|NCT03848065|Immunologic Factors|immunologic factors|mesh-ancestor
101987697|NCT03848065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987698|NCT01110473|Azacitidine|azacitidine|mesh-list
101987699|NCT01110473|Ilorasertib|ilorasertib|mesh-list
101987700|NCT01110473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101987701|NCT01110473|Antimetabolites|antimetabolites|mesh-ancestor
101987702|NCT01110473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987703|NCT01110473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101987704|NCT01110473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101987705|NCT01110473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101987706|NCT05558761|Pentoxifylline|pentoxifylline|mesh-list
101987707|NCT05558761|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101987708|NCT05558761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101987709|NCT05558761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987710|NCT05558761|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101987711|NCT05558761|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101987712|NCT05558761|Protective Agents|protective agents|mesh-ancestor
101987713|NCT05558761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987714|NCT05558761|Vasodilator Agents|vasodilator agents|mesh-ancestor
101987715|NCT05558761|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101987716|NCT05558761|Antioxidants|antioxidants|mesh-ancestor
101987717|NCT03940391|Chlorpheniramine|chlorpheniramine|mesh-list
101987718|NCT03940391|Midazolam|midazolam|mesh-list
101987719|NCT03940391|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101711836|NCT04137302|Hydrocortisone|hydrocortisone|mesh-list
101987720|NCT03940391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101987721|NCT03940391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101987726|NCT03940391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101987727|NCT03940391|Anesthetics, General|anesthetics, general|mesh-ancestor
101987728|NCT03940391|Anesthetics|anesthetics|mesh-ancestor
101987729|NCT03940391|GABA Modulators|gaba modulators|mesh-ancestor
101987730|NCT03940391|GABA Agents|gaba agents|mesh-ancestor
101987731|NCT03940391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101987732|NCT03940391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987733|NCT03940391|Antipruritics|antipruritics|mesh-ancestor
101987734|NCT03940391|Dermatologic Agents|dermatologic agents|mesh-ancestor
101987735|NCT03940391|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101987736|NCT03940391|Histamine Antagonists|histamine antagonists|mesh-ancestor
101987737|NCT03940391|Histamine Agents|histamine agents|mesh-ancestor
101987738|NCT03940391|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101987739|NCT03715881|Prednisolone|prednisolone|mesh-list
101987740|NCT03715881|Epoetin Alfa|epoetin alfa|mesh-list
101987741|NCT03715881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101987742|NCT03715881|Glucocorticoids|glucocorticoids|mesh-ancestor
101987743|NCT03715881|Hormones|hormones|mesh-ancestor
101987744|NCT03715881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101987745|NCT03715881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987746|NCT03715881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101987747|NCT03715881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101987748|NCT03715881|Hematinics|hematinics|mesh-ancestor
101987749|NCT01197781|Verapamil|verapamil|mesh-list
101987750|NCT01197781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101987751|NCT01197781|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101987752|NCT01197781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101987753|NCT01197781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987754|NCT01197781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101987755|NCT01197781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947293|NCT00135226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101947294|NCT00135226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101947295|NCT00135226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101987756|NCT01197781|Vasodilator Agents|vasodilator agents|mesh-ancestor
101987758|NCT01110551|Immunologic Factors|immunologic factors|mesh-ancestor
101987759|NCT01110551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987760|NCT01296139|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
101987761|NCT01296139|Hematinics|hematinics|mesh-ancestor
101707584|NCT04063540|Amiloride|amiloride|mesh-list
101987762|NCT01296139|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101987763|NCT01296139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101987764|NCT03940469|Dexamethasone|dexamethasone|mesh-list
101987765|NCT03940469|Dexamethasone acetate|dexamethasone acetate|mesh-list
101987766|NCT03940469|Dexmedetomidine|dexmedetomidine|mesh-list
101987767|NCT03940469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101987768|NCT03940469|Antiemetics|antiemetics|mesh-ancestor
101987769|NCT03940469|Autonomic Agents|autonomic agents|mesh-ancestor
101987770|NCT03940469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101987771|NCT03940469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987772|NCT03940469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101987773|NCT03940469|Glucocorticoids|glucocorticoids|mesh-ancestor
101987774|NCT03940469|Hormones|hormones|mesh-ancestor
101987775|NCT03940469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101987776|NCT03940469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101987777|NCT03940469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101987778|NCT03940469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101987779|NCT03940469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101987780|NCT03940469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101987781|NCT03940469|Analgesics|analgesics|mesh-ancestor
101987782|NCT03940469|Sensory System Agents|sensory system agents|mesh-ancestor
101987783|NCT03940469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101987784|NCT03940469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101987785|NCT03940469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101987786|NCT03940469|Adrenergic Agents|adrenergic agents|mesh-ancestor
101987787|NCT03940469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101987788|NCT03940469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987789|NCT01110785|Panitumumab|panitumumab|mesh-list
101987790|NCT01110785|Simvastatin|simvastatin|mesh-list
101987791|NCT01110785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101987792|NCT01110785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101987796|NCT01110785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101987797|NCT01110785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101987798|NCT01110785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101987799|NCT01110785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101987800|NCT03846271|Oxytocin|oxytocin|mesh-list
101987801|NCT03846271|Oxytocics|oxytocics|mesh-ancestor
101987802|NCT03846271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101987803|NCT03846271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987804|NCT01110941|Leucovorin|leucovorin|mesh-list
101987805|NCT01110941|Oxaliplatin|oxaliplatin|mesh-list
101987806|NCT01110941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101987807|NCT01110941|Antidotes|antidotes|mesh-ancestor
101987808|NCT01110941|Protective Agents|protective agents|mesh-ancestor
101987809|NCT01110941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987810|NCT01110941|Vitamin B Complex|vitamin b complex|mesh-ancestor
101987811|NCT01110941|Vitamins|vitamins|mesh-ancestor
101987812|NCT01110941|Micronutrients|micronutrients|mesh-ancestor
101987813|NCT03448419|Empagliflozin|empagliflozin|mesh-list
101987814|NCT03448419|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101987815|NCT03448419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987816|NCT03448419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101987817|NCT03448419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987818|NCT01118039|Sunitinib|sunitinib|mesh-list
101987819|NCT01118039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101987820|NCT01118039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101987821|NCT01118039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101987822|NCT01118039|Growth Substances|growth substances|mesh-ancestor
101987823|NCT01118039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987824|NCT01118039|Growth Inhibitors|growth inhibitors|mesh-ancestor
101987825|NCT01118039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101987826|NCT01118039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101987827|NCT01118039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987828|NCT01213433|Artesunate|artesunate|mesh-list
101947297|NCT00135226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947298|NCT00135226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101987829|NCT01213433|Amodiaquine|amodiaquine|mesh-list
101987830|NCT01213433|Antimalarials|antimalarials|mesh-ancestor
101987831|NCT01213433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101987832|NCT01213433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101987833|NCT01213433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101987834|NCT01213433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101987835|NCT01213433|Antiviral Agents|antiviral agents|mesh-ancestor
101987836|NCT01213433|Schistosomicides|schistosomicides|mesh-ancestor
101987837|NCT01213433|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101987838|NCT01213433|Anthelmintics|anthelmintics|mesh-ancestor
101987839|NCT03848533|Metformin|metformin|mesh-list
101987840|NCT03848533|Melatonin|melatonin|mesh-list
101987841|NCT03848533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101987842|NCT03848533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987843|NCT03848533|Antioxidants|antioxidants|mesh-ancestor
101987844|NCT03848533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987845|NCT03848533|Protective Agents|protective agents|mesh-ancestor
101987846|NCT03848533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101987847|NCT01111253|Amoxicillin|amoxicillin|mesh-list
101987848|NCT01111253|Clavulanic Acid|clavulanic acid|mesh-list
101987849|NCT01111253|Clavulanic Acids|clavulanic acids|mesh-list
101987850|NCT01111253|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101987851|NCT01111253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101987852|NCT01111253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101987853|NCT01111253|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101987854|NCT01111253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101987855|NCT01111253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987856|NCT01213667|Ranibizumab|ranibizumab|mesh-list
101987857|NCT01213667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101987858|NCT01213667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101987859|NCT01213667|Growth Substances|growth substances|mesh-ancestor
101711879|NCT00693212|Dopamine Agents|dopamine agents|mesh-ancestor
101987860|NCT01213667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987861|NCT01213667|Growth Inhibitors|growth inhibitors|mesh-ancestor
101987862|NCT01213667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101987863|NCT01196065|Memantine|memantine|mesh-list
101987864|NCT01196065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101987865|NCT01196065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101987875|NCT05258773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101987876|NCT05258773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987878|NCT05258773|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101987879|NCT05258773|Serotonin Agents|serotonin agents|mesh-ancestor
101987880|NCT05258773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101987881|NCT05258773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987882|NCT03845179|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101987883|NCT03845179|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
101987884|NCT03845179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101987885|NCT03845179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987886|NCT03845179|Incretins|incretins|mesh-ancestor
101987887|NCT03845179|Hormones|hormones|mesh-ancestor
101987888|NCT03845179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101987889|NCT03845179|Protease Inhibitors|protease inhibitors|mesh-ancestor
101987890|NCT03845179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101987891|NCT03845179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987892|NCT01121705|Interferons|interferons|mesh-list
101987893|NCT01121705|Ribavirin|ribavirin|mesh-list
101987894|NCT01121705|Interferon-alpha|interferon-alpha|mesh-list
101987895|NCT01121705|Interferon alpha-2|interferon alpha-2|mesh-list
101987896|NCT01121705|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101987897|NCT01121705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101987898|NCT01121705|Antiviral Agents|antiviral agents|mesh-ancestor
101987899|NCT01121705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101987900|NCT01121705|Antimetabolites|antimetabolites|mesh-ancestor
101987901|NCT01121705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987902|NCT01121705|Immunologic Factors|immunologic factors|mesh-ancestor
101987903|NCT01121705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987904|NCT01196455|Capecitabine|capecitabine|mesh-list
101987905|NCT01196455|Mitomycins|mitomycins|mesh-list
101987906|NCT01196455|Mitomycin|mitomycin|mesh-list
101987907|NCT01196455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101987908|NCT01196455|Antimetabolites|antimetabolites|mesh-ancestor
101947299|NCT00135226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101947300|NCT00135226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101947302|NCT01587261|Ascorbic Acid|ascorbic acid|mesh-list
101947303|NCT01587261|Vitamins|vitamins|mesh-ancestor
101947304|NCT01587261|Micronutrients|micronutrients|mesh-ancestor
101987909|NCT01196455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987910|NCT01196455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101987911|NCT01196455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101987912|NCT01196455|Alkylating Agents|alkylating agents|mesh-ancestor
101987913|NCT01196455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101707727|NCT00857766|Hormones|hormones|mesh-ancestor
101987914|NCT01196455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101987915|NCT03846583|Trastuzumab|trastuzumab|mesh-list
101987916|NCT03846583|Tucatinib|tucatinib|mesh-list
101987917|NCT03846583|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101987918|NCT03846583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101987919|NCT03846583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101987920|NCT03846583|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101987921|NCT03846583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101987922|NCT03846583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987923|NCT03846583|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101987924|NCT03846583|Hormone Antagonists|hormone antagonists|mesh-ancestor
101987925|NCT03846583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101987926|NCT03846583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987927|NCT03846583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101987928|NCT01115543|Calcitriol|calcitriol|mesh-list
101987929|NCT01115543|Alfacalcidol|alfacalcidol|mesh-list
101987952|NCT01198249|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101987953|NCT01198249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101987954|NCT01198249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101987955|NCT01198249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101987956|NCT01198249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987957|NCT01198249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101987958|NCT01198249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987959|NCT01198249|Vasodilator Agents|vasodilator agents|mesh-ancestor
101987960|NCT01198249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101987961|NCT01198249|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101987962|NCT01198249|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101987963|NCT01198249|Diuretics|diuretics|mesh-ancestor
101987964|NCT01198249|Natriuretic Agents|natriuretic agents|mesh-ancestor
101987965|NCT01198249|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101987966|NCT02529761|Sorafenib|sorafenib|mesh-list
101987967|NCT02529761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101987968|NCT02529761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101987969|NCT02529761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101987970|NCT02529761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987971|NCT03844243|Mitogens|mitogens|mesh-list
101987972|NCT03844243|Mitosis Modulators|mitosis modulators|mesh-ancestor
101987973|NCT03844243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987974|NCT05479591|Xultophy|xultophy|mesh-list
101987975|NCT05479591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101987976|NCT05479591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987977|NCT05479591|Incretins|incretins|mesh-ancestor
101987978|NCT05479591|Hormones|hormones|mesh-ancestor
101987979|NCT05479591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101987980|NCT01119209|Ropivacaine|ropivacaine|mesh-list
101987981|NCT01119209|Anesthetics, Local|anesthetics, local|mesh-ancestor
101987987|NCT01213901|Insulin Lispro|insulin lispro|mesh-list
101575004|NCT02872389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987988|NCT01213901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101987989|NCT01213901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987990|NCT01116167|Letrozole|letrozole|mesh-list
101987991|NCT01116167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101987992|NCT01116167|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101987993|NCT01116167|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101987994|NCT01116167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101987995|NCT01116167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987996|NCT01116167|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101947305|NCT01587261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947306|NCT01587261|Antioxidants|antioxidants|mesh-ancestor
101971955|NCT00315640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101987997|NCT01116167|Hormone Antagonists|hormone antagonists|mesh-ancestor
101987998|NCT01116167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101987999|NCT01116167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988000|NCT01119521|Isoniazid|isoniazid|mesh-list
101988001|NCT01119521|Antitubercular Agents|antitubercular agents|mesh-ancestor
101988002|NCT01119521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101988003|NCT01119521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101988004|NCT01119521|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101988005|NCT01119521|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101988006|NCT01119521|Antimetabolites|antimetabolites|mesh-ancestor
101988007|NCT01119521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988008|NCT01119521|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101988009|NCT03939923|Glycopyrrolate|glycopyrrolate|mesh-list
101988010|NCT03939923|Rocuronium|rocuronium|mesh-list
101988011|NCT03939923|Neostigmine|neostigmine|mesh-list
101988012|NCT03939923|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101988013|NCT03939923|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101988014|NCT03939923|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101988015|NCT03939923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101988016|NCT03939923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988017|NCT03939923|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101988018|NCT03939923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101988019|NCT03939923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988020|NCT03939923|Cholinergic Agents|cholinergic agents|mesh-ancestor
101988021|NCT03939923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101988022|NCT03939923|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101988023|NCT03939923|Autonomic Agents|autonomic agents|mesh-ancestor
101988024|NCT03939923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101988025|NCT03939923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101988026|NCT03939923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101988027|NCT01119599|Temozolomide|temozolomide|mesh-list
101988028|NCT01119599|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
101988029|NCT01119599|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
101988030|NCT01119599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101988031|NCT01119599|Alkylating Agents|alkylating agents|mesh-ancestor
101988032|NCT01119599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988033|NCT01119599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101988034|NCT01119599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101988035|NCT03419403|Temozolomide|temozolomide|mesh-list
101988036|NCT03419403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
101988037|NCT03419403|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101988038|NCT03419403|ABT-414|abt-414|mesh-list
101988039|NCT03419403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101988040|NCT03419403|Alkylating Agents|alkylating agents|mesh-ancestor
101988041|NCT03419403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988042|NCT03419403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101988043|NCT03419403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101988044|NCT03419403|Immunoconjugates|immunoconjugates|mesh-ancestor
101988045|NCT03419403|Immunologic Factors|immunologic factors|mesh-ancestor
101988046|NCT03419403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988047|NCT05156437|Amoxicillin|amoxicillin|mesh-list
101988053|NCT05156437|Daptomycin|daptomycin|mesh-list
101988054|NCT05156437|Cephalexin|cephalexin|mesh-list
101988055|NCT05156437|Ampicillin|ampicillin|mesh-list
101988056|NCT05156437|Cefepime|cefepime|mesh-list
101988057|NCT05156437|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
101988058|NCT05156437|Oxacillin|oxacillin|mesh-list
101988059|NCT05156437|Dicloxacillin|dicloxacillin|mesh-list
101988060|NCT05156437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101988061|NCT05156437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101988062|NCT05156437|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101988063|NCT05156437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101988064|NCT05156437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101988065|NCT05156437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101988066|NCT05156437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988067|NCT05156437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101988068|NCT05156437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101947307|NCT01587261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947308|NCT01587261|Protective Agents|protective agents|mesh-ancestor
101947309|NCT01269021|Mycophenolic Acid|mycophenolic acid|mesh-list
101947311|NCT01269021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101988069|NCT05156437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101988070|NCT05156437|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101988071|NCT05156437|Antitubercular Agents|antitubercular agents|mesh-ancestor
101988072|NCT05156437|Leprostatic Agents|leprostatic agents|mesh-ancestor
101988073|NCT05156437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101988074|NCT05156437|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101988075|NCT05156437|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101988076|NCT05156437|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101988077|NCT05156437|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101988078|NCT05156437|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101988079|NCT05156437|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101988080|NCT05156437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101988081|NCT01119677|Interferon beta-1a|interferon beta-1a|mesh-list
101988082|NCT01119677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101988083|NCT01119677|Immunologic Factors|immunologic factors|mesh-ancestor
101988084|NCT01119677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988085|NCT01119677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101988086|NCT01119677|Antiviral Agents|antiviral agents|mesh-ancestor
101988087|NCT01119677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101988088|NCT03715725|Warfarin|warfarin|mesh-list
101988089|NCT03715725|Rivaroxaban|rivaroxaban|mesh-list
101988090|NCT03715725|Dabigatran|dabigatran|mesh-list
101988091|NCT03715725|Apixaban|apixaban|mesh-list
101988092|NCT03715725|Anticoagulants|anticoagulants|mesh-ancestor
101988093|NCT03715725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101988094|NCT03715725|Antithrombins|antithrombins|mesh-ancestor
101988095|NCT03715725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101988096|NCT03715725|Protease Inhibitors|protease inhibitors|mesh-ancestor
101988097|NCT03715725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101988098|NCT03715725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988099|NCT01212653|Golimumab|golimumab|mesh-list
101988100|NCT01212653|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101988101|NCT01212653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101988102|NCT01212653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101988103|NCT01212653|Immunologic Factors|immunologic factors|mesh-ancestor
101988104|NCT01212653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988105|NCT01213979|Iron|iron|mesh-list
101988106|NCT01213979|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
101988107|NCT01213979|Ferric Compounds|ferric compounds|mesh-list
101988108|NCT01213979|Trace Elements|trace elements|mesh-ancestor
101988109|NCT01213979|Micronutrients|micronutrients|mesh-ancestor
101988110|NCT01213979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988111|NCT01213979|Hematinics|hematinics|mesh-ancestor
101988112|NCT05282719|Azacitidine|azacitidine|mesh-list
101988113|NCT05282719|Venetoclax|venetoclax|mesh-list
101988114|NCT05282719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101988115|NCT05282719|Antimetabolites|antimetabolites|mesh-ancestor
101988116|NCT05282719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988117|NCT05282719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101988118|NCT05282719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101988119|NCT01118429|Oxybutynin|oxybutynin|mesh-list
101988120|NCT01118429|Parasympatholytics|parasympatholytics|mesh-ancestor
101988121|NCT01118429|Autonomic Agents|autonomic agents|mesh-ancestor
101988122|NCT01118429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101988125|NCT01118429|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101988126|NCT01118429|Cholinergic Agents|cholinergic agents|mesh-ancestor
101988127|NCT01118429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101988128|NCT01118429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988129|NCT01118429|Urological Agents|urological agents|mesh-ancestor
101988130|NCT03447249|Ivacaftor|ivacaftor|mesh-list
101988131|NCT03447249|VX-659|vx-659|mesh-list
101988132|NCT03447249|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101988133|NCT03447249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101988134|NCT03447249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988135|NCT04156555|Amoxicillin|amoxicillin|mesh-list
101988136|NCT04156555|Clavulanic Acid|clavulanic acid|mesh-list
101575005|NCT01179516|Vortioxetine|vortioxetine|mesh-list
101947312|NCT01269021|Glucocorticoids|glucocorticoids|mesh-ancestor
101947313|NCT01269021|Hormones|hormones|mesh-ancestor
101947314|NCT01269021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101947315|NCT01269021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814686|NCT04049045|Empagliflozin|empagliflozin|mesh-list
101988137|NCT04156555|Clavulanic Acids|clavulanic acids|mesh-list
101988138|NCT04156555|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101988139|NCT04156555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101988140|NCT04156555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101988141|NCT04156555|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101988142|NCT04156555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101988143|NCT04156555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988144|NCT01200121|Bevacizumab|bevacizumab|mesh-list
101988145|NCT01200121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101988146|NCT01200121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101988147|NCT01200121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101988148|NCT01200121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101988149|NCT01200121|Growth Substances|growth substances|mesh-ancestor
101988150|NCT01200121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988151|NCT01200121|Growth Inhibitors|growth inhibitors|mesh-ancestor
101988152|NCT01214291|Toremifene|toremifene|mesh-list
101988153|NCT01214291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101988154|NCT01214291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101988155|NCT01214291|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101988156|NCT01214291|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101988157|NCT01214291|Hormone Antagonists|hormone antagonists|mesh-ancestor
101988158|NCT01214291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101988159|NCT01214291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988160|NCT01214291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101988161|NCT01116635|Doxorubicin|doxorubicin|mesh-list
101988162|NCT01116635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101988163|NCT01116635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101988164|NCT01116635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101988165|NCT01116635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101988166|NCT01116635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101988167|NCT01116635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988168|NCT01566799|Metformin|metformin|mesh-list
101988169|NCT01566799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101988170|NCT01566799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988171|NCT04642807|Calpastatin|calpastatin|mesh-list
101988172|NCT04642807|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
101988173|NCT04642807|Protease Inhibitors|protease inhibitors|mesh-ancestor
101988174|NCT04642807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101988175|NCT04642807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988176|NCT01216085|Imatinib Mesylate|imatinib mesylate|mesh-list
101988177|NCT01216085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101988178|NCT01216085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101988179|NCT01216085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101988180|NCT01216085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988181|NCT01198639|Remifentanil|remifentanil|mesh-list
101988182|NCT01198639|Propofol|propofol|mesh-list
101988183|NCT01198639|Anesthetics|anesthetics|mesh-list
101988184|NCT01198639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101988185|NCT01198639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101988186|NCT01198639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988187|NCT01198639|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101988188|NCT01198639|Anesthetics, General|anesthetics, general|mesh-ancestor
101988189|NCT01198639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101988190|NCT01198639|Narcotics|narcotics|mesh-ancestor
101988191|NCT01198639|Analgesics|analgesics|mesh-ancestor
101988192|NCT01198639|Sensory System Agents|sensory system agents|mesh-ancestor
101443258|NCT01989325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101988196|NCT01116713|Antiemetics|antiemetics|mesh-ancestor
101988197|NCT01116713|Autonomic Agents|autonomic agents|mesh-ancestor
101988198|NCT01116713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101988199|NCT01116713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988200|NCT01116713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101988201|NCT01116713|Glucocorticoids|glucocorticoids|mesh-ancestor
101947316|NCT01269021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101947317|NCT01269021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101947318|NCT01269021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101947319|NCT01269021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101947320|NCT01269021|Antitubercular Agents|antitubercular agents|mesh-ancestor
101947321|NCT01269021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101988203|NCT01116713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101988204|NCT01116713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101988205|NCT01116713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101988207|NCT01202149|Emollients|emollients|mesh-list
101988208|NCT01202149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101988209|NCT01202149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101988210|NCT01202149|Analgesics|analgesics|mesh-ancestor
101988211|NCT01202149|Sensory System Agents|sensory system agents|mesh-ancestor
101988212|NCT01202149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101988213|NCT01202149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988214|NCT01202149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101988215|NCT01202149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101988216|NCT01202149|Dermatologic Agents|dermatologic agents|mesh-ancestor
101988217|NCT01202149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101988218|NCT01202149|Immunologic Factors|immunologic factors|mesh-ancestor
101988219|NCT01202149|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101988220|NCT01202149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101988221|NCT01202149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988223|NCT01116791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101988224|NCT03940001|Paclitaxel|paclitaxel|mesh-list
101988225|NCT03940001|Carboplatin|carboplatin|mesh-list
101711906|NCT00499603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101988226|NCT03940001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101988227|NCT03940001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101988228|NCT03940001|Tubulin Modulators|tubulin modulators|mesh-ancestor
101988229|NCT03940001|Antimitotic Agents|antimitotic agents|mesh-ancestor
101988230|NCT03940001|Mitosis Modulators|mitosis modulators|mesh-ancestor
101988231|NCT03940001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988232|NCT01120769|Acetaminophen|acetaminophen|mesh-list
101988233|NCT01120769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101988234|NCT01120769|Analgesics|analgesics|mesh-ancestor
101988235|NCT01120769|Sensory System Agents|sensory system agents|mesh-ancestor
101988236|NCT01120769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101988237|NCT01120769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988238|NCT01120769|Antipyretics|antipyretics|mesh-ancestor
101988239|NCT03715413|Tamoxifen|tamoxifen|mesh-list
101988240|NCT03715413|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101988241|NCT03715413|Hormone Antagonists|hormone antagonists|mesh-ancestor
101988242|NCT03715413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101988243|NCT03715413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988244|NCT03715413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101988245|NCT03715413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101988246|NCT03715413|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101988247|NCT03715413|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101988248|NCT03715413|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101988249|NCT01122251|Valsartan|valsartan|mesh-list
101988250|NCT01122251|Lercanidipine|lercanidipine|mesh-list
101988251|NCT01122251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101988252|NCT01122251|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101988253|NCT01122251|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101988254|NCT01122251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988255|NCT01122251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101988256|NCT01122251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101988257|NCT01122251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101988258|NCT01122251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988259|NCT04600999|Favipiravir|favipiravir|mesh-list
101988260|NCT04600999|Antiviral Agents|antiviral agents|mesh-ancestor
101988261|NCT04600999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101988262|NCT01199029|Prednisone|prednisone|mesh-list
101988263|NCT01199029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101988264|NCT01199029|Glucocorticoids|glucocorticoids|mesh-ancestor
101947322|NCT01269021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101947323|NCT01269021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101947324|NCT01269021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988267|NCT01199029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988268|NCT01199029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101988269|NCT01199029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101988270|NCT01200745|Capsaicin|capsaicin|mesh-list
101988271|NCT01200745|Antipruritics|antipruritics|mesh-ancestor
101988272|NCT01200745|Dermatologic Agents|dermatologic agents|mesh-ancestor
101988273|NCT01200745|Sensory System Agents|sensory system agents|mesh-ancestor
101988274|NCT01200745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101988275|NCT01200745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988276|NCT01585415|Aldesleukin|aldesleukin|mesh-list
101988277|NCT01585415|Cyclophosphamide|cyclophosphamide|mesh-list
101988278|NCT01585415|Fludarabine|fludarabine|mesh-list
101988279|NCT01585415|Vemurafenib|vemurafenib|mesh-list
101988280|NCT01585415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101988281|NCT01585415|Immunologic Factors|immunologic factors|mesh-ancestor
101988282|NCT01585415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988283|NCT01585415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101988284|NCT01585415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101988285|NCT01585415|Alkylating Agents|alkylating agents|mesh-ancestor
101988286|NCT01585415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988287|NCT01585415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101988288|NCT01585415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101988289|NCT01585415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101988290|NCT01585415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101988291|NCT01585415|Antiviral Agents|antiviral agents|mesh-ancestor
101988292|NCT01585415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101988293|NCT01585415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101988294|NCT01585415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101988295|NCT01566643|Metronidazole|metronidazole|mesh-list
101988296|NCT01566643|Rabeprazole|rabeprazole|mesh-list
101988297|NCT01566643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101988298|NCT01566643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101988299|NCT01566643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101988300|NCT01566643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101988301|NCT01566643|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101988302|NCT01566643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101988303|NCT01566643|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101988304|NCT01566643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101988305|NCT01566643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988306|NCT03841747|Paclitaxel|paclitaxel|mesh-list
101988307|NCT03841747|Pembrolizumab|pembrolizumab|mesh-list
101988308|NCT03841747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101988309|NCT03841747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101988310|NCT03841747|Tubulin Modulators|tubulin modulators|mesh-ancestor
101988311|NCT03841747|Antimitotic Agents|antimitotic agents|mesh-ancestor
101988312|NCT03841747|Mitosis Modulators|mitosis modulators|mesh-ancestor
101988313|NCT03841747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988314|NCT03841747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101988315|NCT03841747|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101988316|NCT01121237|Epoetin Alfa|epoetin alfa|mesh-list
101988317|NCT01121237|Hematinics|hematinics|mesh-ancestor
101988318|NCT03841591|Metformin|metformin|mesh-list
101988319|NCT03841591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101988320|NCT03841591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988321|NCT05667727|Epinephrine|epinephrine|mesh-list
101988322|NCT05667727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101988323|NCT05667727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101988324|NCT05667727|Adrenergic Agents|adrenergic agents|mesh-ancestor
101988325|NCT05667727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101988326|NCT05667727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988327|NCT05667727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988328|NCT05667727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101988329|NCT05667727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101988330|NCT05667727|Autonomic Agents|autonomic agents|mesh-ancestor
101988331|NCT05667727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101988332|NCT05667727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101988333|NCT05667727|Respiratory System Agents|respiratory system agents|mesh-ancestor
101988334|NCT05667727|Mydriatics|mydriatics|mesh-ancestor
101988335|NCT05667727|Sympathomimetics|sympathomimetics|mesh-ancestor
101988336|NCT05667727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101947325|NCT01269099|Fentanyl|fentanyl|mesh-list
101947326|NCT01269099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101947327|NCT01269099|Narcotics|narcotics|mesh-ancestor
101988337|NCT01200901|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101443406|NCT01874626|Ibuprofen|ibuprofen|mesh-list
101988354|NCT01214993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988355|NCT01214993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101988356|NCT01214993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101988357|NCT01214993|Antiviral Agents|antiviral agents|mesh-ancestor
101988358|NCT01214993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101988359|NCT03843229|Bufanolides|bufanolides|mesh-list
101988360|NCT03843229|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101988361|NCT03843229|Protective Agents|protective agents|mesh-ancestor
101988362|NCT03843229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988363|NCT01212887|Aldesleukin|aldesleukin|mesh-list
101988365|NCT01212887|Fludarabine|fludarabine|mesh-list
101988366|NCT01212887|Fludarabine phosphate|fludarabine phosphate|mesh-list
101988367|NCT01212887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101988368|NCT01212887|Immunologic Factors|immunologic factors|mesh-ancestor
101988369|NCT01212887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988370|NCT01212887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101988371|NCT01212887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101988372|NCT01212887|Alkylating Agents|alkylating agents|mesh-ancestor
101988373|NCT01212887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988374|NCT01212887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101988375|NCT01212887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101988376|NCT01212887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101988377|NCT01212887|Antimetabolites|antimetabolites|mesh-ancestor
101988378|NCT01212887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101988379|NCT01212887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101988380|NCT01212887|Antiviral Agents|antiviral agents|mesh-ancestor
101988381|NCT01212887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101988382|NCT01215149|Vaccines|vaccines|mesh-list
101988383|NCT01215149|Immunologic Factors|immunologic factors|mesh-ancestor
101988384|NCT01215149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988385|NCT03843307|Immunologic Factors|immunologic factors|mesh-list
101988386|NCT03843307|Immunomodulating Agents|immunomodulating agents|mesh-list
101988387|NCT03843307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988388|NCT04961281|Triamcinolone|triamcinolone|mesh-list
101988389|NCT04961281|Dexmedetomidine|dexmedetomidine|mesh-list
101988390|NCT04961281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101988391|NCT04961281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101988392|NCT04961281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988393|NCT04961281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101988394|NCT04961281|Analgesics|analgesics|mesh-ancestor
101988395|NCT04961281|Sensory System Agents|sensory system agents|mesh-ancestor
101988396|NCT04961281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101988397|NCT04961281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101988398|NCT04961281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101988402|NCT04961281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988404|NCT04961281|Glucocorticoids|glucocorticoids|mesh-ancestor
101988405|NCT04961281|Hormones|hormones|mesh-ancestor
101988406|NCT04961281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101988407|NCT01212965|Selenium|selenium|mesh-list
101988408|NCT01212965|Antioxidants|antioxidants|mesh-ancestor
101988409|NCT01212965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988410|NCT01212965|Protective Agents|protective agents|mesh-ancestor
101988411|NCT01212965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988412|NCT01212965|Trace Elements|trace elements|mesh-ancestor
101988413|NCT01212965|Micronutrients|micronutrients|mesh-ancestor
101988414|NCT02529449|Ipragliflozin|ipragliflozin|mesh-list
101988415|NCT02529449|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101988416|NCT02529449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988417|NCT02529449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101988418|NCT02529449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988419|NCT01216709|Iron|iron|mesh-list
101988420|NCT01216709|Trace Elements|trace elements|mesh-ancestor
101988421|NCT01216709|Micronutrients|micronutrients|mesh-ancestor
101988422|NCT01216709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988423|NCT01216787|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
101988424|NCT01216787|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101988425|NCT01216787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101947328|NCT01269099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101947329|NCT01269099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947330|NCT01269099|Analgesics|analgesics|mesh-ancestor
101947331|NCT01269099|Sensory System Agents|sensory system agents|mesh-ancestor
101947332|NCT01269099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101947333|NCT01269099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101814963|NCT00069121|Antidotes|antidotes|mesh-ancestor
101988426|NCT01216787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988427|NCT05282251|Bupivacaine|bupivacaine|mesh-list
101988428|NCT05282251|Anesthetics, Local|anesthetics, local|mesh-ancestor
101988429|NCT05282251|Anesthetics|anesthetics|mesh-ancestor
101988430|NCT05282251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101988431|NCT05282251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988432|NCT05282251|Sensory System Agents|sensory system agents|mesh-ancestor
101988433|NCT05282251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101988435|NCT01199341|Anticoagulants|anticoagulants|mesh-ancestor
101988436|NCT01215539|Panitumumab|panitumumab|mesh-list
101988437|NCT01215539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101793550|NCT04042220|Hormones|hormones|mesh-ancestor
101988438|NCT01215539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101988439|NCT01203709|Mycophenolic Acid|mycophenolic acid|mesh-list
101988440|NCT01203709|Tacrolimus|tacrolimus|mesh-list
101988441|NCT01203709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101988442|NCT01203709|Immunologic Factors|immunologic factors|mesh-ancestor
101988443|NCT01203709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988444|NCT01203709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101988445|NCT01203709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101988446|NCT01203709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988447|NCT01203709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101988448|NCT01203709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101988449|NCT01203709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101988450|NCT01203709|Antitubercular Agents|antitubercular agents|mesh-ancestor
101988451|NCT01203709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101988452|NCT01203709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101988453|NCT01122407|Trimethaphan|trimethaphan|mesh-list
101988454|NCT01122407|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
101988455|NCT01122407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988456|NCT01122407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101988457|NCT01122407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101988458|NCT01122407|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
101988459|NCT01122407|Autonomic Agents|autonomic agents|mesh-ancestor
101988460|NCT01122407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101988461|NCT01122407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988462|NCT01122407|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101988463|NCT01122407|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101988464|NCT01122407|Cholinergic Agents|cholinergic agents|mesh-ancestor
101988465|NCT01122407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101988466|NCT01122407|Vasodilator Agents|vasodilator agents|mesh-ancestor
101988467|NCT01213121|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101988477|NCT01124435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101988478|NCT01124435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101988480|NCT01124435|Sensory System Agents|sensory system agents|mesh-ancestor
101988481|NCT01124435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101988482|NCT01124435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988483|NCT01124435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101988484|NCT01124435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101988485|NCT01124435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101988486|NCT01124435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101988487|NCT01124435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101988488|NCT01124435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988489|NCT03294304|Gemcitabine|gemcitabine|mesh-list
101988490|NCT03294304|Nivolumab|nivolumab|mesh-list
101988491|NCT03294304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101988492|NCT03294304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101988493|NCT03294304|Antimetabolites|antimetabolites|mesh-ancestor
101988494|NCT03294304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988495|NCT03294304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101947334|NCT01269099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101947335|NCT01269099|Anesthetics, General|anesthetics, general|mesh-ancestor
101947337|NCT01164813|Nabumetone|nabumetone|mesh-list
101971956|NCT00315640|Growth Substances|growth substances|mesh-ancestor
101988496|NCT03294304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101988497|NCT01201213|Anesthetics|anesthetics|mesh-list
101988498|NCT01201213|Anesthetics, Local|anesthetics, local|mesh-list
101988499|NCT01201213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101988500|NCT01201213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988501|NCT01201213|Sensory System Agents|sensory system agents|mesh-ancestor
101988502|NCT01201213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101988503|NCT03472378|Celecoxib|celecoxib|mesh-list
101988504|NCT03472378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101988505|NCT03472378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101988506|NCT03472378|Analgesics|analgesics|mesh-ancestor
101988507|NCT03472378|Sensory System Agents|sensory system agents|mesh-ancestor
101988508|NCT03472378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101988509|NCT03472378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988510|NCT03472378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101988511|NCT03472378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101988512|NCT03472378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101988513|NCT03472378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101988514|NCT03472378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101988515|NCT03472378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988516|NCT03408873|Aripiprazole|aripiprazole|mesh-list
101988517|NCT03408873|Antidepressive Agents|antidepressive agents|mesh-ancestor
101988518|NCT03408873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101988519|NCT03408873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101988520|NCT03408873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101988521|NCT03408873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101988522|NCT03408873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988523|NCT03408873|Dopamine Agonists|dopamine agonists|mesh-ancestor
101988524|NCT03408873|Dopamine Agents|dopamine agents|mesh-ancestor
101988525|NCT03408873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101988526|NCT03408873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988527|NCT03408873|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101988528|NCT03408873|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101988529|NCT03408873|Serotonin Agents|serotonin agents|mesh-ancestor
101988530|NCT03408873|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101988531|NCT03408873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101988540|NCT03715101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101988542|NCT03780959|Etanercept|etanercept|mesh-list
101988543|NCT03780959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101988544|NCT03780959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101988545|NCT03780959|Analgesics|analgesics|mesh-ancestor
101988546|NCT03780959|Sensory System Agents|sensory system agents|mesh-ancestor
101988547|NCT03780959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101988548|NCT03780959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988549|NCT03780959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101988550|NCT03780959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101988551|NCT03780959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101988552|NCT03780959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101988553|NCT03780959|Immunologic Factors|immunologic factors|mesh-ancestor
101988554|NCT03838783|Insulin|insulin|mesh-list
101988555|NCT03838783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101988556|NCT03838783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988557|NCT03408639|Vitamin B 12|vitamin b 12|mesh-list
101988558|NCT03408639|Hydroxocobalamin|hydroxocobalamin|mesh-list
101988559|NCT03408639|Epoetin Alfa|epoetin alfa|mesh-list
101988560|NCT03408639|Vitamins|vitamins|mesh-ancestor
101988561|NCT03408639|Micronutrients|micronutrients|mesh-ancestor
101988562|NCT03408639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988563|NCT03408639|Vitamin B Complex|vitamin b complex|mesh-ancestor
101988564|NCT03408639|Hematinics|hematinics|mesh-ancestor
101988565|NCT01219205|Bevacizumab|bevacizumab|mesh-list
101988566|NCT01219205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101988567|NCT01219205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101988568|NCT01219205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101988569|NCT01219205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101988570|NCT01219205|Growth Substances|growth substances|mesh-ancestor
101947338|NCT01164813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101947339|NCT01164813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101947340|NCT01164813|Analgesics|analgesics|mesh-ancestor
101947341|NCT01164813|Sensory System Agents|sensory system agents|mesh-ancestor
101947342|NCT01164813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101988571|NCT01219205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988572|NCT01219205|Growth Inhibitors|growth inhibitors|mesh-ancestor
101988573|NCT03810235|Lidocaine|lidocaine|mesh-list
101988574|NCT03810235|Anesthetics, Local|anesthetics, local|mesh-ancestor
101988575|NCT03810235|Anesthetics|anesthetics|mesh-ancestor
101988576|NCT03810235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101988577|NCT03810235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988578|NCT03810235|Sensory System Agents|sensory system agents|mesh-ancestor
101988579|NCT03810235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101988580|NCT03810235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101988581|NCT03810235|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101988582|NCT03810235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101988583|NCT03810235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101988584|NCT03810235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988585|NCT03408483|Epinephrine|epinephrine|mesh-list
101988586|NCT03408483|Analgesics, Opioid|analgesics, opioid|mesh-list
101988587|NCT03408483|Bupivacaine|bupivacaine|mesh-list
101988588|NCT03408483|Anesthetics, Local|anesthetics, local|mesh-ancestor
101988589|NCT03408483|Anesthetics|anesthetics|mesh-ancestor
101988590|NCT03408483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101988591|NCT03408483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988592|NCT03408483|Sensory System Agents|sensory system agents|mesh-ancestor
101988593|NCT03408483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101988594|NCT03408483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101988595|NCT03408483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101988596|NCT03408483|Adrenergic Agents|adrenergic agents|mesh-ancestor
101988597|NCT03408483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101988621|NCT03714867|Analgesics|analgesics|mesh-ancestor
101988622|NCT03714867|Sensory System Agents|sensory system agents|mesh-ancestor
101988623|NCT03714867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101988624|NCT03714867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988625|NCT03714867|Anticonvulsants|anticonvulsants|mesh-ancestor
101988626|NCT03714867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101988627|NCT03714867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101988628|NCT03714867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988629|NCT03714867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101988630|NCT03714867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101988631|NCT03714867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101988632|NCT03714867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101988633|NCT03714867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101988634|NCT01204177|Sorafenib|sorafenib|mesh-list
101988635|NCT01204177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101988636|NCT01204177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101988637|NCT01204177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101988638|NCT01204177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988639|NCT01217099|Azithromycin|azithromycin|mesh-list
101988640|NCT01217099|Methylprednisolone|methylprednisolone|mesh-list
101988641|NCT01217099|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101988642|NCT01217099|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101988643|NCT01217099|Prednisolone|prednisolone|mesh-list
101988644|NCT01217099|Prednisolone acetate|prednisolone acetate|mesh-list
101988645|NCT01217099|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101988646|NCT01217099|Prednisolone phosphate|prednisolone phosphate|mesh-list
101988647|NCT01217099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101988648|NCT01217099|Antiemetics|antiemetics|mesh-ancestor
101988649|NCT01217099|Autonomic Agents|autonomic agents|mesh-ancestor
101988650|NCT01217099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101988651|NCT01217099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988652|NCT01217099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101988671|NCT04305457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988672|NCT04305457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101988673|NCT04305457|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101988674|NCT04305457|Vasodilator Agents|vasodilator agents|mesh-ancestor
101947343|NCT01164813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947344|NCT01164813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101815183|NCT00775073|Bevacizumab|bevacizumab|mesh-list
101988675|NCT04305457|Gasotransmitters|gasotransmitters|mesh-ancestor
101988676|NCT04305457|Protective Agents|protective agents|mesh-ancestor
101988677|NCT01122563|Solifenacin Succinate|solifenacin succinate|mesh-list
101988678|NCT01122563|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101988679|NCT01122563|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101988680|NCT01122563|Cholinergic Agents|cholinergic agents|mesh-ancestor
101988681|NCT01122563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101988682|NCT01122563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988683|NCT01122563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988684|NCT01122563|Urological Agents|urological agents|mesh-ancestor
101988685|NCT01217177|Everolimus|everolimus|mesh-list
101988686|NCT01217177|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101988687|NCT01217177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101988688|NCT01217177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101793754|NCT00853502|Hormones|hormones|mesh-ancestor
101988689|NCT01217177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988690|NCT01217177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101988691|NCT01217177|Immunologic Factors|immunologic factors|mesh-ancestor
101988692|NCT01217177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988693|NCT01217177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101988694|NCT01204333|Heparin|heparin|mesh-list
101988695|NCT01204333|Anticoagulants|anticoagulants|mesh-ancestor
101988696|NCT01204333|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101988697|NCT01204333|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101988698|NCT01204333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988699|NCT02529059|Tenofovir|tenofovir|mesh-list
101988700|NCT02529059|Emtricitabine|emtricitabine|mesh-list
101988701|NCT02529059|Rilpivirine|rilpivirine|mesh-list
101988702|NCT02529059|Antiviral Agents|antiviral agents|mesh-ancestor
101988703|NCT02529059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101988704|NCT02529059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101988705|NCT02529059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101988706|NCT02529059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101988707|NCT02529059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988708|NCT02529059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101988722|NCT03932123|Tazobactam|tazobactam|mesh-list
101988723|NCT03932123|Piperacillin|piperacillin|mesh-list
101988724|NCT03932123|Cefotaxime|cefotaxime|mesh-list
101988725|NCT03932123|Cefoxitin|cefoxitin|mesh-list
101988726|NCT03932123|Azlocillin|azlocillin|mesh-list
101988727|NCT03932123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101988728|NCT03932123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101988729|NCT03932123|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101988730|NCT03932123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101988731|NCT03932123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988732|NCT02866279|Contraceptive Agents|contraceptive agents|mesh-list
101988733|NCT02866279|Etonogestrel|etonogestrel|mesh-list
101988734|NCT02866279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101988735|NCT02866279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708546|NCT00666770|Anticonvulsants|anticonvulsants|mesh-ancestor
101988736|NCT02866279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101988737|NCT02866279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101988738|NCT01222169|Propofol|propofol|mesh-list
101988739|NCT01222169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101988740|NCT01222169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101988741|NCT01222169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988742|NCT01222169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101988743|NCT01222169|Anesthetics, General|anesthetics, general|mesh-ancestor
101988744|NCT01222169|Anesthetics|anesthetics|mesh-ancestor
101988745|NCT02871778|Ivacaftor|ivacaftor|mesh-list
101988746|NCT02871778|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101988747|NCT02871778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101988748|NCT02871778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988749|NCT04947592|Fluconazole|fluconazole|mesh-list
101988750|NCT04947592|Antifungal Agents|antifungal agents|mesh-ancestor
101988751|NCT04947592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101988752|NCT04947592|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101988753|NCT04947592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101988754|NCT04947592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101988755|NCT04947592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988756|NCT04947592|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101947345|NCT01164813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101947346|NCT01164813|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101947347|NCT01164813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101947348|NCT01164813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101988757|NCT04947592|Hormone Antagonists|hormone antagonists|mesh-ancestor
101988758|NCT04947592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101988759|NCT04947592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988760|NCT04947592|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101988761|NCT04947592|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101988762|NCT02735473|Choline|choline|mesh-list
101988763|NCT02735473|Lipotropic Agents|lipotropic agents|mesh-ancestor
101988764|NCT02735473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101988765|NCT02735473|Antimetabolites|antimetabolites|mesh-ancestor
101711954|NCT00693524|Antitubercular Agents|antitubercular agents|mesh-ancestor
101988766|NCT02735473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988767|NCT02735473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101443860|NCT00199017|Hormones|hormones|mesh-ancestor
101988773|NCT04199767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101988774|NCT04199767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988775|NCT01125059|Methadone|methadone|mesh-list
101988776|NCT01125059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101988777|NCT01125059|Narcotics|narcotics|mesh-ancestor
101988778|NCT01125059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101988779|NCT01125059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988780|NCT01125059|Analgesics|analgesics|mesh-ancestor
101988781|NCT01125059|Sensory System Agents|sensory system agents|mesh-ancestor
101988782|NCT01125059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101988783|NCT01125059|Antitussive Agents|antitussive agents|mesh-ancestor
101988784|NCT01125059|Respiratory System Agents|respiratory system agents|mesh-ancestor
101988785|NCT01204411|Artesunate|artesunate|mesh-list
101988786|NCT01204411|Amodiaquine|amodiaquine|mesh-list
101988787|NCT01204411|Antimalarials|antimalarials|mesh-ancestor
101988788|NCT01204411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101988789|NCT01204411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101988790|NCT01204411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101988791|NCT01204411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101988792|NCT01204411|Antiviral Agents|antiviral agents|mesh-ancestor
101988793|NCT01204411|Schistosomicides|schistosomicides|mesh-ancestor
101988794|NCT01204411|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101988795|NCT01204411|Anthelmintics|anthelmintics|mesh-ancestor
101988796|NCT01471444|Methotrexate|methotrexate|mesh-list
101988797|NCT01471444|Fludarabine phosphate|fludarabine phosphate|mesh-list
101988798|NCT01471444|Clofarabine|clofarabine|mesh-list
101988799|NCT01471444|Fludarabine|fludarabine|mesh-list
101988800|NCT01471444|Busulfan|busulfan|mesh-list
101988801|NCT01471444|Tacrolimus|tacrolimus|mesh-list
101988802|NCT01471444|Thymoglobulin|thymoglobulin|mesh-list
101988803|NCT01471444|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101988804|NCT01471444|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101988805|NCT01471444|Abortifacient Agents|abortifacient agents|mesh-ancestor
101988806|NCT01471444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101988807|NCT01471444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988808|NCT01471444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101988809|NCT01471444|Antimetabolites|antimetabolites|mesh-ancestor
101988810|NCT01471444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988811|NCT01471444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101988812|NCT01471444|Dermatologic Agents|dermatologic agents|mesh-ancestor
101988813|NCT01471444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101988814|NCT01471444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101988815|NCT01471444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101988816|NCT01471444|Immunologic Factors|immunologic factors|mesh-ancestor
101988817|NCT01471444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101988818|NCT01471444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101988819|NCT01471444|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101988820|NCT01471444|Alkylating Agents|alkylating agents|mesh-ancestor
101988821|NCT01471444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101988822|NCT01471444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101988823|NCT05282407|Tenofovir|tenofovir|mesh-list
101988824|NCT05282407|Antiviral Agents|antiviral agents|mesh-ancestor
101988825|NCT05282407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101988826|NCT05282407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101988827|NCT05282407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101988828|NCT05282407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101947349|NCT01164813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947350|NCT01165905|Gemcitabine|gemcitabine|mesh-list
101947352|NCT01165905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101947353|NCT01165905|Antimetabolites|antimetabolites|mesh-ancestor
101815355|NCT00772187|Morphine|morphine|mesh-list
101988829|NCT05282407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988830|NCT05282407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101988831|NCT05282407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101988832|NCT04209686|Paclitaxel|paclitaxel|mesh-list
101988833|NCT04209686|Pembrolizumab|pembrolizumab|mesh-list
101988834|NCT04209686|Olaparib|olaparib|mesh-list
101988835|NCT04209686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101988836|NCT04209686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101988837|NCT04209686|Tubulin Modulators|tubulin modulators|mesh-ancestor
101988838|NCT04209686|Antimitotic Agents|antimitotic agents|mesh-ancestor
101988839|NCT04209686|Mitosis Modulators|mitosis modulators|mesh-ancestor
101988840|NCT04209686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988841|NCT04209686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101988854|NCT01217723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988855|NCT01217723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101988857|NCT05162872|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101988858|NCT05162872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101988859|NCT05162872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988860|NCT05162872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101988861|NCT01567111|Metomidate|metomidate|mesh-list
101988862|NCT01567111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101988863|NCT01567111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101988864|NCT01567111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988865|NCT03955211|Acetaminophen|acetaminophen|mesh-list
101988866|NCT03955211|Ibuprofen|ibuprofen|mesh-list
101988867|NCT03955211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101988868|NCT03955211|Analgesics|analgesics|mesh-ancestor
101988869|NCT03955211|Sensory System Agents|sensory system agents|mesh-ancestor
101988870|NCT03955211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101988871|NCT03955211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988872|NCT03955211|Antipyretics|antipyretics|mesh-ancestor
101988873|NCT03955211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101988874|NCT03955211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101988875|NCT03955211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101988876|NCT03955211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101988877|NCT03955211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101988878|NCT03955211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988879|NCT03933605|Midazolam|midazolam|mesh-list
101988880|NCT03933605|Palonosetron|palonosetron|mesh-list
101988881|NCT03933605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101988882|NCT03933605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101988883|NCT03933605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101988884|NCT03933605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708694|NCT00662714|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101988885|NCT03933605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101988886|NCT03933605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101988887|NCT03933605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101988888|NCT03933605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101988889|NCT03933605|Anesthetics, General|anesthetics, general|mesh-ancestor
101988891|NCT03933605|GABA Modulators|gaba modulators|mesh-ancestor
101988892|NCT03933605|GABA Agents|gaba agents|mesh-ancestor
101988893|NCT03933605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101988894|NCT03933605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988895|NCT03933605|Antiemetics|antiemetics|mesh-ancestor
101988896|NCT03933605|Autonomic Agents|autonomic agents|mesh-ancestor
101988897|NCT03933605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101988898|NCT03933605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101988899|NCT03933605|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101988900|NCT03933605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101988901|NCT03933605|Serotonin Agents|serotonin agents|mesh-ancestor
101988902|NCT03714789|Dialysis Solutions|dialysis solutions|mesh-list
101988903|NCT03714789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101988904|NCT01127477|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
101947354|NCT01165905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988909|NCT05281861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101988910|NCT05281861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101988911|NCT05281861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988912|NCT05281861|Antimanic Agents|antimanic agents|mesh-ancestor
101988913|NCT05281861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101988914|NCT05281861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101988915|NCT05281861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988916|NCT01311141|Doripenem|doripenem|mesh-list
101988917|NCT01311141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101988918|NCT01311141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101988919|NCT01122641|Vildagliptin|vildagliptin|mesh-list
101988920|NCT01122641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101988921|NCT01122641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988922|NCT01122641|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101988923|NCT01122641|Protease Inhibitors|protease inhibitors|mesh-ancestor
101988924|NCT01122641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101988925|NCT01122641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988927|NCT03714555|Paclitaxel|paclitaxel|mesh-list
101988928|NCT03714555|Gemcitabine|gemcitabine|mesh-list
101988929|NCT03714555|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101988930|NCT03714555|Folfirinox|folfirinox|mesh-list
101988931|NCT03714555|Disulfiram|disulfiram|mesh-list
101988932|NCT03714555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101988933|NCT03714555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101988934|NCT03714555|Tubulin Modulators|tubulin modulators|mesh-ancestor
101988935|NCT03714555|Antimitotic Agents|antimitotic agents|mesh-ancestor
101988936|NCT03714555|Mitosis Modulators|mitosis modulators|mesh-ancestor
101988937|NCT03714555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988938|NCT03714555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101988939|NCT03714555|Antimetabolites|antimetabolites|mesh-ancestor
101988940|NCT03714555|Trace Elements|trace elements|mesh-ancestor
101988941|NCT03714555|Micronutrients|micronutrients|mesh-ancestor
101988942|NCT03714555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988943|NCT03714555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101988944|NCT03714555|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
101988945|NCT03714555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101988946|NCT01125449|Ascorbic Acid|ascorbic acid|mesh-list
101988947|NCT01125449|Vitamins|vitamins|mesh-ancestor
101988948|NCT01125449|Micronutrients|micronutrients|mesh-ancestor
101988949|NCT01125449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988950|NCT01125449|Antioxidants|antioxidants|mesh-ancestor
101988951|NCT01125449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988952|NCT01125449|Protective Agents|protective agents|mesh-ancestor
101988953|NCT01206049|Bevacizumab|bevacizumab|mesh-list
101988954|NCT01206049|Panitumumab|panitumumab|mesh-list
101988955|NCT01206049|Gemcitabine|gemcitabine|mesh-list
101988956|NCT01206049|Capecitabine|capecitabine|mesh-list
101988957|NCT01206049|Oxaliplatin|oxaliplatin|mesh-list
101988958|NCT01206049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101988959|NCT01206049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101988960|NCT01206049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101708768|NCT00662948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988961|NCT01206049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101988962|NCT01206049|Growth Substances|growth substances|mesh-ancestor
101988963|NCT01206049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988964|NCT01206049|Growth Inhibitors|growth inhibitors|mesh-ancestor
101988965|NCT01206049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101988966|NCT01206049|Antimetabolites|antimetabolites|mesh-ancestor
101988967|NCT01206049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988968|NCT03931889|Vitamin D|vitamin d|mesh-list
101988969|NCT03931889|Cholecalciferol|cholecalciferol|mesh-list
101988970|NCT03931889|Vitamins|vitamins|mesh-ancestor
101988971|NCT03931889|Micronutrients|micronutrients|mesh-ancestor
101988972|NCT03931889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988973|NCT03931889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101988974|NCT03931889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101988975|NCT02953821|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101988976|NCT02953821|Hormones|hormones|mesh-ancestor
101988978|NCT02953821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988979|NCT01206205|Lenalidomide|lenalidomide|mesh-list
101988980|NCT01206205|Bortezomib|bortezomib|mesh-list
101988981|NCT01206205|Immunologic Factors|immunologic factors|mesh-ancestor
101947356|NCT01165905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101947357|NCT01165905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101947358|NCT01339000|Vaccines|vaccines|mesh-list
101947359|NCT01339000|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101947360|NCT01339000|Immunologic Factors|immunologic factors|mesh-ancestor
101947361|NCT01339000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947362|NCT01269255|Cisplatin|cisplatin|mesh-list
101947363|NCT01269255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101947364|NCT03563170|Leucovorin|leucovorin|mesh-list
101947365|NCT03563170|Paclitaxel|paclitaxel|mesh-list
101947366|NCT03563170|Cyclophosphamide|cyclophosphamide|mesh-list
101988982|NCT01206205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988983|NCT01206205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101988984|NCT01206205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101988985|NCT01206205|Growth Substances|growth substances|mesh-ancestor
101988986|NCT01206205|Growth Inhibitors|growth inhibitors|mesh-ancestor
101988987|NCT01206205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101988988|NCT03783923|Deflazacort|deflazacort|mesh-list
101988989|NCT03783923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101988990|NCT03783923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101988991|NCT03783923|Immunologic Factors|immunologic factors|mesh-ancestor
101988992|NCT03783923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988993|NCT03472144|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101988994|NCT03472144|Levofloxacin|levofloxacin|mesh-list
101988995|NCT03472144|Ofloxacin|ofloxacin|mesh-list
101988996|NCT03472144|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101988997|NCT03472144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101988998|NCT03472144|Antitubercular Agents|antitubercular agents|mesh-ancestor
101988999|NCT03472144|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101989000|NCT03472144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101989001|NCT03472144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101989002|NCT03472144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101989003|NCT03472144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989004|NCT03472144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101989005|NCT03472144|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101989006|NCT03472144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101989007|NCT03417141|Mechlorethamine|mechlorethamine|mesh-list
101989008|NCT03417141|Alkylating Agents|alkylating agents|mesh-ancestor
101989009|NCT03417141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989010|NCT03417141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101989011|NCT03417141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101989012|NCT01219751|Sunitinib|sunitinib|mesh-list
101989013|NCT01219751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101989014|NCT01219751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101989015|NCT01219751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101989016|NCT01219751|Growth Substances|growth substances|mesh-ancestor
101989017|NCT01219751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989018|NCT01219751|Growth Inhibitors|growth inhibitors|mesh-ancestor
101989019|NCT01219751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101989020|NCT01219751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101989021|NCT01219751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989022|NCT04823091|Cyclophosphamide|cyclophosphamide|mesh-list
101989023|NCT04823091|Fludarabine|fludarabine|mesh-list
101989024|NCT04823091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101989025|NCT04823091|Immunologic Factors|immunologic factors|mesh-ancestor
101989026|NCT04823091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989027|NCT04823091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101989028|NCT04823091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101989029|NCT04823091|Alkylating Agents|alkylating agents|mesh-ancestor
101989030|NCT04823091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989031|NCT04823091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101989032|NCT04823091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101989033|NCT01125527|Vaccines|vaccines|mesh-list
101989034|NCT01125527|Immunologic Factors|immunologic factors|mesh-ancestor
101989035|NCT01125527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947367|NCT03563170|Fluorouracil|fluorouracil|mesh-list
101947368|NCT03563170|Capecitabine|capecitabine|mesh-list
101947370|NCT03563170|Sorafenib|sorafenib|mesh-list
101947371|NCT03563170|Avelumab|avelumab|mesh-list
101947372|NCT03563170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101989036|NCT01298401|Gemcitabine|gemcitabine|mesh-list
101989037|NCT01298401|Capecitabine|capecitabine|mesh-list
101989038|NCT01298401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101989039|NCT01298401|Antimetabolites|antimetabolites|mesh-ancestor
101989040|NCT01298401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989041|NCT01298401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101989042|NCT03931343|Epinephrine|epinephrine|mesh-list
101989043|NCT03931343|Racepinephrine|racepinephrine|mesh-list
101989044|NCT03931343|Bupivacaine|bupivacaine|mesh-list
101989045|NCT03931343|Epinephryl borate|epinephryl borate|mesh-list
101989046|NCT03931343|Anesthetics, Local|anesthetics, local|mesh-ancestor
101989047|NCT03931343|Anesthetics|anesthetics|mesh-ancestor
101989048|NCT03931343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101444119|NCT04676776|Luteolytic Agents|luteolytic agents|mesh-ancestor
101989053|NCT03931343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101989054|NCT03931343|Adrenergic Agents|adrenergic agents|mesh-ancestor
101989055|NCT03931343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101989056|NCT03931343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989057|NCT03931343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101989058|NCT03931343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101989059|NCT03931343|Autonomic Agents|autonomic agents|mesh-ancestor
101989060|NCT03931343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101989061|NCT03931343|Respiratory System Agents|respiratory system agents|mesh-ancestor
101989062|NCT03931343|Mydriatics|mydriatics|mesh-ancestor
101989063|NCT03931343|Sympathomimetics|sympathomimetics|mesh-ancestor
101989064|NCT03931343|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101989065|NCT04867798|Tenofovir|tenofovir|mesh-list
101989066|NCT04867798|Lamivudine|lamivudine|mesh-list
101989067|NCT04867798|Antiviral Agents|antiviral agents|mesh-ancestor
101989068|NCT04867798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101989069|NCT04867798|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101989070|NCT04867798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101989071|NCT04867798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101989072|NCT04867798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989073|NCT04867798|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101989074|NCT04867798|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101989075|NCT01122953|Phenytoin|phenytoin|mesh-list
101989076|NCT01122953|Anticonvulsants|anticonvulsants|mesh-ancestor
101989077|NCT01122953|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101989078|NCT01122953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101989079|NCT01122953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101989080|NCT01122953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989081|NCT01122953|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101989082|NCT01122953|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101989083|NCT01125683|Donepezil|donepezil|mesh-list
101989084|NCT01125683|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101989085|NCT01125683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101989086|NCT01125683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989087|NCT01125683|Cholinergic Agents|cholinergic agents|mesh-ancestor
101989088|NCT01125683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101989089|NCT01125683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989090|NCT01125683|Nootropic Agents|nootropic agents|mesh-ancestor
101989091|NCT01127555|Leucovorin|leucovorin|mesh-list
101989092|NCT01127555|Fluorouracil|fluorouracil|mesh-list
101989093|NCT01127555|Oxaliplatin|oxaliplatin|mesh-list
101989094|NCT01127555|Antimetabolites|antimetabolites|mesh-ancestor
101989095|NCT01127555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989096|NCT01127555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101989097|NCT01127555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101989098|NCT01127555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101989099|NCT01127555|Immunologic Factors|immunologic factors|mesh-ancestor
101989100|NCT01127555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989101|NCT01127555|Antidotes|antidotes|mesh-ancestor
101989102|NCT01127555|Protective Agents|protective agents|mesh-ancestor
101989103|NCT01127555|Vitamin B Complex|vitamin b complex|mesh-ancestor
101989104|NCT01127555|Vitamins|vitamins|mesh-ancestor
101989105|NCT01127555|Micronutrients|micronutrients|mesh-ancestor
101947373|NCT03563170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101947374|NCT03563170|Tubulin Modulators|tubulin modulators|mesh-ancestor
101947375|NCT03563170|Antimitotic Agents|antimitotic agents|mesh-ancestor
101989106|NCT01219907|Cyclophosphamide|cyclophosphamide|mesh-list
101989107|NCT01219907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101989108|NCT01219907|Immunologic Factors|immunologic factors|mesh-ancestor
101989109|NCT01219907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989110|NCT01219907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101989111|NCT01219907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101989112|NCT01219907|Alkylating Agents|alkylating agents|mesh-ancestor
101989113|NCT01219907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989114|NCT01219907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101989115|NCT01219907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101989116|NCT03471988|Voriconazole|voriconazole|mesh-list
101989117|NCT03471988|Antifungal Agents|antifungal agents|mesh-ancestor
101989118|NCT03471988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101444191|NCT04675372|Adrenergic Agents|adrenergic agents|mesh-ancestor
101989131|NCT03442569|Nivolumab|nivolumab|mesh-list
101989132|NCT03442569|Ipilimumab|ipilimumab|mesh-list
101989133|NCT03442569|Panitumumab|panitumumab|mesh-list
101989134|NCT03442569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101989135|NCT03442569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101989136|NCT03442569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101989137|NCT03442569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989138|NCT01123031|Esomeprazole|esomeprazole|mesh-list
101989139|NCT01123031|Lansoprazole|lansoprazole|mesh-list
101989140|NCT01123031|Dexlansoprazole|dexlansoprazole|mesh-list
101989141|NCT01123031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101989142|NCT01123031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101989143|NCT01123031|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101989144|NCT01123031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101989145|NCT01123031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989146|NCT01220063|Irinotecan|irinotecan|mesh-list
101989147|NCT01220063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101989148|NCT01220063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101989149|NCT01220063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101989150|NCT01220063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989151|NCT01220063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101989152|NCT01298713|Tamoxifen|tamoxifen|mesh-list
101989153|NCT01298713|Everolimus|everolimus|mesh-list
101989154|NCT01298713|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101989155|NCT01298713|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101989156|NCT01298713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101989157|NCT01298713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989158|NCT01298713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101989159|NCT01298713|Immunologic Factors|immunologic factors|mesh-ancestor
101989160|NCT01298713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989161|NCT01298713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101989162|NCT01298713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101989163|NCT01298713|Hormone Antagonists|hormone antagonists|mesh-ancestor
101989164|NCT01298713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101989165|NCT01298713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101989166|NCT01298713|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101989167|NCT01298713|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101989168|NCT01298713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101989169|NCT01223339|Ertugliflozin|ertugliflozin|mesh-list
101989170|NCT01223339|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101989171|NCT01223339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989172|NCT01223339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101989173|NCT01223339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989174|NCT01217879|Telmisartan|telmisartan|mesh-list
101989175|NCT01217879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101989176|NCT01217879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101989203|NCT05665075|Alkylating Agents|alkylating agents|mesh-ancestor
101989204|NCT05665075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989205|NCT05665075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101989206|NCT05665075|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101989207|NCT05665075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101989208|NCT05665075|Antimetabolites|antimetabolites|mesh-ancestor
101989209|NCT05665075|Antiviral Agents|antiviral agents|mesh-ancestor
101989210|NCT05665075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101947376|NCT03563170|Mitosis Modulators|mitosis modulators|mesh-ancestor
101947377|NCT03563170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947378|NCT03563170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101947379|NCT03563170|Immunologic Factors|immunologic factors|mesh-ancestor
101989211|NCT03714165|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101989212|NCT03714165|alpha-Defensins|alpha-defensins|mesh-list
101989214|NCT03714165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101989215|NCT03442101|Antipsychotic Agents|antipsychotic agents|mesh-list
101989216|NCT03442101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101989217|NCT03442101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101989218|NCT03442101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989219|NCT03442101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101989220|NCT03932825|Nitrous Oxide|nitrous oxide|mesh-list
101989221|NCT03932825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101989222|NCT03932825|Anesthetics, General|anesthetics, general|mesh-ancestor
101989223|NCT03932825|Anesthetics|anesthetics|mesh-ancestor
101444324|NCT00554086|Bicalutamide|bicalutamide|mesh-list
101989226|NCT03932825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101989227|NCT03932825|Analgesics|analgesics|mesh-ancestor
101989228|NCT03932825|Sensory System Agents|sensory system agents|mesh-ancestor
101989229|NCT03932825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101989230|NCT03932981|Temozolomide|temozolomide|mesh-list
101989231|NCT03932981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101989232|NCT03932981|Alkylating Agents|alkylating agents|mesh-ancestor
101989233|NCT03932981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989234|NCT03932981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101989235|NCT01220219|Pregabalin|pregabalin|mesh-list
101989236|NCT01220219|Analgesics|analgesics|mesh-ancestor
101989237|NCT01220219|Sensory System Agents|sensory system agents|mesh-ancestor
101989238|NCT01220219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101989239|NCT01220219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989240|NCT01220219|Anticonvulsants|anticonvulsants|mesh-ancestor
101989241|NCT01220219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101989242|NCT01220219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101989243|NCT01220219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989244|NCT01220219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101989245|NCT01220219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101989246|NCT01220219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101989247|NCT01220219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101989248|NCT01220219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101989249|NCT03441789|Betamethasone|betamethasone|mesh-list
101989250|NCT03441789|Betamethasone Valerate|betamethasone valerate|mesh-list
101989251|NCT03441789|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101989252|NCT03441789|Betamethasone benzoate|betamethasone benzoate|mesh-list
101989253|NCT03441789|Calcipotriene|calcipotriene|mesh-list
101989254|NCT03441789|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101989255|NCT03441789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101989256|NCT03441789|Glucocorticoids|glucocorticoids|mesh-ancestor
101989257|NCT03441789|Hormones|hormones|mesh-ancestor
101989258|NCT03441789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101989259|NCT03441789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989260|NCT03441789|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101989261|NCT03441789|Respiratory System Agents|respiratory system agents|mesh-ancestor
101989262|NCT03441789|Dermatologic Agents|dermatologic agents|mesh-ancestor
101989263|NCT03359005|Vincristine|vincristine|mesh-list
101989264|NCT03359005|Temozolomide|temozolomide|mesh-list
101989265|NCT03359005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101989266|NCT03359005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101989267|NCT03359005|Tubulin Modulators|tubulin modulators|mesh-ancestor
101989268|NCT03359005|Antimitotic Agents|antimitotic agents|mesh-ancestor
101989269|NCT03359005|Mitosis Modulators|mitosis modulators|mesh-ancestor
101989270|NCT03359005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989271|NCT03359005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101989272|NCT03359005|Alkylating Agents|alkylating agents|mesh-ancestor
101989273|NCT04321174|Ritonavir|ritonavir|mesh-list
101989274|NCT04321174|Lopinavir|lopinavir|mesh-list
101989275|NCT04321174|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101989276|NCT04321174|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101989277|NCT04321174|Protease Inhibitors|protease inhibitors|mesh-ancestor
101989278|NCT04321174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101989279|NCT04321174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947380|NCT03563170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947381|NCT03563170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101947382|NCT03563170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101947383|NCT03563170|Alkylating Agents|alkylating agents|mesh-ancestor
101989280|NCT04321174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101989281|NCT04321174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101989282|NCT04321174|Antiviral Agents|antiviral agents|mesh-ancestor
101989283|NCT04321174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101989284|NCT04321174|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101989285|NCT04321174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101989286|NCT01123265|Methotrexate|methotrexate|mesh-list
101989287|NCT01123265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101989288|NCT01123265|Abortifacient Agents|abortifacient agents|mesh-ancestor
101989289|NCT01123265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101989290|NCT01123265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989291|NCT01123265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101989292|NCT01123265|Antimetabolites|antimetabolites|mesh-ancestor
101989293|NCT01123265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989294|NCT01123265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101989312|NCT01204801|Doxorubicin|doxorubicin|mesh-list
101989313|NCT01204801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101989314|NCT01204801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101989315|NCT01204801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101989316|NCT01204801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101989317|NCT01204801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101989318|NCT01204801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101989319|NCT01204801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989320|NCT04194814|Betamethasone|betamethasone|mesh-list
101989321|NCT04194814|Betamethasone Valerate|betamethasone valerate|mesh-list
101989322|NCT04194814|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101989323|NCT04194814|Betamethasone benzoate|betamethasone benzoate|mesh-list
101989324|NCT04194814|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101989325|NCT04194814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101989326|NCT04194814|Glucocorticoids|glucocorticoids|mesh-ancestor
101989327|NCT04194814|Hormones|hormones|mesh-ancestor
101989328|NCT04194814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101989329|NCT04194814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989330|NCT04194814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101989331|NCT04194814|Respiratory System Agents|respiratory system agents|mesh-ancestor
101709155|NCT00669890|Mycophenolic Acid|mycophenolic acid|mesh-list
101989332|NCT03832621|Nivolumab|nivolumab|mesh-list
101989333|NCT03832621|Ipilimumab|ipilimumab|mesh-list
101989334|NCT03832621|Temozolomide|temozolomide|mesh-list
101989335|NCT03832621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101989336|NCT03832621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101989337|NCT03832621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101989338|NCT03832621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989339|NCT03832621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101989340|NCT03832621|Alkylating Agents|alkylating agents|mesh-ancestor
101989341|NCT01220375|Plerixafor|plerixafor|mesh-list
101989342|NCT01220375|Vinorelbine|vinorelbine|mesh-list
101989343|NCT01220375|Lenograstim|lenograstim|mesh-list
101989344|NCT01220375|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101989345|NCT01220375|Immunologic Factors|immunologic factors|mesh-ancestor
101989346|NCT01220375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989347|NCT01220375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101989348|NCT01220375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101989349|NCT01220375|Tubulin Modulators|tubulin modulators|mesh-ancestor
101989350|NCT01220375|Antimitotic Agents|antimitotic agents|mesh-ancestor
101989351|NCT01220375|Mitosis Modulators|mitosis modulators|mesh-ancestor
101989357|NCT01223729|Acetylcarnitine|acetylcarnitine|mesh-list
101989358|NCT01223729|Vitamin B Complex|vitamin b complex|mesh-ancestor
101989359|NCT01223729|Vitamins|vitamins|mesh-ancestor
101989360|NCT01223729|Micronutrients|micronutrients|mesh-ancestor
101989361|NCT01223729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989362|NCT01223729|Nootropic Agents|nootropic agents|mesh-ancestor
101989363|NCT01126073|Niacin|niacin|mesh-list
101989364|NCT01126073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101989365|NCT01126073|Antimetabolites|antimetabolites|mesh-ancestor
101989366|NCT01126073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989367|NCT01126073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101947384|NCT03563170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101947385|NCT03563170|Antimetabolites|antimetabolites|mesh-ancestor
101947386|NCT03563170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101947387|NCT03563170|Antidotes|antidotes|mesh-ancestor
101947388|NCT03563170|Protective Agents|protective agents|mesh-ancestor
101947389|NCT03563170|Vitamin B Complex|vitamin b complex|mesh-ancestor
101947390|NCT03563170|Vitamins|vitamins|mesh-ancestor
101947391|NCT03563170|Micronutrients|micronutrients|mesh-ancestor
101947392|NCT03563170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101947393|NCT03563170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101947394|NCT03563170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101947395|NCT01281111|Aspirin|aspirin|mesh-list
101947396|NCT01281111|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101947397|NCT01281111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101989368|NCT01126073|Vasodilator Agents|vasodilator agents|mesh-ancestor
101989369|NCT01126073|Vitamin B Complex|vitamin b complex|mesh-ancestor
101989370|NCT01126073|Vitamins|vitamins|mesh-ancestor
101989371|NCT01126073|Micronutrients|micronutrients|mesh-ancestor
101989372|NCT01126073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989373|NCT03287050|Pembrolizumab|pembrolizumab|mesh-list
101989374|NCT03287050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101989375|NCT03287050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101989376|NCT03287050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101989377|NCT03287050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989378|NCT05470881|Atropine|atropine|mesh-list
101989379|NCT05470881|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101989380|NCT05470881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101989381|NCT05470881|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101989382|NCT05470881|Autonomic Agents|autonomic agents|mesh-ancestor
101989383|NCT05470881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101989384|NCT05470881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989385|NCT05470881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101989386|NCT05470881|Respiratory System Agents|respiratory system agents|mesh-ancestor
101989387|NCT05470881|Mydriatics|mydriatics|mesh-ancestor
101989388|NCT05470881|Parasympatholytics|parasympatholytics|mesh-ancestor
101989389|NCT05470881|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101989390|NCT05470881|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101989391|NCT05470881|Cholinergic Agents|cholinergic agents|mesh-ancestor
101989392|NCT05470881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101989393|NCT05470881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989394|NCT03130504|Progesterone|progesterone|mesh-list
101989395|NCT03130504|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
101989396|NCT03130504|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
101989397|NCT03130504|Progestins|progestins|mesh-ancestor
101989398|NCT03130504|Hormones|hormones|mesh-ancestor
101989399|NCT03130504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101989400|NCT03130504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989401|NCT03130504|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101989402|NCT03130504|Hormone Antagonists|hormone antagonists|mesh-ancestor
101989403|NCT03819127|Metformin|metformin|mesh-list
101989404|NCT03819127|Vildagliptin|vildagliptin|mesh-list
101989405|NCT03819127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101709238|NCT00673088|Ropinirole|ropinirole|mesh-list
101989406|NCT03819127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989407|NCT03819127|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101989408|NCT03819127|Protease Inhibitors|protease inhibitors|mesh-ancestor
101989409|NCT03819127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101989410|NCT03819127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989411|NCT02908789|Anti-Infective Agents|anti-infective agents|mesh-list
101989412|NCT02908789|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101989413|NCT05607550|Aflutinib|aflutinib|mesh-list
101989414|NCT05607550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101989415|NCT05607550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101947398|NCT01281111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101947399|NCT01281111|Analgesics|analgesics|mesh-ancestor
101989416|NCT05607550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989417|NCT01299181|Atorvastatin|atorvastatin|mesh-list
101989418|NCT01299181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101989419|NCT01299181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101989420|NCT01299181|Antimetabolites|antimetabolites|mesh-ancestor
101989421|NCT01299181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989434|NCT03930875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101989435|NCT03930875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101989436|NCT03930875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989437|NCT03930875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101989438|NCT03930875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101989439|NCT03930875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101989440|NCT03930875|Antipyretics|antipyretics|mesh-ancestor
101989441|NCT01206907|Oxymorphone|oxymorphone|mesh-list
101989442|NCT01206907|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101989443|NCT01206907|Narcotics|narcotics|mesh-ancestor
101989444|NCT01206907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101989445|NCT01206907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989446|NCT01206907|Analgesics|analgesics|mesh-ancestor
101989447|NCT01206907|Sensory System Agents|sensory system agents|mesh-ancestor
101989448|NCT01206907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101989449|NCT01206907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101989450|NCT03925246|Nivolumab|nivolumab|mesh-list
101989451|NCT03925246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101989452|NCT03925246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101989453|NCT03925246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101989454|NCT03925246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989455|NCT01218347|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101989456|NCT01218347|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101989457|NCT01218347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101989458|NCT01218347|Antimetabolites|antimetabolites|mesh-ancestor
101989459|NCT01218347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989460|NCT01218347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101989461|NCT01218347|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101989462|NCT01218347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101989463|NCT01126229|Resveratrol|resveratrol|mesh-list
101989464|NCT01126229|Antioxidants|antioxidants|mesh-ancestor
101989465|NCT01126229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989466|NCT01126229|Protective Agents|protective agents|mesh-ancestor
101989467|NCT01126229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989468|NCT01126229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101989469|NCT01126229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101989470|NCT03474640|Antibodies|antibodies|mesh-list
101989471|NCT03474640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101989472|NCT03474640|Immunologic Factors|immunologic factors|mesh-ancestor
101989473|NCT03474640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989474|NCT01126307|Verapamil|verapamil|mesh-list
101989475|NCT01126307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101989476|NCT01126307|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101989477|NCT01126307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101989478|NCT01126307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989479|NCT01126307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101989480|NCT01126307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989481|NCT01126307|Vasodilator Agents|vasodilator agents|mesh-ancestor
101989482|NCT03439137|Darbepoetin alfa|darbepoetin alfa|mesh-list
101989487|NCT04173338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989489|NCT04173338|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101989490|NCT03936491|Methylphenidate|methylphenidate|mesh-list
101989491|NCT03936491|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101712030|NCT00688922|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101989492|NCT03936491|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101989493|NCT03936491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989494|NCT03936491|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101989495|NCT03936491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101989496|NCT03936491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101989497|NCT03936491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989498|NCT03936491|Dopamine Agents|dopamine agents|mesh-ancestor
101989499|NCT03936491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101989500|NCT03936491|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101947400|NCT01281111|Sensory System Agents|sensory system agents|mesh-ancestor
101947401|NCT01281111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101947402|NCT01281111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947403|NCT01281111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101989501|NCT03936491|Adrenergic Agents|adrenergic agents|mesh-ancestor
101989503|NCT00890617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101989504|NCT00890617|Glucocorticoids|glucocorticoids|mesh-ancestor
101989505|NCT00890617|Hormones|hormones|mesh-ancestor
101989506|NCT00890617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101989507|NCT00890617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989508|NCT00890617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101989509|NCT00890617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101989510|NCT03468946|Caffeine|caffeine|mesh-list
101989511|NCT03468946|Citric Acid|citric acid|mesh-list
101989512|NCT03468946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101989513|NCT03468946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989514|NCT03468946|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101989515|NCT03468946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101989516|NCT03468946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989517|NCT03468946|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101989518|NCT03468946|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101989519|NCT03468946|Purinergic Agents|purinergic agents|mesh-ancestor
101989520|NCT03468946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101989521|NCT03468946|Anticoagulants|anticoagulants|mesh-ancestor
101989522|NCT03468946|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101989523|NCT03468946|Chelating Agents|chelating agents|mesh-ancestor
101989524|NCT03468946|Sequestering Agents|sequestering agents|mesh-ancestor
101989525|NCT01218425|Levodopa|levodopa|mesh-list
101989526|NCT01218425|Carbidopa|carbidopa|mesh-list
101989527|NCT01218425|Domperidone|domperidone|mesh-list
101989528|NCT01218425|Methylphenidate|methylphenidate|mesh-list
101989529|NCT01218425|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101989530|NCT01218425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989531|NCT01218425|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101989532|NCT01218425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101989533|NCT01218425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101989534|NCT01218425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989535|NCT01218425|Dopamine Agents|dopamine agents|mesh-ancestor
101989536|NCT01218425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101989537|NCT01218425|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101989538|NCT01218425|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101989539|NCT01218425|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101989540|NCT01218425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101989541|NCT01218425|Antiemetics|antiemetics|mesh-ancestor
101989542|NCT01218425|Autonomic Agents|autonomic agents|mesh-ancestor
101989543|NCT01218425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101989544|NCT01218425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101989545|NCT01218425|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101989546|NCT05621005|Rifaximin|rifaximin|mesh-list
101989547|NCT05621005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101712036|NCT00688922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101989548|NCT05621005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101989549|NCT05621005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101989550|NCT01224041|Tacrolimus|tacrolimus|mesh-list
101989551|NCT01224041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101989552|NCT01224041|Immunologic Factors|immunologic factors|mesh-ancestor
101989557|NCT03181828|Acetohydroxamic acid|acetohydroxamic acid|mesh-list
101989558|NCT03181828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101989559|NCT03181828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989560|NCT01123811|Cetuximab|cetuximab|mesh-list
101989561|NCT01123811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101989562|NCT01123811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101989563|NCT01128101|Spironolactone|spironolactone|mesh-list
101989564|NCT01128101|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101989565|NCT01128101|Hormone Antagonists|hormone antagonists|mesh-ancestor
101989566|NCT01128101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101989567|NCT01128101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989568|NCT01128101|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101989569|NCT01128101|Diuretics|diuretics|mesh-ancestor
101989570|NCT01128101|Natriuretic Agents|natriuretic agents|mesh-ancestor
101989571|NCT01299415|Vadimezan|vadimezan|mesh-list
101947404|NCT01281111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101947405|NCT01281111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101947406|NCT01281111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101947407|NCT01281111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947408|NCT01281111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101816022|NCT00773201|Sotalol|sotalol|mesh-list
101989572|NCT01299415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101989573|NCT01123967|Nicotine|nicotine|mesh-list
101989574|NCT01123967|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101989575|NCT01123967|Autonomic Agents|autonomic agents|mesh-ancestor
101989576|NCT01123967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101989577|NCT01123967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989578|NCT01123967|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101989579|NCT01123967|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101989580|NCT01123967|Cholinergic Agents|cholinergic agents|mesh-ancestor
101989581|NCT01123967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101989582|NCT01123967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989583|NCT01126463|Ethiodized Oil|ethiodized oil|mesh-list
101989584|NCT01126463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101989585|NCT01126697|Ubiquinone|ubiquinone|mesh-list
101989586|NCT01126697|Coenzyme Q10|coenzyme q10|mesh-list
101989587|NCT01126697|Lisinopril|lisinopril|mesh-list
101989588|NCT01126697|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101989589|NCT01126697|Protease Inhibitors|protease inhibitors|mesh-ancestor
101989590|NCT01126697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101989591|NCT01126697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989592|NCT01126697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101989593|NCT01126697|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101989594|NCT01126697|Protective Agents|protective agents|mesh-ancestor
101989595|NCT01126697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989596|NCT01126697|Micronutrients|micronutrients|mesh-ancestor
101989597|NCT01126697|Vitamins|vitamins|mesh-ancestor
101989598|NCT01220843|Sevelamer|sevelamer|mesh-list
101989599|NCT01220843|Chelating Agents|chelating agents|mesh-ancestor
101989600|NCT01220843|Sequestering Agents|sequestering agents|mesh-ancestor
101989601|NCT01220843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989602|NCT02804932|Methamphetamine|methamphetamine|mesh-list
101989603|NCT02804932|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101712048|NCT00694460|Vaccines|vaccines|mesh-list
101989604|NCT02804932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989605|NCT02804932|Sympathomimetics|sympathomimetics|mesh-ancestor
101989606|NCT02804932|Autonomic Agents|autonomic agents|mesh-ancestor
101989607|NCT02804932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101989608|NCT02804932|Dopamine Agents|dopamine agents|mesh-ancestor
101989609|NCT02804932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101989610|NCT02804932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989611|NCT02804932|Adrenergic Agents|adrenergic agents|mesh-ancestor
101989612|NCT02804932|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101989613|NCT02804932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101989614|NCT02804932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101989615|NCT02804932|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101989616|NCT03468790|Fluticasone|fluticasone|mesh-list
101989617|NCT03468790|Xhance|xhance|mesh-list
101989618|NCT03468790|Budesonide|budesonide|mesh-list
101989619|NCT03468790|Albuterol|albuterol|mesh-list
101989620|NCT03468790|Formoterol Fumarate|formoterol fumarate|mesh-list
101989621|NCT03468790|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101989622|NCT03468790|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101444705|NCT00176774|Growth Substances|growth substances|mesh-ancestor
101989623|NCT03468790|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101989624|NCT03468790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101989625|NCT03468790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101989626|NCT03468790|Autonomic Agents|autonomic agents|mesh-ancestor
101989627|NCT03468790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101989628|NCT03468790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989629|NCT03468790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101989630|NCT03468790|Respiratory System Agents|respiratory system agents|mesh-ancestor
101989631|NCT03468790|Dermatologic Agents|dermatologic agents|mesh-ancestor
101989632|NCT03468790|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101989633|NCT03468790|Glucocorticoids|glucocorticoids|mesh-ancestor
101989634|NCT03468790|Hormones|hormones|mesh-ancestor
101947409|NCT01281111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101947410|NCT01281111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101947412|NCT01281111|Dermatologic Agents|dermatologic agents|mesh-ancestor
101816090|NCT00995306|Capsaicin|capsaicin|mesh-list
101989635|NCT03468790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101989636|NCT03468790|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101989637|NCT03468790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101989638|NCT03468790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101989639|NCT03468790|Adrenergic Agents|adrenergic agents|mesh-ancestor
101989640|NCT03468790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101989641|NCT03468790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989642|NCT03468790|Tocolytic Agents|tocolytic agents|mesh-ancestor
101989643|NCT03468790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101989644|NCT03468790|Sympathomimetics|sympathomimetics|mesh-ancestor
101989645|NCT01224197|Simeprevir|simeprevir|mesh-list
101989646|NCT01224197|Antiviral Agents|antiviral agents|mesh-ancestor
101989647|NCT01224197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101989648|NCT01224197|Protease Inhibitors|protease inhibitors|mesh-ancestor
101989649|NCT01224197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101989650|NCT01224197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989651|NCT01224353|Thioctic Acid|thioctic acid|mesh-list
101989652|NCT01224353|Antioxidants|antioxidants|mesh-ancestor
101989653|NCT01224353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989654|NCT01224353|Protective Agents|protective agents|mesh-ancestor
101989655|NCT01224353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989656|NCT01224353|Vitamin B Complex|vitamin b complex|mesh-ancestor
101989657|NCT01224353|Vitamins|vitamins|mesh-ancestor
101989658|NCT01224353|Micronutrients|micronutrients|mesh-ancestor
101989659|NCT01207297|Cyclophosphamide|cyclophosphamide|mesh-list
101989660|NCT01207297|Tacrolimus|tacrolimus|mesh-list
101989661|NCT01207297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101989662|NCT01207297|Immunologic Factors|immunologic factors|mesh-ancestor
101989663|NCT01207297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989664|NCT01207297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101989665|NCT01207297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101989666|NCT01207297|Alkylating Agents|alkylating agents|mesh-ancestor
101712065|NCT00689000|Glycine Agents|glycine agents|mesh-ancestor
101989667|NCT01207297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989668|NCT01207297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101989669|NCT01207297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101989670|NCT01207297|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101989671|NCT01207297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101989672|NCT03932435|Bepotastine besilate|bepotastine besilate|mesh-list
101989673|NCT03932435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101989674|NCT03720847|Estradiol|estradiol|mesh-list
101989675|NCT03720847|Progesterone|progesterone|mesh-list
101989676|NCT03720847|Estrogens|estrogens|mesh-ancestor
101989677|NCT03720847|Hormones|hormones|mesh-ancestor
101989678|NCT03720847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101989679|NCT03720847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989680|NCT03720847|Progestins|progestins|mesh-ancestor
101989681|NCT01128257|Alendronate|alendronate|mesh-list
101989682|NCT01128257|Ibandronic Acid|ibandronic acid|mesh-list
101989683|NCT01128257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101989684|NCT01128257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989685|NCT01205347|Simvastatin|simvastatin|mesh-list
101989686|NCT01205347|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101989687|NCT01205347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101989688|NCT01205347|Antimetabolites|antimetabolites|mesh-ancestor
101989689|NCT01205347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989690|NCT01205347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101989691|NCT01205347|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101989692|NCT01205347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101989693|NCT01218737|Gatifloxacin|gatifloxacin|mesh-list
101989694|NCT01218737|Prednisolone|prednisolone|mesh-list
101989695|NCT01218737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101989696|NCT01218737|Methylprednisolone|methylprednisolone|mesh-list
101989697|NCT01218737|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101989698|NCT01218737|Prednisolone acetate|prednisolone acetate|mesh-list
101989701|NCT01218737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101989702|NCT01218737|Glucocorticoids|glucocorticoids|mesh-ancestor
101989703|NCT01218737|Hormones|hormones|mesh-ancestor
101947413|NCT01281111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101947414|NCT01281111|Immunologic Factors|immunologic factors|mesh-ancestor
101947415|NCT03869931|Fenofibrate|fenofibrate|mesh-list
101947416|NCT03869931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101989704|NCT01218737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101989705|NCT01218737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989706|NCT01218737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101989707|NCT01218737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101989708|NCT01218737|Antiemetics|antiemetics|mesh-ancestor
101989709|NCT01218737|Autonomic Agents|autonomic agents|mesh-ancestor
101989710|NCT01218737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101989711|NCT01218737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101989712|NCT01218737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101989713|NCT01218737|Protective Agents|protective agents|mesh-ancestor
101989714|NCT01218737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101989715|NCT01218737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101989716|NCT01218737|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101989717|NCT01218737|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101989718|NCT01218737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101989719|NCT01218737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101989720|NCT01218737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101989721|NCT01218737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989722|NCT03818113|Cardioplegic Solutions|cardioplegic solutions|mesh-list
101989723|NCT03818113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101989724|NCT01224509|Mifepristone|mifepristone|mesh-list
101989725|NCT01224509|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101989726|NCT01224509|Abortifacient Agents|abortifacient agents|mesh-ancestor
101989727|NCT01224509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101989728|NCT01224509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989729|NCT01224509|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101989730|NCT01224509|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101989731|NCT01224509|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101989732|NCT01224509|Contraceptive Agents|contraceptive agents|mesh-ancestor
101989733|NCT01224509|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101989734|NCT01224509|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101989735|NCT01224509|Hormone Antagonists|hormone antagonists|mesh-ancestor
101989736|NCT01224509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101989737|NCT01224509|Luteolytic Agents|luteolytic agents|mesh-ancestor
101989738|NCT01224509|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101989739|NCT01224509|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101989741|NCT01301053|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101989742|NCT01301053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101989743|NCT01301053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989744|NCT01218581|Letrozole|letrozole|mesh-list
101989745|NCT01218581|Goserelin|goserelin|mesh-list
101989746|NCT01218581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101989747|NCT01218581|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101989748|NCT01218581|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101989749|NCT01218581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101989750|NCT01218581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989751|NCT01218581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101989752|NCT01218581|Hormone Antagonists|hormone antagonists|mesh-ancestor
101989753|NCT01218581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101989754|NCT01218581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989755|NCT01218581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101989756|NCT03825133|Hyaluronic Acid|hyaluronic acid|mesh-list
101989757|NCT03825133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101989758|NCT03825133|Immunologic Factors|immunologic factors|mesh-ancestor
101989759|NCT03825133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989760|NCT03825133|Viscosupplements|viscosupplements|mesh-ancestor
101989761|NCT03825133|Protective Agents|protective agents|mesh-ancestor
101989762|NCT03817567|Antibodies|antibodies|mesh-list
101989763|NCT03817567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101989764|NCT03817567|Immunologic Factors|immunologic factors|mesh-ancestor
101989765|NCT03817567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989766|NCT01127009|Cytarabine|cytarabine|mesh-list
101989767|NCT01127009|Etoposide|etoposide|mesh-list
101989768|NCT01127009|Podophyllotoxin|podophyllotoxin|mesh-list
101989769|NCT01127009|Mitoxantrone|mitoxantrone|mesh-list
101989770|NCT01127009|Etoposide phosphate|etoposide phosphate|mesh-list
101989771|NCT01127009|Bortezomib|bortezomib|mesh-list
101947418|NCT03869931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816232|NCT00778505|Anesthetics, General|anesthetics, general|mesh-ancestor
101989772|NCT01127009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101989778|NCT01127009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101989779|NCT01127009|Antimetabolites|antimetabolites|mesh-ancestor
101709595|NCT03997279|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101989780|NCT01127009|Antiviral Agents|antiviral agents|mesh-ancestor
101989781|NCT01127009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101989782|NCT01127009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101989783|NCT01127009|Immunologic Factors|immunologic factors|mesh-ancestor
101989784|NCT01127009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989785|NCT01127009|Analgesics|analgesics|mesh-ancestor
101989786|NCT01127009|Sensory System Agents|sensory system agents|mesh-ancestor
101989787|NCT01127009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101989788|NCT01127009|Keratolytic Agents|keratolytic agents|mesh-ancestor
101989789|NCT01127009|Dermatologic Agents|dermatologic agents|mesh-ancestor
101989790|NCT01127009|Tubulin Modulators|tubulin modulators|mesh-ancestor
101989791|NCT01127009|Antimitotic Agents|antimitotic agents|mesh-ancestor
101989792|NCT01127009|Mitosis Modulators|mitosis modulators|mesh-ancestor
101989793|NCT03817411|Capecitabine|capecitabine|mesh-list
101989794|NCT03817411|Oxaliplatin|oxaliplatin|mesh-list
101989795|NCT03817411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101989796|NCT03817411|Antimetabolites|antimetabolites|mesh-ancestor
101989797|NCT03817411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989798|NCT03817411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101989799|NCT01205737|Rituximab|rituximab|mesh-list
101989800|NCT01205737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101794834|NCT04039880|Olorofim|olorofim|mesh-list
101989801|NCT01205737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101989802|NCT01205737|Immunologic Factors|immunologic factors|mesh-ancestor
101989803|NCT01205737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989804|NCT01205737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101989805|NCT01218893|Chloroquine|chloroquine|mesh-list
101989806|NCT01218893|Proguanil|proguanil|mesh-list
101989807|NCT01218893|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
101989808|NCT01218893|Amebicides|amebicides|mesh-ancestor
101989809|NCT01218893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101989810|NCT01218893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101989811|NCT01218893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101989812|NCT01218893|Antimalarials|antimalarials|mesh-ancestor
101989813|NCT01218893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101989814|NCT01218893|Antimetabolites|antimetabolites|mesh-ancestor
101989815|NCT01218893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989816|NCT03824119|Ibuprofen|ibuprofen|mesh-list
101989817|NCT03824119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101989818|NCT03824119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101989819|NCT03824119|Analgesics|analgesics|mesh-ancestor
101989820|NCT03824119|Sensory System Agents|sensory system agents|mesh-ancestor
101989821|NCT03824119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101989822|NCT03824119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989823|NCT03824119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101989824|NCT03824119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101989825|NCT03824119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101989826|NCT03824119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101989827|NCT03824119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989828|NCT03823417|Tranexamic Acid|tranexamic acid|mesh-list
101989829|NCT03823417|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101989830|NCT03823417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101989831|NCT03823417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989832|NCT03823417|Hemostatics|hemostatics|mesh-ancestor
101989833|NCT03823417|Coagulants|coagulants|mesh-ancestor
101989834|NCT01297777|Imatinib Mesylate|imatinib mesylate|mesh-list
101989835|NCT01297777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101989836|NCT01297777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101989837|NCT01297777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101989838|NCT01297777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989839|NCT01225913|Fluticasone|fluticasone|mesh-list
101989840|NCT01225913|Xhance|xhance|mesh-list
101989841|NCT01225913|Budesonide|budesonide|mesh-list
101989842|NCT01225913|Formoterol Fumarate|formoterol fumarate|mesh-list
101989846|NCT01225913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101989847|NCT01225913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101989848|NCT01225913|Autonomic Agents|autonomic agents|mesh-ancestor
101947419|NCT03869931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101947420|NCT04876066|Ketamine|ketamine|mesh-list
101947421|NCT04876066|Analgesics|analgesics|mesh-ancestor
101816304|NCT00778973|Sertraline|sertraline|mesh-list
101989849|NCT01225913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101989850|NCT01225913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989851|NCT01225913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101989852|NCT01225913|Respiratory System Agents|respiratory system agents|mesh-ancestor
101989853|NCT01225913|Dermatologic Agents|dermatologic agents|mesh-ancestor
101989854|NCT01225913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101989855|NCT01225913|Glucocorticoids|glucocorticoids|mesh-ancestor
101709669|NCT00664196|Hormones|hormones|mesh-list
101989856|NCT01225913|Hormones|hormones|mesh-ancestor
101989857|NCT01225913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101989858|NCT01225913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101989859|NCT01225913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101989860|NCT01225913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101989861|NCT01225913|Adrenergic Agents|adrenergic agents|mesh-ancestor
101989862|NCT01225913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101712089|NCT00689156|Mitosis Modulators|mitosis modulators|mesh-ancestor
101989863|NCT01225913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989864|NCT01225913|Sympathomimetics|sympathomimetics|mesh-ancestor
101989865|NCT01224977|Azithromycin|azithromycin|mesh-list
101989866|NCT01224977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101989867|NCT01224977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101989868|NCT01226069|Magnesium Sulfate|magnesium sulfate|mesh-list
101989869|NCT01226069|Glycerol|glycerol|mesh-list
101989870|NCT01226069|Analgesics|analgesics|mesh-ancestor
101989871|NCT01226069|Sensory System Agents|sensory system agents|mesh-ancestor
101989872|NCT01226069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101989873|NCT01226069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989874|NCT01226069|Anesthetics|anesthetics|mesh-ancestor
101989875|NCT01226069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101989876|NCT01226069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101989877|NCT01226069|Anticonvulsants|anticonvulsants|mesh-ancestor
101989878|NCT01226069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101989879|NCT01226069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101989880|NCT01226069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989881|NCT01226069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101989882|NCT01226069|Tocolytic Agents|tocolytic agents|mesh-ancestor
101989883|NCT01226069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101989884|NCT01226069|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101989885|NCT01226069|Protective Agents|protective agents|mesh-ancestor
101989886|NCT03928691|Magnesium Sulfate|magnesium sulfate|mesh-list
101989887|NCT03928691|Analgesics|analgesics|mesh-ancestor
101989888|NCT03928691|Sensory System Agents|sensory system agents|mesh-ancestor
101989889|NCT03928691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101989890|NCT03928691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989891|NCT03928691|Anesthetics|anesthetics|mesh-ancestor
101989892|NCT03928691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101989893|NCT03928691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101989894|NCT03928691|Anticonvulsants|anticonvulsants|mesh-ancestor
101989895|NCT03928691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101989896|NCT03928691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101989897|NCT03928691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989898|NCT03928691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101989899|NCT03928691|Tocolytic Agents|tocolytic agents|mesh-ancestor
101989900|NCT03928691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101989901|NCT01297855|Rifampin|rifampin|mesh-list
101989902|NCT01297855|Colistin|colistin|mesh-list
101989903|NCT01297855|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101989904|NCT01297855|Antitubercular Agents|antitubercular agents|mesh-ancestor
101989905|NCT01297855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101989906|NCT01297855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101989907|NCT01297855|Leprostatic Agents|leprostatic agents|mesh-ancestor
101989908|NCT01297855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101989909|NCT01297855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101989910|NCT01297855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989911|NCT01297855|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101989923|NCT01298011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101989924|NCT01298011|Tubulin Modulators|tubulin modulators|mesh-ancestor
101989925|NCT01298011|Antimitotic Agents|antimitotic agents|mesh-ancestor
101989926|NCT01298011|Mitosis Modulators|mitosis modulators|mesh-ancestor
101947422|NCT04876066|Sensory System Agents|sensory system agents|mesh-ancestor
101947423|NCT04876066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101947424|NCT04876066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947425|NCT04876066|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101989927|NCT01298011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989928|NCT01298011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101989929|NCT01298011|Antimetabolites|antimetabolites|mesh-ancestor
101989930|NCT01221935|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101989931|NCT01221935|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
101989932|NCT01221935|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
101712104|NCT01016821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101989933|NCT01221935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101989934|NCT01221935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101989935|NCT01221935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989936|NCT01221935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101989937|NCT01221935|Serotonin Agents|serotonin agents|mesh-ancestor
101989938|NCT01221935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989939|NCT01221935|Antidepressive Agents|antidepressive agents|mesh-ancestor
101989940|NCT01221935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101989942|NCT05137678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101989943|NCT05137678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989944|NCT01226303|Tretinoin|tretinoin|mesh-list
101989945|NCT01226303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101989946|NCT01226303|Keratolytic Agents|keratolytic agents|mesh-ancestor
101989947|NCT01226303|Dermatologic Agents|dermatologic agents|mesh-ancestor
101989948|NCT03814759|Cisplatin|cisplatin|mesh-list
101989949|NCT03814759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101989950|NCT05101018|Denosumab|denosumab|mesh-list
101989951|NCT05101018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101989952|NCT05101018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989953|NCT03929861|Fluconazole|fluconazole|mesh-list
101989954|NCT03929861|Antifungal Agents|antifungal agents|mesh-ancestor
101989955|NCT03929861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101989956|NCT03929861|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101989957|NCT03929861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101989958|NCT03929861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101989959|NCT03929861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989960|NCT03929861|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101989961|NCT03929861|Hormone Antagonists|hormone antagonists|mesh-ancestor
101989962|NCT03929861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101989963|NCT03929861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989964|NCT03929861|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101989965|NCT03929861|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101989966|NCT03821623|Niacinamide|niacinamide|mesh-list
101989967|NCT03821623|Niacin|niacin|mesh-list
101989968|NCT03821623|Nicotinic Acids|nicotinic acids|mesh-list
101989969|NCT03821623|Vitamin B Complex|vitamin b complex|mesh-ancestor
101989970|NCT03821623|Vitamins|vitamins|mesh-ancestor
101989971|NCT03821623|Micronutrients|micronutrients|mesh-ancestor
101989972|NCT03821623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989973|NCT03821623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101989974|NCT03821623|Antimetabolites|antimetabolites|mesh-ancestor
101989981|NCT03928145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101989983|NCT03928145|Natriuretic Agents|natriuretic agents|mesh-ancestor
101989984|NCT03928145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989985|NCT03928145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101989986|NCT03928145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101989987|NCT03928145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989988|NCT03928145|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
101989989|NCT03928145|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101989990|NCT03928145|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101989991|NCT03928145|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101989992|NCT01129271|Clopidogrel|clopidogrel|mesh-list
101989993|NCT01129271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101989994|NCT01129271|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101989995|NCT01129271|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101989996|NCT01129271|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101947426|NCT04876066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101947427|NCT04876066|Anesthetics, General|anesthetics, general|mesh-ancestor
101947428|NCT04876066|Anesthetics|anesthetics|mesh-ancestor
101947429|NCT04876066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101989997|NCT01129271|Purinergic Agents|purinergic agents|mesh-ancestor
101989998|NCT01129271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101989999|NCT01129271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990000|NCT01129271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990001|NCT01222013|Imatinib Mesylate|imatinib mesylate|mesh-list
101712113|NCT01011205|Tacrolimus|tacrolimus|mesh-list
101990002|NCT01222013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990003|NCT01222013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101990004|NCT01222013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101990005|NCT01222013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990006|NCT00741988|Bevacizumab|bevacizumab|mesh-list
101990007|NCT00741988|Carboplatin|carboplatin|mesh-list
101990008|NCT00741988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101990009|NCT00741988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990010|NCT00741988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101990011|NCT00741988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101990012|NCT00741988|Growth Substances|growth substances|mesh-ancestor
101990013|NCT00741988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990014|NCT00741988|Growth Inhibitors|growth inhibitors|mesh-ancestor
101990015|NCT01131377|Acetazolamide|acetazolamide|mesh-list
101990016|NCT01131377|Anticonvulsants|anticonvulsants|mesh-ancestor
101990017|NCT01131377|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101990018|NCT01131377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101990019|NCT01131377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990020|NCT01131377|Diuretics|diuretics|mesh-ancestor
101990021|NCT01131377|Natriuretic Agents|natriuretic agents|mesh-ancestor
101990022|NCT01131377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990023|NCT04457050|Ribavirin|ribavirin|mesh-list
101990024|NCT04457050|Sofosbuvir|sofosbuvir|mesh-list
101990025|NCT04457050|Ledipasvir|ledipasvir|mesh-list
101990026|NCT04457050|Antimetabolites|antimetabolites|mesh-ancestor
101990027|NCT04457050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990028|NCT04457050|Antiviral Agents|antiviral agents|mesh-ancestor
101990029|NCT04457050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101990030|NCT01228409|Acitretin|acitretin|mesh-list
101990031|NCT01228409|Keratolytic Agents|keratolytic agents|mesh-ancestor
101990032|NCT01228409|Dermatologic Agents|dermatologic agents|mesh-ancestor
101990033|NCT03470350|Capecitabine|capecitabine|mesh-list
101990034|NCT03470350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101990035|NCT03470350|Antimetabolites|antimetabolites|mesh-ancestor
101990036|NCT03470350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990037|NCT03470350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990038|NCT04565392|Famotidine|famotidine|mesh-list
101990039|NCT04565392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101990040|NCT04565392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101990041|NCT04565392|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101990042|NCT04565392|Histamine Antagonists|histamine antagonists|mesh-ancestor
101990051|NCT05654233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990052|NCT05654233|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101990053|NCT05654233|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101990054|NCT05654233|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101990055|NCT05654233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101990056|NCT05654233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990058|NCT01226771|Antimetabolites|antimetabolites|mesh-ancestor
101990059|NCT01226771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990060|NCT01226771|Antiviral Agents|antiviral agents|mesh-ancestor
101990061|NCT01226771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101990062|NCT03814447|Cyclophosphamide|cyclophosphamide|mesh-list
101990063|NCT03814447|Fludarabine|fludarabine|mesh-list
101990064|NCT03814447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101990065|NCT03814447|Immunologic Factors|immunologic factors|mesh-ancestor
101990066|NCT03814447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990067|NCT03814447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101990068|NCT03814447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101990069|NCT03814447|Alkylating Agents|alkylating agents|mesh-ancestor
101990070|NCT03814447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990071|NCT03814447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990072|NCT03814447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101947430|NCT04876066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101947431|NCT04876066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101947432|NCT04876066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101947433|NCT04876066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990073|NCT01129427|Pantoprazole|pantoprazole|mesh-list
101990074|NCT01129427|Clopidogrel|clopidogrel|mesh-list
101990075|NCT01129427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101990076|NCT01129427|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101990077|NCT01129427|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101990078|NCT01129427|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101990079|NCT01129427|Purinergic Agents|purinergic agents|mesh-ancestor
101990080|NCT01129427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101990081|NCT01129427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990082|NCT01129427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990083|NCT01129427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101990084|NCT01129427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101990085|NCT01129427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101990086|NCT01129427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101990087|NCT03814291|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
101990088|NCT03814291|Immunologic Factors|immunologic factors|mesh-ancestor
101990089|NCT03814291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990090|NCT03354429|Ticagrelor|ticagrelor|mesh-list
101990091|NCT03354429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101990092|NCT03354429|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101990093|NCT03354429|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101990094|NCT03354429|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101990095|NCT03354429|Purinergic Agents|purinergic agents|mesh-ancestor
101990096|NCT03354429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101990097|NCT03354429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990098|NCT03354429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990099|NCT05164198|Adalimumab|adalimumab|mesh-list
101990100|NCT05164198|Infliximab|infliximab|mesh-list
101990101|NCT05164198|Golimumab|golimumab|mesh-list
101990102|NCT05164198|Etanercept|etanercept|mesh-list
101990103|NCT05164198|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101990104|NCT05164198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101990105|NCT05164198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101990106|NCT05164198|Dermatologic Agents|dermatologic agents|mesh-ancestor
101990107|NCT05164198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101990117|NCT03740399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101990118|NCT03740399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990120|NCT05160220|Hallucinogens|hallucinogens|mesh-ancestor
101990121|NCT05160220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990122|NCT05160220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101990123|NCT03924245|Olaparib|olaparib|mesh-list
101990124|NCT03924245|Entinostat|entinostat|mesh-list
101990125|NCT03924245|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101990126|NCT03924245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101990127|NCT03924245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990128|NCT03924245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990129|NCT03924245|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101990130|NCT05647447|SR 142801|sr 142801|mesh-list
101990131|NCT05647447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101990132|NCT05647447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101990133|NCT05647447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101990134|NCT05647447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990135|NCT05647447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101990136|NCT01225445|Ramipril|ramipril|mesh-list
101990137|NCT01225445|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101990138|NCT01225445|Protease Inhibitors|protease inhibitors|mesh-ancestor
101990139|NCT01225445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101990140|NCT01225445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990141|NCT01225445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101990142|NCT05555329|Thalidomide|thalidomide|mesh-list
101990143|NCT05555329|Pomalidomide|pomalidomide|mesh-list
101990144|NCT05555329|Immunologic Factors|immunologic factors|mesh-ancestor
101990145|NCT05555329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990146|NCT05555329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101990147|NCT05555329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101947435|NCT01169805|Palonosetron|palonosetron|mesh-list
101947436|NCT01169805|Ramosetron|ramosetron|mesh-list
101947437|NCT01169805|Antiemetics|antiemetics|mesh-ancestor
101947438|NCT01169805|Autonomic Agents|autonomic agents|mesh-ancestor
101712128|NCT01011205|Antiemetics|antiemetics|mesh-ancestor
101947439|NCT01169805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101816593|NCT00783107|Cyclosporine|cyclosporine|mesh-list
101990148|NCT05555329|Growth Substances|growth substances|mesh-ancestor
101990149|NCT05555329|Growth Inhibitors|growth inhibitors|mesh-ancestor
101990150|NCT05555329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990151|NCT05555329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101709974|NCT00678236|Cimetidine|cimetidine|mesh-list
101990152|NCT05555329|Leprostatic Agents|leprostatic agents|mesh-ancestor
101990153|NCT05555329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101990154|NCT05555329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101990155|NCT05390710|Paclitaxel|paclitaxel|mesh-list
101990156|NCT05390710|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101990157|NCT05390710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101990158|NCT05390710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990159|NCT05390710|Tubulin Modulators|tubulin modulators|mesh-ancestor
101990160|NCT05390710|Antimitotic Agents|antimitotic agents|mesh-ancestor
101990161|NCT05390710|Mitosis Modulators|mitosis modulators|mesh-ancestor
101990162|NCT05390710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990163|NCT01228565|Cetuximab|cetuximab|mesh-list
101990164|NCT01228565|OTD70DERM|otd70derm|mesh-list
101990165|NCT01228565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101990166|NCT01228565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990167|NCT01228565|Protective Agents|protective agents|mesh-ancestor
101990168|NCT01228565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990169|NCT01226849|Rituximab|rituximab|mesh-list
101990170|NCT01226849|Carboplatin|carboplatin|mesh-list
101990171|NCT01226849|Etoposide|etoposide|mesh-list
101990172|NCT01226849|Bortezomib|bortezomib|mesh-list
101990173|NCT01226849|Ifosfamide|ifosfamide|mesh-list
101990176|NCT01226849|Immunologic Factors|immunologic factors|mesh-ancestor
101990177|NCT01226849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990178|NCT01226849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101990179|NCT01226849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101990180|NCT01226849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101990181|NCT01226849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101990182|NCT01226849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101990183|NCT01226849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990184|NCT01226849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101990185|NCT01226849|Alkylating Agents|alkylating agents|mesh-ancestor
101990186|NCT05159674|Dexmedetomidine|dexmedetomidine|mesh-list
101990187|NCT05159674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101990188|NCT05159674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990189|NCT05159674|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101990190|NCT05159674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101990191|NCT05159674|Analgesics|analgesics|mesh-ancestor
101990192|NCT05159674|Sensory System Agents|sensory system agents|mesh-ancestor
101990193|NCT05159674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101990194|NCT05159674|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101990195|NCT05159674|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101990196|NCT05159674|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101990197|NCT05159674|Adrenergic Agents|adrenergic agents|mesh-ancestor
101990198|NCT05159674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101990199|NCT05159674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990200|NCT03813979|Dolutegravir|dolutegravir|mesh-list
101990201|NCT03813979|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101990202|NCT03813979|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101990203|NCT03813979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101990204|NCT03813979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990205|NCT03813979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101990206|NCT03813979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101990207|NCT03813979|Antiviral Agents|antiviral agents|mesh-ancestor
101990208|NCT03813979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101990209|NCT05555121|Progesterone|progesterone|mesh-list
101990210|NCT05555121|Progestins|progestins|mesh-ancestor
101990212|NCT05555121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101990213|NCT05555121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947440|NCT01169805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947441|NCT01169805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101947442|NCT01169805|Antipruritics|antipruritics|mesh-ancestor
101947443|NCT01169805|Dermatologic Agents|dermatologic agents|mesh-ancestor
101712131|NCT01011205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101947444|NCT01169805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101947445|NCT01169805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101990214|NCT05446467|Pembrolizumab|pembrolizumab|mesh-list
101990215|NCT05446467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990216|NCT05446467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101990217|NCT05446467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101990218|NCT05446467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990219|NCT05553613|Clopidogrel|clopidogrel|mesh-list
101990220|NCT05553613|Ticagrelor|ticagrelor|mesh-list
101990221|NCT05553613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101990222|NCT05553613|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101990223|NCT05553613|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101990224|NCT05553613|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101990225|NCT05553613|Purinergic Agents|purinergic agents|mesh-ancestor
101990226|NCT05553613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101990227|NCT05553613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990228|NCT05553613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990230|NCT03901144|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101990231|NCT03901144|Protective Agents|protective agents|mesh-ancestor
101990232|NCT03901144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990233|NCT01129739|Cyclosporine|cyclosporine|mesh-list
101990234|NCT01129739|Cyclosporins|cyclosporins|mesh-list
101990235|NCT01129739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101990236|NCT01129739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990237|NCT01129739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101990238|NCT01129739|Immunologic Factors|immunologic factors|mesh-ancestor
101990239|NCT01129739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990240|NCT01129739|Antifungal Agents|antifungal agents|mesh-ancestor
101990241|NCT01129739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101990242|NCT01129739|Dermatologic Agents|dermatologic agents|mesh-ancestor
101990243|NCT01129739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101990244|NCT01129739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101990255|NCT01301599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101990256|NCT03384693|Defibrotide|defibrotide|mesh-list
101990257|NCT03384693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101990258|NCT03384693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101990259|NCT03384693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990260|NCT03384693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101990261|NCT05533281|Dexamethasone|dexamethasone|mesh-list
101990262|NCT05533281|Metoclopramide|metoclopramide|mesh-list
101990263|NCT05533281|Tropisetron|tropisetron|mesh-list
101990264|NCT05533281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101990265|NCT05533281|Antiemetics|antiemetics|mesh-ancestor
101990266|NCT05533281|Autonomic Agents|autonomic agents|mesh-ancestor
101990267|NCT05533281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101990268|NCT05533281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990269|NCT05533281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101990270|NCT05533281|Glucocorticoids|glucocorticoids|mesh-ancestor
101990272|NCT05533281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101990273|NCT05533281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101990274|NCT05533281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990275|NCT05533281|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101990276|NCT05533281|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101990277|NCT05533281|Dopamine Agents|dopamine agents|mesh-ancestor
101990278|NCT05533281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101990279|NCT05533281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990280|NCT05533281|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101990281|NCT05533281|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101990282|NCT05533281|Serotonin Agents|serotonin agents|mesh-ancestor
101990283|NCT03923075|Dexmedetomidine|dexmedetomidine|mesh-list
101990284|NCT03923075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101990285|NCT03923075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101947446|NCT01169805|Serotonin Agents|serotonin agents|mesh-ancestor
101947447|NCT01169805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101947448|NCT01169805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947449|NCT01283061|Zafirlukast|zafirlukast|mesh-list
101712136|NCT01011205|Protective Agents|protective agents|mesh-ancestor
101947450|NCT01283061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101947451|NCT01283061|Respiratory System Agents|respiratory system agents|mesh-ancestor
101947452|NCT01283061|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101947453|NCT01283061|Hormone Antagonists|hormone antagonists|mesh-ancestor
101947454|NCT01283061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101947455|NCT01283061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947456|NCT03563014|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
101816727|NCT00391846|Enalapril|enalapril|mesh-list
101990286|NCT03923075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990287|NCT03923075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101990288|NCT03923075|Analgesics|analgesics|mesh-ancestor
101990289|NCT03923075|Sensory System Agents|sensory system agents|mesh-ancestor
101990290|NCT03923075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101990291|NCT03923075|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101990292|NCT03923075|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101990293|NCT03923075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101990294|NCT03923075|Adrenergic Agents|adrenergic agents|mesh-ancestor
101990295|NCT03923075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101990296|NCT03923075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990297|NCT03923231|Ritonavir|ritonavir|mesh-list
101990298|NCT03923231|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101990299|NCT03923231|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101990300|NCT03923231|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101990301|NCT03923231|Protease Inhibitors|protease inhibitors|mesh-ancestor
101990302|NCT03923231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101990303|NCT03923231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990304|NCT03923231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101990305|NCT03923231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101990306|NCT03923231|Antiviral Agents|antiviral agents|mesh-ancestor
101990332|NCT01225523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990333|NCT01225523|Tubulin Modulators|tubulin modulators|mesh-ancestor
101990334|NCT01225523|Antimitotic Agents|antimitotic agents|mesh-ancestor
101990335|NCT01225523|Mitosis Modulators|mitosis modulators|mesh-ancestor
101990336|NCT01225523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990337|NCT01225523|Antimetabolites|antimetabolites|mesh-ancestor
101990338|NCT01225523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101990339|NCT01225523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101990340|NCT01225523|Immunologic Factors|immunologic factors|mesh-ancestor
101990341|NCT01225523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990342|NCT03815539|Hyaluronic Acid|hyaluronic acid|mesh-list
101990343|NCT03815539|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101990344|NCT03815539|Immunologic Factors|immunologic factors|mesh-ancestor
101990345|NCT03815539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990346|NCT03815539|Viscosupplements|viscosupplements|mesh-ancestor
101990347|NCT03815539|Protective Agents|protective agents|mesh-ancestor
101990348|NCT03922919|Ceftriaxone|ceftriaxone|mesh-list
101990349|NCT03922919|Cefotaxime|cefotaxime|mesh-list
101990350|NCT03922919|Cefoxitin|cefoxitin|mesh-list
101990351|NCT03922919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101990352|NCT03922919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101990353|NCT03813277|Dexmedetomidine|dexmedetomidine|mesh-list
101990354|NCT03813277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101990355|NCT03813277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101990356|NCT03813277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990357|NCT03813277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101990358|NCT03813277|Analgesics|analgesics|mesh-ancestor
101990359|NCT03813277|Sensory System Agents|sensory system agents|mesh-ancestor
101445461|NCT00178802|Fluorouracil|fluorouracil|mesh-list
101990363|NCT03813277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101947457|NCT03563014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101947458|NCT01167465|Zinc Oxide|zinc oxide|mesh-list
101947459|NCT01167465|Dermatologic Agents|dermatologic agents|mesh-ancestor
101947460|NCT01167465|Sunscreening Agents|sunscreening agents|mesh-ancestor
101947461|NCT01167465|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101990364|NCT03813277|Adrenergic Agents|adrenergic agents|mesh-ancestor
101990365|NCT03813277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101990366|NCT03813277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990368|NCT03815461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101990369|NCT03815461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990370|NCT03815461|Tubulin Modulators|tubulin modulators|mesh-ancestor
101990371|NCT03815461|Antimitotic Agents|antimitotic agents|mesh-ancestor
101990372|NCT03815461|Mitosis Modulators|mitosis modulators|mesh-ancestor
101990373|NCT03815461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990374|NCT01285102|Irinotecan|irinotecan|mesh-list
101990375|NCT01285102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101990376|NCT01285102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101990377|NCT01285102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101990378|NCT01285102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990379|NCT01285102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990380|NCT03740243|Buprenorphine|buprenorphine|mesh-list
101990381|NCT03740243|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101990382|NCT03740243|Naloxone|naloxone|mesh-list
101990383|NCT03740243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101990384|NCT03740243|Narcotics|narcotics|mesh-ancestor
101990385|NCT03740243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101990386|NCT03740243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990387|NCT03740243|Analgesics|analgesics|mesh-ancestor
101990388|NCT03740243|Sensory System Agents|sensory system agents|mesh-ancestor
101990389|NCT03740243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101990390|NCT03740243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101990391|NCT03813043|Midazolam|midazolam|mesh-list
101990392|NCT03813043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101990393|NCT03813043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101990394|NCT03813043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101990395|NCT03813043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990396|NCT03813043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101990397|NCT03813043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101990398|NCT03813043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101990399|NCT03813043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101990400|NCT03813043|Anesthetics, General|anesthetics, general|mesh-ancestor
101990401|NCT03813043|Anesthetics|anesthetics|mesh-ancestor
101990402|NCT03813043|GABA Modulators|gaba modulators|mesh-ancestor
101990403|NCT03813043|GABA Agents|gaba agents|mesh-ancestor
101990404|NCT03813043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101990405|NCT03813043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990406|NCT03382899|Pembrolizumab|pembrolizumab|mesh-list
101990407|NCT03382899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101990408|NCT03382899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990409|NCT03382899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101990410|NCT03382899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990411|NCT03815305|Petrolatum|petrolatum|mesh-list
101990412|NCT03815305|Emollients|emollients|mesh-ancestor
101990413|NCT03815305|Dermatologic Agents|dermatologic agents|mesh-ancestor
101990414|NCT01560013|Naltrexone|naltrexone|mesh-list
101990415|NCT01560013|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101990416|NCT01560013|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101990417|NCT01560013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990418|NCT01560013|Sensory System Agents|sensory system agents|mesh-ancestor
101990419|NCT01560013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101990420|NCT01302145|Metformin|metformin|mesh-list
101990421|NCT01302145|Ipragliflozin|ipragliflozin|mesh-list
101990422|NCT01302145|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101990423|NCT01302145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990424|NCT01302145|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101990425|NCT01302145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990426|NCT01560091|Tamsulosin|tamsulosin|mesh-list
101990427|NCT01560091|Silodosin|silodosin|mesh-list
101990428|NCT01560091|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101990429|NCT01560091|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101990430|NCT01560091|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101947462|NCT01167465|Protective Agents|protective agents|mesh-ancestor
101947463|NCT01167465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947464|NCT01283217|Cisplatin|cisplatin|mesh-list
101990446|NCT03812731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101990447|NCT03812731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990449|NCT03812731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101990450|NCT03812731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101990451|NCT03812731|Narcotics|narcotics|mesh-ancestor
101710274|NCT00680654|Riociguat|riociguat|mesh-list
101990452|NCT03812731|Analgesics|analgesics|mesh-ancestor
101990453|NCT03812731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101712147|NCT00809835|Nootropic Agents|nootropic agents|mesh-ancestor
101990454|NCT03812731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101990455|NCT03812731|Anesthetics, General|anesthetics, general|mesh-ancestor
101990456|NCT03351231|Nivolumab|nivolumab|mesh-list
101990457|NCT03351231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101990458|NCT03351231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990459|NCT03351231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101990460|NCT03351231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990461|NCT03922373|Benzonatate|benzonatate|mesh-list
101990462|NCT03922373|Antitussive Agents|antitussive agents|mesh-ancestor
101990463|NCT03922373|Respiratory System Agents|respiratory system agents|mesh-ancestor
101990464|NCT03709719|Blinatumomab|blinatumomab|mesh-list
101990465|NCT03709719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990466|NCT03926663|Dexmedetomidine|dexmedetomidine|mesh-list
101990467|NCT03926663|Bupivacaine|bupivacaine|mesh-list
101990468|NCT03926663|Anesthetics, Local|anesthetics, local|mesh-ancestor
101990469|NCT03926663|Anesthetics|anesthetics|mesh-ancestor
101990470|NCT03926663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101990471|NCT03926663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990472|NCT03926663|Sensory System Agents|sensory system agents|mesh-ancestor
101990473|NCT03926663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101990474|NCT03926663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101990475|NCT03926663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101990476|NCT03926663|Analgesics|analgesics|mesh-ancestor
101990477|NCT03926663|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101990478|NCT03926663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101990479|NCT03926663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101990480|NCT03926663|Adrenergic Agents|adrenergic agents|mesh-ancestor
101990481|NCT03926663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101990482|NCT03926663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990483|NCT05481775|Immunomodulating Agents|immunomodulating agents|mesh-list
101990484|NCT05481775|Immunologic Factors|immunologic factors|mesh-ancestor
101990485|NCT05481775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990486|NCT05165914|Midazolam|midazolam|mesh-list
101990487|NCT05165914|Anesthetics|anesthetics|mesh-list
101990488|NCT05165914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101990489|NCT05165914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990493|NCT05165914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101990494|NCT05165914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101990495|NCT05165914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101990496|NCT05165914|Anesthetics, General|anesthetics, general|mesh-ancestor
101990497|NCT05165914|GABA Modulators|gaba modulators|mesh-ancestor
101990498|NCT05165914|GABA Agents|gaba agents|mesh-ancestor
101990499|NCT05165914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101990500|NCT05165914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990501|NCT04420975|Nivolumab|nivolumab|mesh-list
101990502|NCT04420975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101990503|NCT04420975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990504|NCT04420975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101990505|NCT04420975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990506|NCT01132157|Propofol|propofol|mesh-list
101990507|NCT01132157|Desflurane|desflurane|mesh-list
101990508|NCT01132157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101990509|NCT01132157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101990510|NCT01132157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990511|NCT01132157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101990512|NCT01132157|Anesthetics, General|anesthetics, general|mesh-ancestor
101990513|NCT01132157|Anesthetics|anesthetics|mesh-ancestor
101990514|NCT01132157|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101990515|NCT05389150|Pregabalin|pregabalin|mesh-list
101990516|NCT05389150|Tramadol|tramadol|mesh-list
101990517|NCT05389150|Analgesics|analgesics|mesh-ancestor
101990518|NCT05389150|Sensory System Agents|sensory system agents|mesh-ancestor
101990519|NCT05389150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101947465|NCT01283217|Docetaxel|docetaxel|mesh-list
101947466|NCT01283217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101947467|NCT01283217|Tubulin Modulators|tubulin modulators|mesh-ancestor
101816935|NCT00408694|Antimetabolites|antimetabolites|mesh-ancestor
101990520|NCT05389150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990521|NCT05389150|Anticonvulsants|anticonvulsants|mesh-ancestor
101990522|NCT05389150|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101990523|NCT05389150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101990524|NCT05389150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990525|NCT05389150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101990526|NCT05389150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101990527|NCT05389150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101990528|NCT05389150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101990529|NCT05389150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101990530|NCT05389150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101990531|NCT05389150|Narcotics|narcotics|mesh-ancestor
101990532|NCT03806101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101990533|NCT03806101|Abrocitinib|abrocitinib|mesh-list
101990534|NCT03806101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101990535|NCT03806101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101990536|NCT03806101|Antimetabolites|antimetabolites|mesh-ancestor
101990537|NCT03806101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990538|NCT03806101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101990539|NCT03806101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101990540|NCT03806101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101990541|NCT03806101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101990542|NCT03812419|Esomeprazole|esomeprazole|mesh-list
101990543|NCT03812419|Pantoprazole|pantoprazole|mesh-list
101990544|NCT03812419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101990545|NCT03812419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101990546|NCT03812419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101990547|NCT03812419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101990548|NCT03812419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990549|NCT01132235|Etanercept|etanercept|mesh-list
101990550|NCT01132235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101990551|NCT01132235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101990552|NCT01132235|Analgesics|analgesics|mesh-ancestor
101990553|NCT01132235|Sensory System Agents|sensory system agents|mesh-ancestor
101990554|NCT01132235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101990555|NCT01132235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990556|NCT01132235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101990557|NCT01132235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101990558|NCT01132235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101990559|NCT01132235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101990560|NCT01132235|Immunologic Factors|immunologic factors|mesh-ancestor
101990561|NCT01131689|Sorafenib|sorafenib|mesh-list
101990562|NCT01131689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990584|NCT05281081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101990585|NCT05281081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990587|NCT05281081|Sensory System Agents|sensory system agents|mesh-ancestor
101990588|NCT05281081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101990589|NCT05281081|Anesthetics, Local|anesthetics, local|mesh-ancestor
101990590|NCT05281081|Anesthetics|anesthetics|mesh-ancestor
101990591|NCT03812965|Botulinum Toxins|botulinum toxins|mesh-list
101990592|NCT03812965|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101990593|NCT03812965|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101990594|NCT03812965|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101990595|NCT03812965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101990596|NCT03812965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990597|NCT03812965|Cholinergic Agents|cholinergic agents|mesh-ancestor
101990598|NCT03812965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101990599|NCT03812965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990600|NCT03812965|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101710420|NCT00685100|Triamcinolone|triamcinolone|mesh-list
101990601|NCT03812965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101990602|NCT01303237|Cetuximab|cetuximab|mesh-list
101990603|NCT01303237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101990604|NCT01303237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990605|NCT01227863|Dexamethasone, neomycin, polymyxin B drug combination|dexamethasone, neomycin, polymyxin b drug combination|mesh-list
101990606|NCT01227863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101990607|NCT01227863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101947468|NCT01283217|Antimitotic Agents|antimitotic agents|mesh-ancestor
101947469|NCT01283217|Mitosis Modulators|mitosis modulators|mesh-ancestor
101712160|NCT00853242|Sequestering Agents|sequestering agents|mesh-ancestor
101947470|NCT01283217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947471|NCT01276431|Buprenorphine|buprenorphine|mesh-list
101947472|NCT01276431|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101947473|NCT01276431|Narcotics|narcotics|mesh-ancestor
101947474|NCT01276431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101947475|NCT01276431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990608|NCT03349515|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101990609|NCT01227941|Doxorubicin|doxorubicin|mesh-list
101990610|NCT01227941|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101990611|NCT01227941|Niraparib|niraparib|mesh-list
101990612|NCT01227941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101990613|NCT01227941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990614|NCT01227941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101445715|NCT00201630|Alfuzosin|alfuzosin|mesh-list
101990625|NCT03919565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101990626|NCT03919565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101990627|NCT03919565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990628|NCT03919565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101990629|NCT03919565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101990631|NCT03380091|Cholecalciferol|cholecalciferol|mesh-list
101990632|NCT03380091|Metformin|metformin|mesh-list
101990633|NCT03380091|Vitamins|vitamins|mesh-ancestor
101990634|NCT03380091|Micronutrients|micronutrients|mesh-ancestor
101990635|NCT03380091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990636|NCT03380091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101990637|NCT03380091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101990638|NCT03380091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101990639|NCT02529293|Insulin Lispro|insulin lispro|mesh-list
101990640|NCT02529293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101990641|NCT02529293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990642|NCT03919253|Paclitaxel|paclitaxel|mesh-list
101990643|NCT03919253|Maleic acid|maleic acid|mesh-list
101990644|NCT03919253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101990645|NCT03919253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990646|NCT03919253|Tubulin Modulators|tubulin modulators|mesh-ancestor
101990647|NCT03919253|Antimitotic Agents|antimitotic agents|mesh-ancestor
101990648|NCT03919253|Mitosis Modulators|mitosis modulators|mesh-ancestor
101990649|NCT03919253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990650|NCT03919253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101990651|NCT05165290|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101990652|NCT05165290|Latanoprost|latanoprost|mesh-list
101990653|NCT05165290|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101990654|NCT01132703|Glyburide|glyburide|mesh-list
101990655|NCT01132703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101990656|NCT01132703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990657|NCT01377922|Amifampridine|amifampridine|mesh-list
101990658|NCT01377922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101990659|NCT01377922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101990660|NCT01377922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990661|NCT01377922|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101990662|NCT01377922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101990663|NCT01377922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990664|NCT03919175|Rituximab|rituximab|mesh-list
101990665|NCT03919175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101990666|NCT03919175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990667|NCT03919175|Immunologic Factors|immunologic factors|mesh-ancestor
101990668|NCT03919175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990669|NCT03919175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101990670|NCT01303471|Remifentanil|remifentanil|mesh-list
101990671|NCT01303471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101990672|NCT01303471|Narcotics|narcotics|mesh-ancestor
101990673|NCT01303471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101990674|NCT01303471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990675|NCT01303471|Analgesics|analgesics|mesh-ancestor
101990676|NCT01303471|Sensory System Agents|sensory system agents|mesh-ancestor
101990677|NCT01303471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101947476|NCT01276431|Analgesics|analgesics|mesh-ancestor
101947477|NCT01276431|Sensory System Agents|sensory system agents|mesh-ancestor
101947478|NCT01276431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101947479|NCT01276431|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101947480|NCT01281579|Canagliflozin|canagliflozin|mesh-list
101990678|NCT03804541|Ensartinib|ensartinib|mesh-list
101990679|NCT03804541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990683|NCT01377844|Bexagliflozin|bexagliflozin|mesh-list
101990684|NCT01377844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101990685|NCT01377844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990686|NCT03710811|Insulin|insulin|mesh-list
101990687|NCT03710811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101990688|NCT03710811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990689|NCT01303549|Amphotericin B|amphotericin b|mesh-list
101990690|NCT01303549|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101990691|NCT01303549|Anidulafungin|anidulafungin|mesh-list
101990692|NCT01303549|Amebicides|amebicides|mesh-ancestor
101990693|NCT01303549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101990694|NCT01303549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101990695|NCT01303549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101990696|NCT01303549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101990697|NCT01303549|Antifungal Agents|antifungal agents|mesh-ancestor
101990698|NCT03796975|Metformin|metformin|mesh-list
101990699|NCT03796975|Pioglitazone|pioglitazone|mesh-list
101990700|NCT03796975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101990701|NCT03796975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990702|NCT01130753|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101990703|NCT01130753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990704|NCT01130753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101990705|NCT01130753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101990706|NCT01130753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990707|NCT05400070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101990708|NCT05400070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990709|NCT05400070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101990710|NCT05400070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990711|NCT01302613|Leucovorin|leucovorin|mesh-list
101990712|NCT01302613|Capecitabine|capecitabine|mesh-list
101990713|NCT01302613|Oxaliplatin|oxaliplatin|mesh-list
101990714|NCT01302613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101990715|NCT01302613|Antimetabolites|antimetabolites|mesh-ancestor
101990716|NCT01302613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990717|NCT01302613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990718|NCT01302613|Antidotes|antidotes|mesh-ancestor
101990719|NCT01302613|Protective Agents|protective agents|mesh-ancestor
101990720|NCT01302613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990721|NCT01302613|Vitamin B Complex|vitamin b complex|mesh-ancestor
101990722|NCT01302613|Vitamins|vitamins|mesh-ancestor
101990723|NCT01302613|Micronutrients|micronutrients|mesh-ancestor
101990724|NCT03803371|Acetaminophen|acetaminophen|mesh-list
101990725|NCT03803371|Tramadol|tramadol|mesh-list
101990726|NCT03803371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101990727|NCT03803371|Analgesics|analgesics|mesh-ancestor
101990728|NCT03803371|Sensory System Agents|sensory system agents|mesh-ancestor
101990729|NCT03803371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101990730|NCT03803371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990731|NCT03803371|Antipyretics|antipyretics|mesh-ancestor
101990732|NCT03803371|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101990733|NCT03803371|Narcotics|narcotics|mesh-ancestor
101990734|NCT03803371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101990735|NCT01130909|Ketamine|ketamine|mesh-list
101990736|NCT01130909|Analgesics|analgesics|mesh-ancestor
101990737|NCT01130909|Sensory System Agents|sensory system agents|mesh-ancestor
101990738|NCT01130909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101990739|NCT01130909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990740|NCT01130909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101990741|NCT01130909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101990742|NCT01130909|Anesthetics, General|anesthetics, general|mesh-ancestor
101990743|NCT01130909|Anesthetics|anesthetics|mesh-ancestor
101990744|NCT01130909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101990745|NCT01130909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101990746|NCT01130909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101990747|NCT01130909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101990748|NCT01130909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947481|NCT01281579|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101712168|NCT00848250|Protease Inhibitors|protease inhibitors|mesh-ancestor
101947482|NCT01281579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990750|NCT03918551|Gout Suppressants|gout suppressants|mesh-ancestor
101990751|NCT03918551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101710572|NCT00618059|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101990752|NCT04453930|Irinotecan|irinotecan|mesh-list
101990773|NCT01132781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101990774|NCT01132781|Autonomic Agents|autonomic agents|mesh-ancestor
101990775|NCT01132781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101990776|NCT01132781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990777|NCT01132781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101990778|NCT01132781|Respiratory System Agents|respiratory system agents|mesh-ancestor
101990779|NCT01132781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101990780|NCT01132781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101990781|NCT01132781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990782|NCT01132781|Vasodilator Agents|vasodilator agents|mesh-ancestor
101990783|NCT01132781|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101990784|NCT01132781|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101990785|NCT01132781|Purinergic Agents|purinergic agents|mesh-ancestor
101990786|NCT01132781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101990787|NCT03497767|Osimertinib|osimertinib|mesh-list
101990788|NCT03497767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990789|NCT03497767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101990790|NCT03497767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101990791|NCT03497767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990792|NCT01303705|Cyclophosphamide|cyclophosphamide|mesh-list
101990793|NCT01303705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101990794|NCT01303705|Immunologic Factors|immunologic factors|mesh-ancestor
101990795|NCT01303705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990796|NCT01303705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101990797|NCT01303705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101990798|NCT01303705|Alkylating Agents|alkylating agents|mesh-ancestor
101990799|NCT01303705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990800|NCT01303705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990801|NCT01303705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101990802|NCT01134341|Vitamins|vitamins|mesh-list
101990803|NCT01134341|Folic Acid|folic acid|mesh-list
101990804|NCT01134341|Vitamin B 12|vitamin b 12|mesh-list
101990805|NCT01134341|Vitamin B Complex|vitamin b complex|mesh-list
101990806|NCT01134341|Bexarotene|bexarotene|mesh-list
101990808|NCT01134341|Aminopterin|aminopterin|mesh-list
101990809|NCT01134341|Micronutrients|micronutrients|mesh-ancestor
101990810|NCT01134341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990811|NCT01134341|Hematinics|hematinics|mesh-ancestor
101990812|NCT01134341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101990813|NCT01134341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101990814|NCT01134341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990815|NCT01134341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990816|NCT04308304|Donepezil|donepezil|mesh-list
101990817|NCT04308304|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101990818|NCT04308304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101990819|NCT04308304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990820|NCT04308304|Cholinergic Agents|cholinergic agents|mesh-ancestor
101990821|NCT04308304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101990822|NCT04308304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990823|NCT04308304|Nootropic Agents|nootropic agents|mesh-ancestor
101990824|NCT05397262|Fluorouracil|fluorouracil|mesh-list
101990825|NCT05397262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990826|NCT05397262|Antimetabolites|antimetabolites|mesh-ancestor
101990827|NCT05397262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990828|NCT05397262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101990829|NCT05397262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101990831|NCT05397262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990832|NCT01230359|Pyridoxine|pyridoxine|mesh-list
101990833|NCT01230359|Vitamin B 6|vitamin b 6|mesh-list
101990834|NCT01230359|Vitamins|vitamins|mesh-ancestor
101990835|NCT01230359|Micronutrients|micronutrients|mesh-ancestor
101990836|NCT01230359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990837|NCT01230359|Vitamin B Complex|vitamin b complex|mesh-ancestor
101990838|NCT05396326|Oxaliplatin|oxaliplatin|mesh-list
101990839|NCT05396326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990840|NCT03795571|Dexamethasone|dexamethasone|mesh-list
101990841|NCT03795571|Rituximab|rituximab|mesh-list
101947483|NCT01281579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101947484|NCT01281579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947485|NCT01281657|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101990842|NCT03795571|Gemcitabine|gemcitabine|mesh-list
101990843|NCT03795571|Oxaliplatin|oxaliplatin|mesh-list
101990844|NCT03795571|Lenalidomide|lenalidomide|mesh-list
101990845|NCT03795571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101990846|NCT03795571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990847|NCT03795571|Immunologic Factors|immunologic factors|mesh-ancestor
101990848|NCT03795571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990849|NCT03795571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101990850|NCT03795571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101990851|NCT03795571|Antiemetics|antiemetics|mesh-ancestor
101990852|NCT03795571|Autonomic Agents|autonomic agents|mesh-ancestor
101990853|NCT03795571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101990854|NCT03795571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101990855|NCT03795571|Glucocorticoids|glucocorticoids|mesh-ancestor
101990856|NCT03795571|Hormones|hormones|mesh-ancestor
101990857|NCT03795571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101990858|NCT03795571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101990859|NCT03795571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101990860|NCT03795571|Antimetabolites|antimetabolites|mesh-ancestor
101990861|NCT03795571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990862|NCT03795571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101990863|NCT03795571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101990864|NCT03795571|Growth Substances|growth substances|mesh-ancestor
101990865|NCT03795571|Growth Inhibitors|growth inhibitors|mesh-ancestor
101990866|NCT03795649|Tranexamic Acid|tranexamic acid|mesh-list
101990867|NCT03795649|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101990868|NCT03795649|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101990869|NCT03795649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990870|NCT03795649|Hemostatics|hemostatics|mesh-ancestor
101990871|NCT03795649|Coagulants|coagulants|mesh-ancestor
101990872|NCT04211272|Sildenafil Citrate|sildenafil citrate|mesh-list
101990873|NCT04211272|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101990874|NCT04211272|Macitentan|macitentan|mesh-list
101990875|NCT04211272|Riociguat|riociguat|mesh-list
101990876|NCT04211272|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101990877|NCT04211272|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101990878|NCT04211272|Antimetabolites|antimetabolites|mesh-ancestor
101990879|NCT04211272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990880|NCT04211272|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101990881|NCT04211272|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101990882|NCT04211272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101445954|NCT00186966|Melphalan|melphalan|mesh-list
101990886|NCT04211272|Urological Agents|urological agents|mesh-ancestor
101990887|NCT04211272|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101990888|NCT04211272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101990889|NCT04211272|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
101990890|NCT04211272|Enzyme Activators|enzyme activators|mesh-ancestor
101990892|NCT05402189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101990893|NCT05402189|Narcotics|narcotics|mesh-ancestor
101990894|NCT05402189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101990895|NCT05402189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990896|NCT05402189|Analgesics|analgesics|mesh-ancestor
101990897|NCT05402189|Sensory System Agents|sensory system agents|mesh-ancestor
101990898|NCT05402189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101990899|NCT05402189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101990900|NCT05402189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101990901|NCT05402189|Anesthetics, General|anesthetics, general|mesh-ancestor
101990902|NCT05402189|Anesthetics|anesthetics|mesh-ancestor
101990903|NCT01304563|Vaccines|vaccines|mesh-list
101990904|NCT01304563|Immunologic Factors|immunologic factors|mesh-ancestor
101990905|NCT01304563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990906|NCT01231997|Udenafil|udenafil|mesh-list
101990907|NCT01231997|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101990908|NCT01231997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101990909|NCT01231997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101990910|NCT01231997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990912|NCT03795805|Anesthetics, Local|anesthetics, local|mesh-ancestor
101990913|NCT03795805|Anesthetics|anesthetics|mesh-ancestor
101990914|NCT03795805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101947486|NCT01281657|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101947487|NCT01281657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947488|NCT01281657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101990915|NCT03795805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990916|NCT03795805|Sensory System Agents|sensory system agents|mesh-ancestor
101990917|NCT03795805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101990918|NCT03795805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101990919|NCT03795805|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101990920|NCT03795805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101990921|NCT03795805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101990922|NCT03795805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990923|NCT04072042|Apatinib|apatinib|mesh-list
101990924|NCT04072042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990925|NCT04072042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101990926|NCT04072042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101990927|NCT04072042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990928|NCT03799315|Nicotine|nicotine|mesh-list
101990929|NCT03799315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101990930|NCT03799315|Autonomic Agents|autonomic agents|mesh-ancestor
101990931|NCT03799315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101990932|NCT03799315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990933|NCT03799315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101990934|NCT03799315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101990935|NCT03799315|Cholinergic Agents|cholinergic agents|mesh-ancestor
101990936|NCT03799315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101990937|NCT03799315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990938|NCT05387200|Alendronate|alendronate|mesh-list
101990939|NCT05387200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101990940|NCT05387200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990941|NCT05386810|Vaccines|vaccines|mesh-list
101990942|NCT05386810|Immunologic Factors|immunologic factors|mesh-ancestor
101990943|NCT05386810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990944|NCT04910269|Immunoglobulins|immunoglobulins|mesh-list
101990945|NCT04910269|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101990946|NCT04910269|Antibodies|antibodies|mesh-list
101990947|NCT04910269|Immunologic Factors|immunologic factors|mesh-ancestor
101990948|NCT04910269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990949|NCT03442972|Teduglutide|teduglutide|mesh-list
101990950|NCT03442972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101990951|NCT03442972|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101990952|NCT03442972|Protective Agents|protective agents|mesh-ancestor
101990953|NCT03442972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990954|NCT03921671|Paclitaxel|paclitaxel|mesh-list
101990973|NCT01131767|Analgesics|analgesics|mesh-ancestor
101990974|NCT01131767|Sensory System Agents|sensory system agents|mesh-ancestor
101990975|NCT01131767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101990976|NCT01131767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990977|NCT01131767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101990978|NCT01131767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101990979|NCT01131767|Gout Suppressants|gout suppressants|mesh-ancestor
101990980|NCT01131767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101990981|NCT01131767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101990982|NCT01131767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990984|NCT01131767|Autonomic Agents|autonomic agents|mesh-ancestor
101990985|NCT01131767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101990986|NCT01131767|Respiratory System Agents|respiratory system agents|mesh-ancestor
101990987|NCT01131767|Nasal Decongestants|nasal decongestants|mesh-ancestor
101990988|NCT01131767|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101990989|NCT01131767|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101990990|NCT01131767|Sympathomimetics|sympathomimetics|mesh-ancestor
101990991|NCT01131767|Adrenergic Agents|adrenergic agents|mesh-ancestor
101990992|NCT01131767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101990993|NCT03795259|Rocuronium|rocuronium|mesh-list
101990994|NCT03795259|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101990995|NCT03795259|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101990996|NCT03795259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101990997|NCT03795259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101990998|NCT03795259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990999|NCT01229189|Vitamin D|vitamin d|mesh-list
101991000|NCT01229189|Vitamins|vitamins|mesh-ancestor
101947489|NCT01281657|Immunologic Factors|immunologic factors|mesh-ancestor
101947490|NCT01281657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991001|NCT01229189|Micronutrients|micronutrients|mesh-ancestor
101991002|NCT01229189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991003|NCT01229189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101991004|NCT05481489|Atropine|atropine|mesh-list
101991005|NCT05481489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101991006|NCT05481489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101991007|NCT05481489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101991008|NCT05481489|Autonomic Agents|autonomic agents|mesh-ancestor
101991009|NCT05481489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101991010|NCT05481489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991011|NCT05481489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101991012|NCT05481489|Respiratory System Agents|respiratory system agents|mesh-ancestor
101991013|NCT05481489|Mydriatics|mydriatics|mesh-ancestor
101446104|NCT00576550|Hormones|hormones|mesh-ancestor
101991017|NCT05481489|Cholinergic Agents|cholinergic agents|mesh-ancestor
101991018|NCT05481489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101991019|NCT05481489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991020|NCT05341180|Lactulose|lactulose|mesh-list
101991021|NCT05341180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101991022|NCT05341180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101991023|NCT01133483|Fexofenadine|fexofenadine|mesh-list
101991024|NCT01133483|Pseudoephedrine|pseudoephedrine|mesh-list
101991025|NCT01133483|Ephedrine|ephedrine|mesh-list
101991026|NCT01133483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101991027|NCT01133483|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101991028|NCT01133483|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101991029|NCT01133483|Histamine Antagonists|histamine antagonists|mesh-ancestor
101991030|NCT01133483|Histamine Agents|histamine agents|mesh-ancestor
101991031|NCT01133483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101991032|NCT01133483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991033|NCT01133483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991034|NCT01133483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101991035|NCT01133483|Autonomic Agents|autonomic agents|mesh-ancestor
101991036|NCT01133483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101991037|NCT01133483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101991038|NCT01133483|Respiratory System Agents|respiratory system agents|mesh-ancestor
101991039|NCT01133483|Nasal Decongestants|nasal decongestants|mesh-ancestor
101991040|NCT01133483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101991041|NCT01133483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101991042|NCT01133483|Sympathomimetics|sympathomimetics|mesh-ancestor
101991043|NCT01133483|Adrenergic Agents|adrenergic agents|mesh-ancestor
101991044|NCT05401721|Arginine Vasopressin|arginine vasopressin|mesh-list
101991045|NCT05401721|Hemostatics|hemostatics|mesh-ancestor
101991046|NCT05401721|Coagulants|coagulants|mesh-ancestor
101991047|NCT05401721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101991048|NCT05401721|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101991049|NCT05401721|Natriuretic Agents|natriuretic agents|mesh-ancestor
101991050|NCT05401721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991051|NCT01560481|Metformin|metformin|mesh-list
101991052|NCT01560481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101991053|NCT01560481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991054|NCT04795531|Insulin|insulin|mesh-list
101991055|NCT04795531|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101991056|NCT04795531|Insulin, Long-Acting|insulin, long-acting|mesh-list
101991057|NCT04795531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101991058|NCT04795531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991059|NCT05238844|Tenofovir|tenofovir|mesh-list
101991060|NCT05238844|Antiviral Agents|antiviral agents|mesh-ancestor
101991061|NCT05238844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101991062|NCT05238844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101991063|NCT05238844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101991064|NCT05238844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101712197|NCT00809757|Tocolytic Agents|tocolytic agents|mesh-ancestor
101991065|NCT05238844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991066|NCT05238844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101991067|NCT05238844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101991068|NCT04785625|Bupivacaine|bupivacaine|mesh-list
101991069|NCT04785625|Anesthetics, Local|anesthetics, local|mesh-ancestor
101991070|NCT04785625|Anesthetics|anesthetics|mesh-ancestor
101991071|NCT04785625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101991072|NCT04785625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991073|NCT04785625|Sensory System Agents|sensory system agents|mesh-ancestor
101947493|NCT01166451|Micronutrients|micronutrients|mesh-ancestor
101947494|NCT01166451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947495|NCT02526615|Metformin|metformin|mesh-list
101947496|NCT02526615|Rosiglitazone|rosiglitazone|mesh-list
101947497|NCT02526615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101947498|NCT02526615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991074|NCT04785625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101991075|NCT03368859|Leucovorin|leucovorin|mesh-list
101991076|NCT03368859|Bevacizumab|bevacizumab|mesh-list
101991077|NCT03368859|Fluorouracil|fluorouracil|mesh-list
101991078|NCT03368859|Irinotecan|irinotecan|mesh-list
101991079|NCT03368859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101991080|NCT03368859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101991081|NCT03368859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101991082|NCT03368859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101991083|NCT03368859|Growth Substances|growth substances|mesh-ancestor
101991084|NCT03368859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991085|NCT03368859|Growth Inhibitors|growth inhibitors|mesh-ancestor
101991086|NCT03368859|Antimetabolites|antimetabolites|mesh-ancestor
101628286|NCT00720499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101991088|NCT03368859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101991089|NCT03368859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101991090|NCT03368859|Immunologic Factors|immunologic factors|mesh-ancestor
101991091|NCT03368859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101991092|NCT03368859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101991093|NCT03368859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101991094|NCT03368859|Antidotes|antidotes|mesh-ancestor
101991095|NCT03368859|Protective Agents|protective agents|mesh-ancestor
101991096|NCT03368859|Vitamin B Complex|vitamin b complex|mesh-ancestor
101991097|NCT03368859|Vitamins|vitamins|mesh-ancestor
101991098|NCT03368859|Micronutrients|micronutrients|mesh-ancestor
101991099|NCT01134965|Digoxin|digoxin|mesh-list
101991100|NCT01134965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101991101|NCT01134965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101991102|NCT01134965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101991103|NCT01134965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991104|NCT01134965|Protective Agents|protective agents|mesh-ancestor
101991105|NCT01134965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991106|NCT03810547|Ketamine|ketamine|mesh-list
101991107|NCT03810547|Propofol|propofol|mesh-list
101991108|NCT03810547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101991109|NCT03810547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101991110|NCT03810547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991111|NCT03810547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101991112|NCT03810547|Anesthetics, General|anesthetics, general|mesh-ancestor
101991113|NCT03810547|Anesthetics|anesthetics|mesh-ancestor
101991114|NCT03810547|Analgesics|analgesics|mesh-ancestor
101991115|NCT03810547|Sensory System Agents|sensory system agents|mesh-ancestor
101991116|NCT03810547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101991117|NCT03810547|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101991118|NCT03810547|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101991119|NCT03810547|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101991120|NCT03810547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101991121|NCT03810547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991122|NCT03096314|Vitamin D|vitamin d|mesh-list
101991123|NCT03096314|Cholecalciferol|cholecalciferol|mesh-list
101991124|NCT03096314|Vitamins|vitamins|mesh-ancestor
101991125|NCT03096314|Micronutrients|micronutrients|mesh-ancestor
101991126|NCT03096314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991127|NCT03096314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101991128|NCT03096314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101991129|NCT03917459|Enalapril|enalapril|mesh-list
101712205|NCT00594464|Rotigotine|rotigotine|mesh-list
101991131|NCT03917459|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101991132|NCT03917459|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101710947|NCT00620867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101991133|NCT03917459|Protease Inhibitors|protease inhibitors|mesh-ancestor
101991134|NCT03917459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101991135|NCT03917459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991136|NCT03917459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101991137|NCT03917459|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101947499|NCT01283763|Imiquimod|imiquimod|mesh-list
101947500|NCT01283763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101947501|NCT01283763|Immunologic Factors|immunologic factors|mesh-ancestor
101947502|NCT01283763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947503|NCT01283763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101991138|NCT03129646|Paromomycin|paromomycin|mesh-list
101991139|NCT03129646|Miltefosine|miltefosine|mesh-list
101991140|NCT03129646|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
101991141|NCT03129646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101991142|NCT03129646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101991143|NCT03129646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101991144|NCT03129646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101991145|NCT03129646|Antifungal Agents|antifungal agents|mesh-ancestor
101991146|NCT03129646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101991147|NCT03129646|Schistosomicides|schistosomicides|mesh-ancestor
101991148|NCT03129646|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101991149|NCT03129646|Anthelmintics|anthelmintics|mesh-ancestor
101991150|NCT03710655|Histamine|histamine|mesh-list
101991151|NCT03710655|Histamine Agonists|histamine agonists|mesh-ancestor
101991152|NCT03710655|Histamine Agents|histamine agents|mesh-ancestor
101991153|NCT03710655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101991154|NCT03710655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991155|NCT03710655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991156|NCT01135199|Pomalidomide|pomalidomide|mesh-list
101991157|NCT01135199|Immunologic Factors|immunologic factors|mesh-ancestor
101991158|NCT01135199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991159|NCT01135199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101991166|NCT03917537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101991167|NCT03917537|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101991168|NCT03917537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991169|NCT03335163|Topiramate|topiramate|mesh-list
101991170|NCT03335163|Anticonvulsants|anticonvulsants|mesh-ancestor
101991171|NCT03335163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101991172|NCT03335163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991173|NCT04749602|Nivolumab|nivolumab|mesh-list
101991174|NCT04749602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101991175|NCT04749602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101991176|NCT04749602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101991177|NCT04749602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991178|NCT03461302|Coal Tar|coal tar|mesh-list
101991179|NCT03461302|Keratolytic Agents|keratolytic agents|mesh-ancestor
101991180|NCT03461302|Dermatologic Agents|dermatologic agents|mesh-ancestor
101991181|NCT01232075|Letrozole|letrozole|mesh-list
101991182|NCT01232075|Citric Acid|citric acid|mesh-list
101991183|NCT01232075|Sodium Citrate|sodium citrate|mesh-list
101991184|NCT01232075|Clomiphene|clomiphene|mesh-list
101991185|NCT01232075|Enclomiphene|enclomiphene|mesh-list
101991186|NCT01232075|Zuclomiphene|zuclomiphene|mesh-list
101991187|NCT01232075|Anticoagulants|anticoagulants|mesh-ancestor
101991188|NCT01232075|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101991189|NCT01232075|Chelating Agents|chelating agents|mesh-ancestor
101991190|NCT01232075|Sequestering Agents|sequestering agents|mesh-ancestor
101991191|NCT01232075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991192|NCT01232075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101991193|NCT01232075|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101991194|NCT01232075|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101991195|NCT01232075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101991196|NCT01232075|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101991197|NCT01232075|Hormone Antagonists|hormone antagonists|mesh-ancestor
101991198|NCT01232075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101991199|NCT01232075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991200|NCT01232075|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101991201|NCT01232075|Fertility Agents|fertility agents|mesh-ancestor
101991202|NCT01232075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101991203|NCT01232075|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101991204|NCT01232075|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101991205|NCT03773822|Hydrocortisone|hydrocortisone|mesh-list
101991206|NCT03773822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101991207|NCT01131845|Treprostinil|treprostinil|mesh-list
101991208|NCT01131845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101991209|NCT03711422|Afatinib|afatinib|mesh-list
101991210|NCT03711422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101991211|NCT03711422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101947504|NCT01283763|Interferon Inducers|interferon inducers|mesh-ancestor
101947505|NCT01283841|Mycophenolic Acid|mycophenolic acid|mesh-list
101947506|NCT01283841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101947507|NCT01283841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101991212|NCT03711422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101991213|NCT03711422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991215|NCT03460678|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101991216|NCT03460678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101991217|NCT03460678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101991218|NCT03460678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991219|NCT03460678|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101991220|NCT03460678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101991221|NCT03460678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101991222|NCT03810391|Butorphanol|butorphanol|mesh-list
101991223|NCT03810391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101991224|NCT03810391|Narcotics|narcotics|mesh-ancestor
101991225|NCT03810391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101991226|NCT03810391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991227|NCT03810391|Analgesics|analgesics|mesh-ancestor
101991228|NCT03810391|Sensory System Agents|sensory system agents|mesh-ancestor
101991232|NCT03810391|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101991233|NCT01229579|Zinc Sulfate|zinc sulfate|mesh-list
101991234|NCT01229579|Astringents|astringents|mesh-ancestor
101991235|NCT01229579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991236|NCT01229579|Dermatologic Agents|dermatologic agents|mesh-ancestor
101991237|NCT01131923|Amlodipine|amlodipine|mesh-list
101991238|NCT01131923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101991239|NCT01131923|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101991240|NCT01131923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101991241|NCT01131923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991242|NCT01131923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101991243|NCT01131923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991244|NCT01131923|Vasodilator Agents|vasodilator agents|mesh-ancestor
101991245|NCT03794557|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
101991246|NCT03794557|Respiratory System Agents|respiratory system agents|mesh-ancestor
101991247|NCT01230983|Leucovorin|leucovorin|mesh-list
101991248|NCT01230983|Cytarabine|cytarabine|mesh-list
101991249|NCT01230983|Prednisone|prednisone|mesh-list
101991250|NCT01230983|Hydrocortisone|hydrocortisone|mesh-list
101991251|NCT01230983|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101991252|NCT01230983|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101991253|NCT01230983|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101991254|NCT01230983|Doxorubicin|doxorubicin|mesh-list
101991255|NCT01230983|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101991256|NCT01230983|Dexrazoxane|dexrazoxane|mesh-list
101991257|NCT01230983|Methotrexate|methotrexate|mesh-list
101991258|NCT01230983|Vincristine|vincristine|mesh-list
101991259|NCT01230983|Asparaginase|asparaginase|mesh-list
101991260|NCT01230983|Mercaptopurine|mercaptopurine|mesh-list
101991261|NCT01230983|Razoxane|razoxane|mesh-list
101991262|NCT01230983|Levoleucovorin|levoleucovorin|mesh-list
101991263|NCT01230983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101991264|NCT01230983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101991265|NCT01230983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101991266|NCT01230983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101991267|NCT01230983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101991268|NCT01230983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991269|NCT01230983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991270|NCT01230983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101991271|NCT01230983|Glucocorticoids|glucocorticoids|mesh-ancestor
101991272|NCT01230983|Hormones|hormones|mesh-ancestor
101991273|NCT01230983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101991274|NCT01230983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101991275|NCT01230983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101991276|NCT01230983|Abortifacient Agents|abortifacient agents|mesh-ancestor
101991277|NCT01230983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101991278|NCT01230983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101991279|NCT01230983|Antimetabolites|antimetabolites|mesh-ancestor
101991280|NCT01230983|Dermatologic Agents|dermatologic agents|mesh-ancestor
101991281|NCT01230983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101947508|NCT01283841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101817652|NCT00792857|Vitamins|vitamins|mesh-ancestor
101991282|NCT01230983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101991283|NCT01230983|Immunologic Factors|immunologic factors|mesh-ancestor
101991284|NCT01230983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101991285|NCT01230983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101991286|NCT01230983|Antiviral Agents|antiviral agents|mesh-ancestor
101991287|NCT01230983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101991288|NCT01230983|Antidotes|antidotes|mesh-ancestor
101991289|NCT01230983|Protective Agents|protective agents|mesh-ancestor
101991290|NCT01230983|Vitamin B Complex|vitamin b complex|mesh-ancestor
101991291|NCT01230983|Vitamins|vitamins|mesh-ancestor
101991292|NCT01230983|Micronutrients|micronutrients|mesh-ancestor
101991293|NCT01230983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101991294|NCT01230983|Tubulin Modulators|tubulin modulators|mesh-ancestor
101991295|NCT01230983|Antimitotic Agents|antimitotic agents|mesh-ancestor
101991296|NCT01230983|Mitosis Modulators|mitosis modulators|mesh-ancestor
101991297|NCT01230983|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101991298|NCT01304797|Cyclophosphamide|cyclophosphamide|mesh-list
101991299|NCT01304797|Trastuzumab|trastuzumab|mesh-list
101991300|NCT01304797|Doxorubicin|doxorubicin|mesh-list
101991301|NCT01304797|Gancotamab|gancotamab|mesh-list
101991302|NCT01304797|Immunoconjugates|immunoconjugates|mesh-list
101991303|NCT01304797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101991313|NCT01304797|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101991314|NCT01304797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101991315|NCT01304797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101991316|NCT01304797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101991317|NCT03707535|Infliximab|infliximab|mesh-list
101991318|NCT03707535|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101991319|NCT03707535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101991320|NCT03707535|Dermatologic Agents|dermatologic agents|mesh-ancestor
101991321|NCT03707535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101991322|NCT03707535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101991323|NCT01133795|Midodrine|midodrine|mesh-list
101991324|NCT01133795|Sympathomimetics|sympathomimetics|mesh-ancestor
101991325|NCT01133795|Autonomic Agents|autonomic agents|mesh-ancestor
101991326|NCT01133795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101991327|NCT01133795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991328|NCT01133795|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101991329|NCT01133795|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101991330|NCT01133795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101991331|NCT01133795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101991332|NCT01133795|Adrenergic Agents|adrenergic agents|mesh-ancestor
101991333|NCT01133795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101991334|NCT01133795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991335|NCT01133873|Dextropropoxyphene|dextropropoxyphene|mesh-list
101991336|NCT01133873|Levopropoxyphene|levopropoxyphene|mesh-list
101991337|NCT01133873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101991338|NCT01133873|Narcotics|narcotics|mesh-ancestor
101991339|NCT01133873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101991340|NCT01133873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991341|NCT01133873|Analgesics|analgesics|mesh-ancestor
101991342|NCT01133873|Sensory System Agents|sensory system agents|mesh-ancestor
101991343|NCT01133873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101991344|NCT01133873|Antitussive Agents|antitussive agents|mesh-ancestor
101991345|NCT01133873|Respiratory System Agents|respiratory system agents|mesh-ancestor
101991346|NCT01229813|Bevacizumab|bevacizumab|mesh-list
101991347|NCT01229813|Capecitabine|capecitabine|mesh-list
101991348|NCT01229813|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101991349|NCT01229813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101991350|NCT01229813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101991351|NCT01229813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101991352|NCT01229813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101991353|NCT01229813|Growth Substances|growth substances|mesh-ancestor
101991354|NCT01229813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991355|NCT01229813|Growth Inhibitors|growth inhibitors|mesh-ancestor
101991356|NCT01229813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101991357|NCT01229813|Antimetabolites|antimetabolites|mesh-ancestor
101991358|NCT01229813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991359|NCT01229813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101991360|NCT01229813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101991361|NCT03920813|Mercaptopurine|mercaptopurine|mesh-list
101991362|NCT03920813|Antimetabolites|antimetabolites|mesh-ancestor
101991363|NCT03920813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947509|NCT01283841|Antitubercular Agents|antitubercular agents|mesh-ancestor
101947510|NCT01283841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101947511|NCT01283841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101947512|NCT01283841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101817718|NCT00801281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101991364|NCT03920813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101991365|NCT03920813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101991366|NCT03920813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101991367|NCT03920813|Immunologic Factors|immunologic factors|mesh-ancestor
101991381|NCT01649947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101991382|NCT01649947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101991383|NCT01649947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101991384|NCT01649947|Growth Substances|growth substances|mesh-ancestor
101991385|NCT01649947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991386|NCT01649947|Growth Inhibitors|growth inhibitors|mesh-ancestor
101991387|NCT01649947|Antimalarials|antimalarials|mesh-ancestor
101991388|NCT01649947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101991389|NCT01649947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101991390|NCT01649947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101991391|NCT01649947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101991392|NCT01649947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101991393|NCT03793075|Ketamine|ketamine|mesh-list
101991394|NCT03793075|Propofol|propofol|mesh-list
101991395|NCT03793075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101991396|NCT03793075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101991397|NCT03793075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991398|NCT03793075|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101991399|NCT03793075|Anesthetics, General|anesthetics, general|mesh-ancestor
101991400|NCT03793075|Anesthetics|anesthetics|mesh-ancestor
101991401|NCT03793075|Analgesics|analgesics|mesh-ancestor
101991402|NCT03793075|Sensory System Agents|sensory system agents|mesh-ancestor
101991403|NCT03793075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101991404|NCT03793075|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101991405|NCT03793075|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101991406|NCT03793075|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101991407|NCT03793075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101991408|NCT03793075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991409|NCT01233167|Clopidogrel|clopidogrel|mesh-list
101991410|NCT01233167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101991411|NCT01233167|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101991412|NCT01233167|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101991413|NCT01233167|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101991414|NCT01233167|Purinergic Agents|purinergic agents|mesh-ancestor
101991415|NCT01233167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101991416|NCT01233167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991417|NCT01233167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991418|NCT01304095|Ranolazine|ranolazine|mesh-list
101991419|NCT01304095|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101991420|NCT01304095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101991421|NCT01304095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991422|NCT03707457|Nivolumab|nivolumab|mesh-list
101991423|NCT03707457|Ipilimumab|ipilimumab|mesh-list
101991424|NCT03707457|MK-4166|mk-4166|mesh-list
101991425|NCT03707457|Antibodies|antibodies|mesh-list
101991426|NCT03707457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101991427|NCT03707457|Immunologic Factors|immunologic factors|mesh-ancestor
101991428|NCT03707457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991429|NCT03707457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101991430|NCT03707457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101991440|NCT01568294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101991441|NCT03422666|Teduglutide|teduglutide|mesh-list
101991442|NCT03422666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101991443|NCT03422666|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101991444|NCT03422666|Protective Agents|protective agents|mesh-ancestor
101991445|NCT03422666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991446|NCT03453190|Apremilast|apremilast|mesh-list
101991447|NCT03453190|Clobetasol|clobetasol|mesh-list
101991448|NCT03453190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101991449|NCT03453190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101991450|NCT03453190|Analgesics|analgesics|mesh-ancestor
101947513|NCT01283841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947514|NCT03872661|Bevacizumab|bevacizumab|mesh-list
101947515|NCT03872661|Carboplatin|carboplatin|mesh-list
101947516|NCT03872661|Pemetrexed|pemetrexed|mesh-list
101817842|NCT00802139|Iron|iron|mesh-list
101991451|NCT03453190|Sensory System Agents|sensory system agents|mesh-ancestor
101991452|NCT03453190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101991453|NCT03453190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991454|NCT03453190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101991455|NCT03453190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101991456|NCT03453190|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101991457|NCT03453190|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101991458|NCT03453190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101991459|NCT03453190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991460|NCT03453190|Glucocorticoids|glucocorticoids|mesh-ancestor
101991461|NCT03453190|Hormones|hormones|mesh-ancestor
101991462|NCT03453190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101991463|NCT01231139|Acetaminophen|acetaminophen|mesh-list
101991464|NCT01231139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101991465|NCT01231139|Analgesics|analgesics|mesh-ancestor
101991466|NCT01231139|Sensory System Agents|sensory system agents|mesh-ancestor
101991467|NCT01231139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101991468|NCT01231139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991469|NCT01231139|Antipyretics|antipyretics|mesh-ancestor
101991470|NCT03382574|Denosumab|denosumab|mesh-list
101991471|NCT03382574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101991472|NCT03382574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991473|NCT01137695|Pramlintide|pramlintide|mesh-list
101991474|NCT01137695|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
101991475|NCT01137695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101991476|NCT01137695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991477|NCT01137695|Appetite Depressants|appetite depressants|mesh-ancestor
101991478|NCT01137695|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101991479|NCT01137695|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
101991480|NCT01137695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991481|NCT03451396|Lifitegrast|lifitegrast|mesh-list
101991482|NCT03451396|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101991483|NCT03451396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101991484|NCT02528825|Remifentanil|remifentanil|mesh-list
101991485|NCT02528825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101991486|NCT02528825|Narcotics|narcotics|mesh-ancestor
101991487|NCT02528825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101991488|NCT02528825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991489|NCT02528825|Analgesics|analgesics|mesh-ancestor
101991490|NCT02528825|Sensory System Agents|sensory system agents|mesh-ancestor
101991491|NCT02528825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101991492|NCT01233245|Interferons|interferons|mesh-list
101991493|NCT01233245|Interferon-beta|interferon-beta|mesh-list
101991494|NCT01233245|Interferon beta-1b|interferon beta-1b|mesh-list
101991495|NCT01233245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101991500|NCT01233245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101991502|NCT03776812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101991503|NCT03776812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101991504|NCT03776812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101991505|NCT03776812|Tubulin Modulators|tubulin modulators|mesh-ancestor
101991506|NCT03776812|Antimitotic Agents|antimitotic agents|mesh-ancestor
101991507|NCT03776812|Mitosis Modulators|mitosis modulators|mesh-ancestor
101991508|NCT03776812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991509|NCT03361605|Propofol|propofol|mesh-list
101991510|NCT03361605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101991511|NCT03361605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101991512|NCT03361605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991513|NCT03361605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101991514|NCT03361605|Anesthetics, General|anesthetics, general|mesh-ancestor
101991515|NCT03361605|Anesthetics|anesthetics|mesh-ancestor
101991516|NCT03794167|Cyclophosphamide|cyclophosphamide|mesh-list
101991517|NCT03794167|Melphalan|melphalan|mesh-list
101991518|NCT03794167|Busulfan|busulfan|mesh-list
101991519|NCT03794167|Etoposide|etoposide|mesh-list
101991520|NCT03794167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101991521|NCT03794167|Immunologic Factors|immunologic factors|mesh-ancestor
101991522|NCT03794167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991523|NCT03794167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101947517|NCT03872661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101947518|NCT03872661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101947519|NCT03872661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101817862|NCT00802373|Urological Agents|urological agents|mesh-ancestor
101991524|NCT03794167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101991525|NCT03794167|Alkylating Agents|alkylating agents|mesh-ancestor
101991526|NCT03794167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991527|NCT03794167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101991528|NCT03794167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101991529|NCT03794167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101991530|NCT03794167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101991531|NCT03794167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101991532|NCT03794167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101991533|NCT05332821|Bevacizumab|bevacizumab|mesh-list
101991534|NCT05332821|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101991535|NCT05332821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101991536|NCT05332821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101991537|NCT05332821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101991538|NCT05332821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101991539|NCT05332821|Growth Substances|growth substances|mesh-ancestor
101991540|NCT05332821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991541|NCT05332821|Growth Inhibitors|growth inhibitors|mesh-ancestor
101991542|NCT05332821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991543|NCT05331651|Glycopyrrolate|glycopyrrolate|mesh-list
101991544|NCT05331651|Tropisetron|tropisetron|mesh-list
101991545|NCT05331651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101991546|NCT05331651|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101991547|NCT05331651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101991548|NCT05331651|Cholinergic Agents|cholinergic agents|mesh-ancestor
101991549|NCT05331651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101991550|NCT05331651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991551|NCT05331651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991552|NCT05331651|Antiemetics|antiemetics|mesh-ancestor
101991553|NCT05331651|Autonomic Agents|autonomic agents|mesh-ancestor
101991554|NCT05331651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101991555|NCT05331651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101991556|NCT05331651|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101991557|NCT05331651|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101991558|NCT05331651|Serotonin Agents|serotonin agents|mesh-ancestor
101991559|NCT01134185|Prucalopride|prucalopride|mesh-list
101991560|NCT01134185|Laxatives|laxatives|mesh-ancestor
101991561|NCT01134185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101991562|NCT01134185|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101991563|NCT01134185|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101991564|NCT01134185|Serotonin Agents|serotonin agents|mesh-ancestor
101991565|NCT01134185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101991577|NCT03829046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101991578|NCT05320588|Pembrolizumab|pembrolizumab|mesh-list
101991579|NCT05320588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101991580|NCT05320588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101991581|NCT05320588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101991582|NCT05320588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991583|NCT01231529|Dolutegravir|dolutegravir|mesh-list
101991584|NCT01231529|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101991585|NCT01231529|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101991586|NCT01231529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101991587|NCT01231529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991589|NCT01231529|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101991590|NCT01231529|Antiviral Agents|antiviral agents|mesh-ancestor
101991591|NCT01231529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101991592|NCT05306704|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
101991593|NCT05306704|Calcifediol|calcifediol|mesh-list
101991595|NCT05306704|Micronutrients|micronutrients|mesh-ancestor
101991596|NCT05306704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991597|NCT05306704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101991598|NCT01231685|Ritonavir|ritonavir|mesh-list
101991599|NCT01231685|Lopinavir|lopinavir|mesh-list
101991600|NCT01231685|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101991601|NCT01231685|Darunavir|darunavir|mesh-list
101991602|NCT01231685|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
101947520|NCT03872661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101947521|NCT03872661|Growth Substances|growth substances|mesh-ancestor
101947522|NCT03872661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947523|NCT03872661|Growth Inhibitors|growth inhibitors|mesh-ancestor
101991603|NCT01231685|Raltegravir Potassium|raltegravir potassium|mesh-list
101991604|NCT01231685|Protease Inhibitors|protease inhibitors|mesh-list
101991605|NCT01231685|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101991606|NCT01231685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101991607|NCT01231685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991608|NCT01231685|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101991609|NCT01231685|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101991610|NCT01231685|Antiviral Agents|antiviral agents|mesh-ancestor
101991611|NCT01231685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101991612|NCT01231685|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101991613|NCT01231685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101991614|NCT01231685|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101991615|NCT01231685|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101991616|NCT05402735|Uric Acid|uric acid|mesh-list
101991617|NCT05402735|Antioxidants|antioxidants|mesh-ancestor
101991618|NCT05402735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991619|NCT05402735|Protective Agents|protective agents|mesh-ancestor
101991620|NCT05402735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991621|NCT01138085|Trametinib|trametinib|mesh-list
101991622|NCT01138085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101991623|NCT01138085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101991624|NCT01138085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101991625|NCT01138085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991626|NCT05278858|Triamcinolone|triamcinolone|mesh-list
101991627|NCT05278858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101991628|NCT05278858|Glucocorticoids|glucocorticoids|mesh-ancestor
101991629|NCT05278858|Hormones|hormones|mesh-ancestor
101446708|NCT00181532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101991635|NCT03792217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101991636|NCT03359811|Bupivacaine|bupivacaine|mesh-list
101991637|NCT03359811|Anesthetics, Local|anesthetics, local|mesh-list
101991638|NCT03359811|Anesthetics|anesthetics|mesh-list
101991639|NCT03359811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101991640|NCT03359811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249025|NCT01687751|Midazolam|midazolam|mesh-list
101991641|NCT03359811|Sensory System Agents|sensory system agents|mesh-ancestor
101991642|NCT03359811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101991643|NCT03728426|Letermovir|letermovir|mesh-list
101991644|NCT03728426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101991645|NCT03728426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101991646|NCT03728426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991647|NCT03728426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101991648|NCT03728426|Antiviral Agents|antiviral agents|mesh-ancestor
101991649|NCT03728426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101991650|NCT01140581|Dronedarone|dronedarone|mesh-list
101991651|NCT01140581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101991652|NCT03792139|Itraconazole|itraconazole|mesh-list
101991653|NCT03792139|Antifungal Agents|antifungal agents|mesh-ancestor
101991654|NCT03792139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101991655|NCT03792139|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101991656|NCT03792139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101991657|NCT03792139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101991658|NCT03792139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991659|NCT03792139|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101991660|NCT03792139|Hormone Antagonists|hormone antagonists|mesh-ancestor
101991661|NCT03792139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101991662|NCT03792139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991663|NCT03792139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101991664|NCT03792295|Acetaminophen|acetaminophen|mesh-list
101991665|NCT03792295|Ibuprofen|ibuprofen|mesh-list
101991666|NCT03792295|Oxycodone|oxycodone|mesh-list
101991667|NCT03792295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101991668|NCT03792295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101991669|NCT03792295|Analgesics|analgesics|mesh-ancestor
101991670|NCT03792295|Sensory System Agents|sensory system agents|mesh-ancestor
101991671|NCT03792295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101991672|NCT03792295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947524|NCT03872661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101947525|NCT03872661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991673|NCT03792295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101991674|NCT03792295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101991675|NCT03792295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101991676|NCT03792295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101991677|NCT03792295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991678|NCT03792295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101991680|NCT03792295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101991681|NCT03792295|Antipyretics|antipyretics|mesh-ancestor
101991682|NCT03449056|Albuterol|albuterol|mesh-list
101991683|NCT03449056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101991684|NCT03449056|Autonomic Agents|autonomic agents|mesh-ancestor
101991685|NCT03449056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101991686|NCT03449056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991687|NCT03449056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101991688|NCT03449056|Respiratory System Agents|respiratory system agents|mesh-ancestor
101991689|NCT03449056|Tocolytic Agents|tocolytic agents|mesh-ancestor
101991690|NCT03449056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101991691|NCT03449056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101991692|NCT03449056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101991693|NCT03449056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101991694|NCT03449056|Adrenergic Agents|adrenergic agents|mesh-ancestor
101991695|NCT03449056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101991696|NCT03449056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991697|NCT01135433|Metformin|metformin|mesh-list
101991698|NCT01135433|Ipragliflozin|ipragliflozin|mesh-list
101991705|NCT04745273|Autonomic Agents|autonomic agents|mesh-ancestor
101991706|NCT04745273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101991707|NCT04745273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991708|NCT04745273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101991709|NCT04745273|Antipruritics|antipruritics|mesh-ancestor
101991710|NCT04745273|Dermatologic Agents|dermatologic agents|mesh-ancestor
101991711|NCT04745273|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101991712|NCT04745273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101991713|NCT04745273|Serotonin Agents|serotonin agents|mesh-ancestor
101991714|NCT04745273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101991715|NCT04745273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991716|NCT01305187|Hyaluronic Acid|hyaluronic acid|mesh-list
101991717|NCT01305187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101991718|NCT01305187|Immunologic Factors|immunologic factors|mesh-ancestor
101991719|NCT01305187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991720|NCT01305187|Viscosupplements|viscosupplements|mesh-ancestor
101991721|NCT01305187|Protective Agents|protective agents|mesh-ancestor
101991722|NCT01138397|Vaccines|vaccines|mesh-list
101991723|NCT01138397|Immunologic Factors|immunologic factors|mesh-ancestor
101991724|NCT01138397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991725|NCT03448744|Entecavir|entecavir|mesh-list
101991726|NCT03448744|Thymalfasin|thymalfasin|mesh-list
101991727|NCT03448744|Antiviral Agents|antiviral agents|mesh-ancestor
101991728|NCT03448744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101991729|NCT03448744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101991730|NCT03448744|Immunologic Factors|immunologic factors|mesh-ancestor
101991731|NCT03448744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991732|NCT03448588|Selenium|selenium|mesh-list
101991733|NCT03448588|Antioxidants|antioxidants|mesh-ancestor
101991734|NCT03448588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991735|NCT03448588|Protective Agents|protective agents|mesh-ancestor
101991736|NCT03448588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711567|NCT00692510|Midazolam|midazolam|mesh-list
101991737|NCT03448588|Trace Elements|trace elements|mesh-ancestor
101991738|NCT03448588|Micronutrients|micronutrients|mesh-ancestor
101991739|NCT03797443|Ascorbic Acid|ascorbic acid|mesh-list
101991740|NCT03797443|Paclitaxel|paclitaxel|mesh-list
101991741|NCT03797443|Gemcitabine|gemcitabine|mesh-list
101991742|NCT03797443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101991743|NCT03797443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101991744|NCT03797443|Tubulin Modulators|tubulin modulators|mesh-ancestor
101991745|NCT03797443|Antimitotic Agents|antimitotic agents|mesh-ancestor
101991746|NCT03797443|Mitosis Modulators|mitosis modulators|mesh-ancestor
101991747|NCT03797443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991748|NCT03797443|Vitamins|vitamins|mesh-ancestor
101991749|NCT03797443|Micronutrients|micronutrients|mesh-ancestor
101947526|NCT03872661|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101947527|NCT03872661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101947528|NCT01167699|Oxycodone|oxycodone|mesh-list
101991750|NCT03797443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991751|NCT03797443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101991752|NCT03797443|Antimetabolites|antimetabolites|mesh-ancestor
101991753|NCT03797443|Antioxidants|antioxidants|mesh-ancestor
101991754|NCT03797443|Protective Agents|protective agents|mesh-ancestor
101991755|NCT01135589|Micafungin|micafungin|mesh-list
101991756|NCT01135589|Antifungal Agents|antifungal agents|mesh-ancestor
101991757|NCT01135589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101991758|NCT01915810|Nicotine|nicotine|mesh-list
101991759|NCT01915810|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101991760|NCT01915810|Autonomic Agents|autonomic agents|mesh-ancestor
101991761|NCT01915810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101991762|NCT01915810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991763|NCT01915810|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101991764|NCT01915810|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101991765|NCT01915810|Cholinergic Agents|cholinergic agents|mesh-ancestor
101991766|NCT01915810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101991767|NCT01915810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991768|NCT01140737|Axitinib|axitinib|mesh-list
101991774|NCT05594095|Fulvestrant|fulvestrant|mesh-list
101991776|NCT05594095|Fluzoparib|fluzoparib|mesh-list
101991777|NCT05594095|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101991778|NCT05594095|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101991779|NCT05594095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101991780|NCT05594095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101991781|NCT05594095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991782|NCT05594095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101991783|NCT05594095|Immunologic Factors|immunologic factors|mesh-ancestor
101991784|NCT05594095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991785|NCT05594095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101991786|NCT05594095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101991787|NCT05594095|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101991788|NCT05594095|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101991789|NCT05594095|Hormone Antagonists|hormone antagonists|mesh-ancestor
101387626|NCT00122343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101991790|NCT05594095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101991791|NCT05594095|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101991792|NCT05594095|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101991793|NCT04951063|Immunomodulating Agents|immunomodulating agents|mesh-list
101991794|NCT04951063|Immunologic Factors|immunologic factors|mesh-ancestor
101991795|NCT04951063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991796|NCT05624671|Fentanyl|fentanyl|mesh-list
101991797|NCT05624671|Bupivacaine|bupivacaine|mesh-list
101991798|NCT05624671|Anesthetics, Local|anesthetics, local|mesh-ancestor
101991799|NCT05624671|Anesthetics|anesthetics|mesh-ancestor
101991800|NCT05624671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101991801|NCT05624671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991802|NCT05624671|Sensory System Agents|sensory system agents|mesh-ancestor
101991803|NCT05624671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101991804|NCT05624671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101991805|NCT05624671|Narcotics|narcotics|mesh-ancestor
101991806|NCT05624671|Analgesics|analgesics|mesh-ancestor
101991807|NCT05624671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101991808|NCT05624671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101711632|NCT00818883|Diuretics|diuretics|mesh-ancestor
101991809|NCT05624671|Anesthetics, General|anesthetics, general|mesh-ancestor
101991810|NCT03578965|Cefazolin|cefazolin|mesh-list
101991811|NCT03578965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101991812|NCT03578965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101991813|NCT03791905|Leucovorin|leucovorin|mesh-list
101991815|NCT03791905|Fluorouracil|fluorouracil|mesh-list
101991816|NCT03791905|Oxaliplatin|oxaliplatin|mesh-list
101991817|NCT03791905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101991818|NCT03791905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101991819|NCT03791905|Tubulin Modulators|tubulin modulators|mesh-ancestor
101991820|NCT03791905|Antimitotic Agents|antimitotic agents|mesh-ancestor
101991821|NCT03791905|Mitosis Modulators|mitosis modulators|mesh-ancestor
101991822|NCT03791905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991823|NCT03791905|Antimetabolites|antimetabolites|mesh-ancestor
101991824|NCT03791905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101991825|NCT03791905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101991826|NCT03791905|Immunologic Factors|immunologic factors|mesh-ancestor
101947529|NCT01167699|Naloxone|naloxone|mesh-list
101947530|NCT01167699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101947531|NCT01167699|Narcotics|narcotics|mesh-ancestor
101818151|NCT00806741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101991827|NCT03791905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991828|NCT03791905|Antidotes|antidotes|mesh-ancestor
101991829|NCT03791905|Protective Agents|protective agents|mesh-ancestor
101991830|NCT03791905|Vitamin B Complex|vitamin b complex|mesh-ancestor
101991831|NCT03791905|Vitamins|vitamins|mesh-ancestor
101991832|NCT03791905|Micronutrients|micronutrients|mesh-ancestor
101991833|NCT01138553|Mifepristone|mifepristone|mesh-list
101991834|NCT01138553|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101991835|NCT01138553|Abortifacient Agents|abortifacient agents|mesh-ancestor
101991836|NCT01138553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101991837|NCT01138553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991838|NCT01138553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101991839|NCT01138553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101991849|NCT05171374|Trametinib|trametinib|mesh-list
101991850|NCT05171374|Dabrafenib|dabrafenib|mesh-list
101991851|NCT05171374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101991852|NCT05171374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101991853|NCT05171374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101991854|NCT05171374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991855|NCT03447184|Androgens|androgens|mesh-list
101991856|NCT03447184|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101991857|NCT03447184|Hormones|hormones|mesh-ancestor
101991858|NCT03447184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101991859|NCT03447184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991860|NCT03447184|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101991861|NCT03447184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101991862|NCT03447184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991863|NCT03447184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101991864|NCT03447184|Hormone Antagonists|hormone antagonists|mesh-ancestor
101991865|NCT03739541|Benzonidazole|benzonidazole|mesh-list
101991866|NCT03739541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101991867|NCT03739541|Immunologic Factors|immunologic factors|mesh-ancestor
101991868|NCT03739541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991869|NCT03739541|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101991870|NCT03739541|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101991871|NCT03739541|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101991872|NCT03739541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101991873|NCT01135667|Clopidogrel|clopidogrel|mesh-list
101991874|NCT01135667|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101991875|NCT01135667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101991876|NCT01135667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101991877|NCT01135667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101991878|NCT01135667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101991879|NCT01135667|Purinergic Agents|purinergic agents|mesh-ancestor
101991880|NCT01135667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101991881|NCT01135667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991882|NCT01135667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991883|NCT03446872|Leucovorin|leucovorin|mesh-list
101991884|NCT03446872|Fluorouracil|fluorouracil|mesh-list
101575006|NCT01179516|Antidepressive Agents|antidepressive agents|mesh-ancestor
101991885|NCT03446872|Antimetabolites|antimetabolites|mesh-ancestor
101991886|NCT03446872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991887|NCT03446872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101991888|NCT03446872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101991889|NCT03446872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101991890|NCT03446872|Immunologic Factors|immunologic factors|mesh-ancestor
101991891|NCT03446872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991892|NCT03446872|Antidotes|antidotes|mesh-ancestor
101991893|NCT03446872|Protective Agents|protective agents|mesh-ancestor
101991894|NCT03446872|Vitamin B Complex|vitamin b complex|mesh-ancestor
101991895|NCT03446872|Vitamins|vitamins|mesh-ancestor
101991896|NCT03446872|Micronutrients|micronutrients|mesh-ancestor
101991897|NCT03446638|Cytarabine|cytarabine|mesh-list
101991898|NCT03446638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101991899|NCT03446638|Antimetabolites|antimetabolites|mesh-ancestor
101991900|NCT03446638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991901|NCT03446638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101991902|NCT03446638|Antiviral Agents|antiviral agents|mesh-ancestor
101991914|NCT05401019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101947532|NCT01167699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101947533|NCT01167699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947534|NCT01167699|Analgesics|analgesics|mesh-ancestor
101991915|NCT05401019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101991916|NCT05401019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101991917|NCT05401019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101991918|NCT05401019|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101991919|NCT05401019|Dopamine Agents|dopamine agents|mesh-ancestor
101991920|NCT05401019|Antioxidants|antioxidants|mesh-ancestor
101991921|NCT05401019|Protective Agents|protective agents|mesh-ancestor
101991922|NCT05401019|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101991923|NCT05401019|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101991924|NCT05401019|Dopamine Agonists|dopamine agonists|mesh-ancestor
101991925|NCT03788863|Diflucortolone|diflucortolone|mesh-list
101991926|NCT03788863|Diflucortolone valerate|diflucortolone valerate|mesh-list
101991927|NCT03788863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101991928|NCT03788863|Glucocorticoids|glucocorticoids|mesh-ancestor
101991930|NCT03788863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101991931|NCT03788863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991932|NCT04659161|Xanomeline|xanomeline|mesh-list
101991933|NCT04659161|Trospium chloride|trospium chloride|mesh-list
101991934|NCT04659161|Parasympatholytics|parasympatholytics|mesh-ancestor
101991935|NCT04659161|Autonomic Agents|autonomic agents|mesh-ancestor
101991936|NCT04659161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101991937|NCT04659161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991938|NCT04659161|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101991939|NCT04659161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101249306|NCT01690832|Fenoldopam|fenoldopam|mesh-list
101991940|NCT04659161|Cholinergic Agents|cholinergic agents|mesh-ancestor
101991941|NCT04659161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101991942|NCT04659161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991943|NCT04659161|Urological Agents|urological agents|mesh-ancestor
101991944|NCT04659161|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101991945|NCT04659161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101991946|NCT04659161|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101991947|NCT04659161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101991948|NCT03129256|Apatinib|apatinib|mesh-list
101991949|NCT03129256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101991950|NCT03129256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101991951|NCT03129256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101991952|NCT03129256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991953|NCT05682807|Caffeine|caffeine|mesh-list
101991954|NCT05682807|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101991955|NCT05682807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991956|NCT05682807|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101991957|NCT05682807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101991958|NCT05682807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991959|NCT05682807|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101575007|NCT01179516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101991960|NCT05682807|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101991961|NCT05682807|Purinergic Agents|purinergic agents|mesh-ancestor
101991962|NCT05682807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101991963|NCT03445780|Ethyl Chloride|ethyl chloride|mesh-list
101991964|NCT03445780|Anesthetics, Local|anesthetics, local|mesh-ancestor
101991965|NCT03445780|Anesthetics|anesthetics|mesh-ancestor
101991973|NCT05364099|Anesthetics|anesthetics|mesh-ancestor
101991974|NCT05364099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101991975|NCT05364099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991976|NCT05364099|Sensory System Agents|sensory system agents|mesh-ancestor
101991977|NCT05364099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101991978|NCT05364099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101991979|NCT05364099|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101991980|NCT05364099|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101991981|NCT05364099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101991982|NCT05364099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991983|NCT05364099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101991984|NCT05364099|Glucocorticoids|glucocorticoids|mesh-ancestor
101991985|NCT05364099|Hormones|hormones|mesh-ancestor
101991986|NCT05364099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101991987|NCT03445702|Metformin|metformin|mesh-list
101991988|NCT03445702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101991989|NCT03445702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947535|NCT01167699|Sensory System Agents|sensory system agents|mesh-ancestor
101947536|NCT01167699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101947537|NCT01167699|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101947538|NCT02526303|Nadroparin|nadroparin|mesh-list
101947539|NCT02526303|Warfarin|warfarin|mesh-list
101947540|NCT02526303|Calcium|calcium|mesh-list
101991990|NCT03445624|Infliximab|infliximab|mesh-list
101991991|NCT03445624|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101991992|NCT03445624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101991993|NCT03445624|Dermatologic Agents|dermatologic agents|mesh-ancestor
101991994|NCT03445624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101991995|NCT03445624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101991996|NCT01312077|Morphine|morphine|mesh-list
101991997|NCT01312077|Levobupivacaine|levobupivacaine|mesh-list
101991998|NCT01312077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101991999|NCT01312077|Narcotics|narcotics|mesh-ancestor
101249370|NCT01691404|Quercetin|quercetin|mesh-list
101992000|NCT01312077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101992001|NCT01312077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992002|NCT01312077|Analgesics|analgesics|mesh-ancestor
101992003|NCT01312077|Sensory System Agents|sensory system agents|mesh-ancestor
101992004|NCT01312077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101992005|NCT01312077|Anesthetics, Local|anesthetics, local|mesh-ancestor
101992006|NCT01312077|Anesthetics|anesthetics|mesh-ancestor
101992007|NCT03793309|Vitamin D|vitamin d|mesh-list
101992008|NCT03793309|Ergocalciferols|ergocalciferols|mesh-list
101992009|NCT03793309|Cholecalciferol|cholecalciferol|mesh-list
101992010|NCT03793309|Vitamins|vitamins|mesh-list
101992011|NCT03793309|Micronutrients|micronutrients|mesh-ancestor
101992012|NCT03793309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992013|NCT03793309|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101992014|NCT03793309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101992015|NCT01140893|Exenatide|exenatide|mesh-list
101992016|NCT01140893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101992017|NCT01140893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992018|NCT01140893|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101992019|NCT01140893|Incretins|incretins|mesh-ancestor
101992020|NCT01140893|Hormones|hormones|mesh-ancestor
101992021|NCT01140893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101992022|NCT03445468|Vaccines|vaccines|mesh-list
101992023|NCT03445468|Immunologic Factors|immunologic factors|mesh-ancestor
101992024|NCT03445468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992025|NCT03791827|Cyclosporine|cyclosporine|mesh-list
101992026|NCT03791827|Mycophenolic Acid|mycophenolic acid|mesh-list
101992027|NCT03791827|Hydroxychloroquine|hydroxychloroquine|mesh-list
101992028|NCT03791827|Prednisone|prednisone|mesh-list
101992029|NCT03791827|Prednisolone|prednisolone|mesh-list
101992030|NCT03791827|Cyclophosphamide|cyclophosphamide|mesh-list
101992031|NCT03791827|Rituximab|rituximab|mesh-list
101992032|NCT03791827|Azathioprine|azathioprine|mesh-list
101992033|NCT03791827|Tacrolimus|tacrolimus|mesh-list
101992034|NCT03791827|Cyclosporins|cyclosporins|mesh-list
101992035|NCT03791827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101575008|NCT01179516|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101992039|NCT03791827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101992040|NCT03791827|Alkylating Agents|alkylating agents|mesh-ancestor
101992041|NCT03791827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992042|NCT03791827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101992043|NCT03791827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101992044|NCT03791827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101992045|NCT03791827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101992047|NCT03791827|Hormones|hormones|mesh-ancestor
101992048|NCT03791827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101992049|NCT03791827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101992050|NCT03791827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101992051|NCT03791827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101992052|NCT03791827|Antifungal Agents|antifungal agents|mesh-ancestor
101992053|NCT03791827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101992054|NCT03791827|Dermatologic Agents|dermatologic agents|mesh-ancestor
101992055|NCT03791827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101992056|NCT03791827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101992057|NCT03791827|Antitubercular Agents|antitubercular agents|mesh-ancestor
101992058|NCT03791827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101992059|NCT03791827|Antimalarials|antimalarials|mesh-ancestor
101992060|NCT03791827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101947541|NCT02526303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101947542|NCT02526303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947544|NCT02526303|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101947545|NCT02526303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101992061|NCT03791827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101992062|NCT03791827|Antimetabolites|antimetabolites|mesh-ancestor
101992063|NCT03791827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101992064|NCT03708861|Ritonavir|ritonavir|mesh-list
101992065|NCT03708861|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101992066|NCT03708861|Maraviroc|maraviroc|mesh-list
101992067|NCT03708861|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101992068|NCT03708861|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101992069|NCT03708861|Protease Inhibitors|protease inhibitors|mesh-ancestor
101992070|NCT03708861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101992071|NCT03708861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992072|NCT03708861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101249423|NCT01691677|Hormones|hormones|mesh-ancestor
101992073|NCT03708861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101992074|NCT03708861|Antiviral Agents|antiviral agents|mesh-ancestor
101992075|NCT03708861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101992076|NCT03708861|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101992077|NCT03708861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101992078|NCT03708861|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101992079|NCT03708861|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101992080|NCT03708861|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101992081|NCT04798755|Adalimumab|adalimumab|mesh-list
101992082|NCT04798755|Methotrexate|methotrexate|mesh-list
101992083|NCT04798755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101992084|NCT04798755|Abortifacient Agents|abortifacient agents|mesh-ancestor
101992085|NCT04798755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101992086|NCT04798755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992087|NCT04798755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101992088|NCT04798755|Antimetabolites|antimetabolites|mesh-ancestor
101992089|NCT04798755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992090|NCT04798755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101992091|NCT04798755|Dermatologic Agents|dermatologic agents|mesh-ancestor
101992092|NCT04798755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101992093|NCT04798755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101992094|NCT04798755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101992095|NCT04798755|Immunologic Factors|immunologic factors|mesh-ancestor
101992096|NCT04798755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101992097|NCT04798755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101992098|NCT04798755|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101992099|NCT04798755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101992100|NCT01308229|Paclitaxel|paclitaxel|mesh-list
101992101|NCT01308229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101992102|NCT01308229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101992103|NCT01308229|Tubulin Modulators|tubulin modulators|mesh-ancestor
101992104|NCT01308229|Antimitotic Agents|antimitotic agents|mesh-ancestor
101992105|NCT01308229|Mitosis Modulators|mitosis modulators|mesh-ancestor
101447166|NCT00216645|Doxorubicin|doxorubicin|mesh-list
101992110|NCT03445078|Protective Agents|protective agents|mesh-ancestor
101992111|NCT03445078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992112|NCT03445078|Trace Elements|trace elements|mesh-ancestor
101992113|NCT03445078|Micronutrients|micronutrients|mesh-ancestor
101992114|NCT01233791|Diazepam|diazepam|mesh-list
101992116|NCT01233791|Anticonvulsants|anticonvulsants|mesh-ancestor
101992117|NCT01233791|Antiemetics|antiemetics|mesh-ancestor
101992118|NCT01233791|Autonomic Agents|autonomic agents|mesh-ancestor
101992119|NCT01233791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101992120|NCT01233791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992121|NCT01233791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101992122|NCT01233791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101992123|NCT01233791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101992124|NCT01233791|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101992125|NCT01233791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101992126|NCT01233791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101992127|NCT01233791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101992128|NCT01233791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101992129|NCT01233791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101992130|NCT01233791|Anesthetics, General|anesthetics, general|mesh-ancestor
101947546|NCT02526303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947548|NCT03869073|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101818441|NCT00569777|Ketotifen|ketotifen|mesh-list
101992131|NCT01233791|Anesthetics|anesthetics|mesh-ancestor
101992132|NCT01233791|GABA Modulators|gaba modulators|mesh-ancestor
101992133|NCT01233791|GABA Agents|gaba agents|mesh-ancestor
101992134|NCT01233791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101992135|NCT01233791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992136|NCT01140971|Misoprostol|misoprostol|mesh-list
101992137|NCT01140971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101992138|NCT01140971|Abortifacient Agents|abortifacient agents|mesh-ancestor
101992139|NCT01140971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101992140|NCT01140971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992141|NCT01140971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101992142|NCT01140971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101992143|NCT01140971|Oxytocics|oxytocics|mesh-ancestor
101992144|NCT01306357|Hormones|hormones|mesh-list
101992145|NCT01306357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101992146|NCT01306357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992147|NCT03129022|Anesthetics|anesthetics|mesh-list
101992148|NCT03129022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101992149|NCT03129022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992150|NCT03342963|Aripiprazole|aripiprazole|mesh-list
101992151|NCT03342963|Sertraline|sertraline|mesh-list
101992152|NCT03342963|Antidepressive Agents|antidepressive agents|mesh-ancestor
101992153|NCT03342963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101992154|NCT03342963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101992155|NCT03342963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101992156|NCT03342963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101992157|NCT03342963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992158|NCT03342963|Dopamine Agonists|dopamine agonists|mesh-ancestor
101992159|NCT03342963|Dopamine Agents|dopamine agents|mesh-ancestor
101992160|NCT03342963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101992161|NCT03342963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992162|NCT03342963|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101992163|NCT03342963|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101992164|NCT03342963|Serotonin Agents|serotonin agents|mesh-ancestor
101992165|NCT03342963|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101992166|NCT03342963|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101992167|NCT03342963|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101992168|NCT03342963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101992169|NCT03342963|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101992170|NCT03342963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101992171|NCT03342963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101992172|NCT03706755|Norepinephrine|norepinephrine|mesh-list
101992173|NCT03706755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101992174|NCT03706755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101992175|NCT03706755|Adrenergic Agents|adrenergic agents|mesh-ancestor
101992176|NCT03706755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101992182|NCT03706755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101992183|NCT03791515|Calcitonin|calcitonin|mesh-list
101992184|NCT03791515|Salmon calcitonin|salmon calcitonin|mesh-list
101992185|NCT03791515|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
101992186|NCT03791515|Katacalcin|katacalcin|mesh-list
101992187|NCT03791515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101711995|NCT00810069|Escitalopram|escitalopram|mesh-list
101992188|NCT03791515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992189|NCT03791515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101992190|NCT03791515|Vasodilator Agents|vasodilator agents|mesh-ancestor
101992192|NCT03361956|Antiviral Agents|antiviral agents|mesh-ancestor
101992193|NCT03361956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101992194|NCT04595591|Remifentanil|remifentanil|mesh-list
101992195|NCT04595591|Rocuronium|rocuronium|mesh-list
101992196|NCT04595591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101992197|NCT04595591|Narcotics|narcotics|mesh-ancestor
101992198|NCT04595591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101992199|NCT04595591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992200|NCT04595591|Analgesics|analgesics|mesh-ancestor
101992201|NCT04595591|Sensory System Agents|sensory system agents|mesh-ancestor
101992202|NCT04595591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101947549|NCT03869073|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101947550|NCT03869073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101947551|NCT03869073|Antimetabolites|antimetabolites|mesh-ancestor
101992203|NCT04595591|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101992204|NCT04595591|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101992205|NCT04595591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101992206|NCT03709953|Apatinib|apatinib|mesh-list
101992207|NCT03709953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101992208|NCT03709953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101992209|NCT03709953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101992210|NCT03709953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992211|NCT03444142|Exenatide|exenatide|mesh-list
101992212|NCT03444142|Dulaglutide|dulaglutide|mesh-list
101992213|NCT03444142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101992214|NCT03444142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992215|NCT03444142|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101992216|NCT03444142|Incretins|incretins|mesh-ancestor
101992217|NCT03444142|Hormones|hormones|mesh-ancestor
101992218|NCT03444142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101992219|NCT01305733|Ketorolac|ketorolac|mesh-list
101992220|NCT01305733|Epinephrine|epinephrine|mesh-list
101992221|NCT01305733|Racepinephrine|racepinephrine|mesh-list
101992222|NCT01305733|Levobupivacaine|levobupivacaine|mesh-list
101992223|NCT01305733|Epinephryl borate|epinephryl borate|mesh-list
101992224|NCT01305733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101992225|NCT01305733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101992226|NCT01305733|Analgesics|analgesics|mesh-ancestor
101992227|NCT01305733|Sensory System Agents|sensory system agents|mesh-ancestor
101992228|NCT01305733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101992229|NCT01305733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992230|NCT01305733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101992231|NCT01305733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101992232|NCT01305733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101992233|NCT01305733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101992234|NCT01305733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992235|NCT01305733|Anesthetics, Local|anesthetics, local|mesh-ancestor
101992236|NCT01305733|Anesthetics|anesthetics|mesh-ancestor
101992237|NCT01305733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101992238|NCT01305733|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101992239|NCT01305733|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101992240|NCT01305733|Adrenergic Agents|adrenergic agents|mesh-ancestor
101992241|NCT01305733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101992242|NCT01305733|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101992243|NCT01305733|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101992244|NCT01305733|Autonomic Agents|autonomic agents|mesh-ancestor
101992245|NCT01305733|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101992246|NCT01305733|Respiratory System Agents|respiratory system agents|mesh-ancestor
101992247|NCT01305733|Mydriatics|mydriatics|mesh-ancestor
101992249|NCT01305733|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101992251|NCT05210153|Antidepressive Agents|antidepressive agents|mesh-ancestor
101992252|NCT05210153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101992253|NCT05210153|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101992254|NCT05210153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101992255|NCT05210153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101992256|NCT05210153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992257|NCT05210153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101992258|NCT05210153|Serotonin Agents|serotonin agents|mesh-ancestor
101992259|NCT05210153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992260|NCT04749459|Sunscreening Agents|sunscreening agents|mesh-list
101992261|NCT04749459|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101992262|NCT04749459|Protective Agents|protective agents|mesh-ancestor
101712068|NCT00489541|Paclitaxel|paclitaxel|mesh-list
101992263|NCT04749459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992264|NCT04749459|Dermatologic Agents|dermatologic agents|mesh-ancestor
101992265|NCT04585295|Betaine|betaine|mesh-list
101992266|NCT04585295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101992267|NCT04585295|Lipotropic Agents|lipotropic agents|mesh-ancestor
101992268|NCT04585295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101992269|NCT04585295|Antimetabolites|antimetabolites|mesh-ancestor
101992270|NCT04585295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992271|NCT04585295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101992272|NCT01136213|Fluoxetine|fluoxetine|mesh-list
101992273|NCT01136213|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101947552|NCT03869073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992274|NCT01136213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101992275|NCT01136213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101992276|NCT01136213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992277|NCT01136213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101992278|NCT01136213|Serotonin Agents|serotonin agents|mesh-ancestor
101992279|NCT01136213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992280|NCT01136213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101992281|NCT01136213|Antidepressive Agents|antidepressive agents|mesh-ancestor
101992282|NCT01136213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101992283|NCT01136213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101992284|NCT01136213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101992285|NCT01136213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101992286|NCT03361176|Triamcinolone|triamcinolone|mesh-list
101992287|NCT03361176|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101992288|NCT03361176|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101992289|NCT03361176|Deoxycholic Acid|deoxycholic acid|mesh-list
101992290|NCT03361176|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101992291|NCT03361176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101992292|NCT03361176|Glucocorticoids|glucocorticoids|mesh-ancestor
101992293|NCT03361176|Hormones|hormones|mesh-ancestor
101992294|NCT03361176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101992295|NCT03361176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992296|NCT03361176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101992297|NCT03361176|Immunologic Factors|immunologic factors|mesh-ancestor
101992298|NCT03361176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101992299|NCT03361176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992300|NCT03361176|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101992301|NCT03361176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101992302|NCT03438214|Vancomycin|vancomycin|mesh-list
101992303|NCT03438214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101992304|NCT03438214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101992305|NCT01141127|Tranexamic Acid|tranexamic acid|mesh-list
101992306|NCT01141127|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101992307|NCT01141127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101992308|NCT01141127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992309|NCT01141127|Hemostatics|hemostatics|mesh-ancestor
101992310|NCT01141127|Coagulants|coagulants|mesh-ancestor
101992311|NCT03708822|Docetaxel|docetaxel|mesh-list
101992312|NCT03708822|Nimotuzumab|nimotuzumab|mesh-list
101992313|NCT03708822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101992314|NCT03708822|Tubulin Modulators|tubulin modulators|mesh-ancestor
101992315|NCT03708822|Antimitotic Agents|antimitotic agents|mesh-ancestor
101992316|NCT03708822|Mitosis Modulators|mitosis modulators|mesh-ancestor
101992317|NCT03708822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992318|NCT03708822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101992319|NCT05280444|Idarubicin|idarubicin|mesh-list
101992323|NCT05280444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101992324|NCT05280444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101992325|NCT05280444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992326|NCT01308541|Propofol|propofol|mesh-list
101992327|NCT01308541|Fospropofol|fospropofol|mesh-list
101992328|NCT01308541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101992329|NCT01308541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101992330|NCT01308541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992331|NCT01308541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101992332|NCT01308541|Anesthetics, General|anesthetics, general|mesh-ancestor
101992333|NCT01308541|Anesthetics|anesthetics|mesh-ancestor
101992334|NCT05679765|Dexamethasone|dexamethasone|mesh-list
101992335|NCT05679765|Dexamethasone acetate|dexamethasone acetate|mesh-list
101992336|NCT05679765|Lidocaine|lidocaine|mesh-list
101992337|NCT05679765|BB 1101|bb 1101|mesh-list
101992338|NCT05679765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101992340|NCT05679765|Autonomic Agents|autonomic agents|mesh-ancestor
101992341|NCT05679765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101992342|NCT05679765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992343|NCT05679765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101992344|NCT05679765|Glucocorticoids|glucocorticoids|mesh-ancestor
101992345|NCT05679765|Hormones|hormones|mesh-ancestor
101387627|NCT00122343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101992346|NCT05679765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101992347|NCT05679765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101992348|NCT05679765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101992349|NCT05679765|Protease Inhibitors|protease inhibitors|mesh-ancestor
101947553|NCT03869073|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101992350|NCT05679765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101992351|NCT05679765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992352|NCT05679765|Anesthetics, Local|anesthetics, local|mesh-ancestor
101992354|NCT05679765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101992355|NCT05679765|Sensory System Agents|sensory system agents|mesh-ancestor
101992356|NCT05679765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101992357|NCT05679765|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101992358|NCT05679765|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101992359|NCT05679765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101992360|NCT03437980|Propofol|propofol|mesh-list
101992361|NCT03437980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101992362|NCT03437980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101992363|NCT03437980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992364|NCT03437980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101992365|NCT03437980|Anesthetics, General|anesthetics, general|mesh-ancestor
101992366|NCT03437980|Anesthetics|anesthetics|mesh-ancestor
101992367|NCT05176119|Ketamine|ketamine|mesh-list
101992368|NCT05176119|Nalbuphine|nalbuphine|mesh-list
101992369|NCT05176119|Analgesics|analgesics|mesh-ancestor
101992370|NCT05176119|Sensory System Agents|sensory system agents|mesh-ancestor
101992371|NCT05176119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101992372|NCT05176119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992373|NCT05176119|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101992374|NCT05176119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101992375|NCT05176119|Anesthetics, General|anesthetics, general|mesh-ancestor
101992376|NCT05176119|Anesthetics|anesthetics|mesh-ancestor
101992377|NCT05176119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101992378|NCT05176119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101992379|NCT05176119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101992380|NCT05176119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101992381|NCT05176119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992382|NCT05176119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101992383|NCT05176119|Narcotics|narcotics|mesh-ancestor
101992384|NCT03437902|Vitamins|vitamins|mesh-list
101992385|NCT03437902|Ascorbic Acid|ascorbic acid|mesh-list
101992386|NCT03437902|Micronutrients|micronutrients|mesh-ancestor
101992387|NCT03437902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992388|NCT03437902|Antioxidants|antioxidants|mesh-ancestor
101992389|NCT03437902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992390|NCT03437902|Protective Agents|protective agents|mesh-ancestor
101992391|NCT05283499|Analgesics, Opioid|analgesics, opioid|mesh-list
101992392|NCT05283499|Analgesics|analgesics|mesh-list
101447451|NCT00216879|Hormones|hormones|mesh-ancestor
101992396|NCT05283499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992398|NCT05283499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101992399|NCT03437824|Vitamin B 12|vitamin b 12|mesh-list
101992400|NCT03437824|Hydroxocobalamin|hydroxocobalamin|mesh-list
101992401|NCT03437824|Vitamins|vitamins|mesh-ancestor
101992402|NCT03437824|Micronutrients|micronutrients|mesh-ancestor
101992403|NCT03437824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992404|NCT03437824|Vitamin B Complex|vitamin b complex|mesh-ancestor
101992405|NCT03437824|Hematinics|hematinics|mesh-ancestor
101992406|NCT03437590|JNJ-55308942|jnj-55308942|mesh-list
101992407|NCT03437590|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
101992408|NCT03437590|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101992409|NCT03437590|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101992410|NCT03437590|Purinergic Agents|purinergic agents|mesh-ancestor
101992411|NCT03437590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101992412|NCT03437590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992413|NCT03437590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992414|NCT01136525|Valacyclovir|valacyclovir|mesh-list
101992415|NCT01136525|Antiviral Agents|antiviral agents|mesh-ancestor
101992416|NCT01136525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101992417|NCT05632445|Apixaban|apixaban|mesh-list
101992418|NCT05632445|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101992419|NCT05632445|Antithrombins|antithrombins|mesh-ancestor
101992420|NCT05632445|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101992421|NCT05632445|Protease Inhibitors|protease inhibitors|mesh-ancestor
101992422|NCT05632445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101992423|NCT05632445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992424|NCT05632445|Anticoagulants|anticoagulants|mesh-ancestor
101947554|NCT03869073|Protease Inhibitors|protease inhibitors|mesh-ancestor
101947555|NCT03869073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101947556|NCT03869073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101992439|NCT01235117|Azacitidine|azacitidine|mesh-list
101992440|NCT01235117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101992441|NCT01235117|Antimetabolites|antimetabolites|mesh-ancestor
101992442|NCT01235117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992443|NCT01235117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101992444|NCT01235117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101992445|NCT01306591|Bevacizumab|bevacizumab|mesh-list
101992446|NCT01306591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101992447|NCT01306591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101992448|NCT01306591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101992449|NCT01306591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101992450|NCT01306591|Growth Substances|growth substances|mesh-ancestor
101992451|NCT01306591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992452|NCT01306591|Growth Inhibitors|growth inhibitors|mesh-ancestor
101992453|NCT03098030|Irinotecan|irinotecan|mesh-list
101992454|NCT03098030|Topotecan|topotecan|mesh-list
101992455|NCT03098030|Dinutuximab|dinutuximab|mesh-list
101992456|NCT03098030|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101992457|NCT03098030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101992458|NCT03098030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101992459|NCT03098030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992460|NCT03098030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101992461|NCT01233947|Fulvestrant|fulvestrant|mesh-list
101992462|NCT01233947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101992463|NCT01233947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101992466|NCT01233947|Hormone Antagonists|hormone antagonists|mesh-ancestor
101992467|NCT01233947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101992468|NCT01233947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992469|NCT01139645|Esomeprazole|esomeprazole|mesh-list
101992470|NCT01139645|Rabeprazole|rabeprazole|mesh-list
101992471|NCT01139645|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101992472|NCT01139645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101992473|NCT01139645|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101992474|NCT01139645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101992475|NCT01139645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992476|NCT03706287|Cisplatin|cisplatin|mesh-list
101992477|NCT03706287|Carboplatin|carboplatin|mesh-list
101992478|NCT03706287|Pemetrexed|pemetrexed|mesh-list
101992479|NCT03706287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101992480|NCT03706287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101992481|NCT03706287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992482|NCT03706287|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101992483|NCT03706287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101992484|NCT05115201|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101992485|NCT05115201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101992486|NCT05107193|Afatinib|afatinib|mesh-list
101575009|NCT01179516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101992487|NCT05107193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101992488|NCT05107193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101992489|NCT05107193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101992490|NCT05107193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992491|NCT03788395|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101992492|NCT03788395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101992493|NCT03788395|Respiratory System Agents|respiratory system agents|mesh-ancestor
101947558|NCT01587495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101947559|NCT01587495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101947560|NCT01170351|Cyclosporine|cyclosporine|mesh-list
101947561|NCT01170351|Cyclosporins|cyclosporins|mesh-list
101947562|NCT01170351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101947563|NCT01170351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992495|NCT02522650|Triamterene|triamterene|mesh-list
101992496|NCT02522650|Diuretics|diuretics|mesh-ancestor
101992497|NCT02522650|Natriuretic Agents|natriuretic agents|mesh-ancestor
101992498|NCT02522650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992499|NCT02522650|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
101992500|NCT02522650|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101992501|NCT02522650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101992502|NCT02522650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992503|NCT02522650|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101992504|NCT02522650|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101992505|NCT05681871|Folic Acid|folic acid|mesh-list
101992506|NCT05681871|Ferrous fumarate|ferrous fumarate|mesh-list
101992507|NCT05681871|Ferrous gluconate|ferrous gluconate|mesh-list
101992508|NCT05681871|Hematinics|hematinics|mesh-ancestor
101992509|NCT05681871|Vitamin B Complex|vitamin b complex|mesh-ancestor
101992510|NCT05681871|Vitamins|vitamins|mesh-ancestor
101992511|NCT05681871|Micronutrients|micronutrients|mesh-ancestor
101992512|NCT05681871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992513|NCT05681871|Trace Elements|trace elements|mesh-ancestor
101992514|NCT04455958|Ritonavir|ritonavir|mesh-list
101992515|NCT04455958|Lopinavir|lopinavir|mesh-list
101992516|NCT04455958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101992517|NCT04455958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101992518|NCT04455958|Protease Inhibitors|protease inhibitors|mesh-ancestor
101992519|NCT04455958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101992520|NCT04455958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992521|NCT04455958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101992522|NCT04455958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101992523|NCT04455958|Antiviral Agents|antiviral agents|mesh-ancestor
101992524|NCT04455958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101992525|NCT04455958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101992526|NCT04455958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101992527|NCT03791125|Salvianolic acid A|salvianolic acid a|mesh-list
101992528|NCT03791125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101992529|NCT03791125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101992530|NCT03791125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992531|NCT03791125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101992532|NCT03788317|Botulinum Toxins|botulinum toxins|mesh-list
101992533|NCT03788317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101992534|NCT03788317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101992535|NCT03788317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101992540|NCT03788317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992541|NCT03788317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101992542|NCT03788317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101992543|NCT01378858|Varenicline|varenicline|mesh-list
101992544|NCT01378858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101992545|NCT01378858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101992546|NCT01378858|Cholinergic Agents|cholinergic agents|mesh-ancestor
101992547|NCT01378858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101992548|NCT01378858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992549|NCT01378858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992550|NCT02891850|Sildenafil Citrate|sildenafil citrate|mesh-list
101992551|NCT02891850|Tadalafil|tadalafil|mesh-list
101992552|NCT02891850|Riociguat|riociguat|mesh-list
101992553|NCT02891850|Vasodilator Agents|vasodilator agents|mesh-ancestor
101992554|NCT02891850|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101992555|NCT02891850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101992556|NCT02891850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101992557|NCT02891850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992558|NCT02891850|Urological Agents|urological agents|mesh-ancestor
101992559|NCT02891850|Enzyme Activators|enzyme activators|mesh-ancestor
101992560|NCT05175027|Povidone-Iodine|povidone-iodine|mesh-list
101992561|NCT05175027|Povidone|povidone|mesh-list
101992562|NCT05175027|Plasma Substitutes|plasma substitutes|mesh-ancestor
101947564|NCT01170351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101947565|NCT01170351|Immunologic Factors|immunologic factors|mesh-ancestor
101947566|NCT01170351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947567|NCT01170351|Antifungal Agents|antifungal agents|mesh-ancestor
101818888|NCT03953989|Ranolazine|ranolazine|mesh-list
101992563|NCT05175027|Blood Substitutes|blood substitutes|mesh-ancestor
101992564|NCT05175027|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101992565|NCT05175027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101992566|NCT03707418|Heparin|heparin|mesh-list
101992567|NCT03707418|Calcium heparin|calcium heparin|mesh-list
101992568|NCT03707418|Bivalirudin|bivalirudin|mesh-list
101992569|NCT03707418|Anticoagulants|anticoagulants|mesh-ancestor
101992570|NCT03707418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101992571|NCT03707418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101992572|NCT03707418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992573|NCT03707418|Antithrombins|antithrombins|mesh-ancestor
101992574|NCT03707418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101992575|NCT03707418|Protease Inhibitors|protease inhibitors|mesh-ancestor
101992576|NCT03707418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101992577|NCT03785041|Tramadol|tramadol|mesh-list
101992578|NCT03785041|Levobupivacaine|levobupivacaine|mesh-list
101992579|NCT03785041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101992580|NCT03785041|Narcotics|narcotics|mesh-ancestor
101992581|NCT03785041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101992582|NCT03785041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992583|NCT03785041|Analgesics|analgesics|mesh-ancestor
101992584|NCT03785041|Sensory System Agents|sensory system agents|mesh-ancestor
101992585|NCT03785041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101992586|NCT03785041|Anesthetics, Local|anesthetics, local|mesh-ancestor
101992587|NCT03785041|Anesthetics|anesthetics|mesh-ancestor
101992588|NCT03710304|Misoprostol|misoprostol|mesh-list
101992589|NCT03710304|Tranexamic Acid|tranexamic acid|mesh-list
101992590|NCT03710304|Oxytocin|oxytocin|mesh-list
101992591|NCT03710304|Oxytocics|oxytocics|mesh-ancestor
101992592|NCT03710304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101992593|NCT03710304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992594|NCT03710304|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101992595|NCT03710304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101992596|NCT03710304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992597|NCT03710304|Hemostatics|hemostatics|mesh-ancestor
101992598|NCT03710304|Coagulants|coagulants|mesh-ancestor
101992599|NCT03710304|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101992600|NCT03710304|Abortifacient Agents|abortifacient agents|mesh-ancestor
101992601|NCT03710304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101992602|NCT03710304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101992603|NCT05605639|Bupivacaine|bupivacaine|mesh-list
101992604|NCT05605639|Anesthetics, Local|anesthetics, local|mesh-ancestor
101992605|NCT05605639|Anesthetics|anesthetics|mesh-ancestor
101992606|NCT05605639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101992607|NCT05605639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447662|NCT00217191|Analgesics|analgesics|mesh-ancestor
101992633|NCT04862650|Antimitotic Agents|antimitotic agents|mesh-ancestor
101992634|NCT04862650|Mitosis Modulators|mitosis modulators|mesh-ancestor
101992635|NCT04862650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992636|NCT04862650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101992637|NCT05163561|Vaccines|vaccines|mesh-list
101992638|NCT05163561|Immunologic Factors|immunologic factors|mesh-ancestor
101992639|NCT05163561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992640|NCT05681403|Cytarabine|cytarabine|mesh-list
101992642|NCT05681403|Melphalan|melphalan|mesh-list
101992643|NCT05681403|Etoposide|etoposide|mesh-list
101992644|NCT05681403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101992645|NCT05681403|Alkylating Agents|alkylating agents|mesh-ancestor
101992646|NCT05681403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992647|NCT05681403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101992648|NCT05681403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101992649|NCT05681403|Antimetabolites|antimetabolites|mesh-ancestor
101992650|NCT05681403|Antiviral Agents|antiviral agents|mesh-ancestor
101992651|NCT05681403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101992652|NCT05681403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101992653|NCT05681403|Immunologic Factors|immunologic factors|mesh-ancestor
101992654|NCT05681403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992655|NCT05681403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101947568|NCT01170351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101947569|NCT01170351|Dermatologic Agents|dermatologic agents|mesh-ancestor
101947570|NCT01170351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101249968|NCT05294744|Antidotes|antidotes|mesh-ancestor
101947571|NCT01170351|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101947572|NCT01170429|Procaterol|procaterol|mesh-list
101947573|NCT01170429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101947574|NCT01170429|Autonomic Agents|autonomic agents|mesh-ancestor
101947575|NCT01170429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101947576|NCT01170429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947577|NCT01170429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101947578|NCT01170429|Respiratory System Agents|respiratory system agents|mesh-ancestor
101947579|NCT01170429|Sympathomimetics|sympathomimetics|mesh-ancestor
101947580|NCT01170429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101947581|NCT01170429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101947582|NCT01170429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101947583|NCT01170429|Adrenergic Agents|adrenergic agents|mesh-ancestor
101947584|NCT01170429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101992656|NCT05681403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101992657|NCT05681403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101992658|NCT05681403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101992659|NCT05681403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101992660|NCT01309009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101992661|NCT01309009|MEN 11420|men 11420|mesh-list
101992676|NCT05418686|Gout Suppressants|gout suppressants|mesh-ancestor
101992677|NCT05418686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101992678|NCT05418686|Tubulin Modulators|tubulin modulators|mesh-ancestor
101992679|NCT05418686|Antimitotic Agents|antimitotic agents|mesh-ancestor
101992680|NCT05418686|Mitosis Modulators|mitosis modulators|mesh-ancestor
101992681|NCT05418686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992682|NCT05418686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101992683|NCT01306981|Ranibizumab|ranibizumab|mesh-list
101992684|NCT01306981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101992685|NCT01306981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101992686|NCT01306981|Growth Substances|growth substances|mesh-ancestor
101992687|NCT01306981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992688|NCT01306981|Growth Inhibitors|growth inhibitors|mesh-ancestor
101992689|NCT01306981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101992690|NCT05552157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101992691|NCT05552157|Immunologic Factors|immunologic factors|mesh-ancestor
101992692|NCT05552157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992693|NCT05076799|Lactulose|lactulose|mesh-list
101992694|NCT05076799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101992695|NCT03784495|Melatonin|melatonin|mesh-list
101992696|NCT03784495|Antioxidants|antioxidants|mesh-ancestor
101992697|NCT03784495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992698|NCT03784495|Protective Agents|protective agents|mesh-ancestor
101992699|NCT03784495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992700|NCT03784495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101992701|NCT04120246|Acetic Acid|acetic acid|mesh-list
101992702|NCT04120246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101992703|NCT04120246|Trastuzumab|trastuzumab|mesh-list
101992704|NCT04120246|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
101992705|NCT04120246|Antibodies|antibodies|mesh-list
101992706|NCT04120246|Immunoglobulins|immunoglobulins|mesh-list
101992707|NCT04120246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101992708|NCT04120246|Immunologic Factors|immunologic factors|mesh-ancestor
101992709|NCT04120246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992710|NCT04120246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101992711|NCT04120246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101992712|NCT04120246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101971957|NCT00315640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992713|NCT05659147|Secretin|secretin|mesh-list
101992714|NCT05659147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101992715|NCT05659147|Hormones|hormones|mesh-ancestor
101992716|NCT05659147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101992717|NCT05659147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992718|NCT05234697|Remifentanil|remifentanil|mesh-list
101992719|NCT05234697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101992720|NCT05234697|Narcotics|narcotics|mesh-ancestor
101992721|NCT05234697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101992722|NCT05234697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992723|NCT05234697|Analgesics|analgesics|mesh-ancestor
101992728|NCT03490760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101992729|NCT02133404|Cinacalcet|cinacalcet|mesh-list
101992730|NCT02133404|ASP7991|asp7991|mesh-list
101992731|NCT02133404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101992732|NCT02133404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992733|NCT02133404|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101992734|NCT02133404|Hormone Antagonists|hormone antagonists|mesh-ancestor
101992735|NCT02133404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101992736|NCT01307215|Ropivacaine|ropivacaine|mesh-list
101992737|NCT01307215|Anesthetics, Local|anesthetics, local|mesh-ancestor
101992738|NCT01307215|Anesthetics|anesthetics|mesh-ancestor
101992739|NCT01307215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101992740|NCT01307215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992741|NCT01307215|Sensory System Agents|sensory system agents|mesh-ancestor
101992742|NCT01307215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101992743|NCT05177601|Cycloserine|cycloserine|mesh-list
101992744|NCT05177601|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101992745|NCT05177601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101992746|NCT05177601|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101992747|NCT05177601|Antitubercular Agents|antitubercular agents|mesh-ancestor
101992748|NCT05177601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101992749|NCT05177601|Antimetabolites|antimetabolites|mesh-ancestor
101992750|NCT05177601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992751|NCT03420794|Analgesics|analgesics|mesh-list
101992752|NCT03420794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
101992753|NCT03420794|Sensory System Agents|sensory system agents|mesh-ancestor
101992754|NCT03420794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101992755|NCT03420794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992756|NCT01568450|Oxycodone|oxycodone|mesh-list
101992757|NCT01568450|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101992758|NCT01568450|Narcotics|narcotics|mesh-ancestor
101992759|NCT01568450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101992760|NCT01568450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992761|NCT01568450|Analgesics|analgesics|mesh-ancestor
101992762|NCT01568450|Sensory System Agents|sensory system agents|mesh-ancestor
101992763|NCT01568450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101992764|NCT05410496|Tenofovir|tenofovir|mesh-list
101992765|NCT05410496|Antiviral Agents|antiviral agents|mesh-ancestor
101992766|NCT05410496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101992767|NCT05410496|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101992768|NCT05410496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101992769|NCT05410496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101992770|NCT05410496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992771|NCT05410496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101992772|NCT05410496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101992773|NCT03784105|Codeine|codeine|mesh-list
101992774|NCT03784105|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101992775|NCT03784105|Narcotics|narcotics|mesh-ancestor
101992776|NCT03784105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101992777|NCT03784105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992778|NCT03784105|Analgesics|analgesics|mesh-ancestor
101992779|NCT03784105|Sensory System Agents|sensory system agents|mesh-ancestor
101992780|NCT03784105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101992781|NCT03784105|Antitussive Agents|antitussive agents|mesh-ancestor
101992782|NCT03784105|Respiratory System Agents|respiratory system agents|mesh-ancestor
101992783|NCT03784261|Abatacept|abatacept|mesh-list
101992784|NCT03784261|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101992785|NCT03784261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992786|NCT03784261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101992787|NCT03784261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101992788|NCT03784261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101992789|NCT03784261|Immunologic Factors|immunologic factors|mesh-ancestor
101947585|NCT01170429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947586|NCT01170507|Vitamin D|vitamin d|mesh-list
101992790|NCT03784261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712603|NCT02563288|Analgesics|analgesics|mesh-ancestor
101992791|NCT03784261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101992792|NCT02989402|Rivastigmine|rivastigmine|mesh-list
101992793|NCT02989402|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101992795|NCT02989402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992797|NCT02989402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101992798|NCT02989402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992799|NCT02989402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101992800|NCT02989402|Protective Agents|protective agents|mesh-ancestor
101992801|NCT03783949|Paclitaxel|paclitaxel|mesh-list
101992802|NCT03783949|Carboplatin|carboplatin|mesh-list
101992803|NCT03783949|Gemcitabine|gemcitabine|mesh-list
101992804|NCT03783949|Niraparib|niraparib|mesh-list
101992805|NCT03783949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101992806|NCT03783949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101992807|NCT03783949|Tubulin Modulators|tubulin modulators|mesh-ancestor
101992808|NCT03783949|Antimitotic Agents|antimitotic agents|mesh-ancestor
101992809|NCT03783949|Mitosis Modulators|mitosis modulators|mesh-ancestor
101992810|NCT03783949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992811|NCT03783949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101992812|NCT03783949|Antimetabolites|antimetabolites|mesh-ancestor
101992813|NCT03783949|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101992814|NCT03783949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101992815|NCT02861950|Bupivacaine|bupivacaine|mesh-list
101992816|NCT02861950|Ropivacaine|ropivacaine|mesh-list
101992817|NCT02861950|Anesthetics, Local|anesthetics, local|mesh-ancestor
101992818|NCT02861950|Anesthetics|anesthetics|mesh-ancestor
101992819|NCT02861950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101992820|NCT02861950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992821|NCT02861950|Sensory System Agents|sensory system agents|mesh-ancestor
101992822|NCT02861950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101992823|NCT05681247|Ezetimibe|ezetimibe|mesh-list
101992824|NCT05681247|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101992825|NCT05681247|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101992826|NCT05681247|Antimetabolites|antimetabolites|mesh-ancestor
101992827|NCT05681247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992828|NCT05681247|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101992829|NCT03787927|Aspirin|aspirin|mesh-list
101992830|NCT03787927|Clopidogrel|clopidogrel|mesh-list
101992831|NCT03787927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101992832|NCT03787927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101992833|NCT03787927|Analgesics|analgesics|mesh-ancestor
101992834|NCT03787927|Sensory System Agents|sensory system agents|mesh-ancestor
101992835|NCT03787927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101992836|NCT03787927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992837|NCT03787927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101992838|NCT03787927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101992839|NCT03787927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101992840|NCT03787927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101992841|NCT03787927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992842|NCT03787927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101992843|NCT03787927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101992844|NCT03787927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101992845|NCT03787927|Antipyretics|antipyretics|mesh-ancestor
101992846|NCT03787927|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101992847|NCT03787927|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101992848|NCT03787927|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101992849|NCT03787927|Purinergic Agents|purinergic agents|mesh-ancestor
101992850|NCT03787927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101992851|NCT00602576|Temozolomide|temozolomide|mesh-list
101992852|NCT00602576|Sorafenib|sorafenib|mesh-list
101992853|NCT00602576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101992854|NCT00602576|Alkylating Agents|alkylating agents|mesh-ancestor
101992855|NCT00602576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992856|NCT00602576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101992857|NCT00602576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101992858|NCT00602576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101992859|NCT05694871|Palbociclib|palbociclib|mesh-list
101992860|NCT05694871|Cemiplimab|cemiplimab|mesh-list
101992861|NCT05694871|Immunoglobulins|immunoglobulins|mesh-list
101992862|NCT05694871|Immunoglobulin G|immunoglobulin g|mesh-list
101947587|NCT01170507|Ergocalciferols|ergocalciferols|mesh-list
101947588|NCT01170507|Cholecalciferol|cholecalciferol|mesh-list
101992863|NCT05694871|Immunologic Factors|immunologic factors|mesh-ancestor
101992864|NCT05694871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712672|NCT00498433|Vasodilator Agents|vasodilator agents|mesh-ancestor
101992865|NCT05694871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101447914|NCT00217386|Etanercept|etanercept|mesh-list
101992871|NCT03359850|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101992872|NCT03359850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387628|NCT00122343|Antifungal Agents|antifungal agents|mesh-ancestor
101992873|NCT03359850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992874|NCT03359850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101992875|NCT01306123|Vitamin B 12|vitamin b 12|mesh-list
101992876|NCT01306123|Hydroxocobalamin|hydroxocobalamin|mesh-list
101992877|NCT01306123|Vitamins|vitamins|mesh-ancestor
101992878|NCT01306123|Micronutrients|micronutrients|mesh-ancestor
101992879|NCT01306123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992880|NCT01306123|Vitamin B Complex|vitamin b complex|mesh-ancestor
101992881|NCT01306123|Hematinics|hematinics|mesh-ancestor
101992882|NCT04803994|Bevacizumab|bevacizumab|mesh-list
101992883|NCT04803994|Atezolizumab|atezolizumab|mesh-list
101992884|NCT04803994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101992885|NCT04803994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101992886|NCT04803994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101992887|NCT04803994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101992888|NCT04803994|Growth Substances|growth substances|mesh-ancestor
101992889|NCT04803994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992890|NCT04803994|Growth Inhibitors|growth inhibitors|mesh-ancestor
101992891|NCT04803994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101992892|NCT04803994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992893|NCT03130426|Insulin|insulin|mesh-list
101992894|NCT03130426|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101992895|NCT03130426|Metformin|metformin|mesh-list
101992896|NCT03130426|Insulin Glargine|insulin glargine|mesh-list
101992897|NCT03130426|Lixisenatide|lixisenatide|mesh-list
101992898|NCT03130426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101992899|NCT03130426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992900|NCT00114140|Temozolomide|temozolomide|mesh-list
101992901|NCT00114140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101992902|NCT00114140|Alkylating Agents|alkylating agents|mesh-ancestor
101992903|NCT00114140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992904|NCT00114140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101992905|NCT03130582|Etoposide|etoposide|mesh-list
101992906|NCT03130582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101992907|NCT03130582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101992908|NCT03130582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101992909|NCT03130582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101992910|NCT03130582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101992911|NCT03130582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992912|NCT04752540|Olorofim|olorofim|mesh-list
101992913|NCT04752540|Antifungal Agents|antifungal agents|mesh-ancestor
101992914|NCT04752540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101992915|NCT04341454|Fexuprazan|fexuprazan|mesh-list
101992916|NCT04341454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101992917|NCT03712345|Vilobelimab|vilobelimab|mesh-list
101992918|NCT03712345|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101992919|NCT03712345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101992920|NCT03712345|Immunologic Factors|immunologic factors|mesh-ancestor
101992921|NCT03712345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992922|NCT03130348|Dexamethasone|dexamethasone|mesh-list
101992923|NCT03130348|Dexamethasone acetate|dexamethasone acetate|mesh-list
101992924|NCT03130348|Bortezomib|bortezomib|mesh-list
101992925|NCT03130348|Ichthammol|ichthammol|mesh-list
101992926|NCT03130348|BB 1101|bb 1101|mesh-list
101992927|NCT03130348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101992928|NCT03130348|Antiemetics|antiemetics|mesh-ancestor
101992929|NCT03130348|Autonomic Agents|autonomic agents|mesh-ancestor
101992930|NCT03130348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101992931|NCT03130348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992932|NCT03130348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101992933|NCT03130348|Glucocorticoids|glucocorticoids|mesh-ancestor
101992934|NCT03130348|Hormones|hormones|mesh-ancestor
101992935|NCT03130348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101447991|NCT00210717|Dopamine Agents|dopamine agents|mesh-ancestor
101992937|NCT03130348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101992939|NCT03130348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101947590|NCT01170507|Micronutrients|micronutrients|mesh-ancestor
101947591|NCT01170507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947592|NCT01170507|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101992940|NCT03130348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992941|NCT03130348|Dermatologic Agents|dermatologic agents|mesh-ancestor
101992942|NCT01307527|Riboflavin|riboflavin|mesh-list
101992943|NCT01307527|Vitamin B Complex|vitamin b complex|mesh-ancestor
101992944|NCT01307527|Vitamins|vitamins|mesh-ancestor
101992945|NCT01307527|Micronutrients|micronutrients|mesh-ancestor
101992946|NCT01307527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992947|NCT01307527|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101992948|NCT01307527|Dermatologic Agents|dermatologic agents|mesh-ancestor
101992949|NCT03789799|Titanium dioxide|titanium dioxide|mesh-list
101992950|NCT03789799|Sunscreening Agents|sunscreening agents|mesh-ancestor
101992951|NCT03789799|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101992952|NCT03789799|Protective Agents|protective agents|mesh-ancestor
101992953|NCT03789799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992954|NCT03789799|Dermatologic Agents|dermatologic agents|mesh-ancestor
101992955|NCT03789799|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101992956|NCT05439772|Ondansetron|ondansetron|mesh-list
101992957|NCT05439772|Antiemetics|antiemetics|mesh-ancestor
101992958|NCT05439772|Autonomic Agents|autonomic agents|mesh-ancestor
101992959|NCT05439772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101992960|NCT05439772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992961|NCT05439772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101992962|NCT05439772|Antipruritics|antipruritics|mesh-ancestor
101992963|NCT05439772|Dermatologic Agents|dermatologic agents|mesh-ancestor
101992964|NCT05439772|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101992965|NCT05439772|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101992966|NCT05439772|Serotonin Agents|serotonin agents|mesh-ancestor
101992967|NCT05439772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101992968|NCT05439772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992969|NCT05694715|Irinotecan|irinotecan|mesh-list
101992970|NCT05694715|Niraparib|niraparib|mesh-list
101992971|NCT05694715|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101992972|NCT05694715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101992973|NCT05694715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101992974|NCT05694715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992975|NCT05694715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101992976|NCT05694715|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101992977|NCT01309399|Teriparatide|teriparatide|mesh-list
101992978|NCT01309399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101992979|NCT01309399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992980|NCT01309399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101992981|NCT03311828|Daratumumab|daratumumab|mesh-list
101992982|NCT03311828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101992983|NCT01309477|Tacrolimus|tacrolimus|mesh-list
101992984|NCT01309477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101992985|NCT01309477|Immunologic Factors|immunologic factors|mesh-ancestor
101992986|NCT01309477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992987|NCT01309477|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101992988|NCT01309477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101992989|NCT01309477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992990|NCT03709992|Tamsulosin|tamsulosin|mesh-list
101992991|NCT03709992|Trospium chloride|trospium chloride|mesh-list
101992992|NCT03709992|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101992993|NCT03709992|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101992994|NCT03709992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101992995|NCT03709992|Adrenergic Agents|adrenergic agents|mesh-ancestor
101992996|NCT03709992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101992997|NCT03709992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992998|NCT03709992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992999|NCT03709992|Urological Agents|urological agents|mesh-ancestor
101993000|NCT03709992|Parasympatholytics|parasympatholytics|mesh-ancestor
101993001|NCT03709992|Autonomic Agents|autonomic agents|mesh-ancestor
101993002|NCT03709992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101993003|NCT03709992|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101993004|NCT03709992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101993005|NCT03709992|Cholinergic Agents|cholinergic agents|mesh-ancestor
101993006|NCT05438992|Bupivacaine|bupivacaine|mesh-list
101993007|NCT05438992|Anesthetics, Local|anesthetics, local|mesh-ancestor
101993008|NCT05438992|Anesthetics|anesthetics|mesh-ancestor
101448061|NCT00184847|Adenosine|adenosine|mesh-list
101947593|NCT01170507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101947594|NCT01170585|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101947595|NCT01170585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101947596|NCT01170585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101993012|NCT05438992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101993014|NCT05361486|Tafenoquine|tafenoquine|mesh-list
101993015|NCT05361486|Antimalarials|antimalarials|mesh-ancestor
101993016|NCT05361486|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101993017|NCT05361486|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101993018|NCT05361486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101993021|NCT03089216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101993022|NCT03089216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993023|NCT03089216|Antacids|antacids|mesh-ancestor
101993024|NCT03089216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993025|NCT03089216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101993026|NCT03339726|Phenylephrine|phenylephrine|mesh-list
101993027|NCT03339726|Oxymetazoline|oxymetazoline|mesh-list
101993028|NCT03339726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101993029|NCT03339726|Mydriatics|mydriatics|mesh-ancestor
101993030|NCT03339726|Autonomic Agents|autonomic agents|mesh-ancestor
101993031|NCT03339726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101993032|NCT03339726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993033|NCT03339726|Sympathomimetics|sympathomimetics|mesh-ancestor
101993034|NCT03339726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101993035|NCT03339726|Nasal Decongestants|nasal decongestants|mesh-ancestor
101993036|NCT03339726|Respiratory System Agents|respiratory system agents|mesh-ancestor
101993037|NCT03339726|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101993038|NCT03339726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101993039|NCT03339726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101993040|NCT03339726|Adrenergic Agents|adrenergic agents|mesh-ancestor
101993041|NCT03339726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101993042|NCT03339726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993043|NCT03339726|Protective Agents|protective agents|mesh-ancestor
101993044|NCT03339297|Defibrotide|defibrotide|mesh-list
101993045|NCT03339297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101993046|NCT03339297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101993047|NCT03339297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993048|NCT03339297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101993049|NCT05434624|Midazolam|midazolam|mesh-list
101993050|NCT05434624|Propofol|propofol|mesh-list
101993051|NCT05434624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101993052|NCT05434624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101993053|NCT05434624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993054|NCT05434624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101993055|NCT05434624|Anesthetics, General|anesthetics, general|mesh-ancestor
101993056|NCT05434624|Anesthetics|anesthetics|mesh-ancestor
101993057|NCT05434624|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101993058|NCT05434624|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101993059|NCT05434624|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101993060|NCT05434624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101993061|NCT05434624|GABA Modulators|gaba modulators|mesh-ancestor
101993062|NCT05434624|GABA Agents|gaba agents|mesh-ancestor
101993063|NCT05434624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101993064|NCT05434624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993065|NCT01309633|Bevacizumab|bevacizumab|mesh-list
101993066|NCT01309633|Sunitinib|sunitinib|mesh-list
101993067|NCT01309633|Cisplatin|cisplatin|mesh-list
101993068|NCT01309633|Gemcitabine|gemcitabine|mesh-list
101993069|NCT01309633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101993070|NCT01309633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101993071|NCT01309633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101993072|NCT01309633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101993073|NCT01309633|Growth Substances|growth substances|mesh-ancestor
101993074|NCT01309633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993075|NCT01309633|Growth Inhibitors|growth inhibitors|mesh-ancestor
101993076|NCT01309633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101993077|NCT01309633|Antimetabolites|antimetabolites|mesh-ancestor
101993078|NCT01309633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993079|NCT01309633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101993080|NCT01309633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101993081|NCT05215431|Antioxidants|antioxidants|mesh-list
101947597|NCT01170585|Antimetabolites|antimetabolites|mesh-ancestor
101971958|NCT00315640|Growth Inhibitors|growth inhibitors|mesh-ancestor
101993090|NCT01310647|Estradiol|estradiol|mesh-list
101993091|NCT01310647|Testosterone|testosterone|mesh-list
101993092|NCT01310647|Estrogens|estrogens|mesh-ancestor
101993093|NCT01310647|Hormones|hormones|mesh-ancestor
101993094|NCT01310647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101993095|NCT01310647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993096|NCT01310647|Androgens|androgens|mesh-ancestor
101993097|NCT05560399|Dexamethasone|dexamethasone|mesh-list
101993098|NCT05560399|Elotuzumab|elotuzumab|mesh-list
101993099|NCT05560399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101993100|NCT05560399|Antiemetics|antiemetics|mesh-ancestor
101993101|NCT05560399|Autonomic Agents|autonomic agents|mesh-ancestor
101993102|NCT05560399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101993103|NCT05560399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993104|NCT05560399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101993105|NCT05560399|Glucocorticoids|glucocorticoids|mesh-ancestor
101993106|NCT05560399|Hormones|hormones|mesh-ancestor
101993107|NCT05560399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101993108|NCT05560399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101993109|NCT05560399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101993110|NCT02949024|Triamcinolone|triamcinolone|mesh-list
101993111|NCT02949024|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101993112|NCT02949024|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101993113|NCT02949024|Aflibercept|aflibercept|mesh-list
101993114|NCT02949024|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101993115|NCT02949024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101993116|NCT02949024|Glucocorticoids|glucocorticoids|mesh-ancestor
101993117|NCT02949024|Hormones|hormones|mesh-ancestor
101993118|NCT02949024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101993119|NCT02949024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993120|NCT02949024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101993121|NCT02949024|Immunologic Factors|immunologic factors|mesh-ancestor
101993122|NCT02949024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101993123|NCT02949024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993124|NCT02949024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101993125|NCT02949024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101993126|NCT02949024|Growth Substances|growth substances|mesh-ancestor
101993127|NCT02949024|Growth Inhibitors|growth inhibitors|mesh-ancestor
101993128|NCT02949024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101993129|NCT04394481|Dexamethasone|dexamethasone|mesh-list
101993130|NCT04394481|Dexmedetomidine|dexmedetomidine|mesh-list
101993131|NCT04394481|Ropivacaine|ropivacaine|mesh-list
101993132|NCT04394481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101993133|NCT04394481|Antiemetics|antiemetics|mesh-ancestor
101993134|NCT04394481|Autonomic Agents|autonomic agents|mesh-ancestor
101993135|NCT04394481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101993136|NCT04394481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993137|NCT04394481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101993138|NCT04394481|Glucocorticoids|glucocorticoids|mesh-ancestor
101993139|NCT04394481|Hormones|hormones|mesh-ancestor
101993140|NCT04394481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101993141|NCT04394481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101993142|NCT04394481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101993143|NCT04394481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101993144|NCT04394481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101993145|NCT04394481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101993146|NCT04394481|Analgesics|analgesics|mesh-ancestor
101993147|NCT04394481|Sensory System Agents|sensory system agents|mesh-ancestor
101993148|NCT04394481|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101993149|NCT04394481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101993160|NCT03782935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993162|NCT03782935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101993163|NCT03782935|Nootropic Agents|nootropic agents|mesh-ancestor
101993164|NCT04370847|Ephedrine|ephedrine|mesh-list
101993165|NCT04370847|Fentanyl|fentanyl|mesh-list
101993166|NCT04370847|Bupivacaine|bupivacaine|mesh-list
101993167|NCT04370847|Oxytocin|oxytocin|mesh-list
101993168|NCT04370847|Anesthetics, Local|anesthetics, local|mesh-ancestor
101993169|NCT04370847|Anesthetics|anesthetics|mesh-ancestor
101993170|NCT04370847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101712974|NCT00639587|Cetirizine|cetirizine|mesh-list
101993171|NCT04370847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250477|NCT05030025|Antiviral Agents|antiviral agents|mesh-ancestor
101993172|NCT04370847|Sensory System Agents|sensory system agents|mesh-ancestor
101947598|NCT01170585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947599|NCT01170585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101947600|NCT01170585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101993173|NCT04370847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101993174|NCT04370847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101993176|NCT04370847|Analgesics|analgesics|mesh-ancestor
101993177|NCT04370847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101993178|NCT04370847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101993179|NCT04370847|Anesthetics, General|anesthetics, general|mesh-ancestor
101993180|NCT04370847|Oxytocics|oxytocics|mesh-ancestor
101993181|NCT04370847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101993182|NCT04370847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101993183|NCT04370847|Sympathomimetics|sympathomimetics|mesh-ancestor
101993184|NCT04370847|Autonomic Agents|autonomic agents|mesh-ancestor
101993185|NCT04370847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101993186|NCT04370847|Adrenergic Agents|adrenergic agents|mesh-ancestor
101993187|NCT04370847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101993188|NCT04370847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993189|NCT03708120|Insect Repellents|insect repellents|mesh-list
101993190|NCT03708120|Protective Agents|protective agents|mesh-ancestor
101993191|NCT03708120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993192|NCT03093428|Pembrolizumab|pembrolizumab|mesh-list
101993193|NCT03093428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101993194|NCT03093428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101993195|NCT03093428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101993196|NCT03093428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993197|NCT02735980|Prexasertib|prexasertib|mesh-list
101993198|NCT02735980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101993199|NCT02735980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101993200|NCT02735980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993202|NCT01309789|Cyclophosphamide|cyclophosphamide|mesh-list
101993203|NCT01309789|Doxorubicin|doxorubicin|mesh-list
101993204|NCT01309789|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101993205|NCT01309789|Vincristine|vincristine|mesh-list
101993206|NCT01309789|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101993207|NCT01309789|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101993208|NCT01309789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101993209|NCT01309789|Immunologic Factors|immunologic factors|mesh-ancestor
101993210|NCT01309789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993211|NCT01309789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101993212|NCT01309789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101993213|NCT01309789|Alkylating Agents|alkylating agents|mesh-ancestor
101993214|NCT01309789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993215|NCT01309789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101993227|NCT01309789|Tubulin Modulators|tubulin modulators|mesh-ancestor
101993228|NCT01309789|Antimitotic Agents|antimitotic agents|mesh-ancestor
101993229|NCT01309789|Mitosis Modulators|mitosis modulators|mesh-ancestor
101993230|NCT01309789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101993231|NCT01309789|Immunotoxins|immunotoxins|mesh-ancestor
101993232|NCT01309789|Immunoconjugates|immunoconjugates|mesh-ancestor
101993233|NCT03707847|Etoposide|etoposide|mesh-list
101993234|NCT03707847|Crizotinib|crizotinib|mesh-list
101993235|NCT03707847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101993236|NCT03707847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101993237|NCT03707847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101993238|NCT03707847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101993239|NCT03707847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101993240|NCT03707847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993241|NCT03707847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101993242|NCT03338400|Dexamethasone|dexamethasone|mesh-list
101993243|NCT03338400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101993244|NCT03338400|Antiemetics|antiemetics|mesh-ancestor
101993245|NCT03338400|Autonomic Agents|autonomic agents|mesh-ancestor
101993246|NCT03338400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101993247|NCT03338400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993248|NCT03338400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101993249|NCT03338400|Glucocorticoids|glucocorticoids|mesh-ancestor
101993250|NCT03338400|Hormones|hormones|mesh-ancestor
101993251|NCT03338400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101947601|NCT01170585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101947603|NCT01170819|Oxytocics|oxytocics|mesh-ancestor
101947604|NCT01170819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101947605|NCT01170819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993252|NCT03338400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101993253|NCT03338400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101993254|NCT03787147|Lidocaine|lidocaine|mesh-list
101993255|NCT03787147|Bupivacaine|bupivacaine|mesh-list
101993256|NCT03787147|Anesthetics, Local|anesthetics, local|mesh-ancestor
101993257|NCT03787147|Anesthetics|anesthetics|mesh-ancestor
101993258|NCT03787147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101993259|NCT03787147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993260|NCT03787147|Sensory System Agents|sensory system agents|mesh-ancestor
101993261|NCT03787147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101993262|NCT03787147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101993263|NCT03787147|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101993264|NCT03787147|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101993265|NCT03787147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101993266|NCT03787147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993267|NCT02620306|Losartan|losartan|mesh-list
101993268|NCT02620306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101993269|NCT02620306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101993270|NCT02620306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101993271|NCT02620306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101993272|NCT02620306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993273|NCT03781843|Lidocaine|lidocaine|mesh-list
101993274|NCT03781843|Anesthetics, Local|anesthetics, local|mesh-ancestor
101993275|NCT03781843|Anesthetics|anesthetics|mesh-ancestor
101993276|NCT03781843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101448341|NCT00218322|Adrenergic Agents|adrenergic agents|mesh-ancestor
101993281|NCT03781843|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101993282|NCT03781843|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101993283|NCT03781843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101993284|NCT03781843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993285|NCT05205447|Itraconazole|itraconazole|mesh-list
101993286|NCT05205447|Carbamazepine|carbamazepine|mesh-list
101993287|NCT05205447|Antifungal Agents|antifungal agents|mesh-ancestor
101993288|NCT05205447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101993289|NCT05205447|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101993290|NCT05205447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101993291|NCT05205447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101993292|NCT05205447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993293|NCT05205447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101993294|NCT05205447|Hormone Antagonists|hormone antagonists|mesh-ancestor
101993295|NCT05205447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101993296|NCT05205447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993297|NCT05205447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101993298|NCT05205447|Anticonvulsants|anticonvulsants|mesh-ancestor
101993299|NCT05205447|Antimanic Agents|antimanic agents|mesh-ancestor
101993300|NCT05205447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101993301|NCT05205447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101993302|NCT05205447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101993303|NCT05205447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101993304|NCT05205447|Analgesics|analgesics|mesh-ancestor
101993305|NCT05205447|Sensory System Agents|sensory system agents|mesh-ancestor
101993306|NCT05205447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101993307|NCT05205447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101993308|NCT05205447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101993309|NCT05205447|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101993310|NCT05205447|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101993311|NCT03781687|Morphine|morphine|mesh-list
101993312|NCT03781687|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101993313|NCT03781687|Narcotics|narcotics|mesh-ancestor
101993314|NCT03781687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101993315|NCT03781687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993316|NCT03781687|Analgesics|analgesics|mesh-ancestor
101993317|NCT03781687|Sensory System Agents|sensory system agents|mesh-ancestor
101947607|NCT03868137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101947608|NCT03868137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101947609|NCT03868137|Analgesics|analgesics|mesh-ancestor
101993318|NCT03781687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101993319|NCT03092726|ASP8062|asp8062|mesh-list
101993320|NCT03092726|Analgesics|analgesics|mesh-ancestor
101993321|NCT03092726|Sensory System Agents|sensory system agents|mesh-ancestor
101993322|NCT03092726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101993323|NCT03092726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993324|NCT03092726|GABA Modulators|gaba modulators|mesh-ancestor
101993325|NCT03092726|GABA Agents|gaba agents|mesh-ancestor
101993326|NCT03092726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101993327|NCT03092726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993328|NCT03786757|Rivaroxaban|rivaroxaban|mesh-list
101993329|NCT03786757|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101993330|NCT03786757|Antithrombins|antithrombins|mesh-ancestor
101993331|NCT03786757|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101993332|NCT03786757|Protease Inhibitors|protease inhibitors|mesh-ancestor
101993333|NCT03786757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101993334|NCT03786757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993335|NCT03786757|Anticoagulants|anticoagulants|mesh-ancestor
101993336|NCT05126511|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101993337|NCT05126511|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
101993338|NCT05126511|beta-Endorphin|beta-endorphin|mesh-list
101993339|NCT05126511|Hormones|hormones|mesh-ancestor
101993340|NCT05126511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101993341|NCT05126511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993342|NCT05126511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101993343|NCT05126511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993344|NCT05598242|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101993346|NCT04494789|Fludrocortisone|fludrocortisone|mesh-list
101993347|NCT04494789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101993348|NCT05598164|Botulinum Toxins|botulinum toxins|mesh-list
101993349|NCT05598164|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101993350|NCT05598164|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101993351|NCT05598164|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101993352|NCT05598164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101993353|NCT05598164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993354|NCT05598164|Cholinergic Agents|cholinergic agents|mesh-ancestor
101993355|NCT05598164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101993356|NCT05598164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993357|NCT05598164|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101993358|NCT05598164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101993360|NCT03787069|Anesthetics, Local|anesthetics, local|mesh-ancestor
101993361|NCT03787069|Anesthetics|anesthetics|mesh-ancestor
101993362|NCT03787069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101993363|NCT03787069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993364|NCT03787069|Sensory System Agents|sensory system agents|mesh-ancestor
101993365|NCT03787069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101993366|NCT03787069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101993367|NCT03787069|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101993368|NCT03787069|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101993369|NCT03787069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101993370|NCT03787069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993371|NCT04447118|Docetaxel|docetaxel|mesh-list
101993372|NCT04447118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101993373|NCT04447118|Tubulin Modulators|tubulin modulators|mesh-ancestor
101993374|NCT04447118|Antimitotic Agents|antimitotic agents|mesh-ancestor
101993375|NCT04447118|Mitosis Modulators|mitosis modulators|mesh-ancestor
101993376|NCT04447118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993377|NCT05532319|Lenvatinib|lenvatinib|mesh-list
101993378|NCT05532319|Tislelizumab|tislelizumab|mesh-list
101993379|NCT05532319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101993380|NCT05532319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101993381|NCT05532319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101993382|NCT05532319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993383|NCT05532319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101993384|NCT01553032|Cetuximab|cetuximab|mesh-list
101947610|NCT03868137|Sensory System Agents|sensory system agents|mesh-ancestor
101947611|NCT03868137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101947612|NCT03868137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993385|NCT01553032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101993386|NCT01553032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101993387|NCT05181124|Naproxen|naproxen|mesh-list
101993388|NCT05181124|Meloxicam|meloxicam|mesh-list
101993389|NCT05181124|Aceclofenac|aceclofenac|mesh-list
101993390|NCT05181124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101713198|NCT02614118|Acetaminophen|acetaminophen|mesh-list
101993392|NCT05181124|Analgesics|analgesics|mesh-ancestor
101993393|NCT05181124|Sensory System Agents|sensory system agents|mesh-ancestor
101993394|NCT05181124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101993395|NCT05181124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993396|NCT05181124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101993397|NCT05181124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101993398|NCT05181124|Gout Suppressants|gout suppressants|mesh-ancestor
101993399|NCT05181124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101993400|NCT05181124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101993401|NCT05181124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993402|NCT05181124|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101993403|NCT02897648|Lactams|lactams|mesh-list
101993404|NCT02897648|beta-Lactams|beta-lactams|mesh-list
101993405|NCT02897648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101993406|NCT02897648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101993407|NCT03338010|Insulin Glargine|insulin glargine|mesh-list
101993408|NCT03338010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101993409|NCT03338010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993410|NCT04959591|Acetaminophen|acetaminophen|mesh-list
101993411|NCT04959591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101993412|NCT04959591|Analgesics|analgesics|mesh-ancestor
101993413|NCT04959591|Sensory System Agents|sensory system agents|mesh-ancestor
101993414|NCT04959591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101993415|NCT04959591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993416|NCT04959591|Antipyretics|antipyretics|mesh-ancestor
101993417|NCT05598086|Tranexamic Acid|tranexamic acid|mesh-list
101993418|NCT05598086|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101993421|NCT05598086|Hemostatics|hemostatics|mesh-ancestor
101993422|NCT05598086|Coagulants|coagulants|mesh-ancestor
101993423|NCT00753532|Vitamin E|vitamin e|mesh-list
101993424|NCT00753532|Tocopherols|tocopherols|mesh-list
101993425|NCT00753532|Tocotrienols|tocotrienols|mesh-list
101993426|NCT00753532|Tocovid|tocovid|mesh-list
101993427|NCT00753532|Vitamins|vitamins|mesh-ancestor
101993428|NCT00753532|Micronutrients|micronutrients|mesh-ancestor
101993429|NCT00753532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993430|NCT00753532|Antioxidants|antioxidants|mesh-ancestor
101993431|NCT00753532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993432|NCT00753532|Protective Agents|protective agents|mesh-ancestor
101993433|NCT03632408|Zopiclone|zopiclone|mesh-list
101993434|NCT03632408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101993435|NCT03632408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101993436|NCT03632408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993437|NCT01307839|Lidocaine|lidocaine|mesh-list
101993438|NCT01307839|Anesthetics, Local|anesthetics, local|mesh-ancestor
101993439|NCT01307839|Anesthetics|anesthetics|mesh-ancestor
101993440|NCT01307839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101993441|NCT01307839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993442|NCT01307839|Sensory System Agents|sensory system agents|mesh-ancestor
101993443|NCT01307839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101993444|NCT01307839|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101993445|NCT01307839|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101993446|NCT01307839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101993447|NCT01307839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101993448|NCT01307839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993449|NCT03777085|Rituximab|rituximab|mesh-list
101993450|NCT03777085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101993451|NCT03777085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101993452|NCT03777085|Immunologic Factors|immunologic factors|mesh-ancestor
101993453|NCT03777085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993454|NCT03777085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101993455|NCT01328548|Vaccines|vaccines|mesh-list
101947613|NCT03868137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101947614|NCT03868137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101947615|NCT03868137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101947616|NCT03868137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101947617|NCT03868137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993456|NCT01328548|Immunologic Factors|immunologic factors|mesh-ancestor
101993457|NCT01328548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993458|NCT04453306|Topiramate|topiramate|mesh-list
101993459|NCT04453306|Anticonvulsants|anticonvulsants|mesh-ancestor
101993460|NCT04453306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101993461|NCT04453306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993462|NCT03777163|Vaccines|vaccines|mesh-list
101993463|NCT03777163|Immunologic Factors|immunologic factors|mesh-ancestor
101993464|NCT03777163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993465|NCT03786289|Epoetin Alfa|epoetin alfa|mesh-list
101993466|NCT03786289|Hematinics|hematinics|mesh-ancestor
101993467|NCT05597540|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101993468|NCT05597540|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101993469|NCT05597540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101993470|NCT05597540|Antitubercular Agents|antitubercular agents|mesh-ancestor
101993471|NCT03776851|Epoetin Alfa|epoetin alfa|mesh-list
101993472|NCT03776851|Hematinics|hematinics|mesh-ancestor
101993473|NCT03337308|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
101993474|NCT03337308|Ezetimibe|ezetimibe|mesh-list
101993475|NCT03337308|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101993476|NCT03337308|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101993477|NCT03337308|Antimetabolites|antimetabolites|mesh-ancestor
101993478|NCT03337308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993479|NCT03337308|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101993480|NCT03337308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101993481|NCT03337308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101993482|NCT03337308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993483|NCT03631862|Apatinib|apatinib|mesh-list
101993484|NCT03631862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101993485|NCT03631862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101993486|NCT03631862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101993487|NCT03631862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993488|NCT03468010|Paclitaxel|paclitaxel|mesh-list
101993489|NCT03468010|Cisplatin|cisplatin|mesh-list
101993490|NCT03468010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101993491|NCT03468010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101993492|NCT03468010|Tubulin Modulators|tubulin modulators|mesh-ancestor
101993493|NCT03468010|Antimitotic Agents|antimitotic agents|mesh-ancestor
101993512|NCT03780205|Dopamine Agents|dopamine agents|mesh-ancestor
101993513|NCT03780205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101993514|NCT03780205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993515|NCT03780205|Adrenergic Agents|adrenergic agents|mesh-ancestor
101993516|NCT03780205|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101993517|NCT03780205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101993518|NCT03780205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101993519|NCT03780205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101993520|NCT04305249|Nivolumab|nivolumab|mesh-list
101993521|NCT04305249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101993522|NCT04305249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101993523|NCT04305249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101993524|NCT04305249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993525|NCT03710161|Vitamin D|vitamin d|mesh-list
101993526|NCT03710161|Vitamins|vitamins|mesh-ancestor
101993527|NCT03710161|Micronutrients|micronutrients|mesh-ancestor
101993528|NCT03710161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993529|NCT03710161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101993530|NCT03707808|Nivolumab|nivolumab|mesh-list
101993531|NCT03707808|Ipilimumab|ipilimumab|mesh-list
101993532|NCT03707808|Avelumab|avelumab|mesh-list
101993533|NCT03707808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101993534|NCT03707808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101993535|NCT03707808|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101993536|NCT03707808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993537|NCT03091400|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101993538|NCT03091400|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101947618|NCT01283919|Pantoprazole|pantoprazole|mesh-list
101947619|NCT01283919|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101947620|NCT01283919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101947621|NCT01283919|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101993539|NCT03091400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101993540|NCT03091400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101993541|NCT03091400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993542|NCT03091400|Adrenergic Agents|adrenergic agents|mesh-ancestor
101993543|NCT03091400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101993544|NCT03091400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993545|NCT04716634|Tislelizumab|tislelizumab|mesh-list
101993546|NCT04716634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101993547|NCT04716634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101993548|NCT02761070|Bevacizumab|bevacizumab|mesh-list
101993549|NCT02761070|Temozolomide|temozolomide|mesh-list
101993550|NCT02761070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101993555|NCT02761070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993556|NCT02761070|Growth Inhibitors|growth inhibitors|mesh-ancestor
101993557|NCT02761070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101993558|NCT02761070|Alkylating Agents|alkylating agents|mesh-ancestor
101993559|NCT02761070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993561|NCT03090152|Anesthetics, Local|anesthetics, local|mesh-ancestor
101993562|NCT03090152|Anesthetics|anesthetics|mesh-ancestor
101993563|NCT03090152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101993564|NCT03090152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993565|NCT03090152|Sensory System Agents|sensory system agents|mesh-ancestor
101993566|NCT03090152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101993567|NCT03466528|Thiamine|thiamine|mesh-list
101993568|NCT03466528|Vitamin B Complex|vitamin b complex|mesh-list
101993569|NCT03466528|Magnesium Sulfate|magnesium sulfate|mesh-list
101993570|NCT03466528|Vitamins|vitamins|mesh-ancestor
101993571|NCT03466528|Micronutrients|micronutrients|mesh-ancestor
101993572|NCT03466528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993573|NCT03466528|Analgesics|analgesics|mesh-ancestor
101993574|NCT03466528|Sensory System Agents|sensory system agents|mesh-ancestor
101993575|NCT03466528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101993576|NCT03466528|Anesthetics|anesthetics|mesh-ancestor
101993577|NCT03466528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101993578|NCT03466528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101993579|NCT03466528|Anticonvulsants|anticonvulsants|mesh-ancestor
101993580|NCT03466528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101993581|NCT03466528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101993582|NCT03466528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993583|NCT03466528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101993584|NCT03466528|Tocolytic Agents|tocolytic agents|mesh-ancestor
101993585|NCT03466528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101993586|NCT03466216|Octreotide|octreotide|mesh-list
101993587|NCT03466216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101993588|NCT03466216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101993589|NCT03466216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101993590|NCT03098654|Metformin|metformin|mesh-list
101993591|NCT03098654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101993592|NCT03098654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993593|NCT05175066|Bisoprolol|bisoprolol|mesh-list
101993594|NCT05175066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101993595|NCT05175066|Sympatholytics|sympatholytics|mesh-ancestor
101993596|NCT05175066|Autonomic Agents|autonomic agents|mesh-ancestor
101993597|NCT05175066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101993598|NCT05175066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993599|NCT05175066|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101993600|NCT05175066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101993601|NCT05175066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101993602|NCT05175066|Adrenergic Agents|adrenergic agents|mesh-ancestor
101993603|NCT05175066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101993604|NCT05175066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993605|NCT03130114|Azithromycin|azithromycin|mesh-list
101993606|NCT03130114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101993607|NCT03130114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101993608|NCT03130270|Apatinib|apatinib|mesh-list
101993609|NCT03130270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101993610|NCT03130270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101947622|NCT01283919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101947623|NCT01283919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947624|NCT01167933|Simvastatin|simvastatin|mesh-list
101947625|NCT01167933|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101819872|NCT01023867|Donepezil|donepezil|mesh-list
101993611|NCT03130270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101993612|NCT03130270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993613|NCT03780361|Aflibercept|aflibercept|mesh-list
101993614|NCT03780361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101993615|NCT03780361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101993616|NCT03780361|Growth Substances|growth substances|mesh-ancestor
101575010|NCT01179516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101993617|NCT03780361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993618|NCT03780361|Growth Inhibitors|growth inhibitors|mesh-ancestor
101448679|NCT00219726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101993623|NCT05183646|Immunologic Factors|immunologic factors|mesh-ancestor
101993624|NCT05183646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993625|NCT04943445|Paclitaxel|paclitaxel|mesh-list
101993626|NCT04943445|Carboplatin|carboplatin|mesh-list
101993627|NCT04943445|Pembrolizumab|pembrolizumab|mesh-list
101993628|NCT04943445|Immunomodulating Agents|immunomodulating agents|mesh-list
101993629|NCT04943445|Immunologic Factors|immunologic factors|mesh-list
101993630|NCT04943445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101993631|NCT04943445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101993632|NCT04943445|Tubulin Modulators|tubulin modulators|mesh-ancestor
101993633|NCT04943445|Antimitotic Agents|antimitotic agents|mesh-ancestor
101993634|NCT04943445|Mitosis Modulators|mitosis modulators|mesh-ancestor
101993635|NCT04943445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993636|NCT04943445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101993637|NCT04943445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101993638|NCT04943445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993639|NCT02522572|Plerixafor|plerixafor|mesh-list
101993640|NCT02522572|Bortezomib|bortezomib|mesh-list
101993641|NCT02522572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101993642|NCT02522572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101993643|NCT02522572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101993644|NCT02522572|Antiviral Agents|antiviral agents|mesh-ancestor
101993645|NCT02522572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101993646|NCT04602507|Ivermectin|ivermectin|mesh-list
101993647|NCT04602507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101993648|NCT04602507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101993649|NCT04645966|Acetaminophen|acetaminophen|mesh-list
101993650|NCT04645966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101993651|NCT04645966|Analgesics|analgesics|mesh-ancestor
101993652|NCT04645966|Sensory System Agents|sensory system agents|mesh-ancestor
101993653|NCT04645966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101993654|NCT04645966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993655|NCT04645966|Antipyretics|antipyretics|mesh-ancestor
101993656|NCT03773809|Vitamin D|vitamin d|mesh-list
101993657|NCT03773809|Ergocalciferols|ergocalciferols|mesh-list
101993658|NCT03773809|Cholecalciferol|cholecalciferol|mesh-list
101993659|NCT03773809|Vitamins|vitamins|mesh-list
101993660|NCT03773809|Micronutrients|micronutrients|mesh-ancestor
101993661|NCT03773809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993662|NCT03773809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101993663|NCT03773809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101993664|NCT01313611|Rituximab|rituximab|mesh-list
101993665|NCT01313611|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101993666|NCT01313611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101993667|NCT01313611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101993668|NCT01313611|Immunologic Factors|immunologic factors|mesh-ancestor
101993669|NCT01313611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993670|NCT01313611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101993671|NCT01313611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101993672|NCT01313611|Alkylating Agents|alkylating agents|mesh-ancestor
101993673|NCT01313611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993674|NCT03776383|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101993675|NCT03776383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101993676|NCT04534582|Denosumab|denosumab|mesh-list
101993677|NCT04534582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101993678|NCT04534582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993679|NCT03780049|Leucovorin|leucovorin|mesh-list
101947627|NCT01167933|Antimetabolites|antimetabolites|mesh-ancestor
101947628|NCT01167933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947629|NCT01167933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101947630|NCT01167933|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101947631|NCT01167933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101993680|NCT03780049|Fluorouracil|fluorouracil|mesh-list
101993681|NCT03780049|Oxaliplatin|oxaliplatin|mesh-list
101993682|NCT03780049|Antimetabolites|antimetabolites|mesh-ancestor
101993683|NCT03780049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993684|NCT03780049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101993685|NCT03780049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101993686|NCT03780049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101993687|NCT03780049|Immunologic Factors|immunologic factors|mesh-ancestor
101993688|NCT03780049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993689|NCT03780049|Antidotes|antidotes|mesh-ancestor
101993690|NCT03780049|Protective Agents|protective agents|mesh-ancestor
101993691|NCT03780049|Vitamin B Complex|vitamin b complex|mesh-ancestor
101993692|NCT03780049|Vitamins|vitamins|mesh-ancestor
101993696|NCT04252287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993697|NCT04252287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101993698|NCT04252287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993699|NCT05681754|Calcium, Dietary|calcium, dietary|mesh-list
101993700|NCT05681754|Calcium|calcium|mesh-list
101993701|NCT05681754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101993702|NCT05681754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993703|NCT05681754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101993704|NCT03465202|Capecitabine|capecitabine|mesh-list
101993705|NCT03465202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101993706|NCT03465202|Antimetabolites|antimetabolites|mesh-ancestor
101993707|NCT03465202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993708|NCT03465202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101993709|NCT04195958|Omalizumab|omalizumab|mesh-list
101993710|NCT04195958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101993711|NCT04195958|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101993712|NCT04195958|Respiratory System Agents|respiratory system agents|mesh-ancestor
101993713|NCT05540262|Edaravone|edaravone|mesh-list
101993714|NCT05540262|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101993715|NCT05540262|Antioxidants|antioxidants|mesh-ancestor
101993716|NCT05540262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993717|NCT05540262|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101993718|NCT05540262|Protective Agents|protective agents|mesh-ancestor
101993719|NCT05540262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993720|NCT04245423|Analgesics, Opioid|analgesics, opioid|mesh-list
101993721|NCT04245423|Narcotics|narcotics|mesh-ancestor
101993722|NCT04245423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101993723|NCT04245423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993724|NCT04245423|Analgesics|analgesics|mesh-ancestor
101993725|NCT04245423|Sensory System Agents|sensory system agents|mesh-ancestor
101993726|NCT04245423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101993727|NCT02735200|Vitamin D|vitamin d|mesh-list
101993728|NCT02735200|Ergocalciferols|ergocalciferols|mesh-list
101993729|NCT02735200|Cholecalciferol|cholecalciferol|mesh-list
101993730|NCT02735200|Vitamins|vitamins|mesh-list
101993731|NCT02735200|Micronutrients|micronutrients|mesh-ancestor
101993732|NCT02735200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993733|NCT02735200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101993734|NCT02735200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101993735|NCT01312311|Docetaxel|docetaxel|mesh-list
101993736|NCT01312311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101993737|NCT01312311|Tubulin Modulators|tubulin modulators|mesh-ancestor
101993738|NCT01312311|Antimitotic Agents|antimitotic agents|mesh-ancestor
101993739|NCT01312311|Mitosis Modulators|mitosis modulators|mesh-ancestor
101993740|NCT01312311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993741|NCT03464968|Leucovorin|leucovorin|mesh-list
101993742|NCT03464968|Oxaliplatin|oxaliplatin|mesh-list
101993743|NCT03464968|Irinotecan|irinotecan|mesh-list
101993744|NCT03464968|Fluorouracil|fluorouracil|mesh-list
101993745|NCT03464968|Levoleucovorin|levoleucovorin|mesh-list
101993746|NCT03464968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101947633|NCT01168011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101947634|NCT01168011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101820018|NCT00813137|Endostatins|endostatins|mesh-list
101993747|NCT03464968|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101993748|NCT03464968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101993749|NCT03464968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101993750|NCT03464968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993751|NCT03464968|Antidotes|antidotes|mesh-ancestor
101993752|NCT03464968|Protective Agents|protective agents|mesh-ancestor
101993753|NCT03464968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993754|NCT03464968|Vitamin B Complex|vitamin b complex|mesh-ancestor
101993755|NCT03464968|Vitamins|vitamins|mesh-ancestor
101993756|NCT03464968|Micronutrients|micronutrients|mesh-ancestor
101993757|NCT03464968|Antimetabolites|antimetabolites|mesh-ancestor
101993758|NCT03464968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101993759|NCT03464968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101993760|NCT03464968|Immunologic Factors|immunologic factors|mesh-ancestor
101993761|NCT05073744|Morphine|morphine|mesh-list
101993762|NCT05073744|Nalbuphine|nalbuphine|mesh-list
101993763|NCT05073744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101993764|NCT05073744|Narcotics|narcotics|mesh-ancestor
101993765|NCT05073744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101993766|NCT05073744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993767|NCT05073744|Analgesics|analgesics|mesh-ancestor
101993772|NCT05681598|Antisickling Agents|antisickling agents|mesh-ancestor
101993773|NCT05681598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101993774|NCT05681598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993775|NCT05681598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101993778|NCT01312350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101993779|NCT01312350|Tubulin Modulators|tubulin modulators|mesh-ancestor
101993780|NCT01312350|Antimitotic Agents|antimitotic agents|mesh-ancestor
101993781|NCT01312350|Mitosis Modulators|mitosis modulators|mesh-ancestor
101993782|NCT01312350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993783|NCT01312350|Antimetabolites|antimetabolites|mesh-ancestor
101993784|NCT01312350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101993785|NCT01312350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101993786|NCT01312350|Immunologic Factors|immunologic factors|mesh-ancestor
101993787|NCT01312350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993788|NCT03464656|Antioxidants|antioxidants|mesh-list
101993789|NCT03464656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993790|NCT03464656|Protective Agents|protective agents|mesh-ancestor
101993791|NCT03464656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993792|NCT04343248|Nitazoxanide|nitazoxanide|mesh-list
101993793|NCT04343248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101993794|NCT04343248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101993795|NCT03705858|Lintuzumab|lintuzumab|mesh-list
101993796|NCT03705858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101993797|NCT03705858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101993798|NCT03463642|Vitamin D|vitamin d|mesh-list
101993799|NCT03463642|Cholecalciferol|cholecalciferol|mesh-list
101993800|NCT03463642|Mineral Oil|mineral oil|mesh-list
101993801|NCT03463642|Vitamins|vitamins|mesh-ancestor
101993802|NCT03463642|Micronutrients|micronutrients|mesh-ancestor
101993803|NCT03463642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993804|NCT03463642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101993805|NCT03463642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101993806|NCT03463642|Emollients|emollients|mesh-ancestor
101993807|NCT03463642|Dermatologic Agents|dermatologic agents|mesh-ancestor
101993808|NCT03463564|Insulin|insulin|mesh-list
101993809|NCT03463564|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101993810|NCT03463564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101993811|NCT03463564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993812|NCT05092386|Vaccines|vaccines|mesh-list
101993813|NCT05092386|Immunologic Factors|immunologic factors|mesh-ancestor
101993814|NCT05092386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993815|NCT03463252|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101993816|NCT03463252|Medroxyprogesterone|medroxyprogesterone|mesh-list
101993817|NCT03463252|Progesterone|progesterone|mesh-list
101993818|NCT03463252|Progestins|progestins|mesh-ancestor
101993819|NCT03463252|Hormones|hormones|mesh-ancestor
101993820|NCT03463252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101993821|NCT03463252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993822|NCT03463252|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101947635|NCT01168011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101947636|NCT01168011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947638|NCT01171209|Interferon-beta|interferon-beta|mesh-list
101947639|NCT01171209|Interferon-alpha|interferon-alpha|mesh-list
101947640|NCT01171209|Interferon beta-1b|interferon beta-1b|mesh-list
101947641|NCT01171209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101947642|NCT01171209|Antiviral Agents|antiviral agents|mesh-ancestor
101947643|NCT01171209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101947644|NCT01171209|Immunologic Factors|immunologic factors|mesh-ancestor
101947645|NCT01171209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947646|NCT01171209|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101947647|NCT01166685|Everolimus|everolimus|mesh-list
101947648|NCT01166685|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101947649|NCT01166685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101947650|NCT01166685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101993823|NCT03463252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101993824|NCT03463252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101993825|NCT03463252|Contraceptive Agents|contraceptive agents|mesh-ancestor
101993826|NCT03463252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101993827|NCT03463252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101993828|NCT03463252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101993829|NCT03463252|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101993830|NCT03463252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101993831|NCT03463252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101993832|NCT05309538|Betahistine|betahistine|mesh-list
101993833|NCT05309538|Vasodilator Agents|vasodilator agents|mesh-ancestor
101993834|NCT05309538|Histamine Agonists|histamine agonists|mesh-ancestor
101993835|NCT05309538|Histamine Agents|histamine agents|mesh-ancestor
101993836|NCT05309538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101993837|NCT05309538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993838|NCT05309538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993839|NCT03462940|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
101993848|NCT03011450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101993849|NCT03638856|Misoprostol|misoprostol|mesh-list
101993850|NCT03638856|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101993851|NCT03638856|Abortifacient Agents|abortifacient agents|mesh-ancestor
101993852|NCT03638856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101993853|NCT03638856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993854|NCT03638856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101993855|NCT03638856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101993856|NCT03638856|Oxytocics|oxytocics|mesh-ancestor
101993857|NCT03705780|Fentanyl|fentanyl|mesh-list
101993858|NCT03705780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101993859|NCT03705780|Narcotics|narcotics|mesh-ancestor
101993860|NCT03705780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101993861|NCT03705780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993862|NCT03705780|Analgesics|analgesics|mesh-ancestor
101993863|NCT03705780|Sensory System Agents|sensory system agents|mesh-ancestor
101993864|NCT03705780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101993865|NCT03705780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101993866|NCT03705780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101993867|NCT03705780|Anesthetics, General|anesthetics, general|mesh-ancestor
101993868|NCT03705780|Anesthetics|anesthetics|mesh-ancestor
101993869|NCT04976790|Flurbiprofen|flurbiprofen|mesh-list
101993870|NCT04976790|Analgesics|analgesics|mesh-ancestor
101993871|NCT04976790|Sensory System Agents|sensory system agents|mesh-ancestor
101993872|NCT04976790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101993873|NCT04976790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993874|NCT04976790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101993875|NCT04976790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101947651|NCT01166685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947652|NCT01166685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101947653|NCT01166685|Immunologic Factors|immunologic factors|mesh-ancestor
101947654|NCT01166685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947655|NCT01166685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101947656|NCT03870711|Lidocaine|lidocaine|mesh-list
101947657|NCT03870711|Anesthetics, Local|anesthetics, local|mesh-ancestor
101947658|NCT03870711|Anesthetics|anesthetics|mesh-ancestor
101993876|NCT04976790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101993877|NCT04976790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101993878|NCT04976790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101993879|NCT04976790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101993880|NCT04976790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993881|NCT04452838|Fesoterodine|fesoterodine|mesh-list
101993882|NCT04452838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101993883|NCT04452838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101993884|NCT04452838|Cholinergic Agents|cholinergic agents|mesh-ancestor
101993885|NCT04452838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101993886|NCT04452838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993887|NCT04452838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993888|NCT04452838|Urological Agents|urological agents|mesh-ancestor
101993889|NCT02967848|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
101993890|NCT02967848|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101993891|NCT02967848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993892|NCT04188860|Paclitaxel|paclitaxel|mesh-list
101993893|NCT04188860|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101993894|NCT04188860|Antibodies|antibodies|mesh-list
101993895|NCT04188860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101993896|NCT04188860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101993897|NCT04188860|Tubulin Modulators|tubulin modulators|mesh-ancestor
101993898|NCT04188860|Antimitotic Agents|antimitotic agents|mesh-ancestor
101993899|NCT04188860|Mitosis Modulators|mitosis modulators|mesh-ancestor
101993900|NCT04188860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993901|NCT04188860|Immunologic Factors|immunologic factors|mesh-ancestor
101993902|NCT04188860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993903|NCT01383668|Sirolimus|sirolimus|mesh-list
101993904|NCT01383668|Gold Sodium Thiomalate|gold sodium thiomalate|mesh-list
101993905|NCT01383668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101993938|NCT02521714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101993940|NCT03768089|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101993941|NCT03768089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101993942|NCT03768089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993943|NCT03548584|Brexpiprazole|brexpiprazole|mesh-list
101993944|NCT03548584|Serotonin Agents|serotonin agents|mesh-ancestor
101993945|NCT03548584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101993946|NCT03548584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993947|NCT03548584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993948|NCT03548584|Dopamine Agonists|dopamine agonists|mesh-ancestor
101993949|NCT03548584|Dopamine Agents|dopamine agents|mesh-ancestor
101993950|NCT01381640|Acetaminophen|acetaminophen|mesh-list
101993951|NCT01381640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101993952|NCT01381640|Analgesics|analgesics|mesh-ancestor
101993953|NCT01381640|Sensory System Agents|sensory system agents|mesh-ancestor
101993954|NCT01381640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101993955|NCT01381640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993956|NCT01381640|Antipyretics|antipyretics|mesh-ancestor
101993957|NCT04483973|Ebselen|ebselen|mesh-list
101993958|NCT04483973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101993959|NCT04483973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101993960|NCT04483973|Analgesics|analgesics|mesh-ancestor
101993961|NCT04483973|Sensory System Agents|sensory system agents|mesh-ancestor
101993962|NCT04483973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101993963|NCT04483973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993964|NCT04483973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101993965|NCT04483973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101993966|NCT04483973|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101947659|NCT03870711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101947660|NCT03870711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993967|NCT04483973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101993968|NCT04483973|Antioxidants|antioxidants|mesh-ancestor
101993969|NCT04483973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993970|NCT04483973|Protective Agents|protective agents|mesh-ancestor
101993971|NCT04483973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101993972|NCT04483973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101993973|NCT04483973|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101993974|NCT04283890|Nivolumab|nivolumab|mesh-list
101993975|NCT04283890|Ipilimumab|ipilimumab|mesh-list
101993976|NCT04283890|Melphalan|melphalan|mesh-list
101993977|NCT04283890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101993978|NCT04283890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101993979|NCT04283890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101993980|NCT04283890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993981|NCT04283890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101993982|NCT04283890|Alkylating Agents|alkylating agents|mesh-ancestor
101993983|NCT04283890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101993984|NCT04283890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101993985|NCT04283890|Immunologic Factors|immunologic factors|mesh-ancestor
101993986|NCT04283890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993987|NCT01139723|Bevacizumab|bevacizumab|mesh-list
101993988|NCT01139723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101993989|NCT01139723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101993990|NCT01139723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101993991|NCT01139723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101993992|NCT01139723|Growth Substances|growth substances|mesh-ancestor
101993993|NCT01139723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993994|NCT01139723|Growth Inhibitors|growth inhibitors|mesh-ancestor
101713797|NCT00638729|GABA Agents|gaba agents|mesh-ancestor
101993995|NCT05068037|Antiemetics|antiemetics|mesh-list
101994020|NCT01141439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101994021|NCT01141439|Glucocorticoids|glucocorticoids|mesh-ancestor
101994022|NCT01141439|Hormones|hormones|mesh-ancestor
101994023|NCT01141439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101994024|NCT05549531|Itraconazole|itraconazole|mesh-list
101994025|NCT05549531|Antifungal Agents|antifungal agents|mesh-ancestor
101994026|NCT05549531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101994027|NCT05549531|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101994028|NCT05549531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101994029|NCT05549531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101994030|NCT05549531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994031|NCT05549531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101994032|NCT05549531|Hormone Antagonists|hormone antagonists|mesh-ancestor
101994033|NCT05549531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101994034|NCT05549531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994035|NCT05549531|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101994036|NCT04452370|Etoposide|etoposide|mesh-list
101994037|NCT04452370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101994038|NCT04452370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101994039|NCT04452370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101994040|NCT04452370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101994041|NCT04452370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101994042|NCT04452370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994043|NCT01232777|Bevacizumab|bevacizumab|mesh-list
101994044|NCT01232777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101994060|NCT03247036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101994061|NCT03247036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994062|NCT04921995|Tislelizumab|tislelizumab|mesh-list
101994063|NCT04921995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101994064|NCT04921995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101994065|NCT03129867|Ticagrelor|ticagrelor|mesh-list
101994066|NCT03129867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101994067|NCT03129867|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101994068|NCT03129867|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101994069|NCT03129867|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101994070|NCT03129867|Purinergic Agents|purinergic agents|mesh-ancestor
101994071|NCT03129867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101947661|NCT03870711|Sensory System Agents|sensory system agents|mesh-ancestor
101947662|NCT03870711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101947663|NCT03870711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101947664|NCT03870711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101947665|NCT03870711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101994072|NCT03129867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994073|NCT03129867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994074|NCT01235273|Hormones|hormones|mesh-list
101994075|NCT01235273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101994076|NCT01235273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994077|NCT01140035|Insulin|insulin|mesh-list
101994078|NCT01140035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101994079|NCT01140035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994080|NCT00872950|Amifampridine|amifampridine|mesh-list
101994081|NCT00872950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101994082|NCT00872950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101994083|NCT00872950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994084|NCT00872950|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101994085|NCT00872950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101994086|NCT00872950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994087|NCT03233217|Vaccines|vaccines|mesh-list
101994088|NCT03233217|Immunologic Factors|immunologic factors|mesh-ancestor
101994089|NCT03233217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994090|NCT01568996|Sulforaphane|sulforaphane|mesh-list
101994091|NCT01568996|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101994092|NCT01568996|Protective Agents|protective agents|mesh-ancestor
101994093|NCT01568996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994094|NCT01568996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101994095|NCT02943993|Edoxaban|edoxaban|mesh-list
101994096|NCT02943993|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101994097|NCT02943993|Antithrombins|antithrombins|mesh-ancestor
101994098|NCT02943993|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101994099|NCT02943993|Protease Inhibitors|protease inhibitors|mesh-ancestor
101994100|NCT02943993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101994101|NCT02943993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994112|NCT04098302|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101994113|NCT04098302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101994114|NCT04098302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101994115|NCT04098302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994116|NCT04098302|Hormone Antagonists|hormone antagonists|mesh-ancestor
101994117|NCT04098302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101994118|NCT04098302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994119|NCT02596126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
101994120|NCT05488613|Midostaurin|midostaurin|mesh-list
101994121|NCT05488613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101994122|NCT05488613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101994123|NCT05488613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101994124|NCT05488613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994125|NCT05420168|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101994126|NCT05420168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101994127|NCT01137383|Interferons|interferons|mesh-list
101994128|NCT01137383|Ribavirin|ribavirin|mesh-list
101994129|NCT01137383|Interferon-alpha|interferon-alpha|mesh-list
101994130|NCT01137383|Interferon alpha-2|interferon alpha-2|mesh-list
101994131|NCT01137383|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101994132|NCT01137383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101994133|NCT01137383|Antiviral Agents|antiviral agents|mesh-ancestor
101994134|NCT01137383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101994135|NCT01137383|Antimetabolites|antimetabolites|mesh-ancestor
101994136|NCT01137383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994137|NCT01137383|Immunologic Factors|immunologic factors|mesh-ancestor
101994138|NCT01137383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994139|NCT03449836|Fluticasone|fluticasone|mesh-list
101713948|NCT00601835|Vaccines|vaccines|mesh-list
101994140|NCT03449836|Mometasone Furoate|mometasone furoate|mesh-list
101994141|NCT03449836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101994142|NCT03449836|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101994143|NCT03449836|Autonomic Agents|autonomic agents|mesh-ancestor
101947666|NCT03870711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101947667|NCT03870711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947669|NCT03872505|Carboplatin|carboplatin|mesh-list
101947670|NCT03872505|Durvalumab|durvalumab|mesh-list
101947671|NCT03872505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101947672|NCT03872505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101994144|NCT03449836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101994145|NCT03449836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994146|NCT03449836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101994147|NCT03449836|Respiratory System Agents|respiratory system agents|mesh-ancestor
101994148|NCT03449836|Dermatologic Agents|dermatologic agents|mesh-ancestor
101994149|NCT03449836|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101994151|NCT03449524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101994152|NCT03961256|Exenatide|exenatide|mesh-list
101994153|NCT03961256|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101994154|NCT03961256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994155|NCT03961256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101994156|NCT03961256|Incretins|incretins|mesh-ancestor
101994157|NCT03961256|Hormones|hormones|mesh-ancestor
101994158|NCT03961256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101994159|NCT03443518|Remifentanil|remifentanil|mesh-list
101994160|NCT03443518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101994161|NCT03443518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994162|NCT03443518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101994163|NCT03443518|Narcotics|narcotics|mesh-ancestor
101994164|NCT03443518|Analgesics|analgesics|mesh-ancestor
101994165|NCT03443518|Sensory System Agents|sensory system agents|mesh-ancestor
101994170|NCT04330625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101994171|NCT04330625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994172|NCT03747497|Linezolid|linezolid|mesh-list
101994173|NCT03747497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101994174|NCT03747497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101994175|NCT03747497|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101994176|NCT03747497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101994177|NCT03747497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994178|NCT03109600|Vaccines|vaccines|mesh-list
101994179|NCT03109600|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101994180|NCT03109600|Immunologic Factors|immunologic factors|mesh-ancestor
101994181|NCT03109600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994182|NCT03679013|Acetaminophen|acetaminophen|mesh-list
101994183|NCT03679013|Gabapentin|gabapentin|mesh-list
101994184|NCT03679013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101994185|NCT03679013|Analgesics|analgesics|mesh-ancestor
101994186|NCT03679013|Sensory System Agents|sensory system agents|mesh-ancestor
101994187|NCT03679013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101994188|NCT03679013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994189|NCT03679013|Antipyretics|antipyretics|mesh-ancestor
101994190|NCT03679013|Anticonvulsants|anticonvulsants|mesh-ancestor
101994191|NCT03679013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101994192|NCT03679013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101994193|NCT03679013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101994194|NCT03679013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101994195|NCT03679013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101994196|NCT03679013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101994197|NCT03679013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101994198|NCT03679013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994199|NCT03679013|Antimanic Agents|antimanic agents|mesh-ancestor
101994200|NCT01140425|Moxifloxacin|moxifloxacin|mesh-list
101994201|NCT01140425|PF 232798|pf 232798|mesh-list
101994202|NCT01140425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101994203|NCT01140425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101994204|NCT01140425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101994205|NCT01140425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101994206|NCT01140425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101994207|NCT01140425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994208|NCT01140425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101994209|NCT01140425|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101994210|NCT01140425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101947673|NCT03872505|Tubulin Modulators|tubulin modulators|mesh-ancestor
101947674|NCT03872505|Antimitotic Agents|antimitotic agents|mesh-ancestor
101947675|NCT03872505|Mitosis Modulators|mitosis modulators|mesh-ancestor
101947676|NCT03872505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947677|NCT03872505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101947678|NCT01171365|Ciclesonide|ciclesonide|mesh-list
101947679|NCT01171365|Glucocorticoids|glucocorticoids|mesh-ancestor
101947680|NCT01171365|Hormones|hormones|mesh-ancestor
101947681|NCT01171365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101947682|NCT01171365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947683|NCT01171365|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101947684|NCT01281891|Morphine|morphine|mesh-list
101947685|NCT01281891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101947686|NCT01281891|Narcotics|narcotics|mesh-ancestor
101947687|NCT01281891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101947688|NCT01281891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947689|NCT01281891|Analgesics|analgesics|mesh-ancestor
101947690|NCT01281891|Sensory System Agents|sensory system agents|mesh-ancestor
101947691|NCT01281891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101947692|NCT01282047|Lenalidomide|lenalidomide|mesh-list
101947693|NCT01282047|Immunologic Factors|immunologic factors|mesh-ancestor
101947694|NCT01282047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947695|NCT01282047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101947696|NCT01282047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101947697|NCT01282047|Growth Substances|growth substances|mesh-ancestor
101947698|NCT01282047|Growth Inhibitors|growth inhibitors|mesh-ancestor
101947699|NCT01282047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101947700|NCT02525991|Loxapine|loxapine|mesh-list
101994211|NCT01140425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101994212|NCT01140425|Antiviral Agents|antiviral agents|mesh-ancestor
101994213|NCT03991013|Dolutegravir|dolutegravir|mesh-list
101994214|NCT03991013|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101994215|NCT03991013|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101994216|NCT03991013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101994217|NCT03991013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994218|NCT03991013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101994219|NCT03991013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101994220|NCT03991013|Antiviral Agents|antiviral agents|mesh-ancestor
101994221|NCT03991013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101994222|NCT03441412|Metoprolol|metoprolol|mesh-list
101994223|NCT03441412|Epinephrine|epinephrine|mesh-list
101994224|NCT03441412|Ticagrelor|ticagrelor|mesh-list
101994225|NCT03441412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101994226|NCT03441412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101994227|NCT03441412|Adrenergic Agents|adrenergic agents|mesh-ancestor
101994228|NCT03441412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101994229|NCT03441412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994230|NCT03441412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947701|NCT02525991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101947702|NCT02525991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101947703|NCT02525991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101947704|NCT02525991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947705|NCT02525991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101947706|NCT02525991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101947707|NCT02525991|Dopamine Agents|dopamine agents|mesh-ancestor
101947708|NCT02525991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101947709|NCT02525991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947710|NCT01171755|Gemcitabine|gemcitabine|mesh-list
101947711|NCT01171755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101947712|NCT01171755|Antimetabolites|antimetabolites|mesh-ancestor
101667530|NCT00899821|Sargramostim|sargramostim|mesh-list
101947713|NCT01171755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947714|NCT01171755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101947715|NCT01172691|Nitric Oxide|nitric oxide|mesh-list
101947716|NCT01172691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101947717|NCT01172691|Autonomic Agents|autonomic agents|mesh-ancestor
101947718|NCT01172691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101947719|NCT01172691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947720|NCT01172691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101947721|NCT01172691|Respiratory System Agents|respiratory system agents|mesh-ancestor
101947722|NCT01172691|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101947723|NCT01172691|Antioxidants|antioxidants|mesh-ancestor
101947724|NCT01172691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947725|NCT01172691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101947726|NCT01172691|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101947727|NCT01172691|Vasodilator Agents|vasodilator agents|mesh-ancestor
101947728|NCT01172691|Gasotransmitters|gasotransmitters|mesh-ancestor
101947729|NCT01172691|Protective Agents|protective agents|mesh-ancestor
101947730|NCT01171833|Sevoflurane|sevoflurane|mesh-list
101947731|NCT01171833|Desflurane|desflurane|mesh-list
101947732|NCT01171833|Isoflurane|isoflurane|mesh-list
101947739|NCT01172769|Sirolimus|sirolimus|mesh-list
101947742|NCT01172769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-list
101947743|NCT01172769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101947744|NCT01172769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947745|NCT01172769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101947746|NCT01172769|Immunologic Factors|immunologic factors|mesh-ancestor
101947747|NCT01172769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947748|NCT01172769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101947749|NCT01172769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101947750|NCT01172769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101947751|NCT01172769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101947752|NCT01172769|Antifungal Agents|antifungal agents|mesh-ancestor
101947753|NCT01584531|ON 01910|on 01910|mesh-list
101947754|NCT01584531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101947755|NCT01584531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101947756|NCT01584531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101820499|NCT04285866|Durvalumab|durvalumab|mesh-list
101994231|NCT03441412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101994232|NCT03441412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101994233|NCT03441412|Autonomic Agents|autonomic agents|mesh-ancestor
101994234|NCT03441412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101994235|NCT03441412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101994236|NCT03441412|Respiratory System Agents|respiratory system agents|mesh-ancestor
101994237|NCT03441412|Mydriatics|mydriatics|mesh-ancestor
101994238|NCT03441412|Sympathomimetics|sympathomimetics|mesh-ancestor
101994244|NCT03441412|Purinergic Agents|purinergic agents|mesh-ancestor
101251570|NCT05219799|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101994245|NCT03441412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101994246|NCT03441412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101994248|NCT03441412|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101994249|NCT03441412|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101994250|NCT03441412|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101994251|NCT01235819|Insulin|insulin|mesh-list
101994252|NCT01235819|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101994253|NCT01235819|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101994254|NCT01235819|Exenatide|exenatide|mesh-list
101994255|NCT01235819|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
101994256|NCT01235819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101994257|NCT01235819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994258|NCT01235819|Incretins|incretins|mesh-ancestor
101994259|NCT01235819|Hormones|hormones|mesh-ancestor
101994260|NCT01235819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101994261|NCT01235819|Protease Inhibitors|protease inhibitors|mesh-ancestor
101994262|NCT01235819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101994263|NCT01235819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994264|NCT01235819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101994265|NCT05275569|Antiemetics|antiemetics|mesh-list
101994266|NCT05275569|Autonomic Agents|autonomic agents|mesh-ancestor
101994267|NCT05275569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101994268|NCT05275569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994269|NCT05275569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101994270|NCT04599933|Pilocarpine|pilocarpine|mesh-list
101994271|NCT04599933|Miotics|miotics|mesh-ancestor
101994272|NCT04599933|Autonomic Agents|autonomic agents|mesh-ancestor
101994273|NCT04599933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101994274|NCT04599933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994275|NCT04599933|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101994276|NCT04599933|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101994277|NCT04599933|Cholinergic Agents|cholinergic agents|mesh-ancestor
101994278|NCT04599933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101994279|NCT04599933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994280|NCT03440788|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101947757|NCT01584531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947758|NCT01171911|Nicardipine|nicardipine|mesh-list
101947759|NCT01171911|Calcium Channel Blockers|calcium channel blockers|mesh-list
101947760|NCT01171911|Esmolol|esmolol|mesh-list
101947761|NCT01171911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101947762|NCT01171911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947763|NCT01171911|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101947764|NCT01171911|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101947765|NCT01171911|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101947766|NCT01171911|Adrenergic Agents|adrenergic agents|mesh-ancestor
101947767|NCT01171911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101947768|NCT01171911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947769|NCT01171911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101947770|NCT01171911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101947771|NCT01171911|Vasodilator Agents|vasodilator agents|mesh-ancestor
101947772|NCT01172925|Tiotropium Bromide|tiotropium bromide|mesh-list
101947773|NCT01172925|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101947774|NCT01172925|Autonomic Agents|autonomic agents|mesh-ancestor
101947775|NCT01172925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101947776|NCT01172925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947777|NCT01172925|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101994281|NCT03440788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101994282|NCT03440788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101994283|NCT03440788|Immunotoxins|immunotoxins|mesh-ancestor
101994284|NCT03440788|Immunoconjugates|immunoconjugates|mesh-ancestor
101994285|NCT03440788|Immunologic Factors|immunologic factors|mesh-ancestor
101994286|NCT03440788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994287|NCT02824575|Paclitaxel|paclitaxel|mesh-list
101994288|NCT02824575|Rebastinib|rebastinib|mesh-list
101251642|NCT04892043|Nivolumab|nivolumab|mesh-list
101994289|NCT02824575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101994290|NCT02824575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101994291|NCT02824575|Tubulin Modulators|tubulin modulators|mesh-ancestor
101714097|NCT00910013|Anesthetics, Local|anesthetics, local|mesh-ancestor
101994292|NCT02824575|Antimitotic Agents|antimitotic agents|mesh-ancestor
101994293|NCT02824575|Mitosis Modulators|mitosis modulators|mesh-ancestor
101994294|NCT02824575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994295|NCT02824575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101994296|NCT02824575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101994297|NCT03780608|Durvalumab|durvalumab|mesh-list
101994298|NCT03780608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101994299|NCT03780608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101994300|NCT03631316|Valganciclovir|valganciclovir|mesh-list
101994301|NCT03631316|Antiviral Agents|antiviral agents|mesh-ancestor
101994302|NCT03631316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101994303|NCT03608865|Durvalumab|durvalumab|mesh-list
101994304|NCT03608865|Tremelimumab|tremelimumab|mesh-list
101994305|NCT03608865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101994306|NCT03608865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101994307|NCT03532451|Nivolumab|nivolumab|mesh-list
101994311|NCT03532451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994312|NCT04704531|Hyaluronic Acid|hyaluronic acid|mesh-list
101994313|NCT04704531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101994314|NCT04704531|Immunologic Factors|immunologic factors|mesh-ancestor
101947778|NCT01172925|Respiratory System Agents|respiratory system agents|mesh-ancestor
101947779|NCT01172925|Parasympatholytics|parasympatholytics|mesh-ancestor
101947780|NCT01172925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101947781|NCT01172925|Cholinergic Agents|cholinergic agents|mesh-ancestor
101947782|NCT01172925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101947783|NCT01172925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947784|NCT01173003|Misoprostol|misoprostol|mesh-list
101947785|NCT01173003|Mifepristone|mifepristone|mesh-list
101947786|NCT01173003|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101947787|NCT01173003|Abortifacient Agents|abortifacient agents|mesh-ancestor
101947788|NCT01173003|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101947789|NCT01173003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947790|NCT01173003|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101947791|NCT01173003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101947792|NCT01173003|Oxytocics|oxytocics|mesh-ancestor
101947793|NCT01173003|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101947794|NCT01173003|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101994315|NCT04704531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994316|NCT04704531|Viscosupplements|viscosupplements|mesh-ancestor
101994317|NCT04704531|Protective Agents|protective agents|mesh-ancestor
101994318|NCT02637531|Nivolumab|nivolumab|mesh-list
101994319|NCT02637531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101994320|NCT02637531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101994321|NCT02637531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101994322|NCT02637531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994323|NCT01237925|Chlorpheniramine|chlorpheniramine|mesh-list
101994324|NCT01237925|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
101994325|NCT01237925|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101994326|NCT01237925|Histamine Antagonists|histamine antagonists|mesh-ancestor
101994327|NCT01237925|Histamine Agents|histamine agents|mesh-ancestor
101994328|NCT01237925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101994329|NCT01237925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994330|NCT01237925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994331|NCT01237925|Antipruritics|antipruritics|mesh-ancestor
101994332|NCT01237925|Dermatologic Agents|dermatologic agents|mesh-ancestor
101994333|NCT01237925|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101994334|NCT01380548|Iron|iron|mesh-list
101994335|NCT01380548|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101994336|NCT01380548|Trace Elements|trace elements|mesh-ancestor
101994337|NCT01380548|Micronutrients|micronutrients|mesh-ancestor
101994338|NCT01380548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994339|NCT01380548|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101994340|NCT01380548|Dermatologic Agents|dermatologic agents|mesh-ancestor
101994341|NCT01313247|Acetaminophen|acetaminophen|mesh-list
101994342|NCT01313247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101994343|NCT01313247|Analgesics|analgesics|mesh-ancestor
101994344|NCT01313247|Sensory System Agents|sensory system agents|mesh-ancestor
101994345|NCT01313247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101994346|NCT01313247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994347|NCT01313247|Antipyretics|antipyretics|mesh-ancestor
101994348|NCT01142453|Interferons|interferons|mesh-list
101994349|NCT01142453|Interferon-beta|interferon-beta|mesh-list
101994350|NCT01142453|Interferon beta-1a|interferon beta-1a|mesh-list
101994351|NCT01142453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101994352|NCT01142453|Antiviral Agents|antiviral agents|mesh-ancestor
101994353|NCT01142453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101994354|NCT01142453|Immunologic Factors|immunologic factors|mesh-ancestor
101994355|NCT01142453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994356|NCT01142453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101947795|NCT01173003|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101947796|NCT01173003|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101947797|NCT01173003|Contraceptive Agents|contraceptive agents|mesh-ancestor
101820672|NCT05254548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101994357|NCT04701424|Insulin|insulin|mesh-list
101994358|NCT04701424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101994359|NCT04701424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994360|NCT03560193|Chlorhexidine|chlorhexidine|mesh-list
101994361|NCT03560193|Ethanol|ethanol|mesh-list
101994362|NCT03560193|Povidone-Iodine|povidone-iodine|mesh-list
101994363|NCT03560193|Povidone|povidone|mesh-list
101994364|NCT03560193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101994365|NCT03560193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101994366|NCT03560193|Disinfectants|disinfectants|mesh-ancestor
101994367|NCT03560193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101994368|NCT03560193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994369|NCT03560193|Plasma Substitutes|plasma substitutes|mesh-ancestor
101994370|NCT03560193|Blood Substitutes|blood substitutes|mesh-ancestor
101994371|NCT04451200|Busulfan|busulfan|mesh-list
101994372|NCT04451200|Alkylating Agents|alkylating agents|mesh-ancestor
101994373|NCT04451200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994374|NCT04451200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101994375|NCT04451200|Immunologic Factors|immunologic factors|mesh-ancestor
101994376|NCT04451200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994377|NCT04451200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101994378|NCT04451200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101994379|NCT04451200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101994380|NCT04678479|Ganaxolone|ganaxolone|mesh-list
101994381|NCT04678479|Neurosteroids|neurosteroids|mesh-ancestor
101994386|NCT04678479|GABA Agents|gaba agents|mesh-ancestor
101994387|NCT04668118|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101994388|NCT04668118|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101994389|NCT02251821|Mycophenolic Acid|mycophenolic acid|mesh-list
101994390|NCT02251821|Cyclophosphamide|cyclophosphamide|mesh-list
101994391|NCT02251821|Melphalan|melphalan|mesh-list
101994392|NCT02251821|Busulfan|busulfan|mesh-list
101994393|NCT02251821|Mechlorethamine|mechlorethamine|mesh-list
101994394|NCT02251821|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
101994395|NCT02251821|Methotrexate|methotrexate|mesh-list
101994396|NCT02251821|Fludarabine|fludarabine|mesh-list
101994397|NCT02251821|Fludarabine phosphate|fludarabine phosphate|mesh-list
101994398|NCT02251821|Tacrolimus|tacrolimus|mesh-list
101994399|NCT02251821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101994400|NCT02251821|Immunologic Factors|immunologic factors|mesh-ancestor
101994401|NCT02251821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994402|NCT02251821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101994403|NCT02251821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101994404|NCT02251821|Alkylating Agents|alkylating agents|mesh-ancestor
101994405|NCT02251821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994406|NCT02251821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101994407|NCT02251821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101994408|NCT02251821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101994409|NCT02251821|Abortifacient Agents|abortifacient agents|mesh-ancestor
101994410|NCT02251821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101994411|NCT02251821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101994412|NCT02251821|Antimetabolites|antimetabolites|mesh-ancestor
101994413|NCT02251821|Dermatologic Agents|dermatologic agents|mesh-ancestor
101994414|NCT02251821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101994415|NCT02251821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101251781|NCT04594187|Immunologic Factors|immunologic factors|mesh-ancestor
101994416|NCT02251821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101994417|NCT02251821|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101994418|NCT02251821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101994419|NCT02251821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101994420|NCT02251821|Antitubercular Agents|antitubercular agents|mesh-ancestor
101994421|NCT02251821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101994422|NCT02251821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101994423|NCT03784781|Dimercaprol|dimercaprol|mesh-list
101994424|NCT03784781|Chelating Agents|chelating agents|mesh-ancestor
101994425|NCT03784781|Sequestering Agents|sequestering agents|mesh-ancestor
101994426|NCT03784781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994427|NCT03428477|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
101994428|NCT03428477|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101994429|NCT03428477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101994430|NCT03425201|Niraparib|niraparib|mesh-list
101947798|NCT01173003|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101947799|NCT01173003|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101947800|NCT01173003|Hormone Antagonists|hormone antagonists|mesh-ancestor
101947801|NCT01173003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101947802|NCT01173003|Luteolytic Agents|luteolytic agents|mesh-ancestor
101947803|NCT01173003|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101947804|NCT01173003|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101947805|NCT03435003|Dexamethasone|dexamethasone|mesh-list
101947806|NCT03435003|Fentanyl|fentanyl|mesh-list
101947807|NCT03435003|Scopolamine|scopolamine|mesh-list
101947808|NCT03435003|Dexmedetomidine|dexmedetomidine|mesh-list
101947809|NCT03435003|Ondansetron|ondansetron|mesh-list
101947810|NCT03435003|Aprepitant|aprepitant|mesh-list
101947811|NCT03435003|Metoclopramide|metoclopramide|mesh-list
101947812|NCT03435003|Prochlorperazine|prochlorperazine|mesh-list
101947813|NCT03435003|Propofol|propofol|mesh-list
101947814|NCT03435003|Sevoflurane|sevoflurane|mesh-list
101947815|NCT03435003|Desflurane|desflurane|mesh-list
101947816|NCT03435003|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101947817|NCT03435003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101947818|NCT03435003|Antiemetics|antiemetics|mesh-ancestor
101947819|NCT03435003|Autonomic Agents|autonomic agents|mesh-ancestor
101820745|NCT01027377|Factor VIII|factor viii|mesh-list
101994431|NCT03425201|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101994432|NCT03425201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101994433|NCT03425201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994434|NCT03425201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101994435|NCT03438604|Donepezil|donepezil|mesh-list
101994436|NCT03438604|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101994437|NCT03438604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101994438|NCT03438604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994439|NCT03438604|Cholinergic Agents|cholinergic agents|mesh-ancestor
101994440|NCT03438604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101994441|NCT03438604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994442|NCT03438604|Nootropic Agents|nootropic agents|mesh-ancestor
101994443|NCT03433378|Tretinoin|tretinoin|mesh-list
101994444|NCT03433378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101994445|NCT03433378|Keratolytic Agents|keratolytic agents|mesh-ancestor
101994447|NCT03433222|Coal Tar|coal tar|mesh-list
101994448|NCT03433222|Keratolytic Agents|keratolytic agents|mesh-ancestor
101994449|NCT03433222|Dermatologic Agents|dermatologic agents|mesh-ancestor
101994450|NCT05016076|Dexamethasone|dexamethasone|mesh-list
101994451|NCT05016076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101994452|NCT05016076|Antiemetics|antiemetics|mesh-ancestor
101994453|NCT05016076|Autonomic Agents|autonomic agents|mesh-ancestor
101449488|NCT00214266|Mycophenolic Acid|mycophenolic acid|mesh-list
101994465|NCT03319953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994466|NCT03319953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101994467|NCT03433144|Tranexamic Acid|tranexamic acid|mesh-list
101994468|NCT03433144|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101994469|NCT03433144|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101994470|NCT03433144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994471|NCT03433144|Hemostatics|hemostatics|mesh-ancestor
101994472|NCT03433144|Coagulants|coagulants|mesh-ancestor
101994473|NCT01384214|Botulinum Toxins|botulinum toxins|mesh-list
101994474|NCT01384214|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101994475|NCT01384214|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101947820|NCT03435003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101947821|NCT03435003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947822|NCT03435003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101947823|NCT03435003|Glucocorticoids|glucocorticoids|mesh-ancestor
101947824|NCT03435003|Hormones|hormones|mesh-ancestor
101820798|NCT03439254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101994476|NCT01384214|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101994477|NCT01384214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101994478|NCT01384214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994479|NCT01384214|Cholinergic Agents|cholinergic agents|mesh-ancestor
101994480|NCT01384214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101994481|NCT01384214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994482|NCT01384214|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101994483|NCT01384214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101994484|NCT02927834|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101994485|NCT02927834|Prednisone|prednisone|mesh-list
101994486|NCT02927834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101994487|NCT02927834|Glucocorticoids|glucocorticoids|mesh-ancestor
101994488|NCT02927834|Hormones|hormones|mesh-ancestor
101994489|NCT02927834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101994490|NCT02927834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994491|NCT02927834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101994492|NCT02927834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101994493|NCT02927834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101994494|NCT02927834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101994495|NCT02927834|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101994496|NCT02927834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101994497|NCT02927834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994498|NCT03170180|Sunitinib|sunitinib|mesh-list
101994499|NCT03170180|Imatinib Mesylate|imatinib mesylate|mesh-list
101994500|NCT03170180|Gefitinib|gefitinib|mesh-list
101994501|NCT03170180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101994502|NCT03170180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101994503|NCT03170180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101994504|NCT03170180|Growth Substances|growth substances|mesh-ancestor
101994505|NCT03170180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994506|NCT03170180|Growth Inhibitors|growth inhibitors|mesh-ancestor
101994507|NCT03170180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101994508|NCT03170180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101994509|NCT03170180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994510|NCT03319667|Dexamethasone|dexamethasone|mesh-list
101994511|NCT03319667|Lenalidomide|lenalidomide|mesh-list
101994512|NCT03319667|Bortezomib|bortezomib|mesh-list
101994513|NCT03319667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101994514|NCT03319667|Antiemetics|antiemetics|mesh-ancestor
101994515|NCT03319667|Autonomic Agents|autonomic agents|mesh-ancestor
101994518|NCT03319667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101994519|NCT03319667|Glucocorticoids|glucocorticoids|mesh-ancestor
101994520|NCT03319667|Hormones|hormones|mesh-ancestor
101994521|NCT03319667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101994522|NCT03319667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101994523|NCT03319667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101994524|NCT03319667|Immunologic Factors|immunologic factors|mesh-ancestor
101994525|NCT03319667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101994526|NCT03319667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101994527|NCT03319667|Growth Substances|growth substances|mesh-ancestor
101994528|NCT03319667|Growth Inhibitors|growth inhibitors|mesh-ancestor
101994529|NCT03432676|Pembrolizumab|pembrolizumab|mesh-list
101994530|NCT03432676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101994531|NCT03432676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101994532|NCT03432676|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101994533|NCT03432676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994534|NCT03432598|Paclitaxel|paclitaxel|mesh-list
101994535|NCT03432598|Etoposide|etoposide|mesh-list
101994536|NCT03432598|Carboplatin|carboplatin|mesh-list
101994537|NCT03432598|Gemcitabine|gemcitabine|mesh-list
101994538|NCT03432598|Pemetrexed|pemetrexed|mesh-list
101994539|NCT03432598|Tislelizumab|tislelizumab|mesh-list
101994540|NCT03432598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101971959|NCT00315640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101994541|NCT03432598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101994542|NCT03432598|Tubulin Modulators|tubulin modulators|mesh-ancestor
101994543|NCT03432598|Antimitotic Agents|antimitotic agents|mesh-ancestor
101994544|NCT03432598|Mitosis Modulators|mitosis modulators|mesh-ancestor
101994545|NCT03432598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994546|NCT03432598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101994547|NCT03432598|Antimetabolites|antimetabolites|mesh-ancestor
101994548|NCT03432598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101994549|NCT03432598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101994550|NCT03432598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101994551|NCT03432598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101994552|NCT03432598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101994553|NCT03432598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101994554|NCT03432442|Ivermectin|ivermectin|mesh-list
101994555|NCT03432442|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101994556|NCT03432442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101994557|NCT01964547|Nabiximols|nabiximols|mesh-list
101994558|NCT01964547|Analgesics|analgesics|mesh-ancestor
101994559|NCT01964547|Sensory System Agents|sensory system agents|mesh-ancestor
101994560|NCT01964547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101994561|NCT01964547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994562|NCT01380314|Miltefosine|miltefosine|mesh-list
101994563|NCT01380314|Imiquimod|imiquimod|mesh-list
101994564|NCT01380314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101994565|NCT01380314|Immunologic Factors|immunologic factors|mesh-ancestor
101994566|NCT01380314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994567|NCT01380314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101994568|NCT01380314|Interferon Inducers|interferon inducers|mesh-ancestor
101994569|NCT01380314|Antifungal Agents|antifungal agents|mesh-ancestor
101994570|NCT01380314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101994571|NCT01380314|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101994572|NCT01380314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101994573|NCT03110510|Leucovorin|leucovorin|mesh-list
101994574|NCT03110510|Fluorouracil|fluorouracil|mesh-list
101994575|NCT03110510|Irinotecan|irinotecan|mesh-list
101994576|NCT03110510|Calcium|calcium|mesh-list
101994577|NCT03110510|Levoleucovorin|levoleucovorin|mesh-list
101994578|NCT03110510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101994579|NCT03110510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994580|NCT03110510|Antimetabolites|antimetabolites|mesh-ancestor
101994581|NCT03110510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994582|NCT03110510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101994583|NCT03110510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101994584|NCT03110510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101994585|NCT03110510|Immunologic Factors|immunologic factors|mesh-ancestor
101994586|NCT03110510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101994587|NCT03110510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101994588|NCT03110510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101994589|NCT03110510|Antidotes|antidotes|mesh-ancestor
101994590|NCT03110510|Protective Agents|protective agents|mesh-ancestor
101994596|NCT01238237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101994597|NCT03319719|Lidocaine|lidocaine|mesh-list
101994598|NCT03319719|Hyaluronic Acid|hyaluronic acid|mesh-list
101994599|NCT03319719|Anesthetics, Local|anesthetics, local|mesh-ancestor
101994600|NCT03319719|Anesthetics|anesthetics|mesh-ancestor
101994601|NCT03319719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101994602|NCT03319719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994603|NCT03319719|Sensory System Agents|sensory system agents|mesh-ancestor
101994604|NCT03319719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101994605|NCT03319719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101994606|NCT03319719|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101994607|NCT03319719|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101994608|NCT03319719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101994609|NCT03319719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994610|NCT03319719|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101994611|NCT03319719|Immunologic Factors|immunologic factors|mesh-ancestor
101994612|NCT03319719|Viscosupplements|viscosupplements|mesh-ancestor
101994613|NCT03319719|Protective Agents|protective agents|mesh-ancestor
101994614|NCT03128242|Oxytocin|oxytocin|mesh-list
101994615|NCT03128242|Oxytocics|oxytocics|mesh-ancestor
101994616|NCT03128242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101994617|NCT03128242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994618|NCT01313689|Ofatumumab|ofatumumab|mesh-list
101947825|NCT03435003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101947826|NCT03435003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101947827|NCT03435003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101947828|NCT03435003|Anesthetics|anesthetics|mesh-ancestor
101994619|NCT01313689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101994620|NCT03431272|Lifitegrast|lifitegrast|mesh-list
101994621|NCT03431272|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101994622|NCT03431272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101994623|NCT02528513|Fentanyl|fentanyl|mesh-list
101994624|NCT02528513|Midazolam|midazolam|mesh-list
101994625|NCT02528513|Dexmedetomidine|dexmedetomidine|mesh-list
101994626|NCT02528513|Propofol|propofol|mesh-list
101994627|NCT02528513|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101994628|NCT02528513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101994629|NCT02528513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994630|NCT02528513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101994631|NCT02528513|Analgesics|analgesics|mesh-ancestor
101994632|NCT02528513|Sensory System Agents|sensory system agents|mesh-ancestor
101994633|NCT02528513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101994634|NCT02528513|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101994635|NCT02528513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101994636|NCT02528513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101994637|NCT02528513|Adrenergic Agents|adrenergic agents|mesh-ancestor
101994638|NCT02528513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101994639|NCT02528513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994640|NCT02528513|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101994641|NCT02528513|Anesthetics, General|anesthetics, general|mesh-ancestor
101994642|NCT02528513|Anesthetics|anesthetics|mesh-ancestor
101994643|NCT02528513|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101994644|NCT02528513|Narcotics|narcotics|mesh-ancestor
101994645|NCT02528513|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101994646|NCT02528513|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101994647|NCT02528513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101994648|NCT02528513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101994649|NCT02528513|GABA Modulators|gaba modulators|mesh-ancestor
101994650|NCT02528513|GABA Agents|gaba agents|mesh-ancestor
101994651|NCT01320007|Furosemide|furosemide|mesh-list
101994652|NCT01320007|Diuretics|diuretics|mesh-ancestor
101994653|NCT01320007|Natriuretic Agents|natriuretic agents|mesh-ancestor
101994654|NCT01320007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994655|NCT01320007|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101994656|NCT01320007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101994657|NCT01320007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994658|NCT03318315|Vaccines|vaccines|mesh-list
101994659|NCT03318315|Immunologic Factors|immunologic factors|mesh-ancestor
101994660|NCT03318315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994661|NCT04460183|Nitric Oxide|nitric oxide|mesh-list
101994662|NCT04460183|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101449690|NCT00191750|Pemetrexed|pemetrexed|mesh-list
101994666|NCT04460183|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101994667|NCT04460183|Respiratory System Agents|respiratory system agents|mesh-ancestor
101994668|NCT04460183|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101994669|NCT04460183|Antioxidants|antioxidants|mesh-ancestor
101994670|NCT04460183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994671|NCT04460183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101575011|NCT01179516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994672|NCT04460183|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101994673|NCT04460183|Vasodilator Agents|vasodilator agents|mesh-ancestor
101994674|NCT04460183|Gasotransmitters|gasotransmitters|mesh-ancestor
101994675|NCT04460183|Protective Agents|protective agents|mesh-ancestor
101994676|NCT01243697|Desogestrel|desogestrel|mesh-list
101994677|NCT01243697|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101994678|NCT01243697|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101994679|NCT01243697|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101994680|NCT01243697|Contraceptive Agents|contraceptive agents|mesh-ancestor
101994681|NCT01243697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101994682|NCT01243697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994683|NCT01243697|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101994684|NCT01243697|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101994685|NCT01243697|Progestins|progestins|mesh-ancestor
101994686|NCT01243697|Hormones|hormones|mesh-ancestor
101947829|NCT03435003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101947830|NCT03435003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101947831|NCT03435003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101947832|NCT03435003|Analgesics|analgesics|mesh-ancestor
101947833|NCT03435003|Sensory System Agents|sensory system agents|mesh-ancestor
101947834|NCT03435003|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101947835|NCT03435003|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101947836|NCT03435003|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101947837|NCT03435003|Adrenergic Agents|adrenergic agents|mesh-ancestor
101947838|NCT03435003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101947839|NCT03435003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947840|NCT03435003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101947841|NCT03435003|Anesthetics, General|anesthetics, general|mesh-ancestor
101947842|NCT03435003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101947843|NCT03435003|Narcotics|narcotics|mesh-ancestor
101947844|NCT03435003|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101994687|NCT01243697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101994688|NCT04703101|Leucovorin|leucovorin|mesh-list
101994689|NCT04703101|Fluorouracil|fluorouracil|mesh-list
101994690|NCT04703101|Capecitabine|capecitabine|mesh-list
101994691|NCT04703101|Oxaliplatin|oxaliplatin|mesh-list
101994692|NCT04703101|Antimetabolites|antimetabolites|mesh-ancestor
101994693|NCT04703101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994694|NCT04703101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101994695|NCT04703101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101994696|NCT04703101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101994697|NCT04703101|Immunologic Factors|immunologic factors|mesh-ancestor
101994698|NCT04703101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994699|NCT04703101|Antidotes|antidotes|mesh-ancestor
101994700|NCT04703101|Protective Agents|protective agents|mesh-ancestor
101994701|NCT04703101|Vitamin B Complex|vitamin b complex|mesh-ancestor
101994702|NCT04703101|Vitamins|vitamins|mesh-ancestor
101994703|NCT04703101|Micronutrients|micronutrients|mesh-ancestor
101994704|NCT01145573|Calcium|calcium|mesh-list
101994705|NCT01145573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101994706|NCT01145573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994707|NCT01320709|Piroxicam|piroxicam|mesh-list
101994708|NCT01320709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101994709|NCT01320709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101994710|NCT01320709|Analgesics|analgesics|mesh-ancestor
101994711|NCT01320709|Sensory System Agents|sensory system agents|mesh-ancestor
101994712|NCT01320709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101994713|NCT01320709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994714|NCT01320709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101994715|NCT01320709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101994716|NCT01320709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101994717|NCT01320709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101994718|NCT01320709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994719|NCT01238393|Ranibizumab|ranibizumab|mesh-list
101994720|NCT01238393|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101994721|NCT01238393|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101994722|NCT01238393|Growth Substances|growth substances|mesh-ancestor
101994723|NCT01238393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994724|NCT01238393|Growth Inhibitors|growth inhibitors|mesh-ancestor
101994725|NCT01238393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101994726|NCT03776305|Imipenem|imipenem|mesh-list
101994727|NCT03776305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101994728|NCT03776305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101994729|NCT01146509|Donepezil|donepezil|mesh-list
101947845|NCT03435003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101947846|NCT03435003|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101947847|NCT03435003|Antipruritics|antipruritics|mesh-ancestor
101947848|NCT03435003|Dermatologic Agents|dermatologic agents|mesh-ancestor
101994730|NCT01146509|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101994731|NCT01146509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101994732|NCT01146509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994733|NCT01146509|Cholinergic Agents|cholinergic agents|mesh-ancestor
101994738|NCT03775993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101994740|NCT03316131|Dapagliflozin|dapagliflozin|mesh-list
101994741|NCT03316131|Febuxostat|febuxostat|mesh-list
101994742|NCT03316131|Verinurad|verinurad|mesh-list
101994743|NCT03316131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101387629|NCT00122343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101994744|NCT03316131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994745|NCT03316131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101994746|NCT03316131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994747|NCT03316131|Gout Suppressants|gout suppressants|mesh-ancestor
101994748|NCT03316131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101994749|NCT03779659|Anesthetics|anesthetics|mesh-list
101994750|NCT03779659|Benzocaine|benzocaine|mesh-list
101994751|NCT03779659|Anesthetics, Local|anesthetics, local|mesh-list
101994752|NCT03779659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101994753|NCT03779659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994754|NCT03779659|Sensory System Agents|sensory system agents|mesh-ancestor
101994755|NCT03779659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101994756|NCT01145807|Terbinafine|terbinafine|mesh-list
101994757|NCT01145807|Antifungal Agents|antifungal agents|mesh-ancestor
101994758|NCT01145807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101994759|NCT01145807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101994760|NCT01145807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994761|NCT03898895|Antibodies|antibodies|mesh-list
101994762|NCT03898895|Immunologic Factors|immunologic factors|mesh-ancestor
101994763|NCT03898895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994764|NCT01245569|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101994765|NCT01245569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101994766|NCT01245569|Autonomic Agents|autonomic agents|mesh-ancestor
101994767|NCT01245569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101994768|NCT01245569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994769|NCT01245569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101994770|NCT01245569|Respiratory System Agents|respiratory system agents|mesh-ancestor
101994771|NCT01245569|Glucocorticoids|glucocorticoids|mesh-ancestor
101994772|NCT01245569|Hormones|hormones|mesh-ancestor
101994773|NCT01245569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101994774|NCT01245569|Sympathomimetics|sympathomimetics|mesh-ancestor
101994775|NCT01314859|Nifedipine|nifedipine|mesh-list
101994776|NCT01314859|Atosiban|atosiban|mesh-list
101994777|NCT01314859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101994778|NCT01314859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101994779|NCT01314859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994780|NCT01314859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101994781|NCT01314859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994782|NCT01314859|Vasodilator Agents|vasodilator agents|mesh-ancestor
101994783|NCT01314859|Tocolytic Agents|tocolytic agents|mesh-ancestor
101994784|NCT01314859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101994785|NCT01314859|Hormone Antagonists|hormone antagonists|mesh-ancestor
101994786|NCT01314859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101994787|NCT02528279|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101994788|NCT02528279|Antimalarials|antimalarials|mesh-ancestor
101994789|NCT02528279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101994790|NCT02528279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101994791|NCT02528279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101994792|NCT01238627|Nicotine|nicotine|mesh-list
101994793|NCT01238627|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101994794|NCT01238627|Autonomic Agents|autonomic agents|mesh-ancestor
101994795|NCT01238627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101994796|NCT01238627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994797|NCT01238627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101994798|NCT01238627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101994799|NCT01238627|Cholinergic Agents|cholinergic agents|mesh-ancestor
101994800|NCT01238627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101947849|NCT03435003|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101947850|NCT03435003|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101947851|NCT03435003|Serotonin Agents|serotonin agents|mesh-ancestor
101947852|NCT03435003|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101947853|NCT03435003|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101947854|NCT03435003|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101947855|NCT03435003|Dopamine Agents|dopamine agents|mesh-ancestor
101947856|NCT03435003|Mydriatics|mydriatics|mesh-ancestor
101947857|NCT03435003|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101947858|NCT03435003|Cholinergic Agents|cholinergic agents|mesh-ancestor
101947859|NCT03435003|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101994801|NCT01238627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994802|NCT01321021|Diphenhydramine|diphenhydramine|mesh-list
101994806|NCT01321021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101994807|NCT01321021|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101994808|NCT01321021|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101994809|NCT01321021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994810|NCT01321021|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101994811|NCT01321021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101994812|NCT01321021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101994813|NCT01321021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994814|NCT01321021|Anesthetics, Local|anesthetics, local|mesh-ancestor
101994815|NCT01321021|Anesthetics|anesthetics|mesh-ancestor
101994816|NCT01321021|Sensory System Agents|sensory system agents|mesh-ancestor
101994817|NCT01321021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101994818|NCT01321021|Antiemetics|antiemetics|mesh-ancestor
101994819|NCT01321021|Autonomic Agents|autonomic agents|mesh-ancestor
101994820|NCT01321021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101994821|NCT01321021|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101994822|NCT01321021|Histamine Antagonists|histamine antagonists|mesh-ancestor
101994823|NCT01321021|Histamine Agents|histamine agents|mesh-ancestor
101994824|NCT01321021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101994825|NCT01321021|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101994827|NCT01321021|Dermatologic Agents|dermatologic agents|mesh-ancestor
101994828|NCT01238705|Metoprolol|metoprolol|mesh-list
101994829|NCT01238705|Felodipine|felodipine|mesh-list
101994830|NCT01238705|Irbesartan|irbesartan|mesh-list
101994831|NCT01238705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101994832|NCT01238705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101994833|NCT01238705|Sympatholytics|sympatholytics|mesh-ancestor
101994834|NCT01238705|Autonomic Agents|autonomic agents|mesh-ancestor
101994835|NCT01238705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101994836|NCT01238705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994837|NCT01238705|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101994838|NCT01238705|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101994839|NCT01238705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101994840|NCT01238705|Adrenergic Agents|adrenergic agents|mesh-ancestor
101994841|NCT01238705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101994842|NCT01238705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994843|NCT01238705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101994844|NCT01238705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101994845|NCT01238705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101994846|NCT01238705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101994847|NCT01238705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101994848|NCT01238705|Vasodilator Agents|vasodilator agents|mesh-ancestor
101994849|NCT03779347|Praziquantel|praziquantel|mesh-list
101994850|NCT03779347|Anthelmintics|anthelmintics|mesh-ancestor
101994851|NCT03779347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101994852|NCT03779347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101994853|NCT01321099|Fe(III)-EDTA|fe(iii)-edta|mesh-list
101994854|NCT01321099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994855|NCT01321099|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101994856|NCT01321099|Chelating Agents|chelating agents|mesh-ancestor
101947860|NCT03435003|Parasympatholytics|parasympatholytics|mesh-ancestor
101947861|NCT03435003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101947862|NCT03435003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101947863|NCT03435003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101947864|NCT01172223|Paclitaxel|paclitaxel|mesh-list
101947865|NCT01172223|Doxorubicin|doxorubicin|mesh-list
101947866|NCT01172223|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101947867|NCT01172223|Lapatinib|lapatinib|mesh-list
101947868|NCT01172223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101947869|NCT01172223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101947870|NCT01172223|Tubulin Modulators|tubulin modulators|mesh-ancestor
101947871|NCT01172223|Antimitotic Agents|antimitotic agents|mesh-ancestor
101947872|NCT01172223|Mitosis Modulators|mitosis modulators|mesh-ancestor
101947873|NCT01172223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947874|NCT01172223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101947875|NCT01172223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101947876|NCT01172223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101947877|NCT01172223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101947878|NCT01172223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101947879|NCT01173081|Teriparatide|teriparatide|mesh-list
101947880|NCT01173081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101947881|NCT01173081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821202|NCT01001364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101994857|NCT01321099|Sequestering Agents|sequestering agents|mesh-ancestor
101994858|NCT01245725|Tirofiban|tirofiban|mesh-list
101994859|NCT01245725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101994860|NCT01245725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101994861|NCT01245725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994862|NCT01245725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101994863|NCT01143545|Celecoxib|celecoxib|mesh-list
101994864|NCT01143545|Cyclophosphamide|cyclophosphamide|mesh-list
101994865|NCT01143545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101994866|NCT01143545|Immunologic Factors|immunologic factors|mesh-ancestor
101994867|NCT01143545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994868|NCT01143545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101994869|NCT01143545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101994870|NCT01143545|Alkylating Agents|alkylating agents|mesh-ancestor
101994871|NCT01143545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994872|NCT01143545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101994873|NCT01143545|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101994874|NCT01143545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101449899|NCT00473824|Immunoglobulins|immunoglobulins|mesh-list
101994879|NCT01143545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101994880|NCT01143545|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101994881|NCT01143545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101994882|NCT01143545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101994883|NCT03779035|Gemcitabine|gemcitabine|mesh-list
101994884|NCT03779035|Capecitabine|capecitabine|mesh-list
101994885|NCT03779035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101994886|NCT03779035|Antimetabolites|antimetabolites|mesh-ancestor
101994887|NCT03779035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994888|NCT03779035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101994889|NCT01586117|Amifostine|amifostine|mesh-list
101947882|NCT01173081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101947883|NCT03866733|Narcotics|narcotics|mesh-list
101947884|NCT03866733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101947885|NCT03866733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947886|NCT03866733|Analgesics|analgesics|mesh-ancestor
101947887|NCT03866733|Sensory System Agents|sensory system agents|mesh-ancestor
101947888|NCT03866733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101947889|NCT01168791|Doxorubicin|doxorubicin|mesh-list
101947890|NCT01168791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101947891|NCT01168791|Isophosphamide mustard|isophosphamide mustard|mesh-list
101947892|NCT01168791|Ifosfamide|ifosfamide|mesh-list
101947893|NCT01168791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101947894|NCT01168791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101947895|NCT01168791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101947896|NCT01168791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101947897|NCT01168791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101947898|NCT01168791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947899|NCT01168791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101947900|NCT01168791|Alkylating Agents|alkylating agents|mesh-ancestor
101947901|NCT01284309|Mirabegron|mirabegron|mesh-list
101947902|NCT01284309|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101821269|NCT00424749|Prednisone|prednisone|mesh-list
101994890|NCT01586117|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101994891|NCT01586117|Protective Agents|protective agents|mesh-ancestor
101994892|NCT01586117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994893|NCT03301415|Valganciclovir|valganciclovir|mesh-list
101994894|NCT03301415|Antiviral Agents|antiviral agents|mesh-ancestor
101994895|NCT03301415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101994896|NCT05449015|Atropine|atropine|mesh-list
101994897|NCT05449015|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101994898|NCT05449015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101994899|NCT05449015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101994900|NCT05449015|Autonomic Agents|autonomic agents|mesh-ancestor
101994901|NCT05449015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101994902|NCT05449015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994903|NCT05449015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101994904|NCT05449015|Respiratory System Agents|respiratory system agents|mesh-ancestor
101994906|NCT05449015|Parasympatholytics|parasympatholytics|mesh-ancestor
101994907|NCT05449015|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101994908|NCT05449015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101994909|NCT05449015|Cholinergic Agents|cholinergic agents|mesh-ancestor
101994910|NCT05449015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101994911|NCT05449015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994912|NCT01239017|Fasinumab|fasinumab|mesh-list
101994913|NCT01239017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101994914|NCT01239017|Analgesics|analgesics|mesh-ancestor
101994915|NCT01239017|Sensory System Agents|sensory system agents|mesh-ancestor
101994916|NCT01239017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101994917|NCT01239017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994918|NCT02732938|Paclitaxel|paclitaxel|mesh-list
101994919|NCT02732938|Gemcitabine|gemcitabine|mesh-list
101994920|NCT02732938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101994921|NCT02732938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101994922|NCT02732938|Tubulin Modulators|tubulin modulators|mesh-ancestor
101947903|NCT01284309|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101947904|NCT01284309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101947905|NCT01284309|Adrenergic Agents|adrenergic agents|mesh-ancestor
101947906|NCT01284309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101947907|NCT01284309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947908|NCT01284309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947909|NCT01284309|Urological Agents|urological agents|mesh-ancestor
101947910|NCT01173237|Pulmonary Surfactants|pulmonary surfactants|mesh-list
101947911|NCT01173237|Respiratory System Agents|respiratory system agents|mesh-ancestor
101994923|NCT02732938|Antimitotic Agents|antimitotic agents|mesh-ancestor
101994924|NCT02732938|Mitosis Modulators|mitosis modulators|mesh-ancestor
101994925|NCT02732938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994926|NCT02732938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101994927|NCT02732938|Antimetabolites|antimetabolites|mesh-ancestor
101994929|NCT03778723|Anesthetics|anesthetics|mesh-list
101994930|NCT03778723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101994931|NCT03778723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994932|NCT03778723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101994933|NCT03778723|Narcotics|narcotics|mesh-ancestor
101994934|NCT03778723|Analgesics|analgesics|mesh-ancestor
101994935|NCT03778723|Sensory System Agents|sensory system agents|mesh-ancestor
101994936|NCT03778723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101994937|NCT03778723|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101994938|NCT03778723|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101994939|NCT03778723|Anesthetics, General|anesthetics, general|mesh-ancestor
101994940|NCT01245959|Cisplatin|cisplatin|mesh-list
101994941|NCT01245959|Docetaxel|docetaxel|mesh-list
101994942|NCT01245959|Fluorouracil|fluorouracil|mesh-list
101994943|NCT01245959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101994944|NCT01245959|Tubulin Modulators|tubulin modulators|mesh-ancestor
101994945|NCT01245959|Antimitotic Agents|antimitotic agents|mesh-ancestor
101994946|NCT01245959|Mitosis Modulators|mitosis modulators|mesh-ancestor
101994947|NCT01245959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994948|NCT01245959|Antimetabolites|antimetabolites|mesh-ancestor
101994952|NCT01245959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994953|NCT03778645|Epinephrine|epinephrine|mesh-list
101994954|NCT03778645|Racepinephrine|racepinephrine|mesh-list
101994955|NCT03778645|Epinephryl borate|epinephryl borate|mesh-list
101994956|NCT03778645|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101994957|NCT03778645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101994958|NCT03778645|Adrenergic Agents|adrenergic agents|mesh-ancestor
101994959|NCT03778645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101994960|NCT03778645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994961|NCT03778645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994962|NCT03778645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101994963|NCT03778645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101994964|NCT03778645|Autonomic Agents|autonomic agents|mesh-ancestor
101994965|NCT03778645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101994966|NCT03778645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101994967|NCT03778645|Respiratory System Agents|respiratory system agents|mesh-ancestor
101994968|NCT03778645|Mydriatics|mydriatics|mesh-ancestor
101994969|NCT03778645|Sympathomimetics|sympathomimetics|mesh-ancestor
101994970|NCT03778645|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101994971|NCT04326478|Azithromycin|azithromycin|mesh-list
101994972|NCT04326478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101994973|NCT04326478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101994974|NCT04647721|Hyaluronic Acid|hyaluronic acid|mesh-list
101714834|NCT02674139|Copper|copper|mesh-list
101994975|NCT04647721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994976|NCT04647721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101994977|NCT04647721|Immunologic Factors|immunologic factors|mesh-ancestor
101994978|NCT04647721|Viscosupplements|viscosupplements|mesh-ancestor
101994979|NCT04647721|Protective Agents|protective agents|mesh-ancestor
101994980|NCT03470038|Mitogens|mitogens|mesh-list
101994981|NCT03470038|Mitosis Modulators|mitosis modulators|mesh-ancestor
101994982|NCT03470038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994983|NCT03250325|Cyclophosphamide|cyclophosphamide|mesh-list
101947912|NCT01169025|Fentanyl|fentanyl|mesh-list
101947913|NCT01169025|Ketamine|ketamine|mesh-list
101947914|NCT01169025|Analgesics|analgesics|mesh-ancestor
101947915|NCT01169025|Sensory System Agents|sensory system agents|mesh-ancestor
101947916|NCT01169025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101947917|NCT01169025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947918|NCT01169025|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101947919|NCT01169025|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101947920|NCT01169025|Anesthetics, General|anesthetics, general|mesh-ancestor
101947921|NCT01169025|Anesthetics|anesthetics|mesh-ancestor
101947922|NCT01169025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101947923|NCT01169025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101947924|NCT01169025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101947925|NCT01169025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101947926|NCT01169025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821374|NCT01031901|Sirolimus|sirolimus|mesh-list
101994984|NCT03250325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101994985|NCT03250325|Immunologic Factors|immunologic factors|mesh-ancestor
101994986|NCT03250325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994987|NCT03250325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101994988|NCT03250325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101994989|NCT03250325|Alkylating Agents|alkylating agents|mesh-ancestor
101994990|NCT03250325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994991|NCT03250325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101994992|NCT03250325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101994993|NCT03778567|Lamivudine|lamivudine|mesh-list
101994994|NCT03778567|Telbivudine|telbivudine|mesh-list
101994995|NCT03778567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101994996|NCT03778567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101994997|NCT03778567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101994998|NCT03778567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994999|NCT03778567|Antiviral Agents|antiviral agents|mesh-ancestor
101995000|NCT03778567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101995001|NCT03778567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101995002|NCT03778567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101995003|NCT03784066|Durvalumab|durvalumab|mesh-list
101995004|NCT03784066|Tremelimumab|tremelimumab|mesh-list
101995005|NCT03784066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101995006|NCT03784066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101995007|NCT03784066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101995008|NCT03784066|Immunologic Factors|immunologic factors|mesh-ancestor
101995009|NCT03784066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995010|NCT05168683|Rasburicase|rasburicase|mesh-list
101995011|NCT05168683|Uric Acid|uric acid|mesh-list
101995012|NCT05168683|Antioxidants|antioxidants|mesh-ancestor
101995013|NCT05168683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995014|NCT05168683|Protective Agents|protective agents|mesh-ancestor
101995015|NCT05168683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995016|NCT05168683|Gout Suppressants|gout suppressants|mesh-ancestor
101995017|NCT05168683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101995018|NCT03113123|Tenofovir|tenofovir|mesh-list
101995019|NCT03113123|Emtricitabine|emtricitabine|mesh-list
101995020|NCT03113123|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101995025|NCT03113123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101995026|NCT03113123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995028|NCT03113123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101995029|NCT04451122|Tea Tree Oil|tea tree oil|mesh-list
101995030|NCT04451122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101995031|NCT04451122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101947927|NCT01169025|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101947928|NCT01169025|Narcotics|narcotics|mesh-ancestor
101947929|NCT01169025|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101947930|NCT01582347|Buprenorphine|buprenorphine|mesh-list
101947931|NCT01582347|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101947932|NCT01582347|Naloxone|naloxone|mesh-list
101947933|NCT01582347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101947934|NCT01582347|Narcotics|narcotics|mesh-ancestor
101947935|NCT01582347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101947936|NCT01582347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947937|NCT01582347|Analgesics|analgesics|mesh-ancestor
101947938|NCT01582347|Sensory System Agents|sensory system agents|mesh-ancestor
101947939|NCT01582347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101947940|NCT01582347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101995032|NCT01143857|Varenicline|varenicline|mesh-list
101995033|NCT01143857|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101995034|NCT01143857|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101995035|NCT01143857|Cholinergic Agents|cholinergic agents|mesh-ancestor
101995036|NCT01143857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101995037|NCT01143857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995038|NCT01143857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995039|NCT05159284|Hydrocortisone|hydrocortisone|mesh-list
101995040|NCT05159284|Lubricant Eye Drops|lubricant eye drops|mesh-list
101995041|NCT05159284|Hyaluronic Acid|hyaluronic acid|mesh-list
101995042|NCT05159284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101995043|NCT05159284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101995044|NCT05159284|Immunologic Factors|immunologic factors|mesh-ancestor
101995045|NCT05159284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995046|NCT05159284|Viscosupplements|viscosupplements|mesh-ancestor
101995047|NCT05159284|Protective Agents|protective agents|mesh-ancestor
101995048|NCT05159284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101995049|NCT05159284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101714848|NCT00484315|Tubulin Modulators|tubulin modulators|mesh-ancestor
101995050|NCT01239173|Propranolol|propranolol|mesh-list
101995051|NCT01239173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101995052|NCT01239173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101995053|NCT01239173|Adrenergic Agents|adrenergic agents|mesh-ancestor
101995054|NCT01239173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101995055|NCT01239173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995056|NCT01239173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995057|NCT01239173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101995058|NCT01239173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101995059|NCT01239173|Vasodilator Agents|vasodilator agents|mesh-ancestor
101995060|NCT03063203|Decitabine|decitabine|mesh-list
101995061|NCT03063203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101995062|NCT03063203|Antimetabolites|antimetabolites|mesh-ancestor
101252555|NCT03569475|Analgesics|analgesics|mesh-ancestor
101995063|NCT03063203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995064|NCT03063203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101995065|NCT03063203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101995066|NCT03435094|Alendronate|alendronate|mesh-list
101995067|NCT03435094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101995068|NCT03435094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995069|NCT03772483|Anesthetics|anesthetics|mesh-list
101995070|NCT03772483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101995071|NCT03772483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995072|NCT01236911|Calcium|calcium|mesh-list
101995073|NCT01236911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101995074|NCT01236911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995075|NCT03772561|Durvalumab|durvalumab|mesh-list
101995076|NCT03772561|Olaparib|olaparib|mesh-list
101995077|NCT03772561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101995078|NCT03772561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101667761|NCT00633698|Niacin|niacin|mesh-list
101947942|NCT01336634|Dabrafenib|dabrafenib|mesh-list
101947943|NCT01336634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101947944|NCT01336634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101947945|NCT01336634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101947946|NCT01336634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947947|NCT01284855|Antivenins|antivenins|mesh-list
101947948|NCT01284855|Immunologic Factors|immunologic factors|mesh-ancestor
101947949|NCT01284855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947950|NCT00785798|Doxorubicin|doxorubicin|mesh-list
101947951|NCT00785798|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101947952|NCT00785798|Vorinostat|vorinostat|mesh-list
101947953|NCT00785798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101947954|NCT00785798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101947955|NCT00785798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101947956|NCT00785798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101947957|NCT00785798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101947958|NCT00785798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821497|NCT00825851|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101995079|NCT03772561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101995080|NCT03772561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101995081|NCT03772561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995082|NCT01239485|Irinotecan|irinotecan|mesh-list
101995083|NCT01239485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101995084|NCT01239485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101995085|NCT01239485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101995086|NCT01239485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995087|NCT01239485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101995088|NCT01146041|Rivastigmine|rivastigmine|mesh-list
101450114|NCT00192842|Curcumin|curcumin|mesh-list
101995091|NCT01146041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995093|NCT01146041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101995094|NCT01146041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995095|NCT01146041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101995096|NCT01146041|Protective Agents|protective agents|mesh-ancestor
101995097|NCT04450576|Chrysarobin|chrysarobin|mesh-list
101995098|NCT04450576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101995099|NCT04450576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101995100|NCT04450576|Analgesics|analgesics|mesh-ancestor
101995101|NCT04450576|Sensory System Agents|sensory system agents|mesh-ancestor
101995102|NCT04450576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101995103|NCT04450576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995104|NCT04450576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101995105|NCT04450576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101995106|NCT03430180|Naloxone|naloxone|mesh-list
101995107|NCT03430180|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101995108|NCT03430180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995109|NCT03430180|Sensory System Agents|sensory system agents|mesh-ancestor
101995110|NCT03430180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101995111|NCT03777787|Denatonium|denatonium|mesh-list
101995112|NCT03777787|Aversive Agents|aversive agents|mesh-ancestor
101995113|NCT03777787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995114|NCT03777787|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
101995115|NCT03777787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995116|NCT03777787|Sensory System Agents|sensory system agents|mesh-ancestor
101947959|NCT00785798|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101947960|NCT01175109|Imatinib Mesylate|imatinib mesylate|mesh-list
101947961|NCT01175109|Panobinostat|panobinostat|mesh-list
101947962|NCT01175109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101947963|NCT01175109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101947964|NCT01175109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101947965|NCT01175109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947966|NCT01175109|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101947967|NCT01282515|Clobetasol|clobetasol|mesh-list
101995117|NCT03777787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101995118|NCT03430024|Estrogens|estrogens|mesh-list
101995119|NCT03430024|Hormones|hormones|mesh-ancestor
101995120|NCT03430024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101995121|NCT03430024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995122|NCT03434782|Listerine|listerine|mesh-list
101995123|NCT03434782|Hydrogen Peroxide|hydrogen peroxide|mesh-list
101995124|NCT03434782|Fluorides|fluorides|mesh-list
101995125|NCT03434782|Sodium Fluoride|sodium fluoride|mesh-list
101995126|NCT03434782|Cariostatic Agents|cariostatic agents|mesh-ancestor
101995127|NCT03434782|Protective Agents|protective agents|mesh-ancestor
101995128|NCT03434782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995129|NCT03434782|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101995130|NCT03434782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101995131|NCT01320397|Losartan|losartan|mesh-list
101995132|NCT01320397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101995133|NCT01320397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101995134|NCT01320397|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101995135|NCT01320397|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101995136|NCT01320397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995137|NCT03434704|Antifungal Agents|antifungal agents|mesh-list
101995138|NCT03434704|Clotrimazole|clotrimazole|mesh-list
101995139|NCT03434704|Miconazole|miconazole|mesh-list
101995140|NCT03434704|Fludarabine|fludarabine|mesh-list
101995141|NCT03434704|Thiotepa|thiotepa|mesh-list
101995142|NCT03434704|Treosulfan|treosulfan|mesh-list
101995143|NCT03434704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101995144|NCT03434704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995145|NCT03434704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101995146|NCT03434704|Immunologic Factors|immunologic factors|mesh-ancestor
101995147|NCT03434704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995148|NCT03434704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101995149|NCT03434704|Alkylating Agents|alkylating agents|mesh-ancestor
101995150|NCT03434704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101995151|NCT03434704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101995152|NCT03434704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101995153|NCT03434704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101995154|NCT03434704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101995155|NCT03434704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101995156|NCT03434704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101995157|NCT03434704|Hormone Antagonists|hormone antagonists|mesh-ancestor
101995158|NCT03434704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101995159|NCT03434704|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101995165|NCT04779151|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101995166|NCT04779151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101995167|NCT04779151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995168|NCT04779151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101995169|NCT02891226|Mirikizumab|mirikizumab|mesh-list
101995170|NCT02891226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101995171|NCT02891226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101995172|NCT02891226|Analgesics|analgesics|mesh-ancestor
101995173|NCT02891226|Sensory System Agents|sensory system agents|mesh-ancestor
101995174|NCT02891226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101995175|NCT02891226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995176|NCT02891226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101995177|NCT02891226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101947968|NCT01282515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101947969|NCT01282515|Glucocorticoids|glucocorticoids|mesh-ancestor
101947970|NCT01282515|Hormones|hormones|mesh-ancestor
101947971|NCT01282515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101947972|NCT01282515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947973|NCT04732910|Ivacaftor|ivacaftor|mesh-list
101947974|NCT04732910|Elexacaftor|elexacaftor|mesh-list
101947975|NCT04732910|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101947976|NCT04732910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101947977|NCT04732910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947978|NCT03329846|Nivolumab|nivolumab|mesh-list
101947979|NCT03329846|Linrodostat|linrodostat|mesh-list
101947980|NCT03329846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101947981|NCT03329846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101947982|NCT03329846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101947983|NCT03329846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995178|NCT02891226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101995179|NCT02891226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101995180|NCT03771781|Empagliflozin|empagliflozin|mesh-list
101995181|NCT03771781|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101995182|NCT03771781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995183|NCT03771781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101995184|NCT03771781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995185|NCT04140721|Moxonidine|moxonidine|mesh-list
101995186|NCT04140721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101995187|NCT03224104|Temozolomide|temozolomide|mesh-list
101995188|NCT03224104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101995189|NCT03224104|Alkylating Agents|alkylating agents|mesh-ancestor
101995190|NCT03224104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995191|NCT03224104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101995192|NCT01320475|Sufentanil|sufentanil|mesh-list
101995193|NCT01320475|Ketamine|ketamine|mesh-list
101995194|NCT01320475|Analgesics|analgesics|mesh-ancestor
101995195|NCT01320475|Sensory System Agents|sensory system agents|mesh-ancestor
101995196|NCT01320475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101995197|NCT01320475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995198|NCT01320475|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101995199|NCT01320475|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101995200|NCT01320475|Anesthetics, General|anesthetics, general|mesh-ancestor
101995201|NCT01320475|Anesthetics|anesthetics|mesh-ancestor
101995202|NCT01320475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101995203|NCT01320475|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101995204|NCT01320475|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101995205|NCT01320475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101995206|NCT01320475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995207|NCT01320475|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101995208|NCT01320475|Narcotics|narcotics|mesh-ancestor
101995209|NCT01320475|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101995210|NCT05177406|Erenumab|erenumab|mesh-list
101995211|NCT05177406|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
101995212|NCT05177406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995213|NCT05177406|Analgesics|analgesics|mesh-ancestor
101995214|NCT05177406|Sensory System Agents|sensory system agents|mesh-ancestor
101995215|NCT05177406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101995216|NCT05177406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995217|NCT02521246|Losartan|losartan|mesh-list
101995218|NCT02521246|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101947984|NCT03329846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101947985|NCT04020848|Melatonin|melatonin|mesh-list
101947986|NCT04020848|Antioxidants|antioxidants|mesh-ancestor
101947987|NCT04020848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101947988|NCT04020848|Protective Agents|protective agents|mesh-ancestor
101947989|NCT04020848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101947990|NCT04020848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101947991|NCT01338610|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101947992|NCT01338610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101947993|NCT01355302|Capecitabine|capecitabine|mesh-list
101995219|NCT02521246|Candesartan|candesartan|mesh-list
101995220|NCT02521246|Candesartan cilexetil|candesartan cilexetil|mesh-list
101995221|NCT02521246|Chlorthalidone|chlorthalidone|mesh-list
101995222|NCT02521246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101387630|NCT00122343|Immunologic Factors|immunologic factors|mesh-ancestor
101995223|NCT02521246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101995224|NCT02521246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101995225|NCT02521246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101995226|NCT02521246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995227|NCT02521246|Diuretics|diuretics|mesh-ancestor
101995228|NCT02521246|Natriuretic Agents|natriuretic agents|mesh-ancestor
101995232|NCT05309070|Acetylcysteine|acetylcysteine|mesh-list
101995233|NCT05309070|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101995234|NCT05309070|Antiviral Agents|antiviral agents|mesh-ancestor
101995235|NCT05309070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101995236|NCT05309070|Expectorants|expectorants|mesh-ancestor
101995237|NCT05309070|Respiratory System Agents|respiratory system agents|mesh-ancestor
101995238|NCT05309070|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101995239|NCT05309070|Antioxidants|antioxidants|mesh-ancestor
101995240|NCT05309070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995241|NCT05309070|Protective Agents|protective agents|mesh-ancestor
101995242|NCT05309070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995243|NCT05309070|Antidotes|antidotes|mesh-ancestor
101995244|NCT04763928|Decitabine|decitabine|mesh-list
101995245|NCT04763928|Venetoclax|venetoclax|mesh-list
101995246|NCT04763928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101995247|NCT04763928|Antimetabolites|antimetabolites|mesh-ancestor
101995248|NCT04763928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995249|NCT04763928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101995250|NCT04763928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101995251|NCT01567501|Cetirizine|cetirizine|mesh-list
101995252|NCT01567501|Levocetirizine|levocetirizine|mesh-list
101995253|NCT01567501|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101995254|NCT01567501|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101995255|NCT01567501|Histamine Antagonists|histamine antagonists|mesh-ancestor
101995256|NCT01567501|Histamine Agents|histamine agents|mesh-ancestor
101995257|NCT01567501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101995258|NCT01567501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995259|NCT01567501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995260|NCT01567501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101995261|NCT01321957|Bevacizumab|bevacizumab|mesh-list
101995262|NCT01321957|Oxaliplatin|oxaliplatin|mesh-list
101995263|NCT01321957|Irinotecan|irinotecan|mesh-list
101995264|NCT01321957|Fluorouracil|fluorouracil|mesh-list
101995265|NCT01321957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101995266|NCT01321957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101995267|NCT01321957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101995268|NCT01321957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101995269|NCT01321957|Growth Substances|growth substances|mesh-ancestor
101995270|NCT01321957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995271|NCT01321957|Growth Inhibitors|growth inhibitors|mesh-ancestor
101995272|NCT01321957|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101995273|NCT01321957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101995274|NCT01321957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101995275|NCT01321957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995276|NCT01321957|Antimetabolites|antimetabolites|mesh-ancestor
101995277|NCT01321957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101947994|NCT01355302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101947995|NCT01355302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101947996|NCT01355302|Antimetabolites|antimetabolites|mesh-ancestor
101947997|NCT01355302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995278|NCT01321957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101995279|NCT01321957|Immunologic Factors|immunologic factors|mesh-ancestor
101995280|NCT05363592|Metformin|metformin|mesh-list
101995281|NCT05363592|Alogliptin|alogliptin|mesh-list
101995282|NCT05363592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101995283|NCT05363592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995284|NCT05363592|Incretins|incretins|mesh-ancestor
101995285|NCT05363592|Hormones|hormones|mesh-ancestor
101995286|NCT05363592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101995287|NCT05363592|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101995288|NCT05363592|Protease Inhibitors|protease inhibitors|mesh-ancestor
101995289|NCT05363592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101995290|NCT05363592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995291|NCT03708211|Esomeprazole|esomeprazole|mesh-list
101995292|NCT03708211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101995293|NCT03708211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101995294|NCT03708211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101995295|NCT03708211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101995296|NCT03708211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995297|NCT03770923|Montelukast|montelukast|mesh-list
101995298|NCT03770923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101995299|NCT03770923|Respiratory System Agents|respiratory system agents|mesh-ancestor
101995300|NCT03770923|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101995308|NCT03433534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101995309|NCT03433534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101995310|NCT03433534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101995311|NCT03433534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995312|NCT05445895|Clopidogrel|clopidogrel|mesh-list
101995313|NCT05445895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101995314|NCT05445895|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101995315|NCT05445895|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101995316|NCT05445895|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101995317|NCT05445895|Purinergic Agents|purinergic agents|mesh-ancestor
101995318|NCT05445895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101995319|NCT05445895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995320|NCT05445895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995321|NCT03367299|Blinatumomab|blinatumomab|mesh-list
101995322|NCT03367299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101995323|NCT03705793|Mometasone Furoate|mometasone furoate|mesh-list
101995324|NCT03705793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101995325|NCT03705793|Dermatologic Agents|dermatologic agents|mesh-ancestor
101995326|NCT03705793|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101995327|NCT04449718|Vitamin D|vitamin d|mesh-list
101995328|NCT04449718|Vitamins|vitamins|mesh-ancestor
101995329|NCT04449718|Micronutrients|micronutrients|mesh-ancestor
101995330|NCT04449718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995331|NCT04449718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101995332|NCT03763279|Triclosan|triclosan|mesh-list
101995333|NCT03763279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101995334|NCT03763279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101995335|NCT03763279|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101995336|NCT03763279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101995337|NCT03763279|Antimetabolites|antimetabolites|mesh-ancestor
101995338|NCT03763279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995339|NCT03763279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101995340|NCT03638037|Vitamin D|vitamin d|mesh-list
101995341|NCT03638037|Vitamins|vitamins|mesh-ancestor
101995342|NCT03638037|Micronutrients|micronutrients|mesh-ancestor
101995343|NCT03638037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995344|NCT03638037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101995345|NCT03763123|Paclitaxel|paclitaxel|mesh-list
101995346|NCT03763123|Topotecan|topotecan|mesh-list
101995347|NCT03763123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101995349|NCT03763123|Tubulin Modulators|tubulin modulators|mesh-ancestor
101995350|NCT03763123|Antimitotic Agents|antimitotic agents|mesh-ancestor
101995351|NCT03763123|Mitosis Modulators|mitosis modulators|mesh-ancestor
101947998|NCT01355068|Phenytoin|phenytoin|mesh-list
101947999|NCT01355068|Anticonvulsants|anticonvulsants|mesh-ancestor
101948000|NCT01355068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101995352|NCT03763123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995353|NCT03763123|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101995354|NCT03763123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101995355|NCT03763123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101995356|NCT03429400|Morphine|morphine|mesh-list
101995357|NCT03429400|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101995358|NCT03429400|Narcotics|narcotics|mesh-ancestor
101995359|NCT03429400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101995360|NCT03429400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995361|NCT03429400|Analgesics|analgesics|mesh-ancestor
101995362|NCT03429400|Sensory System Agents|sensory system agents|mesh-ancestor
101995363|NCT03429400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101995364|NCT03429010|Anesthetics|anesthetics|mesh-list
101995365|NCT03429010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101995366|NCT03429010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995367|NCT02944656|Gabapentin|gabapentin|mesh-list
101995371|NCT02944656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995372|NCT02944656|Anticonvulsants|anticonvulsants|mesh-ancestor
101995373|NCT02944656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101995374|NCT02944656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101995375|NCT02944656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101995376|NCT02944656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101995377|NCT02944656|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101995378|NCT02944656|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101995379|NCT02944656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101995380|NCT02944656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995381|NCT02944656|Antimanic Agents|antimanic agents|mesh-ancestor
101995382|NCT02713529|Pembrolizumab|pembrolizumab|mesh-list
101995383|NCT02713529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101995384|NCT02713529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101995385|NCT02713529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101995386|NCT02713529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995387|NCT03763045|Sildenafil Citrate|sildenafil citrate|mesh-list
101995388|NCT03763045|Vasodilator Agents|vasodilator agents|mesh-ancestor
101995389|NCT03763045|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101995390|NCT03763045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101995391|NCT03763045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101995392|NCT03763045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995393|NCT03763045|Urological Agents|urological agents|mesh-ancestor
101995394|NCT01321489|Sildenafil Citrate|sildenafil citrate|mesh-list
101995395|NCT01321489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995396|NCT01321489|Vasodilator Agents|vasodilator agents|mesh-ancestor
101995397|NCT01321489|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101995398|NCT01321489|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101995399|NCT01321489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101995400|NCT01321489|Urological Agents|urological agents|mesh-ancestor
101995401|NCT04800627|Pembrolizumab|pembrolizumab|mesh-list
101995402|NCT04800627|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101995403|NCT04800627|Pevonedistat|pevonedistat|mesh-list
101995404|NCT04800627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101995405|NCT04800627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101995406|NCT04800627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101995407|NCT04800627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995408|NCT05308602|Vaccines|vaccines|mesh-list
101995409|NCT05308602|Immunologic Factors|immunologic factors|mesh-ancestor
101995410|NCT05308602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995411|NCT03768037|Pemetrexed|pemetrexed|mesh-list
101995412|NCT03768037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101995413|NCT03768037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101995414|NCT03768037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995415|NCT03768037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101995416|NCT03768037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101995417|NCT01146977|Cytarabine|cytarabine|mesh-list
101995418|NCT01146977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101995419|NCT01146977|Antimetabolites|antimetabolites|mesh-ancestor
101995420|NCT01146977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995421|NCT01146977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101948001|NCT01355068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101948002|NCT01355068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101948003|NCT01355068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948004|NCT01355068|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101948005|NCT01355068|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101948006|NCT03562780|Acetaminophen|acetaminophen|mesh-list
101948007|NCT03562780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101948008|NCT03562780|Analgesics|analgesics|mesh-ancestor
101948009|NCT03562780|Sensory System Agents|sensory system agents|mesh-ancestor
101948010|NCT03562780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101948011|NCT03562780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948012|NCT03562780|Antipyretics|antipyretics|mesh-ancestor
101948013|NCT02259946|Bromides|bromides|mesh-list
101948014|NCT02259946|Tiotropium Bromide|tiotropium bromide|mesh-list
101948015|NCT02259946|Olodaterol|olodaterol|mesh-list
101948016|NCT02259946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101948017|NCT02259946|Autonomic Agents|autonomic agents|mesh-ancestor
101948018|NCT02259946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101948019|NCT02259946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948020|NCT02259946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101948021|NCT02259946|Respiratory System Agents|respiratory system agents|mesh-ancestor
101948022|NCT02259946|Parasympatholytics|parasympatholytics|mesh-ancestor
101948023|NCT02259946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101995422|NCT01146977|Antiviral Agents|antiviral agents|mesh-ancestor
101995423|NCT01146977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101995424|NCT01146977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101995425|NCT01146977|Immunologic Factors|immunologic factors|mesh-ancestor
101995426|NCT01146977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995427|NCT03762967|Hormones|hormones|mesh-list
101995428|NCT03762967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101995429|NCT03762967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995430|NCT03762889|Anesthetics|anesthetics|mesh-list
101995431|NCT03762889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101995432|NCT03762889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995433|NCT03746041|Abaloparatide|abaloparatide|mesh-list
101995434|NCT03746041|Bevacizumab|bevacizumab|mesh-list
101995435|NCT03746041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101995436|NCT03746041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101995437|NCT03746041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101995453|NCT01239563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995454|NCT01239563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101995456|NCT01321255|Ramipril|ramipril|mesh-list
101995457|NCT01321255|Simvastatin|simvastatin|mesh-list
101995458|NCT01321255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101995459|NCT01321255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101995460|NCT01321255|Analgesics|analgesics|mesh-ancestor
101995461|NCT01321255|Sensory System Agents|sensory system agents|mesh-ancestor
101995462|NCT01321255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101995463|NCT01321255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995464|NCT01321255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101995465|NCT01321255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101995466|NCT01321255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101948024|NCT02259946|Cholinergic Agents|cholinergic agents|mesh-ancestor
101948025|NCT02259946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101948026|NCT02259946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948027|NCT02259946|Anticonvulsants|anticonvulsants|mesh-ancestor
101948028|NCT03756129|Ketamine|ketamine|mesh-list
101948029|NCT03756129|Analgesics|analgesics|mesh-ancestor
101948030|NCT03756129|Sensory System Agents|sensory system agents|mesh-ancestor
101948031|NCT03756129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101821935|NCT05733468|Calcium|calcium|mesh-list
101995467|NCT01321255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101995468|NCT01321255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995469|NCT01321255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101995470|NCT01321255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101995471|NCT01321255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101995472|NCT01321255|Antipyretics|antipyretics|mesh-ancestor
101995473|NCT01321255|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101995474|NCT01321255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101995475|NCT01321255|Antimetabolites|antimetabolites|mesh-ancestor
101995476|NCT01321255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101995477|NCT01321255|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101995478|NCT01321255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101995479|NCT01321255|Protease Inhibitors|protease inhibitors|mesh-ancestor
101995480|NCT01321255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101995481|NCT01883297|Aldesleukin|aldesleukin|mesh-list
101995482|NCT01883297|Cyclophosphamide|cyclophosphamide|mesh-list
101995483|NCT01883297|Interleukin-2|interleukin-2|mesh-list
101995484|NCT01883297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101995485|NCT01883297|Immunologic Factors|immunologic factors|mesh-ancestor
101995486|NCT01883297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995487|NCT01883297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101995488|NCT01883297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101995489|NCT01883297|Alkylating Agents|alkylating agents|mesh-ancestor
101995490|NCT01883297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995491|NCT01883297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101995492|NCT01883297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101995493|NCT01883297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101995494|NCT01883297|Analgesics|analgesics|mesh-ancestor
101995495|NCT01883297|Sensory System Agents|sensory system agents|mesh-ancestor
101995496|NCT01883297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101995497|NCT01883297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101995498|NCT01883297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101995499|NCT01883297|Antiviral Agents|antiviral agents|mesh-ancestor
101995508|NCT04546581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995509|NCT04546581|Antiviral Agents|antiviral agents|mesh-ancestor
101995510|NCT04546581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101995511|NCT02204254|Doxycycline|doxycycline|mesh-list
101995512|NCT02204254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101995513|NCT02204254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101995514|NCT02204254|Antimalarials|antimalarials|mesh-ancestor
101995515|NCT02204254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101995516|NCT02204254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101995517|NCT03417076|Bexagliflozin|bexagliflozin|mesh-list
101995518|NCT03417076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101995519|NCT03417076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995520|NCT05294172|Cisplatin|cisplatin|mesh-list
101995521|NCT05294172|Gemcitabine|gemcitabine|mesh-list
101995522|NCT05294172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101995523|NCT05294172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101995524|NCT05294172|Antimetabolites|antimetabolites|mesh-ancestor
101995525|NCT05294172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995526|NCT03164655|Leucovorin|leucovorin|mesh-list
101995527|NCT03164655|Bevacizumab|bevacizumab|mesh-list
101995528|NCT03164655|Cetuximab|cetuximab|mesh-list
101995529|NCT03164655|Panitumumab|panitumumab|mesh-list
101995530|NCT03164655|Fluorouracil|fluorouracil|mesh-list
101995531|NCT03164655|Oxaliplatin|oxaliplatin|mesh-list
101995532|NCT03164655|Irinotecan|irinotecan|mesh-list
101995533|NCT03164655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101995534|NCT03164655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101948032|NCT03756129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948033|NCT03756129|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101948034|NCT03756129|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101948035|NCT03756129|Anesthetics, General|anesthetics, general|mesh-ancestor
101948036|NCT03756129|Anesthetics|anesthetics|mesh-ancestor
101948037|NCT03756129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101948038|NCT03756129|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101948039|NCT03756129|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101948040|NCT03756129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101948041|NCT03756129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948042|NCT03863691|Amisulpride|amisulpride|mesh-list
101948043|NCT03863691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101948044|NCT03863691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101948045|NCT03863691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101948046|NCT03863691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948047|NCT03863691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101948048|NCT03863691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101948049|NCT03863691|Dopamine Agents|dopamine agents|mesh-ancestor
101948050|NCT03863691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101971960|NCT00315640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101995535|NCT03164655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101995536|NCT03164655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101995537|NCT03164655|Growth Substances|growth substances|mesh-ancestor
101995538|NCT03164655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995539|NCT03164655|Growth Inhibitors|growth inhibitors|mesh-ancestor
101995540|NCT03164655|Antimetabolites|antimetabolites|mesh-ancestor
101995541|NCT03164655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995542|NCT03164655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101995543|NCT03164655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101995544|NCT03164655|Immunologic Factors|immunologic factors|mesh-ancestor
101995545|NCT03164655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101995546|NCT03164655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101995547|NCT03164655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101995548|NCT03164655|Antidotes|antidotes|mesh-ancestor
101995549|NCT03164655|Protective Agents|protective agents|mesh-ancestor
101995550|NCT03164655|Vitamin B Complex|vitamin b complex|mesh-ancestor
101995551|NCT03164655|Vitamins|vitamins|mesh-ancestor
101995552|NCT03164655|Micronutrients|micronutrients|mesh-ancestor
101995553|NCT02561273|Prednisone|prednisone|mesh-list
101995554|NCT02561273|Cortisone|cortisone|mesh-list
101995555|NCT02561273|Cyclophosphamide|cyclophosphamide|mesh-list
101995556|NCT02561273|Doxorubicin|doxorubicin|mesh-list
101995557|NCT02561273|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101995558|NCT02561273|Etoposide|etoposide|mesh-list
101995559|NCT02561273|Vincristine|vincristine|mesh-list
101995560|NCT02561273|Lenalidomide|lenalidomide|mesh-list
101995561|NCT02561273|Etoposide phosphate|etoposide phosphate|mesh-list
101995562|NCT02561273|Podophyllotoxin|podophyllotoxin|mesh-list
101995563|NCT02561273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101995564|NCT02561273|Immunologic Factors|immunologic factors|mesh-ancestor
101995565|NCT02561273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995566|NCT02561273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101995567|NCT02561273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101995568|NCT02561273|Alkylating Agents|alkylating agents|mesh-ancestor
101995569|NCT02561273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995570|NCT02561273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101948051|NCT03863691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948052|NCT03863691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101948053|NCT03863691|Antidepressive Agents|antidepressive agents|mesh-ancestor
101948055|NCT02822794|Sofosbuvir|sofosbuvir|mesh-list
101948056|NCT02822794|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
101948057|NCT02822794|Velpatasvir|velpatasvir|mesh-list
101948058|NCT02822794|Antimetabolites|antimetabolites|mesh-ancestor
101948059|NCT02822794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948060|NCT02822794|Antiviral Agents|antiviral agents|mesh-ancestor
101948061|NCT02822794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101948062|NCT01173315|Vitamins|vitamins|mesh-list
101948063|NCT01173315|Micronutrients|micronutrients|mesh-ancestor
101995571|NCT02561273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101995580|NCT02561273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101995581|NCT02561273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101995582|NCT02561273|Tubulin Modulators|tubulin modulators|mesh-ancestor
101995583|NCT02561273|Antimitotic Agents|antimitotic agents|mesh-ancestor
101995584|NCT02561273|Mitosis Modulators|mitosis modulators|mesh-ancestor
101995585|NCT02561273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101995586|NCT02561273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101995587|NCT02561273|Growth Substances|growth substances|mesh-ancestor
101995588|NCT02561273|Growth Inhibitors|growth inhibitors|mesh-ancestor
101995589|NCT02561273|Keratolytic Agents|keratolytic agents|mesh-ancestor
101995590|NCT02561273|Dermatologic Agents|dermatologic agents|mesh-ancestor
101995592|NCT02521012|Ergocalciferols|ergocalciferols|mesh-list
101995593|NCT02521012|Cholecalciferol|cholecalciferol|mesh-list
101995594|NCT02521012|Vitamins|vitamins|mesh-list
101995595|NCT02521012|Micronutrients|micronutrients|mesh-ancestor
101995596|NCT02521012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995597|NCT02521012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101995598|NCT02521012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101995599|NCT04756128|Colchicine|colchicine|mesh-list
101995600|NCT04756128|Naltrexone|naltrexone|mesh-list
101995601|NCT04756128|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101995602|NCT04756128|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101995603|NCT04756128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995604|NCT04756128|Sensory System Agents|sensory system agents|mesh-ancestor
101995605|NCT04756128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101995606|NCT04756128|Gout Suppressants|gout suppressants|mesh-ancestor
101995607|NCT04756128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101995608|NCT04756128|Tubulin Modulators|tubulin modulators|mesh-ancestor
101995609|NCT04756128|Antimitotic Agents|antimitotic agents|mesh-ancestor
101995610|NCT04756128|Mitosis Modulators|mitosis modulators|mesh-ancestor
101995611|NCT04756128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995612|NCT04756128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101995613|NCT03427216|Diazepam|diazepam|mesh-list
101995614|NCT03427216|Baclofen|baclofen|mesh-list
101995615|NCT03427216|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101995616|NCT03427216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995617|NCT03427216|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101995618|NCT03427216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101995619|NCT03427216|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101995620|NCT03427216|GABA Agonists|gaba agonists|mesh-ancestor
101995621|NCT03427216|GABA Agents|gaba agents|mesh-ancestor
101995622|NCT03427216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101995623|NCT03427216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995624|NCT03427216|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101995625|NCT03427216|Anticonvulsants|anticonvulsants|mesh-ancestor
101995626|NCT03427216|Antiemetics|antiemetics|mesh-ancestor
101995627|NCT03427216|Autonomic Agents|autonomic agents|mesh-ancestor
101995628|NCT03427216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101995629|NCT03427216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101948064|NCT01173315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948065|NCT01173549|Canagliflozin|canagliflozin|mesh-list
101948066|NCT01173549|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101948067|NCT01173549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948068|NCT01173549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101948069|NCT01173549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948070|NCT01338298|Aripiprazole|aripiprazole|mesh-list
101948071|NCT01338298|Antidepressive Agents|antidepressive agents|mesh-ancestor
101948072|NCT01338298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101948073|NCT01338298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101948074|NCT01338298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101995630|NCT03427216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101995631|NCT03427216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101995632|NCT03427216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101995633|NCT03427216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101995634|NCT03427216|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101995635|NCT03427216|Anesthetics, General|anesthetics, general|mesh-ancestor
101995636|NCT03427216|Anesthetics|anesthetics|mesh-ancestor
101995637|NCT03427216|GABA Modulators|gaba modulators|mesh-ancestor
101995638|NCT01144091|Pentoxifylline|pentoxifylline|mesh-list
101995639|NCT01144091|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101995640|NCT01144091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101450662|NCT00125255|Lidocaine|lidocaine|mesh-list
101995648|NCT01144091|Antioxidants|antioxidants|mesh-ancestor
101995649|NCT02392559|Evolocumab|evolocumab|mesh-list
101995650|NCT02392559|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101995651|NCT02392559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101995652|NCT02392559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101995653|NCT02392559|Antimetabolites|antimetabolites|mesh-ancestor
101995654|NCT02392559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995655|NCT02392559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101995656|NCT02392559|Protease Inhibitors|protease inhibitors|mesh-ancestor
101995657|NCT02392559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101995658|NCT02392559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101995659|NCT03332589|Dabrafenib|dabrafenib|mesh-list
101995660|NCT03332589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101995661|NCT03332589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101995662|NCT03332589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101995663|NCT03332589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995664|NCT03767569|Folic Acid|folic acid|mesh-list
101995665|NCT03767569|Inositol|inositol|mesh-list
101995666|NCT03767569|Hematinics|hematinics|mesh-ancestor
101995667|NCT03767569|Vitamin B Complex|vitamin b complex|mesh-ancestor
101995668|NCT03767569|Vitamins|vitamins|mesh-ancestor
101995669|NCT03767569|Micronutrients|micronutrients|mesh-ancestor
101995670|NCT03767569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995671|NCT03620916|Morphine|morphine|mesh-list
101995672|NCT03620916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101995673|NCT03620916|Narcotics|narcotics|mesh-ancestor
101995674|NCT03620916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101995675|NCT03620916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995676|NCT03620916|Analgesics|analgesics|mesh-ancestor
101995677|NCT03620916|Sensory System Agents|sensory system agents|mesh-ancestor
101995678|NCT03620916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101995679|NCT01237067|Carboplatin|carboplatin|mesh-list
101995680|NCT01237067|Olaparib|olaparib|mesh-list
101995681|NCT01237067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101995682|NCT01237067|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101995683|NCT01237067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101995684|NCT01237067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995685|NCT03426982|Heparin|heparin|mesh-list
101995686|NCT03426982|Calcium heparin|calcium heparin|mesh-list
101995687|NCT03426982|Anticoagulants|anticoagulants|mesh-ancestor
101995688|NCT03426982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101995689|NCT03426982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101995690|NCT03426982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995691|NCT01546948|Methadone|methadone|mesh-list
101948075|NCT01338298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101948076|NCT01338298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995692|NCT01546948|Hydromorphone|hydromorphone|mesh-list
101995693|NCT01546948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101995694|NCT01546948|Narcotics|narcotics|mesh-ancestor
101995695|NCT01546948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101995696|NCT01546948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995697|NCT01546948|Analgesics|analgesics|mesh-ancestor
101995698|NCT01546948|Sensory System Agents|sensory system agents|mesh-ancestor
101995699|NCT01546948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101995700|NCT01546948|Antitussive Agents|antitussive agents|mesh-ancestor
101995701|NCT01546948|Respiratory System Agents|respiratory system agents|mesh-ancestor
101995702|NCT00458003|Phenylephrine|phenylephrine|mesh-list
101995703|NCT00458003|Oxymetazoline|oxymetazoline|mesh-list
101995704|NCT00458003|Ephedrine|ephedrine|mesh-list
101995705|NCT00458003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101995706|NCT00458003|Mydriatics|mydriatics|mesh-ancestor
101995707|NCT00458003|Autonomic Agents|autonomic agents|mesh-ancestor
101995708|NCT00458003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101995709|NCT00458003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995710|NCT00458003|Sympathomimetics|sympathomimetics|mesh-ancestor
101995719|NCT00458003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995721|NCT00458003|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101995722|NCT04599972|Pilocarpine|pilocarpine|mesh-list
101995723|NCT04599972|Miotics|miotics|mesh-ancestor
101995724|NCT04599972|Autonomic Agents|autonomic agents|mesh-ancestor
101995725|NCT04599972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101995726|NCT04599972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995727|NCT04599972|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101995728|NCT04599972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101995729|NCT04599972|Cholinergic Agents|cholinergic agents|mesh-ancestor
101995730|NCT04599972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101995731|NCT04599972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995733|NCT03008616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101995734|NCT03008616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101995735|NCT03008616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101995736|NCT03008616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995737|NCT03008616|Protective Agents|protective agents|mesh-ancestor
101995738|NCT03008616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995739|NCT03422146|Tea Tree Oil|tea tree oil|mesh-list
101995740|NCT03422146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101995741|NCT03422146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101995742|NCT03426592|Vitamin D|vitamin d|mesh-list
101995743|NCT03426592|Cholecalciferol|cholecalciferol|mesh-list
101995744|NCT03426592|Vitamins|vitamins|mesh-ancestor
101995745|NCT03426592|Micronutrients|micronutrients|mesh-ancestor
101995746|NCT03426592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995747|NCT03426592|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101995748|NCT03426592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101995749|NCT01567657|Midazolam|midazolam|mesh-list
101995750|NCT01567657|Meperidine|meperidine|mesh-list
101995751|NCT01567657|Propofol|propofol|mesh-list
101995752|NCT01567657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101995753|NCT01567657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101995754|NCT01567657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995755|NCT01567657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101995756|NCT01567657|Anesthetics, General|anesthetics, general|mesh-ancestor
101995757|NCT01567657|Anesthetics|anesthetics|mesh-ancestor
101995758|NCT01567657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101995759|NCT01567657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101995760|NCT01567657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101995761|NCT01567657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101995762|NCT01567657|GABA Modulators|gaba modulators|mesh-ancestor
101995763|NCT01567657|GABA Agents|gaba agents|mesh-ancestor
101995764|NCT01567657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101995765|NCT01567657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995766|NCT01567657|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101995767|NCT01567657|Narcotics|narcotics|mesh-ancestor
101995768|NCT01567657|Analgesics|analgesics|mesh-ancestor
101995769|NCT01567657|Sensory System Agents|sensory system agents|mesh-ancestor
101995770|NCT01567657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101995771|NCT03416062|Niacinamide|niacinamide|mesh-list
101995772|NCT03416062|Vitamin B Complex|vitamin b complex|mesh-ancestor
101995773|NCT03416062|Vitamins|vitamins|mesh-ancestor
101995774|NCT03416062|Micronutrients|micronutrients|mesh-ancestor
101948077|NCT01338298|Dopamine Agonists|dopamine agonists|mesh-ancestor
101948078|NCT01338298|Dopamine Agents|dopamine agents|mesh-ancestor
101948079|NCT01338298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101948080|NCT01338298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948081|NCT01338298|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101948082|NCT01338298|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101948083|NCT01338298|Serotonin Agents|serotonin agents|mesh-ancestor
101948084|NCT01338298|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101948085|NCT01338298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101948086|NCT01338298|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101948087|NCT01338298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101948088|NCT01169415|Dexamethasone|dexamethasone|mesh-list
101995775|NCT03416062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995776|NCT03761485|Fluorides|fluorides|mesh-list
101995777|NCT03761485|Cariostatic Agents|cariostatic agents|mesh-ancestor
101995778|NCT03761485|Protective Agents|protective agents|mesh-ancestor
101450793|NCT00473512|Glucocorticoids|glucocorticoids|mesh-ancestor
101995781|NCT03766867|Antidepressive Agents|antidepressive agents|mesh-ancestor
101995782|NCT03766867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101995783|NCT03766867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101995784|NCT03766867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101995785|NCT03766867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101995786|NCT03766867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995787|NCT03766867|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101995788|NCT03766867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101995789|NCT03766867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101995790|NCT03766867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995791|NCT03766867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101995792|NCT03766867|Serotonin Agents|serotonin agents|mesh-ancestor
101995793|NCT03766867|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101995794|NCT03766867|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101995795|NCT03766867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101995796|NCT03766867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101995797|NCT02061293|Diphenhydramine|diphenhydramine|mesh-list
101995798|NCT02061293|Promethazine|promethazine|mesh-list
101995799|NCT02061293|Psilocybin|psilocybin|mesh-list
101995800|NCT02061293|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101995801|NCT02061293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101995802|NCT02061293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101995803|NCT02061293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995804|NCT02061293|Anesthetics, Local|anesthetics, local|mesh-ancestor
101995805|NCT02061293|Anesthetics|anesthetics|mesh-ancestor
101995806|NCT02061293|Sensory System Agents|sensory system agents|mesh-ancestor
101995807|NCT02061293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101995808|NCT02061293|Antiemetics|antiemetics|mesh-ancestor
101995809|NCT02061293|Autonomic Agents|autonomic agents|mesh-ancestor
101995810|NCT02061293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101995811|NCT02061293|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101995812|NCT02061293|Histamine Antagonists|histamine antagonists|mesh-ancestor
101995813|NCT02061293|Histamine Agents|histamine agents|mesh-ancestor
101995814|NCT02061293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101995815|NCT02061293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995816|NCT02061293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101995817|NCT02061293|Antipruritics|antipruritics|mesh-ancestor
101995818|NCT02061293|Dermatologic Agents|dermatologic agents|mesh-ancestor
101995819|NCT02061293|Hallucinogens|hallucinogens|mesh-ancestor
101995820|NCT02061293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101995821|NCT03761329|Lidocaine|lidocaine|mesh-list
101995822|NCT03761329|Anesthetics|anesthetics|mesh-list
101995823|NCT03761329|Anesthetics, Local|anesthetics, local|mesh-ancestor
101995824|NCT03761329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101995825|NCT03761329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948090|NCT01169415|BB 1101|bb 1101|mesh-list
101948091|NCT01169415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101948092|NCT01169415|Antiemetics|antiemetics|mesh-ancestor
101948093|NCT01169415|Autonomic Agents|autonomic agents|mesh-ancestor
101948094|NCT01169415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101948095|NCT01169415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948096|NCT01169415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101948097|NCT01169415|Glucocorticoids|glucocorticoids|mesh-ancestor
101948098|NCT01169415|Hormones|hormones|mesh-ancestor
101948099|NCT01169415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101948100|NCT01169415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101948101|NCT01169415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101948102|NCT01169415|Protease Inhibitors|protease inhibitors|mesh-ancestor
101948103|NCT01169415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101948104|NCT01169415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948105|NCT01173627|Fentanyl|fentanyl|mesh-list
101948106|NCT01173627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101948107|NCT01173627|Narcotics|narcotics|mesh-ancestor
101948108|NCT01173627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101948109|NCT01173627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948110|NCT01173627|Analgesics|analgesics|mesh-ancestor
101948111|NCT01173627|Sensory System Agents|sensory system agents|mesh-ancestor
101948112|NCT01173627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101948113|NCT01173627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101948114|NCT01173627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101948115|NCT01173627|Anesthetics, General|anesthetics, general|mesh-ancestor
101948116|NCT01173627|Anesthetics|anesthetics|mesh-ancestor
101948117|NCT01169571|Dexmedetomidine|dexmedetomidine|mesh-list
101948118|NCT01169571|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101948119|NCT01169571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101948120|NCT01169571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948121|NCT01169571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101948122|NCT01169571|Analgesics|analgesics|mesh-ancestor
101948123|NCT01169571|Sensory System Agents|sensory system agents|mesh-ancestor
101995826|NCT03761329|Sensory System Agents|sensory system agents|mesh-ancestor
101995827|NCT03761329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101995828|NCT03761329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101995829|NCT03761329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101995830|NCT03761329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101948124|NCT01169571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101948125|NCT01169571|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101948126|NCT01169571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101948127|NCT01169571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101948128|NCT01169571|Adrenergic Agents|adrenergic agents|mesh-ancestor
101948129|NCT01169571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101948130|NCT01169571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948131|NCT01354132|Acetylcysteine|acetylcysteine|mesh-list
101948132|NCT01354132|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101948133|NCT01354132|Antiviral Agents|antiviral agents|mesh-ancestor
101948134|NCT01354132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101948135|NCT01354132|Expectorants|expectorants|mesh-ancestor
101948136|NCT01354132|Respiratory System Agents|respiratory system agents|mesh-ancestor
101948137|NCT01354132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101948138|NCT01354132|Antioxidants|antioxidants|mesh-ancestor
101948139|NCT01354132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948140|NCT01354132|Protective Agents|protective agents|mesh-ancestor
101948141|NCT01354132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948142|NCT01354132|Antidotes|antidotes|mesh-ancestor
101948143|NCT05707936|Heparin|heparin|mesh-list
101948144|NCT05707936|Anticoagulants|anticoagulants|mesh-ancestor
101995831|NCT03761329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101995832|NCT03761329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995833|NCT03415906|Valsartan|valsartan|mesh-list
101995834|NCT03415906|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101995835|NCT03415906|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
101995836|NCT03415906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101995837|NCT03415906|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101995838|NCT03415906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995839|NCT03415750|Mycophenolic Acid|mycophenolic acid|mesh-list
101995840|NCT03415750|Everolimus|everolimus|mesh-list
101995841|NCT03415750|Tacrolimus|tacrolimus|mesh-list
101995842|NCT03415750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101995843|NCT03415750|Immunologic Factors|immunologic factors|mesh-ancestor
101995844|NCT03415750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995845|NCT03415750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101995846|NCT03415750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101995847|NCT03415750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995848|NCT03415750|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101995849|NCT03415750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101995863|NCT01239719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101995864|NCT01239719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995866|NCT01239719|Glucocorticoids|glucocorticoids|mesh-ancestor
101995867|NCT01239719|Hormones|hormones|mesh-ancestor
101995868|NCT01239719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101995869|NCT01239719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101995870|NCT01239719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101995871|NCT01239719|Protease Inhibitors|protease inhibitors|mesh-ancestor
101995872|NCT01239719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101995873|NCT01239719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995874|NCT01239719|Antipruritics|antipruritics|mesh-ancestor
101995875|NCT01239719|Dermatologic Agents|dermatologic agents|mesh-ancestor
101948145|NCT05707936|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101948146|NCT05707936|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101948147|NCT05707936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948148|NCT03863613|Progesterone|progesterone|mesh-list
101995876|NCT01239719|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101995877|NCT01239719|Histamine Antagonists|histamine antagonists|mesh-ancestor
101995878|NCT01239719|Histamine Agents|histamine agents|mesh-ancestor
101995879|NCT01239719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101995880|NCT01239719|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101995881|NCT03916679|Cyclophosphamide|cyclophosphamide|mesh-list
101995883|NCT03916679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101995884|NCT03916679|Immunologic Factors|immunologic factors|mesh-ancestor
101995885|NCT03916679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995886|NCT03916679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101995887|NCT03916679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101995888|NCT03916679|Alkylating Agents|alkylating agents|mesh-ancestor
101995889|NCT03916679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995890|NCT03916679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101995891|NCT03916679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101995892|NCT03421990|Anesthetics|anesthetics|mesh-list
101995893|NCT03421990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101995894|NCT03421990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995895|NCT02913612|Timolol|timolol|mesh-list
101995896|NCT02913612|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101995897|NCT02913612|Maleic acid|maleic acid|mesh-list
101995898|NCT02913612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101995899|NCT02913612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995900|NCT02913612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101995901|NCT02913612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101995902|NCT02913612|Adrenergic Agents|adrenergic agents|mesh-ancestor
101995903|NCT02913612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101995904|NCT02913612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995905|NCT02913612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101995906|NCT02913612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101995907|NCT03426202|Modafinil|modafinil|mesh-list
101995908|NCT03426202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101995909|NCT03426202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995910|NCT03426202|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101995911|NCT03426202|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101995912|NCT03426202|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101995929|NCT01239875|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101995930|NCT01239875|Immunologic Factors|immunologic factors|mesh-ancestor
101995931|NCT01239875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995932|NCT03415594|Glucagon|glucagon|mesh-list
101995933|NCT03415594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101995934|NCT03415594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101995935|NCT03415594|Hormones|hormones|mesh-ancestor
101995936|NCT03415594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101995937|NCT03415594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995938|NCT03415594|Incretins|incretins|mesh-ancestor
101995939|NCT04219254|Pembrolizumab|pembrolizumab|mesh-list
101995940|NCT04219254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101995941|NCT04219254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101995942|NCT04219254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101995943|NCT04219254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995944|NCT01144169|Hydroxychloroquine|hydroxychloroquine|mesh-list
101995945|NCT01144169|Antimalarials|antimalarials|mesh-ancestor
101995946|NCT01144169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101995947|NCT01144169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101995948|NCT01144169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101995949|NCT01144169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101995950|NCT01144169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995951|NCT01144169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101995952|NCT02709954|Ethanol|ethanol|mesh-list
101995953|NCT02709954|Dronabinol|dronabinol|mesh-list
101995954|NCT02709954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101995955|NCT02709954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101995956|NCT02709954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101995957|NCT02709954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995958|NCT02709954|Hallucinogens|hallucinogens|mesh-ancestor
101948149|NCT03863613|Progestins|progestins|mesh-ancestor
101948150|NCT03863613|Hormones|hormones|mesh-ancestor
101948151|NCT03863613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101948152|NCT03863613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948153|NCT01372150|Fluoxetine|fluoxetine|mesh-list
101948154|NCT01372150|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101948155|NCT01372150|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101948156|NCT01372150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101948157|NCT01372150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101948158|NCT01372150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948159|NCT01372150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101948160|NCT01372150|Serotonin Agents|serotonin agents|mesh-ancestor
101948161|NCT01372150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948162|NCT01372150|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101995959|NCT02709954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101995960|NCT02709954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101995961|NCT02709954|Analgesics|analgesics|mesh-ancestor
101995962|NCT02709954|Sensory System Agents|sensory system agents|mesh-ancestor
101995963|NCT02709954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101995964|NCT02709954|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101995965|NCT02709954|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101995966|NCT02709954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101995967|NCT02709954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995968|NCT02709954|Hormones|hormones|mesh-ancestor
101995969|NCT02709954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101995970|NCT03620838|Contraceptive Agents|contraceptive agents|mesh-list
101995971|NCT03620838|Contraceptives, Oral|contraceptives, oral|mesh-list
101995976|NCT03620838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101253597|NCT01414777|Ondansetron|ondansetron|mesh-list
101995977|NCT03620838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995979|NCT03620838|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101995980|NCT01239953|Paclitaxel|paclitaxel|mesh-list
101995981|NCT01239953|Everolimus|everolimus|mesh-list
101995982|NCT01239953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101995983|NCT01239953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101995984|NCT01239953|Tubulin Modulators|tubulin modulators|mesh-ancestor
101995985|NCT01239953|Antimitotic Agents|antimitotic agents|mesh-ancestor
101995986|NCT01239953|Mitosis Modulators|mitosis modulators|mesh-ancestor
101995987|NCT01239953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995988|NCT01239953|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101995989|NCT01239953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101995990|NCT01239953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101995991|NCT01239953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101995992|NCT01239953|Immunologic Factors|immunologic factors|mesh-ancestor
101995993|NCT01239953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995994|NCT01322191|Morphine|morphine|mesh-list
101995995|NCT01322191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101995996|NCT01322191|Narcotics|narcotics|mesh-ancestor
101995997|NCT01322191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101995998|NCT01322191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995999|NCT01322191|Analgesics|analgesics|mesh-ancestor
101996000|NCT01322191|Sensory System Agents|sensory system agents|mesh-ancestor
101996001|NCT01322191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101996002|NCT03620760|Aspirin|aspirin|mesh-list
101996003|NCT03620760|Ticagrelor|ticagrelor|mesh-list
101996004|NCT03620760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101996005|NCT03620760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101996006|NCT03620760|Analgesics|analgesics|mesh-ancestor
101996007|NCT03620760|Sensory System Agents|sensory system agents|mesh-ancestor
101948163|NCT01372150|Antidepressive Agents|antidepressive agents|mesh-ancestor
101948164|NCT01372150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101948165|NCT01372150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101996008|NCT03620760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101996009|NCT03620760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996010|NCT03620760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101996011|NCT03620760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101996012|NCT03620760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101996013|NCT03620760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101996014|NCT03620760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996015|NCT03620760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101996016|NCT03620760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101996017|NCT03620760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101996018|NCT03620760|Antipyretics|antipyretics|mesh-ancestor
101996019|NCT03620760|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101996020|NCT03620760|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101996021|NCT03620760|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101996022|NCT03620760|Purinergic Agents|purinergic agents|mesh-ancestor
101996023|NCT03620760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101996024|NCT03765931|Amoxicillin|amoxicillin|mesh-list
101996025|NCT03765931|Doxycycline|doxycycline|mesh-list
101996026|NCT03765931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101715823|NCT02657603|Lidocaine|lidocaine|mesh-list
101996027|NCT03765931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101996028|NCT03765931|Antimalarials|antimalarials|mesh-ancestor
101996029|NCT03765931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101996030|NCT03765931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101996031|NCT01240265|Vitamin D|vitamin d|mesh-list
101996032|NCT01240265|Ergocalciferols|ergocalciferols|mesh-list
101996033|NCT01240265|Cholecalciferol|cholecalciferol|mesh-list
101996034|NCT01240265|Vitamins|vitamins|mesh-list
101996035|NCT01240265|Micronutrients|micronutrients|mesh-ancestor
101996036|NCT01240265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996037|NCT01240265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101996038|NCT01240265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101996039|NCT02327455|Dobutamine|dobutamine|mesh-list
101996040|NCT02327455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101253681|NCT01150045|Vitamins|vitamins|mesh-ancestor
101996041|NCT02327455|Sympathomimetics|sympathomimetics|mesh-ancestor
101996042|NCT02327455|Autonomic Agents|autonomic agents|mesh-ancestor
101996043|NCT02327455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101996079|NCT03765697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996087|NCT03311841|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101996088|NCT03311841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101996089|NCT03311841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101996090|NCT03311841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996091|NCT03311841|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101996092|NCT03311841|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101996093|NCT03311841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101996094|NCT03311841|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101996095|NCT03311841|Anesthetics, General|anesthetics, general|mesh-ancestor
101996096|NCT03311841|Anesthetics|anesthetics|mesh-ancestor
101996097|NCT03311841|GABA Modulators|gaba modulators|mesh-ancestor
101996098|NCT03311841|GABA Agents|gaba agents|mesh-ancestor
101996099|NCT03311841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101996100|NCT03311841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996101|NCT03311841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101996102|NCT03311841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101996103|NCT03311841|Antimetabolites|antimetabolites|mesh-ancestor
101996104|NCT03311841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101996105|NCT03311841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101996106|NCT03311841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101996107|NCT03311841|Antithrombins|antithrombins|mesh-ancestor
101996108|NCT03311841|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101996109|NCT03311841|Protease Inhibitors|protease inhibitors|mesh-ancestor
101996110|NCT03311841|Anticoagulants|anticoagulants|mesh-ancestor
101996111|NCT03311841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101996112|NCT03311841|Antitubercular Agents|antitubercular agents|mesh-ancestor
101996113|NCT03311841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101996114|NCT03311841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101996115|NCT03311841|Leprostatic Agents|leprostatic agents|mesh-ancestor
101996116|NCT03311841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101996117|NCT03311841|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101948166|NCT01372150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101948167|NCT01372150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101948168|NCT01372150|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101948169|NCT01285245|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101948170|NCT01285245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101948171|NCT01175577|Carotenoids|carotenoids|mesh-list
101948172|NCT01175577|Antioxidants|antioxidants|mesh-ancestor
101996118|NCT03311841|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101996119|NCT03311841|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101996120|NCT03311841|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101996121|NCT03311841|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101996122|NCT03311841|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101996123|NCT01249937|Triamcinolone|triamcinolone|mesh-list
101996124|NCT01249937|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101996125|NCT01249937|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101996126|NCT01249937|Ranibizumab|ranibizumab|mesh-list
101996127|NCT01249937|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101996128|NCT01249937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101996129|NCT01249937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101996130|NCT01249937|Growth Substances|growth substances|mesh-ancestor
101996131|NCT01249937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996132|NCT01249937|Growth Inhibitors|growth inhibitors|mesh-ancestor
101996133|NCT01249937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101996134|NCT01249937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101996135|NCT01249937|Glucocorticoids|glucocorticoids|mesh-ancestor
101996137|NCT01249937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101996138|NCT01249937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101996139|NCT01249937|Immunologic Factors|immunologic factors|mesh-ancestor
101996140|NCT01249937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101996141|NCT01249937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996142|NCT02528201|Celecoxib|celecoxib|mesh-list
101996143|NCT02528201|Diclofenac|diclofenac|mesh-list
101996144|NCT02528201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101996145|NCT02528201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101996146|NCT02528201|Analgesics|analgesics|mesh-ancestor
101996147|NCT02528201|Sensory System Agents|sensory system agents|mesh-ancestor
101996148|NCT02528201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101451162|NCT00413088|Bemiparin|bemiparin|mesh-list
101996153|NCT02528201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101996154|NCT02528201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101996155|NCT02528201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996156|NCT03758677|Gemcitabine|gemcitabine|mesh-list
101996157|NCT03758677|Docetaxel|docetaxel|mesh-list
101996158|NCT03758677|Pemetrexed|pemetrexed|mesh-list
101996159|NCT03758677|Apatinib|apatinib|mesh-list
101996160|NCT03758677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101996161|NCT03758677|Antimetabolites|antimetabolites|mesh-ancestor
101996162|NCT03758677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996163|NCT03758677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101996164|NCT03758677|Tubulin Modulators|tubulin modulators|mesh-ancestor
101996165|NCT03758677|Antimitotic Agents|antimitotic agents|mesh-ancestor
101996166|NCT03758677|Mitosis Modulators|mitosis modulators|mesh-ancestor
101996167|NCT03758677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101996168|NCT03758677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101996169|NCT03758677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101996170|NCT03758677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101996171|NCT03764683|Suvorexant|suvorexant|mesh-list
101996172|NCT03764683|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101996173|NCT03764683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101996174|NCT03764683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101996175|NCT03764683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996176|NCT03764683|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
101996177|NCT03764683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101996178|NCT03764683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996179|NCT03414892|Globalagliatin|globalagliatin|mesh-list
101996180|NCT03414892|Enzyme Activators|enzyme activators|mesh-ancestor
101948173|NCT01175577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948174|NCT01175577|Protective Agents|protective agents|mesh-ancestor
101948175|NCT01175577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996181|NCT03414892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996183|NCT01242605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101996184|NCT01242605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101996185|NCT01242605|Antimetabolites|antimetabolites|mesh-ancestor
101996186|NCT01242605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996187|NCT03414814|Osimertinib|osimertinib|mesh-list
101996188|NCT03414814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101996189|NCT03414814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101996190|NCT03414814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101996191|NCT03414814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996192|NCT03421366|Posaconazole|posaconazole|mesh-list
101996193|NCT03421366|Antifungal Agents|antifungal agents|mesh-ancestor
101996194|NCT03421366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101996195|NCT03421366|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101996196|NCT03421366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101996197|NCT03421366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101996198|NCT03421366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101996199|NCT03421366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101996200|NCT03421366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101996201|NCT03421366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996202|NCT03421366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101996203|NCT03421366|Hormone Antagonists|hormone antagonists|mesh-ancestor
101996204|NCT03421366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101996205|NCT03421366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996206|NCT03764605|Metformin|metformin|mesh-list
101996207|NCT03764605|Tolvaptan|tolvaptan|mesh-list
101996208|NCT03764605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101996209|NCT03764605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996210|NCT03764605|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101996211|NCT03764605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996212|NCT03764605|Natriuretic Agents|natriuretic agents|mesh-ancestor
101996213|NCT03764527|Artesunate|artesunate|mesh-list
101996214|NCT03764527|Lumefantrine|lumefantrine|mesh-list
101996215|NCT03764527|Artemether|artemether|mesh-list
101996216|NCT03764527|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101996217|NCT03764527|Amodiaquine|amodiaquine|mesh-list
101996218|NCT03764527|Antimalarials|antimalarials|mesh-ancestor
101996223|NCT03764527|Antiviral Agents|antiviral agents|mesh-ancestor
101996224|NCT03764527|Schistosomicides|schistosomicides|mesh-ancestor
101996225|NCT03764527|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101996226|NCT03764527|Anthelmintics|anthelmintics|mesh-ancestor
101996227|NCT01321801|Pregabalin|pregabalin|mesh-list
101996228|NCT01321801|Analgesics|analgesics|mesh-ancestor
101996229|NCT01321801|Sensory System Agents|sensory system agents|mesh-ancestor
101996230|NCT01321801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101996231|NCT01321801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996232|NCT01321801|Anticonvulsants|anticonvulsants|mesh-ancestor
101996233|NCT01321801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101996234|NCT01321801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101996235|NCT01321801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996236|NCT01321801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101996237|NCT01321801|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101996238|NCT01321801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101996239|NCT01321801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101996240|NCT01321801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101996241|NCT01155375|Ferrous fumarate|ferrous fumarate|mesh-list
101996242|NCT01155375|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
101996243|NCT01155375|Hematinics|hematinics|mesh-ancestor
101996244|NCT01155375|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101996245|NCT01155375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101996246|NCT01155375|Trace Elements|trace elements|mesh-ancestor
101996247|NCT01155375|Micronutrients|micronutrients|mesh-ancestor
101996248|NCT01155375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996249|NCT03759301|Cetrorelix|cetrorelix|mesh-list
101996250|NCT03759301|Hormones|hormones|mesh-list
101996251|NCT03759301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101996252|NCT03759301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948176|NCT01175733|Panitumumab|panitumumab|mesh-list
101948177|NCT01175733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101996253|NCT03759301|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101996254|NCT03759301|Fertility Agents|fertility agents|mesh-ancestor
101996255|NCT03759301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101996256|NCT03759301|Hormone Antagonists|hormone antagonists|mesh-ancestor
101996257|NCT03764059|Chlorhexidine|chlorhexidine|mesh-list
101996258|NCT03764059|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101996259|NCT03764059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101996260|NCT03764059|Disinfectants|disinfectants|mesh-ancestor
101996261|NCT02260102|Temocillin|temocillin|mesh-list
101996262|NCT02260102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101996263|NCT02260102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101996264|NCT03425734|Dexmedetomidine|dexmedetomidine|mesh-list
101996265|NCT03425734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101996266|NCT03425734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101996267|NCT03425734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996268|NCT03425734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101996269|NCT03425734|Analgesics|analgesics|mesh-ancestor
101996270|NCT03425734|Sensory System Agents|sensory system agents|mesh-ancestor
101996271|NCT03425734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101996272|NCT03425734|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101996273|NCT03425734|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101996274|NCT03425734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101996275|NCT03425734|Adrenergic Agents|adrenergic agents|mesh-ancestor
101996276|NCT03425734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101996277|NCT03425734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996278|NCT03420586|Nitrous Oxide|nitrous oxide|mesh-list
101996279|NCT03420586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101996280|NCT03420586|Anesthetics, General|anesthetics, general|mesh-ancestor
101996281|NCT03420586|Anesthetics|anesthetics|mesh-ancestor
101253877|NCT01694576|Paclitaxel|paclitaxel|mesh-list
101996282|NCT03420586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101996283|NCT03420586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996284|NCT03420586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101996285|NCT03420586|Analgesics|analgesics|mesh-ancestor
101996286|NCT03420586|Sensory System Agents|sensory system agents|mesh-ancestor
101996287|NCT03420586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101996288|NCT03759067|Clopidogrel|clopidogrel|mesh-list
101996289|NCT03759067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101996290|NCT03759067|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101996296|NCT03759067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996297|NCT03425656|Cyclophosphamide|cyclophosphamide|mesh-list
101996298|NCT03425656|Docetaxel|docetaxel|mesh-list
101996299|NCT03425656|Doxorubicin|doxorubicin|mesh-list
101996300|NCT03425656|Trastuzumab|trastuzumab|mesh-list
101996301|NCT03425656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101996302|NCT03425656|Immunologic Factors|immunologic factors|mesh-ancestor
101996303|NCT03425656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996304|NCT03425656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101996305|NCT03425656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101996306|NCT03425656|Alkylating Agents|alkylating agents|mesh-ancestor
101996307|NCT03425656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996308|NCT03425656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101996309|NCT03425656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101996310|NCT03425656|Tubulin Modulators|tubulin modulators|mesh-ancestor
101996311|NCT03425656|Antimitotic Agents|antimitotic agents|mesh-ancestor
101996312|NCT03425656|Mitosis Modulators|mitosis modulators|mesh-ancestor
101996313|NCT03425656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101996314|NCT03425656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101996315|NCT03425656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101996316|NCT03425656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101996317|NCT03425656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101996318|NCT03413722|Everolimus|everolimus|mesh-list
101996319|NCT03413722|Tacrolimus|tacrolimus|mesh-list
101996320|NCT03413722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101996321|NCT03413722|Immunologic Factors|immunologic factors|mesh-ancestor
101996322|NCT03413722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996323|NCT03413722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101996324|NCT03413722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101996325|NCT03413722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996326|NCT03413722|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101996327|NCT03413722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101996328|NCT03413722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101996329|NCT04843462|Esketamine|esketamine|mesh-list
101948178|NCT01175733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101948179|NCT02035930|Dexmedetomidine|dexmedetomidine|mesh-list
101948180|NCT02035930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101948181|NCT02035930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101948182|NCT02035930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996330|NCT04843462|Antidepressive Agents|antidepressive agents|mesh-ancestor
101996331|NCT04843462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101996332|NCT03420040|Insulin Glargine|insulin glargine|mesh-list
101996333|NCT03420040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101996334|NCT03420040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996335|NCT03413410|Metoprolol|metoprolol|mesh-list
101996336|NCT03413410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101996337|NCT03413410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101996338|NCT03413410|Sympatholytics|sympatholytics|mesh-ancestor
101996339|NCT03413410|Autonomic Agents|autonomic agents|mesh-ancestor
101996340|NCT03413410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101996341|NCT03413410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996342|NCT03413410|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101996343|NCT03413410|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101996344|NCT03413410|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101996345|NCT03413410|Adrenergic Agents|adrenergic agents|mesh-ancestor
101996346|NCT03413410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101996347|NCT03413410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996348|NCT03419806|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101996349|NCT03419806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101996350|NCT03419806|Immunologic Factors|immunologic factors|mesh-ancestor
101996351|NCT03419806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996352|NCT03419806|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101996353|NCT03419806|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101996354|NCT03419806|Dopamine Agonists|dopamine agonists|mesh-ancestor
101996355|NCT03419806|Dopamine Agents|dopamine agents|mesh-ancestor
101996356|NCT03419806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101996357|NCT03419806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996358|NCT03424876|Sunitinib|sunitinib|mesh-list
101996359|NCT03424876|Imatinib Mesylate|imatinib mesylate|mesh-list
101996374|NCT03476577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101996375|NCT03476577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996376|NCT03476577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101996377|NCT03476577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101996378|NCT03476577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101996379|NCT03476577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101996380|NCT03476577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996381|NCT03419650|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101996382|NCT03419650|Hormones|hormones|mesh-ancestor
101996383|NCT03419650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101996384|NCT03419650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996385|NCT04893915|Cyclophosphamide|cyclophosphamide|mesh-list
101996386|NCT04893915|Fludarabine|fludarabine|mesh-list
101996387|NCT04893915|Interleukin-2|interleukin-2|mesh-list
101996388|NCT04893915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101996389|NCT04893915|Immunologic Factors|immunologic factors|mesh-ancestor
101996390|NCT04893915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996391|NCT04893915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101996392|NCT04893915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101996393|NCT04893915|Alkylating Agents|alkylating agents|mesh-ancestor
101996394|NCT04893915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996395|NCT04893915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101996396|NCT04893915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101996397|NCT04893915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101996398|NCT04893915|Analgesics|analgesics|mesh-ancestor
101996399|NCT04893915|Sensory System Agents|sensory system agents|mesh-ancestor
101996400|NCT04893915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101996401|NCT03419494|Doxorubicin|doxorubicin|mesh-list
101996402|NCT03419494|Daunorubicin|daunorubicin|mesh-list
101996403|NCT03419494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101996404|NCT03419494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101996405|NCT03419494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101996406|NCT03419494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101996407|NCT03419494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101948183|NCT02035930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101948184|NCT02035930|Analgesics|analgesics|mesh-ancestor
101948185|NCT02035930|Sensory System Agents|sensory system agents|mesh-ancestor
101948186|NCT02035930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101996408|NCT03419494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101996409|NCT03419494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996410|NCT03413020|Amoxicillin|amoxicillin|mesh-list
101996411|NCT03413020|Metronidazole|metronidazole|mesh-list
101996412|NCT03413020|Clarithromycin|clarithromycin|mesh-list
101996413|NCT03413020|Levofloxacin|levofloxacin|mesh-list
101996414|NCT03413020|Potassium Citrate|potassium citrate|mesh-list
101996415|NCT03413020|Esomeprazole|esomeprazole|mesh-list
101996416|NCT03413020|Bismuth|bismuth|mesh-list
101996417|NCT03413020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996418|NCT03413020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101996419|NCT03413020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101996433|NCT03413020|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101996434|NCT03413020|Antacids|antacids|mesh-ancestor
101996435|NCT03413020|Diuretics|diuretics|mesh-ancestor
101996436|NCT03413020|Natriuretic Agents|natriuretic agents|mesh-ancestor
101996437|NCT03413020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996438|NCT03413020|Expectorants|expectorants|mesh-ancestor
101996439|NCT03413020|Respiratory System Agents|respiratory system agents|mesh-ancestor
101996440|NCT03424408|Aspirin|aspirin|mesh-list
101996441|NCT03424408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101996442|NCT03424408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101996443|NCT03424408|Analgesics|analgesics|mesh-ancestor
101996444|NCT03424408|Sensory System Agents|sensory system agents|mesh-ancestor
101996445|NCT03424408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101996446|NCT03424408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996447|NCT03424408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101996448|NCT03424408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101996449|NCT03424408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101996450|NCT03424408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101996451|NCT03424408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996452|NCT03424408|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101996453|NCT03424408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101996454|NCT03424408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101996455|NCT03424408|Antipyretics|antipyretics|mesh-ancestor
101996456|NCT03305055|Fentanyl|fentanyl|mesh-list
101996457|NCT03305055|Ketamine|ketamine|mesh-list
101996458|NCT03305055|Analgesics|analgesics|mesh-ancestor
101996459|NCT03305055|Sensory System Agents|sensory system agents|mesh-ancestor
101996460|NCT03305055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101996461|NCT03305055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996462|NCT03305055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101996463|NCT03305055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101996464|NCT03305055|Anesthetics, General|anesthetics, general|mesh-ancestor
101996465|NCT03305055|Anesthetics|anesthetics|mesh-ancestor
101996466|NCT03305055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101996467|NCT03305055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101996468|NCT03305055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101996469|NCT03305055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101996470|NCT03305055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996471|NCT03305055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101996472|NCT03305055|Narcotics|narcotics|mesh-ancestor
101996473|NCT03305055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101996474|NCT04547985|Naltrexone|naltrexone|mesh-list
101996475|NCT04547985|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101996476|NCT04547985|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101996477|NCT04547985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996478|NCT04547985|Sensory System Agents|sensory system agents|mesh-ancestor
101996479|NCT04547985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101996480|NCT03412552|Magnesium Sulfate|magnesium sulfate|mesh-list
101996503|NCT03412474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101996504|NCT03412474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101996505|NCT03412474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101996506|NCT03412474|Analgesics|analgesics|mesh-ancestor
101996507|NCT03412474|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101996508|NCT03412474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101996509|NCT03412474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101996510|NCT03412474|Adrenergic Agents|adrenergic agents|mesh-ancestor
101948187|NCT02035930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101948188|NCT02035930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101948189|NCT02035930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101948190|NCT02035930|Adrenergic Agents|adrenergic agents|mesh-ancestor
101948191|NCT02035930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101948192|NCT02035930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948193|NCT01173939|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101948194|NCT01173939|Pravastatin|pravastatin|mesh-list
101948195|NCT01173939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101948196|NCT01173939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101948197|NCT01173939|Antimetabolites|antimetabolites|mesh-ancestor
101948198|NCT01173939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948199|NCT01173939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101971961|NCT00411892|Insulin|insulin|mesh-list
101996511|NCT03412474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101996512|NCT03412474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996513|NCT03412474|Antipyretics|antipyretics|mesh-ancestor
101996514|NCT03273387|Trimetazidine|trimetazidine|mesh-list
101996515|NCT03273387|Vasodilator Agents|vasodilator agents|mesh-ancestor
101996516|NCT04527003|Cannabidiol|cannabidiol|mesh-list
101996517|NCT04527003|Norethindrone|norethindrone|mesh-list
101996518|NCT04527003|Norethindrone Acetate|norethindrone acetate|mesh-list
101996519|NCT04527003|Anticonvulsants|anticonvulsants|mesh-ancestor
101996520|NCT04527003|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101996521|NCT04527003|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101996522|NCT04527003|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101996523|NCT04527003|Contraceptive Agents|contraceptive agents|mesh-ancestor
101996524|NCT04527003|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101996525|NCT04527003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996526|NCT04527003|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101996527|NCT04527003|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101996528|NCT04447612|Gemcitabine|gemcitabine|mesh-list
101996529|NCT04447612|Durvalumab|durvalumab|mesh-list
101996530|NCT04447612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101996531|NCT04447612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101996532|NCT04447612|Antimetabolites|antimetabolites|mesh-ancestor
101451567|NCT00225615|Verapamil|verapamil|mesh-list
101996539|NCT03418558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101996540|NCT03418558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101996541|NCT03418558|Tubulin Modulators|tubulin modulators|mesh-ancestor
101996542|NCT03418558|Antimitotic Agents|antimitotic agents|mesh-ancestor
101996543|NCT03418558|Mitosis Modulators|mitosis modulators|mesh-ancestor
101996544|NCT03418558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996545|NCT03418558|Immunotoxins|immunotoxins|mesh-ancestor
101996546|NCT03418558|Immunoconjugates|immunoconjugates|mesh-ancestor
101996547|NCT03418558|Immunologic Factors|immunologic factors|mesh-ancestor
101996548|NCT03418558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996549|NCT05170828|Mycophenolic Acid|mycophenolic acid|mesh-list
101996550|NCT05170828|Sirolimus|sirolimus|mesh-list
101996551|NCT05170828|Cyclophosphamide|cyclophosphamide|mesh-list
101996552|NCT05170828|Busulfan|busulfan|mesh-list
101996553|NCT05170828|Fludarabine|fludarabine|mesh-list
101996554|NCT05170828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101996555|NCT05170828|Immunologic Factors|immunologic factors|mesh-ancestor
101996556|NCT05170828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996557|NCT05170828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101996558|NCT05170828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101996559|NCT05170828|Alkylating Agents|alkylating agents|mesh-ancestor
101996560|NCT05170828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996561|NCT05170828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101996562|NCT05170828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101996563|NCT05170828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101948200|NCT01173939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101948201|NCT01173939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101948202|NCT01174017|Iodine|iodine|mesh-list
101948203|NCT01174017|Cadexomer iodine|cadexomer iodine|mesh-list
101948204|NCT01174017|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101948205|NCT01174017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101948206|NCT01174017|Trace Elements|trace elements|mesh-ancestor
101948207|NCT01174017|Micronutrients|micronutrients|mesh-ancestor
101948208|NCT01174017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948209|NCT01288131|Cyclosporine|cyclosporine|mesh-list
101948210|NCT01288131|Mycophenolic Acid|mycophenolic acid|mesh-list
101948211|NCT01288131|Cyclophosphamide|cyclophosphamide|mesh-list
101948212|NCT01288131|Cyclosporins|cyclosporins|mesh-list
101948213|NCT01288131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101948214|NCT01288131|Immunologic Factors|immunologic factors|mesh-ancestor
101948215|NCT01288131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948216|NCT01288131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101948217|NCT01288131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101948218|NCT01288131|Alkylating Agents|alkylating agents|mesh-ancestor
101948219|NCT01288131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948220|NCT01288131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101948221|NCT01288131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101948222|NCT01288131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101948223|NCT01288131|Antifungal Agents|antifungal agents|mesh-ancestor
101948224|NCT01288131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101948225|NCT01288131|Dermatologic Agents|dermatologic agents|mesh-ancestor
101948226|NCT01288131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101948227|NCT01288131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101948228|NCT01288131|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101948229|NCT01288131|Antitubercular Agents|antitubercular agents|mesh-ancestor
101948230|NCT01288131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101948231|NCT02525211|Ropivacaine|ropivacaine|mesh-list
101948232|NCT02525211|Anesthetics, Local|anesthetics, local|mesh-ancestor
101996564|NCT05170828|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101996565|NCT05170828|Antitubercular Agents|antitubercular agents|mesh-ancestor
101996566|NCT05170828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101996567|NCT05170828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101996568|NCT05170828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101996569|NCT05170828|Antifungal Agents|antifungal agents|mesh-ancestor
101996570|NCT03412006|Fulacimstat|fulacimstat|mesh-list
101996571|NCT03412006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101996572|NCT03412006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996573|NCT03418246|Calcium|calcium|mesh-list
101948233|NCT02525211|Anesthetics|anesthetics|mesh-ancestor
101948234|NCT02525211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101948235|NCT02525211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948236|NCT02525211|Sensory System Agents|sensory system agents|mesh-ancestor
101948237|NCT02525211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101668062|NCT02824874|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101996574|NCT03418246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101996575|NCT03418246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996576|NCT03411850|Abatacept|abatacept|mesh-list
101996577|NCT03411850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101996578|NCT03411850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996579|NCT03411850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101996580|NCT03411850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101996581|NCT03411850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101996582|NCT03411850|Immunologic Factors|immunologic factors|mesh-ancestor
101996583|NCT03411850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996584|NCT03411850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101996585|NCT05170594|Bevacizumab|bevacizumab|mesh-list
101996586|NCT05170594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
101996587|NCT05170594|Fluzoparib|fluzoparib|mesh-list
101996588|NCT05170594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101996589|NCT05170594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101996590|NCT05170594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101996591|NCT05170594|Growth Substances|growth substances|mesh-ancestor
101996592|NCT05170594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996593|NCT05170594|Growth Inhibitors|growth inhibitors|mesh-ancestor
101996594|NCT05170594|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101996595|NCT05170594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101996596|NCT05170594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996597|NCT03410836|Lidocaine|lidocaine|mesh-list
101996598|NCT03410836|Anesthetics, Local|anesthetics, local|mesh-ancestor
101996599|NCT03410836|Anesthetics|anesthetics|mesh-ancestor
101451615|NCT00225849|Antipyretics|antipyretics|mesh-ancestor
101996604|NCT03410836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101996605|NCT03410836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101996606|NCT03410836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101996607|NCT03410836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101996608|NCT03410836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996610|NCT03273153|Atezolizumab|atezolizumab|mesh-list
101996611|NCT03273153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101996612|NCT03273153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101996613|NCT03273153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101996614|NCT03273153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996615|NCT03418090|Xenon|xenon|mesh-list
101996616|NCT03418090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101996617|NCT03418090|Anesthetics, General|anesthetics, general|mesh-ancestor
101996618|NCT03418090|Anesthetics|anesthetics|mesh-ancestor
101996619|NCT03418090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101996620|NCT03418090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996621|NCT03323034|Irinotecan|irinotecan|mesh-list
101996622|NCT03323034|Temozolomide|temozolomide|mesh-list
101996623|NCT03323034|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101996624|NCT03323034|Pevonedistat|pevonedistat|mesh-list
101996625|NCT03323034|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101996626|NCT03323034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101996627|NCT03323034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996628|NCT03323034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101996629|NCT03323034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101996630|NCT03323034|Alkylating Agents|alkylating agents|mesh-ancestor
101996631|NCT02520934|Miglustat|miglustat|mesh-list
101996632|NCT02520934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387631|NCT00122343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996633|NCT02520934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996634|NCT02520934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101996635|NCT02520934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101996636|NCT02520934|Antiviral Agents|antiviral agents|mesh-ancestor
101996637|NCT02520934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101996638|NCT02520934|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101948238|NCT03865563|Gemcitabine|gemcitabine|mesh-list
101948239|NCT03865563|Ethiodized Oil|ethiodized oil|mesh-list
101948240|NCT03865563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101996639|NCT02520934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101996640|NCT02520934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996641|NCT02749968|Bupivacaine|bupivacaine|mesh-list
101996642|NCT02749968|Anesthetics, Local|anesthetics, local|mesh-ancestor
101996643|NCT02749968|Anesthetics|anesthetics|mesh-ancestor
101996644|NCT02749968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101996645|NCT02749968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996646|NCT02749968|Sensory System Agents|sensory system agents|mesh-ancestor
101996647|NCT02749968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101996648|NCT04787250|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101996649|NCT04787250|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101996650|NCT04787250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101996651|NCT04787250|Antitubercular Agents|antitubercular agents|mesh-ancestor
101996652|NCT03417700|Vitamin D|vitamin d|mesh-list
101996653|NCT03417700|Vitamins|vitamins|mesh-ancestor
101996654|NCT03417700|Micronutrients|micronutrients|mesh-ancestor
101996655|NCT03417700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996656|NCT03417700|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101996657|NCT03410524|Simethicone|simethicone|mesh-list
101996658|NCT03410524|Antifoaming Agents|antifoaming agents|mesh-ancestor
101996659|NCT03410524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996660|NCT03410524|Emollients|emollients|mesh-ancestor
101996661|NCT03410524|Dermatologic Agents|dermatologic agents|mesh-ancestor
101996662|NCT02713776|Pasireotide|pasireotide|mesh-list
101996663|NCT02713776|Somatostatin|somatostatin|mesh-list
101996664|NCT02713776|Hormones|hormones|mesh-ancestor
101996665|NCT02713776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101996666|NCT02713776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996667|NCT05215990|Metformin|metformin|mesh-list
101996668|NCT05215990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101451682|NCT00196391|Progestins|progestins|mesh-ancestor
101996687|NCT05215834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996689|NCT05215834|Anesthetics, General|anesthetics, general|mesh-ancestor
101996690|NCT05215834|Anesthetics|anesthetics|mesh-ancestor
101996691|NCT05215834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101996692|NCT05215834|Narcotics|narcotics|mesh-ancestor
101996693|NCT05215834|Analgesics|analgesics|mesh-ancestor
101996694|NCT05215834|Sensory System Agents|sensory system agents|mesh-ancestor
101996695|NCT05215834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101996696|NCT03394144|Durvalumab|durvalumab|mesh-list
101996697|NCT03394144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101996698|NCT03394144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101996699|NCT05011149|Ibuprofen|ibuprofen|mesh-list
101996700|NCT05011149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101996701|NCT05011149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101996702|NCT05011149|Analgesics|analgesics|mesh-ancestor
101996703|NCT05011149|Sensory System Agents|sensory system agents|mesh-ancestor
101996704|NCT05011149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101996705|NCT05011149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996706|NCT05011149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101996707|NCT05011149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101996708|NCT05011149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101996709|NCT05011149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101996710|NCT05011149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996711|NCT03393988|Fentanyl|fentanyl|mesh-list
101996712|NCT03393988|Dexmedetomidine|dexmedetomidine|mesh-list
101996713|NCT03393988|Sympathomimetics|sympathomimetics|mesh-list
101996714|NCT03393988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101996715|NCT03393988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101996716|NCT03393988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996717|NCT03393988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101996718|NCT03393988|Analgesics|analgesics|mesh-ancestor
101996719|NCT03393988|Sensory System Agents|sensory system agents|mesh-ancestor
101996720|NCT03393988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101996721|NCT03393988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101996722|NCT03393988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101996723|NCT03393988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101996724|NCT03393988|Adrenergic Agents|adrenergic agents|mesh-ancestor
101996725|NCT03393988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101996744|NCT03410212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101996745|NCT03410212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101948241|NCT03865563|Antimetabolites|antimetabolites|mesh-ancestor
101948242|NCT03865563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948243|NCT03865563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101996746|NCT03410212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996748|NCT03397264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101996749|NCT03397264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101996750|NCT03397264|Growth Substances|growth substances|mesh-ancestor
101996751|NCT03397264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996752|NCT03397264|Growth Inhibitors|growth inhibitors|mesh-ancestor
101996753|NCT03397264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101996754|NCT03397186|Trabectedin|trabectedin|mesh-list
101996755|NCT03397186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101996756|NCT03397186|Alkylating Agents|alkylating agents|mesh-ancestor
101996757|NCT03397186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996758|NCT03397186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101996759|NCT03393364|Ketorolac|ketorolac|mesh-list
101996760|NCT03393364|Oxycodone|oxycodone|mesh-list
101996761|NCT03393364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101996762|NCT03393364|Narcotics|narcotics|mesh-ancestor
101996763|NCT03393364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101996764|NCT03393364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996765|NCT03393364|Analgesics|analgesics|mesh-ancestor
101996766|NCT03393364|Sensory System Agents|sensory system agents|mesh-ancestor
101996767|NCT03393364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101996768|NCT03393364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101996769|NCT03393364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101996770|NCT03393364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101996771|NCT03393364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101996772|NCT03393364|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101996773|NCT03393364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101996774|NCT03393364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996775|NCT04632706|Ivermectin|ivermectin|mesh-list
101996776|NCT04632706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101996777|NCT04632706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101996778|NCT03405454|Durvalumab|durvalumab|mesh-list
101996779|NCT03405454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101996780|NCT03405454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101996781|NCT05168176|Dolutegravir|dolutegravir|mesh-list
101451808|NCT00226317|Aripiprazole|aripiprazole|mesh-list
101996793|NCT04539730|Anesthetics|anesthetics|mesh-ancestor
101996794|NCT04539730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101996795|NCT04539730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996796|NCT04539730|Sensory System Agents|sensory system agents|mesh-ancestor
101996797|NCT04539730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101996798|NCT03396484|Methyldopa|methyldopa|mesh-list
101996799|NCT03396484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101996800|NCT03396484|Sympatholytics|sympatholytics|mesh-ancestor
101996801|NCT03396484|Autonomic Agents|autonomic agents|mesh-ancestor
101996802|NCT03396484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101996803|NCT03396484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996804|NCT03396484|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101996805|NCT03396484|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101996806|NCT03396484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101996807|NCT03396484|Adrenergic Agents|adrenergic agents|mesh-ancestor
101996808|NCT03396484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101996809|NCT03396484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996810|NCT03321396|Calcium|calcium|mesh-list
101996811|NCT03321396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101996812|NCT03321396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996813|NCT04809376|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
101996814|NCT04809376|Anticoagulants|anticoagulants|mesh-ancestor
101996815|NCT03321006|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101996816|NCT03321006|Escitalopram|escitalopram|mesh-list
101996817|NCT03321006|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101996818|NCT03321006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101996819|NCT03321006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101996820|NCT03321006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996821|NCT03321006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101996822|NCT03321006|Serotonin Agents|serotonin agents|mesh-ancestor
101996823|NCT03321006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948244|NCT01178151|Everolimus|everolimus|mesh-list
101948245|NCT01178151|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101948246|NCT01178151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101948247|NCT01178151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101971962|NCT00411892|Pioglitazone|pioglitazone|mesh-list
101996824|NCT03321006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101996825|NCT03321006|Antidepressive Agents|antidepressive agents|mesh-ancestor
101996826|NCT03321006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101996827|NCT03321006|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101996828|NCT03321006|Analgesics|analgesics|mesh-ancestor
101996829|NCT03321006|Sensory System Agents|sensory system agents|mesh-ancestor
101996830|NCT03321006|Dopamine Agents|dopamine agents|mesh-ancestor
101996831|NCT01974609|Acetaminophen|acetaminophen|mesh-list
101996832|NCT01974609|Ibuprofen|ibuprofen|mesh-list
101996833|NCT01974609|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
101996834|NCT01974609|Hydrocodone|hydrocodone|mesh-list
101996835|NCT01974609|Narcotics|narcotics|mesh-list
101996836|NCT01974609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101996837|NCT01974609|Analgesics|analgesics|mesh-ancestor
101996838|NCT01974609|Sensory System Agents|sensory system agents|mesh-ancestor
101996839|NCT01974609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101996840|NCT01974609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996841|NCT01974609|Antipyretics|antipyretics|mesh-ancestor
101996842|NCT01974609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101996843|NCT01974609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101996844|NCT01974609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101996845|NCT01974609|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101996853|NCT02593123|Molgramostim|molgramostim|mesh-list
101996854|NCT02593123|Lenograstim|lenograstim|mesh-list
101996855|NCT02593123|Sargramostim|sargramostim|mesh-list
101996856|NCT02593123|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101996857|NCT02593123|Immunologic Factors|immunologic factors|mesh-ancestor
101996858|NCT02593123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996859|NCT02593123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101996860|NCT02593123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101996861|NCT02593123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101996862|NCT02593123|Antitubercular Agents|antitubercular agents|mesh-ancestor
101996863|NCT02593123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101996864|NCT02593123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101996865|NCT02593123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101996866|NCT02593123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996867|NCT03396250|Diphenhydramine|diphenhydramine|mesh-list
101996868|NCT03396250|Promethazine|promethazine|mesh-list
101996869|NCT03396250|Naproxen|naproxen|mesh-list
101996870|NCT03396250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101996871|NCT03396250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101996872|NCT03396250|Analgesics|analgesics|mesh-ancestor
101996873|NCT03396250|Sensory System Agents|sensory system agents|mesh-ancestor
101996874|NCT03396250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101996875|NCT03396250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996876|NCT03396250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101996877|NCT03396250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101996878|NCT03396250|Gout Suppressants|gout suppressants|mesh-ancestor
101996879|NCT03396250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101996880|NCT03396250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101996881|NCT03396250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996882|NCT03396250|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101996883|NCT03396250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101996884|NCT03396250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101996885|NCT03396250|Anesthetics, Local|anesthetics, local|mesh-ancestor
101996886|NCT03396250|Anesthetics|anesthetics|mesh-ancestor
101996887|NCT03396250|Antiemetics|antiemetics|mesh-ancestor
101996888|NCT03396250|Autonomic Agents|autonomic agents|mesh-ancestor
101996889|NCT03396250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101996890|NCT03396250|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101996891|NCT03396250|Histamine Antagonists|histamine antagonists|mesh-ancestor
101996892|NCT03396250|Histamine Agents|histamine agents|mesh-ancestor
101996893|NCT03396250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101996894|NCT03396250|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101996895|NCT03396250|Antipruritics|antipruritics|mesh-ancestor
101996896|NCT03396250|Dermatologic Agents|dermatologic agents|mesh-ancestor
101996897|NCT03302559|Vitamin A|vitamin a|mesh-list
101996898|NCT03302559|Retinol palmitate|retinol palmitate|mesh-list
101948248|NCT01178151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996899|NCT03302559|Sunscreening Agents|sunscreening agents|mesh-list
101996900|NCT03302559|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101996901|NCT03302559|Protective Agents|protective agents|mesh-ancestor
101996902|NCT03302559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996903|NCT03302559|Dermatologic Agents|dermatologic agents|mesh-ancestor
101996905|NCT03302559|Micronutrients|micronutrients|mesh-ancestor
101996906|NCT03302559|Antioxidants|antioxidants|mesh-ancestor
101996907|NCT03302559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996908|NCT03302559|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101996909|NCT03302559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101996910|NCT03763669|Folic Acid|folic acid|mesh-list
101996911|NCT03763669|Vitamin B Complex|vitamin b complex|mesh-list
101996912|NCT03763669|Inositol|inositol|mesh-list
101996913|NCT03763669|Hematinics|hematinics|mesh-ancestor
101996914|NCT03763669|Vitamins|vitamins|mesh-ancestor
101996915|NCT03763669|Micronutrients|micronutrients|mesh-ancestor
101996926|NCT04363840|Vitamin D|vitamin d|mesh-list
101996927|NCT04363840|Vitamins|vitamins|mesh-ancestor
101996928|NCT04363840|Micronutrients|micronutrients|mesh-ancestor
101996929|NCT04363840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996930|NCT04363840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101996931|NCT04363840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101996932|NCT04363840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101996933|NCT04363840|Analgesics|analgesics|mesh-ancestor
101996934|NCT04363840|Sensory System Agents|sensory system agents|mesh-ancestor
101996935|NCT04363840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101996936|NCT04363840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101996937|NCT04363840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101996938|NCT04363840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101996939|NCT04363840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101996940|NCT04363840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996941|NCT04363840|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101996942|NCT04363840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101996943|NCT04363840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101996944|NCT04363840|Antipyretics|antipyretics|mesh-ancestor
101996945|NCT04981665|Tislelizumab|tislelizumab|mesh-list
101996946|NCT04981665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101996947|NCT04981665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101996948|NCT03392740|Lisinopril|lisinopril|mesh-list
101996949|NCT03392740|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101996950|NCT03392740|Protease Inhibitors|protease inhibitors|mesh-ancestor
101996951|NCT03392740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101996952|NCT03392740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996953|NCT03392740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101996954|NCT03392740|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101996955|NCT03392740|Protective Agents|protective agents|mesh-ancestor
101996956|NCT03392740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996957|NCT04919317|Dexamethasone|dexamethasone|mesh-list
101996958|NCT04919317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101996959|NCT04919317|Antiemetics|antiemetics|mesh-ancestor
101996960|NCT04919317|Autonomic Agents|autonomic agents|mesh-ancestor
101996961|NCT04919317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101996962|NCT04919317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996963|NCT04919317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101996964|NCT04919317|Glucocorticoids|glucocorticoids|mesh-ancestor
101996965|NCT04919317|Hormones|hormones|mesh-ancestor
101996966|NCT04919317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101996967|NCT04919317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101996968|NCT04919317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101996969|NCT02818023|Pembrolizumab|pembrolizumab|mesh-list
101996970|NCT02818023|Vemurafenib|vemurafenib|mesh-list
101996971|NCT02818023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101996972|NCT02818023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101996973|NCT02818023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101996974|NCT02818023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996975|NCT02818023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101996976|NCT02818023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101996977|NCT03262389|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101996978|NCT03262389|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101996979|NCT03262389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996991|NCT04631536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101996992|NCT04631536|Hematinics|hematinics|mesh-ancestor
101948249|NCT01178151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101948250|NCT01178151|Immunologic Factors|immunologic factors|mesh-ancestor
101948251|NCT01178151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948252|NCT01178151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101996994|NCT04631536|Micronutrients|micronutrients|mesh-ancestor
101996995|NCT04631536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996996|NCT04631536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101996997|NCT04631536|Vasodilator Agents|vasodilator agents|mesh-ancestor
101996998|NCT04631536|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101996999|NCT04631536|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101997000|NCT04631536|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101997001|NCT04631536|Adrenergic Agents|adrenergic agents|mesh-ancestor
101997002|NCT04631536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101997003|NCT04631536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101997004|NCT03262233|Nicotine|nicotine|mesh-list
101716792|NCT00691054|Paclitaxel|paclitaxel|mesh-list
101997005|NCT03262233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101997006|NCT03262233|Autonomic Agents|autonomic agents|mesh-ancestor
101997007|NCT03262233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101997008|NCT03262233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997009|NCT03262233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101997010|NCT03262233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101997011|NCT03262233|Cholinergic Agents|cholinergic agents|mesh-ancestor
101997012|NCT03262233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101997013|NCT03262233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997014|NCT05166538|Clopidogrel|clopidogrel|mesh-list
101997016|NCT05166538|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101997017|NCT05166538|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101997018|NCT05166538|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101997019|NCT05166538|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101997020|NCT05166538|Purinergic Agents|purinergic agents|mesh-ancestor
101997021|NCT05166538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101997022|NCT05166538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997023|NCT05166538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997024|NCT03260205|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101997025|NCT03260205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101997026|NCT03260205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997027|NCT03260205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101387632|NCT00314080|Antitoxins|antitoxins|mesh-list
101997028|NCT03260205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101997029|NCT03260205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101997030|NCT03260205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997031|NCT03260205|Dopamine Agents|dopamine agents|mesh-ancestor
101997032|NCT03260205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101997033|NCT04666441|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
101997034|NCT04666441|Antiviral Agents|antiviral agents|mesh-ancestor
101997035|NCT04666441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101997036|NCT03320850|Botulinum Toxins|botulinum toxins|mesh-list
101997037|NCT03320850|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101997038|NCT03320850|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101997039|NCT03320850|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101997040|NCT03320850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101997041|NCT03320850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997042|NCT03320850|Cholinergic Agents|cholinergic agents|mesh-ancestor
101997057|NCT04447378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101997058|NCT03125980|Capecitabine|capecitabine|mesh-list
101997059|NCT03125980|Oxaliplatin|oxaliplatin|mesh-list
101997060|NCT03125980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101997061|NCT03125980|Antimetabolites|antimetabolites|mesh-ancestor
101997062|NCT03125980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997063|NCT03125980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101997064|NCT03399604|Treprostinil|treprostinil|mesh-list
101997065|NCT03399604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101997066|NCT03399526|Calcitriol|calcitriol|mesh-list
101997067|NCT03399526|Betamethasone|betamethasone|mesh-list
101997068|NCT03399526|Betamethasone Valerate|betamethasone valerate|mesh-list
101997069|NCT03399526|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101997070|NCT03399526|Betamethasone benzoate|betamethasone benzoate|mesh-list
101997071|NCT03399526|Clobetasol|clobetasol|mesh-list
101997072|NCT03399526|Prednicarbate|prednicarbate|mesh-list
101997073|NCT03399526|Calcipotriene|calcipotriene|mesh-list
101948254|NCT03862287|Bupivacaine|bupivacaine|mesh-list
101948255|NCT03862287|Anesthetics, Local|anesthetics, local|mesh-ancestor
101948256|NCT03862287|Anesthetics|anesthetics|mesh-ancestor
101948257|NCT03862287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101948258|NCT03862287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948259|NCT03862287|Sensory System Agents|sensory system agents|mesh-ancestor
101948260|NCT03862287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101948261|NCT03862287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101948262|NCT03862287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101948263|NCT03862287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101948264|NCT03862287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101971963|NCT00411892|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101997074|NCT03399526|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101997075|NCT03399526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101997076|NCT03399526|Glucocorticoids|glucocorticoids|mesh-ancestor
101997077|NCT03399526|Hormones|hormones|mesh-ancestor
101997078|NCT03399526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101997079|NCT03399526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997080|NCT03399526|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101716860|NCT00848718|Paclitaxel|paclitaxel|mesh-list
101997081|NCT03399526|Respiratory System Agents|respiratory system agents|mesh-ancestor
101997082|NCT03399526|Dermatologic Agents|dermatologic agents|mesh-ancestor
101997083|NCT03399526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101997084|NCT03399526|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101997085|NCT03399526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101997086|NCT03399526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997087|NCT03399526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101997088|NCT03399526|Vitamins|vitamins|mesh-ancestor
101997089|NCT03399526|Micronutrients|micronutrients|mesh-ancestor
101997090|NCT03399526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101997091|NCT03392272|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101997092|NCT03392272|Hemostatics|hemostatics|mesh-ancestor
101997093|NCT03392272|Coagulants|coagulants|mesh-ancestor
101997094|NCT03905902|Vaccines|vaccines|mesh-list
101997095|NCT03905902|Immunologic Factors|immunologic factors|mesh-ancestor
101997096|NCT03905902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997097|NCT03638310|Gentamicins|gentamicins|mesh-list
101997098|NCT03638310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101997099|NCT03638310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101997100|NCT03638310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101997101|NCT03638310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101997102|NCT03638310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997103|NCT04656691|Bamlanivimab|bamlanivimab|mesh-list
101997104|NCT04656691|Antiviral Agents|antiviral agents|mesh-ancestor
101997110|NCT03399448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997111|NCT03399448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101997112|NCT03399448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101997113|NCT03399448|Alkylating Agents|alkylating agents|mesh-ancestor
101997114|NCT03399448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997115|NCT03399448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101997116|NCT03399448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101997117|NCT03755947|Venetoclax|venetoclax|mesh-list
101997118|NCT03755947|Obinutuzumab|obinutuzumab|mesh-list
101997119|NCT03755947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101997120|NCT03755947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101997121|NCT03395470|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101997122|NCT03395470|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101997123|NCT03395470|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101997124|NCT03395470|Antimetabolites|antimetabolites|mesh-ancestor
101997125|NCT03395470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997126|NCT03395470|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101948265|NCT03862287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948266|NCT03862053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101948267|NCT03862053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101948268|NCT01287351|Fluticasone|fluticasone|mesh-list
101948269|NCT01287351|Xhance|xhance|mesh-list
101948270|NCT01287351|Beclomethasone|beclomethasone|mesh-list
101948271|NCT01287351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101997127|NCT03395470|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101997128|NCT03395470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101997129|NCT03257865|Brexpiprazole|brexpiprazole|mesh-list
101997130|NCT03257865|Serotonin Agents|serotonin agents|mesh-ancestor
101997131|NCT03257865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101997132|NCT03257865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997133|NCT03257865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997134|NCT03257865|Dopamine Agonists|dopamine agonists|mesh-ancestor
101997135|NCT03257865|Dopamine Agents|dopamine agents|mesh-ancestor
101997136|NCT01610700|Nabiximols|nabiximols|mesh-list
101997137|NCT01610700|Analgesics|analgesics|mesh-ancestor
101997138|NCT01610700|Sensory System Agents|sensory system agents|mesh-ancestor
101997139|NCT01610700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101997140|NCT01610700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997141|NCT04632459|Pembrolizumab|pembrolizumab|mesh-list
101997142|NCT04632459|Ramucirumab|ramucirumab|mesh-list
101997143|NCT04632459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101997144|NCT04632459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101997145|NCT04632459|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101997146|NCT04632459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997147|NCT03985371|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101997148|NCT03985371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101997149|NCT03316872|Pembrolizumab|pembrolizumab|mesh-list
101997150|NCT03316872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101997151|NCT03316872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101997152|NCT03316872|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101997153|NCT03316872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997154|NCT03256695|Albuterol|albuterol|mesh-list
101997155|NCT03256695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101997156|NCT03256695|Autonomic Agents|autonomic agents|mesh-ancestor
101997157|NCT03256695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101997158|NCT03256695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997159|NCT03256695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101997160|NCT03256695|Respiratory System Agents|respiratory system agents|mesh-ancestor
101997161|NCT03256695|Tocolytic Agents|tocolytic agents|mesh-ancestor
101997162|NCT03256695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101997163|NCT03256695|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101997164|NCT03256695|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101997165|NCT03256695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101997166|NCT03256695|Adrenergic Agents|adrenergic agents|mesh-ancestor
101997167|NCT03256695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101997168|NCT03256695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997169|NCT04623684|Phenylephrine|phenylephrine|mesh-list
101997170|NCT04623684|Oxymetazoline|oxymetazoline|mesh-list
101997171|NCT04623684|Tropicamide|tropicamide|mesh-list
101997172|NCT04623684|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101997173|NCT04623684|Mydriatics|mydriatics|mesh-ancestor
101997174|NCT04623684|Autonomic Agents|autonomic agents|mesh-ancestor
101997182|NCT04623684|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101997184|NCT04623684|Adrenergic Agents|adrenergic agents|mesh-ancestor
101997185|NCT04623684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101997186|NCT04623684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997187|NCT04623684|Protective Agents|protective agents|mesh-ancestor
101997188|NCT04623684|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101997189|NCT04623684|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101997190|NCT04623684|Cholinergic Agents|cholinergic agents|mesh-ancestor
101997191|NCT03297021|Ondansetron|ondansetron|mesh-list
101997192|NCT03297021|Antiemetics|antiemetics|mesh-ancestor
101997193|NCT03297021|Autonomic Agents|autonomic agents|mesh-ancestor
101997194|NCT03297021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101997195|NCT03297021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997196|NCT03297021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101948272|NCT01287351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101948273|NCT01287351|Autonomic Agents|autonomic agents|mesh-ancestor
101948274|NCT01287351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101948275|NCT01287351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823730|NCT00824135|Rituximab|rituximab|mesh-list
101997197|NCT03297021|Antipruritics|antipruritics|mesh-ancestor
101997198|NCT03297021|Dermatologic Agents|dermatologic agents|mesh-ancestor
101997199|NCT03297021|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101997200|NCT03297021|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101997201|NCT03297021|Serotonin Agents|serotonin agents|mesh-ancestor
101997202|NCT03297021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101997203|NCT03297021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997204|NCT03752749|Prednisolone|prednisolone|mesh-list
101997205|NCT03752749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101997206|NCT03752749|Glucocorticoids|glucocorticoids|mesh-ancestor
101997207|NCT03752749|Hormones|hormones|mesh-ancestor
101997208|NCT03752749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101997209|NCT03752749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997210|NCT03752749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101997211|NCT03752749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101997212|NCT01988571|Atorvastatin|atorvastatin|mesh-list
101997213|NCT01988571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101997214|NCT01988571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101997215|NCT01988571|Antimetabolites|antimetabolites|mesh-ancestor
101997216|NCT01988571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997217|NCT01988571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101997218|NCT01988571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101997219|NCT01988571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101997220|NCT00536172|Escitalopram|escitalopram|mesh-list
101997221|NCT00536172|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101997222|NCT00536172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101997223|NCT00536172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101997224|NCT00536172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997225|NCT00536172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101997226|NCT00536172|Serotonin Agents|serotonin agents|mesh-ancestor
101997227|NCT00536172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997228|NCT03755557|Budesonide|budesonide|mesh-list
101997229|NCT03755557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101997230|NCT03755557|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101997231|NCT03755557|Autonomic Agents|autonomic agents|mesh-ancestor
101997232|NCT03755557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101997233|NCT03755557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997234|NCT03755557|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101997235|NCT03755557|Respiratory System Agents|respiratory system agents|mesh-ancestor
101997236|NCT03755557|Glucocorticoids|glucocorticoids|mesh-ancestor
101997237|NCT03755557|Hormones|hormones|mesh-ancestor
101997238|NCT03755557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101997239|NCT03511599|Cycloserine|cycloserine|mesh-list
101997241|NCT03511599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101997242|NCT03511599|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101997243|NCT03511599|Antitubercular Agents|antitubercular agents|mesh-ancestor
101997244|NCT03511599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101997245|NCT03511599|Antimetabolites|antimetabolites|mesh-ancestor
101997246|NCT03511599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997248|NCT01140867|Anticonvulsants|anticonvulsants|mesh-ancestor
101997249|NCT01140867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101997250|NCT01140867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101997251|NCT01140867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997252|NCT01140867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101997253|NCT01140867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997254|NCT04572997|Apremilast|apremilast|mesh-list
101997255|NCT04572997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101997256|NCT04572997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101997257|NCT04572997|Analgesics|analgesics|mesh-ancestor
101997258|NCT04572997|Sensory System Agents|sensory system agents|mesh-ancestor
101997259|NCT04572997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101997260|NCT04572997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948276|NCT01287351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101948277|NCT01287351|Respiratory System Agents|respiratory system agents|mesh-ancestor
101948278|NCT01287351|Dermatologic Agents|dermatologic agents|mesh-ancestor
101948279|NCT01287351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101997261|NCT04572997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101997262|NCT04572997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101997263|NCT04572997|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101997264|NCT04572997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101997265|NCT04572997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101997266|NCT04572997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997267|NCT03292653|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
101997268|NCT03292653|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101997269|NCT03292653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997270|NCT03292653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101997271|NCT03292653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997272|NCT02891070|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101997273|NCT02891070|Hemostatics|hemostatics|mesh-ancestor
101997274|NCT02891070|Coagulants|coagulants|mesh-ancestor
101997275|NCT00381381|Donepezil|donepezil|mesh-list
101997276|NCT00381381|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101997277|NCT00381381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101997278|NCT00381381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997279|NCT00381381|Cholinergic Agents|cholinergic agents|mesh-ancestor
101997280|NCT00381381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101997281|NCT00381381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997282|NCT00381381|Nootropic Agents|nootropic agents|mesh-ancestor
101997283|NCT03637335|Carboplatin|carboplatin|mesh-list
101997284|NCT03637335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101997285|NCT02939937|Phenytoin|phenytoin|mesh-list
101997286|NCT02939937|Anticonvulsants|anticonvulsants|mesh-ancestor
101997287|NCT02939937|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101997288|NCT02939937|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101997289|NCT02939937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101997290|NCT02939937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997291|NCT02939937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101997292|NCT02939937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101997293|NCT02939079|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101997294|NCT02939079|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101997295|NCT02939079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997296|NCT02939079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101997297|NCT02939079|Immunologic Factors|immunologic factors|mesh-ancestor
101997298|NCT02939079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997299|NCT02774265|Aspirin|aspirin|mesh-list
101997300|NCT02774265|Heparin|heparin|mesh-list
101997301|NCT02774265|Enoxaparin|enoxaparin|mesh-list
101997302|NCT02774265|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101997303|NCT02774265|Tinzaparin|tinzaparin|mesh-list
101997304|NCT02774265|Dalteparin|dalteparin|mesh-list
101997305|NCT02774265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101997306|NCT02774265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101997307|NCT02774265|Analgesics|analgesics|mesh-ancestor
101997308|NCT02774265|Sensory System Agents|sensory system agents|mesh-ancestor
101997309|NCT02774265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101997318|NCT02774265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101997320|NCT02774265|Anticoagulants|anticoagulants|mesh-ancestor
101997321|NCT04755595|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101997322|NCT04755595|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101997323|NCT04755595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101997324|NCT04755595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101997325|NCT04755595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997326|NCT04755595|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101997327|NCT04755595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101997328|NCT04755595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997329|NCT04755595|Cholinergic Agents|cholinergic agents|mesh-ancestor
101997330|NCT04755595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101997331|NCT03755479|Insulin|insulin|mesh-list
101997332|NCT03755479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101997333|NCT03755479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997334|NCT05239390|Dronabinol|dronabinol|mesh-list
101948280|NCT01287351|Glucocorticoids|glucocorticoids|mesh-ancestor
101948281|NCT01287351|Hormones|hormones|mesh-ancestor
101823837|NCT04044287|Misoprostol|misoprostol|mesh-list
101997335|NCT05239390|Hallucinogens|hallucinogens|mesh-ancestor
101997336|NCT05239390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997337|NCT05239390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101997338|NCT05239390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101997339|NCT05239390|Analgesics|analgesics|mesh-ancestor
101997340|NCT05239390|Sensory System Agents|sensory system agents|mesh-ancestor
101997341|NCT05239390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101997342|NCT05239390|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101997343|NCT05239390|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101997344|NCT05239390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101997345|NCT05239390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997346|NCT05239390|Hormones|hormones|mesh-ancestor
101997347|NCT05239390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101997348|NCT03752437|Heparin|heparin|mesh-list
101997349|NCT03752437|Anticoagulants|anticoagulants|mesh-ancestor
101997350|NCT03752437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101997351|NCT03752437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101997352|NCT03752437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997353|NCT05239312|Anti-Infective Agents|anti-infective agents|mesh-list
101997354|NCT05239312|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101997355|NCT04748341|Benzocaine|benzocaine|mesh-list
101997356|NCT04748341|Anesthetics, Local|anesthetics, local|mesh-ancestor
101997357|NCT04748341|Anesthetics|anesthetics|mesh-ancestor
101997358|NCT04748341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101997359|NCT04748341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997360|NCT04748341|Sensory System Agents|sensory system agents|mesh-ancestor
101997361|NCT04748341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101997362|NCT01328002|Milnacipran|milnacipran|mesh-list
101997363|NCT01328002|Levomilnacipran|levomilnacipran|mesh-list
101997364|NCT01328002|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101997365|NCT01328002|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101997366|NCT01328002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101997367|NCT01328002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997368|NCT01328002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101997369|NCT01328002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997370|NCT01328002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101997371|NCT01328002|Analgesics|analgesics|mesh-ancestor
101997372|NCT01328002|Sensory System Agents|sensory system agents|mesh-ancestor
101452397|NCT00227448|Protective Agents|protective agents|mesh-ancestor
101997377|NCT05239078|Anesthetics, Local|anesthetics, local|mesh-list
101997378|NCT05239078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101997379|NCT05239078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997380|NCT05239078|Sensory System Agents|sensory system agents|mesh-ancestor
101997381|NCT05239078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101997382|NCT02579265|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101997383|NCT02579265|SMOFlipid|smoflipid|mesh-list
101997384|NCT02579265|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
101997385|NCT02579265|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101997386|NCT02579265|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101997387|NCT05238220|Valganciclovir|valganciclovir|mesh-list
101997388|NCT05238220|Antiviral Agents|antiviral agents|mesh-ancestor
101997389|NCT05238220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101997390|NCT04446598|Tadalafil|tadalafil|mesh-list
101997391|NCT04446598|Vasodilator Agents|vasodilator agents|mesh-ancestor
101997392|NCT04446598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101997393|NCT04446598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101997394|NCT04446598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101997395|NCT04446598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997396|NCT04446598|Urological Agents|urological agents|mesh-ancestor
101997397|NCT03391570|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
101997398|NCT03391570|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101997399|NCT03391570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101997400|NCT03391570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997401|NCT03391570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101997402|NCT03391570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101997403|NCT03391570|Analgesics|analgesics|mesh-ancestor
101997404|NCT03391570|Sensory System Agents|sensory system agents|mesh-ancestor
101997405|NCT03391570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101948282|NCT01287351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101948283|NCT03864783|Curcumin|curcumin|mesh-list
101948284|NCT03864783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101948285|NCT03864783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101948286|NCT03864783|Analgesics|analgesics|mesh-ancestor
101997406|NCT03391570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997407|NCT03391570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101997408|NCT03391570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101997409|NCT03755089|Lidocaine|lidocaine|mesh-list
101997410|NCT03755089|Anesthetics, Local|anesthetics, local|mesh-ancestor
101997411|NCT03755089|Anesthetics|anesthetics|mesh-ancestor
101997412|NCT03755089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101997413|NCT03755089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997414|NCT03755089|Sensory System Agents|sensory system agents|mesh-ancestor
101997415|NCT03755089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101997416|NCT03755089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101997417|NCT03755089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101997418|NCT03755089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101997419|NCT03755089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101997420|NCT03755089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997421|NCT03757117|Hormones|hormones|mesh-list
101997422|NCT03757117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101997423|NCT03757117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997424|NCT03752125|Caffeine|caffeine|mesh-list
101997425|NCT03752125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101997426|NCT03752125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997427|NCT03752125|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101997428|NCT03752125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101997429|NCT03752125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997430|NCT03752125|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101997431|NCT03752125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101997432|NCT03752125|Purinergic Agents|purinergic agents|mesh-ancestor
101997433|NCT03752125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101997434|NCT03289533|Avelumab|avelumab|mesh-list
101997435|NCT03289533|Axitinib|axitinib|mesh-list
101997436|NCT03289533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101997437|NCT03289533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101997438|NCT03289533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101997439|NCT03289533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101997440|NCT03289533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997441|NCT03395002|Fluticasone|fluticasone|mesh-list
101997442|NCT03395002|Xhance|xhance|mesh-list
101997443|NCT03395002|Tiotropium Bromide|tiotropium bromide|mesh-list
101997469|NCT05238064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101997470|NCT05238064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101997471|NCT05238064|Alkylating Agents|alkylating agents|mesh-ancestor
101997472|NCT05238064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997473|NCT05238064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101997474|NCT05238064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101997475|NCT05238064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101997476|NCT05238064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101997477|NCT05238064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101997478|NCT05238064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101997479|NCT05238064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101997480|NCT05238064|Tubulin Modulators|tubulin modulators|mesh-ancestor
101997481|NCT05238064|Antimitotic Agents|antimitotic agents|mesh-ancestor
101997482|NCT05238064|Mitosis Modulators|mitosis modulators|mesh-ancestor
101997484|NCT03390790|Anesthetics, Local|anesthetics, local|mesh-ancestor
101997486|NCT03390790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101997487|NCT03390790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997488|NCT03390790|Sensory System Agents|sensory system agents|mesh-ancestor
101997489|NCT03390790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101997490|NCT03390790|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101997491|NCT03390790|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101997492|NCT03390790|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101997496|NCT03697993|Fosfomycin|fosfomycin|mesh-list
101997497|NCT03697993|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101948287|NCT03864783|Sensory System Agents|sensory system agents|mesh-ancestor
101948288|NCT03864783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101823981|NCT00833339|Mifepristone|mifepristone|mesh-list
101997498|NCT03697993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101997499|NCT03697993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101997500|NCT03697993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101997501|NCT03697993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101997502|NCT03697993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101997503|NCT03697993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997504|NCT03697993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101997505|NCT03697993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101997506|NCT03697993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101997507|NCT05393245|Tiotropium Bromide|tiotropium bromide|mesh-list
101997508|NCT05393245|Olodaterol|olodaterol|mesh-list
101997509|NCT05393245|Cholinergic Agents|cholinergic agents|mesh-list
101997510|NCT05393245|Muscarinic Antagonists|muscarinic antagonists|mesh-list
101997511|NCT05393245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101997512|NCT05393245|Autonomic Agents|autonomic agents|mesh-ancestor
101997513|NCT05393245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101997514|NCT05393245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997515|NCT05393245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101997516|NCT05393245|Respiratory System Agents|respiratory system agents|mesh-ancestor
101997517|NCT05393245|Parasympatholytics|parasympatholytics|mesh-ancestor
101997518|NCT05393245|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101997519|NCT05393245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101997520|NCT05393245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997521|NCT03390712|Risperidone|risperidone|mesh-list
101997522|NCT03390712|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101997523|NCT03390712|Antipsychotic Agents|antipsychotic agents|mesh-list
101997524|NCT03390712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101997525|NCT03390712|Serotonin Agents|serotonin agents|mesh-ancestor
101997526|NCT03390712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101997527|NCT03390712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997528|NCT03390712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997529|NCT03390712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101997530|NCT03390712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101997531|NCT03390712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101997532|NCT03390712|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101997533|NCT03390712|Dopamine Agents|dopamine agents|mesh-ancestor
101997534|NCT03390712|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101997535|NCT03390712|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101997536|NCT03756727|Ascorbic Acid|ascorbic acid|mesh-list
101997537|NCT03756727|Vitamins|vitamins|mesh-ancestor
101997538|NCT03756727|Micronutrients|micronutrients|mesh-ancestor
101997539|NCT03756727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997540|NCT03756727|Antioxidants|antioxidants|mesh-ancestor
101997541|NCT03756727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997542|NCT03756727|Protective Agents|protective agents|mesh-ancestor
101997543|NCT04962724|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101997544|NCT03398434|Apixaban|apixaban|mesh-list
101997545|NCT03398434|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101997546|NCT03398434|Antithrombins|antithrombins|mesh-ancestor
101997547|NCT03398434|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101997548|NCT03398434|Protease Inhibitors|protease inhibitors|mesh-ancestor
101997549|NCT03398434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101997550|NCT03398434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997551|NCT03398434|Anticoagulants|anticoagulants|mesh-ancestor
101997552|NCT03398122|Apatinib|apatinib|mesh-list
101997553|NCT03398122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101997554|NCT03398122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101997555|NCT03398122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101997556|NCT03398122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997557|NCT05459857|Menthol|menthol|mesh-list
101997558|NCT05459857|Antipruritics|antipruritics|mesh-ancestor
101997559|NCT05459857|Dermatologic Agents|dermatologic agents|mesh-ancestor
101997560|NCT03394222|Budesonide|budesonide|mesh-list
101997561|NCT03394222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101997562|NCT03394222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101997563|NCT03394222|Autonomic Agents|autonomic agents|mesh-ancestor
101997564|NCT03394222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101997577|NCT03398044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101997578|NCT03398044|Glucocorticoids|glucocorticoids|mesh-ancestor
101997579|NCT03398044|Hormones|hormones|mesh-ancestor
101948289|NCT03864783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997580|NCT03398044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101997581|NCT03398044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101997582|NCT03398044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101997583|NCT03389776|Anesthetics|anesthetics|mesh-list
101997584|NCT03389776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101997585|NCT03389776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997586|NCT02813200|Tiotropium Bromide|tiotropium bromide|mesh-list
101997587|NCT02813200|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101997588|NCT02813200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101997589|NCT02813200|Autonomic Agents|autonomic agents|mesh-ancestor
101997590|NCT02813200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101997591|NCT02813200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997592|NCT02813200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101997593|NCT02813200|Respiratory System Agents|respiratory system agents|mesh-ancestor
101717387|NCT00576628|Epoetin Alfa|epoetin alfa|mesh-list
101997594|NCT02813200|Parasympatholytics|parasympatholytics|mesh-ancestor
101997595|NCT02813200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101997596|NCT02813200|Cholinergic Agents|cholinergic agents|mesh-ancestor
101997597|NCT02813200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101997598|NCT02813200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997599|NCT02813200|Glucocorticoids|glucocorticoids|mesh-ancestor
101997600|NCT02813200|Hormones|hormones|mesh-ancestor
101997601|NCT02813200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101997602|NCT02813200|Sympathomimetics|sympathomimetics|mesh-ancestor
101997603|NCT04535947|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101997604|NCT04535947|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101997605|NCT03750721|Rifampin|rifampin|mesh-list
101255128|NCT01702974|Vitamin D|vitamin d|mesh-list
101997606|NCT03750721|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101997607|NCT03750721|Antitubercular Agents|antitubercular agents|mesh-ancestor
101997608|NCT03750721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101997609|NCT03750721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101997610|NCT03750721|Leprostatic Agents|leprostatic agents|mesh-ancestor
101997611|NCT03750721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101997612|NCT03750721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101997613|NCT03750721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997614|NCT03750721|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101997615|NCT03750721|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101997616|NCT03750721|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101997617|NCT03750721|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101997618|NCT03750721|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101997619|NCT03750721|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101997620|NCT01481272|Leucovorin|leucovorin|mesh-list
101997621|NCT01481272|Cytarabine|cytarabine|mesh-list
101997622|NCT01481272|Methotrexate|methotrexate|mesh-list
101997623|NCT01481272|Etoposide|etoposide|mesh-list
101997624|NCT01481272|Ofatumumab|ofatumumab|mesh-list
101997625|NCT01481272|Lenograstim|lenograstim|mesh-list
101997656|NCT04478695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997657|NCT02687386|Mitoxantrone|mitoxantrone|mesh-list
101997658|NCT02687386|Analgesics|analgesics|mesh-ancestor
101997659|NCT02687386|Sensory System Agents|sensory system agents|mesh-ancestor
101997660|NCT02687386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101997661|NCT02687386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997662|NCT02687386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101997663|NCT02687386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101997664|NCT02687386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101997665|NCT02687386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101997666|NCT02687386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997667|NCT04531813|Butenafine|butenafine|mesh-list
101997668|NCT04531813|Antifungal Agents|antifungal agents|mesh-ancestor
101452721|NCT00410033|Insulin|insulin|mesh-list
101997678|NCT01305460|Azacitidine|azacitidine|mesh-list
101997679|NCT01305460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101997680|NCT01305460|Antimetabolites|antimetabolites|mesh-ancestor
101997681|NCT01305460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997682|NCT01305460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101997683|NCT01305460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101997685|NCT03754543|Trace Elements|trace elements|mesh-ancestor
101997686|NCT03754543|Micronutrients|micronutrients|mesh-ancestor
101997687|NCT03754543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997688|NCT01199302|Brodalumab|brodalumab|mesh-list
101948290|NCT03864783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101948291|NCT03864783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101948292|NCT03864783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101948293|NCT03864783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101997689|NCT01199302|Dermatologic Agents|dermatologic agents|mesh-ancestor
101997690|NCT03754387|Ceftazidime|ceftazidime|mesh-list
101997691|NCT03754387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101997692|NCT03754387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101997694|NCT03171480|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
101997695|NCT03171480|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
101997696|NCT03171480|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101997697|NCT03171480|Diuretics|diuretics|mesh-ancestor
101997698|NCT03171480|Natriuretic Agents|natriuretic agents|mesh-ancestor
101997699|NCT03171480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997700|NCT03171480|Vasodilator Agents|vasodilator agents|mesh-ancestor
101997701|NCT03171480|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101997702|NCT03171480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997703|NCT04465357|Erenumab|erenumab|mesh-list
101997704|NCT04465357|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
101997705|NCT04465357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997706|NCT04465357|Analgesics|analgesics|mesh-ancestor
101997707|NCT04465357|Sensory System Agents|sensory system agents|mesh-ancestor
101997708|NCT04465357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101997709|NCT04465357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997710|NCT05396690|Sevoflurane|sevoflurane|mesh-list
101997711|NCT05396690|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101997712|NCT05396690|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101997713|NCT05396690|Anesthetics, General|anesthetics, general|mesh-ancestor
101997714|NCT05396690|Anesthetics|anesthetics|mesh-ancestor
101997715|NCT05396690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101997716|NCT05396690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997717|NCT01384058|Simvastatin|simvastatin|mesh-list
101997718|NCT01384058|Ezetimibe|ezetimibe|mesh-list
101997719|NCT01384058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101997720|NCT01384058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101997721|NCT01384058|Antimetabolites|antimetabolites|mesh-ancestor
101997722|NCT01384058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997723|NCT01384058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101997724|NCT01384058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101997725|NCT01384058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101997726|NCT04401384|Pyridoxine|pyridoxine|mesh-list
101997727|NCT04401384|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
101997728|NCT04401384|Doxylamine|doxylamine|mesh-list
101997729|NCT04401384|Dicyclomine|dicyclomine|mesh-list
101997730|NCT04401384|Antiemetics|antiemetics|mesh-ancestor
101997731|NCT04401384|Autonomic Agents|autonomic agents|mesh-ancestor
101997732|NCT04401384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101997733|NCT04401384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997734|NCT04401384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101997739|NCT04401384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997741|NCT04401384|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101997742|NCT04401384|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101997743|NCT04401384|Cholinergic Agents|cholinergic agents|mesh-ancestor
101997744|NCT04401384|Vitamin B Complex|vitamin b complex|mesh-ancestor
101997745|NCT04401384|Vitamins|vitamins|mesh-ancestor
101997746|NCT04401384|Micronutrients|micronutrients|mesh-ancestor
101997747|NCT03312114|Avelumab|avelumab|mesh-list
101997748|NCT03312114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101997749|NCT03312114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101997750|NCT04239222|Ibuprofen|ibuprofen|mesh-list
101997751|NCT04239222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101997752|NCT04239222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101997753|NCT04239222|Analgesics|analgesics|mesh-ancestor
101997754|NCT04239222|Sensory System Agents|sensory system agents|mesh-ancestor
101997755|NCT04239222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101997756|NCT04239222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997757|NCT04239222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101997758|NCT04239222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101997759|NCT04239222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101997760|NCT04239222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101948294|NCT03864783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948296|NCT01287507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101948297|NCT03864705|Metformin|metformin|mesh-list
101948298|NCT03864705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101824234|NCT00356122|Docetaxel|docetaxel|mesh-list
101997761|NCT04239222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997762|NCT04732260|Letermovir|letermovir|mesh-list
101997763|NCT04732260|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101997764|NCT04732260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101997765|NCT04732260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997766|NCT04732260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101997767|NCT04732260|Antiviral Agents|antiviral agents|mesh-ancestor
101997768|NCT04732260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101997769|NCT03084536|Acetaminophen|acetaminophen|mesh-list
101997770|NCT03084536|Celecoxib|celecoxib|mesh-list
101997771|NCT03084536|Fentanyl|fentanyl|mesh-list
101997772|NCT03084536|Midazolam|midazolam|mesh-list
101997773|NCT03084536|Gabapentin|gabapentin|mesh-list
101997774|NCT03084536|Bupivacaine|bupivacaine|mesh-list
101997775|NCT03084536|Anesthetics, Local|anesthetics, local|mesh-ancestor
101997776|NCT03084536|Anesthetics|anesthetics|mesh-ancestor
101997777|NCT03084536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101997778|NCT03084536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997779|NCT03084536|Sensory System Agents|sensory system agents|mesh-ancestor
101997780|NCT03084536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101997781|NCT03084536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101997782|NCT03084536|Narcotics|narcotics|mesh-ancestor
101997783|NCT03084536|Analgesics|analgesics|mesh-ancestor
101997784|NCT03084536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101997785|NCT03084536|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101997786|NCT03084536|Anesthetics, General|anesthetics, general|mesh-ancestor
101997787|NCT03084536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101997788|NCT03084536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101997789|NCT03084536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101997790|NCT03084536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101997791|NCT03084536|GABA Modulators|gaba modulators|mesh-ancestor
101997792|NCT03084536|GABA Agents|gaba agents|mesh-ancestor
101997793|NCT03084536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101997794|NCT03084536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997795|NCT03084536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101997796|NCT03084536|Antipyretics|antipyretics|mesh-ancestor
101997797|NCT03084536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101997798|NCT03084536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101997799|NCT03084536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101997800|NCT03084536|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101997801|NCT03084536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101997802|NCT03084536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101997803|NCT03084536|Anticonvulsants|anticonvulsants|mesh-ancestor
101997804|NCT03084536|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101997805|NCT03084536|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101997806|NCT03084536|Antimanic Agents|antimanic agents|mesh-ancestor
101997809|NCT03311724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997811|NCT03311724|Hormones|hormones|mesh-ancestor
101997812|NCT03311724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101997813|NCT05213312|Paclitaxel|paclitaxel|mesh-list
101997814|NCT05213312|Fluorouracil|fluorouracil|mesh-list
101997815|NCT05213312|Nivolumab|nivolumab|mesh-list
101997816|NCT05213312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101997817|NCT05213312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101997818|NCT05213312|Tubulin Modulators|tubulin modulators|mesh-ancestor
101997819|NCT05213312|Antimitotic Agents|antimitotic agents|mesh-ancestor
101997820|NCT05213312|Mitosis Modulators|mitosis modulators|mesh-ancestor
101997821|NCT05213312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997822|NCT05213312|Antimetabolites|antimetabolites|mesh-ancestor
101997823|NCT05213312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101997824|NCT05213312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101997825|NCT05213312|Immunologic Factors|immunologic factors|mesh-ancestor
101997826|NCT05213312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997827|NCT05213312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101997828|NCT05213312|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101948299|NCT03864705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948300|NCT01287663|Permethrin|permethrin|mesh-list
101948301|NCT01287663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101997829|NCT03311646|Nicotine|nicotine|mesh-list
101997830|NCT03311646|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101997831|NCT03311646|Autonomic Agents|autonomic agents|mesh-ancestor
101997832|NCT03311646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101997833|NCT03311646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997834|NCT03311646|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101997835|NCT03311646|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101997836|NCT03311646|Cholinergic Agents|cholinergic agents|mesh-ancestor
101997837|NCT03311646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101997838|NCT03311646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997839|NCT03680274|Ascorbic Acid|ascorbic acid|mesh-list
101997840|NCT03680274|Vitamins|vitamins|mesh-ancestor
101997841|NCT03680274|Micronutrients|micronutrients|mesh-ancestor
101997842|NCT03680274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997843|NCT03680274|Antioxidants|antioxidants|mesh-ancestor
101997844|NCT03680274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997845|NCT03680274|Protective Agents|protective agents|mesh-ancestor
101997846|NCT03288987|Leucovorin|leucovorin|mesh-list
101997847|NCT03288987|Bevacizumab|bevacizumab|mesh-list
101997848|NCT03288987|Fluorouracil|fluorouracil|mesh-list
101997849|NCT03288987|Irinotecan|irinotecan|mesh-list
101997850|NCT03288987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101997851|NCT03288987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101997852|NCT03288987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101997853|NCT03288987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101997854|NCT03288987|Growth Substances|growth substances|mesh-ancestor
101997855|NCT03288987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997856|NCT03288987|Growth Inhibitors|growth inhibitors|mesh-ancestor
101997857|NCT03288987|Antimetabolites|antimetabolites|mesh-ancestor
101997858|NCT03288987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997859|NCT03288987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101997860|NCT03288987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101997861|NCT03288987|Immunologic Factors|immunologic factors|mesh-ancestor
101997862|NCT03288987|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101997863|NCT03288987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101997864|NCT03288987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101997865|NCT03288987|Antidotes|antidotes|mesh-ancestor
101997866|NCT03288987|Protective Agents|protective agents|mesh-ancestor
101997867|NCT03288987|Vitamin B Complex|vitamin b complex|mesh-ancestor
101997868|NCT03288987|Vitamins|vitamins|mesh-ancestor
101997869|NCT03288987|Micronutrients|micronutrients|mesh-ancestor
101997870|NCT01379846|Vaccines|vaccines|mesh-list
101997871|NCT01379846|Immunologic Factors|immunologic factors|mesh-ancestor
101997872|NCT01379846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997873|NCT01379300|Rivaroxaban|rivaroxaban|mesh-list
101997874|NCT01379300|Dabigatran|dabigatran|mesh-list
101997875|NCT01379300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101997876|NCT01379300|Antithrombins|antithrombins|mesh-ancestor
101997877|NCT01379300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101997878|NCT01379300|Protease Inhibitors|protease inhibitors|mesh-ancestor
101997879|NCT01379300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101997880|NCT01379300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997881|NCT01379300|Anticoagulants|anticoagulants|mesh-ancestor
101997885|NCT03682224|Anesthetics|anesthetics|mesh-ancestor
101997886|NCT03682224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101997887|NCT03682224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997888|NCT03682224|Sensory System Agents|sensory system agents|mesh-ancestor
101997889|NCT03682224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101997890|NCT03682224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101997891|NCT03682224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101997892|NCT03682224|Adrenergic Agents|adrenergic agents|mesh-ancestor
101997893|NCT03682224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101997894|NCT03682224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997895|NCT03682224|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101997896|NCT03682224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101997897|NCT03682224|Autonomic Agents|autonomic agents|mesh-ancestor
101997898|NCT03682224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101997899|NCT03682224|Respiratory System Agents|respiratory system agents|mesh-ancestor
101717680|NCT00659321|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101997900|NCT03682224|Mydriatics|mydriatics|mesh-ancestor
101997901|NCT03682224|Sympathomimetics|sympathomimetics|mesh-ancestor
101997902|NCT03682224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101948302|NCT01287663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948304|NCT01176669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101948305|NCT01176669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101997904|NCT01383044|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101997905|NCT01383044|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101997906|NCT01383044|Adrenergic Agents|adrenergic agents|mesh-ancestor
101997907|NCT01383044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101997908|NCT01383044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997909|NCT01383044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997910|NCT01383044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101997911|NCT01383044|Antioxidants|antioxidants|mesh-ancestor
101997912|NCT01383044|Protective Agents|protective agents|mesh-ancestor
101997913|NCT01383044|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101997914|NCT01383044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101997915|NCT01383044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101997916|NCT01383044|Vasodilator Agents|vasodilator agents|mesh-ancestor
101997917|NCT01383044|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101997918|NCT01383044|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101997919|NCT01377428|Formoterol Fumarate|formoterol fumarate|mesh-list
101997920|NCT01377428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101997921|NCT01377428|Autonomic Agents|autonomic agents|mesh-ancestor
101997922|NCT01377428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101997923|NCT01377428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997924|NCT01377428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101997925|NCT01377428|Respiratory System Agents|respiratory system agents|mesh-ancestor
101997926|NCT01377428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101997927|NCT01377428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101997928|NCT01377428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101997929|NCT01377428|Adrenergic Agents|adrenergic agents|mesh-ancestor
101997930|NCT01377428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101997931|NCT01377428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997932|NCT03083990|Bevacizumab|bevacizumab|mesh-list
101997933|NCT03083990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101997934|NCT03083990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101997935|NCT03083990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101997936|NCT03083990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101997937|NCT03083990|Growth Substances|growth substances|mesh-ancestor
101997938|NCT03083990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997939|NCT03083990|Growth Inhibitors|growth inhibitors|mesh-ancestor
101997940|NCT03252015|Lasmiditan|lasmiditan|mesh-list
101997941|NCT03252015|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101997942|NCT03252015|Serotonin Agents|serotonin agents|mesh-ancestor
101997943|NCT03252015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101997944|NCT03252015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997945|NCT03252015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997946|NCT01314027|Gemcitabine|gemcitabine|mesh-list
101997947|NCT01314027|Oxaliplatin|oxaliplatin|mesh-list
101997948|NCT01314027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101997949|NCT01314027|Antimetabolites|antimetabolites|mesh-ancestor
101997950|NCT01314027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997951|NCT01314027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101997953|NCT03708003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101997954|NCT03083132|Modafinil|modafinil|mesh-list
101997955|NCT03083132|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101997956|NCT03083132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997957|NCT03083132|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101997958|NCT03083132|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101997959|NCT03083132|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101997960|NCT03083132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997961|NCT04121468|Metformin|metformin|mesh-list
101997962|NCT04121468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101997963|NCT04121468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997964|NCT03648489|Paclitaxel|paclitaxel|mesh-list
101997965|NCT03648489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101997966|NCT03648489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101997967|NCT03648489|Tubulin Modulators|tubulin modulators|mesh-ancestor
101997968|NCT03648489|Antimitotic Agents|antimitotic agents|mesh-ancestor
101948306|NCT01176669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101948307|NCT01176669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948308|NCT01176747|Formoterol Fumarate|formoterol fumarate|mesh-list
101997969|NCT03648489|Mitosis Modulators|mitosis modulators|mesh-ancestor
101997970|NCT03648489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997971|NCT01382888|Heparin|heparin|mesh-list
101997972|NCT01382888|Anticoagulants|anticoagulants|mesh-ancestor
101997973|NCT01382888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101997974|NCT01382888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101997975|NCT01382888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997976|NCT03249909|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101997977|NCT03249909|Laxatives|laxatives|mesh-ancestor
101997978|NCT03249909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101997979|NCT04809116|Pimavanserin|pimavanserin|mesh-list
101997980|NCT04809116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101997981|NCT04809116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101997982|NCT04809116|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101997983|NCT04809116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101997984|NCT04809116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101387633|NCT00314080|Botulinum Antitoxin|botulinum antitoxin|mesh-list
101997985|NCT04809116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997986|NCT04809116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101997987|NCT04809116|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101997988|NCT04809116|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101997989|NCT04809116|Serotonin Agents|serotonin agents|mesh-ancestor
101997990|NCT04809116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101997991|NCT04809116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997993|NCT03077438|Immunologic Factors|immunologic factors|mesh-ancestor
101997994|NCT03077438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997995|NCT01382732|Oxytocin|oxytocin|mesh-list
101997996|NCT01382732|Carbetocin|carbetocin|mesh-list
101997997|NCT01382732|Oxytocics|oxytocics|mesh-ancestor
101997998|NCT01382732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101997999|NCT01382732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998000|NCT02183870|Crizotinib|crizotinib|mesh-list
101998001|NCT02183870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101998002|NCT02183870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101998003|NCT02183870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101998004|NCT02183870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998005|NCT03076970|Sumatriptan|sumatriptan|mesh-list
101998006|NCT03076970|Lasmiditan|lasmiditan|mesh-list
101998007|NCT03076970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101998008|NCT03076970|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101998009|NCT03076970|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101998010|NCT03076970|Serotonin Agents|serotonin agents|mesh-ancestor
101998011|NCT03076970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101998012|NCT03076970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998013|NCT03076970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998014|NCT00726596|Hydroxychloroquine|hydroxychloroquine|mesh-list
101998015|NCT00726596|Antimalarials|antimalarials|mesh-ancestor
101998016|NCT00726596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101998017|NCT00726596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101998018|NCT00726596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101998019|NCT00726596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101998020|NCT00726596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998021|NCT00726596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101998022|NCT04897880|Panobinostat|panobinostat|mesh-list
101998023|NCT04897880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101998024|NCT04897880|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101998025|NCT04897880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101998026|NCT04897880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998041|NCT02890992|Protease Inhibitors|protease inhibitors|mesh-ancestor
101998042|NCT02890992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101998043|NCT02890992|Vitamin B Complex|vitamin b complex|mesh-ancestor
101998044|NCT02890992|Vitamins|vitamins|mesh-ancestor
101998045|NCT02890992|Micronutrients|micronutrients|mesh-ancestor
101998046|NCT02890992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998047|NCT02890992|Vasodilator Agents|vasodilator agents|mesh-ancestor
101998048|NCT03603912|Metformin|metformin|mesh-list
101717834|NCT05862064|Immunologic Factors|immunologic factors|mesh-ancestor
101998049|NCT03603912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101998050|NCT03603912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998051|NCT04357730|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101948309|NCT01176747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101948310|NCT01176747|Autonomic Agents|autonomic agents|mesh-ancestor
101948311|NCT01176747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101948312|NCT01176747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998052|NCT04357730|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101998053|NCT04357730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101998054|NCT04357730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998055|NCT05274984|Lidocaine|lidocaine|mesh-list
101998056|NCT05274984|Anesthetics, Local|anesthetics, local|mesh-ancestor
101998057|NCT05274984|Anesthetics|anesthetics|mesh-ancestor
101998058|NCT05274984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101998059|NCT05274984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998060|NCT05274984|Sensory System Agents|sensory system agents|mesh-ancestor
101998061|NCT05274984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101998062|NCT05274984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101998063|NCT05274984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101998064|NCT05274984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101998065|NCT05274984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101998066|NCT05274984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998067|NCT05274672|Ciprofloxacin|ciprofloxacin|mesh-list
101998068|NCT05274672|Cephalexin|cephalexin|mesh-list
101998069|NCT05274672|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101998070|NCT05274672|Nitrofurantoin|nitrofurantoin|mesh-list
101998071|NCT05274672|Trimethoprim|trimethoprim|mesh-list
101998072|NCT05274672|Sulfamethoxazole|sulfamethoxazole|mesh-list
101998073|NCT05274672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101998074|NCT05274672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101998075|NCT05274672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101998076|NCT05274672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101998077|NCT05274672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101998078|NCT05274672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998079|NCT05274672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101998080|NCT05274672|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101998081|NCT05274672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101998082|NCT05274672|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101998083|NCT05274672|Antimalarials|antimalarials|mesh-ancestor
101998084|NCT05274672|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101998085|NCT05274672|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101998086|NCT05274672|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101998087|NCT05274672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101998088|NCT05274672|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101998091|NCT01379144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101998092|NCT01376882|Caffeine|caffeine|mesh-list
101998093|NCT01376882|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101998094|NCT01376882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998095|NCT01376882|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101998096|NCT01376882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101998097|NCT01376882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998098|NCT01376882|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101998099|NCT01376882|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101998100|NCT01376882|Purinergic Agents|purinergic agents|mesh-ancestor
101998101|NCT01376882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101998102|NCT03329196|Darbepoetin alfa|darbepoetin alfa|mesh-list
101998103|NCT03329196|Hematinics|hematinics|mesh-ancestor
101998104|NCT04656002|Vactosertib|vactosertib|mesh-list
101998105|NCT04656002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101998106|NCT04656002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101998107|NCT04656002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998108|NCT01382498|Calcium Dobesilate|calcium dobesilate|mesh-list
101998109|NCT01382498|Calcium|calcium|mesh-list
101998110|NCT01382498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101998111|NCT01382498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998112|NCT01382498|Hemostatics|hemostatics|mesh-ancestor
101998113|NCT01382498|Coagulants|coagulants|mesh-ancestor
101998114|NCT03476538|Gabapentin|gabapentin|mesh-list
101998115|NCT03476538|Analgesics|analgesics|mesh-ancestor
101998116|NCT03476538|Sensory System Agents|sensory system agents|mesh-ancestor
101998117|NCT03476538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101948313|NCT01176747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101948314|NCT01176747|Respiratory System Agents|respiratory system agents|mesh-ancestor
101948315|NCT01176747|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101948316|NCT01176747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101998118|NCT03476538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998119|NCT03476538|Anticonvulsants|anticonvulsants|mesh-ancestor
101998120|NCT03476538|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101998121|NCT03476538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101998122|NCT03476538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101717910|NCT05861635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101998123|NCT03476538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101998124|NCT03476538|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101998125|NCT03476538|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101998126|NCT03476538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101998127|NCT03476538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998128|NCT03476538|Antimanic Agents|antimanic agents|mesh-ancestor
101998129|NCT03326856|Botulinum Toxins|botulinum toxins|mesh-list
101998130|NCT03326856|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101998131|NCT03326856|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101998132|NCT03326856|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101998133|NCT03326856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101998134|NCT03326856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998135|NCT03326856|Cholinergic Agents|cholinergic agents|mesh-ancestor
101998136|NCT03326856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101998137|NCT03326856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998138|NCT03326856|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101998139|NCT03326856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101998140|NCT00000116|Vitamin A|vitamin a|mesh-list
101998141|NCT00000116|Vitamins|vitamins|mesh-ancestor
101998142|NCT00000116|Micronutrients|micronutrients|mesh-ancestor
101998143|NCT00000116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998144|NCT05232396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101998145|NCT05232396|Antibodies|antibodies|mesh-list
101998146|NCT05232396|Immunoglobulins|immunoglobulins|mesh-list
101998147|NCT05232396|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101998148|NCT05232396|Immunologic Factors|immunologic factors|mesh-ancestor
101998149|NCT05232396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998150|NCT05232396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101998151|NCT05222724|Ibuprofen|ibuprofen|mesh-list
101998152|NCT05222724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101998153|NCT05222724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101998154|NCT05222724|Analgesics|analgesics|mesh-ancestor
101998155|NCT05222724|Sensory System Agents|sensory system agents|mesh-ancestor
101998156|NCT05222724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101998157|NCT05222724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998158|NCT05222724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101998159|NCT05222724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101998160|NCT05222724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101998161|NCT05222724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101998165|NCT01382342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101998166|NCT01382342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998167|NCT01382342|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101998168|NCT01382342|Protective Agents|protective agents|mesh-ancestor
101998169|NCT01382342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998170|NCT03471728|Linaclotide|linaclotide|mesh-list
101998171|NCT03471728|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
101998172|NCT03471728|Enzyme Activators|enzyme activators|mesh-ancestor
101998173|NCT03471728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998174|NCT03471728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101998176|NCT03630614|Varenicline|varenicline|mesh-list
101998177|NCT03630614|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101998178|NCT03630614|Autonomic Agents|autonomic agents|mesh-ancestor
101998179|NCT03630614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101998180|NCT03630614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998181|NCT03630614|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101998182|NCT03630614|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101998183|NCT03630614|Cholinergic Agents|cholinergic agents|mesh-ancestor
101998184|NCT03630614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101998185|NCT03630614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948317|NCT01176747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101948318|NCT01176747|Adrenergic Agents|adrenergic agents|mesh-ancestor
101948319|NCT01176747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101971964|NCT00411892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101998186|NCT01378832|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101998187|NCT01378832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101998188|NCT01378754|Fospropofol|fospropofol|mesh-list
101998189|NCT01378754|Propofol|propofol|mesh-list
101998190|NCT01378754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101998191|NCT01378754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101998192|NCT01378754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998193|NCT01378754|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101998194|NCT01378754|Anesthetics, General|anesthetics, general|mesh-ancestor
101998195|NCT01378754|Anesthetics|anesthetics|mesh-ancestor
101998196|NCT05764304|Sinomenine|sinomenine|mesh-list
101998197|NCT05764304|Glucocorticoids|glucocorticoids|mesh-list
101998199|NCT05764304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101998200|NCT05764304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998201|NCT05764304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101998202|NCT03075410|GSK656|gsk656|mesh-list
101998203|NCT03075410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101998204|NCT03075410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101998205|NCT05764226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101998206|NCT02826512|Niraparib|niraparib|mesh-list
101998207|NCT02826512|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101998208|NCT02826512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101998209|NCT02826512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998210|NCT02826512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101998211|NCT05391230|Permethrin|permethrin|mesh-list
101998212|NCT05391230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101998213|NCT05391230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998214|NCT02731352|Apatinib|apatinib|mesh-list
101998215|NCT02731352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101998216|NCT02731352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101998217|NCT02731352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101998218|NCT02731352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998219|NCT05132660|Levodopa|levodopa|mesh-list
101998220|NCT05132660|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101998221|NCT05132660|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101998222|NCT05132660|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101998223|NCT05132660|Dopamine Agents|dopamine agents|mesh-ancestor
101998224|NCT05132660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101998225|NCT05132660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998226|NCT05132660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998227|NCT05132660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101998228|NCT05132660|Immunologic Factors|immunologic factors|mesh-ancestor
101998229|NCT05132660|Dopamine Agonists|dopamine agonists|mesh-ancestor
101998230|NCT05762744|Exenatide|exenatide|mesh-list
101998231|NCT05762744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101998232|NCT05762744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998233|NCT05762744|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101998245|NCT02257424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998246|NCT02257424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101998247|NCT02257424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101998248|NCT02257424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101998249|NCT01858922|Cytarabine|cytarabine|mesh-list
101998250|NCT01858922|Dexamethasone|dexamethasone|mesh-list
101998251|NCT01858922|Prednisone|prednisone|mesh-list
101998252|NCT01858922|Cyclophosphamide|cyclophosphamide|mesh-list
101998253|NCT01858922|Cisplatin|cisplatin|mesh-list
101998254|NCT01858922|Doxorubicin|doxorubicin|mesh-list
101998255|NCT01858922|Etoposide|etoposide|mesh-list
101998256|NCT01858922|Etoposide phosphate|etoposide phosphate|mesh-list
101998257|NCT01858922|Vincristine|vincristine|mesh-list
101998258|NCT01858922|Bleomycin|bleomycin|mesh-list
101998259|NCT01858922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101998260|NCT01858922|Immunologic Factors|immunologic factors|mesh-ancestor
101998261|NCT01858922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998262|NCT01858922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101998263|NCT01858922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101998264|NCT01858922|Alkylating Agents|alkylating agents|mesh-ancestor
101998265|NCT01858922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998266|NCT01858922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101948320|NCT01176747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948321|NCT01174953|Finasteride|finasteride|mesh-list
101948322|NCT01174953|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101255756|NCT01707199|Artesunate|artesunate|mesh-list
101948323|NCT01174953|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101824682|NCT02546141|Caseins|caseins|mesh-list
101998267|NCT01858922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101998268|NCT01858922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101998269|NCT01858922|Antiemetics|antiemetics|mesh-ancestor
101998270|NCT01858922|Autonomic Agents|autonomic agents|mesh-ancestor
101998271|NCT01858922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101998272|NCT01858922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101998273|NCT01858922|Glucocorticoids|glucocorticoids|mesh-ancestor
101998274|NCT01858922|Hormones|hormones|mesh-ancestor
101998275|NCT01858922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101998276|NCT01858922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101998277|NCT01858922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101998278|NCT01858922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101998279|NCT01858922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101998280|NCT01858922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101998281|NCT01858922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101998282|NCT01858922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101998283|NCT01858922|Antimetabolites|antimetabolites|mesh-ancestor
101998284|NCT01858922|Antiviral Agents|antiviral agents|mesh-ancestor
101998285|NCT01858922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101998286|NCT01858922|Tubulin Modulators|tubulin modulators|mesh-ancestor
101998287|NCT01858922|Antimitotic Agents|antimitotic agents|mesh-ancestor
101998288|NCT01858922|Mitosis Modulators|mitosis modulators|mesh-ancestor
101998289|NCT01378286|Artesunate|artesunate|mesh-list
101998290|NCT01378286|Chloroquine|chloroquine|mesh-list
101998291|NCT01378286|Amodiaquine|amodiaquine|mesh-list
101998292|NCT01378286|Antimalarials|antimalarials|mesh-ancestor
101998293|NCT01378286|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101998294|NCT01378286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101998295|NCT01378286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101998296|NCT01378286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101998297|NCT01378286|Antiviral Agents|antiviral agents|mesh-ancestor
101998298|NCT01378286|Schistosomicides|schistosomicides|mesh-ancestor
101998299|NCT01378286|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101998300|NCT01378286|Anthelmintics|anthelmintics|mesh-ancestor
101998301|NCT01378286|Amebicides|amebicides|mesh-ancestor
101998302|NCT01378286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101998315|NCT03071276|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101998316|NCT03071276|Abortifacient Agents|abortifacient agents|mesh-ancestor
101998317|NCT03071276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101998318|NCT03071276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998319|NCT03071276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101998320|NCT03071276|Antimetabolites|antimetabolites|mesh-ancestor
101998321|NCT03071276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998322|NCT03071276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101998323|NCT03071276|Dermatologic Agents|dermatologic agents|mesh-ancestor
101998324|NCT03071276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101998325|NCT03071276|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101998326|NCT03071276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101998327|NCT03071276|Immunologic Factors|immunologic factors|mesh-ancestor
101998328|NCT03071276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101998329|NCT03071276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101998330|NCT03071276|Antiviral Agents|antiviral agents|mesh-ancestor
101998331|NCT03071276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101998332|NCT03071276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101998333|NCT03629600|Indomethacin|indomethacin|mesh-list
101998334|NCT03629600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101998335|NCT03629600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101998336|NCT03629600|Analgesics|analgesics|mesh-ancestor
101998337|NCT03629600|Sensory System Agents|sensory system agents|mesh-ancestor
101998338|NCT03629600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101998339|NCT03629600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998340|NCT03629600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101998341|NCT03629600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101998342|NCT03629600|Gout Suppressants|gout suppressants|mesh-ancestor
101998343|NCT03629600|Tocolytic Agents|tocolytic agents|mesh-ancestor
101998344|NCT03629600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101948324|NCT01174953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101948325|NCT01174953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948326|NCT01174953|Hormone Antagonists|hormone antagonists|mesh-ancestor
101971965|NCT00411892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998345|NCT03629600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101998346|NCT03629600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101998347|NCT03629600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998349|NCT03074162|Capsaicin|capsaicin|mesh-list
101998350|NCT03074162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101998351|NCT03074162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101998352|NCT03074162|Analgesics|analgesics|mesh-ancestor
101998353|NCT03074162|Sensory System Agents|sensory system agents|mesh-ancestor
101998354|NCT03074162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101998355|NCT03074162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998356|NCT03074162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101998357|NCT03074162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101998358|NCT03074162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101998359|NCT03074162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101998360|NCT03074162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998361|NCT03074162|Antipruritics|antipruritics|mesh-ancestor
101998362|NCT03074162|Dermatologic Agents|dermatologic agents|mesh-ancestor
101998363|NCT05069012|Morphine|morphine|mesh-list
101998364|NCT05069012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101998365|NCT05069012|Narcotics|narcotics|mesh-ancestor
101998366|NCT05069012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101998367|NCT05069012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998381|NCT03920306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101998382|NCT02888106|Tenofovir|tenofovir|mesh-list
101998383|NCT02888106|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101998384|NCT02888106|Interferon alpha-2|interferon alpha-2|mesh-list
101998385|NCT02888106|Antiviral Agents|antiviral agents|mesh-ancestor
101998386|NCT02888106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101998387|NCT02888106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101998388|NCT02888106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101998389|NCT02888106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101998390|NCT02888106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998391|NCT02888106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101998392|NCT02888106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101998393|NCT02888106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101998394|NCT03793010|FX006|fx006|mesh-list
101998395|NCT03793010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101998396|NCT03793010|Glucocorticoids|glucocorticoids|mesh-ancestor
101998397|NCT03793010|Hormones|hormones|mesh-ancestor
101998398|NCT03793010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101998399|NCT03793010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998400|NCT03793010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101998401|NCT03793010|Immunologic Factors|immunologic factors|mesh-ancestor
101998402|NCT03055026|Rivaroxaban|rivaroxaban|mesh-list
101998403|NCT03055026|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101998404|NCT03055026|Antithrombins|antithrombins|mesh-ancestor
101998405|NCT03055026|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101998406|NCT03055026|Protease Inhibitors|protease inhibitors|mesh-ancestor
101998407|NCT03055026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101998408|NCT03055026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998409|NCT03055026|Anticoagulants|anticoagulants|mesh-ancestor
101998410|NCT03304626|Prednisone|prednisone|mesh-list
101998411|NCT03304626|Budesonide|budesonide|mesh-list
101998412|NCT03304626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101998413|NCT03304626|Glucocorticoids|glucocorticoids|mesh-ancestor
101998414|NCT03304626|Hormones|hormones|mesh-ancestor
101998415|NCT03304626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101998416|NCT03304626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998417|NCT03304626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101998418|NCT03304626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101998419|NCT03304626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101998420|NCT03304626|Autonomic Agents|autonomic agents|mesh-ancestor
101998421|NCT03304626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101998422|NCT03304626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101998423|NCT03304626|Respiratory System Agents|respiratory system agents|mesh-ancestor
101998424|NCT05121714|Fluvoxamine|fluvoxamine|mesh-list
101998425|NCT05121714|Caffeine|caffeine|mesh-list
101948327|NCT01174953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101948328|NCT01174953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948329|NCT01174953|Urological Agents|urological agents|mesh-ancestor
101998426|NCT05121714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101998427|NCT05121714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998428|NCT05121714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101998429|NCT05121714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101998430|NCT05121714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453452|NCT00413712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101998434|NCT05121714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101998435|NCT05121714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101998436|NCT05121714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101998437|NCT05121714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101998438|NCT05121714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101998439|NCT05121714|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101998440|NCT05121714|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101998441|NCT05121714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101998442|NCT05121714|Serotonin Agents|serotonin agents|mesh-ancestor
101998443|NCT05121714|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101998444|NCT05121714|Antidepressive Agents|antidepressive agents|mesh-ancestor
101998445|NCT05121714|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101998446|NCT05121714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101998447|NCT05121714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101998448|NCT02958150|Dexmedetomidine|dexmedetomidine|mesh-list
101998449|NCT02958150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101998450|NCT02958150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101998451|NCT02958150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998452|NCT02958150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101998453|NCT02958150|Analgesics|analgesics|mesh-ancestor
101998454|NCT02958150|Sensory System Agents|sensory system agents|mesh-ancestor
101998455|NCT02958150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101998456|NCT02958150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101998457|NCT02958150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101998458|NCT02958150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101998459|NCT02958150|Adrenergic Agents|adrenergic agents|mesh-ancestor
101998460|NCT02958150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101998461|NCT02958150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998462|NCT04250142|Methamphetamine|methamphetamine|mesh-list
101998463|NCT04250142|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101998464|NCT04250142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998465|NCT04250142|Sympathomimetics|sympathomimetics|mesh-ancestor
101998466|NCT04250142|Autonomic Agents|autonomic agents|mesh-ancestor
101998467|NCT04250142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101998468|NCT04250142|Dopamine Agents|dopamine agents|mesh-ancestor
101998469|NCT04250142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101998470|NCT04250142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998471|NCT04250142|Adrenergic Agents|adrenergic agents|mesh-ancestor
101998472|NCT04250142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101998473|NCT04250142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101998474|NCT04250142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101998475|NCT04250142|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101998476|NCT02714322|Adalimumab|adalimumab|mesh-list
101998477|NCT02714322|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101998478|NCT02714322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101998479|NCT02714322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101998480|NCT03267576|Metformin|metformin|mesh-list
101998481|NCT03267576|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101998482|NCT03267576|Canagliflozin|canagliflozin|mesh-list
101998483|NCT03267576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101998484|NCT03267576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998485|NCT03267576|Incretins|incretins|mesh-ancestor
101998486|NCT03267576|Hormones|hormones|mesh-ancestor
101305328|NCT02018965|Nicotinic Acids|nicotinic acids|mesh-list
101998487|NCT03267576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101998488|NCT03267576|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101998489|NCT03267576|Protease Inhibitors|protease inhibitors|mesh-ancestor
101998490|NCT03267576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101998491|NCT03267576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948330|NCT01286103|Canagliflozin|canagliflozin|mesh-list
101948331|NCT01286103|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101971966|NCT01336322|Metformin|metformin|mesh-list
101998492|NCT03267576|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101998493|NCT02472912|Adalimumab|adalimumab|mesh-list
101998494|NCT02472912|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101998495|NCT02472912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101998496|NCT02472912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101998497|NCT02356458|Bortezomib|bortezomib|mesh-list
101998498|NCT02356458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101998499|NCT03243630|Menthol|menthol|mesh-list
101998500|NCT03243630|Nicotine|nicotine|mesh-list
101998503|NCT03243630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101998504|NCT03243630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998505|NCT03243630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101998506|NCT03243630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101998507|NCT03243630|Cholinergic Agents|cholinergic agents|mesh-ancestor
101998508|NCT03243630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101998509|NCT03243630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998510|NCT03243630|Antipruritics|antipruritics|mesh-ancestor
101998511|NCT03243630|Dermatologic Agents|dermatologic agents|mesh-ancestor
101998512|NCT04725331|Pembrolizumab|pembrolizumab|mesh-list
101998513|NCT04725331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101998514|NCT04725331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101998515|NCT04725331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101998516|NCT04725331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998517|NCT03753685|Ensartinib|ensartinib|mesh-list
101998518|NCT03753685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101998519|NCT03753685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101998520|NCT03753685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101998521|NCT03753685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998522|NCT05172050|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101998523|NCT05172050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101998524|NCT05172050|Hormone Antagonists|hormone antagonists|mesh-ancestor
101998525|NCT05172050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101998526|NCT05172050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998527|NCT05172050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101998528|NCT05172050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101998529|NCT05172050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101998530|NCT02787044|Vaccines|vaccines|mesh-list
101998531|NCT02787044|Immunologic Factors|immunologic factors|mesh-ancestor
101998532|NCT02787044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998533|NCT01345019|Zoledronic Acid|zoledronic acid|mesh-list
101998534|NCT01345019|Denosumab|denosumab|mesh-list
101998535|NCT01345019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101998536|NCT01345019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998537|NCT03629522|Ondansetron|ondansetron|mesh-list
101998538|NCT03629522|Antiemetics|antiemetics|mesh-ancestor
101998539|NCT03629522|Autonomic Agents|autonomic agents|mesh-ancestor
101998540|NCT03629522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101998541|NCT03629522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998542|NCT03629522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101998543|NCT03629522|Antipruritics|antipruritics|mesh-ancestor
101998544|NCT03629522|Dermatologic Agents|dermatologic agents|mesh-ancestor
101998545|NCT03629522|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101998546|NCT03629522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101998547|NCT03629522|Serotonin Agents|serotonin agents|mesh-ancestor
101998548|NCT03629522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101998549|NCT03629522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998550|NCT03751111|Naloxone|naloxone|mesh-list
101998551|NCT03751111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101998552|NCT03751111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998553|NCT03751111|Sensory System Agents|sensory system agents|mesh-ancestor
101998554|NCT03751111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101998555|NCT05167370|Amifostine|amifostine|mesh-list
101998556|NCT05167370|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101998557|NCT05167370|Protective Agents|protective agents|mesh-ancestor
101998558|NCT05167370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998559|NCT01265537|Tacrolimus|tacrolimus|mesh-list
101998560|NCT01265537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101998561|NCT01265537|Immunologic Factors|immunologic factors|mesh-ancestor
101998562|NCT01265537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948332|NCT01286103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948333|NCT01286103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101948334|NCT01286103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948335|NCT01176903|Glycopyrrolate|glycopyrrolate|mesh-list
101948336|NCT01176903|Tiotropium Bromide|tiotropium bromide|mesh-list
101948337|NCT01176903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101948338|NCT01176903|Autonomic Agents|autonomic agents|mesh-ancestor
101998563|NCT01265537|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101998564|NCT01265537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101998565|NCT01265537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998566|NCT05763836|Ibuprofen|ibuprofen|mesh-list
101998567|NCT05763836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101998568|NCT05763836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101998569|NCT05763836|Analgesics|analgesics|mesh-ancestor
101998570|NCT05763836|Sensory System Agents|sensory system agents|mesh-ancestor
101998571|NCT05763836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101998572|NCT05763836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998576|NCT05763836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101998577|NCT05763836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998579|NCT01237535|Estrogens|estrogens|mesh-list
101998580|NCT01237535|Progestins|progestins|mesh-ancestor
101998581|NCT01237535|Hormones|hormones|mesh-ancestor
101998582|NCT01237535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101998583|NCT01237535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998584|NCT04396639|Factor VIII|factor viii|mesh-list
101998585|NCT04396639|Coagulants|coagulants|mesh-ancestor
101998586|NCT01146431|Anesthetics|anesthetics|mesh-list
101998587|NCT01146431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101998588|NCT01146431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998589|NCT01250249|Vaccines|vaccines|mesh-list
101998590|NCT01250249|BCG Vaccine|bcg vaccine|mesh-list
101998591|NCT01250249|Immunologic Factors|immunologic factors|mesh-ancestor
101998592|NCT01250249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998593|NCT01250249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101998594|NCT03747679|Mannitol|mannitol|mesh-list
101998595|NCT03747679|Sorbitol|sorbitol|mesh-list
101998596|NCT03747679|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101998597|NCT03747679|Diuretics|diuretics|mesh-ancestor
101998598|NCT03747679|Natriuretic Agents|natriuretic agents|mesh-ancestor
101998599|NCT03747679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998600|NCT03747679|Cathartics|cathartics|mesh-ancestor
101998601|NCT03747679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101998602|NCT01243385|Metformin|metformin|mesh-list
101998603|NCT01243385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101998604|NCT01243385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998605|NCT01147133|Clopidogrel|clopidogrel|mesh-list
101998606|NCT01147133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101998607|NCT01147133|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101998608|NCT01147133|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101998609|NCT01147133|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101998610|NCT01147133|Purinergic Agents|purinergic agents|mesh-ancestor
101998611|NCT01147133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101998612|NCT01147133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998613|NCT01147133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998614|NCT02162420|Cyclophosphamide|cyclophosphamide|mesh-list
101998615|NCT02162420|Fludarabine|fludarabine|mesh-list
101998616|NCT02162420|Alemtuzumab|alemtuzumab|mesh-list
101998617|NCT02162420|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101998618|NCT02162420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101998619|NCT02162420|Immunologic Factors|immunologic factors|mesh-ancestor
101998620|NCT02162420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998621|NCT02162420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101998622|NCT02162420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101998623|NCT02162420|Alkylating Agents|alkylating agents|mesh-ancestor
101998624|NCT02162420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998625|NCT02162420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101998626|NCT02162420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101998627|NCT02162420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101998628|NCT04167085|Doxycycline|doxycycline|mesh-list
101948339|NCT01176903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101948340|NCT01176903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948341|NCT01176903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101948342|NCT01176903|Respiratory System Agents|respiratory system agents|mesh-ancestor
101998629|NCT04167085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101998630|NCT04167085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101998631|NCT04167085|Antimalarials|antimalarials|mesh-ancestor
101998632|NCT04167085|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101998633|NCT04167085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101998635|NCT01147289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101998636|NCT01147289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101998637|NCT01147289|Analgesics|analgesics|mesh-ancestor
101998638|NCT01147289|Sensory System Agents|sensory system agents|mesh-ancestor
101998639|NCT01147289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101998640|NCT01147289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998641|NCT01147289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101998642|NCT01147289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101998643|NCT01147289|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101998644|NCT01147289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101998645|NCT01147289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101998651|NCT01237769|Micronutrients|micronutrients|mesh-ancestor
101998652|NCT01237769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998653|NCT01237769|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101998654|NCT01237769|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101998655|NCT03914963|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101998656|NCT03914963|Hemostatics|hemostatics|mesh-ancestor
101998657|NCT03914963|Coagulants|coagulants|mesh-ancestor
101998658|NCT04162795|Loratadine|loratadine|mesh-list
101998659|NCT04162795|Antipruritics|antipruritics|mesh-ancestor
101998660|NCT04162795|Dermatologic Agents|dermatologic agents|mesh-ancestor
101998661|NCT04162795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101998662|NCT04162795|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101998663|NCT04162795|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101998664|NCT04162795|Histamine Antagonists|histamine antagonists|mesh-ancestor
101998665|NCT04162795|Histamine Agents|histamine agents|mesh-ancestor
101998666|NCT04162795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101998667|NCT04162795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998668|NCT04162795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998669|NCT01250951|Deferasirox|deferasirox|mesh-list
101998670|NCT01250951|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101998671|NCT01250951|Chelating Agents|chelating agents|mesh-ancestor
101998672|NCT01250951|Sequestering Agents|sequestering agents|mesh-ancestor
101998673|NCT01250951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998674|NCT03069482|Nicotine|nicotine|mesh-list
101998675|NCT03069482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101998676|NCT03069482|Autonomic Agents|autonomic agents|mesh-ancestor
101998677|NCT03069482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101998678|NCT03069482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998679|NCT03069482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101998680|NCT03069482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101998681|NCT03069482|Cholinergic Agents|cholinergic agents|mesh-ancestor
101256156|NCT01709760|Antimetabolites|antimetabolites|mesh-ancestor
101998682|NCT03069482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101998683|NCT03069482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998684|NCT01250405|Cinacalcet|cinacalcet|mesh-list
101998685|NCT01250405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101998686|NCT01250405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998687|NCT01250405|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101998688|NCT01250405|Hormone Antagonists|hormone antagonists|mesh-ancestor
101998689|NCT01250405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101998690|NCT05083910|Misoprostol|misoprostol|mesh-list
101998691|NCT05083910|Oxytocin|oxytocin|mesh-list
101998692|NCT05083910|Carbetocin|carbetocin|mesh-list
101998693|NCT05083910|Oxytocics|oxytocics|mesh-ancestor
101998694|NCT05083910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101998695|NCT05083910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998696|NCT05083910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101998697|NCT05083910|Abortifacient Agents|abortifacient agents|mesh-ancestor
101998698|NCT05083910|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101998699|NCT05083910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101998700|NCT01250561|Valacyclovir|valacyclovir|mesh-list
101998701|NCT01250561|Gabapentin|gabapentin|mesh-list
101998702|NCT01250561|Analgesics|analgesics|mesh-ancestor
101998703|NCT01250561|Sensory System Agents|sensory system agents|mesh-ancestor
101998704|NCT01250561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101998705|NCT01250561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998706|NCT01250561|Anticonvulsants|anticonvulsants|mesh-ancestor
101998707|NCT01250561|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101998708|NCT01250561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101998709|NCT01250561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101998710|NCT01250561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101998711|NCT01250561|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101998712|NCT01250561|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101998713|NCT01250561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101998714|NCT01250561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998715|NCT01250561|Antimanic Agents|antimanic agents|mesh-ancestor
101998716|NCT01250561|Antiviral Agents|antiviral agents|mesh-ancestor
101998720|NCT05055908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998721|NCT05055908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101998722|NCT05055908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101718522|NCT03684876|Diuretics|diuretics|mesh-list
101998724|NCT01147523|Spironolactone|spironolactone|mesh-list
101998725|NCT01147523|Vitamins|vitamins|mesh-ancestor
101998726|NCT01147523|Micronutrients|micronutrients|mesh-ancestor
101998727|NCT01147523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998728|NCT01147523|Antioxidants|antioxidants|mesh-ancestor
101998729|NCT01147523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998730|NCT01147523|Protective Agents|protective agents|mesh-ancestor
101998731|NCT01147523|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101998732|NCT01147523|Hormone Antagonists|hormone antagonists|mesh-ancestor
101998733|NCT01147523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101998734|NCT01147523|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101998735|NCT01147523|Diuretics|diuretics|mesh-ancestor
101998736|NCT01147523|Natriuretic Agents|natriuretic agents|mesh-ancestor
101998737|NCT01251029|Acetylcysteine|acetylcysteine|mesh-list
101998738|NCT01251029|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101998739|NCT01251029|Antiviral Agents|antiviral agents|mesh-ancestor
101998740|NCT01251029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101998741|NCT01251029|Expectorants|expectorants|mesh-ancestor
101998742|NCT01251029|Respiratory System Agents|respiratory system agents|mesh-ancestor
101998743|NCT01251029|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101998744|NCT01251029|Antioxidants|antioxidants|mesh-ancestor
101998745|NCT01251029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998746|NCT01251029|Protective Agents|protective agents|mesh-ancestor
101998747|NCT01251029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998748|NCT01251029|Antidotes|antidotes|mesh-ancestor
101998749|NCT01251107|Prednisone|prednisone|mesh-list
101998750|NCT01251107|Cyclophosphamide|cyclophosphamide|mesh-list
101998751|NCT01251107|Dacarbazine|dacarbazine|mesh-list
101998752|NCT01251107|Doxorubicin|doxorubicin|mesh-list
101998753|NCT01251107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101998754|NCT01251107|Etoposide|etoposide|mesh-list
101998755|NCT01251107|Etoposide phosphate|etoposide phosphate|mesh-list
101998756|NCT01251107|Vincristine|vincristine|mesh-list
101998757|NCT01251107|Bleomycin|bleomycin|mesh-list
101998758|NCT01251107|Vinblastine|vinblastine|mesh-list
101998759|NCT01251107|Procarbazine|procarbazine|mesh-list
101998760|NCT01251107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101998761|NCT01251107|Immunologic Factors|immunologic factors|mesh-ancestor
101998762|NCT01251107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998763|NCT01251107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101998764|NCT01251107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101998765|NCT01251107|Alkylating Agents|alkylating agents|mesh-ancestor
101998766|NCT01251107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998767|NCT01251107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101998768|NCT01251107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101998769|NCT01251107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101998770|NCT01251107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101998771|NCT01251107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101998772|NCT01251107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101998773|NCT01251107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101998774|NCT01251107|Glucocorticoids|glucocorticoids|mesh-ancestor
101998775|NCT01251107|Hormones|hormones|mesh-ancestor
101998776|NCT01251107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101998777|NCT01251107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101948344|NCT01176903|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101948345|NCT01176903|Cholinergic Agents|cholinergic agents|mesh-ancestor
101948346|NCT01176903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101948347|NCT01176903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998778|NCT01251107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101998779|NCT01251107|Tubulin Modulators|tubulin modulators|mesh-ancestor
101998780|NCT01251107|Antimitotic Agents|antimitotic agents|mesh-ancestor
101998781|NCT01251107|Mitosis Modulators|mitosis modulators|mesh-ancestor
101998782|NCT01125176|Thalidomide|thalidomide|mesh-list
101998783|NCT01125176|Rituximab|rituximab|mesh-list
101998784|NCT01125176|Lenalidomide|lenalidomide|mesh-list
101998785|NCT01125176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101998786|NCT01125176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101998787|NCT01125176|Immunologic Factors|immunologic factors|mesh-ancestor
101998788|NCT01125176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998789|NCT01125176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101998794|NCT01125176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101998795|NCT01125176|Leprostatic Agents|leprostatic agents|mesh-ancestor
101998796|NCT01125176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101998797|NCT01125176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101998799|NCT00882050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101998800|NCT00882050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998801|NCT00882050|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101998802|NCT00882050|Incretins|incretins|mesh-ancestor
101998803|NCT00882050|Hormones|hormones|mesh-ancestor
101998804|NCT00882050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101998806|NCT03912857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101998807|NCT03912857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101998808|NCT03912857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101998809|NCT03912857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998811|NCT04892420|Magnesium Sulfate|magnesium sulfate|mesh-list
101998812|NCT04892420|Dexmedetomidine|dexmedetomidine|mesh-list
101998813|NCT04892420|Bupivacaine|bupivacaine|mesh-list
101998814|NCT04892420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101998815|NCT04892420|Antiemetics|antiemetics|mesh-ancestor
101998816|NCT04892420|Autonomic Agents|autonomic agents|mesh-ancestor
101998817|NCT04892420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101998818|NCT04892420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998819|NCT04892420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101998820|NCT04892420|Glucocorticoids|glucocorticoids|mesh-ancestor
101998821|NCT04892420|Hormones|hormones|mesh-ancestor
101998822|NCT04892420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101998823|NCT04892420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101998824|NCT04892420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101998825|NCT04892420|Anesthetics, Local|anesthetics, local|mesh-ancestor
101998826|NCT04892420|Anesthetics|anesthetics|mesh-ancestor
101998827|NCT04892420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101998828|NCT04892420|Sensory System Agents|sensory system agents|mesh-ancestor
101998829|NCT04892420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101998830|NCT04892420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101998831|NCT04892420|Analgesics|analgesics|mesh-ancestor
101998832|NCT04892420|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101998833|NCT04892420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101998834|NCT04892420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101998835|NCT04892420|Adrenergic Agents|adrenergic agents|mesh-ancestor
101998836|NCT04892420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101998837|NCT04892420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998838|NCT04892420|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101998839|NCT04892420|Anticonvulsants|anticonvulsants|mesh-ancestor
101998840|NCT04892420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101998841|NCT04892420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101998842|NCT04892420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101998843|NCT04892420|Tocolytic Agents|tocolytic agents|mesh-ancestor
101998844|NCT04892420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101998845|NCT01251263|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101998846|NCT01251263|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101998847|NCT01251263|Estradiol|estradiol|mesh-list
101998848|NCT01251263|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101998849|NCT01251263|Estrogens|estrogens|mesh-ancestor
101998850|NCT01251263|Hormones|hormones|mesh-ancestor
101737355|NCT00780416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948348|NCT01176903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101948349|NCT01176903|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101948350|NCT03863925|Propofol|propofol|mesh-list
101948351|NCT03863925|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101948352|NCT03863925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101998851|NCT01251263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101998852|NCT01251263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998853|NCT01251263|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101998854|NCT01251263|Contraceptive Agents|contraceptive agents|mesh-ancestor
101998855|NCT01251263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101998856|NCT01251263|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101998857|NCT04707534|Dexamethasone|dexamethasone|mesh-list
101998858|NCT04707534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101998859|NCT04707534|Antiemetics|antiemetics|mesh-ancestor
101998860|NCT04707534|Autonomic Agents|autonomic agents|mesh-ancestor
101998861|NCT04707534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101453868|NCT00208793|Vitamin D|vitamin d|mesh-list
101998866|NCT04707534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101998868|NCT04707534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101998869|NCT05761730|Dexamethasone|dexamethasone|mesh-list
101998870|NCT05761730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101998871|NCT05761730|Antiemetics|antiemetics|mesh-ancestor
101998872|NCT05761730|Autonomic Agents|autonomic agents|mesh-ancestor
101998873|NCT05761730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101998874|NCT05761730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998875|NCT05761730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101998876|NCT05761730|Glucocorticoids|glucocorticoids|mesh-ancestor
101998877|NCT05761730|Hormones|hormones|mesh-ancestor
101998878|NCT05761730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101998879|NCT05761730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101998880|NCT05761730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101998881|NCT04257500|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101998882|NCT04257500|Etonogestrel|etonogestrel|mesh-list
101998883|NCT04257500|NuvaRing|nuvaring|mesh-list
101998884|NCT04257500|Estradiol|estradiol|mesh-list
101998885|NCT04257500|Estrogens|estrogens|mesh-ancestor
101998886|NCT04257500|Hormones|hormones|mesh-ancestor
101998887|NCT04257500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101998888|NCT04257500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998889|NCT04257500|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101998890|NCT04257500|Contraceptive Agents|contraceptive agents|mesh-ancestor
101998891|NCT04257500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101998892|NCT04257500|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101998893|NCT04257500|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101998894|NCT04257500|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101998895|NCT04353817|Ivacaftor|ivacaftor|mesh-list
101998896|NCT04353817|Elexacaftor|elexacaftor|mesh-list
101998897|NCT04353817|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101998898|NCT04353817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101998899|NCT04353817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998900|NCT00159588|Angiotensin II|angiotensin ii|mesh-list
101998901|NCT00159588|Gabapentin|gabapentin|mesh-list
101998902|NCT00159588|Valproic Acid|valproic acid|mesh-list
101998903|NCT00159588|Antidepressive Agents|antidepressive agents|mesh-list
101998904|NCT00159588|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
101998905|NCT00159588|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101998906|NCT00159588|Analgesics|analgesics|mesh-ancestor
101998907|NCT00159588|Sensory System Agents|sensory system agents|mesh-ancestor
101998908|NCT00159588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101998909|NCT00159588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998910|NCT00159588|Anticonvulsants|anticonvulsants|mesh-ancestor
101998911|NCT00159588|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101998912|NCT00159588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101998913|NCT00159588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101998914|NCT00159588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101998915|NCT00159588|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101998916|NCT00159588|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101998917|NCT00159588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101998918|NCT00159588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998919|NCT00159588|Antimanic Agents|antimanic agents|mesh-ancestor
101948353|NCT03863925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948354|NCT03863925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101948355|NCT03863925|Anesthetics, General|anesthetics, general|mesh-ancestor
101948356|NCT03863925|Anesthetics|anesthetics|mesh-ancestor
101948357|NCT01178697|Triamcinolone|triamcinolone|mesh-list
101948358|NCT01178697|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101998920|NCT00159588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101998921|NCT00159588|GABA Agents|gaba agents|mesh-ancestor
101998922|NCT00159588|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101998923|NCT00159588|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101998924|NCT00159588|Adrenergic Agents|adrenergic agents|mesh-ancestor
101998925|NCT04166942|Belumosudil|belumosudil|mesh-list
101998926|NCT04166942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101998927|NCT04166942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101998928|NCT04166942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998929|NCT03903653|Botulinum Toxins|botulinum toxins|mesh-list
101998930|NCT03903653|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101998931|NCT03903653|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101453939|NCT00209222|Immunologic Factors|immunologic factors|mesh-ancestor
101998934|NCT03903653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998935|NCT03903653|Cholinergic Agents|cholinergic agents|mesh-ancestor
101998936|NCT03903653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101998937|NCT03903653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998938|NCT03903653|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101998939|NCT03903653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101998940|NCT04349917|Methylphenidate|methylphenidate|mesh-list
101998941|NCT04349917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101998942|NCT04349917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998943|NCT04349917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101998944|NCT04349917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101998945|NCT04349917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101998946|NCT04349917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998947|NCT04349917|Dopamine Agents|dopamine agents|mesh-ancestor
101998948|NCT04349917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101998949|NCT03903029|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101998950|NCT03903029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101998951|NCT03903029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101998952|NCT03903029|Antimetabolites|antimetabolites|mesh-ancestor
101998953|NCT03903029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998954|NCT03903029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101998955|NCT03903029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101998956|NCT03903029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101998957|NCT04691856|Acetaminophen|acetaminophen|mesh-list
101998958|NCT04691856|Ibuprofen|ibuprofen|mesh-list
101998959|NCT04691856|Morphine|morphine|mesh-list
101998960|NCT04691856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101998961|NCT04691856|Narcotics|narcotics|mesh-ancestor
101998962|NCT04691856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101998963|NCT04691856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998964|NCT04691856|Analgesics|analgesics|mesh-ancestor
101998965|NCT04691856|Sensory System Agents|sensory system agents|mesh-ancestor
101998966|NCT04691856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101998967|NCT04691856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101998968|NCT04691856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101998969|NCT04691856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101998970|NCT04691856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101998971|NCT04691856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101998972|NCT04691856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101998973|NCT04691856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998974|NCT04691856|Antipyretics|antipyretics|mesh-ancestor
101998975|NCT01254929|Frovatriptan|frovatriptan|mesh-list
101998976|NCT01254929|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101998977|NCT01254929|Serotonin Agents|serotonin agents|mesh-ancestor
101998978|NCT01254929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101998979|NCT01254929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998980|NCT01254929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998981|NCT03300570|Dolcanatide|dolcanatide|mesh-list
101998982|NCT03300570|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
101948359|NCT01178697|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101948360|NCT01178697|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101948361|NCT01178697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101948362|NCT01178697|Glucocorticoids|glucocorticoids|mesh-ancestor
101948363|NCT01178697|Hormones|hormones|mesh-ancestor
101948364|NCT01178697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101998983|NCT03300570|Enzyme Activators|enzyme activators|mesh-ancestor
101998984|NCT03300570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998985|NCT03300570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101998986|NCT03853694|Morphine|morphine|mesh-list
101998987|NCT03853694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101998988|NCT03853694|Narcotics|narcotics|mesh-ancestor
101998989|NCT03853694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101998990|NCT03853694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998991|NCT03853694|Analgesics|analgesics|mesh-ancestor
101998992|NCT03853694|Sensory System Agents|sensory system agents|mesh-ancestor
101998993|NCT03853694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101998994|NCT04154293|Isotretinoin|isotretinoin|mesh-list
101998995|NCT04154293|Dermatologic Agents|dermatologic agents|mesh-ancestor
101998996|NCT01148147|Adenosine|adenosine|mesh-list
101998997|NCT01148147|Analgesics|analgesics|mesh-ancestor
101998998|NCT01148147|Sensory System Agents|sensory system agents|mesh-ancestor
101998999|NCT01148147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101999000|NCT01148147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999001|NCT01148147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101999002|NCT01148147|Vasodilator Agents|vasodilator agents|mesh-ancestor
101999008|NCT03902249|Dexamethasone|dexamethasone|mesh-list
101999009|NCT03902249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101999010|NCT03902249|Antiemetics|antiemetics|mesh-ancestor
101999011|NCT03902249|Autonomic Agents|autonomic agents|mesh-ancestor
101999012|NCT03902249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101999013|NCT03902249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999014|NCT03902249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101999015|NCT03902249|Glucocorticoids|glucocorticoids|mesh-ancestor
101999016|NCT03902249|Hormones|hormones|mesh-ancestor
101999017|NCT03902249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101999018|NCT03902249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101999019|NCT03902249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101999020|NCT03908489|Allyl sulfide|allyl sulfide|mesh-list
101999021|NCT03908489|Antioxidants|antioxidants|mesh-ancestor
101999022|NCT03908489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999023|NCT03908489|Protective Agents|protective agents|mesh-ancestor
101999024|NCT03908489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999025|NCT03908489|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101999026|NCT03908489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101999027|NCT03908489|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101999028|NCT03908489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101999029|NCT04342897|Zansecimab|zansecimab|mesh-list
101999030|NCT04342897|Antiviral Agents|antiviral agents|mesh-ancestor
101999031|NCT04342897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101999032|NCT03263767|Cyclophosphamide|cyclophosphamide|mesh-list
101999033|NCT03263767|Fludarabine|fludarabine|mesh-list
101999034|NCT03263767|Clofarabine|clofarabine|mesh-list
101999035|NCT03263767|Thymoglobulin|thymoglobulin|mesh-list
101999036|NCT03263767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101999037|NCT03263767|Immunologic Factors|immunologic factors|mesh-ancestor
101999038|NCT03263767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999039|NCT03263767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101999040|NCT03263767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101999041|NCT03263767|Alkylating Agents|alkylating agents|mesh-ancestor
101999042|NCT03263767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999043|NCT03263767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101999044|NCT03263767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101999045|NCT03263767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101999046|NCT03263767|Antimetabolites|antimetabolites|mesh-ancestor
101999047|NCT04603742|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101999048|NCT04603742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101999049|NCT03908333|Ascorbic Acid|ascorbic acid|mesh-list
101999050|NCT03908333|Paclitaxel|paclitaxel|mesh-list
101999051|NCT03908333|Gemcitabine|gemcitabine|mesh-list
101948365|NCT01178697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948366|NCT01178697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101948367|NCT01178697|Immunologic Factors|immunologic factors|mesh-ancestor
101948368|NCT01178697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101971967|NCT01336322|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101999052|NCT03908333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101999053|NCT03908333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101999054|NCT03908333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101999055|NCT03908333|Tubulin Modulators|tubulin modulators|mesh-ancestor
101999056|NCT03908333|Antimitotic Agents|antimitotic agents|mesh-ancestor
101999057|NCT03908333|Mitosis Modulators|mitosis modulators|mesh-ancestor
101999058|NCT03908333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999059|NCT03908333|Vitamins|vitamins|mesh-ancestor
101999060|NCT03908333|Micronutrients|micronutrients|mesh-ancestor
101999061|NCT03908333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999062|NCT03908333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101999063|NCT03908333|Antimetabolites|antimetabolites|mesh-ancestor
101999064|NCT03908333|Antioxidants|antioxidants|mesh-ancestor
101999065|NCT03908333|Protective Agents|protective agents|mesh-ancestor
101999066|NCT04340557|Losartan|losartan|mesh-list
101999067|NCT04340557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101999068|NCT04340557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101999069|NCT04340557|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101999070|NCT04340557|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101999071|NCT04340557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999076|NCT04549376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101999077|NCT04549376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101999078|NCT04549376|Trace Elements|trace elements|mesh-ancestor
101999079|NCT04549376|Micronutrients|micronutrients|mesh-ancestor
101999080|NCT04549376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999081|NCT04549376|Plasma Substitutes|plasma substitutes|mesh-ancestor
101999082|NCT04549376|Blood Substitutes|blood substitutes|mesh-ancestor
101999083|NCT01149395|Dexlansoprazole|dexlansoprazole|mesh-list
101999084|NCT01149395|Lansoprazole|lansoprazole|mesh-list
101999085|NCT01149395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101999086|NCT01149395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101999087|NCT01149395|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101999088|NCT01149395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101999089|NCT01149395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999090|NCT02527733|Ranibizumab|ranibizumab|mesh-list
101999091|NCT02527733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101999092|NCT02527733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101999093|NCT02527733|Growth Substances|growth substances|mesh-ancestor
101999094|NCT02527733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999095|NCT02527733|Growth Inhibitors|growth inhibitors|mesh-ancestor
101999096|NCT02527733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101999097|NCT04135495|Ivacaftor|ivacaftor|mesh-list
101999098|NCT04135495|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101999099|NCT04135495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101999100|NCT04135495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999101|NCT01148303|Etoricoxib|etoricoxib|mesh-list
101999102|NCT01148303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101999103|NCT01148303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101999104|NCT01148303|Analgesics|analgesics|mesh-ancestor
101999105|NCT01148303|Sensory System Agents|sensory system agents|mesh-ancestor
101999106|NCT01148303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101999107|NCT01148303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999108|NCT01148303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101999109|NCT01148303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101999110|NCT01148303|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101999111|NCT01148303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101999112|NCT01148303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101999113|NCT01148303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999114|NCT03066830|Metformin|metformin|mesh-list
101999115|NCT03066830|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
101999116|NCT03066830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101999117|NCT03066830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737356|NCT00780416|Antiviral Agents|antiviral agents|mesh-ancestor
101948369|NCT01178697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948370|NCT03329690|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
101948371|NCT03329690|Immunoconjugates|immunoconjugates|mesh-ancestor
101948372|NCT03329690|Immunologic Factors|immunologic factors|mesh-ancestor
101948373|NCT03329690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948374|NCT03328832|Tranylcypromine|tranylcypromine|mesh-list
101948375|NCT03328832|Rivaroxaban|rivaroxaban|mesh-list
101948376|NCT03328832|Tranexamic Acid|tranexamic acid|mesh-list
101999118|NCT03066830|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101999119|NCT03066830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999120|NCT05205200|Paclitaxel|paclitaxel|mesh-list
101999121|NCT05205200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101999122|NCT05205200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101999123|NCT05205200|Tubulin Modulators|tubulin modulators|mesh-ancestor
101999124|NCT05205200|Antimitotic Agents|antimitotic agents|mesh-ancestor
101999125|NCT05205200|Mitosis Modulators|mitosis modulators|mesh-ancestor
101999126|NCT05205200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999127|NCT01149629|Droxidopa|droxidopa|mesh-list
101999128|NCT01149629|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101999129|NCT01149629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101999130|NCT05205122|Mitomycins|mitomycins|mesh-list
101999131|NCT05205122|Mitomycin|mitomycin|mesh-list
101999132|NCT05205122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101999133|NCT05205122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101999134|NCT05205122|Alkylating Agents|alkylating agents|mesh-ancestor
101999135|NCT05205122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999136|NCT05205122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101999137|NCT05205122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101999138|NCT03907163|Dronabinol|dronabinol|mesh-list
101999139|NCT03907163|Hallucinogens|hallucinogens|mesh-ancestor
101999140|NCT03907163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999141|NCT03907163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101999142|NCT03907163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101999143|NCT03907163|Analgesics|analgesics|mesh-ancestor
101454148|NCT00209690|Cisplatin|cisplatin|mesh-list
101999147|NCT03907163|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101999148|NCT03907163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101999149|NCT03907163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999150|NCT03907163|Hormones|hormones|mesh-ancestor
101999151|NCT03907163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101999152|NCT01253681|Paclitaxel|paclitaxel|mesh-list
101999153|NCT01253681|Carboplatin|carboplatin|mesh-list
101999154|NCT01253681|Trebananib|trebananib|mesh-list
101999155|NCT01253681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101999156|NCT01253681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101999157|NCT01253681|Tubulin Modulators|tubulin modulators|mesh-ancestor
101999158|NCT01253681|Antimitotic Agents|antimitotic agents|mesh-ancestor
101999159|NCT01253681|Mitosis Modulators|mitosis modulators|mesh-ancestor
101999160|NCT01253681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999161|NCT01253681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101999162|NCT01253681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101999163|NCT01253681|Growth Substances|growth substances|mesh-ancestor
101999164|NCT01253681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999165|NCT01253681|Growth Inhibitors|growth inhibitors|mesh-ancestor
101999166|NCT01149941|Ibuprofen|ibuprofen|mesh-list
101999167|NCT01149941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101999168|NCT01149941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101999169|NCT01149941|Analgesics|analgesics|mesh-ancestor
101999170|NCT01149941|Sensory System Agents|sensory system agents|mesh-ancestor
101999171|NCT01149941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101999172|NCT01149941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999173|NCT01149941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101999174|NCT01149941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101999175|NCT01149941|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101999176|NCT01149941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101999177|NCT01149941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999178|NCT01589549|Methylprednisolone|methylprednisolone|mesh-list
101948377|NCT03328832|Thrombin|thrombin|mesh-list
101948378|NCT03328832|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101999179|NCT01589549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101999180|NCT01589549|Antiemetics|antiemetics|mesh-ancestor
101999181|NCT01589549|Autonomic Agents|autonomic agents|mesh-ancestor
101999182|NCT01589549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101999183|NCT01589549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999184|NCT01589549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101999185|NCT01589549|Glucocorticoids|glucocorticoids|mesh-ancestor
101999186|NCT01589549|Hormones|hormones|mesh-ancestor
101999187|NCT01589549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101999188|NCT01589549|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101999189|NCT01589549|Protective Agents|protective agents|mesh-ancestor
101999190|NCT03899675|Caffeine|caffeine|mesh-list
101999191|NCT03899675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101999192|NCT03899675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999193|NCT03899675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101999194|NCT03899675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101999195|NCT03899675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999196|NCT03899675|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101999197|NCT03899675|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101999198|NCT03899675|Purinergic Agents|purinergic agents|mesh-ancestor
101999199|NCT03899675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101999200|NCT01562197|Axitinib|axitinib|mesh-list
101999201|NCT01562197|Lomustine|lomustine|mesh-list
101999202|NCT01562197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101999203|NCT01562197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101999204|NCT01562197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101999205|NCT01562197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999206|NCT01562197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101999207|NCT01562197|Alkylating Agents|alkylating agents|mesh-ancestor
101999208|NCT03905837|Lidocaine|lidocaine|mesh-list
101999209|NCT03905837|Piperidine|piperidine|mesh-list
101999210|NCT03905837|Remifentanil|remifentanil|mesh-list
101999211|NCT03905837|Anesthetics, Local|anesthetics, local|mesh-ancestor
101999212|NCT03905837|Anesthetics|anesthetics|mesh-ancestor
101999213|NCT03905837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101999214|NCT03905837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999220|NCT03905837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101999221|NCT03905837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999223|NCT03905837|Narcotics|narcotics|mesh-ancestor
101999224|NCT03905837|Analgesics|analgesics|mesh-ancestor
101999225|NCT03905837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101999226|NCT03905837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101999227|NCT03063632|Interferons|interferons|mesh-list
101999228|NCT03063632|Interferon-gamma|interferon-gamma|mesh-list
101999229|NCT03063632|Pembrolizumab|pembrolizumab|mesh-list
101999230|NCT03063632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101999231|NCT03063632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101999232|NCT03063632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101999233|NCT03063632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999234|NCT03063632|Antiviral Agents|antiviral agents|mesh-ancestor
101999235|NCT03063632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101999236|NCT04328467|Hydroxychloroquine|hydroxychloroquine|mesh-list
101999237|NCT04328467|Antimalarials|antimalarials|mesh-ancestor
101999238|NCT04328467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101999239|NCT04328467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101999240|NCT04328467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101999241|NCT04328467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101999242|NCT04328467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999243|NCT04328467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101999244|NCT01148615|Docetaxel|docetaxel|mesh-list
101999245|NCT01148615|Aflibercept|aflibercept|mesh-list
101999246|NCT01148615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101999247|NCT01148615|Tubulin Modulators|tubulin modulators|mesh-ancestor
101999248|NCT01148615|Antimitotic Agents|antimitotic agents|mesh-ancestor
101999249|NCT01148615|Mitosis Modulators|mitosis modulators|mesh-ancestor
101999250|NCT01148615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999251|NCT01148615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101999252|NCT01148615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101999253|NCT01148615|Growth Substances|growth substances|mesh-ancestor
101999254|NCT01148615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999255|NCT01148615|Growth Inhibitors|growth inhibitors|mesh-ancestor
101999256|NCT03905759|Colchicine|colchicine|mesh-list
101948379|NCT03328832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101948380|NCT03328832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948381|NCT03328832|Hemostatics|hemostatics|mesh-ancestor
101948382|NCT03328832|Coagulants|coagulants|mesh-ancestor
101948383|NCT03328832|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101825683|NCT03639714|Nivolumab|nivolumab|mesh-list
101999257|NCT03905759|Amiodarone|amiodarone|mesh-list
101999258|NCT03905759|Dronedarone|dronedarone|mesh-list
101999259|NCT03905759|Gout Suppressants|gout suppressants|mesh-ancestor
101999260|NCT03905759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101999261|NCT03905759|Tubulin Modulators|tubulin modulators|mesh-ancestor
101999262|NCT03905759|Antimitotic Agents|antimitotic agents|mesh-ancestor
101999263|NCT03905759|Mitosis Modulators|mitosis modulators|mesh-ancestor
101999264|NCT03905759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999265|NCT03905759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101999266|NCT03905759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101999267|NCT03905759|Vasodilator Agents|vasodilator agents|mesh-ancestor
101999268|NCT03905759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101999269|NCT03905759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101999270|NCT03905759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101999271|NCT03905759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101999272|NCT03905759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101999273|NCT03905759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101999274|NCT03905759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101999275|NCT03905759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101999276|NCT03905759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101999277|NCT01255475|Amlodipine|amlodipine|mesh-list
101999278|NCT01255475|Hydralazine|hydralazine|mesh-list
101999279|NCT01255475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101999280|NCT01255475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101305329|NCT02018965|Vitamin B Complex|vitamin b complex|mesh-list
101999281|NCT01255475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101999282|NCT01255475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999285|NCT01255475|Vasodilator Agents|vasodilator agents|mesh-ancestor
101999287|NCT05208398|Apixaban|apixaban|mesh-list
101999288|NCT05208398|Anticoagulants|anticoagulants|mesh-ancestor
101999289|NCT05208398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101999290|NCT05208398|Antithrombins|antithrombins|mesh-ancestor
101999291|NCT05208398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101999292|NCT05208398|Protease Inhibitors|protease inhibitors|mesh-ancestor
101999293|NCT05208398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101999294|NCT05208398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999295|NCT05593601|Neomycin|neomycin|mesh-list
101999296|NCT05593601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101999297|NCT05593601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101999298|NCT05593601|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101999299|NCT05593601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101999300|NCT05593601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999301|NCT03629210|Dexamethasone|dexamethasone|mesh-list
101999302|NCT03629210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101999303|NCT03629210|Antiemetics|antiemetics|mesh-ancestor
101999304|NCT03629210|Autonomic Agents|autonomic agents|mesh-ancestor
101999305|NCT03629210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101999306|NCT03629210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999307|NCT03629210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101999308|NCT03629210|Glucocorticoids|glucocorticoids|mesh-ancestor
101999309|NCT03629210|Hormones|hormones|mesh-ancestor
101999310|NCT03629210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101999311|NCT03629210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101999312|NCT03629210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101999313|NCT05569811|Letrozole|letrozole|mesh-list
101999314|NCT05569811|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
101999315|NCT05569811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101999316|NCT05569811|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101999317|NCT05569811|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101999318|NCT05569811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101999319|NCT05569811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999320|NCT05569811|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101999321|NCT05569811|Hormone Antagonists|hormone antagonists|mesh-ancestor
101999322|NCT05569811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101948384|NCT03328832|Antithrombins|antithrombins|mesh-ancestor
101948385|NCT03328832|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101948386|NCT03328832|Protease Inhibitors|protease inhibitors|mesh-ancestor
101948387|NCT03328832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101948388|NCT03328832|Anticoagulants|anticoagulants|mesh-ancestor
101971968|NCT01336322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101999323|NCT05569811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999324|NCT05569811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101719111|NCT00825162|Vaccines|vaccines|mesh-list
101999326|NCT03899285|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101999327|NCT03899285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101999328|NCT03899285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101999329|NCT03899285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999330|NCT03899285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101999331|NCT03899285|Serotonin Agents|serotonin agents|mesh-ancestor
101999332|NCT03899285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999333|NCT03899285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101999334|NCT03899285|Antidepressive Agents|antidepressive agents|mesh-ancestor
101999335|NCT03899285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101999336|NCT01254071|Tamsulosin|tamsulosin|mesh-list
101999337|NCT01254071|Dutasteride|dutasteride|mesh-list
101999338|NCT01254071|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101999339|NCT01254071|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101999340|NCT01254071|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101999341|NCT01254071|Adrenergic Agents|adrenergic agents|mesh-ancestor
101999342|NCT01254071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101999343|NCT01254071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999344|NCT01254071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999345|NCT01254071|Urological Agents|urological agents|mesh-ancestor
101999346|NCT01254071|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101999347|NCT01254071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101999348|NCT01254071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101999349|NCT01254071|Hormone Antagonists|hormone antagonists|mesh-ancestor
101999350|NCT01254071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101999351|NCT05761418|Misoprostol|misoprostol|mesh-list
101999352|NCT05761418|Dinoprostone|dinoprostone|mesh-list
101999356|NCT05761418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999357|NCT05761418|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101999358|NCT05761418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101999359|NCT05761418|Oxytocics|oxytocics|mesh-ancestor
101999360|NCT05207774|Oxytocin|oxytocin|mesh-list
101999361|NCT05207774|Oxytocics|oxytocics|mesh-ancestor
101999362|NCT05207774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101999363|NCT05207774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999364|NCT02528123|Tobramycin|tobramycin|mesh-list
101999365|NCT02528123|Ofloxacin|ofloxacin|mesh-list
101999366|NCT02528123|Dexamethasone|dexamethasone|mesh-list
101999367|NCT02528123|Benoxinate|benoxinate|mesh-list
101999368|NCT02528123|Proxymetacaine|proxymetacaine|mesh-list
101999369|NCT02528123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101999370|NCT02528123|Antiemetics|antiemetics|mesh-ancestor
101999371|NCT02528123|Autonomic Agents|autonomic agents|mesh-ancestor
101999372|NCT02528123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101999373|NCT02528123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999374|NCT02528123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101999375|NCT02528123|Glucocorticoids|glucocorticoids|mesh-ancestor
101999376|NCT02528123|Hormones|hormones|mesh-ancestor
101999377|NCT02528123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101999378|NCT02528123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101999379|NCT02528123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101999380|NCT02528123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101999381|NCT02528123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101999382|NCT02528123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101999383|NCT02528123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101999384|NCT02528123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101999385|NCT02528123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101999386|NCT02528123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999387|NCT02528123|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101999388|NCT02528123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101948389|NCT03328832|Antidepressive Agents|antidepressive agents|mesh-ancestor
101948390|NCT03328832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101948391|NCT03328832|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101948392|NCT03328832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101948393|NCT03328832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101948394|NCT03328832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101948395|NCT03328832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948396|NCT02820844|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101999389|NCT02528123|Anesthetics, Local|anesthetics, local|mesh-ancestor
101999390|NCT02528123|Anesthetics|anesthetics|mesh-ancestor
101999391|NCT02528123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101999392|NCT02528123|Sensory System Agents|sensory system agents|mesh-ancestor
101999393|NCT02527811|Urinastatin|urinastatin|mesh-list
101999394|NCT02527811|Trypsin Inhibitors|trypsin inhibitors|mesh-list
101999395|NCT02527811|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101999396|NCT02527811|Protease Inhibitors|protease inhibitors|mesh-ancestor
101999397|NCT02527811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101719181|NCT02630303|Dermatologic Agents|dermatologic agents|mesh-ancestor
101999398|NCT02527811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999399|NCT03691831|Hydrogen Peroxide|hydrogen peroxide|mesh-list
101999400|NCT03691831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101999401|NCT03691831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101999402|NCT01254383|Sildenafil Citrate|sildenafil citrate|mesh-list
101999403|NCT01254383|Vasodilator Agents|vasodilator agents|mesh-ancestor
101999404|NCT01254383|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101999405|NCT01254383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101999406|NCT01254383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101999407|NCT01254383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999408|NCT01254383|Urological Agents|urological agents|mesh-ancestor
101999409|NCT03700970|Bupivacaine|bupivacaine|mesh-list
101999410|NCT03700970|Anesthetics, Local|anesthetics, local|mesh-ancestor
101999411|NCT03700970|Anesthetics|anesthetics|mesh-ancestor
101999412|NCT03700970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101999413|NCT03700970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999414|NCT03700970|Sensory System Agents|sensory system agents|mesh-ancestor
101999415|NCT03700970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101999416|NCT01256021|Botulinum Toxins|botulinum toxins|mesh-list
101999417|NCT01256021|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101999418|NCT01256021|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101999419|NCT01256021|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101999420|NCT01256021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101999421|NCT01256021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999422|NCT01256021|Cholinergic Agents|cholinergic agents|mesh-ancestor
101999423|NCT01256021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101999425|NCT01256021|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101999426|NCT01256021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101999427|NCT04320745|Testosterone|testosterone|mesh-list
101999428|NCT04320745|Androgens|androgens|mesh-ancestor
101999430|NCT04320745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101999431|NCT04320745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999432|NCT01254461|Pravastatin|pravastatin|mesh-list
101999433|NCT01254461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101999434|NCT01254461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101999435|NCT01254461|Antimetabolites|antimetabolites|mesh-ancestor
101999436|NCT01254461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999437|NCT01254461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101999438|NCT01254461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101999439|NCT01254461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101999440|NCT03747523|Vitamin D|vitamin d|mesh-list
101999441|NCT03747523|Ergocalciferols|ergocalciferols|mesh-list
101999442|NCT03747523|Vitamins|vitamins|mesh-ancestor
101999443|NCT03747523|Micronutrients|micronutrients|mesh-ancestor
101999444|NCT03747523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999445|NCT03747523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101999446|NCT03747523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101948397|NCT02820844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101948398|NCT02942576|Warfarin|warfarin|mesh-list
101948399|NCT02942576|Edoxaban|edoxaban|mesh-list
101948400|NCT02942576|Acenocoumarol|acenocoumarol|mesh-list
101948401|NCT02942576|Phenprocoumon|phenprocoumon|mesh-list
101948402|NCT02942576|Fluindione|fluindione|mesh-list
101948403|NCT02942576|Anticoagulants|anticoagulants|mesh-ancestor
101999447|NCT05293171|Moxifloxacin|moxifloxacin|mesh-list
101999448|NCT05293171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101999449|NCT05293171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101999450|NCT05293171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101999451|NCT05293171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101999452|NCT05293171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101999453|NCT05293171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999454|NCT05293171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101999455|NCT03063086|Fluticasone|fluticasone|mesh-list
101999456|NCT03063086|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101999457|NCT03063086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101999458|NCT03063086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101999459|NCT03063086|Autonomic Agents|autonomic agents|mesh-ancestor
101999460|NCT03063086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101999461|NCT03063086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999462|NCT03063086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101999463|NCT03063086|Respiratory System Agents|respiratory system agents|mesh-ancestor
101999464|NCT03063086|Dermatologic Agents|dermatologic agents|mesh-ancestor
101999465|NCT03063086|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101999466|NCT03063086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101999467|NCT03063086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101999468|NCT03063086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101999469|NCT03063086|Adrenergic Agents|adrenergic agents|mesh-ancestor
101999470|NCT03063086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101719257|NCT02631239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101999471|NCT03063086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999473|NCT03904745|Hormone Antagonists|hormone antagonists|mesh-ancestor
101999474|NCT03904745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101999475|NCT03904745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999476|NCT03904745|Tocolytic Agents|tocolytic agents|mesh-ancestor
101999477|NCT03904745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101999478|NCT05187338|Pembrolizumab|pembrolizumab|mesh-list
101999479|NCT05187338|Ipilimumab|ipilimumab|mesh-list
101999480|NCT05187338|Durvalumab|durvalumab|mesh-list
101999481|NCT05187338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101999482|NCT05187338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101999483|NCT05187338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101999484|NCT05187338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999485|NCT03898583|Calcitriol|calcitriol|mesh-list
101999486|NCT03898583|Betamethasone|betamethasone|mesh-list
101999487|NCT03898583|Betamethasone Valerate|betamethasone valerate|mesh-list
101999488|NCT03898583|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101999489|NCT03898583|Betamethasone benzoate|betamethasone benzoate|mesh-list
101999490|NCT03898583|Calcipotriene|calcipotriene|mesh-list
101999491|NCT03898583|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101999492|NCT03898583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101999493|NCT03898583|Glucocorticoids|glucocorticoids|mesh-ancestor
101999494|NCT03898583|Hormones|hormones|mesh-ancestor
101999495|NCT03898583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101999496|NCT03898583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999503|NCT03898583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999504|NCT03898583|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101999505|NCT03898583|Vitamins|vitamins|mesh-ancestor
101999506|NCT03898583|Micronutrients|micronutrients|mesh-ancestor
101999507|NCT03898583|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101999508|NCT03898193|Montelukast|montelukast|mesh-list
101999509|NCT03898193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101999510|NCT03898193|Respiratory System Agents|respiratory system agents|mesh-ancestor
101999511|NCT03898193|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101999512|NCT03898193|Hormone Antagonists|hormone antagonists|mesh-ancestor
101999513|NCT03898193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101999514|NCT03898193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999515|NCT03898193|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101948404|NCT02942576|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101948405|NCT02942576|Antithrombins|antithrombins|mesh-ancestor
101948406|NCT02942576|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101948407|NCT02942576|Protease Inhibitors|protease inhibitors|mesh-ancestor
101948408|NCT02942576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101948409|NCT02942576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948410|NCT02820298|Bexagliflozin|bexagliflozin|mesh-list
101948411|NCT02820298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101825952|NCT00864773|Endothelial Growth Factors|endothelial growth factors|mesh-list
101999516|NCT03898193|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101999517|NCT03898193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999519|NCT03321188|Carboplatin|carboplatin|mesh-list
101999520|NCT03321188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101999521|NCT03321188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101999522|NCT03321188|Tubulin Modulators|tubulin modulators|mesh-ancestor
101999523|NCT03321188|Antimitotic Agents|antimitotic agents|mesh-ancestor
101999524|NCT03321188|Mitosis Modulators|mitosis modulators|mesh-ancestor
101999525|NCT03321188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999526|NCT03904355|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101999527|NCT03904355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101999528|NCT03904355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999529|NCT01254617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101999530|NCT01254617|Cetuximab|cetuximab|mesh-list
101999531|NCT01254617|Lenalidomide|lenalidomide|mesh-list
101999532|NCT01254617|Antibodies|antibodies|mesh-list
101999533|NCT01254617|Immunoglobulins|immunoglobulins|mesh-list
101999534|NCT01254617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101999535|NCT01254617|Immunologic Factors|immunologic factors|mesh-ancestor
101999536|NCT01254617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999537|NCT01254617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101999538|NCT01254617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101999539|NCT01254617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101999540|NCT01254617|Growth Substances|growth substances|mesh-ancestor
101999541|NCT01254617|Growth Inhibitors|growth inhibitors|mesh-ancestor
101999542|NCT01150331|Levetiracetam|levetiracetam|mesh-list
101719333|NCT00669695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101999543|NCT01150331|Clonazepam|clonazepam|mesh-list
101999544|NCT01150331|Anticonvulsants|anticonvulsants|mesh-list
101999545|NCT01150331|Nootropic Agents|nootropic agents|mesh-ancestor
101999546|NCT01150331|GABA Modulators|gaba modulators|mesh-ancestor
101999547|NCT01150331|GABA Agents|gaba agents|mesh-ancestor
101999548|NCT01150331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101999549|NCT01150331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999550|NCT01150331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999551|NCT01256489|Infliximab|infliximab|mesh-list
101999552|NCT01256489|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101999553|NCT01256489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101999554|NCT01256489|Dermatologic Agents|dermatologic agents|mesh-ancestor
101999555|NCT01256489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101999556|NCT01256489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101999557|NCT03746119|Nicotine|nicotine|mesh-list
101999558|NCT03746119|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101999559|NCT03746119|Autonomic Agents|autonomic agents|mesh-ancestor
101999560|NCT03746119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101999561|NCT03746119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999562|NCT03746119|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101999563|NCT03746119|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101999564|NCT03746119|Cholinergic Agents|cholinergic agents|mesh-ancestor
101999585|NCT05122130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101999586|NCT02898506|Liraglutide|liraglutide|mesh-list
101999587|NCT02898506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101999588|NCT02898506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999589|NCT02898506|Incretins|incretins|mesh-ancestor
101999590|NCT02898506|Hormones|hormones|mesh-ancestor
101999591|NCT02898506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101999592|NCT04123405|Acetylcysteine|acetylcysteine|mesh-list
101999593|NCT04123405|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101948412|NCT02820298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948413|NCT02036008|Liver Extracts|liver extracts|mesh-list
101948414|NCT02036008|Hematinics|hematinics|mesh-ancestor
101948415|NCT02819440|Tadalafil|tadalafil|mesh-list
101999594|NCT04123405|Antiviral Agents|antiviral agents|mesh-ancestor
101999595|NCT04123405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101999596|NCT04123405|Expectorants|expectorants|mesh-ancestor
101999597|NCT04123405|Respiratory System Agents|respiratory system agents|mesh-ancestor
101999598|NCT04123405|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101999599|NCT04123405|Antioxidants|antioxidants|mesh-ancestor
101999600|NCT04123405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999601|NCT04123405|Protective Agents|protective agents|mesh-ancestor
101999602|NCT04123405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999603|NCT04123405|Antidotes|antidotes|mesh-ancestor
101999604|NCT02611232|Liraglutide|liraglutide|mesh-list
101999605|NCT02611232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101999606|NCT02611232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999607|NCT02611232|Incretins|incretins|mesh-ancestor
101999608|NCT02611232|Hormones|hormones|mesh-ancestor
101999609|NCT02611232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101999610|NCT01150877|Vitamin D|vitamin d|mesh-list
101999611|NCT01150877|Vitamins|vitamins|mesh-ancestor
101999612|NCT01150877|Micronutrients|micronutrients|mesh-ancestor
101999613|NCT01150877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999614|NCT01150877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101999615|NCT03893591|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101999616|NCT03893591|Dalteparin|dalteparin|mesh-list
101999617|NCT03893591|Anticoagulants|anticoagulants|mesh-ancestor
101999618|NCT03893591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101999619|NCT03893591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101999620|NCT03893591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999631|NCT02519738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101999632|NCT02519738|Glucocorticoids|glucocorticoids|mesh-ancestor
101999633|NCT02519738|Hormones|hormones|mesh-ancestor
101999634|NCT02519738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101999635|NCT02519738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999636|NCT02519738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101999637|NCT02519738|Immunologic Factors|immunologic factors|mesh-ancestor
101999638|NCT02519738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101999639|NCT02519738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101999640|NCT03893747|Vaccines|vaccines|mesh-list
101999641|NCT03893747|Immunologic Factors|immunologic factors|mesh-ancestor
101999642|NCT03893747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999643|NCT02343224|Interferons|interferons|mesh-list
101999644|NCT02343224|Interferon-alpha|interferon-alpha|mesh-list
101999645|NCT02343224|Interferon alpha-2|interferon alpha-2|mesh-list
101999646|NCT02343224|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101999647|NCT02343224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101999648|NCT02343224|Antiviral Agents|antiviral agents|mesh-ancestor
101999649|NCT02343224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101999650|NCT02343224|Immunologic Factors|immunologic factors|mesh-ancestor
101999651|NCT02343224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999652|NCT01257035|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
101999653|NCT01257035|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101999654|NCT01257035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999655|NCT04314037|Praziquantel|praziquantel|mesh-list
101999656|NCT04314037|Anthelmintics|anthelmintics|mesh-ancestor
101999657|NCT04314037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101999658|NCT04314037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101999659|NCT05737862|Folic Acid|folic acid|mesh-list
101999660|NCT05737862|Hematinics|hematinics|mesh-ancestor
101999661|NCT05737862|Vitamin B Complex|vitamin b complex|mesh-ancestor
101999662|NCT05737862|Vitamins|vitamins|mesh-ancestor
101999663|NCT05737862|Micronutrients|micronutrients|mesh-ancestor
101999664|NCT05737862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999665|NCT02097680|Letrozole|letrozole|mesh-list
101999666|NCT02097680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101999667|NCT02097680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101999668|NCT02097680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101999669|NCT02097680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101999670|NCT02097680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999671|NCT02097680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101999672|NCT02097680|Hormone Antagonists|hormone antagonists|mesh-ancestor
101999673|NCT02097680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101948416|NCT02819440|Vasodilator Agents|vasodilator agents|mesh-ancestor
101948417|NCT02819440|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101948418|NCT02819440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101948419|NCT02819440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101826093|NCT00877175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101999674|NCT02097680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999675|NCT01150955|Resveratrol|resveratrol|mesh-list
101999676|NCT01150955|Antioxidants|antioxidants|mesh-ancestor
101999677|NCT01150955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999678|NCT01150955|Protective Agents|protective agents|mesh-ancestor
101999679|NCT01150955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999680|NCT01150955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101999681|NCT01150955|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101999682|NCT03897413|Antacids|antacids|mesh-list
101999683|NCT03897413|Calcium Carbonate|calcium carbonate|mesh-list
101999684|NCT03897413|Calcium|calcium|mesh-list
101999685|NCT03897413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101999686|NCT03897413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999687|NCT03897413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999694|NCT01258439|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101999696|NCT01258439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101999697|NCT01258439|Protease Inhibitors|protease inhibitors|mesh-ancestor
101999698|NCT01258439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101999699|NCT01258439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999700|NCT01258439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101999701|NCT01258439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101999702|NCT01258439|Antiviral Agents|antiviral agents|mesh-ancestor
101999703|NCT01258439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101999704|NCT01258439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101999705|NCT01258439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101999706|NCT01258439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101999707|NCT01258439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101999708|NCT01258439|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101999709|NCT01258439|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101999710|NCT01850888|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
101999711|NCT01850888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101999712|NCT01850888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101999713|NCT01850888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101999714|NCT01850888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999715|NCT01850888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101999716|NCT01560572|Mycophenolic Acid|mycophenolic acid|mesh-list
101999717|NCT01560572|Prednisolone|prednisolone|mesh-list
101999719|NCT01560572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101999720|NCT01560572|Immunologic Factors|immunologic factors|mesh-ancestor
101999721|NCT01560572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999722|NCT01560572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101999723|NCT01560572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101999724|NCT01560572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999725|NCT01560572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101999726|NCT01560572|Glucocorticoids|glucocorticoids|mesh-ancestor
101999727|NCT01560572|Hormones|hormones|mesh-ancestor
101999728|NCT01560572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101999729|NCT01560572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101999730|NCT01560572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101999731|NCT01560572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101999732|NCT01560572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101999733|NCT01560572|Antitubercular Agents|antitubercular agents|mesh-ancestor
101999734|NCT01560572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101999735|NCT01560572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101999736|NCT05209256|Pemetrexed|pemetrexed|mesh-list
101999737|NCT05209256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101999738|NCT05209256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101999739|NCT05209256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999740|NCT05209256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101999741|NCT05209256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101999742|NCT03896321|Anticoagulants|anticoagulants|mesh-list
101999743|NCT03896321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
101948420|NCT02819440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948421|NCT02819440|Urological Agents|urological agents|mesh-ancestor
101948422|NCT03562468|Niacinamide|niacinamide|mesh-list
101948423|NCT03562468|Niacin|niacin|mesh-list
101999744|NCT05211050|Cromakalim|cromakalim|mesh-list
101999745|NCT05211050|Sumatriptan|sumatriptan|mesh-list
101999746|NCT05211050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101999747|NCT05211050|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101999748|NCT05211050|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101999749|NCT05211050|Serotonin Agents|serotonin agents|mesh-ancestor
101999750|NCT05211050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101999751|NCT05211050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999752|NCT05211050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999753|NCT05211050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101999754|NCT05211050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101999755|NCT05211050|Autonomic Agents|autonomic agents|mesh-ancestor
101454766|NCT04566796|Neostigmine|neostigmine|mesh-list
101999762|NCT03892499|Antifungal Agents|antifungal agents|mesh-ancestor
101999763|NCT03892499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101999764|NCT03892499|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101999765|NCT03892499|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101999766|NCT03892499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101999767|NCT03892499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999768|NCT03892499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101999769|NCT03892499|Hormone Antagonists|hormone antagonists|mesh-ancestor
101719551|NCT00832650|Fesoterodine|fesoterodine|mesh-list
101999770|NCT03892499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101999771|NCT03892499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999772|NCT03892499|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101999773|NCT01152047|Oxytocin|oxytocin|mesh-list
101999774|NCT01152047|Oxytocics|oxytocics|mesh-ancestor
101999775|NCT01152047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101999776|NCT01152047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999777|NCT01151267|Anesthetics|anesthetics|mesh-list
101999778|NCT01151267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101999779|NCT01151267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999780|NCT01259141|Azithromycin|azithromycin|mesh-list
101999781|NCT01259141|Moxifloxacin|moxifloxacin|mesh-list
101999782|NCT01259141|Cephalosporins|cephalosporins|mesh-list
101999783|NCT01259141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101999784|NCT01259141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101999785|NCT01259141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101999786|NCT01259141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101999787|NCT01259141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101999788|NCT01259141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999789|NCT01259141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101999790|NCT05210192|Lidocaine|lidocaine|mesh-list
101999791|NCT05210192|Anesthetics, Local|anesthetics, local|mesh-ancestor
101999792|NCT05210192|Anesthetics|anesthetics|mesh-ancestor
101999793|NCT05210192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101999794|NCT05210192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257269|NCT01715363|Vitamins|vitamins|mesh-ancestor
101999795|NCT05210192|Sensory System Agents|sensory system agents|mesh-ancestor
101999796|NCT05210192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101999797|NCT05210192|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101999798|NCT05210192|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101999799|NCT05210192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101999800|NCT05210192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101999801|NCT05210192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999802|NCT01152203|Bevacizumab|bevacizumab|mesh-list
101999803|NCT01152203|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101999804|NCT01152203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101999805|NCT01152203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101999806|NCT01152203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101999807|NCT01152203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101999808|NCT01152203|Growth Substances|growth substances|mesh-ancestor
101999809|NCT01152203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999810|NCT01152203|Growth Inhibitors|growth inhibitors|mesh-ancestor
101999811|NCT01152203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101999812|NCT01152203|Alkylating Agents|alkylating agents|mesh-ancestor
101948424|NCT03562468|Nicotinic Acids|nicotinic acids|mesh-list
101948425|NCT03562468|Vitamin B Complex|vitamin b complex|mesh-ancestor
101948427|NCT03562468|Micronutrients|micronutrients|mesh-ancestor
101948428|NCT03562468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948429|NCT03562468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101948430|NCT03562468|Antimetabolites|antimetabolites|mesh-ancestor
101948431|NCT03562468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948432|NCT03562468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101948433|NCT03562468|Vasodilator Agents|vasodilator agents|mesh-ancestor
101948434|NCT02036164|Paclitaxel|paclitaxel|mesh-list
101948435|NCT02036164|Cisplatin|cisplatin|mesh-list
101948436|NCT02036164|Carboplatin|carboplatin|mesh-list
101948437|NCT02036164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101948438|NCT02036164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101948439|NCT02036164|Tubulin Modulators|tubulin modulators|mesh-ancestor
101948440|NCT02036164|Antimitotic Agents|antimitotic agents|mesh-ancestor
101948441|NCT02036164|Mitosis Modulators|mitosis modulators|mesh-ancestor
101826231|NCT04040465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101999813|NCT01152203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999814|NCT01257815|Ranibizumab|ranibizumab|mesh-list
101999815|NCT01257815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101999816|NCT01257815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101999817|NCT01257815|Growth Substances|growth substances|mesh-ancestor
101999818|NCT01257815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999819|NCT01257815|Growth Inhibitors|growth inhibitors|mesh-ancestor
101999820|NCT01257815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101999821|NCT03892421|Cytarabine|cytarabine|mesh-list
101999825|NCT03892421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101999826|NCT03892421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101999827|NCT03892421|Immunologic Factors|immunologic factors|mesh-ancestor
101999828|NCT03892421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999829|NCT03892421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101999830|NCT03892421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101999831|NCT03892421|Antiemetics|antiemetics|mesh-ancestor
101999832|NCT03892421|Autonomic Agents|autonomic agents|mesh-ancestor
101999833|NCT03892421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101999834|NCT03892421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101999835|NCT03892421|Glucocorticoids|glucocorticoids|mesh-ancestor
101999836|NCT03892421|Hormones|hormones|mesh-ancestor
101999837|NCT03892421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101999838|NCT03892421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101999839|NCT03892421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101999840|NCT03892421|Antimetabolites|antimetabolites|mesh-ancestor
101999841|NCT03892421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999842|NCT03892421|Antiviral Agents|antiviral agents|mesh-ancestor
101999843|NCT03892421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101999844|NCT03892421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101999845|NCT05546567|Niacinamide|niacinamide|mesh-list
101999846|NCT05546567|Niacin|niacin|mesh-list
101999847|NCT05546567|Nicotinic Acids|nicotinic acids|mesh-list
101999848|NCT05546567|Vitamin B Complex|vitamin b complex|mesh-ancestor
101999849|NCT05546567|Vitamins|vitamins|mesh-ancestor
101999850|NCT05546567|Micronutrients|micronutrients|mesh-ancestor
101999851|NCT05546567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999852|NCT05546567|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101999853|NCT05546567|Antimetabolites|antimetabolites|mesh-ancestor
101999854|NCT05546567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999855|NCT05546567|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101948442|NCT02036164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948444|NCT02818036|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101948445|NCT02818036|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101999856|NCT05546567|Vasodilator Agents|vasodilator agents|mesh-ancestor
101999857|NCT03895229|Empagliflozin|empagliflozin|mesh-list
101999858|NCT03895229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101999859|NCT03895229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999860|NCT03895229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101999861|NCT03895229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999862|NCT01257893|Aspirin|aspirin|mesh-list
101999863|NCT01257893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101999864|NCT01257893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101999865|NCT01257893|Analgesics|analgesics|mesh-ancestor
101999866|NCT01257893|Sensory System Agents|sensory system agents|mesh-ancestor
101999867|NCT01257893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101999868|NCT01257893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999869|NCT01257893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101999870|NCT01257893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101999871|NCT01257893|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101999872|NCT01257893|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101999873|NCT01257893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999874|NCT01257893|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101999875|NCT01257893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101999876|NCT01257893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101999877|NCT01257893|Antipyretics|antipyretics|mesh-ancestor
101999878|NCT01152593|Mupirocin|mupirocin|mesh-list
101999879|NCT01152593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101999880|NCT01152593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101999881|NCT01152593|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101999882|NCT01152593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101999883|NCT01152593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999884|NCT01259219|Rifabutin|rifabutin|mesh-list
101999885|NCT01259219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101999886|NCT01259219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101999887|NCT01259219|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101999888|NCT01259219|Antitubercular Agents|antitubercular agents|mesh-ancestor
101999889|NCT03891095|Oxytocin|oxytocin|mesh-list
101999890|NCT03891095|Oxytocics|oxytocics|mesh-ancestor
101999891|NCT03891095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101999892|NCT03891095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999893|NCT05667077|Amantadine|amantadine|mesh-list
101999894|NCT05667077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101999895|NCT05667077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101999899|NCT05667077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101999900|NCT05667077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999901|NCT05667077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999902|NCT05667077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101999903|NCT05667077|Analgesics|analgesics|mesh-ancestor
101999904|NCT05667077|Sensory System Agents|sensory system agents|mesh-ancestor
101999905|NCT05667077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101999906|NCT03894839|Chlorhexidine|chlorhexidine|mesh-list
101999907|NCT03894839|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101999908|NCT03894839|Sodium Hypochlorite|sodium hypochlorite|mesh-list
101999909|NCT03894839|Glutaral|glutaral|mesh-list
101999910|NCT03894839|Eusol|eusol|mesh-list
101999911|NCT03894839|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101999912|NCT03894839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101999913|NCT03894839|Disinfectants|disinfectants|mesh-ancestor
101999914|NCT03894839|Dermatologic Agents|dermatologic agents|mesh-ancestor
101999915|NCT01152749|Nicotine|nicotine|mesh-list
101999916|NCT01152749|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101999917|NCT01152749|Autonomic Agents|autonomic agents|mesh-ancestor
101257407|NCT01716416|Cetuximab|cetuximab|mesh-list
101999918|NCT01152749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101999919|NCT01152749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999920|NCT01152749|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101999922|NCT01152749|Cholinergic Agents|cholinergic agents|mesh-ancestor
101999923|NCT01152749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101999924|NCT01152749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999925|NCT03894683|Melatonin|melatonin|mesh-list
101999926|NCT03894683|Antioxidants|antioxidants|mesh-ancestor
101999927|NCT03894683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948446|NCT02818036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948447|NCT02818036|Sensory System Agents|sensory system agents|mesh-ancestor
101948448|NCT02818036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101948449|NCT01287741|Prednisone|prednisone|mesh-list
101948450|NCT01287741|Cyclophosphamide|cyclophosphamide|mesh-list
101948451|NCT01287741|Rituximab|rituximab|mesh-list
101948452|NCT01287741|Doxorubicin|doxorubicin|mesh-list
101948453|NCT01287741|Vincristine|vincristine|mesh-list
101999928|NCT03894683|Protective Agents|protective agents|mesh-ancestor
101999929|NCT03894683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999930|NCT03894683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101999931|NCT01259531|Silodosin|silodosin|mesh-list
101999932|NCT01259531|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101999933|NCT01259531|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101999934|NCT01259531|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101999935|NCT01259531|Adrenergic Agents|adrenergic agents|mesh-ancestor
101999936|NCT01259531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101999937|NCT01259531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999938|NCT01259531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999939|NCT01259531|Urological Agents|urological agents|mesh-ancestor
101999940|NCT01151735|Complement C1s|complement c1s|mesh-list
101999941|NCT01151735|Immunologic Factors|immunologic factors|mesh-ancestor
101999942|NCT01151735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999943|NCT03061214|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101999944|NCT03061214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101999945|NCT03061214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999946|NCT03061214|Incretins|incretins|mesh-ancestor
101999947|NCT03061214|Hormones|hormones|mesh-ancestor
101999948|NCT03061214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101999949|NCT03061214|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101999950|NCT03061214|Protease Inhibitors|protease inhibitors|mesh-ancestor
101999951|NCT03061214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101999952|NCT03061214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999953|NCT01152827|Everolimus|everolimus|mesh-list
101999954|NCT01152827|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101999955|NCT01152827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101999956|NCT01152827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101999957|NCT01152827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999958|NCT01152827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101999959|NCT01152827|Immunologic Factors|immunologic factors|mesh-ancestor
101999960|NCT01152827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999961|NCT01152827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101999962|NCT01153373|Ethanol|ethanol|mesh-list
101999963|NCT01153373|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101999964|NCT01153373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101999965|NCT01153373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101999966|NCT01153373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999967|NCT03889145|Amlodipine|amlodipine|mesh-list
101999968|NCT03889145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101999972|NCT03889145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101999973|NCT03889145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999974|NCT03889145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101999975|NCT03889145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999976|NCT03889145|Vasodilator Agents|vasodilator agents|mesh-ancestor
101999977|NCT03889145|Diuretics|diuretics|mesh-ancestor
101999978|NCT03889145|Natriuretic Agents|natriuretic agents|mesh-ancestor
101999979|NCT03889145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101999980|NCT03889145|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101999981|NCT03889145|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101999982|NCT03888677|Cyclophosphamide|cyclophosphamide|mesh-list
101999983|NCT03888677|Epirubicin|epirubicin|mesh-list
101999984|NCT03888677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101999985|NCT03888677|Immunologic Factors|immunologic factors|mesh-ancestor
101999986|NCT03888677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999987|NCT03888677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101999988|NCT03888677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101999989|NCT03888677|Alkylating Agents|alkylating agents|mesh-ancestor
101948455|NCT01287741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101948456|NCT01287741|Immunologic Factors|immunologic factors|mesh-ancestor
101948457|NCT01287741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948458|NCT01287741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101948459|NCT01287741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101999990|NCT03888677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999991|NCT03888677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101719772|NCT00676871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101999993|NCT03888677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101999994|NCT03888677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101999995|NCT03888677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101999996|NCT03888677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101999997|NCT04655690|Insulin Aspart|insulin aspart|mesh-list
101999998|NCT04655690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101999999|NCT04655690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000000|NCT01260233|Nicotine|nicotine|mesh-list
102000001|NCT01260233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102000002|NCT01260233|Autonomic Agents|autonomic agents|mesh-ancestor
102000003|NCT01260233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102000004|NCT01260233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000005|NCT01260233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102000006|NCT01260233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102000007|NCT01260233|Cholinergic Agents|cholinergic agents|mesh-ancestor
102000008|NCT01260233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102000009|NCT01260233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000010|NCT04435964|Immunomodulating Agents|immunomodulating agents|mesh-list
102000011|NCT04435964|Immunologic Factors|immunologic factors|mesh-ancestor
102000012|NCT04435964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000013|NCT01153919|Interferons|interferons|mesh-list
102000014|NCT01153919|Ribavirin|ribavirin|mesh-list
102000015|NCT01153919|Interferon-alpha|interferon-alpha|mesh-list
102000016|NCT01153919|Interferon alpha-2|interferon alpha-2|mesh-list
102000017|NCT01153919|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102000018|NCT01153919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000019|NCT01153919|Antiviral Agents|antiviral agents|mesh-ancestor
102000020|NCT01153919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102000021|NCT01153919|Antimetabolites|antimetabolites|mesh-ancestor
102000022|NCT01153919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000023|NCT01153919|Immunologic Factors|immunologic factors|mesh-ancestor
102000024|NCT01153919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000025|NCT03912389|Carboplatin|carboplatin|mesh-list
102000026|NCT03912389|Pemetrexed|pemetrexed|mesh-list
102000027|NCT03912389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000028|NCT03912389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102000029|NCT03912389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000030|NCT03912389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102000031|NCT03912389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102000032|NCT01147757|Remifentanil|remifentanil|mesh-list
102000033|NCT01147757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102000034|NCT01147757|Narcotics|narcotics|mesh-ancestor
102000035|NCT01147757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102000036|NCT01147757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000037|NCT01147757|Analgesics|analgesics|mesh-ancestor
102000038|NCT01147757|Sensory System Agents|sensory system agents|mesh-ancestor
102000039|NCT01147757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102000040|NCT01251809|Pegaspargase|pegaspargase|mesh-list
102000047|NCT01154387|Immunologic Factors|immunologic factors|mesh-ancestor
102000048|NCT01154387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000049|NCT01154387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102000050|NCT01154387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102000051|NCT01154387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000052|NCT01154387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102000053|NCT01154387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000054|NCT01154387|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102000055|NCT01154387|Antitubercular Agents|antitubercular agents|mesh-ancestor
102000056|NCT01154387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102000057|NCT01154387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102000058|NCT01154465|Povidone-Iodine|povidone-iodine|mesh-list
101948461|NCT01287741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948462|NCT01287741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000059|NCT01154465|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102000060|NCT01154465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102000061|NCT01260623|Prednisone|prednisone|mesh-list
102000062|NCT01260623|Prednisolone|prednisolone|mesh-list
102000063|NCT01260623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102000064|NCT01260623|Glucocorticoids|glucocorticoids|mesh-ancestor
102000065|NCT01260623|Hormones|hormones|mesh-ancestor
102000066|NCT01260623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102000067|NCT01260623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000068|NCT01260623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102000069|NCT01260623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000070|NCT01252121|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102000071|NCT01252121|Lubricant Eye Drops|lubricant eye drops|mesh-list
102000072|NCT01252121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102000073|NCT01260857|Hydroflumethiazide|hydroflumethiazide|mesh-list
102000074|NCT01260857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102000075|NCT01260857|Diuretics|diuretics|mesh-ancestor
102000076|NCT01260857|Natriuretic Agents|natriuretic agents|mesh-ancestor
102000077|NCT01260857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000078|NCT01260857|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102000079|NCT01260857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102000080|NCT01260857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000081|NCT03890003|Insulin Lispro|insulin lispro|mesh-list
102000082|NCT03890003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102000083|NCT03890003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000084|NCT01153217|Tenofovir|tenofovir|mesh-list
102000085|NCT01153217|Abacavir|abacavir|mesh-list
102000086|NCT01153217|Antiviral Agents|antiviral agents|mesh-ancestor
102000087|NCT01153217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102000088|NCT01153217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102000089|NCT01153217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102000090|NCT01153217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102000091|NCT01153217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000092|NCT01153217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102000093|NCT01153217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102000094|NCT01261169|Mycophenolic Acid|mycophenolic acid|mesh-list
102000095|NCT01261169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102000096|NCT01261169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000097|NCT01261169|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102000098|NCT01261169|Antitubercular Agents|antitubercular agents|mesh-ancestor
102000099|NCT01261169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102000100|NCT01261169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102000101|NCT01261169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102000102|NCT01261169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000103|NCT03889379|Albuterol|albuterol|mesh-list
102000104|NCT03889379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102000105|NCT03889379|Autonomic Agents|autonomic agents|mesh-ancestor
102000106|NCT03889379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102000107|NCT03889379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000108|NCT03889379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102000109|NCT03889379|Respiratory System Agents|respiratory system agents|mesh-ancestor
102000110|NCT03889379|Tocolytic Agents|tocolytic agents|mesh-ancestor
102000125|NCT01586507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102000126|NCT03910361|Pioglitazone|pioglitazone|mesh-list
102000127|NCT03910361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102000128|NCT03910361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000129|NCT03700658|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102000130|NCT03700658|Medroxyprogesterone|medroxyprogesterone|mesh-list
102000131|NCT03700658|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102000132|NCT03700658|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102000133|NCT03700658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102000134|NCT03700658|Contraceptive Agents|contraceptive agents|mesh-ancestor
102000135|NCT03700658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102000136|NCT03700658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000137|NCT03700658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102000138|NCT03700658|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102000139|NCT03700658|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101948463|NCT01287741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101948464|NCT01287741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102000140|NCT03700658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102000141|NCT03700658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000142|NCT03885947|Fludarabine|fludarabine|mesh-list
102000143|NCT03885947|Cyclophosphamide|cyclophosphamide|mesh-list
102000145|NCT03885947|Valproic Acid|valproic acid|mesh-list
102000146|NCT03885947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000147|NCT03885947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000148|NCT03885947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102000149|NCT03885947|Immunologic Factors|immunologic factors|mesh-ancestor
102000150|NCT03885947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000151|NCT03885947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102000152|NCT03885947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102000153|NCT03885947|Alkylating Agents|alkylating agents|mesh-ancestor
102000154|NCT03885947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102000155|NCT03885947|Anticonvulsants|anticonvulsants|mesh-ancestor
102000156|NCT03885947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102000157|NCT03885947|GABA Agents|gaba agents|mesh-ancestor
102000158|NCT03885947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102000159|NCT03885947|Antimanic Agents|antimanic agents|mesh-ancestor
102000160|NCT03885947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102000161|NCT03885947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102000162|NCT03885947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102000163|NCT01261481|Tolvaptan|tolvaptan|mesh-list
102000164|NCT01261481|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102000165|NCT01261481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000166|NCT01261481|Natriuretic Agents|natriuretic agents|mesh-ancestor
102000167|NCT01261481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000168|NCT01261637|Ropivacaine|ropivacaine|mesh-list
102000169|NCT01261637|Anesthetics, Local|anesthetics, local|mesh-ancestor
102000170|NCT01261637|Anesthetics|anesthetics|mesh-ancestor
102000184|NCT01154933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102000186|NCT01155635|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102000187|NCT01155635|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102000188|NCT01155635|Adrenergic Agents|adrenergic agents|mesh-ancestor
102000189|NCT01155635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102000190|NCT01155635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000191|NCT01155635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000192|NCT01155635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102000193|NCT01155635|Antioxidants|antioxidants|mesh-ancestor
102000194|NCT01155635|Protective Agents|protective agents|mesh-ancestor
102000195|NCT01155635|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102000196|NCT01155635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102000197|NCT01155635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102000198|NCT01155635|Vasodilator Agents|vasodilator agents|mesh-ancestor
102000199|NCT01155635|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102000200|NCT01155635|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102000201|NCT01155089|Anastrozole|anastrozole|mesh-list
102000202|NCT01155089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102000203|NCT01155089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000204|NCT01155089|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102000205|NCT01155089|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102000206|NCT01155089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102000207|NCT01155089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000208|NCT01155089|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102000209|NCT01155089|Hormone Antagonists|hormone antagonists|mesh-ancestor
102000210|NCT01155089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102000211|NCT01155089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000212|NCT01155245|Teriparatide|teriparatide|mesh-list
102000213|NCT01155245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102000214|NCT01155245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000215|NCT01155245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102000216|NCT01262417|Hyaluronic Acid|hyaluronic acid|mesh-list
102000217|NCT01262417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102000218|NCT01262417|Immunologic Factors|immunologic factors|mesh-ancestor
102000219|NCT01262417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000220|NCT01262417|Viscosupplements|viscosupplements|mesh-ancestor
102000221|NCT01262417|Protective Agents|protective agents|mesh-ancestor
101948465|NCT01287741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101948466|NCT01287741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101948467|NCT01287741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101948468|NCT01287741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101948469|NCT01287741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101948470|NCT01287741|Glucocorticoids|glucocorticoids|mesh-ancestor
101948472|NCT01287741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101948473|NCT01287741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101948474|NCT01287741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101948475|NCT01287741|Tubulin Modulators|tubulin modulators|mesh-ancestor
101948476|NCT01287741|Antimitotic Agents|antimitotic agents|mesh-ancestor
101948477|NCT01287741|Mitosis Modulators|mitosis modulators|mesh-ancestor
101948478|NCT01180959|Bevacizumab|bevacizumab|mesh-list
101948479|NCT01180959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101948480|NCT01180959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101948481|NCT01180959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101948482|NCT01180959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101948483|NCT01180959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101948484|NCT01180959|Growth Substances|growth substances|mesh-ancestor
101948485|NCT01180959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000222|NCT01155791|Prednisone|prednisone|mesh-list
102000223|NCT01155791|Docetaxel|docetaxel|mesh-list
102000224|NCT01155791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000225|NCT01155791|Tubulin Modulators|tubulin modulators|mesh-ancestor
102000226|NCT01155791|Antimitotic Agents|antimitotic agents|mesh-ancestor
102000227|NCT01155791|Mitosis Modulators|mitosis modulators|mesh-ancestor
102000228|NCT01155791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000229|NCT01155791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102000230|NCT01155791|Glucocorticoids|glucocorticoids|mesh-ancestor
102000237|NCT01157507|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102000238|NCT01157507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102000239|NCT01157507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000240|NCT01157507|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102000241|NCT01157507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102000242|NCT01157507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000243|NCT01157507|Cholinergic Agents|cholinergic agents|mesh-ancestor
102000244|NCT01157507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102000246|NCT03881423|Rocuronium|rocuronium|mesh-list
102000247|NCT03881423|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
102000248|NCT03881423|Anticonvulsants|anticonvulsants|mesh-ancestor
102000249|NCT03881423|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102000250|NCT03881423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102000251|NCT03881423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102000252|NCT03881423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000253|NCT03884465|Treprostinil|treprostinil|mesh-list
102000254|NCT03884465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102000255|NCT01155947|Anastrozole|anastrozole|mesh-list
102000256|NCT01155947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102000257|NCT01155947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000258|NCT01155947|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102000259|NCT01155947|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102000260|NCT01155947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102000261|NCT01155947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948486|NCT01180959|Growth Inhibitors|growth inhibitors|mesh-ancestor
101948487|NCT01180959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101948488|NCT01180959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102000262|NCT01155947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102000263|NCT01155947|Hormone Antagonists|hormone antagonists|mesh-ancestor
102000264|NCT01155947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102000265|NCT01155947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000266|NCT01157585|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102000267|NCT01157585|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102000268|NCT01157585|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102000269|NCT01157585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102000270|NCT01157585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000271|NCT01157585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102000272|NCT01157585|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102000273|NCT01157585|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102000274|NCT01157585|Serotonin Agents|serotonin agents|mesh-ancestor
102000275|NCT01157585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102000276|NCT01157585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000277|NCT01157585|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102000278|NCT01157585|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102000279|NCT01157585|Dopamine Agents|dopamine agents|mesh-ancestor
102000280|NCT01264133|Adefovir|adefovir|mesh-list
102000281|NCT01264133|Clevudine|clevudine|mesh-list
102000282|NCT01264133|Antiviral Agents|antiviral agents|mesh-ancestor
102000283|NCT01264133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102000284|NCT01264133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101305330|NCT02018965|Micronutrients|micronutrients|mesh-ancestor
102000285|NCT01264133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102000286|NCT01264133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102000287|NCT01264133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000288|NCT02527577|Ropivacaine|ropivacaine|mesh-list
101720073|NCT02627573|Mycophenolic Acid|mycophenolic acid|mesh-list
102000290|NCT02527577|Anesthetics|anesthetics|mesh-ancestor
102000291|NCT02527577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102000292|NCT02527577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000293|NCT02527577|Sensory System Agents|sensory system agents|mesh-ancestor
102000294|NCT02527577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102000295|NCT03883841|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102000296|NCT03883841|Hematinics|hematinics|mesh-ancestor
102000299|NCT03881111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102000300|NCT03881111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102000301|NCT03881111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000302|NCT01264211|Diacerein|diacerein|mesh-list
102000303|NCT01264211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102000304|NCT03880877|Leucovorin|leucovorin|mesh-list
102000305|NCT03880877|Antidotes|antidotes|mesh-ancestor
102000306|NCT03880877|Protective Agents|protective agents|mesh-ancestor
102000307|NCT03880877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000308|NCT03880877|Vitamin B Complex|vitamin b complex|mesh-ancestor
102000309|NCT03880877|Vitamins|vitamins|mesh-ancestor
102000310|NCT03880877|Micronutrients|micronutrients|mesh-ancestor
102000311|NCT05666999|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102000312|NCT05666999|Laxatives|laxatives|mesh-ancestor
102000313|NCT05666999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102000314|NCT01262729|Xenon|xenon|mesh-list
102000315|NCT01262729|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102000316|NCT01262729|Anesthetics, General|anesthetics, general|mesh-ancestor
102000317|NCT01262729|Anesthetics|anesthetics|mesh-ancestor
102000318|NCT01262729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102000319|NCT01262729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000320|NCT01264289|Finasteride|finasteride|mesh-list
102000321|NCT01264289|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102000322|NCT01264289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102000323|NCT01264289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102000324|NCT01264289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000325|NCT01264289|Hormone Antagonists|hormone antagonists|mesh-ancestor
102000326|NCT01264289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102000327|NCT01264289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000328|NCT01264289|Urological Agents|urological agents|mesh-ancestor
102000329|NCT03880487|Oxycodone|oxycodone|mesh-list
102000330|NCT03880487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102000331|NCT03880487|Narcotics|narcotics|mesh-ancestor
102000332|NCT03880487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101948489|NCT01180959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948490|NCT01177371|Cyclosporine|cyclosporine|mesh-list
101826778|NCT05883345|Antibodies|antibodies|mesh-list
102000333|NCT03880487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000334|NCT03880487|Analgesics|analgesics|mesh-ancestor
102000335|NCT03880487|Sensory System Agents|sensory system agents|mesh-ancestor
102000336|NCT03880487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102000337|NCT03880409|Lidocaine|lidocaine|mesh-list
102000338|NCT03880409|Epinephrine|epinephrine|mesh-list
102000339|NCT03880409|Racepinephrine|racepinephrine|mesh-list
102000340|NCT03880409|Carticaine|carticaine|mesh-list
102000341|NCT03880409|Epinephryl borate|epinephryl borate|mesh-list
102000342|NCT03880409|Anesthetics, Local|anesthetics, local|mesh-ancestor
102000343|NCT03880409|Anesthetics|anesthetics|mesh-ancestor
102000344|NCT03880409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102000345|NCT03880409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000346|NCT03880409|Sensory System Agents|sensory system agents|mesh-ancestor
102000347|NCT03880409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102000348|NCT03880409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102000349|NCT03880409|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102000350|NCT03880409|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102000351|NCT03880409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102000352|NCT03880409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000353|NCT03880409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102000354|NCT03880409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102000355|NCT03880409|Adrenergic Agents|adrenergic agents|mesh-ancestor
102000356|NCT03880409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102000357|NCT03880409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102000358|NCT03880409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102000359|NCT03880409|Autonomic Agents|autonomic agents|mesh-ancestor
102000360|NCT03880409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102000361|NCT03880409|Respiratory System Agents|respiratory system agents|mesh-ancestor
102000362|NCT03880409|Mydriatics|mydriatics|mesh-ancestor
102000363|NCT03880409|Sympathomimetics|sympathomimetics|mesh-ancestor
101720149|NCT00808665|Analgesics|analgesics|mesh-ancestor
102000364|NCT03880409|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102000365|NCT01157819|Ciprofloxacin|ciprofloxacin|mesh-list
102000366|NCT01157819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102000367|NCT01157819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102000368|NCT01157819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102000369|NCT01157819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102000370|NCT01157819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102000374|NCT01157819|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102000376|NCT01264367|Clevudine|clevudine|mesh-list
102000377|NCT01264367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000378|NCT01264367|Antiviral Agents|antiviral agents|mesh-ancestor
102000379|NCT01264367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102000380|NCT05097716|Tolbutamide|tolbutamide|mesh-list
102000381|NCT05097716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102000382|NCT05097716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000383|NCT01262963|Dabrafenib|dabrafenib|mesh-list
102000384|NCT01262963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000385|NCT01262963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102000386|NCT01262963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102000387|NCT01262963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000388|NCT01264445|Vaccines|vaccines|mesh-list
102000389|NCT01264445|Immunologic Factors|immunologic factors|mesh-ancestor
102000390|NCT01264445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000391|NCT01157975|Pioglitazone|pioglitazone|mesh-list
102000392|NCT01157975|Prednisone|prednisone|mesh-list
102000393|NCT01157975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102000394|NCT01157975|Glucocorticoids|glucocorticoids|mesh-ancestor
102000395|NCT01157975|Hormones|hormones|mesh-ancestor
102000396|NCT01157975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102000397|NCT01157975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000398|NCT01157975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102000399|NCT01157975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000400|NCT01157975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102000401|NCT03060512|Naloxegol|naloxegol|mesh-list
102000402|NCT03060512|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
102000403|NCT03060512|Laxatives|laxatives|mesh-ancestor
102000404|NCT03060512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102000405|NCT03060512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102000406|NCT03060512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948491|NCT01177371|Methylprednisolone|methylprednisolone|mesh-list
101948492|NCT01177371|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102000407|NCT03060512|Sensory System Agents|sensory system agents|mesh-ancestor
102000408|NCT03060512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102000409|NCT01263353|Everolimus|everolimus|mesh-list
102000410|NCT01263353|Pasireotide|pasireotide|mesh-list
102000411|NCT01263353|Somatostatin|somatostatin|mesh-list
102000412|NCT01263353|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102000413|NCT01263353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102000414|NCT01263353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102000415|NCT01263353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000416|NCT01263353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102000417|NCT01263353|Immunologic Factors|immunologic factors|mesh-ancestor
102000418|NCT01263353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000419|NCT01263353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000420|NCT01263353|Hormones|hormones|mesh-ancestor
102000421|NCT01263353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102000422|NCT01158287|Sorafenib|sorafenib|mesh-list
102000423|NCT01158287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101257939|NCT01719588|Tapentadol|tapentadol|mesh-list
102000424|NCT01158287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102000425|NCT01158287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102000426|NCT01158287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000427|NCT01158365|Glycerol|glycerol|mesh-list
102000428|NCT01158365|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102000429|NCT01158365|Protective Agents|protective agents|mesh-ancestor
102000430|NCT01158365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000431|NCT01156649|Acetaminophen|acetaminophen|mesh-list
102000432|NCT01156649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102000433|NCT01156649|Analgesics|analgesics|mesh-ancestor
102000434|NCT01156649|Sensory System Agents|sensory system agents|mesh-ancestor
102000435|NCT01156649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102000436|NCT01156649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000437|NCT01156649|Antipyretics|antipyretics|mesh-ancestor
102000438|NCT01158755|Moxifloxacin|moxifloxacin|mesh-list
102000439|NCT01158755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102000440|NCT01158755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102000441|NCT01158755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102000442|NCT01158755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102000446|NCT03879707|Melatonin|melatonin|mesh-list
102000447|NCT03879707|Antioxidants|antioxidants|mesh-ancestor
102000448|NCT03879707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000449|NCT03879707|Protective Agents|protective agents|mesh-ancestor
102000450|NCT03879707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000451|NCT03879707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102000452|NCT01265147|Nedaplatin|nedaplatin|mesh-list
102000453|NCT01265147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000454|NCT01159145|Omeprazole|omeprazole|mesh-list
102000455|NCT01159145|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102000456|NCT01159145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102000457|NCT01159145|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102000458|NCT01159145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102000459|NCT01159145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000460|NCT01156883|Cytarabine|cytarabine|mesh-list
102000461|NCT01156883|Dexamethasone|dexamethasone|mesh-list
102000462|NCT01156883|Prednisone|prednisone|mesh-list
102000463|NCT01156883|Methylprednisolone|methylprednisolone|mesh-list
102000464|NCT01156883|Cyclophosphamide|cyclophosphamide|mesh-list
102000465|NCT01156883|Ifosfamide|ifosfamide|mesh-list
102000466|NCT01156883|Doxorubicin|doxorubicin|mesh-list
102000467|NCT01156883|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102000468|NCT01156883|Methotrexate|methotrexate|mesh-list
102000469|NCT01156883|Vincristine|vincristine|mesh-list
102000470|NCT01156883|Daunorubicin|daunorubicin|mesh-list
102000471|NCT01156883|Asparaginase|asparaginase|mesh-list
102000472|NCT01156883|Mercaptopurine|mercaptopurine|mesh-list
102000473|NCT01156883|Thioguanine|thioguanine|mesh-list
102000474|NCT01156883|Vindesine|vindesine|mesh-list
102000475|NCT01156883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102000476|NCT01156883|Immunologic Factors|immunologic factors|mesh-ancestor
102000477|NCT01156883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000478|NCT01156883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102000479|NCT01156883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102000480|NCT01156883|Alkylating Agents|alkylating agents|mesh-ancestor
102000481|NCT01156883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000482|NCT01156883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000483|NCT01156883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102000484|NCT01156883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101948493|NCT01177371|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101948494|NCT01177371|Prednisolone|prednisolone|mesh-list
101948495|NCT01177371|Prednisolone acetate|prednisolone acetate|mesh-list
101948496|NCT01177371|Cyclophosphamide|cyclophosphamide|mesh-list
101948497|NCT01177371|Busulfan|busulfan|mesh-list
101948498|NCT01177371|Methotrexate|methotrexate|mesh-list
101948499|NCT01177371|Cyclosporins|cyclosporins|mesh-list
101948500|NCT01177371|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101948501|NCT01177371|Prednisolone phosphate|prednisolone phosphate|mesh-list
101948502|NCT01177371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101948503|NCT01177371|Immunologic Factors|immunologic factors|mesh-ancestor
101948504|NCT01177371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948505|NCT01177371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101948506|NCT01177371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101948507|NCT01177371|Alkylating Agents|alkylating agents|mesh-ancestor
101948508|NCT01177371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948509|NCT01177371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101948510|NCT01177371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101948511|NCT01177371|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101948512|NCT01177371|Abortifacient Agents|abortifacient agents|mesh-ancestor
101948513|NCT01177371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101826922|NCT05881187|Riboflavin|riboflavin|mesh-list
102000485|NCT01156883|Antiemetics|antiemetics|mesh-ancestor
102000486|NCT01156883|Autonomic Agents|autonomic agents|mesh-ancestor
102000487|NCT01156883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102000488|NCT01156883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102000489|NCT01156883|Glucocorticoids|glucocorticoids|mesh-ancestor
102000490|NCT01156883|Hormones|hormones|mesh-ancestor
102000491|NCT01156883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102000492|NCT01156883|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102000493|NCT01156883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102000494|NCT01156883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102000495|NCT01156883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102000496|NCT01156883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102000497|NCT01156883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102000498|NCT01156883|Abortifacient Agents|abortifacient agents|mesh-ancestor
102000499|NCT01156883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102000500|NCT01156883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102000501|NCT01156883|Antimetabolites|antimetabolites|mesh-ancestor
102000502|NCT01156883|Dermatologic Agents|dermatologic agents|mesh-ancestor
102000503|NCT01156883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102000504|NCT01156883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102000505|NCT01156883|Antiviral Agents|antiviral agents|mesh-ancestor
102000506|NCT01156883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102000507|NCT01156883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102000508|NCT01156883|Tubulin Modulators|tubulin modulators|mesh-ancestor
102000509|NCT01156883|Antimitotic Agents|antimitotic agents|mesh-ancestor
102000510|NCT01156883|Mitosis Modulators|mitosis modulators|mesh-ancestor
102000511|NCT01156883|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102000512|NCT01156883|Protective Agents|protective agents|mesh-ancestor
101720300|NCT00753064|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102000513|NCT01156961|Paclitaxel|paclitaxel|mesh-list
102000514|NCT01156961|Bevacizumab|bevacizumab|mesh-list
102000515|NCT01156961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101948514|NCT01177371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101948515|NCT01177371|Antimetabolites|antimetabolites|mesh-ancestor
101948516|NCT01177371|Dermatologic Agents|dermatologic agents|mesh-ancestor
101948517|NCT01177371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102000522|NCT01156961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102000523|NCT01156961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102000524|NCT01156961|Growth Substances|growth substances|mesh-ancestor
102000525|NCT01156961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000526|NCT01156961|Growth Inhibitors|growth inhibitors|mesh-ancestor
102000529|NCT01159301|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
102000530|NCT01159301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000531|NCT01159301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102000532|NCT01159301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102000533|NCT01159301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000534|NCT01159379|Ertapenem|ertapenem|mesh-list
102000535|NCT01159379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102000536|NCT01159379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102000537|NCT01159847|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102000538|NCT01159847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102000539|NCT01159847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000540|NCT01159847|Incretins|incretins|mesh-ancestor
102000541|NCT01159847|Hormones|hormones|mesh-ancestor
102000542|NCT01159847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102000543|NCT01159847|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102000544|NCT01159847|Protease Inhibitors|protease inhibitors|mesh-ancestor
102000545|NCT01159847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102000546|NCT01159847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000547|NCT02539160|Ticagrelor|ticagrelor|mesh-list
102000548|NCT02539160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102000549|NCT02539160|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102000550|NCT02539160|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102000551|NCT02539160|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102000552|NCT02539160|Purinergic Agents|purinergic agents|mesh-ancestor
102000553|NCT02539160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102000554|NCT02539160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000555|NCT02539160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000556|NCT01265927|Trastuzumab|trastuzumab|mesh-list
102000557|NCT01265927|Imetelstat|imetelstat|mesh-list
102000558|NCT01265927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102000559|NCT01265927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000560|NCT01265927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102000561|NCT01265927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000562|NCT01266005|Entecavir|entecavir|mesh-list
102000563|NCT01266005|Clevudine|clevudine|mesh-list
102000564|NCT01266005|Antiviral Agents|antiviral agents|mesh-ancestor
102000565|NCT01266005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102000566|NCT04292899|Remdesivir|remdesivir|mesh-list
102000567|NCT04292899|Antimetabolites|antimetabolites|mesh-ancestor
102000568|NCT04292899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000569|NCT04292899|Antiviral Agents|antiviral agents|mesh-ancestor
102000570|NCT04292899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102000571|NCT03876899|Evening primrose oil|evening primrose oil|mesh-list
102000572|NCT03876899|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102000573|NCT03876899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102000574|NCT03876899|Analgesics|analgesics|mesh-ancestor
102000575|NCT03876899|Sensory System Agents|sensory system agents|mesh-ancestor
102000576|NCT03876899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102000577|NCT03876899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000578|NCT03876899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102000579|NCT03876899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102000580|NCT03876899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102000581|NCT03876899|Antimetabolites|antimetabolites|mesh-ancestor
102000582|NCT03876899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000588|NCT03241173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000589|NCT03241173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102000590|NCT03241173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000591|NCT03264066|Atezolizumab|atezolizumab|mesh-list
102000592|NCT03264066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101948518|NCT01177371|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101948519|NCT01177371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101948520|NCT01177371|Antifungal Agents|antifungal agents|mesh-ancestor
102000593|NCT03264066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102000594|NCT03264066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000595|NCT03264066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102000596|NCT03264066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000597|NCT03264066|Immunologic Factors|immunologic factors|mesh-ancestor
102000598|NCT03264066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000599|NCT03759041|Vancomycin|vancomycin|mesh-list
102000600|NCT03759041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102000601|NCT03759041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102000602|NCT04110145|Linaclotide|linaclotide|mesh-list
102000603|NCT04110145|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102000604|NCT04110145|Enzyme Activators|enzyme activators|mesh-ancestor
102000605|NCT04110145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000606|NCT04110145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102000607|NCT02477618|Brexanolone|brexanolone|mesh-list
102000608|NCT02477618|Neurosteroids|neurosteroids|mesh-ancestor
102000609|NCT02477618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102000610|NCT02477618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000611|NCT02477618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000612|NCT02477618|GABA Modulators|gaba modulators|mesh-ancestor
102000613|NCT02477618|GABA Agents|gaba agents|mesh-ancestor
102000614|NCT01268033|Rituximab|rituximab|mesh-list
102000615|NCT01268033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102000616|NCT01268033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000617|NCT01268033|Immunologic Factors|immunologic factors|mesh-ancestor
102000618|NCT01268033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000619|NCT01268033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102000620|NCT01162031|Bortezomib|bortezomib|mesh-list
102000621|NCT01162031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000622|NCT02879162|Durvalumab|durvalumab|mesh-list
102000623|NCT02879162|Tremelimumab|tremelimumab|mesh-list
102000624|NCT02879162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102000625|NCT02879162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000626|NCT03285477|Tirbanibulin|tirbanibulin|mesh-list
102000627|NCT03285477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102000628|NCT03285477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000629|NCT02285504|Brexanolone|brexanolone|mesh-list
102000630|NCT02285504|Neurosteroids|neurosteroids|mesh-ancestor
102000631|NCT02285504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102000632|NCT02285504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000633|NCT02285504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000634|NCT02285504|GABA Modulators|gaba modulators|mesh-ancestor
102000635|NCT02285504|GABA Agents|gaba agents|mesh-ancestor
102000636|NCT05009927|Imatinib Mesylate|imatinib mesylate|mesh-list
102000637|NCT05009927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000638|NCT05009927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102000639|NCT05009927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102000640|NCT05009927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000641|NCT02227394|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
102000642|NCT02227394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102000643|NCT02227394|Respiratory System Agents|respiratory system agents|mesh-ancestor
102000644|NCT05158491|Irinotecan|irinotecan|mesh-list
102000645|NCT05158491|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102000646|NCT05158491|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102000647|NCT05158491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102000648|NCT05158491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000649|NCT05158491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000650|NCT04276207|Insulin Lispro|insulin lispro|mesh-list
102000651|NCT04276207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102000652|NCT04276207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000656|NCT03876587|Antimitotic Agents|antimitotic agents|mesh-ancestor
102000657|NCT03876587|Mitosis Modulators|mitosis modulators|mesh-ancestor
102000658|NCT03876587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000659|NCT01162889|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102000660|NCT01162889|Immunologic Factors|immunologic factors|mesh-ancestor
102000661|NCT01162889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000662|NCT04635423|Vaccines|vaccines|mesh-list
102000663|NCT04635423|Immunologic Factors|immunologic factors|mesh-ancestor
101948521|NCT01177371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101948522|NCT01177371|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101948523|NCT01177371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101948524|NCT01177371|Antiemetics|antiemetics|mesh-ancestor
101948525|NCT01177371|Autonomic Agents|autonomic agents|mesh-ancestor
101948526|NCT01177371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101948527|NCT01177371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101948528|NCT01177371|Glucocorticoids|glucocorticoids|mesh-ancestor
101948529|NCT01177371|Hormones|hormones|mesh-ancestor
102000664|NCT04635423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000665|NCT03282357|Hyaluronic Acid|hyaluronic acid|mesh-list
101720470|NCT05957653|Lidocaine|lidocaine|mesh-list
102000666|NCT03282357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000667|NCT03282357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102000668|NCT03282357|Immunologic Factors|immunologic factors|mesh-ancestor
102000669|NCT03282357|Viscosupplements|viscosupplements|mesh-ancestor
102000670|NCT03282357|Protective Agents|protective agents|mesh-ancestor
102000671|NCT01162967|Posaconazole|posaconazole|mesh-list
102000672|NCT01162967|Benzonidazole|benzonidazole|mesh-list
102000673|NCT01162967|Antifungal Agents|antifungal agents|mesh-ancestor
102000674|NCT01162967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102000675|NCT01162967|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102000676|NCT01162967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102000677|NCT01162967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102000678|NCT01162967|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102000679|NCT01162967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102000680|NCT01162967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102000681|NCT01162967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000682|NCT01162967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102000683|NCT01162967|Hormone Antagonists|hormone antagonists|mesh-ancestor
102000684|NCT01162967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102000685|NCT01162967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000686|NCT01162967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102000687|NCT01162967|Immunologic Factors|immunologic factors|mesh-ancestor
102000688|NCT01268735|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102000689|NCT01268735|Lubricant Eye Drops|lubricant eye drops|mesh-list
102000690|NCT01268735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102000691|NCT04272775|Dexamethasone|dexamethasone|mesh-list
102000692|NCT04272775|Lenalidomide|lenalidomide|mesh-list
102000693|NCT04272775|Ixazomib|ixazomib|mesh-list
102000694|NCT04272775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102000695|NCT04272775|Antiemetics|antiemetics|mesh-ancestor
102000696|NCT04272775|Autonomic Agents|autonomic agents|mesh-ancestor
102000697|NCT04272775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102000698|NCT04272775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000699|NCT04272775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102000700|NCT04272775|Glucocorticoids|glucocorticoids|mesh-ancestor
102000701|NCT04272775|Hormones|hormones|mesh-ancestor
102000702|NCT04272775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102000703|NCT04272775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102000704|NCT04272775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000705|NCT04272775|Immunologic Factors|immunologic factors|mesh-ancestor
102000706|NCT04272775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102000707|NCT04272775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102000708|NCT04272775|Growth Substances|growth substances|mesh-ancestor
102000709|NCT04272775|Growth Inhibitors|growth inhibitors|mesh-ancestor
102000710|NCT04272775|Protease Inhibitors|protease inhibitors|mesh-ancestor
102000711|NCT04272775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102000712|NCT04272775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000713|NCT03232983|Insulin Lispro|insulin lispro|mesh-list
102000714|NCT03232983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102000715|NCT03232983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000716|NCT01163201|Cyclophosphamide|cyclophosphamide|mesh-list
102000717|NCT01163201|Fludarabine|fludarabine|mesh-list
102000718|NCT01163201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102000719|NCT01163201|Immunologic Factors|immunologic factors|mesh-ancestor
102000720|NCT01163201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000721|NCT01163201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101827174|NCT05875506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102000722|NCT01163201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102000723|NCT01163201|Alkylating Agents|alkylating agents|mesh-ancestor
102000724|NCT01163201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000737|NCT03876041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000738|NCT03876041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101720526|NCT05957302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102000739|NCT03876041|Glucocorticoids|glucocorticoids|mesh-ancestor
102000740|NCT03876041|Hormones|hormones|mesh-ancestor
102000741|NCT03876041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102000742|NCT03876041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102000743|NCT03876041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000744|NCT03876041|Protease Inhibitors|protease inhibitors|mesh-ancestor
102000745|NCT03876041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387634|NCT00314080|Immunologic Factors|immunologic factors|mesh-ancestor
102000746|NCT03876041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000747|NCT03876041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102000748|NCT03876041|Protective Agents|protective agents|mesh-ancestor
102000749|NCT04102345|Zolpidem|zolpidem|mesh-list
102000750|NCT04102345|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102000751|NCT04102345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102000752|NCT04102345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102000753|NCT04102345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000754|NCT04102345|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102000755|NCT04102345|GABA Agonists|gaba agonists|mesh-ancestor
102000756|NCT04102345|GABA Agents|gaba agents|mesh-ancestor
102000757|NCT04102345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102000758|NCT04102345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000759|NCT01163435|Clarithromycin|clarithromycin|mesh-list
102000760|NCT01163435|Levofloxacin|levofloxacin|mesh-list
102000761|NCT01163435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102000762|NCT01163435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102000763|NCT01163435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102000764|NCT01163435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102000765|NCT01163435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000766|NCT01163435|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102000767|NCT01163435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102000768|NCT01163435|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102000769|NCT01163435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102000770|NCT01163435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102000771|NCT01163435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000772|NCT01163435|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102000773|NCT03299244|Cinacalcet|cinacalcet|mesh-list
102000774|NCT03299244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102000775|NCT03299244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000776|NCT03299244|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
102000777|NCT03299244|Hormone Antagonists|hormone antagonists|mesh-ancestor
102000778|NCT03299244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102000779|NCT03875963|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102000780|NCT03875963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102000781|NCT03757715|Dexamethasone|dexamethasone|mesh-list
102000782|NCT03757715|Bupivacaine|bupivacaine|mesh-list
102000783|NCT03757715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102000784|NCT03757715|Antiemetics|antiemetics|mesh-ancestor
102000785|NCT03757715|Autonomic Agents|autonomic agents|mesh-ancestor
102000786|NCT03757715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102000790|NCT03757715|Hormones|hormones|mesh-ancestor
101258364|NCT01731067|Omeprazole|omeprazole|mesh-list
102000791|NCT03757715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102000792|NCT03757715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102000793|NCT03757715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000794|NCT03757715|Anesthetics, Local|anesthetics, local|mesh-ancestor
102000795|NCT03757715|Anesthetics|anesthetics|mesh-ancestor
102000796|NCT03757715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102000797|NCT03757715|Sensory System Agents|sensory system agents|mesh-ancestor
102000798|NCT01163825|Mitogens|mitogens|mesh-list
102000799|NCT01163825|Mitosis Modulators|mitosis modulators|mesh-ancestor
102000800|NCT01163825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000801|NCT01163903|Doxorubicin|doxorubicin|mesh-list
102000802|NCT01163903|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102000803|NCT01163903|Pantoprazole|pantoprazole|mesh-list
102000804|NCT01163903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102000805|NCT01163903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000806|NCT01163903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101948530|NCT01177371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101948531|NCT01177371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101948532|NCT01177371|Protective Agents|protective agents|mesh-ancestor
101948533|NCT01177371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101948534|NCT01178931|Dydrogesterone|dydrogesterone|mesh-list
101948535|NCT01178931|Progesterone|progesterone|mesh-list
101948536|NCT01178931|Progestins|progestins|mesh-ancestor
102000807|NCT01163903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102000808|NCT01163903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102000809|NCT01163903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000810|NCT01163903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102000811|NCT01163903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102000812|NCT01163903|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102000813|NCT03759587|Niraparib|niraparib|mesh-list
102000814|NCT03759587|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102000815|NCT03759587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102000816|NCT03759587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000817|NCT03759587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000818|NCT03745807|Nivolumab|nivolumab|mesh-list
102000819|NCT03745807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102000820|NCT03745807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000821|NCT03745807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102000822|NCT03745807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000823|NCT01164059|Haloperidol|haloperidol|mesh-list
102000824|NCT01164059|Olanzapine|olanzapine|mesh-list
102000825|NCT01164059|Aripiprazole|aripiprazole|mesh-list
102000826|NCT01164059|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102000827|NCT01164059|Haloperidol decanoate|haloperidol decanoate|mesh-list
102000828|NCT01164059|Flupenthixol|flupenthixol|mesh-list
102000829|NCT01164059|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
102000830|NCT01164059|Antiemetics|antiemetics|mesh-ancestor
102000831|NCT01164059|Autonomic Agents|autonomic agents|mesh-ancestor
102000832|NCT01164059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102000833|NCT01164059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000834|NCT01164059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102000835|NCT01164059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102000836|NCT01164059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102000837|NCT01164059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102000838|NCT01164059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102000839|NCT01164059|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102000840|NCT01164059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102000841|NCT01164059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102000842|NCT01164059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000843|NCT01164059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102000844|NCT01164059|Serotonin Agents|serotonin agents|mesh-ancestor
102000845|NCT01164059|Antidepressive Agents|antidepressive agents|mesh-ancestor
102000846|NCT01164059|Dopamine Agonists|dopamine agonists|mesh-ancestor
102000847|NCT01164059|Dopamine Agents|dopamine agents|mesh-ancestor
102000848|NCT01164059|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102000849|NCT01164059|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102000850|NCT01164059|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102000851|NCT01164059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102000852|NCT01164059|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102000853|NCT01164059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102000854|NCT01164059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102000855|NCT03879005|Technetium Tc 99m Dimercaptosuccinic Acid|technetium tc 99m dimercaptosuccinic acid|mesh-list
102000856|NCT03879005|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101455870|NCT00240552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102000916|NCT04245709|Adrenergic Agents|adrenergic agents|mesh-ancestor
102000917|NCT04245709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102000918|NCT04245709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000919|NCT04245709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000920|NCT04245709|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102000921|NCT04245709|Autonomic Agents|autonomic agents|mesh-ancestor
102000922|NCT04245709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102000923|NCT04245709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101948537|NCT01178931|Hormones|hormones|mesh-ancestor
101948538|NCT01178931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101948539|NCT01178931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948540|NCT01181115|Interferon beta-1a|interferon beta-1a|mesh-list
101948541|NCT01181115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102000924|NCT04245709|Respiratory System Agents|respiratory system agents|mesh-ancestor
102000925|NCT04245709|Sympathomimetics|sympathomimetics|mesh-ancestor
102000926|NCT03878693|Fomepizole|fomepizole|mesh-list
102000927|NCT03878693|Antidotes|antidotes|mesh-ancestor
102000928|NCT03878693|Protective Agents|protective agents|mesh-ancestor
102000929|NCT03878693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000930|NCT03878693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102000931|NCT03878693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000932|NCT05305495|Empagliflozin|empagliflozin|mesh-list
101455971|NCT00240708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000943|NCT02527109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102000944|NCT02527109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000945|NCT02527109|Vasodilator Agents|vasodilator agents|mesh-ancestor
102000946|NCT02527109|Tocolytic Agents|tocolytic agents|mesh-ancestor
102000947|NCT02527109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102000948|NCT02940522|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
102000949|NCT02940522|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
102000950|NCT02940522|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102000951|NCT02940522|Hormone Antagonists|hormone antagonists|mesh-ancestor
102000952|NCT02940522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102000953|NCT02940522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000954|NCT02940522|Progestins|progestins|mesh-ancestor
102000955|NCT02940522|Hormones|hormones|mesh-ancestor
102000956|NCT01266785|Infliximab|infliximab|mesh-list
102000957|NCT01266785|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102000958|NCT01266785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102000959|NCT01266785|Dermatologic Agents|dermatologic agents|mesh-ancestor
102000960|NCT01266785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102000961|NCT01266785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102000962|NCT03262038|Ondansetron|ondansetron|mesh-list
102000963|NCT03262038|Antiemetics|antiemetics|mesh-ancestor
102000964|NCT03262038|Autonomic Agents|autonomic agents|mesh-ancestor
102000965|NCT03262038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102000966|NCT03262038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000967|NCT03262038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102000968|NCT03262038|Antipruritics|antipruritics|mesh-ancestor
102000969|NCT03262038|Dermatologic Agents|dermatologic agents|mesh-ancestor
102000970|NCT03262038|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102000971|NCT03262038|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102000972|NCT03262038|Serotonin Agents|serotonin agents|mesh-ancestor
102000973|NCT03262038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102000974|NCT03262038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000975|NCT03746821|Biotin|biotin|mesh-list
102000976|NCT03746821|Vitamin B Complex|vitamin b complex|mesh-ancestor
102000977|NCT03746821|Vitamins|vitamins|mesh-ancestor
102000978|NCT03746821|Micronutrients|micronutrients|mesh-ancestor
102000979|NCT03746821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000980|NCT02472964|Paclitaxel|paclitaxel|mesh-list
102000981|NCT02472964|Docetaxel|docetaxel|mesh-list
102000982|NCT02472964|Trastuzumab|trastuzumab|mesh-list
101258443|NCT01731158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102000983|NCT02472964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102000984|NCT02472964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000985|NCT02472964|Tubulin Modulators|tubulin modulators|mesh-ancestor
102000986|NCT02472964|Antimitotic Agents|antimitotic agents|mesh-ancestor
102000987|NCT02472964|Mitosis Modulators|mitosis modulators|mesh-ancestor
102000988|NCT02472964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000989|NCT02472964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102000990|NCT01160315|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102000991|NCT01160315|Norethindrone|norethindrone|mesh-list
102000992|NCT01160315|Norethindrone Acetate|norethindrone acetate|mesh-list
102000993|NCT01160315|Luteolytic Agents|luteolytic agents|mesh-ancestor
102000994|NCT01160315|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102000995|NCT01160315|Contraceptive Agents|contraceptive agents|mesh-ancestor
102000996|NCT01160315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102000999|NCT01160315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102001000|NCT01160315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101948542|NCT01181115|Immunologic Factors|immunologic factors|mesh-ancestor
101948543|NCT01181115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948544|NCT01181115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101948545|NCT01181115|Antiviral Agents|antiviral agents|mesh-ancestor
101948546|NCT01181115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101948548|NCT01181193|Cholecalciferol|cholecalciferol|mesh-list
101948550|NCT01181193|Vitamins|vitamins|mesh-ancestor
101948551|NCT01181193|Micronutrients|micronutrients|mesh-ancestor
101948552|NCT01181193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948553|NCT01181193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101827390|NCT05771480|Antimitotic Agents|antimitotic agents|mesh-ancestor
102001001|NCT01160315|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102001002|NCT01160315|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102001003|NCT01160315|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102001004|NCT03385174|Carbon Monoxide|carbon monoxide|mesh-list
102001005|NCT03385174|Antimetabolites|antimetabolites|mesh-ancestor
102001006|NCT03385174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001007|NCT03385174|Gasotransmitters|gasotransmitters|mesh-ancestor
102001008|NCT03385174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102001009|NCT03385174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001010|NCT01164605|Raltegravir Potassium|raltegravir potassium|mesh-list
102001011|NCT01164605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102001012|NCT01164605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102001013|NCT01164605|Antiviral Agents|antiviral agents|mesh-ancestor
102001014|NCT01164605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102001015|NCT01164605|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102001016|NCT01164605|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102001017|NCT01164605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102001018|NCT01164605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001019|NCT03380728|Ibogaine|ibogaine|mesh-list
102001020|NCT03380728|Hallucinogens|hallucinogens|mesh-ancestor
102001021|NCT03380728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001022|NCT03380728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102001023|NCT03380728|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102001024|NCT03380728|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102001025|NCT03380728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102001026|NCT03380728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001027|NCT01104922|Cetuximab|cetuximab|mesh-list
102001028|NCT01104922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102001029|NCT01104922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102001030|NCT01164761|Ramipril|ramipril|mesh-list
102001031|NCT01164761|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102001032|NCT01164761|Protease Inhibitors|protease inhibitors|mesh-ancestor
102001033|NCT01164761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102001034|NCT01164761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001035|NCT01164761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102001036|NCT03385096|Cyclophosphamide|cyclophosphamide|mesh-list
102001037|NCT03385096|Melphalan|melphalan|mesh-list
102001038|NCT03385096|Busulfan|busulfan|mesh-list
102001039|NCT03385096|Etoposide|etoposide|mesh-list
102001040|NCT03385096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102001042|NCT03385096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001043|NCT03385096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102001044|NCT03385096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102001045|NCT03385096|Alkylating Agents|alkylating agents|mesh-ancestor
102001046|NCT03385096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001047|NCT03385096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102001048|NCT03385096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102001049|NCT03385096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102001050|NCT03385096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102001051|NCT03385096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102001052|NCT03385096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102001053|NCT02526875|Amlodipine|amlodipine|mesh-list
101948554|NCT01181193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101948555|NCT01181193|Alkylating Agents|alkylating agents|mesh-ancestor
101948556|NCT01181193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001054|NCT02526875|Telmisartan|telmisartan|mesh-list
102001055|NCT02526875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102001056|NCT02526875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102001057|NCT02526875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102001058|NCT02526875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001059|NCT02526875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102001060|NCT02526875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001061|NCT02526875|Vasodilator Agents|vasodilator agents|mesh-ancestor
102001062|NCT02526875|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102001063|NCT02526875|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102001064|NCT04222699|Chlorhexidine|chlorhexidine|mesh-list
102001065|NCT04222699|Mupirocin|mupirocin|mesh-list
102001066|NCT04222699|Calcium|calcium|mesh-list
102001067|NCT04222699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102001068|NCT04222699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001075|NCT04222699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001077|NCT01269203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102001078|NCT01269203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102001079|NCT01269203|Analgesics|analgesics|mesh-ancestor
102001080|NCT01269203|Sensory System Agents|sensory system agents|mesh-ancestor
102001081|NCT01269203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102001082|NCT01269203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001083|NCT01269203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102001084|NCT01269203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102001085|NCT01269203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102001086|NCT01269203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102001087|NCT01269203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001088|NCT01160627|Acetylcysteine|acetylcysteine|mesh-list
102001089|NCT01160627|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102001090|NCT01160627|Antiviral Agents|antiviral agents|mesh-ancestor
102001091|NCT01160627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102001092|NCT01160627|Expectorants|expectorants|mesh-ancestor
102001093|NCT01160627|Respiratory System Agents|respiratory system agents|mesh-ancestor
102001094|NCT01160627|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102001095|NCT01160627|Antioxidants|antioxidants|mesh-ancestor
102001096|NCT01160627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001097|NCT01160627|Protective Agents|protective agents|mesh-ancestor
102001098|NCT01160627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001099|NCT01160627|Antidotes|antidotes|mesh-ancestor
102001100|NCT04075513|Insulin|insulin|mesh-list
102001101|NCT04075513|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102001102|NCT04075513|Insulin Glargine|insulin glargine|mesh-list
102001103|NCT04075513|Insulin, Short-Acting|insulin, short-acting|mesh-list
102001104|NCT04075513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102001105|NCT04075513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001106|NCT03877679|Triamcinolone|triamcinolone|mesh-list
102001107|NCT03877679|Curcumin|curcumin|mesh-list
102001108|NCT03877679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102001109|NCT03877679|Glucocorticoids|glucocorticoids|mesh-ancestor
102001110|NCT03877679|Hormones|hormones|mesh-ancestor
102001111|NCT03877679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102001112|NCT03877679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001113|NCT03877679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101720910|NCT05487755|Antioxidants|antioxidants|mesh-ancestor
102001114|NCT03877679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001115|NCT03877679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102001116|NCT03877679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102001118|NCT03877679|Sensory System Agents|sensory system agents|mesh-ancestor
102001119|NCT03877679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102001120|NCT03877679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102001121|NCT03877679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102001122|NCT03330249|Cisplatin|cisplatin|mesh-list
102001123|NCT03330249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102001124|NCT04652206|Paclitaxel|paclitaxel|mesh-list
102001125|NCT04652206|Gemcitabine|gemcitabine|mesh-list
102001126|NCT04652206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101948557|NCT01181193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101948558|NCT01181193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101948559|NCT01177683|Doxorubicin|doxorubicin|mesh-list
101948560|NCT01177683|Bortezomib|bortezomib|mesh-list
101948561|NCT01177683|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101948562|NCT01177683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101948563|NCT01177683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101948564|NCT01177683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101948565|NCT01177683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101948566|NCT01177683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101827525|NCT05644041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102001127|NCT04652206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102001128|NCT04652206|Tubulin Modulators|tubulin modulators|mesh-ancestor
102001129|NCT04652206|Antimitotic Agents|antimitotic agents|mesh-ancestor
102001130|NCT04652206|Mitosis Modulators|mitosis modulators|mesh-ancestor
102001131|NCT04652206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001132|NCT04652206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102001133|NCT04652206|Antimetabolites|antimetabolites|mesh-ancestor
102001134|NCT01269281|Sumatriptan|sumatriptan|mesh-list
102001135|NCT01269281|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102001136|NCT01269281|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101456151|NCT00411905|Bortezomib|bortezomib|mesh-list
102001143|NCT02778204|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102001144|NCT02778204|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102001145|NCT02778204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001146|NCT02778204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102001147|NCT02778204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102001148|NCT02778204|Antiviral Agents|antiviral agents|mesh-ancestor
102001149|NCT02778204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102001150|NCT02778204|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102001151|NCT01160705|Docetaxel|docetaxel|mesh-list
102001152|NCT01160705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102001153|NCT01160705|Tubulin Modulators|tubulin modulators|mesh-ancestor
102001154|NCT01160705|Antimitotic Agents|antimitotic agents|mesh-ancestor
102001155|NCT01160705|Mitosis Modulators|mitosis modulators|mesh-ancestor
102001156|NCT01160705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001157|NCT03232281|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102001158|NCT03232281|Luteolytic Agents|luteolytic agents|mesh-ancestor
102001159|NCT03232281|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102001160|NCT03232281|Contraceptive Agents|contraceptive agents|mesh-ancestor
102001161|NCT03232281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102001162|NCT03232281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001163|NCT03232281|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102001164|NCT03232281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102001165|NCT03232281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102001166|NCT03261336|Vitamin D|vitamin d|mesh-list
102001167|NCT03261336|Calcitriol|calcitriol|mesh-list
102001168|NCT03261336|Ketoconazole|ketoconazole|mesh-list
102001169|NCT03261336|Hydrocortisone|hydrocortisone|mesh-list
102001170|NCT03261336|Vitamins|vitamins|mesh-ancestor
102001171|NCT03261336|Micronutrients|micronutrients|mesh-ancestor
102001172|NCT03261336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001173|NCT03261336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102001174|NCT03261336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102001175|NCT03261336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102001176|NCT03261336|Antifungal Agents|antifungal agents|mesh-ancestor
102001177|NCT03261336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102001178|NCT03261336|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102001179|NCT03261336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102001180|NCT03261336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102001181|NCT03261336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001182|NCT03261336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102001183|NCT03261336|Hormone Antagonists|hormone antagonists|mesh-ancestor
101737357|NCT00780416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101948567|NCT01177683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948568|NCT01177683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101948569|NCT01177683|Alkylating Agents|alkylating agents|mesh-ancestor
101948570|NCT01181427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-list
102001184|NCT03261336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102001185|NCT03261336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101720975|NCT05371600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102001186|NCT03261336|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102001187|NCT03261336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102001188|NCT03261336|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102001190|NCT03384862|Vitamin B 12|vitamin b 12|mesh-list
102001191|NCT03384862|Hydroxocobalamin|hydroxocobalamin|mesh-list
102001192|NCT03384862|Vitamins|vitamins|mesh-ancestor
102001193|NCT03384862|Micronutrients|micronutrients|mesh-ancestor
102001194|NCT03384862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001195|NCT03384862|Hematinics|hematinics|mesh-ancestor
102001196|NCT03384862|Vitamin B Complex|vitamin b complex|mesh-ancestor
102001197|NCT01269437|Budesonide|budesonide|mesh-list
102001198|NCT01269437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102001199|NCT01269437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102001200|NCT01269437|Autonomic Agents|autonomic agents|mesh-ancestor
102001201|NCT01269437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102001202|NCT01269437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001203|NCT01269437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102001204|NCT01269437|Respiratory System Agents|respiratory system agents|mesh-ancestor
102001210|NCT03909269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001211|NCT03909269|Gasotransmitters|gasotransmitters|mesh-ancestor
102001212|NCT03909269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102001213|NCT03909269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001215|NCT00462748|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102001216|NCT00462748|Simvastatin|simvastatin|mesh-list
102001217|NCT00462748|Ezetimibe|ezetimibe|mesh-list
102001218|NCT00462748|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102001219|NCT00462748|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102001220|NCT00462748|Antimetabolites|antimetabolites|mesh-ancestor
102001221|NCT00462748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001222|NCT00462748|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102001223|NCT00462748|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102001224|NCT00462748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102001225|NCT01161017|Topiramate|topiramate|mesh-list
102001226|NCT01161017|Amitriptyline|amitriptyline|mesh-list
102001227|NCT01161017|Anticonvulsants|anticonvulsants|mesh-ancestor
102001228|NCT01161017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102001229|NCT01161017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001230|NCT01161017|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102001231|NCT01161017|Antidepressive Agents|antidepressive agents|mesh-ancestor
102001232|NCT01161017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102001233|NCT01161017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102001234|NCT01161017|Analgesics|analgesics|mesh-ancestor
102001235|NCT01161017|Sensory System Agents|sensory system agents|mesh-ancestor
102001236|NCT01161017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102001237|NCT01161017|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102001238|NCT01161017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102001239|NCT01161017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102001240|NCT01161017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001241|NCT01161017|Adrenergic Agents|adrenergic agents|mesh-ancestor
102001242|NCT01161017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102001243|NCT03935685|Mirtazapine|mirtazapine|mesh-list
102001244|NCT03935685|Antidepressive Agents|antidepressive agents|mesh-ancestor
102001245|NCT03935685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102001246|NCT03935685|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102001247|NCT03935685|Histamine Antagonists|histamine antagonists|mesh-ancestor
102001248|NCT03935685|Histamine Agents|histamine agents|mesh-ancestor
102001249|NCT03935685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102001250|NCT03935685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001251|NCT03935685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001252|NCT03935685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102001253|NCT03935685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102001254|NCT03935685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101948571|NCT01181427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101971969|NCT01336322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001255|NCT03935685|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102001256|NCT03935685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102001257|NCT03935685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102001258|NCT03935685|Adrenergic Agents|adrenergic agents|mesh-ancestor
102001259|NCT03935685|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102001260|NCT03935685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102001262|NCT03935685|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102001263|NCT01164917|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102001264|NCT01164917|Immunologic Factors|immunologic factors|mesh-ancestor
102001265|NCT01164917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001266|NCT03238911|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
102001267|NCT03238911|Hematinics|hematinics|mesh-ancestor
102001268|NCT01269515|Etoricoxib|etoricoxib|mesh-list
102001269|NCT01269515|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102001270|NCT01269515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102001271|NCT01269515|Analgesics|analgesics|mesh-ancestor
102001272|NCT01269515|Sensory System Agents|sensory system agents|mesh-ancestor
102001273|NCT01269515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102001277|NCT01269515|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102001278|NCT01269515|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102001279|NCT01269515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102001280|NCT01269515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001281|NCT00418834|Atorvastatin|atorvastatin|mesh-list
102001282|NCT00418834|Ezetimibe|ezetimibe|mesh-list
102001283|NCT00418834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102001284|NCT00418834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102001285|NCT00418834|Antimetabolites|antimetabolites|mesh-ancestor
102001286|NCT00418834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001287|NCT00418834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102001288|NCT00418834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102001289|NCT00418834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102001290|NCT01269671|Peppermint oil|peppermint oil|mesh-list
102001291|NCT01269671|Melatonin|melatonin|mesh-list
102001292|NCT01269671|Simethicone|simethicone|mesh-list
102001293|NCT01269671|Antioxidants|antioxidants|mesh-ancestor
102001294|NCT01269671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001295|NCT01269671|Protective Agents|protective agents|mesh-ancestor
102001296|NCT01269671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001297|NCT01269671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102001298|NCT01269671|Antifoaming Agents|antifoaming agents|mesh-ancestor
102001299|NCT01269671|Emollients|emollients|mesh-ancestor
102001300|NCT01269671|Dermatologic Agents|dermatologic agents|mesh-ancestor
102001301|NCT01269671|Antiemetics|antiemetics|mesh-ancestor
102001302|NCT01269671|Autonomic Agents|autonomic agents|mesh-ancestor
102001303|NCT01269671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102001304|NCT01269671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102001305|NCT01269671|Parasympatholytics|parasympatholytics|mesh-ancestor
102001306|NCT04407286|Vitamin D|vitamin d|mesh-list
102001307|NCT04407286|Cholecalciferol|cholecalciferol|mesh-list
102001308|NCT04407286|Vitamins|vitamins|mesh-ancestor
102001309|NCT04407286|Micronutrients|micronutrients|mesh-ancestor
102001310|NCT04407286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001311|NCT04407286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102001312|NCT04407286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102001313|NCT03276975|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102001314|NCT03276975|Hemostatics|hemostatics|mesh-ancestor
102001315|NCT03276975|Coagulants|coagulants|mesh-ancestor
102001316|NCT03125746|Exemestane|exemestane|mesh-list
102001317|NCT03125746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102001318|NCT03125746|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102001319|NCT03125746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102001320|NCT03125746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102001321|NCT03125746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001322|NCT03125746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102001323|NCT03125746|Hormone Antagonists|hormone antagonists|mesh-ancestor
102001324|NCT03125746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102001325|NCT03125746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001326|NCT03877601|Bevacizumab|bevacizumab|mesh-list
102001327|NCT03877601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102001328|NCT03877601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101948572|NCT01181427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948573|NCT03855579|Simendan|simendan|mesh-list
101948574|NCT03855579|Milrinone|milrinone|mesh-list
101948575|NCT03855579|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101948576|NCT03855579|Vasodilator Agents|vasodilator agents|mesh-ancestor
101948577|NCT03855579|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101948578|NCT03855579|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101948579|NCT03855579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102001329|NCT03877601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102001330|NCT03877601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102001331|NCT03877601|Growth Substances|growth substances|mesh-ancestor
102001332|NCT03877601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001333|NCT03877601|Growth Inhibitors|growth inhibitors|mesh-ancestor
102001334|NCT03297216|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
102001335|NCT03297216|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
102001336|NCT03297216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102001337|NCT03297216|Hormone Antagonists|hormone antagonists|mesh-ancestor
102001338|NCT03297216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102001339|NCT03297216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001341|NCT03297216|Hormones|hormones|mesh-ancestor
102001342|NCT03260868|Insulin|insulin|mesh-list
102001343|NCT03260868|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101258828|NCT01733979|Iron|iron|mesh-list
102001344|NCT03260868|Insulin Glargine|insulin glargine|mesh-list
102001345|NCT03260868|Insulin Lispro|insulin lispro|mesh-list
102001346|NCT03260868|Insulin Aspart|insulin aspart|mesh-list
102001347|NCT03260868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102001356|NCT01267487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102001357|NCT01267487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001358|NCT01267487|Heparin Antagonists|heparin antagonists|mesh-ancestor
102001359|NCT01267487|Coagulants|coagulants|mesh-ancestor
102001360|NCT01267643|Alefacept|alefacept|mesh-list
102001361|NCT01267643|Dermatologic Agents|dermatologic agents|mesh-ancestor
102001362|NCT01267643|Immunologic Factors|immunologic factors|mesh-ancestor
102001363|NCT01267643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001364|NCT01269827|Pentoxifylline|pentoxifylline|mesh-list
102001365|NCT01269827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102001366|NCT01269827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102001367|NCT01269827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001368|NCT01269827|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102001369|NCT01269827|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102001370|NCT01269827|Protective Agents|protective agents|mesh-ancestor
102001371|NCT01269827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001372|NCT01269827|Vasodilator Agents|vasodilator agents|mesh-ancestor
102001373|NCT01269827|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102001374|NCT01269827|Antioxidants|antioxidants|mesh-ancestor
102001375|NCT03388372|Temozolomide|temozolomide|mesh-list
102001376|NCT03388372|Nimotuzumab|nimotuzumab|mesh-list
102001377|NCT03388372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102001378|NCT03388372|Alkylating Agents|alkylating agents|mesh-ancestor
102001379|NCT03388372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001380|NCT03388372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102001381|NCT03388372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102001382|NCT05173246|Paclitaxel|paclitaxel|mesh-list
102001383|NCT05173246|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102001384|NCT05173246|Cisplatin|cisplatin|mesh-list
102001385|NCT05173246|Carboplatin|carboplatin|mesh-list
102001386|NCT05173246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102001387|NCT05173246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102001388|NCT05173246|Tubulin Modulators|tubulin modulators|mesh-ancestor
102001389|NCT05173246|Antimitotic Agents|antimitotic agents|mesh-ancestor
102001390|NCT05173246|Mitosis Modulators|mitosis modulators|mesh-ancestor
102001391|NCT05173246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001392|NCT01167101|Pantoprazole|pantoprazole|mesh-list
102001393|NCT01167101|Rebamipide|rebamipide|mesh-list
102001394|NCT01167101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102001395|NCT01167101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102001396|NCT01167101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102001397|NCT01167101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101737358|NCT00780416|Immunologic Factors|immunologic factors|mesh-ancestor
101948580|NCT03855579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948581|NCT03855579|Protective Agents|protective agents|mesh-ancestor
102001398|NCT01167101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001399|NCT01167101|Antioxidants|antioxidants|mesh-ancestor
102001400|NCT01167101|Protective Agents|protective agents|mesh-ancestor
102001401|NCT01167101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001402|NCT05173090|Ropivacaine|ropivacaine|mesh-list
102001403|NCT05173090|Anesthetics, Local|anesthetics, local|mesh-ancestor
102001404|NCT05173090|Anesthetics|anesthetics|mesh-ancestor
102001405|NCT05173090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102001406|NCT05173090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001407|NCT05173090|Sensory System Agents|sensory system agents|mesh-ancestor
102001408|NCT05173090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102001409|NCT02526953|Paclitaxel|paclitaxel|mesh-list
102001410|NCT02526953|Capecitabine|capecitabine|mesh-list
102001411|NCT02526953|Mitomycins|mitomycins|mesh-list
102001412|NCT02526953|Mitomycin|mitomycin|mesh-list
102001413|NCT02526953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102001414|NCT02526953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102001416|NCT02526953|Antimitotic Agents|antimitotic agents|mesh-ancestor
102001417|NCT02526953|Mitosis Modulators|mitosis modulators|mesh-ancestor
102001418|NCT02526953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001420|NCT02526953|Antimetabolites|antimetabolites|mesh-ancestor
102001421|NCT02526953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102001422|NCT02526953|Alkylating Agents|alkylating agents|mesh-ancestor
102001423|NCT02526953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102001424|NCT02526953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102001425|NCT03258762|Leucovorin|leucovorin|mesh-list
102001426|NCT03258762|Pyrimethamine|pyrimethamine|mesh-list
102001427|NCT03258762|Calcium|calcium|mesh-list
102001428|NCT03258762|Levoleucovorin|levoleucovorin|mesh-list
102001429|NCT03258762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102001430|NCT03258762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001431|NCT03258762|Antidotes|antidotes|mesh-ancestor
102001432|NCT03258762|Protective Agents|protective agents|mesh-ancestor
102001433|NCT03258762|Vitamin B Complex|vitamin b complex|mesh-ancestor
102001434|NCT03258762|Vitamins|vitamins|mesh-ancestor
102001435|NCT03258762|Micronutrients|micronutrients|mesh-ancestor
102001436|NCT03258762|Antimalarials|antimalarials|mesh-ancestor
102001437|NCT03258762|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102001438|NCT03258762|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102001439|NCT03258762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102001440|NCT03258762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102001441|NCT03258762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102001442|NCT03258762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001443|NCT05427669|Leucovorin|leucovorin|mesh-list
102001444|NCT05427669|Fluorouracil|fluorouracil|mesh-list
102001445|NCT05427669|Oxaliplatin|oxaliplatin|mesh-list
102001446|NCT05427669|Irinotecan|irinotecan|mesh-list
102001447|NCT05427669|Levoleucovorin|levoleucovorin|mesh-list
102001448|NCT05427669|Antimetabolites|antimetabolites|mesh-ancestor
102001449|NCT05427669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001450|NCT05427669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102001451|NCT05427669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102001452|NCT05427669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102001453|NCT05427669|Immunologic Factors|immunologic factors|mesh-ancestor
102001454|NCT05427669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001455|NCT05427669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102001456|NCT05427669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102001457|NCT05427669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102001458|NCT05427669|Antidotes|antidotes|mesh-ancestor
102001459|NCT05427669|Protective Agents|protective agents|mesh-ancestor
102001460|NCT05427669|Vitamin B Complex|vitamin b complex|mesh-ancestor
102001461|NCT05427669|Vitamins|vitamins|mesh-ancestor
102001462|NCT05427669|Micronutrients|micronutrients|mesh-ancestor
102001463|NCT01270373|Docetaxel|docetaxel|mesh-list
102001464|NCT01270373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102001465|NCT01270373|Tubulin Modulators|tubulin modulators|mesh-ancestor
102001466|NCT01270373|Antimitotic Agents|antimitotic agents|mesh-ancestor
102001467|NCT01270373|Mitosis Modulators|mitosis modulators|mesh-ancestor
102001468|NCT01270373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001469|NCT03713086|Vaccines|vaccines|mesh-list
102001470|NCT03713086|Immunologic Factors|immunologic factors|mesh-ancestor
102001471|NCT03713086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001472|NCT01271231|Azithromycin|azithromycin|mesh-list
102001473|NCT01271231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101948582|NCT03855579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948583|NCT03855579|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101948584|NCT03855423|Tocotrienols|tocotrienols|mesh-list
101948585|NCT03855423|Vitamin E|vitamin e|mesh-list
102001474|NCT01271231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102001475|NCT03697876|Hyaluronic Acid|hyaluronic acid|mesh-list
102001476|NCT03697876|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102001477|NCT03697876|Immunologic Factors|immunologic factors|mesh-ancestor
102001478|NCT03697876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001479|NCT03697876|Viscosupplements|viscosupplements|mesh-ancestor
102001480|NCT03697876|Protective Agents|protective agents|mesh-ancestor
102001481|NCT04526691|Carboplatin|carboplatin|mesh-list
102001482|NCT04526691|Pembrolizumab|pembrolizumab|mesh-list
102001483|NCT04526691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102001484|NCT04526691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102001485|NCT04526691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102001486|NCT04526691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001487|NCT01280669|Sirolimus|sirolimus|mesh-list
102001488|NCT01280669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102001489|NCT01280669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102001490|NCT01280669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102001491|NCT01280669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102001492|NCT01280669|Antifungal Agents|antifungal agents|mesh-ancestor
102001493|NCT01280669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102001494|NCT01280669|Immunologic Factors|immunologic factors|mesh-ancestor
102001495|NCT01280669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001496|NCT03379558|Alirocumab|alirocumab|mesh-list
102001501|NCT03379558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001502|NCT03379558|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102001503|NCT03379558|Protease Inhibitors|protease inhibitors|mesh-ancestor
102001504|NCT03379558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102001505|NCT03379558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102001506|NCT01169909|Ranibizumab|ranibizumab|mesh-list
102001507|NCT01169909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102001508|NCT01169909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102001509|NCT01169909|Growth Substances|growth substances|mesh-ancestor
102001510|NCT01169909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001511|NCT01169909|Growth Inhibitors|growth inhibitors|mesh-ancestor
102001512|NCT01169909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102001513|NCT04502589|Disulfiram|disulfiram|mesh-list
102001514|NCT04502589|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102001515|NCT04502589|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
102001516|NCT04502589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102001517|NCT04502589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001518|NCT03387904|Irinotecan|irinotecan|mesh-list
102001519|NCT03387904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102001520|NCT03387904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102001521|NCT03387904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102001522|NCT03387904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001523|NCT03387904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102001524|NCT03291288|Tolbutamide|tolbutamide|mesh-list
102001525|NCT03291288|Midazolam|midazolam|mesh-list
102001526|NCT03291288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102001527|NCT03291288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102001528|NCT03291288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102001529|NCT03291288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001530|NCT03291288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102001531|NCT03291288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102001532|NCT03291288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102001533|NCT03291288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102001534|NCT03291288|Anesthetics, General|anesthetics, general|mesh-ancestor
102001535|NCT03291288|Anesthetics|anesthetics|mesh-ancestor
102001536|NCT03291288|GABA Modulators|gaba modulators|mesh-ancestor
102001537|NCT03291288|GABA Agents|gaba agents|mesh-ancestor
102001538|NCT03291288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102001539|NCT03291288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001540|NCT03291288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102001541|NCT05172310|FAPI-46|fapi-46|mesh-list
102001542|NCT05172310|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102001543|NCT05172310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001544|NCT03636711|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102001545|NCT03636711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101948586|NCT03855423|Tocopherols|tocopherols|mesh-list
102001546|NCT04084626|Lenalidomide|lenalidomide|mesh-list
102001547|NCT04084626|Antibodies|antibodies|mesh-list
102001548|NCT04084626|Immunologic Factors|immunologic factors|mesh-ancestor
102001549|NCT04084626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001550|NCT04084626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102001551|NCT04084626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102001552|NCT04084626|Growth Substances|growth substances|mesh-ancestor
102001553|NCT04084626|Growth Inhibitors|growth inhibitors|mesh-ancestor
102001554|NCT04084626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102001555|NCT03387826|Ticagrelor|ticagrelor|mesh-list
102001556|NCT03387826|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102001557|NCT03387826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102001558|NCT03387826|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102001559|NCT03387826|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102001560|NCT03387826|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102001561|NCT03387826|Purinergic Agents|purinergic agents|mesh-ancestor
102001562|NCT03387826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102001563|NCT03387826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001564|NCT03387826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001565|NCT03871517|Aspirin|aspirin|mesh-list
102001566|NCT03871517|Indobufen|indobufen|mesh-list
102001567|NCT03871517|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102001568|NCT03871517|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102001573|NCT03871517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102001574|NCT03871517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102001575|NCT03871517|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102001576|NCT03871517|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102001577|NCT03871517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001578|NCT03871517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102001579|NCT03871517|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102001580|NCT03871517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102001582|NCT03387592|Leucovorin|leucovorin|mesh-list
102001583|NCT03387592|Fluorouracil|fluorouracil|mesh-list
102001584|NCT03387592|Capecitabine|capecitabine|mesh-list
102001585|NCT03387592|Temozolomide|temozolomide|mesh-list
102001586|NCT03387592|Levoleucovorin|levoleucovorin|mesh-list
102001587|NCT03387592|Antimetabolites|antimetabolites|mesh-ancestor
102001588|NCT03387592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001589|NCT03387592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102001590|NCT03387592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102001591|NCT03387592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102001592|NCT03387592|Immunologic Factors|immunologic factors|mesh-ancestor
102001593|NCT03387592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001594|NCT03387592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102001595|NCT03387592|Alkylating Agents|alkylating agents|mesh-ancestor
102001596|NCT03387592|Antidotes|antidotes|mesh-ancestor
102001597|NCT03387592|Protective Agents|protective agents|mesh-ancestor
102001598|NCT03387592|Vitamin B Complex|vitamin b complex|mesh-ancestor
102001599|NCT03387592|Vitamins|vitamins|mesh-ancestor
102001600|NCT03387592|Micronutrients|micronutrients|mesh-ancestor
102001601|NCT04445506|Dexamethasone|dexamethasone|mesh-list
102001602|NCT04445506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102001603|NCT04445506|Antiemetics|antiemetics|mesh-ancestor
102001604|NCT04445506|Autonomic Agents|autonomic agents|mesh-ancestor
102001605|NCT04445506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102001606|NCT04445506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001607|NCT04445506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102001608|NCT04445506|Glucocorticoids|glucocorticoids|mesh-ancestor
102001609|NCT04445506|Hormones|hormones|mesh-ancestor
102001610|NCT04445506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102001611|NCT04445506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102001612|NCT04445506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102001613|NCT03379012|Sunitinib|sunitinib|mesh-list
102001614|NCT03379012|Methyltestosterone|methyltestosterone|mesh-list
102001615|NCT03379012|Testosterone|testosterone|mesh-list
102001616|NCT03379012|Testosterone undecanoate|testosterone undecanoate|mesh-list
102001617|NCT03379012|Testosterone enanthate|testosterone enanthate|mesh-list
102001618|NCT03379012|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102001619|NCT03379012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102001620|NCT03379012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102001621|NCT03379012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102001622|NCT03379012|Growth Substances|growth substances|mesh-ancestor
102001623|NCT03379012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001624|NCT03379012|Growth Inhibitors|growth inhibitors|mesh-ancestor
102001625|NCT03379012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101948587|NCT03855423|Tocovid|tocovid|mesh-list
101948588|NCT03855423|Antioxidants|antioxidants|mesh-ancestor
101948589|NCT03855423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948590|NCT03855423|Protective Agents|protective agents|mesh-ancestor
101948591|NCT03855423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001626|NCT03379012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102001627|NCT03379012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001628|NCT03379012|Androgens|androgens|mesh-ancestor
102001629|NCT03379012|Hormones|hormones|mesh-ancestor
102001630|NCT03379012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102001631|NCT03379012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102001632|NCT03379012|Anabolic Agents|anabolic agents|mesh-ancestor
102001633|NCT03383302|Nivolumab|nivolumab|mesh-list
102001634|NCT03383302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102001635|NCT03383302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102001636|NCT03383302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102001637|NCT03383302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001638|NCT03493126|Estradiol|estradiol|mesh-list
102001639|NCT03493126|Estrogens|estrogens|mesh-ancestor
102001640|NCT03493126|Hormones|hormones|mesh-ancestor
101628287|NCT00720499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001659|NCT01281527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001660|NCT01281527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102001661|NCT01281527|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102001662|NCT01281527|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102001663|NCT01281527|Serotonin Agents|serotonin agents|mesh-ancestor
102001664|NCT01281527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102001665|NCT01281527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001666|NCT01281527|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102001667|NCT01281527|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102001668|NCT01281527|Dopamine Agents|dopamine agents|mesh-ancestor
102001669|NCT01281605|Insulin|insulin|mesh-list
102001670|NCT01281605|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102001671|NCT01281605|Insulin Detemir|insulin detemir|mesh-list
102001672|NCT01281605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102001673|NCT01281605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001674|NCT01170143|Trastuzumab|trastuzumab|mesh-list
102001675|NCT01170143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102001676|NCT01170143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102001677|NCT05171530|Lenvatinib|lenvatinib|mesh-list
102001678|NCT05171530|Taxane|taxane|mesh-list
102001679|NCT05171530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102001680|NCT05171530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102001681|NCT05171530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102001682|NCT05171530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001683|NCT02936037|Biotin|biotin|mesh-list
102001684|NCT02936037|Vitamin B Complex|vitamin b complex|mesh-ancestor
102001685|NCT02936037|Vitamins|vitamins|mesh-ancestor
102001686|NCT02936037|Micronutrients|micronutrients|mesh-ancestor
102001687|NCT02936037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001688|NCT04068181|Pembrolizumab|pembrolizumab|mesh-list
102001689|NCT04068181|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
102001690|NCT04068181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102001691|NCT04068181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102001692|NCT04068181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102001693|NCT04068181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001694|NCT01283789|Everolimus|everolimus|mesh-list
102001734|NCT04094298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102001736|NCT04094298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102001737|NCT04094298|Immunologic Factors|immunologic factors|mesh-ancestor
102001738|NCT04194151|Propofol|propofol|mesh-list
102001739|NCT04194151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102001740|NCT04194151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102001741|NCT04194151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001742|NCT04194151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102001743|NCT04194151|Anesthetics, General|anesthetics, general|mesh-ancestor
102001744|NCT04194151|Anesthetics|anesthetics|mesh-ancestor
102001745|NCT01281761|Irinotecan|irinotecan|mesh-list
102001746|NCT01281761|Cetuximab|cetuximab|mesh-list
102001747|NCT01281761|Simvastatin|simvastatin|mesh-list
102001748|NCT01281761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101948592|NCT03855423|Vitamins|vitamins|mesh-ancestor
101948593|NCT03855423|Micronutrients|micronutrients|mesh-ancestor
101948594|NCT01181505|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101948595|NCT01181505|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101948596|NCT01181505|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101948597|NCT01181505|Cholinergic Agents|cholinergic agents|mesh-ancestor
101948598|NCT01181505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101948599|NCT01181505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828095|NCT05997004|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101828096|NCT05997004|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101828097|NCT05997004|Cholinergic Agents|cholinergic agents|mesh-ancestor
101828098|NCT05997004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101828099|NCT05997004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828100|NCT05997004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101828106|NCT05995301|Ropivacaine|ropivacaine|mesh-list
101828107|NCT05995301|Anesthetics, Local|anesthetics, local|mesh-ancestor
101828108|NCT05995301|Anesthetics|anesthetics|mesh-ancestor
101828109|NCT05995301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101828110|NCT05995301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001749|NCT01281761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102001750|NCT01281761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102001751|NCT01281761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001752|NCT01281761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102001753|NCT01281761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102001754|NCT01281761|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102001755|NCT01281761|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102001756|NCT01281761|Antimetabolites|antimetabolites|mesh-ancestor
102001757|NCT01281761|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102001758|NCT01281761|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102001759|NCT04280328|Daratumumab|daratumumab|mesh-list
102001760|NCT04280328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102001761|NCT03748147|Misoprostol|misoprostol|mesh-list
102001762|NCT03748147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102001763|NCT03748147|Abortifacient Agents|abortifacient agents|mesh-ancestor
102001764|NCT03748147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102001765|NCT03748147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001766|NCT03748147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102001767|NCT03748147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102001768|NCT03748147|Oxytocics|oxytocics|mesh-ancestor
102001769|NCT01580813|Acipimox|acipimox|mesh-list
102001770|NCT01580813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102001771|NCT01580813|Antimetabolites|antimetabolites|mesh-ancestor
102001772|NCT01580813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001773|NCT01580813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102001774|NCT04446364|Disinfectants|disinfectants|mesh-list
102001775|NCT04446364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102001776|NCT01588535|Benzocaine|benzocaine|mesh-list
102001777|NCT01588535|Anesthetics, Local|anesthetics, local|mesh-ancestor
102001778|NCT01588535|Anesthetics|anesthetics|mesh-ancestor
102001779|NCT01588535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102001780|NCT01588535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001781|NCT01588535|Sensory System Agents|sensory system agents|mesh-ancestor
102001782|NCT01588535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102001783|NCT01165931|Riociguat|riociguat|mesh-list
102001784|NCT01165931|Enzyme Activators|enzyme activators|mesh-ancestor
101948600|NCT01181505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948601|NCT01181505|Urological Agents|urological agents|mesh-ancestor
101948602|NCT01290783|Irinotecan|irinotecan|mesh-list
101948603|NCT01290783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101948604|NCT01290783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101948605|NCT01290783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101948606|NCT01290783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948607|NCT01290783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101948608|NCT03857763|Paclitaxel|paclitaxel|mesh-list
101948609|NCT03857763|Apatinib|apatinib|mesh-list
101828166|NCT05919823|Cholinergic Agents|cholinergic agents|mesh-ancestor
101828167|NCT05919823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101828168|NCT05919823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828169|NCT05919823|Urological Agents|urological agents|mesh-ancestor
101828170|NCT05919823|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101828171|NCT05919823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101828172|NCT05919823|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101828173|NCT05919823|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101828179|NCT05915728|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
101828180|NCT05915728|Chelating Agents|chelating agents|mesh-ancestor
101828181|NCT05915728|Sequestering Agents|sequestering agents|mesh-ancestor
101828182|NCT05915728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828183|NCT05915702|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
101828184|NCT05915702|Chelating Agents|chelating agents|mesh-ancestor
101828185|NCT05915702|Sequestering Agents|sequestering agents|mesh-ancestor
101828186|NCT05915702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828209|NCT05907304|Trametinib|trametinib|mesh-list
101828210|NCT05907304|Naporafenib|naporafenib|mesh-list
101828211|NCT05907304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101828212|NCT05907304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101828213|NCT05907304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101828215|NCT05904743|Insulin|insulin|mesh-list
101948610|NCT03857763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101948611|NCT03857763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101948612|NCT03857763|Tubulin Modulators|tubulin modulators|mesh-ancestor
101948613|NCT03857763|Antimitotic Agents|antimitotic agents|mesh-ancestor
101948614|NCT03857763|Mitosis Modulators|mitosis modulators|mesh-ancestor
101948615|NCT03857763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948616|NCT03857763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101948617|NCT03857763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101948618|NCT06008522|Bevacizumab|bevacizumab|mesh-list
101948619|NCT06008522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101948620|NCT06008522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101828234|NCT05889182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101828235|NCT05889182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101828236|NCT05889182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828237|NCT05889182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101828238|NCT05885542|Cannabidiol|cannabidiol|mesh-list
101828239|NCT05885542|Anticonvulsants|anticonvulsants|mesh-ancestor
101828245|NCT05862285|Ipatasertib|ipatasertib|mesh-list
101828246|NCT05862285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101828247|NCT05862285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101828248|NCT05862285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101828249|NCT05862285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828250|NCT05856227|Ceftobiprole|ceftobiprole|mesh-list
101828251|NCT05856227|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
101828252|NCT05856227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101828253|NCT05856227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101828254|NCT05853367|Pembrolizumab|pembrolizumab|mesh-list
101828255|NCT05853367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101828256|NCT05853367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101828257|NCT05853367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102001785|NCT01165931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001786|NCT03441282|Fentanyl|fentanyl|mesh-list
102001787|NCT03441282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102001788|NCT03441282|Narcotics|narcotics|mesh-ancestor
102001789|NCT03441282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102001790|NCT03441282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001791|NCT03441282|Analgesics|analgesics|mesh-ancestor
102001792|NCT03441282|Sensory System Agents|sensory system agents|mesh-ancestor
102001793|NCT03441282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102001794|NCT03441282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102001795|NCT03441282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102001796|NCT03441282|Anesthetics, General|anesthetics, general|mesh-ancestor
102001797|NCT03441282|Anesthetics|anesthetics|mesh-ancestor
102001798|NCT01274273|Interferons|interferons|mesh-list
101948621|NCT06008522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101948622|NCT06008522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101948623|NCT06008522|Growth Substances|growth substances|mesh-ancestor
101948624|NCT06008522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948625|NCT06008522|Growth Inhibitors|growth inhibitors|mesh-ancestor
101948626|NCT06008405|Azacitidine|azacitidine|mesh-list
101948627|NCT06008405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101948628|NCT06008405|Antimetabolites|antimetabolites|mesh-ancestor
101948629|NCT06008405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948630|NCT06008405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101828302|NCT05789069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101828303|NCT05789069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101828304|NCT05784246|Mirikizumab|mirikizumab|mesh-list
101828306|NCT05784246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102001799|NCT01274273|Interferon-alpha|interferon-alpha|mesh-list
102001805|NCT01274273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102001806|NCT01274273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102001807|NCT01274273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102001808|NCT01274273|Growth Substances|growth substances|mesh-ancestor
102001809|NCT01274273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001810|NCT01274273|Growth Inhibitors|growth inhibitors|mesh-ancestor
102001811|NCT01274273|Antiviral Agents|antiviral agents|mesh-ancestor
102001812|NCT01274273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102001813|NCT01274273|Immunologic Factors|immunologic factors|mesh-ancestor
102001814|NCT01274273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102001815|NCT01274273|Analgesics|analgesics|mesh-ancestor
102001816|NCT01274273|Sensory System Agents|sensory system agents|mesh-ancestor
102001817|NCT01274273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102001818|NCT01274273|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102001819|NCT01274273|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102001820|NCT04058353|Ivacaftor|ivacaftor|mesh-list
102001821|NCT04058353|Elexacaftor|elexacaftor|mesh-list
102001822|NCT04058353|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102001823|NCT04058353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102001824|NCT04058353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001825|NCT01167725|Leucovorin|leucovorin|mesh-list
102001826|NCT01167725|Bevacizumab|bevacizumab|mesh-list
102001827|NCT01167725|Cetuximab|cetuximab|mesh-list
102001828|NCT01167725|Fluorouracil|fluorouracil|mesh-list
102001829|NCT01167725|Capecitabine|capecitabine|mesh-list
102001830|NCT01167725|Oxaliplatin|oxaliplatin|mesh-list
102001831|NCT01167725|Irinotecan|irinotecan|mesh-list
102001832|NCT01167725|Mitomycins|mitomycins|mesh-list
102001833|NCT01167725|Mitomycin|mitomycin|mesh-list
102001834|NCT01167725|Levoleucovorin|levoleucovorin|mesh-list
102001835|NCT01167725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102001836|NCT01167725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102001837|NCT01167725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101259355|NCT01737671|Leucovorin|leucovorin|mesh-list
102001838|NCT01167725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102001839|NCT01167725|Growth Substances|growth substances|mesh-ancestor
102001840|NCT01167725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001841|NCT01167725|Growth Inhibitors|growth inhibitors|mesh-ancestor
102001842|NCT01167725|Antimetabolites|antimetabolites|mesh-ancestor
102001843|NCT01167725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001844|NCT01167725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102001845|NCT01167725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102001846|NCT01167725|Immunologic Factors|immunologic factors|mesh-ancestor
102001847|NCT01167725|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102001848|NCT01167725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102001849|NCT01167725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102001850|NCT01167725|Antidotes|antidotes|mesh-ancestor
102001851|NCT01167725|Protective Agents|protective agents|mesh-ancestor
101948631|NCT06008405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101948632|NCT06008327|Tretinoin|tretinoin|mesh-list
101948633|NCT06008327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101948634|NCT06008327|Keratolytic Agents|keratolytic agents|mesh-ancestor
101948635|NCT06008327|Dermatologic Agents|dermatologic agents|mesh-ancestor
101948636|NCT06008249|Lithium Carbonate|lithium carbonate|mesh-list
101948637|NCT06008249|Antidepressive Agents|antidepressive agents|mesh-ancestor
101948638|NCT06008249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101948639|NCT06008249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101948640|NCT06008249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948641|NCT06008249|Antimanic Agents|antimanic agents|mesh-ancestor
101948642|NCT06008249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101948643|NCT06008249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101948644|NCT06008249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948645|NCT06008223|Vitamin B 6|vitamin b 6|mesh-list
101948646|NCT06008223|Pyridoxal|pyridoxal|mesh-list
101948647|NCT06008223|Pyridoxine|pyridoxine|mesh-list
101485658|NCT00345696|Antimetabolites|antimetabolites|mesh-ancestor
101828409|NCT05655598|Palbociclib|palbociclib|mesh-list
101828410|NCT05655598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101828411|NCT05655598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101828412|NCT05655598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101828413|NCT05655598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828430|NCT05631899|Cyclophosphamide|cyclophosphamide|mesh-list
101828431|NCT05631899|Ipilimumab|ipilimumab|mesh-list
101828432|NCT05631899|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101828433|NCT05631899|Paclitaxel|paclitaxel|mesh-list
101828434|NCT05631899|Antibodies|antibodies|mesh-list
101828435|NCT05631899|Immunoglobulins|immunoglobulins|mesh-list
101828436|NCT05631899|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101828437|NCT05631899|Antibodies, Blocking|antibodies, blocking|mesh-list
101828438|NCT05631899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101828439|NCT05631899|Immunologic Factors|immunologic factors|mesh-ancestor
101828440|NCT05631899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101828441|NCT05631899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101828442|NCT05631899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101828443|NCT05631899|Alkylating Agents|alkylating agents|mesh-ancestor
101828444|NCT05631899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948648|NCT06008223|Vitamins|vitamins|mesh-ancestor
101948649|NCT06008223|Micronutrients|micronutrients|mesh-ancestor
101948650|NCT06008223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948651|NCT06008223|Vitamin B Complex|vitamin b complex|mesh-ancestor
101948652|NCT06008119|Bevacizumab|bevacizumab|mesh-list
102001852|NCT01167725|Vitamin B Complex|vitamin b complex|mesh-ancestor
102001853|NCT01167725|Vitamins|vitamins|mesh-ancestor
102001854|NCT01167725|Micronutrients|micronutrients|mesh-ancestor
102001855|NCT01167725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102001856|NCT01167725|Alkylating Agents|alkylating agents|mesh-ancestor
102001857|NCT01167725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102001858|NCT04446130|Decitabine|decitabine|mesh-list
102001859|NCT04446130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102001860|NCT04446130|Antimetabolites|antimetabolites|mesh-ancestor
102001861|NCT04446130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001862|NCT04446130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102001863|NCT04446130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102001864|NCT03226275|Amlodipine|amlodipine|mesh-list
102001865|NCT03226275|Bisoprolol|bisoprolol|mesh-list
102001866|NCT03226275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102001867|NCT03226275|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102001868|NCT03226275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102001869|NCT03226275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001870|NCT03226275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102001871|NCT03226275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001872|NCT03226275|Vasodilator Agents|vasodilator agents|mesh-ancestor
102001873|NCT03226275|Sympatholytics|sympatholytics|mesh-ancestor
102001887|NCT03382756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001889|NCT03382756|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102001890|NCT03382756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102001891|NCT03382756|Lipotropic Agents|lipotropic agents|mesh-ancestor
102001892|NCT03382756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102001893|NCT03382756|Nootropic Agents|nootropic agents|mesh-ancestor
102001894|NCT01166087|Fluoxetine|fluoxetine|mesh-list
102001895|NCT01166087|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102001896|NCT01166087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102001897|NCT01166087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102001898|NCT01166087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001899|NCT01166087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102001900|NCT01166087|Serotonin Agents|serotonin agents|mesh-ancestor
102001901|NCT01166087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001902|NCT01166087|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102001903|NCT01166087|Antidepressive Agents|antidepressive agents|mesh-ancestor
102001904|NCT01166087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102001905|NCT01166087|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102001906|NCT01166087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102001907|NCT01166087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102001908|NCT01170767|Bevacizumab|bevacizumab|mesh-list
102001909|NCT01170767|Ranibizumab|ranibizumab|mesh-list
102001910|NCT01170767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102001911|NCT01170767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102001912|NCT01170767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102001913|NCT01170767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102001914|NCT01170767|Growth Substances|growth substances|mesh-ancestor
102001915|NCT01170767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259454|NCT01738282|GABA Agents|gaba agents|mesh-ancestor
102001916|NCT01170767|Growth Inhibitors|growth inhibitors|mesh-ancestor
102001917|NCT01170845|Sivelestat|sivelestat|mesh-list
102001918|NCT01170845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102001919|NCT01170845|Protease Inhibitors|protease inhibitors|mesh-ancestor
102001920|NCT01170845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102001921|NCT01170845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001922|NCT01150890|Brodalumab|brodalumab|mesh-list
102001923|NCT01150890|Dermatologic Agents|dermatologic agents|mesh-ancestor
102001924|NCT01167803|Desflurane|desflurane|mesh-list
102001925|NCT01167803|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102001926|NCT01167803|Anesthetics, General|anesthetics, general|mesh-ancestor
102001927|NCT01167803|Anesthetics|anesthetics|mesh-ancestor
102001928|NCT01167803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102001929|NCT01167803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001930|NCT01275521|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
101948653|NCT06008119|Cetuximab|cetuximab|mesh-list
101948654|NCT06008119|Vemurafenib|vemurafenib|mesh-list
101948655|NCT06008119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101948656|NCT06008119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101948657|NCT06008119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101948658|NCT06008119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101948659|NCT06008119|Growth Substances|growth substances|mesh-ancestor
101948660|NCT06008119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948661|NCT06008119|Growth Inhibitors|growth inhibitors|mesh-ancestor
101948662|NCT06008119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101948663|NCT06008119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101948664|NCT06008119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948665|NCT06008106|Paclitaxel|paclitaxel|mesh-list
101948666|NCT06008106|Cisplatin|cisplatin|mesh-list
101948667|NCT06008106|Carboplatin|carboplatin|mesh-list
101948668|NCT06008106|Temozolomide|temozolomide|mesh-list
101948669|NCT06008106|Dacarbazine|dacarbazine|mesh-list
101948670|NCT06008106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101948671|NCT06008106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101948672|NCT06008106|Tubulin Modulators|tubulin modulators|mesh-ancestor
101948673|NCT06008106|Antimitotic Agents|antimitotic agents|mesh-ancestor
101948674|NCT06008106|Mitosis Modulators|mitosis modulators|mesh-ancestor
101948675|NCT06008106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948676|NCT06008106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102001931|NCT01275521|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102001932|NCT01275521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102001933|NCT01275521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628289|NCT00724243|Infliximab|infliximab|mesh-list
101721734|NCT03331289|Hormones|hormones|mesh-ancestor
102001948|NCT01275911|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102001949|NCT01275911|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102001950|NCT01275911|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102001952|NCT01275911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102001953|NCT01275911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001954|NCT01166165|Cholecalciferol|cholecalciferol|mesh-list
102001955|NCT01166165|Vitamin D|vitamin d|mesh-list
102001956|NCT01166165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102001957|NCT01166165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001958|NCT01166165|Vitamins|vitamins|mesh-ancestor
102001959|NCT01166165|Micronutrients|micronutrients|mesh-ancestor
102001960|NCT01166165|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102001961|NCT03286218|Alprazolam|alprazolam|mesh-list
102001962|NCT03286218|Lasmiditan|lasmiditan|mesh-list
102001963|NCT03286218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102001964|NCT03286218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102001965|NCT03286218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001966|NCT03286218|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102001967|NCT03286218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102001968|NCT03286218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102001969|NCT03286218|GABA Modulators|gaba modulators|mesh-ancestor
102001970|NCT03286218|GABA Agents|gaba agents|mesh-ancestor
102001971|NCT03286218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101948677|NCT06008106|Alkylating Agents|alkylating agents|mesh-ancestor
101948678|NCT06008093|Carboplatin|carboplatin|mesh-list
101948679|NCT06008093|Pembrolizumab|pembrolizumab|mesh-list
101948680|NCT06008093|Pemetrexed|pemetrexed|mesh-list
101948681|NCT06008093|Durvalumab|durvalumab|mesh-list
101948682|NCT06008093|Tremelimumab|tremelimumab|mesh-list
102001972|NCT03286218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001973|NCT03286218|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102001974|NCT03286218|Serotonin Agents|serotonin agents|mesh-ancestor
102001975|NCT03745261|Fluticasone|fluticasone|mesh-list
102001976|NCT03745261|Xhance|xhance|mesh-list
102001977|NCT03745261|Bromides|bromides|mesh-list
102001978|NCT03745261|Albuterol|albuterol|mesh-list
102001979|NCT03745261|Tiotropium Bromide|tiotropium bromide|mesh-list
102001980|NCT03745261|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102001981|NCT03745261|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102001982|NCT03745261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102001983|NCT03745261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102001984|NCT03745261|Autonomic Agents|autonomic agents|mesh-ancestor
102001985|NCT03745261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102001986|NCT03745261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001987|NCT03745261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102001988|NCT03745261|Respiratory System Agents|respiratory system agents|mesh-ancestor
102001989|NCT03745261|Dermatologic Agents|dermatologic agents|mesh-ancestor
102001990|NCT03745261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102001991|NCT03745261|Parasympatholytics|parasympatholytics|mesh-ancestor
102001992|NCT03745261|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102001993|NCT03745261|Cholinergic Agents|cholinergic agents|mesh-ancestor
102001994|NCT03745261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101457011|NCT00559195|Epoetin Alfa|epoetin alfa|mesh-list
102001999|NCT03745261|Adrenergic Agents|adrenergic agents|mesh-ancestor
102002000|NCT03745261|Anticonvulsants|anticonvulsants|mesh-ancestor
102002001|NCT03745261|Tocolytic Agents|tocolytic agents|mesh-ancestor
102002002|NCT03745261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102002003|NCT03745261|Glucocorticoids|glucocorticoids|mesh-ancestor
102002004|NCT03745261|Hormones|hormones|mesh-ancestor
102002005|NCT03745261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102002006|NCT03745261|Sympathomimetics|sympathomimetics|mesh-ancestor
102002007|NCT03744949|Remifentanil|remifentanil|mesh-list
102002008|NCT03744949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102002009|NCT03744949|Narcotics|narcotics|mesh-ancestor
102002010|NCT03744949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102002011|NCT03744949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002012|NCT03744949|Analgesics|analgesics|mesh-ancestor
102002013|NCT03744949|Sensory System Agents|sensory system agents|mesh-ancestor
102002014|NCT03744949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102002015|NCT03870581|Warfarin|warfarin|mesh-list
102002016|NCT03870581|Anticoagulants|anticoagulants|mesh-ancestor
102002017|NCT01277315|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102002018|NCT01277315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102002019|NCT04016779|Viloxazine|viloxazine|mesh-list
102002020|NCT04016779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102002021|NCT04016779|Antidepressive Agents|antidepressive agents|mesh-ancestor
102002022|NCT04016779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102002023|NCT04016779|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102002024|NCT04016779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102002025|NCT04016779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102002026|NCT04016779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002028|NCT04016779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102002029|NCT04016779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002030|NCT03870503|Misoprostol|misoprostol|mesh-list
102002031|NCT03870503|Oxytocin|oxytocin|mesh-list
102002032|NCT03870503|Carbetocin|carbetocin|mesh-list
102002033|NCT03870503|Oxytocics|oxytocics|mesh-ancestor
102002034|NCT03870503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102002035|NCT03870503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002036|NCT03870503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102002037|NCT03870503|Abortifacient Agents|abortifacient agents|mesh-ancestor
102002038|NCT03870503|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102002039|NCT03870503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102002040|NCT02857426|Nivolumab|nivolumab|mesh-list
102002041|NCT02857426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102002042|NCT02857426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101948683|NCT06008093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101948684|NCT06008093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101948685|NCT06008093|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101948686|NCT06008093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948687|NCT06008093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101948688|NCT06008093|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101948689|NCT06008093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101668547|NCT04627142|Irinotecan|irinotecan|mesh-list
101948690|NCT06007937|Ramucirumab|ramucirumab|mesh-list
101948691|NCT06007937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101948692|NCT06007911|Cytarabine|cytarabine|mesh-list
101948693|NCT06007911|Venetoclax|venetoclax|mesh-list
101948694|NCT06007911|Mitoxantrone|mitoxantrone|mesh-list
101948695|NCT06007911|Cladribine|cladribine|mesh-list
101948696|NCT06007911|Navitoclax|navitoclax|mesh-list
102002043|NCT02857426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102002044|NCT02857426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002045|NCT05181033|Letrozole|letrozole|mesh-list
102002046|NCT05181033|Lenvatinib|lenvatinib|mesh-list
102002047|NCT05181033|Fulvestrant|fulvestrant|mesh-list
102002048|NCT05181033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102002049|NCT05181033|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102002050|NCT05181033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102002051|NCT05181033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102002052|NCT05181033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002053|NCT05181033|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102002054|NCT05181033|Hormone Antagonists|hormone antagonists|mesh-ancestor
102002055|NCT05181033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102002056|NCT05181033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002057|NCT05181033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102002058|NCT05181033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102002059|NCT05181033|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102002060|NCT05666765|Isotretinoin|isotretinoin|mesh-list
102002061|NCT05666765|Silymarin|silymarin|mesh-list
102002062|NCT05666765|Dermatologic Agents|dermatologic agents|mesh-ancestor
102002063|NCT05666765|Antioxidants|antioxidants|mesh-ancestor
102002064|NCT05666765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002065|NCT05666765|Protective Agents|protective agents|mesh-ancestor
102002080|NCT01127256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102002081|NCT01127256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002082|NCT01127256|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102002083|NCT01127256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102002084|NCT01127256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102002085|NCT01127256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102002086|NCT03377842|Leucovorin|leucovorin|mesh-list
102002087|NCT03377842|Apatinib|apatinib|mesh-list
102002088|NCT03377842|Fluorouracil|fluorouracil|mesh-list
102002089|NCT03377842|Oxaliplatin|oxaliplatin|mesh-list
102002090|NCT03377842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102002091|NCT03377842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102002092|NCT03377842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102002093|NCT03377842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002094|NCT03377842|Antimetabolites|antimetabolites|mesh-ancestor
102002095|NCT03377842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102002096|NCT03377842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102002097|NCT03377842|Immunologic Factors|immunologic factors|mesh-ancestor
102002098|NCT03377842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002099|NCT03377842|Antidotes|antidotes|mesh-ancestor
102002100|NCT03377842|Protective Agents|protective agents|mesh-ancestor
102002101|NCT03377842|Vitamin B Complex|vitamin b complex|mesh-ancestor
102002102|NCT03377842|Vitamins|vitamins|mesh-ancestor
101948697|NCT06007911|Lenograstim|lenograstim|mesh-list
101948698|NCT06007911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101948699|NCT06007911|Antimetabolites|antimetabolites|mesh-ancestor
101948700|NCT06007911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948701|NCT06007911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101948702|NCT06007911|Antiviral Agents|antiviral agents|mesh-ancestor
101948703|NCT06007911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101948704|NCT06007911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101948705|NCT06007911|Immunologic Factors|immunologic factors|mesh-ancestor
101948706|NCT06007911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948707|NCT06007911|Analgesics|analgesics|mesh-ancestor
101948708|NCT06007911|Sensory System Agents|sensory system agents|mesh-ancestor
101828733|NCT05328908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101828734|NCT05319730|Paclitaxel|paclitaxel|mesh-list
101828735|NCT05319730|Pembrolizumab|pembrolizumab|mesh-list
101828736|NCT05319730|Irinotecan|irinotecan|mesh-list
101828737|NCT05319730|Lenvatinib|lenvatinib|mesh-list
101828738|NCT05319730|Immunoglobulins|immunoglobulins|mesh-list
101828739|NCT05319730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101828740|NCT05319730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101828741|NCT05319730|Tubulin Modulators|tubulin modulators|mesh-ancestor
101828742|NCT05319730|Antimitotic Agents|antimitotic agents|mesh-ancestor
101828743|NCT05319730|Mitosis Modulators|mitosis modulators|mesh-ancestor
101828744|NCT05319730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828745|NCT05319730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101828746|NCT05319730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102002103|NCT03377842|Micronutrients|micronutrients|mesh-ancestor
102002104|NCT03668613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102002105|NCT03668613|Immunologic Factors|immunologic factors|mesh-ancestor
102002106|NCT03668613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002107|NCT01277705|Vaccines|vaccines|mesh-list
102002108|NCT01277705|Immunologic Factors|immunologic factors|mesh-ancestor
102002109|NCT01277705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002110|NCT04757337|Cyclophosphamide|cyclophosphamide|mesh-list
102002111|NCT04757337|Doxorubicin|doxorubicin|mesh-list
102002112|NCT04757337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102002113|NCT04757337|Immunologic Factors|immunologic factors|mesh-ancestor
102002114|NCT04757337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002115|NCT04757337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102002116|NCT04757337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102002117|NCT04757337|Alkylating Agents|alkylating agents|mesh-ancestor
102002118|NCT04757337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002119|NCT04757337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102002120|NCT04757337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102002121|NCT04757337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102002122|NCT04757337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102002123|NCT04757337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102002124|NCT04757337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102002125|NCT03946527|Lanreotide|lanreotide|mesh-list
102002126|NCT03946527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101948709|NCT06007911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101948710|NCT06007911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101948711|NCT06007911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101948712|NCT06007911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101948713|NCT06007911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101948715|NCT06007846|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101948716|NCT06007846|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101948717|NCT06007846|Dopamine Agents|dopamine agents|mesh-ancestor
101948718|NCT06007846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101948719|NCT06007846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948720|NCT06007846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948721|NCT06007846|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101948722|NCT06007846|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101948723|NCT06007586|Aprepitant|aprepitant|mesh-list
101948724|NCT06007586|Antiemetics|antiemetics|mesh-ancestor
101948725|NCT06007586|Autonomic Agents|autonomic agents|mesh-ancestor
101948726|NCT06007586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101948727|NCT06007586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948728|NCT06007586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101948729|NCT06007586|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101948730|NCT06007586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101948731|NCT06007586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948732|NCT06007573|Nimodipine|nimodipine|mesh-list
101948733|NCT06007573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101948734|NCT06007573|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101948735|NCT06007573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101948736|NCT06007573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948737|NCT06007573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102002127|NCT03377608|Tenofovir|tenofovir|mesh-list
101457142|NCT00218660|Naltrexone|naltrexone|mesh-list
102002140|NCT03377608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102002141|NCT03377608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002142|NCT03377608|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102002143|NCT03377608|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102002144|NCT03377608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102002145|NCT03377608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102002146|NCT03377608|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102002147|NCT03377608|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102002148|NCT03377608|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102002149|NCT01282073|Cyclosporine|cyclosporine|mesh-list
102002150|NCT01282073|Mycophenolic Acid|mycophenolic acid|mesh-list
102002151|NCT01282073|Cyclosporins|cyclosporins|mesh-list
101948738|NCT06007573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948739|NCT06007573|Vasodilator Agents|vasodilator agents|mesh-ancestor
101948740|NCT06007547|Poractant alfa|poractant alfa|mesh-list
101948741|NCT06007547|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
102002152|NCT01282073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102002153|NCT01282073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002154|NCT01282073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102002155|NCT01282073|Immunologic Factors|immunologic factors|mesh-ancestor
102002156|NCT01282073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002157|NCT01282073|Antifungal Agents|antifungal agents|mesh-ancestor
102002158|NCT01282073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102002159|NCT01282073|Dermatologic Agents|dermatologic agents|mesh-ancestor
102002160|NCT01282073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102002161|NCT01282073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102002162|NCT01282073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102002163|NCT01282073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102002164|NCT01282073|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102002165|NCT01282073|Antitubercular Agents|antitubercular agents|mesh-ancestor
102002166|NCT01282073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102002167|NCT01166477|Ritonavir|ritonavir|mesh-list
102002168|NCT01166477|Lopinavir|lopinavir|mesh-list
102002169|NCT01166477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102002170|NCT01166477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102002171|NCT01166477|Protease Inhibitors|protease inhibitors|mesh-ancestor
102002172|NCT01166477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102002173|NCT01166477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002174|NCT01166477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102002175|NCT01166477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102002176|NCT01166477|Antiviral Agents|antiviral agents|mesh-ancestor
102002177|NCT01166477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102002178|NCT01166477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102002179|NCT01166477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102002180|NCT01282151|Cisplatin|cisplatin|mesh-list
102002181|NCT01282151|Pemetrexed|pemetrexed|mesh-list
102002182|NCT01282151|Docetaxel|docetaxel|mesh-list
102002183|NCT01282151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102002184|NCT01282151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102002185|NCT01282151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002186|NCT01282151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102002187|NCT01282151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102002188|NCT01282151|Tubulin Modulators|tubulin modulators|mesh-ancestor
102002189|NCT01282151|Antimitotic Agents|antimitotic agents|mesh-ancestor
102002204|NCT03382600|Pembrolizumab|pembrolizumab|mesh-list
102002205|NCT03382600|Oxaliplatin|oxaliplatin|mesh-list
102002206|NCT03382600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102002207|NCT03382600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102002208|NCT03382600|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102002209|NCT03382600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002210|NCT04013191|Padsevonil|padsevonil|mesh-list
102002211|NCT04013191|Anticonvulsants|anticonvulsants|mesh-ancestor
102002212|NCT03867929|Vitamin D|vitamin d|mesh-list
102002213|NCT03867929|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
102002214|NCT03867929|Calcifediol|calcifediol|mesh-list
102002215|NCT03867929|Vitamins|vitamins|mesh-ancestor
102002216|NCT03867929|Micronutrients|micronutrients|mesh-ancestor
102002217|NCT03867929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002218|NCT03867929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102002219|NCT03285594|Insulin Glargine|insulin glargine|mesh-list
102002220|NCT03285594|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
102002221|NCT03285594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102002222|NCT03285594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002223|NCT03285594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102002224|NCT03285594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002225|NCT01171469|Imiquimod|imiquimod|mesh-list
102002226|NCT01171469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102002227|NCT01171469|Immunologic Factors|immunologic factors|mesh-ancestor
102002228|NCT01171469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002229|NCT01171469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101259799|NCT01740960|Analgesics|analgesics|mesh-ancestor
102002230|NCT01171469|Interferon Inducers|interferon inducers|mesh-ancestor
102002231|NCT02695992|Metoprolol|metoprolol|mesh-list
102002232|NCT02695992|Diltiazem|diltiazem|mesh-list
101948742|NCT06007547|Respiratory System Agents|respiratory system agents|mesh-ancestor
101948743|NCT06007508|Insulin Glargine|insulin glargine|mesh-list
101948744|NCT06007508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101948745|NCT06007508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948746|NCT06007352|Gentamicins|gentamicins|mesh-list
101948747|NCT06007352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102002233|NCT02695992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102002234|NCT02695992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102002235|NCT02695992|Sympatholytics|sympatholytics|mesh-ancestor
102002236|NCT02695992|Autonomic Agents|autonomic agents|mesh-ancestor
102002237|NCT02695992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102002238|NCT02695992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002239|NCT02695992|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102002240|NCT02695992|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102002241|NCT02695992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102002242|NCT02695992|Adrenergic Agents|adrenergic agents|mesh-ancestor
102002243|NCT02695992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102002244|NCT02695992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002245|NCT02695992|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102002246|NCT02695992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102002247|NCT02695992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102002248|NCT02695992|Vasodilator Agents|vasodilator agents|mesh-ancestor
102002249|NCT04050865|Dexamethasone|dexamethasone|mesh-list
102002250|NCT04050865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102002251|NCT04050865|Antiemetics|antiemetics|mesh-ancestor
102002252|NCT04050865|Autonomic Agents|autonomic agents|mesh-ancestor
102002260|NCT04050865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102002261|NCT03283566|Hydroxychloroquine|hydroxychloroquine|mesh-list
102002262|NCT03283566|Antimalarials|antimalarials|mesh-ancestor
102002263|NCT03283566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102002264|NCT03283566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102002265|NCT03283566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102002266|NCT03283566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102002267|NCT03283566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002268|NCT03283566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102002269|NCT01171547|Daptomycin|daptomycin|mesh-list
102002270|NCT01171547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102002271|NCT01171547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102002272|NCT04048681|Cocaine|cocaine|mesh-list
102002273|NCT04048681|Anesthetics, Local|anesthetics, local|mesh-ancestor
102002274|NCT04048681|Anesthetics|anesthetics|mesh-ancestor
102002275|NCT04048681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102002276|NCT04048681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002277|NCT04048681|Sensory System Agents|sensory system agents|mesh-ancestor
102002278|NCT04048681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101259873|NCT01741506|Dalteparin|dalteparin|mesh-list
102002279|NCT04048681|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102002280|NCT04048681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102002281|NCT04048681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102002282|NCT04048681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102002283|NCT04048681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002284|NCT04048681|Dopamine Agents|dopamine agents|mesh-ancestor
102002285|NCT04048681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102002286|NCT01282385|Simvastatin|simvastatin|mesh-list
102002287|NCT01282385|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102002288|NCT01282385|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102002289|NCT01282385|Antimetabolites|antimetabolites|mesh-ancestor
102002290|NCT01282385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002291|NCT01282385|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102002292|NCT01282385|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102002293|NCT01282385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102002294|NCT01166711|Chromium|chromium|mesh-list
102002295|NCT01166711|Paclitaxel|paclitaxel|mesh-list
102002296|NCT01166711|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102002297|NCT01166711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102002298|NCT01166711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102002299|NCT01166711|Tubulin Modulators|tubulin modulators|mesh-ancestor
102002300|NCT01166711|Antimitotic Agents|antimitotic agents|mesh-ancestor
102002301|NCT01166711|Mitosis Modulators|mitosis modulators|mesh-ancestor
102002302|NCT01166711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948748|NCT06007352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101948749|NCT06007352|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101948751|NCT06007352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948752|NCT06007222|Aspirin|aspirin|mesh-list
101948753|NCT06007222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101948754|NCT06007222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101948755|NCT06007222|Analgesics|analgesics|mesh-ancestor
101948756|NCT06007222|Sensory System Agents|sensory system agents|mesh-ancestor
101948757|NCT06007222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101948758|NCT06007222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948759|NCT06007222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101829017|NCT04985344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101829018|NCT04985344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829019|NCT04985344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002303|NCT01166711|Trace Elements|trace elements|mesh-ancestor
102002304|NCT01166711|Micronutrients|micronutrients|mesh-ancestor
102002305|NCT01166711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002306|NCT01168739|Quercetin|quercetin|mesh-list
102002307|NCT01168739|Antioxidants|antioxidants|mesh-ancestor
102002308|NCT01168739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002309|NCT01168739|Protective Agents|protective agents|mesh-ancestor
102002310|NCT01168739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002311|NCT01171781|Cisplatin|cisplatin|mesh-list
102002312|NCT01171781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102002313|NCT04006171|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
102002314|NCT04006171|Natriuretic Agents|natriuretic agents|mesh-ancestor
102002315|NCT04006171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002316|NCT01171859|Doxycycline|doxycycline|mesh-list
102002317|NCT01171859|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
102002318|NCT01171859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102002319|NCT01171859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102002339|NCT02652468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102002340|NCT02652468|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102002341|NCT02652468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102002342|NCT02652468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102002343|NCT02652468|Antimetabolites|antimetabolites|mesh-ancestor
102002344|NCT02652468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102002345|NCT02652468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102002346|NCT02652468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102002347|NCT02652468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102002348|NCT02652468|Antitubercular Agents|antitubercular agents|mesh-ancestor
102002349|NCT02652468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102002350|NCT02652468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102002352|NCT04673877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102002353|NCT04673877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102002354|NCT01166789|Lubiprostone|lubiprostone|mesh-list
102002355|NCT01166789|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102002356|NCT01166789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102002357|NCT01166789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002358|NCT01314339|Desloratadine|desloratadine|mesh-list
102002359|NCT01314339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102002360|NCT01314339|Cholinergic Agents|cholinergic agents|mesh-ancestor
102002361|NCT01314339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102002362|NCT01314339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002363|NCT01314339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002364|NCT01314339|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101948760|NCT06007222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101948761|NCT06007222|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101948762|NCT06007222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101948763|NCT06007222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948764|NCT06007222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101948765|NCT06007222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101948766|NCT06007222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101948767|NCT06007222|Antipyretics|antipyretics|mesh-ancestor
101948769|NCT06006949|Hematinics|hematinics|mesh-ancestor
101948770|NCT06006923|Pembrolizumab|pembrolizumab|mesh-list
101948771|NCT06006923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102002365|NCT01314339|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102002366|NCT01314339|Histamine Antagonists|histamine antagonists|mesh-ancestor
102002367|NCT01314339|Histamine Agents|histamine agents|mesh-ancestor
102002368|NCT01168817|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
102002369|NCT01168817|Vasodilator Agents|vasodilator agents|mesh-ancestor
102002370|NCT01168817|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102002371|NCT01168817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102002372|NCT01168817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102002373|NCT01168817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002374|NCT01168817|Urological Agents|urological agents|mesh-ancestor
102002375|NCT01279811|Dopamine|dopamine|mesh-list
102002376|NCT01279811|Norepinephrine|norepinephrine|mesh-list
102002383|NCT01279811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002384|NCT01279811|Sympathomimetics|sympathomimetics|mesh-ancestor
102002385|NCT01279811|Autonomic Agents|autonomic agents|mesh-ancestor
102002386|NCT01279811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102002387|NCT01279811|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102002388|NCT01279811|Dopamine Agents|dopamine agents|mesh-ancestor
102002389|NCT01279811|Protective Agents|protective agents|mesh-ancestor
102002390|NCT01168895|Ciprofloxacin|ciprofloxacin|mesh-list
102002391|NCT01168895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102002392|NCT01168895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102002393|NCT01168895|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102002394|NCT01168895|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102002395|NCT01168895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102002396|NCT01168895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002397|NCT01168895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101722176|NCT00754780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102002398|NCT01168895|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102002399|NCT01168895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102002400|NCT03745105|Dexamethasone|dexamethasone|mesh-list
101259988|NCT01742338|Hormones|hormones|mesh-ancestor
102002401|NCT03745105|Dexamethasone acetate|dexamethasone acetate|mesh-list
102002402|NCT03745105|Piroxicam|piroxicam|mesh-list
102002403|NCT03745105|Mepivacaine|mepivacaine|mesh-list
102002404|NCT03745105|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102002405|NCT03745105|BB 1101|bb 1101|mesh-list
102002406|NCT03745105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102002407|NCT03745105|Antiemetics|antiemetics|mesh-ancestor
102002408|NCT03745105|Autonomic Agents|autonomic agents|mesh-ancestor
102002409|NCT03745105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102002410|NCT03745105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002411|NCT03745105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102002412|NCT03745105|Glucocorticoids|glucocorticoids|mesh-ancestor
102002413|NCT03745105|Hormones|hormones|mesh-ancestor
102002414|NCT03745105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102002415|NCT03745105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102002416|NCT03745105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102002417|NCT03745105|Anesthetics, Local|anesthetics, local|mesh-ancestor
102002418|NCT03745105|Anesthetics|anesthetics|mesh-ancestor
102002419|NCT03745105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102002420|NCT03745105|Sensory System Agents|sensory system agents|mesh-ancestor
102002421|NCT03745105|Protease Inhibitors|protease inhibitors|mesh-ancestor
102002422|NCT03745105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101737359|NCT00780416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948772|NCT06006923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101948773|NCT06006923|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101948774|NCT06006923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948775|NCT06006884|Dimercaprol|dimercaprol|mesh-list
101948776|NCT06006884|Chelating Agents|chelating agents|mesh-ancestor
101948777|NCT06006884|Sequestering Agents|sequestering agents|mesh-ancestor
101948778|NCT06006884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948779|NCT06006663|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101948780|NCT06006663|Metronidazole|metronidazole|mesh-list
101948781|NCT06006663|Ciprofloxacin|ciprofloxacin|mesh-list
101948782|NCT06006663|Clindamycin|clindamycin|mesh-list
101948783|NCT06006663|Ibuprofen|ibuprofen|mesh-list
101948784|NCT06006663|Curcumin|curcumin|mesh-list
101948785|NCT06006663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101948786|NCT06006663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101948787|NCT06006663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101948788|NCT06006663|Analgesics|analgesics|mesh-ancestor
101948789|NCT06006663|Sensory System Agents|sensory system agents|mesh-ancestor
101948790|NCT06006663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101829160|NCT04739800|Topotecan|topotecan|mesh-list
101829161|NCT04739800|Olaparib|olaparib|mesh-list
101829162|NCT04739800|Cediranib|cediranib|mesh-list
101829163|NCT04739800|Maleic acid|maleic acid|mesh-list
101829164|NCT04739800|Immunoglobulins|immunoglobulins|mesh-list
101829165|NCT04739800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101829166|NCT04739800|Immunoglobulin G|immunoglobulin g|mesh-list
101829167|NCT04739800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102002423|NCT03745105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002424|NCT03745105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102002425|NCT03745105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102002426|NCT03745105|Analgesics|analgesics|mesh-ancestor
102002427|NCT03745105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102002428|NCT03745105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102002429|NCT01282541|Botulinum Toxins|botulinum toxins|mesh-list
102002430|NCT01282541|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102002431|NCT01282541|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102002432|NCT01282541|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102002433|NCT01282541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102002434|NCT01282541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002435|NCT01282541|Cholinergic Agents|cholinergic agents|mesh-ancestor
102002436|NCT01282541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102002437|NCT01282541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002438|NCT01282541|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102002439|NCT01282541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102002440|NCT03744247|Lenvatinib|lenvatinib|mesh-list
102002441|NCT03744247|Antibodies|antibodies|mesh-list
102002442|NCT03744247|Immunoglobulins|immunoglobulins|mesh-list
102002443|NCT03744247|Immunologic Factors|immunologic factors|mesh-ancestor
101457443|NCT00219596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102002447|NCT03744247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102002448|NCT03744247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948791|NCT06006663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948792|NCT06006663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101948793|NCT06006663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101948794|NCT06006663|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101948795|NCT06006663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101948796|NCT06006663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948797|NCT06006663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101948798|NCT06006663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101948799|NCT06006663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101948800|NCT06006663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101948801|NCT06006663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102002449|NCT01282619|Huperzine A|huperzine a|mesh-list
102002450|NCT01282619|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102002451|NCT01282619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102002452|NCT01282619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002453|NCT01282619|Cholinergic Agents|cholinergic agents|mesh-ancestor
102002454|NCT01282619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102002455|NCT01282619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002456|NCT01282619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102002457|NCT01282619|Protective Agents|protective agents|mesh-ancestor
102002458|NCT01282697|Sirolimus|sirolimus|mesh-list
102002459|NCT01282697|Irinotecan|irinotecan|mesh-list
102002460|NCT01282697|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102002461|NCT01282697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102002462|NCT01282697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102002463|NCT01282697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002464|NCT01282697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102002465|NCT01282697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102002466|NCT01282697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102002467|NCT01282697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102002468|NCT01282697|Antifungal Agents|antifungal agents|mesh-ancestor
102002469|NCT01282697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102002470|NCT01282697|Immunologic Factors|immunologic factors|mesh-ancestor
102002471|NCT01282697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002472|NCT01169597|Prednisone|prednisone|mesh-list
102002473|NCT01169597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102002474|NCT01169597|Glucocorticoids|glucocorticoids|mesh-ancestor
102002475|NCT01169597|Hormones|hormones|mesh-ancestor
102002476|NCT01169597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102002477|NCT01169597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002478|NCT01169597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102002479|NCT01169597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102002480|NCT02527798|Furosemide|furosemide|mesh-list
102002481|NCT02527798|Diuretics|diuretics|mesh-ancestor
102002482|NCT02527798|Natriuretic Agents|natriuretic agents|mesh-ancestor
102002483|NCT02527798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002484|NCT02527798|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102002485|NCT02527798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102002486|NCT02527798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002487|NCT05331911|Propofol|propofol|mesh-list
102002488|NCT05331911|Sevoflurane|sevoflurane|mesh-list
102002489|NCT05331911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102002490|NCT05331911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102002491|NCT05331911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002492|NCT05331911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102002493|NCT05331911|Anesthetics, General|anesthetics, general|mesh-ancestor
102002494|NCT05331911|Anesthetics|anesthetics|mesh-ancestor
102002495|NCT05331911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102002496|NCT05331911|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102002497|NCT03857542|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102002498|NCT03857542|Pilocarpine|pilocarpine|mesh-list
102002499|NCT03857542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102002500|NCT03857542|Miotics|miotics|mesh-ancestor
101948802|NCT06006663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101948803|NCT06006663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101260120|NCT01742702|Tocolytic Agents|tocolytic agents|mesh-ancestor
101948804|NCT06006663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101948805|NCT06006650|Paclitaxel|paclitaxel|mesh-list
101948806|NCT06006650|Pembrolizumab|pembrolizumab|mesh-list
101948807|NCT06006650|Fluorouracil|fluorouracil|mesh-list
102002501|NCT03857542|Autonomic Agents|autonomic agents|mesh-ancestor
102002502|NCT03857542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102002503|NCT03857542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002504|NCT03857542|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102002505|NCT03857542|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102002506|NCT03857542|Cholinergic Agents|cholinergic agents|mesh-ancestor
102002507|NCT03857542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102002508|NCT03857542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002509|NCT01172717|Panitumumab|panitumumab|mesh-list
102002510|NCT01172717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102002511|NCT01172717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102002512|NCT03209973|Tislelizumab|tislelizumab|mesh-list
102002513|NCT03209973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102002514|NCT03209973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102002519|NCT03751631|Tropicamide|tropicamide|mesh-list
102002520|NCT03751631|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102002521|NCT03751631|Mydriatics|mydriatics|mesh-ancestor
102002522|NCT03751631|Autonomic Agents|autonomic agents|mesh-ancestor
102002523|NCT03751631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102002524|NCT03751631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002525|NCT03751631|Sympathomimetics|sympathomimetics|mesh-ancestor
102002526|NCT03751631|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102002527|NCT03751631|Nasal Decongestants|nasal decongestants|mesh-ancestor
102002528|NCT03751631|Respiratory System Agents|respiratory system agents|mesh-ancestor
102002529|NCT03751631|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102002530|NCT03751631|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102002531|NCT03751631|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102002532|NCT03751631|Adrenergic Agents|adrenergic agents|mesh-ancestor
102002533|NCT03751631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102002534|NCT03751631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002535|NCT03751631|Protective Agents|protective agents|mesh-ancestor
102002536|NCT03751631|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102002537|NCT03751631|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102002538|NCT03751631|Cholinergic Agents|cholinergic agents|mesh-ancestor
102002539|NCT03866681|Sirolimus|sirolimus|mesh-list
102002540|NCT03866681|Warfarin|warfarin|mesh-list
102002541|NCT03866681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102002542|NCT03866681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102002543|NCT03866681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102002544|NCT03866681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102002545|NCT03866681|Antifungal Agents|antifungal agents|mesh-ancestor
102002546|NCT03866681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102002547|NCT03866681|Immunologic Factors|immunologic factors|mesh-ancestor
102002548|NCT03866681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002549|NCT03866681|Anticoagulants|anticoagulants|mesh-ancestor
102002550|NCT03736369|Esomeprazole|esomeprazole|mesh-list
102002551|NCT03736369|Fexuprazan|fexuprazan|mesh-list
102002552|NCT03736369|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102002553|NCT03736369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102002554|NCT03736369|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102002555|NCT03736369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102002556|NCT03736369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002557|NCT03867695|Ropivacaine|ropivacaine|mesh-list
102002558|NCT03867695|Anesthetics, Local|anesthetics, local|mesh-ancestor
102002559|NCT03867695|Anesthetics|anesthetics|mesh-ancestor
102002560|NCT03867695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102002561|NCT03867695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002562|NCT03867695|Sensory System Agents|sensory system agents|mesh-ancestor
102002563|NCT03867695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102002564|NCT01172171|Melatonin|melatonin|mesh-list
102002565|NCT01172171|Antioxidants|antioxidants|mesh-ancestor
102002566|NCT01172171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002567|NCT01172171|Protective Agents|protective agents|mesh-ancestor
102002568|NCT01172171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948808|NCT06006650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101948809|NCT06006650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101260185|NCT01743066|Vitamin E|vitamin e|mesh-list
101948810|NCT06006650|Tubulin Modulators|tubulin modulators|mesh-ancestor
101948811|NCT06006650|Antimitotic Agents|antimitotic agents|mesh-ancestor
101948812|NCT06006650|Mitosis Modulators|mitosis modulators|mesh-ancestor
101948813|NCT06006650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948814|NCT06006650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101948815|NCT06006650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101948816|NCT06006650|Antimetabolites|antimetabolites|mesh-ancestor
101948817|NCT06006650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101948818|NCT06006650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101948819|NCT06006650|Immunologic Factors|immunologic factors|mesh-ancestor
101948820|NCT06006650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948821|NCT06006624|Dexamethasone|dexamethasone|mesh-list
101948822|NCT06006624|Bupivacaine|bupivacaine|mesh-list
101948823|NCT06006624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101948824|NCT06006624|Antiemetics|antiemetics|mesh-ancestor
101948825|NCT06006624|Autonomic Agents|autonomic agents|mesh-ancestor
101948826|NCT06006624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102002569|NCT01172171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102002570|NCT03655717|Ethanol|ethanol|mesh-list
102002571|NCT03655717|Dronabinol|dronabinol|mesh-list
102002572|NCT03655717|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102002573|NCT03655717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102002574|NCT03655717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102002575|NCT03655717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002576|NCT03655717|Hallucinogens|hallucinogens|mesh-ancestor
102002577|NCT03655717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102002578|NCT03655717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102002579|NCT03655717|Analgesics|analgesics|mesh-ancestor
102002580|NCT03655717|Sensory System Agents|sensory system agents|mesh-ancestor
102002581|NCT03655717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102002582|NCT03655717|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102002583|NCT03655717|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102002584|NCT03655717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102002585|NCT03655717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002586|NCT03655717|Hormones|hormones|mesh-ancestor
101457587|NCT04623619|Vitamins|vitamins|mesh-ancestor
102002606|NCT03866993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102002608|NCT03866993|Tubulin Modulators|tubulin modulators|mesh-ancestor
102002609|NCT03866993|Antimitotic Agents|antimitotic agents|mesh-ancestor
102002610|NCT03866993|Mitosis Modulators|mitosis modulators|mesh-ancestor
102002611|NCT03866993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002624|NCT01172405|Ibuprofen|ibuprofen|mesh-list
101722425|NCT00804843|Niacin|niacin|mesh-list
102002625|NCT01172405|Caffeine|caffeine|mesh-list
102002626|NCT01172405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102002627|NCT01172405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102002628|NCT01172405|Analgesics|analgesics|mesh-ancestor
102002629|NCT01172405|Sensory System Agents|sensory system agents|mesh-ancestor
102002630|NCT01172405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102002631|NCT01172405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002632|NCT01172405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102002633|NCT01172405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102002634|NCT01172405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102002635|NCT01172405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101948827|NCT06006624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948828|NCT06006624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101948829|NCT06006624|Glucocorticoids|glucocorticoids|mesh-ancestor
101948830|NCT06006624|Hormones|hormones|mesh-ancestor
101948831|NCT06006624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101948832|NCT06006624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101948833|NCT06006624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101948834|NCT06006624|Anesthetics, Local|anesthetics, local|mesh-ancestor
101948835|NCT06006624|Anesthetics|anesthetics|mesh-ancestor
101829422|NCT04361708|Vitamins|vitamins|mesh-ancestor
101829423|NCT04361708|Micronutrients|micronutrients|mesh-ancestor
101829430|NCT04345146|Bevacizumab|bevacizumab|mesh-list
101829431|NCT04345146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101829432|NCT04345146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829443|NCT04336098|Paclitaxel|paclitaxel|mesh-list
102002636|NCT01172405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002637|NCT01172405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102002638|NCT01172405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101260255|NCT01743300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102002639|NCT01172405|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102002640|NCT01172405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102002641|NCT01172405|Purinergic Agents|purinergic agents|mesh-ancestor
102002642|NCT01172405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102002643|NCT04000165|Mitapivat|mitapivat|mesh-list
102002644|NCT04000165|Enzyme Activators|enzyme activators|mesh-ancestor
102002645|NCT04000165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002646|NCT03375424|Vedolizumab|vedolizumab|mesh-list
102002647|NCT03375424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102002648|NCT03187197|Dabigatran|dabigatran|mesh-list
102002649|NCT03187197|Antithrombins|antithrombins|mesh-ancestor
102002650|NCT03187197|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102002651|NCT03187197|Protease Inhibitors|protease inhibitors|mesh-ancestor
102002652|NCT03187197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102002653|NCT03187197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457657|NCT00242814|Amlodipine|amlodipine|mesh-list
102002661|NCT04000009|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102002662|NCT04000009|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102002663|NCT04000009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102002664|NCT04000009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102002665|NCT04000009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102002666|NCT04000009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002667|NCT04000009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102002668|NCT04000009|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102002669|NCT04000009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102002670|NCT04000009|Serotonin Agents|serotonin agents|mesh-ancestor
102002671|NCT04000009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102002672|NCT04000009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002673|NCT03282240|Vaccines|vaccines|mesh-list
102002674|NCT03282240|Immunologic Factors|immunologic factors|mesh-ancestor
102002675|NCT03282240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002676|NCT01284725|Mycophenolic Acid|mycophenolic acid|mesh-list
102002677|NCT01284725|Azathioprine|azathioprine|mesh-list
102002678|NCT01284725|Immunosuppressive Agents|immunosuppressive agents|mesh-list
102002679|NCT01284725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102002680|NCT01284725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102002681|NCT01284725|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102002682|NCT01284725|Antitubercular Agents|antitubercular agents|mesh-ancestor
102002683|NCT01284725|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102002684|NCT01284725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102002685|NCT01284725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102002686|NCT01284725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948836|NCT06006624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101948837|NCT06006624|Sensory System Agents|sensory system agents|mesh-ancestor
101948838|NCT06006598|Midazolam|midazolam|mesh-list
101948839|NCT06006598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102002687|NCT01284725|Antimetabolites|antimetabolites|mesh-ancestor
102002688|NCT01284725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102002689|NCT01284725|Immunologic Factors|immunologic factors|mesh-ancestor
102002690|NCT01284725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002691|NCT01284725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102002692|NCT03510598|Deoxycholic Acid|deoxycholic acid|mesh-list
102002693|NCT03510598|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102002694|NCT03510598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102002695|NCT01173107|Colchicine|colchicine|mesh-list
102002696|NCT01173107|Gout Suppressants|gout suppressants|mesh-ancestor
102002697|NCT01173107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102002698|NCT01173107|Tubulin Modulators|tubulin modulators|mesh-ancestor
102002699|NCT01173107|Antimitotic Agents|antimitotic agents|mesh-ancestor
102002700|NCT01173107|Mitosis Modulators|mitosis modulators|mesh-ancestor
102002701|NCT01173107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002702|NCT01173107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102002703|NCT03744091|Dronabinol|dronabinol|mesh-list
102002704|NCT03744091|Hallucinogens|hallucinogens|mesh-ancestor
102002705|NCT03744091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002706|NCT03744091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102002707|NCT03744091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102002708|NCT03744091|Analgesics|analgesics|mesh-ancestor
102002709|NCT03744091|Sensory System Agents|sensory system agents|mesh-ancestor
102002710|NCT03744091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102002711|NCT03744091|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102002712|NCT03744091|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102002713|NCT03744091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102002714|NCT03744091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002715|NCT03744091|Hormones|hormones|mesh-ancestor
102002716|NCT03744091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102002717|NCT03376594|Loratadine|loratadine|mesh-list
102002718|NCT03376594|Antipruritics|antipruritics|mesh-ancestor
102002719|NCT03376594|Dermatologic Agents|dermatologic agents|mesh-ancestor
102002720|NCT03376594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102002721|NCT03376594|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102002722|NCT03376594|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102002727|NCT03376594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002728|NCT03381664|Quinidine|quinidine|mesh-list
102002729|NCT03381664|Dextromethorphan|dextromethorphan|mesh-list
102002730|NCT03381664|Antitussive Agents|antitussive agents|mesh-ancestor
102002731|NCT03381664|Respiratory System Agents|respiratory system agents|mesh-ancestor
102002732|NCT03381664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102002733|NCT03381664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102002734|NCT03381664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102002735|NCT03381664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002736|NCT03381664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002737|NCT03381664|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102002738|NCT03381664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102002739|NCT03381664|Adrenergic Agents|adrenergic agents|mesh-ancestor
102002740|NCT03381664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102002741|NCT03381664|Antimalarials|antimalarials|mesh-ancestor
102002742|NCT03381664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102002743|NCT03381664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102002744|NCT03381664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102002745|NCT03381664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102002746|NCT03381664|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102002747|NCT03381664|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102002748|NCT03381664|Cholinergic Agents|cholinergic agents|mesh-ancestor
102002749|NCT03381664|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102002750|NCT03381664|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102002751|NCT03381664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102002752|NCT03381664|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102002753|NCT03381664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102002754|NCT04060758|Latanoprost|latanoprost|mesh-list
102002755|NCT04060758|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102002756|NCT04060758|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102002757|NCT03376438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
101948841|NCT06006598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101948842|NCT06006598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948843|NCT06006598|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101948844|NCT06006598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101948845|NCT06006598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101948846|NCT06006598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101948847|NCT06006598|Anesthetics, General|anesthetics, general|mesh-ancestor
101948848|NCT06006598|Anesthetics|anesthetics|mesh-ancestor
101948849|NCT06006598|GABA Modulators|gaba modulators|mesh-ancestor
101948850|NCT06006598|GABA Agents|gaba agents|mesh-ancestor
101948851|NCT06006598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101948852|NCT06006598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948853|NCT06006546|MEDI9197|medi9197|mesh-list
101948854|NCT06006546|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101948855|NCT06006546|Immunologic Factors|immunologic factors|mesh-ancestor
101948856|NCT06006546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948857|NCT06006143|Varenicline|varenicline|mesh-list
101948858|NCT06006143|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102002758|NCT03863405|Metformin|metformin|mesh-list
102002759|NCT03863405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102002760|NCT03863405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002761|NCT03866369|Moxifloxacin|moxifloxacin|mesh-list
102002762|NCT03866369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102002763|NCT03866369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102002764|NCT03866369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102002765|NCT03866369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102002766|NCT03866369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102002767|NCT03866369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002768|NCT03866369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102002769|NCT04024891|Phentolamine|phentolamine|mesh-list
102002770|NCT04024891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102002771|NCT04024891|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102002772|NCT04024891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102002773|NCT04024891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102002774|NCT04024891|Adrenergic Agents|adrenergic agents|mesh-ancestor
102002775|NCT04024891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102002776|NCT04024891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002777|NCT04024891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002778|NCT04024891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102002779|NCT01178021|Chloroquine|chloroquine|mesh-list
102002780|NCT01178021|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
102002782|NCT01178021|Amebicides|amebicides|mesh-ancestor
102002783|NCT01178021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102002784|NCT01178021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102002785|NCT01178021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102002786|NCT01178021|Antimalarials|antimalarials|mesh-ancestor
102002787|NCT01178021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102002788|NCT01178021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102002789|NCT01178021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102002790|NCT01178021|Analgesics|analgesics|mesh-ancestor
102002791|NCT01178021|Sensory System Agents|sensory system agents|mesh-ancestor
102002792|NCT01178021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102002793|NCT01178021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002798|NCT03250182|Budesonide|budesonide|mesh-list
102002799|NCT03250182|Glycopyrrolate|glycopyrrolate|mesh-list
102002800|NCT03250182|Formoterol Fumarate|formoterol fumarate|mesh-list
101260445|NCT01744314|Analgesics|analgesics|mesh-ancestor
102002801|NCT03250182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101948859|NCT06006143|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101948860|NCT06006143|Cholinergic Agents|cholinergic agents|mesh-ancestor
101948861|NCT06006143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101948862|NCT06006143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948863|NCT06006143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948864|NCT06006117|Rituximab|rituximab|mesh-list
101948865|NCT06006117|Lenalidomide|lenalidomide|mesh-list
101948866|NCT06006117|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101948867|NCT06006117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101948868|NCT06006117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101948869|NCT06006117|Immunologic Factors|immunologic factors|mesh-ancestor
102002802|NCT03250182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102002803|NCT03250182|Autonomic Agents|autonomic agents|mesh-ancestor
102002804|NCT03250182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102002805|NCT03250182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002806|NCT03250182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102002807|NCT03250182|Respiratory System Agents|respiratory system agents|mesh-ancestor
102002808|NCT03250182|Glucocorticoids|glucocorticoids|mesh-ancestor
102002809|NCT03250182|Hormones|hormones|mesh-ancestor
102002810|NCT03250182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102002811|NCT03250182|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102002812|NCT03250182|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102002813|NCT03250182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102002814|NCT03250182|Adrenergic Agents|adrenergic agents|mesh-ancestor
102002815|NCT03250182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102002816|NCT03250182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002817|NCT03250182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102002818|NCT03250182|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102002819|NCT03250182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102002820|NCT03250182|Cholinergic Agents|cholinergic agents|mesh-ancestor
102002821|NCT01173263|Propofol|propofol|mesh-list
102002822|NCT01173263|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102002823|NCT01173263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102002824|NCT01173263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002825|NCT01173263|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102002826|NCT01173263|Anesthetics, General|anesthetics, general|mesh-ancestor
102002827|NCT01173263|Anesthetics|anesthetics|mesh-ancestor
102002828|NCT03381430|Gefitinib|gefitinib|mesh-list
102002829|NCT03381430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102002830|NCT03381430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102002831|NCT03381430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102002832|NCT03381430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002833|NCT01288157|Golimumab|golimumab|mesh-list
102002834|NCT01288157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102002835|NCT01288157|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102002836|NCT01288157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102002837|NCT01288157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102002838|NCT01288157|Immunologic Factors|immunologic factors|mesh-ancestor
102002839|NCT01288157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002840|NCT03993379|Ipilimumab|ipilimumab|mesh-list
102002841|NCT03993379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102002842|NCT03993379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102002843|NCT03993379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102002844|NCT03993379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002845|NCT03866447|Vitamin D|vitamin d|mesh-list
102002846|NCT03866447|Adapalene|adapalene|mesh-list
102002847|NCT03866447|Vitamins|vitamins|mesh-ancestor
102002848|NCT03866447|Micronutrients|micronutrients|mesh-ancestor
102002849|NCT03866447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002850|NCT03866447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102002851|NCT03866447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102002852|NCT03866447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102002853|NCT03866447|Analgesics|analgesics|mesh-ancestor
101948870|NCT06006117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948871|NCT06006117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101948872|NCT06006117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102002854|NCT03866447|Sensory System Agents|sensory system agents|mesh-ancestor
102002855|NCT03866447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102002856|NCT03866447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102002857|NCT03866447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102002858|NCT03866447|Dermatologic Agents|dermatologic agents|mesh-ancestor
102002859|NCT03370120|Padsevonil|padsevonil|mesh-list
102002860|NCT03370120|Anticonvulsants|anticonvulsants|mesh-ancestor
102002861|NCT01175291|Leucovorin|leucovorin|mesh-list
102002862|NCT01175291|Bevacizumab|bevacizumab|mesh-list
102002863|NCT01175291|Fluorouracil|fluorouracil|mesh-list
102002864|NCT01175291|Oxaliplatin|oxaliplatin|mesh-list
102002865|NCT01175291|Levoleucovorin|levoleucovorin|mesh-list
102002866|NCT01175291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101457859|NCT00220532|Riboflavin|riboflavin|mesh-list
102002879|NCT01175291|Protective Agents|protective agents|mesh-ancestor
102002880|NCT01175291|Vitamin B Complex|vitamin b complex|mesh-ancestor
102002882|NCT01175291|Micronutrients|micronutrients|mesh-ancestor
102002883|NCT03230266|Insulin|insulin|mesh-list
102002884|NCT03230266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102002885|NCT03230266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002886|NCT03732469|Acetaminophen|acetaminophen|mesh-list
102002887|NCT03732469|Fentanyl|fentanyl|mesh-list
102002888|NCT03732469|Propofol|propofol|mesh-list
102002889|NCT03732469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102002890|NCT03732469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102002891|NCT03732469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002892|NCT03732469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102002893|NCT03732469|Anesthetics, General|anesthetics, general|mesh-ancestor
102002894|NCT03732469|Anesthetics|anesthetics|mesh-ancestor
102002895|NCT03732469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102002896|NCT03732469|Narcotics|narcotics|mesh-ancestor
102002897|NCT03732469|Analgesics|analgesics|mesh-ancestor
102002898|NCT03732469|Sensory System Agents|sensory system agents|mesh-ancestor
102002899|NCT03732469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102002900|NCT03732469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102002901|NCT03732469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102002902|NCT03732469|Antipyretics|antipyretics|mesh-ancestor
102002903|NCT03381352|Capecitabine|capecitabine|mesh-list
102002904|NCT03381352|Mitomycins|mitomycins|mesh-list
102002905|NCT03381352|Mitomycin|mitomycin|mesh-list
102002906|NCT03381352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102002907|NCT03381352|Antimetabolites|antimetabolites|mesh-ancestor
102002908|NCT03381352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002909|NCT03381352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102002910|NCT03381352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102002911|NCT03381352|Alkylating Agents|alkylating agents|mesh-ancestor
102002912|NCT03381352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102002913|NCT03381352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102002914|NCT01175525|Cromolyn Sodium|cromolyn sodium|mesh-list
102002915|NCT01175525|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
102002916|NCT01175525|Immunologic Factors|immunologic factors|mesh-ancestor
102002917|NCT01175525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002918|NCT01175525|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102002919|NCT01175525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102002920|NCT01175525|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102002921|NCT01175525|Respiratory System Agents|respiratory system agents|mesh-ancestor
102002922|NCT03863249|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102002923|NCT03863249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102002924|NCT03381118|Cytarabine|cytarabine|mesh-list
102002925|NCT03381118|Nivolumab|nivolumab|mesh-list
102002926|NCT03381118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102002927|NCT03381118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102002928|NCT03381118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102002929|NCT03381118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002930|NCT03381118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102002941|NCT03375112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002942|NCT03375112|Sensory System Agents|sensory system agents|mesh-ancestor
102002943|NCT03375112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102002945|NCT02954575|Coagulants|coagulants|mesh-ancestor
102002946|NCT02997358|Doxorubicin|doxorubicin|mesh-list
102002947|NCT02997358|Trabectedin|trabectedin|mesh-list
102002948|NCT02997358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102002949|NCT02997358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101948873|NCT06006117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101948874|NCT06006117|Growth Substances|growth substances|mesh-ancestor
101948875|NCT06006117|Growth Inhibitors|growth inhibitors|mesh-ancestor
101948876|NCT06006117|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102002950|NCT02997358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102002951|NCT02997358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102002952|NCT02997358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102002953|NCT02997358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002954|NCT02997358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102002955|NCT02997358|Alkylating Agents|alkylating agents|mesh-ancestor
102002956|NCT03375034|Clonazepam|clonazepam|mesh-list
102002957|NCT03375034|Anticonvulsants|anticonvulsants|mesh-ancestor
102002958|NCT03375034|GABA Modulators|gaba modulators|mesh-ancestor
102002959|NCT03375034|GABA Agents|gaba agents|mesh-ancestor
102002960|NCT03375034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102002961|NCT03375034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002962|NCT03375034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002963|NCT03381040|Hyaluronic Acid|hyaluronic acid|mesh-list
102002964|NCT03381040|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102002965|NCT03381040|Immunologic Factors|immunologic factors|mesh-ancestor
102002966|NCT03381040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002967|NCT03381040|Viscosupplements|viscosupplements|mesh-ancestor
102002968|NCT03381040|Protective Agents|protective agents|mesh-ancestor
102002969|NCT03376048|Ropivacaine|ropivacaine|mesh-list
102002970|NCT03376048|Anesthetics, Local|anesthetics, local|mesh-ancestor
102002971|NCT03376048|Anesthetics|anesthetics|mesh-ancestor
102002972|NCT03376048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102002973|NCT03376048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002974|NCT03376048|Sensory System Agents|sensory system agents|mesh-ancestor
102002975|NCT03376048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102002976|NCT03374878|Contraceptive Agents|contraceptive agents|mesh-list
102002977|NCT03374878|Contraceptives, Oral|contraceptives, oral|mesh-list
102002978|NCT03374878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102002979|NCT03374878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002980|NCT03374878|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102002981|NCT01285037|Gemcitabine|gemcitabine|mesh-list
102002982|NCT01285037|Cetuximab|cetuximab|mesh-list
102002983|NCT01285037|Ramucirumab|ramucirumab|mesh-list
102002984|NCT01285037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102002985|NCT01285037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102002986|NCT01285037|Antimetabolites|antimetabolites|mesh-ancestor
102002987|NCT01285037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002988|NCT01285037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102002989|NCT03732391|Carboplatin|carboplatin|mesh-list
102002990|NCT03732391|Pembrolizumab|pembrolizumab|mesh-list
102002991|NCT03732391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102002992|NCT03732391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102002993|NCT03732391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102002994|NCT03732391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002995|NCT03374722|Analgesics, Opioid|analgesics, opioid|mesh-list
102002996|NCT03374722|Narcotics|narcotics|mesh-ancestor
102003000|NCT03374722|Sensory System Agents|sensory system agents|mesh-ancestor
102003001|NCT03374722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101722775|NCT00759070|Efavirenz|efavirenz|mesh-list
102003002|NCT03207243|Fluticasone|fluticasone|mesh-list
102003003|NCT03207243|Xhance|xhance|mesh-list
102003005|NCT03207243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102003006|NCT03207243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102003007|NCT03207243|Autonomic Agents|autonomic agents|mesh-ancestor
102003008|NCT03207243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102003009|NCT03207243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003010|NCT03207243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102003011|NCT03207243|Respiratory System Agents|respiratory system agents|mesh-ancestor
102003012|NCT03207243|Dermatologic Agents|dermatologic agents|mesh-ancestor
102003013|NCT03207243|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102003014|NCT03207243|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102003015|NCT03207243|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102003016|NCT03207243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102003017|NCT03207243|Adrenergic Agents|adrenergic agents|mesh-ancestor
102003018|NCT03207243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102003019|NCT03207243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948877|NCT06006117|Alkylating Agents|alkylating agents|mesh-ancestor
101948878|NCT06006117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948879|NCT06006091|Letrozole|letrozole|mesh-list
102003020|NCT01285271|Sevoflurane|sevoflurane|mesh-list
102003021|NCT01285271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102003022|NCT01285271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102003023|NCT01285271|Anesthetics, General|anesthetics, general|mesh-ancestor
102003024|NCT01285271|Anesthetics|anesthetics|mesh-ancestor
102003025|NCT01285271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102003026|NCT01285271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003027|NCT03982069|Vaccines|vaccines|mesh-list
102003028|NCT03982069|Immunologic Factors|immunologic factors|mesh-ancestor
102003029|NCT03982069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003030|NCT03219723|Amoxicillin|amoxicillin|mesh-list
102003031|NCT03219723|Metronidazole|metronidazole|mesh-list
102003032|NCT03219723|Clarithromycin|clarithromycin|mesh-list
102003033|NCT03219723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102003034|NCT03219723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102003035|NCT03219723|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102003036|NCT03219723|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102003037|NCT03219723|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102003038|NCT03219723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102003039|NCT03219723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003040|NCT03219723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102003041|NCT03219723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102003042|NCT03628417|Bleomycin|bleomycin|mesh-list
102003043|NCT03628417|Calcium|calcium|mesh-list
102003044|NCT03628417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102003045|NCT03628417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003046|NCT03628417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102003047|NCT03628417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102003048|NCT03369964|Atezolizumab|atezolizumab|mesh-list
102003049|NCT03369964|Obinutuzumab|obinutuzumab|mesh-list
102003050|NCT03369964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102003051|NCT03369964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003052|NCT03369964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102003053|NCT03369964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102003054|NCT03245736|Tisotumab vedotin|tisotumab vedotin|mesh-list
102003055|NCT03245736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102003056|NCT03245736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102003057|NCT01173809|Amiodarone|amiodarone|mesh-list
102003058|NCT01173809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102003059|NCT01173809|Vasodilator Agents|vasodilator agents|mesh-ancestor
102003060|NCT01173809|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102003061|NCT01173809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102003062|NCT01173809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003063|NCT01173809|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102003064|NCT01173809|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102003065|NCT01173809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102003066|NCT01173809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102003067|NCT01173809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102003073|NCT03375580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003074|NCT03375580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102003075|NCT03375580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102003076|NCT03375580|Antimetabolites|antimetabolites|mesh-ancestor
102003077|NCT03375580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003078|NCT03375580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102003079|NCT03375580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102003080|NCT03375580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102003081|NCT03340896|Docetaxel|docetaxel|mesh-list
102003082|NCT03340896|Fluorouracil|fluorouracil|mesh-list
102003083|NCT03340896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102003084|NCT03340896|Tubulin Modulators|tubulin modulators|mesh-ancestor
102003085|NCT03340896|Antimitotic Agents|antimitotic agents|mesh-ancestor
102003086|NCT03340896|Mitosis Modulators|mitosis modulators|mesh-ancestor
102003087|NCT03340896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003088|NCT03340896|Antimetabolites|antimetabolites|mesh-ancestor
102003089|NCT03340896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102003090|NCT03340896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102003091|NCT03340896|Immunologic Factors|immunologic factors|mesh-ancestor
101737360|NCT02584881|Analgesics, Opioid|analgesics, opioid|mesh-list
101948880|NCT06006091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101948881|NCT06006091|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101948882|NCT06006091|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101948883|NCT06006091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101948884|NCT06006091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948885|NCT06006091|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101948886|NCT06006091|Hormone Antagonists|hormone antagonists|mesh-ancestor
101948887|NCT06006091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101948888|NCT06006091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948889|NCT06006026|Ropivacaine|ropivacaine|mesh-list
101948890|NCT06006026|Anesthetics, Local|anesthetics, local|mesh-ancestor
101948891|NCT06006026|Anesthetics|anesthetics|mesh-ancestor
102003092|NCT03340896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003093|NCT03282981|Timolol|timolol|mesh-list
102003094|NCT03282981|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102003095|NCT03282981|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102003096|NCT03282981|Adrenergic Agents|adrenergic agents|mesh-ancestor
102003097|NCT03282981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102003098|NCT03282981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003099|NCT03282981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003100|NCT03282981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102003101|NCT03282981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102003102|NCT01286909|Lycopene|lycopene|mesh-list
102003103|NCT01286909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102003104|NCT01286909|Antioxidants|antioxidants|mesh-ancestor
102003105|NCT01286909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003106|NCT01286909|Protective Agents|protective agents|mesh-ancestor
102003107|NCT01286909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003108|NCT01286909|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102003109|NCT01286909|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102003110|NCT01286909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102003111|NCT02954887|Cannabidiol|cannabidiol|mesh-list
102003112|NCT02954887|Anticonvulsants|anticonvulsants|mesh-ancestor
102003113|NCT03860129|Sevoflurane|sevoflurane|mesh-list
102003114|NCT03860129|Desflurane|desflurane|mesh-list
102003115|NCT03860129|Isoflurane|isoflurane|mesh-list
102003116|NCT03860129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102003117|NCT03860129|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102003118|NCT03860129|Anesthetics, General|anesthetics, general|mesh-ancestor
102003119|NCT03860129|Anesthetics|anesthetics|mesh-ancestor
102003120|NCT03860129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102003121|NCT03860129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003122|NCT03369808|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102003123|NCT03369808|Vaccines|vaccines|mesh-list
102003124|NCT03369808|Immunologic Factors|immunologic factors|mesh-ancestor
102003125|NCT03369808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003126|NCT03369808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102003127|NCT03369808|Antacids|antacids|mesh-ancestor
102003128|NCT03369808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003129|NCT03369808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102003130|NCT02525237|Apatinib|apatinib|mesh-list
102003131|NCT02525237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102003132|NCT02525237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102003133|NCT02525237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102003134|NCT02525237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003135|NCT01173887|Mogamulizumab|mogamulizumab|mesh-list
102003136|NCT01173887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102003137|NCT03369574|Reslizumab|reslizumab|mesh-list
102003138|NCT03369574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102003143|NCT02651740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102003144|NCT02651740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102003145|NCT03862391|Analgesics|analgesics|mesh-list
102003146|NCT03862391|Antiemetics|antiemetics|mesh-list
101737361|NCT02584881|Narcotics|narcotics|mesh-ancestor
101948892|NCT06006026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101948893|NCT06006026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948894|NCT06006026|Sensory System Agents|sensory system agents|mesh-ancestor
101948895|NCT06006026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101948897|NCT06006013|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101948898|NCT06006013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101948899|NCT06006013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948900|NCT06006013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101948901|NCT06006013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101948902|NCT06006013|Immunologic Factors|immunologic factors|mesh-ancestor
101948903|NCT06006013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948904|NCT06005870|Zanubrutinib|zanubrutinib|mesh-list
101948905|NCT06005870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328103|NCT00388700|Leucovorin|leucovorin|mesh-list
101948906|NCT06005870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101948907|NCT06005870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101948908|NCT06005870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948909|NCT06005818|Pembrolizumab|pembrolizumab|mesh-list
101948910|NCT06005818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101948911|NCT06005818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101948912|NCT06005818|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101948913|NCT06005818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948914|NCT06004037|Delpazolid|delpazolid|mesh-list
101948915|NCT06004037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101668738|NCT02819414|Analgesics|analgesics|mesh-ancestor
101948916|NCT06004037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101948917|NCT06004037|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102003147|NCT03862391|Sensory System Agents|sensory system agents|mesh-ancestor
102003148|NCT03862391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102003149|NCT03862391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003150|NCT03862391|Autonomic Agents|autonomic agents|mesh-ancestor
101722921|NCT00670930|Omalizumab|omalizumab|mesh-list
102003151|NCT03862391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102003152|NCT03859583|Capsaicin|capsaicin|mesh-list
102003153|NCT03859583|Antipruritics|antipruritics|mesh-ancestor
102003154|NCT03859583|Dermatologic Agents|dermatologic agents|mesh-ancestor
102003155|NCT03859583|Sensory System Agents|sensory system agents|mesh-ancestor
102003156|NCT03859583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102003157|NCT03859583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003158|NCT03369262|Atosiban|atosiban|mesh-list
102003159|NCT03369262|Hormone Antagonists|hormone antagonists|mesh-ancestor
102003160|NCT03369262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102003161|NCT03369262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003162|NCT03369262|Tocolytic Agents|tocolytic agents|mesh-ancestor
101948918|NCT06004037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101948919|NCT06004037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948920|NCT06002789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101948921|NCT06002789|Antibodies|antibodies|mesh-list
101948922|NCT06002789|Immunoglobulins|immunoglobulins|mesh-list
101948923|NCT06002789|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101948924|NCT06002789|Immunologic Factors|immunologic factors|mesh-ancestor
101948925|NCT06002789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948926|NCT06002789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101948927|NCT06002295|Chlorhexidine|chlorhexidine|mesh-list
101948928|NCT06002295|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101948929|NCT06002295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101948930|NCT06002295|Disinfectants|disinfectants|mesh-ancestor
101948931|NCT06002152|Bupivacaine|bupivacaine|mesh-list
101948932|NCT06002152|Anesthetics, Local|anesthetics, local|mesh-ancestor
101948933|NCT06002152|Anesthetics|anesthetics|mesh-ancestor
101948934|NCT06002152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101948935|NCT06002152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948936|NCT06002152|Sensory System Agents|sensory system agents|mesh-ancestor
102003163|NCT03369262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102003164|NCT03276078|Bromides|bromides|mesh-list
102003165|NCT03276078|Formoterol Fumarate|formoterol fumarate|mesh-list
102003166|NCT03276078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102003167|NCT03276078|Autonomic Agents|autonomic agents|mesh-ancestor
102003168|NCT03276078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102003169|NCT03276078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003170|NCT03276078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102003171|NCT03276078|Respiratory System Agents|respiratory system agents|mesh-ancestor
102003172|NCT03276078|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102003173|NCT03276078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102003174|NCT03276078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102003175|NCT03276078|Adrenergic Agents|adrenergic agents|mesh-ancestor
102003176|NCT03276078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102003177|NCT03276078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003178|NCT03276078|Anticonvulsants|anticonvulsants|mesh-ancestor
102003179|NCT01288547|Theobromine|theobromine|mesh-list
102003180|NCT01288547|Caffeine|caffeine|mesh-list
102003181|NCT01288547|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102003182|NCT01288547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003183|NCT01288547|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102003184|NCT01288547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102003185|NCT01288547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003186|NCT01288547|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102003187|NCT01288547|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102003188|NCT01288547|Purinergic Agents|purinergic agents|mesh-ancestor
102003189|NCT01288547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102003190|NCT01288547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102003191|NCT01288547|Autonomic Agents|autonomic agents|mesh-ancestor
102003192|NCT01288547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102003193|NCT01288547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102003194|NCT01288547|Respiratory System Agents|respiratory system agents|mesh-ancestor
102003195|NCT01288547|Vasodilator Agents|vasodilator agents|mesh-ancestor
102003196|NCT03373864|Anesthetics|anesthetics|mesh-list
102003197|NCT03373864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102003198|NCT03373864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003199|NCT04597320|Fentanyl|fentanyl|mesh-list
101948937|NCT06002152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101948938|NCT05995457|Haloperidol|haloperidol|mesh-list
101948939|NCT05995457|Haloperidol decanoate|haloperidol decanoate|mesh-list
101948940|NCT05995457|Antiemetics|antiemetics|mesh-ancestor
101948941|NCT05995457|Autonomic Agents|autonomic agents|mesh-ancestor
101971970|NCT01336322|Incretins|incretins|mesh-ancestor
102003200|NCT04597320|Midazolam|midazolam|mesh-list
102003201|NCT04597320|Esketamine|esketamine|mesh-list
102003202|NCT04597320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102003203|NCT04597320|Narcotics|narcotics|mesh-ancestor
102003204|NCT04597320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102003205|NCT04597320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003206|NCT04597320|Analgesics|analgesics|mesh-ancestor
102003207|NCT04597320|Sensory System Agents|sensory system agents|mesh-ancestor
102003208|NCT04597320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102003209|NCT04597320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102003212|NCT04597320|Anesthetics|anesthetics|mesh-ancestor
102003213|NCT04597320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102003214|NCT04597320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102003215|NCT04597320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102003216|NCT04597320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102003217|NCT04597320|GABA Modulators|gaba modulators|mesh-ancestor
102003218|NCT04597320|GABA Agents|gaba agents|mesh-ancestor
102003219|NCT04597320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102003220|NCT04597320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003221|NCT04597320|Antidepressive Agents|antidepressive agents|mesh-ancestor
102003223|NCT03373708|Cyclophosphamide|cyclophosphamide|mesh-list
102003224|NCT03373708|Docetaxel|docetaxel|mesh-list
102003225|NCT03373708|Letrozole|letrozole|mesh-list
102003226|NCT03373708|Epirubicin|epirubicin|mesh-list
102003227|NCT03373708|Goserelin|goserelin|mesh-list
102003228|NCT03373708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102003229|NCT03373708|Immunologic Factors|immunologic factors|mesh-ancestor
102003230|NCT03373708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003231|NCT03373708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102003232|NCT03373708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102003233|NCT03373708|Alkylating Agents|alkylating agents|mesh-ancestor
102003234|NCT03373708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003235|NCT03373708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102003236|NCT03373708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102003237|NCT03373708|Tubulin Modulators|tubulin modulators|mesh-ancestor
102003238|NCT03373708|Antimitotic Agents|antimitotic agents|mesh-ancestor
102003239|NCT03373708|Mitosis Modulators|mitosis modulators|mesh-ancestor
102003240|NCT03373708|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102003241|NCT03373708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102003242|NCT03373708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102003243|NCT03373708|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102003244|NCT03373708|Hormone Antagonists|hormone antagonists|mesh-ancestor
102003245|NCT03373708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102003246|NCT03373708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102003247|NCT03373708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102003248|NCT03373708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102003249|NCT03373708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102003250|NCT03373708|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102003251|NCT03373708|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102003252|NCT03373708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102003253|NCT03123952|ABT-414|abt-414|mesh-list
102003254|NCT03123952|Immunoconjugates|immunoconjugates|mesh-ancestor
102003255|NCT03123952|Immunologic Factors|immunologic factors|mesh-ancestor
102003256|NCT03123952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003257|NCT02519608|Aspirin|aspirin|mesh-list
102003258|NCT02519608|Clopidogrel|clopidogrel|mesh-list
102003259|NCT02519608|Ticagrelor|ticagrelor|mesh-list
102003260|NCT02519608|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102003261|NCT02519608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102003262|NCT02519608|Analgesics|analgesics|mesh-ancestor
102003263|NCT02519608|Sensory System Agents|sensory system agents|mesh-ancestor
102003264|NCT02519608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102003265|NCT02519608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003266|NCT02519608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102003267|NCT02519608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102003268|NCT02519608|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101948942|NCT05995457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101948943|NCT05995457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830203|NCT02458014|Blinatumomab|blinatumomab|mesh-list
102003269|NCT02519608|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102003270|NCT02519608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003271|NCT02519608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102003272|NCT02519608|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102003273|NCT02519608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102003274|NCT02519608|Antipyretics|antipyretics|mesh-ancestor
102003275|NCT02519608|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102003276|NCT02519608|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102003277|NCT02519608|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102003278|NCT02519608|Purinergic Agents|purinergic agents|mesh-ancestor
102003279|NCT02519608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102003280|NCT05181852|Pregabalin|pregabalin|mesh-list
102003281|NCT05181852|Analgesics|analgesics|mesh-ancestor
102003282|NCT05181852|Sensory System Agents|sensory system agents|mesh-ancestor
102003283|NCT05181852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102003285|NCT05181852|Anticonvulsants|anticonvulsants|mesh-ancestor
102003286|NCT05181852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102003287|NCT05181852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102003288|NCT05181852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003289|NCT05181852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102003290|NCT05181852|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102003291|NCT05181852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102003292|NCT05181852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102003293|NCT05181852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102003294|NCT04584684|Ethanol|ethanol|mesh-list
102003295|NCT04584684|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102003296|NCT04584684|Cetylpyridinium|cetylpyridinium|mesh-list
102003297|NCT04584684|Povidone|povidone|mesh-list
102003298|NCT04584684|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102003299|NCT04584684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102003300|NCT04584684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102003301|NCT04584684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723108|NCT00772174|Metformin|metformin|mesh-list
102003302|NCT04584684|Plasma Substitutes|plasma substitutes|mesh-ancestor
102003303|NCT04584684|Blood Substitutes|blood substitutes|mesh-ancestor
102003304|NCT03373318|Plasma-lyte 148|plasma-lyte 148|mesh-list
102003305|NCT03373318|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102003306|NCT03373318|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102003307|NCT03124420|Amoxicillin|amoxicillin|mesh-list
102003308|NCT03124420|Clarithromycin|clarithromycin|mesh-list
102003309|NCT03124420|Lansoprazole|lansoprazole|mesh-list
102003310|NCT03124420|Dexlansoprazole|dexlansoprazole|mesh-list
102003311|NCT03124420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102003312|NCT03124420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102003313|NCT03124420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102003314|NCT03124420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102003315|NCT03124420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003316|NCT03124420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102003317|NCT03124420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102003318|NCT03124420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102003319|NCT03124420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102003320|NCT03124420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102003321|NCT03231228|Cefazolin|cefazolin|mesh-list
102003322|NCT03231228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102003323|NCT03231228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102003324|NCT03510468|Pyridoxine|pyridoxine|mesh-list
102003325|NCT03510468|Isoniazid|isoniazid|mesh-list
102003326|NCT03510468|Rifapentine|rifapentine|mesh-list
102003327|NCT03510468|Antitubercular Agents|antitubercular agents|mesh-ancestor
102003328|NCT03510468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102003329|NCT03510468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102003330|NCT03510468|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102003331|NCT03510468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102003332|NCT03510468|Antimetabolites|antimetabolites|mesh-ancestor
102003333|NCT03510468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003334|NCT03510468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102003335|NCT03510468|Vitamin B Complex|vitamin b complex|mesh-ancestor
102003336|NCT03510468|Vitamins|vitamins|mesh-ancestor
102003337|NCT03510468|Micronutrients|micronutrients|mesh-ancestor
102003338|NCT03510468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948944|NCT05995457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101948945|NCT05995457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101948946|NCT05995457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101948947|NCT05995457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101948948|NCT05995457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101948949|NCT05995457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101948950|NCT05995457|Dopamine Agents|dopamine agents|mesh-ancestor
101948951|NCT05995457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101948952|NCT05995457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948953|NCT05995457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101948954|NCT05991401|Clarithromycin|clarithromycin|mesh-list
101948956|NCT05991401|DA-8010|da-8010|mesh-list
101948957|NCT05991401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101948958|NCT05991401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101948959|NCT05991401|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101948960|NCT05991401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101948961|NCT05991401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101948962|NCT05991401|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101948963|NCT05991401|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101948964|NCT05991401|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101948965|NCT05991401|Antitubercular Agents|antitubercular agents|mesh-ancestor
101948966|NCT05991401|Leprostatic Agents|leprostatic agents|mesh-ancestor
101948967|NCT05991401|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101261044|NCT01748123|Diuretics|diuretics|mesh-ancestor
101948968|NCT05991401|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101948969|NCT05991401|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101948970|NCT05991401|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101948971|NCT05991401|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102003339|NCT03510468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102003340|NCT03510468|Leprostatic Agents|leprostatic agents|mesh-ancestor
102003341|NCT01178645|Cytarabine|cytarabine|mesh-list
102003342|NCT01178645|Etoposide|etoposide|mesh-list
102003343|NCT01178645|Melphalan|melphalan|mesh-list
102003344|NCT01178645|Busulfan|busulfan|mesh-list
102003345|NCT01178645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102003346|NCT01178645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102003347|NCT01178645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102003348|NCT01178645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102003349|NCT01178645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102003350|NCT01178645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003351|NCT01178645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102003352|NCT01178645|Antimetabolites|antimetabolites|mesh-ancestor
102003353|NCT01178645|Antiviral Agents|antiviral agents|mesh-ancestor
102003354|NCT01178645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102003355|NCT01178645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102003356|NCT01178645|Immunologic Factors|immunologic factors|mesh-ancestor
101948972|NCT05991401|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101948973|NCT05991401|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101948974|NCT05991401|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102003357|NCT01178645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003358|NCT01178645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102003362|NCT01285505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102003363|NCT01285505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102003364|NCT01285505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003365|NCT01285505|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102003366|NCT01285505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102003367|NCT01285505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102003368|NCT01285505|GABA Modulators|gaba modulators|mesh-ancestor
102003369|NCT01285505|GABA Agents|gaba agents|mesh-ancestor
102003370|NCT01285505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102003371|NCT01285505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003372|NCT03372850|Esomeprazole|esomeprazole|mesh-list
102003373|NCT03372850|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102003374|NCT03372850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102003375|NCT03372850|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102003376|NCT03372850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102003377|NCT03372850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003378|NCT04525066|Hyaluronic Acid|hyaluronic acid|mesh-list
102003379|NCT04525066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102003380|NCT04525066|Immunologic Factors|immunologic factors|mesh-ancestor
102003381|NCT04525066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003382|NCT04525066|Viscosupplements|viscosupplements|mesh-ancestor
102003383|NCT04525066|Protective Agents|protective agents|mesh-ancestor
102003385|NCT03362788|Anticoagulants|anticoagulants|mesh-list
102003386|NCT03362788|Vitamins|vitamins|mesh-ancestor
102003387|NCT03362788|Micronutrients|micronutrients|mesh-ancestor
102003388|NCT03362788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003389|NCT03362788|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102003390|NCT03362788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102003391|NCT03362788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003392|NCT03362788|Hemostatics|hemostatics|mesh-ancestor
102003393|NCT03362788|Coagulants|coagulants|mesh-ancestor
102003394|NCT03368794|Analgesics, Opioid|analgesics, opioid|mesh-list
102003395|NCT03368794|Narcotics|narcotics|mesh-ancestor
102003396|NCT03368794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102003397|NCT03368794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003398|NCT03368794|Analgesics|analgesics|mesh-ancestor
102003399|NCT03368794|Sensory System Agents|sensory system agents|mesh-ancestor
102003400|NCT03368794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102003401|NCT03862079|Tazobactam|tazobactam|mesh-list
102003402|NCT03862079|Piperacillin|piperacillin|mesh-list
102003403|NCT03862079|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102003404|NCT03862079|Nystatin|nystatin|mesh-list
102003405|NCT03862079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102003406|NCT03862079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102003407|NCT03862079|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102003408|NCT03862079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102003409|NCT03862079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003410|NCT03862079|Antifungal Agents|antifungal agents|mesh-ancestor
102003411|NCT03862079|Ionophores|ionophores|mesh-ancestor
102003412|NCT03862079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102003413|NCT03362632|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102003414|NCT03362632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102003415|NCT01179269|Paclitaxel|paclitaxel|mesh-list
102003416|NCT01179269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102003417|NCT01179269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102003418|NCT01179269|Tubulin Modulators|tubulin modulators|mesh-ancestor
102003419|NCT01179269|Antimitotic Agents|antimitotic agents|mesh-ancestor
102003420|NCT01179269|Mitosis Modulators|mitosis modulators|mesh-ancestor
102003421|NCT01179269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003422|NCT00165724|Donepezil|donepezil|mesh-list
102003423|NCT00165724|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102003424|NCT00165724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102003425|NCT00165724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003426|NCT00165724|Cholinergic Agents|cholinergic agents|mesh-ancestor
102003427|NCT00165724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102003428|NCT00165724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003429|NCT00165724|Nootropic Agents|nootropic agents|mesh-ancestor
101948975|NCT05991401|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101948976|NCT05991401|Cholinergic Agents|cholinergic agents|mesh-ancestor
101948977|NCT05991401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101948978|NCT05991401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003430|NCT01287455|Vitamin D|vitamin d|mesh-list
102003431|NCT01287455|Cholecalciferol|cholecalciferol|mesh-list
102003432|NCT01287455|Vitamins|vitamins|mesh-ancestor
102003433|NCT01287455|Micronutrients|micronutrients|mesh-ancestor
101458425|NCT00222053|Diphosphonates|diphosphonates|mesh-list
102003447|NCT01287533|Ibandronic Acid|ibandronic acid|mesh-list
102003448|NCT01287533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102003449|NCT01287533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003450|NCT03368404|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102003451|NCT03368404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102003452|NCT01287689|Immunoglobulins|immunoglobulins|mesh-list
101723224|NCT00773578|Antioxidants|antioxidants|mesh-ancestor
102003453|NCT01287689|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102003454|NCT01287689|Antibodies|antibodies|mesh-list
102003455|NCT01287689|Immunoglobulin G|immunoglobulin g|mesh-list
102003456|NCT01287689|Immunologic Factors|immunologic factors|mesh-ancestor
102003457|NCT01287689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003458|NCT01179503|Calcium, Dietary|calcium, dietary|mesh-list
102003459|NCT01179503|Vitamin D|vitamin d|mesh-list
102003460|NCT01179503|Calcium|calcium|mesh-list
102003461|NCT01179503|Vitamins|vitamins|mesh-ancestor
102003462|NCT01179503|Micronutrients|micronutrients|mesh-ancestor
102003463|NCT01179503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003464|NCT01179503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102003465|NCT01179503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102003466|NCT03117049|Paclitaxel|paclitaxel|mesh-list
102003467|NCT03117049|Bevacizumab|bevacizumab|mesh-list
102003468|NCT03117049|Carboplatin|carboplatin|mesh-list
102003469|NCT03117049|Nivolumab|nivolumab|mesh-list
102003470|NCT03117049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102003471|NCT03117049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102003472|NCT03117049|Tubulin Modulators|tubulin modulators|mesh-ancestor
102003473|NCT03117049|Antimitotic Agents|antimitotic agents|mesh-ancestor
102003474|NCT03117049|Mitosis Modulators|mitosis modulators|mesh-ancestor
102003475|NCT03117049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003476|NCT03117049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102003477|NCT03117049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102003478|NCT03117049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102003479|NCT03117049|Growth Substances|growth substances|mesh-ancestor
102003480|NCT03117049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003481|NCT03117049|Growth Inhibitors|growth inhibitors|mesh-ancestor
102003482|NCT03117049|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102003483|NCT03372304|Ropivacaine|ropivacaine|mesh-list
102003484|NCT03372304|Anesthetics, Local|anesthetics, local|mesh-ancestor
102003485|NCT03372304|Anesthetics|anesthetics|mesh-ancestor
102003486|NCT03372304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102003487|NCT03372304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003488|NCT03372304|Sensory System Agents|sensory system agents|mesh-ancestor
102003489|NCT03372304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102003490|NCT02525081|Ramipril|ramipril|mesh-list
102003491|NCT02525081|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102003492|NCT02525081|Protease Inhibitors|protease inhibitors|mesh-ancestor
102003493|NCT02525081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102003494|NCT02525081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003495|NCT02525081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102003496|NCT05566548|Bilirubin|bilirubin|mesh-list
102003497|NCT05566548|Antioxidants|antioxidants|mesh-ancestor
102003498|NCT05566548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003504|NCT02525003|Vitamins|vitamins|mesh-list
102003505|NCT02525003|Micronutrients|micronutrients|mesh-ancestor
102003506|NCT02525003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003507|NCT02525003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102003508|NCT02525003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102003509|NCT03464448|Teriflunomide|teriflunomide|mesh-list
102003510|NCT03464448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102003511|NCT03464448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102003512|NCT03464448|Analgesics|analgesics|mesh-ancestor
102003513|NCT03464448|Sensory System Agents|sensory system agents|mesh-ancestor
102003514|NCT03464448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101948979|NCT05990400|Minoxidil|minoxidil|mesh-list
101948980|NCT05990400|Finasteride|finasteride|mesh-list
101948981|NCT05990400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102003515|NCT03464448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003516|NCT03464448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102003517|NCT03464448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102003518|NCT03464448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102003519|NCT03464448|Immunologic Factors|immunologic factors|mesh-ancestor
102003520|NCT03362008|Varenicline|varenicline|mesh-list
102003521|NCT03362008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102003522|NCT03362008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102003523|NCT03362008|Cholinergic Agents|cholinergic agents|mesh-ancestor
102003524|NCT03362008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102003525|NCT03362008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003526|NCT03362008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003527|NCT03123406|Cinacalcet|cinacalcet|mesh-list
102003528|NCT03123406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102003529|NCT03123406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003530|NCT03123406|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
102003531|NCT03123406|Hormone Antagonists|hormone antagonists|mesh-ancestor
102003532|NCT03123406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102003533|NCT01179659|Pantoprazole|pantoprazole|mesh-list
102003534|NCT01179659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102003535|NCT01179659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102003536|NCT01179659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102003537|NCT01179659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102003538|NCT01179659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003539|NCT04523818|Fluorouracil|fluorouracil|mesh-list
102003540|NCT04523818|Capecitabine|capecitabine|mesh-list
102003541|NCT04523818|Antimetabolites|antimetabolites|mesh-ancestor
102003542|NCT04523818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003543|NCT04523818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102003544|NCT04523818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102003545|NCT04523818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102003546|NCT04523818|Immunologic Factors|immunologic factors|mesh-ancestor
102003547|NCT04523818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003548|NCT03361774|Fluorides|fluorides|mesh-list
102003549|NCT03361774|Cariostatic Agents|cariostatic agents|mesh-ancestor
102003550|NCT03361774|Protective Agents|protective agents|mesh-ancestor
102003551|NCT03361774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003552|NCT04523740|Acetaminophen|acetaminophen|mesh-list
102003553|NCT04523740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102003554|NCT04523740|Analgesics|analgesics|mesh-ancestor
102003555|NCT04523740|Sensory System Agents|sensory system agents|mesh-ancestor
102003556|NCT04523740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102003557|NCT04523740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003558|NCT04523740|Antipyretics|antipyretics|mesh-ancestor
102003559|NCT03410706|Rivaroxaban|rivaroxaban|mesh-list
102003560|NCT03410706|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102003561|NCT03410706|Antithrombins|antithrombins|mesh-ancestor
102003562|NCT03410706|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102003563|NCT03410706|Protease Inhibitors|protease inhibitors|mesh-ancestor
102003564|NCT03410706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102003565|NCT03410706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003566|NCT03410706|Anticoagulants|anticoagulants|mesh-ancestor
102003567|NCT04523662|Apatinib|apatinib|mesh-list
102003568|NCT04523662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102003569|NCT04523662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102003572|NCT03371992|Pembrolizumab|pembrolizumab|mesh-list
102003573|NCT03371992|Nivolumab|nivolumab|mesh-list
102003574|NCT03371992|Atezolizumab|atezolizumab|mesh-list
102003575|NCT03371992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102003576|NCT03371992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102003577|NCT03371992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102003578|NCT03371992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003579|NCT03682705|Upadacitinib|upadacitinib|mesh-list
102003580|NCT03682705|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102003581|NCT03682705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102003582|NCT03682705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102003583|NCT03682705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003584|NCT03682705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102003585|NCT03361618|Zinc Sulfate|zinc sulfate|mesh-list
102003586|NCT03361618|Astringents|astringents|mesh-ancestor
102003587|NCT03361618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948982|NCT05990400|Vasodilator Agents|vasodilator agents|mesh-ancestor
101948983|NCT05990400|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101948984|NCT05990400|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101948985|NCT05990400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101948986|NCT05990400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003588|NCT03361618|Dermatologic Agents|dermatologic agents|mesh-ancestor
102003590|NCT01314495|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102003591|NCT01314495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003592|NCT01314495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102003593|NCT01314495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102003594|NCT01314495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102003595|NCT01314495|Immunologic Factors|immunologic factors|mesh-ancestor
102003596|NCT01314495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003597|NCT01314495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102003598|NCT03123484|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102003599|NCT03123484|Gefitinib|gefitinib|mesh-list
102003600|NCT03123484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102003601|NCT03123484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102003602|NCT03123484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102003603|NCT03123484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003604|NCT03179787|Aripiprazole|aripiprazole|mesh-list
102003605|NCT03179787|Antidepressive Agents|antidepressive agents|mesh-ancestor
102003607|NCT03179787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102003608|NCT03179787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102003609|NCT03179787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102003610|NCT03179787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003611|NCT03179787|Dopamine Agonists|dopamine agonists|mesh-ancestor
102003612|NCT03179787|Dopamine Agents|dopamine agents|mesh-ancestor
102003613|NCT03179787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102003614|NCT03179787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003615|NCT03179787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102003616|NCT03179787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102003617|NCT03179787|Serotonin Agents|serotonin agents|mesh-ancestor
102003618|NCT03179787|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102003619|NCT03179787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102003620|NCT03179787|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102003621|NCT03179787|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102003622|NCT02956057|Ascorbic Acid|ascorbic acid|mesh-list
102003623|NCT02956057|Magnesium citrate|magnesium citrate|mesh-list
102003624|NCT02956057|Picosulfate sodium|picosulfate sodium|mesh-list
102003625|NCT02956057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003626|NCT02956057|Antioxidants|antioxidants|mesh-ancestor
102003627|NCT02956057|Protective Agents|protective agents|mesh-ancestor
102003628|NCT02956057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003629|NCT02956057|Vitamins|vitamins|mesh-ancestor
102003630|NCT02956057|Micronutrients|micronutrients|mesh-ancestor
102003631|NCT02956057|Cathartics|cathartics|mesh-ancestor
102003632|NCT02956057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102003633|NCT04526470|Paclitaxel|paclitaxel|mesh-list
102003634|NCT04526470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102003635|NCT04526470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102003636|NCT04526470|Tubulin Modulators|tubulin modulators|mesh-ancestor
102003637|NCT04526470|Antimitotic Agents|antimitotic agents|mesh-ancestor
102003638|NCT04526470|Mitosis Modulators|mitosis modulators|mesh-ancestor
102003639|NCT04526470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003640|NCT03367390|Insulin Lispro|insulin lispro|mesh-list
102003641|NCT03367390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102003642|NCT03367390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003652|NCT04526236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102003653|NCT04526236|Narcotics|narcotics|mesh-ancestor
102003654|NCT04526236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102003655|NCT04526236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003656|NCT04526236|Analgesics|analgesics|mesh-ancestor
102003657|NCT04526236|Sensory System Agents|sensory system agents|mesh-ancestor
102003658|NCT04526236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102003659|NCT04526236|Antitussive Agents|antitussive agents|mesh-ancestor
102003660|NCT04526236|Respiratory System Agents|respiratory system agents|mesh-ancestor
102003661|NCT01179971|Evening primrose oil|evening primrose oil|mesh-list
101948987|NCT05990400|Hormone Antagonists|hormone antagonists|mesh-ancestor
101948988|NCT05990400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101668818|NCT00636246|Sertraline|sertraline|mesh-list
101948989|NCT05990400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948990|NCT05990400|Urological Agents|urological agents|mesh-ancestor
101948991|NCT05988528|Nifuroxazide|nifuroxazide|mesh-list
101948992|NCT05988528|Mesalamine|mesalamine|mesh-list
101971971|NCT01336322|Hormones|hormones|mesh-ancestor
102003662|NCT01179971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102003663|NCT01179971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102003664|NCT01179971|Analgesics|analgesics|mesh-ancestor
102003665|NCT01179971|Sensory System Agents|sensory system agents|mesh-ancestor
102003666|NCT01179971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102003667|NCT01179971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003668|NCT01179971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102003669|NCT01179971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102003670|NCT01179971|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102003671|NCT01179971|Antimetabolites|antimetabolites|mesh-ancestor
102003672|NCT01179971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003673|NCT01179971|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102003674|NCT01179971|Dermatologic Agents|dermatologic agents|mesh-ancestor
102003675|NCT04237584|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
102003676|NCT04237584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102003677|NCT03681691|Estradiol|estradiol|mesh-list
102003678|NCT03681691|Estrogens|estrogens|mesh-ancestor
102003679|NCT03681691|Hormones|hormones|mesh-ancestor
101723448|NCT00881621|Capecitabine|capecitabine|mesh-list
102003680|NCT03681691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102003681|NCT03681691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003682|NCT01289171|Glycolic acid|glycolic acid|mesh-list
102003683|NCT01289171|Keratolytic Agents|keratolytic agents|mesh-ancestor
102003684|NCT01289171|Dermatologic Agents|dermatologic agents|mesh-ancestor
102003685|NCT03360760|Doxorubicin|doxorubicin|mesh-list
102003686|NCT03360760|Methotrexate|methotrexate|mesh-list
102003687|NCT03360760|Ifosfamide|ifosfamide|mesh-list
102003688|NCT03360760|Isophosphamide mustard|isophosphamide mustard|mesh-list
102003689|NCT03360760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102003690|NCT03360760|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102003691|NCT03360760|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102003692|NCT03360760|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102003693|NCT03360760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102003694|NCT03360760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003695|NCT03360760|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102003696|NCT03360760|Abortifacient Agents|abortifacient agents|mesh-ancestor
102003697|NCT03360760|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102003698|NCT03360760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003699|NCT03360760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102003700|NCT03360760|Antimetabolites|antimetabolites|mesh-ancestor
102003701|NCT03360760|Dermatologic Agents|dermatologic agents|mesh-ancestor
102003702|NCT03360760|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102003703|NCT03360760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102003704|NCT03360760|Immunologic Factors|immunologic factors|mesh-ancestor
102003705|NCT03360760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102003706|NCT03360760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101458701|NCT00222833|Serotonin Agents|serotonin agents|mesh-ancestor
102003716|NCT01285661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102003717|NCT01285661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003718|NCT01285661|Hemostatics|hemostatics|mesh-ancestor
102003719|NCT01285661|Coagulants|coagulants|mesh-ancestor
102003720|NCT03360682|Tenofovir|tenofovir|mesh-list
102003721|NCT03360682|Lamivudine|lamivudine|mesh-list
102003722|NCT03360682|Emtricitabine|emtricitabine|mesh-list
102003723|NCT03360682|Dolutegravir|dolutegravir|mesh-list
102003724|NCT03360682|Abacavir|abacavir|mesh-list
102003725|NCT03360682|Antiviral Agents|antiviral agents|mesh-ancestor
102003726|NCT03360682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102003727|NCT03360682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102003728|NCT03360682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102003729|NCT03360682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101948993|NCT05988528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101948994|NCT05988528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101948995|NCT05988528|Analgesics|analgesics|mesh-ancestor
101948996|NCT05988528|Sensory System Agents|sensory system agents|mesh-ancestor
102003730|NCT03360682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003731|NCT03360682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102003732|NCT03360682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102003733|NCT03360682|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102003734|NCT03360682|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102003735|NCT01180205|Amlodipine|amlodipine|mesh-list
102003736|NCT01180205|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102003737|NCT01180205|Telmisartan|telmisartan|mesh-list
102003738|NCT01180205|Olmesartan|olmesartan|mesh-list
102003739|NCT01180205|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
102003740|NCT01180205|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102003741|NCT01180205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102003742|NCT01180205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102003743|NCT01180205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003744|NCT01180205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102003745|NCT01180205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003746|NCT01180205|Vasodilator Agents|vasodilator agents|mesh-ancestor
102003747|NCT01180205|Diuretics|diuretics|mesh-ancestor
102003748|NCT01180205|Natriuretic Agents|natriuretic agents|mesh-ancestor
102003749|NCT01180205|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102003750|NCT01180205|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102003751|NCT01180205|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102003752|NCT04523506|Botulinum Toxins|botulinum toxins|mesh-list
102003753|NCT04523506|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102003754|NCT04523506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102003755|NCT04523506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003756|NCT04523506|Cholinergic Agents|cholinergic agents|mesh-ancestor
102003757|NCT04523506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102003758|NCT04523506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003759|NCT03867084|Pembrolizumab|pembrolizumab|mesh-list
102003760|NCT03867084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102003761|NCT03867084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102003762|NCT03867084|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102003763|NCT03867084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003764|NCT03860831|Midazolam|midazolam|mesh-list
102003765|NCT03860831|Ketamine|ketamine|mesh-list
102003766|NCT03860831|Analgesics|analgesics|mesh-ancestor
102003767|NCT03860831|Sensory System Agents|sensory system agents|mesh-ancestor
102003768|NCT03860831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102003769|NCT03860831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003770|NCT03860831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102003771|NCT03860831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102003772|NCT03860831|Anesthetics, General|anesthetics, general|mesh-ancestor
102003773|NCT03860831|Anesthetics|anesthetics|mesh-ancestor
102003774|NCT03860831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102003778|NCT03860831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003779|NCT03860831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102003780|NCT03860831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102003781|NCT03860831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102003782|NCT03860831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102003783|NCT03860831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102003784|NCT03860831|GABA Modulators|gaba modulators|mesh-ancestor
102003785|NCT03860831|GABA Agents|gaba agents|mesh-ancestor
102003786|NCT01064479|Cisplatin|cisplatin|mesh-list
102003787|NCT01064479|Carboplatin|carboplatin|mesh-list
102003788|NCT01064479|Docetaxel|docetaxel|mesh-list
102003789|NCT01064479|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102003790|NCT01064479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102003791|NCT01064479|Tubulin Modulators|tubulin modulators|mesh-ancestor
102003792|NCT01064479|Antimitotic Agents|antimitotic agents|mesh-ancestor
102003793|NCT01064479|Mitosis Modulators|mitosis modulators|mesh-ancestor
102003794|NCT01064479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003795|NCT01064479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102003796|NCT01064479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102003797|NCT04218708|Nicotine|nicotine|mesh-list
102003798|NCT04218708|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102003799|NCT04218708|Autonomic Agents|autonomic agents|mesh-ancestor
101948997|NCT05988528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101948998|NCT05988528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101948999|NCT05988528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102003800|NCT04218708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102003801|NCT04218708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003802|NCT04218708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102003803|NCT04218708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102003804|NCT04218708|Cholinergic Agents|cholinergic agents|mesh-ancestor
102003805|NCT04218708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102003806|NCT04218708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003807|NCT03667326|Aspirin|aspirin|mesh-list
102003808|NCT03667326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102003809|NCT03667326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102003810|NCT03667326|Analgesics|analgesics|mesh-ancestor
102003811|NCT03667326|Sensory System Agents|sensory system agents|mesh-ancestor
102003812|NCT03667326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102003813|NCT03667326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003814|NCT03667326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102003815|NCT03667326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102003816|NCT03667326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102003817|NCT03667326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102003818|NCT03667326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003819|NCT03667326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102003820|NCT03667326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102003821|NCT03667326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102003822|NCT03667326|Antipyretics|antipyretics|mesh-ancestor
102003823|NCT04525300|Liraglutide|liraglutide|mesh-list
102003824|NCT04525300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102003825|NCT04525300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003826|NCT04525300|Incretins|incretins|mesh-ancestor
102003827|NCT04525300|Hormones|hormones|mesh-ancestor
102003828|NCT04525300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102003829|NCT03865121|Nicotine|nicotine|mesh-list
102003830|NCT03865121|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101723615|NCT00684827|Albuterol|albuterol|mesh-list
102003831|NCT03865121|Autonomic Agents|autonomic agents|mesh-ancestor
102003832|NCT03865121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102003833|NCT03865121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003834|NCT03865121|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102003835|NCT03865121|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102003836|NCT03865121|Cholinergic Agents|cholinergic agents|mesh-ancestor
102003837|NCT03865121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102003838|NCT03865121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003839|NCT03680911|Acetylcysteine|acetylcysteine|mesh-list
102003840|NCT03680911|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102003841|NCT03680911|Antiviral Agents|antiviral agents|mesh-ancestor
102003842|NCT03680911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102003843|NCT03680911|Expectorants|expectorants|mesh-ancestor
102003844|NCT03680911|Respiratory System Agents|respiratory system agents|mesh-ancestor
102003845|NCT03680911|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102003846|NCT03680911|Antioxidants|antioxidants|mesh-ancestor
102003852|NCT03370588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102003853|NCT03370588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102003854|NCT03370588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003855|NCT03370588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102003856|NCT03370588|Analgesics|analgesics|mesh-ancestor
102003857|NCT03370588|Sensory System Agents|sensory system agents|mesh-ancestor
102003858|NCT03370588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102003859|NCT03370588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102003860|NCT03370588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102003861|NCT03370588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102003862|NCT03370588|Adrenergic Agents|adrenergic agents|mesh-ancestor
101261529|NCT01750541|Autonomic Agents|autonomic agents|mesh-ancestor
102003863|NCT03370588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102003864|NCT03370588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003865|NCT05156814|Dydrogesterone|dydrogesterone|mesh-list
102003866|NCT05156814|Progestins|progestins|mesh-ancestor
102003868|NCT05156814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102003869|NCT05156814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003870|NCT01289483|Fospropofol|fospropofol|mesh-list
102003871|NCT01289483|Propofol|propofol|mesh-list
102003872|NCT01289483|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101949000|NCT05988528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101949001|NCT05988528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101949002|NCT05987293|Salicylic Acid|salicylic acid|mesh-list
101949003|NCT05987293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102003873|NCT01289483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102003874|NCT01289483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003875|NCT01289483|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102003876|NCT01289483|Anesthetics, General|anesthetics, general|mesh-ancestor
102003877|NCT01289483|Anesthetics|anesthetics|mesh-ancestor
102003878|NCT03680521|Nivolumab|nivolumab|mesh-list
102003879|NCT03680521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102003880|NCT03680521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102003881|NCT03680521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102003882|NCT03680521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003883|NCT01289327|Midazolam|midazolam|mesh-list
102003884|NCT01289327|Alfentanil|alfentanil|mesh-list
102003885|NCT01289327|Propofol|propofol|mesh-list
102003886|NCT01289327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102003887|NCT01289327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102003888|NCT01289327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003889|NCT01289327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102003890|NCT01289327|Anesthetics, General|anesthetics, general|mesh-ancestor
102003891|NCT01289327|Anesthetics|anesthetics|mesh-ancestor
102003892|NCT01289327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102003893|NCT01289327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102003894|NCT01289327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102003895|NCT01289327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102003896|NCT01289327|GABA Modulators|gaba modulators|mesh-ancestor
102003897|NCT01289327|GABA Agents|gaba agents|mesh-ancestor
102003898|NCT01289327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102003899|NCT01289327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003900|NCT01289327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102003901|NCT01289327|Narcotics|narcotics|mesh-ancestor
102003902|NCT01289327|Analgesics|analgesics|mesh-ancestor
102003903|NCT01289327|Sensory System Agents|sensory system agents|mesh-ancestor
102003904|NCT01289327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102003905|NCT01181063|Budesonide|budesonide|mesh-list
102003906|NCT01181063|Formoterol Fumarate|formoterol fumarate|mesh-list
102003907|NCT01181063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102003908|NCT01181063|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102003909|NCT01181063|Autonomic Agents|autonomic agents|mesh-ancestor
102003910|NCT01181063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102003911|NCT01181063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003912|NCT01181063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102003913|NCT01181063|Respiratory System Agents|respiratory system agents|mesh-ancestor
102003914|NCT01181063|Glucocorticoids|glucocorticoids|mesh-ancestor
102003915|NCT01181063|Hormones|hormones|mesh-ancestor
102003916|NCT01181063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102003917|NCT01181063|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102003921|NCT01181063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102003922|NCT01181063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003924|NCT02596997|Antiviral Agents|antiviral agents|mesh-ancestor
102003925|NCT02596997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102003926|NCT03649477|Carbetocin|carbetocin|mesh-list
102003927|NCT03649477|Oxytocin|oxytocin|mesh-list
102003928|NCT03649477|Oxytocics|oxytocics|mesh-ancestor
102003929|NCT03649477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102003930|NCT03649477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003931|NCT03359746|Grazoprevir|grazoprevir|mesh-list
102003932|NCT03359746|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
102003933|NCT03359746|Antiviral Agents|antiviral agents|mesh-ancestor
102003934|NCT03359746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102003935|NCT01310101|Dexamethasone|dexamethasone|mesh-list
102003936|NCT01310101|Ofatumumab|ofatumumab|mesh-list
102003937|NCT01310101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102003938|NCT01310101|Antiemetics|antiemetics|mesh-ancestor
102003939|NCT01310101|Autonomic Agents|autonomic agents|mesh-ancestor
102003940|NCT01310101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102003941|NCT01310101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003942|NCT01310101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102003943|NCT01310101|Glucocorticoids|glucocorticoids|mesh-ancestor
102003944|NCT01310101|Hormones|hormones|mesh-ancestor
102003945|NCT01310101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101949004|NCT05987293|Antifungal Agents|antifungal agents|mesh-ancestor
101949005|NCT05987293|Keratolytic Agents|keratolytic agents|mesh-ancestor
101949006|NCT05987293|Dermatologic Agents|dermatologic agents|mesh-ancestor
101949007|NCT05986318|Acetylcysteine|acetylcysteine|mesh-list
101949008|NCT05986318|Dexamethasone|dexamethasone|mesh-list
101949009|NCT05986318|Dexamethasone acetate|dexamethasone acetate|mesh-list
102003946|NCT01310101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102003947|NCT01310101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102003948|NCT03639727|Mannitol|mannitol|mesh-list
102003949|NCT03639727|Citric Acid|citric acid|mesh-list
102003950|NCT03639727|Sodium Citrate|sodium citrate|mesh-list
102003951|NCT03639727|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102003952|NCT03639727|Diuretics|diuretics|mesh-ancestor
102003953|NCT03639727|Natriuretic Agents|natriuretic agents|mesh-ancestor
102003954|NCT03639727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003955|NCT03639727|Anticoagulants|anticoagulants|mesh-ancestor
102003956|NCT03639727|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102003957|NCT03639727|Chelating Agents|chelating agents|mesh-ancestor
102003958|NCT03639727|Sequestering Agents|sequestering agents|mesh-ancestor
102003959|NCT03639727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003960|NCT01180751|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102003961|NCT01180751|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102003962|NCT01180751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003963|NCT04523272|Sunitinib|sunitinib|mesh-list
102003964|NCT04523272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102003965|NCT04523272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102003966|NCT04523272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102003967|NCT04523272|Growth Substances|growth substances|mesh-ancestor
102003968|NCT04523272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003969|NCT04523272|Growth Inhibitors|growth inhibitors|mesh-ancestor
102003970|NCT04523272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102003971|NCT04523272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102003972|NCT04523272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003973|NCT01289561|Ethanol|ethanol|mesh-list
102003974|NCT01289561|Quinine|quinine|mesh-list
102003975|NCT01289561|Caffeine|caffeine|mesh-list
102003976|NCT01289561|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102003977|NCT01289561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102003978|NCT01289561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102003979|NCT01289561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003980|NCT01289561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102003981|NCT01289561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102003982|NCT01289561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102003983|NCT01289561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003984|NCT01289561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102003985|NCT01289561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102003986|NCT01289561|Purinergic Agents|purinergic agents|mesh-ancestor
102003987|NCT01289561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102003988|NCT01289561|Antimalarials|antimalarials|mesh-ancestor
102003989|NCT01289561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102003990|NCT01289561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102004003|NCT03855527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102004004|NCT03855527|Disinfectants|disinfectants|mesh-ancestor
102004005|NCT03366064|Pemetrexed|pemetrexed|mesh-list
102004006|NCT03366064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102004007|NCT03366064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102004008|NCT03366064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004009|NCT03366064|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102004010|NCT03366064|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102004011|NCT03677401|Serlopitant|serlopitant|mesh-list
102004012|NCT03677401|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102004013|NCT03677401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102004014|NCT03677401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004015|NCT03677401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004016|NCT03357874|Clopidogrel|clopidogrel|mesh-list
102004017|NCT03357874|Ticagrelor|ticagrelor|mesh-list
102004018|NCT03357874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102004019|NCT03357874|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102004020|NCT03357874|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102004021|NCT03357874|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101949010|NCT05986318|BB 1101|bb 1101|mesh-list
101949011|NCT05986318|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101949012|NCT05986318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101949013|NCT05986318|Antiemetics|antiemetics|mesh-ancestor
101949014|NCT05986318|Autonomic Agents|autonomic agents|mesh-ancestor
101949015|NCT05986318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101949016|NCT05986318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265960|NCT01778803|Paclitaxel|paclitaxel|mesh-list
102004022|NCT03357874|Purinergic Agents|purinergic agents|mesh-ancestor
102004023|NCT03357874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102004024|NCT03357874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004025|NCT03357874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004026|NCT01286051|Ganirelix|ganirelix|mesh-list
102004027|NCT01286051|Hormone Antagonists|hormone antagonists|mesh-ancestor
102004028|NCT01286051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102004029|NCT01286051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004030|NCT03357796|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
102004031|NCT03357796|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102004032|NCT03357796|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102004033|NCT03357796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102004034|NCT03357796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004035|NCT03357796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102004036|NCT03357796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004037|NCT03357796|Antidepressive Agents|antidepressive agents|mesh-ancestor
102004038|NCT03357796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102004039|NCT02359513|Fluoxetine|fluoxetine|mesh-list
102004040|NCT02359513|Antidepressive Agents|antidepressive agents|mesh-list
102004041|NCT02359513|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102004042|NCT02359513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102004043|NCT02359513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102004044|NCT02359513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004045|NCT02359513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102004046|NCT02359513|Serotonin Agents|serotonin agents|mesh-ancestor
102004047|NCT02359513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004048|NCT02359513|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102004049|NCT02359513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102004050|NCT02359513|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102004051|NCT02359513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102004055|NCT03864575|Celecoxib|celecoxib|mesh-list
102004056|NCT03864575|Nivolumab|nivolumab|mesh-list
102004057|NCT03864575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102004058|NCT03864575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102004059|NCT03864575|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102004060|NCT03864575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004061|NCT03864575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102004062|NCT03864575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102004063|NCT03864575|Analgesics|analgesics|mesh-ancestor
102004064|NCT03864575|Sensory System Agents|sensory system agents|mesh-ancestor
102004065|NCT03864575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102004066|NCT03864575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004067|NCT03864575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102004068|NCT03864575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102004069|NCT03864575|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102004070|NCT03864575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102004071|NCT03864575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102004072|NCT03357718|Midazolam|midazolam|mesh-list
102004073|NCT03357718|Dexmedetomidine|dexmedetomidine|mesh-list
102004074|NCT03357718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102004075|NCT03357718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102004076|NCT03357718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004077|NCT03357718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102004078|NCT03357718|Analgesics|analgesics|mesh-ancestor
102004079|NCT03357718|Sensory System Agents|sensory system agents|mesh-ancestor
102004080|NCT03357718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101949017|NCT05986318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101949018|NCT05986318|Glucocorticoids|glucocorticoids|mesh-ancestor
101949019|NCT05986318|Hormones|hormones|mesh-ancestor
102004081|NCT03357718|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102004082|NCT03357718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102004083|NCT03357718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102004084|NCT03357718|Adrenergic Agents|adrenergic agents|mesh-ancestor
102004085|NCT03357718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102004086|NCT03357718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004087|NCT03357718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102004088|NCT03357718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102004089|NCT03357718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102004090|NCT03357718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102004091|NCT03357718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102004092|NCT03357718|Anesthetics, General|anesthetics, general|mesh-ancestor
102004093|NCT03357718|Anesthetics|anesthetics|mesh-ancestor
102004094|NCT03357718|GABA Modulators|gaba modulators|mesh-ancestor
102004095|NCT03357718|GABA Agents|gaba agents|mesh-ancestor
102004096|NCT04521400|Interferons|interferons|mesh-list
102004097|NCT04521400|Ritonavir|ritonavir|mesh-list
102004098|NCT04521400|Lopinavir|lopinavir|mesh-list
102004099|NCT04521400|Interferon-beta|interferon-beta|mesh-list
102004100|NCT04521400|Interferon beta-1a|interferon beta-1a|mesh-list
102004101|NCT04521400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102004102|NCT04521400|Antiviral Agents|antiviral agents|mesh-ancestor
102004103|NCT04521400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102004104|NCT04521400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102004105|NCT04521400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102004106|NCT04521400|Protease Inhibitors|protease inhibitors|mesh-ancestor
102004107|NCT04521400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102004108|NCT04521400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004109|NCT04521400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102004110|NCT04521400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102004111|NCT04521400|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102004112|NCT04521400|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102004113|NCT04521400|Immunologic Factors|immunologic factors|mesh-ancestor
102004114|NCT04521400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004115|NCT04521400|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102004116|NCT03864185|Rituximab|rituximab|mesh-list
102004117|NCT03864185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102004118|NCT03864185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102004119|NCT03864185|Immunologic Factors|immunologic factors|mesh-ancestor
102004120|NCT03864185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004121|NCT03864185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102004122|NCT01185119|Glucagon|glucagon|mesh-list
102004123|NCT01185119|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102004124|NCT01185119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102004125|NCT01185119|Hormones|hormones|mesh-ancestor
102004131|NCT03357640|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
102004132|NCT03357640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102004133|NCT03357640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004134|NCT03357640|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102004135|NCT01185197|Mycophenolic Acid|mycophenolic acid|mesh-list
102004136|NCT01185197|Prednisolone|prednisolone|mesh-list
102004137|NCT01185197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102004138|NCT01185197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102004139|NCT01185197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102004140|NCT01185197|Antitubercular Agents|antitubercular agents|mesh-ancestor
102004141|NCT01185197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102004142|NCT01185197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102004143|NCT01185197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102004144|NCT01185197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004145|NCT01185197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102004146|NCT01185197|Glucocorticoids|glucocorticoids|mesh-ancestor
102004147|NCT01185197|Hormones|hormones|mesh-ancestor
102004148|NCT01185197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102004149|NCT01185197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004150|NCT01185197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102004151|NCT03733873|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
102004152|NCT03733873|Hemostatics|hemostatics|mesh-ancestor
102004153|NCT03733873|Coagulants|coagulants|mesh-ancestor
102004154|NCT03733873|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102004155|NCT03733873|Natriuretic Agents|natriuretic agents|mesh-ancestor
102004156|NCT03733873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949020|NCT05986318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101949021|NCT05986318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101949022|NCT05986318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949023|NCT05986318|Protease Inhibitors|protease inhibitors|mesh-ancestor
101949024|NCT05986318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101266090|NCT01779609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102004157|NCT03733639|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102004158|NCT03733639|Hemostatics|hemostatics|mesh-ancestor
102004159|NCT03733639|Coagulants|coagulants|mesh-ancestor
102004160|NCT03733561|Rotigotine|rotigotine|mesh-list
102004161|NCT03733561|Dopamine Agonists|dopamine agonists|mesh-ancestor
102004162|NCT03733561|Dopamine Agents|dopamine agents|mesh-ancestor
102004163|NCT03733561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102004164|NCT03733561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004165|NCT03733561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004166|NCT03358888|Analgesics, Opioid|analgesics, opioid|mesh-list
102004167|NCT03358888|Narcotics|narcotics|mesh-ancestor
102004168|NCT03358888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102004169|NCT03358888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004170|NCT03358888|Analgesics|analgesics|mesh-ancestor
102004171|NCT03358888|Sensory System Agents|sensory system agents|mesh-ancestor
102004172|NCT03358888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102004173|NCT01291121|Ranibizumab|ranibizumab|mesh-list
102004174|NCT01291121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102004175|NCT01291121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102004176|NCT01291121|Growth Substances|growth substances|mesh-ancestor
102004177|NCT01291121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004178|NCT01291121|Growth Inhibitors|growth inhibitors|mesh-ancestor
102004179|NCT01291121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102004180|NCT01187849|Metformin|metformin|mesh-list
102004181|NCT01187849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102004182|NCT01187849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004183|NCT04522882|Insulin|insulin|mesh-list
102004184|NCT04522882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102004185|NCT04522882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004186|NCT03123718|Methotrexate|methotrexate|mesh-list
102004187|NCT03123718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102004188|NCT03123718|Abortifacient Agents|abortifacient agents|mesh-ancestor
102004189|NCT03123718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102004190|NCT03123718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004191|NCT03123718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102004192|NCT03123718|Antimetabolites|antimetabolites|mesh-ancestor
102004193|NCT03123718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004194|NCT03123718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102004198|NCT03123718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102004199|NCT03123718|Immunologic Factors|immunologic factors|mesh-ancestor
102004200|NCT03123718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102004201|NCT03123718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102004202|NCT01185743|Olanzapine|olanzapine|mesh-list
102004203|NCT01185743|Ziprasidone|ziprasidone|mesh-list
102004204|NCT01185743|Antiemetics|antiemetics|mesh-ancestor
102004205|NCT01185743|Autonomic Agents|autonomic agents|mesh-ancestor
102004206|NCT01185743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102004207|NCT01185743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004208|NCT01185743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102004209|NCT01185743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102004210|NCT01185743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102004211|NCT01185743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102004212|NCT01185743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102004213|NCT01185743|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102004214|NCT01185743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102004215|NCT01185743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102004216|NCT01185743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004217|NCT01185743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102004218|NCT01185743|Serotonin Agents|serotonin agents|mesh-ancestor
102004219|NCT01185743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102004220|NCT01185743|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102004221|NCT01185743|Dopamine Agents|dopamine agents|mesh-ancestor
101949025|NCT05986318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949026|NCT05986318|Antiviral Agents|antiviral agents|mesh-ancestor
101949027|NCT05986318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101949028|NCT05986318|Expectorants|expectorants|mesh-ancestor
101949029|NCT05986318|Respiratory System Agents|respiratory system agents|mesh-ancestor
101949030|NCT05986318|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101949031|NCT05986318|Antioxidants|antioxidants|mesh-ancestor
102004222|NCT01188005|Vitamins|vitamins|mesh-list
102004223|NCT01188005|Vitamin E|vitamin e|mesh-list
102004224|NCT01188005|Vitamin A|vitamin a|mesh-list
102004225|NCT01188005|Acetylcysteine|acetylcysteine|mesh-list
102004226|NCT01188005|Allopurinol|allopurinol|mesh-list
102004227|NCT01188005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102004228|NCT01188005|Micronutrients|micronutrients|mesh-ancestor
102004229|NCT01188005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004230|NCT01188005|Antioxidants|antioxidants|mesh-ancestor
102004231|NCT01188005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004232|NCT01188005|Protective Agents|protective agents|mesh-ancestor
102004233|NCT01188005|Antiviral Agents|antiviral agents|mesh-ancestor
102004234|NCT01188005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102004235|NCT01188005|Expectorants|expectorants|mesh-ancestor
102004236|NCT01188005|Respiratory System Agents|respiratory system agents|mesh-ancestor
102004237|NCT01188005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102004238|NCT01188005|Antidotes|antidotes|mesh-ancestor
102004239|NCT01188005|Antimetabolites|antimetabolites|mesh-ancestor
102004240|NCT01188005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102004241|NCT01188005|Gout Suppressants|gout suppressants|mesh-ancestor
102004242|NCT01188005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102004243|NCT04445194|Vaccines|vaccines|mesh-list
102004244|NCT04445194|Immunologic Factors|immunologic factors|mesh-ancestor
102004245|NCT04445194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004246|NCT01291199|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
102004247|NCT01291199|Vasodilator Agents|vasodilator agents|mesh-ancestor
102004248|NCT01291199|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102004249|NCT01291199|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102004250|NCT01291199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102004251|NCT01291199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004252|NCT01291199|Urological Agents|urological agents|mesh-ancestor
102004253|NCT04444726|Betamethasone|betamethasone|mesh-list
102004254|NCT04444726|Betamethasone Valerate|betamethasone valerate|mesh-list
102004255|NCT04444726|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102004256|NCT04444726|Betamethasone benzoate|betamethasone benzoate|mesh-list
102004257|NCT04444726|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102004258|NCT04444726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102004259|NCT04444726|Glucocorticoids|glucocorticoids|mesh-ancestor
102004260|NCT04444726|Hormones|hormones|mesh-ancestor
102004261|NCT04444726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102004262|NCT04444726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004263|NCT04444726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102004264|NCT04444726|Respiratory System Agents|respiratory system agents|mesh-ancestor
102004265|NCT03733327|Cyclophosphamide|cyclophosphamide|mesh-list
102004266|NCT03733327|Busulfan|busulfan|mesh-list
102004267|NCT03733327|Etoposide|etoposide|mesh-list
102004268|NCT03733327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102004269|NCT03733327|Immunologic Factors|immunologic factors|mesh-ancestor
102004270|NCT03733327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004272|NCT03733327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102004273|NCT03733327|Alkylating Agents|alkylating agents|mesh-ancestor
102004274|NCT03733327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004275|NCT03733327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102004276|NCT03733327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102004277|NCT03733327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102004278|NCT03733327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102004279|NCT03733327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102004280|NCT03733327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102004281|NCT03733171|Epinephrine|epinephrine|mesh-list
102004283|NCT03733171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102004284|NCT03733171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102004285|NCT03733171|Adrenergic Agents|adrenergic agents|mesh-ancestor
102004286|NCT03733171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101949032|NCT05986318|Protective Agents|protective agents|mesh-ancestor
101949033|NCT05986318|Antidotes|antidotes|mesh-ancestor
101949034|NCT05981573|Methadone|methadone|mesh-list
101949035|NCT05981573|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101949036|NCT05981573|Narcotics|narcotics|mesh-ancestor
101261951|NCT01754324|Methadone|methadone|mesh-list
101949037|NCT05981573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101949038|NCT05981573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949039|NCT05981573|Analgesics|analgesics|mesh-ancestor
102004287|NCT03733171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004288|NCT03733171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004289|NCT03733171|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102004290|NCT03733171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102004291|NCT03733171|Autonomic Agents|autonomic agents|mesh-ancestor
102004292|NCT03733171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102004293|NCT03733171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102004294|NCT03733171|Respiratory System Agents|respiratory system agents|mesh-ancestor
102004295|NCT03733171|Mydriatics|mydriatics|mesh-ancestor
102004296|NCT03733171|Sympathomimetics|sympathomimetics|mesh-ancestor
102004297|NCT03733171|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102004298|NCT03733171|Coagulants|coagulants|mesh-ancestor
102004300|NCT03207750|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102004301|NCT03207750|Immunologic Factors|immunologic factors|mesh-ancestor
102004302|NCT03207750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004303|NCT01185977|Fluoxetine|fluoxetine|mesh-list
102004304|NCT01185977|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102004305|NCT01185977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102004306|NCT01185977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102004307|NCT01185977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004308|NCT01185977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102004309|NCT01185977|Serotonin Agents|serotonin agents|mesh-ancestor
102004310|NCT01185977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004311|NCT01185977|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102004312|NCT01185977|Antidepressive Agents|antidepressive agents|mesh-ancestor
102004313|NCT01185977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102004314|NCT01185977|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102004315|NCT01185977|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102004316|NCT01185977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102004317|NCT03857399|Caspofungin|caspofungin|mesh-list
102004318|NCT03857399|Antifungal Agents|antifungal agents|mesh-ancestor
102004319|NCT03857399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102004320|NCT03857399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102004321|NCT03857399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004322|NCT04520620|Enoxaparin|enoxaparin|mesh-list
102004323|NCT04520620|Anticoagulants|anticoagulants|mesh-ancestor
102004324|NCT04520620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102004325|NCT04520620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102004326|NCT04520620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004327|NCT03857711|Amiodarone|amiodarone|mesh-list
102004328|NCT03857711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102004329|NCT03857711|Vasodilator Agents|vasodilator agents|mesh-ancestor
102004330|NCT03857711|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102004331|NCT03857711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102004332|NCT03857711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004333|NCT03857711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102004334|NCT03857711|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102004335|NCT03857711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102004336|NCT03857711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102004337|NCT03857711|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102004338|NCT03857711|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102004339|NCT03857711|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102004340|NCT03672097|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102004341|NCT03672097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102004342|NCT03847896|Budesonide|budesonide|mesh-list
102004351|NCT03847896|Glucocorticoids|glucocorticoids|mesh-ancestor
102004352|NCT03847896|Hormones|hormones|mesh-ancestor
101724120|NCT00683111|Histamine Antagonists|histamine antagonists|mesh-ancestor
102004353|NCT03847896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102004354|NCT03847896|Tocolytic Agents|tocolytic agents|mesh-ancestor
102004355|NCT03847896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102004356|NCT03847896|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102004357|NCT03847896|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102004358|NCT03847896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102004359|NCT03847896|Adrenergic Agents|adrenergic agents|mesh-ancestor
102004360|NCT03847896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102004361|NCT03847896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004362|NCT01186289|Atorvastatin|atorvastatin|mesh-list
102004363|NCT01186289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102004364|NCT01186289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102004365|NCT01186289|Antimetabolites|antimetabolites|mesh-ancestor
102004366|NCT01186289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004367|NCT01186289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102004368|NCT01186289|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102004369|NCT01186289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102004371|NCT01291823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102004372|NCT01291823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102004373|NCT01291823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102004374|NCT01291823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004375|NCT01181765|Infliximab|infliximab|mesh-list
102004376|NCT01181765|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102004377|NCT01181765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102004378|NCT01181765|Dermatologic Agents|dermatologic agents|mesh-ancestor
102004379|NCT01181765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102004380|NCT01181765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102004381|NCT01186445|Morphine|morphine|mesh-list
102004382|NCT01186445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102004383|NCT01186445|Narcotics|narcotics|mesh-ancestor
102004384|NCT01186445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102004385|NCT01186445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004386|NCT01186445|Analgesics|analgesics|mesh-ancestor
102004387|NCT01186445|Sensory System Agents|sensory system agents|mesh-ancestor
102004388|NCT01186445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102004389|NCT03739333|Carbon-11 methionine|carbon-11 methionine|mesh-list
102004390|NCT03739333|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102004391|NCT03739333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004392|NCT04520230|Budesonide|budesonide|mesh-list
102004393|NCT04520230|Formoterol Fumarate|formoterol fumarate|mesh-list
102004394|NCT04520230|Tiotropium Bromide|tiotropium bromide|mesh-list
102004395|NCT04520230|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
102004396|NCT04520230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102004397|NCT04520230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102004398|NCT04520230|Autonomic Agents|autonomic agents|mesh-ancestor
102004399|NCT04520230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102004400|NCT04520230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004401|NCT04520230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102004402|NCT04520230|Respiratory System Agents|respiratory system agents|mesh-ancestor
102004403|NCT04520230|Glucocorticoids|glucocorticoids|mesh-ancestor
102004404|NCT04520230|Hormones|hormones|mesh-ancestor
102004405|NCT04520230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102004422|NCT03852563|Dermatologic Agents|dermatologic agents|mesh-ancestor
102004423|NCT01188317|Ibuprofen|ibuprofen|mesh-list
102004424|NCT01188317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102004425|NCT01188317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102004426|NCT01188317|Analgesics|analgesics|mesh-ancestor
101724199|NCT00690521|Metolazone|metolazone|mesh-list
101262095|NCT01755338|Hormones|hormones|mesh-ancestor
102004427|NCT01188317|Sensory System Agents|sensory system agents|mesh-ancestor
102004428|NCT01188317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102004429|NCT01188317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004430|NCT01188317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102004431|NCT01188317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102004432|NCT01188317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102004433|NCT01188317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102004434|NCT01188317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004435|NCT03206970|Zanubrutinib|zanubrutinib|mesh-list
102004436|NCT03206970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102004437|NCT03206970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102004438|NCT03206970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102004439|NCT03206970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004440|NCT03739021|Ropivacaine|ropivacaine|mesh-list
102004441|NCT03739021|Anesthetics, Local|anesthetics, local|mesh-ancestor
102004442|NCT03739021|Anesthetics|anesthetics|mesh-ancestor
102004443|NCT03739021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102004444|NCT03739021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004445|NCT03739021|Sensory System Agents|sensory system agents|mesh-ancestor
102004446|NCT03739021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102004447|NCT03738943|Pyridoxine|pyridoxine|mesh-list
102004448|NCT03738943|Pyridoxal|pyridoxal|mesh-list
102004449|NCT03738943|Vitamin B 6|vitamin b 6|mesh-list
102004450|NCT03738943|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
102004451|NCT03738943|Adenosine|adenosine|mesh-list
102004452|NCT03738943|Nitroprusside|nitroprusside|mesh-list
102004453|NCT03738943|Acetylcholine|acetylcholine|mesh-list
102004454|NCT03738943|Vitamins|vitamins|mesh-ancestor
102004455|NCT03738943|Micronutrients|micronutrients|mesh-ancestor
102004456|NCT03738943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004457|NCT03738943|Vitamin B Complex|vitamin b complex|mesh-ancestor
102004458|NCT03738943|Analgesics|analgesics|mesh-ancestor
102004459|NCT03738943|Sensory System Agents|sensory system agents|mesh-ancestor
102004460|NCT03738943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102004461|NCT03738943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102004462|NCT03738943|Vasodilator Agents|vasodilator agents|mesh-ancestor
101949064|NCT05962957|Pentoxifylline|pentoxifylline|mesh-list
102004463|NCT03738943|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102004464|NCT03738943|Purinergic Agonists|purinergic agonists|mesh-ancestor
102004465|NCT03738943|Purinergic Agents|purinergic agents|mesh-ancestor
102004466|NCT03738943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102004467|NCT03738943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004468|NCT03738943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102004469|NCT03738943|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102004470|NCT03738943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102004471|NCT03738943|Cholinergic Agents|cholinergic agents|mesh-ancestor
102004472|NCT03178851|Atezolizumab|atezolizumab|mesh-list
102004473|NCT03178851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102004474|NCT03178851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102004475|NCT03178851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004476|NCT03178851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102004477|NCT03178851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102004478|NCT03178851|Immunologic Factors|immunologic factors|mesh-ancestor
102004479|NCT03178851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004486|NCT01291979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102004487|NCT01291979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102004488|NCT01291979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101262157|NCT01755559|Artesunate|artesunate|mesh-list
102004489|NCT01291979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102004490|NCT01291979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102004491|NCT01291979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004492|NCT04443634|Bupivacaine|bupivacaine|mesh-list
102004493|NCT04443634|Anesthetics, Local|anesthetics, local|mesh-ancestor
102004494|NCT04443634|Anesthetics|anesthetics|mesh-ancestor
102004495|NCT04443634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102004496|NCT04443634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004497|NCT04443634|Sensory System Agents|sensory system agents|mesh-ancestor
102004498|NCT04443634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102004499|NCT03643159|Aripiprazole|aripiprazole|mesh-list
102004500|NCT03643159|Antipsychotic Agents|antipsychotic agents|mesh-list
102004501|NCT03643159|Antidepressive Agents|antidepressive agents|mesh-ancestor
102004503|NCT03643159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102004504|NCT03643159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102004505|NCT03643159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004506|NCT03643159|Dopamine Agonists|dopamine agonists|mesh-ancestor
102004507|NCT03643159|Dopamine Agents|dopamine agents|mesh-ancestor
102004508|NCT03643159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102004509|NCT03643159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004510|NCT03643159|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102004511|NCT03643159|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102004512|NCT03643159|Serotonin Agents|serotonin agents|mesh-ancestor
102004513|NCT03643159|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102004514|NCT03643159|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102004515|NCT03643159|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102004516|NCT03643159|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102004518|NCT03205566|Raltegravir Potassium|raltegravir potassium|mesh-list
102004519|NCT03205566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102004520|NCT03205566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102004521|NCT03205566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102004522|NCT03205566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004523|NCT03205566|Antiviral Agents|antiviral agents|mesh-ancestor
102004524|NCT03205566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102004525|NCT03205566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102004526|NCT03205566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102004527|NCT03205566|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102004528|NCT03205566|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102004529|NCT01181999|Rituximab|rituximab|mesh-list
102004530|NCT01181999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102004531|NCT01181999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949065|NCT05962957|Levodopa|levodopa|mesh-list
101949066|NCT05962957|Carbidopa|carbidopa|mesh-list
101949067|NCT05962957|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101949068|NCT05962957|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101949069|NCT05962957|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101949070|NCT05962957|Dopamine Agents|dopamine agents|mesh-ancestor
102004532|NCT01181999|Immunologic Factors|immunologic factors|mesh-ancestor
102004533|NCT01181999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004534|NCT01181999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102004535|NCT04509232|Fluorides|fluorides|mesh-list
102004536|NCT04509232|Cariostatic Agents|cariostatic agents|mesh-ancestor
102004537|NCT04509232|Protective Agents|protective agents|mesh-ancestor
102004538|NCT04509232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004539|NCT03732235|Bevacizumab|bevacizumab|mesh-list
102004540|NCT03732235|Chlorotrianisene|chlorotrianisene|mesh-list
102004541|NCT03732235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102004542|NCT03732235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102004543|NCT03732235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102004544|NCT03732235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102004545|NCT03732235|Growth Substances|growth substances|mesh-ancestor
102004546|NCT03732235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004547|NCT03732235|Growth Inhibitors|growth inhibitors|mesh-ancestor
101459537|NCT00253110|Antiemetics|antiemetics|mesh-ancestor
102004561|NCT01289951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004563|NCT01182077|Peficitinib|peficitinib|mesh-list
102004564|NCT01182077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102004565|NCT01182077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102004566|NCT01182077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102004567|NCT01182077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004568|NCT01182077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102004569|NCT01182077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102004570|NCT01182077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102004571|NCT01182077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102004572|NCT01182077|Anesthetics, General|anesthetics, general|mesh-ancestor
102004573|NCT01182077|Anesthetics|anesthetics|mesh-ancestor
102004574|NCT01182077|GABA Modulators|gaba modulators|mesh-ancestor
102004575|NCT01182077|GABA Agents|gaba agents|mesh-ancestor
102004576|NCT01182077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102004577|NCT01182077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004578|NCT01182077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102004579|NCT01182077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102004580|NCT01182077|Immunologic Factors|immunologic factors|mesh-ancestor
102004581|NCT03618823|Acetaminophen|acetaminophen|mesh-list
102004582|NCT03618823|Ibuprofen|ibuprofen|mesh-list
102004583|NCT03618823|Oxycodone|oxycodone|mesh-list
102004584|NCT03618823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102004585|NCT03618823|Analgesics|analgesics|mesh-ancestor
102004586|NCT03618823|Sensory System Agents|sensory system agents|mesh-ancestor
102004587|NCT03618823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102004588|NCT03618823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004589|NCT03618823|Antipyretics|antipyretics|mesh-ancestor
102004590|NCT03618823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102004591|NCT03618823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102004592|NCT03618823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102004593|NCT03618823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102004594|NCT03618823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102004595|NCT03618823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004596|NCT03618823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102004597|NCT03618823|Narcotics|narcotics|mesh-ancestor
102004598|NCT03618823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102004599|NCT01188707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102004600|NCT01188707|Belinostat|belinostat|mesh-list
102004601|NCT01188707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102004602|NCT01188707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102004603|NCT01188707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102004604|NCT01188707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004605|NCT01188707|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102004606|NCT03356158|Cetuximab|cetuximab|mesh-list
102004607|NCT03356158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102004608|NCT03356158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102004609|NCT03356080|Cytarabine|cytarabine|mesh-list
102004610|NCT03356080|Decitabine|decitabine|mesh-list
101949071|NCT05962957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101949072|NCT05962957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949073|NCT05962957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266574|NCT01783106|Autonomic Agents|autonomic agents|mesh-ancestor
102004612|NCT03356080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102004613|NCT03356080|Antimetabolites|antimetabolites|mesh-ancestor
102004614|NCT03356080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004615|NCT03356080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102004616|NCT03356080|Antiviral Agents|antiviral agents|mesh-ancestor
102004617|NCT03356080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102004618|NCT03356080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102004619|NCT03356080|Immunologic Factors|immunologic factors|mesh-ancestor
102004620|NCT03356080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004621|NCT03356080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102004622|NCT03356080|Keratolytic Agents|keratolytic agents|mesh-ancestor
102004623|NCT03356080|Dermatologic Agents|dermatologic agents|mesh-ancestor
102004624|NCT03640507|Chlorhexidine|chlorhexidine|mesh-list
102004625|NCT03640507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102004626|NCT03640507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102004627|NCT03640507|Disinfectants|disinfectants|mesh-ancestor
102004628|NCT02937636|Fluorides|fluorides|mesh-list
102004629|NCT02937636|Tin Fluorides|tin fluorides|mesh-list
102004630|NCT02937636|Fluorophosphate|fluorophosphate|mesh-list
102004631|NCT02937636|Cariostatic Agents|cariostatic agents|mesh-ancestor
102004632|NCT02937636|Protective Agents|protective agents|mesh-ancestor
102004633|NCT02937636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004634|NCT03638635|Bupivacaine|bupivacaine|mesh-list
102004635|NCT03638635|Anesthetics, Local|anesthetics, local|mesh-ancestor
102004636|NCT03638635|Anesthetics|anesthetics|mesh-ancestor
102004637|NCT03638635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102004638|NCT03638635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004639|NCT03638635|Sensory System Agents|sensory system agents|mesh-ancestor
102004640|NCT03638635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102004641|NCT02518516|Atorvastatin|atorvastatin|mesh-list
102004642|NCT02518516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102004643|NCT02518516|Simvastatin|simvastatin|mesh-list
102004644|NCT02518516|Pravastatin|pravastatin|mesh-list
102004645|NCT02518516|Lovastatin|lovastatin|mesh-list
102004646|NCT02518516|L 647318|l 647318|mesh-list
102004647|NCT02518516|Dihydromevinolin|dihydromevinolin|mesh-list
102004648|NCT02518516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102004649|NCT02518516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102004650|NCT02518516|Antimetabolites|antimetabolites|mesh-ancestor
102004651|NCT02518516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004652|NCT02518516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102004653|NCT02518516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102004654|NCT02518516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102004656|NCT04508686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102004657|NCT04508686|Antimetabolites|antimetabolites|mesh-ancestor
102004658|NCT04508686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004659|NCT04508686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102004660|NCT02518438|Tramadol|tramadol|mesh-list
102004661|NCT02518438|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102004662|NCT02518438|Narcotics|narcotics|mesh-ancestor
102004663|NCT02518438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102004664|NCT02518438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004665|NCT02518438|Analgesics|analgesics|mesh-ancestor
102004666|NCT02518438|Sensory System Agents|sensory system agents|mesh-ancestor
102004667|NCT02518438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102004668|NCT04521556|Morphine|morphine|mesh-list
102004669|NCT04521556|Tramadol|tramadol|mesh-list
102004670|NCT04521556|Anesthetics|anesthetics|mesh-list
102004671|NCT04521556|Ropivacaine|ropivacaine|mesh-list
102004672|NCT04521556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102004673|NCT04521556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004674|NCT04521556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102004675|NCT04521556|Narcotics|narcotics|mesh-ancestor
102004676|NCT04521556|Analgesics|analgesics|mesh-ancestor
102004677|NCT04521556|Sensory System Agents|sensory system agents|mesh-ancestor
102004678|NCT04521556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102004679|NCT04521556|Anesthetics, Local|anesthetics, local|mesh-ancestor
102004680|NCT03204279|Palonosetron|palonosetron|mesh-list
102004681|NCT03204279|Antiemetics|antiemetics|mesh-ancestor
101949074|NCT05962957|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101949075|NCT05962957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102004682|NCT03204279|Autonomic Agents|autonomic agents|mesh-ancestor
102004683|NCT03204279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102004684|NCT03204279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004685|NCT03204279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102004686|NCT03204279|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102004687|NCT03204279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102004688|NCT03204279|Serotonin Agents|serotonin agents|mesh-ancestor
102004689|NCT03204279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102004695|NCT02524301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102004696|NCT03122782|Tranexamic Acid|tranexamic acid|mesh-list
102004697|NCT03122782|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102004698|NCT03122782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102004699|NCT03122782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004700|NCT03122782|Hemostatics|hemostatics|mesh-ancestor
102004701|NCT03122782|Coagulants|coagulants|mesh-ancestor
102004702|NCT01291433|Clodronic Acid|clodronic acid|mesh-list
102004703|NCT01291433|Tocopherols|tocopherols|mesh-list
102004704|NCT01291433|Vitamin E|vitamin e|mesh-list
102004705|NCT01291433|Tocotrienols|tocotrienols|mesh-list
102004706|NCT01291433|alpha-Tocopherol|alpha-tocopherol|mesh-list
102004707|NCT01291433|Pentoxifylline|pentoxifylline|mesh-list
102004708|NCT01291433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102004709|NCT01291433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102004710|NCT01291433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004711|NCT01291433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102004712|NCT01291433|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102004713|NCT01291433|Protective Agents|protective agents|mesh-ancestor
102004714|NCT01291433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004715|NCT01291433|Vasodilator Agents|vasodilator agents|mesh-ancestor
102004716|NCT01291433|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102004717|NCT01291433|Antioxidants|antioxidants|mesh-ancestor
102004718|NCT01291433|Vitamins|vitamins|mesh-ancestor
102004719|NCT01291433|Micronutrients|micronutrients|mesh-ancestor
102004720|NCT01291433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102004721|NCT01314144|Bupivacaine|bupivacaine|mesh-list
102004722|NCT01314144|Anesthetics, Local|anesthetics, local|mesh-ancestor
102004723|NCT01314144|Anesthetics|anesthetics|mesh-ancestor
102004724|NCT01314144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102004725|NCT01314144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004726|NCT01314144|Sensory System Agents|sensory system agents|mesh-ancestor
102004727|NCT01314144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102004728|NCT02954653|Cytarabine|cytarabine|mesh-list
102004729|NCT02954653|Azacitidine|azacitidine|mesh-list
102004730|NCT02954653|Decitabine|decitabine|mesh-list
102004731|NCT02954653|Daunorubicin|daunorubicin|mesh-list
102004732|NCT02954653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102004734|NCT02954653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004735|NCT02954653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102004736|NCT02954653|Antiviral Agents|antiviral agents|mesh-ancestor
102004737|NCT02954653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102004738|NCT02954653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102004739|NCT02954653|Immunologic Factors|immunologic factors|mesh-ancestor
102004740|NCT02954653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004741|NCT02954653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102004742|NCT02954653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102004743|NCT02954653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102004744|NCT02954653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102004745|NCT04508452|Bevacizumab|bevacizumab|mesh-list
102004746|NCT04508452|Capecitabine|capecitabine|mesh-list
102004747|NCT04508452|Oxaliplatin|oxaliplatin|mesh-list
102004748|NCT04508452|Irinotecan|irinotecan|mesh-list
102004749|NCT04508452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102004750|NCT04508452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102004751|NCT04508452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102004752|NCT04508452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102004753|NCT04508452|Growth Substances|growth substances|mesh-ancestor
102004754|NCT04508452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004755|NCT04508452|Growth Inhibitors|growth inhibitors|mesh-ancestor
102004756|NCT04508452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102004757|NCT04508452|Antimetabolites|antimetabolites|mesh-ancestor
102004758|NCT04508452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004759|NCT04508452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101949076|NCT05962957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101949077|NCT05962957|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101949078|NCT05962957|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101949079|NCT05962957|Protective Agents|protective agents|mesh-ancestor
102004760|NCT04508452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102004761|NCT04508452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102004767|NCT03856853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102004768|NCT03856853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102004769|NCT03856853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102004770|NCT03856853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102004771|NCT03856853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102004773|NCT03732703|Dexamethasone|dexamethasone|mesh-list
102004774|NCT03732703|Dexamethasone acetate|dexamethasone acetate|mesh-list
102004775|NCT03732703|Venetoclax|venetoclax|mesh-list
102004776|NCT03732703|Daratumumab|daratumumab|mesh-list
102004777|NCT03732703|Pomalidomide|pomalidomide|mesh-list
102004778|NCT03732703|Ixazomib|ixazomib|mesh-list
102004779|NCT03732703|BB 1101|bb 1101|mesh-list
102004780|NCT03732703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102004781|NCT03732703|Glycine|glycine|mesh-list
102004782|NCT03732703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102004783|NCT03732703|Antiemetics|antiemetics|mesh-ancestor
102004784|NCT03732703|Autonomic Agents|autonomic agents|mesh-ancestor
102004785|NCT03732703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102004786|NCT03732703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004787|NCT03732703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102004788|NCT03732703|Glucocorticoids|glucocorticoids|mesh-ancestor
102004789|NCT03732703|Hormones|hormones|mesh-ancestor
102004790|NCT03732703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102004791|NCT03732703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102004792|NCT03732703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102004793|NCT03732703|Protease Inhibitors|protease inhibitors|mesh-ancestor
102004794|NCT03732703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102004795|NCT03732703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004796|NCT03732703|Immunologic Factors|immunologic factors|mesh-ancestor
102004797|NCT03732703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102004798|NCT03732703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102004799|NCT03732703|Growth Substances|growth substances|mesh-ancestor
102004800|NCT03732703|Growth Inhibitors|growth inhibitors|mesh-ancestor
102004801|NCT03732703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102004802|NCT03732703|Leprostatic Agents|leprostatic agents|mesh-ancestor
102004803|NCT03732703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102004804|NCT03732703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102004805|NCT03732703|Glycine Agents|glycine agents|mesh-ancestor
102004806|NCT03732703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102004807|NCT03636555|Oxytocin|oxytocin|mesh-list
102004808|NCT03636555|Oxytocics|oxytocics|mesh-ancestor
102004809|NCT03636555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102004810|NCT03636555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004811|NCT03123016|Apremilast|apremilast|mesh-list
102004812|NCT03123016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102004813|NCT03123016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102004814|NCT03123016|Analgesics|analgesics|mesh-ancestor
102004815|NCT03123016|Sensory System Agents|sensory system agents|mesh-ancestor
102004816|NCT03123016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102004817|NCT03123016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004818|NCT03123016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102004819|NCT03123016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102004820|NCT03123016|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102004821|NCT03123016|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102004822|NCT03123016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102004823|NCT03123016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004824|NCT03636477|Nivolumab|nivolumab|mesh-list
102004825|NCT03636477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102004826|NCT03636477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102004827|NCT03636477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102004828|NCT03636477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004829|NCT03732001|Docetaxel|docetaxel|mesh-list
102004830|NCT03732001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102004831|NCT03732001|Tubulin Modulators|tubulin modulators|mesh-ancestor
102004832|NCT03732001|Antimitotic Agents|antimitotic agents|mesh-ancestor
101949080|NCT05962957|Vasodilator Agents|vasodilator agents|mesh-ancestor
101949081|NCT05962957|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101949082|NCT05962957|Antioxidants|antioxidants|mesh-ancestor
101949083|NCT05962957|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101949084|NCT05962957|Immunologic Factors|immunologic factors|mesh-ancestor
102004833|NCT03732001|Mitosis Modulators|mitosis modulators|mesh-ancestor
102004835|NCT01186835|Botulinum Toxins|botulinum toxins|mesh-list
102004836|NCT01186835|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102004837|NCT01186835|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102004838|NCT01186835|Hyaluronic Acid|hyaluronic acid|mesh-list
102004839|NCT01186835|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102004840|NCT01186835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102004841|NCT01186835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004842|NCT01186835|Cholinergic Agents|cholinergic agents|mesh-ancestor
102004843|NCT01186835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102004844|NCT01186835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004845|NCT01186835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102004846|NCT01186835|Immunologic Factors|immunologic factors|mesh-ancestor
102004847|NCT01186835|Viscosupplements|viscosupplements|mesh-ancestor
102004848|NCT01186835|Protective Agents|protective agents|mesh-ancestor
102004849|NCT01186835|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102004850|NCT01186835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102004851|NCT03649464|Antineoplastic Agents|antineoplastic agents|mesh-list
102004852|NCT04812951|Cyclosporine|cyclosporine|mesh-list
102004853|NCT04812951|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102004854|NCT04812951|Cyclosporins|cyclosporins|mesh-list
102004855|NCT04812951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102004856|NCT04812951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004857|NCT04812951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102004858|NCT04812951|Immunologic Factors|immunologic factors|mesh-ancestor
102004859|NCT04812951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004860|NCT04812951|Antifungal Agents|antifungal agents|mesh-ancestor
102004861|NCT04812951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102004862|NCT04812951|Dermatologic Agents|dermatologic agents|mesh-ancestor
102004863|NCT04812951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101262519|NCT01757262|Clopidogrel|clopidogrel|mesh-list
102004864|NCT04812951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102004865|NCT04812951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102004866|NCT05666089|Acetylcysteine|acetylcysteine|mesh-list
102004868|NCT05666089|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102004869|NCT05666089|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102004870|NCT05666089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004871|NCT05666089|Antiviral Agents|antiviral agents|mesh-ancestor
102004872|NCT05666089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102004873|NCT05666089|Expectorants|expectorants|mesh-ancestor
102004874|NCT05666089|Respiratory System Agents|respiratory system agents|mesh-ancestor
102004875|NCT05666089|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102004876|NCT05666089|Antioxidants|antioxidants|mesh-ancestor
102004877|NCT05666089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004878|NCT05666089|Protective Agents|protective agents|mesh-ancestor
102004879|NCT05666089|Antidotes|antidotes|mesh-ancestor
102004880|NCT03732625|Raltegravir Potassium|raltegravir potassium|mesh-list
102004881|NCT03732625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102004882|NCT03732625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102004883|NCT03732625|Antiviral Agents|antiviral agents|mesh-ancestor
102004884|NCT03732625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102004885|NCT03732625|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102004886|NCT03732625|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102004887|NCT03732625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102004888|NCT03732625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004889|NCT04597476|Fucoidan|fucoidan|mesh-list
102004890|NCT04597476|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102004891|NCT04597476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102004892|NCT04597476|Anticoagulants|anticoagulants|mesh-ancestor
102004893|NCT04597476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102004894|NCT01188863|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
102004895|NCT01188863|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102004896|NCT01188863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004897|NCT01188863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102004898|NCT01188863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004899|NCT02730208|Ivacaftor|ivacaftor|mesh-list
101949085|NCT05962957|Dopamine Agonists|dopamine agonists|mesh-ancestor
101949086|NCT05957848|Guanfacine|guanfacine|mesh-list
102004900|NCT02730208|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102004901|NCT02730208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102004902|NCT02730208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004903|NCT01291511|Iloperidone|iloperidone|mesh-list
102004904|NCT01291511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102004905|NCT01291511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102004910|NCT01292213|Chelating Agents|chelating agents|mesh-ancestor
102004911|NCT01292213|Sequestering Agents|sequestering agents|mesh-ancestor
102004912|NCT01292213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004913|NCT03122938|Lactoferrin|lactoferrin|mesh-list
102004914|NCT03122938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102004915|NCT04971005|Alemtuzumab|alemtuzumab|mesh-list
102004916|NCT04971005|Ocrelizumab|ocrelizumab|mesh-list
102004917|NCT04971005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102004918|NCT04971005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102004919|NCT04971005|Immunologic Factors|immunologic factors|mesh-ancestor
102004920|NCT04971005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004921|NCT03782532|Prednisone|prednisone|mesh-list
102004922|NCT03782532|Prednisolone|prednisolone|mesh-list
102004923|NCT03782532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102004924|NCT03782532|Glucocorticoids|glucocorticoids|mesh-ancestor
102004925|NCT03782532|Hormones|hormones|mesh-ancestor
101262565|NCT01757756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102004926|NCT03782532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102004927|NCT03782532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004928|NCT03782532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102004929|NCT03782532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102004930|NCT03355768|Romidepsin|romidepsin|mesh-list
102004931|NCT03355768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102004932|NCT03355768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102004933|NCT03355768|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102004934|NCT03355768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102004935|NCT03355768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004936|NCT03349840|Insulin|insulin|mesh-list
102004937|NCT03349840|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102004938|NCT03349840|Insulin Glargine|insulin glargine|mesh-list
102004939|NCT03349840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102004940|NCT03349840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004941|NCT03170271|Benralizumab|benralizumab|mesh-list
102004942|NCT03170271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102004943|NCT03170271|Respiratory System Agents|respiratory system agents|mesh-ancestor
102004944|NCT03355612|Capecitabine|capecitabine|mesh-list
102004945|NCT03355612|Oxaliplatin|oxaliplatin|mesh-list
102004946|NCT03355612|Apatinib|apatinib|mesh-list
102004947|NCT03355612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102004948|NCT03355612|Antimetabolites|antimetabolites|mesh-ancestor
102004949|NCT03355612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004950|NCT03355612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102004951|NCT03355612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102004952|NCT03355612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102004953|NCT03732547|Poly I-C|poly i-c|mesh-list
102004954|NCT03732547|Antiviral Agents|antiviral agents|mesh-ancestor
102004955|NCT03732547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102004956|NCT03732547|Interferon Inducers|interferon inducers|mesh-ancestor
102004957|NCT03732547|Immunologic Factors|immunologic factors|mesh-ancestor
102004958|NCT03732547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004959|NCT04503850|Mirabegron|mirabegron|mesh-list
102004960|NCT04503850|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
102004961|NCT04503850|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102004962|NCT04503850|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102004963|NCT04503850|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102004964|NCT04503850|Adrenergic Agents|adrenergic agents|mesh-ancestor
102004965|NCT04503850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102004966|NCT04503850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004967|NCT04503850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004968|NCT04503850|Urological Agents|urological agents|mesh-ancestor
102004969|NCT04503850|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102004970|NCT03349684|Metformin|metformin|mesh-list
102004971|NCT03349684|Acarbose|acarbose|mesh-list
102004972|NCT03349684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102004973|NCT03349684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004974|NCT03349684|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102004975|NCT03349684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101737362|NCT02584881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101949087|NCT05957848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101949088|NCT05957848|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101949089|NCT05957848|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101949090|NCT05957848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101949091|NCT05957848|Adrenergic Agents|adrenergic agents|mesh-ancestor
102004976|NCT03349684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004977|NCT03856697|Gefitinib|gefitinib|mesh-list
102004991|NCT03349606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102004992|NCT03349606|Dopamine Agents|dopamine agents|mesh-ancestor
102004993|NCT03349606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102004994|NCT03349606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004995|NCT03349606|Adrenergic Agents|adrenergic agents|mesh-ancestor
102004996|NCT03349606|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102004997|NCT03349606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102004998|NCT03349606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102004999|NCT03349606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102005000|NCT03349606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102005002|NCT02843451|Antioxidants|antioxidants|mesh-ancestor
102005003|NCT02843451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005004|NCT02843451|Protective Agents|protective agents|mesh-ancestor
102005005|NCT02843451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005006|NCT01292525|Tacrolimus|tacrolimus|mesh-list
102005007|NCT01292525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102005008|NCT01292525|Immunologic Factors|immunologic factors|mesh-ancestor
102005009|NCT01292525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005010|NCT01292525|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102005011|NCT01292525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102005012|NCT01292525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005013|NCT01189019|Ranibizumab|ranibizumab|mesh-list
102005014|NCT01189019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102005015|NCT01189019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102005016|NCT01189019|Growth Substances|growth substances|mesh-ancestor
102005017|NCT01189019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005018|NCT01189019|Growth Inhibitors|growth inhibitors|mesh-ancestor
102005019|NCT01189019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102005020|NCT01183247|Sirolimus|sirolimus|mesh-list
102005021|NCT01183247|Prednisone|prednisone|mesh-list
102005022|NCT01183247|Everolimus|everolimus|mesh-list
102005023|NCT01183247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102005024|NCT01183247|Glucocorticoids|glucocorticoids|mesh-ancestor
102005025|NCT01183247|Hormones|hormones|mesh-ancestor
102005026|NCT01183247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102005027|NCT01183247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005028|NCT01183247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102005029|NCT01183247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102005030|NCT01183247|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102005031|NCT01183247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102005032|NCT01183247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102005033|NCT01183247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005034|NCT01183247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102005036|NCT01183247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102005037|NCT01183247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102005038|NCT01183247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102005039|NCT01183247|Antifungal Agents|antifungal agents|mesh-ancestor
102005040|NCT03349216|Anesthetics|anesthetics|mesh-list
102005044|NCT04507750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102005045|NCT04507750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102005046|NCT04507750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102005047|NCT04507750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005048|NCT03633331|Letrozole|letrozole|mesh-list
102005049|NCT03633331|Fulvestrant|fulvestrant|mesh-list
102005050|NCT03633331|Palbociclib|palbociclib|mesh-list
102005051|NCT03633331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102005052|NCT03633331|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102005053|NCT03633331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102005054|NCT03633331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102005055|NCT03633331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005056|NCT03633331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102005057|NCT03633331|Hormone Antagonists|hormone antagonists|mesh-ancestor
101949093|NCT05957848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949094|NCT05957848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005058|NCT03633331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102005059|NCT03633331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005060|NCT03633331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102005061|NCT03633331|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102005062|NCT03633331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102005063|NCT01189097|Dextromethorphan|dextromethorphan|mesh-list
102005064|NCT01189097|Antitussive Agents|antitussive agents|mesh-ancestor
102005065|NCT01189097|Respiratory System Agents|respiratory system agents|mesh-ancestor
102005066|NCT01189097|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102005067|NCT01189097|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102005068|NCT01189097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102005069|NCT01189097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005070|NCT01189097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005071|NCT01187303|Ofatumumab|ofatumumab|mesh-list
102005072|NCT01187303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102005073|NCT01187459|Vitamin D|vitamin d|mesh-list
102005074|NCT01187459|Ergocalciferols|ergocalciferols|mesh-list
102005075|NCT01187459|Cholecalciferol|cholecalciferol|mesh-list
102005076|NCT01187459|Vitamins|vitamins|mesh-list
102005077|NCT01187459|Micronutrients|micronutrients|mesh-ancestor
102005078|NCT01187459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005079|NCT01187459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102005080|NCT01187459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102005081|NCT01187537|Bupivacaine|bupivacaine|mesh-list
102005082|NCT01187537|Anesthetics, Local|anesthetics, local|mesh-ancestor
102005083|NCT01187537|Anesthetics|anesthetics|mesh-ancestor
102005084|NCT01187537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102005085|NCT01187537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005086|NCT01187537|Sensory System Agents|sensory system agents|mesh-ancestor
102005087|NCT01187537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102005088|NCT03348826|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102005089|NCT03348826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102005090|NCT03348826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102005091|NCT03348826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102005092|NCT03348826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005093|NCT01290419|Vaccines|vaccines|mesh-list
102005094|NCT01290419|Immunologic Factors|immunologic factors|mesh-ancestor
102005095|NCT01290419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005096|NCT03737773|Methamphetamine|methamphetamine|mesh-list
102005097|NCT03737773|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102005098|NCT03737773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005099|NCT03737773|Sympathomimetics|sympathomimetics|mesh-ancestor
102005100|NCT03737773|Autonomic Agents|autonomic agents|mesh-ancestor
102005101|NCT03737773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102005102|NCT03737773|Dopamine Agents|dopamine agents|mesh-ancestor
102005103|NCT03737773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102005104|NCT03737773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005105|NCT03737773|Adrenergic Agents|adrenergic agents|mesh-ancestor
102005106|NCT03737773|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102005107|NCT03737773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102005108|NCT03737773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102005109|NCT03737773|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101262748|NCT01758627|Icodextrin|icodextrin|mesh-list
102005110|NCT01060579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102005116|NCT04443946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102005117|NCT04443946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102005118|NCT04443946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005119|NCT04443946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102005120|NCT04443946|Anesthetics, General|anesthetics, general|mesh-ancestor
102005121|NCT04443946|Anesthetics|anesthetics|mesh-ancestor
102005122|NCT04443946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102005123|NCT04443946|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102005124|NCT04443946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102005125|NCT04443946|Narcotics|narcotics|mesh-ancestor
102005126|NCT04443946|Analgesics|analgesics|mesh-ancestor
102005127|NCT04443946|Sensory System Agents|sensory system agents|mesh-ancestor
102005128|NCT04443946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101949095|NCT05928871|Misoprostol|misoprostol|mesh-list
101949096|NCT05928871|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101949097|NCT05928871|Abortifacient Agents|abortifacient agents|mesh-ancestor
102005129|NCT04443946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102005130|NCT03729973|Lidocaine|lidocaine|mesh-list
102005131|NCT03729973|Magnesium Sulfate|magnesium sulfate|mesh-list
102005132|NCT03729973|Ketamine|ketamine|mesh-list
102005133|NCT03729973|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102005134|NCT03729973|Anesthetics, Local|anesthetics, local|mesh-ancestor
102005135|NCT03729973|Anesthetics|anesthetics|mesh-ancestor
102005136|NCT03729973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102005137|NCT03729973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005138|NCT03729973|Sensory System Agents|sensory system agents|mesh-ancestor
102005139|NCT03729973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102005140|NCT03729973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102005141|NCT03729973|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102005142|NCT03729973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102005143|NCT03729973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102005144|NCT03729973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005145|NCT03729973|Analgesics|analgesics|mesh-ancestor
102005146|NCT03729973|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102005147|NCT03729973|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102005148|NCT03729973|Anesthetics, General|anesthetics, general|mesh-ancestor
102005149|NCT03729973|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102005150|NCT03729973|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102005151|NCT03729973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102005152|NCT03729973|Anticonvulsants|anticonvulsants|mesh-ancestor
102005153|NCT03729973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102005154|NCT03729973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102005155|NCT03729973|Tocolytic Agents|tocolytic agents|mesh-ancestor
102005156|NCT03729973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102005157|NCT01189253|Doxorubicin|doxorubicin|mesh-list
102005158|NCT01189253|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102005159|NCT01189253|Trabectedin|trabectedin|mesh-list
102005160|NCT01189253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102005161|NCT01189253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102005162|NCT01189253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102005163|NCT01189253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102005164|NCT01189253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102005165|NCT01189253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005166|NCT01189253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102005167|NCT01189253|Alkylating Agents|alkylating agents|mesh-ancestor
102005168|NCT04443868|Nitric Oxide|nitric oxide|mesh-list
102005169|NCT04443868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102005170|NCT04443868|Autonomic Agents|autonomic agents|mesh-ancestor
102005171|NCT04443868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102005172|NCT04443868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005173|NCT04443868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102005174|NCT04443868|Respiratory System Agents|respiratory system agents|mesh-ancestor
102005175|NCT04443868|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102005176|NCT04443868|Antioxidants|antioxidants|mesh-ancestor
102005177|NCT04443868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005178|NCT04443868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102005179|NCT04443868|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102005180|NCT04443868|Vasodilator Agents|vasodilator agents|mesh-ancestor
102005181|NCT04443868|Gasotransmitters|gasotransmitters|mesh-ancestor
102005182|NCT04443868|Protective Agents|protective agents|mesh-ancestor
102005188|NCT03851393|Sequestering Agents|sequestering agents|mesh-ancestor
102005189|NCT03851393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005190|NCT04443556|Tramadol|tramadol|mesh-list
102005191|NCT04443556|Anesthetics|anesthetics|mesh-list
102005192|NCT04443556|Anesthetics, Local|anesthetics, local|mesh-list
102005193|NCT04443556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102005194|NCT04443556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005195|NCT04443556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102005196|NCT04443556|Narcotics|narcotics|mesh-ancestor
102005197|NCT04443556|Analgesics|analgesics|mesh-ancestor
102005198|NCT04443556|Sensory System Agents|sensory system agents|mesh-ancestor
102005199|NCT04443556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102005200|NCT01187615|Cisplatin|cisplatin|mesh-list
102005201|NCT01187615|Pemetrexed|pemetrexed|mesh-list
102005202|NCT01187615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949098|NCT05928871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101949099|NCT05928871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949100|NCT05928871|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101949101|NCT05928871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102005203|NCT01187615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102005204|NCT01187615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005205|NCT01187615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102005206|NCT01187615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102005207|NCT05375097|Erenumab|erenumab|mesh-list
102005208|NCT05375097|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
102005209|NCT05375097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005210|NCT05375097|Analgesics|analgesics|mesh-ancestor
102005211|NCT05375097|Sensory System Agents|sensory system agents|mesh-ancestor
102005212|NCT05375097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102005213|NCT05375097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005214|NCT02752191|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102005215|NCT02752191|Hematinics|hematinics|mesh-ancestor
102005216|NCT02752191|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102005217|NCT02752191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102005218|NCT01290497|Hyaluronic Acid|hyaluronic acid|mesh-list
102005219|NCT01290497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102005220|NCT01290497|Immunologic Factors|immunologic factors|mesh-ancestor
102005221|NCT01290497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005222|NCT01290497|Viscosupplements|viscosupplements|mesh-ancestor
102005223|NCT01290497|Protective Agents|protective agents|mesh-ancestor
102005224|NCT04509466|Mitoxantrone|mitoxantrone|mesh-list
102005225|NCT04509466|Pegaspargase|pegaspargase|mesh-list
102005226|NCT04509466|Asparaginase|asparaginase|mesh-list
102005227|NCT04509466|Analgesics|analgesics|mesh-ancestor
102005228|NCT04509466|Sensory System Agents|sensory system agents|mesh-ancestor
102005229|NCT04509466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102005230|NCT04509466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005231|NCT04509466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102005232|NCT04509466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102005233|NCT04509466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102005234|NCT04509466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102005235|NCT04509466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005236|NCT03738215|Cariprazine|cariprazine|mesh-list
102005237|NCT03738215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102005238|NCT03738215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102005239|NCT03738215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102005240|NCT03738215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005241|NCT03738215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102005242|NCT05352321|Gemcitabine|gemcitabine|mesh-list
102005243|NCT05352321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102005244|NCT05352321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102005245|NCT05352321|Antimetabolites|antimetabolites|mesh-ancestor
101195725|NCT03786783|Vitamin A|vitamin a|mesh-list
102005246|NCT05352321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005247|NCT03199911|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102005248|NCT03199911|Erythromycin|erythromycin|mesh-list
102005249|NCT03199911|Bacitracin|bacitracin|mesh-list
102005250|NCT03199911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102005251|NCT03199911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102005252|NCT03199911|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102005253|NCT03199911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102005254|NCT03199911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005255|NCT03199911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102005266|NCT05303727|Cyclophosphamide|cyclophosphamide|mesh-list
102005267|NCT05303727|Melphalan|melphalan|mesh-list
102005268|NCT05303727|Busulfan|busulfan|mesh-list
102005269|NCT05303727|Thiotepa|thiotepa|mesh-list
102005270|NCT05303727|Methotrexate|methotrexate|mesh-list
102005271|NCT05303727|Fludarabine|fludarabine|mesh-list
102005272|NCT05303727|Topotecan|topotecan|mesh-list
102005273|NCT05303727|Tacrolimus|tacrolimus|mesh-list
102005274|NCT05303727|Cyclosporins|cyclosporins|mesh-list
102005275|NCT05303727|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102005276|NCT05303727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102005277|NCT05303727|Immunologic Factors|immunologic factors|mesh-ancestor
102005278|NCT05303727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005279|NCT05303727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102005280|NCT05303727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101949102|NCT05928871|Oxytocics|oxytocics|mesh-ancestor
101949103|NCT05925127|Vaccines|vaccines|mesh-list
101949104|NCT05925127|Immunologic Factors|immunologic factors|mesh-ancestor
101267230|NCT01787669|Hormones|hormones|mesh-ancestor
102005281|NCT05303727|Alkylating Agents|alkylating agents|mesh-ancestor
102005282|NCT05303727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005283|NCT05303727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102005284|NCT05303727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102005285|NCT05303727|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102005286|NCT05303727|Abortifacient Agents|abortifacient agents|mesh-ancestor
102005287|NCT05303727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102005288|NCT05303727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102005289|NCT05303727|Antimetabolites|antimetabolites|mesh-ancestor
102005290|NCT05303727|Dermatologic Agents|dermatologic agents|mesh-ancestor
102005291|NCT05303727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102005292|NCT05303727|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102005293|NCT05303727|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102005294|NCT05303727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102005295|NCT05303727|Antifungal Agents|antifungal agents|mesh-ancestor
102005296|NCT05303727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102005297|NCT05303727|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102005298|NCT05303727|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102005299|NCT05303727|Antitubercular Agents|antitubercular agents|mesh-ancestor
102005300|NCT05303727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102005301|NCT05303727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102005302|NCT05303727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102005303|NCT04502368|Dimercaprol|dimercaprol|mesh-list
102005304|NCT04502368|Chelating Agents|chelating agents|mesh-ancestor
102005305|NCT04502368|Sequestering Agents|sequestering agents|mesh-ancestor
102005306|NCT04502368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005307|NCT04984083|Vitamin K|vitamin k|mesh-list
102005308|NCT04984083|Vitamins|vitamins|mesh-ancestor
102005309|NCT04984083|Micronutrients|micronutrients|mesh-ancestor
102005310|NCT04984083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005311|NCT04984083|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102005312|NCT04984083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102005313|NCT04984083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005314|NCT04984083|Hemostatics|hemostatics|mesh-ancestor
102005315|NCT04984083|Coagulants|coagulants|mesh-ancestor
102005316|NCT03736967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102005317|NCT03736967|Immunologic Factors|immunologic factors|mesh-ancestor
102005318|NCT03736967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005319|NCT01581203|Interferons|interferons|mesh-list
102005320|NCT01581203|Ribavirin|ribavirin|mesh-list
102005321|NCT01581203|Interferon-alpha|interferon-alpha|mesh-list
102005322|NCT01581203|Interferon alpha-2|interferon alpha-2|mesh-list
102005323|NCT01581203|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102005324|NCT01581203|Asunaprevir|asunaprevir|mesh-list
102005327|NCT01581203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102005328|NCT01581203|Antimetabolites|antimetabolites|mesh-ancestor
102005329|NCT01581203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005330|NCT01581203|Immunologic Factors|immunologic factors|mesh-ancestor
102005331|NCT01581203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005332|NCT01581203|Protease Inhibitors|protease inhibitors|mesh-ancestor
102005333|NCT01581203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102005334|NCT03168555|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
102005336|NCT03168555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101725111|NCT00665392|Docetaxel|docetaxel|mesh-list
102005337|NCT03235050|Liraglutide|liraglutide|mesh-list
102005338|NCT03235050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102005339|NCT03235050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005340|NCT03235050|Incretins|incretins|mesh-ancestor
102005341|NCT03235050|Hormones|hormones|mesh-ancestor
102005342|NCT03235050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102005343|NCT04933149|Ketamine|ketamine|mesh-list
102005344|NCT04933149|Analgesics|analgesics|mesh-ancestor
102005345|NCT04933149|Sensory System Agents|sensory system agents|mesh-ancestor
102005346|NCT04933149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102005347|NCT04933149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005348|NCT04933149|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102005349|NCT04933149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102005350|NCT04933149|Anesthetics, General|anesthetics, general|mesh-ancestor
102005351|NCT04933149|Anesthetics|anesthetics|mesh-ancestor
102005352|NCT04933149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101949105|NCT05925127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267301|NCT01788280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005353|NCT04933149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102005354|NCT04933149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102005355|NCT04933149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102005356|NCT04933149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005357|NCT01189721|Propofol|propofol|mesh-list
102005358|NCT01189721|Sevoflurane|sevoflurane|mesh-list
102005359|NCT01189721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102005360|NCT01189721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102005361|NCT01189721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005362|NCT01189721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102005363|NCT01189721|Anesthetics, General|anesthetics, general|mesh-ancestor
102005364|NCT01189721|Anesthetics|anesthetics|mesh-ancestor
102005365|NCT01189721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102005366|NCT01189721|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102005367|NCT03167619|Durvalumab|durvalumab|mesh-list
102005368|NCT03167619|Olaparib|olaparib|mesh-list
102005369|NCT03167619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102005370|NCT03167619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102005371|NCT03167619|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102005372|NCT03167619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102005373|NCT03167619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005374|NCT03198507|Amoxicillin|amoxicillin|mesh-list
102005375|NCT03198507|Rifabutin|rifabutin|mesh-list
102005376|NCT03198507|Omeprazole|omeprazole|mesh-list
102005377|NCT03198507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102005378|NCT03198507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102005379|NCT03198507|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102005380|NCT03198507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102005381|NCT03198507|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102005382|NCT03198507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102005383|NCT03198507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005384|NCT03198507|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102005385|NCT03198507|Antitubercular Agents|antitubercular agents|mesh-ancestor
102005386|NCT03850769|Paclitaxel|paclitaxel|mesh-list
102005387|NCT03850769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102005388|NCT03850769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102005389|NCT03850769|Tubulin Modulators|tubulin modulators|mesh-ancestor
102005390|NCT03850769|Antimitotic Agents|antimitotic agents|mesh-ancestor
102005391|NCT03850769|Mitosis Modulators|mitosis modulators|mesh-ancestor
102005392|NCT03850769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005393|NCT04663464|Abaloparatide|abaloparatide|mesh-list
102005394|NCT04663464|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
102005395|NCT04663464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102005396|NCT04663464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005399|NCT01292993|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
102005401|NCT01292993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005402|NCT01292993|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102005403|NCT01292993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005405|NCT03849833|Cholecalciferol|cholecalciferol|mesh-list
102005406|NCT03849833|Vitamins|vitamins|mesh-ancestor
102005407|NCT03849833|Micronutrients|micronutrients|mesh-ancestor
102005408|NCT03849833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005409|NCT03849833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102005410|NCT03849833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102005412|NCT03167151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102005413|NCT03167151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102005414|NCT03167151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102005415|NCT03167151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005416|NCT01191203|Copper|copper|mesh-list
102005417|NCT01191203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102005418|NCT01191203|Medroxyprogesterone|medroxyprogesterone|mesh-list
102005419|NCT01191203|Trace Elements|trace elements|mesh-ancestor
102005420|NCT01191203|Micronutrients|micronutrients|mesh-ancestor
102005421|NCT01191203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005422|NCT01191203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102005423|NCT01191203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101949107|NCT05909995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101949108|NCT05909995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102005424|NCT01191203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102005425|NCT01191203|Contraceptive Agents|contraceptive agents|mesh-ancestor
102005426|NCT01191203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102005427|NCT01191203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102005428|NCT01191203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102005429|NCT01191203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102005430|NCT01191203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102005431|NCT01191203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102005432|NCT03197883|Sunscreening Agents|sunscreening agents|mesh-list
102005433|NCT03197883|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102005434|NCT03197883|Protective Agents|protective agents|mesh-ancestor
102005435|NCT03197883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005436|NCT03197883|Dermatologic Agents|dermatologic agents|mesh-ancestor
102005437|NCT03729505|Lidocaine|lidocaine|mesh-list
102005438|NCT03729505|Magnesium Sulfate|magnesium sulfate|mesh-list
102005439|NCT03729505|Anesthetics, Local|anesthetics, local|mesh-ancestor
102005440|NCT03729505|Anesthetics|anesthetics|mesh-ancestor
102005441|NCT03729505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102005442|NCT03729505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005443|NCT03729505|Sensory System Agents|sensory system agents|mesh-ancestor
102005444|NCT03729505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102005445|NCT03729505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102005446|NCT03729505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102005447|NCT03729505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102005448|NCT03729505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102005449|NCT03729505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005450|NCT03729505|Analgesics|analgesics|mesh-ancestor
102005451|NCT03729505|Anticonvulsants|anticonvulsants|mesh-ancestor
102005452|NCT03729505|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102005453|NCT03729505|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102005454|NCT03729505|Tocolytic Agents|tocolytic agents|mesh-ancestor
102005455|NCT03729505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102005456|NCT03234036|Ritonavir|ritonavir|mesh-list
102005457|NCT03234036|GSK-2838232|gsk-2838232|mesh-list
102005458|NCT03234036|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102005459|NCT03234036|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102005460|NCT03234036|Protease Inhibitors|protease inhibitors|mesh-ancestor
102005461|NCT03234036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102005462|NCT03234036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005463|NCT03234036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102005464|NCT03234036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102005465|NCT03234036|Antiviral Agents|antiviral agents|mesh-ancestor
102005466|NCT03234036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102005477|NCT01191359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005479|NCT01293071|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102005480|NCT01293071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102005481|NCT01293071|Antitubercular Agents|antitubercular agents|mesh-ancestor
102005482|NCT01193855|Dutasteride|dutasteride|mesh-list
102005483|NCT01193855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101725249|NCT00790114|Midazolam|midazolam|mesh-list
102005485|NCT01193855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102005486|NCT01193855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005487|NCT01193855|Hormone Antagonists|hormone antagonists|mesh-ancestor
102005488|NCT01193855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102005489|NCT01193855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005490|NCT01190345|Bevacizumab|bevacizumab|mesh-list
102005491|NCT01190345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102005492|NCT01190345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102005493|NCT01190345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102005494|NCT01190345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102005495|NCT01190345|Growth Substances|growth substances|mesh-ancestor
102005496|NCT01190345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005497|NCT01190345|Growth Inhibitors|growth inhibitors|mesh-ancestor
102005498|NCT02729896|Rituximab|rituximab|mesh-list
102005499|NCT02729896|Atezolizumab|atezolizumab|mesh-list
102005500|NCT02729896|Obinutuzumab|obinutuzumab|mesh-list
102005501|NCT02729896|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
102005502|NCT02729896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102005503|NCT02729896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102005504|NCT02729896|Immunologic Factors|immunologic factors|mesh-ancestor
101949109|NCT05909995|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101949110|NCT05909995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005505|NCT02729896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005506|NCT02729896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102005507|NCT02729896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102005508|NCT02729896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005510|NCT04540380|Cyclophosphamide|cyclophosphamide|mesh-list
102005511|NCT04540380|Rituximab|rituximab|mesh-list
102005512|NCT04540380|Fludarabine|fludarabine|mesh-list
102005513|NCT04540380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102005514|NCT04540380|Immunologic Factors|immunologic factors|mesh-ancestor
102005515|NCT04540380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005516|NCT04540380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102005517|NCT04540380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102005518|NCT04540380|Alkylating Agents|alkylating agents|mesh-ancestor
102005519|NCT04540380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005520|NCT04540380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102005521|NCT04540380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102005522|NCT04540380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102005523|NCT04506034|Lidocaine|lidocaine|mesh-list
102005524|NCT04506034|Anesthetics, Local|anesthetics, local|mesh-ancestor
102005525|NCT04506034|Anesthetics|anesthetics|mesh-ancestor
102005526|NCT04506034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102005527|NCT04506034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005528|NCT04506034|Sensory System Agents|sensory system agents|mesh-ancestor
102005529|NCT04506034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102005534|NCT04506034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005536|NCT01294631|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102005537|NCT01294631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005538|NCT01294631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102005539|NCT01294631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005540|NCT03849209|Pancrelipase|pancrelipase|mesh-list
102005541|NCT03849209|Pancreatin|pancreatin|mesh-list
102005542|NCT03849209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102005543|NCT05342662|Methamphetamine|methamphetamine|mesh-list
102005544|NCT05342662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102005545|NCT05342662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005546|NCT05342662|Sympathomimetics|sympathomimetics|mesh-ancestor
102005547|NCT05342662|Autonomic Agents|autonomic agents|mesh-ancestor
102005548|NCT05342662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102005549|NCT05342662|Dopamine Agents|dopamine agents|mesh-ancestor
102005550|NCT05342662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102005551|NCT05342662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005552|NCT05342662|Adrenergic Agents|adrenergic agents|mesh-ancestor
102005553|NCT05342662|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102005554|NCT05342662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101725331|NCT00660010|Leuprolide|leuprolide|mesh-list
102005555|NCT05342662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102005556|NCT05342662|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102005557|NCT03847571|Acetazolamide|acetazolamide|mesh-list
102005558|NCT03847571|Anticonvulsants|anticonvulsants|mesh-ancestor
102005559|NCT03847571|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102005560|NCT03847571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102005561|NCT03847571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005562|NCT03847571|Diuretics|diuretics|mesh-ancestor
102005563|NCT03847571|Natriuretic Agents|natriuretic agents|mesh-ancestor
102005564|NCT03847571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005565|NCT01293149|Clonidine|clonidine|mesh-list
102005566|NCT01293149|Ropivacaine|ropivacaine|mesh-list
102005567|NCT01293149|Anesthetics, Local|anesthetics, local|mesh-ancestor
102005568|NCT01293149|Anesthetics|anesthetics|mesh-ancestor
102005569|NCT01293149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102005570|NCT01293149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005571|NCT01293149|Sensory System Agents|sensory system agents|mesh-ancestor
102005572|NCT01293149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102005573|NCT01293149|Analgesics|analgesics|mesh-ancestor
102005574|NCT01293149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102005575|NCT01293149|Sympatholytics|sympatholytics|mesh-ancestor
102005576|NCT01293149|Autonomic Agents|autonomic agents|mesh-ancestor
102005577|NCT01293149|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101949112|NCT05906914|Cladribine|cladribine|mesh-list
101949113|NCT05906914|Homoharringtonine|homoharringtonine|mesh-list
102005578|NCT01293149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102005579|NCT01293149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102005580|NCT01293149|Adrenergic Agents|adrenergic agents|mesh-ancestor
102005581|NCT01293149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102005582|NCT01293149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005583|NCT03575065|Pamiparib|pamiparib|mesh-list
102005584|NCT03575065|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102005585|NCT03575065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102005586|NCT03575065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005587|NCT03575065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102005588|NCT04454424|Midazolam|midazolam|mesh-list
102005589|NCT04454424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101263153|NCT01760642|Ketoconazole|ketoconazole|mesh-list
102005590|NCT04454424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102005591|NCT04454424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102005592|NCT04454424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005593|NCT04454424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102005594|NCT04454424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102005595|NCT04454424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102005596|NCT04454424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102005613|NCT04505644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263159|NCT01760642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102005614|NCT04505644|Sensory System Agents|sensory system agents|mesh-ancestor
102005615|NCT04505644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102005616|NCT04505644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102005617|NCT04505644|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102005618|NCT04505644|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102005619|NCT04505644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101317917|NCT00014404|Celecoxib|celecoxib|mesh-list
102005620|NCT04505644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005621|NCT04505800|Tryptophan|tryptophan|mesh-list
102005622|NCT04505800|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102005623|NCT04505800|Antidepressive Agents|antidepressive agents|mesh-ancestor
102005624|NCT04505800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102005625|NCT05200156|Choline|choline|mesh-list
102005626|NCT05200156|Lipotropic Agents|lipotropic agents|mesh-ancestor
101318002|NCT00005987|Carmustine|carmustine|mesh-list
102005627|NCT05200156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102005628|NCT05200156|Antimetabolites|antimetabolites|mesh-ancestor
102005629|NCT05200156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005630|NCT05200156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102005631|NCT05200156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102005632|NCT05200156|Nootropic Agents|nootropic agents|mesh-ancestor
102005633|NCT03347968|Warfarin|warfarin|mesh-list
102005634|NCT03347968|Esmolol|esmolol|mesh-list
102005635|NCT03347968|Anticoagulants|anticoagulants|mesh-ancestor
102005636|NCT03347968|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102005637|NCT03347968|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102005638|NCT03347968|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102005639|NCT03347968|Adrenergic Agents|adrenergic agents|mesh-ancestor
102005640|NCT03347968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102005641|NCT03347968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318103|NCT00015067|Dopamine Agents|dopamine agents|mesh-ancestor
102005642|NCT03347968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005643|NCT01191593|Ropivacaine|ropivacaine|mesh-list
102005644|NCT01191593|Anesthetics, Local|anesthetics, local|mesh-ancestor
102005645|NCT01191593|Anesthetics|anesthetics|mesh-ancestor
102005646|NCT01191593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102005647|NCT01191593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005648|NCT01191593|Sensory System Agents|sensory system agents|mesh-ancestor
102005649|NCT01191593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102005650|NCT03347890|Liraglutide|liraglutide|mesh-list
102005651|NCT03347890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102005652|NCT03347890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005653|NCT03347890|Incretins|incretins|mesh-ancestor
102005654|NCT03347890|Hormones|hormones|mesh-ancestor
102005655|NCT03347890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102005656|NCT01296503|Thalidomide|thalidomide|mesh-list
102005669|NCT01296503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102005670|NCT01296503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102005671|NCT01296503|Protease Inhibitors|protease inhibitors|mesh-ancestor
102005672|NCT01296503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102005673|NCT01296503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005674|NCT01296503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101949114|NCT05906914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101949115|NCT05906914|Antimetabolites|antimetabolites|mesh-ancestor
101949116|NCT05906914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005675|NCT01296503|Immunologic Factors|immunologic factors|mesh-ancestor
102005676|NCT01296503|Leprostatic Agents|leprostatic agents|mesh-ancestor
102005677|NCT01296503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102005678|NCT01296503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102005679|NCT01296503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102005680|NCT01296503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102005681|NCT01296503|Growth Substances|growth substances|mesh-ancestor
102005682|NCT01296503|Growth Inhibitors|growth inhibitors|mesh-ancestor
102005683|NCT01295099|Triamcinolone|triamcinolone|mesh-list
102005684|NCT01295099|Fluorouracil|fluorouracil|mesh-list
102005685|NCT01295099|Antimetabolites|antimetabolites|mesh-ancestor
102005686|NCT01295099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005687|NCT01295099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102005688|NCT01295099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102005689|NCT01295099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102005690|NCT01295099|Immunologic Factors|immunologic factors|mesh-ancestor
101318436|NCT00386672|Vitamin D|vitamin d|mesh-list
102005691|NCT01295099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005692|NCT01295099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102005693|NCT01295099|Glucocorticoids|glucocorticoids|mesh-ancestor
102005695|NCT01295099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102005696|NCT01426529|Norepinephrine|norepinephrine|mesh-list
102005697|NCT01426529|Angiotensin II|angiotensin ii|mesh-list
102005698|NCT01426529|Giapreza|giapreza|mesh-list
102005699|NCT01426529|Angiotensinogen|angiotensinogen|mesh-list
102005700|NCT01426529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102005701|NCT01426529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102005702|NCT01426529|Adrenergic Agents|adrenergic agents|mesh-ancestor
102005703|NCT01426529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101725474|NCT04135313|Capecitabine|capecitabine|mesh-list
102005704|NCT01426529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005705|NCT01426529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005707|NCT01426529|Autonomic Agents|autonomic agents|mesh-ancestor
102005708|NCT01426529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102005709|NCT01426529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102005710|NCT01426529|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102005711|NCT01426529|Protease Inhibitors|protease inhibitors|mesh-ancestor
102005712|NCT01426529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102005713|NCT03122158|Escitalopram|escitalopram|mesh-list
102005714|NCT03122158|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102005715|NCT03122158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102005716|NCT03122158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102005717|NCT03122158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005718|NCT03122158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102005719|NCT03122158|Serotonin Agents|serotonin agents|mesh-ancestor
102005723|NCT02668653|Idarubicin|idarubicin|mesh-list
102005724|NCT02668653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102005725|NCT02668653|Antimetabolites|antimetabolites|mesh-ancestor
102005726|NCT02668653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005727|NCT02668653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102005728|NCT02668653|Antiviral Agents|antiviral agents|mesh-ancestor
102005729|NCT02668653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102005730|NCT02668653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102005731|NCT02668653|Immunologic Factors|immunologic factors|mesh-ancestor
102005732|NCT02668653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005733|NCT02668653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102005734|NCT02668653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102005735|NCT02668653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102005736|NCT02668653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102005737|NCT03555565|Metformin|metformin|mesh-list
102005738|NCT03555565|Alogliptin|alogliptin|mesh-list
102005739|NCT03555565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102005740|NCT03555565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005741|NCT03555565|Incretins|incretins|mesh-ancestor
102005742|NCT03555565|Hormones|hormones|mesh-ancestor
102005743|NCT03555565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101263247|NCT01760967|Analgesics|analgesics|mesh-ancestor
102005744|NCT03555565|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102005745|NCT03555565|Protease Inhibitors|protease inhibitors|mesh-ancestor
101949117|NCT05906914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949118|NCT05906914|Antiviral Agents|antiviral agents|mesh-ancestor
101949119|NCT05906914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101949120|NCT05906914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101949121|NCT05906914|Immunologic Factors|immunologic factors|mesh-ancestor
102005746|NCT03555565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102005747|NCT03555565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005749|NCT01190735|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102005750|NCT01190735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005751|NCT01190735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101318805|NCT00017992|Lopinavir|lopinavir|mesh-list
102005752|NCT01190735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102005753|NCT01190735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005754|NCT01190735|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102005755|NCT01190735|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102005756|NCT01190735|Purinergic Agents|purinergic agents|mesh-ancestor
102005757|NCT01190735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102005758|NCT05097118|Ketamine|ketamine|mesh-list
102005759|NCT05097118|Bupivacaine|bupivacaine|mesh-list
102005760|NCT05097118|Anesthetics, Local|anesthetics, local|mesh-ancestor
102005761|NCT05097118|Anesthetics|anesthetics|mesh-ancestor
102005762|NCT05097118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102005763|NCT05097118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005764|NCT05097118|Sensory System Agents|sensory system agents|mesh-ancestor
102005765|NCT05097118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102005766|NCT05097118|Analgesics|analgesics|mesh-ancestor
102005767|NCT05097118|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102005768|NCT05097118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102005769|NCT05097118|Anesthetics, General|anesthetics, general|mesh-ancestor
102005770|NCT05097118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102005771|NCT05097118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102005772|NCT05097118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102005773|NCT05097118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005774|NCT01194791|Dexamethasone|dexamethasone|mesh-list
102005775|NCT01194791|Cyclophosphamide|cyclophosphamide|mesh-list
102005776|NCT01194791|Lenalidomide|lenalidomide|mesh-list
102005777|NCT01194791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102005778|NCT01194791|Immunologic Factors|immunologic factors|mesh-ancestor
101263275|NCT01761071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102005779|NCT01194791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005780|NCT01194791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102005781|NCT01194791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102005782|NCT01194791|Alkylating Agents|alkylating agents|mesh-ancestor
102005783|NCT01194791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005784|NCT01194791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102005785|NCT01194791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102005786|NCT01194791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102005787|NCT01194791|Antiemetics|antiemetics|mesh-ancestor
102005788|NCT01194791|Autonomic Agents|autonomic agents|mesh-ancestor
102005789|NCT01194791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102005790|NCT01194791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102005791|NCT01194791|Glucocorticoids|glucocorticoids|mesh-ancestor
102005795|NCT01194791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102005796|NCT01194791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102005797|NCT01194791|Growth Substances|growth substances|mesh-ancestor
102005798|NCT01194791|Growth Inhibitors|growth inhibitors|mesh-ancestor
102005800|NCT03351322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102005801|NCT03351322|Vasodilator Agents|vasodilator agents|mesh-ancestor
102005802|NCT01296971|Ribavirin|ribavirin|mesh-list
102005803|NCT01296971|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101263297|NCT01761201|Ofloxacin|ofloxacin|mesh-list
102005804|NCT01296971|Antimetabolites|antimetabolites|mesh-ancestor
102005805|NCT01296971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005806|NCT01296971|Antiviral Agents|antiviral agents|mesh-ancestor
102005807|NCT01296971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102005808|NCT01195181|Ribavirin|ribavirin|mesh-list
102005809|NCT01195181|Antimetabolites|antimetabolites|mesh-ancestor
102005810|NCT01195181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005811|NCT01195181|Antiviral Agents|antiviral agents|mesh-ancestor
102005812|NCT01195181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102005813|NCT01197053|Immunomodulating Agents|immunomodulating agents|mesh-list
102005814|NCT01197053|Immunologic Factors|immunologic factors|mesh-ancestor
101949122|NCT05906914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949123|NCT05906914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101949124|NCT05906914|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101319151|NCT05171179|Lidocaine|lidocaine|mesh-list
101949125|NCT05906914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101949126|NCT05906303|Sodium Benzoate|sodium benzoate|mesh-list
101949127|NCT05906303|Caffeine, sodium benzoate drug combination|caffeine, sodium benzoate drug combination|mesh-list
102005815|NCT01197053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005817|NCT03845699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102005818|NCT03845699|Narcotics|narcotics|mesh-ancestor
102005819|NCT03845699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102005820|NCT03845699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005821|NCT03845699|Analgesics|analgesics|mesh-ancestor
102005822|NCT03845699|Sensory System Agents|sensory system agents|mesh-ancestor
102005823|NCT03845699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102005824|NCT03845699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102005825|NCT03845699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102005826|NCT03845699|Anesthetics, General|anesthetics, general|mesh-ancestor
102005827|NCT03845699|Anesthetics|anesthetics|mesh-ancestor
102005828|NCT03845777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
102005829|NCT03845777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102005830|NCT00709618|Vinorelbine|vinorelbine|mesh-list
102005831|NCT00709618|Lapatinib|lapatinib|mesh-list
102005832|NCT00709618|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102005833|NCT00709618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102005834|NCT00709618|Tubulin Modulators|tubulin modulators|mesh-ancestor
102005835|NCT00709618|Antimitotic Agents|antimitotic agents|mesh-ancestor
102005836|NCT00709618|Mitosis Modulators|mitosis modulators|mesh-ancestor
102005837|NCT00709618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005838|NCT00709618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102005839|NCT00709618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102005840|NCT01195259|Metformin|metformin|mesh-list
102005841|NCT01195259|Rosiglitazone|rosiglitazone|mesh-list
102005842|NCT01195259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102005843|NCT01195259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005844|NCT05584228|Infliximab|infliximab|mesh-list
102005845|NCT05584228|Azathioprine|azathioprine|mesh-list
102005846|NCT05584228|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102005847|NCT05584228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102005848|NCT05584228|Dermatologic Agents|dermatologic agents|mesh-ancestor
102005849|NCT05584228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102005850|NCT05584228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102005851|NCT05584228|Antimetabolites|antimetabolites|mesh-ancestor
102005852|NCT05584228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005853|NCT05584228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102005854|NCT05584228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102005855|NCT05584228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102005856|NCT05584228|Immunologic Factors|immunologic factors|mesh-ancestor
102005857|NCT05584228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005858|NCT03193047|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
102005859|NCT03193047|Evolocumab|evolocumab|mesh-list
102005860|NCT03193047|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102005861|NCT03193047|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102005862|NCT03193047|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102005863|NCT03193047|Antimetabolites|antimetabolites|mesh-ancestor
101460850|NCT00571753|Isoniazid|isoniazid|mesh-list
102005874|NCT03845387|Pramipexole|pramipexole|mesh-list
102005875|NCT03845387|Antioxidants|antioxidants|mesh-ancestor
102005876|NCT03845387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005877|NCT03845387|Protective Agents|protective agents|mesh-ancestor
102005878|NCT03845387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005879|NCT03845387|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102005880|NCT03845387|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102005881|NCT03845387|Dopamine Agonists|dopamine agonists|mesh-ancestor
102005882|NCT03845387|Dopamine Agents|dopamine agents|mesh-ancestor
102005883|NCT03845387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102005884|NCT01295177|Insulin|insulin|mesh-list
101303007|NCT02009189|Taurolidine|taurolidine|mesh-list
102005885|NCT01295177|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102005886|NCT01295177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102005887|NCT01295177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949128|NCT05906303|Caffeine|caffeine|mesh-list
101949129|NCT05906303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101949130|NCT05906303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949131|NCT05906303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101267799|NCT01797718|Hormones|hormones|mesh-ancestor
102005888|NCT02918019|Astegolimab|astegolimab|mesh-list
102005889|NCT02918019|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102005890|NCT02918019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102005891|NCT02918019|Antiviral Agents|antiviral agents|mesh-ancestor
102005892|NCT02918019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102005893|NCT04848454|Vinorelbine|vinorelbine|mesh-list
102005894|NCT04848454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102005895|NCT04848454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102005896|NCT04848454|Tubulin Modulators|tubulin modulators|mesh-ancestor
102005897|NCT04848454|Antimitotic Agents|antimitotic agents|mesh-ancestor
102005898|NCT04848454|Mitosis Modulators|mitosis modulators|mesh-ancestor
102005899|NCT04848454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005900|NCT04842292|Heparin|heparin|mesh-list
102005901|NCT04842292|Anticoagulants|anticoagulants|mesh-ancestor
102005902|NCT04842292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102005903|NCT04842292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101303222|NCT05291403|Erythromycin|erythromycin|mesh-list
102005904|NCT04842292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005905|NCT01191983|Epoetin Alfa|epoetin alfa|mesh-list
102005906|NCT01191983|Hematinics|hematinics|mesh-ancestor
102005907|NCT03055988|Fluticasone|fluticasone|mesh-list
102005909|NCT03055988|Tiotropium Bromide|tiotropium bromide|mesh-list
102005910|NCT03055988|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102005911|NCT03055988|Olodaterol|olodaterol|mesh-list
102005912|NCT03055988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102005913|NCT03055988|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102005914|NCT03055988|Autonomic Agents|autonomic agents|mesh-ancestor
102005915|NCT03055988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102005916|NCT03055988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005917|NCT03055988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102005918|NCT03055988|Respiratory System Agents|respiratory system agents|mesh-ancestor
102005919|NCT03055988|Dermatologic Agents|dermatologic agents|mesh-ancestor
102005920|NCT03055988|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101303410|NCT04278833|Hormones|hormones|mesh-ancestor
102005921|NCT03055988|Parasympatholytics|parasympatholytics|mesh-ancestor
102005922|NCT03055988|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102005923|NCT03055988|Cholinergic Agents|cholinergic agents|mesh-ancestor
102005924|NCT03055988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102005925|NCT03055988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005926|NCT03055988|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102005927|NCT03055988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102005928|NCT03055988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102005929|NCT03055988|Adrenergic Agents|adrenergic agents|mesh-ancestor
102005933|NCT03346642|Antimetabolites|antimetabolites|mesh-ancestor
102005934|NCT03346642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005935|NCT03346642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102005936|NCT03346642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102005937|NCT03346642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102005938|NCT02912949|Immunoglobulin G|immunoglobulin g|mesh-list
102005939|NCT02912949|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102005940|NCT02912949|Immunologic Factors|immunologic factors|mesh-ancestor
102005941|NCT02912949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005942|NCT01250912|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
102005943|NCT01250912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102005944|NCT01250912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102005945|NCT01250912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005946|NCT01250912|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102005947|NCT04789304|Midazolam|midazolam|mesh-list
102005948|NCT04789304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101303650|NCT03329508|Antioxidants|antioxidants|mesh-ancestor
102005949|NCT04789304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102005950|NCT04789304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102005951|NCT04789304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005952|NCT04789304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102005953|NCT04789304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102005954|NCT04789304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102005955|NCT04789304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102005956|NCT04789304|Anesthetics, General|anesthetics, general|mesh-ancestor
102005957|NCT04789304|Anesthetics|anesthetics|mesh-ancestor
101949132|NCT05906303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101949133|NCT05906303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949134|NCT05906303|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101949135|NCT05906303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102005958|NCT04789304|GABA Modulators|gaba modulators|mesh-ancestor
102005959|NCT04789304|GABA Agents|gaba agents|mesh-ancestor
102005960|NCT04789304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102005961|NCT04789304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005962|NCT04780724|Nitrox|nitrox|mesh-list
102005963|NCT04780724|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102005964|NCT04780724|Protective Agents|protective agents|mesh-ancestor
102005965|NCT04780724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005966|NCT03128866|Tranexamic Acid|tranexamic acid|mesh-list
102005967|NCT03128866|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102005968|NCT03128866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102005969|NCT03128866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005970|NCT03128866|Hemostatics|hemostatics|mesh-ancestor
102005971|NCT03128866|Coagulants|coagulants|mesh-ancestor
102005972|NCT05583214|Dexamethasone|dexamethasone|mesh-list
102005973|NCT05583214|Ondansetron|ondansetron|mesh-list
102005974|NCT05583214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102005975|NCT05583214|Antiemetics|antiemetics|mesh-ancestor
102005976|NCT05583214|Autonomic Agents|autonomic agents|mesh-ancestor
102005977|NCT05583214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102005978|NCT05583214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303922|NCT02009280|Sevoflurane|sevoflurane|mesh-list
102005979|NCT05583214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102005980|NCT05583214|Glucocorticoids|glucocorticoids|mesh-ancestor
102005981|NCT05583214|Hormones|hormones|mesh-ancestor
102005982|NCT05583214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102005983|NCT05583214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102005984|NCT05583214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102005985|NCT05583214|Antipruritics|antipruritics|mesh-ancestor
102005986|NCT05583214|Dermatologic Agents|dermatologic agents|mesh-ancestor
102005987|NCT05583214|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102005988|NCT05583214|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102005989|NCT05583214|Serotonin Agents|serotonin agents|mesh-ancestor
102005990|NCT05583214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102005991|NCT05583214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005992|NCT02871297|Vortioxetine|vortioxetine|mesh-list
102005993|NCT02871297|Antidepressive Agents|antidepressive agents|mesh-ancestor
102005994|NCT02871297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102005995|NCT02871297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102005996|NCT02871297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102005997|NCT02871297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102005998|NCT02871297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005999|NCT02871297|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102006000|NCT02871297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102006001|NCT02871297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102006005|NCT02871297|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102006006|NCT02871297|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101304125|NCT02011347|Ketamine|ketamine|mesh-list
102006007|NCT02871297|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102006008|NCT02871297|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102006009|NCT03628430|Lidocaine|lidocaine|mesh-list
102006010|NCT03628430|Epinephrine|epinephrine|mesh-list
102006011|NCT03628430|Anesthetics, Local|anesthetics, local|mesh-ancestor
102006012|NCT03628430|Anesthetics|anesthetics|mesh-ancestor
102006013|NCT03628430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102006014|NCT03628430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006015|NCT03628430|Sensory System Agents|sensory system agents|mesh-ancestor
102006016|NCT03628430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102006017|NCT03628430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102006018|NCT03628430|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102006019|NCT03628430|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102006020|NCT03628430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102006021|NCT03628430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006022|NCT03628430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102006023|NCT03628430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102006024|NCT03628430|Adrenergic Agents|adrenergic agents|mesh-ancestor
102006025|NCT03628430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102006026|NCT03628430|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102006027|NCT03628430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102006028|NCT03628430|Autonomic Agents|autonomic agents|mesh-ancestor
102006029|NCT03628430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102006030|NCT03628430|Respiratory System Agents|respiratory system agents|mesh-ancestor
102006031|NCT03628430|Mydriatics|mydriatics|mesh-ancestor
102006032|NCT03628430|Sympathomimetics|sympathomimetics|mesh-ancestor
102006033|NCT03628430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102006034|NCT03121846|Apatinib|apatinib|mesh-list
102006035|NCT03121846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102006036|NCT03121846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102006037|NCT03121846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102006038|NCT03121846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006039|NCT03122314|Acetaminophen|acetaminophen|mesh-list
102006040|NCT03122314|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
102006041|NCT03122314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102006042|NCT03122314|Analgesics|analgesics|mesh-ancestor
102006043|NCT03122314|Sensory System Agents|sensory system agents|mesh-ancestor
102006044|NCT03122314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102006045|NCT03122314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006046|NCT03122314|Antipyretics|antipyretics|mesh-ancestor
102006047|NCT03122314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102006048|NCT03122314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102006049|NCT03122314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102006050|NCT03554005|Acetaminophen|acetaminophen|mesh-list
102006051|NCT03554005|Interferons|interferons|mesh-list
102006052|NCT03554005|Interferon-alpha|interferon-alpha|mesh-list
102006053|NCT03554005|Interferon alpha-2|interferon alpha-2|mesh-list
102006054|NCT03554005|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102006055|NCT03554005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102006056|NCT03554005|Antiviral Agents|antiviral agents|mesh-ancestor
102006057|NCT03554005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102006058|NCT03554005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102006059|NCT03554005|Analgesics|analgesics|mesh-ancestor
102006060|NCT03554005|Sensory System Agents|sensory system agents|mesh-ancestor
102006061|NCT03554005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102006062|NCT03554005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006063|NCT03554005|Antipyretics|antipyretics|mesh-ancestor
102006064|NCT03554005|Immunologic Factors|immunologic factors|mesh-ancestor
102006065|NCT00709228|Ribavirin|ribavirin|mesh-list
102006066|NCT00709228|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102006067|NCT00709228|Antimetabolites|antimetabolites|mesh-ancestor
102006068|NCT00709228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006069|NCT00709228|Antiviral Agents|antiviral agents|mesh-ancestor
102006070|NCT00709228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102006071|NCT01584557|Tolvaptan|tolvaptan|mesh-list
102006072|NCT01584557|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101461054|NCT00225173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102006073|NCT01584557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006075|NCT01584557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006076|NCT05214872|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
102006077|NCT05214872|Calcium|calcium|mesh-list
102006078|NCT05214872|Mitogens|mitogens|mesh-list
102006079|NCT05214872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102006080|NCT05214872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725846|NCT02617199|Ropivacaine|ropivacaine|mesh-list
102006081|NCT05214872|Mitosis Modulators|mitosis modulators|mesh-ancestor
102006082|NCT05214872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006083|NCT05214872|Natriuretic Agents|natriuretic agents|mesh-ancestor
102006084|NCT01195571|Vaccines|vaccines|mesh-list
102006085|NCT01195571|Immunologic Factors|immunologic factors|mesh-ancestor
102006086|NCT01195571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006087|NCT03219372|Pravastatin|pravastatin|mesh-list
102006088|NCT03219372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102006089|NCT03219372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102006090|NCT03219372|Antimetabolites|antimetabolites|mesh-ancestor
102006091|NCT03219372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006092|NCT03219372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102006093|NCT03219372|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102006094|NCT03219372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102006095|NCT03304080|Trastuzumab|trastuzumab|mesh-list
102006096|NCT03304080|Pertuzumab|pertuzumab|mesh-list
102006097|NCT03304080|Palbociclib|palbociclib|mesh-list
102006098|NCT03304080|Anastrozole|anastrozole|mesh-list
101949136|NCT05906303|Purinergic Agents|purinergic agents|mesh-ancestor
101949137|NCT05906303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101949138|NCT05906303|Antifungal Agents|antifungal agents|mesh-ancestor
101949139|NCT05906303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102006099|NCT03304080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102006100|NCT03304080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102006101|NCT03304080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102006102|NCT03304080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102006103|NCT03304080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006104|NCT03304080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102006105|NCT03304080|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102006106|NCT03304080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102006107|NCT03304080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102006108|NCT03304080|Hormone Antagonists|hormone antagonists|mesh-ancestor
102006109|NCT03304080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102006110|NCT03304080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006111|NCT02422641|Methotrexate|methotrexate|mesh-list
102006112|NCT02422641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102006113|NCT02422641|Abortifacient Agents|abortifacient agents|mesh-ancestor
102006114|NCT02422641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102006115|NCT02422641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006116|NCT02422641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102006117|NCT02422641|Antimetabolites|antimetabolites|mesh-ancestor
102006118|NCT02422641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006119|NCT02422641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102006120|NCT02422641|Dermatologic Agents|dermatologic agents|mesh-ancestor
102006121|NCT02422641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102006122|NCT02422641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102006123|NCT02422641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102006124|NCT02422641|Immunologic Factors|immunologic factors|mesh-ancestor
102006125|NCT02422641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102006126|NCT02422641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102006127|NCT03628040|Ropivacaine|ropivacaine|mesh-list
102006128|NCT03628040|Anesthetics, Local|anesthetics, local|mesh-ancestor
102006129|NCT03628040|Anesthetics|anesthetics|mesh-ancestor
102006130|NCT03628040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102006131|NCT03628040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006132|NCT03628040|Sensory System Agents|sensory system agents|mesh-ancestor
102006133|NCT03628040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102006134|NCT04715763|Telmisartan|telmisartan|mesh-list
102006135|NCT04715763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102006136|NCT04715763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102006137|NCT04715763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102006138|NCT04715763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006139|NCT04338828|Nitric Oxide|nitric oxide|mesh-list
102006140|NCT04338828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102006141|NCT04338828|Autonomic Agents|autonomic agents|mesh-ancestor
102006142|NCT04338828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102006143|NCT04338828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006150|NCT04338828|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102006151|NCT04338828|Vasodilator Agents|vasodilator agents|mesh-ancestor
102006152|NCT04338828|Gasotransmitters|gasotransmitters|mesh-ancestor
102006153|NCT04338828|Protective Agents|protective agents|mesh-ancestor
102006154|NCT01295567|Dipyridamole|dipyridamole|mesh-list
102006155|NCT01295567|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102006156|NCT01295567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102006157|NCT01295567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006158|NCT01295567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102006159|NCT01295567|Vasodilator Agents|vasodilator agents|mesh-ancestor
102006160|NCT01192529|Phentermine|phentermine|mesh-list
102006161|NCT01192529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102006162|NCT01192529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006163|NCT01192529|Appetite Depressants|appetite depressants|mesh-ancestor
102006164|NCT01192529|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102006165|NCT01192529|Sympathomimetics|sympathomimetics|mesh-ancestor
102006166|NCT01192529|Autonomic Agents|autonomic agents|mesh-ancestor
102006167|NCT01192529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102006168|NCT01192529|Adrenergic Agents|adrenergic agents|mesh-ancestor
102006169|NCT01192529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101949140|NCT05906303|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101504750|NCT02952573|Dexamethasone|dexamethasone|mesh-list
101949141|NCT05906303|Protective Agents|protective agents|mesh-ancestor
101949142|NCT05906303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101949143|NCT05906303|Analgesics|analgesics|mesh-ancestor
101949144|NCT05906303|Sensory System Agents|sensory system agents|mesh-ancestor
101268084|NCT01801774|Glucocorticoids|glucocorticoids|mesh-ancestor
102006170|NCT01192529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006172|NCT01195649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102006173|NCT01195649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102006174|NCT01195649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102006175|NCT01195649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006176|NCT01195727|Apixaban|apixaban|mesh-list
102006177|NCT01195727|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102006178|NCT01195727|Antithrombins|antithrombins|mesh-ancestor
102006179|NCT01195727|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102006180|NCT01195727|Protease Inhibitors|protease inhibitors|mesh-ancestor
102006181|NCT01195727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102006182|NCT01195727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006183|NCT01195727|Anticoagulants|anticoagulants|mesh-ancestor
102006184|NCT04958876|Naltrexone|naltrexone|mesh-list
101188607|NCT00003000|Morphine|morphine|mesh-list
102006185|NCT04958876|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102006186|NCT04958876|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102006187|NCT04958876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006188|NCT04958876|Sensory System Agents|sensory system agents|mesh-ancestor
102006189|NCT04958876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102006190|NCT01195805|Amiloride|amiloride|mesh-list
102006191|NCT01195805|Spironolactone|spironolactone|mesh-list
102006192|NCT01195805|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102006193|NCT01195805|Hormone Antagonists|hormone antagonists|mesh-ancestor
102006194|NCT01195805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102006195|NCT01195805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006196|NCT01195805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102006197|NCT01195805|Diuretics|diuretics|mesh-ancestor
102006198|NCT01195805|Natriuretic Agents|natriuretic agents|mesh-ancestor
102006199|NCT01195805|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
102006200|NCT01195805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102006201|NCT01195805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102006202|NCT01195805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006203|NCT01195805|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
102006204|NCT04899986|Chlorhexidine|chlorhexidine|mesh-list
102006205|NCT04899986|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102006206|NCT04899986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102006207|NCT04899986|Disinfectants|disinfectants|mesh-ancestor
102006208|NCT01791478|Letrozole|letrozole|mesh-list
101505235|NCT00504413|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102006209|NCT01791478|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
102006210|NCT01791478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102006211|NCT01791478|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102006214|NCT01791478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006215|NCT01791478|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102006216|NCT01791478|Hormone Antagonists|hormone antagonists|mesh-ancestor
102006217|NCT01791478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102006218|NCT01791478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006219|NCT03845153|Metformin|metformin|mesh-list
102006220|NCT03845153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102006221|NCT03845153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006222|NCT00198718|Vitamin A|vitamin a|mesh-list
102006223|NCT00198718|Retinol palmitate|retinol palmitate|mesh-list
102006224|NCT00198718|Vitamins|vitamins|mesh-ancestor
102006225|NCT00198718|Micronutrients|micronutrients|mesh-ancestor
102006226|NCT00198718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006227|NCT00198718|Antioxidants|antioxidants|mesh-ancestor
101505380|NCT00513786|Growth Inhibitors|growth inhibitors|mesh-ancestor
102006228|NCT00198718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006230|NCT00198718|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102006231|NCT00198718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102006232|NCT04500808|Macitentan|macitentan|mesh-list
102006233|NCT04500808|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
102006234|NCT04500808|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102006235|NCT04500808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949145|NCT05906303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102006236|NCT04500808|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
101387635|NCT00314080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387637|NCT00314158|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102006237|NCT01192763|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
102006238|NCT01192763|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
102006239|NCT01192763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102006240|NCT01192763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006241|NCT04539548|Prednisolone|prednisolone|mesh-list
102006242|NCT04539548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102006243|NCT04539548|Glucocorticoids|glucocorticoids|mesh-ancestor
102006244|NCT04539548|Hormones|hormones|mesh-ancestor
102006245|NCT04539548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102006246|NCT04539548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006247|NCT04539548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102006248|NCT04539548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102006249|NCT00708916|Apremilast|apremilast|mesh-list
102006250|NCT00708916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102006251|NCT00708916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102006252|NCT00708916|Analgesics|analgesics|mesh-ancestor
102006253|NCT00708916|Sensory System Agents|sensory system agents|mesh-ancestor
102006254|NCT00708916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102006255|NCT00708916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006256|NCT00708916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102006257|NCT00708916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102006258|NCT00708916|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102006259|NCT00708916|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102006260|NCT00708916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387638|NCT00314158|Brinzolamide|brinzolamide|mesh-list
102006261|NCT00708916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006262|NCT02352753|Denosumab|denosumab|mesh-list
102006263|NCT02352753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102006264|NCT02352753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006265|NCT02517736|Sorafenib|sorafenib|mesh-list
102006266|NCT02517736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102006267|NCT02517736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102006268|NCT02517736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387639|NCT00314158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102006269|NCT02517736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006270|NCT03727971|Omalizumab|omalizumab|mesh-list
102006271|NCT03727971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102006272|NCT03727971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102006273|NCT03727971|Respiratory System Agents|respiratory system agents|mesh-ancestor
102006274|NCT03844841|Dexmedetomidine|dexmedetomidine|mesh-list
102006275|NCT03844841|Propofol|propofol|mesh-list
102006276|NCT03844841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101506014|NCT01246206|Thymoglobulin|thymoglobulin|mesh-list
102006277|NCT03844841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102006278|NCT03844841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006279|NCT03844841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102006280|NCT03844841|Analgesics|analgesics|mesh-ancestor
102006281|NCT03844841|Sensory System Agents|sensory system agents|mesh-ancestor
101461262|NCT00574600|Vaccines|vaccines|mesh-list
102006284|NCT03844841|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102006285|NCT03844841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102006286|NCT03844841|Adrenergic Agents|adrenergic agents|mesh-ancestor
102006287|NCT03844841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102006288|NCT03844841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006289|NCT03844841|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102006290|NCT03844841|Anesthetics, General|anesthetics, general|mesh-ancestor
102006291|NCT03844841|Anesthetics|anesthetics|mesh-ancestor
102006292|NCT03197766|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
102006293|NCT03197766|Natriuretic Agents|natriuretic agents|mesh-ancestor
102006294|NCT03197766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006295|NCT04501900|Clopidogrel|clopidogrel|mesh-list
102006296|NCT04501900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102006297|NCT04501900|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102006298|NCT04501900|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101506228|NCT00517218|Oblimersen|oblimersen|mesh-list
102006299|NCT04501900|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102006300|NCT04501900|Purinergic Agents|purinergic agents|mesh-ancestor
102006301|NCT04501900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102006302|NCT04501900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006303|NCT04501900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006304|NCT03637556|Deferasirox|deferasirox|mesh-list
102006305|NCT03637556|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101949146|NCT05902533|Capecitabine|capecitabine|mesh-list
101949147|NCT05902533|Mitomycins|mitomycins|mesh-list
101949148|NCT05902533|Mitomycin|mitomycin|mesh-list
101949149|NCT05902533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101949150|NCT05902533|Antimetabolites|antimetabolites|mesh-ancestor
101268230|NCT01802814|Epratuzumab|epratuzumab|mesh-list
102006306|NCT03637556|Chelating Agents|chelating agents|mesh-ancestor
102006307|NCT03637556|Sequestering Agents|sequestering agents|mesh-ancestor
102006308|NCT03637556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006310|NCT01193387|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102006311|NCT01193387|Insulin, Long-Acting|insulin, long-acting|mesh-list
102006312|NCT01193387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102006313|NCT01193387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006314|NCT01198223|Nystatin|nystatin|mesh-list
102006315|NCT01198223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102006316|NCT01198223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102006317|NCT01198223|Antifungal Agents|antifungal agents|mesh-ancestor
102006318|NCT01198223|Ionophores|ionophores|mesh-ancestor
102006319|NCT01198223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102006320|NCT01198223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006321|NCT01193465|Anesthetics|anesthetics|mesh-list
101506500|NCT02276300|Cyclophosphamide|cyclophosphamide|mesh-list
102006322|NCT01193465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102006323|NCT01193465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006324|NCT03347344|Riluzole|riluzole|mesh-list
102006325|NCT03347344|Anticonvulsants|anticonvulsants|mesh-ancestor
102006326|NCT03347344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102006327|NCT03347344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102006328|NCT03347344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102006329|NCT03347344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006330|NCT03347344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006331|NCT03347344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101506639|NCT02949258|Etoposide|etoposide|mesh-list
102006332|NCT03347344|Protective Agents|protective agents|mesh-ancestor
102006333|NCT04220866|Pembrolizumab|pembrolizumab|mesh-list
102006334|NCT04220866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102006335|NCT04220866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102006336|NCT04220866|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102006337|NCT04220866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006338|NCT03173456|Acetaminophen|acetaminophen|mesh-list
102006339|NCT03173456|Ibuprofen|ibuprofen|mesh-list
102006340|NCT03173456|Oxycodone|oxycodone|mesh-list
102006341|NCT03173456|Hydrocodone|hydrocodone|mesh-list
102006342|NCT03173456|Codeine|codeine|mesh-list
101506708|NCT00519363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102006343|NCT03173456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102006344|NCT03173456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102006345|NCT03173456|Analgesics|analgesics|mesh-ancestor
102006346|NCT03173456|Sensory System Agents|sensory system agents|mesh-ancestor
102006347|NCT03173456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102006348|NCT03173456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006349|NCT03173456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102006350|NCT03173456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102006351|NCT03173456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102006352|NCT03173456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102006353|NCT03173456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006355|NCT03173456|Narcotics|narcotics|mesh-ancestor
102006356|NCT03173456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102006357|NCT03173456|Antipyretics|antipyretics|mesh-ancestor
102006358|NCT03173456|Antitussive Agents|antitussive agents|mesh-ancestor
102006359|NCT03173456|Respiratory System Agents|respiratory system agents|mesh-ancestor
102006360|NCT01193621|Haloperidol|haloperidol|mesh-list
102006361|NCT01193621|Haloperidol decanoate|haloperidol decanoate|mesh-list
102006362|NCT01193621|Antiemetics|antiemetics|mesh-ancestor
102006363|NCT01193621|Autonomic Agents|autonomic agents|mesh-ancestor
102006364|NCT01193621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102006365|NCT01193621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006366|NCT01193621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102006367|NCT01193621|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102006368|NCT01193621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102006369|NCT01193621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102006370|NCT01193621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102006371|NCT01193621|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102006372|NCT01193621|Dopamine Agents|dopamine agents|mesh-ancestor
101949151|NCT05902533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949152|NCT05902533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949153|NCT05902533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101949154|NCT05902533|Alkylating Agents|alkylating agents|mesh-ancestor
102006373|NCT01193621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102006374|NCT01193621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006375|NCT01193621|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102006377|NCT02517424|Hallucinogens|hallucinogens|mesh-ancestor
102006378|NCT02517424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006379|NCT02517424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102006380|NCT02517424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102006381|NCT02517424|Analgesics|analgesics|mesh-ancestor
102006382|NCT02517424|Sensory System Agents|sensory system agents|mesh-ancestor
102006383|NCT02517424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102006384|NCT02517424|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102006385|NCT02517424|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102006386|NCT02517424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102006387|NCT02517424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006388|NCT02517424|Hormones|hormones|mesh-ancestor
101387640|NCT00314158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102006389|NCT02517424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102006390|NCT01567904|Semuloparin|semuloparin|mesh-list
102006391|NCT01567904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102006392|NCT01567904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102006393|NCT01567904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006394|NCT01196507|Carvedilol|carvedilol|mesh-list
102006395|NCT01196507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102006396|NCT01196507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102006397|NCT01196507|Adrenergic Agents|adrenergic agents|mesh-ancestor
102006398|NCT01196507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102006399|NCT01196507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006400|NCT01196507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006401|NCT01196507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102006402|NCT01196507|Antioxidants|antioxidants|mesh-ancestor
102006403|NCT01196507|Protective Agents|protective agents|mesh-ancestor
102006404|NCT01196507|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102006405|NCT01196507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102006406|NCT01196507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102006407|NCT01196507|Vasodilator Agents|vasodilator agents|mesh-ancestor
102006408|NCT01196507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102006409|NCT01196507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102006410|NCT05670509|Midazolam|midazolam|mesh-list
102006411|NCT05670509|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102006412|NCT05670509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102006413|NCT05670509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102006414|NCT05670509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006415|NCT05670509|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102006416|NCT05670509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102006417|NCT05670509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101507106|NCT00523692|Antimetabolites|antimetabolites|mesh-ancestor
102006418|NCT05670509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102006419|NCT05670509|Anesthetics, General|anesthetics, general|mesh-ancestor
102006420|NCT05670509|Anesthetics|anesthetics|mesh-ancestor
102006421|NCT05670509|GABA Modulators|gaba modulators|mesh-ancestor
102006422|NCT05670509|GABA Agents|gaba agents|mesh-ancestor
102006423|NCT05670509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102006424|NCT05670509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006425|NCT05282771|Nicotinic Acids|nicotinic acids|mesh-list
102006426|NCT05282771|Clobetasol|clobetasol|mesh-list
102006427|NCT05282771|Halobetasol|halobetasol|mesh-list
102006428|NCT05282771|Tazarotene|tazarotene|mesh-list
102006434|NCT05282771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006435|NCT05282771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102006436|NCT05282771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102006437|NCT05282771|Glucocorticoids|glucocorticoids|mesh-ancestor
102006438|NCT05282771|Hormones|hormones|mesh-ancestor
102006439|NCT05282771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102006440|NCT05487833|Insulin|insulin|mesh-list
102006441|NCT05487833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102006442|NCT05487833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006443|NCT03600805|Prednisone|prednisone|mesh-list
102006444|NCT03600805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101949155|NCT05902533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101949156|NCT05902533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101949157|NCT05892237|Immunomodulating Agents|immunomodulating agents|mesh-list
101949158|NCT05892237|Immunologic Factors|immunologic factors|mesh-ancestor
101949159|NCT05892237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949161|NCT05864118|Immunologic Factors|immunologic factors|mesh-ancestor
101949162|NCT05864118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949163|NCT05855200|Dostarlimab|dostarlimab|mesh-list
101949164|NCT05855200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949165|NCT05840016|Carboplatin|carboplatin|mesh-list
101949166|NCT05840016|Tislelizumab|tislelizumab|mesh-list
101949167|NCT05840016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949168|NCT05840016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101949169|NCT05819541|Albuterol|albuterol|mesh-list
101268369|NCT01804205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102006445|NCT03600805|Glucocorticoids|glucocorticoids|mesh-ancestor
102006446|NCT03600805|Hormones|hormones|mesh-ancestor
102006447|NCT03600805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102006448|NCT03600805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006449|NCT03600805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102006450|NCT03600805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102006451|NCT01198379|Aspirin|aspirin|mesh-list
102006452|NCT01198379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102006453|NCT01198379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102006454|NCT01198379|Analgesics|analgesics|mesh-ancestor
102006455|NCT01198379|Sensory System Agents|sensory system agents|mesh-ancestor
102006456|NCT01198379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102006457|NCT01198379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006458|NCT01198379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102006459|NCT01198379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102006460|NCT01198379|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102006461|NCT01198379|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102006462|NCT01198379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006463|NCT01198379|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102006464|NCT01198379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102006465|NCT01198379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102006466|NCT01198379|Antipyretics|antipyretics|mesh-ancestor
102006467|NCT03848039|Vaccines|vaccines|mesh-list
102006468|NCT03848039|Immunologic Factors|immunologic factors|mesh-ancestor
102006469|NCT03848039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006470|NCT01296269|Vasopressins|vasopressins|mesh-list
102006471|NCT01296269|Arginine Vasopressin|arginine vasopressin|mesh-list
102006472|NCT01296269|Oxytocin|oxytocin|mesh-list
102006473|NCT01296269|Oxytocics|oxytocics|mesh-ancestor
102006474|NCT01296269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102006475|NCT01296269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006476|NCT01296269|Hemostatics|hemostatics|mesh-ancestor
102006477|NCT01296269|Coagulants|coagulants|mesh-ancestor
102006478|NCT01296269|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102006479|NCT01296269|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102006480|NCT01296269|Natriuretic Agents|natriuretic agents|mesh-ancestor
102006481|NCT05595772|Mitogens|mitogens|mesh-list
102006482|NCT05595772|Mitosis Modulators|mitosis modulators|mesh-ancestor
102006483|NCT05595772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006484|NCT03844451|Epinephrine|epinephrine|mesh-list
102006485|NCT03844451|Bupivacaine|bupivacaine|mesh-list
102006486|NCT03844451|Anesthetics, Local|anesthetics, local|mesh-ancestor
102006487|NCT03844451|Anesthetics|anesthetics|mesh-ancestor
102006488|NCT03844451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102006489|NCT03844451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949170|NCT05819541|Montelukast|montelukast|mesh-list
101949171|NCT05819541|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101949172|NCT05819541|Respiratory System Agents|respiratory system agents|mesh-ancestor
101949173|NCT05819541|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101949174|NCT05819541|Hormone Antagonists|hormone antagonists|mesh-ancestor
101507621|NCT00525486|Nifedipine|nifedipine|mesh-list
101268429|NCT01804387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102006490|NCT03844451|Sensory System Agents|sensory system agents|mesh-ancestor
102006491|NCT03844451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102006492|NCT03844451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102006493|NCT03844451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102006494|NCT03844451|Adrenergic Agents|adrenergic agents|mesh-ancestor
102006495|NCT03844451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102006496|NCT03844451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006497|NCT03844451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102006498|NCT03844451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101507688|NCT02945982|Carvedilol|carvedilol|mesh-list
102006499|NCT03844451|Autonomic Agents|autonomic agents|mesh-ancestor
102006500|NCT03844451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102006512|NCT03346096|Immunologic Factors|immunologic factors|mesh-ancestor
102006513|NCT03346096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006514|NCT01198457|Clodronic Acid|clodronic acid|mesh-list
102006515|NCT01198457|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102006516|NCT01198457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006517|NCT03386214|Pevonedistat|pevonedistat|mesh-list
102006518|NCT03386214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102006519|NCT03386214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006520|NCT01198535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102006521|NCT01198535|Cetuximab|cetuximab|mesh-list
102006522|NCT01198535|Antibodies|antibodies|mesh-list
102006523|NCT01198535|Immunoglobulins|immunoglobulins|mesh-list
102006524|NCT01198535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102006525|NCT01198535|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
102006526|NCT01198535|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
102006527|NCT01198535|Immunologic Factors|immunologic factors|mesh-ancestor
102006528|NCT01198535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006529|NCT01198535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102006530|NCT01198535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102006531|NCT01198535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006532|NCT05081219|Insulin|insulin|mesh-list
102006533|NCT05081219|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102006534|NCT05081219|Empagliflozin|empagliflozin|mesh-list
102006535|NCT05081219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102006536|NCT05081219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507959|NCT00509015|Artesunate|artesunate|mesh-list
102006537|NCT05081219|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102006538|NCT05081219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006539|NCT03860038|Dexamethasone|dexamethasone|mesh-list
102006540|NCT03860038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102006541|NCT03860038|Antiemetics|antiemetics|mesh-ancestor
102006542|NCT03860038|Autonomic Agents|autonomic agents|mesh-ancestor
102006543|NCT03860038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102006544|NCT03860038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508028|NCT00528177|Analgesics|analgesics|mesh-ancestor
102006545|NCT03860038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102006546|NCT03860038|Glucocorticoids|glucocorticoids|mesh-ancestor
102006547|NCT03860038|Hormones|hormones|mesh-ancestor
102006548|NCT03860038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102006549|NCT03860038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101318069|NCT00014989|Anesthetics|anesthetics|mesh-ancestor
102006550|NCT03860038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102006551|NCT03844763|Cyclophosphamide|cyclophosphamide|mesh-list
102006552|NCT03844763|Avelumab|avelumab|mesh-list
102006553|NCT03844763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102006554|NCT03844763|Immunologic Factors|immunologic factors|mesh-ancestor
102006555|NCT03844763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006556|NCT03844763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102006557|NCT03844763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102006558|NCT03844763|Alkylating Agents|alkylating agents|mesh-ancestor
102006559|NCT03844763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006560|NCT03844763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102006561|NCT03844763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101949175|NCT05819541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101949176|NCT05819541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949177|NCT05819541|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101949178|NCT05819541|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101949179|NCT05819541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949180|NCT05819541|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101949181|NCT05819541|Autonomic Agents|autonomic agents|mesh-ancestor
101949182|NCT05819541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101949183|NCT05819541|Tocolytic Agents|tocolytic agents|mesh-ancestor
101949184|NCT05819541|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101949185|NCT05819541|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101949186|NCT05819541|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101949187|NCT05819541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101949188|NCT05819541|Adrenergic Agents|adrenergic agents|mesh-ancestor
101949190|NCT05803941|177Lu-PSMA-617|177lu-psma-617|mesh-list
101949235|NCT05777733|Acetylcysteine|acetylcysteine|mesh-list
101949236|NCT05777733|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101268526|NCT01807741|Asenapine|asenapine|mesh-list
101461549|NCT00226382|Interferons|interferons|mesh-list
102006565|NCT01198925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102006567|NCT03844139|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102006568|NCT03844139|Protective Agents|protective agents|mesh-ancestor
102006569|NCT03844139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006570|NCT04500496|Isoniazid|isoniazid|mesh-list
102006571|NCT04500496|Dinoprostone|dinoprostone|mesh-list
102006572|NCT04500496|Oxytocics|oxytocics|mesh-ancestor
102006573|NCT04500496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102006574|NCT04500496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006575|NCT04500496|Antitubercular Agents|antitubercular agents|mesh-ancestor
102006576|NCT04500496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102006577|NCT04500496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102006578|NCT04500496|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102006579|NCT04500496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102006580|NCT04500496|Antimetabolites|antimetabolites|mesh-ancestor
101387641|NCT00314158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102006581|NCT04500496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006582|NCT04500496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102006583|NCT01199081|Dronedarone|dronedarone|mesh-list
102006584|NCT01199081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102006585|NCT04989335|Fludarabine|fludarabine|mesh-list
102006586|NCT04989335|Clofarabine|clofarabine|mesh-list
102006587|NCT04989335|Bisantrene|bisantrene|mesh-list
102006588|NCT04989335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102006589|NCT04989335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102006590|NCT04989335|Antimetabolites|antimetabolites|mesh-ancestor
102006591|NCT04989335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006592|NCT04989335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102006593|NCT03345940|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102006594|NCT03345940|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101387642|NCT00314158|Adrenergic Agents|adrenergic agents|mesh-ancestor
102006595|NCT03345940|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102006596|NCT03345940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006597|NCT03345940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102006598|NCT03345940|Immunologic Factors|immunologic factors|mesh-ancestor
102006599|NCT03345940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006600|NCT03345940|Dermatologic Agents|dermatologic agents|mesh-ancestor
102006601|NCT05670353|Contraceptive Agents|contraceptive agents|mesh-list
101508560|NCT00513968|Adefovir|adefovir|mesh-list
102006602|NCT05670353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-list
102006603|NCT05670353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102006604|NCT05670353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006605|NCT01199159|Vitamin B 6|vitamin b 6|mesh-list
102006606|NCT01199159|Pyridoxal|pyridoxal|mesh-list
102006607|NCT01199159|Pyridoxine|pyridoxine|mesh-list
101508626|NCT00530478|Donepezil|donepezil|mesh-list
102006608|NCT01199159|Misoprostol|misoprostol|mesh-list
102006609|NCT01199159|Vitamins|vitamins|mesh-ancestor
102006610|NCT01199159|Micronutrients|micronutrients|mesh-ancestor
102006611|NCT01199159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006612|NCT01199159|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102006613|NCT01199159|Abortifacient Agents|abortifacient agents|mesh-ancestor
102006614|NCT01199159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102006615|NCT01199159|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102006616|NCT01199159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102006617|NCT01199159|Oxytocics|oxytocics|mesh-ancestor
102006618|NCT01199159|Vitamin B Complex|vitamin b complex|mesh-ancestor
102006619|NCT05669963|Lactoferrin|lactoferrin|mesh-list
102006620|NCT05669963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102006621|NCT02507440|Lidocaine|lidocaine|mesh-list
102006622|NCT02507440|Propofol|propofol|mesh-list
102006623|NCT02507440|Anesthetics, Local|anesthetics, local|mesh-ancestor
102006624|NCT02507440|Anesthetics|anesthetics|mesh-ancestor
102006625|NCT02507440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101508824|NCT02943135|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102006626|NCT02507440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006627|NCT02507440|Sensory System Agents|sensory system agents|mesh-ancestor
102006628|NCT02507440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102006629|NCT02507440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102006630|NCT02507440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102006631|NCT02507440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102006632|NCT02507440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101949237|NCT05777733|Antidotes|antidotes|mesh-ancestor
101949238|NCT05777733|Protective Agents|protective agents|mesh-ancestor
101949239|NCT05777733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949240|NCT05777733|Antioxidants|antioxidants|mesh-ancestor
102006633|NCT02507440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461613|NCT00255762|Paclitaxel|paclitaxel|mesh-list
102006644|NCT02507362|Dermatologic Agents|dermatologic agents|mesh-ancestor
102006645|NCT02507362|Anticoagulants|anticoagulants|mesh-ancestor
102006646|NCT02507362|Plasma Substitutes|plasma substitutes|mesh-ancestor
102006647|NCT02507362|Blood Substitutes|blood substitutes|mesh-ancestor
102006648|NCT05640830|Paclitaxel|paclitaxel|mesh-list
102006649|NCT05640830|Bevacizumab|bevacizumab|mesh-list
102006650|NCT05640830|Trastuzumab|trastuzumab|mesh-list
102006651|NCT05640830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101509063|NCT02951039|Edoxaban|edoxaban|mesh-list
102006652|NCT05640830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102006653|NCT05640830|Tubulin Modulators|tubulin modulators|mesh-ancestor
102006654|NCT05640830|Antimitotic Agents|antimitotic agents|mesh-ancestor
102006655|NCT05640830|Mitosis Modulators|mitosis modulators|mesh-ancestor
102006656|NCT05640830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006657|NCT05640830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102006658|NCT05640830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102006659|NCT05640830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102006660|NCT05640830|Growth Substances|growth substances|mesh-ancestor
102006661|NCT05640830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006662|NCT05640830|Growth Inhibitors|growth inhibitors|mesh-ancestor
102006663|NCT03730961|Furosemide|furosemide|mesh-list
102006664|NCT03730961|Diuretics|diuretics|mesh-ancestor
102006665|NCT03730961|Natriuretic Agents|natriuretic agents|mesh-ancestor
102006666|NCT03730961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006667|NCT03730961|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102006668|NCT03730961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102006669|NCT03730961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006670|NCT01078454|Dexamethasone|dexamethasone|mesh-list
102006671|NCT01078454|Bortezomib|bortezomib|mesh-list
102006672|NCT01078454|Melphalan|melphalan|mesh-list
101726447|NCT00867035|Chlorhexidine|chlorhexidine|mesh-list
102006673|NCT01078454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102006674|NCT01078454|Antiemetics|antiemetics|mesh-ancestor
102006675|NCT01078454|Autonomic Agents|autonomic agents|mesh-ancestor
102006676|NCT01078454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102006677|NCT01078454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006678|NCT01078454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102006679|NCT01078454|Glucocorticoids|glucocorticoids|mesh-ancestor
102006680|NCT01078454|Hormones|hormones|mesh-ancestor
102006681|NCT01078454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102006682|NCT01078454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102006683|NCT01078454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102006684|NCT01078454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102006685|NCT01078454|Alkylating Agents|alkylating agents|mesh-ancestor
102006686|NCT01078454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006687|NCT01078454|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102006688|NCT01078454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102006689|NCT01078454|Immunologic Factors|immunologic factors|mesh-ancestor
102006690|NCT02968602|Minocycline|minocycline|mesh-list
102006691|NCT02968602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102006692|NCT02968602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102006693|NCT03345004|Vitamin D|vitamin d|mesh-list
102006694|NCT03345004|Ergocalciferols|ergocalciferols|mesh-list
102006695|NCT03345004|Cholecalciferol|cholecalciferol|mesh-list
102006696|NCT03345004|Vitamins|vitamins|mesh-list
102006697|NCT03345004|Micronutrients|micronutrients|mesh-ancestor
102006698|NCT03345004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006699|NCT03345004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102006700|NCT03345004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102006708|NCT03003468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006709|NCT03345628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
102006710|NCT03345628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102006711|NCT03345628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006713|NCT03552523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102006714|NCT03728101|Dabigatran|dabigatran|mesh-list
102006715|NCT03728101|Simvastatin|simvastatin|mesh-list
102006716|NCT03728101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101949241|NCT05777733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268659|NCT01808768|Alcaftadine|alcaftadine|mesh-list
102006717|NCT03728101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102006718|NCT03728101|Antimetabolites|antimetabolites|mesh-ancestor
102006719|NCT03728101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006720|NCT03728101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102006721|NCT03728101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102006722|NCT03728101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102006723|NCT03728101|Antithrombins|antithrombins|mesh-ancestor
102006724|NCT03728101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102006725|NCT03728101|Protease Inhibitors|protease inhibitors|mesh-ancestor
102006726|NCT03728101|Anticoagulants|anticoagulants|mesh-ancestor
102006727|NCT03844217|Tryptophan|tryptophan|mesh-list
102006728|NCT03844217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101509417|NCT00517946|Autonomic Agents|autonomic agents|mesh-ancestor
102006729|NCT03844217|Antidepressive Agents|antidepressive agents|mesh-ancestor
102006730|NCT03844217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102006731|NCT04170972|Insulin|insulin|mesh-list
102006732|NCT04170972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102006733|NCT04170972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006734|NCT02515864|Moxifloxacin|moxifloxacin|mesh-list
102006735|NCT02515864|Dotinurad|dotinurad|mesh-list
102006736|NCT02515864|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102006737|NCT02515864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102006738|NCT02515864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102006739|NCT02515864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102006740|NCT02515864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102006741|NCT02515864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102006742|NCT02515864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006743|NCT02515864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102006744|NCT02515864|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101726537|NCT00871871|Isosorbide|isosorbide|mesh-list
102006745|NCT02515864|Contraceptive Agents|contraceptive agents|mesh-ancestor
102006746|NCT02515864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102006747|NCT02515864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006748|NCT02515864|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102006749|NCT02515864|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102006750|NCT02515864|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102006751|NCT02515864|Uricosuric Agents|uricosuric agents|mesh-ancestor
102006752|NCT02515864|Gout Suppressants|gout suppressants|mesh-ancestor
102006753|NCT02515864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102006754|NCT02507206|Dihydrexidine|dihydrexidine|mesh-list
102006755|NCT02507206|Dopamine Agonists|dopamine agonists|mesh-ancestor
102006756|NCT02507206|Dopamine Agents|dopamine agents|mesh-ancestor
102006757|NCT02507206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102006758|NCT02507206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006759|NCT02507206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006760|NCT02892409|Amoxicillin|amoxicillin|mesh-list
102006761|NCT02892409|Clarithromycin|clarithromycin|mesh-list
102006762|NCT02892409|Lansoprazole|lansoprazole|mesh-list
102006763|NCT02892409|Dexlansoprazole|dexlansoprazole|mesh-list
102006764|NCT02892409|Bismuth|bismuth|mesh-list
102006765|NCT02892409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102006766|NCT02892409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102006767|NCT02892409|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102006768|NCT02892409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102006791|NCT03844529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102006792|NCT03844529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102006793|NCT03844529|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102006794|NCT03844529|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102006795|NCT03844529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102006796|NCT03844529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006797|NCT02292758|Bevacizumab|bevacizumab|mesh-list
102006798|NCT02292758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102006799|NCT02292758|Cetuximab|cetuximab|mesh-list
102006800|NCT02292758|Irinotecan|irinotecan|mesh-list
102006801|NCT02292758|Endothelial Growth Factors|endothelial growth factors|mesh-list
102006802|NCT02292758|Antibodies|antibodies|mesh-list
102006803|NCT02292758|Immunoglobulins|immunoglobulins|mesh-list
102006804|NCT02292758|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102006805|NCT02292758|Immunoglobulin G|immunoglobulin g|mesh-list
102006806|NCT02292758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101509982|NCT00522821|Antibodies|antibodies|mesh-list
102006807|NCT02292758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102006808|NCT02292758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102006809|NCT02292758|Growth Substances|growth substances|mesh-ancestor
101949242|NCT05777733|Antiviral Agents|antiviral agents|mesh-ancestor
101949243|NCT05777733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101949244|NCT05777733|Expectorants|expectorants|mesh-ancestor
101949245|NCT05777733|Respiratory System Agents|respiratory system agents|mesh-ancestor
102006810|NCT02292758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006811|NCT02292758|Growth Inhibitors|growth inhibitors|mesh-ancestor
102006812|NCT02292758|Immunologic Factors|immunologic factors|mesh-ancestor
102006813|NCT02292758|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102006814|NCT02292758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102006815|NCT02292758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102006816|NCT02292758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006817|NCT03727867|Mitogens|mitogens|mesh-list
102006818|NCT03727867|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102006819|NCT03727867|Mitosis Modulators|mitosis modulators|mesh-ancestor
102006820|NCT03727867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006824|NCT02832648|Antioxidants|antioxidants|mesh-ancestor
101387643|NCT00314158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102006825|NCT02832648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006826|NCT02832648|Protective Agents|protective agents|mesh-ancestor
102006827|NCT02832648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006828|NCT02832648|Trace Elements|trace elements|mesh-ancestor
102006829|NCT02832648|Micronutrients|micronutrients|mesh-ancestor
102006830|NCT04497766|Magnesium Sulfate|magnesium sulfate|mesh-list
102006831|NCT04497766|Analgesics|analgesics|mesh-ancestor
102006832|NCT04497766|Sensory System Agents|sensory system agents|mesh-ancestor
102006833|NCT04497766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102006834|NCT04497766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006835|NCT04497766|Anesthetics|anesthetics|mesh-ancestor
101510242|NCT02935764|Leucovorin|leucovorin|mesh-list
102006836|NCT04497766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102006837|NCT04497766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102006838|NCT04497766|Anticonvulsants|anticonvulsants|mesh-ancestor
102006839|NCT04497766|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102006840|NCT04497766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102006841|NCT04497766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006842|NCT04497766|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102006843|NCT04497766|Tocolytic Agents|tocolytic agents|mesh-ancestor
102006844|NCT04497766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102006846|NCT03841721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101510310|NCT00525005|Oxaliplatin|oxaliplatin|mesh-list
102006847|NCT03841721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102006848|NCT03841721|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102006849|NCT03841721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102006850|NCT03841721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006851|NCT03164057|Cytarabine|cytarabine|mesh-list
102006852|NCT03164057|Hydrocortisone|hydrocortisone|mesh-list
102006853|NCT03164057|Methotrexate|methotrexate|mesh-list
102006854|NCT03164057|Azacitidine|azacitidine|mesh-list
102006855|NCT03164057|Decitabine|decitabine|mesh-list
102006856|NCT03164057|Fludarabine|fludarabine|mesh-list
102006857|NCT03164057|Etoposide|etoposide|mesh-list
102006858|NCT03164057|Etoposide phosphate|etoposide phosphate|mesh-list
102006859|NCT03164057|Sorafenib|sorafenib|mesh-list
102006860|NCT03164057|Daunorubicin|daunorubicin|mesh-list
102006861|NCT03164057|Asparaginase|asparaginase|mesh-list
102006862|NCT03164057|Mitoxantrone|mitoxantrone|mesh-list
102006863|NCT03164057|Idarubicin|idarubicin|mesh-list
102006864|NCT03164057|Dexrazoxane|dexrazoxane|mesh-list
102006865|NCT03164057|Razoxane|razoxane|mesh-list
102006866|NCT03164057|Asparaginase erwinia chrysanthemi, recombinant-rywn|asparaginase erwinia chrysanthemi, recombinant-rywn|mesh-list
102006867|NCT03164057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102006868|NCT03164057|Abortifacient Agents|abortifacient agents|mesh-ancestor
102006869|NCT03164057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102006870|NCT03164057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006871|NCT03164057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102006872|NCT03164057|Antimetabolites|antimetabolites|mesh-ancestor
102006873|NCT03164057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006874|NCT03164057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102006875|NCT03164057|Dermatologic Agents|dermatologic agents|mesh-ancestor
102006876|NCT03164057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102006877|NCT03164057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102006878|NCT03164057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102006879|NCT03164057|Immunologic Factors|immunologic factors|mesh-ancestor
102006880|NCT03164057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101949246|NCT05777733|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101949247|NCT05777109|Denosumab|denosumab|mesh-list
101949248|NCT05777109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101949249|NCT05777109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949250|NCT05774639|Omalizumab|omalizumab|mesh-list
102006881|NCT03164057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102006882|NCT03164057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102006883|NCT03164057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102006884|NCT03164057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102006885|NCT03164057|Antiviral Agents|antiviral agents|mesh-ancestor
102006886|NCT03164057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102006887|NCT03164057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102006888|NCT03164057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102006889|NCT03164057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102006890|NCT03164057|Analgesics|analgesics|mesh-ancestor
102006891|NCT03164057|Sensory System Agents|sensory system agents|mesh-ancestor
102006892|NCT03164057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102006893|NCT03164057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102006894|NCT03164057|Protective Agents|protective agents|mesh-ancestor
102006895|NCT03164057|Antimitotic Agents|antimitotic agents|mesh-ancestor
102006901|NCT04532346|Antimalarials|antimalarials|mesh-ancestor
102006902|NCT04532346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102006903|NCT04532346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102006904|NCT04532346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102006905|NCT04532346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102006906|NCT04532346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006907|NCT04532346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102006908|NCT03843749|Trastuzumab|trastuzumab|mesh-list
102006909|NCT03843749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102006910|NCT03843749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102006911|NCT01199783|Vancomycin|vancomycin|mesh-list
102006912|NCT01199783|Daptomycin|daptomycin|mesh-list
102006913|NCT01199783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102006914|NCT01199783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102006915|NCT03192306|Ethanol|ethanol|mesh-list
102006916|NCT03192306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102006917|NCT03192306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102006918|NCT03192306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102006919|NCT03192306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006920|NCT03216954|Acetylcysteine|acetylcysteine|mesh-list
102006921|NCT03216954|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102006922|NCT03216954|Antiviral Agents|antiviral agents|mesh-ancestor
102006923|NCT03216954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102006924|NCT03216954|Expectorants|expectorants|mesh-ancestor
102006925|NCT03216954|Respiratory System Agents|respiratory system agents|mesh-ancestor
102006926|NCT03216954|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102006927|NCT03216954|Antioxidants|antioxidants|mesh-ancestor
102006928|NCT03216954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006929|NCT03216954|Protective Agents|protective agents|mesh-ancestor
102006930|NCT03216954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006931|NCT03216954|Antidotes|antidotes|mesh-ancestor
102006932|NCT05669807|Paclitaxel|paclitaxel|mesh-list
102006933|NCT05669807|Irinotecan|irinotecan|mesh-list
102006934|NCT05669807|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102006935|NCT05669807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102006936|NCT05669807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102006937|NCT05669807|Tubulin Modulators|tubulin modulators|mesh-ancestor
102006938|NCT05669807|Antimitotic Agents|antimitotic agents|mesh-ancestor
102006939|NCT05669807|Mitosis Modulators|mitosis modulators|mesh-ancestor
102006940|NCT05669807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006941|NCT05669807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102006942|NCT05669807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102006943|NCT05669807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102006944|NCT03599089|Acetaminophen|acetaminophen|mesh-list
102006945|NCT03599089|Ketorolac|ketorolac|mesh-list
102006946|NCT03599089|Oxycodone|oxycodone|mesh-list
102006947|NCT03599089|Bupivacaine|bupivacaine|mesh-list
102006948|NCT03599089|Anesthetics, Local|anesthetics, local|mesh-ancestor
102006949|NCT03599089|Anesthetics|anesthetics|mesh-ancestor
102006950|NCT03599089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101511121|NCT00528983|Antimetabolites|antimetabolites|mesh-ancestor
102006951|NCT03599089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006952|NCT03599089|Sensory System Agents|sensory system agents|mesh-ancestor
101949251|NCT05774639|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101949252|NCT05774639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101949253|NCT05774639|Respiratory System Agents|respiratory system agents|mesh-ancestor
101949254|NCT05773365|Anesthetics|anesthetics|mesh-list
101949255|NCT05773365|Anesthetics, Local|anesthetics, local|mesh-list
102006953|NCT03599089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102006954|NCT03599089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102006955|NCT03599089|Analgesics|analgesics|mesh-ancestor
102006956|NCT03599089|Antipyretics|antipyretics|mesh-ancestor
102006957|NCT03599089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102006958|NCT03599089|Narcotics|narcotics|mesh-ancestor
102006959|NCT03599089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102006960|NCT03599089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102006961|NCT03599089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102006962|NCT03599089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102006963|NCT03599089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102006964|NCT03599089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006965|NCT03597529|Melatonin|melatonin|mesh-list
102006966|NCT03597529|Antioxidants|antioxidants|mesh-ancestor
102006967|NCT03597529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006968|NCT03597529|Protective Agents|protective agents|mesh-ancestor
102006982|NCT05420454|Pertuzumab|pertuzumab|mesh-list
102006983|NCT05420454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102006984|NCT05420454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102006985|NCT05420454|Tubulin Modulators|tubulin modulators|mesh-ancestor
102006986|NCT05420454|Antimitotic Agents|antimitotic agents|mesh-ancestor
102006987|NCT05420454|Mitosis Modulators|mitosis modulators|mesh-ancestor
102006988|NCT05420454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006989|NCT05420454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102006990|NCT05420454|Immunologic Factors|immunologic factors|mesh-ancestor
102006991|NCT05420454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006992|NCT05420454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102006993|NCT05420454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102006994|NCT05420454|Alkylating Agents|alkylating agents|mesh-ancestor
102006995|NCT05420454|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102006996|NCT05420454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101511386|NCT00531440|Everolimus|everolimus|mesh-list
102006997|NCT05420454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102006998|NCT05420454|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102006999|NCT05420454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102007000|NCT05420454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102007001|NCT03180528|Benzoic Acid|benzoic acid|mesh-list
102007002|NCT03180528|Antifungal Agents|antifungal agents|mesh-ancestor
102007003|NCT03180528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102007004|NCT04667507|Dexamethasone|dexamethasone|mesh-list
102007005|NCT04667507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102007006|NCT04667507|Antiemetics|antiemetics|mesh-ancestor
102007007|NCT04667507|Autonomic Agents|autonomic agents|mesh-ancestor
102007008|NCT04667507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101511509|NCT02943317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102007009|NCT04667507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511579|NCT02920827|Antiviral Agents|antiviral agents|mesh-ancestor
102007010|NCT04667507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102007011|NCT04667507|Glucocorticoids|glucocorticoids|mesh-ancestor
102007012|NCT04667507|Hormones|hormones|mesh-ancestor
102007013|NCT04667507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102007014|NCT04667507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102007015|NCT04667507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102007016|NCT01200251|Bimatoprost|bimatoprost|mesh-list
102007017|NCT01200251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102007018|NCT03597139|Cyclosporine|cyclosporine|mesh-list
102007019|NCT03597139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102007020|NCT03597139|Cyclosporins|cyclosporins|mesh-list
102007021|NCT03597139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101511731|NCT02916420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102007022|NCT03597139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007023|NCT03597139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102007024|NCT03597139|Immunologic Factors|immunologic factors|mesh-ancestor
102007025|NCT03597139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511811|NCT02919579|Esketamine|esketamine|mesh-list
102007026|NCT03597139|Antifungal Agents|antifungal agents|mesh-ancestor
102007027|NCT03597139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102007028|NCT03597139|Dermatologic Agents|dermatologic agents|mesh-ancestor
102007029|NCT03597139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102007030|NCT03597139|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101949256|NCT05773365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101949257|NCT05773365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007031|NCT03597139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102007032|NCT01202435|Pregabalin|pregabalin|mesh-list
102007036|NCT01202435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007037|NCT01202435|Anticonvulsants|anticonvulsants|mesh-ancestor
102007038|NCT01202435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102007039|NCT01202435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102007040|NCT01202435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007041|NCT01202435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102007042|NCT01202435|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102007043|NCT01202435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102007044|NCT01202435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102007045|NCT01202435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102007046|NCT05406102|Propofol|propofol|mesh-list
102007047|NCT05406102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102007048|NCT05406102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102007049|NCT05406102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007050|NCT05406102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102007051|NCT05406102|Anesthetics, General|anesthetics, general|mesh-ancestor
101726820|NCT00922844|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102007052|NCT05406102|Anesthetics|anesthetics|mesh-ancestor
102007053|NCT01204307|Cisplatin|cisplatin|mesh-list
102007054|NCT01204307|Docetaxel|docetaxel|mesh-list
102007055|NCT01204307|Pemetrexed|pemetrexed|mesh-list
102007056|NCT01204307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102007057|NCT01204307|Tubulin Modulators|tubulin modulators|mesh-ancestor
102007058|NCT01204307|Antimitotic Agents|antimitotic agents|mesh-ancestor
102007059|NCT01204307|Mitosis Modulators|mitosis modulators|mesh-ancestor
102007060|NCT01204307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007061|NCT01204307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102007062|NCT01204307|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102007063|NCT01204307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102007064|NCT00708214|Letrozole|letrozole|mesh-list
102007065|NCT00708214|Afatinib|afatinib|mesh-list
102007066|NCT00708214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102007067|NCT00708214|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102007068|NCT00708214|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102007069|NCT00708214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102007070|NCT00708214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007071|NCT00708214|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102007072|NCT00708214|Hormone Antagonists|hormone antagonists|mesh-ancestor
102007073|NCT00708214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102007074|NCT00708214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007075|NCT00708214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102007076|NCT02506894|Magnesium Sulfate|magnesium sulfate|mesh-list
102007077|NCT02506894|Analgesics|analgesics|mesh-ancestor
102007078|NCT02506894|Sensory System Agents|sensory system agents|mesh-ancestor
102007079|NCT02506894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102007080|NCT02506894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007081|NCT02506894|Anesthetics|anesthetics|mesh-ancestor
102007082|NCT02506894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101512551|NCT02912637|Xenon|xenon|mesh-list
102007083|NCT02506894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102007084|NCT02506894|Anticonvulsants|anticonvulsants|mesh-ancestor
102007085|NCT02506894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102007086|NCT02506894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102007087|NCT02506894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007088|NCT02506894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102007089|NCT02506894|Tocolytic Agents|tocolytic agents|mesh-ancestor
102007090|NCT02506894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102007091|NCT03909737|Azithromycin|azithromycin|mesh-list
102007092|NCT03909737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102007093|NCT03909737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102007094|NCT04891250|Ivermectin|ivermectin|mesh-list
102007095|NCT04891250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102007096|NCT04891250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102007097|NCT03570697|Evolocumab|evolocumab|mesh-list
102007098|NCT03570697|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102007099|NCT03570697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102007100|NCT03570697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102007101|NCT03570697|Antimetabolites|antimetabolites|mesh-ancestor
101949259|NCT05773365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101269023|NCT01811459|Autonomic Agents|autonomic agents|mesh-ancestor
102007102|NCT03570697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007103|NCT03570697|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102007107|NCT02511574|Progesterone|progesterone|mesh-list
102007108|NCT02511574|Progestins|progestins|mesh-ancestor
102007109|NCT02511574|Hormones|hormones|mesh-ancestor
102007110|NCT02511574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102007111|NCT02511574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007112|NCT01200641|Gabapentin|gabapentin|mesh-list
102007113|NCT01200641|Melatonin|melatonin|mesh-list
102007114|NCT01200641|Analgesics|analgesics|mesh-ancestor
102007115|NCT01200641|Sensory System Agents|sensory system agents|mesh-ancestor
102007116|NCT01200641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102007117|NCT01200641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007118|NCT01200641|Anticonvulsants|anticonvulsants|mesh-ancestor
102007119|NCT01200641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102007120|NCT01200641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102007121|NCT01200641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102007122|NCT01200641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102007123|NCT01200641|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102007124|NCT01200641|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102007125|NCT01200641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102007126|NCT01200641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007127|NCT01200641|Antimanic Agents|antimanic agents|mesh-ancestor
102007128|NCT01200641|Antioxidants|antioxidants|mesh-ancestor
102007130|NCT01856270|Amitriptyline|amitriptyline|mesh-list
102007131|NCT01856270|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102007132|NCT01856270|Antidepressive Agents|antidepressive agents|mesh-ancestor
102007133|NCT01856270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102007134|NCT01856270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102007135|NCT01856270|Analgesics|analgesics|mesh-ancestor
102007136|NCT01856270|Sensory System Agents|sensory system agents|mesh-ancestor
102007137|NCT01856270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102007138|NCT01856270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007139|NCT01856270|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102007140|NCT01856270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102007141|NCT01856270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102007142|NCT01856270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007143|NCT01856270|Adrenergic Agents|adrenergic agents|mesh-ancestor
102007144|NCT01856270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102007145|NCT02511340|Flumatinib|flumatinib|mesh-list
102007146|NCT02511340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102007147|NCT02511340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102007148|NCT02511340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007149|NCT02506348|Diclofenac|diclofenac|mesh-list
102007150|NCT02506348|Nepafenac|nepafenac|mesh-list
102007151|NCT02506348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102007152|NCT02506348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102007153|NCT02506348|Analgesics|analgesics|mesh-ancestor
102007154|NCT02506348|Sensory System Agents|sensory system agents|mesh-ancestor
102007155|NCT02506348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102007156|NCT02506348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007157|NCT02506348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102007158|NCT02506348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102007159|NCT02506348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102007160|NCT02506348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102007161|NCT02506348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007162|NCT01318070|Pioglitazone|pioglitazone|mesh-list
102007163|NCT01318070|Alogliptin|alogliptin|mesh-list
102007164|NCT01318070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102007165|NCT01318070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007166|NCT01318070|Incretins|incretins|mesh-ancestor
102007167|NCT01318070|Hormones|hormones|mesh-ancestor
102007168|NCT01318070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102007169|NCT01318070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102007170|NCT01318070|Protease Inhibitors|protease inhibitors|mesh-ancestor
102007171|NCT01318070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102007172|NCT01318070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007173|NCT01202513|Bimatoprost|bimatoprost|mesh-list
102007174|NCT01202513|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102007175|NCT01202513|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102007176|NCT01202513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102007179|NCT03835715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102007180|NCT03835715|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102007181|NCT03835715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102007182|NCT03835715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102007183|NCT03835715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007184|NCT03835715|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102007185|NCT03835715|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101513079|NCT02934204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102007186|NCT03835715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102007187|NCT03835715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007188|NCT03835715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102007189|NCT03835715|Serotonin Agents|serotonin agents|mesh-ancestor
102007190|NCT03835715|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102007191|NCT03835715|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102007192|NCT03835715|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102007193|NCT03835715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102007194|NCT02505802|Botulinum Toxins|botulinum toxins|mesh-list
102007195|NCT02505802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102007196|NCT02505802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102007197|NCT02505802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102007198|NCT02505802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007199|NCT02505802|Cholinergic Agents|cholinergic agents|mesh-ancestor
101726981|NCT00703898|Nevirapine|nevirapine|mesh-list
102007200|NCT02505802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102007201|NCT02505802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007202|NCT02505802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102007203|NCT02505802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102007204|NCT03627884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102007206|NCT03843281|Morphine|morphine|mesh-list
102007207|NCT03843281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102007208|NCT03843281|Narcotics|narcotics|mesh-ancestor
101513357|NCT01283542|Hormones|hormones|mesh-ancestor
102007209|NCT03843281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102007210|NCT03843281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007211|NCT03843281|Analgesics|analgesics|mesh-ancestor
102007212|NCT03843281|Sensory System Agents|sensory system agents|mesh-ancestor
102007213|NCT03843281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102007214|NCT03843281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102007215|NCT03843281|Antipyretics|antipyretics|mesh-ancestor
102007216|NCT02515240|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102007217|NCT02515240|Immunologic Factors|immunologic factors|mesh-ancestor
102007218|NCT02515240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007219|NCT03843515|Nivolumab|nivolumab|mesh-list
102007220|NCT03843515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102007221|NCT03843515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102007222|NCT03843515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101513499|NCT01281865|Everolimus|everolimus|mesh-list
102007223|NCT03843515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007224|NCT00245960|Etanercept|etanercept|mesh-list
102007225|NCT00245960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102007226|NCT00245960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102007227|NCT00245960|Analgesics|analgesics|mesh-ancestor
102007228|NCT00245960|Sensory System Agents|sensory system agents|mesh-ancestor
102007229|NCT00245960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102007230|NCT00245960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007231|NCT00245960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102007232|NCT00245960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102007233|NCT00245960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102007234|NCT00245960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102007235|NCT00245960|Immunologic Factors|immunologic factors|mesh-ancestor
102007236|NCT04443322|Durvalumab|durvalumab|mesh-list
102007237|NCT04443322|Lenvatinib|lenvatinib|mesh-list
102007238|NCT04443322|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102007239|NCT04443322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102007240|NCT04443322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102007241|NCT04443322|Immunologic Factors|immunologic factors|mesh-ancestor
102007242|NCT04443322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007243|NCT04443322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102007244|NCT04443322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101949265|NCT05685004|Temozolomide|temozolomide|mesh-list
101949266|NCT05685004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101949267|NCT05685004|Alkylating Agents|alkylating agents|mesh-ancestor
101269170|NCT01812551|Alendronate|alendronate|mesh-list
102007245|NCT04443322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007246|NCT01202825|Simeprevir|simeprevir|mesh-list
102007247|NCT01202825|Antiviral Agents|antiviral agents|mesh-ancestor
101513772|NCT02918825|Autonomic Agents|autonomic agents|mesh-ancestor
102007248|NCT01202825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102007253|NCT02510872|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102007254|NCT02510872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007255|NCT05222204|Paclitaxel|paclitaxel|mesh-list
102007256|NCT05222204|Gemcitabine|gemcitabine|mesh-list
102007257|NCT05222204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102007258|NCT05222204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102007259|NCT05222204|Tubulin Modulators|tubulin modulators|mesh-ancestor
102007260|NCT05222204|Antimitotic Agents|antimitotic agents|mesh-ancestor
102007261|NCT05222204|Mitosis Modulators|mitosis modulators|mesh-ancestor
102007262|NCT05222204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007263|NCT05222204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102007264|NCT05222204|Antimetabolites|antimetabolites|mesh-ancestor
102007265|NCT02558465|Rivaroxaban|rivaroxaban|mesh-list
102007266|NCT02558465|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102007267|NCT02558465|Antithrombins|antithrombins|mesh-ancestor
102007268|NCT02558465|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102007269|NCT02558465|Protease Inhibitors|protease inhibitors|mesh-ancestor
102007270|NCT02558465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102007271|NCT02558465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007272|NCT02558465|Anticoagulants|anticoagulants|mesh-ancestor
102007273|NCT05218616|Sunitinib|sunitinib|mesh-list
102007274|NCT05218616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102007275|NCT05218616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102007276|NCT05218616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102007277|NCT05218616|Growth Substances|growth substances|mesh-ancestor
102007278|NCT05218616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007279|NCT05218616|Growth Inhibitors|growth inhibitors|mesh-ancestor
102007280|NCT05218616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102007281|NCT05218616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102007282|NCT05218616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007283|NCT02505880|Anesthetics|anesthetics|mesh-list
102007284|NCT02505880|Anesthetics, Local|anesthetics, local|mesh-list
102007285|NCT02505880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101513977|NCT05321316|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102007286|NCT02505880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007287|NCT02505880|Sensory System Agents|sensory system agents|mesh-ancestor
102007288|NCT02505880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102007289|NCT02510950|Temozolomide|temozolomide|mesh-list
102007290|NCT02510950|Poly ICLC|poly iclc|mesh-list
102007291|NCT02510950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102007292|NCT02510950|Alkylating Agents|alkylating agents|mesh-ancestor
102007293|NCT02510950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007294|NCT02510950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102007295|NCT02510950|Interferon Inducers|interferon inducers|mesh-ancestor
102007296|NCT02510950|Immunologic Factors|immunologic factors|mesh-ancestor
102007297|NCT02510950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007298|NCT05221736|Ethanol|ethanol|mesh-list
101514184|NCT00532857|Paclitaxel|paclitaxel|mesh-list
102007299|NCT05221736|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102007300|NCT05221736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102007301|NCT05221736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102007302|NCT05221736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007303|NCT02514850|Insulin Lispro|insulin lispro|mesh-list
102007304|NCT02514850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102007305|NCT02514850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007306|NCT04454411|Naltrexone|naltrexone|mesh-list
102007307|NCT04454411|Buprenorphine|buprenorphine|mesh-list
102007308|NCT04454411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102007309|NCT04454411|Narcotics|narcotics|mesh-ancestor
102007310|NCT04454411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102007311|NCT04454411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007312|NCT04454411|Analgesics|analgesics|mesh-ancestor
101949268|NCT05685004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949269|NCT05685004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949270|NCT05683223|Sertraline|sertraline|mesh-list
101949271|NCT05683223|Antidepressive Agents|antidepressive agents|mesh-ancestor
101949272|NCT05683223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101949273|NCT05683223|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102007313|NCT04454411|Sensory System Agents|sensory system agents|mesh-ancestor
102007314|NCT04454411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102007315|NCT04454411|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102007316|NCT04454411|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102007317|NCT02505568|Infliximab|infliximab|mesh-list
102007318|NCT02505568|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102007319|NCT02505568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102007331|NCT05217836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102007332|NCT05217836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007333|NCT05217836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102007335|NCT05217836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102007336|NCT02510248|1-2-isopropoxy-2-oxidodihydro-4H,6H-spiro(furo(3,2-d)(1,3,2)dioxaphosphinine-7,2'-oxetan)-6-yl)pyrimidine-2,4(1H,3H)-dione|1-2-isopropoxy-2-oxidodihydro-4h,6h-spiro(furo(3,2-d)(1,3,2)dioxaphosphinine-7,2'-oxetan)-6-yl)pyrimidine-2,4(1h,3h)-dione|mesh-list
101514596|NCT04885686|Thymol|thymol|mesh-list
102007337|NCT02510248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102007338|NCT02510248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007339|NCT02514538|Acetaminophen|acetaminophen|mesh-list
102007340|NCT02514538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102007341|NCT02514538|Analgesics|analgesics|mesh-ancestor
102007342|NCT02514538|Sensory System Agents|sensory system agents|mesh-ancestor
102007343|NCT02514538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101514609|NCT04885686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102007344|NCT02514538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007345|NCT02514538|Antipyretics|antipyretics|mesh-ancestor
102007346|NCT05669417|Magnesium Sulfate|magnesium sulfate|mesh-list
102007347|NCT05669417|Analgesics|analgesics|mesh-ancestor
102007348|NCT05669417|Sensory System Agents|sensory system agents|mesh-ancestor
102007349|NCT05669417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102007350|NCT05669417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007352|NCT05669417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101514685|NCT05470166|Anesthetics|anesthetics|mesh-ancestor
102007353|NCT05669417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102007354|NCT05669417|Anticonvulsants|anticonvulsants|mesh-ancestor
102007355|NCT05669417|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102007356|NCT05669417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101514754|NCT05469113|Repaglinide|repaglinide|mesh-list
102007357|NCT05669417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007358|NCT05669417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102007359|NCT05669417|Tocolytic Agents|tocolytic agents|mesh-ancestor
102007360|NCT05669417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102007361|NCT03832673|Pembrolizumab|pembrolizumab|mesh-list
102007362|NCT03832673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102007363|NCT03832673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102007364|NCT03832673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102007365|NCT03832673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007366|NCT02504944|Propranolol|propranolol|mesh-list
102007367|NCT02504944|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102007368|NCT02504944|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102007369|NCT02504944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102007370|NCT02504944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102007371|NCT02504944|Adrenergic Agents|adrenergic agents|mesh-ancestor
102007372|NCT02504944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102007373|NCT02504944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007374|NCT02504944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007375|NCT02504944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102007376|NCT02504944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102007377|NCT02504944|Vasodilator Agents|vasodilator agents|mesh-ancestor
102007378|NCT01201499|Morphine|morphine|mesh-list
102007379|NCT01201499|Remifentanil|remifentanil|mesh-list
102007380|NCT01201499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102007381|NCT01201499|Narcotics|narcotics|mesh-ancestor
101462366|NCT00236457|Dopamine Agents|dopamine agents|mesh-ancestor
102007384|NCT01201499|Analgesics|analgesics|mesh-ancestor
102007385|NCT01201499|Sensory System Agents|sensory system agents|mesh-ancestor
102007386|NCT01201499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101949274|NCT05683223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101949275|NCT05683223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101269310|NCT01813552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102007387|NCT03473639|Capecitabine|capecitabine|mesh-list
102007388|NCT03473639|Entinostat|entinostat|mesh-list
102007389|NCT03473639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102007390|NCT03473639|Antimetabolites|antimetabolites|mesh-ancestor
102007391|NCT03473639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007392|NCT03473639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102007393|NCT03473639|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102007394|NCT03473639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102007395|NCT03121690|Prednisone|prednisone|mesh-list
102007396|NCT03121690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102007397|NCT03121690|Glucocorticoids|glucocorticoids|mesh-ancestor
102007398|NCT03121690|Hormones|hormones|mesh-ancestor
102007399|NCT03121690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102007400|NCT03121690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007401|NCT03121690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102007402|NCT03121690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102007403|NCT03831269|Azithromycin|azithromycin|mesh-list
102007404|NCT03831269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102007405|NCT03831269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102007406|NCT02504476|Midazolam|midazolam|mesh-list
102007407|NCT02504476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102007408|NCT02504476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102007409|NCT02504476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102007410|NCT02504476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007411|NCT02504476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102007412|NCT02504476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102007413|NCT02504476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102007414|NCT02504476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102007415|NCT02504476|Anesthetics, General|anesthetics, general|mesh-ancestor
102007416|NCT02504476|Anesthetics|anesthetics|mesh-ancestor
102007417|NCT02504476|GABA Modulators|gaba modulators|mesh-ancestor
102007418|NCT02504476|GABA Agents|gaba agents|mesh-ancestor
102007419|NCT02504476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101515177|NCT00598858|Hormones|hormones|mesh-ancestor
102007420|NCT02504476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007421|NCT02504398|Methamphetamine|methamphetamine|mesh-list
102007422|NCT02504398|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102007424|NCT02504398|Sympathomimetics|sympathomimetics|mesh-ancestor
102007425|NCT02504398|Autonomic Agents|autonomic agents|mesh-ancestor
102007426|NCT02504398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102007427|NCT02504398|Dopamine Agents|dopamine agents|mesh-ancestor
102007428|NCT02504398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102007429|NCT02504398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007430|NCT02504398|Adrenergic Agents|adrenergic agents|mesh-ancestor
102007431|NCT02504398|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102007432|NCT02504398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102007433|NCT02504398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102007434|NCT02504398|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102007435|NCT01205009|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102007436|NCT01205009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102007437|NCT01205009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007438|NCT03830489|Ascorbic Acid|ascorbic acid|mesh-list
102007439|NCT03830489|Antioxidants|antioxidants|mesh-ancestor
102007440|NCT03830489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007441|NCT03830489|Protective Agents|protective agents|mesh-ancestor
102007442|NCT03830489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007443|NCT03830489|Vitamins|vitamins|mesh-ancestor
102007444|NCT03830489|Micronutrients|micronutrients|mesh-ancestor
102007445|NCT02509468|Sirolimus|sirolimus|mesh-list
102007446|NCT02509468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102007447|NCT02509468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102007448|NCT02509468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102007449|NCT02509468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102007450|NCT02509468|Antifungal Agents|antifungal agents|mesh-ancestor
102007451|NCT02509468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102007452|NCT02509468|Immunologic Factors|immunologic factors|mesh-ancestor
102007453|NCT02509468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007454|NCT03344614|Apatinib|apatinib|mesh-list
102007455|NCT03344614|Raltitrexed|raltitrexed|mesh-list
102007457|NCT03344614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101949276|NCT05683223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949277|NCT05683223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102007458|NCT03344614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102007459|NCT03344614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515213|NCT02909478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102007460|NCT03344614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102007461|NCT03344614|Antimetabolites|antimetabolites|mesh-ancestor
102007462|NCT03344614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102007464|NCT01205087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102007465|NCT01205087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102007466|NCT01205087|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102007467|NCT01205087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102007468|NCT01205087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007469|NCT01205243|Abacavir|abacavir|mesh-list
102007470|NCT01205243|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102007471|NCT01205243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102007472|NCT01205243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102007473|NCT01205243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007474|NCT01205243|Antiviral Agents|antiviral agents|mesh-ancestor
102007475|NCT01205243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102007476|NCT01205243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102007477|NCT01205243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102007478|NCT02504164|Midazolam|midazolam|mesh-list
102007479|NCT02504164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102007480|NCT02504164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102007481|NCT02504164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102007482|NCT02504164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007483|NCT02504164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102007484|NCT02504164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102007485|NCT02504164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102007486|NCT02504164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102007487|NCT02504164|Anesthetics, General|anesthetics, general|mesh-ancestor
102007488|NCT02504164|Anesthetics|anesthetics|mesh-ancestor
102007489|NCT02504164|GABA Modulators|gaba modulators|mesh-ancestor
102007490|NCT02504164|GABA Agents|gaba agents|mesh-ancestor
102007491|NCT02504164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101515299|NCT05469984|Ampicillin|ampicillin|mesh-list
102007492|NCT02504164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007493|NCT02509234|Irinotecan|irinotecan|mesh-list
102007494|NCT02509234|Trabectedin|trabectedin|mesh-list
102007495|NCT02509234|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102007496|NCT02509234|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102007497|NCT02509234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101515365|NCT00537251|Insulin Glargine|insulin glargine|mesh-list
102007498|NCT02509234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007499|NCT02509234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102007500|NCT02509234|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102007501|NCT02509234|Alkylating Agents|alkylating agents|mesh-ancestor
102007502|NCT01205321|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
102007504|NCT01205321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102007505|NCT01205321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007506|NCT01205321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515436|NCT00537524|Vaccines|vaccines|mesh-list
102007507|NCT01205321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102007508|NCT02504008|Zoledronic Acid|zoledronic acid|mesh-list
102007509|NCT02504008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102007510|NCT02504008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007511|NCT03566485|Atezolizumab|atezolizumab|mesh-list
102007512|NCT03566485|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102007513|NCT03566485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007514|NCT03566485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102007515|NCT03566485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102007516|NCT02513290|Loratadine|loratadine|mesh-list
102007517|NCT02513290|Antipruritics|antipruritics|mesh-ancestor
102007518|NCT02513290|Dermatologic Agents|dermatologic agents|mesh-ancestor
102007519|NCT02513290|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102007520|NCT02513290|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102007521|NCT02513290|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102007522|NCT02513290|Histamine Antagonists|histamine antagonists|mesh-ancestor
102007523|NCT02513290|Histamine Agents|histamine agents|mesh-ancestor
102007524|NCT02513290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102007525|NCT02513290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007526|NCT02513290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007527|NCT02501200|Ezetimibe|ezetimibe|mesh-list
101949278|NCT05683223|Serotonin Agents|serotonin agents|mesh-ancestor
101949279|NCT05683223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949280|NCT05678673|Nivolumab|nivolumab|mesh-list
101949281|NCT05678673|Sunitinib|sunitinib|mesh-list
101949282|NCT05678673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102007528|NCT02501200|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102007529|NCT02501200|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102007536|NCT02501278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102007537|NCT03176238|Everolimus|everolimus|mesh-list
102007538|NCT03176238|Exemestane|exemestane|mesh-list
102007539|NCT03176238|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102007540|NCT03176238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102007541|NCT03176238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102007542|NCT03176238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007543|NCT03176238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102007544|NCT03176238|Immunologic Factors|immunologic factors|mesh-ancestor
102007545|NCT03176238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007546|NCT03176238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102007547|NCT03176238|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102007548|NCT03176238|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102007549|NCT03176238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102007550|NCT03176238|Hormone Antagonists|hormone antagonists|mesh-ancestor
102007551|NCT03176238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102007552|NCT01957332|Trastuzumab|trastuzumab|mesh-list
102007553|NCT01957332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102007554|NCT01957332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102007555|NCT01205711|Leucovorin|leucovorin|mesh-list
102007556|NCT01205711|Fluorouracil|fluorouracil|mesh-list
102007557|NCT01205711|Irinotecan|irinotecan|mesh-list
102007558|NCT01205711|Calcium|calcium|mesh-list
102007559|NCT01205711|Levoleucovorin|levoleucovorin|mesh-list
102007560|NCT01205711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102007561|NCT01205711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007562|NCT01205711|Antimetabolites|antimetabolites|mesh-ancestor
102007563|NCT01205711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007564|NCT01205711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102007565|NCT01205711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102007566|NCT01205711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102007567|NCT01205711|Immunologic Factors|immunologic factors|mesh-ancestor
102007568|NCT01205711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102007569|NCT01205711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102007570|NCT01205711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102007571|NCT01205711|Antidotes|antidotes|mesh-ancestor
102007573|NCT01205711|Vitamin B Complex|vitamin b complex|mesh-ancestor
102007574|NCT01205711|Vitamins|vitamins|mesh-ancestor
102007575|NCT01205711|Micronutrients|micronutrients|mesh-ancestor
102007576|NCT02508922|Vitamin D|vitamin d|mesh-list
102007577|NCT02508922|Cholecalciferol|cholecalciferol|mesh-list
102007578|NCT02508922|Vitamins|vitamins|mesh-ancestor
102007579|NCT02508922|Micronutrients|micronutrients|mesh-ancestor
102007580|NCT02508922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007581|NCT02508922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102007582|NCT02508922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102007583|NCT01860456|Imatinib Mesylate|imatinib mesylate|mesh-list
102007584|NCT01860456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102007585|NCT01860456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102007586|NCT01860456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102007587|NCT01860456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007588|NCT03730675|Sorafenib|sorafenib|mesh-list
102007589|NCT03730675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102007590|NCT03730675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102007591|NCT03730675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102007592|NCT03730675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007593|NCT01765140|Amifampridine|amifampridine|mesh-list
102007594|NCT01765140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102007595|NCT01765140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102007596|NCT01765140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007597|NCT01765140|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102007598|NCT01765140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102007599|NCT01765140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007602|NCT01345682|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101949283|NCT05678673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949284|NCT05678673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101949285|NCT05678673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007604|NCT01345682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102007605|NCT01345682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007606|NCT01345682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102007607|NCT01345682|Antimetabolites|antimetabolites|mesh-ancestor
102007608|NCT01345682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007609|NCT01345682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102007610|NCT01345682|Dermatologic Agents|dermatologic agents|mesh-ancestor
102007611|NCT01345682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102007612|NCT01345682|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102007613|NCT01345682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102007614|NCT01345682|Immunologic Factors|immunologic factors|mesh-ancestor
102007615|NCT01345682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102007616|NCT01345682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102007617|NCT01345682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102007618|NCT03562117|Gepotidacin|gepotidacin|mesh-list
102007619|NCT03562117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102007620|NCT03562117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102007621|NCT03562117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007622|NCT03562117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102007623|NCT02503462|Ritonavir|ritonavir|mesh-list
102007624|NCT02503462|Darunavir|darunavir|mesh-list
102007625|NCT02503462|Cobicistat|cobicistat|mesh-list
102007626|NCT02503462|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102007627|NCT02503462|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102007628|NCT02503462|Protease Inhibitors|protease inhibitors|mesh-ancestor
102007629|NCT02503462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102007630|NCT02503462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007631|NCT02503462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102007632|NCT02503462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102007633|NCT02503462|Antiviral Agents|antiviral agents|mesh-ancestor
102007634|NCT02503462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102007635|NCT02503462|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102007636|NCT02503462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102007637|NCT03343678|Venetoclax|venetoclax|mesh-list
102007638|NCT03343678|BI 836826|bi 836826|mesh-list
102007639|NCT03343678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102007640|NCT03343678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102007641|NCT05216822|Racecadotril|racecadotril|mesh-list
102007642|NCT05216822|Antidiarrheals|antidiarrheals|mesh-ancestor
101727419|NCT00708344|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102007643|NCT05216822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102007644|NCT05216822|Protease Inhibitors|protease inhibitors|mesh-ancestor
102007645|NCT05216822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102007646|NCT05216822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007647|NCT04498936|Sofosbuvir|sofosbuvir|mesh-list
102007648|NCT04498936|Ledipasvir|ledipasvir|mesh-list
102007649|NCT04498936|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102007650|NCT04498936|Nitazoxanide|nitazoxanide|mesh-list
102007651|NCT04498936|Antiviral Agents|antiviral agents|mesh-ancestor
102007652|NCT04498936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102007653|NCT04498936|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102007654|NCT03627260|Sunscreening Agents|sunscreening agents|mesh-list
102007655|NCT03627260|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102007656|NCT03627260|Protective Agents|protective agents|mesh-ancestor
102007657|NCT03627260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007658|NCT03627260|Dermatologic Agents|dermatologic agents|mesh-ancestor
102007659|NCT05706038|Adalimumab|adalimumab|mesh-list
102007660|NCT05706038|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102007661|NCT05706038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102007662|NCT05706038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102007663|NCT03546907|Cholinergic Agents|cholinergic agents|mesh-list
102007664|NCT03546907|Muscarinic Agonists|muscarinic agonists|mesh-list
102007665|NCT03546907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102007666|NCT03546907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007667|NCT03546907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007668|NCT03546907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102007669|NCT05126264|Ibuprofen|ibuprofen|mesh-list
102007670|NCT05126264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102007671|NCT05126264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101949286|NCT05678673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101949287|NCT05678673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101949288|NCT05678673|Growth Substances|growth substances|mesh-ancestor
101949289|NCT05678673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949290|NCT05678673|Growth Inhibitors|growth inhibitors|mesh-ancestor
102007672|NCT05126264|Analgesics|analgesics|mesh-ancestor
102007676|NCT05126264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102007677|NCT05126264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102007678|NCT05126264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102007679|NCT05126264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102007680|NCT05126264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007681|NCT03001817|Fenofibrate|fenofibrate|mesh-list
102007682|NCT03001817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102007683|NCT03001817|Antimetabolites|antimetabolites|mesh-ancestor
102007684|NCT03001817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007685|NCT03001817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102007686|NCT02502682|Chlorhexidine|chlorhexidine|mesh-list
102007687|NCT02502682|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102007688|NCT02502682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102007689|NCT02502682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102007690|NCT02502682|Disinfectants|disinfectants|mesh-ancestor
102007691|NCT02502682|Dermatologic Agents|dermatologic agents|mesh-ancestor
102007692|NCT03590743|Apixaban|apixaban|mesh-list
102007693|NCT03590743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102007694|NCT03590743|Antithrombins|antithrombins|mesh-ancestor
102007695|NCT03590743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102007696|NCT03590743|Protease Inhibitors|protease inhibitors|mesh-ancestor
102007697|NCT03590743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102007698|NCT03590743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007699|NCT03590743|Anticoagulants|anticoagulants|mesh-ancestor
102007700|NCT03343600|Imatinib Mesylate|imatinib mesylate|mesh-list
102007701|NCT03343600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102007702|NCT03343600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102007703|NCT03343600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102007704|NCT03343600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007705|NCT03589885|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102007706|NCT03589885|Immunologic Factors|immunologic factors|mesh-ancestor
102007707|NCT03589885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007708|NCT03121222|Acetylcysteine|acetylcysteine|mesh-list
102007709|NCT03121222|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102007710|NCT03121222|Antiviral Agents|antiviral agents|mesh-ancestor
102007711|NCT03121222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102007712|NCT03121222|Expectorants|expectorants|mesh-ancestor
102007713|NCT03121222|Respiratory System Agents|respiratory system agents|mesh-ancestor
102007714|NCT03121222|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102007715|NCT03121222|Antioxidants|antioxidants|mesh-ancestor
102007716|NCT03121222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007717|NCT03121222|Protective Agents|protective agents|mesh-ancestor
102007718|NCT03121222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007719|NCT03121222|Antidotes|antidotes|mesh-ancestor
102007720|NCT03639493|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
102007721|NCT03639493|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102007722|NCT03639493|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102007724|NCT03639493|Antimetabolites|antimetabolites|mesh-ancestor
102007725|NCT03639493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007726|NCT03639493|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102007727|NCT03639493|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102007728|NCT03639493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102007729|NCT03639493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102007730|NCT03344302|Oxytocin|oxytocin|mesh-list
102007731|NCT03344302|Oxytocics|oxytocics|mesh-ancestor
102007732|NCT03344302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102007733|NCT03344302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007734|NCT03545503|Ketamine|ketamine|mesh-list
102007735|NCT03545503|Etomidate|etomidate|mesh-list
102007736|NCT03545503|Analgesics|analgesics|mesh-ancestor
102007737|NCT03545503|Sensory System Agents|sensory system agents|mesh-ancestor
102007738|NCT03545503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102007739|NCT03545503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007740|NCT03545503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102007741|NCT03545503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101949291|NCT05678673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101949292|NCT05678673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102007742|NCT03545503|Anesthetics, General|anesthetics, general|mesh-ancestor
102007743|NCT03545503|Anesthetics|anesthetics|mesh-ancestor
102007744|NCT03545503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101462716|NCT00177307|Growth Substances|growth substances|mesh-ancestor
102007750|NCT01297829|Ibuprofen|ibuprofen|mesh-list
102007751|NCT01297829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102007752|NCT01297829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102007753|NCT01297829|Analgesics|analgesics|mesh-ancestor
102007754|NCT01297829|Sensory System Agents|sensory system agents|mesh-ancestor
102007755|NCT01297829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102007756|NCT01297829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007757|NCT01297829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102007758|NCT01297829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102007759|NCT01297829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102007760|NCT01297829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102007761|NCT01297829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007762|NCT03829943|Vitamin D|vitamin d|mesh-list
102007763|NCT03829943|Vitamins|vitamins|mesh-ancestor
102007764|NCT03829943|Micronutrients|micronutrients|mesh-ancestor
102007765|NCT03829943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007766|NCT03829943|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102007767|NCT02508142|Scopolamine|scopolamine|mesh-list
102007768|NCT02508142|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102007769|NCT02508142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102007770|NCT02508142|Antiemetics|antiemetics|mesh-ancestor
102007771|NCT02508142|Autonomic Agents|autonomic agents|mesh-ancestor
102007772|NCT02508142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102007773|NCT02508142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007774|NCT02508142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102007775|NCT02508142|Mydriatics|mydriatics|mesh-ancestor
102007776|NCT02508142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102007777|NCT02508142|Cholinergic Agents|cholinergic agents|mesh-ancestor
102007778|NCT02508142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102007779|NCT02508142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007780|NCT02508142|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102007781|NCT02508142|Parasympatholytics|parasympatholytics|mesh-ancestor
102007782|NCT02508220|Oxytocin|oxytocin|mesh-list
102007783|NCT02508220|Oxytocics|oxytocics|mesh-ancestor
102007784|NCT02508220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102007785|NCT02508220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007786|NCT01297907|Methacholine Chloride|methacholine chloride|mesh-list
102007787|NCT01297907|Miotics|miotics|mesh-ancestor
102007788|NCT01297907|Autonomic Agents|autonomic agents|mesh-ancestor
102007789|NCT01297907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102007790|NCT01297907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007791|NCT01297907|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102007792|NCT01297907|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
102007793|NCT01297907|Respiratory System Agents|respiratory system agents|mesh-ancestor
102007794|NCT01297907|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102007795|NCT01297907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102007796|NCT01297907|Cholinergic Agents|cholinergic agents|mesh-ancestor
102007797|NCT01297907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102007798|NCT01297907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007799|NCT02508064|Fostemsavir|fostemsavir|mesh-list
102007800|NCT02508064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101516338|NCT01244620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102007801|NCT02508064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102007802|NCT02508064|Antiviral Agents|antiviral agents|mesh-ancestor
102007803|NCT02508064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102007804|NCT02508064|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102007805|NCT02508064|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102007806|NCT02508064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007807|NCT05705570|Cyclophosphamide|cyclophosphamide|mesh-list
102007808|NCT05705570|Fludarabine|fludarabine|mesh-list
102007809|NCT05705570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102007810|NCT05705570|Immunologic Factors|immunologic factors|mesh-ancestor
102007811|NCT05705570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007812|NCT05705570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101462787|NCT00200447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102007816|NCT05705570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102007817|NCT05705570|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102007818|NCT05670236|Lidocaine|lidocaine|mesh-list
102007819|NCT05670236|Anesthetics, Local|anesthetics, local|mesh-ancestor
102007820|NCT05670236|Anesthetics|anesthetics|mesh-ancestor
102007821|NCT05670236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101516403|NCT03736616|Carboplatin|carboplatin|mesh-list
102007822|NCT05670236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007823|NCT05670236|Sensory System Agents|sensory system agents|mesh-ancestor
102007824|NCT05670236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102007825|NCT05670236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102007826|NCT05670236|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102007827|NCT05670236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102007828|NCT05670236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102007829|NCT05670236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007830|NCT03214380|Insulin|insulin|mesh-list
102007831|NCT03214380|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102007832|NCT03214380|Metformin|metformin|mesh-list
102007833|NCT03214380|Insulin Glargine|insulin glargine|mesh-list
102007834|NCT03214380|Insulin Lispro|insulin lispro|mesh-list
102007835|NCT03214380|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102007836|NCT03214380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102007837|NCT03214380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007838|NCT03214380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007839|NCT04498234|Bupivacaine|bupivacaine|mesh-list
102007840|NCT04498234|Anesthetics, Local|anesthetics, local|mesh-ancestor
102007841|NCT04498234|Anesthetics|anesthetics|mesh-ancestor
102007842|NCT04498234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102007843|NCT04498234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007844|NCT04498234|Sensory System Agents|sensory system agents|mesh-ancestor
102007845|NCT04498234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102007846|NCT03343444|Sofosbuvir|sofosbuvir|mesh-list
102007847|NCT03343444|Ledipasvir|ledipasvir|mesh-list
102007848|NCT03343444|Antiviral Agents|antiviral agents|mesh-ancestor
102007849|NCT03343444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102007850|NCT03819101|Aspirin|aspirin|mesh-list
102007851|NCT03819101|Atorvastatin|atorvastatin|mesh-list
102007852|NCT03819101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102007853|NCT03819101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102007854|NCT03819101|Antimetabolites|antimetabolites|mesh-ancestor
102007855|NCT03819101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007856|NCT03819101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102007857|NCT03819101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102007858|NCT03819101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102007859|NCT03819101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102007860|NCT03819101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102007861|NCT03819101|Analgesics|analgesics|mesh-ancestor
102007862|NCT03819101|Sensory System Agents|sensory system agents|mesh-ancestor
102007863|NCT03819101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102007864|NCT03819101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007865|NCT03819101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102007866|NCT03819101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102007867|NCT03819101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102007868|NCT03819101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102007869|NCT03819101|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102007870|NCT03819101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102007871|NCT03819101|Antipyretics|antipyretics|mesh-ancestor
102007872|NCT05199324|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102007873|NCT05199324|Ciprofloxacin|ciprofloxacin|mesh-list
102007874|NCT05199324|Cefazolin|cefazolin|mesh-list
102007875|NCT05199324|Ceftriaxone|ceftriaxone|mesh-list
102007876|NCT05199324|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102007877|NCT05199324|Fluoroquinolones|fluoroquinolones|mesh-list
102007878|NCT05199324|Trimethoprim|trimethoprim|mesh-list
102007879|NCT05199324|Sulfamethoxazole|sulfamethoxazole|mesh-list
102007880|NCT05199324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102007881|NCT05199324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102007882|NCT05199324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102007883|NCT05199324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101462857|NCT00200681|Bortezomib|bortezomib|mesh-list
102007886|NCT05199324|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102007887|NCT05199324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102007888|NCT05199324|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102007890|NCT05199324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102007892|NCT05199324|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102007893|NCT05199324|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102007894|NCT05199324|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102007895|NCT05199324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102007896|NCT03343366|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102007897|NCT03343366|Metronidazole|metronidazole|mesh-list
102007898|NCT03343366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102007899|NCT03343366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102007900|NCT03343366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102007901|NCT01298297|Morphine|morphine|mesh-list
102007902|NCT01298297|Buprenorphine|buprenorphine|mesh-list
102007903|NCT01298297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102007904|NCT01298297|Narcotics|narcotics|mesh-ancestor
102007905|NCT01298297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102007906|NCT01298297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007907|NCT01298297|Analgesics|analgesics|mesh-ancestor
102007908|NCT01298297|Sensory System Agents|sensory system agents|mesh-ancestor
102007909|NCT01298297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102007910|NCT01298297|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102007911|NCT03818945|Listerine|listerine|mesh-list
102007912|NCT03818945|Fluorides|fluorides|mesh-list
102007913|NCT03818945|Sodium Fluoride|sodium fluoride|mesh-list
102007914|NCT03818945|Fluorides, Topical|fluorides, topical|mesh-list
102007915|NCT03818945|Cariostatic Agents|cariostatic agents|mesh-ancestor
102007916|NCT03818945|Protective Agents|protective agents|mesh-ancestor
102007917|NCT03818945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007918|NCT03818945|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102007919|NCT03818945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102007920|NCT04300751|Analgesics, Opioid|analgesics, opioid|mesh-list
102007921|NCT04300751|Narcotics|narcotics|mesh-ancestor
102007922|NCT04300751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102007923|NCT04300751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007924|NCT04300751|Analgesics|analgesics|mesh-ancestor
102007925|NCT04300751|Sensory System Agents|sensory system agents|mesh-ancestor
102007926|NCT04300751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102007927|NCT03842423|Anesthetics|anesthetics|mesh-list
102007928|NCT03842423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102007929|NCT03842423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007930|NCT03172026|Maraviroc|maraviroc|mesh-list
102007931|NCT03172026|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102007932|NCT03172026|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102007933|NCT03172026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007934|NCT03172026|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102007935|NCT03172026|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102007936|NCT03172026|Antiviral Agents|antiviral agents|mesh-ancestor
102007937|NCT03172026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102007938|NCT03172026|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102007939|NCT01201577|Azithromycin|azithromycin|mesh-list
102007940|NCT01201577|Sulfalene|sulfalene|mesh-list
102007941|NCT01201577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102007942|NCT01201577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102007943|NCT01201577|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102007944|NCT01201577|Antimalarials|antimalarials|mesh-ancestor
102007945|NCT01201577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102007946|NCT01201577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102007947|NCT04496050|Alprostadil|alprostadil|mesh-list
102007948|NCT04496050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102007949|NCT04496050|Vasodilator Agents|vasodilator agents|mesh-ancestor
102007950|NCT04496050|Urological Agents|urological agents|mesh-ancestor
102007951|NCT01300793|Rituximab|rituximab|mesh-list
102007952|NCT01300793|Carboplatin|carboplatin|mesh-list
102007953|NCT01300793|Etoposide|etoposide|mesh-list
102007954|NCT01300793|Bortezomib|bortezomib|mesh-list
102007955|NCT01300793|Ifosfamide|ifosfamide|mesh-list
102007956|NCT01300793|Isophosphamide mustard|isophosphamide mustard|mesh-list
102007957|NCT01300793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101462927|NCT00201305|Antidotes|antidotes|mesh-ancestor
102007963|NCT01300793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102007964|NCT01300793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102007965|NCT01300793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101517024|NCT00547053|Amiloride|amiloride|mesh-list
102007966|NCT01300793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007967|NCT01300793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102007968|NCT01300793|Alkylating Agents|alkylating agents|mesh-ancestor
102007969|NCT03342040|Bupivacaine|bupivacaine|mesh-list
102007970|NCT03342040|Ropivacaine|ropivacaine|mesh-list
102007971|NCT03342040|Anesthetics, Local|anesthetics, local|mesh-ancestor
102007972|NCT03342040|Anesthetics|anesthetics|mesh-ancestor
102007973|NCT03342040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102007974|NCT03342040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007975|NCT03342040|Sensory System Agents|sensory system agents|mesh-ancestor
102007976|NCT03342040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102007977|NCT01298843|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
102007978|NCT01298843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102007979|NCT01298843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102007980|NCT03336970|Calcium|calcium|mesh-list
102007981|NCT03336970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102007982|NCT03336970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007983|NCT03336814|Terlipressin|terlipressin|mesh-list
102007984|NCT03336814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102007985|NCT03336814|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102007986|NCT02495584|Vitamin D|vitamin d|mesh-list
102007987|NCT02495584|Ergocalciferols|ergocalciferols|mesh-list
102007988|NCT02495584|Cholecalciferol|cholecalciferol|mesh-list
102007989|NCT02495584|Vitamins|vitamins|mesh-list
102007990|NCT02495584|Micronutrients|micronutrients|mesh-ancestor
102007991|NCT02495584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007992|NCT02495584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102007993|NCT02495584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102007994|NCT02495818|Lidocaine|lidocaine|mesh-list
102007995|NCT02495818|Anesthetics, Local|anesthetics, local|mesh-ancestor
102007996|NCT02495818|Anesthetics|anesthetics|mesh-ancestor
102007997|NCT02495818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102007998|NCT02495818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007999|NCT02495818|Sensory System Agents|sensory system agents|mesh-ancestor
102008000|NCT02495818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102008001|NCT02495818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102008002|NCT02495818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102008003|NCT02495818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102008004|NCT02495818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102008005|NCT02495818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008006|NCT02495662|Prednisolone|prednisolone|mesh-list
102008007|NCT02495662|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102008008|NCT02495662|Methylprednisolone|methylprednisolone|mesh-list
102008009|NCT02495662|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102008010|NCT02495662|Prednisolone acetate|prednisolone acetate|mesh-list
102008011|NCT02495662|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102008012|NCT02495662|Prednisolone phosphate|prednisolone phosphate|mesh-list
102008013|NCT02495662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102008014|NCT02495662|Glucocorticoids|glucocorticoids|mesh-ancestor
102008015|NCT02495662|Hormones|hormones|mesh-ancestor
102008016|NCT02495662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102008017|NCT02495662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008018|NCT02495662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102008019|NCT02495662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102008020|NCT02495662|Antiemetics|antiemetics|mesh-ancestor
102008021|NCT02495662|Autonomic Agents|autonomic agents|mesh-ancestor
102008022|NCT02495662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102008023|NCT02495662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102008024|NCT02495662|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102008025|NCT02495662|Protective Agents|protective agents|mesh-ancestor
102008026|NCT02496052|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102008033|NCT02496052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101517331|NCT02907632|Metoclopramide|metoclopramide|mesh-list
102008034|NCT02496052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008035|NCT02496052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102008036|NCT02496052|Contraceptive Agents|contraceptive agents|mesh-ancestor
102008037|NCT02496052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102008038|NCT02496052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102008039|NCT02496052|Progestins|progestins|mesh-ancestor
102008040|NCT01206569|Tacrolimus|tacrolimus|mesh-list
102008041|NCT01206569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102008042|NCT01206569|Immunologic Factors|immunologic factors|mesh-ancestor
102008043|NCT01206569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008044|NCT01206569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102008045|NCT01206569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102008046|NCT01206569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008047|NCT01206647|Metformin|metformin|mesh-list
102008048|NCT01206647|Saxagliptin|saxagliptin|mesh-list
102008049|NCT01206647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102008050|NCT01206647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008051|NCT01206647|Incretins|incretins|mesh-ancestor
102008052|NCT01206647|Hormones|hormones|mesh-ancestor
102008053|NCT01206647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101517536|NCT00548964|Antimanic Agents|antimanic agents|mesh-ancestor
102008054|NCT01206647|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102008055|NCT01206647|Protease Inhibitors|protease inhibitors|mesh-ancestor
102008056|NCT01206647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102008057|NCT01206647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008058|NCT03341884|Ipatasertib|ipatasertib|mesh-list
102008059|NCT03341884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102008060|NCT03341884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102008061|NCT03341884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102008062|NCT03341884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008063|NCT03560245|Bryostatin 1|bryostatin 1|mesh-list
102008064|NCT03560245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102008065|NCT03560245|Immunologic Factors|immunologic factors|mesh-ancestor
102008066|NCT03560245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517668|NCT02897765|Nivolumab|nivolumab|mesh-list
102008067|NCT03560245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102008068|NCT02495272|Oxytocin|oxytocin|mesh-list
102008069|NCT02495272|Oxytocics|oxytocics|mesh-ancestor
102008070|NCT02495272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102008071|NCT02495272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008072|NCT03336346|Efavirenz|efavirenz|mesh-list
102008073|NCT03336346|Dolutegravir|dolutegravir|mesh-list
102008074|NCT03336346|Etonogestrel|etonogestrel|mesh-list
102008075|NCT03336346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101517801|NCT03556696|Remifentanil|remifentanil|mesh-list
102008076|NCT03336346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102008077|NCT03336346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102008078|NCT03336346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008079|NCT03336346|Antiviral Agents|antiviral agents|mesh-ancestor
102008080|NCT03336346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102008081|NCT03336346|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102008082|NCT03336346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101517874|NCT00551889|Celecoxib|celecoxib|mesh-list
102008083|NCT03336346|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102008084|NCT03336346|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102008085|NCT03336346|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102008086|NCT03336346|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102008087|NCT03336346|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102008088|NCT03336346|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102008089|NCT03336346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102008090|NCT03336346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102008091|NCT03336346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102008092|NCT03336346|Contraceptive Agents|contraceptive agents|mesh-ancestor
102008093|NCT03336346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102008094|NCT03336346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008095|NCT03336346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102008096|NCT03841292|Varenicline|varenicline|mesh-list
102008100|NCT03841292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102008101|NCT03841292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008102|NCT03841292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008103|NCT03814577|Antioxidants|antioxidants|mesh-list
102008104|NCT03814577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008105|NCT03814577|Protective Agents|protective agents|mesh-ancestor
102008106|NCT03814577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008107|NCT03730363|Pentamidine|pentamidine|mesh-list
102008108|NCT03730363|Antifungal Agents|antifungal agents|mesh-ancestor
102008109|NCT03730363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102008110|NCT03730363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102008111|NCT03730363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102008112|NCT03730363|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102008113|NCT01206803|Ganirelix|ganirelix|mesh-list
102008114|NCT01206803|Hormone Antagonists|hormone antagonists|mesh-ancestor
102008115|NCT01206803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102008116|NCT01206803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008117|NCT03335956|Pioglitazone|pioglitazone|mesh-list
102008118|NCT03335956|Prednisone|prednisone|mesh-list
102008119|NCT03335956|Cortisone|cortisone|mesh-list
102008120|NCT03335956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102008121|NCT03335956|Glucocorticoids|glucocorticoids|mesh-ancestor
102008122|NCT03335956|Hormones|hormones|mesh-ancestor
102008123|NCT03335956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102008124|NCT03335956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008125|NCT03335956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102008126|NCT03335956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102008127|NCT03335956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102008128|NCT03817931|Solifenacin Succinate|solifenacin succinate|mesh-list
102008129|NCT03817931|Mirabegron|mirabegron|mesh-list
102008130|NCT03817931|Cholinergic Antagonists|cholinergic antagonists|mesh-list
102008131|NCT03817931|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-list
102008132|NCT03817931|Adrenergic Agents|adrenergic agents|mesh-list
102008133|NCT03817931|Adrenergic Agonists|adrenergic agonists|mesh-list
102008134|NCT03817931|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102008135|NCT03817931|Cholinergic Agents|cholinergic agents|mesh-ancestor
102008136|NCT03817931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102008137|NCT03817931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008138|NCT03817931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008139|NCT03817931|Urological Agents|urological agents|mesh-ancestor
102008140|NCT03817931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102008141|NCT01206881|Cyclophosphamide|cyclophosphamide|mesh-list
102008142|NCT01206881|Docetaxel|docetaxel|mesh-list
102008143|NCT01206881|Doxorubicin|doxorubicin|mesh-list
102008144|NCT01206881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102008145|NCT01206881|Trastuzumab|trastuzumab|mesh-list
102008146|NCT01206881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102008147|NCT01206881|Immunologic Factors|immunologic factors|mesh-ancestor
102008148|NCT01206881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008149|NCT01206881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102008150|NCT01206881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102008151|NCT01206881|Alkylating Agents|alkylating agents|mesh-ancestor
102008152|NCT01206881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008153|NCT01206881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102008154|NCT01206881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102008155|NCT01206881|Tubulin Modulators|tubulin modulators|mesh-ancestor
102008156|NCT01206881|Antimitotic Agents|antimitotic agents|mesh-ancestor
102008157|NCT01206881|Mitosis Modulators|mitosis modulators|mesh-ancestor
102008158|NCT01206881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102008159|NCT01206881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102008160|NCT01206881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102008161|NCT01206881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102008162|NCT01206881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102008163|NCT02494804|Temozolomide|temozolomide|mesh-list
102008164|NCT02494804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102008165|NCT02494804|Alkylating Agents|alkylating agents|mesh-ancestor
102008166|NCT02494804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008167|NCT02494804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102008168|NCT03558997|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102008181|NCT03814343|Protective Agents|protective agents|mesh-ancestor
102008182|NCT03814343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008183|NCT03814343|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102008184|NCT03814343|Antioxidants|antioxidants|mesh-ancestor
102008185|NCT03814343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008186|NCT03817541|Propofol|propofol|mesh-list
102008187|NCT03817541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102008188|NCT03817541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102008189|NCT03817541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008190|NCT03817541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102008191|NCT03817541|Anesthetics, General|anesthetics, general|mesh-ancestor
102008192|NCT03817541|Anesthetics|anesthetics|mesh-ancestor
102008193|NCT03341494|Thalidomide|thalidomide|mesh-list
102008194|NCT03341494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102008195|NCT03341494|Immunologic Factors|immunologic factors|mesh-ancestor
102008196|NCT03341494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008197|NCT03341494|Leprostatic Agents|leprostatic agents|mesh-ancestor
102008198|NCT03341494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102008199|NCT03341494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102008200|NCT03341494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102008201|NCT03341494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102008202|NCT03341494|Growth Substances|growth substances|mesh-ancestor
102008203|NCT03341494|Growth Inhibitors|growth inhibitors|mesh-ancestor
102008204|NCT03341494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102008206|NCT03586609|Azacitidine|azacitidine|mesh-list
102008207|NCT03586609|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
102008208|NCT03586609|Venetoclax|venetoclax|mesh-list
102008209|NCT03586609|Cladribine|cladribine|mesh-list
102008210|NCT03586609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102008211|NCT03586609|Antimetabolites|antimetabolites|mesh-ancestor
102008212|NCT03586609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008213|NCT03586609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102008214|NCT03586609|Antiviral Agents|antiviral agents|mesh-ancestor
102008215|NCT03586609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102008216|NCT03586609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102008217|NCT03586609|Immunologic Factors|immunologic factors|mesh-ancestor
102008218|NCT03586609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008219|NCT03586609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102008220|NCT03817619|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
102008221|NCT03817619|Antiviral Agents|antiviral agents|mesh-ancestor
102008222|NCT03817619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102008223|NCT03725995|Lidocaine|lidocaine|mesh-list
102008224|NCT03725995|Midazolam|midazolam|mesh-list
102008225|NCT03725995|Anesthetics, Local|anesthetics, local|mesh-ancestor
102008226|NCT03725995|Anesthetics|anesthetics|mesh-ancestor
102008227|NCT03725995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102008228|NCT03725995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008229|NCT03725995|Sensory System Agents|sensory system agents|mesh-ancestor
102008230|NCT03725995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102008231|NCT03725995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101463208|NCT00171223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102008234|NCT03725995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102008235|NCT03725995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008237|NCT03725995|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102008238|NCT03725995|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102008239|NCT03725995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102008240|NCT03725995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102008241|NCT03725995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102008242|NCT03725995|Anesthetics, General|anesthetics, general|mesh-ancestor
102008243|NCT03725995|GABA Modulators|gaba modulators|mesh-ancestor
102008244|NCT03725995|GABA Agents|gaba agents|mesh-ancestor
102008245|NCT03725995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102008246|NCT03341260|Diclofenac|diclofenac|mesh-list
102008247|NCT03341260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102008248|NCT03341260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102008249|NCT03341260|Analgesics|analgesics|mesh-ancestor
102008250|NCT03341260|Sensory System Agents|sensory system agents|mesh-ancestor
102008251|NCT03341260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102008252|NCT03341260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008253|NCT03341260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102008254|NCT03341260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102008255|NCT03341260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102008256|NCT03341260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102008257|NCT03341260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008258|NCT03052400|Mifepristone|mifepristone|mesh-list
102008259|NCT03052400|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102008260|NCT03052400|Abortifacient Agents|abortifacient agents|mesh-ancestor
102008261|NCT03052400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102008262|NCT03052400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008263|NCT03052400|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102008264|NCT03052400|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102008265|NCT03052400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102008266|NCT03052400|Contraceptive Agents|contraceptive agents|mesh-ancestor
102008267|NCT03052400|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102008268|NCT03052400|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102008269|NCT03052400|Hormone Antagonists|hormone antagonists|mesh-ancestor
102008270|NCT03052400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102008271|NCT03052400|Luteolytic Agents|luteolytic agents|mesh-ancestor
102008272|NCT03052400|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102008273|NCT03052400|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102008274|NCT03341104|Bupivacaine|bupivacaine|mesh-list
102008275|NCT03341104|Anesthetics, Local|anesthetics, local|mesh-ancestor
102008276|NCT03341104|Anesthetics|anesthetics|mesh-ancestor
102008277|NCT03341104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102008278|NCT03341104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008279|NCT03341104|Sensory System Agents|sensory system agents|mesh-ancestor
102008280|NCT03341104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102008281|NCT03335098|Thalidomide|thalidomide|mesh-list
102008282|NCT03335098|Dexamethasone|dexamethasone|mesh-list
102008283|NCT03335098|Bortezomib|bortezomib|mesh-list
102008284|NCT03335098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102008285|NCT03335098|Antiemetics|antiemetics|mesh-ancestor
102008286|NCT03335098|Autonomic Agents|autonomic agents|mesh-ancestor
102008287|NCT03335098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102008288|NCT03335098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008289|NCT03335098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102008290|NCT03335098|Glucocorticoids|glucocorticoids|mesh-ancestor
102008291|NCT03335098|Hormones|hormones|mesh-ancestor
102008292|NCT03335098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102008293|NCT03335098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102008294|NCT03335098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102008295|NCT03335098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102008296|NCT03335098|Immunologic Factors|immunologic factors|mesh-ancestor
102008297|NCT03335098|Leprostatic Agents|leprostatic agents|mesh-ancestor
102008298|NCT03335098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102008299|NCT03335098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102008300|NCT03335098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102008301|NCT03335098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101463271|NCT00479674|Paclitaxel|paclitaxel|mesh-list
102008303|NCT03335098|Growth Inhibitors|growth inhibitors|mesh-ancestor
102008304|NCT03639571|Ibuprofen|ibuprofen|mesh-list
102008305|NCT03639571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102008306|NCT03639571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102008307|NCT03639571|Analgesics|analgesics|mesh-ancestor
102008308|NCT03639571|Sensory System Agents|sensory system agents|mesh-ancestor
102008309|NCT03639571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102008310|NCT03639571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008311|NCT03639571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102008312|NCT03639571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102008313|NCT03639571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102008314|NCT03639571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102008315|NCT03639571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008316|NCT03052322|Adalimumab|adalimumab|mesh-list
102008317|NCT03052322|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102008318|NCT03052322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102008319|NCT03052322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102008320|NCT03521791|Bromfenac|bromfenac|mesh-list
102008321|NCT03521791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102008322|NCT03521791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102008323|NCT03521791|Analgesics|analgesics|mesh-ancestor
102008324|NCT03521791|Sensory System Agents|sensory system agents|mesh-ancestor
102008326|NCT03521791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008327|NCT03521791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102008328|NCT03521791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102008329|NCT03521635|Pramipexole|pramipexole|mesh-list
102008330|NCT03521635|Antioxidants|antioxidants|mesh-ancestor
102008331|NCT03521635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008332|NCT03521635|Protective Agents|protective agents|mesh-ancestor
102008333|NCT03521635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008334|NCT03521635|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102008335|NCT03521635|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102008336|NCT03521635|Dopamine Agonists|dopamine agonists|mesh-ancestor
102008337|NCT03521635|Dopamine Agents|dopamine agents|mesh-ancestor
102008338|NCT03521635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102008339|NCT03170544|Insulin Glargine|insulin glargine|mesh-list
102008340|NCT03170544|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102008341|NCT03170544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008342|NCT03813641|Capecitabine|capecitabine|mesh-list
102008343|NCT03813641|Raltitrexed|raltitrexed|mesh-list
102008344|NCT03813641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102008345|NCT03813641|Antimetabolites|antimetabolites|mesh-ancestor
102008346|NCT03813641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008347|NCT03813641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102008348|NCT03813641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102008349|NCT03813641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102008350|NCT02492464|Red yeast rice|red yeast rice|mesh-list
102008351|NCT02492464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102008352|NCT02492464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102008353|NCT02492464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102008354|NCT02492464|Antimetabolites|antimetabolites|mesh-ancestor
102008355|NCT02492464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008356|NCT02492464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102008357|NCT02492464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102008358|NCT05255159|Furosemide|furosemide|mesh-list
102008359|NCT05255159|Diuretics|diuretics|mesh-ancestor
102008360|NCT05255159|Natriuretic Agents|natriuretic agents|mesh-ancestor
102008361|NCT05255159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008362|NCT05255159|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102008363|NCT05255159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102008364|NCT05255159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008365|NCT03340558|Atezolizumab|atezolizumab|mesh-list
102008366|NCT03340558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102008367|NCT03340558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008368|NCT03340558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102008369|NCT03340558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102008370|NCT04905108|Riboflavin|riboflavin|mesh-list
102008371|NCT04905108|Vitamin B Complex|vitamin b complex|mesh-ancestor
102008372|NCT04905108|Vitamins|vitamins|mesh-ancestor
102008373|NCT04905108|Micronutrients|micronutrients|mesh-ancestor
102008374|NCT04905108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008375|NCT04905108|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102008376|NCT04905108|Dermatologic Agents|dermatologic agents|mesh-ancestor
102008392|NCT01560221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102008393|NCT01560221|Antitussive Agents|antitussive agents|mesh-ancestor
102008394|NCT01560221|Respiratory System Agents|respiratory system agents|mesh-ancestor
102008395|NCT03813329|Calcium Carbonate|calcium carbonate|mesh-list
102008396|NCT03813329|Calcium|calcium|mesh-list
102008397|NCT03813329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102008398|NCT03813329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008399|NCT03813329|Antacids|antacids|mesh-ancestor
102008400|NCT03813329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008401|NCT03813329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102008402|NCT03639415|Oxycodone|oxycodone|mesh-list
102008403|NCT03639415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102008404|NCT03639415|Narcotics|narcotics|mesh-ancestor
102008405|NCT03639415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102008406|NCT03639415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008407|NCT03639415|Analgesics|analgesics|mesh-ancestor
102008408|NCT03639415|Sensory System Agents|sensory system agents|mesh-ancestor
102008409|NCT03639415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102008410|NCT02492386|Everolimus|everolimus|mesh-list
102008411|NCT02492386|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102008412|NCT02492386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102008413|NCT02492386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102008414|NCT02492386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008415|NCT02492386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101949363|NCT05671757|Daratumumab|daratumumab|mesh-list
101949364|NCT05671757|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101949365|NCT05671757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949366|NCT05671757|Immunologic Factors|immunologic factors|mesh-ancestor
101949367|NCT05671757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949368|NCT05665387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101949369|NCT05665387|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101949376|NCT05525455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101949377|NCT05525455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949378|NCT05525455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101949379|NCT05525455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949380|NCT05503030|Nintedanib|nintedanib|mesh-list
101949381|NCT05503030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101518068|NCT00550992|Antidotes|antidotes|mesh-ancestor
101949382|NCT05503030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101949383|NCT05503030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101949384|NCT05503030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949385|NCT05471609|Levodopa|levodopa|mesh-list
101949386|NCT05471609|Carbidopa|carbidopa|mesh-list
101949387|NCT05471609|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101949419|NCT05372315|Autonomic Agents|autonomic agents|mesh-ancestor
101949420|NCT05372315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101949421|NCT05372315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949422|NCT05372315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101949423|NCT05372315|Glucocorticoids|glucocorticoids|mesh-ancestor
102008416|NCT02492386|Immunologic Factors|immunologic factors|mesh-ancestor
102008417|NCT02492386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008418|NCT02492386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102008419|NCT03340168|Bisphenol A|bisphenol a|mesh-list
102008420|NCT03340168|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102008421|NCT03340168|Estrogens|estrogens|mesh-ancestor
102008422|NCT03340168|Hormones|hormones|mesh-ancestor
102008423|NCT03340168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102008424|NCT03340168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008425|NCT03340168|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102008426|NCT03340168|Antioxidants|antioxidants|mesh-ancestor
102008427|NCT03340168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008428|NCT03340168|Protective Agents|protective agents|mesh-ancestor
102008429|NCT01299701|Vadimezan|vadimezan|mesh-list
102008430|NCT01299701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102008431|NCT01299779|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
102008432|NCT01299779|Laxatives|laxatives|mesh-ancestor
102008433|NCT01299779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102008434|NCT03812939|Octreotide|octreotide|mesh-list
102008435|NCT03812939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102008436|NCT03812939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102008437|NCT03812939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102008438|NCT03339700|Cyclophosphamide|cyclophosphamide|mesh-list
102008442|NCT03339700|Immunologic Factors|immunologic factors|mesh-ancestor
102008443|NCT03339700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008444|NCT03339700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102008445|NCT03339700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102008446|NCT03339700|Alkylating Agents|alkylating agents|mesh-ancestor
102008447|NCT03339700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008448|NCT03339700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102008449|NCT03339700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102008450|NCT03339700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102008451|NCT03339700|Antimetabolites|antimetabolites|mesh-ancestor
102008452|NCT05661149|Insulin|insulin|mesh-list
102008453|NCT05661149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102008454|NCT05661149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008455|NCT01299857|Rituximab|rituximab|mesh-list
102008456|NCT01299857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102008457|NCT01299857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102008458|NCT01299857|Immunologic Factors|immunologic factors|mesh-ancestor
102008459|NCT01299857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008460|NCT01299857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102008461|NCT03478969|Insulin|insulin|mesh-list
102008462|NCT03478969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101518080|NCT00550992|Analgesics|analgesics|mesh-ancestor
102008463|NCT03478969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008464|NCT03812783|Sorafenib|sorafenib|mesh-list
102008465|NCT03812783|Folfirinox|folfirinox|mesh-list
102008466|NCT03812783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102008467|NCT03812783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102008468|NCT03812783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102008469|NCT03812783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008470|NCT02500498|Abatacept|abatacept|mesh-list
102008471|NCT02500498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102008472|NCT02500498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008473|NCT02500498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102008474|NCT02500498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102008475|NCT02500498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102008476|NCT02500498|Immunologic Factors|immunologic factors|mesh-ancestor
102008477|NCT02500498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008478|NCT02500498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101949424|NCT05372315|Hormones|hormones|mesh-ancestor
101949425|NCT05372315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101270365|NCT01820325|Paclitaxel|paclitaxel|mesh-list
102008486|NCT02500108|Domperidone|domperidone|mesh-list
102008487|NCT02500108|Antiemetics|antiemetics|mesh-ancestor
102008488|NCT02500108|Autonomic Agents|autonomic agents|mesh-ancestor
102008489|NCT02500108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102008490|NCT02500108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008491|NCT02500108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102008492|NCT02500108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102008493|NCT02500108|Dopamine Agents|dopamine agents|mesh-ancestor
102008494|NCT02500108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102008495|NCT02500108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008496|NCT02499874|Tenofovir|tenofovir|mesh-list
102008497|NCT02499874|Lamivudine|lamivudine|mesh-list
102008498|NCT02499874|Emtricitabine|emtricitabine|mesh-list
102008499|NCT02499874|Zidovudine|zidovudine|mesh-list
102008500|NCT02499874|Efavirenz|efavirenz|mesh-list
102008501|NCT02499874|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
102008502|NCT02499874|Antiviral Agents|antiviral agents|mesh-ancestor
102008503|NCT02499874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102008504|NCT02499874|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102008505|NCT02499874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102008506|NCT02499874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102008507|NCT02499874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008508|NCT02499874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102008509|NCT02499874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102008510|NCT02499874|Antimetabolites|antimetabolites|mesh-ancestor
102008511|NCT02499874|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101463483|NCT00231530|Topiramate|topiramate|mesh-list
102008526|NCT05865470|Analgesics|analgesics|mesh-ancestor
102008527|NCT05865470|Sensory System Agents|sensory system agents|mesh-ancestor
102008528|NCT05865470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102008529|NCT05865470|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102008530|NCT05865470|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102008531|NCT05865470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102008532|NCT05865470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008533|NCT05865470|Hormones|hormones|mesh-ancestor
102008534|NCT05865470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102008535|NCT05865431|Zinc Oxide|zinc oxide|mesh-list
102008536|NCT05865431|Avobenzone|avobenzone|mesh-list
102008537|NCT05865431|Dermatologic Agents|dermatologic agents|mesh-ancestor
102008538|NCT05865431|Sunscreening Agents|sunscreening agents|mesh-ancestor
102008539|NCT05865431|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102008540|NCT05865431|Protective Agents|protective agents|mesh-ancestor
102008541|NCT05865431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008542|NCT05865288|Oxytocin|oxytocin|mesh-list
102008543|NCT05865288|Oxytocics|oxytocics|mesh-ancestor
102008544|NCT05865288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102008545|NCT05865288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008546|NCT05865132|Palbociclib|palbociclib|mesh-list
102008547|NCT05865132|Afatinib|afatinib|mesh-list
102008548|NCT05865132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102008549|NCT05865132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101728333|NCT00450385|Hormones|hormones|mesh-ancestor
102008550|NCT05865132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102008551|NCT05865132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008552|NCT05864885|Minoxidil|minoxidil|mesh-list
102008553|NCT05864885|Latanoprost|latanoprost|mesh-list
102008554|NCT05864885|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102008555|NCT05864885|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102008556|NCT05864885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102008557|NCT05864885|Vasodilator Agents|vasodilator agents|mesh-ancestor
102008558|NCT05864677|Cerebrolysin|cerebrolysin|mesh-list
102008559|NCT05864677|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102008560|NCT05864677|Protective Agents|protective agents|mesh-ancestor
102008561|NCT05864677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008562|NCT05864677|Nootropic Agents|nootropic agents|mesh-ancestor
102008563|NCT05864664|Anesthetics|anesthetics|mesh-list
102008564|NCT05864664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102008565|NCT05864664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008566|NCT05864508|Oxytocin|oxytocin|mesh-list
102008567|NCT05864508|Oxytocics|oxytocics|mesh-ancestor
101949426|NCT05372315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101949427|NCT05372315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949428|NCT05372315|Protease Inhibitors|protease inhibitors|mesh-ancestor
101270434|NCT01820832|Vitamins|vitamins|mesh-ancestor
102008568|NCT05864508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102008569|NCT05864508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008570|NCT05864053|Ketamine|ketamine|mesh-list
102008571|NCT05864053|Analgesics|analgesics|mesh-ancestor
102008572|NCT05864053|Sensory System Agents|sensory system agents|mesh-ancestor
102008578|NCT05864053|Anesthetics|anesthetics|mesh-ancestor
102008579|NCT05864053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102008580|NCT05864053|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102008581|NCT05864053|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102008582|NCT05864053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102008583|NCT05864053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008584|NCT05863975|Interferons|interferons|mesh-list
102008585|NCT05863975|Interferon-alpha|interferon-alpha|mesh-list
102008586|NCT05863975|Interferon alpha-2|interferon alpha-2|mesh-list
102008587|NCT05863975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102008588|NCT05863975|Antiviral Agents|antiviral agents|mesh-ancestor
102008589|NCT05863975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102008590|NCT05863975|Immunologic Factors|immunologic factors|mesh-ancestor
102008591|NCT05863975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008592|NCT05863949|Vitamin D|vitamin d|mesh-list
102008593|NCT05863949|Calcium|calcium|mesh-list
102008594|NCT05863949|Vitamins|vitamins|mesh-ancestor
102008595|NCT05863949|Micronutrients|micronutrients|mesh-ancestor
101518117|NCT02894606|Thymoglobulin|thymoglobulin|mesh-list
102008596|NCT05863949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008597|NCT05863949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102008598|NCT05863949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102008599|NCT05863936|Methylprednisolone|methylprednisolone|mesh-list
102008600|NCT05863936|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102008601|NCT05863936|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102008602|NCT05863936|Prednisolone|prednisolone|mesh-list
102008603|NCT05863936|Prednisolone acetate|prednisolone acetate|mesh-list
102008604|NCT05863936|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102008605|NCT05863936|Prednisolone phosphate|prednisolone phosphate|mesh-list
102008606|NCT05863936|Belimumab|belimumab|mesh-list
102008607|NCT05863936|Immunosuppressive Agents|immunosuppressive agents|mesh-list
102008608|NCT05863936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102008609|NCT05863936|Antiemetics|antiemetics|mesh-ancestor
102008610|NCT05863936|Autonomic Agents|autonomic agents|mesh-ancestor
102008611|NCT05863936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102008612|NCT05863936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008613|NCT05863936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102008614|NCT05863936|Glucocorticoids|glucocorticoids|mesh-ancestor
102008615|NCT05863936|Hormones|hormones|mesh-ancestor
102008616|NCT05863936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102008617|NCT05863936|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102008618|NCT05863936|Protective Agents|protective agents|mesh-ancestor
102008619|NCT05863936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102008620|NCT05863936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102008621|NCT05863936|Immunologic Factors|immunologic factors|mesh-ancestor
102008622|NCT05863858|Amoxicillin|amoxicillin|mesh-list
102008623|NCT05863858|Moxifloxacin|moxifloxacin|mesh-list
102008624|NCT05863858|Levofloxacin|levofloxacin|mesh-list
102008625|NCT05863858|Ofloxacin|ofloxacin|mesh-list
102008626|NCT05863858|Tinidazole|tinidazole|mesh-list
102008627|NCT05863858|Omeprazole|omeprazole|mesh-list
102008628|NCT05863858|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102008629|NCT05863858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102008630|NCT05863858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102008631|NCT05863858|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102008632|NCT05863858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102008633|NCT05863858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102008634|NCT05863858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008635|NCT05863858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102008636|NCT05863858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102008637|NCT05863858|Contraceptive Agents|contraceptive agents|mesh-ancestor
102008638|NCT05863858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102008639|NCT05863858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008640|NCT05863858|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102008641|NCT05863858|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101949429|NCT05372315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101949430|NCT05372315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949432|NCT05364190|Canagliflozin|canagliflozin|mesh-list
101949433|NCT05364190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102008642|NCT05863858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102008643|NCT05863858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102008647|NCT05863858|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102008648|NCT05863858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102008649|NCT05863858|Alkylating Agents|alkylating agents|mesh-ancestor
102008650|NCT05863858|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
102008651|NCT05863858|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102008652|NCT05863858|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102008654|NCT05863845|Etoposide|etoposide|mesh-list
102008655|NCT05863845|Melphalan|melphalan|mesh-list
102008656|NCT05863845|Venetoclax|venetoclax|mesh-list
102008657|NCT05863845|Carmustine|carmustine|mesh-list
102008658|NCT05863845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102008659|NCT05863845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102008660|NCT05863845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102008661|NCT05863845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102008662|NCT05863845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102008663|NCT05863845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008664|NCT05863845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102008665|NCT05863845|Antimetabolites|antimetabolites|mesh-ancestor
102008666|NCT05863845|Antiviral Agents|antiviral agents|mesh-ancestor
102008667|NCT05863845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102008668|NCT05863845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102008669|NCT05863845|Immunologic Factors|immunologic factors|mesh-ancestor
102008670|NCT05863845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008671|NCT05863845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102008672|NCT05863845|Alkylating Agents|alkylating agents|mesh-ancestor
102008673|NCT05863845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102008674|NCT05863832|Metronidazole|metronidazole|mesh-list
102008675|NCT05863832|Ciprofloxacin|ciprofloxacin|mesh-list
102008676|NCT05863832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102008677|NCT05863832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102008678|NCT05863832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102008679|NCT05863832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102008680|NCT05863832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102008681|NCT05863832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102008682|NCT05863832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102008683|NCT05863832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008684|NCT05863832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102008685|NCT05863832|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102008686|NCT05863832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102008687|NCT05863585|MEDI9197|medi9197|mesh-list
102008688|NCT05863585|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102008689|NCT05863585|Immunologic Factors|immunologic factors|mesh-ancestor
102008690|NCT05863585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008691|NCT05863455|Midazolam|midazolam|mesh-list
102008692|NCT05863455|Sufentanil|sufentanil|mesh-list
102008693|NCT05863455|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102008694|NCT05863455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101518190|NCT00552747|Fenofibrate|fenofibrate|mesh-list
102008695|NCT05863455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102008696|NCT05863455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008697|NCT05863455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102008698|NCT05863455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102008699|NCT05863455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102008700|NCT05863455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102008701|NCT05863455|Anesthetics, General|anesthetics, general|mesh-ancestor
102008702|NCT05863455|Anesthetics|anesthetics|mesh-ancestor
102008703|NCT05863455|GABA Modulators|gaba modulators|mesh-ancestor
102008704|NCT05863455|GABA Agents|gaba agents|mesh-ancestor
102008705|NCT05863455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102008706|NCT05863455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008707|NCT05863455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102008708|NCT05863455|Narcotics|narcotics|mesh-ancestor
102008709|NCT05863455|Analgesics|analgesics|mesh-ancestor
102008710|NCT05863455|Sensory System Agents|sensory system agents|mesh-ancestor
102008711|NCT05863455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101949434|NCT05364190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949435|NCT05364190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101949436|NCT05364190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949437|NCT05359133|Tetrodotoxin|tetrodotoxin|mesh-list
101949438|NCT05359133|Anesthetics, Local|anesthetics, local|mesh-ancestor
102008712|NCT05863442|Eculizumab|eculizumab|mesh-list
102008713|NCT05863442|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102008714|NCT05863442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102008715|NCT05863442|Immunologic Factors|immunologic factors|mesh-ancestor
102008716|NCT05863442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008731|NCT05863325|Docetaxel|docetaxel|mesh-list
102008732|NCT05863325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102008733|NCT05863325|Tubulin Modulators|tubulin modulators|mesh-ancestor
102008734|NCT05863325|Antimitotic Agents|antimitotic agents|mesh-ancestor
102008735|NCT05863325|Mitosis Modulators|mitosis modulators|mesh-ancestor
102008736|NCT05863325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008748|NCT05863273|Apremilast|apremilast|mesh-list
102008749|NCT05863273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102008750|NCT05863273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102008751|NCT05863273|Analgesics|analgesics|mesh-ancestor
102008752|NCT05863273|Sensory System Agents|sensory system agents|mesh-ancestor
102008753|NCT05863273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102008754|NCT05863273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008755|NCT05863273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102008756|NCT05863273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102008757|NCT05863273|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102008758|NCT05863273|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102008759|NCT05863273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102008760|NCT05863273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008761|NCT05862272|Relugolix|relugolix|mesh-list
102008762|NCT05862272|Androgen Antagonists|androgen antagonists|mesh-ancestor
102008763|NCT05862272|Hormone Antagonists|hormone antagonists|mesh-ancestor
102008764|NCT05862272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102008765|NCT05862272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008766|NCT05860998|Antibodies|antibodies|mesh-list
102008767|NCT05860998|Immunoglobulin G|immunoglobulin g|mesh-list
102008768|NCT05860998|Immunologic Factors|immunologic factors|mesh-ancestor
102008769|NCT05860998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008770|NCT05860452|Ropivacaine|ropivacaine|mesh-list
102008771|NCT05860452|Anesthetics, Local|anesthetics, local|mesh-ancestor
102008772|NCT05860452|Anesthetics|anesthetics|mesh-ancestor
102008773|NCT05860452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102008774|NCT05860452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008775|NCT05860452|Sensory System Agents|sensory system agents|mesh-ancestor
102008776|NCT05860452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102008777|NCT05856500|Curcumin|curcumin|mesh-list
102008778|NCT05856500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102008779|NCT05856500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102008781|NCT05856500|Sensory System Agents|sensory system agents|mesh-ancestor
102008782|NCT05856500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102008783|NCT05856500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008784|NCT05856500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102008785|NCT05856500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102008786|NCT05856500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102008787|NCT05856500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102008797|NCT05847517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102008798|NCT05847517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102008799|NCT05847517|Sympatholytics|sympatholytics|mesh-ancestor
102008800|NCT05847517|Autonomic Agents|autonomic agents|mesh-ancestor
102008801|NCT05847517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102008802|NCT05847517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008803|NCT05847517|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102008804|NCT05847517|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101518270|NCT01260922|Cholinergic Agents|cholinergic agents|mesh-ancestor
102008805|NCT05847517|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102008806|NCT05847517|Adrenergic Agents|adrenergic agents|mesh-ancestor
102008807|NCT05847517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102008808|NCT05847517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008809|NCT05828303|Metformin|metformin|mesh-list
102008810|NCT05828303|Digoxin|digoxin|mesh-list
101949440|NCT05359133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101949441|NCT05359133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949442|NCT05359133|Sensory System Agents|sensory system agents|mesh-ancestor
102008811|NCT05828303|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102008812|NCT05828303|Calcium|calcium|mesh-list
102008813|NCT05828303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102008814|NCT05828303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008815|NCT05828303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102008816|NCT05828303|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102008817|NCT05828303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102008818|NCT05828303|Antimetabolites|antimetabolites|mesh-ancestor
102008819|NCT05828303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008820|NCT05828303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102008821|NCT05828303|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102008822|NCT05828303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102008823|NCT05828303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102008824|NCT05828303|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102008825|NCT05828303|Protective Agents|protective agents|mesh-ancestor
102008826|NCT05801705|Tamoxifen|tamoxifen|mesh-list
102008827|NCT05801705|Toremifene|toremifene|mesh-list
102008828|NCT05801705|Hormones|hormones|mesh-list
102008829|NCT05801705|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102008830|NCT05801705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102008831|NCT05801705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008832|NCT05801705|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102008833|NCT05801705|Hormone Antagonists|hormone antagonists|mesh-ancestor
102008834|NCT05801705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102008835|NCT05801705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102008836|NCT05801705|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102008837|NCT05801705|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102008838|NCT05801705|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101518334|NCT04335305|Pembrolizumab|pembrolizumab|mesh-list
102008839|NCT05801705|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102008840|NCT05801705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102008841|NCT05801705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008842|NCT05780216|Harmine|harmine|mesh-list
102008843|NCT05780216|Hallucinogens|hallucinogens|mesh-ancestor
102008844|NCT05780216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008845|NCT05780216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102008846|NCT05780216|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102008847|NCT05780216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102008848|NCT05780216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008849|NCT05778617|Ambroxol|ambroxol|mesh-list
102008850|NCT05778617|Expectorants|expectorants|mesh-ancestor
102008851|NCT05778617|Respiratory System Agents|respiratory system agents|mesh-ancestor
102008852|NCT05766345|BCG Vaccine|bcg vaccine|mesh-list
102008857|NCT05756153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102008858|NCT05756153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102008860|NCT05743777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102008861|NCT05743777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102008862|NCT05743777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102008863|NCT05743777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008864|NCT05701007|Docetaxel|docetaxel|mesh-list
102008865|NCT05701007|Goserelin|goserelin|mesh-list
102008866|NCT05701007|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102008867|NCT05701007|Leuprolide|leuprolide|mesh-list
102008868|NCT05701007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102008869|NCT05701007|Tubulin Modulators|tubulin modulators|mesh-ancestor
102008870|NCT05701007|Antimitotic Agents|antimitotic agents|mesh-ancestor
102008871|NCT05701007|Mitosis Modulators|mitosis modulators|mesh-ancestor
102008872|NCT05701007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008873|NCT05701007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102008874|NCT05701007|Luteolytic Agents|luteolytic agents|mesh-ancestor
102008875|NCT05701007|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102008876|NCT05701007|Contraceptive Agents|contraceptive agents|mesh-ancestor
102008877|NCT05701007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102008878|NCT05701007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008879|NCT05701007|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102008880|NCT05701007|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102008881|NCT05701007|Fertility Agents|fertility agents|mesh-ancestor
101949443|NCT05359133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101949444|NCT05359133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101949445|NCT05359133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101270713|NCT01822613|Tubulin Modulators|tubulin modulators|mesh-ancestor
102008883|NCT05676203|Androgens|androgens|mesh-list
102008884|NCT05676203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102008885|NCT05676203|Tubulin Modulators|tubulin modulators|mesh-ancestor
102008886|NCT05676203|Antimitotic Agents|antimitotic agents|mesh-ancestor
102008887|NCT05676203|Mitosis Modulators|mitosis modulators|mesh-ancestor
102008888|NCT05676203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008889|NCT05676203|Hormones|hormones|mesh-ancestor
102008890|NCT05676203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102008891|NCT05676203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008892|NCT05673928|Trastuzumab|trastuzumab|mesh-list
102008893|NCT05673928|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102008894|NCT05673928|Maytansine|maytansine|mesh-list
102008895|NCT05673928|Tucatinib|tucatinib|mesh-list
102008896|NCT05673928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102008897|NCT05673928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102008898|NCT05673928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102008899|NCT05673928|Tubulin Modulators|tubulin modulators|mesh-ancestor
102008900|NCT05673928|Antimitotic Agents|antimitotic agents|mesh-ancestor
102008901|NCT05673928|Mitosis Modulators|mitosis modulators|mesh-ancestor
102008902|NCT05673928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008903|NCT05673928|Immunotoxins|immunotoxins|mesh-ancestor
102008904|NCT05673928|Immunoconjugates|immunoconjugates|mesh-ancestor
102008905|NCT05673928|Immunologic Factors|immunologic factors|mesh-ancestor
102008906|NCT05673928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008907|NCT05673928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102008908|NCT05673928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102008910|NCT05615779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102008911|NCT05591092|Iodine|iodine|mesh-list
102008912|NCT05591092|Cadexomer iodine|cadexomer iodine|mesh-list
102008913|NCT05591092|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102008914|NCT05591092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102008915|NCT05591092|Trace Elements|trace elements|mesh-ancestor
102008916|NCT05591092|Micronutrients|micronutrients|mesh-ancestor
102008917|NCT05591092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008918|NCT05580003|Moxifloxacin|moxifloxacin|mesh-list
102008919|NCT05580003|Midazolam|midazolam|mesh-list
102008920|NCT05580003|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102008921|NCT05580003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102008922|NCT05580003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102008923|NCT05580003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008924|NCT05580003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102008925|NCT05580003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102008928|NCT05580003|Anesthetics, General|anesthetics, general|mesh-ancestor
102008929|NCT05580003|Anesthetics|anesthetics|mesh-ancestor
102008930|NCT05580003|GABA Modulators|gaba modulators|mesh-ancestor
102008931|NCT05580003|GABA Agents|gaba agents|mesh-ancestor
102008932|NCT05580003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102008933|NCT05580003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008934|NCT05580003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102008935|NCT05580003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102008936|NCT05580003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102008937|NCT05580003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102008938|NCT05580003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102008939|NCT05580003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102008940|NCT05548283|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102008941|NCT05548283|Lactams|lactams|mesh-list
102008942|NCT05548283|beta-Lactams|beta-lactams|mesh-list
102008943|NCT05548283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102008944|NCT05513560|Pentoxifylline|pentoxifylline|mesh-list
102008945|NCT05513560|Ibudilast|ibudilast|mesh-list
102008946|NCT05513560|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102008947|NCT05513560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102008948|NCT05513560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008949|NCT05513560|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102008950|NCT05513560|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102008951|NCT05513560|Protective Agents|protective agents|mesh-ancestor
102008952|NCT05513560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008953|NCT05513560|Vasodilator Agents|vasodilator agents|mesh-ancestor
101949446|NCT05359133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949447|NCT05333458|Atezolizumab|atezolizumab|mesh-list
101949448|NCT05333458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101949449|NCT05333458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101949450|NCT05333458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949451|NCT05333458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102008954|NCT05513560|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102008955|NCT05513560|Antioxidants|antioxidants|mesh-ancestor
102008956|NCT05513560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102008957|NCT05513560|Autonomic Agents|autonomic agents|mesh-ancestor
102008958|NCT05513560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102008959|NCT05513560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102008960|NCT05513560|Respiratory System Agents|respiratory system agents|mesh-ancestor
102008962|NCT05489796|Fentanyl|fentanyl|mesh-list
102008963|NCT05489796|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102008964|NCT05489796|Narcotics|narcotics|mesh-ancestor
102008965|NCT05489796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102008966|NCT05489796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008967|NCT05489796|Analgesics|analgesics|mesh-ancestor
102008968|NCT05489796|Sensory System Agents|sensory system agents|mesh-ancestor
102008969|NCT05489796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102008970|NCT05489796|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102008971|NCT05489796|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102008972|NCT05489796|Anesthetics, General|anesthetics, general|mesh-ancestor
102008973|NCT05489796|Anesthetics|anesthetics|mesh-ancestor
102008974|NCT05489796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102008975|NCT05489796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102008976|NCT05489796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102008977|NCT05489796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102008978|NCT05489796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102008979|NCT05489796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102008980|NCT05489796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008981|NCT05435547|Dexamethasone|dexamethasone|mesh-list
102008982|NCT05435547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102008983|NCT05435547|Antiemetics|antiemetics|mesh-ancestor
102008984|NCT05435547|Autonomic Agents|autonomic agents|mesh-ancestor
102008985|NCT05435547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102008986|NCT05435547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008987|NCT05435547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102008988|NCT05435547|Glucocorticoids|glucocorticoids|mesh-ancestor
102008989|NCT05435547|Hormones|hormones|mesh-ancestor
102008990|NCT05435547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102008991|NCT05435547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102008992|NCT05435547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102008993|NCT05422131|Clozapine|clozapine|mesh-list
102008994|NCT05422131|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102008995|NCT05422131|Serotonin Agents|serotonin agents|mesh-ancestor
102008996|NCT05422131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102008997|NCT05422131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463962|NCT04564144|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102009014|NCT05357079|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102009015|NCT05357079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102009016|NCT05357079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009018|NCT05357079|Coagulants|coagulants|mesh-ancestor
102009019|NCT05326997|Tranexamic Acid|tranexamic acid|mesh-list
102009020|NCT05326997|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102009021|NCT05326997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102009022|NCT05326997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009023|NCT05326997|Hemostatics|hemostatics|mesh-ancestor
102009024|NCT05326997|Coagulants|coagulants|mesh-ancestor
102009025|NCT05309629|Carboplatin|carboplatin|mesh-list
102009026|NCT05309629|Etoposide|etoposide|mesh-list
102009027|NCT05309629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101518463|NCT03911336|Antipyretics|antipyretics|mesh-ancestor
102009028|NCT05309629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102009029|NCT05309629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102009030|NCT05309629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102009031|NCT05309629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101949452|NCT05333458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949453|NCT05333458|Immunologic Factors|immunologic factors|mesh-ancestor
102009032|NCT05309629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009033|NCT05209620|Pemetrexed|pemetrexed|mesh-list
102009034|NCT05209620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009035|NCT05209620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102009036|NCT05209620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009037|NCT05209620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102009038|NCT05209620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102009039|NCT05204836|Zoledronic Acid|zoledronic acid|mesh-list
102009040|NCT05204836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102009041|NCT05204836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009042|NCT05184062|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
102009043|NCT05184062|Antiviral Agents|antiviral agents|mesh-ancestor
102009044|NCT05184062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102009045|NCT05153304|Nivolumab|nivolumab|mesh-list
102009046|NCT05153304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102009047|NCT05153304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009048|NCT05153304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102009049|NCT05153304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009050|NCT05109728|Temozolomide|temozolomide|mesh-list
102009051|NCT05109728|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
102009052|NCT05109728|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
101464036|NCT00232895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009058|NCT05109728|Sequestering Agents|sequestering agents|mesh-ancestor
102009059|NCT05109728|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102009065|NCT05071183|Trametinib|trametinib|mesh-list
102009066|NCT05071183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009067|NCT05071183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102009068|NCT05071183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102009069|NCT05071183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009070|NCT05068726|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
102009071|NCT05068726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009072|NCT05022901|Melphalan|melphalan|mesh-list
102009073|NCT05022901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102009074|NCT05022901|Alkylating Agents|alkylating agents|mesh-ancestor
102009075|NCT05022901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009076|NCT05022901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009077|NCT05022901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102009078|NCT05022901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102009080|NCT05022901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009081|NCT05009862|Aspirin|aspirin|mesh-list
102009082|NCT05009862|Rivaroxaban|rivaroxaban|mesh-list
102009083|NCT05009862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102009084|NCT05009862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102009085|NCT05009862|Analgesics|analgesics|mesh-ancestor
102009086|NCT05009862|Sensory System Agents|sensory system agents|mesh-ancestor
102009087|NCT05009862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102009088|NCT05009862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009089|NCT05009862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102009090|NCT05009862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102009091|NCT05009862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102009092|NCT05009862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102009093|NCT05009862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009094|NCT05009862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102009095|NCT05009862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102009096|NCT05009862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102009097|NCT05009862|Antipyretics|antipyretics|mesh-ancestor
102009098|NCT05009862|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102009099|NCT05009862|Antithrombins|antithrombins|mesh-ancestor
102009100|NCT05009862|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102009101|NCT05009862|Protease Inhibitors|protease inhibitors|mesh-ancestor
102009102|NCT05009862|Anticoagulants|anticoagulants|mesh-ancestor
102009103|NCT04973748|Analgesics, Opioid|analgesics, opioid|mesh-list
102009104|NCT04973748|Narcotics|narcotics|mesh-ancestor
101949454|NCT05333458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949455|NCT05267613|Esomeprazole|esomeprazole|mesh-list
101949456|NCT05267613|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101949457|NCT05267613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101949458|NCT05267613|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101949459|NCT05267613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101949460|NCT05267613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949461|NCT05265208|Capecitabine|capecitabine|mesh-list
101949462|NCT05265208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101949463|NCT05265208|Antimetabolites|antimetabolites|mesh-ancestor
101949464|NCT05265208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009105|NCT04973748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102009106|NCT04973748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009107|NCT04973748|Analgesics|analgesics|mesh-ancestor
102009108|NCT04973748|Sensory System Agents|sensory system agents|mesh-ancestor
102009109|NCT04973748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102009110|NCT04968054|Propofol|propofol|mesh-list
102009111|NCT04968054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102009112|NCT04968054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102009113|NCT04968054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009114|NCT04968054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102009115|NCT04968054|Anesthetics, General|anesthetics, general|mesh-ancestor
102009116|NCT04968054|Anesthetics|anesthetics|mesh-ancestor
102009117|NCT04967495|Lenvatinib|lenvatinib|mesh-list
102009118|NCT04967495|Chlorotrianisene|chlorotrianisene|mesh-list
102009119|NCT04967495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009120|NCT04967495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102009121|NCT04967495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628290|NCT00724243|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102009126|NCT04967495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102009127|NCT04967495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009128|NCT04967495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102009129|NCT04965766|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
102009130|NCT04965766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102009131|NCT04965766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009132|NCT04933721|Berotralstat|berotralstat|mesh-list
102009133|NCT04933721|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102009134|NCT04933721|Protease Inhibitors|protease inhibitors|mesh-ancestor
102009135|NCT04933721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102009136|NCT04933721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009137|NCT04883528|Valsartan|valsartan|mesh-list
102009138|NCT04883528|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102009139|NCT04883528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102009140|NCT04883528|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102009141|NCT04883528|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102009142|NCT04883528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009143|NCT04828135|Xenon|xenon|mesh-list
102009144|NCT04828135|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102009145|NCT04828135|Anesthetics, General|anesthetics, general|mesh-ancestor
102009146|NCT04828135|Anesthetics|anesthetics|mesh-ancestor
102009147|NCT04828135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102009148|NCT04828135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009149|NCT04815720|Pembrolizumab|pembrolizumab|mesh-list
101728922|NCT00807196|Cyclophosphamide|cyclophosphamide|mesh-list
102009150|NCT04815720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102009151|NCT04815720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009152|NCT04815720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102009153|NCT04815720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009154|NCT04777851|Pembrolizumab|pembrolizumab|mesh-list
102009155|NCT04777851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102009156|NCT04777851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949465|NCT05265208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949466|NCT05261139|Ritonavir|ritonavir|mesh-list
102009157|NCT04777851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102009158|NCT04777851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009159|NCT04765111|Rituximab|rituximab|mesh-list
102009160|NCT04765111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102009161|NCT04765111|Acalabrutinib|acalabrutinib|mesh-list
102009162|NCT04765111|Antibodies|antibodies|mesh-list
102009163|NCT04765111|Immunoglobulins|immunoglobulins|mesh-list
102009164|NCT04765111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102009165|NCT04765111|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102009166|NCT04765111|Immunologic Factors|immunologic factors|mesh-ancestor
102009167|NCT04765111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009168|NCT04765111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009169|NCT04765111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102009170|NCT04765111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102009171|NCT04765111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102009172|NCT04765111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009173|NCT04737889|Rituximab|rituximab|mesh-list
102009174|NCT04737889|Methotrexate|methotrexate|mesh-list
102009175|NCT04737889|Lenalidomide|lenalidomide|mesh-list
102009176|NCT04737889|Temozolomide|temozolomide|mesh-list
102009177|NCT04737889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102009178|NCT04737889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009179|NCT04737889|Immunologic Factors|immunologic factors|mesh-ancestor
102009180|NCT04737889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009181|NCT04737889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102009182|NCT04737889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102009183|NCT04737889|Abortifacient Agents|abortifacient agents|mesh-ancestor
102009184|NCT04737889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102009185|NCT04737889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102009186|NCT04737889|Antimetabolites|antimetabolites|mesh-ancestor
102009187|NCT04737889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009188|NCT04737889|Dermatologic Agents|dermatologic agents|mesh-ancestor
102009194|NCT04737889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102009195|NCT04737889|Growth Substances|growth substances|mesh-ancestor
102009196|NCT04737889|Growth Inhibitors|growth inhibitors|mesh-ancestor
102009197|NCT04737889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102009198|NCT04737889|Alkylating Agents|alkylating agents|mesh-ancestor
102009199|NCT04735354|Valsartan|valsartan|mesh-list
102009200|NCT04735354|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102009201|NCT04735354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102009202|NCT04735354|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102009203|NCT04735354|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102009204|NCT04735354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009205|NCT04679740|Sirolimus|sirolimus|mesh-list
102009206|NCT04679740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102009207|NCT04679740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102009208|NCT04679740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102009209|NCT04679740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009210|NCT04679740|Antifungal Agents|antifungal agents|mesh-ancestor
102009211|NCT04679740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102009212|NCT04679740|Immunologic Factors|immunologic factors|mesh-ancestor
102009213|NCT04679740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009214|NCT04672291|Poly I-C|poly i-c|mesh-list
102009215|NCT04672291|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102009216|NCT04672291|Poly ICLC|poly iclc|mesh-list
102009217|NCT04672291|Interferon Inducers|interferon inducers|mesh-ancestor
102009218|NCT04672291|Immunologic Factors|immunologic factors|mesh-ancestor
102009219|NCT04672291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009220|NCT04672291|Laxatives|laxatives|mesh-ancestor
102009221|NCT04672291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102009222|NCT04672291|Antiviral Agents|antiviral agents|mesh-ancestor
102009223|NCT04672291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102009224|NCT04668365|Prednisone|prednisone|mesh-list
102009225|NCT04668365|Cyclophosphamide|cyclophosphamide|mesh-list
102009226|NCT04668365|Rituximab|rituximab|mesh-list
102009227|NCT04668365|Vincristine|vincristine|mesh-list
102009228|NCT04668365|Epirubicin|epirubicin|mesh-list
102009229|NCT04668365|Zanubrutinib|zanubrutinib|mesh-list
102009230|NCT04668365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102009231|NCT04668365|Immunologic Factors|immunologic factors|mesh-ancestor
102009232|NCT04668365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009233|NCT04668365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101949467|NCT05261139|Nirmatrelvir|nirmatrelvir|mesh-list
101949468|NCT05261139|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101949469|NCT05261139|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101949470|NCT05261139|Protease Inhibitors|protease inhibitors|mesh-ancestor
102009234|NCT04668365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102009235|NCT04668365|Alkylating Agents|alkylating agents|mesh-ancestor
102009236|NCT04668365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009237|NCT04668365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009238|NCT04668365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102009239|NCT04668365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102009240|NCT04668365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102009241|NCT04668365|Glucocorticoids|glucocorticoids|mesh-ancestor
102009242|NCT04668365|Hormones|hormones|mesh-ancestor
102009243|NCT04668365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102009244|NCT04668365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102009245|NCT04668365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102009246|NCT04668365|Tubulin Modulators|tubulin modulators|mesh-ancestor
102009247|NCT04668365|Antimitotic Agents|antimitotic agents|mesh-ancestor
102009248|NCT04668365|Mitosis Modulators|mitosis modulators|mesh-ancestor
102009249|NCT04668365|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102009250|NCT04668365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102009251|NCT04668365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102009252|NCT04668365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102009253|NCT04668365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102009254|NCT04646395|Acalabrutinib|acalabrutinib|mesh-list
102009255|NCT04646395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009256|NCT04616729|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102009257|NCT04616729|Luteolytic Agents|luteolytic agents|mesh-ancestor
102009258|NCT04616729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102009262|NCT04616729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102009263|NCT04616729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102009264|NCT04616729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009265|NCT04496401|Tacrolimus|tacrolimus|mesh-list
102009266|NCT04496401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102009267|NCT04496401|Immunologic Factors|immunologic factors|mesh-ancestor
102009268|NCT04496401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009269|NCT04496401|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102009270|NCT04496401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102009271|NCT04496401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009272|NCT04433156|Prednisone|prednisone|mesh-list
102009273|NCT04433156|Cyclophosphamide|cyclophosphamide|mesh-list
102009274|NCT04433156|Rituximab|rituximab|mesh-list
102009275|NCT04433156|Bortezomib|bortezomib|mesh-list
102009276|NCT04433156|Epirubicin|epirubicin|mesh-list
102009277|NCT04433156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102009278|NCT04433156|Immunologic Factors|immunologic factors|mesh-ancestor
102009279|NCT04433156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009280|NCT04433156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102009281|NCT04433156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102009282|NCT04433156|Alkylating Agents|alkylating agents|mesh-ancestor
102009283|NCT04433156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009284|NCT04433156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009285|NCT04433156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102009286|NCT04433156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102009287|NCT04433156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102009288|NCT04433156|Glucocorticoids|glucocorticoids|mesh-ancestor
102009289|NCT04433156|Hormones|hormones|mesh-ancestor
102009290|NCT04433156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102009291|NCT04433156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102009292|NCT04433156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102009293|NCT04433156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102009294|NCT04433156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102009295|NCT04433156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102009296|NCT04388176|Compound 21|compound 21|mesh-list
102009297|NCT04388176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102009298|NCT04354129|Immunoglobulins|immunoglobulins|mesh-list
102009299|NCT04354129|Immunologic Factors|immunologic factors|mesh-ancestor
102009300|NCT04354129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009302|NCT04311489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102009303|NCT04311489|Autonomic Agents|autonomic agents|mesh-ancestor
102009304|NCT04311489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101949471|NCT05261139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101949472|NCT05261139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949473|NCT05261139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101949474|NCT05261139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101949475|NCT05261139|Antiviral Agents|antiviral agents|mesh-ancestor
101949476|NCT05261139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101271133|NCT01825551|Lenograstim|lenograstim|mesh-list
102009305|NCT04311489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009306|NCT04311489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102009307|NCT04311489|Respiratory System Agents|respiratory system agents|mesh-ancestor
102009308|NCT04311489|Diuretics|diuretics|mesh-ancestor
102009309|NCT04311489|Natriuretic Agents|natriuretic agents|mesh-ancestor
102009310|NCT04305405|Benralizumab|benralizumab|mesh-list
102009311|NCT04305405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102009312|NCT04305405|Respiratory System Agents|respiratory system agents|mesh-ancestor
102009313|NCT04258488|Vitamin K|vitamin k|mesh-list
102009314|NCT04258488|Warfarin|warfarin|mesh-list
102009315|NCT04258488|Rivaroxaban|rivaroxaban|mesh-list
102009316|NCT04258488|Vitamins|vitamins|mesh-ancestor
102009317|NCT04258488|Micronutrients|micronutrients|mesh-ancestor
102009318|NCT04258488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009319|NCT04258488|Anticoagulants|anticoagulants|mesh-ancestor
102009320|NCT04258488|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102009321|NCT04258488|Antithrombins|antithrombins|mesh-ancestor
102009322|NCT04258488|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102009323|NCT04258488|Protease Inhibitors|protease inhibitors|mesh-ancestor
102009324|NCT04258488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102009325|NCT04258488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009326|NCT04258488|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102009327|NCT04258488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102009328|NCT04258488|Hemostatics|hemostatics|mesh-ancestor
102009329|NCT04258488|Coagulants|coagulants|mesh-ancestor
102009330|NCT04255134|Adalimumab|adalimumab|mesh-list
102009331|NCT04255134|Abatacept|abatacept|mesh-list
102009332|NCT04255134|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102009333|NCT04255134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102009337|NCT04255134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102009338|NCT04255134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009339|NCT04255134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102009340|NCT04255134|Immunologic Factors|immunologic factors|mesh-ancestor
102009341|NCT04255134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009342|NCT04214626|Prednisone|prednisone|mesh-list
102009343|NCT04214626|Cyclophosphamide|cyclophosphamide|mesh-list
102009344|NCT04214626|Rituximab|rituximab|mesh-list
102009345|NCT04214626|Methotrexate|methotrexate|mesh-list
102009346|NCT04214626|Vincristine|vincristine|mesh-list
102009347|NCT04214626|Lenalidomide|lenalidomide|mesh-list
102009348|NCT04214626|Epirubicin|epirubicin|mesh-list
102009349|NCT04214626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102009350|NCT04214626|Immunologic Factors|immunologic factors|mesh-ancestor
102009351|NCT04214626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009352|NCT04214626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102009353|NCT04214626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102009354|NCT04214626|Alkylating Agents|alkylating agents|mesh-ancestor
102009355|NCT04214626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009356|NCT04214626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009357|NCT04214626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102009358|NCT04214626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102009359|NCT04214626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102009360|NCT04214626|Glucocorticoids|glucocorticoids|mesh-ancestor
102009361|NCT04214626|Hormones|hormones|mesh-ancestor
102009362|NCT04214626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102009363|NCT04214626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102009364|NCT04214626|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102009365|NCT04214626|Abortifacient Agents|abortifacient agents|mesh-ancestor
102009366|NCT04214626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101518623|NCT05093205|Antimetabolites|antimetabolites|mesh-ancestor
102009367|NCT04214626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102009368|NCT04214626|Antimetabolites|antimetabolites|mesh-ancestor
102009369|NCT04214626|Dermatologic Agents|dermatologic agents|mesh-ancestor
102009370|NCT04214626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102009371|NCT04214626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101949477|NCT05261139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101949478|NCT05261139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101949479|NCT05252416|Carboplatin|carboplatin|mesh-list
101949480|NCT05252416|Fulvestrant|fulvestrant|mesh-list
101271198|NCT01825993|Anesthetics, Local|anesthetics, local|mesh-ancestor
102009372|NCT04214626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101729190|NCT01019785|Vitamin D|vitamin d|mesh-list
102009373|NCT04214626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102009374|NCT04214626|Tubulin Modulators|tubulin modulators|mesh-ancestor
102009375|NCT04214626|Antimitotic Agents|antimitotic agents|mesh-ancestor
102009376|NCT04214626|Mitosis Modulators|mitosis modulators|mesh-ancestor
102009377|NCT04214626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102009378|NCT04214626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102009379|NCT04214626|Growth Substances|growth substances|mesh-ancestor
102009380|NCT04214626|Growth Inhibitors|growth inhibitors|mesh-ancestor
102009381|NCT04214626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102009382|NCT04214626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102009383|NCT04214626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102009384|NCT04192370|Cannabidiol|cannabidiol|mesh-list
102009385|NCT04192370|Anticonvulsants|anticonvulsants|mesh-ancestor
102009386|NCT04180371|Nivolumab|nivolumab|mesh-list
102009387|NCT04180371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102009388|NCT04180371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009389|NCT04180371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102009390|NCT04180371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009391|NCT04165083|Pembrolizumab|pembrolizumab|mesh-list
102009392|NCT04165083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102009393|NCT04165083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009394|NCT04165083|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102009395|NCT04165083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009396|NCT04160910|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
102009397|NCT04160910|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102009398|NCT04160910|Antidepressive Agents|antidepressive agents|mesh-ancestor
102009399|NCT04160910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102009400|NCT04125472|Lumasiran|lumasiran|mesh-list
102009401|NCT04125472|Renal Agents|renal agents|mesh-ancestor
102009402|NCT04067037|Vincristine|vincristine|mesh-list
102009403|NCT04067037|Epirubicin|epirubicin|mesh-list
102009404|NCT04067037|Dacarbazine|dacarbazine|mesh-list
102009408|NCT04067037|Antimitotic Agents|antimitotic agents|mesh-ancestor
102009409|NCT04067037|Mitosis Modulators|mitosis modulators|mesh-ancestor
102009410|NCT04067037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009411|NCT04067037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102009412|NCT04067037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102009413|NCT04067037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102009414|NCT04067037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102009415|NCT04067037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102009416|NCT04067037|Alkylating Agents|alkylating agents|mesh-ancestor
102009418|NCT03668119|Ipilimumab|ipilimumab|mesh-list
102009419|NCT03668119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102009420|NCT03668119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009421|NCT03668119|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101518649|NCT02469155|Risperidone|risperidone|mesh-list
102009422|NCT03668119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009423|NCT03632941|Pembrolizumab|pembrolizumab|mesh-list
102009424|NCT03632941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102009425|NCT03632941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009426|NCT03632941|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102009427|NCT03632941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009428|NCT03601507|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
102009429|NCT03601507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102009430|NCT03601507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009431|NCT03568058|Pembrolizumab|pembrolizumab|mesh-list
102009432|NCT03568058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102009433|NCT03568058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009434|NCT03568058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102009435|NCT03568058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009436|NCT03514017|Pembrolizumab|pembrolizumab|mesh-list
102009437|NCT03514017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101949481|NCT05252416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949482|NCT05252416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102009438|NCT03514017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009439|NCT03514017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102009440|NCT03514017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009441|NCT03502785|Atezolizumab|atezolizumab|mesh-list
102009442|NCT03502785|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102009443|NCT03502785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009444|NCT03502785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102009445|NCT03502785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009446|NCT03495960|Rituximab|rituximab|mesh-list
102009447|NCT03495960|Methotrexate|methotrexate|mesh-list
102009448|NCT03495960|Lenalidomide|lenalidomide|mesh-list
102009449|NCT03495960|Temozolomide|temozolomide|mesh-list
102009450|NCT03495960|Procarbazine|procarbazine|mesh-list
102009451|NCT03495960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102009452|NCT03495960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009453|NCT03495960|Immunologic Factors|immunologic factors|mesh-ancestor
102009454|NCT03495960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009455|NCT03495960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102009456|NCT03495960|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102009457|NCT03495960|Abortifacient Agents|abortifacient agents|mesh-ancestor
102009458|NCT03495960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102009459|NCT03495960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102009460|NCT03495960|Antimetabolites|antimetabolites|mesh-ancestor
102009461|NCT03495960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009462|NCT03495960|Dermatologic Agents|dermatologic agents|mesh-ancestor
102009463|NCT03495960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102009464|NCT03495960|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102009465|NCT03495960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102009466|NCT03495960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102009467|NCT03495960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102009468|NCT03495960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102009469|NCT03495960|Growth Substances|growth substances|mesh-ancestor
102009470|NCT03495960|Growth Inhibitors|growth inhibitors|mesh-ancestor
102009471|NCT03495960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102009472|NCT03495960|Alkylating Agents|alkylating agents|mesh-ancestor
102009482|NCT03351296|Temozolomide|temozolomide|mesh-list
102009483|NCT03351296|Streptozocin|streptozocin|mesh-list
102009484|NCT03351296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102009485|NCT03351296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009486|NCT03351296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102009487|NCT03351296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102009488|NCT03351296|Growth Substances|growth substances|mesh-ancestor
102009489|NCT03351296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009490|NCT03351296|Growth Inhibitors|growth inhibitors|mesh-ancestor
102009491|NCT03351296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102009492|NCT03351296|Antimetabolites|antimetabolites|mesh-ancestor
102009493|NCT03351296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009494|NCT03351296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102009495|NCT03351296|Alkylating Agents|alkylating agents|mesh-ancestor
102009496|NCT03351296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102009497|NCT03345823|Upadacitinib|upadacitinib|mesh-list
102009498|NCT03345823|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102009499|NCT03345823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102009500|NCT03345823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102009501|NCT03345823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009502|NCT03345823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102009503|NCT03203850|Deferasirox|deferasirox|mesh-list
102009504|NCT03203850|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102009505|NCT03203850|Chelating Agents|chelating agents|mesh-ancestor
102009506|NCT03203850|Sequestering Agents|sequestering agents|mesh-ancestor
102009507|NCT03203850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009508|NCT03138161|Nivolumab|nivolumab|mesh-list
102009509|NCT03138161|Ipilimumab|ipilimumab|mesh-list
102009510|NCT03138161|Trabectedin|trabectedin|mesh-list
102009511|NCT03138161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102009512|NCT03138161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009513|NCT03138161|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102009514|NCT03138161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009515|NCT03138161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101949483|NCT05252416|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101949484|NCT05252416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101949485|NCT05252416|Hormone Antagonists|hormone antagonists|mesh-ancestor
101949486|NCT05252416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101949487|NCT05252416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009516|NCT03138161|Alkylating Agents|alkylating agents|mesh-ancestor
102009517|NCT03091075|Oxandrolone|oxandrolone|mesh-list
102009518|NCT03091075|Androgens|androgens|mesh-ancestor
102009519|NCT03091075|Hormones|hormones|mesh-ancestor
102009520|NCT03091075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102009521|NCT03091075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009522|NCT03091075|Anabolic Agents|anabolic agents|mesh-ancestor
102009523|NCT03031821|Metformin|metformin|mesh-list
102009524|NCT03031821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102009525|NCT03031821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009526|NCT02907359|Guadecitabine|guadecitabine|mesh-list
102009527|NCT02907359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009528|NCT02714205|Nitroglycerin|nitroglycerin|mesh-list
102009529|NCT02714205|Vasodilator Agents|vasodilator agents|mesh-ancestor
102009530|NCT02669173|Bevacizumab|bevacizumab|mesh-list
102009531|NCT02669173|Capecitabine|capecitabine|mesh-list
102009532|NCT02669173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102009533|NCT02669173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009534|NCT02669173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102009535|NCT02669173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102009536|NCT02669173|Growth Substances|growth substances|mesh-ancestor
102009537|NCT02669173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009538|NCT02669173|Growth Inhibitors|growth inhibitors|mesh-ancestor
101464518|NCT04561921|Anesthetics|anesthetics|mesh-ancestor
102009543|NCT02647437|Anticonvulsants|anticonvulsants|mesh-ancestor
102009544|NCT02647437|Nootropic Agents|nootropic agents|mesh-ancestor
102009545|NCT02329080|Cytarabine|cytarabine|mesh-list
102009546|NCT02329080|Rituximab|rituximab|mesh-list
102009547|NCT02329080|Methotrexate|methotrexate|mesh-list
102009548|NCT02329080|Etoposide|etoposide|mesh-list
102009549|NCT02329080|Ifosfamide|ifosfamide|mesh-list
102009550|NCT02329080|Thiotepa|thiotepa|mesh-list
102009551|NCT02329080|Carmustine|carmustine|mesh-list
102009552|NCT02329080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102009553|NCT02329080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009554|NCT02329080|Immunologic Factors|immunologic factors|mesh-ancestor
102009555|NCT02329080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009556|NCT02329080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102009557|NCT02329080|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102009558|NCT02329080|Abortifacient Agents|abortifacient agents|mesh-ancestor
102009559|NCT02329080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102009560|NCT02329080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102009561|NCT02329080|Antimetabolites|antimetabolites|mesh-ancestor
102009562|NCT02329080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009563|NCT02329080|Dermatologic Agents|dermatologic agents|mesh-ancestor
102009564|NCT02329080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102009565|NCT02329080|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102009566|NCT02329080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102009567|NCT02329080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102009568|NCT02329080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102009569|NCT02329080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102009570|NCT02329080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102009571|NCT02329080|Antiviral Agents|antiviral agents|mesh-ancestor
102009572|NCT02329080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102009573|NCT02329080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102009574|NCT02329080|Alkylating Agents|alkylating agents|mesh-ancestor
102009575|NCT02329080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102009576|NCT02227927|Domperidone|domperidone|mesh-list
102009577|NCT02227927|Antiemetics|antiemetics|mesh-ancestor
102009578|NCT02227927|Autonomic Agents|autonomic agents|mesh-ancestor
102009579|NCT02227927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102009580|NCT02227927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009581|NCT02227927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102009582|NCT02227927|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102009583|NCT02227927|Dopamine Agents|dopamine agents|mesh-ancestor
102009584|NCT02227927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101949488|NCT05242315|Tacrolimus|tacrolimus|mesh-list
101949489|NCT05242315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101949490|NCT05242315|Immunologic Factors|immunologic factors|mesh-ancestor
101949491|NCT05242315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009585|NCT02227927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009586|NCT02152995|Iodine|iodine|mesh-list
102009587|NCT02152995|Cadexomer iodine|cadexomer iodine|mesh-list
102009588|NCT02152995|Trametinib|trametinib|mesh-list
102009589|NCT02152995|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102009590|NCT02152995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102009591|NCT02152995|Trace Elements|trace elements|mesh-ancestor
102009592|NCT02152995|Micronutrients|micronutrients|mesh-ancestor
102009593|NCT02152995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009594|NCT02152995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009595|NCT02152995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102009596|NCT02152995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102009597|NCT02152995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009598|NCT01820910|Doxycycline|doxycycline|mesh-list
102009599|NCT01820910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102009600|NCT01820910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102009601|NCT01820910|Antimalarials|antimalarials|mesh-ancestor
102009602|NCT01820910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102009603|NCT01820910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102009604|NCT01808599|Rituximab|rituximab|mesh-list
102009605|NCT01808599|Chlorambucil|chlorambucil|mesh-list
102009606|NCT01808599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102009607|NCT01808599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009608|NCT01808599|Immunologic Factors|immunologic factors|mesh-ancestor
102009609|NCT01808599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009610|NCT01808599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102009611|NCT01808599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102009617|NCT00071071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009618|NCT00071071|Immunologic Factors|immunologic factors|mesh-ancestor
102009619|NCT00071071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009620|NCT05465278|Alirocumab|alirocumab|mesh-list
102009621|NCT05465278|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102009622|NCT05465278|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102009623|NCT05465278|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102009624|NCT05465278|Antimetabolites|antimetabolites|mesh-ancestor
102009625|NCT05465278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009626|NCT05465278|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102009627|NCT05465278|Protease Inhibitors|protease inhibitors|mesh-ancestor
102009628|NCT05465278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102009629|NCT05465278|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102009630|NCT01302275|Oxcarbazepine|oxcarbazepine|mesh-list
102009631|NCT01302275|Anticonvulsants|anticonvulsants|mesh-ancestor
102009632|NCT01302275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102009633|NCT01302275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102009634|NCT01302275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102009635|NCT01302275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009636|NCT01302275|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102009637|NCT01302275|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102009638|NCT03339544|Celecoxib|celecoxib|mesh-list
102009639|NCT03339544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102009640|NCT03339544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102009641|NCT03339544|Analgesics|analgesics|mesh-ancestor
102009642|NCT03339544|Sensory System Agents|sensory system agents|mesh-ancestor
102009643|NCT03339544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102009644|NCT03339544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009645|NCT03339544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102009646|NCT03339544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102009647|NCT03339544|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102009648|NCT03339544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102009649|NCT03339544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102009650|NCT03339544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009651|NCT03332602|Vitamins|vitamins|mesh-list
102009652|NCT03332602|Folic Acid|folic acid|mesh-list
102009653|NCT03332602|Vitamin A|vitamin a|mesh-list
102009654|NCT03332602|Retinol palmitate|retinol palmitate|mesh-list
102009655|NCT03332602|Fesoterodine|fesoterodine|mesh-list
102009656|NCT03332602|Hyaluronic Acid|hyaluronic acid|mesh-list
102009657|NCT03332602|Micronutrients|micronutrients|mesh-ancestor
101949492|NCT05242315|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101949493|NCT05242315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101949494|NCT05242315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949495|NCT05190770|Triamcinolone|triamcinolone|mesh-list
101949496|NCT05190770|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101949497|NCT05190770|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101271487|NCT01828385|Analgesics|analgesics|mesh-ancestor
102009658|NCT03332602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009659|NCT03332602|Hematinics|hematinics|mesh-ancestor
102009660|NCT03332602|Vitamin B Complex|vitamin b complex|mesh-ancestor
102009661|NCT03332602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102009662|NCT03332602|Immunologic Factors|immunologic factors|mesh-ancestor
102009663|NCT03332602|Viscosupplements|viscosupplements|mesh-ancestor
102009664|NCT03332602|Protective Agents|protective agents|mesh-ancestor
102009665|NCT03332602|Antioxidants|antioxidants|mesh-ancestor
102009666|NCT03332602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009667|NCT03332602|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102009668|NCT03332602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009669|NCT03332602|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102009670|NCT03332602|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102009671|NCT03332602|Cholinergic Agents|cholinergic agents|mesh-ancestor
102009672|NCT03332602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102009673|NCT03332602|Urological Agents|urological agents|mesh-ancestor
102009674|NCT01302353|Isoflurane|isoflurane|mesh-list
102009675|NCT01302353|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102009676|NCT01302353|Anesthetics, General|anesthetics, general|mesh-ancestor
102009677|NCT01302353|Anesthetics|anesthetics|mesh-ancestor
102009678|NCT01302353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102009679|NCT01302353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009680|NCT03812315|Propolis|propolis|mesh-list
102009681|NCT03812315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102009682|NCT03332524|Chlorpheniramine|chlorpheniramine|mesh-list
102009688|NCT03332524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102009689|NCT03332524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009690|NCT03332524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102009691|NCT03332524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102009692|NCT03332524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102009693|NCT03332524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102009694|NCT03332524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009695|NCT03332524|Antipruritics|antipruritics|mesh-ancestor
102009696|NCT03332524|Dermatologic Agents|dermatologic agents|mesh-ancestor
102009697|NCT03332524|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102009698|NCT03332524|Histamine Antagonists|histamine antagonists|mesh-ancestor
102009699|NCT03332524|Histamine Agents|histamine agents|mesh-ancestor
102009700|NCT03332524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102009701|NCT03332524|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102009702|NCT02499484|Nitroglycerin|nitroglycerin|mesh-list
102009703|NCT02499484|Vasodilator Agents|vasodilator agents|mesh-ancestor
102009704|NCT03812003|Remifentanil|remifentanil|mesh-list
102009705|NCT03812003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102009706|NCT03812003|Narcotics|narcotics|mesh-ancestor
102009707|NCT03812003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102009708|NCT03812003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009709|NCT03812003|Analgesics|analgesics|mesh-ancestor
102009710|NCT03812003|Sensory System Agents|sensory system agents|mesh-ancestor
102009711|NCT03812003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102009712|NCT04874610|Methylprednisolone|methylprednisolone|mesh-list
102009713|NCT04874610|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102009714|NCT04874610|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102009715|NCT04874610|Prednisolone|prednisolone|mesh-list
102009716|NCT04874610|Prednisolone acetate|prednisolone acetate|mesh-list
102009717|NCT04874610|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102009718|NCT04874610|Prednisolone phosphate|prednisolone phosphate|mesh-list
102009719|NCT04874610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102009720|NCT04874610|Antiemetics|antiemetics|mesh-ancestor
102009721|NCT04874610|Autonomic Agents|autonomic agents|mesh-ancestor
102009722|NCT04874610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102009723|NCT04874610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009724|NCT04874610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102009725|NCT04874610|Glucocorticoids|glucocorticoids|mesh-ancestor
102009726|NCT04874610|Hormones|hormones|mesh-ancestor
101949498|NCT05190770|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101949499|NCT05190770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101949500|NCT05190770|Glucocorticoids|glucocorticoids|mesh-ancestor
101949501|NCT05190770|Hormones|hormones|mesh-ancestor
101949502|NCT05190770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102009727|NCT04874610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102009728|NCT04874610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102009729|NCT04874610|Protective Agents|protective agents|mesh-ancestor
102009730|NCT04874610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102009731|NCT04874610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009732|NCT03518125|Vaccines|vaccines|mesh-list
102009733|NCT03518125|Immunologic Factors|immunologic factors|mesh-ancestor
102009734|NCT03518125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009735|NCT02492230|Warfarin|warfarin|mesh-list
102009736|NCT02492230|Anticoagulants|anticoagulants|mesh-ancestor
102009737|NCT03169530|Ethanol|ethanol|mesh-list
102009738|NCT03169530|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102009739|NCT03169530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102009740|NCT03169530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102009741|NCT03169530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009742|NCT03723187|Heparin|heparin|mesh-list
102009743|NCT03723187|Anticoagulants|anticoagulants|mesh-ancestor
102009744|NCT03723187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102009745|NCT03723187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101518758|NCT03147612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102009746|NCT03723187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009747|NCT02440230|Anastrozole|anastrozole|mesh-list
102009748|NCT02440230|Exemestane|exemestane|mesh-list
102009749|NCT02440230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102009750|NCT02440230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009751|NCT02440230|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102009752|NCT02440230|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102009753|NCT02440230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102009754|NCT02440230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009759|NCT03478891|Ansuvimab|ansuvimab|mesh-list
102009760|NCT03478891|Antiviral Agents|antiviral agents|mesh-ancestor
102009761|NCT03478891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102009762|NCT00706966|Dutasteride|dutasteride|mesh-list
102009763|NCT00706966|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102009764|NCT00706966|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102009765|NCT00706966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102009766|NCT00706966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009767|NCT00706966|Hormone Antagonists|hormone antagonists|mesh-ancestor
102009768|NCT00706966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102009769|NCT00706966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009770|NCT01330524|Triamcinolone|triamcinolone|mesh-list
102009771|NCT01330524|Bevacizumab|bevacizumab|mesh-list
102009772|NCT01330524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102009773|NCT01330524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009774|NCT01330524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102009775|NCT01330524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102009776|NCT01330524|Growth Substances|growth substances|mesh-ancestor
102009777|NCT01330524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009778|NCT01330524|Growth Inhibitors|growth inhibitors|mesh-ancestor
102009779|NCT01330524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102009780|NCT01330524|Glucocorticoids|glucocorticoids|mesh-ancestor
102009781|NCT01330524|Hormones|hormones|mesh-ancestor
102009782|NCT01330524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102009783|NCT01560065|Folic Acid|folic acid|mesh-list
102009784|NCT01560065|Vitamin B Complex|vitamin b complex|mesh-list
102009785|NCT01560065|Inositol|inositol|mesh-list
102009786|NCT01560065|Hematinics|hematinics|mesh-ancestor
102009787|NCT01560065|Vitamins|vitamins|mesh-ancestor
102009788|NCT01560065|Micronutrients|micronutrients|mesh-ancestor
102009789|NCT01560065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009790|NCT01302587|Albuterol|albuterol|mesh-list
102009791|NCT01302587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102009792|NCT01302587|Autonomic Agents|autonomic agents|mesh-ancestor
102009793|NCT01302587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102009794|NCT01302587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009795|NCT01302587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102009796|NCT01302587|Respiratory System Agents|respiratory system agents|mesh-ancestor
101949503|NCT05190770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949504|NCT05190770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101949505|NCT05190770|Immunologic Factors|immunologic factors|mesh-ancestor
101949506|NCT05190770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101949507|NCT05190770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009797|NCT01302587|Tocolytic Agents|tocolytic agents|mesh-ancestor
102009798|NCT01302587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102009799|NCT01302587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102009800|NCT01302587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102009801|NCT01302587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102009802|NCT01302587|Adrenergic Agents|adrenergic agents|mesh-ancestor
102009803|NCT01302587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102009804|NCT01302587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009805|NCT03723109|Anesthetics|anesthetics|mesh-list
102009806|NCT03723109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102009807|NCT03723109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009808|NCT03018288|Pembrolizumab|pembrolizumab|mesh-list
102009809|NCT03018288|Temozolomide|temozolomide|mesh-list
102009810|NCT03018288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102009811|NCT03018288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009812|NCT03018288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102009813|NCT03018288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009814|NCT03018288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102009815|NCT03018288|Alkylating Agents|alkylating agents|mesh-ancestor
102009816|NCT03515941|Leucovorin|leucovorin|mesh-list
102009817|NCT03515941|Fluorouracil|fluorouracil|mesh-list
102009818|NCT03515941|Capecitabine|capecitabine|mesh-list
102009819|NCT03515941|Oxaliplatin|oxaliplatin|mesh-list
102009820|NCT03515941|Antimetabolites|antimetabolites|mesh-ancestor
102009821|NCT03515941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009822|NCT03515941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102009823|NCT03515941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009824|NCT03515941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102009847|NCT02492074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102009848|NCT03819647|Stiripentol|stiripentol|mesh-list
102009849|NCT03819647|Anticonvulsants|anticonvulsants|mesh-ancestor
102009850|NCT02498938|Protease Inhibitors|protease inhibitors|mesh-list
102009851|NCT02498938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102009852|NCT02498938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009853|NCT02498860|Pemetrexed|pemetrexed|mesh-list
102009854|NCT02498860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009855|NCT02498860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102009856|NCT02498860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009857|NCT02498860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102009858|NCT02498860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102009859|NCT03011034|Daratumumab|daratumumab|mesh-list
102009860|NCT03011034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009861|NCT05464966|Insulin|insulin|mesh-list
102009862|NCT05464966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102009863|NCT05464966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009864|NCT03515629|Pembrolizumab|pembrolizumab|mesh-list
102009865|NCT03515629|Cemiplimab|cemiplimab|mesh-list
102009866|NCT03515629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102009867|NCT03515629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009868|NCT03515629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102009869|NCT03515629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009870|NCT01302821|Tryptophan|tryptophan|mesh-list
102009871|NCT01302821|Vaccines|vaccines|mesh-list
102009872|NCT01302821|Immunologic Factors|immunologic factors|mesh-ancestor
102009873|NCT01302821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009874|NCT01302821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102009875|NCT01302821|Antidepressive Agents|antidepressive agents|mesh-ancestor
102009876|NCT01302821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102009877|NCT03331432|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
102009878|NCT03331432|Antiviral Agents|antiviral agents|mesh-ancestor
101464876|NCT02212561|Cytarabine|cytarabine|mesh-list
102009884|NCT03512353|Antiemetics|antiemetics|mesh-ancestor
102009885|NCT03512353|Autonomic Agents|autonomic agents|mesh-ancestor
102009886|NCT03512353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101949508|NCT05178862|Fluconazole|fluconazole|mesh-list
101949509|NCT05178862|Caspofungin|caspofungin|mesh-list
101949510|NCT05178862|Micafungin|micafungin|mesh-list
101949511|NCT05178862|Anidulafungin|anidulafungin|mesh-list
101949512|NCT05178862|Ibrexafungerp|ibrexafungerp|mesh-list
101949513|NCT05178862|Echinocandins|echinocandins|mesh-list
101271702|NCT01830270|Paclitaxel|paclitaxel|mesh-list
102009887|NCT03512353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009888|NCT03512353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102009889|NCT03512353|Glucocorticoids|glucocorticoids|mesh-ancestor
102009890|NCT03512353|Hormones|hormones|mesh-ancestor
102009891|NCT03512353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102009892|NCT03512353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102009893|NCT03512353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009894|NCT04959006|Antioxidants|antioxidants|mesh-list
102009895|NCT04959006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009896|NCT04959006|Protective Agents|protective agents|mesh-ancestor
102009897|NCT04959006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009898|NCT01300637|Metformin|metformin|mesh-list
102009899|NCT01300637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102009900|NCT01300637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009901|NCT04851522|Sodium Hypochlorite|sodium hypochlorite|mesh-list
102009902|NCT04851522|Eusol|eusol|mesh-list
102009903|NCT04851522|Petrolatum|petrolatum|mesh-list
102009904|NCT04851522|Disinfectants|disinfectants|mesh-ancestor
102009905|NCT04851522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102009906|NCT04851522|Emollients|emollients|mesh-ancestor
102009907|NCT04851522|Dermatologic Agents|dermatologic agents|mesh-ancestor
102009908|NCT03512275|Antibodies|antibodies|mesh-list
102009909|NCT03512275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102009910|NCT03512275|Immunologic Factors|immunologic factors|mesh-ancestor
102009911|NCT03512275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009912|NCT03809897|Nicotine|nicotine|mesh-list
102009913|NCT03809897|Varenicline|varenicline|mesh-list
102009914|NCT03809897|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102009915|NCT03809897|Autonomic Agents|autonomic agents|mesh-ancestor
102009916|NCT03809897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102009917|NCT03809897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009918|NCT03809897|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102009919|NCT03809897|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102009920|NCT03809897|Cholinergic Agents|cholinergic agents|mesh-ancestor
102009921|NCT03809897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102009922|NCT03809897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009923|NCT03473197|Diacerein|diacerein|mesh-list
102009924|NCT03473197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102009925|NCT01560299|Methimazole|methimazole|mesh-list
102009926|NCT01560299|Antithyroid Agents|antithyroid agents|mesh-ancestor
102009927|NCT01560299|Hormone Antagonists|hormone antagonists|mesh-ancestor
102009928|NCT01560299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102009929|NCT01560299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009930|NCT03337828|Ethanol|ethanol|mesh-list
102009931|NCT03337828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102009932|NCT03337828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102009933|NCT03337828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102009934|NCT03337828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009935|NCT03510715|Nicotinic Acids|nicotinic acids|mesh-list
102009936|NCT03510715|Niacin|niacin|mesh-list
102009937|NCT03510715|Niacinamide|niacinamide|mesh-list
102009938|NCT03510715|Atorvastatin|atorvastatin|mesh-list
102009939|NCT03510715|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102009940|NCT03510715|Simvastatin|simvastatin|mesh-list
102009941|NCT03510715|Ezetimibe|ezetimibe|mesh-list
102009942|NCT03510715|Pravastatin|pravastatin|mesh-list
102009943|NCT03510715|Alirocumab|alirocumab|mesh-list
102009944|NCT03510715|Lovastatin|lovastatin|mesh-list
102009945|NCT03510715|Cholestyramine Resin|cholestyramine resin|mesh-list
102009946|NCT03510715|Fenofibrate|fenofibrate|mesh-list
102009947|NCT03510715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102009948|NCT03510715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102009949|NCT03510715|Antimetabolites|antimetabolites|mesh-ancestor
102009950|NCT03510715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009951|NCT03510715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101464920|NCT00268593|Glucocorticoids|glucocorticoids|mesh-ancestor
102009955|NCT03510715|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102009956|NCT03510715|Protease Inhibitors|protease inhibitors|mesh-ancestor
101949514|NCT05178862|Antifungal Agents|antifungal agents|mesh-ancestor
101949515|NCT05178862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102009957|NCT03510715|Vitamin B Complex|vitamin b complex|mesh-ancestor
102009958|NCT03510715|Vitamins|vitamins|mesh-ancestor
102009959|NCT03510715|Micronutrients|micronutrients|mesh-ancestor
102009960|NCT03510715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009961|NCT03510715|Vasodilator Agents|vasodilator agents|mesh-ancestor
102009962|NCT03815279|Dexamethasone|dexamethasone|mesh-list
102009963|NCT03815279|Lenalidomide|lenalidomide|mesh-list
102009964|NCT03815279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102009965|NCT03815279|Antiemetics|antiemetics|mesh-ancestor
102009966|NCT03815279|Autonomic Agents|autonomic agents|mesh-ancestor
102009967|NCT03815279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102009968|NCT03815279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009969|NCT03815279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102009970|NCT03815279|Glucocorticoids|glucocorticoids|mesh-ancestor
102009971|NCT03815279|Hormones|hormones|mesh-ancestor
102009972|NCT03815279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102009973|NCT03815279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102009974|NCT03815279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009975|NCT03815279|Immunologic Factors|immunologic factors|mesh-ancestor
102009976|NCT03815279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102009977|NCT03815279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102009978|NCT03815279|Growth Substances|growth substances|mesh-ancestor
102009979|NCT03815279|Growth Inhibitors|growth inhibitors|mesh-ancestor
102009980|NCT03814733|Ketamine|ketamine|mesh-list
102009981|NCT03814733|Alprazolam|alprazolam|mesh-list
102009982|NCT03814733|Analgesics|analgesics|mesh-ancestor
102009983|NCT03814733|Sensory System Agents|sensory system agents|mesh-ancestor
102009984|NCT03814733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102009985|NCT03814733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009986|NCT03814733|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102009987|NCT03814733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102009988|NCT03814733|Anesthetics, General|anesthetics, general|mesh-ancestor
102009989|NCT03814733|Anesthetics|anesthetics|mesh-ancestor
102009990|NCT03814733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102009991|NCT03814733|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102009992|NCT03814733|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102009993|NCT03814733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102009994|NCT03814733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009995|NCT03814733|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102009996|NCT03814733|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102009997|NCT03814733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102009998|NCT03814733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102009999|NCT03814733|GABA Modulators|gaba modulators|mesh-ancestor
102010000|NCT03814733|GABA Agents|gaba agents|mesh-ancestor
102010001|NCT03721627|Sofosbuvir|sofosbuvir|mesh-list
102010002|NCT03721627|Ledipasvir|ledipasvir|mesh-list
102010003|NCT03721627|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102010004|NCT03721627|Antiviral Agents|antiviral agents|mesh-ancestor
102010005|NCT03721627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102010006|NCT03811223|Evolocumab|evolocumab|mesh-list
102010007|NCT03811223|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102010008|NCT03811223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102010009|NCT03811223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102010010|NCT03811223|Antimetabolites|antimetabolites|mesh-ancestor
102010011|NCT03811223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010012|NCT03811223|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102010013|NCT03811223|Protease Inhibitors|protease inhibitors|mesh-ancestor
102010014|NCT03811223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102010015|NCT03811223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102010016|NCT03723031|Misoprostol|misoprostol|mesh-list
102010017|NCT03723031|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102010018|NCT03723031|Abortifacient Agents|abortifacient agents|mesh-ancestor
102010019|NCT03723031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101518864|NCT02884206|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101518865|NCT02884206|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101518866|NCT02884206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518867|NCT04961541|Vaccines|vaccines|mesh-list
101518868|NCT04961541|Immunologic Factors|immunologic factors|mesh-ancestor
101518869|NCT04961541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518870|NCT02326454|Talaporfin|talaporfin|mesh-list
101518871|NCT02326454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102010020|NCT03723031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010021|NCT03723031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102010022|NCT03723031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102010023|NCT03723031|Oxytocics|oxytocics|mesh-ancestor
102010024|NCT03722875|Apatinib|apatinib|mesh-list
102010025|NCT03722875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102010028|NCT03722875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010031|NCT04860713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102010032|NCT04860713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102010033|NCT04860713|Analgesics|analgesics|mesh-ancestor
101949516|NCT05178862|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101949517|NCT05178862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101518884|NCT02324309|Insulin Lispro|insulin lispro|mesh-list
101518885|NCT02324309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101949518|NCT05178862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101271837|NCT01836614|Sensory System Agents|sensory system agents|mesh-ancestor
102010034|NCT04860713|Sensory System Agents|sensory system agents|mesh-ancestor
102010035|NCT04860713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102010036|NCT04860713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010037|NCT04860713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102010038|NCT04860713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102010039|NCT04860713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102010040|NCT04860713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102010041|NCT04860713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010042|NCT04860713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102010043|NCT04860713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102010044|NCT04860713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102010045|NCT04860713|Antipyretics|antipyretics|mesh-ancestor
102010046|NCT04860713|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102010047|NCT04860713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102010048|NCT04860713|Anesthetics, General|anesthetics, general|mesh-ancestor
102010049|NCT04860713|Anesthetics|anesthetics|mesh-ancestor
102010050|NCT04860713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102010051|NCT04860713|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102010052|NCT04860713|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102010053|NCT04860713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102010054|NCT03528577|Albuterol|albuterol|mesh-list
102010055|NCT03528577|Procaterol|procaterol|mesh-list
102010056|NCT03528577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102010057|NCT03528577|Autonomic Agents|autonomic agents|mesh-ancestor
102010058|NCT03528577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102010059|NCT03528577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010060|NCT03528577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102010061|NCT03528577|Respiratory System Agents|respiratory system agents|mesh-ancestor
102010062|NCT03528577|Tocolytic Agents|tocolytic agents|mesh-ancestor
102010063|NCT03528577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102010064|NCT03528577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102010065|NCT03528577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102010066|NCT03528577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102010067|NCT03528577|Adrenergic Agents|adrenergic agents|mesh-ancestor
102010068|NCT03528577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102010069|NCT03528577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010070|NCT03528577|Sympathomimetics|sympathomimetics|mesh-ancestor
102010071|NCT05432414|Dexamethasone|dexamethasone|mesh-list
102010072|NCT05432414|Bortezomib|bortezomib|mesh-list
102010073|NCT05432414|Pomalidomide|pomalidomide|mesh-list
102010074|NCT05432414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102010075|NCT05432414|Antiemetics|antiemetics|mesh-ancestor
102010076|NCT05432414|Autonomic Agents|autonomic agents|mesh-ancestor
102010077|NCT05432414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102010078|NCT05432414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010079|NCT05432414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102010080|NCT05432414|Glucocorticoids|glucocorticoids|mesh-ancestor
102010081|NCT05432414|Hormones|hormones|mesh-ancestor
102010082|NCT05432414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102010083|NCT05432414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101518947|NCT04857645|Antimetabolites|antimetabolites|mesh-ancestor
102010084|NCT05432414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102010085|NCT05432414|Immunologic Factors|immunologic factors|mesh-ancestor
102010086|NCT05432414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102010087|NCT05432414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102010088|NCT05432414|Growth Substances|growth substances|mesh-ancestor
102010089|NCT05432414|Growth Inhibitors|growth inhibitors|mesh-ancestor
102010090|NCT03796403|Diclofenac|diclofenac|mesh-list
102010091|NCT03796403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102010092|NCT03796403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102010093|NCT03796403|Analgesics|analgesics|mesh-ancestor
102010094|NCT03796403|Sensory System Agents|sensory system agents|mesh-ancestor
102010095|NCT03796403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102010096|NCT03796403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465061|NCT02212990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102010099|NCT03796403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102010100|NCT03796403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101949519|NCT05178862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949520|NCT05178862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101949521|NCT05178862|Hormone Antagonists|hormone antagonists|mesh-ancestor
101271905|NCT01837446|Narcotics|narcotics|mesh-ancestor
102010101|NCT03796403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010103|NCT00706654|Antidepressive Agents|antidepressive agents|mesh-ancestor
102010104|NCT00706654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102010105|NCT00706654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102010106|NCT00706654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102010107|NCT00706654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102010108|NCT00706654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010109|NCT00706654|Dopamine Agonists|dopamine agonists|mesh-ancestor
102010110|NCT00706654|Dopamine Agents|dopamine agents|mesh-ancestor
102010111|NCT00706654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102010112|NCT00706654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010113|NCT00706654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102010114|NCT00706654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102010115|NCT00706654|Serotonin Agents|serotonin agents|mesh-ancestor
102010116|NCT00706654|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102010117|NCT00706654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102010118|NCT00706654|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102010119|NCT00706654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102010120|NCT03471871|Lemborexant|lemborexant|mesh-list
102010121|NCT03471871|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102010122|NCT03471871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102010123|NCT03471871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010124|NCT03471871|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102010125|NCT03471871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102010126|NCT03471871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102010127|NCT03471871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010128|NCT04313153|Darbepoetin alfa|darbepoetin alfa|mesh-list
102010129|NCT04313153|Hematinics|hematinics|mesh-ancestor
102010131|NCT03337672|Dexmedetomidine|dexmedetomidine|mesh-list
102010132|NCT03337672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102010133|NCT03337672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102010134|NCT03337672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010135|NCT03337672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102010136|NCT03337672|Analgesics|analgesics|mesh-ancestor
102010137|NCT03337672|Sensory System Agents|sensory system agents|mesh-ancestor
102010138|NCT03337672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102010139|NCT03337672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102010140|NCT03337672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102010141|NCT03337672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102010142|NCT03337672|Adrenergic Agents|adrenergic agents|mesh-ancestor
102010143|NCT03337672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101518965|NCT02224235|Antipyretics|antipyretics|mesh-ancestor
102010144|NCT03337672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010145|NCT03337672|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102010146|NCT03337672|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102010147|NCT03337672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102010148|NCT03337672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102010149|NCT03337672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102010150|NCT03337672|Anesthetics, General|anesthetics, general|mesh-ancestor
102010151|NCT03337672|Anesthetics|anesthetics|mesh-ancestor
102010152|NCT03337672|GABA Modulators|gaba modulators|mesh-ancestor
102010153|NCT03337672|GABA Agents|gaba agents|mesh-ancestor
102010154|NCT03330808|Anesthetics|anesthetics|mesh-list
102010155|NCT03330808|Ropivacaine|ropivacaine|mesh-list
102010156|NCT03330808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102010157|NCT03330808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010158|NCT03330808|Anesthetics, Local|anesthetics, local|mesh-ancestor
102010159|NCT03330808|Sensory System Agents|sensory system agents|mesh-ancestor
102010160|NCT03330808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102010161|NCT01303055|Metformin|metformin|mesh-list
102010162|NCT01303055|Alogliptin|alogliptin|mesh-list
102010163|NCT01303055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102010164|NCT01303055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010165|NCT01303055|Incretins|incretins|mesh-ancestor
102010166|NCT01303055|Hormones|hormones|mesh-ancestor
102010167|NCT01303055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101949522|NCT05178862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101949523|NCT05178862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949524|NCT05178862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102010168|NCT01303055|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102010173|NCT03636048|Anesthetics|anesthetics|mesh-list
102010175|NCT03636048|Anesthetics, Local|anesthetics, local|mesh-ancestor
102010176|NCT03636048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102010177|NCT03636048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010178|NCT03636048|Sensory System Agents|sensory system agents|mesh-ancestor
102010179|NCT03636048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102010180|NCT03636048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102010181|NCT03636048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102010182|NCT03636048|Anesthetics, General|anesthetics, general|mesh-ancestor
102010183|NCT03527173|Vaccines|vaccines|mesh-list
102010184|NCT03527173|Immunologic Factors|immunologic factors|mesh-ancestor
102010185|NCT03527173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010186|NCT04718922|Chlorhexidine|chlorhexidine|mesh-list
102010187|NCT04718922|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102010188|NCT04718922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102010189|NCT04718922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102010190|NCT04718922|Disinfectants|disinfectants|mesh-ancestor
102010191|NCT04718922|Dermatologic Agents|dermatologic agents|mesh-ancestor
102010192|NCT01303601|Olanzapine|olanzapine|mesh-list
102010193|NCT01303601|Antiemetics|antiemetics|mesh-ancestor
102010194|NCT01303601|Autonomic Agents|autonomic agents|mesh-ancestor
102010195|NCT01303601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102010196|NCT01303601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010197|NCT01303601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102010198|NCT01303601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102010199|NCT01303601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102010200|NCT01303601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102010201|NCT01303601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102010202|NCT01303601|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102010203|NCT01303601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102010204|NCT01303601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102010205|NCT01303601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010206|NCT01303601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102010207|NCT01303601|Serotonin Agents|serotonin agents|mesh-ancestor
102010208|NCT00707980|Vortioxetine|vortioxetine|mesh-list
102010209|NCT00707980|Antidepressive Agents|antidepressive agents|mesh-ancestor
102010210|NCT00707980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102010211|NCT00707980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102010212|NCT00707980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102010213|NCT00707980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102010214|NCT00707980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010215|NCT00707980|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102010216|NCT00707980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102010217|NCT00707980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102010218|NCT00707980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010219|NCT00707980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102010220|NCT00707980|Serotonin Agents|serotonin agents|mesh-ancestor
102010221|NCT00707980|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102010222|NCT00707980|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102010223|NCT00707980|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102010224|NCT00707980|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102010225|NCT01304537|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
102010226|NCT01304537|Protein C Inhibitor|protein c inhibitor|mesh-list
102010227|NCT01304537|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102010228|NCT01304537|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102010229|NCT01304537|Protease Inhibitors|protease inhibitors|mesh-ancestor
102010230|NCT01304537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102010231|NCT01304537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010233|NCT03051620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102010234|NCT03051620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010235|NCT02861183|Hyaluronic Acid|hyaluronic acid|mesh-list
102010236|NCT02861183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102010237|NCT02861183|Immunologic Factors|immunologic factors|mesh-ancestor
102010238|NCT02861183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949525|NCT05178862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101949526|NCT05176483|Nivolumab|nivolumab|mesh-list
101949527|NCT05176483|Ipilimumab|ipilimumab|mesh-list
101949528|NCT05176483|Relatlimab|relatlimab|mesh-list
101272064|NCT01841242|Povidone|povidone|mesh-list
102010242|NCT02498002|Anesthetics, Local|anesthetics, local|mesh-ancestor
102010243|NCT02498002|Anesthetics|anesthetics|mesh-ancestor
102010244|NCT02498002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102010245|NCT02498002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010246|NCT02498002|Sensory System Agents|sensory system agents|mesh-ancestor
102010247|NCT02498002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102010248|NCT02498002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102010249|NCT02498002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102010250|NCT02498002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102010251|NCT02498002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102010252|NCT02498002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010253|NCT03810209|Magnesium Sulfate|magnesium sulfate|mesh-list
102010254|NCT03810209|Analgesics|analgesics|mesh-ancestor
102010255|NCT03810209|Sensory System Agents|sensory system agents|mesh-ancestor
102010256|NCT03810209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102010257|NCT03810209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010258|NCT03810209|Anesthetics|anesthetics|mesh-ancestor
102010259|NCT03810209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102010260|NCT03810209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102010261|NCT03810209|Anticonvulsants|anticonvulsants|mesh-ancestor
102010262|NCT03810209|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102010263|NCT03810209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102010264|NCT03810209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010265|NCT03810209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102010266|NCT03810209|Tocolytic Agents|tocolytic agents|mesh-ancestor
102010267|NCT03810209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102010268|NCT04186988|9-arabinofuranosylguanine|9-arabinofuranosylguanine|mesh-list
102010269|NCT04186988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102010270|NCT01303679|Paclitaxel|paclitaxel|mesh-list
102010271|NCT01303679|Bevacizumab|bevacizumab|mesh-list
102010272|NCT01303679|Exemestane|exemestane|mesh-list
102010273|NCT01303679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102010274|NCT01303679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102010275|NCT01303679|Tubulin Modulators|tubulin modulators|mesh-ancestor
102010276|NCT01303679|Antimitotic Agents|antimitotic agents|mesh-ancestor
102010277|NCT01303679|Mitosis Modulators|mitosis modulators|mesh-ancestor
102010278|NCT01303679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010279|NCT01303679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102010280|NCT01303679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102010281|NCT01303679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102010282|NCT01303679|Growth Substances|growth substances|mesh-ancestor
101730048|NCT00814658|Nimodipine|nimodipine|mesh-list
102010283|NCT01303679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010284|NCT01303679|Growth Inhibitors|growth inhibitors|mesh-ancestor
102010285|NCT01303679|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102010286|NCT01303679|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102010287|NCT01303679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102010288|NCT01303679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102010289|NCT01303679|Hormone Antagonists|hormone antagonists|mesh-ancestor
102010290|NCT01303679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102010292|NCT03337282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102010293|NCT03337282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010294|NCT03801707|Sofosbuvir|sofosbuvir|mesh-list
102010295|NCT03801707|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102010296|NCT03801707|Velpatasvir|velpatasvir|mesh-list
102010297|NCT03801707|Antiviral Agents|antiviral agents|mesh-ancestor
102010298|NCT03801707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102010299|NCT04576871|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102010300|NCT04576871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102010301|NCT04576871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010302|NCT04239872|Calcium, Dietary|calcium, dietary|mesh-list
102010303|NCT04239872|Calcium|calcium|mesh-list
102010304|NCT04239872|Fluorides|fluorides|mesh-list
102010305|NCT04239872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102010306|NCT04239872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949529|NCT05176483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101949530|NCT05176483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949531|NCT05176483|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101949532|NCT05176483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272118|NCT01841411|Antidotes|antidotes|mesh-ancestor
102010307|NCT04239872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102010308|NCT04239872|Cariostatic Agents|cariostatic agents|mesh-ancestor
102010309|NCT04239872|Protective Agents|protective agents|mesh-ancestor
102010310|NCT03164772|Durvalumab|durvalumab|mesh-list
102010314|NCT03801317|Micronutrients|micronutrients|mesh-list
102010315|NCT03801317|Trace Elements|trace elements|mesh-list
102010316|NCT03801317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010317|NCT03337126|Metronidazole|metronidazole|mesh-list
102010318|NCT03337126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102010319|NCT03337126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102010320|NCT03337126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102010321|NCT03337126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102010322|NCT04710732|Enoxaparin|enoxaparin|mesh-list
102010323|NCT04710732|Enoxaparin sodium|enoxaparin sodium|mesh-list
102010324|NCT04710732|Anticoagulants|anticoagulants|mesh-ancestor
102010325|NCT04710732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102010326|NCT04710732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102010327|NCT04710732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010328|NCT05014334|Amoxicillin|amoxicillin|mesh-list
102010329|NCT05014334|Clarithromycin|clarithromycin|mesh-list
102010330|NCT05014334|Rabeprazole|rabeprazole|mesh-list
102010331|NCT05014334|Bismuth|bismuth|mesh-list
102010332|NCT05014334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102010333|NCT05014334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102010334|NCT05014334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102010335|NCT05014334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102010336|NCT05014334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010337|NCT05014334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102010338|NCT05014334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102010339|NCT05014334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102010340|NCT05014334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102010341|NCT05014334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102010342|NCT05014334|Antacids|antacids|mesh-ancestor
102010343|NCT02497378|Dexamethasone|dexamethasone|mesh-list
102010344|NCT02497378|Bortezomib|bortezomib|mesh-list
102010345|NCT02497378|Daratumumab|daratumumab|mesh-list
102010346|NCT02497378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102010347|NCT02497378|Antiemetics|antiemetics|mesh-ancestor
102010348|NCT02497378|Autonomic Agents|autonomic agents|mesh-ancestor
102010349|NCT02497378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102010350|NCT02497378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010351|NCT02497378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102010352|NCT02497378|Glucocorticoids|glucocorticoids|mesh-ancestor
102010353|NCT02497378|Hormones|hormones|mesh-ancestor
102010354|NCT02497378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102010355|NCT02497378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102010356|NCT02497378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102010357|NCT02497222|RNS60|rns60|mesh-list
101730118|NCT00444925|Tolterodine Tartrate|tolterodine tartrate|mesh-list
102010358|NCT02497222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102010359|NCT02497222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102010360|NCT02497222|Analgesics|analgesics|mesh-ancestor
102010361|NCT02497222|Sensory System Agents|sensory system agents|mesh-ancestor
102010362|NCT02497222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102010363|NCT02497222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010364|NCT02497222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102010365|NCT02497222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102010366|NCT02497222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102010367|NCT02491606|Tafenoquine|tafenoquine|mesh-list
102010368|NCT02491606|Antimalarials|antimalarials|mesh-ancestor
102010369|NCT02491606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102010370|NCT02491606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102010371|NCT02491606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102010372|NCT03329638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102010373|NCT03329638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102010374|NCT03050450|Lenalidomide|lenalidomide|mesh-list
102010375|NCT03050450|Vorinostat|vorinostat|mesh-list
102010376|NCT03050450|Immunologic Factors|immunologic factors|mesh-ancestor
101949533|NCT05170399|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101949534|NCT05170399|Immunologic Factors|immunologic factors|mesh-ancestor
101949535|NCT05170399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949536|NCT05160922|Crizotinib|crizotinib|mesh-list
101949537|NCT05160922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949538|NCT05160922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102010377|NCT03050450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010378|NCT03050450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102010379|NCT03050450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102010380|NCT03050450|Growth Substances|growth substances|mesh-ancestor
102010381|NCT03050450|Growth Inhibitors|growth inhibitors|mesh-ancestor
102010382|NCT03050450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102010383|NCT03050450|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101465346|NCT00236327|Narcotics|narcotics|mesh-ancestor
102010393|NCT03505021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010394|NCT03505021|Protective Agents|protective agents|mesh-ancestor
102010395|NCT03505021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010397|NCT03793283|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102010398|NCT03793283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102010399|NCT03793283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010400|NCT02496988|Temozolomide|temozolomide|mesh-list
102010401|NCT02496988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102010402|NCT02496988|Alkylating Agents|alkylating agents|mesh-ancestor
102010403|NCT02496988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010404|NCT02496988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102010405|NCT03793205|Lenograstim|lenograstim|mesh-list
102010406|NCT03793205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102010407|NCT03793205|Immunologic Factors|immunologic factors|mesh-ancestor
102010408|NCT03793205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010409|NCT03329248|Leucovorin|leucovorin|mesh-list
102010410|NCT03329248|Paclitaxel|paclitaxel|mesh-list
102010411|NCT03329248|Cyclophosphamide|cyclophosphamide|mesh-list
102010412|NCT03329248|Bevacizumab|bevacizumab|mesh-list
102010413|NCT03329248|Fluorouracil|fluorouracil|mesh-list
102010414|NCT03329248|Capecitabine|capecitabine|mesh-list
102010415|NCT03329248|Oxaliplatin|oxaliplatin|mesh-list
102010416|NCT03329248|Avelumab|avelumab|mesh-list
102010417|NCT03329248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102010418|NCT03329248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102010419|NCT03329248|Tubulin Modulators|tubulin modulators|mesh-ancestor
102010420|NCT03329248|Antimitotic Agents|antimitotic agents|mesh-ancestor
102010421|NCT03329248|Mitosis Modulators|mitosis modulators|mesh-ancestor
102010422|NCT03329248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010423|NCT03329248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102010424|NCT03329248|Immunologic Factors|immunologic factors|mesh-ancestor
102010425|NCT03329248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010426|NCT03329248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102010427|NCT03329248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102010428|NCT03329248|Alkylating Agents|alkylating agents|mesh-ancestor
102010429|NCT03329248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102010430|NCT03329248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102010431|NCT03329248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102010432|NCT03329248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102010433|NCT03329248|Growth Substances|growth substances|mesh-ancestor
102010434|NCT03329248|Growth Inhibitors|growth inhibitors|mesh-ancestor
102010435|NCT03329248|Antimetabolites|antimetabolites|mesh-ancestor
102010436|NCT03329248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102010437|NCT03329248|Antidotes|antidotes|mesh-ancestor
102010438|NCT03329248|Protective Agents|protective agents|mesh-ancestor
102010439|NCT03329248|Vitamin B Complex|vitamin b complex|mesh-ancestor
102010440|NCT03329248|Vitamins|vitamins|mesh-ancestor
102010441|NCT03329248|Micronutrients|micronutrients|mesh-ancestor
102010442|NCT03795311|Bevacizumab|bevacizumab|mesh-list
102010443|NCT03795311|Folfirinox|folfirinox|mesh-list
102010444|NCT03795311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102010445|NCT03795311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102010446|NCT03795311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102010447|NCT03795311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102010448|NCT03795311|Growth Substances|growth substances|mesh-ancestor
102010449|NCT03795311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949539|NCT05160922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101949540|NCT05160922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949541|NCT05142696|Carboplatin|carboplatin|mesh-list
102010450|NCT03795311|Growth Inhibitors|growth inhibitors|mesh-ancestor
102010457|NCT03792971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102010458|NCT03792971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010459|NCT03792971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010460|NCT03792971|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102010461|NCT03792971|Antioxidants|antioxidants|mesh-ancestor
102010462|NCT03792971|Protective Agents|protective agents|mesh-ancestor
102010463|NCT03328936|Melphalan|melphalan|mesh-list
102010464|NCT03328936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102010465|NCT03328936|Alkylating Agents|alkylating agents|mesh-ancestor
102010466|NCT03328936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010467|NCT03328936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102010468|NCT03328936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102010469|NCT03328936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102010470|NCT03328936|Immunologic Factors|immunologic factors|mesh-ancestor
102010471|NCT03328936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010472|NCT02496754|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
102010473|NCT02496754|Hormones|hormones|mesh-ancestor
102010474|NCT02496754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102010475|NCT02496754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010476|NCT04887194|Nivolumab|nivolumab|mesh-list
102010477|NCT04887194|Digoxin|digoxin|mesh-list
102010478|NCT04887194|Midazolam|midazolam|mesh-list
102010479|NCT04887194|Dextromethorphan|dextromethorphan|mesh-list
102010480|NCT04887194|Warfarin|warfarin|mesh-list
102010481|NCT04887194|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102010482|NCT04887194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102010483|NCT04887194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102010484|NCT04887194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102010485|NCT04887194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010486|NCT04887194|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102010487|NCT04887194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102010488|NCT04887194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102010489|NCT04887194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010490|NCT04887194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102010491|NCT04887194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102010492|NCT04887194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102010493|NCT04887194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102010494|NCT04887194|Anesthetics, General|anesthetics, general|mesh-ancestor
102010495|NCT04887194|Anesthetics|anesthetics|mesh-ancestor
102010496|NCT04887194|GABA Modulators|gaba modulators|mesh-ancestor
102010497|NCT04887194|GABA Agents|gaba agents|mesh-ancestor
102010498|NCT04887194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102010499|NCT04887194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102010500|NCT04887194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102010501|NCT04887194|Antimetabolites|antimetabolites|mesh-ancestor
102010502|NCT04887194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102010503|NCT04887194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102010504|NCT04887194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102010505|NCT04887194|Anticoagulants|anticoagulants|mesh-ancestor
102010506|NCT04887194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102010507|NCT04887194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102010508|NCT04887194|Protective Agents|protective agents|mesh-ancestor
102010509|NCT04887194|Antitussive Agents|antitussive agents|mesh-ancestor
102010510|NCT04887194|Respiratory System Agents|respiratory system agents|mesh-ancestor
102010511|NCT04887194|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102010512|NCT04887194|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102010513|NCT02496910|Amlodipine|amlodipine|mesh-list
102010514|NCT02496910|Telmisartan|telmisartan|mesh-list
102010515|NCT02496910|Chlorthalidone|chlorthalidone|mesh-list
102010516|NCT02496910|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
102010517|NCT02496910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102010518|NCT02496910|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102010519|NCT02496910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102010522|NCT02496910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010524|NCT02496910|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102010525|NCT02496910|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102010526|NCT02496910|Diuretics|diuretics|mesh-ancestor
102010527|NCT02496910|Natriuretic Agents|natriuretic agents|mesh-ancestor
101949542|NCT05142696|Etoposide|etoposide|mesh-list
101949543|NCT05142696|Tislelizumab|tislelizumab|mesh-list
101949544|NCT05142696|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
101949545|NCT05142696|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102010528|NCT02496910|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102010529|NCT03342352|Carboplatin|carboplatin|mesh-list
102010530|NCT03342352|Fluorouracil|fluorouracil|mesh-list
102010531|NCT03342352|Nivolumab|nivolumab|mesh-list
102010532|NCT03342352|Cetuximab|cetuximab|mesh-list
102010533|NCT03342352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102010534|NCT03342352|Antimetabolites|antimetabolites|mesh-ancestor
102010535|NCT03342352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010536|NCT03342352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102010537|NCT03342352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102010538|NCT03342352|Immunologic Factors|immunologic factors|mesh-ancestor
102010539|NCT03342352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010540|NCT03342352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102010541|NCT03342352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102010542|NCT03120442|Fentanyl|fentanyl|mesh-list
102010543|NCT03120442|Dexmedetomidine|dexmedetomidine|mesh-list
102010544|NCT03120442|Propofol|propofol|mesh-list
102010545|NCT03120442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102010546|NCT03120442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102010547|NCT03120442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010548|NCT03120442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102010549|NCT03120442|Analgesics|analgesics|mesh-ancestor
102010550|NCT03120442|Sensory System Agents|sensory system agents|mesh-ancestor
102010551|NCT03120442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102010552|NCT03120442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102010553|NCT03120442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102010554|NCT03120442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102010555|NCT03120442|Adrenergic Agents|adrenergic agents|mesh-ancestor
102010556|NCT03120442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102010557|NCT03120442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010558|NCT03120442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102010559|NCT03120442|Anesthetics, General|anesthetics, general|mesh-ancestor
102010560|NCT03120442|Anesthetics|anesthetics|mesh-ancestor
102010561|NCT03120442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102010562|NCT03120442|Narcotics|narcotics|mesh-ancestor
102010563|NCT03120442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102010564|NCT00852696|Solifenacin Succinate|solifenacin succinate|mesh-list
102010565|NCT00852696|Tolterodine Tartrate|tolterodine tartrate|mesh-list
102010566|NCT00852696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102010567|NCT00852696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102010568|NCT00852696|Cholinergic Agents|cholinergic agents|mesh-ancestor
102010569|NCT00852696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102010570|NCT00852696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010571|NCT00852696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010572|NCT00852696|Urological Agents|urological agents|mesh-ancestor
102010573|NCT02496832|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
102010574|NCT02496832|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102010575|NCT02496832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010576|NCT03324490|Fentanyl|fentanyl|mesh-list
102010577|NCT03324490|Dexmedetomidine|dexmedetomidine|mesh-list
102010578|NCT03324490|Bupivacaine|bupivacaine|mesh-list
102010579|NCT03324490|Anesthetics|anesthetics|mesh-list
102010580|NCT03324490|Anesthetics, Local|anesthetics, local|mesh-ancestor
102010581|NCT03324490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102010582|NCT03324490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730339|NCT03840811|Ceftriaxone|ceftriaxone|mesh-list
102010583|NCT03324490|Sensory System Agents|sensory system agents|mesh-ancestor
102010584|NCT03324490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102010585|NCT03324490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102010586|NCT03324490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102010587|NCT03324490|Analgesics|analgesics|mesh-ancestor
102010588|NCT03324490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102010589|NCT03324490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101519098|NCT01209832|GABA Agents|gaba agents|mesh-ancestor
102010591|NCT03324490|Adrenergic Agents|adrenergic agents|mesh-ancestor
102010592|NCT03324490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102010593|NCT03324490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010594|NCT03324490|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101949546|NCT05142696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949547|NCT05142696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101949548|NCT05142696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101949549|NCT05142696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101949550|NCT05142696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102010596|NCT03324490|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102010597|NCT03324490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102010598|NCT03324490|Anesthetics, General|anesthetics, general|mesh-ancestor
102010599|NCT03798899|Methoxyflurane|methoxyflurane|mesh-list
102010600|NCT03798899|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102010601|NCT03798899|Anesthetics, General|anesthetics, general|mesh-ancestor
102010602|NCT03798899|Anesthetics|anesthetics|mesh-ancestor
102010603|NCT03798899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102010604|NCT03798899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010605|NCT03274661|Pembrolizumab|pembrolizumab|mesh-list
102010606|NCT03274661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102010607|NCT03274661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102010608|NCT03274661|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102010609|NCT03274661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010610|NCT03798821|Sulfalene|sulfalene|mesh-list
102010611|NCT03798821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102010612|NCT03798821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102010613|NCT03798821|Antimalarials|antimalarials|mesh-ancestor
102010614|NCT03798821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102010615|NCT03798821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102010616|NCT03324334|Antibodies|antibodies|mesh-list
102010617|NCT03324334|Immunologic Factors|immunologic factors|mesh-ancestor
102010618|NCT03324334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010619|NCT03792815|Etoposide|etoposide|mesh-list
102010620|NCT03792815|Melphalan|melphalan|mesh-list
102010621|NCT03792815|Busulfan|busulfan|mesh-list
102010622|NCT03792815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102010623|NCT03792815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102010624|NCT03792815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102010625|NCT03792815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102010626|NCT03792815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102010627|NCT03792815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010628|NCT03792815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102010629|NCT03792815|Alkylating Agents|alkylating agents|mesh-ancestor
102010630|NCT03792815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102010631|NCT03792815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102010632|NCT03792815|Immunologic Factors|immunologic factors|mesh-ancestor
102010633|NCT03792815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010634|NCT04381364|Ciclesonide|ciclesonide|mesh-list
102010635|NCT04381364|Glucocorticoids|glucocorticoids|mesh-ancestor
102010636|NCT04381364|Hormones|hormones|mesh-ancestor
101519115|NCT04683159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010637|NCT04381364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102010638|NCT04381364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010639|NCT04381364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102010640|NCT01331382|Resveratrol|resveratrol|mesh-list
102010641|NCT01331382|Antioxidants|antioxidants|mesh-ancestor
102010642|NCT01331382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010643|NCT01331382|Protective Agents|protective agents|mesh-ancestor
102010644|NCT01331382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010645|NCT01331382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102010646|NCT01331382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102010647|NCT03794765|Metronidazole|metronidazole|mesh-list
102010648|NCT03794765|Ceftriaxone|ceftriaxone|mesh-list
102010649|NCT03794765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102010650|NCT03794765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102010651|NCT03794765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102010652|NCT03794765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102010653|NCT02496286|Bevacizumab|bevacizumab|mesh-list
102010654|NCT02496286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102010655|NCT02496286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102010656|NCT02496286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102010657|NCT02496286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102010658|NCT02496286|Growth Substances|growth substances|mesh-ancestor
102010659|NCT02496286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730412|NCT04110288|Paclitaxel|paclitaxel|mesh-list
101949551|NCT05142696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949552|NCT05142696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101949553|NCT05142696|Chelating Agents|chelating agents|mesh-ancestor
101272468|NCT01843738|Vemurafenib|vemurafenib|mesh-list
102010660|NCT02496286|Growth Inhibitors|growth inhibitors|mesh-ancestor
102010661|NCT01489176|Regadenoson|regadenoson|mesh-list
102010662|NCT01489176|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
102010663|NCT01489176|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102010667|NCT01489176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010668|NCT01489176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010670|NCT03792503|Apatinib|apatinib|mesh-list
102010671|NCT03792503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102010672|NCT03792503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102010673|NCT03792503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010674|NCT03792503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102010675|NCT03792503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102010676|NCT03792503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102010677|NCT03794843|Nimodipine|nimodipine|mesh-list
102010678|NCT03794843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102010679|NCT03794843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102010680|NCT03794843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102010681|NCT03794843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010682|NCT03794843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101519139|NCT04667351|Fluorouracil|fluorouracil|mesh-list
102010683|NCT03794843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010684|NCT03794843|Vasodilator Agents|vasodilator agents|mesh-ancestor
102010685|NCT01333800|Ciclesonide|ciclesonide|mesh-list
102010686|NCT01333800|Beclomethasone|beclomethasone|mesh-list
102010687|NCT01333800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102010688|NCT01333800|Glucocorticoids|glucocorticoids|mesh-ancestor
102010689|NCT01333800|Hormones|hormones|mesh-ancestor
102010690|NCT01333800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102010691|NCT01333800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010692|NCT01333800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102010693|NCT01333800|Respiratory System Agents|respiratory system agents|mesh-ancestor
102010694|NCT01333800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102010695|NCT04494100|Lidocaine|lidocaine|mesh-list
102010696|NCT04494100|Epinephrine|epinephrine|mesh-list
102010697|NCT04494100|Ropivacaine|ropivacaine|mesh-list
102010698|NCT04494100|Anesthetics, Local|anesthetics, local|mesh-ancestor
102010699|NCT04494100|Anesthetics|anesthetics|mesh-ancestor
102010700|NCT04494100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102010701|NCT04494100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010702|NCT04494100|Sensory System Agents|sensory system agents|mesh-ancestor
102010703|NCT04494100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102010704|NCT04494100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102010705|NCT04494100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102010706|NCT04494100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102010707|NCT04494100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102010708|NCT04494100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010709|NCT04494100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102010710|NCT04494100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102010711|NCT04494100|Adrenergic Agents|adrenergic agents|mesh-ancestor
102010712|NCT04494100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102010713|NCT04494100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102010714|NCT04494100|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102010715|NCT04494100|Autonomic Agents|autonomic agents|mesh-ancestor
102010716|NCT04494100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102010717|NCT04494100|Respiratory System Agents|respiratory system agents|mesh-ancestor
102010718|NCT04494100|Mydriatics|mydriatics|mesh-ancestor
102010719|NCT04494100|Sympathomimetics|sympathomimetics|mesh-ancestor
102010720|NCT04494100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102010721|NCT01333878|Abatacept|abatacept|mesh-list
102010722|NCT01333878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102010723|NCT01333878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010724|NCT01333878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102010725|NCT01333878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102010726|NCT01333878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102010727|NCT01333878|Immunologic Factors|immunologic factors|mesh-ancestor
102010728|NCT01333878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949554|NCT05142696|Sequestering Agents|sequestering agents|mesh-ancestor
101949555|NCT05142696|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101949556|NCT05121883|Edaravone|edaravone|mesh-list
101949557|NCT05121883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101272543|NCT01843998|Sirolimus|sirolimus|mesh-list
102010729|NCT01333878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102010730|NCT03328312|Atropine|atropine|mesh-list
102010731|NCT03328312|Neostigmine|neostigmine|mesh-list
102010732|NCT03328312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102010733|NCT03328312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102010734|NCT03328312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102010737|NCT03328312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010739|NCT03328312|Respiratory System Agents|respiratory system agents|mesh-ancestor
102010740|NCT03328312|Mydriatics|mydriatics|mesh-ancestor
102010741|NCT03328312|Parasympatholytics|parasympatholytics|mesh-ancestor
102010742|NCT03328312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102010743|NCT03328312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102010744|NCT03328312|Cholinergic Agents|cholinergic agents|mesh-ancestor
102010745|NCT03328312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102010746|NCT03328312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010747|NCT03328312|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102010748|NCT03328312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102010749|NCT03328312|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102010750|NCT04051580|Plasma-lyte 148|plasma-lyte 148|mesh-list
102010751|NCT04051580|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102010752|NCT04051580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102010753|NCT03328234|Paclitaxel|paclitaxel|mesh-list
102010754|NCT03328234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102010755|NCT03328234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102010756|NCT03328234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102010757|NCT03328234|Tubulin Modulators|tubulin modulators|mesh-ancestor
102010758|NCT03328234|Antimitotic Agents|antimitotic agents|mesh-ancestor
102010759|NCT03328234|Mitosis Modulators|mitosis modulators|mesh-ancestor
102010760|NCT03328234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010761|NCT04781192|Durvalumab|durvalumab|mesh-list
102010762|NCT04781192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102010763|NCT04781192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102010764|NCT03323710|Sunitinib|sunitinib|mesh-list
102010765|NCT03323710|Propranolol|propranolol|mesh-list
102010766|NCT03323710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102010767|NCT03323710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101519191|NCT01209520|Paclitaxel|paclitaxel|mesh-list
102010768|NCT03323710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102010769|NCT03323710|Growth Substances|growth substances|mesh-ancestor
102010770|NCT03323710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010771|NCT03323710|Growth Inhibitors|growth inhibitors|mesh-ancestor
102010772|NCT03323710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102010773|NCT03323710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102010774|NCT03323710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010775|NCT03323710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102010776|NCT03323710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102010777|NCT03323710|Adrenergic Agents|adrenergic agents|mesh-ancestor
102010778|NCT03323710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102010779|NCT03323710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102010780|NCT03323710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102010781|NCT03323710|Vasodilator Agents|vasodilator agents|mesh-ancestor
102010782|NCT03792269|Capecitabine|capecitabine|mesh-list
102010783|NCT03792269|Oxaliplatin|oxaliplatin|mesh-list
102010784|NCT03792269|Irinotecan|irinotecan|mesh-list
102010785|NCT03792269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102010786|NCT03792269|Antimetabolites|antimetabolites|mesh-ancestor
102010787|NCT03792269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010788|NCT03792269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102010789|NCT03792269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102010790|NCT03792269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102010791|NCT03792269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102010792|NCT02488564|Metformin|metformin|mesh-list
102010793|NCT02488564|Docetaxel|docetaxel|mesh-list
102010794|NCT02488564|Doxorubicin|doxorubicin|mesh-list
102010795|NCT02488564|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102010796|NCT02488564|Trastuzumab|trastuzumab|mesh-list
102010797|NCT02488564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102010798|NCT02488564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010799|NCT02488564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102010800|NCT02488564|Tubulin Modulators|tubulin modulators|mesh-ancestor
101949558|NCT05121883|Antioxidants|antioxidants|mesh-ancestor
101949559|NCT05121883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949560|NCT05121883|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102010801|NCT02488564|Antimitotic Agents|antimitotic agents|mesh-ancestor
102010802|NCT02488564|Mitosis Modulators|mitosis modulators|mesh-ancestor
102010803|NCT02488564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010804|NCT02488564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102010805|NCT02488564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102010806|NCT02488564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102010827|NCT04697186|Clarithromycin|clarithromycin|mesh-list
102010828|NCT04697186|Rabeprazole|rabeprazole|mesh-list
102010829|NCT04697186|Bismuth|bismuth|mesh-list
102010830|NCT04697186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102010831|NCT04697186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102010832|NCT04697186|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102010833|NCT04697186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102010834|NCT04697186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519219|NCT04784754|Melatonin|melatonin|mesh-list
102010835|NCT04697186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102010836|NCT04697186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102010837|NCT04697186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102010838|NCT04697186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102010839|NCT04697186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102010840|NCT04697186|Antacids|antacids|mesh-ancestor
102010841|NCT02488642|Isosorbide|isosorbide|mesh-list
102010842|NCT02488642|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
102010843|NCT02488642|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
102010844|NCT02488642|Misoprostol|misoprostol|mesh-list
102010845|NCT02488642|Oxytocin|oxytocin|mesh-list
102010846|NCT02488642|Oxytocics|oxytocics|mesh-ancestor
102010847|NCT02488642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102010848|NCT02488642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010849|NCT02488642|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102010850|NCT02488642|Abortifacient Agents|abortifacient agents|mesh-ancestor
102010851|NCT02488642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102010852|NCT02488642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102010853|NCT02488642|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102010854|NCT02488642|Diuretics|diuretics|mesh-ancestor
102010855|NCT02488642|Natriuretic Agents|natriuretic agents|mesh-ancestor
102010856|NCT02488642|Vasodilator Agents|vasodilator agents|mesh-ancestor
102010857|NCT02488642|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102010858|NCT02488642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010859|NCT02488486|Remifentanil|remifentanil|mesh-list
102010860|NCT02488486|Propofol|propofol|mesh-list
102010861|NCT02488486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102010862|NCT02488486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102010866|NCT02488486|Anesthetics|anesthetics|mesh-ancestor
102010867|NCT02488486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102010868|NCT02488486|Narcotics|narcotics|mesh-ancestor
102010869|NCT02488486|Analgesics|analgesics|mesh-ancestor
102010870|NCT02488486|Sensory System Agents|sensory system agents|mesh-ancestor
102010871|NCT02488486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102010872|NCT04144517|Pembrolizumab|pembrolizumab|mesh-list
102010873|NCT04144517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102010874|NCT04144517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102010875|NCT04144517|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102010876|NCT04144517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010877|NCT01389024|Hydroxyurea|hydroxyurea|mesh-list
102010878|NCT01389024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102010879|NCT01389024|Antisickling Agents|antisickling agents|mesh-ancestor
102010880|NCT01389024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102010881|NCT01389024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010882|NCT01389024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102010883|NCT03327766|Calcifediol|calcifediol|mesh-list
102010884|NCT03327766|Vitamins|vitamins|mesh-ancestor
102010885|NCT03327766|Micronutrients|micronutrients|mesh-ancestor
102010886|NCT03327766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010887|NCT03327766|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102010888|NCT03798119|Tenofovir|tenofovir|mesh-list
102010889|NCT03798119|Antiviral Agents|antiviral agents|mesh-ancestor
102010890|NCT03798119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102010891|NCT03798119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102010892|NCT03798119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102010893|NCT03798119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101949561|NCT05121883|Protective Agents|protective agents|mesh-ancestor
101949562|NCT05121883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519248|NCT04721457|Eusol|eusol|mesh-list
101949563|NCT05104983|Sirolimus|sirolimus|mesh-list
102010894|NCT03798119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010895|NCT03798119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102010896|NCT03798119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102010897|NCT03794219|Naproxen|naproxen|mesh-list
102010898|NCT03794219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102010899|NCT03794219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102010900|NCT03794219|Analgesics|analgesics|mesh-ancestor
102010901|NCT03794219|Sensory System Agents|sensory system agents|mesh-ancestor
102010902|NCT03794219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102010903|NCT03794219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010904|NCT03794219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102010905|NCT03794219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102010906|NCT03794219|Gout Suppressants|gout suppressants|mesh-ancestor
102010907|NCT03794219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102010908|NCT03794219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102010909|NCT03794219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010910|NCT01297764|Dexamethasone|dexamethasone|mesh-list
102010911|NCT01297764|Dexamethasone acetate|dexamethasone acetate|mesh-list
102010912|NCT01297764|Lenalidomide|lenalidomide|mesh-list
102010913|NCT01297764|Vorinostat|vorinostat|mesh-list
102010914|NCT01297764|BB 1101|bb 1101|mesh-list
102010915|NCT01297764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102010916|NCT01297764|Antiemetics|antiemetics|mesh-ancestor
102010917|NCT01297764|Autonomic Agents|autonomic agents|mesh-ancestor
102010918|NCT01297764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102010919|NCT01297764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010920|NCT01297764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102010921|NCT01297764|Glucocorticoids|glucocorticoids|mesh-ancestor
102010922|NCT01297764|Hormones|hormones|mesh-ancestor
102010923|NCT01297764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102010924|NCT01297764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102010925|NCT01297764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102010926|NCT01297764|Protease Inhibitors|protease inhibitors|mesh-ancestor
102010927|NCT01297764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102010928|NCT01297764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010929|NCT01297764|Immunologic Factors|immunologic factors|mesh-ancestor
102010930|NCT01297764|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102010931|NCT01297764|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102010932|NCT01297764|Growth Substances|growth substances|mesh-ancestor
102010933|NCT01297764|Growth Inhibitors|growth inhibitors|mesh-ancestor
102010934|NCT01297764|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102010949|NCT03050060|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101519260|NCT04665986|Docetaxel|docetaxel|mesh-list
102010950|NCT03050060|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102010951|NCT03050060|Protease Inhibitors|protease inhibitors|mesh-ancestor
102010952|NCT03050060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102010953|NCT03050060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102010954|NCT03050060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102010955|NCT03050060|Antiviral Agents|antiviral agents|mesh-ancestor
102010956|NCT03050060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102010958|NCT01334112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102010959|NCT01334112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102010960|NCT01334112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101730710|NCT00819676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102010961|NCT01334112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010962|NCT03791957|Chrysarobin|chrysarobin|mesh-list
102010963|NCT03791957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102010964|NCT03791957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102010965|NCT03791957|Analgesics|analgesics|mesh-ancestor
102010966|NCT03791957|Sensory System Agents|sensory system agents|mesh-ancestor
102010967|NCT03791957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102010968|NCT03791957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010969|NCT03791957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102010970|NCT03791957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102010971|NCT02491450|Sofosbuvir|sofosbuvir|mesh-list
102010972|NCT02491450|Antiviral Agents|antiviral agents|mesh-ancestor
102010973|NCT02491450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102010974|NCT03792113|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102010975|NCT03792113|Hemostatics|hemostatics|mesh-ancestor
102010976|NCT03792113|Coagulants|coagulants|mesh-ancestor
102010977|NCT02491528|Insulin|insulin|mesh-list
102010978|NCT02491528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101949564|NCT05104983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101949565|NCT05104983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101949566|NCT05104983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102010979|NCT02491528|Insulin Aspart|insulin aspart|mesh-list
102010980|NCT02491528|Insulin, Long-Acting|insulin, long-acting|mesh-list
102010981|NCT02491528|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102010982|NCT02491528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102010983|NCT02491528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010984|NCT01304927|Vitamin D|vitamin d|mesh-list
102010985|NCT01304927|Cholecalciferol|cholecalciferol|mesh-list
102010986|NCT01304927|Calcium|calcium|mesh-list
102010987|NCT01304927|Vitamins|vitamins|mesh-ancestor
102010988|NCT01304927|Micronutrients|micronutrients|mesh-ancestor
102010989|NCT01304927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010990|NCT01304927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102010991|NCT01304927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102010992|NCT05464940|Caffeine|caffeine|mesh-list
102010993|NCT05464940|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102010994|NCT05464940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010995|NCT05464940|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102010996|NCT05464940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102010999|NCT05464940|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102011000|NCT05464940|Purinergic Agents|purinergic agents|mesh-ancestor
102011001|NCT05464940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102011003|NCT01305551|Saxagliptin|saxagliptin|mesh-list
102011004|NCT01305551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102011005|NCT01305551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011006|NCT01305551|Incretins|incretins|mesh-ancestor
102011007|NCT01305551|Hormones|hormones|mesh-ancestor
102011008|NCT01305551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102011009|NCT01305551|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102011010|NCT01305551|Protease Inhibitors|protease inhibitors|mesh-ancestor
102011011|NCT01305551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102011012|NCT01305551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011013|NCT03799757|Bupivacaine|bupivacaine|mesh-list
102011014|NCT03799757|Anesthetics, Local|anesthetics, local|mesh-ancestor
102011015|NCT03799757|Anesthetics|anesthetics|mesh-ancestor
102011016|NCT03799757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102011017|NCT03799757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011018|NCT03799757|Sensory System Agents|sensory system agents|mesh-ancestor
102011019|NCT03799757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102011020|NCT03327454|Etanercept|etanercept|mesh-list
102011021|NCT03327454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102011022|NCT03327454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102011023|NCT03327454|Analgesics|analgesics|mesh-ancestor
102011024|NCT03327454|Sensory System Agents|sensory system agents|mesh-ancestor
102011025|NCT03327454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102011026|NCT03327454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011027|NCT03327454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102011028|NCT03327454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102011029|NCT03327454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102011030|NCT03327454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102011031|NCT03327454|Immunologic Factors|immunologic factors|mesh-ancestor
102011032|NCT03799913|Cyclophosphamide|cyclophosphamide|mesh-list
102011033|NCT03799913|Fludarabine|fludarabine|mesh-list
102011034|NCT03799913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102011035|NCT03799913|Immunologic Factors|immunologic factors|mesh-ancestor
102011036|NCT03799913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011037|NCT03799913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102011038|NCT03799913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102011039|NCT03799913|Alkylating Agents|alkylating agents|mesh-ancestor
102011040|NCT03799913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011041|NCT03799913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102011042|NCT03799913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102011044|NCT01304069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102011045|NCT01304069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102011046|NCT01304069|Analgesics|analgesics|mesh-ancestor
102011047|NCT01304069|Sensory System Agents|sensory system agents|mesh-ancestor
102011048|NCT01304069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102011049|NCT01304069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011050|NCT01304069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101272834|NCT01845584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011051|NCT01304069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102011052|NCT01304069|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102011053|NCT01304069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101519316|NCT04432974|Anesthetics|anesthetics|mesh-list
102011054|NCT01304069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102011055|NCT01304069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011056|NCT05459402|Methadone|methadone|mesh-list
102011057|NCT05459402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102011058|NCT05459402|Narcotics|narcotics|mesh-ancestor
102011059|NCT05459402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102011060|NCT05459402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011061|NCT05459402|Analgesics|analgesics|mesh-ancestor
102011062|NCT05459402|Sensory System Agents|sensory system agents|mesh-ancestor
102011063|NCT05459402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102011064|NCT05459402|Antitussive Agents|antitussive agents|mesh-ancestor
102011065|NCT05459402|Respiratory System Agents|respiratory system agents|mesh-ancestor
102011066|NCT03799601|Carboplatin|carboplatin|mesh-list
102011067|NCT03799601|Docetaxel|docetaxel|mesh-list
102011068|NCT03799601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102011073|NCT03791801|Glycopyrrolate|glycopyrrolate|mesh-list
102011074|NCT03791801|Rocuronium|rocuronium|mesh-list
102011075|NCT03791801|Neostigmine|neostigmine|mesh-list
102011076|NCT03791801|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102011077|NCT03791801|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102011078|NCT03791801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102011079|NCT03791801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102011080|NCT03791801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011081|NCT03791801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102011082|NCT03791801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102011083|NCT03791801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011084|NCT03791801|Cholinergic Agents|cholinergic agents|mesh-ancestor
102011085|NCT03791801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102011086|NCT03791801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102011087|NCT03791801|Autonomic Agents|autonomic agents|mesh-ancestor
102011088|NCT03791801|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102011089|NCT03791801|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102011090|NCT03791801|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102011091|NCT01305083|Udenafil|udenafil|mesh-list
102011092|NCT01305083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102011093|NCT01305083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102011094|NCT01305083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102011095|NCT01305083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011096|NCT03791723|Valsartan|valsartan|mesh-list
102011097|NCT03791723|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102011098|NCT03791723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102011099|NCT03791723|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102011100|NCT03791723|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102011101|NCT03791723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011102|NCT05452070|Lidocaine|lidocaine|mesh-list
102011103|NCT05452070|Anesthetics, Local|anesthetics, local|mesh-ancestor
102011104|NCT05452070|Anesthetics|anesthetics|mesh-ancestor
102011105|NCT05452070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102011106|NCT05452070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011107|NCT05452070|Sensory System Agents|sensory system agents|mesh-ancestor
102011108|NCT05452070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102011109|NCT05452070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102011110|NCT05452070|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101730895|NCT00626392|Niacin|niacin|mesh-list
102011111|NCT05452070|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102011112|NCT05452070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102011113|NCT05452070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011114|NCT03920657|Deferasirox|deferasirox|mesh-list
102011115|NCT03920657|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102011116|NCT03920657|Chelating Agents|chelating agents|mesh-ancestor
102011117|NCT03920657|Sequestering Agents|sequestering agents|mesh-ancestor
102011118|NCT03920657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011119|NCT03420950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
102011120|NCT03420950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102011121|NCT03420950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011122|NCT03501277|Pioglitazone|pioglitazone|mesh-list
102011123|NCT03501277|Alogliptin|alogliptin|mesh-list
102011124|NCT03501277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101949567|NCT05104983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949568|NCT05104983|Antifungal Agents|antifungal agents|mesh-ancestor
101949569|NCT05104983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101949570|NCT05104983|Immunologic Factors|immunologic factors|mesh-ancestor
101272913|NCT01846273|Dermatologic Agents|dermatologic agents|mesh-ancestor
102011125|NCT03501277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011126|NCT03501277|Incretins|incretins|mesh-ancestor
102011127|NCT03501277|Hormones|hormones|mesh-ancestor
102011128|NCT03501277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102011129|NCT03501277|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102011130|NCT03501277|Protease Inhibitors|protease inhibitors|mesh-ancestor
102011131|NCT03501277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102011132|NCT03501277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011133|NCT03797729|Tirofiban|tirofiban|mesh-list
102011134|NCT03797729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102011135|NCT03797729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101466100|NCT00415584|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
102011140|NCT02487940|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102011141|NCT02487940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102011142|NCT02487706|Dolutegravir|dolutegravir|mesh-list
102011143|NCT02487706|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102011144|NCT02487706|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102011145|NCT02487706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102011146|NCT02487706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011147|NCT02487706|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102011148|NCT02487706|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102011149|NCT02487706|Antiviral Agents|antiviral agents|mesh-ancestor
102011150|NCT02487706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102011151|NCT04551950|Paclitaxel|paclitaxel|mesh-list
102011152|NCT04551950|Bevacizumab|bevacizumab|mesh-list
102011153|NCT04551950|Carboplatin|carboplatin|mesh-list
102011154|NCT04551950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102011155|NCT04551950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102011156|NCT04551950|Tubulin Modulators|tubulin modulators|mesh-ancestor
102011157|NCT04551950|Antimitotic Agents|antimitotic agents|mesh-ancestor
102011158|NCT04551950|Mitosis Modulators|mitosis modulators|mesh-ancestor
102011159|NCT04551950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011160|NCT04551950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102011161|NCT04551950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102011162|NCT04551950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102011163|NCT04551950|Growth Substances|growth substances|mesh-ancestor
102011164|NCT04551950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011165|NCT04551950|Growth Inhibitors|growth inhibitors|mesh-ancestor
102011166|NCT03326752|Nivolumab|nivolumab|mesh-list
102011167|NCT03326752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102011168|NCT03326752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102011169|NCT03326752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102011170|NCT03326752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011171|NCT03326674|Capecitabine|capecitabine|mesh-list
102011172|NCT03326674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102011173|NCT03326674|Antimetabolites|antimetabolites|mesh-ancestor
102011174|NCT03326674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011175|NCT03326674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102011176|NCT01316900|Bromides|bromides|mesh-list
102011177|NCT01316900|Tiotropium Bromide|tiotropium bromide|mesh-list
102011178|NCT01316900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102011179|NCT01316900|Autonomic Agents|autonomic agents|mesh-ancestor
102011180|NCT01316900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102011181|NCT01316900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011182|NCT01316900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102011183|NCT01316900|Respiratory System Agents|respiratory system agents|mesh-ancestor
102011184|NCT01316900|Parasympatholytics|parasympatholytics|mesh-ancestor
102011185|NCT01316900|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102011186|NCT01316900|Cholinergic Agents|cholinergic agents|mesh-ancestor
102011187|NCT01316900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102011188|NCT01316900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011189|NCT01316900|Anticonvulsants|anticonvulsants|mesh-ancestor
102011191|NCT03714815|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
102011192|NCT03714815|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101949571|NCT05104983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949572|NCT05062044|Folic Acid|folic acid|mesh-list
101949573|NCT05062044|Hematinics|hematinics|mesh-ancestor
101949574|NCT05062044|Vitamin B Complex|vitamin b complex|mesh-ancestor
102011193|NCT03714815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011194|NCT03714815|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
102011195|NCT02490982|Teriflunomide|teriflunomide|mesh-list
102011196|NCT02490982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102011197|NCT02490982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102011198|NCT02490982|Analgesics|analgesics|mesh-ancestor
102011199|NCT02490982|Sensory System Agents|sensory system agents|mesh-ancestor
102011200|NCT02490982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102011201|NCT02490982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011202|NCT02490982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102011203|NCT02490982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102011204|NCT02490982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102011211|NCT03322150|Autonomic Agents|autonomic agents|mesh-ancestor
102011212|NCT03322150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102011213|NCT03322150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011214|NCT03322150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102011215|NCT03322150|Respiratory System Agents|respiratory system agents|mesh-ancestor
102011216|NCT03322150|Mydriatics|mydriatics|mesh-ancestor
102011217|NCT03322150|Parasympatholytics|parasympatholytics|mesh-ancestor
102011218|NCT03322150|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102011219|NCT03322150|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102011220|NCT03322150|Cholinergic Agents|cholinergic agents|mesh-ancestor
102011221|NCT03322150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102011222|NCT03322150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011223|NCT00936390|Leuprolide|leuprolide|mesh-list
102011224|NCT00936390|Goserelin|goserelin|mesh-list
102011225|NCT00936390|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102011226|NCT00936390|Flutamide|flutamide|mesh-list
102011227|NCT00936390|Bicalutamide|bicalutamide|mesh-list
102011228|NCT00936390|Buserelin|buserelin|mesh-list
102011229|NCT00936390|Androgens|androgens|mesh-list
102011230|NCT00936390|Androgen Antagonists|androgen antagonists|mesh-list
102011231|NCT00936390|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102011232|NCT00936390|Fertility Agents|fertility agents|mesh-ancestor
102011233|NCT00936390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102011234|NCT00936390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011235|NCT00936390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102011236|NCT00936390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102011237|NCT00936390|Hormones|hormones|mesh-ancestor
102011238|NCT00936390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102011239|NCT00936390|Hormone Antagonists|hormone antagonists|mesh-ancestor
102011240|NCT00936390|Luteolytic Agents|luteolytic agents|mesh-ancestor
102011241|NCT00936390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102011242|NCT00936390|Contraceptive Agents|contraceptive agents|mesh-ancestor
102011243|NCT00936390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102011244|NCT03326596|Tranexamic Acid|tranexamic acid|mesh-list
102011245|NCT03326596|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102011246|NCT03326596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102011247|NCT03326596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011248|NCT03326596|Hemostatics|hemostatics|mesh-ancestor
102011249|NCT03326596|Coagulants|coagulants|mesh-ancestor
102011250|NCT03499873|Nepafenac|nepafenac|mesh-list
102011251|NCT03499873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102011252|NCT03499873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102011253|NCT03499873|Analgesics|analgesics|mesh-ancestor
102011254|NCT03499873|Sensory System Agents|sensory system agents|mesh-ancestor
102011255|NCT03499873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102011256|NCT03499873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011257|NCT03499873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102011258|NCT03499873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102011259|NCT01305707|Diazepam|diazepam|mesh-list
102011260|NCT01305707|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102011261|NCT01305707|Lorazepam|lorazepam|mesh-list
102011262|NCT01305707|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
102011263|NCT01305707|Dexetimide|dexetimide|mesh-list
102011264|NCT01305707|Olanzapine|olanzapine|mesh-list
102011265|NCT01305707|Risperidone|risperidone|mesh-list
102011266|NCT01305707|Aripiprazole|aripiprazole|mesh-list
102011267|NCT01305707|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102011268|NCT01305707|Antipsychotic Agents|antipsychotic agents|mesh-list
101949575|NCT05062044|Vitamins|vitamins|mesh-ancestor
101949576|NCT05062044|Micronutrients|micronutrients|mesh-ancestor
101949577|NCT05062044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949578|NCT05030194|Nicotine|nicotine|mesh-list
101949579|NCT05030194|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102011269|NCT01305707|Lithium Carbonate|lithium carbonate|mesh-list
102011270|NCT01305707|Mirtazapine|mirtazapine|mesh-list
102011271|NCT01305707|Citalopram|citalopram|mesh-list
102011272|NCT01305707|Sertraline|sertraline|mesh-list
102011273|NCT01305707|Fluoxetine|fluoxetine|mesh-list
102011274|NCT01305707|Paroxetine|paroxetine|mesh-list
102011275|NCT01305707|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102011276|NCT01305707|Nortriptyline|nortriptyline|mesh-list
102011277|NCT01305707|Imipramine|imipramine|mesh-list
102011278|NCT01305707|Clomipramine|clomipramine|mesh-list
102011279|NCT01305707|Mianserin|mianserin|mesh-list
101466247|NCT02216227|Vancomycin|vancomycin|mesh-list
102011291|NCT01305707|Dopamine Agents|dopamine agents|mesh-ancestor
102011292|NCT01305707|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102011293|NCT01305707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102011294|NCT01305707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102011295|NCT01305707|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102011296|NCT01305707|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102011297|NCT01305707|Parasympatholytics|parasympatholytics|mesh-ancestor
102011298|NCT01305707|Autonomic Agents|autonomic agents|mesh-ancestor
102011299|NCT01305707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102011300|NCT01305707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102011301|NCT01305707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102011302|NCT01305707|Cholinergic Agents|cholinergic agents|mesh-ancestor
102011303|NCT01305707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102011304|NCT01305707|Antiemetics|antiemetics|mesh-ancestor
102011305|NCT01305707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102011306|NCT01305707|Dopamine Agonists|dopamine agonists|mesh-ancestor
102011307|NCT01305707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102011308|NCT01305707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102011309|NCT01305707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102011310|NCT01305707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102011311|NCT01305707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102011312|NCT01305707|Analgesics|analgesics|mesh-ancestor
102011313|NCT01305707|Sensory System Agents|sensory system agents|mesh-ancestor
102011314|NCT01305707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102011315|NCT01305707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102011316|NCT01305707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102011317|NCT01305707|Antimanic Agents|antimanic agents|mesh-ancestor
102011318|NCT01305707|Anticonvulsants|anticonvulsants|mesh-ancestor
102011319|NCT01305707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102011320|NCT01305707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102011321|NCT01305707|GABA Modulators|gaba modulators|mesh-ancestor
102011322|NCT01305707|GABA Agents|gaba agents|mesh-ancestor
102011323|NCT01305707|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102011324|NCT01305707|Histamine Antagonists|histamine antagonists|mesh-ancestor
102011325|NCT01305707|Histamine Agents|histamine agents|mesh-ancestor
102011326|NCT01305707|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102011327|NCT01305707|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102011328|NCT01305707|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102011329|NCT01305707|Adrenergic Agents|adrenergic agents|mesh-ancestor
102011330|NCT01305707|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102011331|NCT01305707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102011332|NCT01305707|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102011333|NCT01305707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102011334|NCT01305707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102011335|NCT01305707|Anesthetics, General|anesthetics, general|mesh-ancestor
102011336|NCT01305707|Anesthetics|anesthetics|mesh-ancestor
102011337|NCT01305707|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102011338|NCT01305707|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102011340|NCT04051970|Antiviral Agents|antiviral agents|mesh-ancestor
102011341|NCT04051970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102011342|NCT03722329|Eculizumab|eculizumab|mesh-list
102011343|NCT03722329|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102011356|NCT03185000|Immunomodulating Agents|immunomodulating agents|mesh-list
102011357|NCT03185000|Immunologic Factors|immunologic factors|mesh-ancestor
102011358|NCT03185000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011359|NCT03791255|Calcium, Dietary|calcium, dietary|mesh-list
102011360|NCT03791255|Calcium|calcium|mesh-list
101949580|NCT05030194|Autonomic Agents|autonomic agents|mesh-ancestor
101949581|NCT05030194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101949582|NCT05030194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949583|NCT05030194|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101949584|NCT05030194|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102011361|NCT03791255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102011362|NCT03791255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011363|NCT03791255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102011364|NCT03742349|Spartalizumab|spartalizumab|mesh-list
102011365|NCT03742349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102011366|NCT03742349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011367|NCT03742349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102011368|NCT03742349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102011369|NCT03319420|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102011370|NCT03319420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102011371|NCT03794297|Trametinib|trametinib|mesh-list
102011372|NCT03794297|Dabrafenib|dabrafenib|mesh-list
102011373|NCT03794297|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
102011374|NCT03794297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102011375|NCT03794297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102011376|NCT03794297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102011377|NCT03794297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519455|NCT04662125|Hormones|hormones|mesh-ancestor
102011378|NCT03794297|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102011379|NCT03794297|Protective Agents|protective agents|mesh-ancestor
102011380|NCT03794297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011381|NCT03794297|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102011382|NCT03794297|Antioxidants|antioxidants|mesh-ancestor
102011383|NCT03048500|Metformin|metformin|mesh-list
102011384|NCT03048500|Nivolumab|nivolumab|mesh-list
102011385|NCT03048500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102011386|NCT03048500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011387|NCT03048500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102011388|NCT03048500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102011389|NCT03048500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102011390|NCT03048500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011391|NCT03790787|Empagliflozin|empagliflozin|mesh-list
102011392|NCT03790787|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102011393|NCT03790787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011394|NCT03790787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102011395|NCT03790787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011396|NCT01334268|Paclitaxel|paclitaxel|mesh-list
102011397|NCT01334268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102011398|NCT01334268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102011399|NCT01334268|Tubulin Modulators|tubulin modulators|mesh-ancestor
102011400|NCT01334268|Antimitotic Agents|antimitotic agents|mesh-ancestor
102011401|NCT01334268|Mitosis Modulators|mitosis modulators|mesh-ancestor
102011402|NCT01334268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011403|NCT04493398|Erythritol|erythritol|mesh-list
102011404|NCT04493398|Vasodilator Agents|vasodilator agents|mesh-ancestor
102011405|NCT00908076|Lubiprostone|lubiprostone|mesh-list
102011406|NCT00908076|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102011407|NCT00908076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102011416|NCT01305317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102011417|NCT02613416|Denosumab|denosumab|mesh-list
102011418|NCT02613416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102011419|NCT02613416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011420|NCT03326050|Ciprofloxacin|ciprofloxacin|mesh-list
102011421|NCT03326050|Rifampin|rifampin|mesh-list
102011422|NCT03326050|Gemifloxacin|gemifloxacin|mesh-list
102011423|NCT03326050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102011424|NCT03326050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102011425|NCT03326050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102011426|NCT03326050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102011427|NCT03326050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102011428|NCT03326050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011429|NCT03326050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102011430|NCT03326050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102011431|NCT03326050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102011432|NCT03326050|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101949585|NCT05030194|Cholinergic Agents|cholinergic agents|mesh-ancestor
101949586|NCT05030194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101949587|NCT05030194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949588|NCT04929028|Fluorouracil|fluorouracil|mesh-list
101949589|NCT04929028|Capecitabine|capecitabine|mesh-list
101949590|NCT04929028|Nivolumab|nivolumab|mesh-list
101949591|NCT04929028|Mitomycins|mitomycins|mesh-list
101949592|NCT04929028|Mitomycin|mitomycin|mesh-list
101949593|NCT04929028|Antimetabolites|antimetabolites|mesh-ancestor
101273199|NCT01848652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102011433|NCT03326050|Antitubercular Agents|antitubercular agents|mesh-ancestor
102011434|NCT03326050|Leprostatic Agents|leprostatic agents|mesh-ancestor
102011435|NCT03326050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102011436|NCT03326050|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102011437|NCT03326050|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101519473|NCT04662125|Antipyretics|antipyretics|mesh-ancestor
102011438|NCT03326050|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102011439|NCT03326050|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102011440|NCT03326050|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102011441|NCT03326050|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102011442|NCT01334424|Propofol|propofol|mesh-list
102011443|NCT01334424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102011444|NCT01334424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102011445|NCT01334424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011446|NCT01334424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102011447|NCT01334424|Anesthetics, General|anesthetics, general|mesh-ancestor
102011448|NCT01334424|Anesthetics|anesthetics|mesh-ancestor
102011449|NCT05083637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102011450|NCT05664685|Bismuth|bismuth|mesh-list
102011451|NCT05664685|Antacids|antacids|mesh-ancestor
102011452|NCT05664685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011453|NCT05664685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102011454|NCT03793517|Decitabine|decitabine|mesh-list
102011455|NCT03793517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102011456|NCT03793517|Antimetabolites|antimetabolites|mesh-ancestor
102011457|NCT03793517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011458|NCT03793517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102011459|NCT03793517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102011460|NCT02886702|Nicotinic Acids|nicotinic acids|mesh-list
102011461|NCT02886702|Tazarotene|tazarotene|mesh-list
102011462|NCT02886702|Dermatologic Agents|dermatologic agents|mesh-ancestor
102011463|NCT02886702|Keratolytic Agents|keratolytic agents|mesh-ancestor
102011464|NCT02886702|Vitamin B Complex|vitamin b complex|mesh-ancestor
102011465|NCT02886702|Vitamins|vitamins|mesh-ancestor
102011466|NCT02886702|Micronutrients|micronutrients|mesh-ancestor
102011467|NCT02886702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011468|NCT03498313|Estradiol|estradiol|mesh-list
102011469|NCT03498313|Progesterone|progesterone|mesh-list
102011470|NCT03498313|Estrogens|estrogens|mesh-ancestor
102011471|NCT03498313|Hormones|hormones|mesh-ancestor
102011472|NCT03498313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101466452|NCT00238784|Hormones|hormones|mesh-ancestor
102011475|NCT03721081|Lidocaine|lidocaine|mesh-list
102011476|NCT03721081|Anesthetics, Local|anesthetics, local|mesh-ancestor
102011477|NCT03721081|Anesthetics|anesthetics|mesh-ancestor
102011478|NCT03721081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102011479|NCT03721081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011480|NCT03721081|Sensory System Agents|sensory system agents|mesh-ancestor
102011481|NCT03721081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102011482|NCT03721081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102011483|NCT03721081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102011484|NCT03721081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101519503|NCT00557180|Hormones|hormones|mesh-ancestor
102011485|NCT03721081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102011486|NCT03721081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011487|NCT04493554|Vasopressins|vasopressins|mesh-list
102011488|NCT04493554|Arginine Vasopressin|arginine vasopressin|mesh-list
102011489|NCT04493554|Hemostatics|hemostatics|mesh-ancestor
102011490|NCT04493554|Coagulants|coagulants|mesh-ancestor
102011491|NCT04493554|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101949594|NCT04929028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949595|NCT04929028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101949596|NCT04929028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949597|NCT04929028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101949598|NCT04929028|Immunologic Factors|immunologic factors|mesh-ancestor
102011492|NCT04493554|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102011493|NCT04493554|Natriuretic Agents|natriuretic agents|mesh-ancestor
102011494|NCT04493554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011496|NCT02601014|Ipilimumab|ipilimumab|mesh-list
102011497|NCT02601014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102011498|NCT02601014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102011499|NCT02601014|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102011500|NCT02601014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011501|NCT01307046|Losartan|losartan|mesh-list
102011502|NCT01307046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102011503|NCT01307046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102011504|NCT01307046|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102011505|NCT01307046|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102011506|NCT01307046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011507|NCT05419115|Furosemide|furosemide|mesh-list
102011508|NCT05419115|Diuretics|diuretics|mesh-ancestor
102011509|NCT05419115|Natriuretic Agents|natriuretic agents|mesh-ancestor
102011510|NCT05419115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011511|NCT05419115|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102011512|NCT05419115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102011513|NCT05419115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011514|NCT02490592|Fluorides|fluorides|mesh-list
102011515|NCT02490592|Cariostatic Agents|cariostatic agents|mesh-ancestor
102011516|NCT02490592|Protective Agents|protective agents|mesh-ancestor
102011517|NCT02490592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011518|NCT03075462|Apatinib|apatinib|mesh-list
102011519|NCT03075462|Fluzoparib|fluzoparib|mesh-list
102011520|NCT03075462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102011521|NCT03075462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102011522|NCT03075462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102011523|NCT03075462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011524|NCT03075462|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102011525|NCT01305395|Sirolimus|sirolimus|mesh-list
102011526|NCT01305395|Temsirolimus|temsirolimus|mesh-list
102011527|NCT01305395|MTOR Inhibitors|mtor inhibitors|mesh-list
102011528|NCT01305395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102011529|NCT01305395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102011530|NCT01305395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102011531|NCT01305395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102011532|NCT01305395|Antifungal Agents|antifungal agents|mesh-ancestor
102011533|NCT01305395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102011534|NCT01305395|Immunologic Factors|immunologic factors|mesh-ancestor
102011535|NCT01305395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011536|NCT01305395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102011537|NCT01305395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102011538|NCT01305395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011539|NCT02886624|Grazoprevir|grazoprevir|mesh-list
102011540|NCT02886624|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
102011541|NCT02886624|Antiviral Agents|antiviral agents|mesh-ancestor
102011542|NCT02886624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102011543|NCT02487316|Crizotinib|crizotinib|mesh-list
102011544|NCT02487316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102011545|NCT02487316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102011554|NCT03318718|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102011555|NCT03318718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102011556|NCT03318718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102011558|NCT03325348|Nifedipine|nifedipine|mesh-list
102011559|NCT03325348|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102011560|NCT03325348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101731306|NCT04102566|Analgesics|analgesics|mesh-ancestor
102011561|NCT03325348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011562|NCT03325348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101949599|NCT04929028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949600|NCT04929028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102011563|NCT03325348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011564|NCT03325348|Vasodilator Agents|vasodilator agents|mesh-ancestor
102011565|NCT03325348|Tocolytic Agents|tocolytic agents|mesh-ancestor
102011566|NCT03325348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102011567|NCT03325348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102011568|NCT03325348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102011569|NCT03325348|Adrenergic Agents|adrenergic agents|mesh-ancestor
102011570|NCT03325348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102011571|NCT03325348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102011572|NCT03325348|Sympathomimetics|sympathomimetics|mesh-ancestor
102011573|NCT03325348|Autonomic Agents|autonomic agents|mesh-ancestor
102011574|NCT03325348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102011575|NCT03325348|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102011576|NCT03325348|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102011577|NCT03790163|Levobupivacaine|levobupivacaine|mesh-list
102011578|NCT03790163|Anesthetics, Local|anesthetics, local|mesh-ancestor
102011580|NCT03790163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102011581|NCT03790163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011582|NCT03790163|Sensory System Agents|sensory system agents|mesh-ancestor
102011583|NCT03790163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102011584|NCT03325270|Ferrous fumarate|ferrous fumarate|mesh-list
102011585|NCT03325270|Trace Elements|trace elements|mesh-ancestor
102011586|NCT03325270|Micronutrients|micronutrients|mesh-ancestor
102011587|NCT03325270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011588|NCT02963766|Dulaglutide|dulaglutide|mesh-list
102011589|NCT02963766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102011590|NCT02963766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011592|NCT01334502|Cyclophosphamide|cyclophosphamide|mesh-list
102011593|NCT01334502|Rituximab|rituximab|mesh-list
102011594|NCT01334502|Doxorubicin|doxorubicin|mesh-list
102011595|NCT01334502|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102011596|NCT01334502|Vincristine|vincristine|mesh-list
102011597|NCT01334502|Everolimus|everolimus|mesh-list
102011598|NCT01334502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102011599|NCT01334502|Immunologic Factors|immunologic factors|mesh-ancestor
102011600|NCT01334502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011601|NCT01334502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102011602|NCT01334502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102011603|NCT01334502|Alkylating Agents|alkylating agents|mesh-ancestor
102011604|NCT01334502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011605|NCT01334502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102011606|NCT01334502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102011607|NCT01334502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102011608|NCT01334502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102011609|NCT01334502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102011610|NCT01334502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102011611|NCT01334502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102011615|NCT01334502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102011616|NCT01334502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102011617|NCT01334502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102011618|NCT01334502|Tubulin Modulators|tubulin modulators|mesh-ancestor
102011619|NCT01334502|Antimitotic Agents|antimitotic agents|mesh-ancestor
102011620|NCT01334502|Mitosis Modulators|mitosis modulators|mesh-ancestor
102011621|NCT01334502|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102011622|NCT01334502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102011623|NCT02487082|Melatonin|melatonin|mesh-list
102011624|NCT02487082|Donepezil|donepezil|mesh-list
102011625|NCT02487082|Antioxidants|antioxidants|mesh-ancestor
102011626|NCT02487082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011627|NCT02487082|Protective Agents|protective agents|mesh-ancestor
102011628|NCT02487082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011629|NCT02487082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102011630|NCT02487082|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102011631|NCT02487082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102011632|NCT02487082|Cholinergic Agents|cholinergic agents|mesh-ancestor
102011633|NCT02487082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102011634|NCT02487082|Nootropic Agents|nootropic agents|mesh-ancestor
102011635|NCT03788681|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102011636|NCT03788681|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102011637|NCT03788681|Estradiol|estradiol|mesh-list
101949601|NCT04929028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101949602|NCT04929028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101949603|NCT04929028|Alkylating Agents|alkylating agents|mesh-ancestor
101273409|NCT01850251|Vitamin D|vitamin d|mesh-list
102011638|NCT03788681|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102011639|NCT03788681|Estrogens|estrogens|mesh-ancestor
102011640|NCT03788681|Hormones|hormones|mesh-ancestor
102011641|NCT03788681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102011642|NCT03788681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011643|NCT03788681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102011644|NCT03788681|Contraceptive Agents|contraceptive agents|mesh-ancestor
102011645|NCT03788681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102011646|NCT03788681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102011647|NCT01308203|Niacin|niacin|mesh-list
102011648|NCT01308203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102011649|NCT01308203|Antimetabolites|antimetabolites|mesh-ancestor
102011650|NCT01308203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011651|NCT01308203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102011652|NCT01308203|Vasodilator Agents|vasodilator agents|mesh-ancestor
102011653|NCT01308203|Vitamin B Complex|vitamin b complex|mesh-ancestor
102011654|NCT01308203|Vitamins|vitamins|mesh-ancestor
102011655|NCT01308203|Micronutrients|micronutrients|mesh-ancestor
102011656|NCT01308203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011657|NCT03790085|Olanzapine|olanzapine|mesh-list
102011658|NCT03790085|Risperidone|risperidone|mesh-list
102011659|NCT03790085|Aripiprazole|aripiprazole|mesh-list
102011660|NCT03790085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102011661|NCT03790085|Serotonin Agents|serotonin agents|mesh-ancestor
102011662|NCT03790085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102011663|NCT03790085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011664|NCT03790085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011665|NCT03790085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102011666|NCT03790085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102011667|NCT03790085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102011668|NCT03790085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102011669|NCT03790085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102011670|NCT03790085|Dopamine Agents|dopamine agents|mesh-ancestor
102011671|NCT03790085|Antiemetics|antiemetics|mesh-ancestor
102011672|NCT03790085|Autonomic Agents|autonomic agents|mesh-ancestor
102011673|NCT03790085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102011674|NCT03790085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102011675|NCT03790085|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102011676|NCT03790085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102011677|NCT03790085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102011678|NCT03790085|Antidepressive Agents|antidepressive agents|mesh-ancestor
102011679|NCT03790085|Dopamine Agonists|dopamine agonists|mesh-ancestor
102011680|NCT03790085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102011681|NCT03790085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102011682|NCT03790085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102011683|NCT03790085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102011684|NCT01306097|Zinc|zinc|mesh-list
102011685|NCT01306097|Zinc Sulfate|zinc sulfate|mesh-list
102011686|NCT01306097|Trace Elements|trace elements|mesh-ancestor
102011687|NCT01306097|Micronutrients|micronutrients|mesh-ancestor
102011688|NCT01306097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011689|NCT01306097|Astringents|astringents|mesh-ancestor
102011690|NCT01306097|Dermatologic Agents|dermatologic agents|mesh-ancestor
102011691|NCT03790007|Bupivacaine|bupivacaine|mesh-list
102011692|NCT03790007|Anesthetics, Local|anesthetics, local|mesh-ancestor
102011693|NCT03790007|Anesthetics|anesthetics|mesh-ancestor
102011694|NCT03790007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102011695|NCT03790007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011696|NCT03790007|Sensory System Agents|sensory system agents|mesh-ancestor
102011697|NCT03790007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102011699|NCT03789695|Antithrombins|antithrombins|mesh-ancestor
102011700|NCT03789695|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101519602|NCT01208038|Hormones|hormones|mesh-ancestor
102011701|NCT03789695|Protease Inhibitors|protease inhibitors|mesh-ancestor
102011702|NCT03789695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102011703|NCT03789695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011704|NCT03789695|Anticoagulants|anticoagulants|mesh-ancestor
102011705|NCT00739674|Losartan|losartan|mesh-list
102011706|NCT00739674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102011707|NCT00739674|Calcium Channel Blockers|calcium channel blockers|mesh-list
101949604|NCT04929028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101949605|NCT04929028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101949606|NCT04915729|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101949607|NCT04915729|Tenecteplase|tenecteplase|mesh-list
102011708|NCT00739674|Calcium|calcium|mesh-list
102011709|NCT00739674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102011710|NCT00739674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011711|NCT00739674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102011712|NCT00739674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102011713|NCT00739674|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102011714|NCT00739674|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102011715|NCT00739674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011716|NCT00739674|Diuretics|diuretics|mesh-ancestor
102011717|NCT00739674|Natriuretic Agents|natriuretic agents|mesh-ancestor
102011718|NCT00739674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102011719|NCT00739674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102011720|NCT01306409|Darbepoetin alfa|darbepoetin alfa|mesh-list
102011721|NCT01306409|Hematinics|hematinics|mesh-ancestor
102011722|NCT01331928|Docetaxel|docetaxel|mesh-list
102011723|NCT01331928|Capecitabine|capecitabine|mesh-list
102011724|NCT01331928|Oxaliplatin|oxaliplatin|mesh-list
102011725|NCT01331928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102011726|NCT01331928|Tubulin Modulators|tubulin modulators|mesh-ancestor
102011727|NCT01331928|Antimitotic Agents|antimitotic agents|mesh-ancestor
102011728|NCT01331928|Mitosis Modulators|mitosis modulators|mesh-ancestor
102011729|NCT01331928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011730|NCT01331928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102011731|NCT01331928|Antimetabolites|antimetabolites|mesh-ancestor
102011732|NCT01334580|Methadone|methadone|mesh-list
102011733|NCT01334580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102011734|NCT01334580|Narcotics|narcotics|mesh-ancestor
102011735|NCT01334580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102011736|NCT01334580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011737|NCT01334580|Analgesics|analgesics|mesh-ancestor
102011738|NCT01334580|Sensory System Agents|sensory system agents|mesh-ancestor
102011739|NCT01334580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102011740|NCT01334580|Antitussive Agents|antitussive agents|mesh-ancestor
102011741|NCT01334580|Respiratory System Agents|respiratory system agents|mesh-ancestor
102011742|NCT02694588|Infliximab|infliximab|mesh-list
102011743|NCT02694588|Vedolizumab|vedolizumab|mesh-list
102011744|NCT02694588|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102011745|NCT02694588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102011746|NCT02694588|Dermatologic Agents|dermatologic agents|mesh-ancestor
102011747|NCT02694588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102011748|NCT02694588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102011749|NCT03789539|Vaccines|vaccines|mesh-list
102011750|NCT03789539|Immunologic Factors|immunologic factors|mesh-ancestor
102011751|NCT03789539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011752|NCT00400218|Losartan|losartan|mesh-list
102011753|NCT00400218|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102011754|NCT00400218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102011755|NCT00400218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102011756|NCT00400218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102011757|NCT00400218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102011758|NCT00400218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011759|NCT00400218|Diuretics|diuretics|mesh-ancestor
102011760|NCT00400218|Natriuretic Agents|natriuretic agents|mesh-ancestor
101466720|NCT05896033|Menthol|menthol|mesh-list
102011762|NCT00400218|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102011763|NCT00400218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102011765|NCT02486848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102011766|NCT02486848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102011767|NCT02486848|Vasodilator Agents|vasodilator agents|mesh-ancestor
102011768|NCT01306565|Atorvastatin|atorvastatin|mesh-list
102011769|NCT01306565|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102011770|NCT01306565|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102011771|NCT01306565|Antimetabolites|antimetabolites|mesh-ancestor
102011772|NCT01306565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011773|NCT01306565|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102011774|NCT01306565|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102011775|NCT01306565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102011776|NCT03716791|Dimethyl sulfone|dimethyl sulfone|mesh-list
101949608|NCT04915729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101949609|NCT04915729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101949610|NCT04915729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011777|NCT03716791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102011778|NCT03786029|Acetaminophen|acetaminophen|mesh-list
102011779|NCT03786029|Ibuprofen|ibuprofen|mesh-list
102011780|NCT03786029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102011781|NCT03786029|Analgesics|analgesics|mesh-ancestor
102011782|NCT03786029|Sensory System Agents|sensory system agents|mesh-ancestor
102011783|NCT03786029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102011784|NCT03786029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011785|NCT03786029|Antipyretics|antipyretics|mesh-ancestor
102011786|NCT03786029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102011787|NCT03786029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102011788|NCT03786029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102011789|NCT03786029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102011790|NCT03786029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102011791|NCT03786029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011792|NCT01334892|Cyclosporine|cyclosporine|mesh-list
102011793|NCT01334892|Cyclosporins|cyclosporins|mesh-list
102011794|NCT01334892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102011795|NCT01334892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011796|NCT01334892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102011797|NCT01334892|Immunologic Factors|immunologic factors|mesh-ancestor
102011798|NCT01334892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011799|NCT01334892|Antifungal Agents|antifungal agents|mesh-ancestor
102011800|NCT01334892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102011801|NCT01334892|Dermatologic Agents|dermatologic agents|mesh-ancestor
102011802|NCT01334892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102011803|NCT01334892|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102011804|NCT04730219|Paclitaxel|paclitaxel|mesh-list
102011805|NCT04730219|Tislelizumab|tislelizumab|mesh-list
102011806|NCT04730219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102011807|NCT04730219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102011808|NCT04730219|Tubulin Modulators|tubulin modulators|mesh-ancestor
102011809|NCT04730219|Antimitotic Agents|antimitotic agents|mesh-ancestor
102011810|NCT04730219|Mitosis Modulators|mitosis modulators|mesh-ancestor
102011811|NCT04730219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011812|NCT04730219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102011813|NCT04492774|Dexamethasone|dexamethasone|mesh-list
102011814|NCT04492774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102011815|NCT04492774|Antiemetics|antiemetics|mesh-ancestor
102011816|NCT04492774|Autonomic Agents|autonomic agents|mesh-ancestor
102011817|NCT04492774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102011818|NCT04492774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011819|NCT04492774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102011820|NCT04492774|Glucocorticoids|glucocorticoids|mesh-ancestor
102011821|NCT04492774|Hormones|hormones|mesh-ancestor
102011822|NCT04492774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102011823|NCT04492774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102011824|NCT04492774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102011825|NCT03321292|Aspirin|aspirin|mesh-list
102011826|NCT03321292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102011827|NCT03321292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102011828|NCT03321292|Analgesics|analgesics|mesh-ancestor
102011829|NCT03321292|Sensory System Agents|sensory system agents|mesh-ancestor
102011830|NCT03321292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102011831|NCT03321292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011832|NCT03321292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102011833|NCT03321292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102011846|NCT01306721|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102011848|NCT01306721|Histamine Antagonists|histamine antagonists|mesh-ancestor
102011849|NCT01306721|Histamine Agents|histamine agents|mesh-ancestor
102011850|NCT01306721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102011851|NCT01306721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011852|NCT01306721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011853|NCT01306721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102011854|NCT01306721|Autonomic Agents|autonomic agents|mesh-ancestor
101519644|NCT00540345|Interferon alpha-2|interferon alpha-2|mesh-list
102011855|NCT01306721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102011856|NCT01306721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102011857|NCT01306721|Respiratory System Agents|respiratory system agents|mesh-ancestor
101949611|NCT04914741|Prednisolone|prednisolone|mesh-list
101949612|NCT04914741|Cyclophosphamide|cyclophosphamide|mesh-list
101949613|NCT04914741|Rituximab|rituximab|mesh-list
101949614|NCT04914741|Doxorubicin|doxorubicin|mesh-list
101949615|NCT04914741|Vincristine|vincristine|mesh-list
101949616|NCT04914741|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
101949617|NCT04914741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102011858|NCT01306721|Nasal Decongestants|nasal decongestants|mesh-ancestor
102011859|NCT01306721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102011860|NCT01306721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102011861|NCT01306721|Sympathomimetics|sympathomimetics|mesh-ancestor
102011862|NCT01306721|Adrenergic Agents|adrenergic agents|mesh-ancestor
102011863|NCT01337466|Fialuridine|fialuridine|mesh-list
102011864|NCT01337466|Antiviral Agents|antiviral agents|mesh-ancestor
102011865|NCT01337466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102011866|NCT01337466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102011867|NCT01337466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102011868|NCT01337466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011869|NCT02486926|Remifentanil|remifentanil|mesh-list
102011870|NCT02486926|Alfentanil|alfentanil|mesh-list
102011871|NCT02486926|Thiopental|thiopental|mesh-list
102011872|NCT02486926|Sevoflurane|sevoflurane|mesh-list
102011873|NCT02486926|Rocuronium|rocuronium|mesh-list
102011874|NCT02486926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102011875|NCT02486926|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102011876|NCT02486926|Anesthetics, General|anesthetics, general|mesh-ancestor
102011877|NCT02486926|Anesthetics|anesthetics|mesh-ancestor
102011878|NCT02486926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102011879|NCT02486926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011880|NCT02486926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102011881|NCT02486926|Narcotics|narcotics|mesh-ancestor
102011882|NCT02486926|Analgesics|analgesics|mesh-ancestor
102011883|NCT02486926|Sensory System Agents|sensory system agents|mesh-ancestor
102011884|NCT02486926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102011885|NCT02486926|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102011886|NCT02486926|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102011887|NCT02486926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102011888|NCT02486926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102011889|NCT02486926|Anticonvulsants|anticonvulsants|mesh-ancestor
102011890|NCT02486926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102011891|NCT02486926|GABA Modulators|gaba modulators|mesh-ancestor
102011892|NCT02486926|GABA Agents|gaba agents|mesh-ancestor
102011893|NCT02486926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102011894|NCT02486926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011895|NCT01335048|Clopidogrel|clopidogrel|mesh-list
102011896|NCT01335048|Atorvastatin|atorvastatin|mesh-list
101466867|NCT05611905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102011900|NCT01335048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011901|NCT01335048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102011902|NCT01335048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102011903|NCT01335048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102011904|NCT01335048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101312430|NCT00007878|Antidotes|antidotes|mesh-ancestor
102011905|NCT01335048|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102011906|NCT01335048|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102011907|NCT01335048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102011908|NCT01335048|Purinergic Agents|purinergic agents|mesh-ancestor
102011909|NCT01335048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102011910|NCT01335048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011911|NCT01335126|Lubricant Eye Drops|lubricant eye drops|mesh-list
102011912|NCT01335126|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102011913|NCT01335126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102011914|NCT01567475|Rituximab|rituximab|mesh-list
102011915|NCT01567475|Everolimus|everolimus|mesh-list
102011916|NCT01567475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102011917|NCT01567475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102011918|NCT01567475|Immunologic Factors|immunologic factors|mesh-ancestor
102011919|NCT01567475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011920|NCT01567475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102011921|NCT01567475|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102011922|NCT01567475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102011923|NCT01567475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101949618|NCT04914741|Immunologic Factors|immunologic factors|mesh-ancestor
101949619|NCT04914741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011924|NCT01567475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011925|NCT01567475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102011926|NCT03435055|Nitrous Oxide|nitrous oxide|mesh-list
102011927|NCT03435055|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102011928|NCT03435055|Anesthetics, General|anesthetics, general|mesh-ancestor
102011929|NCT03435055|Anesthetics|anesthetics|mesh-ancestor
102011930|NCT03435055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102011931|NCT03435055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011932|NCT03435055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102011933|NCT03435055|Analgesics|analgesics|mesh-ancestor
102011934|NCT03435055|Sensory System Agents|sensory system agents|mesh-ancestor
102011935|NCT03435055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102011936|NCT05693246|Glycopyrrolate|glycopyrrolate|mesh-list
102011937|NCT05693246|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102011938|NCT05693246|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102011939|NCT05693246|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102011940|NCT05693246|Cholinergic Agents|cholinergic agents|mesh-ancestor
102011941|NCT05693246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102011942|NCT05693246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011943|NCT05693246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011944|NCT03316066|Ropivacaine|ropivacaine|mesh-list
102011945|NCT03316066|Anesthetics, Local|anesthetics, local|mesh-ancestor
102011946|NCT03316066|Anesthetics|anesthetics|mesh-ancestor
102011947|NCT03316066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102011948|NCT03316066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011949|NCT03316066|Sensory System Agents|sensory system agents|mesh-ancestor
102011950|NCT03316066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102011951|NCT03318016|Cyclophosphamide|cyclophosphamide|mesh-list
102011952|NCT03318016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102011953|NCT03318016|Immunologic Factors|immunologic factors|mesh-ancestor
102011954|NCT03318016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011955|NCT03318016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102011956|NCT03318016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102011957|NCT03318016|Alkylating Agents|alkylating agents|mesh-ancestor
102011958|NCT03318016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011959|NCT03318016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102011960|NCT03318016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102011961|NCT03434977|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
102011962|NCT03434977|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101519708|NCT01206322|Insulin|insulin|mesh-list
102011963|NCT03434977|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102011964|NCT03434977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011965|NCT01335360|Nevirapine|nevirapine|mesh-list
102011966|NCT01335360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102011979|NCT02489266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102011980|NCT02489266|Immunologic Factors|immunologic factors|mesh-ancestor
102011981|NCT02489266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011982|NCT02489266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102011983|NCT02489266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102011984|NCT02489266|Alkylating Agents|alkylating agents|mesh-ancestor
102011985|NCT02489266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011986|NCT02489266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102011987|NCT02489266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102011988|NCT02489266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102011989|NCT02489266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102011990|NCT02489266|Antiviral Agents|antiviral agents|mesh-ancestor
102011991|NCT02489266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102011992|NCT03434119|Insulin|insulin|mesh-list
102011993|NCT03434119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102011994|NCT03434119|Insulin Glargine|insulin glargine|mesh-list
102011995|NCT03434119|Lixisenatide|lixisenatide|mesh-list
102011996|NCT03434119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102011997|NCT03434119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011998|NCT02484352|Oxycodone|oxycodone|mesh-list
102011999|NCT02484352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102012000|NCT02484352|Narcotics|narcotics|mesh-ancestor
102012001|NCT02484352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102012002|NCT02484352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012003|NCT02484352|Analgesics|analgesics|mesh-ancestor
102012004|NCT02484352|Sensory System Agents|sensory system agents|mesh-ancestor
102012005|NCT02484352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101949620|NCT04914741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101949621|NCT04914741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101949622|NCT04914741|Alkylating Agents|alkylating agents|mesh-ancestor
101273763|NCT01852565|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102012007|NCT01308671|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102012008|NCT01308671|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102012009|NCT01308671|Cholinergic Agents|cholinergic agents|mesh-ancestor
102012010|NCT01308671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102012011|NCT01308671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012012|NCT01308671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012013|NCT00378378|Mometasone Furoate|mometasone furoate|mesh-list
102012014|NCT00378378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102012015|NCT00378378|Dermatologic Agents|dermatologic agents|mesh-ancestor
102012016|NCT00378378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102012017|NCT03315676|Esomeprazole|esomeprazole|mesh-list
102012018|NCT03315676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102012019|NCT03315676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102012020|NCT03315676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102012021|NCT03315676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102012022|NCT03315676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012023|NCT01307189|Tiotropium Bromide|tiotropium bromide|mesh-list
102012024|NCT01307189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102012025|NCT01307189|Autonomic Agents|autonomic agents|mesh-ancestor
102012026|NCT01307189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102012027|NCT01307189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012028|NCT01307189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102012029|NCT01307189|Respiratory System Agents|respiratory system agents|mesh-ancestor
101467007|NCT05028062|Naltrexone|naltrexone|mesh-list
102012031|NCT01307189|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102012032|NCT01307189|Cholinergic Agents|cholinergic agents|mesh-ancestor
102012033|NCT01307189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102012034|NCT01307189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012035|NCT02486458|Listerine|listerine|mesh-list
102012036|NCT02486458|Fluorides|fluorides|mesh-list
102012037|NCT02486458|Sodium Fluoride|sodium fluoride|mesh-list
102012038|NCT02486458|Fluorides, Topical|fluorides, topical|mesh-list
102012039|NCT02486458|Cariostatic Agents|cariostatic agents|mesh-ancestor
102012040|NCT02486458|Protective Agents|protective agents|mesh-ancestor
102012041|NCT02486458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012042|NCT02486458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102012043|NCT02486458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102012044|NCT01335516|Terlipressin|terlipressin|mesh-list
102012045|NCT01335516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102012046|NCT01335516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102012047|NCT05694923|Empagliflozin|empagliflozin|mesh-list
102012048|NCT05694923|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102012049|NCT05694923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012050|NCT05694923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102012051|NCT05694923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012052|NCT01332396|Lapatinib|lapatinib|mesh-list
102012053|NCT01332396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102012054|NCT01332396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102012055|NCT01332396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102012056|NCT01332396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012057|NCT03719053|Tenofovir|tenofovir|mesh-list
102012058|NCT03719053|Antiviral Agents|antiviral agents|mesh-ancestor
102012059|NCT03719053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102012060|NCT03719053|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102012061|NCT03719053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102012062|NCT03719053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102012063|NCT03719053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012064|NCT03719053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102012065|NCT03719053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102012066|NCT03526848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102012067|NCT03526848|Antibodies|antibodies|mesh-list
102012068|NCT03526848|Immunoglobulins|immunoglobulins|mesh-list
102012069|NCT03526848|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102012070|NCT03526848|Immunologic Factors|immunologic factors|mesh-ancestor
102012071|NCT03526848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012072|NCT03526848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949623|NCT04914741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949624|NCT04914741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949625|NCT04914741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102012073|NCT03321136|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
102012074|NCT03321136|Hallucinogens|hallucinogens|mesh-ancestor
102012075|NCT03321136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012076|NCT03321136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102012077|NCT03321136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102012078|NCT03321136|Serotonin Agents|serotonin agents|mesh-ancestor
102012079|NCT03321136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102012080|NCT03321136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012081|NCT03321136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102012082|NCT01332552|Ritonavir|ritonavir|mesh-list
102012083|NCT01332552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102012084|NCT01332552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102012085|NCT01332552|Protease Inhibitors|protease inhibitors|mesh-ancestor
102012086|NCT01332552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102012087|NCT01332552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012088|NCT01332552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102012090|NCT01332552|Antiviral Agents|antiviral agents|mesh-ancestor
102012091|NCT01332552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102012092|NCT01332552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102012093|NCT01332552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102012094|NCT03720223|Bupivacaine|bupivacaine|mesh-list
101519730|NCT04658732|Dexmedetomidine|dexmedetomidine|mesh-list
102012095|NCT03720223|Anesthetics, Local|anesthetics, local|mesh-ancestor
102012096|NCT03720223|Anesthetics|anesthetics|mesh-ancestor
102012097|NCT03720223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102012098|NCT03720223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012099|NCT03720223|Sensory System Agents|sensory system agents|mesh-ancestor
102012100|NCT03720223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102012101|NCT03160716|Lidocaine|lidocaine|mesh-list
102012102|NCT03160716|Anesthetics, Local|anesthetics, local|mesh-ancestor
102012103|NCT03160716|Anesthetics|anesthetics|mesh-ancestor
102012104|NCT03160716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102012107|NCT03160716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102012108|NCT03160716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102012109|NCT03160716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102012110|NCT03160716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102012111|NCT03160716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102012112|NCT03160716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012113|NCT00092664|Simvastatin|simvastatin|mesh-list
102012114|NCT00092664|Ezetimibe|ezetimibe|mesh-list
102012115|NCT00092664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102012116|NCT00092664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102012117|NCT00092664|Antimetabolites|antimetabolites|mesh-ancestor
102012118|NCT00092664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012119|NCT00092664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102012120|NCT00092664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102012121|NCT00092664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102012122|NCT02483884|Bombesin|bombesin|mesh-list
102012123|NCT02483884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102012124|NCT02483884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012125|NCT02483884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012126|NCT03317548|Progesterone|progesterone|mesh-list
102012127|NCT03317548|Progestins|progestins|mesh-ancestor
102012128|NCT03317548|Hormones|hormones|mesh-ancestor
102012129|NCT03317548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102012130|NCT03317548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012131|NCT00092586|Ezetimibe|ezetimibe|mesh-list
102012132|NCT00092586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102012133|NCT00092586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102012134|NCT00092586|Antimetabolites|antimetabolites|mesh-ancestor
102012135|NCT00092586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012136|NCT00092586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102012137|NCT03786887|Nalbuphine|nalbuphine|mesh-list
102012138|NCT03786887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102012139|NCT03786887|Narcotics|narcotics|mesh-ancestor
102012140|NCT03786887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102012141|NCT03786887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012142|NCT03786887|Analgesics|analgesics|mesh-ancestor
101949626|NCT04914741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101949628|NCT04914741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101949629|NCT04914741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101519757|NCT04658420|Ketamine|ketamine|mesh-list
101949630|NCT04914741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101949631|NCT04914741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101273907|NCT01853956|Alprazolam|alprazolam|mesh-list
102012143|NCT03786887|Sensory System Agents|sensory system agents|mesh-ancestor
102012144|NCT03786887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102012145|NCT03787043|Metformin|metformin|mesh-list
102012146|NCT03787043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102012147|NCT03787043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012148|NCT00090168|Atorvastatin|atorvastatin|mesh-list
102012149|NCT00090168|Simvastatin|simvastatin|mesh-list
102012150|NCT00090168|Ezetimibe|ezetimibe|mesh-list
102012151|NCT00090168|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102012152|NCT00090168|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102012153|NCT00090168|Antimetabolites|antimetabolites|mesh-ancestor
102012154|NCT00090168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012155|NCT00090168|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102012156|NCT00090168|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102012157|NCT00090168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102012158|NCT01332786|Tigecycline|tigecycline|mesh-list
102012159|NCT01332786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102012160|NCT01332786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102012161|NCT01332786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102012162|NCT01332786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102012163|NCT01332786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012164|NCT01338090|Bevacizumab|bevacizumab|mesh-list
102012166|NCT01338090|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
102012167|NCT01338090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102012168|NCT01338090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102012169|NCT01338090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102012170|NCT01338090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102012171|NCT01338090|Growth Substances|growth substances|mesh-ancestor
102012172|NCT01338090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012173|NCT01338090|Growth Inhibitors|growth inhibitors|mesh-ancestor
102012174|NCT01338090|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102012175|NCT01338090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102012176|NCT01338090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102012177|NCT01338090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012186|NCT01307969|Anesthetics, Local|anesthetics, local|mesh-ancestor
102012187|NCT01307969|Anesthetics|anesthetics|mesh-ancestor
102012188|NCT01307969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102012189|NCT01307969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012190|NCT01307969|Sensory System Agents|sensory system agents|mesh-ancestor
102012191|NCT01307969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102012192|NCT01307969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102012193|NCT01307969|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102012194|NCT01307969|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102012195|NCT01307969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102012196|NCT01307969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012197|NCT01307969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102012198|NCT01307969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102012199|NCT01307969|Adrenergic Agents|adrenergic agents|mesh-ancestor
102012200|NCT01307969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102012201|NCT01307969|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102012202|NCT01307969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102012203|NCT01307969|Autonomic Agents|autonomic agents|mesh-ancestor
102012204|NCT01307969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102012205|NCT01307969|Respiratory System Agents|respiratory system agents|mesh-ancestor
102012206|NCT01307969|Mydriatics|mydriatics|mesh-ancestor
102012207|NCT01307969|Sympathomimetics|sympathomimetics|mesh-ancestor
102012208|NCT01307969|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102012209|NCT03786419|Atezolizumab|atezolizumab|mesh-list
102012210|NCT03786419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101737363|NCT02584881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949632|NCT04914741|Tubulin Modulators|tubulin modulators|mesh-ancestor
101949633|NCT04914741|Antimitotic Agents|antimitotic agents|mesh-ancestor
101949634|NCT04914741|Mitosis Modulators|mitosis modulators|mesh-ancestor
101949635|NCT04914741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101949636|NCT04914741|Glucocorticoids|glucocorticoids|mesh-ancestor
101949637|NCT04914741|Hormones|hormones|mesh-ancestor
101949638|NCT04914741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101949639|NCT04914741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101949640|NCT04914741|Immunoconjugates|immunoconjugates|mesh-ancestor
101949641|NCT04913675|Sotrovimab|sotrovimab|mesh-list
101949642|NCT04913675|Antiviral Agents|antiviral agents|mesh-ancestor
101949643|NCT04913675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101949644|NCT04862260|Atorvastatin|atorvastatin|mesh-list
101949645|NCT04862260|Ezetimibe|ezetimibe|mesh-list
101949646|NCT04862260|Evolocumab|evolocumab|mesh-list
101949647|NCT04862260|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
101949648|NCT04862260|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102012211|NCT03786419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012212|NCT03786419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102012213|NCT03786419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102012214|NCT01338324|Simvastatin|simvastatin|mesh-list
102012215|NCT01338324|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102012216|NCT01338324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102012217|NCT01338324|Antimetabolites|antimetabolites|mesh-ancestor
102012218|NCT01338324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012219|NCT01338324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102012220|NCT01338324|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102012221|NCT01338324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102012222|NCT01336062|Paclitaxel|paclitaxel|mesh-list
102012223|NCT01336062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102012224|NCT01336062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102012225|NCT01336062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102012226|NCT01336062|Tubulin Modulators|tubulin modulators|mesh-ancestor
102012227|NCT01336062|Antimitotic Agents|antimitotic agents|mesh-ancestor
102012228|NCT01336062|Mitosis Modulators|mitosis modulators|mesh-ancestor
102012229|NCT01336062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012230|NCT05694221|Metformin|metformin|mesh-list
102012231|NCT05694221|Digoxin|digoxin|mesh-list
102012232|NCT05694221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102012233|NCT05694221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012234|NCT05694221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102012235|NCT05694221|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102012236|NCT05694221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101731979|NCT00851903|Metformin|metformin|mesh-list
102012237|NCT05694221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012238|NCT05694221|Protective Agents|protective agents|mesh-ancestor
102012239|NCT01308047|Bupivacaine|bupivacaine|mesh-list
102012240|NCT01308047|Anesthetics, Local|anesthetics, local|mesh-ancestor
102012241|NCT01308047|Anesthetics|anesthetics|mesh-ancestor
101519791|NCT00541008|Sunitinib|sunitinib|mesh-list
102012242|NCT01308047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102012243|NCT01308047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012244|NCT01308047|Sensory System Agents|sensory system agents|mesh-ancestor
101467212|NCT04150497|Alemtuzumab|alemtuzumab|mesh-list
102012259|NCT01316861|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102012260|NCT01316861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102012261|NCT01316861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012262|NCT01316861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102012263|NCT01316861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012264|NCT01336218|Rifampin|rifampin|mesh-list
102012265|NCT01336218|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102012266|NCT01336218|Antitubercular Agents|antitubercular agents|mesh-ancestor
101949650|NCT04862260|Antimetabolites|antimetabolites|mesh-ancestor
101274034|NCT01854723|Insulin|insulin|mesh-list
102012267|NCT01336218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102012268|NCT01336218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102012269|NCT01336218|Leprostatic Agents|leprostatic agents|mesh-ancestor
102012270|NCT01336218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102012271|NCT01336218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102012272|NCT01336218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012273|NCT01336218|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102012274|NCT01336218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102012275|NCT01336218|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102012276|NCT01336218|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102012277|NCT01336218|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102012278|NCT01336218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102012279|NCT05029115|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102012280|NCT05029115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012281|NCT05029115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102012282|NCT05029115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012283|NCT03776279|Mitoxantrone|mitoxantrone|mesh-list
102012284|NCT03776279|Analgesics|analgesics|mesh-ancestor
102012285|NCT03776279|Sensory System Agents|sensory system agents|mesh-ancestor
101519801|NCT00541047|Leuprolide|leuprolide|mesh-list
102012286|NCT03776279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102012287|NCT03776279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012288|NCT03776279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102012289|NCT03776279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102012290|NCT03776279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102012291|NCT03776279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102012292|NCT03776279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012293|NCT01561391|Factor VIII|factor viii|mesh-list
102012294|NCT01561391|Coagulants|coagulants|mesh-ancestor
102012295|NCT03775655|Dexmedetomidine|dexmedetomidine|mesh-list
102012296|NCT03775655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102012297|NCT03775655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102012298|NCT03775655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012299|NCT03775655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102012300|NCT03775655|Analgesics|analgesics|mesh-ancestor
102012301|NCT03775655|Sensory System Agents|sensory system agents|mesh-ancestor
102012302|NCT03775655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102012303|NCT03775655|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102012308|NCT03775655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012309|NCT01310465|Zoledronic Acid|zoledronic acid|mesh-list
102012310|NCT01310465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102012311|NCT01310465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012312|NCT03781895|Cholecalciferol|cholecalciferol|mesh-list
102012313|NCT03781895|Vitamin D|vitamin d|mesh-list
102012314|NCT03781895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102012315|NCT03781895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012316|NCT03781895|Vitamins|vitamins|mesh-ancestor
102012317|NCT03781895|Micronutrients|micronutrients|mesh-ancestor
102012318|NCT03781895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102012319|NCT00706030|Vinorelbine|vinorelbine|mesh-list
102012320|NCT00706030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102012321|NCT00706030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102012322|NCT00706030|Tubulin Modulators|tubulin modulators|mesh-ancestor
102012323|NCT00706030|Antimitotic Agents|antimitotic agents|mesh-ancestor
102012324|NCT00706030|Mitosis Modulators|mitosis modulators|mesh-ancestor
102012325|NCT00706030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012326|NCT03781505|Acetaminophen|acetaminophen|mesh-list
102012327|NCT03781505|Ropivacaine|ropivacaine|mesh-list
102012328|NCT03781505|Anesthetics, Local|anesthetics, local|mesh-ancestor
102012329|NCT03781505|Anesthetics|anesthetics|mesh-ancestor
102012330|NCT03781505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102012331|NCT03781505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012332|NCT03781505|Sensory System Agents|sensory system agents|mesh-ancestor
102012333|NCT03781505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102012334|NCT03781505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102012335|NCT03781505|Analgesics|analgesics|mesh-ancestor
102012336|NCT03781505|Antipyretics|antipyretics|mesh-ancestor
102012337|NCT03781115|Olanzapine|olanzapine|mesh-list
102012338|NCT03781115|Ziprasidone|ziprasidone|mesh-list
102012339|NCT03781115|Antiemetics|antiemetics|mesh-ancestor
101949651|NCT04862260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949652|NCT04862260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101949653|NCT04862260|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101949654|NCT04862260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101949655|NCT04862260|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101949656|NCT04862260|Protease Inhibitors|protease inhibitors|mesh-ancestor
101949658|NCT04862221|Promethazine|promethazine|mesh-list
101949659|NCT04862221|Methylprednisolone|methylprednisolone|mesh-list
101949660|NCT04862221|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102012340|NCT03781115|Autonomic Agents|autonomic agents|mesh-ancestor
102012341|NCT03781115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102012342|NCT03781115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012343|NCT03781115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102012344|NCT03781115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102012345|NCT03781115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102012346|NCT03781115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102012347|NCT03781115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102012348|NCT03781115|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102012349|NCT03781115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102012350|NCT03781115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102012351|NCT03781115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012352|NCT03781115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102012353|NCT03781115|Serotonin Agents|serotonin agents|mesh-ancestor
102012354|NCT03781115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102012355|NCT03781115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102012356|NCT03781115|Dopamine Agents|dopamine agents|mesh-ancestor
102012357|NCT03317236|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102012358|NCT03317236|Antidepressive Agents|antidepressive agents|mesh-ancestor
102012359|NCT03317236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102012360|NCT03317236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102012361|NCT03317236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102012362|NCT03317236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102012363|NCT03317236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012364|NCT01313429|Celecoxib|celecoxib|mesh-list
102012365|NCT01313429|Cyclophosphamide|cyclophosphamide|mesh-list
102012366|NCT01313429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102012367|NCT01313429|Immunologic Factors|immunologic factors|mesh-ancestor
102012368|NCT01313429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012369|NCT01313429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102012370|NCT01313429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102012371|NCT01313429|Alkylating Agents|alkylating agents|mesh-ancestor
102012372|NCT01313429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012373|NCT01313429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467342|NCT03568890|Anticoagulants|anticoagulants|mesh-ancestor
102012382|NCT01313429|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102012383|NCT01313429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102012384|NCT03488251|Gemcitabine|gemcitabine|mesh-list
102012385|NCT03488251|Oxaliplatin|oxaliplatin|mesh-list
102012386|NCT03488251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102012387|NCT03488251|Antimetabolites|antimetabolites|mesh-ancestor
101519867|NCT00541125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102012388|NCT03488251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012389|NCT03488251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102012390|NCT02727322|Nitrofurantoin|nitrofurantoin|mesh-list
102012391|NCT02727322|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102012392|NCT02727322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102012393|NCT02727322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102012394|NCT03315520|Cytarabine|cytarabine|mesh-list
102012395|NCT03315520|Cyclophosphamide|cyclophosphamide|mesh-list
102012396|NCT03315520|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102012397|NCT03315520|Etoposide|etoposide|mesh-list
102012398|NCT03315520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102012399|NCT03315520|Immunologic Factors|immunologic factors|mesh-ancestor
102012400|NCT03315520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949661|NCT04862221|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101949663|NCT04862221|Prednisolone acetate|prednisolone acetate|mesh-list
101274183|NCT01855581|Ketamine|ketamine|mesh-list
102012401|NCT03315520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102012402|NCT03315520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102012403|NCT03315520|Alkylating Agents|alkylating agents|mesh-ancestor
102012404|NCT03315520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012405|NCT03315520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102012406|NCT03315520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102012407|NCT03315520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102012408|NCT03315520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102012409|NCT03315520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102012410|NCT03315520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102012411|NCT03315520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102012412|NCT03315520|Antimetabolites|antimetabolites|mesh-ancestor
102012413|NCT03315520|Antiviral Agents|antiviral agents|mesh-ancestor
102012414|NCT03315520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102012415|NCT02483182|Acyclovir|acyclovir|mesh-list
102012416|NCT02483182|Antiviral Agents|antiviral agents|mesh-ancestor
102012417|NCT02483182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102012418|NCT01338558|Bevacizumab|bevacizumab|mesh-list
102012419|NCT01338558|Cetuximab|cetuximab|mesh-list
102012420|NCT01338558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102012421|NCT01338558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102012422|NCT01338558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102012423|NCT01338558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102012424|NCT01338558|Growth Substances|growth substances|mesh-ancestor
102012425|NCT01338558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012426|NCT01338558|Growth Inhibitors|growth inhibitors|mesh-ancestor
102012427|NCT03780569|Temozolomide|temozolomide|mesh-list
102012428|NCT03780569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102012429|NCT03780569|Alkylating Agents|alkylating agents|mesh-ancestor
102012430|NCT03780569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012431|NCT03780569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102012432|NCT03487549|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102012433|NCT03487549|Cantharidin|cantharidin|mesh-list
102012434|NCT03487549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102012435|NCT03487549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012436|NCT01313585|Beclomethasone|beclomethasone|mesh-list
102012437|NCT01313585|Albuterol|albuterol|mesh-list
102012438|NCT01313585|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102012439|NCT01313585|Autonomic Agents|autonomic agents|mesh-ancestor
102012440|NCT01313585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102012452|NCT01313585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102012453|NCT01313585|Glucocorticoids|glucocorticoids|mesh-ancestor
102012454|NCT01313585|Hormones|hormones|mesh-ancestor
101387644|NCT00314158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012455|NCT01313585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101732204|NCT04098861|Timolol|timolol|mesh-list
102012456|NCT01561235|Hormones|hormones|mesh-list
102012457|NCT01561235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102012458|NCT01561235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012460|NCT02485990|Tremelimumab|tremelimumab|mesh-list
102012461|NCT02485990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102012462|NCT02485990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102012463|NCT02485990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012464|NCT02485990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102012465|NCT01313819|Amantadine|amantadine|mesh-list
102012466|NCT01313819|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102012467|NCT01313819|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102012468|NCT01313819|Antiviral Agents|antiviral agents|mesh-ancestor
102012469|NCT01313819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102012470|NCT01313819|Dopamine Agents|dopamine agents|mesh-ancestor
102012471|NCT01313819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102012472|NCT01313819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012473|NCT01313819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012474|NCT01313819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102012475|NCT01313819|Analgesics|analgesics|mesh-ancestor
102012476|NCT01313819|Sensory System Agents|sensory system agents|mesh-ancestor
102012477|NCT01313819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102012478|NCT03315442|Caffeine|caffeine|mesh-list
101737364|NCT02584881|Analgesics|analgesics|mesh-ancestor
101949664|NCT04862221|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101949665|NCT04862221|Prednisolone phosphate|prednisolone phosphate|mesh-list
101949666|NCT04862221|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101949667|NCT04862221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101949668|NCT04862221|Antiemetics|antiemetics|mesh-ancestor
101949669|NCT04862221|Autonomic Agents|autonomic agents|mesh-ancestor
101949670|NCT04862221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101949671|NCT04862221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949672|NCT04862221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101949673|NCT04862221|Glucocorticoids|glucocorticoids|mesh-ancestor
101949674|NCT04862221|Hormones|hormones|mesh-ancestor
102012479|NCT03315442|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102012480|NCT03315442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012481|NCT03315442|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102012482|NCT03315442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102012483|NCT03315442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012484|NCT03315442|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102012485|NCT03315442|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102012486|NCT03315442|Purinergic Agents|purinergic agents|mesh-ancestor
102012487|NCT03315442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102012488|NCT03464383|Escitalopram|escitalopram|mesh-list
102012489|NCT03464383|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102012490|NCT03464383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102012491|NCT03464383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102012492|NCT03464383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012493|NCT03464383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102012494|NCT03464383|Serotonin Agents|serotonin agents|mesh-ancestor
102012495|NCT03464383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012496|NCT03315364|Paclitaxel|paclitaxel|mesh-list
102012497|NCT03315364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102012498|NCT03315364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102012499|NCT03315364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102012500|NCT03315364|Tubulin Modulators|tubulin modulators|mesh-ancestor
101467486|NCT02864992|Tepotinib|tepotinib|mesh-list
102012506|NCT03779633|Hormones|hormones|mesh-ancestor
102012507|NCT03779633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102012508|NCT03779633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012509|NCT03720067|Propranolol|propranolol|mesh-list
102012510|NCT03720067|Carvedilol|carvedilol|mesh-list
102012511|NCT03720067|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102012512|NCT03720067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102012513|NCT03720067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102012514|NCT03720067|Antimetabolites|antimetabolites|mesh-ancestor
102012515|NCT03720067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012516|NCT03720067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102012517|NCT03720067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102012518|NCT03720067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102012519|NCT03720067|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102012520|NCT03720067|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102012521|NCT03720067|Adrenergic Agents|adrenergic agents|mesh-ancestor
102012522|NCT03720067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102012523|NCT03720067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012524|NCT03720067|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102012525|NCT03720067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102012526|NCT03720067|Vasodilator Agents|vasodilator agents|mesh-ancestor
102012527|NCT03720067|Antioxidants|antioxidants|mesh-ancestor
102012528|NCT03720067|Protective Agents|protective agents|mesh-ancestor
102012529|NCT03720067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102012530|NCT03720067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102012531|NCT03720067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102012532|NCT03720067|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102012533|NCT03720067|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102012535|NCT01444092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101949675|NCT04862221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101949676|NCT04862221|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101949677|NCT04862221|Protective Agents|protective agents|mesh-ancestor
102012536|NCT01444092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102012537|NCT01444092|Autonomic Agents|autonomic agents|mesh-ancestor
102012538|NCT01444092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102012539|NCT01444092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012540|NCT01444092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102012541|NCT01444092|Respiratory System Agents|respiratory system agents|mesh-ancestor
102012542|NCT01444092|Glucocorticoids|glucocorticoids|mesh-ancestor
102012543|NCT01444092|Hormones|hormones|mesh-ancestor
102012544|NCT01444092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102012545|NCT03719989|Azacitidine|azacitidine|mesh-list
102012546|NCT03719989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102012547|NCT03719989|Antimetabolites|antimetabolites|mesh-ancestor
102012548|NCT03719989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012549|NCT03719989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102012550|NCT03719989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102012551|NCT05462470|Liver Extracts|liver extracts|mesh-list
102012552|NCT05462470|Hematinics|hematinics|mesh-ancestor
102012553|NCT03779087|Amoxicillin|amoxicillin|mesh-list
102012554|NCT03779087|Levofloxacin|levofloxacin|mesh-list
102012555|NCT03779087|Ofloxacin|ofloxacin|mesh-list
102012556|NCT03779087|Tetracycline|tetracycline|mesh-list
102012557|NCT03779087|Esomeprazole|esomeprazole|mesh-list
102012558|NCT03779087|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102012559|NCT03779087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102012560|NCT03779087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102012561|NCT03779087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102012562|NCT03779087|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102012563|NCT03779087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102012564|NCT03779087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012565|NCT03779087|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102012566|NCT03779087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102012567|NCT03779087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102012568|NCT03779087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102012569|NCT03779087|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102012570|NCT03779087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102012571|NCT03779087|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102012575|NCT05692271|Propranolol|propranolol|mesh-list
102012576|NCT05692271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102012577|NCT05692271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102012578|NCT05692271|Adrenergic Agents|adrenergic agents|mesh-ancestor
102012579|NCT05692271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102012580|NCT05692271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012581|NCT05692271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012582|NCT05692271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102012583|NCT05692271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102012584|NCT05692271|Vasodilator Agents|vasodilator agents|mesh-ancestor
102012585|NCT03774953|Vitamins|vitamins|mesh-list
102012586|NCT03774953|Micronutrients|micronutrients|mesh-ancestor
102012587|NCT03774953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012588|NCT02483026|Vitamin D|vitamin d|mesh-list
102012589|NCT02483026|Vitamins|vitamins|mesh-list
102012590|NCT02483026|Micronutrients|micronutrients|mesh-ancestor
102012591|NCT02483026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012592|NCT02483026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102012593|NCT02483104|Paclitaxel|paclitaxel|mesh-list
102012594|NCT02483104|Carboplatin|carboplatin|mesh-list
102012595|NCT02483104|Veliparib|veliparib|mesh-list
102012596|NCT02483104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102012597|NCT02483104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102012598|NCT02483104|Tubulin Modulators|tubulin modulators|mesh-ancestor
102012599|NCT02483104|Antimitotic Agents|antimitotic agents|mesh-ancestor
102012600|NCT02483104|Mitosis Modulators|mitosis modulators|mesh-ancestor
102012601|NCT02483104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732349|NCT00703469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102012602|NCT02483104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102012603|NCT02483104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102012604|NCT00116220|Goserelin|goserelin|mesh-list
102012605|NCT00116220|Flutamide|flutamide|mesh-list
102012606|NCT00116220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949678|NCT04862221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101949679|NCT04862221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949680|NCT04862221|Immunologic Factors|immunologic factors|mesh-ancestor
101949681|NCT04862221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101949682|NCT04862221|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101949683|NCT04862221|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101274393|NCT01856946|Vitamin D|vitamin d|mesh-list
102012607|NCT00116220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102012609|NCT00116220|Androgen Antagonists|androgen antagonists|mesh-ancestor
102012610|NCT00116220|Hormone Antagonists|hormone antagonists|mesh-ancestor
102012611|NCT00116220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102012612|NCT03785015|Aspirin|aspirin|mesh-list
102012613|NCT03785015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102012614|NCT03785015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102012615|NCT03785015|Analgesics|analgesics|mesh-ancestor
102012616|NCT03785015|Sensory System Agents|sensory system agents|mesh-ancestor
102012617|NCT03785015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102012618|NCT03785015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012619|NCT03785015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102012620|NCT03785015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102012621|NCT03785015|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102012622|NCT03785015|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102012623|NCT03785015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012624|NCT03785015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102012625|NCT03785015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102012626|NCT03785015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102012627|NCT03785015|Antipyretics|antipyretics|mesh-ancestor
102012628|NCT04867343|Fentanyl|fentanyl|mesh-list
102012629|NCT04867343|Remifentanil|remifentanil|mesh-list
102012630|NCT04867343|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102012631|NCT04867343|Narcotics|narcotics|mesh-ancestor
102012632|NCT04867343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102012633|NCT04867343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012634|NCT04867343|Analgesics|analgesics|mesh-ancestor
102012635|NCT04867343|Sensory System Agents|sensory system agents|mesh-ancestor
102012636|NCT04867343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102012637|NCT04867343|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102012638|NCT04867343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102012639|NCT04867343|Anesthetics, General|anesthetics, general|mesh-ancestor
102012640|NCT04867343|Anesthetics|anesthetics|mesh-ancestor
102012641|NCT05185518|Insulin|insulin|mesh-list
102012642|NCT05185518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102012643|NCT05185518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012644|NCT03316690|Metformin|metformin|mesh-list
102012645|NCT03316690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102012663|NCT03315052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102012664|NCT03315052|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102012665|NCT03315052|Antitubercular Agents|antitubercular agents|mesh-ancestor
102012666|NCT03315052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102012667|NCT03315052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102012668|NCT03315052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102012669|NCT03315052|Autonomic Agents|autonomic agents|mesh-ancestor
102012670|NCT03315052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102012671|NCT03315052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102012672|NCT03315052|Respiratory System Agents|respiratory system agents|mesh-ancestor
102012673|NCT03778619|Cyclophosphamide|cyclophosphamide|mesh-list
102012674|NCT03778619|Rituximab|rituximab|mesh-list
102012675|NCT03778619|Fludarabine|fludarabine|mesh-list
102012676|NCT03778619|Interleukin-2|interleukin-2|mesh-list
102012677|NCT03778619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102012678|NCT03778619|Immunologic Factors|immunologic factors|mesh-ancestor
102012679|NCT03778619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012680|NCT03778619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101732427|NCT00703625|Sirolimus|sirolimus|mesh-list
102012681|NCT03778619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102012682|NCT03778619|Alkylating Agents|alkylating agents|mesh-ancestor
102012683|NCT03778619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012684|NCT03778619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102012685|NCT03778619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101949684|NCT04862221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101949685|NCT04862221|Anesthetics, Local|anesthetics, local|mesh-ancestor
102012686|NCT03778619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102012687|NCT03778619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102012689|NCT03778619|Sensory System Agents|sensory system agents|mesh-ancestor
102012690|NCT03778619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102012691|NCT05714176|Lactoferrin|lactoferrin|mesh-list
102012693|NCT05714176|Iron-Dextran Complex|iron-dextran complex|mesh-list
102012694|NCT05714176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102012695|NCT05714176|Anticoagulants|anticoagulants|mesh-ancestor
102012696|NCT05714176|Plasma Substitutes|plasma substitutes|mesh-ancestor
102012697|NCT05714176|Blood Substitutes|blood substitutes|mesh-ancestor
102012698|NCT05714176|Hematinics|hematinics|mesh-ancestor
102012699|NCT03156504|Ketamine|ketamine|mesh-list
102012700|NCT03156504|Analgesics|analgesics|mesh-ancestor
102012701|NCT03156504|Sensory System Agents|sensory system agents|mesh-ancestor
102012702|NCT03156504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102012703|NCT03156504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012704|NCT03156504|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102012723|NCT03316534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102012724|NCT03316534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012725|NCT03316534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102012726|NCT03316534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102012727|NCT03316534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102012728|NCT03316534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102012729|NCT03316534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012730|NCT03316534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102012731|NCT03316534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102012732|NCT03316534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102012733|NCT03316534|Antipyretics|antipyretics|mesh-ancestor
102012734|NCT04476420|Betamethasone|betamethasone|mesh-list
102012735|NCT04476420|Betamethasone Valerate|betamethasone valerate|mesh-list
102012736|NCT04476420|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102012737|NCT04476420|Betamethasone benzoate|betamethasone benzoate|mesh-list
102012738|NCT04476420|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102012739|NCT04476420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102012740|NCT04476420|Glucocorticoids|glucocorticoids|mesh-ancestor
102012741|NCT04476420|Hormones|hormones|mesh-ancestor
102012742|NCT04476420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102012743|NCT04476420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012744|NCT04476420|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102012745|NCT04476420|Respiratory System Agents|respiratory system agents|mesh-ancestor
102012746|NCT03778541|Temozolomide|temozolomide|mesh-list
102012747|NCT03778541|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102012748|NCT03778541|Alkylating Agents|alkylating agents|mesh-ancestor
102012749|NCT03778541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012750|NCT03778541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102012751|NCT02479828|Ropivacaine|ropivacaine|mesh-list
102012752|NCT02479828|Anesthetics, Local|anesthetics, local|mesh-ancestor
102012753|NCT02479828|Anesthetics|anesthetics|mesh-ancestor
101732495|NCT00836927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102012754|NCT02479828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102012755|NCT02479828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012756|NCT02479828|Sensory System Agents|sensory system agents|mesh-ancestor
102012757|NCT02479828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102012767|NCT03158220|Immunologic Factors|immunologic factors|mesh-ancestor
102012768|NCT03158220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012769|NCT01308983|Amiloride|amiloride|mesh-list
102012770|NCT01308983|Diuretics|diuretics|mesh-ancestor
102012771|NCT01308983|Natriuretic Agents|natriuretic agents|mesh-ancestor
102012772|NCT01308983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012773|NCT01308983|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
102012774|NCT01308983|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102012775|NCT01308983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102012776|NCT01308983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012777|NCT01308983|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
102012778|NCT01308983|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102012779|NCT01336842|Pemetrexed|pemetrexed|mesh-list
102012780|NCT01336842|Panobinostat|panobinostat|mesh-list
102012781|NCT01336842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102012782|NCT01336842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101949687|NCT04862221|Sensory System Agents|sensory system agents|mesh-ancestor
101949688|NCT04862221|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102012783|NCT01336842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012784|NCT01336842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102012785|NCT01336842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102012786|NCT01336842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102012787|NCT05178407|Micronutrients|micronutrients|mesh-list
102012788|NCT05178407|Trace Elements|trace elements|mesh-list
102012789|NCT05178407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012790|NCT01339026|Clopidogrel|clopidogrel|mesh-list
102012791|NCT01339026|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102012792|NCT01339026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102012793|NCT01339026|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102012794|NCT01339026|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102012795|NCT01339026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102012796|NCT01339026|Purinergic Agents|purinergic agents|mesh-ancestor
102012797|NCT01339026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102012798|NCT01339026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012799|NCT01339026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012800|NCT03314740|Paclitaxel|paclitaxel|mesh-list
102012801|NCT03314740|Olaparib|olaparib|mesh-list
102012802|NCT03314740|Cediranib|cediranib|mesh-list
102012803|NCT03314740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102012804|NCT03314740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102012805|NCT03314740|Tubulin Modulators|tubulin modulators|mesh-ancestor
102012806|NCT03314740|Antimitotic Agents|antimitotic agents|mesh-ancestor
102012807|NCT03314740|Mitosis Modulators|mitosis modulators|mesh-ancestor
102012808|NCT03314740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012809|NCT03314740|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102012810|NCT03314740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101520042|NCT02546583|Diuretics|diuretics|mesh-list
102012811|NCT03314740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102012812|NCT02482636|Vaccines|vaccines|mesh-list
102012813|NCT02482636|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102012814|NCT02482636|Immunologic Factors|immunologic factors|mesh-ancestor
102012815|NCT02482636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012816|NCT02482402|Iloprost|iloprost|mesh-list
102012817|NCT02482402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102012818|NCT02482402|Vasodilator Agents|vasodilator agents|mesh-ancestor
102012819|NCT03774095|Pycnogenols|pycnogenols|mesh-list
102012820|NCT03774095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102012821|NCT03774095|Immunologic Factors|immunologic factors|mesh-ancestor
102012822|NCT03774095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012823|NCT03774095|Antioxidants|antioxidants|mesh-ancestor
102012843|NCT02482090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012845|NCT02482090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102012846|NCT02482090|Alkylating Agents|alkylating agents|mesh-ancestor
102012847|NCT02482090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012848|NCT02482090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102012849|NCT02482090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102012850|NCT02482090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102012851|NCT02482090|Analgesics|analgesics|mesh-ancestor
102012852|NCT02482090|Sensory System Agents|sensory system agents|mesh-ancestor
102012853|NCT02482090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102012854|NCT02482324|Ibuprofen|ibuprofen|mesh-list
102012855|NCT02482324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102012856|NCT02482324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102012857|NCT02482324|Analgesics|analgesics|mesh-ancestor
102012858|NCT02482324|Sensory System Agents|sensory system agents|mesh-ancestor
102012859|NCT02482324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102012860|NCT02482324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012861|NCT02482324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102012862|NCT02482324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102012863|NCT02482324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102012864|NCT02482324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102012865|NCT02482324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012866|NCT05185284|Remdesivir|remdesivir|mesh-list
102012867|NCT05185284|Favipiravir|favipiravir|mesh-list
102012868|NCT05185284|Antimetabolites|antimetabolites|mesh-ancestor
102012869|NCT05185284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012870|NCT05185284|Antiviral Agents|antiviral agents|mesh-ancestor
101949689|NCT04862221|Histamine Antagonists|histamine antagonists|mesh-ancestor
101949690|NCT04862221|Histamine Agents|histamine agents|mesh-ancestor
101949691|NCT04862221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101949692|NCT04862221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949693|NCT04862221|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101949694|NCT04862221|Antipruritics|antipruritics|mesh-ancestor
102012871|NCT05185284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102012872|NCT03784703|Atorvastatin|atorvastatin|mesh-list
102012873|NCT03784703|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102012874|NCT03784703|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102012875|NCT03784703|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102012876|NCT03784703|Antimetabolites|antimetabolites|mesh-ancestor
102012877|NCT03784703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012878|NCT03784703|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102012882|NCT02724592|Fluorides, Topical|fluorides, topical|mesh-list
101520078|NCT02293980|Nivolumab|nivolumab|mesh-list
102012883|NCT02724592|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
102012884|NCT02724592|Cariostatic Agents|cariostatic agents|mesh-ancestor
102012885|NCT02724592|Protective Agents|protective agents|mesh-ancestor
102012886|NCT02724592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012887|NCT02476864|Macitentan|macitentan|mesh-list
102012888|NCT02476864|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
102012889|NCT02476864|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102012890|NCT02476864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012891|NCT02476864|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
102012892|NCT05451550|Anesthetics|anesthetics|mesh-list
102012893|NCT05451550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102012894|NCT05451550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012895|NCT02476708|Curcumin|curcumin|mesh-list
102012896|NCT02476708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102012897|NCT02476708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102012898|NCT02476708|Analgesics|analgesics|mesh-ancestor
102012899|NCT02476708|Sensory System Agents|sensory system agents|mesh-ancestor
102012900|NCT02476708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102012901|NCT02476708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012902|NCT02476708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102012903|NCT02476708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102012904|NCT02476708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102012905|NCT02476708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102012906|NCT02476708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012907|NCT02479204|Atenolol|atenolol|mesh-list
102012908|NCT02479204|Diltiazem|diltiazem|mesh-list
102012909|NCT02479204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102012910|NCT02479204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102012911|NCT02479204|Sympatholytics|sympatholytics|mesh-ancestor
102012912|NCT02479204|Autonomic Agents|autonomic agents|mesh-ancestor
102012913|NCT02479204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102012914|NCT02479204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012915|NCT02479204|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102012916|NCT02479204|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102012917|NCT02479204|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102012918|NCT02479204|Adrenergic Agents|adrenergic agents|mesh-ancestor
102012919|NCT02479204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102012920|NCT02479204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012921|NCT02479204|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102012922|NCT02479204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102012923|NCT02479204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102012924|NCT02479204|Vasodilator Agents|vasodilator agents|mesh-ancestor
102012925|NCT03784547|Ocrelizumab|ocrelizumab|mesh-list
102012926|NCT03784547|Immunologic Factors|immunologic factors|mesh-ancestor
102012927|NCT03784547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012928|NCT01339572|Plerixafor|plerixafor|mesh-list
102012929|NCT01339572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102012930|NCT01339572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102012931|NCT01339572|Antiviral Agents|antiviral agents|mesh-ancestor
102012932|NCT01339572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102012933|NCT04199117|Nicotine|nicotine|mesh-list
102012934|NCT04199117|Varenicline|varenicline|mesh-list
102012935|NCT04199117|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102012936|NCT04199117|Autonomic Agents|autonomic agents|mesh-ancestor
101949695|NCT04862221|Dermatologic Agents|dermatologic agents|mesh-ancestor
101949696|NCT04821310|Pantoprazole|pantoprazole|mesh-list
101949697|NCT04821310|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101520096|NCT04653506|Antipyretics|antipyretics|mesh-ancestor
101949698|NCT04821310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101949699|NCT04821310|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101949700|NCT04821310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101949701|NCT04821310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949702|NCT04799275|Prednisone|prednisone|mesh-list
101949703|NCT04799275|Cortisone|cortisone|mesh-list
102012937|NCT04199117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102012938|NCT04199117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012939|NCT04199117|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102012940|NCT04199117|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102012941|NCT04199117|Cholinergic Agents|cholinergic agents|mesh-ancestor
102012942|NCT04199117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102012943|NCT04199117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012944|NCT01309139|Tiotropium Bromide|tiotropium bromide|mesh-list
102012945|NCT01309139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102012946|NCT01309139|Autonomic Agents|autonomic agents|mesh-ancestor
102012947|NCT01309139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102012948|NCT01309139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467915|NCT02218684|Telmisartan|telmisartan|mesh-list
102012950|NCT01309139|Respiratory System Agents|respiratory system agents|mesh-ancestor
102012952|NCT01309139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102012953|NCT01309139|Cholinergic Agents|cholinergic agents|mesh-ancestor
102012954|NCT01309139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102012955|NCT01309139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012956|NCT03154476|Sildenafil Citrate|sildenafil citrate|mesh-list
102012957|NCT03154476|Vasodilator Agents|vasodilator agents|mesh-ancestor
102012958|NCT03154476|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102012959|NCT03154476|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102012960|NCT03154476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102012961|NCT03154476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012962|NCT03154476|Urological Agents|urological agents|mesh-ancestor
102012963|NCT03784391|Nifurtimox|nifurtimox|mesh-list
102012964|NCT03784391|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102012965|NCT03784391|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102012966|NCT03784391|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102012967|NCT03784391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102012968|NCT02476552|Niraparib|niraparib|mesh-list
102012969|NCT02476552|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102012970|NCT02476552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102012971|NCT02476552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012972|NCT02476552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102012973|NCT01316718|Mesalamine|mesalamine|mesh-list
102012974|NCT01316718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102012975|NCT01316718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101732726|NCT00818753|Antithrombins|antithrombins|mesh-ancestor
102012976|NCT01316718|Analgesics|analgesics|mesh-ancestor
102012977|NCT01316718|Sensory System Agents|sensory system agents|mesh-ancestor
102012978|NCT01316718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102012979|NCT01316718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012980|NCT01316718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102012981|NCT01316718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102012982|NCT01316952|Carvedilol|carvedilol|mesh-list
102012983|NCT01316952|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102012984|NCT01316952|Adrenergic Agents|adrenergic agents|mesh-list
102012985|NCT01316952|Adrenergic Antagonists|adrenergic antagonists|mesh-list
102012986|NCT01316952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102012987|NCT01316952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012988|NCT01316952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012989|NCT01316952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102012990|NCT01316952|Antioxidants|antioxidants|mesh-ancestor
102012991|NCT01316952|Protective Agents|protective agents|mesh-ancestor
102012992|NCT01316952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102012993|NCT01316952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101949704|NCT04799275|Cyclophosphamide|cyclophosphamide|mesh-list
101949705|NCT04799275|Rituximab|rituximab|mesh-list
101949706|NCT04799275|Doxorubicin|doxorubicin|mesh-list
101949707|NCT04799275|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101949708|NCT04799275|Vincristine|vincristine|mesh-list
101949709|NCT04799275|Azacitidine|azacitidine|mesh-list
101949710|NCT04799275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101949711|NCT04799275|Antibodies|antibodies|mesh-list
101949712|NCT04799275|Immunoglobulins|immunoglobulins|mesh-list
101274742|NCT01858090|Autonomic Agents|autonomic agents|mesh-ancestor
102012994|NCT01316952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102012995|NCT01316952|Vasodilator Agents|vasodilator agents|mesh-ancestor
102012996|NCT01316952|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102012997|NCT01316952|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102012998|NCT03768869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102012999|NCT03768869|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102013000|NCT03768869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102013001|NCT03768869|Antitubercular Agents|antitubercular agents|mesh-ancestor
102013002|NCT01320917|Levonorgestrel|levonorgestrel|mesh-list
102013003|NCT01320917|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102013004|NCT01320917|Contraceptive Agents|contraceptive agents|mesh-ancestor
102013005|NCT01320917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102013006|NCT01320917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013007|NCT01320917|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102013008|NCT01320917|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102013009|NCT01320917|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102013010|NCT03768713|Suvorexant|suvorexant|mesh-list
102013011|NCT03768713|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102013012|NCT03768713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102013013|NCT03768713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102013014|NCT03768713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013015|NCT03768713|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102013016|NCT03768713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102013017|NCT03768713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013018|NCT02481076|Monensin|monensin|mesh-list
102013019|NCT02481076|Antifungal Agents|antifungal agents|mesh-ancestor
102013021|NCT02481076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102013022|NCT02481076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102013023|NCT02481076|Coccidiostats|coccidiostats|mesh-ancestor
102013024|NCT02481076|Proton Ionophores|proton ionophores|mesh-ancestor
102013025|NCT02481076|Uncoupling Agents|uncoupling agents|mesh-ancestor
102013026|NCT02481076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102013027|NCT02481076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013029|NCT02481076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102013030|NCT02481076|Sodium Ionophores|sodium ionophores|mesh-ancestor
102013031|NCT05713396|Losartan|losartan|mesh-list
102013032|NCT05713396|Quinapril|quinapril|mesh-list
102013033|NCT05713396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102013034|NCT05713396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102013035|NCT05713396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102013036|NCT05713396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102013037|NCT05713396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013038|NCT05713396|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102013039|NCT05713396|Protease Inhibitors|protease inhibitors|mesh-ancestor
102013040|NCT05713396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102013041|NCT02480608|Imatinib Mesylate|imatinib mesylate|mesh-list
102013042|NCT02480608|Hydroxyurea|hydroxyurea|mesh-list
102013043|NCT02480608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102013044|NCT02480608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102013045|NCT02480608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102013046|NCT02480608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732799|NCT00764946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102013047|NCT02480608|Antisickling Agents|antisickling agents|mesh-ancestor
102013048|NCT02480608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102013049|NCT02480686|Sofosbuvir|sofosbuvir|mesh-list
102013050|NCT02480686|Antiviral Agents|antiviral agents|mesh-ancestor
102013051|NCT02480686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101949713|NCT04799275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101949714|NCT04799275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101949715|NCT04799275|Immunologic Factors|immunologic factors|mesh-ancestor
101949716|NCT04799275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949717|NCT04799275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101949718|NCT04799275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101949719|NCT04799275|Alkylating Agents|alkylating agents|mesh-ancestor
101949720|NCT04799275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949721|NCT04799275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949722|NCT04799275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101949723|NCT04799275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101949724|NCT04799275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101949725|NCT04799275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101949726|NCT04799275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102013052|NCT02475382|Nivolumab|nivolumab|mesh-list
102013053|NCT02475382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102013054|NCT02475382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102013055|NCT02475382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102013056|NCT02475382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013057|NCT02475304|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102013058|NCT02475304|Dermatologic Agents|dermatologic agents|mesh-ancestor
102013059|NCT02475304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102013060|NCT02475304|Immunologic Factors|immunologic factors|mesh-ancestor
102013061|NCT02475304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013062|NCT05371288|Thioctic Acid|thioctic acid|mesh-list
102013063|NCT05371288|Acetylcysteine|acetylcysteine|mesh-list
102013064|NCT05371288|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102013065|NCT05371288|Antioxidants|antioxidants|mesh-ancestor
102013066|NCT05371288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013067|NCT05371288|Protective Agents|protective agents|mesh-ancestor
102013068|NCT05371288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013069|NCT05371288|Vitamin B Complex|vitamin b complex|mesh-ancestor
102013070|NCT05371288|Vitamins|vitamins|mesh-ancestor
102013071|NCT05371288|Micronutrients|micronutrients|mesh-ancestor
102013072|NCT05371288|Antiviral Agents|antiviral agents|mesh-ancestor
102013073|NCT05371288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102013074|NCT05371288|Expectorants|expectorants|mesh-ancestor
102013075|NCT05371288|Respiratory System Agents|respiratory system agents|mesh-ancestor
102013076|NCT05371288|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102013077|NCT05371288|Antidotes|antidotes|mesh-ancestor
102013078|NCT02478424|Cyclosporine|cyclosporine|mesh-list
102013079|NCT02478424|Methotrexate|methotrexate|mesh-list
102013080|NCT02478424|Cannabidiol|cannabidiol|mesh-list
102013081|NCT02478424|Cyclosporins|cyclosporins|mesh-list
102013082|NCT02478424|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102013083|NCT02478424|Abortifacient Agents|abortifacient agents|mesh-ancestor
102013084|NCT02478424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102013085|NCT02478424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013086|NCT02478424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102013087|NCT02478424|Antimetabolites|antimetabolites|mesh-ancestor
102013088|NCT02478424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013089|NCT02478424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102013090|NCT02478424|Dermatologic Agents|dermatologic agents|mesh-ancestor
102013091|NCT02478424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102013092|NCT02478424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102013093|NCT02478424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102013112|NCT04053881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102013113|NCT04053881|Immunologic Factors|immunologic factors|mesh-ancestor
102013114|NCT04053881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013115|NCT04053881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101949727|NCT04799275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102013116|NCT03768557|Minocycline|minocycline|mesh-list
102013117|NCT03768557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102013118|NCT03768557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102013119|NCT03783845|Amoxicillin|amoxicillin|mesh-list
102013120|NCT03783845|Metronidazole|metronidazole|mesh-list
102013121|NCT03783845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102013122|NCT03783845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102013123|NCT03783845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102013124|NCT03783845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102013125|NCT01560689|Budesonide|budesonide|mesh-list
102013126|NCT01560689|Formoterol Fumarate|formoterol fumarate|mesh-list
102013127|NCT01560689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102013128|NCT01560689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102013129|NCT01560689|Autonomic Agents|autonomic agents|mesh-ancestor
102013130|NCT01560689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102013131|NCT01560689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013132|NCT01560689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102013133|NCT01560689|Respiratory System Agents|respiratory system agents|mesh-ancestor
102013134|NCT01560689|Glucocorticoids|glucocorticoids|mesh-ancestor
102013135|NCT01560689|Hormones|hormones|mesh-ancestor
102013136|NCT01560689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102013137|NCT01560689|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102013138|NCT01560689|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102013139|NCT01560689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102013140|NCT01560689|Adrenergic Agents|adrenergic agents|mesh-ancestor
102013141|NCT01560689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102013142|NCT01560689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013143|NCT02474914|Octreotide|octreotide|mesh-list
102013144|NCT02474914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102013145|NCT02474914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102013146|NCT02474914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102013147|NCT03769103|Osimertinib|osimertinib|mesh-list
102013148|NCT03769103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102013149|NCT03769103|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102013150|NCT03769103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102013151|NCT03769103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013152|NCT04998214|Thrombin|thrombin|mesh-list
102013158|NCT01309607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102013159|NCT01309607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102013160|NCT01309607|Tubulin Modulators|tubulin modulators|mesh-ancestor
102013161|NCT01309607|Antimitotic Agents|antimitotic agents|mesh-ancestor
102013162|NCT01309607|Mitosis Modulators|mitosis modulators|mesh-ancestor
101520156|NCT00542802|Analgesics|analgesics|mesh-ancestor
102013163|NCT01309607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013164|NCT01309607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102013165|NCT01309607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102013166|NCT03783455|Hyaluronic Acid|hyaluronic acid|mesh-list
102013167|NCT03783455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102013168|NCT03783455|Immunologic Factors|immunologic factors|mesh-ancestor
102013169|NCT03783455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013170|NCT03783455|Viscosupplements|viscosupplements|mesh-ancestor
102013171|NCT03783455|Protective Agents|protective agents|mesh-ancestor
102013172|NCT05305066|Adalimumab|adalimumab|mesh-list
102013173|NCT05305066|Golimumab|golimumab|mesh-list
102013174|NCT05305066|Etanercept|etanercept|mesh-list
102013175|NCT05305066|Upadacitinib|upadacitinib|mesh-list
102013176|NCT05305066|Tofacitinib|tofacitinib|mesh-list
102013177|NCT05305066|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102013178|NCT05305066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102013179|NCT05305066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102013180|NCT05305066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102013181|NCT05305066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102013182|NCT05305066|Analgesics|analgesics|mesh-ancestor
102013183|NCT05305066|Sensory System Agents|sensory system agents|mesh-ancestor
102013184|NCT05305066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102013185|NCT05305066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013186|NCT05305066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102013187|NCT05305066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102013188|NCT05305066|Immunologic Factors|immunologic factors|mesh-ancestor
102013189|NCT05305066|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102013190|NCT05305066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102013191|NCT05305066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102013192|NCT05305066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013193|NCT05251714|Fulvestrant|fulvestrant|mesh-list
101949729|NCT04799275|Hormones|hormones|mesh-ancestor
101949730|NCT04799275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101949731|NCT04799275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101949732|NCT04799275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101949733|NCT04799275|Tubulin Modulators|tubulin modulators|mesh-ancestor
101949734|NCT04799275|Antimitotic Agents|antimitotic agents|mesh-ancestor
101949735|NCT04799275|Mitosis Modulators|mitosis modulators|mesh-ancestor
101949736|NCT04799275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101949737|NCT04799275|Antimetabolites|antimetabolites|mesh-ancestor
101949738|NCT04795336|Melatonin|melatonin|mesh-list
101949739|NCT04795336|Antioxidants|antioxidants|mesh-ancestor
101949740|NCT04795336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949741|NCT04795336|Protective Agents|protective agents|mesh-ancestor
101274943|NCT01859234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102013194|NCT05251714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102013195|NCT05251714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102013196|NCT05251714|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102013197|NCT05251714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102013198|NCT05251714|Hormone Antagonists|hormone antagonists|mesh-ancestor
102013199|NCT05251714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102013200|NCT05251714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013201|NCT02478034|Fludrocortisone|fludrocortisone|mesh-list
102013202|NCT02478034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101732957|NCT00759915|Morphine|morphine|mesh-list
102013203|NCT02477956|Vitamin D|vitamin d|mesh-list
102013204|NCT02477956|Ergocalciferols|ergocalciferols|mesh-list
102013205|NCT02477956|Cholecalciferol|cholecalciferol|mesh-list
102013206|NCT02477956|Vitamins|vitamins|mesh-list
102013207|NCT02477956|Micronutrients|micronutrients|mesh-ancestor
102013208|NCT02477956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013209|NCT02477956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101520175|NCT04652765|Camostat|camostat|mesh-list
102013210|NCT02477956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102013211|NCT02472574|Plasminogen|plasminogen|mesh-list
102013212|NCT02472574|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102013213|NCT02472574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102013214|NCT02472574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102013215|NCT02472574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013216|NCT05708248|Pentoxifylline|pentoxifylline|mesh-list
102013217|NCT05708248|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102013218|NCT05708248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102013219|NCT05708248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013220|NCT05708248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102013221|NCT05708248|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102013222|NCT05708248|Protective Agents|protective agents|mesh-ancestor
102013223|NCT05708248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013224|NCT05708248|Vasodilator Agents|vasodilator agents|mesh-ancestor
102013229|NCT05685394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013231|NCT05685394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013232|NCT03772223|Budesonide|budesonide|mesh-list
102013233|NCT03772223|Albuterol|albuterol|mesh-list
102013234|NCT03772223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102013235|NCT03772223|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102013236|NCT03772223|Autonomic Agents|autonomic agents|mesh-ancestor
102013237|NCT03772223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102013238|NCT03772223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013239|NCT03772223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102013240|NCT03772223|Respiratory System Agents|respiratory system agents|mesh-ancestor
102013241|NCT03772223|Glucocorticoids|glucocorticoids|mesh-ancestor
102013242|NCT03772223|Hormones|hormones|mesh-ancestor
101737365|NCT02584881|Sensory System Agents|sensory system agents|mesh-ancestor
101949742|NCT04795336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949743|NCT04795336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101949745|NCT04793958|Adagrasib|adagrasib|mesh-list
101949746|NCT04793958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101949747|NCT04793958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102013243|NCT03772223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102013244|NCT03772223|Tocolytic Agents|tocolytic agents|mesh-ancestor
102013245|NCT03772223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102013246|NCT03772223|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102013247|NCT03772223|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102013248|NCT03772223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102013249|NCT03772223|Adrenergic Agents|adrenergic agents|mesh-ancestor
102013250|NCT03772223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102013251|NCT03772223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013252|NCT03783299|Lumefantrine|lumefantrine|mesh-list
102013253|NCT03783299|Artemether|artemether|mesh-list
102013254|NCT03783299|Primaquine|primaquine|mesh-list
102013255|NCT03783299|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102013256|NCT03783299|Antimalarials|antimalarials|mesh-ancestor
102013257|NCT03783299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102013258|NCT03783299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102013259|NCT03783299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102013260|NCT03771755|Acetaminophen|acetaminophen|mesh-list
102013261|NCT03771755|Ibuprofen|ibuprofen|mesh-list
102013262|NCT03771755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102013263|NCT03771755|Analgesics|analgesics|mesh-ancestor
102013264|NCT03771755|Sensory System Agents|sensory system agents|mesh-ancestor
102013265|NCT03771755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102013266|NCT03771755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013267|NCT03771755|Antipyretics|antipyretics|mesh-ancestor
102013268|NCT03771755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102013269|NCT03771755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102013270|NCT03771755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102013271|NCT03771755|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102013272|NCT03771755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102013273|NCT03771755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013274|NCT02477566|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102013275|NCT02477566|Luteolytic Agents|luteolytic agents|mesh-ancestor
102013276|NCT02477566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101733029|NCT00833027|Incretins|incretins|mesh-ancestor
102013277|NCT02477566|Contraceptive Agents|contraceptive agents|mesh-ancestor
102013278|NCT02477566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102013279|NCT02477566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013280|NCT02477566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102013281|NCT02477566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102013282|NCT02477566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102013283|NCT05432531|Cyclophosphamide|cyclophosphamide|mesh-list
102013284|NCT05432531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102013285|NCT05432531|Immunologic Factors|immunologic factors|mesh-ancestor
102013286|NCT05432531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013287|NCT05432531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102013288|NCT05432531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102013289|NCT05432531|Alkylating Agents|alkylating agents|mesh-ancestor
102013290|NCT05432531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013291|NCT05432531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102013292|NCT05432531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102013294|NCT01309685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102013298|NCT01309685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013299|NCT01309685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013301|NCT03772067|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102013302|NCT03772067|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102013303|NCT03772067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102013304|NCT03772067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013305|NCT03772067|Incretins|incretins|mesh-ancestor
102013306|NCT03772067|Hormones|hormones|mesh-ancestor
102013307|NCT03772067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102013308|NCT03783065|Propranolol|propranolol|mesh-list
102013309|NCT03783065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101949748|NCT04789096|Pembrolizumab|pembrolizumab|mesh-list
101949749|NCT04789096|Trastuzumab|trastuzumab|mesh-list
101949750|NCT04789096|Capecitabine|capecitabine|mesh-list
101949751|NCT04789096|Tucatinib|tucatinib|mesh-list
101949752|NCT04789096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102013310|NCT03783065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102013311|NCT03783065|Adrenergic Agents|adrenergic agents|mesh-ancestor
102013312|NCT03783065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102013313|NCT03783065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013314|NCT03783065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013315|NCT03783065|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102013316|NCT03783065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102013317|NCT03783065|Vasodilator Agents|vasodilator agents|mesh-ancestor
102013318|NCT03766997|Hydrocortisone|hydrocortisone|mesh-list
102013319|NCT03766997|Betamethasone|betamethasone|mesh-list
102013320|NCT03766997|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
102013321|NCT03766997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102013322|NCT03766997|Glucocorticoids|glucocorticoids|mesh-ancestor
102013323|NCT03766997|Hormones|hormones|mesh-ancestor
102013324|NCT03766997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102013325|NCT03766997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013326|NCT03766997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102013327|NCT03766997|Respiratory System Agents|respiratory system agents|mesh-ancestor
102013328|NCT03766997|Dermatologic Agents|dermatologic agents|mesh-ancestor
102013329|NCT03782831|Antibodies|antibodies|mesh-list
102013330|NCT03782831|Immunologic Factors|immunologic factors|mesh-ancestor
102013331|NCT03782831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013332|NCT05539391|Rocuronium|rocuronium|mesh-list
102013333|NCT05539391|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102013334|NCT05539391|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102013335|NCT05539391|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102013336|NCT05539391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102013337|NCT05539391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013338|NCT03766607|Paclitaxel|paclitaxel|mesh-list
102013339|NCT03766607|Trastuzumab|trastuzumab|mesh-list
102013340|NCT03766607|Ramucirumab|ramucirumab|mesh-list
102013341|NCT03766607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102013342|NCT03766607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102013343|NCT03766607|Tubulin Modulators|tubulin modulators|mesh-ancestor
102013344|NCT03766607|Antimitotic Agents|antimitotic agents|mesh-ancestor
102013345|NCT03766607|Mitosis Modulators|mitosis modulators|mesh-ancestor
102013346|NCT03766607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013347|NCT03766607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102013348|NCT01567709|Vorinostat|vorinostat|mesh-list
102013349|NCT01567709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102013350|NCT01567709|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102013351|NCT01567709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102013352|NCT01567709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013353|NCT03765827|Vitamins|vitamins|mesh-list
102013354|NCT03765827|Vitamin E|vitamin e|mesh-list
102013355|NCT03765827|Tocopherols|tocopherols|mesh-list
102013356|NCT03765827|Tocotrienols|tocotrienols|mesh-list
102013357|NCT03765827|alpha-Tocopherol|alpha-tocopherol|mesh-list
102013358|NCT03765827|Micronutrients|micronutrients|mesh-ancestor
102013359|NCT03765827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013360|NCT03765827|Antioxidants|antioxidants|mesh-ancestor
102013361|NCT03765827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013362|NCT03765827|Protective Agents|protective agents|mesh-ancestor
102013363|NCT03771053|Simvastatin|simvastatin|mesh-list
102013364|NCT03771053|Ezetimibe|ezetimibe|mesh-list
102013365|NCT03771053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102013366|NCT03771053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102013367|NCT03771053|Antimetabolites|antimetabolites|mesh-ancestor
102013383|NCT03770663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102013384|NCT03770663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102013385|NCT03770663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102013386|NCT03770663|Antimetabolites|antimetabolites|mesh-ancestor
102013387|NCT03770663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102013388|NCT03048422|Tenofovir|tenofovir|mesh-list
102013389|NCT03048422|Emtricitabine|emtricitabine|mesh-list
102013390|NCT03048422|Efavirenz|efavirenz|mesh-list
102013391|NCT03048422|Dolutegravir|dolutegravir|mesh-list
102013392|NCT03048422|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101949753|NCT04789096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949754|NCT04789096|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101949755|NCT04789096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949756|NCT04789096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101949757|NCT04789096|Antimetabolites|antimetabolites|mesh-ancestor
101949758|NCT04789096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101949759|NCT04789096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101949760|NCT04788615|Interferons|interferons|mesh-list
101949761|NCT04788615|Interferon-beta|interferon-beta|mesh-list
101949762|NCT04788615|Interferon beta-1a|interferon beta-1a|mesh-list
101949763|NCT04788615|Teriflunomide|teriflunomide|mesh-list
101949764|NCT04788615|Ofatumumab|ofatumumab|mesh-list
102013393|NCT03048422|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
102013394|NCT03048422|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102013395|NCT03048422|Antiviral Agents|antiviral agents|mesh-ancestor
102013396|NCT03048422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102013397|NCT03048422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102013398|NCT03048422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102013399|NCT03048422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102013400|NCT03048422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013401|NCT03048422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102013402|NCT03048422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102013403|NCT03048422|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102013404|NCT03048422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102013405|NCT03048422|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102013406|NCT03048422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102013407|NCT03048422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102013408|NCT03048422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102013409|NCT03048422|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102013410|NCT03048422|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102013411|NCT01561781|Digoxin|digoxin|mesh-list
102013412|NCT01561781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102013413|NCT01561781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102013414|NCT01561781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102013415|NCT01561781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013416|NCT01561781|Protective Agents|protective agents|mesh-ancestor
102013417|NCT01561781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013418|NCT03770039|PF-06700841|pf-06700841|mesh-list
102013419|NCT03770039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102013420|NCT03770039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102013421|NCT03770039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013422|NCT01321775|Paclitaxel|paclitaxel|mesh-list
102013423|NCT01321775|Cyclophosphamide|cyclophosphamide|mesh-list
102013438|NCT01321775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102013439|NCT01321775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102013440|NCT01321775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102013441|NCT01321775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102013442|NCT01321775|Growth Substances|growth substances|mesh-ancestor
102013443|NCT01321775|Growth Inhibitors|growth inhibitors|mesh-ancestor
102013444|NCT05514509|Cabotegravir|cabotegravir|mesh-list
101520327|NCT02324283|Propofol|propofol|mesh-list
102013445|NCT05514509|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102013446|NCT05514509|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102013447|NCT05514509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102013448|NCT05514509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013449|NCT05514509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102013450|NCT05514509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102013451|NCT05514509|Antiviral Agents|antiviral agents|mesh-ancestor
102013452|NCT05514509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102013453|NCT03764267|Lidocaine|lidocaine|mesh-list
102013454|NCT03764267|Remifentanil|remifentanil|mesh-list
102013455|NCT03764267|Anesthetics|anesthetics|mesh-list
102013456|NCT03764267|Anesthetics, General|anesthetics, general|mesh-list
102013457|NCT03764267|Anesthetics, Local|anesthetics, local|mesh-ancestor
101949765|NCT04788615|Glatiramer Acetate|glatiramer acetate|mesh-list
101949766|NCT04788615|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101949767|NCT04788615|(T,G)-A-L|(t,g)-a-l|mesh-list
101520367|NCT05077254|Vaccines|vaccines|mesh-list
101949768|NCT04788615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949769|NCT04788615|Antiviral Agents|antiviral agents|mesh-ancestor
101949770|NCT04788615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101275223|NCT01860833|Ibuprofen|ibuprofen|mesh-list
102013458|NCT03764267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102013459|NCT03764267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013460|NCT03764267|Sensory System Agents|sensory system agents|mesh-ancestor
102013461|NCT03764267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102013462|NCT03764267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102013463|NCT03764267|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102013464|NCT03764267|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102013465|NCT03764267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102013466|NCT03764267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013467|NCT03764267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102013468|NCT03764267|Narcotics|narcotics|mesh-ancestor
102013469|NCT03764267|Analgesics|analgesics|mesh-ancestor
102013470|NCT01321931|Nicotine|nicotine|mesh-list
102013471|NCT01321931|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102013472|NCT01321931|Autonomic Agents|autonomic agents|mesh-ancestor
102013473|NCT01321931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102013474|NCT01321931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013475|NCT01321931|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102013476|NCT01321931|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102013477|NCT01321931|Cholinergic Agents|cholinergic agents|mesh-ancestor
102013478|NCT01321931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102013479|NCT01321931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013480|NCT03763409|Losartan|losartan|mesh-list
102013481|NCT03763409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102013482|NCT03763409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102013483|NCT03763409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102013487|NCT01322477|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102013488|NCT01322477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013489|NCT03762785|Dexmedetomidine|dexmedetomidine|mesh-list
102013490|NCT03762785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102013491|NCT03762785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102013492|NCT03762785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013493|NCT03762785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102013494|NCT03762785|Analgesics|analgesics|mesh-ancestor
102013495|NCT03762785|Sensory System Agents|sensory system agents|mesh-ancestor
102013496|NCT03762785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102013497|NCT03762785|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102013498|NCT03762785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102013499|NCT03762785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102013500|NCT03762785|Adrenergic Agents|adrenergic agents|mesh-ancestor
102013501|NCT03762785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102013502|NCT03762785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013504|NCT03758729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102013505|NCT03758729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102013506|NCT03758729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102013507|NCT03758729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013508|NCT03756623|Metformin|metformin|mesh-list
102013509|NCT03756623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102013510|NCT03756623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013511|NCT03756233|Remifentanil|remifentanil|mesh-list
102013512|NCT03756233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102013513|NCT03756233|Narcotics|narcotics|mesh-ancestor
101520421|NCT00544011|Growth Substances|growth substances|mesh-ancestor
102013514|NCT03756233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102013515|NCT03756233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013516|NCT03756233|Analgesics|analgesics|mesh-ancestor
102013517|NCT03756233|Sensory System Agents|sensory system agents|mesh-ancestor
102013518|NCT03756233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102013519|NCT03758339|Tucatinib|tucatinib|mesh-list
102013520|NCT03758339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102013521|NCT03758339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102013522|NCT03758339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101949771|NCT04788615|Immunologic Factors|immunologic factors|mesh-ancestor
101949772|NCT04788615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949773|NCT04788615|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101949774|NCT04788615|Dermatologic Agents|dermatologic agents|mesh-ancestor
101949775|NCT04788615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101949776|NCT04788615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101949777|NCT04788615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102013523|NCT03758339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013524|NCT03565913|Calcium, Dietary|calcium, dietary|mesh-list
102013525|NCT03565913|Magnesium citrate|magnesium citrate|mesh-list
102013526|NCT03565913|Calcium|calcium|mesh-list
102013527|NCT03565913|Calcium acetate|calcium acetate|mesh-list
102013528|NCT03565913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102013529|NCT03565913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013530|NCT03565913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102013531|NCT03565913|Chelating Agents|chelating agents|mesh-ancestor
102013532|NCT03565913|Sequestering Agents|sequestering agents|mesh-ancestor
102013533|NCT03565913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013534|NCT03565913|Cathartics|cathartics|mesh-ancestor
102013535|NCT03565913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102013536|NCT05085665|Ivermectin|ivermectin|mesh-list
102013537|NCT05085665|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102013538|NCT05085665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102013539|NCT05004077|Amiodarone|amiodarone|mesh-list
102013540|NCT05004077|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102013541|NCT05004077|Vasodilator Agents|vasodilator agents|mesh-ancestor
102013542|NCT05004077|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102013543|NCT05004077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102013544|NCT05004077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013545|NCT05004077|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102013546|NCT05004077|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102013547|NCT05004077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102013548|NCT05004077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102013549|NCT05004077|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102013550|NCT05004077|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102013551|NCT05004077|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102013552|NCT03755609|Fentanyl|fentanyl|mesh-list
102013553|NCT03755609|Oxycodone|oxycodone|mesh-list
101520438|NCT04649723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102013556|NCT03755609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102013557|NCT03755609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013558|NCT03755609|Analgesics|analgesics|mesh-ancestor
102013559|NCT03755609|Sensory System Agents|sensory system agents|mesh-ancestor
102013560|NCT03755609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102013561|NCT03755609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102013562|NCT03755609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102013563|NCT03755609|Anesthetics, General|anesthetics, general|mesh-ancestor
102013564|NCT03755609|Anesthetics|anesthetics|mesh-ancestor
102013565|NCT03760445|Cytarabine|cytarabine|mesh-list
102013566|NCT03760445|Posaconazole|posaconazole|mesh-list
102013567|NCT03760445|Daunorubicin|daunorubicin|mesh-list
102013568|NCT03760445|Idarubicin|idarubicin|mesh-list
102013569|NCT03760445|Midostaurin|midostaurin|mesh-list
102013570|NCT03760445|Midazolam|midazolam|mesh-list
102013571|NCT03760445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102013572|NCT03760445|Antimetabolites|antimetabolites|mesh-ancestor
101733316|NCT00823979|Antiviral Agents|antiviral agents|mesh-ancestor
102013573|NCT03760445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013574|NCT03760445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102013575|NCT03760445|Antiviral Agents|antiviral agents|mesh-ancestor
102013576|NCT03760445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102013577|NCT03760445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102013578|NCT03760445|Immunologic Factors|immunologic factors|mesh-ancestor
102013579|NCT03760445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013580|NCT03760445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102013581|NCT03760445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102013582|NCT03760445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102013583|NCT03760445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102013584|NCT03760445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101949778|NCT04788615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101949779|NCT04788615|Analgesics|analgesics|mesh-ancestor
101949780|NCT04788615|Sensory System Agents|sensory system agents|mesh-ancestor
101949781|NCT04788615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101949782|NCT04788615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101949783|NCT04739813|Prednisone|prednisone|mesh-list
101949784|NCT04739813|Lenalidomide|lenalidomide|mesh-list
101949785|NCT04739813|Venetoclax|venetoclax|mesh-list
101949786|NCT04739813|Obinutuzumab|obinutuzumab|mesh-list
101949787|NCT04739813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101949788|NCT04739813|Glucocorticoids|glucocorticoids|mesh-ancestor
101949789|NCT04739813|Hormones|hormones|mesh-ancestor
101949790|NCT04739813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101949791|NCT04739813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949792|NCT04739813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101949793|NCT04739813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949794|NCT04739813|Immunologic Factors|immunologic factors|mesh-ancestor
101949795|NCT04739813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101949796|NCT04739813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101949797|NCT04739813|Growth Substances|growth substances|mesh-ancestor
101949798|NCT04739813|Growth Inhibitors|growth inhibitors|mesh-ancestor
101275344|NCT01862003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013585|NCT03760445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102013586|NCT03760445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102013587|NCT03760445|Anesthetics, General|anesthetics, general|mesh-ancestor
102013588|NCT03760445|Anesthetics|anesthetics|mesh-ancestor
102013589|NCT03760445|GABA Modulators|gaba modulators|mesh-ancestor
102013590|NCT03760445|GABA Agents|gaba agents|mesh-ancestor
102013591|NCT03760445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102013592|NCT03760445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102013593|NCT03760445|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102013594|NCT03760445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102013595|NCT03760445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102013596|NCT03760445|Antifungal Agents|antifungal agents|mesh-ancestor
102013597|NCT03760445|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102013598|NCT03760445|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102013599|NCT03760445|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102013600|NCT03760445|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102013601|NCT03760445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102013602|NCT03760445|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102013603|NCT03760445|Hormone Antagonists|hormone antagonists|mesh-ancestor
102013604|NCT03760445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102013605|NCT03760445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102013606|NCT05460377|Vaccines|vaccines|mesh-list
102013607|NCT05460377|Immunologic Factors|immunologic factors|mesh-ancestor
102013608|NCT05460377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013609|NCT04956575|Vaccines|vaccines|mesh-list
102013610|NCT04956575|Immunologic Factors|immunologic factors|mesh-ancestor
102013611|NCT04956575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013612|NCT05692856|Clenbuterol|clenbuterol|mesh-list
102013613|NCT05692856|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102013614|NCT05692856|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102013615|NCT05692856|Adrenergic Agents|adrenergic agents|mesh-ancestor
102013616|NCT05692856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101949799|NCT04739813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101949800|NCT04738318|Dexamethasone|dexamethasone|mesh-list
101949801|NCT04738318|Methylprednisolone|methylprednisolone|mesh-list
101949802|NCT04738318|Glucocorticoids|glucocorticoids|mesh-list
101949803|NCT04738318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101949804|NCT04738318|Antiemetics|antiemetics|mesh-ancestor
102013617|NCT05692856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013618|NCT05692856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013619|NCT05692856|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102013620|NCT05692856|Autonomic Agents|autonomic agents|mesh-ancestor
102013621|NCT05692856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102013622|NCT05692856|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102013623|NCT05692856|Respiratory System Agents|respiratory system agents|mesh-ancestor
102013624|NCT05692856|Sympathomimetics|sympathomimetics|mesh-ancestor
102013625|NCT03755531|Oxytocin|oxytocin|mesh-list
102013626|NCT03755531|Carbetocin|carbetocin|mesh-list
102013627|NCT03755531|Oxytocics|oxytocics|mesh-ancestor
102013628|NCT03755531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102013632|NCT04854707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102013633|NCT04854707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102013634|NCT04854707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013635|NCT04854707|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102013636|NCT04854707|Fertility Agents|fertility agents|mesh-ancestor
102013637|NCT04854707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102013638|NCT03215069|Empagliflozin|empagliflozin|mesh-list
102013639|NCT03215069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102013640|NCT03215069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013641|NCT03215069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102013642|NCT03215069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013643|NCT03759353|Lactoferrin|lactoferrin|mesh-list
102013644|NCT03759353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102013645|NCT03757559|Hydromorphone|hydromorphone|mesh-list
102013646|NCT03757559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102013647|NCT03757559|Narcotics|narcotics|mesh-ancestor
101733398|NCT00708539|Hormones|hormones|mesh-ancestor
102013648|NCT03757559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102013649|NCT03757559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013650|NCT03757559|Analgesics|analgesics|mesh-ancestor
102013651|NCT03757559|Sensory System Agents|sensory system agents|mesh-ancestor
102013652|NCT03757559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102013653|NCT02658929|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
102013654|NCT02658929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102013655|NCT02658929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102013656|NCT04784897|Brilacidin|brilacidin|mesh-list
102013657|NCT04784897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102013658|NCT02780804|Entinostat|entinostat|mesh-list
102013659|NCT02780804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102013660|NCT02780804|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102013661|NCT02780804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102013662|NCT02780804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013663|NCT01322711|Atorvastatin|atorvastatin|mesh-list
102013664|NCT01322711|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102013665|NCT01322711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102013666|NCT01322711|Antimetabolites|antimetabolites|mesh-ancestor
102013667|NCT01322711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013668|NCT01322711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102013669|NCT01322711|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102013670|NCT01322711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102013671|NCT04532099|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102013672|NCT04532099|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102013673|NCT04532099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102013674|NCT03041792|Liraglutide|liraglutide|mesh-list
102013675|NCT03041792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102013676|NCT03041792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013677|NCT03041792|Incretins|incretins|mesh-ancestor
102013678|NCT03041792|Hormones|hormones|mesh-ancestor
102013679|NCT03041792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102013680|NCT03753581|Cytarabine|cytarabine|mesh-list
102013681|NCT03753581|Methotrexate|methotrexate|mesh-list
102013682|NCT03753581|Etoposide|etoposide|mesh-list
101949805|NCT04738318|Autonomic Agents|autonomic agents|mesh-ancestor
101949806|NCT04738318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101949807|NCT04738318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949808|NCT04738318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101949809|NCT04738318|Hormones|hormones|mesh-ancestor
101949810|NCT04738318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101275470|NCT01863069|Antiviral Agents|antiviral agents|mesh-ancestor
102013683|NCT03753581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102013684|NCT03753581|Antimetabolites|antimetabolites|mesh-ancestor
102013685|NCT03753581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013686|NCT03753581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102013687|NCT03753581|Antiviral Agents|antiviral agents|mesh-ancestor
102013688|NCT03753581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102013689|NCT03753581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102013690|NCT03753581|Immunologic Factors|immunologic factors|mesh-ancestor
102013691|NCT03753581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013692|NCT03753581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102013693|NCT03753581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102013694|NCT03753581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102013695|NCT03753581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102013696|NCT03753581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102013697|NCT03753581|Abortifacient Agents|abortifacient agents|mesh-ancestor
102013698|NCT03753581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102013699|NCT03753581|Dermatologic Agents|dermatologic agents|mesh-ancestor
102013704|NCT04507763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102013706|NCT04507763|Analgesics|analgesics|mesh-ancestor
102013707|NCT04507763|Sensory System Agents|sensory system agents|mesh-ancestor
102013708|NCT04507763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102013709|NCT04507763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013710|NCT04507763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102013711|NCT04507763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102013712|NCT04507763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102013713|NCT04507763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102013714|NCT04507763|Immunologic Factors|immunologic factors|mesh-ancestor
102013715|NCT00705484|Infliximab|infliximab|mesh-list
102013716|NCT00705484|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102013717|NCT00705484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102013718|NCT00705484|Dermatologic Agents|dermatologic agents|mesh-ancestor
102013719|NCT00705484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102013720|NCT00705484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102013721|NCT05459597|Anticonvulsants|anticonvulsants|mesh-list
101733476|NCT02606552|Aspirin|aspirin|mesh-list
102013722|NCT05358626|Antibodies|antibodies|mesh-list
102013723|NCT05358626|Immunoglobulin G|immunoglobulin g|mesh-list
102013724|NCT05358626|Immunologic Factors|immunologic factors|mesh-ancestor
102013725|NCT05358626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013726|NCT03753269|Fasudil|fasudil|mesh-list
102013727|NCT03753269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102013728|NCT03753269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102013729|NCT03753269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013730|NCT03753269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102013731|NCT03753269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013732|NCT03753269|Vasodilator Agents|vasodilator agents|mesh-ancestor
102013733|NCT03753269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102013734|NCT03753269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102013735|NCT05459441|Pemetrexed|pemetrexed|mesh-list
102013736|NCT05459441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102013737|NCT05459441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102013738|NCT05459441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013739|NCT05459441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102013740|NCT05459441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102013741|NCT04523831|Doxycycline|doxycycline|mesh-list
102013742|NCT04523831|Ivermectin|ivermectin|mesh-list
102013743|NCT04523831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102013744|NCT04523831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102013745|NCT04523831|Antimalarials|antimalarials|mesh-ancestor
102013746|NCT04523831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102013747|NCT04523831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101949811|NCT04738318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101949812|NCT04738318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101275534|NCT01863355|Fentanyl|fentanyl|mesh-list
102013748|NCT05691764|Cyclosporine|cyclosporine|mesh-list
102013749|NCT05691764|Cyclosporins|cyclosporins|mesh-list
102013750|NCT05691764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102013751|NCT05691764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013752|NCT05691764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102013753|NCT05691764|Immunologic Factors|immunologic factors|mesh-ancestor
102013754|NCT05691764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013755|NCT05691764|Antifungal Agents|antifungal agents|mesh-ancestor
102013756|NCT05691764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102013757|NCT05691764|Dermatologic Agents|dermatologic agents|mesh-ancestor
102013758|NCT05691764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102013759|NCT05691764|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102013760|NCT04707664|Sargramostim|sargramostim|mesh-list
102013761|NCT04707664|Immunologic Factors|immunologic factors|mesh-ancestor
102013762|NCT04707664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013763|NCT01316276|Amikacin|amikacin|mesh-list
102013764|NCT01316276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102013765|NCT01316276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102013766|NCT02474290|Sorafenib|sorafenib|mesh-list
102013767|NCT02474290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102013768|NCT02474290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102013769|NCT02474290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102013770|NCT02474290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013777|NCT05200286|Antifungal Agents|antifungal agents|mesh-ancestor
102013778|NCT05200286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102013779|NCT02474446|Vitamin D|vitamin d|mesh-list
102013780|NCT02474446|Vitamins|vitamins|mesh-ancestor
102013781|NCT02474446|Micronutrients|micronutrients|mesh-ancestor
102013782|NCT02474446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013783|NCT02474446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102013784|NCT05199818|Palonosetron|palonosetron|mesh-list
102013785|NCT05199818|Antiemetics|antiemetics|mesh-ancestor
102013786|NCT05199818|Autonomic Agents|autonomic agents|mesh-ancestor
102013787|NCT05199818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102013788|NCT05199818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013789|NCT05199818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102013790|NCT05199818|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102013791|NCT05199818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102013792|NCT05199818|Serotonin Agents|serotonin agents|mesh-ancestor
102013793|NCT05199818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102013794|NCT05199818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013795|NCT02474134|Interferons|interferons|mesh-list
102013796|NCT02474134|Interferon-beta|interferon-beta|mesh-list
102013797|NCT02474134|Interferon beta-1b|interferon beta-1b|mesh-list
102013798|NCT02474134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102013799|NCT02474134|Antiviral Agents|antiviral agents|mesh-ancestor
102013800|NCT02474134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102013801|NCT02474134|Immunologic Factors|immunologic factors|mesh-ancestor
102013802|NCT02474134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013803|NCT02474134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102013804|NCT02473900|Oseltamivir|oseltamivir|mesh-list
102013805|NCT02473900|Antiviral Agents|antiviral agents|mesh-ancestor
102013806|NCT02473900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102013807|NCT02473900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102013808|NCT02473900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013809|NCT02471950|Isoflurane|isoflurane|mesh-list
102013810|NCT02471950|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102013811|NCT02471950|Anesthetics, General|anesthetics, general|mesh-ancestor
102013812|NCT02471950|Anesthetics|anesthetics|mesh-ancestor
102013813|NCT02471950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102013814|NCT02471950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013815|NCT01322867|Alprazolam|alprazolam|mesh-list
102013816|NCT01322867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102013817|NCT01322867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102013818|NCT01322867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013819|NCT01322867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102013820|NCT01322867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102013821|NCT01322867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102013822|NCT01322867|GABA Modulators|gaba modulators|mesh-ancestor
102013823|NCT01322867|GABA Agents|gaba agents|mesh-ancestor
102013824|NCT01322867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101949813|NCT04738318|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101949814|NCT04738318|Protective Agents|protective agents|mesh-ancestor
101949815|NCT04725032|Propofol|propofol|mesh-list
101949816|NCT04725032|Sevoflurane|sevoflurane|mesh-list
101949817|NCT04725032|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101949818|NCT04725032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101949819|NCT04725032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949820|NCT04725032|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101949821|NCT04725032|Anesthetics, General|anesthetics, general|mesh-ancestor
101949822|NCT04725032|Anesthetics|anesthetics|mesh-ancestor
101949823|NCT04725032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101949824|NCT04725032|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101949825|NCT04720157|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101949826|NCT04720157|177Lu-PSMA-617|177lu-psma-617|mesh-list
101949827|NCT04720157|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101949828|NCT04720157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949829|NCT04699838|Carboplatin|carboplatin|mesh-list
101949830|NCT04699838|Etoposide|etoposide|mesh-list
101949831|NCT04699838|Durvalumab|durvalumab|mesh-list
101949832|NCT04699838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949833|NCT04699838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101949834|NCT04699838|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101949835|NCT04699838|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101949836|NCT04699838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101949837|NCT04699838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949838|NCT04699838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101949839|NCT04686786|PF-06372865|pf-06372865|mesh-list
101949840|NCT04686786|GABA Modulators|gaba modulators|mesh-ancestor
101949841|NCT04686786|GABA Agents|gaba agents|mesh-ancestor
101949842|NCT04686786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101949843|NCT04686786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949844|NCT04686786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949845|NCT04678895|Naltrexone|naltrexone|mesh-list
101949846|NCT04678895|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102013825|NCT01322867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013826|NCT04624828|Androgens|androgens|mesh-list
102013827|NCT04624828|Hormones|hormones|mesh-ancestor
102013828|NCT04624828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102013829|NCT04624828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013830|NCT02471560|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102013831|NCT02471560|Dermatologic Agents|dermatologic agents|mesh-ancestor
102013832|NCT02471560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101949847|NCT04678895|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101949848|NCT04678895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949849|NCT04678895|Sensory System Agents|sensory system agents|mesh-ancestor
102013833|NCT02471560|Immunologic Factors|immunologic factors|mesh-ancestor
102013834|NCT02471560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013835|NCT02477488|Allopurinol|allopurinol|mesh-list
102013836|NCT02477488|Antimetabolites|antimetabolites|mesh-ancestor
102013837|NCT02477488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013838|NCT02477488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102013839|NCT02477488|Gout Suppressants|gout suppressants|mesh-ancestor
102013840|NCT02477488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102013841|NCT02477488|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102013847|NCT05163106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102013848|NCT05163106|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102013849|NCT05163106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102013850|NCT05163106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102013851|NCT05163106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013852|NCT05163106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102013853|NCT05163106|Hormone Antagonists|hormone antagonists|mesh-ancestor
102013854|NCT05163106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102013855|NCT05163106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013856|NCT05163106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102013857|NCT02477098|Ropivacaine|ropivacaine|mesh-list
102013858|NCT02477098|Anesthetics, Local|anesthetics, local|mesh-ancestor
102013859|NCT02477098|Anesthetics|anesthetics|mesh-ancestor
102013860|NCT02477098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102013861|NCT02477098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013862|NCT02477098|Sensory System Agents|sensory system agents|mesh-ancestor
102013863|NCT02477098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102013864|NCT04518046|Nivolumab|nivolumab|mesh-list
102013865|NCT04518046|Ipilimumab|ipilimumab|mesh-list
102013866|NCT04518046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102013867|NCT04518046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102013868|NCT04518046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102013869|NCT04518046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013870|NCT05571670|Sirolimus|sirolimus|mesh-list
101733616|NCT02599857|Adrenergic Agents|adrenergic agents|mesh-ancestor
102013871|NCT05571670|MTOR Inhibitors|mtor inhibitors|mesh-list
102013872|NCT05571670|Temsirolimus|temsirolimus|mesh-list
102013873|NCT05571670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013874|NCT05571670|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102013875|NCT05571670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102013876|NCT05571670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013877|NCT05571670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102013878|NCT05571670|Immunologic Factors|immunologic factors|mesh-ancestor
102013879|NCT05571670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102013880|NCT05571670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102013881|NCT05571670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102013882|NCT05571670|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102013883|NCT05571670|Antifungal Agents|antifungal agents|mesh-ancestor
101520584|NCT01229449|Ibuprofen|ibuprofen|mesh-list
102013884|NCT02473354|Remifentanil|remifentanil|mesh-list
102013885|NCT02473354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102013886|NCT02473354|Narcotics|narcotics|mesh-ancestor
102013887|NCT02473354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102013888|NCT02473354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013889|NCT02473354|Analgesics|analgesics|mesh-ancestor
102013890|NCT02473354|Sensory System Agents|sensory system agents|mesh-ancestor
102013891|NCT02473354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102013892|NCT02470858|Sofosbuvir|sofosbuvir|mesh-list
102013893|NCT02470858|Asunaprevir|asunaprevir|mesh-list
102013894|NCT02470858|Antiviral Agents|antiviral agents|mesh-ancestor
102013895|NCT02470858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102013896|NCT02470858|Protease Inhibitors|protease inhibitors|mesh-ancestor
102013897|NCT02470858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102013898|NCT02470858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013899|NCT02473198|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102013900|NCT02473198|Morphine|morphine|mesh-list
102013901|NCT02473198|Bupivacaine|bupivacaine|mesh-list
102013902|NCT02473198|Anesthetics, Local|anesthetics, local|mesh-ancestor
102013903|NCT02473198|Anesthetics|anesthetics|mesh-ancestor
102013904|NCT02473198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102013905|NCT02473198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949850|NCT04678895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101949851|NCT04677569|Azithromycin|azithromycin|mesh-list
101949852|NCT04677569|Amikacin|amikacin|mesh-list
101949853|NCT04677569|Ethambutol|ethambutol|mesh-list
101949854|NCT04677569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101949855|NCT04677569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102013906|NCT02473198|Sensory System Agents|sensory system agents|mesh-ancestor
102013907|NCT02473198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102013908|NCT02473198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102013909|NCT02473198|Narcotics|narcotics|mesh-ancestor
102013910|NCT02473198|Analgesics|analgesics|mesh-ancestor
102013911|NCT02473198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102013912|NCT02473198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102013914|NCT02473198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102013915|NCT02473198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102013916|NCT02473198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102013917|NCT02473198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013919|NCT03614728|GSK-3326595|gsk-3326595|mesh-list
102013920|NCT03614728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102013921|NCT03614728|Antimetabolites|antimetabolites|mesh-ancestor
102013922|NCT03614728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013923|NCT03614728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102013924|NCT03614728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102013925|NCT05069974|Linezolid|linezolid|mesh-list
102013926|NCT05069974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102013927|NCT05069974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102013928|NCT05069974|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102013929|NCT05069974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102013930|NCT05069974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013931|NCT05336266|Ketorolac|ketorolac|mesh-list
102013932|NCT05336266|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102013933|NCT05336266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102013934|NCT05336266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102013935|NCT05336266|Analgesics|analgesics|mesh-ancestor
102013936|NCT05336266|Sensory System Agents|sensory system agents|mesh-ancestor
102013937|NCT05336266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102013938|NCT05336266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013939|NCT05336266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102013940|NCT05336266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102013941|NCT05336266|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102013942|NCT05336266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102013943|NCT05336266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013944|NCT02470780|Rifaximin|rifaximin|mesh-list
102013945|NCT02470780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102013946|NCT02470780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102013947|NCT02470780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101733688|NCT02598414|Fluorophosphate|fluorophosphate|mesh-list
102013948|NCT05180292|Carvedilol|carvedilol|mesh-list
102013949|NCT05180292|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102013950|NCT05180292|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102013951|NCT05180292|Adrenergic Agents|adrenergic agents|mesh-ancestor
102013952|NCT05180292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102013953|NCT05180292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013954|NCT05180292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013955|NCT05180292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102013957|NCT05180292|Protective Agents|protective agents|mesh-ancestor
102013958|NCT05180292|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102013959|NCT05180292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102013960|NCT05180292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102013961|NCT05180292|Vasodilator Agents|vasodilator agents|mesh-ancestor
102013962|NCT05180292|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102013963|NCT05180292|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102013964|NCT01315938|Abatacept|abatacept|mesh-list
102013965|NCT01315938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102013966|NCT01315938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013967|NCT01315938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102013968|NCT01315938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102013969|NCT01315938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102013970|NCT01315938|Immunologic Factors|immunologic factors|mesh-ancestor
101949856|NCT04677569|Antitubercular Agents|antitubercular agents|mesh-ancestor
101949857|NCT04665570|Metformin|metformin|mesh-list
101949858|NCT04665570|Acarbose|acarbose|mesh-list
101949859|NCT04665570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102013971|NCT01315938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013972|NCT01315938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102013973|NCT01339884|Resveratrol|resveratrol|mesh-list
102013974|NCT01339884|Antioxidants|antioxidants|mesh-ancestor
102013975|NCT01339884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013976|NCT01339884|Protective Agents|protective agents|mesh-ancestor
102013977|NCT01339884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013978|NCT01339884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102013979|NCT01339884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102013980|NCT04736394|Epirubicin|epirubicin|mesh-list
102013981|NCT04736394|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102013982|NCT04736394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102013983|NCT04736394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102013984|NCT04736394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102013996|NCT01341834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102013997|NCT01341834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102013998|NCT01340118|Budesonide|budesonide|mesh-list
102013999|NCT01340118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102014000|NCT01340118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102014001|NCT01340118|Autonomic Agents|autonomic agents|mesh-ancestor
102014002|NCT01340118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102014003|NCT01340118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014004|NCT01340118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102014005|NCT01340118|Respiratory System Agents|respiratory system agents|mesh-ancestor
102014006|NCT01340118|Glucocorticoids|glucocorticoids|mesh-ancestor
102014007|NCT01340118|Hormones|hormones|mesh-ancestor
102014008|NCT01340118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102014009|NCT03401398|Hydrocortisone|hydrocortisone|mesh-list
102014010|NCT03401398|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102014011|NCT03401398|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102014012|NCT03401398|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102014013|NCT03401398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102014014|NCT02470702|Oritavancin|oritavancin|mesh-list
102014015|NCT02470702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102014016|NCT02470702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102014017|NCT01375582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102014018|NCT01375582|Lubricant Eye Drops|lubricant eye drops|mesh-list
102014019|NCT01375582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102014020|NCT04409964|Lidocaine|lidocaine|mesh-list
102014021|NCT04409964|Dexmedetomidine|dexmedetomidine|mesh-list
102014022|NCT04409964|Remifentanil|remifentanil|mesh-list
101733759|NCT04091763|Polidocanol|polidocanol|mesh-list
102014023|NCT04409964|Anesthetics, Local|anesthetics, local|mesh-ancestor
102014025|NCT04409964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102014026|NCT04409964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014027|NCT04409964|Sensory System Agents|sensory system agents|mesh-ancestor
102014028|NCT04409964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102014029|NCT04409964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102014030|NCT04409964|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101520635|NCT02908581|Folic Acid|folic acid|mesh-list
102014031|NCT04409964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102014032|NCT04409964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102014033|NCT04409964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014034|NCT04409964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102014035|NCT04409964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102014036|NCT04409964|Analgesics|analgesics|mesh-ancestor
102014037|NCT04409964|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102014038|NCT04409964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102014039|NCT04409964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102014040|NCT04409964|Adrenergic Agents|adrenergic agents|mesh-ancestor
102014041|NCT04409964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102014042|NCT04409964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102014043|NCT04409964|Narcotics|narcotics|mesh-ancestor
102014044|NCT01342146|Hormones|hormones|mesh-list
102014045|NCT01342146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102014046|NCT01342146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014047|NCT03212716|Oseltamivir|oseltamivir|mesh-list
102014052|NCT03212716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014053|NCT03212716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101949860|NCT04665570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949861|NCT04665570|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101949862|NCT04665570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101949863|NCT04665570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014054|NCT03212716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102014055|NCT03212716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102014056|NCT03212716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102014057|NCT03212716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014058|NCT03212716|Vasodilator Agents|vasodilator agents|mesh-ancestor
102014060|NCT04762836|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102014061|NCT04762836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102014062|NCT04762836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102014063|NCT04762836|Antitubercular Agents|antitubercular agents|mesh-ancestor
102014064|NCT04762836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102014065|NCT04762836|Antimetabolites|antimetabolites|mesh-ancestor
102014066|NCT04762836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014067|NCT00705406|Peramivir|peramivir|mesh-list
102014068|NCT00705406|Antiviral Agents|antiviral agents|mesh-ancestor
102014069|NCT00705406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102014070|NCT00705406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102014071|NCT00705406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014072|NCT01342224|Gemcitabine|gemcitabine|mesh-list
102014073|NCT01342224|Tadalafil|tadalafil|mesh-list
102014074|NCT01342224|Sargramostim|sargramostim|mesh-list
102014075|NCT01342224|Immunologic Factors|immunologic factors|mesh-ancestor
102014076|NCT01342224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014077|NCT01342224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102014078|NCT01342224|Antimetabolites|antimetabolites|mesh-ancestor
102014079|NCT01342224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014080|NCT01342224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102014081|NCT01342224|Vasodilator Agents|vasodilator agents|mesh-ancestor
102014082|NCT01342224|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102014083|NCT01342224|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102014084|NCT01342224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102014085|NCT01342224|Urological Agents|urological agents|mesh-ancestor
102014086|NCT03155178|Ethanol|ethanol|mesh-list
102014087|NCT03155178|Chlorhexidine|chlorhexidine|mesh-list
102014088|NCT03155178|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102014089|NCT03155178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102014090|NCT03155178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102014091|NCT03155178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102014092|NCT03155178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014093|NCT03155178|Disinfectants|disinfectants|mesh-ancestor
102014094|NCT03155178|Dermatologic Agents|dermatologic agents|mesh-ancestor
102014095|NCT02470546|Metformin|metformin|mesh-list
102014096|NCT02470546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102014097|NCT02470546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014098|NCT03310762|Silicon|silicon|mesh-list
102014099|NCT03310762|Trace Elements|trace elements|mesh-ancestor
102014100|NCT03310762|Micronutrients|micronutrients|mesh-ancestor
102014101|NCT03310762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014102|NCT03310606|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102014103|NCT03310606|Lactams|lactams|mesh-list
102014104|NCT03310606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102014105|NCT01315704|Vitamin D|vitamin d|mesh-list
102014106|NCT01315704|Vitamins|vitamins|mesh-ancestor
102014107|NCT01315704|Micronutrients|micronutrients|mesh-ancestor
102014108|NCT01315704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014109|NCT01315704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102014110|NCT05158608|Cyclophosphamide|cyclophosphamide|mesh-list
102014111|NCT05158608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102014112|NCT05158608|Immunologic Factors|immunologic factors|mesh-ancestor
102014113|NCT05158608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014114|NCT05158608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102014115|NCT05158608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102014116|NCT05158608|Alkylating Agents|alkylating agents|mesh-ancestor
102014117|NCT05158608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014118|NCT05158608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102014119|NCT05158608|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102014124|NCT04702776|Viscosupplements|viscosupplements|mesh-ancestor
102014125|NCT04702776|Protective Agents|protective agents|mesh-ancestor
101949864|NCT04648930|Omalizumab|omalizumab|mesh-list
101949865|NCT04648930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101949866|NCT04648930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101949867|NCT04648930|Respiratory System Agents|respiratory system agents|mesh-ancestor
101275948|NCT01866254|Morphine|morphine|mesh-list
102014127|NCT03310372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102014128|NCT03310372|Alkylating Agents|alkylating agents|mesh-ancestor
102014129|NCT03310372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014130|NCT03310372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102014131|NCT03108664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102014132|NCT03108664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102014133|NCT01342614|Metformin|metformin|mesh-list
102014134|NCT01342614|Fosinopril|fosinopril|mesh-list
102014135|NCT01342614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102014136|NCT01342614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014137|NCT01342614|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102014138|NCT01342614|Protease Inhibitors|protease inhibitors|mesh-ancestor
102014139|NCT01342614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102014140|NCT01342614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014141|NCT01342614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102014142|NCT01342692|Lenalidomide|lenalidomide|mesh-list
102014143|NCT01342692|Azacitidine|azacitidine|mesh-list
102014144|NCT01342692|Idarubicin|idarubicin|mesh-list
102014145|NCT01342692|Valproic Acid|valproic acid|mesh-list
102014146|NCT01342692|Immunologic Factors|immunologic factors|mesh-ancestor
102014147|NCT01342692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014148|NCT01342692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102014149|NCT01342692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102014150|NCT01342692|Growth Substances|growth substances|mesh-ancestor
102014151|NCT01342692|Growth Inhibitors|growth inhibitors|mesh-ancestor
102014152|NCT01342692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102014153|NCT01342692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102014154|NCT01342692|Antimetabolites|antimetabolites|mesh-ancestor
102014155|NCT01342692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014156|NCT01342692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102014157|NCT01342692|Anticonvulsants|anticonvulsants|mesh-ancestor
102014158|NCT01342692|GABA Agents|gaba agents|mesh-ancestor
102014159|NCT01342692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102014160|NCT01342692|Antimanic Agents|antimanic agents|mesh-ancestor
102014161|NCT01342692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102014162|NCT01342692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102014163|NCT01342692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102014164|NCT01342692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102014165|NCT01342692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102014166|NCT01342692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102014167|NCT05153772|Octreotide|octreotide|mesh-list
102014168|NCT05153772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102014169|NCT05153772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102014170|NCT05153772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102014171|NCT03310060|Tranexamic Acid|tranexamic acid|mesh-list
102014172|NCT03310060|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102014173|NCT03310060|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102014174|NCT03310060|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102014175|NCT03310060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014176|NCT03310060|Hemostatics|hemostatics|mesh-ancestor
102014177|NCT03310060|Coagulants|coagulants|mesh-ancestor
102014178|NCT03740958|Argatroban|argatroban|mesh-list
102014179|NCT03740958|Antithrombins|antithrombins|mesh-ancestor
102014180|NCT03740958|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102014181|NCT03740958|Protease Inhibitors|protease inhibitors|mesh-ancestor
102014182|NCT03740958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102014183|NCT03740958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014184|NCT03740958|Anticoagulants|anticoagulants|mesh-ancestor
102014185|NCT03740958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102014186|NCT01340820|BCG Vaccine|bcg vaccine|mesh-list
102014187|NCT01340820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102014188|NCT01340820|Immunologic Factors|immunologic factors|mesh-ancestor
102014189|NCT01340820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014190|NCT03685188|Sufentanil|sufentanil|mesh-list
102014191|NCT03685188|Oxycodone|oxycodone|mesh-list
102014192|NCT03685188|Dsuvia|dsuvia|mesh-list
102014196|NCT03685188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014197|NCT03685188|Analgesics|analgesics|mesh-ancestor
101949868|NCT04633148|Cyclophosphamide|cyclophosphamide|mesh-list
101949869|NCT04633148|Fludarabine|fludarabine|mesh-list
101949870|NCT04633148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101949871|NCT04633148|Immunologic Factors|immunologic factors|mesh-ancestor
101949872|NCT04633148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949873|NCT04633148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102014198|NCT03685188|Sensory System Agents|sensory system agents|mesh-ancestor
102014199|NCT03685188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102014200|NCT03685188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102014201|NCT03685188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102014202|NCT03685188|Anesthetics, General|anesthetics, general|mesh-ancestor
102014203|NCT03685188|Anesthetics|anesthetics|mesh-ancestor
102014205|NCT02305654|Ifosfamide|ifosfamide|mesh-list
102014206|NCT02305654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102014207|NCT02305654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102014208|NCT02305654|Tubulin Modulators|tubulin modulators|mesh-ancestor
102014209|NCT02305654|Antimitotic Agents|antimitotic agents|mesh-ancestor
102014210|NCT02305654|Mitosis Modulators|mitosis modulators|mesh-ancestor
102014211|NCT02305654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014212|NCT02305654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102014213|NCT02305654|Alkylating Agents|alkylating agents|mesh-ancestor
102014214|NCT05251584|Gentamicins|gentamicins|mesh-list
102014215|NCT05251584|Mupirocin|mupirocin|mesh-list
102014216|NCT05251584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102014217|NCT05251584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102014218|NCT05251584|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102014219|NCT05251584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102014220|NCT05251584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014221|NCT03309748|Anti-Infective Agents|anti-infective agents|mesh-list
102014222|NCT03309748|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102014223|NCT00705250|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102014224|NCT00705250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102014225|NCT00705250|Alkylating Agents|alkylating agents|mesh-ancestor
102014226|NCT00705250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014227|NCT00705250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102014228|NCT03309592|Ambrisentan|ambrisentan|mesh-list
102014229|NCT03309592|Tadalafil|tadalafil|mesh-list
102014230|NCT03309592|Vasodilator Agents|vasodilator agents|mesh-ancestor
102014231|NCT03309592|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102014232|NCT03309592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102014233|NCT03309592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102014234|NCT03309592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014235|NCT03309592|Urological Agents|urological agents|mesh-ancestor
102014236|NCT03309592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102014237|NCT04641312|Dulaglutide|dulaglutide|mesh-list
102014238|NCT04641312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102014239|NCT04641312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014241|NCT03078192|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102014242|NCT03078192|Anesthetics, General|anesthetics, general|mesh-ancestor
102014243|NCT03078192|Anesthetics|anesthetics|mesh-ancestor
102014244|NCT03078192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102014245|NCT03078192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014246|NCT00703846|Ketoconazole|ketoconazole|mesh-list
102014247|NCT00703846|Antifungal Agents|antifungal agents|mesh-ancestor
102014248|NCT00703846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102014249|NCT00703846|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102014250|NCT00703846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102014252|NCT00703846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014253|NCT00703846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102014254|NCT00703846|Hormone Antagonists|hormone antagonists|mesh-ancestor
102014255|NCT00703846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102014256|NCT00703846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014257|NCT00703846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102014258|NCT03309436|Clomiphene|clomiphene|mesh-list
102014259|NCT03309436|Enclomiphene|enclomiphene|mesh-list
102014260|NCT03309436|Zuclomiphene|zuclomiphene|mesh-list
102014261|NCT03309436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102014262|NCT03309436|Hormone Antagonists|hormone antagonists|mesh-ancestor
101949874|NCT04633148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101949875|NCT04633148|Alkylating Agents|alkylating agents|mesh-ancestor
102014263|NCT03309436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102014264|NCT03309436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014289|NCT03304444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014290|NCT03304444|Sensory System Agents|sensory system agents|mesh-ancestor
102014291|NCT03304444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102014293|NCT03304288|Tretinoin|tretinoin|mesh-list
102014294|NCT03304288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102014295|NCT03304288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102014296|NCT03304288|Immunologic Factors|immunologic factors|mesh-ancestor
102014297|NCT03304288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014298|NCT03304288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102014299|NCT03304288|Keratolytic Agents|keratolytic agents|mesh-ancestor
102014300|NCT03304288|Dermatologic Agents|dermatologic agents|mesh-ancestor
102014301|NCT03304210|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102014302|NCT03304210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102014303|NCT03313960|Insulin|insulin|mesh-list
102014304|NCT03313960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102014305|NCT03313960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014306|NCT03308890|Entecavir|entecavir|mesh-list
102014307|NCT03308890|Antiviral Agents|antiviral agents|mesh-ancestor
102014308|NCT03308890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102014309|NCT03313726|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
102014310|NCT03313726|Hormones|hormones|mesh-ancestor
102014311|NCT03313726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102014312|NCT03313726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014313|NCT03303976|Vaccines|vaccines|mesh-list
102014314|NCT03303976|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102014322|NCT02468518|Vitamin E|vitamin e|mesh-list
102014323|NCT02468518|Vitamins|vitamins|mesh-ancestor
101734062|NCT02595840|Pemetrexed|pemetrexed|mesh-list
102014324|NCT02468518|Micronutrients|micronutrients|mesh-ancestor
102014325|NCT02468518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014326|NCT02468518|Antioxidants|antioxidants|mesh-ancestor
102014327|NCT02468518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014328|NCT02468518|Protective Agents|protective agents|mesh-ancestor
102014329|NCT03313336|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
102014330|NCT03313336|Anesthetics, Local|anesthetics, local|mesh-ancestor
102014331|NCT03313336|Anesthetics|anesthetics|mesh-ancestor
102014332|NCT03313336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102014333|NCT03313336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014334|NCT03313336|Sensory System Agents|sensory system agents|mesh-ancestor
102014335|NCT03313336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102014336|NCT03313336|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
102014337|NCT05262322|Rivaroxaban|rivaroxaban|mesh-list
102014339|NCT05262322|Edoxaban|edoxaban|mesh-list
102014340|NCT05262322|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102014341|NCT05262322|Antithrombins|antithrombins|mesh-ancestor
102014342|NCT05262322|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102014343|NCT05262322|Protease Inhibitors|protease inhibitors|mesh-ancestor
102014344|NCT05262322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102014345|NCT05262322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014346|NCT05262322|Anticoagulants|anticoagulants|mesh-ancestor
102014347|NCT04490980|Butorphanol|butorphanol|mesh-list
102014348|NCT04490980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102014349|NCT04490980|Narcotics|narcotics|mesh-ancestor
102014350|NCT04490980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102014351|NCT04490980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014352|NCT04490980|Analgesics|analgesics|mesh-ancestor
102014353|NCT04490980|Sensory System Agents|sensory system agents|mesh-ancestor
102014354|NCT04490980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102014355|NCT04490980|Antitussive Agents|antitussive agents|mesh-ancestor
102014356|NCT04490980|Respiratory System Agents|respiratory system agents|mesh-ancestor
102014357|NCT04490980|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102014358|NCT03307720|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102014359|NCT03307720|Hormones|hormones|mesh-list
102014360|NCT03307720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102014361|NCT03307720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014362|NCT03307720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102014363|NCT04608786|Capecitabine|capecitabine|mesh-list
101949876|NCT04633148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949877|NCT04633148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949878|NCT04633148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101949879|NCT04630730|Gemcitabine|gemcitabine|mesh-list
101949880|NCT04630730|Atezolizumab|atezolizumab|mesh-list
101949881|NCT04630730|BCG Vaccine|bcg vaccine|mesh-list
101276157|NCT01867892|Vitamins|vitamins|mesh-ancestor
102014364|NCT04608786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102014365|NCT04608786|Antimetabolites|antimetabolites|mesh-ancestor
102014366|NCT04608786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014367|NCT04608786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102014368|NCT01314872|Tolterodine Tartrate|tolterodine tartrate|mesh-list
102014369|NCT01314872|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102014370|NCT01314872|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102014371|NCT01314872|Cholinergic Agents|cholinergic agents|mesh-ancestor
102014372|NCT01314872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102014373|NCT01314872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014374|NCT01314872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014375|NCT01314872|Urological Agents|urological agents|mesh-ancestor
102014376|NCT01343628|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102014377|NCT01343628|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102014378|NCT01343628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102014379|NCT01343628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102014380|NCT01343628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014381|NCT01343628|Adrenergic Agents|adrenergic agents|mesh-ancestor
101469343|NCT00283218|Insulin Aspart|insulin aspart|mesh-list
102014389|NCT03302650|Norepinephrine|norepinephrine|mesh-list
102014390|NCT03302650|Angiotensin II|angiotensin ii|mesh-list
102014391|NCT03302650|Giapreza|giapreza|mesh-list
102014392|NCT03302650|Angiotensinogen|angiotensinogen|mesh-list
102014393|NCT03302650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102014394|NCT03302650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102014395|NCT03302650|Adrenergic Agents|adrenergic agents|mesh-ancestor
102014396|NCT03302650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101520751|NCT01237678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102014397|NCT03302650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014398|NCT03302650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014400|NCT03302650|Autonomic Agents|autonomic agents|mesh-ancestor
102014401|NCT03302650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102014402|NCT03302650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102014403|NCT03302650|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102014404|NCT03302650|Protease Inhibitors|protease inhibitors|mesh-ancestor
102014405|NCT03302650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102014406|NCT01343706|BI 409306|bi 409306|mesh-list
102014407|NCT01343706|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102014408|NCT01343706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102014409|NCT01343706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014410|NCT03312478|Antibodies|antibodies|mesh-list
102014411|NCT03312478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014412|NCT03312478|Immunologic Factors|immunologic factors|mesh-ancestor
102014413|NCT03312244|Bromides|bromides|mesh-list
102014414|NCT03312244|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
102014415|NCT03312244|Anticonvulsants|anticonvulsants|mesh-ancestor
102014416|NCT03312244|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102014417|NCT03312244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102014418|NCT03312244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014419|NCT03312244|Cholinergic Agents|cholinergic agents|mesh-ancestor
102014420|NCT03312244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102014421|NCT03312244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014422|NCT03306940|Botulinum Toxins|botulinum toxins|mesh-list
102014423|NCT03306940|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102014424|NCT03306940|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102014425|NCT03306940|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102014426|NCT03306940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102014427|NCT03306940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014428|NCT03306940|Cholinergic Agents|cholinergic agents|mesh-ancestor
102014429|NCT03306940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102014430|NCT03306940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014431|NCT03306940|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101949882|NCT04630730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949883|NCT04630730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101949884|NCT04630730|Antimetabolites|antimetabolites|mesh-ancestor
101949885|NCT04630730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949886|NCT04630730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101949887|NCT04630730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101949888|NCT04630730|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101949889|NCT04630730|Immunologic Factors|immunologic factors|mesh-ancestor
101949890|NCT04630730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949891|NCT04628767|Cisplatin|cisplatin|mesh-list
101949892|NCT04628767|Gemcitabine|gemcitabine|mesh-list
101949893|NCT04628767|Doxorubicin|doxorubicin|mesh-list
101949894|NCT04628767|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101949895|NCT04628767|Methotrexate|methotrexate|mesh-list
101949896|NCT04628767|Durvalumab|durvalumab|mesh-list
101949897|NCT04628767|Vinblastine|vinblastine|mesh-list
101949898|NCT04628767|Lenograstim|lenograstim|mesh-list
101949899|NCT04628767|Immunoglobulins|immunoglobulins|mesh-list
101949901|NCT04628767|Immunoglobulin G|immunoglobulin g|mesh-list
101949902|NCT04628767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949903|NCT04628767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101949904|NCT04628767|Antimetabolites|antimetabolites|mesh-ancestor
101949905|NCT04628767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949906|NCT04628767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101949907|NCT04628767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101949908|NCT04628767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101949909|NCT04628767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101949910|NCT04628767|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101949911|NCT04628767|Abortifacient Agents|abortifacient agents|mesh-ancestor
102014432|NCT03306940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102014433|NCT00739050|Simvastatin|simvastatin|mesh-list
102014434|NCT00739050|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102014435|NCT00739050|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102014436|NCT00739050|Antimetabolites|antimetabolites|mesh-ancestor
102014437|NCT00739050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014438|NCT00739050|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102014439|NCT00739050|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102014440|NCT00739050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102014441|NCT03302182|Ritonavir|ritonavir|mesh-list
102014442|NCT03302182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102014443|NCT03302182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102014444|NCT03302182|Protease Inhibitors|protease inhibitors|mesh-ancestor
102014445|NCT03302182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102014446|NCT03302182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014447|NCT03302182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102014448|NCT03302182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102014449|NCT03302182|Antiviral Agents|antiviral agents|mesh-ancestor
101949912|NCT04628767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101949913|NCT04628767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014450|NCT03302182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101469411|NCT00244361|Rituximab|rituximab|mesh-list
102014453|NCT01343862|Cycloserine|cycloserine|mesh-list
102014454|NCT01343862|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102014455|NCT01343862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102014456|NCT01343862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102014457|NCT01343862|Antitubercular Agents|antitubercular agents|mesh-ancestor
102014458|NCT01343862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102014459|NCT01343862|Antimetabolites|antimetabolites|mesh-ancestor
102014460|NCT01343862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014461|NCT03311932|Hydrocortisone|hydrocortisone|mesh-list
102014462|NCT03311932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102014463|NCT00604812|Rizatriptan|rizatriptan|mesh-list
102014464|NCT00604812|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102014465|NCT00604812|Serotonin Agents|serotonin agents|mesh-ancestor
102014466|NCT00604812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101520799|NCT01237327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014467|NCT00604812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014468|NCT00604812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014469|NCT04347408|Antibodies|antibodies|mesh-list
102014470|NCT04347408|Immunologic Factors|immunologic factors|mesh-ancestor
102014471|NCT04347408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014472|NCT03306550|Aspirin|aspirin|mesh-list
102014473|NCT03306550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102014474|NCT03306550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102014475|NCT03306550|Analgesics|analgesics|mesh-ancestor
102014476|NCT03306550|Sensory System Agents|sensory system agents|mesh-ancestor
102014477|NCT03306550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102014478|NCT03306550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014479|NCT03306550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102014480|NCT03306550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102014481|NCT03306550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102014482|NCT03306550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102014483|NCT03306550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014484|NCT03306550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102014485|NCT03306550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102014486|NCT03306550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102014487|NCT03306550|Antipyretics|antipyretics|mesh-ancestor
102014488|NCT03306472|Letrozole|letrozole|mesh-list
102014489|NCT03306472|Megestrol|megestrol|mesh-list
102014490|NCT03306472|Megestrol Acetate|megestrol acetate|mesh-list
102014491|NCT03306472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102014492|NCT03306472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102014493|NCT03306472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102014494|NCT03306472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102014495|NCT03306472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014496|NCT03306472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102014497|NCT03306472|Hormone Antagonists|hormone antagonists|mesh-ancestor
102014498|NCT03306472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102014499|NCT03306472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014500|NCT03306472|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102014501|NCT03306472|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102014502|NCT03306472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102014503|NCT03306472|Contraceptive Agents|contraceptive agents|mesh-ancestor
101520826|NCT04647695|Immunologic Factors|immunologic factors|mesh-ancestor
102014504|NCT03306472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102014505|NCT03306472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102014506|NCT03306472|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102014507|NCT03306472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102014508|NCT03306472|Appetite Stimulants|appetite stimulants|mesh-ancestor
102014509|NCT03306472|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102014510|NCT03311542|Pembrolizumab|pembrolizumab|mesh-list
102014511|NCT03311542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102014512|NCT03311542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102014513|NCT03311542|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102014514|NCT03311542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014515|NCT03311464|Adalimumab|adalimumab|mesh-list
102014516|NCT03311464|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102014517|NCT03311464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102014518|NCT03311464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102014519|NCT05214066|Thymoglobulin|thymoglobulin|mesh-list
102014520|NCT05214066|Immunologic Factors|immunologic factors|mesh-ancestor
101949914|NCT04628767|Dermatologic Agents|dermatologic agents|mesh-ancestor
101949915|NCT04628767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101949916|NCT04628767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101949917|NCT04628767|Immunologic Factors|immunologic factors|mesh-ancestor
101276340|NCT01869556|Ergonovine|ergonovine|mesh-list
102014521|NCT05214066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014525|NCT02468206|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102014526|NCT01344174|Lamivudine|lamivudine|mesh-list
102014527|NCT01344174|Dexamethasone|dexamethasone|mesh-list
102014528|NCT01344174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102014529|NCT01344174|Antiemetics|antiemetics|mesh-ancestor
102014530|NCT01344174|Autonomic Agents|autonomic agents|mesh-ancestor
102014531|NCT01344174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102014532|NCT01344174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014533|NCT01344174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102014534|NCT01344174|Glucocorticoids|glucocorticoids|mesh-ancestor
102014535|NCT01344174|Hormones|hormones|mesh-ancestor
102014536|NCT01344174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102014537|NCT01344174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102014538|NCT01344174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102014539|NCT01344174|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102014540|NCT01344174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102014541|NCT01344174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102014542|NCT01344174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014543|NCT01344174|Antiviral Agents|antiviral agents|mesh-ancestor
102014544|NCT01344174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102014545|NCT01344174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101734282|NCT00729183|Vitamin D|vitamin d|mesh-list
102014546|NCT01344174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102014547|NCT05162274|Lazertinib|lazertinib|mesh-list
102014548|NCT05162274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102014549|NCT05162274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102014550|NCT05162274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014551|NCT03023566|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
102014552|NCT03023566|Chelating Agents|chelating agents|mesh-ancestor
102014553|NCT03023566|Sequestering Agents|sequestering agents|mesh-ancestor
102014554|NCT03023566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014555|NCT03311386|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102014556|NCT03311386|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102014557|NCT03311386|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102014558|NCT03311386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014559|NCT02468908|Molgramostim|molgramostim|mesh-list
102014560|NCT02468908|Sargramostim|sargramostim|mesh-list
102014561|NCT02468908|Immunologic Factors|immunologic factors|mesh-ancestor
102014562|NCT02468908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014563|NCT02468908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102014564|NCT02468128|Nalbuphine|nalbuphine|mesh-list
102014565|NCT02468128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102014566|NCT02468128|Narcotics|narcotics|mesh-ancestor
102014567|NCT02468128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102014568|NCT02468128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014569|NCT02468128|Analgesics|analgesics|mesh-ancestor
102014570|NCT02468128|Sensory System Agents|sensory system agents|mesh-ancestor
102014571|NCT02468128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102014572|NCT03305536|Vitamin D|vitamin d|mesh-list
102014573|NCT03305536|Vitamins|vitamins|mesh-list
102014574|NCT03305536|Vitamin K|vitamin k|mesh-list
102014575|NCT03305536|Vitamin K 2|vitamin k 2|mesh-list
102014576|NCT03305536|Menaquinone 7|menaquinone 7|mesh-list
102014577|NCT03305536|Micronutrients|micronutrients|mesh-ancestor
102014578|NCT03305536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014579|NCT03305536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102014580|NCT03305536|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102014581|NCT03305536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102014582|NCT03305536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014583|NCT03305536|Hemostatics|hemostatics|mesh-ancestor
102014584|NCT03305536|Coagulants|coagulants|mesh-ancestor
102014585|NCT03210688|Alfacalcidol|alfacalcidol|mesh-list
102014586|NCT03210688|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
102014587|NCT03210688|Prednisone|prednisone|mesh-list
102014588|NCT03210688|Prednisolone|prednisolone|mesh-list
102014589|NCT03210688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101949918|NCT04628767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101949919|NCT04628767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101949920|NCT04628767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101949921|NCT04628767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102014591|NCT03210688|Hormones|hormones|mesh-ancestor
102014592|NCT03210688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102014593|NCT03210688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469544|NCT00244907|Risedronic Acid|risedronic acid|mesh-list
102014596|NCT03210688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102014598|NCT03210688|Micronutrients|micronutrients|mesh-ancestor
102014599|NCT02467426|Mitoxantrone|mitoxantrone|mesh-list
102014600|NCT02467426|Analgesics|analgesics|mesh-ancestor
102014601|NCT02467426|Sensory System Agents|sensory system agents|mesh-ancestor
102014602|NCT02467426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102014603|NCT02467426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014604|NCT02467426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102014605|NCT02467426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102014606|NCT02467426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102014607|NCT02467426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102014608|NCT02467426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014609|NCT04296942|Trastuzumab|trastuzumab|mesh-list
102014610|NCT04296942|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102014611|NCT04296942|Maytansine|maytansine|mesh-list
102014612|NCT04296942|Entinostat|entinostat|mesh-list
102014613|NCT04296942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102014614|NCT04296942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102014615|NCT04296942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102014616|NCT04296942|Tubulin Modulators|tubulin modulators|mesh-ancestor
102014617|NCT04296942|Antimitotic Agents|antimitotic agents|mesh-ancestor
102014618|NCT04296942|Mitosis Modulators|mitosis modulators|mesh-ancestor
102014619|NCT04296942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014620|NCT04296942|Immunotoxins|immunotoxins|mesh-ancestor
102014621|NCT04296942|Immunoconjugates|immunoconjugates|mesh-ancestor
102014622|NCT04296942|Immunologic Factors|immunologic factors|mesh-ancestor
102014623|NCT04296942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014624|NCT04296942|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102014625|NCT04296942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102014626|NCT01344564|Leuprolide|leuprolide|mesh-list
102014627|NCT01344564|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102014628|NCT01344564|Fertility Agents|fertility agents|mesh-ancestor
102014629|NCT01344564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102014630|NCT01344564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014631|NCT01344564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102014632|NCT01344564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102014633|NCT01344720|Etoricoxib|etoricoxib|mesh-list
102014634|NCT01344720|Oxycodone|oxycodone|mesh-list
102014635|NCT01344720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102014636|NCT01344720|Narcotics|narcotics|mesh-ancestor
102014637|NCT01344720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102014638|NCT01344720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014639|NCT01344720|Analgesics|analgesics|mesh-ancestor
102014640|NCT01344720|Sensory System Agents|sensory system agents|mesh-ancestor
102014641|NCT01344720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102014642|NCT01344720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102014643|NCT01344720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102014644|NCT01344720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102014645|NCT01344720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102014646|NCT01344720|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102014647|NCT01344720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102014648|NCT01344720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102014649|NCT01344720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014650|NCT03220854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102014651|NCT03220854|Antibodies|antibodies|mesh-list
102014652|NCT03220854|Immunoglobulins|immunoglobulins|mesh-list
102014653|NCT03220854|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102014654|NCT03220854|Immunologic Factors|immunologic factors|mesh-ancestor
102014655|NCT03220854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014656|NCT03220854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102014657|NCT03305068|Celecoxib|celecoxib|mesh-list
101737366|NCT02584881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101949922|NCT04628767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101949924|NCT04628767|Antimitotic Agents|antimitotic agents|mesh-ancestor
102014658|NCT03305068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102014659|NCT03305068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102014660|NCT03305068|Analgesics|analgesics|mesh-ancestor
102014661|NCT03305068|Sensory System Agents|sensory system agents|mesh-ancestor
102014662|NCT03305068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102014663|NCT03305068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014664|NCT03305068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102014665|NCT03305068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102014666|NCT03305068|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102014669|NCT03305068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014671|NCT04490590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102014672|NCT04490590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102014673|NCT04490590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102014674|NCT04490590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102014675|NCT04490590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102014676|NCT04490590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014677|NCT03299998|Anesthetics|anesthetics|mesh-list
102014678|NCT03299998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102014679|NCT03299998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014680|NCT03299842|Fenfluramine|fenfluramine|mesh-list
102014681|NCT03299842|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102014682|NCT03299842|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102014683|NCT03299842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102014684|NCT03299842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014685|NCT03299842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102014686|NCT03299842|Serotonin Agents|serotonin agents|mesh-ancestor
102014687|NCT03299842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014688|NCT02720536|Deferasirox|deferasirox|mesh-list
102014689|NCT02720536|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102014690|NCT02720536|Chelating Agents|chelating agents|mesh-ancestor
102014691|NCT02720536|Sequestering Agents|sequestering agents|mesh-ancestor
102014692|NCT02720536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014693|NCT03168438|Cyclophosphamide|cyclophosphamide|mesh-list
102014694|NCT03168438|Pembrolizumab|pembrolizumab|mesh-list
102014695|NCT03168438|Fludarabine|fludarabine|mesh-list
102014696|NCT03168438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102014697|NCT03168438|Immunologic Factors|immunologic factors|mesh-ancestor
102014698|NCT03168438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014699|NCT03168438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101521007|NCT04681911|Paclitaxel|paclitaxel|mesh-list
102014700|NCT03168438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102014701|NCT03168438|Alkylating Agents|alkylating agents|mesh-ancestor
102014702|NCT03168438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014703|NCT03168438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102014704|NCT03168438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102014705|NCT03168438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102014706|NCT03168438|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102014708|NCT03299296|Rivaroxaban|rivaroxaban|mesh-list
102014709|NCT03299296|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102014710|NCT03299296|Antithrombins|antithrombins|mesh-ancestor
102014711|NCT03299296|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102014712|NCT03299296|Protease Inhibitors|protease inhibitors|mesh-ancestor
102014713|NCT03299296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102014714|NCT03299296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014715|NCT03299296|Anticoagulants|anticoagulants|mesh-ancestor
102014716|NCT03299296|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102014717|NCT03299296|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102014718|NCT03137784|Glycopyrrolate|glycopyrrolate|mesh-list
102014719|NCT03137784|Bromides|bromides|mesh-list
102014720|NCT03137784|Anticonvulsants|anticonvulsants|mesh-ancestor
102014721|NCT03137784|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102014722|NCT03137784|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102014723|NCT03137784|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102014724|NCT03137784|Cholinergic Agents|cholinergic agents|mesh-ancestor
102014725|NCT03137784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102014726|NCT03137784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014727|NCT03137784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014728|NCT01344954|Rivaroxaban|rivaroxaban|mesh-list
101949925|NCT04628767|Mitosis Modulators|mitosis modulators|mesh-ancestor
101949926|NCT04624633|Acalabrutinib|acalabrutinib|mesh-list
102014729|NCT01344954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102014730|NCT01344954|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102014731|NCT01344954|Antithrombins|antithrombins|mesh-ancestor
102014732|NCT01344954|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102014733|NCT01344954|Protease Inhibitors|protease inhibitors|mesh-ancestor
102014734|NCT01344954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102014735|NCT01344954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014736|NCT01344954|Anticoagulants|anticoagulants|mesh-ancestor
102014737|NCT01344954|Immunologic Factors|immunologic factors|mesh-ancestor
102014738|NCT01344954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014740|NCT01347996|Histamine|histamine|mesh-list
102014741|NCT01347996|Histamine phosphate|histamine phosphate|mesh-list
102014742|NCT01347996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102014743|NCT01347996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102014744|NCT01347996|Analgesics|analgesics|mesh-ancestor
102014745|NCT01347996|Sensory System Agents|sensory system agents|mesh-ancestor
102014746|NCT01347996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102014747|NCT01347996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014748|NCT01347996|Histamine Agonists|histamine agonists|mesh-ancestor
102014749|NCT01347996|Histamine Agents|histamine agents|mesh-ancestor
102014750|NCT01347996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102014751|NCT01347996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014752|NCT01352988|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102014753|NCT01352988|Dermatologic Agents|dermatologic agents|mesh-ancestor
102014754|NCT01352988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102014755|NCT01352988|Immunologic Factors|immunologic factors|mesh-ancestor
102014756|NCT01352988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014757|NCT02466802|Sildenafil Citrate|sildenafil citrate|mesh-list
101521039|NCT02905305|Dexamethasone|dexamethasone|mesh-list
102014758|NCT02466802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014759|NCT02466802|Vasodilator Agents|vasodilator agents|mesh-ancestor
102014760|NCT02466802|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102014761|NCT02466802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102014762|NCT02466802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102014763|NCT02466802|Urological Agents|urological agents|mesh-ancestor
102014764|NCT01348308|Maraviroc|maraviroc|mesh-list
102014765|NCT01348308|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102014766|NCT01348308|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102014767|NCT01348308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014768|NCT01348308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102014769|NCT01348308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102014770|NCT01348308|Antiviral Agents|antiviral agents|mesh-ancestor
102014771|NCT01348308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102014772|NCT01348308|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102014773|NCT04074174|Acetaminophen|acetaminophen|mesh-list
102014774|NCT04074174|Contraceptive Agents|contraceptive agents|mesh-list
102014775|NCT04074174|Contraceptives, Oral|contraceptives, oral|mesh-list
102014776|NCT04074174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102014777|NCT04074174|Analgesics|analgesics|mesh-ancestor
102014778|NCT04074174|Sensory System Agents|sensory system agents|mesh-ancestor
102014779|NCT04074174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102014780|NCT04074174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014781|NCT04074174|Antipyretics|antipyretics|mesh-ancestor
102014782|NCT04074174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102014783|NCT04074174|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102014784|NCT04752826|Pembrolizumab|pembrolizumab|mesh-list
102014785|NCT04752826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102014786|NCT04752826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102014787|NCT04752826|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102014788|NCT04752826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014789|NCT03620292|Bevacizumab|bevacizumab|mesh-list
102014790|NCT03620292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102014791|NCT03620292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102014792|NCT03620292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102014793|NCT03620292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102014794|NCT03620292|Growth Substances|growth substances|mesh-ancestor
102014795|NCT03620292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014796|NCT03620292|Growth Inhibitors|growth inhibitors|mesh-ancestor
102014797|NCT01353378|Dexmedetomidine|dexmedetomidine|mesh-list
102014798|NCT01353378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102014799|NCT01353378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102014800|NCT01353378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949927|NCT04624633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949928|NCT04597125|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
101949929|NCT04597125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949931|NCT04576455|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101949932|NCT04576455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102014801|NCT01353378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102014802|NCT01353378|Analgesics|analgesics|mesh-ancestor
102014803|NCT01353378|Sensory System Agents|sensory system agents|mesh-ancestor
102014804|NCT01353378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102014805|NCT01353378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102014806|NCT01353378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102014807|NCT01353378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102014808|NCT01353378|Adrenergic Agents|adrenergic agents|mesh-ancestor
102014809|NCT01353378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102014810|NCT01353378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014811|NCT05245006|Antibodies|antibodies|mesh-list
102014812|NCT05245006|Immunoglobulins|immunoglobulins|mesh-list
102014817|NCT01465334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102014818|NCT01465334|Prednisolone|prednisolone|mesh-list
102014819|NCT01465334|Prednisolone acetate|prednisolone acetate|mesh-list
102014820|NCT01465334|Alemtuzumab|alemtuzumab|mesh-list
102014821|NCT01465334|Ofatumumab|ofatumumab|mesh-list
102014822|NCT01465334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102014823|NCT01465334|Prednisolone phosphate|prednisolone phosphate|mesh-list
102014824|NCT01465334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102014825|NCT01465334|Antiemetics|antiemetics|mesh-ancestor
102014826|NCT01465334|Autonomic Agents|autonomic agents|mesh-ancestor
102014827|NCT01465334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102014828|NCT01465334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014829|NCT01465334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102014830|NCT01465334|Glucocorticoids|glucocorticoids|mesh-ancestor
102014831|NCT01465334|Hormones|hormones|mesh-ancestor
102014832|NCT01465334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102014833|NCT01465334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102014834|NCT01465334|Protective Agents|protective agents|mesh-ancestor
102014835|NCT01465334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102014836|NCT01465334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102014837|NCT01465334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102014838|NCT04019262|Temozolomide|temozolomide|mesh-list
102014839|NCT04019262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102014840|NCT04019262|Alkylating Agents|alkylating agents|mesh-ancestor
102014841|NCT04019262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014842|NCT04019262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102014843|NCT05549726|Cabotegravir|cabotegravir|mesh-list
102014844|NCT05549726|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102014845|NCT05549726|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102014846|NCT05549726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102014847|NCT05549726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014848|NCT05549726|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102014849|NCT05549726|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102014850|NCT05549726|Antiviral Agents|antiviral agents|mesh-ancestor
102014851|NCT05549726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102014852|NCT01353456|Dexmedetomidine|dexmedetomidine|mesh-list
102014853|NCT01353456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102014854|NCT01353456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102014855|NCT01353456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014856|NCT01353456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102014857|NCT01353456|Analgesics|analgesics|mesh-ancestor
102014858|NCT01353456|Sensory System Agents|sensory system agents|mesh-ancestor
102014859|NCT01353456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102014860|NCT01353456|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102014861|NCT01353456|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102014862|NCT01353456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102014863|NCT01353456|Adrenergic Agents|adrenergic agents|mesh-ancestor
102014864|NCT01353456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102014865|NCT01353456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014866|NCT04289142|Dexmedetomidine|dexmedetomidine|mesh-list
102014867|NCT04289142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101949933|NCT04576455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949934|NCT04576455|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101949935|NCT04576455|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101949936|NCT04576455|Hormone Antagonists|hormone antagonists|mesh-ancestor
101276692|NCT01871454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102014868|NCT04289142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102014869|NCT04289142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014870|NCT04289142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102014871|NCT04289142|Analgesics|analgesics|mesh-ancestor
102014872|NCT04289142|Sensory System Agents|sensory system agents|mesh-ancestor
102014873|NCT04289142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102014874|NCT04289142|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102014875|NCT04289142|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102014876|NCT04289142|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102014877|NCT04289142|Adrenergic Agents|adrenergic agents|mesh-ancestor
102014878|NCT04289142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102014879|NCT04289142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014880|NCT04948814|Vancomycin|vancomycin|mesh-list
102014881|NCT04948814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102014882|NCT04948814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102014891|NCT05726734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102014892|NCT05726734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102014893|NCT05726734|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102014894|NCT05726734|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102014895|NCT05726734|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102014896|NCT05726734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102014897|NCT05726734|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102014898|NCT05726734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102014899|NCT05726734|Antacids|antacids|mesh-ancestor
102014900|NCT05726734|Diuretics|diuretics|mesh-ancestor
102014901|NCT05726734|Natriuretic Agents|natriuretic agents|mesh-ancestor
102014902|NCT05726734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014903|NCT05726734|Expectorants|expectorants|mesh-ancestor
102014904|NCT05726734|Respiratory System Agents|respiratory system agents|mesh-ancestor
102014905|NCT01317966|Rituximab|rituximab|mesh-list
102014906|NCT01317966|Oprelvekin|oprelvekin|mesh-list
102014907|NCT01317966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102014908|NCT01317966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102014909|NCT01317966|Immunologic Factors|immunologic factors|mesh-ancestor
102014910|NCT01317966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014911|NCT01317966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102014912|NCT01345734|Liraglutide|liraglutide|mesh-list
102014913|NCT01345734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102014914|NCT01345734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014915|NCT01345734|Incretins|incretins|mesh-ancestor
102014916|NCT01345734|Hormones|hormones|mesh-ancestor
102014917|NCT01345734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102014918|NCT04674670|Naltrexone|naltrexone|mesh-list
102014919|NCT04674670|Bromocriptine|bromocriptine|mesh-list
102014920|NCT04674670|Amisulpride|amisulpride|mesh-list
102014921|NCT04674670|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102014922|NCT04674670|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102014923|NCT04674670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014924|NCT04674670|Sensory System Agents|sensory system agents|mesh-ancestor
102014925|NCT04674670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102014926|NCT04674670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102014927|NCT04674670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102014928|NCT04674670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102014929|NCT04674670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102014930|NCT04674670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102014931|NCT04674670|Dopamine Agents|dopamine agents|mesh-ancestor
102014932|NCT04674670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102014933|NCT04674670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014934|NCT04674670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102014935|NCT04674670|Antidepressive Agents|antidepressive agents|mesh-ancestor
102014936|NCT04674670|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102014937|NCT04674670|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102014938|NCT04674670|Hormone Antagonists|hormone antagonists|mesh-ancestor
102014939|NCT04674670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102014940|NCT04674670|Dopamine Agonists|dopamine agonists|mesh-ancestor
102014941|NCT01318044|Thiopental|thiopental|mesh-list
101949937|NCT04576455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101949938|NCT04576455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949939|NCT04576455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102014943|NCT01318044|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102014944|NCT01318044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102014945|NCT01318044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014946|NCT01318044|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102014947|NCT01318044|Anesthetics, General|anesthetics, general|mesh-ancestor
102014948|NCT01318044|Anesthetics|anesthetics|mesh-ancestor
102014949|NCT01318044|Anticonvulsants|anticonvulsants|mesh-ancestor
102014950|NCT01318044|GABA Modulators|gaba modulators|mesh-ancestor
102014951|NCT01318044|GABA Agents|gaba agents|mesh-ancestor
102014952|NCT01318044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102014953|NCT01318044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014957|NCT01353846|Estradiol|estradiol|mesh-list
102014958|NCT01353846|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102014959|NCT01353846|Progesterone|progesterone|mesh-list
102014960|NCT01353846|Estrogens|estrogens|mesh-ancestor
102014961|NCT01353846|Hormones|hormones|mesh-ancestor
102014962|NCT01353846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102014963|NCT01353846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014964|NCT01353846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102014965|NCT01353846|Contraceptive Agents|contraceptive agents|mesh-ancestor
102014966|NCT01353846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102014967|NCT01353846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102014968|NCT01353846|Progestins|progestins|mesh-ancestor
102014969|NCT01353846|Luteolytic Agents|luteolytic agents|mesh-ancestor
102014970|NCT01353846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102014971|NCT01353846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102014972|NCT01349010|Probucol|probucol|mesh-list
102014973|NCT01349010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102014974|NCT01349010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102014975|NCT01349010|Antimetabolites|antimetabolites|mesh-ancestor
102014976|NCT01349010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014977|NCT01349010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102014978|NCT01349010|Antioxidants|antioxidants|mesh-ancestor
102014979|NCT01349010|Protective Agents|protective agents|mesh-ancestor
102014980|NCT01349010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014981|NCT05232370|Losartan|losartan|mesh-list
102014982|NCT05232370|Enalapril|enalapril|mesh-list
102014983|NCT05232370|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
102014984|NCT05232370|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101521110|NCT00559169|Verapamil|verapamil|mesh-list
102014985|NCT05232370|Enzyme Inhibitors|enzyme inhibitors|mesh-list
102014986|NCT05232370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102014987|NCT05232370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102014988|NCT05232370|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102014989|NCT05232370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014990|NCT05232370|Protease Inhibitors|protease inhibitors|mesh-ancestor
102014991|NCT01349088|Niacinamide|niacinamide|mesh-list
102014992|NCT01349088|Capecitabine|capecitabine|mesh-list
102014993|NCT01349088|Motesanib diphosphate|motesanib diphosphate|mesh-list
102014994|NCT01349088|Imetelstat|imetelstat|mesh-list
102014995|NCT01349088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102014996|NCT01349088|Antimetabolites|antimetabolites|mesh-ancestor
102014997|NCT01349088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014998|NCT01349088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102014999|NCT01349088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102015000|NCT01349088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102015001|NCT01349088|Vitamin B Complex|vitamin b complex|mesh-ancestor
102015002|NCT01349088|Vitamins|vitamins|mesh-ancestor
102015003|NCT01349088|Micronutrients|micronutrients|mesh-ancestor
102015004|NCT01349088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015005|NCT04490434|Celecoxib|celecoxib|mesh-list
102015006|NCT04490434|Naproxen|naproxen|mesh-list
102015007|NCT04490434|Meloxicam|meloxicam|mesh-list
102015008|NCT04490434|Fexuprazan|fexuprazan|mesh-list
102015009|NCT04490434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102015010|NCT04490434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102015011|NCT04490434|Analgesics|analgesics|mesh-ancestor
102015012|NCT04490434|Sensory System Agents|sensory system agents|mesh-ancestor
102015013|NCT04490434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101737367|NCT00761462|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101949940|NCT04576455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101949941|NCT04576455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949943|NCT04567303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101949944|NCT04567303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101949945|NCT04567303|Growth Substances|growth substances|mesh-ancestor
101949946|NCT04567303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949947|NCT04567303|Growth Inhibitors|growth inhibitors|mesh-ancestor
102015014|NCT04490434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015015|NCT04490434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102015016|NCT04490434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102015017|NCT04490434|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102015018|NCT04490434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102015019|NCT04490434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102015020|NCT04490434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015021|NCT04490434|Gout Suppressants|gout suppressants|mesh-ancestor
102015022|NCT04490434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102015023|NCT01353924|Aluminum sulfate|aluminum sulfate|mesh-list
102015024|NCT01353924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102015025|NCT01353924|Immunologic Factors|immunologic factors|mesh-ancestor
102015026|NCT01353924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015027|NCT03143166|Telmisartan|telmisartan|mesh-list
102015032|NCT03143166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015034|NCT03143166|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102015035|NCT03143166|Protease Inhibitors|protease inhibitors|mesh-ancestor
102015036|NCT03143166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102015037|NCT03143166|Anticoagulants|anticoagulants|mesh-ancestor
102015038|NCT02466568|Nivolumab|nivolumab|mesh-list
102015039|NCT02466568|Vaccines|vaccines|mesh-list
102015040|NCT02466568|Immunologic Factors|immunologic factors|mesh-ancestor
102015041|NCT02466568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015042|NCT02466568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102015043|NCT02466568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102015044|NCT02466568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102015045|NCT02466568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015046|NCT02879994|Pembrolizumab|pembrolizumab|mesh-list
102015047|NCT02879994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102015048|NCT02879994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102015049|NCT02879994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102015050|NCT02879994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015051|NCT02466022|Fentanyl|fentanyl|mesh-list
102015052|NCT02466022|Midazolam|midazolam|mesh-list
102015053|NCT02466022|Dexmedetomidine|dexmedetomidine|mesh-list
102015054|NCT02466022|Bupivacaine|bupivacaine|mesh-list
102015055|NCT02466022|Anesthetics, Local|anesthetics, local|mesh-ancestor
102015056|NCT02466022|Anesthetics|anesthetics|mesh-ancestor
102015057|NCT02466022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102015058|NCT02466022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015059|NCT02466022|Sensory System Agents|sensory system agents|mesh-ancestor
102015060|NCT02466022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102015061|NCT02466022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102015062|NCT02466022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102015063|NCT02466022|Analgesics|analgesics|mesh-ancestor
102015064|NCT02466022|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102015065|NCT02466022|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102015066|NCT02466022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102015067|NCT02466022|Adrenergic Agents|adrenergic agents|mesh-ancestor
102015068|NCT02466022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102015069|NCT02466022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015070|NCT02466022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102015071|NCT02466022|Narcotics|narcotics|mesh-ancestor
102015072|NCT02466022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101734820|NCT00801632|Hormones|hormones|mesh-ancestor
102015073|NCT02466022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102015074|NCT02466022|Anesthetics, General|anesthetics, general|mesh-ancestor
102015075|NCT02466022|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102015076|NCT02466022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101949948|NCT04567303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949949|NCT04565236|Factor VIII|factor viii|mesh-list
101949950|NCT04565236|Coagulants|coagulants|mesh-ancestor
101949951|NCT04550260|Cisplatin|cisplatin|mesh-list
101949952|NCT04550260|Fluorouracil|fluorouracil|mesh-list
101949953|NCT04550260|Capecitabine|capecitabine|mesh-list
101949954|NCT04550260|Durvalumab|durvalumab|mesh-list
101949955|NCT04550260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949956|NCT04550260|Antimetabolites|antimetabolites|mesh-ancestor
102015077|NCT02466022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102015078|NCT02466022|GABA Modulators|gaba modulators|mesh-ancestor
102015079|NCT02466022|GABA Agents|gaba agents|mesh-ancestor
102015080|NCT03937596|Cycloserine|cycloserine|mesh-list
102015081|NCT03937596|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102015082|NCT03937596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102015083|NCT03937596|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102015084|NCT03937596|Antitubercular Agents|antitubercular agents|mesh-ancestor
102015085|NCT03937596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102015086|NCT03937596|Antimetabolites|antimetabolites|mesh-ancestor
102015087|NCT03937596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015088|NCT03578172|Menotropins|menotropins|mesh-list
102015089|NCT03578172|Hormones|hormones|mesh-list
102015090|NCT03578172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102015091|NCT03578172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521141|NCT02904564|Fluorouracil|fluorouracil|mesh-list
102015092|NCT03578172|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102015093|NCT03578172|Fertility Agents|fertility agents|mesh-ancestor
102015094|NCT03578172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102015095|NCT03928158|Valsartan|valsartan|mesh-list
102015096|NCT03928158|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102015099|NCT03928158|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102015100|NCT03928158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015102|NCT05174884|Desogestrel|desogestrel|mesh-list
102015103|NCT05174884|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102015104|NCT05174884|Contraceptive Agents|contraceptive agents|mesh-ancestor
102015105|NCT05174884|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102015106|NCT05174884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015107|NCT05174884|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102015108|NCT05174884|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102015109|NCT05174884|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102015110|NCT05174884|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102015111|NCT05174884|Progestins|progestins|mesh-ancestor
102015112|NCT05174884|Hormones|hormones|mesh-ancestor
102015113|NCT05174884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102015114|NCT01354158|Droxidopa|droxidopa|mesh-list
102015115|NCT01354158|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102015116|NCT01354158|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102015117|NCT02466490|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102015118|NCT02466490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102015119|NCT02466490|Diuretics|diuretics|mesh-ancestor
102015120|NCT02466490|Natriuretic Agents|natriuretic agents|mesh-ancestor
102015121|NCT02466490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015122|NCT02466490|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102015123|NCT02466490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102015124|NCT02466490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015125|NCT04547842|Dexamethasone|dexamethasone|mesh-list
102015126|NCT04547842|Mirtazapine|mirtazapine|mesh-list
102015127|NCT04547842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102015128|NCT04547842|Antiemetics|antiemetics|mesh-ancestor
102015129|NCT04547842|Autonomic Agents|autonomic agents|mesh-ancestor
102015130|NCT04547842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102015131|NCT04547842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015132|NCT04547842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102015133|NCT04547842|Glucocorticoids|glucocorticoids|mesh-ancestor
102015134|NCT04547842|Hormones|hormones|mesh-ancestor
102015135|NCT04547842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102015136|NCT04547842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102015137|NCT04547842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102015138|NCT04547842|Antidepressive Agents|antidepressive agents|mesh-ancestor
101949957|NCT04550260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949958|NCT04550260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101949959|NCT04550260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102015139|NCT04547842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102015140|NCT04547842|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102015141|NCT04547842|Histamine Antagonists|histamine antagonists|mesh-ancestor
102015142|NCT04547842|Histamine Agents|histamine agents|mesh-ancestor
102015143|NCT04547842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102015144|NCT04547842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015145|NCT04547842|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101734890|NCT00806819|Hematinics|hematinics|mesh-ancestor
102015146|NCT04547842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102015147|NCT04547842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102015148|NCT04547842|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102015149|NCT04547842|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102015150|NCT04547842|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102015151|NCT04547842|Adrenergic Agents|adrenergic agents|mesh-ancestor
102015152|NCT04547842|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102015153|NCT04547842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102015154|NCT04547842|Serotonin Agents|serotonin agents|mesh-ancestor
102015155|NCT04547842|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102015156|NCT03142932|Carbon Monoxide|carbon monoxide|mesh-list
102015157|NCT03142932|Antimetabolites|antimetabolites|mesh-ancestor
101521211|NCT04640285|Menthol|menthol|mesh-list
102015158|NCT03142932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015159|NCT03142932|Gasotransmitters|gasotransmitters|mesh-ancestor
102015160|NCT03142932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102015161|NCT03142932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015163|NCT00702052|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102015164|NCT00702052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102015165|NCT00702052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102015166|NCT00702052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015177|NCT01354470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015178|NCT01349556|Tretinoin|tretinoin|mesh-list
102015179|NCT01349556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102015180|NCT01349556|Keratolytic Agents|keratolytic agents|mesh-ancestor
102015181|NCT01349556|Dermatologic Agents|dermatologic agents|mesh-ancestor
102015182|NCT01354704|Enoxaparin|enoxaparin|mesh-list
102015183|NCT01354704|Anticoagulants|anticoagulants|mesh-ancestor
102015184|NCT01354704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102015185|NCT01354704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102015186|NCT01354704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015187|NCT01346670|Lovastatin|lovastatin|mesh-list
102015188|NCT01346670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102015189|NCT01346670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102015190|NCT01346670|Antimetabolites|antimetabolites|mesh-ancestor
102015191|NCT01346670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015192|NCT01346670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102015193|NCT01346670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102015194|NCT01346670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102015195|NCT03136068|Digoxin|digoxin|mesh-list
102015196|NCT03136068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102015197|NCT03136068|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102015198|NCT03136068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102015199|NCT03136068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015200|NCT03136068|Protective Agents|protective agents|mesh-ancestor
102015201|NCT03136068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015202|NCT01350024|Lidocaine|lidocaine|mesh-list
102015203|NCT01350024|Epinephrine|epinephrine|mesh-list
102015204|NCT01350024|Racepinephrine|racepinephrine|mesh-list
102015205|NCT01350024|Epinephryl borate|epinephryl borate|mesh-list
102015206|NCT01350024|Anesthetics, Local|anesthetics, local|mesh-ancestor
102015207|NCT01350024|Anesthetics|anesthetics|mesh-ancestor
102015208|NCT01350024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102015209|NCT01350024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015210|NCT01350024|Sensory System Agents|sensory system agents|mesh-ancestor
102015211|NCT01350024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102015212|NCT01350024|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102015213|NCT01350024|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102015214|NCT01350024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102015215|NCT01350024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101949960|NCT04550260|Immunologic Factors|immunologic factors|mesh-ancestor
101949961|NCT04550260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949962|NCT04550260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102015216|NCT01350024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015217|NCT01350024|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102015218|NCT01350024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102015219|NCT01350024|Adrenergic Agents|adrenergic agents|mesh-ancestor
102015220|NCT01350024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102015221|NCT01350024|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102015222|NCT01350024|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102015223|NCT01350024|Autonomic Agents|autonomic agents|mesh-ancestor
102015224|NCT01350024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102015225|NCT01350024|Respiratory System Agents|respiratory system agents|mesh-ancestor
102015227|NCT01350024|Sympathomimetics|sympathomimetics|mesh-ancestor
102015228|NCT01350024|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102015229|NCT01318590|Triamcinolone|triamcinolone|mesh-list
102015230|NCT01318590|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102015235|NCT01318590|Anesthetics|anesthetics|mesh-ancestor
102015236|NCT01318590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102015237|NCT01318590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015238|NCT01318590|Sensory System Agents|sensory system agents|mesh-ancestor
102015239|NCT01318590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102015240|NCT01318590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102015241|NCT01318590|Glucocorticoids|glucocorticoids|mesh-ancestor
102015242|NCT01318590|Hormones|hormones|mesh-ancestor
102015243|NCT01318590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102015244|NCT01318590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102015245|NCT01318590|Immunologic Factors|immunologic factors|mesh-ancestor
102015246|NCT01318590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102015247|NCT01318590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015248|NCT01346826|Infliximab|infliximab|mesh-list
102015249|NCT01346826|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102015250|NCT01346826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102015251|NCT01346826|Dermatologic Agents|dermatologic agents|mesh-ancestor
102015252|NCT01346826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102015253|NCT01346826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102015254|NCT01354860|Lobeline|lobeline|mesh-list
102015255|NCT01354860|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102015256|NCT01354860|Autonomic Agents|autonomic agents|mesh-ancestor
102015257|NCT01354860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102015258|NCT01354860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015259|NCT01354860|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102015260|NCT01354860|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102015261|NCT01354860|Cholinergic Agents|cholinergic agents|mesh-ancestor
102015262|NCT01354860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102015263|NCT01354860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015264|NCT01354860|Respiratory System Agents|respiratory system agents|mesh-ancestor
102015265|NCT02556606|Midazolam|midazolam|mesh-list
102015266|NCT02556606|Ketamine|ketamine|mesh-list
102015267|NCT02556606|Analgesics|analgesics|mesh-ancestor
102015268|NCT02556606|Sensory System Agents|sensory system agents|mesh-ancestor
102015269|NCT02556606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102015270|NCT02556606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015271|NCT02556606|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102015272|NCT02556606|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102015273|NCT02556606|Anesthetics, General|anesthetics, general|mesh-ancestor
102015274|NCT02556606|Anesthetics|anesthetics|mesh-ancestor
102015275|NCT02556606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102015276|NCT02556606|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102015277|NCT02556606|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102015278|NCT02556606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102015279|NCT02556606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015280|NCT02556606|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102015281|NCT02556606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102015282|NCT02556606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102015283|NCT02556606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102015284|NCT02556606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102015285|NCT02556606|GABA Modulators|gaba modulators|mesh-ancestor
102015286|NCT02556606|GABA Agents|gaba agents|mesh-ancestor
102015287|NCT01355562|Interleukin-2|interleukin-2|mesh-list
102015288|NCT01355562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101949963|NCT04501861|Vasopressins|vasopressins|mesh-list
101949964|NCT04501861|Arginine Vasopressin|arginine vasopressin|mesh-list
101949965|NCT04501861|Norepinephrine|norepinephrine|mesh-list
101949966|NCT04501861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102015289|NCT01355562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102015290|NCT01355562|Analgesics|analgesics|mesh-ancestor
102015291|NCT01355562|Sensory System Agents|sensory system agents|mesh-ancestor
102015292|NCT01355562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102015293|NCT01355562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015294|NCT01350570|Loperamide|loperamide|mesh-list
102015295|NCT01350570|Antidiarrheals|antidiarrheals|mesh-list
102015296|NCT01350570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102015297|NCT01355718|Repaglinide|repaglinide|mesh-list
102015298|NCT01355718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102015299|NCT01355718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015300|NCT03377790|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102015301|NCT03377790|Cantharidin|cantharidin|mesh-list
102015302|NCT03377790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628291|NCT00724243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102015308|NCT02422368|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102015309|NCT02422368|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102015310|NCT02422368|Prednisolone|prednisolone|mesh-list
102015311|NCT02422368|Prednisolone acetate|prednisolone acetate|mesh-list
102015312|NCT02422368|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102015313|NCT02422368|Prednisolone phosphate|prednisolone phosphate|mesh-list
102015314|NCT02422368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102015315|NCT02422368|Antiemetics|antiemetics|mesh-ancestor
102015316|NCT02422368|Autonomic Agents|autonomic agents|mesh-ancestor
102015317|NCT02422368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102015318|NCT02422368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015319|NCT02422368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102015320|NCT02422368|Glucocorticoids|glucocorticoids|mesh-ancestor
102015321|NCT02422368|Hormones|hormones|mesh-ancestor
102015322|NCT02422368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102015323|NCT02422368|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102015324|NCT02422368|Protective Agents|protective agents|mesh-ancestor
102015325|NCT02422368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102015326|NCT02422368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102015327|NCT01355952|Thioctic Acid|thioctic acid|mesh-list
102015328|NCT01355952|Antioxidants|antioxidants|mesh-ancestor
102015329|NCT01355952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015330|NCT01355952|Protective Agents|protective agents|mesh-ancestor
102015331|NCT01355952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015332|NCT01355952|Vitamin B Complex|vitamin b complex|mesh-ancestor
102015333|NCT01355952|Vitamins|vitamins|mesh-ancestor
102015334|NCT01355952|Micronutrients|micronutrients|mesh-ancestor
102015335|NCT05720572|Antazoline|antazoline|mesh-list
102015336|NCT05720572|Propafenone|propafenone|mesh-list
102015337|NCT05720572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102015338|NCT05720572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102015339|NCT05720572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102015340|NCT05720572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102015341|NCT05720572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015342|NCT05720572|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102015343|NCT05720572|Histamine Antagonists|histamine antagonists|mesh-ancestor
102015344|NCT05720572|Histamine Agents|histamine agents|mesh-ancestor
102015345|NCT05720572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102015346|NCT05720572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015347|NCT05720572|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102015348|NCT05111002|Doxycycline|doxycycline|mesh-list
102015349|NCT05111002|Lefamulin|lefamulin|mesh-list
102015350|NCT05111002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102015351|NCT05111002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102015352|NCT05111002|Antimalarials|antimalarials|mesh-ancestor
102015353|NCT05111002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102015354|NCT05111002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102015355|NCT01347684|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
102015356|NCT01347684|Antidepressive Agents|antidepressive agents|mesh-ancestor
102015357|NCT01347684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102015358|NCT05716750|Vitamin D|vitamin d|mesh-list
102015359|NCT05716750|Vitamins|vitamins|mesh-ancestor
102015360|NCT05716750|Micronutrients|micronutrients|mesh-ancestor
102015361|NCT05716750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015362|NCT05716750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102015363|NCT01350882|Rituximab|rituximab|mesh-list
101949967|NCT04501861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101277190|NCT05855187|Modafinil|modafinil|mesh-list
102015364|NCT01350882|Citric Acid|citric acid|mesh-list
102015365|NCT01350882|Sodium Citrate|sodium citrate|mesh-list
102015366|NCT01350882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102015367|NCT01350882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102015368|NCT01350882|Immunologic Factors|immunologic factors|mesh-ancestor
102015369|NCT01350882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015370|NCT01350882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102015371|NCT01350882|Anticoagulants|anticoagulants|mesh-ancestor
102015372|NCT01350882|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102015373|NCT01350882|Chelating Agents|chelating agents|mesh-ancestor
102015375|NCT01350882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015379|NCT00618098|Thrombin|thrombin|mesh-list
102015380|NCT00618098|Hemostatics|hemostatics|mesh-ancestor
102015381|NCT00618098|Coagulants|coagulants|mesh-ancestor
102015382|NCT02464228|Tipifarnib|tipifarnib|mesh-list
102015383|NCT02464228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102015384|NCT01351038|Capecitabine|capecitabine|mesh-list
102015385|NCT01351038|Oxaliplatin|oxaliplatin|mesh-list
102015386|NCT01351038|Panitumumab|panitumumab|mesh-list
102015387|NCT01351038|Epirubicin|epirubicin|mesh-list
102015388|NCT01351038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102015389|NCT01351038|Antimetabolites|antimetabolites|mesh-ancestor
102015390|NCT01351038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015391|NCT01351038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102015392|NCT01351038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102015393|NCT01351038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102015394|NCT01351038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102015395|NCT01351038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102015396|NCT01351038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102015397|NCT02464462|Vitamin D|vitamin d|mesh-list
102015398|NCT02464462|Cholecalciferol|cholecalciferol|mesh-list
102015399|NCT02464462|Calcium|calcium|mesh-list
102015400|NCT02464462|Vitamins|vitamins|mesh-ancestor
102015401|NCT02464462|Micronutrients|micronutrients|mesh-ancestor
102015402|NCT02464462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015403|NCT02464462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102015404|NCT02464462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102015405|NCT04270864|Nivolumab|nivolumab|mesh-list
102015406|NCT04270864|Ipilimumab|ipilimumab|mesh-list
102015407|NCT04270864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102015408|NCT04270864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102015409|NCT04270864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102015410|NCT04270864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015411|NCT01318668|Vaccines|vaccines|mesh-list
102015412|NCT01318668|Immunologic Factors|immunologic factors|mesh-ancestor
102015413|NCT01318668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015414|NCT01351272|Methylphenidate|methylphenidate|mesh-list
102015415|NCT01351272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102015416|NCT01351272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015417|NCT01351272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102015418|NCT01351272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102015419|NCT01351272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102015420|NCT01351272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015421|NCT01351272|Dopamine Agents|dopamine agents|mesh-ancestor
102015422|NCT01351272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102015423|NCT01351428|Nifedipine|nifedipine|mesh-list
102015424|NCT01351428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102015425|NCT01351428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102015426|NCT01351428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015427|NCT01351428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102015428|NCT01351428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015429|NCT01351428|Vasodilator Agents|vasodilator agents|mesh-ancestor
102015430|NCT01351428|Tocolytic Agents|tocolytic agents|mesh-ancestor
102015431|NCT01351428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102015432|NCT05006326|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102015433|NCT05006326|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102015434|NCT05006326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015435|NCT00701662|Immunoglobulins|immunoglobulins|mesh-list
102015436|NCT00701662|Immunologic Factors|immunologic factors|mesh-ancestor
102015437|NCT00701662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015438|NCT02464306|Fidaxomicin|fidaxomicin|mesh-list
102015439|NCT02464306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101949968|NCT04501861|Adrenergic Agents|adrenergic agents|mesh-ancestor
101949969|NCT04501861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101277261|NCT05854537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102015440|NCT02464306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102015441|NCT01351818|Hormones|hormones|mesh-list
102015442|NCT01351818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102015443|NCT01351818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015444|NCT02463994|Atezolizumab|atezolizumab|mesh-list
102015445|NCT02463994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102015446|NCT02463994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735185|NCT00789698|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102015453|NCT04235686|Sympathomimetics|sympathomimetics|mesh-ancestor
102015454|NCT04235686|Autonomic Agents|autonomic agents|mesh-ancestor
102015455|NCT04235686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102015456|NCT04235686|Dopamine Agents|dopamine agents|mesh-ancestor
102015457|NCT04235686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102015458|NCT04235686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015459|NCT04235686|Adrenergic Agents|adrenergic agents|mesh-ancestor
102015460|NCT04235686|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102015461|NCT04235686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102015462|NCT04235686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102015463|NCT04235686|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102015464|NCT02079948|Folic Acid|folic acid|mesh-list
102015465|NCT02079948|Vitamin B Complex|vitamin b complex|mesh-list
102015466|NCT02079948|Methotrexate|methotrexate|mesh-list
102015467|NCT02079948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102015468|NCT02079948|Abortifacient Agents|abortifacient agents|mesh-ancestor
102015469|NCT02079948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102015470|NCT02079948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015471|NCT02079948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102015472|NCT02079948|Antimetabolites|antimetabolites|mesh-ancestor
102015473|NCT02079948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015474|NCT02079948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102015475|NCT02079948|Dermatologic Agents|dermatologic agents|mesh-ancestor
102015476|NCT02079948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102015477|NCT02079948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102015478|NCT02079948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102015479|NCT02079948|Immunologic Factors|immunologic factors|mesh-ancestor
102015480|NCT02079948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102015481|NCT02079948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102015482|NCT02079948|Hematinics|hematinics|mesh-ancestor
102015483|NCT02079948|Vitamins|vitamins|mesh-ancestor
102015484|NCT02079948|Micronutrients|micronutrients|mesh-ancestor
102015485|NCT01357902|Lamotrigine|lamotrigine|mesh-list
102015486|NCT01357902|Anticonvulsants|anticonvulsants|mesh-ancestor
102015487|NCT01357902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102015488|NCT01357902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102015489|NCT01357902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015490|NCT01357902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102015491|NCT01357902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015492|NCT01357902|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102015493|NCT01357902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102015494|NCT01357902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102015495|NCT01357902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102015496|NCT01357902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102015497|NCT04634409|Bamlanivimab|bamlanivimab|mesh-list
102015498|NCT04634409|Sotrovimab|sotrovimab|mesh-list
102015499|NCT04634409|Antiviral Agents|antiviral agents|mesh-ancestor
102015500|NCT04634409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102015501|NCT01352130|Ondansetron|ondansetron|mesh-list
102015502|NCT01352130|Granisetron|granisetron|mesh-list
102015503|NCT01352130|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
102015504|NCT01352130|Antiemetics|antiemetics|mesh-ancestor
102015505|NCT01352130|Autonomic Agents|autonomic agents|mesh-ancestor
102015506|NCT01352130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102015507|NCT01352130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015508|NCT01352130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102015509|NCT01352130|Antipruritics|antipruritics|mesh-ancestor
102015510|NCT01352130|Dermatologic Agents|dermatologic agents|mesh-ancestor
102015511|NCT01352130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102015512|NCT01352130|Serotonin Agents|serotonin agents|mesh-ancestor
102015513|NCT01352130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101949970|NCT04501861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101949971|NCT04501861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949972|NCT04501861|Sympathomimetics|sympathomimetics|mesh-ancestor
101949973|NCT04501861|Autonomic Agents|autonomic agents|mesh-ancestor
101949974|NCT04501861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101949975|NCT04501861|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101949976|NCT04501861|Hemostatics|hemostatics|mesh-ancestor
101949977|NCT04501861|Coagulants|coagulants|mesh-ancestor
101949978|NCT04501861|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101949979|NCT04501861|Natriuretic Agents|natriuretic agents|mesh-ancestor
101949980|NCT04494529|Betamethasone|betamethasone|mesh-list
101949981|NCT04494529|Betamethasone Valerate|betamethasone valerate|mesh-list
101949982|NCT04494529|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101949983|NCT04494529|Betamethasone benzoate|betamethasone benzoate|mesh-list
102015514|NCT01352130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015515|NCT05605834|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102015523|NCT00005780|Sargramostim|sargramostim|mesh-list
102015524|NCT00005780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102015525|NCT00005780|Immunologic Factors|immunologic factors|mesh-ancestor
102015526|NCT00005780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015527|NCT00005780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102015528|NCT00005780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102015529|NCT00005780|Alkylating Agents|alkylating agents|mesh-ancestor
102015530|NCT00005780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015531|NCT00005780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102015532|NCT00005780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102015533|NCT00005780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102015534|NCT00005780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102015535|NCT00005780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102015536|NCT00005780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102015537|NCT00005780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102015538|NCT00005780|Glucocorticoids|glucocorticoids|mesh-ancestor
102015539|NCT00005780|Hormones|hormones|mesh-ancestor
102015540|NCT00005780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102015541|NCT00005780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102015542|NCT00005780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102015543|NCT00005780|Tubulin Modulators|tubulin modulators|mesh-ancestor
102015544|NCT00005780|Antimitotic Agents|antimitotic agents|mesh-ancestor
102015545|NCT00005780|Mitosis Modulators|mitosis modulators|mesh-ancestor
102015546|NCT01356732|Sufentanil|sufentanil|mesh-list
102015547|NCT01356732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102015548|NCT01356732|Narcotics|narcotics|mesh-ancestor
102015549|NCT01356732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102015550|NCT01356732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015551|NCT01356732|Analgesics|analgesics|mesh-ancestor
102015552|NCT01356732|Sensory System Agents|sensory system agents|mesh-ancestor
102015553|NCT01356732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102015554|NCT01356732|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102015555|NCT01356732|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102015556|NCT01356732|Anesthetics, General|anesthetics, general|mesh-ancestor
102015557|NCT01356732|Anesthetics|anesthetics|mesh-ancestor
102015558|NCT02463682|Insulin|insulin|mesh-list
102015559|NCT02463682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102015560|NCT02463682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015561|NCT01978938|Levofloxacin|levofloxacin|mesh-list
102015562|NCT01978938|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102015563|NCT01978938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102015564|NCT01978938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102015565|NCT01978938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102015566|NCT01978938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102015567|NCT01978938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101737368|NCT00761462|Ciprofloxacin|ciprofloxacin|mesh-list
101949984|NCT04494529|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101949985|NCT04494529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101949986|NCT04494529|Glucocorticoids|glucocorticoids|mesh-ancestor
101949987|NCT04494529|Hormones|hormones|mesh-ancestor
101949988|NCT04494529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101949989|NCT04494529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101949990|NCT04494529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101949991|NCT04494529|Respiratory System Agents|respiratory system agents|mesh-ancestor
101949992|NCT04447768|Venetoclax|venetoclax|mesh-list
101949993|NCT04447768|Obinutuzumab|obinutuzumab|mesh-list
101949994|NCT04447768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101521323|NCT04639232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101949995|NCT04447768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101949996|NCT04442022|Dexamethasone|dexamethasone|mesh-list
101949997|NCT04442022|Rituximab|rituximab|mesh-list
102015568|NCT01978938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015569|NCT01978938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102015570|NCT01978938|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102015571|NCT01978938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102015572|NCT02465320|Lidocaine|lidocaine|mesh-list
102015573|NCT02465320|Anesthetics, Local|anesthetics, local|mesh-ancestor
102015574|NCT02465320|Anesthetics|anesthetics|mesh-ancestor
102015575|NCT02465320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102015576|NCT02465320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015577|NCT02465320|Sensory System Agents|sensory system agents|mesh-ancestor
102015578|NCT02465320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102015579|NCT02465320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102015580|NCT02465320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102015581|NCT02465320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102015582|NCT02465320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102015583|NCT02465320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015584|NCT02465008|Levobupivacaine|levobupivacaine|mesh-list
102015589|NCT02465008|Sensory System Agents|sensory system agents|mesh-ancestor
102015590|NCT02465008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102015591|NCT03228186|Docetaxel|docetaxel|mesh-list
102015592|NCT03228186|Pevonedistat|pevonedistat|mesh-list
102015593|NCT03228186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102015594|NCT03228186|Tubulin Modulators|tubulin modulators|mesh-ancestor
102015595|NCT03228186|Antimitotic Agents|antimitotic agents|mesh-ancestor
102015596|NCT03228186|Mitosis Modulators|mitosis modulators|mesh-ancestor
102015597|NCT03228186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015598|NCT03228186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102015599|NCT04105114|Buspirone|buspirone|mesh-list
102015600|NCT04105114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102015601|NCT04105114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102015602|NCT04105114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102015603|NCT04105114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015604|NCT04105114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102015605|NCT04105114|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102015606|NCT04105114|Serotonin Agents|serotonin agents|mesh-ancestor
102015607|NCT04105114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102015608|NCT04105114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015609|NCT05573230|Cyclosporine|cyclosporine|mesh-list
102015610|NCT05573230|Midazolam|midazolam|mesh-list
102015611|NCT05573230|Cyclosporins|cyclosporins|mesh-list
102015612|NCT05573230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102015613|NCT05573230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102015614|NCT05573230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102015615|NCT05573230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015616|NCT05573230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102015617|NCT05573230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102015618|NCT05573230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101949998|NCT04442022|Gemcitabine|gemcitabine|mesh-list
101949999|NCT04442022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101950000|NCT04442022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101950001|NCT04442022|Immunologic Factors|immunologic factors|mesh-ancestor
101950002|NCT04442022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950003|NCT04442022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101950004|NCT04442022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101950005|NCT04442022|Antiemetics|antiemetics|mesh-ancestor
101950006|NCT04442022|Autonomic Agents|autonomic agents|mesh-ancestor
101950007|NCT04442022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101277456|NCT05651633|Lidocaine|lidocaine|mesh-list
102015619|NCT05573230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102015620|NCT05573230|Anesthetics, General|anesthetics, general|mesh-ancestor
102015621|NCT05573230|Anesthetics|anesthetics|mesh-ancestor
102015622|NCT05573230|GABA Modulators|gaba modulators|mesh-ancestor
102015623|NCT05573230|GABA Agents|gaba agents|mesh-ancestor
102015624|NCT05573230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102015625|NCT05573230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015626|NCT05573230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102015627|NCT05573230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102015628|NCT05573230|Immunologic Factors|immunologic factors|mesh-ancestor
102015629|NCT05573230|Antifungal Agents|antifungal agents|mesh-ancestor
102015630|NCT05573230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102015631|NCT05573230|Dermatologic Agents|dermatologic agents|mesh-ancestor
102015632|NCT05573230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102015633|NCT05573230|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102015634|NCT05550142|Vaccines|vaccines|mesh-list
102015635|NCT05550142|Immunologic Factors|immunologic factors|mesh-ancestor
102015636|NCT05550142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015637|NCT00116142|Ascorbic Acid|ascorbic acid|mesh-list
102015638|NCT00116142|Docetaxel|docetaxel|mesh-list
102015639|NCT00116142|Methyltestosterone|methyltestosterone|mesh-list
102015640|NCT00116142|Androgens|androgens|mesh-list
102015641|NCT00116142|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
102015642|NCT00116142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102015643|NCT00116142|Tubulin Modulators|tubulin modulators|mesh-ancestor
102015644|NCT00116142|Antimitotic Agents|antimitotic agents|mesh-ancestor
102015645|NCT00116142|Mitosis Modulators|mitosis modulators|mesh-ancestor
102015646|NCT00116142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015647|NCT00116142|Hormones|hormones|mesh-ancestor
102015648|NCT00116142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102015649|NCT00116142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015650|NCT00116142|Antioxidants|antioxidants|mesh-ancestor
102015651|NCT00116142|Protective Agents|protective agents|mesh-ancestor
102015652|NCT00116142|Vitamins|vitamins|mesh-ancestor
102015653|NCT00116142|Micronutrients|micronutrients|mesh-ancestor
102015654|NCT00116142|Estrogens|estrogens|mesh-ancestor
102015655|NCT00116142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102015656|NCT00116142|Anabolic Agents|anabolic agents|mesh-ancestor
102015657|NCT05547256|Vaccines|vaccines|mesh-list
101470608|NCT00250094|Topotecan|topotecan|mesh-list
102015666|NCT01757782|Urological Agents|urological agents|mesh-ancestor
102015667|NCT02023905|Everolimus|everolimus|mesh-list
102015668|NCT02023905|Temozolomide|temozolomide|mesh-list
102015669|NCT02023905|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102015670|NCT02023905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102015671|NCT02023905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102015672|NCT02023905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015673|NCT02023905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102015674|NCT02023905|Immunologic Factors|immunologic factors|mesh-ancestor
102015675|NCT02023905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015676|NCT02023905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102015677|NCT02023905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102015678|NCT02023905|Alkylating Agents|alkylating agents|mesh-ancestor
102015679|NCT01330563|Ketoconazole|ketoconazole|mesh-list
102015680|NCT01330563|Antifungal Agents|antifungal agents|mesh-ancestor
102015681|NCT01330563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102015682|NCT01330563|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101950008|NCT04442022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101950009|NCT04442022|Glucocorticoids|glucocorticoids|mesh-ancestor
101950010|NCT04442022|Hormones|hormones|mesh-ancestor
101950011|NCT04442022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101950012|NCT04442022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101950013|NCT04442022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101950014|NCT04442022|Antimetabolites|antimetabolites|mesh-ancestor
101950015|NCT04442022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015683|NCT01330563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102015684|NCT01330563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102015685|NCT01330563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015686|NCT01330563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102015687|NCT01330563|Hormone Antagonists|hormone antagonists|mesh-ancestor
102015688|NCT01330563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102015689|NCT01330563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015690|NCT01330563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102015691|NCT01991379|Imatinib Mesylate|imatinib mesylate|mesh-list
102015692|NCT01991379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102015693|NCT01991379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102015694|NCT01991379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102015695|NCT01991379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015696|NCT02875080|Brexpiprazole|brexpiprazole|mesh-list
102015697|NCT02875080|Serotonin Agents|serotonin agents|mesh-ancestor
102015698|NCT02875080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102015699|NCT02875080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015700|NCT02875080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015701|NCT02875080|Dopamine Agonists|dopamine agonists|mesh-ancestor
102015702|NCT02875080|Dopamine Agents|dopamine agents|mesh-ancestor
102015703|NCT04897503|Riboflavin|riboflavin|mesh-list
102015704|NCT04897503|Vitamin B Complex|vitamin b complex|mesh-ancestor
102015705|NCT04897503|Vitamins|vitamins|mesh-ancestor
102015706|NCT04897503|Micronutrients|micronutrients|mesh-ancestor
102015707|NCT04897503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015708|NCT04897503|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102015709|NCT04897503|Dermatologic Agents|dermatologic agents|mesh-ancestor
102015710|NCT01333917|Curcumin|curcumin|mesh-list
101316400|NCT00390871|Narcotics|narcotics|mesh-ancestor
102015711|NCT01333917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102015712|NCT01333917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102015713|NCT01333917|Analgesics|analgesics|mesh-ancestor
102015714|NCT01333917|Sensory System Agents|sensory system agents|mesh-ancestor
102015715|NCT01333917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102015716|NCT01333917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015717|NCT01333917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102015718|NCT01333917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102015719|NCT01333917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102015720|NCT01333917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102015721|NCT01333917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015722|NCT03129360|Levetiracetam|levetiracetam|mesh-list
102015735|NCT01319448|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
102015737|NCT01319448|Mefloquine|mefloquine|mesh-list
102015738|NCT01319448|Proguanil|proguanil|mesh-list
102015739|NCT01319448|Antimalarials|antimalarials|mesh-ancestor
102015740|NCT01319448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102015741|NCT01319448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102015742|NCT01319448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102015743|NCT01319448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102015744|NCT01319448|Antiviral Agents|antiviral agents|mesh-ancestor
102015745|NCT01319448|Schistosomicides|schistosomicides|mesh-ancestor
102015746|NCT01319448|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102015747|NCT01319448|Anthelmintics|anthelmintics|mesh-ancestor
102015748|NCT01319448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102015749|NCT01319448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102015750|NCT01319448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950027|NCT04401774|Nivolumab|nivolumab|mesh-list
101950028|NCT04401774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101950029|NCT04401774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101950030|NCT04401774|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101950031|NCT04401774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950032|NCT04356209|Pravastatin|pravastatin|mesh-list
101950033|NCT04356209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101950034|NCT04356209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101950035|NCT04356209|Antimetabolites|antimetabolites|mesh-ancestor
101950036|NCT04356209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950037|NCT04356209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101950038|NCT04356209|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101950039|NCT04356209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102015751|NCT01319448|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102015752|NCT01319448|Antimetabolites|antimetabolites|mesh-ancestor
102015753|NCT01334073|Everolimus|everolimus|mesh-list
102015754|NCT01334073|Axitinib|axitinib|mesh-list
102015755|NCT01334073|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102015756|NCT01334073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102015757|NCT01334073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102015758|NCT01334073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015759|NCT01334073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102015760|NCT01334073|Immunologic Factors|immunologic factors|mesh-ancestor
102015761|NCT01334073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015762|NCT01334073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102015763|NCT01928199|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102015764|NCT01928199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102015765|NCT01928199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015766|NCT01928199|Incretins|incretins|mesh-ancestor
102015767|NCT01928199|Hormones|hormones|mesh-ancestor
102015768|NCT01928199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102015769|NCT01928199|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102015770|NCT01928199|Protease Inhibitors|protease inhibitors|mesh-ancestor
102015771|NCT01928199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102015772|NCT01928199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015773|NCT01845441|Fentanyl|fentanyl|mesh-list
102015774|NCT01845441|Midazolam|midazolam|mesh-list
102015775|NCT01845441|Dexmedetomidine|dexmedetomidine|mesh-list
102015776|NCT01845441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102015777|NCT01845441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102015778|NCT01845441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015779|NCT01845441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102015780|NCT01845441|Analgesics|analgesics|mesh-ancestor
102015781|NCT01845441|Sensory System Agents|sensory system agents|mesh-ancestor
102015782|NCT01845441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102015783|NCT01845441|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102015784|NCT01845441|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102015785|NCT01845441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102015786|NCT01845441|Adrenergic Agents|adrenergic agents|mesh-ancestor
102015787|NCT01845441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102015790|NCT01845441|Narcotics|narcotics|mesh-ancestor
101950040|NCT04346394|Yohimbine|yohimbine|mesh-list
101950041|NCT04346394|Mydriatics|mydriatics|mesh-ancestor
101950042|NCT04346394|Autonomic Agents|autonomic agents|mesh-ancestor
101950043|NCT04346394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101950044|NCT04346394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950045|NCT04346394|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101669861|NCT04930744|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101950046|NCT04346394|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101950047|NCT04346394|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101950048|NCT04346394|Adrenergic Agents|adrenergic agents|mesh-ancestor
101950049|NCT04346394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101950050|NCT04346394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950051|NCT04346394|Urological Agents|urological agents|mesh-ancestor
101950052|NCT04344873|Abatacept|abatacept|mesh-list
101950053|NCT04344873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102015791|NCT01845441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102015792|NCT01845441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102015793|NCT01845441|Anesthetics, General|anesthetics, general|mesh-ancestor
102015794|NCT01845441|Anesthetics|anesthetics|mesh-ancestor
102015795|NCT01845441|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102015796|NCT01845441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102015797|NCT01845441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102015798|NCT01845441|GABA Modulators|gaba modulators|mesh-ancestor
102015799|NCT01845441|GABA Agents|gaba agents|mesh-ancestor
102015800|NCT03296488|Fentanyl|fentanyl|mesh-list
102015801|NCT03296488|Nalbuphine|nalbuphine|mesh-list
102015802|NCT03296488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102015803|NCT03296488|Narcotics|narcotics|mesh-ancestor
102015804|NCT03296488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102015805|NCT03296488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015806|NCT03296488|Analgesics|analgesics|mesh-ancestor
102015807|NCT03296488|Sensory System Agents|sensory system agents|mesh-ancestor
102015808|NCT03296488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102015809|NCT03296488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102015810|NCT03296488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102015811|NCT03296488|Anesthetics, General|anesthetics, general|mesh-ancestor
102015812|NCT03296488|Anesthetics|anesthetics|mesh-ancestor
102015813|NCT01365936|Menotropins|menotropins|mesh-list
102015814|NCT01365936|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102015815|NCT01365936|Fertility Agents|fertility agents|mesh-ancestor
102015816|NCT01365936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102015817|NCT01365936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015818|NCT01334151|Insulin|insulin|mesh-list
102015819|NCT01334151|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102015820|NCT01334151|Insulin Lispro|insulin lispro|mesh-list
102015821|NCT01334151|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102015822|NCT01334151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015823|NCT04216017|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102015824|NCT04216017|Lidocaine|lidocaine|mesh-list
102015825|NCT04216017|Anesthetics, Local|anesthetics, local|mesh-ancestor
102015826|NCT04216017|Anesthetics|anesthetics|mesh-ancestor
102015827|NCT04216017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102015828|NCT04216017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015829|NCT04216017|Sensory System Agents|sensory system agents|mesh-ancestor
102015830|NCT04216017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102015832|NCT04216017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102015833|NCT04216017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102015834|NCT04216017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102015835|NCT04216017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015836|NCT04216017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102015837|NCT04216017|Glucocorticoids|glucocorticoids|mesh-ancestor
102015838|NCT04216017|Hormones|hormones|mesh-ancestor
101950054|NCT04344873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950055|NCT04344873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101950056|NCT04344873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101950057|NCT04344873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101950058|NCT04344873|Immunologic Factors|immunologic factors|mesh-ancestor
101950059|NCT04344873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950060|NCT04344873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101950061|NCT04322318|Cyclophosphamide|cyclophosphamide|mesh-list
101950062|NCT04322318|Ifosfamide|ifosfamide|mesh-list
101950063|NCT04322318|Isophosphamide mustard|isophosphamide mustard|mesh-list
101950064|NCT04322318|Carboplatin|carboplatin|mesh-list
101950065|NCT04322318|Doxorubicin|doxorubicin|mesh-list
101950066|NCT04322318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101950067|NCT04322318|Irinotecan|irinotecan|mesh-list
101950068|NCT04322318|Etoposide|etoposide|mesh-list
101950069|NCT04322318|Vincristine|vincristine|mesh-list
101950070|NCT04322318|Etoposide phosphate|etoposide phosphate|mesh-list
101950071|NCT04322318|Daunorubicin|daunorubicin|mesh-list
101950072|NCT04322318|Topotecan|topotecan|mesh-list
101521441|NCT02897037|Heparin|heparin|mesh-list
101950073|NCT04322318|Podophyllotoxin|podophyllotoxin|mesh-list
101950074|NCT04322318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101950075|NCT04322318|Immunologic Factors|immunologic factors|mesh-ancestor
101950076|NCT04322318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950077|NCT04322318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101950078|NCT04322318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101950079|NCT04322318|Alkylating Agents|alkylating agents|mesh-ancestor
101950080|NCT04322318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950081|NCT04322318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102015839|NCT04216017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102015840|NCT04216017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102015841|NCT04216017|Immunologic Factors|immunologic factors|mesh-ancestor
102015842|NCT03296410|Vaccines|vaccines|mesh-list
102015843|NCT03296410|Immunologic Factors|immunologic factors|mesh-ancestor
102015844|NCT03296410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015845|NCT05189184|Paclitaxel|paclitaxel|mesh-list
102015846|NCT05189184|Apatinib|apatinib|mesh-list
102015847|NCT05189184|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102015848|NCT05189184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102015849|NCT05189184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102015850|NCT05189184|Tubulin Modulators|tubulin modulators|mesh-ancestor
102015851|NCT05189184|Antimitotic Agents|antimitotic agents|mesh-ancestor
102015852|NCT05189184|Mitosis Modulators|mitosis modulators|mesh-ancestor
102015853|NCT05189184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015854|NCT05189184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102015855|NCT05189184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102015856|NCT01362036|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
102015857|NCT01362036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102015858|NCT01362036|Vasodilator Agents|vasodilator agents|mesh-ancestor
102015859|NCT04623099|Escitalopram|escitalopram|mesh-list
102015860|NCT04623099|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101950082|NCT04322318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101950083|NCT04322318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101950084|NCT04322318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101950085|NCT04322318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101950086|NCT04322318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101950087|NCT04322318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101950088|NCT04322318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101950089|NCT04322318|Tubulin Modulators|tubulin modulators|mesh-ancestor
101950090|NCT04322318|Antimitotic Agents|antimitotic agents|mesh-ancestor
101950091|NCT04322318|Mitosis Modulators|mitosis modulators|mesh-ancestor
101950092|NCT04322318|Keratolytic Agents|keratolytic agents|mesh-ancestor
101950093|NCT04322318|Dermatologic Agents|dermatologic agents|mesh-ancestor
101950094|NCT04310397|Trametinib|trametinib|mesh-list
101950095|NCT04310397|Dabrafenib|dabrafenib|mesh-list
101950096|NCT04310397|Spartalizumab|spartalizumab|mesh-list
101950097|NCT04310397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101950098|NCT04310397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101950099|NCT04310397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101277742|NCT05139420|Topiramate|topiramate|mesh-list
102015861|NCT04623099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102015862|NCT04623099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102015864|NCT04623099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102015865|NCT04623099|Serotonin Agents|serotonin agents|mesh-ancestor
102015866|NCT04623099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015867|NCT01358916|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102015868|NCT01358916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102015869|NCT03735290|Pembrolizumab|pembrolizumab|mesh-list
102015870|NCT03735290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102015871|NCT03735290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102015872|NCT03735290|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102015873|NCT03735290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015874|NCT03619538|Nefopam|nefopam|mesh-list
102015875|NCT03619538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102015876|NCT03619538|Analgesics|analgesics|mesh-ancestor
102015877|NCT03619538|Sensory System Agents|sensory system agents|mesh-ancestor
102015878|NCT03619538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102015879|NCT03619538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015880|NCT03296098|Ulipristal acetate|ulipristal acetate|mesh-list
102015881|NCT03296098|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102015882|NCT03296098|Contraceptive Agents|contraceptive agents|mesh-ancestor
102015883|NCT03296098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102015884|NCT03296098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015885|NCT03296098|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102015886|NCT01366326|Bromides|bromides|mesh-list
102015887|NCT01366326|Methylnaltrexone|methylnaltrexone|mesh-list
102015888|NCT01366326|Anticonvulsants|anticonvulsants|mesh-ancestor
102015889|NCT01366326|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102015890|NCT01366326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015891|NCT01366326|Sensory System Agents|sensory system agents|mesh-ancestor
102015892|NCT01366326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102015893|NCT01822275|Temozolomide|temozolomide|mesh-list
102015894|NCT01822275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102015895|NCT01822275|Alkylating Agents|alkylating agents|mesh-ancestor
102015896|NCT01822275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015897|NCT01822275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102015898|NCT01331421|Exemestane|exemestane|mesh-list
102015899|NCT01331421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102015900|NCT01331421|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101950100|NCT04310397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950101|NCT04310397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101950102|NCT04310397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101277804|NCT04965454|Choline|choline|mesh-list
102015901|NCT01331421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102015902|NCT01331421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102015903|NCT01331421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015904|NCT01331421|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102015905|NCT01331421|Hormone Antagonists|hormone antagonists|mesh-ancestor
102015906|NCT01331421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102015907|NCT01331421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015908|NCT01656434|Ferrous fumarate|ferrous fumarate|mesh-list
102015909|NCT01656434|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102015910|NCT01656434|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102015911|NCT01656434|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102015912|NCT01656434|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102015913|NCT01656434|Contraceptive Agents|contraceptive agents|mesh-ancestor
102015914|NCT01656434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102015915|NCT01656434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015916|NCT01656434|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102015917|NCT01656434|Estrogens|estrogens|mesh-ancestor
102015918|NCT01656434|Hormones|hormones|mesh-ancestor
102015919|NCT01656434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102015920|NCT01656434|Trace Elements|trace elements|mesh-ancestor
102015921|NCT01656434|Micronutrients|micronutrients|mesh-ancestor
102015922|NCT01319214|Propranolol|propranolol|mesh-list
102015923|NCT01319214|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102015924|NCT01319214|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102015925|NCT01319214|Adrenergic Agents|adrenergic agents|mesh-ancestor
102015926|NCT01319214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102015927|NCT01319214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015928|NCT01319214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015929|NCT01319214|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102015930|NCT01319214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102015931|NCT01319214|Vasodilator Agents|vasodilator agents|mesh-ancestor
102015932|NCT01359228|Rifaximin|rifaximin|mesh-list
102015933|NCT01359228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102015934|NCT01359228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102015939|NCT02461030|Protective Agents|protective agents|mesh-ancestor
102015940|NCT02461030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015941|NCT02461030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102015942|NCT02461030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102015943|NCT05168618|Atezolizumab|atezolizumab|mesh-list
102015944|NCT05168618|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102015945|NCT05168618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102015946|NCT05168618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015947|NCT05168618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102015948|NCT05168618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102015949|NCT05168618|Immunologic Factors|immunologic factors|mesh-ancestor
102015950|NCT05168618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015951|NCT01599494|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102015952|NCT01599494|Progesterone|progesterone|mesh-list
102015953|NCT01599494|Ganirelix|ganirelix|mesh-list
102015954|NCT01599494|Progestins|progestins|mesh-ancestor
102015955|NCT01599494|Hormones|hormones|mesh-ancestor
102015956|NCT01599494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102015957|NCT01599494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015958|NCT01599494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102015959|NCT01599494|Hormone Antagonists|hormone antagonists|mesh-ancestor
102015960|NCT03295786|Dopamine|dopamine|mesh-list
102015961|NCT03295786|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102015962|NCT03295786|Sympathomimetics|sympathomimetics|mesh-ancestor
102015963|NCT03295786|Autonomic Agents|autonomic agents|mesh-ancestor
102015964|NCT03295786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102015965|NCT03295786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015966|NCT03295786|Dopamine Agents|dopamine agents|mesh-ancestor
102015967|NCT03295786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102015968|NCT03295786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950104|NCT04299490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950105|NCT04299490|Sensory System Agents|sensory system agents|mesh-ancestor
101521580|NCT04637360|Calcitriol|calcitriol|mesh-list
101950106|NCT04299490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101950107|NCT04299438|Propranolol|propranolol|mesh-list
101950108|NCT04299438|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101950109|NCT04299438|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101950110|NCT04299438|Adrenergic Agents|adrenergic agents|mesh-ancestor
101950111|NCT04299438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101950112|NCT04299438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950113|NCT04299438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950114|NCT04299438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101950115|NCT04299438|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101277868|NCT04788667|Erenumab|erenumab|mesh-list
102015969|NCT03295786|Protective Agents|protective agents|mesh-ancestor
102015970|NCT03194932|Cytarabine|cytarabine|mesh-list
102015971|NCT03194932|Hydrocortisone|hydrocortisone|mesh-list
102015972|NCT03194932|Methotrexate|methotrexate|mesh-list
102015973|NCT03194932|Azacitidine|azacitidine|mesh-list
102015974|NCT03194932|Venetoclax|venetoclax|mesh-list
102015975|NCT03194932|Idarubicin|idarubicin|mesh-list
102015976|NCT03194932|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102015977|NCT03194932|Abortifacient Agents|abortifacient agents|mesh-ancestor
101575012|NCT01179516|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102015978|NCT03194932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102015979|NCT03194932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015980|NCT03194932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102015981|NCT03194932|Antimetabolites|antimetabolites|mesh-ancestor
102015982|NCT03194932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015983|NCT03194932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102015984|NCT03194932|Dermatologic Agents|dermatologic agents|mesh-ancestor
102015985|NCT03194932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102015986|NCT03194932|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102015987|NCT03194932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102015988|NCT03194932|Immunologic Factors|immunologic factors|mesh-ancestor
102015989|NCT03194932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102015990|NCT03194932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102015991|NCT03194932|Antiviral Agents|antiviral agents|mesh-ancestor
102015992|NCT03194932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102015993|NCT03194932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102015994|NCT03194932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102015995|NCT03194932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102015996|NCT03194932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102015997|NCT03037580|Treprostinil|treprostinil|mesh-list
102015998|NCT03037580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102015999|NCT05154734|Belimumab|belimumab|mesh-list
102016000|NCT05154734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102016001|NCT05154734|Immunologic Factors|immunologic factors|mesh-ancestor
102016002|NCT05154734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016003|NCT02978404|Nivolumab|nivolumab|mesh-list
102016004|NCT02978404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102016005|NCT02978404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102016006|NCT02978404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102016011|NCT04441918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016012|NCT01331655|Tetrahydrofolates|tetrahydrofolates|mesh-list
102016014|NCT01331655|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102016015|NCT01331655|Hormone Antagonists|hormone antagonists|mesh-ancestor
102016016|NCT01331655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102016017|NCT01331655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016018|NCT01331655|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102016019|NCT01331655|Diuretics|diuretics|mesh-ancestor
102016020|NCT01331655|Natriuretic Agents|natriuretic agents|mesh-ancestor
102016021|NCT01331655|Vitamin B Complex|vitamin b complex|mesh-ancestor
101950116|NCT04299438|Vasodilator Agents|vasodilator agents|mesh-ancestor
101950117|NCT04265872|Pembrolizumab|pembrolizumab|mesh-list
101950118|NCT04265872|Bortezomib|bortezomib|mesh-list
101950119|NCT04265872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101950120|NCT04265872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101950121|NCT04265872|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101950122|NCT04265872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950123|NCT04249362|Durvalumab|durvalumab|mesh-list
101950124|NCT04249362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101950125|NCT04249362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101950126|NCT04245514|Durvalumab|durvalumab|mesh-list
101950127|NCT04245514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101950128|NCT04245514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102016022|NCT01331655|Vitamins|vitamins|mesh-ancestor
102016023|NCT01331655|Micronutrients|micronutrients|mesh-ancestor
102016024|NCT03289390|Acetaminophen|acetaminophen|mesh-list
102016025|NCT03289390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102016026|NCT03289390|Analgesics|analgesics|mesh-ancestor
102016027|NCT03289390|Sensory System Agents|sensory system agents|mesh-ancestor
102016028|NCT03289390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102016029|NCT03289390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016030|NCT03289390|Antipyretics|antipyretics|mesh-ancestor
102016031|NCT00897104|Sumatriptan|sumatriptan|mesh-list
102016032|NCT00897104|Rizatriptan|rizatriptan|mesh-list
102016033|NCT00897104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102016034|NCT00897104|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102016035|NCT00897104|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102016036|NCT00897104|Serotonin Agents|serotonin agents|mesh-ancestor
102016037|NCT00897104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102016038|NCT00897104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016039|NCT00897104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016040|NCT00792506|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
102016041|NCT00792506|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
102016042|NCT00792506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102016043|NCT00792506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016044|NCT03295162|Melatonin|melatonin|mesh-list
102016045|NCT03295162|Antioxidants|antioxidants|mesh-ancestor
102016046|NCT03295162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016047|NCT03295162|Protective Agents|protective agents|mesh-ancestor
102016048|NCT03295162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016049|NCT03295162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102016050|NCT05237492|Tramadol|tramadol|mesh-list
102016051|NCT05237492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102016052|NCT05237492|Narcotics|narcotics|mesh-ancestor
102016053|NCT05237492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102016054|NCT05237492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016055|NCT05237492|Analgesics|analgesics|mesh-ancestor
102016056|NCT05237492|Sensory System Agents|sensory system agents|mesh-ancestor
102016057|NCT05237492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102016058|NCT03295084|Capecitabine|capecitabine|mesh-list
102016059|NCT03295084|Irinotecan|irinotecan|mesh-list
102016060|NCT03295084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102016061|NCT03295084|Antimetabolites|antimetabolites|mesh-ancestor
102016062|NCT03295084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016063|NCT03295084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102016064|NCT03295084|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102016065|NCT03295084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102016066|NCT03295084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102016067|NCT04710134|Reslizumab|reslizumab|mesh-list
102016068|NCT04710134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102016069|NCT04710134|Respiratory System Agents|respiratory system agents|mesh-ancestor
102016070|NCT01339689|Ganaxolone|ganaxolone|mesh-list
102016071|NCT01339689|Neurosteroids|neurosteroids|mesh-ancestor
101950129|NCT04240821|Theophylline|theophylline|mesh-list
101950130|NCT04240821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101950131|NCT04240821|Autonomic Agents|autonomic agents|mesh-ancestor
101950132|NCT04240821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101950133|NCT04240821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950134|NCT04240821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101950135|NCT04240821|Respiratory System Agents|respiratory system agents|mesh-ancestor
101950136|NCT04240821|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101950137|NCT04240821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101950138|NCT04240821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950139|NCT04240821|Vasodilator Agents|vasodilator agents|mesh-ancestor
101950140|NCT04240821|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101950141|NCT04240821|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101950142|NCT04240821|Purinergic Agents|purinergic agents|mesh-ancestor
101950143|NCT04240821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101950144|NCT04214678|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101950145|NCT04214678|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
101950146|NCT04214678|beta-Endorphin|beta-endorphin|mesh-list
101950147|NCT04214678|Hormones|hormones|mesh-ancestor
101950148|NCT04214678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101950149|NCT04214678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950150|NCT04214678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101950151|NCT04214678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950152|NCT04207619|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101950153|NCT04207619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950154|NCT04196491|Cyclophosphamide|cyclophosphamide|mesh-list
101950155|NCT04196491|Fludarabine|fludarabine|mesh-list
101950156|NCT04196491|Lenalidomide|lenalidomide|mesh-list
101950157|NCT04196491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101950158|NCT04196491|Immunologic Factors|immunologic factors|mesh-ancestor
101950170|NCT04182204|Rituximab|rituximab|mesh-list
101950172|NCT04182204|Oxaliplatin|oxaliplatin|mesh-list
101950173|NCT04182204|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
101950174|NCT04182204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101950175|NCT04182204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101950176|NCT04182204|Immunologic Factors|immunologic factors|mesh-ancestor
101950177|NCT04182204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016072|NCT01339689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102016073|NCT01339689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016074|NCT01339689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016075|NCT01339689|GABA Modulators|gaba modulators|mesh-ancestor
102016076|NCT01339689|GABA Agents|gaba agents|mesh-ancestor
102016077|NCT00702806|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102016096|NCT00696878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102016097|NCT00696878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016099|NCT04493151|Relebactam|relebactam|mesh-list
102016100|NCT04493151|Cilastatin|cilastatin|mesh-list
102016101|NCT04493151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102016102|NCT04493151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102016103|NCT04493151|Protease Inhibitors|protease inhibitors|mesh-ancestor
102016104|NCT04493151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102016105|NCT04493151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016106|NCT04493151|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102016107|NCT00731757|Adalimumab|adalimumab|mesh-list
102016108|NCT00731757|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102016109|NCT00731757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101521627|NCT02904369|Tenofovir|tenofovir|mesh-list
102016110|NCT00731757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102016111|NCT03108274|Fexofenadine|fexofenadine|mesh-list
102016112|NCT03108274|Mycophenolic Acid|mycophenolic acid|mesh-list
102016113|NCT03108274|Midazolam|midazolam|mesh-list
102016114|NCT03108274|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102016115|NCT03108274|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102016116|NCT03108274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102016117|NCT03108274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016118|NCT03108274|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102016119|NCT03108274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102016120|NCT03108274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102016121|NCT03108274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102016122|NCT03108274|Anesthetics, General|anesthetics, general|mesh-ancestor
102016123|NCT03108274|Anesthetics|anesthetics|mesh-ancestor
102016124|NCT03108274|GABA Modulators|gaba modulators|mesh-ancestor
102016125|NCT03108274|GABA Agents|gaba agents|mesh-ancestor
101735855|NCT02603198|Mydriatics|mydriatics|mesh-ancestor
102016126|NCT03108274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102016127|NCT03108274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016128|NCT03108274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102016129|NCT03108274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102016130|NCT03108274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102016131|NCT03108274|Antitubercular Agents|antitubercular agents|mesh-ancestor
102016132|NCT03108274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102016133|NCT03108274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102016134|NCT03108274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102016162|NCT03294772|Hand Sanitizers|hand sanitizers|mesh-list
102016163|NCT03294772|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102016164|NCT03294772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102016165|NCT03294772|Disinfectants|disinfectants|mesh-ancestor
102016167|NCT03288532|Tremelimumab|tremelimumab|mesh-list
102016168|NCT03288532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102016169|NCT03288532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102016170|NCT00598208|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102016171|NCT00598208|Hormones|hormones|mesh-ancestor
102016172|NCT00598208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102016173|NCT00598208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016174|NCT00480662|Alendronate|alendronate|mesh-list
102016175|NCT00480662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102016176|NCT00480662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016177|NCT00398606|Alendronate|alendronate|mesh-list
102016178|NCT00398606|Calcium Carbonate|calcium carbonate|mesh-list
102016179|NCT00398606|Calcium|calcium|mesh-list
102016180|NCT00398606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101950178|NCT04182204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101950179|NCT04182204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101950180|NCT04182204|Antimetabolites|antimetabolites|mesh-ancestor
101950181|NCT04182204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950182|NCT04182204|Immunoconjugates|immunoconjugates|mesh-ancestor
102016181|NCT00398606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016182|NCT00398606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016186|NCT00395408|Beclomethasone|beclomethasone|mesh-list
102016187|NCT00395408|Montelukast|montelukast|mesh-list
102016188|NCT00395408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016189|NCT00395408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016190|NCT00395408|Respiratory System Agents|respiratory system agents|mesh-ancestor
102016191|NCT00395408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102016192|NCT00395408|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102016193|NCT00395408|Hormone Antagonists|hormone antagonists|mesh-ancestor
102016194|NCT00395408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102016195|NCT00395408|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102016196|NCT00395408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102016197|NCT00395408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102016198|NCT00395408|Glucocorticoids|glucocorticoids|mesh-ancestor
102016199|NCT00395408|Hormones|hormones|mesh-ancestor
102016200|NCT02462044|Iodine|iodine|mesh-list
102016201|NCT02462044|Cadexomer iodine|cadexomer iodine|mesh-list
102016202|NCT02462044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102016203|NCT02462044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102016204|NCT02462044|Trace Elements|trace elements|mesh-ancestor
102016205|NCT02462044|Micronutrients|micronutrients|mesh-ancestor
102016206|NCT02462044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016207|NCT00289874|Montelukast|montelukast|mesh-list
102016208|NCT00289874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102016209|NCT00289874|Respiratory System Agents|respiratory system agents|mesh-ancestor
102016210|NCT00289874|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102016211|NCT00289874|Hormone Antagonists|hormone antagonists|mesh-ancestor
102016212|NCT00289874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102016213|NCT00289874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016214|NCT00289874|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102016215|NCT00289874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102016216|NCT00289874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016217|NCT00245570|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102016218|NCT00245570|Montelukast|montelukast|mesh-list
102016219|NCT00245570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102016220|NCT00245570|Autonomic Agents|autonomic agents|mesh-ancestor
102016221|NCT00245570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102016222|NCT00245570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016223|NCT00245570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102016224|NCT00245570|Respiratory System Agents|respiratory system agents|mesh-ancestor
102016225|NCT00245570|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102016226|NCT00245570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102016227|NCT00245570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102016228|NCT00245570|Adrenergic Agents|adrenergic agents|mesh-ancestor
102016229|NCT00245570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102016230|NCT00245570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016231|NCT00245570|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102016232|NCT00245570|Hormone Antagonists|hormone antagonists|mesh-ancestor
102016233|NCT00245570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102016234|NCT00245570|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102016235|NCT00245570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102016236|NCT02461888|Dexamethasone|dexamethasone|mesh-list
102016237|NCT02461888|Cyclophosphamide|cyclophosphamide|mesh-list
102016238|NCT02461888|Ixazomib|ixazomib|mesh-list
102016239|NCT02461888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102016240|NCT02461888|Immunologic Factors|immunologic factors|mesh-ancestor
102016241|NCT02461888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016242|NCT02461888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102016243|NCT02461888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102016244|NCT02461888|Alkylating Agents|alkylating agents|mesh-ancestor
102016245|NCT02461888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016246|NCT02461888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102016247|NCT02461888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102016248|NCT02461888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102016249|NCT02461888|Antiemetics|antiemetics|mesh-ancestor
102016250|NCT02461888|Autonomic Agents|autonomic agents|mesh-ancestor
102016251|NCT02461888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102016252|NCT02461888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102016256|NCT02461888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102016258|NCT02461888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102016259|NCT00229970|Montelukast|montelukast|mesh-list
102016260|NCT00229970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102016261|NCT00229970|Respiratory System Agents|respiratory system agents|mesh-ancestor
102016262|NCT00229970|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102016263|NCT00229970|Hormone Antagonists|hormone antagonists|mesh-ancestor
102016264|NCT00229970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101521658|NCT02894892|Antacids|antacids|mesh-ancestor
102016265|NCT00229970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016266|NCT00229970|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102016267|NCT00229970|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102016268|NCT00229970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016269|NCT00111722|Rizatriptan|rizatriptan|mesh-list
102016270|NCT00111722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102016271|NCT00111722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016272|NCT00111722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016273|NCT00111722|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102016274|NCT00111722|Serotonin Agents|serotonin agents|mesh-ancestor
101736004|NCT02607371|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102016275|NCT04626596|Etonogestrel|etonogestrel|mesh-list
102016276|NCT04626596|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102016277|NCT04626596|Contraceptive Agents|contraceptive agents|mesh-ancestor
102016278|NCT04626596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102016279|NCT04626596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016280|NCT04626596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102016282|NCT05235100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102016283|NCT05235100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102016284|NCT05235100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102016285|NCT05235100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016286|NCT03294382|Botulinum Toxins|botulinum toxins|mesh-list
102016287|NCT03294382|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102016288|NCT03294382|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102016289|NCT03294382|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102016290|NCT03294382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102016291|NCT03294382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016292|NCT03294382|Cholinergic Agents|cholinergic agents|mesh-ancestor
102016293|NCT03294382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102016294|NCT03294382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016295|NCT03294382|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102016296|NCT03294382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102016297|NCT00092066|Cholecalciferol|cholecalciferol|mesh-list
102016298|NCT00092066|Vitamin D|vitamin d|mesh-list
102016299|NCT00092066|Alendronate|alendronate|mesh-list
102016300|NCT00092066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102016301|NCT00092066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016302|NCT00092066|Vitamins|vitamins|mesh-ancestor
102016303|NCT00092066|Micronutrients|micronutrients|mesh-ancestor
102016304|NCT00092066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102016305|NCT01334619|Ropivacaine|ropivacaine|mesh-list
102016306|NCT01334619|Anesthetics, Local|anesthetics, local|mesh-ancestor
102016307|NCT01334619|Anesthetics|anesthetics|mesh-ancestor
102016308|NCT01334619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102016309|NCT01334619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016310|NCT01334619|Sensory System Agents|sensory system agents|mesh-ancestor
102016311|NCT01334619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102016312|NCT03287128|Gemtuzumab|gemtuzumab|mesh-list
102016313|NCT03287128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102016314|NCT03287128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102016315|NCT03287128|Immunotoxins|immunotoxins|mesh-ancestor
101950201|NCT04165967|Nivolumab|nivolumab|mesh-list
101950202|NCT04165967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101950203|NCT04165967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101950204|NCT04165967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101950205|NCT04165967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950206|NCT04165317|BCG Vaccine|bcg vaccine|mesh-list
102016316|NCT03287128|Immunoconjugates|immunoconjugates|mesh-ancestor
102016317|NCT03287128|Immunologic Factors|immunologic factors|mesh-ancestor
102016318|NCT03287128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016319|NCT00457275|Ezetimibe|ezetimibe|mesh-list
102016320|NCT00457275|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102016321|NCT00457275|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101471284|NCT02758717|Nivolumab|nivolumab|mesh-list
102016328|NCT03294070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102016329|NCT03294070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016330|NCT03294070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102016331|NCT03294070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016332|NCT03294070|Vasodilator Agents|vasodilator agents|mesh-ancestor
102016333|NCT04479566|Lithium Carbonate|lithium carbonate|mesh-list
102016334|NCT04479566|Calcium Carbonate|calcium carbonate|mesh-list
102016335|NCT04479566|Calcium|calcium|mesh-list
102016336|NCT04479566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102016337|NCT04479566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016338|NCT04479566|Antidepressive Agents|antidepressive agents|mesh-ancestor
102016339|NCT04479566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102016340|NCT04479566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102016341|NCT04479566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016342|NCT04479566|Antimanic Agents|antimanic agents|mesh-ancestor
102016343|NCT04479566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102016344|NCT04479566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102016345|NCT04479566|Antacids|antacids|mesh-ancestor
102016346|NCT04479566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102016347|NCT03293992|Latanoprost|latanoprost|mesh-list
102016348|NCT03293992|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101736087|NCT00732498|Cytarabine|cytarabine|mesh-list
102016349|NCT03293992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102016350|NCT01332201|Tacrolimus|tacrolimus|mesh-list
102016351|NCT01332201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102016352|NCT01332201|Immunologic Factors|immunologic factors|mesh-ancestor
102016353|NCT01332201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016354|NCT01332201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102016355|NCT01332201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102016356|NCT01332201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016357|NCT01332279|Everolimus|everolimus|mesh-list
102016358|NCT01332279|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102016359|NCT01332279|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102016360|NCT01332279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102016361|NCT01332279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102016362|NCT01332279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016363|NCT01332279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102016364|NCT01332279|Immunologic Factors|immunologic factors|mesh-ancestor
102016365|NCT01332279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016366|NCT01332279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102016367|NCT03298906|Ticlopidine|ticlopidine|mesh-list
102016368|NCT03298906|Esketamine|esketamine|mesh-list
102016369|NCT03298906|Antidepressive Agents|antidepressive agents|mesh-ancestor
102016370|NCT03298906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102016371|NCT03298906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102016372|NCT03298906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101950208|NCT04165317|Immunologic Factors|immunologic factors|mesh-ancestor
102016373|NCT03298906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016374|NCT03298906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102016375|NCT03298906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102016376|NCT03298906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102016377|NCT03298906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102016378|NCT03298906|Purinergic Agents|purinergic agents|mesh-ancestor
102016379|NCT03298906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102016380|NCT03298906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016381|NCT03298906|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102016382|NCT03298906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102016383|NCT03298906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102016384|NCT03697629|Daratumumab|daratumumab|mesh-list
102016385|NCT03697629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102016386|NCT00398541|Losartan|losartan|mesh-list
102016387|NCT00398541|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102016388|NCT00398541|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102016416|NCT02460640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102016417|NCT02460640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016418|NCT02460640|Analgesics|analgesics|mesh-ancestor
102016419|NCT02460640|Sensory System Agents|sensory system agents|mesh-ancestor
102016420|NCT02460640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102016421|NCT02460640|Anesthetics, Local|anesthetics, local|mesh-ancestor
102016422|NCT02460640|Anesthetics|anesthetics|mesh-ancestor
102016423|NCT03298516|Azacitidine|azacitidine|mesh-list
102016424|NCT03298516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102016425|NCT03298516|Antimetabolites|antimetabolites|mesh-ancestor
102016426|NCT03298516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016427|NCT03298516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102016428|NCT03298516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102016429|NCT05120960|Osimertinib|osimertinib|mesh-list
102016430|NCT05120960|Tepotinib|tepotinib|mesh-list
102016431|NCT05120960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102016432|NCT05120960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102016433|NCT05120960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102016437|NCT03843008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016438|NCT03843008|Protective Agents|protective agents|mesh-ancestor
102016439|NCT03843008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016440|NCT03843008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102016441|NCT03285802|Everolimus|everolimus|mesh-list
102016442|NCT03285802|Letrozole|letrozole|mesh-list
102016443|NCT03285802|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102016444|NCT03285802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102016445|NCT03285802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102016446|NCT03285802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016447|NCT03285802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102016448|NCT03285802|Immunologic Factors|immunologic factors|mesh-ancestor
102016449|NCT03285802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016450|NCT03285802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102016451|NCT03285802|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102016452|NCT03285802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102016453|NCT03285802|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102016454|NCT03285802|Hormone Antagonists|hormone antagonists|mesh-ancestor
102016455|NCT03285802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102016456|NCT05130086|Islatravir|islatravir|mesh-list
102016457|NCT05130086|Antiviral Agents|antiviral agents|mesh-ancestor
102016458|NCT05130086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102016459|NCT05130086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102016460|NCT05130086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016461|NCT05130086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102016462|NCT05130086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102016463|NCT05130086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102016464|NCT02461186|Piperaquine|piperaquine|mesh-list
102016465|NCT02461186|Artenimol|artenimol|mesh-list
102016466|NCT02461186|Antimalarials|antimalarials|mesh-ancestor
102016467|NCT02461186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102016468|NCT02461186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102016469|NCT02461186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102016470|NCT04921670|Infliximab|infliximab|mesh-list
102016471|NCT04921670|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102016472|NCT04921670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102016473|NCT04921670|Dermatologic Agents|dermatologic agents|mesh-ancestor
101950209|NCT04165317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950210|NCT04064359|Antibodies|antibodies|mesh-list
101950211|NCT04064359|Immunoconjugates|immunoconjugates|mesh-list
101950212|NCT04064359|Immunologic Factors|immunologic factors|mesh-ancestor
101950213|NCT04064359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950214|NCT04044859|Pembrolizumab|pembrolizumab|mesh-list
101950215|NCT04044859|Nivolumab|nivolumab|mesh-list
101278368|NCT02783092|Cannabidiol|cannabidiol|mesh-list
102016474|NCT04921670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102016475|NCT04921670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102016476|NCT03512210|Sofosbuvir|sofosbuvir|mesh-list
102016477|NCT03512210|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102016478|NCT03512210|Velpatasvir|velpatasvir|mesh-list
102016479|NCT03512210|Antiviral Agents|antiviral agents|mesh-ancestor
102016480|NCT03512210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102016481|NCT00383721|Mometasone Furoate|mometasone furoate|mesh-list
102016482|NCT00383721|Formoterol Fumarate|formoterol fumarate|mesh-list
102016483|NCT00383721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102016484|NCT00383721|Autonomic Agents|autonomic agents|mesh-ancestor
102016485|NCT00383721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102016486|NCT00383721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016487|NCT00383721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102016488|NCT00383721|Respiratory System Agents|respiratory system agents|mesh-ancestor
102016489|NCT00383721|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102016490|NCT00383721|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102016491|NCT00383721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102016492|NCT00383721|Adrenergic Agents|adrenergic agents|mesh-ancestor
102016493|NCT00383721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102016494|NCT00383721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016495|NCT00383721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102016496|NCT00383721|Dermatologic Agents|dermatologic agents|mesh-ancestor
102016497|NCT00383721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102016498|NCT03292822|Paclitaxel|paclitaxel|mesh-list
102016499|NCT03292822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102016500|NCT03292822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102016501|NCT03292822|Tubulin Modulators|tubulin modulators|mesh-ancestor
102016502|NCT03292822|Antimitotic Agents|antimitotic agents|mesh-ancestor
102016503|NCT03292822|Mitosis Modulators|mitosis modulators|mesh-ancestor
102016504|NCT03292822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016505|NCT03297502|Pimecrolimus|pimecrolimus|mesh-list
102016519|NCT03297502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102016520|NCT03297502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016521|NCT03292744|Cholecalciferol|cholecalciferol|mesh-list
102016523|NCT03292744|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
102016524|NCT03292744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102016525|NCT03292744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016526|NCT03292744|Vitamins|vitamins|mesh-ancestor
102016527|NCT03292744|Micronutrients|micronutrients|mesh-ancestor
102016528|NCT03292744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102016529|NCT03035942|Dexamethasone|dexamethasone|mesh-list
102016530|NCT03035942|Ondansetron|ondansetron|mesh-list
102016531|NCT03035942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102016532|NCT03035942|Antiemetics|antiemetics|mesh-ancestor
102016533|NCT03035942|Autonomic Agents|autonomic agents|mesh-ancestor
102016534|NCT03035942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102016535|NCT03035942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016536|NCT03035942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102016537|NCT03035942|Glucocorticoids|glucocorticoids|mesh-ancestor
102016538|NCT03035942|Hormones|hormones|mesh-ancestor
102016539|NCT03035942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102016540|NCT03035942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102016541|NCT03035942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102016542|NCT03035942|Antipruritics|antipruritics|mesh-ancestor
102016543|NCT03035942|Dermatologic Agents|dermatologic agents|mesh-ancestor
102016544|NCT03035942|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102016545|NCT03035942|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102016546|NCT03035942|Serotonin Agents|serotonin agents|mesh-ancestor
102016547|NCT03035942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102016548|NCT03035942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950216|NCT04044859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101950217|NCT04044859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101950218|NCT04044859|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101950219|NCT04044859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016549|NCT02820519|Loxapine|loxapine|mesh-list
102016550|NCT02820519|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102016551|NCT02820519|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102016552|NCT02820519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102016553|NCT02820519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016554|NCT02820519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102016555|NCT02820519|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102016556|NCT02820519|Dopamine Agents|dopamine agents|mesh-ancestor
102016557|NCT02820519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102016558|NCT02820519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016559|NCT02616146|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102016560|NCT02616146|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102016561|NCT02616146|Levonorgestrel|levonorgestrel|mesh-list
102016562|NCT02616146|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102016563|NCT02616146|Etonogestrel|etonogestrel|mesh-list
102016564|NCT02616146|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
102016565|NCT02616146|Estradiol|estradiol|mesh-list
102016566|NCT02616146|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102016567|NCT02616146|Estrogens|estrogens|mesh-ancestor
102016572|NCT02616146|Contraceptive Agents|contraceptive agents|mesh-ancestor
101736308|NCT00918489|Vorinostat|vorinostat|mesh-list
102016573|NCT02616146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102016574|NCT02616146|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102016575|NCT02616146|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102016576|NCT02616146|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102016577|NCT02616146|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102016578|NCT02616146|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102016580|NCT01332747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102016581|NCT01332747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102016582|NCT01332747|Antimetabolites|antimetabolites|mesh-ancestor
102016583|NCT01332747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016584|NCT01332747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102016585|NCT01332747|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102016586|NCT01332747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102016587|NCT03442413|Nicotine|nicotine|mesh-list
102016588|NCT03442413|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102016589|NCT03442413|Autonomic Agents|autonomic agents|mesh-ancestor
102016590|NCT03442413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102016591|NCT03442413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016592|NCT03442413|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102016593|NCT03442413|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102016594|NCT03442413|Cholinergic Agents|cholinergic agents|mesh-ancestor
102016595|NCT03442413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102016596|NCT03442413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016597|NCT01337427|Interferons|interferons|mesh-list
102016598|NCT01337427|Interferon-beta|interferon-beta|mesh-list
102016599|NCT01337427|Interferon beta-1a|interferon beta-1a|mesh-list
102016600|NCT01337427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102016601|NCT01337427|Antiviral Agents|antiviral agents|mesh-ancestor
102016602|NCT01337427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102016603|NCT01337427|Immunologic Factors|immunologic factors|mesh-ancestor
102016604|NCT01337427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016605|NCT01337427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102016606|NCT02459938|Glucagon|glucagon|mesh-list
102016607|NCT02459938|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102016608|NCT02459938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102016609|NCT02459938|Hormones|hormones|mesh-ancestor
102016610|NCT02459938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102016611|NCT02459938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016612|NCT02459938|Incretins|incretins|mesh-ancestor
102016613|NCT03284164|Tenofovir|tenofovir|mesh-list
102016614|NCT03284164|Antiviral Agents|antiviral agents|mesh-ancestor
102016615|NCT03284164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102016616|NCT03284164|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102016617|NCT03284164|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101950221|NCT04007224|Oxytocics|oxytocics|mesh-ancestor
101950222|NCT04007224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101950223|NCT04007224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950224|NCT04006457|Vaccines|vaccines|mesh-list
101950225|NCT04006457|Immunologic Factors|immunologic factors|mesh-ancestor
101950226|NCT04006457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950227|NCT03995628|Dexamethasone|dexamethasone|mesh-list
101950228|NCT03995628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101950229|NCT03995628|Antiemetics|antiemetics|mesh-ancestor
101950230|NCT03995628|Autonomic Agents|autonomic agents|mesh-ancestor
101950231|NCT03995628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101950232|NCT03995628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950233|NCT03995628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101950234|NCT03995628|Glucocorticoids|glucocorticoids|mesh-ancestor
101950235|NCT03995628|Hormones|hormones|mesh-ancestor
101950236|NCT03995628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101950237|NCT03995628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101950238|NCT03995628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101950239|NCT03952585|Deoxyglucose|deoxyglucose|mesh-list
102016618|NCT03284164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102016619|NCT03284164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016620|NCT03284164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102016621|NCT03284164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102016622|NCT01337583|Dapivirine|dapivirine|mesh-list
102016623|NCT01337583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102016624|NCT01337583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102016625|NCT01337583|Antiviral Agents|antiviral agents|mesh-ancestor
102016626|NCT01337583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102016627|NCT03107962|Pembrolizumab|pembrolizumab|mesh-list
102016628|NCT03107962|Antibodies|antibodies|mesh-list
102016629|NCT03107962|Antibodies, Blocking|antibodies, blocking|mesh-list
102016630|NCT03107962|Immunologic Factors|immunologic factors|mesh-ancestor
101521821|NCT05427903|Mydriatics|mydriatics|mesh-ancestor
102016631|NCT03107962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016632|NCT03107962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102016633|NCT03107962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102016634|NCT03107962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102016635|NCT03107962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016636|NCT04891172|Immunoglobulins|immunoglobulins|mesh-list
102016637|NCT04891172|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102016642|NCT04891172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016644|NCT03135249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102016645|NCT03135249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102016646|NCT01335321|Triamcinolone|triamcinolone|mesh-list
102016647|NCT01335321|Hyaluronic Acid|hyaluronic acid|mesh-list
102016648|NCT01335321|Hylan|hylan|mesh-list
102016649|NCT01335321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102016650|NCT01335321|Glucocorticoids|glucocorticoids|mesh-ancestor
102016652|NCT01335321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102016653|NCT01335321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016654|NCT01335321|Immunologic Factors|immunologic factors|mesh-ancestor
102016655|NCT01335321|Viscosupplements|viscosupplements|mesh-ancestor
102016656|NCT01335321|Protective Agents|protective agents|mesh-ancestor
102016657|NCT01335321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102016658|NCT01333137|Carboplatin|carboplatin|mesh-list
102016659|NCT01333137|Gemcitabine|gemcitabine|mesh-list
102016660|NCT01333137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102016661|NCT01333137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102016662|NCT01333137|Antimetabolites|antimetabolites|mesh-ancestor
101950241|NCT03952585|Nivolumab|nivolumab|mesh-list
101950242|NCT03952585|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101950243|NCT03952585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101950244|NCT03952585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101950245|NCT03952585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101950246|NCT03952585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950247|NCT03952585|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101950248|NCT03952585|Antimetabolites|antimetabolites|mesh-ancestor
101950249|NCT03952585|Antiviral Agents|antiviral agents|mesh-ancestor
101950250|NCT03952585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101950251|NCT03923556|Neostigmine|neostigmine|mesh-list
101950252|NCT03923556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101950253|NCT03923556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101950254|NCT03923556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016663|NCT01333137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016664|NCT03282838|Celecoxib|celecoxib|mesh-list
102016665|NCT03282838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102016666|NCT03282838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102016667|NCT03282838|Analgesics|analgesics|mesh-ancestor
102016668|NCT03282838|Sensory System Agents|sensory system agents|mesh-ancestor
102016669|NCT03282838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102016670|NCT03282838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016671|NCT03282838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102016672|NCT03282838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102016673|NCT03282838|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102016674|NCT03282838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102016675|NCT03282838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102016676|NCT03282838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016677|NCT04431466|Ivermectin|ivermectin|mesh-list
102016678|NCT04431466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102016679|NCT04431466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102016680|NCT03291418|Naproxen|naproxen|mesh-list
102016681|NCT03291418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102016682|NCT03291418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102016683|NCT03291418|Analgesics|analgesics|mesh-ancestor
102016684|NCT03291418|Sensory System Agents|sensory system agents|mesh-ancestor
102016685|NCT03291418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102016686|NCT03291418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016687|NCT03291418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102016688|NCT03291418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102016689|NCT03291418|Gout Suppressants|gout suppressants|mesh-ancestor
102016690|NCT03291418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102016691|NCT03291418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102016692|NCT03291418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016693|NCT02885181|Methotrexate|methotrexate|mesh-list
102016694|NCT02885181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102016695|NCT02885181|Abortifacient Agents|abortifacient agents|mesh-ancestor
102016696|NCT02885181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102016697|NCT02885181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016698|NCT02885181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102016699|NCT02885181|Antimetabolites|antimetabolites|mesh-ancestor
102016700|NCT02885181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016701|NCT02885181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102016702|NCT02885181|Dermatologic Agents|dermatologic agents|mesh-ancestor
102016703|NCT02885181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102016704|NCT02885181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102016705|NCT02885181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102016706|NCT02885181|Immunologic Factors|immunologic factors|mesh-ancestor
101950255|NCT03923556|Cholinergic Agents|cholinergic agents|mesh-ancestor
101950256|NCT03923556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101950257|NCT03923556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950258|NCT03923556|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101950259|NCT03923556|Autonomic Agents|autonomic agents|mesh-ancestor
101950260|NCT03923556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101950261|NCT03914300|Nivolumab|nivolumab|mesh-list
101950262|NCT03914300|Ipilimumab|ipilimumab|mesh-list
101950263|NCT03914300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101950264|NCT03914300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101950265|NCT03914300|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101950266|NCT03914300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950267|NCT03913247|Metronidazole|metronidazole|mesh-list
101950268|NCT03913247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101950269|NCT03913247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101950270|NCT03913247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101950271|NCT03913247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101950272|NCT03866382|Nivolumab|nivolumab|mesh-list
101950273|NCT03866382|Ipilimumab|ipilimumab|mesh-list
102016707|NCT02885181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102016708|NCT02885181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102016709|NCT02459782|Anesthetics|anesthetics|mesh-list
102016714|NCT02884089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016715|NCT01315431|Capecitabine|capecitabine|mesh-list
102016716|NCT01315431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102016717|NCT01315431|Antimetabolites|antimetabolites|mesh-ancestor
102016718|NCT01315431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016719|NCT01315431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102016721|NCT00092625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102016722|NCT00092625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102016723|NCT00092625|Antimetabolites|antimetabolites|mesh-ancestor
102016724|NCT00092625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016725|NCT00092625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102016726|NCT01333449|Decitabine|decitabine|mesh-list
102016727|NCT01333449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102016728|NCT01333449|Antimetabolites|antimetabolites|mesh-ancestor
102016729|NCT01333449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016730|NCT01333449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102016731|NCT01333449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102016732|NCT01341717|Metformin|metformin|mesh-list
102016733|NCT01341717|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102016734|NCT01341717|Glimepiride|glimepiride|mesh-list
102016735|NCT01341717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102016736|NCT01341717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016737|NCT01341717|Incretins|incretins|mesh-ancestor
102016738|NCT01341717|Hormones|hormones|mesh-ancestor
102016739|NCT01341717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102016740|NCT01341717|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102016741|NCT01341717|Protease Inhibitors|protease inhibitors|mesh-ancestor
102016742|NCT01341717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102016743|NCT01341717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016744|NCT01341717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102016745|NCT01341717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102016746|NCT01341717|Immunologic Factors|immunologic factors|mesh-ancestor
102016747|NCT03157089|Pembrolizumab|pembrolizumab|mesh-list
102016748|NCT03157089|Afatinib|afatinib|mesh-list
102016749|NCT03157089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101950274|NCT03866382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101950275|NCT03866382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101950276|NCT03866382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101950277|NCT03866382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016750|NCT03157089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102016751|NCT03157089|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102016752|NCT03157089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016753|NCT03157089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102016754|NCT03157089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102016755|NCT01338129|Ascorbic Acid|ascorbic acid|mesh-list
102016756|NCT01338129|Vitamins|vitamins|mesh-ancestor
102016757|NCT01338129|Micronutrients|micronutrients|mesh-ancestor
102016758|NCT01338129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016759|NCT01338129|Antioxidants|antioxidants|mesh-ancestor
101521881|NCT01225822|Anticoagulants|anticoagulants|mesh-ancestor
102016760|NCT01338129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016761|NCT01338129|Protective Agents|protective agents|mesh-ancestor
102016762|NCT05181969|Dextrans|dextrans|mesh-list
102016763|NCT05181969|Anticoagulants|anticoagulants|mesh-ancestor
102016764|NCT05181969|Plasma Substitutes|plasma substitutes|mesh-ancestor
102016765|NCT05181969|Blood Substitutes|blood substitutes|mesh-ancestor
102016766|NCT00092157|Simvastatin|simvastatin|mesh-list
102016767|NCT00092157|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102016768|NCT00092157|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102016769|NCT00092157|Antimetabolites|antimetabolites|mesh-ancestor
102016770|NCT00092157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016771|NCT00092157|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102016772|NCT00092157|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102016773|NCT00092157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102016774|NCT00089895|Eptifibatide|eptifibatide|mesh-list
102016775|NCT00089895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102016776|NCT05166291|Anesthetics|anesthetics|mesh-list
102016777|NCT05166291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102016778|NCT05166291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016779|NCT01338441|Erythromycin|erythromycin|mesh-list
102016780|NCT01338441|Erythromycin Estolate|erythromycin estolate|mesh-list
102016788|NCT01338441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016789|NCT01341951|Lenograstim|lenograstim|mesh-list
102016790|NCT01341951|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102016791|NCT01341951|Immunologic Factors|immunologic factors|mesh-ancestor
102016792|NCT01341951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016793|NCT01342185|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
102016794|NCT01342185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102016795|NCT02714218|Nivolumab|nivolumab|mesh-list
102016796|NCT02714218|Ipilimumab|ipilimumab|mesh-list
102016797|NCT02714218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102016798|NCT02714218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102016799|NCT02714218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102016800|NCT02714218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016802|NCT05185869|Gemcitabine|gemcitabine|mesh-list
102016803|NCT05185869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102016804|NCT05185869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102016805|NCT05185869|Tubulin Modulators|tubulin modulators|mesh-ancestor
102016806|NCT05185869|Antimitotic Agents|antimitotic agents|mesh-ancestor
102016807|NCT05185869|Mitosis Modulators|mitosis modulators|mesh-ancestor
102016808|NCT05185869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016809|NCT05185869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102016810|NCT05185869|Antimetabolites|antimetabolites|mesh-ancestor
102016811|NCT01338675|Busulfan|busulfan|mesh-list
102016812|NCT01338675|Alkylating Agents|alkylating agents|mesh-ancestor
102016813|NCT01338675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016814|NCT01338675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102016815|NCT01338675|Immunologic Factors|immunologic factors|mesh-ancestor
102016816|NCT01338675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016817|NCT01338675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102016818|NCT01338675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102016819|NCT01338675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102016820|NCT01338753|Bevacizumab|bevacizumab|mesh-list
102016821|NCT01338753|Docetaxel|docetaxel|mesh-list
101950279|NCT03816982|Anesthetics, Local|anesthetics, local|mesh-ancestor
101521894|NCT00445874|Histamine Agents|histamine agents|mesh-ancestor
101950281|NCT03816982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101278765|NCT01874028|Trientine|trientine|mesh-list
102016822|NCT01338753|Doxorubicin|doxorubicin|mesh-list
102016823|NCT01338753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102016824|NCT01338753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102016825|NCT01338753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102016826|NCT01338753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102016827|NCT01338753|Growth Substances|growth substances|mesh-ancestor
102016828|NCT01338753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016829|NCT01338753|Growth Inhibitors|growth inhibitors|mesh-ancestor
102016830|NCT01338753|Tubulin Modulators|tubulin modulators|mesh-ancestor
102016831|NCT01338753|Antimitotic Agents|antimitotic agents|mesh-ancestor
102016832|NCT01338753|Mitosis Modulators|mitosis modulators|mesh-ancestor
102016833|NCT01338753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016834|NCT01338753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102016835|NCT01338753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102016836|NCT01338753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102016837|NCT01338753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102016838|NCT02457286|Metformin|metformin|mesh-list
102016839|NCT02457286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102016840|NCT02457286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016841|NCT01338909|Clopidogrel|clopidogrel|mesh-list
102016842|NCT01338909|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102016843|NCT01338909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102016844|NCT01338909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102016845|NCT01338909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102016846|NCT01338909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102016847|NCT01338909|Purinergic Agents|purinergic agents|mesh-ancestor
102016848|NCT01338909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102016860|NCT03156621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016861|NCT03156621|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102016862|NCT03156621|Protease Inhibitors|protease inhibitors|mesh-ancestor
102016863|NCT03156621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102016864|NCT03156621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102016866|NCT03264586|Prilocaine|prilocaine|mesh-list
102016867|NCT03264586|Mepivacaine|mepivacaine|mesh-list
102016868|NCT03264586|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
102016869|NCT03264586|Anesthetics, Local|anesthetics, local|mesh-ancestor
102016870|NCT03264586|Anesthetics|anesthetics|mesh-ancestor
102016871|NCT03264586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102016872|NCT03264586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016873|NCT03264586|Sensory System Agents|sensory system agents|mesh-ancestor
102016874|NCT03264586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102016875|NCT03264586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102016876|NCT03264586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102016877|NCT03264586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102016878|NCT03264586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102016879|NCT03264586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016880|NCT03264586|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
102016882|NCT01342731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102016883|NCT01342731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102016884|NCT01342731|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102016885|NCT01342731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102016886|NCT01342731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016887|NCT01339065|Ketamine|ketamine|mesh-list
102016888|NCT01339065|Analgesics|analgesics|mesh-ancestor
102016889|NCT01339065|Sensory System Agents|sensory system agents|mesh-ancestor
102016890|NCT01339065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102016891|NCT01339065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521910|NCT01225549|Hormones|hormones|mesh-ancestor
102016892|NCT01339065|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102016893|NCT01339065|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102016894|NCT01339065|Anesthetics, General|anesthetics, general|mesh-ancestor
102016895|NCT01339065|Anesthetics|anesthetics|mesh-ancestor
102016896|NCT01339065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102016897|NCT01339065|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102016898|NCT01339065|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102016899|NCT01339065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101950282|NCT03816982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950283|NCT03816982|Sensory System Agents|sensory system agents|mesh-ancestor
101950284|NCT03816982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101950286|NCT03816397|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102016900|NCT01339065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016901|NCT02460016|Ziresovir|ziresovir|mesh-list
102016902|NCT02460016|Antiviral Agents|antiviral agents|mesh-ancestor
102016903|NCT02460016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102016904|NCT05187507|Theobromine|theobromine|mesh-list
102016905|NCT05187507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102016906|NCT05187507|Autonomic Agents|autonomic agents|mesh-ancestor
102016907|NCT05187507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102016908|NCT05187507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016909|NCT05187507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102016910|NCT05187507|Respiratory System Agents|respiratory system agents|mesh-ancestor
102016911|NCT05187507|Vasodilator Agents|vasodilator agents|mesh-ancestor
102016918|NCT01339143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102016919|NCT01339143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016921|NCT03264430|Bupivacaine|bupivacaine|mesh-list
102016922|NCT03264430|Anesthetics, Local|anesthetics, local|mesh-ancestor
102016923|NCT03264430|Anesthetics|anesthetics|mesh-ancestor
102016924|NCT03264430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102016925|NCT03264430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016926|NCT03264430|Sensory System Agents|sensory system agents|mesh-ancestor
102016927|NCT03264430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102016928|NCT03264430|Analgesics|analgesics|mesh-ancestor
102016929|NCT03264430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102016930|NCT03264430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102016931|NCT03264430|Anesthetics, General|anesthetics, general|mesh-ancestor
102016932|NCT03264430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102016933|NCT03264430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102016934|NCT03264430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102016935|NCT03264430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016936|NCT05250843|Lenvatinib|lenvatinib|mesh-list
102016937|NCT05250843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102016938|NCT05250843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102016939|NCT05250843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102016940|NCT05250843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016941|NCT03264274|Aflibercept|aflibercept|mesh-list
102016942|NCT03264274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102016943|NCT03264274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102016944|NCT03264274|Growth Substances|growth substances|mesh-ancestor
102016945|NCT03264274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016946|NCT03264274|Growth Inhibitors|growth inhibitors|mesh-ancestor
102016947|NCT03264274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102016949|NCT02457208|Isoniazid|isoniazid|mesh-list
102016950|NCT02457208|Pyrazinamide|pyrazinamide|mesh-list
102016951|NCT02457208|Ethambutol|ethambutol|mesh-list
102016952|NCT02457208|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102016953|NCT02457208|Antitubercular Agents|antitubercular agents|mesh-ancestor
102016954|NCT02457208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102016955|NCT02457208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102016956|NCT02457208|Leprostatic Agents|leprostatic agents|mesh-ancestor
102016957|NCT02457208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102016958|NCT02457208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102016959|NCT02457208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016960|NCT02457208|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102016961|NCT02457208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102016962|NCT02457208|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102016963|NCT02457208|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102016964|NCT02457208|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102016965|NCT02457208|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102016966|NCT02457208|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102016967|NCT02457208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102016968|NCT02457208|Antimetabolites|antimetabolites|mesh-ancestor
102016969|NCT02457208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102016970|NCT02457130|Clopidogrel|clopidogrel|mesh-list
102016971|NCT02457130|Ticagrelor|ticagrelor|mesh-list
101950287|NCT03816397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101950288|NCT03816397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101950289|NCT03794999|Benralizumab|benralizumab|mesh-list
101950290|NCT03794999|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101950291|NCT03794999|Respiratory System Agents|respiratory system agents|mesh-ancestor
101950292|NCT03751436|Venetoclax|venetoclax|mesh-list
101950293|NCT03751436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101950294|NCT03736629|Azithromycin|azithromycin|mesh-list
101950295|NCT03736629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101950296|NCT03736629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101950297|NCT03704363|Infliximab|infliximab|mesh-list
101278896|NCT01875185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102016972|NCT02457130|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102016973|NCT02457130|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102016974|NCT02457130|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102016975|NCT02457130|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102016976|NCT02457130|Purinergic Agents|purinergic agents|mesh-ancestor
102016977|NCT02457130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102016978|NCT02457130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016979|NCT02457130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016983|NCT01340235|Erythromycin stearate|erythromycin stearate|mesh-list
102016984|NCT01340235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102016985|NCT01340235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102016986|NCT01340235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102016987|NCT01340235|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102016988|NCT01340235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102016989|NCT01340235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016990|NCT03263962|Canrenone|canrenone|mesh-list
102016991|NCT03263962|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102016992|NCT03263962|Hormone Antagonists|hormone antagonists|mesh-ancestor
102016993|NCT03263962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102016994|NCT03263962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016995|NCT03263962|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102016996|NCT03263962|Diuretics|diuretics|mesh-ancestor
102016997|NCT03263962|Natriuretic Agents|natriuretic agents|mesh-ancestor
102016998|NCT05186649|Warfarin|warfarin|mesh-list
102016999|NCT05186649|Anticoagulants|anticoagulants|mesh-ancestor
102017000|NCT05184465|Anesthetics|anesthetics|mesh-list
102017001|NCT05184465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102017002|NCT05184465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017003|NCT03152019|Tacrolimus|tacrolimus|mesh-list
102017004|NCT03152019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102017005|NCT03152019|Immunologic Factors|immunologic factors|mesh-ancestor
102017006|NCT03152019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017007|NCT03152019|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102017008|NCT03152019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102017009|NCT03152019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017010|NCT04813107|Tislelizumab|tislelizumab|mesh-list
102017011|NCT04813107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102017012|NCT04813107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102017013|NCT02714062|Topiramate|topiramate|mesh-list
102017014|NCT02714062|Phentermine|phentermine|mesh-list
102017015|NCT02714062|Anticonvulsants|anticonvulsants|mesh-ancestor
102017016|NCT02714062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102017017|NCT02714062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017018|NCT02714062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102017019|NCT02714062|Appetite Depressants|appetite depressants|mesh-ancestor
102017020|NCT02714062|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102017021|NCT02714062|Sympathomimetics|sympathomimetics|mesh-ancestor
102017022|NCT02714062|Autonomic Agents|autonomic agents|mesh-ancestor
102017023|NCT02714062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102017024|NCT02714062|Adrenergic Agents|adrenergic agents|mesh-ancestor
102017025|NCT02714062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102017026|NCT02714062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950298|NCT03704363|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101950300|NCT03704363|Dermatologic Agents|dermatologic agents|mesh-ancestor
101950301|NCT03704363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101950302|NCT03704363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101950303|NCT03686124|Nivolumab|nivolumab|mesh-list
101950304|NCT03686124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101950305|NCT03686124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101950306|NCT03686124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101950307|NCT03686124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950308|NCT03681639|Cobalt|cobalt|mesh-list
101950309|NCT03681639|Chromium|chromium|mesh-list
101950310|NCT03681639|Trace Elements|trace elements|mesh-ancestor
101950311|NCT03681639|Micronutrients|micronutrients|mesh-ancestor
101950312|NCT03681639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950313|NCT03645928|Pembrolizumab|pembrolizumab|mesh-list
101950314|NCT03645928|Nivolumab|nivolumab|mesh-list
101950315|NCT03645928|Ipilimumab|ipilimumab|mesh-list
101278959|NCT01875822|Curcumin|curcumin|mesh-list
102017027|NCT03280342|Topiramate|topiramate|mesh-list
102017028|NCT03280342|Anticonvulsants|anticonvulsants|mesh-ancestor
102017029|NCT03280342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102017030|NCT03280342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017031|NCT04965519|Trastuzumab|trastuzumab|mesh-list
102017032|NCT04965519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102017033|NCT04965519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102017034|NCT03279796|Betamethasone|betamethasone|mesh-list
102017035|NCT03279796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102017036|NCT03279796|Glucocorticoids|glucocorticoids|mesh-ancestor
102017037|NCT03279796|Hormones|hormones|mesh-ancestor
102017038|NCT03279796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102017039|NCT03279796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017040|NCT03279796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102017041|NCT03279796|Respiratory System Agents|respiratory system agents|mesh-ancestor
102017042|NCT02713828|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
102017043|NCT02713828|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102017044|NCT02713828|Immunoconjugates|immunoconjugates|mesh-ancestor
102017045|NCT02713828|Immunologic Factors|immunologic factors|mesh-ancestor
102017046|NCT02713828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017047|NCT02713828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102017048|NCT02713828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102017049|NCT05183997|Verapamil|verapamil|mesh-list
102017050|NCT05183997|Thrombin|thrombin|mesh-list
102017051|NCT05183997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101628292|NCT00724243|Dermatologic Agents|dermatologic agents|mesh-ancestor
102017055|NCT05183997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102017056|NCT05183997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017057|NCT05183997|Vasodilator Agents|vasodilator agents|mesh-ancestor
102017058|NCT05183997|Hemostatics|hemostatics|mesh-ancestor
102017059|NCT05183997|Coagulants|coagulants|mesh-ancestor
102017060|NCT05119101|Magnesium Sulfate|magnesium sulfate|mesh-list
102017061|NCT05119101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102017062|NCT05119101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017063|NCT05119101|Analgesics|analgesics|mesh-ancestor
102017064|NCT05119101|Sensory System Agents|sensory system agents|mesh-ancestor
102017065|NCT05119101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102017066|NCT05119101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017067|NCT05119101|Anesthetics|anesthetics|mesh-ancestor
102017068|NCT05119101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102017069|NCT05119101|Anticonvulsants|anticonvulsants|mesh-ancestor
101950316|NCT03645928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101950317|NCT03645928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101950318|NCT03645928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101950319|NCT03645928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279017|NCT01876108|Antacids|antacids|mesh-ancestor
102017070|NCT05119101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102017071|NCT05119101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102017072|NCT05119101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102017073|NCT05119101|Tocolytic Agents|tocolytic agents|mesh-ancestor
102017074|NCT05119101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102017075|NCT01340547|Isophosphamide mustard|isophosphamide mustard|mesh-list
102017077|NCT01340547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102017078|NCT01340547|Alkylating Agents|alkylating agents|mesh-ancestor
102017079|NCT01340547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017080|NCT01340547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102017081|NCT05183841|Fenoterol|fenoterol|mesh-list
102017082|NCT05183841|Ipratropium|ipratropium|mesh-list
102017083|NCT05183841|Bronchodilator Agents|bronchodilator agents|mesh-list
102017084|NCT05183841|Autonomic Agents|autonomic agents|mesh-ancestor
102017085|NCT05183841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102017086|NCT05183841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017087|NCT05183841|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102017088|NCT05183841|Respiratory System Agents|respiratory system agents|mesh-ancestor
102017089|NCT05183841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102017090|NCT05183841|Cholinergic Agents|cholinergic agents|mesh-ancestor
102017091|NCT05183841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102017092|NCT05183841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017093|NCT05183841|Sympathomimetics|sympathomimetics|mesh-ancestor
102017094|NCT05183841|Tocolytic Agents|tocolytic agents|mesh-ancestor
102017095|NCT05183841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102017096|NCT05183841|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102017097|NCT05183841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102017098|NCT05183841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102017099|NCT05183841|Adrenergic Agents|adrenergic agents|mesh-ancestor
102017100|NCT03277222|Insulin|insulin|mesh-list
102017101|NCT03277222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102017102|NCT03277222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017103|NCT04931667|Lorecivivint|lorecivivint|mesh-list
102017104|NCT04931667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102017105|NCT03262948|Paclitaxel|paclitaxel|mesh-list
102017106|NCT03262948|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102017107|NCT03262948|Carboplatin|carboplatin|mesh-list
102017108|NCT03262948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102017109|NCT03262948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102017110|NCT03262948|Tubulin Modulators|tubulin modulators|mesh-ancestor
102017111|NCT03262948|Antimitotic Agents|antimitotic agents|mesh-ancestor
102017112|NCT03262948|Mitosis Modulators|mitosis modulators|mesh-ancestor
102017113|NCT03262948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017114|NCT02876328|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
102017115|NCT02876328|Antiviral Agents|antiviral agents|mesh-ancestor
102017116|NCT02876328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102017117|NCT03276598|Losartan|losartan|mesh-list
102017118|NCT03276598|Amlodipine|amlodipine|mesh-list
102017119|NCT03276598|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102017120|NCT03276598|Bisoprolol|bisoprolol|mesh-list
102017121|NCT03276598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101472084|NCT00253799|Hylan|hylan|mesh-list
102017130|NCT03276598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102017132|NCT03276598|Natriuretic Agents|natriuretic agents|mesh-ancestor
102017133|NCT03276598|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102017134|NCT03276598|Sympatholytics|sympatholytics|mesh-ancestor
102017135|NCT03276598|Autonomic Agents|autonomic agents|mesh-ancestor
102017136|NCT03276598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102017137|NCT03276598|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102017138|NCT03276598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102017139|NCT03276598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102017140|NCT03276598|Adrenergic Agents|adrenergic agents|mesh-ancestor
102017141|NCT03276598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102017142|NCT03262792|Andrographolide|andrographolide|mesh-list
101950321|NCT03530683|Azacitidine|azacitidine|mesh-list
101950322|NCT03530683|Venetoclax|venetoclax|mesh-list
101950323|NCT03530683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101950324|NCT03530683|Antiemetics|antiemetics|mesh-ancestor
101950325|NCT03530683|Autonomic Agents|autonomic agents|mesh-ancestor
101950326|NCT03530683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101950327|NCT03530683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950328|NCT03530683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101950329|NCT03530683|Glucocorticoids|glucocorticoids|mesh-ancestor
101950330|NCT03530683|Hormones|hormones|mesh-ancestor
101950331|NCT03530683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101522019|NCT05657704|Tramadol|tramadol|mesh-list
101950332|NCT03530683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101950333|NCT03530683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101950334|NCT03530683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101950335|NCT03530683|Antimetabolites|antimetabolites|mesh-ancestor
101950336|NCT03530683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950337|NCT03530683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101950338|NCT03482115|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
102017143|NCT03262792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102017144|NCT03262792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102017145|NCT03262792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102017146|NCT03262792|Analgesics|analgesics|mesh-ancestor
102017147|NCT03262792|Sensory System Agents|sensory system agents|mesh-ancestor
102017148|NCT03262792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102017149|NCT03262792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017150|NCT03262792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102017151|NCT03262792|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102017152|NCT03262792|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102017153|NCT03262792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102017154|NCT03262792|Antiviral Agents|antiviral agents|mesh-ancestor
102017155|NCT03262792|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102017156|NCT01359462|Tolvaptan|tolvaptan|mesh-list
102017157|NCT01359462|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102017158|NCT01359462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017159|NCT01359462|Natriuretic Agents|natriuretic agents|mesh-ancestor
102017160|NCT01359462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017161|NCT02875392|Fucoidan|fucoidan|mesh-list
102017162|NCT02875392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102017163|NCT02875392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102017164|NCT02875392|Anticoagulants|anticoagulants|mesh-ancestor
102017165|NCT02875392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102017166|NCT01359618|Moxifloxacin|moxifloxacin|mesh-list
102017167|NCT01359618|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102017168|NCT01359618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102017169|NCT01359618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102017170|NCT01359618|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102017171|NCT01359618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102017172|NCT01359618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102017173|NCT01359618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017174|NCT01359618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102017175|NCT01359618|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102017176|NCT01359618|Contraceptive Agents|contraceptive agents|mesh-ancestor
102017177|NCT01359618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102017178|NCT01359618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950339|NCT03482115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950340|NCT03476798|Bevacizumab|bevacizumab|mesh-list
101950341|NCT03476798|Rucaparib|rucaparib|mesh-list
101950342|NCT03476798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101950343|NCT03476798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101950344|NCT03476798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101522080|NCT02902380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101950345|NCT03476798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101950346|NCT03476798|Growth Substances|growth substances|mesh-ancestor
101950347|NCT03476798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950348|NCT03476798|Growth Inhibitors|growth inhibitors|mesh-ancestor
101950349|NCT03476798|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102017179|NCT01359618|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102017180|NCT01359618|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102017181|NCT01359618|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102017182|NCT03267628|Morphine|morphine|mesh-list
102017183|NCT03267628|Anesthetics|anesthetics|mesh-list
102017184|NCT03267628|Anesthetics, Local|anesthetics, local|mesh-list
102017199|NCT03268018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017200|NCT01362426|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102017201|NCT01362426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102017202|NCT01362426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102017203|NCT01362426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102017204|NCT01362426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017205|NCT01362426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102017206|NCT01362426|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102017207|NCT01362426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102017208|NCT01362426|Serotonin Agents|serotonin agents|mesh-ancestor
102017209|NCT01362426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102017210|NCT01362426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017211|NCT01362426|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102017212|NCT01362426|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102017213|NCT01362426|Dopamine Agents|dopamine agents|mesh-ancestor
102017214|NCT01367028|Bevacizumab|bevacizumab|mesh-list
102017215|NCT01367028|Trastuzumab|trastuzumab|mesh-list
102017216|NCT01367028|Docetaxel|docetaxel|mesh-list
102017217|NCT01367028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102017218|NCT01367028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102017219|NCT01367028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102017220|NCT01367028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102017221|NCT01367028|Growth Substances|growth substances|mesh-ancestor
102017222|NCT01367028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017223|NCT01367028|Growth Inhibitors|growth inhibitors|mesh-ancestor
102017224|NCT01367028|Tubulin Modulators|tubulin modulators|mesh-ancestor
102017225|NCT01367028|Antimitotic Agents|antimitotic agents|mesh-ancestor
102017226|NCT01367028|Mitosis Modulators|mitosis modulators|mesh-ancestor
102017227|NCT01367028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017228|NCT03965962|Vaccines|vaccines|mesh-list
102017229|NCT03965962|Immunoglobulins|immunoglobulins|mesh-list
102017230|NCT03965962|Antibodies|antibodies|mesh-list
102017231|NCT03965962|gamma-Globulins|gamma-globulins|mesh-list
102017232|NCT03965962|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102017233|NCT03965962|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102017234|NCT03965962|Immunologic Factors|immunologic factors|mesh-ancestor
102017235|NCT03965962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017236|NCT03273088|Etanercept|etanercept|mesh-list
102017237|NCT03273088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102017238|NCT03273088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102017239|NCT03273088|Analgesics|analgesics|mesh-ancestor
102017240|NCT03273088|Sensory System Agents|sensory system agents|mesh-ancestor
102017241|NCT03273088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102017242|NCT03273088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017243|NCT03273088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102017244|NCT03273088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102017245|NCT03273088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101950350|NCT03476798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101950351|NCT03476798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950353|NCT03456076|Gemcitabine|gemcitabine|mesh-list
101950354|NCT03456076|Pemetrexed|pemetrexed|mesh-list
101950355|NCT03456076|Vinorelbine|vinorelbine|mesh-list
101950356|NCT03456076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101950357|NCT03456076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101950358|NCT03456076|Antimetabolites|antimetabolites|mesh-ancestor
101950359|NCT03456076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950360|NCT03456076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101950361|NCT03456076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101950362|NCT03456076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101950363|NCT03456076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101950364|NCT03456076|Tubulin Modulators|tubulin modulators|mesh-ancestor
101950365|NCT03456076|Antimitotic Agents|antimitotic agents|mesh-ancestor
101950366|NCT03456076|Mitosis Modulators|mitosis modulators|mesh-ancestor
101950367|NCT03453632|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101950368|NCT03453632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101950369|NCT03453632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101950370|NCT03453632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950371|NCT03453632|Cholinergic Agents|cholinergic agents|mesh-ancestor
101950372|NCT03453632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102017251|NCT04235634|Urological Agents|urological agents|mesh-ancestor
102017252|NCT03262090|Dexmedetomidine|dexmedetomidine|mesh-list
102017253|NCT03262090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102017254|NCT03262090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102017255|NCT03262090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017256|NCT03262090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102017257|NCT03262090|Analgesics|analgesics|mesh-ancestor
102017258|NCT03262090|Sensory System Agents|sensory system agents|mesh-ancestor
102017259|NCT03262090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102017260|NCT03262090|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102017261|NCT03262090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102017262|NCT03262090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102017263|NCT03262090|Adrenergic Agents|adrenergic agents|mesh-ancestor
102017264|NCT03262090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102017265|NCT03262090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017266|NCT03151551|Adalimumab|adalimumab|mesh-list
102017267|NCT03151551|Ixekizumab|ixekizumab|mesh-list
102017268|NCT03151551|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102017269|NCT03151551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102017270|NCT03151551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102017271|NCT03151551|Dermatologic Agents|dermatologic agents|mesh-ancestor
102017272|NCT03267316|Paclitaxel|paclitaxel|mesh-list
102017273|NCT03267316|Gemcitabine|gemcitabine|mesh-list
102017274|NCT03267316|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102017275|NCT03267316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102017276|NCT03267316|Tubulin Modulators|tubulin modulators|mesh-ancestor
102017277|NCT03267316|Antimitotic Agents|antimitotic agents|mesh-ancestor
102017278|NCT03267316|Mitosis Modulators|mitosis modulators|mesh-ancestor
102017279|NCT03267316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017280|NCT03267316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101950373|NCT03453632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950374|NCT03448393|Cyclophosphamide|cyclophosphamide|mesh-list
101950375|NCT03448393|Fludarabine|fludarabine|mesh-list
101950376|NCT03448393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101950377|NCT03448393|Immunologic Factors|immunologic factors|mesh-ancestor
101950378|NCT03448393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950379|NCT03448393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101522122|NCT05426499|Fluconazole|fluconazole|mesh-list
101950380|NCT03448393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101950381|NCT03448393|Alkylating Agents|alkylating agents|mesh-ancestor
101950382|NCT03448393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950383|NCT03448393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101950384|NCT03448393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101950385|NCT03351348|Bupivacaine|bupivacaine|mesh-list
101950386|NCT03351348|Anesthetics, Local|anesthetics, local|mesh-ancestor
101950387|NCT03351348|Anesthetics|anesthetics|mesh-ancestor
101950388|NCT03351348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101950389|NCT03351348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950390|NCT03351348|Sensory System Agents|sensory system agents|mesh-ancestor
101950391|NCT03351348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101950392|NCT03217201|Methamphetamine|methamphetamine|mesh-list
101950393|NCT03217201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101950394|NCT03217201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950395|NCT03217201|Sympathomimetics|sympathomimetics|mesh-ancestor
101950396|NCT03217201|Autonomic Agents|autonomic agents|mesh-ancestor
101950397|NCT03217201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101950398|NCT03217201|Dopamine Agents|dopamine agents|mesh-ancestor
102017281|NCT03267316|Antimetabolites|antimetabolites|mesh-ancestor
102017282|NCT01359930|Naltrexone|naltrexone|mesh-list
102017283|NCT01359930|Bupropion|bupropion|mesh-list
102017284|NCT01359930|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102017285|NCT01359930|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102017286|NCT01359930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017287|NCT01359930|Sensory System Agents|sensory system agents|mesh-ancestor
102017288|NCT01359930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102017289|NCT01359930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102017290|NCT01359930|Antidepressive Agents|antidepressive agents|mesh-ancestor
102017291|NCT01359930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102017292|NCT01359930|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102017293|NCT01359930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102017294|NCT01359930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102017295|NCT01359930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017296|NCT01359930|Dopamine Agents|dopamine agents|mesh-ancestor
102017297|NCT01359930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102017298|NCT01359930|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102017299|NCT01359930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102017300|NCT01359930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102017301|NCT05075512|Fulvestrant|fulvestrant|mesh-list
102017302|NCT05075512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101950400|NCT03217201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950401|NCT03217201|Adrenergic Agents|adrenergic agents|mesh-ancestor
102017303|NCT05075512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102017304|NCT05075512|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102017305|NCT05075512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102017306|NCT05075512|Hormone Antagonists|hormone antagonists|mesh-ancestor
102017307|NCT05075512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102017308|NCT05075512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017309|NCT01316757|Paclitaxel|paclitaxel|mesh-list
102017310|NCT01316757|Carboplatin|carboplatin|mesh-list
102017311|NCT01316757|Cetuximab|cetuximab|mesh-list
102017312|NCT01316757|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102017313|NCT01316757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102017314|NCT01316757|Antibodies|antibodies|mesh-list
102017315|NCT01316757|Immunoglobulins|immunoglobulins|mesh-list
102017323|NCT01316757|Immunologic Factors|immunologic factors|mesh-ancestor
102017324|NCT01316757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017325|NCT01316757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102017326|NCT01316757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102017327|NCT05074966|Cetuximab|cetuximab|mesh-list
102017328|NCT05074966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102017329|NCT05074966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102017330|NCT03266926|Bupivacaine|bupivacaine|mesh-list
102017331|NCT03266926|Estrogens|estrogens|mesh-list
102017332|NCT03266926|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
102017333|NCT03266926|Anesthetics, Local|anesthetics, local|mesh-ancestor
102017334|NCT03266926|Anesthetics|anesthetics|mesh-ancestor
102017335|NCT03266926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102017336|NCT03266926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017337|NCT03266926|Sensory System Agents|sensory system agents|mesh-ancestor
102017338|NCT03266926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102017339|NCT03266926|Hormones|hormones|mesh-ancestor
102017340|NCT03266926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102017341|NCT01343745|Formoterol Fumarate|formoterol fumarate|mesh-list
102017342|NCT01343745|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102017343|NCT01343745|Autonomic Agents|autonomic agents|mesh-ancestor
102017344|NCT01343745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102017345|NCT01343745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017346|NCT01343745|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102017347|NCT01343745|Respiratory System Agents|respiratory system agents|mesh-ancestor
102017348|NCT01343745|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102017349|NCT01343745|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102017350|NCT01343745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102017351|NCT01343745|Adrenergic Agents|adrenergic agents|mesh-ancestor
102017352|NCT01343745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102017353|NCT01343745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017354|NCT01367418|Sufentanil|sufentanil|mesh-list
102017355|NCT01367418|Morphine|morphine|mesh-list
102017356|NCT01367418|Bupivacaine|bupivacaine|mesh-list
102017357|NCT01367418|Ropivacaine|ropivacaine|mesh-list
102017358|NCT01367418|Anesthetics, Local|anesthetics, local|mesh-ancestor
102017359|NCT01367418|Anesthetics|anesthetics|mesh-ancestor
102017360|NCT01367418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102017361|NCT01367418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017362|NCT01367418|Sensory System Agents|sensory system agents|mesh-ancestor
102017363|NCT01367418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102017364|NCT01367418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102017365|NCT01367418|Narcotics|narcotics|mesh-ancestor
102017366|NCT01367418|Analgesics|analgesics|mesh-ancestor
102017367|NCT01367418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102017368|NCT01367418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102017369|NCT01367418|Anesthetics, General|anesthetics, general|mesh-ancestor
102017370|NCT01360086|Leucovorin|leucovorin|mesh-list
102017371|NCT01360086|Fluorouracil|fluorouracil|mesh-list
102017372|NCT01360086|Cetuximab|cetuximab|mesh-list
102017373|NCT01360086|Calcium|calcium|mesh-list
102017374|NCT01360086|Levoleucovorin|levoleucovorin|mesh-list
102017375|NCT01360086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101387645|NCT00314158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017376|NCT01360086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102017377|NCT01360086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017378|NCT01360086|Antimetabolites|antimetabolites|mesh-ancestor
102017379|NCT01360086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950402|NCT03217201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101950403|NCT03217201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101950404|NCT03217201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101950405|NCT03217201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102017380|NCT01360086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102017381|NCT01360086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102017382|NCT01360086|Immunologic Factors|immunologic factors|mesh-ancestor
102017396|NCT02458924|Vitamins|vitamins|mesh-ancestor
102017397|NCT02458924|Micronutrients|micronutrients|mesh-ancestor
102017398|NCT02458924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017399|NCT01367496|Naltrexone|naltrexone|mesh-list
102017400|NCT01367496|Methylnaltrexone|methylnaltrexone|mesh-list
102017401|NCT01367496|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102017402|NCT01367496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017403|NCT01367496|Sensory System Agents|sensory system agents|mesh-ancestor
102017404|NCT01367496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102017405|NCT01367496|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102017406|NCT02459158|Arbekacin|arbekacin|mesh-list
102017407|NCT02459158|Dibekacin|dibekacin|mesh-list
102017408|NCT02459158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102017409|NCT02459158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102017410|NCT02459158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102017411|NCT01367574|Methylnaltrexone|methylnaltrexone|mesh-list
102017412|NCT01367574|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102017413|NCT01367574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017414|NCT01367574|Sensory System Agents|sensory system agents|mesh-ancestor
102017415|NCT01367574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102017416|NCT04693689|Vaccines|vaccines|mesh-list
102017417|NCT04693689|Immunologic Factors|immunologic factors|mesh-ancestor
102017418|NCT04693689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017419|NCT03126786|Triamcinolone|triamcinolone|mesh-list
102017420|NCT03126786|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102017421|NCT03126786|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102017422|NCT03126786|Aflibercept|aflibercept|mesh-list
102017423|NCT03126786|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102017424|NCT03126786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102017425|NCT03126786|Glucocorticoids|glucocorticoids|mesh-ancestor
102017426|NCT03126786|Hormones|hormones|mesh-ancestor
102017427|NCT03126786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102017428|NCT03126786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017429|NCT03126786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102017430|NCT03126786|Immunologic Factors|immunologic factors|mesh-ancestor
102017431|NCT03126786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102017432|NCT03126786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017433|NCT03126786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102017434|NCT03126786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102017435|NCT03126786|Growth Substances|growth substances|mesh-ancestor
102017436|NCT03126786|Growth Inhibitors|growth inhibitors|mesh-ancestor
102017437|NCT03126786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102017438|NCT01367652|Letrozole|letrozole|mesh-list
101522175|NCT00447356|Antiviral Agents|antiviral agents|mesh-ancestor
102017439|NCT01367652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102017440|NCT01367652|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102017441|NCT01367652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102017442|NCT01367652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102017443|NCT01367652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017444|NCT01367652|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102017445|NCT01367652|Hormone Antagonists|hormone antagonists|mesh-ancestor
102017446|NCT01367652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102017447|NCT01367652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017448|NCT02456584|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102017453|NCT02456584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017454|NCT02456584|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102017455|NCT02456584|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102017456|NCT02456584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102017457|NCT02456584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102017458|NCT02456584|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102017459|NCT02456584|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102017460|NCT02456584|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102017461|NCT03146403|Vaccines|vaccines|mesh-list
102017462|NCT03146403|Immunologic Factors|immunologic factors|mesh-ancestor
101950406|NCT03199053|Dapagliflozin|dapagliflozin|mesh-list
101950407|NCT03199053|Saxagliptin|saxagliptin|mesh-list
101950408|NCT03199053|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101950409|NCT03199053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950410|NCT03199053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101950411|NCT03199053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950412|NCT03199053|Incretins|incretins|mesh-ancestor
101950413|NCT03199053|Hormones|hormones|mesh-ancestor
101950414|NCT03199053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101279452|NCT01879527|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102017463|NCT03146403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017464|NCT01360476|Vitamin D|vitamin d|mesh-list
102017465|NCT01360476|Cholecalciferol|cholecalciferol|mesh-list
102017466|NCT01360476|Vitamins|vitamins|mesh-ancestor
102017467|NCT01360476|Micronutrients|micronutrients|mesh-ancestor
102017468|NCT01360476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017469|NCT01360476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102017470|NCT01360476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102017471|NCT01317069|Fluorouracil|fluorouracil|mesh-list
102017472|NCT01317069|Antimetabolites|antimetabolites|mesh-ancestor
102017473|NCT01317069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017474|NCT01317069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102017475|NCT01317069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102017476|NCT01317069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102017477|NCT01317069|Immunologic Factors|immunologic factors|mesh-ancestor
102017478|NCT01317069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017479|NCT01317225|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
102017480|NCT01317225|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
102017481|NCT01317225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102017482|NCT01317225|Hormone Antagonists|hormone antagonists|mesh-ancestor
102017483|NCT01317225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102017484|NCT01317225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017485|NCT01317225|Progestins|progestins|mesh-ancestor
102017486|NCT01317225|Hormones|hormones|mesh-ancestor
102017487|NCT01363206|Ipilimumab|ipilimumab|mesh-list
102017488|NCT01363206|Molgramostim|molgramostim|mesh-list
102017489|NCT01363206|Sargramostim|sargramostim|mesh-list
102017490|NCT01363206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102017491|NCT01363206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102017492|NCT01363206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102017493|NCT01363206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017494|NCT01363206|Immunologic Factors|immunologic factors|mesh-ancestor
102017495|NCT01363206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017496|NCT01344213|Celecoxib|celecoxib|mesh-list
102017497|NCT01344213|Pregabalin|pregabalin|mesh-list
102017498|NCT01344213|Analgesics|analgesics|mesh-ancestor
102017499|NCT01344213|Sensory System Agents|sensory system agents|mesh-ancestor
102017500|NCT01344213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102017501|NCT01344213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017502|NCT01344213|Anticonvulsants|anticonvulsants|mesh-ancestor
102017503|NCT01344213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102017504|NCT01344213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102017505|NCT01344213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017506|NCT01344213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102017507|NCT01344213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102017508|NCT01344213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102017509|NCT01344213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102017510|NCT01344213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102017511|NCT01344213|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102017512|NCT01344213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102017513|NCT01344213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102017514|NCT01344213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102017515|NCT01344213|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101950415|NCT03199053|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101950417|NCT03199053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101950418|NCT03029429|Theophylline|theophylline|mesh-list
102017516|NCT01344213|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102017517|NCT01344213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102017518|NCT04416048|Rivaroxaban|rivaroxaban|mesh-list
102017521|NCT04416048|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102017522|NCT04416048|Protease Inhibitors|protease inhibitors|mesh-ancestor
102017523|NCT04416048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102017524|NCT04416048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017525|NCT04416048|Anticoagulants|anticoagulants|mesh-ancestor
102017526|NCT01363284|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102017527|NCT01363284|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102017528|NCT01363284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102017529|NCT01363284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102017530|NCT01363284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017531|NCT01363284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102017532|NCT01363284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017533|NCT01363284|Analgesics|analgesics|mesh-ancestor
102017534|NCT01363284|Sensory System Agents|sensory system agents|mesh-ancestor
102017535|NCT01363284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102017536|NCT01363284|Antidepressive Agents|antidepressive agents|mesh-ancestor
102017537|NCT01363284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102017538|NCT01363284|Dopamine Agents|dopamine agents|mesh-ancestor
102017539|NCT03265834|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102017540|NCT03265834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102017541|NCT03265834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102017542|NCT03265834|Antitubercular Agents|antitubercular agents|mesh-ancestor
102017543|NCT01344291|Curcumin|curcumin|mesh-list
102017544|NCT01344291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102017545|NCT01344291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102017546|NCT01344291|Analgesics|analgesics|mesh-ancestor
102017547|NCT01344291|Sensory System Agents|sensory system agents|mesh-ancestor
102017548|NCT01344291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102017549|NCT01344291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017550|NCT01344291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102017551|NCT01344291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102017552|NCT01344291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102017553|NCT01344291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102017554|NCT01344291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017555|NCT01367964|Hormones|hormones|mesh-list
102017556|NCT01367964|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102017557|NCT01367964|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
102017558|NCT01367964|beta-Endorphin|beta-endorphin|mesh-list
102017559|NCT01367964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102017560|NCT01367964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017561|NCT01367964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102017562|NCT01367964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017563|NCT04326933|Imatinib Mesylate|imatinib mesylate|mesh-list
102017564|NCT04326933|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102017565|NCT04326933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102017566|NCT04326933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102017567|NCT04326933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102017568|NCT04326933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017569|NCT04733560|Bupivacaine|bupivacaine|mesh-list
102017570|NCT04733560|Anesthetics, Local|anesthetics, local|mesh-ancestor
102017571|NCT04733560|Anesthetics|anesthetics|mesh-ancestor
102017572|NCT04733560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102017573|NCT04733560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017574|NCT04733560|Sensory System Agents|sensory system agents|mesh-ancestor
102017575|NCT04733560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102017576|NCT01347957|Nitric Oxide|nitric oxide|mesh-list
102017577|NCT01347957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102017578|NCT01347957|Autonomic Agents|autonomic agents|mesh-ancestor
102017579|NCT01347957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102017580|NCT01347957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017581|NCT01347957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101950419|NCT03029429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101950420|NCT03029429|Autonomic Agents|autonomic agents|mesh-ancestor
101950421|NCT03029429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101950422|NCT03029429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950423|NCT03029429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101950424|NCT03029429|Respiratory System Agents|respiratory system agents|mesh-ancestor
102017582|NCT01347957|Respiratory System Agents|respiratory system agents|mesh-ancestor
102017583|NCT01347957|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102017584|NCT01347957|Antioxidants|antioxidants|mesh-ancestor
102017585|NCT01347957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017586|NCT01347957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102017587|NCT01347957|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102017588|NCT01347957|Vasodilator Agents|vasodilator agents|mesh-ancestor
102017595|NCT04735965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017596|NCT04735965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102017597|NCT04735965|Analgesics|analgesics|mesh-ancestor
102017598|NCT04735965|Sensory System Agents|sensory system agents|mesh-ancestor
102017599|NCT04735965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102017600|NCT04735965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102017601|NCT04735965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102017602|NCT04735965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102017603|NCT04735965|Adrenergic Agents|adrenergic agents|mesh-ancestor
102017604|NCT04735965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102017605|NCT04735965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017606|NCT04735965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102017607|NCT04735965|Narcotics|narcotics|mesh-ancestor
102017608|NCT04735965|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102017609|NCT02456428|Insulin|insulin|mesh-list
102017610|NCT02456428|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102017611|NCT02456428|Metformin|metformin|mesh-list
102017612|NCT02456428|Pioglitazone|pioglitazone|mesh-list
102017613|NCT02456428|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102017614|NCT02456428|Liraglutide|liraglutide|mesh-list
102017615|NCT02456428|Exenatide|exenatide|mesh-list
102017616|NCT02456428|Glimepiride|glimepiride|mesh-list
102017617|NCT02456428|Rosiglitazone|rosiglitazone|mesh-list
102017619|NCT02456428|Saxagliptin|saxagliptin|mesh-list
102017620|NCT02456428|Acarbose|acarbose|mesh-list
102017621|NCT02456428|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102017622|NCT02456428|Repaglinide|repaglinide|mesh-list
102017623|NCT02456428|Gliclazide|gliclazide|mesh-list
102017624|NCT02456428|Glipizide|glipizide|mesh-list
102017625|NCT02456428|Biguanides|biguanides|mesh-list
102017626|NCT02456428|Tolbutamide|tolbutamide|mesh-list
102017627|NCT02456428|Voglibose|voglibose|mesh-list
102017628|NCT02456428|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
102017629|NCT02456428|Nateglinide|nateglinide|mesh-list
102017630|NCT02456428|Miglitol|miglitol|mesh-list
102017631|NCT02456428|Meglitinide|meglitinide|mesh-list
102017632|NCT02456428|Troglitazone|troglitazone|mesh-list
102017633|NCT02456428|Acetohexamide|acetohexamide|mesh-list
102017634|NCT02456428|Buformin|buformin|mesh-list
102017635|NCT02456428|Chlorpropamide|chlorpropamide|mesh-list
102017636|NCT02456428|Phenformin|phenformin|mesh-list
102017637|NCT02456428|Gliquidone|gliquidone|mesh-list
102017638|NCT02456428|Carbutamide|carbutamide|mesh-list
102017639|NCT02456428|Tolazamide|tolazamide|mesh-list
102017640|NCT02456428|Glibornuride|glibornuride|mesh-list
102017641|NCT02456428|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
102017642|NCT02456428|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
102017643|NCT02456428|Incretins|incretins|mesh-list
102017644|NCT02456428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017645|NCT02456428|Hormones|hormones|mesh-ancestor
102017646|NCT02456428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102017647|NCT02456428|Protease Inhibitors|protease inhibitors|mesh-ancestor
102017648|NCT02456428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102017649|NCT02456428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017650|NCT02456428|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102017651|NCT02456428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102017652|NCT02456428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102017653|NCT02456428|Immunologic Factors|immunologic factors|mesh-ancestor
102017654|NCT03259516|Cytarabine|cytarabine|mesh-list
102017655|NCT03259516|Cyclophosphamide|cyclophosphamide|mesh-list
102017656|NCT03259516|Melphalan|melphalan|mesh-list
101950425|NCT03029429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101950426|NCT03029429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101950427|NCT03029429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950428|NCT03029429|Vasodilator Agents|vasodilator agents|mesh-ancestor
101950429|NCT03029429|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101950430|NCT03029429|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102017657|NCT03259516|Nivolumab|nivolumab|mesh-list
102017658|NCT03259516|Fludarabine|fludarabine|mesh-list
102017659|NCT03259516|Azacitidine|azacitidine|mesh-list
102017660|NCT03259516|Tretinoin|tretinoin|mesh-list
102017661|NCT03259516|Sildenafil Citrate|sildenafil citrate|mesh-list
102017662|NCT03259516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102017663|NCT03259516|Immunologic Factors|immunologic factors|mesh-ancestor
102017664|NCT03259516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017665|NCT03259516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102017666|NCT03259516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102017667|NCT03259516|Alkylating Agents|alkylating agents|mesh-ancestor
102017669|NCT03259516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102017670|NCT03259516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102017671|NCT03259516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102017672|NCT03259516|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102017673|NCT03259516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102017674|NCT03259516|Antimetabolites|antimetabolites|mesh-ancestor
102017675|NCT03259516|Antiviral Agents|antiviral agents|mesh-ancestor
102017676|NCT03259516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102017677|NCT03259516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102017678|NCT03259516|Vasodilator Agents|vasodilator agents|mesh-ancestor
102017679|NCT03259516|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102017680|NCT03259516|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102017681|NCT03259516|Urological Agents|urological agents|mesh-ancestor
102017682|NCT03259516|Keratolytic Agents|keratolytic agents|mesh-ancestor
102017683|NCT03259516|Dermatologic Agents|dermatologic agents|mesh-ancestor
102017684|NCT01344681|Itraconazole|itraconazole|mesh-list
102017685|NCT01344681|Micafungin|micafungin|mesh-list
102017686|NCT01344681|Antifungal Agents|antifungal agents|mesh-ancestor
102017687|NCT01344681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102017688|NCT01344681|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102017689|NCT01344681|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102017690|NCT01344681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102017691|NCT01344681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017692|NCT01344681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102017693|NCT01344681|Hormone Antagonists|hormone antagonists|mesh-ancestor
102017694|NCT01344681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102017695|NCT01344681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017696|NCT01344681|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102017697|NCT01348269|Zoledronic Acid|zoledronic acid|mesh-list
102017698|NCT01348269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102017699|NCT01348269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017700|NCT03259672|Sevoflurane|sevoflurane|mesh-list
102017701|NCT03259672|Desflurane|desflurane|mesh-list
102017702|NCT03259672|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102017703|NCT03259672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102017704|NCT03259672|Anesthetics, General|anesthetics, general|mesh-ancestor
102017705|NCT03259672|Anesthetics|anesthetics|mesh-ancestor
102017706|NCT03259672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102017707|NCT03259672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017708|NCT03537742|Alirocumab|alirocumab|mesh-list
102017709|NCT03537742|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102017710|NCT03537742|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102017711|NCT03537742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102017712|NCT03537742|Antimetabolites|antimetabolites|mesh-ancestor
102017713|NCT03537742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017714|NCT03537742|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102017715|NCT03537742|Protease Inhibitors|protease inhibitors|mesh-ancestor
102017716|NCT03537742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102017717|NCT03537742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102017718|NCT03259282|gamma-Globulins|gamma-globulins|mesh-list
102017719|NCT03259282|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101950431|NCT03029429|Purinergic Agents|purinergic agents|mesh-ancestor
101950432|NCT03029429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101950434|NCT03012529|Rifampin|rifampin|mesh-list
102017720|NCT03259282|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102017721|NCT03259282|Immunologic Factors|immunologic factors|mesh-ancestor
102017722|NCT03259282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017723|NCT02456194|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102017724|NCT02456194|Calcium|calcium|mesh-list
102017725|NCT02456194|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102017726|NCT02456194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017727|NCT02456194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102017728|NCT03265288|Fenretinide|fenretinide|mesh-list
102017729|NCT03265288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102017730|NCT03265288|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102017731|NCT03265288|Protective Agents|protective agents|mesh-ancestor
102017732|NCT03265288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017733|NCT03261310|Acetaminophen|acetaminophen|mesh-list
102017734|NCT03261310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102017735|NCT03261310|Analgesics|analgesics|mesh-ancestor
102017736|NCT03261310|Sensory System Agents|sensory system agents|mesh-ancestor
102017737|NCT03261310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102017738|NCT03261310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017739|NCT03261310|Antipyretics|antipyretics|mesh-ancestor
102017740|NCT02456350|Cyclophosphamide|cyclophosphamide|mesh-list
102017773|NCT01360710|Irbesartan|irbesartan|mesh-list
102017774|NCT01360710|Moxonidine|moxonidine|mesh-list
102017775|NCT01360710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102017776|NCT01360710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102017777|NCT01360710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102017778|NCT01360710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017779|NCT01360788|Albuterol|albuterol|mesh-list
102017780|NCT01360788|Ipratropium|ipratropium|mesh-list
102017781|NCT01360788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102017782|NCT01360788|Autonomic Agents|autonomic agents|mesh-ancestor
102017783|NCT01360788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102017788|NCT01360788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102017789|NCT01360788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102017790|NCT01360788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102017791|NCT01360788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102017792|NCT01360788|Adrenergic Agents|adrenergic agents|mesh-ancestor
102017793|NCT01360788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102017794|NCT01360788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017795|NCT01360788|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102017796|NCT01360788|Cholinergic Agents|cholinergic agents|mesh-ancestor
102017797|NCT01361022|Brotizolam|brotizolam|mesh-list
102017798|NCT01361022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102017799|NCT01361022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102017800|NCT01361022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017801|NCT01364220|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102017802|NCT01364220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102017803|NCT01364220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102017804|NCT01364220|Antimetabolites|antimetabolites|mesh-ancestor
102017805|NCT01364220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017806|NCT01364220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102017807|NCT01364220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102017808|NCT01364220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102017809|NCT02713204|Aflibercept|aflibercept|mesh-list
102017810|NCT02713204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102017811|NCT02713204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102017812|NCT02713204|Growth Substances|growth substances|mesh-ancestor
102017813|NCT02713204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017814|NCT02713204|Growth Inhibitors|growth inhibitors|mesh-ancestor
102017815|NCT02713204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102017816|NCT03695172|Ropivacaine|ropivacaine|mesh-list
102017817|NCT03695172|Anesthetics, Local|anesthetics, local|mesh-ancestor
102017818|NCT03695172|Anesthetics|anesthetics|mesh-ancestor
102017819|NCT03695172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102017820|NCT03695172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017821|NCT03695172|Sensory System Agents|sensory system agents|mesh-ancestor
102017822|NCT03695172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102017823|NCT01364376|Leucovorin|leucovorin|mesh-list
102017824|NCT01364376|Oxaliplatin|oxaliplatin|mesh-list
102017825|NCT01364376|Calcium|calcium|mesh-list
102017826|NCT01364376|Levoleucovorin|levoleucovorin|mesh-list
101279801|NCT01883011|Nootropic Agents|nootropic agents|mesh-ancestor
102017827|NCT01364376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102017828|NCT01364376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017829|NCT01364376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102017830|NCT01364376|Antidotes|antidotes|mesh-ancestor
102017831|NCT01364376|Protective Agents|protective agents|mesh-ancestor
102017832|NCT01364376|Vitamin B Complex|vitamin b complex|mesh-ancestor
102017833|NCT01364376|Vitamins|vitamins|mesh-ancestor
102017834|NCT01364376|Micronutrients|micronutrients|mesh-ancestor
102017835|NCT01348503|Lenalidomide|lenalidomide|mesh-list
102017836|NCT01348503|Sorafenib|sorafenib|mesh-list
102017837|NCT01348503|Immunologic Factors|immunologic factors|mesh-ancestor
102017838|NCT01348503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017839|NCT01348503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102017840|NCT01348503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102017841|NCT01348503|Growth Substances|growth substances|mesh-ancestor
102017842|NCT01348503|Growth Inhibitors|growth inhibitors|mesh-ancestor
102017843|NCT01348503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102017844|NCT01348503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102017845|NCT01348503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102017846|NCT01348503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017847|NCT01369290|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102017848|NCT01369290|Bupropion|bupropion|mesh-list
102017849|NCT01369290|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102017850|NCT01369290|Escitalopram|escitalopram|mesh-list
102017851|NCT01369290|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102017852|NCT01369290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102017853|NCT01369290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102017854|NCT01369290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017856|NCT01369290|Serotonin Agents|serotonin agents|mesh-ancestor
102017857|NCT01369290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017858|NCT01369290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102017859|NCT01369290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102017860|NCT01369290|Antidepressive Agents|antidepressive agents|mesh-ancestor
102017861|NCT01369290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102017862|NCT01369290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102017863|NCT01369290|Dopamine Agents|dopamine agents|mesh-ancestor
102017864|NCT01369290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102017865|NCT01369290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102017866|NCT01369290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102017867|NCT01369290|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102017868|NCT01369290|Analgesics|analgesics|mesh-ancestor
102017869|NCT01369290|Sensory System Agents|sensory system agents|mesh-ancestor
102017870|NCT03533452|Ropivacaine|ropivacaine|mesh-list
102017871|NCT03533452|Anesthetics, Local|anesthetics, local|mesh-ancestor
102017872|NCT03533452|Anesthetics|anesthetics|mesh-ancestor
102017873|NCT03533452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102017874|NCT03533452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017875|NCT03533452|Sensory System Agents|sensory system agents|mesh-ancestor
102017876|NCT03533452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102017877|NCT04359147|Hydrocortisone|hydrocortisone|mesh-list
102017878|NCT04359147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102017879|NCT04359147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102017880|NCT04359147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102017881|NCT04359147|Yohimbine|yohimbine|mesh-list
102017882|NCT04359147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102017883|NCT04359147|Mydriatics|mydriatics|mesh-ancestor
102017884|NCT04359147|Autonomic Agents|autonomic agents|mesh-ancestor
102017885|NCT04359147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102017886|NCT04359147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017887|NCT04359147|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102017888|NCT04359147|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102017889|NCT04359147|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102017890|NCT04359147|Adrenergic Agents|adrenergic agents|mesh-ancestor
102017891|NCT04359147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102017892|NCT04359147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017893|NCT04359147|Urological Agents|urological agents|mesh-ancestor
102017894|NCT01369368|Azacitidine|azacitidine|mesh-list
102017895|NCT01369368|Valproic Acid|valproic acid|mesh-list
102017896|NCT01369368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102017897|NCT01369368|Antimetabolites|antimetabolites|mesh-ancestor
102017898|NCT01369368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017899|NCT01369368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101950435|NCT03012529|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101950436|NCT03012529|Antitubercular Agents|antitubercular agents|mesh-ancestor
102017900|NCT01369368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102017901|NCT01369368|Anticonvulsants|anticonvulsants|mesh-ancestor
102017902|NCT01369368|GABA Agents|gaba agents|mesh-ancestor
102017903|NCT01369368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102017904|NCT01369368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017905|NCT01369368|Antimanic Agents|antimanic agents|mesh-ancestor
102017906|NCT01369368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102017907|NCT01369368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102017908|NCT01369368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102017909|NCT04074759|Pembrolizumab|pembrolizumab|mesh-list
102017910|NCT04074759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102017911|NCT04074759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102017912|NCT04074759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102017913|NCT04074759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017914|NCT01369602|Nicotinic Acids|nicotinic acids|mesh-list
101387646|NCT00314158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101387647|NCT00314158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102017915|NCT01369602|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
102017916|NCT01369602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102017917|NCT01369602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017918|NCT01369602|Vitamin B Complex|vitamin b complex|mesh-ancestor
102017919|NCT01369602|Vitamins|vitamins|mesh-ancestor
102017920|NCT01369602|Micronutrients|micronutrients|mesh-ancestor
102017921|NCT01369602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737662|NCT02689089|Rifapentine|rifapentine|mesh-list
102017922|NCT03252496|Ephedrine|ephedrine|mesh-list
102017923|NCT03252496|Fentanyl|fentanyl|mesh-list
102017924|NCT03252496|Bupivacaine|bupivacaine|mesh-list
102017925|NCT03252496|Oxytocin|oxytocin|mesh-list
102017926|NCT03252496|Anesthetics, Local|anesthetics, local|mesh-ancestor
102017950|NCT03252418|Protective Agents|protective agents|mesh-ancestor
102017951|NCT03252418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017953|NCT03252418|Micronutrients|micronutrients|mesh-ancestor
102017954|NCT01364688|Alfacalcidol|alfacalcidol|mesh-list
102017955|NCT01364688|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
102017956|NCT01364688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102017957|NCT01364688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017958|NCT01364688|Vitamins|vitamins|mesh-ancestor
102017959|NCT01364688|Micronutrients|micronutrients|mesh-ancestor
102017960|NCT01370148|Conivaptan|conivaptan|mesh-list
102017961|NCT01370148|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102017962|NCT01370148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017963|NCT01370148|Natriuretic Agents|natriuretic agents|mesh-ancestor
102017964|NCT01370148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017965|NCT04684953|Hormones|hormones|mesh-list
102017966|NCT04684953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102017967|NCT04684953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017968|NCT01349127|Calcium, Dietary|calcium, dietary|mesh-list
102017969|NCT01349127|Vitamin D|vitamin d|mesh-list
102017970|NCT01349127|Ergocalciferols|ergocalciferols|mesh-list
102017971|NCT01349127|Cholecalciferol|cholecalciferol|mesh-list
102017972|NCT01349127|Vitamins|vitamins|mesh-list
102017973|NCT01349127|Calcium|calcium|mesh-list
102017974|NCT01349127|Micronutrients|micronutrients|mesh-ancestor
102017975|NCT01349127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017976|NCT01349127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102017977|NCT01349127|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101472957|NCT00256256|Hormones|hormones|mesh-ancestor
102017983|NCT03486964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017984|NCT01349205|Sodium Benzoate|sodium benzoate|mesh-list
102017985|NCT01349205|Caffeine, sodium benzoate drug combination|caffeine, sodium benzoate drug combination|mesh-list
102017986|NCT01349205|Caffeine|caffeine|mesh-list
102017987|NCT01349205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102017988|NCT01349205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017989|NCT01349205|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102017990|NCT01349205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102017991|NCT01349205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017992|NCT01349205|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102017993|NCT01349205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102017994|NCT01349205|Purinergic Agents|purinergic agents|mesh-ancestor
102017995|NCT01349205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102017996|NCT01349205|Antifungal Agents|antifungal agents|mesh-ancestor
101737740|NCT00772070|Vaccines|vaccines|mesh-list
101950437|NCT03012529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101950438|NCT03012529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101950439|NCT03012529|Leprostatic Agents|leprostatic agents|mesh-ancestor
101950440|NCT03012529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101950441|NCT03012529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101950442|NCT03012529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950443|NCT03012529|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101950444|NCT03012529|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101950445|NCT03012529|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101950446|NCT03012529|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101950447|NCT03012529|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101950448|NCT03012529|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101522342|NCT02901288|Isoniazid|isoniazid|mesh-list
101950449|NCT03012529|Vitamin B Complex|vitamin b complex|mesh-ancestor
102017997|NCT01349205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102017998|NCT01349205|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
102017999|NCT01349205|Protective Agents|protective agents|mesh-ancestor
102018000|NCT01349205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102018002|NCT01349205|Sensory System Agents|sensory system agents|mesh-ancestor
102018003|NCT01349205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102018004|NCT01370304|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102018005|NCT01370304|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102018006|NCT01370304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102018007|NCT01370304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102018008|NCT01370304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018009|NCT01370304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102018010|NCT01370304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018011|NCT01370304|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102018012|NCT01370304|Antidepressive Agents|antidepressive agents|mesh-ancestor
102018013|NCT01370304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102018014|NCT03982485|Paclitaxel|paclitaxel|mesh-list
102018015|NCT03982485|Apatinib|apatinib|mesh-list
102018016|NCT03982485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102018017|NCT03982485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102018018|NCT03982485|Tubulin Modulators|tubulin modulators|mesh-ancestor
102018019|NCT03982485|Antimitotic Agents|antimitotic agents|mesh-ancestor
102018020|NCT03982485|Mitosis Modulators|mitosis modulators|mesh-ancestor
102018021|NCT03982485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018022|NCT03982485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102018023|NCT03982485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102018024|NCT03966339|Hormones|hormones|mesh-list
102018025|NCT03966339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102018026|NCT03966339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018027|NCT03251872|Olaparib|olaparib|mesh-list
102018028|NCT03251872|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102018029|NCT03251872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102018030|NCT03251872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018031|NCT03251872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102018032|NCT03160521|Risperidone|risperidone|mesh-list
102018033|NCT03160521|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102018034|NCT03160521|Serotonin Agents|serotonin agents|mesh-ancestor
102018035|NCT03160521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102018036|NCT03160521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018037|NCT03160521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018038|NCT03160521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102018039|NCT03160521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102018040|NCT03160521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102018041|NCT03160521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101950450|NCT03012529|Vitamins|vitamins|mesh-ancestor
101950451|NCT03012529|Micronutrients|micronutrients|mesh-ancestor
101950452|NCT03012529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950453|NCT03012529|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101950454|NCT03012529|Dermatologic Agents|dermatologic agents|mesh-ancestor
101950455|NCT03007147|Calcium, Dietary|calcium, dietary|mesh-list
101950456|NCT03007147|Leucovorin|leucovorin|mesh-list
101950457|NCT03007147|Folic Acid|folic acid|mesh-list
102018042|NCT03160521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102018043|NCT03160521|Dopamine Agents|dopamine agents|mesh-ancestor
102018044|NCT01365000|Naloxegol|naloxegol|mesh-list
102018049|NCT03147040|Carboplatin|carboplatin|mesh-list
102018050|NCT03147040|Atezolizumab|atezolizumab|mesh-list
102018051|NCT03147040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102018052|NCT03147040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102018053|NCT03147040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018054|NCT03147040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102018055|NCT03251170|Fentanyl|fentanyl|mesh-list
102018056|NCT03251170|Midazolam|midazolam|mesh-list
102018057|NCT03251170|Ketamine|ketamine|mesh-list
102018058|NCT03251170|Analgesics|analgesics|mesh-ancestor
102018059|NCT03251170|Sensory System Agents|sensory system agents|mesh-ancestor
102018060|NCT03251170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102018061|NCT03251170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018062|NCT03251170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102018063|NCT03251170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102018064|NCT03251170|Anesthetics, General|anesthetics, general|mesh-ancestor
102018065|NCT03251170|Anesthetics|anesthetics|mesh-ancestor
102018066|NCT03251170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102018067|NCT03251170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102018068|NCT03251170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102018069|NCT03251170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102018070|NCT03251170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018071|NCT03251170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102018072|NCT03251170|Narcotics|narcotics|mesh-ancestor
102018073|NCT03251170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102018074|NCT03251170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102018075|NCT03251170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102018076|NCT03251170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102018077|NCT03251170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102018078|NCT03251170|GABA Modulators|gaba modulators|mesh-ancestor
102018079|NCT03251170|GABA Agents|gaba agents|mesh-ancestor
102018080|NCT03539601|Hydrocortisone|hydrocortisone|mesh-list
102018081|NCT03539601|Pimecrolimus|pimecrolimus|mesh-list
102018082|NCT03539601|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
102018083|NCT03539601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102018084|NCT03539601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102018085|NCT03539601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102018086|NCT03539601|Analgesics|analgesics|mesh-ancestor
102018087|NCT03539601|Sensory System Agents|sensory system agents|mesh-ancestor
102018088|NCT03539601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102018089|NCT03539601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018090|NCT03539601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102018091|NCT03539601|Dermatologic Agents|dermatologic agents|mesh-ancestor
102018092|NCT03539601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102018093|NCT03539601|Immunologic Factors|immunologic factors|mesh-ancestor
102018094|NCT03539601|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102018095|NCT03539601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102018096|NCT03539601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018097|NCT02455180|Ascorbic Acid|ascorbic acid|mesh-list
102018098|NCT02455180|Vitamins|vitamins|mesh-ancestor
102018099|NCT02455180|Micronutrients|micronutrients|mesh-ancestor
102018100|NCT02455180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018101|NCT02455180|Antioxidants|antioxidants|mesh-ancestor
102018102|NCT02455180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018103|NCT02455180|Protective Agents|protective agents|mesh-ancestor
102018104|NCT03514719|Avelumab|avelumab|mesh-list
102018105|NCT03514719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102018106|NCT03514719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102018107|NCT03514719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102018108|NCT03514719|Immunologic Factors|immunologic factors|mesh-ancestor
101950459|NCT03007147|Dexamethasone|dexamethasone|mesh-list
101950460|NCT03007147|Dexamethasone acetate|dexamethasone acetate|mesh-list
101950461|NCT03007147|Methylprednisolone|methylprednisolone|mesh-list
101950462|NCT03007147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101950463|NCT03007147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101950464|NCT03007147|Prednisolone|prednisolone|mesh-list
101950465|NCT03007147|Prednisolone acetate|prednisolone acetate|mesh-list
101950466|NCT03007147|Hydrocortisone|hydrocortisone|mesh-list
101280077|NCT01884857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102018109|NCT03514719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018110|NCT01349439|Propranolol|propranolol|mesh-list
102018111|NCT01349439|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102018112|NCT01349439|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102018113|NCT01349439|Adrenergic Agents|adrenergic agents|mesh-ancestor
102018114|NCT01349439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102018115|NCT01349439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473083|NCT02270788|Antidotes|antidotes|mesh-ancestor
102018122|NCT03245554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102018123|NCT03245554|Adrenergic Agents|adrenergic agents|mesh-ancestor
102018124|NCT03245554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102018125|NCT03245554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018126|NCT03245554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018127|NCT03245554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102018128|NCT03245554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102018129|NCT03245554|Vasodilator Agents|vasodilator agents|mesh-ancestor
102018130|NCT01346007|Vaccines|vaccines|mesh-list
102018131|NCT01346007|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102018132|NCT01346007|Immunologic Factors|immunologic factors|mesh-ancestor
102018133|NCT01346007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018134|NCT01349751|Levobupivacaine|levobupivacaine|mesh-list
102018135|NCT01349751|Anesthetics, Local|anesthetics, local|mesh-ancestor
102018136|NCT01349751|Anesthetics|anesthetics|mesh-ancestor
102018137|NCT01349751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102018138|NCT01349751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018139|NCT01349751|Sensory System Agents|sensory system agents|mesh-ancestor
102018140|NCT01349751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102018141|NCT03004131|Fluticasone|fluticasone|mesh-list
102018142|NCT03004131|Xhance|xhance|mesh-list
102018143|NCT03004131|Loratadine|loratadine|mesh-list
101737889|NCT02581761|Misoprostol|misoprostol|mesh-list
102018144|NCT03004131|Azelastine|azelastine|mesh-list
102018145|NCT03004131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102018146|NCT03004131|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102018147|NCT03004131|Autonomic Agents|autonomic agents|mesh-ancestor
102018148|NCT03004131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102018149|NCT03004131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018150|NCT03004131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102018151|NCT03004131|Respiratory System Agents|respiratory system agents|mesh-ancestor
102018152|NCT03004131|Dermatologic Agents|dermatologic agents|mesh-ancestor
102018153|NCT03004131|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102018154|NCT03004131|Antipruritics|antipruritics|mesh-ancestor
101387648|NCT00314158|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102018155|NCT03004131|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102018156|NCT03004131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102018157|NCT03004131|Histamine Antagonists|histamine antagonists|mesh-ancestor
102018158|NCT03004131|Histamine Agents|histamine agents|mesh-ancestor
102018159|NCT03004131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102018160|NCT03004131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018161|NCT03004131|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
102018162|NCT03004131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102018163|NCT01350063|Troclosene|troclosene|mesh-list
102018164|NCT01350063|Antifungal Agents|antifungal agents|mesh-ancestor
102018165|NCT01350063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102018166|NCT01350063|Antiviral Agents|antiviral agents|mesh-ancestor
102018167|NCT01350063|Disinfectants|disinfectants|mesh-ancestor
102018168|NCT03421041|Dexamethasone|dexamethasone|mesh-list
102018169|NCT03421041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102018170|NCT03421041|Antiemetics|antiemetics|mesh-ancestor
102018171|NCT03421041|Autonomic Agents|autonomic agents|mesh-ancestor
101950467|NCT03007147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101950468|NCT03007147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101950469|NCT03007147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101950470|NCT03007147|Cyclophosphamide|cyclophosphamide|mesh-list
101950471|NCT03007147|Ifosfamide|ifosfamide|mesh-list
101950472|NCT03007147|Isophosphamide mustard|isophosphamide mustard|mesh-list
101950473|NCT03007147|Doxorubicin|doxorubicin|mesh-list
101950474|NCT03007147|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101950475|NCT03007147|Methotrexate|methotrexate|mesh-list
101950476|NCT03007147|Etoposide|etoposide|mesh-list
101950477|NCT03007147|Vincristine|vincristine|mesh-list
101950478|NCT03007147|Etoposide phosphate|etoposide phosphate|mesh-list
102018172|NCT03421041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102018173|NCT03421041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018174|NCT03421041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102018175|NCT03421041|Glucocorticoids|glucocorticoids|mesh-ancestor
102018176|NCT03421041|Hormones|hormones|mesh-ancestor
102018177|NCT03421041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102018178|NCT03421041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102018179|NCT03421041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102018180|NCT03244774|Paclitaxel|paclitaxel|mesh-list
102018181|NCT03244774|Fluorouracil|fluorouracil|mesh-list
102018182|NCT03244774|Oxaliplatin|oxaliplatin|mesh-list
102018183|NCT03244774|Apatinib|apatinib|mesh-list
102018184|NCT03244774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102018185|NCT03244774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102018188|NCT03244774|Mitosis Modulators|mitosis modulators|mesh-ancestor
102018189|NCT03244774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018190|NCT03244774|Antimetabolites|antimetabolites|mesh-ancestor
102018191|NCT03244774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102018192|NCT03244774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102018193|NCT03244774|Immunologic Factors|immunologic factors|mesh-ancestor
102018194|NCT03244774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018195|NCT03244774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102018196|NCT03244774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102018197|NCT02903823|Baclofen|baclofen|mesh-list
102018198|NCT02903823|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102018199|NCT02903823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018200|NCT02903823|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102018201|NCT02903823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102018202|NCT02903823|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102018203|NCT02903823|GABA Agonists|gaba agonists|mesh-ancestor
102018204|NCT02903823|GABA Agents|gaba agents|mesh-ancestor
102018205|NCT02903823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102018206|NCT02903823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018207|NCT03244930|Plerixafor|plerixafor|mesh-list
102018208|NCT03244930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102018209|NCT03244930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102018210|NCT03244930|Antiviral Agents|antiviral agents|mesh-ancestor
102018211|NCT03244930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102018212|NCT02855697|Olaparib|olaparib|mesh-list
102018213|NCT02855697|Cediranib|cediranib|mesh-list
102018214|NCT02855697|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102018215|NCT02855697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102018216|NCT02855697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018217|NCT02855697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102018218|NCT02855697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102018219|NCT03894501|Methadone|methadone|mesh-list
102018220|NCT03894501|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102018221|NCT03894501|Narcotics|narcotics|mesh-ancestor
102018222|NCT03894501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102018223|NCT03894501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018224|NCT03894501|Analgesics|analgesics|mesh-ancestor
102018225|NCT03894501|Sensory System Agents|sensory system agents|mesh-ancestor
102018226|NCT03894501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102018227|NCT03894501|Antitussive Agents|antitussive agents|mesh-ancestor
101950479|NCT03007147|Imatinib Mesylate|imatinib mesylate|mesh-list
101950480|NCT03007147|Daunorubicin|daunorubicin|mesh-list
101950481|NCT03007147|Asparaginase|asparaginase|mesh-list
101950482|NCT03007147|Mercaptopurine|mercaptopurine|mesh-list
102018228|NCT03894501|Respiratory System Agents|respiratory system agents|mesh-ancestor
102018229|NCT01346865|Cilostazol|cilostazol|mesh-list
102018230|NCT01346865|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102018231|NCT01346865|Autonomic Agents|autonomic agents|mesh-ancestor
102018232|NCT01346865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102018233|NCT01346865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018234|NCT01346865|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102018235|NCT01346865|Respiratory System Agents|respiratory system agents|mesh-ancestor
102018236|NCT01346865|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102018237|NCT01346865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102018238|NCT01346865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018239|NCT01346865|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102018240|NCT01346865|Vasodilator Agents|vasodilator agents|mesh-ancestor
102018241|NCT01346865|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102018242|NCT01346865|Protective Agents|protective agents|mesh-ancestor
102018243|NCT01346865|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102018244|NCT01346865|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102018245|NCT01346865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102018246|NCT03244462|Methotrexate|methotrexate|mesh-list
102018247|NCT03244462|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102018248|NCT03244462|Abortifacient Agents|abortifacient agents|mesh-ancestor
102018249|NCT03244462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102018250|NCT03244462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018251|NCT03244462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102018252|NCT03244462|Antimetabolites|antimetabolites|mesh-ancestor
102018253|NCT03244462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018254|NCT03244462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102018255|NCT03244462|Dermatologic Agents|dermatologic agents|mesh-ancestor
102018256|NCT03244462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102018257|NCT03244462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101473223|NCT02272582|Heparin|heparin|mesh-list
102018277|NCT03244540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102018278|NCT03244540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102018279|NCT03244540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102018280|NCT03244540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102018281|NCT03244540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018282|NCT03249298|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
102018283|NCT03249298|Plasma Substitutes|plasma substitutes|mesh-ancestor
102018284|NCT03249298|Blood Substitutes|blood substitutes|mesh-ancestor
102018285|NCT02454868|Remifentanil|remifentanil|mesh-list
102018286|NCT02454868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102018287|NCT02454868|Narcotics|narcotics|mesh-ancestor
102018288|NCT02454868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102018289|NCT02454868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018290|NCT02454868|Analgesics|analgesics|mesh-ancestor
102018291|NCT02454868|Sensory System Agents|sensory system agents|mesh-ancestor
102018292|NCT02454868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102018293|NCT03753087|Empagliflozin|empagliflozin|mesh-list
102018294|NCT03753087|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102018295|NCT03753087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018296|NCT03753087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102018297|NCT03753087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018298|NCT02454712|Naltrexone|naltrexone|mesh-list
102018299|NCT02454712|Oxycodone|oxycodone|mesh-list
102018300|NCT02454712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102018301|NCT02454712|Narcotics|narcotics|mesh-ancestor
102018302|NCT02454712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102018303|NCT02454712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018304|NCT02454712|Analgesics|analgesics|mesh-ancestor
102018305|NCT02454712|Sensory System Agents|sensory system agents|mesh-ancestor
102018306|NCT02454712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102018307|NCT02454712|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102018308|NCT02454712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102018309|NCT00832455|Montelukast|montelukast|mesh-list
102018310|NCT00832455|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102018311|NCT00832455|Respiratory System Agents|respiratory system agents|mesh-ancestor
102018312|NCT00832455|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102018313|NCT00832455|Hormone Antagonists|hormone antagonists|mesh-ancestor
101950483|NCT03007147|Podophyllotoxin|podophyllotoxin|mesh-list
101950484|NCT03007147|Pegaspargase|pegaspargase|mesh-list
101950485|NCT03007147|Thioguanine|thioguanine|mesh-list
101950486|NCT03007147|Dexrazoxane|dexrazoxane|mesh-list
101950487|NCT03007147|Razoxane|razoxane|mesh-list
101950488|NCT03007147|Azathioprine|azathioprine|mesh-list
101950489|NCT03007147|Lenograstim|lenograstim|mesh-list
101950490|NCT03007147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101950491|NCT03007147|Prednisolone phosphate|prednisolone phosphate|mesh-list
101950492|NCT03007147|BB 1101|bb 1101|mesh-list
102018314|NCT00832455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101473293|NCT00257348|Capecitabine|capecitabine|mesh-list
102018336|NCT00423579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102018337|NCT00423579|Antimetabolites|antimetabolites|mesh-ancestor
102018338|NCT00423579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018339|NCT00423579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102018340|NCT00423579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102018341|NCT00423579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102018342|NCT03243604|Hormones|hormones|mesh-list
102018343|NCT03243604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102018344|NCT03243604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018345|NCT02454556|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102018346|NCT02454556|Hormones|hormones|mesh-ancestor
102018347|NCT02454556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102018348|NCT02454556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018349|NCT01352559|Milnacipran|milnacipran|mesh-list
102018350|NCT01352559|Mirtazapine|mirtazapine|mesh-list
102018351|NCT01352559|Sertraline|sertraline|mesh-list
102018352|NCT01352559|Fluoxetine|fluoxetine|mesh-list
102018353|NCT01352559|Paroxetine|paroxetine|mesh-list
102018354|NCT01352559|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102018355|NCT01352559|Nortriptyline|nortriptyline|mesh-list
102018356|NCT01352559|Antidepressive Agents|antidepressive agents|mesh-ancestor
102018357|NCT01352559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102018358|NCT01352559|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102018359|NCT01352559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102018360|NCT01352559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102018361|NCT01352559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018362|NCT01352559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102018363|NCT01352559|Serotonin Agents|serotonin agents|mesh-ancestor
101473356|NCT01601899|Antimetabolites|antimetabolites|mesh-ancestor
102018378|NCT01352559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101522561|NCT03276143|Enoxaparin|enoxaparin|mesh-list
102018379|NCT01352559|Adrenergic Agents|adrenergic agents|mesh-ancestor
102018380|NCT01352559|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102018381|NCT01352559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102018382|NCT01352559|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102018383|NCT01352559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102018384|NCT01352559|Analgesics|analgesics|mesh-ancestor
102018385|NCT01352559|Sensory System Agents|sensory system agents|mesh-ancestor
102018386|NCT01352559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102018387|NCT01352559|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102018388|NCT01352559|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102018389|NCT03247972|Evolocumab|evolocumab|mesh-list
102018390|NCT03247972|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102018391|NCT03247972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102018392|NCT03247972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102018393|NCT03247972|Antimetabolites|antimetabolites|mesh-ancestor
102018394|NCT03247972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018395|NCT03247972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102018396|NCT03247972|Protease Inhibitors|protease inhibitors|mesh-ancestor
102018397|NCT03247972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102018398|NCT03247972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102018399|NCT01350609|Candesartan|candesartan|mesh-list
102018400|NCT01350609|Candesartan cilexetil|candesartan cilexetil|mesh-list
102018401|NCT01350609|Nifedipine|nifedipine|mesh-list
102018402|NCT01350609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102018403|NCT01350609|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102018404|NCT01350609|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101950493|NCT03007147|Calcium|calcium|mesh-list
101950494|NCT03007147|2-Aminopurine|2-aminopurine|mesh-list
101950495|NCT03007147|Levoleucovorin|levoleucovorin|mesh-list
101950496|NCT03007147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101950497|NCT03007147|Immunologic Factors|immunologic factors|mesh-ancestor
102018405|NCT01350609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018406|NCT01350609|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102018407|NCT01350609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102018408|NCT01350609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102018409|NCT01350609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018410|NCT01350609|Vasodilator Agents|vasodilator agents|mesh-ancestor
102018411|NCT01350609|Tocolytic Agents|tocolytic agents|mesh-ancestor
102018412|NCT01350609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102018413|NCT03269409|Coal Tar|coal tar|mesh-list
102018414|NCT03269409|Keratolytic Agents|keratolytic agents|mesh-ancestor
102018415|NCT03269409|Dermatologic Agents|dermatologic agents|mesh-ancestor
102018416|NCT03778372|Methadone|methadone|mesh-list
102018417|NCT03778372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102018418|NCT03778372|Narcotics|narcotics|mesh-ancestor
102018419|NCT03778372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102018420|NCT03778372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018452|NCT03268005|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102018453|NCT03268005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102018454|NCT03268005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018455|NCT03239314|Dexamethasone|dexamethasone|mesh-list
102018456|NCT03239314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102018457|NCT03239314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102018458|NCT03239314|Antiemetics|antiemetics|mesh-ancestor
102018459|NCT03239314|Autonomic Agents|autonomic agents|mesh-ancestor
102018460|NCT03239314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102018461|NCT03239314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018462|NCT03239314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102018463|NCT03239314|Glucocorticoids|glucocorticoids|mesh-ancestor
102018478|NCT03241888|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102018479|NCT03241888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102018480|NCT03241888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102018481|NCT03241888|Appetite Stimulants|appetite stimulants|mesh-ancestor
102018482|NCT03241888|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102018483|NCT02454088|Calcium, Dietary|calcium, dietary|mesh-list
102018484|NCT02454088|Triamcinolone|triamcinolone|mesh-list
102018485|NCT02454088|Calcium|calcium|mesh-list
102018486|NCT02454088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102018487|NCT02454088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018488|NCT02454088|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102018489|NCT02454088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102018490|NCT02454088|Glucocorticoids|glucocorticoids|mesh-ancestor
102018491|NCT02454088|Hormones|hormones|mesh-ancestor
102018492|NCT02454088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102018493|NCT02456116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
102018494|NCT02456116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102018495|NCT02456116|Analgesics|analgesics|mesh-ancestor
102018496|NCT02456116|Sensory System Agents|sensory system agents|mesh-ancestor
102018497|NCT02456116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102018498|NCT02456116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018499|NCT02456116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102018500|NCT02456116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102018501|NCT03239236|Anesthetics|anesthetics|mesh-list
102018502|NCT03239236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102018503|NCT03239236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018504|NCT03257800|Ketamine|ketamine|mesh-list
102018505|NCT03257800|Nitrous Oxide|nitrous oxide|mesh-list
102018506|NCT03257800|Sevoflurane|sevoflurane|mesh-list
102018507|NCT03257800|Analgesics|analgesics|mesh-ancestor
102018508|NCT03257800|Sensory System Agents|sensory system agents|mesh-ancestor
102018509|NCT03257800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102018510|NCT03257800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018511|NCT03257800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102018512|NCT03257800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102018513|NCT03257800|Anesthetics, General|anesthetics, general|mesh-ancestor
102018514|NCT03257800|Anesthetics|anesthetics|mesh-ancestor
102018515|NCT03257800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101950498|NCT03007147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950499|NCT03007147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101950500|NCT03007147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101950501|NCT03007147|Alkylating Agents|alkylating agents|mesh-ancestor
101950502|NCT03007147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280423|NCT01887223|Timolol|timolol|mesh-list
102018516|NCT03257800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102018517|NCT03257800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102018518|NCT03257800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101738271|NCT04076865|Lidocaine|lidocaine|mesh-list
102018519|NCT03257800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018520|NCT03257800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102018521|NCT03257800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102018522|NCT03257800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102018523|NCT01353339|Levofloxacin|levofloxacin|mesh-list
102018534|NCT01353339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102018536|NCT03239080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102018537|NCT03239080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018538|NCT03149055|Isavuconazole|isavuconazole|mesh-list
102018539|NCT03149055|Antifungal Agents|antifungal agents|mesh-ancestor
102018540|NCT03149055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102018541|NCT01352091|Goserelin|goserelin|mesh-list
102018542|NCT01352091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102018543|NCT01352091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102018544|NCT02954523|Dasatinib|dasatinib|mesh-list
102018545|NCT02954523|Osimertinib|osimertinib|mesh-list
102018546|NCT02954523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102018547|NCT02954523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102018548|NCT02954523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102018549|NCT02954523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018550|NCT04486612|Anesthetics|anesthetics|mesh-list
102018551|NCT04486612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102018552|NCT04486612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018553|NCT01353729|Moxifloxacin|moxifloxacin|mesh-list
102018554|NCT01353729|Zanamivir|zanamivir|mesh-list
102018555|NCT01353729|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102018556|NCT01353729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102018557|NCT01353729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102018558|NCT01353729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102018559|NCT01353729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102018560|NCT01353729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102018561|NCT01353729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018562|NCT01353729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102018563|NCT01353729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102018564|NCT01353729|Contraceptive Agents|contraceptive agents|mesh-ancestor
102018565|NCT01353729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102018566|NCT01353729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018567|NCT01353729|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102018568|NCT01353729|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102018569|NCT01353729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102018570|NCT01353729|Antiviral Agents|antiviral agents|mesh-ancestor
102018571|NCT01357317|Calcium, Dietary|calcium, dietary|mesh-list
102018572|NCT01357317|Calcium|calcium|mesh-list
102018573|NCT01357317|Calcium acetate|calcium acetate|mesh-list
102018574|NCT01357317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102018575|NCT01357317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018576|NCT01357317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102018577|NCT01357317|Chelating Agents|chelating agents|mesh-ancestor
102018578|NCT01357317|Sequestering Agents|sequestering agents|mesh-ancestor
102018579|NCT01357317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018580|NCT03238612|Clarithromycin|clarithromycin|mesh-list
102018581|NCT03238612|Oseltamivir|oseltamivir|mesh-list
102018582|NCT03238612|Antiviral Agents|antiviral agents|mesh-list
102018583|NCT03238612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102018584|NCT03238612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102018585|NCT03238612|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102018586|NCT03238612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102018590|NCT03137121|Olanzapine|olanzapine|mesh-list
101950503|NCT03007147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101950504|NCT03007147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101950505|NCT03007147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101950507|NCT03007147|Autonomic Agents|autonomic agents|mesh-ancestor
101280500|NCT01887561|Dasatinib|dasatinib|mesh-list
102018591|NCT03137121|Antiemetics|antiemetics|mesh-ancestor
101738344|NCT03904563|Bevacizumab|bevacizumab|mesh-list
102018592|NCT03137121|Autonomic Agents|autonomic agents|mesh-ancestor
102018593|NCT03137121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102018594|NCT03137121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018595|NCT03137121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102018596|NCT03137121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102018597|NCT03137121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102018598|NCT03137121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102018599|NCT03137121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102018600|NCT03137121|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102018601|NCT03137121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102018602|NCT03137121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102018603|NCT03137121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018604|NCT03137121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102018605|NCT03137121|Serotonin Agents|serotonin agents|mesh-ancestor
102018606|NCT02453776|Infliximab|infliximab|mesh-list
102018607|NCT02453776|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102018608|NCT02453776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102018609|NCT02453776|Dermatologic Agents|dermatologic agents|mesh-ancestor
102018610|NCT02453776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102018611|NCT02453776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102018612|NCT03256864|Everolimus|everolimus|mesh-list
102018613|NCT03256864|Tacrolimus|tacrolimus|mesh-list
102018614|NCT03256864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102018615|NCT03256864|Immunologic Factors|immunologic factors|mesh-ancestor
102018616|NCT03256864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018617|NCT03256864|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102018618|NCT03256864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102018619|NCT03256864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018620|NCT03256864|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102018621|NCT03256864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102018622|NCT03256864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102018623|NCT01317849|Vitamins|vitamins|mesh-list
102018624|NCT01317849|Folic Acid|folic acid|mesh-list
102018625|NCT01317849|Vitamin B 12|vitamin b 12|mesh-list
102018626|NCT01317849|Pyridoxine|pyridoxine|mesh-list
102018627|NCT01317849|Pyridoxal|pyridoxal|mesh-list
102018628|NCT01317849|Vitamin B 6|vitamin b 6|mesh-list
102018629|NCT01317849|Vitamin B Complex|vitamin b complex|mesh-list
102018630|NCT01317849|Micronutrients|micronutrients|mesh-ancestor
102018631|NCT01317849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018632|NCT01317849|Hematinics|hematinics|mesh-ancestor
102018633|NCT01317927|Belinostat|belinostat|mesh-list
102018634|NCT01317927|Warfarin|warfarin|mesh-list
102018635|NCT01317927|Anticoagulants|anticoagulants|mesh-ancestor
102018636|NCT01317927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102018637|NCT01317927|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102018638|NCT01317927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102018639|NCT01317927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018640|NCT02901483|Cisplatin|cisplatin|mesh-list
102018641|NCT02901483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102018642|NCT02874651|Apatinib|apatinib|mesh-list
102018643|NCT02874651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102018644|NCT02874651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102018645|NCT02874651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102018646|NCT02874651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018647|NCT02453932|Donepezil|donepezil|mesh-list
102018648|NCT02453932|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102018649|NCT02453932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102018650|NCT02453932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018651|NCT02453932|Cholinergic Agents|cholinergic agents|mesh-ancestor
102018652|NCT02453932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102018653|NCT02453932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018654|NCT02453932|Nootropic Agents|nootropic agents|mesh-ancestor
102018655|NCT00700570|Bevacizumab|bevacizumab|mesh-list
102018656|NCT00700570|Capecitabine|capecitabine|mesh-list
101950508|NCT03007147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101950509|NCT03007147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101950510|NCT03007147|Glucocorticoids|glucocorticoids|mesh-ancestor
101950511|NCT03007147|Hormones|hormones|mesh-ancestor
101280558|NCT01887704|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102018657|NCT00700570|Oxaliplatin|oxaliplatin|mesh-list
102018658|NCT00700570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102018667|NCT00700570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018668|NCT02453698|Methylphenidate|methylphenidate|mesh-list
102018669|NCT02453698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102018670|NCT02453698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018671|NCT02453698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102018672|NCT02453698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102018673|NCT02453698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102018674|NCT02453698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018675|NCT02453698|Dopamine Agents|dopamine agents|mesh-ancestor
102018676|NCT02453698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102018677|NCT01354275|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
102018678|NCT01354275|Hormones|hormones|mesh-ancestor
101387649|NCT00314158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102018679|NCT01354275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102018680|NCT01354275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018681|NCT01318161|Morphine|morphine|mesh-list
102018682|NCT01318161|Ropivacaine|ropivacaine|mesh-list
102018683|NCT01318161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102018684|NCT01318161|Narcotics|narcotics|mesh-ancestor
102018685|NCT01318161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102018686|NCT01318161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018687|NCT01318161|Analgesics|analgesics|mesh-ancestor
102018688|NCT01318161|Sensory System Agents|sensory system agents|mesh-ancestor
102018689|NCT01318161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102018690|NCT01318161|Anesthetics, Local|anesthetics, local|mesh-ancestor
102018691|NCT01318161|Anesthetics|anesthetics|mesh-ancestor
102018692|NCT03255226|Tolvaptan|tolvaptan|mesh-list
102018693|NCT03255226|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102018694|NCT03255226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018695|NCT03255226|Natriuretic Agents|natriuretic agents|mesh-ancestor
102018696|NCT03255226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018697|NCT02455726|Pregabalin|pregabalin|mesh-list
102018698|NCT02455726|Oxycodone|oxycodone|mesh-list
102018699|NCT02455726|Magnesium Oxide|magnesium oxide|mesh-list
102018700|NCT02455726|Analgesics|analgesics|mesh-ancestor
102018701|NCT02455726|Sensory System Agents|sensory system agents|mesh-ancestor
102018702|NCT02455726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102018703|NCT02455726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018704|NCT02455726|Anticonvulsants|anticonvulsants|mesh-ancestor
102018705|NCT02455726|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102018706|NCT02455726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102018707|NCT02455726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018708|NCT02455726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102018709|NCT02455726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102018710|NCT02455726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102018711|NCT02455726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102018712|NCT02455726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102018713|NCT02455726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102018714|NCT02455726|Narcotics|narcotics|mesh-ancestor
102018715|NCT02455726|Antacids|antacids|mesh-ancestor
102018716|NCT02455726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102018717|NCT04488172|Vitamins|vitamins|mesh-list
102018718|NCT04488172|Micronutrients|micronutrients|mesh-ancestor
102018719|NCT04488172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018720|NCT03239860|Antibodies|antibodies|mesh-list
102018721|NCT03239860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102018722|NCT03239860|Immunologic Factors|immunologic factors|mesh-ancestor
102018723|NCT03239860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018724|NCT04486690|Ketamine|ketamine|mesh-list
102018735|NCT04486690|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102018736|NCT04486690|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102018737|NCT04486690|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102018738|NCT04486690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102018739|NCT04486690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950512|NCT03007147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101950513|NCT03007147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101950514|NCT03007147|Protease Inhibitors|protease inhibitors|mesh-ancestor
102018740|NCT03255148|Oxytocin|oxytocin|mesh-list
102018741|NCT03255148|Oxytocics|oxytocics|mesh-ancestor
102018742|NCT03255148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102018743|NCT03255148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018744|NCT03236818|Bosentan|bosentan|mesh-list
102018745|NCT03236818|Sildenafil Citrate|sildenafil citrate|mesh-list
102018746|NCT03236818|Tadalafil|tadalafil|mesh-list
102018747|NCT03236818|Macitentan|macitentan|mesh-list
102018748|NCT03236818|Vasodilator Agents|vasodilator agents|mesh-ancestor
102018749|NCT03236818|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102018750|NCT03236818|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102018751|NCT03236818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102018752|NCT03236818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018753|NCT03236818|Urological Agents|urological agents|mesh-ancestor
102018754|NCT03236818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102018755|NCT03236818|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102018756|NCT03236818|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
102018757|NCT03236818|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
102018758|NCT03236974|Fulvestrant|fulvestrant|mesh-list
102018759|NCT03236974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102018760|NCT03236974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102018761|NCT03236974|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102018762|NCT03236974|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102018763|NCT03236974|Hormone Antagonists|hormone antagonists|mesh-ancestor
102018764|NCT03236974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102018765|NCT03236974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018766|NCT03748043|Lactoferrin|lactoferrin|mesh-list
102018767|NCT03748043|Teferrol|teferrol|mesh-list
102018768|NCT03748043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102018769|NCT03748043|Hematinics|hematinics|mesh-ancestor
102018770|NCT03750773|Gabapentin|gabapentin|mesh-list
102018771|NCT03750773|Analgesics|analgesics|mesh-ancestor
102018772|NCT03750773|Sensory System Agents|sensory system agents|mesh-ancestor
102018773|NCT03750773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102018774|NCT03750773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018775|NCT03750773|Anticonvulsants|anticonvulsants|mesh-ancestor
102018776|NCT03750773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102018777|NCT03750773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102018778|NCT03750773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102018779|NCT03750773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102018780|NCT03750773|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102018781|NCT03750773|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102018782|NCT03750773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102018783|NCT03750773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018784|NCT03750773|Antimanic Agents|antimanic agents|mesh-ancestor
102018785|NCT02874924|Sirolimus|sirolimus|mesh-list
102018786|NCT02874924|Temsirolimus|temsirolimus|mesh-list
102018787|NCT02874924|MTOR Inhibitors|mtor inhibitors|mesh-list
102018788|NCT02874924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102018789|NCT02874924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101473771|NCT00290901|Celecoxib|celecoxib|mesh-list
102018792|NCT02874924|Antifungal Agents|antifungal agents|mesh-ancestor
102018793|NCT02874924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102018794|NCT02874924|Immunologic Factors|immunologic factors|mesh-ancestor
102018795|NCT02874924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018796|NCT02874924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102018797|NCT02874924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102018798|NCT02874924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018799|NCT04425863|Aspirin|aspirin|mesh-list
102018800|NCT04425863|Ivermectin|ivermectin|mesh-list
102018801|NCT04425863|Dexamethasone|dexamethasone|mesh-list
102018802|NCT04425863|Dexamethasone acetate|dexamethasone acetate|mesh-list
102018803|NCT04425863|Enoxaparin|enoxaparin|mesh-list
102018804|NCT04425863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102018805|NCT04425863|BB 1101|bb 1101|mesh-list
102018806|NCT04425863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102018807|NCT04425863|Antiemetics|antiemetics|mesh-ancestor
102018808|NCT04425863|Autonomic Agents|autonomic agents|mesh-ancestor
102018809|NCT04425863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102018810|NCT04425863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950515|NCT03007147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101950516|NCT03007147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101950517|NCT03007147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102018811|NCT04425863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102018813|NCT04425863|Hormones|hormones|mesh-ancestor
102018814|NCT04425863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102018815|NCT04425863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102018816|NCT04425863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102018817|NCT04425863|Protease Inhibitors|protease inhibitors|mesh-ancestor
102018818|NCT04425863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102018819|NCT04425863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018820|NCT04425863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102018821|NCT04425863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102018823|NCT04425863|Sensory System Agents|sensory system agents|mesh-ancestor
102018824|NCT04425863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102018825|NCT04425863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102018826|NCT04425863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102018827|NCT04425863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102018828|NCT04425863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102018829|NCT04425863|Antipyretics|antipyretics|mesh-ancestor
102018830|NCT04425863|Anticoagulants|anticoagulants|mesh-ancestor
102018831|NCT04425863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102018832|NCT04425863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102018833|NCT01370772|Cyclophosphamide|cyclophosphamide|mesh-list
102018834|NCT01370772|Rituximab|rituximab|mesh-list
102018835|NCT01370772|Fludarabine|fludarabine|mesh-list
102018836|NCT01370772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102018837|NCT01370772|Immunologic Factors|immunologic factors|mesh-ancestor
102018838|NCT01370772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018839|NCT01370772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102018840|NCT01370772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102018841|NCT01370772|Alkylating Agents|alkylating agents|mesh-ancestor
102018842|NCT01370772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018843|NCT01370772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102018844|NCT01370772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102018845|NCT01370772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102018846|NCT01842282|Amlexanox|amlexanox|mesh-list
102018847|NCT01842282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102018848|NCT03234244|Cholecalciferol|cholecalciferol|mesh-list
102018849|NCT03234244|Vitamin D|vitamin d|mesh-list
102018850|NCT03234244|Bazedoxifene|bazedoxifene|mesh-list
102018851|NCT03234244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102018852|NCT03234244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018853|NCT03234244|Vitamins|vitamins|mesh-ancestor
102018854|NCT03234244|Micronutrients|micronutrients|mesh-ancestor
102018855|NCT03234244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102018856|NCT03234244|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102018857|NCT03234244|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102018858|NCT03234244|Hormone Antagonists|hormone antagonists|mesh-ancestor
102018859|NCT03234244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102018860|NCT03234400|Dapivirine|dapivirine|mesh-list
102018861|NCT03234400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102018862|NCT03234400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102018863|NCT03234400|Antiviral Agents|antiviral agents|mesh-ancestor
102018864|NCT03234400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102018867|NCT03254368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018869|NCT03236740|Metformin|metformin|mesh-list
102018870|NCT03236740|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102018871|NCT03236740|Estradiol|estradiol|mesh-list
102018872|NCT03236740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102018873|NCT03236740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018874|NCT03236740|Estrogens|estrogens|mesh-ancestor
102018875|NCT03236740|Hormones|hormones|mesh-ancestor
102018876|NCT03236740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102018877|NCT03236740|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102018878|NCT03236740|Contraceptive Agents|contraceptive agents|mesh-ancestor
102018879|NCT03236740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102018880|NCT03236740|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102018881|NCT03236740|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102018882|NCT03236740|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102018883|NCT02453464|Leucovorin|leucovorin|mesh-list
101950518|NCT03007147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101950519|NCT03007147|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101950520|NCT03007147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101950521|NCT03007147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101950522|NCT03007147|Abortifacient Agents|abortifacient agents|mesh-ancestor
101950523|NCT03007147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101950524|NCT03007147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102018884|NCT02453464|Irinotecan|irinotecan|mesh-list
102018885|NCT02453464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102018886|NCT02453464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102018887|NCT02453464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102018888|NCT02453464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018889|NCT02453464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102018890|NCT02453464|Antidotes|antidotes|mesh-ancestor
102018891|NCT02453464|Protective Agents|protective agents|mesh-ancestor
102018892|NCT02453464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018893|NCT02453464|Vitamin B Complex|vitamin b complex|mesh-ancestor
102018894|NCT02453464|Vitamins|vitamins|mesh-ancestor
102018895|NCT02453464|Micronutrients|micronutrients|mesh-ancestor
102018896|NCT03233932|Leuprolide|leuprolide|mesh-list
102018897|NCT03233932|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102018898|NCT03233932|Fertility Agents|fertility agents|mesh-ancestor
102018899|NCT03233932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102018900|NCT03233932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018901|NCT03233932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102018902|NCT03233932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102018904|NCT03236584|Lamivudine|lamivudine|mesh-list
102018905|NCT03236584|Adefovir|adefovir|mesh-list
102018906|NCT03236584|Antiviral Agents|antiviral agents|mesh-ancestor
102018907|NCT03236584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102018908|NCT03236584|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102018909|NCT03236584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102018910|NCT03236584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102018911|NCT03236584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018912|NCT03236584|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102018913|NCT03236584|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102018914|NCT03233776|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102018915|NCT03233776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102018916|NCT04614168|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102018917|NCT04614168|Glycerol|glycerol|mesh-list
102018918|NCT04614168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018919|NCT04614168|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102018920|NCT04614168|Protective Agents|protective agents|mesh-ancestor
102018921|NCT01365312|Ethanol|ethanol|mesh-list
102018922|NCT01365312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102018923|NCT01365312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102018924|NCT01365312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102018925|NCT01365312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018926|NCT04495283|Acetaminophen|acetaminophen|mesh-list
102018927|NCT04495283|Pregabalin|pregabalin|mesh-list
102018928|NCT04495283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102018929|NCT04495283|Analgesics|analgesics|mesh-ancestor
102018930|NCT04495283|Sensory System Agents|sensory system agents|mesh-ancestor
102018931|NCT04495283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102018932|NCT04495283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018933|NCT04495283|Antipyretics|antipyretics|mesh-ancestor
102018934|NCT04495283|Anticonvulsants|anticonvulsants|mesh-ancestor
102018935|NCT04495283|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102018936|NCT04495283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102018937|NCT04495283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018938|NCT04495283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102018939|NCT04495283|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102018944|NCT03634020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102018945|NCT03634020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102018946|NCT03634020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102018947|NCT03634020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102018948|NCT03634020|Antifungal Agents|antifungal agents|mesh-ancestor
101950525|NCT03007147|Antimetabolites|antimetabolites|mesh-ancestor
101950526|NCT03007147|Dermatologic Agents|dermatologic agents|mesh-ancestor
101950527|NCT03007147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102018949|NCT03634020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102018950|NCT03634020|Immunologic Factors|immunologic factors|mesh-ancestor
102018951|NCT03634020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018952|NCT03253276|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
102018953|NCT03253276|Cathartics|cathartics|mesh-ancestor
102018954|NCT03253276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102018955|NCT01372644|Pasireotide|pasireotide|mesh-list
102018957|NCT01372644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102018958|NCT01372644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018959|NCT03253198|Bupivacaine|bupivacaine|mesh-list
102018960|NCT03253198|Anesthetics, Local|anesthetics, local|mesh-ancestor
102018961|NCT03253198|Anesthetics|anesthetics|mesh-ancestor
102018962|NCT03253198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102018963|NCT03253198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018964|NCT03253198|Sensory System Agents|sensory system agents|mesh-ancestor
102018965|NCT03253198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102018966|NCT04285086|Anagrelide|anagrelide|mesh-list
102018967|NCT04285086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102018968|NCT04285086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102018969|NCT04285086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018970|NCT04285086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102018971|NCT04485988|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102018972|NCT04485988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102018973|NCT04485988|Adrenergic Agents|adrenergic agents|mesh-ancestor
102018974|NCT04485988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102018975|NCT04485988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018976|NCT04485988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018978|NCT04234464|Albuterol|albuterol|mesh-list
102018979|NCT04234464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102018980|NCT04234464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102018981|NCT04234464|Autonomic Agents|autonomic agents|mesh-ancestor
102018982|NCT04234464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101522749|NCT00450398|Antiviral Agents|antiviral agents|mesh-ancestor
102018983|NCT04234464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018984|NCT04234464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102018985|NCT04234464|Respiratory System Agents|respiratory system agents|mesh-ancestor
102018986|NCT04234464|Glucocorticoids|glucocorticoids|mesh-ancestor
102018987|NCT04234464|Hormones|hormones|mesh-ancestor
102018988|NCT04234464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102018989|NCT04234464|Tocolytic Agents|tocolytic agents|mesh-ancestor
102018990|NCT04234464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102018991|NCT04234464|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102018992|NCT04234464|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102018993|NCT04234464|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102018994|NCT04234464|Adrenergic Agents|adrenergic agents|mesh-ancestor
102018995|NCT04234464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102018996|NCT04234464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018997|NCT03233152|Nivolumab|nivolumab|mesh-list
102018998|NCT03233152|Ipilimumab|ipilimumab|mesh-list
102018999|NCT03233152|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102019000|NCT03233152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102019001|NCT03233152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102019002|NCT03233152|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102019003|NCT03233152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019004|NCT03229096|Apatinib|apatinib|mesh-list
102019005|NCT03229096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102019006|NCT03229096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102019007|NCT03229096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102019008|NCT03229096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019009|NCT03123588|Anagrelide|anagrelide|mesh-list
102019010|NCT03123588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102019015|NCT02452918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102019016|NCT02452918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102019018|NCT02821026|Sirolimus|sirolimus|mesh-list
102019019|NCT02821026|Etanercept|etanercept|mesh-list
102019020|NCT02821026|Tacrolimus|tacrolimus|mesh-list
102019021|NCT02821026|Thymoglobulin|thymoglobulin|mesh-list
102019022|NCT02821026|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102019023|NCT02821026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102019024|NCT02821026|Immunologic Factors|immunologic factors|mesh-ancestor
101950528|NCT03007147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101950529|NCT03007147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101950530|NCT03007147|Antiviral Agents|antiviral agents|mesh-ancestor
101280918|NCT01889368|Antioxidants|antioxidants|mesh-ancestor
102019025|NCT02821026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019026|NCT02821026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102019027|NCT02821026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102019028|NCT02821026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019029|NCT02821026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102019030|NCT02821026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102019031|NCT02821026|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102019032|NCT02821026|Antitubercular Agents|antitubercular agents|mesh-ancestor
102019033|NCT02821026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102019034|NCT02821026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102019035|NCT02821026|Antifungal Agents|antifungal agents|mesh-ancestor
102019036|NCT02821026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102019037|NCT02821026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102019038|NCT02821026|Analgesics|analgesics|mesh-ancestor
102019039|NCT02821026|Sensory System Agents|sensory system agents|mesh-ancestor
102019040|NCT02821026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102019041|NCT02821026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102019042|NCT02821026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102019043|NCT02821026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102019044|NCT03228628|Nitrous Oxide|nitrous oxide|mesh-list
101738793|NCT02517099|Azithromycin|azithromycin|mesh-list
102019045|NCT03228628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102019046|NCT03228628|Anesthetics, General|anesthetics, general|mesh-ancestor
102019047|NCT03228628|Anesthetics|anesthetics|mesh-ancestor
102019048|NCT03228628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102019049|NCT03228628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019050|NCT03228628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102019051|NCT03228628|Analgesics|analgesics|mesh-ancestor
102019052|NCT03228628|Sensory System Agents|sensory system agents|mesh-ancestor
102019053|NCT03228628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102019054|NCT03232450|Aspirin|aspirin|mesh-list
102019055|NCT03232450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102019056|NCT03232450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102019057|NCT03232450|Analgesics|analgesics|mesh-ancestor
102019058|NCT03232450|Sensory System Agents|sensory system agents|mesh-ancestor
102019059|NCT03232450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102019060|NCT03232450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019061|NCT03232450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102019062|NCT03232450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102019063|NCT03232450|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102019064|NCT03232450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102019065|NCT03232450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019066|NCT03232450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102019067|NCT03232450|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102019068|NCT03232450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102019069|NCT03232450|Antipyretics|antipyretics|mesh-ancestor
102019070|NCT04411667|gamma-Globulins|gamma-globulins|mesh-list
102019071|NCT04411667|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102019072|NCT04411667|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102019073|NCT04411667|Immunologic Factors|immunologic factors|mesh-ancestor
102019074|NCT04411667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019075|NCT04948697|Tislelizumab|tislelizumab|mesh-list
102019076|NCT04948697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102019077|NCT04948697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102019078|NCT04358549|Favipiravir|favipiravir|mesh-list
102019079|NCT04358549|Antiviral Agents|antiviral agents|mesh-ancestor
102019080|NCT04358549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102019085|NCT01562483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102019087|NCT01562483|Sensory System Agents|sensory system agents|mesh-ancestor
102019088|NCT01562483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102019089|NCT01562483|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102019090|NCT01562483|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102019091|NCT01562483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102019092|NCT01562483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019093|NCT01562483|Hormones|hormones|mesh-ancestor
102019094|NCT01562483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101950531|NCT03007147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101950532|NCT03007147|Antidotes|antidotes|mesh-ancestor
101950533|NCT03007147|Protective Agents|protective agents|mesh-ancestor
102019095|NCT00700180|Bevacizumab|bevacizumab|mesh-list
102019096|NCT00700180|Carboplatin|carboplatin|mesh-list
102019097|NCT00700180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102019098|NCT00700180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102019099|NCT00700180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102019100|NCT00700180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102019101|NCT00700180|Growth Substances|growth substances|mesh-ancestor
102019102|NCT00700180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019103|NCT00700180|Growth Inhibitors|growth inhibitors|mesh-ancestor
102019104|NCT03222544|Methylene Blue|methylene blue|mesh-list
102019105|NCT03222544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102019106|NCT03222544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019107|NCT03228862|Ergocalciferols|ergocalciferols|mesh-list
102019108|NCT03228862|Vitamin D|vitamin d|mesh-list
102019109|NCT03228862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102019110|NCT03228862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019111|NCT03228862|Vitamins|vitamins|mesh-ancestor
102019112|NCT03228862|Micronutrients|micronutrients|mesh-ancestor
102019113|NCT03228862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102019114|NCT03228238|Vitamins|vitamins|mesh-list
102019115|NCT03228238|Ascorbic Acid|ascorbic acid|mesh-list
102019116|NCT03228238|Vitamin E|vitamin e|mesh-list
102019117|NCT03228238|Tocopherols|tocopherols|mesh-list
102019118|NCT03228238|Calcium Channel Blockers|calcium channel blockers|mesh-list
102019119|NCT03228238|Atorvastatin|atorvastatin|mesh-list
102019120|NCT03228238|Micronutrients|micronutrients|mesh-ancestor
102019121|NCT03228238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019122|NCT03228238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102019123|NCT03228238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102019124|NCT03228238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102019126|NCT03228238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019127|NCT03228238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102019128|NCT03228238|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102019129|NCT03228238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102019130|NCT03228238|Antioxidants|antioxidants|mesh-ancestor
102019131|NCT03228238|Protective Agents|protective agents|mesh-ancestor
102019132|NCT03228238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102019133|NCT03232216|Vitamin D|vitamin d|mesh-list
102019134|NCT03232216|Cholecalciferol|cholecalciferol|mesh-list
102019135|NCT03232216|Vitamins|vitamins|mesh-ancestor
102019136|NCT03232216|Micronutrients|micronutrients|mesh-ancestor
102019137|NCT03232216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019138|NCT03232216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102019139|NCT03232216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102019140|NCT03231982|Amlodipine|amlodipine|mesh-list
102019141|NCT03231982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102019142|NCT03231982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102019143|NCT03231982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102019144|NCT03231982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019145|NCT03231982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102019146|NCT03231982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019147|NCT03231982|Vasodilator Agents|vasodilator agents|mesh-ancestor
102019148|NCT03222310|Itraconazole|itraconazole|mesh-list
102019149|NCT03222310|Ipatasertib|ipatasertib|mesh-list
102019150|NCT03222310|Antifungal Agents|antifungal agents|mesh-ancestor
102019151|NCT03222310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102019152|NCT03222310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102019158|NCT03222310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102019159|NCT03222310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019160|NCT03222310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102019161|NCT03222310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102019162|NCT03222310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102019163|NCT04485520|Chlorhexidine|chlorhexidine|mesh-list
102019164|NCT04485520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102019165|NCT04485520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102019166|NCT04485520|Disinfectants|disinfectants|mesh-ancestor
102019167|NCT03231436|Bupivacaine|bupivacaine|mesh-list
102019168|NCT03231436|Anesthetics, Local|anesthetics, local|mesh-ancestor
102019169|NCT03231436|Anesthetics|anesthetics|mesh-ancestor
102019170|NCT03231436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101950534|NCT03007147|Vitamin B Complex|vitamin b complex|mesh-ancestor
101950536|NCT03007147|Micronutrients|micronutrients|mesh-ancestor
101950537|NCT03007147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102019171|NCT03231436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019172|NCT03231436|Sensory System Agents|sensory system agents|mesh-ancestor
102019173|NCT03231436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102019174|NCT02452450|Acetaminophen|acetaminophen|mesh-list
102019175|NCT02452450|Ibuprofen|ibuprofen|mesh-list
102019176|NCT02452450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102019177|NCT02452450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102019178|NCT02452450|Analgesics|analgesics|mesh-ancestor
102019179|NCT02452450|Sensory System Agents|sensory system agents|mesh-ancestor
102019180|NCT02452450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102019181|NCT02452450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019182|NCT02452450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102019183|NCT02452450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102019184|NCT02452450|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102019185|NCT02452450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102019186|NCT02452450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019187|NCT02452450|Antipyretics|antipyretics|mesh-ancestor
102019188|NCT01204684|Poly ICLC|poly iclc|mesh-list
102019189|NCT01204684|Interferon Inducers|interferon inducers|mesh-ancestor
102019190|NCT01204684|Immunologic Factors|immunologic factors|mesh-ancestor
102019191|NCT01204684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019192|NCT00594334|Risedronic Acid|risedronic acid|mesh-list
102019193|NCT00594334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102019194|NCT00594334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102019195|NCT00594334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019196|NCT00594334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102019197|NCT00594334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019198|NCT00594334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102019200|NCT00238420|Trastuzumab|trastuzumab|mesh-list
102019201|NCT00238420|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102019202|NCT00238420|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
102019203|NCT00238420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102019204|NCT00238420|Antibodies|antibodies|mesh-list
102019205|NCT00238420|Immunoglobulins|immunoglobulins|mesh-list
102019206|NCT00238420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102019207|NCT00238420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102019208|NCT00238420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102019209|NCT00238420|Tubulin Modulators|tubulin modulators|mesh-ancestor
102019210|NCT00238420|Antimitotic Agents|antimitotic agents|mesh-ancestor
102019211|NCT00238420|Mitosis Modulators|mitosis modulators|mesh-ancestor
102019212|NCT00238420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019213|NCT00238420|Immunologic Factors|immunologic factors|mesh-ancestor
102019214|NCT00238420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019215|NCT03221998|Acetaminophen|acetaminophen|mesh-list
102019216|NCT03221998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102019217|NCT03221998|Analgesics|analgesics|mesh-ancestor
102019218|NCT03221998|Sensory System Agents|sensory system agents|mesh-ancestor
102019219|NCT03221998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102019220|NCT03221998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019221|NCT03221998|Antipyretics|antipyretics|mesh-ancestor
102019238|NCT04936763|Viscosupplements|viscosupplements|mesh-ancestor
102019239|NCT04936763|Protective Agents|protective agents|mesh-ancestor
102019240|NCT03226522|Bupropion|bupropion|mesh-list
102019241|NCT03226522|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102019242|NCT03226522|Antidepressive Agents|antidepressive agents|mesh-ancestor
102019243|NCT03226522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102019244|NCT03226522|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102019245|NCT03226522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102019246|NCT03226522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102019247|NCT03226522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019248|NCT03226522|Dopamine Agents|dopamine agents|mesh-ancestor
102019249|NCT03226522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102019250|NCT03226522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019251|NCT03226522|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102019252|NCT03226522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102019253|NCT03226522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102019254|NCT03752333|Pembrolizumab|pembrolizumab|mesh-list
101950538|NCT03007147|Tubulin Modulators|tubulin modulators|mesh-ancestor
101950539|NCT03007147|Antimitotic Agents|antimitotic agents|mesh-ancestor
101950540|NCT03007147|Mitosis Modulators|mitosis modulators|mesh-ancestor
101950541|NCT03007147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102019255|NCT03752333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102019256|NCT03752333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102019257|NCT03752333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102019258|NCT03752333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019259|NCT03750383|Cyclosporine|cyclosporine|mesh-list
102019260|NCT03750383|Prednisone|prednisone|mesh-list
102019261|NCT03750383|Cyclosporins|cyclosporins|mesh-list
102019262|NCT03750383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102019263|NCT03750383|Glucocorticoids|glucocorticoids|mesh-ancestor
102019264|NCT03750383|Hormones|hormones|mesh-ancestor
102019265|NCT03750383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102019266|NCT03750383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019267|NCT03750383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101739022|NCT01021579|Metformin|metformin|mesh-list
102019268|NCT03750383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102019269|NCT03750383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102019270|NCT03750383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019271|NCT03750383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102019272|NCT03750383|Immunologic Factors|immunologic factors|mesh-ancestor
102019273|NCT03750383|Antifungal Agents|antifungal agents|mesh-ancestor
102019274|NCT03750383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102019275|NCT03750383|Dermatologic Agents|dermatologic agents|mesh-ancestor
102019276|NCT03750383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102019277|NCT03750383|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102019278|NCT03226210|Insulin|insulin|mesh-list
102019279|NCT03226210|Insulin Aspart|insulin aspart|mesh-list
102019280|NCT03226210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102019285|NCT03220126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102019286|NCT03220126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102019287|NCT03220126|Analgesics|analgesics|mesh-ancestor
102019288|NCT03220126|Sensory System Agents|sensory system agents|mesh-ancestor
102019289|NCT03220126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102019290|NCT03220126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019291|NCT03220126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102019292|NCT03220126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102019293|NCT03220126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102019294|NCT03220126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102019295|NCT02452684|Eszopiclone|eszopiclone|mesh-list
102019296|NCT02452684|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102019297|NCT02452684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102019298|NCT02452684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019299|NCT03119428|Nivolumab|nivolumab|mesh-list
102019300|NCT03119428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102019301|NCT03119428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102019302|NCT03119428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102019303|NCT03119428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019304|NCT04345367|Abrocitinib|abrocitinib|mesh-list
102019305|NCT04345367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102019306|NCT04345367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102019307|NCT04345367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019308|NCT02452606|Levodopa|levodopa|mesh-list
102019309|NCT02452606|Carbidopa|carbidopa|mesh-list
102019310|NCT02452606|Entacapone|entacapone|mesh-list
102019311|NCT02452606|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102019312|NCT02452606|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102019313|NCT02452606|Dopamine Agents|dopamine agents|mesh-ancestor
102019314|NCT02452606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102019315|NCT02452606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019316|NCT02452606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019317|NCT02452606|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102019318|NCT02452606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102019319|NCT02452606|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102019320|NCT03225352|Aspirin|aspirin|mesh-list
102019321|NCT03225352|Ibuprofen|ibuprofen|mesh-list
102019322|NCT03225352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102019323|NCT03225352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102019324|NCT03225352|Analgesics|analgesics|mesh-ancestor
101950542|NCT03007147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101950544|NCT03007147|Keratolytic Agents|keratolytic agents|mesh-ancestor
101950545|NCT03007147|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101950546|NCT02959463|Pembrolizumab|pembrolizumab|mesh-list
102019325|NCT03225352|Sensory System Agents|sensory system agents|mesh-ancestor
102019326|NCT03225352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102019327|NCT03225352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019328|NCT03225352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102019329|NCT03225352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102019330|NCT03225352|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102019331|NCT03225352|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102019332|NCT03225352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019333|NCT03225352|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102019334|NCT03225352|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102019335|NCT03225352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102019336|NCT03225352|Antipyretics|antipyretics|mesh-ancestor
102019337|NCT03208270|Antithrombins|antithrombins|mesh-list
102019338|NCT03208270|Antithrombin III|antithrombin iii|mesh-list
102019339|NCT03208270|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102019340|NCT03208270|Protease Inhibitors|protease inhibitors|mesh-ancestor
102019341|NCT03208270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102019342|NCT03208270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019343|NCT03208270|Anticoagulants|anticoagulants|mesh-ancestor
102019344|NCT03208426|Amoxicillin|amoxicillin|mesh-list
102019345|NCT03208426|Metronidazole|metronidazole|mesh-list
102019346|NCT03208426|Clarithromycin|clarithromycin|mesh-list
102019347|NCT03208426|Tetracycline|tetracycline|mesh-list
102019348|NCT03208426|Esomeprazole|esomeprazole|mesh-list
102019349|NCT03208426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102019350|NCT03208426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102019351|NCT03208426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102019352|NCT03208426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102019356|NCT03208426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102019357|NCT03208426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019358|NCT03208426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102019359|NCT03208426|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102019360|NCT03208426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102019361|NCT03216070|Dasatinib|dasatinib|mesh-list
102019362|NCT03216070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102019363|NCT03216070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102019364|NCT03216070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102019365|NCT03216070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019366|NCT03215602|Pyrantel|pyrantel|mesh-list
102019367|NCT03215602|Pyrantel Pamoate|pyrantel pamoate|mesh-list
102019368|NCT03215602|Antinematodal Agents|antinematodal agents|mesh-ancestor
102019369|NCT03215602|Anthelmintics|anthelmintics|mesh-ancestor
102019370|NCT03215602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102019371|NCT03215602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102019372|NCT03215602|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
102019373|NCT03215602|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102019374|NCT03215602|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102019375|NCT03215602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102019376|NCT03215602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019377|NCT02450968|Dexamethasone|dexamethasone|mesh-list
102019378|NCT02450968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102019379|NCT02450968|Antiemetics|antiemetics|mesh-ancestor
102019380|NCT02450968|Autonomic Agents|autonomic agents|mesh-ancestor
102019381|NCT02450968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102019382|NCT02450968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019383|NCT02450968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102019384|NCT02450968|Glucocorticoids|glucocorticoids|mesh-ancestor
102019385|NCT02450968|Hormones|hormones|mesh-ancestor
102019386|NCT02450968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102019387|NCT02450968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102019388|NCT02450968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102019389|NCT03749915|Tetracaine|tetracaine|mesh-list
102019390|NCT03749915|Anesthetics, Local|anesthetics, local|mesh-ancestor
102019391|NCT03749915|Anesthetics|anesthetics|mesh-ancestor
102019392|NCT03749915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102019393|NCT03749915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950547|NCT02959463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101281309|NCT01900496|Rituximab|rituximab|mesh-list
102019394|NCT03749915|Sensory System Agents|sensory system agents|mesh-ancestor
102019395|NCT03749915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102019396|NCT03119116|Rivaroxaban|rivaroxaban|mesh-list
102019397|NCT03119116|Apixaban|apixaban|mesh-list
102019398|NCT03119116|Dabigatran|dabigatran|mesh-list
102019399|NCT03119116|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102019400|NCT03119116|Antithrombins|antithrombins|mesh-ancestor
102019401|NCT03119116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102019402|NCT03119116|Protease Inhibitors|protease inhibitors|mesh-ancestor
102019403|NCT03119116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102019404|NCT03119116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019405|NCT03119116|Anticoagulants|anticoagulants|mesh-ancestor
102019406|NCT04329923|Hydroxychloroquine|hydroxychloroquine|mesh-list
102019407|NCT04329923|Antimalarials|antimalarials|mesh-ancestor
102019408|NCT04329923|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102019409|NCT04329923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102019410|NCT04329923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102019411|NCT04329923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102019412|NCT04329923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019413|NCT04329923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102019414|NCT04403399|Varenicline|varenicline|mesh-list
102019415|NCT04403399|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102019416|NCT04403399|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101739167|NCT01032109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102019417|NCT04403399|Cholinergic Agents|cholinergic agents|mesh-ancestor
102019418|NCT04403399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102019419|NCT04403399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019420|NCT04403399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019421|NCT03224572|Ascorbic Acid|ascorbic acid|mesh-list
102019422|NCT03224572|Vitamins|vitamins|mesh-ancestor
102019423|NCT03224572|Micronutrients|micronutrients|mesh-ancestor
102019424|NCT03224572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019431|NCT02452216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102019433|NCT03207334|Midostaurin|midostaurin|mesh-list
102019434|NCT03207334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102019435|NCT03207334|Antimetabolites|antimetabolites|mesh-ancestor
102019436|NCT03207334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019437|NCT03207334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102019438|NCT03207334|Antiviral Agents|antiviral agents|mesh-ancestor
102019439|NCT03207334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102019440|NCT03207334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102019441|NCT03207334|Immunologic Factors|immunologic factors|mesh-ancestor
102019442|NCT03207334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019443|NCT03207334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102019444|NCT03207334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102019445|NCT03212950|Insulin|insulin|mesh-list
102019446|NCT03212950|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102019447|NCT03212950|Insulin Aspart|insulin aspart|mesh-list
102019448|NCT03212950|Insulin, Long-Acting|insulin, long-acting|mesh-list
102019449|NCT03212950|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102019450|NCT03212950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102019451|NCT03212950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019452|NCT03207100|Antihypertensive Agents|antihypertensive agents|mesh-list
102019453|NCT01561937|Warfarin|warfarin|mesh-list
102019454|NCT01561937|Anticoagulants|anticoagulants|mesh-ancestor
102019455|NCT03210766|Nabilone|nabilone|mesh-list
102019456|NCT03210766|Antiemetics|antiemetics|mesh-ancestor
102019457|NCT03210766|Autonomic Agents|autonomic agents|mesh-ancestor
102019458|NCT03210766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102019459|NCT03210766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019460|NCT03210766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102019461|NCT03210766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102019462|NCT03210766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102019463|NCT03210766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102019464|NCT03210766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102019465|NCT03747341|Fentanyl|fentanyl|mesh-list
102019466|NCT03747341|Oxycodone|oxycodone|mesh-list
102019467|NCT03747341|Buprenorphine|buprenorphine|mesh-list
102019468|NCT03747341|Ondansetron|ondansetron|mesh-list
102019469|NCT03747341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102019470|NCT03747341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102019471|NCT03747341|Narcotics|narcotics|mesh-ancestor
102019472|NCT03747341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102019473|NCT03747341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950548|NCT02959463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101950549|NCT02959463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101950550|NCT02959463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019474|NCT03747341|Analgesics|analgesics|mesh-ancestor
102019475|NCT03747341|Sensory System Agents|sensory system agents|mesh-ancestor
102019476|NCT03747341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102019477|NCT03747341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102019478|NCT03747341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102019479|NCT03747341|Anesthetics, General|anesthetics, general|mesh-ancestor
102019480|NCT03747341|Anesthetics|anesthetics|mesh-ancestor
102019481|NCT03747341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102019482|NCT03747341|Antiemetics|antiemetics|mesh-ancestor
102019483|NCT03747341|Autonomic Agents|autonomic agents|mesh-ancestor
102019484|NCT03747341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102019485|NCT03747341|Antipruritics|antipruritics|mesh-ancestor
102019486|NCT03747341|Dermatologic Agents|dermatologic agents|mesh-ancestor
102019487|NCT03747341|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102019488|NCT03747341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102019489|NCT03747341|Serotonin Agents|serotonin agents|mesh-ancestor
102019490|NCT03747341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102019491|NCT03747341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739242|NCT00754442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019492|NCT04401293|Heparin|heparin|mesh-list
102019493|NCT04401293|Enoxaparin|enoxaparin|mesh-list
102019494|NCT04401293|Calcium heparin|calcium heparin|mesh-list
102019495|NCT04401293|Dalteparin|dalteparin|mesh-list
102019500|NCT04401293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019501|NCT03209908|Tenofovir|tenofovir|mesh-list
102019502|NCT03209908|Antiviral Agents|antiviral agents|mesh-ancestor
102019503|NCT03209908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102019504|NCT03209908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102019505|NCT03209908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102019506|NCT03209908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102019507|NCT03209908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019508|NCT03209908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102019509|NCT03209908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102019510|NCT04484740|Gepotidacin|gepotidacin|mesh-list
102019511|NCT04484740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102019512|NCT04484740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102019513|NCT04484740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019514|NCT04484740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102019515|NCT04319159|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102019516|NCT04319159|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102019517|NCT04319159|Dermatologic Agents|dermatologic agents|mesh-ancestor
102019518|NCT03224338|Dolutegravir|dolutegravir|mesh-list
102019519|NCT03224338|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102019520|NCT03224338|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102019521|NCT03224338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102019522|NCT03224338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019523|NCT03224338|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102019524|NCT03224338|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102019525|NCT03224338|Antiviral Agents|antiviral agents|mesh-ancestor
102019526|NCT03224338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102019527|NCT04318535|Griseofulvin|griseofulvin|mesh-list
102019528|NCT04318535|Antifungal Agents|antifungal agents|mesh-ancestor
102019529|NCT04318535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102019530|NCT02451826|Ulipristal acetate|ulipristal acetate|mesh-list
102019531|NCT02451826|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102019532|NCT02451826|Contraceptive Agents|contraceptive agents|mesh-ancestor
102019533|NCT02451826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102019534|NCT02451826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019535|NCT02451826|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102019536|NCT03224416|Ethanol|ethanol|mesh-list
102019537|NCT03224416|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102019538|NCT03224416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102019539|NCT03224416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102019540|NCT03224416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019541|NCT01562561|Repaglinide|repaglinide|mesh-list
102019542|NCT01562561|Isophane Insulin, Human|isophane insulin, human|mesh-list
102019543|NCT01562561|Insulin, Isophane|insulin, isophane|mesh-list
102019544|NCT01562561|Isophane insulin, beef|isophane insulin, beef|mesh-list
102019545|NCT01562561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101950551|NCT02830594|Pembrolizumab|pembrolizumab|mesh-list
101950552|NCT02830594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101950553|NCT02830594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101950554|NCT02830594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101950555|NCT02830594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950556|NCT02754765|Moxifloxacin|moxifloxacin|mesh-list
101950557|NCT02754765|Levofloxacin|levofloxacin|mesh-list
101950558|NCT02754765|Linezolid|linezolid|mesh-list
101950559|NCT02754765|Pyrazinamide|pyrazinamide|mesh-list
101950560|NCT02754765|Bedaquiline|bedaquiline|mesh-list
101950561|NCT02754765|Clofazimine|clofazimine|mesh-list
101950562|NCT02754765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101950563|NCT02754765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101950615|NCT02498613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101950616|NCT02498613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101950617|NCT02498613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101950618|NCT02498613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101950619|NCT02498613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101950620|NCT01622543|Leucovorin|leucovorin|mesh-list
101950621|NCT01622543|Bevacizumab|bevacizumab|mesh-list
102019546|NCT01562561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019547|NCT03206944|Aspirin|aspirin|mesh-list
102019548|NCT03206944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102019549|NCT03206944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102019550|NCT03206944|Analgesics|analgesics|mesh-ancestor
102019551|NCT03206944|Sensory System Agents|sensory system agents|mesh-ancestor
102019552|NCT03206944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102019553|NCT03206944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019554|NCT03206944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102019555|NCT03206944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102019556|NCT03206944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102019557|NCT03206944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102019558|NCT03206944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019559|NCT03206944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102019560|NCT03206944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102019561|NCT03206944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102019562|NCT03206944|Antipyretics|antipyretics|mesh-ancestor
102019563|NCT04454567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
102019564|NCT04454567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102019565|NCT04454567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101474542|NCT00298662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102019570|NCT03206554|Anesthetics, Local|anesthetics, local|mesh-ancestor
102019571|NCT03206554|Anesthetics|anesthetics|mesh-ancestor
102019572|NCT03206554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102019573|NCT03206554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019574|NCT03206554|Sensory System Agents|sensory system agents|mesh-ancestor
102019575|NCT03206554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102019576|NCT03209206|Docetaxel|docetaxel|mesh-list
102019577|NCT03209206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102019578|NCT03209206|Tubulin Modulators|tubulin modulators|mesh-ancestor
102019579|NCT03209206|Antimitotic Agents|antimitotic agents|mesh-ancestor
102019580|NCT03209206|Mitosis Modulators|mitosis modulators|mesh-ancestor
102019581|NCT03209206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019582|NCT03223402|Lamivudine|lamivudine|mesh-list
102019583|NCT03223402|Nevirapine|nevirapine|mesh-list
102019584|NCT03223402|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102019585|NCT03223402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102019586|NCT03223402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102019587|NCT03223402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019588|NCT03223402|Antiviral Agents|antiviral agents|mesh-ancestor
102019589|NCT03223402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102019590|NCT03223402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102019591|NCT03223402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102019592|NCT03223402|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102019593|NCT03223402|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102019594|NCT03208972|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102019595|NCT03208972|Menotropins|menotropins|mesh-list
102019596|NCT03208972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102019597|NCT03208972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019598|NCT03208972|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102019599|NCT03208972|Fertility Agents|fertility agents|mesh-ancestor
102019600|NCT03206866|Antibodies|antibodies|mesh-list
102019601|NCT03206866|Immunologic Factors|immunologic factors|mesh-ancestor
102019602|NCT03206866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019603|NCT02451748|Hydroxychloroquine|hydroxychloroquine|mesh-list
102019604|NCT02451748|Sulfasalazine|sulfasalazine|mesh-list
102019605|NCT02451748|Prednisone|prednisone|mesh-list
102019606|NCT02451748|Triamcinolone|triamcinolone|mesh-list
102019607|NCT02451748|Naproxen|naproxen|mesh-list
102019608|NCT02451748|Certolizumab Pegol|certolizumab pegol|mesh-list
102019609|NCT02451748|Methotrexate|methotrexate|mesh-list
102019610|NCT02451748|Leflunomide|leflunomide|mesh-list
102019611|NCT02451748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102019612|NCT02451748|Glucocorticoids|glucocorticoids|mesh-ancestor
101950622|NCT01622543|Fluorouracil|fluorouracil|mesh-list
101950623|NCT01622543|Oxaliplatin|oxaliplatin|mesh-list
101950624|NCT01622543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101950625|NCT01622543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101950626|NCT01622543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101950627|NCT01622543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101950628|NCT01622543|Growth Substances|growth substances|mesh-ancestor
101950629|NCT01622543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950630|NCT01622543|Growth Inhibitors|growth inhibitors|mesh-ancestor
101950631|NCT01622543|Antimetabolites|antimetabolites|mesh-ancestor
101950632|NCT01622543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950633|NCT01622543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101950634|NCT01622543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101950635|NCT01622543|Immunologic Factors|immunologic factors|mesh-ancestor
102019613|NCT02451748|Hormones|hormones|mesh-ancestor
102019614|NCT02451748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102019615|NCT02451748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019616|NCT02451748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102019617|NCT02451748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102019618|NCT02451748|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102019619|NCT02451748|Abortifacient Agents|abortifacient agents|mesh-ancestor
102019620|NCT02451748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102019621|NCT02451748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102019622|NCT02451748|Antimetabolites|antimetabolites|mesh-ancestor
102019623|NCT02451748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019624|NCT02451748|Dermatologic Agents|dermatologic agents|mesh-ancestor
102019625|NCT02451748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102019626|NCT02451748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102019627|NCT02451748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102019628|NCT02451748|Immunologic Factors|immunologic factors|mesh-ancestor
102019629|NCT02451748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102019630|NCT02451748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102019631|NCT02451748|Antimalarials|antimalarials|mesh-ancestor
102019632|NCT02451748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102019633|NCT02451748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102019634|NCT02451748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102019635|NCT02451748|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101474611|NCT00261365|Ipilimumab|ipilimumab|mesh-list
102019639|NCT02451748|Sensory System Agents|sensory system agents|mesh-ancestor
102019640|NCT02451748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102019641|NCT02451748|Gout Suppressants|gout suppressants|mesh-ancestor
102019642|NCT02451748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102019643|NCT02451748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102019644|NCT03208894|Furosemide|furosemide|mesh-list
102019645|NCT03208894|Diuretics|diuretics|mesh-ancestor
101575013|NCT01179516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102019646|NCT03208894|Natriuretic Agents|natriuretic agents|mesh-ancestor
102019647|NCT03208894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019648|NCT03208894|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102019649|NCT03208894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102019650|NCT03208894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019651|NCT02450656|Docetaxel|docetaxel|mesh-list
102019652|NCT02450656|Afatinib|afatinib|mesh-list
102019653|NCT02450656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102019654|NCT02450656|Tubulin Modulators|tubulin modulators|mesh-ancestor
102019655|NCT02450656|Antimitotic Agents|antimitotic agents|mesh-ancestor
102019656|NCT02450656|Mitosis Modulators|mitosis modulators|mesh-ancestor
102019657|NCT02450656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019658|NCT02450656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101950636|NCT01622543|Antidotes|antidotes|mesh-ancestor
101950637|NCT01622543|Protective Agents|protective agents|mesh-ancestor
101950638|NCT01622543|Vitamin B Complex|vitamin b complex|mesh-ancestor
102019659|NCT02450656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102019660|NCT03206320|Lidocaine|lidocaine|mesh-list
102019661|NCT03206320|Anesthetics, Local|anesthetics, local|mesh-ancestor
102019662|NCT03206320|Anesthetics|anesthetics|mesh-ancestor
102019663|NCT03206320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102019664|NCT03206320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019665|NCT03206320|Sensory System Agents|sensory system agents|mesh-ancestor
102019666|NCT03206320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102019667|NCT03206320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102019668|NCT03206320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102019669|NCT03206320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102019670|NCT03206320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102019671|NCT03206320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019672|NCT04448561|Morphine|morphine|mesh-list
102019673|NCT04448561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102019674|NCT04448561|Narcotics|narcotics|mesh-ancestor
102019675|NCT04448561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102019676|NCT04448561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019677|NCT04448561|Analgesics|analgesics|mesh-ancestor
102019678|NCT04448561|Sensory System Agents|sensory system agents|mesh-ancestor
102019679|NCT04448561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102019680|NCT03206008|Magnesium Sulfate|magnesium sulfate|mesh-list
102019681|NCT03206008|Analgesics|analgesics|mesh-ancestor
102019682|NCT03206008|Sensory System Agents|sensory system agents|mesh-ancestor
102019683|NCT03206008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102019684|NCT03206008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019685|NCT03206008|Anesthetics|anesthetics|mesh-ancestor
102019686|NCT03206008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102019687|NCT03206008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102019688|NCT03206008|Anticonvulsants|anticonvulsants|mesh-ancestor
102019689|NCT03206008|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102019690|NCT03206008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102019691|NCT03206008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019692|NCT03206008|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102019693|NCT03206008|Tocolytic Agents|tocolytic agents|mesh-ancestor
102019694|NCT03206008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102019695|NCT04978259|Remdesivir|remdesivir|mesh-list
102019696|NCT04978259|Antimetabolites|antimetabolites|mesh-ancestor
102019697|NCT04978259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019698|NCT04978259|Antiviral Agents|antiviral agents|mesh-ancestor
102019699|NCT04978259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102019700|NCT03208582|Risedronic Acid|risedronic acid|mesh-list
102019701|NCT03208582|Diphosphonates|diphosphonates|mesh-list
102019702|NCT03208582|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102019703|NCT03208582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102019704|NCT03208582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019712|NCT03200938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019713|NCT03200938|Dermatologic Agents|dermatologic agents|mesh-ancestor
102019714|NCT03200938|Sunscreening Agents|sunscreening agents|mesh-ancestor
102019715|NCT03200938|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102019716|NCT03200938|Protective Agents|protective agents|mesh-ancestor
102019718|NCT04297241|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
101739465|NCT00580983|Antimetabolites|antimetabolites|mesh-ancestor
102019719|NCT04297241|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
102019720|NCT04297241|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102019721|NCT04297241|Diuretics|diuretics|mesh-ancestor
102019722|NCT04297241|Natriuretic Agents|natriuretic agents|mesh-ancestor
102019723|NCT04297241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019724|NCT04297241|Vasodilator Agents|vasodilator agents|mesh-ancestor
102019725|NCT04297241|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102019726|NCT04297241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019727|NCT04292171|Gabapentin|gabapentin|mesh-list
102019728|NCT04292171|Analgesics|analgesics|mesh-ancestor
102019729|NCT04292171|Sensory System Agents|sensory system agents|mesh-ancestor
102019730|NCT04292171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102019731|NCT04292171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019732|NCT04292171|Anticonvulsants|anticonvulsants|mesh-ancestor
102019733|NCT04292171|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102019734|NCT04292171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101950639|NCT01622543|Vitamins|vitamins|mesh-ancestor
101950640|NCT01622543|Micronutrients|micronutrients|mesh-ancestor
101950641|NCT01618357|Veliparib|veliparib|mesh-list
101281633|NCT01901861|Protease Inhibitors|protease inhibitors|mesh-ancestor
102019735|NCT04292171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102019736|NCT04292171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102019737|NCT04292171|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102019738|NCT04292171|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102019739|NCT04292171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102019740|NCT04292171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019741|NCT04292171|Antimanic Agents|antimanic agents|mesh-ancestor
102019742|NCT03200782|Empagliflozin|empagliflozin|mesh-list
102019743|NCT03200782|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102019744|NCT03200782|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102019745|NCT03200782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019746|NCT03200782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102019747|NCT03200782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019748|NCT03200782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102019749|NCT02449954|Ketorolac|ketorolac|mesh-list
102019750|NCT02449954|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102019751|NCT02449954|Morphine|morphine|mesh-list
102019752|NCT02449954|Tramadol|tramadol|mesh-list
102019753|NCT02449954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102019754|NCT02449954|Narcotics|narcotics|mesh-ancestor
102019755|NCT02449954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102019756|NCT02449954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019757|NCT02449954|Analgesics|analgesics|mesh-ancestor
102019758|NCT02449954|Sensory System Agents|sensory system agents|mesh-ancestor
102019759|NCT02449954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102019760|NCT02449954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102019761|NCT02449954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102019762|NCT02449954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102019763|NCT02449954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102019764|NCT02449954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102019765|NCT02449954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102019766|NCT02449954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019767|NCT04393493|Chlorthalidone|chlorthalidone|mesh-list
102019768|NCT04393493|Furosemide|furosemide|mesh-list
102019769|NCT04393493|Spironolactone|spironolactone|mesh-list
102019770|NCT04393493|Diuretics|diuretics|mesh-ancestor
102019771|NCT04393493|Natriuretic Agents|natriuretic agents|mesh-ancestor
102019772|NCT04393493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019775|NCT04393493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019776|NCT04393493|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102019778|NCT04393493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102019779|NCT04393493|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102019780|NCT04393493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102019781|NCT04393493|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102019782|NCT02448082|Ichthammol|ichthammol|mesh-list
102019783|NCT02448082|Dermatologic Agents|dermatologic agents|mesh-ancestor
102019784|NCT03205228|Flupenthixol|flupenthixol|mesh-list
102019785|NCT03205228|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
102019786|NCT03205228|Omeprazole|omeprazole|mesh-list
102019787|NCT03205228|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102019788|NCT03205228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102019789|NCT03205228|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102019790|NCT03205228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102019791|NCT03205228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019792|NCT03205228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102019793|NCT03205228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102019794|NCT03205228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102019795|NCT03205228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019796|NCT03205228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102019797|NCT03205228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102019798|NCT03205228|Dopamine Agents|dopamine agents|mesh-ancestor
102019799|NCT03205228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102019801|NCT03195946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102019802|NCT03195946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102019803|NCT03195946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102019804|NCT03195946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019805|NCT03195946|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101950642|NCT01618357|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101950643|NCT01618357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101950644|NCT01618357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950645|NCT01618357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101950646|NCT01176006|Cyclophosphamide|cyclophosphamide|mesh-list
102019806|NCT03195946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102019807|NCT03195946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102019808|NCT03195946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102019809|NCT03195946|Anesthetics, General|anesthetics, general|mesh-ancestor
102019810|NCT03195946|Anesthetics|anesthetics|mesh-ancestor
102019811|NCT03195946|GABA Modulators|gaba modulators|mesh-ancestor
102019812|NCT03195946|GABA Agents|gaba agents|mesh-ancestor
102019813|NCT03195946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102019814|NCT03195946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019815|NCT03204760|Dexamethasone|dexamethasone|mesh-list
102019816|NCT03204760|Prednisolone|prednisolone|mesh-list
102019817|NCT03204760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102019818|NCT03204760|Antiemetics|antiemetics|mesh-ancestor
102019819|NCT03204760|Autonomic Agents|autonomic agents|mesh-ancestor
102019820|NCT03204760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102019821|NCT03204760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019822|NCT03204760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102019823|NCT03204760|Glucocorticoids|glucocorticoids|mesh-ancestor
102019824|NCT03204760|Hormones|hormones|mesh-ancestor
102019825|NCT03204760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102019826|NCT03204760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102019827|NCT03204760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102019828|NCT03200392|Chromium|chromium|mesh-list
102019829|NCT03200392|Trace Elements|trace elements|mesh-ancestor
102019830|NCT03200392|Micronutrients|micronutrients|mesh-ancestor
102019831|NCT03200392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019832|NCT03200080|Amphetamine|amphetamine|mesh-list
102019833|NCT03200080|Dextroamphetamine|dextroamphetamine|mesh-list
102019834|NCT03200080|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102019835|NCT03200080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019836|NCT03200080|Sympathomimetics|sympathomimetics|mesh-ancestor
102019837|NCT03200080|Autonomic Agents|autonomic agents|mesh-ancestor
102019838|NCT03200080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102019839|NCT03200080|Dopamine Agents|dopamine agents|mesh-ancestor
102019840|NCT03200080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102019841|NCT03200080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019842|NCT03200080|Adrenergic Agents|adrenergic agents|mesh-ancestor
102019843|NCT03200080|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101474824|NCT00299208|Antiviral Agents|antiviral agents|mesh-ancestor
102019847|NCT03200236|Nicotine|nicotine|mesh-list
102019848|NCT03200236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102019849|NCT03200236|Autonomic Agents|autonomic agents|mesh-ancestor
102019850|NCT03200236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102019851|NCT03200236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019852|NCT03200236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102019853|NCT03200236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102019854|NCT03200236|Cholinergic Agents|cholinergic agents|mesh-ancestor
102019855|NCT03200236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102019856|NCT03200236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019857|NCT03200002|Mycophenolic Acid|mycophenolic acid|mesh-list
102019858|NCT03200002|Cyclophosphamide|cyclophosphamide|mesh-list
102019859|NCT03200002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102019860|NCT03200002|Immunologic Factors|immunologic factors|mesh-ancestor
102019861|NCT03200002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019862|NCT03200002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102019863|NCT03200002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102019864|NCT03200002|Alkylating Agents|alkylating agents|mesh-ancestor
102019865|NCT03200002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019866|NCT03200002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102019867|NCT03200002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102019868|NCT03200002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102019869|NCT03200002|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102019870|NCT03200002|Antitubercular Agents|antitubercular agents|mesh-ancestor
102019871|NCT03200002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102019872|NCT03200002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101950647|NCT01176006|Busulfan|busulfan|mesh-list
101950648|NCT01176006|Fludarabine|fludarabine|mesh-list
101950649|NCT01176006|Fludarabine phosphate|fludarabine phosphate|mesh-list
101950650|NCT01176006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102019873|NCT03200002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102019874|NCT02447380|Docetaxel|docetaxel|mesh-list
102019875|NCT02447380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102019876|NCT02447380|Tubulin Modulators|tubulin modulators|mesh-ancestor
102019877|NCT02447380|Antimitotic Agents|antimitotic agents|mesh-ancestor
102019878|NCT02447380|Mitosis Modulators|mitosis modulators|mesh-ancestor
102019879|NCT02447380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019880|NCT02447224|Metronidazole|metronidazole|mesh-list
102019881|NCT02447224|Ertapenem|ertapenem|mesh-list
102019882|NCT02447224|Cefdinir|cefdinir|mesh-list
102019883|NCT02447224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102019884|NCT02447224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102019885|NCT02447224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102019886|NCT02447224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102019887|NCT03199690|Rifampin|rifampin|mesh-list
102019888|NCT03199690|Dolutegravir|dolutegravir|mesh-list
102019889|NCT03199690|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102019890|NCT03199690|Antitubercular Agents|antitubercular agents|mesh-ancestor
102019891|NCT03199690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102019892|NCT03199690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102019893|NCT03199690|Leprostatic Agents|leprostatic agents|mesh-ancestor
102019894|NCT03199690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102019895|NCT03199690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387650|NCT00090480|Vaccines|vaccines|mesh-list
102019896|NCT03199690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019897|NCT03199690|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102019898|NCT03199690|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102019899|NCT03199690|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102019900|NCT03199690|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102019901|NCT03199690|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102019902|NCT03199690|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102019903|NCT03199690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102019904|NCT03199690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102019905|NCT03199690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102019906|NCT03199690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102019907|NCT03199690|Antiviral Agents|antiviral agents|mesh-ancestor
102019908|NCT03204058|Metformin|metformin|mesh-list
102019909|NCT03204058|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102019910|NCT03204058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102019911|NCT03204058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019912|NCT03204058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102019913|NCT03204058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102019914|NCT03204058|Antimetabolites|antimetabolites|mesh-ancestor
101628293|NCT00724243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102019919|NCT03203746|Lycopene|lycopene|mesh-list
102019920|NCT03203746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102019921|NCT03203746|Antioxidants|antioxidants|mesh-ancestor
102019922|NCT03203746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019923|NCT03203746|Protective Agents|protective agents|mesh-ancestor
102019924|NCT03203746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019925|NCT03203746|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102019926|NCT03203746|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102019927|NCT03203746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102019928|NCT03203668|Choline|choline|mesh-list
102019929|NCT03203668|Lipotropic Agents|lipotropic agents|mesh-ancestor
102019930|NCT03203668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102019931|NCT03203668|Antimetabolites|antimetabolites|mesh-ancestor
102019932|NCT03203668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019933|NCT03203668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102019934|NCT03203668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102019935|NCT03203668|Nootropic Agents|nootropic agents|mesh-ancestor
102019936|NCT03199534|Botulinum Toxins|botulinum toxins|mesh-list
102019937|NCT03199534|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102019938|NCT03199534|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102019939|NCT03199534|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101739692|NCT01298193|Dopamine Agents|dopamine agents|mesh-ancestor
102019940|NCT03199534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102019941|NCT03199534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019942|NCT03199534|Cholinergic Agents|cholinergic agents|mesh-ancestor
102019943|NCT03199534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101950651|NCT01176006|Immunologic Factors|immunologic factors|mesh-ancestor
101950652|NCT01176006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950653|NCT01176006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101950654|NCT01176006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102019944|NCT03199534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019945|NCT03199534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102019946|NCT03199534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102019948|NCT03203356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102019949|NCT03203356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019950|NCT04280705|Remdesivir|remdesivir|mesh-list
102019951|NCT04280705|Antimetabolites|antimetabolites|mesh-ancestor
102019952|NCT04280705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019953|NCT04280705|Antiviral Agents|antiviral agents|mesh-ancestor
102019954|NCT04280705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102019955|NCT03203590|Carboplatin|carboplatin|mesh-list
102019956|NCT03203590|Vinorelbine|vinorelbine|mesh-list
102019957|NCT03203590|Gefitinib|gefitinib|mesh-list
102019958|NCT03203590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102019959|NCT03203590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102019960|NCT03203590|Tubulin Modulators|tubulin modulators|mesh-ancestor
102019961|NCT03203590|Antimitotic Agents|antimitotic agents|mesh-ancestor
102019962|NCT03203590|Mitosis Modulators|mitosis modulators|mesh-ancestor
102019963|NCT03203590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019964|NCT03203590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102019965|NCT03203590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102019966|NCT02077166|Rituximab|rituximab|mesh-list
102019967|NCT02077166|Lenalidomide|lenalidomide|mesh-list
102019968|NCT02077166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102019969|NCT02077166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102019970|NCT02077166|Immunologic Factors|immunologic factors|mesh-ancestor
102019971|NCT02077166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019972|NCT02077166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102019973|NCT02077166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102019974|NCT02077166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102019975|NCT02077166|Growth Substances|growth substances|mesh-ancestor
102019976|NCT02077166|Growth Inhibitors|growth inhibitors|mesh-ancestor
102019977|NCT02450188|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
102019978|NCT02450188|Vasodilator Agents|vasodilator agents|mesh-ancestor
102019979|NCT02450188|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102019980|NCT02450188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102019981|NCT02450188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102019982|NCT02450188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019992|NCT04484506|Etoposide|etoposide|mesh-list
102019993|NCT04484506|Vincristine|vincristine|mesh-list
102019994|NCT04484506|Pegaspargase|pegaspargase|mesh-list
102019995|NCT04484506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102019996|NCT04484506|Immunologic Factors|immunologic factors|mesh-ancestor
102019997|NCT04484506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019998|NCT04484506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102019999|NCT04484506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102020000|NCT04484506|Alkylating Agents|alkylating agents|mesh-ancestor
102020001|NCT04484506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020002|NCT04484506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102020003|NCT04484506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102020004|NCT04484506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102020005|NCT04484506|Glucocorticoids|glucocorticoids|mesh-ancestor
102020006|NCT04484506|Hormones|hormones|mesh-ancestor
102020007|NCT04484506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102020008|NCT04484506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102020009|NCT04484506|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102020010|NCT04484506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102020011|NCT04484506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102020012|NCT04484506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102020013|NCT04484506|Tubulin Modulators|tubulin modulators|mesh-ancestor
102020014|NCT04484506|Antimitotic Agents|antimitotic agents|mesh-ancestor
102020015|NCT04484506|Mitosis Modulators|mitosis modulators|mesh-ancestor
102020016|NCT04332653|Pembrolizumab|pembrolizumab|mesh-list
102020017|NCT04332653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102020018|NCT04332653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101950655|NCT01176006|Alkylating Agents|alkylating agents|mesh-ancestor
101950656|NCT01176006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020019|NCT04332653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101387651|NCT00090480|Immunologic Factors|immunologic factors|mesh-ancestor
102020020|NCT04332653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020022|NCT02449564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102020023|NCT02449564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102020024|NCT02449564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102020025|NCT02449564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102020026|NCT02449564|Antifungal Agents|antifungal agents|mesh-ancestor
102020027|NCT02449564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102020028|NCT02449564|Immunologic Factors|immunologic factors|mesh-ancestor
102020029|NCT02449564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020030|NCT02449720|Ropivacaine|ropivacaine|mesh-list
102020031|NCT02449720|Anesthetics, Local|anesthetics, local|mesh-ancestor
102020032|NCT02449720|Anesthetics|anesthetics|mesh-ancestor
102020033|NCT02449720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102020034|NCT02449720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020035|NCT02449720|Sensory System Agents|sensory system agents|mesh-ancestor
102020036|NCT02449720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102020037|NCT03194620|Proanthocyanidin|proanthocyanidin|mesh-list
102020038|NCT03194620|Epicatechin gallate|epicatechin gallate|mesh-list
102020039|NCT03194620|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
102020040|NCT03194620|Procyanidin|procyanidin|mesh-list
102020041|NCT03194620|Theaflavin|theaflavin|mesh-list
102020042|NCT03194620|Antioxidants|antioxidants|mesh-ancestor
102020043|NCT03194620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020044|NCT03194620|Protective Agents|protective agents|mesh-ancestor
102020045|NCT03194620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020046|NCT03194620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102020047|NCT03194620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102020048|NCT03194620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102020049|NCT03194620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102020050|NCT03194620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102020055|NCT03194620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102020056|NCT03194620|Chelating Agents|chelating agents|mesh-ancestor
102020057|NCT03194620|Sequestering Agents|sequestering agents|mesh-ancestor
102020058|NCT02445976|Seviteronel|seviteronel|mesh-list
102020059|NCT02445976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102020060|NCT02445976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102020061|NCT02445976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102020062|NCT02445976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020063|NCT03198442|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102020064|NCT03198442|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102020065|NCT03198442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020066|NCT03198208|Fentanyl|fentanyl|mesh-list
102020067|NCT03198208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102020068|NCT03198208|Narcotics|narcotics|mesh-ancestor
102020069|NCT03198208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102020070|NCT03198208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020071|NCT03198208|Analgesics|analgesics|mesh-ancestor
102020072|NCT03198208|Sensory System Agents|sensory system agents|mesh-ancestor
102020073|NCT03198208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102020074|NCT03198208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102020075|NCT03198208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102020076|NCT03198208|Anesthetics, General|anesthetics, general|mesh-ancestor
102020077|NCT03198208|Anesthetics|anesthetics|mesh-ancestor
102020078|NCT01044056|Contraceptive Agents|contraceptive agents|mesh-list
102020079|NCT01044056|Levonorgestrel|levonorgestrel|mesh-list
102020080|NCT01044056|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102020081|NCT01044056|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
102020082|NCT01044056|NuvaRing|nuvaring|mesh-list
102020083|NCT01044056|Contraceptives, Oral|contraceptives, oral|mesh-list
102020084|NCT01044056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102020085|NCT01044056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020086|NCT01044056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102020087|NCT01044056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102020088|NCT01044056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102020089|NCT01044056|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102020090|NCT01044056|Estrogens|estrogens|mesh-ancestor
102020091|NCT01044056|Hormones|hormones|mesh-ancestor
101739862|NCT00579501|Hormones|hormones|mesh-ancestor
101737369|NCT00761462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101950657|NCT01176006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101523140|NCT04798287|Adalimumab|adalimumab|mesh-list
101950658|NCT01176006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101950659|NCT01176006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101950660|NCT01176006|Antimetabolites|antimetabolites|mesh-ancestor
101950661|NCT00954226|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101950662|NCT00954226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101950663|NCT00954226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102020092|NCT01044056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102020093|NCT01044056|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102020094|NCT01005056|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102020095|NCT01005056|Desogestrel|desogestrel|mesh-list
102020096|NCT01005056|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102020097|NCT01005056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102020098|NCT01005056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102020099|NCT01005056|Contraceptive Agents|contraceptive agents|mesh-ancestor
102020100|NCT01005056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102020101|NCT01005056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020102|NCT01005056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102020103|NCT01005056|Estrogens|estrogens|mesh-ancestor
102020104|NCT01005056|Hormones|hormones|mesh-ancestor
102020105|NCT01005056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102020106|NCT01005056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102020107|NCT01005056|Progestins|progestins|mesh-ancestor
102020108|NCT04796714|Aspirin|aspirin|mesh-list
102020109|NCT04796714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102020110|NCT04796714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102020111|NCT04796714|Analgesics|analgesics|mesh-ancestor
102020112|NCT04796714|Sensory System Agents|sensory system agents|mesh-ancestor
102020113|NCT04796714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102020114|NCT04796714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020115|NCT04796714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102020116|NCT04796714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102020117|NCT04796714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102020118|NCT04796714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102020119|NCT04796714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628294|NCT00724243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102020142|NCT02445898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102020143|NCT02445898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102020144|NCT02445820|Plasma-lyte 148|plasma-lyte 148|mesh-list
102020145|NCT02445820|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102020146|NCT02445820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102020147|NCT03198130|Cemiplimab|cemiplimab|mesh-list
102020148|NCT03198130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102020149|NCT03198130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102020150|NCT04238780|Fentanyl|fentanyl|mesh-list
102020151|NCT04238780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102020152|NCT04238780|Narcotics|narcotics|mesh-ancestor
102020153|NCT04238780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102020154|NCT04238780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020155|NCT04238780|Analgesics|analgesics|mesh-ancestor
102020156|NCT04238780|Sensory System Agents|sensory system agents|mesh-ancestor
102020157|NCT04238780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102020158|NCT04238780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102020159|NCT04238780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102020160|NCT04238780|Anesthetics, General|anesthetics, general|mesh-ancestor
102020161|NCT04238780|Anesthetics|anesthetics|mesh-ancestor
102020162|NCT00944216|Emollients|emollients|mesh-list
102020163|NCT00944216|Dermatologic Agents|dermatologic agents|mesh-ancestor
102020164|NCT04238663|Bevacizumab|bevacizumab|mesh-list
102020165|NCT04238663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102020166|NCT04238663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101739917|NCT02598830|Vitamin D|vitamin d|mesh-list
102020167|NCT04238663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102020168|NCT04238663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102020169|NCT04238663|Growth Substances|growth substances|mesh-ancestor
102020170|NCT04238663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020171|NCT04238663|Growth Inhibitors|growth inhibitors|mesh-ancestor
102020172|NCT00878462|Asenapine|asenapine|mesh-list
102020173|NCT00878462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101950664|NCT00954226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101950665|NCT00954226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950666|NCT00882193|Ribavirin|ribavirin|mesh-list
102020176|NCT00878462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020177|NCT00878462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102020178|NCT03197818|Budesonide|budesonide|mesh-list
102020179|NCT03197818|Formoterol Fumarate|formoterol fumarate|mesh-list
102020180|NCT03197818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102020181|NCT03197818|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102020182|NCT03197818|Autonomic Agents|autonomic agents|mesh-ancestor
102020183|NCT03197818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102020184|NCT03197818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020185|NCT03197818|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102020186|NCT03197818|Respiratory System Agents|respiratory system agents|mesh-ancestor
102020187|NCT03197818|Glucocorticoids|glucocorticoids|mesh-ancestor
102020188|NCT03197818|Hormones|hormones|mesh-ancestor
102020189|NCT03197818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102020190|NCT03197818|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102020191|NCT03197818|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102020192|NCT03197818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102020193|NCT03197818|Adrenergic Agents|adrenergic agents|mesh-ancestor
102020194|NCT03197818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102020195|NCT03197818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020196|NCT03442088|Apremilast|apremilast|mesh-list
102020197|NCT03442088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102020198|NCT03442088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102020199|NCT03442088|Analgesics|analgesics|mesh-ancestor
102020200|NCT03442088|Sensory System Agents|sensory system agents|mesh-ancestor
102020201|NCT03442088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102020202|NCT03442088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020203|NCT03442088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102020204|NCT03442088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102020205|NCT03442088|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102020206|NCT03442088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102020207|NCT03442088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102020208|NCT03442088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020209|NCT01562405|Dexamethasone|dexamethasone|mesh-list
102020210|NCT01562405|Lenalidomide|lenalidomide|mesh-list
102020211|NCT01562405|Pomalidomide|pomalidomide|mesh-list
102020212|NCT01562405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102020213|NCT01562405|Antiemetics|antiemetics|mesh-ancestor
102020214|NCT01562405|Autonomic Agents|autonomic agents|mesh-ancestor
102020215|NCT01562405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102020216|NCT01562405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020217|NCT01562405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102020218|NCT01562405|Glucocorticoids|glucocorticoids|mesh-ancestor
102020219|NCT01562405|Hormones|hormones|mesh-ancestor
102020220|NCT01562405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102020221|NCT01562405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102020222|NCT01562405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102020223|NCT01562405|Immunologic Factors|immunologic factors|mesh-ancestor
102020224|NCT01562405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102020225|NCT01562405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102020226|NCT01562405|Growth Substances|growth substances|mesh-ancestor
102020227|NCT01562405|Growth Inhibitors|growth inhibitors|mesh-ancestor
102020228|NCT03119194|Opicapone|opicapone|mesh-list
102020229|NCT03119194|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102020230|NCT03119194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102020231|NCT03119194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020232|NCT03119194|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102020233|NCT03119194|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102020234|NCT03107338|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
102020235|NCT03107338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102020236|NCT03107338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102020237|NCT03107338|Analgesics|analgesics|mesh-ancestor
102020238|NCT03107338|Sensory System Agents|sensory system agents|mesh-ancestor
102020239|NCT03107338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102020240|NCT03107338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020241|NCT03107338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102020242|NCT03107338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102020243|NCT05581940|Bupivacaine|bupivacaine|mesh-list
101950667|NCT00882193|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101950669|NCT00882193|Antimetabolites|antimetabolites|mesh-ancestor
101950670|NCT00882193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950671|NCT00882193|Antiviral Agents|antiviral agents|mesh-ancestor
101950672|NCT00882193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101950673|NCT00882193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101950674|NCT00882193|Lipotropic Agents|lipotropic agents|mesh-ancestor
101950675|NCT00882193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101950676|NCT00882193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101950677|NCT00662740|Tiotropium Bromide|tiotropium bromide|mesh-list
101950678|NCT00662740|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101950679|NCT00662740|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101950680|NCT00662740|Autonomic Agents|autonomic agents|mesh-ancestor
101950681|NCT00662740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101950682|NCT00662740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950683|NCT00662740|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101950684|NCT00662740|Respiratory System Agents|respiratory system agents|mesh-ancestor
101950685|NCT00662740|Parasympatholytics|parasympatholytics|mesh-ancestor
101282137|NCT01905566|Ticagrelor|ticagrelor|mesh-list
102020244|NCT05581940|Anesthetics|anesthetics|mesh-list
102020245|NCT05581940|Anesthetics, Local|anesthetics, local|mesh-ancestor
102020248|NCT05581940|Sensory System Agents|sensory system agents|mesh-ancestor
102020249|NCT05581940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102020250|NCT02445508|Cholecystokinin|cholecystokinin|mesh-list
102020251|NCT02445508|Sevelamer|sevelamer|mesh-list
102020252|NCT02445508|Chelating Agents|chelating agents|mesh-ancestor
102020253|NCT02445508|Sequestering Agents|sequestering agents|mesh-ancestor
102020254|NCT02445508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020255|NCT02445508|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102020256|NCT02445508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102020257|NCT03197584|Leucovorin|leucovorin|mesh-list
102020258|NCT03197584|Cyclophosphamide|cyclophosphamide|mesh-list
102020259|NCT03197584|Bevacizumab|bevacizumab|mesh-list
102020260|NCT03197584|Fluorouracil|fluorouracil|mesh-list
102020261|NCT03197584|Capecitabine|capecitabine|mesh-list
102020262|NCT03197584|Oxaliplatin|oxaliplatin|mesh-list
102020263|NCT03197584|Fulvestrant|fulvestrant|mesh-list
102020264|NCT03197584|Avelumab|avelumab|mesh-list
102020265|NCT03197584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102020266|NCT03197584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020267|NCT03197584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102020268|NCT03197584|Immunologic Factors|immunologic factors|mesh-ancestor
102020269|NCT03197584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020270|NCT03197584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102020271|NCT03197584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102020272|NCT03197584|Alkylating Agents|alkylating agents|mesh-ancestor
102020273|NCT03197584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102020274|NCT03197584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102020275|NCT03197584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102020276|NCT03197584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102020277|NCT03197584|Growth Substances|growth substances|mesh-ancestor
102020278|NCT03197584|Growth Inhibitors|growth inhibitors|mesh-ancestor
102020279|NCT03197584|Antimetabolites|antimetabolites|mesh-ancestor
102020280|NCT03197584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102020281|NCT03197584|Antidotes|antidotes|mesh-ancestor
102020282|NCT03197584|Protective Agents|protective agents|mesh-ancestor
102020283|NCT03197584|Vitamin B Complex|vitamin b complex|mesh-ancestor
102020284|NCT03197584|Vitamins|vitamins|mesh-ancestor
101950686|NCT00662740|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101950687|NCT00662740|Cholinergic Agents|cholinergic agents|mesh-ancestor
101950688|NCT00662740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102020285|NCT03197584|Micronutrients|micronutrients|mesh-ancestor
102020286|NCT03197584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102020287|NCT03197584|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102020288|NCT03197584|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102020289|NCT03197584|Hormone Antagonists|hormone antagonists|mesh-ancestor
102020290|NCT03197584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102020291|NCT03722576|Calcium|calcium|mesh-list
102020292|NCT03722576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102020293|NCT03722576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020294|NCT03416348|Ethanol|ethanol|mesh-list
102020295|NCT03416348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102020296|NCT03416348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102020297|NCT03416348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102020298|NCT03416348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020299|NCT03236012|Botulinum Toxins|botulinum toxins|mesh-list
102020300|NCT03236012|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102020301|NCT03236012|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102020302|NCT03236012|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102020303|NCT03236012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102020304|NCT03236012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020305|NCT03236012|Cholinergic Agents|cholinergic agents|mesh-ancestor
102020306|NCT03236012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102020307|NCT03236012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020308|NCT03236012|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102020309|NCT03236012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102020310|NCT02449486|Ropivacaine|ropivacaine|mesh-list
102020311|NCT02449486|Anesthetics, Local|anesthetics, local|mesh-ancestor
102020312|NCT02449486|Anesthetics|anesthetics|mesh-ancestor
102020313|NCT02449486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102020314|NCT02449486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020315|NCT02449486|Sensory System Agents|sensory system agents|mesh-ancestor
102020316|NCT02449486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102020317|NCT03202186|Progesterone|progesterone|mesh-list
102020318|NCT03202186|Progestins|progestins|mesh-ancestor
102020325|NCT03625076|Anesthetics, Local|anesthetics, local|mesh-ancestor
102020326|NCT03625076|Anesthetics|anesthetics|mesh-ancestor
102020327|NCT03625076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102020328|NCT03625076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020329|NCT03625076|Sensory System Agents|sensory system agents|mesh-ancestor
102020330|NCT03625076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102020331|NCT03625076|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102020332|NCT03625076|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102020333|NCT03625076|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102020334|NCT03625076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102020335|NCT03625076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020336|NCT03625076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102020337|NCT03625076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102020338|NCT03625076|Anesthetics, General|anesthetics, general|mesh-ancestor
102020339|NCT02445352|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102020340|NCT02445352|Ezetimibe|ezetimibe|mesh-list
102020341|NCT02445352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102020342|NCT02445352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102020343|NCT02445352|Antimetabolites|antimetabolites|mesh-ancestor
102020344|NCT02445352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020345|NCT02445352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102020346|NCT02445352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102020347|NCT02445352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102020348|NCT03693989|Fluprednisolone|fluprednisolone|mesh-list
102020349|NCT03693989|Difluprednate|difluprednate|mesh-list
102020350|NCT03693989|Glucocorticoids|glucocorticoids|mesh-ancestor
102020351|NCT03693989|Hormones|hormones|mesh-ancestor
102020352|NCT03693989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102020353|NCT03693989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020354|NCT03693989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102020355|NCT04944212|Vitamin D|vitamin d|mesh-list
102020356|NCT04944212|Vitamins|vitamins|mesh-ancestor
102020357|NCT04944212|Micronutrients|micronutrients|mesh-ancestor
102020358|NCT04944212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950689|NCT00662740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950690|NCT00662740|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101282264|NCT01906762|Analgesics|analgesics|mesh-ancestor
102020359|NCT04944212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102020360|NCT03197740|Donepezil|donepezil|mesh-list
102020361|NCT03197740|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102020362|NCT03197740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102020363|NCT03197740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020364|NCT03197740|Cholinergic Agents|cholinergic agents|mesh-ancestor
102020365|NCT03197740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102020366|NCT03197740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020367|NCT03197740|Nootropic Agents|nootropic agents|mesh-ancestor
102020368|NCT03201796|Levofloxacin|levofloxacin|mesh-list
102020369|NCT03201796|Prulifloxacin|prulifloxacin|mesh-list
102020370|NCT03201796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102020371|NCT03201796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102020372|NCT03201796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102020373|NCT03201796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102020374|NCT03201796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102020375|NCT03201796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102020376|NCT03201796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020377|NCT03201796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102020378|NCT03201796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102020379|NCT03201796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102020380|NCT02727998|Midazolam|midazolam|mesh-list
102020381|NCT02727998|Ketamine|ketamine|mesh-list
102020382|NCT02727998|Analgesics|analgesics|mesh-ancestor
102020383|NCT02727998|Sensory System Agents|sensory system agents|mesh-ancestor
102020384|NCT02727998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102020385|NCT02727998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020386|NCT02727998|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101475373|NCT00265031|Prednisone|prednisone|mesh-list
102020392|NCT02727998|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102020393|NCT02727998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102020394|NCT02727998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020395|NCT02727998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102020396|NCT02727998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102020397|NCT02727998|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102020398|NCT02727998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102020399|NCT02727998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102020400|NCT02727998|GABA Modulators|gaba modulators|mesh-ancestor
102020402|NCT02636270|Mecasermin|mecasermin|mesh-list
102020403|NCT02636270|Growth Substances|growth substances|mesh-ancestor
102020404|NCT02636270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020405|NCT02108990|Acetaminophen|acetaminophen|mesh-list
102020406|NCT02108990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102020407|NCT02108990|Analgesics|analgesics|mesh-ancestor
102020408|NCT02108990|Sensory System Agents|sensory system agents|mesh-ancestor
102020409|NCT02108990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102020410|NCT02108990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020411|NCT02108990|Antipyretics|antipyretics|mesh-ancestor
102020412|NCT03194074|Propofol|propofol|mesh-list
102020413|NCT03194074|Desflurane|desflurane|mesh-list
102020414|NCT03194074|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102020415|NCT03194074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102020416|NCT03194074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020417|NCT03194074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102020418|NCT03194074|Anesthetics, General|anesthetics, general|mesh-ancestor
102020419|NCT03194074|Anesthetics|anesthetics|mesh-ancestor
102020420|NCT03194074|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102020421|NCT03201952|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102020422|NCT03201952|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102020423|NCT03201952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102020424|NCT04179461|Vitamin D|vitamin d|mesh-list
102020425|NCT04179461|Cholecalciferol|cholecalciferol|mesh-list
102020426|NCT04179461|Fluticasone|fluticasone|mesh-list
102020427|NCT04179461|Xhance|xhance|mesh-list
102020428|NCT04179461|Mometasone Furoate|mometasone furoate|mesh-list
102020429|NCT04179461|Cetirizine|cetirizine|mesh-list
102020430|NCT04179461|Loratadine|loratadine|mesh-list
102020431|NCT04179461|Azithromycin|azithromycin|mesh-list
102020432|NCT04179461|Budesonide|budesonide|mesh-list
102020433|NCT04179461|Beclomethasone|beclomethasone|mesh-list
102020434|NCT04179461|Emollients|emollients|mesh-list
102020435|NCT04179461|Formoterol Fumarate|formoterol fumarate|mesh-list
101950691|NCT00662740|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101950692|NCT00662740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101950693|NCT00662740|Adrenergic Agents|adrenergic agents|mesh-ancestor
102020436|NCT04179461|Tiotropium Bromide|tiotropium bromide|mesh-list
102020437|NCT04179461|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102020438|NCT04179461|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102020439|NCT04179461|Histamine Antagonists|histamine antagonists|mesh-list
102020440|NCT04179461|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
102020442|NCT04179461|Micronutrients|micronutrients|mesh-ancestor
102020443|NCT04179461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020444|NCT04179461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102020445|NCT04179461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102020446|NCT04179461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102020447|NCT04179461|Autonomic Agents|autonomic agents|mesh-ancestor
102020448|NCT04179461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102020449|NCT04179461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102020450|NCT04179461|Respiratory System Agents|respiratory system agents|mesh-ancestor
102020451|NCT04179461|Dermatologic Agents|dermatologic agents|mesh-ancestor
102020452|NCT04179461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102020453|NCT04179461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102020454|NCT04179461|Glucocorticoids|glucocorticoids|mesh-ancestor
102020455|NCT04179461|Hormones|hormones|mesh-ancestor
102020456|NCT04179461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102020457|NCT04179461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102020458|NCT04179461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102020459|NCT04179461|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102020463|NCT04179461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102020464|NCT04179461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020465|NCT04179461|Parasympatholytics|parasympatholytics|mesh-ancestor
102020466|NCT04179461|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102020467|NCT04179461|Cholinergic Agents|cholinergic agents|mesh-ancestor
102020468|NCT04179461|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102020470|NCT04179461|Antipruritics|antipruritics|mesh-ancestor
102020471|NCT04179461|Sympathomimetics|sympathomimetics|mesh-ancestor
102020472|NCT04844528|Niacinamide|niacinamide|mesh-list
102020473|NCT04844528|Niacin|niacin|mesh-list
102020474|NCT04844528|Nicotinic Acids|nicotinic acids|mesh-list
102020475|NCT04844528|Vitamin B Complex|vitamin b complex|mesh-ancestor
102020476|NCT04844528|Vitamins|vitamins|mesh-ancestor
102020477|NCT04844528|Micronutrients|micronutrients|mesh-ancestor
102020478|NCT04844528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020479|NCT04844528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102020480|NCT04844528|Antimetabolites|antimetabolites|mesh-ancestor
102020481|NCT04844528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020482|NCT04844528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102020483|NCT04844528|Vasodilator Agents|vasodilator agents|mesh-ancestor
102020484|NCT03196882|Iron|iron|mesh-list
102020485|NCT03196882|Trace Elements|trace elements|mesh-ancestor
102020486|NCT03196882|Micronutrients|micronutrients|mesh-ancestor
102020487|NCT03196882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020488|NCT04172831|Cyclobenzaprine|cyclobenzaprine|mesh-list
102020489|NCT04172831|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102020490|NCT04172831|Antidepressive Agents|antidepressive agents|mesh-ancestor
102020491|NCT04172831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102020492|NCT04172831|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102020493|NCT04172831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020494|NCT04172831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102020495|NCT04172831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102020496|NCT04172831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102020497|NCT04172831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102020498|NCT01562717|Ibuprofen|ibuprofen|mesh-list
102020499|NCT01562717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102020500|NCT01562717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102020501|NCT01562717|Analgesics|analgesics|mesh-ancestor
102020502|NCT01562717|Sensory System Agents|sensory system agents|mesh-ancestor
102020503|NCT01562717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102020504|NCT01562717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020505|NCT01562717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102020506|NCT01562717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102020507|NCT01562717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102020508|NCT01562717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101737370|NCT00761462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101950694|NCT00451815|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
101950695|NCT00451815|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
102020509|NCT01562717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020510|NCT03196648|Fluorides|fluorides|mesh-list
102020511|NCT03196648|Antioxidants|antioxidants|mesh-list
102020512|NCT03196648|Cariostatic Agents|cariostatic agents|mesh-ancestor
102020513|NCT03196648|Protective Agents|protective agents|mesh-ancestor
102020514|NCT03196648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020515|NCT03196648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020516|NCT03625310|Listerine|listerine|mesh-list
102020517|NCT03625310|Fluorides|fluorides|mesh-list
102020518|NCT03625310|Sodium Fluoride|sodium fluoride|mesh-list
102020519|NCT03625310|Cariostatic Agents|cariostatic agents|mesh-ancestor
102020520|NCT03625310|Protective Agents|protective agents|mesh-ancestor
102020521|NCT03625310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020522|NCT03625310|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102020523|NCT03625310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102020524|NCT05058404|Prednisone|prednisone|mesh-list
102020525|NCT05058404|Rituximab|rituximab|mesh-list
102020526|NCT05058404|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102020527|NCT05058404|Cyclophosphamide|cyclophosphamide|mesh-list
102020528|NCT05058404|Vincristine|vincristine|mesh-list
102020529|NCT05058404|Doxorubicin|doxorubicin|mesh-list
102020530|NCT05058404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102020531|NCT05058404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102020532|NCT05058404|Immunologic Factors|immunologic factors|mesh-ancestor
102020533|NCT05058404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020536|NCT05058404|Alkylating Agents|alkylating agents|mesh-ancestor
102020537|NCT05058404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020538|NCT05058404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102020539|NCT05058404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102020540|NCT05058404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102020541|NCT05058404|Glucocorticoids|glucocorticoids|mesh-ancestor
102020542|NCT05058404|Hormones|hormones|mesh-ancestor
102020543|NCT05058404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102020544|NCT05058404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102020545|NCT05058404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102020546|NCT05058404|Tubulin Modulators|tubulin modulators|mesh-ancestor
101740299|NCT00715455|Heparin|heparin|mesh-list
102020547|NCT05058404|Antimitotic Agents|antimitotic agents|mesh-ancestor
102020548|NCT05058404|Mitosis Modulators|mitosis modulators|mesh-ancestor
102020549|NCT05058404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102020550|NCT05058404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102020551|NCT05058404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102020552|NCT05058404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102020554|NCT03118336|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102020555|NCT03118336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020556|NCT03118336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102020557|NCT03118336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020558|NCT02444572|Enoxaparin|enoxaparin|mesh-list
102020559|NCT02444572|Anticoagulants|anticoagulants|mesh-ancestor
102020560|NCT02444572|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102020561|NCT02444572|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102020562|NCT02444572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020563|NCT04165031|Docetaxel|docetaxel|mesh-list
102020564|NCT04165031|Cetuximab|cetuximab|mesh-list
102020565|NCT04165031|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102020566|NCT04165031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102020567|NCT04165031|Tubulin Modulators|tubulin modulators|mesh-ancestor
102020568|NCT04165031|Antimitotic Agents|antimitotic agents|mesh-ancestor
102020569|NCT04165031|Mitosis Modulators|mitosis modulators|mesh-ancestor
102020570|NCT04165031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020571|NCT04165031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102020572|NCT04165031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102020573|NCT04165031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102020574|NCT05480150|Dexetimide|dexetimide|mesh-list
102020575|NCT05480150|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102020576|NCT05480150|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102020577|NCT05480150|Citalopram|citalopram|mesh-list
102020578|NCT05480150|Escitalopram|escitalopram|mesh-list
102020579|NCT05480150|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101950696|NCT00451815|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101950697|NCT00451815|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102020580|NCT05480150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102020581|NCT05480150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102020582|NCT05480150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020583|NCT05480150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102020585|NCT05480150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020586|NCT05480150|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102020587|NCT05480150|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102020588|NCT05480150|Parasympatholytics|parasympatholytics|mesh-ancestor
102020589|NCT05480150|Autonomic Agents|autonomic agents|mesh-ancestor
102020590|NCT05480150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102020591|NCT05480150|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102020592|NCT05480150|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102020593|NCT05480150|Cholinergic Agents|cholinergic agents|mesh-ancestor
102020594|NCT05480150|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102020595|NCT05480150|Antidepressive Agents|antidepressive agents|mesh-ancestor
102020596|NCT05480150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102020597|NCT05480150|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102020598|NCT05480150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102020599|NCT05480150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102020600|NCT05480150|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102020601|NCT05480150|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102020602|NCT05480150|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102020603|NCT05480150|Adrenergic Agents|adrenergic agents|mesh-ancestor
102020604|NCT05480150|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102020611|NCT05464628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102020612|NCT05464628|Antimetabolites|antimetabolites|mesh-ancestor
102020613|NCT05464628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020614|NCT05464628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102020615|NCT05464628|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102020616|NCT05464628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102020617|NCT03193918|Paclitaxel|paclitaxel|mesh-list
102020618|NCT03193918|Ramucirumab|ramucirumab|mesh-list
102020619|NCT03193918|Crenolanib|crenolanib|mesh-list
102020620|NCT03193918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102020621|NCT03193918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102020622|NCT03193918|Tubulin Modulators|tubulin modulators|mesh-ancestor
102020623|NCT03193918|Antimitotic Agents|antimitotic agents|mesh-ancestor
102020624|NCT03193918|Mitosis Modulators|mitosis modulators|mesh-ancestor
102020625|NCT03193918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020626|NCT03117790|Dexmedetomidine|dexmedetomidine|mesh-list
102020628|NCT03117790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102020629|NCT03117790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102020630|NCT03117790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020631|NCT03117790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102020632|NCT03117790|Analgesics|analgesics|mesh-ancestor
102020633|NCT03117790|Sensory System Agents|sensory system agents|mesh-ancestor
102020634|NCT03117790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102020635|NCT03117790|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102020636|NCT03117790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102020637|NCT03117790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102020638|NCT03117790|Adrenergic Agents|adrenergic agents|mesh-ancestor
102020639|NCT03117790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102020640|NCT03117790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020641|NCT03117790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102020642|NCT03117790|Narcotics|narcotics|mesh-ancestor
102020643|NCT03193372|Azelaic acid|azelaic acid|mesh-list
102020644|NCT03193372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102020645|NCT03193372|Dermatologic Agents|dermatologic agents|mesh-ancestor
102020646|NCT03034772|Timolol|timolol|mesh-list
102020647|NCT03034772|Dorzolamide|dorzolamide|mesh-list
102020648|NCT03034772|Lubricant Eye Drops|lubricant eye drops|mesh-list
102020649|NCT03034772|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102020650|NCT03034772|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102020651|NCT03034772|Adrenergic Agents|adrenergic agents|mesh-ancestor
102020652|NCT03034772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102020653|NCT03034772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020654|NCT03034772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020655|NCT03034772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101950698|NCT00451815|Purinergic Agents|purinergic agents|mesh-ancestor
101950699|NCT00451815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101950700|NCT00451815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950701|NCT00451815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282561|NCT01908335|Interferon-alpha|interferon-alpha|mesh-list
102020656|NCT03034772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102020657|NCT03034772|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102020658|NCT03034772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102020659|NCT03034772|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102020660|NCT03034772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102020661|NCT03193606|Fluorides|fluorides|mesh-list
102020662|NCT03193606|Cariostatic Agents|cariostatic agents|mesh-ancestor
102020663|NCT03193606|Protective Agents|protective agents|mesh-ancestor
102020664|NCT03193606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020665|NCT02448784|Donepezil|donepezil|mesh-list
102020666|NCT02448784|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102020667|NCT02448784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102020668|NCT02448784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020669|NCT02448784|Cholinergic Agents|cholinergic agents|mesh-ancestor
102020670|NCT02448784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102020671|NCT02448784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020672|NCT02448784|Nootropic Agents|nootropic agents|mesh-ancestor
102020673|NCT04050488|Zinc Sulfate|zinc sulfate|mesh-list
102020674|NCT04050488|Astringents|astringents|mesh-ancestor
102020675|NCT04050488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020682|NCT02449252|Immunologic Factors|immunologic factors|mesh-ancestor
102020683|NCT02449252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020684|NCT02449252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102020685|NCT02449252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102020686|NCT02449252|Alkylating Agents|alkylating agents|mesh-ancestor
102020687|NCT02449252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020688|NCT02449252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102020689|NCT02449252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102020690|NCT02449252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102020691|NCT02449252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102020692|NCT02449252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102020693|NCT02449252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102020694|NCT02449252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102020695|NCT02449252|Glucocorticoids|glucocorticoids|mesh-ancestor
102020696|NCT02449252|Hormones|hormones|mesh-ancestor
102020697|NCT02449252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102020698|NCT02449252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102020699|NCT02449252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102020700|NCT02449252|Tubulin Modulators|tubulin modulators|mesh-ancestor
102020701|NCT02449252|Antimitotic Agents|antimitotic agents|mesh-ancestor
102020702|NCT02449252|Mitosis Modulators|mitosis modulators|mesh-ancestor
102020703|NCT04779554|Mitomycins|mitomycins|mesh-list
102020704|NCT04779554|Mitomycin|mitomycin|mesh-list
102020705|NCT04779554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102020706|NCT04779554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102020707|NCT04779554|Alkylating Agents|alkylating agents|mesh-ancestor
102020708|NCT04779554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020709|NCT04779554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102020710|NCT04779554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102020711|NCT02444260|Lidocaine|lidocaine|mesh-list
102020712|NCT02444260|Midazolam|midazolam|mesh-list
102020713|NCT02444260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102020714|NCT02444260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102020715|NCT02444260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102020716|NCT02444260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020717|NCT02444260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102020718|NCT02444260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102020719|NCT02444260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102020720|NCT02444260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102020721|NCT02444260|Anesthetics, General|anesthetics, general|mesh-ancestor
102020722|NCT02444260|Anesthetics|anesthetics|mesh-ancestor
102020723|NCT02444260|GABA Modulators|gaba modulators|mesh-ancestor
102020724|NCT02444260|GABA Agents|gaba agents|mesh-ancestor
102020725|NCT02444260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101950703|NCT00233662|Dermatologic Agents|dermatologic agents|mesh-ancestor
101950704|NCT00233662|Immunologic Factors|immunologic factors|mesh-ancestor
101950705|NCT00233662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950706|NCT00078949|Cytarabine|cytarabine|mesh-list
102020726|NCT02444260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020727|NCT02444260|Anesthetics, Local|anesthetics, local|mesh-ancestor
102020728|NCT02444260|Sensory System Agents|sensory system agents|mesh-ancestor
102020729|NCT02444260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102020730|NCT02444260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102020731|NCT02444260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102020732|NCT02444260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102020733|NCT02444260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102020734|NCT03195634|Carvedilol|carvedilol|mesh-list
102020735|NCT03195634|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102020736|NCT03195634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102020737|NCT03195634|Adrenergic Agents|adrenergic agents|mesh-ancestor
102020738|NCT03195634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102020739|NCT03195634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020740|NCT03195634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020741|NCT03195634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102020742|NCT03195634|Antioxidants|antioxidants|mesh-ancestor
102020743|NCT03195634|Protective Agents|protective agents|mesh-ancestor
102020744|NCT03195634|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102020745|NCT03195634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102020748|NCT03195634|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102020750|NCT02448550|Heparin|heparin|mesh-list
102020751|NCT02448550|Calcium heparin|calcium heparin|mesh-list
102020752|NCT02448550|Bivalirudin|bivalirudin|mesh-list
102020753|NCT02448550|Anticoagulants|anticoagulants|mesh-ancestor
102020754|NCT02448550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102020755|NCT02448550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102020756|NCT02448550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020757|NCT02448550|Antithrombins|antithrombins|mesh-ancestor
102020758|NCT02448550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102020759|NCT02448550|Protease Inhibitors|protease inhibitors|mesh-ancestor
102020760|NCT02448550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102020761|NCT03701750|Heparin|heparin|mesh-list
102020762|NCT03701750|Enoxaparin|enoxaparin|mesh-list
102020763|NCT03701750|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102020764|NCT03701750|Tinzaparin|tinzaparin|mesh-list
102020765|NCT03701750|Dalteparin|dalteparin|mesh-list
102020766|NCT03701750|Enoxaparin sodium|enoxaparin sodium|mesh-list
102020767|NCT03701750|Anticoagulants|anticoagulants|mesh-ancestor
102020768|NCT03701750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102020769|NCT03701750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102020770|NCT03701750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020771|NCT03704246|Antibodies|antibodies|mesh-list
101740518|NCT00919776|Glucocorticoids|glucocorticoids|mesh-ancestor
102020772|NCT03704246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102020773|NCT03704246|Immunologic Factors|immunologic factors|mesh-ancestor
102020774|NCT03704246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020775|NCT05239910|Tenalisib|tenalisib|mesh-list
102020776|NCT05239910|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
102020777|NCT05239910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102020778|NCT05239910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020779|NCT03701672|Analgesics, Opioid|analgesics, opioid|mesh-list
102020780|NCT03701672|Analgesics|analgesics|mesh-list
102020781|NCT03701672|Narcotics|narcotics|mesh-ancestor
102020782|NCT03701672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102020783|NCT03701672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020784|NCT03701672|Sensory System Agents|sensory system agents|mesh-ancestor
102020785|NCT03701672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102020786|NCT03624530|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102020787|NCT03624530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102020788|NCT03624530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102020789|NCT03624530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020790|NCT03746327|Tedizolid phosphate|tedizolid phosphate|mesh-list
102020791|NCT03746327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102020792|NCT03746327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102020793|NCT03746249|Lenvatinib|lenvatinib|mesh-list
102020794|NCT03746249|Antibodies|antibodies|mesh-list
102020795|NCT03746249|Immunoglobulins|immunoglobulins|mesh-list
102020796|NCT03746249|Immunologic Factors|immunologic factors|mesh-ancestor
101950707|NCT00078949|Dexamethasone|dexamethasone|mesh-list
101950708|NCT00078949|Rituximab|rituximab|mesh-list
101950709|NCT00078949|Gemcitabine|gemcitabine|mesh-list
101950710|NCT00078949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101282705|NCT01909856|Glucocorticoids|glucocorticoids|mesh-ancestor
102020797|NCT03746249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020798|NCT03746249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102020799|NCT03746249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102020800|NCT03746249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102020801|NCT03746249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020802|NCT03698474|Ascorbic Acid|ascorbic acid|mesh-list
102020803|NCT03698474|Magnesium Sulfate|magnesium sulfate|mesh-list
102020804|NCT03698474|Magnesium citrate|magnesium citrate|mesh-list
102020805|NCT03698474|Picosulfate sodium|picosulfate sodium|mesh-list
102020806|NCT03698474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020807|NCT03698474|Analgesics|analgesics|mesh-ancestor
102020808|NCT03698474|Sensory System Agents|sensory system agents|mesh-ancestor
102020809|NCT03698474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102020810|NCT03698474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020811|NCT03698474|Anesthetics|anesthetics|mesh-ancestor
102020812|NCT03698474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102020813|NCT03698474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102020814|NCT03698474|Anticonvulsants|anticonvulsants|mesh-ancestor
102020815|NCT03698474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102020816|NCT03698474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102020817|NCT03698474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102020822|NCT03698474|Vitamins|vitamins|mesh-ancestor
102020823|NCT03698474|Micronutrients|micronutrients|mesh-ancestor
102020824|NCT03698474|Cathartics|cathartics|mesh-ancestor
102020825|NCT03698474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102020826|NCT04709276|Carboplatin|carboplatin|mesh-list
102020827|NCT04709276|Nivolumab|nivolumab|mesh-list
102020828|NCT04709276|Ipilimumab|ipilimumab|mesh-list
102020829|NCT04709276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102020830|NCT04709276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102020831|NCT04709276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102020832|NCT04709276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020833|NCT01194622|Fluticasone|fluticasone|mesh-list
102020834|NCT01194622|Xhance|xhance|mesh-list
102020835|NCT01194622|Azelastine|azelastine|mesh-list
102020836|NCT01194622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102020837|NCT01194622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102020838|NCT01194622|Autonomic Agents|autonomic agents|mesh-ancestor
102020839|NCT01194622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102020840|NCT01194622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020841|NCT01194622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102020842|NCT01194622|Respiratory System Agents|respiratory system agents|mesh-ancestor
102020843|NCT01194622|Dermatologic Agents|dermatologic agents|mesh-ancestor
102020844|NCT01194622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102020845|NCT01194622|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
102020846|NCT01194622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101740615|NCT00578643|Busulfan|busulfan|mesh-list
102020847|NCT01194622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020848|NCT01194622|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102020849|NCT01194622|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102020850|NCT01194622|Histamine Antagonists|histamine antagonists|mesh-ancestor
102020851|NCT01194622|Histamine Agents|histamine agents|mesh-ancestor
102020852|NCT01194622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102020853|NCT02448316|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102020854|NCT02448316|Methylprednisolone|methylprednisolone|mesh-list
102020855|NCT02448316|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102020856|NCT02448316|Prednisolone|prednisolone|mesh-list
102020857|NCT02448316|Prednisolone acetate|prednisolone acetate|mesh-list
102020858|NCT02448316|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102020859|NCT02448316|Prednisolone phosphate|prednisolone phosphate|mesh-list
102020860|NCT02448316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102020861|NCT02448316|Antiemetics|antiemetics|mesh-ancestor
102020862|NCT02448316|Autonomic Agents|autonomic agents|mesh-ancestor
102020863|NCT02448316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102020864|NCT02448316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020865|NCT02448316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102020866|NCT02448316|Glucocorticoids|glucocorticoids|mesh-ancestor
102020867|NCT02448316|Hormones|hormones|mesh-ancestor
101950711|NCT00078949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101950712|NCT00078949|Immunologic Factors|immunologic factors|mesh-ancestor
101950713|NCT00078949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950714|NCT00078949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101950715|NCT00078949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101950716|NCT00078949|Antiemetics|antiemetics|mesh-ancestor
101950717|NCT00078949|Autonomic Agents|autonomic agents|mesh-ancestor
101950718|NCT00078949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101950719|NCT00078949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101950720|NCT00078949|Glucocorticoids|glucocorticoids|mesh-ancestor
101950721|NCT00078949|Hormones|hormones|mesh-ancestor
101950722|NCT00078949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101950723|NCT00078949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101950724|NCT00078949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101950725|NCT00078949|Antimetabolites|antimetabolites|mesh-ancestor
101950726|NCT00078949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950727|NCT00078949|Antiviral Agents|antiviral agents|mesh-ancestor
101950728|NCT00078949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101950729|NCT00078949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101387652|NCT00090480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020868|NCT02448316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102020869|NCT02448316|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102020870|NCT02448316|Protective Agents|protective agents|mesh-ancestor
102020871|NCT02448316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102020872|NCT02448316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102020873|NCT04564898|Trifluridine|trifluridine|mesh-list
102020874|NCT04564898|Bevacizumab|bevacizumab|mesh-list
102020875|NCT04564898|Capecitabine|capecitabine|mesh-list
102020876|NCT04564898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102020877|NCT04564898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102020878|NCT04564898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102020879|NCT04564898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102020880|NCT04564898|Growth Substances|growth substances|mesh-ancestor
102020881|NCT04564898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020882|NCT04564898|Growth Inhibitors|growth inhibitors|mesh-ancestor
102020883|NCT04564898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102020884|NCT04564898|Antimetabolites|antimetabolites|mesh-ancestor
102020885|NCT04564898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020886|NCT04564898|Antiviral Agents|antiviral agents|mesh-ancestor
102020887|NCT04564898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102020888|NCT02443714|Insulin|insulin|mesh-list
102020889|NCT02443714|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102020890|NCT02443714|Insulin Lispro|insulin lispro|mesh-list
102020894|NCT03703310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102020895|NCT03703154|Tacrolimus|tacrolimus|mesh-list
102020896|NCT03703154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102020897|NCT03703154|Immunologic Factors|immunologic factors|mesh-ancestor
102020898|NCT03703154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020899|NCT03703154|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102020900|NCT03703154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102020901|NCT03703154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020902|NCT02434276|Hemagglutinins|hemagglutinins|mesh-list
102020903|NCT02434276|Immunologic Factors|immunologic factors|mesh-ancestor
102020904|NCT02434276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020905|NCT02434276|Agglutinins|agglutinins|mesh-ancestor
102020906|NCT02434276|Coagulants|coagulants|mesh-ancestor
102020907|NCT03190642|Methylprednisolone|methylprednisolone|mesh-list
101950730|NCT01289769|Dexmedetomidine|dexmedetomidine|mesh-list
101950731|NCT01289769|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102020908|NCT03190642|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102020909|NCT03190642|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102020910|NCT03190642|Prednisolone|prednisolone|mesh-list
102020911|NCT03190642|Prednisolone acetate|prednisolone acetate|mesh-list
102020912|NCT03190642|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102020913|NCT03190642|Prednisolone phosphate|prednisolone phosphate|mesh-list
102020914|NCT03190642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102020915|NCT03190642|Antiemetics|antiemetics|mesh-ancestor
102020916|NCT03190642|Autonomic Agents|autonomic agents|mesh-ancestor
102020917|NCT03190642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102020918|NCT03190642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020919|NCT03190642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102020920|NCT03190642|Glucocorticoids|glucocorticoids|mesh-ancestor
102020921|NCT03190642|Hormones|hormones|mesh-ancestor
101740684|NCT00578565|Rituximab|rituximab|mesh-list
102020922|NCT03190642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102020923|NCT03190642|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102020924|NCT03190642|Protective Agents|protective agents|mesh-ancestor
102020925|NCT03190642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102020926|NCT03190642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102020927|NCT03702530|Albendazole|albendazole|mesh-list
102020928|NCT03702530|Anthelmintics|anthelmintics|mesh-ancestor
102020929|NCT03702530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102020930|NCT03702530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102020931|NCT03702530|Anticestodal Agents|anticestodal agents|mesh-ancestor
102020932|NCT03702530|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102020933|NCT03702530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102020934|NCT03702530|Tubulin Modulators|tubulin modulators|mesh-ancestor
101523417|NCT04688723|Dabigatran|dabigatran|mesh-list
102020935|NCT03702530|Antimitotic Agents|antimitotic agents|mesh-ancestor
102020936|NCT03702530|Mitosis Modulators|mitosis modulators|mesh-ancestor
102020937|NCT03702530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020938|NCT03702530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102020939|NCT02443246|Vitamin D|vitamin d|mesh-list
102020940|NCT02443246|Cholecalciferol|cholecalciferol|mesh-list
102020941|NCT02443246|Vitamins|vitamins|mesh-ancestor
102020942|NCT02443246|Micronutrients|micronutrients|mesh-ancestor
102020943|NCT02443246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020944|NCT02443246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102020945|NCT02443246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102020946|NCT03031496|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102020947|NCT03031496|Amiloride|amiloride|mesh-list
102020948|NCT03031496|Amiloride, hydrochlorothiazide drug combination|amiloride, hydrochlorothiazide drug combination|mesh-list
102020949|NCT03031496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102020950|NCT03031496|Diuretics|diuretics|mesh-ancestor
102020951|NCT03031496|Natriuretic Agents|natriuretic agents|mesh-ancestor
102020952|NCT03031496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020953|NCT03031496|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102020954|NCT03031496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102020955|NCT03031496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020956|NCT03031496|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
102020957|NCT03031496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102020958|NCT03031496|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
102020959|NCT03031496|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102020960|NCT03187912|Riboflavin|riboflavin|mesh-list
102020961|NCT03187912|Vitamin B Complex|vitamin b complex|mesh-ancestor
102020962|NCT03187912|Vitamins|vitamins|mesh-ancestor
102020968|NCT02443012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102020969|NCT02443012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102020970|NCT02443012|Analgesics|analgesics|mesh-ancestor
102020971|NCT02443012|Sensory System Agents|sensory system agents|mesh-ancestor
102020972|NCT02443012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102020973|NCT02443012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020974|NCT02443012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102020975|NCT02443012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102020976|NCT04670432|Troxerutin|troxerutin|mesh-list
102020977|NCT04670432|Anticoagulants|anticoagulants|mesh-ancestor
102020978|NCT03701126|Bupivacaine|bupivacaine|mesh-list
102020979|NCT03701126|Anesthetics, Local|anesthetics, local|mesh-ancestor
102020980|NCT03701126|Anesthetics|anesthetics|mesh-ancestor
102020981|NCT03701126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102020982|NCT03701126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020983|NCT03701126|Sensory System Agents|sensory system agents|mesh-ancestor
101950732|NCT01289769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101950733|NCT01289769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282903|NCT01910766|Fertility Agents|fertility agents|mesh-ancestor
102020984|NCT03701126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102020986|NCT03702140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102020987|NCT03702140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020988|NCT03702140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102020989|NCT03700814|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102020990|NCT03700814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102020991|NCT03700814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102020992|NCT03700814|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102020993|NCT03700814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102020994|NCT03700814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020995|NCT02433808|Neostigmine|neostigmine|mesh-list
102020996|NCT02433808|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102020997|NCT02433808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102020998|NCT02433808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102020999|NCT02433808|Cholinergic Agents|cholinergic agents|mesh-ancestor
102021000|NCT02433808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102021001|NCT02433808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021002|NCT02433808|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102021003|NCT02433808|Autonomic Agents|autonomic agents|mesh-ancestor
102021004|NCT02433808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102021005|NCT03701984|Lidocaine|lidocaine|mesh-list
102021006|NCT03701984|Tramadol|tramadol|mesh-list
102021007|NCT03701984|Anesthetics, Local|anesthetics, local|mesh-ancestor
102021008|NCT03701984|Anesthetics|anesthetics|mesh-ancestor
102021009|NCT03701984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102021010|NCT03701984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021011|NCT03701984|Sensory System Agents|sensory system agents|mesh-ancestor
102021012|NCT03701984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102021013|NCT03701984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102021014|NCT03701984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102021015|NCT03701984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102021016|NCT03701984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102021017|NCT03701984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523534|NCT01658826|Pritelivir|pritelivir|mesh-list
102021018|NCT03701984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102021019|NCT03701984|Narcotics|narcotics|mesh-ancestor
102021020|NCT03701984|Analgesics|analgesics|mesh-ancestor
102021021|NCT04651400|Antithrombins|antithrombins|mesh-list
102021022|NCT04651400|Antithrombin III|antithrombin iii|mesh-list
102021023|NCT04651400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102021024|NCT04651400|Protease Inhibitors|protease inhibitors|mesh-ancestor
102021025|NCT04651400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102021026|NCT04651400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021027|NCT04651400|Anticoagulants|anticoagulants|mesh-ancestor
102021028|NCT02439190|Aspirin|aspirin|mesh-list
102021029|NCT02439190|Clopidogrel|clopidogrel|mesh-list
102021030|NCT02439190|BMS-986120|bms-986120|mesh-list
102021031|NCT02439190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102021032|NCT02439190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102021043|NCT02439190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102021044|NCT02439190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102021045|NCT02439190|Antipyretics|antipyretics|mesh-ancestor
102021046|NCT02439190|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102021047|NCT02439190|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102021048|NCT02439190|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102021049|NCT02439190|Purinergic Agents|purinergic agents|mesh-ancestor
102021050|NCT02439190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102021051|NCT02442466|BQ 788|bq 788|mesh-list
102021052|NCT02442466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102021053|NCT02442466|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
102021054|NCT02442466|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102021055|NCT02442466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021056|NCT02439034|Acetaminophen|acetaminophen|mesh-list
102021057|NCT02439034|Ketoprofen|ketoprofen|mesh-list
102021058|NCT02439034|Codeine|codeine|mesh-list
102021059|NCT02439034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102021060|NCT02439034|Analgesics|analgesics|mesh-ancestor
102021061|NCT02439034|Sensory System Agents|sensory system agents|mesh-ancestor
101950734|NCT01289769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101950736|NCT01289769|Sensory System Agents|sensory system agents|mesh-ancestor
101950737|NCT01289769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101282975|NCT01911299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102021062|NCT02439034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102021063|NCT02439034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021064|NCT02439034|Antipyretics|antipyretics|mesh-ancestor
102021065|NCT02439034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102021066|NCT02439034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102021067|NCT02439034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102021068|NCT02439034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102021069|NCT02439034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102021070|NCT02439034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021071|NCT02439034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102021073|NCT02439034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102021074|NCT02439034|Antitussive Agents|antitussive agents|mesh-ancestor
102021075|NCT02439034|Respiratory System Agents|respiratory system agents|mesh-ancestor
102021076|NCT04483492|Caffeine|caffeine|mesh-list
102021077|NCT04483492|Caffeine citrate|caffeine citrate|mesh-list
102021078|NCT04483492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021079|NCT04483492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102021080|NCT04483492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021081|NCT04483492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102021082|NCT04483492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102021083|NCT04483492|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102021084|NCT04483492|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102021085|NCT04483492|Purinergic Agents|purinergic agents|mesh-ancestor
102021086|NCT04483492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102021087|NCT03186742|Eplerenone|eplerenone|mesh-list
102021088|NCT03186742|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102021089|NCT03186742|Hormone Antagonists|hormone antagonists|mesh-ancestor
102021090|NCT03186742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102021091|NCT03186742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021092|NCT03186742|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102021093|NCT03186742|Diuretics|diuretics|mesh-ancestor
102021094|NCT03186742|Natriuretic Agents|natriuretic agents|mesh-ancestor
102021095|NCT03186742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102021096|NCT03186664|Nabiximols|nabiximols|mesh-list
102021100|NCT03186664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021102|NCT02441842|Lisinopril|lisinopril|mesh-list
102021103|NCT02441842|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102021104|NCT02441842|Protease Inhibitors|protease inhibitors|mesh-ancestor
102021105|NCT02441842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102021106|NCT02441842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021107|NCT02441842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102021108|NCT02441842|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102021109|NCT02441842|Protective Agents|protective agents|mesh-ancestor
102021110|NCT02441842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021111|NCT02441842|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102021112|NCT02441842|Sympatholytics|sympatholytics|mesh-ancestor
102021113|NCT02441842|Autonomic Agents|autonomic agents|mesh-ancestor
102021114|NCT02441842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102021115|NCT02441842|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102021116|NCT02441842|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102021117|NCT02441842|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102021118|NCT02441842|Adrenergic Agents|adrenergic agents|mesh-ancestor
102021119|NCT02441842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102021120|NCT02438566|Tranexamic Acid|tranexamic acid|mesh-list
102021121|NCT02438566|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102021122|NCT02438566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102021123|NCT02438566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021124|NCT02438566|Hemostatics|hemostatics|mesh-ancestor
102021125|NCT02438566|Coagulants|coagulants|mesh-ancestor
102021126|NCT02433652|Vaccines|vaccines|mesh-list
102021127|NCT02433652|Immunologic Factors|immunologic factors|mesh-ancestor
102021128|NCT02433652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021129|NCT03186586|Ulipristal acetate|ulipristal acetate|mesh-list
102021130|NCT03186586|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101950738|NCT01289769|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101950739|NCT01289769|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101950740|NCT01289769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101950741|NCT01289769|Adrenergic Agents|adrenergic agents|mesh-ancestor
101950742|NCT01289769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101950743|NCT01289769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950744|NCT01185015|Nicorandil|nicorandil|mesh-list
101950745|NCT01185015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101950746|NCT01185015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101950747|NCT01185015|Vasodilator Agents|vasodilator agents|mesh-ancestor
101950748|NCT01185015|Vitamin B Complex|vitamin b complex|mesh-ancestor
101950749|NCT01185015|Vitamins|vitamins|mesh-ancestor
101950750|NCT01185015|Micronutrients|micronutrients|mesh-ancestor
101950751|NCT01185015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950752|NCT01289925|Selenium|selenium|mesh-list
101950753|NCT01289925|Antioxidants|antioxidants|mesh-ancestor
101950754|NCT01289925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950755|NCT01289925|Protective Agents|protective agents|mesh-ancestor
101950756|NCT01289925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950757|NCT01289925|Trace Elements|trace elements|mesh-ancestor
101950758|NCT01289925|Micronutrients|micronutrients|mesh-ancestor
101950759|NCT01290939|Bevacizumab|bevacizumab|mesh-list
101950760|NCT01290939|Lomustine|lomustine|mesh-list
101950761|NCT01290939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101950762|NCT01290939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101950763|NCT01290939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101950764|NCT01290939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101950765|NCT01290939|Growth Substances|growth substances|mesh-ancestor
102021131|NCT03186586|Contraceptive Agents|contraceptive agents|mesh-ancestor
102021132|NCT03186586|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102021133|NCT03186586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021134|NCT03186586|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102021135|NCT02433418|Diclofenac|diclofenac|mesh-list
102021136|NCT02433418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102021137|NCT02433418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102021138|NCT02433418|Analgesics|analgesics|mesh-ancestor
102021139|NCT02433418|Sensory System Agents|sensory system agents|mesh-ancestor
102021140|NCT02433418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102021141|NCT02433418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021142|NCT02433418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102021143|NCT02433418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102021144|NCT02433418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102021145|NCT02433418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102021146|NCT02433418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021147|NCT02433730|Testosterone|testosterone|mesh-list
102021148|NCT02433730|Androgens|androgens|mesh-ancestor
102021149|NCT02433730|Hormones|hormones|mesh-ancestor
102021150|NCT02433730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101950766|NCT01290939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950767|NCT01290939|Growth Inhibitors|growth inhibitors|mesh-ancestor
101950768|NCT01290939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102021151|NCT02433730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021152|NCT02438098|Rivaroxaban|rivaroxaban|mesh-list
102021153|NCT02438098|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102021154|NCT02438098|Antithrombins|antithrombins|mesh-ancestor
102021155|NCT02438098|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102021156|NCT02438098|Protease Inhibitors|protease inhibitors|mesh-ancestor
102021157|NCT02438098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102021158|NCT02438098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021159|NCT02438098|Anticoagulants|anticoagulants|mesh-ancestor
102021160|NCT02441530|Vitamin D|vitamin d|mesh-list
102021161|NCT02441530|Vitamins|vitamins|mesh-list
102021162|NCT02441530|Vitamin E|vitamin e|mesh-list
102021163|NCT02441530|Ibuprofen|ibuprofen|mesh-list
102021164|NCT02441530|Micronutrients|micronutrients|mesh-ancestor
102021165|NCT02441530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021166|NCT02441530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102021167|NCT02441530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102021168|NCT02441530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102021172|NCT02441530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102021173|NCT02441530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102021174|NCT02441530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102021175|NCT02441530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102021176|NCT02441530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021177|NCT02441530|Antioxidants|antioxidants|mesh-ancestor
102021178|NCT02441530|Protective Agents|protective agents|mesh-ancestor
102021179|NCT02433184|Hydroxychloroquine|hydroxychloroquine|mesh-list
102021180|NCT02433184|Sulfasalazine|sulfasalazine|mesh-list
102021182|NCT02433184|Methotrexate|methotrexate|mesh-list
102021183|NCT02433184|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102021184|NCT02433184|Abortifacient Agents|abortifacient agents|mesh-ancestor
102021185|NCT02433184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102021186|NCT02433184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021187|NCT02433184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102021188|NCT02433184|Antimetabolites|antimetabolites|mesh-ancestor
102021189|NCT02433184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021190|NCT02433184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102021191|NCT02433184|Dermatologic Agents|dermatologic agents|mesh-ancestor
102021192|NCT02433184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102021193|NCT02433184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102021194|NCT02433184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102021195|NCT02433184|Immunologic Factors|immunologic factors|mesh-ancestor
102021196|NCT02433184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102021197|NCT02433184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102021198|NCT02433184|Antimalarials|antimalarials|mesh-ancestor
102021199|NCT02433184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102021200|NCT02433184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102021201|NCT02433184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102021202|NCT02433184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102021203|NCT02433184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102021204|NCT02433184|Analgesics|analgesics|mesh-ancestor
102021205|NCT02433184|Sensory System Agents|sensory system agents|mesh-ancestor
102021206|NCT02433184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102021207|NCT02433184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102021208|NCT02433184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102021209|NCT02438020|Metformin|metformin|mesh-list
102021210|NCT02438020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102021211|NCT02438020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021212|NCT02440750|Dienogest|dienogest|mesh-list
102021213|NCT02440750|Ulipristal acetate|ulipristal acetate|mesh-list
102021214|NCT02440750|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102021215|NCT02440750|Contraceptive Agents|contraceptive agents|mesh-ancestor
102021216|NCT02440750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102021217|NCT02440750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021218|NCT02440750|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102021219|NCT02440750|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102021220|NCT02440750|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102021221|NCT02440750|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102021222|NCT02440750|Hormone Antagonists|hormone antagonists|mesh-ancestor
102021223|NCT02440750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101950769|NCT01290939|Alkylating Agents|alkylating agents|mesh-ancestor
101950770|NCT01290939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950771|NCT01288755|Raltegravir Potassium|raltegravir potassium|mesh-list
101950772|NCT01288755|Rilpivirine|rilpivirine|mesh-list
101950773|NCT01288755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101950774|NCT01288755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101950775|NCT01288755|Antiviral Agents|antiviral agents|mesh-ancestor
101950776|NCT01288755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101950777|NCT01288755|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101950778|NCT01288755|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101950779|NCT01288755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101950780|NCT01288755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950781|NCT01288755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102021224|NCT02440750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102021225|NCT02440750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102021226|NCT03186352|Anti-Infective Agents|anti-infective agents|mesh-list
102021227|NCT03186352|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102021228|NCT02432872|Cytarabine|cytarabine|mesh-list
102021229|NCT02432872|Daunorubicin|daunorubicin|mesh-list
102021230|NCT02432872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102021231|NCT02432872|Antimetabolites|antimetabolites|mesh-ancestor
102021232|NCT02432872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021233|NCT02432872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102021234|NCT02432872|Antiviral Agents|antiviral agents|mesh-ancestor
102021235|NCT02432872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102021236|NCT02432872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102021237|NCT02432872|Immunologic Factors|immunologic factors|mesh-ancestor
102021238|NCT02432872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021239|NCT02432872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101628295|NCT02590705|Lidocaine|lidocaine|mesh-list
102021244|NCT02436928|Immunologic Factors|immunologic factors|mesh-ancestor
102021245|NCT02436928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021246|NCT02436538|Hormones|hormones|mesh-list
102021247|NCT02436538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102021248|NCT02436538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021249|NCT02436694|Dexamethasone|dexamethasone|mesh-list
102021250|NCT02436694|Dexamethasone acetate|dexamethasone acetate|mesh-list
102021251|NCT02436694|Ropivacaine|ropivacaine|mesh-list
102021252|NCT02436694|Anesthetics, Local|anesthetics, local|mesh-list
102021253|NCT02436694|Anesthetics|anesthetics|mesh-list
102021254|NCT02436694|BB 1101|bb 1101|mesh-list
102021255|NCT02436694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102021256|NCT02436694|Antiemetics|antiemetics|mesh-ancestor
102021257|NCT02436694|Autonomic Agents|autonomic agents|mesh-ancestor
102021258|NCT02436694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102021259|NCT02436694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021260|NCT02436694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102021261|NCT02436694|Glucocorticoids|glucocorticoids|mesh-ancestor
102021262|NCT02436694|Hormones|hormones|mesh-ancestor
102021263|NCT02436694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102021264|NCT02436694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102021265|NCT02436694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102021266|NCT02436694|Protease Inhibitors|protease inhibitors|mesh-ancestor
102021267|NCT02436694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102021268|NCT02436694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021269|NCT02436694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102021270|NCT02436694|Sensory System Agents|sensory system agents|mesh-ancestor
102021271|NCT03186040|Lacosamide|lacosamide|mesh-list
102021272|NCT03186040|Anticonvulsants|anticonvulsants|mesh-ancestor
102021273|NCT03186040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102021274|NCT03186040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102021275|NCT03186040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101950782|NCT01288755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101950783|NCT01290003|Tazobactam|tazobactam|mesh-list
101950784|NCT01290003|Piperacillin|piperacillin|mesh-list
101950785|NCT01290003|Amikacin|amikacin|mesh-list
102021276|NCT03186040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021277|NCT02659020|Gemcitabine|gemcitabine|mesh-list
102021278|NCT02659020|Docetaxel|docetaxel|mesh-list
102021279|NCT02659020|Olaratumab|olaratumab|mesh-list
102021280|NCT02659020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102021281|NCT02659020|Antimetabolites|antimetabolites|mesh-ancestor
102021282|NCT02659020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021283|NCT02659020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102021284|NCT02659020|Tubulin Modulators|tubulin modulators|mesh-ancestor
102021285|NCT02659020|Antimitotic Agents|antimitotic agents|mesh-ancestor
102021286|NCT02659020|Mitosis Modulators|mitosis modulators|mesh-ancestor
102021287|NCT03482011|Mirikizumab|mirikizumab|mesh-list
102021288|NCT03482011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101523643|NCT02063997|Colchicine|colchicine|mesh-list
102021289|NCT03482011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102021290|NCT03482011|Analgesics|analgesics|mesh-ancestor
102021291|NCT03482011|Sensory System Agents|sensory system agents|mesh-ancestor
102021292|NCT03482011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102021293|NCT03482011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021294|NCT03482011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101741052|NCT00787787|Capecitabine|capecitabine|mesh-list
102021295|NCT03482011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102021296|NCT03482011|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102021297|NCT03482011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102021298|NCT02436226|Citric Acid|citric acid|mesh-list
102021299|NCT02436226|Sodium Citrate|sodium citrate|mesh-list
102021300|NCT02436226|Clomiphene|clomiphene|mesh-list
102021301|NCT02436226|Enclomiphene|enclomiphene|mesh-list
102021302|NCT02436226|Zuclomiphene|zuclomiphene|mesh-list
102021303|NCT02436226|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102021304|NCT02436226|Anticoagulants|anticoagulants|mesh-ancestor
102021305|NCT02436226|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102021306|NCT02436226|Chelating Agents|chelating agents|mesh-ancestor
102021307|NCT02436226|Sequestering Agents|sequestering agents|mesh-ancestor
102021308|NCT02436226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021309|NCT02436226|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102021310|NCT02436226|Hormone Antagonists|hormone antagonists|mesh-ancestor
102021311|NCT02436226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102021314|NCT02436226|Fertility Agents|fertility agents|mesh-ancestor
102021315|NCT02436226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102021316|NCT02436226|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102021317|NCT02436226|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102021318|NCT01374126|Azithromycin|azithromycin|mesh-list
102021319|NCT01374126|Artesunate|artesunate|mesh-list
102021320|NCT01374126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102021321|NCT01374126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102021322|NCT01374126|Antimalarials|antimalarials|mesh-ancestor
102021323|NCT01374126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102021324|NCT01374126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102021325|NCT01374126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102021326|NCT01374126|Antiviral Agents|antiviral agents|mesh-ancestor
102021327|NCT01374126|Schistosomicides|schistosomicides|mesh-ancestor
102021328|NCT01374126|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102021329|NCT01374126|Anthelmintics|anthelmintics|mesh-ancestor
102021330|NCT02584920|Rituximab|rituximab|mesh-list
102021331|NCT02584920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102021332|NCT02584920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102021333|NCT02584920|Immunologic Factors|immunologic factors|mesh-ancestor
102021334|NCT02584920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021335|NCT02584920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102021336|NCT02431936|Prazosin|prazosin|mesh-list
102021337|NCT02431936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102021338|NCT02431936|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102021339|NCT02431936|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102021340|NCT02431936|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102021341|NCT02431936|Adrenergic Agents|adrenergic agents|mesh-ancestor
102021342|NCT02431936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102021343|NCT02431936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021344|NCT02431936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021345|NCT02440828|Tobramycin|tobramycin|mesh-list
102021346|NCT02440828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101950786|NCT01290003|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101950788|NCT01290003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101950789|NCT01290003|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101950790|NCT01290003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102021347|NCT02440828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102021348|NCT01311037|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102021349|NCT01311037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102021350|NCT01311037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102021351|NCT01311037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021352|NCT01311037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102021353|NCT01311037|Hormone Antagonists|hormone antagonists|mesh-ancestor
102021354|NCT01311037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102021355|NCT01311037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021356|NCT03789318|Acetaminophen|acetaminophen|mesh-list
102021357|NCT03789318|Fentanyl|fentanyl|mesh-list
102021358|NCT03789318|Oxycodone|oxycodone|mesh-list
102021359|NCT03789318|Hydromorphone|hydromorphone|mesh-list
102021360|NCT03789318|Bupivacaine|bupivacaine|mesh-list
102021361|NCT03789318|Anesthetics, Local|anesthetics, local|mesh-ancestor
102021362|NCT03789318|Anesthetics|anesthetics|mesh-ancestor
102021363|NCT03789318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102021364|NCT03789318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021365|NCT03789318|Sensory System Agents|sensory system agents|mesh-ancestor
102021366|NCT03789318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102021367|NCT03789318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102021368|NCT03789318|Narcotics|narcotics|mesh-ancestor
102021369|NCT03789318|Analgesics|analgesics|mesh-ancestor
102021370|NCT03789318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102021371|NCT03789318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102021372|NCT03789318|Anesthetics, General|anesthetics, general|mesh-ancestor
102021373|NCT03789318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102021375|NCT02435368|Mycophenolic Acid|mycophenolic acid|mesh-list
102021376|NCT02435368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102021377|NCT02435368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102021378|NCT02435368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102021379|NCT02435368|Antitubercular Agents|antitubercular agents|mesh-ancestor
102021380|NCT02435368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102021381|NCT02435368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102021382|NCT02435368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102021383|NCT02435368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021384|NCT05160090|Bupropion|bupropion|mesh-list
102021385|NCT05160090|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102021386|NCT05160090|Antidepressive Agents|antidepressive agents|mesh-ancestor
102021389|NCT05160090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102021390|NCT05160090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102021391|NCT05160090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021392|NCT05160090|Dopamine Agents|dopamine agents|mesh-ancestor
102021393|NCT05160090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102021394|NCT05160090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021395|NCT05160090|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102021396|NCT05160090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102021397|NCT05160090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102021398|NCT04516616|Paclitaxel|paclitaxel|mesh-list
102021399|NCT04516616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102021400|NCT04516616|Cisplatin|cisplatin|mesh-list
102021401|NCT04516616|Antibodies|antibodies|mesh-list
102021402|NCT04516616|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102021403|NCT04516616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102021404|NCT04516616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102021405|NCT04516616|Tubulin Modulators|tubulin modulators|mesh-ancestor
102021406|NCT04516616|Antimitotic Agents|antimitotic agents|mesh-ancestor
102021407|NCT04516616|Mitosis Modulators|mitosis modulators|mesh-ancestor
102021408|NCT04516616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021409|NCT04516616|Immunologic Factors|immunologic factors|mesh-ancestor
102021410|NCT04516616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021411|NCT00511134|Eszopiclone|eszopiclone|mesh-list
102021412|NCT00511134|Bupropion|bupropion|mesh-list
102021413|NCT00511134|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101950791|NCT01290003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950792|NCT01291095|Cisplatin|cisplatin|mesh-list
101950793|NCT01291095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101950794|NCT03739203|Cariprazine|cariprazine|mesh-list
101950795|NCT03739203|Antidepressive Agents|antidepressive agents|mesh-list
101950796|NCT03739203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101950797|NCT03739203|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101950798|NCT03739203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101950799|NCT03739203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101950800|NCT03739203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021414|NCT00511134|Antidepressive Agents|antidepressive agents|mesh-ancestor
102021415|NCT00511134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102021416|NCT00511134|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102021417|NCT00511134|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102021418|NCT00511134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102021419|NCT00511134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021420|NCT00511134|Dopamine Agents|dopamine agents|mesh-ancestor
102021421|NCT00511134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102021422|NCT00511134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021423|NCT00511134|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102021424|NCT00511134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102021425|NCT00511134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102021426|NCT00511134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102021427|NCT00511134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102021428|NCT05103228|Menotropins|menotropins|mesh-list
102021429|NCT05103228|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102021430|NCT05103228|Hormones|hormones|mesh-ancestor
102021431|NCT05103228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102021432|NCT05103228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021433|NCT05103228|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102021434|NCT05103228|Fertility Agents|fertility agents|mesh-ancestor
102021435|NCT05103228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102021436|NCT01372384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102021437|NCT01372384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102021438|NCT01372384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102021439|NCT01372384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102021440|NCT01372384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021441|NCT03190798|Canagliflozin|canagliflozin|mesh-list
102021442|NCT03190798|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101741200|NCT00723411|Immunologic Factors|immunologic factors|mesh-ancestor
102021443|NCT03190798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021444|NCT03190798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102021445|NCT03190798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021446|NCT03696290|Aztreonam|aztreonam|mesh-list
102021447|NCT03696290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102021448|NCT03696290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102021449|NCT03696212|Pembrolizumab|pembrolizumab|mesh-list
102021450|NCT03696212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102021451|NCT03696212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102021452|NCT03696212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102021453|NCT03696212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021454|NCT03692546|Bupivacaine|bupivacaine|mesh-list
102021455|NCT03692546|Anesthetics, Local|anesthetics, local|mesh-ancestor
102021461|NCT03480763|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102021462|NCT03480763|Immunologic Factors|immunologic factors|mesh-ancestor
102021463|NCT03480763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021464|NCT02434822|Vaccines|vaccines|mesh-list
102021465|NCT02434822|Immunologic Factors|immunologic factors|mesh-ancestor
102021466|NCT02434822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021467|NCT01371474|Paroxetine|paroxetine|mesh-list
102021468|NCT01371474|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102021469|NCT01371474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101950801|NCT01185405|Voriconazole|voriconazole|mesh-list
101950802|NCT01185405|Antifungal Agents|antifungal agents|mesh-ancestor
101950803|NCT01185405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101950804|NCT01185405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101950805|NCT01185405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102021470|NCT01371474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102021471|NCT01371474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021472|NCT01371474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102021473|NCT01371474|Serotonin Agents|serotonin agents|mesh-ancestor
102021474|NCT01371474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021475|NCT01371474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102021476|NCT01371474|Antidepressive Agents|antidepressive agents|mesh-ancestor
102021477|NCT01371474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102021478|NCT01371474|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102021479|NCT01371474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102021480|NCT01371474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102021481|NCT03185104|Fluorides|fluorides|mesh-list
102021482|NCT03185104|Cariostatic Agents|cariostatic agents|mesh-ancestor
102021483|NCT03185104|Protective Agents|protective agents|mesh-ancestor
102021484|NCT03185104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021485|NCT01319994|Metformin|metformin|mesh-list
102021486|NCT01319994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102021487|NCT01319994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021488|NCT02430298|Melatonin|melatonin|mesh-list
102021489|NCT02430298|Antioxidants|antioxidants|mesh-ancestor
102021490|NCT02430298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021491|NCT02430298|Protective Agents|protective agents|mesh-ancestor
102021492|NCT02430298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021493|NCT02430298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102021494|NCT03626376|Valacyclovir|valacyclovir|mesh-list
102021495|NCT03626376|Acyclovir|acyclovir|mesh-list
102021496|NCT03626376|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102021497|NCT03626376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102021498|NCT03626376|Antiviral Agents|antiviral agents|mesh-ancestor
102021499|NCT03626376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102021500|NCT03695822|Mirabegron|mirabegron|mesh-list
102021501|NCT03695822|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102021502|NCT03695822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102021503|NCT03695822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102021504|NCT03695822|Adrenergic Agents|adrenergic agents|mesh-ancestor
102021505|NCT03695822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102021506|NCT03695822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021507|NCT03695822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021508|NCT03695822|Urological Agents|urological agents|mesh-ancestor
102021509|NCT03718507|Atropine|atropine|mesh-list
102021510|NCT03718507|Fentanyl|fentanyl|mesh-list
102021511|NCT03718507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102021512|NCT03718507|Narcotics|narcotics|mesh-ancestor
101387653|NCT00322660|Epinephrine|epinephrine|mesh-list
102021513|NCT03718507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102021514|NCT03718507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021515|NCT03718507|Analgesics|analgesics|mesh-ancestor
102021516|NCT03718507|Sensory System Agents|sensory system agents|mesh-ancestor
101741278|NCT00920244|Atropine|atropine|mesh-list
102021517|NCT03718507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102021518|NCT03718507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102021519|NCT03718507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102021520|NCT03718507|Anesthetics, General|anesthetics, general|mesh-ancestor
102021521|NCT03718507|Anesthetics|anesthetics|mesh-ancestor
102021522|NCT03718507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102021523|NCT03718507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102021524|NCT03718507|Autonomic Agents|autonomic agents|mesh-ancestor
102021528|NCT03718507|Parasympatholytics|parasympatholytics|mesh-ancestor
102021529|NCT03718507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102021530|NCT03718507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102021531|NCT03718507|Cholinergic Agents|cholinergic agents|mesh-ancestor
102021532|NCT03718507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102021533|NCT03718507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021534|NCT01374282|Penicillamine|penicillamine|mesh-list
102021535|NCT01374282|Antidotes|antidotes|mesh-ancestor
102021536|NCT01374282|Protective Agents|protective agents|mesh-ancestor
102021537|NCT01374282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950806|NCT01185405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101950807|NCT01185405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950808|NCT01185405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101950809|NCT01185405|Hormone Antagonists|hormone antagonists|mesh-ancestor
101950810|NCT01185405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101950811|NCT01185405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950812|NCT01185405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101950814|NCT01182129|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101950815|NCT01182129|Autonomic Agents|autonomic agents|mesh-ancestor
101950816|NCT01182129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101950817|NCT01182129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950818|NCT01182129|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101950819|NCT01182129|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101950820|NCT01182129|Cholinergic Agents|cholinergic agents|mesh-ancestor
101950821|NCT01182129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101950822|NCT01182129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950823|NCT01587729|Antidepressive Agents|antidepressive agents|mesh-list
101950824|NCT01587729|Serotonin|serotonin|mesh-list
102021538|NCT01374282|Chelating Agents|chelating agents|mesh-ancestor
102021539|NCT01374282|Sequestering Agents|sequestering agents|mesh-ancestor
102021540|NCT01374282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021541|NCT01374282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102021542|NCT03691922|Epinephrine|epinephrine|mesh-list
102021543|NCT03691922|Racepinephrine|racepinephrine|mesh-list
102021544|NCT03691922|Bupivacaine|bupivacaine|mesh-list
102021545|NCT03691922|Epinephryl borate|epinephryl borate|mesh-list
102021546|NCT03691922|Anesthetics, Local|anesthetics, local|mesh-ancestor
102021547|NCT03691922|Anesthetics|anesthetics|mesh-ancestor
102021548|NCT03691922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102021549|NCT03691922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021550|NCT03691922|Sensory System Agents|sensory system agents|mesh-ancestor
102021551|NCT03691922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102021552|NCT03691922|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102021553|NCT03691922|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102021554|NCT03691922|Adrenergic Agents|adrenergic agents|mesh-ancestor
102021555|NCT03691922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102021556|NCT03691922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021557|NCT03691922|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102021558|NCT03691922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102021559|NCT03691922|Autonomic Agents|autonomic agents|mesh-ancestor
102021560|NCT03691922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101387654|NCT00322660|Racepinephrine|racepinephrine|mesh-list
102021561|NCT03691922|Respiratory System Agents|respiratory system agents|mesh-ancestor
102021562|NCT03691922|Mydriatics|mydriatics|mesh-ancestor
102021563|NCT03691922|Sympathomimetics|sympathomimetics|mesh-ancestor
102021564|NCT03691922|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102021565|NCT03453151|Anesthetics|anesthetics|mesh-list
102021566|NCT03453151|Anesthetics, Local|anesthetics, local|mesh-list
102021567|NCT03453151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102021568|NCT03453151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021569|NCT03453151|Sensory System Agents|sensory system agents|mesh-ancestor
102021570|NCT03453151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102021571|NCT03433248|Empagliflozin|empagliflozin|mesh-list
102021572|NCT03433248|Gliclazide|gliclazide|mesh-list
102021573|NCT03433248|Linagliptin|linagliptin|mesh-list
102021574|NCT03433248|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101950825|NCT01587729|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
101950827|NCT01587729|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101283564|NCT01915069|Cilostazol|cilostazol|mesh-list
102021575|NCT03433248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021576|NCT03433248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102021577|NCT03433248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021578|NCT03433248|Incretins|incretins|mesh-ancestor
102021579|NCT03433248|Hormones|hormones|mesh-ancestor
102021580|NCT03433248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102021581|NCT03433248|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102021582|NCT03433248|Protease Inhibitors|protease inhibitors|mesh-ancestor
102021583|NCT03433248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102021584|NCT03691688|Aspirin|aspirin|mesh-list
102021585|NCT03691688|Clopidogrel|clopidogrel|mesh-list
102021586|NCT03691688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102021587|NCT03691688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102021588|NCT03691688|Analgesics|analgesics|mesh-ancestor
102021589|NCT03691688|Sensory System Agents|sensory system agents|mesh-ancestor
102021590|NCT03691688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101741356|NCT00724035|GABA Modulators|gaba modulators|mesh-ancestor
102021591|NCT03691688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021592|NCT03691688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102021593|NCT03691688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102021594|NCT03691688|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102021595|NCT03691688|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101628296|NCT02590705|Anesthetics, Local|anesthetics, local|mesh-ancestor
102021601|NCT03691688|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102021602|NCT03691688|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102021604|NCT03691688|Purinergic Agents|purinergic agents|mesh-ancestor
102021605|NCT03691688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102021607|NCT02887248|Gemcitabine|gemcitabine|mesh-list
102021608|NCT02887248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102021609|NCT02887248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102021610|NCT02887248|Tubulin Modulators|tubulin modulators|mesh-ancestor
102021611|NCT02887248|Antimitotic Agents|antimitotic agents|mesh-ancestor
102021612|NCT02887248|Mitosis Modulators|mitosis modulators|mesh-ancestor
102021613|NCT02887248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021614|NCT02887248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102021615|NCT02887248|Antimetabolites|antimetabolites|mesh-ancestor
102021616|NCT02425462|Dienogest|dienogest|mesh-list
102021617|NCT02425462|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102021618|NCT02425462|Contraceptive Agents|contraceptive agents|mesh-ancestor
102021619|NCT02425462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102021620|NCT02425462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021621|NCT02425462|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101523725|NCT01186744|Tofacitinib|tofacitinib|mesh-list
102021622|NCT02425462|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102021623|NCT02425462|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102021624|NCT02425462|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102021625|NCT02425462|Hormone Antagonists|hormone antagonists|mesh-ancestor
102021626|NCT02425462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102021627|NCT02425462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102021628|NCT02425462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102021629|NCT03452527|Aflibercept|aflibercept|mesh-list
102021630|NCT03452527|Immunoconjugates|immunoconjugates|mesh-list
102021631|NCT03452527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102021632|NCT03452527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102021633|NCT03452527|Growth Substances|growth substances|mesh-ancestor
102021634|NCT03452527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021635|NCT03452527|Growth Inhibitors|growth inhibitors|mesh-ancestor
102021636|NCT03452527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102021637|NCT03452527|Immunologic Factors|immunologic factors|mesh-ancestor
102021638|NCT04878510|Dexmedetomidine|dexmedetomidine|mesh-list
102021639|NCT04878510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102021640|NCT04878510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102021641|NCT04878510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021642|NCT04878510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102021643|NCT04878510|Analgesics|analgesics|mesh-ancestor
102021644|NCT04878510|Sensory System Agents|sensory system agents|mesh-ancestor
102021645|NCT04878510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101950828|NCT01587729|Serotonin Agents|serotonin agents|mesh-ancestor
101950829|NCT01587729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101950830|NCT01587729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021646|NCT04878510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102021647|NCT04878510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102021648|NCT04878510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102021649|NCT04878510|Adrenergic Agents|adrenergic agents|mesh-ancestor
102021650|NCT04878510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102021651|NCT04878510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021652|NCT03028142|Tiotropium Bromide|tiotropium bromide|mesh-list
102021653|NCT03028142|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102021654|NCT03028142|Autonomic Agents|autonomic agents|mesh-ancestor
102021655|NCT03028142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102021656|NCT03028142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021657|NCT03028142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102021658|NCT03028142|Respiratory System Agents|respiratory system agents|mesh-ancestor
102021659|NCT03028142|Parasympatholytics|parasympatholytics|mesh-ancestor
102021660|NCT03028142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102021661|NCT03028142|Cholinergic Agents|cholinergic agents|mesh-ancestor
102021662|NCT03028142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101628297|NCT02590705|Anesthetics|anesthetics|mesh-ancestor
102021681|NCT03715777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021682|NCT03715777|Cholinergic Agents|cholinergic agents|mesh-ancestor
102021683|NCT03715777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102021684|NCT03715699|Prednisone|prednisone|mesh-list
102021685|NCT03715699|Leflunomide|leflunomide|mesh-list
102021686|NCT03715699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102021687|NCT03715699|Glucocorticoids|glucocorticoids|mesh-ancestor
102021688|NCT03715699|Hormones|hormones|mesh-ancestor
102021689|NCT03715699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102021690|NCT03715699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021691|NCT03715699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102021692|NCT03715699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102021693|NCT03715699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102021694|NCT03715699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021695|NCT03715699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102021696|NCT03715699|Immunologic Factors|immunologic factors|mesh-ancestor
102021697|NCT04776408|Nitric Oxide|nitric oxide|mesh-list
102021698|NCT04776408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102021699|NCT04776408|Autonomic Agents|autonomic agents|mesh-ancestor
102021700|NCT04776408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102021701|NCT04776408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021702|NCT04776408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102021703|NCT04776408|Respiratory System Agents|respiratory system agents|mesh-ancestor
102021704|NCT04776408|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102021705|NCT04776408|Antioxidants|antioxidants|mesh-ancestor
102021706|NCT04776408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021707|NCT04776408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102021708|NCT04776408|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102021709|NCT04776408|Vasodilator Agents|vasodilator agents|mesh-ancestor
102021710|NCT04776408|Gasotransmitters|gasotransmitters|mesh-ancestor
102021711|NCT04776408|Protective Agents|protective agents|mesh-ancestor
102021712|NCT02429596|Lamotrigine|lamotrigine|mesh-list
102021713|NCT02429596|Carbamazepine|carbamazepine|mesh-list
102021714|NCT02429596|Anticonvulsants|anticonvulsants|mesh-ancestor
102021715|NCT02429596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102021716|NCT02429596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102021719|NCT02429596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021720|NCT02429596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102021721|NCT02429596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102021722|NCT02429596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102021723|NCT02429596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102021724|NCT02429596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102021725|NCT02429596|Antimanic Agents|antimanic agents|mesh-ancestor
102021726|NCT02429596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102021728|NCT02429596|Sensory System Agents|sensory system agents|mesh-ancestor
102021729|NCT02429596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102021730|NCT02429596|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102021731|NCT02429596|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102021732|NCT03418675|Brexpiprazole|brexpiprazole|mesh-list
102021733|NCT03418675|Serotonin Agents|serotonin agents|mesh-ancestor
101950832|NCT01587729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101283704|NCT01916174|Incretins|incretins|mesh-ancestor
102021734|NCT03418675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102021735|NCT03418675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021736|NCT03418675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021737|NCT03418675|Dopamine Agonists|dopamine agonists|mesh-ancestor
102021739|NCT02653092|Heparin|heparin|mesh-list
102021740|NCT02653092|Anticoagulants|anticoagulants|mesh-list
102021741|NCT02653092|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102021742|NCT02653092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102021743|NCT02653092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102021744|NCT02653092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021745|NCT02653092|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102021746|NCT02653092|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102021747|NCT02653092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102021748|NCT03691454|Docetaxel|docetaxel|mesh-list
102021749|NCT03691454|Oxaliplatin|oxaliplatin|mesh-list
102021750|NCT03691454|Trastuzumab|trastuzumab|mesh-list
102021751|NCT03691454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102021752|NCT03691454|Tubulin Modulators|tubulin modulators|mesh-ancestor
102021753|NCT03691454|Antimitotic Agents|antimitotic agents|mesh-ancestor
102021754|NCT03691454|Mitosis Modulators|mitosis modulators|mesh-ancestor
102021755|NCT03691454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021756|NCT03691454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102021757|NCT03718273|Digoxin|digoxin|mesh-list
102021758|NCT03718273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102021759|NCT03718273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102021760|NCT03718273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102021761|NCT03718273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021762|NCT03718273|Protective Agents|protective agents|mesh-ancestor
102021763|NCT03718273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021764|NCT02421640|Cisplatin|cisplatin|mesh-list
102021765|NCT02421640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102021766|NCT03715387|Bacitracin|bacitracin|mesh-list
102021767|NCT03715387|Polymyxin B|polymyxin b|mesh-list
102021768|NCT03715387|Tacrolimus|tacrolimus|mesh-list
102021769|NCT03715387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102021770|NCT03715387|Immunologic Factors|immunologic factors|mesh-ancestor
102021771|NCT03715387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021772|NCT03715387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102021773|NCT03715387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102021774|NCT03715387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021775|NCT03715387|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102021776|NCT03715387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102021777|NCT03715387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102021778|NCT03715309|Lenalidomide|lenalidomide|mesh-list
102021779|NCT03715309|Immunologic Factors|immunologic factors|mesh-ancestor
102021780|NCT03715309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021781|NCT03715309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102021782|NCT03715309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102021783|NCT03715309|Growth Substances|growth substances|mesh-ancestor
102021784|NCT03715309|Growth Inhibitors|growth inhibitors|mesh-ancestor
102021785|NCT03715309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102021786|NCT03179254|Metformin|metformin|mesh-list
102021787|NCT03179254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102021788|NCT03179254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021789|NCT04147715|Dolutegravir|dolutegravir|mesh-list
102021803|NCT04147715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102021804|NCT04147715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021805|NCT04147715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102021806|NCT04147715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102021807|NCT04147715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102021808|NCT04147715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102021809|NCT04147715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102021810|NCT04147715|Antiviral Agents|antiviral agents|mesh-ancestor
102021811|NCT04147715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102021812|NCT02420938|Rituximab|rituximab|mesh-list
102021813|NCT02420938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102021814|NCT02420938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102021815|NCT02420938|Immunologic Factors|immunologic factors|mesh-ancestor
102021816|NCT02420938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021817|NCT02420938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101950833|NCT01587729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101950834|NCT03855267|Propofol|propofol|mesh-list
101950835|NCT03855267|Etomidate|etomidate|mesh-list
101950836|NCT03855267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101950837|NCT03855267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102021818|NCT02429440|Molgramostim|molgramostim|mesh-list
102021819|NCT02429440|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
102021820|NCT02429440|Sargramostim|sargramostim|mesh-list
102021821|NCT02429440|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102021822|NCT02429440|Immunologic Factors|immunologic factors|mesh-ancestor
102021823|NCT02429440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021824|NCT02429440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102021825|NCT02429518|Miltefosine|miltefosine|mesh-list
102021826|NCT02429518|Antifungal Agents|antifungal agents|mesh-ancestor
102021827|NCT02429518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102021828|NCT02429518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102021829|NCT02429518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102021830|NCT02429518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102021831|NCT00708526|Anesthetics|anesthetics|mesh-list
102021832|NCT00708526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102021833|NCT00708526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021834|NCT03712735|Fentanyl|fentanyl|mesh-list
102021835|NCT03712735|Bupivacaine|bupivacaine|mesh-list
102021836|NCT03712735|Anesthetics, Local|anesthetics, local|mesh-ancestor
102021837|NCT03712735|Anesthetics|anesthetics|mesh-ancestor
102021838|NCT03712735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102021839|NCT03712735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021840|NCT03712735|Sensory System Agents|sensory system agents|mesh-ancestor
102021841|NCT03712735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102021842|NCT03712735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102021843|NCT03712735|Narcotics|narcotics|mesh-ancestor
102021844|NCT03712735|Analgesics|analgesics|mesh-ancestor
102021845|NCT03712735|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102021846|NCT03712735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102021847|NCT03712735|Anesthetics, General|anesthetics, general|mesh-ancestor
102021848|NCT03182218|Heparin|heparin|mesh-list
102021849|NCT03182218|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102021850|NCT03182218|Tinzaparin|tinzaparin|mesh-list
102021851|NCT03182218|Dalteparin|dalteparin|mesh-list
102021852|NCT03182218|Anticoagulants|anticoagulants|mesh-list
102021853|NCT03182218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102021854|NCT03182218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102021855|NCT03182218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021864|NCT02452554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021865|NCT02452554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102021866|NCT02452554|Immunotoxins|immunotoxins|mesh-ancestor
102021867|NCT02452554|Immunoconjugates|immunoconjugates|mesh-ancestor
102021868|NCT02452554|Immunologic Factors|immunologic factors|mesh-ancestor
102021869|NCT02452554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021870|NCT03182296|Exenatide|exenatide|mesh-list
102021871|NCT03182296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102021872|NCT03182296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021873|NCT03182296|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102021874|NCT03182296|Incretins|incretins|mesh-ancestor
102021875|NCT03182296|Hormones|hormones|mesh-ancestor
102021876|NCT03182296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102021878|NCT03182374|Viscosupplements|viscosupplements|mesh-ancestor
102021879|NCT03182374|Protective Agents|protective agents|mesh-ancestor
102021880|NCT03182374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021881|NCT01319682|Lidocaine|lidocaine|mesh-list
102021882|NCT01319682|Anesthetics, Local|anesthetics, local|mesh-ancestor
102021883|NCT01319682|Anesthetics|anesthetics|mesh-ancestor
102021884|NCT01319682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102021885|NCT01319682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021886|NCT01319682|Sensory System Agents|sensory system agents|mesh-ancestor
102021887|NCT01319682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102021888|NCT01319682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102021889|NCT01319682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102021890|NCT01319682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102021891|NCT01319682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102021892|NCT01319682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021893|NCT04009577|Lemborexant|lemborexant|mesh-list
101950838|NCT03855267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021894|NCT04009577|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102021895|NCT04009577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102021896|NCT04009577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523780|NCT02912702|Dexamethasone|dexamethasone|mesh-list
102021897|NCT04009577|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102021898|NCT04009577|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102021899|NCT04009577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102021900|NCT04009577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021901|NCT02176668|Esomeprazole|esomeprazole|mesh-list
102021902|NCT02176668|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102021903|NCT02176668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102021904|NCT02176668|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102021905|NCT02176668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102021906|NCT02176668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021907|NCT03712423|Docetaxel|docetaxel|mesh-list
102021908|NCT03712423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102021909|NCT03712423|Tubulin Modulators|tubulin modulators|mesh-ancestor
102021910|NCT03712423|Antimitotic Agents|antimitotic agents|mesh-ancestor
102021911|NCT03712423|Mitosis Modulators|mitosis modulators|mesh-ancestor
102021912|NCT03712423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021913|NCT04620252|Calcium, Dietary|calcium, dietary|mesh-list
102021914|NCT04620252|Calcium Carbonate|calcium carbonate|mesh-list
102021915|NCT04620252|Citric Acid|citric acid|mesh-list
102021916|NCT04620252|Sodium Citrate|sodium citrate|mesh-list
102021917|NCT04620252|Calcium|calcium|mesh-list
102021918|NCT04620252|Fluorides|fluorides|mesh-list
102021919|NCT04620252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102021920|NCT04620252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021921|NCT04620252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102021922|NCT04620252|Anticoagulants|anticoagulants|mesh-ancestor
102021929|NCT04620252|Antacids|antacids|mesh-ancestor
102021930|NCT04620252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102021931|NCT03694886|Caffeine|caffeine|mesh-list
102021932|NCT03694886|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102021933|NCT03694886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021934|NCT03694886|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102021935|NCT03694886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102021936|NCT03694886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021937|NCT03694886|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102021938|NCT03694886|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102021939|NCT03694886|Purinergic Agents|purinergic agents|mesh-ancestor
102021940|NCT03694886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102021941|NCT05602675|Repaglinide|repaglinide|mesh-list
102021942|NCT05602675|Methotrexate|methotrexate|mesh-list
102021943|NCT05602675|Midazolam|midazolam|mesh-list
102021944|NCT05602675|Dextromethorphan|dextromethorphan|mesh-list
102021945|NCT05602675|Warfarin|warfarin|mesh-list
102021946|NCT05602675|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102021947|NCT05602675|Abortifacient Agents|abortifacient agents|mesh-ancestor
102021948|NCT05602675|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102021949|NCT05602675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021950|NCT05602675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102021951|NCT05602675|Antimetabolites|antimetabolites|mesh-ancestor
102021952|NCT05602675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021953|NCT05602675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102021954|NCT05602675|Dermatologic Agents|dermatologic agents|mesh-ancestor
102021955|NCT05602675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102021956|NCT05602675|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102021957|NCT05602675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102021958|NCT05602675|Immunologic Factors|immunologic factors|mesh-ancestor
102021959|NCT05602675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102021960|NCT05602675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102021961|NCT05602675|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102021962|NCT05602675|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102021963|NCT05602675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102021964|NCT05602675|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102021965|NCT05602675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102021966|NCT05602675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102021967|NCT05602675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102021968|NCT05602675|Anesthetics, General|anesthetics, general|mesh-ancestor
102021969|NCT05602675|Anesthetics|anesthetics|mesh-ancestor
102021970|NCT05602675|GABA Modulators|gaba modulators|mesh-ancestor
102021971|NCT05602675|GABA Agents|gaba agents|mesh-ancestor
102021972|NCT05602675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102021973|NCT05602675|Anticoagulants|anticoagulants|mesh-ancestor
101950839|NCT03855267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101950840|NCT03855267|Anesthetics, General|anesthetics, general|mesh-ancestor
101950841|NCT03855267|Anesthetics|anesthetics|mesh-ancestor
101950842|NCT01185873|Ritonavir|ritonavir|mesh-list
101950843|NCT01185873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102021974|NCT05602675|Antitussive Agents|antitussive agents|mesh-ancestor
102021975|NCT05602675|Respiratory System Agents|respiratory system agents|mesh-ancestor
102021976|NCT05602675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102021977|NCT05602675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102021978|NCT05602675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102021979|NCT03714685|Firibastat|firibastat|mesh-list
102021980|NCT03714685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102021981|NCT02705716|Fluorides|fluorides|mesh-list
102021982|NCT02705716|Tin Fluorides|tin fluorides|mesh-list
102021983|NCT02705716|Fluorophosphate|fluorophosphate|mesh-list
102021984|NCT02705716|Cariostatic Agents|cariostatic agents|mesh-ancestor
102021985|NCT02705716|Protective Agents|protective agents|mesh-ancestor
102021986|NCT02705716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021987|NCT02429050|Morphine|morphine|mesh-list
102021988|NCT02429050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102021989|NCT02429050|Narcotics|narcotics|mesh-ancestor
102021990|NCT02429050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102021991|NCT02429050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021992|NCT02429050|Analgesics|analgesics|mesh-ancestor
102021993|NCT02429050|Sensory System Agents|sensory system agents|mesh-ancestor
102022007|NCT01374750|Immunologic Factors|immunologic factors|mesh-ancestor
102022008|NCT01374750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022009|NCT01374750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102022010|NCT01374750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102022011|NCT01374750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022012|NCT01374750|Antifungal Agents|antifungal agents|mesh-ancestor
102022013|NCT01374750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102022014|NCT01374750|Dermatologic Agents|dermatologic agents|mesh-ancestor
102022015|NCT01374750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102022016|NCT01374750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102022017|NCT01374750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102022018|NCT01374750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102022019|NCT03182140|Levonorgestrel|levonorgestrel|mesh-list
102022020|NCT03182140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102022021|NCT03182140|Contraceptive Agents|contraceptive agents|mesh-ancestor
102022022|NCT03182140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102022023|NCT03182140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022024|NCT03182140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102022025|NCT03182140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102022026|NCT03182140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102022027|NCT01374828|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102022028|NCT01374828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102022029|NCT01374828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102022030|NCT01374828|Analgesics|analgesics|mesh-ancestor
102022031|NCT01374828|Sensory System Agents|sensory system agents|mesh-ancestor
102022032|NCT01374828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102022033|NCT01374828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022034|NCT01374828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102022035|NCT01374828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102022036|NCT01374828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102022037|NCT01374828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102022038|NCT01374828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022039|NCT03634332|Pembrolizumab|pembrolizumab|mesh-list
102022040|NCT03634332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102022041|NCT03634332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102022042|NCT03634332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102022043|NCT03634332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022045|NCT03744767|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101523806|NCT02010333|Benzyl Alcohol|benzyl alcohol|mesh-list
102022046|NCT03744767|Hormone Antagonists|hormone antagonists|mesh-ancestor
102022047|NCT03744767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102022048|NCT03744767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022049|NCT03744767|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102022050|NCT03744767|Diuretics|diuretics|mesh-ancestor
102022051|NCT03744767|Natriuretic Agents|natriuretic agents|mesh-ancestor
102022052|NCT02428972|Propofol|propofol|mesh-list
102022053|NCT02428972|Sevoflurane|sevoflurane|mesh-list
101950844|NCT01185873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101950845|NCT01185873|Protease Inhibitors|protease inhibitors|mesh-ancestor
101950846|NCT01185873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102022054|NCT02428972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102022055|NCT02428972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101477043|NCT00282165|Naratriptan|naratriptan|mesh-list
102022060|NCT02428972|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102022061|NCT02428972|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102022062|NCT03699332|Labetuzumab|labetuzumab|mesh-list
102022063|NCT03699332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102022064|NCT03699332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102022065|NCT03389893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102022066|NCT03389893|Immunologic Factors|immunologic factors|mesh-ancestor
102022067|NCT03389893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022068|NCT03178708|Amantadine|amantadine|mesh-list
102022069|NCT03178708|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102022070|NCT03178708|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102022071|NCT03178708|Antiviral Agents|antiviral agents|mesh-ancestor
102022072|NCT03178708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102022073|NCT03178708|Dopamine Agents|dopamine agents|mesh-ancestor
102022074|NCT03178708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102022075|NCT03178708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022076|NCT03178708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022077|NCT03178708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102022078|NCT03178708|Analgesics|analgesics|mesh-ancestor
102022079|NCT03178708|Sensory System Agents|sensory system agents|mesh-ancestor
102022080|NCT03178708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102022081|NCT00787176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102022082|NCT00787176|Oxytocin|oxytocin|mesh-list
102022083|NCT00787176|Oxytocics|oxytocics|mesh-ancestor
102022084|NCT00787176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102022085|NCT00787176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022086|NCT03744689|Bupivacaine|bupivacaine|mesh-list
102022087|NCT03744689|Anesthetics, Local|anesthetics, local|mesh-ancestor
102022088|NCT03744689|Anesthetics|anesthetics|mesh-ancestor
102022089|NCT03744689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102022090|NCT03744689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022091|NCT03744689|Sensory System Agents|sensory system agents|mesh-ancestor
102022092|NCT03744689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102022093|NCT02424214|Ionophores|ionophores|mesh-list
102022094|NCT02424214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102022095|NCT02424214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022096|NCT03712111|Norepinephrine|norepinephrine|mesh-list
102022097|NCT03712111|Bupivacaine|bupivacaine|mesh-list
102022098|NCT03712111|Anesthetics, Local|anesthetics, local|mesh-ancestor
102022099|NCT03712111|Anesthetics|anesthetics|mesh-ancestor
102022100|NCT03712111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102022101|NCT03712111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022102|NCT03712111|Sensory System Agents|sensory system agents|mesh-ancestor
102022103|NCT03712111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102022104|NCT03712111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102022105|NCT03712111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102022106|NCT03712111|Adrenergic Agents|adrenergic agents|mesh-ancestor
102022107|NCT03712111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102022108|NCT03712111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022109|NCT03712111|Sympathomimetics|sympathomimetics|mesh-ancestor
102022110|NCT03712111|Autonomic Agents|autonomic agents|mesh-ancestor
102022111|NCT03712111|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102022112|NCT02925494|Norethindrone|norethindrone|mesh-list
101523813|NCT02008344|Favipiravir|favipiravir|mesh-list
102022113|NCT02925494|Norethindrone Acetate|norethindrone acetate|mesh-list
102022114|NCT02925494|Estradiol|estradiol|mesh-list
102022115|NCT02925494|Estrogens|estrogens|mesh-ancestor
102022116|NCT02925494|Hormones|hormones|mesh-ancestor
102022117|NCT02925494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102022118|NCT02925494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022119|NCT02925494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102022120|NCT02925494|Contraceptive Agents|contraceptive agents|mesh-ancestor
102022121|NCT02925494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102022122|NCT02925494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102022123|NCT02925494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102022124|NCT02925494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102022125|NCT02925494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102022126|NCT03717415|Carboplatin|carboplatin|mesh-list
101950847|NCT01185873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950848|NCT01185873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101950849|NCT01185873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101950850|NCT01185873|Antiviral Agents|antiviral agents|mesh-ancestor
101950851|NCT01185873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101284063|NCT01917799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102022127|NCT03717415|Rebastinib|rebastinib|mesh-list
102022151|NCT04207710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102022152|NCT04207710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022153|NCT04207710|Sensory System Agents|sensory system agents|mesh-ancestor
102022154|NCT04207710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102022155|NCT03119610|Oxytocin|oxytocin|mesh-list
102022156|NCT03119610|Oxytocics|oxytocics|mesh-ancestor
102022157|NCT03119610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102022158|NCT03119610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022159|NCT01373736|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
102022160|NCT01373736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102022161|NCT01373736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102022162|NCT01373736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022163|NCT01373736|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102022164|NCT03401749|Chlorhexidine|chlorhexidine|mesh-list
102022165|NCT03401749|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102022166|NCT03401749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102022167|NCT03401749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102022168|NCT03401749|Disinfectants|disinfectants|mesh-ancestor
102022169|NCT03401749|Dermatologic Agents|dermatologic agents|mesh-ancestor
102022170|NCT03689114|Topiramate|topiramate|mesh-list
102022171|NCT03689114|Lamotrigine|lamotrigine|mesh-list
102022172|NCT03689114|Zonisamide|zonisamide|mesh-list
102022173|NCT03689114|Carbamazepine|carbamazepine|mesh-list
102022174|NCT03689114|Oxcarbazepine|oxcarbazepine|mesh-list
102022175|NCT03689114|Gabapentin|gabapentin|mesh-list
102022176|NCT03689114|Levetiracetam|levetiracetam|mesh-list
102022177|NCT03689114|Anticonvulsants|anticonvulsants|mesh-list
102022178|NCT03689114|Valproic Acid|valproic acid|mesh-list
102022179|NCT03689114|Analgesics|analgesics|mesh-ancestor
102022180|NCT03689114|Sensory System Agents|sensory system agents|mesh-ancestor
102022181|NCT03689114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101477176|NCT00273533|Ramipril|ramipril|mesh-list
102022184|NCT03689114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102022185|NCT03689114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102022186|NCT03689114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102022187|NCT03689114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102022188|NCT03689114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102022189|NCT03689114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102022190|NCT03689114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022191|NCT03689114|Antimanic Agents|antimanic agents|mesh-ancestor
102022192|NCT03689114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102022193|NCT03689114|Nootropic Agents|nootropic agents|mesh-ancestor
102022194|NCT03689114|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102022195|NCT03689114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102022196|NCT03689114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102022197|NCT03689114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102022198|NCT03689114|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102022199|NCT03689114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102022200|NCT03689114|GABA Agents|gaba agents|mesh-ancestor
102022201|NCT03689114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102022202|NCT03689114|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102022203|NCT03689114|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102022204|NCT03689114|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102022205|NCT02952001|Triamcinolone|triamcinolone|mesh-list
102022206|NCT02952001|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102022207|NCT02952001|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102022208|NCT02952001|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102022209|NCT02952001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102022210|NCT02952001|Glucocorticoids|glucocorticoids|mesh-ancestor
102022211|NCT02952001|Hormones|hormones|mesh-ancestor
102022212|NCT02952001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102022213|NCT02952001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022214|NCT02952001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102022215|NCT02952001|Immunologic Factors|immunologic factors|mesh-ancestor
102022216|NCT02952001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102022217|NCT02952001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022218|NCT04050176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
102022219|NCT04050176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102022220|NCT04050176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022221|NCT01311739|Vitamin B 12|vitamin b 12|mesh-list
102022222|NCT01311739|Hydroxocobalamin|hydroxocobalamin|mesh-list
102022223|NCT01311739|Vitamin B Complex|vitamin b complex|mesh-ancestor
102022224|NCT01311739|Vitamins|vitamins|mesh-ancestor
102022225|NCT01311739|Micronutrients|micronutrients|mesh-ancestor
102022226|NCT01311739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022227|NCT01311739|Hematinics|hematinics|mesh-ancestor
102022228|NCT05507359|Benzocaine|benzocaine|mesh-list
102022229|NCT05507359|Anesthetics, Local|anesthetics, local|mesh-ancestor
102022230|NCT05507359|Anesthetics|anesthetics|mesh-ancestor
102022231|NCT05507359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102022232|NCT05507359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022233|NCT05507359|Sensory System Agents|sensory system agents|mesh-ancestor
102022234|NCT05507359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102022235|NCT04123067|Pioglitazone|pioglitazone|mesh-list
102022236|NCT04123067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102022237|NCT04123067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022238|NCT03703050|Nivolumab|nivolumab|mesh-list
102022239|NCT03703050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102022240|NCT03703050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102022241|NCT03703050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102022242|NCT03703050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022244|NCT03688958|Cadexomer iodine|cadexomer iodine|mesh-list
102022245|NCT03688958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102022246|NCT03688958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102022247|NCT03688958|Trace Elements|trace elements|mesh-ancestor
102022248|NCT03688958|Micronutrients|micronutrients|mesh-ancestor
102022249|NCT03688958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022250|NCT04117607|Rezafungin|rezafungin|mesh-list
102022251|NCT04117607|Antifungal Agents|antifungal agents|mesh-ancestor
102022252|NCT04117607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102022253|NCT03688568|Imatinib Mesylate|imatinib mesylate|mesh-list
101477228|NCT00273884|Amonafide|amonafide|mesh-list
102022263|NCT03693872|Dopamine Agonists|dopamine agonists|mesh-list
102022264|NCT03693872|Emetics|emetics|mesh-ancestor
102022265|NCT03693872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022266|NCT03693872|Autonomic Agents|autonomic agents|mesh-ancestor
102022267|NCT03693872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102022268|NCT03693872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102022269|NCT03693872|Dopamine Agents|dopamine agents|mesh-ancestor
102022270|NCT03693872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101575014|NCT01179516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102022271|NCT03693872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022272|NCT03693872|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102022273|NCT03693872|Sympathomimetics|sympathomimetics|mesh-ancestor
102022274|NCT03693872|Protective Agents|protective agents|mesh-ancestor
102022275|NCT03693638|Fentanyl|fentanyl|mesh-list
102022276|NCT03693638|Bupivacaine|bupivacaine|mesh-list
102022277|NCT03693638|Anesthetics, Local|anesthetics, local|mesh-ancestor
102022278|NCT03693638|Anesthetics|anesthetics|mesh-ancestor
102022279|NCT03693638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102022280|NCT03693638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022281|NCT03693638|Sensory System Agents|sensory system agents|mesh-ancestor
102022282|NCT03693638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102022283|NCT03693638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102022284|NCT03693638|Narcotics|narcotics|mesh-ancestor
102022285|NCT03693638|Analgesics|analgesics|mesh-ancestor
102022286|NCT03693638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102022287|NCT03693638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102022288|NCT03693638|Anesthetics, General|anesthetics, general|mesh-ancestor
102022289|NCT04112303|Sofosbuvir|sofosbuvir|mesh-list
102022290|NCT04112303|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102022291|NCT04112303|Antiviral Agents|antiviral agents|mesh-ancestor
102022292|NCT04112303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102022293|NCT01319838|Isotretinoin|isotretinoin|mesh-list
102022294|NCT01319838|Dermatologic Agents|dermatologic agents|mesh-ancestor
102022295|NCT05191914|Fulvestrant|fulvestrant|mesh-list
102022296|NCT05191914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102022297|NCT05191914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102022298|NCT05191914|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101950852|NCT01185873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101950853|NCT01185873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101950854|NCT01182597|Pantoprazole|pantoprazole|mesh-list
101950855|NCT01182597|Lansoprazole|lansoprazole|mesh-list
101950856|NCT01182597|Dexlansoprazole|dexlansoprazole|mesh-list
101950857|NCT01182597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101950858|NCT01182597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101950859|NCT01182597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102022299|NCT05191914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102022300|NCT05191914|Hormone Antagonists|hormone antagonists|mesh-ancestor
102022301|NCT05191914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102022302|NCT05191914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022303|NCT04060394|Prednisone|prednisone|mesh-list
102022304|NCT04060394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102022305|NCT04060394|Glucocorticoids|glucocorticoids|mesh-ancestor
102022306|NCT04060394|Hormones|hormones|mesh-ancestor
102022307|NCT04060394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102022308|NCT04060394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022309|NCT04060394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102022310|NCT04060394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102022311|NCT04099277|Pembrolizumab|pembrolizumab|mesh-list
102022312|NCT04099277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102022313|NCT04099277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102022314|NCT04099277|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102022315|NCT04099277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022316|NCT03743987|Pemetrexed|pemetrexed|mesh-list
102022317|NCT03743987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102022318|NCT03743987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102022320|NCT03743987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102022321|NCT03743987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102022322|NCT03693326|Spartalizumab|spartalizumab|mesh-list
102022323|NCT03693326|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102022324|NCT03693326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022325|NCT03693326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102022326|NCT03693326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102022327|NCT03988907|Midazolam|midazolam|mesh-list
102022328|NCT03988907|Risdiplam|risdiplam|mesh-list
102022329|NCT03988907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102022330|NCT03988907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102022331|NCT03988907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102022332|NCT03988907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022333|NCT03988907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102022334|NCT03988907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102022335|NCT03988907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102022336|NCT03988907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102022337|NCT03988907|Anesthetics, General|anesthetics, general|mesh-ancestor
102022338|NCT03988907|Anesthetics|anesthetics|mesh-ancestor
102022339|NCT03988907|GABA Modulators|gaba modulators|mesh-ancestor
102022340|NCT03988907|GABA Agents|gaba agents|mesh-ancestor
102022341|NCT03988907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102022342|NCT03988907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022343|NCT03988907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102022344|NCT03988907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101742111|NCT00737373|Vitamins|vitamins|mesh-ancestor
102022345|NCT03693248|Paclitaxel|paclitaxel|mesh-list
102022346|NCT03693248|Carboplatin|carboplatin|mesh-list
102022347|NCT03693248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102022348|NCT03693248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102022349|NCT03693248|Tubulin Modulators|tubulin modulators|mesh-ancestor
102022350|NCT03693248|Antimitotic Agents|antimitotic agents|mesh-ancestor
102022351|NCT03693248|Mitosis Modulators|mitosis modulators|mesh-ancestor
102022352|NCT03693248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022353|NCT03987191|Insulin|insulin|mesh-list
102022354|NCT03987191|Insulin Aspart|insulin aspart|mesh-list
102022355|NCT03987191|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
102022356|NCT03987191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102022357|NCT03987191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950860|NCT01182597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101950861|NCT01182597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950862|NCT01185951|Polidocanol|polidocanol|mesh-list
101950863|NCT01185951|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102022358|NCT01373970|Pantoprazole|pantoprazole|mesh-list
102022359|NCT01373970|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102022360|NCT01373970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102022361|NCT01373970|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102022362|NCT01373970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102022363|NCT01373970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022364|NCT04050098|Metformin|metformin|mesh-list
102022365|NCT04050098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102022366|NCT04050098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022367|NCT03745625|Propofol|propofol|mesh-list
102022368|NCT03745625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102022369|NCT03745625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102022370|NCT03745625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022371|NCT03745625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102022372|NCT03745625|Anesthetics, General|anesthetics, general|mesh-ancestor
102022373|NCT03745625|Anesthetics|anesthetics|mesh-ancestor
102022374|NCT03698630|Dexamethasone|dexamethasone|mesh-list
102022375|NCT03698630|Prednisolone|prednisolone|mesh-list
102022376|NCT03698630|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102022377|NCT03698630|Methylprednisolone|methylprednisolone|mesh-list
102022378|NCT03698630|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102022379|NCT03698630|Prednisolone acetate|prednisolone acetate|mesh-list
102022380|NCT03698630|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102022381|NCT03698630|Prednisolone phosphate|prednisolone phosphate|mesh-list
102022382|NCT03698630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102022383|NCT03698630|Antiemetics|antiemetics|mesh-ancestor
102022384|NCT03698630|Autonomic Agents|autonomic agents|mesh-ancestor
102022385|NCT03698630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102022386|NCT03698630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022387|NCT03698630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102022388|NCT03698630|Glucocorticoids|glucocorticoids|mesh-ancestor
102022389|NCT03698630|Hormones|hormones|mesh-ancestor
102022390|NCT03698630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102022391|NCT03698630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102022396|NCT01375452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102022397|NCT01375452|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102022398|NCT01375452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102022399|NCT01375452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102022400|NCT01375452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022401|NCT01375452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102022402|NCT01375452|Hormone Antagonists|hormone antagonists|mesh-ancestor
102022403|NCT01375452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102022404|NCT01375452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022405|NCT03046836|Oxytocin|oxytocin|mesh-list
102022406|NCT03046836|Oxytocics|oxytocics|mesh-ancestor
102022407|NCT03046836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102022408|NCT03046836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022409|NCT03400033|Epoetin Alfa|epoetin alfa|mesh-list
102022410|NCT03400033|Hematinics|hematinics|mesh-ancestor
102022411|NCT05123820|Midazolam|midazolam|mesh-list
102022412|NCT05123820|Omeprazole|omeprazole|mesh-list
102022413|NCT05123820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102022414|NCT05123820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102022415|NCT05123820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102022416|NCT05123820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022417|NCT05123820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102022418|NCT05123820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102022419|NCT05123820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102022420|NCT05123820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101742222|NCT00712335|Xhance|xhance|mesh-list
102022421|NCT05123820|Anesthetics, General|anesthetics, general|mesh-ancestor
102022423|NCT05123820|GABA Modulators|gaba modulators|mesh-ancestor
102022424|NCT05123820|GABA Agents|gaba agents|mesh-ancestor
102022425|NCT05123820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102022426|NCT05123820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523888|NCT04676061|Norethindrone|norethindrone|mesh-list
102022427|NCT05123820|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102022428|NCT05123820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102022429|NCT05123820|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101950864|NCT01185951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101950865|NCT01587807|Dimercaprol|dimercaprol|mesh-list
101950866|NCT01587807|Chelating Agents|chelating agents|mesh-ancestor
101950867|NCT01587807|Sequestering Agents|sequestering agents|mesh-ancestor
101950868|NCT01587807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950869|NCT01186185|Fludrocortisone|fludrocortisone|mesh-list
101950870|NCT01186185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101950871|NCT01180179|Lansoprazole|lansoprazole|mesh-list
102022430|NCT05123820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102022431|NCT03118518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
102022432|NCT02876835|Darbepoetin alfa|darbepoetin alfa|mesh-list
102022433|NCT02876835|Hematinics|hematinics|mesh-ancestor
102022434|NCT03503318|Risperidone|risperidone|mesh-list
102022435|NCT03503318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102022436|NCT03503318|Serotonin Agents|serotonin agents|mesh-ancestor
102022437|NCT03503318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102022438|NCT03503318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022439|NCT03503318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022440|NCT03503318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102022441|NCT03503318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102022442|NCT03503318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102022443|NCT03503318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102022444|NCT03503318|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102022445|NCT03503318|Dopamine Agents|dopamine agents|mesh-ancestor
102022446|NCT01375920|Metyrapone|metyrapone|mesh-list
102022447|NCT01375920|Antimetabolites|antimetabolites|mesh-ancestor
102022448|NCT01375920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022449|NCT01375920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102022450|NCT03683108|Resveratrol|resveratrol|mesh-list
102022451|NCT03683108|Antioxidants|antioxidants|mesh-ancestor
102022452|NCT03683108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022453|NCT03683108|Protective Agents|protective agents|mesh-ancestor
102022454|NCT03683108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022455|NCT03683108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102022456|NCT03683108|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102022457|NCT05137860|Bortezomib|bortezomib|mesh-list
102022458|NCT05137860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102022459|NCT03682952|Alprostadil|alprostadil|mesh-list
102022460|NCT03682952|Beraprost|beraprost|mesh-list
102022461|NCT03682952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102022462|NCT03682952|Vasodilator Agents|vasodilator agents|mesh-ancestor
102022463|NCT03682952|Urological Agents|urological agents|mesh-ancestor
102022464|NCT03682718|Misoprostol|misoprostol|mesh-list
101477442|NCT00274508|Parasympatholytics|parasympatholytics|mesh-ancestor
102022467|NCT03682718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102022468|NCT03682718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022469|NCT03682718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102022470|NCT03682718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102022471|NCT03682718|Oxytocics|oxytocics|mesh-ancestor
102022472|NCT03682640|Insulin|insulin|mesh-list
102022473|NCT03682640|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102022474|NCT03682640|Insulin Lispro|insulin lispro|mesh-list
102022475|NCT03682640|Azithromycin|azithromycin|mesh-list
102022476|NCT03682640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102022477|NCT03682640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022478|NCT03682640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102022479|NCT03682640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102022480|NCT04084769|Vaccines|vaccines|mesh-list
102022481|NCT04084769|Immunologic Factors|immunologic factors|mesh-ancestor
102022482|NCT04084769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022483|NCT01376076|Moxifloxacin|moxifloxacin|mesh-list
102022484|NCT01376076|Risperidone|risperidone|mesh-list
102022485|NCT01376076|Cariprazine|cariprazine|mesh-list
102022486|NCT01376076|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102022487|NCT01376076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102022488|NCT01376076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102022489|NCT01376076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102022490|NCT01376076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102022491|NCT01376076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102022492|NCT01376076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950872|NCT01180179|Dexlansoprazole|dexlansoprazole|mesh-list
101950873|NCT01180179|Famotidine|famotidine|mesh-list
101950874|NCT01180179|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101950875|NCT01180179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102022493|NCT01376076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102022494|NCT01376076|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102022495|NCT01376076|Contraceptive Agents|contraceptive agents|mesh-ancestor
102022496|NCT01376076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102022497|NCT01376076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022498|NCT01376076|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102022499|NCT01376076|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102022500|NCT01376076|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102022501|NCT01376076|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102022502|NCT01376076|Serotonin Agents|serotonin agents|mesh-ancestor
102022503|NCT01376076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102022504|NCT01376076|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102022505|NCT01376076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102022506|NCT01376076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102022507|NCT01376076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102022508|NCT01376076|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102022509|NCT01376076|Dopamine Agents|dopamine agents|mesh-ancestor
102022510|NCT03395353|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102022511|NCT03395353|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102022512|NCT03395353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102022513|NCT03395353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102022514|NCT03395353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022515|NCT03395353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102022516|NCT03395353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022517|NCT03395353|Analgesics|analgesics|mesh-ancestor
102022518|NCT03395353|Sensory System Agents|sensory system agents|mesh-ancestor
102022519|NCT03395353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102022520|NCT03395353|Antidepressive Agents|antidepressive agents|mesh-ancestor
102022521|NCT03395353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102022522|NCT03395353|Dopamine Agents|dopamine agents|mesh-ancestor
102022523|NCT01376154|Lamivudine|lamivudine|mesh-list
102022524|NCT01376154|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102022525|NCT01376154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102022526|NCT01376154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102022527|NCT01376154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022528|NCT01376154|Antiviral Agents|antiviral agents|mesh-ancestor
102022529|NCT01376154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102022530|NCT01376154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102022531|NCT01376154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102022532|NCT01562951|Adalimumab|adalimumab|mesh-list
102022533|NCT01562951|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102022534|NCT01562951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102022535|NCT01562951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102022536|NCT01375842|Atezolizumab|atezolizumab|mesh-list
102022537|NCT01375842|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102022544|NCT03682367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102022545|NCT03682367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022546|NCT03682367|Anticonvulsants|anticonvulsants|mesh-ancestor
102022547|NCT03682367|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102022548|NCT03682367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102022549|NCT03682367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102022550|NCT03682367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102022551|NCT03682367|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102022552|NCT03682367|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102022553|NCT03682367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102022554|NCT03682367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022555|NCT03682367|Antimanic Agents|antimanic agents|mesh-ancestor
102022556|NCT05170464|Caffeine|caffeine|mesh-list
102022557|NCT05170464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102022558|NCT05170464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022559|NCT05170464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102022560|NCT05170464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102022561|NCT05170464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022562|NCT05170464|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102022563|NCT05170464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102022564|NCT05170464|Purinergic Agents|purinergic agents|mesh-ancestor
101950876|NCT01180179|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101950878|NCT01180179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950879|NCT01180179|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101950880|NCT01180179|Histamine Antagonists|histamine antagonists|mesh-ancestor
102022565|NCT05170464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102022566|NCT03677492|Cytochalasin D|cytochalasin d|mesh-list
102022567|NCT03677492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102022568|NCT03677492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102022569|NCT03677492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022570|NCT03394885|Paclitaxel|paclitaxel|mesh-list
102022571|NCT03394885|Bevacizumab|bevacizumab|mesh-list
102022572|NCT03394885|Carboplatin|carboplatin|mesh-list
102022573|NCT03394885|Atezolizumab|atezolizumab|mesh-list
102022574|NCT03394885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102022575|NCT03394885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102022576|NCT03394885|Tubulin Modulators|tubulin modulators|mesh-ancestor
102022577|NCT03394885|Antimitotic Agents|antimitotic agents|mesh-ancestor
102022578|NCT03394885|Mitosis Modulators|mitosis modulators|mesh-ancestor
102022579|NCT03394885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022580|NCT03394885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102022581|NCT03394885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102022582|NCT03394885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102022583|NCT03394885|Growth Substances|growth substances|mesh-ancestor
102022584|NCT03394885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022585|NCT03394885|Growth Inhibitors|growth inhibitors|mesh-ancestor
102022586|NCT03394885|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102022587|NCT01361373|Levodopa|levodopa|mesh-list
102022588|NCT01361373|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102022589|NCT01361373|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102022590|NCT01361373|Dopamine Agents|dopamine agents|mesh-ancestor
102022591|NCT01361373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102022592|NCT01361373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022593|NCT01361373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022594|NCT03677336|Progesterone|progesterone|mesh-list
102022595|NCT03677336|Dydrogesterone|dydrogesterone|mesh-list
102022596|NCT03677336|Progestins|progestins|mesh-ancestor
102022597|NCT03677336|Hormones|hormones|mesh-ancestor
102022598|NCT03677336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102022599|NCT03677336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022600|NCT02877927|Linezolid|linezolid|mesh-list
102022601|NCT02877927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102022602|NCT02877927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102022603|NCT02877927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102022604|NCT02877927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101477585|NCT00315003|Azithromycin|azithromycin|mesh-list
102022607|NCT02706886|Renal Agents|renal agents|mesh-ancestor
102022608|NCT02809131|Levofloxacin|levofloxacin|mesh-list
102022609|NCT02809131|Clindamycin|clindamycin|mesh-list
102022610|NCT02809131|Clindamycin palmitate|clindamycin palmitate|mesh-list
102022611|NCT02809131|Clindamycin phosphate|clindamycin phosphate|mesh-list
102022613|NCT02809131|Polymyxins|polymyxins|mesh-list
102022614|NCT02809131|Bacitracin|bacitracin|mesh-list
102022615|NCT02809131|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102022616|NCT02809131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102022617|NCT02809131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102022618|NCT02809131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102022619|NCT02809131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102022620|NCT02809131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102022621|NCT02809131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022622|NCT02809131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102022623|NCT02809131|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102022624|NCT02809131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102022625|NCT02809131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102022626|NCT02809131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102022627|NCT05032950|Ritonavir|ritonavir|mesh-list
102022628|NCT05032950|Nirmatrelvir|nirmatrelvir|mesh-list
102022629|NCT05032950|Midazolam|midazolam|mesh-list
102022630|NCT05032950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102022631|NCT05032950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102022632|NCT05032950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102022633|NCT05032950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950881|NCT01180179|Histamine Agents|histamine agents|mesh-ancestor
101950882|NCT01180179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101950883|NCT01180179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284567|NCT01927679|Protective Agents|protective agents|mesh-ancestor
102022634|NCT05032950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102022635|NCT05032950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102022636|NCT05032950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102022637|NCT05032950|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102022638|NCT05032950|Anesthetics, General|anesthetics, general|mesh-ancestor
102022639|NCT05032950|Anesthetics|anesthetics|mesh-ancestor
102022640|NCT05032950|GABA Modulators|gaba modulators|mesh-ancestor
102022641|NCT05032950|GABA Agents|gaba agents|mesh-ancestor
102022642|NCT05032950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102022643|NCT05032950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022644|NCT05032950|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101742406|NCT00738777|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102022645|NCT05032950|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102022646|NCT05032950|Protease Inhibitors|protease inhibitors|mesh-ancestor
102022647|NCT05032950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102022649|NCT05032950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102022650|NCT05032950|Antiviral Agents|antiviral agents|mesh-ancestor
102022651|NCT05032950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102022652|NCT05032950|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102022653|NCT05032950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102022654|NCT01442649|Leucovorin|leucovorin|mesh-list
102022655|NCT01442649|Folic Acid|folic acid|mesh-list
102022656|NCT01442649|Bevacizumab|bevacizumab|mesh-list
102022657|NCT01442649|Cetuximab|cetuximab|mesh-list
102022658|NCT01442649|Oxaliplatin|oxaliplatin|mesh-list
102022659|NCT01442649|Irinotecan|irinotecan|mesh-list
102022660|NCT01442649|Fluorouracil|fluorouracil|mesh-list
102022661|NCT01442649|Levoleucovorin|levoleucovorin|mesh-list
102022662|NCT01442649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102022663|NCT01442649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102022664|NCT01442649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102022665|NCT01442649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102022666|NCT01442649|Growth Substances|growth substances|mesh-ancestor
102022667|NCT01442649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022668|NCT01442649|Growth Inhibitors|growth inhibitors|mesh-ancestor
102022669|NCT01442649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102022670|NCT01442649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102022671|NCT01442649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102022672|NCT01442649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022673|NCT01442649|Antidotes|antidotes|mesh-ancestor
102022674|NCT01442649|Protective Agents|protective agents|mesh-ancestor
102022675|NCT01442649|Vitamin B Complex|vitamin b complex|mesh-ancestor
102022676|NCT01442649|Vitamins|vitamins|mesh-ancestor
102022677|NCT01442649|Micronutrients|micronutrients|mesh-ancestor
102022678|NCT01442649|Hematinics|hematinics|mesh-ancestor
102022679|NCT01442649|Antimetabolites|antimetabolites|mesh-ancestor
102022680|NCT01442649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102022686|NCT04995120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102022687|NCT04995120|Tubulin Modulators|tubulin modulators|mesh-ancestor
102022688|NCT04995120|Antimitotic Agents|antimitotic agents|mesh-ancestor
102022689|NCT04995120|Mitosis Modulators|mitosis modulators|mesh-ancestor
102022690|NCT04995120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022691|NCT01376232|Gemfibrozil|gemfibrozil|mesh-list
102022692|NCT01376232|Glycine|glycine|mesh-list
102022693|NCT01376232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102022694|NCT01376232|Antimetabolites|antimetabolites|mesh-ancestor
102022695|NCT01376232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022696|NCT01376232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102022697|NCT01376232|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102022698|NCT01376232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102022699|NCT01376232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102022700|NCT01376232|Glycine Agents|glycine agents|mesh-ancestor
102022701|NCT01376232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102022702|NCT01376232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022703|NCT01354665|Interferons|interferons|mesh-list
102022704|NCT01354665|Interferon-beta|interferon-beta|mesh-list
102022705|NCT01354665|Interferon beta-1b|interferon beta-1b|mesh-list
102022706|NCT01354665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102022707|NCT01354665|Antiviral Agents|antiviral agents|mesh-ancestor
102022708|NCT01354665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101950884|NCT01289223|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101950885|NCT01289223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101950886|NCT01289223|Alkylating Agents|alkylating agents|mesh-ancestor
101284638|NCT01930370|Hemodialysis Solutions|hemodialysis solutions|mesh-list
102022709|NCT01354665|Immunologic Factors|immunologic factors|mesh-ancestor
102022710|NCT01354665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022711|NCT01354665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102022712|NCT01354743|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102022713|NCT01354743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102022714|NCT01354743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102022715|NCT01354743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022716|NCT01354743|Cholinergic Agents|cholinergic agents|mesh-ancestor
102022717|NCT01354743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102022718|NCT01354743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022719|NCT05008575|Fludarabine|fludarabine|mesh-list
102022720|NCT05008575|Cyclophosphamide|cyclophosphamide|mesh-list
102022721|NCT05008575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102022722|NCT05008575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022723|NCT05008575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102022725|NCT05008575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022726|NCT05008575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102022727|NCT05008575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102022728|NCT05008575|Alkylating Agents|alkylating agents|mesh-ancestor
102022729|NCT05008575|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102022730|NCT01319487|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102022731|NCT01319487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102022732|NCT03111108|Grazoprevir|grazoprevir|mesh-list
102022733|NCT03111108|Antiviral Agents|antiviral agents|mesh-ancestor
102022734|NCT03111108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102022735|NCT00702520|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102022736|NCT00702520|Hormones|hormones|mesh-list
102022737|NCT00702520|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102022738|NCT00702520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102022739|NCT00702520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022740|NCT00702520|Luteolytic Agents|luteolytic agents|mesh-ancestor
102022741|NCT00702520|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102022742|NCT00702520|Contraceptive Agents|contraceptive agents|mesh-ancestor
102022743|NCT00702520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102022744|NCT00702520|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102022745|NCT00702520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102022746|NCT00702520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102022747|NCT05198856|Thalidomide|thalidomide|mesh-list
102022748|NCT05198856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102022749|NCT05198856|Immunologic Factors|immunologic factors|mesh-ancestor
102022750|NCT05198856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022751|NCT05198856|Leprostatic Agents|leprostatic agents|mesh-ancestor
102022758|NCT05198856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102022759|NCT02876601|Defibrotide|defibrotide|mesh-list
102022760|NCT02876601|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102022761|NCT02876601|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102022762|NCT02876601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022763|NCT02876601|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102022764|NCT04059536|Aspirin|aspirin|mesh-list
102022765|NCT04059536|Heparin|heparin|mesh-list
102022766|NCT04059536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102022767|NCT04059536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102022768|NCT04059536|Analgesics|analgesics|mesh-ancestor
102022769|NCT04059536|Sensory System Agents|sensory system agents|mesh-ancestor
102022770|NCT04059536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102022771|NCT04059536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022772|NCT04059536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102022773|NCT04059536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102022774|NCT04059536|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102022775|NCT04059536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102022776|NCT04059536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022777|NCT04059536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102022778|NCT04059536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102022779|NCT04059536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102022780|NCT04059536|Antipyretics|antipyretics|mesh-ancestor
102022781|NCT04059536|Anticoagulants|anticoagulants|mesh-ancestor
101950887|NCT01289223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950888|NCT01289223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101950889|NCT01186497|Rabeprazole|rabeprazole|mesh-list
102022820|NCT03178396|Melatonin|melatonin|mesh-list
102022821|NCT03178396|Antioxidants|antioxidants|mesh-ancestor
102022822|NCT03178396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022833|NCT01361763|Antithrombins|antithrombins|mesh-ancestor
102022834|NCT01361763|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102022835|NCT01361763|Protease Inhibitors|protease inhibitors|mesh-ancestor
102022836|NCT01361763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102022837|NCT01361763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022838|NCT01361763|Anticoagulants|anticoagulants|mesh-ancestor
102022839|NCT02420782|Itraconazole|itraconazole|mesh-list
102022840|NCT02420782|Midazolam|midazolam|mesh-list
102022841|NCT02420782|Pilocarpine|pilocarpine|mesh-list
102022842|NCT02420782|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102022843|NCT02420782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102022844|NCT02420782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102022845|NCT02420782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022846|NCT02420782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102022847|NCT02420782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102022848|NCT02420782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102022849|NCT02420782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102022850|NCT02420782|Anesthetics, General|anesthetics, general|mesh-ancestor
102022851|NCT02420782|Anesthetics|anesthetics|mesh-ancestor
102022852|NCT02420782|GABA Modulators|gaba modulators|mesh-ancestor
102022853|NCT02420782|GABA Agents|gaba agents|mesh-ancestor
102022854|NCT02420782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102022855|NCT02420782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022856|NCT02420782|Antifungal Agents|antifungal agents|mesh-ancestor
102022857|NCT02420782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102022858|NCT02420782|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102022859|NCT02420782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102022860|NCT02420782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102022861|NCT02420782|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102022862|NCT02420782|Hormone Antagonists|hormone antagonists|mesh-ancestor
101950890|NCT01186497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101950891|NCT01186497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101950892|NCT01186497|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101950893|NCT01186497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101950894|NCT01186497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950896|NCT03854409|Antidepressive Agents|antidepressive agents|mesh-ancestor
101950897|NCT03854409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101950898|NCT03854409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101950899|NCT03854409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101950900|NCT03854409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101950901|NCT03854409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950902|NCT03854409|Dopamine Agonists|dopamine agonists|mesh-ancestor
101950903|NCT03854409|Dopamine Agents|dopamine agents|mesh-ancestor
101950904|NCT03854409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101950905|NCT03854409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950906|NCT03854409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101950907|NCT03854409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101950908|NCT03854409|Serotonin Agents|serotonin agents|mesh-ancestor
101950909|NCT03854409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102022863|NCT02420782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102022864|NCT02420782|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102022865|NCT02420782|Miotics|miotics|mesh-ancestor
102022866|NCT02420782|Autonomic Agents|autonomic agents|mesh-ancestor
102022867|NCT02420782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102022868|NCT02420782|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102022869|NCT02420782|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102022870|NCT02420782|Cholinergic Agents|cholinergic agents|mesh-ancestor
102022871|NCT04054193|Dexamethasone|dexamethasone|mesh-list
102022872|NCT04054193|Fosaprepitant|fosaprepitant|mesh-list
102022873|NCT04054193|Aprepitant|aprepitant|mesh-list
102022874|NCT04054193|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
102022875|NCT04054193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102022876|NCT04054193|Antiemetics|antiemetics|mesh-ancestor
102022877|NCT04054193|Autonomic Agents|autonomic agents|mesh-ancestor
102022878|NCT04054193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102022879|NCT04054193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022880|NCT04054193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102022881|NCT04054193|Glucocorticoids|glucocorticoids|mesh-ancestor
102022882|NCT04054193|Hormones|hormones|mesh-ancestor
102022883|NCT04054193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102022884|NCT04054193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102022885|NCT04054193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102022886|NCT04054193|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102022887|NCT04054193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101477873|NCT00316095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102022893|NCT03682172|Glucagon|glucagon|mesh-list
102022894|NCT03682172|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102022895|NCT03682172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102022896|NCT03682172|Hormones|hormones|mesh-ancestor
102022897|NCT03682172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102022898|NCT03682172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022899|NCT03682172|Incretins|incretins|mesh-ancestor
102022900|NCT03184480|Fluticasone|fluticasone|mesh-list
101950910|NCT03854409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101950911|NCT03854409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101950912|NCT03854409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101950913|NCT01186653|Fluticasone|fluticasone|mesh-list
101950914|NCT01186653|Budesonide|budesonide|mesh-list
101950915|NCT01186653|Formoterol Fumarate|formoterol fumarate|mesh-list
102022901|NCT03184480|Xhance|xhance|mesh-list
102022902|NCT03184480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102022903|NCT03184480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102022904|NCT03184480|Autonomic Agents|autonomic agents|mesh-ancestor
102022905|NCT03184480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102022906|NCT03184480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022907|NCT03184480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102022908|NCT03184480|Respiratory System Agents|respiratory system agents|mesh-ancestor
102022909|NCT03184480|Dermatologic Agents|dermatologic agents|mesh-ancestor
102022910|NCT03184480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102022911|NCT03136107|Sunscreening Agents|sunscreening agents|mesh-list
102022912|NCT03136107|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102022913|NCT03136107|Protective Agents|protective agents|mesh-ancestor
102022914|NCT03136107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022915|NCT03136107|Dermatologic Agents|dermatologic agents|mesh-ancestor
102022916|NCT03686774|Memantine|memantine|mesh-list
102022917|NCT03686774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102022918|NCT03686774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102022919|NCT03686774|Dopamine Agents|dopamine agents|mesh-ancestor
102022920|NCT03686774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102022921|NCT03686774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022922|NCT03686774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022923|NCT03686774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102022924|NCT03686774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102022925|NCT02420392|Dapagliflozin|dapagliflozin|mesh-list
102022926|NCT02420392|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102022927|NCT02420392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022928|NCT02420392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102022929|NCT02420392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022930|NCT01562795|Fluorometholone|fluorometholone|mesh-list
102022931|NCT01562795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102022932|NCT01562795|Lubricant Eye Drops|lubricant eye drops|mesh-list
102022933|NCT01562795|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102022934|NCT01562795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102022935|NCT01562795|Glucocorticoids|glucocorticoids|mesh-ancestor
102022936|NCT01562795|Hormones|hormones|mesh-ancestor
102022937|NCT01562795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102022938|NCT01562795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022939|NCT01562795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102022940|NCT02424136|Nitric Oxide|nitric oxide|mesh-list
102022941|NCT02424136|Immunoglobulins|immunoglobulins|mesh-list
102022942|NCT02424136|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102022943|NCT02424136|Antibodies|antibodies|mesh-list
102022944|NCT02424136|Immunologic Factors|immunologic factors|mesh-ancestor
102022945|NCT02424136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022946|NCT02424136|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102022947|NCT02424136|Autonomic Agents|autonomic agents|mesh-ancestor
102022948|NCT02424136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102022949|NCT02424136|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102022950|NCT02424136|Respiratory System Agents|respiratory system agents|mesh-ancestor
101400256|NCT05921968|Iron|iron|mesh-list
102022951|NCT02424136|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102022952|NCT02424136|Antioxidants|antioxidants|mesh-ancestor
102022953|NCT02424136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022954|NCT02424136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102022955|NCT02424136|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102022956|NCT02424136|Vasodilator Agents|vasodilator agents|mesh-ancestor
102022966|NCT01361841|Bimatoprost|bimatoprost|mesh-list
102022967|NCT01361841|Travoprost|travoprost|mesh-list
102022968|NCT01361841|Latanoprost|latanoprost|mesh-list
102022969|NCT01361841|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102022970|NCT01361841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102022971|NCT01361841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102022972|NCT02583789|Treprostinil|treprostinil|mesh-list
102022973|NCT02583789|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101950916|NCT01186653|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101950917|NCT01186653|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101950918|NCT01186653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102022974|NCT01355367|Nifedipine|nifedipine|mesh-list
102022975|NCT01355367|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102022976|NCT01355367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102022977|NCT01355367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022978|NCT01355367|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102022979|NCT01355367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022980|NCT01355367|Vasodilator Agents|vasodilator agents|mesh-ancestor
102022981|NCT01355367|Tocolytic Agents|tocolytic agents|mesh-ancestor
102022982|NCT01355367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102022983|NCT05759520|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102022984|NCT05759520|Immunologic Factors|immunologic factors|mesh-ancestor
102022985|NCT05759520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022986|NCT02427880|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102022987|NCT02427880|Furosemide|furosemide|mesh-list
102022988|NCT02427880|Acetazolamide|acetazolamide|mesh-list
102022989|NCT02427880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102022990|NCT02427880|Diuretics|diuretics|mesh-ancestor
102022991|NCT02427880|Natriuretic Agents|natriuretic agents|mesh-ancestor
102022992|NCT02427880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022993|NCT02427880|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102022994|NCT02427880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102022995|NCT02427880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022996|NCT02427880|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102022997|NCT02427880|Anticonvulsants|anticonvulsants|mesh-ancestor
102022998|NCT02427880|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102022999|NCT02427880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102023000|NCT01355445|Irinotecan|irinotecan|mesh-list
102023001|NCT01355445|Vincristine|vincristine|mesh-list
102023002|NCT01355445|Temozolomide|temozolomide|mesh-list
102023003|NCT01355445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102023004|NCT01355445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102023005|NCT01355445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102023006|NCT01355445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023007|NCT01355445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102023008|NCT01355445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102023009|NCT01355445|Tubulin Modulators|tubulin modulators|mesh-ancestor
102023010|NCT01355445|Antimitotic Agents|antimitotic agents|mesh-ancestor
102023011|NCT01355445|Mitosis Modulators|mitosis modulators|mesh-ancestor
101523989|NCT01217437|Temozolomide|temozolomide|mesh-list
102023012|NCT01355445|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102023013|NCT01355445|Alkylating Agents|alkylating agents|mesh-ancestor
102023014|NCT02420080|Brincidofovir|brincidofovir|mesh-list
102023015|NCT02420080|Antiviral Agents|antiviral agents|mesh-ancestor
102023016|NCT02420080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102023017|NCT04483258|Sevoflurane|sevoflurane|mesh-list
102023018|NCT04483258|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102023019|NCT04483258|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102023020|NCT04483258|Anesthetics, General|anesthetics, general|mesh-ancestor
102023021|NCT04483258|Anesthetics|anesthetics|mesh-ancestor
102023022|NCT04483258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102023023|NCT04483258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023041|NCT04275531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102023042|NCT04275531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023043|NCT04275531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102023044|NCT04275531|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102023045|NCT04275531|Anesthetics, General|anesthetics, general|mesh-ancestor
102023046|NCT04275531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102023047|NCT04275531|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102023049|NCT03689712|Avasopasem manganese|avasopasem manganese|mesh-list
102023050|NCT03689712|Trace Elements|trace elements|mesh-ancestor
102023051|NCT03689712|Micronutrients|micronutrients|mesh-ancestor
102023052|NCT03689712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023053|NCT03689712|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102023054|NCT03689712|Antioxidants|antioxidants|mesh-ancestor
102023055|NCT03689712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023056|NCT03689712|Protective Agents|protective agents|mesh-ancestor
102023057|NCT01361997|Ethanol|ethanol|mesh-list
102023058|NCT01361997|Chlorhexidine|chlorhexidine|mesh-list
102023059|NCT01361997|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101950919|NCT01186653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101950920|NCT01186653|Autonomic Agents|autonomic agents|mesh-ancestor
101950921|NCT01186653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102023060|NCT01361997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102023061|NCT01361997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102023062|NCT01361997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023063|NCT01361997|Disinfectants|disinfectants|mesh-ancestor
102023064|NCT04750824|Afatinib|afatinib|mesh-list
102023065|NCT04750824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102023066|NCT04750824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102023067|NCT04750824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102023068|NCT04750824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023069|NCT03180970|Lugol's solution|lugol's solution|mesh-list
102023070|NCT03180970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102023071|NCT03180970|Hemostatics|hemostatics|mesh-ancestor
102023072|NCT03180970|Coagulants|coagulants|mesh-ancestor
102023073|NCT03631446|Picosulfate sodium|picosulfate sodium|mesh-list
102023074|NCT03631446|Magnesium Oxide|magnesium oxide|mesh-list
102023075|NCT03631446|Citric Acid|citric acid|mesh-list
102023076|NCT03631446|Sodium Citrate|sodium citrate|mesh-list
102023077|NCT03631446|Anticoagulants|anticoagulants|mesh-ancestor
102023078|NCT03631446|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102023079|NCT03631446|Chelating Agents|chelating agents|mesh-ancestor
102023080|NCT03631446|Sequestering Agents|sequestering agents|mesh-ancestor
102023081|NCT03631446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023082|NCT03631446|Cathartics|cathartics|mesh-ancestor
102023083|NCT03631446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102023084|NCT03631446|Antacids|antacids|mesh-ancestor
102023085|NCT01362153|Golimumab|golimumab|mesh-list
102023086|NCT01362153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102023107|NCT02427334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023108|NCT02427334|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102023109|NCT02427334|Antidepressive Agents|antidepressive agents|mesh-ancestor
102023110|NCT02427334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102023111|NCT02427334|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102023112|NCT02427334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102023113|NCT02427334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102023114|NCT02427334|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102023115|NCT02427334|Contraceptive Agents|contraceptive agents|mesh-ancestor
102023116|NCT02427334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102023117|NCT02427334|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102023118|NCT02427334|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102023119|NCT02427334|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102023120|NCT02427334|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102023121|NCT02427334|Hormone Antagonists|hormone antagonists|mesh-ancestor
102023122|NCT02427334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102023123|NCT02427334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102023124|NCT02427334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102023125|NCT03620253|Modafinil|modafinil|mesh-list
102023126|NCT03620253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102023127|NCT03620253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023128|NCT03620253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102023129|NCT03620253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102023130|NCT03620253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102023131|NCT03620253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023132|NCT01355991|Tiotropium Bromide|tiotropium bromide|mesh-list
102023133|NCT01355991|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102023134|NCT01355991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102023135|NCT01355991|Autonomic Agents|autonomic agents|mesh-ancestor
102023136|NCT01355991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102023137|NCT01355991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023138|NCT01355991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102023139|NCT01355991|Respiratory System Agents|respiratory system agents|mesh-ancestor
102023146|NCT01355991|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102023147|NCT01355991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102023148|NCT01355991|Adrenergic Agents|adrenergic agents|mesh-ancestor
102023149|NCT01358253|Cytarabine|cytarabine|mesh-list
102023150|NCT01358253|Dexamethasone|dexamethasone|mesh-list
102023151|NCT01358253|Prednisone|prednisone|mesh-list
102023152|NCT01358253|Cyclophosphamide|cyclophosphamide|mesh-list
102023153|NCT01358253|Rituximab|rituximab|mesh-list
102023154|NCT01358253|Doxorubicin|doxorubicin|mesh-list
102023155|NCT01358253|Methotrexate|methotrexate|mesh-list
101285045|NCT01932541|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102023156|NCT01358253|Vincristine|vincristine|mesh-list
102023157|NCT01358253|Asparaginase|asparaginase|mesh-list
102023158|NCT01358253|Mercaptopurine|mercaptopurine|mesh-list
102023159|NCT01358253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102023160|NCT01358253|Immunologic Factors|immunologic factors|mesh-ancestor
102023161|NCT01358253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023162|NCT01358253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102023163|NCT01358253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102023164|NCT01358253|Alkylating Agents|alkylating agents|mesh-ancestor
102023165|NCT01358253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023166|NCT01358253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102023167|NCT01358253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102023168|NCT01358253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102023169|NCT01358253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102023170|NCT01358253|Antiemetics|antiemetics|mesh-ancestor
102023171|NCT01358253|Autonomic Agents|autonomic agents|mesh-ancestor
102023172|NCT01358253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102023173|NCT01358253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102023174|NCT01358253|Glucocorticoids|glucocorticoids|mesh-ancestor
102023176|NCT01358253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102023177|NCT01358253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102023178|NCT01358253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102023179|NCT01358253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102023180|NCT01358253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102023181|NCT01358253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102023182|NCT01358253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102023183|NCT01358253|Abortifacient Agents|abortifacient agents|mesh-ancestor
102023184|NCT01358253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101524025|NCT04316377|Hydroxychloroquine|hydroxychloroquine|mesh-list
102023185|NCT01358253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102023186|NCT01358253|Antimetabolites|antimetabolites|mesh-ancestor
102023187|NCT01358253|Dermatologic Agents|dermatologic agents|mesh-ancestor
102023188|NCT01358253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102023189|NCT01358253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102023190|NCT01358253|Antiviral Agents|antiviral agents|mesh-ancestor
102023191|NCT01358253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102023192|NCT01358253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102023193|NCT01358253|Tubulin Modulators|tubulin modulators|mesh-ancestor
102023194|NCT01358253|Antimitotic Agents|antimitotic agents|mesh-ancestor
102023195|NCT01358253|Mitosis Modulators|mitosis modulators|mesh-ancestor
102023196|NCT03180346|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102023197|NCT03180346|Laxatives|laxatives|mesh-ancestor
102023198|NCT03180346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102023199|NCT01356225|Ketorolac|ketorolac|mesh-list
102023200|NCT01356225|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102023201|NCT01356225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102023202|NCT01356225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102023203|NCT01356225|Analgesics|analgesics|mesh-ancestor
102023204|NCT01356225|Sensory System Agents|sensory system agents|mesh-ancestor
102023205|NCT01356225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102023206|NCT01356225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023207|NCT01356225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102023208|NCT01356225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101478195|NCT00310518|Beta-lapachone|beta-lapachone|mesh-list
102023212|NCT02427412|Tranexamic Acid|tranexamic acid|mesh-list
102023213|NCT02427412|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102023214|NCT02427412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102023215|NCT02427412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023216|NCT02427412|Hemostatics|hemostatics|mesh-ancestor
102023217|NCT02427412|Coagulants|coagulants|mesh-ancestor
102023218|NCT01356303|Docetaxel|docetaxel|mesh-list
102023219|NCT01356303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102023220|NCT01356303|Tubulin Modulators|tubulin modulators|mesh-ancestor
102023221|NCT01356303|Antimitotic Agents|antimitotic agents|mesh-ancestor
102023222|NCT01356303|Mitosis Modulators|mitosis modulators|mesh-ancestor
102023223|NCT01356303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023224|NCT02220309|Pramipexole|pramipexole|mesh-list
102023225|NCT02220309|Antioxidants|antioxidants|mesh-ancestor
102023226|NCT02220309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023227|NCT02220309|Protective Agents|protective agents|mesh-ancestor
102023228|NCT02220309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023229|NCT02220309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102023230|NCT02220309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101950922|NCT01186653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950923|NCT01186653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101950924|NCT01186653|Respiratory System Agents|respiratory system agents|mesh-ancestor
101950925|NCT01186653|Dermatologic Agents|dermatologic agents|mesh-ancestor
101950926|NCT01186653|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101950927|NCT01186653|Glucocorticoids|glucocorticoids|mesh-ancestor
101950928|NCT01186653|Hormones|hormones|mesh-ancestor
101950929|NCT01186653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101950930|NCT01186653|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101950931|NCT01186653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101950932|NCT01186653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101950933|NCT01186653|Adrenergic Agents|adrenergic agents|mesh-ancestor
101950934|NCT01186653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101950935|NCT01186653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950936|NCT01186653|Sympathomimetics|sympathomimetics|mesh-ancestor
101950937|NCT01186731|Docetaxel|docetaxel|mesh-list
101950938|NCT01186731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101950939|NCT01186731|Tubulin Modulators|tubulin modulators|mesh-ancestor
101950940|NCT01186731|Antimitotic Agents|antimitotic agents|mesh-ancestor
101950941|NCT01186731|Mitosis Modulators|mitosis modulators|mesh-ancestor
101950942|NCT01186731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950943|NCT01186887|Celecoxib|celecoxib|mesh-list
101950944|NCT01186887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101950945|NCT01186887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101950946|NCT01186887|Analgesics|analgesics|mesh-ancestor
101950947|NCT01186887|Sensory System Agents|sensory system agents|mesh-ancestor
101950948|NCT01186887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101670758|NCT04262999|Levetiracetam|levetiracetam|mesh-list
101950949|NCT01186887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950950|NCT01186887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102023231|NCT02220309|Dopamine Agonists|dopamine agonists|mesh-ancestor
102023232|NCT02220309|Dopamine Agents|dopamine agents|mesh-ancestor
102023233|NCT02220309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102023234|NCT02419534|Diltiazem|diltiazem|mesh-list
102023235|NCT02419534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102023236|NCT02419534|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102023237|NCT02419534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102023238|NCT02419534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023239|NCT02419534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102023240|NCT02419534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023241|NCT02419534|Vasodilator Agents|vasodilator agents|mesh-ancestor
102023242|NCT03527316|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
102023243|NCT03527316|Hallucinogens|hallucinogens|mesh-ancestor
102023244|NCT03527316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950951|NCT01186887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101950952|NCT01186887|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101950953|NCT01186887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101950954|NCT01186887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101950955|NCT01186887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950957|NCT01180413|Amlodipine|amlodipine|mesh-list
101950958|NCT01180413|Ramipril|ramipril|mesh-list
101950959|NCT01180413|Lercanidipine|lercanidipine|mesh-list
101950960|NCT01180413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102023245|NCT03527316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102023246|NCT03527316|Serotonin Agents|serotonin agents|mesh-ancestor
102023247|NCT03527316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102023248|NCT03527316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023249|NCT03527316|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102023250|NCT03527316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102023251|NCT03527316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102023252|NCT03527316|Adrenergic Agents|adrenergic agents|mesh-ancestor
102023253|NCT01358409|Nebivolol|nebivolol|mesh-list
102023254|NCT01358409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102023255|NCT01358409|Vasodilator Agents|vasodilator agents|mesh-ancestor
102023256|NCT01358409|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102023257|NCT01358409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102023258|NCT01358409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102023259|NCT01358409|Adrenergic Agents|adrenergic agents|mesh-ancestor
102023260|NCT01358409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102023261|NCT01358409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023262|NCT01358409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023263|NCT02423590|Carboplatin|carboplatin|mesh-list
102023264|NCT02423590|Gemcitabine|gemcitabine|mesh-list
102023265|NCT02423590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102023266|NCT02423590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102023267|NCT02423590|Antimetabolites|antimetabolites|mesh-ancestor
102023268|NCT02423590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023269|NCT01362309|Cycloserine|cycloserine|mesh-list
102023270|NCT01362309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102023271|NCT01362309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102023272|NCT01362309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102023273|NCT01362309|Antitubercular Agents|antitubercular agents|mesh-ancestor
102023274|NCT01362309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102023275|NCT01362309|Antimetabolites|antimetabolites|mesh-ancestor
102023276|NCT01362309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023277|NCT03710863|Vorolanib|vorolanib|mesh-list
102023278|NCT03710863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102023285|NCT03178084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102023286|NCT03178084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102023287|NCT03178084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102023288|NCT03178084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023289|NCT03178084|Antiviral Agents|antiviral agents|mesh-ancestor
102023290|NCT03178084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102023291|NCT03178084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102023292|NCT03178084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102023293|NCT03178084|Antimetabolites|antimetabolites|mesh-ancestor
102023294|NCT03178084|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102023295|NCT03178084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102023296|NCT03178084|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102023297|NCT03178084|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102023298|NCT03178084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102023299|NCT03178084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102023300|NCT03178084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102023301|NCT03178084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102023302|NCT03178084|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102023303|NCT01356381|Vildagliptin|vildagliptin|mesh-list
102023304|NCT01356381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101950962|NCT01180413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101950963|NCT01180413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950964|NCT01180413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101950965|NCT01180413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950966|NCT01180413|Vasodilator Agents|vasodilator agents|mesh-ancestor
101950967|NCT01180413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101950968|NCT01180413|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101950969|NCT01180413|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101950970|NCT01180413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101950971|NCT01180413|Protease Inhibitors|protease inhibitors|mesh-ancestor
101950972|NCT01180413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101950973|NCT03858387|Meropenem|meropenem|mesh-list
101950974|NCT03858387|Imipenem|imipenem|mesh-list
101950975|NCT03858387|Cilastatin|cilastatin|mesh-list
101950976|NCT03858387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101950977|NCT03858387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101950978|NCT03858387|Protease Inhibitors|protease inhibitors|mesh-ancestor
101950979|NCT03858387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101950980|NCT03858387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950981|NCT01289301|Cyclosporine|cyclosporine|mesh-list
101950982|NCT01289301|Sirolimus|sirolimus|mesh-list
102023305|NCT01356381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023306|NCT01356381|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102023307|NCT01356381|Protease Inhibitors|protease inhibitors|mesh-ancestor
102023308|NCT01356381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102023309|NCT01356381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023310|NCT03117166|Lidocaine|lidocaine|mesh-list
102023311|NCT03117166|Anesthetics, Local|anesthetics, local|mesh-ancestor
102023312|NCT03117166|Anesthetics|anesthetics|mesh-ancestor
102023313|NCT03117166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102023314|NCT03117166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023315|NCT03117166|Sensory System Agents|sensory system agents|mesh-ancestor
102023316|NCT03117166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102023317|NCT03117166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102023318|NCT03117166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102023319|NCT03117166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102023320|NCT03117166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102023321|NCT03117166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023322|NCT03302286|Mannitol|mannitol|mesh-list
102023323|NCT03302286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102023324|NCT03302286|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102023325|NCT03302286|Diuretics|diuretics|mesh-ancestor
102023326|NCT03302286|Natriuretic Agents|natriuretic agents|mesh-ancestor
102023327|NCT03302286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023329|NCT01356615|Calcium heparin|calcium heparin|mesh-list
102023330|NCT01356615|Enoxaparin|enoxaparin|mesh-list
102023331|NCT01356615|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102023332|NCT01356615|Tinzaparin|tinzaparin|mesh-list
102023333|NCT01356615|Dalteparin|dalteparin|mesh-list
102023334|NCT01356615|Enoxaparin sodium|enoxaparin sodium|mesh-list
102023335|NCT01356615|Anticoagulants|anticoagulants|mesh-ancestor
102023336|NCT01356615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101950983|NCT01289301|Everolimus|everolimus|mesh-list
101950984|NCT01289301|MTOR Inhibitors|mtor inhibitors|mesh-list
101950985|NCT01289301|Temsirolimus|temsirolimus|mesh-list
101950986|NCT01289301|Tacrolimus|tacrolimus|mesh-list
101950987|NCT01289301|Cyclosporins|cyclosporins|mesh-list
101950988|NCT01289301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
102023337|NCT01356615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102023338|NCT01356615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023339|NCT03180190|Hydroxychloroquine|hydroxychloroquine|mesh-list
102023340|NCT03180190|Antimalarials|antimalarials|mesh-ancestor
102023341|NCT03180190|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102023342|NCT03180190|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102023343|NCT03180190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102023344|NCT03180190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102023345|NCT03180190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023346|NCT03180190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102023347|NCT04583592|Gabexate|gabexate|mesh-list
102023348|NCT04583592|Camostat|camostat|mesh-list
102023349|NCT04583592|Protease Inhibitors|protease inhibitors|mesh-ancestor
102023359|NCT02418988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102023360|NCT02418988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023361|NCT02418988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102023362|NCT02418988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102023363|NCT01356927|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102023364|NCT01356927|Etonogestrel|etonogestrel|mesh-list
102023365|NCT01356927|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102023366|NCT01356927|Contraceptive Agents|contraceptive agents|mesh-ancestor
102023367|NCT01356927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102023368|NCT01356927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023369|NCT01356927|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102023370|NCT01356927|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102023371|NCT01356927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102023372|NCT01356927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102023373|NCT03439670|Prednisone|prednisone|mesh-list
102023374|NCT03439670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102023375|NCT03439670|Glucocorticoids|glucocorticoids|mesh-ancestor
102023376|NCT03439670|Hormones|hormones|mesh-ancestor
102023377|NCT03439670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102023378|NCT03439670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023379|NCT03439670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102023380|NCT03439670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102023381|NCT02930343|Folic Acid|folic acid|mesh-list
102023382|NCT02930343|Hydroxychloroquine|hydroxychloroquine|mesh-list
102023383|NCT02930343|Sulfasalazine|sulfasalazine|mesh-list
102023384|NCT02930343|Prednisolone|prednisolone|mesh-list
102023385|NCT02930343|Methotrexate|methotrexate|mesh-list
102023386|NCT02930343|Leflunomide|leflunomide|mesh-list
102023387|NCT02930343|Glucocorticoids|glucocorticoids|mesh-list
102023388|NCT02930343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102023389|NCT02930343|Abortifacient Agents|abortifacient agents|mesh-ancestor
102023390|NCT02930343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102023391|NCT02930343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023392|NCT02930343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102023393|NCT02930343|Antimetabolites|antimetabolites|mesh-ancestor
102023394|NCT02930343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023395|NCT02930343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102023396|NCT02930343|Dermatologic Agents|dermatologic agents|mesh-ancestor
102023397|NCT02930343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102023398|NCT02930343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102023399|NCT02930343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102023400|NCT02930343|Immunologic Factors|immunologic factors|mesh-ancestor
102023401|NCT02930343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102023402|NCT02930343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102023403|NCT02930343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102023405|NCT02930343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102023406|NCT02930343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102023407|NCT02930343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102023408|NCT02930343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102023409|NCT02930343|Antimalarials|antimalarials|mesh-ancestor
102023410|NCT02930343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102023411|NCT02930343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101950989|NCT01289301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101950990|NCT01289301|Immunologic Factors|immunologic factors|mesh-ancestor
101950991|NCT01289301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101950992|NCT01289301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101950993|NCT01289301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101950994|NCT01289301|Antifungal Agents|antifungal agents|mesh-ancestor
101950995|NCT01289301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101950996|NCT01289301|Dermatologic Agents|dermatologic agents|mesh-ancestor
101950997|NCT01289301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101950998|NCT01289301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101950999|NCT01289301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101951000|NCT01289301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101951001|NCT01289301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101951002|NCT02524899|Guanfacine|guanfacine|mesh-list
101951003|NCT02524899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101951004|NCT02524899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101951005|NCT02524899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101951006|NCT02524899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102023412|NCT02930343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102023413|NCT02930343|Hematinics|hematinics|mesh-ancestor
102023414|NCT02930343|Vitamin B Complex|vitamin b complex|mesh-ancestor
102023415|NCT02930343|Vitamins|vitamins|mesh-ancestor
102023416|NCT02930343|Micronutrients|micronutrients|mesh-ancestor
102023421|NCT03686618|Secretin|secretin|mesh-list
102023422|NCT03686618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102023423|NCT03686618|Hormones|hormones|mesh-ancestor
102023424|NCT03686618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102023425|NCT03686618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023426|NCT02426866|Efavirenz|efavirenz|mesh-list
102023427|NCT02426866|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102023428|NCT02426866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102023429|NCT02426866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102023430|NCT02426866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023431|NCT02426866|Antiviral Agents|antiviral agents|mesh-ancestor
102023432|NCT02426866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102023433|NCT02426866|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102023434|NCT02426866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102023435|NCT02426866|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102023436|NCT02426866|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102023437|NCT02426866|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102023438|NCT02426866|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102023439|NCT02423824|Liraglutide|liraglutide|mesh-list
102023440|NCT02423824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102023441|NCT02423824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023442|NCT02423824|Incretins|incretins|mesh-ancestor
102023443|NCT02423824|Hormones|hormones|mesh-ancestor
102023444|NCT02423824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102023445|NCT01012167|Galantamine|galantamine|mesh-list
102023446|NCT01012167|Oxytocin|oxytocin|mesh-list
102023447|NCT01012167|Oxytocics|oxytocics|mesh-ancestor
102023448|NCT01012167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102023449|NCT01012167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387655|NCT00322660|Epinephryl borate|epinephryl borate|mesh-list
102023450|NCT01012167|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102023451|NCT01012167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102023452|NCT01012167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023453|NCT01012167|Cholinergic Agents|cholinergic agents|mesh-ancestor
101951007|NCT02524899|Adrenergic Agents|adrenergic agents|mesh-ancestor
101951008|NCT02524899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101951009|NCT02524899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951010|NCT02524899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951011|NCT02524821|Metformin|metformin|mesh-list
101951012|NCT02524821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101951013|NCT02524821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951014|NCT01183455|Protease Inhibitors|protease inhibitors|mesh-list
101951015|NCT01183455|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
101951016|NCT01183455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101951017|NCT01183455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951018|NCT01183455|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101951019|NCT01183455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101951020|NCT03854175|Sildenafil Citrate|sildenafil citrate|mesh-list
101951021|NCT03854175|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101951022|NCT03854175|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101951023|NCT03854175|Estradiol|estradiol|mesh-list
101951024|NCT03854175|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101951026|NCT03854175|Estrogens|estrogens|mesh-ancestor
101951063|NCT01183767|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101951064|NCT01183767|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101951065|NCT01183767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101951066|NCT01183767|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101951067|NCT03853785|Podophyllin|podophyllin|mesh-list
101951068|NCT03853785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101951069|NCT03853785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101951070|NCT03853785|Keratolytic Agents|keratolytic agents|mesh-ancestor
101951071|NCT03853785|Dermatologic Agents|dermatologic agents|mesh-ancestor
101951072|NCT01290471|U3-1565|u3-1565|mesh-list
101951073|NCT01290471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101951074|NCT01290471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101951075|NCT01291563|Moxifloxacin|moxifloxacin|mesh-list
101951076|NCT01291563|Bedaquiline|bedaquiline|mesh-list
101951077|NCT01291563|Diarylquinolines|diarylquinolines|mesh-list
101951078|NCT01291563|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101951079|NCT01291563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101951080|NCT01291563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101951081|NCT01291563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101951082|NCT01291563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101951083|NCT01291563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101951084|NCT01291563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951085|NCT01291563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101951086|NCT01291563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101951087|NCT01291563|Contraceptive Agents|contraceptive agents|mesh-ancestor
101951088|NCT01291563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101951089|NCT01291563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951090|NCT01291563|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101951091|NCT01291563|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101951092|NCT01291563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101951093|NCT01291563|Antitubercular Agents|antitubercular agents|mesh-ancestor
101951094|NCT01187589|Albuterol|albuterol|mesh-list
101951095|NCT01187589|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101951096|NCT01187589|Autonomic Agents|autonomic agents|mesh-ancestor
101951097|NCT01187589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101951098|NCT01187589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285447|NCT01935505|Nicotine|nicotine|mesh-list
102023454|NCT01012167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101951099|NCT01187589|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101951100|NCT01187589|Respiratory System Agents|respiratory system agents|mesh-ancestor
101951101|NCT01187589|Tocolytic Agents|tocolytic agents|mesh-ancestor
101951102|NCT01187589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101951103|NCT01187589|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101951104|NCT01187589|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101951105|NCT01187589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101951106|NCT01187589|Adrenergic Agents|adrenergic agents|mesh-ancestor
101951107|NCT01187589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101524085|NCT04675086|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
101951108|NCT01187589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951109|NCT01290549|Rituximab|rituximab|mesh-list
101951110|NCT01290549|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
101285477|NCT01935531|Diclofenac|diclofenac|mesh-list
102023455|NCT01012167|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102023456|NCT01012167|Autonomic Agents|autonomic agents|mesh-ancestor
102023457|NCT01012167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102023458|NCT01012167|Nootropic Agents|nootropic agents|mesh-ancestor
102023459|NCT02423278|Oxaliplatin|oxaliplatin|mesh-list
102023460|NCT02423278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102023461|NCT05189067|Paclitaxel|paclitaxel|mesh-list
102023462|NCT05189067|Docetaxel|docetaxel|mesh-list
102023463|NCT05189067|Trastuzumab|trastuzumab|mesh-list
102023464|NCT05189067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102023465|NCT05189067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102023466|NCT05189067|Tubulin Modulators|tubulin modulators|mesh-ancestor
102023467|NCT05189067|Antimitotic Agents|antimitotic agents|mesh-ancestor
102023468|NCT05189067|Mitosis Modulators|mitosis modulators|mesh-ancestor
102023469|NCT05189067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023470|NCT05189067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102023471|NCT03133767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102023472|NCT02422966|Acetaminophen|acetaminophen|mesh-list
102023473|NCT02422966|Ibuprofen|ibuprofen|mesh-list
102023474|NCT02422966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102023475|NCT02422966|Analgesics|analgesics|mesh-ancestor
102023476|NCT02422966|Sensory System Agents|sensory system agents|mesh-ancestor
102023477|NCT02422966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102023478|NCT02422966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023479|NCT02422966|Antipyretics|antipyretics|mesh-ancestor
102023480|NCT02422966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102023481|NCT02422966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102023482|NCT02422966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102023483|NCT02422966|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102023484|NCT02422966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102023485|NCT02422966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023486|NCT02422888|Ticagrelor|ticagrelor|mesh-list
101478472|NCT00281645|Analgesics|analgesics|mesh-list
102023494|NCT02422888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023495|NCT02422888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023496|NCT03633552|Temozolomide|temozolomide|mesh-list
102023497|NCT03633552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102023498|NCT03633552|Alkylating Agents|alkylating agents|mesh-ancestor
102023499|NCT03633552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023500|NCT03633552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102023501|NCT05760456|Metformin|metformin|mesh-list
102023502|NCT05760456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102023503|NCT05760456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023504|NCT02418130|Inositol|inositol|mesh-list
102023505|NCT02418130|Thiamine|thiamine|mesh-list
102023506|NCT02418130|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102023507|NCT02418130|Vitamin B Complex|vitamin b complex|mesh-ancestor
102023508|NCT02418130|Vitamins|vitamins|mesh-ancestor
102023509|NCT02418130|Micronutrients|micronutrients|mesh-ancestor
102023510|NCT02418130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023511|NCT02418130|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101951111|NCT01290549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101951112|NCT01290549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101951113|NCT01290549|Immunologic Factors|immunologic factors|mesh-ancestor
101951114|NCT01290549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951115|NCT01290549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101951116|NCT01290549|Immunoconjugates|immunoconjugates|mesh-ancestor
101951117|NCT01184235|Antipsychotic Agents|antipsychotic agents|mesh-list
101951118|NCT01184235|Antidepressive Agents|antidepressive agents|mesh-list
101951119|NCT01184235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101951120|NCT01184235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101951121|NCT01184235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101951122|NCT01184235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951123|NCT04951947|Lenvatinib|lenvatinib|mesh-list
101951124|NCT04951947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101951125|NCT04951947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101951126|NCT04951947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101951127|NCT04951947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023512|NCT02418130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102023513|NCT03391765|Tilavonemab|tilavonemab|mesh-list
102023514|NCT03391765|Nootropic Agents|nootropic agents|mesh-ancestor
102023515|NCT02802228|Ifetroban|ifetroban|mesh-list
102023516|NCT02802228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102023517|NCT02801448|Sulforaphane|sulforaphane|mesh-list
102023518|NCT02801448|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102023519|NCT02801448|Protective Agents|protective agents|mesh-ancestor
102023520|NCT02801448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023521|NCT02801448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102023522|NCT03179332|Insulin Lispro|insulin lispro|mesh-list
102023523|NCT03179332|Insulin Aspart|insulin aspart|mesh-list
102023524|NCT03179332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102023525|NCT03179332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023526|NCT03674177|Vaccines|vaccines|mesh-list
102023527|NCT03674177|Immunologic Factors|immunologic factors|mesh-ancestor
102023528|NCT03674177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023529|NCT02675790|Hydroxyurea|hydroxyurea|mesh-list
102023530|NCT02675790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102023531|NCT02675790|Antisickling Agents|antisickling agents|mesh-ancestor
102023532|NCT02675790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102023533|NCT02675790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023534|NCT02675790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102023535|NCT02417896|Spironolactone|spironolactone|mesh-list
102023536|NCT02417896|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102023537|NCT02417896|Hormone Antagonists|hormone antagonists|mesh-ancestor
102023538|NCT02417896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102023539|NCT02417896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023540|NCT02417896|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102023541|NCT02417896|Diuretics|diuretics|mesh-ancestor
102023542|NCT02417896|Natriuretic Agents|natriuretic agents|mesh-ancestor
102023543|NCT03183544|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102023544|NCT03183544|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102023545|NCT03183544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023546|NCT04380090|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
102023547|NCT04380090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102023548|NCT04380090|Antidiarrheals|antidiarrheals|mesh-ancestor
102023549|NCT03116776|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102023550|NCT03116776|Hyaluronic Acid|hyaluronic acid|mesh-list
102023551|NCT03116776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102023552|NCT03116776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101951129|NCT01184391|Anticonvulsants|anticonvulsants|mesh-ancestor
101951130|NCT01184391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101951131|NCT01184391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951132|NCT01184391|GABA Agents|gaba agents|mesh-ancestor
101951133|NCT01184391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101951134|NCT01184391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951135|NCT01184391|Antimanic Agents|antimanic agents|mesh-ancestor
101951136|NCT01184391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101951137|NCT01184391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101951138|NCT01184391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101951139|NCT02524743|Acetaminophen|acetaminophen|mesh-list
101951140|NCT02524743|Lidocaine|lidocaine|mesh-list
101951141|NCT02524743|Anesthetics, Local|anesthetics, local|mesh-ancestor
101951142|NCT02524743|Anesthetics|anesthetics|mesh-ancestor
101951143|NCT02524743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102023553|NCT03116776|Immunologic Factors|immunologic factors|mesh-ancestor
102023554|NCT03116776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023558|NCT02505204|Analgesics|analgesics|mesh-ancestor
102023559|NCT02505204|Sensory System Agents|sensory system agents|mesh-ancestor
102023560|NCT02505204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102023561|NCT02505204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023562|NCT02505204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102023563|NCT02505204|Sympatholytics|sympatholytics|mesh-ancestor
102023564|NCT02505204|Autonomic Agents|autonomic agents|mesh-ancestor
102023565|NCT02505204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102023566|NCT02505204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102023567|NCT02505204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102023568|NCT02505204|Adrenergic Agents|adrenergic agents|mesh-ancestor
102023569|NCT02505204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102023570|NCT02505204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023571|NCT04351698|Montelukast|montelukast|mesh-list
102023572|NCT04351698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102023573|NCT04351698|Respiratory System Agents|respiratory system agents|mesh-ancestor
102023574|NCT04351698|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102023575|NCT04351698|Hormone Antagonists|hormone antagonists|mesh-ancestor
102023576|NCT04351698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102023577|NCT04351698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023578|NCT04351698|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102023579|NCT04351698|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102023580|NCT04351698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023581|NCT01359423|Cilostazol|cilostazol|mesh-list
102023582|NCT01359423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102023583|NCT01359423|Autonomic Agents|autonomic agents|mesh-ancestor
102023584|NCT01359423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102023585|NCT01359423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023586|NCT01359423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102023587|NCT01359423|Respiratory System Agents|respiratory system agents|mesh-ancestor
102023588|NCT01359423|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102023589|NCT01359423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102023590|NCT01359423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023591|NCT01359423|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102023592|NCT01359423|Vasodilator Agents|vasodilator agents|mesh-ancestor
102023593|NCT01359423|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102023594|NCT01359423|Protective Agents|protective agents|mesh-ancestor
102023595|NCT01359423|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102023596|NCT01359423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102023597|NCT01359423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102023598|NCT01363089|Ketorolac|ketorolac|mesh-list
101951144|NCT02524743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951145|NCT02524743|Sensory System Agents|sensory system agents|mesh-ancestor
101951146|NCT02524743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101951147|NCT02524743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101951148|NCT02524743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101951149|NCT02524743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101951150|NCT02524743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101951151|NCT02524743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951152|NCT02524743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101951153|NCT02524743|Analgesics|analgesics|mesh-ancestor
101951154|NCT02524743|Antipyretics|antipyretics|mesh-ancestor
101951155|NCT01188057|Alprazolam|alprazolam|mesh-list
101951156|NCT01188057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101951157|NCT01188057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101951158|NCT01188057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951159|NCT01188057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101951160|NCT01188057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101951161|NCT01188057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101951162|NCT01188057|GABA Modulators|gaba modulators|mesh-ancestor
101951163|NCT01188057|GABA Agents|gaba agents|mesh-ancestor
102023599|NCT01363089|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102023600|NCT01363089|Phenylephrine|phenylephrine|mesh-list
102023601|NCT01363089|Oxymetazoline|oxymetazoline|mesh-list
102023602|NCT01363089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102023603|NCT01363089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102023604|NCT01363089|Analgesics|analgesics|mesh-ancestor
102023605|NCT01363089|Sensory System Agents|sensory system agents|mesh-ancestor
102023606|NCT01363089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102023607|NCT01363089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023608|NCT01363089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102023609|NCT01363089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102023610|NCT01363089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102023611|NCT01363089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102023612|NCT01363089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023613|NCT01363089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102023614|NCT01363089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102023615|NCT01363089|Adrenergic Agents|adrenergic agents|mesh-ancestor
102023616|NCT01363089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102023617|NCT01363089|Sympathomimetics|sympathomimetics|mesh-ancestor
102023618|NCT01363089|Autonomic Agents|autonomic agents|mesh-ancestor
102023619|NCT01363089|Nasal Decongestants|nasal decongestants|mesh-ancestor
102023620|NCT01363089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102023621|NCT01363089|Respiratory System Agents|respiratory system agents|mesh-ancestor
102023622|NCT01363089|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102023623|NCT01363089|Mydriatics|mydriatics|mesh-ancestor
101743389|NCT02594462|Contraceptive Agents|contraceptive agents|mesh-list
102023624|NCT01363089|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102023625|NCT01363089|Protective Agents|protective agents|mesh-ancestor
102023626|NCT01365741|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102023634|NCT03681548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102023635|NCT03681548|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102023636|NCT03681548|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102023637|NCT03681548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102023638|NCT03681548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023639|NCT02417506|Ibuprofen|ibuprofen|mesh-list
101951164|NCT01188057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101951165|NCT01188057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951167|NCT01291641|Probucol|probucol|mesh-list
102023640|NCT02417506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102023641|NCT02417506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102023642|NCT02417506|Analgesics|analgesics|mesh-ancestor
102023643|NCT02417506|Sensory System Agents|sensory system agents|mesh-ancestor
102023644|NCT02417506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102023645|NCT02417506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023646|NCT02417506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102023647|NCT02417506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102023648|NCT02417506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102023649|NCT02417506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102023650|NCT02417506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023651|NCT05188911|Prednisone|prednisone|mesh-list
102023652|NCT05188911|Androgens|androgens|mesh-list
102023653|NCT05188911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102023654|NCT05188911|Glucocorticoids|glucocorticoids|mesh-ancestor
102023655|NCT05188911|Hormones|hormones|mesh-ancestor
102023656|NCT05188911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102023657|NCT05188911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023658|NCT05188911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102023659|NCT05188911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102023660|NCT03676946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102023661|NCT03676946|Antibodies|antibodies|mesh-list
102023662|NCT03676946|Immunoglobulins|immunoglobulins|mesh-list
102023663|NCT03676946|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102023664|NCT03676946|Immunologic Factors|immunologic factors|mesh-ancestor
102023665|NCT03676946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023666|NCT03676946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102023667|NCT01363167|Vitamin D|vitamin d|mesh-list
102023668|NCT01363167|Cholecalciferol|cholecalciferol|mesh-list
102023669|NCT01363167|Vitamins|vitamins|mesh-ancestor
102023670|NCT01363167|Micronutrients|micronutrients|mesh-ancestor
102023671|NCT01363167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023672|NCT01363167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102023673|NCT01363167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102023674|NCT01359579|Varespladib methyl|varespladib methyl|mesh-list
102023675|NCT01359579|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
102023676|NCT01359579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102023677|NCT01359579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023678|NCT02422654|Eliglustat|eliglustat|mesh-list
102023679|NCT02422654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102023680|NCT02422654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023681|NCT05188833|Paroxetine|paroxetine|mesh-list
102023682|NCT05188833|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102023683|NCT05188833|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102023684|NCT05188833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102023685|NCT05188833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023686|NCT05188833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102023687|NCT05188833|Serotonin Agents|serotonin agents|mesh-ancestor
102023688|NCT05188833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023689|NCT05188833|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102023690|NCT05188833|Antidepressive Agents|antidepressive agents|mesh-ancestor
102023691|NCT05188833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102023692|NCT05188833|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102023707|NCT02426164|Analgesics|analgesics|mesh-ancestor
102023708|NCT02426164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102023709|NCT02426164|Antiemetics|antiemetics|mesh-ancestor
102023710|NCT02426164|Autonomic Agents|autonomic agents|mesh-ancestor
102023711|NCT02426164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102023712|NCT02426164|Glucocorticoids|glucocorticoids|mesh-ancestor
102023713|NCT02426164|Hormones|hormones|mesh-ancestor
102023714|NCT02426164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102023715|NCT02426164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102023716|NCT02426164|Protective Agents|protective agents|mesh-ancestor
102023717|NCT02426164|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102023718|NCT02426164|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102023719|NCT02426164|Adrenergic Agents|adrenergic agents|mesh-ancestor
101951168|NCT01291641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
101951169|NCT01291641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101951170|NCT01291641|Autonomic Agents|autonomic agents|mesh-ancestor
101285805|NCT01937338|AZD7624|azd7624|mesh-list
102023720|NCT02426164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102023721|NCT02426164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023722|NCT02426164|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102023723|NCT02426164|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102023724|NCT02426164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102023725|NCT02426164|Respiratory System Agents|respiratory system agents|mesh-ancestor
102023726|NCT02426164|Mydriatics|mydriatics|mesh-ancestor
102023727|NCT02426164|Sympathomimetics|sympathomimetics|mesh-ancestor
102023728|NCT02426164|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102023729|NCT03745157|Insulin|insulin|mesh-list
102023730|NCT03745157|Insulin Aspart|insulin aspart|mesh-list
102023731|NCT03745157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102023732|NCT03745157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023733|NCT02426008|Mitogens|mitogens|mesh-list
102023734|NCT02426008|Mitosis Modulators|mitosis modulators|mesh-ancestor
102023735|NCT02426008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023736|NCT04050371|Tenofovir|tenofovir|mesh-list
102023737|NCT04050371|Emtricitabine|emtricitabine|mesh-list
102023738|NCT04050371|Antiviral Agents|antiviral agents|mesh-ancestor
102023739|NCT04050371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102023740|NCT04050371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102023741|NCT04050371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102023742|NCT04050371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102023743|NCT04050371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023744|NCT04050371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102023745|NCT04050371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102023746|NCT04447287|Buprenorphine|buprenorphine|mesh-list
102023747|NCT04447287|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102023748|NCT04447287|ASP8062|asp8062|mesh-list
102023749|NCT04447287|Naloxone|naloxone|mesh-list
102023750|NCT04447287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102023751|NCT04447287|Narcotics|narcotics|mesh-ancestor
102023752|NCT04447287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102023753|NCT04447287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023754|NCT04447287|Analgesics|analgesics|mesh-ancestor
102023755|NCT04447287|Sensory System Agents|sensory system agents|mesh-ancestor
102023756|NCT04447287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101524125|NCT02909933|Metformin|metformin|mesh-list
102023760|NCT04447287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102023761|NCT04447287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023762|NCT01879319|Evolocumab|evolocumab|mesh-list
102023763|NCT01879319|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102023764|NCT01879319|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102023765|NCT01879319|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102023766|NCT01879319|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102023767|NCT01879319|Antimetabolites|antimetabolites|mesh-ancestor
102023768|NCT01879319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023769|NCT01879319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102023770|NCT01879319|Protease Inhibitors|protease inhibitors|mesh-ancestor
102023771|NCT01879319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102023772|NCT01879319|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102023773|NCT01879319|Immunologic Factors|immunologic factors|mesh-ancestor
102023774|NCT01879319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023775|NCT04165122|Valacyclovir|valacyclovir|mesh-list
102023776|NCT04165122|Antiviral Agents|antiviral agents|mesh-ancestor
102023777|NCT04165122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102023778|NCT02422030|Atorvastatin|atorvastatin|mesh-list
102023779|NCT02422030|Fenofibric acid|fenofibric acid|mesh-list
102023780|NCT02422030|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102023781|NCT02422030|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102023782|NCT02422030|Antimetabolites|antimetabolites|mesh-ancestor
102023783|NCT02422030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023784|NCT02422030|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102023785|NCT02422030|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102023786|NCT02422030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102023787|NCT02425930|Oxaliplatin|oxaliplatin|mesh-list
102023788|NCT02425930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102023789|NCT01365897|Modafinil|modafinil|mesh-list
102023790|NCT01365897|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101951171|NCT01291641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101670974|NCT00926809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101951172|NCT01291641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951173|NCT01291641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101951174|NCT01291641|Respiratory System Agents|respiratory system agents|mesh-ancestor
101951175|NCT01291641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101951176|NCT01291641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101951177|NCT01291641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951178|NCT01291641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101951179|NCT01291641|Vasodilator Agents|vasodilator agents|mesh-ancestor
101951180|NCT01291641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101951181|NCT01291641|Protective Agents|protective agents|mesh-ancestor
101951182|NCT01291641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101951183|NCT01291641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101951184|NCT01291641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101951185|NCT01291641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102023791|NCT01365897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023792|NCT01365897|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102023793|NCT01365897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102023794|NCT01365897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102023795|NCT01365897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023796|NCT02422108|Denosumab|denosumab|mesh-list
102023797|NCT02422108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102023798|NCT02422108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023799|NCT01359657|Dexamethasone|dexamethasone|mesh-list
102023800|NCT01359657|Dexamethasone acetate|dexamethasone acetate|mesh-list
102023801|NCT01359657|Lenalidomide|lenalidomide|mesh-list
102023802|NCT01359657|Bortezomib|bortezomib|mesh-list
102023803|NCT01359657|BB 1101|bb 1101|mesh-list
102023804|NCT01359657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102023805|NCT01359657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102023806|NCT01359657|Antiemetics|antiemetics|mesh-ancestor
102023807|NCT01359657|Autonomic Agents|autonomic agents|mesh-ancestor
102023808|NCT01359657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102023809|NCT01359657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023810|NCT01359657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102023811|NCT01359657|Glucocorticoids|glucocorticoids|mesh-ancestor
102023812|NCT01359657|Hormones|hormones|mesh-ancestor
102023813|NCT01359657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102023814|NCT01359657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102023815|NCT01359657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102023816|NCT01359657|Protease Inhibitors|protease inhibitors|mesh-ancestor
102023817|NCT01359657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102023818|NCT01359657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023819|NCT01359657|Immunologic Factors|immunologic factors|mesh-ancestor
102023820|NCT01359657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102023821|NCT01359657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102023822|NCT01359657|Growth Substances|growth substances|mesh-ancestor
102023823|NCT01359657|Growth Inhibitors|growth inhibitors|mesh-ancestor
102023824|NCT02417116|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102023825|NCT02417116|Hyaluronic Acid|hyaluronic acid|mesh-list
102023826|NCT02417116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102023827|NCT02417116|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102023828|NCT02417116|Immunologic Factors|immunologic factors|mesh-ancestor
102023829|NCT02417116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023834|NCT03183310|Autonomic Agents|autonomic agents|mesh-ancestor
102023835|NCT03183310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101951186|NCT01291641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101951187|NCT01291641|Antimetabolites|antimetabolites|mesh-ancestor
101951188|NCT01291641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101951190|NCT03855501|Calcium|calcium|mesh-list
101951191|NCT03855501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101951192|NCT03855501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951193|NCT01588587|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101951194|NCT01588587|Vildagliptin|vildagliptin|mesh-list
101951195|NCT01588587|Alogliptin|alogliptin|mesh-list
101951196|NCT01588587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101951197|NCT01588587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951198|NCT01588587|Incretins|incretins|mesh-ancestor
101951199|NCT01588587|Hormones|hormones|mesh-ancestor
101951200|NCT01588587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101951201|NCT01588587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101951202|NCT01588587|Protease Inhibitors|protease inhibitors|mesh-ancestor
101951203|NCT01588587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101951204|NCT01588587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951205|NCT03325712|Midazolam|midazolam|mesh-list
101951206|NCT03325712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101951207|NCT03325712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101951208|NCT03325712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101951209|NCT03325712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951210|NCT03325712|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101951211|NCT03325712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101951212|NCT03325712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101951213|NCT03325712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101951214|NCT03325712|Anesthetics, General|anesthetics, general|mesh-ancestor
101951215|NCT03325712|Anesthetics|anesthetics|mesh-ancestor
101951216|NCT03325712|GABA Modulators|gaba modulators|mesh-ancestor
101951217|NCT03325712|GABA Agents|gaba agents|mesh-ancestor
101951218|NCT03325712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101951219|NCT03325712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951220|NCT01293747|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101951221|NCT01293747|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101951222|NCT01293747|Estradiol|estradiol|mesh-list
101285912|NCT01937806|Antiviral Agents|antiviral agents|mesh-ancestor
102023836|NCT03183310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951224|NCT01293747|Progesterone|progesterone|mesh-list
101951225|NCT01293747|Estrogens|estrogens|mesh-ancestor
101951226|NCT01293747|Hormones|hormones|mesh-ancestor
101951227|NCT01293747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101951228|NCT01293747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951229|NCT01293747|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101951230|NCT01293747|Contraceptive Agents|contraceptive agents|mesh-ancestor
101951231|NCT01293747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101951232|NCT01293747|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101951233|NCT01293747|Progestins|progestins|mesh-ancestor
101951234|NCT03849729|Phentermine|phentermine|mesh-list
101951235|NCT03849729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101951236|NCT03849729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951237|NCT03849729|Appetite Depressants|appetite depressants|mesh-ancestor
101951238|NCT03849729|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101951239|NCT03849729|Sympathomimetics|sympathomimetics|mesh-ancestor
101951240|NCT03849729|Autonomic Agents|autonomic agents|mesh-ancestor
101951241|NCT03849729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101951242|NCT03849729|Adrenergic Agents|adrenergic agents|mesh-ancestor
101951243|NCT03849729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101951244|NCT03849729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951245|NCT03325556|Pimavanserin|pimavanserin|mesh-list
101951246|NCT03325556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101951247|NCT03325556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101951248|NCT03325556|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101951249|NCT03325556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101951250|NCT03325556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101951251|NCT03325556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951252|NCT03325556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101951253|NCT03325556|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101951254|NCT03325556|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101951255|NCT03325556|Serotonin Agents|serotonin agents|mesh-ancestor
101951256|NCT03325556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102023837|NCT03183310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102023838|NCT03183310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102023839|NCT03183310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102023840|NCT03183310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102023841|NCT03183310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102023842|NCT03183310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102023843|NCT03183310|Dopamine Agents|dopamine agents|mesh-ancestor
101951257|NCT03325556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951258|NCT01188213|Dimethyl sulfone|dimethyl sulfone|mesh-list
101951259|NCT01188213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101524172|NCT01959282|Vitamins|vitamins|mesh-ancestor
101951260|NCT03320564|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101951261|NCT03320564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101951262|NCT03320564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951263|NCT03852303|Ivermectin|ivermectin|mesh-list
101951264|NCT03852303|Anticonvulsants|anticonvulsants|mesh-list
101951265|NCT03852303|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101951266|NCT03852303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101951267|NCT03325166|Pembrolizumab|pembrolizumab|mesh-list
102023844|NCT03183310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102023845|NCT03183310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023846|NCT03177850|Acetazolamide|acetazolamide|mesh-list
102023847|NCT03177850|Anticonvulsants|anticonvulsants|mesh-ancestor
102023848|NCT03177850|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102023849|NCT03177850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102023850|NCT03177850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023851|NCT03177850|Diuretics|diuretics|mesh-ancestor
102023852|NCT03177850|Natriuretic Agents|natriuretic agents|mesh-ancestor
102023853|NCT03177850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023854|NCT03102918|Cannabidiol|cannabidiol|mesh-list
102023855|NCT03102918|Anticonvulsants|anticonvulsants|mesh-ancestor
102023856|NCT03102762|Botulinum Toxins|botulinum toxins|mesh-list
102023857|NCT03102762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102023858|NCT03102762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102023859|NCT03102762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102023860|NCT03102762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102023861|NCT03102762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023862|NCT03102762|Cholinergic Agents|cholinergic agents|mesh-ancestor
102023863|NCT03102762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102023864|NCT03102762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023865|NCT03102762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102023866|NCT03102762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102023867|NCT03684824|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102023868|NCT03684824|Luteolytic Agents|luteolytic agents|mesh-ancestor
102023869|NCT03684824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102023870|NCT03684824|Contraceptive Agents|contraceptive agents|mesh-ancestor
102023871|NCT03684824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102023872|NCT03684824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023873|NCT03684824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102023874|NCT03684824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102023875|NCT03684824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102023876|NCT03177538|Menotropins|menotropins|mesh-list
102023877|NCT03177538|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102023878|NCT03177538|Hormones|hormones|mesh-ancestor
102023879|NCT03177538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102023880|NCT03177538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023881|NCT03177538|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102023882|NCT03177538|Fertility Agents|fertility agents|mesh-ancestor
102023883|NCT03177538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102023884|NCT01363323|Moxifloxacin|moxifloxacin|mesh-list
102023885|NCT01363323|Naltrexone|naltrexone|mesh-list
102023886|NCT01363323|Methylnaltrexone|methylnaltrexone|mesh-list
102023887|NCT01363323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102023888|NCT01363323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102023889|NCT01363323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102023890|NCT01363323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102023891|NCT01363323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102023892|NCT01363323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023893|NCT01363323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102023894|NCT01363323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023895|NCT01363323|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101951268|NCT03325166|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
101951269|NCT03325166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101951270|NCT03325166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101951271|NCT03325166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101951272|NCT03325166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951273|NCT03325166|Hematinics|hematinics|mesh-ancestor
101951274|NCT03325166|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101951275|NCT03325166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101951276|NCT03847623|Curcumin|curcumin|mesh-list
101951277|NCT03847623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101951278|NCT03847623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101951279|NCT03847623|Analgesics|analgesics|mesh-ancestor
101951280|NCT03847623|Sensory System Agents|sensory system agents|mesh-ancestor
101951281|NCT03847623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101951282|NCT03847623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951283|NCT03847623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101951284|NCT03847623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101951285|NCT03847623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101951286|NCT03847623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101951287|NCT03847623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951288|NCT01294059|Milnacipran|milnacipran|mesh-list
101951289|NCT01294059|Levomilnacipran|levomilnacipran|mesh-list
101951290|NCT01294059|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101951291|NCT01294059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101951292|NCT01294059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101951293|NCT01294059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951294|NCT01294059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101951295|NCT01294059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951296|NCT01294059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101951311|NCT03847155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951312|NCT01294215|Nifedipine|nifedipine|mesh-list
101951313|NCT01294215|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101951314|NCT01294215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101951315|NCT01294215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951316|NCT01294215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101951317|NCT01294215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951318|NCT01294215|Vasodilator Agents|vasodilator agents|mesh-ancestor
101951319|NCT01294215|Tocolytic Agents|tocolytic agents|mesh-ancestor
101951320|NCT01294215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101671126|NCT02812394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101951321|NCT01296555|Letrozole|letrozole|mesh-list
101951322|NCT01296555|Fulvestrant|fulvestrant|mesh-list
101951323|NCT01296555|Midazolam|midazolam|mesh-list
101951324|NCT01296555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101951325|NCT01296555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101951326|NCT01296555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102023896|NCT01363323|Sensory System Agents|sensory system agents|mesh-ancestor
102023897|NCT01363323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102023898|NCT01363323|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102023899|NCT03183076|Anticonvulsants|anticonvulsants|mesh-list
102023900|NCT03106948|Ascorbic Acid|ascorbic acid|mesh-list
102023901|NCT03106948|Penicillamine|penicillamine|mesh-list
102023905|NCT03106948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023906|NCT03106948|Vitamins|vitamins|mesh-ancestor
102023907|NCT03106948|Micronutrients|micronutrients|mesh-ancestor
102023908|NCT03106948|Antidotes|antidotes|mesh-ancestor
102023909|NCT03106948|Chelating Agents|chelating agents|mesh-ancestor
102023910|NCT03106948|Sequestering Agents|sequestering agents|mesh-ancestor
102023911|NCT03106948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102023912|NCT01366365|Methylnaltrexone|methylnaltrexone|mesh-list
102023913|NCT01366365|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102023914|NCT01366365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023915|NCT01366365|Sensory System Agents|sensory system agents|mesh-ancestor
102023916|NCT01366365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102023917|NCT01881048|Celecoxib|celecoxib|mesh-list
102023918|NCT01881048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102023919|NCT01881048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102023920|NCT01881048|Analgesics|analgesics|mesh-ancestor
102023921|NCT01881048|Sensory System Agents|sensory system agents|mesh-ancestor
102023922|NCT01881048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102023923|NCT01881048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023924|NCT01881048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102023925|NCT01881048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102023926|NCT01881048|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102023927|NCT01881048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102023928|NCT01881048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102023929|NCT01881048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023930|NCT01363557|Gefitinib|gefitinib|mesh-list
102023931|NCT01363557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102023932|NCT01363557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102023933|NCT01363557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102023934|NCT01363557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023935|NCT01346475|Valacyclovir|valacyclovir|mesh-list
102023936|NCT01346475|Antiviral Agents|antiviral agents|mesh-ancestor
102023937|NCT01346475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102023938|NCT01338636|Ambrisentan|ambrisentan|mesh-list
102023939|NCT01338636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102023940|NCT02416258|Betamethasone|betamethasone|mesh-list
101951327|NCT01296555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951328|NCT01296555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101951329|NCT01296555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101951330|NCT01296555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101951331|NCT01296555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101951332|NCT01296555|Anesthetics, General|anesthetics, general|mesh-ancestor
101951333|NCT01296555|Anesthetics|anesthetics|mesh-ancestor
101951334|NCT01296555|GABA Modulators|gaba modulators|mesh-ancestor
101951335|NCT01296555|GABA Agents|gaba agents|mesh-ancestor
101951336|NCT01296555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101951337|NCT01296555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951338|NCT01296555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101951339|NCT01296555|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101951340|NCT01296555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101951341|NCT01296555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101951342|NCT01296555|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101951343|NCT01296555|Hormone Antagonists|hormone antagonists|mesh-ancestor
101951344|NCT01296555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101951345|NCT01296555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101951346|NCT01296555|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101951347|NCT01294293|Paclitaxel|paclitaxel|mesh-list
101951348|NCT01294293|Doxorubicin|doxorubicin|mesh-list
101951349|NCT01294293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101951350|NCT01294293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101951351|NCT01294293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101951352|NCT01294293|Tubulin Modulators|tubulin modulators|mesh-ancestor
101951353|NCT01294293|Antimitotic Agents|antimitotic agents|mesh-ancestor
101951354|NCT01294293|Mitosis Modulators|mitosis modulators|mesh-ancestor
101951355|NCT01294293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951359|NCT01294293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101951373|NCT01294761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101951374|NCT01294761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101951375|NCT01294761|Antiviral Agents|antiviral agents|mesh-ancestor
101951376|NCT01294761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101951377|NCT01294761|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101951378|NCT01294761|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101951379|NCT01294761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101951380|NCT01294761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951381|NCT01294761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101951382|NCT01294761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101951383|NCT01294761|Protease Inhibitors|protease inhibitors|mesh-ancestor
101951384|NCT03849183|Nitroglycerin|nitroglycerin|mesh-list
101951385|NCT03849183|Vasodilator Agents|vasodilator agents|mesh-ancestor
101951386|NCT03305666|Bupivacaine|bupivacaine|mesh-list
101951387|NCT03305666|Anesthetics, Local|anesthetics, local|mesh-ancestor
101951388|NCT03305666|Anesthetics|anesthetics|mesh-ancestor
101951435|NCT04633226|Vaccines|vaccines|mesh-list
101951436|NCT04633226|Immunologic Factors|immunologic factors|mesh-ancestor
101951437|NCT04633226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951438|NCT03849027|Methoxyflurane|methoxyflurane|mesh-list
101951439|NCT03849027|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101951440|NCT03849027|Anesthetics, General|anesthetics, general|mesh-ancestor
101951441|NCT03849027|Anesthetics|anesthetics|mesh-ancestor
101951442|NCT03849027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101951443|NCT03849027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951444|NCT01188759|Voriconazole|voriconazole|mesh-list
101951445|NCT01188759|Anidulafungin|anidulafungin|mesh-list
101951446|NCT01188759|Antifungal Agents|antifungal agents|mesh-ancestor
101951447|NCT01188759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101951448|NCT01188759|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101951449|NCT01188759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101951450|NCT01188759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101951451|NCT01188759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951452|NCT01188759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101951453|NCT01188759|Hormone Antagonists|hormone antagonists|mesh-ancestor
101951454|NCT01188759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101951455|NCT01188759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951456|NCT01188759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101951457|NCT01295073|Trientine|trientine|mesh-list
101951458|NCT01295073|Chelating Agents|chelating agents|mesh-ancestor
101951459|NCT01295073|Sequestering Agents|sequestering agents|mesh-ancestor
101951460|NCT01295073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951461|NCT01292109|Picosulfate sodium|picosulfate sodium|mesh-list
101951462|NCT01292109|Cathartics|cathartics|mesh-ancestor
101951463|NCT01292109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101951464|NCT01191645|Remifentanil|remifentanil|mesh-list
101951465|NCT01191645|Metoclopramide|metoclopramide|mesh-list
101951480|NCT01191645|Dopamine Agents|dopamine agents|mesh-ancestor
101951481|NCT01191645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101951482|NCT01191645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951483|NCT03736785|Insulin|insulin|mesh-list
101951484|NCT03736785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101951485|NCT03736785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951486|NCT03734991|Ibrexafungerp|ibrexafungerp|mesh-list
101951487|NCT03734991|Antifungal Agents|antifungal agents|mesh-ancestor
101951488|NCT03734991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101951489|NCT01295151|Adalimumab|adalimumab|mesh-list
101951490|NCT01295151|Infliximab|infliximab|mesh-list
101951491|NCT01295151|Golimumab|golimumab|mesh-list
101951492|NCT01295151|Certolizumab Pegol|certolizumab pegol|mesh-list
101951493|NCT01295151|Etanercept|etanercept|mesh-list
101951494|NCT01295151|Rituximab|rituximab|mesh-list
101951495|NCT01295151|Abatacept|abatacept|mesh-list
101951496|NCT01295151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101951497|NCT01295151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101951498|NCT01295151|Immunologic Factors|immunologic factors|mesh-ancestor
101951499|NCT01295151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951500|NCT01295151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101951501|NCT01295151|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101951502|NCT01295151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101951503|NCT01295151|Dermatologic Agents|dermatologic agents|mesh-ancestor
101951504|NCT01295151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101951505|NCT01295151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101951506|NCT01295151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101951507|NCT01295151|Analgesics|analgesics|mesh-ancestor
101951508|NCT01295151|Sensory System Agents|sensory system agents|mesh-ancestor
101951509|NCT01295151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101951510|NCT01295151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101951511|NCT01295151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101951512|NCT01295151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951513|NCT01295307|Clofarabine|clofarabine|mesh-list
101951514|NCT01295307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101951515|NCT01295307|Antimetabolites|antimetabolites|mesh-ancestor
101951520|NCT01292343|Fluorides|fluorides|mesh-list
101951521|NCT01292343|Sodium Fluoride|sodium fluoride|mesh-list
101951522|NCT01292343|Cariostatic Agents|cariostatic agents|mesh-ancestor
101951523|NCT01292343|Protective Agents|protective agents|mesh-ancestor
101951524|NCT01292343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951525|NCT01292343|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101951526|NCT01292343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101951527|NCT01292343|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101951528|NCT01292343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101951529|NCT01292343|Antimetabolites|antimetabolites|mesh-ancestor
101951530|NCT01292343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951531|NCT01292343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101951532|NCT01192113|Vitamin B 12|vitamin b 12|mesh-list
101951533|NCT01192113|Vitamin B Complex|vitamin b complex|mesh-ancestor
102023941|NCT02416258|Betamethasone Valerate|betamethasone valerate|mesh-list
102023942|NCT02416258|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102023943|NCT02416258|Betamethasone benzoate|betamethasone benzoate|mesh-list
102023944|NCT02416258|Calcipotriene|calcipotriene|mesh-list
102023945|NCT02416258|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102023946|NCT02416258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102023947|NCT02416258|Glucocorticoids|glucocorticoids|mesh-ancestor
102023948|NCT02416258|Hormones|hormones|mesh-ancestor
102023949|NCT02416258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102023950|NCT02416258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023951|NCT02416258|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102023952|NCT02416258|Respiratory System Agents|respiratory system agents|mesh-ancestor
102023953|NCT02416258|Dermatologic Agents|dermatologic agents|mesh-ancestor
102023954|NCT02410720|Picosulfate sodium|picosulfate sodium|mesh-list
102023955|NCT02410720|Cathartics|cathartics|mesh-ancestor
102023956|NCT02410720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102023957|NCT02416570|Clarithromycin|clarithromycin|mesh-list
102023958|NCT02416570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102023959|NCT02416570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102023960|NCT02416570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102023961|NCT02416570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102023962|NCT02416570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023963|NCT02416570|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102023964|NCT02416570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102023965|NCT05328336|Paclitaxel|paclitaxel|mesh-list
102023966|NCT05328336|Tislelizumab|tislelizumab|mesh-list
102023967|NCT05328336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102023968|NCT05328336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102023969|NCT05328336|Tubulin Modulators|tubulin modulators|mesh-ancestor
102023970|NCT05328336|Antimitotic Agents|antimitotic agents|mesh-ancestor
102023971|NCT05328336|Mitosis Modulators|mitosis modulators|mesh-ancestor
102023972|NCT05328336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023973|NCT05328336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102023978|NCT02873754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102023979|NCT02873754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023981|NCT02873754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102023982|NCT02873754|Cholinergic Agents|cholinergic agents|mesh-ancestor
102023983|NCT02873754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102023984|NCT02873754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023985|NCT02873754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102023986|NCT02873754|Antidepressive Agents|antidepressive agents|mesh-ancestor
102023987|NCT02873754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102023988|NCT02873754|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102023989|NCT02873754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102023990|NCT02873754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102023991|NCT02873754|Dopamine Agents|dopamine agents|mesh-ancestor
101951534|NCT01192113|Vitamins|vitamins|mesh-ancestor
101951535|NCT01192113|Micronutrients|micronutrients|mesh-ancestor
102023992|NCT02873754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102023993|NCT02873754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102023994|NCT02873754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102023995|NCT03669614|Gallium citrate|gallium citrate|mesh-list
101524229|NCT02909465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102023996|NCT03669614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023997|NCT03669614|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102023998|NCT05200260|Niraparib|niraparib|mesh-list
102023999|NCT05200260|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102024000|NCT05200260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102024001|NCT05200260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024002|NCT05200260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102024003|NCT02416804|Buprenorphine|buprenorphine|mesh-list
102024004|NCT02416804|Tramadol|tramadol|mesh-list
102024005|NCT02416804|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102024006|NCT02416804|Narcotics|narcotics|mesh-ancestor
102024007|NCT02416804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102024008|NCT02416804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024009|NCT02416804|Analgesics|analgesics|mesh-ancestor
102024010|NCT02416804|Sensory System Agents|sensory system agents|mesh-ancestor
102024011|NCT02416804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102024012|NCT02416804|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102024013|NCT04792320|Charcoal|charcoal|mesh-list
102024014|NCT04792320|Antidotes|antidotes|mesh-ancestor
102024015|NCT04792320|Protective Agents|protective agents|mesh-ancestor
102024016|NCT04792320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024017|NCT03176758|Anesthetics|anesthetics|mesh-list
102024018|NCT03176758|Anesthetics, General|anesthetics, general|mesh-list
102024019|NCT03176758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102024020|NCT03176758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024021|NCT03177070|Methylene Blue|methylene blue|mesh-list
102024022|NCT03177070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102024023|NCT03177070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024024|NCT03680612|Cefepime|cefepime|mesh-list
102024025|NCT03680612|Enmetazobactam|enmetazobactam|mesh-list
102024026|NCT03680612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102024027|NCT03680612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102024028|NCT03680612|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102024029|NCT03680612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102024030|NCT03680612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024031|NCT02410096|Methacholine Chloride|methacholine chloride|mesh-list
102024032|NCT02410096|Miotics|miotics|mesh-ancestor
102024033|NCT02410096|Autonomic Agents|autonomic agents|mesh-ancestor
102024034|NCT02410096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102024035|NCT02410096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024036|NCT02410096|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102024037|NCT02410096|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
102024038|NCT02410096|Respiratory System Agents|respiratory system agents|mesh-ancestor
102024039|NCT02410096|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102024040|NCT02410096|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102024041|NCT02410096|Cholinergic Agents|cholinergic agents|mesh-ancestor
102024042|NCT02410096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102024043|NCT02410096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024044|NCT04046939|Pramipexole|pramipexole|mesh-list
102024047|NCT04046939|Protective Agents|protective agents|mesh-ancestor
102024048|NCT04046939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024049|NCT04046939|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102024050|NCT04046939|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102024051|NCT04046939|Dopamine Agonists|dopamine agonists|mesh-ancestor
102024053|NCT04046939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102024054|NCT05188131|Diclofenac|diclofenac|mesh-list
102024055|NCT05188131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102024056|NCT05188131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102024057|NCT05188131|Analgesics|analgesics|mesh-ancestor
102024058|NCT05188131|Sensory System Agents|sensory system agents|mesh-ancestor
102024059|NCT05188131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102024060|NCT05188131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024061|NCT05188131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102024062|NCT05188131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102024063|NCT05188131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102024064|NCT05188131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387656|NCT00322660|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102024065|NCT05188131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024066|NCT01360437|Ticagrelor|ticagrelor|mesh-list
101951536|NCT01192113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951537|NCT03303092|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101286403|NCT01940718|Hormones|hormones|mesh-ancestor
102024067|NCT01360437|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102024068|NCT01360437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102024069|NCT01360437|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102024070|NCT01360437|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102024071|NCT01360437|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102024072|NCT01360437|Purinergic Agents|purinergic agents|mesh-ancestor
101743843|NCT00776009|Methylphenidate|methylphenidate|mesh-list
102024073|NCT01360437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102024074|NCT01360437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024075|NCT01360437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024076|NCT02409862|Oxytocin|oxytocin|mesh-list
102024077|NCT02409862|Oxytocics|oxytocics|mesh-ancestor
102024078|NCT02409862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102024079|NCT02409862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024080|NCT01360671|Sildenafil Citrate|sildenafil citrate|mesh-list
102024081|NCT01360671|Vasodilator Agents|vasodilator agents|mesh-ancestor
102024082|NCT01360671|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102024083|NCT01360671|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102024084|NCT01360671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102024085|NCT01360671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024086|NCT01360671|Urological Agents|urological agents|mesh-ancestor
102024087|NCT02955797|Vaccines|vaccines|mesh-list
102024088|NCT02955797|Immunologic Factors|immunologic factors|mesh-ancestor
102024089|NCT02955797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024090|NCT03680378|Cefepime|cefepime|mesh-list
102024091|NCT03680378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102024092|NCT03680378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102024093|NCT01319331|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
102024094|NCT01319331|Protein C Inhibitor|protein c inhibitor|mesh-list
102024095|NCT01319331|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102024096|NCT01319331|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102024097|NCT01319331|Protease Inhibitors|protease inhibitors|mesh-ancestor
102024098|NCT01319331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102024099|NCT01319331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024108|NCT03010176|Pembrolizumab|pembrolizumab|mesh-list
102024109|NCT03010176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102024110|NCT03010176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102024111|NCT03010176|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102024112|NCT03010176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024113|NCT03176524|Glucagon|glucagon|mesh-list
101479104|NCT00319566|Estrogens|estrogens|mesh-ancestor
102024118|NCT03176524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024120|NCT03676088|Mitogens|mitogens|mesh-list
102024121|NCT03676088|Mitosis Modulators|mitosis modulators|mesh-ancestor
102024122|NCT03676088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024123|NCT02414464|Calcium, Dietary|calcium, dietary|mesh-list
102024124|NCT02414464|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102024125|NCT02414464|Calcium|calcium|mesh-list
102024126|NCT02414464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102024127|NCT02414464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024128|NCT02414464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102024129|NCT02414464|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102024130|NCT02414464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102024131|NCT03226418|Cytarabine|cytarabine|mesh-list
102024132|NCT03226418|Azacitidine|azacitidine|mesh-list
102024133|NCT03226418|Decitabine|decitabine|mesh-list
102024134|NCT03226418|Daunorubicin|daunorubicin|mesh-list
102024135|NCT03226418|Venetoclax|venetoclax|mesh-list
102024136|NCT03226418|Idarubicin|idarubicin|mesh-list
102024137|NCT03226418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102024138|NCT03226418|Antimetabolites|antimetabolites|mesh-ancestor
101951538|NCT03303092|Immunologic Factors|immunologic factors|mesh-ancestor
101951539|NCT03303092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951540|NCT03851679|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101951541|NCT03851679|Natriuretic Agents|natriuretic agents|mesh-ancestor
101951542|NCT03851679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951543|NCT01192503|Rasagiline|rasagiline|mesh-list
101524247|NCT01184989|Dabigatran|dabigatran|mesh-list
101951544|NCT01192503|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101951545|NCT01192503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101951546|NCT01192503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951547|NCT01192503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102024139|NCT03226418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024140|NCT03226418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102024141|NCT03226418|Antiviral Agents|antiviral agents|mesh-ancestor
102024142|NCT03226418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102024143|NCT03226418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102024144|NCT03226418|Immunologic Factors|immunologic factors|mesh-ancestor
102024145|NCT03226418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024146|NCT03226418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102024147|NCT03226418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102024148|NCT03226418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102024149|NCT03226418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102024150|NCT04039503|Tirzepatide|tirzepatide|mesh-list
102024152|NCT04039503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024153|NCT04039503|Incretins|incretins|mesh-ancestor
102024154|NCT04039503|Hormones|hormones|mesh-ancestor
102024155|NCT04039503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102024156|NCT05418114|Magnesium Sulfate|magnesium sulfate|mesh-list
102024157|NCT05418114|Analgesics|analgesics|mesh-ancestor
102024158|NCT05418114|Sensory System Agents|sensory system agents|mesh-ancestor
102024159|NCT05418114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102024160|NCT05418114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024161|NCT05418114|Anesthetics|anesthetics|mesh-ancestor
102024162|NCT05418114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102024163|NCT05418114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102024164|NCT05418114|Anticonvulsants|anticonvulsants|mesh-ancestor
102024165|NCT05418114|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102024166|NCT05418114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102024167|NCT05418114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024168|NCT05418114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102024169|NCT05418114|Tocolytic Agents|tocolytic agents|mesh-ancestor
102024170|NCT05418114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102024171|NCT05528952|Bevacizumab|bevacizumab|mesh-list
102024172|NCT05528952|Atezolizumab|atezolizumab|mesh-list
102024173|NCT05528952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102024174|NCT05528952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102024175|NCT05528952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102024176|NCT05528952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102024177|NCT05528952|Growth Substances|growth substances|mesh-ancestor
102024178|NCT05528952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024179|NCT05528952|Growth Inhibitors|growth inhibitors|mesh-ancestor
102024180|NCT05528952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102024181|NCT05528952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024182|NCT05189769|Levonorgestrel|levonorgestrel|mesh-list
102024183|NCT05189769|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102024184|NCT05189769|Contraceptive Agents|contraceptive agents|mesh-ancestor
102024218|NCT05029726|Sympathomimetics|sympathomimetics|mesh-ancestor
102024219|NCT05029726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102024220|NCT05029726|Analgesics|analgesics|mesh-ancestor
102024221|NCT05029726|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102024222|NCT05029726|Sympatholytics|sympatholytics|mesh-ancestor
102024223|NCT05029726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102024224|NCT05186883|Parathyroid Hormone|parathyroid hormone|mesh-list
102024225|NCT05186883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101951548|NCT01192503|Protective Agents|protective agents|mesh-ancestor
101951549|NCT01192503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951550|NCT01192581|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
102024226|NCT05186883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024227|NCT05007652|Plerixafor|plerixafor|mesh-list
102024228|NCT05007652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102024229|NCT05007652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102024230|NCT05007652|Antiviral Agents|antiviral agents|mesh-ancestor
102024231|NCT05007652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102024232|NCT03632772|Solifenacin Succinate|solifenacin succinate|mesh-list
102024233|NCT03632772|Mirabegron|mirabegron|mesh-list
102024234|NCT03632772|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102024235|NCT03632772|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102024236|NCT03632772|Cholinergic Agents|cholinergic agents|mesh-ancestor
102024237|NCT03632772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102024238|NCT03632772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024239|NCT03632772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024240|NCT03632772|Urological Agents|urological agents|mesh-ancestor
102024241|NCT03632772|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102024242|NCT03632772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102024243|NCT03632772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102024244|NCT03632772|Adrenergic Agents|adrenergic agents|mesh-ancestor
102024245|NCT01360749|Lidocaine|lidocaine|mesh-list
102024246|NCT01360749|Anesthetics, Local|anesthetics, local|mesh-ancestor
102024247|NCT01360749|Anesthetics|anesthetics|mesh-ancestor
102024248|NCT01360749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102024249|NCT01360749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024250|NCT01360749|Sensory System Agents|sensory system agents|mesh-ancestor
102024251|NCT01360749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102024252|NCT01360749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102024253|NCT01360749|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102024254|NCT01360749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102024255|NCT01360749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102024256|NCT01360749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024257|NCT01367223|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
102024258|NCT01367223|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102024259|NCT01367223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102024260|NCT03675854|Cefazolin|cefazolin|mesh-list
102024261|NCT03675854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102024262|NCT03675854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102024263|NCT01360827|Cisplatin|cisplatin|mesh-list
102024264|NCT01360827|Fluorouracil|fluorouracil|mesh-list
102024265|NCT01360827|Cetuximab|cetuximab|mesh-list
102024266|NCT01360827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102024267|NCT01360827|Antimetabolites|antimetabolites|mesh-ancestor
102024268|NCT01360827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024269|NCT01360827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102024270|NCT01360827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102024271|NCT01360827|Immunologic Factors|immunologic factors|mesh-ancestor
102024272|NCT01360827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024273|NCT01360827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102024274|NCT03171610|Fentanyl|fentanyl|mesh-list
102024275|NCT03171610|Sufentanil|sufentanil|mesh-list
102024276|NCT03171610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102024277|NCT03171610|Narcotics|narcotics|mesh-ancestor
102024278|NCT03171610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102024279|NCT03171610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024280|NCT03171610|Analgesics|analgesics|mesh-ancestor
102024281|NCT03171610|Sensory System Agents|sensory system agents|mesh-ancestor
102024282|NCT03171610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102024283|NCT03171610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102024284|NCT03171610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102024285|NCT03171610|Anesthetics, General|anesthetics, general|mesh-ancestor
102024286|NCT03171610|Anesthetics|anesthetics|mesh-ancestor
102024287|NCT01364181|Udenafil|udenafil|mesh-list
102024291|NCT01364181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024292|NCT03679442|Acetylcysteine|acetylcysteine|mesh-list
102024293|NCT03679442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102024294|NCT03679442|Antidotes|antidotes|mesh-list
102024295|NCT03679442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024296|NCT03679442|Antiviral Agents|antiviral agents|mesh-ancestor
101951551|NCT01192581|Plasma Substitutes|plasma substitutes|mesh-ancestor
101951552|NCT01192581|Blood Substitutes|blood substitutes|mesh-ancestor
101951553|NCT03851289|Calcium|calcium|mesh-list
101951554|NCT03851289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101951555|NCT03851289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951556|NCT03733899|Anesthetics|anesthetics|mesh-list
101286613|NCT01941966|Antimetabolites|antimetabolites|mesh-ancestor
102024297|NCT03679442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102024298|NCT03679442|Expectorants|expectorants|mesh-ancestor
102024299|NCT03679442|Respiratory System Agents|respiratory system agents|mesh-ancestor
102024300|NCT03679442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102024301|NCT03679442|Antioxidants|antioxidants|mesh-ancestor
102024302|NCT03679442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024303|NCT03679442|Protective Agents|protective agents|mesh-ancestor
102024304|NCT01367535|Naltrexone|naltrexone|mesh-list
102024305|NCT01367535|Methylnaltrexone|methylnaltrexone|mesh-list
102024306|NCT01367535|Paroxetine|paroxetine|mesh-list
102024307|NCT01367535|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102024308|NCT01367535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102024309|NCT01367535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102024310|NCT01367535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024311|NCT01367535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102024312|NCT01367535|Serotonin Agents|serotonin agents|mesh-ancestor
102024313|NCT01367535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024314|NCT01367535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102024315|NCT01367535|Antidepressive Agents|antidepressive agents|mesh-ancestor
102024316|NCT01367535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102024317|NCT01367535|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102024318|NCT01367535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102024319|NCT01367535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102024320|NCT01367535|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102024321|NCT01367535|Sensory System Agents|sensory system agents|mesh-ancestor
102024322|NCT01367535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102024323|NCT01367535|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102024324|NCT02414776|Hydroxychloroquine|hydroxychloroquine|mesh-list
102024325|NCT02414776|Antimalarials|antimalarials|mesh-ancestor
102024326|NCT02414776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102024327|NCT02414776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102024328|NCT02414776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102024329|NCT02414776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102024330|NCT02414776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024331|NCT02414776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102024332|NCT05187663|Chlorhexidine|chlorhexidine|mesh-list
102024333|NCT05187663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102024334|NCT05187663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102024335|NCT05187663|Disinfectants|disinfectants|mesh-ancestor
102024336|NCT04482712|Sirolimus|sirolimus|mesh-list
102024337|NCT04482712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102024338|NCT04482712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102024339|NCT04482712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102024340|NCT04482712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102024341|NCT04482712|Antifungal Agents|antifungal agents|mesh-ancestor
102024342|NCT04482712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102024343|NCT04482712|Immunologic Factors|immunologic factors|mesh-ancestor
102024344|NCT04482712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024345|NCT02409004|Rifampin|rifampin|mesh-list
102024346|NCT02409004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102024347|NCT02409004|Antitubercular Agents|antitubercular agents|mesh-ancestor
102024348|NCT02409004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102024349|NCT02409004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102024350|NCT02409004|Leprostatic Agents|leprostatic agents|mesh-ancestor
102024351|NCT02409004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102024352|NCT02409004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102024353|NCT02409004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024354|NCT02409004|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102024355|NCT02409004|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102024356|NCT02409004|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102024357|NCT02409004|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101951557|NCT03733899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101951558|NCT03733899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951559|NCT01196013|Clofarabine|clofarabine|mesh-list
101951560|NCT01196013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101479351|NCT00286988|Topiramate|topiramate|mesh-list
102024371|NCT01367613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024372|NCT01367613|Sensory System Agents|sensory system agents|mesh-ancestor
102024373|NCT01367613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101744141|NCT00741585|Atenolol|atenolol|mesh-list
102024374|NCT02405104|Chlorzoxazone|chlorzoxazone|mesh-list
102024375|NCT02405104|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102024376|NCT02405104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024377|NCT02405104|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102024378|NCT02405104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102024379|NCT01364415|Pasireotide|pasireotide|mesh-list
102024380|NCT01364415|Hormones|hormones|mesh-ancestor
102024381|NCT01364415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102024382|NCT01364415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024383|NCT03176446|Anesthetics|anesthetics|mesh-list
102024384|NCT03176446|Anesthetics, Local|anesthetics, local|mesh-list
102024385|NCT03176446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102024386|NCT03176446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024387|NCT03176446|Sensory System Agents|sensory system agents|mesh-ancestor
102024388|NCT03176446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102024389|NCT03176212|Milk fat globule|milk fat globule|mesh-list
102024390|NCT03176212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102024391|NCT04035473|Paclitaxel|paclitaxel|mesh-list
102024392|NCT04035473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102024393|NCT04035473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102024394|NCT04035473|Tubulin Modulators|tubulin modulators|mesh-ancestor
102024395|NCT04035473|Antimitotic Agents|antimitotic agents|mesh-ancestor
102024396|NCT04035473|Mitosis Modulators|mitosis modulators|mesh-ancestor
102024397|NCT04035473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024398|NCT02408926|Vaccines|vaccines|mesh-list
102024399|NCT02408926|Immunologic Factors|immunologic factors|mesh-ancestor
102024400|NCT02408926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024401|NCT00704158|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
102024402|NCT00704158|Immunoconjugates|immunoconjugates|mesh-ancestor
102024403|NCT00704158|Immunologic Factors|immunologic factors|mesh-ancestor
102024404|NCT00704158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024405|NCT00704158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102024406|NCT00704158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102024407|NCT03738527|Tranexamic Acid|tranexamic acid|mesh-list
102024408|NCT03738527|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102024409|NCT03738527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102024410|NCT03738527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024411|NCT03738527|Hemostatics|hemostatics|mesh-ancestor
102024412|NCT03738527|Coagulants|coagulants|mesh-ancestor
102024413|NCT02915978|Fentanyl|fentanyl|mesh-list
102024414|NCT02915978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102024415|NCT02915978|Narcotics|narcotics|mesh-ancestor
102024416|NCT02915978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102024417|NCT02915978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024418|NCT02915978|Analgesics|analgesics|mesh-ancestor
102024419|NCT02915978|Sensory System Agents|sensory system agents|mesh-ancestor
102024424|NCT02915978|Anesthetics|anesthetics|mesh-ancestor
102024425|NCT02412904|Menotropins|menotropins|mesh-list
102024426|NCT02412904|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102024427|NCT02412904|Fertility Agents|fertility agents|mesh-ancestor
102024428|NCT02412904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102024429|NCT02412904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024430|NCT02408302|Midazolam|midazolam|mesh-list
102024431|NCT02408302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102024432|NCT02408302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102024433|NCT02408302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102024434|NCT02408302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024435|NCT02408302|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102024436|NCT02408302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102024437|NCT02408302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102024438|NCT02408302|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101951561|NCT01196013|Antimetabolites|antimetabolites|mesh-ancestor
101951562|NCT01196013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951563|NCT01196013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101951564|NCT01196169|Vancomycin|vancomycin|mesh-list
102024439|NCT02408302|Anesthetics, General|anesthetics, general|mesh-ancestor
102024440|NCT02408302|Anesthetics|anesthetics|mesh-ancestor
102024441|NCT02408302|GABA Modulators|gaba modulators|mesh-ancestor
102024442|NCT02408302|GABA Agents|gaba agents|mesh-ancestor
102024443|NCT02408302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102024444|NCT02408302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024445|NCT02408146|Celecoxib|celecoxib|mesh-list
102024446|NCT02408146|Parecoxib|parecoxib|mesh-list
102024447|NCT02408146|Fentanyl|fentanyl|mesh-list
102024448|NCT02408146|Ondansetron|ondansetron|mesh-list
101744217|NCT00741741|Antiviral Agents|antiviral agents|mesh-ancestor
102024449|NCT02408146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102024450|NCT02408146|Narcotics|narcotics|mesh-ancestor
102024451|NCT02408146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102024452|NCT02408146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024453|NCT02408146|Analgesics|analgesics|mesh-ancestor
102024454|NCT02408146|Sensory System Agents|sensory system agents|mesh-ancestor
102024455|NCT02408146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102024456|NCT02408146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102024457|NCT02408146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102024458|NCT02408146|Anesthetics, General|anesthetics, general|mesh-ancestor
102024459|NCT02408146|Anesthetics|anesthetics|mesh-ancestor
102024460|NCT02408146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024461|NCT02408146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102024462|NCT02408146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102024463|NCT02408146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102024464|NCT02408146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102024465|NCT02408146|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102024466|NCT02408146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102024467|NCT02408146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102024468|NCT02408146|Antiemetics|antiemetics|mesh-ancestor
102024469|NCT02408146|Autonomic Agents|autonomic agents|mesh-ancestor
102024470|NCT02408146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102024471|NCT02408146|Antipruritics|antipruritics|mesh-ancestor
102024472|NCT02408146|Dermatologic Agents|dermatologic agents|mesh-ancestor
102024473|NCT02408146|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102024474|NCT02408146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102024475|NCT02408146|Serotonin Agents|serotonin agents|mesh-ancestor
102024476|NCT02408146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102024477|NCT03175666|Leucovorin|leucovorin|mesh-list
102024478|NCT03175666|Paclitaxel|paclitaxel|mesh-list
102024479|NCT03175666|Cyclophosphamide|cyclophosphamide|mesh-list
102024480|NCT03175666|Bevacizumab|bevacizumab|mesh-list
102024481|NCT03175666|Fluorouracil|fluorouracil|mesh-list
102024482|NCT03175666|Capecitabine|capecitabine|mesh-list
102024483|NCT03175666|Avelumab|avelumab|mesh-list
102024484|NCT03175666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102024485|NCT03175666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102024486|NCT03175666|Tubulin Modulators|tubulin modulators|mesh-ancestor
102024487|NCT03175666|Antimitotic Agents|antimitotic agents|mesh-ancestor
102024488|NCT03175666|Mitosis Modulators|mitosis modulators|mesh-ancestor
102024489|NCT03175666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024490|NCT03175666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102024491|NCT03175666|Immunologic Factors|immunologic factors|mesh-ancestor
102024492|NCT03175666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024498|NCT03175666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102024499|NCT03175666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102024500|NCT03175666|Growth Substances|growth substances|mesh-ancestor
102024501|NCT03175666|Growth Inhibitors|growth inhibitors|mesh-ancestor
102024502|NCT03175666|Antimetabolites|antimetabolites|mesh-ancestor
102024503|NCT03175666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102024504|NCT03175666|Antidotes|antidotes|mesh-ancestor
102024505|NCT03175666|Protective Agents|protective agents|mesh-ancestor
102024506|NCT03175666|Vitamin B Complex|vitamin b complex|mesh-ancestor
102024507|NCT03175666|Vitamins|vitamins|mesh-ancestor
102024508|NCT03175666|Micronutrients|micronutrients|mesh-ancestor
102024509|NCT03101358|Paclitaxel|paclitaxel|mesh-list
102024510|NCT03101358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102024511|NCT03101358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102024512|NCT03101358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102024513|NCT03101358|Tubulin Modulators|tubulin modulators|mesh-ancestor
101951565|NCT01196169|Daptomycin|daptomycin|mesh-list
101951566|NCT01196169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101951567|NCT01196169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101951568|NCT01196481|Carvedilol|carvedilol|mesh-list
101951569|NCT01196481|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102024514|NCT03101358|Antimitotic Agents|antimitotic agents|mesh-ancestor
102024515|NCT03101358|Mitosis Modulators|mitosis modulators|mesh-ancestor
102024516|NCT03101358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024517|NCT03171220|Cyclophosphamide|cyclophosphamide|mesh-list
102024518|NCT03171220|Fludarabine|fludarabine|mesh-list
102024519|NCT03171220|Interleukin-2|interleukin-2|mesh-list
102024520|NCT03171220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102024521|NCT03171220|Immunologic Factors|immunologic factors|mesh-ancestor
102024522|NCT03171220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744291|NCT00719264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102024523|NCT03171220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102024524|NCT03171220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102024525|NCT03171220|Alkylating Agents|alkylating agents|mesh-ancestor
102024526|NCT03171220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024527|NCT03171220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102024528|NCT03171220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102024529|NCT03171220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102024530|NCT03171220|Analgesics|analgesics|mesh-ancestor
102024531|NCT03171220|Sensory System Agents|sensory system agents|mesh-ancestor
102024532|NCT03171220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102024533|NCT04853004|Antibodies|antibodies|mesh-list
102024534|NCT04853004|Immunologic Factors|immunologic factors|mesh-ancestor
102024535|NCT04853004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024536|NCT03116542|Alovudine|alovudine|mesh-list
102024537|NCT03116542|Antiviral Agents|antiviral agents|mesh-ancestor
102024538|NCT03116542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102024539|NCT03170596|Tazarotene|tazarotene|mesh-list
102024540|NCT03170596|Dermatologic Agents|dermatologic agents|mesh-ancestor
102024541|NCT03170596|Keratolytic Agents|keratolytic agents|mesh-ancestor
102024542|NCT03173326|Anesthetics|anesthetics|mesh-list
102024543|NCT03173326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102024544|NCT03173326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024545|NCT03172858|Oxytocin|oxytocin|mesh-list
102024546|NCT03172858|Oxytocics|oxytocics|mesh-ancestor
102024547|NCT03172858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102024548|NCT03172858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024549|NCT02403856|Methylprednisolone|methylprednisolone|mesh-list
102024550|NCT02403856|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102024551|NCT02403856|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102024552|NCT02403856|Prednisolone|prednisolone|mesh-list
102024553|NCT02403856|Prednisolone acetate|prednisolone acetate|mesh-list
102024554|NCT02403856|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102024555|NCT02403856|Prednisolone phosphate|prednisolone phosphate|mesh-list
102024556|NCT02403856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102024557|NCT02403856|Antiemetics|antiemetics|mesh-ancestor
102024558|NCT02403856|Autonomic Agents|autonomic agents|mesh-ancestor
102024559|NCT02403856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102024560|NCT02403856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024561|NCT02403856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102024562|NCT02403856|Glucocorticoids|glucocorticoids|mesh-ancestor
102024563|NCT02403856|Hormones|hormones|mesh-ancestor
101479557|NCT00320853|Vitamin D|vitamin d|mesh-list
102024569|NCT03170284|Bevacizumab|bevacizumab|mesh-list
102024570|NCT03170284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102024571|NCT03170284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102024572|NCT03170284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102024573|NCT03170284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102024574|NCT03170284|Growth Substances|growth substances|mesh-ancestor
102024575|NCT03170284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024576|NCT03170284|Growth Inhibitors|growth inhibitors|mesh-ancestor
102024577|NCT02407912|Cisplatin|cisplatin|mesh-list
102024578|NCT02407912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102024579|NCT03170050|Lidocaine|lidocaine|mesh-list
102024580|NCT03170050|Anesthetics, Local|anesthetics, local|mesh-ancestor
102024581|NCT03170050|Anesthetics|anesthetics|mesh-ancestor
102024582|NCT03170050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102024583|NCT03170050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024584|NCT03170050|Sensory System Agents|sensory system agents|mesh-ancestor
102024585|NCT03170050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101951570|NCT01196481|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101951571|NCT01196481|Adrenergic Agents|adrenergic agents|mesh-ancestor
101951572|NCT01196481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102024586|NCT03170050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102024587|NCT03170050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102024588|NCT03170050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102024589|NCT03170050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102024590|NCT03170050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024591|NCT02407834|Sodium Hypochlorite|sodium hypochlorite|mesh-list
102024592|NCT02407834|Eusol|eusol|mesh-list
102024593|NCT02407834|Disinfectants|disinfectants|mesh-ancestor
102024594|NCT02407834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102024595|NCT03169738|Leucovorin|leucovorin|mesh-list
102024596|NCT03169738|Cyclophosphamide|cyclophosphamide|mesh-list
102024597|NCT03169738|Bevacizumab|bevacizumab|mesh-list
102024598|NCT03169738|Fluorouracil|fluorouracil|mesh-list
102024599|NCT03169738|Capecitabine|capecitabine|mesh-list
102024600|NCT03169738|Oxaliplatin|oxaliplatin|mesh-list
101744364|NCT00716456|Cetuximab|cetuximab|mesh-list
102024601|NCT03169738|Nivolumab|nivolumab|mesh-list
102024602|NCT03169738|Fulvestrant|fulvestrant|mesh-list
102024603|NCT03169738|Avelumab|avelumab|mesh-list
102024604|NCT03169738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102024605|NCT03169738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024606|NCT03169738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102024608|NCT03169738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024609|NCT03169738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102024610|NCT03169738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102024611|NCT03169738|Alkylating Agents|alkylating agents|mesh-ancestor
102024612|NCT03169738|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102024613|NCT03169738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102024614|NCT03169738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102024615|NCT03169738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102024616|NCT03169738|Growth Substances|growth substances|mesh-ancestor
102024617|NCT03169738|Growth Inhibitors|growth inhibitors|mesh-ancestor
102024618|NCT03169738|Antimetabolites|antimetabolites|mesh-ancestor
102024619|NCT03169738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102024620|NCT03169738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102024621|NCT03169738|Antidotes|antidotes|mesh-ancestor
102024622|NCT03169738|Protective Agents|protective agents|mesh-ancestor
102024623|NCT03169738|Vitamin B Complex|vitamin b complex|mesh-ancestor
102024624|NCT03169738|Vitamins|vitamins|mesh-ancestor
102024625|NCT03169738|Micronutrients|micronutrients|mesh-ancestor
102024626|NCT03169738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102024627|NCT03169738|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102024628|NCT03169738|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102024629|NCT03169738|Hormone Antagonists|hormone antagonists|mesh-ancestor
102024630|NCT03169738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102024631|NCT02407600|Aprepitant|aprepitant|mesh-list
102024632|NCT02407600|Fosaprepitant|fosaprepitant|mesh-list
102024633|NCT02407600|Antiemetics|antiemetics|mesh-ancestor
102024634|NCT02407600|Autonomic Agents|autonomic agents|mesh-ancestor
102024639|NCT02407600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102024640|NCT02407600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024641|NCT02403544|Capecitabine|capecitabine|mesh-list
102024642|NCT02403544|Oxaliplatin|oxaliplatin|mesh-list
102024643|NCT02403544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102024644|NCT02403544|Antimetabolites|antimetabolites|mesh-ancestor
102024645|NCT02403544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024646|NCT02403544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102024647|NCT02411344|Pertuzumab|pertuzumab|mesh-list
102024648|NCT02411344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102024649|NCT02411344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102024650|NCT03657095|Beraprost|beraprost|mesh-list
102024651|NCT03657095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102024652|NCT03657095|Vasodilator Agents|vasodilator agents|mesh-ancestor
102024653|NCT02407366|Carboplatin|carboplatin|mesh-list
102024654|NCT02407366|Pemetrexed|pemetrexed|mesh-list
102024655|NCT02407366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102024656|NCT02407366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102024657|NCT02407366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024658|NCT02407366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101951573|NCT01196481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951574|NCT01196481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951575|NCT01196481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101951576|NCT01196481|Antioxidants|antioxidants|mesh-ancestor
101951577|NCT01196481|Protective Agents|protective agents|mesh-ancestor
102024659|NCT02407366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102024660|NCT03738137|Lidocaine|lidocaine|mesh-list
102024661|NCT03738137|Midazolam|midazolam|mesh-list
102024662|NCT03738137|Sufentanil|sufentanil|mesh-list
102024663|NCT03738137|Anesthetics, Local|anesthetics, local|mesh-ancestor
102024664|NCT03738137|Anesthetics|anesthetics|mesh-ancestor
102024665|NCT03738137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102024666|NCT03738137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024667|NCT03738137|Sensory System Agents|sensory system agents|mesh-ancestor
102024668|NCT03738137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102024669|NCT03738137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102024670|NCT03738137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102024671|NCT03738137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102024672|NCT03738137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102024673|NCT03738137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024674|NCT03738137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102024675|NCT03738137|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102024676|NCT03738137|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102024677|NCT03738137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102024678|NCT03738137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102024679|NCT03738137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102024680|NCT03738137|Anesthetics, General|anesthetics, general|mesh-ancestor
102024681|NCT03738137|GABA Modulators|gaba modulators|mesh-ancestor
102024682|NCT03738137|GABA Agents|gaba agents|mesh-ancestor
102024683|NCT03738137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102024684|NCT03738137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102024685|NCT03738137|Narcotics|narcotics|mesh-ancestor
102024686|NCT03738137|Analgesics|analgesics|mesh-ancestor
102024687|NCT02407210|Olmesartan|olmesartan|mesh-list
102024688|NCT02407210|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
102024689|NCT02407210|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
102024690|NCT02407210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102024691|NCT02407210|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102024692|NCT02407210|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102024693|NCT02407210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024694|NCT03737201|Chlorhexidine|chlorhexidine|mesh-list
102024695|NCT03737201|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102024696|NCT03737201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102024697|NCT03737201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102024698|NCT03737201|Disinfectants|disinfectants|mesh-ancestor
102024699|NCT03737201|Dermatologic Agents|dermatologic agents|mesh-ancestor
102024700|NCT03175042|Chrysarobin|chrysarobin|mesh-list
102024701|NCT03175042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102024702|NCT03175042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102024703|NCT03175042|Analgesics|analgesics|mesh-ancestor
102024704|NCT03175042|Sensory System Agents|sensory system agents|mesh-ancestor
102024705|NCT03175042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102024711|NCT03738059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102024712|NCT03738059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024713|NCT03738059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102024714|NCT03738059|Analgesics|analgesics|mesh-ancestor
102024715|NCT03738059|Sensory System Agents|sensory system agents|mesh-ancestor
102024716|NCT03738059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102024717|NCT03738059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102024718|NCT03738059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102024719|NCT03738059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102024720|NCT03738059|Adrenergic Agents|adrenergic agents|mesh-ancestor
102024721|NCT03738059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102024722|NCT03738059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024723|NCT05233462|Bupivacaine|bupivacaine|mesh-list
102024724|NCT05233462|Anesthetics, Local|anesthetics, local|mesh-ancestor
102024725|NCT05233462|Anesthetics|anesthetics|mesh-ancestor
102024726|NCT05233462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102024727|NCT05233462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951578|NCT01196481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101951579|NCT01196481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101951580|NCT01196481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102024728|NCT05233462|Sensory System Agents|sensory system agents|mesh-ancestor
102024729|NCT05233462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102024731|NCT02700412|Anticonvulsants|anticonvulsants|mesh-ancestor
102024732|NCT02351544|Botulinum Toxins|botulinum toxins|mesh-list
102024733|NCT02351544|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102024734|NCT02351544|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102024735|NCT02351544|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102024736|NCT02351544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102024737|NCT02351544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024738|NCT02351544|Cholinergic Agents|cholinergic agents|mesh-ancestor
102024739|NCT02351544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102024740|NCT02351544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024741|NCT02351544|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102024742|NCT02351544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102024743|NCT02288832|Azithromycin|azithromycin|mesh-list
102024744|NCT02288832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102024745|NCT02288832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102024746|NCT03116308|Opicapone|opicapone|mesh-list
102024747|NCT03116308|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
102024748|NCT03116308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102024749|NCT03116308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024750|NCT03116308|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102024751|NCT03116308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102024752|NCT03665441|Leucovorin|leucovorin|mesh-list
102024753|NCT03665441|Paclitaxel|paclitaxel|mesh-list
102024754|NCT03665441|Gemcitabine|gemcitabine|mesh-list
102024755|NCT03665441|Irinotecan|irinotecan|mesh-list
102024756|NCT03665441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102024757|NCT03665441|Asparaginase|asparaginase|mesh-list
102024758|NCT03665441|Eryaspase|eryaspase|mesh-list
102024759|NCT03665441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102024760|NCT03665441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102024761|NCT03665441|Tubulin Modulators|tubulin modulators|mesh-ancestor
102024762|NCT03665441|Antimitotic Agents|antimitotic agents|mesh-ancestor
102024763|NCT03665441|Mitosis Modulators|mitosis modulators|mesh-ancestor
102024764|NCT03665441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024765|NCT03665441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102024766|NCT03665441|Antimetabolites|antimetabolites|mesh-ancestor
102024767|NCT03665441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024768|NCT03665441|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102024769|NCT03665441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102024770|NCT03665441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102024771|NCT03665441|Antidotes|antidotes|mesh-ancestor
102024772|NCT03665441|Protective Agents|protective agents|mesh-ancestor
102024773|NCT03665441|Vitamin B Complex|vitamin b complex|mesh-ancestor
102024774|NCT03665441|Vitamins|vitamins|mesh-ancestor
102024775|NCT03665441|Micronutrients|micronutrients|mesh-ancestor
102024776|NCT03169660|Aflibercept|aflibercept|mesh-list
102024779|NCT03169660|Mitosis Modulators|mitosis modulators|mesh-ancestor
102024780|NCT03169660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024781|NCT03169660|Growth Substances|growth substances|mesh-ancestor
102024782|NCT03169660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024783|NCT03169660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102024784|NCT03169660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102024785|NCT03169660|Growth Inhibitors|growth inhibitors|mesh-ancestor
102024786|NCT03169660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102024787|NCT02401828|Dolutegravir|dolutegravir|mesh-list
102024788|NCT02401828|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102024789|NCT02401828|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102024790|NCT02401828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102024791|NCT02401828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024792|NCT02401828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102024793|NCT02401828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102024794|NCT02401828|Antiviral Agents|antiviral agents|mesh-ancestor
102024795|NCT02401828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102024796|NCT02401594|Enoxaparin|enoxaparin|mesh-list
102024797|NCT02401594|Rivaroxaban|rivaroxaban|mesh-list
102024798|NCT02401594|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102024799|NCT02401594|Antithrombins|antithrombins|mesh-ancestor
101951582|NCT01196481|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101951583|NCT01196481|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101951584|NCT05283057|Empagliflozin|empagliflozin|mesh-list
101951585|NCT05283057|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102024800|NCT02401594|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102024801|NCT02401594|Protease Inhibitors|protease inhibitors|mesh-ancestor
102024802|NCT02401594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102024803|NCT02401594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024804|NCT02401594|Anticoagulants|anticoagulants|mesh-ancestor
102024805|NCT02401594|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102024806|NCT02401594|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102024807|NCT02406508|Sorafenib|sorafenib|mesh-list
102024808|NCT02406508|Melphalan|melphalan|mesh-list
102024809|NCT02406508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102024810|NCT02406508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102024811|NCT02406508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102024812|NCT02406508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024813|NCT02406508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102024814|NCT02406508|Alkylating Agents|alkylating agents|mesh-ancestor
102024815|NCT02406508|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102024816|NCT02406508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102024817|NCT02406508|Immunologic Factors|immunologic factors|mesh-ancestor
102024818|NCT02406508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024819|NCT03662789|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
102024820|NCT03662789|Hematinics|hematinics|mesh-ancestor
102024821|NCT04481932|Trastuzumab|trastuzumab|mesh-list
102024822|NCT04481932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102024823|NCT04481932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102024824|NCT03169582|Sildenafil Citrate|sildenafil citrate|mesh-list
102024825|NCT03169582|Vasodilator Agents|vasodilator agents|mesh-ancestor
102024826|NCT03169582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102024827|NCT03169582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102024828|NCT03169582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102024829|NCT03169582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024830|NCT03169582|Urological Agents|urological agents|mesh-ancestor
102024831|NCT03655691|Botulinum Toxins|botulinum toxins|mesh-list
102024832|NCT03655691|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102024833|NCT03655691|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102024834|NCT03655691|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102024835|NCT03655691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102024836|NCT03655691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024837|NCT03655691|Cholinergic Agents|cholinergic agents|mesh-ancestor
102024838|NCT03655691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102024839|NCT03655691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024840|NCT03655691|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102024841|NCT03655691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102024842|NCT03169504|Fluticasone|fluticasone|mesh-list
102024844|NCT03169504|Bromides|bromides|mesh-list
102024845|NCT03169504|Tiotropium Bromide|tiotropium bromide|mesh-list
102024846|NCT03169504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102024847|NCT03169504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102024848|NCT03169504|Autonomic Agents|autonomic agents|mesh-ancestor
102024849|NCT03169504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102024850|NCT03169504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479835|NCT00321516|Aripiprazole|aripiprazole|mesh-list
102024858|NCT03169504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102024859|NCT03169504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024860|NCT03169504|Anticonvulsants|anticonvulsants|mesh-ancestor
102024861|NCT03169426|Carvedilol|carvedilol|mesh-list
102024862|NCT03169426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102024863|NCT03169426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102024864|NCT03169426|Adrenergic Agents|adrenergic agents|mesh-ancestor
102024865|NCT03169426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102024866|NCT03169426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024867|NCT03169426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024868|NCT03169426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102024869|NCT03169426|Antioxidants|antioxidants|mesh-ancestor
102024870|NCT03169426|Protective Agents|protective agents|mesh-ancestor
101951586|NCT05283057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951588|NCT05283057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951589|NCT01193595|Bevacizumab|bevacizumab|mesh-list
101951590|NCT01193595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101287181|NCT05410483|Docetaxel|docetaxel|mesh-list
102024871|NCT03169426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102024872|NCT03169426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102024873|NCT03169426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102024874|NCT03169426|Vasodilator Agents|vasodilator agents|mesh-ancestor
102024875|NCT03169426|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102024876|NCT03169426|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102024877|NCT03580928|Venetoclax|venetoclax|mesh-list
102024878|NCT03580928|Obinutuzumab|obinutuzumab|mesh-list
102024879|NCT03580928|Acalabrutinib|acalabrutinib|mesh-list
102024880|NCT03580928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102024881|NCT03580928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102024882|NCT03169348|Sofosbuvir|sofosbuvir|mesh-list
102024883|NCT03169348|Ledipasvir|ledipasvir|mesh-list
102024884|NCT03169348|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
102024885|NCT03169348|Antiviral Agents|antiviral agents|mesh-ancestor
102024886|NCT03169348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102024887|NCT03631355|Tranexamic Acid|tranexamic acid|mesh-list
102024888|NCT03631355|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102024889|NCT03631355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102024890|NCT03631355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024891|NCT03631355|Hemostatics|hemostatics|mesh-ancestor
102024892|NCT03631355|Coagulants|coagulants|mesh-ancestor
102024893|NCT03571568|Rituximab|rituximab|mesh-list
102024894|NCT03571568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102024895|NCT03571568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102024896|NCT03571568|Immunologic Factors|immunologic factors|mesh-ancestor
102024897|NCT03571568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024898|NCT03571568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102024899|NCT03169192|Zoledronic Acid|zoledronic acid|mesh-list
102024900|NCT03169192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102024901|NCT03169192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024902|NCT03679052|Clonidine|clonidine|mesh-list
102024903|NCT03679052|Mirtazapine|mirtazapine|mesh-list
102024904|NCT03679052|Analgesics|analgesics|mesh-ancestor
101744667|NCT00755859|Glucocorticoids|glucocorticoids|mesh-ancestor
102024905|NCT03679052|Sensory System Agents|sensory system agents|mesh-ancestor
102024906|NCT03679052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102024907|NCT03679052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024908|NCT03679052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102024909|NCT03679052|Sympatholytics|sympatholytics|mesh-ancestor
102024910|NCT03679052|Autonomic Agents|autonomic agents|mesh-ancestor
102024911|NCT03679052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102024912|NCT03679052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102024913|NCT03679052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102024914|NCT03679052|Adrenergic Agents|adrenergic agents|mesh-ancestor
102024915|NCT03679052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102024916|NCT03679052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024917|NCT03679052|Antidepressive Agents|antidepressive agents|mesh-ancestor
102024918|NCT03679052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102024932|NCT03540914|Acetazolamide|acetazolamide|mesh-list
102024933|NCT03540914|Anticonvulsants|anticonvulsants|mesh-ancestor
102024934|NCT03540914|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102024935|NCT03540914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102024936|NCT03540914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024937|NCT03540914|Diuretics|diuretics|mesh-ancestor
102024938|NCT03540914|Natriuretic Agents|natriuretic agents|mesh-ancestor
102024939|NCT03540914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024940|NCT03629249|Indoleacetic Acids|indoleacetic acids|mesh-list
102024941|NCT03629249|Plant Growth Regulators|plant growth regulators|mesh-ancestor
102024942|NCT03629249|Growth Substances|growth substances|mesh-ancestor
102024943|NCT03629249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024944|NCT03671174|Aspirin|aspirin|mesh-list
102024945|NCT03671174|Hydroxychloroquine|hydroxychloroquine|mesh-list
102024946|NCT03671174|Prednisone|prednisone|mesh-list
101951592|NCT01193595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101951593|NCT01193595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101951594|NCT01193595|Growth Substances|growth substances|mesh-ancestor
101951595|NCT01193595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951596|NCT01193595|Growth Inhibitors|growth inhibitors|mesh-ancestor
101951597|NCT01196559|Gemcitabine|gemcitabine|mesh-list
102024947|NCT03671174|Heparin|heparin|mesh-list
102024948|NCT03671174|Enoxaparin|enoxaparin|mesh-list
102024949|NCT03671174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102024950|NCT03671174|Tinzaparin|tinzaparin|mesh-list
102024951|NCT03671174|Dalteparin|dalteparin|mesh-list
102024952|NCT03671174|Nadroparin|nadroparin|mesh-list
102024953|NCT03671174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102024954|NCT03671174|Glucocorticoids|glucocorticoids|mesh-ancestor
102024955|NCT03671174|Hormones|hormones|mesh-ancestor
102024956|NCT03671174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102024957|NCT03671174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024958|NCT03671174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102024959|NCT03671174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102024960|NCT03671174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102024961|NCT03671174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102024962|NCT03671174|Analgesics|analgesics|mesh-ancestor
102024963|NCT03671174|Sensory System Agents|sensory system agents|mesh-ancestor
102024964|NCT03671174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102024965|NCT03671174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102024966|NCT03671174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102024967|NCT03671174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102024968|NCT03671174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024969|NCT03671174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102024970|NCT03671174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102024971|NCT03671174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102024972|NCT03671174|Antipyretics|antipyretics|mesh-ancestor
102024973|NCT03671174|Anticoagulants|anticoagulants|mesh-ancestor
102024974|NCT03671174|Antimalarials|antimalarials|mesh-ancestor
102024975|NCT03671174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102024976|NCT03671174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102024977|NCT03671174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102024978|NCT03172234|Amantadine|amantadine|mesh-list
102024979|NCT03172234|Gabapentin|gabapentin|mesh-list
102024980|NCT03172234|Analgesics|analgesics|mesh-ancestor
102024981|NCT03172234|Sensory System Agents|sensory system agents|mesh-ancestor
102024986|NCT03172234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102024987|NCT03172234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102024988|NCT03172234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102024989|NCT03172234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102024990|NCT03172234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102024991|NCT03172234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102024992|NCT03172234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024993|NCT03172234|Antimanic Agents|antimanic agents|mesh-ancestor
102024994|NCT03172234|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102024995|NCT03172234|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102024996|NCT03172234|Antiviral Agents|antiviral agents|mesh-ancestor
102024997|NCT03172234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102024998|NCT03172234|Dopamine Agents|dopamine agents|mesh-ancestor
102024999|NCT03172234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102025000|NCT03709849|Citric Acid|citric acid|mesh-list
102025001|NCT03709849|Sodium Citrate|sodium citrate|mesh-list
102025002|NCT03709849|Clomiphene|clomiphene|mesh-list
102025003|NCT03709849|Enclomiphene|enclomiphene|mesh-list
102025004|NCT03709849|Zuclomiphene|zuclomiphene|mesh-list
102025005|NCT03709849|Anticoagulants|anticoagulants|mesh-ancestor
102025006|NCT03709849|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102025007|NCT03709849|Chelating Agents|chelating agents|mesh-ancestor
102025008|NCT03709849|Sequestering Agents|sequestering agents|mesh-ancestor
102025009|NCT03709849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025010|NCT03709849|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102025011|NCT03709849|Hormone Antagonists|hormone antagonists|mesh-ancestor
102025012|NCT03709849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102025013|NCT03709849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287307|NCT04724655|Emollients|emollients|mesh-ancestor
102025014|NCT03709849|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102025015|NCT03709849|Fertility Agents|fertility agents|mesh-ancestor
102025016|NCT03709849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102025017|NCT03709849|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102025018|NCT03709849|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102025019|NCT05343325|Paclitaxel|paclitaxel|mesh-list
102025020|NCT05343325|Cisplatin|cisplatin|mesh-list
102025021|NCT05343325|Tislelizumab|tislelizumab|mesh-list
102025022|NCT05343325|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102025023|NCT05343325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102025024|NCT05343325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102025025|NCT05343325|Tubulin Modulators|tubulin modulators|mesh-ancestor
102025026|NCT05343325|Antimitotic Agents|antimitotic agents|mesh-ancestor
102025027|NCT05343325|Mitosis Modulators|mitosis modulators|mesh-ancestor
102025028|NCT05343325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025029|NCT05343325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102025030|NCT03349333|Folic Acid|folic acid|mesh-list
102025031|NCT03349333|Vitamin B 12|vitamin b 12|mesh-list
102025032|NCT03349333|Hydroxocobalamin|hydroxocobalamin|mesh-list
102025033|NCT03349333|Vitamins|vitamins|mesh-ancestor
102025034|NCT03349333|Micronutrients|micronutrients|mesh-ancestor
102025035|NCT03349333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025036|NCT03349333|Hematinics|hematinics|mesh-ancestor
102025037|NCT03349333|Vitamin B Complex|vitamin b complex|mesh-ancestor
102025038|NCT03365791|Spartalizumab|spartalizumab|mesh-list
102025039|NCT03365791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102025040|NCT03365791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025041|NCT03365791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102025042|NCT03365791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102025043|NCT03365011|Nitrous Oxide|nitrous oxide|mesh-list
102025044|NCT03365011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101524351|NCT00555087|Testosterone|testosterone|mesh-list
102025045|NCT03365011|Anesthetics, General|anesthetics, general|mesh-ancestor
102025046|NCT03365011|Anesthetics|anesthetics|mesh-ancestor
102025047|NCT03365011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102025048|NCT03365011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025049|NCT03365011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102025050|NCT03365011|Analgesics|analgesics|mesh-ancestor
102025051|NCT03365011|Sensory System Agents|sensory system agents|mesh-ancestor
102025052|NCT03365011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102025053|NCT03627767|Abrocitinib|abrocitinib|mesh-list
102025057|NCT03732365|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102025058|NCT03732365|Cefazolin|cefazolin|mesh-list
102025059|NCT03732365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102025060|NCT03732287|Anesthetics|anesthetics|mesh-list
102025061|NCT03732287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102025062|NCT03732287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025063|NCT02142738|Paclitaxel|paclitaxel|mesh-list
102025064|NCT02142738|Carboplatin|carboplatin|mesh-list
102025065|NCT02142738|Gemcitabine|gemcitabine|mesh-list
102025066|NCT02142738|Pembrolizumab|pembrolizumab|mesh-list
102025067|NCT02142738|Pemetrexed|pemetrexed|mesh-list
102025068|NCT02142738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102025069|NCT02142738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102025070|NCT02142738|Tubulin Modulators|tubulin modulators|mesh-ancestor
102025071|NCT02142738|Antimitotic Agents|antimitotic agents|mesh-ancestor
102025072|NCT02142738|Mitosis Modulators|mitosis modulators|mesh-ancestor
102025073|NCT02142738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025074|NCT02142738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102025075|NCT02142738|Antimetabolites|antimetabolites|mesh-ancestor
102025076|NCT02142738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102025077|NCT02142738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102025078|NCT02142738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102025079|NCT02142738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102025080|NCT02142738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102025081|NCT03617861|Secretin|secretin|mesh-list
102025082|NCT03617861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102025083|NCT03617861|Hormones|hormones|mesh-ancestor
102025084|NCT03617861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102025085|NCT03617861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025086|NCT03614975|Vaccines|vaccines|mesh-list
102025087|NCT03614975|Immunologic Factors|immunologic factors|mesh-ancestor
102025088|NCT03614975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025089|NCT03613649|Moxifloxacin|moxifloxacin|mesh-list
102025090|NCT03613649|Zoliflodacin|zoliflodacin|mesh-list
101951599|NCT01196559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101951600|NCT01196559|Antimetabolites|antimetabolites|mesh-ancestor
101951601|NCT01196559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287383|NCT04411940|Dopamine Agents|dopamine agents|mesh-ancestor
102025091|NCT03613649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102025092|NCT03613649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102025093|NCT03613649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102025094|NCT03613649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102025095|NCT03613649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102025096|NCT03613649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025097|NCT03613649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102025098|NCT03096288|Evolocumab|evolocumab|mesh-list
102025099|NCT03096288|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102025100|NCT03096288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102025101|NCT03096288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102025102|NCT03096288|Antimetabolites|antimetabolites|mesh-ancestor
102025103|NCT03096288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025104|NCT03096288|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102025105|NCT03096288|Protease Inhibitors|protease inhibitors|mesh-ancestor
102025106|NCT03096288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102025107|NCT03096288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102025108|NCT03731897|Lidocaine|lidocaine|mesh-list
102025109|NCT03731897|Anesthetics, Local|anesthetics, local|mesh-ancestor
102025110|NCT03731897|Anesthetics|anesthetics|mesh-ancestor
101387657|NCT00322660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102025111|NCT03731897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102025112|NCT03731897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025113|NCT03731897|Sensory System Agents|sensory system agents|mesh-ancestor
102025114|NCT03731897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102025115|NCT03731897|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102025116|NCT03731897|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102025117|NCT03731897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102025118|NCT03731897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102025119|NCT03731897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025120|NCT02072148|Cisplatin|cisplatin|mesh-list
102025121|NCT02072148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102025122|NCT04456608|Aspirin|aspirin|mesh-list
102025123|NCT04456608|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102025124|NCT04456608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102025125|NCT04456608|Analgesics|analgesics|mesh-ancestor
102025141|NCT04450212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025142|NCT04450212|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102025143|NCT04450212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102025144|NCT04450212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025146|NCT04450212|Coagulants|coagulants|mesh-ancestor
102025147|NCT05074290|Taxane|taxane|mesh-list
102025148|NCT05074290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102025149|NCT03095508|Menthol|menthol|mesh-list
102025150|NCT03095508|Antipruritics|antipruritics|mesh-ancestor
102025151|NCT03095508|Dermatologic Agents|dermatologic agents|mesh-ancestor
102025152|NCT03632538|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
102025153|NCT03632538|Protein C Inhibitor|protein c inhibitor|mesh-list
102025154|NCT03632538|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102025155|NCT03632538|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102025156|NCT03632538|Protease Inhibitors|protease inhibitors|mesh-ancestor
102025157|NCT03632538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102025158|NCT03632538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025159|NCT03731741|Pentoxifylline|pentoxifylline|mesh-list
102025160|NCT03731741|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102025161|NCT03731741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102025162|NCT03731741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025163|NCT03731741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102025164|NCT03731741|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102025165|NCT03731741|Protective Agents|protective agents|mesh-ancestor
102025166|NCT03731741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025167|NCT03731741|Vasodilator Agents|vasodilator agents|mesh-ancestor
102025168|NCT03731741|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102025169|NCT03731741|Antioxidants|antioxidants|mesh-ancestor
102025170|NCT03736187|Metronidazole|metronidazole|mesh-list
102025171|NCT03736187|Cephalexin|cephalexin|mesh-list
102025172|NCT03736187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102025173|NCT03736187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101951603|NCT01196559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101951604|NCT01196559|Tubulin Modulators|tubulin modulators|mesh-ancestor
101951605|NCT01196559|Antimitotic Agents|antimitotic agents|mesh-ancestor
101951606|NCT01196559|Mitosis Modulators|mitosis modulators|mesh-ancestor
101951607|NCT01295775|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
101951608|NCT01295775|Anticoagulants|anticoagulants|mesh-ancestor
101951609|NCT01295775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101951610|NCT01295775|Antimetabolites|antimetabolites|mesh-ancestor
101951611|NCT01295775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951612|NCT01295775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101951613|NCT01295775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101951614|NCT01295775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101951615|NCT01295775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101951616|NCT01295775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951617|NCT01581177|Albuterol|albuterol|mesh-list
101951618|NCT01581177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101951619|NCT01581177|Autonomic Agents|autonomic agents|mesh-ancestor
101951620|NCT01581177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101951621|NCT01581177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951622|NCT01581177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101951623|NCT01581177|Respiratory System Agents|respiratory system agents|mesh-ancestor
101951624|NCT01581177|Tocolytic Agents|tocolytic agents|mesh-ancestor
101951625|NCT01581177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101287453|NCT03532516|Anticonvulsants|anticonvulsants|mesh-ancestor
102025174|NCT03736187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102025175|NCT03736187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102025176|NCT03731429|Lidocaine|lidocaine|mesh-list
102025177|NCT03731429|Anesthetics, Local|anesthetics, local|mesh-ancestor
102025178|NCT03731429|Anesthetics|anesthetics|mesh-ancestor
102025179|NCT03731429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102025180|NCT03731429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025181|NCT03731429|Sensory System Agents|sensory system agents|mesh-ancestor
102025182|NCT03731429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102025183|NCT03731429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102025184|NCT03731429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102025185|NCT03731429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102025186|NCT03731429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101480188|NCT00303576|Dapivirine|dapivirine|mesh-list
102025195|NCT03653429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025197|NCT03653429|Coagulants|coagulants|mesh-ancestor
102025198|NCT03731117|Furosemide|furosemide|mesh-list
102025199|NCT03731117|Diuretics|diuretics|mesh-ancestor
102025200|NCT03731117|Natriuretic Agents|natriuretic agents|mesh-ancestor
102025201|NCT03731117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025202|NCT03731117|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102025203|NCT03731117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102025204|NCT03731117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025205|NCT03735251|Metoprolol|metoprolol|mesh-list
102025206|NCT03735251|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
101951626|NCT01581177|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101951627|NCT01581177|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101951628|NCT01581177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101951629|NCT01581177|Adrenergic Agents|adrenergic agents|mesh-ancestor
101951630|NCT01581177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101951631|NCT01581177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951632|NCT01580007|Cholecalciferol|cholecalciferol|mesh-list
101951633|NCT01580007|Vitamin D|vitamin d|mesh-list
101951634|NCT01580007|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
101951635|NCT01580007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101951636|NCT01580007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951637|NCT01580007|Vitamins|vitamins|mesh-ancestor
101951638|NCT01580007|Micronutrients|micronutrients|mesh-ancestor
101951639|NCT01580007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101951640|NCT01580007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102025207|NCT03735251|Diuretics|diuretics|mesh-list
102025208|NCT03735251|Natriuretic Agents|natriuretic agents|mesh-ancestor
102025209|NCT03735251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025210|NCT03735251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102025211|NCT03735251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102025212|NCT03735251|Sympatholytics|sympatholytics|mesh-ancestor
102025213|NCT03735251|Autonomic Agents|autonomic agents|mesh-ancestor
102025214|NCT03735251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102025215|NCT03735251|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102025216|NCT03735251|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102025217|NCT03735251|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102025218|NCT03735251|Adrenergic Agents|adrenergic agents|mesh-ancestor
102025219|NCT03735251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102025220|NCT03735251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025221|NCT03098550|Nivolumab|nivolumab|mesh-list
102025222|NCT03098550|Daratumumab|daratumumab|mesh-list
102025223|NCT03098550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102025224|NCT03098550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102025225|NCT03098550|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102025226|NCT03098550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025227|NCT03095118|Daratumumab|daratumumab|mesh-list
102025228|NCT03095118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102025229|NCT04224480|Pembrolizumab|pembrolizumab|mesh-list
102025230|NCT04224480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102025231|NCT04224480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102025232|NCT04224480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101387658|NCT00322660|Adrenergic Agents|adrenergic agents|mesh-ancestor
102025233|NCT04224480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025234|NCT05386758|Molnupiravir|molnupiravir|mesh-list
102025235|NCT05386758|Antiviral Agents|antiviral agents|mesh-ancestor
102025236|NCT05386758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102025237|NCT05013216|Poly ICLC|poly iclc|mesh-list
102025238|NCT05013216|Interferon Inducers|interferon inducers|mesh-ancestor
102025239|NCT05013216|Immunologic Factors|immunologic factors|mesh-ancestor
102025240|NCT05013216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025241|NCT03169114|Amikacin|amikacin|mesh-list
102025242|NCT03169114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102025243|NCT03169114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102025244|NCT03115762|Bevacizumab|bevacizumab|mesh-list
102025245|NCT03115762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102025246|NCT03115762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102025247|NCT03115762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102025248|NCT03115762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101480242|NCT00324363|Exenatide|exenatide|mesh-list
102025254|NCT03168958|Narcotics|narcotics|mesh-ancestor
102025255|NCT03168958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101951642|NCT01189695|Lopinavir|lopinavir|mesh-list
101951643|NCT01189695|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101951644|NCT01189695|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102025256|NCT03168958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025257|NCT03168958|Analgesics|analgesics|mesh-ancestor
102025258|NCT03168958|Sensory System Agents|sensory system agents|mesh-ancestor
102025259|NCT03168958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102025260|NCT03168958|Antitussive Agents|antitussive agents|mesh-ancestor
102025261|NCT03168958|Respiratory System Agents|respiratory system agents|mesh-ancestor
102025262|NCT03632460|Dexmedetomidine|dexmedetomidine|mesh-list
102025263|NCT03632460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102025264|NCT03632460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102025265|NCT03632460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025266|NCT03632460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102025267|NCT03632460|Analgesics|analgesics|mesh-ancestor
102025268|NCT03632460|Sensory System Agents|sensory system agents|mesh-ancestor
102025269|NCT03632460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102025270|NCT03632460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102025271|NCT03632460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102025272|NCT03632460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102025273|NCT03632460|Adrenergic Agents|adrenergic agents|mesh-ancestor
102025274|NCT03632460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102025275|NCT03632460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025276|NCT05418660|Pembrolizumab|pembrolizumab|mesh-list
102025277|NCT05418660|Nivolumab|nivolumab|mesh-list
102025278|NCT05418660|Atezolizumab|atezolizumab|mesh-list
102025279|NCT05418660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102025280|NCT05418660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102025281|NCT05418660|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102025282|NCT05418660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025283|NCT03364309|Ixekizumab|ixekizumab|mesh-list
102025284|NCT03364309|Dermatologic Agents|dermatologic agents|mesh-ancestor
102025285|NCT03168178|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102025286|NCT03168178|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102025287|NCT03168178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102025288|NCT03168178|Antitubercular Agents|antitubercular agents|mesh-ancestor
102025290|NCT05166096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102025291|NCT05166096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102025292|NCT05166096|Analgesics|analgesics|mesh-ancestor
102025293|NCT05166096|Sensory System Agents|sensory system agents|mesh-ancestor
102025294|NCT05166096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102025295|NCT05166096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025296|NCT05166096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102025297|NCT05166096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102025298|NCT05166096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102025299|NCT05166096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102025300|NCT05166096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025301|NCT05166096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102025302|NCT05166096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102025303|NCT05166096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102025304|NCT05166096|Antipyretics|antipyretics|mesh-ancestor
102025305|NCT03168412|Vaccines|vaccines|mesh-list
102025306|NCT03168412|Immunologic Factors|immunologic factors|mesh-ancestor
102025307|NCT03168412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025308|NCT05110638|Luliconazole|luliconazole|mesh-list
102025309|NCT05110638|Antifungal Agents|antifungal agents|mesh-ancestor
102025310|NCT05110638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102025311|NCT03700788|Chlorhexidine|chlorhexidine|mesh-list
102025312|NCT03700788|Calcium|calcium|mesh-list
102025313|NCT03700788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102025314|NCT03700788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025315|NCT03700788|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102025316|NCT03700788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102025317|NCT03700788|Disinfectants|disinfectants|mesh-ancestor
102025318|NCT03334903|Gabapentin|gabapentin|mesh-list
102025319|NCT03334903|Analgesics|analgesics|mesh-ancestor
102025320|NCT03334903|Sensory System Agents|sensory system agents|mesh-ancestor
102025325|NCT03334903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102025326|NCT03334903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102025327|NCT03334903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102025328|NCT03334903|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101951645|NCT01189695|Protease Inhibitors|protease inhibitors|mesh-ancestor
101951646|NCT01189695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101951647|NCT01189695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951648|NCT01189695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101951649|NCT01189695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101951650|NCT01189695|Antiviral Agents|antiviral agents|mesh-ancestor
101951651|NCT01189695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101287633|NCT05303038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102025329|NCT03334903|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102025330|NCT03334903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102025331|NCT03334903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025332|NCT03334903|Antimanic Agents|antimanic agents|mesh-ancestor
102025333|NCT03168100|Dexamethasone|dexamethasone|mesh-list
102025334|NCT03168100|Lenalidomide|lenalidomide|mesh-list
102025335|NCT03168100|Bortezomib|bortezomib|mesh-list
102025336|NCT03168100|Elotuzumab|elotuzumab|mesh-list
102025337|NCT03168100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102025338|NCT03168100|Antiemetics|antiemetics|mesh-ancestor
102025339|NCT03168100|Autonomic Agents|autonomic agents|mesh-ancestor
102025340|NCT03168100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102025341|NCT03168100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025342|NCT03168100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102025343|NCT03168100|Glucocorticoids|glucocorticoids|mesh-ancestor
102025344|NCT03168100|Hormones|hormones|mesh-ancestor
102025345|NCT03168100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102025346|NCT03168100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102025347|NCT03168100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102025348|NCT03168100|Immunologic Factors|immunologic factors|mesh-ancestor
102025349|NCT03168100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102025350|NCT03168100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102025351|NCT03168100|Growth Substances|growth substances|mesh-ancestor
102025352|NCT03168100|Growth Inhibitors|growth inhibitors|mesh-ancestor
102025353|NCT03709381|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102025354|NCT03709381|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
102025355|NCT03709381|Cosyntropin|cosyntropin|mesh-list
102025356|NCT03709381|beta-Endorphin|beta-endorphin|mesh-list
102025357|NCT03709381|Hormones|hormones|mesh-ancestor
102025358|NCT03709381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101745114|NCT00757731|Analgesics|analgesics|mesh-ancestor
102025359|NCT03709381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025360|NCT03709381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102025361|NCT03709381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025362|NCT01353664|Romidepsin|romidepsin|mesh-list
102025363|NCT01353664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102025364|NCT01353664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102025365|NCT01353664|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102025366|NCT01353664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102025367|NCT01353664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025368|NCT02395744|Paclitaxel|paclitaxel|mesh-list
102025369|NCT02395744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102025370|NCT02395744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102025371|NCT02395744|Tubulin Modulators|tubulin modulators|mesh-ancestor
102025372|NCT02395744|Antimitotic Agents|antimitotic agents|mesh-ancestor
102025373|NCT02395744|Mitosis Modulators|mitosis modulators|mesh-ancestor
102025374|NCT02395744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025375|NCT02400268|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102025376|NCT02400268|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102025377|NCT02400268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102025378|NCT02400268|Antitubercular Agents|antitubercular agents|mesh-ancestor
102025379|NCT03168568|Valsartan|valsartan|mesh-list
102025380|NCT03168568|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102025381|NCT03168568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102025382|NCT03168568|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102025383|NCT03168568|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102025384|NCT03168568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025385|NCT02400112|Vancomycin|vancomycin|mesh-list
101951652|NCT01189695|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101951653|NCT01189695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101951654|NCT01196715|Darbepoetin alfa|darbepoetin alfa|mesh-list
102025386|NCT02400112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102025387|NCT02400112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102025388|NCT02694328|Olanzapine|olanzapine|mesh-list
102025389|NCT02694328|Antiemetics|antiemetics|mesh-ancestor
102025403|NCT02694328|Serotonin Agents|serotonin agents|mesh-ancestor
102025404|NCT02395510|Vortioxetine|vortioxetine|mesh-list
102025405|NCT02395510|Antidepressive Agents|antidepressive agents|mesh-ancestor
102025406|NCT02395510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102025407|NCT02395510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102025408|NCT02395510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102025409|NCT02395510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102025410|NCT02395510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025411|NCT02395510|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102025412|NCT02395510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102025413|NCT02395510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102025414|NCT02395510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025415|NCT02395510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102025416|NCT02395510|Serotonin Agents|serotonin agents|mesh-ancestor
102025417|NCT02395510|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102025418|NCT02395510|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102025419|NCT02395510|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102025420|NCT02395510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102025421|NCT02399800|Triamcinolone|triamcinolone|mesh-list
102025422|NCT02399800|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102025423|NCT02399800|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102025424|NCT02399800|Bupivacaine|bupivacaine|mesh-list
102025425|NCT02399800|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102025426|NCT02399800|Anesthetics, Local|anesthetics, local|mesh-ancestor
102025427|NCT02399800|Anesthetics|anesthetics|mesh-ancestor
102025428|NCT02399800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102025429|NCT02399800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025430|NCT02399800|Sensory System Agents|sensory system agents|mesh-ancestor
102025431|NCT02399800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102025433|NCT02399800|Glucocorticoids|glucocorticoids|mesh-ancestor
102025435|NCT02399800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102025436|NCT02399800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102025437|NCT02399800|Immunologic Factors|immunologic factors|mesh-ancestor
102025438|NCT02399800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102025439|NCT02399800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025440|NCT02399566|Pemetrexed|pemetrexed|mesh-list
102025441|NCT02399566|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102025442|NCT02399566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102025443|NCT02399566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102025444|NCT02399566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025445|NCT02399566|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102025446|NCT02399566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102025447|NCT02399566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102025455|NCT03167164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102025456|NCT03167164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102025457|NCT03167164|Tubulin Modulators|tubulin modulators|mesh-ancestor
102025458|NCT03167164|Antimitotic Agents|antimitotic agents|mesh-ancestor
102025459|NCT03167164|Mitosis Modulators|mitosis modulators|mesh-ancestor
102025460|NCT03167164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025461|NCT03167164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102025462|NCT03167164|Immunologic Factors|immunologic factors|mesh-ancestor
102025463|NCT03167164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025464|NCT03167164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102025465|NCT03167164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102025466|NCT03167164|Alkylating Agents|alkylating agents|mesh-ancestor
102025467|NCT03167164|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102025468|NCT03167164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102025469|NCT03167164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102025470|NCT03167164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102025471|NCT03167164|Growth Substances|growth substances|mesh-ancestor
102025472|NCT03167164|Growth Inhibitors|growth inhibitors|mesh-ancestor
102025473|NCT03167164|Antimetabolites|antimetabolites|mesh-ancestor
101951655|NCT01196715|Hematinics|hematinics|mesh-ancestor
101951656|NCT03848091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101951657|NCT03848091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101951658|NCT01189773|Ibuprofen|ibuprofen|mesh-list
101951659|NCT01189773|Codeine|codeine|mesh-list
101951660|NCT01189773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101951661|NCT01189773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101951662|NCT01189773|Analgesics|analgesics|mesh-ancestor
102025474|NCT03167164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102025475|NCT03167164|Antidotes|antidotes|mesh-ancestor
102025476|NCT03167164|Protective Agents|protective agents|mesh-ancestor
102025477|NCT03167164|Vitamin B Complex|vitamin b complex|mesh-ancestor
102025478|NCT03167164|Vitamins|vitamins|mesh-ancestor
102025479|NCT03167164|Micronutrients|micronutrients|mesh-ancestor
102025480|NCT03334747|Lumefantrine|lumefantrine|mesh-list
102025481|NCT03334747|Artemether|artemether|mesh-list
102025482|NCT03334747|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102025483|NCT03334747|Antimalarials|antimalarials|mesh-ancestor
102025484|NCT03334747|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102025485|NCT03334747|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102025486|NCT03334747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102025487|NCT02394652|Metformin|metformin|mesh-list
102025488|NCT02394652|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
102025489|NCT02394652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102025490|NCT02394652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025491|NCT02394652|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102025492|NCT02394652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025493|NCT02394496|Fulvestrant|fulvestrant|mesh-list
102025494|NCT02394496|Lapatinib|lapatinib|mesh-list
102025495|NCT02394496|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102025496|NCT02394496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102025497|NCT02394496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102025498|NCT02394496|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102025499|NCT02394496|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102025500|NCT02394496|Hormone Antagonists|hormone antagonists|mesh-ancestor
102025501|NCT02394496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102025502|NCT02394496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025503|NCT02394496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102025504|NCT02394496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102025505|NCT02394496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025506|NCT02394496|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102025507|NCT02394418|Dexmedetomidine|dexmedetomidine|mesh-list
102025508|NCT02394418|Propofol|propofol|mesh-list
102025509|NCT02394418|Sevoflurane|sevoflurane|mesh-list
102025510|NCT02394418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102025511|NCT02394418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102025512|NCT02394418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025513|NCT02394418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102025514|NCT02394418|Analgesics|analgesics|mesh-ancestor
102025515|NCT02394418|Sensory System Agents|sensory system agents|mesh-ancestor
102025516|NCT02394418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102025517|NCT02394418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102025518|NCT02394418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102025522|NCT02394418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025523|NCT02394418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102025524|NCT02394418|Anesthetics, General|anesthetics, general|mesh-ancestor
102025525|NCT02394418|Anesthetics|anesthetics|mesh-ancestor
102025526|NCT02394418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102025527|NCT02394418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102025528|NCT02693002|Norethindrone|norethindrone|mesh-list
102025529|NCT02693002|Norethindrone Acetate|norethindrone acetate|mesh-list
102025530|NCT02693002|Estradiol|estradiol|mesh-list
102025531|NCT02693002|Estrogens|estrogens|mesh-ancestor
102025532|NCT02693002|Hormones|hormones|mesh-ancestor
102025533|NCT02693002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102025534|NCT02693002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025535|NCT02693002|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102025536|NCT02693002|Contraceptive Agents|contraceptive agents|mesh-ancestor
102025537|NCT02693002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101951663|NCT01189773|Sensory System Agents|sensory system agents|mesh-ancestor
101951664|NCT01189773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101951665|NCT01189773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025538|NCT02693002|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102025539|NCT02693002|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102025540|NCT02693002|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102025541|NCT02693002|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102025542|NCT05408923|Chlorhexidine|chlorhexidine|mesh-list
102025543|NCT05408923|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102025544|NCT05408923|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102025545|NCT05408923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102025546|NCT05408923|Disinfectants|disinfectants|mesh-ancestor
102025547|NCT05408923|Dermatologic Agents|dermatologic agents|mesh-ancestor
102025548|NCT03707509|Gemcitabine|gemcitabine|mesh-list
102025549|NCT03707509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102025550|NCT03707509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102025551|NCT03707509|Antimetabolites|antimetabolites|mesh-ancestor
102025552|NCT03707509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025553|NCT03710395|Nifedipine|nifedipine|mesh-list
102025554|NCT03710395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102025555|NCT03710395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102025556|NCT03710395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025557|NCT03710395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102025558|NCT03710395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025559|NCT03710395|Vasodilator Agents|vasodilator agents|mesh-ancestor
102025560|NCT03710395|Tocolytic Agents|tocolytic agents|mesh-ancestor
102025561|NCT03710395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102025562|NCT03093870|Capecitabine|capecitabine|mesh-list
102025563|NCT03093870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102025564|NCT03093870|Antimetabolites|antimetabolites|mesh-ancestor
102025565|NCT03093870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025566|NCT03093870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102025567|NCT05744908|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
102025568|NCT05744908|Anticoagulants|anticoagulants|mesh-ancestor
102025569|NCT02394106|Ofatumumab|ofatumumab|mesh-list
102025570|NCT02394106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102025571|NCT04793646|Acetylcysteine|acetylcysteine|mesh-list
102025572|NCT04793646|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102025573|NCT04793646|Antiviral Agents|antiviral agents|mesh-ancestor
102025574|NCT04793646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102025575|NCT04793646|Expectorants|expectorants|mesh-ancestor
102025576|NCT04793646|Respiratory System Agents|respiratory system agents|mesh-ancestor
102025577|NCT04793646|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102025578|NCT04793646|Antioxidants|antioxidants|mesh-ancestor
102025579|NCT04793646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025580|NCT04793646|Protective Agents|protective agents|mesh-ancestor
102025581|NCT04793646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025582|NCT04793646|Antidotes|antidotes|mesh-ancestor
102025583|NCT03607890|Nivolumab|nivolumab|mesh-list
102025584|NCT03607890|Relatlimab|relatlimab|mesh-list
102025585|NCT03607890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102025586|NCT03607890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102025587|NCT03607890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102025588|NCT03607890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025589|NCT02393482|Cholecalciferol|cholecalciferol|mesh-list
102025590|NCT02393482|Vitamin D|vitamin d|mesh-list
102025591|NCT02393482|Leuprolide|leuprolide|mesh-list
102025595|NCT02393482|Estradiol|estradiol|mesh-list
102025596|NCT02393482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102025597|NCT02393482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025598|NCT02393482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102025599|NCT02393482|Estrogens|estrogens|mesh-ancestor
102025600|NCT02393482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102025601|NCT02393482|Antacids|antacids|mesh-ancestor
102025602|NCT02393482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025603|NCT02393482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102025604|NCT02393482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102025605|NCT02393482|Fertility Agents|fertility agents|mesh-ancestor
102025606|NCT02393482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102025607|NCT02393482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102025608|NCT02393482|Androgen Antagonists|androgen antagonists|mesh-ancestor
101951666|NCT01189773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101951667|NCT01189773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101951668|NCT01189773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101951669|NCT01189773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101951670|NCT01189773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951671|NCT01189773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102025609|NCT02393482|Hormone Antagonists|hormone antagonists|mesh-ancestor
102025610|NCT02393482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102025611|NCT02393482|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102025612|NCT02393482|Anabolic Agents|anabolic agents|mesh-ancestor
102025613|NCT02393482|Vitamins|vitamins|mesh-ancestor
102025614|NCT02393482|Micronutrients|micronutrients|mesh-ancestor
102025615|NCT02393482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102025616|NCT03346057|Glycopyrrolate|glycopyrrolate|mesh-list
102025617|NCT03346057|Rocuronium|rocuronium|mesh-list
102025618|NCT03346057|Vecuronium Bromide|vecuronium bromide|mesh-list
102025619|NCT03346057|Neostigmine|neostigmine|mesh-list
102025620|NCT03346057|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102025621|NCT03346057|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102025622|NCT03346057|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102025623|NCT03346057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102025624|NCT03346057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025625|NCT03346057|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102025626|NCT03346057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102025627|NCT03346057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025628|NCT03346057|Cholinergic Agents|cholinergic agents|mesh-ancestor
102025629|NCT03346057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102025630|NCT03346057|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102025631|NCT03346057|Autonomic Agents|autonomic agents|mesh-ancestor
102025632|NCT03346057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102025633|NCT03346057|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102025634|NCT03346057|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102025635|NCT03346057|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102025636|NCT03166306|Bevacizumab|bevacizumab|mesh-list
102025637|NCT03166306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102025638|NCT03166306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102025639|NCT03166306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102025640|NCT03166306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102025641|NCT03166306|Growth Substances|growth substances|mesh-ancestor
102025642|NCT03166306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025643|NCT03166306|Growth Inhibitors|growth inhibitors|mesh-ancestor
102025644|NCT02398630|Hormones|hormones|mesh-list
102025645|NCT02398630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102025646|NCT02398630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025647|NCT02398552|Sunitinib|sunitinib|mesh-list
102025648|NCT02398552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102025649|NCT02398552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102025650|NCT02398552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102025651|NCT02398552|Growth Substances|growth substances|mesh-ancestor
102025652|NCT02398552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025653|NCT02398552|Growth Inhibitors|growth inhibitors|mesh-ancestor
102025654|NCT02398552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102025655|NCT02398552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102025656|NCT02398552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025657|NCT03345979|Aripiprazole|aripiprazole|mesh-list
102025658|NCT03345979|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102025659|NCT03345979|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
102025660|NCT03345979|Antidepressive Agents|antidepressive agents|mesh-ancestor
102025661|NCT03345979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102025662|NCT03345979|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102025663|NCT03345979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102025664|NCT03345979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102025668|NCT03345979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102025669|NCT03345979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025670|NCT03345979|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102025671|NCT03345979|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102025673|NCT03345979|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102025674|NCT03345979|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101951673|NCT01189773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101951674|NCT01189773|Antitussive Agents|antitussive agents|mesh-ancestor
102025675|NCT03345979|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102025676|NCT03345979|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102025677|NCT02696434|Naltrexone|naltrexone|mesh-list
102025678|NCT02696434|Buprenorphine|buprenorphine|mesh-list
102025679|NCT02696434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102025680|NCT02696434|Narcotics|narcotics|mesh-ancestor
102025681|NCT02696434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102025682|NCT02696434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025683|NCT02696434|Analgesics|analgesics|mesh-ancestor
102025684|NCT02696434|Sensory System Agents|sensory system agents|mesh-ancestor
102025685|NCT02696434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102025686|NCT02696434|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102025687|NCT02696434|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102025688|NCT03709147|Metformin|metformin|mesh-list
102025689|NCT03709147|Carboplatin|carboplatin|mesh-list
102025690|NCT03709147|Pembrolizumab|pembrolizumab|mesh-list
102025691|NCT03709147|Pemetrexed|pemetrexed|mesh-list
102025692|NCT03709147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101524453|NCT04790045|Venetoclax|venetoclax|mesh-list
102025693|NCT03709147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102025694|NCT03709147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025695|NCT03709147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102025696|NCT03709147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102025697|NCT03709147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025698|NCT03709147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102025699|NCT03709147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102025700|NCT03709147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102025701|NCT02398474|Ropivacaine|ropivacaine|mesh-list
102025702|NCT02398474|Anesthetics, Local|anesthetics, local|mesh-ancestor
102025703|NCT02398474|Anesthetics|anesthetics|mesh-ancestor
102025704|NCT02398474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102025705|NCT02398474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025706|NCT02398474|Sensory System Agents|sensory system agents|mesh-ancestor
102025707|NCT02398474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102025708|NCT03710317|Misoprostol|misoprostol|mesh-list
102025709|NCT03710317|Tranexamic Acid|tranexamic acid|mesh-list
102025710|NCT03710317|Carbetocin|carbetocin|mesh-list
102025711|NCT03710317|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102025712|NCT03710317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102025713|NCT03710317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025714|NCT03710317|Hemostatics|hemostatics|mesh-ancestor
102025715|NCT03710317|Coagulants|coagulants|mesh-ancestor
102025716|NCT03710317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102025717|NCT03710317|Abortifacient Agents|abortifacient agents|mesh-ancestor
102025718|NCT03710317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102025719|NCT03710317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025720|NCT03710317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102025721|NCT03710317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102025722|NCT03710317|Oxytocics|oxytocics|mesh-ancestor
102025723|NCT02392780|Methylprednisolone|methylprednisolone|mesh-list
102025724|NCT02392780|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102025725|NCT02392780|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102025726|NCT02392780|Prednisolone|prednisolone|mesh-list
102025727|NCT02392780|Prednisolone acetate|prednisolone acetate|mesh-list
102025728|NCT02392780|Cannabidiol|cannabidiol|mesh-list
102025729|NCT02392780|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102025730|NCT02392780|Prednisolone phosphate|prednisolone phosphate|mesh-list
102025731|NCT02392780|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
102025732|NCT02392780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102025733|NCT02392780|Antiemetics|antiemetics|mesh-ancestor
102025734|NCT02392780|Autonomic Agents|autonomic agents|mesh-ancestor
102025735|NCT02392780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102025736|NCT02392780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025737|NCT02392780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102025740|NCT02392780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102025741|NCT02392780|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102025742|NCT02392780|Protective Agents|protective agents|mesh-ancestor
102025743|NCT02392780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102025744|NCT02392780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102025745|NCT02392780|Anticonvulsants|anticonvulsants|mesh-ancestor
102025746|NCT02392780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101737371|NCT00761462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101951675|NCT01189773|Respiratory System Agents|respiratory system agents|mesh-ancestor
102025747|NCT02392780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025748|NCT04053478|Phenylephrine|phenylephrine|mesh-list
102025749|NCT04053478|Vasopressins|vasopressins|mesh-list
102025750|NCT04053478|Arginine Vasopressin|arginine vasopressin|mesh-list
102025751|NCT04053478|Oxymetazoline|oxymetazoline|mesh-list
102025752|NCT04053478|Norepinephrine|norepinephrine|mesh-list
102025753|NCT04053478|Ephedrine|ephedrine|mesh-list
102025754|NCT04053478|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102025755|NCT04053478|Mydriatics|mydriatics|mesh-ancestor
102025756|NCT04053478|Autonomic Agents|autonomic agents|mesh-ancestor
102025757|NCT04053478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102025758|NCT04053478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025759|NCT04053478|Sympathomimetics|sympathomimetics|mesh-ancestor
102025760|NCT04053478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102025761|NCT04053478|Nasal Decongestants|nasal decongestants|mesh-ancestor
102025762|NCT04053478|Respiratory System Agents|respiratory system agents|mesh-ancestor
102025763|NCT04053478|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102025764|NCT04053478|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102025765|NCT04053478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102025766|NCT04053478|Adrenergic Agents|adrenergic agents|mesh-ancestor
102025767|NCT04053478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102025768|NCT04053478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025769|NCT04053478|Protective Agents|protective agents|mesh-ancestor
102025770|NCT04053478|Hemostatics|hemostatics|mesh-ancestor
102025771|NCT04053478|Coagulants|coagulants|mesh-ancestor
102025772|NCT04053478|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102025773|NCT04053478|Natriuretic Agents|natriuretic agents|mesh-ancestor
102025774|NCT04053478|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102025775|NCT02392390|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
102025776|NCT02392390|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102025777|NCT02392390|Dermatologic Agents|dermatologic agents|mesh-ancestor
102025778|NCT03593915|Azacitidine|azacitidine|mesh-list
102025779|NCT03593915|Decitabine|decitabine|mesh-list
102025780|NCT03593915|Alvocidib|alvocidib|mesh-list
102025781|NCT03593915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102025782|NCT03593915|Antimetabolites|antimetabolites|mesh-ancestor
102025783|NCT03593915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025784|NCT03593915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102025785|NCT03593915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102025786|NCT03593915|Growth Inhibitors|growth inhibitors|mesh-ancestor
102025787|NCT03593915|Growth Substances|growth substances|mesh-ancestor
102025788|NCT03593915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025789|NCT03593915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102025790|NCT02392702|Ivacaftor|ivacaftor|mesh-list
102025791|NCT02392702|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102025792|NCT02392702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102025793|NCT02392702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025794|NCT02392468|BI 409306|bi 409306|mesh-list
102025795|NCT02392468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102025796|NCT02392468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102025797|NCT02392468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025798|NCT02397928|Carboplatin|carboplatin|mesh-list
102025799|NCT02397928|Pemetrexed|pemetrexed|mesh-list
102025800|NCT02397928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102025801|NCT02397928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102025802|NCT02397928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025803|NCT02397928|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102025804|NCT02397928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102025805|NCT03734627|Acetaminophen|acetaminophen|mesh-list
102025806|NCT03734627|Sulfasalazine|sulfasalazine|mesh-list
102025807|NCT03734627|Octreotide|octreotide|mesh-list
102025808|NCT03734627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102025809|NCT03734627|Analgesics|analgesics|mesh-ancestor
102025810|NCT03734627|Sensory System Agents|sensory system agents|mesh-ancestor
102025811|NCT03734627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102025812|NCT03734627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025815|NCT03734627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102025816|NCT03734627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102025817|NCT03734627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102025818|NCT03734627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102025819|NCT03734627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102025820|NCT03734627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102025821|NCT02397772|Albendazole|albendazole|mesh-list
101951678|NCT01189929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101951679|NCT01189929|Antimetabolites|antimetabolites|mesh-ancestor
101951680|NCT01189929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951681|NCT01189929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101951682|NCT03845673|Psyllium|psyllium|mesh-list
102025822|NCT02397772|Anthelmintics|anthelmintics|mesh-ancestor
102025823|NCT02397772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102025824|NCT02397772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102025825|NCT02397772|Anticestodal Agents|anticestodal agents|mesh-ancestor
102025826|NCT02397772|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102025827|NCT02397772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102025828|NCT02397772|Tubulin Modulators|tubulin modulators|mesh-ancestor
102025829|NCT02397772|Antimitotic Agents|antimitotic agents|mesh-ancestor
102025830|NCT02397772|Mitosis Modulators|mitosis modulators|mesh-ancestor
101387659|NCT00322660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102025831|NCT02397772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025832|NCT02397772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102025833|NCT03592277|Vitamins|vitamins|mesh-list
102025834|NCT03592277|Ascorbic Acid|ascorbic acid|mesh-list
102025835|NCT03592277|Thiamine|thiamine|mesh-list
102025836|NCT03592277|Micronutrients|micronutrients|mesh-ancestor
102025837|NCT03592277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025838|NCT03592277|Antioxidants|antioxidants|mesh-ancestor
102025839|NCT03592277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025840|NCT03592277|Protective Agents|protective agents|mesh-ancestor
102025841|NCT03592277|Vitamin B Complex|vitamin b complex|mesh-ancestor
102025842|NCT03106402|Bromfenac|bromfenac|mesh-list
102025843|NCT03106402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102025844|NCT03106402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102025845|NCT03106402|Analgesics|analgesics|mesh-ancestor
102025846|NCT03106402|Sensory System Agents|sensory system agents|mesh-ancestor
102025847|NCT03106402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102025848|NCT03106402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025849|NCT03106402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102025850|NCT03106402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102025851|NCT03734159|Ropivacaine|ropivacaine|mesh-list
102025852|NCT03734159|Anesthetics, Local|anesthetics, local|mesh-ancestor
102025853|NCT03734159|Anesthetics|anesthetics|mesh-ancestor
102025854|NCT03734159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102025855|NCT03734159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025856|NCT03734159|Sensory System Agents|sensory system agents|mesh-ancestor
102025857|NCT03734159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102025858|NCT02397382|Midazolam|midazolam|mesh-list
102025859|NCT02397382|Dextromethorphan|dextromethorphan|mesh-list
102025860|NCT02397382|Caffeine|caffeine|mesh-list
102025861|NCT02397382|Omeprazole|omeprazole|mesh-list
102025862|NCT02397382|Warfarin|warfarin|mesh-list
102025863|NCT02397382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102025864|NCT02397382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102025865|NCT02397382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102025866|NCT02397382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025867|NCT02397382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102025868|NCT02397382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102025869|NCT02397382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102025870|NCT02397382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102025871|NCT02397382|Anesthetics, General|anesthetics, general|mesh-ancestor
102025872|NCT02397382|Anesthetics|anesthetics|mesh-ancestor
102025873|NCT02397382|GABA Modulators|gaba modulators|mesh-ancestor
102025874|NCT02397382|GABA Agents|gaba agents|mesh-ancestor
102025875|NCT02397382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102025876|NCT02397382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025877|NCT02397382|Anticoagulants|anticoagulants|mesh-ancestor
102025878|NCT02397382|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102025879|NCT02397382|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102025880|NCT02397382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102025881|NCT02397382|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102025882|NCT02397382|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102025883|NCT02397382|Purinergic Agents|purinergic agents|mesh-ancestor
102025884|NCT02397382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102025885|NCT02397382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102025886|NCT02397382|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101951683|NCT03845673|Cathartics|cathartics|mesh-ancestor
101951684|NCT03845673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101951685|NCT01190163|Oxytocin|oxytocin|mesh-list
101951686|NCT01190163|Dinoprostone|dinoprostone|mesh-list
101951687|NCT01190163|Oxytocics|oxytocics|mesh-ancestor
101951688|NCT01190163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102025887|NCT02397382|Antitussive Agents|antitussive agents|mesh-ancestor
101480874|NCT00294359|Antimetabolites|antimetabolites|mesh-ancestor
102025892|NCT02697916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102025894|NCT02697916|Analgesics|analgesics|mesh-ancestor
102025895|NCT02697916|Sensory System Agents|sensory system agents|mesh-ancestor
102025896|NCT02697916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102025897|NCT02697916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025898|NCT02697916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102025899|NCT02697916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102025900|NCT02697916|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102025901|NCT02697916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102025902|NCT02697916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025903|NCT02697916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102025904|NCT02697916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102025905|NCT02697916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102025906|NCT02697916|Antipyretics|antipyretics|mesh-ancestor
102025907|NCT04762680|Vaccines|vaccines|mesh-list
102025908|NCT04762680|Immunologic Factors|immunologic factors|mesh-ancestor
102025909|NCT04762680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025910|NCT03650387|Lidocaine|lidocaine|mesh-list
102025911|NCT03650387|Anesthetics, Local|anesthetics, local|mesh-ancestor
102025912|NCT03650387|Anesthetics|anesthetics|mesh-ancestor
102025913|NCT03650387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102025914|NCT03650387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025915|NCT03650387|Sensory System Agents|sensory system agents|mesh-ancestor
102025916|NCT03650387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102025917|NCT03650387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102025918|NCT03650387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102025919|NCT03650387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102025920|NCT03650387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102025921|NCT03650387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025922|NCT02392156|Factor VIII|factor viii|mesh-list
102025923|NCT02392156|Coagulants|coagulants|mesh-ancestor
102025924|NCT03115060|Plasma-lyte 148|plasma-lyte 148|mesh-list
102025925|NCT03115060|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102025926|NCT03115060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102025927|NCT03359473|GSK2881078|gsk2881078|mesh-list
102025928|NCT03359473|Anabolic Agents|anabolic agents|mesh-ancestor
102025929|NCT03359473|Hormones|hormones|mesh-ancestor
102025930|NCT03359473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102025931|NCT03359473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025932|NCT03632304|Anesthetics|anesthetics|mesh-list
102025933|NCT03632304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102025934|NCT03632304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025935|NCT02397538|Amlodipine|amlodipine|mesh-list
102025936|NCT02397538|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102025937|NCT02397538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102025938|NCT02397538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102025939|NCT02397538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102025940|NCT02397538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025941|NCT02397538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102025942|NCT02397538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025943|NCT02397538|Vasodilator Agents|vasodilator agents|mesh-ancestor
102025944|NCT02397538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102025945|NCT02397538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102025946|NCT02397538|Antimetabolites|antimetabolites|mesh-ancestor
102025947|NCT02397538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102025948|NCT02397538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102025949|NCT02397538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102025950|NCT03589469|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
102025951|NCT03589469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102025952|NCT03589469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102025953|NCT03359395|Alfentanil|alfentanil|mesh-list
102025954|NCT03359395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101951689|NCT01190163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951690|NCT01199445|Vitamin A|vitamin a|mesh-list
102025955|NCT03359395|Narcotics|narcotics|mesh-ancestor
102025956|NCT03359395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102025968|NCT03733691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102025969|NCT03733691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102025970|NCT03733691|Growth Substances|growth substances|mesh-ancestor
102025971|NCT03733691|Growth Inhibitors|growth inhibitors|mesh-ancestor
102025972|NCT03733691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102025973|NCT03733691|Protease Inhibitors|protease inhibitors|mesh-ancestor
102025974|NCT03733691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102025975|NCT03733691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025976|NCT03358147|Tiotropium Bromide|tiotropium bromide|mesh-list
102025977|NCT03358147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102025978|NCT03358147|Autonomic Agents|autonomic agents|mesh-ancestor
102025979|NCT03358147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102025980|NCT03358147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025981|NCT03358147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102025982|NCT03358147|Respiratory System Agents|respiratory system agents|mesh-ancestor
102025983|NCT03358147|Parasympatholytics|parasympatholytics|mesh-ancestor
102025984|NCT03358147|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102025985|NCT03358147|Cholinergic Agents|cholinergic agents|mesh-ancestor
102025986|NCT03358147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102025987|NCT03358147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025988|NCT03093402|Dronabinol|dronabinol|mesh-list
102025989|NCT03093402|Lenabasum|lenabasum|mesh-list
102025990|NCT03093402|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102025991|NCT03093402|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102025992|NCT03093402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102025993|NCT03093402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025994|NCT03093402|Hormones|hormones|mesh-ancestor
102025995|NCT03093402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102025996|NCT03093402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025997|NCT03093402|Hallucinogens|hallucinogens|mesh-ancestor
102025998|NCT03093402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102025999|NCT03093402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102026000|NCT03093402|Analgesics|analgesics|mesh-ancestor
102026001|NCT03093402|Sensory System Agents|sensory system agents|mesh-ancestor
102026002|NCT03093402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102026003|NCT02397070|Salicylic Acid|salicylic acid|mesh-list
102026004|NCT02397070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102026005|NCT02397070|Antifungal Agents|antifungal agents|mesh-ancestor
102026006|NCT02397070|Keratolytic Agents|keratolytic agents|mesh-ancestor
102026007|NCT02397070|Dermatologic Agents|dermatologic agents|mesh-ancestor
102026008|NCT03733379|Amoxicillin|amoxicillin|mesh-list
102026009|NCT03733379|Metronidazole|metronidazole|mesh-list
102026010|NCT03733379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102026011|NCT03733379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102026012|NCT03733379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102026013|NCT03733379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102026014|NCT05733676|Calcium|calcium|mesh-list
102026015|NCT05733676|Fluorides|fluorides|mesh-list
102026016|NCT05733676|Caseins|caseins|mesh-list
102026017|NCT05733676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102026018|NCT05733676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026019|NCT05733676|Cariostatic Agents|cariostatic agents|mesh-ancestor
102026020|NCT05733676|Protective Agents|protective agents|mesh-ancestor
102026021|NCT05733676|Chelating Agents|chelating agents|mesh-ancestor
101481013|NCT00326352|Remifentanil|remifentanil|mesh-list
102026027|NCT03343639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524505|NCT04607252|Metformin|metformin|mesh-list
102026028|NCT03343639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026029|NCT04479748|Dexamethasone|dexamethasone|mesh-list
102026030|NCT04479748|Prednisolone|prednisolone|mesh-list
102026031|NCT04479748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102026032|NCT04479748|Methylprednisolone|methylprednisolone|mesh-list
102026033|NCT04479748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102026034|NCT04479748|Prednisolone acetate|prednisolone acetate|mesh-list
102026035|NCT04479748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102026036|NCT04479748|Prednisolone phosphate|prednisolone phosphate|mesh-list
102026037|NCT04479748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102026038|NCT04479748|Antiemetics|antiemetics|mesh-ancestor
102026039|NCT04479748|Autonomic Agents|autonomic agents|mesh-ancestor
102026040|NCT04479748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102026041|NCT04479748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026042|NCT04479748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101951691|NCT01199445|Vitamins|vitamins|mesh-ancestor
101951692|NCT01199445|Micronutrients|micronutrients|mesh-ancestor
101951693|NCT01199445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951694|NCT01199523|Moxifloxacin|moxifloxacin|mesh-list
101951695|NCT01199523|Mirabegron|mirabegron|mesh-list
101288362|NCT02900560|Pembrolizumab|pembrolizumab|mesh-list
102026043|NCT04479748|Glucocorticoids|glucocorticoids|mesh-ancestor
102026044|NCT04479748|Hormones|hormones|mesh-ancestor
102026045|NCT04479748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102026046|NCT04479748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102026047|NCT04479748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102026048|NCT04479748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102026049|NCT04479748|Protective Agents|protective agents|mesh-ancestor
102026050|NCT02690974|Valsartan|valsartan|mesh-list
102026051|NCT02690974|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102026052|NCT02690974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102026053|NCT02690974|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102026054|NCT02690974|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102026055|NCT02690974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026056|NCT03093324|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102026057|NCT03093324|Dermatologic Agents|dermatologic agents|mesh-ancestor
102026058|NCT03093324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102026059|NCT03093324|Immunologic Factors|immunologic factors|mesh-ancestor
102026060|NCT03093324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026061|NCT03584009|Venetoclax|venetoclax|mesh-list
102026062|NCT03584009|Fulvestrant|fulvestrant|mesh-list
102026063|NCT03584009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102026064|NCT03584009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102026065|NCT03584009|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102026066|NCT03584009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102026067|NCT03584009|Hormone Antagonists|hormone antagonists|mesh-ancestor
102026068|NCT03584009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102026069|NCT03584009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026070|NCT03709927|Moxifloxacin|moxifloxacin|mesh-list
102026071|NCT03709927|Fosfomycin|fosfomycin|mesh-list
102026072|NCT03709927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102026073|NCT03709927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102026074|NCT03709927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102026075|NCT03709927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102026076|NCT03709927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102026077|NCT03709927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026078|NCT03709927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102026079|NCT03730181|Isoniazid|isoniazid|mesh-list
102026080|NCT03730181|Rifapentine|rifapentine|mesh-list
102026081|NCT03730181|Antitubercular Agents|antitubercular agents|mesh-ancestor
102026082|NCT03730181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102026083|NCT03730181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102026084|NCT03730181|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102026085|NCT03730181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102026086|NCT03730181|Antimetabolites|antimetabolites|mesh-ancestor
102026087|NCT03730181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026088|NCT03730181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101481075|NCT00326469|Lanreotide|lanreotide|mesh-list
102026093|NCT04167462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102026094|NCT04167462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102026095|NCT04167462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026096|NCT04160520|Morphine|morphine|mesh-list
102026097|NCT04160520|Pramipexole|pramipexole|mesh-list
102026098|NCT04160520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102026099|NCT04160520|Narcotics|narcotics|mesh-ancestor
102026100|NCT04160520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102026101|NCT04160520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026102|NCT04160520|Analgesics|analgesics|mesh-ancestor
102026103|NCT04160520|Sensory System Agents|sensory system agents|mesh-ancestor
102026104|NCT04160520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102026105|NCT04160520|Antioxidants|antioxidants|mesh-ancestor
102026106|NCT04160520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026107|NCT04160520|Protective Agents|protective agents|mesh-ancestor
102026108|NCT04160520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102026109|NCT04160520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101951696|NCT01199523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102026110|NCT04160520|Dopamine Agonists|dopamine agonists|mesh-ancestor
102026111|NCT04160520|Dopamine Agents|dopamine agents|mesh-ancestor
101745869|NCT02585648|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102026112|NCT04160520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102026114|NCT03583385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102026115|NCT03583385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026116|NCT05288335|Methamphetamine|methamphetamine|mesh-list
102026117|NCT05288335|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102026118|NCT05288335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026119|NCT05288335|Sympathomimetics|sympathomimetics|mesh-ancestor
102026120|NCT05288335|Autonomic Agents|autonomic agents|mesh-ancestor
102026121|NCT05288335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102026122|NCT05288335|Dopamine Agents|dopamine agents|mesh-ancestor
102026123|NCT05288335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102026124|NCT05288335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026125|NCT05288335|Adrenergic Agents|adrenergic agents|mesh-ancestor
102026126|NCT05288335|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102026127|NCT05288335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102026128|NCT05288335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102026129|NCT05288335|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102026130|NCT04792801|Choline|choline|mesh-list
102026131|NCT04792801|Lipotropic Agents|lipotropic agents|mesh-ancestor
102026132|NCT04792801|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102026133|NCT04792801|Antimetabolites|antimetabolites|mesh-ancestor
102026134|NCT04792801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026135|NCT04792801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102026136|NCT04792801|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102026137|NCT04792801|Nootropic Agents|nootropic agents|mesh-ancestor
102026138|NCT05420922|Lenvatinib|lenvatinib|mesh-list
102026139|NCT05420922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102026140|NCT05420922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102026141|NCT05420922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102026142|NCT05420922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102026143|NCT05420922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026144|NCT05420922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102026145|NCT03582215|Salicylates|salicylates|mesh-list
102026146|NCT03582215|Avobenzone|avobenzone|mesh-list
102026147|NCT03582215|Homosalate|homosalate|mesh-list
102026148|NCT03582215|Oxybenzone|oxybenzone|mesh-list
102026149|NCT03582215|2-ethylhexyl salicylate|2-ethylhexyl salicylate|mesh-list
102026150|NCT03582215|Octylmethoxycinnamate|octylmethoxycinnamate|mesh-list
102026151|NCT03582215|Sunscreening Agents|sunscreening agents|mesh-ancestor
102026152|NCT03582215|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102026153|NCT03582215|Protective Agents|protective agents|mesh-ancestor
102026154|NCT03582215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026155|NCT03582215|Dermatologic Agents|dermatologic agents|mesh-ancestor
102026156|NCT03582215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102026157|NCT03582215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102026158|NCT03582215|Analgesics|analgesics|mesh-ancestor
102026159|NCT03582215|Sensory System Agents|sensory system agents|mesh-ancestor
102026160|NCT03582215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102026168|NCT05175703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102026170|NCT05175703|Antimitotic Agents|antimitotic agents|mesh-ancestor
102026171|NCT05175703|Mitosis Modulators|mitosis modulators|mesh-ancestor
102026172|NCT05175703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026173|NCT04102800|Benralizumab|benralizumab|mesh-list
102026174|NCT04102800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102026175|NCT04102800|Respiratory System Agents|respiratory system agents|mesh-ancestor
102026176|NCT03323346|Disulfiram|disulfiram|mesh-list
102026177|NCT03323346|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102026178|NCT03323346|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
102026179|NCT03323346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102026180|NCT03323346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026181|NCT05628571|Fluorides|fluorides|mesh-list
102026182|NCT05628571|Cariostatic Agents|cariostatic agents|mesh-ancestor
102026183|NCT05628571|Protective Agents|protective agents|mesh-ancestor
102026184|NCT05628571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745948|NCT00764907|Alkylating Agents|alkylating agents|mesh-ancestor
102026185|NCT05255016|Riboflavin|riboflavin|mesh-list
102026186|NCT05255016|Lubricant Eye Drops|lubricant eye drops|mesh-list
102026187|NCT05255016|Vitamin B Complex|vitamin b complex|mesh-ancestor
102026188|NCT05255016|Vitamins|vitamins|mesh-ancestor
102026189|NCT05255016|Micronutrients|micronutrients|mesh-ancestor
102026190|NCT05255016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951697|NCT01199523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101951698|NCT01199523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101951699|NCT01199523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101951700|NCT01199523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101288497|NCT01946035|Doxazosin|doxazosin|mesh-list
102026191|NCT05255016|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102026192|NCT05255016|Dermatologic Agents|dermatologic agents|mesh-ancestor
102026193|NCT05255016|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102026194|NCT05255016|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102026195|NCT05178888|Palbociclib|palbociclib|mesh-list
102026196|NCT05178888|Adagrasib|adagrasib|mesh-list
102026197|NCT05178888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102026198|NCT05178888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102026199|NCT05178888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102026200|NCT05178888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026201|NCT03342001|Calcitonin|calcitonin|mesh-list
102026202|NCT03342001|Salmon calcitonin|salmon calcitonin|mesh-list
102026203|NCT03342001|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
102026204|NCT03342001|Katacalcin|katacalcin|mesh-list
102026205|NCT03342001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102026206|NCT03342001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026207|NCT03342001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102026208|NCT03342001|Vasodilator Agents|vasodilator agents|mesh-ancestor
102026209|NCT03579719|Itraconazole|itraconazole|mesh-list
102026210|NCT03579719|Balovaptan|balovaptan|mesh-list
102026211|NCT03579719|Antifungal Agents|antifungal agents|mesh-ancestor
102026212|NCT03579719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102026213|NCT03579719|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102026214|NCT03579719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102026215|NCT03579719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102026216|NCT03579719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026217|NCT03579719|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102026218|NCT03579719|Hormone Antagonists|hormone antagonists|mesh-ancestor
102026219|NCT03579719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102026220|NCT03579719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026221|NCT03579719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102026222|NCT03579719|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102026223|NCT03579719|Natriuretic Agents|natriuretic agents|mesh-ancestor
102026224|NCT03631602|Antifungal Agents|antifungal agents|mesh-list
102026225|NCT03631602|Clotrimazole|clotrimazole|mesh-list
102026226|NCT03631602|Miconazole|miconazole|mesh-list
102026233|NCT03631602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102026235|NCT03631602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102026236|NCT03631602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026237|NCT03631602|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102026238|NCT03631602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102026239|NCT02688088|Midazolam|midazolam|mesh-list
102026240|NCT02688088|Dextromethorphan|dextromethorphan|mesh-list
102026241|NCT02688088|Caffeine|caffeine|mesh-list
102026242|NCT02688088|Warfarin|warfarin|mesh-list
102026243|NCT02688088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102026244|NCT02688088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102026245|NCT02688088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102026246|NCT02688088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026247|NCT02688088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102026248|NCT02688088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102026249|NCT02688088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102026250|NCT02688088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102026251|NCT02688088|Anesthetics, General|anesthetics, general|mesh-ancestor
102026252|NCT02688088|Anesthetics|anesthetics|mesh-ancestor
102026253|NCT02688088|GABA Modulators|gaba modulators|mesh-ancestor
102026254|NCT02688088|GABA Agents|gaba agents|mesh-ancestor
102026255|NCT02688088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102026256|NCT02688088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026257|NCT02688088|Anticoagulants|anticoagulants|mesh-ancestor
102026258|NCT02688088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102026259|NCT02688088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102026260|NCT02688088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102026261|NCT02688088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102026262|NCT02688088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101951701|NCT01199523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288590|NCT01946607|Citalopram|citalopram|mesh-list
102026263|NCT02688088|Purinergic Agents|purinergic agents|mesh-ancestor
102026264|NCT02688088|Antitussive Agents|antitussive agents|mesh-ancestor
102026265|NCT02688088|Respiratory System Agents|respiratory system agents|mesh-ancestor
102026266|NCT02688088|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102026267|NCT02688088|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102026268|NCT03641651|Frovatriptan|frovatriptan|mesh-list
102026269|NCT03641651|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102026270|NCT03641651|Serotonin Agents|serotonin agents|mesh-ancestor
102026271|NCT03641651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102026272|NCT03641651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026273|NCT03641651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026274|NCT03341299|Insulin Lispro|insulin lispro|mesh-list
102026275|NCT03341299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102026276|NCT03341299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026277|NCT05666219|Aminophylline|aminophylline|mesh-list
102026278|NCT05666219|Theophylline|theophylline|mesh-list
102026279|NCT05666219|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102026280|NCT05666219|Autonomic Agents|autonomic agents|mesh-ancestor
102026281|NCT05666219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102026282|NCT05666219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026283|NCT05666219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102026284|NCT05666219|Respiratory System Agents|respiratory system agents|mesh-ancestor
102026285|NCT05666219|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102026286|NCT05666219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102026287|NCT05666219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026288|NCT05666219|Vasodilator Agents|vasodilator agents|mesh-ancestor
102026289|NCT05666219|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102026290|NCT05666219|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102026291|NCT05666219|Purinergic Agents|purinergic agents|mesh-ancestor
101481282|NCT00296933|Bupropion|bupropion|mesh-list
102026293|NCT05666219|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102026294|NCT05666219|Protective Agents|protective agents|mesh-ancestor
102026295|NCT02949271|Fentanyl|fentanyl|mesh-list
102026296|NCT02949271|Ropivacaine|ropivacaine|mesh-list
102026297|NCT02949271|Anesthetics, Local|anesthetics, local|mesh-ancestor
102026298|NCT02949271|Anesthetics|anesthetics|mesh-ancestor
102026299|NCT02949271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102026300|NCT02949271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026301|NCT02949271|Sensory System Agents|sensory system agents|mesh-ancestor
102026302|NCT02949271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102026303|NCT02949271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102026304|NCT02949271|Narcotics|narcotics|mesh-ancestor
102026305|NCT02949271|Analgesics|analgesics|mesh-ancestor
102026306|NCT02949271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102026307|NCT02949271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102026308|NCT02949271|Anesthetics, General|anesthetics, general|mesh-ancestor
102026309|NCT03339583|Zopiclone|zopiclone|mesh-list
102026310|NCT03339583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102026311|NCT03339583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102026312|NCT03339583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026313|NCT03639779|Sodium thiosulfate|sodium thiosulfate|mesh-list
102026314|NCT03639779|Antidotes|antidotes|mesh-ancestor
102026315|NCT03639779|Protective Agents|protective agents|mesh-ancestor
102026316|NCT03639779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026317|NCT03639779|Antioxidants|antioxidants|mesh-ancestor
102026318|NCT03639779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026319|NCT03639779|Antitubercular Agents|antitubercular agents|mesh-ancestor
102026320|NCT03639779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102026321|NCT03639779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102026322|NCT03639779|Chelating Agents|chelating agents|mesh-ancestor
102026323|NCT03639779|Sequestering Agents|sequestering agents|mesh-ancestor
102026324|NCT05682547|Lubricant Eye Drops|lubricant eye drops|mesh-list
102026325|NCT05682547|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102026326|NCT05682547|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102026327|NCT05173441|Immunoglobulins|immunoglobulins|mesh-list
102026328|NCT05173441|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102026329|NCT05173441|Antibodies|antibodies|mesh-list
102026330|NCT05173441|Immunologic Factors|immunologic factors|mesh-ancestor
102026331|NCT05173441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026332|NCT03708133|Nifurtimox|nifurtimox|mesh-list
102026333|NCT03708133|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102026334|NCT03708133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102026335|NCT03708133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101951702|NCT01199523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101951703|NCT01199523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951704|NCT01199523|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101951705|NCT01199523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101951706|NCT01199523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102026336|NCT03708133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102026337|NCT05075161|Pirfenidone|pirfenidone|mesh-list
102026338|NCT05075161|Analgesics|analgesics|mesh-ancestor
102026339|NCT05075161|Sensory System Agents|sensory system agents|mesh-ancestor
102026340|NCT05075161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102026341|NCT05075161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524568|NCT04573556|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102026342|NCT05075161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102026343|NCT05075161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102026344|NCT05075161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102026345|NCT05075161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102026346|NCT05075161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102026347|NCT05095831|Pancrelipase|pancrelipase|mesh-list
102026348|NCT05095831|Pancreatin|pancreatin|mesh-list
102026349|NCT05095831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102026350|NCT03638869|Methadone|methadone|mesh-list
102026351|NCT03638869|D-methadone|d-methadone|mesh-list
102026352|NCT03638869|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102026353|NCT03638869|Narcotics|narcotics|mesh-ancestor
102026354|NCT03638869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102026355|NCT03638869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026356|NCT03638869|Analgesics|analgesics|mesh-ancestor
102026357|NCT03638869|Sensory System Agents|sensory system agents|mesh-ancestor
102026358|NCT03638869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102026359|NCT03638869|Antitussive Agents|antitussive agents|mesh-ancestor
102026360|NCT03638869|Respiratory System Agents|respiratory system agents|mesh-ancestor
102026361|NCT03638869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102026362|NCT03091920|Praliciguat|praliciguat|mesh-list
102026363|NCT03091920|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102026364|NCT03091920|Enzyme Activators|enzyme activators|mesh-ancestor
102026365|NCT03091920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026366|NCT03091920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102026367|NCT03338569|Ascorbic Acid|ascorbic acid|mesh-list
102026368|NCT03338569|Vitamins|vitamins|mesh-ancestor
102026369|NCT03338569|Micronutrients|micronutrients|mesh-ancestor
102026372|NCT03338569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026374|NCT03338023|Insulin Lispro|insulin lispro|mesh-list
102026375|NCT03338023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102026376|NCT03338023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026377|NCT05053633|Anesthetics|anesthetics|mesh-list
102026378|NCT05053633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102026379|NCT05053633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026380|NCT03337477|Insulin|insulin|mesh-list
102026381|NCT03337477|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102026382|NCT03337477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102026383|NCT03337477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026384|NCT03707899|Amlodipine|amlodipine|mesh-list
102026385|NCT03707899|Telmisartan|telmisartan|mesh-list
102026386|NCT03707899|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
102026387|NCT03707899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102026388|NCT03707899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102026389|NCT03707899|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102026390|NCT03707899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102026391|NCT03707899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026392|NCT03707899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102026393|NCT03707899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026394|NCT03707899|Vasodilator Agents|vasodilator agents|mesh-ancestor
102026395|NCT03707899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102026396|NCT03707899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102026397|NCT03707899|Antimetabolites|antimetabolites|mesh-ancestor
102026398|NCT03707899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102026399|NCT03707899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102026400|NCT03707899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102026401|NCT03707899|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102026402|NCT03707899|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102026403|NCT03336619|Nitazoxanide|nitazoxanide|mesh-list
101951707|NCT01199523|Adrenergic Agents|adrenergic agents|mesh-ancestor
101951708|NCT01199523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101951709|NCT01199523|Urological Agents|urological agents|mesh-ancestor
101951710|NCT01190241|Everolimus|everolimus|mesh-list
102026404|NCT03336619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102026405|NCT03336619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102026406|NCT03114904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
102026407|NCT03114904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102026408|NCT03114904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026409|NCT03706339|Tranexamic Acid|tranexamic acid|mesh-list
102026410|NCT03706339|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101746169|NCT02557737|Cholinergic Agents|cholinergic agents|mesh-ancestor
102026411|NCT03706339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102026412|NCT03706339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026413|NCT03706339|Hemostatics|hemostatics|mesh-ancestor
102026414|NCT03706339|Coagulants|coagulants|mesh-ancestor
102026415|NCT03739476|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102026416|NCT03739476|Antidepressive Agents|antidepressive agents|mesh-ancestor
102026417|NCT03739476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102026418|NCT03739476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102026419|NCT03739476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102026420|NCT03739476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102026421|NCT03739476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026422|NCT03639558|Promethazine|promethazine|mesh-list
102026423|NCT03639558|Diphenhydramine|diphenhydramine|mesh-list
102026424|NCT03639558|Haloperidol|haloperidol|mesh-list
102026425|NCT03639558|Chlorpromazine|chlorpromazine|mesh-list
102026426|NCT03639558|Haloperidol decanoate|haloperidol decanoate|mesh-list
102026427|NCT03639558|Antiemetics|antiemetics|mesh-ancestor
102026428|NCT03639558|Autonomic Agents|autonomic agents|mesh-ancestor
102026429|NCT03639558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102026430|NCT03639558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026431|NCT03639558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102026432|NCT03639558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102026433|NCT03639558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102026434|NCT03639558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102026435|NCT03639558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102026436|NCT03639558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102026437|NCT03639558|Dopamine Agents|dopamine agents|mesh-ancestor
102026438|NCT03639558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102026439|NCT03639558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026440|NCT03639558|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102026443|NCT03639558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102026444|NCT03639558|Histamine Antagonists|histamine antagonists|mesh-ancestor
102026445|NCT03639558|Histamine Agents|histamine agents|mesh-ancestor
102026446|NCT03639558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102026447|NCT03639558|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102026448|NCT03639558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102026449|NCT03639558|Anesthetics, Local|anesthetics, local|mesh-ancestor
102026450|NCT03639558|Anesthetics|anesthetics|mesh-ancestor
102026451|NCT03639558|Sensory System Agents|sensory system agents|mesh-ancestor
102026453|NCT01353508|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102026454|NCT01353508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102026455|NCT01353508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102026456|NCT01353508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102026457|NCT01353508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026458|NCT01568268|Palonosetron|palonosetron|mesh-list
102026459|NCT01568268|Antiemetics|antiemetics|mesh-ancestor
102026460|NCT01568268|Autonomic Agents|autonomic agents|mesh-ancestor
102026461|NCT01568268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102026462|NCT01568268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026463|NCT01568268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102026464|NCT01568268|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102026465|NCT01568268|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102026466|NCT01568268|Serotonin Agents|serotonin agents|mesh-ancestor
102026467|NCT01568268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102026468|NCT01568268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026469|NCT04911361|Dexamethasone|dexamethasone|mesh-list
102026470|NCT04911361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102026471|NCT04911361|Antiemetics|antiemetics|mesh-ancestor
102026472|NCT04911361|Autonomic Agents|autonomic agents|mesh-ancestor
102026473|NCT04911361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101288785|NCT01947998|Warfarin|warfarin|mesh-list
102026474|NCT04911361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026475|NCT04911361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102026476|NCT04911361|Glucocorticoids|glucocorticoids|mesh-ancestor
102026477|NCT04911361|Hormones|hormones|mesh-ancestor
102026478|NCT04911361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102026479|NCT04911361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102026480|NCT04911361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102026481|NCT04475731|Ponatinib|ponatinib|mesh-list
102026482|NCT04475731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102026483|NCT04475731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102026484|NCT04475731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102026485|NCT04475731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026486|NCT03087786|Nicotine|nicotine|mesh-list
102026488|NCT03087786|Autonomic Agents|autonomic agents|mesh-ancestor
102026489|NCT03087786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102026490|NCT03087786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026491|NCT03087786|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102026492|NCT03087786|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102026493|NCT03087786|Cholinergic Agents|cholinergic agents|mesh-ancestor
102026494|NCT03087786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102026495|NCT03087786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026496|NCT03635957|Folic Acid|folic acid|mesh-list
102026497|NCT03635957|Methotrexate|methotrexate|mesh-list
102026498|NCT03635957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102026499|NCT03635957|Abortifacient Agents|abortifacient agents|mesh-ancestor
102026500|NCT03635957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102026501|NCT03635957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026502|NCT03635957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102026503|NCT03635957|Antimetabolites|antimetabolites|mesh-ancestor
102026504|NCT03635957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026505|NCT03635957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102026506|NCT03635957|Dermatologic Agents|dermatologic agents|mesh-ancestor
102026507|NCT03635957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102026508|NCT03635957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102026509|NCT03635957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102026510|NCT03635957|Immunologic Factors|immunologic factors|mesh-ancestor
102026511|NCT03635957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102026512|NCT03635957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102026513|NCT03635957|Hematinics|hematinics|mesh-ancestor
102026514|NCT03635957|Vitamin B Complex|vitamin b complex|mesh-ancestor
102026542|NCT02684344|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102026544|NCT02684344|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102026545|NCT02684344|Adrenergic Agents|adrenergic agents|mesh-ancestor
102026546|NCT02684344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102026547|NCT02684344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026548|NCT02684344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026549|NCT02684344|Urological Agents|urological agents|mesh-ancestor
102026550|NCT03974100|Denosumab|denosumab|mesh-list
102026551|NCT03974100|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102026552|NCT03974100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026553|NCT02689804|Contraceptive Agents|contraceptive agents|mesh-list
102026554|NCT02689804|Levonorgestrel|levonorgestrel|mesh-list
102026555|NCT02689804|Ulipristal acetate|ulipristal acetate|mesh-list
102026556|NCT02689804|Contraceptives, Postcoital|contraceptives, postcoital|mesh-list
102026557|NCT02689804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102026558|NCT02689804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026559|NCT02689804|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102026560|NCT02689804|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101746320|NCT00671853|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102026561|NCT02689804|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101481572|NCT00299039|Antipyretics|antipyretics|mesh-ancestor
102026565|NCT04353271|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102026566|NCT04353271|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102026567|NCT04353271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102026568|NCT04353271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102026569|NCT04353271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026570|NCT04353271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102026571|NCT01374568|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102026572|NCT01374568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102026573|NCT01374568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026574|NCT01374568|Incretins|incretins|mesh-ancestor
102026575|NCT01374568|Hormones|hormones|mesh-ancestor
101737372|NCT00761462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101951711|NCT01190241|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101951713|NCT01190241|Sunitinib|sunitinib|mesh-list
101951714|NCT01190241|Lapatinib|lapatinib|mesh-list
102026576|NCT01374568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102026577|NCT01374568|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102026578|NCT01374568|Protease Inhibitors|protease inhibitors|mesh-ancestor
102026579|NCT01374568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102026580|NCT01374568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026581|NCT01312441|Ergocalciferols|ergocalciferols|mesh-list
102026582|NCT01312441|Vitamin D|vitamin d|mesh-list
102026583|NCT01312441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102026584|NCT01312441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026585|NCT01312441|Vitamins|vitamins|mesh-ancestor
102026586|NCT01312441|Micronutrients|micronutrients|mesh-ancestor
102026587|NCT01312441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102026588|NCT02682784|Oxytocin|oxytocin|mesh-list
102026589|NCT02682784|Oxytocics|oxytocics|mesh-ancestor
102026590|NCT02682784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102026591|NCT02682784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026592|NCT03705949|Lubricant Eye Drops|lubricant eye drops|mesh-list
102026593|NCT03705949|Hyaluronic Acid|hyaluronic acid|mesh-list
102026594|NCT03705949|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102026595|NCT03705949|Immunologic Factors|immunologic factors|mesh-ancestor
102026596|NCT03705949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026597|NCT03705949|Viscosupplements|viscosupplements|mesh-ancestor
102026598|NCT03705949|Protective Agents|protective agents|mesh-ancestor
102026599|NCT03705949|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102026600|NCT03705949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102026601|NCT03162562|Oregovomab|oregovomab|mesh-list
102026602|NCT03162562|Poly ICLC|poly iclc|mesh-list
102026603|NCT03162562|Interferon Inducers|interferon inducers|mesh-ancestor
102026604|NCT03162562|Immunologic Factors|immunologic factors|mesh-ancestor
102026605|NCT03162562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026606|NCT03162562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102026607|NCT03162562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102026608|NCT03164590|Dexmedetomidine|dexmedetomidine|mesh-list
102026609|NCT03164590|Ketamine|ketamine|mesh-list
102026610|NCT03164590|Bupivacaine|bupivacaine|mesh-list
102026611|NCT03164590|Anesthetics, Local|anesthetics, local|mesh-ancestor
102026612|NCT03164590|Anesthetics|anesthetics|mesh-ancestor
102026613|NCT03164590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102026614|NCT03164590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026615|NCT03164590|Sensory System Agents|sensory system agents|mesh-ancestor
102026616|NCT03164590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102026617|NCT03164590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102026618|NCT03164590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102026619|NCT03164590|Analgesics|analgesics|mesh-ancestor
102026620|NCT03164590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102026621|NCT03164590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102026622|NCT03164590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102026623|NCT03164590|Adrenergic Agents|adrenergic agents|mesh-ancestor
102026624|NCT03164590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102026625|NCT03164590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026626|NCT03164590|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102026627|NCT03164590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102026628|NCT03164590|Anesthetics, General|anesthetics, general|mesh-ancestor
102026629|NCT03164590|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102026630|NCT03164590|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102026631|NCT05119075|Dopamine|dopamine|mesh-list
102026632|NCT05119075|Dopamine Agonists|dopamine agonists|mesh-list
102026633|NCT05119075|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102026634|NCT05119075|Sympathomimetics|sympathomimetics|mesh-ancestor
102026635|NCT05119075|Autonomic Agents|autonomic agents|mesh-ancestor
102026637|NCT05119075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026638|NCT05119075|Dopamine Agents|dopamine agents|mesh-ancestor
102026639|NCT05119075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102026640|NCT05119075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026641|NCT05119075|Protective Agents|protective agents|mesh-ancestor
102026642|NCT03387852|Fluticasone|fluticasone|mesh-list
102026643|NCT03387852|Xhance|xhance|mesh-list
102026644|NCT03387852|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102026645|NCT03387852|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102026646|NCT03387852|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101951715|NCT01190241|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101951716|NCT01190241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101951717|NCT01190241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101951718|NCT01190241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951719|NCT01190241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101951720|NCT01190241|Immunologic Factors|immunologic factors|mesh-ancestor
102026647|NCT03387852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102026648|NCT03387852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102026649|NCT03387852|Autonomic Agents|autonomic agents|mesh-ancestor
102026650|NCT03387852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102026651|NCT03387852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026652|NCT03387852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102026653|NCT03387852|Respiratory System Agents|respiratory system agents|mesh-ancestor
102026654|NCT03387852|Dermatologic Agents|dermatologic agents|mesh-ancestor
102026655|NCT03387852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102026656|NCT03387852|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102026657|NCT03387852|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102026658|NCT03387852|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102026659|NCT03387852|Adrenergic Agents|adrenergic agents|mesh-ancestor
102026660|NCT03387852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102026661|NCT03387852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026662|NCT03387852|Immunologic Factors|immunologic factors|mesh-ancestor
102026663|NCT03387852|Glucocorticoids|glucocorticoids|mesh-ancestor
102026664|NCT03387852|Hormones|hormones|mesh-ancestor
102026665|NCT03387852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102026666|NCT03387852|Sympathomimetics|sympathomimetics|mesh-ancestor
102026667|NCT02679274|Methyltestosterone|methyltestosterone|mesh-list
102026668|NCT02679274|Testosterone|testosterone|mesh-list
102026669|NCT02679274|Testosterone undecanoate|testosterone undecanoate|mesh-list
102026670|NCT02679274|Testosterone enanthate|testosterone enanthate|mesh-list
102026671|NCT02679274|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102026672|NCT02679274|Androgens|androgens|mesh-ancestor
102026673|NCT02679274|Hormones|hormones|mesh-ancestor
101524699|NCT00556257|Dermatologic Agents|dermatologic agents|mesh-ancestor
102026674|NCT02679274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102026675|NCT02679274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026676|NCT02679274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102026677|NCT02679274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102026678|NCT02679274|Anabolic Agents|anabolic agents|mesh-ancestor
102026679|NCT03620929|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102026680|NCT03620929|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102026681|NCT03620929|Estradiol|estradiol|mesh-list
102026682|NCT03620929|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102026683|NCT03620929|Dydrogesterone|dydrogesterone|mesh-list
102026684|NCT03620929|Estrogens|estrogens|mesh-ancestor
102026685|NCT03620929|Hormones|hormones|mesh-ancestor
102026686|NCT03620929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102026687|NCT03620929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026688|NCT03620929|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102026689|NCT03620929|Contraceptive Agents|contraceptive agents|mesh-ancestor
102026690|NCT03620929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102026691|NCT03620929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102026692|NCT03620929|Progestins|progestins|mesh-ancestor
102026693|NCT04969861|Pembrolizumab|pembrolizumab|mesh-list
102026694|NCT04969861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102026695|NCT04969861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102026696|NCT04969861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102026697|NCT04969861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026698|NCT05308849|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102026699|NCT05308849|beta-Lactams|beta-lactams|mesh-list
102026700|NCT05308849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102026701|NCT02678416|Acetaminophen|acetaminophen|mesh-list
102026702|NCT02678416|Morphine|morphine|mesh-list
102026703|NCT02678416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102026704|NCT02678416|Narcotics|narcotics|mesh-ancestor
102026705|NCT02678416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102026706|NCT02678416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026707|NCT02678416|Analgesics|analgesics|mesh-ancestor
102026708|NCT02678416|Sensory System Agents|sensory system agents|mesh-ancestor
102026721|NCT03631836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101951721|NCT01190241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951722|NCT01190241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102026722|NCT03631836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102026723|NCT03631836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102026724|NCT03631836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102026725|NCT03631836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102026726|NCT03631836|Growth Substances|growth substances|mesh-ancestor
102026727|NCT03631836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026728|NCT03631836|Growth Inhibitors|growth inhibitors|mesh-ancestor
102026729|NCT03631836|Immunologic Factors|immunologic factors|mesh-ancestor
102026730|NCT03162094|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102026731|NCT03162094|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102026732|NCT03086460|Formoterol Fumarate|formoterol fumarate|mesh-list
102026733|NCT03086460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102026734|NCT03086460|Autonomic Agents|autonomic agents|mesh-ancestor
102026735|NCT03086460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102026736|NCT03086460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026737|NCT03086460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102026738|NCT03086460|Respiratory System Agents|respiratory system agents|mesh-ancestor
101524715|NCT01712451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102026739|NCT03086460|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102026740|NCT03086460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102026741|NCT03086460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102026742|NCT03086460|Adrenergic Agents|adrenergic agents|mesh-ancestor
102026743|NCT03086460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102026744|NCT03086460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026745|NCT03670706|Analgesics|analgesics|mesh-list
102026746|NCT03670706|Sensory System Agents|sensory system agents|mesh-ancestor
102026747|NCT03670706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102026748|NCT03670706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026749|NCT03114280|Carboplatin|carboplatin|mesh-list
102026750|NCT03114280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102026751|NCT01312363|Rivastigmine|rivastigmine|mesh-list
102026752|NCT01312363|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102026753|NCT01312363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102026754|NCT01312363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026755|NCT01312363|Cholinergic Agents|cholinergic agents|mesh-ancestor
102026756|NCT01312363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102026757|NCT01312363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026758|NCT01312363|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102026759|NCT01312363|Protective Agents|protective agents|mesh-ancestor
102026760|NCT03161678|Clopidogrel|clopidogrel|mesh-list
102026761|NCT03161678|Ticagrelor|ticagrelor|mesh-list
102026762|NCT03161678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102026763|NCT03161678|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102026764|NCT03161678|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102026765|NCT03161678|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102026766|NCT03161678|Purinergic Agents|purinergic agents|mesh-ancestor
102026767|NCT03161678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102026768|NCT03161678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026769|NCT03161678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026770|NCT05597280|Rifampin|rifampin|mesh-list
102026771|NCT05597280|Bedaquiline|bedaquiline|mesh-list
102026772|NCT05597280|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102026773|NCT05597280|Antitubercular Agents|antitubercular agents|mesh-ancestor
102026774|NCT05597280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102026775|NCT05597280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102026776|NCT05597280|Leprostatic Agents|leprostatic agents|mesh-ancestor
102026782|NCT05597280|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102026783|NCT05597280|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102026784|NCT05597280|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102026785|NCT05597280|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102026786|NCT03674606|Aspirin|aspirin|mesh-list
102026787|NCT03674606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102026788|NCT03674606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102026789|NCT03674606|Analgesics|analgesics|mesh-ancestor
102026790|NCT03674606|Sensory System Agents|sensory system agents|mesh-ancestor
102026791|NCT03674606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102026792|NCT03674606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026793|NCT03674606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102026794|NCT03674606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102026795|NCT03674606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101951723|NCT01190241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101951724|NCT01190241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101951725|NCT01190241|Growth Substances|growth substances|mesh-ancestor
101951726|NCT01190241|Growth Inhibitors|growth inhibitors|mesh-ancestor
101951727|NCT01197261|Oxycodone|oxycodone|mesh-list
101951728|NCT01197261|Naloxone|naloxone|mesh-list
101951729|NCT01197261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101951730|NCT01197261|Narcotics|narcotics|mesh-ancestor
102026796|NCT03674606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102026797|NCT03674606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026798|NCT03674606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102026799|NCT03674606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102026800|NCT03674606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102026801|NCT03674606|Antipyretics|antipyretics|mesh-ancestor
102026802|NCT02677324|Venetoclax|venetoclax|mesh-list
102026803|NCT02677324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102026804|NCT03163966|Methotrexate|methotrexate|mesh-list
102026805|NCT03163966|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102026806|NCT03163966|Abortifacient Agents|abortifacient agents|mesh-ancestor
102026807|NCT03163966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102026808|NCT03163966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026809|NCT03163966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102026810|NCT03163966|Antimetabolites|antimetabolites|mesh-ancestor
102026811|NCT03163966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026812|NCT03163966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102026813|NCT03163966|Dermatologic Agents|dermatologic agents|mesh-ancestor
102026814|NCT03163966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102026815|NCT03163966|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102026816|NCT03163966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102026817|NCT03163966|Immunologic Factors|immunologic factors|mesh-ancestor
102026818|NCT03163966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102026819|NCT03163966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102026820|NCT03678116|Caffeine|caffeine|mesh-list
102026821|NCT03678116|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102026822|NCT03678116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026823|NCT03678116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102026824|NCT03678116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102026825|NCT03678116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026826|NCT03678116|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102026827|NCT03678116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102026828|NCT03678116|Purinergic Agents|purinergic agents|mesh-ancestor
102026829|NCT03678116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102026830|NCT03678038|Triamcinolone|triamcinolone|mesh-list
102026831|NCT03678038|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102026832|NCT03678038|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102026833|NCT03678038|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102026834|NCT03678038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102026835|NCT03678038|Glucocorticoids|glucocorticoids|mesh-ancestor
102026836|NCT03678038|Hormones|hormones|mesh-ancestor
102026837|NCT03678038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102026838|NCT03678038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026839|NCT03678038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102026840|NCT03678038|Immunologic Factors|immunologic factors|mesh-ancestor
102026841|NCT03678038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102026842|NCT03678038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524762|NCT00533312|Vitamins|vitamins|mesh-ancestor
102026845|NCT03163420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102026847|NCT03163420|Sensory System Agents|sensory system agents|mesh-ancestor
102026848|NCT03163420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102026849|NCT03163420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026850|NCT03163420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102026851|NCT03163420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102026852|NCT03163420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102026853|NCT03163420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102026854|NCT03163420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026855|NCT04440436|Cyclophosphamide|cyclophosphamide|mesh-list
102026856|NCT04440436|Fludarabine|fludarabine|mesh-list
102026857|NCT04440436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101951731|NCT01197261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101951732|NCT01197261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951734|NCT01197261|Sensory System Agents|sensory system agents|mesh-ancestor
101951735|NCT01197261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102026858|NCT04440436|Immunologic Factors|immunologic factors|mesh-ancestor
102026859|NCT04440436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026860|NCT04440436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102026861|NCT04440436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102026862|NCT04440436|Alkylating Agents|alkylating agents|mesh-ancestor
102026863|NCT04440436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026864|NCT04440436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102026865|NCT04440436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102026866|NCT05405686|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102026867|NCT05405686|Hormones|hormones|mesh-ancestor
102026868|NCT05405686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102026869|NCT05405686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026870|NCT04711122|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102026871|NCT04711122|Cephalosporins|cephalosporins|mesh-list
102026872|NCT04711122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102026873|NCT05272696|Paclitaxel|paclitaxel|mesh-list
102026874|NCT05272696|Pembrolizumab|pembrolizumab|mesh-list
102026875|NCT05272696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102026876|NCT05272696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102026877|NCT05272696|Tubulin Modulators|tubulin modulators|mesh-ancestor
102026878|NCT05272696|Antimitotic Agents|antimitotic agents|mesh-ancestor
102026879|NCT05272696|Mitosis Modulators|mitosis modulators|mesh-ancestor
102026880|NCT05272696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026881|NCT05272696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102026882|NCT05272696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102026883|NCT05563116|Calcium|calcium|mesh-list
102026884|NCT05563116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102026885|NCT05563116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026886|NCT03520946|Ramucirumab|ramucirumab|mesh-list
102026887|NCT03520946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102026888|NCT03709758|Cytarabine|cytarabine|mesh-list
102026889|NCT03709758|Daunorubicin|daunorubicin|mesh-list
102026890|NCT03709758|Venetoclax|venetoclax|mesh-list
102026891|NCT03709758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102026892|NCT03709758|Antimetabolites|antimetabolites|mesh-ancestor
102026893|NCT03709758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026894|NCT03709758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102026895|NCT03709758|Antiviral Agents|antiviral agents|mesh-ancestor
102026896|NCT03709758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102026897|NCT03709758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102026898|NCT03709758|Immunologic Factors|immunologic factors|mesh-ancestor
102026899|NCT03709758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026900|NCT03709758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102026901|NCT03709758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102026902|NCT03709758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102026903|NCT03709758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102026904|NCT03674060|Sorafenib|sorafenib|mesh-list
102026905|NCT03674060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102026906|NCT03674060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102026907|NCT03674060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102026908|NCT03674060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026909|NCT03163576|Niacin|niacin|mesh-list
102026910|NCT03163576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102026911|NCT03163576|Antimetabolites|antimetabolites|mesh-ancestor
102026912|NCT03163576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026913|NCT03163576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102026914|NCT03163576|Vasodilator Agents|vasodilator agents|mesh-ancestor
102026918|NCT03163576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026919|NCT01374178|Insulin Glargine|insulin glargine|mesh-list
102026920|NCT01374178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102026921|NCT01374178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026922|NCT03673280|Morphine|morphine|mesh-list
102026923|NCT03673280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102026924|NCT03673280|Narcotics|narcotics|mesh-ancestor
101951736|NCT01197261|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101951737|NCT01190553|Amantadine|amantadine|mesh-list
101951738|NCT01190553|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102026925|NCT03673280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102026926|NCT03673280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026927|NCT03673280|Analgesics|analgesics|mesh-ancestor
102026928|NCT03673280|Sensory System Agents|sensory system agents|mesh-ancestor
102026929|NCT03673280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102026930|NCT05420220|Axitinib|axitinib|mesh-list
102026931|NCT05420220|Antibodies|antibodies|mesh-list
102026932|NCT05420220|Immunologic Factors|immunologic factors|mesh-ancestor
102026933|NCT05420220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026934|NCT05420220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102026935|NCT05420220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102026936|NCT05420220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102026937|NCT05420220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026938|NCT05383560|Vaccines|vaccines|mesh-list
102026939|NCT05383560|Immunologic Factors|immunologic factors|mesh-ancestor
102026940|NCT05383560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026941|NCT01382004|Azithromycin|azithromycin|mesh-list
102026942|NCT01382004|Penicillins|penicillins|mesh-list
102026943|NCT01382004|Penicillin G|penicillin g|mesh-list
102026944|NCT01382004|Penicillin G Benzathine|penicillin g benzathine|mesh-list
102026945|NCT01382004|Penicillin G Procaine|penicillin g procaine|mesh-list
102026946|NCT01382004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102026947|NCT01382004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102026948|NCT03669224|Chlorhexidine|chlorhexidine|mesh-list
102026949|NCT03669224|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102026950|NCT03669224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102026951|NCT03669224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102026952|NCT03669224|Disinfectants|disinfectants|mesh-ancestor
102026953|NCT03669224|Dermatologic Agents|dermatologic agents|mesh-ancestor
102026954|NCT01381848|Doripenem|doripenem|mesh-list
102026955|NCT01381848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102026956|NCT01381848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102026957|NCT04546620|Prednisolone|prednisolone|mesh-list
102026958|NCT04546620|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102026959|NCT04546620|Methylprednisolone|methylprednisolone|mesh-list
102026960|NCT04546620|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102026961|NCT04546620|Prednisolone acetate|prednisolone acetate|mesh-list
102026962|NCT04546620|Prednisone|prednisone|mesh-list
102026963|NCT04546620|Cyclophosphamide|cyclophosphamide|mesh-list
102026964|NCT04546620|Rituximab|rituximab|mesh-list
102026965|NCT04546620|Doxorubicin|doxorubicin|mesh-list
102026966|NCT04546620|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102026967|NCT04546620|Vincristine|vincristine|mesh-list
102026968|NCT04546620|Acalabrutinib|acalabrutinib|mesh-list
102026969|NCT04546620|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102026970|NCT04546620|Prednisolone phosphate|prednisolone phosphate|mesh-list
102026971|NCT04546620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102026972|NCT04546620|Immunologic Factors|immunologic factors|mesh-ancestor
102026973|NCT04546620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026974|NCT04546620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102026975|NCT04546620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102026976|NCT04546620|Alkylating Agents|alkylating agents|mesh-ancestor
102026977|NCT04546620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026978|NCT04546620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102026979|NCT04546620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102026980|NCT04546620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102026981|NCT04546620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102026982|NCT04546620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102026983|NCT04546620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102026984|NCT04546620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102026985|NCT04546620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102026986|NCT04546620|Tubulin Modulators|tubulin modulators|mesh-ancestor
102026987|NCT04546620|Antimitotic Agents|antimitotic agents|mesh-ancestor
102026988|NCT04546620|Mitosis Modulators|mitosis modulators|mesh-ancestor
102026989|NCT04546620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102026990|NCT04546620|Glucocorticoids|glucocorticoids|mesh-ancestor
102026993|NCT04546620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102026995|NCT04546620|Autonomic Agents|autonomic agents|mesh-ancestor
102026996|NCT04546620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102026997|NCT04546620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102026998|NCT04546620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102026999|NCT04546620|Protective Agents|protective agents|mesh-ancestor
102027000|NCT04058210|Ivacaftor|ivacaftor|mesh-list
101951739|NCT01190553|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101951740|NCT01190553|Antiviral Agents|antiviral agents|mesh-ancestor
101951741|NCT01190553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101951742|NCT01190553|Dopamine Agents|dopamine agents|mesh-ancestor
101951743|NCT01190553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101289282|NCT01951144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102027002|NCT04058210|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102027003|NCT04058210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102027004|NCT04058210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027005|NCT02250300|Ixazomib|ixazomib|mesh-list
102027006|NCT02250300|Glycine|glycine|mesh-list
102027007|NCT02250300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102027008|NCT02250300|Protease Inhibitors|protease inhibitors|mesh-ancestor
102027009|NCT02250300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102027010|NCT02250300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027011|NCT02250300|Glycine Agents|glycine agents|mesh-ancestor
102027012|NCT02250300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102027013|NCT02250300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027015|NCT03020966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102027016|NCT03020966|Analgesics|analgesics|mesh-ancestor
102027017|NCT03020966|Sensory System Agents|sensory system agents|mesh-ancestor
102027018|NCT03020966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102027019|NCT03020966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027020|NCT03020966|Antipyretics|antipyretics|mesh-ancestor
102027021|NCT04051268|Vaccines|vaccines|mesh-list
102027022|NCT04051268|Immunologic Factors|immunologic factors|mesh-ancestor
102027023|NCT04051268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027024|NCT04595786|Tranexamic Acid|tranexamic acid|mesh-list
102027025|NCT04595786|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102027026|NCT04595786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102027027|NCT04595786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027028|NCT04595786|Hemostatics|hemostatics|mesh-ancestor
102027029|NCT04595786|Coagulants|coagulants|mesh-ancestor
102027030|NCT02108652|Atezolizumab|atezolizumab|mesh-list
102027031|NCT02108652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102027032|NCT02108652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027033|NCT02108652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102027034|NCT02108652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102027035|NCT01381614|Bevacizumab|bevacizumab|mesh-list
102027036|NCT01381614|Sunitinib|sunitinib|mesh-list
102027037|NCT01381614|Sorafenib|sorafenib|mesh-list
102027038|NCT01381614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102027039|NCT01381614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102027040|NCT01381614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102027041|NCT01381614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102027042|NCT01381614|Growth Substances|growth substances|mesh-ancestor
102027043|NCT01381614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027044|NCT01381614|Growth Inhibitors|growth inhibitors|mesh-ancestor
102027045|NCT01381614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102027046|NCT01381614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102027047|NCT01381614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027048|NCT01381536|Belimumab|belimumab|mesh-list
102027049|NCT01381536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102027050|NCT01381536|Immunologic Factors|immunologic factors|mesh-ancestor
102027051|NCT01381536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027052|NCT03162406|Vitamin D|vitamin d|mesh-list
102027053|NCT03162406|Cholecalciferol|cholecalciferol|mesh-list
102027054|NCT03162406|Vitamins|vitamins|mesh-ancestor
102027055|NCT03162406|Micronutrients|micronutrients|mesh-ancestor
102027056|NCT03162406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027057|NCT03162406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102027058|NCT03162406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102027059|NCT02946385|Vaccines|vaccines|mesh-list
102027060|NCT02946385|Immunologic Factors|immunologic factors|mesh-ancestor
101524837|NCT00556413|Antidotes|antidotes|mesh-ancestor
102027061|NCT02946385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027062|NCT05676190|Immunomodulating Agents|immunomodulating agents|mesh-list
102027063|NCT05676190|Immunologic Factors|immunologic factors|mesh-ancestor
102027064|NCT05676190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027103|NCT05681221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101951744|NCT01190553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951745|NCT01190553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027104|NCT05681221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027105|NCT04303507|Hydroxychloroquine|hydroxychloroquine|mesh-list
102027106|NCT04303507|Chloroquine|chloroquine|mesh-list
102027107|NCT04303507|Antimalarials|antimalarials|mesh-ancestor
102027108|NCT04303507|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102027109|NCT04303507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102027110|NCT04303507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102027111|NCT04303507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102027112|NCT04303507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027113|NCT04303507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102027114|NCT04303507|Amebicides|amebicides|mesh-ancestor
102027115|NCT03202537|Dexlansoprazole|dexlansoprazole|mesh-list
102027116|NCT03202537|Lansoprazole|lansoprazole|mesh-list
102027117|NCT03202537|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102027118|NCT03202537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102027119|NCT03202537|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102027120|NCT03202537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102027121|NCT03202537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027122|NCT03631134|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
102027123|NCT03631134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027124|NCT03631134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102027125|NCT03631134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027126|NCT04138615|Morphine|morphine|mesh-list
102027127|NCT04138615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102027128|NCT04138615|Narcotics|narcotics|mesh-ancestor
102027129|NCT04138615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102027130|NCT04138615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027131|NCT04138615|Analgesics|analgesics|mesh-ancestor
102027132|NCT04138615|Sensory System Agents|sensory system agents|mesh-ancestor
102027133|NCT04138615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102027134|NCT01383330|Megestrol Acetate|megestrol acetate|mesh-list
102027135|NCT01383330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102027136|NCT01383330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102027137|NCT01383330|Appetite Stimulants|appetite stimulants|mesh-ancestor
102027138|NCT01383330|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102027139|NCT01383330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027140|NCT03018938|Insulin|insulin|mesh-list
102027141|NCT03018938|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102027142|NCT03018938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102027143|NCT03018938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027144|NCT04776499|Perphenazine|perphenazine|mesh-list
102027145|NCT04776499|Riociguat|riociguat|mesh-list
102027146|NCT04776499|Propylthiouracil|propylthiouracil|mesh-list
102027147|NCT04776499|Enzyme Activators|enzyme activators|mesh-ancestor
102027148|NCT04776499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027149|NCT04776499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102027150|NCT04776499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102027151|NCT04776499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102027152|NCT04776499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027153|NCT04776499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102027154|NCT04776499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102027155|NCT04776499|Dopamine Agents|dopamine agents|mesh-ancestor
102027156|NCT04776499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102027157|NCT04776499|Antimetabolites|antimetabolites|mesh-ancestor
102027158|NCT04776499|Antithyroid Agents|antithyroid agents|mesh-ancestor
102027159|NCT04776499|Hormone Antagonists|hormone antagonists|mesh-ancestor
102027160|NCT04776499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102027161|NCT03668054|Bevacizumab|bevacizumab|mesh-list
102027162|NCT03668054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102027163|NCT03668054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102027164|NCT03668054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102027165|NCT03668054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102027166|NCT03668054|Growth Substances|growth substances|mesh-ancestor
102027167|NCT03668054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027168|NCT03668054|Growth Inhibitors|growth inhibitors|mesh-ancestor
102027169|NCT04698187|Nivolumab|nivolumab|mesh-list
102027170|NCT04698187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102027171|NCT04698187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102027174|NCT03623048|Chlorhexidine|chlorhexidine|mesh-list
102027175|NCT03623048|Propolis|propolis|mesh-list
101951746|NCT01190553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101951747|NCT01190553|Analgesics|analgesics|mesh-ancestor
101951748|NCT01190553|Sensory System Agents|sensory system agents|mesh-ancestor
101951749|NCT01190553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101289424|NCT01951911|Ketamine|ketamine|mesh-list
102027176|NCT03623048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102027177|NCT03623048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102027178|NCT03623048|Disinfectants|disinfectants|mesh-ancestor
102027179|NCT03016598|Oxytocin|oxytocin|mesh-list
102027180|NCT03016598|Oxytocics|oxytocics|mesh-ancestor
102027181|NCT03016598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102027182|NCT03016598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027183|NCT03017846|Cantharidin|cantharidin|mesh-list
102027184|NCT03017846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102027185|NCT03017846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027186|NCT03638401|Morphine|morphine|mesh-list
102027187|NCT03638401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102027188|NCT03638401|Narcotics|narcotics|mesh-ancestor
102027189|NCT03638401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102027190|NCT03638401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027191|NCT03638401|Analgesics|analgesics|mesh-ancestor
102027192|NCT03638401|Sensory System Agents|sensory system agents|mesh-ancestor
102027193|NCT03638401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102027194|NCT03666650|Edoxaban|edoxaban|mesh-list
102027195|NCT03666650|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102027196|NCT03666650|Antithrombins|antithrombins|mesh-ancestor
102027197|NCT03666650|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102027198|NCT03666650|Protease Inhibitors|protease inhibitors|mesh-ancestor
102027199|NCT03666650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102027200|NCT03666650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027201|NCT03666650|Anticoagulants|anticoagulants|mesh-ancestor
102027202|NCT02942485|Metronidazole|metronidazole|mesh-list
102027203|NCT02942485|Tinidazole|tinidazole|mesh-list
102027204|NCT02942485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102027205|NCT02942485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102027206|NCT02942485|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102027207|NCT02942485|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102027208|NCT02942485|Alkylating Agents|alkylating agents|mesh-ancestor
102027209|NCT02942485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027210|NCT02942485|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
102027211|NCT03666494|Fentanyl|fentanyl|mesh-list
102027212|NCT03666494|Ketamine|ketamine|mesh-list
102027213|NCT03666494|Propofol|propofol|mesh-list
102027214|NCT03666494|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102027215|NCT03666494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102027216|NCT03666494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027217|NCT03666494|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102027218|NCT03666494|Anesthetics, General|anesthetics, general|mesh-ancestor
102027219|NCT03666494|Anesthetics|anesthetics|mesh-ancestor
102027220|NCT03666494|Analgesics|analgesics|mesh-ancestor
102027221|NCT03666494|Sensory System Agents|sensory system agents|mesh-ancestor
102027222|NCT03666494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102027223|NCT03666494|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102027224|NCT03666494|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102027225|NCT03666494|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102027226|NCT03666494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102027227|NCT03666494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027228|NCT03666494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102027229|NCT03666494|Narcotics|narcotics|mesh-ancestor
102027230|NCT03666494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102027231|NCT03666884|Cyclosporine|cyclosporine|mesh-list
102027232|NCT03666884|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102027233|NCT03666884|Cyclosporins|cyclosporins|mesh-list
102027234|NCT03666884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102027235|NCT03666884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102027236|NCT03666884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027237|NCT03666884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102027238|NCT03666884|Immunologic Factors|immunologic factors|mesh-ancestor
102027239|NCT03666884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027240|NCT03666884|Antifungal Agents|antifungal agents|mesh-ancestor
102027241|NCT03666884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102027243|NCT03666884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102027244|NCT03666884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101951750|NCT01199757|Fluticasone|fluticasone|mesh-list
101951751|NCT01199757|Xhance|xhance|mesh-list
101951752|NCT01199757|Mometasone Furoate|mometasone furoate|mesh-list
101951753|NCT01199757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101951754|NCT01199757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101951755|NCT01199757|Autonomic Agents|autonomic agents|mesh-ancestor
101951756|NCT01199757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101951757|NCT01199757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951758|NCT01199757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101951759|NCT01199757|Respiratory System Agents|respiratory system agents|mesh-ancestor
101951760|NCT01199757|Dermatologic Agents|dermatologic agents|mesh-ancestor
101289490|NCT01952652|Narcotics|narcotics|mesh-ancestor
102027245|NCT02942407|Warfarin|warfarin|mesh-list
102027246|NCT02942407|Apixaban|apixaban|mesh-list
102027247|NCT02942407|Anticoagulants|anticoagulants|mesh-ancestor
102027276|NCT03320941|Licogliflozin|licogliflozin|mesh-list
102027277|NCT03320941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102027278|NCT03320941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027279|NCT03320941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102027280|NCT03320941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027281|NCT04730947|Dapagliflozin|dapagliflozin|mesh-list
102027282|NCT04730947|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102027283|NCT04730947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027284|NCT04730947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102027285|NCT04730947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027286|NCT03559699|Mitapivat|mitapivat|mesh-list
102027287|NCT03559699|Enzyme Activators|enzyme activators|mesh-ancestor
102027288|NCT03559699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027289|NCT03557281|GSK656|gsk656|mesh-list
102027290|NCT03557281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102027291|NCT03557281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102027292|NCT02573233|Fluticasone|fluticasone|mesh-list
102027293|NCT02573233|Xhance|xhance|mesh-list
102027294|NCT02573233|Mometasone Furoate|mometasone furoate|mesh-list
102027295|NCT02573233|Budesonide|budesonide|mesh-list
102027296|NCT02573233|Formoterol Fumarate|formoterol fumarate|mesh-list
102027299|NCT02573233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102027300|NCT02573233|Autonomic Agents|autonomic agents|mesh-ancestor
102027301|NCT02573233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102027302|NCT02573233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027303|NCT02573233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102027304|NCT02573233|Respiratory System Agents|respiratory system agents|mesh-ancestor
102027305|NCT02573233|Dermatologic Agents|dermatologic agents|mesh-ancestor
102027306|NCT02573233|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102027307|NCT02573233|Glucocorticoids|glucocorticoids|mesh-ancestor
102027309|NCT02573233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102027310|NCT02573233|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102027311|NCT02573233|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102027312|NCT02573233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102027313|NCT02573233|Adrenergic Agents|adrenergic agents|mesh-ancestor
102027314|NCT02573233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102027315|NCT02573233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027316|NCT03867487|Empagliflozin|empagliflozin|mesh-list
102027317|NCT03867487|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102027318|NCT03867487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027319|NCT03867487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102027320|NCT03867487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027321|NCT01569048|Dexmedetomidine|dexmedetomidine|mesh-list
102027322|NCT01569048|Remifentanil|remifentanil|mesh-list
102027323|NCT01569048|Propofol|propofol|mesh-list
102027324|NCT01569048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102027325|NCT01569048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102027326|NCT01569048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027327|NCT01569048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102027328|NCT01569048|Analgesics|analgesics|mesh-ancestor
101951761|NCT01199757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101951762|NCT03302234|Pembrolizumab|pembrolizumab|mesh-list
101951763|NCT03302234|Ipilimumab|ipilimumab|mesh-list
101951764|NCT03302234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101951765|NCT03302234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102027329|NCT01569048|Sensory System Agents|sensory system agents|mesh-ancestor
102027330|NCT01569048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102027331|NCT01569048|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102027332|NCT01569048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102027333|NCT01569048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102027334|NCT01569048|Adrenergic Agents|adrenergic agents|mesh-ancestor
102027335|NCT01569048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102027336|NCT01569048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027337|NCT01569048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102027338|NCT01569048|Anesthetics, General|anesthetics, general|mesh-ancestor
102027339|NCT01569048|Anesthetics|anesthetics|mesh-ancestor
102027340|NCT01569048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102027341|NCT01569048|Narcotics|narcotics|mesh-ancestor
102027342|NCT01380912|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102027343|NCT01380912|Methylprednisolone|methylprednisolone|mesh-list
102027344|NCT01380912|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102027345|NCT01380912|Prednisolone|prednisolone|mesh-list
102027346|NCT01380912|Prednisolone acetate|prednisolone acetate|mesh-list
102027347|NCT01380912|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102027348|NCT01380912|Prednisolone phosphate|prednisolone phosphate|mesh-list
102027349|NCT01380912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102027350|NCT01380912|Antiemetics|antiemetics|mesh-ancestor
102027351|NCT01380912|Autonomic Agents|autonomic agents|mesh-ancestor
102027352|NCT01380912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102027353|NCT01380912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027354|NCT01380912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102027355|NCT01380912|Glucocorticoids|glucocorticoids|mesh-ancestor
102027356|NCT01380912|Hormones|hormones|mesh-ancestor
102027357|NCT01380912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102027358|NCT01380912|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102027359|NCT01380912|Protective Agents|protective agents|mesh-ancestor
102027360|NCT01380912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102027361|NCT01380912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102027362|NCT03315793|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102027363|NCT03315793|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102027364|NCT03315793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102027365|NCT03315793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102027366|NCT03315793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027367|NCT03315793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102027370|NCT03315793|Sensory System Agents|sensory system agents|mesh-ancestor
102027371|NCT03315793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102027372|NCT03315793|Antidepressive Agents|antidepressive agents|mesh-ancestor
102027373|NCT03315793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102027374|NCT03315793|Dopamine Agents|dopamine agents|mesh-ancestor
102027375|NCT01569204|Dexamethasone|dexamethasone|mesh-list
102027376|NCT01569204|Prednisone|prednisone|mesh-list
102027377|NCT01569204|Cyclophosphamide|cyclophosphamide|mesh-list
102027378|NCT01569204|Dacarbazine|dacarbazine|mesh-list
102027379|NCT01569204|Doxorubicin|doxorubicin|mesh-list
102027380|NCT01569204|Etoposide|etoposide|mesh-list
102027381|NCT01569204|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102027382|NCT01569204|Procarbazine|procarbazine|mesh-list
102027383|NCT01569204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102027384|NCT01569204|Immunologic Factors|immunologic factors|mesh-ancestor
102027385|NCT01569204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027386|NCT01569204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102027387|NCT01569204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102027388|NCT01569204|Alkylating Agents|alkylating agents|mesh-ancestor
102027389|NCT01569204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027390|NCT01569204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102027391|NCT01569204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101747141|NCT00433537|Rituximab|rituximab|mesh-list
102027392|NCT01569204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102027393|NCT01569204|Antiemetics|antiemetics|mesh-ancestor
102027394|NCT01569204|Autonomic Agents|autonomic agents|mesh-ancestor
102027395|NCT01569204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101951766|NCT03302234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101951767|NCT03302234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951768|NCT03843879|Lidocaine|lidocaine|mesh-list
101951769|NCT03843879|Anesthetics, Local|anesthetics, local|mesh-ancestor
101951770|NCT03843879|Anesthetics|anesthetics|mesh-ancestor
101951771|NCT03843879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101289626|NCT05875519|Mepivacaine|mepivacaine|mesh-list
102027396|NCT01569204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102027397|NCT01569204|Glucocorticoids|glucocorticoids|mesh-ancestor
102027398|NCT01569204|Hormones|hormones|mesh-ancestor
102027399|NCT01569204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102027400|NCT01569204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102027401|NCT01569204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102027402|NCT01569204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102027403|NCT01569204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102027404|NCT01569204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102027405|NCT01569204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102027406|NCT01569204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102027407|NCT01569204|Immunotoxins|immunotoxins|mesh-ancestor
102027408|NCT01569204|Immunoconjugates|immunoconjugates|mesh-ancestor
102027409|NCT02676466|Losartan|losartan|mesh-list
102027410|NCT02676466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102027411|NCT02676466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102027412|NCT02676466|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102027413|NCT02676466|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102027414|NCT02676466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027415|NCT04439890|Carboplatin|carboplatin|mesh-list
102027416|NCT04439890|Pemetrexed|pemetrexed|mesh-list
102027417|NCT04439890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102027418|NCT04439890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102027419|NCT04439890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027420|NCT04439890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102027421|NCT04439890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102027422|NCT02324725|Naltrexone|naltrexone|mesh-list
102027423|NCT02324725|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102027424|NCT02324725|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102027425|NCT02324725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027426|NCT02324725|Sensory System Agents|sensory system agents|mesh-ancestor
102027427|NCT02324725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102027428|NCT01380678|Bevacizumab|bevacizumab|mesh-list
102027429|NCT01380678|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
102027430|NCT01380678|Histamine Antagonists|histamine antagonists|mesh-list
102027431|NCT01380678|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
102027432|NCT01380678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102027433|NCT01380678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102027434|NCT01380678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102027435|NCT01380678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102027436|NCT01380678|Growth Substances|growth substances|mesh-ancestor
102027437|NCT01380678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027438|NCT01380678|Growth Inhibitors|growth inhibitors|mesh-ancestor
102027439|NCT01380678|Histamine Agents|histamine agents|mesh-ancestor
102027440|NCT01380678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102027445|NCT01380600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027446|NCT01380600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102027447|NCT03264118|Tolonium Chloride|tolonium chloride|mesh-list
102027448|NCT03264118|Hemostatics|hemostatics|mesh-ancestor
102027449|NCT03264118|Coagulants|coagulants|mesh-ancestor
102027450|NCT03264118|Heparin Antagonists|heparin antagonists|mesh-ancestor
102027451|NCT03264118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027452|NCT02674204|Atorvastatin|atorvastatin|mesh-list
102027453|NCT02674204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102027454|NCT02674204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102027455|NCT02674204|Antimetabolites|antimetabolites|mesh-ancestor
102027456|NCT02674204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027457|NCT02674204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102027458|NCT02674204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102027459|NCT02674204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101951772|NCT03843879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951773|NCT03843879|Sensory System Agents|sensory system agents|mesh-ancestor
101951774|NCT03843879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102027460|NCT05675644|Drospirenone|drospirenone|mesh-list
102027461|NCT05675644|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102027462|NCT05675644|Hormone Antagonists|hormone antagonists|mesh-ancestor
102027463|NCT05675644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102027464|NCT05675644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027465|NCT05675644|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102027466|NCT05675644|Diuretics|diuretics|mesh-ancestor
102027467|NCT05675644|Natriuretic Agents|natriuretic agents|mesh-ancestor
102027469|NCT02579044|Lonafarnib|lonafarnib|mesh-list
102027470|NCT02579044|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102027471|NCT02579044|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102027472|NCT02579044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102027473|NCT02579044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027474|NCT02579044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102027475|NCT02579044|Immunologic Factors|immunologic factors|mesh-ancestor
102027476|NCT02579044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027477|NCT02579044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102027478|NCT02464696|Methylprednisolone|methylprednisolone|mesh-list
102027479|NCT02464696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102027480|NCT02464696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102027481|NCT02464696|Prednisolone|prednisolone|mesh-list
102027482|NCT02464696|Prednisolone acetate|prednisolone acetate|mesh-list
102027483|NCT02464696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102027484|NCT02464696|Prednisolone phosphate|prednisolone phosphate|mesh-list
102027485|NCT02464696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102027486|NCT02464696|Antiemetics|antiemetics|mesh-ancestor
102027487|NCT02464696|Autonomic Agents|autonomic agents|mesh-ancestor
102027488|NCT02464696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102027489|NCT02464696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027490|NCT02464696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102027491|NCT02464696|Glucocorticoids|glucocorticoids|mesh-ancestor
102027492|NCT02464696|Hormones|hormones|mesh-ancestor
102027493|NCT02464696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102027494|NCT02464696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102027495|NCT02464696|Protective Agents|protective agents|mesh-ancestor
102027496|NCT02464696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102027497|NCT02464696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102027498|NCT04503694|Nivolumab|nivolumab|mesh-list
102027499|NCT04503694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102027500|NCT04503694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102027501|NCT04503694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102027502|NCT04503694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027503|NCT03525379|Resveratrol|resveratrol|mesh-list
102027504|NCT03525379|Antioxidants|antioxidants|mesh-ancestor
102027505|NCT03525379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027506|NCT03525379|Protective Agents|protective agents|mesh-ancestor
102027507|NCT03525379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027508|NCT03525379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102027509|NCT03525379|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102027510|NCT03476551|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102027515|NCT03476551|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102027516|NCT03476551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102027517|NCT03476551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027519|NCT04702789|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102027520|NCT04702789|Dorzolamide|dorzolamide|mesh-list
102027521|NCT04702789|Latanoprost|latanoprost|mesh-list
102027522|NCT04702789|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102027523|NCT04702789|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102027524|NCT04702789|Adrenergic Agents|adrenergic agents|mesh-ancestor
102027525|NCT04702789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102027526|NCT04702789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027527|NCT04702789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027528|NCT04702789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102027529|NCT04702789|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102027530|NCT04702789|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102027531|NCT04702789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102027532|NCT04702789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101951775|NCT03843879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101951776|NCT03843879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101671574|NCT05656742|Micronutrients|micronutrients|mesh-ancestor
101951777|NCT03843879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101951778|NCT03843879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101289765|NCT05874583|Coagulants|coagulants|mesh-ancestor
102027533|NCT04702789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102027534|NCT04702789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102027535|NCT04702789|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102027536|NCT04702789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102027537|NCT03521934|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
102027538|NCT03521934|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101747305|NCT00666705|Maraviroc|maraviroc|mesh-list
102027539|NCT03521934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027540|NCT03521934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102027541|NCT03521934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027542|NCT03374137|Obinutuzumab|obinutuzumab|mesh-list
102027543|NCT03374137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102027544|NCT03374137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102027545|NCT01380522|Metronidazole|metronidazole|mesh-list
102027546|NCT01380522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102027547|NCT01380522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102027548|NCT01380522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102027549|NCT01380522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102027550|NCT02913326|Warfarin|warfarin|mesh-list
102027551|NCT02913326|Dabigatran|dabigatran|mesh-list
102027552|NCT02913326|Anticoagulants|anticoagulants|mesh-ancestor
102027553|NCT02913326|Antithrombins|antithrombins|mesh-ancestor
102027554|NCT02913326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102027555|NCT02913326|Protease Inhibitors|protease inhibitors|mesh-ancestor
102027556|NCT02913326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102027557|NCT02913326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027558|NCT03725891|Aspirin|aspirin|mesh-list
102027559|NCT03725891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102027560|NCT03725891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102027561|NCT03725891|Analgesics|analgesics|mesh-ancestor
102027562|NCT03725891|Sensory System Agents|sensory system agents|mesh-ancestor
102027563|NCT03725891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102027564|NCT03725891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027565|NCT03725891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102027566|NCT03725891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102027567|NCT03725891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102027568|NCT03725891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102027569|NCT03725891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027570|NCT03725891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102027571|NCT03725891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102027572|NCT03725891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102027573|NCT03725891|Antipyretics|antipyretics|mesh-ancestor
102027574|NCT03751163|Sunscreening Agents|sunscreening agents|mesh-list
102027575|NCT03751163|Tranexamic Acid|tranexamic acid|mesh-list
102027576|NCT03751163|Hydroquinone|hydroquinone|mesh-list
102027577|NCT03751163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102027578|NCT03751163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102027584|NCT03751163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027585|NCT03751163|Dermatologic Agents|dermatologic agents|mesh-ancestor
102027586|NCT03751163|Antioxidants|antioxidants|mesh-ancestor
102027588|NCT03639545|Empagliflozin|empagliflozin|mesh-list
102027589|NCT03639545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102027590|NCT03639545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027591|NCT03639545|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102027592|NCT03639545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027593|NCT03181386|Warfarin|warfarin|mesh-list
102027594|NCT03181386|Rivaroxaban|rivaroxaban|mesh-list
102027595|NCT03181386|Dabigatran|dabigatran|mesh-list
102027596|NCT03181386|Apixaban|apixaban|mesh-list
102027597|NCT03181386|Anticoagulants|anticoagulants|mesh-ancestor
102027598|NCT03181386|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102027599|NCT03181386|Antithrombins|antithrombins|mesh-ancestor
102027600|NCT03181386|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101951779|NCT03843879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951781|NCT03850587|Tramadol|tramadol|mesh-list
101951782|NCT03850587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101951783|NCT03850587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101951784|NCT03850587|Analgesics|analgesics|mesh-ancestor
101289837|NCT05872412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102027601|NCT03181386|Protease Inhibitors|protease inhibitors|mesh-ancestor
102027602|NCT03181386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102027603|NCT03181386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027604|NCT02912468|Mometasone Furoate|mometasone furoate|mesh-list
102027605|NCT02912468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102027606|NCT02912468|Dermatologic Agents|dermatologic agents|mesh-ancestor
102027607|NCT02912468|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102027608|NCT03639467|Gemcitabine|gemcitabine|mesh-list
102027609|NCT03639467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102027610|NCT03639467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102027611|NCT03639467|Antimetabolites|antimetabolites|mesh-ancestor
101747365|NCT00774423|Riluzole|riluzole|mesh-list
102027612|NCT03639467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027613|NCT01382706|Docetaxel|docetaxel|mesh-list
102027614|NCT01382706|Lapatinib|lapatinib|mesh-list
102027615|NCT01382706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102027616|NCT01382706|Tubulin Modulators|tubulin modulators|mesh-ancestor
102027617|NCT01382706|Antimitotic Agents|antimitotic agents|mesh-ancestor
102027618|NCT01382706|Mitosis Modulators|mitosis modulators|mesh-ancestor
102027619|NCT01382706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027620|NCT01382706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102027621|NCT01382706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102027622|NCT03665402|Isoniazid|isoniazid|mesh-list
102027623|NCT03665402|Antitubercular Agents|antitubercular agents|mesh-ancestor
102027624|NCT03665402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102027625|NCT03665402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102027626|NCT03665402|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102027627|NCT03665402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102027628|NCT03665402|Antimetabolites|antimetabolites|mesh-ancestor
102027629|NCT03665402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027630|NCT03665402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102027631|NCT01380288|Rivastigmine|rivastigmine|mesh-list
102027632|NCT01380288|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102027633|NCT01380288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102027634|NCT01380288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027635|NCT01380288|Cholinergic Agents|cholinergic agents|mesh-ancestor
102027636|NCT01380288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102027637|NCT01380288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027638|NCT01380288|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102027639|NCT01380288|Protective Agents|protective agents|mesh-ancestor
102027640|NCT03110484|Pemetrexed|pemetrexed|mesh-list
102027641|NCT03110484|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102027642|NCT03110484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102027643|NCT03110484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102027644|NCT03110484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027645|NCT03110484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102027646|NCT03110484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102027647|NCT03110484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102027648|NCT03110328|Pembrolizumab|pembrolizumab|mesh-list
101525049|NCT04666623|Antidepressive Agents|antidepressive agents|mesh-ancestor
102027652|NCT03110328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027653|NCT00002874|Bicalutamide|bicalutamide|mesh-list
102027654|NCT00002874|Androgen Antagonists|androgen antagonists|mesh-ancestor
102027655|NCT00002874|Hormone Antagonists|hormone antagonists|mesh-ancestor
102027656|NCT00002874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102027657|NCT00002874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027658|NCT00002874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102027659|NCT03001076|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
102027660|NCT03001076|Ezetimibe|ezetimibe|mesh-list
102027661|NCT03001076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102027662|NCT03001076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102027663|NCT03001076|Antimetabolites|antimetabolites|mesh-ancestor
101951785|NCT03850587|Sensory System Agents|sensory system agents|mesh-ancestor
101951786|NCT03850587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101951787|NCT03850587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951788|NCT03850587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101951789|NCT03850587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101951790|NCT03850587|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101951791|NCT03850587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101951792|NCT03850587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101951793|NCT03850587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951794|NCT03850587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101951795|NCT03850587|Narcotics|narcotics|mesh-ancestor
101951796|NCT03850587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101951797|NCT01199835|Calcium|calcium|mesh-list
101951798|NCT01199835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101951799|NCT01199835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951800|NCT05671497|Antirheumatic Agents|antirheumatic agents|mesh-list
101951801|NCT05671497|Cilostazol|cilostazol|mesh-list
102027664|NCT03001076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027665|NCT03001076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102027666|NCT03001076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102027667|NCT03001076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102027668|NCT03001076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027669|NCT03555305|Insulin|insulin|mesh-list
102027670|NCT03555305|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102027671|NCT03555305|Insulin Glargine|insulin glargine|mesh-list
102027672|NCT03555305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102027673|NCT03555305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027674|NCT03018834|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102027675|NCT03018834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102027676|NCT05422716|Baclofen|baclofen|mesh-list
102027677|NCT05422716|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102027678|NCT05422716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027679|NCT05422716|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102027680|NCT05422716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102027681|NCT05422716|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102027682|NCT05422716|GABA Agonists|gaba agonists|mesh-ancestor
102027683|NCT05422716|GABA Agents|gaba agents|mesh-ancestor
102027684|NCT05422716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102027685|NCT05422716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027686|NCT03728777|Resveratrol|resveratrol|mesh-list
102027687|NCT03728777|Antioxidants|antioxidants|mesh-ancestor
102027688|NCT03728777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027689|NCT03728777|Protective Agents|protective agents|mesh-ancestor
102027690|NCT03728777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027691|NCT03728777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102027692|NCT03728777|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102027693|NCT05421936|Osimertinib|osimertinib|mesh-list
102027694|NCT05421936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102027695|NCT05421936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102027696|NCT05421936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102027697|NCT05421936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027698|NCT01382472|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102027699|NCT01382472|Simvastatin|simvastatin|mesh-list
102027700|NCT01382472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102027701|NCT01382472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102027702|NCT01382472|Antimetabolites|antimetabolites|mesh-ancestor
101525058|NCT00556959|Clonidine|clonidine|mesh-list
102027703|NCT01382472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951802|NCT05671497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101951803|NCT05671497|Autonomic Agents|autonomic agents|mesh-ancestor
102027704|NCT01382472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102027705|NCT01382472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102027706|NCT01382472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102027707|NCT03725423|Apatinib|apatinib|mesh-list
102027708|NCT03725423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102027709|NCT03725423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102027710|NCT03725423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102027711|NCT03725423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027712|NCT03521141|Nicotine|nicotine|mesh-list
102027713|NCT03521141|Varenicline|varenicline|mesh-list
102027714|NCT03521141|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102027715|NCT03521141|Autonomic Agents|autonomic agents|mesh-ancestor
102027716|NCT03521141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102027717|NCT03521141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027718|NCT03521141|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102027730|NCT02997176|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102027732|NCT02997176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027733|NCT02997176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102027734|NCT03000452|Durvalumab|durvalumab|mesh-list
102027735|NCT03000452|Daratumumab|daratumumab|mesh-list
102027736|NCT03000452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102027737|NCT03000452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102027738|NCT03664388|Clopidogrel|clopidogrel|mesh-list
102027739|NCT03664388|Ticagrelor|ticagrelor|mesh-list
102027740|NCT03664388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102027741|NCT03664388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102027742|NCT03664388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102027743|NCT03664388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102027744|NCT03664388|Purinergic Agents|purinergic agents|mesh-ancestor
102027745|NCT03664388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102027746|NCT03664388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027747|NCT03664388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027748|NCT01373164|Gemcitabine|gemcitabine|mesh-list
102027749|NCT01373164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102027750|NCT01373164|Antimetabolites|antimetabolites|mesh-ancestor
102027751|NCT01373164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027752|NCT01373164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102027753|NCT02999984|Busulfan|busulfan|mesh-list
102027754|NCT02999984|Alkylating Agents|alkylating agents|mesh-ancestor
102027755|NCT02999984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027756|NCT02999984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102027757|NCT02999984|Immunologic Factors|immunologic factors|mesh-ancestor
102027758|NCT02999984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027759|NCT02999984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102027760|NCT02999984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102027761|NCT02999984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102027762|NCT03550313|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102027763|NCT03550313|Immunologic Factors|immunologic factors|mesh-ancestor
102027764|NCT03550313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027765|NCT03312907|Rituximab|rituximab|mesh-list
102027766|NCT03312907|Belimumab|belimumab|mesh-list
102027767|NCT03312907|Immunosuppressive Agents|immunosuppressive agents|mesh-list
102027768|NCT03312907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102027769|NCT03312907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102027770|NCT03312907|Immunologic Factors|immunologic factors|mesh-ancestor
102027771|NCT03312907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027772|NCT03312907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102027773|NCT02999672|Trastuzumab|trastuzumab|mesh-list
102027774|NCT02999672|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102027775|NCT02999672|Maytansine|maytansine|mesh-list
102027776|NCT02999672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102027777|NCT02999672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102027778|NCT02999672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102027779|NCT02999672|Tubulin Modulators|tubulin modulators|mesh-ancestor
102027784|NCT02999672|Immunoconjugates|immunoconjugates|mesh-ancestor
102027785|NCT02999672|Immunologic Factors|immunologic factors|mesh-ancestor
102027786|NCT02999672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027787|NCT03664622|Ketamine|ketamine|mesh-list
102027788|NCT03664622|Morphine|morphine|mesh-list
102027789|NCT03664622|Analgesics|analgesics|mesh-ancestor
102027790|NCT03664622|Sensory System Agents|sensory system agents|mesh-ancestor
101951804|NCT05671497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101951805|NCT05671497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951806|NCT05671497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102027791|NCT03664622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102027792|NCT03664622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027793|NCT03664622|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102027794|NCT03664622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102027795|NCT03664622|Anesthetics, General|anesthetics, general|mesh-ancestor
102027797|NCT03664622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102027798|NCT03664622|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102027799|NCT03664622|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102027800|NCT03664622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102027801|NCT03664622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027802|NCT03664622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102027803|NCT03664622|Narcotics|narcotics|mesh-ancestor
102027804|NCT04056182|Lofexidine|lofexidine|mesh-list
102027805|NCT04056182|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102027806|NCT04056182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102027807|NCT04056182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027808|NCT04056182|Sensory System Agents|sensory system agents|mesh-ancestor
102027809|NCT04056182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102027810|NCT04056182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102027811|NCT04056182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102027812|NCT04056182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102027813|NCT04056182|Adrenergic Agents|adrenergic agents|mesh-ancestor
102027814|NCT04056182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102027815|NCT04056182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027816|NCT03573323|Ixekizumab|ixekizumab|mesh-list
102027817|NCT03573323|Dermatologic Agents|dermatologic agents|mesh-ancestor
102027818|NCT04058054|Histamine|histamine|mesh-list
102027819|NCT04058054|Histamine Agonists|histamine agonists|mesh-ancestor
102027820|NCT04058054|Histamine Agents|histamine agents|mesh-ancestor
102027821|NCT04058054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102027822|NCT04058054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027823|NCT04058054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027824|NCT04498286|Antibodies|antibodies|mesh-list
102027825|NCT04498286|Immunologic Factors|immunologic factors|mesh-ancestor
102027826|NCT04498286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027827|NCT01069172|Dipivefrin|dipivefrin|mesh-list
102027828|NCT01069172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102027829|NCT01069172|Adrenergic Agents|adrenergic agents|mesh-ancestor
102027830|NCT01069172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102027831|NCT01069172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027832|NCT01069172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027833|NCT04245280|Ropivacaine|ropivacaine|mesh-list
102027834|NCT04245280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102027835|NCT04245280|Anesthetics, Local|anesthetics, local|mesh-ancestor
102027836|NCT04245280|Anesthetics|anesthetics|mesh-ancestor
102027837|NCT04245280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102027838|NCT04245280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027839|NCT04245280|Sensory System Agents|sensory system agents|mesh-ancestor
102027840|NCT04245280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102027841|NCT03724955|Estradiol|estradiol|mesh-list
102027842|NCT03724955|Estrogens|estrogens|mesh-ancestor
102027843|NCT03724955|Hormones|hormones|mesh-ancestor
102027844|NCT03724955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102027845|NCT03724955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027846|NCT04220008|Mycophenolic Acid|mycophenolic acid|mesh-list
102027847|NCT04220008|Cyclophosphamide|cyclophosphamide|mesh-list
102027848|NCT04220008|Busulfan|busulfan|mesh-list
102027849|NCT04220008|Rituximab|rituximab|mesh-list
102027850|NCT04220008|Gemcitabine|gemcitabine|mesh-list
102027851|NCT04220008|Vorinostat|vorinostat|mesh-list
102027852|NCT04220008|Clofarabine|clofarabine|mesh-list
102027858|NCT04220008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102027859|NCT04220008|Immunologic Factors|immunologic factors|mesh-ancestor
102027860|NCT04220008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027861|NCT04220008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102027862|NCT04220008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102027863|NCT04220008|Alkylating Agents|alkylating agents|mesh-ancestor
102027864|NCT04220008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951807|NCT05671497|Respiratory System Agents|respiratory system agents|mesh-ancestor
101951808|NCT05671497|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101951809|NCT05671497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102027865|NCT04220008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102027866|NCT04220008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102027867|NCT04220008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102027868|NCT04220008|Antimetabolites|antimetabolites|mesh-ancestor
102027869|NCT04220008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102027870|NCT04220008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102027871|NCT04220008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102027872|NCT04220008|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102027873|NCT04220008|Antitubercular Agents|antitubercular agents|mesh-ancestor
102027874|NCT04220008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102027875|NCT04220008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102027876|NCT04220008|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102027877|NCT03721991|Butyric Acid|butyric acid|mesh-list
102027878|NCT03721991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102027879|NCT03721991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027880|NCT03721991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027881|NCT03721991|Histamine Antagonists|histamine antagonists|mesh-ancestor
102027882|NCT03721991|Histamine Agents|histamine agents|mesh-ancestor
102027883|NCT02911688|Vitamin E|vitamin e|mesh-list
102027884|NCT02911688|Tocopherols|tocopherols|mesh-list
102027885|NCT02911688|Tocotrienols|tocotrienols|mesh-list
102027886|NCT02911688|alpha-Tocopherol|alpha-tocopherol|mesh-list
102027887|NCT02911688|gamma-Tocopherol|gamma-tocopherol|mesh-list
102027888|NCT02911688|Vitamins|vitamins|mesh-ancestor
102027889|NCT02911688|Micronutrients|micronutrients|mesh-ancestor
102027890|NCT02911688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027891|NCT02911688|Antioxidants|antioxidants|mesh-ancestor
102027892|NCT02911688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027893|NCT02911688|Protective Agents|protective agents|mesh-ancestor
102027894|NCT05580250|Metformin|metformin|mesh-list
102027895|NCT05580250|Simvastatin|simvastatin|mesh-list
102027896|NCT05580250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102027897|NCT05580250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027898|NCT05580250|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102027899|NCT05580250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102027900|NCT05580250|Antimetabolites|antimetabolites|mesh-ancestor
102027901|NCT05580250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027902|NCT05580250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102027903|NCT05580250|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102027904|NCT05580250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102027905|NCT03431948|Nivolumab|nivolumab|mesh-list
102027906|NCT03431948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102027907|NCT03431948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102027908|NCT03431948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102027909|NCT03431948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027910|NCT03662516|Levonorgestrel|levonorgestrel|mesh-list
102027911|NCT03662516|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102027912|NCT03662516|Contraceptive Agents|contraceptive agents|mesh-list
102027913|NCT03662516|Contraceptives, Oral|contraceptives, oral|mesh-list
102027914|NCT03662516|Estradiol|estradiol|mesh-list
102027915|NCT03662516|Abrocitinib|abrocitinib|mesh-list
102027917|NCT03662516|Hormones|hormones|mesh-ancestor
102027918|NCT03662516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102027919|NCT03662516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027920|NCT03662516|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102027921|NCT03662516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102027922|NCT03662516|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102027923|NCT03662516|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102027924|NCT03662516|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102027931|NCT03728465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102027932|NCT03728465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102027933|NCT03728465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027934|NCT03662984|Ciprofibrate|ciprofibrate|mesh-list
102027935|NCT03662984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102027936|NCT03662984|Antimetabolites|antimetabolites|mesh-ancestor
102027937|NCT03662984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027938|NCT03662984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102027939|NCT02994056|Sofosbuvir|sofosbuvir|mesh-list
102027940|NCT02994056|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
101951810|NCT05671497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951811|NCT05671497|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101951812|NCT05671497|Vasodilator Agents|vasodilator agents|mesh-ancestor
102027941|NCT02994056|Velpatasvir|velpatasvir|mesh-list
102027942|NCT02994056|Antiviral Agents|antiviral agents|mesh-ancestor
102027943|NCT02994056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102027944|NCT03728153|Fluoxetine|fluoxetine|mesh-list
102027945|NCT03728153|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102027946|NCT03728153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102027947|NCT03728153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102027948|NCT03728153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027949|NCT03728153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102027950|NCT03728153|Serotonin Agents|serotonin agents|mesh-ancestor
102027951|NCT03728153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027952|NCT03728153|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102027953|NCT03728153|Antidepressive Agents|antidepressive agents|mesh-ancestor
102027954|NCT03728153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102027955|NCT03728153|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102027956|NCT03728153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102027957|NCT03728153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102027958|NCT04056806|Ceftriaxone|ceftriaxone|mesh-list
102027959|NCT04056806|Terlipressin|terlipressin|mesh-list
102027960|NCT04056806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102027961|NCT04056806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102027962|NCT04056806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102027963|NCT04056806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102027964|NCT03305575|Bupivacaine|bupivacaine|mesh-list
102027965|NCT03305575|Chloroprocaine|chloroprocaine|mesh-list
102027966|NCT03305575|Anesthetics, Local|anesthetics, local|mesh-ancestor
102027967|NCT03305575|Anesthetics|anesthetics|mesh-ancestor
102027968|NCT03305575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102027969|NCT03305575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027970|NCT03305575|Sensory System Agents|sensory system agents|mesh-ancestor
102027971|NCT03305575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102027972|NCT02993822|Maleic acid|maleic acid|mesh-list
102027973|NCT02993822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102027974|NCT02993822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027975|NCT02391844|Oxycodone|oxycodone|mesh-list
102027976|NCT02391844|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102027977|NCT02391844|Narcotics|narcotics|mesh-ancestor
102027978|NCT02391844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102027979|NCT02391844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027980|NCT02391844|Analgesics|analgesics|mesh-ancestor
102027981|NCT02391844|Sensory System Agents|sensory system agents|mesh-ancestor
102027982|NCT02391844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102027983|NCT02391688|Fexofenadine|fexofenadine|mesh-list
102027984|NCT02391688|Flurbiprofen|flurbiprofen|mesh-list
102027985|NCT02391688|Midazolam|midazolam|mesh-list
102027986|NCT02391688|Dextromethorphan|dextromethorphan|mesh-list
102027987|NCT02391688|Caffeine|caffeine|mesh-list
102027988|NCT02391688|Bupropion|bupropion|mesh-list
102027989|NCT02391688|Omeprazole|omeprazole|mesh-list
102027990|NCT02391688|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102027991|NCT02391688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102027992|NCT02391688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102027993|NCT02391688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027994|NCT02391688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102028002|NCT02391688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102028003|NCT02391688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028004|NCT02391688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102028005|NCT02391688|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102028006|NCT02391688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102028007|NCT02391688|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102028008|NCT02391688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102028009|NCT02391688|Purinergic Agents|purinergic agents|mesh-ancestor
102028010|NCT02391688|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102028011|NCT02391688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102028012|NCT02391688|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102028013|NCT02391688|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102028014|NCT02391688|Antidepressive Agents|antidepressive agents|mesh-ancestor
101951813|NCT05671497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101951814|NCT05671497|Protective Agents|protective agents|mesh-ancestor
101951815|NCT05671497|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101951816|NCT05671497|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101951885|NCT01200693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951886|NCT01200693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101951887|NCT01200693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101951888|NCT01200693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101951889|NCT01200693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101951890|NCT01200693|Antifungal Agents|antifungal agents|mesh-ancestor
101951891|NCT03844581|Propiverine|propiverine|mesh-list
101951892|NCT03844581|Parasympatholytics|parasympatholytics|mesh-ancestor
101951893|NCT03844581|Autonomic Agents|autonomic agents|mesh-ancestor
101951894|NCT03844581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101951895|NCT03844581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951896|NCT03844581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101951897|NCT03844581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101951898|NCT03844581|Cholinergic Agents|cholinergic agents|mesh-ancestor
101951899|NCT03844581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101951900|NCT03844581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028015|NCT02391688|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102028016|NCT02391688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102028017|NCT02391688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102028018|NCT02391688|Dopamine Agents|dopamine agents|mesh-ancestor
102028019|NCT02391688|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102028020|NCT02391688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102028021|NCT02391688|Antitussive Agents|antitussive agents|mesh-ancestor
102028022|NCT02391688|Respiratory System Agents|respiratory system agents|mesh-ancestor
102028023|NCT02391688|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102028024|NCT02391688|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102028025|NCT02391688|Analgesics|analgesics|mesh-ancestor
102028026|NCT02391688|Sensory System Agents|sensory system agents|mesh-ancestor
102028027|NCT02391688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102028028|NCT02391688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102028029|NCT02391688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102028030|NCT02391688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102028031|NCT02391688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102028032|NCT02391688|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102028033|NCT02391688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102028034|NCT02391688|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102028035|NCT02391688|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102028036|NCT02391688|Histamine Antagonists|histamine antagonists|mesh-ancestor
102028037|NCT02391688|Histamine Agents|histamine agents|mesh-ancestor
102028038|NCT01068860|Insulin|insulin|mesh-list
102028039|NCT01068860|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102028040|NCT01068860|Metformin|metformin|mesh-list
102028041|NCT01068860|Glimepiride|glimepiride|mesh-list
102028042|NCT01068860|Insulin Lispro|insulin lispro|mesh-list
102028043|NCT01068860|Insulin, Isophane|insulin, isophane|mesh-list
102028044|NCT01068860|Glyburide|glyburide|mesh-list
102028045|NCT01068860|Glipizide|glipizide|mesh-list
102028046|NCT01068860|Troglitazone|troglitazone|mesh-list
102028047|NCT01068860|Tolbutamide|tolbutamide|mesh-list
102028048|NCT01068860|Acetohexamide|acetohexamide|mesh-list
102028049|NCT01068860|Insulin, Regular, Pork|insulin, regular, pork|mesh-list
102028050|NCT01068860|Tolazamide|tolazamide|mesh-list
102028051|NCT01068860|Chlorpropamide|chlorpropamide|mesh-list
102028052|NCT01068860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102028053|NCT01068860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102028054|NCT01068860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028055|NCT01068860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102028056|NCT01068860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102028057|NCT01068860|Immunologic Factors|immunologic factors|mesh-ancestor
102028058|NCT04056650|Caffeine|caffeine|mesh-list
101951901|NCT03844581|Urological Agents|urological agents|mesh-ancestor
101951902|NCT01202097|Fluticasone|fluticasone|mesh-list
101951903|NCT01202097|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101951904|NCT01202097|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101951905|NCT01202097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101951906|NCT01202097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101951907|NCT01202097|Autonomic Agents|autonomic agents|mesh-ancestor
101951908|NCT01202097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101951909|NCT01202097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951910|NCT01202097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102028059|NCT04056650|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102028060|NCT04056650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028061|NCT04056650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102028062|NCT04056650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102028063|NCT04056650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028064|NCT04056650|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102028075|NCT03158090|Octreotide|octreotide|mesh-list
102028076|NCT03158090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102028077|NCT03158090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102028078|NCT03158090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102028079|NCT02670538|Cariprazine|cariprazine|mesh-list
102028080|NCT02670538|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102028081|NCT02670538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102028082|NCT02670538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102028083|NCT02670538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028084|NCT02670538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102028085|NCT03727763|Cetuximab|cetuximab|mesh-list
101525119|NCT05449522|Vitamins|vitamins|mesh-ancestor
102028086|NCT03727763|Vemurafenib|vemurafenib|mesh-list
102028087|NCT03727763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102028088|NCT03727763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102028089|NCT03727763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102028090|NCT03727763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102028091|NCT03727763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028092|NCT01310621|Pulmonary Surfactants|pulmonary surfactants|mesh-list
102028093|NCT01310621|Respiratory System Agents|respiratory system agents|mesh-ancestor
102028094|NCT02991482|Gemcitabine|gemcitabine|mesh-list
102028095|NCT02991482|Pembrolizumab|pembrolizumab|mesh-list
102028096|NCT02991482|Vinorelbine|vinorelbine|mesh-list
102028097|NCT02991482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102028098|NCT02991482|Antimetabolites|antimetabolites|mesh-ancestor
102028099|NCT02991482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028100|NCT02991482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102028101|NCT02991482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102028102|NCT02991482|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102028103|NCT02991482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102028104|NCT02991482|Tubulin Modulators|tubulin modulators|mesh-ancestor
102028105|NCT02991482|Antimitotic Agents|antimitotic agents|mesh-ancestor
102028106|NCT02991482|Mitosis Modulators|mitosis modulators|mesh-ancestor
102028107|NCT02391142|Lidocaine|lidocaine|mesh-list
102028108|NCT02391142|Ropivacaine|ropivacaine|mesh-list
102028109|NCT02391142|Anesthetics, Local|anesthetics, local|mesh-ancestor
102028110|NCT02391142|Anesthetics|anesthetics|mesh-ancestor
102028111|NCT02391142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102028112|NCT02391142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028113|NCT02391142|Sensory System Agents|sensory system agents|mesh-ancestor
102028114|NCT02391142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102028115|NCT02391142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102028116|NCT02391142|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102028117|NCT02391142|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102028118|NCT02391142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102028119|NCT02391142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028120|NCT02987972|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102028121|NCT02987972|Immunologic Factors|immunologic factors|mesh-ancestor
101951911|NCT01202097|Respiratory System Agents|respiratory system agents|mesh-ancestor
101951912|NCT01202097|Dermatologic Agents|dermatologic agents|mesh-ancestor
101951913|NCT01202097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101951914|NCT01202097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102028122|NCT02987972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028123|NCT04479202|Bentonite|bentonite|mesh-list
102028124|NCT04479202|Antidotes|antidotes|mesh-ancestor
102028125|NCT04479202|Protective Agents|protective agents|mesh-ancestor
102028126|NCT04479202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028127|NCT01372618|Pasireotide|pasireotide|mesh-list
102028128|NCT01372618|Hormones|hormones|mesh-ancestor
102028129|NCT01372618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102028130|NCT01372618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028137|NCT04526509|Immunologic Factors|immunologic factors|mesh-ancestor
102028138|NCT04526509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028139|NCT04526509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102028140|NCT04526509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102028141|NCT04526509|Alkylating Agents|alkylating agents|mesh-ancestor
102028142|NCT04526509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028143|NCT04526509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102028144|NCT04526509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102028145|NCT03660020|Anesthetics|anesthetics|mesh-list
102028146|NCT03660020|Anesthetics, Local|anesthetics, local|mesh-list
102028147|NCT03660020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102028148|NCT03660020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028149|NCT03660020|Sensory System Agents|sensory system agents|mesh-ancestor
102028150|NCT03660020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102028151|NCT03661892|Dronabinol|dronabinol|mesh-list
102028152|NCT03661892|Hallucinogens|hallucinogens|mesh-ancestor
102028153|NCT03661892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028154|NCT03661892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102028155|NCT03661892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102028156|NCT03661892|Analgesics|analgesics|mesh-ancestor
102028157|NCT03661892|Sensory System Agents|sensory system agents|mesh-ancestor
102028158|NCT03661892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102028159|NCT03661892|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102028160|NCT03661892|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102028161|NCT03661892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102028162|NCT03661892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028163|NCT03661892|Hormones|hormones|mesh-ancestor
102028164|NCT03661892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102028165|NCT03658850|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102028166|NCT03658850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102028167|NCT03658850|Diuretics|diuretics|mesh-ancestor
102028168|NCT03658850|Natriuretic Agents|natriuretic agents|mesh-ancestor
102028169|NCT03658850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028170|NCT03658850|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102028171|NCT03658850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102028172|NCT03658850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028173|NCT03659162|Antifungal Agents|antifungal agents|mesh-list
102028174|NCT03659162|Clotrimazole|clotrimazole|mesh-list
102028175|NCT03659162|Miconazole|miconazole|mesh-list
102028176|NCT03659162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102028177|NCT03659162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102028178|NCT03659162|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102028179|NCT03659162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102028180|NCT03659162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102028181|NCT03659162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028182|NCT03659162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102028183|NCT03659162|Hormone Antagonists|hormone antagonists|mesh-ancestor
102028184|NCT03659162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102028185|NCT03659162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028186|NCT03659162|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102028187|NCT03659162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102028188|NCT03659084|Deferasirox|deferasirox|mesh-list
102028189|NCT03659084|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102028190|NCT03659084|Chelating Agents|chelating agents|mesh-ancestor
102028191|NCT03659084|Sequestering Agents|sequestering agents|mesh-ancestor
101525163|NCT05335915|Autonomic Agents|autonomic agents|mesh-ancestor
101951915|NCT01202097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101951916|NCT01202097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101951917|NCT01202097|Adrenergic Agents|adrenergic agents|mesh-ancestor
101951918|NCT01202097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101951919|NCT01202097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951920|NCT01202097|Glucocorticoids|glucocorticoids|mesh-ancestor
102028192|NCT03659084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028193|NCT01068626|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102028194|NCT01068626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102028195|NCT01068626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102028196|NCT01068626|Antimetabolites|antimetabolites|mesh-ancestor
102028197|NCT01068626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028200|NCT01068626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102028201|NCT02921750|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102028202|NCT02921750|Laxatives|laxatives|mesh-ancestor
102028203|NCT02921750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102028204|NCT03657836|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102028205|NCT03657836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102028206|NCT03622502|Dexmedetomidine|dexmedetomidine|mesh-list
102028207|NCT03622502|Remifentanil|remifentanil|mesh-list
102028208|NCT03622502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102028209|NCT03622502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102028210|NCT03622502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028211|NCT03622502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102028212|NCT03622502|Analgesics|analgesics|mesh-ancestor
102028213|NCT03622502|Sensory System Agents|sensory system agents|mesh-ancestor
102028214|NCT03622502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102028215|NCT03622502|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102028216|NCT03622502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102028217|NCT03622502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102028218|NCT03622502|Adrenergic Agents|adrenergic agents|mesh-ancestor
102028219|NCT03622502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102028220|NCT03622502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028221|NCT03622502|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102028223|NCT04397354|Dexamethasone|dexamethasone|mesh-list
102028224|NCT04397354|Dexamethasone acetate|dexamethasone acetate|mesh-list
102028225|NCT04397354|BB 1101|bb 1101|mesh-list
102028226|NCT04397354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102028227|NCT04397354|Antiemetics|antiemetics|mesh-ancestor
102028228|NCT04397354|Autonomic Agents|autonomic agents|mesh-ancestor
102028229|NCT04397354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102028230|NCT04397354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028231|NCT04397354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102028232|NCT04397354|Glucocorticoids|glucocorticoids|mesh-ancestor
102028233|NCT04397354|Hormones|hormones|mesh-ancestor
102028234|NCT04397354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102028235|NCT04397354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102028236|NCT04397354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102028237|NCT04397354|Protease Inhibitors|protease inhibitors|mesh-ancestor
102028238|NCT04397354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102028239|NCT04397354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028240|NCT03657758|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102028241|NCT03657758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102028242|NCT03657758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102028243|NCT03657758|Antimetabolites|antimetabolites|mesh-ancestor
102028244|NCT03657758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028245|NCT03657758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102028246|NCT03657758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102028247|NCT03657758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102028248|NCT01068158|Ivermectin|ivermectin|mesh-list
102028249|NCT01068158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102028250|NCT01068158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102028251|NCT03303079|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102028252|NCT03303079|Immunologic Factors|immunologic factors|mesh-ancestor
102028253|NCT03303079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028254|NCT01067846|Cycloserine|cycloserine|mesh-list
102028255|NCT01067846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101525181|NCT03527576|Dexamethasone|dexamethasone|mesh-list
102028256|NCT01067846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101951921|NCT01202097|Hormones|hormones|mesh-ancestor
101951922|NCT01202097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102028257|NCT01067846|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102028258|NCT01067846|Antitubercular Agents|antitubercular agents|mesh-ancestor
102028259|NCT01067846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102028260|NCT01067846|Antimetabolites|antimetabolites|mesh-ancestor
102028261|NCT01067846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028262|NCT03874234|GSK3186899|gsk3186899|mesh-list
102028263|NCT03874234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102028264|NCT03874234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102028265|NCT03874234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028266|NCT03657446|Moxifloxacin|moxifloxacin|mesh-list
102028267|NCT03657446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102028268|NCT03657446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102028269|NCT03657446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102028270|NCT03657446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102028275|NCT05276323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102028276|NCT05275777|Paclitaxel|paclitaxel|mesh-list
102028277|NCT05275777|Cyclophosphamide|cyclophosphamide|mesh-list
102028278|NCT05275777|Doxorubicin|doxorubicin|mesh-list
102028279|NCT05275777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102028280|NCT05275777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102028281|NCT05275777|Tubulin Modulators|tubulin modulators|mesh-ancestor
102028282|NCT05275777|Antimitotic Agents|antimitotic agents|mesh-ancestor
102028283|NCT05275777|Mitosis Modulators|mitosis modulators|mesh-ancestor
102028284|NCT05275777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028285|NCT05275777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102028286|NCT05275777|Immunologic Factors|immunologic factors|mesh-ancestor
102028287|NCT05275777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028288|NCT05275777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102028289|NCT05275777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102028290|NCT05275777|Alkylating Agents|alkylating agents|mesh-ancestor
102028291|NCT05275777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102028292|NCT05275777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102028293|NCT05275777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102028294|NCT05275777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102028295|NCT05275777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102028296|NCT05672212|Sufentanil|sufentanil|mesh-list
102028297|NCT05672212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102028298|NCT05672212|Narcotics|narcotics|mesh-ancestor
102028299|NCT05672212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102028300|NCT05672212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028301|NCT05672212|Analgesics|analgesics|mesh-ancestor
102028302|NCT05672212|Sensory System Agents|sensory system agents|mesh-ancestor
102028303|NCT05672212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102028304|NCT05672212|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102028305|NCT05672212|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102028306|NCT05672212|Anesthetics, General|anesthetics, general|mesh-ancestor
102028307|NCT05672212|Anesthetics|anesthetics|mesh-ancestor
102028308|NCT02390674|Cyclosporine|cyclosporine|mesh-list
102028309|NCT02390674|Cyclosporins|cyclosporins|mesh-list
102028310|NCT02390674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102028311|NCT02390674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028312|NCT02390674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102028313|NCT02390674|Immunologic Factors|immunologic factors|mesh-ancestor
102028314|NCT02390674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028315|NCT02390674|Antifungal Agents|antifungal agents|mesh-ancestor
102028316|NCT02390674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102028317|NCT02390674|Dermatologic Agents|dermatologic agents|mesh-ancestor
102028318|NCT02390674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102028319|NCT02390674|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102028320|NCT02390596|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102028321|NCT02390596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102028322|NCT02663674|Fluconazole|fluconazole|mesh-list
102028323|NCT02663674|Antifungal Agents|antifungal agents|mesh-ancestor
102028324|NCT02663674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102028325|NCT02663674|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102028326|NCT02663674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102028327|NCT02663674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102028328|NCT02663674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028329|NCT02663674|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102028330|NCT02663674|Hormone Antagonists|hormone antagonists|mesh-ancestor
101951923|NCT01202097|Sympathomimetics|sympathomimetics|mesh-ancestor
101951924|NCT05670015|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101951925|NCT05670015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101951926|NCT01201005|Hydroxocobalamin|hydroxocobalamin|mesh-list
102028331|NCT02663674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102028332|NCT02663674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028333|NCT02663674|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102028334|NCT02663674|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102028335|NCT03657212|Zolpidem|zolpidem|mesh-list
102028336|NCT03657212|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102028337|NCT03657212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102028338|NCT03657212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102028339|NCT03657212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028340|NCT03657212|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102028348|NCT03310411|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102028349|NCT03310411|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102028350|NCT03310411|Serotonin Agents|serotonin agents|mesh-ancestor
102028351|NCT03310411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102028352|NCT03310411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028353|NCT03310411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028354|NCT02909504|Lithium Carbonate|lithium carbonate|mesh-list
102028355|NCT02909504|Antidepressive Agents|antidepressive agents|mesh-ancestor
102028356|NCT02909504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102028357|NCT02909504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102028358|NCT02909504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748109|NCT00786669|Growth Inhibitors|growth inhibitors|mesh-ancestor
102028359|NCT02909504|Antimanic Agents|antimanic agents|mesh-ancestor
102028360|NCT02909504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102028361|NCT02909504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102028362|NCT02909504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028363|NCT02390440|Bupivacaine|bupivacaine|mesh-list
102028364|NCT02390440|Anesthetics, Local|anesthetics, local|mesh-ancestor
102028365|NCT02390440|Anesthetics|anesthetics|mesh-ancestor
102028366|NCT02390440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102028367|NCT02390440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028368|NCT02390440|Sensory System Agents|sensory system agents|mesh-ancestor
102028369|NCT02390440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102028370|NCT03677830|Acetaminophen|acetaminophen|mesh-list
102028371|NCT03677830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102028372|NCT03677830|Analgesics|analgesics|mesh-ancestor
102028373|NCT03677830|Sensory System Agents|sensory system agents|mesh-ancestor
102028374|NCT03677830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102028375|NCT03677830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028376|NCT03677830|Antipyretics|antipyretics|mesh-ancestor
102028377|NCT02199691|Vaccines|vaccines|mesh-list
102028378|NCT02199691|Immunologic Factors|immunologic factors|mesh-ancestor
102028379|NCT02199691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028380|NCT05667454|Atropine|atropine|mesh-list
102028381|NCT05667454|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102028382|NCT05667454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102028383|NCT05667454|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102028384|NCT05667454|Autonomic Agents|autonomic agents|mesh-ancestor
102028385|NCT05667454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102028386|NCT05667454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028387|NCT05667454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102028388|NCT05667454|Respiratory System Agents|respiratory system agents|mesh-ancestor
102028389|NCT05667454|Mydriatics|mydriatics|mesh-ancestor
102028390|NCT05667454|Parasympatholytics|parasympatholytics|mesh-ancestor
102028391|NCT05667454|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102028392|NCT05667454|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102028393|NCT05667454|Cholinergic Agents|cholinergic agents|mesh-ancestor
102028394|NCT05667454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102028395|NCT05667454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028396|NCT02389972|Dasatinib|dasatinib|mesh-list
101525251|NCT04663269|Hormones|hormones|mesh-ancestor
102028397|NCT02389972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102028398|NCT02389972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102028399|NCT02389972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102028400|NCT02389972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028401|NCT03495232|Cimetidine|cimetidine|mesh-list
102028402|NCT03495232|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101951927|NCT01201005|Vitamin B 12|vitamin b 12|mesh-list
101951929|NCT01201005|Vitamin B Complex|vitamin b complex|mesh-ancestor
101951930|NCT01201005|Vitamins|vitamins|mesh-ancestor
101951931|NCT01201005|Micronutrients|micronutrients|mesh-ancestor
102028403|NCT03495232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102028404|NCT03495232|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102028405|NCT03495232|Histamine Antagonists|histamine antagonists|mesh-ancestor
102028406|NCT03495232|Histamine Agents|histamine agents|mesh-ancestor
102028407|NCT03495232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101483379|NCT00336219|Pantoprazole|pantoprazole|mesh-list
102028420|NCT02389582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102028421|NCT02389582|Protease Inhibitors|protease inhibitors|mesh-ancestor
102028422|NCT02389582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102028424|NCT02389426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102028425|NCT02389426|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102028426|NCT02389426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028427|NCT02389348|Artefenomel|artefenomel|mesh-list
102028428|NCT02389348|Antimalarials|antimalarials|mesh-ancestor
102028429|NCT02389348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102028430|NCT02389348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102028431|NCT02389348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102028432|NCT02387242|Rifampin|rifampin|mesh-list
102028433|NCT02387242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102028434|NCT02387242|Antitubercular Agents|antitubercular agents|mesh-ancestor
102028435|NCT02387242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102028436|NCT02387242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102028437|NCT02387242|Leprostatic Agents|leprostatic agents|mesh-ancestor
102028438|NCT02387242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102028439|NCT02387242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102028440|NCT02387242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028441|NCT02387242|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102028442|NCT02387242|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102028443|NCT02387242|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102028444|NCT02387242|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102028445|NCT02387242|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102028446|NCT02387242|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102028447|NCT03656588|Iodine|iodine|mesh-list
102028448|NCT03656588|Chlorhexidine|chlorhexidine|mesh-list
102028449|NCT03656588|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102028450|NCT03656588|Cadexomer iodine|cadexomer iodine|mesh-list
102028451|NCT03656588|Hydrogen Peroxide|hydrogen peroxide|mesh-list
101525286|NCT03299946|Nivolumab|nivolumab|mesh-list
102028452|NCT03656588|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102028453|NCT03656588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102028454|NCT03656588|Disinfectants|disinfectants|mesh-ancestor
102028455|NCT03656588|Dermatologic Agents|dermatologic agents|mesh-ancestor
102028456|NCT03656588|Trace Elements|trace elements|mesh-ancestor
102028457|NCT03656588|Micronutrients|micronutrients|mesh-ancestor
102028458|NCT03656588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028459|NCT02387086|Aspirin|aspirin|mesh-list
102028460|NCT02387086|Thalidomide|thalidomide|mesh-list
102028461|NCT02387086|Gefitinib|gefitinib|mesh-list
102028462|NCT02387086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102028463|NCT02387086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102028464|NCT02387086|Analgesics|analgesics|mesh-ancestor
102028465|NCT02387086|Sensory System Agents|sensory system agents|mesh-ancestor
102028466|NCT02387086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102028467|NCT02387086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028468|NCT02387086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102028469|NCT02387086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102028472|NCT02387086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028473|NCT02387086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102028474|NCT02387086|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102028475|NCT02387086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102028476|NCT02387086|Antipyretics|antipyretics|mesh-ancestor
102028477|NCT02387086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102028478|NCT02387086|Immunologic Factors|immunologic factors|mesh-ancestor
102028479|NCT02387086|Leprostatic Agents|leprostatic agents|mesh-ancestor
102028480|NCT02387086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102028481|NCT02387086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102028482|NCT02387086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102028483|NCT02387086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102028484|NCT02387086|Growth Substances|growth substances|mesh-ancestor
101951932|NCT01201005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951934|NCT01198665|Doxorubicin|doxorubicin|mesh-list
102028485|NCT02387086|Growth Inhibitors|growth inhibitors|mesh-ancestor
102028486|NCT02387086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102028487|NCT02387086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102028488|NCT02383030|Fulvestrant|fulvestrant|mesh-list
102028489|NCT02383030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102028490|NCT02383030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102028491|NCT02383030|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102028492|NCT02383030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102028493|NCT02383030|Hormone Antagonists|hormone antagonists|mesh-ancestor
102028494|NCT02383030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102028495|NCT02383030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028496|NCT02388802|Immunosuppressive Agents|immunosuppressive agents|mesh-list
102028497|NCT02388802|Immunologic Factors|immunologic factors|mesh-ancestor
102028498|NCT02388802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028499|NCT02983604|Fulvestrant|fulvestrant|mesh-list
102028500|NCT02983604|Exemestane|exemestane|mesh-list
102028501|NCT02983604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102028502|NCT02983604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102028503|NCT02983604|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102028504|NCT02983604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102028505|NCT02983604|Hormone Antagonists|hormone antagonists|mesh-ancestor
102028506|NCT02983604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102028507|NCT02983604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028508|NCT02983604|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102028509|NCT02983604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102028510|NCT02983604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102028511|NCT02983604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028513|NCT03656432|Cariostatic Agents|cariostatic agents|mesh-ancestor
102028514|NCT03656432|Protective Agents|protective agents|mesh-ancestor
102028515|NCT03656432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028516|NCT02386462|Dexmedetomidine|dexmedetomidine|mesh-list
102028517|NCT02386462|Propofol|propofol|mesh-list
102028518|NCT02386462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102028519|NCT02386462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102028520|NCT02386462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028521|NCT02386462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102028522|NCT02386462|Analgesics|analgesics|mesh-ancestor
102028523|NCT02386462|Sensory System Agents|sensory system agents|mesh-ancestor
102028524|NCT02386462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102028525|NCT02386462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102028526|NCT02386462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102028527|NCT02386462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102028528|NCT02386462|Adrenergic Agents|adrenergic agents|mesh-ancestor
102028529|NCT02386462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102028530|NCT02386462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028531|NCT02386462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102028532|NCT02386462|Anesthetics, General|anesthetics, general|mesh-ancestor
102028533|NCT02386462|Anesthetics|anesthetics|mesh-ancestor
102028534|NCT02382328|Thioctic Acid|thioctic acid|mesh-list
102028535|NCT02382328|Antioxidants|antioxidants|mesh-ancestor
102028536|NCT02382328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028537|NCT02382328|Protective Agents|protective agents|mesh-ancestor
102028538|NCT02382328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028539|NCT02382328|Vitamin B Complex|vitamin b complex|mesh-ancestor
102028540|NCT02382328|Vitamins|vitamins|mesh-ancestor
102028541|NCT02382328|Micronutrients|micronutrients|mesh-ancestor
102028542|NCT02388490|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102028546|NCT02388490|Immunoconjugates|immunoconjugates|mesh-ancestor
102028547|NCT02388490|Immunologic Factors|immunologic factors|mesh-ancestor
102028548|NCT02388490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028549|NCT02382094|Bicalutamide|bicalutamide|mesh-list
102028550|NCT02382094|Androgen Antagonists|androgen antagonists|mesh-ancestor
102028551|NCT02382094|Hormone Antagonists|hormone antagonists|mesh-ancestor
102028552|NCT02382094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102028553|NCT02382094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028554|NCT02382094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102028555|NCT02386150|Vaccines|vaccines|mesh-list
102028556|NCT02386150|Immunologic Factors|immunologic factors|mesh-ancestor
101951935|NCT01198665|Vincristine|vincristine|mesh-list
101951936|NCT01198665|Everolimus|everolimus|mesh-list
101951937|NCT01198665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101951938|NCT01198665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101951939|NCT01198665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101951940|NCT01198665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101951941|NCT01198665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101951942|NCT01198665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290862|NCT02106572|Mitomycins|mitomycins|mesh-list
102028557|NCT02386150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028558|NCT02377180|Anesthetics|anesthetics|mesh-list
102028559|NCT02377180|Anesthetics, Local|anesthetics, local|mesh-list
102028560|NCT02377180|Capsaicin|capsaicin|mesh-list
102028561|NCT02377180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102028562|NCT02377180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028563|NCT02377180|Sensory System Agents|sensory system agents|mesh-ancestor
102028564|NCT02377180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102028565|NCT02377180|Antipruritics|antipruritics|mesh-ancestor
102028566|NCT02377180|Dermatologic Agents|dermatologic agents|mesh-ancestor
102028567|NCT03656042|Lenograstim|lenograstim|mesh-list
102028568|NCT03656042|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102028569|NCT03656042|Immunologic Factors|immunologic factors|mesh-ancestor
102028570|NCT03656042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028571|NCT03655964|Olmesartan|olmesartan|mesh-list
102028572|NCT03655964|Nebivolol|nebivolol|mesh-list
102028573|NCT03655964|Antihypertensive Agents|antihypertensive agents|mesh-list
102028574|NCT03655964|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102028575|NCT03655964|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102028576|NCT03655964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028577|NCT03655964|Vasodilator Agents|vasodilator agents|mesh-ancestor
102028578|NCT03655964|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102028579|NCT03655964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102028580|NCT03655964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102028581|NCT03655964|Adrenergic Agents|adrenergic agents|mesh-ancestor
102028582|NCT03655964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102028583|NCT03655964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748347|NCT00788463|Hormones|hormones|mesh-ancestor
102028584|NCT02982590|Warfarin|warfarin|mesh-list
102028585|NCT02982590|Apixaban|apixaban|mesh-list
102028587|NCT02982590|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102028588|NCT02982590|Antithrombins|antithrombins|mesh-ancestor
102028589|NCT02982590|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102028590|NCT02982590|Protease Inhibitors|protease inhibitors|mesh-ancestor
102028591|NCT02982590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102028592|NCT02982590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028593|NCT02381548|Belinostat|belinostat|mesh-list
102028594|NCT02381548|Adavosertib|adavosertib|mesh-list
102028595|NCT02381548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102028596|NCT02381548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028597|NCT02381548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102028598|NCT02381548|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102028599|NCT02381314|Ipilimumab|ipilimumab|mesh-list
102028600|NCT02381314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102028601|NCT02381314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102028602|NCT02381314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102028603|NCT02381314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028604|NCT02386072|Mirabegron|mirabegron|mesh-list
102028605|NCT02386072|Oxybutynin|oxybutynin|mesh-list
102028606|NCT02386072|Muscarinic Antagonists|muscarinic antagonists|mesh-list
102028607|NCT02386072|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102028608|NCT02386072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102028609|NCT02386072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102028610|NCT02386072|Adrenergic Agents|adrenergic agents|mesh-ancestor
102028611|NCT02386072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102028612|NCT02386072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028613|NCT02386072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028614|NCT02386072|Urological Agents|urological agents|mesh-ancestor
101951943|NCT01198665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101951944|NCT01198665|Tubulin Modulators|tubulin modulators|mesh-ancestor
101951945|NCT01198665|Antimitotic Agents|antimitotic agents|mesh-ancestor
101951946|NCT01198665|Mitosis Modulators|mitosis modulators|mesh-ancestor
102028615|NCT02386072|Parasympatholytics|parasympatholytics|mesh-ancestor
102028641|NCT02381470|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102028642|NCT02381158|Beclomethasone|beclomethasone|mesh-list
102028643|NCT02381158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102028644|NCT02381158|Glucocorticoids|glucocorticoids|mesh-ancestor
102028645|NCT02381158|Hormones|hormones|mesh-ancestor
102028646|NCT02381158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102028647|NCT02381158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028648|NCT02381158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102028649|NCT02381158|Respiratory System Agents|respiratory system agents|mesh-ancestor
102028650|NCT02381080|Voriconazole|voriconazole|mesh-list
102028651|NCT02381080|Erythromycin|erythromycin|mesh-list
102028652|NCT02381080|Erythromycin Estolate|erythromycin estolate|mesh-list
102028653|NCT02381080|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
102028654|NCT02381080|Erythromycin stearate|erythromycin stearate|mesh-list
102028655|NCT02381080|Antifungal Agents|antifungal agents|mesh-ancestor
102028656|NCT02381080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102028657|NCT02381080|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102028658|NCT02381080|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101748412|NCT02577848|Hormones|hormones|mesh-ancestor
102028659|NCT02381080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102028660|NCT02381080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028661|NCT02381080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102028662|NCT02381080|Hormone Antagonists|hormone antagonists|mesh-ancestor
102028665|NCT02381080|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102028666|NCT02381080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102028667|NCT02381080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102028668|NCT02381080|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102028669|NCT04694248|Aspirin|aspirin|mesh-list
102028670|NCT04694248|Rivaroxaban|rivaroxaban|mesh-list
102028671|NCT04694248|Anticoagulants|anticoagulants|mesh-list
102028672|NCT04694248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102028673|NCT04694248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102028674|NCT04694248|Analgesics|analgesics|mesh-ancestor
102028675|NCT04694248|Sensory System Agents|sensory system agents|mesh-ancestor
102028676|NCT04694248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102028677|NCT04694248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028678|NCT04694248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102028679|NCT04694248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102028680|NCT04694248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102028681|NCT04694248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102028682|NCT04694248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028683|NCT04694248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102028684|NCT04694248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102028685|NCT04694248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102028686|NCT04694248|Antipyretics|antipyretics|mesh-ancestor
102028687|NCT04694248|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102028688|NCT04694248|Antithrombins|antithrombins|mesh-ancestor
102028689|NCT04694248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102028690|NCT04694248|Protease Inhibitors|protease inhibitors|mesh-ancestor
102028691|NCT02376478|Folic Acid|folic acid|mesh-list
102028692|NCT02376478|Sulfasalazine|sulfasalazine|mesh-list
102028693|NCT02376478|Adalimumab|adalimumab|mesh-list
102028694|NCT02376478|Infliximab|infliximab|mesh-list
102028695|NCT02376478|Etanercept|etanercept|mesh-list
102028696|NCT02376478|Methotrexate|methotrexate|mesh-list
102028697|NCT02376478|Mercaptopurine|mercaptopurine|mesh-list
102028698|NCT02376478|Folic Acid Antagonists|folic acid antagonists|mesh-list
102028699|NCT02376478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102028700|NCT02376478|Abortifacient Agents|abortifacient agents|mesh-ancestor
102028701|NCT02376478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102028702|NCT02376478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028703|NCT02376478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102028704|NCT02376478|Antimetabolites|antimetabolites|mesh-ancestor
102028705|NCT02376478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028706|NCT02376478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102028707|NCT02376478|Dermatologic Agents|dermatologic agents|mesh-ancestor
102028708|NCT02376478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101951947|NCT01198665|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101951948|NCT01198665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102028709|NCT02376478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102028710|NCT02376478|Immunologic Factors|immunologic factors|mesh-ancestor
102028711|NCT02376478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102028712|NCT02376478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102028713|NCT02376478|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102028714|NCT02376478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102028715|NCT02376478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102028716|NCT02376478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102028717|NCT02376478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102028718|NCT02376478|Analgesics|analgesics|mesh-ancestor
102028719|NCT02376478|Sensory System Agents|sensory system agents|mesh-ancestor
102028720|NCT02376478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102028721|NCT02376478|Hematinics|hematinics|mesh-ancestor
102028722|NCT02376478|Vitamin B Complex|vitamin b complex|mesh-ancestor
102028723|NCT02376478|Vitamins|vitamins|mesh-ancestor
102028724|NCT02376478|Micronutrients|micronutrients|mesh-ancestor
102028725|NCT02376478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102028726|NCT02385448|Dienogest|dienogest|mesh-list
102028727|NCT02385448|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
102028728|NCT02385448|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
102028729|NCT02385448|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102028730|NCT02385448|Contraceptive Agents|contraceptive agents|mesh-ancestor
102028731|NCT02385448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102028732|NCT02385448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748485|NCT00711308|Coagulants|coagulants|mesh-ancestor
102028733|NCT02385448|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102028734|NCT02385448|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102028736|NCT02385448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102028738|NCT02385448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102028739|NCT02385448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102028740|NCT02385448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102028741|NCT02385448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102028742|NCT02385448|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102028743|NCT02385448|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
102028744|NCT02385448|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102028745|NCT02385448|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102028746|NCT02376400|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
102028747|NCT02376400|Antiviral Agents|antiviral agents|mesh-ancestor
102028748|NCT02376400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102028749|NCT02385058|Mebendazole|mebendazole|mesh-list
102028750|NCT02385058|Piperazine|piperazine|mesh-list
102028751|NCT02385058|Piperazine citrate|piperazine citrate|mesh-list
102028752|NCT02385058|DMP 777|dmp 777|mesh-list
102028753|NCT02385058|Antinematodal Agents|antinematodal agents|mesh-ancestor
102028754|NCT02385058|Anthelmintics|anthelmintics|mesh-ancestor
102028755|NCT02385058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102028756|NCT02385058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102028757|NCT02385058|Tubulin Modulators|tubulin modulators|mesh-ancestor
102028758|NCT02385058|Antimitotic Agents|antimitotic agents|mesh-ancestor
102028759|NCT02385058|Mitosis Modulators|mitosis modulators|mesh-ancestor
102028760|NCT02385058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028761|NCT02385058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102028762|NCT02385058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102028763|NCT02376088|Methimazole|methimazole|mesh-list
102028764|NCT02376088|Antithyroid Agents|antithyroid agents|mesh-ancestor
102028765|NCT02376088|Hormone Antagonists|hormone antagonists|mesh-ancestor
102028766|NCT02376088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102028767|NCT02376088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028768|NCT03310021|Rivaroxaban|rivaroxaban|mesh-list
102028769|NCT03310021|Apixaban|apixaban|mesh-list
102028770|NCT03310021|Edoxaban|edoxaban|mesh-list
102028771|NCT03310021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102028772|NCT03310021|Antithrombins|antithrombins|mesh-ancestor
102028773|NCT03310021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102028774|NCT03310021|Protease Inhibitors|protease inhibitors|mesh-ancestor
102028775|NCT03310021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102028776|NCT03310021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028777|NCT03310021|Anticoagulants|anticoagulants|mesh-ancestor
102028778|NCT03333109|Erenumab|erenumab|mesh-list
102028779|NCT03333109|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
101951949|NCT01198665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101951950|NCT01198665|Immunologic Factors|immunologic factors|mesh-ancestor
101951951|NCT01198665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951952|NCT01198665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101951954|NCT01198665|Hormones|hormones|mesh-ancestor
101291038|NCT01953419|Pemetrexed|pemetrexed|mesh-list
102028780|NCT03333109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028781|NCT03333109|Analgesics|analgesics|mesh-ancestor
102028782|NCT03333109|Sensory System Agents|sensory system agents|mesh-ancestor
102028783|NCT03333109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102028784|NCT03333109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028785|NCT02940223|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
102028786|NCT02940223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102028787|NCT02940223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102028788|NCT01312831|Vitamin B 12|vitamin b 12|mesh-list
102028789|NCT01312831|Hydroxocobalamin|hydroxocobalamin|mesh-list
102028790|NCT01312831|Vitamins|vitamins|mesh-ancestor
102028791|NCT01312831|Micronutrients|micronutrients|mesh-ancestor
102028792|NCT01312831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028793|NCT01312831|Vitamin B Complex|vitamin b complex|mesh-ancestor
102028794|NCT01312831|Hematinics|hematinics|mesh-ancestor
102028795|NCT04431193|Oxytocin|oxytocin|mesh-list
102028796|NCT04431193|Oxytocics|oxytocics|mesh-ancestor
102028797|NCT04431193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102028798|NCT04431193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028799|NCT03293485|Imipenem|imipenem|mesh-list
102028800|NCT03293485|Relebactam|relebactam|mesh-list
102028801|NCT03293485|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
102028802|NCT03293485|Cilastatin|cilastatin|mesh-list
102028803|NCT03293485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102028804|NCT03293485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102028805|NCT03293485|Protease Inhibitors|protease inhibitors|mesh-ancestor
102028806|NCT03293485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102028807|NCT03293485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028812|NCT03309943|Adrenergic Agents|adrenergic agents|mesh-ancestor
102028813|NCT03309943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102028814|NCT03309943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028815|NCT03309943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028816|NCT03309943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102028817|NCT03309943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102028818|NCT03309943|Vasodilator Agents|vasodilator agents|mesh-ancestor
102028820|NCT01732627|Immunologic Factors|immunologic factors|mesh-ancestor
102028821|NCT01732627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028822|NCT04296799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102028823|NCT03331315|Celecoxib|celecoxib|mesh-list
102028824|NCT03331315|Ketorolac|ketorolac|mesh-list
102028825|NCT03331315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102028826|NCT03331315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102028827|NCT03331315|Analgesics|analgesics|mesh-ancestor
102028828|NCT03331315|Sensory System Agents|sensory system agents|mesh-ancestor
102028829|NCT03331315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102028830|NCT03331315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028831|NCT03331315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102028832|NCT03331315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102028833|NCT03331315|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102028834|NCT03331315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102028835|NCT03331315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102028836|NCT03331315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028837|NCT03287869|Brexpiprazole|brexpiprazole|mesh-list
102028838|NCT03287869|Serotonin Agents|serotonin agents|mesh-ancestor
102028839|NCT03287869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102028840|NCT03287869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028841|NCT03287869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028842|NCT03287869|Dopamine Agonists|dopamine agonists|mesh-ancestor
102028843|NCT03287869|Dopamine Agents|dopamine agents|mesh-ancestor
102028844|NCT02661490|Vaccines|vaccines|mesh-list
102028845|NCT02661490|Immunologic Factors|immunologic factors|mesh-ancestor
102028846|NCT02661490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028847|NCT03287791|Azelaic acid|azelaic acid|mesh-list
101971983|NCT01339676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102028848|NCT03287791|Sunscreening Agents|sunscreening agents|mesh-list
102028849|NCT03287791|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102028850|NCT03287791|Protective Agents|protective agents|mesh-ancestor
102028851|NCT03287791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028852|NCT03287791|Dermatologic Agents|dermatologic agents|mesh-ancestor
102028853|NCT03287791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102028854|NCT03287635|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102028856|NCT03287635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102028857|NCT03287635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028858|NCT03287089|Nitrofurantoin|nitrofurantoin|mesh-list
102028859|NCT03287089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102028860|NCT03287089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102028861|NCT03287089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102028862|NCT02380768|Chlorhexidine|chlorhexidine|mesh-list
102028863|NCT02380768|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102028864|NCT02380768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102028865|NCT02380768|Disinfectants|disinfectants|mesh-ancestor
102028866|NCT02385136|Temozolomide|temozolomide|mesh-list
102028867|NCT02385136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102028868|NCT02385136|Alkylating Agents|alkylating agents|mesh-ancestor
102028869|NCT02385136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028870|NCT02385136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102028871|NCT02940691|Grazoprevir|grazoprevir|mesh-list
102028872|NCT02940691|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
102028873|NCT02940691|Antiviral Agents|antiviral agents|mesh-ancestor
102028874|NCT02940691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102028875|NCT04949269|Deucravacitinib|deucravacitinib|mesh-list
102028876|NCT04949269|Famotidine|famotidine|mesh-list
102028877|NCT04949269|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102028878|NCT04949269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102028882|NCT04949269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101748635|NCT03015792|Ichthammol|ichthammol|mesh-list
102028883|NCT04949269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028884|NCT04949269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028885|NCT04949269|Dermatologic Agents|dermatologic agents|mesh-ancestor
102028886|NCT04949269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102028887|NCT04949269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102028888|NCT02379754|Gentamicins|gentamicins|mesh-list
102028889|NCT02379754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102028890|NCT02379754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102028891|NCT02379754|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102028892|NCT02379754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102028893|NCT02379754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028894|NCT04914793|Anti-Infective Agents|anti-infective agents|mesh-list
102028895|NCT04914793|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102028896|NCT01313377|Gemcitabine|gemcitabine|mesh-list
102028897|NCT01313377|Oxaliplatin|oxaliplatin|mesh-list
102028898|NCT01313377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102028899|NCT01313377|Antimetabolites|antimetabolites|mesh-ancestor
102028900|NCT01313377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028901|NCT01313377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102028902|NCT02384746|Fulvestrant|fulvestrant|mesh-list
102028903|NCT02384746|Ixazomib|ixazomib|mesh-list
102028904|NCT02384746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102028905|NCT02384746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102028906|NCT02384746|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102028907|NCT02384746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102028908|NCT02384746|Hormone Antagonists|hormone antagonists|mesh-ancestor
102028909|NCT02384746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102028910|NCT02384746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028911|NCT02384746|Protease Inhibitors|protease inhibitors|mesh-ancestor
102028912|NCT02384746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102028913|NCT02384746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028914|NCT02375464|Octreotide|octreotide|mesh-list
102028915|NCT02375464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102028916|NCT02375464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102028917|NCT02375464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102028918|NCT03113344|Amoxicillin|amoxicillin|mesh-list
102028919|NCT03113344|Azithromycin|azithromycin|mesh-list
102028920|NCT03113344|Meropenem|meropenem|mesh-list
102028921|NCT03113344|Ceftriaxone|ceftriaxone|mesh-list
102028922|NCT03113344|Penicillins|penicillins|mesh-list
101951955|NCT01198665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101951956|NCT01198665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102028923|NCT03113344|Imipenem|imipenem|mesh-list
102028924|NCT03113344|Erythromycin|erythromycin|mesh-list
102028925|NCT03113344|Ceftazidime|ceftazidime|mesh-list
102028926|NCT03113344|Ampicillin|ampicillin|mesh-list
102028927|NCT03113344|Cephalosporins|cephalosporins|mesh-list
102028928|NCT03113344|Acyclovir|acyclovir|mesh-list
102028929|NCT03113344|Ganciclovir|ganciclovir|mesh-list
102028930|NCT03113344|Antiviral Agents|antiviral agents|mesh-list
102028931|NCT03113344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102028932|NCT03113344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102028933|NCT03113344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102028934|NCT03113344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028935|NCT03113344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101525410|NCT01183390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102028936|NCT03113344|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102028937|NCT03113266|Antibodies|antibodies|mesh-list
102028938|NCT03113266|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102028939|NCT03113266|Immunologic Factors|immunologic factors|mesh-ancestor
102028940|NCT03113266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028941|NCT02379676|Clopidogrel|clopidogrel|mesh-list
102028942|NCT02379676|Ticagrelor|ticagrelor|mesh-list
102028943|NCT02379676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102028944|NCT02379676|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102028945|NCT02379676|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102028946|NCT02379676|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102028947|NCT02379676|Purinergic Agents|purinergic agents|mesh-ancestor
102028948|NCT02379676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102028949|NCT02379676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028950|NCT02379676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028951|NCT04715230|Lorazepam|lorazepam|mesh-list
102028954|NCT04715230|Antiemetics|antiemetics|mesh-ancestor
102028955|NCT04715230|Autonomic Agents|autonomic agents|mesh-ancestor
102028956|NCT04715230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101748709|NCT00793377|Tubulin Modulators|tubulin modulators|mesh-ancestor
102028957|NCT04715230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028958|NCT04715230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102028959|NCT04715230|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102028960|NCT04715230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102028961|NCT04715230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102028962|NCT04715230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102028963|NCT04715230|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102028965|NCT04715230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102028966|NCT04715230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028967|NCT04715230|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102028968|NCT04715230|Anticonvulsants|anticonvulsants|mesh-ancestor
102028969|NCT04715230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102028970|NCT04715230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102028971|NCT04715230|GABA Modulators|gaba modulators|mesh-ancestor
102028972|NCT04715230|GABA Agents|gaba agents|mesh-ancestor
102028973|NCT02378740|Ketamine|ketamine|mesh-list
102028974|NCT02378740|Analgesics|analgesics|mesh-ancestor
102028975|NCT02378740|Sensory System Agents|sensory system agents|mesh-ancestor
102028976|NCT02378740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102028977|NCT02378740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028978|NCT02378740|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102028979|NCT02378740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102028980|NCT02378740|Anesthetics, General|anesthetics, general|mesh-ancestor
102028981|NCT02378740|Anesthetics|anesthetics|mesh-ancestor
102028982|NCT02378740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102028983|NCT02378740|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102028984|NCT02378740|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102028985|NCT02378740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102028986|NCT02378740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028987|NCT01411267|Cytarabine|cytarabine|mesh-list
102028988|NCT01411267|Methotrexate|methotrexate|mesh-list
102028989|NCT01411267|Etoposide|etoposide|mesh-list
102028990|NCT01411267|Etoposide phosphate|etoposide phosphate|mesh-list
102028991|NCT01411267|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102028992|NCT01411267|Abortifacient Agents|abortifacient agents|mesh-ancestor
102028993|NCT01411267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102028994|NCT01411267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951958|NCT05030415|Dermatologic Agents|dermatologic agents|mesh-ancestor
101951959|NCT01198821|Gemcitabine|gemcitabine|mesh-list
101951960|NCT01198821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101951961|NCT01198821|Antimetabolites|antimetabolites|mesh-ancestor
101971984|NCT01339754|Trabectedin|trabectedin|mesh-list
102028995|NCT01411267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102028996|NCT01411267|Antimetabolites|antimetabolites|mesh-ancestor
102028997|NCT01411267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028998|NCT01411267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102028999|NCT01411267|Dermatologic Agents|dermatologic agents|mesh-ancestor
102029000|NCT01411267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102029001|NCT01411267|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102029002|NCT01411267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102029003|NCT01411267|Immunologic Factors|immunologic factors|mesh-ancestor
102029004|NCT01411267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102029005|NCT01411267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102029006|NCT01411267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102029007|NCT01411267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102029008|NCT01411267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102029009|NCT01411267|Antiviral Agents|antiviral agents|mesh-ancestor
102029010|NCT01411267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102029011|NCT03113110|Empagliflozin|empagliflozin|mesh-list
102029012|NCT03113110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102029013|NCT03113110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029014|NCT03113110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102029015|NCT03113110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029016|NCT02378428|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
102029017|NCT02378428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102029018|NCT02378428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102029019|NCT02378428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029020|NCT02378428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102029021|NCT02383888|BI 425809|bi 425809|mesh-list
102029022|NCT02383888|Nootropic Agents|nootropic agents|mesh-ancestor
102029023|NCT02377960|Antihypertensive Agents|antihypertensive agents|mesh-list
102029024|NCT03130959|Nivolumab|nivolumab|mesh-list
102029025|NCT03130959|Ipilimumab|ipilimumab|mesh-list
101525462|NCT00537953|Miltefosine|miltefosine|mesh-list
102029029|NCT03130959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029031|NCT01370031|Antidotes|antidotes|mesh-ancestor
101748789|NCT01650792|Aspirin|aspirin|mesh-list
102029032|NCT01370031|Protective Agents|protective agents|mesh-ancestor
102029033|NCT01370031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029035|NCT02373514|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
102029036|NCT02373514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102029037|NCT02373514|Analgesics|analgesics|mesh-ancestor
102029038|NCT02373514|Sensory System Agents|sensory system agents|mesh-ancestor
102029039|NCT02373514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102029040|NCT02373514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029041|NCT02373514|Antipyretics|antipyretics|mesh-ancestor
102029042|NCT02373514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102029043|NCT02373514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102029044|NCT02373514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102029045|NCT01364493|Capecitabine|capecitabine|mesh-list
102029046|NCT01364493|Oxaliplatin|oxaliplatin|mesh-list
102029047|NCT01364493|Trastuzumab|trastuzumab|mesh-list
102029048|NCT01364493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102029049|NCT01364493|Antimetabolites|antimetabolites|mesh-ancestor
102029050|NCT01364493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029051|NCT01364493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102029052|NCT01364493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102029053|NCT01370187|Montelukast|montelukast|mesh-list
102029054|NCT01370187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102029055|NCT01370187|Respiratory System Agents|respiratory system agents|mesh-ancestor
102029056|NCT01370187|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102029057|NCT01370187|Hormone Antagonists|hormone antagonists|mesh-ancestor
102029058|NCT01370187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102029059|NCT01370187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029060|NCT01370187|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102029061|NCT01370187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102029062|NCT01370187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029063|NCT04483960|Nafamostat|nafamostat|mesh-list
101951962|NCT01198821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951963|NCT01198821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101951964|NCT05013801|Hydroquinone|hydroquinone|mesh-list
101951965|NCT05013801|Antioxidants|antioxidants|mesh-ancestor
101951966|NCT05013801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951967|NCT05013801|Protective Agents|protective agents|mesh-ancestor
102029064|NCT04483960|Enoxaparin|enoxaparin|mesh-list
102029065|NCT04483960|Dalteparin|dalteparin|mesh-list
102029066|NCT04483960|Tinzaparin|tinzaparin|mesh-list
102029067|NCT04483960|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102029068|NCT04483960|Anticoagulants|anticoagulants|mesh-ancestor
102029069|NCT04483960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102029070|NCT04483960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102029071|NCT04483960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029072|NCT04483960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102029073|NCT04483960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102029074|NCT04483960|Analgesics|analgesics|mesh-ancestor
102029075|NCT04483960|Sensory System Agents|sensory system agents|mesh-ancestor
102029076|NCT04483960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102029077|NCT04483960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029078|NCT04483960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102029079|NCT04483960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102029080|NCT04483960|Protease Inhibitors|protease inhibitors|mesh-ancestor
102029081|NCT04483960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102029082|NCT04483960|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102029083|NCT04483960|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102029084|NCT04483960|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102029085|NCT04483960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102029086|NCT04483960|Immunologic Factors|immunologic factors|mesh-ancestor
102029087|NCT01370343|Nicotinic Acids|nicotinic acids|mesh-list
102029088|NCT01370343|Cyclosporine|cyclosporine|mesh-list
102029089|NCT01370343|Cyclosporins|cyclosporins|mesh-list
102029090|NCT01370343|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
102029091|NCT01370343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102029092|NCT01370343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029093|NCT01370343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102029094|NCT01370343|Immunologic Factors|immunologic factors|mesh-ancestor
102029098|NCT01370343|Dermatologic Agents|dermatologic agents|mesh-ancestor
102029099|NCT01370343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102029100|NCT01370343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102029101|NCT01370343|Vitamin B Complex|vitamin b complex|mesh-ancestor
102029102|NCT01370343|Vitamins|vitamins|mesh-ancestor
102029103|NCT01370343|Micronutrients|micronutrients|mesh-ancestor
102029104|NCT01368003|Dutasteride|dutasteride|mesh-list
102029105|NCT01368003|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102029106|NCT01368003|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102029107|NCT01368003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102029108|NCT01368003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029109|NCT01368003|Hormone Antagonists|hormone antagonists|mesh-ancestor
102029110|NCT01368003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102029111|NCT01368003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029112|NCT01364571|Vaccines|vaccines|mesh-list
102029113|NCT01364571|Immunologic Factors|immunologic factors|mesh-ancestor
102029114|NCT01364571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029115|NCT04222257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102029116|NCT04222257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102029117|NCT04222257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102029118|NCT04222257|Antitubercular Agents|antitubercular agents|mesh-ancestor
102029119|NCT03933904|Sirolimus|sirolimus|mesh-list
102029120|NCT03933904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102029121|NCT03933904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102029122|NCT03933904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102029123|NCT03933904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102029124|NCT03933904|Antifungal Agents|antifungal agents|mesh-ancestor
102029125|NCT03933904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102029126|NCT03933904|Immunologic Factors|immunologic factors|mesh-ancestor
102029127|NCT03933904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029128|NCT02377648|Everolimus|everolimus|mesh-list
101951968|NCT05013801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951969|NCT05013801|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101291389|NCT01955174|Botulinum Toxins|botulinum toxins|mesh-list
102029129|NCT02377648|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102029130|NCT02377648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102029131|NCT02377648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102029132|NCT02377648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029133|NCT02377648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102029134|NCT02377648|Immunologic Factors|immunologic factors|mesh-ancestor
102029135|NCT02377648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029136|NCT02377648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102029137|NCT02371408|Ribavirin|ribavirin|mesh-list
102029138|NCT02371408|Sofosbuvir|sofosbuvir|mesh-list
102029139|NCT02371408|Antimetabolites|antimetabolites|mesh-ancestor
102029140|NCT02371408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029141|NCT02371408|Antiviral Agents|antiviral agents|mesh-ancestor
102029142|NCT02371408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102029143|NCT01364805|Ascorbic Acid|ascorbic acid|mesh-list
102029144|NCT01364805|Gemcitabine|gemcitabine|mesh-list
102029145|NCT01364805|Vitamins|vitamins|mesh-ancestor
102029146|NCT01364805|Micronutrients|micronutrients|mesh-ancestor
102029147|NCT01364805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029148|NCT01364805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102029149|NCT01364805|Antimetabolites|antimetabolites|mesh-ancestor
102029150|NCT01364805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029151|NCT01364805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102029152|NCT01364805|Antioxidants|antioxidants|mesh-ancestor
102029153|NCT01364805|Protective Agents|protective agents|mesh-ancestor
102029154|NCT01370889|Resveratrol|resveratrol|mesh-list
102029155|NCT01370889|Antioxidants|antioxidants|mesh-ancestor
102029156|NCT01370889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029157|NCT01370889|Protective Agents|protective agents|mesh-ancestor
102029158|NCT01370889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029159|NCT01370889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102029160|NCT01370889|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102029161|NCT02373046|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
102029162|NCT02373046|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102029163|NCT02373046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029164|NCT02373046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101484138|NCT00310154|Gefitinib|gefitinib|mesh-list
102029170|NCT04382404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102029171|NCT02371096|Rituximab|rituximab|mesh-list
102029172|NCT02371096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102029173|NCT02371096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102029174|NCT02371096|Immunologic Factors|immunologic factors|mesh-ancestor
102029175|NCT02371096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029176|NCT02371096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102029177|NCT04420455|Enoximone|enoximone|mesh-list
102029178|NCT04420455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102029179|NCT04420455|Vasodilator Agents|vasodilator agents|mesh-ancestor
102029180|NCT04420455|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102029181|NCT04420455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102029182|NCT04420455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102029183|NCT04420455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029184|NCT04420455|Protective Agents|protective agents|mesh-ancestor
102029185|NCT04420455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029187|NCT04381936|Empagliflozin|empagliflozin|mesh-list
102029188|NCT04381936|Ritonavir|ritonavir|mesh-list
102029189|NCT04381936|Lopinavir|lopinavir|mesh-list
102029190|NCT04381936|Azithromycin|azithromycin|mesh-list
102029191|NCT04381936|Hydroxychloroquine|hydroxychloroquine|mesh-list
102029192|NCT04381936|Nirmatrelvir|nirmatrelvir|mesh-list
102029193|NCT04381936|Sotrovimab|sotrovimab|mesh-list
102029194|NCT04381936|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
102029195|NCT04381936|Molnupiravir|molnupiravir|mesh-list
102029196|NCT04381936|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
102029197|NCT04381936|Colchicine|colchicine|mesh-list
102029198|NCT04381936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102029199|NCT04381936|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102029200|NCT04381936|Antibodies|antibodies|mesh-list
102029201|NCT04381936|Immunoglobulins|immunoglobulins|mesh-list
101951971|NCT01566669|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101951972|NCT01566669|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101951973|NCT01566669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101951974|NCT01566669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951975|NCT01566669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101951976|NCT01566669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101951978|NCT01566669|Sensory System Agents|sensory system agents|mesh-ancestor
101951979|NCT01566669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101951980|NCT01566669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951981|NCT01566669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101525567|NCT04661709|Diuretics|diuretics|mesh-ancestor
101951982|NCT01566669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101951983|NCT03841773|Cyclobenzaprine|cyclobenzaprine|mesh-list
101951984|NCT03841773|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101951985|NCT03841773|Antidepressive Agents|antidepressive agents|mesh-ancestor
101951986|NCT03841773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102029202|NCT04381936|Immunologic Factors|immunologic factors|mesh-ancestor
102029203|NCT04381936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029204|NCT04381936|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102029205|NCT04381936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102029206|NCT04381936|Analgesics|analgesics|mesh-ancestor
102029207|NCT04381936|Sensory System Agents|sensory system agents|mesh-ancestor
102029208|NCT04381936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102029209|NCT04381936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102029210|NCT04381936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102029211|NCT04381936|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102029212|NCT04381936|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102029213|NCT04381936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029214|NCT04381936|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102029215|NCT04381936|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102029216|NCT04381936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102029217|NCT04381936|Antipyretics|antipyretics|mesh-ancestor
102029218|NCT04381936|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102029219|NCT04381936|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102029220|NCT04381936|Protease Inhibitors|protease inhibitors|mesh-ancestor
102029221|NCT04381936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102029222|NCT04381936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102029223|NCT04381936|Antiviral Agents|antiviral agents|mesh-ancestor
102029224|NCT04381936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102029225|NCT04381936|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102029226|NCT04381936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102029227|NCT04381936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102029228|NCT04381936|Antimalarials|antimalarials|mesh-ancestor
102029229|NCT04381936|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102029230|NCT04381936|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102029231|NCT04381936|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102029232|NCT04381936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102029233|NCT04381936|Gout Suppressants|gout suppressants|mesh-ancestor
102029234|NCT04381936|Tubulin Modulators|tubulin modulators|mesh-ancestor
102029235|NCT04381936|Antimitotic Agents|antimitotic agents|mesh-ancestor
102029236|NCT04381936|Mitosis Modulators|mitosis modulators|mesh-ancestor
102029237|NCT04381936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102029241|NCT03124407|Antipruritics|antipruritics|mesh-ancestor
102029242|NCT03124407|Dermatologic Agents|dermatologic agents|mesh-ancestor
102029243|NCT03124407|Sensory System Agents|sensory system agents|mesh-ancestor
102029244|NCT03124407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102029245|NCT03124407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951988|NCT03841773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951989|NCT03841773|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102029246|NCT01364961|Resveratrol|resveratrol|mesh-list
102029247|NCT01364961|Antioxidants|antioxidants|mesh-ancestor
102029248|NCT01364961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525615|NCT02462811|Anesthetics|anesthetics|mesh-ancestor
102029249|NCT01364961|Protective Agents|protective agents|mesh-ancestor
102029250|NCT01364961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029251|NCT01364961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102029252|NCT01364961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102029253|NCT02370862|Glycopyrrolate|glycopyrrolate|mesh-list
102029254|NCT02370862|Neostigmine|neostigmine|mesh-list
101749009|NCT00796185|Serotonin Agents|serotonin agents|mesh-ancestor
102029255|NCT02370862|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102029256|NCT02370862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102029257|NCT02370862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029258|NCT02370862|Cholinergic Agents|cholinergic agents|mesh-ancestor
102029259|NCT02370862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102029260|NCT02370862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029261|NCT02370862|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102029262|NCT02370862|Autonomic Agents|autonomic agents|mesh-ancestor
102029263|NCT02370862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102029264|NCT02370862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102029265|NCT02370862|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102029266|NCT02370862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102029267|NCT03620578|Nivolumab|nivolumab|mesh-list
102029268|NCT03620578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102029269|NCT03620578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102029270|NCT03620578|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102029271|NCT03620578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029272|NCT02373280|Amoxicillin|amoxicillin|mesh-list
102029273|NCT02373280|Moxifloxacin|moxifloxacin|mesh-list
102029274|NCT02373280|Metronidazole|metronidazole|mesh-list
102029275|NCT02373280|Clarithromycin|clarithromycin|mesh-list
102029276|NCT02373280|Esomeprazole|esomeprazole|mesh-list
102029277|NCT02373280|Bismuth|bismuth|mesh-list
102029278|NCT02373280|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102029279|NCT02373280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102029280|NCT02373280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102029281|NCT02373280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102029282|NCT02373280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102029283|NCT02373280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102029284|NCT02373280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029285|NCT02373280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102029286|NCT02373280|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102029287|NCT02373280|Contraceptive Agents|contraceptive agents|mesh-ancestor
102029288|NCT02373280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102029289|NCT02373280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029290|NCT02373280|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102029291|NCT02373280|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102029292|NCT02373280|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102029293|NCT02373280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102029294|NCT02373280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102029295|NCT02373280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102029296|NCT02373280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102029297|NCT02373280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102029298|NCT02373280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102029299|NCT02373280|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102029300|NCT02373280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102029301|NCT02373280|Antacids|antacids|mesh-ancestor
102029302|NCT02370550|Cyclosporine|cyclosporine|mesh-list
102029303|NCT02370550|Prednisone|prednisone|mesh-list
102029304|NCT02370550|Calcium Carbonate|calcium carbonate|mesh-list
102029305|NCT02370550|Calcium|calcium|mesh-list
102029306|NCT02370550|Cyclosporins|cyclosporins|mesh-list
102029307|NCT02370550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102029308|NCT02370550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029309|NCT02370550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102029313|NCT02370550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102029315|NCT02370550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102029316|NCT02370550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029317|NCT02370550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101951990|NCT03841773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101951992|NCT03841773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101951993|NCT01201161|Ranibizumab|ranibizumab|mesh-list
102029318|NCT02370550|Immunologic Factors|immunologic factors|mesh-ancestor
102029319|NCT02370550|Antifungal Agents|antifungal agents|mesh-ancestor
102029320|NCT02370550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102029321|NCT02370550|Dermatologic Agents|dermatologic agents|mesh-ancestor
102029322|NCT02370550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102029323|NCT02370550|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102029324|NCT02370550|Antacids|antacids|mesh-ancestor
102029325|NCT02370550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102029326|NCT02365402|Entecavir|entecavir|mesh-list
102029327|NCT02365402|Antiviral Agents|antiviral agents|mesh-ancestor
102029328|NCT02365402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102029329|NCT02364934|Propofol|propofol|mesh-list
102029330|NCT02364934|Sevoflurane|sevoflurane|mesh-list
102029331|NCT02364934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102029332|NCT02364934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102029333|NCT02364934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029334|NCT02364934|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102029335|NCT02364934|Anesthetics, General|anesthetics, general|mesh-ancestor
102029336|NCT02364934|Anesthetics|anesthetics|mesh-ancestor
102029337|NCT02364934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102029338|NCT02364934|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102029339|NCT02372656|Metformin|metformin|mesh-list
102029340|NCT02372656|Simvastatin|simvastatin|mesh-list
102029341|NCT02372656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102029342|NCT02372656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029343|NCT02372656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102029344|NCT02372656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102029345|NCT02372656|Antimetabolites|antimetabolites|mesh-ancestor
102029346|NCT02372656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029347|NCT02372656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102029348|NCT02372656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102029349|NCT02372656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102029350|NCT03123939|Tisagenlecleucel|tisagenlecleucel|mesh-list
102029351|NCT03123939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102029352|NCT03123939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102029353|NCT01368627|Sirolimus|sirolimus|mesh-list
102029354|NCT01368627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102029355|NCT01368627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102029356|NCT01368627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102029357|NCT01368627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102029358|NCT01368627|Antifungal Agents|antifungal agents|mesh-ancestor
102029359|NCT01368627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102029360|NCT01368627|Immunologic Factors|immunologic factors|mesh-ancestor
102029361|NCT01368627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029362|NCT02358681|Ketorolac|ketorolac|mesh-list
102029363|NCT02358681|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102029364|NCT02358681|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102029365|NCT02358681|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102029366|NCT02358681|Analgesics|analgesics|mesh-ancestor
102029367|NCT02358681|Sensory System Agents|sensory system agents|mesh-ancestor
102029368|NCT02358681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102029369|NCT02358681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029370|NCT02358681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102029371|NCT02358681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102029372|NCT02358681|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102029373|NCT02358681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102029374|NCT02358681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029375|NCT03123861|Gabapentin|gabapentin|mesh-list
102029376|NCT03123861|Analgesics|analgesics|mesh-ancestor
102029377|NCT03123861|Sensory System Agents|sensory system agents|mesh-ancestor
102029378|NCT03123861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102029379|NCT03123861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029380|NCT03123861|Anticonvulsants|anticonvulsants|mesh-ancestor
102029381|NCT03123861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102029385|NCT03123861|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102029386|NCT03123861|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102029387|NCT03123861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102029388|NCT03123861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101951994|NCT01201161|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101951995|NCT01201161|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101951996|NCT01201161|Growth Substances|growth substances|mesh-ancestor
102029389|NCT03123861|Antimanic Agents|antimanic agents|mesh-ancestor
102029391|NCT01368783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102029393|NCT01368783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102029394|NCT01368783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102029395|NCT01368783|Protease Inhibitors|protease inhibitors|mesh-ancestor
102029396|NCT01368783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102029397|NCT01368783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029398|NCT01368783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102029399|NCT01368783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102029400|NCT01368783|Antiviral Agents|antiviral agents|mesh-ancestor
102029401|NCT01368783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102029402|NCT01368783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102029403|NCT01368783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102029404|NCT01368783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102029405|NCT01368783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102029406|NCT01509339|Vancomycin|vancomycin|mesh-list
102029407|NCT01509339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102029408|NCT01509339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102029409|NCT03123471|Apremilast|apremilast|mesh-list
102029410|NCT03123471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102029411|NCT03123471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102029412|NCT03123471|Analgesics|analgesics|mesh-ancestor
102029413|NCT03123471|Sensory System Agents|sensory system agents|mesh-ancestor
102029414|NCT03123471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102029415|NCT03123471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029416|NCT03123471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102029417|NCT03123471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102029418|NCT03123471|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102029419|NCT03123471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102029420|NCT03123471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102029421|NCT03123471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029422|NCT02661178|Emodepside|emodepside|mesh-list
102029423|NCT02661178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102029424|NCT02661178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102029425|NCT01365117|Insulin|insulin|mesh-list
102029426|NCT01365117|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102029427|NCT01365117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102029428|NCT01365117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029429|NCT02372812|Dexamethasone|dexamethasone|mesh-list
102029430|NCT02372812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102029431|NCT02372812|Antiemetics|antiemetics|mesh-ancestor
102029432|NCT02372812|Autonomic Agents|autonomic agents|mesh-ancestor
102029433|NCT02372812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102029434|NCT02372812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029435|NCT02372812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102029436|NCT02372812|Glucocorticoids|glucocorticoids|mesh-ancestor
102029437|NCT02372812|Hormones|hormones|mesh-ancestor
102029438|NCT02372812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102029439|NCT02372812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102029440|NCT02372812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102029441|NCT02365012|Midodrine|midodrine|mesh-list
102029442|NCT02365012|Sympathomimetics|sympathomimetics|mesh-ancestor
102029443|NCT02365012|Autonomic Agents|autonomic agents|mesh-ancestor
102029444|NCT02365012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102029445|NCT02365012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029446|NCT02365012|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102029447|NCT02365012|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102029448|NCT02365012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102029449|NCT02365012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102029450|NCT02365012|Adrenergic Agents|adrenergic agents|mesh-ancestor
102029451|NCT02365012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102029452|NCT02365012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029460|NCT01372449|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102029461|NCT01372449|Dopamine Agents|dopamine agents|mesh-ancestor
102029462|NCT01372449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102029463|NCT01372449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029464|NCT01372449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951997|NCT01201161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101951998|NCT01201161|Growth Inhibitors|growth inhibitors|mesh-ancestor
101951999|NCT01201161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101952000|NCT03841383|Dipyridamole|dipyridamole|mesh-list
101952001|NCT03841383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101952002|NCT03841383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101952003|NCT03841383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029465|NCT01372449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102029466|NCT01372449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102029467|NCT04666389|Atorvastatin|atorvastatin|mesh-list
102029468|NCT04666389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102029469|NCT04666389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102029470|NCT04666389|Antimetabolites|antimetabolites|mesh-ancestor
102029471|NCT04666389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029472|NCT04666389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102029473|NCT04666389|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102029474|NCT04666389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102029475|NCT02372110|Caffeine|caffeine|mesh-list
102029476|NCT02372110|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101525694|NCT00538694|Daptomycin|daptomycin|mesh-list
102029477|NCT02372110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029478|NCT02372110|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102029479|NCT02372110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102029480|NCT02372110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029481|NCT02372110|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102029482|NCT02372110|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102029484|NCT02372110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102029485|NCT02372188|Caffeine|caffeine|mesh-list
102029486|NCT02372188|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102029487|NCT02372188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029488|NCT02372188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102029489|NCT02372188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102029490|NCT02372188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029491|NCT02372188|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102029492|NCT02372188|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102029493|NCT02372188|Purinergic Agents|purinergic agents|mesh-ancestor
102029494|NCT02372188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102029495|NCT01371435|Paroxetine|paroxetine|mesh-list
102029496|NCT01371435|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102029497|NCT01371435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102029498|NCT01371435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102029499|NCT01371435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029500|NCT01371435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102029501|NCT01371435|Serotonin Agents|serotonin agents|mesh-ancestor
102029502|NCT01371435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029503|NCT01371435|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102029504|NCT01371435|Antidepressive Agents|antidepressive agents|mesh-ancestor
102029505|NCT01371435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102029506|NCT01371435|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102029507|NCT01371435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102029508|NCT01371435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102029509|NCT01369719|Deferasirox|deferasirox|mesh-list
102029510|NCT01369719|Deferoxamine|deferoxamine|mesh-list
102029511|NCT01369719|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102029512|NCT01369719|Chelating Agents|chelating agents|mesh-ancestor
102029513|NCT01369719|Sequestering Agents|sequestering agents|mesh-ancestor
102029514|NCT01369719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029515|NCT01369719|Siderophores|siderophores|mesh-ancestor
102029516|NCT02369380|Hyaluronic Acid|hyaluronic acid|mesh-list
102029517|NCT02369380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101525712|NCT00538811|Amantadine|amantadine|mesh-list
102029524|NCT02038816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102029525|NCT02038816|Antimetabolites|antimetabolites|mesh-ancestor
102029526|NCT02038816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029527|NCT02038816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102029528|NCT02038816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101952004|NCT03841383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102029529|NCT02038816|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102029530|NCT02038816|Chelating Agents|chelating agents|mesh-ancestor
102029531|NCT02038816|Sequestering Agents|sequestering agents|mesh-ancestor
102029532|NCT04809831|Chlorhexidine|chlorhexidine|mesh-list
102029533|NCT04809831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102029534|NCT04809831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102029535|NCT04809831|Disinfectants|disinfectants|mesh-ancestor
102029537|NCT02359162|Cyclophosphamide|cyclophosphamide|mesh-list
102029538|NCT02359162|Gemcitabine|gemcitabine|mesh-list
102029539|NCT02359162|Doxorubicin|doxorubicin|mesh-list
102029540|NCT02359162|Oxaliplatin|oxaliplatin|mesh-list
102029541|NCT02359162|Etoposide|etoposide|mesh-list
102029542|NCT02359162|Vincristine|vincristine|mesh-list
102029543|NCT02359162|Pegaspargase|pegaspargase|mesh-list
102029544|NCT02359162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102029545|NCT02359162|Immunologic Factors|immunologic factors|mesh-ancestor
102029546|NCT02359162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029547|NCT02359162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102029548|NCT02359162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102029549|NCT02359162|Alkylating Agents|alkylating agents|mesh-ancestor
102029550|NCT02359162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029551|NCT02359162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102029552|NCT02359162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102029553|NCT02359162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102029554|NCT02359162|Antimetabolites|antimetabolites|mesh-ancestor
102029555|NCT02359162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102029556|NCT02359162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102029557|NCT02359162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102029558|NCT02359162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102029559|NCT02359162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102029560|NCT02359162|Glucocorticoids|glucocorticoids|mesh-ancestor
102029562|NCT02359162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102029563|NCT02359162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102029564|NCT02359162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102029565|NCT02359162|Tubulin Modulators|tubulin modulators|mesh-ancestor
102029566|NCT02359162|Antimitotic Agents|antimitotic agents|mesh-ancestor
102029567|NCT02359162|Mitosis Modulators|mitosis modulators|mesh-ancestor
102029568|NCT03634605|Tetracycline|tetracycline|mesh-list
102029569|NCT03634605|Lidocaine|lidocaine|mesh-list
102029570|NCT03634605|Anesthetics, Local|anesthetics, local|mesh-ancestor
102029571|NCT03634605|Anesthetics|anesthetics|mesh-ancestor
102029572|NCT03634605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102029573|NCT03634605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029574|NCT03634605|Sensory System Agents|sensory system agents|mesh-ancestor
102029575|NCT03634605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102029576|NCT03634605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102029577|NCT03634605|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102029578|NCT03634605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102029579|NCT03634605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102029580|NCT03634605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029581|NCT03634605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102029582|NCT03634605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102029583|NCT03634605|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102029584|NCT03634605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102029585|NCT02363764|Dimercaprol|dimercaprol|mesh-list
102029586|NCT02363764|Chelating Agents|chelating agents|mesh-ancestor
102029587|NCT02363764|Sequestering Agents|sequestering agents|mesh-ancestor
102029588|NCT02363764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029595|NCT03654794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029597|NCT03654170|Nootropic Agents|nootropic agents|mesh-ancestor
102029599|NCT02369146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102029600|NCT02369146|Antiviral Agents|antiviral agents|mesh-ancestor
102029601|NCT02369146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102029602|NCT02363452|Lamivudine|lamivudine|mesh-list
102029603|NCT02363452|Zidovudine|zidovudine|mesh-list
102029604|NCT02363452|Abacavir|abacavir|mesh-list
102029605|NCT02363452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
102029606|NCT02363452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102029607|NCT02363452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102029608|NCT02363452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029609|NCT02363452|Antiviral Agents|antiviral agents|mesh-ancestor
102029610|NCT02363452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102029611|NCT02363452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101952005|NCT03841383|Vasodilator Agents|vasodilator agents|mesh-ancestor
101952006|NCT05667987|Lidocaine|lidocaine|mesh-list
101952007|NCT05667987|Anesthetics, Local|anesthetics, local|mesh-ancestor
101952008|NCT05667987|Anesthetics|anesthetics|mesh-ancestor
101952009|NCT05667987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101952010|NCT05667987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952011|NCT05667987|Sensory System Agents|sensory system agents|mesh-ancestor
101952012|NCT05667987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101291873|NCT01958775|Incretins|incretins|mesh-ancestor
102029612|NCT02363452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102029613|NCT02363452|Antimetabolites|antimetabolites|mesh-ancestor
102029614|NCT03634137|Afamelanotide|afamelanotide|mesh-list
102029615|NCT03634137|alpha-MSH|alpha-msh|mesh-list
102029616|NCT03634137|Dermatologic Agents|dermatologic agents|mesh-ancestor
102029617|NCT03634137|Hormones|hormones|mesh-ancestor
102029618|NCT03634137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102029619|NCT03634137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029620|NCT02358694|Immunoglobulins|immunoglobulins|mesh-list
102029621|NCT02358694|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102029622|NCT02358694|Antibodies|antibodies|mesh-list
102029623|NCT02358694|Immunologic Factors|immunologic factors|mesh-ancestor
102029624|NCT02358694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029625|NCT04473807|Sotalol|sotalol|mesh-list
102029626|NCT04473807|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102029627|NCT04473807|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102029628|NCT04473807|Adrenergic Agents|adrenergic agents|mesh-ancestor
101749395|NCT00656799|Bromides|bromides|mesh-list
102029629|NCT04473807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102029630|NCT04473807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029631|NCT04473807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029632|NCT04473807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102029634|NCT04473807|Autonomic Agents|autonomic agents|mesh-ancestor
102029635|NCT04473807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102029636|NCT02323659|Interferons|interferons|mesh-list
102029637|NCT02323659|Interferon-alpha|interferon-alpha|mesh-list
102029638|NCT02323659|Interferon alpha-2|interferon alpha-2|mesh-list
102029639|NCT02323659|Methotrexate|methotrexate|mesh-list
102029640|NCT02323659|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102029641|NCT02323659|Abortifacient Agents|abortifacient agents|mesh-ancestor
102029642|NCT02323659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102029643|NCT02323659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029644|NCT02323659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102029645|NCT02323659|Antimetabolites|antimetabolites|mesh-ancestor
102029646|NCT02323659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029647|NCT02323659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102029648|NCT02323659|Dermatologic Agents|dermatologic agents|mesh-ancestor
102029649|NCT02323659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102029650|NCT02323659|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102029651|NCT02323659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102029652|NCT02323659|Immunologic Factors|immunologic factors|mesh-ancestor
102029653|NCT02323659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102029654|NCT02323659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102029655|NCT02323659|Antiviral Agents|antiviral agents|mesh-ancestor
102029656|NCT02323659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102029657|NCT03634059|Apatinib|apatinib|mesh-list
102029658|NCT03634059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102029659|NCT03634059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102029662|NCT02358304|Calcitonin|calcitonin|mesh-list
102029663|NCT02358304|Salmon calcitonin|salmon calcitonin|mesh-list
102029664|NCT02358304|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
102029665|NCT02358304|Katacalcin|katacalcin|mesh-list
102029666|NCT02358304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102029667|NCT02358304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525790|NCT00539396|Insulin|insulin|mesh-list
102029668|NCT02358304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102029669|NCT02358304|Vasodilator Agents|vasodilator agents|mesh-ancestor
102029670|NCT02363530|Ethyl cellulose|ethyl cellulose|mesh-list
102029671|NCT02363530|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102029672|NCT02363530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101952013|NCT05667987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101952014|NCT05667987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101952015|NCT05667987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102029673|NCT01316523|Rituximab|rituximab|mesh-list
102029674|NCT01316523|Lenalidomide|lenalidomide|mesh-list
102029675|NCT01316523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102029676|NCT01316523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102029677|NCT01316523|Immunologic Factors|immunologic factors|mesh-ancestor
102029678|NCT01316523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029679|NCT01316523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102029680|NCT01316523|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102029681|NCT01316523|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102029682|NCT01316523|Growth Substances|growth substances|mesh-ancestor
102029683|NCT01316523|Growth Inhibitors|growth inhibitors|mesh-ancestor
102029684|NCT02362906|Azithromycin|azithromycin|mesh-list
102029685|NCT02362906|Erythromycin|erythromycin|mesh-list
102029686|NCT02362906|Erythromycin Estolate|erythromycin estolate|mesh-list
102029687|NCT02362906|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
102029688|NCT02362906|Erythromycin stearate|erythromycin stearate|mesh-list
102029689|NCT02362906|Cephalosporins|cephalosporins|mesh-list
102029690|NCT02362906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102029691|NCT02362906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102029692|NCT02362906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102029693|NCT02362906|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102029694|NCT02362906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102029695|NCT02362906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029696|NCT04469530|Sirolimus|sirolimus|mesh-list
102029697|NCT04469530|Celecoxib|celecoxib|mesh-list
102029698|NCT04469530|Cyclophosphamide|cyclophosphamide|mesh-list
102029699|NCT04469530|Etoposide|etoposide|mesh-list
102029700|NCT04469530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102029701|NCT04469530|Immunologic Factors|immunologic factors|mesh-ancestor
102029702|NCT04469530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029703|NCT04469530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102029704|NCT04469530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102029705|NCT04469530|Alkylating Agents|alkylating agents|mesh-ancestor
102029706|NCT04469530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029707|NCT04469530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102029708|NCT04469530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102029709|NCT04469530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102029710|NCT04469530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102029711|NCT04469530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102029712|NCT04469530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102029713|NCT04469530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102029714|NCT04469530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102029715|NCT04469530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102029716|NCT04469530|Antifungal Agents|antifungal agents|mesh-ancestor
102029717|NCT04469530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102029718|NCT04469530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102029719|NCT04469530|Analgesics|analgesics|mesh-ancestor
102029720|NCT04469530|Sensory System Agents|sensory system agents|mesh-ancestor
102029721|NCT04469530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102029722|NCT04469530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102029723|NCT04469530|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102029724|NCT04469530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102029725|NCT03085914|Leucovorin|leucovorin|mesh-list
102029726|NCT03085914|Paclitaxel|paclitaxel|mesh-list
102029727|NCT03085914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102029728|NCT03085914|Cyclophosphamide|cyclophosphamide|mesh-list
102029729|NCT03085914|Carboplatin|carboplatin|mesh-list
102029730|NCT03085914|Gemcitabine|gemcitabine|mesh-list
102029731|NCT03085914|Pembrolizumab|pembrolizumab|mesh-list
102029732|NCT03085914|Fluorouracil|fluorouracil|mesh-list
102029733|NCT03085914|Oxaliplatin|oxaliplatin|mesh-list
102029734|NCT03085914|Pemetrexed|pemetrexed|mesh-list
102029737|NCT03085914|Tubulin Modulators|tubulin modulators|mesh-ancestor
102029738|NCT03085914|Antimitotic Agents|antimitotic agents|mesh-ancestor
102029739|NCT03085914|Mitosis Modulators|mitosis modulators|mesh-ancestor
102029740|NCT03085914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029741|NCT03085914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102029742|NCT03085914|Immunologic Factors|immunologic factors|mesh-ancestor
102029743|NCT03085914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029744|NCT03085914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102029745|NCT03085914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101952016|NCT05667987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101952017|NCT05667987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952018|NCT01201239|Raltegravir Potassium|raltegravir potassium|mesh-list
102029746|NCT03085914|Alkylating Agents|alkylating agents|mesh-ancestor
102029747|NCT03085914|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102029748|NCT03085914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102029749|NCT03085914|Antimetabolites|antimetabolites|mesh-ancestor
102029750|NCT03085914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102029751|NCT03085914|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102029752|NCT03085914|Antidotes|antidotes|mesh-ancestor
102029753|NCT03085914|Protective Agents|protective agents|mesh-ancestor
102029754|NCT03085914|Vitamin B Complex|vitamin b complex|mesh-ancestor
102029755|NCT03085914|Vitamins|vitamins|mesh-ancestor
102029756|NCT03085914|Micronutrients|micronutrients|mesh-ancestor
102029757|NCT03085914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102029758|NCT03085914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102029759|NCT03085914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102029760|NCT02467608|Isoniazid|isoniazid|mesh-list
102029761|NCT02467608|Antitubercular Agents|antitubercular agents|mesh-ancestor
102029762|NCT02467608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102029763|NCT02467608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102029764|NCT02467608|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102029765|NCT02467608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102029766|NCT02467608|Antimetabolites|antimetabolites|mesh-ancestor
102029767|NCT02467608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029768|NCT02467608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102029769|NCT02368288|Entecavir|entecavir|mesh-list
102029770|NCT02368288|Antiviral Agents|antiviral agents|mesh-ancestor
102029771|NCT02368288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102029772|NCT02357524|Oritavancin|oritavancin|mesh-list
102029773|NCT02357524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102029774|NCT02357524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102029775|NCT02368054|Epinephrine|epinephrine|mesh-list
102029776|NCT02368054|Racepinephrine|racepinephrine|mesh-list
102029777|NCT02368054|Bupivacaine|bupivacaine|mesh-list
102029778|NCT02368054|Epinephryl borate|epinephryl borate|mesh-list
102029779|NCT02368054|Anesthetics, Local|anesthetics, local|mesh-ancestor
102029780|NCT02368054|Anesthetics|anesthetics|mesh-ancestor
102029781|NCT02368054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102029782|NCT02368054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029783|NCT02368054|Sensory System Agents|sensory system agents|mesh-ancestor
102029784|NCT02368054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102029786|NCT02368054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102029787|NCT02368054|Adrenergic Agents|adrenergic agents|mesh-ancestor
102029788|NCT02368054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102029789|NCT02368054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029790|NCT02368054|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102029791|NCT02368054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102029792|NCT02368054|Autonomic Agents|autonomic agents|mesh-ancestor
102029793|NCT02368054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102029794|NCT02368054|Respiratory System Agents|respiratory system agents|mesh-ancestor
102029795|NCT02368054|Mydriatics|mydriatics|mesh-ancestor
102029796|NCT02368054|Sympathomimetics|sympathomimetics|mesh-ancestor
102029797|NCT02368054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102029798|NCT02357602|Tenofovir|tenofovir|mesh-list
102029799|NCT02357602|Antiviral Agents|antiviral agents|mesh-ancestor
102029800|NCT02357602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102029801|NCT02357602|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102029802|NCT02357602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102029803|NCT02357602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102029804|NCT02357602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029805|NCT02357602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102029806|NCT02357602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102029807|NCT01379196|Azithromycin|azithromycin|mesh-list
102029808|NCT01379196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102029809|NCT01379196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102029814|NCT01382238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029815|NCT01382238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102029816|NCT01382238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102029817|NCT01382238|Antiviral Agents|antiviral agents|mesh-ancestor
102029818|NCT01382238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101952020|NCT01201239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101952021|NCT01201239|Antiviral Agents|antiviral agents|mesh-ancestor
101952022|NCT01201239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101952023|NCT01201239|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102029819|NCT03112564|Fentanyl|fentanyl|mesh-list
102029820|NCT03112564|Sevoflurane|sevoflurane|mesh-list
102029821|NCT03112564|Rocuronium|rocuronium|mesh-list
102029822|NCT03112564|Cisatracurium|cisatracurium|mesh-list
102029823|NCT03112564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102029824|NCT03112564|Narcotics|narcotics|mesh-ancestor
102029825|NCT03112564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102029826|NCT03112564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029827|NCT03112564|Analgesics|analgesics|mesh-ancestor
102029828|NCT03112564|Sensory System Agents|sensory system agents|mesh-ancestor
102029829|NCT03112564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102029830|NCT03112564|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102029831|NCT03112564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102029832|NCT03112564|Anesthetics, General|anesthetics, general|mesh-ancestor
102029833|NCT03112564|Anesthetics|anesthetics|mesh-ancestor
101525876|NCT04660110|Piperaquine|piperaquine|mesh-list
102029834|NCT03112564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102029835|NCT03112564|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102029836|NCT03112564|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102029837|NCT03112564|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102029838|NCT03112564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102029839|NCT01379976|Acetylcarnitine|acetylcarnitine|mesh-list
102029840|NCT01379976|Vitamin B Complex|vitamin b complex|mesh-ancestor
102029841|NCT01379976|Vitamins|vitamins|mesh-ancestor
102029842|NCT01379976|Micronutrients|micronutrients|mesh-ancestor
102029843|NCT01379976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029844|NCT01379976|Nootropic Agents|nootropic agents|mesh-ancestor
102029845|NCT01379898|Doxazosin|doxazosin|mesh-list
102029846|NCT01379898|Phenoxybenzamine|phenoxybenzamine|mesh-list
102029847|NCT01379898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102029848|NCT01379898|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102029849|NCT01379898|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102029850|NCT01379898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102029851|NCT01379898|Adrenergic Agents|adrenergic agents|mesh-ancestor
102029852|NCT01379898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102029853|NCT01379898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029854|NCT01379898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029855|NCT01379898|Vasodilator Agents|vasodilator agents|mesh-ancestor
102029856|NCT02362516|BI 425809|bi 425809|mesh-list
102029857|NCT02362516|Nootropic Agents|nootropic agents|mesh-ancestor
102029858|NCT02367664|Vaccines|vaccines|mesh-list
102029859|NCT02367664|Immunologic Factors|immunologic factors|mesh-ancestor
102029860|NCT02367664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029861|NCT05421000|Anesthetics|anesthetics|mesh-list
102029862|NCT05421000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102029863|NCT05421000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029864|NCT02357212|Adenosine|adenosine|mesh-list
102029865|NCT02357212|Analgesics|analgesics|mesh-ancestor
102029866|NCT02357212|Sensory System Agents|sensory system agents|mesh-ancestor
102029867|NCT02357212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102029868|NCT02357212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029869|NCT02357212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102029870|NCT02357212|Vasodilator Agents|vasodilator agents|mesh-ancestor
102029871|NCT02357212|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102029872|NCT02357212|Purinergic Agonists|purinergic agonists|mesh-ancestor
102029873|NCT02357212|Purinergic Agents|purinergic agents|mesh-ancestor
102029874|NCT02357212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102029875|NCT02357212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029876|NCT01382160|Adalimumab|adalimumab|mesh-list
102029877|NCT01382160|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102029878|NCT01382160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102029879|NCT01382160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102029880|NCT00735748|Tramadol|tramadol|mesh-list
102029881|NCT00735748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102029882|NCT00735748|Narcotics|narcotics|mesh-ancestor
102029883|NCT00735748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102029891|NCT02367196|Immunologic Factors|immunologic factors|mesh-ancestor
102029892|NCT02367196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029893|NCT02367196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102029894|NCT05418504|Anesthetics|anesthetics|mesh-list
102029895|NCT05418504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101952024|NCT01201239|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101952025|NCT01201239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101952026|NCT01201239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952027|NCT01199367|Letrozole|letrozole|mesh-list
101952028|NCT01199367|Lapatinib|lapatinib|mesh-list
101952029|NCT01199367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101952030|NCT01199367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101952031|NCT01199367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101952032|NCT01199367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101952033|NCT01199367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952034|NCT01199367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101952035|NCT01199367|Hormone Antagonists|hormone antagonists|mesh-ancestor
101952036|NCT01199367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101952037|NCT01199367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952038|NCT01199367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101952039|NCT01203735|Valproic Acid|valproic acid|mesh-list
101952040|NCT01203735|Anticonvulsants|anticonvulsants|mesh-ancestor
102029896|NCT05418504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029898|NCT03408886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102029899|NCT03408886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102029900|NCT02361892|Ulipristal acetate|ulipristal acetate|mesh-list
102029901|NCT02361892|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102029902|NCT02361892|Contraceptive Agents|contraceptive agents|mesh-ancestor
102029903|NCT02361892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102029904|NCT02361892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029905|NCT02361892|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102029906|NCT04013334|Nivolumab|nivolumab|mesh-list
102029907|NCT04013334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102029908|NCT04013334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102029909|NCT04013334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102029910|NCT04013334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029911|NCT02366884|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102029912|NCT02366884|Antifungal Agents|antifungal agents|mesh-list
102029913|NCT02366884|Clotrimazole|clotrimazole|mesh-list
102029914|NCT02366884|Miconazole|miconazole|mesh-list
102029915|NCT02366884|Antiprotozoal Agents|antiprotozoal agents|mesh-list
102029916|NCT02366884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102029917|NCT02366884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102029918|NCT02366884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102029919|NCT02366884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102029920|NCT02366884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102029921|NCT02366884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029922|NCT02366884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102029923|NCT02366884|Hormone Antagonists|hormone antagonists|mesh-ancestor
102029924|NCT02366884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101525903|NCT00540605|Tenofovir|tenofovir|mesh-list
102029925|NCT02366884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029926|NCT02366884|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102029927|NCT02366884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102029928|NCT02366884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102029929|NCT02361502|Mirabegron|mirabegron|mesh-list
102029930|NCT02361502|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102029931|NCT02361502|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102029932|NCT02361502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102029933|NCT02361502|Adrenergic Agents|adrenergic agents|mesh-ancestor
102029934|NCT02361502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101952042|NCT01203735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952043|NCT01203735|GABA Agents|gaba agents|mesh-ancestor
101952044|NCT01203735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102029935|NCT02361502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029936|NCT02361502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029937|NCT02361502|Urological Agents|urological agents|mesh-ancestor
102029938|NCT02367118|Prednisone|prednisone|mesh-list
102029939|NCT02367118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102029940|NCT02367118|Glucocorticoids|glucocorticoids|mesh-ancestor
102029941|NCT02367118|Hormones|hormones|mesh-ancestor
102029942|NCT02367118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102029943|NCT02367118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029944|NCT02367118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102029945|NCT02367118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102029946|NCT00979212|Paclitaxel|paclitaxel|mesh-list
102029947|NCT00979212|Carboplatin|carboplatin|mesh-list
102029948|NCT00979212|Panitumumab|panitumumab|mesh-list
102029949|NCT00979212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102029952|NCT00979212|Antimitotic Agents|antimitotic agents|mesh-ancestor
102029953|NCT00979212|Mitosis Modulators|mitosis modulators|mesh-ancestor
102029954|NCT00979212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029955|NCT00979212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102029956|NCT02361190|Methyltestosterone|methyltestosterone|mesh-list
102029957|NCT02361190|Testosterone|testosterone|mesh-list
102029958|NCT02361190|Testosterone undecanoate|testosterone undecanoate|mesh-list
102029959|NCT02361190|Testosterone enanthate|testosterone enanthate|mesh-list
102029960|NCT02361190|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102029961|NCT02361190|Androgens|androgens|mesh-ancestor
102029962|NCT02361190|Hormones|hormones|mesh-ancestor
102029963|NCT02361190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102029964|NCT02361190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029965|NCT02361190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102029966|NCT02361190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102029967|NCT02361190|Anabolic Agents|anabolic agents|mesh-ancestor
102029968|NCT02361112|Capecitabine|capecitabine|mesh-list
102029969|NCT02361112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102029970|NCT02361112|Antimetabolites|antimetabolites|mesh-ancestor
102029971|NCT02361112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029972|NCT02361112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102029973|NCT02360956|Olmesartan|olmesartan|mesh-list
102029974|NCT02360956|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
102029975|NCT02360956|Antihypertensive Agents|antihypertensive agents|mesh-list
102029976|NCT02360956|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102029977|NCT02360956|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102029978|NCT02360956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029979|NCT02360800|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102029980|NCT02360800|Hemostatics|hemostatics|mesh-list
102029981|NCT02360800|Coagulants|coagulants|mesh-ancestor
102029982|NCT03501966|Acetazolamide|acetazolamide|mesh-list
102029983|NCT03501966|Diuretics|diuretics|mesh-list
102029984|NCT03501966|Natriuretic Agents|natriuretic agents|mesh-ancestor
102029985|NCT03501966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029986|NCT03501966|Anticonvulsants|anticonvulsants|mesh-ancestor
102029987|NCT03501966|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102029988|NCT03501966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102029989|NCT03501966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029990|NCT02355184|Leronlimab|leronlimab|mesh-list
102029991|NCT02355184|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102029992|NCT02355184|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102029993|NCT02355184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029994|NCT02355184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102029995|NCT02355184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102029996|NCT02355184|Antiviral Agents|antiviral agents|mesh-ancestor
102029997|NCT02355184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102029998|NCT03477630|Hyaluronic Acid|hyaluronic acid|mesh-list
102029999|NCT03477630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102030000|NCT03477630|Immunologic Factors|immunologic factors|mesh-ancestor
102030001|NCT03477630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030002|NCT03477630|Viscosupplements|viscosupplements|mesh-ancestor
101952045|NCT01203735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952046|NCT01203735|Antimanic Agents|antimanic agents|mesh-ancestor
101952047|NCT01203735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102030003|NCT03477630|Protective Agents|protective agents|mesh-ancestor
102030004|NCT02981342|Gemcitabine|gemcitabine|mesh-list
102030005|NCT02981342|Capecitabine|capecitabine|mesh-list
102030006|NCT02981342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102030007|NCT02981342|Antimetabolites|antimetabolites|mesh-ancestor
101749755|NCT02547844|Antiviral Agents|antiviral agents|mesh-ancestor
102030008|NCT02981342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030009|NCT02981342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102030010|NCT02639026|Durvalumab|durvalumab|mesh-list
102030011|NCT02639026|Tremelimumab|tremelimumab|mesh-list
102030012|NCT02639026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102030013|NCT02639026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102030014|NCT02360644|Vitamin D|vitamin d|mesh-list
102030015|NCT02360644|Cholecalciferol|cholecalciferol|mesh-list
102030016|NCT02360644|Vitamins|vitamins|mesh-ancestor
102030017|NCT02360644|Micronutrients|micronutrients|mesh-ancestor
102030018|NCT02360644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030019|NCT02360644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102030020|NCT02360644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102030021|NCT02365948|Certolizumab Pegol|certolizumab pegol|mesh-list
102030022|NCT02365948|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102030026|NCT02365948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030027|NCT02365948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102030028|NCT02354950|Cabotegravir|cabotegravir|mesh-list
102030029|NCT02354950|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102030030|NCT02354950|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102030031|NCT02354950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102030032|NCT02354950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030033|NCT02354950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102030034|NCT02354950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102030035|NCT02354950|Antiviral Agents|antiviral agents|mesh-ancestor
102030036|NCT02354950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102030037|NCT02980874|Triamcinolone|triamcinolone|mesh-list
102030038|NCT02980874|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102030039|NCT02980874|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102030040|NCT02980874|Aflibercept|aflibercept|mesh-list
102030041|NCT02980874|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102030042|NCT02980874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102030043|NCT02980874|Glucocorticoids|glucocorticoids|mesh-ancestor
102030044|NCT02980874|Hormones|hormones|mesh-ancestor
101525939|NCT00540800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102030045|NCT02980874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102030046|NCT02980874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030047|NCT02980874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102030048|NCT02980874|Immunologic Factors|immunologic factors|mesh-ancestor
102030049|NCT02980874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102030050|NCT02980874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030051|NCT02980874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102030052|NCT02980874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102030053|NCT02980874|Growth Substances|growth substances|mesh-ancestor
102030054|NCT02980874|Growth Inhibitors|growth inhibitors|mesh-ancestor
102030055|NCT02980874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102030056|NCT02354872|Nicotine|nicotine|mesh-list
102030057|NCT02354872|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102030058|NCT02354872|Autonomic Agents|autonomic agents|mesh-ancestor
102030059|NCT02354872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102030060|NCT02354872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030061|NCT02354872|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102030062|NCT02354872|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102030063|NCT02354872|Cholinergic Agents|cholinergic agents|mesh-ancestor
102030064|NCT02354872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102030065|NCT02354872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030066|NCT02354638|Nicotine|nicotine|mesh-list
102030067|NCT02354638|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102030068|NCT02354638|Autonomic Agents|autonomic agents|mesh-ancestor
102030069|NCT02354638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102030070|NCT02354638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030071|NCT02354638|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102030072|NCT02354638|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102030073|NCT02354638|Cholinergic Agents|cholinergic agents|mesh-ancestor
102030074|NCT02354638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101952048|NCT01203735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101952049|NCT01203735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101952050|NCT03842631|Timolol|timolol|mesh-list
101952051|NCT03842631|Maleic acid|maleic acid|mesh-list
101952052|NCT03842631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101292356|NCT01962454|Hormones|hormones|mesh-ancestor
102030075|NCT02354638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030076|NCT02360254|Insulin|insulin|mesh-list
102030077|NCT02360254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102030078|NCT02360254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030079|NCT03112642|Anesthetics|anesthetics|mesh-list
102030080|NCT03112642|Bupivacaine|bupivacaine|mesh-list
102030081|NCT03112642|Anesthetics, Local|anesthetics, local|mesh-list
102030082|NCT03112642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102030083|NCT03112642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030084|NCT03112642|Sensory System Agents|sensory system agents|mesh-ancestor
102030085|NCT03112642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102030086|NCT01377324|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102030087|NCT01377324|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102030088|NCT01377324|Estradiol|estradiol|mesh-list
102030089|NCT01377324|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102030090|NCT01377324|Estrogens|estrogens|mesh-ancestor
102030091|NCT01377324|Hormones|hormones|mesh-ancestor
102030092|NCT01377324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102030093|NCT01377324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030094|NCT01377324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102030112|NCT02354560|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102030113|NCT02354560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102030114|NCT02354560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030115|NCT01378884|Domperidone|domperidone|mesh-list
102030116|NCT01378884|Antiemetics|antiemetics|mesh-ancestor
102030117|NCT01378884|Autonomic Agents|autonomic agents|mesh-ancestor
102030118|NCT01378884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102030119|NCT01378884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030120|NCT01378884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102030121|NCT01378884|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102030122|NCT01378884|Dopamine Agents|dopamine agents|mesh-ancestor
102030123|NCT01378884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102030124|NCT01378884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030125|NCT02039050|Tiotropium Bromide|tiotropium bromide|mesh-list
102030126|NCT02039050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102030127|NCT02039050|Autonomic Agents|autonomic agents|mesh-ancestor
102030128|NCT02039050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102030129|NCT02039050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030130|NCT02039050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102030131|NCT02039050|Respiratory System Agents|respiratory system agents|mesh-ancestor
102030132|NCT02039050|Parasympatholytics|parasympatholytics|mesh-ancestor
102030133|NCT02039050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102030134|NCT02039050|Cholinergic Agents|cholinergic agents|mesh-ancestor
102030135|NCT02039050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102030136|NCT02039050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030137|NCT02354170|Mifepristone|mifepristone|mesh-list
102030138|NCT02354170|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102030139|NCT02354170|Abortifacient Agents|abortifacient agents|mesh-ancestor
102030140|NCT02354170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102030141|NCT02354170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030142|NCT02354170|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102030143|NCT02354170|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102030144|NCT02354170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102030145|NCT02354170|Contraceptive Agents|contraceptive agents|mesh-ancestor
102030146|NCT02354170|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102030147|NCT02354170|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102030148|NCT02354170|Hormone Antagonists|hormone antagonists|mesh-ancestor
102030149|NCT02354170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102030150|NCT02354170|Luteolytic Agents|luteolytic agents|mesh-ancestor
101485129|NCT00421395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102030155|NCT01377246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102030156|NCT01377246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102030157|NCT02353936|Afatinib|afatinib|mesh-list
101952053|NCT03842631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952054|NCT03842631|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101952055|NCT03842631|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101952056|NCT03842631|Adrenergic Agents|adrenergic agents|mesh-ancestor
101952057|NCT03842631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101952058|NCT03842631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952059|NCT03842631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101952060|NCT03842631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101952061|NCT05669781|Metoclopramide|metoclopramide|mesh-list
101952062|NCT05669781|Antiemetics|antiemetics|mesh-ancestor
101952063|NCT05669781|Autonomic Agents|autonomic agents|mesh-ancestor
101952064|NCT05669781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101952065|NCT05669781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952066|NCT05669781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101952067|NCT05669781|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101952068|NCT05669781|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101952069|NCT05669781|Dopamine Agents|dopamine agents|mesh-ancestor
101952070|NCT05669781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101952071|NCT05669781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952072|NCT01202331|Azithromycin|azithromycin|mesh-list
101952073|NCT01202331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102030158|NCT02353936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102030159|NCT02353936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102030160|NCT02353936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102030161|NCT02353936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030162|NCT02353858|Fluorouracil|fluorouracil|mesh-list
102030163|NCT02353858|Antimetabolites|antimetabolites|mesh-ancestor
102030164|NCT02353858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030165|NCT02353858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102030166|NCT02353858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102030167|NCT02353858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102030168|NCT02353858|Immunologic Factors|immunologic factors|mesh-ancestor
102030169|NCT02353858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030170|NCT02353702|Ropivacaine|ropivacaine|mesh-list
102030171|NCT02353702|Anesthetics, Local|anesthetics, local|mesh-ancestor
102030172|NCT02353702|Anesthetics|anesthetics|mesh-ancestor
102030173|NCT02353702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102030174|NCT02353702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030175|NCT02353702|Sensory System Agents|sensory system agents|mesh-ancestor
102030176|NCT02353702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102030177|NCT02532660|Dexetimide|dexetimide|mesh-list
102030178|NCT02532660|Citalopram|citalopram|mesh-list
102030179|NCT02532660|Escitalopram|escitalopram|mesh-list
102030180|NCT02532660|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102030181|NCT02532660|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102030182|NCT02532660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102030183|NCT02532660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030184|NCT02532660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102030185|NCT02532660|Serotonin Agents|serotonin agents|mesh-ancestor
102030186|NCT02532660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030187|NCT02532660|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102030188|NCT02532660|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101952074|NCT01202331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101952075|NCT01201551|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101952076|NCT01201551|Latanoprost|latanoprost|mesh-list
101952077|NCT01201551|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101952078|NCT01201551|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101952079|NCT01201551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101292479|NCT01963754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030189|NCT02532660|Parasympatholytics|parasympatholytics|mesh-ancestor
102030190|NCT02532660|Autonomic Agents|autonomic agents|mesh-ancestor
102030191|NCT02532660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102030192|NCT02532660|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102030193|NCT02532660|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102030194|NCT02532660|Cholinergic Agents|cholinergic agents|mesh-ancestor
102030195|NCT02532660|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102030196|NCT02532660|Antidepressive Agents|antidepressive agents|mesh-ancestor
102030197|NCT02532660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102030198|NCT01377168|Naltrexone|naltrexone|mesh-list
102030199|NCT01377168|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102030200|NCT01377168|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102030201|NCT01377168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030202|NCT01377168|Sensory System Agents|sensory system agents|mesh-ancestor
102030203|NCT01377168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102030204|NCT02892149|Darbepoetin alfa|darbepoetin alfa|mesh-list
102030205|NCT02892149|Hematinics|hematinics|mesh-ancestor
102030206|NCT02348398|Topotecan|topotecan|mesh-list
102030207|NCT02348398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102030208|NCT02348398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102030209|NCT02348398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102030210|NCT02348398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030211|NCT02348398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102030212|NCT05278338|Denosumab|denosumab|mesh-list
102030213|NCT05278338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102030214|NCT05278338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030215|NCT03721757|Nivolumab|nivolumab|mesh-list
102030216|NCT03721757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102030217|NCT03721757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102030218|NCT03721757|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102030219|NCT03721757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030220|NCT03727607|Propofol|propofol|mesh-list
102030221|NCT03727607|Desflurane|desflurane|mesh-list
102030225|NCT03727607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102030226|NCT03727607|Anesthetics, General|anesthetics, general|mesh-ancestor
102030227|NCT03727607|Anesthetics|anesthetics|mesh-ancestor
102030228|NCT03727607|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102030229|NCT02348242|Lubricant Eye Drops|lubricant eye drops|mesh-list
102030230|NCT02348242|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102030231|NCT02348242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101749978|NCT00429793|Antifungal Agents|antifungal agents|mesh-ancestor
102030233|NCT03157804|Lenograstim|lenograstim|mesh-list
102030234|NCT03157804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102030235|NCT03157804|Immunologic Factors|immunologic factors|mesh-ancestor
102030236|NCT03157804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030237|NCT03157804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102030238|NCT03157804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102030239|NCT03157804|Antiviral Agents|antiviral agents|mesh-ancestor
102030240|NCT03157804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102030241|NCT03157414|Empagliflozin|empagliflozin|mesh-list
102030242|NCT03157414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102030243|NCT03157414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030244|NCT03157414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102030245|NCT03157414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030246|NCT03147196|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
102030247|NCT03147196|Bicalutamide|bicalutamide|mesh-list
102030248|NCT03147196|Androgen Antagonists|androgen antagonists|mesh-ancestor
102030249|NCT03147196|Hormone Antagonists|hormone antagonists|mesh-ancestor
102030250|NCT03147196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102030251|NCT03147196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030252|NCT03147196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102030253|NCT03147196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101952081|NCT01201551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101952082|NCT01201551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101952083|NCT01201551|Adrenergic Agents|adrenergic agents|mesh-ancestor
102030254|NCT03147196|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102030255|NCT03147196|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102030256|NCT03147196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102030257|NCT03153436|Inositol|inositol|mesh-list
102030258|NCT03153436|Vitamin B Complex|vitamin b complex|mesh-ancestor
102030259|NCT03153436|Vitamins|vitamins|mesh-ancestor
102030260|NCT03153436|Micronutrients|micronutrients|mesh-ancestor
102030261|NCT03153436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030262|NCT03544229|Maleic acid|maleic acid|mesh-list
102030263|NCT03544229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102030264|NCT03544229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030265|NCT02351908|Tenofovir|tenofovir|mesh-list
102030266|NCT02351908|Raltegravir Potassium|raltegravir potassium|mesh-list
102030267|NCT02351908|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102030268|NCT02351908|Dolutegravir|dolutegravir|mesh-list
102030269|NCT02351908|Cobicistat|cobicistat|mesh-list
102030270|NCT02351908|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102030271|NCT02351908|Elvitegravir|elvitegravir|mesh-list
102030272|NCT02351908|Antiviral Agents|antiviral agents|mesh-ancestor
102030273|NCT02351908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102030274|NCT02351908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102030275|NCT02351908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102030276|NCT02351908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102030277|NCT02351908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030278|NCT02351908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102030279|NCT02351908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102030280|NCT02351908|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102030281|NCT02351908|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102030282|NCT02351908|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102030283|NCT02351908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102030284|NCT01371240|Secretin|secretin|mesh-list
102030285|NCT01371240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102030286|NCT01371240|Hormones|hormones|mesh-ancestor
101526062|NCT00541736|Vasodilator Agents|vasodilator agents|mesh-ancestor
102030287|NCT01371240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102030288|NCT01371240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030289|NCT02352064|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101485260|NCT00349518|Dasatinib|dasatinib|mesh-list
102030294|NCT03723941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102030295|NCT03723941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102030296|NCT03723941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102030297|NCT03723941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102030298|NCT03723941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102030299|NCT03723941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030300|NCT03723941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102030301|NCT03721679|Pembrolizumab|pembrolizumab|mesh-list
102030302|NCT03721679|Nivolumab|nivolumab|mesh-list
102030303|NCT03721679|Atezolizumab|atezolizumab|mesh-list
102030304|NCT03721679|Durvalumab|durvalumab|mesh-list
102030305|NCT03721679|Poly ICLC|poly iclc|mesh-list
102030306|NCT03721679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102030307|NCT03721679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102030308|NCT03721679|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102030309|NCT03721679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030310|NCT03721679|Interferon Inducers|interferon inducers|mesh-ancestor
102030311|NCT03721679|Immunologic Factors|immunologic factors|mesh-ancestor
102030312|NCT03721679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030313|NCT03639948|Carboplatin|carboplatin|mesh-list
102030314|NCT03639948|Docetaxel|docetaxel|mesh-list
102030315|NCT03639948|Pembrolizumab|pembrolizumab|mesh-list
102030316|NCT03639948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102030317|NCT03639948|Tubulin Modulators|tubulin modulators|mesh-ancestor
102030318|NCT03639948|Antimitotic Agents|antimitotic agents|mesh-ancestor
102030319|NCT03639948|Mitosis Modulators|mitosis modulators|mesh-ancestor
102030320|NCT03639948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030321|NCT03639948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101952084|NCT01201551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101952085|NCT01201551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030322|NCT03639948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102030323|NCT03510455|Infigratinib|infigratinib|mesh-list
102030324|NCT03510455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102030325|NCT03509675|Ibuprofen|ibuprofen|mesh-list
102030326|NCT03509675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102030327|NCT03509675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102030328|NCT03509675|Analgesics|analgesics|mesh-ancestor
102030329|NCT03509675|Sensory System Agents|sensory system agents|mesh-ancestor
102030330|NCT03509675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102030331|NCT03509675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030332|NCT03509675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101526077|NCT00541853|Cilnidipine|cilnidipine|mesh-list
102030333|NCT03509675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102030334|NCT03509675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102030335|NCT03509675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102030336|NCT03509675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030337|NCT02351752|Hydroxychloroquine|hydroxychloroquine|mesh-list
102030338|NCT02351752|Antimalarials|antimalarials|mesh-ancestor
102030339|NCT02351752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102030340|NCT02351752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102030341|NCT02351752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102030342|NCT02351752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102030343|NCT02351752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030344|NCT02351752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102030345|NCT02353078|Sucralfate|sucralfate|mesh-list
102030346|NCT02353078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102030347|NCT02353078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102030348|NCT03509207|Vorinostat|vorinostat|mesh-list
102030349|NCT03509207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102030350|NCT03509207|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102030351|NCT03509207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102030352|NCT03509207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030353|NCT03727295|Idebenone|idebenone|mesh-list
102030354|NCT03727295|Antioxidants|antioxidants|mesh-ancestor
102030355|NCT03727295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030356|NCT03727295|Protective Agents|protective agents|mesh-ancestor
102030357|NCT03727295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030358|NCT01378650|Cilostazol|cilostazol|mesh-list
102030359|NCT01378650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102030360|NCT01378650|Autonomic Agents|autonomic agents|mesh-ancestor
102030361|NCT01378650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102030366|NCT01378650|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102030367|NCT01378650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030368|NCT01378650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102030369|NCT01378650|Vasodilator Agents|vasodilator agents|mesh-ancestor
102030370|NCT01378650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102030371|NCT01378650|Protective Agents|protective agents|mesh-ancestor
102030372|NCT01378650|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102030373|NCT01378650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102030374|NCT01378650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102030375|NCT04796922|Rituximab|rituximab|mesh-list
102030376|NCT04796922|Obinutuzumab|obinutuzumab|mesh-list
102030377|NCT04796922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102030378|NCT04796922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102030379|NCT04796922|Immunologic Factors|immunologic factors|mesh-ancestor
102030380|NCT04796922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030381|NCT04796922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102030383|NCT03723785|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102030384|NCT03723785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102030385|NCT03723785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030386|NCT03543137|Nicotine|nicotine|mesh-list
101526100|NCT02301234|Immunologic Factors|immunologic factors|mesh-ancestor
102030387|NCT03543137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102030388|NCT03543137|Autonomic Agents|autonomic agents|mesh-ancestor
102030389|NCT03543137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102030390|NCT03543137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030391|NCT03543137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102030392|NCT03543137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102030393|NCT03543137|Cholinergic Agents|cholinergic agents|mesh-ancestor
102030394|NCT03543137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102030395|NCT03543137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030396|NCT03146650|Nivolumab|nivolumab|mesh-list
102030397|NCT03146650|Ipilimumab|ipilimumab|mesh-list
101952086|NCT01201551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952088|NCT01204125|Iniparib|iniparib|mesh-list
101952089|NCT01204125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101952090|NCT01204125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101952091|NCT01204125|Tubulin Modulators|tubulin modulators|mesh-ancestor
101952092|NCT01204125|Antimitotic Agents|antimitotic agents|mesh-ancestor
101952093|NCT01204125|Mitosis Modulators|mitosis modulators|mesh-ancestor
101952094|NCT01204125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952095|NCT01204125|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101952096|NCT01204125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101952097|NCT03074240|Anesthetics|anesthetics|mesh-list
101952098|NCT03074240|Anesthetics, General|anesthetics, general|mesh-list
101952099|NCT03074240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101952100|NCT03074240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952101|NCT03725085|Guaifenesin|guaifenesin|mesh-list
101952102|NCT03725085|Expectorants|expectorants|mesh-ancestor
101952103|NCT03725085|Respiratory System Agents|respiratory system agents|mesh-ancestor
101952104|NCT03755804|Prednisone|prednisone|mesh-list
101952105|NCT03755804|Prednisolone|prednisolone|mesh-list
101952106|NCT03755804|Cyclophosphamide|cyclophosphamide|mesh-list
101952107|NCT03755804|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101952108|NCT03755804|Dacarbazine|dacarbazine|mesh-list
101952109|NCT03755804|Doxorubicin|doxorubicin|mesh-list
101952110|NCT03755804|Etoposide|etoposide|mesh-list
101952111|NCT03755804|Vincristine|vincristine|mesh-list
101952112|NCT03755804|Bleomycin|bleomycin|mesh-list
101952113|NCT03755804|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101952114|NCT03755804|Vinblastine|vinblastine|mesh-list
101952115|NCT03755804|Imidazole|imidazole|mesh-list
101952116|NCT03755804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101952117|NCT03755804|Immunologic Factors|immunologic factors|mesh-ancestor
101952118|NCT03755804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952119|NCT03755804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102030398|NCT03146650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102030399|NCT03146650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102030400|NCT03146650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102030401|NCT03146650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030402|NCT02343484|Ethanol|ethanol|mesh-list
102030403|NCT02343484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102030404|NCT02343484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102030405|NCT02343484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102030406|NCT02343484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030407|NCT03630042|Rituximab|rituximab|mesh-list
102030408|NCT03630042|Pembrolizumab|pembrolizumab|mesh-list
102030409|NCT03630042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102030410|NCT03630042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101952120|NCT03755804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101952121|NCT03755804|Alkylating Agents|alkylating agents|mesh-ancestor
101952122|NCT03755804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952123|NCT03755804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101952124|NCT03755804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101952125|NCT03755804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101952126|NCT03755804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101952127|NCT03755804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101952128|NCT03755804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101952129|NCT03755804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101952130|NCT03755804|Glucocorticoids|glucocorticoids|mesh-ancestor
101952132|NCT03755804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101952133|NCT03755804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101952134|NCT03755804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101952135|NCT03755804|Tubulin Modulators|tubulin modulators|mesh-ancestor
101952136|NCT03755804|Antimitotic Agents|antimitotic agents|mesh-ancestor
101952137|NCT03755804|Mitosis Modulators|mitosis modulators|mesh-ancestor
101952138|NCT03755804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101952139|NCT03755804|Immunotoxins|immunotoxins|mesh-ancestor
101952140|NCT03755804|Immunoconjugates|immunoconjugates|mesh-ancestor
101952141|NCT01566825|Amitriptyline|amitriptyline|mesh-list
101952142|NCT01566825|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101952143|NCT01566825|Antidepressive Agents|antidepressive agents|mesh-ancestor
101952144|NCT01566825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101952145|NCT01566825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101952146|NCT01566825|Analgesics|analgesics|mesh-ancestor
101952147|NCT01566825|Sensory System Agents|sensory system agents|mesh-ancestor
101952148|NCT01566825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101952149|NCT01566825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952163|NCT03559010|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101952164|NCT03559010|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101952165|NCT03298412|Blinatumomab|blinatumomab|mesh-list
101952166|NCT03298412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101952167|NCT03297398|Ascorbic Acid|ascorbic acid|mesh-list
101952168|NCT03297398|Methyltestosterone|methyltestosterone|mesh-list
102030411|NCT03630042|Immunologic Factors|immunologic factors|mesh-ancestor
102030412|NCT03630042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030413|NCT03630042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102030414|NCT03630042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102030415|NCT03630042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030416|NCT03073980|Acetaminophen|acetaminophen|mesh-list
102030417|NCT03073980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102030418|NCT03073980|Analgesics|analgesics|mesh-ancestor
102030419|NCT03073980|Sensory System Agents|sensory system agents|mesh-ancestor
102030420|NCT03073980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102030421|NCT03073980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030422|NCT03073980|Antipyretics|antipyretics|mesh-ancestor
102030423|NCT03930186|Apremilast|apremilast|mesh-list
102030424|NCT03930186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102030425|NCT03930186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102030426|NCT03930186|Analgesics|analgesics|mesh-ancestor
102030427|NCT03930186|Sensory System Agents|sensory system agents|mesh-ancestor
102030428|NCT03930186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102030429|NCT03930186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030430|NCT03930186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102030431|NCT03930186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102030432|NCT03930186|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102030436|NCT02351440|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102030437|NCT02351440|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102030438|NCT02351440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102030439|NCT02351440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102030440|NCT02351440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030441|NCT02351440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102030442|NCT02351440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030443|NCT02351440|Analgesics|analgesics|mesh-ancestor
102030444|NCT02351440|Sensory System Agents|sensory system agents|mesh-ancestor
102030445|NCT02351440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102030446|NCT02351440|Antidepressive Agents|antidepressive agents|mesh-ancestor
102030447|NCT02351440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102030448|NCT02351440|Dopamine Agents|dopamine agents|mesh-ancestor
102030449|NCT03504917|Balovaptan|balovaptan|mesh-list
102030450|NCT03504917|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102030451|NCT03504917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030452|NCT03504917|Natriuretic Agents|natriuretic agents|mesh-ancestor
102030453|NCT03504917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030454|NCT02351128|Lanreotide|lanreotide|mesh-list
102030455|NCT02351128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102030456|NCT02343250|Valsartan|valsartan|mesh-list
102030457|NCT02343250|Cilnidipine|cilnidipine|mesh-list
102030458|NCT02343250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102030459|NCT02343250|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102030460|NCT02343250|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102030461|NCT02343250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030462|NCT02343250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102030463|NCT02343250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102030464|NCT02343250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102030465|NCT02343250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030466|NCT03781440|Lidocaine|lidocaine|mesh-list
102030467|NCT03781440|Anesthetics, Local|anesthetics, local|mesh-ancestor
102030468|NCT03781440|Anesthetics|anesthetics|mesh-ancestor
102030469|NCT03781440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102030470|NCT03781440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030471|NCT03781440|Sensory System Agents|sensory system agents|mesh-ancestor
102030472|NCT03781440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102030473|NCT03781440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102030474|NCT03781440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101952169|NCT03297398|Androgens|androgens|mesh-list
101952170|NCT03297398|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101952171|NCT03297398|Hormones|hormones|mesh-ancestor
101952172|NCT03297398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101952173|NCT03297398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030475|NCT03781440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102030476|NCT03781440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102030477|NCT03781440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030478|NCT03565211|Progesterone|progesterone|mesh-list
102030479|NCT03565211|Progestins|progestins|mesh-ancestor
102030480|NCT03565211|Hormones|hormones|mesh-ancestor
102030481|NCT03565211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102030482|NCT03565211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030483|NCT03723395|Repaglinide|repaglinide|mesh-list
102030484|NCT03723395|Tolbutamide|tolbutamide|mesh-list
102030485|NCT03723395|Itraconazole|itraconazole|mesh-list
102030486|NCT03723395|Rifampin|rifampin|mesh-list
102030487|NCT03723395|Tucatinib|tucatinib|mesh-list
102030488|NCT03723395|Digoxin|digoxin|mesh-list
102030489|NCT03723395|Midazolam|midazolam|mesh-list
102030490|NCT03723395|Gemfibrozil|gemfibrozil|mesh-list
102030491|NCT03723395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102030492|NCT03723395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102030493|NCT03723395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102030494|NCT03723395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030495|NCT03723395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102030496|NCT03723395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102030497|NCT03723395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102030498|NCT03723395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102030499|NCT03723395|Anesthetics, General|anesthetics, general|mesh-ancestor
102030500|NCT03723395|Anesthetics|anesthetics|mesh-ancestor
102030501|NCT03723395|GABA Modulators|gaba modulators|mesh-ancestor
102030502|NCT03723395|GABA Agents|gaba agents|mesh-ancestor
102030503|NCT03723395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102030509|NCT03723395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102030510|NCT03723395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102030511|NCT03723395|Hormone Antagonists|hormone antagonists|mesh-ancestor
102030512|NCT03723395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102030513|NCT03723395|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102030514|NCT03723395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102030515|NCT03723395|Antitubercular Agents|antitubercular agents|mesh-ancestor
102030516|NCT03723395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102030517|NCT03723395|Leprostatic Agents|leprostatic agents|mesh-ancestor
102030518|NCT03723395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102030519|NCT03723395|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102030520|NCT03723395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102030521|NCT03723395|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102030522|NCT03723395|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102030523|NCT03723395|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102030524|NCT03723395|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102030525|NCT03723395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102030526|NCT03723395|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102030527|NCT03723395|Protective Agents|protective agents|mesh-ancestor
102030528|NCT03723395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102030529|NCT03723395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102030530|NCT03723395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102030531|NCT03723395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102030532|NCT03723395|Antimetabolites|antimetabolites|mesh-ancestor
102030533|NCT03723395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102030534|NCT03723395|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102030535|NCT03531905|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
102030536|NCT03531905|Ezetimibe|ezetimibe|mesh-list
102030537|NCT03531905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102030538|NCT03531905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102030539|NCT03531905|Antimetabolites|antimetabolites|mesh-ancestor
102030540|NCT03531905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030541|NCT03531905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102030542|NCT03531905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102030543|NCT03531905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101952175|NCT03297398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952176|NCT03297398|Protective Agents|protective agents|mesh-ancestor
101952177|NCT03297398|Vitamins|vitamins|mesh-ancestor
101952178|NCT03297398|Micronutrients|micronutrients|mesh-ancestor
101952179|NCT03297398|Estrogens|estrogens|mesh-ancestor
101952180|NCT03297398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102030544|NCT03531905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030545|NCT02350426|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102030546|NCT02350426|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102030547|NCT02350426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030548|NCT02346682|Clonazepam|clonazepam|mesh-list
102030549|NCT02346682|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102030550|NCT02346682|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102030551|NCT02346682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102030552|NCT02346682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102030553|NCT02346682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030554|NCT02346682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102030555|NCT02346682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030556|NCT02346682|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102030557|NCT02346682|Antidepressive Agents|antidepressive agents|mesh-ancestor
102030558|NCT02346682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102030559|NCT02346682|Anticonvulsants|anticonvulsants|mesh-ancestor
102030560|NCT02346682|GABA Modulators|gaba modulators|mesh-ancestor
102030561|NCT02346682|GABA Agents|gaba agents|mesh-ancestor
102030562|NCT05764590|Sevelamer|sevelamer|mesh-list
102030563|NCT05764590|Chelating Agents|chelating agents|mesh-ancestor
102030564|NCT05764590|Sequestering Agents|sequestering agents|mesh-ancestor
102030565|NCT05764590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030566|NCT05764512|Endorphins|endorphins|mesh-list
102030567|NCT05764512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102030568|NCT05764512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030583|NCT02342002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102030584|NCT02342002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102030585|NCT02342002|Oxytocics|oxytocics|mesh-ancestor
102030586|NCT02342002|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102030587|NCT02342002|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102030588|NCT02342002|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102030589|NCT02342002|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102030590|NCT02342002|Contraceptive Agents|contraceptive agents|mesh-ancestor
102030591|NCT02342002|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102030592|NCT02342002|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102030593|NCT02342002|Hormone Antagonists|hormone antagonists|mesh-ancestor
102030594|NCT02342002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102030595|NCT02342002|Luteolytic Agents|luteolytic agents|mesh-ancestor
102030596|NCT02342002|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102030597|NCT02342002|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102030598|NCT03657264|Moxifloxacin|moxifloxacin|mesh-list
102030599|NCT03657264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101750354|NCT00709488|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102030600|NCT03657264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102030601|NCT03657264|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102030602|NCT03657264|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102030603|NCT03657264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102030604|NCT03657264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030605|NCT03657264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102030606|NCT02345902|Haloperidol|haloperidol|mesh-list
102030607|NCT02345902|Haloperidol decanoate|haloperidol decanoate|mesh-list
102030608|NCT02345902|Antiemetics|antiemetics|mesh-ancestor
102030609|NCT02345902|Autonomic Agents|autonomic agents|mesh-ancestor
102030610|NCT02345902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102030611|NCT02345902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030612|NCT02345902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102030613|NCT02345902|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102030614|NCT02345902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102030615|NCT02345902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102030616|NCT02345902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101952181|NCT03297398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101952182|NCT03297398|Anabolic Agents|anabolic agents|mesh-ancestor
101952183|NCT03293654|Bevacizumab|bevacizumab|mesh-list
101952184|NCT03293654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101952185|NCT03293654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101952186|NCT03293654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101952187|NCT03293654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101952188|NCT03293654|Growth Substances|growth substances|mesh-ancestor
101952189|NCT03293654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952190|NCT03293654|Growth Inhibitors|growth inhibitors|mesh-ancestor
101952191|NCT03930615|Letermovir|letermovir|mesh-list
101952192|NCT03930615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101952193|NCT03930615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101952194|NCT03930615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952195|NCT03930615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101952196|NCT03930615|Antiviral Agents|antiviral agents|mesh-ancestor
101952197|NCT03930615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101952198|NCT03838029|Etodolac|etodolac|mesh-list
101952199|NCT03838029|Propranolol|propranolol|mesh-list
101952200|NCT03838029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101952201|NCT03838029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101952202|NCT03838029|Adrenergic Agents|adrenergic agents|mesh-ancestor
101952203|NCT03838029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101952204|NCT03838029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952205|NCT03838029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952206|NCT03838029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101952207|NCT03838029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101952208|NCT03838029|Vasodilator Agents|vasodilator agents|mesh-ancestor
101952209|NCT03838029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101952210|NCT03838029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101952222|NCT04708340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952223|NCT04708340|Protective Agents|protective agents|mesh-ancestor
101952224|NCT04708340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952225|NCT03292640|Nicotinic Acids|nicotinic acids|mesh-list
101952226|NCT03292640|Tazarotene|tazarotene|mesh-list
101952227|NCT03292640|Dermatologic Agents|dermatologic agents|mesh-ancestor
101952228|NCT03292640|Keratolytic Agents|keratolytic agents|mesh-ancestor
101952229|NCT03292640|Vitamin B Complex|vitamin b complex|mesh-ancestor
101952230|NCT03292640|Vitamins|vitamins|mesh-ancestor
101952231|NCT03292640|Micronutrients|micronutrients|mesh-ancestor
101952232|NCT03292640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952233|NCT01567215|Ethanol|ethanol|mesh-list
101952234|NCT01567215|Silver Nitrate|silver nitrate|mesh-list
101952235|NCT01567215|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101952236|NCT01567215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101952237|NCT01567215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101952238|NCT01567215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952239|NCT02871141|Antidepressive Agents|antidepressive agents|mesh-list
101952240|NCT02871141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102030617|NCT02345902|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102030618|NCT02345902|Dopamine Agents|dopamine agents|mesh-ancestor
102030619|NCT02345902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102030620|NCT02345902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030621|NCT02345902|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102030622|NCT03601806|Thalidomide|thalidomide|mesh-list
102030623|NCT03601806|Pomalidomide|pomalidomide|mesh-list
102030624|NCT03601806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102030625|NCT03601806|Immunologic Factors|immunologic factors|mesh-ancestor
102030626|NCT03601806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030627|NCT03601806|Leprostatic Agents|leprostatic agents|mesh-ancestor
102030631|NCT03601806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102030632|NCT03601806|Growth Substances|growth substances|mesh-ancestor
102030633|NCT03601806|Growth Inhibitors|growth inhibitors|mesh-ancestor
102030634|NCT03601806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102030635|NCT02345980|Sildenafil Citrate|sildenafil citrate|mesh-list
102030636|NCT02345980|Vasodilator Agents|vasodilator agents|mesh-ancestor
102030637|NCT02345980|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102030638|NCT02345980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102030639|NCT02345980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102030640|NCT02345980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030641|NCT02345980|Urological Agents|urological agents|mesh-ancestor
102030642|NCT02345746|Leucovorin|leucovorin|mesh-list
102030643|NCT02345746|Folic Acid|folic acid|mesh-list
102030644|NCT02345746|Fluorouracil|fluorouracil|mesh-list
102030645|NCT02345746|Oxaliplatin|oxaliplatin|mesh-list
102030646|NCT02345746|Levoleucovorin|levoleucovorin|mesh-list
102030647|NCT02345746|Antimetabolites|antimetabolites|mesh-ancestor
102030648|NCT02345746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030649|NCT02345746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102030650|NCT02345746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102030651|NCT02345746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102030652|NCT02345746|Immunologic Factors|immunologic factors|mesh-ancestor
102030653|NCT02345746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030654|NCT02345746|Antidotes|antidotes|mesh-ancestor
102030655|NCT02345746|Protective Agents|protective agents|mesh-ancestor
102030656|NCT02345746|Vitamin B Complex|vitamin b complex|mesh-ancestor
102030657|NCT02345746|Vitamins|vitamins|mesh-ancestor
102030658|NCT02345746|Micronutrients|micronutrients|mesh-ancestor
102030659|NCT02345746|Hematinics|hematinics|mesh-ancestor
101952241|NCT01202487|Lidocaine|lidocaine|mesh-list
101952242|NCT01202487|Epinephrine|epinephrine|mesh-list
101952243|NCT01202487|Tetracaine|tetracaine|mesh-list
101952244|NCT01202487|Anesthetics, Local|anesthetics, local|mesh-ancestor
101952245|NCT01202487|Anesthetics|anesthetics|mesh-ancestor
101952246|NCT01202487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101952247|NCT01202487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952248|NCT01202487|Sensory System Agents|sensory system agents|mesh-ancestor
101526313|NCT00543686|Dermatologic Agents|dermatologic agents|mesh-ancestor
101952249|NCT01202487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101952250|NCT01202487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101952251|NCT01202487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101952252|NCT01202487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101952253|NCT01202487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101952254|NCT01202487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952255|NCT01202487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101952256|NCT01202487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101952257|NCT01202487|Adrenergic Agents|adrenergic agents|mesh-ancestor
101952258|NCT01202487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101952259|NCT01202487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101952260|NCT01202487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101952261|NCT01202487|Autonomic Agents|autonomic agents|mesh-ancestor
101952262|NCT01202487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101952263|NCT01202487|Respiratory System Agents|respiratory system agents|mesh-ancestor
101952264|NCT01202487|Mydriatics|mydriatics|mesh-ancestor
101952265|NCT01202487|Sympathomimetics|sympathomimetics|mesh-ancestor
101952266|NCT01202487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101952267|NCT01204437|Paclitaxel|paclitaxel|mesh-list
101952268|NCT01204437|Cyclophosphamide|cyclophosphamide|mesh-list
101952269|NCT01204437|Capecitabine|capecitabine|mesh-list
101952270|NCT01204437|Methotrexate|methotrexate|mesh-list
101952271|NCT01204437|Epirubicin|epirubicin|mesh-list
101952272|NCT01204437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102030660|NCT03794778|Paclitaxel|paclitaxel|mesh-list
102030661|NCT03794778|Carboplatin|carboplatin|mesh-list
102030662|NCT03794778|Doxorubicin|doxorubicin|mesh-list
102030663|NCT03794778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102030664|NCT03794778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102030665|NCT03794778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102030666|NCT03794778|Tubulin Modulators|tubulin modulators|mesh-ancestor
102030667|NCT03794778|Antimitotic Agents|antimitotic agents|mesh-ancestor
102030668|NCT03794778|Mitosis Modulators|mitosis modulators|mesh-ancestor
102030669|NCT03794778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030670|NCT03794778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102030671|NCT03794778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102030672|NCT03794778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102030673|NCT03794778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101952273|NCT01204437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101952274|NCT01204437|Tubulin Modulators|tubulin modulators|mesh-ancestor
101952275|NCT01204437|Antimitotic Agents|antimitotic agents|mesh-ancestor
101952276|NCT01204437|Mitosis Modulators|mitosis modulators|mesh-ancestor
101952277|NCT01204437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952278|NCT01204437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101952279|NCT01204437|Immunologic Factors|immunologic factors|mesh-ancestor
101952280|NCT01204437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952281|NCT01204437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101952282|NCT01204437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102030674|NCT02341300|Iron|iron|mesh-list
102030675|NCT02341300|Trace Elements|trace elements|mesh-ancestor
102030676|NCT02341300|Micronutrients|micronutrients|mesh-ancestor
102030677|NCT02341300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030678|NCT05462496|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102030680|NCT05462496|Ciprofloxacin|ciprofloxacin|mesh-list
102030681|NCT05462496|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102030682|NCT05462496|Pembrolizumab|pembrolizumab|mesh-list
102030683|NCT05462496|Folfirinox|folfirinox|mesh-list
102030684|NCT05462496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102030685|NCT05462496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102030686|NCT05462496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102030687|NCT05462496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030688|NCT05462496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102030689|NCT05462496|Antitubercular Agents|antitubercular agents|mesh-ancestor
102030690|NCT05462496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102030691|NCT05462496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102030692|NCT05462496|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102030693|NCT05462496|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102030694|NCT05462496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102030695|NCT05462496|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102030696|NCT05462496|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102030697|NCT03785340|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102030698|NCT03785340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102030699|NCT03785340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102030700|NCT03785340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102030701|NCT03785340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102030702|NCT03785340|Adrenergic Agents|adrenergic agents|mesh-ancestor
102030704|NCT03785340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030705|NCT03785340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030707|NCT02345590|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102030708|NCT02345590|Hormone Antagonists|hormone antagonists|mesh-ancestor
102030709|NCT02345590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102030710|NCT02345590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030711|NCT02345590|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102030712|NCT02345590|Diuretics|diuretics|mesh-ancestor
102030713|NCT02345590|Natriuretic Agents|natriuretic agents|mesh-ancestor
102030714|NCT02345590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102030715|NCT03723083|Thalidomide|thalidomide|mesh-list
102030716|NCT03723083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102030717|NCT03723083|Immunologic Factors|immunologic factors|mesh-ancestor
102030718|NCT03723083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030719|NCT03723083|Leprostatic Agents|leprostatic agents|mesh-ancestor
102030720|NCT03723083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102030721|NCT03723083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102030722|NCT03723083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102030723|NCT03723083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102030724|NCT03723083|Growth Substances|growth substances|mesh-ancestor
102030725|NCT03723083|Growth Inhibitors|growth inhibitors|mesh-ancestor
102030726|NCT03723083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102030727|NCT03562481|Lidocaine|lidocaine|mesh-list
102030728|NCT03562481|Epinephrine|epinephrine|mesh-list
102030729|NCT03562481|Racepinephrine|racepinephrine|mesh-list
102030730|NCT03562481|Epinephryl borate|epinephryl borate|mesh-list
101952284|NCT01204437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101952285|NCT01204437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101952286|NCT01204437|Antimetabolites|antimetabolites|mesh-ancestor
101952287|NCT01204437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101952288|NCT01204437|Abortifacient Agents|abortifacient agents|mesh-ancestor
101952289|NCT01204437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101952290|NCT01204437|Dermatologic Agents|dermatologic agents|mesh-ancestor
101952291|NCT01204437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101952292|NCT01204437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101952293|NCT01204437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101952294|NCT01204437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101952295|NCT01204437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101952296|NCT01204437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101952297|NCT02633241|Dexmedetomidine|dexmedetomidine|mesh-list
101952298|NCT02633241|Propofol|propofol|mesh-list
101952299|NCT02633241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101952300|NCT02633241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101952301|NCT02633241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952302|NCT02633241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101952303|NCT02633241|Analgesics|analgesics|mesh-ancestor
101952304|NCT02633241|Sensory System Agents|sensory system agents|mesh-ancestor
101952305|NCT02633241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101952306|NCT02633241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101952307|NCT02633241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101952308|NCT02633241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101952309|NCT02633241|Adrenergic Agents|adrenergic agents|mesh-ancestor
101952310|NCT02633241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101952329|NCT01206075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101952330|NCT01206075|Antiviral Agents|antiviral agents|mesh-ancestor
101952331|NCT01206075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101952332|NCT03289676|Nicotine|nicotine|mesh-list
101952333|NCT03289676|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101952334|NCT03289676|Autonomic Agents|autonomic agents|mesh-ancestor
101952335|NCT03289676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101952336|NCT03289676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952337|NCT03289676|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101952338|NCT03289676|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101952339|NCT03289676|Cholinergic Agents|cholinergic agents|mesh-ancestor
101952340|NCT03289676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101952341|NCT03289676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952342|NCT03834831|Selenium|selenium|mesh-list
101952343|NCT03834831|Ubiquinone|ubiquinone|mesh-list
101952344|NCT03834831|Coenzyme Q10|coenzyme q10|mesh-list
101952345|NCT03834831|Antioxidants|antioxidants|mesh-ancestor
101952346|NCT03834831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952347|NCT03834831|Protective Agents|protective agents|mesh-ancestor
101952348|NCT03834831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952349|NCT03834831|Trace Elements|trace elements|mesh-ancestor
101952350|NCT03834831|Micronutrients|micronutrients|mesh-ancestor
101952351|NCT03834831|Vitamins|vitamins|mesh-ancestor
101952352|NCT01206153|Metformin|metformin|mesh-list
101952353|NCT01206153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101952354|NCT01206153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952355|NCT01298271|Propranolol|propranolol|mesh-list
101952356|NCT01298271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101952357|NCT01298271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101952358|NCT01298271|Adrenergic Agents|adrenergic agents|mesh-ancestor
101952359|NCT01298271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101952360|NCT01298271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952361|NCT01298271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952362|NCT01298271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101952363|NCT01298271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101952364|NCT01298271|Vasodilator Agents|vasodilator agents|mesh-ancestor
101952365|NCT05281965|Tretinoin|tretinoin|mesh-list
101293209|NCT01967927|Imidazole|imidazole|mesh-list
102030731|NCT03562481|Anesthetics, Local|anesthetics, local|mesh-ancestor
102030732|NCT03562481|Anesthetics|anesthetics|mesh-ancestor
102030733|NCT03562481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101952366|NCT05281965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101952367|NCT05281965|Keratolytic Agents|keratolytic agents|mesh-ancestor
101952368|NCT05281965|Dermatologic Agents|dermatologic agents|mesh-ancestor
101952369|NCT04251884|Ropivacaine|ropivacaine|mesh-list
101952370|NCT04251884|Anesthetics, Local|anesthetics, local|mesh-list
101952371|NCT04251884|Anesthetics|anesthetics|mesh-list
101952372|NCT04251884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101952373|NCT04251884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952374|NCT04251884|Sensory System Agents|sensory system agents|mesh-ancestor
101952375|NCT04251884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101672249|NCT03742414|Xhance|xhance|mesh-list
101952376|NCT01202799|Diclofenac|diclofenac|mesh-list
101952377|NCT01202799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101952378|NCT01202799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101952379|NCT01202799|Analgesics|analgesics|mesh-ancestor
101952380|NCT01202799|Sensory System Agents|sensory system agents|mesh-ancestor
101952381|NCT01202799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101952382|NCT01202799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952383|NCT01202799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101952384|NCT01202799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101952385|NCT01202799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101952386|NCT01202799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101293249|NCT01968005|Analgesics|analgesics|mesh-ancestor
102030734|NCT03562481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030735|NCT03562481|Sensory System Agents|sensory system agents|mesh-ancestor
102030736|NCT03562481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102030737|NCT03562481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102030738|NCT03562481|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102030739|NCT03562481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102030740|NCT03562481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102030741|NCT03562481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030742|NCT03562481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102030743|NCT03562481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102030744|NCT03562481|Adrenergic Agents|adrenergic agents|mesh-ancestor
102030745|NCT03562481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102030746|NCT03562481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102030747|NCT03562481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102030748|NCT03562481|Autonomic Agents|autonomic agents|mesh-ancestor
102030749|NCT03562481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102030750|NCT03562481|Respiratory System Agents|respiratory system agents|mesh-ancestor
102030751|NCT03562481|Mydriatics|mydriatics|mesh-ancestor
102030752|NCT03562481|Sympathomimetics|sympathomimetics|mesh-ancestor
102030753|NCT03562481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102030755|NCT03726593|Mefloquine|mefloquine|mesh-list
102030756|NCT03726593|Atovaquone|atovaquone|mesh-list
102030757|NCT03726593|Pyronaridine|pyronaridine|mesh-list
102030758|NCT03726593|Proguanil|proguanil|mesh-list
102030759|NCT03726593|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
102030760|NCT03726593|Antimalarials|antimalarials|mesh-ancestor
102030761|NCT03726593|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102030762|NCT03726593|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102030763|NCT03726593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102030764|NCT03726593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102030765|NCT03726593|Antiviral Agents|antiviral agents|mesh-ancestor
102030766|NCT03726593|Schistosomicides|schistosomicides|mesh-ancestor
101952387|NCT01202799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952388|NCT03829605|Hydrogen Sulfide|hydrogen sulfide|mesh-list
101952389|NCT03829605|Gasotransmitters|gasotransmitters|mesh-ancestor
101952390|NCT03829605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102030767|NCT03726593|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102030768|NCT03726593|Anthelmintics|anthelmintics|mesh-ancestor
102030769|NCT03726593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102030770|NCT03726593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030771|NCT03726593|Antimetabolites|antimetabolites|mesh-ancestor
102030772|NCT03197064|Fosaprepitant|fosaprepitant|mesh-list
102030773|NCT03197064|Aprepitant|aprepitant|mesh-list
102030774|NCT03197064|Antiemetics|antiemetics|mesh-ancestor
102030775|NCT03197064|Autonomic Agents|autonomic agents|mesh-ancestor
102030776|NCT03197064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102030777|NCT03197064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030778|NCT03197064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102030782|NCT02345044|Eplerenone|eplerenone|mesh-list
102030783|NCT02345044|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102030784|NCT02345044|Hormone Antagonists|hormone antagonists|mesh-ancestor
102030785|NCT02345044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102030786|NCT02345044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030787|NCT02345044|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102030788|NCT02345044|Diuretics|diuretics|mesh-ancestor
102030789|NCT02345044|Natriuretic Agents|natriuretic agents|mesh-ancestor
102030790|NCT02345044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102030791|NCT02349802|Exenatide|exenatide|mesh-list
102030792|NCT02349802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102030793|NCT02349802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030794|NCT02349802|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102030795|NCT02349802|Incretins|incretins|mesh-ancestor
102030796|NCT02349802|Hormones|hormones|mesh-ancestor
102030797|NCT02349802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102030798|NCT03145714|Dexmedetomidine|dexmedetomidine|mesh-list
102030799|NCT03145714|Anesthetics|anesthetics|mesh-list
102030800|NCT03145714|Propofol|propofol|mesh-list
102030801|NCT03145714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102030802|NCT03145714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030803|NCT03145714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102030804|NCT03145714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102030805|NCT03145714|Analgesics|analgesics|mesh-ancestor
102030806|NCT03145714|Sensory System Agents|sensory system agents|mesh-ancestor
102030807|NCT03145714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102030808|NCT03145714|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102030809|NCT03145714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102030810|NCT03145714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102030811|NCT03145714|Adrenergic Agents|adrenergic agents|mesh-ancestor
102030812|NCT03145714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102030813|NCT03145714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030814|NCT03145714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102030815|NCT03145714|Anesthetics, General|anesthetics, general|mesh-ancestor
102030816|NCT02349958|Doxorubicin|doxorubicin|mesh-list
102030817|NCT02349958|Cisplatin|cisplatin|mesh-list
101526437|NCT00544349|Calcium|calcium|mesh-list
102030818|NCT02349958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102030819|NCT02349958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102030820|NCT02349958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102030821|NCT02349958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102030822|NCT02349958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102030823|NCT02349958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030824|NCT04872426|Insulin|insulin|mesh-list
101750585|NCT05809609|Anesthetics|anesthetics|mesh-ancestor
102030825|NCT04872426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102030826|NCT04872426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030827|NCT02344888|Folic Acid|folic acid|mesh-list
102030828|NCT02344888|Vitamin B Complex|vitamin b complex|mesh-list
102030829|NCT02344888|Prednisolone|prednisolone|mesh-list
102030830|NCT02344888|Citric Acid|citric acid|mesh-list
102030831|NCT02344888|Sodium Citrate|sodium citrate|mesh-list
102030833|NCT02344888|Enclomiphene|enclomiphene|mesh-list
102030834|NCT02344888|Zuclomiphene|zuclomiphene|mesh-list
102030835|NCT02344888|Anticoagulants|anticoagulants|mesh-ancestor
102030836|NCT02344888|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102030837|NCT02344888|Chelating Agents|chelating agents|mesh-ancestor
102030838|NCT02344888|Sequestering Agents|sequestering agents|mesh-ancestor
101952391|NCT03829605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952392|NCT03829605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952393|NCT01298505|Fexofenadine|fexofenadine|mesh-list
102030839|NCT02344888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030840|NCT02344888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102030841|NCT02344888|Glucocorticoids|glucocorticoids|mesh-ancestor
102030842|NCT02344888|Hormones|hormones|mesh-ancestor
102030843|NCT02344888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102030844|NCT02344888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030845|NCT02344888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102030846|NCT02344888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102030847|NCT02344888|Hematinics|hematinics|mesh-ancestor
102030848|NCT02344888|Vitamins|vitamins|mesh-ancestor
102030849|NCT02344888|Micronutrients|micronutrients|mesh-ancestor
102030850|NCT02344888|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102030851|NCT02344888|Hormone Antagonists|hormone antagonists|mesh-ancestor
102030867|NCT03146104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102030868|NCT03146104|Anesthetics, General|anesthetics, general|mesh-ancestor
102030869|NCT03146104|Anesthetics|anesthetics|mesh-ancestor
102030870|NCT03146104|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102030871|NCT03497039|Diclofenac|diclofenac|mesh-list
102030872|NCT03497039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102030873|NCT03497039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102030874|NCT03497039|Analgesics|analgesics|mesh-ancestor
102030875|NCT03497039|Sensory System Agents|sensory system agents|mesh-ancestor
102030876|NCT03497039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102030877|NCT03497039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030878|NCT03497039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102030879|NCT03497039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102030880|NCT03497039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102030881|NCT03497039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102030882|NCT03497039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030883|NCT02340910|Oxymetazoline|oxymetazoline|mesh-list
102030884|NCT02340910|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102030885|NCT02340910|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102030886|NCT02340910|Adrenergic Agents|adrenergic agents|mesh-ancestor
102030887|NCT02340910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102030888|NCT02340910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030889|NCT02340910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030890|NCT02340910|Sympathomimetics|sympathomimetics|mesh-ancestor
102030891|NCT02340910|Autonomic Agents|autonomic agents|mesh-ancestor
102030892|NCT02340910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102030893|NCT02340910|Nasal Decongestants|nasal decongestants|mesh-ancestor
102030894|NCT02340910|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102030895|NCT02340910|Respiratory System Agents|respiratory system agents|mesh-ancestor
102030896|NCT02349490|Hemostatics|hemostatics|mesh-list
102030897|NCT02349490|Coagulants|coagulants|mesh-ancestor
102030898|NCT03720899|Nicotine|nicotine|mesh-list
102030899|NCT03720899|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102030900|NCT03720899|Autonomic Agents|autonomic agents|mesh-ancestor
102030901|NCT03720899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102030902|NCT03720899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030903|NCT03720899|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101750705|NCT05696938|Niacin|niacin|mesh-list
102030904|NCT03720899|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102030905|NCT03720899|Cholinergic Agents|cholinergic agents|mesh-ancestor
102030906|NCT03720899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102030907|NCT03720899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030908|NCT02340988|Oritavancin|oritavancin|mesh-list
102030909|NCT02340988|Warfarin|warfarin|mesh-list
102030910|NCT02340988|Anticoagulants|anticoagulants|mesh-ancestor
102030925|NCT05665283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030927|NCT03071094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102030928|NCT03071094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102030929|NCT03071094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102030930|NCT03071094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030931|NCT03148990|Vaccines|vaccines|mesh-list
102030932|NCT03148990|Immunologic Factors|immunologic factors|mesh-ancestor
102030933|NCT03148990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030934|NCT04477642|Abatacept|abatacept|mesh-list
102030935|NCT04477642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101952395|NCT01298505|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101952396|NCT01298505|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101952397|NCT01298505|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102030936|NCT04477642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030937|NCT04477642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102030938|NCT04477642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102030939|NCT04477642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102030940|NCT04477642|Immunologic Factors|immunologic factors|mesh-ancestor
102030941|NCT04477642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030942|NCT04477642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102030943|NCT02344732|Polymyxins|polymyxins|mesh-list
102030944|NCT02344732|Neomycin|neomycin|mesh-list
102030945|NCT02344732|Polymyxin B|polymyxin b|mesh-list
102030946|NCT02344732|Dexamethasone|dexamethasone|mesh-list
102030947|NCT02344732|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102030948|NCT02344732|Homatropine|homatropine|mesh-list
102030949|NCT02344732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102030950|NCT02344732|Antiemetics|antiemetics|mesh-ancestor
102030951|NCT02344732|Autonomic Agents|autonomic agents|mesh-ancestor
102030952|NCT02344732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102030953|NCT02344732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030954|NCT02344732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102030955|NCT02344732|Glucocorticoids|glucocorticoids|mesh-ancestor
102030956|NCT02344732|Hormones|hormones|mesh-ancestor
102030957|NCT02344732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102030958|NCT02344732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102030959|NCT02344732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102030960|NCT02344732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102030961|NCT02344732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102030962|NCT02344732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102030963|NCT02344732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102030964|NCT02344732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102030965|NCT02344732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030966|NCT02344732|Parasympatholytics|parasympatholytics|mesh-ancestor
102030967|NCT03720665|Caffeine|caffeine|mesh-list
102030968|NCT03720665|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102030969|NCT03720665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030972|NCT03720665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030973|NCT03720665|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102030974|NCT03720665|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102030975|NCT03720665|Purinergic Agents|purinergic agents|mesh-ancestor
101526450|NCT00544349|Vitamins|vitamins|mesh-ancestor
102030976|NCT03720665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101750734|NCT05695508|Growth Substances|growth substances|mesh-ancestor
102030977|NCT03726281|Nivolumab|nivolumab|mesh-list
102030978|NCT03726281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102030979|NCT03726281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102030980|NCT03726281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102030981|NCT03726281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030982|NCT02344264|Ropivacaine|ropivacaine|mesh-list
102030983|NCT02344264|Anesthetics, Local|anesthetics, local|mesh-ancestor
102030984|NCT02344264|Anesthetics|anesthetics|mesh-ancestor
102030985|NCT02344264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102030986|NCT02344264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030987|NCT02344264|Sensory System Agents|sensory system agents|mesh-ancestor
102030988|NCT02344264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102030989|NCT02344030|Pyrithione zinc|pyrithione zinc|mesh-list
102030990|NCT02344030|Keratolytic Agents|keratolytic agents|mesh-ancestor
102030991|NCT02344030|Dermatologic Agents|dermatologic agents|mesh-ancestor
102030992|NCT02339662|Gabapentin|gabapentin|mesh-list
102030993|NCT02339662|Amitriptyline|amitriptyline|mesh-list
102030994|NCT02339662|Analgesics|analgesics|mesh-ancestor
102030995|NCT02339662|Sensory System Agents|sensory system agents|mesh-ancestor
102030996|NCT02339662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102030997|NCT02339662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030998|NCT02339662|Anticonvulsants|anticonvulsants|mesh-ancestor
102030999|NCT02339662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102031000|NCT02339662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102031001|NCT02339662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102031002|NCT02339662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102031003|NCT02339662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101952398|NCT01298505|Histamine Antagonists|histamine antagonists|mesh-ancestor
101952399|NCT01298505|Histamine Agents|histamine agents|mesh-ancestor
101952400|NCT01298505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101952401|NCT01298505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031004|NCT02339662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102031005|NCT02339662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102031006|NCT02339662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031007|NCT02339662|Antimanic Agents|antimanic agents|mesh-ancestor
102031008|NCT02339662|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102031009|NCT02339662|Antidepressive Agents|antidepressive agents|mesh-ancestor
102031010|NCT02339662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102031011|NCT02339662|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102031012|NCT02339662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102031013|NCT02339662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102031014|NCT02339662|Adrenergic Agents|adrenergic agents|mesh-ancestor
102031016|NCT02343718|Temsirolimus|temsirolimus|mesh-list
102031017|NCT02343718|MTOR Inhibitors|mtor inhibitors|mesh-list
102031018|NCT02343718|Vinblastine|vinblastine|mesh-list
102031019|NCT02343718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102031020|NCT02343718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102031021|NCT02343718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031022|NCT02343718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102031023|NCT02343718|Immunologic Factors|immunologic factors|mesh-ancestor
102031024|NCT02343718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031025|NCT02343718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102031026|NCT02343718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102031027|NCT02343718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102031028|NCT02343718|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102031029|NCT02343718|Antifungal Agents|antifungal agents|mesh-ancestor
102031030|NCT02343718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102031031|NCT02343718|Tubulin Modulators|tubulin modulators|mesh-ancestor
102031032|NCT02343718|Antimitotic Agents|antimitotic agents|mesh-ancestor
102031033|NCT02343718|Mitosis Modulators|mitosis modulators|mesh-ancestor
102031034|NCT03148522|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102031035|NCT03148522|Mirtazapine|mirtazapine|mesh-list
102031036|NCT03148522|Escitalopram|escitalopram|mesh-list
102031037|NCT03148522|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102031038|NCT03148522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102031039|NCT03148522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102031040|NCT03148522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031044|NCT03148522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102031045|NCT03148522|Antidepressive Agents|antidepressive agents|mesh-ancestor
102031047|NCT03148522|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102031048|NCT03148522|Analgesics|analgesics|mesh-ancestor
102031049|NCT03148522|Sensory System Agents|sensory system agents|mesh-ancestor
102031050|NCT03148522|Dopamine Agents|dopamine agents|mesh-ancestor
102031051|NCT03148522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102031052|NCT03148522|Histamine Antagonists|histamine antagonists|mesh-ancestor
102031053|NCT03148522|Histamine Agents|histamine agents|mesh-ancestor
102031054|NCT03148522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102031055|NCT03148522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102031056|NCT03148522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102031057|NCT03148522|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102031058|NCT03148522|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102031059|NCT03148522|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102031060|NCT03148522|Adrenergic Agents|adrenergic agents|mesh-ancestor
102031061|NCT03148522|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102031062|NCT03148522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102031063|NCT03148522|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102031064|NCT03148444|Cephalexin|cephalexin|mesh-list
102031065|NCT03148444|Roxithromycin|roxithromycin|mesh-list
102031066|NCT03148444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102031067|NCT03148444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102031068|NCT03148132|Bevacizumab|bevacizumab|mesh-list
102031069|NCT03148132|Ranibizumab|ranibizumab|mesh-list
102031070|NCT03148132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102031071|NCT03148132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102031072|NCT03148132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101952402|NCT01298505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293580|NCT01970059|Antioxidants|antioxidants|mesh-ancestor
102031073|NCT03148132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102031074|NCT03148132|Growth Substances|growth substances|mesh-ancestor
102031075|NCT03148132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031076|NCT03148132|Growth Inhibitors|growth inhibitors|mesh-ancestor
102031077|NCT02339350|Methotrexate|methotrexate|mesh-list
102031078|NCT02339350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102031079|NCT02339350|Abortifacient Agents|abortifacient agents|mesh-ancestor
102031080|NCT02339350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102031081|NCT02339350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031082|NCT02339350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102031083|NCT02339350|Antimetabolites|antimetabolites|mesh-ancestor
102031084|NCT02339350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031085|NCT02339350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102031086|NCT02339350|Dermatologic Agents|dermatologic agents|mesh-ancestor
102031087|NCT02339350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102031088|NCT02339350|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102031089|NCT02339350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102031090|NCT02339350|Immunologic Factors|immunologic factors|mesh-ancestor
102031091|NCT02339350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102031092|NCT02339350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102031093|NCT05166304|Rebamipide|rebamipide|mesh-list
102031094|NCT05166304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102031095|NCT05166304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102031096|NCT05166304|Antioxidants|antioxidants|mesh-ancestor
102031097|NCT05166304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031098|NCT05166304|Protective Agents|protective agents|mesh-ancestor
102031099|NCT05166304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031100|NCT05166304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102031101|NCT02339428|Diclofenac|diclofenac|mesh-list
102031102|NCT02339428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102031103|NCT02339428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102031104|NCT02339428|Analgesics|analgesics|mesh-ancestor
102031105|NCT02339428|Sensory System Agents|sensory system agents|mesh-ancestor
102031106|NCT02339428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102031107|NCT02339428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031108|NCT02339428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102031109|NCT02339428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102031110|NCT02339428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102031111|NCT02339428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102031113|NCT02337322|Ritonavir|ritonavir|mesh-list
102031114|NCT02337322|Darunavir|darunavir|mesh-list
102031115|NCT02337322|Dolutegravir|dolutegravir|mesh-list
102031116|NCT02337322|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102031117|NCT02337322|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102031118|NCT02337322|Protease Inhibitors|protease inhibitors|mesh-ancestor
102031119|NCT02337322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102031120|NCT02337322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031121|NCT02337322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102031122|NCT02337322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102031123|NCT02337322|Antiviral Agents|antiviral agents|mesh-ancestor
102031124|NCT02337322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102031125|NCT02337322|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102031126|NCT02337322|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102031127|NCT02337322|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102031128|NCT02337322|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102031129|NCT02337166|Hyaluronic Acid|hyaluronic acid|mesh-list
102031130|NCT02337166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102031131|NCT02337166|Immunologic Factors|immunologic factors|mesh-ancestor
102031132|NCT02337166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031133|NCT02337166|Viscosupplements|viscosupplements|mesh-ancestor
102031134|NCT02337166|Protective Agents|protective agents|mesh-ancestor
102031135|NCT03148288|Vitamin D|vitamin d|mesh-list
102031136|NCT03148288|Vitamins|vitamins|mesh-ancestor
102031137|NCT03148288|Micronutrients|micronutrients|mesh-ancestor
102031138|NCT03148288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031139|NCT03148288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102031140|NCT02039362|Tenofovir|tenofovir|mesh-list
102031141|NCT02039362|Antiviral Agents|antiviral agents|mesh-ancestor
102031142|NCT02039362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102031143|NCT02039362|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102031144|NCT02039362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101952404|NCT01204593|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101952405|NCT01204593|Insulin Glargine|insulin glargine|mesh-list
101952406|NCT01204593|Insulin glulisine|insulin glulisine|mesh-list
101526481|NCT00544700|Bevacizumab|bevacizumab|mesh-list
102031145|NCT02039362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102031146|NCT02039362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031147|NCT02039362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102031148|NCT02039362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102031149|NCT02339116|Bevacizumab|bevacizumab|mesh-list
102031150|NCT02339116|Oxaliplatin|oxaliplatin|mesh-list
102031151|NCT02339116|Irinotecan|irinotecan|mesh-list
102031152|NCT02339116|Fluorouracil|fluorouracil|mesh-list
102031153|NCT02339116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102031154|NCT02339116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102031155|NCT02339116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102031156|NCT02339116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102031157|NCT02339116|Growth Substances|growth substances|mesh-ancestor
102031158|NCT02339116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031159|NCT02339116|Growth Inhibitors|growth inhibitors|mesh-ancestor
102031160|NCT02339116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102031161|NCT02339116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102031162|NCT02339116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102031163|NCT02339116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031164|NCT02339116|Antimetabolites|antimetabolites|mesh-ancestor
102031165|NCT02339116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102031166|NCT02339116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102031167|NCT02339116|Immunologic Factors|immunologic factors|mesh-ancestor
102031168|NCT04824274|Fentanyl|fentanyl|mesh-list
102031169|NCT04824274|Morphine|morphine|mesh-list
102031170|NCT04824274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102031171|NCT04824274|Narcotics|narcotics|mesh-ancestor
102031172|NCT04824274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102031173|NCT04824274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031174|NCT04824274|Analgesics|analgesics|mesh-ancestor
102031175|NCT04824274|Sensory System Agents|sensory system agents|mesh-ancestor
102031176|NCT04824274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102031177|NCT04824274|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102031178|NCT04824274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102031179|NCT04824274|Anesthetics, General|anesthetics, general|mesh-ancestor
102031180|NCT04824274|Anesthetics|anesthetics|mesh-ancestor
102031181|NCT02509494|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
102031182|NCT02509494|Antiviral Agents|antiviral agents|mesh-ancestor
102031183|NCT02509494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102031184|NCT02348788|Chloroquine|chloroquine|mesh-list
102031185|NCT02348788|Lumefantrine|lumefantrine|mesh-list
102031186|NCT02348788|Artemether|artemether|mesh-list
102031187|NCT02348788|Primaquine|primaquine|mesh-list
102031194|NCT02348788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102031195|NCT02337010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
102031196|NCT02338570|Everolimus|everolimus|mesh-list
102031197|NCT02338570|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102031198|NCT02338570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102031199|NCT02338570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102031200|NCT02338570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031201|NCT02338570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102031202|NCT02338570|Immunologic Factors|immunologic factors|mesh-ancestor
102031203|NCT02338570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031204|NCT02338570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102031206|NCT02336854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102031207|NCT02336854|Immunologic Factors|immunologic factors|mesh-ancestor
102031208|NCT02336854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031209|NCT02336854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102031210|NCT02336854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102031211|NCT02336854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031212|NCT02338024|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101526519|NCT05823883|Metformin|metformin|mesh-list
102031213|NCT02338024|Antiviral Agents|antiviral agents|mesh-ancestor
102031214|NCT02338024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102031215|NCT02332174|Rufinamide|rufinamide|mesh-list
102031216|NCT02332174|Anticonvulsants|anticonvulsants|mesh-ancestor
102031217|NCT02332174|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102031218|NCT02332174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102031219|NCT02332174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102031220|NCT02332174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031221|NCT03493451|Tislelizumab|tislelizumab|mesh-list
101952407|NCT01204593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101952408|NCT01204593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952409|NCT03310970|Lidocaine|lidocaine|mesh-list
101952410|NCT03310970|Anesthetics, Local|anesthetics, local|mesh-ancestor
101952411|NCT03310970|Anesthetics|anesthetics|mesh-ancestor
101293724|NCT01971424|Magnesium Oxide|magnesium oxide|mesh-list
102031222|NCT03493451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102031223|NCT03493451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102031224|NCT03726125|Insulin|insulin|mesh-list
102031225|NCT03726125|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102031226|NCT03726125|Insulin, Long-Acting|insulin, long-acting|mesh-list
102031227|NCT03726125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102031228|NCT03726125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031229|NCT02336308|Ketamine|ketamine|mesh-list
102031230|NCT02336308|Analgesics|analgesics|mesh-ancestor
102031231|NCT02336308|Sensory System Agents|sensory system agents|mesh-ancestor
102031232|NCT02336308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102031233|NCT02336308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031234|NCT02336308|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102031235|NCT02336308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102031236|NCT02336308|Anesthetics, General|anesthetics, general|mesh-ancestor
102031237|NCT02336308|Anesthetics|anesthetics|mesh-ancestor
102031238|NCT02336308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102031239|NCT02336308|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102031240|NCT02336308|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102031241|NCT02336308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102031242|NCT02336308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031243|NCT02336386|Dexamethasone|dexamethasone|mesh-list
102031244|NCT02336386|Cyclophosphamide|cyclophosphamide|mesh-list
102031245|NCT02336386|Doxorubicin|doxorubicin|mesh-list
102031246|NCT02336386|Bortezomib|bortezomib|mesh-list
102031247|NCT02336386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102031248|NCT02336386|Immunologic Factors|immunologic factors|mesh-ancestor
102031249|NCT02336386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031250|NCT02336386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102031251|NCT02336386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102031252|NCT02336386|Alkylating Agents|alkylating agents|mesh-ancestor
102031253|NCT02336386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031254|NCT02336386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102031255|NCT02336386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102031256|NCT02336386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102031257|NCT02336386|Antiemetics|antiemetics|mesh-ancestor
102031260|NCT02336386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102031261|NCT02336386|Glucocorticoids|glucocorticoids|mesh-ancestor
102031262|NCT02336386|Hormones|hormones|mesh-ancestor
102031263|NCT02336386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102031264|NCT02336386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102031265|NCT02336386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102031266|NCT02336386|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102031267|NCT02336386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102031268|NCT02336386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102031269|NCT02337712|Etoposide|etoposide|mesh-list
102031270|NCT02337712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102031271|NCT02337712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102031272|NCT02337712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102031273|NCT02337712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102031274|NCT02337712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102031275|NCT02337712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751035|NCT05042687|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102031276|NCT03492281|Tolterodine Tartrate|tolterodine tartrate|mesh-list
102031277|NCT03492281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102031278|NCT03492281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102031279|NCT03492281|Cholinergic Agents|cholinergic agents|mesh-ancestor
102031280|NCT03492281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102031281|NCT03492281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031282|NCT03492281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031283|NCT03492281|Urological Agents|urological agents|mesh-ancestor
102031284|NCT02336152|Anesthetics|anesthetics|mesh-list
102031285|NCT02336152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101952412|NCT03310970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101952413|NCT03310970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952414|NCT03310970|Sensory System Agents|sensory system agents|mesh-ancestor
101952415|NCT03310970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101952416|NCT03310970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101952417|NCT03310970|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102031286|NCT02336152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031287|NCT02331862|Methylprednisolone|methylprednisolone|mesh-list
102031288|NCT02331862|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102031289|NCT02331862|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102031290|NCT02331862|Prednisolone|prednisolone|mesh-list
102031291|NCT02331862|Prednisolone acetate|prednisolone acetate|mesh-list
102031292|NCT02331862|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102031293|NCT02331862|Prednisolone phosphate|prednisolone phosphate|mesh-list
102031294|NCT02331862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102031295|NCT02331862|Antiemetics|antiemetics|mesh-ancestor
102031296|NCT02331862|Autonomic Agents|autonomic agents|mesh-ancestor
102031297|NCT02331862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102031298|NCT02331862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031299|NCT02331862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102031300|NCT02331862|Glucocorticoids|glucocorticoids|mesh-ancestor
102031301|NCT02331862|Hormones|hormones|mesh-ancestor
102031302|NCT02331862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102031303|NCT02331862|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102031304|NCT02331862|Protective Agents|protective agents|mesh-ancestor
101526546|NCT05823623|Vinorelbine|vinorelbine|mesh-list
102031305|NCT02331862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102031306|NCT02331862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102031307|NCT03525119|Vaccines|vaccines|mesh-list
102031308|NCT03525119|Immunologic Factors|immunologic factors|mesh-ancestor
102031309|NCT03525119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031310|NCT05230654|Fosaprepitant|fosaprepitant|mesh-list
102031311|NCT05230654|Aprepitant|aprepitant|mesh-list
102031312|NCT05230654|Antiemetics|antiemetics|mesh-ancestor
102031313|NCT05230654|Autonomic Agents|autonomic agents|mesh-ancestor
102031314|NCT05230654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102031315|NCT05230654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031316|NCT05230654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102031317|NCT05230654|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102031318|NCT05230654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102031319|NCT05230654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031320|NCT02039518|Gemcitabine|gemcitabine|mesh-list
102031321|NCT02039518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102031322|NCT02039518|Antimetabolites|antimetabolites|mesh-ancestor
102031323|NCT02039518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031324|NCT02039518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102031325|NCT03722381|Amlodipine|amlodipine|mesh-list
102031326|NCT03722381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102031327|NCT03722381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102031328|NCT03722381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102031334|NCT04352608|Immunologic Factors|immunologic factors|mesh-ancestor
102031335|NCT04352608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031336|NCT03722303|Cortisone|cortisone|mesh-list
102031337|NCT03722303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102031338|NCT03558503|Mitomycins|mitomycins|mesh-list
102031339|NCT03558503|Mitomycin|mitomycin|mesh-list
102031340|NCT03558503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102031341|NCT03558503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102031342|NCT03558503|Alkylating Agents|alkylating agents|mesh-ancestor
102031343|NCT03558503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031344|NCT03558503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102031345|NCT03558503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102031346|NCT02331706|Interferons|interferons|mesh-list
102031347|NCT02331706|Interferon-alpha|interferon-alpha|mesh-list
101751110|NCT04925648|Dasatinib|dasatinib|mesh-list
102031348|NCT02331706|Interferon alpha-2|interferon alpha-2|mesh-list
102031349|NCT02331706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102031350|NCT02331706|Antiviral Agents|antiviral agents|mesh-ancestor
102031351|NCT02331706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102031352|NCT02331706|Immunologic Factors|immunologic factors|mesh-ancestor
101952418|NCT03310970|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101952419|NCT03310970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101952420|NCT03310970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952421|NCT03427814|Pamiparib|pamiparib|mesh-list
101952422|NCT03427814|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102031353|NCT02331706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031355|NCT03489863|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102031356|NCT03489863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102031357|NCT03489863|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102031358|NCT03489863|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102031359|NCT03489863|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102031360|NCT03489863|Purinergic Agents|purinergic agents|mesh-ancestor
102031361|NCT03489863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102031362|NCT03489863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031363|NCT03489863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031364|NCT04344444|Azithromycin|azithromycin|mesh-list
102031365|NCT04344444|Hydroxychloroquine|hydroxychloroquine|mesh-list
102031366|NCT04344444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102031367|NCT04344444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102031368|NCT04344444|Antimalarials|antimalarials|mesh-ancestor
102031369|NCT04344444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102031370|NCT04344444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102031371|NCT04344444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102031372|NCT04344444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031373|NCT04344444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102031374|NCT03489551|Haloperidol|haloperidol|mesh-list
102031375|NCT03489551|Antiemetics|antiemetics|mesh-ancestor
102031376|NCT03489551|Autonomic Agents|autonomic agents|mesh-ancestor
102031377|NCT03489551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102031378|NCT03489551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031379|NCT03489551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102031380|NCT03489551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102031381|NCT03489551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102031382|NCT03489551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102031383|NCT03489551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102031384|NCT03489551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102031385|NCT03489551|Dopamine Agents|dopamine agents|mesh-ancestor
102031386|NCT03489551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102031387|NCT03489551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031388|NCT03489551|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102031389|NCT05762952|Dapagliflozin|dapagliflozin|mesh-list
102031390|NCT05762952|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102031391|NCT05762952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031392|NCT05762952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102031393|NCT05762952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031394|NCT02335684|Methamphetamine|methamphetamine|mesh-list
102031395|NCT02335684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102031396|NCT02335684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031397|NCT02335684|Sympathomimetics|sympathomimetics|mesh-ancestor
102031402|NCT02335684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031403|NCT02335684|Adrenergic Agents|adrenergic agents|mesh-ancestor
102031404|NCT02335684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102031405|NCT02335684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102031406|NCT02335684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102031407|NCT02335684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102031409|NCT05198388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102031410|NCT05198388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031411|NCT05198388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031412|NCT04210180|Varenicline|varenicline|mesh-list
102031413|NCT04210180|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102031414|NCT04210180|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102031415|NCT04210180|Cholinergic Agents|cholinergic agents|mesh-ancestor
102031416|NCT04210180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102031417|NCT04210180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031418|NCT04210180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031419|NCT03523715|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
101952423|NCT03427814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101952424|NCT03427814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952425|NCT03427814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101952426|NCT05281419|Triamcinolone|triamcinolone|mesh-list
101952427|NCT05281419|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101952428|NCT05281419|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101952429|NCT05281419|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101952430|NCT05281419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101952431|NCT05281419|Glucocorticoids|glucocorticoids|mesh-ancestor
101952433|NCT05281419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101952434|NCT05281419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952435|NCT05281419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101952436|NCT05281419|Immunologic Factors|immunologic factors|mesh-ancestor
101952437|NCT05281419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101952438|NCT05281419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952439|NCT04427072|Docetaxel|docetaxel|mesh-list
101952440|NCT04427072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101952441|NCT04427072|Tubulin Modulators|tubulin modulators|mesh-ancestor
101952442|NCT04427072|Antimitotic Agents|antimitotic agents|mesh-ancestor
101293946|NCT01973010|Ibuprofen|ibuprofen|mesh-list
102031420|NCT03523715|Antidiarrheals|antidiarrheals|mesh-ancestor
102031421|NCT03523715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102031422|NCT03523091|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101751183|NCT04690608|Hormones|hormones|mesh-ancestor
102031423|NCT03523091|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102031424|NCT03523091|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102031425|NCT03523091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102031426|NCT03523091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031427|NCT03523091|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102031428|NCT03523091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102031429|NCT03523091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031430|NCT03523091|Cholinergic Agents|cholinergic agents|mesh-ancestor
102031431|NCT03523091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102031432|NCT03105310|Interferons|interferons|mesh-list
102031433|NCT03105310|Interferon-alpha|interferon-alpha|mesh-list
102031434|NCT03105310|Ezetimibe|ezetimibe|mesh-list
102031435|NCT03105310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102031436|NCT03105310|Antiviral Agents|antiviral agents|mesh-ancestor
102031437|NCT03105310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102031438|NCT03105310|Immunologic Factors|immunologic factors|mesh-ancestor
102031439|NCT03105310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031440|NCT03105310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102031441|NCT03105310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102031442|NCT03105310|Antimetabolites|antimetabolites|mesh-ancestor
102031443|NCT03105310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031444|NCT03105310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102031445|NCT03144466|Pembrolizumab|pembrolizumab|mesh-list
102031446|NCT03144466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102031447|NCT03144466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102031448|NCT03144466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102031449|NCT03144466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031450|NCT03105466|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
102031451|NCT03105466|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101952443|NCT04427072|Mitosis Modulators|mitosis modulators|mesh-ancestor
101952444|NCT04427072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952445|NCT03537651|Ivacaftor|ivacaftor|mesh-list
102031452|NCT03105466|Tacrolimus|tacrolimus|mesh-list
102031453|NCT03105466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102031454|NCT03105466|Immunologic Factors|immunologic factors|mesh-ancestor
102031455|NCT03105466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031456|NCT03105466|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102031457|NCT03105466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102031458|NCT03105466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031459|NCT03105466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102031460|NCT03105466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102031461|NCT03105466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102031462|NCT03105466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102031463|NCT03105466|Glucocorticoids|glucocorticoids|mesh-ancestor
102031464|NCT03105466|Hormones|hormones|mesh-ancestor
102031465|NCT03105466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102031470|NCT02335372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102031471|NCT02335372|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102031472|NCT02335372|Immunologic Factors|immunologic factors|mesh-ancestor
102031473|NCT02335372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031474|NCT02335372|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102031475|NCT02335372|Protective Agents|protective agents|mesh-ancestor
102031476|NCT02335372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102031477|NCT02335372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102031478|NCT03488225|Calcium, Dietary|calcium, dietary|mesh-list
102031479|NCT03488225|Leucovorin|leucovorin|mesh-list
102031480|NCT03488225|Folic Acid|folic acid|mesh-list
102031481|NCT03488225|Cytarabine|cytarabine|mesh-list
102031482|NCT03488225|Dexamethasone|dexamethasone|mesh-list
102031483|NCT03488225|Prednisone|prednisone|mesh-list
102031484|NCT03488225|Dexamethasone acetate|dexamethasone acetate|mesh-list
102031485|NCT03488225|Cortisone|cortisone|mesh-list
102031486|NCT03488225|Cyclophosphamide|cyclophosphamide|mesh-list
102031487|NCT03488225|Rituximab|rituximab|mesh-list
102031488|NCT03488225|Doxorubicin|doxorubicin|mesh-list
102031489|NCT03488225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102031490|NCT03488225|Methotrexate|methotrexate|mesh-list
102031491|NCT03488225|Vincristine|vincristine|mesh-list
102031492|NCT03488225|Mercaptopurine|mercaptopurine|mesh-list
102031493|NCT03488225|Ofatumumab|ofatumumab|mesh-list
102031494|NCT03488225|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
102031495|NCT03488225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102031496|NCT03488225|Antibodies|antibodies|mesh-list
102031497|NCT03488225|Immunoglobulins|immunoglobulins|mesh-list
102031498|NCT03488225|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102031499|NCT03488225|BB 1101|bb 1101|mesh-list
102031500|NCT03488225|Calcium|calcium|mesh-list
102031501|NCT03488225|Levoleucovorin|levoleucovorin|mesh-list
101751259|NCT04536532|Entecavir|entecavir|mesh-list
102031502|NCT03488225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102031503|NCT03488225|Immunologic Factors|immunologic factors|mesh-ancestor
102031504|NCT03488225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031505|NCT03488225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102031506|NCT03488225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102031507|NCT03488225|Alkylating Agents|alkylating agents|mesh-ancestor
102031508|NCT03488225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031509|NCT03488225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102031510|NCT03488225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102031511|NCT03488225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102031512|NCT03488225|Antiemetics|antiemetics|mesh-ancestor
102031513|NCT03488225|Autonomic Agents|autonomic agents|mesh-ancestor
102031514|NCT03488225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102031515|NCT03488225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102031516|NCT03488225|Glucocorticoids|glucocorticoids|mesh-ancestor
102031517|NCT03488225|Hormones|hormones|mesh-ancestor
102031518|NCT03488225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102031519|NCT03488225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102031520|NCT03488225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102031521|NCT03488225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102031522|NCT03488225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102031523|NCT03488225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102031524|NCT03488225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102031525|NCT03488225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102031526|NCT03488225|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101952446|NCT03537651|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101952447|NCT03537651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101526626|NCT05794503|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101952448|NCT03537651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952449|NCT01203111|Insulin|insulin|mesh-list
101952450|NCT01203111|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101952451|NCT01203111|Insulin Glargine|insulin glargine|mesh-list
101952452|NCT01203111|Insulin glulisine|insulin glulisine|mesh-list
101952453|NCT01203111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102031527|NCT03488225|Abortifacient Agents|abortifacient agents|mesh-ancestor
102031528|NCT03488225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102031529|NCT03488225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102031530|NCT03488225|Antimetabolites|antimetabolites|mesh-ancestor
102031531|NCT03488225|Dermatologic Agents|dermatologic agents|mesh-ancestor
102031532|NCT03488225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102031533|NCT03488225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102031534|NCT03488225|Antiviral Agents|antiviral agents|mesh-ancestor
102031535|NCT03488225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102031536|NCT03488225|Antidotes|antidotes|mesh-ancestor
102031537|NCT03488225|Protective Agents|protective agents|mesh-ancestor
102031538|NCT03488225|Vitamin B Complex|vitamin b complex|mesh-ancestor
102031539|NCT03488225|Vitamins|vitamins|mesh-ancestor
102031540|NCT03488225|Micronutrients|micronutrients|mesh-ancestor
102031541|NCT03488225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102031563|NCT02334904|Dopamine Agonists|dopamine agonists|mesh-ancestor
102031564|NCT02334904|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102031565|NCT02334904|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102031566|NCT02334904|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102031567|NCT02334904|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102031568|NCT02326090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102031569|NCT02326090|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102031570|NCT03437447|Praziquantel|praziquantel|mesh-list
102031571|NCT03437447|Anthelmintics|anthelmintics|mesh-ancestor
102031572|NCT03437447|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102031573|NCT03437447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102031574|NCT03720041|Dexamethasone|dexamethasone|mesh-list
102031575|NCT03720041|Dexamethasone acetate|dexamethasone acetate|mesh-list
102031576|NCT03720041|Lenalidomide|lenalidomide|mesh-list
102031579|NCT03720041|Glycine|glycine|mesh-list
102031580|NCT03720041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102031581|NCT03720041|Antiemetics|antiemetics|mesh-ancestor
102031582|NCT03720041|Autonomic Agents|autonomic agents|mesh-ancestor
102031583|NCT03720041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102031584|NCT03720041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031585|NCT03720041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102031586|NCT03720041|Glucocorticoids|glucocorticoids|mesh-ancestor
102031587|NCT03720041|Hormones|hormones|mesh-ancestor
102031588|NCT03720041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102031589|NCT03720041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102031590|NCT03720041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102031591|NCT03720041|Protease Inhibitors|protease inhibitors|mesh-ancestor
102031592|NCT03720041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102031593|NCT03720041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031594|NCT03720041|Immunologic Factors|immunologic factors|mesh-ancestor
102031595|NCT03720041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102031596|NCT03720041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102031597|NCT03720041|Growth Substances|growth substances|mesh-ancestor
102031598|NCT03720041|Growth Inhibitors|growth inhibitors|mesh-ancestor
102031602|NCT02326168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102031603|NCT02326168|Immunologic Factors|immunologic factors|mesh-ancestor
102031604|NCT02326168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031605|NCT02334670|Fluconazole|fluconazole|mesh-list
102031606|NCT02334670|Antifungal Agents|antifungal agents|mesh-ancestor
102031607|NCT02334670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102031608|NCT02334670|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102031609|NCT02334670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102031610|NCT02334670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102031611|NCT02334670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031612|NCT02334670|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101952454|NCT01203111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952456|NCT02722941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101294128|NCT01974167|Alfacalcidol|alfacalcidol|mesh-list
102031613|NCT02334670|Hormone Antagonists|hormone antagonists|mesh-ancestor
102031614|NCT02334670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102031615|NCT02334670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031616|NCT02334670|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102031617|NCT02334670|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102031618|NCT02974868|PF-06700841|pf-06700841|mesh-list
102031619|NCT02974868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102031620|NCT02974868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102031621|NCT02974868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031622|NCT02330770|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102031623|NCT02330770|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102031624|NCT02330770|Luteolytic Agents|luteolytic agents|mesh-ancestor
102031625|NCT02330770|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102031626|NCT02330770|Contraceptive Agents|contraceptive agents|mesh-ancestor
102031627|NCT02330770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102031628|NCT02330770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031629|NCT02330770|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102031630|NCT02330770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102031631|NCT02330770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102031632|NCT05076526|Hyaluronic Acid|hyaluronic acid|mesh-list
102031633|NCT05076526|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102031634|NCT05076526|Immunologic Factors|immunologic factors|mesh-ancestor
102031635|NCT05076526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031636|NCT05076526|Viscosupplements|viscosupplements|mesh-ancestor
102031637|NCT05076526|Protective Agents|protective agents|mesh-ancestor
102031638|NCT02330614|Carbamide Peroxide|carbamide peroxide|mesh-list
102031639|NCT02330614|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102031640|NCT02330614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102031641|NCT03143998|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
102031642|NCT03143998|Grazoprevir|grazoprevir|mesh-list
102031643|NCT03143998|Antiviral Agents|antiviral agents|mesh-ancestor
102031644|NCT03143998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102031645|NCT02334046|Remifentanil|remifentanil|mesh-list
102031646|NCT02334046|Sevoflurane|sevoflurane|mesh-list
102031647|NCT02334046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102031648|NCT02334046|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102031649|NCT02334046|Anesthetics, General|anesthetics, general|mesh-ancestor
102031650|NCT02334046|Anesthetics|anesthetics|mesh-ancestor
102031651|NCT02334046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102031652|NCT02334046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031654|NCT02334046|Narcotics|narcotics|mesh-ancestor
102031655|NCT02334046|Analgesics|analgesics|mesh-ancestor
102031656|NCT02334046|Sensory System Agents|sensory system agents|mesh-ancestor
102031657|NCT02334046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102031658|NCT02330380|Adalimumab|adalimumab|mesh-list
102031659|NCT02330380|Etanercept|etanercept|mesh-list
102031660|NCT02330380|Methotrexate|methotrexate|mesh-list
102031661|NCT02330380|Ustekinumab|ustekinumab|mesh-list
102031662|NCT02330380|Acitretin|acitretin|mesh-list
102031663|NCT02330380|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102031664|NCT02330380|Abortifacient Agents|abortifacient agents|mesh-ancestor
102031665|NCT02330380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102031666|NCT02330380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031667|NCT02330380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102031668|NCT02330380|Antimetabolites|antimetabolites|mesh-ancestor
102031669|NCT02330380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031670|NCT02330380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102031671|NCT02330380|Dermatologic Agents|dermatologic agents|mesh-ancestor
102031686|NCT02330380|Keratolytic Agents|keratolytic agents|mesh-ancestor
102031687|NCT04278404|Metformin|metformin|mesh-list
102031688|NCT04278404|Interferons|interferons|mesh-list
102031689|NCT04278404|Ritonavir|ritonavir|mesh-list
102031690|NCT04278404|Ribavirin|ribavirin|mesh-list
102031691|NCT04278404|Lopinavir|lopinavir|mesh-list
102031692|NCT04278404|Oseltamivir|oseltamivir|mesh-list
102031693|NCT04278404|Remdesivir|remdesivir|mesh-list
102031694|NCT04278404|Azithromycin|azithromycin|mesh-list
102031695|NCT04278404|Clindamycin|clindamycin|mesh-list
102031696|NCT04278404|Meropenem|meropenem|mesh-list
102031697|NCT04278404|Voriconazole|voriconazole|mesh-list
102031698|NCT04278404|Ceftazidime|ceftazidime|mesh-list
101952457|NCT02722941|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101952458|NCT02722941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102031699|NCT04278404|Cefepime|cefepime|mesh-list
102031700|NCT04278404|Fosfomycin|fosfomycin|mesh-list
102031701|NCT04278404|Cefdinir|cefdinir|mesh-list
102031702|NCT04278404|Dexamethasone|dexamethasone|mesh-list
102031703|NCT04278404|Budesonide|budesonide|mesh-list
102031704|NCT04278404|Hydrocortisone|hydrocortisone|mesh-list
102031705|NCT04278404|Colchicine|colchicine|mesh-list
102031706|NCT04278404|Amiodarone|amiodarone|mesh-list
102031707|NCT04278404|Bosentan|bosentan|mesh-list
102031708|NCT04278404|Guanfacine|guanfacine|mesh-list
102031709|NCT04278404|Labetalol|labetalol|mesh-list
102031710|NCT04278404|Nicardipine|nicardipine|mesh-list
102031711|NCT04278404|Nifedipine|nifedipine|mesh-list
102031712|NCT04278404|Milrinone|milrinone|mesh-list
102031713|NCT04278404|Furosemide|furosemide|mesh-list
102031714|NCT04278404|Spironolactone|spironolactone|mesh-list
102031715|NCT04278404|Dexmedetomidine|dexmedetomidine|mesh-list
102031716|NCT04278404|Oxycodone|oxycodone|mesh-list
102031717|NCT04278404|Gabapentin|gabapentin|mesh-list
102031718|NCT04278404|Nalbuphine|nalbuphine|mesh-list
102031719|NCT04278404|Clobazam|clobazam|mesh-list
102031720|NCT04278404|Zolpidem|zolpidem|mesh-list
102031721|NCT04278404|Risperidone|risperidone|mesh-list
102031722|NCT04278404|Amphetamine|amphetamine|mesh-list
102031723|NCT04278404|Dextroamphetamine|dextroamphetamine|mesh-list
102031724|NCT04278404|Sertraline|sertraline|mesh-list
102031725|NCT04278404|Tranexamic Acid|tranexamic acid|mesh-list
102031726|NCT04278404|Aminocaproic Acid|aminocaproic acid|mesh-list
102031727|NCT04278404|Terbutaline|terbutaline|mesh-list
102031728|NCT04278404|Sevelamer|sevelamer|mesh-list
102031729|NCT04278404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102031730|NCT04278404|Antiemetics|antiemetics|mesh-ancestor
102031731|NCT04278404|Autonomic Agents|autonomic agents|mesh-ancestor
102031732|NCT04278404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102031733|NCT04278404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031734|NCT04278404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102031735|NCT04278404|Glucocorticoids|glucocorticoids|mesh-ancestor
102031736|NCT04278404|Hormones|hormones|mesh-ancestor
102031737|NCT04278404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102031738|NCT04278404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102031739|NCT04278404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102031740|NCT04278404|Protease Inhibitors|protease inhibitors|mesh-ancestor
102031741|NCT04278404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628298|NCT02590705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102031746|NCT04278404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102031747|NCT04278404|Analgesics|analgesics|mesh-ancestor
102031748|NCT04278404|Sensory System Agents|sensory system agents|mesh-ancestor
102031749|NCT04278404|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102031750|NCT04278404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102031751|NCT04278404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102031752|NCT04278404|Adrenergic Agents|adrenergic agents|mesh-ancestor
102031753|NCT04278404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102031754|NCT04278404|Antiviral Agents|antiviral agents|mesh-ancestor
102031755|NCT04278404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102031756|NCT04278404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102031757|NCT04278404|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102031758|NCT04278404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102031759|NCT04278404|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102031760|NCT04278404|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102031761|NCT04278404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102031762|NCT04278404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102031763|NCT04278404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102031764|NCT04278404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102031765|NCT04278404|Antimetabolites|antimetabolites|mesh-ancestor
102031766|NCT04278404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102031767|NCT04278404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102031768|NCT04278404|Respiratory System Agents|respiratory system agents|mesh-ancestor
102031769|NCT04278404|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102031770|NCT04278404|Hemostatics|hemostatics|mesh-ancestor
102031771|NCT04278404|Coagulants|coagulants|mesh-ancestor
102031772|NCT04278404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102031773|NCT04278404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102031774|NCT04278404|Narcotics|narcotics|mesh-ancestor
102031775|NCT04278404|Anticonvulsants|anticonvulsants|mesh-ancestor
102031776|NCT04278404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102031777|NCT04278404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102031778|NCT04278404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102031779|NCT04278404|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102031780|NCT04278404|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101952459|NCT02722941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952460|NCT03420339|Adderall|adderall|mesh-list
101952461|NCT03420339|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101294275|NCT01975441|Ivermectin|ivermectin|mesh-list
102031781|NCT04278404|Antimanic Agents|antimanic agents|mesh-ancestor
102031782|NCT04278404|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102031783|NCT04278404|Serotonin Agents|serotonin agents|mesh-ancestor
102031784|NCT04278404|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102031785|NCT04278404|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102031786|NCT04278404|Dopamine Agents|dopamine agents|mesh-ancestor
102031787|NCT04278404|Antidepressive Agents|antidepressive agents|mesh-ancestor
102031788|NCT04278404|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102031789|NCT04278404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102031790|NCT04278404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102031791|NCT04278404|Diuretics|diuretics|mesh-ancestor
102031792|NCT04278404|Natriuretic Agents|natriuretic agents|mesh-ancestor
102031793|NCT04278404|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102031794|NCT04278404|Gout Suppressants|gout suppressants|mesh-ancestor
102031795|NCT04278404|Tubulin Modulators|tubulin modulators|mesh-ancestor
102031796|NCT04278404|Antimitotic Agents|antimitotic agents|mesh-ancestor
102031797|NCT04278404|Mitosis Modulators|mitosis modulators|mesh-ancestor
102031798|NCT04278404|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102031799|NCT04278404|Hormone Antagonists|hormone antagonists|mesh-ancestor
102031800|NCT04278404|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102031801|NCT04278404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102031802|NCT04278404|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102031803|NCT04278404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102031804|NCT04278404|Vasodilator Agents|vasodilator agents|mesh-ancestor
102031805|NCT04278404|Tocolytic Agents|tocolytic agents|mesh-ancestor
102031806|NCT04278404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102031807|NCT04278404|Antifungal Agents|antifungal agents|mesh-ancestor
102031808|NCT04278404|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102031809|NCT04278404|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102031810|NCT04278404|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102031811|NCT04278404|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102031823|NCT04278404|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102031824|NCT04278404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102031825|NCT04278404|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102031827|NCT04278404|Sequestering Agents|sequestering agents|mesh-ancestor
102031828|NCT04278404|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102031829|NCT04278404|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101526712|NCT05681572|GABA Modulators|gaba modulators|mesh-ancestor
102031830|NCT04278404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102031831|NCT04278404|Protective Agents|protective agents|mesh-ancestor
102031832|NCT04278404|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102031833|NCT04278404|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102031834|NCT04278404|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102031835|NCT04278404|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102031836|NCT04278404|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102031837|NCT04278404|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102031838|NCT02333890|Chloroquine|chloroquine|mesh-list
102031839|NCT02333890|Amebicides|amebicides|mesh-ancestor
102031840|NCT02333890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102031841|NCT02333890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102031842|NCT02333890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102031843|NCT02333890|Antimalarials|antimalarials|mesh-ancestor
102031844|NCT02333890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102031845|NCT02330302|Ropivacaine|ropivacaine|mesh-list
102031846|NCT02330302|Anesthetics, Local|anesthetics, local|mesh-ancestor
102031847|NCT02330302|Anesthetics|anesthetics|mesh-ancestor
102031848|NCT02330302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102031849|NCT02330302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031850|NCT02330302|Sensory System Agents|sensory system agents|mesh-ancestor
102031851|NCT02330302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102031852|NCT03143530|Ropivacaine|ropivacaine|mesh-list
102031853|NCT03143530|Anesthetics, Local|anesthetics, local|mesh-ancestor
102031854|NCT03143530|Anesthetics|anesthetics|mesh-ancestor
102031855|NCT03143530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102031856|NCT03143530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031857|NCT03143530|Sensory System Agents|sensory system agents|mesh-ancestor
102031858|NCT03143530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101952462|NCT03420339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952463|NCT01297179|Levonorgestrel|levonorgestrel|mesh-list
102031859|NCT01065818|Telbivudine|telbivudine|mesh-list
102031860|NCT01065818|Antiviral Agents|antiviral agents|mesh-ancestor
102031861|NCT01065818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102031862|NCT01065818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102031863|NCT01065818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102031864|NCT01065818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031865|NCT03697408|Everolimus|everolimus|mesh-list
102031866|NCT03697408|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102031867|NCT03697408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102031868|NCT03697408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102031869|NCT03697408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031870|NCT03697408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102031871|NCT03697408|Immunologic Factors|immunologic factors|mesh-ancestor
102031872|NCT03697408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031873|NCT03697408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102031880|NCT03143452|Anesthetics, Local|anesthetics, local|mesh-ancestor
102031882|NCT03143452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102031883|NCT03143452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031884|NCT03143452|Sensory System Agents|sensory system agents|mesh-ancestor
102031885|NCT03143452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102031886|NCT03143452|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101751642|NCT03579784|Durvalumab|durvalumab|mesh-list
102031887|NCT03143452|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102031888|NCT03143452|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102031889|NCT03143452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102031890|NCT03143452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031891|NCT03143452|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102031892|NCT01063868|Oxycodone|oxycodone|mesh-list
102031893|NCT01063868|Tapentadol|tapentadol|mesh-list
102031894|NCT01063868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102031895|NCT01063868|Narcotics|narcotics|mesh-ancestor
102031896|NCT01063868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102031897|NCT01063868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031898|NCT01063868|Analgesics|analgesics|mesh-ancestor
102031899|NCT01063868|Sensory System Agents|sensory system agents|mesh-ancestor
102031900|NCT01063868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102031901|NCT01063868|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102031902|NCT01063868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102031903|NCT01063868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102031904|NCT01063868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031905|NCT01063868|Adrenergic Agents|adrenergic agents|mesh-ancestor
102031906|NCT01063868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102031907|NCT04993924|Cetrorelix|cetrorelix|mesh-list
102031908|NCT04993924|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102031909|NCT04993924|Fertility Agents|fertility agents|mesh-ancestor
102031910|NCT04993924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102031911|NCT04993924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031912|NCT04993924|Hormone Antagonists|hormone antagonists|mesh-ancestor
102031913|NCT04993924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102031914|NCT02330068|Citalopram|citalopram|mesh-list
102031915|NCT02330068|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102031916|NCT02330068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102031917|NCT02330068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102031918|NCT02330068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031919|NCT02330068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102031920|NCT02330068|Serotonin Agents|serotonin agents|mesh-ancestor
102031921|NCT02330068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031922|NCT02330068|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102031923|NCT02330068|Antidepressive Agents|antidepressive agents|mesh-ancestor
102031924|NCT02330068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102031925|NCT02333344|Zoledronic Acid|zoledronic acid|mesh-list
102031926|NCT02333344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102031927|NCT02333344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031928|NCT01312857|Panitumumab|panitumumab|mesh-list
102031929|NCT01312857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102031930|NCT01312857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102031931|NCT02974010|Cycloserine|cycloserine|mesh-list
102031932|NCT02974010|Ketamine|ketamine|mesh-list
102031933|NCT02974010|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
101952464|NCT01297179|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101952465|NCT01297179|Mirabegron|mirabegron|mesh-list
101952466|NCT01297179|Estradiol|estradiol|mesh-list
101952467|NCT01297179|Estrogens|estrogens|mesh-ancestor
101952468|NCT01297179|Hormones|hormones|mesh-ancestor
101952469|NCT01297179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102031934|NCT02974010|Analgesics|analgesics|mesh-ancestor
102031935|NCT02974010|Sensory System Agents|sensory system agents|mesh-ancestor
102031936|NCT02974010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102031937|NCT02974010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031938|NCT02974010|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102031939|NCT02974010|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102031940|NCT02974010|Anesthetics, General|anesthetics, general|mesh-ancestor
102031951|NCT02974010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102031952|NCT02974010|Antimetabolites|antimetabolites|mesh-ancestor
102031953|NCT02974010|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102031954|NCT02974010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102031955|NCT02974010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102031956|NCT02974010|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102031957|NCT02974010|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102031958|NCT02974010|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102031959|NCT02974010|Adrenergic Agents|adrenergic agents|mesh-ancestor
102031960|NCT02974010|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102031961|NCT02974010|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102031962|NCT02974010|Serotonin Agents|serotonin agents|mesh-ancestor
102031963|NCT02974010|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102031964|NCT02974010|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102031965|NCT02974010|Dopamine Agents|dopamine agents|mesh-ancestor
102031966|NCT01061606|Sirolimus|sirolimus|mesh-list
102031967|NCT01061606|Temsirolimus|temsirolimus|mesh-list
102031968|NCT01061606|MTOR Inhibitors|mtor inhibitors|mesh-list
102031969|NCT01061606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102031970|NCT01061606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102031971|NCT01061606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031972|NCT01061606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102031973|NCT01061606|Immunologic Factors|immunologic factors|mesh-ancestor
102031974|NCT01061606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031975|NCT01061606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102031976|NCT01061606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102031977|NCT01061606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102031978|NCT01061606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102031979|NCT01061606|Antifungal Agents|antifungal agents|mesh-ancestor
102031980|NCT04696822|Epinephrine|epinephrine|mesh-list
102031981|NCT04696822|Racepinephrine|racepinephrine|mesh-list
102031982|NCT04696822|Epinephryl borate|epinephryl borate|mesh-list
102031983|NCT04696822|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102031984|NCT04696822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102031985|NCT04696822|Adrenergic Agents|adrenergic agents|mesh-ancestor
102031986|NCT04696822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102031987|NCT04696822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031988|NCT04696822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031989|NCT04696822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102031990|NCT04696822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102031991|NCT04696822|Autonomic Agents|autonomic agents|mesh-ancestor
102031992|NCT04696822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102031993|NCT04696822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102031994|NCT04696822|Respiratory System Agents|respiratory system agents|mesh-ancestor
102031995|NCT04696822|Mydriatics|mydriatics|mesh-ancestor
102031996|NCT04696822|Sympathomimetics|sympathomimetics|mesh-ancestor
102031997|NCT04696822|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102031998|NCT02329756|Tranexamic Acid|tranexamic acid|mesh-list
102031999|NCT02329756|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102032000|NCT02329756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102032001|NCT02329756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032002|NCT02329756|Hemostatics|hemostatics|mesh-ancestor
102032003|NCT02329756|Coagulants|coagulants|mesh-ancestor
102032004|NCT02329288|Triamcinolone|triamcinolone|mesh-list
102032028|NCT04407988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102032029|NCT04407988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102032030|NCT04407988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032031|NCT04407988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101526926|NCT04790474|Growth Substances|growth substances|mesh-ancestor
101952470|NCT01297179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032033|NCT04407988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102032034|NCT04407988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032035|NCT02329132|Ranibizumab|ranibizumab|mesh-list
102032036|NCT02329132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102032037|NCT02329132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102032038|NCT02329132|Growth Substances|growth substances|mesh-ancestor
102032039|NCT02329132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032040|NCT02329132|Growth Inhibitors|growth inhibitors|mesh-ancestor
102032041|NCT02329132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102032042|NCT04342078|Vitamin D|vitamin d|mesh-list
102032043|NCT04342078|Vitamins|vitamins|mesh-ancestor
102032044|NCT04342078|Micronutrients|micronutrients|mesh-ancestor
102032045|NCT04342078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032046|NCT04342078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102032047|NCT02332954|Vortioxetine|vortioxetine|mesh-list
102032048|NCT02332954|Antidepressive Agents|antidepressive agents|mesh-ancestor
102032049|NCT02332954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102032050|NCT02332954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102032051|NCT02332954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102032052|NCT02332954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102032053|NCT02332954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032054|NCT02332954|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102032055|NCT02332954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102032056|NCT02332954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102032060|NCT02332954|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102032061|NCT02332954|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102032062|NCT02332954|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102032063|NCT02332954|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102032064|NCT01372761|CKD732|ckd732|mesh-list
102032065|NCT01372761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102032066|NCT01372761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102032067|NCT01372761|Growth Substances|growth substances|mesh-ancestor
102032068|NCT01372761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032069|NCT01372761|Growth Inhibitors|growth inhibitors|mesh-ancestor
102032070|NCT01372761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102032071|NCT03873675|Hormones|hormones|mesh-list
102032072|NCT03873675|Parathyroid Hormone|parathyroid hormone|mesh-list
102032073|NCT03873675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102032074|NCT03873675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032075|NCT03873675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102032076|NCT05173857|Paclitaxel|paclitaxel|mesh-list
102032077|NCT05173857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102032078|NCT05173857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102032079|NCT05173857|Tubulin Modulators|tubulin modulators|mesh-ancestor
102032080|NCT05173857|Antimitotic Agents|antimitotic agents|mesh-ancestor
102032081|NCT05173857|Mitosis Modulators|mitosis modulators|mesh-ancestor
102032082|NCT05173857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032083|NCT03417999|Dexmedetomidine|dexmedetomidine|mesh-list
102032084|NCT03417999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102032085|NCT03417999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101527020|NCT04593940|Antimetabolites|antimetabolites|mesh-ancestor
102032086|NCT03417999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032087|NCT03417999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102032088|NCT03417999|Analgesics|analgesics|mesh-ancestor
102032089|NCT03417999|Sensory System Agents|sensory system agents|mesh-ancestor
102032090|NCT03417999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102032091|NCT03417999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102032092|NCT03417999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102032093|NCT03417999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102032094|NCT03417999|Adrenergic Agents|adrenergic agents|mesh-ancestor
102032095|NCT03417999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102032096|NCT03417999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032097|NCT03142516|Leucovorin|leucovorin|mesh-list
102032098|NCT03142516|Folic Acid|folic acid|mesh-list
102032099|NCT03142516|Fluorouracil|fluorouracil|mesh-list
102032100|NCT03142516|Irinotecan|irinotecan|mesh-list
102032101|NCT03142516|Panitumumab|panitumumab|mesh-list
102032102|NCT03142516|Levoleucovorin|levoleucovorin|mesh-list
102032103|NCT03142516|Antimetabolites|antimetabolites|mesh-ancestor
102032104|NCT03142516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032105|NCT03142516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101952471|NCT01297179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101952472|NCT01297179|Contraceptive Agents|contraceptive agents|mesh-ancestor
101952473|NCT01297179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102032106|NCT03142516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102032107|NCT03142516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101751870|NCT02138617|Growth Inhibitors|growth inhibitors|mesh-ancestor
102032108|NCT03142516|Immunologic Factors|immunologic factors|mesh-ancestor
102032109|NCT03142516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032110|NCT03142516|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102032111|NCT03142516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102032112|NCT03142516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102032113|NCT03142516|Antidotes|antidotes|mesh-ancestor
102032114|NCT03142516|Protective Agents|protective agents|mesh-ancestor
102032115|NCT03142516|Vitamin B Complex|vitamin b complex|mesh-ancestor
102032116|NCT03142516|Vitamins|vitamins|mesh-ancestor
102032117|NCT03142516|Micronutrients|micronutrients|mesh-ancestor
102032118|NCT03142516|Hematinics|hematinics|mesh-ancestor
102032119|NCT03142516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102032120|NCT03719729|Rifaximin|rifaximin|mesh-list
102032121|NCT03719729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102032122|NCT03719729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102032123|NCT03719729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102032124|NCT05077462|Cryptophycin 52|cryptophycin 52|mesh-list
102032125|NCT05077462|Antimitotic Agents|antimitotic agents|mesh-ancestor
102032126|NCT05077462|Mitosis Modulators|mitosis modulators|mesh-ancestor
102032127|NCT05077462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032131|NCT03714113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032132|NCT03472547|Diacerein|diacerein|mesh-list
102032133|NCT03472547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102032134|NCT00799396|Aspirin|aspirin|mesh-list
102032135|NCT00799396|Clopidogrel|clopidogrel|mesh-list
102032136|NCT00799396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102032137|NCT00799396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102032138|NCT00799396|Analgesics|analgesics|mesh-ancestor
102032139|NCT00799396|Sensory System Agents|sensory system agents|mesh-ancestor
102032140|NCT00799396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102032141|NCT00799396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032142|NCT00799396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102032143|NCT00799396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102032144|NCT00799396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102032145|NCT00799396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102032146|NCT00799396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032147|NCT00799396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102032148|NCT00799396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102032149|NCT00799396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102032150|NCT00799396|Antipyretics|antipyretics|mesh-ancestor
102032151|NCT00799396|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102032152|NCT00799396|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102032153|NCT00799396|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102032154|NCT00799396|Purinergic Agents|purinergic agents|mesh-ancestor
102032155|NCT00799396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102032156|NCT02624128|Cetuximab|cetuximab|mesh-list
102032157|NCT02624128|Valproic Acid|valproic acid|mesh-list
102032158|NCT02624128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102032159|NCT02624128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102032160|NCT02624128|Anticonvulsants|anticonvulsants|mesh-ancestor
102032161|NCT02624128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102032162|NCT02624128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032163|NCT02624128|GABA Agents|gaba agents|mesh-ancestor
102032164|NCT02624128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102032165|NCT02624128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032166|NCT02624128|Antimanic Agents|antimanic agents|mesh-ancestor
102032167|NCT02624128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102032168|NCT02624128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102032169|NCT02624128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102032170|NCT03469349|Actovegin|actovegin|mesh-list
102032171|NCT03469349|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102032172|NCT03469349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032173|NCT03469349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102032174|NCT03469349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102032175|NCT03469349|Antioxidants|antioxidants|mesh-ancestor
102032176|NCT03469349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032177|NCT03469349|Protective Agents|protective agents|mesh-ancestor
101952474|NCT01297179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101952475|NCT01297179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101952476|NCT01297179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101952477|NCT01297179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101952478|NCT01297179|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101294640|NCT01978457|Adrenergic Agents|adrenergic agents|mesh-ancestor
102032178|NCT03469349|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102032179|NCT03467945|Metformin|metformin|mesh-list
102032180|NCT03467945|Gliclazide|gliclazide|mesh-list
102032181|NCT03467945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102032182|NCT03467945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032183|NCT03719261|Sodium Hypochlorite|sodium hypochlorite|mesh-list
102032186|NCT03719261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102032187|NCT03719261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102032188|NCT03719261|Antimetabolites|antimetabolites|mesh-ancestor
102032189|NCT03719261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032190|NCT03719261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102032191|NCT03719261|Chelating Agents|chelating agents|mesh-ancestor
102032192|NCT03719261|Sequestering Agents|sequestering agents|mesh-ancestor
102032193|NCT03719261|Hemostatics|hemostatics|mesh-ancestor
102032194|NCT03719261|Coagulants|coagulants|mesh-ancestor
102032195|NCT03719261|Disinfectants|disinfectants|mesh-ancestor
102032196|NCT03719261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102032197|NCT00069238|Prednisone|prednisone|mesh-list
102032198|NCT00069238|Cyclophosphamide|cyclophosphamide|mesh-list
102032199|NCT00069238|Doxorubicin|doxorubicin|mesh-list
102032200|NCT00069238|Etoposide|etoposide|mesh-list
102032201|NCT00069238|Vincristine|vincristine|mesh-list
102032202|NCT00069238|Alemtuzumab|alemtuzumab|mesh-list
102032203|NCT00069238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101487162|NCT00427128|Serotonin Agents|serotonin agents|mesh-ancestor
102032208|NCT00069238|Alkylating Agents|alkylating agents|mesh-ancestor
102032209|NCT00069238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032210|NCT00069238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102032211|NCT00069238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102032212|NCT00069238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102032213|NCT00069238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102032214|NCT00069238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102032215|NCT00069238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102032216|NCT00069238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102032217|NCT00069238|Glucocorticoids|glucocorticoids|mesh-ancestor
102032218|NCT00069238|Hormones|hormones|mesh-ancestor
102032219|NCT00069238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102032220|NCT00069238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102032221|NCT00069238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102032222|NCT00069238|Tubulin Modulators|tubulin modulators|mesh-ancestor
102032223|NCT00069238|Antimitotic Agents|antimitotic agents|mesh-ancestor
102032224|NCT00069238|Mitosis Modulators|mitosis modulators|mesh-ancestor
102032225|NCT00069238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102032226|NCT03639155|Glycine|glycine|mesh-list
102032227|NCT03639155|Glycine Agents|glycine agents|mesh-ancestor
102032228|NCT03639155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102032229|NCT03639155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032230|NCT03639155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032231|NCT05080348|Ropivacaine|ropivacaine|mesh-list
102032232|NCT05080348|Anesthetics, Local|anesthetics, local|mesh-ancestor
102032233|NCT05080348|Anesthetics|anesthetics|mesh-ancestor
102032234|NCT05080348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102032235|NCT05080348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032236|NCT05080348|Sensory System Agents|sensory system agents|mesh-ancestor
102032237|NCT05080348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102032238|NCT03073200|Etanercept|etanercept|mesh-list
102032239|NCT03073200|Ixekizumab|ixekizumab|mesh-list
102032240|NCT03073200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102032241|NCT03073200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102032242|NCT03073200|Analgesics|analgesics|mesh-ancestor
102032243|NCT03073200|Sensory System Agents|sensory system agents|mesh-ancestor
101527124|NCT04293562|Antimetabolites|antimetabolites|mesh-ancestor
102032244|NCT03073200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102032245|NCT03073200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952479|NCT01297179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101952480|NCT01297179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101952481|NCT01297179|Adrenergic Agents|adrenergic agents|mesh-ancestor
101952482|NCT01297179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101952483|NCT01297179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032246|NCT03073200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102032247|NCT03073200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102032248|NCT03073200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102032249|NCT03073200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102032250|NCT03073200|Immunologic Factors|immunologic factors|mesh-ancestor
102032251|NCT03073200|Dermatologic Agents|dermatologic agents|mesh-ancestor
102032252|NCT02030860|Gemcitabine|gemcitabine|mesh-list
102032253|NCT02030860|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102032254|NCT02030860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102032255|NCT02030860|Antimetabolites|antimetabolites|mesh-ancestor
102032256|NCT02030860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032257|NCT02030860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102032258|NCT01569984|Bevacizumab|bevacizumab|mesh-list
102032259|NCT01569984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102032260|NCT01569984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102032261|NCT01569984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102032262|NCT01569984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102032263|NCT01569984|Growth Substances|growth substances|mesh-ancestor
102032264|NCT01569984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032265|NCT01569984|Growth Inhibitors|growth inhibitors|mesh-ancestor
102032267|NCT02328118|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102032268|NCT02328118|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102032269|NCT02328118|Ranibizumab|ranibizumab|mesh-list
102032270|NCT02328118|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102032271|NCT02328118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102032272|NCT02328118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102032273|NCT02328118|Growth Substances|growth substances|mesh-ancestor
102032274|NCT02328118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032277|NCT02328118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102032278|NCT02328118|Glucocorticoids|glucocorticoids|mesh-ancestor
102032279|NCT02328118|Hormones|hormones|mesh-ancestor
102032280|NCT02328118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102032281|NCT02328118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102032282|NCT02328118|Immunologic Factors|immunologic factors|mesh-ancestor
102032283|NCT02328118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102032284|NCT02328118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032285|NCT02602314|Imatinib Mesylate|imatinib mesylate|mesh-list
102032286|NCT02602314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102032287|NCT02602314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102032288|NCT02602314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102032289|NCT02602314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032290|NCT05079880|Caffeine|caffeine|mesh-list
102032291|NCT05079880|Caffeine citrate|caffeine citrate|mesh-list
102032292|NCT05079880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032293|NCT05079880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102032294|NCT05079880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032295|NCT05079880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102032296|NCT05079880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102032297|NCT05079880|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102032298|NCT05079880|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102032299|NCT05079880|Purinergic Agents|purinergic agents|mesh-ancestor
102032300|NCT05079880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102032301|NCT03716765|Vitamin D|vitamin d|mesh-list
102032302|NCT03716765|Vitamins|vitamins|mesh-ancestor
102032303|NCT03716765|Micronutrients|micronutrients|mesh-ancestor
101527131|NCT04293562|Immunologic Factors|immunologic factors|mesh-ancestor
102032304|NCT03716765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032305|NCT03716765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102032306|NCT03070002|Denosumab|denosumab|mesh-list
102032307|NCT03070002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102032308|NCT03070002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032309|NCT02327728|Botulinum Toxins|botulinum toxins|mesh-list
102032310|NCT02327728|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102032311|NCT02327728|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102032312|NCT02327728|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101952484|NCT01297179|Urological Agents|urological agents|mesh-ancestor
101952485|NCT01205139|Simeprevir|simeprevir|mesh-list
102032313|NCT02327728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102032314|NCT02327728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032315|NCT02327728|Cholinergic Agents|cholinergic agents|mesh-ancestor
102032316|NCT02327728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102032317|NCT02327728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032318|NCT02327728|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102032319|NCT02327728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102032320|NCT02918318|Esketamine|esketamine|mesh-list
102032321|NCT02918318|Antidepressive Agents|antidepressive agents|mesh-ancestor
102032322|NCT02918318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102032323|NCT04926454|Dexmedetomidine|dexmedetomidine|mesh-list
102032324|NCT04926454|Bupivacaine|bupivacaine|mesh-list
102032325|NCT04926454|Anesthetics, Local|anesthetics, local|mesh-ancestor
102032326|NCT04926454|Anesthetics|anesthetics|mesh-ancestor
102032327|NCT04926454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102032328|NCT04926454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032329|NCT04926454|Sensory System Agents|sensory system agents|mesh-ancestor
102032330|NCT04926454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102032331|NCT04926454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102032332|NCT04926454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102032333|NCT04926454|Analgesics|analgesics|mesh-ancestor
102032334|NCT04926454|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102032335|NCT04926454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102032337|NCT04926454|Adrenergic Agents|adrenergic agents|mesh-ancestor
102032338|NCT04926454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102032339|NCT04926454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032340|NCT03652376|Benralizumab|benralizumab|mesh-list
102032341|NCT03652376|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102032342|NCT03652376|Respiratory System Agents|respiratory system agents|mesh-ancestor
102032343|NCT03142828|Chlorhexidine|chlorhexidine|mesh-list
102032344|NCT03142828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102032345|NCT03142828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102032346|NCT03142828|Disinfectants|disinfectants|mesh-ancestor
102032347|NCT01372839|Atorvastatin|atorvastatin|mesh-list
101487304|NCT05354258|Sulfadoxine|sulfadoxine|mesh-list
101735813|NCT05737355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735814|NCT05737355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101735815|NCT05737355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101735817|NCT03540017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101735818|NCT02606981|Vitamins|vitamins|mesh-list
101735819|NCT02606981|Ascorbic Acid|ascorbic acid|mesh-list
101735820|NCT02606981|Micronutrients|micronutrients|mesh-ancestor
101735822|NCT02606981|Antioxidants|antioxidants|mesh-ancestor
101735823|NCT02606981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735824|NCT02606981|Protective Agents|protective agents|mesh-ancestor
101735825|NCT00914888|Metronidazole|metronidazole|mesh-list
101735826|NCT00914888|Clarithromycin|clarithromycin|mesh-list
101735827|NCT00914888|Ceftriaxone|ceftriaxone|mesh-list
101735828|NCT00914888|Tigecycline|tigecycline|mesh-list
101735829|NCT00914888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101735830|NCT00914888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101735831|NCT00914888|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101735832|NCT00914888|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101735833|NCT00914888|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101527141|NCT04293562|Analgesics|analgesics|mesh-ancestor
101735834|NCT00914888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101735835|NCT00914888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735836|NCT00914888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101735837|NCT00914888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101735838|NCT02603198|Epinephrine|epinephrine|mesh-list
101735839|NCT02603198|Nordefrin|nordefrin|mesh-list
101735840|NCT02603198|Anesthetics|anesthetics|mesh-list
101735841|NCT02603198|Mepivacaine|mepivacaine|mesh-list
101735842|NCT02603198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101735843|NCT02603198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735844|NCT02603198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101735845|NCT02603198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101735846|NCT02603198|Adrenergic Agents|adrenergic agents|mesh-ancestor
101735847|NCT02603198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101735848|NCT02603198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735849|NCT02603198|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101735850|NCT02603198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101735851|NCT02603198|Autonomic Agents|autonomic agents|mesh-ancestor
101735852|NCT02603198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101952487|NCT01205139|Antiviral Agents|antiviral agents|mesh-ancestor
101952488|NCT01205139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101952489|NCT01205139|Protease Inhibitors|protease inhibitors|mesh-ancestor
101735853|NCT02603198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101735854|NCT02603198|Respiratory System Agents|respiratory system agents|mesh-ancestor
101393330|NCT04113018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101735856|NCT02603198|Sympathomimetics|sympathomimetics|mesh-ancestor
101735857|NCT02603198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101735858|NCT02603198|Anesthetics, Local|anesthetics, local|mesh-ancestor
101735859|NCT02603198|Sensory System Agents|sensory system agents|mesh-ancestor
101735860|NCT00719043|Vaccines|vaccines|mesh-list
101735861|NCT00719043|Immunologic Factors|immunologic factors|mesh-ancestor
101735862|NCT00719043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735863|NCT00786422|Rivaroxaban|rivaroxaban|mesh-list
101735864|NCT00786422|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101487431|NCT00428064|Sirolimus|sirolimus|mesh-list
101735870|NCT00786422|Anticoagulants|anticoagulants|mesh-ancestor
101735872|NCT00718887|Adefovir|adefovir|mesh-list
101735873|NCT00718887|Antiviral Agents|antiviral agents|mesh-ancestor
101735874|NCT00718887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101735875|NCT00718887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101735876|NCT00718887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101735877|NCT00718887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101735878|NCT00718887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735879|NCT00786188|Paroxetine|paroxetine|mesh-list
101735880|NCT00786188|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101735881|NCT00786188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101735882|NCT00786188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101735883|NCT00786188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735884|NCT00786188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101735885|NCT00786188|Serotonin Agents|serotonin agents|mesh-ancestor
101735886|NCT00786188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735887|NCT00786188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101735888|NCT00786188|Antidepressive Agents|antidepressive agents|mesh-ancestor
101735889|NCT00786188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101735890|NCT00786188|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101735891|NCT00786188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101735892|NCT00786188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101735893|NCT00733824|Plerixafor|plerixafor|mesh-list
101735894|NCT00733824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101735895|NCT00733824|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101735897|NCT00733824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101735898|NCT00718809|Saracatinib|saracatinib|mesh-list
101735899|NCT00718809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101735900|NCT00718809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101735901|NCT00718809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735902|NCT00585039|Albuterol|albuterol|mesh-list
101735903|NCT00585039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101735904|NCT00585039|Autonomic Agents|autonomic agents|mesh-ancestor
101735905|NCT00585039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101735906|NCT00585039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735907|NCT00585039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101735908|NCT00585039|Respiratory System Agents|respiratory system agents|mesh-ancestor
101735909|NCT00585039|Tocolytic Agents|tocolytic agents|mesh-ancestor
101735910|NCT00585039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101735911|NCT00585039|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101735912|NCT00585039|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101735913|NCT00585039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101735914|NCT00585039|Adrenergic Agents|adrenergic agents|mesh-ancestor
101735915|NCT00585039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101735916|NCT00585039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735917|NCT04085913|Lidocaine|lidocaine|mesh-list
101735918|NCT04085913|Epinephrine|epinephrine|mesh-list
101735919|NCT04085913|Racepinephrine|racepinephrine|mesh-list
101735920|NCT04085913|Bupivacaine|bupivacaine|mesh-list
101735921|NCT04085913|Epinephryl borate|epinephryl borate|mesh-list
101735922|NCT04085913|Anesthetics, Local|anesthetics, local|mesh-ancestor
101735923|NCT04085913|Anesthetics|anesthetics|mesh-ancestor
101735924|NCT04085913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101735925|NCT04085913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735926|NCT04085913|Sensory System Agents|sensory system agents|mesh-ancestor
101952490|NCT01205139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101952491|NCT01205139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952492|NCT01205139|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101294936|NCT01980810|Paclitaxel|paclitaxel|mesh-list
101735927|NCT04085913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101735928|NCT04085913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101393408|NCT04029038|Fludarabine|fludarabine|mesh-list
101735929|NCT04085913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101735930|NCT04085913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101735931|NCT04085913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101735932|NCT04085913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735947|NCT00806195|Immunologic Factors|immunologic factors|mesh-ancestor
101735948|NCT00806195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735949|NCT03462329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101735951|NCT03462329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101735952|NCT03462329|Antimalarials|antimalarials|mesh-ancestor
101735953|NCT03462329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101735954|NCT03462329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101735955|NCT05728151|Epinephrine|epinephrine|mesh-list
101735956|NCT05728151|Levobupivacaine|levobupivacaine|mesh-list
101735957|NCT05728151|Mepivacaine|mepivacaine|mesh-list
101735958|NCT05728151|Carticaine|carticaine|mesh-list
101735959|NCT05728151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101735960|NCT05728151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101735961|NCT05728151|Adrenergic Agents|adrenergic agents|mesh-ancestor
101735962|NCT05728151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101735963|NCT05728151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735964|NCT05728151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735965|NCT05728151|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101735966|NCT05728151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101735967|NCT05728151|Autonomic Agents|autonomic agents|mesh-ancestor
101735968|NCT05728151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101735969|NCT05728151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101735970|NCT05728151|Respiratory System Agents|respiratory system agents|mesh-ancestor
101735971|NCT05728151|Mydriatics|mydriatics|mesh-ancestor
101735972|NCT05728151|Sympathomimetics|sympathomimetics|mesh-ancestor
101735973|NCT05728151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101735974|NCT05728151|Anesthetics, Local|anesthetics, local|mesh-ancestor
101735975|NCT05728151|Anesthetics|anesthetics|mesh-ancestor
101735976|NCT05728151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101735977|NCT05728151|Sensory System Agents|sensory system agents|mesh-ancestor
101735978|NCT00733746|Gemcitabine|gemcitabine|mesh-list
101735979|NCT00733746|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101735980|NCT00733746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101735981|NCT00733746|Antimetabolites|antimetabolites|mesh-ancestor
101735982|NCT00733746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735983|NCT00733746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101735984|NCT00733746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101735985|NCT00733746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101735986|NCT03422705|Lisinopril|lisinopril|mesh-list
101735987|NCT03422705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101735988|NCT03422705|Protease Inhibitors|protease inhibitors|mesh-ancestor
101735989|NCT03422705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101735990|NCT03422705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735991|NCT03422705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101735992|NCT03422705|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101735993|NCT03422705|Protective Agents|protective agents|mesh-ancestor
101735994|NCT03422705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736013|NCT04085757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101736014|NCT04085757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736015|NCT00727194|Eculizumab|eculizumab|mesh-list
101736016|NCT00727194|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101736017|NCT00727194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101736018|NCT00727194|Immunologic Factors|immunologic factors|mesh-ancestor
101736019|NCT00727194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736020|NCT00717093|Varenicline|varenicline|mesh-list
101736021|NCT00717093|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101736022|NCT00717093|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101736023|NCT00717093|Cholinergic Agents|cholinergic agents|mesh-ancestor
101736024|NCT00717093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101952493|NCT01205139|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101952494|NCT01205139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101952495|NCT01205139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101736025|NCT00717093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736026|NCT00717093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736028|NCT00716859|Latanoprost|latanoprost|mesh-list
101736029|NCT00716859|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101736030|NCT00716859|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101736031|NCT00716859|Adrenergic Agents|adrenergic agents|mesh-ancestor
101736032|NCT00716859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101736033|NCT00716859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736034|NCT00716859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736035|NCT00716859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101736036|NCT00716859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101736037|NCT00716859|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101736038|NCT00716859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101736039|NCT00590135|Atorvastatin|atorvastatin|mesh-list
101736040|NCT00590135|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101736041|NCT00590135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101736042|NCT00590135|Antimetabolites|antimetabolites|mesh-ancestor
101736043|NCT00590135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736044|NCT00590135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101736045|NCT00590135|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101736046|NCT00590135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101736047|NCT00589667|Gemcitabine|gemcitabine|mesh-list
101736048|NCT00589667|Pemetrexed|pemetrexed|mesh-list
101736049|NCT00589667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101736050|NCT00589667|Antimetabolites|antimetabolites|mesh-ancestor
101736051|NCT00589667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736052|NCT00589667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101736055|NCT00589667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101736056|NCT00737568|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101736057|NCT00737568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101736058|NCT00737568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101736059|NCT00737568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101736060|NCT00737568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736061|NCT00737568|Antiviral Agents|antiviral agents|mesh-ancestor
101736062|NCT00737568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101736063|NCT00737568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101736064|NCT00737568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101736065|NCT05752799|Analgesics, Opioid|analgesics, opioid|mesh-list
101736066|NCT05752799|Anesthetics|anesthetics|mesh-list
101736067|NCT05752799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101736068|NCT05752799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736069|NCT05752799|Narcotics|narcotics|mesh-ancestor
101736070|NCT05752799|Analgesics|analgesics|mesh-ancestor
101736071|NCT05752799|Sensory System Agents|sensory system agents|mesh-ancestor
101736072|NCT05752799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101736073|NCT00737100|Bromides|bromides|mesh-list
101736074|NCT00737100|Tiotropium Bromide|tiotropium bromide|mesh-list
101736075|NCT00737100|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101736076|NCT00737100|Autonomic Agents|autonomic agents|mesh-ancestor
101736077|NCT00737100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101736078|NCT00737100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736079|NCT00737100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101736080|NCT00737100|Respiratory System Agents|respiratory system agents|mesh-ancestor
101736081|NCT00737100|Parasympatholytics|parasympatholytics|mesh-ancestor
101736082|NCT00737100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101736083|NCT00737100|Cholinergic Agents|cholinergic agents|mesh-ancestor
101736084|NCT00737100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101736085|NCT00737100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736086|NCT00737100|Anticonvulsants|anticonvulsants|mesh-ancestor
101736088|NCT00732498|Methylprednisolone|methylprednisolone|mesh-list
101736089|NCT00732498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101736090|NCT00732498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101736091|NCT00732498|Prednisolone|prednisolone|mesh-list
101736092|NCT00732498|Prednisolone acetate|prednisolone acetate|mesh-list
101736093|NCT00732498|Rituximab|rituximab|mesh-list
101736094|NCT00732498|Etoposide|etoposide|mesh-list
101736095|NCT00732498|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101952496|NCT01205217|Paclitaxel|paclitaxel|mesh-list
101952497|NCT01205217|Cyclophosphamide|cyclophosphamide|mesh-list
101952498|NCT01205217|Trastuzumab|trastuzumab|mesh-list
101952499|NCT01205217|Epirubicin|epirubicin|mesh-list
101952500|NCT01205217|Lapatinib|lapatinib|mesh-list
101736096|NCT00732498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101736097|NCT00732498|Prednisolone phosphate|prednisolone phosphate|mesh-list
101736098|NCT00732498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101736099|NCT00732498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101736100|NCT00732498|Immunologic Factors|immunologic factors|mesh-ancestor
101736101|NCT00732498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736102|NCT00732498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101736103|NCT00732498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101736104|NCT00732498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101736105|NCT00732498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101736106|NCT00732498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101736107|NCT00732498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736108|NCT00732498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101736109|NCT00732498|Antimetabolites|antimetabolites|mesh-ancestor
101736110|NCT00732498|Antiviral Agents|antiviral agents|mesh-ancestor
101736111|NCT00732498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101736112|NCT00732498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101736113|NCT00732498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101736114|NCT00732498|Antiemetics|antiemetics|mesh-ancestor
101736115|NCT00732498|Autonomic Agents|autonomic agents|mesh-ancestor
101736116|NCT00732498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101736117|NCT00732498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101736118|NCT00732498|Glucocorticoids|glucocorticoids|mesh-ancestor
101736119|NCT00732498|Hormones|hormones|mesh-ancestor
101736120|NCT00732498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101736121|NCT00732498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101736122|NCT00732498|Protective Agents|protective agents|mesh-ancestor
101736123|NCT00732498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101736124|NCT00790400|Everolimus|everolimus|mesh-list
101736125|NCT00790400|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101736126|NCT00790400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101736133|NCT00915512|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101736134|NCT00915512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101736135|NCT00915512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101527228|NCT03456882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101736136|NCT00915512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101736137|NCT00915512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736138|NCT00915512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101736139|NCT00915512|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101736140|NCT00915512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101736141|NCT00915512|Serotonin Agents|serotonin agents|mesh-ancestor
101736142|NCT00915512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101736143|NCT00915512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736144|NCT00915512|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101736145|NCT00915512|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101736146|NCT00915512|Dopamine Agents|dopamine agents|mesh-ancestor
101736147|NCT02602652|Vaccines|vaccines|mesh-list
101736148|NCT02602652|Immunologic Factors|immunologic factors|mesh-ancestor
101736149|NCT02602652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736150|NCT02593500|Budesonide|budesonide|mesh-list
101736151|NCT02593500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101736152|NCT02593500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101736153|NCT02593500|Autonomic Agents|autonomic agents|mesh-ancestor
101736154|NCT02593500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101736155|NCT02593500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736156|NCT02593500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101736157|NCT02593500|Respiratory System Agents|respiratory system agents|mesh-ancestor
101736158|NCT02593500|Glucocorticoids|glucocorticoids|mesh-ancestor
101736159|NCT02593500|Hormones|hormones|mesh-ancestor
101736160|NCT02593500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101736161|NCT02594358|Caffeine|caffeine|mesh-list
101736162|NCT02594358|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101736163|NCT02594358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736164|NCT02594358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101736165|NCT02594358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101736166|NCT02594358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736167|NCT02594358|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101952501|NCT01205217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101952502|NCT01205217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101952503|NCT01205217|Tubulin Modulators|tubulin modulators|mesh-ancestor
101736168|NCT02594358|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101736169|NCT02594358|Purinergic Agents|purinergic agents|mesh-ancestor
101736170|NCT02594358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101736171|NCT00785486|Quinine|quinine|mesh-list
101736172|NCT00785486|Midazolam|midazolam|mesh-list
101736173|NCT00785486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101736174|NCT00785486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101736175|NCT00785486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101736176|NCT00785486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736177|NCT00785486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101736178|NCT00785486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101736179|NCT00785486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101736180|NCT00785486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101736181|NCT00785486|Anesthetics, General|anesthetics, general|mesh-ancestor
101736182|NCT00785486|Anesthetics|anesthetics|mesh-ancestor
101736183|NCT00785486|GABA Modulators|gaba modulators|mesh-ancestor
101736184|NCT00785486|GABA Agents|gaba agents|mesh-ancestor
101736185|NCT00785486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101736186|NCT00785486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736187|NCT00785486|Antimalarials|antimalarials|mesh-ancestor
101736188|NCT00785486|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101736189|NCT00785486|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101736190|NCT00785486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101736191|NCT00785486|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101736192|NCT00785486|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101736193|NCT00785486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101736194|NCT00785486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101736202|NCT00589979|Lidocaine|lidocaine|mesh-list
101736203|NCT00589979|Anesthetics, Local|anesthetics, local|mesh-ancestor
101736204|NCT00589979|Anesthetics|anesthetics|mesh-ancestor
101736205|NCT00589979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101736206|NCT00589979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736207|NCT00589979|Sensory System Agents|sensory system agents|mesh-ancestor
101736208|NCT00589979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101736209|NCT00589979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101736210|NCT00589979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101736211|NCT00589979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101736212|NCT00589979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101736213|NCT00589979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736214|NCT02590653|Atorvastatin|atorvastatin|mesh-list
101736215|NCT02590653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101736216|NCT02590653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101736217|NCT02590653|Antimetabolites|antimetabolites|mesh-ancestor
101736218|NCT02590653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736219|NCT02590653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101736220|NCT02590653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101736221|NCT02590653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101736222|NCT00915746|Ketoconazole|ketoconazole|mesh-list
101736223|NCT00915746|Antifungal Agents|antifungal agents|mesh-ancestor
101736224|NCT00915746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101736225|NCT00915746|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101736226|NCT00915746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101736227|NCT00915746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101736228|NCT00915746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736229|NCT00915746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101736230|NCT00915746|Hormone Antagonists|hormone antagonists|mesh-ancestor
101736231|NCT00915746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101736232|NCT00915746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736233|NCT00915746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101736234|NCT00736944|Cisplatin|cisplatin|mesh-list
101736235|NCT00736944|Cetuximab|cetuximab|mesh-list
101736236|NCT00736944|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101736237|NCT00736944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101736238|NCT00736944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101736239|NCT02603510|Insulin Lispro|insulin lispro|mesh-list
101736240|NCT02603510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101736241|NCT02603510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736242|NCT04084977|Antibodies|antibodies|mesh-list
101952504|NCT01205217|Antimitotic Agents|antimitotic agents|mesh-ancestor
101952505|NCT01205217|Mitosis Modulators|mitosis modulators|mesh-ancestor
101952506|NCT01205217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736243|NCT04084977|Immunologic Factors|immunologic factors|mesh-ancestor
101736244|NCT04084977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736246|NCT04107194|Metronidazole|metronidazole|mesh-list
101736247|NCT04107194|Clarithromycin|clarithromycin|mesh-list
101736248|NCT04107194|Levofloxacin|levofloxacin|mesh-list
101736249|NCT04107194|Tetracycline|tetracycline|mesh-list
101736250|NCT04107194|Rifabutin|rifabutin|mesh-list
101736251|NCT04107194|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
101736252|NCT04107194|Pantoprazole|pantoprazole|mesh-list
101736253|NCT04107194|Bismuth|bismuth|mesh-list
101736254|NCT04107194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101736255|NCT04107194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101736256|NCT04107194|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101736257|NCT04107194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101736258|NCT04107194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101736259|NCT04107194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101736260|NCT04107194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736261|NCT04107194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101736262|NCT04107194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101736263|NCT04107194|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101736269|NCT04107194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101736270|NCT04107194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101736271|NCT04107194|Antacids|antacids|mesh-ancestor
101736272|NCT04107194|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101736273|NCT04107194|Antitubercular Agents|antitubercular agents|mesh-ancestor
101736274|NCT02590263|Temozolomide|temozolomide|mesh-list
101736275|NCT02590263|ABT-414|abt-414|mesh-list
101736276|NCT02590263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101736277|NCT02590263|Alkylating Agents|alkylating agents|mesh-ancestor
101736278|NCT02590263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736279|NCT02590263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101736280|NCT02590263|Immunoconjugates|immunoconjugates|mesh-ancestor
101736281|NCT02590263|Immunologic Factors|immunologic factors|mesh-ancestor
101736282|NCT02590263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736283|NCT00736476|Vaccines|vaccines|mesh-list
101736284|NCT00736476|Immunologic Factors|immunologic factors|mesh-ancestor
101736285|NCT00736476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736286|NCT02606357|Insulin Glargine|insulin glargine|mesh-list
101736287|NCT02606357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101736288|NCT02606357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736289|NCT04019496|Calcitonin|calcitonin|mesh-list
101736290|NCT04019496|Salmon calcitonin|salmon calcitonin|mesh-list
101736291|NCT04019496|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
101736292|NCT04019496|Antibodies|antibodies|mesh-list
101736293|NCT04019496|Katacalcin|katacalcin|mesh-list
101736294|NCT04019496|Immunologic Factors|immunologic factors|mesh-ancestor
101736295|NCT04019496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736296|NCT04019496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101736297|NCT04019496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101736298|NCT04019496|Vasodilator Agents|vasodilator agents|mesh-ancestor
101736309|NCT00918489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101736310|NCT00918489|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101736311|NCT00918489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101736312|NCT00918489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736313|NCT02604992|Dronabinol|dronabinol|mesh-list
101736314|NCT02604992|Hallucinogens|hallucinogens|mesh-ancestor
101736315|NCT02604992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736316|NCT02604992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101736317|NCT02604992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101736318|NCT02604992|Analgesics|analgesics|mesh-ancestor
101952508|NCT01205217|Immunologic Factors|immunologic factors|mesh-ancestor
101952509|NCT01205217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952510|NCT01205217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101952511|NCT01205217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101952512|NCT01205217|Alkylating Agents|alkylating agents|mesh-ancestor
101295291|NCT01983735|Vitamins|vitamins|mesh-ancestor
101736319|NCT02604992|Sensory System Agents|sensory system agents|mesh-ancestor
101736320|NCT02604992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101736321|NCT02604992|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101736322|NCT02604992|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101736323|NCT02604992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101736324|NCT02604992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736325|NCT02604992|Hormones|hormones|mesh-ancestor
101736326|NCT02604992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101736327|NCT03899597|Oxytocin|oxytocin|mesh-list
101736328|NCT03899597|Oxytocics|oxytocics|mesh-ancestor
101736329|NCT03899597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101736330|NCT03899597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736331|NCT00714285|Vaccines|vaccines|mesh-list
101736332|NCT00714285|Immunologic Factors|immunologic factors|mesh-ancestor
101736333|NCT00714285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736334|NCT00776984|Tiotropium Bromide|tiotropium bromide|mesh-list
101736368|NCT00784784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736369|NCT00587288|Reslizumab|reslizumab|mesh-list
101736370|NCT00587288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101736371|NCT00587288|Respiratory System Agents|respiratory system agents|mesh-ancestor
101736372|NCT00800735|Interferons|interferons|mesh-list
101736373|NCT00800735|Ribavirin|ribavirin|mesh-list
101736374|NCT00800735|Interferon-alpha|interferon-alpha|mesh-list
101736375|NCT00800735|Interferon alpha-2|interferon alpha-2|mesh-list
101736376|NCT00800735|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101736377|NCT00800735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101736378|NCT00800735|Antiviral Agents|antiviral agents|mesh-ancestor
101736401|NCT00730158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736402|NCT00730158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101736404|NCT04114643|Hemostatics|hemostatics|mesh-ancestor
101736405|NCT04114643|Coagulants|coagulants|mesh-ancestor
101736406|NCT02989662|Mifepristone|mifepristone|mesh-list
101736407|NCT02989662|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101736408|NCT02989662|Abortifacient Agents|abortifacient agents|mesh-ancestor
101736409|NCT02989662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101736410|NCT02989662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736411|NCT02989662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101736412|NCT02989662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101736413|NCT02989662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101736414|NCT02989662|Contraceptive Agents|contraceptive agents|mesh-ancestor
101736415|NCT02989662|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101736416|NCT02989662|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101736417|NCT02989662|Hormone Antagonists|hormone antagonists|mesh-ancestor
101736418|NCT02989662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101736419|NCT02989662|Luteolytic Agents|luteolytic agents|mesh-ancestor
101736420|NCT02989662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101736421|NCT02989662|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101736422|NCT00784550|Fluticasone|fluticasone|mesh-list
101736423|NCT00784550|Xhance|xhance|mesh-list
101736424|NCT00784550|Bromides|bromides|mesh-list
101736425|NCT00784550|Tiotropium Bromide|tiotropium bromide|mesh-list
101736426|NCT00784550|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101736427|NCT00784550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101736428|NCT00784550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101736429|NCT00784550|Autonomic Agents|autonomic agents|mesh-ancestor
101736436|NCT00784550|Parasympatholytics|parasympatholytics|mesh-ancestor
101736437|NCT00784550|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101736438|NCT00784550|Cholinergic Agents|cholinergic agents|mesh-ancestor
101736439|NCT00784550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101736440|NCT00784550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736441|NCT00784550|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101952513|NCT01205217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101952514|NCT01205217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101952515|NCT01205217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101736442|NCT00784550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101736443|NCT00784550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101736444|NCT00784550|Adrenergic Agents|adrenergic agents|mesh-ancestor
101736445|NCT00784550|Anticonvulsants|anticonvulsants|mesh-ancestor
101736446|NCT00729690|Pregabalin|pregabalin|mesh-list
101736447|NCT00729690|Analgesics|analgesics|mesh-ancestor
101736448|NCT00729690|Sensory System Agents|sensory system agents|mesh-ancestor
101736449|NCT00729690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101736450|NCT00729690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736451|NCT00729690|Anticonvulsants|anticonvulsants|mesh-ancestor
101736452|NCT00729690|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101736453|NCT00729690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101736454|NCT00729690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736455|NCT00729690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101736456|NCT00729690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101736457|NCT00729690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101736458|NCT00729690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101736459|NCT00729690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101736460|NCT04027829|Dexmedetomidine|dexmedetomidine|mesh-list
101736461|NCT04027829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101736462|NCT04027829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101736463|NCT04027829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736464|NCT04027829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101736465|NCT04027829|Analgesics|analgesics|mesh-ancestor
101736466|NCT04027829|Sensory System Agents|sensory system agents|mesh-ancestor
101736467|NCT04027829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101736468|NCT04027829|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101736469|NCT04027829|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101736470|NCT04027829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101736471|NCT04027829|Adrenergic Agents|adrenergic agents|mesh-ancestor
101736472|NCT04027829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101736473|NCT04027829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736474|NCT00784238|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101736475|NCT00784238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101736476|NCT00784238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101736477|NCT00784238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101736478|NCT00784238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736479|NCT00784238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101736480|NCT00784238|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101736481|NCT00784238|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101736482|NCT00784238|Serotonin Agents|serotonin agents|mesh-ancestor
101736483|NCT00784238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101736484|NCT00784238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736485|NCT00784238|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101736486|NCT00784238|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101736487|NCT00784238|Dopamine Agents|dopamine agents|mesh-ancestor
101736488|NCT00729612|Paclitaxel|paclitaxel|mesh-list
101736489|NCT00729612|Carboplatin|carboplatin|mesh-list
101736490|NCT00729612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101736491|NCT00729612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101736492|NCT00729612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101736493|NCT00729612|Tubulin Modulators|tubulin modulators|mesh-ancestor
101736494|NCT00729612|Antimitotic Agents|antimitotic agents|mesh-ancestor
101736495|NCT00729612|Mitosis Modulators|mitosis modulators|mesh-ancestor
101736496|NCT00729612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736503|NCT00585546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101736504|NCT00585546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736505|NCT00585546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736506|NCT00585546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101736508|NCT00585546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101736509|NCT00585546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101736510|NCT00585546|Respiratory System Agents|respiratory system agents|mesh-ancestor
101736511|NCT00585546|Sympathomimetics|sympathomimetics|mesh-ancestor
101736512|NCT00768248|Ropivacaine|ropivacaine|mesh-list
101736513|NCT00768248|Anesthetics, Local|anesthetics, local|mesh-ancestor
101736514|NCT00768248|Anesthetics|anesthetics|mesh-ancestor
101736515|NCT00768248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101952516|NCT01205217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101952517|NCT01205217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101952518|NCT01205217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101952519|NCT01205217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101952520|NCT01203267|Paclitaxel|paclitaxel|mesh-list
101736516|NCT00768248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736517|NCT00768248|Sensory System Agents|sensory system agents|mesh-ancestor
101736518|NCT00768248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101736519|NCT02589717|Atezolizumab|atezolizumab|mesh-list
101736520|NCT02589717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101736521|NCT02589717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736522|NCT02589717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101736523|NCT02589717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101736524|NCT02602028|Colchicine|colchicine|mesh-list
101736525|NCT02602028|Gout Suppressants|gout suppressants|mesh-ancestor
101736526|NCT02602028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101736527|NCT02602028|Tubulin Modulators|tubulin modulators|mesh-ancestor
101736528|NCT02602028|Antimitotic Agents|antimitotic agents|mesh-ancestor
101736529|NCT02602028|Mitosis Modulators|mitosis modulators|mesh-ancestor
101736530|NCT02602028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736531|NCT02602028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101736532|NCT04103684|Dexamethasone|dexamethasone|mesh-list
101736533|NCT04103684|Methylprednisolone|methylprednisolone|mesh-list
101736534|NCT04103684|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101736535|NCT04103684|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101736536|NCT04103684|Prednisolone|prednisolone|mesh-list
101736537|NCT04103684|Prednisolone acetate|prednisolone acetate|mesh-list
101736538|NCT04103684|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101736539|NCT04103684|Prednisolone phosphate|prednisolone phosphate|mesh-list
101736540|NCT04103684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101736541|NCT04103684|Antiemetics|antiemetics|mesh-ancestor
101736542|NCT04103684|Autonomic Agents|autonomic agents|mesh-ancestor
101736543|NCT04103684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101736544|NCT04103684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736545|NCT04103684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101736546|NCT04103684|Glucocorticoids|glucocorticoids|mesh-ancestor
101736547|NCT04103684|Hormones|hormones|mesh-ancestor
101736548|NCT04103684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101736549|NCT04103684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101736550|NCT04103684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101736551|NCT04103684|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101736552|NCT04103684|Protective Agents|protective agents|mesh-ancestor
101736553|NCT00775268|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101736554|NCT00775268|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101736555|NCT00775268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736556|NCT00775190|Moxifloxacin|moxifloxacin|mesh-list
101736557|NCT00775190|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101736558|NCT00775190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101736559|NCT00775190|Contraceptive Agents|contraceptive agents|mesh-ancestor
101736560|NCT00775190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101736561|NCT00775190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736562|NCT00775190|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101736563|NCT00775190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101527334|NCT02695771|Antimetabolites|antimetabolites|mesh-ancestor
101736564|NCT00775190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101488109|NCT00329810|Serotonin Agents|serotonin agents|mesh-ancestor
101736568|NCT00775190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101736569|NCT00775190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101736570|NCT00775190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736571|NCT00775190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101736572|NCT00479557|Saponin QA-21V1|saponin qa-21v1|mesh-list
101736573|NCT00479557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101736574|NCT00479557|Immunologic Factors|immunologic factors|mesh-ancestor
101736575|NCT00479557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736576|NCT00774800|Insulin|insulin|mesh-list
101736577|NCT00774800|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101736578|NCT00774800|Insulin Lispro|insulin lispro|mesh-list
101736579|NCT00774800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101736580|NCT00774800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736581|NCT00439309|Thrombin|thrombin|mesh-list
101736582|NCT00439309|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
101952522|NCT01203267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101672331|NCT03493854|Tubulin Modulators|tubulin modulators|mesh-ancestor
101952523|NCT01203267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101295532|NCT01985373|Antibodies|antibodies|mesh-list
101736583|NCT00439309|Hemostatics|hemostatics|mesh-ancestor
101736584|NCT00439309|Coagulants|coagulants|mesh-ancestor
101736585|NCT00479167|Bortezomib|bortezomib|mesh-list
101736586|NCT00479167|Tositumomab I-131|tositumomab i-131|mesh-list
101736587|NCT00479167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101736588|NCT00725322|Botulinum Toxins|botulinum toxins|mesh-list
101736589|NCT00725322|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101736590|NCT00725322|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101736591|NCT00725322|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101736592|NCT00725322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101736593|NCT00725322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736594|NCT00725322|Cholinergic Agents|cholinergic agents|mesh-ancestor
101736595|NCT00725322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101736596|NCT00725322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736597|NCT00725322|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101736598|NCT00725322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101736599|NCT00725010|Temozolomide|temozolomide|mesh-list
101736600|NCT00725010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101736601|NCT00725010|Alkylating Agents|alkylating agents|mesh-ancestor
101394076|NCT03374085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101736602|NCT00725010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736603|NCT00725010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101736604|NCT05216055|Dexamethasone|dexamethasone|mesh-list
101736605|NCT05216055|Dexamethasone acetate|dexamethasone acetate|mesh-list
101736606|NCT05216055|Dexmedetomidine|dexmedetomidine|mesh-list
101736607|NCT05216055|Bupivacaine|bupivacaine|mesh-list
101736608|NCT05216055|Ropivacaine|ropivacaine|mesh-list
101736609|NCT05216055|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101736610|NCT05216055|BB 1101|bb 1101|mesh-list
101736611|NCT05216055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101736612|NCT05216055|Antiemetics|antiemetics|mesh-ancestor
101736613|NCT05216055|Autonomic Agents|autonomic agents|mesh-ancestor
101736614|NCT05216055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101736615|NCT05216055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736616|NCT05216055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101736617|NCT05216055|Glucocorticoids|glucocorticoids|mesh-ancestor
101736618|NCT05216055|Hormones|hormones|mesh-ancestor
101736619|NCT05216055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101736620|NCT05216055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101736621|NCT05216055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101736622|NCT05216055|Anesthetics, Local|anesthetics, local|mesh-ancestor
101736623|NCT05216055|Anesthetics|anesthetics|mesh-ancestor
101736624|NCT05216055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101736625|NCT05216055|Sensory System Agents|sensory system agents|mesh-ancestor
101736626|NCT05216055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101736627|NCT05216055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101736628|NCT05216055|Analgesics|analgesics|mesh-ancestor
101736629|NCT05216055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101736630|NCT05216055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101736631|NCT05216055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101736632|NCT05216055|Adrenergic Agents|adrenergic agents|mesh-ancestor
101736633|NCT05216055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101736634|NCT05216055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736636|NCT05216055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101736637|NCT00767000|Metformin|metformin|mesh-list
101736638|NCT00767000|Insulin Glargine|insulin glargine|mesh-list
101736643|NCT05194449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736645|NCT00724932|Bromides|bromides|mesh-list
101736646|NCT00724932|Rocuronium|rocuronium|mesh-list
101736647|NCT00724932|Neostigmine|neostigmine|mesh-list
101736648|NCT00724932|Anticonvulsants|anticonvulsants|mesh-ancestor
101736649|NCT00724932|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101736650|NCT00724932|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101736651|NCT00724932|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101736652|NCT00724932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101736653|NCT00724932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736654|NCT00724932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101952524|NCT01203267|Tubulin Modulators|tubulin modulators|mesh-ancestor
101952525|NCT01203267|Antimitotic Agents|antimitotic agents|mesh-ancestor
101952526|NCT01203267|Mitosis Modulators|mitosis modulators|mesh-ancestor
101952527|NCT01203267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952528|NCT01207245|Tobramycin|tobramycin|mesh-list
101736655|NCT00724932|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101736656|NCT00724932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101736657|NCT00724932|Autonomic Agents|autonomic agents|mesh-ancestor
101736658|NCT00724932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101736659|NCT00724932|Respiratory System Agents|respiratory system agents|mesh-ancestor
101736660|NCT00724932|Mydriatics|mydriatics|mesh-ancestor
101736661|NCT00724932|Parasympatholytics|parasympatholytics|mesh-ancestor
101736662|NCT00724932|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101736663|NCT00724932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101736664|NCT00724932|Cholinergic Agents|cholinergic agents|mesh-ancestor
101736665|NCT00724932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101736666|NCT00724932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736667|NCT00724932|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101736668|NCT00724932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101736669|NCT00724932|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101736670|NCT00766532|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101736671|NCT00766532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101736672|NCT00766532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101736673|NCT00766532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736674|NCT00766532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101736675|NCT00766532|Hormone Antagonists|hormone antagonists|mesh-ancestor
101736676|NCT00766532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101736677|NCT00766532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736678|NCT04083807|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101736679|NCT04083807|Thrombin|thrombin|mesh-list
101736680|NCT04083807|Hemostatics|hemostatics|mesh-ancestor
101736681|NCT04083807|Coagulants|coagulants|mesh-ancestor
101736682|NCT05163483|Bevacizumab|bevacizumab|mesh-list
101736683|NCT05163483|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101736684|NCT05163483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101736685|NCT05163483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101736686|NCT05163483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101736687|NCT05163483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101736688|NCT05163483|Growth Substances|growth substances|mesh-ancestor
101736689|NCT05163483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736690|NCT05163483|Growth Inhibitors|growth inhibitors|mesh-ancestor
101736691|NCT05163483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736692|NCT00766142|Leucovorin|leucovorin|mesh-list
101736693|NCT00766142|Fluorouracil|fluorouracil|mesh-list
101736694|NCT00766142|Oxaliplatin|oxaliplatin|mesh-list
101736695|NCT00766142|Cetuximab|cetuximab|mesh-list
101736696|NCT00766142|Calcium|calcium|mesh-list
101736697|NCT00766142|Levoleucovorin|levoleucovorin|mesh-list
101736698|NCT00766142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101736699|NCT00766142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340256|NCT03991130|Nivolumab|nivolumab|mesh-list
101736700|NCT00766142|Antimetabolites|antimetabolites|mesh-ancestor
101736701|NCT00766142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736702|NCT00766142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101736703|NCT00766142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101736704|NCT00766142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101736705|NCT00766142|Immunologic Factors|immunologic factors|mesh-ancestor
101736706|NCT00766142|Antidotes|antidotes|mesh-ancestor
101736707|NCT00766142|Protective Agents|protective agents|mesh-ancestor
101736708|NCT00766142|Vitamin B Complex|vitamin b complex|mesh-ancestor
101736709|NCT00766142|Vitamins|vitamins|mesh-ancestor
101736711|NCT00766142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101736713|NCT00916526|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101736714|NCT00916526|Diuretics|diuretics|mesh-ancestor
101736715|NCT00916526|Natriuretic Agents|natriuretic agents|mesh-ancestor
101736716|NCT00916526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736717|NCT00724854|Ribavirin|ribavirin|mesh-list
101736718|NCT00724854|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101736719|NCT00724854|Interferon-alpha|interferon-alpha|mesh-list
101736720|NCT00724854|Antimetabolites|antimetabolites|mesh-ancestor
101736721|NCT00724854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736722|NCT00724854|Antiviral Agents|antiviral agents|mesh-ancestor
101952529|NCT01207245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101952530|NCT01207245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101952531|NCT01297569|Ranibizumab|ranibizumab|mesh-list
101295662|NCT01985854|Desflurane|desflurane|mesh-list
101736723|NCT00724854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101736724|NCT00724854|Immunologic Factors|immunologic factors|mesh-ancestor
101736725|NCT00724854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736726|NCT04083651|Bromides|bromides|mesh-list
101736727|NCT04083651|Methylnaltrexone|methylnaltrexone|mesh-list
101736728|NCT04083651|Anticonvulsants|anticonvulsants|mesh-ancestor
101736729|NCT04083651|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101736730|NCT04083651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736731|NCT04083651|Sensory System Agents|sensory system agents|mesh-ancestor
101736732|NCT04083651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101736733|NCT00728988|Atorvastatin|atorvastatin|mesh-list
101736734|NCT00728988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101736735|NCT00728988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101736736|NCT00728988|Antimetabolites|antimetabolites|mesh-ancestor
101736737|NCT00728988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736738|NCT00728988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101736739|NCT00728988|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101736740|NCT00728988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101736741|NCT04087746|Ranibizumab|ranibizumab|mesh-list
101736742|NCT04087746|Aflibercept|aflibercept|mesh-list
101736743|NCT04087746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101736744|NCT04087746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101736745|NCT04087746|Growth Substances|growth substances|mesh-ancestor
101736746|NCT04087746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736747|NCT04087746|Growth Inhibitors|growth inhibitors|mesh-ancestor
101736748|NCT04087746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101736749|NCT04083417|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101736750|NCT04083417|Penicillins|penicillins|mesh-list
101736751|NCT04083417|Penicillin V|penicillin v|mesh-list
101736752|NCT04083417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101736753|NCT02588937|Entecavir|entecavir|mesh-list
101736754|NCT02588937|Antiviral Agents|antiviral agents|mesh-ancestor
101736755|NCT02588937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101736756|NCT04083105|Midazolam|midazolam|mesh-list
101736757|NCT04083105|Nitrous Oxide|nitrous oxide|mesh-list
101736758|NCT04083105|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101736759|NCT04083105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101736760|NCT04083105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101736761|NCT04083105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736762|NCT04083105|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101736763|NCT04083105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101736764|NCT04083105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101736765|NCT04083105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101736766|NCT04083105|Anesthetics, General|anesthetics, general|mesh-ancestor
101736767|NCT04083105|Anesthetics|anesthetics|mesh-ancestor
101736768|NCT04083105|GABA Modulators|gaba modulators|mesh-ancestor
101736769|NCT04083105|GABA Agents|gaba agents|mesh-ancestor
101736770|NCT04083105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101736771|NCT04083105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736772|NCT04083105|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101736773|NCT04083105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101736774|NCT04083105|Analgesics|analgesics|mesh-ancestor
101736775|NCT04083105|Sensory System Agents|sensory system agents|mesh-ancestor
101736776|NCT04083105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101736777|NCT00735696|Paclitaxel|paclitaxel|mesh-list
101736778|NCT00735696|Carboplatin|carboplatin|mesh-list
101736779|NCT00735696|Ramucirumab|ramucirumab|mesh-list
101736780|NCT00735696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101736781|NCT00735696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101736782|NCT00735696|Tubulin Modulators|tubulin modulators|mesh-ancestor
101736783|NCT00735696|Antimitotic Agents|antimitotic agents|mesh-ancestor
101736784|NCT00735696|Mitosis Modulators|mitosis modulators|mesh-ancestor
101736785|NCT00735696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488389|NCT00431145|Niacin|niacin|mesh-list
101736801|NCT00478231|Maraviroc|maraviroc|mesh-list
101736802|NCT00478231|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101736803|NCT00478231|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101736804|NCT00478231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736805|NCT00478231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101736806|NCT00478231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101736807|NCT00478231|Antiviral Agents|antiviral agents|mesh-ancestor
101952532|NCT01297569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101952533|NCT01297569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101736808|NCT00478231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101736809|NCT00478231|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101736810|NCT00474175|Benzocaine|benzocaine|mesh-list
101736811|NCT00474175|Anesthetics, Local|anesthetics, local|mesh-ancestor
101736812|NCT00474175|Anesthetics|anesthetics|mesh-ancestor
101736813|NCT00474175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101736814|NCT00474175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736815|NCT00474175|Sensory System Agents|sensory system agents|mesh-ancestor
101736816|NCT00474175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101736817|NCT03002389|Fluticasone|fluticasone|mesh-list
101736818|NCT03002389|Xhance|xhance|mesh-list
101736819|NCT03002389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101736820|NCT03002389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101736821|NCT03002389|Autonomic Agents|autonomic agents|mesh-ancestor
101736822|NCT03002389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101736823|NCT03002389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736824|NCT03002389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101736825|NCT03002389|Respiratory System Agents|respiratory system agents|mesh-ancestor
101736826|NCT03002389|Dermatologic Agents|dermatologic agents|mesh-ancestor
101736827|NCT03002389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101736828|NCT04082949|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101736829|NCT04082949|Hemostatics|hemostatics|mesh-ancestor
101736830|NCT04082949|Coagulants|coagulants|mesh-ancestor
101736831|NCT01020643|Propofol|propofol|mesh-list
101736832|NCT01020643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101736833|NCT01020643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101736834|NCT01020643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736835|NCT01020643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101736836|NCT01020643|Anesthetics, General|anesthetics, general|mesh-ancestor
101736837|NCT01020643|Anesthetics|anesthetics|mesh-ancestor
101736838|NCT03537391|Fluorides|fluorides|mesh-list
101736839|NCT03537391|Cariostatic Agents|cariostatic agents|mesh-ancestor
101736840|NCT03537391|Protective Agents|protective agents|mesh-ancestor
101736841|NCT03537391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736842|NCT04082715|Celecoxib|celecoxib|mesh-list
101736843|NCT04082715|Levodopa|levodopa|mesh-list
101736844|NCT04082715|Carbidopa|carbidopa|mesh-list
101527380|NCT01792934|Irinotecan|irinotecan|mesh-list
101736845|NCT04082715|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101736846|NCT04082715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101736847|NCT04082715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101736848|NCT04082715|Analgesics|analgesics|mesh-ancestor
101736849|NCT04082715|Sensory System Agents|sensory system agents|mesh-ancestor
101736855|NCT04082715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101736856|NCT04082715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101736857|NCT04082715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736858|NCT04082715|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101736859|NCT04082715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101736861|NCT04082715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101736862|NCT04082715|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101736863|NCT04082715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101736864|NCT04082715|Immunologic Factors|immunologic factors|mesh-ancestor
101736865|NCT04082715|Dopamine Agonists|dopamine agonists|mesh-ancestor
101736866|NCT00443209|Rizatriptan|rizatriptan|mesh-list
101736867|NCT00443209|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101736868|NCT00443209|Serotonin Agents|serotonin agents|mesh-ancestor
101736869|NCT00443209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101736870|NCT00443209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736871|NCT00443209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736872|NCT02588235|Atorvastatin|atorvastatin|mesh-list
101736873|NCT02588235|Ezetimibe|ezetimibe|mesh-list
101736874|NCT02588235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101736875|NCT02588235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101736876|NCT02588235|Antimetabolites|antimetabolites|mesh-ancestor
101736877|NCT02588235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736878|NCT02588235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101736879|NCT02588235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101736880|NCT02588235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101736881|NCT01020955|Mecasermin|mecasermin|mesh-list
101736882|NCT01020955|Growth Substances|growth substances|mesh-ancestor
101736883|NCT01020955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736884|NCT04082793|Diclofenac|diclofenac|mesh-list
101736885|NCT04082793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101952534|NCT01297569|Growth Substances|growth substances|mesh-ancestor
101952535|NCT01297569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101952536|NCT01297569|Growth Inhibitors|growth inhibitors|mesh-ancestor
101952537|NCT01297569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101952538|NCT01203345|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101952539|NCT01203345|Immunologic Factors|immunologic factors|mesh-ancestor
101952540|NCT01203345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736886|NCT04082793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101736887|NCT04082793|Analgesics|analgesics|mesh-ancestor
101736888|NCT04082793|Sensory System Agents|sensory system agents|mesh-ancestor
101736889|NCT04082793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101736890|NCT04082793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736891|NCT04082793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101736892|NCT04082793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101736893|NCT04082793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101736894|NCT04082793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101736895|NCT04082793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736896|NCT00439231|Lenalidomide|lenalidomide|mesh-list
101736897|NCT00439231|Immunologic Factors|immunologic factors|mesh-ancestor
101736898|NCT00439231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736899|NCT00439231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101736900|NCT00439231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101736901|NCT00439231|Growth Substances|growth substances|mesh-ancestor
101736902|NCT00439231|Growth Inhibitors|growth inhibitors|mesh-ancestor
101736903|NCT00439231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101736904|NCT00783692|Vedolizumab|vedolizumab|mesh-list
101736905|NCT00783692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101736906|NCT04992273|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
101736907|NCT04992273|Antiviral Agents|antiviral agents|mesh-ancestor
101736908|NCT04992273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101394385|NCT03118492|Melphalan|melphalan|mesh-list
101736909|NCT00783224|Fluticasone|fluticasone|mesh-list
101736910|NCT00783224|Mometasone Furoate|mometasone furoate|mesh-list
101736911|NCT00783224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101736912|NCT00783224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101736913|NCT00783224|Autonomic Agents|autonomic agents|mesh-ancestor
101736914|NCT00783224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101736915|NCT00783224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736916|NCT00783224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101736917|NCT00783224|Respiratory System Agents|respiratory system agents|mesh-ancestor
101736918|NCT00783224|Dermatologic Agents|dermatologic agents|mesh-ancestor
101736927|NCT04082559|Doxycycline|doxycycline|mesh-list
101736928|NCT04082559|Ciprofloxacin|ciprofloxacin|mesh-list
101736929|NCT04082559|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101736930|NCT04082559|Complement Factor H|complement factor h|mesh-list
101736931|NCT04082559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101736932|NCT04082559|Antitubercular Agents|antitubercular agents|mesh-ancestor
101736933|NCT04082559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101736934|NCT04082559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101736935|NCT04082559|Antimalarials|antimalarials|mesh-ancestor
101736936|NCT04082559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101736937|NCT04082559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101736938|NCT04082559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101736939|NCT04082559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736940|NCT04082559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101736941|NCT04082559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101736942|NCT04082559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101736943|NCT04082559|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101736944|NCT04082559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101736945|NCT04082559|Immunologic Factors|immunologic factors|mesh-ancestor
101736946|NCT04082559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736947|NCT02587845|Tranexamic Acid|tranexamic acid|mesh-list
101736948|NCT02587845|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101736949|NCT02587845|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101736950|NCT02587845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736951|NCT02587845|Hemostatics|hemostatics|mesh-ancestor
101736952|NCT02587845|Coagulants|coagulants|mesh-ancestor
101736954|NCT00765674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101736955|NCT00765674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101736956|NCT00765674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101736957|NCT00765674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101736958|NCT00765674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736959|NCT00765674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101736960|NCT00765674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736961|NCT00765674|Vasodilator Agents|vasodilator agents|mesh-ancestor
101736962|NCT00765674|Diuretics|diuretics|mesh-ancestor
101736963|NCT00765674|Natriuretic Agents|natriuretic agents|mesh-ancestor
101736964|NCT00765674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101736965|NCT00586898|Ketoconazole|ketoconazole|mesh-list
101736966|NCT00586898|Bicalutamide|bicalutamide|mesh-list
101736967|NCT00586898|Testosterone|testosterone|mesh-list
101736968|NCT00586898|Estrogens|estrogens|mesh-list
101736969|NCT00586898|Androgens|androgens|mesh-ancestor
101736970|NCT00586898|Hormones|hormones|mesh-ancestor
101736971|NCT00586898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101736972|NCT00586898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736973|NCT00586898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101736974|NCT00586898|Antifungal Agents|antifungal agents|mesh-ancestor
101736975|NCT00586898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101736976|NCT00586898|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101736977|NCT00586898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101736978|NCT00586898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101736979|NCT00586898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736980|NCT00586898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101736981|NCT00586898|Hormone Antagonists|hormone antagonists|mesh-ancestor
101736982|NCT00586898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101736983|NCT00586898|Androgen Antagonists|androgen antagonists|mesh-ancestor
101736984|NCT02587455|Pembrolizumab|pembrolizumab|mesh-list
101737011|NCT04101812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101737012|NCT04101812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101737013|NCT04101812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737014|NCT04923867|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101737015|NCT04923867|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101737016|NCT04923867|Estradiol|estradiol|mesh-list
101737017|NCT04923867|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101737018|NCT04923867|Estrogens|estrogens|mesh-ancestor
101737019|NCT04923867|Hormones|hormones|mesh-ancestor
101737020|NCT04923867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101737021|NCT04923867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737022|NCT04923867|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101737023|NCT04923867|Contraceptive Agents|contraceptive agents|mesh-ancestor
101737024|NCT04923867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101737025|NCT04923867|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101737026|NCT02587533|Dopamine|dopamine|mesh-list
101737027|NCT02587533|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101737028|NCT02587533|Sympathomimetics|sympathomimetics|mesh-ancestor
101737029|NCT02587533|Autonomic Agents|autonomic agents|mesh-ancestor
101737030|NCT02587533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101737031|NCT02587533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737032|NCT02587533|Dopamine Agents|dopamine agents|mesh-ancestor
101737033|NCT02587533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101737034|NCT02587533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737042|NCT00919815|Prednisolone|prednisolone|mesh-list
101737043|NCT00919815|Cyclosporins|cyclosporins|mesh-list
101737044|NCT00919815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101737045|NCT00919815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737046|NCT00919815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101737047|NCT00919815|Immunologic Factors|immunologic factors|mesh-ancestor
101737048|NCT00919815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737049|NCT00919815|Antifungal Agents|antifungal agents|mesh-ancestor
101737050|NCT00919815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101737051|NCT00919815|Dermatologic Agents|dermatologic agents|mesh-ancestor
101737052|NCT00919815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101737053|NCT00919815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101737054|NCT00919815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101737055|NCT00919815|Glucocorticoids|glucocorticoids|mesh-ancestor
101737056|NCT00919815|Hormones|hormones|mesh-ancestor
101737057|NCT00919815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101737058|NCT00919815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101737059|NCT00919815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101737060|NCT00796991|Paclitaxel|paclitaxel|mesh-list
101952542|NCT01299597|Simvastatin|simvastatin|mesh-list
101952543|NCT01299597|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101952544|NCT01299597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101952545|NCT01299597|Antimetabolites|antimetabolites|mesh-ancestor
101952546|NCT01299597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952547|NCT01299597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101971985|NCT01339754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101737061|NCT00796991|Carboplatin|carboplatin|mesh-list
101737063|NCT00796991|Dacarbazine|dacarbazine|mesh-list
101737064|NCT00796991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101737065|NCT00796991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101737066|NCT00796991|Tubulin Modulators|tubulin modulators|mesh-ancestor
101737067|NCT00796991|Antimitotic Agents|antimitotic agents|mesh-ancestor
101737068|NCT00796991|Mitosis Modulators|mitosis modulators|mesh-ancestor
101737069|NCT00796991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737070|NCT00796991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101737071|NCT00796991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101737072|NCT00796991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101737073|NCT00796991|Alkylating Agents|alkylating agents|mesh-ancestor
101737074|NCT04112147|Ubiquinone|ubiquinone|mesh-list
101737075|NCT04112147|Micronutrients|micronutrients|mesh-ancestor
101737076|NCT04112147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737077|NCT00914771|Vaccines|vaccines|mesh-list
101737078|NCT00914771|Immunologic Factors|immunologic factors|mesh-ancestor
101737079|NCT00914771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737080|NCT02586987|Durvalumab|durvalumab|mesh-list
101737081|NCT02586987|Tremelimumab|tremelimumab|mesh-list
101737082|NCT02586987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101737083|NCT02586987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101737084|NCT02586753|Paclitaxel|paclitaxel|mesh-list
101737085|NCT02586753|Cisplatin|cisplatin|mesh-list
101737086|NCT02586753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101737087|NCT02586753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101737088|NCT02586753|Tubulin Modulators|tubulin modulators|mesh-ancestor
101737089|NCT02586753|Antimitotic Agents|antimitotic agents|mesh-ancestor
101737090|NCT02586753|Mitosis Modulators|mitosis modulators|mesh-ancestor
101737091|NCT02586753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737092|NCT00799487|Methylphenidate|methylphenidate|mesh-list
101737093|NCT00799487|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101737094|NCT00799487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737095|NCT00799487|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101737096|NCT00799487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101737097|NCT00799487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101737098|NCT00799487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737099|NCT00799487|Dopamine Agents|dopamine agents|mesh-ancestor
101737100|NCT00799487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101737101|NCT00799409|Methylphenidate|methylphenidate|mesh-list
101737102|NCT00799409|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101737103|NCT00799409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737104|NCT00799409|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101737111|NCT00782210|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101737112|NCT00782210|Autonomic Agents|autonomic agents|mesh-ancestor
101737113|NCT00782210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101737114|NCT00782210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737115|NCT00782210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101737116|NCT00782210|Respiratory System Agents|respiratory system agents|mesh-ancestor
101737117|NCT01558115|Denosumab|denosumab|mesh-list
101737118|NCT01558115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101737119|NCT01558115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737120|NCT02605265|Capecitabine|capecitabine|mesh-list
101737121|NCT02605265|Oxaliplatin|oxaliplatin|mesh-list
101737122|NCT02605265|Irinotecan|irinotecan|mesh-list
101737123|NCT02605265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101737124|NCT02605265|Antimetabolites|antimetabolites|mesh-ancestor
101737125|NCT02605265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737126|NCT02605265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101737127|NCT02605265|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101952548|NCT01299597|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101952549|NCT01299597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101952550|NCT03723915|Pembrolizumab|pembrolizumab|mesh-list
101737128|NCT02605265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101737129|NCT02605265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101737130|NCT04101500|Aminophylline|aminophylline|mesh-list
101737131|NCT04101500|Bromides|bromides|mesh-list
101737132|NCT04101500|Ipratropium|ipratropium|mesh-list
101737133|NCT04101500|Anticonvulsants|anticonvulsants|mesh-ancestor
101737134|NCT04101500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101737135|NCT04101500|Autonomic Agents|autonomic agents|mesh-ancestor
101394610|NCT02703220|Diuretics|diuretics|mesh-ancestor
101737136|NCT04101500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101737137|NCT04101500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737138|NCT04101500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101737139|NCT04101500|Respiratory System Agents|respiratory system agents|mesh-ancestor
101737140|NCT04101500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101737141|NCT04101500|Cholinergic Agents|cholinergic agents|mesh-ancestor
101737142|NCT04101500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101737143|NCT04101500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737144|NCT04101500|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101737145|NCT04101500|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101737146|NCT04101500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101737147|NCT04101500|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101737148|NCT04101500|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101737149|NCT04101500|Purinergic Agents|purinergic agents|mesh-ancestor
101737150|NCT04101500|Protective Agents|protective agents|mesh-ancestor
101737151|NCT02586441|Bromides|bromides|mesh-list
101737152|NCT02586441|Propofol|propofol|mesh-list
101737153|NCT02586441|Rocuronium|rocuronium|mesh-list
101737154|NCT02586441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101737155|NCT02586441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101737156|NCT02586441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737157|NCT02586441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101737158|NCT02586441|Anesthetics, General|anesthetics, general|mesh-ancestor
101737159|NCT02586441|Anesthetics|anesthetics|mesh-ancestor
101737160|NCT02586441|Anticonvulsants|anticonvulsants|mesh-ancestor
101737161|NCT02586441|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101737162|NCT02586441|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101737163|NCT02586441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101737164|NCT02586441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101737165|NCT02586363|Entecavir|entecavir|mesh-list
101737166|NCT02586363|Antiviral Agents|antiviral agents|mesh-ancestor
101737167|NCT02586363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101737168|NCT02586129|Metformin|metformin|mesh-list
101737169|NCT02586129|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101737170|NCT02586129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101737171|NCT02586129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737172|NCT02586129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101737173|NCT02586129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101737177|NCT02586129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101737178|NCT02586129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101737180|NCT04081077|Linezolid|linezolid|mesh-list
101737181|NCT04081077|Bedaquiline|bedaquiline|mesh-list
101737182|NCT04081077|Clofazimine|clofazimine|mesh-list
101737183|NCT04081077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101737184|NCT04081077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101737185|NCT04081077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101737186|NCT04081077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101737187|NCT04081077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101737188|NCT04081077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737189|NCT04081077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101737190|NCT04081077|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101737191|NCT04081077|Antitubercular Agents|antitubercular agents|mesh-ancestor
101737192|NCT04081077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101737193|NCT04081077|Leprostatic Agents|leprostatic agents|mesh-ancestor
101737194|NCT04669665|Ketamine|ketamine|mesh-list
101737195|NCT04669665|Analgesics|analgesics|mesh-ancestor
101737196|NCT04669665|Sensory System Agents|sensory system agents|mesh-ancestor
101737197|NCT04669665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101737198|NCT04669665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737199|NCT04669665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101737200|NCT04669665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101737201|NCT04669665|Anesthetics, General|anesthetics, general|mesh-ancestor
101952551|NCT03723915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101952552|NCT03723915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101952553|NCT03723915|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101737202|NCT04669665|Anesthetics|anesthetics|mesh-ancestor
101737203|NCT04669665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101737204|NCT04669665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101737205|NCT04669665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101737206|NCT04669665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101737207|NCT04669665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737208|NCT02586051|Obinutuzumab|obinutuzumab|mesh-list
101737209|NCT02586051|Immunoglobulins|immunoglobulins|mesh-list
101737210|NCT02586051|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101737211|NCT02586051|Antibodies|antibodies|mesh-list
101737212|NCT02586051|gamma-Globulins|gamma-globulins|mesh-list
101737213|NCT02586051|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101737214|NCT02586051|Immunologic Factors|immunologic factors|mesh-ancestor
101737215|NCT02586051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737216|NCT02586051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101737217|NCT02586051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101737218|NCT00763958|Buprenorphine|buprenorphine|mesh-list
101737219|NCT00763958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101737220|NCT00763958|Narcotics|narcotics|mesh-ancestor
101737221|NCT00763958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101737222|NCT00763958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737223|NCT00763958|Analgesics|analgesics|mesh-ancestor
101737224|NCT00763958|Sensory System Agents|sensory system agents|mesh-ancestor
101737225|NCT00763958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101737226|NCT00763958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101737227|NCT04101578|Cyclosporine|cyclosporine|mesh-list
101737228|NCT04101578|Mycophenolic Acid|mycophenolic acid|mesh-list
101737229|NCT04101578|Prednisone|prednisone|mesh-list
101737230|NCT04101578|Methylprednisolone|methylprednisolone|mesh-list
101737231|NCT04101578|Cyclophosphamide|cyclophosphamide|mesh-list
101737232|NCT04101578|Methotrexate|methotrexate|mesh-list
101737233|NCT04101578|Azathioprine|azathioprine|mesh-list
101737234|NCT04101578|Bromides|bromides|mesh-list
101737235|NCT04101578|Tacrolimus|tacrolimus|mesh-list
101737236|NCT04101578|Cyclosporins|cyclosporins|mesh-list
101737237|NCT04101578|Immunosuppressive Agents|immunosuppressive agents|mesh-list
101737238|NCT04101578|Immunoglobulins|immunoglobulins|mesh-list
101737239|NCT04101578|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101737240|NCT04101578|gamma-Globulins|gamma-globulins|mesh-list
101737241|NCT04101578|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101737242|NCT04101578|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
101737243|NCT04101578|Immunologic Factors|immunologic factors|mesh-ancestor
101737244|NCT04101578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737245|NCT04101578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101737246|NCT04101578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101737247|NCT04101578|Alkylating Agents|alkylating agents|mesh-ancestor
101737254|NCT04101578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101737255|NCT04101578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101737256|NCT04101578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101737258|NCT04101578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101737259|NCT04101578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101737260|NCT04101578|Antimetabolites|antimetabolites|mesh-ancestor
101737261|NCT04101578|Dermatologic Agents|dermatologic agents|mesh-ancestor
101737262|NCT04101578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101737263|NCT04101578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101737264|NCT04101578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101737265|NCT04101578|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101737266|NCT04101578|Antifungal Agents|antifungal agents|mesh-ancestor
101737267|NCT04101578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101737268|NCT04101578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101737269|NCT04101578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101737270|NCT04101578|Antitubercular Agents|antitubercular agents|mesh-ancestor
101737271|NCT04101578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101737272|NCT04101578|Antiemetics|antiemetics|mesh-ancestor
101737273|NCT04101578|Autonomic Agents|autonomic agents|mesh-ancestor
101737274|NCT04101578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101737275|NCT04101578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101737276|NCT04101578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101737277|NCT04101578|Protective Agents|protective agents|mesh-ancestor
101737278|NCT04101578|Anticonvulsants|anticonvulsants|mesh-ancestor
101952554|NCT03723915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952556|NCT03840057|Metoclopramide|metoclopramide|mesh-list
101952557|NCT03840057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101971986|NCT01339754|Alkylating Agents|alkylating agents|mesh-ancestor
101737279|NCT04101578|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101737280|NCT04101578|Cholinergic Agents|cholinergic agents|mesh-ancestor
101737281|NCT04101578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101737282|NCT00763256|Triclosan|triclosan|mesh-list
101737283|NCT00763256|Fluorides|fluorides|mesh-list
101737284|NCT00763256|Cariostatic Agents|cariostatic agents|mesh-ancestor
101737285|NCT00763256|Protective Agents|protective agents|mesh-ancestor
101737286|NCT00763256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737287|NCT00763256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101737288|NCT00763256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101737289|NCT00763256|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101737290|NCT00763256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101737291|NCT00763256|Antimetabolites|antimetabolites|mesh-ancestor
101737292|NCT00763256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737293|NCT00763256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101737294|NCT02585973|Cisplatin|cisplatin|mesh-list
101737295|NCT02585973|Adavosertib|adavosertib|mesh-list
101737296|NCT02585973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101737297|NCT02585973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101263299|NCT01761201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101527413|NCT01549587|Cariostatic Agents|cariostatic agents|mesh-ancestor
101737298|NCT02585973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737300|NCT00920283|Trace Elements|trace elements|mesh-ancestor
101737301|NCT00920283|Micronutrients|micronutrients|mesh-ancestor
101737302|NCT00920283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737303|NCT00583947|Albuterol|albuterol|mesh-list
101737304|NCT00583947|Formoterol Fumarate|formoterol fumarate|mesh-list
101737305|NCT00583947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101737306|NCT00583947|Autonomic Agents|autonomic agents|mesh-ancestor
101737307|NCT00583947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101737308|NCT00583947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737309|NCT00583947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101737310|NCT00583947|Respiratory System Agents|respiratory system agents|mesh-ancestor
101737311|NCT00583947|Tocolytic Agents|tocolytic agents|mesh-ancestor
101737312|NCT00583947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101737313|NCT00583947|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101737314|NCT00583947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101737315|NCT00583947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101737317|NCT00583947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101737318|NCT00583947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737320|NCT00772928|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101737321|NCT00772928|Immunologic Factors|immunologic factors|mesh-ancestor
101737322|NCT00772928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737323|NCT00762164|Simvastatin|simvastatin|mesh-list
101737324|NCT00762164|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
101737325|NCT00762164|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101737326|NCT00762164|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101737327|NCT00762164|Antimetabolites|antimetabolites|mesh-ancestor
101737328|NCT00762164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737329|NCT00762164|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101737330|NCT00762164|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101737331|NCT00762164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101737332|NCT00761774|Brivaracetam|brivaracetam|mesh-list
101737333|NCT00761774|Anticonvulsants|anticonvulsants|mesh-ancestor
101737334|NCT04080375|Dinoprostone|dinoprostone|mesh-list
101737335|NCT04080375|Oxytocics|oxytocics|mesh-ancestor
101737336|NCT04080375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101737337|NCT04080375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737338|NCT00781274|Ribavirin|ribavirin|mesh-list
101737339|NCT00781274|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101737340|NCT00781274|Antimetabolites|antimetabolites|mesh-ancestor
101737341|NCT00781274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737342|NCT00781274|Antiviral Agents|antiviral agents|mesh-ancestor
101737343|NCT00781274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101737344|NCT05520177|Ranibizumab|ranibizumab|mesh-list
101737345|NCT05520177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101573996|NCT02199184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101573997|NCT02199184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101573998|NCT02199184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101573999|NCT02199184|Tubulin Modulators|tubulin modulators|mesh-ancestor
101574000|NCT02199184|Antimitotic Agents|antimitotic agents|mesh-ancestor
101574001|NCT02199184|Mitosis Modulators|mitosis modulators|mesh-ancestor
101574002|NCT02199184|Keratolytic Agents|keratolytic agents|mesh-ancestor
101574003|NCT02199184|Dermatologic Agents|dermatologic agents|mesh-ancestor
101574004|NCT05378100|Midazolam|midazolam|mesh-list
101574005|NCT05378100|Ketamine|ketamine|mesh-list
101574006|NCT05378100|Analgesics|analgesics|mesh-ancestor
101574007|NCT05378100|Sensory System Agents|sensory system agents|mesh-ancestor
101574008|NCT05378100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101527420|NCT01356290|Celecoxib|celecoxib|mesh-list
101574009|NCT05378100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574010|NCT05378100|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101574011|NCT05378100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101574012|NCT05378100|Anesthetics, General|anesthetics, general|mesh-ancestor
101574013|NCT05378100|Anesthetics|anesthetics|mesh-ancestor
101574014|NCT05378100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101574015|NCT05378100|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101574016|NCT05378100|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101574017|NCT05378100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101574018|NCT05378100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574019|NCT05378100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101574020|NCT05378100|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101574021|NCT05378100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101574022|NCT05378100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101574023|NCT05378100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101574024|NCT05378100|GABA Modulators|gaba modulators|mesh-ancestor
101574025|NCT05378100|GABA Agents|gaba agents|mesh-ancestor
101574026|NCT02752477|Anesthetics|anesthetics|mesh-list
101574027|NCT02752477|Anesthetics, General|anesthetics, general|mesh-list
101574028|NCT02752477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101574029|NCT02752477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574030|NCT04204096|Vaccines|vaccines|mesh-list
101574031|NCT04204096|Immunologic Factors|immunologic factors|mesh-ancestor
101574032|NCT04204096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574033|NCT05376852|Decitabine|decitabine|mesh-list
101574034|NCT05376852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101574035|NCT05376852|Antimetabolites|antimetabolites|mesh-ancestor
101574036|NCT05376852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574037|NCT05376852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101574038|NCT05376852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101574039|NCT00061282|Clotrimazole|clotrimazole|mesh-list
101574040|NCT00061282|Miconazole|miconazole|mesh-list
101574041|NCT00061282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101574042|NCT00061282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101574043|NCT00061282|Antifungal Agents|antifungal agents|mesh-ancestor
101574044|NCT00061282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101574045|NCT00061282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101574046|NCT00061282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101574047|NCT00061282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574048|NCT00061282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101574049|NCT00061282|Hormone Antagonists|hormone antagonists|mesh-ancestor
101574050|NCT00061282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101574051|NCT00061282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574052|NCT00061282|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101574053|NCT00061282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101574054|NCT05657496|Triamcinolone|triamcinolone|mesh-list
101574055|NCT05657496|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101574056|NCT05657496|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101574057|NCT05657496|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101574058|NCT05657496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101511352|NCT02922387|Varenicline|varenicline|mesh-list
101574059|NCT05657496|Glucocorticoids|glucocorticoids|mesh-ancestor
101574060|NCT05657496|Hormones|hormones|mesh-ancestor
101574061|NCT05657496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101574062|NCT05657496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574063|NCT05657496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101574065|NCT05657496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101574066|NCT05657496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574067|NCT04268524|Miltefosine|miltefosine|mesh-list
101574068|NCT04268524|Antifungal Agents|antifungal agents|mesh-ancestor
101574069|NCT04268524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101574070|NCT04268524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101574071|NCT04268524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101574072|NCT04268524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101574074|NCT02855632|Progesterone|progesterone|mesh-list
101574075|NCT02855632|Lenograstim|lenograstim|mesh-list
101574076|NCT02855632|Estrogens|estrogens|mesh-list
101574077|NCT02855632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102096765|NCT04977778|Protective Agents|protective agents|mesh-ancestor
102096766|NCT04977778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574078|NCT02855632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574079|NCT02855632|Progestins|progestins|mesh-ancestor
101574080|NCT02855632|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101574081|NCT02855632|Immunologic Factors|immunologic factors|mesh-ancestor
101574082|NCT04220281|Nitroglycerin|nitroglycerin|mesh-list
101574083|NCT04220281|Propofol|propofol|mesh-list
101574084|NCT04220281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101574085|NCT04220281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101574086|NCT04220281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574087|NCT04220281|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101574088|NCT04220281|Anesthetics, General|anesthetics, general|mesh-ancestor
101574089|NCT04220281|Anesthetics|anesthetics|mesh-ancestor
101574090|NCT04220281|Vasodilator Agents|vasodilator agents|mesh-ancestor
101574091|NCT02751619|Lidocaine|lidocaine|mesh-list
101574092|NCT02751619|Anesthetics, Local|anesthetics, local|mesh-ancestor
101574093|NCT02751619|Anesthetics|anesthetics|mesh-ancestor
101574094|NCT02751619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101574095|NCT02751619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574096|NCT02751619|Sensory System Agents|sensory system agents|mesh-ancestor
101574097|NCT02751619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101574098|NCT02751619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101574099|NCT02751619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101574100|NCT02751619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101574101|NCT02751619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101574102|NCT02751619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574103|NCT02751541|Sunscreening Agents|sunscreening agents|mesh-list
101574104|NCT02751541|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101574105|NCT02751541|Protective Agents|protective agents|mesh-ancestor
101574106|NCT02751541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574107|NCT02751541|Dermatologic Agents|dermatologic agents|mesh-ancestor
101574108|NCT02755753|Lansoprazole|lansoprazole|mesh-list
101574109|NCT02755753|Dexlansoprazole|dexlansoprazole|mesh-list
101574110|NCT02755753|Rebamipide|rebamipide|mesh-list
101574111|NCT02755753|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101574112|NCT02755753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101574113|NCT02755753|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101574114|NCT02755753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101574115|NCT02755753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574116|NCT02755753|Antioxidants|antioxidants|mesh-ancestor
101574117|NCT02755753|Protective Agents|protective agents|mesh-ancestor
101574118|NCT02755753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574119|NCT02755909|Anesthetics|anesthetics|mesh-list
101574120|NCT02755909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101574121|NCT02755909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574122|NCT02761291|Valganciclovir|valganciclovir|mesh-list
101574123|NCT02761291|Gemcitabine|gemcitabine|mesh-list
101574124|NCT02761291|Valproic Acid|valproic acid|mesh-list
101574125|NCT02761291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101574126|NCT02761291|Antimetabolites|antimetabolites|mesh-ancestor
101574127|NCT02761291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574128|NCT02761291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101574129|NCT02761291|Anticonvulsants|anticonvulsants|mesh-ancestor
101574130|NCT02761291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101574131|NCT02761291|GABA Agents|gaba agents|mesh-ancestor
101574132|NCT02761291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101952566|NCT03840057|Dopamine Agents|dopamine agents|mesh-ancestor
101574133|NCT02761291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574135|NCT02761291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101574136|NCT02761291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101574137|NCT02761291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101574138|NCT02761291|Antiviral Agents|antiviral agents|mesh-ancestor
101574139|NCT02761291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101574140|NCT01187550|Hormones|hormones|mesh-list
101574141|NCT01187550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101574142|NCT01187550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574143|NCT02855866|Acetaminophen|acetaminophen|mesh-list
101231035|NCT03983993|Panitumumab|panitumumab|mesh-list
101574144|NCT02855866|Dexamethasone|dexamethasone|mesh-list
101574145|NCT02855866|Cortisone|cortisone|mesh-list
101574146|NCT02855866|Dexamethasone acetate|dexamethasone acetate|mesh-list
101574147|NCT02855866|BB 1101|bb 1101|mesh-list
101574148|NCT02855866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101574149|NCT02855866|Antiemetics|antiemetics|mesh-ancestor
101574150|NCT02855866|Autonomic Agents|autonomic agents|mesh-ancestor
101574151|NCT02855866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101574152|NCT02855866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574153|NCT02855866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101574154|NCT02855866|Glucocorticoids|glucocorticoids|mesh-ancestor
101574155|NCT02855866|Hormones|hormones|mesh-ancestor
101574156|NCT02855866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101574157|NCT02855866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101574158|NCT02855866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101574159|NCT02855866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101574160|NCT02855866|Analgesics|analgesics|mesh-ancestor
101574161|NCT02855866|Sensory System Agents|sensory system agents|mesh-ancestor
101574162|NCT02855866|Antipyretics|antipyretics|mesh-ancestor
101574163|NCT02855866|Protease Inhibitors|protease inhibitors|mesh-ancestor
101574164|NCT02855866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101574165|NCT02855866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574166|NCT02751307|Metformin|metformin|mesh-list
101574167|NCT02751307|Clozapine|clozapine|mesh-list
101574168|NCT02751307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101574169|NCT02751307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574170|NCT02751307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101574171|NCT02751307|Serotonin Agents|serotonin agents|mesh-ancestor
101574172|NCT02751307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101574173|NCT02751307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574174|NCT02751307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101574175|NCT02751307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101574176|NCT02751307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101574177|NCT02751307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101574178|NCT02751307|GABA Antagonists|gaba antagonists|mesh-ancestor
101574179|NCT02751307|GABA Agents|gaba agents|mesh-ancestor
101574180|NCT00638209|Insulin|insulin|mesh-list
101574181|NCT00638209|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101574182|NCT00638209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101574183|NCT00638209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574184|NCT05429671|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101574185|NCT05429671|Gentamicins|gentamicins|mesh-list
101574186|NCT05429671|Tobramycin|tobramycin|mesh-list
101574187|NCT05429671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101574188|NCT05429671|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101574189|NCT05429671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101574190|NCT05429671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574191|NCT01186770|Methylnaltrexone|methylnaltrexone|mesh-list
101574192|NCT01186770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101574193|NCT01186770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574194|NCT01186770|Sensory System Agents|sensory system agents|mesh-ancestor
101574195|NCT01186770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101574196|NCT02754817|Liraglutide|liraglutide|mesh-list
101574197|NCT02754817|Xultophy|xultophy|mesh-list
101574198|NCT02754817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101574199|NCT02754817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574200|NCT02754817|Incretins|incretins|mesh-ancestor
101574201|NCT02754817|Hormones|hormones|mesh-ancestor
101574202|NCT02754817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101574203|NCT04230031|Daratumumab|daratumumab|mesh-list
101574204|NCT04230031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101574205|NCT01186458|Rituximab|rituximab|mesh-list
101574206|NCT01186458|Fludarabine|fludarabine|mesh-list
101574207|NCT01186458|Bortezomib|bortezomib|mesh-list
101574208|NCT01186458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101574209|NCT01186458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101574210|NCT01186458|Immunologic Factors|immunologic factors|mesh-ancestor
101574211|NCT01186458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574212|NCT01186458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101574213|NCT01185366|Everolimus|everolimus|mesh-list
101574214|NCT01185366|Sunitinib|sunitinib|mesh-list
101574215|NCT01185366|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101574216|NCT01185366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101574217|NCT01185366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101574218|NCT01185366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574219|NCT01185366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101574220|NCT01185366|Immunologic Factors|immunologic factors|mesh-ancestor
101574221|NCT01185366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574222|NCT01185366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101574223|NCT01185366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101574224|NCT01185366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101574225|NCT01185366|Growth Substances|growth substances|mesh-ancestor
101574226|NCT01185366|Growth Inhibitors|growth inhibitors|mesh-ancestor
101574227|NCT01185288|Adalimumab|adalimumab|mesh-list
101574228|NCT01185288|Methotrexate|methotrexate|mesh-list
101574229|NCT01185288|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101574230|NCT01185288|Abortifacient Agents|abortifacient agents|mesh-ancestor
101574231|NCT01185288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101574232|NCT01185288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574233|NCT01185288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101574234|NCT01185288|Antimetabolites|antimetabolites|mesh-ancestor
101574235|NCT01185288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574236|NCT01185288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101574237|NCT01185288|Dermatologic Agents|dermatologic agents|mesh-ancestor
101574238|NCT01185288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101574239|NCT01185288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101574240|NCT01185288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101574241|NCT01185288|Immunologic Factors|immunologic factors|mesh-ancestor
101574242|NCT01185288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101574243|NCT01185288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101574244|NCT01185288|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101574245|NCT01185288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101574246|NCT01184118|Fluticasone|fluticasone|mesh-list
101574247|NCT01184118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101574248|NCT01184118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101574249|NCT01184118|Autonomic Agents|autonomic agents|mesh-ancestor
101574250|NCT01184118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101574251|NCT01184118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574252|NCT01184118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101574253|NCT01184118|Respiratory System Agents|respiratory system agents|mesh-ancestor
101574254|NCT01184118|Dermatologic Agents|dermatologic agents|mesh-ancestor
101574255|NCT01184118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101574256|NCT01183884|Tretinoin|tretinoin|mesh-list
101574257|NCT01183884|Isotretinoin|isotretinoin|mesh-list
101574258|NCT01183884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101574259|NCT01183884|Keratolytic Agents|keratolytic agents|mesh-ancestor
101574260|NCT01183884|Dermatologic Agents|dermatologic agents|mesh-ancestor
101574261|NCT05344248|Antibodies|antibodies|mesh-list
101574262|NCT05344248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101574263|NCT05344248|Immunologic Factors|immunologic factors|mesh-ancestor
101574264|NCT05344248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574265|NCT01191762|Sevelamer|sevelamer|mesh-list
101574266|NCT01191762|Chelating Agents|chelating agents|mesh-ancestor
101574267|NCT01191762|Sequestering Agents|sequestering agents|mesh-ancestor
101574268|NCT01191762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574269|NCT04315974|Rivaroxaban|rivaroxaban|mesh-list
101574270|NCT04315974|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101574271|NCT04315974|Antithrombins|antithrombins|mesh-ancestor
101574272|NCT04315974|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101574273|NCT04315974|Protease Inhibitors|protease inhibitors|mesh-ancestor
101574274|NCT04315974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101574275|NCT04315974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574276|NCT04315974|Anticoagulants|anticoagulants|mesh-ancestor
101574277|NCT01723774|Anastrozole|anastrozole|mesh-list
101574279|NCT01723774|Palbociclib|palbociclib|mesh-list
101574280|NCT01723774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101574281|NCT01723774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101574282|NCT01723774|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101574283|NCT01723774|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101574284|NCT01723774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101574285|NCT01723774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574286|NCT01723774|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101574287|NCT01723774|Hormone Antagonists|hormone antagonists|mesh-ancestor
101574288|NCT01723774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101574289|NCT01723774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574290|NCT01723774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101574291|NCT02855788|Leucovorin|leucovorin|mesh-list
101574292|NCT02855788|Paclitaxel|paclitaxel|mesh-list
101574293|NCT02855788|Oxaliplatin|oxaliplatin|mesh-list
101574294|NCT02855788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101574295|NCT02855788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101574296|NCT02855788|Tubulin Modulators|tubulin modulators|mesh-ancestor
101574297|NCT02855788|Antimitotic Agents|antimitotic agents|mesh-ancestor
101574298|NCT02855788|Mitosis Modulators|mitosis modulators|mesh-ancestor
101574299|NCT02855788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574301|NCT02855788|Protective Agents|protective agents|mesh-ancestor
101574302|NCT02855788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574303|NCT02855788|Vitamin B Complex|vitamin b complex|mesh-ancestor
101574304|NCT02855788|Vitamins|vitamins|mesh-ancestor
101574305|NCT02855788|Micronutrients|micronutrients|mesh-ancestor
101574306|NCT01190514|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101574307|NCT01190514|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101574308|NCT01190514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101574309|NCT01190514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101574310|NCT01190514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574311|NCT01190514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101574312|NCT01190514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574313|NCT01190514|Antidepressive Agents|antidepressive agents|mesh-ancestor
101574314|NCT01190514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101574315|NCT01190436|Bisoprolol|bisoprolol|mesh-list
101574316|NCT01190436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101574317|NCT01190436|Sympatholytics|sympatholytics|mesh-ancestor
101574318|NCT01190436|Autonomic Agents|autonomic agents|mesh-ancestor
101574319|NCT01190436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101574320|NCT01190436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574321|NCT01190436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101574322|NCT01190436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101574323|NCT01190436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101574324|NCT01190436|Adrenergic Agents|adrenergic agents|mesh-ancestor
101574325|NCT01190436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101574326|NCT01190436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574327|NCT02852122|Choline|choline|mesh-list
101574328|NCT02852122|Lipotropic Agents|lipotropic agents|mesh-ancestor
101574329|NCT02852122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101574330|NCT02852122|Antimetabolites|antimetabolites|mesh-ancestor
101574331|NCT02852122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574332|NCT02852122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101574333|NCT02852122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101574334|NCT02852122|Nootropic Agents|nootropic agents|mesh-ancestor
101574335|NCT01035255|Enalapril|enalapril|mesh-list
101574336|NCT01035255|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101574337|NCT01035255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101574338|NCT01035255|Protease Inhibitors|protease inhibitors|mesh-ancestor
101574339|NCT01035255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101574340|NCT01035255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574341|NCT01035255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101574342|NCT01035255|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101574343|NCT00602524|Pilocarpine|pilocarpine|mesh-list
101574344|NCT00602524|Miotics|miotics|mesh-ancestor
101574345|NCT00602524|Autonomic Agents|autonomic agents|mesh-ancestor
101574346|NCT00602524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101574347|NCT00602524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574349|NCT00602524|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101574350|NCT00602524|Cholinergic Agents|cholinergic agents|mesh-ancestor
101574351|NCT00602524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101574352|NCT00602524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574353|NCT01189890|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101574354|NCT01189890|Glimepiride|glimepiride|mesh-list
101574355|NCT01189890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101574356|NCT01189890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574357|NCT01189890|Incretins|incretins|mesh-ancestor
101574358|NCT01189890|Hormones|hormones|mesh-ancestor
101574359|NCT01189890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101574360|NCT01189890|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101574361|NCT01189890|Protease Inhibitors|protease inhibitors|mesh-ancestor
101574362|NCT01189890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101574363|NCT01189890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574364|NCT01189890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101574365|NCT01189890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101574366|NCT01189890|Immunologic Factors|immunologic factors|mesh-ancestor
101574367|NCT01189812|Lithium Carbonate|lithium carbonate|mesh-list
101574368|NCT01189812|Citalopram|citalopram|mesh-list
101574369|NCT01189812|Antidepressive Agents|antidepressive agents|mesh-ancestor
101574370|NCT01189812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101574371|NCT01189812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101231255|NCT03569085|Isoflurane|isoflurane|mesh-list
101574372|NCT01189812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574373|NCT01189812|Antimanic Agents|antimanic agents|mesh-ancestor
101574374|NCT01189812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101574375|NCT01189812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101574376|NCT01189812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574377|NCT01189812|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101574378|NCT01189812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102096767|NCT03055234|Treprostinil|treprostinil|mesh-list
101574379|NCT01189812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101574380|NCT01189812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101574381|NCT01189812|Serotonin Agents|serotonin agents|mesh-ancestor
101574382|NCT01189812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101574383|NCT01189500|Tamoxifen|tamoxifen|mesh-list
101574384|NCT01189500|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101574385|NCT01189500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101574386|NCT01189500|Hormone Antagonists|hormone antagonists|mesh-ancestor
101574387|NCT01189500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101574388|NCT01189500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574389|NCT01189500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101574390|NCT01189500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101574391|NCT01189500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101574392|NCT01189500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101574393|NCT01189500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101574394|NCT01189500|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101574395|NCT01189500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101574396|NCT01189500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101574397|NCT01189500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574398|NCT01189500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101574399|NCT01189500|Antidepressive Agents|antidepressive agents|mesh-ancestor
101574400|NCT01189500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101574401|NCT00938860|Cyclosporine|cyclosporine|mesh-list
101574402|NCT00938860|Tacrolimus|tacrolimus|mesh-list
101574403|NCT00938860|Cyclosporins|cyclosporins|mesh-list
101574404|NCT00938860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101574405|NCT00938860|Immunologic Factors|immunologic factors|mesh-ancestor
101574406|NCT00938860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574407|NCT00938860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101574408|NCT00938860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101574409|NCT00938860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574410|NCT00938860|Antifungal Agents|antifungal agents|mesh-ancestor
101574411|NCT00938860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101574412|NCT00938860|Dermatologic Agents|dermatologic agents|mesh-ancestor
101574413|NCT00938860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101574414|NCT00604396|Insulin|insulin|mesh-list
101574415|NCT00604396|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101574417|NCT00604396|Isophane Insulin, Human|isophane insulin, human|mesh-list
101574418|NCT00604396|Insulin, Isophane|insulin, isophane|mesh-list
101574419|NCT00604396|Isophane insulin, beef|isophane insulin, beef|mesh-list
101574420|NCT00604396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101574421|NCT00604396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574422|NCT00938470|Docetaxel|docetaxel|mesh-list
101574423|NCT00938470|Fluorouracil|fluorouracil|mesh-list
101574424|NCT00938470|Capecitabine|capecitabine|mesh-list
101574425|NCT00938470|Oxaliplatin|oxaliplatin|mesh-list
101574426|NCT00938470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101574427|NCT00938470|Tubulin Modulators|tubulin modulators|mesh-ancestor
101574428|NCT00938470|Antimitotic Agents|antimitotic agents|mesh-ancestor
101574429|NCT00938470|Mitosis Modulators|mitosis modulators|mesh-ancestor
101574430|NCT00938470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574431|NCT00938470|Antimetabolites|antimetabolites|mesh-ancestor
101574432|NCT00938470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101574433|NCT00938470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101574434|NCT00938470|Immunologic Factors|immunologic factors|mesh-ancestor
101574435|NCT00938470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574436|NCT00602680|Donepezil|donepezil|mesh-list
101574437|NCT00602680|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101574438|NCT00602680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101574439|NCT00602680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574440|NCT00602680|Cholinergic Agents|cholinergic agents|mesh-ancestor
101574441|NCT00602680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101574442|NCT00602680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574443|NCT00602680|Nootropic Agents|nootropic agents|mesh-ancestor
101574444|NCT00938392|Vaccines|vaccines|mesh-list
101574445|NCT00938392|Immunologic Factors|immunologic factors|mesh-ancestor
101574446|NCT00938392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574447|NCT02851888|Ropivacaine|ropivacaine|mesh-list
101574448|NCT02851888|Anesthetics|anesthetics|mesh-ancestor
101574449|NCT02851888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101574450|NCT02851888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574451|NCT02851888|Anesthetics, Local|anesthetics, local|mesh-ancestor
101574452|NCT02851888|Sensory System Agents|sensory system agents|mesh-ancestor
101574453|NCT02851888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101574455|NCT05381428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101574456|NCT05381428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101574457|NCT05381428|Analgesics|analgesics|mesh-ancestor
101574458|NCT05381428|Sensory System Agents|sensory system agents|mesh-ancestor
101574459|NCT05381428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101574460|NCT05381428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574461|NCT05381428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101574462|NCT05381428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101574463|NCT05381428|Gout Suppressants|gout suppressants|mesh-ancestor
101574464|NCT05381428|Tocolytic Agents|tocolytic agents|mesh-ancestor
101574465|NCT05381428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101574466|NCT05381428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101574467|NCT05381428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101574468|NCT05381428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574469|NCT01022853|Nintedanib|nintedanib|mesh-list
101574470|NCT01022853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101574471|NCT01022853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101574472|NCT01022853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101574473|NCT01022853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574474|NCT00937768|Leuprolide|leuprolide|mesh-list
101574475|NCT00937768|Goserelin|goserelin|mesh-list
101574476|NCT00937768|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101574477|NCT00937768|Fertility Agents|fertility agents|mesh-ancestor
101574478|NCT00937768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101574479|NCT00937768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574480|NCT00937768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101574481|NCT00937768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101574482|NCT00631228|Everolimus|everolimus|mesh-list
101574483|NCT00631228|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101574484|NCT00631228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101574485|NCT00631228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101574486|NCT00631228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574487|NCT00631228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101952586|NCT01205997|Narcotics|narcotics|mesh-ancestor
101574488|NCT00631228|Immunologic Factors|immunologic factors|mesh-ancestor
101574489|NCT00631228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574490|NCT00631228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101574491|NCT05381038|Paclitaxel|paclitaxel|mesh-list
101574492|NCT05381038|Docetaxel|docetaxel|mesh-list
101574493|NCT05381038|Irinotecan|irinotecan|mesh-list
101574494|NCT05381038|Azacitidine|azacitidine|mesh-list
101574495|NCT05381038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101574496|NCT05381038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101574497|NCT05381038|Tubulin Modulators|tubulin modulators|mesh-ancestor
101574498|NCT05381038|Antimitotic Agents|antimitotic agents|mesh-ancestor
101574499|NCT05381038|Mitosis Modulators|mitosis modulators|mesh-ancestor
101574500|NCT05381038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574501|NCT05381038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101574502|NCT05381038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101574503|NCT05381038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101574504|NCT05381038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101574505|NCT05381038|Antimetabolites|antimetabolites|mesh-ancestor
101574506|NCT05380960|Fibrin fragment D|fibrin fragment d|mesh-list
101574507|NCT05380960|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101574508|NCT05380960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101574509|NCT05380960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574510|NCT05380960|Hemostatics|hemostatics|mesh-ancestor
101574511|NCT05380960|Coagulants|coagulants|mesh-ancestor
101574512|NCT00604630|Epoetin Alfa|epoetin alfa|mesh-list
101574513|NCT00604630|Hematinics|hematinics|mesh-ancestor
101574514|NCT01189266|Vorinostat|vorinostat|mesh-list
101574515|NCT01189266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101574516|NCT01189266|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101574517|NCT01189266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101574518|NCT01189266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574519|NCT01189032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101574520|NCT01189032|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101574521|NCT01188798|Methotrexate|methotrexate|mesh-list
101574523|NCT01188798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101574524|NCT01188798|Abortifacient Agents|abortifacient agents|mesh-ancestor
101574525|NCT01188798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101574526|NCT01188798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574527|NCT01188798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101574528|NCT01188798|Antimetabolites|antimetabolites|mesh-ancestor
101574529|NCT01188798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574530|NCT01188798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101574531|NCT01188798|Dermatologic Agents|dermatologic agents|mesh-ancestor
101574532|NCT01188798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101574533|NCT01188798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101574534|NCT01188798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101574535|NCT01188798|Immunologic Factors|immunologic factors|mesh-ancestor
101574536|NCT01188798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101574537|NCT01188798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101574538|NCT01188798|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
101574539|NCT01183104|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101574540|NCT01183104|Glimepiride|glimepiride|mesh-list
101574541|NCT01183104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101574542|NCT01183104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574543|NCT01183104|Incretins|incretins|mesh-ancestor
101574544|NCT01183104|Hormones|hormones|mesh-ancestor
101574545|NCT01183104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101574546|NCT01183104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101574547|NCT01183104|Protease Inhibitors|protease inhibitors|mesh-ancestor
101574548|NCT01183104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101574549|NCT01183104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574550|NCT01183104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101574551|NCT01183104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101574552|NCT01183104|Immunologic Factors|immunologic factors|mesh-ancestor
101574553|NCT02885688|Insulin|insulin|mesh-list
101574554|NCT02885688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101574555|NCT02885688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574556|NCT00950248|Idebenone|idebenone|mesh-list
101574557|NCT00950248|Antioxidants|antioxidants|mesh-ancestor
101574558|NCT00950248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574559|NCT00950248|Protective Agents|protective agents|mesh-ancestor
101574560|NCT00950248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574561|NCT04269928|Epinephrine|epinephrine|mesh-list
101574562|NCT04269928|Racepinephrine|racepinephrine|mesh-list
101574563|NCT04269928|Epinephryl borate|epinephryl borate|mesh-list
101574564|NCT04269928|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101574565|NCT04269928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101574566|NCT04269928|Adrenergic Agents|adrenergic agents|mesh-ancestor
101574567|NCT04269928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101574568|NCT04269928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574569|NCT04269928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574570|NCT04269928|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101574571|NCT04269928|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101527566|NCT04684667|Propranolol|propranolol|mesh-list
101574572|NCT04269928|Autonomic Agents|autonomic agents|mesh-ancestor
101574573|NCT04269928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101574574|NCT04269928|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101574575|NCT04269928|Respiratory System Agents|respiratory system agents|mesh-ancestor
101574576|NCT04269928|Mydriatics|mydriatics|mesh-ancestor
101574577|NCT04269928|Sympathomimetics|sympathomimetics|mesh-ancestor
101574578|NCT04269928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101574579|NCT00950170|Factor VIII|factor viii|mesh-list
101574580|NCT00950170|Coagulants|coagulants|mesh-ancestor
101574581|NCT00604864|Infliximab|infliximab|mesh-list
101574582|NCT00604864|Antibodies|antibodies|mesh-list
101574583|NCT00604864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101574584|NCT00604864|Immunologic Factors|immunologic factors|mesh-ancestor
101574585|NCT00604864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574586|NCT00604864|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101574587|NCT00604864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101574588|NCT00604864|Dermatologic Agents|dermatologic agents|mesh-ancestor
101574589|NCT00604864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101574590|NCT00604864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101574591|NCT01227824|Raltegravir Potassium|raltegravir potassium|mesh-list
101574592|NCT01227824|Dolutegravir|dolutegravir|mesh-list
101574593|NCT01227824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101574594|NCT01227824|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101574595|NCT01227824|Antiviral Agents|antiviral agents|mesh-ancestor
101574596|NCT01227824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101574597|NCT01227824|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101574598|NCT01227824|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101574599|NCT01227824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101574600|NCT01227824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574601|NCT00949702|Vemurafenib|vemurafenib|mesh-list
101574602|NCT00949702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101574603|NCT00949702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101574604|NCT00949702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101574605|NCT00949702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574607|NCT01034631|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101574608|NCT01034631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101574610|NCT01034631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574611|NCT01034631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101574612|NCT01034631|Immunologic Factors|immunologic factors|mesh-ancestor
101574613|NCT01034631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574614|NCT01034631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101574615|NCT01227668|Aripiprazole|aripiprazole|mesh-list
101574616|NCT01227668|Antidepressive Agents|antidepressive agents|mesh-ancestor
101574617|NCT01227668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101574618|NCT01227668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101574619|NCT01227668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101574620|NCT01227668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101574621|NCT01227668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574622|NCT01227668|Dopamine Agonists|dopamine agonists|mesh-ancestor
101574623|NCT01227668|Dopamine Agents|dopamine agents|mesh-ancestor
101574624|NCT01227668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101574625|NCT01227668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574626|NCT01227668|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101574627|NCT01227668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101574628|NCT01227668|Serotonin Agents|serotonin agents|mesh-ancestor
101574629|NCT01227668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101574630|NCT01227668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101574631|NCT01227668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101574632|NCT01227668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101574633|NCT01227512|Tolvaptan|tolvaptan|mesh-list
101574634|NCT01227512|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101574635|NCT01227512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574636|NCT01227512|Natriuretic Agents|natriuretic agents|mesh-ancestor
101574637|NCT01227512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574638|NCT01227278|Benralizumab|benralizumab|mesh-list
101574639|NCT01227278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101574640|NCT01227278|Respiratory System Agents|respiratory system agents|mesh-ancestor
101574641|NCT01227044|Naltrexone|naltrexone|mesh-list
101574642|NCT01227044|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101574643|NCT01227044|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101574644|NCT01227044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574645|NCT01227044|Sensory System Agents|sensory system agents|mesh-ancestor
101574646|NCT01227044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101574647|NCT01034163|Panobinostat|panobinostat|mesh-list
101574648|NCT01034163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101574649|NCT01034163|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101574650|NCT01034163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101574651|NCT01034163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574652|NCT01162122|Vaccines|vaccines|mesh-list
101574653|NCT01162122|Immunologic Factors|immunologic factors|mesh-ancestor
101574654|NCT01162122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574655|NCT01033071|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101574656|NCT01033071|Olmesartan|olmesartan|mesh-list
101574657|NCT01033071|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101574658|NCT01033071|Chlorthalidone|chlorthalidone|mesh-list
101574659|NCT01033071|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
101574660|NCT01033071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101574661|NCT01033071|Diuretics|diuretics|mesh-ancestor
101574662|NCT01033071|Natriuretic Agents|natriuretic agents|mesh-ancestor
101574663|NCT01033071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574664|NCT01033071|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101574665|NCT01033071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101574666|NCT01033071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574667|NCT01033071|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101574668|NCT01033071|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101574669|NCT01032915|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101231552|NCT03020030|Cyclophosphamide|cyclophosphamide|mesh-list
101574670|NCT01032915|Immunologic Factors|immunologic factors|mesh-ancestor
101574671|NCT01032915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574673|NCT04589325|Dermatologic Agents|dermatologic agents|mesh-ancestor
101574674|NCT01161498|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
101574675|NCT01161498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101574676|NCT01161498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101574677|NCT02873559|Testosterone|testosterone|mesh-list
101574678|NCT02873559|Androgens|androgens|mesh-ancestor
101574679|NCT02873559|Hormones|hormones|mesh-ancestor
101574680|NCT02873559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102096768|NCT03055234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101574681|NCT02873559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574682|NCT01029795|Glyburide|glyburide|mesh-list
101574683|NCT01029795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101574684|NCT01029795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574685|NCT02885454|Simeprevir|simeprevir|mesh-list
101574686|NCT02885454|Odalasvir|odalasvir|mesh-list
101574687|NCT02885454|Drospirenone|drospirenone|mesh-list
101574688|NCT02885454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101574689|NCT02885454|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
101574690|NCT02885454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101574691|NCT02885454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101574692|NCT02885454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101574693|NCT02885454|Contraceptive Agents|contraceptive agents|mesh-ancestor
101574694|NCT02885454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101574695|NCT02885454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574696|NCT02885454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101574697|NCT02885454|Estrogens|estrogens|mesh-ancestor
101574698|NCT02885454|Hormones|hormones|mesh-ancestor
101574699|NCT02885454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101574700|NCT02885454|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101574701|NCT02885454|Hormone Antagonists|hormone antagonists|mesh-ancestor
101574702|NCT02885454|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101574703|NCT02885454|Diuretics|diuretics|mesh-ancestor
101574704|NCT02885454|Natriuretic Agents|natriuretic agents|mesh-ancestor
101574705|NCT02885454|Antiviral Agents|antiviral agents|mesh-ancestor
101574706|NCT02885454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101574707|NCT02885454|Protease Inhibitors|protease inhibitors|mesh-ancestor
101574708|NCT02885454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101574709|NCT02885454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574710|NCT01032837|Oseltamivir|oseltamivir|mesh-list
101574711|NCT01032837|Antiviral Agents|antiviral agents|mesh-ancestor
101574712|NCT01032837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101574713|NCT01032837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101574714|NCT01032837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574715|NCT01180296|Progesterone|progesterone|mesh-list
101574716|NCT01180296|Progestins|progestins|mesh-ancestor
101574717|NCT01180296|Hormones|hormones|mesh-ancestor
101574718|NCT01180296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101574719|NCT01180296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574720|NCT01160640|Metronidazole|metronidazole|mesh-list
101574721|NCT01160640|Doxycycline|doxycycline|mesh-list
101574722|NCT01160640|Ceftriaxone|ceftriaxone|mesh-list
101574723|NCT01160640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101574724|NCT01160640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101574725|NCT01160640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101574726|NCT01160640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101574727|NCT01160640|Antimalarials|antimalarials|mesh-ancestor
101574728|NCT01160484|Lenalidomide|lenalidomide|mesh-list
101574729|NCT01160484|Bortezomib|bortezomib|mesh-list
101574730|NCT01160484|Immunologic Factors|immunologic factors|mesh-ancestor
101574731|NCT01160484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574732|NCT01160484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101574733|NCT01160484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101574734|NCT01160484|Growth Substances|growth substances|mesh-ancestor
101574735|NCT01160484|Growth Inhibitors|growth inhibitors|mesh-ancestor
101574736|NCT01160484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101574737|NCT01032291|Lenalidomide|lenalidomide|mesh-list
101574738|NCT01032291|Cetuximab|cetuximab|mesh-list
101574739|NCT01032291|Immunologic Factors|immunologic factors|mesh-ancestor
101574740|NCT01032291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574741|NCT01032291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101574742|NCT01032291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101574743|NCT01032291|Growth Substances|growth substances|mesh-ancestor
101574744|NCT01032291|Growth Inhibitors|growth inhibitors|mesh-ancestor
101574745|NCT01032291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101574746|NCT01032291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101574747|NCT01159938|Insulin Lispro|insulin lispro|mesh-list
101574748|NCT01159938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101574749|NCT01159938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574750|NCT02873871|Hemostatics|hemostatics|mesh-list
101574751|NCT02873871|Coagulants|coagulants|mesh-ancestor
101574753|NCT04301739|Cyclophosphamide|cyclophosphamide|mesh-list
101574754|NCT04301739|Carboplatin|carboplatin|mesh-list
101574755|NCT04301739|Doxorubicin|doxorubicin|mesh-list
101574756|NCT04301739|Epirubicin|epirubicin|mesh-list
101574757|NCT04301739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101574758|NCT04301739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101574759|NCT04301739|Tubulin Modulators|tubulin modulators|mesh-ancestor
101574760|NCT04301739|Antimitotic Agents|antimitotic agents|mesh-ancestor
101574761|NCT04301739|Mitosis Modulators|mitosis modulators|mesh-ancestor
101574762|NCT04301739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574763|NCT04301739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101574764|NCT04301739|Immunologic Factors|immunologic factors|mesh-ancestor
101574765|NCT04301739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574766|NCT04301739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101574767|NCT04301739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101574768|NCT04301739|Alkylating Agents|alkylating agents|mesh-ancestor
101574769|NCT04301739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101574770|NCT04301739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101574771|NCT04301739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101574772|NCT04301739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101574773|NCT04301739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101574774|NCT04301583|Proanthocyanidin|proanthocyanidin|mesh-list
101574775|NCT04301583|Procyanidin|procyanidin|mesh-list
101574776|NCT04301583|Antioxidants|antioxidants|mesh-ancestor
101574777|NCT04301583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574778|NCT04301583|Protective Agents|protective agents|mesh-ancestor
101574779|NCT04301583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574780|NCT04301583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101574782|NCT04301583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101574783|NCT01021683|Itraconazole|itraconazole|mesh-list
101574784|NCT01021683|Antifungal Agents|antifungal agents|mesh-ancestor
101574785|NCT01021683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101574786|NCT01021683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101574787|NCT01021683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101574788|NCT01021683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101574789|NCT01021683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574790|NCT01021683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101574791|NCT01021683|Hormone Antagonists|hormone antagonists|mesh-ancestor
101574792|NCT01021683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101574793|NCT01021683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574794|NCT01021683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101574795|NCT04625725|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
101574796|NCT04625725|Antiviral Agents|antiviral agents|mesh-ancestor
101574797|NCT04625725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101574798|NCT01021215|Celecoxib|celecoxib|mesh-list
101574799|NCT01021215|Zileuton|zileuton|mesh-list
101574800|NCT01021215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101574801|NCT01021215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101574802|NCT01021215|Analgesics|analgesics|mesh-ancestor
101574803|NCT01021215|Sensory System Agents|sensory system agents|mesh-ancestor
101574804|NCT01021215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101574805|NCT01021215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574806|NCT01021215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101574807|NCT01021215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101574808|NCT01021215|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101574809|NCT01021215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101574810|NCT01021215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101574811|NCT01021215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574812|NCT01021215|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101574813|NCT01021215|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101574814|NCT01021215|Hormone Antagonists|hormone antagonists|mesh-ancestor
101574815|NCT01021215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101574816|NCT02760979|Denosumab|denosumab|mesh-list
101574817|NCT02760979|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101574818|NCT02760979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574819|NCT02873325|Antiviral Agents|antiviral agents|mesh-list
101574820|NCT02873325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101574821|NCT02760901|Acetylcysteine|acetylcysteine|mesh-list
101574822|NCT02760901|Mannitol|mannitol|mesh-list
101574823|NCT02760901|Acetazolamide|acetazolamide|mesh-list
101574824|NCT02760901|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101574825|NCT02760901|Antiviral Agents|antiviral agents|mesh-ancestor
101574826|NCT02760901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101574827|NCT02760901|Expectorants|expectorants|mesh-ancestor
101574828|NCT02760901|Respiratory System Agents|respiratory system agents|mesh-ancestor
101574829|NCT02760901|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101574830|NCT02760901|Antioxidants|antioxidants|mesh-ancestor
101574831|NCT02760901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096769|NCT03055312|Bicalutamide|bicalutamide|mesh-list
101574832|NCT02760901|Protective Agents|protective agents|mesh-ancestor
101574833|NCT02760901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574834|NCT02760901|Antidotes|antidotes|mesh-ancestor
101574835|NCT02760901|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101574836|NCT02760901|Diuretics|diuretics|mesh-ancestor
101574837|NCT02760901|Natriuretic Agents|natriuretic agents|mesh-ancestor
101574838|NCT02760901|Anticonvulsants|anticonvulsants|mesh-ancestor
101574839|NCT02760901|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101574840|NCT02760901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101574841|NCT00635713|Fulvestrant|fulvestrant|mesh-list
101574842|NCT00635713|Anastrozole|anastrozole|mesh-list
101574843|NCT00635713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101574844|NCT00635713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101574845|NCT00635713|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101574846|NCT00635713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101574847|NCT00635713|Hormone Antagonists|hormone antagonists|mesh-ancestor
101952604|NCT03818997|Paclitaxel|paclitaxel|mesh-list
101574848|NCT00635713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101574849|NCT00635713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574850|NCT00635713|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101574851|NCT00635713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101574852|NCT00635713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101574853|NCT00635713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574855|NCT02760823|Antioxidants|antioxidants|mesh-ancestor
101574856|NCT02760823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574857|NCT02760823|Protective Agents|protective agents|mesh-ancestor
101574858|NCT02760823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574859|NCT02760823|Vitamin B Complex|vitamin b complex|mesh-ancestor
101574860|NCT02760823|Vitamins|vitamins|mesh-ancestor
101574861|NCT02760823|Micronutrients|micronutrients|mesh-ancestor
101574862|NCT01020747|Bevacizumab|bevacizumab|mesh-list
101574863|NCT01020747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101574864|NCT01020747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101574865|NCT01020747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101574866|NCT01020747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101574867|NCT01020747|Growth Substances|growth substances|mesh-ancestor
101574868|NCT01020747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574869|NCT01020747|Growth Inhibitors|growth inhibitors|mesh-ancestor
101574870|NCT02754739|Pravastatin|pravastatin|mesh-list
101574871|NCT02754739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101574872|NCT02754739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101574873|NCT02754739|Antimetabolites|antimetabolites|mesh-ancestor
101574874|NCT02754739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574875|NCT02754739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101574876|NCT02754739|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101574877|NCT02754739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101574878|NCT01031979|Yohimbine|yohimbine|mesh-list
101574879|NCT01031979|Mydriatics|mydriatics|mesh-ancestor
101574880|NCT01031979|Autonomic Agents|autonomic agents|mesh-ancestor
101574881|NCT01031979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101574882|NCT01031979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574883|NCT01031979|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101574884|NCT01031979|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101574885|NCT01031979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101574886|NCT01031979|Adrenergic Agents|adrenergic agents|mesh-ancestor
101574887|NCT01031979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101574888|NCT01031979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830333|NCT05327010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830334|NCT05327010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830335|NCT05316493|Megestrol|megestrol|mesh-list
101830336|NCT05316493|Megestrol Acetate|megestrol acetate|mesh-list
101830337|NCT05316493|Contraceptive Agents|contraceptive agents|mesh-list
101830338|NCT05316493|Levonorgestrel|levonorgestrel|mesh-list
101830339|NCT05316493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101830340|NCT05316493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830341|NCT05316493|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101830342|NCT05316493|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101830343|NCT05316493|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101830344|NCT05316493|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101830345|NCT05316493|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101830346|NCT05316493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101830347|NCT05316493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830348|NCT05316493|Appetite Stimulants|appetite stimulants|mesh-ancestor
101830349|NCT05316493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101830350|NCT05316467|Megestrol|megestrol|mesh-list
101830351|NCT05316467|Megestrol Acetate|megestrol acetate|mesh-list
101830352|NCT05316467|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101830353|NCT05316467|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101830354|NCT05316467|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101830355|NCT05316467|Contraceptive Agents|contraceptive agents|mesh-ancestor
101830356|NCT05316467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101830357|NCT05316467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830358|NCT05316467|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101952607|NCT03818997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830359|NCT05316467|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101830360|NCT05316467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101830361|NCT05316467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830362|NCT05316467|Appetite Stimulants|appetite stimulants|mesh-ancestor
101830363|NCT05316467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101830364|NCT05304949|Ranibizumab|ranibizumab|mesh-list
101830365|NCT05304949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101830366|NCT05304949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101830367|NCT05304949|Growth Substances|growth substances|mesh-ancestor
101830368|NCT05304949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830369|NCT05304949|Growth Inhibitors|growth inhibitors|mesh-ancestor
101830370|NCT05304949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830371|NCT05294341|Norethindrone|norethindrone|mesh-list
101830372|NCT05294341|Norethindrone Acetate|norethindrone acetate|mesh-list
101830373|NCT05294341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101830374|NCT05294341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101830375|NCT05294341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101830376|NCT05294341|Contraceptive Agents|contraceptive agents|mesh-ancestor
101830377|NCT05294341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101830378|NCT05294341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830379|NCT05294341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101830380|NCT05294341|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101830381|NCT05293964|Everolimus|everolimus|mesh-list
101830382|NCT05293964|Palbociclib|palbociclib|mesh-list
101830383|NCT05293964|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101830384|NCT05293964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101830385|NCT05293964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101830386|NCT05293964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830387|NCT05293964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101830388|NCT05293964|Immunologic Factors|immunologic factors|mesh-ancestor
101830389|NCT05293964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830390|NCT05293964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830391|NCT05290207|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101830392|NCT05290207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830393|NCT05271240|Bevacizumab|bevacizumab|mesh-list
101830394|NCT05271240|Temozolomide|temozolomide|mesh-list
101830395|NCT05271240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101830396|NCT05271240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830397|NCT05271240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101830398|NCT05271240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101830399|NCT05271240|Growth Substances|growth substances|mesh-ancestor
101830400|NCT05271240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830401|NCT05271240|Growth Inhibitors|growth inhibitors|mesh-ancestor
101830402|NCT05271240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101830403|NCT05271240|Alkylating Agents|alkylating agents|mesh-ancestor
101830404|NCT05271240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830405|NCT05269459|Cannabidiol|cannabidiol|mesh-list
101830406|NCT05269459|Anticonvulsants|anticonvulsants|mesh-ancestor
101830408|NCT05264883|Decitabine|decitabine|mesh-list
101830409|NCT05264883|Venetoclax|venetoclax|mesh-list
101830410|NCT05264883|Aclarubicin|aclarubicin|mesh-list
101830411|NCT05264883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101830412|NCT05264883|Antimetabolites|antimetabolites|mesh-ancestor
101830413|NCT05264883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830414|NCT05264883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830415|NCT05264883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101830416|NCT05264883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101830417|NCT05264883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101830418|NCT05264883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101830419|NCT05263453|Vemurafenib|vemurafenib|mesh-list
101830420|NCT05263453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830421|NCT05263453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101830422|NCT05263453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101830423|NCT05263453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830424|NCT05257629|Nicotine|nicotine|mesh-list
102096770|NCT03055312|Androgen Antagonists|androgen antagonists|mesh-ancestor
101830425|NCT05257629|Varenicline|varenicline|mesh-list
101830426|NCT05257629|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101830427|NCT05257629|Autonomic Agents|autonomic agents|mesh-ancestor
101952614|NCT03818919|Acetaminophen|acetaminophen|mesh-list
101830428|NCT05257629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101830429|NCT05257629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830430|NCT05257629|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101830431|NCT05257629|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101830432|NCT05257629|Cholinergic Agents|cholinergic agents|mesh-ancestor
101830433|NCT05257629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101830434|NCT05257629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830435|NCT05245669|Denosumab|denosumab|mesh-list
101830436|NCT05245669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101830437|NCT05245669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830438|NCT05233332|Vemurafenib|vemurafenib|mesh-list
101830439|NCT05233332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830440|NCT05233332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101830441|NCT05233332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101830442|NCT05233332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830443|NCT05232084|Fentanyl|fentanyl|mesh-list
101830444|NCT05232084|Bupivacaine|bupivacaine|mesh-list
101830445|NCT05232084|Anesthetics, Local|anesthetics, local|mesh-ancestor
101830446|NCT05232084|Anesthetics|anesthetics|mesh-ancestor
101830447|NCT05232084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101830448|NCT05232084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830449|NCT05232084|Sensory System Agents|sensory system agents|mesh-ancestor
101830450|NCT05232084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101830451|NCT05232084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101830452|NCT05232084|Narcotics|narcotics|mesh-ancestor
101830453|NCT05232084|Analgesics|analgesics|mesh-ancestor
101830454|NCT05232084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101830455|NCT05232084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101830456|NCT05232084|Anesthetics, General|anesthetics, general|mesh-ancestor
101830457|NCT05195619|Cyclophosphamide|cyclophosphamide|mesh-list
101830458|NCT05195619|Vaccines|vaccines|mesh-list
101830459|NCT05195619|Immunologic Factors|immunologic factors|mesh-ancestor
101830460|NCT05195619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830461|NCT05195619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101830462|NCT05195619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101830463|NCT05195619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101830464|NCT05195619|Alkylating Agents|alkylating agents|mesh-ancestor
101830465|NCT05195619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830466|NCT05195619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830467|NCT05195619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101830468|NCT05158517|Vedolizumab|vedolizumab|mesh-list
101830469|NCT05158517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101830470|NCT05139914|Dapagliflozin|dapagliflozin|mesh-list
101830471|NCT05139914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101830472|NCT05139914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830473|NCT05139914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101830474|NCT05139914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830475|NCT05138835|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101830476|NCT05138835|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101830477|NCT05138835|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101830478|NCT05138835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101830479|NCT05138835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830480|NCT05138835|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101830481|NCT05138835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101830482|NCT05138835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830483|NCT05138835|Cholinergic Agents|cholinergic agents|mesh-ancestor
101830484|NCT05138835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101830485|NCT05132231|Brodalumab|brodalumab|mesh-list
101830486|NCT05132231|Dermatologic Agents|dermatologic agents|mesh-ancestor
101830487|NCT05099107|Albuterol|albuterol|mesh-list
101830488|NCT05099107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101830489|NCT05099107|Autonomic Agents|autonomic agents|mesh-ancestor
101830490|NCT05099107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101830491|NCT05099107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830492|NCT05099107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101830493|NCT05099107|Respiratory System Agents|respiratory system agents|mesh-ancestor
101830494|NCT05099107|Tocolytic Agents|tocolytic agents|mesh-ancestor
101830495|NCT05099107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101830496|NCT05099107|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101830497|NCT05099107|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101830498|NCT05099107|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102096771|NCT03055312|Hormone Antagonists|hormone antagonists|mesh-ancestor
101830499|NCT05099107|Adrenergic Agents|adrenergic agents|mesh-ancestor
101830500|NCT05099107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101830501|NCT05099107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830502|NCT05090280|Nafamostat|nafamostat|mesh-list
101830503|NCT05090280|Naltrexone|naltrexone|mesh-list
101830504|NCT05090280|Oxycodone|oxycodone|mesh-list
101830505|NCT05090280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101830506|NCT05090280|Narcotics|narcotics|mesh-ancestor
101830507|NCT05090280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101830508|NCT05090280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830509|NCT05090280|Analgesics|analgesics|mesh-ancestor
101830510|NCT05090280|Sensory System Agents|sensory system agents|mesh-ancestor
101830511|NCT05090280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101830512|NCT05090280|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101830513|NCT05090280|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101830514|NCT05090280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101830515|NCT05090280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101830516|NCT05090280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101830517|NCT05090280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101830518|NCT05090280|Anticoagulants|anticoagulants|mesh-ancestor
101830519|NCT05090280|Protease Inhibitors|protease inhibitors|mesh-ancestor
101830520|NCT05090280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101830521|NCT05090280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830522|NCT05090280|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101830523|NCT05090280|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101830524|NCT05090280|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101830525|NCT05090280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101830526|NCT05090280|Immunologic Factors|immunologic factors|mesh-ancestor
101830527|NCT05078866|Vaccines|vaccines|mesh-list
101830528|NCT05078866|Immunologic Factors|immunologic factors|mesh-ancestor
101830529|NCT05078866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830530|NCT05065970|Felzartamab|felzartamab|mesh-list
101830531|NCT05065970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830532|NCT05065970|Immunologic Factors|immunologic factors|mesh-ancestor
101830533|NCT05065970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830534|NCT05029063|Rivaroxaban|rivaroxaban|mesh-list
101830535|NCT05029063|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101830536|NCT05029063|Antithrombins|antithrombins|mesh-ancestor
101830537|NCT05029063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101830538|NCT05029063|Protease Inhibitors|protease inhibitors|mesh-ancestor
101830539|NCT05029063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101830540|NCT05029063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830541|NCT05029063|Anticoagulants|anticoagulants|mesh-ancestor
101830542|NCT04998786|Dexamethasone|dexamethasone|mesh-list
101830543|NCT04998786|Ixazomib|ixazomib|mesh-list
101830544|NCT04998786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101830545|NCT04998786|Antiemetics|antiemetics|mesh-ancestor
101830546|NCT04998786|Autonomic Agents|autonomic agents|mesh-ancestor
101830547|NCT04998786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101830548|NCT04998786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830549|NCT04998786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101830550|NCT04998786|Glucocorticoids|glucocorticoids|mesh-ancestor
101830551|NCT04998786|Hormones|hormones|mesh-ancestor
101830552|NCT04998786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101830553|NCT04998786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101830554|NCT04998786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830555|NCT04998786|Protease Inhibitors|protease inhibitors|mesh-ancestor
101830556|NCT04998786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101830557|NCT04998786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830559|NCT04998500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101830560|NCT04998500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830561|NCT04992624|Dronabinol|dronabinol|mesh-list
101830562|NCT04992624|Cannabidiol|cannabidiol|mesh-list
101830563|NCT04992624|Anticonvulsants|anticonvulsants|mesh-ancestor
101830564|NCT04992624|Hallucinogens|hallucinogens|mesh-ancestor
101830565|NCT04992624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830566|NCT04992624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101830567|NCT04992624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101830568|NCT04992624|Analgesics|analgesics|mesh-ancestor
101830569|NCT04992624|Sensory System Agents|sensory system agents|mesh-ancestor
101830570|NCT04992624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101830571|NCT04992624|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101830572|NCT04992624|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101830573|NCT04992624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101830574|NCT04992624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830575|NCT04992624|Hormones|hormones|mesh-ancestor
101830576|NCT04992624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101830577|NCT04990258|Infliximab|infliximab|mesh-list
101830578|NCT04990258|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101830579|NCT04990258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101830580|NCT04990258|Dermatologic Agents|dermatologic agents|mesh-ancestor
101830581|NCT04990258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101830582|NCT04990258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101830583|NCT04988295|Carboplatin|carboplatin|mesh-list
101830584|NCT04988295|Pemetrexed|pemetrexed|mesh-list
101830585|NCT04988295|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
101830586|NCT04988295|Lazertinib|lazertinib|mesh-list
101830587|NCT04988295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830588|NCT04988295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101830589|NCT04988295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830590|NCT04988295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101830591|NCT04988295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101830592|NCT04988295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101830593|NCT04988295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101830594|NCT04965493|Rituximab|rituximab|mesh-list
101830595|NCT04965493|Venetoclax|venetoclax|mesh-list
101830596|NCT04965493|Pirtobrutinib|pirtobrutinib|mesh-list
101830597|NCT04965493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101830598|NCT04965493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830599|NCT04965493|Immunologic Factors|immunologic factors|mesh-ancestor
101830600|NCT04965493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830601|NCT04965493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101830602|NCT04965493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101830603|NCT04965493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101830604|NCT04965493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830605|NCT04964089|Aflibercept|aflibercept|mesh-list
101830606|NCT04964089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101830607|NCT04964089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101830608|NCT04964089|Growth Substances|growth substances|mesh-ancestor
101830609|NCT04964089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830610|NCT04964089|Growth Inhibitors|growth inhibitors|mesh-ancestor
101830611|NCT04964089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830612|NCT04940299|Nivolumab|nivolumab|mesh-list
101830613|NCT04940299|Ipilimumab|ipilimumab|mesh-list
101830614|NCT04940299|Immunoglobulins|immunoglobulins|mesh-list
101830615|NCT04940299|Immunoglobulin G|immunoglobulin g|mesh-list
101830616|NCT04940299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101830617|NCT04940299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830618|NCT04940299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101830619|NCT04940299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830620|NCT04940299|Immunologic Factors|immunologic factors|mesh-ancestor
101830621|NCT04940299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830622|NCT04931355|Cetrorelix|cetrorelix|mesh-list
101830623|NCT04931355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101830624|NCT04931355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830625|NCT04931355|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101830626|NCT04931355|Fertility Agents|fertility agents|mesh-ancestor
101830627|NCT04931355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101830628|NCT04931355|Hormone Antagonists|hormone antagonists|mesh-ancestor
101830629|NCT04924374|Pembrolizumab|pembrolizumab|mesh-list
101830630|NCT04924374|Atezolizumab|atezolizumab|mesh-list
101830631|NCT04924374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101550431|NCT00623207|Mydriatics|mydriatics|mesh-ancestor
101830632|NCT04924374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101830633|NCT04924374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830634|NCT04924374|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101830635|NCT04924374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830636|NCT04924374|Immunologic Factors|immunologic factors|mesh-ancestor
101830637|NCT04924374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527896|NCT00549146|Xhance|xhance|mesh-list
101830638|NCT04918147|Acetaminophen|acetaminophen|mesh-list
101830639|NCT04918147|Diphenhydramine|diphenhydramine|mesh-list
101830640|NCT04918147|Promethazine|promethazine|mesh-list
101830641|NCT04918147|Prednisone|prednisone|mesh-list
101830643|NCT04918147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101830644|NCT04918147|Elotuzumab|elotuzumab|mesh-list
101830645|NCT04918147|Famotidine|famotidine|mesh-list
101830646|NCT04918147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101830647|NCT04918147|Glucocorticoids|glucocorticoids|mesh-ancestor
101830648|NCT04918147|Hormones|hormones|mesh-ancestor
101830649|NCT04918147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101830650|NCT04918147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830651|NCT04918147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101830652|NCT04918147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830653|NCT04918147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101830654|NCT04918147|Analgesics|analgesics|mesh-ancestor
101830655|NCT04918147|Sensory System Agents|sensory system agents|mesh-ancestor
101830656|NCT04918147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101830657|NCT04918147|Antipyretics|antipyretics|mesh-ancestor
101830658|NCT04918147|Antiemetics|antiemetics|mesh-ancestor
101830659|NCT04918147|Autonomic Agents|autonomic agents|mesh-ancestor
101830660|NCT04918147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101830661|NCT04918147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101830662|NCT04918147|Protective Agents|protective agents|mesh-ancestor
101830663|NCT04918147|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101830664|NCT04918147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101830665|NCT04918147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101830666|NCT04918147|Anesthetics, Local|anesthetics, local|mesh-ancestor
101830667|NCT04918147|Anesthetics|anesthetics|mesh-ancestor
101830668|NCT04918147|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101830669|NCT04918147|Histamine Antagonists|histamine antagonists|mesh-ancestor
101830670|NCT04918147|Histamine Agents|histamine agents|mesh-ancestor
101830671|NCT04918147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101830672|NCT04918147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830673|NCT04918147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101830674|NCT04918147|Antipruritics|antipruritics|mesh-ancestor
101830675|NCT04918147|Dermatologic Agents|dermatologic agents|mesh-ancestor
101830676|NCT04918147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101830677|NCT04918147|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101830678|NCT04916197|Dexmedetomidine|dexmedetomidine|mesh-list
101830679|NCT04916197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101830680|NCT04916197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101830681|NCT04916197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830682|NCT04916197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101830683|NCT04916197|Analgesics|analgesics|mesh-ancestor
101830684|NCT04916197|Sensory System Agents|sensory system agents|mesh-ancestor
101830685|NCT04916197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101830686|NCT04916197|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101830687|NCT04916197|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101830688|NCT04916197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101830689|NCT04916197|Adrenergic Agents|adrenergic agents|mesh-ancestor
101830690|NCT04916197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101830691|NCT04916197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830692|NCT04915768|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101830693|NCT04915768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101830694|NCT04915768|Immunologic Factors|immunologic factors|mesh-ancestor
101830695|NCT04915768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830696|NCT04915768|Antacids|antacids|mesh-ancestor
101830697|NCT04915768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830698|NCT04915768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101830699|NCT04902625|Naltrexone|naltrexone|mesh-list
101830700|NCT04902625|Bupropion|bupropion|mesh-list
101830701|NCT04902625|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101830702|NCT04902625|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101830703|NCT04902625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830704|NCT04902625|Sensory System Agents|sensory system agents|mesh-ancestor
101830705|NCT04902625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101830706|NCT04902625|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101830707|NCT04902625|Antidepressive Agents|antidepressive agents|mesh-ancestor
101830708|NCT04902625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101830709|NCT04902625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101830710|NCT04902625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101830711|NCT04902625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101830712|NCT04902625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830713|NCT04902625|Dopamine Agents|dopamine agents|mesh-ancestor
101830714|NCT04902625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101830715|NCT04902625|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101830716|NCT04902625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101830717|NCT04902625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101830718|NCT04892303|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
101830719|NCT04892303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830720|NCT04848792|Sulforaphane|sulforaphane|mesh-list
101830721|NCT04848792|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101830722|NCT04848792|Protective Agents|protective agents|mesh-ancestor
101830723|NCT04848792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830724|NCT04848792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830725|NCT04805775|Desflurane|desflurane|mesh-list
101830726|NCT04805775|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101830727|NCT04805775|Anesthetics, General|anesthetics, general|mesh-ancestor
101830728|NCT04805775|Anesthetics|anesthetics|mesh-ancestor
101830729|NCT04805775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101830730|NCT04805775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830731|NCT04796194|Pembrolizumab|pembrolizumab|mesh-list
101830732|NCT04796194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101830733|NCT04796194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830734|NCT04796194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101830735|NCT04796194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830736|NCT04755647|Nitric Oxide|nitric oxide|mesh-list
101830737|NCT04755647|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101830738|NCT04755647|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101830739|NCT04755647|Autonomic Agents|autonomic agents|mesh-ancestor
101830740|NCT04755647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101830741|NCT04755647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830742|NCT04755647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101830743|NCT04755647|Respiratory System Agents|respiratory system agents|mesh-ancestor
101830744|NCT04755647|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101830745|NCT04755647|Antioxidants|antioxidants|mesh-ancestor
101830746|NCT04755647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830747|NCT04755647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101830748|NCT04755647|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101830749|NCT04755647|Vasodilator Agents|vasodilator agents|mesh-ancestor
101830750|NCT04755647|Gasotransmitters|gasotransmitters|mesh-ancestor
101830751|NCT04755647|Protective Agents|protective agents|mesh-ancestor
101830752|NCT04733040|Felzartamab|felzartamab|mesh-list
101830753|NCT04733040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830754|NCT04733040|Immunologic Factors|immunologic factors|mesh-ancestor
101830755|NCT04733040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830756|NCT04699123|Pembrolizumab|pembrolizumab|mesh-list
101830757|NCT04699123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101830758|NCT04699123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830759|NCT04699123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101830760|NCT04699123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830761|NCT04677972|Ebselen|ebselen|mesh-list
101830762|NCT04677972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101830763|NCT04677972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101830764|NCT04677972|Analgesics|analgesics|mesh-ancestor
101830765|NCT04677972|Sensory System Agents|sensory system agents|mesh-ancestor
101830766|NCT04677972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101830767|NCT04677972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830768|NCT04677972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101830769|NCT04677972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101830770|NCT04677972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101830771|NCT04677972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101830772|NCT04677972|Antioxidants|antioxidants|mesh-ancestor
101830773|NCT04677972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830774|NCT04677972|Protective Agents|protective agents|mesh-ancestor
101830775|NCT04677972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101830776|NCT04677972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101830777|NCT04677972|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101830778|NCT04648046|Cyclophosphamide|cyclophosphamide|mesh-list
101830779|NCT04648046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101830780|NCT04648046|Immunologic Factors|immunologic factors|mesh-ancestor
101952634|NCT03818919|Anticonvulsants|anticonvulsants|mesh-ancestor
101830781|NCT04648046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830782|NCT04648046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101830783|NCT04648046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101830784|NCT04648046|Alkylating Agents|alkylating agents|mesh-ancestor
101830785|NCT04648046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830786|NCT04648046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830787|NCT04648046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101830788|NCT04648020|Clonidine|clonidine|mesh-list
101830789|NCT04648020|Analgesics|analgesics|mesh-ancestor
101830790|NCT04648020|Sensory System Agents|sensory system agents|mesh-ancestor
101830791|NCT04648020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101830792|NCT04648020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830793|NCT04648020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101830794|NCT04648020|Sympatholytics|sympatholytics|mesh-ancestor
101830795|NCT04648020|Autonomic Agents|autonomic agents|mesh-ancestor
101830796|NCT04648020|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101830797|NCT04648020|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101830798|NCT04648020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101830799|NCT04648020|Adrenergic Agents|adrenergic agents|mesh-ancestor
101830800|NCT04648020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101830801|NCT04648020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830802|NCT04630145|Clarithromycin|clarithromycin|mesh-list
101830804|NCT04630145|Ethambutol|ethambutol|mesh-list
101830805|NCT04630145|Rifabutin|rifabutin|mesh-list
101830806|NCT04630145|Bedaquiline|bedaquiline|mesh-list
101830807|NCT04630145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101830808|NCT04630145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101830809|NCT04630145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101830810|NCT04630145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101830811|NCT04630145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528025|NCT04643301|Liraglutide|liraglutide|mesh-list
101830812|NCT04630145|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101830813|NCT04630145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101830814|NCT04630145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101830815|NCT04630145|Antitubercular Agents|antitubercular agents|mesh-ancestor
101830816|NCT04630145|Leprostatic Agents|leprostatic agents|mesh-ancestor
101830817|NCT04630145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101830818|NCT04630145|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101830819|NCT04630145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101830820|NCT04630145|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101830821|NCT04630145|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101830822|NCT04630145|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101830823|NCT04630145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101830824|NCT04629651|Captopril|captopril|mesh-list
101830825|NCT04629651|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101830826|NCT04629651|Protease Inhibitors|protease inhibitors|mesh-ancestor
101830827|NCT04629651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101830828|NCT04629651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830829|NCT04629651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101830830|NCT04623398|Lithium Carbonate|lithium carbonate|mesh-list
101830831|NCT04623398|Antidepressive Agents|antidepressive agents|mesh-ancestor
101830832|NCT04623398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101830833|NCT04623398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101830834|NCT04623398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830835|NCT04623398|Antimanic Agents|antimanic agents|mesh-ancestor
101830836|NCT04623398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101830837|NCT04623398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101830838|NCT04623398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830839|NCT04614194|Letrozole|letrozole|mesh-list
101830840|NCT04614194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830841|NCT04614194|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101830842|NCT04614194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101830843|NCT04614194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101830844|NCT04614194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830845|NCT04614194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101830846|NCT04614194|Hormone Antagonists|hormone antagonists|mesh-ancestor
101830847|NCT04614194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101830848|NCT04614194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830849|NCT04603001|Azacitidine|azacitidine|mesh-list
101830850|NCT04603001|Venetoclax|venetoclax|mesh-list
101830851|NCT04603001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101830852|NCT04603001|Antimetabolites|antimetabolites|mesh-ancestor
101550658|NCT01300767|Contact Lens Solutions|contact lens solutions|mesh-list
101830853|NCT04603001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528075|NCT00550901|Dexrazoxane|dexrazoxane|mesh-list
101830854|NCT04603001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830855|NCT04603001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101830856|NCT04593654|Dalteparin|dalteparin|mesh-list
101830857|NCT04593654|Tinzaparin|tinzaparin|mesh-list
101830858|NCT04593654|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101830859|NCT04593654|Anticoagulants|anticoagulants|mesh-ancestor
101830860|NCT04593654|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101830861|NCT04593654|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101830862|NCT04593654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830863|NCT04591210|Angiotensin II|angiotensin ii|mesh-list
101830864|NCT04591210|Giapreza|giapreza|mesh-list
101830865|NCT04591210|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101830866|NCT04591210|Angiotensinogen|angiotensinogen|mesh-list
101830867|NCT04591210|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101830868|NCT04591210|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
101830869|NCT04591210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830870|NCT04591210|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101830871|NCT04591210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101830872|NCT04591210|Protease Inhibitors|protease inhibitors|mesh-ancestor
101830873|NCT04585893|Rituximab|rituximab|mesh-list
101830874|NCT04585893|Etoposide|etoposide|mesh-list
101830875|NCT04585893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101830876|NCT04585893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830877|NCT04585893|Immunologic Factors|immunologic factors|mesh-ancestor
101830878|NCT04585893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830879|NCT04585893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101830880|NCT04585893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101830881|NCT04585893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101830882|NCT04585893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101830883|NCT04585893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101830884|NCT04585893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830885|NCT04573478|Atrasentan|atrasentan|mesh-list
101830886|NCT04573478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830887|NCT04573478|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101830888|NCT04573478|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101830889|NCT04573478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830890|NCT04547946|Trametinib|trametinib|mesh-list
101830891|NCT04547946|Dabrafenib|dabrafenib|mesh-list
101830892|NCT04547946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830893|NCT04547946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101830894|NCT04547946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101830895|NCT04547946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830896|NCT04542824|Prednisone|prednisone|mesh-list
101830897|NCT04542824|Cyclophosphamide|cyclophosphamide|mesh-list
101830898|NCT04542824|Rituximab|rituximab|mesh-list
101830899|NCT04542824|Gemcitabine|gemcitabine|mesh-list
101830900|NCT04542824|Doxorubicin|doxorubicin|mesh-list
101830901|NCT04542824|Oxaliplatin|oxaliplatin|mesh-list
101830902|NCT04542824|Vincristine|vincristine|mesh-list
101830903|NCT04542824|Lenalidomide|lenalidomide|mesh-list
101830904|NCT04542824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101830905|NCT04542824|Immunologic Factors|immunologic factors|mesh-ancestor
101830906|NCT04542824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830907|NCT04542824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101830908|NCT04542824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101830909|NCT04542824|Alkylating Agents|alkylating agents|mesh-ancestor
101830910|NCT04542824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830911|NCT04542824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830912|NCT04542824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101830913|NCT04542824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101830914|NCT04542824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101830915|NCT04542824|Antimetabolites|antimetabolites|mesh-ancestor
101830916|NCT04542824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101830917|NCT04542824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101830918|NCT04542824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101830919|NCT04542824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101830920|NCT04542824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101830921|NCT04542824|Glucocorticoids|glucocorticoids|mesh-ancestor
101830922|NCT04542824|Hormones|hormones|mesh-ancestor
101830923|NCT04542824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101830924|NCT04542824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101830925|NCT04542824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101830926|NCT04542824|Tubulin Modulators|tubulin modulators|mesh-ancestor
101830927|NCT04542824|Antimitotic Agents|antimitotic agents|mesh-ancestor
101830928|NCT04542824|Mitosis Modulators|mitosis modulators|mesh-ancestor
101830929|NCT04542824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101830930|NCT04542824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101830931|NCT04542824|Growth Substances|growth substances|mesh-ancestor
101830932|NCT04542824|Growth Inhibitors|growth inhibitors|mesh-ancestor
101830933|NCT04535700|Pioglitazone|pioglitazone|mesh-list
101830934|NCT04535700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101830935|NCT04535700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830936|NCT04521686|Gemcitabine|gemcitabine|mesh-list
101830937|NCT04521686|Durvalumab|durvalumab|mesh-list
101830938|NCT04521686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830939|NCT04521686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101830940|NCT04521686|Antimetabolites|antimetabolites|mesh-ancestor
101830941|NCT04521686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830942|NCT04521686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101830943|NCT04512911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
101830944|NCT04510051|Cyclophosphamide|cyclophosphamide|mesh-list
101830945|NCT04510051|Fludarabine|fludarabine|mesh-list
101830946|NCT04510051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101830948|NCT04510051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830949|NCT04510051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101830950|NCT04510051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101830951|NCT04510051|Alkylating Agents|alkylating agents|mesh-ancestor
101830952|NCT04510051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830953|NCT04510051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830954|NCT04510051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101830955|NCT04478279|Temozolomide|temozolomide|mesh-list
101528102|NCT00551018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101830956|NCT04478279|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101830957|NCT04478279|Alkylating Agents|alkylating agents|mesh-ancestor
101830958|NCT04478279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830959|NCT04478279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830960|NCT04471428|Docetaxel|docetaxel|mesh-list
101830961|NCT04471428|Atezolizumab|atezolizumab|mesh-list
101830962|NCT04471428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830963|NCT04471428|Tubulin Modulators|tubulin modulators|mesh-ancestor
101830964|NCT04471428|Antimitotic Agents|antimitotic agents|mesh-ancestor
101830965|NCT04471428|Mitosis Modulators|mitosis modulators|mesh-ancestor
101830966|NCT04471428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830967|NCT04471428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101830968|NCT04471428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101830969|NCT04437225|Glycolic acid|glycolic acid|mesh-list
101830970|NCT04437225|Keratolytic Agents|keratolytic agents|mesh-ancestor
101830971|NCT04437225|Dermatologic Agents|dermatologic agents|mesh-ancestor
101830972|NCT04429555|Ibudilast|ibudilast|mesh-list
101830973|NCT04429555|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101830974|NCT04429555|Autonomic Agents|autonomic agents|mesh-ancestor
101830975|NCT04429555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101830976|NCT04429555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830977|NCT04429555|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101830978|NCT04429555|Respiratory System Agents|respiratory system agents|mesh-ancestor
101830979|NCT04429555|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101830980|NCT04429555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101830981|NCT04429555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830982|NCT04429555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101830983|NCT04429555|Vasodilator Agents|vasodilator agents|mesh-ancestor
101830984|NCT04421378|Bevacizumab|bevacizumab|mesh-list
101830985|NCT04421378|Temozolomide|temozolomide|mesh-list
101830986|NCT04421378|Carmustine|carmustine|mesh-list
101830987|NCT04421378|Lomustine|lomustine|mesh-list
101830988|NCT04421378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101830989|NCT04421378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830990|NCT04421378|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101830991|NCT04421378|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101830992|NCT04421378|Growth Substances|growth substances|mesh-ancestor
101830993|NCT04421378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830994|NCT04421378|Growth Inhibitors|growth inhibitors|mesh-ancestor
101830995|NCT04421378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101830996|NCT04421378|Alkylating Agents|alkylating agents|mesh-ancestor
101830997|NCT04421378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830998|NCT04400474|Atezolizumab|atezolizumab|mesh-list
101830999|NCT04400474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101831000|NCT04400474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528140|NCT01125761|Histamine Agents|histamine agents|mesh-ancestor
101831001|NCT04400474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101831027|NCT04319627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831028|NCT04319627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101831029|NCT04319627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101831030|NCT04319627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101831031|NCT04307576|Dexamethasone|dexamethasone|mesh-list
101831032|NCT04307576|Doxorubicin|doxorubicin|mesh-list
101831033|NCT04307576|Vincristine|vincristine|mesh-list
101831034|NCT04307576|Imatinib Mesylate|imatinib mesylate|mesh-list
101831035|NCT04307576|Blinatumomab|blinatumomab|mesh-list
101831036|NCT04307576|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
101831037|NCT04307576|Thioguanine|thioguanine|mesh-list
101831038|NCT04307576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101831039|NCT04307576|Antiemetics|antiemetics|mesh-ancestor
101831040|NCT04307576|Autonomic Agents|autonomic agents|mesh-ancestor
101831041|NCT04307576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101831042|NCT04307576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831043|NCT04307576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101831044|NCT04307576|Glucocorticoids|glucocorticoids|mesh-ancestor
101831045|NCT04307576|Hormones|hormones|mesh-ancestor
101831046|NCT04307576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101831047|NCT04307576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101831048|NCT04307576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831049|NCT04307576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101831050|NCT04307576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101831051|NCT04307576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101831052|NCT04307576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101831053|NCT04307576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831054|NCT04307576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101831055|NCT04307576|Tubulin Modulators|tubulin modulators|mesh-ancestor
101831056|NCT04307576|Antimitotic Agents|antimitotic agents|mesh-ancestor
101831057|NCT04307576|Mitosis Modulators|mitosis modulators|mesh-ancestor
101831058|NCT04307576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101831059|NCT04307576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101831060|NCT04307576|Immunotoxins|immunotoxins|mesh-ancestor
101831061|NCT04307576|Immunoconjugates|immunoconjugates|mesh-ancestor
101831062|NCT04307576|Immunologic Factors|immunologic factors|mesh-ancestor
101831063|NCT04307576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101831064|NCT04307576|Antimetabolites|antimetabolites|mesh-ancestor
101831065|NCT04305496|Fulvestrant|fulvestrant|mesh-list
101831066|NCT04305496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101831067|NCT04305496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831068|NCT04305496|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101831069|NCT04305496|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101831070|NCT04305496|Hormone Antagonists|hormone antagonists|mesh-ancestor
101831071|NCT04305496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101831072|NCT04305496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831073|NCT04301934|Estradiol|estradiol|mesh-list
101831074|NCT04301934|Estrogens|estrogens|mesh-list
101550884|NCT01320683|Antidotes|antidotes|mesh-ancestor
101831075|NCT04301934|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101831076|NCT04301934|Hormones|hormones|mesh-ancestor
101831077|NCT04301934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101831078|NCT04301934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831079|NCT04281017|Anesthetics|anesthetics|mesh-list
101831080|NCT04281017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101831081|NCT04281017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831082|NCT04261036|Ascorbic Acid|ascorbic acid|mesh-list
101831083|NCT04261036|Antioxidants|antioxidants|mesh-ancestor
101831084|NCT04261036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831085|NCT04261036|Protective Agents|protective agents|mesh-ancestor
101831086|NCT04261036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831087|NCT04261036|Vitamins|vitamins|mesh-ancestor
101831088|NCT04261036|Micronutrients|micronutrients|mesh-ancestor
101831089|NCT04255407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101831090|NCT04155190|Veratrum Alkaloids|veratrum alkaloids|mesh-list
101831091|NCT04155190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101831093|NCT04145440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831094|NCT04145440|Immunologic Factors|immunologic factors|mesh-ancestor
101831095|NCT04145440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831096|NCT04095832|Anesthetics|anesthetics|mesh-list
101831097|NCT04095832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101831098|NCT04095832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831099|NCT04083365|Capecitabine|capecitabine|mesh-list
101831100|NCT04083365|Durvalumab|durvalumab|mesh-list
101831101|NCT04083365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101831102|NCT04083365|Antimetabolites|antimetabolites|mesh-ancestor
101831103|NCT04083365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831104|NCT04083365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831105|NCT04083365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101831106|NCT04072068|Edoxaban|edoxaban|mesh-list
101831107|NCT04072068|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101831108|NCT04072068|Antithrombins|antithrombins|mesh-ancestor
101831109|NCT04072068|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101831110|NCT04072068|Protease Inhibitors|protease inhibitors|mesh-ancestor
101831111|NCT04072068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101831112|NCT04072068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831113|NCT04072068|Anticoagulants|anticoagulants|mesh-ancestor
101831114|NCT04036305|Lidocaine|lidocaine|mesh-list
101831115|NCT04036305|Bupivacaine|bupivacaine|mesh-list
101831116|NCT04036305|Anesthetics, Local|anesthetics, local|mesh-ancestor
101831117|NCT04036305|Anesthetics|anesthetics|mesh-ancestor
101831118|NCT04036305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101831119|NCT04036305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831121|NCT04036305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101831122|NCT04036305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101831123|NCT04036305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101831124|NCT04036305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101831125|NCT04036305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101831126|NCT04036305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831127|NCT04021108|Nivolumab|nivolumab|mesh-list
101831128|NCT04021108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101831129|NCT04021108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831130|NCT04021108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101831131|NCT04021108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831132|NCT04019327|Temozolomide|temozolomide|mesh-list
101831133|NCT04019327|Talazoparib|talazoparib|mesh-list
101831134|NCT04019327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101831135|NCT04019327|Alkylating Agents|alkylating agents|mesh-ancestor
101831136|NCT04019327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831137|NCT04019327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831138|NCT04019327|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101831139|NCT04019327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101831148|NCT03970655|Dexamethasone|dexamethasone|mesh-list
101831149|NCT03970655|Dexamethasone acetate|dexamethasone acetate|mesh-list
101550969|NCT01313273|Lanreotide|lanreotide|mesh-list
101831150|NCT03970655|Epinephrine|epinephrine|mesh-list
101831151|NCT03970655|Racepinephrine|racepinephrine|mesh-list
101831152|NCT03970655|Bupivacaine|bupivacaine|mesh-list
101831153|NCT03970655|Ropivacaine|ropivacaine|mesh-list
101831154|NCT03970655|Epinephryl borate|epinephryl borate|mesh-list
101831155|NCT03970655|BB 1101|bb 1101|mesh-list
101831156|NCT03970655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101831157|NCT03970655|Antiemetics|antiemetics|mesh-ancestor
101831158|NCT03970655|Autonomic Agents|autonomic agents|mesh-ancestor
101831159|NCT03970655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101831160|NCT03970655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831161|NCT03970655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101831162|NCT03970655|Glucocorticoids|glucocorticoids|mesh-ancestor
101831163|NCT03970655|Hormones|hormones|mesh-ancestor
101831164|NCT03970655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101831165|NCT03970655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101831166|NCT03970655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831167|NCT03970655|Protease Inhibitors|protease inhibitors|mesh-ancestor
101831168|NCT03970655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101831169|NCT03970655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831170|NCT03970655|Anesthetics, Local|anesthetics, local|mesh-ancestor
101831171|NCT03970655|Anesthetics|anesthetics|mesh-ancestor
101831172|NCT03970655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101831173|NCT03970655|Sensory System Agents|sensory system agents|mesh-ancestor
101831174|NCT03970655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101831175|NCT03970655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101831176|NCT03970655|Adrenergic Agents|adrenergic agents|mesh-ancestor
101831177|NCT03970655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101831178|NCT03970655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101831179|NCT03970655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101831180|NCT03970655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101831181|NCT03970655|Respiratory System Agents|respiratory system agents|mesh-ancestor
101831182|NCT03970655|Mydriatics|mydriatics|mesh-ancestor
101831183|NCT03970655|Sympathomimetics|sympathomimetics|mesh-ancestor
101831184|NCT03970655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101831185|NCT03916627|Cemiplimab|cemiplimab|mesh-list
101831186|NCT03916627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101831187|NCT03916627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831188|NCT03912064|Ipilimumab|ipilimumab|mesh-list
101831189|NCT03912064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101831190|NCT03912064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831191|NCT03912064|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101831192|NCT03912064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831193|NCT03911453|Rucaparib|rucaparib|mesh-list
101831194|NCT03911453|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101831195|NCT03911453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101831196|NCT03911453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831197|NCT03911453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831199|NCT03870919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831200|NCT03870919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101831201|NCT03870919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101831202|NCT03870919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831203|NCT03865290|Ondansetron|ondansetron|mesh-list
101831204|NCT03865290|Antiemetics|antiemetics|mesh-ancestor
101831205|NCT03865290|Autonomic Agents|autonomic agents|mesh-ancestor
101831206|NCT03865290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101831207|NCT03865290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831208|NCT03865290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101831209|NCT03865290|Antipruritics|antipruritics|mesh-ancestor
101831210|NCT03865290|Dermatologic Agents|dermatologic agents|mesh-ancestor
101831211|NCT03865290|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101831212|NCT03865290|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101831213|NCT03865290|Serotonin Agents|serotonin agents|mesh-ancestor
101831214|NCT03865290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101831215|NCT03865290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831216|NCT03843359|Dostarlimab|dostarlimab|mesh-list
101831217|NCT03843359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831218|NCT03840291|Edoxaban|edoxaban|mesh-list
101831219|NCT03840291|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101831220|NCT03840291|Antithrombins|antithrombins|mesh-ancestor
101831221|NCT03840291|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101831222|NCT03840291|Protease Inhibitors|protease inhibitors|mesh-ancestor
101831223|NCT03840291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101831224|NCT03840291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831225|NCT03840291|Anticoagulants|anticoagulants|mesh-ancestor
101831226|NCT03837626|Amiloride|amiloride|mesh-list
101831227|NCT03837626|Diuretics|diuretics|mesh-ancestor
101831228|NCT03837626|Natriuretic Agents|natriuretic agents|mesh-ancestor
101831229|NCT03837626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831230|NCT03837626|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
101831231|NCT03837626|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101831232|NCT03837626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101831233|NCT03837626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831234|NCT03837626|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101831235|NCT03837626|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101831236|NCT03781219|Vemurafenib|vemurafenib|mesh-list
101831237|NCT03781219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831238|NCT03781219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101831239|NCT03781219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101831240|NCT03781219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831241|NCT03773237|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101831242|NCT03773237|SMOFlipid|smoflipid|mesh-list
101831243|NCT03773237|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101831244|NCT03773237|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101831245|NCT03773237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101831246|NCT03747484|Interferons|interferons|mesh-list
101831247|NCT03747484|Interferon-gamma|interferon-gamma|mesh-list
101831248|NCT03747484|Pembrolizumab|pembrolizumab|mesh-list
101831249|NCT03747484|Avelumab|avelumab|mesh-list
101831250|NCT03747484|Immunoglobulins|immunoglobulins|mesh-list
101831251|NCT03747484|Immunoglobulin G|immunoglobulin g|mesh-list
101831252|NCT03747484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101831253|NCT03747484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101831254|NCT03747484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831255|NCT03747484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101831256|NCT03747484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831257|NCT03747484|Antiviral Agents|antiviral agents|mesh-ancestor
101831258|NCT03747484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101831259|NCT03747484|Immunologic Factors|immunologic factors|mesh-ancestor
101831260|NCT03747484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831261|NCT03745950|Olaparib|olaparib|mesh-list
101831262|NCT03745950|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101831263|NCT03745950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101831264|NCT03745950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831265|NCT03745950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831266|NCT03694808|Vaccines|vaccines|mesh-list
101831267|NCT03694808|Immunologic Factors|immunologic factors|mesh-ancestor
101831268|NCT03694808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831269|NCT03659539|Propofol|propofol|mesh-list
101831270|NCT03659539|Desflurane|desflurane|mesh-list
101831271|NCT03659539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101831272|NCT03659539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101831273|NCT03659539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831274|NCT03659539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101831275|NCT03659539|Anesthetics, General|anesthetics, general|mesh-ancestor
101831276|NCT03659539|Anesthetics|anesthetics|mesh-ancestor
101831277|NCT03659539|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101831278|NCT03659136|Everolimus|everolimus|mesh-list
101831279|NCT03659136|Exemestane|exemestane|mesh-list
101831280|NCT03659136|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101831281|NCT03659136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101831282|NCT03659136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101831283|NCT03659136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831284|NCT03659136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101831285|NCT03659136|Immunologic Factors|immunologic factors|mesh-ancestor
101831286|NCT03659136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831287|NCT03659136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831288|NCT03659136|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101831289|NCT03659136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101831290|NCT03659136|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101831291|NCT03659136|Hormone Antagonists|hormone antagonists|mesh-ancestor
101831292|NCT03659136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101831293|NCT03632044|Ropivacaine|ropivacaine|mesh-list
101831294|NCT03632044|Anesthetics, Local|anesthetics, local|mesh-ancestor
101831295|NCT03632044|Anesthetics|anesthetics|mesh-ancestor
101831296|NCT03632044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101528305|NCT04628559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101831297|NCT03632044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831298|NCT03632044|Sensory System Agents|sensory system agents|mesh-ancestor
101831299|NCT03632044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101831300|NCT03629418|Phenylephrine|phenylephrine|mesh-list
101831301|NCT03629418|Norepinephrine|norepinephrine|mesh-list
101831302|NCT03629418|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101831303|NCT03629418|Mydriatics|mydriatics|mesh-ancestor
101831304|NCT03629418|Autonomic Agents|autonomic agents|mesh-ancestor
101831305|NCT03629418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101831306|NCT03629418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831307|NCT03629418|Sympathomimetics|sympathomimetics|mesh-ancestor
101831308|NCT03629418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101831309|NCT03629418|Nasal Decongestants|nasal decongestants|mesh-ancestor
101831310|NCT03629418|Respiratory System Agents|respiratory system agents|mesh-ancestor
101831311|NCT03629418|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101831312|NCT03629418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101831313|NCT03629418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101831314|NCT03629418|Adrenergic Agents|adrenergic agents|mesh-ancestor
101831315|NCT03629418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101831316|NCT03629418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831317|NCT03629418|Protective Agents|protective agents|mesh-ancestor
101831318|NCT03606213|Vaccines|vaccines|mesh-list
101831319|NCT03606213|Immunologic Factors|immunologic factors|mesh-ancestor
101831320|NCT03606213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831321|NCT03605719|Dexamethasone|dexamethasone|mesh-list
101831322|NCT03605719|Nivolumab|nivolumab|mesh-list
101831323|NCT03605719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101831324|NCT03605719|Antiemetics|antiemetics|mesh-ancestor
101831325|NCT03605719|Autonomic Agents|autonomic agents|mesh-ancestor
101831326|NCT03605719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101831327|NCT03605719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831328|NCT03605719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101831329|NCT03605719|Glucocorticoids|glucocorticoids|mesh-ancestor
101831330|NCT03605719|Hormones|hormones|mesh-ancestor
101831331|NCT03605719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101223277|NCT01517399|Anesthetics, General|anesthetics, general|mesh-ancestor
101831332|NCT03605719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101831333|NCT03605719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831334|NCT03605719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101831335|NCT03605719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101831336|NCT03605719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831337|NCT03529422|Durvalumab|durvalumab|mesh-list
101831338|NCT03529422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101831339|NCT03529422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831340|NCT03518203|Eculizumab|eculizumab|mesh-list
101831341|NCT03518203|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101831342|NCT03518203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101831343|NCT03518203|Immunologic Factors|immunologic factors|mesh-ancestor
101831344|NCT03518203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831346|NCT03514108|Hydralazine|hydralazine|mesh-list
101831347|NCT03514108|Isosorbide|isosorbide|mesh-list
101831348|NCT03514108|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
101831349|NCT03514108|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
101831350|NCT03514108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101831351|NCT03514108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831352|NCT03514108|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101831353|NCT03514108|Diuretics|diuretics|mesh-ancestor
101831354|NCT03514108|Natriuretic Agents|natriuretic agents|mesh-ancestor
101831355|NCT03514108|Vasodilator Agents|vasodilator agents|mesh-ancestor
101831356|NCT03514108|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101831357|NCT03514108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831358|NCT03514108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101831359|NCT03390036|Triamcinolone|triamcinolone|mesh-list
101831360|NCT03390036|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101831361|NCT03390036|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101831362|NCT03390036|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101831363|NCT03390036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101831364|NCT03390036|Glucocorticoids|glucocorticoids|mesh-ancestor
101831365|NCT03390036|Hormones|hormones|mesh-ancestor
101831366|NCT03390036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101831367|NCT03390036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831368|NCT03390036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101831369|NCT03390036|Immunologic Factors|immunologic factors|mesh-ancestor
101831370|NCT03390036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101831371|NCT03390036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831372|NCT03379506|Grazoprevir|grazoprevir|mesh-list
101831373|NCT03379506|Antiviral Agents|antiviral agents|mesh-ancestor
101831374|NCT03379506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101831375|NCT03375788|Hormones|hormones|mesh-list
101831376|NCT03375788|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
101831377|NCT03375788|Tesamorelin|tesamorelin|mesh-list
101831378|NCT03375788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101831379|NCT03375788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831380|NCT03375788|Growth Substances|growth substances|mesh-ancestor
101831381|NCT03366844|Pembrolizumab|pembrolizumab|mesh-list
101831382|NCT03366844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101831383|NCT03366844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831384|NCT03366844|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101831385|NCT03366844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831386|NCT03348969|Mitomycins|mitomycins|mesh-list
101831387|NCT03348969|Mitomycin|mitomycin|mesh-list
101831388|NCT03348969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101831389|NCT03348969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831390|NCT03348969|Alkylating Agents|alkylating agents|mesh-ancestor
101831391|NCT03348969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831392|NCT03348969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101831393|NCT03348969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101831394|NCT03341936|Nivolumab|nivolumab|mesh-list
101831395|NCT03341936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101831396|NCT03341936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831397|NCT03341936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101831398|NCT03341936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831399|NCT03318900|Aldesleukin|aldesleukin|mesh-list
101831400|NCT03318900|Cyclophosphamide|cyclophosphamide|mesh-list
101831401|NCT03318900|Interleukin-2|interleukin-2|mesh-list
101831402|NCT03318900|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101831403|NCT03318900|Immunoglobulin G|immunoglobulin g|mesh-list
101831404|NCT03318900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101831405|NCT03318900|Immunologic Factors|immunologic factors|mesh-ancestor
101831406|NCT03318900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223371|NCT01517932|Dexmedetomidine|dexmedetomidine|mesh-list
101831407|NCT03318900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101831408|NCT03318900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101831409|NCT03318900|Alkylating Agents|alkylating agents|mesh-ancestor
101831410|NCT03318900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831411|NCT03318900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831412|NCT03318900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101831413|NCT03318900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101831414|NCT03318900|Analgesics|analgesics|mesh-ancestor
101831415|NCT03318900|Sensory System Agents|sensory system agents|mesh-ancestor
101831416|NCT03318900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101831417|NCT03318900|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101825238|NCT00519636|Xhance|xhance|mesh-list
101831418|NCT03318900|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101831419|NCT03318900|Antiviral Agents|antiviral agents|mesh-ancestor
101831420|NCT03318900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101831421|NCT03306446|Adalimumab|adalimumab|mesh-list
101831422|NCT03306446|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101831423|NCT03306446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101831424|NCT03306446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101831425|NCT03306264|Decitabine|decitabine|mesh-list
101831426|NCT03306264|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
101831427|NCT03306264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101831428|NCT03306264|Antimetabolites|antimetabolites|mesh-ancestor
101831429|NCT03306264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831430|NCT03306264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831431|NCT03306264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101831432|NCT03292133|Gefitinib|gefitinib|mesh-list
101831433|NCT03292133|Nazartinib|nazartinib|mesh-list
101831434|NCT03292133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831435|NCT03292133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101831436|NCT03292133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101831437|NCT03292133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831438|NCT03289728|Dobutamine|dobutamine|mesh-list
101831439|NCT03289728|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101831440|NCT03289728|Sympathomimetics|sympathomimetics|mesh-ancestor
101831441|NCT03289728|Autonomic Agents|autonomic agents|mesh-ancestor
101831442|NCT03289728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101831443|NCT03289728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831444|NCT03289728|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101831445|NCT03289728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101831446|NCT03289728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101831447|NCT03289728|Adrenergic Agents|adrenergic agents|mesh-ancestor
101831448|NCT03289728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101831449|NCT03289728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831450|NCT03289728|Protective Agents|protective agents|mesh-ancestor
101831452|NCT03283917|Dexamethasone acetate|dexamethasone acetate|mesh-list
101831453|NCT03283917|Daratumumab|daratumumab|mesh-list
101831454|NCT03283917|Ixazomib|ixazomib|mesh-list
101831455|NCT03283917|Ichthammol|ichthammol|mesh-list
101831456|NCT03283917|BB 1101|bb 1101|mesh-list
101831457|NCT03283917|Glycine|glycine|mesh-list
101831458|NCT03283917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101831459|NCT03283917|Antiemetics|antiemetics|mesh-ancestor
101831460|NCT03283917|Autonomic Agents|autonomic agents|mesh-ancestor
101831461|NCT03283917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101831462|NCT03283917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831463|NCT03283917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101831464|NCT03283917|Glucocorticoids|glucocorticoids|mesh-ancestor
101831465|NCT03283917|Hormones|hormones|mesh-ancestor
101831466|NCT03283917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101831467|NCT03283917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101831468|NCT03283917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831469|NCT03283917|Protease Inhibitors|protease inhibitors|mesh-ancestor
101831470|NCT03283917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101831471|NCT03283917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831472|NCT03283917|Dermatologic Agents|dermatologic agents|mesh-ancestor
101831473|NCT03283917|Glycine Agents|glycine agents|mesh-ancestor
101831474|NCT03283917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101831475|NCT03275415|Budesonide|budesonide|mesh-list
101831476|NCT03275415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101831477|NCT03275415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101831478|NCT03275415|Autonomic Agents|autonomic agents|mesh-ancestor
101831479|NCT03275415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101831480|NCT03275415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831481|NCT03275415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101831482|NCT03275415|Respiratory System Agents|respiratory system agents|mesh-ancestor
101831483|NCT03275415|Glucocorticoids|glucocorticoids|mesh-ancestor
101831484|NCT03275415|Hormones|hormones|mesh-ancestor
101831485|NCT03275415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101831486|NCT03233724|Pembrolizumab|pembrolizumab|mesh-list
101831487|NCT03233724|Decitabine|decitabine|mesh-list
101831488|NCT03233724|Tetrahydrouridine|tetrahydrouridine|mesh-list
101831489|NCT03233724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101831490|NCT03233724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831491|NCT03233724|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101831492|NCT03233724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831493|NCT03233724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101831494|NCT03233724|Antimetabolites|antimetabolites|mesh-ancestor
101831495|NCT03233724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101831496|NCT03230734|Docetaxel|docetaxel|mesh-list
101831497|NCT03230734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831498|NCT03230734|Tubulin Modulators|tubulin modulators|mesh-ancestor
101831499|NCT03230734|Antimitotic Agents|antimitotic agents|mesh-ancestor
101831500|NCT03230734|Mitosis Modulators|mitosis modulators|mesh-ancestor
101831501|NCT03230734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831502|NCT03229408|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
101831503|NCT03229408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101831504|NCT03229408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101831505|NCT03229408|Analgesics|analgesics|mesh-ancestor
101831506|NCT03229408|Sensory System Agents|sensory system agents|mesh-ancestor
101831507|NCT03229408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101831508|NCT03229408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831509|NCT03229408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101831510|NCT03229408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101831511|NCT03174197|Temozolomide|temozolomide|mesh-list
101831512|NCT03174197|Atezolizumab|atezolizumab|mesh-list
101831513|NCT03174197|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101831514|NCT03174197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101831515|NCT03174197|Alkylating Agents|alkylating agents|mesh-ancestor
101831516|NCT03174197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831517|NCT03174197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831518|NCT03174197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101831519|NCT03174197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101831520|NCT03174197|Immunologic Factors|immunologic factors|mesh-ancestor
101831521|NCT03174197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831522|NCT03146962|Ascorbic Acid|ascorbic acid|mesh-list
101831523|NCT03146962|Vitamins|vitamins|mesh-ancestor
101831524|NCT03146962|Micronutrients|micronutrients|mesh-ancestor
101831525|NCT03146962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831526|NCT03146962|Antioxidants|antioxidants|mesh-ancestor
101831527|NCT03146962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831529|NCT03110978|Nivolumab|nivolumab|mesh-list
101831530|NCT03110978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101831531|NCT03110978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831532|NCT03110978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101831533|NCT03110978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831534|NCT03085810|Ocrelizumab|ocrelizumab|mesh-list
101831535|NCT03085810|Immunologic Factors|immunologic factors|mesh-ancestor
101831536|NCT03085810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831537|NCT03077451|Nelfinavir|nelfinavir|mesh-list
101831538|NCT03077451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101223450|NCT01518231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101831539|NCT03077451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101831540|NCT03077451|Protease Inhibitors|protease inhibitors|mesh-ancestor
101831541|NCT03077451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101831542|NCT03077451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831543|NCT03077451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101831544|NCT03077451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101831545|NCT03077451|Antiviral Agents|antiviral agents|mesh-ancestor
101831546|NCT03077451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101831547|NCT02998268|Paclitaxel|paclitaxel|mesh-list
101831548|NCT02998268|Carboplatin|carboplatin|mesh-list
101831549|NCT02998268|Pembrolizumab|pembrolizumab|mesh-list
101831550|NCT02998268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101831551|NCT02998268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831552|NCT02998268|Tubulin Modulators|tubulin modulators|mesh-ancestor
101831553|NCT02998268|Antimitotic Agents|antimitotic agents|mesh-ancestor
101831554|NCT02998268|Mitosis Modulators|mitosis modulators|mesh-ancestor
101831555|NCT02998268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831556|NCT02998268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101831557|NCT02998268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101831558|NCT02947685|Trastuzumab|trastuzumab|mesh-list
101831559|NCT02947685|Pertuzumab|pertuzumab|mesh-list
101831560|NCT02947685|Letrozole|letrozole|mesh-list
101831561|NCT02947685|Fulvestrant|fulvestrant|mesh-list
101831562|NCT02947685|Palbociclib|palbociclib|mesh-list
101831563|NCT02947685|Anastrozole|anastrozole|mesh-list
101831564|NCT02947685|Exemestane|exemestane|mesh-list
101831565|NCT02947685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101831566|NCT02947685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831567|NCT02947685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101831568|NCT02947685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101831569|NCT02947685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101831570|NCT02947685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831571|NCT02947685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101831572|NCT02947685|Hormone Antagonists|hormone antagonists|mesh-ancestor
101831573|NCT02947685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101831574|NCT02947685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831575|NCT02947685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101831576|NCT02947685|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101831577|NCT02947685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101831578|NCT02879695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101831580|NCT02879695|Ipilimumab|ipilimumab|mesh-list
101831581|NCT02879695|Blinatumomab|blinatumomab|mesh-list
101831582|NCT02879695|Antibodies|antibodies|mesh-list
101831583|NCT02879695|Immunoglobulins|immunoglobulins|mesh-list
101831584|NCT02879695|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101831585|NCT02879695|Muromonab-CD3|muromonab-cd3|mesh-list
101831586|NCT02879695|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101831587|NCT02879695|Immunologic Factors|immunologic factors|mesh-ancestor
101831588|NCT02879695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831589|NCT02879695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831590|NCT02879695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101831591|NCT02879695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831592|NCT02879695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101223487|NCT01518465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101831593|NCT02871882|Bile Acids and Salts|bile acids and salts|mesh-list
101831594|NCT02871882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101831595|NCT02824276|Morphine|morphine|mesh-list
101831596|NCT02824276|Oxycodone|oxycodone|mesh-list
101831597|NCT02824276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101831598|NCT02824276|Narcotics|narcotics|mesh-ancestor
101831599|NCT02824276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101831600|NCT02824276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831601|NCT02824276|Analgesics|analgesics|mesh-ancestor
101831602|NCT02824276|Sensory System Agents|sensory system agents|mesh-ancestor
101831603|NCT02824276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101831605|NCT02813135|Dexamethasone|dexamethasone|mesh-list
101831606|NCT02813135|Cyclophosphamide|cyclophosphamide|mesh-list
101831607|NCT02813135|Temozolomide|temozolomide|mesh-list
101831608|NCT02813135|Carboplatin|carboplatin|mesh-list
101831609|NCT02813135|Nivolumab|nivolumab|mesh-list
101831610|NCT02813135|Irinotecan|irinotecan|mesh-list
101831611|NCT02813135|Everolimus|everolimus|mesh-list
101831612|NCT02813135|Topotecan|topotecan|mesh-list
101831613|NCT02813135|Olaparib|olaparib|mesh-list
101831614|NCT02813135|Futibatinib|futibatinib|mesh-list
101831615|NCT02813135|Adavosertib|adavosertib|mesh-list
101831616|NCT02813135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101831617|NCT02813135|Immunologic Factors|immunologic factors|mesh-ancestor
101831618|NCT02813135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831619|NCT02813135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101831620|NCT02813135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101831621|NCT02813135|Alkylating Agents|alkylating agents|mesh-ancestor
101831622|NCT02813135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831623|NCT02813135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831624|NCT02813135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101831625|NCT02813135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101831626|NCT02813135|Antiemetics|antiemetics|mesh-ancestor
101831627|NCT02813135|Autonomic Agents|autonomic agents|mesh-ancestor
101831628|NCT02813135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101831629|NCT02813135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101831630|NCT02813135|Glucocorticoids|glucocorticoids|mesh-ancestor
101831631|NCT02813135|Hormones|hormones|mesh-ancestor
101831632|NCT02813135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101831633|NCT02813135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101831634|NCT02813135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101831635|NCT02813135|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101831636|NCT02813135|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101831637|NCT02813135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101831638|NCT02813135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101831639|NCT02813135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101831640|NCT02813135|Antimetabolites|antimetabolites|mesh-ancestor
101831641|NCT02813135|Antiviral Agents|antiviral agents|mesh-ancestor
101831642|NCT02813135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101831643|NCT02813135|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101831644|NCT02813135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101831645|NCT02813135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101831646|NCT02732288|Melatonin|melatonin|mesh-list
101831647|NCT02732288|Antioxidants|antioxidants|mesh-ancestor
101831648|NCT02732288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223509|NCT01518595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101831650|NCT02732288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831651|NCT02732288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101831652|NCT02687958|Everolimus|everolimus|mesh-list
101831653|NCT02687958|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101831654|NCT02687958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101831655|NCT02687958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101831656|NCT02687958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831657|NCT02687958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101831658|NCT02687958|Immunologic Factors|immunologic factors|mesh-ancestor
101831659|NCT02687958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831660|NCT02687958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831661|NCT02478710|Vancomycin|vancomycin|mesh-list
101831662|NCT02478710|Tobramycin|tobramycin|mesh-list
101831663|NCT02478710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101831664|NCT02478710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101831665|NCT02476279|Indomethacin|indomethacin|mesh-list
101831666|NCT02476279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101831667|NCT02476279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101831668|NCT02476279|Analgesics|analgesics|mesh-ancestor
101831669|NCT02476279|Sensory System Agents|sensory system agents|mesh-ancestor
101831670|NCT02476279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101831671|NCT02476279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831672|NCT02476279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101831673|NCT02476279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101831674|NCT02476279|Gout Suppressants|gout suppressants|mesh-ancestor
101831675|NCT02476279|Tocolytic Agents|tocolytic agents|mesh-ancestor
101831676|NCT02476279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101551475|NCT02872597|Glucocorticoids|glucocorticoids|mesh-ancestor
101831677|NCT02476279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101831678|NCT02476279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101831679|NCT02476279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831680|NCT02425865|Golimumab|golimumab|mesh-list
101831681|NCT02425865|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101831682|NCT02425865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101831683|NCT02425865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101831684|NCT02425865|Immunologic Factors|immunologic factors|mesh-ancestor
101831685|NCT02425865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831686|NCT02425852|Prednisolone|prednisolone|mesh-list
101831687|NCT02425852|Hydrocortisone|hydrocortisone|mesh-list
101831688|NCT02425852|Infliximab|infliximab|mesh-list
101831689|NCT02425852|Azathioprine|azathioprine|mesh-list
101831690|NCT02425852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101831691|NCT02425852|Glucocorticoids|glucocorticoids|mesh-ancestor
101831692|NCT02425852|Hormones|hormones|mesh-ancestor
101831693|NCT02425852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101831694|NCT02425852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831695|NCT02425852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101831696|NCT02425852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831697|NCT02425852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101831698|NCT02425852|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101831699|NCT02425852|Dermatologic Agents|dermatologic agents|mesh-ancestor
101831700|NCT02425852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101831701|NCT02425852|Antimetabolites|antimetabolites|mesh-ancestor
101831702|NCT02425852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831703|NCT02425852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101831704|NCT02425852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101831705|NCT02425852|Immunologic Factors|immunologic factors|mesh-ancestor
101831706|NCT02382549|Vaccines|vaccines|mesh-list
101831707|NCT02382549|Immunologic Factors|immunologic factors|mesh-ancestor
101831708|NCT02382549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831709|NCT02333188|Leucovorin|leucovorin|mesh-list
101831710|NCT02333188|Paclitaxel|paclitaxel|mesh-list
101831711|NCT02333188|Fluorouracil|fluorouracil|mesh-list
101831712|NCT02333188|Irinotecan|irinotecan|mesh-list
101831713|NCT02333188|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101831714|NCT02333188|Calcium|calcium|mesh-list
101831715|NCT02333188|Levoleucovorin|levoleucovorin|mesh-list
101831716|NCT02333188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101831717|NCT02333188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831718|NCT02333188|Tubulin Modulators|tubulin modulators|mesh-ancestor
101831719|NCT02333188|Antimitotic Agents|antimitotic agents|mesh-ancestor
101831720|NCT02333188|Mitosis Modulators|mitosis modulators|mesh-ancestor
101831721|NCT02333188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831722|NCT02333188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101825537|NCT00865085|Cholinergic Agents|cholinergic agents|mesh-ancestor
101831723|NCT02333188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831724|NCT02333188|Antimetabolites|antimetabolites|mesh-ancestor
101831725|NCT02333188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101831726|NCT02333188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101831727|NCT02333188|Immunologic Factors|immunologic factors|mesh-ancestor
101831728|NCT02333188|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101831729|NCT02333188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101831730|NCT02333188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101831731|NCT02333188|Antidotes|antidotes|mesh-ancestor
101831732|NCT02333188|Protective Agents|protective agents|mesh-ancestor
101831733|NCT02333188|Vitamin B Complex|vitamin b complex|mesh-ancestor
101831735|NCT02333188|Micronutrients|micronutrients|mesh-ancestor
101831736|NCT02282358|Mocetinostat|mocetinostat|mesh-list
101831737|NCT02282358|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101831738|NCT02282358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101831739|NCT02282358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831740|NCT02177578|Temozolomide|temozolomide|mesh-list
101831741|NCT02177578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101831742|NCT02177578|Alkylating Agents|alkylating agents|mesh-ancestor
101831743|NCT02177578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831744|NCT02177578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831745|NCT02166463|Prednisone|prednisone|mesh-list
101831746|NCT02166463|Methylprednisolone|methylprednisolone|mesh-list
101831747|NCT02166463|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101831748|NCT02166463|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101831749|NCT02166463|Prednisolone|prednisolone|mesh-list
101831750|NCT02166463|Prednisolone acetate|prednisolone acetate|mesh-list
101831751|NCT02166463|Cortisone|cortisone|mesh-list
101831752|NCT02166463|Cyclophosphamide|cyclophosphamide|mesh-list
101831753|NCT02166463|Doxorubicin|doxorubicin|mesh-list
101831754|NCT02166463|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101831755|NCT02166463|Etoposide|etoposide|mesh-list
101831756|NCT02166463|Vincristine|vincristine|mesh-list
101831757|NCT02166463|Etoposide phosphate|etoposide phosphate|mesh-list
101831758|NCT02166463|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101831759|NCT02166463|Bleomycin|bleomycin|mesh-list
101831760|NCT02166463|Podophyllotoxin|podophyllotoxin|mesh-list
101831761|NCT02166463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101831762|NCT02166463|Antibodies|antibodies|mesh-list
101831763|NCT02166463|Immunoglobulins|immunoglobulins|mesh-list
101831764|NCT02166463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101831765|NCT02166463|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101831766|NCT02166463|Prednisolone phosphate|prednisolone phosphate|mesh-list
101831767|NCT02166463|Immunoconjugates|immunoconjugates|mesh-list
101831768|NCT02166463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101831769|NCT02166463|Immunologic Factors|immunologic factors|mesh-ancestor
101831770|NCT02166463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831771|NCT02166463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101831772|NCT02166463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101831773|NCT02166463|Alkylating Agents|alkylating agents|mesh-ancestor
101831774|NCT02166463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831775|NCT02166463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831776|NCT02166463|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101831777|NCT02166463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101831778|NCT02166463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101831779|NCT02166463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101831780|NCT02166463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101831781|NCT02166463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101831782|NCT02166463|Glucocorticoids|glucocorticoids|mesh-ancestor
101831783|NCT02166463|Hormones|hormones|mesh-ancestor
101831784|NCT02166463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101831785|NCT02166463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101831786|NCT02166463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101831787|NCT02166463|Tubulin Modulators|tubulin modulators|mesh-ancestor
101831788|NCT02166463|Antimitotic Agents|antimitotic agents|mesh-ancestor
101831789|NCT02166463|Mitosis Modulators|mitosis modulators|mesh-ancestor
101831790|NCT02166463|Antiemetics|antiemetics|mesh-ancestor
101831791|NCT02166463|Autonomic Agents|autonomic agents|mesh-ancestor
101831792|NCT02166463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101831793|NCT02166463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101831794|NCT02166463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101831795|NCT02166463|Protective Agents|protective agents|mesh-ancestor
101831796|NCT02166463|Immunotoxins|immunotoxins|mesh-ancestor
101831797|NCT02166463|Keratolytic Agents|keratolytic agents|mesh-ancestor
101831798|NCT02166463|Dermatologic Agents|dermatologic agents|mesh-ancestor
101831799|NCT02112526|Acalabrutinib|acalabrutinib|mesh-list
101831800|NCT02112526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831801|NCT02094794|Cyclophosphamide|cyclophosphamide|mesh-list
101831802|NCT02094794|Etoposide|etoposide|mesh-list
101831803|NCT02094794|Etoposide phosphate|etoposide phosphate|mesh-list
101831804|NCT02094794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101831805|NCT02094794|Immunologic Factors|immunologic factors|mesh-ancestor
101831806|NCT02094794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831807|NCT02094794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101831808|NCT02094794|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101831809|NCT02094794|Alkylating Agents|alkylating agents|mesh-ancestor
101831810|NCT02094794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831811|NCT02094794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831812|NCT02094794|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101831813|NCT02094794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101831814|NCT02094794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101831815|NCT02094794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101831816|NCT02094794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101831817|NCT01902173|Trametinib|trametinib|mesh-list
101831818|NCT01902173|Dabrafenib|dabrafenib|mesh-list
101831819|NCT01902173|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
101831820|NCT01902173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831821|NCT01902173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101831822|NCT01902173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101831823|NCT01902173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831824|NCT01902173|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101831825|NCT01902173|Protective Agents|protective agents|mesh-ancestor
101831826|NCT01902173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831827|NCT01902173|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101831828|NCT01902173|Antioxidants|antioxidants|mesh-ancestor
101831829|NCT01892709|Hydromorphone|hydromorphone|mesh-list
101831830|NCT01892709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101831831|NCT01892709|Narcotics|narcotics|mesh-ancestor
101831832|NCT01892709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101551625|NCT01287195|Omeprazole|omeprazole|mesh-list
101831833|NCT01892709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831834|NCT01892709|Analgesics|analgesics|mesh-ancestor
101831835|NCT01892709|Sensory System Agents|sensory system agents|mesh-ancestor
101831836|NCT01892709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101831838|NCT01806571|Daunorubicin|daunorubicin|mesh-list
101831839|NCT01806571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101831840|NCT01806571|Antimetabolites|antimetabolites|mesh-ancestor
101831841|NCT01806571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831842|NCT01806571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831843|NCT01806571|Antiviral Agents|antiviral agents|mesh-ancestor
101831844|NCT01806571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101831845|NCT01806571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101831846|NCT01806571|Immunologic Factors|immunologic factors|mesh-ancestor
101831847|NCT01806571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831848|NCT01806571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101223621|NCT01519154|Ketamine|ketamine|mesh-list
101831849|NCT01806571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101831850|NCT01806571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101831851|NCT01806571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101831852|NCT01633177|Vitamin D|vitamin d|mesh-list
101831853|NCT01633177|Ergocalciferols|ergocalciferols|mesh-list
101831854|NCT01633177|Cholecalciferol|cholecalciferol|mesh-list
101831855|NCT01633177|Vitamins|vitamins|mesh-list
101831856|NCT01633177|Micronutrients|micronutrients|mesh-ancestor
101831857|NCT01633177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831858|NCT01633177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101831859|NCT01633177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101831860|NCT01517451|Androgens|androgens|mesh-list
101831861|NCT01517451|Hormones|hormones|mesh-ancestor
101831862|NCT01517451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101831863|NCT01517451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831864|NCT01409200|Ascorbic Acid|ascorbic acid|mesh-list
101831865|NCT01409200|Methyltestosterone|methyltestosterone|mesh-list
101831866|NCT01409200|Axitinib|axitinib|mesh-list
101831867|NCT01409200|Hormones|hormones|mesh-list
101831868|NCT01409200|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101831870|NCT01409200|Androgen Antagonists|androgen antagonists|mesh-list
101831871|NCT01409200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101831872|NCT01409200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831873|NCT01409200|Antioxidants|antioxidants|mesh-ancestor
101831874|NCT01409200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831875|NCT01409200|Protective Agents|protective agents|mesh-ancestor
101831876|NCT01409200|Vitamins|vitamins|mesh-ancestor
101831877|NCT01409200|Micronutrients|micronutrients|mesh-ancestor
101831879|NCT01409200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101831880|NCT01409200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831881|NCT01409200|Anabolic Agents|anabolic agents|mesh-ancestor
101831882|NCT01409200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101831883|NCT01409200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101831884|NCT01409200|Hormone Antagonists|hormone antagonists|mesh-ancestor
101831885|NCT01204216|Biotin|biotin|mesh-list
101831886|NCT01204216|Vitamin B Complex|vitamin b complex|mesh-ancestor
101831887|NCT01204216|Vitamins|vitamins|mesh-ancestor
101831888|NCT01204216|Micronutrients|micronutrients|mesh-ancestor
101831889|NCT01204216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831890|NCT01104350|Gemcitabine|gemcitabine|mesh-list
101831891|NCT01104350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101831892|NCT01104350|Antimetabolites|antimetabolites|mesh-ancestor
101831893|NCT01104350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831894|NCT01104350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831895|NCT01100892|Insulin Detemir|insulin detemir|mesh-list
101831896|NCT01100892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101831897|NCT01100892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831898|NCT01025089|Cyclophosphamide|cyclophosphamide|mesh-list
101831899|NCT01025089|Doxorubicin|doxorubicin|mesh-list
101831900|NCT01025089|Cetuximab|cetuximab|mesh-list
101831901|NCT01025089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101831902|NCT01025089|Immunologic Factors|immunologic factors|mesh-ancestor
101831903|NCT01025089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831904|NCT01025089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101831905|NCT01025089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101831906|NCT01025089|Alkylating Agents|alkylating agents|mesh-ancestor
101831907|NCT01025089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831908|NCT01025089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831909|NCT01025089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101831910|NCT01025089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101831911|NCT01025089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101831912|NCT01025089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101831913|NCT01025089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101831914|NCT01025089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101831916|NCT00999037|Chelating Agents|chelating agents|mesh-ancestor
101831917|NCT00999037|Sequestering Agents|sequestering agents|mesh-ancestor
101831918|NCT00999037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831919|NCT00921856|Acetylcholine|acetylcholine|mesh-list
101831920|NCT00921856|Vasodilator Agents|vasodilator agents|mesh-ancestor
101831921|NCT00921856|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101831922|NCT00921856|Cholinergic Agents|cholinergic agents|mesh-ancestor
101831923|NCT00921856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101831924|NCT00921856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831925|NCT00921856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831926|NCT00861705|Paclitaxel|paclitaxel|mesh-list
101831927|NCT00861705|Cyclophosphamide|cyclophosphamide|mesh-list
101831928|NCT00861705|Bevacizumab|bevacizumab|mesh-list
101831929|NCT00861705|Carboplatin|carboplatin|mesh-list
101831930|NCT00861705|Doxorubicin|doxorubicin|mesh-list
101831931|NCT00861705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101831932|NCT00861705|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101831933|NCT00861705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101831934|NCT00861705|Antibodies|antibodies|mesh-list
101831935|NCT00861705|Immunoglobulins|immunoglobulins|mesh-list
101831936|NCT00861705|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101831937|NCT00861705|Immunoglobulin G|immunoglobulin g|mesh-list
101831938|NCT00861705|Endothelial Growth Factors|endothelial growth factors|mesh-list
101831939|NCT00861705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101831940|NCT00861705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831941|NCT00861705|Tubulin Modulators|tubulin modulators|mesh-ancestor
101298627|NCT05970666|Bevacizumab|bevacizumab|mesh-list
101831942|NCT00861705|Antimitotic Agents|antimitotic agents|mesh-ancestor
101831943|NCT00861705|Mitosis Modulators|mitosis modulators|mesh-ancestor
101831944|NCT00861705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831945|NCT00861705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101831946|NCT00861705|Immunologic Factors|immunologic factors|mesh-ancestor
101831947|NCT00861705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831948|NCT00861705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101831949|NCT00861705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101831950|NCT00861705|Alkylating Agents|alkylating agents|mesh-ancestor
101831951|NCT00861705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101831952|NCT00861705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101831953|NCT00861705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101831954|NCT00861705|Growth Substances|growth substances|mesh-ancestor
101831955|NCT00861705|Growth Inhibitors|growth inhibitors|mesh-ancestor
101831956|NCT00861705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101831957|NCT00861705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101831958|NCT00861705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101831959|NCT00861705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101831961|NCT00833664|Antifungal Agents|antifungal agents|mesh-ancestor
101831962|NCT00833664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101831963|NCT00833664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101831964|NCT00833664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101831965|NCT00696111|Leuprolide|leuprolide|mesh-list
101831966|NCT00696111|Progesterone|progesterone|mesh-list
101831967|NCT00696111|Estrogens|estrogens|mesh-list
101831968|NCT00696111|Progestins|progestins|mesh-ancestor
101831969|NCT00696111|Hormones|hormones|mesh-ancestor
101831970|NCT00696111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101831971|NCT00696111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101831972|NCT00696111|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101831973|NCT00696111|Fertility Agents|fertility agents|mesh-ancestor
101831974|NCT00696111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101831975|NCT00696111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101831976|NCT00696111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101831998|NCT00224393|Etanercept|etanercept|mesh-list
101831999|NCT00224393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101832000|NCT00224393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101832001|NCT00224393|Analgesics|analgesics|mesh-ancestor
101832002|NCT00224393|Sensory System Agents|sensory system agents|mesh-ancestor
101832003|NCT00224393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101832004|NCT00224393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832005|NCT00224393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101832006|NCT00224393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101832007|NCT00224393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101832008|NCT00224393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101832009|NCT00224393|Immunologic Factors|immunologic factors|mesh-ancestor
101832010|NCT00199862|Antibodies|antibodies|mesh-list
101832011|NCT00199862|Immunologic Factors|immunologic factors|mesh-ancestor
101832012|NCT00199862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832013|NCT00128310|Gemcitabine|gemcitabine|mesh-list
101832014|NCT00128310|Vinorelbine|vinorelbine|mesh-list
101832015|NCT00128310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101832016|NCT00128310|Antimetabolites|antimetabolites|mesh-ancestor
101832017|NCT00128310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832018|NCT00128310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101832019|NCT00128310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101832020|NCT00128310|Tubulin Modulators|tubulin modulators|mesh-ancestor
101832021|NCT00128310|Antimitotic Agents|antimitotic agents|mesh-ancestor
101832022|NCT00128310|Mitosis Modulators|mitosis modulators|mesh-ancestor
101832023|NCT00885443|Propofol|propofol|mesh-list
101832024|NCT00885443|Sevoflurane|sevoflurane|mesh-list
101223690|NCT01519544|Temazepam|temazepam|mesh-list
101832025|NCT00885443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101832026|NCT00885443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101832027|NCT00885443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832028|NCT00885443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101832029|NCT00885443|Anesthetics, General|anesthetics, general|mesh-ancestor
101832030|NCT00885443|Anesthetics|anesthetics|mesh-ancestor
101832031|NCT00885443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101832032|NCT00885443|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101832033|NCT00882869|Sorafenib|sorafenib|mesh-list
101832034|NCT00882869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101832035|NCT00882869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101832036|NCT00882869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101832037|NCT00882869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832038|NCT00882947|Iloprost|iloprost|mesh-list
101832039|NCT00882947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101832040|NCT00882947|Vasodilator Agents|vasodilator agents|mesh-ancestor
101832041|NCT00531050|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101832042|NCT00531050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101832043|NCT00531050|Autonomic Agents|autonomic agents|mesh-ancestor
101832044|NCT00531050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101832045|NCT00531050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832046|NCT00531050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101832047|NCT00531050|Respiratory System Agents|respiratory system agents|mesh-ancestor
101832048|NCT00531050|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101832049|NCT00531050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101832050|NCT00531050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101832051|NCT00531050|Adrenergic Agents|adrenergic agents|mesh-ancestor
101832052|NCT00531050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101832053|NCT00531050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832054|NCT00530348|Interferons|interferons|mesh-list
101832055|NCT00530348|Interferon-beta|interferon-beta|mesh-list
101223719|NCT01519726|Anesthetics|anesthetics|mesh-ancestor
101832056|NCT00530348|Interferon beta-1a|interferon beta-1a|mesh-list
101832057|NCT00530348|Alemtuzumab|alemtuzumab|mesh-list
101832058|NCT00530348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101551852|NCT01313676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101832059|NCT00530348|Antiviral Agents|antiviral agents|mesh-ancestor
101832060|NCT00530348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101832061|NCT00530348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101832063|NCT00530348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832064|NCT00530348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101832065|NCT01007864|Pramipexole|pramipexole|mesh-list
101832066|NCT01007864|Ropinirole|ropinirole|mesh-list
101832067|NCT01007864|Piribedil|piribedil|mesh-list
101832068|NCT01007864|Antioxidants|antioxidants|mesh-ancestor
101832069|NCT01007864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832070|NCT01007864|Protective Agents|protective agents|mesh-ancestor
101832071|NCT01007864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832072|NCT01007864|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101832073|NCT01007864|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101832074|NCT01007864|Dopamine Agonists|dopamine agonists|mesh-ancestor
101832075|NCT01007864|Dopamine Agents|dopamine agents|mesh-ancestor
101832076|NCT01007864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101832077|NCT01008020|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
101832078|NCT01008020|Antioxidants|antioxidants|mesh-ancestor
101832079|NCT01008020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832080|NCT01008020|Protective Agents|protective agents|mesh-ancestor
101832081|NCT01008020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832082|NCT01008020|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101832083|NCT01008020|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101832084|NCT01008020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101832085|NCT01008020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101832087|NCT01008098|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101832088|NCT01008098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101832089|NCT01008098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101832090|NCT01008098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832091|NCT01008098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101832092|NCT01008098|Serotonin Agents|serotonin agents|mesh-ancestor
101832093|NCT01008098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832094|NCT00530270|Dexamethasone|dexamethasone|mesh-list
101832095|NCT00530270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101832096|NCT00530270|Antiemetics|antiemetics|mesh-ancestor
101832097|NCT00530270|Autonomic Agents|autonomic agents|mesh-ancestor
101832098|NCT00530270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101832099|NCT00530270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832100|NCT00530270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101832101|NCT00530270|Glucocorticoids|glucocorticoids|mesh-ancestor
101832102|NCT00530270|Hormones|hormones|mesh-ancestor
101832103|NCT00530270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101832104|NCT00530270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101832105|NCT00530270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101223757|NCT01520103|Everolimus|everolimus|mesh-list
101832106|NCT01008488|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101832107|NCT01008488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101832108|NCT01001624|Hydroquinone|hydroquinone|mesh-list
101832109|NCT01001624|Antioxidants|antioxidants|mesh-ancestor
101832110|NCT01001624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832111|NCT01001624|Protective Agents|protective agents|mesh-ancestor
101832112|NCT01001624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832113|NCT01001624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101832114|NCT01001780|Cyclophosphamide|cyclophosphamide|mesh-list
101832115|NCT01001780|Rituximab|rituximab|mesh-list
101832116|NCT01001780|Pentostatin|pentostatin|mesh-list
101832117|NCT01001780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101832118|NCT01001780|Immunologic Factors|immunologic factors|mesh-ancestor
101832119|NCT01001780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832120|NCT01001780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101832121|NCT01001780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101832122|NCT01001780|Alkylating Agents|alkylating agents|mesh-ancestor
101832123|NCT01001780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832124|NCT01001780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101832125|NCT01001780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101832126|NCT01001780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101832127|NCT01001780|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
101832128|NCT01001780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101832129|NCT01008566|Sorafenib|sorafenib|mesh-list
101832130|NCT01008566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101832131|NCT01008566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101832132|NCT01008566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101832133|NCT01008566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101551927|NCT00637663|Antiviral Agents|antiviral agents|mesh-ancestor
101832134|NCT01008566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832135|NCT01008566|Immunologic Factors|immunologic factors|mesh-ancestor
101832136|NCT01008566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832137|NCT03885596|Acetaminophen|acetaminophen|mesh-list
101832138|NCT03885596|Celecoxib|celecoxib|mesh-list
101832139|NCT03885596|Ketorolac|ketorolac|mesh-list
101832140|NCT03885596|Lidocaine|lidocaine|mesh-list
101832141|NCT03885596|Fentanyl|fentanyl|mesh-list
101832142|NCT03885596|Bupivacaine|bupivacaine|mesh-list
101832143|NCT03885596|Anesthetics, Local|anesthetics, local|mesh-ancestor
101832144|NCT03885596|Anesthetics|anesthetics|mesh-ancestor
101832145|NCT03885596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101832146|NCT03885596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223780|NCT01520181|Lactams|lactams|mesh-list
101832147|NCT03885596|Sensory System Agents|sensory system agents|mesh-ancestor
101832148|NCT03885596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101832149|NCT03885596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101832150|NCT03885596|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101832151|NCT03885596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101832152|NCT03885596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101832153|NCT03885596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832154|NCT03885596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101832155|NCT03885596|Narcotics|narcotics|mesh-ancestor
101832156|NCT03885596|Analgesics|analgesics|mesh-ancestor
101832157|NCT03885596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101832158|NCT03885596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101832159|NCT03885596|Anesthetics, General|anesthetics, general|mesh-ancestor
101832160|NCT03885596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101832161|NCT03885596|Antipyretics|antipyretics|mesh-ancestor
101832162|NCT03885596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101832163|NCT03885596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101832164|NCT03885596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101832165|NCT03885596|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101832166|NCT03885596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101832167|NCT03885596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101832168|NCT01002092|Endostar protein|endostar protein|mesh-list
101832169|NCT01002092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101832170|NCT01002092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101832171|NCT01002092|Growth Substances|growth substances|mesh-ancestor
101832172|NCT01002092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832173|NCT01002092|Growth Inhibitors|growth inhibitors|mesh-ancestor
101832174|NCT01002092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101832175|NCT03999866|Pyrithione zinc|pyrithione zinc|mesh-list
101832176|NCT03999866|Keratolytic Agents|keratolytic agents|mesh-ancestor
101832177|NCT03999866|Dermatologic Agents|dermatologic agents|mesh-ancestor
101832178|NCT00529100|Cisplatin|cisplatin|mesh-list
101832179|NCT00529100|Pemetrexed|pemetrexed|mesh-list
101832180|NCT00529100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101832181|NCT00529100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101832182|NCT00529100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832183|NCT00529100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101832184|NCT00529100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101832185|NCT05732948|Cyclophosphamide|cyclophosphamide|mesh-list
101832186|NCT05732948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101832187|NCT05732948|Immunologic Factors|immunologic factors|mesh-ancestor
101832188|NCT05732948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832189|NCT05732948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101832190|NCT05732948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101832191|NCT05732948|Alkylating Agents|alkylating agents|mesh-ancestor
101832192|NCT05732948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832193|NCT05732948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101832194|NCT05732948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101832195|NCT00529802|Everolimus|everolimus|mesh-list
101832196|NCT00529802|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101832197|NCT00529802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101832198|NCT00529802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101832199|NCT00529802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832200|NCT00529802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101832201|NCT00529802|Immunologic Factors|immunologic factors|mesh-ancestor
101832202|NCT00529802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832203|NCT00529802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101832204|NCT00528866|Docetaxel|docetaxel|mesh-list
101832205|NCT00528866|Bicalutamide|bicalutamide|mesh-list
101832206|NCT00528866|Flutamide|flutamide|mesh-list
101832207|NCT00528866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101832208|NCT00528866|Tubulin Modulators|tubulin modulators|mesh-ancestor
101832209|NCT00528866|Antimitotic Agents|antimitotic agents|mesh-ancestor
101552016|NCT01012609|Irinotecan|irinotecan|mesh-list
101832210|NCT00528866|Mitosis Modulators|mitosis modulators|mesh-ancestor
101832211|NCT00528866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832212|NCT00528866|Androgen Antagonists|androgen antagonists|mesh-ancestor
101832213|NCT00528866|Hormone Antagonists|hormone antagonists|mesh-ancestor
101832214|NCT00528866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101832215|NCT00528866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832216|NCT00528866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101832217|NCT05730920|Methadone|methadone|mesh-list
101832218|NCT05730920|Bupivacaine|bupivacaine|mesh-list
101832219|NCT05730920|Anesthetics, Local|anesthetics, local|mesh-ancestor
101832220|NCT05730920|Anesthetics|anesthetics|mesh-ancestor
101832221|NCT05730920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101832222|NCT05730920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832223|NCT05730920|Sensory System Agents|sensory system agents|mesh-ancestor
101832224|NCT05730920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101832225|NCT05730920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101832226|NCT05730920|Narcotics|narcotics|mesh-ancestor
101832227|NCT05730920|Analgesics|analgesics|mesh-ancestor
101832228|NCT05730920|Antitussive Agents|antitussive agents|mesh-ancestor
101832229|NCT05730920|Respiratory System Agents|respiratory system agents|mesh-ancestor
101832230|NCT03999008|Budesonide|budesonide|mesh-list
101832231|NCT03999008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101832232|NCT03999008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101832233|NCT03999008|Autonomic Agents|autonomic agents|mesh-ancestor
101832234|NCT03999008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101832235|NCT03999008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832236|NCT03999008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101832237|NCT03999008|Respiratory System Agents|respiratory system agents|mesh-ancestor
101832238|NCT03999008|Glucocorticoids|glucocorticoids|mesh-ancestor
101832239|NCT03999008|Hormones|hormones|mesh-ancestor
101832240|NCT03999008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101832241|NCT05140148|Amantadine|amantadine|mesh-list
101832242|NCT05140148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101832243|NCT05140148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101832244|NCT05140148|Antiviral Agents|antiviral agents|mesh-ancestor
101832245|NCT05140148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101832246|NCT05140148|Dopamine Agents|dopamine agents|mesh-ancestor
101832247|NCT05140148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101832248|NCT05140148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832249|NCT05140148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832250|NCT05140148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101832251|NCT05140148|Analgesics|analgesics|mesh-ancestor
101832252|NCT05140148|Sensory System Agents|sensory system agents|mesh-ancestor
101832253|NCT05140148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101832254|NCT04932746|Dexmedetomidine|dexmedetomidine|mesh-list
101832255|NCT04932746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101832256|NCT04932746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101832257|NCT04932746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832258|NCT04932746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101832259|NCT04932746|Analgesics|analgesics|mesh-ancestor
101832260|NCT04932746|Sensory System Agents|sensory system agents|mesh-ancestor
101832261|NCT04932746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101832262|NCT04932746|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101832263|NCT04932746|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101832264|NCT04932746|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101832265|NCT04932746|Adrenergic Agents|adrenergic agents|mesh-ancestor
101832266|NCT04932746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101832267|NCT04932746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832268|NCT00614393|Irinotecan|irinotecan|mesh-list
101832269|NCT00614393|Cetuximab|cetuximab|mesh-list
101832270|NCT00614393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101832271|NCT00614393|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101832272|NCT00614393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101832273|NCT00614393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101832274|NCT00614393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832275|NCT00614393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101832276|NCT00614393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101832277|NCT00614393|Immunologic Factors|immunologic factors|mesh-ancestor
101832278|NCT00614393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832279|NCT00880529|Morphine|morphine|mesh-list
101832280|NCT00880529|Bupivacaine|bupivacaine|mesh-list
101832281|NCT00880529|Anesthetics, Local|anesthetics, local|mesh-ancestor
101832282|NCT00880529|Anesthetics|anesthetics|mesh-ancestor
101832283|NCT00880529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101832284|NCT00880529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832285|NCT00880529|Sensory System Agents|sensory system agents|mesh-ancestor
101832286|NCT00880529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101832287|NCT00880529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101832289|NCT00880529|Analgesics|analgesics|mesh-ancestor
101832290|NCT00880841|Buprenorphine|buprenorphine|mesh-list
101832291|NCT00880841|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101832292|NCT00880841|Naloxone|naloxone|mesh-list
101832293|NCT00880841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101832294|NCT00880841|Narcotics|narcotics|mesh-ancestor
101832295|NCT00880841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101832296|NCT00880841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832297|NCT00880841|Analgesics|analgesics|mesh-ancestor
101832298|NCT00880841|Sensory System Agents|sensory system agents|mesh-ancestor
101832299|NCT00880841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101832300|NCT00880841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101832301|NCT00883259|Metformin|metformin|mesh-list
101832302|NCT00883259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101832303|NCT00883259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832304|NCT00885599|Listerine|listerine|mesh-list
101832305|NCT00885599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
101832306|NCT00885599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101832307|NCT04366115|Dexamethasone|dexamethasone|mesh-list
101832308|NCT04366115|Dexamethasone acetate|dexamethasone acetate|mesh-list
101832309|NCT04366115|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101832310|NCT04366115|BB 1101|bb 1101|mesh-list
101832311|NCT04366115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101832312|NCT04366115|Antiemetics|antiemetics|mesh-ancestor
101832313|NCT04366115|Autonomic Agents|autonomic agents|mesh-ancestor
101832314|NCT04366115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101832315|NCT04366115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832316|NCT04366115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101832317|NCT04366115|Glucocorticoids|glucocorticoids|mesh-ancestor
101832318|NCT04366115|Hormones|hormones|mesh-ancestor
101832319|NCT04366115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101832320|NCT04366115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101832321|NCT04366115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101832322|NCT04366115|Protease Inhibitors|protease inhibitors|mesh-ancestor
101832323|NCT04366115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101832324|NCT04366115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832325|NCT04038125|Dexamethasone|dexamethasone|mesh-list
101832326|NCT04038125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101832327|NCT04038125|Antiemetics|antiemetics|mesh-ancestor
101832328|NCT04038125|Autonomic Agents|autonomic agents|mesh-ancestor
101832329|NCT04038125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101832330|NCT04038125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832331|NCT04038125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101832332|NCT04038125|Glucocorticoids|glucocorticoids|mesh-ancestor
101832333|NCT04038125|Hormones|hormones|mesh-ancestor
101832334|NCT04038125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101832335|NCT04038125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101832336|NCT04038125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101832337|NCT00881153|Cefprozil|cefprozil|mesh-list
101832338|NCT00881153|Cephalosporins|cephalosporins|mesh-list
101832339|NCT00881153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101832340|NCT00881153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101832341|NCT00885833|Fludarabine|fludarabine|mesh-list
101832342|NCT00885833|Busulfan|busulfan|mesh-list
101832343|NCT00885833|Thymoglobulin|thymoglobulin|mesh-list
101832344|NCT00885833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101832345|NCT00885833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832346|NCT00885833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101832347|NCT00885833|Immunologic Factors|immunologic factors|mesh-ancestor
101832348|NCT00885833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832349|NCT00885833|Alkylating Agents|alkylating agents|mesh-ancestor
101832350|NCT00885833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101832351|NCT00885833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101832352|NCT00612677|Oxaliplatin|oxaliplatin|mesh-list
101832353|NCT00612677|Pemetrexed|pemetrexed|mesh-list
101832354|NCT00612677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101832355|NCT00612677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101832356|NCT00612677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832357|NCT00612677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101832358|NCT00612677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101832359|NCT04038749|Cabergoline|cabergoline|mesh-list
101832360|NCT04038749|Bromocriptine|bromocriptine|mesh-list
101832361|NCT04038749|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101832362|NCT04038749|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101832363|NCT04038749|Dopamine Agonists|dopamine agonists|mesh-ancestor
101832364|NCT04038749|Dopamine Agents|dopamine agents|mesh-ancestor
101832365|NCT04038749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101832366|NCT04038749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832367|NCT04038749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832368|NCT04038749|Hormone Antagonists|hormone antagonists|mesh-ancestor
101832369|NCT04038749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101832370|NCT00881231|Cilostazol|cilostazol|mesh-list
101832371|NCT00881231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101832372|NCT00881231|Autonomic Agents|autonomic agents|mesh-ancestor
101832373|NCT00881231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101832374|NCT00881231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832375|NCT00881231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101832376|NCT00881231|Respiratory System Agents|respiratory system agents|mesh-ancestor
101832377|NCT00881231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101832378|NCT00881231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101832379|NCT00881231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832380|NCT00881231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101832381|NCT00881231|Vasodilator Agents|vasodilator agents|mesh-ancestor
101832382|NCT00881231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101832383|NCT00881231|Protective Agents|protective agents|mesh-ancestor
101832384|NCT00881231|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101832385|NCT00881231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101832386|NCT00881231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101832387|NCT00883727|Plasma-lyte 148|plasma-lyte 148|mesh-list
101832388|NCT00883727|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101832389|NCT00883727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101832390|NCT00881387|Rituximab|rituximab|mesh-list
101832391|NCT00881387|Gemcitabine|gemcitabine|mesh-list
101832392|NCT00881387|Vinorelbine|vinorelbine|mesh-list
101832393|NCT00881387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101832394|NCT00881387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101832395|NCT00881387|Immunologic Factors|immunologic factors|mesh-ancestor
101832396|NCT00881387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832397|NCT00881387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101832398|NCT00881387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101832399|NCT00881387|Antimetabolites|antimetabolites|mesh-ancestor
101832400|NCT00881387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832401|NCT00881387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101832402|NCT00881387|Tubulin Modulators|tubulin modulators|mesh-ancestor
101832403|NCT00881387|Antimitotic Agents|antimitotic agents|mesh-ancestor
101832404|NCT00881387|Mitosis Modulators|mitosis modulators|mesh-ancestor
101832405|NCT00883883|Cefdinir|cefdinir|mesh-list
101832406|NCT00883883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101832407|NCT00883883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101832408|NCT00881543|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101832409|NCT00881543|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
101832410|NCT00881543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101832411|NCT00881543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832412|NCT00881543|Incretins|incretins|mesh-ancestor
101832413|NCT00881543|Hormones|hormones|mesh-ancestor
101832414|NCT00881543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101832415|NCT00881543|Protease Inhibitors|protease inhibitors|mesh-ancestor
101832416|NCT00881543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101952758|NCT03310580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101832417|NCT00881543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832419|NCT00881855|Cephalosporins|cephalosporins|mesh-list
101832420|NCT00881855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101832421|NCT00881855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101832422|NCT04015115|Analgesics, Opioid|analgesics, opioid|mesh-list
101832423|NCT04015115|Narcotics|narcotics|mesh-ancestor
101832424|NCT04015115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101832425|NCT04015115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832426|NCT04015115|Analgesics|analgesics|mesh-ancestor
101832427|NCT04015115|Sensory System Agents|sensory system agents|mesh-ancestor
101832428|NCT04015115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101832429|NCT02543645|Atezolizumab|atezolizumab|mesh-list
101832430|NCT02543645|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101832431|NCT02543645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832432|NCT02543645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101832433|NCT02543645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101832434|NCT02543411|Lidocaine|lidocaine|mesh-list
101832435|NCT02543411|Anesthetics, Local|anesthetics, local|mesh-ancestor
101832436|NCT02543411|Anesthetics|anesthetics|mesh-ancestor
101832437|NCT02543411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101832438|NCT02543411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832439|NCT02543411|Sensory System Agents|sensory system agents|mesh-ancestor
101832440|NCT02543411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101832441|NCT02543411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101832442|NCT02543411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101832443|NCT02543411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101832444|NCT02543411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101832445|NCT02543411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832446|NCT00882323|Cyclophosphamide|cyclophosphamide|mesh-list
101832448|NCT00882323|Thymoglobulin|thymoglobulin|mesh-list
101832449|NCT00882323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101832450|NCT00882323|Immunologic Factors|immunologic factors|mesh-ancestor
101832451|NCT00882323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832452|NCT00882323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101832453|NCT00882323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101832454|NCT00882323|Alkylating Agents|alkylating agents|mesh-ancestor
101832455|NCT00882323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832456|NCT00882323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101832457|NCT00882323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101832458|NCT00882401|Vitamin D|vitamin d|mesh-list
101832459|NCT00882401|Ergocalciferols|ergocalciferols|mesh-list
101832460|NCT00882401|Vitamins|vitamins|mesh-ancestor
101832461|NCT00882401|Micronutrients|micronutrients|mesh-ancestor
101832462|NCT00882401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832463|NCT00882401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101832464|NCT00882401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101832465|NCT00886457|Interferons|interferons|mesh-list
101832466|NCT00886457|Interferon-alpha|interferon-alpha|mesh-list
101832467|NCT00886457|Interferon alpha-2|interferon alpha-2|mesh-list
101832468|NCT00886457|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101832469|NCT00886457|Decitabine|decitabine|mesh-list
101832470|NCT00886457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101832471|NCT00886457|Antiviral Agents|antiviral agents|mesh-ancestor
101832472|NCT00886457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101832473|NCT00886457|Immunologic Factors|immunologic factors|mesh-ancestor
101832474|NCT00886457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832475|NCT00886457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101832476|NCT00886457|Antimetabolites|antimetabolites|mesh-ancestor
101832477|NCT00886457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832478|NCT00886457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101832479|NCT04038671|Anti-Infective Agents|anti-infective agents|mesh-list
101832480|NCT04038671|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101832481|NCT04038671|Charcoal|charcoal|mesh-list
101832482|NCT04038671|Antidotes|antidotes|mesh-ancestor
101832483|NCT04038671|Protective Agents|protective agents|mesh-ancestor
101832484|NCT04038671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832485|NCT02543099|Policosanol|policosanol|mesh-list
101832486|NCT02543099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101832487|NCT02543099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101832488|NCT02543099|Antimetabolites|antimetabolites|mesh-ancestor
101832489|NCT02543099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832490|NCT02543099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101832491|NCT02543099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101832492|NCT00882635|Heparin|heparin|mesh-list
101832493|NCT00882635|Enoxaparin|enoxaparin|mesh-list
101832494|NCT00882635|Calcium heparin|calcium heparin|mesh-list
101832495|NCT00882635|Anticoagulants|anticoagulants|mesh-ancestor
101832496|NCT00882635|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101832497|NCT00882635|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101832498|NCT00882635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832499|NCT00609869|Rituximab|rituximab|mesh-list
101832500|NCT00609869|Lenalidomide|lenalidomide|mesh-list
101832501|NCT00609869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101832502|NCT00609869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101832503|NCT00609869|Immunologic Factors|immunologic factors|mesh-ancestor
101832504|NCT00609869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832505|NCT00609869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101832506|NCT00609869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101832507|NCT00609869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101832508|NCT00609869|Growth Substances|growth substances|mesh-ancestor
101832509|NCT00609869|Growth Inhibitors|growth inhibitors|mesh-ancestor
101832510|NCT00888797|Etodolac|etodolac|mesh-list
101832511|NCT00888797|Propranolol|propranolol|mesh-list
101832512|NCT00888797|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101832513|NCT00888797|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101832514|NCT00888797|Adrenergic Agents|adrenergic agents|mesh-ancestor
101832515|NCT00888797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101832516|NCT00888797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832517|NCT00888797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832518|NCT00888797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101832519|NCT00888797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101832520|NCT00888797|Vasodilator Agents|vasodilator agents|mesh-ancestor
101832521|NCT00888797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101832522|NCT00888797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101832523|NCT00888797|Analgesics|analgesics|mesh-ancestor
101832524|NCT00888797|Sensory System Agents|sensory system agents|mesh-ancestor
101832525|NCT00888797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101832526|NCT00888797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101832527|NCT00888797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101832528|NCT00888797|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101832529|NCT00888797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101832530|NCT00888797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101832531|NCT00884663|Propranolol|propranolol|mesh-list
101832532|NCT00884663|Candesartan|candesartan|mesh-list
101832533|NCT00884663|Candesartan cilexetil|candesartan cilexetil|mesh-list
101832534|NCT00884663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101832535|NCT00884663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101832536|NCT00884663|Adrenergic Agents|adrenergic agents|mesh-ancestor
101832537|NCT00884663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101832538|NCT00884663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832539|NCT00884663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832540|NCT00884663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101832541|NCT00884663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101832542|NCT00884663|Vasodilator Agents|vasodilator agents|mesh-ancestor
101832543|NCT00884663|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101832544|NCT00884663|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101832545|NCT00887003|Methylprednisolone|methylprednisolone|mesh-list
101832546|NCT00887003|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101832547|NCT00887003|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101832548|NCT00887003|Prednisolone|prednisolone|mesh-list
101832549|NCT00887003|Prednisolone acetate|prednisolone acetate|mesh-list
101832550|NCT00887003|Bupivacaine|bupivacaine|mesh-list
101832551|NCT00887003|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101832552|NCT00887003|Prednisolone phosphate|prednisolone phosphate|mesh-list
101832553|NCT00887003|Anesthetics, Local|anesthetics, local|mesh-ancestor
101832554|NCT00887003|Anesthetics|anesthetics|mesh-ancestor
101832555|NCT00887003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101832556|NCT00887003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832557|NCT00887003|Sensory System Agents|sensory system agents|mesh-ancestor
101832558|NCT00887003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101832559|NCT00887003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101832560|NCT00887003|Antiemetics|antiemetics|mesh-ancestor
101832561|NCT00887003|Autonomic Agents|autonomic agents|mesh-ancestor
101832562|NCT00887003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101832563|NCT00887003|Glucocorticoids|glucocorticoids|mesh-ancestor
101832565|NCT00887003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101832566|NCT00887003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101832567|NCT00887003|Protective Agents|protective agents|mesh-ancestor
101832568|NCT00887003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101832569|NCT00887003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101832570|NCT00887081|Ribavirin|ribavirin|mesh-list
101832571|NCT00887081|Interferon-alpha|interferon-alpha|mesh-list
101832572|NCT00887081|Interferon alpha-2|interferon alpha-2|mesh-list
101832573|NCT00887081|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
101832574|NCT00887081|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101832575|NCT00887081|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101832576|NCT00887081|Antimetabolites|antimetabolites|mesh-ancestor
101223966|NCT01521455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101832577|NCT00887081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832578|NCT00887081|Antiviral Agents|antiviral agents|mesh-ancestor
101832579|NCT00887081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101832580|NCT00887081|Immunologic Factors|immunologic factors|mesh-ancestor
101832581|NCT00887081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832582|NCT00887081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101832583|NCT03998696|Cisplatin|cisplatin|mesh-list
101832584|NCT03998696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101832585|NCT00611975|Bupropion|bupropion|mesh-list
101832586|NCT00611975|Fluoxetine|fluoxetine|mesh-list
101832587|NCT00611975|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101832588|NCT00611975|Antidepressive Agents|antidepressive agents|mesh-ancestor
101832590|NCT00611975|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101832591|NCT00611975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101832592|NCT00611975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101832593|NCT00611975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832594|NCT00611975|Dopamine Agents|dopamine agents|mesh-ancestor
101832595|NCT00611975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101832596|NCT00611975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832597|NCT00611975|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101832598|NCT00611975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101832599|NCT00611975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101832600|NCT00611975|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101832601|NCT00611975|Serotonin Agents|serotonin agents|mesh-ancestor
101832602|NCT05695352|Meloxicam|meloxicam|mesh-list
101832603|NCT05695352|Levonorgestrel|levonorgestrel|mesh-list
101832604|NCT05695352|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101832605|NCT05695352|Contraceptive Agents|contraceptive agents|mesh-ancestor
101832606|NCT05695352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101832607|NCT05695352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832608|NCT05695352|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101832609|NCT05695352|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101832610|NCT05695352|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101832611|NCT05695352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101832612|NCT05695352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101832613|NCT05695352|Analgesics|analgesics|mesh-ancestor
101832614|NCT05695352|Sensory System Agents|sensory system agents|mesh-ancestor
101832615|NCT05695352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101832616|NCT05695352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101832617|NCT05695352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101832618|NCT05695352|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101832619|NCT05695352|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101832620|NCT05695352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101832621|NCT05695352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832622|NCT04895306|Methyltestosterone|methyltestosterone|mesh-list
101832623|NCT04895306|Testosterone|testosterone|mesh-list
101832624|NCT04895306|Testosterone undecanoate|testosterone undecanoate|mesh-list
101832625|NCT04895306|Testosterone enanthate|testosterone enanthate|mesh-list
101832626|NCT04895306|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101832628|NCT04895306|Hormones|hormones|mesh-ancestor
101832629|NCT04895306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101223981|NCT01521572|Albuterol|albuterol|mesh-list
101832630|NCT04895306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832631|NCT04895306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101832632|NCT04895306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101832633|NCT04895306|Anabolic Agents|anabolic agents|mesh-ancestor
101832634|NCT02542241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101832635|NCT00889343|Leucovorin|leucovorin|mesh-list
101832636|NCT00889343|Fluorouracil|fluorouracil|mesh-list
101832637|NCT00889343|Oxaliplatin|oxaliplatin|mesh-list
101832638|NCT00889343|Irinotecan|irinotecan|mesh-list
101832639|NCT00889343|Sorafenib|sorafenib|mesh-list
101832640|NCT00889343|Antimetabolites|antimetabolites|mesh-ancestor
101832641|NCT00889343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832642|NCT00889343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101832643|NCT00889343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101832644|NCT00889343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101832645|NCT00889343|Immunologic Factors|immunologic factors|mesh-ancestor
101832646|NCT00889343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832647|NCT00889343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101832648|NCT00889343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101832649|NCT00889343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101832650|NCT00889343|Antidotes|antidotes|mesh-ancestor
101832651|NCT00889343|Protective Agents|protective agents|mesh-ancestor
101832652|NCT00889343|Vitamin B Complex|vitamin b complex|mesh-ancestor
101832653|NCT00889343|Vitamins|vitamins|mesh-ancestor
101832654|NCT00889343|Micronutrients|micronutrients|mesh-ancestor
101832655|NCT00889343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101832656|NCT00884819|Fenofibrate|fenofibrate|mesh-list
101832657|NCT00884819|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101832658|NCT00884819|Antimetabolites|antimetabolites|mesh-ancestor
101832659|NCT00884819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832660|NCT00884819|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101832661|NCT00573131|Paclitaxel|paclitaxel|mesh-list
101832662|NCT00573131|Cisplatin|cisplatin|mesh-list
101552451|NCT00624039|Pilocarpine|pilocarpine|mesh-list
101832663|NCT00573131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101832664|NCT00573131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101832665|NCT00573131|Tubulin Modulators|tubulin modulators|mesh-ancestor
101832666|NCT00573131|Antimitotic Agents|antimitotic agents|mesh-ancestor
101832667|NCT00573131|Mitosis Modulators|mitosis modulators|mesh-ancestor
101832668|NCT00573131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832669|NCT01565018|Rotigotine|rotigotine|mesh-list
101832670|NCT01565018|Dopamine Agonists|dopamine agonists|mesh-ancestor
101832671|NCT01565018|Dopamine Agents|dopamine agents|mesh-ancestor
101832672|NCT01565018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101832673|NCT01565018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832674|NCT01565018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832675|NCT01565096|Metformin|metformin|mesh-list
101832676|NCT01565096|Glimepiride|glimepiride|mesh-list
101832677|NCT01565096|Vildagliptin|vildagliptin|mesh-list
101832678|NCT01565096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101832679|NCT01565096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832680|NCT01565096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101832681|NCT01565096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101832682|NCT01565096|Immunologic Factors|immunologic factors|mesh-ancestor
101832683|NCT01565096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101832684|NCT01565096|Protease Inhibitors|protease inhibitors|mesh-ancestor
101832685|NCT01565096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101832686|NCT01565096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832687|NCT00889499|Tropisetron|tropisetron|mesh-list
101832688|NCT00889499|Antiemetics|antiemetics|mesh-ancestor
101832689|NCT00889499|Autonomic Agents|autonomic agents|mesh-ancestor
101832690|NCT00889499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101832691|NCT00889499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832692|NCT00889499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101832693|NCT00889499|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101832694|NCT00889499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101832695|NCT00889499|Serotonin Agents|serotonin agents|mesh-ancestor
101832696|NCT00889499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101224001|NCT01521689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101832697|NCT00889499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832698|NCT00889655|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101832699|NCT00889655|Laxatives|laxatives|mesh-ancestor
101832700|NCT00889655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101832701|NCT05002946|Naltrexone|naltrexone|mesh-list
101832702|NCT05002946|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101832703|NCT05002946|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101832704|NCT05002946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832705|NCT05002946|Sensory System Agents|sensory system agents|mesh-ancestor
101832706|NCT05002946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101832707|NCT04641338|Dipyrone|dipyrone|mesh-list
101832708|NCT04641338|Codeine|codeine|mesh-list
101832709|NCT04641338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101832710|NCT04641338|Narcotics|narcotics|mesh-ancestor
101832711|NCT04641338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101832712|NCT04641338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832713|NCT04641338|Analgesics|analgesics|mesh-ancestor
101832714|NCT04641338|Sensory System Agents|sensory system agents|mesh-ancestor
101832715|NCT04641338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101832716|NCT04641338|Antitussive Agents|antitussive agents|mesh-ancestor
101832717|NCT04641338|Respiratory System Agents|respiratory system agents|mesh-ancestor
101832718|NCT04641338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101832719|NCT04641338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101832720|NCT04641338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101832721|NCT04641338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101832722|NCT04641338|Antipyretics|antipyretics|mesh-ancestor
101832723|NCT04635098|Dexmedetomidine|dexmedetomidine|mesh-list
101832724|NCT04635098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101832725|NCT04635098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101832726|NCT04635098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832727|NCT04635098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101832728|NCT04635098|Analgesics|analgesics|mesh-ancestor
101832729|NCT04635098|Sensory System Agents|sensory system agents|mesh-ancestor
101832730|NCT04635098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101832731|NCT04635098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101832732|NCT04635098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101832733|NCT04635098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101832734|NCT04635098|Adrenergic Agents|adrenergic agents|mesh-ancestor
101832735|NCT04635098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101832736|NCT04635098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832737|NCT00521144|Topotecan|topotecan|mesh-list
101832738|NCT00521144|Obatoclax|obatoclax|mesh-list
101832739|NCT00521144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101832740|NCT00521144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101832741|NCT00521144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101832742|NCT00521144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832743|NCT00521144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101832744|NCT00520676|Carboplatin|carboplatin|mesh-list
101832745|NCT00520676|Docetaxel|docetaxel|mesh-list
101832746|NCT00520676|Pemetrexed|pemetrexed|mesh-list
101832747|NCT00520676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101832748|NCT00520676|Tubulin Modulators|tubulin modulators|mesh-ancestor
101832749|NCT00520676|Antimitotic Agents|antimitotic agents|mesh-ancestor
101832750|NCT00520676|Mitosis Modulators|mitosis modulators|mesh-ancestor
101832751|NCT00520676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832752|NCT00520676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101832753|NCT00520676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101832754|NCT00520676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101832755|NCT00889733|Cisplatin|cisplatin|mesh-list
101832756|NCT00889733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101832757|NCT00887627|Conivaptan|conivaptan|mesh-list
101832758|NCT00887627|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101224011|NCT01521767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832759|NCT00887627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832760|NCT00887627|Natriuretic Agents|natriuretic agents|mesh-ancestor
101832761|NCT00887627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832762|NCT00885287|Lumefantrine|lumefantrine|mesh-list
101832763|NCT00885287|Artemether|artemether|mesh-list
101832764|NCT00885287|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101832765|NCT00885287|Antimalarials|antimalarials|mesh-ancestor
101832766|NCT00885287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101832767|NCT00885287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101832768|NCT00885287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101832770|NCT02542007|Temsirolimus|temsirolimus|mesh-list
101832771|NCT02542007|MTOR Inhibitors|mtor inhibitors|mesh-list
101832772|NCT02542007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101832773|NCT02542007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101832774|NCT02542007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101832775|NCT02542007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101832776|NCT02542007|Antifungal Agents|antifungal agents|mesh-ancestor
101832777|NCT02542007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101832778|NCT02542007|Immunologic Factors|immunologic factors|mesh-ancestor
101832779|NCT02542007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832780|NCT02542007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101832781|NCT02542007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101832782|NCT02542007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832783|NCT00892541|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101832784|NCT00892541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101832785|NCT00892541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101832786|NCT00892541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101832787|NCT00892541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832788|NCT00892541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101832789|NCT00892541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101832790|NCT00892541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101832791|NCT00892541|Serotonin Agents|serotonin agents|mesh-ancestor
101832792|NCT00892541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101832793|NCT00892541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832794|NCT00892541|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101832795|NCT00892541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101832796|NCT00892541|Dopamine Agents|dopamine agents|mesh-ancestor
101832797|NCT00890279|Imidapril|imidapril|mesh-list
101832798|NCT00890279|Cilnidipine|cilnidipine|mesh-list
101832799|NCT00890279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101832800|NCT00890279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101832801|NCT00890279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832802|NCT00890279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101832803|NCT00890279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832804|NCT00890279|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101832805|NCT00890279|Protease Inhibitors|protease inhibitors|mesh-ancestor
101832806|NCT00890279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101832807|NCT00890279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101832808|NCT00608543|Aripiprazole|aripiprazole|mesh-list
101832809|NCT00608543|Antidepressive Agents|antidepressive agents|mesh-ancestor
101832810|NCT00608543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101832811|NCT00608543|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101832812|NCT00608543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101832813|NCT00608543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101832814|NCT00608543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832815|NCT00608543|Dopamine Agonists|dopamine agonists|mesh-ancestor
101832816|NCT00608543|Dopamine Agents|dopamine agents|mesh-ancestor
101832817|NCT00608543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101832818|NCT00608543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224027|NCT01521936|Vitamin D|vitamin d|mesh-list
101832819|NCT00608543|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101832820|NCT00608543|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101832821|NCT00608543|Serotonin Agents|serotonin agents|mesh-ancestor
101832822|NCT00608543|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101832823|NCT00608543|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101832824|NCT00608543|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101832825|NCT00608543|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101832826|NCT02541383|Thalidomide|thalidomide|mesh-list
101832827|NCT02541383|Dexamethasone|dexamethasone|mesh-list
101832828|NCT02541383|Dexamethasone acetate|dexamethasone acetate|mesh-list
101832829|NCT02541383|Bortezomib|bortezomib|mesh-list
101832830|NCT02541383|Daratumumab|daratumumab|mesh-list
101832831|NCT02541383|BB 1101|bb 1101|mesh-list
101832832|NCT02541383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101832833|NCT02541383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101832834|NCT02541383|Antiemetics|antiemetics|mesh-ancestor
101832835|NCT02541383|Autonomic Agents|autonomic agents|mesh-ancestor
101832836|NCT02541383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101832837|NCT02541383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832838|NCT02541383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101832839|NCT02541383|Glucocorticoids|glucocorticoids|mesh-ancestor
101832840|NCT02541383|Hormones|hormones|mesh-ancestor
101832841|NCT02541383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101832842|NCT02541383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101832843|NCT02541383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101832844|NCT02541383|Protease Inhibitors|protease inhibitors|mesh-ancestor
101832845|NCT02541383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101832846|NCT02541383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832847|NCT02541383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101832848|NCT02541383|Immunologic Factors|immunologic factors|mesh-ancestor
101832849|NCT02541383|Leprostatic Agents|leprostatic agents|mesh-ancestor
101832850|NCT02541383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101832851|NCT02541383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101832852|NCT02541383|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101832853|NCT02541383|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101832854|NCT02541383|Growth Substances|growth substances|mesh-ancestor
101832855|NCT02541383|Growth Inhibitors|growth inhibitors|mesh-ancestor
101832856|NCT04036487|Propofol|propofol|mesh-list
101832857|NCT04036487|Desflurane|desflurane|mesh-list
101832858|NCT04036487|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101832859|NCT04036487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101832860|NCT04036487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832861|NCT04036487|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101832862|NCT04036487|Anesthetics, General|anesthetics, general|mesh-ancestor
101832863|NCT04036487|Anesthetics|anesthetics|mesh-ancestor
101832864|NCT04036487|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101832865|NCT05278793|Ferrous fumarate|ferrous fumarate|mesh-list
101832866|NCT05278793|Trace Elements|trace elements|mesh-ancestor
101832867|NCT05278793|Micronutrients|micronutrients|mesh-ancestor
101832868|NCT05278793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832869|NCT04037657|Propofol|propofol|mesh-list
101832870|NCT04037657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101832871|NCT04037657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101832872|NCT04037657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832873|NCT04037657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101832874|NCT04037657|Anesthetics, General|anesthetics, general|mesh-ancestor
101832875|NCT04037657|Anesthetics|anesthetics|mesh-ancestor
101832876|NCT00893009|Theophylline|theophylline|mesh-list
101832877|NCT00893009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101832878|NCT00893009|Autonomic Agents|autonomic agents|mesh-ancestor
101832879|NCT00893009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101832880|NCT00893009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832881|NCT00893009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101832882|NCT00893009|Respiratory System Agents|respiratory system agents|mesh-ancestor
101832883|NCT00893009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101832884|NCT00893009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101832885|NCT00893009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832886|NCT00893009|Vasodilator Agents|vasodilator agents|mesh-ancestor
101832887|NCT00893009|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101832888|NCT00893009|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101832889|NCT00893009|Purinergic Agents|purinergic agents|mesh-ancestor
101832890|NCT00893009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101832891|NCT00890747|Sunitinib|sunitinib|mesh-list
101832892|NCT00890747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101832893|NCT00890747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101832894|NCT00890747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101832895|NCT00890747|Growth Substances|growth substances|mesh-ancestor
101832896|NCT00890747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832897|NCT00890747|Growth Inhibitors|growth inhibitors|mesh-ancestor
101832898|NCT00890747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101832899|NCT00890747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101832900|NCT00890747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832901|NCT04017845|Tribenoside|tribenoside|mesh-list
101832902|NCT04017845|Lidocaine|lidocaine|mesh-list
101832903|NCT04017845|Diltiazem|diltiazem|mesh-list
101832904|NCT04017845|Calcium Channel Blockers|calcium channel blockers|mesh-list
101832905|NCT04017845|Nitroglycerin|nitroglycerin|mesh-list
101832906|NCT04017845|Bisacodyl|bisacodyl|mesh-list
101832907|NCT04017845|Anesthetics, Local|anesthetics, local|mesh-ancestor
101832908|NCT04017845|Anesthetics|anesthetics|mesh-ancestor
101832909|NCT04017845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101832910|NCT04017845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832912|NCT04017845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101832913|NCT04017845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101832914|NCT04017845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101832915|NCT04017845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101832916|NCT04017845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101832917|NCT04017845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832918|NCT04017845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101832919|NCT04017845|Vasodilator Agents|vasodilator agents|mesh-ancestor
101832920|NCT04017845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101832921|NCT04017845|Cathartics|cathartics|mesh-ancestor
101832922|NCT04017845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101832923|NCT04017845|Laxatives|laxatives|mesh-ancestor
101832924|NCT04017845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101832925|NCT04017845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101832926|NCT04017845|Analgesics|analgesics|mesh-ancestor
101832927|NCT04017845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101832928|NCT04017845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101832929|NCT00520130|Cytarabine|cytarabine|mesh-list
101832930|NCT00520130|Cyclosporine|cyclosporine|mesh-list
101832931|NCT00520130|Rituximab|rituximab|mesh-list
101832932|NCT00520130|Alemtuzumab|alemtuzumab|mesh-list
101832933|NCT00520130|Fludarabine|fludarabine|mesh-list
101832934|NCT00520130|Cyclosporins|cyclosporins|mesh-list
101832935|NCT00520130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101832936|NCT00520130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101832937|NCT00520130|Immunologic Factors|immunologic factors|mesh-ancestor
101832938|NCT00520130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832939|NCT00520130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101832940|NCT00520130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101832941|NCT00520130|Antimetabolites|antimetabolites|mesh-ancestor
101832942|NCT00520130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832943|NCT00520130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101832944|NCT00520130|Antiviral Agents|antiviral agents|mesh-ancestor
101832945|NCT00520130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101832946|NCT00520130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101832947|NCT00520130|Antifungal Agents|antifungal agents|mesh-ancestor
101832948|NCT00520130|Dermatologic Agents|dermatologic agents|mesh-ancestor
101832949|NCT00520130|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101832951|NCT00519896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101832952|NCT00519896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101832953|NCT00519896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101832954|NCT00519896|Growth Substances|growth substances|mesh-ancestor
101832955|NCT00519896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832956|NCT00519896|Growth Inhibitors|growth inhibitors|mesh-ancestor
101832957|NCT00519896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101832958|NCT00519896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101832959|NCT00519896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832960|NCT00527618|Valacyclovir|valacyclovir|mesh-list
101832961|NCT00527618|Acyclovir|acyclovir|mesh-list
101832962|NCT00527618|Antiviral Agents|antiviral agents|mesh-ancestor
101832963|NCT00527618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101832964|NCT00527072|Infliximab|infliximab|mesh-list
101832965|NCT00527072|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101832966|NCT00527072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101832967|NCT00527072|Dermatologic Agents|dermatologic agents|mesh-ancestor
101832968|NCT00527072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101832969|NCT00527072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101832971|NCT00519428|Citalopram|citalopram|mesh-list
101832972|NCT00519428|Bupropion|bupropion|mesh-list
101832973|NCT00519428|Escitalopram|escitalopram|mesh-list
101832974|NCT00519428|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101832975|NCT00519428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101832976|NCT00519428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101832977|NCT00519428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101832978|NCT00519428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101832979|NCT00519428|Serotonin Agents|serotonin agents|mesh-ancestor
101832980|NCT00519428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101832981|NCT00519428|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101832982|NCT00519428|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101832983|NCT00519428|Parasympatholytics|parasympatholytics|mesh-ancestor
101832984|NCT00519428|Autonomic Agents|autonomic agents|mesh-ancestor
101832985|NCT00519428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101832986|NCT00519428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101832987|NCT00519428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101832988|NCT00519428|Cholinergic Agents|cholinergic agents|mesh-ancestor
101832989|NCT00519428|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101832990|NCT00519428|Antidepressive Agents|antidepressive agents|mesh-ancestor
101832991|NCT00519428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101832992|NCT00519428|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101832993|NCT00519428|Dopamine Agents|dopamine agents|mesh-ancestor
101832994|NCT00519428|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101832995|NCT00519428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101832996|NCT00519428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101832997|NCT00431847|Anesthetics|anesthetics|mesh-list
101832998|NCT00431847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101832999|NCT00431847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833000|NCT00431067|Afatinib|afatinib|mesh-list
101833001|NCT00431067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101833002|NCT00431067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101833003|NCT00431067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101833004|NCT00431067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833005|NCT00430989|Nitrous Oxide|nitrous oxide|mesh-list
101833006|NCT00430989|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101833007|NCT00430989|Anesthetics, General|anesthetics, general|mesh-ancestor
101833008|NCT00430989|Anesthetics|anesthetics|mesh-ancestor
101833009|NCT00430989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101833010|NCT00430989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833011|NCT00430989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101833012|NCT00430989|Analgesics|analgesics|mesh-ancestor
101833013|NCT00430989|Sensory System Agents|sensory system agents|mesh-ancestor
101833014|NCT00430989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101833015|NCT00518882|Liraglutide|liraglutide|mesh-list
101833016|NCT00518882|Exenatide|exenatide|mesh-list
101833017|NCT00518882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101833018|NCT00518882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833019|NCT00518882|Incretins|incretins|mesh-ancestor
101833020|NCT00518882|Hormones|hormones|mesh-ancestor
101833021|NCT00518882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101833022|NCT00518882|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101833023|NCT00518180|Lactitol|lactitol|mesh-list
101833024|NCT00518180|Vaccines|vaccines|mesh-list
101833025|NCT00518180|Immunologic Factors|immunologic factors|mesh-ancestor
101833026|NCT00518180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833027|NCT00518180|Cathartics|cathartics|mesh-ancestor
101833028|NCT00518180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101833029|NCT00525902|Adalimumab|adalimumab|mesh-list
101833030|NCT00525902|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101833031|NCT00525902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101833032|NCT00525902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101833033|NCT00525824|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101833034|NCT00525824|Simvastatin|simvastatin|mesh-list
101833035|NCT00525824|Ezetimibe|ezetimibe|mesh-list
101833036|NCT00525824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101833037|NCT00525824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101833038|NCT00525824|Antimetabolites|antimetabolites|mesh-ancestor
101833039|NCT00525824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833040|NCT00525824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101833041|NCT00525824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101833042|NCT00525824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101833044|NCT00525590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101833045|NCT00525590|Alkylating Agents|alkylating agents|mesh-ancestor
101833046|NCT00525590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833047|NCT00525590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101833048|NCT00430677|Mycophenolic Acid|mycophenolic acid|mesh-list
101833050|NCT00430677|Prednisolone|prednisolone|mesh-list
101833051|NCT00430677|Abatacept|abatacept|mesh-list
101833052|NCT00430677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101833053|NCT00430677|Glucocorticoids|glucocorticoids|mesh-ancestor
101833054|NCT00430677|Hormones|hormones|mesh-ancestor
101833055|NCT00430677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101833056|NCT00430677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833057|NCT00430677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101833058|NCT00430677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101833059|NCT00430677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101833060|NCT00430677|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101833061|NCT00430677|Antitubercular Agents|antitubercular agents|mesh-ancestor
101833062|NCT00430677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101833063|NCT00430677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101833064|NCT00430677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101833065|NCT00430677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833066|NCT00430677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101833067|NCT00430677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101833068|NCT00430677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101833069|NCT00430677|Immunologic Factors|immunologic factors|mesh-ancestor
101833070|NCT00430677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101833071|NCT02631759|Levetiracetam|levetiracetam|mesh-list
101833072|NCT02631759|Anticonvulsants|anticonvulsants|mesh-ancestor
101833073|NCT02631759|Nootropic Agents|nootropic agents|mesh-ancestor
101833074|NCT01035801|Insulin Lispro|insulin lispro|mesh-list
101833075|NCT01035801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101833076|NCT01035801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833077|NCT00525512|Tiotropium Bromide|tiotropium bromide|mesh-list
101833078|NCT00525512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101833079|NCT00525512|Autonomic Agents|autonomic agents|mesh-ancestor
101833080|NCT00525512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101833081|NCT00525512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833082|NCT00525512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101833083|NCT00525512|Respiratory System Agents|respiratory system agents|mesh-ancestor
101833084|NCT00525512|Parasympatholytics|parasympatholytics|mesh-ancestor
101833085|NCT00525512|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101833086|NCT00525512|Cholinergic Agents|cholinergic agents|mesh-ancestor
101833087|NCT00525512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101833088|NCT00525512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833089|NCT04501406|Pioglitazone|pioglitazone|mesh-list
101833090|NCT04501406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101833091|NCT04501406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833092|NCT03656666|Thalidomide|thalidomide|mesh-list
101833093|NCT03656666|Apremilast|apremilast|mesh-list
101833094|NCT03656666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101833095|NCT03656666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101833096|NCT03656666|Analgesics|analgesics|mesh-ancestor
101833097|NCT03656666|Sensory System Agents|sensory system agents|mesh-ancestor
101833098|NCT03656666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101833099|NCT03656666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833100|NCT03656666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101833101|NCT03656666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101833102|NCT03656666|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101833103|NCT03656666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101833104|NCT03656666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101833105|NCT03656666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833106|NCT03656666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101833107|NCT03656666|Immunologic Factors|immunologic factors|mesh-ancestor
101833108|NCT03656666|Leprostatic Agents|leprostatic agents|mesh-ancestor
101833109|NCT03656666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101833110|NCT03656666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101833111|NCT03656666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101833112|NCT03656666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101833113|NCT03656666|Growth Substances|growth substances|mesh-ancestor
101833114|NCT03656666|Growth Inhibitors|growth inhibitors|mesh-ancestor
101833115|NCT03656666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101833116|NCT00430521|Vaccines|vaccines|mesh-list
101833118|NCT00430521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833119|NCT01036035|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101833120|NCT01036035|Pilocarpine|pilocarpine|mesh-list
101833121|NCT01036035|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101833122|NCT01036035|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101833123|NCT01036035|Cholinergic Agents|cholinergic agents|mesh-ancestor
101833124|NCT01036035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101833125|NCT01036035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833126|NCT01036035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833127|NCT01036035|Urological Agents|urological agents|mesh-ancestor
101833128|NCT01036035|Miotics|miotics|mesh-ancestor
101833129|NCT01036035|Autonomic Agents|autonomic agents|mesh-ancestor
101833130|NCT01036035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101833131|NCT01036035|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101833132|NCT01036035|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101833133|NCT01036659|Ecallantide|ecallantide|mesh-list
101833134|NCT01036659|Bradykinin|bradykinin|mesh-list
101833135|NCT01036659|Kallikreins|kallikreins|mesh-list
101833136|NCT01036659|Kininogens|kininogens|mesh-list
101833137|NCT01036659|Vasodilator Agents|vasodilator agents|mesh-ancestor
101833138|NCT01036659|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
101833139|NCT01036659|Protease Inhibitors|protease inhibitors|mesh-ancestor
101833140|NCT01036659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101833141|NCT01036659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833142|NCT01036659|Analgesics|analgesics|mesh-ancestor
101833143|NCT01036659|Sensory System Agents|sensory system agents|mesh-ancestor
101833144|NCT01036659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101833145|NCT01036659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833146|NCT01036659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101833147|NCT01036659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101833148|NCT01036659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101833149|NCT01036659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101833150|NCT01036659|Coagulants|coagulants|mesh-ancestor
101833151|NCT01036659|Fertility Agents, Male|fertility agents, male|mesh-ancestor
101833152|NCT01036659|Fertility Agents|fertility agents|mesh-ancestor
101833153|NCT01036659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101833154|NCT01033149|Acetylcysteine|acetylcysteine|mesh-list
101833155|NCT01033149|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101833156|NCT01033149|Antiviral Agents|antiviral agents|mesh-ancestor
101833157|NCT01033149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101833158|NCT01033149|Expectorants|expectorants|mesh-ancestor
101833159|NCT01033149|Respiratory System Agents|respiratory system agents|mesh-ancestor
101833160|NCT01033149|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101833161|NCT01033149|Antioxidants|antioxidants|mesh-ancestor
101833162|NCT01033149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833163|NCT01033149|Protective Agents|protective agents|mesh-ancestor
101833164|NCT01033149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833165|NCT01033149|Antidotes|antidotes|mesh-ancestor
101833166|NCT00440271|Ritonavir|ritonavir|mesh-list
101833167|NCT00440271|Raltegravir Potassium|raltegravir potassium|mesh-list
101833168|NCT00440271|Maraviroc|maraviroc|mesh-list
101833169|NCT00440271|Tipranavir|tipranavir|mesh-list
101833170|NCT00440271|Enfuvirtide|enfuvirtide|mesh-list
101833171|NCT00440271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
101833172|NCT00440271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101833173|NCT00440271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101833174|NCT00440271|Protease Inhibitors|protease inhibitors|mesh-ancestor
101833175|NCT00440271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101833176|NCT00440271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833177|NCT00440271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101833178|NCT00440271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101833179|NCT00440271|Antiviral Agents|antiviral agents|mesh-ancestor
101833180|NCT00440271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101833181|NCT00440271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101833182|NCT00440271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101833183|NCT00440271|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101833184|NCT00440271|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101833185|NCT00440271|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101952828|NCT03310268|Sodium Fluoride|sodium fluoride|mesh-list
101833186|NCT00440271|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101833187|NCT00440271|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101833188|NCT00440271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101833189|NCT00346216|Ibuprofen|ibuprofen|mesh-list
101833190|NCT00346216|Celecoxib|celecoxib|mesh-list
101833191|NCT00346216|Naproxen|naproxen|mesh-list
101833192|NCT00346216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101833193|NCT00346216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101833194|NCT00346216|Analgesics|analgesics|mesh-ancestor
101833195|NCT00346216|Sensory System Agents|sensory system agents|mesh-ancestor
101833196|NCT00346216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101833197|NCT00346216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833198|NCT00346216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101833199|NCT00346216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101833200|NCT00346216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101833201|NCT00346216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101833202|NCT00346216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833203|NCT00346216|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101833204|NCT00346216|Gout Suppressants|gout suppressants|mesh-ancestor
101833205|NCT01051648|Triamcinolone|triamcinolone|mesh-list
101833206|NCT01051648|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101833207|NCT01051648|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101833208|NCT01051648|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101833209|NCT01051648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101833210|NCT01051648|Glucocorticoids|glucocorticoids|mesh-ancestor
101833211|NCT01051648|Hormones|hormones|mesh-ancestor
101833212|NCT01051648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101833213|NCT01051648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833214|NCT01051648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101833215|NCT01051648|Immunologic Factors|immunologic factors|mesh-ancestor
101833216|NCT01051648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101833217|NCT01051648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833218|NCT00429273|Guanfacine|guanfacine|mesh-list
101833219|NCT00429273|Methylphenidate|methylphenidate|mesh-list
101833220|NCT00429273|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
101833221|NCT00429273|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101833222|NCT00429273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833223|NCT00429273|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101833224|NCT00429273|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101833225|NCT00429273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101833226|NCT00429273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833227|NCT00429273|Dopamine Agents|dopamine agents|mesh-ancestor
101833228|NCT00429273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101833229|NCT00429273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101833230|NCT00429273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101833231|NCT00429273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101833232|NCT00429273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101833233|NCT00429273|Adrenergic Agents|adrenergic agents|mesh-ancestor
101833234|NCT00359632|Linezolid|linezolid|mesh-list
101833235|NCT00359632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101833236|NCT00359632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101833237|NCT00359632|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101833238|NCT00359632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101833239|NCT00359632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833240|NCT01324960|Aldesleukin|aldesleukin|mesh-list
101833241|NCT01324960|Azacitidine|azacitidine|mesh-list
101833242|NCT01324960|Histamine|histamine|mesh-list
101833243|NCT01324960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101833244|NCT01324960|Antimetabolites|antimetabolites|mesh-ancestor
101833245|NCT01324960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833246|NCT01324960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101833247|NCT01324960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101833248|NCT01324960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833249|NCT01324960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101833250|NCT01324960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101833251|NCT01324960|Antiviral Agents|antiviral agents|mesh-ancestor
101833252|NCT01324960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101833253|NCT01324960|Histamine Agonists|histamine agonists|mesh-ancestor
101833254|NCT01324960|Histamine Agents|histamine agents|mesh-ancestor
101833255|NCT01324960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101833256|NCT00417885|Sunitinib|sunitinib|mesh-list
101833257|NCT00417885|Exemestane|exemestane|mesh-list
101833258|NCT00417885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101833259|NCT00417885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101833260|NCT00417885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101833261|NCT00417885|Growth Substances|growth substances|mesh-ancestor
101833262|NCT00417885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833263|NCT00417885|Growth Inhibitors|growth inhibitors|mesh-ancestor
101833264|NCT00417885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101833265|NCT00417885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101833266|NCT00417885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833267|NCT00417885|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101833268|NCT00417885|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101833269|NCT00417885|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101833270|NCT00417885|Hormone Antagonists|hormone antagonists|mesh-ancestor
101224096|NCT01522326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101833271|NCT00417885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101833272|NCT01036893|Prucalopride|prucalopride|mesh-list
101833273|NCT01036893|Laxatives|laxatives|mesh-ancestor
101833274|NCT01036893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101833275|NCT01036893|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101833276|NCT01036893|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101833277|NCT01036893|Serotonin Agents|serotonin agents|mesh-ancestor
101833278|NCT01036893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101833279|NCT01036893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833280|NCT01036893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833281|NCT00525044|Ambroxol|ambroxol|mesh-list
101833282|NCT00525044|Expectorants|expectorants|mesh-ancestor
101833283|NCT00525044|Respiratory System Agents|respiratory system agents|mesh-ancestor
101833284|NCT00355342|Fluticasone|fluticasone|mesh-list
101833285|NCT00355342|Xhance|xhance|mesh-list
101833286|NCT00355342|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101833287|NCT00355342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101833288|NCT00355342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101833289|NCT00355342|Autonomic Agents|autonomic agents|mesh-ancestor
101833290|NCT00355342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101833291|NCT00355342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833292|NCT00355342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101833293|NCT00355342|Respiratory System Agents|respiratory system agents|mesh-ancestor
101833294|NCT00355342|Dermatologic Agents|dermatologic agents|mesh-ancestor
101833295|NCT00355342|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101833296|NCT00355342|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101833297|NCT00355342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101833298|NCT00355342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101833299|NCT00355342|Adrenergic Agents|adrenergic agents|mesh-ancestor
101833300|NCT00355342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101833301|NCT00355342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833302|NCT01051804|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101833303|NCT01051804|Lubricant Eye Drops|lubricant eye drops|mesh-list
101833304|NCT01051804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101833305|NCT01573754|Hydroxychloroquine|hydroxychloroquine|mesh-list
101833306|NCT01573754|Antimalarials|antimalarials|mesh-ancestor
101833307|NCT01573754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101833308|NCT01573754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101833309|NCT01573754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101833310|NCT01573754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101833311|NCT01573754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833312|NCT01573754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101833313|NCT03989830|Endostatins|endostatins|mesh-list
101833314|NCT03989830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101833315|NCT03989830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101833316|NCT03989830|Growth Substances|growth substances|mesh-ancestor
101833317|NCT03989830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833318|NCT03989830|Growth Inhibitors|growth inhibitors|mesh-ancestor
101833319|NCT03989830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101833320|NCT02533648|Allopurinol|allopurinol|mesh-list
101833321|NCT02533648|Antimetabolites|antimetabolites|mesh-ancestor
101833322|NCT02533648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833323|NCT02533648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101833324|NCT02533648|Gout Suppressants|gout suppressants|mesh-ancestor
101833325|NCT02533648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101833326|NCT02533648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101833327|NCT02533648|Antioxidants|antioxidants|mesh-ancestor
101833328|NCT02533648|Protective Agents|protective agents|mesh-ancestor
101833329|NCT02533648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833330|NCT02533492|Triclosan|triclosan|mesh-list
101833331|NCT02533492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101833332|NCT02533492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101833333|NCT02533492|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101833334|NCT02533492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101833335|NCT02533492|Antimetabolites|antimetabolites|mesh-ancestor
101833336|NCT02533492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833337|NCT02533492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101833338|NCT01056874|Maraviroc|maraviroc|mesh-list
101833339|NCT01056874|Digoxin|digoxin|mesh-list
101833340|NCT01056874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101833341|NCT01056874|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101833342|NCT01056874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101833343|NCT01056874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833344|NCT01056874|Protective Agents|protective agents|mesh-ancestor
101833345|NCT01056874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833346|NCT01056874|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101833347|NCT01056874|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101833348|NCT01056874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101833349|NCT01056874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101833350|NCT01056874|Antiviral Agents|antiviral agents|mesh-ancestor
101833351|NCT01056874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101833352|NCT01056874|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101833353|NCT00355030|Leuprolide|leuprolide|mesh-list
101833354|NCT00355030|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101833355|NCT00355030|Fertility Agents|fertility agents|mesh-ancestor
101833356|NCT00355030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101833357|NCT00355030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833358|NCT00355030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101833359|NCT00355030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101833360|NCT01057030|BMS 708163|bms 708163|mesh-list
101833361|NCT01057030|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
101833362|NCT01057030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101833363|NCT01057030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833364|NCT01057186|Alfacalcidol|alfacalcidol|mesh-list
101833365|NCT01057186|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
101833366|NCT01057186|Sevelamer|sevelamer|mesh-list
101833367|NCT01057186|Chelating Agents|chelating agents|mesh-ancestor
101833368|NCT01057186|Sequestering Agents|sequestering agents|mesh-ancestor
101833369|NCT01057186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833370|NCT01057186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101833371|NCT01057186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833372|NCT01057186|Vitamins|vitamins|mesh-ancestor
101833373|NCT01057186|Micronutrients|micronutrients|mesh-ancestor
101833374|NCT01057264|Paclitaxel|paclitaxel|mesh-list
101833375|NCT01057264|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101833376|NCT01057264|Bevacizumab|bevacizumab|mesh-list
101833377|NCT01057264|Gemcitabine|gemcitabine|mesh-list
101833378|NCT01057264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101833379|NCT01057264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101833380|NCT01057264|Tubulin Modulators|tubulin modulators|mesh-ancestor
101833381|NCT01057264|Antimitotic Agents|antimitotic agents|mesh-ancestor
101833382|NCT01057264|Mitosis Modulators|mitosis modulators|mesh-ancestor
101833383|NCT01057264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833384|NCT01057264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101833385|NCT01057264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101833386|NCT01057264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101833387|NCT01057264|Growth Substances|growth substances|mesh-ancestor
101833388|NCT01057264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833389|NCT01057264|Growth Inhibitors|growth inhibitors|mesh-ancestor
101833390|NCT01057264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101833391|NCT01057264|Antimetabolites|antimetabolites|mesh-ancestor
101833393|NCT03991312|Rifampin|rifampin|mesh-list
101833394|NCT03991312|Mitapivat|mitapivat|mesh-list
101833395|NCT03991312|Antifungal Agents|antifungal agents|mesh-ancestor
101833396|NCT03991312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101833397|NCT03991312|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101833398|NCT03991312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101833399|NCT03991312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101833400|NCT03991312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833401|NCT03991312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101833402|NCT03991312|Hormone Antagonists|hormone antagonists|mesh-ancestor
101833403|NCT03991312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101833404|NCT03991312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833405|NCT03991312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101833406|NCT03991312|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101833407|NCT03991312|Antitubercular Agents|antitubercular agents|mesh-ancestor
101833408|NCT03991312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101833409|NCT03991312|Leprostatic Agents|leprostatic agents|mesh-ancestor
101833410|NCT03991312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101833411|NCT03991312|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101833412|NCT03991312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101833413|NCT03991312|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101833414|NCT03991312|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101833415|NCT03991312|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101833416|NCT03991312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101833417|NCT03991312|Enzyme Activators|enzyme activators|mesh-ancestor
101833418|NCT01057342|Paclitaxel|paclitaxel|mesh-list
101833419|NCT01057342|Carboplatin|carboplatin|mesh-list
101833420|NCT01057342|Vadimezan|vadimezan|mesh-list
101833421|NCT01057342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101833422|NCT01057342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101833423|NCT01057342|Tubulin Modulators|tubulin modulators|mesh-ancestor
101833424|NCT01057342|Antimitotic Agents|antimitotic agents|mesh-ancestor
101833425|NCT01057342|Mitosis Modulators|mitosis modulators|mesh-ancestor
101833426|NCT01057342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833427|NCT01057498|RNS60|rns60|mesh-list
101833428|NCT01057498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101833429|NCT01057498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101833430|NCT01057498|Analgesics|analgesics|mesh-ancestor
101833431|NCT01057498|Sensory System Agents|sensory system agents|mesh-ancestor
101833432|NCT01057498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101833433|NCT01057498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833434|NCT01057498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101833435|NCT01057498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101833436|NCT01057498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101833437|NCT03742258|Prednisone|prednisone|mesh-list
101833438|NCT03742258|Cortisone|cortisone|mesh-list
101833439|NCT03742258|Cyclophosphamide|cyclophosphamide|mesh-list
101833440|NCT03742258|Rituximab|rituximab|mesh-list
101833441|NCT03742258|Doxorubicin|doxorubicin|mesh-list
101833442|NCT03742258|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101833443|NCT03742258|Vincristine|vincristine|mesh-list
101833444|NCT03742258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101833445|NCT03742258|Antibodies|antibodies|mesh-list
101833446|NCT03742258|Immunoglobulins|immunoglobulins|mesh-list
101833447|NCT03742258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101833448|NCT03742258|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101833449|NCT03742258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101833450|NCT03742258|Immunologic Factors|immunologic factors|mesh-ancestor
101833451|NCT03742258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833452|NCT03742258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101833453|NCT03742258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101833454|NCT03742258|Alkylating Agents|alkylating agents|mesh-ancestor
101833455|NCT03742258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833456|NCT03742258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101833457|NCT03742258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101833458|NCT03742258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101833459|NCT03742258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101833460|NCT03742258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101833461|NCT03742258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101833462|NCT03742258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101833463|NCT03742258|Glucocorticoids|glucocorticoids|mesh-ancestor
101833465|NCT03742258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101833466|NCT03742258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101833467|NCT03742258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101833468|NCT03742258|Tubulin Modulators|tubulin modulators|mesh-ancestor
101833469|NCT03742258|Antimitotic Agents|antimitotic agents|mesh-ancestor
101224134|NCT01522612|Antidotes|antidotes|mesh-ancestor
101833470|NCT03742258|Mitosis Modulators|mitosis modulators|mesh-ancestor
101833471|NCT03742258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101833472|NCT00354172|Cyclosporine|cyclosporine|mesh-list
101833473|NCT00354172|Mycophenolic Acid|mycophenolic acid|mesh-list
101833474|NCT00354172|Aldesleukin|aldesleukin|mesh-list
101833475|NCT00354172|Methylprednisolone|methylprednisolone|mesh-list
101833476|NCT00354172|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101833477|NCT00354172|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101833478|NCT00354172|Prednisolone|prednisolone|mesh-list
101833479|NCT00354172|Prednisolone acetate|prednisolone acetate|mesh-list
101833480|NCT00354172|Cyclophosphamide|cyclophosphamide|mesh-list
101833481|NCT00354172|Fludarabine|fludarabine|mesh-list
101833482|NCT00354172|Fludarabine phosphate|fludarabine phosphate|mesh-list
101833483|NCT00354172|Interleukin-2|interleukin-2|mesh-list
101833484|NCT00354172|Cyclosporins|cyclosporins|mesh-list
101833485|NCT00354172|Lenograstim|lenograstim|mesh-list
101833486|NCT00354172|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101833487|NCT00354172|Prednisolone phosphate|prednisolone phosphate|mesh-list
101833488|NCT00354172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101833489|NCT00354172|Immunologic Factors|immunologic factors|mesh-ancestor
101833490|NCT00354172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833491|NCT00354172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101833492|NCT00354172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101833493|NCT00354172|Alkylating Agents|alkylating agents|mesh-ancestor
101553282|NCT01269918|Remifentanil|remifentanil|mesh-list
101833494|NCT00354172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833495|NCT00354172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101833496|NCT00354172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101833497|NCT00354172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101833498|NCT00354172|Antimetabolites|antimetabolites|mesh-ancestor
101833499|NCT00354172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101833500|NCT00354172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101833501|NCT00354172|Antifungal Agents|antifungal agents|mesh-ancestor
101833502|NCT00354172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101833503|NCT00354172|Dermatologic Agents|dermatologic agents|mesh-ancestor
101833504|NCT00354172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101833505|NCT00354172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101833506|NCT00354172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101833507|NCT00354172|Antitubercular Agents|antitubercular agents|mesh-ancestor
101833508|NCT00354172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101833509|NCT00354172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101833510|NCT00354172|Antiemetics|antiemetics|mesh-ancestor
101833511|NCT00354172|Autonomic Agents|autonomic agents|mesh-ancestor
101833512|NCT00354172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101833513|NCT00354172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101833514|NCT00354172|Glucocorticoids|glucocorticoids|mesh-ancestor
101833515|NCT00354172|Hormones|hormones|mesh-ancestor
101833516|NCT00354172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101833517|NCT00354172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101833518|NCT00354172|Protective Agents|protective agents|mesh-ancestor
101833519|NCT00354172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101833520|NCT00354172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101833521|NCT00354172|Analgesics|analgesics|mesh-ancestor
101833522|NCT00354172|Sensory System Agents|sensory system agents|mesh-ancestor
101833523|NCT00354172|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101833524|NCT00354172|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101833525|NCT00354172|Antiviral Agents|antiviral agents|mesh-ancestor
101833526|NCT00353704|Pregabalin|pregabalin|mesh-list
101833527|NCT00353704|Morphine|morphine|mesh-list
101833528|NCT00353704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101833529|NCT00353704|Narcotics|narcotics|mesh-ancestor
101833530|NCT00353704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101833531|NCT00353704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833532|NCT00353704|Analgesics|analgesics|mesh-ancestor
101833533|NCT00353704|Sensory System Agents|sensory system agents|mesh-ancestor
101833534|NCT00353704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101833535|NCT00353704|Anticonvulsants|anticonvulsants|mesh-ancestor
101833536|NCT00353704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101833537|NCT00353704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101833538|NCT00353704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833539|NCT00353704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101833540|NCT00353704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101833541|NCT00353704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101833542|NCT00353704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101833543|NCT03742180|Ketorolac|ketorolac|mesh-list
101833544|NCT03742180|Dexmedetomidine|dexmedetomidine|mesh-list
101833545|NCT03742180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101833546|NCT03742180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101833547|NCT03742180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833548|NCT03742180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101833549|NCT03742180|Analgesics|analgesics|mesh-ancestor
101833550|NCT03742180|Sensory System Agents|sensory system agents|mesh-ancestor
101833551|NCT03742180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101833552|NCT03742180|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101833553|NCT03742180|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101833554|NCT03742180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101833555|NCT03742180|Adrenergic Agents|adrenergic agents|mesh-ancestor
101833556|NCT03742180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101833557|NCT03742180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833558|NCT03742180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101833559|NCT03742180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101833560|NCT03742180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101833561|NCT03742180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101833562|NCT03742180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101833563|NCT00512252|Cytarabine|cytarabine|mesh-list
101833564|NCT00512252|Plerixafor|plerixafor|mesh-list
101833565|NCT00512252|Etoposide|etoposide|mesh-list
101833566|NCT00512252|Mitoxantrone|mitoxantrone|mesh-list
101833567|NCT00512252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101833568|NCT00512252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101553352|NCT04732000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101833569|NCT00512252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101833570|NCT00512252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101833571|NCT00512252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101833572|NCT00512252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833573|NCT00512252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101833574|NCT00512252|Antimetabolites|antimetabolites|mesh-ancestor
101833575|NCT00512252|Antiviral Agents|antiviral agents|mesh-ancestor
101833576|NCT00512252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101833577|NCT00512252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101833578|NCT00512252|Immunologic Factors|immunologic factors|mesh-ancestor
101833579|NCT00512252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833580|NCT00512252|Analgesics|analgesics|mesh-ancestor
101833581|NCT00512252|Sensory System Agents|sensory system agents|mesh-ancestor
101833582|NCT00512252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101833583|NCT00512252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101833584|NCT00512252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101833585|NCT00516386|Mecasermin|mecasermin|mesh-list
101833586|NCT00516386|Growth Substances|growth substances|mesh-ancestor
101833587|NCT00516386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833588|NCT00512096|Paclitaxel|paclitaxel|mesh-list
101833589|NCT00512096|Cisplatin|cisplatin|mesh-list
101833590|NCT00512096|Ifosfamide|ifosfamide|mesh-list
101833591|NCT00512096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101833592|NCT00512096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101833593|NCT00512096|Tubulin Modulators|tubulin modulators|mesh-ancestor
101833594|NCT00512096|Antimitotic Agents|antimitotic agents|mesh-ancestor
101833595|NCT00512096|Mitosis Modulators|mitosis modulators|mesh-ancestor
101833596|NCT00512096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833597|NCT00512096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101833598|NCT00512096|Alkylating Agents|alkylating agents|mesh-ancestor
101833599|NCT04462796|Magnesium citrate|magnesium citrate|mesh-list
101833600|NCT04462796|Cathartics|cathartics|mesh-ancestor
101833601|NCT04462796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101833602|NCT00524030|Pregabalin|pregabalin|mesh-list
101833603|NCT00524030|Analgesics|analgesics|mesh-ancestor
101833604|NCT00524030|Sensory System Agents|sensory system agents|mesh-ancestor
101833605|NCT00524030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101833606|NCT00524030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833607|NCT00524030|Anticonvulsants|anticonvulsants|mesh-ancestor
101833608|NCT00524030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101833609|NCT00524030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101833610|NCT00524030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833611|NCT00524030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101833612|NCT00524030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101833613|NCT00524030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101833614|NCT00524030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101833615|NCT00524030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101833616|NCT00523718|Riluzole|riluzole|mesh-list
101833618|NCT00523718|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101833619|NCT00523718|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101833620|NCT00523718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101833621|NCT00523718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833622|NCT00523718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833623|NCT00523718|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101833624|NCT00523718|Protective Agents|protective agents|mesh-ancestor
101833625|NCT00523640|Bevacizumab|bevacizumab|mesh-list
101833626|NCT00523640|Gemcitabine|gemcitabine|mesh-list
101833627|NCT00523640|Capecitabine|capecitabine|mesh-list
101833628|NCT00523640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101833629|NCT00523640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101833630|NCT00523640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101833631|NCT00523640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101833632|NCT00523640|Growth Substances|growth substances|mesh-ancestor
101833633|NCT00523640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833634|NCT00523640|Growth Inhibitors|growth inhibitors|mesh-ancestor
101833635|NCT00523640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101833636|NCT00523640|Antimetabolites|antimetabolites|mesh-ancestor
101833637|NCT00523640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833638|NCT00345358|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101833639|NCT00345358|Immunologic Factors|immunologic factors|mesh-ancestor
101833640|NCT00345358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833641|NCT00516074|Exenatide|exenatide|mesh-list
101833642|NCT00516074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101833643|NCT00516074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833644|NCT00516074|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101833645|NCT00516074|Incretins|incretins|mesh-ancestor
101833646|NCT00516074|Hormones|hormones|mesh-ancestor
101833647|NCT00516074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101833648|NCT01057654|Pravastatin|pravastatin|mesh-list
101833649|NCT01057654|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101833650|NCT01057654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101833651|NCT01057654|Antimetabolites|antimetabolites|mesh-ancestor
101833652|NCT01057654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833653|NCT01057654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101833654|NCT01057654|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101833655|NCT01057654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101833656|NCT00515294|Caffeine|caffeine|mesh-list
101833657|NCT00515294|Methamphetamine|methamphetamine|mesh-list
101833658|NCT00515294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101833659|NCT00515294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833660|NCT00515294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101833661|NCT00515294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101833662|NCT00515294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833663|NCT00515294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101833664|NCT00515294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101833665|NCT00515294|Purinergic Agents|purinergic agents|mesh-ancestor
101833666|NCT00515294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101833667|NCT00515294|Sympathomimetics|sympathomimetics|mesh-ancestor
101833668|NCT00515294|Autonomic Agents|autonomic agents|mesh-ancestor
101833669|NCT00515294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101833670|NCT00515294|Dopamine Agents|dopamine agents|mesh-ancestor
101833671|NCT00515294|Adrenergic Agents|adrenergic agents|mesh-ancestor
101833672|NCT00515294|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101833673|NCT00515294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101833674|NCT00515294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101833675|NCT00515294|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101833676|NCT00345046|Prednisolone|prednisolone|mesh-list
101833677|NCT00345046|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101833678|NCT00345046|Methylprednisolone|methylprednisolone|mesh-list
101833679|NCT00345046|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101833680|NCT00345046|Prednisolone acetate|prednisolone acetate|mesh-list
101833681|NCT00345046|Prednisone|prednisone|mesh-list
101833682|NCT00345046|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101833683|NCT00345046|Prednisolone phosphate|prednisolone phosphate|mesh-list
101833684|NCT00345046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101833685|NCT00345046|Glucocorticoids|glucocorticoids|mesh-ancestor
101833686|NCT00345046|Hormones|hormones|mesh-ancestor
101833687|NCT00345046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101833688|NCT00345046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827487|NCT05663242|Anesthetics, General|anesthetics, general|mesh-ancestor
101833689|NCT00345046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101833690|NCT00345046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101833691|NCT00345046|Antiemetics|antiemetics|mesh-ancestor
101833692|NCT00345046|Autonomic Agents|autonomic agents|mesh-ancestor
101833693|NCT00345046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101833694|NCT00345046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101833695|NCT00345046|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101833696|NCT00345046|Protective Agents|protective agents|mesh-ancestor
101833698|NCT00515216|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
101833699|NCT00515216|Tetrahydrofolates|tetrahydrofolates|mesh-list
101833700|NCT00515216|Fluorouracil|fluorouracil|mesh-list
101833701|NCT00515216|Oxaliplatin|oxaliplatin|mesh-list
101833702|NCT00515216|Levoleucovorin|levoleucovorin|mesh-list
101833703|NCT00515216|Antimetabolites|antimetabolites|mesh-ancestor
101833704|NCT00515216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833705|NCT00515216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101833706|NCT00515216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101833707|NCT00515216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101833708|NCT00515216|Immunologic Factors|immunologic factors|mesh-ancestor
101833709|NCT00515216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833710|NCT00515216|Antidotes|antidotes|mesh-ancestor
101833711|NCT00515216|Protective Agents|protective agents|mesh-ancestor
101833712|NCT00515216|Vitamin B Complex|vitamin b complex|mesh-ancestor
101833713|NCT00515216|Vitamins|vitamins|mesh-ancestor
101833714|NCT00515216|Micronutrients|micronutrients|mesh-ancestor
101833715|NCT01004978|Cisplatin|cisplatin|mesh-list
101833716|NCT01004978|Doxorubicin|doxorubicin|mesh-list
101833717|NCT01004978|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101833718|NCT01004978|Sorafenib|sorafenib|mesh-list
101833719|NCT01004978|Mitomycins|mitomycins|mesh-list
101833720|NCT01004978|Mitomycin|mitomycin|mesh-list
101833721|NCT01004978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101833722|NCT01004978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101224179|NCT01522872|Dexamethasone acetate|dexamethasone acetate|mesh-list
101833723|NCT01004978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101833724|NCT01004978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101833725|NCT01004978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101833726|NCT01004978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833727|NCT01004978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101833728|NCT01004978|Alkylating Agents|alkylating agents|mesh-ancestor
101833729|NCT01004978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101833730|NCT00440193|Enoxaparin|enoxaparin|mesh-list
101833731|NCT00440193|Rivaroxaban|rivaroxaban|mesh-list
101833732|NCT00440193|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101833733|NCT00440193|Antithrombins|antithrombins|mesh-ancestor
101833734|NCT00440193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101833735|NCT00440193|Protease Inhibitors|protease inhibitors|mesh-ancestor
101833736|NCT00440193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101833737|NCT00440193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833738|NCT00440193|Anticoagulants|anticoagulants|mesh-ancestor
101833739|NCT00440193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101833740|NCT00440193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101833741|NCT00511472|Insulin Glargine|insulin glargine|mesh-list
101833742|NCT00511472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101833743|NCT00511472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833744|NCT01033305|Cyclosporine|cyclosporine|mesh-list
101833745|NCT01033305|Cyclosporins|cyclosporins|mesh-list
101833746|NCT01033305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101833747|NCT01033305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952876|NCT02036554|Everolimus|everolimus|mesh-list
101833748|NCT01033305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101833749|NCT01033305|Immunologic Factors|immunologic factors|mesh-ancestor
101833750|NCT01033305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833751|NCT01033305|Antifungal Agents|antifungal agents|mesh-ancestor
101833752|NCT01033305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101833753|NCT01033305|Dermatologic Agents|dermatologic agents|mesh-ancestor
101833754|NCT01033305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101833755|NCT01033305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101833757|NCT00514904|Immunologic Factors|immunologic factors|mesh-ancestor
101833758|NCT00514904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833759|NCT00440115|Bupropion|bupropion|mesh-list
101833760|NCT00440115|Nicotine|nicotine|mesh-list
101833761|NCT00440115|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101833762|NCT00440115|Autonomic Agents|autonomic agents|mesh-ancestor
101833763|NCT00440115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101833764|NCT00440115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833765|NCT00440115|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101833766|NCT00440115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101833767|NCT00440115|Cholinergic Agents|cholinergic agents|mesh-ancestor
101833768|NCT00440115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101833769|NCT00440115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833770|NCT00440115|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101833771|NCT00440115|Antidepressive Agents|antidepressive agents|mesh-ancestor
101833772|NCT00440115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101833773|NCT00440115|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101833774|NCT00440115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101833775|NCT00440115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101833776|NCT00440115|Dopamine Agents|dopamine agents|mesh-ancestor
101833777|NCT00440115|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101833778|NCT00440115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101833779|NCT00440115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101833780|NCT01033461|Calcium|calcium|mesh-list
101833781|NCT01033461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101833782|NCT01033461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833783|NCT01030731|Ceftobiprole|ceftobiprole|mesh-list
101833784|NCT01030731|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
101833785|NCT01030731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101833786|NCT01030731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101833787|NCT00416715|Calcium, Dietary|calcium, dietary|mesh-list
101833788|NCT00416715|Vitamin D|vitamin d|mesh-list
101833789|NCT00416715|Cholecalciferol|cholecalciferol|mesh-list
101833790|NCT00416715|Letrozole|letrozole|mesh-list
101833791|NCT00416715|Calcium Carbonate|calcium carbonate|mesh-list
101833792|NCT00416715|Citric Acid|citric acid|mesh-list
101833793|NCT00416715|Sodium Citrate|sodium citrate|mesh-list
101833794|NCT00416715|Calcium|calcium|mesh-list
101833795|NCT00416715|Vitamins|vitamins|mesh-ancestor
101833796|NCT00416715|Micronutrients|micronutrients|mesh-ancestor
101833797|NCT00416715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833798|NCT00416715|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101833799|NCT00416715|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101833800|NCT00416715|Anticoagulants|anticoagulants|mesh-ancestor
101833801|NCT00416715|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101833802|NCT00416715|Chelating Agents|chelating agents|mesh-ancestor
101833803|NCT00416715|Sequestering Agents|sequestering agents|mesh-ancestor
101833804|NCT00416715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833805|NCT00416715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101833806|NCT00416715|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101833807|NCT00416715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101833808|NCT00416715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101833809|NCT00416715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101833810|NCT00416715|Hormone Antagonists|hormone antagonists|mesh-ancestor
101833811|NCT00416715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101833812|NCT00416715|Antacids|antacids|mesh-ancestor
101833813|NCT00416715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101833814|NCT01037517|Plerixafor|plerixafor|mesh-list
101833815|NCT01037517|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101833816|NCT01037517|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101833817|NCT01037517|Antiviral Agents|antiviral agents|mesh-ancestor
101833818|NCT01037517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101833819|NCT00406029|Levodopa|levodopa|mesh-list
101833820|NCT00406029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101833821|NCT00406029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101833822|NCT00406029|Dopamine Agents|dopamine agents|mesh-ancestor
101833823|NCT00406029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101833824|NCT00406029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833825|NCT00406029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833826|NCT00514514|Cyclosporine|cyclosporine|mesh-list
101833827|NCT00514514|Mycophenolic Acid|mycophenolic acid|mesh-list
101833828|NCT00514514|Everolimus|everolimus|mesh-list
101833829|NCT00514514|Cyclosporins|cyclosporins|mesh-list
101833830|NCT00514514|Basiliximab|basiliximab|mesh-list
101833831|NCT00514514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101833832|NCT00514514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833833|NCT00514514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101833834|NCT00514514|Immunologic Factors|immunologic factors|mesh-ancestor
101833835|NCT00514514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833836|NCT00514514|Antifungal Agents|antifungal agents|mesh-ancestor
101833837|NCT00514514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101833838|NCT00514514|Dermatologic Agents|dermatologic agents|mesh-ancestor
101833839|NCT00514514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101833840|NCT00514514|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101833841|NCT00514514|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101833842|NCT00514514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101833843|NCT00514514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101833844|NCT00514514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101833845|NCT00514514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101833846|NCT00514514|Antitubercular Agents|antitubercular agents|mesh-ancestor
101833847|NCT00514514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101833848|NCT00405639|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101833849|NCT00405639|Natriuretic Agents|natriuretic agents|mesh-ancestor
101833850|NCT00405639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833851|NCT00439725|Rivaroxaban|rivaroxaban|mesh-list
101833852|NCT00439725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101833853|NCT00439725|Antithrombins|antithrombins|mesh-ancestor
101833854|NCT00439725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101833855|NCT00439725|Protease Inhibitors|protease inhibitors|mesh-ancestor
101224205|NCT01522989|Fluorouracil|fluorouracil|mesh-list
101833856|NCT00439725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101833857|NCT00439725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833858|NCT00439725|Anticoagulants|anticoagulants|mesh-ancestor
101833859|NCT00521586|Vaccines|vaccines|mesh-list
101833860|NCT00521586|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101833861|NCT00521586|Immunologic Factors|immunologic factors|mesh-ancestor
101833862|NCT00521586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833863|NCT00515502|Tiotropium Bromide|tiotropium bromide|mesh-list
101833864|NCT00515502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101833865|NCT00515502|Autonomic Agents|autonomic agents|mesh-ancestor
101833866|NCT00515502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101833867|NCT00515502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833868|NCT00515502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101833869|NCT00515502|Respiratory System Agents|respiratory system agents|mesh-ancestor
101833870|NCT00515502|Parasympatholytics|parasympatholytics|mesh-ancestor
101833871|NCT00515502|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101833872|NCT00515502|Cholinergic Agents|cholinergic agents|mesh-ancestor
101833873|NCT00515502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101833874|NCT00515502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833875|NCT01010646|Ribavirin|ribavirin|mesh-list
101553660|NCT01030900|Hormones|hormones|mesh-ancestor
101833876|NCT01010646|Interferon-alpha|interferon-alpha|mesh-list
101833877|NCT01010646|Interferon alpha-2|interferon alpha-2|mesh-list
101833878|NCT01010646|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
101833879|NCT01010646|Antimetabolites|antimetabolites|mesh-ancestor
101833880|NCT01010646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833881|NCT01010646|Antiviral Agents|antiviral agents|mesh-ancestor
101833882|NCT01010646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101833883|NCT01010646|Immunologic Factors|immunologic factors|mesh-ancestor
101833884|NCT01010646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833885|NCT01010646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101833886|NCT00439647|Zoledronic Acid|zoledronic acid|mesh-list
101833887|NCT00439647|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101952884|NCT02036554|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101833888|NCT00439647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833890|NCT00515112|Androgens|androgens|mesh-ancestor
101833891|NCT00515112|Hormones|hormones|mesh-ancestor
101833892|NCT00515112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101833893|NCT00515112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833894|NCT03742557|Ketamine|ketamine|mesh-list
101833895|NCT03742557|Analgesics|analgesics|mesh-ancestor
101833896|NCT03742557|Sensory System Agents|sensory system agents|mesh-ancestor
101833897|NCT03742557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101833898|NCT03742557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833899|NCT03742557|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101833900|NCT03742557|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101833901|NCT03742557|Anesthetics, General|anesthetics, general|mesh-ancestor
101833902|NCT03742557|Anesthetics|anesthetics|mesh-ancestor
101833903|NCT03742557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101833904|NCT03742557|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101833905|NCT03742557|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101833906|NCT03742557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101833907|NCT03742557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833908|NCT01324089|Resveratrol|resveratrol|mesh-list
101833909|NCT01324089|Piperine|piperine|mesh-list
101833910|NCT01324089|Antioxidants|antioxidants|mesh-ancestor
101833911|NCT01324089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833912|NCT01324089|Protective Agents|protective agents|mesh-ancestor
101833913|NCT01324089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833914|NCT01324089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101833915|NCT01324089|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101833916|NCT01324089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101833917|NCT00404547|Ciclesonide|ciclesonide|mesh-list
101833918|NCT00404547|Glucocorticoids|glucocorticoids|mesh-ancestor
101833919|NCT00404547|Hormones|hormones|mesh-ancestor
101833920|NCT00404547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101833921|NCT00404547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833922|NCT00404547|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101833923|NCT00515034|Imipenem|imipenem|mesh-list
101833924|NCT00515034|Doripenem|doripenem|mesh-list
101833925|NCT00515034|Cilastatin|cilastatin|mesh-list
101833926|NCT00515034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101833927|NCT00515034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101833928|NCT00515034|Protease Inhibitors|protease inhibitors|mesh-ancestor
101833929|NCT00515034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101833930|NCT00515034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833931|NCT00404235|Paclitaxel|paclitaxel|mesh-list
101833932|NCT00404235|Carboplatin|carboplatin|mesh-list
101833933|NCT00404235|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101833934|NCT00404235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101833935|NCT00404235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101833936|NCT00404235|Tubulin Modulators|tubulin modulators|mesh-ancestor
101833937|NCT00404235|Antimitotic Agents|antimitotic agents|mesh-ancestor
101833938|NCT00404235|Mitosis Modulators|mitosis modulators|mesh-ancestor
101833939|NCT00404235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833940|NCT00509262|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101833941|NCT00509262|Glipizide|glipizide|mesh-list
101833942|NCT00509262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101833943|NCT00509262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833944|NCT00509262|Incretins|incretins|mesh-ancestor
101833945|NCT00509262|Hormones|hormones|mesh-ancestor
101833946|NCT00509262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101833947|NCT00509262|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101833948|NCT00509262|Protease Inhibitors|protease inhibitors|mesh-ancestor
101833949|NCT00509262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101833950|NCT00509262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833951|NCT00509106|Ceftriaxone|ceftriaxone|mesh-list
101833952|NCT00509106|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
101833953|NCT00509106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101833954|NCT00509106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101833955|NCT00607919|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101952892|NCT05577117|Fentanyl|fentanyl|mesh-list
101833956|NCT00607919|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101833957|NCT00607919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101833958|NCT00607919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101833959|NCT00607919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833960|NCT00607919|Adrenergic Agents|adrenergic agents|mesh-ancestor
101833961|NCT00607919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101833962|NCT00607919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833963|NCT00344968|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
101833964|NCT00344968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101833965|NCT00344968|Glucocorticoids|glucocorticoids|mesh-ancestor
101833966|NCT00344968|Hormones|hormones|mesh-ancestor
101833967|NCT00344968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101833968|NCT00344968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833969|NCT00509028|Budesonide|budesonide|mesh-list
101833970|NCT00509028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101833971|NCT00509028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101833972|NCT00509028|Autonomic Agents|autonomic agents|mesh-ancestor
101833973|NCT00509028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101833974|NCT00509028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833975|NCT00509028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101833976|NCT00509028|Respiratory System Agents|respiratory system agents|mesh-ancestor
101833977|NCT00509028|Glucocorticoids|glucocorticoids|mesh-ancestor
101833978|NCT00509028|Hormones|hormones|mesh-ancestor
101833979|NCT00509028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101833980|NCT00352846|Vitamin D|vitamin d|mesh-list
101833981|NCT00352846|Zoledronic Acid|zoledronic acid|mesh-list
101833982|NCT00352846|Calcium Carbonate|calcium carbonate|mesh-list
101833983|NCT00352846|Calcium|calcium|mesh-list
101833984|NCT00352846|Vitamins|vitamins|mesh-ancestor
101833985|NCT00352846|Micronutrients|micronutrients|mesh-ancestor
101833986|NCT00352846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101833987|NCT00352846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101833988|NCT00352846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101833989|NCT00352846|Antacids|antacids|mesh-ancestor
101833990|NCT00352846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101833991|NCT00352846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101833992|NCT00508872|Leucovorin|leucovorin|mesh-list
101833993|NCT00508872|Bevacizumab|bevacizumab|mesh-list
101833994|NCT00508872|Fluorouracil|fluorouracil|mesh-list
101833995|NCT00508872|Oxaliplatin|oxaliplatin|mesh-list
101833996|NCT00508872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101833997|NCT00508872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101833998|NCT00508872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101833999|NCT00508872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101834000|NCT00508872|Growth Substances|growth substances|mesh-ancestor
101834001|NCT00508872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834002|NCT00508872|Growth Inhibitors|growth inhibitors|mesh-ancestor
101834003|NCT00508872|Antimetabolites|antimetabolites|mesh-ancestor
101834004|NCT00508872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834005|NCT00508872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101834006|NCT00508872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101834007|NCT00508872|Immunologic Factors|immunologic factors|mesh-ancestor
101834008|NCT00508872|Antidotes|antidotes|mesh-ancestor
101834009|NCT00508872|Protective Agents|protective agents|mesh-ancestor
101834010|NCT00508872|Vitamin B Complex|vitamin b complex|mesh-ancestor
101834011|NCT00508872|Vitamins|vitamins|mesh-ancestor
101834012|NCT00508872|Micronutrients|micronutrients|mesh-ancestor
101834013|NCT00508482|Lactulose|lactulose|mesh-list
101834014|NCT00508482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101834015|NCT00344032|Vaccines|vaccines|mesh-list
101834016|NCT00344032|Immunologic Factors|immunologic factors|mesh-ancestor
101834017|NCT00344032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834018|NCT00607373|Mipomersen|mipomersen|mesh-list
101834019|NCT00607373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101834020|NCT00607373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101834021|NCT00607373|Antimetabolites|antimetabolites|mesh-ancestor
101834022|NCT00607373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834023|NCT00607373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101834024|NCT00508404|Panitumumab|panitumumab|mesh-list
101834025|NCT00508404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101834026|NCT00508404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101834027|NCT00352690|Paclitaxel|paclitaxel|mesh-list
101834028|NCT00352690|Carboplatin|carboplatin|mesh-list
101834029|NCT00352690|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
101834030|NCT00352690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101834031|NCT00352690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101834032|NCT00352690|Tubulin Modulators|tubulin modulators|mesh-ancestor
101834033|NCT00352690|Antimitotic Agents|antimitotic agents|mesh-ancestor
101834034|NCT00352690|Mitosis Modulators|mitosis modulators|mesh-ancestor
101834035|NCT00352690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834036|NCT00895505|Warfarin|warfarin|mesh-list
101834037|NCT00895505|Phenprocoumon|phenprocoumon|mesh-list
101834038|NCT00895505|Anticoagulants|anticoagulants|mesh-ancestor
101834039|NCT03502577|Cyclophosphamide|cyclophosphamide|mesh-list
101834040|NCT03502577|Fludarabine|fludarabine|mesh-list
101834041|NCT03502577|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
101834042|NCT03502577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101834043|NCT03502577|Immunologic Factors|immunologic factors|mesh-ancestor
101834044|NCT03502577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834045|NCT03502577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101834046|NCT03502577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101834047|NCT03502577|Alkylating Agents|alkylating agents|mesh-ancestor
101834048|NCT03502577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834049|NCT03502577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101834050|NCT03502577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101834051|NCT03502577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101834052|NCT03249012|Calcium, Dietary|calcium, dietary|mesh-list
101834053|NCT03249012|Calcitriol|calcitriol|mesh-list
101834054|NCT03249012|Calcium Carbonate|calcium carbonate|mesh-list
101834055|NCT03249012|Calcium|calcium|mesh-list
101834056|NCT03249012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101834057|NCT03249012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834058|NCT03249012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101834059|NCT03249012|Antacids|antacids|mesh-ancestor
101834060|NCT03249012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834061|NCT03249012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101834062|NCT03249012|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101834063|NCT03249012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101834064|NCT03249012|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101834065|NCT03249012|Vitamins|vitamins|mesh-ancestor
101834066|NCT03249012|Micronutrients|micronutrients|mesh-ancestor
101834067|NCT03477539|Lenalidomide|lenalidomide|mesh-list
101834068|NCT03477539|Daratumumab|daratumumab|mesh-list
101834069|NCT03477539|Immunologic Factors|immunologic factors|mesh-ancestor
101834070|NCT03477539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834071|NCT03477539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101834072|NCT03477539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101834073|NCT03477539|Growth Substances|growth substances|mesh-ancestor
101834074|NCT03477539|Growth Inhibitors|growth inhibitors|mesh-ancestor
101834075|NCT03477539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101834077|NCT00893477|Sargramostim|sargramostim|mesh-list
101834078|NCT00893477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101834079|NCT00893477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101834080|NCT00893477|Immunologic Factors|immunologic factors|mesh-ancestor
101834081|NCT00893477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834082|NCT00893477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101834083|NCT00609245|Valproic Acid|valproic acid|mesh-list
101834084|NCT00609245|Anticonvulsants|anticonvulsants|mesh-ancestor
101834085|NCT00609245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101834086|NCT00609245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834087|NCT00609245|GABA Agents|gaba agents|mesh-ancestor
101834088|NCT00609245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101834089|NCT00609245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834090|NCT00609245|Antimanic Agents|antimanic agents|mesh-ancestor
101834091|NCT00609245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101834092|NCT00609245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101834093|NCT00609245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101834094|NCT01010802|Epoetin Alfa|epoetin alfa|mesh-list
101834095|NCT01010802|Hematinics|hematinics|mesh-ancestor
101834096|NCT04036253|Epoetin Alfa|epoetin alfa|mesh-list
101834097|NCT04036253|Hematinics|hematinics|mesh-ancestor
101834098|NCT00893555|Voriconazole|voriconazole|mesh-list
101834099|NCT00893555|Antifungal Agents|antifungal agents|mesh-ancestor
101834100|NCT00893555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101672702|NCT01552434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101834101|NCT00893555|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101834102|NCT00893555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101834103|NCT00893555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101834104|NCT00893555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834105|NCT00893555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101834106|NCT00893555|Hormone Antagonists|hormone antagonists|mesh-ancestor
101834107|NCT00893555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101834108|NCT00893555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834109|NCT00893555|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101834110|NCT02541071|Clonidine|clonidine|mesh-list
101834111|NCT02541071|Yohimbine|yohimbine|mesh-list
101834112|NCT02541071|Analgesics|analgesics|mesh-ancestor
101834113|NCT02541071|Sensory System Agents|sensory system agents|mesh-ancestor
101834114|NCT02541071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101834115|NCT02541071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834116|NCT02541071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101834117|NCT02541071|Sympatholytics|sympatholytics|mesh-ancestor
101834118|NCT02541071|Autonomic Agents|autonomic agents|mesh-ancestor
101834119|NCT02541071|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101834120|NCT02541071|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101834121|NCT02541071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101834122|NCT02541071|Adrenergic Agents|adrenergic agents|mesh-ancestor
101834123|NCT02541071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101834124|NCT02541071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834125|NCT02541071|Mydriatics|mydriatics|mesh-ancestor
101834126|NCT02541071|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101834127|NCT02541071|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101834128|NCT02541071|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101834129|NCT02541071|Urological Agents|urological agents|mesh-ancestor
101834130|NCT01058824|Lincomycin|lincomycin|mesh-list
101834131|NCT01058824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101834132|NCT01058824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101834133|NCT01058824|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101834134|NCT01058824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101834135|NCT01058824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834136|NCT00895739|Cyclosporine|cyclosporine|mesh-list
101834137|NCT00895739|Alemtuzumab|alemtuzumab|mesh-list
101834138|NCT00895739|Cyclosporins|cyclosporins|mesh-list
101834139|NCT00895739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101224223|NCT01523002|Autonomic Agents|autonomic agents|mesh-ancestor
101834140|NCT00895739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834141|NCT00895739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101834142|NCT00895739|Immunologic Factors|immunologic factors|mesh-ancestor
101834143|NCT00895739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834144|NCT00895739|Antifungal Agents|antifungal agents|mesh-ancestor
101834145|NCT00895739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101834146|NCT00895739|Dermatologic Agents|dermatologic agents|mesh-ancestor
101834147|NCT00895739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101834148|NCT00895739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101834149|NCT00895739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101834150|NCT00895739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101834152|NCT01058902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101834153|NCT01058902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101834154|NCT01058902|Analgesics|analgesics|mesh-ancestor
101834155|NCT01058902|Sensory System Agents|sensory system agents|mesh-ancestor
101834156|NCT01058902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101834157|NCT01058902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834158|NCT01058902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101834159|NCT01058902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101834160|NCT01058902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101834161|NCT01058902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101834162|NCT01058902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834163|NCT01058902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101834164|NCT01058902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101834165|NCT01058902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101834166|NCT01058902|Antipyretics|antipyretics|mesh-ancestor
101834167|NCT00609167|Dexamethasone|dexamethasone|mesh-list
101834168|NCT00609167|Cyclophosphamide|cyclophosphamide|mesh-list
101834169|NCT00609167|Bortezomib|bortezomib|mesh-list
101834170|NCT00609167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101834171|NCT00609167|Immunologic Factors|immunologic factors|mesh-ancestor
101834172|NCT00609167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834174|NCT00609167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101834175|NCT00609167|Alkylating Agents|alkylating agents|mesh-ancestor
101834176|NCT00609167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834177|NCT00609167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101834178|NCT00609167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101834179|NCT00609167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101834180|NCT00609167|Antiemetics|antiemetics|mesh-ancestor
101834181|NCT00609167|Autonomic Agents|autonomic agents|mesh-ancestor
101834182|NCT00609167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101834183|NCT00609167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101834184|NCT00609167|Glucocorticoids|glucocorticoids|mesh-ancestor
101834185|NCT00609167|Hormones|hormones|mesh-ancestor
101834186|NCT00609167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101834187|NCT00609167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101834188|NCT01055236|Hydroxyzine|hydroxyzine|mesh-list
101834189|NCT01055236|Antipruritics|antipruritics|mesh-ancestor
101834190|NCT01055236|Dermatologic Agents|dermatologic agents|mesh-ancestor
101834191|NCT01055236|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101834192|NCT01055236|Histamine Antagonists|histamine antagonists|mesh-ancestor
101834193|NCT01055236|Histamine Agents|histamine agents|mesh-ancestor
101834194|NCT01055236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101834195|NCT01055236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834196|NCT01055236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834197|NCT00606281|Aripiprazole|aripiprazole|mesh-list
101834198|NCT00606281|Antidepressive Agents|antidepressive agents|mesh-ancestor
101834199|NCT00606281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101834200|NCT00606281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101834201|NCT00606281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101834202|NCT00606281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101834203|NCT00606281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834204|NCT00606281|Dopamine Agonists|dopamine agonists|mesh-ancestor
101834205|NCT00606281|Dopamine Agents|dopamine agents|mesh-ancestor
101834206|NCT00606281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101834207|NCT00606281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834208|NCT00606281|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101224232|NCT01523002|Antimalarials|antimalarials|mesh-ancestor
101834209|NCT00606281|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101834210|NCT00606281|Serotonin Agents|serotonin agents|mesh-ancestor
101834211|NCT00606281|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101834212|NCT00606281|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101834213|NCT00606281|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101834214|NCT00606281|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101834215|NCT00506142|Vincristine|vincristine|mesh-list
101834216|NCT00506142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101834217|NCT00506142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101828016|NCT06013150|Epinephrine|epinephrine|mesh-list
101834218|NCT00506142|Tubulin Modulators|tubulin modulators|mesh-ancestor
101834219|NCT00506142|Antimitotic Agents|antimitotic agents|mesh-ancestor
101834220|NCT00506142|Mitosis Modulators|mitosis modulators|mesh-ancestor
101834221|NCT00506142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834223|NCT00891605|Navitoclax|navitoclax|mesh-list
101834224|NCT00891605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101834225|NCT00891605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101834226|NCT00891605|Tubulin Modulators|tubulin modulators|mesh-ancestor
101834227|NCT00891605|Antimitotic Agents|antimitotic agents|mesh-ancestor
101834228|NCT00891605|Mitosis Modulators|mitosis modulators|mesh-ancestor
101834229|NCT00891605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834230|NCT00893711|Vitamin D|vitamin d|mesh-list
101834231|NCT00893711|Vitamins|vitamins|mesh-ancestor
101834232|NCT00893711|Micronutrients|micronutrients|mesh-ancestor
101834233|NCT00893711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834234|NCT00893711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101834235|NCT00514020|Leucovorin|leucovorin|mesh-list
101834236|NCT00514020|Fluorouracil|fluorouracil|mesh-list
101834237|NCT00514020|Oxaliplatin|oxaliplatin|mesh-list
101834238|NCT00514020|Calcium|calcium|mesh-list
101834239|NCT00514020|Levoleucovorin|levoleucovorin|mesh-list
101834240|NCT00514020|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101834241|NCT00514020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834242|NCT00514020|Antimetabolites|antimetabolites|mesh-ancestor
101834243|NCT00514020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101952905|NCT05577117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101834245|NCT00514020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101834246|NCT00514020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101834247|NCT00514020|Immunologic Factors|immunologic factors|mesh-ancestor
101834248|NCT00514020|Antidotes|antidotes|mesh-ancestor
101834249|NCT00514020|Protective Agents|protective agents|mesh-ancestor
101834250|NCT00514020|Vitamin B Complex|vitamin b complex|mesh-ancestor
101834251|NCT00514020|Vitamins|vitamins|mesh-ancestor
101834252|NCT00514020|Micronutrients|micronutrients|mesh-ancestor
101834253|NCT03570827|Ascorbic Acid|ascorbic acid|mesh-list
101834254|NCT03570827|Methyltestosterone|methyltestosterone|mesh-list
101834255|NCT03570827|Androgens|androgens|mesh-list
101834256|NCT03570827|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101834257|NCT03570827|Hormones|hormones|mesh-ancestor
101834258|NCT03570827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101834259|NCT03570827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834260|NCT03570827|Antioxidants|antioxidants|mesh-ancestor
101834261|NCT03570827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834262|NCT03570827|Protective Agents|protective agents|mesh-ancestor
101834263|NCT03570827|Vitamins|vitamins|mesh-ancestor
101834264|NCT03570827|Micronutrients|micronutrients|mesh-ancestor
101834265|NCT03570827|Estrogens|estrogens|mesh-ancestor
101834266|NCT03570827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101834267|NCT03570827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101834268|NCT03570827|Anabolic Agents|anabolic agents|mesh-ancestor
101834269|NCT03560531|Palbociclib|palbociclib|mesh-list
101834270|NCT03560531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101834271|NCT03560531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101834272|NCT03560531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101834273|NCT03560531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834274|NCT00896285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101834275|NCT00896285|Analgesics|analgesics|mesh-list
101834276|NCT00896285|Opiate Alkaloids|opiate alkaloids|mesh-list
101834277|NCT00896285|Sensory System Agents|sensory system agents|mesh-ancestor
101834278|NCT00896285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101834279|NCT00896285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834280|NCT00896285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101834281|NCT00896285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101834282|NCT00896285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101834283|NCT00896285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101834284|NCT00896285|Narcotics|narcotics|mesh-ancestor
101834285|NCT00896285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101834286|NCT00891761|Dexamethasone|dexamethasone|mesh-list
101834287|NCT00891761|Dexamethasone acetate|dexamethasone acetate|mesh-list
101834288|NCT00891761|Ondansetron|ondansetron|mesh-list
101834289|NCT00891761|Casopitant|casopitant|mesh-list
101834290|NCT00891761|BB 1101|bb 1101|mesh-list
101834291|NCT00891761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101834292|NCT00891761|Antiemetics|antiemetics|mesh-ancestor
101834293|NCT00891761|Autonomic Agents|autonomic agents|mesh-ancestor
101834294|NCT00891761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101834295|NCT00891761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834296|NCT00891761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101834297|NCT00891761|Glucocorticoids|glucocorticoids|mesh-ancestor
101834298|NCT00891761|Hormones|hormones|mesh-ancestor
101834299|NCT00891761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101834300|NCT00891761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101834301|NCT00891761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101834302|NCT00891761|Protease Inhibitors|protease inhibitors|mesh-ancestor
101834303|NCT00891761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101834304|NCT00891761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834305|NCT00891761|Antipruritics|antipruritics|mesh-ancestor
101834306|NCT00891761|Dermatologic Agents|dermatologic agents|mesh-ancestor
101834307|NCT00891761|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101834308|NCT00891761|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101834309|NCT00891761|Serotonin Agents|serotonin agents|mesh-ancestor
101834310|NCT00891761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101834311|NCT00891761|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101834312|NCT01012830|Huperzine A|huperzine a|mesh-list
101834313|NCT01012830|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101834314|NCT01012830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101834315|NCT01012830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834316|NCT01012830|Cholinergic Agents|cholinergic agents|mesh-ancestor
101834317|NCT01012830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101834318|NCT01012830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834319|NCT01012830|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101834320|NCT01012830|Protective Agents|protective agents|mesh-ancestor
101834321|NCT00513474|Cyclosporine|cyclosporine|mesh-list
101834322|NCT00513474|Sirolimus|sirolimus|mesh-list
101834323|NCT00513474|Cyclophosphamide|cyclophosphamide|mesh-list
101834324|NCT00513474|Busulfan|busulfan|mesh-list
101834325|NCT00513474|Methotrexate|methotrexate|mesh-list
101834326|NCT00513474|Fludarabine|fludarabine|mesh-list
101834327|NCT00513474|Etoposide|etoposide|mesh-list
101834328|NCT00513474|Allopurinol|allopurinol|mesh-list
101834329|NCT00513474|Rasburicase|rasburicase|mesh-list
101834330|NCT00513474|Tacrolimus|tacrolimus|mesh-list
101834331|NCT00513474|Cyclosporins|cyclosporins|mesh-list
101834332|NCT00513474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101834333|NCT00513474|Immunologic Factors|immunologic factors|mesh-ancestor
101834334|NCT00513474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834335|NCT00513474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101834336|NCT00513474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101834337|NCT00513474|Alkylating Agents|alkylating agents|mesh-ancestor
101834338|NCT00513474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834339|NCT00513474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101834340|NCT00513474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101834341|NCT00513474|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101834342|NCT00513474|Abortifacient Agents|abortifacient agents|mesh-ancestor
101834343|NCT00513474|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101834344|NCT00513474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101834345|NCT00513474|Antimetabolites|antimetabolites|mesh-ancestor
101834346|NCT00513474|Dermatologic Agents|dermatologic agents|mesh-ancestor
101834347|NCT00513474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101834348|NCT00513474|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101834349|NCT00513474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101834350|NCT00513474|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101834351|NCT00513474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101834352|NCT00513474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101834353|NCT00513474|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101834354|NCT00513474|Antifungal Agents|antifungal agents|mesh-ancestor
101834355|NCT00513474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101834356|NCT00513474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101834357|NCT00513474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101834358|NCT00513474|Gout Suppressants|gout suppressants|mesh-ancestor
101834359|NCT00513474|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101834360|NCT00513474|Antioxidants|antioxidants|mesh-ancestor
101834361|NCT00513474|Protective Agents|protective agents|mesh-ancestor
101834362|NCT01010958|Valproic Acid|valproic acid|mesh-list
101834363|NCT01010958|Anticonvulsants|anticonvulsants|mesh-ancestor
101834364|NCT01010958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101834365|NCT01010958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834366|NCT01010958|GABA Agents|gaba agents|mesh-ancestor
101834367|NCT01010958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101834368|NCT01010958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834369|NCT01010958|Antimanic Agents|antimanic agents|mesh-ancestor
101834370|NCT01010958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101834371|NCT01010958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101834372|NCT01010958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101834374|NCT00896519|Cyclophosphamide|cyclophosphamide|mesh-list
101834375|NCT00896519|Rituximab|rituximab|mesh-list
101834376|NCT00896519|Doxorubicin|doxorubicin|mesh-list
101834377|NCT00896519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101834378|NCT00896519|Vincristine|vincristine|mesh-list
101834379|NCT00896519|Sargramostim|sargramostim|mesh-list
101834380|NCT00896519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101834381|NCT00896519|Immunologic Factors|immunologic factors|mesh-ancestor
101834382|NCT00896519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834383|NCT00896519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101834384|NCT00896519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101834385|NCT00896519|Alkylating Agents|alkylating agents|mesh-ancestor
101834386|NCT00896519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834387|NCT00896519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101834388|NCT00896519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101834389|NCT00896519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101834390|NCT00896519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101952911|NCT05577117|Anesthetics, General|anesthetics, general|mesh-ancestor
101834391|NCT00896519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101834392|NCT00896519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101834393|NCT00896519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101834394|NCT00896519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101834396|NCT00896519|Hormones|hormones|mesh-ancestor
101834397|NCT00896519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101834398|NCT00896519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101834399|NCT00896519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101834400|NCT00896519|Tubulin Modulators|tubulin modulators|mesh-ancestor
101834401|NCT00896519|Antimitotic Agents|antimitotic agents|mesh-ancestor
101834402|NCT00896519|Mitosis Modulators|mitosis modulators|mesh-ancestor
101834403|NCT00505752|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101834404|NCT00505752|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101834405|NCT00505752|Hormones|hormones|mesh-ancestor
101554176|NCT01235949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101834406|NCT00505752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101834407|NCT00505752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834408|NCT00505752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101834409|NCT01011036|Clonazepam|clonazepam|mesh-list
101834410|NCT01011036|Clobazam|clobazam|mesh-list
101834411|NCT01011036|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101834412|NCT01011036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101834413|NCT01011036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101834414|NCT01011036|Cholinergic Agents|cholinergic agents|mesh-ancestor
101834415|NCT01011036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101834416|NCT01011036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834417|NCT01011036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834418|NCT01011036|Urological Agents|urological agents|mesh-ancestor
101834419|NCT01011036|Anticonvulsants|anticonvulsants|mesh-ancestor
101834420|NCT01011036|GABA Modulators|gaba modulators|mesh-ancestor
101834421|NCT01011036|GABA Agents|gaba agents|mesh-ancestor
101834422|NCT01011036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101834423|NCT01011036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101834424|NCT01011036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101834425|NCT01011036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101834426|NCT01011036|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101834427|NCT01011036|GABA Agonists|gaba agonists|mesh-ancestor
101834428|NCT03601637|Ivacaftor|ivacaftor|mesh-list
101834429|NCT03601637|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101834430|NCT03601637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101834431|NCT03601637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834432|NCT00894023|Abciximab|abciximab|mesh-list
101834433|NCT00894023|Anticoagulants|anticoagulants|mesh-ancestor
101834434|NCT00894023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101834435|NCT00892073|Metformin|metformin|mesh-list
101834436|NCT00892073|Diazoxide|diazoxide|mesh-list
101834437|NCT00892073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101834438|NCT00892073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834439|NCT00892073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101834440|NCT00892073|Vasodilator Agents|vasodilator agents|mesh-ancestor
101834441|NCT00896831|N-Methylaspartate|n-methylaspartate|mesh-list
101834442|NCT00896831|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
101834443|NCT00896831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101834444|NCT00896831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101834445|NCT00896831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834446|NCT00896831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834447|NCT02541227|Cerebrolysin|cerebrolysin|mesh-list
101834448|NCT02541227|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101834449|NCT02541227|Protective Agents|protective agents|mesh-ancestor
101834450|NCT02541227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834451|NCT02541227|Nootropic Agents|nootropic agents|mesh-ancestor
101834452|NCT00896987|Lamotrigine|lamotrigine|mesh-list
101834453|NCT00896987|Carbamazepine|carbamazepine|mesh-list
101834454|NCT00896987|Anticonvulsants|anticonvulsants|mesh-ancestor
101834455|NCT00896987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101834456|NCT00896987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101834457|NCT00896987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834458|NCT00896987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101834459|NCT00896987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834460|NCT00896987|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101834461|NCT00896987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101834462|NCT00896987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101834463|NCT00896987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101834464|NCT00896987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101834465|NCT00896987|Antimanic Agents|antimanic agents|mesh-ancestor
101834466|NCT00896987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101834467|NCT00896987|Analgesics|analgesics|mesh-ancestor
101834468|NCT00896987|Sensory System Agents|sensory system agents|mesh-ancestor
101834469|NCT00896987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101834470|NCT00896987|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101834471|NCT00896987|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101834472|NCT00897065|Antibodies|antibodies|mesh-list
101834473|NCT00897065|Immunologic Factors|immunologic factors|mesh-ancestor
101834474|NCT00897065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834475|NCT00343252|Teriparatide|teriparatide|mesh-list
101834476|NCT00343252|Risedronic Acid|risedronic acid|mesh-list
101834477|NCT00343252|Etidronic Acid|etidronic acid|mesh-list
101834478|NCT00343252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101834479|NCT00343252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834480|NCT00343252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101554250|NCT01233609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101834481|NCT00343252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101834482|NCT00343252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101834483|NCT00343252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834484|NCT00892229|Misoprostol|misoprostol|mesh-list
101834485|NCT00892229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101834486|NCT00892229|Abortifacient Agents|abortifacient agents|mesh-ancestor
101834487|NCT00892229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101834488|NCT00892229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834489|NCT00892229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101834490|NCT00892229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101834491|NCT00892229|Oxytocics|oxytocics|mesh-ancestor
101834492|NCT00897221|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101834493|NCT00897221|Deferiprone|deferiprone|mesh-list
101834494|NCT00897221|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101834495|NCT00897221|Chelating Agents|chelating agents|mesh-ancestor
101834496|NCT00897221|Sequestering Agents|sequestering agents|mesh-ancestor
101834497|NCT00897221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834499|NCT00892307|Analgesics|analgesics|mesh-ancestor
101834500|NCT00892307|Sensory System Agents|sensory system agents|mesh-ancestor
101834501|NCT00892307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101834502|NCT00892307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834503|NCT00892307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101834504|NCT00892307|Vasodilator Agents|vasodilator agents|mesh-ancestor
101834505|NCT00892307|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101834506|NCT00892307|Purinergic Agonists|purinergic agonists|mesh-ancestor
101834507|NCT00892307|Purinergic Agents|purinergic agents|mesh-ancestor
101834508|NCT00892307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101834509|NCT00892307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834510|NCT00342628|Vaccines|vaccines|mesh-list
101834511|NCT00342628|Immunologic Factors|immunologic factors|mesh-ancestor
101834512|NCT00342628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834513|NCT00897377|Temozolomide|temozolomide|mesh-list
101834514|NCT00897377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101834515|NCT00897377|Alkylating Agents|alkylating agents|mesh-ancestor
101834516|NCT00897377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834517|NCT00897377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101834518|NCT00894569|Paclitaxel|paclitaxel|mesh-list
101834519|NCT00894569|Carboplatin|carboplatin|mesh-list
101834520|NCT00894569|Cetuximab|cetuximab|mesh-list
101834521|NCT00894569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101834522|NCT00894569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101834523|NCT00894569|Tubulin Modulators|tubulin modulators|mesh-ancestor
101834524|NCT00894569|Antimitotic Agents|antimitotic agents|mesh-ancestor
101834525|NCT00894569|Mitosis Modulators|mitosis modulators|mesh-ancestor
101834526|NCT00894569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834527|NCT00894569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101834528|NCT00337168|Cytarabine|cytarabine|mesh-list
101834529|NCT00337168|Clofarabine|clofarabine|mesh-list
101834530|NCT00337168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101834531|NCT00337168|Antimetabolites|antimetabolites|mesh-ancestor
101834532|NCT00337168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834534|NCT00337168|Antiviral Agents|antiviral agents|mesh-ancestor
101834535|NCT00337168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101834536|NCT00337168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101834537|NCT00337168|Immunologic Factors|immunologic factors|mesh-ancestor
101834538|NCT00337168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834539|NCT00892385|Temozolomide|temozolomide|mesh-list
101834540|NCT00892385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101834541|NCT00892385|Alkylating Agents|alkylating agents|mesh-ancestor
101834542|NCT00892385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834543|NCT00892385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101834544|NCT00892463|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101834545|NCT00892463|Antidepressive Agents|antidepressive agents|mesh-ancestor
101834546|NCT00892463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101834547|NCT00892463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101834548|NCT00892463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101834549|NCT00892463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101834550|NCT00892463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834551|NCT01011114|Cinacalcet|cinacalcet|mesh-list
101834552|NCT01011114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101834553|NCT01011114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834554|NCT01011114|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101834555|NCT01011114|Hormone Antagonists|hormone antagonists|mesh-ancestor
101834556|NCT01011114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101834557|NCT00606905|Immunoglobulins|immunoglobulins|mesh-list
101834558|NCT00606905|gamma-Globulins|gamma-globulins|mesh-list
101834559|NCT00606905|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101834560|NCT00606905|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101834561|NCT00606905|Immunologic Factors|immunologic factors|mesh-ancestor
101834562|NCT00606905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834563|NCT01055392|Lithium Carbonate|lithium carbonate|mesh-list
101834564|NCT01055392|Antidepressive Agents|antidepressive agents|mesh-ancestor
101834565|NCT01055392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101834566|NCT01055392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101834567|NCT01055392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834568|NCT01055392|Antimanic Agents|antimanic agents|mesh-ancestor
101834569|NCT01055392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101834570|NCT01055392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101834571|NCT01055392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834572|NCT03063762|Bevacizumab|bevacizumab|mesh-list
101834573|NCT03063762|Atezolizumab|atezolizumab|mesh-list
101834574|NCT03063762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101834575|NCT03063762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101834576|NCT03063762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101834577|NCT03063762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101834578|NCT03063762|Growth Substances|growth substances|mesh-ancestor
101834579|NCT03063762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834580|NCT03063762|Growth Inhibitors|growth inhibitors|mesh-ancestor
101834581|NCT03063762|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101834582|NCT03063762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834583|NCT05278637|Aspirin|aspirin|mesh-list
101834584|NCT05278637|Ticagrelor|ticagrelor|mesh-list
101834585|NCT05278637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101834586|NCT05278637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101834587|NCT05278637|Analgesics|analgesics|mesh-ancestor
101834588|NCT05278637|Sensory System Agents|sensory system agents|mesh-ancestor
101834589|NCT05278637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101834590|NCT05278637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834591|NCT05278637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101834592|NCT05278637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101834593|NCT05278637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101834594|NCT05278637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102096772|NCT03055312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101834595|NCT05278637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834596|NCT05278637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101834597|NCT05278637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101834598|NCT05278637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101834599|NCT05278637|Antipyretics|antipyretics|mesh-ancestor
101834600|NCT05278637|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101834601|NCT05278637|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101834602|NCT05278637|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101834603|NCT05278637|Purinergic Agents|purinergic agents|mesh-ancestor
101834604|NCT05278637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101834606|NCT04017377|Cisplatin|cisplatin|mesh-list
101834607|NCT04017377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101834608|NCT04017377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101834609|NCT04017377|Tubulin Modulators|tubulin modulators|mesh-ancestor
101834610|NCT04017377|Antimitotic Agents|antimitotic agents|mesh-ancestor
101834611|NCT04017377|Mitosis Modulators|mitosis modulators|mesh-ancestor
101834612|NCT04017377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834613|NCT04035785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101834614|NCT04035707|Rocuronium|rocuronium|mesh-list
101834615|NCT04035707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834616|NCT04035707|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101834617|NCT04035707|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101834618|NCT04035707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101834619|NCT04035707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101834620|NCT02539745|Vitamin D|vitamin d|mesh-list
101834621|NCT02539745|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
101834622|NCT02539745|Vitamins|vitamins|mesh-ancestor
101834623|NCT02539745|Micronutrients|micronutrients|mesh-ancestor
101834624|NCT02539745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834625|NCT02539745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101834626|NCT00894959|Heparin|heparin|mesh-list
101834627|NCT00894959|Calcium heparin|calcium heparin|mesh-list
101834628|NCT00894959|Anticoagulants|anticoagulants|mesh-ancestor
101834629|NCT00894959|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101554413|NCT01256658|Artemether|artemether|mesh-list
101834630|NCT00894959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101834631|NCT00894959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834632|NCT00895115|Vitamin E|vitamin e|mesh-list
101834633|NCT00895115|Vitamins|vitamins|mesh-ancestor
101834634|NCT00895115|Micronutrients|micronutrients|mesh-ancestor
101834635|NCT00895115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834636|NCT00895115|Antioxidants|antioxidants|mesh-ancestor
101834637|NCT00895115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834638|NCT00895115|Protective Agents|protective agents|mesh-ancestor
101834639|NCT00901745|Norepinephrine|norepinephrine|mesh-list
101834640|NCT00901745|Angiotensin II|angiotensin ii|mesh-list
101834641|NCT00901745|Giapreza|giapreza|mesh-list
101834642|NCT00901745|Angiotensinogen|angiotensinogen|mesh-list
101834643|NCT00901745|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101834644|NCT00901745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101834645|NCT00901745|Adrenergic Agents|adrenergic agents|mesh-ancestor
101834646|NCT00901745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101834647|NCT00901745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834648|NCT00901745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834649|NCT00901745|Sympathomimetics|sympathomimetics|mesh-ancestor
101834650|NCT00901745|Autonomic Agents|autonomic agents|mesh-ancestor
101834651|NCT00901745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101834652|NCT00901745|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101834653|NCT00901745|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101834654|NCT00901745|Protease Inhibitors|protease inhibitors|mesh-ancestor
101834655|NCT00901745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101834656|NCT02540837|Bupivacaine|bupivacaine|mesh-list
101834657|NCT02540837|Anesthetics, Local|anesthetics, local|mesh-ancestor
101834658|NCT02540837|Anesthetics|anesthetics|mesh-ancestor
101834659|NCT02540837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101834660|NCT02540837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834661|NCT02540837|Sensory System Agents|sensory system agents|mesh-ancestor
101347021|NCT03559985|Antipyretics|antipyretics|mesh-ancestor
101834662|NCT02540837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101834663|NCT00901823|Diazoxide|diazoxide|mesh-list
101834664|NCT00901823|Choline|choline|mesh-list
101834665|NCT00901823|Lipotropic Agents|lipotropic agents|mesh-ancestor
101834666|NCT00901823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101834667|NCT00901823|Antimetabolites|antimetabolites|mesh-ancestor
101834668|NCT00901823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834669|NCT00901823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101834670|NCT00901823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101834671|NCT00901823|Nootropic Agents|nootropic agents|mesh-ancestor
101834672|NCT00901823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101834673|NCT00901823|Vasodilator Agents|vasodilator agents|mesh-ancestor
101834674|NCT00902057|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101834675|NCT00902057|Hemostatics|hemostatics|mesh-ancestor
101834676|NCT00902057|Coagulants|coagulants|mesh-ancestor
101834677|NCT00902057|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101834678|NCT00902057|Natriuretic Agents|natriuretic agents|mesh-ancestor
101834679|NCT00902057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834680|NCT00902135|Interferons|interferons|mesh-list
101834681|NCT00902135|Interferon-beta|interferon-beta|mesh-list
101834682|NCT00902135|Interferon beta-1b|interferon beta-1b|mesh-list
101834683|NCT00902135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101834684|NCT00902135|Antiviral Agents|antiviral agents|mesh-ancestor
101834685|NCT00902135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101834686|NCT00902135|Immunologic Factors|immunologic factors|mesh-ancestor
101834687|NCT00902135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834688|NCT00902135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101834689|NCT02540369|Aflibercept|aflibercept|mesh-list
101834690|NCT02540369|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101834691|NCT02540369|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101834692|NCT02540369|Growth Substances|growth substances|mesh-ancestor
101834693|NCT02540369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834694|NCT02540369|Growth Inhibitors|growth inhibitors|mesh-ancestor
101834695|NCT02540369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101834696|NCT00605267|Tamoxifen|tamoxifen|mesh-list
101834697|NCT00605267|Goserelin|goserelin|mesh-list
101834698|NCT00605267|Anastrozole|anastrozole|mesh-list
101834699|NCT00605267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101834700|NCT00605267|Hormone Antagonists|hormone antagonists|mesh-ancestor
101834701|NCT00605267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101834702|NCT00605267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834703|NCT00605267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101834704|NCT00605267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101834705|NCT00605267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101834706|NCT00605267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101834707|NCT00605267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101834708|NCT00605267|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101834709|NCT00605267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101834710|NCT00605267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101834711|NCT00605267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834712|NCT00902525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101834713|NCT00902525|Immunologic Factors|immunologic factors|mesh-ancestor
101834714|NCT00902525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834715|NCT00902603|Iloprost|iloprost|mesh-list
101834716|NCT00902603|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101834717|NCT00902603|Vasodilator Agents|vasodilator agents|mesh-ancestor
101834718|NCT00902681|Fesoterodine|fesoterodine|mesh-list
101834719|NCT00902681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101834720|NCT00902681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101834721|NCT00902681|Cholinergic Agents|cholinergic agents|mesh-ancestor
101834722|NCT00902681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101834723|NCT00902681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834724|NCT00902681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834725|NCT00902681|Urological Agents|urological agents|mesh-ancestor
101834726|NCT00906113|Melphalan|melphalan|mesh-list
101834727|NCT00906113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101834728|NCT00906113|Alkylating Agents|alkylating agents|mesh-ancestor
101834729|NCT00906113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834730|NCT00906113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101834731|NCT00906113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101834732|NCT00906113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101834733|NCT00906113|Immunologic Factors|immunologic factors|mesh-ancestor
101834734|NCT00906113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834735|NCT00902837|Oxycodone|oxycodone|mesh-list
101834736|NCT00902837|Naloxone|naloxone|mesh-list
101834737|NCT00902837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101834738|NCT00902837|Narcotics|narcotics|mesh-ancestor
101834739|NCT00902837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101834740|NCT00902837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834741|NCT00902837|Analgesics|analgesics|mesh-ancestor
101834742|NCT00902837|Sensory System Agents|sensory system agents|mesh-ancestor
101834743|NCT00902837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101834744|NCT00902837|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101834745|NCT00605813|Sertraline|sertraline|mesh-list
101834746|NCT00605813|Antidepressive Agents|antidepressive agents|mesh-ancestor
101952931|NCT03813303|GABA Modulators|gaba modulators|mesh-ancestor
101834748|NCT00605813|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101834749|NCT00605813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101834750|NCT00605813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101834751|NCT00605813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834752|NCT00605813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101834753|NCT00605813|Serotonin Agents|serotonin agents|mesh-ancestor
101834754|NCT00605813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834755|NCT00906269|Sildenafil Citrate|sildenafil citrate|mesh-list
101834756|NCT00906269|Vasodilator Agents|vasodilator agents|mesh-ancestor
101834757|NCT00906269|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101834758|NCT00906269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101834759|NCT00906269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101834760|NCT00906269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834761|NCT00906269|Urological Agents|urological agents|mesh-ancestor
101834763|NCT00902915|Lenalidomide|lenalidomide|mesh-list
101834764|NCT00902915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101834765|NCT00902915|Antiemetics|antiemetics|mesh-ancestor
101834766|NCT00902915|Autonomic Agents|autonomic agents|mesh-ancestor
101834767|NCT00902915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101834768|NCT00902915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834769|NCT00902915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101834770|NCT00902915|Glucocorticoids|glucocorticoids|mesh-ancestor
101834771|NCT00902915|Hormones|hormones|mesh-ancestor
101834772|NCT00902915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101834773|NCT00902915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101834774|NCT00902915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101834775|NCT00902915|Immunologic Factors|immunologic factors|mesh-ancestor
101834776|NCT00902915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101834777|NCT00902915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101834778|NCT00902915|Growth Substances|growth substances|mesh-ancestor
101834779|NCT00902915|Growth Inhibitors|growth inhibitors|mesh-ancestor
101834780|NCT04034771|Propofol|propofol|mesh-list
101554547|NCT01007149|Omalizumab|omalizumab|mesh-list
101834782|NCT04034771|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101834783|NCT04034771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101834784|NCT04034771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834785|NCT04034771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101834786|NCT04034771|Anesthetics, General|anesthetics, general|mesh-ancestor
101834787|NCT04034771|Anesthetics|anesthetics|mesh-ancestor
101834788|NCT04034771|Antioxidants|antioxidants|mesh-ancestor
101834789|NCT04034771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834790|NCT04034771|Protective Agents|protective agents|mesh-ancestor
101834791|NCT00899483|Insulin|insulin|mesh-list
101834792|NCT00899483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101834793|NCT00899483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834794|NCT02539199|Misoprostol|misoprostol|mesh-list
101834795|NCT02539199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101834796|NCT02539199|Abortifacient Agents|abortifacient agents|mesh-ancestor
101834797|NCT02539199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101834798|NCT02539199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834799|NCT02539199|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101834800|NCT02539199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101834801|NCT02539199|Oxytocics|oxytocics|mesh-ancestor
101834802|NCT00903227|Fluticasone|fluticasone|mesh-list
101834803|NCT00903227|Xhance|xhance|mesh-list
101834804|NCT00903227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101834805|NCT00903227|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101834806|NCT00903227|Autonomic Agents|autonomic agents|mesh-ancestor
101834807|NCT00903227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101834808|NCT00903227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834809|NCT00903227|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101834810|NCT00903227|Respiratory System Agents|respiratory system agents|mesh-ancestor
101834811|NCT00903227|Dermatologic Agents|dermatologic agents|mesh-ancestor
101834812|NCT00903227|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101834813|NCT00605657|Valproic Acid|valproic acid|mesh-list
101834814|NCT00605657|Anticonvulsants|anticonvulsants|mesh-ancestor
101834815|NCT00605657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101834816|NCT00605657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834817|NCT00605657|GABA Agents|gaba agents|mesh-ancestor
101834818|NCT00605657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101834819|NCT00605657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834820|NCT00605657|Antimanic Agents|antimanic agents|mesh-ancestor
101834822|NCT00605657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101834823|NCT00605657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101834824|NCT00899951|Fentanyl|fentanyl|mesh-list
101834825|NCT00899951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101834826|NCT00899951|Narcotics|narcotics|mesh-ancestor
101834827|NCT00899951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101834828|NCT00899951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834829|NCT00899951|Analgesics|analgesics|mesh-ancestor
101834830|NCT00899951|Sensory System Agents|sensory system agents|mesh-ancestor
101834831|NCT00899951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101834832|NCT00899951|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101834833|NCT00899951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101834834|NCT00899951|Anesthetics, General|anesthetics, general|mesh-ancestor
101834835|NCT00899951|Anesthetics|anesthetics|mesh-ancestor
101834836|NCT02539979|Acetaminophen|acetaminophen|mesh-list
101834837|NCT02539979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101834838|NCT02539979|Analgesics|analgesics|mesh-ancestor
101834839|NCT02539979|Sensory System Agents|sensory system agents|mesh-ancestor
101834840|NCT02539979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101834841|NCT02539979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834842|NCT02539979|Antipyretics|antipyretics|mesh-ancestor
101834843|NCT05277701|Lazertinib|lazertinib|mesh-list
101834844|NCT05277701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101834845|NCT05277701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101834846|NCT05277701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834847|NCT00605345|Darbepoetin alfa|darbepoetin alfa|mesh-list
101834848|NCT00605345|Hematinics|hematinics|mesh-ancestor
101834849|NCT00903851|Lidocaine|lidocaine|mesh-list
101834850|NCT00903851|Anesthetics, Local|anesthetics, local|mesh-ancestor
101834851|NCT00903851|Anesthetics|anesthetics|mesh-ancestor
101834852|NCT00903851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101834853|NCT00903851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834854|NCT00903851|Sensory System Agents|sensory system agents|mesh-ancestor
101834855|NCT00903851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101834856|NCT00903851|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101834857|NCT00903851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101834858|NCT00903851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101834859|NCT00903851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101834860|NCT00903851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834861|NCT00900887|Ketorolac|ketorolac|mesh-list
101834862|NCT00900887|Nepafenac|nepafenac|mesh-list
101834863|NCT00900887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101834864|NCT00900887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101834865|NCT00900887|Analgesics|analgesics|mesh-ancestor
101834866|NCT00900887|Sensory System Agents|sensory system agents|mesh-ancestor
101834867|NCT00900887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101834868|NCT00900887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834869|NCT00900887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101952952|NCT03813069|Permethrin|permethrin|mesh-list
101834871|NCT00900887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101834872|NCT00900887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101834873|NCT00900887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834874|NCT00904085|Oxymorphone|oxymorphone|mesh-list
101834875|NCT00904085|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101834876|NCT00904085|Narcotics|narcotics|mesh-ancestor
101834877|NCT00904085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101834878|NCT00904085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834879|NCT00904085|Analgesics|analgesics|mesh-ancestor
101834880|NCT00904085|Sensory System Agents|sensory system agents|mesh-ancestor
101834881|NCT00904085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101834882|NCT00904085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101834883|NCT00908453|Fosphenytoin|fosphenytoin|mesh-list
101834884|NCT00908453|Anticonvulsants|anticonvulsants|mesh-ancestor
101834885|NCT00908453|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101834886|NCT00908453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101834887|NCT00908453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834888|NCT00908531|Letrozole|letrozole|mesh-list
101834889|NCT00908531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101834890|NCT00908531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101834891|NCT00908531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101834892|NCT00908531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101834893|NCT00908531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834894|NCT00908531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101834895|NCT00908531|Hormone Antagonists|hormone antagonists|mesh-ancestor
101834896|NCT00908531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102096773|NCT03055312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834897|NCT00908531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834898|NCT00904397|Celecoxib|celecoxib|mesh-list
101834899|NCT00904397|Lidocaine|lidocaine|mesh-list
101834900|NCT00904397|Anesthetics, Local|anesthetics, local|mesh-ancestor
101834901|NCT00904397|Anesthetics|anesthetics|mesh-ancestor
101834902|NCT00904397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101834903|NCT00904397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834904|NCT00904397|Sensory System Agents|sensory system agents|mesh-ancestor
101834905|NCT00904397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101834906|NCT00904397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101834907|NCT00904397|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101834908|NCT00904397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101834909|NCT00904397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101834910|NCT00904397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834911|NCT00904397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101834912|NCT00904397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101834913|NCT00904397|Analgesics|analgesics|mesh-ancestor
101834914|NCT00904397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101834915|NCT00904397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101834916|NCT00904397|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101834917|NCT00904397|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101834918|NCT00904397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101834919|NCT00904475|Lidocaine|lidocaine|mesh-list
101834920|NCT00904475|Anesthetics, Local|anesthetics, local|mesh-ancestor
101834921|NCT00904475|Anesthetics|anesthetics|mesh-ancestor
101834922|NCT00904475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101834923|NCT00904475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834924|NCT00904475|Sensory System Agents|sensory system agents|mesh-ancestor
101834925|NCT00904475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101834926|NCT00904475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101834927|NCT00904475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101834928|NCT00904475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101952962|NCT03276026|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101834929|NCT00904475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101834930|NCT00904475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834931|NCT00908921|Glimepiride|glimepiride|mesh-list
101834932|NCT00908921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101834933|NCT00908921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101834934|NCT00908921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834935|NCT00908921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101834936|NCT00908921|Immunologic Factors|immunologic factors|mesh-ancestor
101834937|NCT00904631|Salicylic Acid|salicylic acid|mesh-list
101834938|NCT00904631|Salicylates|salicylates|mesh-list
101834939|NCT00904631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101834940|NCT00904631|Antifungal Agents|antifungal agents|mesh-ancestor
101834941|NCT00904631|Keratolytic Agents|keratolytic agents|mesh-ancestor
101834942|NCT00904631|Dermatologic Agents|dermatologic agents|mesh-ancestor
101834943|NCT00904631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101834944|NCT00904631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101834945|NCT00904631|Analgesics|analgesics|mesh-ancestor
101834946|NCT00904631|Sensory System Agents|sensory system agents|mesh-ancestor
101834947|NCT00904631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101834948|NCT00904631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834949|NCT00904631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101834950|NCT00904631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101834951|NCT00904631|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101834952|NCT00904631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101834953|NCT00904631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834954|NCT00909077|Dexamethasone|dexamethasone|mesh-list
101834955|NCT00909077|Dexamethasone acetate|dexamethasone acetate|mesh-list
101834956|NCT00909077|Rituximab|rituximab|mesh-list
101834957|NCT00909077|BB 1101|bb 1101|mesh-list
101834958|NCT00909077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101834959|NCT00909077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101834960|NCT00909077|Immunologic Factors|immunologic factors|mesh-ancestor
101834961|NCT00909077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834962|NCT00909077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101834963|NCT00909077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101834964|NCT00909077|Antiemetics|antiemetics|mesh-ancestor
101834965|NCT00909077|Autonomic Agents|autonomic agents|mesh-ancestor
101834966|NCT00909077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101834967|NCT00909077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101834968|NCT00909077|Glucocorticoids|glucocorticoids|mesh-ancestor
101834969|NCT00909077|Hormones|hormones|mesh-ancestor
101834970|NCT00909077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101834971|NCT00909077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101834972|NCT00909077|Protease Inhibitors|protease inhibitors|mesh-ancestor
101834973|NCT00909077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101834974|NCT00909077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834975|NCT00904709|Tranexamic Acid|tranexamic acid|mesh-list
101834976|NCT00904709|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101834977|NCT00904709|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101834978|NCT00904709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834979|NCT00904709|Hemostatics|hemostatics|mesh-ancestor
101834980|NCT00904709|Coagulants|coagulants|mesh-ancestor
101834981|NCT00340834|Interferons|interferons|mesh-list
101834982|NCT00340834|Interferon-beta|interferon-beta|mesh-list
101834983|NCT00340834|Interferon beta-1a|interferon beta-1a|mesh-list
101834984|NCT00340834|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101834985|NCT00340834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101834986|NCT00340834|Antiviral Agents|antiviral agents|mesh-ancestor
101834987|NCT00340834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101834988|NCT00340834|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101834989|NCT00340834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101834990|NCT00340834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101834991|NCT00340834|Immunologic Factors|immunologic factors|mesh-ancestor
101834992|NCT00340834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834993|NCT00340834|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101834994|NCT01057966|Vitamins|vitamins|mesh-list
101834995|NCT01057966|Micronutrients|micronutrients|mesh-ancestor
101834996|NCT01057966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101834998|NCT00603941|Efatutazone|efatutazone|mesh-list
101834999|NCT00603941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101835000|NCT00603941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101835001|NCT00603941|Tubulin Modulators|tubulin modulators|mesh-ancestor
101835002|NCT00603941|Antimitotic Agents|antimitotic agents|mesh-ancestor
101835003|NCT00603941|Mitosis Modulators|mitosis modulators|mesh-ancestor
101554772|NCT01019980|Antipyretics|antipyretics|mesh-ancestor
101835004|NCT00603941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835005|NCT00340678|Losartan|losartan|mesh-list
101835006|NCT00340678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101835007|NCT00340678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101835008|NCT00340678|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101835009|NCT00340678|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101835010|NCT00340678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835011|NCT01055470|Diclofenac|diclofenac|mesh-list
101835012|NCT01055470|Lornoxicam|lornoxicam|mesh-list
101835013|NCT01055470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101835014|NCT01055470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101835015|NCT01055470|Analgesics|analgesics|mesh-ancestor
101835016|NCT01055470|Sensory System Agents|sensory system agents|mesh-ancestor
101835017|NCT01055470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101835018|NCT01055470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835019|NCT01055470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101835020|NCT01055470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101835021|NCT01055470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101835022|NCT01055470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101835023|NCT01055470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835024|NCT03986008|Liraglutide|liraglutide|mesh-list
101835025|NCT03986008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101835026|NCT03986008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835027|NCT03986008|Incretins|incretins|mesh-ancestor
101835028|NCT03986008|Hormones|hormones|mesh-ancestor
101835029|NCT03986008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101835030|NCT00909233|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101835031|NCT00909233|Vasodilator Agents|vasodilator agents|mesh-ancestor
101835032|NCT00909233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101835033|NCT00909233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101835034|NCT00909233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101835035|NCT00909233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835036|NCT00909233|Urological Agents|urological agents|mesh-ancestor
101835037|NCT00909311|Ritonavir|ritonavir|mesh-list
101835038|NCT00909311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101835039|NCT00909311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101835040|NCT00909311|Protease Inhibitors|protease inhibitors|mesh-ancestor
101835041|NCT00909311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102096774|NCT03055312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101835042|NCT00909311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835043|NCT00909311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101835044|NCT00909311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101835045|NCT00909311|Antiviral Agents|antiviral agents|mesh-ancestor
101835046|NCT00909311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101835047|NCT00909311|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101835048|NCT00909311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101835049|NCT00907751|Rituximab|rituximab|mesh-list
101835050|NCT00907751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101835051|NCT00907751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101835052|NCT00907751|Immunologic Factors|immunologic factors|mesh-ancestor
101835053|NCT00907751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835054|NCT00907751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101835055|NCT00905333|Felodipine|felodipine|mesh-list
101835056|NCT00905333|Candesartan|candesartan|mesh-list
101835057|NCT00905333|Candesartan cilexetil|candesartan cilexetil|mesh-list
101835058|NCT00905333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101835059|NCT00905333|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101835060|NCT00905333|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101835061|NCT00905333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835062|NCT00905333|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101835063|NCT00905333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101835064|NCT00905333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101835065|NCT00905333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101835066|NCT00905333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835067|NCT00905333|Vasodilator Agents|vasodilator agents|mesh-ancestor
101835069|NCT00907829|Anesthetics, Local|anesthetics, local|mesh-ancestor
101835070|NCT00907829|Anesthetics|anesthetics|mesh-ancestor
101835071|NCT00907829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101835072|NCT00907829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835073|NCT00907829|Sensory System Agents|sensory system agents|mesh-ancestor
101835074|NCT00907829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101835075|NCT00907829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101835076|NCT00907829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101835077|NCT00907829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101835078|NCT00907829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101835079|NCT00907829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835081|NCT00336544|Cethromycin|cethromycin|mesh-list
101835082|NCT00336544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101835083|NCT00336544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101835084|NCT00336544|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101835085|NCT00336544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101835086|NCT00336544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835087|NCT00336544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101835088|NCT00336544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101835089|NCT01059058|Fluorides|fluorides|mesh-list
101835090|NCT01059058|Fluorides, Topical|fluorides, topical|mesh-list
101835091|NCT01059058|Cariostatic Agents|cariostatic agents|mesh-ancestor
101835092|NCT01059058|Protective Agents|protective agents|mesh-ancestor
101835093|NCT01059058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835094|NCT00605033|Buprenorphine|buprenorphine|mesh-list
101835095|NCT00605033|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101835096|NCT00605033|Naloxone|naloxone|mesh-list
101835097|NCT00605033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101835098|NCT00605033|Narcotics|narcotics|mesh-ancestor
101835099|NCT00605033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101835100|NCT00605033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835101|NCT00605033|Analgesics|analgesics|mesh-ancestor
101835102|NCT00605033|Sensory System Agents|sensory system agents|mesh-ancestor
101835103|NCT00605033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101835104|NCT00605033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101835105|NCT03988114|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101835106|NCT03988114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101835107|NCT03988114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101835108|NCT03988114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835109|NCT03988114|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101835110|NCT03988114|Hormone Antagonists|hormone antagonists|mesh-ancestor
101835111|NCT03988114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101835112|NCT03988114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835113|NCT00905723|Estradiol|estradiol|mesh-list
101835114|NCT00905723|Estrogens|estrogens|mesh-ancestor
101835115|NCT00905723|Hormones|hormones|mesh-ancestor
102096775|NCT04977544|Sertraline|sertraline|mesh-list
101835116|NCT00905723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101835117|NCT00905723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835118|NCT00907985|Lamotrigine|lamotrigine|mesh-list
101835119|NCT00907985|Vofopitant|vofopitant|mesh-list
101835120|NCT00907985|Anticonvulsants|anticonvulsants|mesh-ancestor
101835121|NCT00907985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101835122|NCT00907985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101835123|NCT00907985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835124|NCT00907985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101835125|NCT00907985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835126|NCT00907985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101835127|NCT00907985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101835128|NCT00907985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101835129|NCT00907985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101835130|NCT00907985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101835131|NCT00907985|Antiemetics|antiemetics|mesh-ancestor
101835132|NCT00907985|Autonomic Agents|autonomic agents|mesh-ancestor
101835133|NCT00907985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101835134|NCT00907985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101835135|NCT00907985|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101835136|NCT00907985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101835137|NCT01325194|Cytarabine|cytarabine|mesh-list
101835138|NCT01325194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101835139|NCT01325194|Antimetabolites|antimetabolites|mesh-ancestor
101835140|NCT01325194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835141|NCT01325194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101835142|NCT01325194|Antiviral Agents|antiviral agents|mesh-ancestor
101835143|NCT01325194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101835144|NCT01325194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101835145|NCT01325194|Immunologic Factors|immunologic factors|mesh-ancestor
101835146|NCT01325194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835147|NCT00908219|Bevacizumab|bevacizumab|mesh-list
101835148|NCT00908219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101835149|NCT00908219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101835150|NCT00908219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101835151|NCT00908219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101835152|NCT00908219|Growth Substances|growth substances|mesh-ancestor
101835153|NCT00908219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835154|NCT00908219|Growth Inhibitors|growth inhibitors|mesh-ancestor
101835155|NCT00908297|Ubiquinone|ubiquinone|mesh-list
101835156|NCT00908297|Coenzyme Q10|coenzyme q10|mesh-list
101835157|NCT00908297|Micronutrients|micronutrients|mesh-ancestor
101835158|NCT00908297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835159|NCT00908297|Vitamins|vitamins|mesh-ancestor
101835160|NCT00927407|Malathion|malathion|mesh-list
101835161|NCT00927407|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101835162|NCT00927407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101835163|NCT00927407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835164|NCT00927407|Cholinergic Agents|cholinergic agents|mesh-ancestor
101835165|NCT00927407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101835166|NCT00927407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835167|NCT00931697|Mefloquine|mefloquine|mesh-list
101835168|NCT00931697|Antimalarials|antimalarials|mesh-ancestor
101835169|NCT00931697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101835170|NCT00931697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101835171|NCT00931697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101835172|NCT00927797|Cyclophosphamide|cyclophosphamide|mesh-list
101835173|NCT00927797|Rituximab|rituximab|mesh-list
101835174|NCT00927797|Pentostatin|pentostatin|mesh-list
101835175|NCT00927797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101835176|NCT00927797|Immunologic Factors|immunologic factors|mesh-ancestor
101835177|NCT00927797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224390|NCT01523574|Vitamin E|vitamin e|mesh-list
101835178|NCT00927797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101835179|NCT00927797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101835180|NCT00927797|Alkylating Agents|alkylating agents|mesh-ancestor
101835181|NCT00927797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835182|NCT00927797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101835183|NCT00927797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101835184|NCT00927797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101835185|NCT00927797|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
101835186|NCT00927797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101835187|NCT00338962|Naltrexone|naltrexone|mesh-list
101835188|NCT00338962|Paroxetine|paroxetine|mesh-list
101835189|NCT00338962|Desipramine|desipramine|mesh-list
101835190|NCT00338962|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101835191|NCT00338962|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101835192|NCT00338962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835193|NCT00338962|Sensory System Agents|sensory system agents|mesh-ancestor
101835194|NCT00338962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101835195|NCT00338962|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101835196|NCT00338962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101835197|NCT00338962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101835198|NCT00338962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835199|NCT00338962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101835200|NCT00338962|Serotonin Agents|serotonin agents|mesh-ancestor
101835201|NCT00338962|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101835202|NCT00338962|Antidepressive Agents|antidepressive agents|mesh-ancestor
101835203|NCT00338962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101835204|NCT00338962|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101835205|NCT00338962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101835206|NCT00338962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101835207|NCT00338962|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101952983|NCT03804177|Ascorbic Acid|ascorbic acid|mesh-list
101835208|NCT00338962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101835209|NCT00338962|Adrenergic Agents|adrenergic agents|mesh-ancestor
101835210|NCT00931775|Pindolol|pindolol|mesh-list
101835211|NCT00931775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101835212|NCT00931775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101835213|NCT00931775|Adrenergic Agents|adrenergic agents|mesh-ancestor
101835214|NCT00931775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101835215|NCT00931775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835216|NCT00931775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835217|NCT00931775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101835218|NCT00931775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101835219|NCT00931775|Serotonin Agents|serotonin agents|mesh-ancestor
101835220|NCT00931775|Vasodilator Agents|vasodilator agents|mesh-ancestor
101835221|NCT00927875|Carboplatin|carboplatin|mesh-list
101835222|NCT00927875|Etoposide|etoposide|mesh-list
101835223|NCT00927875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101835224|NCT00927875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101835225|NCT00927875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101835226|NCT00927875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101835227|NCT00927875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101835228|NCT00927875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835230|NCT00568061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101835231|NCT00568061|Autonomic Agents|autonomic agents|mesh-ancestor
101835232|NCT00568061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101835233|NCT00568061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835234|NCT00568061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101835235|NCT00568061|Respiratory System Agents|respiratory system agents|mesh-ancestor
101835236|NCT00568061|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101835237|NCT00568061|Antioxidants|antioxidants|mesh-ancestor
101835238|NCT00568061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835239|NCT00568061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101835240|NCT00568061|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101835241|NCT00568061|Vasodilator Agents|vasodilator agents|mesh-ancestor
101835242|NCT00568061|Gasotransmitters|gasotransmitters|mesh-ancestor
101835243|NCT00568061|Protective Agents|protective agents|mesh-ancestor
101835244|NCT03547427|Acetaminophen|acetaminophen|mesh-list
101835245|NCT03547427|Insulin|insulin|mesh-list
101835246|NCT03547427|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101835247|NCT03547427|Pramlintide|pramlintide|mesh-list
101835248|NCT03547427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101835249|NCT03547427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835250|NCT03547427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101835251|NCT03547427|Analgesics|analgesics|mesh-ancestor
101835252|NCT03547427|Sensory System Agents|sensory system agents|mesh-ancestor
101835253|NCT03547427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101835254|NCT03547427|Antipyretics|antipyretics|mesh-ancestor
101835255|NCT00338884|Sunitinib|sunitinib|mesh-list
101835256|NCT00338884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101835257|NCT00338884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101835258|NCT00338884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101835259|NCT00338884|Growth Substances|growth substances|mesh-ancestor
101835260|NCT00338884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835261|NCT00338884|Growth Inhibitors|growth inhibitors|mesh-ancestor
101835262|NCT00338884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101835263|NCT00338884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101835264|NCT00338884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835265|NCT03038100|Paclitaxel|paclitaxel|mesh-list
101835266|NCT03038100|Bevacizumab|bevacizumab|mesh-list
101835267|NCT03038100|Carboplatin|carboplatin|mesh-list
101835268|NCT03038100|Atezolizumab|atezolizumab|mesh-list
101835269|NCT03038100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101835270|NCT03038100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101835271|NCT03038100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101835272|NCT03038100|Tubulin Modulators|tubulin modulators|mesh-ancestor
101835273|NCT03038100|Antimitotic Agents|antimitotic agents|mesh-ancestor
101835274|NCT03038100|Mitosis Modulators|mitosis modulators|mesh-ancestor
101835275|NCT03038100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835276|NCT03038100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101835277|NCT03038100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101835278|NCT03038100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101835279|NCT03038100|Growth Substances|growth substances|mesh-ancestor
101302118|NCT02003222|Etoposide|etoposide|mesh-list
101835280|NCT03038100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835281|NCT03038100|Growth Inhibitors|growth inhibitors|mesh-ancestor
101835282|NCT03038100|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101835283|NCT03038100|Immunologic Factors|immunologic factors|mesh-ancestor
101835284|NCT00338728|Letrozole|letrozole|mesh-list
101835285|NCT00338728|Imatinib Mesylate|imatinib mesylate|mesh-list
101835286|NCT00338728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101835287|NCT00338728|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101835288|NCT00338728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101835289|NCT00338728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101835290|NCT00338728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835291|NCT00338728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101835292|NCT00338728|Hormone Antagonists|hormone antagonists|mesh-ancestor
101835293|NCT00338728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101835294|NCT00338728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835295|NCT00338728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101835296|NCT01059136|Spironolactone|spironolactone|mesh-list
101835297|NCT01059136|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101835298|NCT01059136|Hormone Antagonists|hormone antagonists|mesh-ancestor
101835299|NCT01059136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101835300|NCT01059136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835301|NCT01059136|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101835302|NCT01059136|Diuretics|diuretics|mesh-ancestor
101835303|NCT01059136|Natriuretic Agents|natriuretic agents|mesh-ancestor
101835304|NCT00336856|Irinotecan|irinotecan|mesh-list
101835305|NCT00336856|Cetuximab|cetuximab|mesh-list
101835306|NCT00336856|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101835307|NCT00336856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101835308|NCT00336856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101835309|NCT00336856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835310|NCT00336856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101835311|NCT00336856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101835312|NCT00566501|Donepezil|donepezil|mesh-list
101835313|NCT00566501|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101835314|NCT00566501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101835315|NCT00566501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835316|NCT00566501|Cholinergic Agents|cholinergic agents|mesh-ancestor
101835317|NCT00566501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101835318|NCT00566501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835319|NCT00566501|Nootropic Agents|nootropic agents|mesh-ancestor
101835320|NCT00504894|Thiopental|thiopental|mesh-list
101835321|NCT00504894|Propofol|propofol|mesh-list
101835322|NCT00504894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101835323|NCT00504894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101835324|NCT00504894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835325|NCT00504894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101835326|NCT00504894|Anesthetics, General|anesthetics, general|mesh-ancestor
101835327|NCT00504894|Anesthetics|anesthetics|mesh-ancestor
101835328|NCT00504894|Anticonvulsants|anticonvulsants|mesh-ancestor
101835329|NCT00504894|GABA Modulators|gaba modulators|mesh-ancestor
101835330|NCT00504894|GABA Agents|gaba agents|mesh-ancestor
101835331|NCT00504894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101835332|NCT00504894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835333|NCT00924755|Caffeine|caffeine|mesh-list
101835334|NCT00924755|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101835335|NCT00924755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835336|NCT00924755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101835337|NCT00924755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101835338|NCT00924755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835339|NCT00924755|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101835341|NCT00924755|Purinergic Agents|purinergic agents|mesh-ancestor
101835342|NCT00924755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101835343|NCT01011348|Ubiquinone|ubiquinone|mesh-list
101835344|NCT01011348|Coenzyme Q10|coenzyme q10|mesh-list
101835345|NCT01011348|Micronutrients|micronutrients|mesh-ancestor
101835346|NCT01011348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835347|NCT01011348|Vitamins|vitamins|mesh-ancestor
101835348|NCT00928655|Acetazolamide|acetazolamide|mesh-list
101835349|NCT00928655|Anticonvulsants|anticonvulsants|mesh-ancestor
101835350|NCT00928655|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101835351|NCT00928655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101835352|NCT00928655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835354|NCT00928655|Natriuretic Agents|natriuretic agents|mesh-ancestor
101835355|NCT00928655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835356|NCT01011426|Bisacodyl|bisacodyl|mesh-list
101835357|NCT01011426|Cathartics|cathartics|mesh-ancestor
101835358|NCT01011426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101835359|NCT01011426|Laxatives|laxatives|mesh-ancestor
101835360|NCT00932555|Factor VIII|factor viii|mesh-list
101835361|NCT00932555|Coagulants|coagulants|mesh-ancestor
101835362|NCT04722575|Atezolizumab|atezolizumab|mesh-list
101835363|NCT04722575|Vemurafenib|vemurafenib|mesh-list
101835364|NCT04722575|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101835365|NCT04722575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835366|NCT04722575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101835367|NCT04722575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101835368|NCT04722575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101835369|NCT04722575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101835370|NCT00513240|Epoetin Alfa|epoetin alfa|mesh-list
101835371|NCT00513240|Hematinics|hematinics|mesh-ancestor
101835372|NCT00928811|Basiliximab|basiliximab|mesh-list
101835373|NCT00928811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101555160|NCT00982657|Sunitinib|sunitinib|mesh-list
101835374|NCT00928811|Immunologic Factors|immunologic factors|mesh-ancestor
101835375|NCT00928811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835376|NCT00932867|Telmisartan|telmisartan|mesh-list
101835377|NCT00932867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101835378|NCT00932867|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101835379|NCT00932867|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101835380|NCT00932867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835381|NCT00928967|Interferons|interferons|mesh-list
101835382|NCT00928967|Interferon-beta|interferon-beta|mesh-list
101835383|NCT00928967|Interferon beta-1b|interferon beta-1b|mesh-list
101835384|NCT00928967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101835385|NCT00928967|Antiviral Agents|antiviral agents|mesh-ancestor
101835386|NCT00928967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101835387|NCT00928967|Immunologic Factors|immunologic factors|mesh-ancestor
101835388|NCT00928967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835389|NCT00928967|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101835390|NCT00933023|Hydrocortisone|hydrocortisone|mesh-list
101835391|NCT00933023|Betamethasone|betamethasone|mesh-list
101835392|NCT00933023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101835393|NCT00933023|Glucocorticoids|glucocorticoids|mesh-ancestor
101835394|NCT00933023|Hormones|hormones|mesh-ancestor
101835395|NCT00933023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101835396|NCT00933023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835397|NCT00933023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101835398|NCT00933023|Respiratory System Agents|respiratory system agents|mesh-ancestor
101835399|NCT00933179|Levonorgestrel|levonorgestrel|mesh-list
101835400|NCT00933179|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
101835401|NCT00933179|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
101835402|NCT00933179|Gestodene|gestodene|mesh-list
101835403|NCT00933179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101835404|NCT00933179|Contraceptive Agents|contraceptive agents|mesh-ancestor
101835405|NCT00933179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101835406|NCT00933179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835407|NCT00933179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101835408|NCT00933179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101835409|NCT00933179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101835410|NCT00933179|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101835411|NCT00933179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101835412|NCT00933179|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
101835413|NCT00933179|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101829213|NCT04646707|Sensory System Agents|sensory system agents|mesh-ancestor
101835414|NCT00933179|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101835415|NCT00933179|Progestins|progestins|mesh-ancestor
101835416|NCT00933179|Hormones|hormones|mesh-ancestor
101835417|NCT00933179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101835418|NCT00504348|Tacrolimus|tacrolimus|mesh-list
101835419|NCT00504348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101835420|NCT00504348|Immunologic Factors|immunologic factors|mesh-ancestor
101835421|NCT00504348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835422|NCT00504348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101835423|NCT00504348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101835424|NCT00504348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835425|NCT00929045|Hormones|hormones|mesh-list
101835426|NCT00929045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101835427|NCT00929045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835428|NCT00925457|Domperidone|domperidone|mesh-list
101835429|NCT00925457|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101835430|NCT00925457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101835431|NCT00925457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835432|NCT00925457|Antiemetics|antiemetics|mesh-ancestor
101835433|NCT00925457|Autonomic Agents|autonomic agents|mesh-ancestor
101835434|NCT00925457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101835435|NCT00925457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835436|NCT00925457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101835437|NCT00925457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101835438|NCT00925457|Dopamine Agents|dopamine agents|mesh-ancestor
101835439|NCT00925457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101835440|NCT00929279|Abciximab|abciximab|mesh-list
101835441|NCT00929279|Anticoagulants|anticoagulants|mesh-ancestor
101835442|NCT00929279|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101835443|NCT00567593|Rosiglitazone|rosiglitazone|mesh-list
101835444|NCT00567593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101835445|NCT00567593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835446|NCT00335764|Sirolimus|sirolimus|mesh-list
101835447|NCT00335764|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101835448|NCT00335764|Sorafenib|sorafenib|mesh-list
101835449|NCT00335764|Temsirolimus|temsirolimus|mesh-list
101835450|NCT00335764|Tipifarnib|tipifarnib|mesh-list
101555228|NCT01004614|Amlodipine|amlodipine|mesh-list
101835451|NCT00335764|MTOR Inhibitors|mtor inhibitors|mesh-list
101835452|NCT00335764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101835453|NCT00335764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101835454|NCT00335764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101835455|NCT00335764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835456|NCT00335764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101835457|NCT00335764|Immunologic Factors|immunologic factors|mesh-ancestor
101835458|NCT00335764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835459|NCT00335764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101835460|NCT00335764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101835461|NCT00335764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101835462|NCT00335764|Antifungal Agents|antifungal agents|mesh-ancestor
101835463|NCT03743285|Insulin Lispro|insulin lispro|mesh-list
101835464|NCT03743285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101835465|NCT03743285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835466|NCT03981484|Thrombin|thrombin|mesh-list
101835467|NCT03981484|Hemostatics|hemostatics|mesh-ancestor
101835468|NCT03981484|Coagulants|coagulants|mesh-ancestor
101835469|NCT00567359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101835470|NCT00567359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101835471|NCT00567359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101835472|NCT00567359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101835473|NCT00567359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835474|NCT01063660|Treosulfan|treosulfan|mesh-list
101835475|NCT01063660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101835476|NCT01063660|Alkylating Agents|alkylating agents|mesh-ancestor
101835477|NCT01063660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835478|NCT01063660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101835479|NCT00925847|Lithium Carbonate|lithium carbonate|mesh-list
101835480|NCT00925847|Antidepressive Agents|antidepressive agents|mesh-ancestor
101835481|NCT00925847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101835482|NCT00925847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101835483|NCT00925847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835484|NCT00925847|Antimanic Agents|antimanic agents|mesh-ancestor
101835485|NCT00925847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101835486|NCT00925847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101835487|NCT00925847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835488|NCT00492726|Moxifloxacin|moxifloxacin|mesh-list
101835490|NCT00492726|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101835491|NCT00492726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101835492|NCT00492726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101835493|NCT00492726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101835494|NCT00492726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101835495|NCT00492726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101835496|NCT00492726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835497|NCT00492726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101835498|NCT00492726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101835499|NCT00492726|Contraceptive Agents|contraceptive agents|mesh-ancestor
101835500|NCT00492726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101835501|NCT00492726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835502|NCT00492726|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101835503|NCT00492726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101835504|NCT00492726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101835505|NCT00309946|Cediranib|cediranib|mesh-list
101835506|NCT00309946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101835507|NCT00309946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835508|NCT00309946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101835509|NCT00309946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101835510|NCT00929591|Tamoxifen|tamoxifen|mesh-list
101835511|NCT00929591|Cyclophosphamide|cyclophosphamide|mesh-list
101835512|NCT00929591|Doxorubicin|doxorubicin|mesh-list
101835513|NCT00929591|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101835514|NCT00929591|Fluorouracil|fluorouracil|mesh-list
101835515|NCT00929591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101835516|NCT00929591|Immunologic Factors|immunologic factors|mesh-ancestor
101835517|NCT00929591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835518|NCT00929591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101835519|NCT00929591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101835520|NCT00929591|Alkylating Agents|alkylating agents|mesh-ancestor
101835521|NCT00929591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835522|NCT00929591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101835523|NCT00929591|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101835524|NCT00929591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101835525|NCT00929591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101835526|NCT00929591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101835527|NCT00929591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101835528|NCT00929591|Antimetabolites|antimetabolites|mesh-ancestor
101835529|NCT00929591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101835530|NCT00929591|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101835531|NCT00929591|Hormone Antagonists|hormone antagonists|mesh-ancestor
101835532|NCT00929591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101835533|NCT00929591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101835534|NCT00929591|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101835535|NCT00929591|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101835536|NCT00929591|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101835537|NCT03997500|Norepinephrine|norepinephrine|mesh-list
101835538|NCT03997500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101835539|NCT03997500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101835540|NCT03997500|Adrenergic Agents|adrenergic agents|mesh-ancestor
101835541|NCT03997500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101835542|NCT03997500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835543|NCT03997500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835544|NCT03997500|Sympathomimetics|sympathomimetics|mesh-ancestor
101835545|NCT03997500|Autonomic Agents|autonomic agents|mesh-ancestor
101835546|NCT03997500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101835547|NCT03997500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101835548|NCT01011660|Amlodipine|amlodipine|mesh-list
101835549|NCT01011660|Telmisartan|telmisartan|mesh-list
101835550|NCT01011660|Amiloride|amiloride|mesh-list
101835551|NCT01011660|Simvastatin|simvastatin|mesh-list
101835552|NCT01011660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101835553|NCT01011660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101835554|NCT01011660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101835555|NCT01011660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835556|NCT01011660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101835557|NCT01011660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835558|NCT01011660|Vasodilator Agents|vasodilator agents|mesh-ancestor
101835559|NCT01011660|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101835560|NCT01011660|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101835561|NCT01011660|Antimetabolites|antimetabolites|mesh-ancestor
101835562|NCT01011660|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101835563|NCT01011660|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101835564|NCT01011660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101835565|NCT01011660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101835566|NCT01011660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101835567|NCT01011660|Diuretics|diuretics|mesh-ancestor
101835568|NCT01011660|Natriuretic Agents|natriuretic agents|mesh-ancestor
101835569|NCT01011660|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
101835570|NCT01011660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101835571|NCT01011660|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101835572|NCT01011660|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101835573|NCT01015248|Rituximab|rituximab|mesh-list
101835574|NCT01015248|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101835575|NCT01015248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101835576|NCT01015248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101835577|NCT01015248|Immunologic Factors|immunologic factors|mesh-ancestor
101835578|NCT01015248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835579|NCT01015248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101835580|NCT01015248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101835581|NCT01015248|Alkylating Agents|alkylating agents|mesh-ancestor
101835582|NCT01015248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835583|NCT00506922|Methotrexate|methotrexate|mesh-list
101835584|NCT00506922|Pentostatin|pentostatin|mesh-list
101835585|NCT00506922|Tacrolimus|tacrolimus|mesh-list
101835586|NCT00506922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101835587|NCT00506922|Abortifacient Agents|abortifacient agents|mesh-ancestor
101835588|NCT00506922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101835589|NCT00506922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835590|NCT00506922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101835591|NCT00506922|Antimetabolites|antimetabolites|mesh-ancestor
101835592|NCT00506922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835593|NCT00506922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101835594|NCT00506922|Dermatologic Agents|dermatologic agents|mesh-ancestor
101835595|NCT00506922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101835596|NCT00506922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101835597|NCT00506922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101835598|NCT00506922|Immunologic Factors|immunologic factors|mesh-ancestor
101835599|NCT00506922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101835600|NCT00506922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101835601|NCT00506922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101835602|NCT00506922|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
101835603|NCT00934193|Gabapentin|gabapentin|mesh-list
101835604|NCT00934193|Analgesics|analgesics|mesh-ancestor
101835605|NCT00934193|Sensory System Agents|sensory system agents|mesh-ancestor
101835606|NCT00934193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101835607|NCT00934193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835608|NCT00934193|Anticonvulsants|anticonvulsants|mesh-ancestor
101835609|NCT00934193|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101835610|NCT00934193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101835611|NCT00934193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101835612|NCT00934193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101835613|NCT00934193|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101835614|NCT00934193|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101835615|NCT00934193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101835616|NCT00934193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835617|NCT00934193|Antimanic Agents|antimanic agents|mesh-ancestor
101835618|NCT00492024|Moxifloxacin|moxifloxacin|mesh-list
101835619|NCT00492024|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101835620|NCT00492024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101835621|NCT00492024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101835622|NCT00492024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101835623|NCT00492024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101835624|NCT00492024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101835625|NCT00492024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835626|NCT00492024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101835627|NCT00492024|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101835628|NCT00492024|Contraceptive Agents|contraceptive agents|mesh-ancestor
101835629|NCT00492024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101224449|NCT01524068|Rituximab|rituximab|mesh-list
101835630|NCT00492024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835631|NCT00492024|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101835632|NCT00492024|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101835633|NCT00492024|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101835634|NCT00934427|Nitroglycerin|nitroglycerin|mesh-list
101835635|NCT00934427|Vasodilator Agents|vasodilator agents|mesh-ancestor
101835636|NCT00926315|Calcitriol|calcitriol|mesh-list
101835637|NCT00926315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101835638|NCT00926315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835639|NCT00926315|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101835640|NCT00926315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101835641|NCT00926315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835642|NCT00926315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101835643|NCT00926315|Vitamins|vitamins|mesh-ancestor
101835644|NCT00926315|Micronutrients|micronutrients|mesh-ancestor
101835645|NCT00926315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101835646|NCT01013454|Varenicline|varenicline|mesh-list
101835647|NCT01013454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101835648|NCT01013454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101835649|NCT01013454|Cholinergic Agents|cholinergic agents|mesh-ancestor
101835650|NCT01013454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101835651|NCT01013454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835652|NCT01013454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835653|NCT00491556|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101835654|NCT00491556|Antiviral Agents|antiviral agents|mesh-ancestor
101835655|NCT00491556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101835656|NCT00926627|Bosentan|bosentan|mesh-list
101835657|NCT00926627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101835658|NCT00926627|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101835659|NCT00926627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835660|NCT00934739|Thalidomide|thalidomide|mesh-list
101835661|NCT00934739|Dexamethasone|dexamethasone|mesh-list
101835662|NCT00934739|Celecoxib|celecoxib|mesh-list
101835663|NCT00934739|Cyclophosphamide|cyclophosphamide|mesh-list
101835664|NCT00934739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101835665|NCT00934739|Immunologic Factors|immunologic factors|mesh-ancestor
101835666|NCT00934739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835667|NCT00934739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101835668|NCT00934739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101835669|NCT00934739|Alkylating Agents|alkylating agents|mesh-ancestor
101835670|NCT00934739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555469|NCT01211769|Naltrexone|naltrexone|mesh-list
101835671|NCT00934739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101835672|NCT00934739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101835673|NCT00934739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101835674|NCT00934739|Antiemetics|antiemetics|mesh-ancestor
101835675|NCT00934739|Autonomic Agents|autonomic agents|mesh-ancestor
101835676|NCT00934739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101835677|NCT00934739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101835678|NCT00934739|Glucocorticoids|glucocorticoids|mesh-ancestor
101835679|NCT00934739|Hormones|hormones|mesh-ancestor
101835680|NCT00934739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101835681|NCT00934739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101835682|NCT00934739|Leprostatic Agents|leprostatic agents|mesh-ancestor
101835683|NCT00934739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101835684|NCT00934739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101835685|NCT00934739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101835686|NCT00934739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101835687|NCT00934739|Growth Substances|growth substances|mesh-ancestor
101835688|NCT00934739|Growth Inhibitors|growth inhibitors|mesh-ancestor
101835689|NCT00934739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101835690|NCT00934739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101835691|NCT00934739|Analgesics|analgesics|mesh-ancestor
101835692|NCT00934739|Sensory System Agents|sensory system agents|mesh-ancestor
101835693|NCT00934739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101835694|NCT00934739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101835695|NCT00934739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101835696|NCT01015482|Midazolam|midazolam|mesh-list
101835697|NCT01015482|Remifentanil|remifentanil|mesh-list
101835698|NCT01015482|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101835699|NCT01015482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101835700|NCT01015482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101835701|NCT01015482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835702|NCT01015482|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101835703|NCT01015482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101835704|NCT01015482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101835705|NCT01015482|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101835706|NCT01015482|Anesthetics, General|anesthetics, general|mesh-ancestor
101835707|NCT01015482|Anesthetics|anesthetics|mesh-ancestor
101835708|NCT01015482|GABA Modulators|gaba modulators|mesh-ancestor
101835710|NCT01015482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101835711|NCT01015482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835712|NCT01015482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101835713|NCT01015482|Narcotics|narcotics|mesh-ancestor
101835714|NCT01015482|Analgesics|analgesics|mesh-ancestor
101835715|NCT01015482|Sensory System Agents|sensory system agents|mesh-ancestor
101835716|NCT01015482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101835717|NCT03760679|Chlorhexidine|chlorhexidine|mesh-list
101835718|NCT03760679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101835719|NCT03760679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101835720|NCT03760679|Disinfectants|disinfectants|mesh-ancestor
101835721|NCT00934817|Metformin|metformin|mesh-list
101835722|NCT00934817|Glimepiride|glimepiride|mesh-list
101835723|NCT00934817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101835724|NCT00934817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835725|NCT00934817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101835726|NCT00934817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101835727|NCT00934817|Immunologic Factors|immunologic factors|mesh-ancestor
101835728|NCT01013532|Aspirin|aspirin|mesh-list
101835729|NCT01013532|Cilostazol|cilostazol|mesh-list
101835730|NCT01013532|Probucol|probucol|mesh-list
101835731|NCT01013532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101835732|NCT01013532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101835733|NCT01013532|Analgesics|analgesics|mesh-ancestor
101835734|NCT01013532|Sensory System Agents|sensory system agents|mesh-ancestor
101835735|NCT01013532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101835736|NCT01013532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835737|NCT01013532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101835738|NCT01013532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101835739|NCT01013532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101835740|NCT01013532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101835741|NCT01013532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555521|NCT05406765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835742|NCT01013532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101835743|NCT01013532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101835744|NCT01013532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101835745|NCT01013532|Antipyretics|antipyretics|mesh-ancestor
101835746|NCT01013532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101835748|NCT01013532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101835749|NCT01013532|Respiratory System Agents|respiratory system agents|mesh-ancestor
101835750|NCT01013532|Vasodilator Agents|vasodilator agents|mesh-ancestor
101835751|NCT01013532|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101835752|NCT01013532|Protective Agents|protective agents|mesh-ancestor
101835753|NCT01013532|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101835754|NCT01013532|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101835755|NCT01013532|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101835756|NCT01013532|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101835757|NCT01013532|Antimetabolites|antimetabolites|mesh-ancestor
101835758|NCT01013532|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101835759|NCT01013532|Antioxidants|antioxidants|mesh-ancestor
101835760|NCT00934895|Paclitaxel|paclitaxel|mesh-list
101835761|NCT00934895|Everolimus|everolimus|mesh-list
101835762|NCT00934895|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101835763|NCT00934895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101835764|NCT00934895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101835765|NCT00934895|Tubulin Modulators|tubulin modulators|mesh-ancestor
101835766|NCT00934895|Antimitotic Agents|antimitotic agents|mesh-ancestor
101835767|NCT00934895|Mitosis Modulators|mitosis modulators|mesh-ancestor
101835768|NCT00934895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835769|NCT00934895|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101835770|NCT00934895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101835771|NCT00934895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101835772|NCT00934895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101835773|NCT00934895|Immunologic Factors|immunologic factors|mesh-ancestor
101835774|NCT00934895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835775|NCT00926705|Fentanyl|fentanyl|mesh-list
101835776|NCT00926705|Dexmedetomidine|dexmedetomidine|mesh-list
101835777|NCT00926705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101835778|NCT00926705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101835779|NCT00926705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835780|NCT00926705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101835781|NCT00926705|Analgesics|analgesics|mesh-ancestor
101835782|NCT00926705|Sensory System Agents|sensory system agents|mesh-ancestor
101835783|NCT00926705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101835784|NCT00926705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101835785|NCT00926705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101835786|NCT00926705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101835787|NCT00926705|Adrenergic Agents|adrenergic agents|mesh-ancestor
101835788|NCT00926705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101835789|NCT00926705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835790|NCT00926705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101835792|NCT00926705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101835793|NCT00926705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101835794|NCT00926705|Anesthetics, General|anesthetics, general|mesh-ancestor
101835795|NCT00926705|Anesthetics|anesthetics|mesh-ancestor
101835796|NCT01012284|Bedaquiline|bedaquiline|mesh-list
101835797|NCT01012284|Antitubercular Agents|antitubercular agents|mesh-ancestor
101835798|NCT01012284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101835799|NCT01012284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101835800|NCT00934973|Mebeverine|mebeverine|mesh-list
101835801|NCT00934973|Alverine|alverine|mesh-list
101835802|NCT00934973|Anticonvulsants|anticonvulsants|mesh-ancestor
101835803|NCT00934973|Parasympatholytics|parasympatholytics|mesh-ancestor
101835804|NCT00934973|Autonomic Agents|autonomic agents|mesh-ancestor
101835805|NCT00934973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101835806|NCT00934973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835807|NCT00485472|Lacosamide|lacosamide|mesh-list
101835808|NCT00485472|Anticonvulsants|anticonvulsants|mesh-ancestor
101835809|NCT00485472|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101835810|NCT00485472|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101835811|NCT00485472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101835812|NCT00485472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835813|NCT00930605|Alemtuzumab|alemtuzumab|mesh-list
101835814|NCT00930605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101835815|NCT00930605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101835816|NCT01018836|Riluzole|riluzole|mesh-list
101835817|NCT01018836|Anticonvulsants|anticonvulsants|mesh-ancestor
101835818|NCT01018836|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101835819|NCT01018836|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101835820|NCT01018836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101224486|NCT01524094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101835821|NCT01018836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555595|NCT00628576|Heparin|heparin|mesh-list
101835822|NCT01018836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835823|NCT01018836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101835824|NCT01018836|Protective Agents|protective agents|mesh-ancestor
101835825|NCT04015661|Paclitaxel|paclitaxel|mesh-list
101835826|NCT04015661|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101835827|NCT04015661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101835828|NCT04015661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101835829|NCT04015661|Tubulin Modulators|tubulin modulators|mesh-ancestor
101835830|NCT04015661|Antimitotic Agents|antimitotic agents|mesh-ancestor
101835831|NCT04015661|Mitosis Modulators|mitosis modulators|mesh-ancestor
101835832|NCT04015661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835833|NCT00491400|Atorvastatin|atorvastatin|mesh-list
101835834|NCT00491400|Fenofibrate|fenofibrate|mesh-list
101835835|NCT00491400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101835836|NCT00491400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101835837|NCT00491400|Antimetabolites|antimetabolites|mesh-ancestor
101835838|NCT00491400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835839|NCT00491400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101835840|NCT00491400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101953023|NCT02047552|Androgens|androgens|mesh-ancestor
101835841|NCT00491400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101835842|NCT00491322|Ergocalciferols|ergocalciferols|mesh-list
101835843|NCT00491322|Vitamin D|vitamin d|mesh-list
101835844|NCT00491322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101835845|NCT00491322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835846|NCT00491322|Vitamins|vitamins|mesh-ancestor
101835847|NCT00491322|Micronutrients|micronutrients|mesh-ancestor
101835848|NCT00491322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101835849|NCT00930683|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101835850|NCT00930683|Immunologic Factors|immunologic factors|mesh-ancestor
101835851|NCT00930683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835852|NCT00930839|Aspirin|aspirin|mesh-list
101835854|NCT00930839|Nicotinic Acids|nicotinic acids|mesh-list
101835855|NCT00930839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101835856|NCT00930839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101835857|NCT00930839|Analgesics|analgesics|mesh-ancestor
101835858|NCT00930839|Sensory System Agents|sensory system agents|mesh-ancestor
101835859|NCT00930839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101835860|NCT00930839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835861|NCT00930839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101835862|NCT00930839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101835863|NCT00930839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101835864|NCT00930839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101835865|NCT00930839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835866|NCT00930839|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101835867|NCT00930839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101835868|NCT00930839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101835869|NCT00930839|Antipyretics|antipyretics|mesh-ancestor
101835870|NCT00930839|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101835871|NCT00930839|Antimetabolites|antimetabolites|mesh-ancestor
101835872|NCT00930839|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101835873|NCT00930839|Vasodilator Agents|vasodilator agents|mesh-ancestor
101835874|NCT00930839|Vitamin B Complex|vitamin b complex|mesh-ancestor
101835875|NCT00930839|Vitamins|vitamins|mesh-ancestor
101835876|NCT00930839|Micronutrients|micronutrients|mesh-ancestor
101835877|NCT01015794|Ephedrine|ephedrine|mesh-list
101835878|NCT01015794|Pseudoephedrine|pseudoephedrine|mesh-list
101835879|NCT01015794|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101835880|NCT01015794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835881|NCT01015794|Sympathomimetics|sympathomimetics|mesh-ancestor
101835882|NCT01015794|Autonomic Agents|autonomic agents|mesh-ancestor
101835883|NCT01015794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101835884|NCT01015794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101835885|NCT01015794|Adrenergic Agents|adrenergic agents|mesh-ancestor
101835886|NCT01015794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101835887|NCT01015794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835888|NCT01015794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101835889|NCT01015794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101835890|NCT01015794|Respiratory System Agents|respiratory system agents|mesh-ancestor
101835891|NCT01015794|Nasal Decongestants|nasal decongestants|mesh-ancestor
101835892|NCT00935363|Glyburide|glyburide|mesh-list
101835893|NCT00935363|Rifampin|rifampin|mesh-list
101555669|NCT01205529|Procainamide|procainamide|mesh-list
101835894|NCT00935363|Fluconazole|fluconazole|mesh-list
101835895|NCT00935363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101835896|NCT00935363|Antitubercular Agents|antitubercular agents|mesh-ancestor
101835897|NCT00935363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101835898|NCT00935363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101835899|NCT00935363|Leprostatic Agents|leprostatic agents|mesh-ancestor
101835900|NCT00935363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101835901|NCT00935363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101835902|NCT00935363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835903|NCT00935363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101835904|NCT00935363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101835905|NCT00935363|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101835906|NCT00935363|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101835907|NCT00935363|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101835908|NCT00935363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101835909|NCT00935363|Antifungal Agents|antifungal agents|mesh-ancestor
101835910|NCT00935363|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101835911|NCT00935363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101835912|NCT00935363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101835914|NCT00935363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101835915|NCT00935363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835916|NCT00935363|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101835917|NCT00935363|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101835918|NCT00935363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101835919|NCT00930995|Candesartan|candesartan|mesh-list
101835920|NCT00930995|Candesartan cilexetil|candesartan cilexetil|mesh-list
101835921|NCT00930995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101835922|NCT00930995|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101835923|NCT00930995|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101835924|NCT00930995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835925|NCT00931073|Ketoconazole|ketoconazole|mesh-list
101835926|NCT00931073|Omeprazole|omeprazole|mesh-list
101835927|NCT00931073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101835928|NCT00931073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101835929|NCT00931073|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101835930|NCT00931073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102096776|NCT04977544|Antidepressive Agents|antidepressive agents|mesh-ancestor
101829738|NCT03629171|Venetoclax|venetoclax|mesh-list
101835931|NCT00931073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835932|NCT00931073|Antifungal Agents|antifungal agents|mesh-ancestor
101835933|NCT00931073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101835934|NCT00931073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101835935|NCT00931073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101835936|NCT00931073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101835937|NCT00931073|Hormone Antagonists|hormone antagonists|mesh-ancestor
101835938|NCT00931073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101835939|NCT00931073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835940|NCT00931073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101835941|NCT00936689|Doxorubicin|doxorubicin|mesh-list
101835942|NCT00936689|Chlorotrianisene|chlorotrianisene|mesh-list
101835943|NCT00936689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101835944|NCT00936689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101835945|NCT00936689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101835946|NCT00936689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101835947|NCT00936689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101835948|NCT00936689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224514|NCT01524354|Anesthetics|anesthetics|mesh-list
101835949|NCT00936689|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101835950|NCT00936689|Estrogens|estrogens|mesh-ancestor
101835951|NCT00936689|Hormones|hormones|mesh-ancestor
101835952|NCT00936689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101835953|NCT00936689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835954|NCT00936689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101835955|NCT01018914|Mycophenolic Acid|mycophenolic acid|mesh-list
101835956|NCT01018914|Tacrolimus|tacrolimus|mesh-list
101835957|NCT01018914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101835958|NCT01018914|Immunologic Factors|immunologic factors|mesh-ancestor
101835959|NCT01018914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835960|NCT01018914|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101835961|NCT01018914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101835962|NCT01018914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835963|NCT01018914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101835964|NCT01018914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101835965|NCT01018914|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101835966|NCT01018914|Antitubercular Agents|antitubercular agents|mesh-ancestor
101835967|NCT01018914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101835968|NCT01018914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101835969|NCT01019070|Asunaprevir|asunaprevir|mesh-list
101835970|NCT01019070|Protease Inhibitors|protease inhibitors|mesh-ancestor
101835971|NCT01019070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101835972|NCT01019070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835973|NCT00936767|Artesunate|artesunate|mesh-list
101835974|NCT00936767|Mefloquine|mefloquine|mesh-list
101835975|NCT00936767|Antimalarials|antimalarials|mesh-ancestor
101835976|NCT00936767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101835977|NCT00936767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101835978|NCT00936767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101835979|NCT00936767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101835980|NCT00936767|Antiviral Agents|antiviral agents|mesh-ancestor
101835981|NCT00936767|Schistosomicides|schistosomicides|mesh-ancestor
101835982|NCT00936767|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101835983|NCT00936767|Anthelmintics|anthelmintics|mesh-ancestor
101835984|NCT00931229|Entecavir|entecavir|mesh-list
101835985|NCT00931229|Antiviral Agents|antiviral agents|mesh-ancestor
101835986|NCT00931229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101835987|NCT00936923|Furosemide|furosemide|mesh-list
101835988|NCT00936923|Diuretics|diuretics|mesh-list
101835989|NCT00936923|Natriuretic Agents|natriuretic agents|mesh-ancestor
101835990|NCT00936923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101835991|NCT00936923|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101835992|NCT00936923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101835993|NCT00936923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835994|NCT01019382|Gemcitabine|gemcitabine|mesh-list
101835995|NCT01019382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101835996|NCT01019382|Antimetabolites|antimetabolites|mesh-ancestor
101835997|NCT01019382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101835998|NCT01019382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101835999|NCT00935675|Escitalopram|escitalopram|mesh-list
101836000|NCT00935675|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101836001|NCT00935675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101836002|NCT00935675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101836003|NCT00935675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836004|NCT00935675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101836005|NCT00935675|Serotonin Agents|serotonin agents|mesh-ancestor
101836006|NCT00935675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836007|NCT01016184|Vitamin D|vitamin d|mesh-list
101836008|NCT01016184|Vitamins|vitamins|mesh-ancestor
101836009|NCT01016184|Micronutrients|micronutrients|mesh-ancestor
101836010|NCT01016184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836011|NCT01016184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101836012|NCT02567825|Amoxicillin|amoxicillin|mesh-list
101836013|NCT02567825|Ceftriaxone|ceftriaxone|mesh-list
101836014|NCT02567825|Clavulanic Acid|clavulanic acid|mesh-list
101836015|NCT02567825|Clavulanic Acids|clavulanic acids|mesh-list
101224516|NCT01524354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836016|NCT02567825|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101836017|NCT02567825|Ofloxacin|ofloxacin|mesh-list
101836018|NCT02567825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101836019|NCT02567825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101836020|NCT02567825|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101836021|NCT02567825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101836022|NCT02567825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836023|NCT02567825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101836024|NCT02567825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101836025|NCT02567825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101836026|NCT02567825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101836027|NCT02567825|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101836028|NCT02567825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101836029|NCT00490776|Panobinostat|panobinostat|mesh-list
101836030|NCT00490776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101836031|NCT00490776|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101836032|NCT00490776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101836033|NCT00490776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836034|NCT00566735|Galantamine|galantamine|mesh-list
101836035|NCT00566735|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101836036|NCT00566735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101836037|NCT00566735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836038|NCT00566735|Cholinergic Agents|cholinergic agents|mesh-ancestor
101836039|NCT00566735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101836040|NCT00566735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836041|NCT00566735|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101836042|NCT00566735|Autonomic Agents|autonomic agents|mesh-ancestor
101836043|NCT00566735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101836044|NCT00566735|Nootropic Agents|nootropic agents|mesh-ancestor
101836045|NCT00936143|Infliximab|infliximab|mesh-list
101836046|NCT00936143|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101836047|NCT00936143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101836048|NCT00936143|Dermatologic Agents|dermatologic agents|mesh-ancestor
101836049|NCT00936143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101836050|NCT00936143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101836051|NCT00937079|Exenatide|exenatide|mesh-list
101836052|NCT00937079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101836053|NCT00937079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836054|NCT00937079|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101836055|NCT00937079|Incretins|incretins|mesh-ancestor
101836056|NCT00937079|Hormones|hormones|mesh-ancestor
101836057|NCT00937079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101836058|NCT00566111|Ceftriaxone|ceftriaxone|mesh-list
101836059|NCT00566111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101836060|NCT00566111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101836061|NCT00937625|Cyclophosphamide|cyclophosphamide|mesh-list
101836062|NCT00937625|Fludarabine|fludarabine|mesh-list
101836063|NCT00937625|Fludarabine phosphate|fludarabine phosphate|mesh-list
101836064|NCT00937625|Interleukin-2|interleukin-2|mesh-list
101836065|NCT00937625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101836066|NCT00937625|Immunologic Factors|immunologic factors|mesh-ancestor
101836067|NCT00937625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836068|NCT00937625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101836069|NCT00937625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101836070|NCT00937625|Alkylating Agents|alkylating agents|mesh-ancestor
101836071|NCT00937625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836072|NCT00937625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101836073|NCT00937625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101836074|NCT00937625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101836075|NCT00937625|Antimetabolites|antimetabolites|mesh-ancestor
101836076|NCT00937625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101836077|NCT00937625|Analgesics|analgesics|mesh-ancestor
101836078|NCT00937625|Sensory System Agents|sensory system agents|mesh-ancestor
102096777|NCT04977544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101836079|NCT00937625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101836080|NCT04014101|Apatinib|apatinib|mesh-list
101836081|NCT04014101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101836082|NCT04014101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101836083|NCT04014101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101836084|NCT04014101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348719|NCT00846872|Mannitol|mannitol|mesh-list
101836085|NCT00936533|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101836086|NCT00936533|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101836087|NCT00936533|Botulinum Toxins|botulinum toxins|mesh-list
101836088|NCT00936533|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101836089|NCT00936533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101836090|NCT00936533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836091|NCT00936533|Cholinergic Agents|cholinergic agents|mesh-ancestor
101836092|NCT00936533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101836093|NCT00936533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836094|NCT00936533|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101836095|NCT00936533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101836096|NCT00564629|Acetaminophen|acetaminophen|mesh-list
101836097|NCT00564629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101836098|NCT00564629|Analgesics|analgesics|mesh-ancestor
101836099|NCT00564629|Sensory System Agents|sensory system agents|mesh-ancestor
101836100|NCT00564629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101836101|NCT00564629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836102|NCT00564629|Antipyretics|antipyretics|mesh-ancestor
101836103|NCT00564395|Insulin|insulin|mesh-list
101836104|NCT00564395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101836105|NCT00564395|Insulin Detemir|insulin detemir|mesh-list
101836106|NCT00564395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101836107|NCT00564395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836108|NCT04013243|Magnesium Sulfate|magnesium sulfate|mesh-list
101836109|NCT04013243|Analgesics|analgesics|mesh-ancestor
101836110|NCT04013243|Sensory System Agents|sensory system agents|mesh-ancestor
101836111|NCT04013243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101836112|NCT04013243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836113|NCT04013243|Anesthetics|anesthetics|mesh-ancestor
101836114|NCT04013243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101836115|NCT04013243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101836116|NCT04013243|Anticonvulsants|anticonvulsants|mesh-ancestor
101836117|NCT04013243|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101836118|NCT04013243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101836119|NCT04013243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836120|NCT04013243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101836121|NCT04013243|Tocolytic Agents|tocolytic agents|mesh-ancestor
101836122|NCT04013243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101836123|NCT00938171|Anesthetics|anesthetics|mesh-list
101302984|NCT02009007|Dopamine|dopamine|mesh-list
101836124|NCT00938171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101836125|NCT00938171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836126|NCT05280275|Dexamethasone|dexamethasone|mesh-list
101836127|NCT05280275|Lenalidomide|lenalidomide|mesh-list
101836128|NCT05280275|Daratumumab|daratumumab|mesh-list
101836129|NCT05280275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101836130|NCT05280275|Antiemetics|antiemetics|mesh-ancestor
101836131|NCT05280275|Autonomic Agents|autonomic agents|mesh-ancestor
101836132|NCT05280275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101836133|NCT05280275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836134|NCT05280275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101836135|NCT05280275|Glucocorticoids|glucocorticoids|mesh-ancestor
101836136|NCT05280275|Hormones|hormones|mesh-ancestor
101836137|NCT05280275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101836138|NCT05280275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101836139|NCT05280275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101836140|NCT05280275|Immunologic Factors|immunologic factors|mesh-ancestor
101836141|NCT05280275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101836142|NCT05280275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101836143|NCT05280275|Growth Substances|growth substances|mesh-ancestor
101836144|NCT05280275|Growth Inhibitors|growth inhibitors|mesh-ancestor
101836145|NCT00939497|Risperidone|risperidone|mesh-list
101836146|NCT00939497|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101836147|NCT00939497|Serotonin Agents|serotonin agents|mesh-ancestor
101836148|NCT00939497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101836149|NCT00939497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836150|NCT00939497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836151|NCT00939497|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101836152|NCT00939497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101836153|NCT00939497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101836154|NCT00939497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101836155|NCT00939497|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101836156|NCT00939497|Dopamine Agents|dopamine agents|mesh-ancestor
101836157|NCT00502242|Ramipril|ramipril|mesh-list
101836158|NCT00502242|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101836159|NCT00502242|Protease Inhibitors|protease inhibitors|mesh-ancestor
101836160|NCT00502242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101836161|NCT00502242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836162|NCT00502242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101836163|NCT00938405|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
101836164|NCT00938405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101836165|NCT00938405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101836166|NCT00938405|Antimetabolites|antimetabolites|mesh-ancestor
101836167|NCT00938405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836168|NCT00938405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101836169|NCT03045653|Tamoxifen|tamoxifen|mesh-list
101836170|NCT03045653|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101836171|NCT03045653|Hormone Antagonists|hormone antagonists|mesh-ancestor
101836172|NCT03045653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101836173|NCT03045653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836174|NCT03045653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101836175|NCT03045653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101836176|NCT03045653|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101836177|NCT03045653|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101836178|NCT03045653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101836179|NCT02991365|Insulin|insulin|mesh-list
101836180|NCT02991365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101836181|NCT02991365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836182|NCT03972137|Nicotine|nicotine|mesh-list
101836183|NCT03972137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101836184|NCT03972137|Autonomic Agents|autonomic agents|mesh-ancestor
101836185|NCT03972137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101836186|NCT03972137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836187|NCT03972137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101836188|NCT03972137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101836189|NCT03972137|Cholinergic Agents|cholinergic agents|mesh-ancestor
101836190|NCT03972137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101836191|NCT03972137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555964|NCT00969709|Analgesics|analgesics|mesh-ancestor
101836192|NCT00490698|Zoledronic Acid|zoledronic acid|mesh-list
101836193|NCT00490698|Atorvastatin|atorvastatin|mesh-list
101836194|NCT00490698|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101836195|NCT00490698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101836196|NCT00490698|Antimetabolites|antimetabolites|mesh-ancestor
101836197|NCT00490698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836198|NCT00490698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101836199|NCT00490698|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101836200|NCT00490698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101836201|NCT00490698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101836202|NCT00490698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836203|NCT04492254|Enoxaparin|enoxaparin|mesh-list
101836204|NCT04492254|Anticoagulants|anticoagulants|mesh-ancestor
101836205|NCT04492254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101836206|NCT04492254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101836207|NCT04492254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836208|NCT03855228|Mometasone Furoate|mometasone furoate|mesh-list
101836209|NCT03855228|Loratadine|loratadine|mesh-list
101836210|NCT03855228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101836211|NCT03855228|Dermatologic Agents|dermatologic agents|mesh-ancestor
101836212|NCT03855228|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101836213|NCT03855228|Antipruritics|antipruritics|mesh-ancestor
101836214|NCT03855228|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101836215|NCT03855228|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101836216|NCT03855228|Histamine Antagonists|histamine antagonists|mesh-ancestor
101836217|NCT03855228|Histamine Agents|histamine agents|mesh-ancestor
101836218|NCT03855228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101836219|NCT03855228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836220|NCT03855228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836221|NCT04013477|Donepezil|donepezil|mesh-list
101836222|NCT04013477|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101836223|NCT04013477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101836224|NCT04013477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836225|NCT04013477|Cholinergic Agents|cholinergic agents|mesh-ancestor
101836226|NCT04013477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101836227|NCT04013477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836228|NCT04013477|Nootropic Agents|nootropic agents|mesh-ancestor
101836230|NCT00940667|Amlodipine|amlodipine|mesh-list
101836231|NCT00940667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101836232|NCT00940667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101836233|NCT00940667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101836234|NCT00940667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836235|NCT00940667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101836236|NCT00940667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836237|NCT00940667|Vasodilator Agents|vasodilator agents|mesh-ancestor
101836238|NCT00940667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101836239|NCT00940667|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101836240|NCT00940667|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101836241|NCT01019772|Vaccines|vaccines|mesh-list
101836242|NCT01019772|Immunologic Factors|immunologic factors|mesh-ancestor
101836243|NCT01019772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836244|NCT00513500|Amoxicillin|amoxicillin|mesh-list
101836245|NCT00513500|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101836246|NCT00513500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101836247|NCT00513500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101836248|NCT00513500|Antimalarials|antimalarials|mesh-ancestor
101836249|NCT00513500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101836250|NCT00513500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101836251|NCT00511004|Albendazole|albendazole|mesh-list
101836252|NCT00511004|Diethylcarbamazine|diethylcarbamazine|mesh-list
101836253|NCT00511004|Anthelmintics|anthelmintics|mesh-ancestor
101836254|NCT00511004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101836255|NCT00511004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101836256|NCT00511004|Anticestodal Agents|anticestodal agents|mesh-ancestor
101836257|NCT00511004|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101836258|NCT00511004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101836259|NCT00511004|Tubulin Modulators|tubulin modulators|mesh-ancestor
101836260|NCT00511004|Antimitotic Agents|antimitotic agents|mesh-ancestor
101836261|NCT00511004|Mitosis Modulators|mitosis modulators|mesh-ancestor
101836262|NCT00511004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836263|NCT00511004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101836264|NCT00511004|Filaricides|filaricides|mesh-ancestor
101836265|NCT00511004|Antinematodal Agents|antinematodal agents|mesh-ancestor
101836266|NCT00511004|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101836267|NCT00511004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101836268|NCT02550197|Vaccines|vaccines|mesh-list
101836269|NCT02550197|Immunologic Factors|immunologic factors|mesh-ancestor
101836270|NCT02550197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836271|NCT00939965|Isotretinoin|isotretinoin|mesh-list
101836272|NCT00939965|Dermatologic Agents|dermatologic agents|mesh-ancestor
101836273|NCT04012541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
101836274|NCT02877134|Ustekinumab|ustekinumab|mesh-list
101836275|NCT02877134|Dermatologic Agents|dermatologic agents|mesh-ancestor
101836276|NCT00563381|Bromides|bromides|mesh-list
101836277|NCT00563381|Tiotropium Bromide|tiotropium bromide|mesh-list
101836278|NCT00563381|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101836279|NCT00563381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101836280|NCT00563381|Autonomic Agents|autonomic agents|mesh-ancestor
101836281|NCT00563381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101836282|NCT00563381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836283|NCT00563381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101836284|NCT00563381|Respiratory System Agents|respiratory system agents|mesh-ancestor
101836285|NCT00563381|Parasympatholytics|parasympatholytics|mesh-ancestor
101836286|NCT00563381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101836287|NCT00563381|Cholinergic Agents|cholinergic agents|mesh-ancestor
101836288|NCT00563381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101836289|NCT00563381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836290|NCT00563381|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101836291|NCT00563381|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101836292|NCT00563381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101836293|NCT00563381|Adrenergic Agents|adrenergic agents|mesh-ancestor
101836294|NCT00563381|Anticonvulsants|anticonvulsants|mesh-ancestor
101836295|NCT00512798|Temozolomide|temozolomide|mesh-list
101836296|NCT00512798|Bortezomib|bortezomib|mesh-list
101836297|NCT00512798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101836298|NCT00512798|Alkylating Agents|alkylating agents|mesh-ancestor
101836299|NCT00512798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836300|NCT00512798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101836301|NCT00940121|Mirabegron|mirabegron|mesh-list
101836302|NCT00940121|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101836303|NCT00940121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101836304|NCT00940121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101836305|NCT00940121|Adrenergic Agents|adrenergic agents|mesh-ancestor
101836306|NCT00940121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101836307|NCT00940121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836308|NCT00940121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836309|NCT00940121|Urological Agents|urological agents|mesh-ancestor
101836310|NCT04012619|Cisplatin|cisplatin|mesh-list
101836311|NCT04012619|Carboplatin|carboplatin|mesh-list
101836312|NCT04012619|Pemetrexed|pemetrexed|mesh-list
101836313|NCT04012619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101836314|NCT04012619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101836315|NCT04012619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836316|NCT04012619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101836317|NCT04012619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101836318|NCT00941057|Calcium, Dietary|calcium, dietary|mesh-list
101836319|NCT00941057|Tetrahydrofolates|tetrahydrofolates|mesh-list
101836320|NCT00941057|Dienogest|dienogest|mesh-list
101836321|NCT00941057|Calcium|calcium|mesh-list
101836322|NCT00941057|Nandrolone|nandrolone|mesh-list
101836323|NCT00941057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101836324|NCT00941057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836325|NCT00941057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101836326|NCT00941057|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101836327|NCT00941057|Contraceptive Agents|contraceptive agents|mesh-ancestor
101836328|NCT00941057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101836329|NCT00941057|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101836330|NCT00941057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101836331|NCT00941057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101836332|NCT00941057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101836333|NCT00941057|Hormone Antagonists|hormone antagonists|mesh-ancestor
101836334|NCT00941057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101836335|NCT00941057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101836336|NCT00941057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101836337|NCT00941057|Androgens|androgens|mesh-ancestor
101836338|NCT00941057|Hormones|hormones|mesh-ancestor
101836339|NCT00941057|Anabolic Agents|anabolic agents|mesh-ancestor
101836340|NCT00941057|Vitamin B Complex|vitamin b complex|mesh-ancestor
101836341|NCT00941057|Vitamins|vitamins|mesh-ancestor
101836342|NCT00941057|Micronutrients|micronutrients|mesh-ancestor
101836343|NCT00561821|Mirtazapine|mirtazapine|mesh-list
101836344|NCT00561821|Antidepressive Agents|antidepressive agents|mesh-ancestor
101836346|NCT00561821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101836347|NCT00561821|Histamine Antagonists|histamine antagonists|mesh-ancestor
101836348|NCT00561821|Histamine Agents|histamine agents|mesh-ancestor
101836349|NCT00561821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101836350|NCT00561821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836351|NCT00561821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836352|NCT00561821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101836353|NCT00561821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101836354|NCT00561821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101836355|NCT00561821|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101836356|NCT00561821|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101836357|NCT00561821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101836358|NCT00561821|Adrenergic Agents|adrenergic agents|mesh-ancestor
101836359|NCT00561821|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101836360|NCT00561821|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101836361|NCT00561821|Serotonin Agents|serotonin agents|mesh-ancestor
101836362|NCT00561821|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101836363|NCT03684044|Baloxavir|baloxavir|mesh-list
101836364|NCT03684044|Antiviral Agents|antiviral agents|mesh-ancestor
101836365|NCT03684044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101836366|NCT03684044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101836367|NCT03684044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836368|NCT01009502|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
101836369|NCT01009502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101836370|NCT01009502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101836371|NCT01009502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101836372|NCT01009502|Schistosomicides|schistosomicides|mesh-ancestor
101836373|NCT01009502|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101836374|NCT01009502|Anthelmintics|anthelmintics|mesh-ancestor
101836375|NCT00335452|Clopidogrel|clopidogrel|mesh-list
101836376|NCT00335452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101836377|NCT00335452|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101836378|NCT00335452|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101836380|NCT00335452|Purinergic Agents|purinergic agents|mesh-ancestor
101836381|NCT00335452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101836382|NCT00335452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836383|NCT00335452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836384|NCT00522548|Mycophenolic Acid|mycophenolic acid|mesh-list
101836385|NCT00522548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101836386|NCT00522548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101836387|NCT00522548|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101836388|NCT00522548|Antitubercular Agents|antitubercular agents|mesh-ancestor
101836389|NCT00522548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101836390|NCT00522548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101836391|NCT00522548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101836392|NCT00522548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836393|NCT00522392|Dexamethasone|dexamethasone|mesh-list
101836394|NCT00522392|Lenalidomide|lenalidomide|mesh-list
101836395|NCT00522392|Bortezomib|bortezomib|mesh-list
101836396|NCT00522392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101836397|NCT00522392|Antiemetics|antiemetics|mesh-ancestor
101836398|NCT00522392|Autonomic Agents|autonomic agents|mesh-ancestor
101836399|NCT00522392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101836400|NCT00522392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836401|NCT00522392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101836402|NCT00522392|Glucocorticoids|glucocorticoids|mesh-ancestor
101836403|NCT00522392|Hormones|hormones|mesh-ancestor
101836404|NCT00522392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101836405|NCT00522392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101836406|NCT00522392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101836407|NCT00522392|Immunologic Factors|immunologic factors|mesh-ancestor
101836408|NCT00522392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101836409|NCT00522392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101224562|NCT01524575|Gemcitabine|gemcitabine|mesh-list
101836410|NCT00522392|Growth Substances|growth substances|mesh-ancestor
101836411|NCT00522392|Growth Inhibitors|growth inhibitors|mesh-ancestor
101836412|NCT01061320|Tocopherols|tocopherols|mesh-list
101836413|NCT01061320|Vitamin E|vitamin e|mesh-list
101836414|NCT01061320|Tocotrienols|tocotrienols|mesh-list
101836415|NCT01061320|alpha-Tocopherol|alpha-tocopherol|mesh-list
101556193|NCT01304693|Ranibizumab|ranibizumab|mesh-list
101836416|NCT01061320|Vitamins|vitamins|mesh-ancestor
101836417|NCT01061320|Micronutrients|micronutrients|mesh-ancestor
101836418|NCT01061320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836419|NCT01061320|Antioxidants|antioxidants|mesh-ancestor
101836420|NCT01061320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836421|NCT01061320|Protective Agents|protective agents|mesh-ancestor
101836422|NCT01012544|Clopidogrel|clopidogrel|mesh-list
101836423|NCT01012544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101836424|NCT01012544|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101836425|NCT01012544|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101836426|NCT01012544|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101836427|NCT01012544|Purinergic Agents|purinergic agents|mesh-ancestor
101836428|NCT01012544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101836429|NCT01012544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836430|NCT01012544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836431|NCT01012700|Poly ICLC|poly iclc|mesh-list
101836432|NCT01012700|Interferon Inducers|interferon inducers|mesh-ancestor
101836433|NCT01012700|Immunologic Factors|immunologic factors|mesh-ancestor
101836434|NCT01012700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836435|NCT01565720|Moxifloxacin|moxifloxacin|mesh-list
101836436|NCT01565720|Isavuconazole|isavuconazole|mesh-list
101836437|NCT01565720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101836438|NCT01565720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102096778|NCT04977544|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102096779|NCT04977544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102096780|NCT04977544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102096781|NCT04977544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096782|NCT04977544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102096783|NCT04977544|Serotonin Agents|serotonin agents|mesh-ancestor
102096784|NCT04977544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096785|NCT02626000|Pembrolizumab|pembrolizumab|mesh-list
102096786|NCT02626000|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
102096787|NCT02626000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102096788|NCT02626000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096789|NCT02626000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101836439|NCT01565720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102096790|NCT02626000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096791|NCT03769376|Salvin|salvin|mesh-list
102096792|NCT03769376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102096793|NCT03769376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102096794|NCT03769376|Antioxidants|antioxidants|mesh-ancestor
102096795|NCT03769376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096796|NCT03769376|Protective Agents|protective agents|mesh-ancestor
102096797|NCT03769376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096798|NCT05156450|Prednisone|prednisone|mesh-list
102096799|NCT05156450|Abiraterone Acetate|abiraterone acetate|mesh-list
102096800|NCT05156450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102096801|NCT05156450|Glucocorticoids|glucocorticoids|mesh-ancestor
102096802|NCT05156450|Hormones|hormones|mesh-ancestor
102096803|NCT05156450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102096804|NCT05156450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096805|NCT05156450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102096806|NCT05156450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096807|NCT05156450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102096808|NCT05156450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101224575|NCT01524601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102096809|NCT05156450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096810|NCT05156450|Hormone Antagonists|hormone antagonists|mesh-ancestor
102096811|NCT05156450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102096812|NCT03060304|Tamoxifen|tamoxifen|mesh-list
102096813|NCT03060304|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102096814|NCT03060304|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102096815|NCT03060304|Estradiol|estradiol|mesh-list
102096816|NCT03060304|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102096817|NCT03060304|Estrogens|estrogens|mesh-ancestor
102096818|NCT03060304|Hormones|hormones|mesh-ancestor
102096819|NCT03060304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102096820|NCT03060304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096821|NCT03060304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102096822|NCT03060304|Contraceptive Agents|contraceptive agents|mesh-ancestor
102096823|NCT03060304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102096824|NCT03060304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102096825|NCT03060304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102096826|NCT03060304|Hormone Antagonists|hormone antagonists|mesh-ancestor
102096827|NCT03060304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102096828|NCT03060304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096829|NCT03060304|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102096830|NCT03060304|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102096831|NCT03060304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102096832|NCT04432402|Gemcitabine|gemcitabine|mesh-list
102096833|NCT04432402|Oxaliplatin|oxaliplatin|mesh-list
102096834|NCT04432402|Lenalidomide|lenalidomide|mesh-list
102096835|NCT04432402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096836|NCT04432402|Immunologic Factors|immunologic factors|mesh-ancestor
102096837|NCT04432402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096838|NCT04432402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102096839|NCT04432402|Antimetabolites|antimetabolites|mesh-ancestor
102096840|NCT04432402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096841|NCT04432402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102096842|NCT04432402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102096843|NCT04432402|Growth Substances|growth substances|mesh-ancestor
102096844|NCT04432402|Growth Inhibitors|growth inhibitors|mesh-ancestor
102096845|NCT04432324|Immunoglobulins|immunoglobulins|mesh-list
102096846|NCT04432324|Antibodies|antibodies|mesh-list
102096847|NCT04432324|gamma-Globulins|gamma-globulins|mesh-list
102096848|NCT04432324|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102096849|NCT04432324|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102096850|NCT04432324|Immunologic Factors|immunologic factors|mesh-ancestor
102096851|NCT04432324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096852|NCT02736890|Botulinum Toxins|botulinum toxins|mesh-list
102096853|NCT02736890|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102096854|NCT02736890|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102096855|NCT02736890|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102096856|NCT02736890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102096857|NCT02736890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096858|NCT02736890|Cholinergic Agents|cholinergic agents|mesh-ancestor
102096859|NCT02736890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102096860|NCT02736890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096861|NCT02736890|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102096862|NCT02736890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102096863|NCT04977388|Droxidopa|droxidopa|mesh-list
102096864|NCT04977388|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102096865|NCT04977388|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102096867|NCT03470480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102096868|NCT03470480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096869|NCT03470480|Sympathomimetics|sympathomimetics|mesh-ancestor
102096870|NCT03470480|Autonomic Agents|autonomic agents|mesh-ancestor
102096871|NCT03470480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102096872|NCT03470480|Dopamine Agents|dopamine agents|mesh-ancestor
102096873|NCT03470480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101224587|NCT01524705|Insulin Glargine|insulin glargine|mesh-list
102096874|NCT03470480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096875|NCT03470480|Adrenergic Agents|adrenergic agents|mesh-ancestor
102096876|NCT03470480|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102096877|NCT03470480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102096878|NCT03470480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102096879|NCT03470480|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102096880|NCT03469856|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102096881|NCT03469856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102096882|NCT04917250|Dexamethasone|dexamethasone|mesh-list
102096883|NCT04917250|Gemcitabine|gemcitabine|mesh-list
102096884|NCT04917250|Etoposide|etoposide|mesh-list
102096885|NCT04917250|Pegaspargase|pegaspargase|mesh-list
102096886|NCT04917250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102096887|NCT04917250|Antiemetics|antiemetics|mesh-ancestor
102096888|NCT04917250|Autonomic Agents|autonomic agents|mesh-ancestor
101953053|NCT02260024|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102096889|NCT04917250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102096890|NCT04917250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096891|NCT04917250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102096892|NCT04917250|Glucocorticoids|glucocorticoids|mesh-ancestor
102096893|NCT04917250|Hormones|hormones|mesh-ancestor
102096894|NCT04917250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102096895|NCT04917250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102096896|NCT04917250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096897|NCT04917250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102096898|NCT04917250|Antimetabolites|antimetabolites|mesh-ancestor
102096899|NCT04917250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096900|NCT04917250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102096901|NCT04917250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102096902|NCT04917250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102096903|NCT04917250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102096904|NCT04859582|Pembrolizumab|pembrolizumab|mesh-list
102096905|NCT04859582|Fluorouracil|fluorouracil|mesh-list
102096906|NCT04859582|Capecitabine|capecitabine|mesh-list
102096907|NCT04859582|Oxaliplatin|oxaliplatin|mesh-list
102096908|NCT04859582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096909|NCT04859582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102096910|NCT04859582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102096911|NCT04859582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096912|NCT04859582|Antimetabolites|antimetabolites|mesh-ancestor
102096913|NCT04859582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102096914|NCT04859582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102096915|NCT04859582|Immunologic Factors|immunologic factors|mesh-ancestor
102096916|NCT04859582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096917|NCT03469700|Anesthetics|anesthetics|mesh-list
102096918|NCT03469700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102096919|NCT03469700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096920|NCT04912726|Sildenafil Citrate|sildenafil citrate|mesh-list
102096921|NCT04912726|Vasodilator Agents|vasodilator agents|mesh-ancestor
102096922|NCT04912726|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102096923|NCT04912726|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102096924|NCT04912726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102096925|NCT04912726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096926|NCT04912726|Urological Agents|urological agents|mesh-ancestor
102096927|NCT02603900|Bupivacaine|bupivacaine|mesh-list
102096928|NCT02603900|Ropivacaine|ropivacaine|mesh-list
102096929|NCT02603900|Anesthetics, Local|anesthetics, local|mesh-ancestor
102096930|NCT02603900|Anesthetics|anesthetics|mesh-ancestor
102096931|NCT02603900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102096932|NCT02603900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096933|NCT02603900|Sensory System Agents|sensory system agents|mesh-ancestor
102096934|NCT02603900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102096935|NCT01669798|Nintedanib|nintedanib|mesh-list
102096936|NCT01669798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096937|NCT01669798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102096938|NCT01669798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102096939|NCT01669798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096940|NCT02334722|Levetiracetam|levetiracetam|mesh-list
102096941|NCT02334722|Anticonvulsants|anticonvulsants|mesh-ancestor
102096942|NCT02334722|Nootropic Agents|nootropic agents|mesh-ancestor
102096943|NCT04458116|Curcumin|curcumin|mesh-list
101224597|NCT01524731|Dexamethasone acetate|dexamethasone acetate|mesh-list
102096944|NCT04458116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102096945|NCT04458116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102096946|NCT04458116|Analgesics|analgesics|mesh-ancestor
102096947|NCT04458116|Sensory System Agents|sensory system agents|mesh-ancestor
102096948|NCT04458116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102096949|NCT04458116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096950|NCT04458116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102096951|NCT04458116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102096952|NCT04458116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096953|NCT04458116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102096954|NCT04458116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096955|NCT03469544|Hormones|hormones|mesh-list
102096956|NCT03469544|Antibodies|antibodies|mesh-list
102096957|NCT03469544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102096958|NCT03469544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096959|NCT03469544|Immunologic Factors|immunologic factors|mesh-ancestor
102096960|NCT03062254|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
102096961|NCT03062254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096962|NCT04912258|Irinotecan|irinotecan|mesh-list
102096963|NCT04912258|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102096964|NCT04912258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102096965|NCT04912258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102096966|NCT04912258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096967|NCT04912258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096968|NCT01952288|Simvastatin|simvastatin|mesh-list
102096969|NCT01952288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102096970|NCT01952288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102096971|NCT01952288|Antimetabolites|antimetabolites|mesh-ancestor
102096972|NCT01952288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096973|NCT01952288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102096974|NCT01952288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102096975|NCT01952288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102096976|NCT03054532|Durvalumab|durvalumab|mesh-list
102096977|NCT03054532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102096978|NCT03054532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096979|NCT04975360|Caffeine|caffeine|mesh-list
102096980|NCT04975360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102096981|NCT04975360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096982|NCT04975360|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102096983|NCT04975360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102096984|NCT04975360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096985|NCT04975360|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102096986|NCT04975360|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102096987|NCT04975360|Purinergic Agents|purinergic agents|mesh-ancestor
102096988|NCT04975360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102096989|NCT00563576|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102096990|NCT00563576|Medroxyprogesterone|medroxyprogesterone|mesh-list
102096991|NCT00563576|Estradiol|estradiol|mesh-list
102096992|NCT00563576|Estrogens|estrogens|mesh-ancestor
102096993|NCT00563576|Hormones|hormones|mesh-ancestor
102096994|NCT00563576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102096995|NCT00563576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096996|NCT00563576|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102096997|NCT00563576|Contraceptive Agents|contraceptive agents|mesh-ancestor
102096998|NCT00563576|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102096999|NCT00563576|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102097000|NCT00563576|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102097001|NCT00563576|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102097002|NCT00563576|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102097003|NCT00563576|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102097004|NCT00563576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102097005|NCT00563576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102097006|NCT04915846|Tamoxifen|tamoxifen|mesh-list
102097007|NCT04915846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102097008|NCT04915846|Hormone Antagonists|hormone antagonists|mesh-ancestor
102097009|NCT04915846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102097010|NCT04915846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097011|NCT04915846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102097012|NCT04915846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102097013|NCT04915846|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102097014|NCT04915846|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102097015|NCT04915846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102097017|NCT03782636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102097018|NCT03782636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102097019|NCT03782636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102097020|NCT03782636|Antiviral Agents|antiviral agents|mesh-ancestor
102097021|NCT03782636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102097022|NCT04911244|Dimercaprol|dimercaprol|mesh-list
102097023|NCT04911244|Chelating Agents|chelating agents|mesh-ancestor
102097024|NCT04911244|Sequestering Agents|sequestering agents|mesh-ancestor
102097025|NCT04911244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097026|NCT03761810|Tretinoin|tretinoin|mesh-list
102097027|NCT03761810|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102097028|NCT03761810|Dermatologic Agents|dermatologic agents|mesh-ancestor
102097029|NCT03761810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102097030|NCT03761810|Keratolytic Agents|keratolytic agents|mesh-ancestor
102097031|NCT04915456|Prednisolone|prednisolone|mesh-list
102097032|NCT04915456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102097033|NCT04915456|Glucocorticoids|glucocorticoids|mesh-ancestor
102097034|NCT04915456|Hormones|hormones|mesh-ancestor
102097035|NCT04915456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102097036|NCT04915456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097037|NCT04915456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102097038|NCT04915456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102097039|NCT04841668|Metformin|metformin|mesh-list
102097040|NCT04841668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102097041|NCT04841668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097042|NCT04914910|Insulin|insulin|mesh-list
102097043|NCT04914910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102097044|NCT04914910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097045|NCT03469310|Acetaminophen|acetaminophen|mesh-list
102097046|NCT03469310|Tramadol|tramadol|mesh-list
102097047|NCT03469310|Codeine|codeine|mesh-list
102097048|NCT03469310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102097049|NCT03469310|Analgesics|analgesics|mesh-ancestor
102097050|NCT03469310|Sensory System Agents|sensory system agents|mesh-ancestor
102097051|NCT03469310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102097052|NCT03469310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097053|NCT03469310|Antipyretics|antipyretics|mesh-ancestor
102097054|NCT03469310|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102097055|NCT03469310|Narcotics|narcotics|mesh-ancestor
102097056|NCT03469310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102097057|NCT03469310|Antitussive Agents|antitussive agents|mesh-ancestor
102097058|NCT03469310|Respiratory System Agents|respiratory system agents|mesh-ancestor
102097059|NCT03527186|Risperidone|risperidone|mesh-list
102097060|NCT03527186|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102097061|NCT03527186|Serotonin Agents|serotonin agents|mesh-ancestor
102097062|NCT03527186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102097063|NCT03527186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097064|NCT03527186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097065|NCT03527186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102097066|NCT03527186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102097067|NCT03527186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102097068|NCT03527186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102097069|NCT03527186|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102097070|NCT03527186|Dopamine Agents|dopamine agents|mesh-ancestor
102097071|NCT05159882|Dapagliflozin|dapagliflozin|mesh-list
102097072|NCT05159882|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102097073|NCT05159882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097074|NCT05159882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102097075|NCT05159882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097076|NCT04910698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102097077|NCT04910698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102097078|NCT04455464|Midodrine|midodrine|mesh-list
102097079|NCT04455464|Sympathomimetics|sympathomimetics|mesh-ancestor
102097080|NCT04455464|Autonomic Agents|autonomic agents|mesh-ancestor
102097081|NCT04455464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102097082|NCT04455464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097083|NCT04455464|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102097084|NCT04455464|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102097085|NCT04455464|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102097086|NCT04455464|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102097087|NCT04455464|Adrenergic Agents|adrenergic agents|mesh-ancestor
102097088|NCT04455464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102097089|NCT04455464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097091|NCT04914598|Endostar protein|endostar protein|mesh-list
102097092|NCT04914598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102097093|NCT04914598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102097094|NCT04914598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102097095|NCT04914598|Growth Substances|growth substances|mesh-ancestor
102097096|NCT04914598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097097|NCT04914598|Growth Inhibitors|growth inhibitors|mesh-ancestor
102097098|NCT03054220|Tramadol|tramadol|mesh-list
102097099|NCT03054220|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101953069|NCT02047630|Latanoprost|latanoprost|mesh-list
102097100|NCT03054220|Dextromethorphan|dextromethorphan|mesh-list
102097101|NCT03054220|Paroxetine|paroxetine|mesh-list
102097102|NCT03054220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102097103|NCT03054220|Narcotics|narcotics|mesh-ancestor
102097104|NCT03054220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102097105|NCT03054220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097106|NCT03054220|Analgesics|analgesics|mesh-ancestor
102097107|NCT03054220|Sensory System Agents|sensory system agents|mesh-ancestor
102097108|NCT03054220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102097109|NCT03054220|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102097110|NCT03054220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102097111|NCT03054220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102097112|NCT03054220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097113|NCT03054220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102097114|NCT03054220|Antidepressive Agents|antidepressive agents|mesh-ancestor
102097115|NCT03054220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102097116|NCT03054220|Dopamine Agents|dopamine agents|mesh-ancestor
102097117|NCT03054220|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102097118|NCT03054220|Serotonin Agents|serotonin agents|mesh-ancestor
102097119|NCT03054220|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102097120|NCT03054220|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102097121|NCT03054220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102097122|NCT03054220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102097123|NCT03054220|Antitussive Agents|antitussive agents|mesh-ancestor
102097124|NCT03054220|Respiratory System Agents|respiratory system agents|mesh-ancestor
102097125|NCT03054220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102097126|NCT03054220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102097127|NCT05388188|Sufentanil|sufentanil|mesh-list
102097128|NCT05388188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102097129|NCT05388188|Narcotics|narcotics|mesh-ancestor
102097130|NCT05388188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102097131|NCT05388188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097132|NCT05388188|Analgesics|analgesics|mesh-ancestor
102097133|NCT05388188|Sensory System Agents|sensory system agents|mesh-ancestor
102097134|NCT05388188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102097135|NCT05388188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102097136|NCT05388188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102097137|NCT05388188|Anesthetics, General|anesthetics, general|mesh-ancestor
102097138|NCT05388188|Anesthetics|anesthetics|mesh-ancestor
102097139|NCT04118036|Pembrolizumab|pembrolizumab|mesh-list
102097140|NCT04118036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102097141|NCT04118036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102097142|NCT04118036|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102097143|NCT04118036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097144|NCT04909918|Dexamethasone|dexamethasone|mesh-list
102097145|NCT04909918|Methylprednisolone|methylprednisolone|mesh-list
102097146|NCT04909918|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102097147|NCT04909918|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102097148|NCT04909918|Prednisolone|prednisolone|mesh-list
102097149|NCT04909918|Prednisolone acetate|prednisolone acetate|mesh-list
102097150|NCT04909918|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102097151|NCT04909918|Prednisolone phosphate|prednisolone phosphate|mesh-list
102097152|NCT04909918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102097153|NCT04909918|Antiemetics|antiemetics|mesh-ancestor
102097154|NCT04909918|Autonomic Agents|autonomic agents|mesh-ancestor
102097155|NCT04909918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102097156|NCT04909918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097157|NCT04909918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102097158|NCT04909918|Glucocorticoids|glucocorticoids|mesh-ancestor
102097159|NCT04909918|Hormones|hormones|mesh-ancestor
102097160|NCT04909918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102097161|NCT04909918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102097162|NCT04909918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102097163|NCT04909918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102097164|NCT04909918|Protective Agents|protective agents|mesh-ancestor
102097165|NCT04903678|Melphalan|melphalan|mesh-list
102097166|NCT04903678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102097167|NCT04903678|Alkylating Agents|alkylating agents|mesh-ancestor
102097168|NCT04903678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097169|NCT04903678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102097171|NCT04903678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102097172|NCT04903678|Immunologic Factors|immunologic factors|mesh-ancestor
102097173|NCT04903678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097174|NCT04903366|Timolol|timolol|mesh-list
102097175|NCT04903366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097176|NCT04903366|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102097177|NCT04903366|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102097178|NCT04903366|Adrenergic Agents|adrenergic agents|mesh-ancestor
102097179|NCT04903366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102097180|NCT04903366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097181|NCT04903366|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102097182|NCT04903366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102097183|NCT03054610|Betamethasone|betamethasone|mesh-list
102097184|NCT03054610|Betamethasone Valerate|betamethasone valerate|mesh-list
102097185|NCT03054610|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102097186|NCT03054610|Betamethasone benzoate|betamethasone benzoate|mesh-list
102097187|NCT03054610|Ropivacaine|ropivacaine|mesh-list
102097188|NCT03054610|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
102097189|NCT03054610|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102097190|NCT03054610|Botulinum Toxins|botulinum toxins|mesh-list
102097191|NCT03054610|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102097192|NCT03054610|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102097193|NCT03054610|Anesthetics, Local|anesthetics, local|mesh-ancestor
102097194|NCT03054610|Anesthetics|anesthetics|mesh-ancestor
102097195|NCT03054610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102097196|NCT03054610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097197|NCT03054610|Sensory System Agents|sensory system agents|mesh-ancestor
102097198|NCT03054610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102097199|NCT03054610|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102097200|NCT03054610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102097201|NCT03054610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097202|NCT03054610|Cholinergic Agents|cholinergic agents|mesh-ancestor
102097203|NCT03054610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102097204|NCT03054610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102097205|NCT03054610|Glucocorticoids|glucocorticoids|mesh-ancestor
102097206|NCT03054610|Hormones|hormones|mesh-ancestor
102097207|NCT03054610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102097208|NCT03054610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102097209|NCT03054610|Respiratory System Agents|respiratory system agents|mesh-ancestor
102097210|NCT03054610|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102097211|NCT03054610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102097212|NCT03054610|Autonomic Agents|autonomic agents|mesh-ancestor
102097213|NCT03053830|Ketamine|ketamine|mesh-list
102097214|NCT03053830|Analgesics|analgesics|mesh-ancestor
102097215|NCT03053830|Sensory System Agents|sensory system agents|mesh-ancestor
102097216|NCT03053830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102097217|NCT03053830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097218|NCT03053830|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102097219|NCT03053830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102097220|NCT03053830|Anesthetics, General|anesthetics, general|mesh-ancestor
102097221|NCT03053830|Anesthetics|anesthetics|mesh-ancestor
102097222|NCT03053830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102097223|NCT03053830|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102097224|NCT03053830|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102097225|NCT03053830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102097226|NCT03053830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097227|NCT04913896|Oxaliplatin|oxaliplatin|mesh-list
102097228|NCT04913896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102097229|NCT04913896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102097230|NCT04913896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097231|NCT04913896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102097232|NCT03053284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102097233|NCT03053284|Pasireotide|pasireotide|mesh-list
102097234|NCT03053284|Hormones|hormones|mesh-ancestor
102097235|NCT03053284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102097236|NCT03053284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097237|NCT04901884|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102097238|NCT04901884|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102097239|NCT04901884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097240|NCT04908982|Aspirin|aspirin|mesh-list
102097241|NCT04908982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102097242|NCT04908982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102097243|NCT04908982|Analgesics|analgesics|mesh-ancestor
102097244|NCT04908982|Sensory System Agents|sensory system agents|mesh-ancestor
102097245|NCT04908982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102097246|NCT04908982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097247|NCT04908982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102097248|NCT04908982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102097249|NCT04908982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102097250|NCT04908982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102097251|NCT04908982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224643|NCT01524861|Thioctic Acid|thioctic acid|mesh-list
102097252|NCT04908982|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102097253|NCT04908982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102097254|NCT04908982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102097255|NCT04908982|Antipyretics|antipyretics|mesh-ancestor
102097256|NCT04430998|Chlorhexidine|chlorhexidine|mesh-list
102097257|NCT04430998|Polaprezinc|polaprezinc|mesh-list
102097258|NCT04430998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102097259|NCT04430998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102097260|NCT04430998|Disinfectants|disinfectants|mesh-ancestor
102097261|NCT04430998|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102097262|NCT04430998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102097263|NCT04900948|Methylprednisolone|methylprednisolone|mesh-list
102097264|NCT04900948|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102097265|NCT04900948|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102097266|NCT04900948|Prednisolone|prednisolone|mesh-list
102097267|NCT04900948|Prednisolone acetate|prednisolone acetate|mesh-list
102097268|NCT04900948|Pimecrolimus|pimecrolimus|mesh-list
102097269|NCT04900948|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
102097270|NCT04900948|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102097271|NCT04900948|Prednisolone phosphate|prednisolone phosphate|mesh-list
102097272|NCT04900948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102097273|NCT04900948|Antiemetics|antiemetics|mesh-ancestor
102097274|NCT04900948|Autonomic Agents|autonomic agents|mesh-ancestor
102097275|NCT04900948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102097276|NCT04900948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097277|NCT04900948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102097278|NCT04900948|Glucocorticoids|glucocorticoids|mesh-ancestor
102097279|NCT04900948|Hormones|hormones|mesh-ancestor
102097280|NCT04900948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102097281|NCT04900948|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102097282|NCT04900948|Protective Agents|protective agents|mesh-ancestor
102097283|NCT04900948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102097284|NCT04900948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102097285|NCT04900948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102097286|NCT04900948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102097287|NCT04900948|Analgesics|analgesics|mesh-ancestor
102097288|NCT04900948|Sensory System Agents|sensory system agents|mesh-ancestor
102097289|NCT04900948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102097290|NCT04900948|Dermatologic Agents|dermatologic agents|mesh-ancestor
102097291|NCT04900948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102097292|NCT04900948|Immunologic Factors|immunologic factors|mesh-ancestor
102097293|NCT04900948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102097294|NCT04900948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102097295|NCT04900948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097296|NCT04901104|Thymalfasin|thymalfasin|mesh-list
102097297|NCT04901104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102097298|NCT04901104|Immunologic Factors|immunologic factors|mesh-ancestor
102097299|NCT04901104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097300|NCT04907812|Tranexamic Acid|tranexamic acid|mesh-list
102097301|NCT04907812|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102097302|NCT04907812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102097303|NCT04907812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097304|NCT04907812|Hemostatics|hemostatics|mesh-ancestor
102097305|NCT04907812|Coagulants|coagulants|mesh-ancestor
102097306|NCT01889186|Venetoclax|venetoclax|mesh-list
102097307|NCT01889186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102097308|NCT04892212|Sirolimus|sirolimus|mesh-list
101550661|NCT02890173|Eplerenone|eplerenone|mesh-list
102097309|NCT04892212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102097310|NCT04892212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102097311|NCT04892212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102097312|NCT04892212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102097313|NCT04892212|Antifungal Agents|antifungal agents|mesh-ancestor
102097314|NCT04892212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102097315|NCT04892212|Immunologic Factors|immunologic factors|mesh-ancestor
102097316|NCT04892212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097317|NCT01510184|Rituximab|rituximab|mesh-list
102097318|NCT01510184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102097319|NCT01510184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102097320|NCT01510184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102097321|NCT01510184|Immunologic Factors|immunologic factors|mesh-ancestor
102097322|NCT01510184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097323|NCT01510184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102097324|NCT04907344|Paclitaxel|paclitaxel|mesh-list
102097325|NCT04907344|Carboplatin|carboplatin|mesh-list
102097326|NCT04907344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102097327|NCT04907344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102097328|NCT04907344|Tubulin Modulators|tubulin modulators|mesh-ancestor
102097329|NCT04907344|Antimitotic Agents|antimitotic agents|mesh-ancestor
102097330|NCT04907344|Mitosis Modulators|mitosis modulators|mesh-ancestor
102097331|NCT04907344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097332|NCT04906876|Gemcitabine|gemcitabine|mesh-list
102097333|NCT04906876|Docetaxel|docetaxel|mesh-list
102097334|NCT04906876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102097335|NCT04906876|Antimetabolites|antimetabolites|mesh-ancestor
102097336|NCT04906876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097337|NCT04906876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102097338|NCT04906876|Tubulin Modulators|tubulin modulators|mesh-ancestor
102097339|NCT04906876|Antimitotic Agents|antimitotic agents|mesh-ancestor
102097340|NCT04906876|Mitosis Modulators|mitosis modulators|mesh-ancestor
102097341|NCT04891744|Thalidomide|thalidomide|mesh-list
102097342|NCT04891744|Dexamethasone|dexamethasone|mesh-list
102097343|NCT04891744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102097344|NCT04891744|Antiemetics|antiemetics|mesh-ancestor
102097345|NCT04891744|Autonomic Agents|autonomic agents|mesh-ancestor
102097346|NCT04891744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102097347|NCT04891744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097348|NCT04891744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102097349|NCT04891744|Glucocorticoids|glucocorticoids|mesh-ancestor
102097350|NCT04891744|Hormones|hormones|mesh-ancestor
102097351|NCT04891744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102097352|NCT04891744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102097353|NCT04891744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102097354|NCT04891744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102097355|NCT04891744|Immunologic Factors|immunologic factors|mesh-ancestor
102097356|NCT04891744|Leprostatic Agents|leprostatic agents|mesh-ancestor
102097357|NCT04891744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102097358|NCT04891744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102097359|NCT04891744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102097360|NCT04891744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102097361|NCT04891744|Growth Substances|growth substances|mesh-ancestor
102097362|NCT04891744|Growth Inhibitors|growth inhibitors|mesh-ancestor
102097363|NCT04891900|Capecitabine|capecitabine|mesh-list
102097364|NCT04891900|Oxaliplatin|oxaliplatin|mesh-list
102097365|NCT04891900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102097366|NCT04891900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102097367|NCT04891900|Antimetabolites|antimetabolites|mesh-ancestor
102097368|NCT04891900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097369|NCT04891900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102097370|NCT04891900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102097371|NCT04891588|Timolol|timolol|mesh-list
102097372|NCT04891588|Latanoprost|latanoprost|mesh-list
102097373|NCT04891588|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102097374|NCT04891588|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102097375|NCT04891588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097376|NCT04891588|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102097377|NCT04891588|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102097378|NCT04891588|Adrenergic Agents|adrenergic agents|mesh-ancestor
102097379|NCT04891588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102097380|NCT04891588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097381|NCT04891588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102097382|NCT04891588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102097383|NCT03050866|Antiemetics|antiemetics|mesh-list
102097384|NCT03050866|Histamine|histamine|mesh-list
102097385|NCT03050866|Histamine Antagonists|histamine antagonists|mesh-list
102097386|NCT03050866|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
102097387|NCT03050866|Histamine Agonists|histamine agonists|mesh-ancestor
102097388|NCT03050866|Histamine Agents|histamine agents|mesh-ancestor
102097389|NCT03050866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102097390|NCT03050866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097391|NCT03050866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097392|NCT03050866|Autonomic Agents|autonomic agents|mesh-ancestor
102097393|NCT03050866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102097394|NCT03050866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102097395|NCT03052660|Midazolam|midazolam|mesh-list
102097396|NCT03052660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102097397|NCT03052660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102097398|NCT03052660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102097399|NCT03052660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097400|NCT03052660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102097401|NCT03052660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102097402|NCT03052660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102097403|NCT03052660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102097404|NCT03052660|Anesthetics, General|anesthetics, general|mesh-ancestor
102097405|NCT03052660|Anesthetics|anesthetics|mesh-ancestor
102097406|NCT03052660|GABA Modulators|gaba modulators|mesh-ancestor
102097407|NCT03052660|GABA Agents|gaba agents|mesh-ancestor
102097408|NCT03052660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102097409|NCT03052660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097410|NCT05162456|Antibodies|antibodies|mesh-list
102097411|NCT05162456|Immunoglobulins|immunoglobulins|mesh-list
102097412|NCT05162456|Immunoglobulin G|immunoglobulin g|mesh-list
102097413|NCT05162456|Immunologic Factors|immunologic factors|mesh-ancestor
102097414|NCT05162456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097415|NCT05137886|Decitabine|decitabine|mesh-list
102097416|NCT05137886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102097417|NCT05137886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102097418|NCT05137886|Antimetabolites|antimetabolites|mesh-ancestor
102097419|NCT05137886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097420|NCT05137886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102097421|NCT05137886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102097422|NCT05137886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102097423|NCT04890418|Ketamine|ketamine|mesh-list
102097424|NCT04890418|Analgesics|analgesics|mesh-ancestor
102097425|NCT04890418|Sensory System Agents|sensory system agents|mesh-ancestor
102097426|NCT04890418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102097427|NCT04890418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097428|NCT04890418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102097429|NCT04890418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102097430|NCT04890418|Anesthetics, General|anesthetics, general|mesh-ancestor
102097431|NCT04890418|Anesthetics|anesthetics|mesh-ancestor
102097432|NCT04890418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101224704|NCT01525537|Anesthetics|anesthetics|mesh-ancestor
102097433|NCT04890418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102097434|NCT04890418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102097435|NCT04890418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102097436|NCT04890418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097437|NCT04455932|Liver Extracts|liver extracts|mesh-list
102097438|NCT04455932|Hematinics|hematinics|mesh-ancestor
102097439|NCT03051022|Dexamethasone|dexamethasone|mesh-list
102097440|NCT03051022|Morphine|morphine|mesh-list
102097441|NCT03051022|Bupivacaine|bupivacaine|mesh-list
102097442|NCT03051022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102097443|NCT03051022|Antiemetics|antiemetics|mesh-ancestor
102097444|NCT03051022|Autonomic Agents|autonomic agents|mesh-ancestor
102097445|NCT03051022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102097446|NCT03051022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097447|NCT03051022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102097448|NCT03051022|Glucocorticoids|glucocorticoids|mesh-ancestor
102097449|NCT03051022|Hormones|hormones|mesh-ancestor
102097450|NCT03051022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102097451|NCT03051022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102097452|NCT03051022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102097453|NCT03051022|Anesthetics, Local|anesthetics, local|mesh-ancestor
102097454|NCT03051022|Anesthetics|anesthetics|mesh-ancestor
102097455|NCT03051022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102097456|NCT03051022|Sensory System Agents|sensory system agents|mesh-ancestor
102097457|NCT03051022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102097458|NCT03051022|Narcotics|narcotics|mesh-ancestor
102097459|NCT03051022|Analgesics|analgesics|mesh-ancestor
102097460|NCT04648826|Azacitidine|azacitidine|mesh-list
102097461|NCT04648826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102097462|NCT04648826|Antimetabolites|antimetabolites|mesh-ancestor
102097463|NCT04648826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097464|NCT04648826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102097465|NCT04648826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102097466|NCT03052348|Fusidic Acid|fusidic acid|mesh-list
102097467|NCT03052348|Betamethasone|betamethasone|mesh-list
102097468|NCT03052348|Betamethasone Valerate|betamethasone valerate|mesh-list
102097469|NCT03052348|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102097470|NCT03052348|Betamethasone benzoate|betamethasone benzoate|mesh-list
102097472|NCT03052348|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102097473|NCT03052348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102097474|NCT03052348|Glucocorticoids|glucocorticoids|mesh-ancestor
102097475|NCT03052348|Hormones|hormones|mesh-ancestor
102097476|NCT03052348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102097477|NCT03052348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097478|NCT03052348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102097479|NCT03052348|Respiratory System Agents|respiratory system agents|mesh-ancestor
102097480|NCT03052348|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102097481|NCT03052348|Anesthetics, General|anesthetics, general|mesh-ancestor
102097482|NCT03052348|Anesthetics|anesthetics|mesh-ancestor
102097483|NCT03052348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102097484|NCT03052348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102097485|NCT03052348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102097486|NCT03052348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102097487|NCT03052348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102097488|NCT03052348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097489|NCT03963518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102097490|NCT03963518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097491|NCT03963518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102097492|NCT03963518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102097493|NCT04101890|Zinc Oxide|zinc oxide|mesh-list
102097494|NCT04101890|Dermatologic Agents|dermatologic agents|mesh-ancestor
102097495|NCT04101890|Sunscreening Agents|sunscreening agents|mesh-ancestor
102097496|NCT04101890|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102097497|NCT04101890|Protective Agents|protective agents|mesh-ancestor
102097498|NCT04101890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097499|NCT04456712|Ciprofloxacin|ciprofloxacin|mesh-list
102097500|NCT04456712|Levofloxacin|levofloxacin|mesh-list
102097501|NCT04456712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102097502|NCT04456712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102097503|NCT04456712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102097504|NCT04456712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102097505|NCT04456712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102097506|NCT04456712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097507|NCT04456712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102097508|NCT04456712|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102097509|NCT04456712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102097510|NCT04456712|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102097511|NCT04884490|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102097512|NCT04884490|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102097513|NCT04884490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102097514|NCT04884490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102097515|NCT04884490|Antimalarials|antimalarials|mesh-ancestor
102097516|NCT04884490|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102097517|NCT04884490|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102097518|NCT04854434|Trifluridine|trifluridine|mesh-list
102097519|NCT04854434|Pembrolizumab|pembrolizumab|mesh-list
102097520|NCT04854434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102097521|NCT04854434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102097522|NCT04854434|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102097523|NCT04854434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097524|NCT04854434|Antimetabolites|antimetabolites|mesh-ancestor
102097525|NCT04854434|Antiviral Agents|antiviral agents|mesh-ancestor
102097526|NCT04854434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102097527|NCT04897984|Anti-Infective Agents|anti-infective agents|mesh-list
102097528|NCT04897984|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102097529|NCT04456088|Nitric Oxide|nitric oxide|mesh-list
102097530|NCT04456088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102097531|NCT04456088|Autonomic Agents|autonomic agents|mesh-ancestor
102097532|NCT04456088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102097533|NCT04456088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097534|NCT04456088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102097535|NCT04456088|Respiratory System Agents|respiratory system agents|mesh-ancestor
101550886|NCT01320683|Vitamin B Complex|vitamin b complex|mesh-ancestor
102097536|NCT04456088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102097537|NCT04456088|Antioxidants|antioxidants|mesh-ancestor
102097538|NCT04456088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097539|NCT04456088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102097540|NCT04456088|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102097541|NCT04456088|Vasodilator Agents|vasodilator agents|mesh-ancestor
102097542|NCT04456088|Gasotransmitters|gasotransmitters|mesh-ancestor
102097543|NCT04456088|Protective Agents|protective agents|mesh-ancestor
102097544|NCT04454840|Riluzole|riluzole|mesh-list
102097545|NCT04454840|Anticonvulsants|anticonvulsants|mesh-ancestor
102097546|NCT04454840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102097547|NCT04454840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102097548|NCT04454840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102097549|NCT04454840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097550|NCT04454840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097551|NCT04454840|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102097552|NCT04454840|Protective Agents|protective agents|mesh-ancestor
102097553|NCT03050710|Lidocaine|lidocaine|mesh-list
102097554|NCT03050710|Anesthetics, Local|anesthetics, local|mesh-ancestor
102097555|NCT03050710|Anesthetics|anesthetics|mesh-ancestor
102097556|NCT03050710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102097557|NCT03050710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097558|NCT03050710|Sensory System Agents|sensory system agents|mesh-ancestor
102097559|NCT03050710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102097560|NCT03050710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102097561|NCT03050710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102097562|NCT03050710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102097563|NCT03050710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102097564|NCT03050710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224729|NCT01525771|Cisplatin|cisplatin|mesh-list
102097565|NCT03051568|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102097566|NCT03051568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102097567|NCT03051568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097568|NCT04897516|Benzonidazole|benzonidazole|mesh-list
102097569|NCT04897516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102097570|NCT04897516|Immunologic Factors|immunologic factors|mesh-ancestor
102097571|NCT04897516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097572|NCT04897516|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102097573|NCT04897516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102097574|NCT04897516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102097575|NCT04897516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102097576|NCT03993314|Bupivacaine|bupivacaine|mesh-list
102097577|NCT03993314|Chloroprocaine|chloroprocaine|mesh-list
102097578|NCT03993314|Anesthetics, Local|anesthetics, local|mesh-ancestor
102097579|NCT03993314|Anesthetics|anesthetics|mesh-ancestor
102097580|NCT03993314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102097581|NCT03993314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097582|NCT03993314|Sensory System Agents|sensory system agents|mesh-ancestor
102097583|NCT03993314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102097584|NCT04883164|Antibodies|antibodies|mesh-list
102097585|NCT04883164|Immunologic Factors|immunologic factors|mesh-ancestor
102097586|NCT04883164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097587|NCT03161054|Prednisone|prednisone|mesh-list
102097588|NCT03161054|Cyclophosphamide|cyclophosphamide|mesh-list
102097589|NCT03161054|Rituximab|rituximab|mesh-list
102097590|NCT03161054|Etoposide|etoposide|mesh-list
102097591|NCT03161054|Vinorelbine|vinorelbine|mesh-list
102097592|NCT03161054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102097593|NCT03161054|Immunologic Factors|immunologic factors|mesh-ancestor
102097594|NCT03161054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097595|NCT03161054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102097596|NCT03161054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102097598|NCT03161054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097599|NCT03161054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102097600|NCT03161054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102097601|NCT03161054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102097602|NCT03161054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102097603|NCT03161054|Glucocorticoids|glucocorticoids|mesh-ancestor
102097604|NCT03161054|Hormones|hormones|mesh-ancestor
102097605|NCT03161054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102097606|NCT03161054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102097607|NCT03161054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102097608|NCT03161054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102097609|NCT03161054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102097610|NCT03161054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102097611|NCT03161054|Tubulin Modulators|tubulin modulators|mesh-ancestor
102097612|NCT03161054|Antimitotic Agents|antimitotic agents|mesh-ancestor
102097613|NCT03161054|Mitosis Modulators|mitosis modulators|mesh-ancestor
102097614|NCT03050554|Avelumab|avelumab|mesh-list
102097615|NCT03050554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102097616|NCT03050554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102097617|NCT03050164|Gefitinib|gefitinib|mesh-list
102097618|NCT03050164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102097619|NCT03050164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102097620|NCT03050164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102097621|NCT03050164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097622|NCT03049930|Ketamine|ketamine|mesh-list
102097623|NCT03049930|Analgesics|analgesics|mesh-ancestor
102097624|NCT03049930|Sensory System Agents|sensory system agents|mesh-ancestor
102097625|NCT03049930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102097626|NCT03049930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097627|NCT03049930|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102097628|NCT03049930|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102097629|NCT03049930|Anesthetics, General|anesthetics, general|mesh-ancestor
102097630|NCT03049930|Anesthetics|anesthetics|mesh-ancestor
102097631|NCT03049930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102097632|NCT03049930|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102097633|NCT03049930|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102097634|NCT03049930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102097635|NCT03049930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097636|NCT02036463|Prednisone|prednisone|mesh-list
102097637|NCT02036463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102097638|NCT02036463|Glucocorticoids|glucocorticoids|mesh-ancestor
102097639|NCT02036463|Hormones|hormones|mesh-ancestor
102097640|NCT02036463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102097641|NCT02036463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097642|NCT02036463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102097643|NCT02036463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102097644|NCT04887844|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
102097645|NCT04887844|Lidocaine|lidocaine|mesh-list
102097646|NCT04887844|Anesthetics, Local|anesthetics, local|mesh-ancestor
102097647|NCT04887844|Anesthetics|anesthetics|mesh-ancestor
102097648|NCT04887844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102097649|NCT04887844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097650|NCT04887844|Sensory System Agents|sensory system agents|mesh-ancestor
102097651|NCT04887844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102097652|NCT04887844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102097653|NCT04887844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102097654|NCT04887844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102097655|NCT04887844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102097656|NCT04887844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097657|NCT04887844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102097658|NCT04887844|Glucocorticoids|glucocorticoids|mesh-ancestor
102097659|NCT04887844|Hormones|hormones|mesh-ancestor
102097660|NCT04887844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102097661|NCT02595320|Capecitabine|capecitabine|mesh-list
102097662|NCT02595320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102097663|NCT02595320|Antimetabolites|antimetabolites|mesh-ancestor
102097664|NCT02595320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097665|NCT02595320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102097667|NCT02809053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102097668|NCT02809053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102097669|NCT02809053|Immunologic Factors|immunologic factors|mesh-ancestor
102097670|NCT02809053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097671|NCT02809053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102097672|NCT04666688|Paclitaxel|paclitaxel|mesh-list
102097673|NCT04666688|Gemcitabine|gemcitabine|mesh-list
102097674|NCT04666688|Tislelizumab|tislelizumab|mesh-list
102097675|NCT04666688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102097676|NCT04666688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102097677|NCT04666688|Tubulin Modulators|tubulin modulators|mesh-ancestor
102097678|NCT04666688|Antimitotic Agents|antimitotic agents|mesh-ancestor
102097679|NCT04666688|Mitosis Modulators|mitosis modulators|mesh-ancestor
102097680|NCT04666688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097681|NCT04666688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101836440|NCT01565720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102097682|NCT04666688|Antimetabolites|antimetabolites|mesh-ancestor
102097683|NCT04666688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102097684|NCT03462290|Botulinum Toxins|botulinum toxins|mesh-list
102097685|NCT03462290|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102097686|NCT03462290|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102097687|NCT03462290|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102097688|NCT03462290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102097689|NCT03462290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097690|NCT03462290|Cholinergic Agents|cholinergic agents|mesh-ancestor
102097691|NCT03462290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102097692|NCT03462290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097693|NCT03462290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102097694|NCT03462290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102097695|NCT02047539|Aspirin|aspirin|mesh-list
102097696|NCT02047539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102097697|NCT02047539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102097698|NCT02047539|Analgesics|analgesics|mesh-ancestor
102097699|NCT02047539|Sensory System Agents|sensory system agents|mesh-ancestor
102097700|NCT02047539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102097701|NCT02047539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097702|NCT02047539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102097703|NCT02047539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102097704|NCT02047539|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102097705|NCT02047539|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102097706|NCT02047539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097707|NCT02047539|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102097708|NCT02047539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102097709|NCT02047539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102097710|NCT02047539|Antipyretics|antipyretics|mesh-ancestor
102097711|NCT02522858|Atropine|atropine|mesh-list
102097712|NCT02522858|Ephedrine|ephedrine|mesh-list
102097713|NCT02522858|Dexmedetomidine|dexmedetomidine|mesh-list
102097714|NCT02522858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102097715|NCT02522858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102097716|NCT02522858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097717|NCT02522858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102097718|NCT02522858|Analgesics|analgesics|mesh-ancestor
102097719|NCT02522858|Sensory System Agents|sensory system agents|mesh-ancestor
102097720|NCT02522858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102097721|NCT02522858|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102097722|NCT02522858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102097723|NCT02522858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102097724|NCT02522858|Adrenergic Agents|adrenergic agents|mesh-ancestor
102097725|NCT02522858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102097726|NCT02522858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097727|NCT02522858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102097728|NCT02522858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102097729|NCT02522858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102097730|NCT02522858|Autonomic Agents|autonomic agents|mesh-ancestor
102097731|NCT02522858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102097732|NCT02522858|Respiratory System Agents|respiratory system agents|mesh-ancestor
102097733|NCT02522858|Mydriatics|mydriatics|mesh-ancestor
102097734|NCT02522858|Parasympatholytics|parasympatholytics|mesh-ancestor
102097735|NCT02522858|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102097736|NCT02522858|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102097737|NCT02522858|Cholinergic Agents|cholinergic agents|mesh-ancestor
102097738|NCT02522858|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102097739|NCT02522858|Sympathomimetics|sympathomimetics|mesh-ancestor
102097740|NCT02522858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102097741|NCT02036697|Fentanyl|fentanyl|mesh-list
102097742|NCT02036697|Morphine|morphine|mesh-list
102097743|NCT02036697|Bupivacaine|bupivacaine|mesh-list
102097744|NCT02036697|Anesthetics, Local|anesthetics, local|mesh-ancestor
102097745|NCT02036697|Anesthetics|anesthetics|mesh-ancestor
102097746|NCT02036697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102097747|NCT02036697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097748|NCT02036697|Sensory System Agents|sensory system agents|mesh-ancestor
102097749|NCT02036697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102097750|NCT02036697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102097751|NCT02036697|Narcotics|narcotics|mesh-ancestor
101836441|NCT01565720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102097752|NCT02036697|Analgesics|analgesics|mesh-ancestor
102097753|NCT02036697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102097754|NCT02036697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102097755|NCT02036697|Anesthetics, General|anesthetics, general|mesh-ancestor
102097756|NCT04882462|Nimotuzumab|nimotuzumab|mesh-list
102097757|NCT04882462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102097758|NCT04882462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102097760|NCT03106688|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102097761|NCT03106688|Narcotics|narcotics|mesh-ancestor
102097762|NCT03106688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102097763|NCT03106688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097764|NCT03106688|Analgesics|analgesics|mesh-ancestor
102097765|NCT03106688|Sensory System Agents|sensory system agents|mesh-ancestor
102097766|NCT03106688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102097767|NCT02037009|Anesthetics|anesthetics|mesh-list
102097768|NCT02037009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102097769|NCT02037009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097770|NCT02260011|Bromides|bromides|mesh-list
102097771|NCT02260011|Norflurane|norflurane|mesh-list
102097772|NCT02260011|Ipratropium|ipratropium|mesh-list
102097773|NCT02260011|Anticonvulsants|anticonvulsants|mesh-ancestor
102097774|NCT02260011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102097775|NCT02260011|Autonomic Agents|autonomic agents|mesh-ancestor
102097776|NCT02260011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102097777|NCT02260011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097778|NCT02260011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102097779|NCT02260011|Respiratory System Agents|respiratory system agents|mesh-ancestor
102097780|NCT02260011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102097781|NCT02260011|Cholinergic Agents|cholinergic agents|mesh-ancestor
102097782|NCT02260011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102097783|NCT02260011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097784|NCT02260011|Anesthetics|anesthetics|mesh-ancestor
102097785|NCT02260011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102097786|NCT02047773|Meropenem|meropenem|mesh-list
102097787|NCT02047773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102097788|NCT02047773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102097789|NCT04886752|Vitamins|vitamins|mesh-list
102097790|NCT04886752|Ascorbic Acid|ascorbic acid|mesh-list
102097791|NCT04886752|Vitamin B Complex|vitamin b complex|mesh-list
102097792|NCT04886752|Micronutrients|micronutrients|mesh-ancestor
102097793|NCT04886752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097794|NCT04886752|Antioxidants|antioxidants|mesh-ancestor
102097795|NCT04886752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097796|NCT04886752|Protective Agents|protective agents|mesh-ancestor
102097797|NCT04895800|Caffeine|caffeine|mesh-list
102097798|NCT04895800|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102097799|NCT04895800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097800|NCT04895800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102097801|NCT04895800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102097802|NCT04895800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101953102|NCT04216251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102097803|NCT04895800|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102097804|NCT04895800|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102097805|NCT04895800|Purinergic Agents|purinergic agents|mesh-ancestor
102097806|NCT04895800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102097807|NCT04886362|Ivermectin|ivermectin|mesh-list
102097808|NCT04886362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102097809|NCT04886362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102097810|NCT02048007|Azithromycin|azithromycin|mesh-list
102097811|NCT02048007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102097812|NCT02048007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102097813|NCT02048085|Clopidogrel|clopidogrel|mesh-list
102097814|NCT02048085|Ticagrelor|ticagrelor|mesh-list
102097815|NCT02048085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102097816|NCT02048085|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102097817|NCT02048085|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102097818|NCT02048085|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102097819|NCT02048085|Purinergic Agents|purinergic agents|mesh-ancestor
102097820|NCT02048085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102097821|NCT02048085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097822|NCT02048085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097823|NCT02808975|Adalimumab|adalimumab|mesh-list
102097824|NCT02808975|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102097825|NCT02808975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102097826|NCT02808975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102097827|NCT04885894|Ozanimod|ozanimod|mesh-list
102097828|NCT04885894|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102097829|NCT04885894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097830|NCT04885894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102097831|NCT04885894|Immunologic Factors|immunologic factors|mesh-ancestor
102097832|NCT04885894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097834|NCT04885660|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102097835|NCT04885660|Protease Inhibitors|protease inhibitors|mesh-ancestor
102097836|NCT04885660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102097837|NCT04885660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097838|NCT04885660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102097839|NCT04885660|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102097840|NCT04885660|Protective Agents|protective agents|mesh-ancestor
102097841|NCT04885660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097842|NCT02037633|Fentanyl|fentanyl|mesh-list
102097843|NCT02037633|Ropivacaine|ropivacaine|mesh-list
102097844|NCT02037633|Anesthetics, Local|anesthetics, local|mesh-ancestor
102097845|NCT02037633|Anesthetics|anesthetics|mesh-ancestor
102097846|NCT02037633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102097847|NCT02037633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097848|NCT02037633|Sensory System Agents|sensory system agents|mesh-ancestor
102097849|NCT02037633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102097850|NCT02037633|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102097851|NCT02037633|Narcotics|narcotics|mesh-ancestor
102097852|NCT02037633|Analgesics|analgesics|mesh-ancestor
102097853|NCT02037633|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102097854|NCT02037633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102097855|NCT02037633|Anesthetics, General|anesthetics, general|mesh-ancestor
102097856|NCT05684211|Cetuximab|cetuximab|mesh-list
102097857|NCT05684211|Antibodies|antibodies|mesh-list
102097858|NCT05684211|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102097859|NCT05684211|Immunologic Factors|immunologic factors|mesh-ancestor
102097860|NCT05684211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097861|NCT05684211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102097862|NCT05684211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102097863|NCT03130634|Silymarin|silymarin|mesh-list
102097864|NCT03130634|Antioxidants|antioxidants|mesh-ancestor
102097865|NCT03130634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097866|NCT03130634|Protective Agents|protective agents|mesh-ancestor
102097867|NCT03130634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097868|NCT02124824|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
102097869|NCT02124824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102097870|NCT02124824|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102097871|NCT02124824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097872|NCT04880746|Cladribine|cladribine|mesh-list
102097873|NCT04880746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102097874|NCT04880746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102097875|NCT04880746|Immunologic Factors|immunologic factors|mesh-ancestor
102097876|NCT04880746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097877|NCT03050086|Minocycline|minocycline|mesh-list
102097878|NCT03050086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102097879|NCT03050086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102097880|NCT03050242|Glycopyrrolate|glycopyrrolate|mesh-list
102097881|NCT03050242|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102097882|NCT03050242|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102097883|NCT03050242|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102097884|NCT03050242|Cholinergic Agents|cholinergic agents|mesh-ancestor
102097885|NCT03050242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102097886|NCT03050242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097887|NCT03050242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097888|NCT04894630|Anti-Infective Agents|anti-infective agents|mesh-list
102097889|NCT04894630|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102097890|NCT04885270|Cisplatin|cisplatin|mesh-list
102097891|NCT04885270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102097892|NCT04885426|Metformin|metformin|mesh-list
102097893|NCT04885426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102097894|NCT04885426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097895|NCT02808819|Benralizumab|benralizumab|mesh-list
102097896|NCT02808819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102097897|NCT02808819|Respiratory System Agents|respiratory system agents|mesh-ancestor
102097898|NCT04872244|Levonorgestrel|levonorgestrel|mesh-list
102097899|NCT04872244|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102097900|NCT04872244|Contraceptive Agents|contraceptive agents|mesh-ancestor
102097901|NCT04872244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102097902|NCT04872244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097903|NCT04872244|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102097904|NCT04872244|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102097905|NCT04872244|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102097906|NCT04872322|Ropivacaine|ropivacaine|mesh-list
102097907|NCT04872322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102097909|NCT04872322|Anesthetics|anesthetics|mesh-ancestor
102097910|NCT04872322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102097911|NCT04872322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097912|NCT04872322|Sensory System Agents|sensory system agents|mesh-ancestor
102097913|NCT04872322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102097914|NCT04879030|Moxifloxacin|moxifloxacin|mesh-list
102097915|NCT04879030|Ciprofloxacin|ciprofloxacin|mesh-list
102097916|NCT04879030|Levofloxacin|levofloxacin|mesh-list
102097917|NCT04879030|Meropenem|meropenem|mesh-list
102097918|NCT04879030|Ceftriaxone|ceftriaxone|mesh-list
102097919|NCT04879030|Tazobactam|tazobactam|mesh-list
102097920|NCT04879030|Piperacillin|piperacillin|mesh-list
102097921|NCT04879030|Clavulanic Acid|clavulanic acid|mesh-list
102097922|NCT04879030|Imipenem|imipenem|mesh-list
102097923|NCT04879030|Ceftazidime|ceftazidime|mesh-list
102097924|NCT04879030|Ertapenem|ertapenem|mesh-list
102097925|NCT04879030|Lactams|lactams|mesh-list
102097926|NCT04879030|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102097927|NCT04879030|Cefotaxime|cefotaxime|mesh-list
102097928|NCT04879030|Cefixime|cefixime|mesh-list
102097929|NCT04879030|beta-Lactams|beta-lactams|mesh-list
102097930|NCT04879030|Fluoroquinolones|fluoroquinolones|mesh-list
102097931|NCT04879030|Ticarcillin|ticarcillin|mesh-list
102097932|NCT04879030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102097933|NCT04879030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102097934|NCT04879030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102097935|NCT04879030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102097936|NCT04879030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102097937|NCT04879030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097938|NCT04879030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102097939|NCT04879030|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102097940|NCT04879030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102097941|NCT04879030|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102097942|NCT04879030|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102097943|NCT04879030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102097944|NCT04878718|Vancomycin|vancomycin|mesh-list
102097945|NCT04878718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102097946|NCT04878718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102097947|NCT04878016|Carboplatin|carboplatin|mesh-list
102097948|NCT04878016|Etoposide|etoposide|mesh-list
102097949|NCT04878016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102097950|NCT04878016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102097951|NCT04878016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102097952|NCT04878016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102097953|NCT04878016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102097954|NCT04878016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097955|NCT04871152|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102097956|NCT04871152|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102097957|NCT04871152|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102097958|NCT04871152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102097959|NCT04871152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097960|NCT04871152|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102097961|NCT04871152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102097962|NCT04871152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097963|NCT04871152|Cholinergic Agents|cholinergic agents|mesh-ancestor
102097964|NCT04871152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102097965|NCT04870372|Selegiline|selegiline|mesh-list
102097966|NCT04870372|Antidepressive Agents|antidepressive agents|mesh-ancestor
102097967|NCT04870372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102097968|NCT04870372|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102097969|NCT04870372|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102097970|NCT04870372|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102097971|NCT04870372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102097972|NCT04870372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097973|NCT04870372|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102097974|NCT04870372|Protective Agents|protective agents|mesh-ancestor
102097975|NCT04870372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097976|NCT02048319|Ethanol|ethanol|mesh-list
102097977|NCT02048319|Pasireotide|pasireotide|mesh-list
102097978|NCT02048319|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102097979|NCT02048319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102097980|NCT02048319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102097981|NCT02048319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097982|NCT02048319|Hormones|hormones|mesh-ancestor
101836442|NCT01565720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102097983|NCT02048319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102097984|NCT01594762|Pexiganan|pexiganan|mesh-list
102097985|NCT01594762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102097986|NCT01594762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102097987|NCT02048475|Desflurane|desflurane|mesh-list
102097988|NCT02048475|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102097989|NCT02048475|Anesthetics, General|anesthetics, general|mesh-ancestor
102097990|NCT02048475|Anesthetics|anesthetics|mesh-ancestor
102097991|NCT02048475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102097992|NCT02048475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097993|NCT03562143|Iron|iron|mesh-list
102097994|NCT03562143|Trace Elements|trace elements|mesh-ancestor
102097995|NCT03562143|Micronutrients|micronutrients|mesh-ancestor
102097996|NCT03562143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102097997|NCT02048865|Apixaban|apixaban|mesh-list
102097998|NCT02048865|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102097999|NCT02048865|Antithrombins|antithrombins|mesh-ancestor
102098000|NCT02048865|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102098001|NCT02048865|Protease Inhibitors|protease inhibitors|mesh-ancestor
102098002|NCT02048865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102098003|NCT02048865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098004|NCT02048865|Anticoagulants|anticoagulants|mesh-ancestor
102098005|NCT02048943|Paclitaxel|paclitaxel|mesh-list
102098006|NCT02048943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102098007|NCT02048943|Gemcitabine|gemcitabine|mesh-list
102098008|NCT02048943|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102098009|NCT02048943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102098010|NCT02048943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102098011|NCT02048943|Tubulin Modulators|tubulin modulators|mesh-ancestor
102098012|NCT02048943|Antimitotic Agents|antimitotic agents|mesh-ancestor
102098013|NCT02048943|Mitosis Modulators|mitosis modulators|mesh-ancestor
102098014|NCT02048943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098015|NCT02048943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102098016|NCT02048943|Antimetabolites|antimetabolites|mesh-ancestor
102098017|NCT02048943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102098018|NCT02048943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102098019|NCT02050893|Midazolam|midazolam|mesh-list
102098020|NCT02050893|Propofol|propofol|mesh-list
102098021|NCT02050893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
102098022|NCT02050893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102098023|NCT02050893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098024|NCT02050893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102098025|NCT02050893|Anesthetics, General|anesthetics, general|mesh-ancestor
102098026|NCT02050893|Anesthetics|anesthetics|mesh-ancestor
102098027|NCT02050893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102098028|NCT02050893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102098029|NCT02050893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102098030|NCT02050893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102098031|NCT02050893|GABA Modulators|gaba modulators|mesh-ancestor
102098032|NCT02050893|GABA Agents|gaba agents|mesh-ancestor
102098033|NCT02050893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102098034|NCT02050893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098035|NCT02806947|Sirolimus|sirolimus|mesh-list
102098036|NCT02806947|Prednisone|prednisone|mesh-list
102098037|NCT02806947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102098038|NCT02806947|Glucocorticoids|glucocorticoids|mesh-ancestor
102098039|NCT02806947|Hormones|hormones|mesh-ancestor
102098040|NCT02806947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102098041|NCT02806947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098042|NCT02806947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102098043|NCT02806947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101224778|NCT01526083|Lacosamide|lacosamide|mesh-list
102098044|NCT02806947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102098045|NCT02806947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102098046|NCT02806947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102098047|NCT02806947|Antifungal Agents|antifungal agents|mesh-ancestor
102098048|NCT02806947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102098049|NCT02806947|Immunologic Factors|immunologic factors|mesh-ancestor
102098050|NCT03442114|Hydroxyurea|hydroxyurea|mesh-list
102098051|NCT03442114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102098052|NCT03442114|Antisickling Agents|antisickling agents|mesh-ancestor
102098053|NCT03442114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102098054|NCT03442114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098055|NCT03442114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102098056|NCT02037399|Dexamethasone|dexamethasone|mesh-list
101836443|NCT01565720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102098057|NCT02037399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102098058|NCT02037399|Antiemetics|antiemetics|mesh-ancestor
102098059|NCT02037399|Autonomic Agents|autonomic agents|mesh-ancestor
102098060|NCT02037399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102098061|NCT02037399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098062|NCT02037399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102098063|NCT02037399|Glucocorticoids|glucocorticoids|mesh-ancestor
102098064|NCT02037399|Hormones|hormones|mesh-ancestor
102098065|NCT02037399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102098066|NCT02037399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102098067|NCT02037399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102098068|NCT02260089|Telmisartan|telmisartan|mesh-list
102098069|NCT02260089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102098070|NCT02260089|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102098071|NCT02260089|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102098072|NCT02260089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098073|NCT02049255|Bupivacaine|bupivacaine|mesh-list
102098074|NCT02049255|Chloroprocaine|chloroprocaine|mesh-list
102098075|NCT02049255|Anesthetics, Local|anesthetics, local|mesh-ancestor
102098076|NCT02049255|Anesthetics|anesthetics|mesh-ancestor
102098077|NCT02049255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102098078|NCT02049255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098079|NCT02049255|Sensory System Agents|sensory system agents|mesh-ancestor
102098080|NCT02049255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102098081|NCT02037711|Levobupivacaine|levobupivacaine|mesh-list
102098082|NCT02037711|Anesthetics, Local|anesthetics, local|mesh-ancestor
102098083|NCT02037711|Anesthetics|anesthetics|mesh-ancestor
102098084|NCT02037711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102098085|NCT02037711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098086|NCT02037711|Sensory System Agents|sensory system agents|mesh-ancestor
102098087|NCT02037711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102098088|NCT03561675|Acetazolamide|acetazolamide|mesh-list
102098089|NCT03561675|Anticonvulsants|anticonvulsants|mesh-ancestor
102098090|NCT03561675|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102098091|NCT03561675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102098092|NCT03561675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098093|NCT03561675|Diuretics|diuretics|mesh-ancestor
102098094|NCT03561675|Natriuretic Agents|natriuretic agents|mesh-ancestor
102098095|NCT03561675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098096|NCT02049411|Ketamine|ketamine|mesh-list
102098097|NCT02049411|Analgesics|analgesics|mesh-ancestor
102098098|NCT02049411|Sensory System Agents|sensory system agents|mesh-ancestor
102098099|NCT02049411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102098100|NCT02049411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098101|NCT02049411|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102098102|NCT02049411|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102098103|NCT02049411|Anesthetics, General|anesthetics, general|mesh-ancestor
102098104|NCT02049411|Anesthetics|anesthetics|mesh-ancestor
102098105|NCT02049411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102098106|NCT02049411|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102098107|NCT02049411|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102098108|NCT02049411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102098109|NCT02049411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098110|NCT02807493|Salicylic Acid|salicylic acid|mesh-list
102098111|NCT02807493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102098112|NCT02807493|Antifungal Agents|antifungal agents|mesh-ancestor
102098113|NCT02807493|Keratolytic Agents|keratolytic agents|mesh-ancestor
102098114|NCT02807493|Dermatologic Agents|dermatologic agents|mesh-ancestor
102098115|NCT02051751|Paclitaxel|paclitaxel|mesh-list
102098116|NCT02051751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102098117|NCT02051751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102098118|NCT02051751|Tubulin Modulators|tubulin modulators|mesh-ancestor
102098119|NCT02051751|Antimitotic Agents|antimitotic agents|mesh-ancestor
102098120|NCT02051751|Mitosis Modulators|mitosis modulators|mesh-ancestor
102098121|NCT02051751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098122|NCT02049801|Cytarabine|cytarabine|mesh-list
102098123|NCT02049801|Idarubicin|idarubicin|mesh-list
102098124|NCT02049801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102098125|NCT02049801|Antimetabolites|antimetabolites|mesh-ancestor
102098126|NCT02049801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098127|NCT02049801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102098128|NCT02049801|Antiviral Agents|antiviral agents|mesh-ancestor
102098129|NCT02049801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102098130|NCT02049801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102098131|NCT02049801|Immunologic Factors|immunologic factors|mesh-ancestor
102098132|NCT02049801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098133|NCT02049801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102098134|NCT02049801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102098135|NCT02049801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102098136|NCT02049801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102098138|NCT02802345|Sildenafil Citrate|sildenafil citrate|mesh-list
102098139|NCT02802345|Vasodilator Agents|vasodilator agents|mesh-ancestor
102098140|NCT02802345|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102098141|NCT02802345|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102098142|NCT02802345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102098143|NCT02802345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098144|NCT02802345|Urological Agents|urological agents|mesh-ancestor
102098145|NCT02802345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102098146|NCT02802345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102098147|NCT02053779|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102098148|NCT02053779|Luteolytic Agents|luteolytic agents|mesh-ancestor
102098149|NCT02053779|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102098150|NCT02053779|Contraceptive Agents|contraceptive agents|mesh-ancestor
102098151|NCT02053779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102098152|NCT02053779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098153|NCT02053779|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102098154|NCT02053779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102098155|NCT02053779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102098156|NCT02056041|Liver Extracts|liver extracts|mesh-list
102098157|NCT02056041|Hematinics|hematinics|mesh-ancestor
102098158|NCT02053857|Amoxicillin|amoxicillin|mesh-list
102098159|NCT02053857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102098160|NCT02053857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102098161|NCT02053935|Dopamine|dopamine|mesh-list
102098162|NCT02053935|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102098163|NCT02053935|Sympathomimetics|sympathomimetics|mesh-ancestor
102098164|NCT02053935|Autonomic Agents|autonomic agents|mesh-ancestor
102098165|NCT02053935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102098166|NCT02053935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098167|NCT02053935|Dopamine Agents|dopamine agents|mesh-ancestor
102098168|NCT02053935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102098169|NCT02053935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098170|NCT02053935|Protective Agents|protective agents|mesh-ancestor
102098171|NCT02056353|Insulin|insulin|mesh-list
102098172|NCT02056353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102098173|NCT02056353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098174|NCT02056587|Everolimus|everolimus|mesh-list
102098175|NCT02056587|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102098176|NCT02056587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102098177|NCT02056587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102098178|NCT02056587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098179|NCT02056587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102098180|NCT02056587|Immunologic Factors|immunologic factors|mesh-ancestor
102098181|NCT02056587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098182|NCT02056587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102098183|NCT02038335|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102098184|NCT02038335|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102098185|NCT02038335|Levonorgestrel|levonorgestrel|mesh-list
102098186|NCT02038335|Medroxyprogesterone|medroxyprogesterone|mesh-list
102098187|NCT02038335|Etonogestrel|etonogestrel|mesh-list
102098188|NCT02038335|Norethindrone|norethindrone|mesh-list
102098189|NCT02038335|Estradiol|estradiol|mesh-list
102098190|NCT02038335|Estrogens|estrogens|mesh-ancestor
102098191|NCT02038335|Hormones|hormones|mesh-ancestor
102098192|NCT02038335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102098193|NCT02038335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098194|NCT02038335|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102098195|NCT02038335|Contraceptive Agents|contraceptive agents|mesh-ancestor
102098196|NCT02038335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102098197|NCT02038335|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102098198|NCT02038335|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101953158|NCT01303887|Rituximab|rituximab|mesh-list
102098199|NCT02038335|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102098200|NCT02038335|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102098201|NCT02038335|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102098202|NCT02038335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102098203|NCT02038335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102098204|NCT02056665|Minocycline|minocycline|mesh-list
102098205|NCT02056665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102098206|NCT02056665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102098207|NCT02056743|Fexofenadine|fexofenadine|mesh-list
102098208|NCT02056743|Losartan|losartan|mesh-list
102098209|NCT02056743|Midazolam|midazolam|mesh-list
102098210|NCT02056743|Dextromethorphan|dextromethorphan|mesh-list
102098211|NCT02056743|Caffeine|caffeine|mesh-list
102098212|NCT02056743|Omeprazole|omeprazole|mesh-list
102098213|NCT02056743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102098214|NCT02056743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102098215|NCT02056743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102098216|NCT02056743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098217|NCT02056743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102098218|NCT02056743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102098219|NCT02056743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102098220|NCT02056743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102098221|NCT02056743|Anesthetics, General|anesthetics, general|mesh-ancestor
102098222|NCT02056743|Anesthetics|anesthetics|mesh-ancestor
102098223|NCT02056743|GABA Modulators|gaba modulators|mesh-ancestor
102098224|NCT02056743|GABA Agents|gaba agents|mesh-ancestor
102098225|NCT02056743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102098226|NCT02056743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098227|NCT02056743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102098228|NCT02056743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102098229|NCT02056743|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102098230|NCT02056743|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102098231|NCT02056743|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102098232|NCT02056743|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102098233|NCT02056743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102098234|NCT02056743|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102098235|NCT02056743|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102098236|NCT02056743|Purinergic Agents|purinergic agents|mesh-ancestor
102098237|NCT02056743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102098238|NCT02056743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102098239|NCT02056743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102098240|NCT02056743|Antitussive Agents|antitussive agents|mesh-ancestor
102098241|NCT02056743|Respiratory System Agents|respiratory system agents|mesh-ancestor
102098242|NCT02056743|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102098243|NCT02056743|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102098244|NCT02056743|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102098245|NCT02056743|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102098246|NCT02056743|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102098247|NCT02056743|Histamine Antagonists|histamine antagonists|mesh-ancestor
102098248|NCT02056743|Histamine Agents|histamine agents|mesh-ancestor
102098249|NCT02052375|ASP2408|asp2408|mesh-list
102098250|NCT02052375|Immunoconjugates|immunoconjugates|mesh-ancestor
102098251|NCT02052375|Immunologic Factors|immunologic factors|mesh-ancestor
102098252|NCT02052375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098253|NCT02054637|Lanreotide|lanreotide|mesh-list
102098254|NCT02054637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102098255|NCT02054793|Itraconazole|itraconazole|mesh-list
102098256|NCT02054793|Antifungal Agents|antifungal agents|mesh-ancestor
102098257|NCT02054793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102098258|NCT02054793|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102098259|NCT02054793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102098260|NCT02054793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102098261|NCT02054793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098262|NCT02054793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102098263|NCT02054793|Hormone Antagonists|hormone antagonists|mesh-ancestor
102098264|NCT02054793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102098265|NCT02054793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098266|NCT02054793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102098267|NCT02052687|Imiquimod|imiquimod|mesh-list
102098268|NCT02052687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102098269|NCT02052687|Immunologic Factors|immunologic factors|mesh-ancestor
102098270|NCT02052687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098271|NCT02052687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102098272|NCT02052687|Interferon Inducers|interferon inducers|mesh-ancestor
102098273|NCT02057289|Micafungin|micafungin|mesh-list
102098274|NCT02057289|Antifungal Agents|antifungal agents|mesh-ancestor
102098275|NCT02057289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102098276|NCT02057367|Bupivacaine|bupivacaine|mesh-list
102098277|NCT02057367|Anesthetics, Local|anesthetics, local|mesh-ancestor
102098278|NCT02057367|Anesthetics|anesthetics|mesh-ancestor
102098279|NCT02057367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102098280|NCT02057367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098281|NCT02057367|Sensory System Agents|sensory system agents|mesh-ancestor
102098282|NCT02057367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102098283|NCT02054949|Acetylcysteine|acetylcysteine|mesh-list
102098284|NCT02054949|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102098285|NCT02054949|Antiviral Agents|antiviral agents|mesh-ancestor
102098286|NCT02054949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102098287|NCT02054949|Expectorants|expectorants|mesh-ancestor
102098288|NCT02054949|Respiratory System Agents|respiratory system agents|mesh-ancestor
102098289|NCT02054949|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102098290|NCT02054949|Antioxidants|antioxidants|mesh-ancestor
102098291|NCT02054949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098292|NCT02054949|Protective Agents|protective agents|mesh-ancestor
102098293|NCT02054949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098294|NCT02054949|Antidotes|antidotes|mesh-ancestor
102098295|NCT02748057|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102098296|NCT02748057|Ezetimibe|ezetimibe|mesh-list
102098297|NCT02748057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102098298|NCT02748057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102098299|NCT02748057|Antimetabolites|antimetabolites|mesh-ancestor
102098300|NCT02748057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098301|NCT02748057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102098302|NCT02748057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102098303|NCT02748057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102098304|NCT02057601|Levobupivacaine|levobupivacaine|mesh-list
102098305|NCT02057601|Anesthetics, Local|anesthetics, local|mesh-ancestor
102098306|NCT02057601|Anesthetics|anesthetics|mesh-ancestor
102098307|NCT02057601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102098308|NCT02057601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098309|NCT02057601|Sensory System Agents|sensory system agents|mesh-ancestor
102098310|NCT02057601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102098311|NCT02057679|Amoxicillin|amoxicillin|mesh-list
102098312|NCT02057679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102098313|NCT02057679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102098314|NCT02038491|Anesthetics|anesthetics|mesh-list
102098315|NCT02038491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102098316|NCT02038491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098317|NCT02055183|Antitoxins|antitoxins|mesh-list
102098318|NCT02055183|Botulinum Antitoxin|botulinum antitoxin|mesh-list
102098319|NCT02055183|Immunologic Factors|immunologic factors|mesh-ancestor
102098320|NCT02055183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098321|NCT02748213|Docetaxel|docetaxel|mesh-list
102098322|NCT02748213|Capecitabine|capecitabine|mesh-list
102098323|NCT02748213|Trastuzumab|trastuzumab|mesh-list
102098324|NCT02748213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102098325|NCT02748213|Tubulin Modulators|tubulin modulators|mesh-ancestor
102098326|NCT02748213|Antimitotic Agents|antimitotic agents|mesh-ancestor
102098327|NCT02748213|Mitosis Modulators|mitosis modulators|mesh-ancestor
102098328|NCT02748213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098329|NCT02748213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102098330|NCT02748213|Antimetabolites|antimetabolites|mesh-ancestor
102098331|NCT02748213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102098332|NCT03804099|Aflibercept|aflibercept|mesh-list
102098333|NCT03804099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102098334|NCT03804099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102098335|NCT03804099|Growth Substances|growth substances|mesh-ancestor
102098336|NCT03804099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098337|NCT03804099|Growth Inhibitors|growth inhibitors|mesh-ancestor
102098338|NCT03804099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102098339|NCT02058303|Bupivacaine|bupivacaine|mesh-list
102098340|NCT02058303|Anesthetics, Local|anesthetics, local|mesh-ancestor
102098341|NCT02058303|Anesthetics|anesthetics|mesh-ancestor
102098342|NCT02058303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102098343|NCT02058303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098344|NCT02058303|Sensory System Agents|sensory system agents|mesh-ancestor
102098345|NCT02058303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102098346|NCT05256472|Axitinib|axitinib|mesh-list
102098347|NCT05256472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102098348|NCT05256472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102098349|NCT05256472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102098350|NCT05256472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098351|NCT04870060|Curcumin|curcumin|mesh-list
102098352|NCT04870060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102098353|NCT04870060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102098354|NCT04870060|Analgesics|analgesics|mesh-ancestor
102098355|NCT04870060|Sensory System Agents|sensory system agents|mesh-ancestor
102098356|NCT04870060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102098357|NCT04870060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098358|NCT04870060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102098359|NCT04870060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102098360|NCT04870060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102098362|NCT04870060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098363|NCT02613910|Acetaminophen|acetaminophen|mesh-list
102098364|NCT02613910|Cetirizine|cetirizine|mesh-list
102098365|NCT02613910|Prednisone|prednisone|mesh-list
102098366|NCT02613910|Prednisolone|prednisolone|mesh-list
102098367|NCT02613910|Ofatumumab|ofatumumab|mesh-list
102098368|NCT02613910|Histamine Antagonists|histamine antagonists|mesh-list
102098369|NCT02613910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
102098370|NCT02613910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102098371|NCT02613910|Glucocorticoids|glucocorticoids|mesh-ancestor
102098372|NCT02613910|Hormones|hormones|mesh-ancestor
102098373|NCT02613910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102098374|NCT02613910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098375|NCT02613910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102098376|NCT02613910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102098377|NCT02613910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102098378|NCT02613910|Analgesics|analgesics|mesh-ancestor
102098379|NCT02613910|Sensory System Agents|sensory system agents|mesh-ancestor
102098380|NCT02613910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102098381|NCT02613910|Antipyretics|antipyretics|mesh-ancestor
102098382|NCT02613910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102098383|NCT02613910|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102098384|NCT02613910|Histamine Agents|histamine agents|mesh-ancestor
102098385|NCT02613910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102098386|NCT02613910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098387|NCT02802735|Apremilast|apremilast|mesh-list
102098388|NCT02802735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102098389|NCT02802735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102098390|NCT02802735|Analgesics|analgesics|mesh-ancestor
102098391|NCT02802735|Sensory System Agents|sensory system agents|mesh-ancestor
102098392|NCT02802735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102098393|NCT02802735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098394|NCT02802735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102098395|NCT02802735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102098396|NCT02802735|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102098397|NCT02802735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102098398|NCT02802735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102098399|NCT02802735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098400|NCT03048214|Anesthetics|anesthetics|mesh-list
102098401|NCT03048214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102098402|NCT03048214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098403|NCT02060955|Bevacizumab|bevacizumab|mesh-list
102098404|NCT02060955|Irinotecan|irinotecan|mesh-list
102098405|NCT02060955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102098406|NCT02060955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102098407|NCT02060955|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102098408|NCT02060955|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102098409|NCT02060955|Growth Substances|growth substances|mesh-ancestor
102098410|NCT02060955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098411|NCT02060955|Growth Inhibitors|growth inhibitors|mesh-ancestor
102098412|NCT02060955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102098413|NCT02060955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102098414|NCT02060955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102098415|NCT02060955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098416|NCT02273362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102098417|NCT02273362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102098418|NCT02273362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102098419|NCT02273362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102098420|NCT02273362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098421|NCT04877626|Artesunate|artesunate|mesh-list
102098422|NCT04877626|Antimalarials|antimalarials|mesh-ancestor
102098423|NCT04877626|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102098424|NCT04877626|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102098425|NCT04877626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102098426|NCT04877626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102098427|NCT04877626|Antiviral Agents|antiviral agents|mesh-ancestor
102098428|NCT04877626|Schistosomicides|schistosomicides|mesh-ancestor
102098429|NCT04877626|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102098430|NCT04877626|Anthelmintics|anthelmintics|mesh-ancestor
102098431|NCT05255848|Heparin|heparin|mesh-list
102098432|NCT05255848|Calcium heparin|calcium heparin|mesh-list
102098433|NCT05255848|Anticoagulants|anticoagulants|mesh-ancestor
102098434|NCT05255848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102098435|NCT05255848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101836444|NCT01565720|Antifungal Agents|antifungal agents|mesh-ancestor
102098436|NCT05255848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098437|NCT04430062|Anesthetics|anesthetics|mesh-list
102098438|NCT04430062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102098439|NCT04430062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098440|NCT02799381|Levodopa|levodopa|mesh-list
102098441|NCT02799381|Carbidopa|carbidopa|mesh-list
102098442|NCT02799381|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102098443|NCT02799381|Antiparkinson Agents|antiparkinson agents|mesh-list
102098444|NCT02799381|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102098445|NCT02799381|Dopamine Agents|dopamine agents|mesh-ancestor
102098446|NCT02799381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102098447|NCT02799381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098448|NCT02799381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098449|NCT02799381|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102098450|NCT02799381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102098451|NCT02799381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102098452|NCT02799381|Immunologic Factors|immunologic factors|mesh-ancestor
102098453|NCT02799381|Dopamine Agonists|dopamine agonists|mesh-ancestor
102098454|NCT04387942|Aldesleukin|aldesleukin|mesh-list
102098455|NCT04387942|Interleukin-2|interleukin-2|mesh-list
102098456|NCT04387942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102098457|NCT04387942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102098458|NCT04387942|Analgesics|analgesics|mesh-ancestor
102098459|NCT04387942|Sensory System Agents|sensory system agents|mesh-ancestor
102098460|NCT04387942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102098461|NCT04387942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098462|NCT04387942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102098463|NCT04387942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102098464|NCT04387942|Antiviral Agents|antiviral agents|mesh-ancestor
102098465|NCT04387942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102098466|NCT01333059|Fentanyl|fentanyl|mesh-list
102098467|NCT01333059|Midazolam|midazolam|mesh-list
102098468|NCT01333059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102098469|NCT01333059|Narcotics|narcotics|mesh-ancestor
102098470|NCT01333059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102098471|NCT01333059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098472|NCT01333059|Analgesics|analgesics|mesh-ancestor
102098473|NCT01333059|Sensory System Agents|sensory system agents|mesh-ancestor
102098474|NCT01333059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102098475|NCT01333059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102098476|NCT01333059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102098477|NCT01333059|Anesthetics, General|anesthetics, general|mesh-ancestor
102098478|NCT01333059|Anesthetics|anesthetics|mesh-ancestor
102098479|NCT01333059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102098480|NCT01333059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102098481|NCT01333059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102098482|NCT01333059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102098483|NCT01333059|GABA Modulators|gaba modulators|mesh-ancestor
102098484|NCT01333059|GABA Agents|gaba agents|mesh-ancestor
102098485|NCT01333059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102098486|NCT01333059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098487|NCT02060253|Paclitaxel|paclitaxel|mesh-list
102098488|NCT02060253|Trastuzumab|trastuzumab|mesh-list
102098489|NCT02060253|Pertuzumab|pertuzumab|mesh-list
102098490|NCT02060253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102098491|NCT02060253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102098492|NCT02060253|Tubulin Modulators|tubulin modulators|mesh-ancestor
102098493|NCT02060253|Antimitotic Agents|antimitotic agents|mesh-ancestor
102098494|NCT02060253|Mitosis Modulators|mitosis modulators|mesh-ancestor
102098495|NCT02060253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098496|NCT02060253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102098497|NCT04364620|Docetaxel|docetaxel|mesh-list
102098498|NCT04364620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102098499|NCT04364620|Tubulin Modulators|tubulin modulators|mesh-ancestor
102098500|NCT04364620|Antimitotic Agents|antimitotic agents|mesh-ancestor
102098501|NCT04364620|Mitosis Modulators|mitosis modulators|mesh-ancestor
101224843|NCT01526278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102098502|NCT04364620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098503|NCT03560973|Gemcitabine|gemcitabine|mesh-list
102098504|NCT03560973|Ramucirumab|ramucirumab|mesh-list
102098505|NCT03560973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102098506|NCT03560973|Antimetabolites|antimetabolites|mesh-ancestor
102098507|NCT03560973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098508|NCT03560973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102098509|NCT04383574|Vaccines|vaccines|mesh-list
102098510|NCT04383574|Immunologic Factors|immunologic factors|mesh-ancestor
102098511|NCT04383574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098512|NCT03046108|Triamcinolone|triamcinolone|mesh-list
102098513|NCT03046108|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102098514|NCT03046108|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102098516|NCT03046108|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102098517|NCT03046108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102098518|NCT03046108|Glucocorticoids|glucocorticoids|mesh-ancestor
102098520|NCT03046108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102098521|NCT03046108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098522|NCT03046108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102098523|NCT03046108|Immunologic Factors|immunologic factors|mesh-ancestor
102098524|NCT03046108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102098525|NCT03046108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098526|NCT03046108|Anesthetics, Local|anesthetics, local|mesh-ancestor
102098527|NCT03046108|Anesthetics|anesthetics|mesh-ancestor
102098528|NCT03046108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102098529|NCT03046108|Sensory System Agents|sensory system agents|mesh-ancestor
102098530|NCT03046108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102098531|NCT02061267|Niacin|niacin|mesh-list
102098532|NCT02061267|Nicotinic Acids|nicotinic acids|mesh-list
102098533|NCT02061267|Vitamins|vitamins|mesh-ancestor
102098534|NCT02061267|Micronutrients|micronutrients|mesh-ancestor
102098535|NCT02061267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098536|NCT02061267|Vitamin B Complex|vitamin b complex|mesh-ancestor
102098537|NCT02061267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102098538|NCT02061267|Antimetabolites|antimetabolites|mesh-ancestor
102098539|NCT02061267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098540|NCT02061267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102098541|NCT02061267|Vasodilator Agents|vasodilator agents|mesh-ancestor
102098542|NCT01370655|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102098543|NCT01370655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102098544|NCT01370655|Diuretics|diuretics|mesh-ancestor
102098545|NCT01370655|Natriuretic Agents|natriuretic agents|mesh-ancestor
102098546|NCT01370655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098547|NCT01370655|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102098548|NCT01370655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102098549|NCT01370655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098550|NCT02612194|Crizotinib|crizotinib|mesh-list
102098551|NCT02612194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102098552|NCT02612194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102098553|NCT02612194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102098554|NCT02612194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098555|NCT03044626|Nivolumab|nivolumab|mesh-list
102098556|NCT03044626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102098557|NCT03044626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102098558|NCT03044626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102098559|NCT03044626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098560|NCT04865224|Chrysarobin|chrysarobin|mesh-list
102098561|NCT04865224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102098562|NCT04865224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102098563|NCT04865224|Analgesics|analgesics|mesh-ancestor
102098564|NCT04865224|Sensory System Agents|sensory system agents|mesh-ancestor
102098565|NCT04865224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102098566|NCT04865224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098567|NCT04865224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102098568|NCT04865224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102098569|NCT04865380|Tranexamic Acid|tranexamic acid|mesh-list
102098570|NCT04865380|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101224852|NCT01526317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102098571|NCT04865380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102098572|NCT04865380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098573|NCT04865380|Hemostatics|hemostatics|mesh-ancestor
102098574|NCT04865380|Coagulants|coagulants|mesh-ancestor
102098575|NCT04869046|Acetaminophen|acetaminophen|mesh-list
102098576|NCT04869046|Ibuprofen|ibuprofen|mesh-list
102098577|NCT04869046|Analgesics|analgesics|mesh-list
102098578|NCT04869046|Levobupivacaine|levobupivacaine|mesh-list
102098579|NCT04869046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102098580|NCT04869046|Sensory System Agents|sensory system agents|mesh-ancestor
102098581|NCT04869046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102098582|NCT04869046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098583|NCT04869046|Antipyretics|antipyretics|mesh-ancestor
101953231|NCT02037802|Narcotics|narcotics|mesh-ancestor
102098584|NCT04869046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102098585|NCT04869046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102098586|NCT04869046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102098588|NCT04869046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102098589|NCT04869046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098590|NCT04869046|Anesthetics, Local|anesthetics, local|mesh-ancestor
102098591|NCT04869046|Anesthetics|anesthetics|mesh-ancestor
102098592|NCT04869046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102098593|NCT04385680|Chlorhexidine|chlorhexidine|mesh-list
102098594|NCT04385680|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102098595|NCT04385680|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102098596|NCT04385680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102098597|NCT04385680|Disinfectants|disinfectants|mesh-ancestor
102098598|NCT04385680|Dermatologic Agents|dermatologic agents|mesh-ancestor
102098599|NCT02798211|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102098600|NCT02798211|Immunologic Factors|immunologic factors|mesh-ancestor
102098601|NCT02798211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098602|NCT02060019|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
102098603|NCT02060019|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102098604|NCT02060019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102098605|NCT02060019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102098606|NCT02060019|Antimetabolites|antimetabolites|mesh-ancestor
102098607|NCT02060019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098608|NCT02060019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102098609|NCT02060019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102098610|NCT02060019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102098611|NCT02060019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102098612|NCT05654415|Melatonin|melatonin|mesh-list
102098613|NCT05654415|Antioxidants|antioxidants|mesh-ancestor
102098614|NCT05654415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098615|NCT05654415|Protective Agents|protective agents|mesh-ancestor
102098616|NCT05654415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098617|NCT05654415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102098618|NCT03044938|Albuterol|albuterol|mesh-list
102098619|NCT03044938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102098620|NCT03044938|Autonomic Agents|autonomic agents|mesh-ancestor
102098621|NCT03044938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102098622|NCT03044938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098623|NCT03044938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102098624|NCT03044938|Respiratory System Agents|respiratory system agents|mesh-ancestor
102098625|NCT03044938|Tocolytic Agents|tocolytic agents|mesh-ancestor
102098626|NCT03044938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102098627|NCT03044938|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102098628|NCT03044938|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102098629|NCT03044938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102098630|NCT03044938|Adrenergic Agents|adrenergic agents|mesh-ancestor
102098631|NCT03044938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102098632|NCT03044938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098633|NCT03045484|Oxycodone|oxycodone|mesh-list
102098634|NCT03045484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102098635|NCT03045484|Narcotics|narcotics|mesh-ancestor
102098636|NCT03045484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102098637|NCT03045484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098638|NCT03045484|Analgesics|analgesics|mesh-ancestor
102098639|NCT03045484|Sensory System Agents|sensory system agents|mesh-ancestor
102098640|NCT03045484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102098641|NCT04874506|TEMPO|tempo|mesh-list
102098642|NCT04874506|TEMPOL-H|tempol-h|mesh-list
102098643|NCT04874506|Antioxidants|antioxidants|mesh-ancestor
102098644|NCT04874506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098645|NCT04874506|Protective Agents|protective agents|mesh-ancestor
102098646|NCT04874506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098647|NCT04874506|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102098648|NCT04874428|Rivaroxaban|rivaroxaban|mesh-list
102098649|NCT04874428|Apixaban|apixaban|mesh-list
102098650|NCT04874428|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102098651|NCT04874428|Antithrombins|antithrombins|mesh-ancestor
102098652|NCT04874428|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102098653|NCT04874428|Protease Inhibitors|protease inhibitors|mesh-ancestor
101953234|NCT02051530|Tryptophan|tryptophan|mesh-list
102098654|NCT04874428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102098655|NCT04874428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098656|NCT04874428|Anticoagulants|anticoagulants|mesh-ancestor
102098657|NCT04867720|Everolimus|everolimus|mesh-list
102098658|NCT04867720|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102098659|NCT04867720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102098660|NCT04867720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101836445|NCT00309244|Insulin|insulin|mesh-list
102098661|NCT04867720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098662|NCT04867720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102098663|NCT04867720|Immunologic Factors|immunologic factors|mesh-ancestor
102098664|NCT04867720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098665|NCT04867720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102098666|NCT02799069|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102098667|NCT02799069|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102098668|NCT02799069|Dermatologic Agents|dermatologic agents|mesh-ancestor
102098669|NCT02062047|Chlorhexidine|chlorhexidine|mesh-list
102098670|NCT02062047|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102098671|NCT02062047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102098672|NCT02062047|Disinfectants|disinfectants|mesh-ancestor
102098673|NCT03045406|Dalteparin|dalteparin|mesh-list
102098674|NCT03045406|Tinzaparin|tinzaparin|mesh-list
102098675|NCT03045406|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102098676|NCT03045406|Apixaban|apixaban|mesh-list
102098677|NCT03045406|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102098678|NCT03045406|Antithrombins|antithrombins|mesh-ancestor
102098679|NCT03045406|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102098680|NCT03045406|Protease Inhibitors|protease inhibitors|mesh-ancestor
102098681|NCT03045406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102098682|NCT03045406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098683|NCT03045406|Anticoagulants|anticoagulants|mesh-ancestor
102098684|NCT03045406|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102098685|NCT03045406|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102098686|NCT02798835|Dexamethasone|dexamethasone|mesh-list
102098687|NCT02798835|Dexamethasone acetate|dexamethasone acetate|mesh-list
102098688|NCT02798835|Fentanyl|fentanyl|mesh-list
102098689|NCT02798835|Bupivacaine|bupivacaine|mesh-list
102098690|NCT02798835|Ropivacaine|ropivacaine|mesh-list
102098691|NCT02798835|BB 1101|bb 1101|mesh-list
102098692|NCT02798835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102098693|NCT02798835|Antiemetics|antiemetics|mesh-ancestor
102098694|NCT02798835|Autonomic Agents|autonomic agents|mesh-ancestor
102098695|NCT02798835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102098696|NCT02798835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098697|NCT02798835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102098698|NCT02798835|Glucocorticoids|glucocorticoids|mesh-ancestor
102098699|NCT02798835|Hormones|hormones|mesh-ancestor
102098700|NCT02798835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102098701|NCT02798835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102098702|NCT02798835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102098703|NCT02798835|Protease Inhibitors|protease inhibitors|mesh-ancestor
102098704|NCT02798835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102098705|NCT02798835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098706|NCT02798835|Anesthetics, Local|anesthetics, local|mesh-ancestor
102098707|NCT02798835|Anesthetics|anesthetics|mesh-ancestor
102098708|NCT02798835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102098709|NCT02798835|Sensory System Agents|sensory system agents|mesh-ancestor
102098710|NCT02798835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102098711|NCT02798835|Narcotics|narcotics|mesh-ancestor
102098712|NCT02798835|Analgesics|analgesics|mesh-ancestor
102098713|NCT02798835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102098714|NCT02798835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102098715|NCT02798835|Anesthetics, General|anesthetics, general|mesh-ancestor
102098716|NCT02061657|Misoprostol|misoprostol|mesh-list
102098717|NCT02061657|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102098718|NCT02061657|Abortifacient Agents|abortifacient agents|mesh-ancestor
102098719|NCT02061657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102098720|NCT02061657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098721|NCT02061657|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102098722|NCT02061657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102098723|NCT02061657|Oxytocics|oxytocics|mesh-ancestor
102098724|NCT03048136|Nivolumab|nivolumab|mesh-list
102098725|NCT03048136|Ipilimumab|ipilimumab|mesh-list
102098726|NCT03048136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102098727|NCT03048136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102098728|NCT03048136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102098729|NCT03048136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098730|NCT02062203|Moxifloxacin|moxifloxacin|mesh-list
102098731|NCT02062203|Glycine|glycine|mesh-list
102098732|NCT02062203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102098733|NCT02062203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101836446|NCT00309244|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102098734|NCT02062203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102098735|NCT02062203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102098736|NCT02062203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102098737|NCT02062203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098738|NCT02062203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102098739|NCT02062203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098740|NCT02062203|Glycine Agents|glycine agents|mesh-ancestor
102098741|NCT02062203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102098742|NCT04863742|Prednisolone|prednisolone|mesh-list
102098743|NCT04863742|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102098744|NCT04863742|Methylprednisolone|methylprednisolone|mesh-list
102098745|NCT04863742|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102098746|NCT04863742|Prednisolone acetate|prednisolone acetate|mesh-list
102098747|NCT04863742|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102098748|NCT04863742|Prednisolone phosphate|prednisolone phosphate|mesh-list
102098749|NCT04863742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102098750|NCT04863742|Glucocorticoids|glucocorticoids|mesh-ancestor
102098751|NCT04863742|Hormones|hormones|mesh-ancestor
102098752|NCT04863742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102098753|NCT04863742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098754|NCT04863742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102098755|NCT04863742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102098756|NCT04863742|Antiemetics|antiemetics|mesh-ancestor
102098757|NCT04863742|Autonomic Agents|autonomic agents|mesh-ancestor
102098758|NCT04863742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102098759|NCT04863742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102098760|NCT04863742|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102098761|NCT04863742|Protective Agents|protective agents|mesh-ancestor
102098762|NCT02611882|Edetic Acid|edetic acid|mesh-list
102098763|NCT02611882|N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid|n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid|mesh-list
102098764|NCT02611882|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102098765|NCT02611882|Chelating Agents|chelating agents|mesh-ancestor
102098766|NCT02611882|Sequestering Agents|sequestering agents|mesh-ancestor
102098767|NCT02611882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098768|NCT02611882|Anticoagulants|anticoagulants|mesh-ancestor
102098769|NCT02611882|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102098770|NCT02611882|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102098771|NCT02062281|Vaccines|vaccines|mesh-list
102098772|NCT02062281|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102098773|NCT02062281|Immunologic Factors|immunologic factors|mesh-ancestor
102098774|NCT02062281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098775|NCT05590455|Adalimumab|adalimumab|mesh-list
102098776|NCT05590455|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102098777|NCT05590455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102098778|NCT05590455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102098779|NCT03560583|Metoclopramide|metoclopramide|mesh-list
102098780|NCT03560583|Antiemetics|antiemetics|mesh-ancestor
102098781|NCT03560583|Autonomic Agents|autonomic agents|mesh-ancestor
102098782|NCT03560583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102098783|NCT03560583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098784|NCT03560583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102098785|NCT03560583|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102098786|NCT03560583|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102098787|NCT03560583|Dopamine Agents|dopamine agents|mesh-ancestor
102098788|NCT03560583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102098789|NCT03560583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098790|NCT03560427|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102098791|NCT03560427|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102098792|NCT03560427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102098793|NCT03560427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101953243|NCT03797703|Sensory System Agents|sensory system agents|mesh-ancestor
102098794|NCT03560427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098795|NCT03560427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102098796|NCT03560427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098797|NCT03560427|Analgesics|analgesics|mesh-ancestor
102098798|NCT03560427|Sensory System Agents|sensory system agents|mesh-ancestor
102098799|NCT03560427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102098800|NCT03560427|Antidepressive Agents|antidepressive agents|mesh-ancestor
102098801|NCT03560427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102098802|NCT03560427|Dopamine Agents|dopamine agents|mesh-ancestor
102098803|NCT03797547|Aflibercept|aflibercept|mesh-list
102098804|NCT03797547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102098805|NCT03797547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102098806|NCT03797547|Growth Substances|growth substances|mesh-ancestor
102098807|NCT03797547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098808|NCT03797547|Growth Inhibitors|growth inhibitors|mesh-ancestor
102098809|NCT03797547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102098810|NCT04867252|Inositol|inositol|mesh-list
102098811|NCT04867252|Metformin|metformin|mesh-list
102098812|NCT04867252|Pioglitazone|pioglitazone|mesh-list
102098813|NCT04867252|Resveratrol|resveratrol|mesh-list
102098814|NCT04867252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102098815|NCT04867252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098816|NCT04867252|Antioxidants|antioxidants|mesh-ancestor
102098817|NCT04867252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098818|NCT04867252|Protective Agents|protective agents|mesh-ancestor
102098819|NCT04867252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102098820|NCT04867252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102098821|NCT04867252|Vitamin B Complex|vitamin b complex|mesh-ancestor
102098823|NCT04867252|Micronutrients|micronutrients|mesh-ancestor
102098824|NCT04863274|Atorvastatin|atorvastatin|mesh-list
102098825|NCT04863274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102098826|NCT04863274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102098827|NCT04863274|Antimetabolites|antimetabolites|mesh-ancestor
102098828|NCT04863274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098829|NCT04863274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102098830|NCT04863274|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102098831|NCT04863274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102098832|NCT02063373|Hyaluronic Acid|hyaluronic acid|mesh-list
102098833|NCT02063373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102098834|NCT02063373|Immunologic Factors|immunologic factors|mesh-ancestor
102098835|NCT02063373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098836|NCT02063373|Viscosupplements|viscosupplements|mesh-ancestor
102098837|NCT02063373|Protective Agents|protective agents|mesh-ancestor
102098838|NCT02062749|Oxaliplatin|oxaliplatin|mesh-list
102098839|NCT02062749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102098840|NCT02796651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102098841|NCT02796651|Formoterol Fumarate|formoterol fumarate|mesh-list
102098842|NCT02796651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102098843|NCT02796651|Autonomic Agents|autonomic agents|mesh-ancestor
102098844|NCT02796651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102098845|NCT02796651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098846|NCT02796651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102098847|NCT02796651|Respiratory System Agents|respiratory system agents|mesh-ancestor
102098848|NCT02796651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102098849|NCT02796651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102098850|NCT02796651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102098851|NCT02796651|Adrenergic Agents|adrenergic agents|mesh-ancestor
102098852|NCT02796651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102098853|NCT02796651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098854|NCT03044080|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102098855|NCT03044080|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102098856|NCT03044080|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102098857|NCT03044080|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102098858|NCT03044080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102098859|NCT03044080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098860|NCT03044080|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102098861|NCT03044080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102098862|NCT03044080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098863|NCT03044080|Cholinergic Agents|cholinergic agents|mesh-ancestor
102098864|NCT03044080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102098865|NCT04429282|Ibuprofen|ibuprofen|mesh-list
102098866|NCT04429282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102098867|NCT04429282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102098868|NCT04429282|Analgesics|analgesics|mesh-ancestor
102098869|NCT04429282|Sensory System Agents|sensory system agents|mesh-ancestor
102098870|NCT04429282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102098871|NCT04429282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098872|NCT04429282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102098873|NCT04429282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102098874|NCT04429282|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102098875|NCT04429282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102098876|NCT04429282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098877|NCT02063529|Leucovorin|leucovorin|mesh-list
102098878|NCT02063529|Fluorouracil|fluorouracil|mesh-list
102098879|NCT02063529|Oxaliplatin|oxaliplatin|mesh-list
102098880|NCT02063529|Irinotecan|irinotecan|mesh-list
102098881|NCT02063529|Cetuximab|cetuximab|mesh-list
102098882|NCT02063529|Levoleucovorin|levoleucovorin|mesh-list
102098883|NCT02063529|Antimetabolites|antimetabolites|mesh-ancestor
102098884|NCT02063529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098885|NCT02063529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102098886|NCT02063529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101836447|NCT00309244|Insulin Aspart|insulin aspart|mesh-list
102098887|NCT02063529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102098888|NCT02063529|Immunologic Factors|immunologic factors|mesh-ancestor
102098889|NCT02063529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098890|NCT02063529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102098891|NCT02063529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102098892|NCT02063529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102098893|NCT02063529|Antidotes|antidotes|mesh-ancestor
102098894|NCT02063529|Protective Agents|protective agents|mesh-ancestor
102098895|NCT02063529|Vitamin B Complex|vitamin b complex|mesh-ancestor
102098896|NCT02063529|Vitamins|vitamins|mesh-ancestor
102098897|NCT02063529|Micronutrients|micronutrients|mesh-ancestor
102098898|NCT02063529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102098899|NCT02062983|Trastuzumab|trastuzumab|mesh-list
102098900|NCT02062983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102098901|NCT02062983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102098902|NCT02613208|Paclitaxel|paclitaxel|mesh-list
102098903|NCT02613208|Bevacizumab|bevacizumab|mesh-list
102098904|NCT02613208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102098905|NCT02613208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102098906|NCT02613208|Tubulin Modulators|tubulin modulators|mesh-ancestor
102098907|NCT02613208|Antimitotic Agents|antimitotic agents|mesh-ancestor
102098908|NCT02613208|Mitosis Modulators|mitosis modulators|mesh-ancestor
102098909|NCT02613208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098910|NCT02613208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102098911|NCT02613208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102098912|NCT02613208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102098913|NCT02613208|Growth Substances|growth substances|mesh-ancestor
102098914|NCT02613208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098915|NCT02613208|Growth Inhibitors|growth inhibitors|mesh-ancestor
102098916|NCT02063841|Bismuth|bismuth|mesh-list
102098917|NCT02063841|Antacids|antacids|mesh-ancestor
102098918|NCT02063841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098919|NCT02063841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102098920|NCT02064153|Dialysis Solutions|dialysis solutions|mesh-list
102098921|NCT02064153|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102098922|NCT04872634|Cetuximab|cetuximab|mesh-list
102098923|NCT04872634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102098924|NCT04872634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102098925|NCT01668784|Nivolumab|nivolumab|mesh-list
102098926|NCT01668784|Everolimus|everolimus|mesh-list
102098927|NCT01668784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102098928|NCT01668784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102098929|NCT01668784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102098930|NCT01668784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098931|NCT01668784|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102098932|NCT01668784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101505545|NCT01244126|Narcotics|narcotics|mesh-ancestor
102098933|NCT01668784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102098934|NCT01668784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102098935|NCT01668784|Immunologic Factors|immunologic factors|mesh-ancestor
102098936|NCT01668784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098937|NCT02750514|Nivolumab|nivolumab|mesh-list
102098938|NCT02750514|Ipilimumab|ipilimumab|mesh-list
102098939|NCT02750514|Relatlimab|relatlimab|mesh-list
102098940|NCT02750514|Dasatinib|dasatinib|mesh-list
102098941|NCT02750514|Linrodostat|linrodostat|mesh-list
102098942|NCT02750514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102098943|NCT02750514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102098944|NCT02750514|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102098945|NCT02750514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098946|NCT02750514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102098947|NCT02750514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102098948|NCT02229240|rGLP-1 protein|rglp-1 protein|mesh-list
102098949|NCT02229240|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102098950|NCT02229240|Incretins|incretins|mesh-ancestor
102098951|NCT02229240|Hormones|hormones|mesh-ancestor
102098952|NCT02229240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102098953|NCT02229240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098954|NCT02820714|Laxatives|laxatives|mesh-list
102098955|NCT02820714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102098956|NCT02259426|Primaquine|primaquine|mesh-list
102098957|NCT02259426|Piperaquine|piperaquine|mesh-list
102098958|NCT02259426|Artenimol|artenimol|mesh-list
102098959|NCT02259426|Antimalarials|antimalarials|mesh-ancestor
102098960|NCT02259426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102098961|NCT02259426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102098962|NCT02259426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102098963|NCT03742518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102098964|NCT03738618|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102098965|NCT03738618|Hormones|hormones|mesh-ancestor
102098966|NCT03738618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102098967|NCT03738618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098968|NCT03412890|Norethindrone|norethindrone|mesh-list
102098969|NCT03412890|Norethindrone Acetate|norethindrone acetate|mesh-list
102098970|NCT03412890|Estradiol|estradiol|mesh-list
102098971|NCT03412890|Relugolix|relugolix|mesh-list
102098972|NCT03412890|Estrogens|estrogens|mesh-ancestor
102098973|NCT03412890|Hormones|hormones|mesh-ancestor
102098974|NCT03412890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102098975|NCT03412890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098976|NCT03412890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102098977|NCT03412890|Contraceptive Agents|contraceptive agents|mesh-ancestor
102098978|NCT03412890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102098979|NCT03412890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102098980|NCT03412890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102098981|NCT03412890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102098982|NCT03412890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102098983|NCT03412890|Androgen Antagonists|androgen antagonists|mesh-ancestor
102098984|NCT03412890|Hormone Antagonists|hormone antagonists|mesh-ancestor
102098985|NCT03371082|Insulin Glargine|insulin glargine|mesh-list
102098986|NCT03371082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102098987|NCT03371082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098988|NCT03340974|Avasopasem manganese|avasopasem manganese|mesh-list
102098989|NCT03340974|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102098990|NCT03340974|Antioxidants|antioxidants|mesh-ancestor
102098991|NCT03340974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102098992|NCT03340974|Protective Agents|protective agents|mesh-ancestor
102098993|NCT03340974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102098994|NCT02229786|Acetaminophen|acetaminophen|mesh-list
102098995|NCT02229786|Scopolamine|scopolamine|mesh-list
102098996|NCT02229786|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
102098997|NCT02229786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102098998|NCT02229786|Analgesics|analgesics|mesh-ancestor
102098999|NCT02229786|Sensory System Agents|sensory system agents|mesh-ancestor
102099000|NCT02229786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102099001|NCT02229786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099002|NCT02229786|Antipyretics|antipyretics|mesh-ancestor
102099003|NCT02229786|Parasympatholytics|parasympatholytics|mesh-ancestor
102099004|NCT02229786|Autonomic Agents|autonomic agents|mesh-ancestor
102099005|NCT02229786|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102099006|NCT02229786|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102099007|NCT02229786|Cholinergic Agents|cholinergic agents|mesh-ancestor
102099008|NCT02229786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102099009|NCT02229786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099010|NCT02229786|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102099011|NCT02229786|Antiemetics|antiemetics|mesh-ancestor
102099012|NCT02229786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102099013|NCT02229786|Mydriatics|mydriatics|mesh-ancestor
102099014|NCT03287232|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
102099015|NCT03287232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102099016|NCT03287232|Immunologic Factors|immunologic factors|mesh-ancestor
102099017|NCT03287232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099018|NCT02229942|Rituximab|rituximab|mesh-list
102099019|NCT02229942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102099020|NCT02229942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102099021|NCT02229942|Immunologic Factors|immunologic factors|mesh-ancestor
102099022|NCT02229942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099023|NCT02229942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102099024|NCT03047278|Cetirizine|cetirizine|mesh-list
102099025|NCT03047278|Gabapentin|gabapentin|mesh-list
102099026|NCT03047278|Analgesics|analgesics|mesh-ancestor
102099027|NCT03047278|Sensory System Agents|sensory system agents|mesh-ancestor
102099028|NCT03047278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102099029|NCT03047278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099030|NCT03047278|Anticonvulsants|anticonvulsants|mesh-ancestor
102099031|NCT03047278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102099032|NCT03047278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102099033|NCT03047278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102099034|NCT03047278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102099035|NCT03047278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102099036|NCT03047278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101552384|NCT01263015|Lamivudine|lamivudine|mesh-list
102099037|NCT03047278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101224909|NCT01526525|Sensory System Agents|sensory system agents|mesh-ancestor
102099038|NCT03047278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099039|NCT03047278|Antimanic Agents|antimanic agents|mesh-ancestor
102099040|NCT03047278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102099041|NCT03047278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102099042|NCT03047278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102099043|NCT03047278|Histamine Antagonists|histamine antagonists|mesh-ancestor
102099044|NCT03047278|Histamine Agents|histamine agents|mesh-ancestor
102099046|NCT03045016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102099047|NCT03045016|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102099048|NCT03045016|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102099049|NCT03045016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102099050|NCT03045016|Adrenergic Agents|adrenergic agents|mesh-ancestor
102099051|NCT03045016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102099052|NCT03045016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099053|NCT03045016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099054|NCT04849858|Bupivacaine|bupivacaine|mesh-list
102099055|NCT04849858|Anesthetics, Local|anesthetics, local|mesh-ancestor
102099056|NCT04849858|Anesthetics|anesthetics|mesh-ancestor
102099057|NCT04849858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102099058|NCT04849858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099059|NCT04849858|Sensory System Agents|sensory system agents|mesh-ancestor
102099060|NCT04849858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102099061|NCT03043612|Doxazosin|doxazosin|mesh-list
102099062|NCT03043612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102099063|NCT03043612|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102099064|NCT03043612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102099065|NCT03043612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102099066|NCT03043612|Adrenergic Agents|adrenergic agents|mesh-ancestor
102099067|NCT03043612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102099068|NCT03043612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099069|NCT03043612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099070|NCT02230176|Sunitinib|sunitinib|mesh-list
102099071|NCT02230176|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102099072|NCT02230176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102099073|NCT02230176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102099074|NCT02230176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102099075|NCT02230176|Growth Substances|growth substances|mesh-ancestor
102099076|NCT02230176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099077|NCT02230176|Growth Inhibitors|growth inhibitors|mesh-ancestor
102099078|NCT02230176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102099079|NCT02230176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102099080|NCT02230176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099081|NCT02230176|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102099082|NCT02232516|Lenalidomide|lenalidomide|mesh-list
102099083|NCT02232516|Romidepsin|romidepsin|mesh-list
102099084|NCT02232516|Immunologic Factors|immunologic factors|mesh-ancestor
102099085|NCT02232516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099086|NCT02232516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102099087|NCT02232516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102099088|NCT02232516|Growth Substances|growth substances|mesh-ancestor
102099089|NCT02232516|Growth Inhibitors|growth inhibitors|mesh-ancestor
102099090|NCT02232516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102099091|NCT02232516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102099092|NCT02232516|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102099093|NCT02232516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102099094|NCT02232516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099095|NCT04849390|Mometasone Furoate|mometasone furoate|mesh-list
102099096|NCT04849390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102099097|NCT04849390|Dermatologic Agents|dermatologic agents|mesh-ancestor
102099098|NCT04849390|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102099099|NCT03647592|Bevacizumab|bevacizumab|mesh-list
102099100|NCT03647592|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102099101|NCT03647592|Gefitinib|gefitinib|mesh-list
102099102|NCT03647592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102099103|NCT03647592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102099104|NCT03647592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102099105|NCT03647592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102099106|NCT03647592|Growth Substances|growth substances|mesh-ancestor
102099107|NCT03647592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099108|NCT03647592|Growth Inhibitors|growth inhibitors|mesh-ancestor
102099109|NCT03647592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102099110|NCT03647592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102099111|NCT03647592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099112|NCT02232594|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
102099113|NCT02232594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102099114|NCT02232594|Autonomic Agents|autonomic agents|mesh-ancestor
102099115|NCT02232594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102099116|NCT02232594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099117|NCT02232594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102099118|NCT02232594|Respiratory System Agents|respiratory system agents|mesh-ancestor
102099119|NCT04858516|Trastuzumab|trastuzumab|mesh-list
102099120|NCT04858516|Palbociclib|palbociclib|mesh-list
102099121|NCT04858516|Exemestane|exemestane|mesh-list
102099122|NCT04858516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102099123|NCT04858516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102099124|NCT04858516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102099125|NCT04858516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102099126|NCT04858516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099127|NCT04858516|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102099128|NCT04858516|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102099129|NCT04858516|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102099130|NCT04858516|Hormone Antagonists|hormone antagonists|mesh-ancestor
102099131|NCT04858516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102099132|NCT04858516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099133|NCT03148860|Methotrexate|methotrexate|mesh-list
102099134|NCT03148860|Ustekinumab|ustekinumab|mesh-list
102099135|NCT03148860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102099136|NCT03148860|Abortifacient Agents|abortifacient agents|mesh-ancestor
102099137|NCT03148860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102099138|NCT03148860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099139|NCT03148860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102099140|NCT03148860|Antimetabolites|antimetabolites|mesh-ancestor
102099141|NCT03148860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099142|NCT03148860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102099143|NCT03148860|Dermatologic Agents|dermatologic agents|mesh-ancestor
102099144|NCT03148860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102099145|NCT03148860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102099146|NCT03148860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102099147|NCT03148860|Immunologic Factors|immunologic factors|mesh-ancestor
102099148|NCT03148860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102099149|NCT03148860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102099150|NCT03131154|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102099151|NCT03131154|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102099152|NCT02232672|Choline|choline|mesh-list
102099153|NCT02232672|Lipotropic Agents|lipotropic agents|mesh-ancestor
102099154|NCT02232672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102099155|NCT02232672|Antimetabolites|antimetabolites|mesh-ancestor
102099156|NCT02232672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099157|NCT02232672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102099158|NCT02232672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102099159|NCT02232672|Nootropic Agents|nootropic agents|mesh-ancestor
102099160|NCT05072262|Dexamethasone|dexamethasone|mesh-list
102099161|NCT05072262|Nepafenac|nepafenac|mesh-list
102099162|NCT05072262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102099163|NCT05072262|Antiemetics|antiemetics|mesh-ancestor
102099164|NCT05072262|Autonomic Agents|autonomic agents|mesh-ancestor
102099165|NCT05072262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102099166|NCT05072262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099167|NCT05072262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102099168|NCT05072262|Glucocorticoids|glucocorticoids|mesh-ancestor
102099169|NCT05072262|Hormones|hormones|mesh-ancestor
102099170|NCT05072262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102099171|NCT05072262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102099172|NCT05072262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102099173|NCT05072262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102099174|NCT05072262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102099175|NCT05072262|Analgesics|analgesics|mesh-ancestor
102099176|NCT05072262|Sensory System Agents|sensory system agents|mesh-ancestor
102099177|NCT05072262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102099178|NCT05001984|Alirocumab|alirocumab|mesh-list
102099179|NCT05001984|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102099180|NCT05001984|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102099181|NCT05001984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102099182|NCT05001984|Antimetabolites|antimetabolites|mesh-ancestor
102099183|NCT05001984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099184|NCT05001984|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102099185|NCT05001984|Protease Inhibitors|protease inhibitors|mesh-ancestor
102099186|NCT05001984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102099187|NCT05001984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102099188|NCT04858048|Anesthetics|anesthetics|mesh-list
102099189|NCT04858048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102099190|NCT04858048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099192|NCT02234466|Ondansetron|ondansetron|mesh-list
102099193|NCT02234466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102099194|NCT02234466|Antiemetics|antiemetics|mesh-ancestor
102099195|NCT02234466|Autonomic Agents|autonomic agents|mesh-ancestor
102099196|NCT02234466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102099197|NCT02234466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099198|NCT02234466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102099199|NCT02234466|Glucocorticoids|glucocorticoids|mesh-ancestor
102099200|NCT02234466|Hormones|hormones|mesh-ancestor
102099201|NCT02234466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102099202|NCT02234466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102099203|NCT02234466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102099204|NCT02234466|Antipruritics|antipruritics|mesh-ancestor
102099205|NCT02234466|Dermatologic Agents|dermatologic agents|mesh-ancestor
102099206|NCT02234466|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102099207|NCT02234466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102099208|NCT02234466|Serotonin Agents|serotonin agents|mesh-ancestor
102099209|NCT02234466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102099210|NCT02234466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099211|NCT02230800|Tocovid|tocovid|mesh-list
102099212|NCT02230800|Pentoxifylline|pentoxifylline|mesh-list
102099213|NCT02230800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102099214|NCT02230800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102099215|NCT02230800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099216|NCT02230800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102099217|NCT02230800|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102099218|NCT02230800|Protective Agents|protective agents|mesh-ancestor
102099219|NCT02230800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099220|NCT02230800|Vasodilator Agents|vasodilator agents|mesh-ancestor
102099221|NCT02230800|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102099222|NCT02230800|Antioxidants|antioxidants|mesh-ancestor
102099223|NCT02230800|Vitamins|vitamins|mesh-ancestor
102099224|NCT02230800|Micronutrients|micronutrients|mesh-ancestor
102099225|NCT02234544|Vitamin D|vitamin d|mesh-list
102099226|NCT02234544|Cholecalciferol|cholecalciferol|mesh-list
102099227|NCT02234544|Ezetimibe|ezetimibe|mesh-list
102099228|NCT02234544|Vitamins|vitamins|mesh-ancestor
102099229|NCT02234544|Micronutrients|micronutrients|mesh-ancestor
102099230|NCT02234544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099231|NCT02234544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102099232|NCT02234544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102099233|NCT02234544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102099234|NCT02234544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102099235|NCT02234544|Antimetabolites|antimetabolites|mesh-ancestor
102099236|NCT02234544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099237|NCT02234544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102099238|NCT03043066|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102099239|NCT03043066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102099240|NCT03043066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102099241|NCT03043066|Antitubercular Agents|antitubercular agents|mesh-ancestor
102099242|NCT04860076|Pembrolizumab|pembrolizumab|mesh-list
102099243|NCT04860076|Nivolumab|nivolumab|mesh-list
102099244|NCT04860076|Ipilimumab|ipilimumab|mesh-list
102099245|NCT04860076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102099246|NCT04860076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102099247|NCT04860076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102099248|NCT04860076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099249|NCT04856878|Vancomycin|vancomycin|mesh-list
102099250|NCT04856878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102099251|NCT04856878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102099252|NCT04856644|Moxifloxacin|moxifloxacin|mesh-list
102099253|NCT04856644|Rifapentine|rifapentine|mesh-list
102099254|NCT04856644|Rifampin|rifampin|mesh-list
102099255|NCT04856644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102099256|NCT04856644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102099257|NCT04856644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102099258|NCT04856644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102099259|NCT04856644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102099260|NCT04856644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552609|NCT04320225|Glucocorticoids|glucocorticoids|mesh-ancestor
102099261|NCT04856644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102099262|NCT04856644|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102099263|NCT04856644|Antitubercular Agents|antitubercular agents|mesh-ancestor
102099264|NCT04856644|Leprostatic Agents|leprostatic agents|mesh-ancestor
102099265|NCT04856644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102099266|NCT04856644|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102099267|NCT04856644|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102099268|NCT04856644|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102099269|NCT04856644|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102099270|NCT04856644|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102099271|NCT04856644|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102099272|NCT01329978|Sofosbuvir|sofosbuvir|mesh-list
102099273|NCT01329978|Antiviral Agents|antiviral agents|mesh-ancestor
102099274|NCT01329978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102099275|NCT04984278|Nabiximols|nabiximols|mesh-list
102099276|NCT04984278|Analgesics|analgesics|mesh-ancestor
102099277|NCT04984278|Sensory System Agents|sensory system agents|mesh-ancestor
102099278|NCT04984278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102099279|NCT04984278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099280|NCT02233218|Amlodipine|amlodipine|mesh-list
102099281|NCT02233218|Telmisartan|telmisartan|mesh-list
102099282|NCT02233218|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102099283|NCT02233218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102099284|NCT02233218|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102099285|NCT02233218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102099286|NCT02233218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099287|NCT02233218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102099288|NCT02233218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099289|NCT02233218|Vasodilator Agents|vasodilator agents|mesh-ancestor
102099290|NCT02233218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102099291|NCT02233218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102099292|NCT02233218|Antimetabolites|antimetabolites|mesh-ancestor
102099293|NCT02233218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101224949|NCT01526694|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102099294|NCT02233218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102099295|NCT02233218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102099296|NCT02233218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102099297|NCT02233218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102099298|NCT02262546|Moxifloxacin|moxifloxacin|mesh-list
102099299|NCT02262546|Pramipexole|pramipexole|mesh-list
102099300|NCT02262546|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102099301|NCT02262546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102099302|NCT02262546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102099303|NCT02262546|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102099304|NCT02262546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102099305|NCT02262546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102099306|NCT02262546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099307|NCT02262546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102099308|NCT02262546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102099309|NCT02262546|Contraceptive Agents|contraceptive agents|mesh-ancestor
102099310|NCT02262546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102099311|NCT02262546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099312|NCT02262546|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102099313|NCT02262546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102099314|NCT02262546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102099315|NCT02262546|Antioxidants|antioxidants|mesh-ancestor
102099316|NCT02262546|Protective Agents|protective agents|mesh-ancestor
102099317|NCT02262546|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102099318|NCT02262546|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102099319|NCT02262546|Dopamine Agonists|dopamine agonists|mesh-ancestor
102099320|NCT02262546|Dopamine Agents|dopamine agents|mesh-ancestor
102099321|NCT02262546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102099322|NCT03042052|Botulinum Toxins|botulinum toxins|mesh-list
102099323|NCT03042052|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102099324|NCT03042052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102099325|NCT03042052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099326|NCT03042052|Cholinergic Agents|cholinergic agents|mesh-ancestor
102099327|NCT03042052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102099328|NCT03042052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099329|NCT04856098|Glycopyrrolate|glycopyrrolate|mesh-list
102099330|NCT04856098|Bromides|bromides|mesh-list
102099331|NCT04856098|Maleic acid|maleic acid|mesh-list
102099332|NCT04856098|Charcoal|charcoal|mesh-list
102099333|NCT04856098|Anticonvulsants|anticonvulsants|mesh-ancestor
102099334|NCT04856098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102099335|NCT04856098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099336|NCT04856098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102099337|NCT04856098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102099338|NCT04856098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102099339|NCT04856098|Cholinergic Agents|cholinergic agents|mesh-ancestor
102099340|NCT04856098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102099341|NCT04856098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099342|NCT04856098|Antidotes|antidotes|mesh-ancestor
102099343|NCT04856098|Protective Agents|protective agents|mesh-ancestor
102099344|NCT04859452|Metformin|metformin|mesh-list
102099345|NCT04859452|Glyburide|glyburide|mesh-list
102099346|NCT04859452|Valsartan|valsartan|mesh-list
102099347|NCT04859452|Simvastatin|simvastatin|mesh-list
102099348|NCT04859452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102099349|NCT04859452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099350|NCT04859452|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102099351|NCT04859452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102099352|NCT04859452|Antimetabolites|antimetabolites|mesh-ancestor
102099353|NCT04859452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099354|NCT04859452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102099355|NCT04859452|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102099356|NCT04859452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102099357|NCT04859452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102099358|NCT04859452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102099359|NCT04859452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102099360|NCT02262624|Telmisartan|telmisartan|mesh-list
102099361|NCT02262624|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102099362|NCT02262624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102099363|NCT02262624|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102099364|NCT02262624|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102099365|NCT02262624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099366|NCT02262624|Diuretics|diuretics|mesh-ancestor
102099367|NCT02262624|Natriuretic Agents|natriuretic agents|mesh-ancestor
102099368|NCT02262624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099369|NCT02262624|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102099370|NCT02262624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102099371|NCT02233452|Ketamine|ketamine|mesh-list
102099372|NCT02233452|Methadone|methadone|mesh-list
102099373|NCT02233452|Analgesics|analgesics|mesh-ancestor
102099374|NCT02233452|Sensory System Agents|sensory system agents|mesh-ancestor
102099375|NCT02233452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102099376|NCT02233452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099377|NCT02233452|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102099378|NCT02233452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102099379|NCT02233452|Anesthetics, General|anesthetics, general|mesh-ancestor
102099380|NCT02233452|Anesthetics|anesthetics|mesh-ancestor
102099381|NCT02233452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102099382|NCT02233452|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102099383|NCT02233452|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102099384|NCT02233452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102099385|NCT02233452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099386|NCT02233452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102099387|NCT02233452|Narcotics|narcotics|mesh-ancestor
102099388|NCT02233452|Antitussive Agents|antitussive agents|mesh-ancestor
102099389|NCT02233452|Respiratory System Agents|respiratory system agents|mesh-ancestor
102099390|NCT02262702|Acetaminophen|acetaminophen|mesh-list
102099391|NCT02262702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102099392|NCT02262702|Analgesics|analgesics|mesh-ancestor
102099393|NCT02262702|Sensory System Agents|sensory system agents|mesh-ancestor
102099394|NCT02262702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102099395|NCT02262702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099396|NCT02262702|Antipyretics|antipyretics|mesh-ancestor
102099397|NCT04846894|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102099398|NCT04846894|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102099399|NCT04846894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099400|NCT04845880|Myeloma Proteins|myeloma proteins|mesh-list
102099401|NCT04845880|Paraproteins|paraproteins|mesh-list
102099402|NCT04845880|Immunologic Factors|immunologic factors|mesh-ancestor
102099403|NCT04845880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099404|NCT04600752|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102099405|NCT04600752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102099406|NCT04600752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102099407|NCT04600752|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102099408|NCT04600752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102099409|NCT04600752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836448|NCT00309244|Protamines|protamines|mesh-list
101552757|NCT01300260|Hormones|hormones|mesh-ancestor
102099412|NCT03041506|Ketamine|ketamine|mesh-list
102099413|NCT03041506|Anesthetics, Local|anesthetics, local|mesh-ancestor
102099414|NCT03041506|Anesthetics|anesthetics|mesh-ancestor
102099415|NCT03041506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102099416|NCT03041506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099417|NCT03041506|Sensory System Agents|sensory system agents|mesh-ancestor
102099418|NCT03041506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102099419|NCT03041506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102099420|NCT03041506|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102099421|NCT03041506|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102099422|NCT03041506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102099423|NCT03041506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099424|NCT03041506|Analgesics|analgesics|mesh-ancestor
102099425|NCT03041506|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102099426|NCT03041506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102099427|NCT03041506|Anesthetics, General|anesthetics, general|mesh-ancestor
102099428|NCT03041506|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102099429|NCT03041506|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102099430|NCT03041506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102099431|NCT03041506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102099432|NCT03041506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102099433|NCT03041506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102099434|NCT03041506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102099435|NCT03041506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102099436|NCT03041506|GABA Modulators|gaba modulators|mesh-ancestor
102099437|NCT03041506|GABA Agents|gaba agents|mesh-ancestor
102099438|NCT02580708|Trametinib|trametinib|mesh-list
102099439|NCT02580708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102099440|NCT02580708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102099441|NCT02580708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102099442|NCT02580708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099443|NCT02262780|Telmisartan|telmisartan|mesh-list
102099444|NCT02262780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102099445|NCT02262780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102099446|NCT02262780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102099447|NCT02262780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099448|NCT04845646|Itraconazole|itraconazole|mesh-list
102099449|NCT04845646|Phenytoin|phenytoin|mesh-list
102099450|NCT04845646|Antifungal Agents|antifungal agents|mesh-ancestor
102099451|NCT04845646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102099452|NCT04845646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102099453|NCT04845646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102099454|NCT04845646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102099455|NCT04845646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099456|NCT04845646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102099457|NCT04845646|Hormone Antagonists|hormone antagonists|mesh-ancestor
102099458|NCT04845646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102099459|NCT04845646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099460|NCT04845646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102099461|NCT04845646|Anticonvulsants|anticonvulsants|mesh-ancestor
101953319|NCT03797079|Bupivacaine|bupivacaine|mesh-list
102099462|NCT04845646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102099463|NCT04845646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102099464|NCT04845646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102099465|NCT04845646|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102099466|NCT04845646|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102099467|NCT03038776|Hemagglutinins|hemagglutinins|mesh-list
102099468|NCT03038776|Agglutinins|agglutinins|mesh-ancestor
102099469|NCT03038776|Immunologic Factors|immunologic factors|mesh-ancestor
102099470|NCT03038776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099471|NCT03038776|Coagulants|coagulants|mesh-ancestor
102099472|NCT02570490|Linezolid|linezolid|mesh-list
102099473|NCT02570490|Fusidic Acid|fusidic acid|mesh-list
102099474|NCT02570490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102099475|NCT02570490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102099476|NCT02570490|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102099477|NCT02570490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102099478|NCT02570490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099479|NCT02565732|Botulinum Toxins|botulinum toxins|mesh-list
102099480|NCT02565732|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102099481|NCT02565732|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102099482|NCT02565732|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101552838|NCT01297062|Incretins|incretins|mesh-ancestor
102099483|NCT02565732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102099484|NCT02565732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099485|NCT02565732|Cholinergic Agents|cholinergic agents|mesh-ancestor
102099486|NCT02565732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102099487|NCT02565732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099488|NCT02565732|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102099489|NCT02565732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102099490|NCT02561442|Ceftriaxone|ceftriaxone|mesh-list
102099491|NCT02561442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102099492|NCT02561442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102099493|NCT02262858|Telmisartan|telmisartan|mesh-list
102099494|NCT02262858|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102099495|NCT02262858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102099496|NCT02262858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102099497|NCT02262858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102099498|NCT02262858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099499|NCT02262858|Diuretics|diuretics|mesh-ancestor
102099500|NCT02262858|Natriuretic Agents|natriuretic agents|mesh-ancestor
102099501|NCT02262858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099502|NCT02262858|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102099503|NCT02262858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102099504|NCT02235012|Ketamine|ketamine|mesh-list
102099505|NCT02235012|Analgesics|analgesics|mesh-ancestor
102099506|NCT02235012|Sensory System Agents|sensory system agents|mesh-ancestor
102099507|NCT02235012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102099508|NCT02235012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099509|NCT02235012|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102099510|NCT02235012|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102099511|NCT02235012|Anesthetics, General|anesthetics, general|mesh-ancestor
102099512|NCT02235012|Anesthetics|anesthetics|mesh-ancestor
102099513|NCT02235012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102099514|NCT02235012|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102099515|NCT02235012|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102099516|NCT02235012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102099517|NCT02235012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099518|NCT02262936|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
102099519|NCT02262936|Fesoterodine|fesoterodine|mesh-list
102099520|NCT02262936|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102099521|NCT02262936|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102099522|NCT02262936|Cholinergic Agents|cholinergic agents|mesh-ancestor
102099523|NCT02262936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102099524|NCT02262936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099525|NCT02262936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099526|NCT02262936|Urological Agents|urological agents|mesh-ancestor
102099527|NCT02262936|Hemostatics|hemostatics|mesh-ancestor
102099528|NCT02262936|Coagulants|coagulants|mesh-ancestor
102099529|NCT02262936|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102099530|NCT02262936|Natriuretic Agents|natriuretic agents|mesh-ancestor
101953326|NCT02049268|Ethanol|ethanol|mesh-list
102099531|NCT04838704|Mycophenolic Acid|mycophenolic acid|mesh-list
102099532|NCT04838704|Methotrexate|methotrexate|mesh-list
102099533|NCT04838704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102099534|NCT04838704|Abortifacient Agents|abortifacient agents|mesh-ancestor
102099535|NCT04838704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102099536|NCT04838704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099537|NCT04838704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102099538|NCT04838704|Antimetabolites|antimetabolites|mesh-ancestor
102099539|NCT04838704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099540|NCT04838704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102099541|NCT04838704|Dermatologic Agents|dermatologic agents|mesh-ancestor
102099542|NCT04838704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102099543|NCT04838704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102099544|NCT04838704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102099545|NCT04838704|Immunologic Factors|immunologic factors|mesh-ancestor
102099546|NCT04838704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102099547|NCT04838704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102099548|NCT04838704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102099549|NCT04838704|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102099550|NCT04838704|Antitubercular Agents|antitubercular agents|mesh-ancestor
102099551|NCT04838704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102099552|NCT04838704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102099553|NCT02259738|Kallikreins|kallikreins|mesh-list
102099554|NCT02259738|Coagulants|coagulants|mesh-ancestor
102099555|NCT02259738|Fertility Agents, Male|fertility agents, male|mesh-ancestor
102099556|NCT02259738|Fertility Agents|fertility agents|mesh-ancestor
102099557|NCT02259738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102099558|NCT02259738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099559|NCT04854460|Ivermectin|ivermectin|mesh-list
102099560|NCT04854460|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102099561|NCT04854460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102099562|NCT04854538|Budesonide|budesonide|mesh-list
102099563|NCT04854538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102099564|NCT04854538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102099565|NCT04854538|Autonomic Agents|autonomic agents|mesh-ancestor
102099566|NCT04854538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102099567|NCT04854538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099568|NCT04854538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102099569|NCT04854538|Respiratory System Agents|respiratory system agents|mesh-ancestor
102099570|NCT04854538|Glucocorticoids|glucocorticoids|mesh-ancestor
102099571|NCT04854538|Hormones|hormones|mesh-ancestor
102099572|NCT04854538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102099573|NCT05331690|Dexamethasone|dexamethasone|mesh-list
102099574|NCT05331690|Nepafenac|nepafenac|mesh-list
102099575|NCT05331690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102099576|NCT05331690|Antiemetics|antiemetics|mesh-ancestor
102099577|NCT05331690|Autonomic Agents|autonomic agents|mesh-ancestor
102099578|NCT05331690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102099579|NCT05331690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099580|NCT05331690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102099581|NCT05331690|Glucocorticoids|glucocorticoids|mesh-ancestor
102099582|NCT05331690|Hormones|hormones|mesh-ancestor
102099583|NCT05331690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102099584|NCT05331690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102099585|NCT05331690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102099586|NCT05331690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102099587|NCT05331690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102099588|NCT05331690|Analgesics|analgesics|mesh-ancestor
102099589|NCT05331690|Sensory System Agents|sensory system agents|mesh-ancestor
102099590|NCT05331690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102099591|NCT04373668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
102099592|NCT04373668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102099593|NCT04373668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099594|NCT02263170|Phenobarbital|phenobarbital|mesh-list
102099595|NCT02263170|Anticonvulsants|anticonvulsants|mesh-ancestor
102099596|NCT02263170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102099597|NCT02263170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102099598|NCT02263170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099599|NCT02263170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102099600|NCT02263170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102099601|NCT02263170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102099602|NCT02263170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099603|NCT02263170|GABA Modulators|gaba modulators|mesh-ancestor
102099604|NCT02263170|GABA Agents|gaba agents|mesh-ancestor
102099605|NCT02263170|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102099606|NCT02263170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102099607|NCT02263170|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102099608|NCT02543268|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
102099609|NCT02543268|Antiviral Agents|antiviral agents|mesh-ancestor
102099610|NCT02543268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102099611|NCT05252988|Loperamide|loperamide|mesh-list
102099612|NCT05252988|Antidiarrheals|antidiarrheals|mesh-list
102099613|NCT05252988|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
102099614|NCT05252988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102099615|NCT05252988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102099616|NCT05252988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102099617|NCT05252988|Antimetabolites|antimetabolites|mesh-ancestor
102099618|NCT05252988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099619|NCT05252988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102099620|NCT03038230|Antibodies|antibodies|mesh-list
102099621|NCT03038230|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102099622|NCT03038230|Immunologic Factors|immunologic factors|mesh-ancestor
102099623|NCT03038230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099624|NCT04853758|Valsartan|valsartan|mesh-list
102099625|NCT04853758|Enalapril|enalapril|mesh-list
102099626|NCT04853758|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102099627|NCT04853758|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102099628|NCT04853758|Enzyme Inhibitors|enzyme inhibitors|mesh-list
102099629|NCT04853758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102099630|NCT04853758|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102099631|NCT04853758|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102099632|NCT04853758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099633|NCT04853758|Protease Inhibitors|protease inhibitors|mesh-ancestor
102099635|NCT02784288|Carboplatin|carboplatin|mesh-list
102099636|NCT02784288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102099637|NCT02784288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102099638|NCT02784288|Tubulin Modulators|tubulin modulators|mesh-ancestor
102099639|NCT02784288|Antimitotic Agents|antimitotic agents|mesh-ancestor
102099640|NCT02784288|Mitosis Modulators|mitosis modulators|mesh-ancestor
102099641|NCT02784288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099642|NCT03040180|Bleomycin|bleomycin|mesh-list
102099643|NCT03040180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102099644|NCT03040180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102099645|NCT02235246|Magnesium Sulfate|magnesium sulfate|mesh-list
102099646|NCT02235246|Analgesics|analgesics|mesh-ancestor
102099647|NCT02235246|Sensory System Agents|sensory system agents|mesh-ancestor
102099648|NCT02235246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102099649|NCT02235246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099650|NCT02235246|Anesthetics|anesthetics|mesh-ancestor
102099651|NCT02235246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102099652|NCT02235246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102099653|NCT02235246|Anticonvulsants|anticonvulsants|mesh-ancestor
102099654|NCT02235246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102099655|NCT02235246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102099656|NCT02235246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099657|NCT02235246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102099658|NCT02235246|Tocolytic Agents|tocolytic agents|mesh-ancestor
102099659|NCT02235246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102099660|NCT02235324|Leucovorin|leucovorin|mesh-list
102099661|NCT02235324|Fluorouracil|fluorouracil|mesh-list
102099662|NCT02235324|Aflibercept|aflibercept|mesh-list
102099663|NCT02235324|Calcium|calcium|mesh-list
102099664|NCT02235324|Levoleucovorin|levoleucovorin|mesh-list
102099665|NCT02235324|Endothelial Growth Factors|endothelial growth factors|mesh-list
101953338|NCT02049268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102099666|NCT02235324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102099667|NCT02235324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099668|NCT02235324|Antimetabolites|antimetabolites|mesh-ancestor
102099669|NCT02235324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099670|NCT02235324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102099671|NCT02235324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102099672|NCT02235324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102099673|NCT02235324|Immunologic Factors|immunologic factors|mesh-ancestor
102099674|NCT02235324|Antidotes|antidotes|mesh-ancestor
102099675|NCT02235324|Protective Agents|protective agents|mesh-ancestor
102099676|NCT02235324|Vitamin B Complex|vitamin b complex|mesh-ancestor
102099677|NCT02235324|Vitamins|vitamins|mesh-ancestor
102099678|NCT02235324|Micronutrients|micronutrients|mesh-ancestor
102099679|NCT02235324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102099680|NCT02235324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102099681|NCT02235324|Growth Substances|growth substances|mesh-ancestor
102099682|NCT02235324|Growth Inhibitors|growth inhibitors|mesh-ancestor
102099683|NCT01230242|Levonorgestrel|levonorgestrel|mesh-list
102099684|NCT01230242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102099685|NCT01230242|Contraceptive Agents|contraceptive agents|mesh-ancestor
102099686|NCT01230242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102099687|NCT01230242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099688|NCT01230242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102099689|NCT01230242|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102099690|NCT01230242|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102099691|NCT02263248|Buprenorphine|buprenorphine|mesh-list
102099692|NCT02263248|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102099693|NCT02263248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102099694|NCT02263248|Narcotics|narcotics|mesh-ancestor
101224996|NCT01526876|Clevidipine|clevidipine|mesh-list
102099695|NCT02263248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102099696|NCT02263248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099697|NCT02263248|Analgesics|analgesics|mesh-ancestor
102099698|NCT02263248|Sensory System Agents|sensory system agents|mesh-ancestor
102099699|NCT02263248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102099700|NCT02263248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102099701|NCT02263248|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102099702|NCT02263248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102099703|NCT02263248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102099704|NCT02263248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099705|NCT02263248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102099706|NCT02263248|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102099707|NCT02263248|Antidepressive Agents|antidepressive agents|mesh-ancestor
102099708|NCT02263248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102099709|NCT04838860|Siltuximab|siltuximab|mesh-list
102099710|NCT04838860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102099711|NCT04853524|Tenofovir|tenofovir|mesh-list
102099712|NCT04853524|Emtricitabine|emtricitabine|mesh-list
102099713|NCT04853524|JNJ-56136379|jnj-56136379|mesh-list
102099714|NCT04853524|Antiviral Agents|antiviral agents|mesh-ancestor
102099715|NCT04853524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102099716|NCT04853524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102099717|NCT04853524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102099718|NCT04853524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102099719|NCT04853524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099720|NCT04853524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102099721|NCT04853524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102099722|NCT04852510|Metformin|metformin|mesh-list
102099723|NCT04852510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102099724|NCT04852510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099725|NCT05163704|Dexmedetomidine|dexmedetomidine|mesh-list
102099726|NCT05163704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102099727|NCT05163704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102099728|NCT05163704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099729|NCT05163704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102099730|NCT05163704|Analgesics|analgesics|mesh-ancestor
102099731|NCT05163704|Sensory System Agents|sensory system agents|mesh-ancestor
102099732|NCT05163704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102099733|NCT05163704|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102099734|NCT05163704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102099735|NCT05163704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102099736|NCT05163704|Adrenergic Agents|adrenergic agents|mesh-ancestor
102099737|NCT05163704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102099738|NCT05163704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099739|NCT03130556|Rabeprazole|rabeprazole|mesh-list
102099740|NCT03130556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102099741|NCT03130556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102099742|NCT03130556|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102099743|NCT03130556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102099744|NCT03130556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099745|NCT04838080|Vaccines|vaccines|mesh-list
102099746|NCT04838080|Immunologic Factors|immunologic factors|mesh-ancestor
102099747|NCT04838080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099748|NCT04842838|Paclitaxel|paclitaxel|mesh-list
102099749|NCT04842838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102099750|NCT04842838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102099751|NCT04842838|Tubulin Modulators|tubulin modulators|mesh-ancestor
102099752|NCT04842838|Antimitotic Agents|antimitotic agents|mesh-ancestor
102099753|NCT04842838|Mitosis Modulators|mitosis modulators|mesh-ancestor
102099754|NCT04842838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099755|NCT03037606|Rabeprazole|rabeprazole|mesh-list
102099756|NCT03037606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102099757|NCT03037606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102099758|NCT03037606|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102099759|NCT03037606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102099760|NCT03037606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099761|NCT04842370|PHI-101|phi-101|mesh-list
102099762|NCT04842370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101225002|NCT01526941|Insulin|insulin|mesh-list
102099763|NCT04842370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099764|NCT04842370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102099765|NCT04842370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102099766|NCT03037372|Atorvastatin|atorvastatin|mesh-list
102099767|NCT03037372|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102099768|NCT03037372|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
102099769|NCT03037372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102099770|NCT03037372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102099771|NCT03037372|Antimetabolites|antimetabolites|mesh-ancestor
102099772|NCT03037372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099773|NCT03037372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102099774|NCT03037372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102099775|NCT04842526|Irinotecan|irinotecan|mesh-list
102099776|NCT04842526|Temozolomide|temozolomide|mesh-list
102099777|NCT04842526|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101836449|NCT00309244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102099778|NCT04842526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102099779|NCT04842526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102099780|NCT04842526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099781|NCT04842526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102099782|NCT04842526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102099783|NCT04842526|Alkylating Agents|alkylating agents|mesh-ancestor
102099785|NCT04850950|Antiviral Agents|antiviral agents|mesh-ancestor
102099786|NCT04850950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102099787|NCT04850950|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102099788|NCT04850950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102099789|NCT04850950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102099790|NCT04850950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099791|NCT04850950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102099792|NCT04850950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102099793|NCT05164952|Zoledronic Acid|zoledronic acid|mesh-list
102099794|NCT05164952|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102099795|NCT05164952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099796|NCT04850560|Decitabine|decitabine|mesh-list
101953348|NCT03564873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102099797|NCT04850560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102099798|NCT04850560|Antimetabolites|antimetabolites|mesh-ancestor
102099799|NCT04850560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099800|NCT04850560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102099801|NCT04850560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102099802|NCT04850404|Ropivacaine|ropivacaine|mesh-list
102099803|NCT04850404|Rocuronium|rocuronium|mesh-list
102099804|NCT04850404|Anesthetics, Local|anesthetics, local|mesh-ancestor
102099805|NCT04850404|Anesthetics|anesthetics|mesh-ancestor
102099806|NCT04850404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102099807|NCT04850404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099808|NCT04850404|Sensory System Agents|sensory system agents|mesh-ancestor
102099809|NCT04850404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102099810|NCT04850404|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102099811|NCT04850404|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102099812|NCT04850404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102099813|NCT04428814|Ustekinumab|ustekinumab|mesh-list
102099814|NCT04428814|Dermatologic Agents|dermatologic agents|mesh-ancestor
102099815|NCT03036514|Sufentanil|sufentanil|mesh-list
102099816|NCT03036514|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102099817|NCT03036514|Narcotics|narcotics|mesh-ancestor
102099818|NCT03036514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102099819|NCT03036514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099820|NCT03036514|Analgesics|analgesics|mesh-ancestor
102099821|NCT03036514|Sensory System Agents|sensory system agents|mesh-ancestor
102099822|NCT03036514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102099823|NCT03036514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102099824|NCT03036514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102099825|NCT03036514|Anesthetics, General|anesthetics, general|mesh-ancestor
102099826|NCT03036514|Anesthetics|anesthetics|mesh-ancestor
102099827|NCT04835896|Paclitaxel|paclitaxel|mesh-list
102099828|NCT04835896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102099829|NCT04835896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102099830|NCT04835896|Tubulin Modulators|tubulin modulators|mesh-ancestor
102099831|NCT04835896|Antimitotic Agents|antimitotic agents|mesh-ancestor
102099832|NCT04835896|Mitosis Modulators|mitosis modulators|mesh-ancestor
102099833|NCT04835896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099834|NCT01668004|Golimumab|golimumab|mesh-list
102099835|NCT01668004|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102099836|NCT01668004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102099837|NCT01668004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102099838|NCT01668004|Immunologic Factors|immunologic factors|mesh-ancestor
102099839|NCT01668004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099840|NCT04835350|Pancrelipase|pancrelipase|mesh-list
102099841|NCT04835350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102099842|NCT01667926|Ketamine|ketamine|mesh-list
102099843|NCT01667926|Analgesics|analgesics|mesh-ancestor
102099844|NCT01667926|Sensory System Agents|sensory system agents|mesh-ancestor
102099845|NCT01667926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102099846|NCT01667926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099847|NCT01667926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102099848|NCT01667926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102099849|NCT01667926|Anesthetics, General|anesthetics, general|mesh-ancestor
102099850|NCT01667926|Anesthetics|anesthetics|mesh-ancestor
102099851|NCT01667926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102099852|NCT01667926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102099853|NCT01667926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102099854|NCT01667926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102099855|NCT01667926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099856|NCT03039478|Erythritol|erythritol|mesh-list
102099857|NCT03039478|Vasodilator Agents|vasodilator agents|mesh-ancestor
102099858|NCT04832776|Bevacizumab|bevacizumab|mesh-list
102099859|NCT04832776|Cetuximab|cetuximab|mesh-list
102099860|NCT04832776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102099861|NCT04832776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102099862|NCT04832776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102099863|NCT04832776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102099864|NCT04832776|Growth Substances|growth substances|mesh-ancestor
102099865|NCT04832776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099866|NCT04832776|Growth Inhibitors|growth inhibitors|mesh-ancestor
102099867|NCT04835116|Acetaminophen|acetaminophen|mesh-list
102099868|NCT04835116|Tramadol|tramadol|mesh-list
102099869|NCT04835116|Analgesics|analgesics|mesh-list
102099870|NCT04835116|Orphenadrine|orphenadrine|mesh-list
102099871|NCT04835116|Dimenhydrinate|dimenhydrinate|mesh-list
102099872|NCT04835116|Bupivacaine|bupivacaine|mesh-list
102099873|NCT04835116|Anesthetics, Local|anesthetics, local|mesh-ancestor
102099874|NCT04835116|Anesthetics|anesthetics|mesh-ancestor
102099875|NCT04835116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102099876|NCT04835116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099877|NCT04835116|Sensory System Agents|sensory system agents|mesh-ancestor
102099878|NCT04835116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102099879|NCT04835116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102099880|NCT04835116|Antipyretics|antipyretics|mesh-ancestor
102099881|NCT04835116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102099882|NCT04835116|Narcotics|narcotics|mesh-ancestor
102099883|NCT04835116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102099884|NCT04835116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102099885|NCT04835116|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102099886|NCT04835116|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102099887|NCT04835116|Parasympatholytics|parasympatholytics|mesh-ancestor
102099888|NCT04835116|Autonomic Agents|autonomic agents|mesh-ancestor
102099889|NCT04835116|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102099890|NCT04835116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102099891|NCT04835116|Cholinergic Agents|cholinergic agents|mesh-ancestor
102099892|NCT04835116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102099893|NCT04835116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099894|NCT04835116|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
102099895|NCT04835116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102099896|NCT04835116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102099897|NCT04835116|Antiemetics|antiemetics|mesh-ancestor
102099898|NCT04835116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102099899|NCT04835116|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102099900|NCT04835116|Histamine Antagonists|histamine antagonists|mesh-ancestor
102099901|NCT04835116|Histamine Agents|histamine agents|mesh-ancestor
102099902|NCT03036826|Meropenem|meropenem|mesh-list
102099903|NCT03036826|Tazobactam|tazobactam|mesh-list
102099904|NCT03036826|Piperacillin|piperacillin|mesh-list
102099905|NCT03036826|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102099906|NCT03036826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102099907|NCT03036826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102099908|NCT03036826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102099909|NCT03036826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102099910|NCT03036826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099911|NCT03036046|Fluconazole|fluconazole|mesh-list
102099912|NCT03036046|Posaconazole|posaconazole|mesh-list
102099913|NCT03036046|Olorofim|olorofim|mesh-list
102099914|NCT03036046|Antifungal Agents|antifungal agents|mesh-ancestor
102099915|NCT03036046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102099916|NCT03036046|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102099917|NCT03036046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102099918|NCT03036046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102099919|NCT03036046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099920|NCT03036046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102099921|NCT03036046|Hormone Antagonists|hormone antagonists|mesh-ancestor
102099922|NCT03036046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102099923|NCT03036046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099924|NCT03036046|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102099925|NCT03036046|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102099926|NCT03036046|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102099927|NCT03036046|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102099928|NCT03036046|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101553279|NCT01038856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102099929|NCT04831528|Bevacizumab|bevacizumab|mesh-list
102099930|NCT04831528|Trastuzumab|trastuzumab|mesh-list
102099931|NCT04831528|Cetuximab|cetuximab|mesh-list
102099932|NCT04831528|Pertuzumab|pertuzumab|mesh-list
102099933|NCT04831528|Lapatinib|lapatinib|mesh-list
102099934|NCT04831528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102099935|NCT04831528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102099936|NCT04831528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102099937|NCT04831528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102099938|NCT04831528|Growth Substances|growth substances|mesh-ancestor
102099939|NCT04831528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099940|NCT04831528|Growth Inhibitors|growth inhibitors|mesh-ancestor
102099941|NCT04831528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102099942|NCT04831528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101953361|NCT02049580|Cyclophosphamide|cyclophosphamide|mesh-list
102099943|NCT04831528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099944|NCT04824586|Insulin|insulin|mesh-list
102099945|NCT04824586|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102099946|NCT04824586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102099947|NCT04824586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099948|NCT04824898|Simvastatin|simvastatin|mesh-list
102099949|NCT04824898|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102099950|NCT04824898|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102099951|NCT04824898|Antimetabolites|antimetabolites|mesh-ancestor
102099952|NCT04824898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099953|NCT04824898|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102099954|NCT04824898|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102099955|NCT04824898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102099956|NCT04824352|Apatinib|apatinib|mesh-list
102099957|NCT04824352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102099958|NCT04824352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102099959|NCT04824352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102099960|NCT04824352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099961|NCT04319614|Tranexamic Acid|tranexamic acid|mesh-list
102099962|NCT04319614|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102099963|NCT04319614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102099964|NCT04319614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099965|NCT04319614|Hemostatics|hemostatics|mesh-ancestor
102099966|NCT04319614|Coagulants|coagulants|mesh-ancestor
102099967|NCT01359904|Dialysis Solutions|dialysis solutions|mesh-list
102099968|NCT01359904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102099969|NCT04823260|Niacinamide|niacinamide|mesh-list
102099971|NCT04823260|Nicotinic Acids|nicotinic acids|mesh-list
102099972|NCT04823260|Vitamin B Complex|vitamin b complex|mesh-ancestor
102099973|NCT04823260|Vitamins|vitamins|mesh-ancestor
102099974|NCT04823260|Micronutrients|micronutrients|mesh-ancestor
102099975|NCT04823260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099976|NCT04823260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102099977|NCT04823260|Antimetabolites|antimetabolites|mesh-ancestor
102099978|NCT04823260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099979|NCT04823260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102099980|NCT04823260|Vasodilator Agents|vasodilator agents|mesh-ancestor
102099981|NCT04816240|Midodrine|midodrine|mesh-list
102099982|NCT04816240|Sympathomimetics|sympathomimetics|mesh-ancestor
102099983|NCT04816240|Autonomic Agents|autonomic agents|mesh-ancestor
102099984|NCT04816240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102099985|NCT04816240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099986|NCT04816240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102099987|NCT04816240|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102099988|NCT04816240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102099989|NCT04816240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102099990|NCT04816240|Adrenergic Agents|adrenergic agents|mesh-ancestor
102099991|NCT04816240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102099992|NCT04816240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102099993|NCT04822012|Antibodies|antibodies|mesh-list
102099994|NCT04822012|Immunoglobulin G|immunoglobulin g|mesh-list
102099995|NCT04822012|Progesterone|progesterone|mesh-list
102099996|NCT04822012|Estrogens|estrogens|mesh-list
102099997|NCT04822012|Immunologic Factors|immunologic factors|mesh-ancestor
102099998|NCT04822012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102099999|NCT04822012|Progestins|progestins|mesh-ancestor
102100000|NCT04822012|Hormones|hormones|mesh-ancestor
102100001|NCT04822012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102100002|NCT05399732|Cyclosporine|cyclosporine|mesh-list
102100003|NCT05399732|Luspatercept|luspatercept|mesh-list
101553356|NCT04732000|Antioxidants|antioxidants|mesh-ancestor
102100004|NCT05399732|Cyclosporins|cyclosporins|mesh-list
102100005|NCT05399732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102100006|NCT05399732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100007|NCT05399732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102100008|NCT05399732|Immunologic Factors|immunologic factors|mesh-ancestor
102100009|NCT05399732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100010|NCT05399732|Antifungal Agents|antifungal agents|mesh-ancestor
102100011|NCT05399732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102100012|NCT05399732|Dermatologic Agents|dermatologic agents|mesh-ancestor
102100013|NCT05399732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102100014|NCT05399732|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102100015|NCT05399732|Hematinics|hematinics|mesh-ancestor
102100016|NCT05399576|Nicorandil|nicorandil|mesh-list
102100017|NCT05399576|Verapamil|verapamil|mesh-list
102100018|NCT05399576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102100019|NCT05399576|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102100020|NCT05399576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102100021|NCT05399576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100022|NCT05399576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102100023|NCT05399576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100024|NCT05399576|Vasodilator Agents|vasodilator agents|mesh-ancestor
102100025|NCT05399576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102100026|NCT05399576|Vitamin B Complex|vitamin b complex|mesh-ancestor
102100027|NCT05399576|Vitamins|vitamins|mesh-ancestor
102100028|NCT05399576|Micronutrients|micronutrients|mesh-ancestor
102100029|NCT05398718|Sotrovimab|sotrovimab|mesh-list
102100030|NCT05398718|Antiviral Agents|antiviral agents|mesh-ancestor
102100031|NCT05398718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102100032|NCT05255900|Metyrapone|metyrapone|mesh-list
102100033|NCT05255900|Antimetabolites|antimetabolites|mesh-ancestor
102100034|NCT05255900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100035|NCT05255900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102100036|NCT04615286|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102100037|NCT04615286|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102100038|NCT04615286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102100039|NCT04615286|Antitubercular Agents|antitubercular agents|mesh-ancestor
102100040|NCT05397938|Alendronate|alendronate|mesh-list
102100041|NCT05397938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102100042|NCT05397938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100043|NCT05133674|Tamoxifen|tamoxifen|mesh-list
102100044|NCT05133674|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102100045|NCT05133674|Hormone Antagonists|hormone antagonists|mesh-ancestor
102100046|NCT05133674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102100047|NCT05133674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100048|NCT05133674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102100049|NCT05133674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102100050|NCT05133674|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102100051|NCT05133674|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102100052|NCT05133674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102100053|NCT02522936|Muramidase|muramidase|mesh-list
102100054|NCT02522936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102100055|NCT04525898|Methadone|methadone|mesh-list
102100056|NCT04525898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102100057|NCT04525898|Narcotics|narcotics|mesh-ancestor
102100058|NCT04525898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102100059|NCT04525898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100060|NCT04525898|Analgesics|analgesics|mesh-ancestor
102100061|NCT04525898|Sensory System Agents|sensory system agents|mesh-ancestor
102100062|NCT04525898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102100063|NCT04525898|Antitussive Agents|antitussive agents|mesh-ancestor
102100064|NCT04525898|Respiratory System Agents|respiratory system agents|mesh-ancestor
102100065|NCT04282070|Paclitaxel|paclitaxel|mesh-list
102100066|NCT04282070|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102100067|NCT04282070|Cisplatin|cisplatin|mesh-list
102100068|NCT04282070|Gemcitabine|gemcitabine|mesh-list
102100069|NCT04282070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102100070|NCT04282070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102100071|NCT04282070|Tubulin Modulators|tubulin modulators|mesh-ancestor
102100072|NCT04282070|Antimitotic Agents|antimitotic agents|mesh-ancestor
102100073|NCT04282070|Mitosis Modulators|mitosis modulators|mesh-ancestor
102100074|NCT04282070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100075|NCT04282070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102100076|NCT04282070|Antimetabolites|antimetabolites|mesh-ancestor
102100077|NCT04347122|Tranexamic Acid|tranexamic acid|mesh-list
102100078|NCT04347122|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102100079|NCT04347122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102100080|NCT04347122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100081|NCT04347122|Hemostatics|hemostatics|mesh-ancestor
102100082|NCT04347122|Coagulants|coagulants|mesh-ancestor
102100083|NCT03467438|Polaprezinc|polaprezinc|mesh-list
102100084|NCT03467438|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102100085|NCT03467438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102100086|NCT05397236|Dexamethasone|dexamethasone|mesh-list
102100087|NCT05397236|Bupivacaine|bupivacaine|mesh-list
102100088|NCT05397236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102100089|NCT05397236|Antiemetics|antiemetics|mesh-ancestor
102100090|NCT05397236|Autonomic Agents|autonomic agents|mesh-ancestor
102100091|NCT05397236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102100092|NCT05397236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100093|NCT05397236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102100094|NCT05397236|Glucocorticoids|glucocorticoids|mesh-ancestor
102100095|NCT05397236|Hormones|hormones|mesh-ancestor
102100096|NCT05397236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102100097|NCT05397236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102100098|NCT05397236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102100099|NCT05397236|Anesthetics, Local|anesthetics, local|mesh-ancestor
102100100|NCT05397236|Anesthetics|anesthetics|mesh-ancestor
102100101|NCT05397236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102100102|NCT05397236|Sensory System Agents|sensory system agents|mesh-ancestor
102100103|NCT05439278|Temozolomide|temozolomide|mesh-list
102100104|NCT05439278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102100105|NCT05439278|Alkylating Agents|alkylating agents|mesh-ancestor
102100106|NCT05439278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100107|NCT05439278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102100108|NCT03130010|Nefopam|nefopam|mesh-list
102100109|NCT03130010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102100110|NCT03130010|Analgesics|analgesics|mesh-ancestor
102100111|NCT03130010|Sensory System Agents|sensory system agents|mesh-ancestor
102100112|NCT03130010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102100113|NCT03130010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100114|NCT05396144|Nitrous Oxide|nitrous oxide|mesh-list
102100115|NCT05396144|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102100116|NCT05396144|Anesthetics, General|anesthetics, general|mesh-ancestor
102100117|NCT05396144|Anesthetics|anesthetics|mesh-ancestor
102100118|NCT05396144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102100119|NCT05396144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100120|NCT05396144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102100121|NCT05396144|Analgesics|analgesics|mesh-ancestor
102100122|NCT05396144|Sensory System Agents|sensory system agents|mesh-ancestor
102100123|NCT05396144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102100124|NCT00157248|Dabigatran|dabigatran|mesh-list
102100125|NCT00157248|Antithrombins|antithrombins|mesh-ancestor
102100126|NCT00157248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102100127|NCT00157248|Protease Inhibitors|protease inhibitors|mesh-ancestor
102100128|NCT00157248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102100129|NCT00157248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100130|NCT00157248|Anticoagulants|anticoagulants|mesh-ancestor
102100131|NCT02504580|Bupivacaine|bupivacaine|mesh-list
102100132|NCT02504580|Anesthetics, Local|anesthetics, local|mesh-ancestor
102100133|NCT02504580|Anesthetics|anesthetics|mesh-ancestor
102100134|NCT02504580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102100135|NCT02504580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100136|NCT02504580|Sensory System Agents|sensory system agents|mesh-ancestor
102100137|NCT02504580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102100138|NCT02235402|Lacidipine|lacidipine|mesh-list
102100139|NCT02235402|Bendroflumethiazide|bendroflumethiazide|mesh-list
102100140|NCT02235402|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102100141|NCT02235402|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102100142|NCT02235402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102100143|NCT02235402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100144|NCT02235402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102100145|NCT02235402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100146|NCT02235402|Diuretics|diuretics|mesh-ancestor
102100147|NCT02235402|Natriuretic Agents|natriuretic agents|mesh-ancestor
102100148|NCT02235402|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102100149|NCT02235480|Tazarotene|tazarotene|mesh-list
102100150|NCT02235480|Dermatologic Agents|dermatologic agents|mesh-ancestor
102100151|NCT02235480|Keratolytic Agents|keratolytic agents|mesh-ancestor
102100152|NCT02235558|Verapamil|verapamil|mesh-list
102100153|NCT02235558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101553503|NCT01029262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102100154|NCT02235558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102100155|NCT02235558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102100156|NCT02235558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100157|NCT02235558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102100158|NCT02235558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100159|NCT02235558|Vasodilator Agents|vasodilator agents|mesh-ancestor
102100160|NCT04214418|Hydroxychloroquine|hydroxychloroquine|mesh-list
102100161|NCT04214418|Atezolizumab|atezolizumab|mesh-list
102100162|NCT04214418|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102100163|NCT04214418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100164|NCT04214418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102100165|NCT04214418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102100166|NCT04214418|Antimalarials|antimalarials|mesh-ancestor
102100167|NCT04214418|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102100168|NCT04214418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102100169|NCT04214418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102100170|NCT04214418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102100171|NCT04214418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102100172|NCT02233920|Oxitropium|oxitropium|mesh-list
102100173|NCT02233920|Parasympatholytics|parasympatholytics|mesh-ancestor
102100174|NCT02233920|Autonomic Agents|autonomic agents|mesh-ancestor
102100175|NCT02233920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102100176|NCT02233920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100177|NCT02235948|Folic Acid|folic acid|mesh-list
102100178|NCT02235948|Hematinics|hematinics|mesh-ancestor
102100179|NCT02235948|Vitamin B Complex|vitamin b complex|mesh-ancestor
102100180|NCT02235948|Vitamins|vitamins|mesh-ancestor
102100181|NCT02235948|Micronutrients|micronutrients|mesh-ancestor
102100182|NCT02235948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100183|NCT02236026|Moxifloxacin|moxifloxacin|mesh-list
102100184|NCT02236026|ST 1435|st 1435|mesh-list
102100185|NCT02236026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102100186|NCT02236026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102100187|NCT02236026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102100188|NCT02236026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102100189|NCT02236026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102100190|NCT02236026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100191|NCT02236026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102100192|NCT02236026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102100193|NCT02236026|Contraceptive Agents|contraceptive agents|mesh-ancestor
102100194|NCT02236026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102100195|NCT02236026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100196|NCT02236026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102100198|NCT02236182|Ipratropium|ipratropium|mesh-list
102100199|NCT02236182|Anticonvulsants|anticonvulsants|mesh-ancestor
102100200|NCT02236182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102100201|NCT02236182|Autonomic Agents|autonomic agents|mesh-ancestor
102100202|NCT02236182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102100203|NCT02236182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100204|NCT02236182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102100205|NCT02236182|Respiratory System Agents|respiratory system agents|mesh-ancestor
102100206|NCT02236182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102100207|NCT02236182|Cholinergic Agents|cholinergic agents|mesh-ancestor
102100208|NCT02236182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102100209|NCT02236182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100210|NCT04453280|Antibodies|antibodies|mesh-list
102100211|NCT04453280|Immunologic Factors|immunologic factors|mesh-ancestor
102100212|NCT04453280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100213|NCT01328756|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102100214|NCT01328756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102100215|NCT01328756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100216|NCT01328756|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102100217|NCT01328756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102100218|NCT01328756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102100219|NCT01328756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100220|NCT01328756|Dopamine Agents|dopamine agents|mesh-ancestor
102100221|NCT01328756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102100222|NCT03466502|Vancomycin|vancomycin|mesh-list
102100223|NCT03466502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102100224|NCT03466502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102100225|NCT05392634|Amoxicillin|amoxicillin|mesh-list
102100226|NCT05392634|Meropenem|meropenem|mesh-list
102100227|NCT05392634|Clavulanic Acids|clavulanic acids|mesh-list
102100228|NCT05392634|Clavulanic Acid|clavulanic acid|mesh-list
102100229|NCT05392634|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102100230|NCT05392634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101553575|NCT01237899|Eplerenone|eplerenone|mesh-list
102100231|NCT05392634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102100232|NCT05392634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102100233|NCT05392634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100234|NCT05392634|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102100235|NCT01593228|Paclitaxel|paclitaxel|mesh-list
102100236|NCT01593228|Carboplatin|carboplatin|mesh-list
102100237|NCT01593228|Gemcitabine|gemcitabine|mesh-list
102100238|NCT01593228|Doxorubicin|doxorubicin|mesh-list
102100239|NCT01593228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102100240|NCT01593228|Irinotecan|irinotecan|mesh-list
102100241|NCT01593228|Topotecan|topotecan|mesh-list
102100242|NCT01593228|Iniparib|iniparib|mesh-list
102100243|NCT01593228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102100244|NCT01593228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102100245|NCT01593228|Tubulin Modulators|tubulin modulators|mesh-ancestor
102100246|NCT01593228|Antimitotic Agents|antimitotic agents|mesh-ancestor
102100247|NCT01593228|Mitosis Modulators|mitosis modulators|mesh-ancestor
102100248|NCT01593228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100249|NCT01593228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102100250|NCT01593228|Antimetabolites|antimetabolites|mesh-ancestor
102100251|NCT01593228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102100252|NCT01593228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102100253|NCT01593228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102100254|NCT01593228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102100255|NCT01593228|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102100256|NCT01593228|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102100257|NCT02263638|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102100258|NCT02263638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102100259|NCT02236260|Lidocaine|lidocaine|mesh-list
102100260|NCT02236260|Anesthetics, Local|anesthetics, local|mesh-ancestor
102100261|NCT02236260|Anesthetics|anesthetics|mesh-ancestor
102100262|NCT02236260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102100263|NCT02236260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100264|NCT02236260|Sensory System Agents|sensory system agents|mesh-ancestor
102100265|NCT02236260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102100266|NCT02236260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102100267|NCT02236260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102100268|NCT02236260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102100269|NCT02236260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102100270|NCT02236260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100271|NCT01555554|Propranolol|propranolol|mesh-list
102100272|NCT01555554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102100273|NCT01555554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102100274|NCT01555554|Adrenergic Agents|adrenergic agents|mesh-ancestor
102100275|NCT01555554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102100276|NCT01555554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100277|NCT01555554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100278|NCT01555554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102100279|NCT01555554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102100280|NCT01555554|Vasodilator Agents|vasodilator agents|mesh-ancestor
102100281|NCT01435044|Sofosbuvir|sofosbuvir|mesh-list
102100282|NCT01435044|Ribavirin|ribavirin|mesh-list
102100283|NCT01435044|Antiviral Agents|antiviral agents|mesh-ancestor
102100284|NCT01435044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102100285|NCT01435044|Antimetabolites|antimetabolites|mesh-ancestor
102100286|NCT01435044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100287|NCT01434498|Ribavirin|ribavirin|mesh-list
102100288|NCT01434498|Ledipasvir|ledipasvir|mesh-list
102100289|NCT01434498|Antimetabolites|antimetabolites|mesh-ancestor
102100290|NCT01434498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100291|NCT01434498|Antiviral Agents|antiviral agents|mesh-ancestor
102100292|NCT01434498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102100293|NCT03735966|Carboplatin|carboplatin|mesh-list
102100294|NCT03735966|Docetaxel|docetaxel|mesh-list
102100295|NCT03735966|Trastuzumab|trastuzumab|mesh-list
102100296|NCT03735966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102100297|NCT03735966|Tubulin Modulators|tubulin modulators|mesh-ancestor
102100298|NCT03735966|Antimitotic Agents|antimitotic agents|mesh-ancestor
102100299|NCT03735966|Mitosis Modulators|mitosis modulators|mesh-ancestor
102100300|NCT03735966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100301|NCT03735966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102100302|NCT01554696|Methotrexate|methotrexate|mesh-list
102100303|NCT01554696|Peficitinib|peficitinib|mesh-list
102100304|NCT01554696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102100305|NCT01554696|Abortifacient Agents|abortifacient agents|mesh-ancestor
102100306|NCT01554696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102100307|NCT01554696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100308|NCT01554696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102100309|NCT01554696|Antimetabolites|antimetabolites|mesh-ancestor
102100310|NCT01554696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100311|NCT01554696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102100312|NCT01554696|Dermatologic Agents|dermatologic agents|mesh-ancestor
102100313|NCT01554696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102100314|NCT01554696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102100315|NCT01554696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102100316|NCT01554696|Immunologic Factors|immunologic factors|mesh-ancestor
102100317|NCT01554696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102100318|NCT01554696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102100319|NCT02265276|Pioglitazone|pioglitazone|mesh-list
102100320|NCT02265276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102100321|NCT02265276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100322|NCT02263872|Minocycline|minocycline|mesh-list
102100323|NCT02263872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102100324|NCT02263872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102100326|NCT02261376|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102100327|NCT02261376|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102100328|NCT02261376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102100329|NCT02261376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100330|NCT01535508|Vitamin D|vitamin d|mesh-list
102100331|NCT01535508|Vitamins|vitamins|mesh-ancestor
102100332|NCT01535508|Micronutrients|micronutrients|mesh-ancestor
102100333|NCT01535508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100334|NCT01535508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102100335|NCT02626338|Cytarabine|cytarabine|mesh-list
102100336|NCT02626338|Fludarabine|fludarabine|mesh-list
102100337|NCT02626338|Fludarabine phosphate|fludarabine phosphate|mesh-list
102100338|NCT02626338|Etoposide|etoposide|mesh-list
102100339|NCT02626338|Etoposide phosphate|etoposide phosphate|mesh-list
102100340|NCT02626338|Mitoxantrone|mitoxantrone|mesh-list
102100341|NCT02626338|Idarubicin|idarubicin|mesh-list
102100342|NCT02626338|Crenolanib|crenolanib|mesh-list
102100343|NCT02626338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102100344|NCT02626338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102100345|NCT02626338|Antimetabolites|antimetabolites|mesh-ancestor
102100346|NCT02626338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100347|NCT02626338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102100348|NCT02626338|Immunologic Factors|immunologic factors|mesh-ancestor
102100349|NCT02626338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100350|NCT02626338|Antiviral Agents|antiviral agents|mesh-ancestor
102100351|NCT02626338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102100352|NCT02626338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102100353|NCT02626338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102100354|NCT02626338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102100355|NCT02626338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102100356|NCT02626338|Analgesics|analgesics|mesh-ancestor
102100357|NCT02626338|Sensory System Agents|sensory system agents|mesh-ancestor
102100358|NCT02626338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102100359|NCT02626338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102100360|NCT01416402|Colchicine|colchicine|mesh-list
102100361|NCT01416402|Febuxostat|febuxostat|mesh-list
102100362|NCT01416402|Gout Suppressants|gout suppressants|mesh-ancestor
102100363|NCT01416402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102100364|NCT01416402|Tubulin Modulators|tubulin modulators|mesh-ancestor
102100365|NCT01416402|Antimitotic Agents|antimitotic agents|mesh-ancestor
102100366|NCT01416402|Mitosis Modulators|mitosis modulators|mesh-ancestor
102100367|NCT01416402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100368|NCT01416402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102100369|NCT01414920|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102100370|NCT01414920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102100371|NCT01414920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100372|NCT01414920|Incretins|incretins|mesh-ancestor
102100373|NCT01414920|Hormones|hormones|mesh-ancestor
102100374|NCT01414920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102100375|NCT01414920|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102100376|NCT01414920|Protease Inhibitors|protease inhibitors|mesh-ancestor
102100377|NCT01414920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102100378|NCT01414920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100379|NCT02263950|Artemether|artemether|mesh-list
102100380|NCT02263950|Antimalarials|antimalarials|mesh-ancestor
102100381|NCT02263950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102100382|NCT02263950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102100383|NCT02263950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102100384|NCT02261844|Resveratrol|resveratrol|mesh-list
102100385|NCT02261844|Antioxidants|antioxidants|mesh-ancestor
102100386|NCT02261844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100387|NCT02261844|Protective Agents|protective agents|mesh-ancestor
102100388|NCT02261844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100389|NCT02261844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102100390|NCT02261844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102100391|NCT02261922|Ticagrelor|ticagrelor|mesh-list
102100392|NCT02261922|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102100393|NCT02261922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102100394|NCT02261922|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102100395|NCT02261922|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102100396|NCT02261922|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102100397|NCT02261922|Purinergic Agents|purinergic agents|mesh-ancestor
102100398|NCT02261922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102100399|NCT02261922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100400|NCT02261922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100401|NCT02264028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102100402|NCT02264106|Pantoprazole|pantoprazole|mesh-list
102100403|NCT02264106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102100404|NCT02264106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102100405|NCT02264106|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102100406|NCT02264106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101225099|NCT01527422|Sargramostim|sargramostim|mesh-list
102100407|NCT02264106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100408|NCT02262156|Antidepressive Agents|antidepressive agents|mesh-list
102100409|NCT02262156|Serotonin|serotonin|mesh-list
102100410|NCT02262156|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
102100411|NCT02262156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102100412|NCT02262156|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102100413|NCT02262156|Serotonin Agents|serotonin agents|mesh-ancestor
102100414|NCT02262156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102100415|NCT02262156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100416|NCT02262156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100417|NCT02262156|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102100418|NCT02262156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102100419|NCT02612922|Nitazoxanide|nitazoxanide|mesh-list
102100420|NCT02612922|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102100421|NCT02612922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102100422|NCT01516476|Liraglutide|liraglutide|mesh-list
102100423|NCT01516476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102100424|NCT01516476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100425|NCT01516476|Incretins|incretins|mesh-ancestor
102100426|NCT01516476|Hormones|hormones|mesh-ancestor
102100427|NCT01516476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102100428|NCT01516086|Fluticasone|fluticasone|mesh-list
102100429|NCT01516086|Xhance|xhance|mesh-list
102100430|NCT01516086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102100431|NCT01516086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102100432|NCT01516086|Autonomic Agents|autonomic agents|mesh-ancestor
102100433|NCT01516086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102100434|NCT01516086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100435|NCT01516086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102100436|NCT01516086|Respiratory System Agents|respiratory system agents|mesh-ancestor
102100437|NCT01516086|Dermatologic Agents|dermatologic agents|mesh-ancestor
102100438|NCT01516086|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102100439|NCT01497834|Asunaprevir|asunaprevir|mesh-list
102100440|NCT01497834|Protease Inhibitors|protease inhibitors|mesh-ancestor
102100441|NCT01497834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102100442|NCT01497834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100443|NCT02265822|Midazolam|midazolam|mesh-list
102100444|NCT02265822|Melatonin|melatonin|mesh-list
102100445|NCT02265822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102100446|NCT02265822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102100447|NCT02265822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102100448|NCT02265822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100449|NCT02265822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102100450|NCT02265822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102100451|NCT02265822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102100452|NCT02265822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102100453|NCT02265822|Anesthetics, General|anesthetics, general|mesh-ancestor
102100454|NCT02265822|Anesthetics|anesthetics|mesh-ancestor
102100455|NCT02265822|GABA Modulators|gaba modulators|mesh-ancestor
102100456|NCT02265822|GABA Agents|gaba agents|mesh-ancestor
102100457|NCT02265822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102100458|NCT02265822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100459|NCT02265822|Antioxidants|antioxidants|mesh-ancestor
102100460|NCT02265822|Protective Agents|protective agents|mesh-ancestor
102100461|NCT02607930|Lamivudine|lamivudine|mesh-list
102100462|NCT02607930|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102100463|NCT02607930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102100464|NCT02607930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102100465|NCT02607930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100466|NCT02607930|Antiviral Agents|antiviral agents|mesh-ancestor
102100467|NCT02607930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102100468|NCT02607930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102100469|NCT02607930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102100470|NCT02264184|Paroxetine|paroxetine|mesh-list
102100471|NCT02264184|Tamsulosin|tamsulosin|mesh-list
102100472|NCT02264184|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102100473|NCT02264184|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101225111|NCT01527422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102100474|NCT02264184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102100475|NCT02264184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100476|NCT02264184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102100477|NCT02264184|Serotonin Agents|serotonin agents|mesh-ancestor
102100478|NCT02264184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100479|NCT02264184|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102100480|NCT02264184|Antidepressive Agents|antidepressive agents|mesh-ancestor
102100481|NCT02264184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102100482|NCT02264184|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102100483|NCT02264184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102100484|NCT02264184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102100485|NCT02264184|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102100486|NCT02264184|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102100487|NCT02264184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102100488|NCT02264184|Adrenergic Agents|adrenergic agents|mesh-ancestor
102100489|NCT02264184|Urological Agents|urological agents|mesh-ancestor
102100490|NCT01260870|Paclitaxel|paclitaxel|mesh-list
102100491|NCT01260870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102100492|NCT01260870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102100493|NCT01260870|Tubulin Modulators|tubulin modulators|mesh-ancestor
102100494|NCT01260870|Antimitotic Agents|antimitotic agents|mesh-ancestor
102100495|NCT01260870|Mitosis Modulators|mitosis modulators|mesh-ancestor
102100496|NCT01260870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100497|NCT02266056|Rocuronium|rocuronium|mesh-list
102100498|NCT02266056|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102100499|NCT02266056|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102100500|NCT02266056|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102100501|NCT02266056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102100502|NCT02266056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100503|NCT01482390|Ribavirin|ribavirin|mesh-list
102100504|NCT01482390|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102100505|NCT01482390|Antimetabolites|antimetabolites|mesh-ancestor
102100506|NCT01482390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100507|NCT01482390|Antiviral Agents|antiviral agents|mesh-ancestor
102100508|NCT01482390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102100509|NCT01478178|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
102100510|NCT01478178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102100511|NCT01478178|Alkylating Agents|alkylating agents|mesh-ancestor
102100512|NCT01478178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100513|NCT01478178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102100514|NCT01366014|Oxycodone|oxycodone|mesh-list
102100515|NCT01366014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102100516|NCT01366014|Narcotics|narcotics|mesh-ancestor
102100517|NCT01366014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102100518|NCT01366014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100519|NCT01366014|Analgesics|analgesics|mesh-ancestor
102100520|NCT01366014|Sensory System Agents|sensory system agents|mesh-ancestor
102100521|NCT01366014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102100522|NCT01361802|Ambroxol|ambroxol|mesh-list
102100523|NCT01361802|Expectorants|expectorants|mesh-ancestor
102100524|NCT01361802|Respiratory System Agents|respiratory system agents|mesh-ancestor
102100525|NCT01235754|Methyltestosterone|methyltestosterone|mesh-list
102100526|NCT01235754|Testosterone|testosterone|mesh-list
102100527|NCT01235754|Testosterone undecanoate|testosterone undecanoate|mesh-list
102100528|NCT01235754|Testosterone enanthate|testosterone enanthate|mesh-list
102100529|NCT01235754|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102100530|NCT01235754|Androgens|androgens|mesh-ancestor
102100531|NCT01235754|Hormones|hormones|mesh-ancestor
102100532|NCT01235754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102100533|NCT01235754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100534|NCT01235754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102100535|NCT01235754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102100537|NCT01234038|Paclitaxel|paclitaxel|mesh-list
102100538|NCT01234038|Carboplatin|carboplatin|mesh-list
102100539|NCT01234038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102100540|NCT01234038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102100541|NCT01234038|Tubulin Modulators|tubulin modulators|mesh-ancestor
102100542|NCT01234038|Antimitotic Agents|antimitotic agents|mesh-ancestor
102100543|NCT01234038|Mitosis Modulators|mitosis modulators|mesh-ancestor
102100544|NCT01234038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100545|NCT01233960|Remestemcel-l|remestemcel-l|mesh-list
102100546|NCT01233960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102100547|NCT01233960|Antiviral Agents|antiviral agents|mesh-ancestor
102100548|NCT01233960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102100549|NCT01229982|Latanoprost|latanoprost|mesh-list
102100550|NCT01229982|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102100551|NCT01229982|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102100552|NCT01225380|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102100553|NCT01225380|Interferon-alpha|interferon-alpha|mesh-list
102100554|NCT01225380|Ribavirin|ribavirin|mesh-list
102100555|NCT01225380|Antiviral Agents|antiviral agents|mesh-ancestor
102100556|NCT01225380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102100557|NCT01225380|Immunologic Factors|immunologic factors|mesh-ancestor
102100558|NCT01225380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100559|NCT01225380|Antimetabolites|antimetabolites|mesh-ancestor
102100560|NCT01225380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100561|NCT01349868|Formoterol Fumarate|formoterol fumarate|mesh-list
102100562|NCT01349868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102100563|NCT01349868|Autonomic Agents|autonomic agents|mesh-ancestor
102100564|NCT01349868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102100565|NCT01349868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100566|NCT01349868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102100567|NCT01349868|Respiratory System Agents|respiratory system agents|mesh-ancestor
102100568|NCT01349868|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102100569|NCT01349868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102100570|NCT01349868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102100571|NCT01349868|Adrenergic Agents|adrenergic agents|mesh-ancestor
102100572|NCT01349868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102100573|NCT01349868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100574|NCT02266524|Tamsulosin|tamsulosin|mesh-list
102100575|NCT02266524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102100576|NCT02266524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102100577|NCT02266524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102100578|NCT02266524|Adrenergic Agents|adrenergic agents|mesh-ancestor
102100579|NCT02266524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102100580|NCT02266524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100581|NCT02266524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100582|NCT02266524|Urological Agents|urological agents|mesh-ancestor
102100583|NCT01336686|Colchicine|colchicine|mesh-list
102100584|NCT01336686|Gout Suppressants|gout suppressants|mesh-ancestor
102100585|NCT01336686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102100586|NCT01336686|Tubulin Modulators|tubulin modulators|mesh-ancestor
102100587|NCT01336686|Antimitotic Agents|antimitotic agents|mesh-ancestor
102100588|NCT01336686|Mitosis Modulators|mitosis modulators|mesh-ancestor
102100589|NCT01336686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100590|NCT01336686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102100591|NCT01455090|Ribavirin|ribavirin|mesh-list
102100592|NCT01455090|Asunaprevir|asunaprevir|mesh-list
102100593|NCT01455090|Antimetabolites|antimetabolites|mesh-ancestor
102100594|NCT01455090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100595|NCT01455090|Antiviral Agents|antiviral agents|mesh-ancestor
102100596|NCT01455090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102100597|NCT01455090|Protease Inhibitors|protease inhibitors|mesh-ancestor
102100598|NCT01455090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102100599|NCT02056782|Heparin|heparin|mesh-list
102100600|NCT02056782|Anticoagulants|anticoagulants|mesh-ancestor
102100601|NCT02056782|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101953453|NCT03637972|Nicotine|nicotine|mesh-list
102100602|NCT02056782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102100603|NCT02056782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100604|NCT01198626|Moxifloxacin|moxifloxacin|mesh-list
102100605|NCT01198626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102100606|NCT01198626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102100607|NCT01198626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102100608|NCT01198626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101553950|NCT01261338|Antimetabolites|antimetabolites|mesh-ancestor
102100631|NCT01331850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102100632|NCT01331850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102100633|NCT01331850|Immunologic Factors|immunologic factors|mesh-ancestor
102100634|NCT01331850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100635|NCT01331850|Antimetabolites|antimetabolites|mesh-ancestor
102100636|NCT02101034|Cetuximab|cetuximab|mesh-list
102100637|NCT02101034|Palbociclib|palbociclib|mesh-list
102100638|NCT02101034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102100639|NCT02101034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102100640|NCT02101034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102100641|NCT02101034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102100642|NCT02101034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100643|NCT01328808|Acetaminophen|acetaminophen|mesh-list
102100644|NCT01328808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102100645|NCT01328808|Analgesics|analgesics|mesh-ancestor
102100646|NCT01328808|Sensory System Agents|sensory system agents|mesh-ancestor
102100647|NCT01328808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102100648|NCT01328808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100649|NCT01328808|Antipyretics|antipyretics|mesh-ancestor
102100650|NCT01968590|Vitamin D|vitamin d|mesh-list
102100651|NCT01968590|Cholecalciferol|cholecalciferol|mesh-list
102100652|NCT01968590|Vitamins|vitamins|mesh-ancestor
102100653|NCT01968590|Micronutrients|micronutrients|mesh-ancestor
102100654|NCT01968590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100655|NCT01968590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102100656|NCT01968590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102100679|NCT01314222|Pregabalin|pregabalin|mesh-list
102100680|NCT01314222|Analgesics|analgesics|mesh-ancestor
102100681|NCT01314222|Sensory System Agents|sensory system agents|mesh-ancestor
102100682|NCT01314222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102100683|NCT01314222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100684|NCT01314222|Anticonvulsants|anticonvulsants|mesh-ancestor
102100685|NCT01314222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102100686|NCT01314222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102100687|NCT01314222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100688|NCT01314222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102100689|NCT01314222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102100690|NCT01314222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102100691|NCT01314222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102100692|NCT01314222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102100694|NCT05222828|Anesthetics, Local|anesthetics, local|mesh-ancestor
102100695|NCT05222828|Anesthetics|anesthetics|mesh-ancestor
102100696|NCT05222828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102100697|NCT05222828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100698|NCT05222828|Sensory System Agents|sensory system agents|mesh-ancestor
102100699|NCT05222828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102100700|NCT01309932|Interferons|interferons|mesh-list
102100701|NCT01309932|Ribavirin|ribavirin|mesh-list
102100702|NCT01309932|Interferon-alpha|interferon-alpha|mesh-list
102100703|NCT01309932|Interferon alpha-2|interferon alpha-2|mesh-list
102100704|NCT01309932|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102100705|NCT01309932|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
102100706|NCT01309932|Protease Inhibitors|protease inhibitors|mesh-list
102100707|NCT01309932|Asunaprevir|asunaprevir|mesh-list
102100708|NCT01309932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102100709|NCT01309932|Antiviral Agents|antiviral agents|mesh-ancestor
102100710|NCT01309932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102100711|NCT01309932|Antimetabolites|antimetabolites|mesh-ancestor
102100712|NCT01309932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100713|NCT01309932|Immunologic Factors|immunologic factors|mesh-ancestor
102100714|NCT01309932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100715|NCT01309932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102100716|NCT01309932|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102100717|NCT01309932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102100718|NCT01309932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102100719|NCT01733888|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102100720|NCT01733888|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102100721|NCT01733888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102100722|NCT01181622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102100724|NCT01101594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102100725|NCT01101594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102100726|NCT01101594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102100727|NCT01101594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102100728|NCT01101594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102100729|NCT01101594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100730|NCT02269176|Losartan|losartan|mesh-list
102100731|NCT02269176|Telmisartan|telmisartan|mesh-list
102100732|NCT02269176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102100733|NCT02269176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102100734|NCT02269176|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102100735|NCT02269176|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102100736|NCT02269176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100737|NCT01094262|Oxycodone|oxycodone|mesh-list
102100738|NCT01094262|Analgesics|analgesics|mesh-list
102100739|NCT01094262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102100740|NCT01094262|Narcotics|narcotics|mesh-ancestor
102100741|NCT01094262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102100742|NCT01094262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100743|NCT01094262|Sensory System Agents|sensory system agents|mesh-ancestor
102100744|NCT01094262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102100745|NCT04476186|Acyclovir|acyclovir|mesh-list
102100746|NCT04476186|Antiviral Agents|antiviral agents|mesh-ancestor
102100747|NCT04476186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102100748|NCT03440216|Meropenem|meropenem|mesh-list
102100749|NCT03440216|Ceftriaxone|ceftriaxone|mesh-list
102100750|NCT03440216|Temocillin|temocillin|mesh-list
102100751|NCT03440216|Penicillins|penicillins|mesh-list
102100752|NCT03440216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102100753|NCT03440216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102100754|NCT01166412|Levonorgestrel|levonorgestrel|mesh-list
102100755|NCT01166412|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102100756|NCT01166412|Contraceptive Agents|contraceptive agents|mesh-ancestor
102100757|NCT01166412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102100758|NCT01166412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100759|NCT01166412|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101953463|NCT03383679|Capecitabine|capecitabine|mesh-list
102100760|NCT01166412|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102100761|NCT01166412|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102100763|NCT05370716|Analgesics|analgesics|mesh-ancestor
102100764|NCT05370716|Sensory System Agents|sensory system agents|mesh-ancestor
102100765|NCT05370716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102100766|NCT05370716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100767|NCT05370716|Anticonvulsants|anticonvulsants|mesh-ancestor
102100768|NCT05370716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102100769|NCT05370716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102100770|NCT05370716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100771|NCT05370716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102100772|NCT05370716|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102100773|NCT05370716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102100774|NCT05370716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102100775|NCT05370716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102100776|NCT01038804|Docetaxel|docetaxel|mesh-list
102100777|NCT01038804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102100778|NCT01038804|Tubulin Modulators|tubulin modulators|mesh-ancestor
102100779|NCT01038804|Antimitotic Agents|antimitotic agents|mesh-ancestor
102100780|NCT01038804|Mitosis Modulators|mitosis modulators|mesh-ancestor
102100781|NCT01038804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100782|NCT05118776|Bevacizumab|bevacizumab|mesh-list
102100783|NCT05118776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102100784|NCT05118776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102100785|NCT05118776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102100786|NCT05118776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102100787|NCT05118776|Growth Substances|growth substances|mesh-ancestor
102100788|NCT05118776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100789|NCT05118776|Growth Inhibitors|growth inhibitors|mesh-ancestor
102100790|NCT02269644|Azithromycin|azithromycin|mesh-list
102100791|NCT02269644|Linezolid|linezolid|mesh-list
102100792|NCT02269644|Dalbavancin|dalbavancin|mesh-list
102100793|NCT02269644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102100794|NCT02269644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102100795|NCT02269644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102100796|NCT02269644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102100797|NCT02269644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100798|NCT03367988|Analgesics, Opioid|analgesics, opioid|mesh-list
102100799|NCT03367988|Anesthetics|anesthetics|mesh-list
102100800|NCT03367988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102100801|NCT03367988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100802|NCT03367988|Narcotics|narcotics|mesh-ancestor
102100803|NCT03367988|Analgesics|analgesics|mesh-ancestor
102100804|NCT03367988|Sensory System Agents|sensory system agents|mesh-ancestor
102100805|NCT03367988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102100806|NCT03465488|Albendazole|albendazole|mesh-list
102100807|NCT03465488|Anthelmintics|anthelmintics|mesh-ancestor
102100808|NCT03465488|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102100809|NCT03465488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102100810|NCT03465488|Anticestodal Agents|anticestodal agents|mesh-ancestor
102100811|NCT03465488|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102100812|NCT03465488|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102100813|NCT03465488|Tubulin Modulators|tubulin modulators|mesh-ancestor
102100814|NCT03465488|Antimitotic Agents|antimitotic agents|mesh-ancestor
102100815|NCT03465488|Mitosis Modulators|mitosis modulators|mesh-ancestor
102100816|NCT03465488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100817|NCT03465488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102100818|NCT02267304|Morphine|morphine|mesh-list
102100819|NCT02267304|Naloxone|naloxone|mesh-list
102100820|NCT02267304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102100821|NCT02267304|Narcotics|narcotics|mesh-ancestor
102100822|NCT02267304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102100823|NCT02267304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100824|NCT02267304|Analgesics|analgesics|mesh-ancestor
102100825|NCT02267304|Sensory System Agents|sensory system agents|mesh-ancestor
102100826|NCT02267304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102100827|NCT02267304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102100828|NCT03465410|Tacrolimus|tacrolimus|mesh-list
102100829|NCT03465410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102100830|NCT03465410|Immunologic Factors|immunologic factors|mesh-ancestor
101953492|NCT04639011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102100831|NCT03465410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100832|NCT03465410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102100833|NCT03465410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102100834|NCT03465410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100835|NCT02522234|Lenograstim|lenograstim|mesh-list
102100836|NCT02522234|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102100837|NCT02522234|Immunologic Factors|immunologic factors|mesh-ancestor
102100838|NCT02522234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100839|NCT00154284|Cyclosporine|cyclosporine|mesh-list
102100840|NCT00154284|Prednisone|prednisone|mesh-list
102100841|NCT00154284|Everolimus|everolimus|mesh-list
102100842|NCT00154284|Cyclosporins|cyclosporins|mesh-list
102100843|NCT00154284|Basiliximab|basiliximab|mesh-list
102100844|NCT00154284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102100845|NCT00154284|Glucocorticoids|glucocorticoids|mesh-ancestor
102100846|NCT00154284|Hormones|hormones|mesh-ancestor
102100847|NCT00154284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102100848|NCT00154284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100849|NCT00154284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102100850|NCT00154284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102100851|NCT00154284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102100852|NCT00154284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100853|NCT00154284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102100854|NCT00154284|Immunologic Factors|immunologic factors|mesh-ancestor
102100855|NCT00154284|Antifungal Agents|antifungal agents|mesh-ancestor
102100856|NCT00154284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102100857|NCT00154284|Dermatologic Agents|dermatologic agents|mesh-ancestor
102100858|NCT00154284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102100859|NCT00154284|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102100860|NCT00154284|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102100861|NCT00154284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102100862|NCT04973306|Tislelizumab|tislelizumab|mesh-list
102100863|NCT04973306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102100864|NCT04973306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102100865|NCT01037166|Entecavir|entecavir|mesh-list
102100866|NCT01037166|Antiviral Agents|antiviral agents|mesh-ancestor
102100867|NCT01037166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102100868|NCT04491032|Anesthetics|anesthetics|mesh-list
102100869|NCT04491032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102100870|NCT04491032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100871|NCT02269800|Benzalkonium Compounds|benzalkonium compounds|mesh-list
102100872|NCT02269800|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102100873|NCT02269800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102100874|NCT04487756|Carboplatin|carboplatin|mesh-list
102100875|NCT04487756|Atezolizumab|atezolizumab|mesh-list
102100876|NCT04487756|Vaccines|vaccines|mesh-list
102100877|NCT04487756|Immunologic Factors|immunologic factors|mesh-ancestor
102100878|NCT04487756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100879|NCT04487756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102100880|NCT04487756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102100881|NCT04487756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100882|NCT04487756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102100883|NCT01281462|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
102100884|NCT01281462|Cephalosporins|cephalosporins|mesh-list
102100885|NCT01281462|Avibactam|avibactam|mesh-list
102100886|NCT01281462|Doripenem|doripenem|mesh-list
102100887|NCT01281462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102100888|NCT01281462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102100889|NCT01281462|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102100890|NCT01281462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102100891|NCT01281462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100892|NCT04453124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
102100893|NCT04453124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102100894|NCT01024062|Paclitaxel|paclitaxel|mesh-list
102100895|NCT01024062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102100896|NCT01024062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102100897|NCT01024062|Tubulin Modulators|tubulin modulators|mesh-ancestor
102100898|NCT01024062|Antimitotic Agents|antimitotic agents|mesh-ancestor
102100899|NCT01024062|Mitosis Modulators|mitosis modulators|mesh-ancestor
102100900|NCT01024062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100901|NCT04453436|Tenofovir|tenofovir|mesh-list
102100902|NCT04453436|Lamivudine|lamivudine|mesh-list
102100903|NCT04453436|Dolutegravir|dolutegravir|mesh-list
102100904|NCT04453436|Antiviral Agents|antiviral agents|mesh-ancestor
102100905|NCT04453436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101953498|NCT04639011|Autonomic Agents|autonomic agents|mesh-ancestor
102100906|NCT04453436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102100907|NCT04453436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102100908|NCT04453436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102100909|NCT04453436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100910|NCT04453436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102100911|NCT04453436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102100912|NCT04453436|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102100913|NCT04453436|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102100914|NCT02267616|Etonogestrel|etonogestrel|mesh-list
102100915|NCT02267616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102100916|NCT02267616|Contraceptive Agents|contraceptive agents|mesh-ancestor
102100917|NCT02267616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102100918|NCT02267616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100919|NCT02267616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102100921|NCT05232734|Caffeine citrate|caffeine citrate|mesh-list
102100922|NCT05232734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100923|NCT05232734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102100924|NCT05232734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100925|NCT05232734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102100926|NCT05232734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102100927|NCT05232734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102100928|NCT05232734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102100929|NCT05232734|Purinergic Agents|purinergic agents|mesh-ancestor
102100930|NCT05232734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102100931|NCT03465098|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102100932|NCT03465098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102100933|NCT03465098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100934|NCT01023204|Paclitaxel|paclitaxel|mesh-list
102100935|NCT01023204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102100936|NCT01023204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102100937|NCT01023204|Tubulin Modulators|tubulin modulators|mesh-ancestor
102100938|NCT01023204|Antimitotic Agents|antimitotic agents|mesh-ancestor
102100939|NCT01023204|Mitosis Modulators|mitosis modulators|mesh-ancestor
102100940|NCT01023204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100941|NCT04460456|Pembrolizumab|pembrolizumab|mesh-list
102100942|NCT04460456|Cemiplimab|cemiplimab|mesh-list
102100943|NCT04460456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102100944|NCT04460456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102100945|NCT04460456|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102100946|NCT04460456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100947|NCT02268006|Capecitabine|capecitabine|mesh-list
102100948|NCT02268006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102100949|NCT02268006|Antimetabolites|antimetabolites|mesh-ancestor
102100950|NCT02268006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100951|NCT02268006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102100952|NCT03462212|Paclitaxel|paclitaxel|mesh-list
102100953|NCT03462212|Bevacizumab|bevacizumab|mesh-list
102100954|NCT03462212|Carboplatin|carboplatin|mesh-list
102100955|NCT03462212|Rucaparib|rucaparib|mesh-list
102100956|NCT03462212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102100957|NCT03462212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102100958|NCT03462212|Tubulin Modulators|tubulin modulators|mesh-ancestor
102100959|NCT03462212|Antimitotic Agents|antimitotic agents|mesh-ancestor
102100960|NCT03462212|Mitosis Modulators|mitosis modulators|mesh-ancestor
102100961|NCT03462212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102100962|NCT03462212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102100963|NCT03462212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102100964|NCT03462212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102100965|NCT03462212|Growth Substances|growth substances|mesh-ancestor
102100966|NCT03462212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100967|NCT03462212|Growth Inhibitors|growth inhibitors|mesh-ancestor
102100968|NCT03462212|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102100969|NCT03462212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102100970|NCT01016808|Morphine|morphine|mesh-list
102100972|NCT01016808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102100973|NCT01016808|Narcotics|narcotics|mesh-ancestor
102100974|NCT01016808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102100975|NCT01016808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100976|NCT01016808|Analgesics|analgesics|mesh-ancestor
102100977|NCT01016808|Sensory System Agents|sensory system agents|mesh-ancestor
102100978|NCT01016808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102100979|NCT01014078|Azithromycin|azithromycin|mesh-list
102100980|NCT01014078|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102100981|NCT01014078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102100982|NCT01014078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102100983|NCT01014078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102100984|NCT02522078|Misoprostol|misoprostol|mesh-list
102100985|NCT02522078|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102100986|NCT02522078|Abortifacient Agents|abortifacient agents|mesh-ancestor
102100987|NCT02522078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101554340|NCT01052272|Ramipril|ramipril|mesh-list
102100988|NCT02522078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102100989|NCT02522078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102100990|NCT02522078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102100991|NCT02522078|Oxytocics|oxytocics|mesh-ancestor
102100992|NCT00911274|Mycophenolic Acid|mycophenolic acid|mesh-list
102100993|NCT00911274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102100994|NCT00911274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102100995|NCT00911274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102100996|NCT00911274|Antitubercular Agents|antitubercular agents|mesh-ancestor
102100997|NCT00911274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102100998|NCT00911274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102100999|NCT00911274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102101000|NCT00911274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101001|NCT03468296|Aflibercept|aflibercept|mesh-list
102101002|NCT03468296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102101003|NCT03468296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102101004|NCT03468296|Growth Substances|growth substances|mesh-ancestor
102101005|NCT03468296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101006|NCT03468296|Growth Inhibitors|growth inhibitors|mesh-ancestor
102101007|NCT03468296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102101008|NCT01130142|Gemcitabine|gemcitabine|mesh-list
102101009|NCT01130142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102101010|NCT01130142|Antimetabolites|antimetabolites|mesh-ancestor
102101011|NCT01130142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101012|NCT01130142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102101013|NCT03464864|Treprostinil|treprostinil|mesh-list
102101014|NCT03464864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102101015|NCT03468140|Eculizumab|eculizumab|mesh-list
102101016|NCT03468140|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102101017|NCT03468140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102101018|NCT03468140|Immunologic Factors|immunologic factors|mesh-ancestor
102101019|NCT03468140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101020|NCT01009242|Methotrexate|methotrexate|mesh-list
102101021|NCT01009242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102101022|NCT01009242|Abortifacient Agents|abortifacient agents|mesh-ancestor
102101023|NCT01009242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102101024|NCT01009242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101025|NCT01009242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102101026|NCT01009242|Antimetabolites|antimetabolites|mesh-ancestor
102101027|NCT01009242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101028|NCT01009242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102101029|NCT01009242|Dermatologic Agents|dermatologic agents|mesh-ancestor
102101030|NCT01009242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102101031|NCT01009242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102101032|NCT01009242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102101033|NCT01009242|Immunologic Factors|immunologic factors|mesh-ancestor
102101034|NCT01009242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102101035|NCT01009242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102101036|NCT03468062|Dexmedetomidine|dexmedetomidine|mesh-list
102101037|NCT03468062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102101038|NCT03468062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102101039|NCT03468062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101040|NCT03468062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102101041|NCT03468062|Analgesics|analgesics|mesh-ancestor
102101042|NCT03468062|Sensory System Agents|sensory system agents|mesh-ancestor
102101043|NCT03468062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102101044|NCT03468062|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102101045|NCT03468062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102101046|NCT03468062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102101047|NCT03468062|Adrenergic Agents|adrenergic agents|mesh-ancestor
102101048|NCT03468062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102101049|NCT03468062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101050|NCT03464552|Celecoxib|celecoxib|mesh-list
102101051|NCT03464552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102101052|NCT03464552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102101053|NCT03464552|Analgesics|analgesics|mesh-ancestor
102101054|NCT03464552|Sensory System Agents|sensory system agents|mesh-ancestor
102101055|NCT03464552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102101056|NCT03464552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101057|NCT03464552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102101058|NCT03464552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102101059|NCT03464552|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102101060|NCT03464552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102101061|NCT03464552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102101062|NCT03464552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101063|NCT05628558|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
102101065|NCT05628558|Coagulants|coagulants|mesh-ancestor
102101066|NCT05628558|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102101067|NCT05628558|Natriuretic Agents|natriuretic agents|mesh-ancestor
102101068|NCT05628558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101069|NCT01007292|Rituximab|rituximab|mesh-list
102101070|NCT01007292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102101071|NCT01007292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102101072|NCT01007292|Immunologic Factors|immunologic factors|mesh-ancestor
102101073|NCT01007292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101074|NCT01007292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102101075|NCT03467984|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102101076|NCT03467984|Immunologic Factors|immunologic factors|mesh-ancestor
102101077|NCT03467984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101078|NCT01005108|Gabapentin|gabapentin|mesh-list
102101079|NCT01005108|Analgesics|analgesics|mesh-ancestor
102101080|NCT01005108|Sensory System Agents|sensory system agents|mesh-ancestor
102101081|NCT01005108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102101082|NCT01005108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101083|NCT01005108|Anticonvulsants|anticonvulsants|mesh-ancestor
102101084|NCT01005108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102101085|NCT01005108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102101086|NCT01005108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102101087|NCT01005108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102101088|NCT01005108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102101089|NCT01005108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102101090|NCT01005108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102101091|NCT01005108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101092|NCT01005108|Antimanic Agents|antimanic agents|mesh-ancestor
102101093|NCT00905346|Topiramate|topiramate|mesh-list
102101094|NCT00905346|Anticonvulsants|anticonvulsants|mesh-ancestor
102101095|NCT00905346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102101096|NCT00905346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101097|NCT00902928|Enoxaparin|enoxaparin|mesh-list
102101098|NCT00902928|Anticoagulants|anticoagulants|mesh-ancestor
102101099|NCT00902928|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102101100|NCT00902928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102101101|NCT00902928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101102|NCT01129674|Olanzapine|olanzapine|mesh-list
102101103|NCT01129674|Risperidone|risperidone|mesh-list
102101104|NCT01129674|Aripiprazole|aripiprazole|mesh-list
102101105|NCT01129674|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102101106|NCT01129674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102101107|NCT01129674|Serotonin Agents|serotonin agents|mesh-ancestor
102101108|NCT01129674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102101109|NCT01129674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101110|NCT01129674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101111|NCT01129674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102101112|NCT01129674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101507687|NCT02945982|Entecavir|entecavir|mesh-list
102101113|NCT01129674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102101115|NCT01129674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102101116|NCT01129674|Dopamine Agents|dopamine agents|mesh-ancestor
102101117|NCT01129674|Antiemetics|antiemetics|mesh-ancestor
102101118|NCT01129674|Autonomic Agents|autonomic agents|mesh-ancestor
102101119|NCT01129674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102101120|NCT01129674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102101121|NCT01129674|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102101122|NCT01129674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102101123|NCT01129674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102101124|NCT01129674|Antidepressive Agents|antidepressive agents|mesh-ancestor
102101125|NCT01129674|Dopamine Agonists|dopamine agonists|mesh-ancestor
102101126|NCT01129674|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102101127|NCT01129674|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102101128|NCT01129674|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102101129|NCT01129674|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102101130|NCT05045378|Midazolam|midazolam|mesh-list
102101131|NCT05045378|Ketamine|ketamine|mesh-list
102101132|NCT05045378|Analgesics|analgesics|mesh-ancestor
102101133|NCT05045378|Sensory System Agents|sensory system agents|mesh-ancestor
102101134|NCT05045378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102101135|NCT05045378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554477|NCT01225887|Nintedanib|nintedanib|mesh-list
102101136|NCT05045378|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102101137|NCT05045378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102101138|NCT05045378|Anesthetics, General|anesthetics, general|mesh-ancestor
102101139|NCT05045378|Anesthetics|anesthetics|mesh-ancestor
102101140|NCT05045378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102101141|NCT05045378|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102101142|NCT05045378|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102101143|NCT05045378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102101144|NCT05045378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101145|NCT05045378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102101146|NCT05045378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102101147|NCT05045378|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102101148|NCT05045378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102101149|NCT05045378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102101150|NCT05045378|GABA Modulators|gaba modulators|mesh-ancestor
102101151|NCT05045378|GABA Agents|gaba agents|mesh-ancestor
102101152|NCT05209152|Azacitidine|azacitidine|mesh-list
102101153|NCT05209152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102101154|NCT05209152|Antimetabolites|antimetabolites|mesh-ancestor
102101155|NCT05209152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101156|NCT05209152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102101157|NCT05209152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102101158|NCT03460964|Pilocarpine|pilocarpine|mesh-list
102101159|NCT03460964|Miotics|miotics|mesh-ancestor
102101160|NCT03460964|Autonomic Agents|autonomic agents|mesh-ancestor
102101161|NCT03460964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102101162|NCT03460964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101163|NCT03460964|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102101164|NCT03460964|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102101165|NCT03460964|Cholinergic Agents|cholinergic agents|mesh-ancestor
102101166|NCT03460964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102101167|NCT03460964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101168|NCT03460808|Acetylcysteine|acetylcysteine|mesh-list
102101169|NCT03460808|Atorvastatin|atorvastatin|mesh-list
102101170|NCT03460808|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102101171|NCT03460808|Danazol|danazol|mesh-list
102101172|NCT03460808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102101173|NCT03460808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102101174|NCT03460808|Antimetabolites|antimetabolites|mesh-ancestor
102101175|NCT03460808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101176|NCT03460808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102101177|NCT03460808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102101178|NCT03460808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102101179|NCT03460808|Antiviral Agents|antiviral agents|mesh-ancestor
102101180|NCT03460808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102101181|NCT03460808|Expectorants|expectorants|mesh-ancestor
101953515|NCT03809949|Fentanyl|fentanyl|mesh-list
102101182|NCT03460808|Respiratory System Agents|respiratory system agents|mesh-ancestor
102101183|NCT03460808|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102101185|NCT03460808|Protective Agents|protective agents|mesh-ancestor
102101186|NCT03460808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101187|NCT03460808|Antidotes|antidotes|mesh-ancestor
102101188|NCT03460808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102101189|NCT03460808|Hormone Antagonists|hormone antagonists|mesh-ancestor
102101190|NCT03460808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102101191|NCT04946630|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102101192|NCT04946630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102101193|NCT04946630|Autonomic Agents|autonomic agents|mesh-ancestor
102101194|NCT04946630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102101195|NCT04946630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101196|NCT04946630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102101197|NCT04946630|Respiratory System Agents|respiratory system agents|mesh-ancestor
102101198|NCT04946630|Glucocorticoids|glucocorticoids|mesh-ancestor
102101199|NCT04946630|Hormones|hormones|mesh-ancestor
102101200|NCT04946630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102101201|NCT04946630|Sympathomimetics|sympathomimetics|mesh-ancestor
102101202|NCT00900900|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
102101203|NCT00900900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102101204|NCT00900900|Immunologic Factors|immunologic factors|mesh-ancestor
102101205|NCT00900900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101206|NCT03460730|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102101207|NCT03460730|Immunologic Factors|immunologic factors|mesh-ancestor
102101208|NCT03460730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101209|NCT05627778|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101836450|NCT00309244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101210|NCT05627778|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101836451|NCT00309244|Heparin Antagonists|heparin antagonists|mesh-ancestor
102101211|NCT05627778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101213|NCT01120470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102101214|NCT01120470|Glucocorticoids|glucocorticoids|mesh-ancestor
102101215|NCT01120470|Hormones|hormones|mesh-ancestor
102101216|NCT01120470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102101217|NCT01120470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101218|NCT01120470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102101219|NCT01120470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102101220|NCT01117584|Metformin|metformin|mesh-list
102101221|NCT01117584|Ipragliflozin|ipragliflozin|mesh-list
102101222|NCT01117584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102101223|NCT01117584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101224|NCT01117584|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102101225|NCT01117584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101226|NCT03135054|Homoharringtonine|homoharringtonine|mesh-list
102101227|NCT03135054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102101228|NCT03135054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102101229|NCT03135054|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102101230|NCT03135054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102101231|NCT03135054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101232|NCT00991068|Lidocaine|lidocaine|mesh-list
102101233|NCT00991068|Tetracaine|tetracaine|mesh-list
102101234|NCT00991068|Anesthetics, Local|anesthetics, local|mesh-ancestor
102101235|NCT00991068|Anesthetics|anesthetics|mesh-ancestor
102101236|NCT00991068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102101237|NCT00991068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101238|NCT00991068|Sensory System Agents|sensory system agents|mesh-ancestor
102101239|NCT00991068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102101240|NCT00991068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102101241|NCT00991068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102101242|NCT00991068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102101243|NCT00991068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102101244|NCT00991068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101245|NCT01114698|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102101246|NCT01114698|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102101247|NCT01114698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102101248|NCT01114698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102101249|NCT01114698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101250|NCT01114698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102101251|NCT01114698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101252|NCT01114698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102101253|NCT01114698|Antidepressive Agents|antidepressive agents|mesh-ancestor
102101254|NCT01114698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102101255|NCT01114308|Buprenorphine|buprenorphine|mesh-list
102101256|NCT01114308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102101257|NCT01114308|Narcotics|narcotics|mesh-ancestor
102101258|NCT01114308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102101259|NCT01114308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101260|NCT01114308|Analgesics|analgesics|mesh-ancestor
102101261|NCT01114308|Sensory System Agents|sensory system agents|mesh-ancestor
102101262|NCT01114308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102101263|NCT01114308|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102101264|NCT05469126|Clarithromycin|clarithromycin|mesh-list
102101265|NCT05469126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102101266|NCT05469126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102101267|NCT05469126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102101268|NCT05469126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102101269|NCT05469126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101270|NCT05469126|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102101271|NCT05469126|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102101272|NCT00887250|Losartan|losartan|mesh-list
102101273|NCT00887250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102101274|NCT00887250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102101275|NCT00887250|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102101276|NCT00887250|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102101277|NCT00887250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101278|NCT00990912|Carboplatin|carboplatin|mesh-list
102101279|NCT00990912|Irinotecan|irinotecan|mesh-list
102101280|NCT00990912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102101281|NCT00990912|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102101282|NCT00990912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102101283|NCT00990912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102101284|NCT00990912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101285|NCT00973284|Mannitol|mannitol|mesh-list
102101286|NCT00973284|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102101287|NCT00973284|Diuretics|diuretics|mesh-ancestor
102101288|NCT00973284|Natriuretic Agents|natriuretic agents|mesh-ancestor
102101289|NCT00973284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101290|NCT02599402|Nivolumab|nivolumab|mesh-list
102101291|NCT02599402|Ipilimumab|ipilimumab|mesh-list
102101292|NCT02599402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102101293|NCT02599402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102101294|NCT02599402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102101295|NCT02599402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101296|NCT00879762|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
102101297|NCT00879762|Antiviral Agents|antiviral agents|mesh-ancestor
102101298|NCT00879762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102101299|NCT04768166|Miglustat|miglustat|mesh-list
102101300|NCT04768166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102101301|NCT04768166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101302|NCT04768166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102101304|NCT04768166|Antiviral Agents|antiviral agents|mesh-ancestor
102101305|NCT04768166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102101306|NCT04768166|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102101307|NCT04768166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102101308|NCT04768166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101309|NCT04822090|Immunoglobulins|immunoglobulins|mesh-list
102101310|NCT04822090|Antibodies|antibodies|mesh-list
102101311|NCT04822090|gamma-Globulins|gamma-globulins|mesh-list
102101312|NCT04822090|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102101313|NCT04822090|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102101314|NCT04822090|Immunologic Factors|immunologic factors|mesh-ancestor
102101315|NCT04822090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101316|NCT03463382|Bupivacaine|bupivacaine|mesh-list
102101317|NCT03463382|Anesthetics, Local|anesthetics, local|mesh-ancestor
102101318|NCT03463382|Anesthetics|anesthetics|mesh-ancestor
102101319|NCT03463382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102101320|NCT03463382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101321|NCT03463382|Sensory System Agents|sensory system agents|mesh-ancestor
102101322|NCT03463382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102101323|NCT05618236|Atropine|atropine|mesh-list
102101324|NCT05618236|Neostigmine|neostigmine|mesh-list
102101325|NCT05618236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102101326|NCT05618236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102101327|NCT05618236|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102101328|NCT05618236|Autonomic Agents|autonomic agents|mesh-ancestor
102101329|NCT05618236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102101330|NCT05618236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101331|NCT05618236|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102101332|NCT05618236|Respiratory System Agents|respiratory system agents|mesh-ancestor
102101333|NCT05618236|Mydriatics|mydriatics|mesh-ancestor
102101334|NCT05618236|Parasympatholytics|parasympatholytics|mesh-ancestor
102101335|NCT05618236|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102101336|NCT05618236|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102101337|NCT05618236|Cholinergic Agents|cholinergic agents|mesh-ancestor
102101338|NCT05618236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102101339|NCT05618236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101340|NCT05618236|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102101341|NCT05618236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102101342|NCT05618236|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102101343|NCT00872430|Laxatives|laxatives|mesh-list
102101344|NCT00872430|Cathartics|cathartics|mesh-list
102101345|NCT00872430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102101346|NCT00871182|Tiotropium Bromide|tiotropium bromide|mesh-list
102101347|NCT00871182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102101348|NCT00871182|Autonomic Agents|autonomic agents|mesh-ancestor
102101349|NCT00871182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102101350|NCT00871182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101351|NCT00871182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102101352|NCT00871182|Respiratory System Agents|respiratory system agents|mesh-ancestor
102101353|NCT00871182|Parasympatholytics|parasympatholytics|mesh-ancestor
102101354|NCT00871182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102101355|NCT00871182|Cholinergic Agents|cholinergic agents|mesh-ancestor
102101356|NCT00871182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102101357|NCT00871182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101358|NCT04814056|Afatinib|afatinib|mesh-list
102101359|NCT04814056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102101360|NCT04814056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102101361|NCT04814056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102101362|NCT04814056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101363|NCT05627154|Citalopram|citalopram|mesh-list
102101364|NCT05627154|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102101365|NCT05627154|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102101366|NCT05627154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102101367|NCT05627154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101368|NCT05627154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102101369|NCT05627154|Serotonin Agents|serotonin agents|mesh-ancestor
102101370|NCT05627154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101371|NCT05627154|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102101372|NCT05627154|Antidepressive Agents|antidepressive agents|mesh-ancestor
102101373|NCT05627154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102101374|NCT03974854|Gemcitabine|gemcitabine|mesh-list
102101375|NCT03974854|Capecitabine|capecitabine|mesh-list
102101376|NCT03974854|Irinotecan|irinotecan|mesh-list
102101377|NCT03974854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102101378|NCT03974854|Antimetabolites|antimetabolites|mesh-ancestor
102101379|NCT03974854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101380|NCT03974854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102101381|NCT03974854|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102101382|NCT03974854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102101383|NCT03974854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102101384|NCT00957918|Nicotine|nicotine|mesh-list
102101385|NCT00957918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102101386|NCT00957918|Autonomic Agents|autonomic agents|mesh-ancestor
102101387|NCT00957918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102101388|NCT00957918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101389|NCT00957918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102101390|NCT00957918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102101391|NCT00957918|Cholinergic Agents|cholinergic agents|mesh-ancestor
102101392|NCT00957918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102101393|NCT00957918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101394|NCT02734862|Fluconazole|fluconazole|mesh-list
102101395|NCT02734862|Caspofungin|caspofungin|mesh-list
102101396|NCT02734862|Rezafungin|rezafungin|mesh-list
102101397|NCT02734862|Antifungal Agents|antifungal agents|mesh-ancestor
102101398|NCT02734862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102101399|NCT02734862|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102101400|NCT02734862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102101401|NCT02734862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102101402|NCT02734862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101403|NCT02734862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102101404|NCT02734862|Hormone Antagonists|hormone antagonists|mesh-ancestor
102101405|NCT02734862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102101406|NCT02734862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101407|NCT02734862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102101408|NCT02734862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102101409|NCT00818844|Nepafenac|nepafenac|mesh-list
102101410|NCT00818844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102101411|NCT00818844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102101412|NCT00818844|Analgesics|analgesics|mesh-ancestor
102101413|NCT00818844|Sensory System Agents|sensory system agents|mesh-ancestor
102101414|NCT00818844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102101415|NCT00818844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101416|NCT00818844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102101417|NCT00818844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102101418|NCT00862524|Gemcitabine|gemcitabine|mesh-list
102101419|NCT00862524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102101420|NCT00862524|Antimetabolites|antimetabolites|mesh-ancestor
102101421|NCT00862524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101422|NCT00862524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102101423|NCT00858702|Olmesartan|olmesartan|mesh-list
102101424|NCT00858702|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
102101425|NCT00858702|Diuretics|diuretics|mesh-list
102101426|NCT00858702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102101427|NCT00858702|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101554779|NCT00993499|Sirolimus|sirolimus|mesh-list
102101428|NCT00858702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102101429|NCT00858702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101430|NCT00858702|Natriuretic Agents|natriuretic agents|mesh-ancestor
102101431|NCT00858702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101432|NCT00817986|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
102101433|NCT00817986|Baclofen|baclofen|mesh-list
102101434|NCT00817986|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102101435|NCT00817986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101436|NCT00817986|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102101437|NCT00817986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102101438|NCT00817986|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102101439|NCT00817986|GABA Agonists|gaba agonists|mesh-ancestor
102101440|NCT00817986|GABA Agents|gaba agents|mesh-ancestor
102101441|NCT00817986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102101442|NCT00817986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101443|NCT02598934|Ibandronic Acid|ibandronic acid|mesh-list
102101444|NCT02598934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102101445|NCT02598934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101446|NCT00817362|Trastuzumab|trastuzumab|mesh-list
102101447|NCT00817362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102101448|NCT00817362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102101449|NCT04176848|Durvalumab|durvalumab|mesh-list
102101450|NCT04176848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102101451|NCT04176848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102101452|NCT04163978|Budesonide|budesonide|mesh-list
102101453|NCT04163978|Nitric Oxide|nitric oxide|mesh-list
102101454|NCT04163978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102101455|NCT04163978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102101456|NCT04163978|Autonomic Agents|autonomic agents|mesh-ancestor
102101457|NCT04163978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102101458|NCT04163978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101459|NCT04163978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102101460|NCT04163978|Respiratory System Agents|respiratory system agents|mesh-ancestor
102101461|NCT04163978|Glucocorticoids|glucocorticoids|mesh-ancestor
102101462|NCT04163978|Hormones|hormones|mesh-ancestor
102101463|NCT04163978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102101464|NCT04163978|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102101465|NCT04163978|Antioxidants|antioxidants|mesh-ancestor
102101466|NCT04163978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101467|NCT04163978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102101468|NCT04163978|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102101469|NCT04163978|Vasodilator Agents|vasodilator agents|mesh-ancestor
102101470|NCT04163978|Gasotransmitters|gasotransmitters|mesh-ancestor
102101471|NCT04163978|Protective Agents|protective agents|mesh-ancestor
102101472|NCT02598622|Acetylcarnitine|acetylcarnitine|mesh-list
102101473|NCT02598622|Vitamin B Complex|vitamin b complex|mesh-ancestor
102101474|NCT02598622|Vitamins|vitamins|mesh-ancestor
102101475|NCT02598622|Micronutrients|micronutrients|mesh-ancestor
102101476|NCT02598622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101477|NCT02598622|Nootropic Agents|nootropic agents|mesh-ancestor
102101478|NCT03463070|Misoprostol|misoprostol|mesh-list
102101479|NCT03463070|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102101480|NCT03463070|Abortifacient Agents|abortifacient agents|mesh-ancestor
102101481|NCT03463070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102101482|NCT03463070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101483|NCT03463070|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102101484|NCT03463070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102101485|NCT03463070|Oxytocics|oxytocics|mesh-ancestor
102101486|NCT00807612|Paclitaxel|paclitaxel|mesh-list
102101487|NCT00807612|Carboplatin|carboplatin|mesh-list
102101488|NCT00807612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102101489|NCT00807612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102101490|NCT00807612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102101491|NCT00807612|Tubulin Modulators|tubulin modulators|mesh-ancestor
102101492|NCT00807612|Antimitotic Agents|antimitotic agents|mesh-ancestor
102101493|NCT00807612|Mitosis Modulators|mitosis modulators|mesh-ancestor
102101494|NCT00807612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101495|NCT00807612|Immunologic Factors|immunologic factors|mesh-ancestor
102101496|NCT00807612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101497|NCT00805350|SR 46349B|sr 46349b|mesh-list
102101498|NCT00805350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102101499|NCT00805350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102101500|NCT00805350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101501|NCT00805350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102101502|NCT00805350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102101514|NCT03462836|Anesthetics|anesthetics|mesh-ancestor
102101515|NCT03462836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102101516|NCT03462836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101517|NCT03462836|Sensory System Agents|sensory system agents|mesh-ancestor
102101518|NCT03462836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102101519|NCT03462836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102101520|NCT03462836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102101521|NCT03462836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102101522|NCT03462836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102101523|NCT03462836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101524|NCT03462836|Analgesics|analgesics|mesh-ancestor
102101525|NCT03462836|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102101526|NCT03462836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102101527|NCT03462836|Anesthetics, General|anesthetics, general|mesh-ancestor
102101528|NCT03462836|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102101529|NCT03462836|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102101530|NCT03462836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102101531|NCT00849576|Insulin|insulin|mesh-list
102101532|NCT00849576|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102101533|NCT00849576|Insulin Lispro|insulin lispro|mesh-list
102101534|NCT00849576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102101535|NCT00849576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101536|NCT00841698|Paroxetine|paroxetine|mesh-list
102101537|NCT00841698|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102101538|NCT00841698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102101539|NCT00841698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102101540|NCT00841698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101541|NCT00841698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102101542|NCT00841698|Serotonin Agents|serotonin agents|mesh-ancestor
102101543|NCT00841698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101544|NCT00841698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102101545|NCT00841698|Antidepressive Agents|antidepressive agents|mesh-ancestor
102101546|NCT00841698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102101547|NCT00841698|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102101548|NCT00841698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102101549|NCT00841698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102101550|NCT04383002|Nitric Oxide|nitric oxide|mesh-list
102101551|NCT04383002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102101552|NCT04383002|Autonomic Agents|autonomic agents|mesh-ancestor
102101553|NCT04383002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102101554|NCT04383002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101555|NCT04383002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102101556|NCT04383002|Respiratory System Agents|respiratory system agents|mesh-ancestor
102101557|NCT04383002|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102101558|NCT04383002|Antioxidants|antioxidants|mesh-ancestor
102101559|NCT04383002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101560|NCT04383002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102101561|NCT04383002|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102101562|NCT04383002|Vasodilator Agents|vasodilator agents|mesh-ancestor
102101563|NCT04383002|Gasotransmitters|gasotransmitters|mesh-ancestor
102101564|NCT04383002|Protective Agents|protective agents|mesh-ancestor
102101565|NCT00841542|Amlodipine|amlodipine|mesh-list
102101566|NCT00841542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102101567|NCT00841542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102101568|NCT00841542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102101569|NCT00841542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101570|NCT00841542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102101571|NCT00841542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101572|NCT00841542|Vasodilator Agents|vasodilator agents|mesh-ancestor
102101573|NCT03623750|Cyclophosphamide|cyclophosphamide|mesh-list
102101574|NCT03623750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101554924|NCT02868931|Insulin|insulin|mesh-list
102101575|NCT03623750|Immunologic Factors|immunologic factors|mesh-ancestor
102101576|NCT03623750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101577|NCT03623750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102101578|NCT03623750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102101579|NCT03623750|Alkylating Agents|alkylating agents|mesh-ancestor
102101580|NCT03623750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101581|NCT03623750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102101582|NCT03623750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102101583|NCT00840840|Amoxicillin|amoxicillin|mesh-list
102101584|NCT00840840|Clavulanic Acid|clavulanic acid|mesh-list
102101585|NCT00840840|Clavulanic Acids|clavulanic acids|mesh-list
102101586|NCT00840840|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102101587|NCT00840840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102101588|NCT00840840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102101589|NCT00840840|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102101590|NCT00840840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102101591|NCT00840840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101592|NCT03595982|Nifedipine|nifedipine|mesh-list
102101593|NCT03595982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102101594|NCT03595982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102101595|NCT03595982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101596|NCT03595982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102101597|NCT03595982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101598|NCT03595982|Vasodilator Agents|vasodilator agents|mesh-ancestor
102101599|NCT03595982|Tocolytic Agents|tocolytic agents|mesh-ancestor
102101600|NCT03595982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102101602|NCT00944970|Binodenoson|binodenoson|mesh-list
102101603|NCT00944970|Analgesics|analgesics|mesh-ancestor
102101604|NCT00944970|Sensory System Agents|sensory system agents|mesh-ancestor
102101605|NCT00944970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102101606|NCT00944970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225293|NCT01528371|Anesthetics|anesthetics|mesh-ancestor
102101607|NCT00944970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102101608|NCT00944970|Vasodilator Agents|vasodilator agents|mesh-ancestor
102101609|NCT00944970|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102101610|NCT00944970|Purinergic Agonists|purinergic agonists|mesh-ancestor
102101611|NCT00944970|Purinergic Agents|purinergic agents|mesh-ancestor
102101612|NCT00944970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102101613|NCT00944970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101614|NCT00840216|Clarithromycin|clarithromycin|mesh-list
102101615|NCT00840216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102101616|NCT00840216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102101617|NCT00840216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102101618|NCT00840216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102101619|NCT00840216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101620|NCT00840216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102101621|NCT00840216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102101622|NCT03462446|Vitamin K|vitamin k|mesh-list
102101623|NCT03462446|Rivaroxaban|rivaroxaban|mesh-list
102101624|NCT03462446|Vitamins|vitamins|mesh-ancestor
102101625|NCT03462446|Micronutrients|micronutrients|mesh-ancestor
102101626|NCT03462446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101627|NCT03462446|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102101628|NCT03462446|Antithrombins|antithrombins|mesh-ancestor
102101629|NCT03462446|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102101630|NCT03462446|Protease Inhibitors|protease inhibitors|mesh-ancestor
102101631|NCT03462446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102101632|NCT03462446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101633|NCT03462446|Anticoagulants|anticoagulants|mesh-ancestor
102101634|NCT03462446|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102101635|NCT03462446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102101636|NCT03462446|Hemostatics|hemostatics|mesh-ancestor
102101637|NCT03462446|Coagulants|coagulants|mesh-ancestor
102101638|NCT00944892|Fasinumab|fasinumab|mesh-list
102101639|NCT00944892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102101640|NCT00944892|Analgesics|analgesics|mesh-ancestor
102101641|NCT00944892|Sensory System Agents|sensory system agents|mesh-ancestor
102101642|NCT00944892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102101643|NCT00944892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101644|NCT00939276|Nepafenac|nepafenac|mesh-list
102101645|NCT00939276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102101646|NCT00939276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102101647|NCT00939276|Analgesics|analgesics|mesh-ancestor
102101648|NCT00939276|Sensory System Agents|sensory system agents|mesh-ancestor
102101649|NCT00939276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102101650|NCT00939276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101651|NCT00939276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102101652|NCT00939276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102101653|NCT03455426|Letrozole|letrozole|mesh-list
102101654|NCT03455426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102101655|NCT03455426|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102101656|NCT03455426|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102101657|NCT03455426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102101658|NCT03455426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101659|NCT03455426|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102101660|NCT03455426|Hormone Antagonists|hormone antagonists|mesh-ancestor
102101661|NCT03455426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102101662|NCT03455426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101663|NCT00791154|Carboplatin|carboplatin|mesh-list
102101664|NCT00791154|Etoposide|etoposide|mesh-list
102101665|NCT00791154|Rilotumumab|rilotumumab|mesh-list
102101666|NCT00791154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102101667|NCT00791154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102101668|NCT00791154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102101669|NCT00791154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102101670|NCT00791154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101225298|NCT01528501|Panobinostat|panobinostat|mesh-list
102101671|NCT00791154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101672|NCT00791154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102101673|NCT00938652|Carboplatin|carboplatin|mesh-list
102101674|NCT00938652|Gemcitabine|gemcitabine|mesh-list
102101675|NCT00938652|Iniparib|iniparib|mesh-list
102101676|NCT00938652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102101677|NCT00938652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102101678|NCT00938652|Antimetabolites|antimetabolites|mesh-ancestor
102101679|NCT00938652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101680|NCT00938652|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102101681|NCT00938652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102101682|NCT00928590|Timolol|timolol|mesh-list
102101683|NCT00928590|Travoprost|travoprost|mesh-list
102101684|NCT00928590|Cloprostenol|cloprostenol|mesh-list
102101685|NCT00928590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101686|NCT00928590|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102101687|NCT00928590|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102101688|NCT00928590|Adrenergic Agents|adrenergic agents|mesh-ancestor
102101689|NCT00928590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102101690|NCT00928590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101691|NCT00928590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102101692|NCT00928590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102101693|NCT00928590|Luteolytic Agents|luteolytic agents|mesh-ancestor
102101694|NCT00928590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102101695|NCT00928590|Contraceptive Agents|contraceptive agents|mesh-ancestor
102101696|NCT00928590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102101697|NCT00928590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102101698|NCT03512756|Sirolimus|sirolimus|mesh-list
102101699|NCT03512756|Gemcitabine|gemcitabine|mesh-list
102101700|NCT03512756|Capecitabine|capecitabine|mesh-list
102101701|NCT03512756|Phenytoin|phenytoin|mesh-list
102101702|NCT03512756|Methoxsalen|methoxsalen|mesh-list
102101703|NCT03512756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102101704|NCT03512756|Antimetabolites|antimetabolites|mesh-ancestor
102101705|NCT03512756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101706|NCT03512756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102101707|NCT03512756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102101708|NCT03512756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102101709|NCT03512756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102101710|NCT03512756|Antifungal Agents|antifungal agents|mesh-ancestor
102101711|NCT03512756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102101712|NCT03512756|Immunologic Factors|immunologic factors|mesh-ancestor
102101713|NCT03512756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101714|NCT03512756|Anticonvulsants|anticonvulsants|mesh-ancestor
102101715|NCT03512756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102101716|NCT03512756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102101717|NCT03512756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102101718|NCT03512756|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102101719|NCT03512756|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102101720|NCT03512756|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102101721|NCT03512756|Dermatologic Agents|dermatologic agents|mesh-ancestor
102101722|NCT04697940|Cyclophosphamide|cyclophosphamide|mesh-list
102101723|NCT04697940|Fludarabine|fludarabine|mesh-list
102101724|NCT04697940|Fludarabine phosphate|fludarabine phosphate|mesh-list
102101725|NCT04697940|Decitabine|decitabine|mesh-list
102101726|NCT04697940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102101727|NCT04697940|Immunologic Factors|immunologic factors|mesh-ancestor
102101728|NCT04697940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101729|NCT04697940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102101730|NCT04697940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102101731|NCT04697940|Alkylating Agents|alkylating agents|mesh-ancestor
102101732|NCT04697940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101733|NCT04697940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102101734|NCT04697940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102101735|NCT04697940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102101736|NCT04697940|Antimetabolites|antimetabolites|mesh-ancestor
102101737|NCT04697940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102101738|NCT00836706|Clarithromycin|clarithromycin|mesh-list
102101739|NCT00836706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102101740|NCT00836706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102101741|NCT00836706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102101742|NCT00836706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102101743|NCT00836706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101744|NCT00836706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102101745|NCT00836706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102101747|NCT00836472|Glyburide|glyburide|mesh-list
102101748|NCT00836472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102101749|NCT00836472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101750|NCT04473846|Anesthetics|anesthetics|mesh-list
102101751|NCT04473846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102101752|NCT04473846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101753|NCT03129698|Apatinib|apatinib|mesh-list
102101754|NCT03129698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102101755|NCT03129698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102101756|NCT03129698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102101757|NCT03129698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101758|NCT03355118|Anesthetics|anesthetics|mesh-list
102101759|NCT03355118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102101760|NCT03355118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101761|NCT03263078|Propofol|propofol|mesh-list
102101762|NCT03263078|Sevoflurane|sevoflurane|mesh-list
102101763|NCT03263078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102101764|NCT03263078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101225346|NCT01528800|Vitamin K|vitamin k|mesh-list
102101765|NCT03263078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101766|NCT03263078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102101767|NCT03263078|Anesthetics, General|anesthetics, general|mesh-ancestor
102101768|NCT03263078|Anesthetics|anesthetics|mesh-ancestor
102101769|NCT03263078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102101770|NCT03263078|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102101771|NCT05349006|Azathioprine|azathioprine|mesh-list
102101772|NCT05349006|Antimetabolites|antimetabolites|mesh-ancestor
102101773|NCT05349006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101774|NCT05349006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102101775|NCT05349006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102101776|NCT05349006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102101777|NCT05349006|Immunologic Factors|immunologic factors|mesh-ancestor
102101778|NCT05349006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101779|NCT05349006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102101780|NCT00785226|Sorafenib|sorafenib|mesh-list
102101781|NCT00785226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102101782|NCT00785226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102101783|NCT00785226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102101784|NCT00785226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101785|NCT02598388|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
102101786|NCT02598388|Antiviral Agents|antiviral agents|mesh-ancestor
102101787|NCT02598388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102101788|NCT03448640|Tropicamide|tropicamide|mesh-list
102101789|NCT03448640|Mydriatics|mydriatics|mesh-ancestor
102101790|NCT03448640|Autonomic Agents|autonomic agents|mesh-ancestor
102101791|NCT03448640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102101792|NCT03448640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101793|NCT03448640|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102101794|NCT03448640|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102101795|NCT03448640|Cholinergic Agents|cholinergic agents|mesh-ancestor
102101796|NCT03448640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102101797|NCT03448640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555170|NCT02867839|Oxaliplatin|oxaliplatin|mesh-list
102101799|NCT00836004|Clindamycin palmitate|clindamycin palmitate|mesh-list
102101800|NCT00836004|Clindamycin phosphate|clindamycin phosphate|mesh-list
102101801|NCT00836004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102101802|NCT00836004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102101803|NCT00836004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102101804|NCT00836004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102101805|NCT00836004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101806|NCT00917826|Valganciclovir|valganciclovir|mesh-list
102101807|NCT00917826|Ganciclovir|ganciclovir|mesh-list
102101808|NCT00917826|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102101809|NCT00917826|Arginine butyrate|arginine butyrate|mesh-list
102101810|NCT00917826|Antiviral Agents|antiviral agents|mesh-ancestor
102101811|NCT00917826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102101812|NCT00917826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102101813|NCT00917826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102101814|NCT00917826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101815|NCT00917826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102101816|NCT04819906|Moxifloxacin|moxifloxacin|mesh-list
102101817|NCT04819906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102101818|NCT04819906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102101819|NCT04819906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102101820|NCT04819906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102101821|NCT04819906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102101822|NCT04819906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101823|NCT04819906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102101824|NCT03102320|Gemcitabine|gemcitabine|mesh-list
102101825|NCT03102320|Maytansine|maytansine|mesh-list
102101826|NCT03102320|Anetumab ravtansine|anetumab ravtansine|mesh-list
102101827|NCT03102320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102101828|NCT03102320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102101829|NCT03102320|Antimetabolites|antimetabolites|mesh-ancestor
102101830|NCT03102320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101831|NCT03102320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102101832|NCT03102320|Tubulin Modulators|tubulin modulators|mesh-ancestor
102101833|NCT03102320|Antimitotic Agents|antimitotic agents|mesh-ancestor
102101834|NCT03102320|Mitosis Modulators|mitosis modulators|mesh-ancestor
102101835|NCT03102320|Immunoconjugates|immunoconjugates|mesh-ancestor
102101836|NCT03102320|Immunologic Factors|immunologic factors|mesh-ancestor
102101837|NCT03102320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101838|NCT00835692|Clarithromycin|clarithromycin|mesh-list
102101839|NCT00835692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102101840|NCT00835692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102101841|NCT00835692|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102101842|NCT00835692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102101843|NCT00835692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101844|NCT00835692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102101845|NCT00835692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102101846|NCT00835614|Cefprozil|cefprozil|mesh-list
102101847|NCT00835614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102101848|NCT00835614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102101849|NCT00835536|Ribavirin|ribavirin|mesh-list
102101850|NCT00835536|Antimetabolites|antimetabolites|mesh-ancestor
102101851|NCT00835536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101852|NCT00835536|Antiviral Agents|antiviral agents|mesh-ancestor
102101853|NCT00835536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102101854|NCT04561362|Pembrolizumab|pembrolizumab|mesh-list
102101855|NCT04561362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102101856|NCT04561362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102101857|NCT04561362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102101858|NCT04561362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101859|NCT04060628|Docetaxel|docetaxel|mesh-list
102101860|NCT04060628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102101861|NCT04060628|Tubulin Modulators|tubulin modulators|mesh-ancestor
102101862|NCT04060628|Antimitotic Agents|antimitotic agents|mesh-ancestor
102101863|NCT04060628|Mitosis Modulators|mitosis modulators|mesh-ancestor
102101864|NCT04060628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101865|NCT04356664|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102101866|NCT04356664|Luteolytic Agents|luteolytic agents|mesh-ancestor
102101867|NCT04356664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102101868|NCT04356664|Contraceptive Agents|contraceptive agents|mesh-ancestor
102101869|NCT04356664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102101870|NCT04356664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101871|NCT04356664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102101872|NCT04356664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102101874|NCT04037072|Mitomycins|mitomycins|mesh-list
102101875|NCT04037072|Mitomycin|mitomycin|mesh-list
102101876|NCT04037072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102101877|NCT04037072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102101878|NCT04037072|Alkylating Agents|alkylating agents|mesh-ancestor
102101879|NCT04037072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101880|NCT04037072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102101881|NCT04037072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102101882|NCT04819438|Riluzole|riluzole|mesh-list
102101883|NCT04819438|Anticonvulsants|anticonvulsants|mesh-ancestor
102101884|NCT04819438|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102101885|NCT04819438|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102101886|NCT04819438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102101887|NCT04819438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101888|NCT04819438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101889|NCT04819438|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102101890|NCT04819438|Protective Agents|protective agents|mesh-ancestor
102101891|NCT05616910|Nitric Oxide|nitric oxide|mesh-list
102101892|NCT05616910|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102101893|NCT05616910|Autonomic Agents|autonomic agents|mesh-ancestor
102101894|NCT05616910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102101895|NCT05616910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101896|NCT05616910|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102101897|NCT05616910|Respiratory System Agents|respiratory system agents|mesh-ancestor
102101898|NCT05616910|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102101899|NCT05616910|Antioxidants|antioxidants|mesh-ancestor
102101900|NCT05616910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101901|NCT05616910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102101902|NCT05616910|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102101903|NCT05616910|Vasodilator Agents|vasodilator agents|mesh-ancestor
102101904|NCT05616910|Gasotransmitters|gasotransmitters|mesh-ancestor
102101905|NCT05616910|Protective Agents|protective agents|mesh-ancestor
102101906|NCT04537026|Dexamethasone|dexamethasone|mesh-list
102101907|NCT04537026|Dexamethasone acetate|dexamethasone acetate|mesh-list
102101908|NCT04537026|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102101909|NCT04537026|BB 1101|bb 1101|mesh-list
102101910|NCT04537026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102101911|NCT04537026|Antiemetics|antiemetics|mesh-ancestor
102101912|NCT04537026|Autonomic Agents|autonomic agents|mesh-ancestor
102101913|NCT04537026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102101914|NCT04537026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101915|NCT04537026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102101916|NCT04537026|Glucocorticoids|glucocorticoids|mesh-ancestor
102101917|NCT04537026|Hormones|hormones|mesh-ancestor
102101918|NCT04537026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102101919|NCT04537026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102101920|NCT04537026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102101921|NCT04537026|Protease Inhibitors|protease inhibitors|mesh-ancestor
102101922|NCT04537026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102101923|NCT04537026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101924|NCT04819828|Diclofenac|diclofenac|mesh-list
102101925|NCT04819828|Tamsulosin|tamsulosin|mesh-list
102101926|NCT04819828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102101927|NCT04819828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102101928|NCT04819828|Analgesics|analgesics|mesh-ancestor
102101929|NCT04819828|Sensory System Agents|sensory system agents|mesh-ancestor
102101930|NCT04819828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102101931|NCT04819828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101932|NCT04819828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102101933|NCT04819828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102101934|NCT04819828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102101935|NCT04819828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102101936|NCT04819828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101937|NCT04819828|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102101938|NCT04819828|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102101939|NCT04819828|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102101940|NCT04819828|Adrenergic Agents|adrenergic agents|mesh-ancestor
102101941|NCT04819828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102101942|NCT04819828|Urological Agents|urological agents|mesh-ancestor
102101943|NCT02602288|Nicotine|nicotine|mesh-list
102101944|NCT02602288|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102101945|NCT02602288|Autonomic Agents|autonomic agents|mesh-ancestor
102101946|NCT02602288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102101947|NCT02602288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101949|NCT02602288|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102101950|NCT02602288|Cholinergic Agents|cholinergic agents|mesh-ancestor
102101951|NCT02602288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102101952|NCT02602288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101953|NCT03745352|Azacitidine|azacitidine|mesh-list
102101954|NCT03745352|Enzyme Inhibitors|enzyme inhibitors|mesh-list
102101955|NCT03745352|Pevonedistat|pevonedistat|mesh-list
102101956|NCT03745352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102101957|NCT03745352|Antimetabolites|antimetabolites|mesh-ancestor
102101958|NCT03745352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101959|NCT03745352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102101960|NCT03740126|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102101961|NCT03740126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102101962|NCT03740126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101963|NCT05617690|Propofol|propofol|mesh-list
102101964|NCT05617690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102101965|NCT05617690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102101966|NCT05617690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101967|NCT05617690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102101968|NCT05617690|Anesthetics, General|anesthetics, general|mesh-ancestor
102101969|NCT05617690|Anesthetics|anesthetics|mesh-ancestor
102101970|NCT03448094|Resveratrol|resveratrol|mesh-list
102101971|NCT03448094|Antioxidants|antioxidants|mesh-ancestor
102101972|NCT03448094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102101973|NCT03448094|Protective Agents|protective agents|mesh-ancestor
101953612|NCT03794505|Ropivacaine|ropivacaine|mesh-list
102101974|NCT03448094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101975|NCT03448094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102101976|NCT03448094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102101977|NCT04819204|Cetrorelix|cetrorelix|mesh-list
102101978|NCT04819204|Testosterone|testosterone|mesh-list
102101979|NCT04819204|Androgens|androgens|mesh-ancestor
102101980|NCT04819204|Hormones|hormones|mesh-ancestor
102101981|NCT04819204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102101982|NCT04819204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101983|NCT04819204|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102101984|NCT04819204|Fertility Agents|fertility agents|mesh-ancestor
102101985|NCT04819204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102101986|NCT04819204|Hormone Antagonists|hormone antagonists|mesh-ancestor
102101987|NCT02807454|Dexamethasone|dexamethasone|mesh-list
102101988|NCT02807454|Durvalumab|durvalumab|mesh-list
102101989|NCT02807454|Daratumumab|daratumumab|mesh-list
102101990|NCT02807454|Pomalidomide|pomalidomide|mesh-list
102101991|NCT02807454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102101992|NCT02807454|Antiemetics|antiemetics|mesh-ancestor
102101993|NCT02807454|Autonomic Agents|autonomic agents|mesh-ancestor
102101994|NCT02807454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102101995|NCT02807454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102101996|NCT02807454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102101997|NCT02807454|Glucocorticoids|glucocorticoids|mesh-ancestor
102101998|NCT02807454|Hormones|hormones|mesh-ancestor
102101999|NCT02807454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102102000|NCT02807454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102102001|NCT02807454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102102002|NCT02807454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102102003|NCT02807454|Immunologic Factors|immunologic factors|mesh-ancestor
102102004|NCT02807454|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102102005|NCT02807454|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102102006|NCT02807454|Growth Substances|growth substances|mesh-ancestor
102102007|NCT02807454|Growth Inhibitors|growth inhibitors|mesh-ancestor
102102008|NCT03718286|Alirocumab|alirocumab|mesh-list
102102009|NCT03718286|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102102010|NCT03718286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102102011|NCT03718286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102102012|NCT03718286|Antimetabolites|antimetabolites|mesh-ancestor
102102013|NCT03718286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102014|NCT03718286|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102102015|NCT03718286|Protease Inhibitors|protease inhibitors|mesh-ancestor
102102016|NCT03718286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102102017|NCT03718286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102102018|NCT05320874|Antibodies|antibodies|mesh-list
102102019|NCT05320874|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101953627|NCT03794505|Antiemetics|antiemetics|mesh-ancestor
101555375|NCT01002820|GABA Agents|gaba agents|mesh-ancestor
102102021|NCT05320874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102022|NCT05320640|Decitabine|decitabine|mesh-list
102102023|NCT05320640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102102024|NCT05320640|Antibodies|antibodies|mesh-list
102102025|NCT05320640|Immunologic Factors|immunologic factors|mesh-ancestor
102102026|NCT05320640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102027|NCT05320640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102102028|NCT05320640|Antimetabolites|antimetabolites|mesh-ancestor
102102029|NCT05320640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102030|NCT05320640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102102031|NCT05320640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102102032|NCT05320640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102102033|NCT00835146|Ribavirin|ribavirin|mesh-list
102102034|NCT00835146|Antimetabolites|antimetabolites|mesh-ancestor
102102035|NCT00835146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102036|NCT00835146|Antiviral Agents|antiviral agents|mesh-ancestor
102102037|NCT00835146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102102038|NCT04472910|Folfirinox|folfirinox|mesh-list
102102039|NCT04472910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102102040|NCT01479842|Rituximab|rituximab|mesh-list
102102041|NCT01479842|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102102042|NCT01479842|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102102043|NCT01479842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102102044|NCT01479842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102102045|NCT01479842|Immunologic Factors|immunologic factors|mesh-ancestor
102102046|NCT01479842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102047|NCT01479842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102102048|NCT01479842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102102049|NCT01479842|Alkylating Agents|alkylating agents|mesh-ancestor
102102050|NCT01479842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102051|NCT01479842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102102052|NCT01479842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102102053|NCT04818736|Vaccines|vaccines|mesh-list
102102054|NCT04818736|Immunologic Factors|immunologic factors|mesh-ancestor
102102055|NCT04818736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102056|NCT03719430|Doxorubicin|doxorubicin|mesh-list
101953655|NCT05624853|Pregabalin|pregabalin|mesh-list
102102057|NCT03719430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102102058|NCT03719430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102102059|NCT03719430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102102060|NCT03719430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102102061|NCT03719430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102102062|NCT03719430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102063|NCT04811326|Latanoprost|latanoprost|mesh-list
102102064|NCT04811326|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102102065|NCT04811326|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102102066|NCT00834990|Valproic Acid|valproic acid|mesh-list
102102067|NCT00834990|Anticonvulsants|anticonvulsants|mesh-ancestor
102102068|NCT00834990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102102069|NCT00834990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102070|NCT00834990|GABA Agents|gaba agents|mesh-ancestor
102102071|NCT00834990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102102072|NCT00834990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102073|NCT00834990|Antimanic Agents|antimanic agents|mesh-ancestor
102102074|NCT00834990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102102075|NCT00834990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102102076|NCT00834990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102102077|NCT04479072|Aspirin|aspirin|mesh-list
102102078|NCT04479072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102102079|NCT04479072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102102080|NCT04479072|Analgesics|analgesics|mesh-ancestor
102102081|NCT04479072|Sensory System Agents|sensory system agents|mesh-ancestor
102102082|NCT04479072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102102083|NCT04479072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102084|NCT04479072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102102085|NCT04479072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102102086|NCT04479072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102102087|NCT04479072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102102088|NCT04479072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102089|NCT04479072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102102090|NCT04479072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102102091|NCT04479072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102102092|NCT04479072|Antipyretics|antipyretics|mesh-ancestor
102102093|NCT03036202|Epinephrine|epinephrine|mesh-list
102102094|NCT03036202|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102102095|NCT03036202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102102096|NCT03036202|Adrenergic Agents|adrenergic agents|mesh-ancestor
102102097|NCT03036202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101225475|NCT01529190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102102098|NCT03036202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102099|NCT03036202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102100|NCT03036202|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102102101|NCT03036202|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102102102|NCT03036202|Autonomic Agents|autonomic agents|mesh-ancestor
102102103|NCT03036202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102102104|NCT03036202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102102105|NCT03036202|Respiratory System Agents|respiratory system agents|mesh-ancestor
102102106|NCT03036202|Mydriatics|mydriatics|mesh-ancestor
102102107|NCT03036202|Sympathomimetics|sympathomimetics|mesh-ancestor
102102108|NCT03036202|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102102109|NCT03245918|Aprepitant|aprepitant|mesh-list
102102110|NCT03245918|Fosaprepitant|fosaprepitant|mesh-list
102102111|NCT03245918|Antiemetics|antiemetics|mesh-ancestor
102102112|NCT03245918|Autonomic Agents|autonomic agents|mesh-ancestor
102102113|NCT03245918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102102114|NCT03245918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102115|NCT03245918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102102116|NCT03245918|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102102117|NCT03245918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102102118|NCT03245918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102119|NCT00834756|Azithromycin|azithromycin|mesh-list
102102120|NCT00834756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102102121|NCT00834756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102102123|NCT00828854|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102102124|NCT00828854|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102102125|NCT00828854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102102126|NCT00828854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102127|NCT00828854|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102102128|NCT00828854|Hormone Antagonists|hormone antagonists|mesh-ancestor
102102129|NCT00828854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102102130|NCT00828854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102131|NCT00828854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102102132|NCT00828854|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102102133|NCT00834522|Granisetron|granisetron|mesh-list
102102134|NCT00834522|Antiemetics|antiemetics|mesh-ancestor
102102135|NCT00834522|Autonomic Agents|autonomic agents|mesh-ancestor
102102136|NCT00834522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102102137|NCT00834522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102138|NCT00834522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102102139|NCT00834522|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102102140|NCT00834522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102102141|NCT00834522|Serotonin Agents|serotonin agents|mesh-ancestor
102102142|NCT00834522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102102143|NCT00834522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102144|NCT00834444|Famciclovir|famciclovir|mesh-list
102102145|NCT00834444|Antiviral Agents|antiviral agents|mesh-ancestor
102102146|NCT00834444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102102147|NCT00834444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102102148|NCT00834444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102102149|NCT00834444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102150|NCT05174858|Hemostatics|hemostatics|mesh-list
102102151|NCT05174858|Coagulants|coagulants|mesh-ancestor
102102152|NCT00834132|Azithromycin|azithromycin|mesh-list
102102153|NCT00834132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102102154|NCT00834132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102102155|NCT00833586|Terbinafine|terbinafine|mesh-list
102102156|NCT00833586|Antifungal Agents|antifungal agents|mesh-ancestor
102102157|NCT00833586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102102158|NCT00833586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102102159|NCT00833586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102160|NCT02605954|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
102102161|NCT02605954|Antiviral Agents|antiviral agents|mesh-ancestor
102102162|NCT02605954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102102163|NCT03447470|Nivolumab|nivolumab|mesh-list
102102164|NCT03447470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102102165|NCT03447470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102102166|NCT03447470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102102167|NCT03447470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102168|NCT04817800|Azelastine|azelastine|mesh-list
102102169|NCT04817800|Beclomethasone|beclomethasone|mesh-list
102102170|NCT04817800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102102171|NCT04817800|Glucocorticoids|glucocorticoids|mesh-ancestor
102102172|NCT04817800|Hormones|hormones|mesh-ancestor
102102173|NCT04817800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102102174|NCT04817800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102175|NCT04817800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102102176|NCT04817800|Respiratory System Agents|respiratory system agents|mesh-ancestor
102102177|NCT04817800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102102178|NCT04817800|Autonomic Agents|autonomic agents|mesh-ancestor
101953713|NCT03793725|Apatinib|apatinib|mesh-list
102102179|NCT04817800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102102180|NCT04817800|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
102102181|NCT04817800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102102182|NCT04817800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102183|NCT04817800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102102184|NCT04817800|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102102185|NCT04817800|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102102186|NCT04817800|Histamine Antagonists|histamine antagonists|mesh-ancestor
102102187|NCT04817800|Histamine Agents|histamine agents|mesh-ancestor
102102188|NCT04817800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102102189|NCT00765804|Dexamethasone|dexamethasone|mesh-list
102102190|NCT00765804|Citric Acid|citric acid|mesh-list
102102191|NCT00765804|Sodium Citrate|sodium citrate|mesh-list
102102192|NCT00765804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102102193|NCT00765804|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102102194|NCT00765804|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102102195|NCT00765804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102102196|NCT00765804|Antiemetics|antiemetics|mesh-ancestor
102102197|NCT00765804|Autonomic Agents|autonomic agents|mesh-ancestor
102102198|NCT00765804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102102199|NCT00765804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102200|NCT00765804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102102201|NCT00765804|Glucocorticoids|glucocorticoids|mesh-ancestor
102102202|NCT00765804|Hormones|hormones|mesh-ancestor
102102203|NCT00765804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102102204|NCT00765804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102102205|NCT00765804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102102206|NCT00765804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102207|NCT00765804|Anticoagulants|anticoagulants|mesh-ancestor
102102208|NCT00765804|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102102209|NCT00765804|Chelating Agents|chelating agents|mesh-ancestor
102102210|NCT00765804|Sequestering Agents|sequestering agents|mesh-ancestor
102102211|NCT00764634|Vaccines|vaccines|mesh-list
102102212|NCT00764634|Immunologic Factors|immunologic factors|mesh-ancestor
102102213|NCT00764634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102214|NCT03443726|Epinephrine|epinephrine|mesh-list
102102215|NCT03443726|Carticaine|carticaine|mesh-list
102102216|NCT03443726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102102217|NCT03443726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102102218|NCT03443726|Adrenergic Agents|adrenergic agents|mesh-ancestor
102102219|NCT03443726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102102220|NCT03443726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102221|NCT03443726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102222|NCT03443726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102102223|NCT03443726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102102224|NCT03443726|Autonomic Agents|autonomic agents|mesh-ancestor
102102225|NCT03443726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102102226|NCT03443726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102102227|NCT03443726|Respiratory System Agents|respiratory system agents|mesh-ancestor
102102228|NCT03443726|Mydriatics|mydriatics|mesh-ancestor
102102229|NCT03443726|Sympathomimetics|sympathomimetics|mesh-ancestor
102102230|NCT03443726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102102231|NCT03443726|Anesthetics, Local|anesthetics, local|mesh-ancestor
102102232|NCT03443726|Anesthetics|anesthetics|mesh-ancestor
102102233|NCT03443726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102102234|NCT03443726|Sensory System Agents|sensory system agents|mesh-ancestor
102102235|NCT00760344|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102102236|NCT00760344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102102237|NCT00760344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102238|NCT00760344|Incretins|incretins|mesh-ancestor
102102239|NCT00760344|Hormones|hormones|mesh-ancestor
102102240|NCT00760344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102102241|NCT00760344|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102102242|NCT00760344|Protease Inhibitors|protease inhibitors|mesh-ancestor
102102243|NCT00760344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102102244|NCT00760344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102245|NCT03443570|Rituximab|rituximab|mesh-list
102102246|NCT03443570|Bortezomib|bortezomib|mesh-list
102102247|NCT03443570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102102248|NCT03443570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102102249|NCT03443570|Immunologic Factors|immunologic factors|mesh-ancestor
102102250|NCT03443570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102251|NCT03443570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102102252|NCT02718404|Analgesics|analgesics|mesh-list
102102253|NCT02718404|Sensory System Agents|sensory system agents|mesh-ancestor
102102254|NCT02718404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102102255|NCT02718404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102256|NCT03443492|Leucovorin|leucovorin|mesh-list
102102257|NCT03443492|Gemcitabine|gemcitabine|mesh-list
102102258|NCT03443492|Oxaliplatin|oxaliplatin|mesh-list
102102259|NCT03443492|Irinotecan|irinotecan|mesh-list
102102260|NCT03443492|Levoleucovorin|levoleucovorin|mesh-list
102102261|NCT03443492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102102262|NCT03443492|Antimetabolites|antimetabolites|mesh-ancestor
102102263|NCT03443492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102264|NCT03443492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102102265|NCT03443492|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102102266|NCT03443492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102102267|NCT03443492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102102268|NCT03443492|Antidotes|antidotes|mesh-ancestor
102102269|NCT03443492|Protective Agents|protective agents|mesh-ancestor
102102270|NCT03443492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102271|NCT03443492|Vitamin B Complex|vitamin b complex|mesh-ancestor
102102272|NCT03443492|Vitamins|vitamins|mesh-ancestor
102102273|NCT03443492|Micronutrients|micronutrients|mesh-ancestor
102102274|NCT00724698|Desloratadine|desloratadine|mesh-list
102102275|NCT00724698|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102102276|NCT00724698|Cholinergic Agents|cholinergic agents|mesh-ancestor
102102277|NCT00724698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102102278|NCT00724698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102279|NCT00724698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102280|NCT00724698|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102102281|NCT00724698|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102102282|NCT00724698|Histamine Antagonists|histamine antagonists|mesh-ancestor
102102283|NCT00724698|Histamine Agents|histamine agents|mesh-ancestor
102102284|NCT00722592|Doxorubicin|doxorubicin|mesh-list
102102285|NCT00722592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102102286|NCT00722592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102102287|NCT00722592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102102288|NCT00722592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102102289|NCT00722592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102102290|NCT00722592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102102291|NCT00722592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102292|NCT00829998|Zaleplon|zaleplon|mesh-list
102102293|NCT00829998|Anticonvulsants|anticonvulsants|mesh-ancestor
102102294|NCT00829998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102102295|NCT00829998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102102296|NCT00829998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102297|NCT00829998|GABA Modulators|gaba modulators|mesh-ancestor
102102298|NCT00829998|GABA Agents|gaba agents|mesh-ancestor
102102299|NCT00829998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102102300|NCT00829998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102301|NCT00722358|Asunaprevir|asunaprevir|mesh-list
102102302|NCT00722358|Protease Inhibitors|protease inhibitors|mesh-ancestor
102102303|NCT00722358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102102304|NCT00722358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102305|NCT00719550|Capecitabine|capecitabine|mesh-list
102102306|NCT00719550|Epirubicin|epirubicin|mesh-list
102102307|NCT00719550|Rilotumumab|rilotumumab|mesh-list
102102308|NCT00719550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102102309|NCT00719550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102102310|NCT00719550|Antimetabolites|antimetabolites|mesh-ancestor
102102311|NCT00719550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102312|NCT00719550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102102313|NCT00719550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102102314|NCT00719550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102102315|NCT00719550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101953720|NCT02056366|Thioctic Acid|thioctic acid|mesh-list
102102316|NCT00719550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102102317|NCT03443180|Trypsin Inhibitors|trypsin inhibitors|mesh-list
102102318|NCT03443180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102102319|NCT03443180|Protease Inhibitors|protease inhibitors|mesh-ancestor
102102320|NCT03443180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102102321|NCT03443180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102323|NCT05016518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102102324|NCT05016518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102102325|NCT05016518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102326|NCT05016518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102102327|NCT05016518|Anesthetics, General|anesthetics, general|mesh-ancestor
102102328|NCT05016518|Anesthetics|anesthetics|mesh-ancestor
102102329|NCT03446534|Amoxicillin|amoxicillin|mesh-list
102102330|NCT03446534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102102331|NCT03446534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102102332|NCT00829764|Doxycycline|doxycycline|mesh-list
102102333|NCT00829764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102102334|NCT00829764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102102335|NCT00829764|Antimalarials|antimalarials|mesh-ancestor
102102336|NCT00829764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102102337|NCT00829764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102102338|NCT00718224|Enoxaparin|enoxaparin|mesh-list
102102339|NCT00718224|Semuloparin|semuloparin|mesh-list
102102340|NCT00718224|Anticoagulants|anticoagulants|mesh-ancestor
102102341|NCT00718224|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102102342|NCT00718224|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102102343|NCT00718224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102344|NCT03129542|Midodrine|midodrine|mesh-list
102102345|NCT03129542|Sympathomimetics|sympathomimetics|mesh-ancestor
102102346|NCT03129542|Autonomic Agents|autonomic agents|mesh-ancestor
102102347|NCT03129542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102102348|NCT03129542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102349|NCT03129542|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102102350|NCT03129542|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102102351|NCT03129542|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102102352|NCT03129542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102102353|NCT03129542|Adrenergic Agents|adrenergic agents|mesh-ancestor
102102354|NCT03129542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102102355|NCT03129542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102356|NCT03129074|Capecitabine|capecitabine|mesh-list
102102357|NCT03129074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102102358|NCT03129074|Antimetabolites|antimetabolites|mesh-ancestor
102102359|NCT03129074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102360|NCT03129074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102102361|NCT03449654|Liraglutide|liraglutide|mesh-list
102102362|NCT03449654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102102363|NCT03449654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102364|NCT03449654|Incretins|incretins|mesh-ancestor
102102365|NCT03449654|Hormones|hormones|mesh-ancestor
102102366|NCT03449654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102102367|NCT03388008|Mycophenolic Acid|mycophenolic acid|mesh-list
102102368|NCT03388008|Prednisone|prednisone|mesh-list
102102369|NCT03388008|Methylprednisolone|methylprednisolone|mesh-list
102102370|NCT03388008|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102102371|NCT03388008|Abatacept|abatacept|mesh-list
102102372|NCT03388008|Tacrolimus|tacrolimus|mesh-list
102102373|NCT03388008|Thymoglobulin|thymoglobulin|mesh-list
102102374|NCT03388008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102102375|NCT03388008|Glucocorticoids|glucocorticoids|mesh-ancestor
102102376|NCT03388008|Hormones|hormones|mesh-ancestor
102102377|NCT03388008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102102378|NCT03388008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102379|NCT03388008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102102380|NCT03388008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102102381|NCT03388008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102102382|NCT03388008|Immunologic Factors|immunologic factors|mesh-ancestor
102102383|NCT03388008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102102384|NCT03388008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102102385|NCT03388008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102386|NCT03388008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102102387|NCT03388008|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102102388|NCT03388008|Antitubercular Agents|antitubercular agents|mesh-ancestor
102102389|NCT03388008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102102390|NCT03388008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102102391|NCT03388008|Antiemetics|antiemetics|mesh-ancestor
102102392|NCT03388008|Autonomic Agents|autonomic agents|mesh-ancestor
102102393|NCT03388008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102102394|NCT03388008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102102395|NCT03388008|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102102396|NCT03388008|Protective Agents|protective agents|mesh-ancestor
102102397|NCT03388008|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102102398|NCT03388008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102102399|NCT03388008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102102400|NCT00710580|Etanercept|etanercept|mesh-list
102102401|NCT00710580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102102402|NCT00710580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102102403|NCT00710580|Analgesics|analgesics|mesh-ancestor
102102404|NCT00710580|Sensory System Agents|sensory system agents|mesh-ancestor
102102405|NCT00710580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102102406|NCT00710580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102407|NCT00710580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102102408|NCT00710580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102102409|NCT00710580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102102410|NCT00710580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102102411|NCT00710580|Immunologic Factors|immunologic factors|mesh-ancestor
102102412|NCT00829686|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101225534|NCT01529320|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102102413|NCT00829686|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102102414|NCT00829686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102102415|NCT00829686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102102416|NCT00829686|Antimalarials|antimalarials|mesh-ancestor
102102417|NCT00829686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102102418|NCT00829686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102102419|NCT00829530|Ramipril|ramipril|mesh-list
102102420|NCT00829530|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102102421|NCT00829530|Protease Inhibitors|protease inhibitors|mesh-ancestor
102102422|NCT00829530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102102423|NCT00829530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102424|NCT00829530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102102425|NCT01377194|Milnacipran|milnacipran|mesh-list
102102426|NCT01377194|Levomilnacipran|levomilnacipran|mesh-list
102102427|NCT01377194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102102428|NCT01377194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102102429|NCT01377194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102102430|NCT01377194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102431|NCT01377194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102102432|NCT01377194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102433|NCT01377194|Antidepressive Agents|antidepressive agents|mesh-ancestor
102102434|NCT01377194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102102435|NCT01377194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102102436|NCT01377194|Analgesics|analgesics|mesh-ancestor
102102437|NCT01377194|Sensory System Agents|sensory system agents|mesh-ancestor
102102438|NCT01377194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102102439|NCT00829452|Ramipril|ramipril|mesh-list
102102440|NCT00829452|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102102441|NCT00829452|Protease Inhibitors|protease inhibitors|mesh-ancestor
102102442|NCT00829452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102102443|NCT00829452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102444|NCT00829452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102102445|NCT00747318|Fluticasone|fluticasone|mesh-list
102102447|NCT00747318|Formoterol Fumarate|formoterol fumarate|mesh-list
102102448|NCT00747318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102102449|NCT00747318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102102450|NCT00747318|Autonomic Agents|autonomic agents|mesh-ancestor
102102451|NCT00747318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102102452|NCT00747318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102453|NCT00747318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102102454|NCT00747318|Respiratory System Agents|respiratory system agents|mesh-ancestor
102102455|NCT00747318|Dermatologic Agents|dermatologic agents|mesh-ancestor
102102456|NCT00747318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102102457|NCT00747318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102102458|NCT00747318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102102459|NCT00747318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102102460|NCT00747318|Adrenergic Agents|adrenergic agents|mesh-ancestor
102102461|NCT00747318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102102462|NCT00747318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102463|NCT00744276|Danazol|danazol|mesh-list
102102464|NCT00744276|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102102465|NCT00744276|Hormone Antagonists|hormone antagonists|mesh-ancestor
102102466|NCT00744276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102102467|NCT00744276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102468|NCT03438344|Vaccines|vaccines|mesh-list
102102469|NCT03438344|Immunologic Factors|immunologic factors|mesh-ancestor
102102470|NCT03438344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102471|NCT04640402|Vaccines|vaccines|mesh-list
102102472|NCT04640402|Immunologic Factors|immunologic factors|mesh-ancestor
102102473|NCT04640402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102474|NCT03445910|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102102475|NCT03445910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102102476|NCT03445910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102477|NCT00646542|Vildagliptin|vildagliptin|mesh-list
102102478|NCT00646542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102102479|NCT00646542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102480|NCT00646542|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102102481|NCT00646542|Protease Inhibitors|protease inhibitors|mesh-ancestor
102102482|NCT00646542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102102483|NCT00646542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102484|NCT03256344|Atezolizumab|atezolizumab|mesh-list
102102485|NCT03256344|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
102102486|NCT03256344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102102487|NCT03256344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102488|NCT03256344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102102489|NCT03256344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102102490|NCT02063139|Fluticasone|fluticasone|mesh-list
102102491|NCT02063139|Beclomethasone|beclomethasone|mesh-list
102102492|NCT02063139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102102493|NCT02063139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102102494|NCT02063139|Autonomic Agents|autonomic agents|mesh-ancestor
102102495|NCT02063139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102102496|NCT02063139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102497|NCT02063139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102102498|NCT02063139|Respiratory System Agents|respiratory system agents|mesh-ancestor
102102499|NCT02063139|Dermatologic Agents|dermatologic agents|mesh-ancestor
102102500|NCT02063139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102102501|NCT02063139|Glucocorticoids|glucocorticoids|mesh-ancestor
102102502|NCT02063139|Hormones|hormones|mesh-ancestor
102102503|NCT02063139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102102504|NCT00690456|Metformin|metformin|mesh-list
102102505|NCT00690456|Rimonabant|rimonabant|mesh-list
102102506|NCT00690456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102102507|NCT00690456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102508|NCT00690456|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102102509|NCT00690456|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
102102510|NCT00690456|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102102511|NCT00690456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102102512|NCT00690456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102513|NCT00690456|Hormones|hormones|mesh-ancestor
102102514|NCT00690456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102102515|NCT01370499|Serotonin|serotonin|mesh-list
102102516|NCT01370499|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
102102517|NCT01370499|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102102518|NCT01370499|Serotonin Agents|serotonin agents|mesh-ancestor
102102519|NCT01370499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102102520|NCT01370499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102521|NCT01370499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102522|NCT01370499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102102523|NCT01370499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102102524|NCT03445286|Fluorides|fluorides|mesh-list
102102525|NCT03445286|Cariostatic Agents|cariostatic agents|mesh-ancestor
102102526|NCT03445286|Protective Agents|protective agents|mesh-ancestor
102102527|NCT03445286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102528|NCT00626106|Fulvestrant|fulvestrant|mesh-list
102102529|NCT00626106|Exemestane|exemestane|mesh-list
102102530|NCT00626106|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102102531|NCT00626106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102102532|NCT00626106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102102533|NCT00626106|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102102534|NCT00626106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102102535|NCT00626106|Hormone Antagonists|hormone antagonists|mesh-ancestor
102102536|NCT00626106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102102537|NCT00626106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102538|NCT00626106|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102102539|NCT00626106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102102540|NCT00626106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102102541|NCT00626106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102542|NCT00626106|Immunologic Factors|immunologic factors|mesh-ancestor
102102543|NCT02064465|Lamotrigine|lamotrigine|mesh-list
102102544|NCT02064465|Anticonvulsants|anticonvulsants|mesh-list
102102545|NCT02064465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102102546|NCT02064465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102102547|NCT02064465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102548|NCT02064465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102102549|NCT02064465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102550|NCT02064465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102102551|NCT02064465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102102552|NCT02064465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102102553|NCT02064465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102102554|NCT02064465|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102102555|NCT04530656|Vaccines|vaccines|mesh-list
102102556|NCT04530656|Immunologic Factors|immunologic factors|mesh-ancestor
102102557|NCT04530656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102558|NCT00690066|Remestemcel-l|remestemcel-l|mesh-list
102102559|NCT00690066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102102560|NCT00690066|Antiviral Agents|antiviral agents|mesh-ancestor
102102561|NCT00690066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102102562|NCT04509596|Capecitabine|capecitabine|mesh-list
102102563|NCT04509596|Trastuzumab|trastuzumab|mesh-list
102102564|NCT04509596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102102565|NCT04509596|Antimetabolites|antimetabolites|mesh-ancestor
102102566|NCT04509596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102567|NCT04509596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102102568|NCT04509596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102102569|NCT01370265|Adenosine|adenosine|mesh-list
102102570|NCT01370265|Regadenoson|regadenoson|mesh-list
102102571|NCT01370265|Analgesics|analgesics|mesh-ancestor
102102572|NCT01370265|Sensory System Agents|sensory system agents|mesh-ancestor
102102573|NCT01370265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102102574|NCT01370265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102575|NCT01370265|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102102576|NCT01370265|Vasodilator Agents|vasodilator agents|mesh-ancestor
102102577|NCT01370265|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102102578|NCT01370265|Purinergic Agonists|purinergic agonists|mesh-ancestor
102102579|NCT01370265|Purinergic Agents|purinergic agents|mesh-ancestor
102102580|NCT01370265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102102581|NCT01370265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102582|NCT01370265|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
102102583|NCT00734292|Fluticasone|fluticasone|mesh-list
102102584|NCT00734292|Xhance|xhance|mesh-list
102102585|NCT00734292|Formoterol Fumarate|formoterol fumarate|mesh-list
102102586|NCT00734292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102102587|NCT00734292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102102588|NCT00734292|Autonomic Agents|autonomic agents|mesh-ancestor
102102589|NCT00734292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102102590|NCT00734292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102591|NCT00734292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102102592|NCT00734292|Respiratory System Agents|respiratory system agents|mesh-ancestor
102102593|NCT00734292|Dermatologic Agents|dermatologic agents|mesh-ancestor
102102594|NCT00734292|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102102595|NCT00734292|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102102596|NCT00734292|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102102597|NCT00734292|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102102598|NCT00734292|Adrenergic Agents|adrenergic agents|mesh-ancestor
102102599|NCT00734292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102102600|NCT00734292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102601|NCT00687882|Anticoagulants|anticoagulants|mesh-list
102102602|NCT02064621|Amlodipine|amlodipine|mesh-list
102102603|NCT02064621|Candesartan|candesartan|mesh-list
102102604|NCT02064621|Candesartan cilexetil|candesartan cilexetil|mesh-list
102102605|NCT02064621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102102606|NCT02064621|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102102607|NCT02064621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102102608|NCT02064621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102609|NCT02064621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102102610|NCT02064621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102611|NCT02064621|Vasodilator Agents|vasodilator agents|mesh-ancestor
102102612|NCT02064621|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102102613|NCT02064621|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102102614|NCT00684918|Obatoclax|obatoclax|mesh-list
102102615|NCT00684918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102102616|NCT00684918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102617|NCT00726336|Tenofovir|tenofovir|mesh-list
102102618|NCT00726336|Dolutegravir|dolutegravir|mesh-list
101556026|NCT01192191|Xhance|xhance|mesh-list
102102619|NCT00726336|Antiviral Agents|antiviral agents|mesh-ancestor
102102620|NCT00726336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102102621|NCT00726336|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102102622|NCT00726336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102102623|NCT00726336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102102624|NCT00726336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102625|NCT00726336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102102626|NCT00726336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102102627|NCT00726336|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102102628|NCT00726336|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102102629|NCT02280720|Tryptophan|tryptophan|mesh-list
102102630|NCT02280720|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102102631|NCT02280720|Antidepressive Agents|antidepressive agents|mesh-ancestor
102102632|NCT02280720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102102633|NCT02068131|Capecitabine|capecitabine|mesh-list
102102634|NCT02068131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102102635|NCT02068131|Antimetabolites|antimetabolites|mesh-ancestor
102102636|NCT02068131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102637|NCT02068131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102102638|NCT02068209|Tramadol|tramadol|mesh-list
102102639|NCT02068209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102102640|NCT02068209|Narcotics|narcotics|mesh-ancestor
102102641|NCT02068209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102102642|NCT02068209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102643|NCT02068209|Analgesics|analgesics|mesh-ancestor
102102644|NCT02068209|Sensory System Agents|sensory system agents|mesh-ancestor
102102645|NCT02068209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102102646|NCT00680784|Ketoprofen|ketoprofen|mesh-list
101225596|NCT01529619|Rivastigmine|rivastigmine|mesh-list
102102647|NCT00680784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102102648|NCT00680784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102102649|NCT00680784|Analgesics|analgesics|mesh-ancestor
102102650|NCT00680784|Sensory System Agents|sensory system agents|mesh-ancestor
102102651|NCT00680784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102102652|NCT00680784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102653|NCT00680784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102102654|NCT00680784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102102655|NCT00680784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102102656|NCT00680784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102102657|NCT00680784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102658|NCT02068287|Esmolol|esmolol|mesh-list
102102659|NCT02068287|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102102660|NCT02068287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102102661|NCT02068287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102102662|NCT02068287|Adrenergic Agents|adrenergic agents|mesh-ancestor
102102663|NCT02068287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102102664|NCT02068287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102665|NCT02068287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102666|NCT02280876|Andrographolide|andrographolide|mesh-list
102102667|NCT02280876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102102668|NCT02280876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102102669|NCT02280876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102102670|NCT02280876|Analgesics|analgesics|mesh-ancestor
102102671|NCT02280876|Sensory System Agents|sensory system agents|mesh-ancestor
102102672|NCT02280876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102102673|NCT02280876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102674|NCT02280876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102102675|NCT02280876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102102676|NCT02280876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102102677|NCT02280876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102102678|NCT02280876|Antiviral Agents|antiviral agents|mesh-ancestor
102102679|NCT02280876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102102680|NCT00680472|Ketoprofen|ketoprofen|mesh-list
102102681|NCT00680472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102102682|NCT00680472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102102683|NCT00680472|Analgesics|analgesics|mesh-ancestor
102102684|NCT00680472|Sensory System Agents|sensory system agents|mesh-ancestor
102102685|NCT00680472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102102686|NCT00680472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102687|NCT00680472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102102688|NCT00680472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102102689|NCT00680472|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102102690|NCT00680472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101556051|NCT01307111|Oxytocics|oxytocics|mesh-ancestor
102102691|NCT00680472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102692|NCT03444662|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
102102693|NCT03444662|Nootropic Agents|nootropic agents|mesh-ancestor
102102694|NCT03444506|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
102102695|NCT03444506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102102696|NCT03444506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102102697|NCT03444506|Analgesics|analgesics|mesh-ancestor
102102698|NCT03444506|Sensory System Agents|sensory system agents|mesh-ancestor
102102699|NCT03444506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102102700|NCT03444506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102701|NCT03444506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102102702|NCT03444506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102102703|NCT03444506|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102102704|NCT03444506|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102102705|NCT03444506|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102102706|NCT03444506|Histamine Antagonists|histamine antagonists|mesh-ancestor
102102707|NCT03444506|Histamine Agents|histamine agents|mesh-ancestor
102102708|NCT03444506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102102709|NCT03444506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102711|NCT02065947|Epinephrine|epinephrine|mesh-list
102102712|NCT02065947|Racepinephrine|racepinephrine|mesh-list
102102713|NCT02065947|Fentanyl|fentanyl|mesh-list
102102714|NCT02065947|Midazolam|midazolam|mesh-list
102102715|NCT02065947|Ketamine|ketamine|mesh-list
102102716|NCT02065947|Bupivacaine|bupivacaine|mesh-list
102102717|NCT02065947|Propofol|propofol|mesh-list
102102718|NCT02065947|Sevoflurane|sevoflurane|mesh-list
102102719|NCT02065947|Epinephryl borate|epinephryl borate|mesh-list
102102720|NCT02065947|Atracurium|atracurium|mesh-list
102102721|NCT02065947|Anesthetics, Local|anesthetics, local|mesh-ancestor
102102722|NCT02065947|Anesthetics|anesthetics|mesh-ancestor
102102723|NCT02065947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102102724|NCT02065947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102725|NCT02065947|Sensory System Agents|sensory system agents|mesh-ancestor
102102726|NCT02065947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102102727|NCT02065947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102102728|NCT02065947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102102729|NCT02065947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102102730|NCT02065947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102102731|NCT02065947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102732|NCT02065947|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102102733|NCT02065947|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102102734|NCT02065947|Anesthetics, General|anesthetics, general|mesh-ancestor
102102735|NCT02065947|Analgesics|analgesics|mesh-ancestor
102102736|NCT02065947|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102102737|NCT02065947|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102102738|NCT02065947|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102102739|NCT02065947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102102740|NCT02065947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102102741|NCT02065947|Narcotics|narcotics|mesh-ancestor
102102742|NCT02065947|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102102743|NCT02065947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102102744|NCT02065947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102102745|NCT02065947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102102746|NCT02065947|GABA Modulators|gaba modulators|mesh-ancestor
102102747|NCT02065947|GABA Agents|gaba agents|mesh-ancestor
102102748|NCT02065947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102102749|NCT02065947|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102102750|NCT02065947|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102102751|NCT02065947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102102752|NCT02065947|Adrenergic Agents|adrenergic agents|mesh-ancestor
102102753|NCT02065947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102102754|NCT02065947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102102755|NCT02065947|Autonomic Agents|autonomic agents|mesh-ancestor
102102756|NCT02065947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102102757|NCT02065947|Respiratory System Agents|respiratory system agents|mesh-ancestor
102102758|NCT02065947|Mydriatics|mydriatics|mesh-ancestor
102102759|NCT02065947|Sympathomimetics|sympathomimetics|mesh-ancestor
102102760|NCT02065947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101556123|NCT01305941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102102761|NCT02065947|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102102762|NCT02065947|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102102763|NCT02065947|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102102764|NCT02065947|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102102765|NCT02065947|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102102766|NCT02065947|Cholinergic Agents|cholinergic agents|mesh-ancestor
102102767|NCT03436472|Dexmedetomidine|dexmedetomidine|mesh-list
102102768|NCT03436472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102102769|NCT03436472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102102770|NCT03436472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102771|NCT03436472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102102772|NCT03436472|Analgesics|analgesics|mesh-ancestor
102102773|NCT03436472|Sensory System Agents|sensory system agents|mesh-ancestor
101225622|NCT01529892|Sympathomimetics|sympathomimetics|mesh-ancestor
102102774|NCT03436472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102102775|NCT03436472|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102102776|NCT03436472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102102777|NCT03436472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102102778|NCT03436472|Adrenergic Agents|adrenergic agents|mesh-ancestor
102102779|NCT03436472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102102780|NCT03436472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102781|NCT02066103|Paclitaxel|paclitaxel|mesh-list
102102782|NCT02066103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102102783|NCT02066103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102102784|NCT02066103|Tubulin Modulators|tubulin modulators|mesh-ancestor
102102785|NCT02066103|Antimitotic Agents|antimitotic agents|mesh-ancestor
102102786|NCT02066103|Mitosis Modulators|mitosis modulators|mesh-ancestor
102102787|NCT02066103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102788|NCT04809532|Tramadol|tramadol|mesh-list
102102789|NCT04809532|Bupivacaine|bupivacaine|mesh-list
102102790|NCT04809532|Anesthetics, Local|anesthetics, local|mesh-ancestor
102102791|NCT04809532|Anesthetics|anesthetics|mesh-ancestor
102102792|NCT04809532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102102793|NCT04809532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102794|NCT04809532|Sensory System Agents|sensory system agents|mesh-ancestor
102102795|NCT04809532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102102796|NCT04809532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102102797|NCT04809532|Narcotics|narcotics|mesh-ancestor
102102798|NCT04809532|Analgesics|analgesics|mesh-ancestor
102102799|NCT04809142|Gemcitabine|gemcitabine|mesh-list
102102800|NCT04809142|Capecitabine|capecitabine|mesh-list
102102801|NCT04809142|Oxaliplatin|oxaliplatin|mesh-list
102102802|NCT04809142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102102803|NCT04809142|Antimetabolites|antimetabolites|mesh-ancestor
102102804|NCT04809142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102805|NCT04809142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102102806|NCT02064777|Tacrolimus|tacrolimus|mesh-list
102102807|NCT02064777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102102808|NCT02064777|Immunologic Factors|immunologic factors|mesh-ancestor
102102809|NCT02064777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102810|NCT02064777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102102811|NCT02064777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102102812|NCT02064777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102813|NCT02069145|Sorafenib|sorafenib|mesh-list
102102814|NCT02069145|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
102102815|NCT02069145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102102816|NCT02069145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102102817|NCT02069145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102102818|NCT02069145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102819|NCT02069145|Immunologic Factors|immunologic factors|mesh-ancestor
102102820|NCT02069145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102821|NCT04830358|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102102822|NCT04830358|Immunologic Factors|immunologic factors|mesh-ancestor
102102823|NCT04830358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102824|NCT03444272|Sofosbuvir|sofosbuvir|mesh-list
102102825|NCT03444272|Antiviral Agents|antiviral agents|mesh-ancestor
102102826|NCT03444272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102102827|NCT03347331|Befiradol|befiradol|mesh-list
102102828|NCT03347331|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102102829|NCT03347331|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102102830|NCT03347331|Serotonin Agents|serotonin agents|mesh-ancestor
102102831|NCT03347331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102102832|NCT03347331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102833|NCT03347331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102834|NCT05573373|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102102835|NCT05573373|Antineoplastic Agents|antineoplastic agents|mesh-list
102102836|NCT05573373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102102837|NCT05573373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102838|NCT03109652|Tranexamic Acid|tranexamic acid|mesh-list
102102839|NCT03109652|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102102840|NCT03109652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102102841|NCT03109652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102842|NCT03109652|Hemostatics|hemostatics|mesh-ancestor
102102843|NCT03109652|Coagulants|coagulants|mesh-ancestor
102102844|NCT02069301|Fluoxetine|fluoxetine|mesh-list
102102845|NCT02069301|Antidepressive Agents|antidepressive agents|mesh-list
102102846|NCT02069301|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102102847|NCT02069301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102102848|NCT02069301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102102849|NCT02069301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102850|NCT02069301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102102851|NCT02069301|Serotonin Agents|serotonin agents|mesh-ancestor
102102852|NCT02069301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102853|NCT02069301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102102854|NCT02069301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102102855|NCT02069301|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102102856|NCT02069301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102102857|NCT02069301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102102858|NCT03035656|Ropivacaine|ropivacaine|mesh-list
102102859|NCT03035656|Anesthetics, Local|anesthetics, local|mesh-ancestor
102102860|NCT03035656|Anesthetics|anesthetics|mesh-ancestor
102102861|NCT03035656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102102862|NCT03035656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102863|NCT03035656|Sensory System Agents|sensory system agents|mesh-ancestor
102102864|NCT03035656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102102865|NCT03443960|Amitriptyline|amitriptyline|mesh-list
102102866|NCT03443960|Cyclobenzaprine|cyclobenzaprine|mesh-list
102102867|NCT03443960|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102102868|NCT03443960|Antidepressive Agents|antidepressive agents|mesh-ancestor
102102869|NCT03443960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102102870|NCT03443960|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102102871|NCT03443960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102872|NCT03443960|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102102873|NCT03443960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102102874|NCT03443960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102102875|NCT03443960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102102876|NCT03443960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102102877|NCT03443960|Analgesics|analgesics|mesh-ancestor
102102878|NCT03443960|Sensory System Agents|sensory system agents|mesh-ancestor
102102879|NCT03443960|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102102880|NCT03443960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102102881|NCT03443960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102102882|NCT03443960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102883|NCT03443960|Adrenergic Agents|adrenergic agents|mesh-ancestor
102102884|NCT03443960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102102885|NCT05616754|Vaccines|vaccines|mesh-list
102102886|NCT05616754|Immunologic Factors|immunologic factors|mesh-ancestor
102102887|NCT05616754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102888|NCT03440996|Listerine|listerine|mesh-list
102102889|NCT03440996|Sodium Fluoride|sodium fluoride|mesh-list
102102890|NCT03440996|Cariostatic Agents|cariostatic agents|mesh-ancestor
102102891|NCT03440996|Protective Agents|protective agents|mesh-ancestor
102102892|NCT03440996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102893|NCT03440996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102102894|NCT03440996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102102895|NCT04451174|Prednisone|prednisone|mesh-list
102102896|NCT04451174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102102897|NCT04451174|Glucocorticoids|glucocorticoids|mesh-ancestor
102102898|NCT04451174|Hormones|hormones|mesh-ancestor
102102899|NCT04451174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102102900|NCT04451174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102901|NCT04451174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102102902|NCT04451174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102102903|NCT04828642|Vitamins|vitamins|mesh-list
102102904|NCT04828642|Ascorbic Acid|ascorbic acid|mesh-list
102102905|NCT04828642|Vitamin E|vitamin e|mesh-list
102102906|NCT04828642|Tocopherols|tocopherols|mesh-list
102102907|NCT04828642|Micronutrients|micronutrients|mesh-ancestor
102102908|NCT04828642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102909|NCT04828642|Antioxidants|antioxidants|mesh-ancestor
102102910|NCT04828642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102911|NCT04828642|Protective Agents|protective agents|mesh-ancestor
102102912|NCT03433352|Methimazole|methimazole|mesh-list
102102913|NCT03433352|Propylthiouracil|propylthiouracil|mesh-list
102102914|NCT03433352|Antithyroid Agents|antithyroid agents|mesh-ancestor
102102915|NCT03433352|Hormone Antagonists|hormone antagonists|mesh-ancestor
102102916|NCT03433352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102102917|NCT03433352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102918|NCT03433352|Antimetabolites|antimetabolites|mesh-ancestor
102102919|NCT03433352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102920|NCT04828564|Ribavirin|ribavirin|mesh-list
102102921|NCT04828564|Favipiravir|favipiravir|mesh-list
102102922|NCT04828564|Antimetabolites|antimetabolites|mesh-ancestor
102102923|NCT04828564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102924|NCT04828564|Antiviral Agents|antiviral agents|mesh-ancestor
102102925|NCT04828564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102102927|NCT03435302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102102928|NCT03435302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102102929|NCT03435302|Alkylating Agents|alkylating agents|mesh-ancestor
102102930|NCT03435302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102931|NCT04973150|Anesthetics|anesthetics|mesh-list
102102932|NCT04973150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102102933|NCT04973150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102934|NCT03433196|Atorvastatin|atorvastatin|mesh-list
102102935|NCT03433196|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102102936|NCT03433196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102102937|NCT03433196|Antimetabolites|antimetabolites|mesh-ancestor
102102938|NCT03433196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102939|NCT03433196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102102940|NCT03433196|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102102941|NCT03433196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102102942|NCT02792829|Lenvatinib|lenvatinib|mesh-list
102102943|NCT02792829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102102944|NCT02792829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102102945|NCT02792829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102102946|NCT02792829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102947|NCT02066571|Droxidopa|droxidopa|mesh-list
102102948|NCT02066571|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102102949|NCT02066571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102102950|NCT02066649|Carvedilol|carvedilol|mesh-list
102102951|NCT02066649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102102952|NCT02066649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102102953|NCT02066649|Adrenergic Agents|adrenergic agents|mesh-ancestor
102102954|NCT02066649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102102955|NCT02066649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102956|NCT02066649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102957|NCT02066649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102102958|NCT02066649|Antioxidants|antioxidants|mesh-ancestor
102102959|NCT02066649|Protective Agents|protective agents|mesh-ancestor
102102960|NCT02066649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102102961|NCT02066649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102102962|NCT02066649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102102963|NCT02066649|Vasodilator Agents|vasodilator agents|mesh-ancestor
102102964|NCT02066649|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102102965|NCT02066649|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102102966|NCT02070003|Analgesics, Opioid|analgesics, opioid|mesh-list
102102967|NCT02070003|Narcotics|narcotics|mesh-ancestor
102102968|NCT02070003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102102969|NCT02070003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102970|NCT02070003|Analgesics|analgesics|mesh-ancestor
102102971|NCT02070003|Sensory System Agents|sensory system agents|mesh-ancestor
102102972|NCT02070003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102102973|NCT02070159|Clopidogrel|clopidogrel|mesh-list
102102974|NCT02070159|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102102975|NCT02070159|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102102976|NCT02070159|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102102977|NCT02070159|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102102978|NCT02070159|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102102979|NCT02070159|Purinergic Agents|purinergic agents|mesh-ancestor
102102980|NCT02070159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102102981|NCT02070159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102982|NCT02070159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102983|NCT05619328|Vitamins|vitamins|mesh-list
102102984|NCT05619328|Vitamin B Complex|vitamin b complex|mesh-list
102102985|NCT05619328|Micronutrients|micronutrients|mesh-ancestor
102102986|NCT05619328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102102987|NCT05559099|Tecovirimat|tecovirimat|mesh-list
101556353|NCT05926895|Betamethasone|betamethasone|mesh-list
102102988|NCT05559099|Antiviral Agents|antiviral agents|mesh-ancestor
102102989|NCT05559099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102102990|NCT03432884|Moxifloxacin|moxifloxacin|mesh-list
102102991|NCT03432884|Zanubrutinib|zanubrutinib|mesh-list
102102992|NCT03432884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102102993|NCT03432884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102102994|NCT03432884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102102995|NCT03432884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102102996|NCT03432884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102102997|NCT03432884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102102998|NCT03432884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102102999|NCT03432884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102103000|NCT04827784|Anesthetics|anesthetics|mesh-list
102103001|NCT04827784|Anesthetics, Local|anesthetics, local|mesh-list
102103002|NCT04827784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102103003|NCT04827784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103004|NCT04827784|Sensory System Agents|sensory system agents|mesh-ancestor
102103005|NCT04827784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102103006|NCT03986996|Amoxicillin|amoxicillin|mesh-list
102103007|NCT03986996|Metronidazole|metronidazole|mesh-list
102103008|NCT03986996|Doxycycline|doxycycline|mesh-list
102103009|NCT03986996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102103010|NCT03986996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102103011|NCT03986996|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102103012|NCT03986996|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102103013|NCT03986996|Antimalarials|antimalarials|mesh-ancestor
102103014|NCT04827472|Fexuprazan|fexuprazan|mesh-list
102103015|NCT04827472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102103016|NCT04796428|Dapagliflozin|dapagliflozin|mesh-list
102103017|NCT04796428|Empagliflozin|empagliflozin|mesh-list
102103018|NCT04796428|Canagliflozin|canagliflozin|mesh-list
102103019|NCT04796428|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102103020|NCT04796428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103021|NCT04796428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102103022|NCT04796428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103023|NCT03432728|Anesthetics|anesthetics|mesh-list
102103024|NCT03432728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102103025|NCT03432728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103026|NCT04450160|Temozolomide|temozolomide|mesh-list
102103027|NCT04450160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102103028|NCT04450160|Alkylating Agents|alkylating agents|mesh-ancestor
102103029|NCT04450160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103030|NCT04450160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102103031|NCT03432572|Riboflavin|riboflavin|mesh-list
102103032|NCT03432572|Thiamine|thiamine|mesh-list
102103033|NCT03432572|Vitamin B Complex|vitamin b complex|mesh-ancestor
102103034|NCT03432572|Vitamins|vitamins|mesh-ancestor
102103035|NCT03432572|Micronutrients|micronutrients|mesh-ancestor
102103036|NCT03432572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103037|NCT03432572|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102103038|NCT03432572|Dermatologic Agents|dermatologic agents|mesh-ancestor
102103039|NCT02260323|Antirheumatic Agents|antirheumatic agents|mesh-list
102103040|NCT02805504|Bupivacaine|bupivacaine|mesh-list
102103041|NCT02805504|Anesthetics, Local|anesthetics, local|mesh-ancestor
102103042|NCT02805504|Anesthetics|anesthetics|mesh-ancestor
102103043|NCT02805504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102103044|NCT02805504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103045|NCT02805504|Sensory System Agents|sensory system agents|mesh-ancestor
102103046|NCT02805504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102103047|NCT02783508|Meperidine|meperidine|mesh-list
102103048|NCT02783508|Nitrous Oxide|nitrous oxide|mesh-list
102103049|NCT02783508|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102103050|NCT02783508|Anesthetics, General|anesthetics, general|mesh-ancestor
102103051|NCT02783508|Anesthetics|anesthetics|mesh-ancestor
102103052|NCT02783508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102103053|NCT02783508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103054|NCT02783508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102103055|NCT02783508|Analgesics|analgesics|mesh-ancestor
102103056|NCT02783508|Sensory System Agents|sensory system agents|mesh-ancestor
102103057|NCT02783508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102103058|NCT02783508|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102103059|NCT02783508|Narcotics|narcotics|mesh-ancestor
102103060|NCT02783508|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102103061|NCT02071407|Midazolam|midazolam|mesh-list
102103062|NCT02071407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102103063|NCT02071407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102103064|NCT02071407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102103065|NCT02071407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103066|NCT02071407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102103067|NCT02071407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102103068|NCT02071407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102103069|NCT02071407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102103070|NCT02071407|Anesthetics, General|anesthetics, general|mesh-ancestor
102103071|NCT02071407|Anesthetics|anesthetics|mesh-ancestor
102103072|NCT02071407|GABA Modulators|gaba modulators|mesh-ancestor
102103073|NCT02071407|GABA Agents|gaba agents|mesh-ancestor
102103074|NCT02071407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102103075|NCT02071407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103077|NCT02281266|Thymalfasin|thymalfasin|mesh-list
102103078|NCT02281266|Antiviral Agents|antiviral agents|mesh-ancestor
102103079|NCT02281266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102103080|NCT02281266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102103081|NCT02281266|Immunologic Factors|immunologic factors|mesh-ancestor
102103082|NCT02281266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103083|NCT00625326|Calcipotriene|calcipotriene|mesh-list
102103084|NCT00625326|Dermatologic Agents|dermatologic agents|mesh-ancestor
102103085|NCT03434054|Losartan|losartan|mesh-list
102103086|NCT03434054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102103087|NCT03434054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102103088|NCT03434054|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102103089|NCT03434054|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102103090|NCT03434054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103091|NCT03433976|Anesthetics|anesthetics|mesh-list
102103092|NCT03433976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102103093|NCT03433976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103094|NCT04473144|Urinastatin|urinastatin|mesh-list
102103095|NCT04473144|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102103096|NCT04473144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102103097|NCT04473144|Protease Inhibitors|protease inhibitors|mesh-ancestor
102103098|NCT04473144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102103099|NCT04473144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103100|NCT02605642|Infliximab|infliximab|mesh-list
102103101|NCT02605642|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102103102|NCT02605642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102103103|NCT02605642|Dermatologic Agents|dermatologic agents|mesh-ancestor
102103104|NCT02605642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102103105|NCT02605642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102103106|NCT00624858|Naltrexone|naltrexone|mesh-list
102103107|NCT00624858|Bupropion|bupropion|mesh-list
102103108|NCT00624858|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102103109|NCT00624858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102103110|NCT00624858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103111|NCT00624858|Sensory System Agents|sensory system agents|mesh-ancestor
102103112|NCT00624858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102103113|NCT00624858|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102103114|NCT00624858|Antidepressive Agents|antidepressive agents|mesh-ancestor
102103115|NCT00624858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102103116|NCT00624858|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102103117|NCT00624858|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102103118|NCT00624858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102103119|NCT00624858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103120|NCT00624858|Dopamine Agents|dopamine agents|mesh-ancestor
102103121|NCT00624858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102103122|NCT00624858|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102103123|NCT00624858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102103124|NCT00624858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102103125|NCT03128528|Empagliflozin|empagliflozin|mesh-list
102103126|NCT03128528|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102103127|NCT03128528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103128|NCT03128528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102103129|NCT03128528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103130|NCT02071641|Sunitinib|sunitinib|mesh-list
102103131|NCT02071641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102103132|NCT02071641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102103133|NCT02071641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102103135|NCT02071641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103136|NCT02071641|Growth Inhibitors|growth inhibitors|mesh-ancestor
102103137|NCT02071641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102103138|NCT02071641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101556510|NCT05876182|Vancomycin|vancomycin|mesh-list
102103139|NCT02071641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103140|NCT02253810|Tranexamic Acid|tranexamic acid|mesh-list
102103141|NCT02253810|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102103142|NCT02253810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102103143|NCT02253810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103144|NCT02253810|Hemostatics|hemostatics|mesh-ancestor
102103145|NCT02253810|Coagulants|coagulants|mesh-ancestor
102103146|NCT03298893|Nivolumab|nivolumab|mesh-list
102103147|NCT03298893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102103148|NCT03298893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102103149|NCT03298893|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102103150|NCT03298893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103151|NCT00673062|Pseudoephedrine|pseudoephedrine|mesh-list
102103152|NCT00673062|Ephedrine|ephedrine|mesh-list
102103153|NCT00673062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102103154|NCT00673062|Autonomic Agents|autonomic agents|mesh-ancestor
102103155|NCT00673062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102103156|NCT00673062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103157|NCT00673062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102103158|NCT00673062|Respiratory System Agents|respiratory system agents|mesh-ancestor
102103159|NCT00673062|Nasal Decongestants|nasal decongestants|mesh-ancestor
102103160|NCT00673062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102103161|NCT00673062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102103162|NCT00673062|Sympathomimetics|sympathomimetics|mesh-ancestor
102103163|NCT00673062|Adrenergic Agents|adrenergic agents|mesh-ancestor
102103164|NCT00673062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102103165|NCT00673062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103166|NCT03559803|Cisplatin|cisplatin|mesh-list
102103167|NCT03559803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102103168|NCT03439358|Magnesium Sulfate|magnesium sulfate|mesh-list
102103169|NCT03439358|Analgesics|analgesics|mesh-ancestor
102103170|NCT03439358|Sensory System Agents|sensory system agents|mesh-ancestor
102103171|NCT03439358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102103172|NCT03439358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103173|NCT03439358|Anesthetics|anesthetics|mesh-ancestor
102103174|NCT03439358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102103175|NCT03439358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102103176|NCT03439358|Anticonvulsants|anticonvulsants|mesh-ancestor
102103177|NCT03439358|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102103178|NCT03439358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102103179|NCT03439358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103180|NCT03439358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102103181|NCT03439358|Tocolytic Agents|tocolytic agents|mesh-ancestor
102103182|NCT03439358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102103183|NCT02072031|Sunitinib|sunitinib|mesh-list
101556579|NCT05690984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101556580|NCT05690984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101556581|NCT05690984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101556582|NCT05690984|Immunologic Factors|immunologic factors|mesh-ancestor
101556583|NCT05690984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101556584|NCT05690984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101556585|NCT05690984|Growth Substances|growth substances|mesh-ancestor
101556586|NCT05690984|Growth Inhibitors|growth inhibitors|mesh-ancestor
101556587|NCT05688332|Metformin|metformin|mesh-list
101556588|NCT05688332|Glyburide|glyburide|mesh-list
101556589|NCT05688332|Voglibose|voglibose|mesh-list
101556590|NCT05688332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101556591|NCT05688332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556592|NCT05688332|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101556593|NCT05688332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101556594|NCT05688332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556595|NCT05645536|Tamoxifen|tamoxifen|mesh-list
101556596|NCT05645536|Letrozole|letrozole|mesh-list
101556597|NCT05645536|Anastrozole|anastrozole|mesh-list
101556599|NCT05645536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101556600|NCT05645536|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101556601|NCT05645536|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101556602|NCT05645536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101556603|NCT05645536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556604|NCT05645536|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101556605|NCT05645536|Hormone Antagonists|hormone antagonists|mesh-ancestor
101556606|NCT05645536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102103184|NCT02072031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102103185|NCT02072031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102103186|NCT02072031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102103187|NCT02072031|Growth Substances|growth substances|mesh-ancestor
102103188|NCT02072031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103189|NCT02072031|Growth Inhibitors|growth inhibitors|mesh-ancestor
102103190|NCT02072031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102103191|NCT02072031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102103192|NCT02072031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103193|NCT05616442|Vitamin E|vitamin e|mesh-list
102103194|NCT05616442|Ketotifen|ketotifen|mesh-list
102103195|NCT05616442|Vitamins|vitamins|mesh-ancestor
102103196|NCT05616442|Micronutrients|micronutrients|mesh-ancestor
102103197|NCT05616442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103198|NCT05616442|Antioxidants|antioxidants|mesh-ancestor
102103199|NCT05616442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103200|NCT05616442|Protective Agents|protective agents|mesh-ancestor
102103201|NCT05616442|Antipruritics|antipruritics|mesh-ancestor
102103202|NCT05616442|Dermatologic Agents|dermatologic agents|mesh-ancestor
102103203|NCT05616442|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102103204|NCT05616442|Histamine Antagonists|histamine antagonists|mesh-ancestor
102103205|NCT05616442|Histamine Agents|histamine agents|mesh-ancestor
102103206|NCT05616442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102103207|NCT05616442|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102103208|NCT02065401|Magnesium Hydroxide|magnesium hydroxide|mesh-list
102103209|NCT02065401|Antacids|antacids|mesh-ancestor
102103210|NCT02065401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103211|NCT02065401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102103212|NCT00620256|Timolol|timolol|mesh-list
102103213|NCT00620256|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102103214|NCT00620256|Latanoprost|latanoprost|mesh-list
102103215|NCT00620256|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102103216|NCT00620256|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102103217|NCT00620256|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102103218|NCT00620256|Adrenergic Agents|adrenergic agents|mesh-ancestor
102103219|NCT00620256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102103220|NCT00620256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103221|NCT00620256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103222|NCT00620256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102103223|NCT00620256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102103224|NCT04805710|Rivaroxaban|rivaroxaban|mesh-list
102103225|NCT04805710|Clopidogrel|clopidogrel|mesh-list
102103226|NCT04805710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102103227|NCT04805710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102103228|NCT04805710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102103229|NCT04805710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102103230|NCT04805710|Purinergic Agents|purinergic agents|mesh-ancestor
102103231|NCT04805710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102103232|NCT04805710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103233|NCT04805710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103234|NCT04805710|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102103235|NCT04805710|Antithrombins|antithrombins|mesh-ancestor
102103236|NCT04805710|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102103237|NCT04805710|Protease Inhibitors|protease inhibitors|mesh-ancestor
102103238|NCT04805710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102103239|NCT04805710|Anticoagulants|anticoagulants|mesh-ancestor
102103240|NCT02076477|Docetaxel|docetaxel|mesh-list
102103241|NCT02076477|Pemetrexed|pemetrexed|mesh-list
102103242|NCT02076477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102103243|NCT02076477|Tubulin Modulators|tubulin modulators|mesh-ancestor
102103244|NCT02076477|Antimitotic Agents|antimitotic agents|mesh-ancestor
102103245|NCT02076477|Mitosis Modulators|mitosis modulators|mesh-ancestor
102103246|NCT02076477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509872|NCT02937363|Antioxidants|antioxidants|mesh-ancestor
102103247|NCT02076477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102103248|NCT02076477|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102103249|NCT02076477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102103250|NCT04472832|Mitapivat|mitapivat|mesh-list
102103251|NCT04472832|Enzyme Activators|enzyme activators|mesh-ancestor
102103252|NCT04472832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103253|NCT04879550|Antithrombins|antithrombins|mesh-list
102103254|NCT04879550|Antithrombin III|antithrombin iii|mesh-list
102103255|NCT04879550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101556654|NCT05589363|Bupivacaine|bupivacaine|mesh-list
102103256|NCT04879550|Protease Inhibitors|protease inhibitors|mesh-ancestor
102103257|NCT04879550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102103258|NCT04879550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103259|NCT04879550|Anticoagulants|anticoagulants|mesh-ancestor
102103260|NCT00613002|Testosterone|testosterone|mesh-list
102103261|NCT00613002|Androgens|androgens|mesh-ancestor
102103262|NCT00613002|Hormones|hormones|mesh-ancestor
102103263|NCT00613002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102103264|NCT00613002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103265|NCT02076945|Lidocaine|lidocaine|mesh-list
102103266|NCT02076945|Bupivacaine|bupivacaine|mesh-list
102103267|NCT02076945|Anesthetics, Local|anesthetics, local|mesh-ancestor
102103268|NCT02076945|Anesthetics|anesthetics|mesh-ancestor
102103269|NCT02076945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102103270|NCT02076945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103271|NCT02076945|Sensory System Agents|sensory system agents|mesh-ancestor
102103272|NCT02076945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102103273|NCT02076945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101225687|NCT01530230|Oxytocin|oxytocin|mesh-list
102103274|NCT02076945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102103275|NCT02076945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102103276|NCT02076945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102103277|NCT02076945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103278|NCT03438890|Chlorhexidine|chlorhexidine|mesh-list
102103279|NCT03438890|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102103280|NCT03438890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102103281|NCT03438890|Disinfectants|disinfectants|mesh-ancestor
102103282|NCT00668772|Tiotropium Bromide|tiotropium bromide|mesh-list
102103283|NCT00668772|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102103284|NCT00668772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102103285|NCT00668772|Autonomic Agents|autonomic agents|mesh-ancestor
102103286|NCT00668772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102103287|NCT00668772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103288|NCT00668772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102103289|NCT00668772|Respiratory System Agents|respiratory system agents|mesh-ancestor
102103290|NCT00668772|Parasympatholytics|parasympatholytics|mesh-ancestor
102103291|NCT00668772|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102103292|NCT00668772|Cholinergic Agents|cholinergic agents|mesh-ancestor
102103293|NCT00668772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102103294|NCT00668772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103295|NCT00668772|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102103296|NCT00668772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102103297|NCT00668772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102103298|NCT00668772|Adrenergic Agents|adrenergic agents|mesh-ancestor
102103299|NCT03438812|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
102103300|NCT03438812|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102103301|NCT03438812|Immunologic Factors|immunologic factors|mesh-ancestor
102103302|NCT03438812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103303|NCT02077257|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102103304|NCT02077257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102103305|NCT02077257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102103306|NCT02077257|Antimetabolites|antimetabolites|mesh-ancestor
102103307|NCT02077257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103308|NCT02077257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102103309|NCT02077257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102103310|NCT02077257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102103311|NCT02732912|Zopiclone|zopiclone|mesh-list
102103312|NCT02732912|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102103313|NCT02732912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102103314|NCT02732912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103315|NCT02792517|Erenumab|erenumab|mesh-list
102103316|NCT02792517|Norgestimate|norgestimate|mesh-list
102103317|NCT02792517|Contraceptive Agents|contraceptive agents|mesh-list
102103318|NCT02792517|Contraceptives, Oral|contraceptives, oral|mesh-list
102103320|NCT02792517|Estrogens|estrogens|mesh-ancestor
102103321|NCT02792517|Hormones|hormones|mesh-ancestor
102103322|NCT02792517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102103323|NCT02792517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103324|NCT02792517|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102103325|NCT02792517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102103326|NCT02792517|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102103327|NCT02792517|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
102103328|NCT02792517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103329|NCT02792517|Analgesics|analgesics|mesh-ancestor
102103330|NCT02792517|Sensory System Agents|sensory system agents|mesh-ancestor
102103331|NCT02792517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101556745|NCT05392946|Bortezomib|bortezomib|mesh-list
102103333|NCT03431714|Artesunate|artesunate|mesh-list
102103334|NCT03431714|Piperaquine|piperaquine|mesh-list
102103335|NCT03431714|Amodiaquine|amodiaquine|mesh-list
102103336|NCT03431714|Artenimol|artenimol|mesh-list
102103337|NCT03431714|Antimalarials|antimalarials|mesh-ancestor
102103338|NCT03431714|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102103339|NCT03431714|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102103340|NCT03431714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102103341|NCT03431714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102103342|NCT03431714|Antiviral Agents|antiviral agents|mesh-ancestor
102103343|NCT03431714|Schistosomicides|schistosomicides|mesh-ancestor
102103344|NCT03431714|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102103345|NCT03431714|Anthelmintics|anthelmintics|mesh-ancestor
102103346|NCT03433586|Aspirin|aspirin|mesh-list
102103347|NCT03433586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102103348|NCT03433586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102103349|NCT03433586|Analgesics|analgesics|mesh-ancestor
102103350|NCT03433586|Sensory System Agents|sensory system agents|mesh-ancestor
102103351|NCT03433586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102103352|NCT03433586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103353|NCT03433586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102103354|NCT03433586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102103355|NCT03433586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102103356|NCT03433586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102103357|NCT03433586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103358|NCT03433586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102103359|NCT03433586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102103360|NCT03433586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102103361|NCT03433586|Antipyretics|antipyretics|mesh-ancestor
102103362|NCT03431558|Lactoferrin|lactoferrin|mesh-list
102103363|NCT03431558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102103364|NCT02273622|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
102103365|NCT02273622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102103366|NCT02273622|Antioxidants|antioxidants|mesh-ancestor
102103367|NCT02273622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103368|NCT02273622|Protective Agents|protective agents|mesh-ancestor
102103369|NCT02273622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103370|NCT02273622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102103371|NCT02077803|Metformin|metformin|mesh-list
102103372|NCT02077803|Canagliflozin|canagliflozin|mesh-list
102103373|NCT02077803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102103374|NCT02077803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103375|NCT02077803|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102103376|NCT02077803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103377|NCT02072811|Cytarabine|cytarabine|mesh-list
102103378|NCT02072811|Daunorubicin|daunorubicin|mesh-list
102103379|NCT02072811|Mitoxantrone|mitoxantrone|mesh-list
102103380|NCT02072811|Cladribine|cladribine|mesh-list
102103381|NCT02072811|Lenograstim|lenograstim|mesh-list
102103382|NCT02072811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102103383|NCT02072811|Antimetabolites|antimetabolites|mesh-ancestor
102103384|NCT02072811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103385|NCT02072811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102103386|NCT02072811|Antiviral Agents|antiviral agents|mesh-ancestor
102103387|NCT02072811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102103388|NCT02072811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102103389|NCT02072811|Immunologic Factors|immunologic factors|mesh-ancestor
102103390|NCT02072811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103391|NCT02072811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102103393|NCT02072811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102103394|NCT02072811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102103395|NCT02072811|Analgesics|analgesics|mesh-ancestor
102103396|NCT02072811|Sensory System Agents|sensory system agents|mesh-ancestor
102103397|NCT02072811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102103398|NCT02072811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102103399|NCT02080377|Glyburide|glyburide|mesh-list
102103400|NCT02080377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102103401|NCT02080377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103402|NCT02072967|Rituximab|rituximab|mesh-list
102103403|NCT02072967|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102103404|NCT02072967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102103405|NCT02072967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101225717|NCT01530386|Lacosamide|lacosamide|mesh-list
102103406|NCT02072967|Immunologic Factors|immunologic factors|mesh-ancestor
102103407|NCT02072967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103408|NCT02072967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102103409|NCT02072967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102103410|NCT02072967|Alkylating Agents|alkylating agents|mesh-ancestor
102103411|NCT02072967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103412|NCT02073357|Anesthetics|anesthetics|mesh-list
102103413|NCT02073357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102103414|NCT02073357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103415|NCT02073669|Interferons|interferons|mesh-list
102103416|NCT02073669|Interferon-gamma|interferon-gamma|mesh-list
102103417|NCT02073669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102103418|NCT02073669|Antiviral Agents|antiviral agents|mesh-ancestor
102103419|NCT02073669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102103420|NCT03428282|Anesthetics|anesthetics|mesh-list
102103421|NCT03428282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102103422|NCT03428282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103423|NCT00463242|Agomelatine|agomelatine|mesh-list
102103424|NCT00463242|Paroxetine|paroxetine|mesh-list
102103425|NCT00463242|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102103426|NCT00463242|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102103427|NCT00463242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102103428|NCT00463242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103429|NCT00463242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102103430|NCT00463242|Serotonin Agents|serotonin agents|mesh-ancestor
102103431|NCT00463242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103432|NCT00463242|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102103433|NCT00463242|Antidepressive Agents|antidepressive agents|mesh-ancestor
102103434|NCT00463242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102103435|NCT00463242|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102103436|NCT00463242|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102103437|NCT00463242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102103438|NCT00463242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102103439|NCT00463242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102103440|NCT02074137|Prednisone|prednisone|mesh-list
102103441|NCT02074137|Prednisolone|prednisolone|mesh-list
102103442|NCT02074137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102103443|NCT02074137|Glucocorticoids|glucocorticoids|mesh-ancestor
102103444|NCT02074137|Hormones|hormones|mesh-ancestor
102103445|NCT02074137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102103446|NCT02074137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103447|NCT02074137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102103448|NCT02074137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102103449|NCT00600288|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102103450|NCT00600288|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102103451|NCT00594984|Irinotecan|irinotecan|mesh-list
102103452|NCT00594984|Cetuximab|cetuximab|mesh-list
102103453|NCT00594984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102103454|NCT00594984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102103455|NCT00594984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102103456|NCT00594984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103457|NCT00594984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102103458|NCT00594984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102103459|NCT01369485|Caffeine|caffeine|mesh-list
102103460|NCT01369485|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102103461|NCT01369485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103462|NCT01369485|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102103464|NCT01369485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103465|NCT01369485|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102103466|NCT01369485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102103467|NCT01369485|Purinergic Agents|purinergic agents|mesh-ancestor
102103468|NCT01369485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102103469|NCT03422978|Dexmedetomidine|dexmedetomidine|mesh-list
102103470|NCT03422978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102103471|NCT03422978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102103472|NCT03422978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103473|NCT03422978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102103474|NCT03422978|Analgesics|analgesics|mesh-ancestor
102103475|NCT03422978|Sensory System Agents|sensory system agents|mesh-ancestor
102103476|NCT03422978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102103477|NCT03422978|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102103478|NCT03422978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102103479|NCT03422978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102103480|NCT03422978|Adrenergic Agents|adrenergic agents|mesh-ancestor
102103481|NCT03422978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102103482|NCT03422978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103483|NCT02278692|Vitamin K|vitamin k|mesh-list
102103484|NCT02278692|Vitamins|vitamins|mesh-ancestor
102103485|NCT02278692|Micronutrients|micronutrients|mesh-ancestor
102103486|NCT02278692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103487|NCT02278692|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102103488|NCT02278692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102103489|NCT02278692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103490|NCT02278692|Hemostatics|hemostatics|mesh-ancestor
102103491|NCT02278692|Coagulants|coagulants|mesh-ancestor
102103492|NCT02281968|Naproxen|naproxen|mesh-list
102103493|NCT02281968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102103494|NCT02281968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102103495|NCT02281968|Analgesics|analgesics|mesh-ancestor
102103496|NCT02281968|Sensory System Agents|sensory system agents|mesh-ancestor
102103497|NCT02281968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102103498|NCT02281968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103499|NCT02281968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102103500|NCT02281968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102103501|NCT02281968|Gout Suppressants|gout suppressants|mesh-ancestor
102103502|NCT02281968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102103503|NCT02281968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102103504|NCT02281968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103505|NCT02080845|Theobromine|theobromine|mesh-list
102103506|NCT02080845|Caffeine|caffeine|mesh-list
102103507|NCT02080845|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102103508|NCT02080845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103509|NCT02080845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102103510|NCT02080845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102103511|NCT02080845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103512|NCT02080845|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102103513|NCT02080845|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102103514|NCT02080845|Purinergic Agents|purinergic agents|mesh-ancestor
102103515|NCT02080845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102103516|NCT02080845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102103517|NCT02080845|Autonomic Agents|autonomic agents|mesh-ancestor
102103518|NCT02080845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102103519|NCT02080845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102103520|NCT02080845|Respiratory System Agents|respiratory system agents|mesh-ancestor
102103521|NCT02080845|Vasodilator Agents|vasodilator agents|mesh-ancestor
102103522|NCT02284230|Liraglutide|liraglutide|mesh-list
102103523|NCT02284230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102103524|NCT02284230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103525|NCT02284230|Incretins|incretins|mesh-ancestor
102103526|NCT02284230|Hormones|hormones|mesh-ancestor
101225737|NCT01530490|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102103527|NCT02284230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102103528|NCT02792088|Tenofovir|tenofovir|mesh-list
102103529|NCT02792088|Antiviral Agents|antiviral agents|mesh-ancestor
102103530|NCT02792088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102103531|NCT02792088|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102103532|NCT02792088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102103533|NCT02792088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102103534|NCT02792088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103535|NCT02792088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102103536|NCT02792088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102103537|NCT02074293|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102103538|NCT02074293|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102103539|NCT02074293|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102103540|NCT02074293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102103541|NCT02074293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103542|NCT02074293|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102103543|NCT02074293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102103544|NCT02074293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103545|NCT02074293|Cholinergic Agents|cholinergic agents|mesh-ancestor
102103546|NCT02074293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102103547|NCT00451152|Hydrocortisone|hydrocortisone|mesh-list
102103548|NCT00451152|Anecortave|anecortave|mesh-list
102103549|NCT00451152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102103550|NCT00451152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102103551|NCT00451152|Growth Substances|growth substances|mesh-ancestor
101556953|NCT04706507|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101556954|NCT04706507|Antiviral Agents|antiviral agents|mesh-ancestor
101556955|NCT04706507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102103552|NCT00451152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103553|NCT00451152|Growth Inhibitors|growth inhibitors|mesh-ancestor
102103554|NCT00451152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102103555|NCT00451152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102103556|NCT02078583|Fentanyl|fentanyl|mesh-list
102103557|NCT02078583|Remifentanil|remifentanil|mesh-list
102103558|NCT02078583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102103559|NCT02078583|Narcotics|narcotics|mesh-ancestor
102103560|NCT02078583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102103561|NCT02078583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103562|NCT02078583|Analgesics|analgesics|mesh-ancestor
102103563|NCT02078583|Sensory System Agents|sensory system agents|mesh-ancestor
102103564|NCT02078583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102103565|NCT02078583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102103566|NCT02078583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102103567|NCT02078583|Anesthetics, General|anesthetics, general|mesh-ancestor
102103568|NCT02078583|Anesthetics|anesthetics|mesh-ancestor
102103569|NCT03069638|Dexmedetomidine|dexmedetomidine|mesh-list
102103570|NCT03069638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
102103571|NCT03069638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102103572|NCT03069638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103573|NCT03069638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102103574|NCT03069638|Analgesics|analgesics|mesh-ancestor
102103575|NCT03069638|Sensory System Agents|sensory system agents|mesh-ancestor
102103576|NCT03069638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102103577|NCT03069638|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102103578|NCT03069638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102103579|NCT03069638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102103580|NCT03069638|Adrenergic Agents|adrenergic agents|mesh-ancestor
102103581|NCT03069638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102103582|NCT03069638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103583|NCT02948660|Zolpidem|zolpidem|mesh-list
102103584|NCT02948660|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101225754|NCT01530542|Oxycodone|oxycodone|mesh-list
102103585|NCT02948660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102103586|NCT02948660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102103587|NCT02948660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103588|NCT02948660|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102103589|NCT02948660|GABA Agonists|gaba agonists|mesh-ancestor
102103590|NCT02948660|GABA Agents|gaba agents|mesh-ancestor
102103591|NCT02948660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102103592|NCT02948660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103593|NCT02074605|Interferons|interferons|mesh-list
102103594|NCT02074605|Interferon-alpha|interferon-alpha|mesh-list
102103595|NCT02074605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102103596|NCT02074605|Antiviral Agents|antiviral agents|mesh-ancestor
102103597|NCT02074605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102103598|NCT02074605|Immunologic Factors|immunologic factors|mesh-ancestor
102103599|NCT02074605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103600|NCT00448422|Prulifloxacin|prulifloxacin|mesh-list
102103601|NCT00448422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102103602|NCT00448422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102103603|NCT00448422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102103604|NCT00448422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102103605|NCT00448422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102103606|NCT00448422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103607|NCT00448422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102103609|NCT00583830|Carboplatin|carboplatin|mesh-list
102103610|NCT00583830|Mapatumumab|mapatumumab|mesh-list
102103611|NCT00583830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102103612|NCT00583830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102103613|NCT00583830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102103614|NCT00583830|Tubulin Modulators|tubulin modulators|mesh-ancestor
102103615|NCT00583830|Antimitotic Agents|antimitotic agents|mesh-ancestor
102103616|NCT00583830|Mitosis Modulators|mitosis modulators|mesh-ancestor
102103617|NCT00583830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103618|NCT00583830|Immunologic Factors|immunologic factors|mesh-ancestor
102103619|NCT00583830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103620|NCT03430544|Cariprazine|cariprazine|mesh-list
102103621|NCT03430544|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102103622|NCT03430544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102103623|NCT03430544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102103624|NCT03430544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103625|NCT03430544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102103626|NCT00583674|Cisplatin|cisplatin|mesh-list
101557032|NCT04339777|Busulfan|busulfan|mesh-list
102103627|NCT00583674|Capecitabine|capecitabine|mesh-list
102103628|NCT00583674|Trebananib|trebananib|mesh-list
102103629|NCT00583674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102103630|NCT00583674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102103631|NCT00583674|Antimetabolites|antimetabolites|mesh-ancestor
102103632|NCT00583674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103633|NCT00583674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102103634|NCT00583674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102103635|NCT00583674|Growth Substances|growth substances|mesh-ancestor
102103636|NCT00583674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103637|NCT00583674|Growth Inhibitors|growth inhibitors|mesh-ancestor
102103638|NCT03422510|CXA-10|cxa-10|mesh-list
102103639|NCT03422510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102103640|NCT03430466|Fulvestrant|fulvestrant|mesh-list
102103641|NCT03430466|Tremelimumab|tremelimumab|mesh-list
102103642|NCT03430466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102103643|NCT03430466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102103644|NCT03430466|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102103645|NCT03430466|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102103646|NCT03430466|Hormone Antagonists|hormone antagonists|mesh-ancestor
102103647|NCT03430466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102103648|NCT03430466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103649|NCT02280174|Linagliptin|linagliptin|mesh-list
102103650|NCT02280174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102103651|NCT02280174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103652|NCT02280174|Incretins|incretins|mesh-ancestor
102103653|NCT02280174|Hormones|hormones|mesh-ancestor
102103654|NCT02280174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102103655|NCT02280174|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102103656|NCT02280174|Protease Inhibitors|protease inhibitors|mesh-ancestor
102103657|NCT02280174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102103658|NCT02280174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103659|NCT00447564|Buprenorphine|buprenorphine|mesh-list
102103660|NCT00447564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102103661|NCT00447564|Narcotics|narcotics|mesh-ancestor
102103662|NCT00447564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102103663|NCT00447564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103664|NCT00447564|Analgesics|analgesics|mesh-ancestor
102103665|NCT00447564|Sensory System Agents|sensory system agents|mesh-ancestor
102103666|NCT00447564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102103667|NCT00447564|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102103668|NCT00576810|Picosulfate sodium|picosulfate sodium|mesh-list
102103669|NCT00576810|Cathartics|cathartics|mesh-ancestor
102103670|NCT00576810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102103671|NCT00576342|Timolol|timolol|mesh-list
102103672|NCT00576342|Dorzolamide|dorzolamide|mesh-list
102103673|NCT00576342|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102103674|NCT00576342|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102103675|NCT00576342|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102103676|NCT00576342|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102103677|NCT00576342|Adrenergic Agents|adrenergic agents|mesh-ancestor
102103678|NCT00576342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102103679|NCT00576342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103680|NCT00576342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103681|NCT00576342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102103682|NCT00576342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102103683|NCT00576342|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102103684|NCT00576342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102103685|NCT02282280|Prilocaine|prilocaine|mesh-list
102103686|NCT02282280|Anesthetics, Local|anesthetics, local|mesh-ancestor
102103687|NCT02282280|Anesthetics|anesthetics|mesh-ancestor
102103688|NCT02282280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102103689|NCT02282280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103690|NCT02282280|Sensory System Agents|sensory system agents|mesh-ancestor
102103691|NCT02282280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102103692|NCT03429998|Evolocumab|evolocumab|mesh-list
102103693|NCT03429998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102103694|NCT03429998|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102103695|NCT03429998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102103696|NCT03429998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102103697|NCT03429998|Antimetabolites|antimetabolites|mesh-ancestor
102103698|NCT03429998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103699|NCT03429998|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102103700|NCT03429998|Protease Inhibitors|protease inhibitors|mesh-ancestor
102103701|NCT03429998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102103702|NCT03429998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102103703|NCT03429998|Immunologic Factors|immunologic factors|mesh-ancestor
102103704|NCT03429998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103705|NCT00658008|Paroxetine|paroxetine|mesh-list
102103706|NCT00658008|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102103707|NCT00658008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102103708|NCT00658008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102103709|NCT00658008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103710|NCT00658008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102103711|NCT00658008|Serotonin Agents|serotonin agents|mesh-ancestor
102103712|NCT00658008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103713|NCT00658008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102103714|NCT00658008|Antidepressive Agents|antidepressive agents|mesh-ancestor
102103715|NCT00658008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102103716|NCT00658008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102103717|NCT00658008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102103718|NCT00658008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102103719|NCT03427502|Epinephrine|epinephrine|mesh-list
102103720|NCT03427502|Bupivacaine|bupivacaine|mesh-list
102103721|NCT03427502|Anesthetics, Local|anesthetics, local|mesh-ancestor
102103722|NCT03427502|Anesthetics|anesthetics|mesh-ancestor
102103723|NCT03427502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102103724|NCT03427502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103725|NCT03427502|Sensory System Agents|sensory system agents|mesh-ancestor
102103726|NCT03427502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102103727|NCT03427502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102103728|NCT03427502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102103729|NCT03427502|Adrenergic Agents|adrenergic agents|mesh-ancestor
102103730|NCT03427502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102103731|NCT03427502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103732|NCT03427502|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102103733|NCT03427502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102103734|NCT03427502|Autonomic Agents|autonomic agents|mesh-ancestor
102103735|NCT03427502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102103736|NCT03427502|Respiratory System Agents|respiratory system agents|mesh-ancestor
102103737|NCT03427502|Mydriatics|mydriatics|mesh-ancestor
102103738|NCT03427502|Sympathomimetics|sympathomimetics|mesh-ancestor
102103739|NCT03427502|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102103740|NCT00440388|Rituximab|rituximab|mesh-list
102103741|NCT00440388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102103742|NCT00440388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102103743|NCT00440388|Immunologic Factors|immunologic factors|mesh-ancestor
102103744|NCT00440388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103745|NCT00440388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102103746|NCT03422042|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102103747|NCT03422042|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102103748|NCT03422042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102103749|NCT03422042|Antitubercular Agents|antitubercular agents|mesh-ancestor
102103750|NCT04449224|Etanercept|etanercept|mesh-list
102103751|NCT04449224|Abatacept|abatacept|mesh-list
102103752|NCT04449224|Tofacitinib|tofacitinib|mesh-list
102103753|NCT04449224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102103754|NCT04449224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102103755|NCT04449224|Analgesics|analgesics|mesh-ancestor
102103756|NCT04449224|Sensory System Agents|sensory system agents|mesh-ancestor
102103757|NCT04449224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102103758|NCT04449224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103759|NCT04449224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102103760|NCT04449224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102103761|NCT04449224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102103762|NCT04449224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102103763|NCT04449224|Immunologic Factors|immunologic factors|mesh-ancestor
102103764|NCT04449224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102103765|NCT04449224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103766|NCT04449224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102103767|NCT04449224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102103768|NCT04449224|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102103769|NCT04449224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102103770|NCT04449224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102103771|NCT00437112|Insulin|insulin|mesh-list
102103772|NCT00437112|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102103773|NCT00437112|Insulin Glargine|insulin glargine|mesh-list
102103774|NCT00437112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102103775|NCT00437112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103776|NCT00434850|Gusperimus|gusperimus|mesh-list
101557179|NCT03999710|Durvalumab|durvalumab|mesh-list
102103777|NCT00434850|Sirolimus|sirolimus|mesh-list
102103778|NCT00434850|Etanercept|etanercept|mesh-list
102103779|NCT00434850|Tacrolimus|tacrolimus|mesh-list
102103780|NCT00434850|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102103781|NCT00434850|Basiliximab|basiliximab|mesh-list
102103782|NCT00434850|Daclizumab|daclizumab|mesh-list
102103783|NCT00434850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102103784|NCT00434850|Immunologic Factors|immunologic factors|mesh-ancestor
102103785|NCT00434850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103786|NCT00434850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102103787|NCT00434850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101356542|NCT00034541|Cetuximab|cetuximab|mesh-list
102103788|NCT00434850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103789|NCT00434850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102103790|NCT00434850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102103791|NCT00434850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102103792|NCT00434850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102103793|NCT00434850|Antifungal Agents|antifungal agents|mesh-ancestor
102103794|NCT00434850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102103795|NCT00434850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102103796|NCT00434850|Analgesics|analgesics|mesh-ancestor
102103797|NCT00434850|Sensory System Agents|sensory system agents|mesh-ancestor
102103798|NCT00434850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102103799|NCT00434850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102103800|NCT00434850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102103801|NCT00434850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102103802|NCT00434850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102103803|NCT00434850|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102103804|NCT00434850|Protective Agents|protective agents|mesh-ancestor
102103805|NCT04449380|Interferons|interferons|mesh-list
102103806|NCT04449380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102103807|NCT04449380|Antiviral Agents|antiviral agents|mesh-ancestor
102103808|NCT04449380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102103809|NCT03128216|Bupivacaine|bupivacaine|mesh-list
102103810|NCT03128216|Ropivacaine|ropivacaine|mesh-list
102103811|NCT03128216|Anesthetics, Local|anesthetics, local|mesh-list
102103812|NCT03128216|Anesthetics|anesthetics|mesh-list
102103813|NCT03128216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102103814|NCT03128216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103815|NCT03128216|Sensory System Agents|sensory system agents|mesh-ancestor
102103816|NCT03128216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102103817|NCT00566202|Escitalopram|escitalopram|mesh-list
102103818|NCT00566202|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102103819|NCT00566202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102103820|NCT00566202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102103821|NCT00566202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103822|NCT00566202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102103823|NCT00566202|Serotonin Agents|serotonin agents|mesh-ancestor
102103824|NCT00566202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103825|NCT02280486|Glimepiride|glimepiride|mesh-list
102103826|NCT02280486|Saxagliptin|saxagliptin|mesh-list
102103827|NCT02280486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102103828|NCT02280486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102103829|NCT02280486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103830|NCT02280486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102103831|NCT02280486|Immunologic Factors|immunologic factors|mesh-ancestor
102103832|NCT02280486|Incretins|incretins|mesh-ancestor
102103833|NCT02280486|Hormones|hormones|mesh-ancestor
102103834|NCT02280486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102103835|NCT02280486|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102103836|NCT02280486|Protease Inhibitors|protease inhibitors|mesh-ancestor
102103837|NCT02280486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102103838|NCT02280486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103839|NCT00434226|Paclitaxel|paclitaxel|mesh-list
102103840|NCT00434226|Bevacizumab|bevacizumab|mesh-list
102103841|NCT00434226|Carboplatin|carboplatin|mesh-list
102103842|NCT00434226|Sunitinib|sunitinib|mesh-list
102103843|NCT00434226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102103844|NCT00434226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102103845|NCT00434226|Tubulin Modulators|tubulin modulators|mesh-ancestor
102103846|NCT00434226|Antimitotic Agents|antimitotic agents|mesh-ancestor
102103847|NCT00434226|Mitosis Modulators|mitosis modulators|mesh-ancestor
101225787|NCT01530620|Propiverine|propiverine|mesh-list
102103848|NCT00434226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103849|NCT00434226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102103850|NCT00434226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102103851|NCT00434226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102103852|NCT00434226|Growth Substances|growth substances|mesh-ancestor
102103853|NCT00434226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103854|NCT00434226|Growth Inhibitors|growth inhibitors|mesh-ancestor
102103855|NCT00434226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102103856|NCT00434226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102103857|NCT00430950|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102103858|NCT00430950|Olmesartan|olmesartan|mesh-list
102103859|NCT00430950|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
102103860|NCT00430950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102103861|NCT00430950|Diuretics|diuretics|mesh-ancestor
102103862|NCT00430950|Natriuretic Agents|natriuretic agents|mesh-ancestor
102103863|NCT00430950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103864|NCT00430950|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102103865|NCT00430950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102103866|NCT00430950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103867|NCT00430950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102103868|NCT00430950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102103869|NCT00549744|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
102103870|NCT00549744|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102103871|NCT00549744|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102103872|NCT00549744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102103873|NCT00549744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103875|NCT02081391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102103876|NCT02081391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102103877|NCT02081391|Narcotics|narcotics|mesh-ancestor
102103878|NCT02081391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102103879|NCT02081391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103880|NCT02081391|Analgesics|analgesics|mesh-ancestor
102103881|NCT02081391|Sensory System Agents|sensory system agents|mesh-ancestor
102103882|NCT02081391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102103883|NCT02081391|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102103884|NCT02081391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102103885|NCT02081391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102103886|NCT02081391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103887|NCT02081391|Adrenergic Agents|adrenergic agents|mesh-ancestor
102103888|NCT02081391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102103889|NCT00549510|Lisinopril|lisinopril|mesh-list
102103890|NCT00549510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102103891|NCT00549510|Protease Inhibitors|protease inhibitors|mesh-ancestor
102103892|NCT00549510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102103893|NCT00549510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103894|NCT00549510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102103895|NCT00549510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102103896|NCT00549510|Protective Agents|protective agents|mesh-ancestor
102103897|NCT00549510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103898|NCT00430092|Fluprednisolone|fluprednisolone|mesh-list
102103899|NCT00430092|Difluprednate|difluprednate|mesh-list
102103900|NCT00430092|Glucocorticoids|glucocorticoids|mesh-ancestor
102103901|NCT00430092|Hormones|hormones|mesh-ancestor
102103902|NCT00430092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102103903|NCT00430092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103904|NCT00430092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102103905|NCT00427440|Rilotumumab|rilotumumab|mesh-list
102103906|NCT00427440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102103907|NCT00427440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102103908|NCT00427440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102103909|NCT00427440|Immunologic Factors|immunologic factors|mesh-ancestor
102103910|NCT00427440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103911|NCT00650832|Darunavir|darunavir|mesh-list
102103912|NCT00650832|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102103913|NCT00650832|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102103914|NCT00650832|Protease Inhibitors|protease inhibitors|mesh-ancestor
102103915|NCT00650832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102103916|NCT00650832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103917|NCT00650832|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102103918|NCT00650832|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102103919|NCT00650832|Antiviral Agents|antiviral agents|mesh-ancestor
102103920|NCT00650832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102103921|NCT00425100|Fesoterodine|fesoterodine|mesh-list
102103922|NCT00425100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102103923|NCT00425100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102103924|NCT00425100|Cholinergic Agents|cholinergic agents|mesh-ancestor
102103925|NCT00425100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102103926|NCT00425100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103927|NCT00425100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103928|NCT00425100|Urological Agents|urological agents|mesh-ancestor
102103929|NCT00546780|Bortezomib|bortezomib|mesh-list
102103930|NCT00546780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102103931|NCT00420888|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102103932|NCT00420888|Naptumomab estafenatox|naptumomab estafenatox|mesh-list
102103933|NCT00420888|Immunoconjugates|immunoconjugates|mesh-list
102103934|NCT00420888|Immunologic Factors|immunologic factors|mesh-ancestor
102103935|NCT00420888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103936|NCT00543582|Azacitidine|azacitidine|mesh-list
102103937|NCT00543582|Mocetinostat|mocetinostat|mesh-list
102103938|NCT00543582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102103939|NCT00543582|Antimetabolites|antimetabolites|mesh-ancestor
102103940|NCT00543582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103941|NCT00543582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102103942|NCT00543582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102103943|NCT00543582|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102103944|NCT00542724|Insulin|insulin|mesh-list
102103945|NCT00542724|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102103946|NCT00542724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102103947|NCT00542724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103949|NCT00412932|Olmesartan|olmesartan|mesh-list
102103950|NCT00412932|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
102103951|NCT00412932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102103952|NCT00412932|Diuretics|diuretics|mesh-ancestor
102103953|NCT00412932|Natriuretic Agents|natriuretic agents|mesh-ancestor
102103954|NCT00412932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103955|NCT00412932|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102103956|NCT00412932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102103957|NCT00412932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103958|NCT00412932|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102103959|NCT00412932|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102103960|NCT00411528|Prednisone|prednisone|mesh-list
102103961|NCT00411528|Docetaxel|docetaxel|mesh-list
102103962|NCT00411528|Epothilone B|epothilone b|mesh-list
102103963|NCT00411528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102103964|NCT00411528|Tubulin Modulators|tubulin modulators|mesh-ancestor
102103965|NCT00411528|Antimitotic Agents|antimitotic agents|mesh-ancestor
102103966|NCT00411528|Mitosis Modulators|mitosis modulators|mesh-ancestor
102103967|NCT00411528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103968|NCT00411528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102103969|NCT00411528|Glucocorticoids|glucocorticoids|mesh-ancestor
102103970|NCT00411528|Hormones|hormones|mesh-ancestor
102103971|NCT00411528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102103972|NCT00411528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103973|NCT00411528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102103974|NCT00384150|Galiximab|galiximab|mesh-list
102103975|NCT00384150|Rituximab|rituximab|mesh-list
102103976|NCT00384150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102103977|NCT00384150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102103978|NCT00384150|Immunologic Factors|immunologic factors|mesh-ancestor
102103979|NCT00384150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103980|NCT00384150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102103981|NCT00384150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102103982|NCT00532038|Ketoprofen|ketoprofen|mesh-list
102103983|NCT00532038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102103984|NCT00532038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102103985|NCT00532038|Analgesics|analgesics|mesh-ancestor
102103986|NCT00532038|Sensory System Agents|sensory system agents|mesh-ancestor
102103987|NCT00532038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102103988|NCT00532038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102103989|NCT00532038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102103990|NCT00532038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102103991|NCT00532038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102103992|NCT00532038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102103993|NCT00532038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102103994|NCT00403416|Mycophenolic Acid|mycophenolic acid|mesh-list
102103995|NCT00403416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102103996|NCT00403416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102103997|NCT00403416|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102103998|NCT00403416|Antitubercular Agents|antitubercular agents|mesh-ancestor
102103999|NCT00403416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102104000|NCT00403416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102104001|NCT00403416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102104002|NCT00403416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104003|NCT00401388|Allopurinol|allopurinol|mesh-list
102104004|NCT00401388|Antiemetics|antiemetics|mesh-list
102104005|NCT00401388|Loperamide|loperamide|mesh-list
102104006|NCT00401388|Antidiarrheals|antidiarrheals|mesh-list
102104007|NCT00401388|Antimetabolites|antimetabolites|mesh-ancestor
102104008|NCT00401388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104009|NCT00401388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102104010|NCT00401388|Gout Suppressants|gout suppressants|mesh-ancestor
102104011|NCT00401388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102104012|NCT00401388|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102104013|NCT00401388|Antioxidants|antioxidants|mesh-ancestor
102104014|NCT00401388|Protective Agents|protective agents|mesh-ancestor
102104015|NCT00401388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104016|NCT00401388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102104017|NCT00401388|Autonomic Agents|autonomic agents|mesh-ancestor
102104018|NCT00401388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102104019|NCT02282826|Acyclovir|acyclovir|mesh-list
102104021|NCT02282826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102104022|NCT00374166|Paroxetine|paroxetine|mesh-list
102104023|NCT00374166|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102104024|NCT00374166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102104025|NCT00374166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102104026|NCT00374166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104027|NCT00374166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102104028|NCT00374166|Serotonin Agents|serotonin agents|mesh-ancestor
102104029|NCT00374166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104030|NCT00374166|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102104031|NCT00374166|Antidepressive Agents|antidepressive agents|mesh-ancestor
102104032|NCT00374166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102104033|NCT00374166|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102104034|NCT00374166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102104035|NCT00374166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102104036|NCT03559413|Imiquimod|imiquimod|mesh-list
102104037|NCT03559413|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102104038|NCT03559413|Immunologic Factors|immunologic factors|mesh-ancestor
102104039|NCT03559413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104040|NCT03559413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102104041|NCT03559413|Interferon Inducers|interferon inducers|mesh-ancestor
102104042|NCT02078895|Botulinum Toxins|botulinum toxins|mesh-list
102104043|NCT02078895|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102104044|NCT02078895|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102104045|NCT02078895|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102104046|NCT02078895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102104047|NCT02078895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104048|NCT02078895|Cholinergic Agents|cholinergic agents|mesh-ancestor
102104049|NCT02078895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102104050|NCT02078895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104051|NCT02078895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102104052|NCT02078895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102104053|NCT02078973|Tolvaptan|tolvaptan|mesh-list
102104054|NCT02078973|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102104055|NCT02078973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104056|NCT02078973|Natriuretic Agents|natriuretic agents|mesh-ancestor
102104057|NCT02078973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104058|NCT00397254|Rizatriptan|rizatriptan|mesh-list
102104059|NCT00397254|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102104060|NCT00397254|Serotonin Agents|serotonin agents|mesh-ancestor
102104061|NCT00397254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102104062|NCT00397254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104063|NCT00397254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104064|NCT01369641|Sodium thiosulfate|sodium thiosulfate|mesh-list
102104065|NCT01369641|Cisplatin|cisplatin|mesh-list
102104066|NCT01369641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102104067|NCT01369641|Antidotes|antidotes|mesh-ancestor
102104068|NCT01369641|Protective Agents|protective agents|mesh-ancestor
102104069|NCT01369641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104070|NCT01369641|Antioxidants|antioxidants|mesh-ancestor
102104071|NCT01369641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104072|NCT01369641|Antitubercular Agents|antitubercular agents|mesh-ancestor
102104073|NCT01369641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102104074|NCT01369641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102104075|NCT01369641|Chelating Agents|chelating agents|mesh-ancestor
102104076|NCT01369641|Sequestering Agents|sequestering agents|mesh-ancestor
102104077|NCT02283060|Tenofovir|tenofovir|mesh-list
102104078|NCT02283060|Emtricitabine|emtricitabine|mesh-list
102104079|NCT02283060|Efavirenz|efavirenz|mesh-list
102104080|NCT02283060|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102104081|NCT02283060|Cobicistat|cobicistat|mesh-list
102104082|NCT02283060|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101953858|NCT01305837|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101953859|NCT01305837|Prednisolone|prednisolone|mesh-list
102104083|NCT02283060|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102104084|NCT02283060|Elvitegravir|elvitegravir|mesh-list
102104085|NCT02283060|Antiviral Agents|antiviral agents|mesh-ancestor
102104086|NCT02283060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102104087|NCT02283060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102104088|NCT02283060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102104089|NCT02283060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102104090|NCT02283060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104091|NCT02283060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102104092|NCT02283060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102104093|NCT02283060|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102104094|NCT02283060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102104095|NCT02283060|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102104096|NCT02283060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102104097|NCT02283060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102104098|NCT02283060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102104099|NCT02283060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101225838|NCT01531049|Varenicline|varenicline|mesh-list
102104100|NCT02283060|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102104101|NCT03559725|Menthol|menthol|mesh-list
102104102|NCT03559725|Nicotine|nicotine|mesh-list
102104103|NCT03559725|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102104104|NCT03559725|Autonomic Agents|autonomic agents|mesh-ancestor
102104105|NCT03559725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102104106|NCT03559725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104107|NCT03559725|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102104108|NCT03559725|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102104109|NCT03559725|Cholinergic Agents|cholinergic agents|mesh-ancestor
102104110|NCT03559725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102104111|NCT03559725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104112|NCT03559725|Antipruritics|antipruritics|mesh-ancestor
102104113|NCT03559725|Dermatologic Agents|dermatologic agents|mesh-ancestor
102104114|NCT00529152|Deferiprone|deferiprone|mesh-list
102104115|NCT00529152|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102104116|NCT00529152|Chelating Agents|chelating agents|mesh-ancestor
102104117|NCT00529152|Sequestering Agents|sequestering agents|mesh-ancestor
102104118|NCT00529152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104119|NCT00525330|Metformin|metformin|mesh-list
102104120|NCT00525330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102104121|NCT00525330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104122|NCT02287272|Cimetidine|cimetidine|mesh-list
102104123|NCT02287272|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102104124|NCT02287272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102104125|NCT02287272|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102104126|NCT02287272|Histamine Antagonists|histamine antagonists|mesh-ancestor
102104127|NCT02287272|Histamine Agents|histamine agents|mesh-ancestor
102104128|NCT02287272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102104129|NCT02287272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104130|NCT02287272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104131|NCT02287272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102104132|NCT02287272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102104133|NCT02287272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102104134|NCT00392574|Prulifloxacin|prulifloxacin|mesh-list
102104135|NCT00392574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102104136|NCT00392574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102104137|NCT00392574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102104138|NCT00392574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102104139|NCT00392574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102104140|NCT00392574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104141|NCT00392574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102104142|NCT04470414|Antibodies|antibodies|mesh-list
102104143|NCT04470414|Immunoglobulin G|immunoglobulin g|mesh-list
102104144|NCT04470414|Immunologic Factors|immunologic factors|mesh-ancestor
102104145|NCT04470414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557629|NCT02332668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102104146|NCT00363636|Galiximab|galiximab|mesh-list
102104147|NCT00363636|Rituximab|rituximab|mesh-list
102104148|NCT00363636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102104149|NCT00363636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102104150|NCT00363636|Immunologic Factors|immunologic factors|mesh-ancestor
102104151|NCT00363636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104152|NCT00363636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102104153|NCT00363636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102104154|NCT02605174|Lasmiditan|lasmiditan|mesh-list
102104155|NCT02605174|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102104156|NCT02605174|Serotonin Agents|serotonin agents|mesh-ancestor
102104157|NCT02605174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102104158|NCT02605174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104159|NCT02605174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104160|NCT00522834|Paclitaxel|paclitaxel|mesh-list
102104161|NCT00522834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102104162|NCT00522834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102104163|NCT00522834|Tubulin Modulators|tubulin modulators|mesh-ancestor
102104164|NCT00522834|Antimitotic Agents|antimitotic agents|mesh-ancestor
102104165|NCT00522834|Mitosis Modulators|mitosis modulators|mesh-ancestor
102104166|NCT00522834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104167|NCT02075619|Amlodipine|amlodipine|mesh-list
102104168|NCT02075619|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102104169|NCT02075619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102104170|NCT02075619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102104171|NCT02075619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102104172|NCT02075619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104173|NCT02075619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102104174|NCT02075619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104175|NCT02075619|Vasodilator Agents|vasodilator agents|mesh-ancestor
102104176|NCT02075619|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102104177|NCT02075619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102104178|NCT02075619|Antimetabolites|antimetabolites|mesh-ancestor
102104179|NCT02075619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102104180|NCT02075619|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102104181|NCT02075619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102104182|NCT00358878|Satavaptan|satavaptan|mesh-list
102104183|NCT00358878|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102104184|NCT00358878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104185|NCT00358878|Natriuretic Agents|natriuretic agents|mesh-ancestor
102104186|NCT00358878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104187|NCT02283372|Paclitaxel|paclitaxel|mesh-list
102104188|NCT02283372|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102104189|NCT02283372|Gemcitabine|gemcitabine|mesh-list
102104190|NCT02283372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102104191|NCT02283372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102104192|NCT02283372|Tubulin Modulators|tubulin modulators|mesh-ancestor
102104193|NCT02283372|Antimitotic Agents|antimitotic agents|mesh-ancestor
102104194|NCT02283372|Mitosis Modulators|mitosis modulators|mesh-ancestor
101953886|NCT03790605|Sensory System Agents|sensory system agents|mesh-ancestor
102104195|NCT02283372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104196|NCT02283372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101557630|NCT02332668|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101557631|NCT02332668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557632|NCT02213328|Tenofovir|tenofovir|mesh-list
101557633|NCT02213328|Emtricitabine|emtricitabine|mesh-list
101557634|NCT02213328|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101557635|NCT02213328|Antiviral Agents|antiviral agents|mesh-ancestor
101557636|NCT02213328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101557637|NCT02213328|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101557638|NCT02213328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101557639|NCT02213328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101557640|NCT02213328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557641|NCT02213328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101557642|NCT02213328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101557643|NCT02204241|Dexamethasone|dexamethasone|mesh-list
101557644|NCT02204241|Cyclophosphamide|cyclophosphamide|mesh-list
101557645|NCT02204241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101557646|NCT02204241|Immunologic Factors|immunologic factors|mesh-ancestor
101557647|NCT02204241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557648|NCT02204241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101557649|NCT02204241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102104197|NCT02283372|Antimetabolites|antimetabolites|mesh-ancestor
102104198|NCT00507936|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102104199|NCT00507936|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102104200|NCT00507936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102104201|NCT00507936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102104202|NCT00507936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104203|NCT00507936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102104204|NCT00507936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104205|NCT00507936|Analgesics|analgesics|mesh-ancestor
102104206|NCT00507936|Sensory System Agents|sensory system agents|mesh-ancestor
102104207|NCT00507936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102104208|NCT00507936|Antidepressive Agents|antidepressive agents|mesh-ancestor
102104209|NCT00507936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102104210|NCT00507936|Dopamine Agents|dopamine agents|mesh-ancestor
102104211|NCT04427020|Caseins|caseins|mesh-list
102104212|NCT04427020|Chelating Agents|chelating agents|mesh-ancestor
102104213|NCT04427020|Sequestering Agents|sequestering agents|mesh-ancestor
102104214|NCT04427020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104215|NCT02083575|Vitamins|vitamins|mesh-list
102104216|NCT02083575|Ascorbic Acid|ascorbic acid|mesh-list
102104217|NCT02083575|Deferiprone|deferiprone|mesh-list
102104218|NCT02083575|Micronutrients|micronutrients|mesh-ancestor
102104219|NCT02083575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104220|NCT02083575|Antioxidants|antioxidants|mesh-ancestor
102104221|NCT02083575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104222|NCT02083575|Protective Agents|protective agents|mesh-ancestor
102104223|NCT02083575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102104224|NCT02083575|Chelating Agents|chelating agents|mesh-ancestor
102104225|NCT02083575|Sequestering Agents|sequestering agents|mesh-ancestor
102104226|NCT02286258|Calcium, Dietary|calcium, dietary|mesh-list
102104227|NCT02286258|Edetic Acid|edetic acid|mesh-list
102104228|NCT02286258|Calcium|calcium|mesh-list
102104229|NCT02286258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102104230|NCT02286258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104231|NCT02286258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102104232|NCT02286258|Chelating Agents|chelating agents|mesh-ancestor
102104233|NCT02286258|Sequestering Agents|sequestering agents|mesh-ancestor
102104234|NCT02286258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104235|NCT02286258|Anticoagulants|anticoagulants|mesh-ancestor
102104236|NCT02286258|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102104237|NCT02088411|Diclofenac|diclofenac|mesh-list
102104238|NCT02088411|Wobenzym|wobenzym|mesh-list
102104239|NCT02088411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102104240|NCT02088411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102104241|NCT02088411|Analgesics|analgesics|mesh-ancestor
102104242|NCT02088411|Sensory System Agents|sensory system agents|mesh-ancestor
102104243|NCT02088411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102104244|NCT02088411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101953901|NCT01306851|Hemostatics|hemostatics|mesh-ancestor
102104245|NCT02088411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102104246|NCT02088411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102104247|NCT02088411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102104248|NCT02088411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102104249|NCT02088411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104250|NCT02088411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102104251|NCT02088411|Immunologic Factors|immunologic factors|mesh-ancestor
102104252|NCT02082327|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
102104253|NCT02082327|Antiviral Agents|antiviral agents|mesh-ancestor
102104254|NCT02082327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102104255|NCT02082327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102104256|NCT02082327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104257|NCT02604550|Naproxen|naproxen|mesh-list
102104258|NCT02604550|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
102104259|NCT02604550|Ropivacaine|ropivacaine|mesh-list
102104260|NCT02604550|Anesthetics, Local|anesthetics, local|mesh-ancestor
102104261|NCT02604550|Anesthetics|anesthetics|mesh-ancestor
102104262|NCT02604550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102104263|NCT02604550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225873|NCT01531192|Nystatin|nystatin|mesh-list
102104264|NCT02604550|Sensory System Agents|sensory system agents|mesh-ancestor
102104265|NCT02604550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102104266|NCT02604550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102104267|NCT02604550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102104268|NCT02604550|Analgesics|analgesics|mesh-ancestor
102104269|NCT02604550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102104270|NCT02604550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102104271|NCT02604550|Gout Suppressants|gout suppressants|mesh-ancestor
102104272|NCT02604550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102104273|NCT02604550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102104274|NCT02604550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104275|NCT02604550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102104277|NCT02084043|Amikacin|amikacin|mesh-list
102104278|NCT02084043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102104279|NCT02084043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102104280|NCT03530670|Midazolam|midazolam|mesh-list
102104281|NCT03530670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102104282|NCT03530670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102104283|NCT03530670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102104284|NCT03530670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104285|NCT03530670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102104286|NCT03530670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102104287|NCT03530670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102104288|NCT03530670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102104289|NCT03530670|Anesthetics, General|anesthetics, general|mesh-ancestor
102104290|NCT03530670|Anesthetics|anesthetics|mesh-ancestor
102104291|NCT03530670|GABA Modulators|gaba modulators|mesh-ancestor
102104292|NCT03530670|GABA Agents|gaba agents|mesh-ancestor
102104293|NCT03530670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102104294|NCT03530670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104295|NCT00120042|Misoprostol|misoprostol|mesh-list
102104296|NCT00120042|Oxytocin|oxytocin|mesh-list
102104297|NCT00120042|Oxytocics|oxytocics|mesh-ancestor
102104298|NCT00120042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102104299|NCT00120042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104300|NCT00120042|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102104301|NCT00120042|Abortifacient Agents|abortifacient agents|mesh-ancestor
102104302|NCT00120042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102104303|NCT00120042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102104304|NCT02084355|Fentanyl|fentanyl|mesh-list
102104305|NCT02084355|Oxycodone|oxycodone|mesh-list
102104306|NCT02084355|Hydromorphone|hydromorphone|mesh-list
102104307|NCT02084355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102104308|NCT02084355|Narcotics|narcotics|mesh-ancestor
102104309|NCT02084355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102104310|NCT02084355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104311|NCT02084355|Analgesics|analgesics|mesh-ancestor
102104312|NCT02084355|Sensory System Agents|sensory system agents|mesh-ancestor
102104313|NCT02084355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102104314|NCT02084355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102104315|NCT02084355|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102104316|NCT02084355|Anesthetics, General|anesthetics, general|mesh-ancestor
102104317|NCT02084355|Anesthetics|anesthetics|mesh-ancestor
102104318|NCT00353574|Darusentan|darusentan|mesh-list
102104319|NCT00353574|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102104320|NCT00353574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104322|NCT02082405|Cyclophosphamide|cyclophosphamide|mesh-list
102104323|NCT02082405|Bortezomib|bortezomib|mesh-list
102104324|NCT02082405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102104325|NCT02082405|Immunologic Factors|immunologic factors|mesh-ancestor
102104326|NCT02082405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104327|NCT02082405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102104328|NCT02082405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102104329|NCT02082405|Alkylating Agents|alkylating agents|mesh-ancestor
102104330|NCT02082405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104331|NCT02082405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102104332|NCT02082405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102104333|NCT02082405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102104334|NCT02082405|Antiemetics|antiemetics|mesh-ancestor
102104335|NCT02082405|Autonomic Agents|autonomic agents|mesh-ancestor
102104336|NCT02082405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102104337|NCT02082405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102104338|NCT02082405|Glucocorticoids|glucocorticoids|mesh-ancestor
102104339|NCT02082405|Hormones|hormones|mesh-ancestor
102104340|NCT02082405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102104341|NCT02082405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102104342|NCT04428268|Chloroquine|chloroquine|mesh-list
102104343|NCT04428268|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
102104344|NCT04428268|Losartan|losartan|mesh-list
102104345|NCT04428268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102104346|NCT04428268|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101557781|NCT01864109|Etoposide|etoposide|mesh-list
102104347|NCT04428268|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102104348|NCT04428268|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102104349|NCT04428268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104350|NCT04428268|Amebicides|amebicides|mesh-ancestor
102104351|NCT04428268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102104352|NCT04428268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102104353|NCT04428268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102104354|NCT04428268|Antimalarials|antimalarials|mesh-ancestor
102104355|NCT04428268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102104356|NCT04428268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102104357|NCT04428268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102104358|NCT04428268|Analgesics|analgesics|mesh-ancestor
102104359|NCT04428268|Sensory System Agents|sensory system agents|mesh-ancestor
102104360|NCT04428268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102104361|NCT04428268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104362|NCT04428268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102104363|NCT04428268|Filaricides|filaricides|mesh-ancestor
102104364|NCT04428268|Antinematodal Agents|antinematodal agents|mesh-ancestor
102104365|NCT04428268|Anthelmintics|anthelmintics|mesh-ancestor
102104366|NCT02084433|Anesthetics|anesthetics|mesh-list
102104367|NCT02084433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102104368|NCT02084433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104369|NCT04427098|Enoxaparin|enoxaparin|mesh-list
102104370|NCT04427098|Enoxaparin sodium|enoxaparin sodium|mesh-list
102104371|NCT04427098|Anticoagulants|anticoagulants|mesh-ancestor
102104372|NCT04427098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102104373|NCT04427098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102104374|NCT04427098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104375|NCT00352560|Irbesartan|irbesartan|mesh-list
102104376|NCT00352560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102104377|NCT00352560|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102104378|NCT00352560|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102104379|NCT00352560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104380|NCT00115050|Darunavir|darunavir|mesh-list
102104381|NCT00115050|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102104382|NCT00115050|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102104383|NCT00115050|Protease Inhibitors|protease inhibitors|mesh-ancestor
102104384|NCT00115050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102104385|NCT00115050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104386|NCT00115050|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102104387|NCT00115050|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102104388|NCT00115050|Antiviral Agents|antiviral agents|mesh-ancestor
102104389|NCT00115050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102104390|NCT05616364|Dexmedetomidine|dexmedetomidine|mesh-list
102104391|NCT05616364|Tramadol|tramadol|mesh-list
102104392|NCT05616364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102104393|NCT05616364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102104394|NCT05616364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104395|NCT05616364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102104396|NCT05616364|Analgesics|analgesics|mesh-ancestor
102104397|NCT05616364|Sensory System Agents|sensory system agents|mesh-ancestor
101225889|NCT01531244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102104398|NCT05616364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102104399|NCT05616364|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102104400|NCT05616364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102104401|NCT05616364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102104402|NCT05616364|Adrenergic Agents|adrenergic agents|mesh-ancestor
102104403|NCT05616364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102104404|NCT05616364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104405|NCT05616364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102104406|NCT05616364|Narcotics|narcotics|mesh-ancestor
102104408|NCT00345618|Enoxaparin|enoxaparin|mesh-list
102104409|NCT00345618|Warfarin|warfarin|mesh-list
102104410|NCT00345618|Idraparinux|idraparinux|mesh-list
102104411|NCT00345618|Idrabiotaparinux|idrabiotaparinux|mesh-list
102104412|NCT00345618|Anticoagulants|anticoagulants|mesh-ancestor
102104413|NCT00345618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102104414|NCT00345618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102104415|NCT00345618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104416|NCT00345618|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102104417|NCT00345618|Antithrombins|antithrombins|mesh-ancestor
102104418|NCT00345618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102104419|NCT00345618|Protease Inhibitors|protease inhibitors|mesh-ancestor
102104420|NCT00345618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102104421|NCT00345618|Vitamin B Complex|vitamin b complex|mesh-ancestor
102104422|NCT00345618|Vitamins|vitamins|mesh-ancestor
102104423|NCT00345618|Micronutrients|micronutrients|mesh-ancestor
102104424|NCT00345618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104425|NCT03611868|Pembrolizumab|pembrolizumab|mesh-list
102104426|NCT03611868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102104427|NCT03611868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102104428|NCT03611868|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102104429|NCT03611868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104431|NCT00116298|Efavirenz|efavirenz|mesh-list
102104432|NCT00116298|Stavudine|stavudine|mesh-list
102104433|NCT00116298|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102104434|NCT00116298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102104435|NCT00116298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102104436|NCT00116298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104437|NCT00116298|Antiviral Agents|antiviral agents|mesh-ancestor
102104438|NCT00116298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102104439|NCT00116298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102104440|NCT00116298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102104441|NCT00116298|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102104442|NCT00116298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102104443|NCT00116298|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102104444|NCT00116298|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102104445|NCT00116298|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102104446|NCT00116298|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102104447|NCT00116298|Antimetabolites|antimetabolites|mesh-ancestor
102104448|NCT01866111|Cenobamate|cenobamate|mesh-list
102104449|NCT01866111|Anticonvulsants|anticonvulsants|mesh-ancestor
102104450|NCT02084589|Fentanyl|fentanyl|mesh-list
102104451|NCT02084589|Ropivacaine|ropivacaine|mesh-list
102104452|NCT02084589|Anesthetics, Local|anesthetics, local|mesh-ancestor
102104453|NCT02084589|Anesthetics|anesthetics|mesh-ancestor
102104454|NCT02084589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102104455|NCT02084589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104456|NCT02084589|Sensory System Agents|sensory system agents|mesh-ancestor
102104457|NCT02084589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102104458|NCT02084589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102104459|NCT02084589|Narcotics|narcotics|mesh-ancestor
102104460|NCT02084589|Analgesics|analgesics|mesh-ancestor
102104461|NCT02084589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102104462|NCT02084589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102104463|NCT02084589|Anesthetics, General|anesthetics, general|mesh-ancestor
102104464|NCT03557853|Golimumab|golimumab|mesh-list
102104465|NCT03557853|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102104466|NCT03557853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102104467|NCT03557853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102104468|NCT03557853|Immunologic Factors|immunologic factors|mesh-ancestor
102104469|NCT03557853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104470|NCT04346290|Dexmedetomidine|dexmedetomidine|mesh-list
102104471|NCT04346290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102104472|NCT04346290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102104473|NCT04346290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104474|NCT04346290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102104475|NCT04346290|Analgesics|analgesics|mesh-ancestor
102104476|NCT04346290|Sensory System Agents|sensory system agents|mesh-ancestor
102104477|NCT04346290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102104478|NCT04346290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102104479|NCT04346290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102104480|NCT04346290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102104481|NCT04346290|Adrenergic Agents|adrenergic agents|mesh-ancestor
102104482|NCT04346290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102104483|NCT04346290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104484|NCT04426552|Dexmedetomidine|dexmedetomidine|mesh-list
102104485|NCT04426552|Sevoflurane|sevoflurane|mesh-list
102104486|NCT04426552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102104487|NCT04426552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102104488|NCT04426552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104489|NCT04426552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102104490|NCT04426552|Analgesics|analgesics|mesh-ancestor
102104491|NCT04426552|Sensory System Agents|sensory system agents|mesh-ancestor
102104492|NCT04426552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102104493|NCT04426552|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102104494|NCT04426552|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102104495|NCT04426552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102104496|NCT04426552|Adrenergic Agents|adrenergic agents|mesh-ancestor
102104497|NCT04426552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102104498|NCT04426552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104499|NCT04426552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102104500|NCT04426552|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102104501|NCT04426552|Anesthetics, General|anesthetics, general|mesh-ancestor
102104502|NCT04426552|Anesthetics|anesthetics|mesh-ancestor
102104503|NCT04803370|Antibodies|antibodies|mesh-list
102104504|NCT04803370|Immunologic Factors|immunologic factors|mesh-ancestor
102104505|NCT04803370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104506|NCT01369329|Ustekinumab|ustekinumab|mesh-list
102104507|NCT01369329|Dermatologic Agents|dermatologic agents|mesh-ancestor
102104508|NCT04802980|Paclitaxel|paclitaxel|mesh-list
102104509|NCT04802980|Carboplatin|carboplatin|mesh-list
102104510|NCT04802980|Gemcitabine|gemcitabine|mesh-list
102104511|NCT04802980|Capecitabine|capecitabine|mesh-list
102104512|NCT04802980|Oxaliplatin|oxaliplatin|mesh-list
102104513|NCT04802980|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102104514|NCT04802980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102104515|NCT04802980|Tubulin Modulators|tubulin modulators|mesh-ancestor
102104516|NCT04802980|Antimitotic Agents|antimitotic agents|mesh-ancestor
102104517|NCT04802980|Mitosis Modulators|mitosis modulators|mesh-ancestor
102104518|NCT04802980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104519|NCT04802980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102104520|NCT04802980|Antimetabolites|antimetabolites|mesh-ancestor
102104521|NCT02088645|Cholecystokinin|cholecystokinin|mesh-list
102104522|NCT02088645|Gastrins|gastrins|mesh-list
102104523|NCT02088645|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102104524|NCT02088645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102104525|NCT02088645|Hormones|hormones|mesh-ancestor
102104526|NCT02088645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102104527|NCT02088645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104528|NCT03558477|Esomeprazole|esomeprazole|mesh-list
102104529|NCT03558477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102104530|NCT03558477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101225908|NCT01531361|Sorafenib|sorafenib|mesh-list
102104531|NCT03558477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102104532|NCT03558477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102104533|NCT03558477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104535|NCT04792840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102104536|NCT04792840|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102104537|NCT04792840|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102104538|NCT04792840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102104539|NCT04792840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104540|NCT04792840|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102104541|NCT04792840|Hormone Antagonists|hormone antagonists|mesh-ancestor
102104542|NCT04792840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102104543|NCT04792840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104544|NCT02085213|Nitroglycerin|nitroglycerin|mesh-list
102104545|NCT02085213|Vasodilator Agents|vasodilator agents|mesh-ancestor
102104546|NCT02088801|Pyrithione zinc|pyrithione zinc|mesh-list
102104547|NCT02088801|Keratolytic Agents|keratolytic agents|mesh-ancestor
102104548|NCT02088801|Dermatologic Agents|dermatologic agents|mesh-ancestor
102104549|NCT02085291|Norepinephrine|norepinephrine|mesh-list
102104550|NCT02085291|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102104551|NCT02085291|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102104552|NCT02085291|Adrenergic Agents|adrenergic agents|mesh-ancestor
102104553|NCT02085291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102104554|NCT02085291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104555|NCT02085291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104556|NCT02085291|Sympathomimetics|sympathomimetics|mesh-ancestor
102104557|NCT02085291|Autonomic Agents|autonomic agents|mesh-ancestor
102104558|NCT02085291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102104559|NCT02085291|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102104560|NCT04792138|Phenobarbital|phenobarbital|mesh-list
102104561|NCT04792138|Anticonvulsants|anticonvulsants|mesh-ancestor
102104562|NCT04792138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102104563|NCT04792138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102104564|NCT04792138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104565|NCT04792138|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102104566|NCT04792138|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102104567|NCT04792138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102104568|NCT04792138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104569|NCT04792138|GABA Modulators|gaba modulators|mesh-ancestor
102104570|NCT04792138|GABA Agents|gaba agents|mesh-ancestor
102104571|NCT04792138|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102104572|NCT04792138|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102104573|NCT04792138|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102104574|NCT04802122|Propofol|propofol|mesh-list
102104575|NCT04802122|Sevoflurane|sevoflurane|mesh-list
102104576|NCT04802122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102104577|NCT04802122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102104578|NCT04802122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104579|NCT04802122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102104580|NCT04802122|Anesthetics, General|anesthetics, general|mesh-ancestor
102104581|NCT04802122|Anesthetics|anesthetics|mesh-ancestor
102104582|NCT04802122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102104583|NCT04802122|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102104584|NCT04784728|Lidocaine|lidocaine|mesh-list
102104585|NCT04784728|Anesthetics, Local|anesthetics, local|mesh-ancestor
102104586|NCT04784728|Anesthetics|anesthetics|mesh-ancestor
102104587|NCT04784728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102104588|NCT04784728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104589|NCT04784728|Sensory System Agents|sensory system agents|mesh-ancestor
102104590|NCT04784728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102104591|NCT04784728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102104592|NCT04784728|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102104593|NCT04784728|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102104594|NCT04784728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102104595|NCT04784728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104596|NCT02085603|Saracatinib|saracatinib|mesh-list
102104597|NCT02085603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102104598|NCT02085603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102104599|NCT02085603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104601|NCT02090829|Oxytocics|oxytocics|mesh-ancestor
102104602|NCT02090829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102104603|NCT02090829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104604|NCT04801888|Vaccines|vaccines|mesh-list
102104605|NCT04801888|Immunologic Factors|immunologic factors|mesh-ancestor
102104606|NCT04801888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104607|NCT02089503|Ranibizumab|ranibizumab|mesh-list
102104608|NCT02089503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102104609|NCT02089503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102104610|NCT02089503|Growth Substances|growth substances|mesh-ancestor
102104611|NCT02089503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104612|NCT02089503|Growth Inhibitors|growth inhibitors|mesh-ancestor
102104613|NCT02089503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102104614|NCT02091063|Ricolinostat|ricolinostat|mesh-list
102104615|NCT02091063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102104616|NCT02091063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102104617|NCT02091063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102104618|NCT02091063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104619|NCT02091219|Vitamin D|vitamin d|mesh-list
102104620|NCT02091219|Cholecalciferol|cholecalciferol|mesh-list
102104621|NCT02091219|Calcifediol|calcifediol|mesh-list
102104622|NCT02091219|Vitamins|vitamins|mesh-ancestor
102104623|NCT02091219|Micronutrients|micronutrients|mesh-ancestor
102104624|NCT02091219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104625|NCT02091219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102104626|NCT02091219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102104627|NCT02091297|Acetaminophen|acetaminophen|mesh-list
102104628|NCT02091297|Morphine|morphine|mesh-list
102104629|NCT02091297|Ropivacaine|ropivacaine|mesh-list
102104630|NCT02091297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102104631|NCT02091297|Narcotics|narcotics|mesh-ancestor
102104632|NCT02091297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102104633|NCT02091297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104634|NCT02091297|Analgesics|analgesics|mesh-ancestor
102104635|NCT02091297|Sensory System Agents|sensory system agents|mesh-ancestor
102104636|NCT02091297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102104637|NCT02091297|Anesthetics, Local|anesthetics, local|mesh-ancestor
102104638|NCT02091297|Anesthetics|anesthetics|mesh-ancestor
102104639|NCT02091297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102104640|NCT02091297|Antipyretics|antipyretics|mesh-ancestor
102104641|NCT04791202|Methylprednisolone|methylprednisolone|mesh-list
102104642|NCT04791202|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102104643|NCT04791202|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102104644|NCT04791202|Prednisolone|prednisolone|mesh-list
102104645|NCT04791202|Prednisolone acetate|prednisolone acetate|mesh-list
102104646|NCT04791202|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102104647|NCT04791202|Prednisolone phosphate|prednisolone phosphate|mesh-list
102104648|NCT04791202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102104649|NCT04791202|Antiemetics|antiemetics|mesh-ancestor
101836452|NCT00309244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104650|NCT04791202|Autonomic Agents|autonomic agents|mesh-ancestor
102104651|NCT04791202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102104652|NCT04791202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104653|NCT04791202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102104654|NCT04791202|Glucocorticoids|glucocorticoids|mesh-ancestor
102104655|NCT04791202|Hormones|hormones|mesh-ancestor
102104656|NCT04791202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101225934|NCT01531595|Irinotecan|irinotecan|mesh-list
102104657|NCT04791202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102104658|NCT04791202|Protective Agents|protective agents|mesh-ancestor
102104659|NCT04791202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102104660|NCT04791202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102104661|NCT04801342|Memantine|memantine|mesh-list
102104662|NCT04801342|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102104663|NCT04801342|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102104664|NCT04801342|Dopamine Agents|dopamine agents|mesh-ancestor
102104665|NCT04801342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102104666|NCT04801342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104667|NCT04801342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104668|NCT04801342|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102104669|NCT04801342|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102104671|NCT04801264|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
102104672|NCT04801264|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102104673|NCT04801264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104674|NCT02590588|Idelalisib|idelalisib|mesh-list
102104675|NCT02590588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102104676|NCT02590588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102104677|NCT02590588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104678|NCT02086227|Glucagon|glucagon|mesh-list
102104679|NCT02086227|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102104680|NCT02086227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102104681|NCT02086227|Hormones|hormones|mesh-ancestor
102104682|NCT02086227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102104683|NCT02086227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104684|NCT02086227|Incretins|incretins|mesh-ancestor
102104685|NCT02086929|Trazodone|trazodone|mesh-list
102104686|NCT02086929|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102104687|NCT02086929|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102104688|NCT02086929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102104689|NCT02086929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102104690|NCT02086929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104691|NCT02086929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102104692|NCT02086929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104693|NCT02086929|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102104694|NCT02086929|Antidepressive Agents|antidepressive agents|mesh-ancestor
102104695|NCT02086929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102104696|NCT02086929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102104697|NCT02086929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102104698|NCT02086929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102104699|NCT02086929|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102104700|NCT02086929|Serotonin Agents|serotonin agents|mesh-ancestor
102104701|NCT02249013|Paclitaxel|paclitaxel|mesh-list
102104702|NCT02249013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102104703|NCT02249013|Carboplatin|carboplatin|mesh-list
102104704|NCT02249013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102104705|NCT02249013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102104706|NCT02249013|Tubulin Modulators|tubulin modulators|mesh-ancestor
102104707|NCT02249013|Antimitotic Agents|antimitotic agents|mesh-ancestor
102104708|NCT02249013|Mitosis Modulators|mitosis modulators|mesh-ancestor
102104709|NCT02249013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104710|NCT02249871|Omeprazole|omeprazole|mesh-list
102104711|NCT02249871|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102104712|NCT02249871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102104713|NCT02249871|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102104714|NCT02249871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102104715|NCT02249871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104716|NCT02087007|Cilostazol|cilostazol|mesh-list
102104717|NCT02087007|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102104718|NCT02087007|Autonomic Agents|autonomic agents|mesh-ancestor
102104719|NCT02087007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102104720|NCT02087007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225944|NCT01531595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102104721|NCT02087007|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102104723|NCT02087007|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102104724|NCT02087007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102104725|NCT02087007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104726|NCT02087007|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102104727|NCT02087007|Vasodilator Agents|vasodilator agents|mesh-ancestor
102104728|NCT02087007|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102104729|NCT02087007|Protective Agents|protective agents|mesh-ancestor
102104730|NCT02087007|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102104731|NCT02087007|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102104732|NCT02087007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102104733|NCT01434602|Everolimus|everolimus|mesh-list
102104734|NCT01434602|Sorafenib|sorafenib|mesh-list
102104735|NCT01434602|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102104736|NCT01434602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102104737|NCT01434602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102104738|NCT01434602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104739|NCT01434602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102104740|NCT01434602|Immunologic Factors|immunologic factors|mesh-ancestor
101953932|NCT03790293|Rituximab|rituximab|mesh-list
102104741|NCT01434602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104742|NCT01434602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102104743|NCT02087475|Fluorouracil|fluorouracil|mesh-list
102104744|NCT02087475|Irinotecan|irinotecan|mesh-list
102104745|NCT02087475|Antimetabolites|antimetabolites|mesh-ancestor
102104746|NCT02087475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104747|NCT02087475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102104748|NCT02087475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102104749|NCT02087475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102104750|NCT02087475|Immunologic Factors|immunologic factors|mesh-ancestor
102104751|NCT02087475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104752|NCT02087475|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102104753|NCT02087475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102104754|NCT02087475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102104755|NCT05486949|Itraconazole|itraconazole|mesh-list
102104756|NCT05486949|Carbamazepine|carbamazepine|mesh-list
102104757|NCT05486949|Antifungal Agents|antifungal agents|mesh-ancestor
102104758|NCT05486949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102104759|NCT05486949|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102104760|NCT05486949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102104761|NCT05486949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102104762|NCT05486949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104763|NCT05486949|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102104764|NCT05486949|Hormone Antagonists|hormone antagonists|mesh-ancestor
102104765|NCT05486949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102104766|NCT05486949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104767|NCT05486949|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102104768|NCT05486949|Anticonvulsants|anticonvulsants|mesh-ancestor
102104769|NCT05486949|Antimanic Agents|antimanic agents|mesh-ancestor
102104770|NCT05486949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102104771|NCT05486949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102104772|NCT05486949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102104773|NCT05486949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102104774|NCT05486949|Analgesics|analgesics|mesh-ancestor
102104775|NCT05486949|Sensory System Agents|sensory system agents|mesh-ancestor
102104776|NCT05486949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102104777|NCT05486949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102104778|NCT05486949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102104779|NCT05486949|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102104780|NCT05486949|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102104781|NCT03558243|Hemostatics|hemostatics|mesh-list
102104782|NCT03558243|Coagulants|coagulants|mesh-ancestor
102104783|NCT03426956|Canagliflozin|canagliflozin|mesh-list
102104784|NCT03426956|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102104785|NCT03426956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104786|NCT03426956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102104787|NCT03426956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104788|NCT03557229|Vitamins|vitamins|mesh-list
102104789|NCT03557229|Vitamin E|vitamin e|mesh-list
102104790|NCT03557229|Acetylcysteine|acetylcysteine|mesh-list
102104791|NCT03557229|Melatonin|melatonin|mesh-list
102104792|NCT03557229|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102104793|NCT03557229|Micronutrients|micronutrients|mesh-ancestor
102104794|NCT03557229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104795|NCT03557229|Antioxidants|antioxidants|mesh-ancestor
102104796|NCT03557229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104797|NCT03557229|Protective Agents|protective agents|mesh-ancestor
102104798|NCT03557229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102104799|NCT03557229|Antiviral Agents|antiviral agents|mesh-ancestor
102104800|NCT03557229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102104802|NCT03557229|Respiratory System Agents|respiratory system agents|mesh-ancestor
102104803|NCT03557229|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102104804|NCT03557229|Antidotes|antidotes|mesh-ancestor
102104805|NCT02087631|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102104806|NCT02087631|Antidepressive Agents|antidepressive agents|mesh-ancestor
102104807|NCT02087631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102104808|NCT02087631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102104809|NCT02087631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102104810|NCT02087631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102104811|NCT02087631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104812|NCT00940940|Vaccines|vaccines|mesh-list
102104813|NCT00940940|Immunologic Factors|immunologic factors|mesh-ancestor
102104814|NCT00940940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104815|NCT03557840|Temocillin|temocillin|mesh-list
102104816|NCT03557840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102104817|NCT03557840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102104818|NCT02092701|Cholecalciferol|cholecalciferol|mesh-list
102104819|NCT02092701|Vitamin D|vitamin d|mesh-list
102104820|NCT02092701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102104821|NCT02092701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104822|NCT02092701|Vitamins|vitamins|mesh-ancestor
102104823|NCT02092701|Micronutrients|micronutrients|mesh-ancestor
102104824|NCT02092701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102104825|NCT01767129|Quinidine|quinidine|mesh-list
102104826|NCT01767129|Dextromethorphan|dextromethorphan|mesh-list
102104827|NCT01767129|Antitussive Agents|antitussive agents|mesh-ancestor
102104828|NCT01767129|Respiratory System Agents|respiratory system agents|mesh-ancestor
102104829|NCT01767129|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102104830|NCT01767129|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102104831|NCT01767129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102104832|NCT01767129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104833|NCT01767129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104834|NCT01767129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102104835|NCT01767129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102104836|NCT01767129|Adrenergic Agents|adrenergic agents|mesh-ancestor
102104837|NCT01767129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102104838|NCT01767129|Antimalarials|antimalarials|mesh-ancestor
102104839|NCT01767129|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102104840|NCT01767129|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102104841|NCT01767129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102104842|NCT01767129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102104843|NCT01767129|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102104844|NCT01767129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102104845|NCT01767129|Cholinergic Agents|cholinergic agents|mesh-ancestor
102104846|NCT01767129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102104847|NCT01767129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102104848|NCT01767129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102104849|NCT01767129|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102104850|NCT01767129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102104851|NCT01309191|Minoxidil|minoxidil|mesh-list
102104852|NCT01309191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102104853|NCT01309191|Vasodilator Agents|vasodilator agents|mesh-ancestor
102104854|NCT03420638|Epinephrine|epinephrine|mesh-list
102104855|NCT03420638|Bupivacaine|bupivacaine|mesh-list
102104856|NCT03420638|Anesthetics, Local|anesthetics, local|mesh-ancestor
102104857|NCT03420638|Anesthetics|anesthetics|mesh-ancestor
102104858|NCT03420638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102104859|NCT03420638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104860|NCT03420638|Sensory System Agents|sensory system agents|mesh-ancestor
102104861|NCT03420638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102104862|NCT03420638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102104863|NCT03420638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102104864|NCT03420638|Adrenergic Agents|adrenergic agents|mesh-ancestor
102104865|NCT03420638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102104866|NCT03420638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104867|NCT03420638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102104868|NCT03420638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102104869|NCT03420638|Autonomic Agents|autonomic agents|mesh-ancestor
102104870|NCT03420638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102104871|NCT03420638|Respiratory System Agents|respiratory system agents|mesh-ancestor
102104872|NCT03420638|Mydriatics|mydriatics|mesh-ancestor
102104873|NCT03420638|Sympathomimetics|sympathomimetics|mesh-ancestor
102104874|NCT03420638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102104875|NCT00715988|Methadone|methadone|mesh-list
102104876|NCT00715988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102104877|NCT00715988|Narcotics|narcotics|mesh-ancestor
102104878|NCT00715988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102104879|NCT00715988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104880|NCT00715988|Analgesics|analgesics|mesh-ancestor
102104881|NCT00715988|Sensory System Agents|sensory system agents|mesh-ancestor
102104882|NCT00715988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102104883|NCT00715988|Antitussive Agents|antitussive agents|mesh-ancestor
102104884|NCT00715988|Respiratory System Agents|respiratory system agents|mesh-ancestor
102104885|NCT02093091|Vitremer|vitremer|mesh-list
102104886|NCT02093091|Cariostatic Agents|cariostatic agents|mesh-ancestor
102104887|NCT02093091|Protective Agents|protective agents|mesh-ancestor
102104888|NCT02093091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104889|NCT02791269|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102104890|NCT02791269|Antiviral Agents|antiviral agents|mesh-ancestor
102104891|NCT02791269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102104892|NCT03556917|Caffeine|caffeine|mesh-list
102104893|NCT03556917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102104894|NCT03556917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104895|NCT03556917|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102104896|NCT03556917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102104897|NCT03556917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104898|NCT03556917|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102104899|NCT03556917|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102104900|NCT03556917|Purinergic Agents|purinergic agents|mesh-ancestor
102104901|NCT03556917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102104902|NCT02090439|Silodosin|silodosin|mesh-list
102104903|NCT02090439|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102104904|NCT02090439|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102104905|NCT02090439|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102104906|NCT02090439|Adrenergic Agents|adrenergic agents|mesh-ancestor
102104907|NCT02090439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102104908|NCT02090439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104909|NCT02090439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104910|NCT02090439|Urological Agents|urological agents|mesh-ancestor
102104911|NCT02696564|Losartan|losartan|mesh-list
102104912|NCT02696564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102104913|NCT02696564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102104914|NCT02696564|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102104915|NCT02696564|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102104916|NCT02696564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104917|NCT02093403|Decitabine|decitabine|mesh-list
102104918|NCT02093403|Azacitidine|azacitidine|mesh-list
102104919|NCT02093403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101225970|NCT01531764|Vinorelbine|vinorelbine|mesh-list
102104920|NCT02093403|Antimetabolites|antimetabolites|mesh-ancestor
102104921|NCT02093403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104922|NCT02093403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102104923|NCT02093403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102104924|NCT03426176|Oxytocin|oxytocin|mesh-list
102104925|NCT03426176|Oxytocics|oxytocics|mesh-ancestor
102104926|NCT03426176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102104927|NCT03426176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104928|NCT02095899|Rufinamide|rufinamide|mesh-list
102104929|NCT02095899|Anticonvulsants|anticonvulsants|mesh-ancestor
102104930|NCT02095899|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102104931|NCT02095899|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102104932|NCT02095899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102104933|NCT02095899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104934|NCT03525002|Bromocriptine|bromocriptine|mesh-list
102104935|NCT03525002|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102104936|NCT03525002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102104937|NCT03525002|Hormone Antagonists|hormone antagonists|mesh-ancestor
102104938|NCT03525002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102104939|NCT03525002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104940|NCT03525002|Dopamine Agonists|dopamine agonists|mesh-ancestor
102104941|NCT03525002|Dopamine Agents|dopamine agents|mesh-ancestor
102104942|NCT03525002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102104943|NCT03525002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104944|NCT03426020|Midazolam|midazolam|mesh-list
102104945|NCT03426020|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102104946|NCT03426020|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102104947|NCT03426020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102104948|NCT03426020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104949|NCT03426020|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102104950|NCT03426020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102104951|NCT03426020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102104952|NCT03426020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102104953|NCT03426020|Anesthetics, General|anesthetics, general|mesh-ancestor
102104954|NCT03426020|Anesthetics|anesthetics|mesh-ancestor
102104955|NCT03426020|GABA Modulators|gaba modulators|mesh-ancestor
102104956|NCT03426020|GABA Agents|gaba agents|mesh-ancestor
102104957|NCT03426020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102104958|NCT03426020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104959|NCT03428906|Oxytocin|oxytocin|mesh-list
102104960|NCT03428906|Oxytocics|oxytocics|mesh-ancestor
102104961|NCT03428906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102104962|NCT03428906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104963|NCT02521298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102104964|NCT02521298|Methylprednisolone|methylprednisolone|mesh-list
102104965|NCT02521298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102104966|NCT02521298|Prednisolone|prednisolone|mesh-list
102104967|NCT02521298|Prednisolone acetate|prednisolone acetate|mesh-list
102104968|NCT02521298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102104969|NCT02521298|Prednisolone phosphate|prednisolone phosphate|mesh-list
102104970|NCT02521298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102104971|NCT02521298|Antiemetics|antiemetics|mesh-ancestor
102104972|NCT02521298|Autonomic Agents|autonomic agents|mesh-ancestor
102104973|NCT02521298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102104974|NCT02521298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104975|NCT02521298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102104976|NCT02521298|Glucocorticoids|glucocorticoids|mesh-ancestor
102104977|NCT02521298|Hormones|hormones|mesh-ancestor
102104978|NCT02521298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102104979|NCT02521298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102104980|NCT02521298|Protective Agents|protective agents|mesh-ancestor
102104981|NCT02521298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102104982|NCT02521298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102104983|NCT00389870|Cyclosporine|cyclosporine|mesh-list
102104984|NCT00389870|Irinotecan|irinotecan|mesh-list
102104985|NCT00389870|Panitumumab|panitumumab|mesh-list
102104986|NCT00389870|Cyclosporins|cyclosporins|mesh-list
102104987|NCT00389870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102104988|NCT00389870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102104989|NCT00389870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102104990|NCT00389870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102104991|NCT00389870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102104992|NCT00389870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102104993|NCT00389870|Immunologic Factors|immunologic factors|mesh-ancestor
102104994|NCT00389870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102104995|NCT00389870|Antifungal Agents|antifungal agents|mesh-ancestor
102104996|NCT00389870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102104997|NCT00389870|Dermatologic Agents|dermatologic agents|mesh-ancestor
102104998|NCT00389870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102104999|NCT00389870|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102105000|NCT00389870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102105001|NCT03419858|Naloxone|naloxone|mesh-list
102105002|NCT03419858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102105003|NCT03419858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105004|NCT03419858|Sensory System Agents|sensory system agents|mesh-ancestor
102105005|NCT03419858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102105006|NCT03417206|Remifentanil|remifentanil|mesh-list
102105007|NCT03417206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102105008|NCT03417206|Narcotics|narcotics|mesh-ancestor
102105009|NCT03417206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102105010|NCT03417206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105011|NCT03417206|Analgesics|analgesics|mesh-ancestor
102105012|NCT03417206|Sensory System Agents|sensory system agents|mesh-ancestor
102105013|NCT03417206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102105014|NCT00003716|Rituximab|rituximab|mesh-list
102105015|NCT00003716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102105016|NCT00003716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102105017|NCT00003716|Immunologic Factors|immunologic factors|mesh-ancestor
102105018|NCT00003716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558468|NCT01177293|Amlodipine|amlodipine|mesh-list
102105019|NCT00003716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102105020|NCT02593786|Nivolumab|nivolumab|mesh-list
102105021|NCT02593786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102105022|NCT02593786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102105023|NCT02593786|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101953947|NCT05694585|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102105024|NCT02593786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105026|NCT03425708|Gout Suppressants|gout suppressants|mesh-ancestor
102105027|NCT03425708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102105028|NCT03425552|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102105029|NCT03425552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102105030|NCT03425552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102105031|NCT03425552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102105032|NCT03425552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105033|NCT03425552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102105034|NCT03425552|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102105035|NCT03425552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102105036|NCT03425552|Serotonin Agents|serotonin agents|mesh-ancestor
102105037|NCT03425552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102105038|NCT03425552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105039|NCT03425552|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102105040|NCT03425552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102105041|NCT03425552|Dopamine Agents|dopamine agents|mesh-ancestor
102105042|NCT04791046|Antihypertensive Agents|antihypertensive agents|mesh-list
102105043|NCT03425474|Propofol|propofol|mesh-list
102105044|NCT03425474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102105045|NCT03425474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102105046|NCT03425474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105047|NCT03425474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102105048|NCT03425474|Anesthetics, General|anesthetics, general|mesh-ancestor
102105049|NCT03425474|Anesthetics|anesthetics|mesh-ancestor
102105050|NCT03419624|Metformin|metformin|mesh-list
102105051|NCT03419624|Dapagliflozin|dapagliflozin|mesh-list
102105052|NCT03419624|Exenatide|exenatide|mesh-list
102105053|NCT03419624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102105054|NCT03419624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105055|NCT03419624|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102105056|NCT03419624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105057|NCT03419624|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102105058|NCT03419624|Incretins|incretins|mesh-ancestor
102105059|NCT03419624|Hormones|hormones|mesh-ancestor
102105060|NCT03419624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102105061|NCT02096055|Idarubicin|idarubicin|mesh-list
102105062|NCT02096055|Cladribine|cladribine|mesh-list
102105063|NCT02096055|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
102105064|NCT02096055|Guadecitabine|guadecitabine|mesh-list
102105065|NCT02096055|Azacitidine|azacitidine|mesh-list
102105066|NCT02096055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102105067|NCT02096055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102105068|NCT02096055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102105069|NCT02096055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102105070|NCT02096055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102105071|NCT02096055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105072|NCT02096055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102105073|NCT02096055|Immunologic Factors|immunologic factors|mesh-ancestor
102105074|NCT02096055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105075|NCT02096055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102105076|NCT02096055|Antimetabolites|antimetabolites|mesh-ancestor
102105077|NCT03425162|Morphine|morphine|mesh-list
102105078|NCT03425162|Bupivacaine|bupivacaine|mesh-list
102105079|NCT03425162|Anesthetics, Local|anesthetics, local|mesh-ancestor
102105080|NCT03425162|Anesthetics|anesthetics|mesh-ancestor
102105081|NCT03425162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102105082|NCT03425162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105083|NCT03425162|Sensory System Agents|sensory system agents|mesh-ancestor
102105084|NCT03425162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102105085|NCT03425162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102105086|NCT03425162|Narcotics|narcotics|mesh-ancestor
102105087|NCT03425162|Analgesics|analgesics|mesh-ancestor
102105088|NCT02096133|Cholecalciferol|cholecalciferol|mesh-list
102105089|NCT02096133|Vitamin D|vitamin d|mesh-list
102105090|NCT02096133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102105091|NCT02096133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105092|NCT02096133|Vitamins|vitamins|mesh-ancestor
102105093|NCT02096133|Micronutrients|micronutrients|mesh-ancestor
102105094|NCT02096133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102105095|NCT02096289|Thioridazine|thioridazine|mesh-list
102105096|NCT02096289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102105097|NCT02096289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102105098|NCT02096289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102105099|NCT02096289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105100|NCT02096289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102105101|NCT02096289|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102105102|NCT02096289|Dopamine Agents|dopamine agents|mesh-ancestor
102105103|NCT02096289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102105104|NCT02096289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105105|NCT02090673|Exenatide|exenatide|mesh-list
102105106|NCT02090673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102105107|NCT02090673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105108|NCT02090673|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102105109|NCT02090673|Incretins|incretins|mesh-ancestor
102105110|NCT02090673|Hormones|hormones|mesh-ancestor
102105111|NCT02090673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102105112|NCT03556371|Acetylcysteine|acetylcysteine|mesh-list
102105113|NCT03556371|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102105114|NCT03556371|Antiviral Agents|antiviral agents|mesh-ancestor
102105115|NCT03556371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102105116|NCT03556371|Expectorants|expectorants|mesh-ancestor
102105117|NCT03556371|Respiratory System Agents|respiratory system agents|mesh-ancestor
102105118|NCT03556371|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102105119|NCT03556371|Antioxidants|antioxidants|mesh-ancestor
102105120|NCT03556371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105121|NCT03556371|Protective Agents|protective agents|mesh-ancestor
102105122|NCT03556371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105123|NCT03556371|Antidotes|antidotes|mesh-ancestor
102105124|NCT02827526|Ketamine|ketamine|mesh-list
102105125|NCT02827526|Analgesics|analgesics|mesh-ancestor
102105126|NCT02827526|Sensory System Agents|sensory system agents|mesh-ancestor
102105127|NCT02827526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102105128|NCT02827526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105129|NCT02827526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102105130|NCT02827526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102105131|NCT02827526|Anesthetics, General|anesthetics, general|mesh-ancestor
102105132|NCT02827526|Anesthetics|anesthetics|mesh-ancestor
102105133|NCT02827526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102105134|NCT02827526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102105135|NCT02827526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102105136|NCT02827526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102105137|NCT02827526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105138|NCT04799314|Tislelizumab|tislelizumab|mesh-list
102105139|NCT04799314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102105140|NCT04799314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102105141|NCT04799314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102105142|NCT04799314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105143|NCT03425084|Morphine|morphine|mesh-list
102105144|NCT03425084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102105145|NCT03425084|Narcotics|narcotics|mesh-ancestor
102105146|NCT03425084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102105147|NCT03425084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105148|NCT03425084|Analgesics|analgesics|mesh-ancestor
102105149|NCT03425084|Sensory System Agents|sensory system agents|mesh-ancestor
102105150|NCT03425084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102105151|NCT03424928|Thalidomide|thalidomide|mesh-list
102105152|NCT03424928|Pomalidomide|pomalidomide|mesh-list
102105153|NCT03424928|Immunologic Factors|immunologic factors|mesh-ancestor
102105154|NCT03424928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105155|NCT03424928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102105156|NCT03424928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102105157|NCT03424928|Growth Substances|growth substances|mesh-ancestor
102105158|NCT03424928|Growth Inhibitors|growth inhibitors|mesh-ancestor
102105159|NCT03424928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102105160|NCT03424928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102105161|NCT03424928|Leprostatic Agents|leprostatic agents|mesh-ancestor
102105162|NCT03424928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102105163|NCT03424928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102105164|NCT04799002|Melphalan|melphalan|mesh-list
102105165|NCT04799002|Topotecan|topotecan|mesh-list
102105166|NCT04799002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102105167|NCT04799002|Alkylating Agents|alkylating agents|mesh-ancestor
102105168|NCT04799002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105169|NCT04799002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102105170|NCT04799002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102105171|NCT04799002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102105172|NCT04799002|Immunologic Factors|immunologic factors|mesh-ancestor
102105173|NCT04799002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105174|NCT04799002|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102105175|NCT04799002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102105176|NCT04799002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102105177|NCT02098785|Caffeine|caffeine|mesh-list
102105178|NCT02098785|Caffeine citrate|caffeine citrate|mesh-list
102105179|NCT02098785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105180|NCT02098785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102105181|NCT02098785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105182|NCT02098785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102105183|NCT02098785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102105184|NCT02098785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102105185|NCT02098785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102105186|NCT02098785|Purinergic Agents|purinergic agents|mesh-ancestor
102105187|NCT02098785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102105188|NCT02521064|Prednisone|prednisone|mesh-list
102105189|NCT02521064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102105190|NCT02521064|Glucocorticoids|glucocorticoids|mesh-ancestor
102105191|NCT02521064|Hormones|hormones|mesh-ancestor
102105192|NCT02521064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102105193|NCT02521064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105194|NCT02521064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102105195|NCT02521064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102105196|NCT02096913|Ibuprofen|ibuprofen|mesh-list
102105197|NCT02096913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102105198|NCT02096913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102105199|NCT02096913|Analgesics|analgesics|mesh-ancestor
102105200|NCT02096913|Sensory System Agents|sensory system agents|mesh-ancestor
102105201|NCT02096913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102105202|NCT02096913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105203|NCT02096913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102105204|NCT02096913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102105205|NCT02096913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102105206|NCT02096913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102105207|NCT02096913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105208|NCT03418610|Azelaic acid|azelaic acid|mesh-list
102105209|NCT03418610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102105210|NCT03418610|Dermatologic Agents|dermatologic agents|mesh-ancestor
102105211|NCT04604366|Alprostadil|alprostadil|mesh-list
102105212|NCT04604366|Misoprostol|misoprostol|mesh-list
102105213|NCT04604366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102105214|NCT04604366|Abortifacient Agents|abortifacient agents|mesh-ancestor
102105215|NCT04604366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102105216|NCT04604366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105217|NCT04604366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102105218|NCT04604366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102105219|NCT04604366|Oxytocics|oxytocics|mesh-ancestor
102105220|NCT04604366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102105221|NCT04604366|Vasodilator Agents|vasodilator agents|mesh-ancestor
102105222|NCT04604366|Urological Agents|urological agents|mesh-ancestor
102105223|NCT02099253|Dexmedetomidine|dexmedetomidine|mesh-list
102105224|NCT02099253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102105225|NCT02099253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102105226|NCT02099253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105227|NCT02099253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102105228|NCT02099253|Analgesics|analgesics|mesh-ancestor
102105229|NCT02099253|Sensory System Agents|sensory system agents|mesh-ancestor
102105230|NCT02099253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102105231|NCT02099253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102105232|NCT02099253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102105233|NCT02099253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102105234|NCT02099253|Adrenergic Agents|adrenergic agents|mesh-ancestor
102105235|NCT02099253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101953961|NCT03712917|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102105236|NCT02099253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105237|NCT05818111|Lidocaine|lidocaine|mesh-list
102105238|NCT05818111|Anesthetics, Local|anesthetics, local|mesh-ancestor
102105239|NCT05818111|Anesthetics|anesthetics|mesh-ancestor
102105240|NCT05818111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102105241|NCT05818111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105242|NCT05818111|Sensory System Agents|sensory system agents|mesh-ancestor
102105243|NCT05818111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102105244|NCT05818111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101558687|NCT02862145|Glucocorticoids|glucocorticoids|mesh-ancestor
102105245|NCT05818111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102105246|NCT05818111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102105247|NCT05818111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102105248|NCT05818111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105249|NCT05818007|Hyaluronic Acid|hyaluronic acid|mesh-list
102105250|NCT05818007|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102105251|NCT05818007|Immunologic Factors|immunologic factors|mesh-ancestor
102105252|NCT05818007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105253|NCT05818007|Viscosupplements|viscosupplements|mesh-ancestor
102105254|NCT05818007|Protective Agents|protective agents|mesh-ancestor
102105255|NCT05817955|Azacitidine|azacitidine|mesh-list
102105256|NCT05817955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102105257|NCT05817955|Antimetabolites|antimetabolites|mesh-ancestor
102105258|NCT05817955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105259|NCT05817955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102105260|NCT05817955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102105261|NCT05817409|Baclofen|baclofen|mesh-list
102105262|NCT05817409|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102105263|NCT05817409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105264|NCT05817409|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102105265|NCT05817409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102105266|NCT05817409|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102105267|NCT05817409|GABA Agonists|gaba agonists|mesh-ancestor
102105268|NCT05817409|GABA Agents|gaba agents|mesh-ancestor
102105269|NCT05817409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102105270|NCT05817409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105271|NCT05817253|Coal Tar|coal tar|mesh-list
102105272|NCT05817253|Keratolytic Agents|keratolytic agents|mesh-ancestor
102105273|NCT05817253|Dermatologic Agents|dermatologic agents|mesh-ancestor
102105274|NCT05817201|Tegafur|tegafur|mesh-list
102105275|NCT05817201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102105276|NCT05817201|Antimetabolites|antimetabolites|mesh-ancestor
102105277|NCT05817201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105278|NCT05817201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102105279|NCT05817019|Neostigmine|neostigmine|mesh-list
102105280|NCT05817019|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102105281|NCT05817019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102105282|NCT05817019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105283|NCT05817019|Cholinergic Agents|cholinergic agents|mesh-ancestor
102105284|NCT05817019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102105285|NCT05817019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105286|NCT05817019|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102105287|NCT05817019|Autonomic Agents|autonomic agents|mesh-ancestor
102105288|NCT05817019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102105289|NCT05816772|Calcium|calcium|mesh-list
102105290|NCT05816772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102105291|NCT05816772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105292|NCT05816733|Dapagliflozin|dapagliflozin|mesh-list
102105293|NCT05816733|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102105294|NCT05816733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105295|NCT05816733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102105296|NCT05816733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105297|NCT05816720|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102105298|NCT05816720|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102105299|NCT05816720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105300|NCT05816707|Turmeric extract|turmeric extract|mesh-list
102105301|NCT05816707|Antioxidants|antioxidants|mesh-ancestor
102105302|NCT05816707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105303|NCT05816707|Protective Agents|protective agents|mesh-ancestor
101953966|NCT03787017|Metformin|metformin|mesh-list
102105304|NCT05816707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105305|NCT05816694|Paclitaxel|paclitaxel|mesh-list
102105306|NCT05816694|Cyclophosphamide|cyclophosphamide|mesh-list
102105307|NCT05816694|Cisplatin|cisplatin|mesh-list
102105308|NCT05816694|Epirubicin|epirubicin|mesh-list
102105309|NCT05816694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102105310|NCT05816694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102105311|NCT05816694|Tubulin Modulators|tubulin modulators|mesh-ancestor
102105312|NCT05816694|Antimitotic Agents|antimitotic agents|mesh-ancestor
102105313|NCT05816694|Mitosis Modulators|mitosis modulators|mesh-ancestor
102105314|NCT05816694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105315|NCT05816694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101836453|NCT00309244|Coagulants|coagulants|mesh-ancestor
102105316|NCT05816694|Immunologic Factors|immunologic factors|mesh-ancestor
102105317|NCT05816694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105323|NCT05816694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102105325|NCT05816694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102105326|NCT05816668|Tranexamic Acid|tranexamic acid|mesh-list
102105327|NCT05816668|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102105328|NCT05816668|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102105329|NCT05816668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105330|NCT05816668|Hemostatics|hemostatics|mesh-ancestor
102105331|NCT05816668|Coagulants|coagulants|mesh-ancestor
102105332|NCT05816655|Fulvestrant|fulvestrant|mesh-list
102105333|NCT05816655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102105334|NCT05816655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102105335|NCT05816655|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102105336|NCT05816655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102105337|NCT05816655|Hormone Antagonists|hormone antagonists|mesh-ancestor
102105338|NCT05816655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102105339|NCT05816655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105340|NCT05816642|Sunitinib|sunitinib|mesh-list
102105341|NCT05816642|Axitinib|axitinib|mesh-list
102105342|NCT05816642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102105343|NCT05816642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102105344|NCT05816642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102105345|NCT05816642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102105346|NCT05816642|Growth Substances|growth substances|mesh-ancestor
102105347|NCT05816642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105348|NCT05816642|Growth Inhibitors|growth inhibitors|mesh-ancestor
102105349|NCT05816642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102105350|NCT05816642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102105351|NCT05816642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105352|NCT05816642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102105353|NCT05816538|Anesthetics|anesthetics|mesh-list
102105354|NCT05816538|Levobupivacaine|levobupivacaine|mesh-list
102105355|NCT05816538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102105356|NCT05816538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105357|NCT05816538|Anesthetics, Local|anesthetics, local|mesh-ancestor
102105358|NCT05816538|Sensory System Agents|sensory system agents|mesh-ancestor
102105359|NCT05816538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102105366|NCT05809583|Ozanimod|ozanimod|mesh-list
102105367|NCT05809583|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102105368|NCT05809583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105369|NCT05809583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102105370|NCT05809583|Immunologic Factors|immunologic factors|mesh-ancestor
102105371|NCT05809583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105372|NCT05809453|Lidocaine|lidocaine|mesh-list
102105373|NCT05809453|Cocaine|cocaine|mesh-list
102105374|NCT05809453|Anesthetics, Local|anesthetics, local|mesh-ancestor
102105375|NCT05809453|Anesthetics|anesthetics|mesh-ancestor
102105376|NCT05809453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102105377|NCT05809453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105378|NCT05809453|Sensory System Agents|sensory system agents|mesh-ancestor
102105379|NCT05809453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102105380|NCT05809453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102105381|NCT05809453|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102105382|NCT05809453|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101953974|NCT01308177|Ecabet|ecabet|mesh-list
102105384|NCT05809453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105385|NCT05809453|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102105386|NCT05809453|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102105387|NCT05809453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102105388|NCT05809453|Dopamine Agents|dopamine agents|mesh-ancestor
102105389|NCT05809453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102105390|NCT05803629|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102105391|NCT05803629|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102105392|NCT05803629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105393|NCT05803434|Cannabidiol|cannabidiol|mesh-list
102105394|NCT05803434|Anticonvulsants|anticonvulsants|mesh-ancestor
102105395|NCT05781542|MEDI9197|medi9197|mesh-list
102105396|NCT05781542|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102105397|NCT05781542|Immunologic Factors|immunologic factors|mesh-ancestor
102105398|NCT05781542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105399|NCT05777226|Epalrestat|epalrestat|mesh-list
102105400|NCT05777226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102105401|NCT05777226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105402|NCT05776160|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
102105403|NCT05776160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102105404|NCT05776160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102105405|NCT05769920|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102105406|NCT05769920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102105407|NCT05769010|Bevacizumab|bevacizumab|mesh-list
102105408|NCT05769010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102105409|NCT05769010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102105410|NCT05769010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102105411|NCT05769010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102105412|NCT05769010|Growth Substances|growth substances|mesh-ancestor
102105413|NCT05769010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105414|NCT05769010|Growth Inhibitors|growth inhibitors|mesh-ancestor
102105415|NCT05719883|Sirolimus|sirolimus|mesh-list
102105416|NCT05719883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102105417|NCT05719883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102105418|NCT05719883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102105419|NCT05719883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102105420|NCT05719883|Antifungal Agents|antifungal agents|mesh-ancestor
102105421|NCT05719883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102105422|NCT05719883|Immunologic Factors|immunologic factors|mesh-ancestor
102105423|NCT05719883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105424|NCT05716607|Hydrocortisone|hydrocortisone|mesh-list
102105425|NCT05716607|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
102105426|NCT05716607|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
102105427|NCT05716607|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102105428|NCT05716607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102105429|NCT05688579|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
102105430|NCT05688579|Mineralocorticoids|mineralocorticoids|mesh-list
102105431|NCT05688579|Hormone Antagonists|hormone antagonists|mesh-ancestor
102105432|NCT05688579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102105433|NCT05688579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105434|NCT05688579|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102105435|NCT05688579|Diuretics|diuretics|mesh-ancestor
102105436|NCT05688579|Natriuretic Agents|natriuretic agents|mesh-ancestor
102105437|NCT05688579|Hormones|hormones|mesh-ancestor
102105438|NCT05675501|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102105439|NCT05675501|Dermatologic Agents|dermatologic agents|mesh-ancestor
102105440|NCT05662111|Etidronic Acid|etidronic acid|mesh-list
102105441|NCT05662111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102105442|NCT05662111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105443|NCT05659927|Antibodies|antibodies|mesh-list
102105444|NCT05659927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102105445|NCT05659927|Immunologic Factors|immunologic factors|mesh-ancestor
102105446|NCT05659927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105447|NCT05659823|Fentanyl|fentanyl|mesh-list
102105448|NCT05659823|Morphine|morphine|mesh-list
102105449|NCT05659823|Bupivacaine|bupivacaine|mesh-list
102105450|NCT05659823|Anesthetics, Local|anesthetics, local|mesh-ancestor
102105451|NCT05659823|Anesthetics|anesthetics|mesh-ancestor
102105452|NCT05659823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102105453|NCT05659823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105454|NCT05659823|Sensory System Agents|sensory system agents|mesh-ancestor
102105455|NCT05659823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102105456|NCT05659823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102105457|NCT05659823|Narcotics|narcotics|mesh-ancestor
102105458|NCT05659823|Analgesics|analgesics|mesh-ancestor
102105459|NCT05659823|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102105460|NCT05659823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102105461|NCT05659823|Anesthetics, General|anesthetics, general|mesh-ancestor
102105462|NCT05640453|Pregabalin|pregabalin|mesh-list
102105463|NCT05640453|Dexmedetomidine|dexmedetomidine|mesh-list
101558921|NCT04315155|Nivolumab|nivolumab|mesh-list
102105464|NCT05640453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102105465|NCT05640453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102105466|NCT05640453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836454|NCT00483756|Cyclosporine|cyclosporine|mesh-list
102105467|NCT05640453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102105468|NCT05640453|Analgesics|analgesics|mesh-ancestor
102105469|NCT05640453|Sensory System Agents|sensory system agents|mesh-ancestor
102105470|NCT05640453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102105471|NCT05640453|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102105472|NCT05640453|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102105473|NCT05640453|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102105474|NCT05640453|Adrenergic Agents|adrenergic agents|mesh-ancestor
102105475|NCT05640453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102105476|NCT05640453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105477|NCT05640453|Anticonvulsants|anticonvulsants|mesh-ancestor
102105478|NCT05640453|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102105479|NCT05640453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102105480|NCT05640453|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102105481|NCT05640453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102105482|NCT05640453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102105483|NCT05640453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102105484|NCT05635851|Nitroglycerin|nitroglycerin|mesh-list
102105485|NCT05635851|Vasodilator Agents|vasodilator agents|mesh-ancestor
102105489|NCT05599789|Docetaxel|docetaxel|mesh-list
102105490|NCT05599789|Pembrolizumab|pembrolizumab|mesh-list
102105491|NCT05599789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102105492|NCT05599789|Tubulin Modulators|tubulin modulators|mesh-ancestor
102105493|NCT05599789|Antimitotic Agents|antimitotic agents|mesh-ancestor
102105494|NCT05599789|Mitosis Modulators|mitosis modulators|mesh-ancestor
102105495|NCT05599789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105496|NCT05599789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102105497|NCT05599789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102105498|NCT05583617|Lenalidomide|lenalidomide|mesh-list
102105499|NCT05583617|Immunologic Factors|immunologic factors|mesh-ancestor
102105500|NCT05583617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105501|NCT05583617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102105502|NCT05583617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102105503|NCT05583617|Growth Substances|growth substances|mesh-ancestor
102105504|NCT05583617|Growth Inhibitors|growth inhibitors|mesh-ancestor
102105505|NCT05583617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102105506|NCT05581901|Methadone|methadone|mesh-list
102105507|NCT05581901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102105508|NCT05581901|Narcotics|narcotics|mesh-ancestor
102105509|NCT05581901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102105510|NCT05581901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105511|NCT05581901|Analgesics|analgesics|mesh-ancestor
102105512|NCT05581901|Sensory System Agents|sensory system agents|mesh-ancestor
102105513|NCT05581901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102105514|NCT05581901|Antitussive Agents|antitussive agents|mesh-ancestor
102105515|NCT05581901|Respiratory System Agents|respiratory system agents|mesh-ancestor
102105516|NCT05564637|Treprostinil|treprostinil|mesh-list
102105517|NCT05564637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102105518|NCT05520814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102105519|NCT05520814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105520|NCT05520814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102105521|NCT05520814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102105522|NCT05508061|Insulin|insulin|mesh-list
102105523|NCT05508061|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102105524|NCT05508061|Insulin Lispro|insulin lispro|mesh-list
102105525|NCT05508061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102105526|NCT05508061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105527|NCT05504642|Nivolumab|nivolumab|mesh-list
102105528|NCT05504642|Ipilimumab|ipilimumab|mesh-list
102105529|NCT05504642|Immunomodulating Agents|immunomodulating agents|mesh-list
102105530|NCT05504642|Immunologic Factors|immunologic factors|mesh-list
102105531|NCT05504642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102105532|NCT05504642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102105533|NCT05504642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102105534|NCT05504642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105535|NCT05504642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105536|NCT05490953|Pentoxifylline|pentoxifylline|mesh-list
102105537|NCT05490953|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102105538|NCT05490953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102105539|NCT05490953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105540|NCT05490953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102105541|NCT05490953|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102105542|NCT05490953|Protective Agents|protective agents|mesh-ancestor
102105543|NCT05490953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105544|NCT05490953|Vasodilator Agents|vasodilator agents|mesh-ancestor
102105545|NCT05490953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102105546|NCT05490953|Antioxidants|antioxidants|mesh-ancestor
102105547|NCT05475483|Bevantolol|bevantolol|mesh-list
102105548|NCT05475483|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102105549|NCT05475483|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102105550|NCT05475483|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102105551|NCT05475483|Adrenergic Agents|adrenergic agents|mesh-ancestor
102105552|NCT05475483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102105553|NCT05475483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105554|NCT05475483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105555|NCT05474729|Minocycline|minocycline|mesh-list
102105556|NCT05474729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102105557|NCT05474729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102105558|NCT05474001|Fentanyl|fentanyl|mesh-list
102105559|NCT05474001|Bupivacaine|bupivacaine|mesh-list
102105560|NCT05474001|Anesthetics, Local|anesthetics, local|mesh-ancestor
102105561|NCT05474001|Anesthetics|anesthetics|mesh-ancestor
102105562|NCT05474001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102105563|NCT05474001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105564|NCT05474001|Sensory System Agents|sensory system agents|mesh-ancestor
102105565|NCT05474001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102105566|NCT05474001|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102105567|NCT05474001|Narcotics|narcotics|mesh-ancestor
102105568|NCT05474001|Analgesics|analgesics|mesh-ancestor
102105569|NCT05474001|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102105570|NCT05474001|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102105571|NCT05474001|Anesthetics, General|anesthetics, general|mesh-ancestor
102105572|NCT05445232|Midazolam|midazolam|mesh-list
102105573|NCT05445232|Caffeine|caffeine|mesh-list
102105574|NCT05445232|Warfarin|warfarin|mesh-list
102105575|NCT05445232|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102105576|NCT05445232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102105577|NCT05445232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102105578|NCT05445232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105579|NCT05445232|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102105580|NCT05445232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102105581|NCT05445232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102105582|NCT05445232|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102105583|NCT05445232|Anesthetics, General|anesthetics, general|mesh-ancestor
102105584|NCT05445232|Anesthetics|anesthetics|mesh-ancestor
102105585|NCT05445232|GABA Modulators|gaba modulators|mesh-ancestor
102105586|NCT05445232|GABA Agents|gaba agents|mesh-ancestor
102105587|NCT05445232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102105588|NCT05445232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105589|NCT05445232|Anticoagulants|anticoagulants|mesh-ancestor
102105590|NCT05445232|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102105591|NCT05445232|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101953985|NCT01308255|Vitamins|vitamins|mesh-list
102105592|NCT05445232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102105593|NCT05445232|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102105594|NCT05445232|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102105595|NCT05445232|Purinergic Agents|purinergic agents|mesh-ancestor
102105596|NCT05420805|Zinc Oxide|zinc oxide|mesh-list
102105597|NCT05420805|Butyric Acid|butyric acid|mesh-list
102105598|NCT05420805|Dermatologic Agents|dermatologic agents|mesh-ancestor
102105599|NCT05420805|Sunscreening Agents|sunscreening agents|mesh-ancestor
102105600|NCT05420805|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102105601|NCT05420805|Protective Agents|protective agents|mesh-ancestor
102105602|NCT05420805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105603|NCT05420805|Histamine Antagonists|histamine antagonists|mesh-ancestor
102105604|NCT05420805|Histamine Agents|histamine agents|mesh-ancestor
102105605|NCT05420805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102105606|NCT05420805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105607|NCT05419830|Antihypertensive Agents|antihypertensive agents|mesh-list
102105608|NCT05406583|Dolutegravir|dolutegravir|mesh-list
102105609|NCT05406583|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102105610|NCT05406583|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102105611|NCT05406583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102105612|NCT05406583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105613|NCT05406583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102105614|NCT05406583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101836455|NCT00483756|Cyclosporins|cyclosporins|mesh-list
102105615|NCT05406583|Antiviral Agents|antiviral agents|mesh-ancestor
102105616|NCT05406583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102105617|NCT05395533|Antibodies|antibodies|mesh-list
102105618|NCT05395533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102105619|NCT05395533|Immunologic Factors|immunologic factors|mesh-ancestor
102105620|NCT05395533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105621|NCT05389527|Pembrolizumab|pembrolizumab|mesh-list
102105622|NCT05389527|Lenvatinib|lenvatinib|mesh-list
102105623|NCT05389527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102105624|NCT05389527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102105625|NCT05389527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102105626|NCT05389527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105627|NCT05389527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102105628|NCT05389527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102105629|NCT05358522|Analgesics, Opioid|analgesics, opioid|mesh-list
102105630|NCT05358522|Narcotics|narcotics|mesh-ancestor
102105631|NCT05358522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102105632|NCT05358522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105633|NCT05358522|Analgesics|analgesics|mesh-ancestor
102105634|NCT05358522|Sensory System Agents|sensory system agents|mesh-ancestor
102105635|NCT05358522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102105636|NCT05355974|Norepinephrine|norepinephrine|mesh-list
102105637|NCT05355974|Plasma-lyte 148|plasma-lyte 148|mesh-list
102105638|NCT05355974|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102105639|NCT05355974|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102105640|NCT05355974|Adrenergic Agents|adrenergic agents|mesh-ancestor
102105641|NCT05355974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102105642|NCT05355974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105643|NCT05355974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105644|NCT05355974|Sympathomimetics|sympathomimetics|mesh-ancestor
102105645|NCT05355974|Autonomic Agents|autonomic agents|mesh-ancestor
102105646|NCT05355974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102105647|NCT05355974|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102105648|NCT05355974|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102105649|NCT05355974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102105650|NCT05340413|Olaparib|olaparib|mesh-list
102105651|NCT05340413|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102105652|NCT05340413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102105653|NCT05340413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105654|NCT05340413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102105655|NCT05323955|Trastuzumab|trastuzumab|mesh-list
102105656|NCT05323955|Pertuzumab|pertuzumab|mesh-list
102105657|NCT05323955|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102105658|NCT05323955|Maytansine|maytansine|mesh-list
102105659|NCT05323955|Tucatinib|tucatinib|mesh-list
102105660|NCT05323955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102105661|NCT05323955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102105662|NCT05323955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102105663|NCT05323955|Tubulin Modulators|tubulin modulators|mesh-ancestor
102105664|NCT05323955|Antimitotic Agents|antimitotic agents|mesh-ancestor
102105665|NCT05323955|Mitosis Modulators|mitosis modulators|mesh-ancestor
102105666|NCT05323955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105667|NCT05323955|Immunotoxins|immunotoxins|mesh-ancestor
102105668|NCT05323955|Immunoconjugates|immunoconjugates|mesh-ancestor
102105669|NCT05323955|Immunologic Factors|immunologic factors|mesh-ancestor
102105670|NCT05323955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105671|NCT05323955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102105672|NCT05323955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102105673|NCT05312385|Propofol|propofol|mesh-list
102105674|NCT05312385|Isoflurane|isoflurane|mesh-list
102105675|NCT05312385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102105676|NCT05312385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102105677|NCT05312385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105678|NCT05312385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102105679|NCT05312385|Anesthetics, General|anesthetics, general|mesh-ancestor
102105680|NCT05312385|Anesthetics|anesthetics|mesh-ancestor
102105681|NCT05312385|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102105682|NCT05289193|Nivolumab|nivolumab|mesh-list
102105683|NCT05289193|Ipilimumab|ipilimumab|mesh-list
102105684|NCT05289193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102105685|NCT05289193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102105686|NCT05289193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102105687|NCT05289193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105688|NCT05259137|Enalaprilat|enalaprilat|mesh-list
102105689|NCT05259137|Enalapril|enalapril|mesh-list
102105690|NCT05259137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102105691|NCT05259137|Protease Inhibitors|protease inhibitors|mesh-ancestor
102105692|NCT05259137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102105693|NCT05259137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105694|NCT05259137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102105695|NCT05225558|Vancomycin|vancomycin|mesh-list
102105696|NCT05225558|Delpazolid|delpazolid|mesh-list
102105697|NCT05225558|Oxazolidinones|oxazolidinones|mesh-list
102105698|NCT05225558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102105699|NCT05225558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102105700|NCT05225558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102105701|NCT05225558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102105702|NCT05225558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105703|NCT05200988|Nivolumab|nivolumab|mesh-list
102105704|NCT05200988|Ipilimumab|ipilimumab|mesh-list
102105705|NCT05200988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102105706|NCT05200988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102105707|NCT05200988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102105708|NCT05200988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105709|NCT05159830|Cannabidiol|cannabidiol|mesh-list
102105710|NCT05159830|Anticonvulsants|anticonvulsants|mesh-ancestor
102105711|NCT05148715|Tacrolimus|tacrolimus|mesh-list
102105712|NCT05148715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102105713|NCT05148715|Immunologic Factors|immunologic factors|mesh-ancestor
102105714|NCT05148715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105715|NCT05148715|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102105716|NCT05148715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102105717|NCT05148715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105718|NCT05112211|Doxycycline|doxycycline|mesh-list
102105719|NCT05112211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102105720|NCT05112211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102105721|NCT05112211|Antimalarials|antimalarials|mesh-ancestor
102105722|NCT05112211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102105723|NCT05112211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102105724|NCT05110040|Immunosuppressive Agents|immunosuppressive agents|mesh-list
102105725|NCT05110040|Immunologic Factors|immunologic factors|mesh-ancestor
102105726|NCT05110040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105728|NCT05107427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102105729|NCT05107427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102105730|NCT05036226|Metformin|metformin|mesh-list
102105731|NCT05036226|Sirolimus|sirolimus|mesh-list
102105732|NCT05036226|Hydroxychloroquine|hydroxychloroquine|mesh-list
102105733|NCT05036226|Nelfinavir|nelfinavir|mesh-list
102105734|NCT05036226|Temsirolimus|temsirolimus|mesh-list
102105735|NCT05036226|Dasatinib|dasatinib|mesh-list
102105736|NCT05036226|MTOR Inhibitors|mtor inhibitors|mesh-list
102105737|NCT05036226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102105738|NCT05036226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105739|NCT05036226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102105740|NCT05036226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102105741|NCT05036226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102105742|NCT05036226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102105743|NCT05036226|Antifungal Agents|antifungal agents|mesh-ancestor
102105744|NCT05036226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102105745|NCT05036226|Immunologic Factors|immunologic factors|mesh-ancestor
102105746|NCT05036226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102105747|NCT05036226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102105748|NCT05036226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105749|NCT05036226|Antimalarials|antimalarials|mesh-ancestor
102105750|NCT05036226|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102105751|NCT05036226|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102105752|NCT05036226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102105753|NCT05036226|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102105754|NCT05036226|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102105755|NCT05036226|Protease Inhibitors|protease inhibitors|mesh-ancestor
102105756|NCT05036226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102105757|NCT05036226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102105758|NCT05036226|Antiviral Agents|antiviral agents|mesh-ancestor
102105759|NCT05035745|Talazoparib|talazoparib|mesh-list
102105760|NCT05035745|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102105761|NCT05035745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102105762|NCT05035745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105763|NCT05035745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102105764|NCT05033080|Ivacaftor|ivacaftor|mesh-list
102105765|NCT05033080|Elexacaftor|elexacaftor|mesh-list
102105766|NCT05033080|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102105767|NCT05033080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102105768|NCT05033080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105769|NCT05005897|Vitamin B 12|vitamin b 12|mesh-list
102105770|NCT05005897|Hydroxocobalamin|hydroxocobalamin|mesh-list
102105771|NCT05005897|Vitamins|vitamins|mesh-ancestor
102105772|NCT05005897|Micronutrients|micronutrients|mesh-ancestor
102105773|NCT05005897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105774|NCT05005897|Vitamin B Complex|vitamin b complex|mesh-ancestor
102105775|NCT05005897|Hematinics|hematinics|mesh-ancestor
102105776|NCT04994977|Carboplatin|carboplatin|mesh-list
102105777|NCT04994977|Melphalan|melphalan|mesh-list
102105778|NCT04994977|Topotecan|topotecan|mesh-list
102105779|NCT04994977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102105780|NCT04994977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102105781|NCT04994977|Alkylating Agents|alkylating agents|mesh-ancestor
102105782|NCT04994977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105783|NCT04994977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102105784|NCT04994977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102105785|NCT04994977|Immunologic Factors|immunologic factors|mesh-ancestor
102105786|NCT04994977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105787|NCT04994977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102105788|NCT04994977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102105789|NCT04994977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102105790|NCT04931615|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102105791|NCT04931615|Thrombin|thrombin|mesh-list
102105792|NCT04931615|Hemostatics|hemostatics|mesh-ancestor
102105793|NCT04931615|Coagulants|coagulants|mesh-ancestor
102105794|NCT04869943|Exemestane|exemestane|mesh-list
102105795|NCT04869943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102105796|NCT04869943|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102105797|NCT04869943|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102105798|NCT04869943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102105799|NCT04869943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105800|NCT04869943|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102105801|NCT04869943|Hormone Antagonists|hormone antagonists|mesh-ancestor
101954009|NCT01308255|Autonomic Agents|autonomic agents|mesh-ancestor
102105802|NCT04869943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102105803|NCT04869943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105805|NCT04866706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102105806|NCT04866706|Immunologic Factors|immunologic factors|mesh-ancestor
102105807|NCT04866706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105808|NCT04866706|Viscosupplements|viscosupplements|mesh-ancestor
102105809|NCT04866706|Protective Agents|protective agents|mesh-ancestor
102105810|NCT04846478|Talazoparib|talazoparib|mesh-list
102105811|NCT04846478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102105812|NCT04846478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102105813|NCT04846478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105814|NCT04846478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102105815|NCT04844606|Mirikizumab|mirikizumab|mesh-list
102105816|NCT04844606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102105817|NCT04844606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102105818|NCT04844606|Analgesics|analgesics|mesh-ancestor
102105819|NCT04844606|Sensory System Agents|sensory system agents|mesh-ancestor
102105820|NCT04844606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102105821|NCT04844606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105822|NCT04844606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102105823|NCT04844606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102105824|NCT04844606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102105825|NCT04844606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102105826|NCT04834973|Pembrolizumab|pembrolizumab|mesh-list
102105827|NCT04834973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102105828|NCT04834973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102105829|NCT04834973|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102105830|NCT04834973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105831|NCT04798781|Pembrolizumab|pembrolizumab|mesh-list
102105832|NCT04798781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102105833|NCT04798781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102105834|NCT04798781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102105835|NCT04798781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105836|NCT04764825|Morphine|morphine|mesh-list
102105837|NCT04764825|Methadone|methadone|mesh-list
102105838|NCT04764825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102105839|NCT04764825|Narcotics|narcotics|mesh-ancestor
102105840|NCT04764825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102105841|NCT04764825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105842|NCT04764825|Analgesics|analgesics|mesh-ancestor
102105843|NCT04764825|Sensory System Agents|sensory system agents|mesh-ancestor
102105844|NCT04764825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102105845|NCT04764825|Antitussive Agents|antitussive agents|mesh-ancestor
102105846|NCT04764825|Respiratory System Agents|respiratory system agents|mesh-ancestor
102105847|NCT04760743|Aluminum sulfate|aluminum sulfate|mesh-list
102105848|NCT04760743|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102105849|NCT04760743|Immunologic Factors|immunologic factors|mesh-ancestor
102105850|NCT04760743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105851|NCT04756687|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102105852|NCT04756687|Dermatologic Agents|dermatologic agents|mesh-ancestor
102105853|NCT04756687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102105854|NCT04756687|Immunologic Factors|immunologic factors|mesh-ancestor
102105855|NCT04756687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105856|NCT04742738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102105857|NCT04742738|Aluminum sulfate|aluminum sulfate|mesh-list
102105858|NCT04742738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102105859|NCT04742738|Immunologic Factors|immunologic factors|mesh-ancestor
102105860|NCT04742738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105861|NCT04706910|Furosemide|furosemide|mesh-list
102105862|NCT04706910|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
102105863|NCT04706910|Diuretics|diuretics|mesh-ancestor
102105864|NCT04706910|Natriuretic Agents|natriuretic agents|mesh-ancestor
102105865|NCT04706910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105866|NCT04706910|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102105867|NCT04706910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102105868|NCT04706910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105869|NCT04706910|Dopamine Agents|dopamine agents|mesh-ancestor
102105870|NCT04706910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102105871|NCT04704271|Dronabinol|dronabinol|mesh-list
101954013|NCT01308255|Hormones|hormones|mesh-ancestor
102105872|NCT04704271|Hallucinogens|hallucinogens|mesh-ancestor
102105873|NCT04704271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105874|NCT04704271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102105875|NCT04704271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102105876|NCT04704271|Analgesics|analgesics|mesh-ancestor
102105877|NCT04704271|Sensory System Agents|sensory system agents|mesh-ancestor
102105878|NCT04704271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102105879|NCT04704271|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102105880|NCT04704271|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102105881|NCT04704271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102105882|NCT04704271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105883|NCT04704271|Hormones|hormones|mesh-ancestor
102105884|NCT04704271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102105885|NCT04693234|Tislelizumab|tislelizumab|mesh-list
102105886|NCT04693234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102105887|NCT04693234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102105888|NCT04680286|Methadone|methadone|mesh-list
102105889|NCT04680286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102105890|NCT04680286|Narcotics|narcotics|mesh-ancestor
102105891|NCT04680286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102105892|NCT04680286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105893|NCT04680286|Analgesics|analgesics|mesh-ancestor
102105894|NCT04680286|Sensory System Agents|sensory system agents|mesh-ancestor
102105895|NCT04680286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102105896|NCT04680286|Antitussive Agents|antitussive agents|mesh-ancestor
102105897|NCT04680286|Respiratory System Agents|respiratory system agents|mesh-ancestor
102105898|NCT04675762|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102105899|NCT04675762|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102105900|NCT04675762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105901|NCT04675762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102105902|NCT04675762|Immunologic Factors|immunologic factors|mesh-ancestor
102105903|NCT04675762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105904|NCT04672018|Omeprazole|omeprazole|mesh-list
102105905|NCT04672018|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102105906|NCT04672018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102105907|NCT04672018|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102105908|NCT04672018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102105909|NCT04672018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105910|NCT04656184|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102105911|NCT04656184|Immunoglobulins|immunoglobulins|mesh-list
102105912|NCT04656184|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102105913|NCT04656184|Antibodies|antibodies|mesh-list
102105914|NCT04656184|gamma-Globulins|gamma-globulins|mesh-list
102105915|NCT04656184|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102105916|NCT04656184|Immunologic Factors|immunologic factors|mesh-ancestor
102105917|NCT04656184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105918|NCT04656184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102105919|NCT04638881|Magnesium Sulfate|magnesium sulfate|mesh-list
101559357|NCT00956839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102105920|NCT04638881|Analgesics|analgesics|mesh-ancestor
102105921|NCT04638881|Sensory System Agents|sensory system agents|mesh-ancestor
102105922|NCT04638881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102105923|NCT04638881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105924|NCT04638881|Anesthetics|anesthetics|mesh-ancestor
102105925|NCT04638881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102105926|NCT04638881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102105927|NCT04638881|Anticonvulsants|anticonvulsants|mesh-ancestor
102105928|NCT04638881|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102105929|NCT04638881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102105930|NCT04638881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105931|NCT04638881|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102105932|NCT04638881|Tocolytic Agents|tocolytic agents|mesh-ancestor
102105933|NCT04638881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102105935|NCT04627753|Lenalidomide|lenalidomide|mesh-list
102105936|NCT04627753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102105937|NCT04627753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102105938|NCT04627753|Immunologic Factors|immunologic factors|mesh-ancestor
102105939|NCT04627753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105940|NCT04627753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102105941|NCT04627753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102105942|NCT04627753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102105943|NCT04627753|Growth Substances|growth substances|mesh-ancestor
102105944|NCT04627753|Growth Inhibitors|growth inhibitors|mesh-ancestor
102105945|NCT04564612|Itraconazole|itraconazole|mesh-list
102105946|NCT04564612|Rabeprazole|rabeprazole|mesh-list
102105947|NCT04564612|Antifungal Agents|antifungal agents|mesh-ancestor
102105948|NCT04564612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102105949|NCT04564612|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102105950|NCT04564612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102105951|NCT04564612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102105952|NCT04564612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105953|NCT04564612|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102105954|NCT04564612|Hormone Antagonists|hormone antagonists|mesh-ancestor
102105955|NCT04564612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102105956|NCT04564612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102105957|NCT04564612|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102105958|NCT04564612|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102105959|NCT04564612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102105960|NCT04564612|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102105961|NCT04549311|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102105962|NCT04549311|Amoxicillin|amoxicillin|mesh-list
102105963|NCT04549311|Metronidazole|metronidazole|mesh-list
102105964|NCT04549311|Ciprofloxacin|ciprofloxacin|mesh-list
102105965|NCT04549311|Clavulanic Acids|clavulanic acids|mesh-list
102105966|NCT04549311|Clavulanic Acid|clavulanic acid|mesh-list
102105967|NCT04549311|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102105968|NCT04549311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102105969|NCT04549311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102105970|NCT04549311|Antitubercular Agents|antitubercular agents|mesh-ancestor
102105971|NCT04549311|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102105972|NCT04549311|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102105973|NCT04549311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102105974|NCT04549311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102105975|NCT04549311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102105976|NCT04549311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105977|NCT04549311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102105978|NCT04549311|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102105979|NCT04549311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102105980|NCT04549311|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102105981|NCT04518319|Olanzapine|olanzapine|mesh-list
102105982|NCT04518319|Antiemetics|antiemetics|mesh-ancestor
102105983|NCT04518319|Autonomic Agents|autonomic agents|mesh-ancestor
102105984|NCT04518319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102105985|NCT04518319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226120|NCT01532856|Glucocorticoids|glucocorticoids|mesh-ancestor
102105986|NCT04518319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102105987|NCT04518319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102105988|NCT04518319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102105989|NCT04518319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102105990|NCT04518319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102105991|NCT04518319|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102105992|NCT04518319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102105993|NCT04518319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102105994|NCT04518319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102105995|NCT04518319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102105996|NCT04518319|Serotonin Agents|serotonin agents|mesh-ancestor
102105997|NCT04516226|Chlorhexidine|chlorhexidine|mesh-list
102105998|NCT04516226|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102105999|NCT04516226|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102106000|NCT04516226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102106001|NCT04516226|Disinfectants|disinfectants|mesh-ancestor
102106002|NCT04516226|Dermatologic Agents|dermatologic agents|mesh-ancestor
102106003|NCT04495868|Lidocaine|lidocaine|mesh-list
102106004|NCT04495868|Anesthetics, Local|anesthetics, local|mesh-ancestor
102106005|NCT04495868|Anesthetics|anesthetics|mesh-ancestor
102106006|NCT04495868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102106007|NCT04495868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106008|NCT04495868|Sensory System Agents|sensory system agents|mesh-ancestor
102106009|NCT04495868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102106010|NCT04495868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102106011|NCT04495868|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102106012|NCT04495868|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102106013|NCT04495868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102106014|NCT04495868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106015|NCT04483544|Pembrolizumab|pembrolizumab|mesh-list
102106016|NCT04483544|Olaparib|olaparib|mesh-list
102106017|NCT04483544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102106018|NCT04483544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106019|NCT04483544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102106020|NCT04483544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106021|NCT04483544|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102106022|NCT04483544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102106023|NCT04475029|Morphine|morphine|mesh-list
102106024|NCT04475029|Methadone|methadone|mesh-list
102106025|NCT04475029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102106026|NCT04475029|Narcotics|narcotics|mesh-ancestor
102106027|NCT04475029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102106028|NCT04475029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106029|NCT04475029|Analgesics|analgesics|mesh-ancestor
102106030|NCT04475029|Sensory System Agents|sensory system agents|mesh-ancestor
102106031|NCT04475029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102106032|NCT04475029|Antitussive Agents|antitussive agents|mesh-ancestor
102106033|NCT04475029|Respiratory System Agents|respiratory system agents|mesh-ancestor
102106034|NCT04457089|Simvastatin|simvastatin|mesh-list
102106035|NCT04457089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102106036|NCT04457089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102106037|NCT04457089|Antimetabolites|antimetabolites|mesh-ancestor
102106038|NCT04457089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226135|NCT01532895|Narcotics|narcotics|mesh-ancestor
102106039|NCT04457089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102106040|NCT04457089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102106041|NCT04457089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102106054|NCT04443062|177Lu-PSMA-617|177lu-psma-617|mesh-list
102106055|NCT04443062|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102106056|NCT04443062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106057|NCT04307485|Ticagrelor|ticagrelor|mesh-list
102106058|NCT04307485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102106059|NCT04307485|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102106060|NCT04307485|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102106061|NCT04307485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102106062|NCT04307485|Purinergic Agents|purinergic agents|mesh-ancestor
102106063|NCT04307485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102106064|NCT04307485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106065|NCT04307485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106066|NCT04289467|Fenfluramine|fenfluramine|mesh-list
102106067|NCT04289467|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102106068|NCT04289467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102106069|NCT04289467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101954029|NCT03782025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106070|NCT04289467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106071|NCT04289467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102106072|NCT04289467|Serotonin Agents|serotonin agents|mesh-ancestor
102106073|NCT04289467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106074|NCT04279574|Lithium Carbonate|lithium carbonate|mesh-list
102106075|NCT04279574|Antidepressive Agents|antidepressive agents|mesh-ancestor
102106076|NCT04279574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102106077|NCT04279574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102106078|NCT04279574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106079|NCT04279574|Antimanic Agents|antimanic agents|mesh-ancestor
102106080|NCT04279574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102106081|NCT04279574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102106082|NCT04279574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106083|NCT04253561|Trastuzumab|trastuzumab|mesh-list
102106084|NCT04253561|Pertuzumab|pertuzumab|mesh-list
102106085|NCT04253561|Ipatasertib|ipatasertib|mesh-list
102106086|NCT04253561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102106087|NCT04253561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106088|NCT04253561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102106089|NCT04253561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102106090|NCT04253561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106091|NCT04240171|Dapagliflozin|dapagliflozin|mesh-list
102106092|NCT04240171|Glimepiride|glimepiride|mesh-list
102106093|NCT04240171|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102106094|NCT04240171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106095|NCT04240171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102106096|NCT04240171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106097|NCT04240171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102106098|NCT04240171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102106099|NCT04240171|Immunologic Factors|immunologic factors|mesh-ancestor
102106100|NCT04191616|Dexamethasone|dexamethasone|mesh-list
102106101|NCT04191616|Pomalidomide|pomalidomide|mesh-list
102106102|NCT04191616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102106103|NCT04191616|Antiemetics|antiemetics|mesh-ancestor
102106104|NCT04191616|Autonomic Agents|autonomic agents|mesh-ancestor
102106105|NCT04191616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102106106|NCT04191616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106107|NCT04191616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102106108|NCT04191616|Glucocorticoids|glucocorticoids|mesh-ancestor
102106109|NCT04191616|Hormones|hormones|mesh-ancestor
102106110|NCT04191616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102106111|NCT04191616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102106112|NCT04191616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106113|NCT04191616|Immunologic Factors|immunologic factors|mesh-ancestor
102106114|NCT04191616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102106115|NCT04191616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102106116|NCT04191616|Growth Substances|growth substances|mesh-ancestor
102106117|NCT04191616|Growth Inhibitors|growth inhibitors|mesh-ancestor
102106118|NCT04170738|Amphetamine|amphetamine|mesh-list
102106119|NCT04170738|Adderall|adderall|mesh-list
102106120|NCT04170738|Dextroamphetamine|dextroamphetamine|mesh-list
102106121|NCT04170738|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102106122|NCT04170738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106123|NCT04170738|Sympathomimetics|sympathomimetics|mesh-ancestor
102106124|NCT04170738|Autonomic Agents|autonomic agents|mesh-ancestor
102106125|NCT04170738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102106126|NCT04170738|Dopamine Agents|dopamine agents|mesh-ancestor
102106127|NCT04170738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102106128|NCT04170738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106129|NCT04170738|Adrenergic Agents|adrenergic agents|mesh-ancestor
102106130|NCT04170738|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102106131|NCT04170738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102106132|NCT04170738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102106133|NCT04170738|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102106134|NCT04094142|Lenalidomide|lenalidomide|mesh-list
102106135|NCT04094142|Acalabrutinib|acalabrutinib|mesh-list
102106136|NCT04094142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106137|NCT04094142|Immunologic Factors|immunologic factors|mesh-ancestor
102106138|NCT04094142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106139|NCT04094142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102106140|NCT04094142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102106141|NCT04094142|Growth Substances|growth substances|mesh-ancestor
102106142|NCT04094142|Growth Inhibitors|growth inhibitors|mesh-ancestor
102106143|NCT04089514|Adalimumab|adalimumab|mesh-list
102106144|NCT04089514|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102106145|NCT04089514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102106146|NCT04089514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102106147|NCT04088409|Adalimumab|adalimumab|mesh-list
102106148|NCT04088409|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102106149|NCT04088409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102106150|NCT04088409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102106151|NCT04084314|Erenumab|erenumab|mesh-list
102106152|NCT04084314|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
102106153|NCT04084314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106154|NCT04084314|Analgesics|analgesics|mesh-ancestor
102106155|NCT04084314|Sensory System Agents|sensory system agents|mesh-ancestor
102106156|NCT04084314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102106157|NCT04084314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106158|NCT04068207|Minocycline|minocycline|mesh-list
102106159|NCT04068207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102106160|NCT04068207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102106161|NCT04024761|Cyclophosphamide|cyclophosphamide|mesh-list
102106162|NCT04024761|Fludarabine|fludarabine|mesh-list
102106163|NCT04024761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102106164|NCT04024761|Immunologic Factors|immunologic factors|mesh-ancestor
102106165|NCT04024761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106166|NCT04024761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102106167|NCT04024761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102106168|NCT04024761|Alkylating Agents|alkylating agents|mesh-ancestor
102106169|NCT04024761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106170|NCT04024761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106171|NCT04024761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102106172|NCT04013854|Nivolumab|nivolumab|mesh-list
102106173|NCT04013854|Ipilimumab|ipilimumab|mesh-list
102106174|NCT04013854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102106175|NCT04013854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106176|NCT04013854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102106177|NCT04013854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106178|NCT04004988|Tirzepatide|tirzepatide|mesh-list
102106179|NCT04004988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102106180|NCT04004988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106181|NCT04004988|Incretins|incretins|mesh-ancestor
102106182|NCT04004988|Hormones|hormones|mesh-ancestor
102106183|NCT04004988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102106184|NCT03950817|Ketamine|ketamine|mesh-list
102106185|NCT03950817|Analgesics|analgesics|mesh-ancestor
102106186|NCT03950817|Sensory System Agents|sensory system agents|mesh-ancestor
102106187|NCT03950817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102106188|NCT03950817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106189|NCT03950817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102106190|NCT03950817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102106191|NCT03950817|Anesthetics, General|anesthetics, general|mesh-ancestor
102106192|NCT03950817|Anesthetics|anesthetics|mesh-ancestor
102106193|NCT03950817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102106194|NCT03950817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102106195|NCT03950817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102106196|NCT03950817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102106197|NCT03950817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106198|NCT03934840|Prednisone|prednisone|mesh-list
102106199|NCT03934840|Carboplatin|carboplatin|mesh-list
102106200|NCT03934840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106201|NCT03934840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102106202|NCT03934840|Glucocorticoids|glucocorticoids|mesh-ancestor
102106203|NCT03934840|Hormones|hormones|mesh-ancestor
102106204|NCT03934840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102106205|NCT03934840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106206|NCT03934840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102106207|NCT03879538|Nitrous Oxide|nitrous oxide|mesh-list
102106208|NCT03879538|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102106209|NCT03879538|Anesthetics, General|anesthetics, general|mesh-ancestor
102106210|NCT03879538|Anesthetics|anesthetics|mesh-ancestor
102106211|NCT03879538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102106212|NCT03879538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106213|NCT03879538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102106214|NCT03879538|Analgesics|analgesics|mesh-ancestor
101836456|NCT00483756|Tofacitinib|tofacitinib|mesh-list
102106215|NCT03879538|Sensory System Agents|sensory system agents|mesh-ancestor
102106216|NCT03879538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102106218|NCT03783442|Fluorouracil|fluorouracil|mesh-list
102106219|NCT03783442|Capecitabine|capecitabine|mesh-list
102106220|NCT03783442|Oxaliplatin|oxaliplatin|mesh-list
102106221|NCT03783442|Tislelizumab|tislelizumab|mesh-list
102106222|NCT03783442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102106223|NCT03783442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106224|NCT03783442|Tubulin Modulators|tubulin modulators|mesh-ancestor
102106225|NCT03783442|Antimitotic Agents|antimitotic agents|mesh-ancestor
102106226|NCT03783442|Mitosis Modulators|mitosis modulators|mesh-ancestor
102106227|NCT03783442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106228|NCT03783442|Antimetabolites|antimetabolites|mesh-ancestor
102106229|NCT03783442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102106230|NCT03783442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102106231|NCT03783442|Immunologic Factors|immunologic factors|mesh-ancestor
102106232|NCT03783442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106233|NCT03783442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102106234|NCT03781765|Methylphenidate|methylphenidate|mesh-list
102106235|NCT03781765|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102106236|NCT03781765|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102106237|NCT03781765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106238|NCT03781765|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102106239|NCT03781765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102106240|NCT03781765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102106241|NCT03781765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106242|NCT03781765|Dopamine Agents|dopamine agents|mesh-ancestor
102106243|NCT03781765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102106244|NCT03781765|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102106245|NCT03781765|Adrenergic Agents|adrenergic agents|mesh-ancestor
102106246|NCT03781752|Methylphenidate|methylphenidate|mesh-list
102106247|NCT03781752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102106248|NCT03781752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106249|NCT03781752|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102106250|NCT03781752|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102106251|NCT03781752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102106252|NCT03781752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106253|NCT03781752|Dopamine Agents|dopamine agents|mesh-ancestor
102106254|NCT03781752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102106255|NCT03772457|Rivaroxaban|rivaroxaban|mesh-list
102106256|NCT03772457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102106257|NCT03772457|Antithrombins|antithrombins|mesh-ancestor
102106258|NCT03772457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102106259|NCT03772457|Protease Inhibitors|protease inhibitors|mesh-ancestor
102106260|NCT03772457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102106261|NCT03772457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106262|NCT03772457|Anticoagulants|anticoagulants|mesh-ancestor
102106263|NCT03714958|Trametinib|trametinib|mesh-list
102106264|NCT03714958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106265|NCT03714958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102106266|NCT03714958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102106267|NCT03714958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106268|NCT03708315|Dexmedetomidine|dexmedetomidine|mesh-list
102106269|NCT03708315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102106270|NCT03708315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102106271|NCT03708315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106272|NCT03708315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102106273|NCT03708315|Analgesics|analgesics|mesh-ancestor
102106274|NCT03708315|Sensory System Agents|sensory system agents|mesh-ancestor
102106275|NCT03708315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102106276|NCT03708315|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102106277|NCT03708315|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102106278|NCT03708315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102106279|NCT03708315|Adrenergic Agents|adrenergic agents|mesh-ancestor
102106280|NCT03708315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102106281|NCT03708315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106282|NCT03693300|Durvalumab|durvalumab|mesh-list
102106283|NCT03693300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102106284|NCT03693300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106285|NCT03582033|Dexamethasone|dexamethasone|mesh-list
102106286|NCT03582033|Pomalidomide|pomalidomide|mesh-list
102106287|NCT03582033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102106289|NCT03582033|Autonomic Agents|autonomic agents|mesh-ancestor
102106290|NCT03582033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102106291|NCT03582033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106292|NCT03582033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102106293|NCT03582033|Glucocorticoids|glucocorticoids|mesh-ancestor
102106294|NCT03582033|Hormones|hormones|mesh-ancestor
102106295|NCT03582033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102106296|NCT03582033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102106297|NCT03582033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106298|NCT03582033|Immunologic Factors|immunologic factors|mesh-ancestor
102106299|NCT03582033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102106300|NCT03582033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102106301|NCT03582033|Growth Substances|growth substances|mesh-ancestor
102106302|NCT03582033|Growth Inhibitors|growth inhibitors|mesh-ancestor
102106303|NCT03579966|Amifampridine|amifampridine|mesh-list
102106304|NCT03579966|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102106305|NCT03579966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102106306|NCT03579966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362826|NCT00045539|Antidotes|antidotes|mesh-ancestor
102106307|NCT03579966|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102106308|NCT03579966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102106309|NCT03579966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106310|NCT03551691|Omeprazole|omeprazole|mesh-list
102106311|NCT03551691|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102106312|NCT03551691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102106313|NCT03551691|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102106314|NCT03551691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102106315|NCT03551691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106316|NCT03543189|Nivolumab|nivolumab|mesh-list
102106317|NCT03543189|Androgens|androgens|mesh-list
102106318|NCT03543189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102106319|NCT03543189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106320|NCT03543189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102106321|NCT03543189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106322|NCT03543189|Hormones|hormones|mesh-ancestor
102106323|NCT03543189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102106324|NCT03543189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106325|NCT03510208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102106326|NCT03510208|Panitumumab|panitumumab|mesh-list
102106327|NCT03510208|Antibodies|antibodies|mesh-list
102106328|NCT03510208|Immunoglobulins|immunoglobulins|mesh-list
102106329|NCT03510208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102106330|NCT03510208|Immunologic Factors|immunologic factors|mesh-ancestor
102106331|NCT03510208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106332|NCT03510208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106333|NCT03508869|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102106334|NCT03508869|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102106335|NCT03508869|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102106336|NCT03508869|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102106337|NCT03508869|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102106338|NCT03508869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102106339|NCT03508869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102106340|NCT03508869|Adrenergic Agents|adrenergic agents|mesh-ancestor
102106341|NCT03508869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102106342|NCT03508869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106343|NCT03508869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106344|NCT03508869|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102106345|NCT03508869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102106346|NCT03508869|Cholinergic Agents|cholinergic agents|mesh-ancestor
102106347|NCT03508869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102106348|NCT03508869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102106350|NCT03507699|Ipilimumab|ipilimumab|mesh-list
102106351|NCT03507699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102106352|NCT03507699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106353|NCT03507699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102106354|NCT03507699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226202|NCT01533272|Lopinavir|lopinavir|mesh-list
102106355|NCT03497923|Magnesium Sulfate|magnesium sulfate|mesh-list
102106356|NCT03497923|Analgesics|analgesics|mesh-ancestor
102106357|NCT03497923|Sensory System Agents|sensory system agents|mesh-ancestor
102106358|NCT03497923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102106359|NCT03497923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106360|NCT03497923|Anesthetics|anesthetics|mesh-ancestor
102106361|NCT03497923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102106362|NCT03497923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102106364|NCT03497923|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102106365|NCT03497923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102106366|NCT03497923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106367|NCT03497923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102106368|NCT03497923|Tocolytic Agents|tocolytic agents|mesh-ancestor
102106369|NCT03497923|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102106370|NCT03383692|Ritonavir|ritonavir|mesh-list
102106371|NCT03383692|Itraconazole|itraconazole|mesh-list
102106372|NCT03383692|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
102106373|NCT03383692|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102106374|NCT03383692|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102106375|NCT03383692|Protease Inhibitors|protease inhibitors|mesh-ancestor
102106376|NCT03383692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102106377|NCT03383692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106378|NCT03383692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102106379|NCT03383692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102106380|NCT03383692|Antiviral Agents|antiviral agents|mesh-ancestor
102106381|NCT03383692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102106382|NCT03383692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102106383|NCT03383692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102106384|NCT03383692|Antifungal Agents|antifungal agents|mesh-ancestor
102106385|NCT03383692|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102106386|NCT03383692|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102106387|NCT03383692|Hormone Antagonists|hormone antagonists|mesh-ancestor
102106388|NCT03383692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102106389|NCT03383692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106390|NCT03383692|Immunoconjugates|immunoconjugates|mesh-ancestor
102106391|NCT03383692|Immunologic Factors|immunologic factors|mesh-ancestor
102106392|NCT03377387|Capecitabine|capecitabine|mesh-list
102106393|NCT03377387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102106394|NCT03377387|Antimetabolites|antimetabolites|mesh-ancestor
102106395|NCT03377387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106396|NCT03377387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106397|NCT03372837|Rituximab|rituximab|mesh-list
102106398|NCT03372837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102106399|NCT03372837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106400|NCT03372837|Immunologic Factors|immunologic factors|mesh-ancestor
102106401|NCT03372837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106402|NCT03372837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102106403|NCT03312699|Vaccines|vaccines|mesh-list
102106404|NCT03312699|Immunologic Factors|immunologic factors|mesh-ancestor
102106405|NCT03312699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106406|NCT03300557|Exemestane|exemestane|mesh-list
102106407|NCT03300557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106408|NCT03300557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102106409|NCT03300557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102106410|NCT03300557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102106411|NCT03300557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106412|NCT03300557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102106413|NCT03300557|Hormone Antagonists|hormone antagonists|mesh-ancestor
102106414|NCT03300557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102106415|NCT03300557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106416|NCT03290079|Pembrolizumab|pembrolizumab|mesh-list
102106417|NCT03290079|Lenvatinib|lenvatinib|mesh-list
102106418|NCT03290079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102106419|NCT03290079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106420|NCT03290079|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102106421|NCT03290079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106422|NCT03290079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102106423|NCT03290079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102106424|NCT03261284|Heparin|heparin|mesh-list
102106425|NCT03261284|Calcium heparin|calcium heparin|mesh-list
102106426|NCT03261284|Anticoagulants|anticoagulants|mesh-ancestor
102106427|NCT03261284|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102106428|NCT03261284|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102106429|NCT03261284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106430|NCT03219450|Cyclophosphamide|cyclophosphamide|mesh-list
102106431|NCT03219450|Pembrolizumab|pembrolizumab|mesh-list
102106432|NCT03219450|Immunologic Factors|immunologic factors|mesh-ancestor
102106433|NCT03219450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106434|NCT03219450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102106435|NCT03219450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102106436|NCT03219450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102106437|NCT03219450|Alkylating Agents|alkylating agents|mesh-ancestor
102106438|NCT03219450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106439|NCT03219450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106440|NCT03219450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102106441|NCT03219450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102106442|NCT03219450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102106443|NCT03198078|Aripiprazole|aripiprazole|mesh-list
102106444|NCT03198078|Brexpiprazole|brexpiprazole|mesh-list
102106445|NCT03198078|Antidepressive Agents|antidepressive agents|mesh-ancestor
102106446|NCT03198078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102106447|NCT03198078|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102106448|NCT03198078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102106449|NCT03198078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102106450|NCT03198078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106451|NCT03198078|Dopamine Agonists|dopamine agonists|mesh-ancestor
102106452|NCT03198078|Dopamine Agents|dopamine agents|mesh-ancestor
102106453|NCT03198078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102106454|NCT03198078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106455|NCT03198078|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102106456|NCT03198078|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102106457|NCT03198078|Serotonin Agents|serotonin agents|mesh-ancestor
102106458|NCT03198078|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102106459|NCT03198078|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102106460|NCT03198078|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102106461|NCT03198078|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102106462|NCT03127267|Riluzole|riluzole|mesh-list
102106463|NCT03127267|Anticonvulsants|anticonvulsants|mesh-ancestor
102106464|NCT03127267|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102106465|NCT03127267|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102106466|NCT03127267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102106467|NCT03127267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106468|NCT03127267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106469|NCT03127267|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102106470|NCT03127267|Protective Agents|protective agents|mesh-ancestor
102106471|NCT03092466|Ropivacaine|ropivacaine|mesh-list
102106472|NCT03092466|Anesthetics, Local|anesthetics, local|mesh-ancestor
102106473|NCT03092466|Anesthetics|anesthetics|mesh-ancestor
102106474|NCT03092466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102106475|NCT03092466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106476|NCT03092466|Sensory System Agents|sensory system agents|mesh-ancestor
102106477|NCT03092466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102106478|NCT03017872|Ritonavir|ritonavir|mesh-list
102106479|NCT03017872|Darunavir|darunavir|mesh-list
102106480|NCT03017872|Dolutegravir|dolutegravir|mesh-list
102106481|NCT03017872|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102106482|NCT03017872|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102106483|NCT03017872|Protease Inhibitors|protease inhibitors|mesh-ancestor
102106484|NCT03017872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102106485|NCT03017872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106486|NCT03017872|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102106487|NCT03017872|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102106488|NCT03017872|Antiviral Agents|antiviral agents|mesh-ancestor
102106489|NCT03017872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102106490|NCT03017872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102106491|NCT03017872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102106492|NCT03017872|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102106493|NCT03017872|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102106494|NCT03000205|Lidocaine|lidocaine|mesh-list
102106495|NCT03000205|Anesthetics, Local|anesthetics, local|mesh-ancestor
102106496|NCT03000205|Anesthetics|anesthetics|mesh-ancestor
102106497|NCT03000205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102106498|NCT03000205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106499|NCT03000205|Sensory System Agents|sensory system agents|mesh-ancestor
102106500|NCT03000205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102106501|NCT03000205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102106502|NCT03000205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102106503|NCT03000205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102106504|NCT03000205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102106505|NCT03000205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106506|NCT02942095|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102106507|NCT02942095|Ixazomib|ixazomib|mesh-list
102106508|NCT02942095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106509|NCT02942095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102106510|NCT02942095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102106511|NCT02942095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106512|NCT02942095|Protease Inhibitors|protease inhibitors|mesh-ancestor
102106513|NCT02882282|Pembrolizumab|pembrolizumab|mesh-list
102106514|NCT02882282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102106515|NCT02882282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106516|NCT02882282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102106517|NCT02882282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106518|NCT02872467|Oxytocin|oxytocin|mesh-list
102106519|NCT02872467|Oxytocics|oxytocics|mesh-ancestor
102106520|NCT02872467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102106521|NCT02872467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106522|NCT02781519|Dronabinol|dronabinol|mesh-list
102106523|NCT02781519|Hallucinogens|hallucinogens|mesh-ancestor
102106524|NCT02781519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106525|NCT02781519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102106526|NCT02781519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102106527|NCT02781519|Analgesics|analgesics|mesh-ancestor
102106528|NCT02781519|Sensory System Agents|sensory system agents|mesh-ancestor
102106529|NCT02781519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102106530|NCT02781519|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102106531|NCT02781519|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102106532|NCT02781519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102106533|NCT02781519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106534|NCT02781519|Hormones|hormones|mesh-ancestor
102106535|NCT02781519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102106536|NCT02706353|Pembrolizumab|pembrolizumab|mesh-list
102106537|NCT02706353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102106538|NCT02706353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106539|NCT02706353|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101954074|NCT03785613|Analgesics|analgesics|mesh-ancestor
102106540|NCT02706353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106541|NCT02638090|Pembrolizumab|pembrolizumab|mesh-list
102106542|NCT02638090|Vorinostat|vorinostat|mesh-list
102106543|NCT02638090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102106544|NCT02638090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106545|NCT02638090|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102106546|NCT02638090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226242|NCT01533389|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102106547|NCT02638090|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102106548|NCT02638090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102106549|NCT02617277|Durvalumab|durvalumab|mesh-list
102106550|NCT02617277|Adavosertib|adavosertib|mesh-list
102106551|NCT02617277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102106552|NCT02617277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106553|NCT02617277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102106554|NCT02617277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106555|NCT02584465|Tamoxifen|tamoxifen|mesh-list
102106556|NCT02584465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102106557|NCT02584465|Hormone Antagonists|hormone antagonists|mesh-ancestor
102106558|NCT02584465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102106559|NCT02584465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106560|NCT02584465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102106561|NCT02584465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106562|NCT02584465|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102106563|NCT02584465|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102106564|NCT02584465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102106565|NCT02536664|Rituximab|rituximab|mesh-list
102106566|NCT02536664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102106567|NCT02536664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106568|NCT02536664|Immunologic Factors|immunologic factors|mesh-ancestor
102106569|NCT02536664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106570|NCT02536664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102106571|NCT02426892|Nivolumab|nivolumab|mesh-list
102106572|NCT02426892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102106573|NCT02426892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106574|NCT02426892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102106575|NCT02426892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106576|NCT02375555|Dexamethasone|dexamethasone|mesh-list
102106577|NCT02375555|Lenalidomide|lenalidomide|mesh-list
102106578|NCT02375555|Bortezomib|bortezomib|mesh-list
101560061|NCT02884479|Docetaxel|docetaxel|mesh-list
101836457|NCT00483756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102106579|NCT02375555|Elotuzumab|elotuzumab|mesh-list
102106580|NCT02375555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102106581|NCT02375555|Antiemetics|antiemetics|mesh-ancestor
102106582|NCT02375555|Autonomic Agents|autonomic agents|mesh-ancestor
102106583|NCT02375555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102106584|NCT02375555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106585|NCT02375555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102106586|NCT02375555|Glucocorticoids|glucocorticoids|mesh-ancestor
102106587|NCT02375555|Hormones|hormones|mesh-ancestor
102106588|NCT02375555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102106589|NCT02375555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102106590|NCT02375555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106591|NCT02375555|Immunologic Factors|immunologic factors|mesh-ancestor
102106592|NCT02375555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102106593|NCT02375555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102106594|NCT02375555|Growth Substances|growth substances|mesh-ancestor
102106595|NCT02375555|Growth Inhibitors|growth inhibitors|mesh-ancestor
102106596|NCT02364713|Paclitaxel|paclitaxel|mesh-list
102106597|NCT02364713|Bevacizumab|bevacizumab|mesh-list
102106598|NCT02364713|Gemcitabine|gemcitabine|mesh-list
102106599|NCT02364713|Doxorubicin|doxorubicin|mesh-list
102106600|NCT02364713|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102106601|NCT02364713|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102106602|NCT02364713|Topotecan|topotecan|mesh-list
102106603|NCT02364713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102106604|NCT02364713|Endothelial Growth Factors|endothelial growth factors|mesh-list
102106605|NCT02364713|Antibodies|antibodies|mesh-list
102106606|NCT02364713|Immunoglobulins|immunoglobulins|mesh-list
102106607|NCT02364713|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102106608|NCT02364713|Immunoglobulin G|immunoglobulin g|mesh-list
102106609|NCT02364713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102106610|NCT02364713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106611|NCT02364713|Tubulin Modulators|tubulin modulators|mesh-ancestor
102106612|NCT02364713|Antimitotic Agents|antimitotic agents|mesh-ancestor
102106613|NCT02364713|Mitosis Modulators|mitosis modulators|mesh-ancestor
102106614|NCT02364713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106615|NCT02364713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102106616|NCT02364713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102106617|NCT02364713|Growth Substances|growth substances|mesh-ancestor
102106618|NCT02364713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106619|NCT02364713|Growth Inhibitors|growth inhibitors|mesh-ancestor
102106620|NCT02364713|Immunologic Factors|immunologic factors|mesh-ancestor
102106621|NCT02364713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102106622|NCT02364713|Antimetabolites|antimetabolites|mesh-ancestor
102106623|NCT02364713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102106624|NCT02364713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102106625|NCT02364713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102106626|NCT02364713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102106627|NCT02364713|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102106628|NCT02231775|Trametinib|trametinib|mesh-list
102106629|NCT02231775|Dabrafenib|dabrafenib|mesh-list
102106630|NCT02231775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106631|NCT02231775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102106632|NCT02231775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102106633|NCT02231775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106634|NCT02107703|Fulvestrant|fulvestrant|mesh-list
102106635|NCT02107703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102106636|NCT02107703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106637|NCT02107703|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102106638|NCT02107703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102106639|NCT02107703|Hormone Antagonists|hormone antagonists|mesh-ancestor
102106640|NCT02107703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102106641|NCT02107703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106642|NCT02094625|Acetylcysteine|acetylcysteine|mesh-list
102106643|NCT02094625|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102106644|NCT02094625|Antiviral Agents|antiviral agents|mesh-ancestor
102106645|NCT02094625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102106646|NCT02094625|Expectorants|expectorants|mesh-ancestor
102106647|NCT02094625|Respiratory System Agents|respiratory system agents|mesh-ancestor
102106648|NCT02094625|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102106649|NCT02094625|Antioxidants|antioxidants|mesh-ancestor
102106650|NCT02094625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106651|NCT02094625|Protective Agents|protective agents|mesh-ancestor
102106652|NCT02094625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106653|NCT02094625|Antidotes|antidotes|mesh-ancestor
102106654|NCT02054520|Pembrolizumab|pembrolizumab|mesh-list
102106655|NCT02054520|Nivolumab|nivolumab|mesh-list
102106656|NCT02054520|Ipilimumab|ipilimumab|mesh-list
102106657|NCT02054520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102106658|NCT02054520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106659|NCT02054520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102106660|NCT02054520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106661|NCT01922921|polysaccharide-K|polysaccharide-k|mesh-list
102106662|NCT01922921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102106663|NCT01922921|Trastuzumab|trastuzumab|mesh-list
102106664|NCT01922921|Pertuzumab|pertuzumab|mesh-list
102106665|NCT01922921|Antibodies|antibodies|mesh-list
102106666|NCT01922921|Immunoglobulins|immunoglobulins|mesh-list
102106667|NCT01922921|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102106668|NCT01922921|Immunologic Factors|immunologic factors|mesh-ancestor
102106669|NCT01922921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106670|NCT01922921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363237|NCT00131443|Topiramate|topiramate|mesh-list
102106671|NCT01922921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102106672|NCT01922921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102106673|NCT01922921|Antiviral Agents|antiviral agents|mesh-ancestor
102106674|NCT01922921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102106675|NCT01922921|Interferon Inducers|interferon inducers|mesh-ancestor
102106676|NCT01922921|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102106677|NCT01922921|Protective Agents|protective agents|mesh-ancestor
102106678|NCT01546987|Leuprolide|leuprolide|mesh-list
102106679|NCT01546987|Goserelin|goserelin|mesh-list
102106680|NCT01546987|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102106681|NCT01546987|Flutamide|flutamide|mesh-list
102106683|NCT01546987|Buserelin|buserelin|mesh-list
102106684|NCT01546987|Androgens|androgens|mesh-list
102106685|NCT01546987|Androgen Antagonists|androgen antagonists|mesh-list
102106686|NCT01546987|Hormones|hormones|mesh-ancestor
102106687|NCT01546987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102106688|NCT01546987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106689|NCT01546987|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102106690|NCT01546987|Fertility Agents|fertility agents|mesh-ancestor
102106691|NCT01546987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102106692|NCT01546987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102106693|NCT01546987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106694|NCT01546987|Hormone Antagonists|hormone antagonists|mesh-ancestor
102106695|NCT01546987|Luteolytic Agents|luteolytic agents|mesh-ancestor
102106696|NCT01546987|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102106697|NCT01546987|Contraceptive Agents|contraceptive agents|mesh-ancestor
102106698|NCT01546987|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102106699|NCT00977691|Sirolimus|sirolimus|mesh-list
102106700|NCT00977691|Cyclophosphamide|cyclophosphamide|mesh-list
102106701|NCT00977691|Alemtuzumab|alemtuzumab|mesh-list
102106702|NCT00977691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102106703|NCT00977691|Immunologic Factors|immunologic factors|mesh-ancestor
102106704|NCT00977691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106705|NCT00977691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102106706|NCT00977691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102106707|NCT00977691|Alkylating Agents|alkylating agents|mesh-ancestor
102106708|NCT00977691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106709|NCT00977691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106710|NCT00977691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102106711|NCT00977691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102106712|NCT00977691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102106713|NCT00977691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102106714|NCT00977691|Antifungal Agents|antifungal agents|mesh-ancestor
102106715|NCT00977691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102106716|NCT00588185|Deoxyglucose|deoxyglucose|mesh-list
102106717|NCT00588185|Testosterone|testosterone|mesh-list
102106718|NCT00588185|Dihydrotestosterone|dihydrotestosterone|mesh-list
102106719|NCT00588185|Androgens|androgens|mesh-ancestor
102106720|NCT00588185|Hormones|hormones|mesh-ancestor
102106721|NCT00588185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102106722|NCT00588185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106723|NCT00588185|Antimetabolites|antimetabolites|mesh-ancestor
102106724|NCT00588185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106725|NCT00588185|Antiviral Agents|antiviral agents|mesh-ancestor
102106726|NCT00588185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101560181|NCT01148511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102106727|NCT00268476|Zoledronic Acid|zoledronic acid|mesh-list
102106728|NCT00268476|Metformin|metformin|mesh-list
102106729|NCT00268476|Prednisone|prednisone|mesh-list
102106730|NCT00268476|Prednisolone|prednisolone|mesh-list
102106731|NCT00268476|Celecoxib|celecoxib|mesh-list
102106732|NCT00268476|Docetaxel|docetaxel|mesh-list
102106733|NCT00268476|Estradiol|estradiol|mesh-list
102106734|NCT00268476|Androgens|androgens|mesh-list
102106735|NCT00268476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102106736|NCT00268476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106737|NCT00268476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106738|NCT00268476|Tubulin Modulators|tubulin modulators|mesh-ancestor
102106739|NCT00268476|Antimitotic Agents|antimitotic agents|mesh-ancestor
102106740|NCT00268476|Mitosis Modulators|mitosis modulators|mesh-ancestor
101226275|NCT01533545|Respiratory System Agents|respiratory system agents|mesh-ancestor
102106741|NCT00268476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106742|NCT00268476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102106743|NCT00268476|Glucocorticoids|glucocorticoids|mesh-ancestor
102106744|NCT00268476|Hormones|hormones|mesh-ancestor
102106745|NCT00268476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102106746|NCT00268476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102106747|NCT00268476|Estrogens|estrogens|mesh-ancestor
102106748|NCT00268476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102106749|NCT00268476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102106750|NCT00268476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102106751|NCT00268476|Analgesics|analgesics|mesh-ancestor
102106752|NCT00268476|Sensory System Agents|sensory system agents|mesh-ancestor
102106753|NCT00268476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101954087|NCT01308723|Sorafenib|sorafenib|mesh-list
102106754|NCT00268476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102106755|NCT00268476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102106756|NCT00268476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102106757|NCT00268476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102106758|NCT00261443|Valproic Acid|valproic acid|mesh-list
102106759|NCT00261443|Aripiprazole|aripiprazole|mesh-list
102106760|NCT00261443|Lithium Carbonate|lithium carbonate|mesh-list
102106761|NCT00261443|Antidepressive Agents|antidepressive agents|mesh-ancestor
102106762|NCT00261443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102106763|NCT00261443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102106764|NCT00261443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102106765|NCT00261443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102106766|NCT00261443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106767|NCT00261443|Dopamine Agonists|dopamine agonists|mesh-ancestor
102106768|NCT00261443|Dopamine Agents|dopamine agents|mesh-ancestor
102106769|NCT00261443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102106770|NCT00261443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106771|NCT00261443|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102106772|NCT00261443|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102106773|NCT00261443|Serotonin Agents|serotonin agents|mesh-ancestor
102106774|NCT00261443|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102106775|NCT00261443|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102106776|NCT00261443|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102106777|NCT00261443|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102106778|NCT00261443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102106779|NCT00261443|Antimanic Agents|antimanic agents|mesh-ancestor
102106780|NCT00261443|Anticonvulsants|anticonvulsants|mesh-ancestor
102106781|NCT00261443|GABA Agents|gaba agents|mesh-ancestor
102106782|NCT00093379|Capecitabine|capecitabine|mesh-list
102106783|NCT00093379|Oxaliplatin|oxaliplatin|mesh-list
102106784|NCT00093379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102106785|NCT00093379|Antimetabolites|antimetabolites|mesh-ancestor
102106786|NCT00093379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106787|NCT00093379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106788|NCT00000524|Cyclosporine|cyclosporine|mesh-list
102106790|NCT00000524|Cyclosporins|cyclosporins|mesh-list
102106791|NCT00000524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102106792|NCT00000524|Glucocorticoids|glucocorticoids|mesh-ancestor
102106793|NCT00000524|Hormones|hormones|mesh-ancestor
102106794|NCT00000524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102106795|NCT00000524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106796|NCT00000524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102106797|NCT00000524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106798|NCT00000524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102106799|NCT00000524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106800|NCT00000524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102106801|NCT00000524|Immunologic Factors|immunologic factors|mesh-ancestor
102106802|NCT00000524|Antifungal Agents|antifungal agents|mesh-ancestor
102106803|NCT00000524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102106804|NCT00000524|Dermatologic Agents|dermatologic agents|mesh-ancestor
102106805|NCT00000524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102106806|NCT00000524|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102106807|NCT02099331|Melatonin|melatonin|mesh-list
102106808|NCT02099331|Antioxidants|antioxidants|mesh-ancestor
102106809|NCT02099331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106810|NCT02099331|Protective Agents|protective agents|mesh-ancestor
102106811|NCT02099331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106812|NCT02099331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102106813|NCT05328388|Lycopene|lycopene|mesh-list
102106814|NCT05328388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102106815|NCT05328388|Antioxidants|antioxidants|mesh-ancestor
102106816|NCT05328388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106817|NCT05328388|Protective Agents|protective agents|mesh-ancestor
102106818|NCT05328388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106819|NCT05328388|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102106820|NCT05328388|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102106821|NCT05328388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106822|NCT02097069|Folic Acid|folic acid|mesh-list
102106823|NCT02097069|Inositol|inositol|mesh-list
102106825|NCT02097069|Vitamin B Complex|vitamin b complex|mesh-ancestor
102106826|NCT02097069|Vitamins|vitamins|mesh-ancestor
102106827|NCT02097069|Micronutrients|micronutrients|mesh-ancestor
102106828|NCT02097069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106829|NCT03424226|Acetazolamide|acetazolamide|mesh-list
102106830|NCT03424226|Anticonvulsants|anticonvulsants|mesh-ancestor
102106831|NCT03424226|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102106832|NCT03424226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102106833|NCT03424226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106834|NCT03424226|Diuretics|diuretics|mesh-ancestor
102106835|NCT03424226|Natriuretic Agents|natriuretic agents|mesh-ancestor
102106836|NCT03424226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106837|NCT02250729|Pholcodine|pholcodine|mesh-list
102106838|NCT02250729|Analgesics|analgesics|mesh-ancestor
102106839|NCT02250729|Sensory System Agents|sensory system agents|mesh-ancestor
102106840|NCT02250729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102106841|NCT02250729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106842|NCT02250729|Antitussive Agents|antitussive agents|mesh-ancestor
102106843|NCT02250729|Respiratory System Agents|respiratory system agents|mesh-ancestor
102106844|NCT02097147|Paroxetine|paroxetine|mesh-list
102106845|NCT02097147|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
102106846|NCT02097147|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102106847|NCT02097147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102106848|NCT02097147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102106849|NCT02097147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106850|NCT02097147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102106851|NCT02097147|Serotonin Agents|serotonin agents|mesh-ancestor
102106852|NCT02097147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106853|NCT02097147|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102106854|NCT02097147|Antidepressive Agents|antidepressive agents|mesh-ancestor
102106855|NCT02097147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102106856|NCT02097147|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102106857|NCT02097147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102106858|NCT02097147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102106859|NCT02097147|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102106860|NCT02097147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102106861|NCT03556839|Paclitaxel|paclitaxel|mesh-list
102106862|NCT03556839|Bevacizumab|bevacizumab|mesh-list
102106863|NCT03556839|Carboplatin|carboplatin|mesh-list
102106864|NCT03556839|Atezolizumab|atezolizumab|mesh-list
102106865|NCT03556839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102106866|NCT03556839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106867|NCT03556839|Tubulin Modulators|tubulin modulators|mesh-ancestor
102106868|NCT03556839|Antimitotic Agents|antimitotic agents|mesh-ancestor
102106869|NCT03556839|Mitosis Modulators|mitosis modulators|mesh-ancestor
102106870|NCT03556839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106871|NCT03556839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102106872|NCT03556839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102106873|NCT03556839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102106874|NCT03556839|Growth Substances|growth substances|mesh-ancestor
102106875|NCT03556839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106876|NCT03556839|Growth Inhibitors|growth inhibitors|mesh-ancestor
102106877|NCT03556839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102106878|NCT03415802|Paclitaxel|paclitaxel|mesh-list
102106879|NCT03415802|Tegafur|tegafur|mesh-list
102106880|NCT03415802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102106881|NCT03415802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106882|NCT03415802|Tubulin Modulators|tubulin modulators|mesh-ancestor
101560330|NCT01146873|Ritonavir|ritonavir|mesh-list
102106883|NCT03415802|Antimitotic Agents|antimitotic agents|mesh-ancestor
102106884|NCT03415802|Mitosis Modulators|mitosis modulators|mesh-ancestor
102106885|NCT03415802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106886|NCT03415802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102106887|NCT03415802|Antimetabolites|antimetabolites|mesh-ancestor
102106889|NCT02099877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102106890|NCT02099877|Narcotics|narcotics|mesh-ancestor
102106891|NCT02099877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102106892|NCT02099877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106893|NCT02099877|Analgesics|analgesics|mesh-ancestor
102106894|NCT02099877|Sensory System Agents|sensory system agents|mesh-ancestor
101954098|NCT01313403|Antidepressive Agents|antidepressive agents|mesh-list
102106895|NCT02099877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102106896|NCT02099877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102106897|NCT02099877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102106898|NCT02099877|Anesthetics, General|anesthetics, general|mesh-ancestor
102106899|NCT02099877|Anesthetics|anesthetics|mesh-ancestor
102106900|NCT02097381|Ritonavir|ritonavir|mesh-list
102106901|NCT02097381|Lopinavir|lopinavir|mesh-list
102106902|NCT02097381|Darunavir|darunavir|mesh-list
102106903|NCT02097381|Tenofovir|tenofovir|mesh-list
102106904|NCT02097381|Emtricitabine|emtricitabine|mesh-list
102106905|NCT02097381|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102106906|NCT02097381|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102106907|NCT02097381|Protease Inhibitors|protease inhibitors|mesh-ancestor
102106908|NCT02097381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102106909|NCT02097381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106910|NCT02097381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102106911|NCT02097381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102106912|NCT02097381|Antiviral Agents|antiviral agents|mesh-ancestor
102106913|NCT02097381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102106914|NCT02097381|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102106915|NCT02097381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102106916|NCT02097381|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102106917|NCT02097381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102106918|NCT02099955|Vitamin D|vitamin d|mesh-list
102106919|NCT02099955|Cholecalciferol|cholecalciferol|mesh-list
102106920|NCT02099955|Vitamins|vitamins|mesh-ancestor
102106921|NCT02099955|Micronutrients|micronutrients|mesh-ancestor
102106922|NCT02099955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106923|NCT02099955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102106924|NCT02099955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102106925|NCT02097459|Tamoxifen|tamoxifen|mesh-list
102106926|NCT02097459|Toremifene|toremifene|mesh-list
102106927|NCT02097459|Anastrozole|anastrozole|mesh-list
102106928|NCT02097459|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102106929|NCT02097459|Hormone Antagonists|hormone antagonists|mesh-ancestor
102106930|NCT02097459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102106931|NCT02097459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106932|NCT02097459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102106933|NCT02097459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102106934|NCT02097459|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102106935|NCT02097459|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102106936|NCT02097459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102106937|NCT02097459|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102106938|NCT02097459|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102106939|NCT02097459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102106940|NCT02097459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106941|NCT02097615|Chlorhexidine|chlorhexidine|mesh-list
102106942|NCT02097615|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102106943|NCT02097615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102106944|NCT02097615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102106945|NCT02097615|Disinfectants|disinfectants|mesh-ancestor
102106946|NCT02097615|Dermatologic Agents|dermatologic agents|mesh-ancestor
102106947|NCT02590432|Linaclotide|linaclotide|mesh-list
102106948|NCT02590432|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102106949|NCT02590432|Enzyme Activators|enzyme activators|mesh-ancestor
102106950|NCT02590432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106951|NCT02590432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102106952|NCT02094339|Analgesics|analgesics|mesh-list
102106953|NCT02094339|Ropivacaine|ropivacaine|mesh-list
102106954|NCT02094339|Anesthetics, Local|anesthetics, local|mesh-ancestor
102106955|NCT02094339|Anesthetics|anesthetics|mesh-ancestor
101560412|NCT00602407|Cilostazol|cilostazol|mesh-list
102106956|NCT02094339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102106957|NCT02094339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106958|NCT02094339|Sensory System Agents|sensory system agents|mesh-ancestor
102106959|NCT02094339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102106961|NCT03415646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102106962|NCT03415646|Narcotics|narcotics|mesh-ancestor
102106963|NCT03415646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102106964|NCT03415646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106965|NCT03415646|Analgesics|analgesics|mesh-ancestor
102106966|NCT03415646|Sensory System Agents|sensory system agents|mesh-ancestor
102106967|NCT03415646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102106968|NCT03417518|Propofol|propofol|mesh-list
102106969|NCT03417518|Desflurane|desflurane|mesh-list
102106970|NCT03417518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102106971|NCT03417518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102106972|NCT03417518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106973|NCT03417518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102106974|NCT03417518|Anesthetics, General|anesthetics, general|mesh-ancestor
102106975|NCT03417518|Anesthetics|anesthetics|mesh-ancestor
102106976|NCT03417518|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102106977|NCT02094651|Valproic Acid|valproic acid|mesh-list
102106978|NCT02094651|Anticonvulsants|anticonvulsants|mesh-ancestor
102106979|NCT02094651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102106980|NCT02094651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102106981|NCT02094651|GABA Agents|gaba agents|mesh-ancestor
102106982|NCT02094651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102106983|NCT02094651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106984|NCT02094651|Antimanic Agents|antimanic agents|mesh-ancestor
102106985|NCT02094651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102106986|NCT02094651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102106987|NCT02094651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102106988|NCT02094807|Acetaminophen|acetaminophen|mesh-list
102106989|NCT02094807|Diclofenac|diclofenac|mesh-list
102106990|NCT02094807|Oxycodone|oxycodone|mesh-list
102106991|NCT02094807|Tramadol|tramadol|mesh-list
102106992|NCT02094807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102106993|NCT02094807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102106994|NCT02094807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102106995|NCT02094807|Analgesics|analgesics|mesh-ancestor
102106996|NCT02094807|Sensory System Agents|sensory system agents|mesh-ancestor
102106997|NCT02094807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102106998|NCT02094807|Antipyretics|antipyretics|mesh-ancestor
102106999|NCT02094807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102107000|NCT02094807|Narcotics|narcotics|mesh-ancestor
102107001|NCT02094807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102107002|NCT02094807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102107003|NCT02094807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102107004|NCT02094807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102107005|NCT02094807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102107006|NCT02094807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107007|NCT05139472|Empagliflozin|empagliflozin|mesh-list
102107008|NCT05139472|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102107009|NCT05139472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107010|NCT05139472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102107011|NCT05139472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107012|NCT04757090|Trastuzumab|trastuzumab|mesh-list
102107013|NCT04757090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102107014|NCT04757090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102107015|NCT03397862|Donepezil|donepezil|mesh-list
102107016|NCT03397862|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102107017|NCT03397862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102107018|NCT03397862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107019|NCT03397862|Cholinergic Agents|cholinergic agents|mesh-ancestor
102107020|NCT03397862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102107021|NCT03397862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107022|NCT03397862|Nootropic Agents|nootropic agents|mesh-ancestor
102107023|NCT02100267|Methacholine Chloride|methacholine chloride|mesh-list
102107024|NCT02100267|Miotics|miotics|mesh-ancestor
102107025|NCT02100267|Autonomic Agents|autonomic agents|mesh-ancestor
102107026|NCT02100267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102107027|NCT02100267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107028|NCT02100267|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102107029|NCT02100267|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
102107030|NCT02100267|Respiratory System Agents|respiratory system agents|mesh-ancestor
102107031|NCT02100267|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102107032|NCT02100267|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102107033|NCT02100267|Cholinergic Agents|cholinergic agents|mesh-ancestor
102107034|NCT02100267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102107035|NCT02100267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107036|NCT02094963|Clopidogrel|clopidogrel|mesh-list
102107037|NCT02094963|Ticagrelor|ticagrelor|mesh-list
102107038|NCT02094963|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102107039|NCT02094963|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102107040|NCT02094963|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102107041|NCT02094963|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102107042|NCT02094963|Purinergic Agents|purinergic agents|mesh-ancestor
102107043|NCT02094963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102107044|NCT02094963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107045|NCT02094963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107046|NCT03982810|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102107047|NCT03982810|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102107048|NCT03982810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102107049|NCT03982810|Antitubercular Agents|antitubercular agents|mesh-ancestor
102107050|NCT02098317|Vitamin D|vitamin d|mesh-list
102107051|NCT02098317|Vitamins|vitamins|mesh-ancestor
102107052|NCT02098317|Micronutrients|micronutrients|mesh-ancestor
102107053|NCT02098317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107054|NCT02098317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102107055|NCT02100423|Vitamin D|vitamin d|mesh-list
102107056|NCT02100423|Cholecalciferol|cholecalciferol|mesh-list
102107057|NCT02100423|Curcumin|curcumin|mesh-list
102107058|NCT02100423|Vitamins|vitamins|mesh-ancestor
102107059|NCT02100423|Micronutrients|micronutrients|mesh-ancestor
102107060|NCT02100423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107061|NCT02100423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102107062|NCT02100423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102107063|NCT02100423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102107064|NCT02100423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102107065|NCT02100423|Analgesics|analgesics|mesh-ancestor
102107066|NCT02100423|Sensory System Agents|sensory system agents|mesh-ancestor
102107067|NCT02100423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102107068|NCT02100423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102107069|NCT02100423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102107070|NCT02100423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102107071|NCT02100423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101226324|NCT01533740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102107072|NCT02100423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107073|NCT05614648|Clonidine|clonidine|mesh-list
102107074|NCT05614648|Analgesics|analgesics|mesh-ancestor
102107075|NCT05614648|Sensory System Agents|sensory system agents|mesh-ancestor
102107076|NCT05614648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102107077|NCT05614648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107078|NCT05614648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102107079|NCT05614648|Sympatholytics|sympatholytics|mesh-ancestor
102107080|NCT05614648|Autonomic Agents|autonomic agents|mesh-ancestor
102107081|NCT05614648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102107082|NCT05614648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102107083|NCT05614648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102107084|NCT05614648|Adrenergic Agents|adrenergic agents|mesh-ancestor
102107085|NCT05614648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102107086|NCT05614648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107087|NCT02520752|Midazolam|midazolam|mesh-list
102107088|NCT02520752|Caffeine|caffeine|mesh-list
102107089|NCT02520752|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102107090|NCT02520752|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102107091|NCT02520752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102107092|NCT02520752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107093|NCT02520752|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102107094|NCT02520752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102107095|NCT02520752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102107096|NCT02520752|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102107097|NCT02520752|Anesthetics, General|anesthetics, general|mesh-ancestor
102107098|NCT02520752|Anesthetics|anesthetics|mesh-ancestor
102107099|NCT02520752|GABA Modulators|gaba modulators|mesh-ancestor
102107100|NCT02520752|GABA Agents|gaba agents|mesh-ancestor
102107101|NCT02520752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102107102|NCT02520752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107103|NCT02520752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102107104|NCT02520752|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102107105|NCT02520752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102107106|NCT02520752|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102107107|NCT02520752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102107108|NCT02520752|Purinergic Agents|purinergic agents|mesh-ancestor
102107109|NCT02095119|Gemcitabine|gemcitabine|mesh-list
102107110|NCT02095119|Nimotuzumab|nimotuzumab|mesh-list
102107111|NCT02095119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102107112|NCT02095119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102107113|NCT02095119|Antimetabolites|antimetabolites|mesh-ancestor
102107114|NCT02095119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107115|NCT02095119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102107116|NCT02098629|Milrinone|milrinone|mesh-list
102107117|NCT02098629|Esmolol|esmolol|mesh-list
102107118|NCT02098629|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102107119|NCT02098629|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102107120|NCT02098629|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102107121|NCT02098629|Adrenergic Agents|adrenergic agents|mesh-ancestor
102107122|NCT02098629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102107123|NCT02098629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107124|NCT02098629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107125|NCT02098629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102107126|NCT02098629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102107127|NCT02098629|Vasodilator Agents|vasodilator agents|mesh-ancestor
102107128|NCT02098629|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102107129|NCT02098629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102107130|NCT02098629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102107131|NCT02098629|Protective Agents|protective agents|mesh-ancestor
102107132|NCT02095509|Enoxaparin|enoxaparin|mesh-list
102107133|NCT02095509|Anticoagulants|anticoagulants|mesh-ancestor
102107134|NCT02095509|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102107135|NCT02095509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102107136|NCT02095509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107137|NCT03397082|Lidocaine|lidocaine|mesh-list
102107138|NCT03397082|Anesthetics, Local|anesthetics, local|mesh-ancestor
102107139|NCT03397082|Anesthetics|anesthetics|mesh-ancestor
102107140|NCT03397082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102107141|NCT03397082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107142|NCT03397082|Sensory System Agents|sensory system agents|mesh-ancestor
102107143|NCT03397082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102107144|NCT03397082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102107145|NCT03397082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102107146|NCT03397082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102107147|NCT03397082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102107148|NCT03397082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107149|NCT02101047|Phenylephrine|phenylephrine|mesh-list
102107150|NCT02101047|Oxymetazoline|oxymetazoline|mesh-list
102107151|NCT02101047|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102107152|NCT02101047|Mydriatics|mydriatics|mesh-ancestor
102107153|NCT02101047|Autonomic Agents|autonomic agents|mesh-ancestor
102107154|NCT02101047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102107155|NCT02101047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107156|NCT02101047|Sympathomimetics|sympathomimetics|mesh-ancestor
102107157|NCT02101047|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102107158|NCT02101047|Nasal Decongestants|nasal decongestants|mesh-ancestor
102107159|NCT02101047|Respiratory System Agents|respiratory system agents|mesh-ancestor
102107160|NCT02101047|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102107161|NCT02101047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102107162|NCT02101047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102107163|NCT02101047|Adrenergic Agents|adrenergic agents|mesh-ancestor
102107164|NCT02101047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102107165|NCT02101047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107166|NCT02101047|Protective Agents|protective agents|mesh-ancestor
102107167|NCT02095665|Acetaminophen|acetaminophen|mesh-list
102107168|NCT02095665|Tamsulosin|tamsulosin|mesh-list
102107169|NCT02095665|Mirabegron|mirabegron|mesh-list
102107170|NCT02095665|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102107171|NCT02095665|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102107172|NCT02095665|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102107173|NCT02095665|Adrenergic Agents|adrenergic agents|mesh-ancestor
102107174|NCT02095665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102107175|NCT02095665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107176|NCT02095665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107177|NCT02095665|Urological Agents|urological agents|mesh-ancestor
102107178|NCT02095665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102107179|NCT02095665|Analgesics|analgesics|mesh-ancestor
102107180|NCT02095665|Sensory System Agents|sensory system agents|mesh-ancestor
102107181|NCT02095665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101560625|NCT01218516|Antimitotic Agents|antimitotic agents|mesh-ancestor
102107182|NCT02095665|Antipyretics|antipyretics|mesh-ancestor
102107183|NCT02095665|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102107184|NCT02095665|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102107185|NCT02095665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102107186|NCT03548428|Atezolizumab|atezolizumab|mesh-list
102107187|NCT03548428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102107188|NCT03548428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107189|NCT03548428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102107190|NCT03548428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102107191|NCT02101125|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102107192|NCT02101125|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102107193|NCT02101125|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102107194|NCT02101125|Antimetabolites|antimetabolites|mesh-ancestor
102107195|NCT02101125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107196|NCT02101125|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102107197|NCT02101125|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102107198|NCT02101125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102107199|NCT02101203|Buspirone|buspirone|mesh-list
102107200|NCT02101203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102107201|NCT02101203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102107202|NCT02101203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101226339|NCT01533870|Rifampin|rifampin|mesh-list
102107203|NCT02101203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107204|NCT02101203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102107205|NCT02101203|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102107206|NCT02101203|Serotonin Agents|serotonin agents|mesh-ancestor
102107207|NCT02101203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102107208|NCT02101203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107209|NCT04523246|Vaccines|vaccines|mesh-list
102107210|NCT04523246|Immunologic Factors|immunologic factors|mesh-ancestor
102107211|NCT04523246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107212|NCT03396380|Calcium, Dietary|calcium, dietary|mesh-list
102107213|NCT03396380|Vitamin D|vitamin d|mesh-list
102107214|NCT03396380|Citric Acid|citric acid|mesh-list
102107215|NCT03396380|Sodium Citrate|sodium citrate|mesh-list
102107216|NCT03396380|Clomiphene|clomiphene|mesh-list
102107217|NCT03396380|Enclomiphene|enclomiphene|mesh-list
102107218|NCT03396380|Zuclomiphene|zuclomiphene|mesh-list
102107219|NCT03396380|Calcium|calcium|mesh-list
102107220|NCT03396380|Vitamins|vitamins|mesh-ancestor
102107221|NCT03396380|Micronutrients|micronutrients|mesh-ancestor
102107222|NCT03396380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107223|NCT03396380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102107224|NCT03396380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102107225|NCT03396380|Anticoagulants|anticoagulants|mesh-ancestor
102107226|NCT03396380|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102107227|NCT03396380|Chelating Agents|chelating agents|mesh-ancestor
102107228|NCT03396380|Sequestering Agents|sequestering agents|mesh-ancestor
102107229|NCT03396380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107230|NCT03396380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102107231|NCT03396380|Hormone Antagonists|hormone antagonists|mesh-ancestor
102107232|NCT03396380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102107233|NCT03396380|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102107234|NCT03396380|Fertility Agents|fertility agents|mesh-ancestor
102107235|NCT03396380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102107236|NCT03396380|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102107237|NCT03396380|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102107238|NCT05040568|Cyclophosphamide|cyclophosphamide|mesh-list
102107239|NCT05040568|Fludarabine|fludarabine|mesh-list
102107240|NCT05040568|Fludarabine phosphate|fludarabine phosphate|mesh-list
102107241|NCT05040568|Cetuximab|cetuximab|mesh-list
102107242|NCT05040568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102107243|NCT05040568|Immunologic Factors|immunologic factors|mesh-ancestor
102107244|NCT05040568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107245|NCT05040568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102107246|NCT05040568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102107247|NCT05040568|Alkylating Agents|alkylating agents|mesh-ancestor
101954115|NCT03785067|Telmisartan|telmisartan|mesh-list
102107248|NCT05040568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107250|NCT05040568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102107251|NCT05040568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102107252|NCT05040568|Antimetabolites|antimetabolites|mesh-ancestor
102107253|NCT05040568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102107254|NCT03414164|Procyanidin|procyanidin|mesh-list
102107255|NCT03414164|Antioxidants|antioxidants|mesh-ancestor
102107256|NCT03414164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363769|NCT00080847|Vincristine|vincristine|mesh-list
102107258|NCT03414164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107259|NCT05613478|Apatinib|apatinib|mesh-list
102107260|NCT05613478|Chlorotrianisene|chlorotrianisene|mesh-list
102107261|NCT05613478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102107262|NCT05613478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102107263|NCT05613478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102107264|NCT05613478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107265|NCT05613478|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102107266|NCT05613478|Estrogens|estrogens|mesh-ancestor
102107267|NCT05613478|Hormones|hormones|mesh-ancestor
102107268|NCT05613478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102107269|NCT05613478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107270|NCT05613478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102107271|NCT04412018|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
102107272|NCT04412018|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102107273|NCT04412018|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102107274|NCT03406988|Nifedipine|nifedipine|mesh-list
102107275|NCT03406988|Iloprost|iloprost|mesh-list
102107276|NCT03406988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102107277|NCT03406988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102107278|NCT03406988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107279|NCT03406988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102107280|NCT03406988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107281|NCT03406988|Vasodilator Agents|vasodilator agents|mesh-ancestor
102107282|NCT03406988|Tocolytic Agents|tocolytic agents|mesh-ancestor
102107283|NCT03406988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102107284|NCT03406988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102107285|NCT03406832|Nitroprusside|nitroprusside|mesh-list
102107286|NCT03406832|Tirofiban|tirofiban|mesh-list
102107287|NCT03406832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102107288|NCT03406832|Vasodilator Agents|vasodilator agents|mesh-ancestor
102107289|NCT03406832|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102107290|NCT03406832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107291|NCT03406832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102107292|NCT03406832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102107293|NCT03406832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102107294|NCT03405974|Aspirin|aspirin|mesh-list
102107295|NCT03405974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102107296|NCT03405974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102107297|NCT03405974|Analgesics|analgesics|mesh-ancestor
102107298|NCT03405974|Sensory System Agents|sensory system agents|mesh-ancestor
102107299|NCT03405974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102107300|NCT03405974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107301|NCT03405974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102107302|NCT03405974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102107303|NCT03405974|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102107304|NCT03405974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102107305|NCT03405974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107306|NCT03405974|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102107307|NCT03405974|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102107308|NCT03405974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102107309|NCT03405974|Antipyretics|antipyretics|mesh-ancestor
102107310|NCT04337060|Lidocaine|lidocaine|mesh-list
102107311|NCT04337060|Morphine|morphine|mesh-list
102107312|NCT04337060|Bupivacaine|bupivacaine|mesh-list
102107313|NCT04337060|Anesthetics, Local|anesthetics, local|mesh-ancestor
102107314|NCT04337060|Anesthetics|anesthetics|mesh-ancestor
102107315|NCT04337060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102107316|NCT04337060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107317|NCT04337060|Sensory System Agents|sensory system agents|mesh-ancestor
102107318|NCT04337060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102107319|NCT04337060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102107320|NCT04337060|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102107321|NCT04337060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102107322|NCT04337060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102107323|NCT04337060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107324|NCT04337060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102107325|NCT04337060|Narcotics|narcotics|mesh-ancestor
102107326|NCT04337060|Analgesics|analgesics|mesh-ancestor
102107327|NCT04339036|Capecitabine|capecitabine|mesh-list
102107328|NCT04339036|Temozolomide|temozolomide|mesh-list
102107329|NCT04339036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102107330|NCT04339036|Antimetabolites|antimetabolites|mesh-ancestor
102107331|NCT04339036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107332|NCT04339036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102107333|NCT04339036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102107334|NCT04339036|Alkylating Agents|alkylating agents|mesh-ancestor
102107335|NCT04447274|Apatinib|apatinib|mesh-list
102107336|NCT04447274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102107337|NCT04447274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102107338|NCT04447274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102107339|NCT04447274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107340|NCT02977156|Ipilimumab|ipilimumab|mesh-list
102107341|NCT02977156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102107342|NCT02977156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102107343|NCT02977156|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102107344|NCT02977156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107345|NCT02413138|Hormones|hormones|mesh-list
102107346|NCT02413138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102107347|NCT02413138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107348|NCT01014598|Cisplatin|cisplatin|mesh-list
102107349|NCT01014598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102107350|NCT03404804|Amoxicillin|amoxicillin|mesh-list
102107351|NCT03404804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102107352|NCT03404804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102107353|NCT03403946|Pyrithione zinc|pyrithione zinc|mesh-list
102107354|NCT03403946|Keratolytic Agents|keratolytic agents|mesh-ancestor
102107355|NCT03403946|Dermatologic Agents|dermatologic agents|mesh-ancestor
102107356|NCT05611372|Rasagiline|rasagiline|mesh-list
102107357|NCT05611372|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102107358|NCT05611372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102107359|NCT05611372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107360|NCT05611372|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102107361|NCT05611372|Protective Agents|protective agents|mesh-ancestor
102107362|NCT05611372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107363|NCT03395756|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102107364|NCT03395756|Medroxyprogesterone|medroxyprogesterone|mesh-list
102107365|NCT03395756|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102107366|NCT03395756|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102107367|NCT03395756|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102107368|NCT03395756|Contraceptive Agents|contraceptive agents|mesh-ancestor
102107369|NCT03395756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102107370|NCT03395756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107371|NCT03395756|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102107372|NCT03395756|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102107373|NCT03395756|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102107374|NCT03395756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102107375|NCT03395756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102107376|NCT05613166|Everolimus|everolimus|mesh-list
102107377|NCT05613166|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102107378|NCT05613166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102107379|NCT05613166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102107380|NCT05613166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107381|NCT05613166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102107382|NCT05613166|Immunologic Factors|immunologic factors|mesh-ancestor
102107383|NCT05613166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107384|NCT05613166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102107385|NCT05166668|Letrozole|letrozole|mesh-list
102107386|NCT05166668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102107387|NCT05166668|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102107388|NCT05166668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102107389|NCT05166668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102107390|NCT05166668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107392|NCT05166668|Hormone Antagonists|hormone antagonists|mesh-ancestor
102107393|NCT05166668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102107394|NCT05166668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107395|NCT05558176|Sildenafil Citrate|sildenafil citrate|mesh-list
102107396|NCT05558176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107397|NCT05558176|Vasodilator Agents|vasodilator agents|mesh-ancestor
102107398|NCT05558176|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102107399|NCT05558176|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102107400|NCT05558176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102107401|NCT05558176|Urological Agents|urological agents|mesh-ancestor
101560850|NCT00934843|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101836458|NCT00483756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107402|NCT04748224|Dexmedetomidine|dexmedetomidine|mesh-list
102107403|NCT04748224|Bupivacaine|bupivacaine|mesh-list
102107404|NCT04748224|Anesthetics, Local|anesthetics, local|mesh-ancestor
102107405|NCT04748224|Anesthetics|anesthetics|mesh-ancestor
102107406|NCT04748224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102107407|NCT04748224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107408|NCT04748224|Sensory System Agents|sensory system agents|mesh-ancestor
102107409|NCT04748224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102107410|NCT04748224|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102107411|NCT04748224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102107412|NCT04748224|Analgesics|analgesics|mesh-ancestor
102107413|NCT04748224|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102107414|NCT04748224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102107415|NCT04748224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102107416|NCT04748224|Adrenergic Agents|adrenergic agents|mesh-ancestor
102107417|NCT04748224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102107418|NCT04748224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107420|NCT03413150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102107421|NCT03413150|Vasodilator Agents|vasodilator agents|mesh-ancestor
102107422|NCT03413150|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102107423|NCT03413150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102107424|NCT03413150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107425|NCT03413150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102107426|NCT03413150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102107427|NCT03413150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102107428|NCT03413150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102107429|NCT03413150|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102107430|NCT03413150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102107431|NCT03413150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102107432|NCT05474716|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102107433|NCT05474716|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102107434|NCT05474716|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101226383|NCT01534169|Hormones|hormones|mesh-ancestor
102107435|NCT05474716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102107436|NCT05474716|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102107437|NCT05474716|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102107438|NCT05474716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102107439|NCT05474716|Adrenergic Agents|adrenergic agents|mesh-ancestor
102107440|NCT05474716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102107441|NCT05474716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107442|NCT05474716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107443|NCT03126578|Midazolam|midazolam|mesh-list
102107444|NCT03126578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102107445|NCT03126578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102107446|NCT03126578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102107447|NCT03126578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107448|NCT03126578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102107449|NCT03126578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102107450|NCT03126578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102107451|NCT03126578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102107452|NCT03126578|Anesthetics, General|anesthetics, general|mesh-ancestor
102107453|NCT03126578|Anesthetics|anesthetics|mesh-ancestor
102107454|NCT03126578|GABA Modulators|gaba modulators|mesh-ancestor
102107455|NCT03126578|GABA Agents|gaba agents|mesh-ancestor
102107456|NCT03126578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102107457|NCT03126578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107458|NCT03412994|Apatinib|apatinib|mesh-list
102107459|NCT03412994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102107460|NCT03412994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102107461|NCT03412994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102107462|NCT03412994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107463|NCT02588248|Peppermint oil|peppermint oil|mesh-list
102107464|NCT02588248|Menthol|menthol|mesh-list
102107465|NCT02588248|Antipruritics|antipruritics|mesh-ancestor
102107466|NCT02588248|Dermatologic Agents|dermatologic agents|mesh-ancestor
102107467|NCT02588248|Antiemetics|antiemetics|mesh-ancestor
102107468|NCT02588248|Autonomic Agents|autonomic agents|mesh-ancestor
102107469|NCT02588248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102107470|NCT02588248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107471|NCT02588248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102107472|NCT02588248|Parasympatholytics|parasympatholytics|mesh-ancestor
102107473|NCT03412682|Budesonide|budesonide|mesh-list
102107474|NCT03412682|Mesalamine|mesalamine|mesh-list
102107475|NCT03412682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102107476|NCT03412682|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102107477|NCT03412682|Autonomic Agents|autonomic agents|mesh-ancestor
102107478|NCT03412682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102107479|NCT03412682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107480|NCT03412682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102107481|NCT03412682|Respiratory System Agents|respiratory system agents|mesh-ancestor
102107482|NCT03412682|Glucocorticoids|glucocorticoids|mesh-ancestor
102107483|NCT03412682|Hormones|hormones|mesh-ancestor
102107484|NCT03412682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102107485|NCT03412682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102107486|NCT03412682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102107487|NCT03412682|Analgesics|analgesics|mesh-ancestor
102107488|NCT03412682|Sensory System Agents|sensory system agents|mesh-ancestor
102107489|NCT03412682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102107490|NCT03412526|Fludarabine|fludarabine|mesh-list
102107491|NCT03412526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102107492|NCT03126422|Dexmedetomidine|dexmedetomidine|mesh-list
102107493|NCT03126422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102107494|NCT03126422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102107495|NCT03126422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107496|NCT03126422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102107497|NCT03126422|Analgesics|analgesics|mesh-ancestor
102107498|NCT03126422|Sensory System Agents|sensory system agents|mesh-ancestor
102107499|NCT03126422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102107500|NCT03126422|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102107501|NCT03126422|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102107502|NCT03126422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102107503|NCT03126422|Adrenergic Agents|adrenergic agents|mesh-ancestor
102107504|NCT03126422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102107505|NCT03126422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107506|NCT03395132|Fusidic Acid|fusidic acid|mesh-list
102107507|NCT03395132|Betamethasone|betamethasone|mesh-list
102107508|NCT03395132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102107509|NCT03395132|Glucocorticoids|glucocorticoids|mesh-ancestor
102107510|NCT03395132|Hormones|hormones|mesh-ancestor
102107511|NCT03395132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102107512|NCT03395132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107513|NCT03395132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102107514|NCT03395132|Respiratory System Agents|respiratory system agents|mesh-ancestor
102107515|NCT03395132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102107516|NCT03395132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102107517|NCT03395132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102107518|NCT03395132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102107519|NCT03395132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107520|NCT03127124|Leucovorin|leucovorin|mesh-list
102107521|NCT03127124|Fluorouracil|fluorouracil|mesh-list
102107522|NCT03127124|Bevacizumab|bevacizumab|mesh-list
102107523|NCT03127124|Oxaliplatin|oxaliplatin|mesh-list
102107524|NCT03127124|Calcium|calcium|mesh-list
102107525|NCT03127124|Levoleucovorin|levoleucovorin|mesh-list
102107526|NCT03127124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102107527|NCT03127124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107528|NCT03127124|Antimetabolites|antimetabolites|mesh-ancestor
102107529|NCT03127124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107530|NCT03127124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101954127|NCT03785067|Natriuretic Agents|natriuretic agents|mesh-ancestor
102107531|NCT03127124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102107532|NCT03127124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102107533|NCT03127124|Immunologic Factors|immunologic factors|mesh-ancestor
102107534|NCT03127124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102107535|NCT03127124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102107536|NCT03127124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102107537|NCT03127124|Growth Substances|growth substances|mesh-ancestor
102107538|NCT03127124|Growth Inhibitors|growth inhibitors|mesh-ancestor
102107539|NCT03127124|Antidotes|antidotes|mesh-ancestor
102107540|NCT03127124|Protective Agents|protective agents|mesh-ancestor
102107541|NCT03127124|Vitamin B Complex|vitamin b complex|mesh-ancestor
102107542|NCT03127124|Vitamins|vitamins|mesh-ancestor
102107543|NCT03127124|Micronutrients|micronutrients|mesh-ancestor
102107544|NCT03399110|Capecitabine|capecitabine|mesh-list
102107545|NCT03399110|Oxaliplatin|oxaliplatin|mesh-list
102107546|NCT03399110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102107547|NCT03399110|Antimetabolites|antimetabolites|mesh-ancestor
102107548|NCT03399110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836459|NCT00483756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102107549|NCT03399110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102107550|NCT03127046|Aceclofenac|aceclofenac|mesh-list
102107551|NCT03127046|Diclofenac|diclofenac|mesh-list
102107552|NCT03127046|Esomeprazole|esomeprazole|mesh-list
102107553|NCT03127046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102107554|NCT03127046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102107555|NCT03127046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102107556|NCT03127046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102107557|NCT03127046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107558|NCT03127046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102107559|NCT03127046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102107560|NCT03127046|Analgesics|analgesics|mesh-ancestor
102107561|NCT03127046|Sensory System Agents|sensory system agents|mesh-ancestor
102107562|NCT03127046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101226410|NCT01534442|Mydriatics|mydriatics|mesh-ancestor
102107563|NCT03127046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107564|NCT03127046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102107565|NCT03127046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102107566|NCT03127046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102107567|NCT05105672|Cisplatin|cisplatin|mesh-list
102107568|NCT05105672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102107569|NCT03399032|Caspofungin|caspofungin|mesh-list
102107570|NCT03399032|Antifungal Agents|antifungal agents|mesh-ancestor
102107571|NCT03399032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102107572|NCT03399032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102107573|NCT03399032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107574|NCT03394820|Dexamethasone|dexamethasone|mesh-list
102107575|NCT03394820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102107576|NCT03394820|Antiemetics|antiemetics|mesh-ancestor
102107577|NCT03394820|Autonomic Agents|autonomic agents|mesh-ancestor
102107578|NCT03394820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102107579|NCT03394820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107580|NCT03394820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102107581|NCT03394820|Glucocorticoids|glucocorticoids|mesh-ancestor
102107582|NCT03394820|Hormones|hormones|mesh-ancestor
102107583|NCT03394820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102107584|NCT03394820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102107585|NCT03394820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102107586|NCT01328054|Lapatinib|lapatinib|mesh-list
102107587|NCT01328054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102107588|NCT01328054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102107589|NCT01328054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102107590|NCT01328054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107591|NCT05067920|Antibodies|antibodies|mesh-list
102107592|NCT05067920|Immunologic Factors|immunologic factors|mesh-ancestor
102107593|NCT05067920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107594|NCT05002244|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102107595|NCT05002244|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
102107596|NCT05002244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102107597|NCT05002244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102107598|NCT05002244|Antimetabolites|antimetabolites|mesh-ancestor
102107599|NCT05002244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107600|NCT05002244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102107601|NCT05002244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102107602|NCT05002244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101954130|NCT05688111|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102107603|NCT05002244|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102107604|NCT05002244|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102107605|NCT03398876|Nicotine|nicotine|mesh-list
102107606|NCT03398876|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102107607|NCT03398876|Autonomic Agents|autonomic agents|mesh-ancestor
102107608|NCT03398876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102107609|NCT03398876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107610|NCT03398876|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102107611|NCT03398876|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102107612|NCT03398876|Cholinergic Agents|cholinergic agents|mesh-ancestor
102107613|NCT03398876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102107614|NCT03398876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107615|NCT03394586|Golimumab|golimumab|mesh-list
102107616|NCT03394586|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102107617|NCT03394586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102107618|NCT03394586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102107619|NCT03394586|Immunologic Factors|immunologic factors|mesh-ancestor
102107620|NCT03394586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107621|NCT03394430|Midazolam|midazolam|mesh-list
102107622|NCT03394430|Dexmedetomidine|dexmedetomidine|mesh-list
102107623|NCT03394430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102107624|NCT03394430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102107625|NCT03394430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107626|NCT03394430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102107627|NCT03394430|Analgesics|analgesics|mesh-ancestor
102107628|NCT03394430|Sensory System Agents|sensory system agents|mesh-ancestor
102107629|NCT03394430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102107630|NCT03394430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102107631|NCT03394430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102107632|NCT03394430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102107633|NCT03394430|Adrenergic Agents|adrenergic agents|mesh-ancestor
102107634|NCT03394430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102107635|NCT03394430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107636|NCT03394430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102107637|NCT03394430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102107638|NCT03394430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102107639|NCT03394430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102107640|NCT03394430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102107641|NCT03394430|Anesthetics, General|anesthetics, general|mesh-ancestor
102107642|NCT03394430|Anesthetics|anesthetics|mesh-ancestor
102107643|NCT03394430|GABA Modulators|gaba modulators|mesh-ancestor
102107644|NCT03394430|GABA Agents|gaba agents|mesh-ancestor
102107645|NCT03394196|Ritonavir|ritonavir|mesh-list
102107646|NCT03394196|Lopinavir|lopinavir|mesh-list
102107647|NCT03394196|Darunavir|darunavir|mesh-list
102107648|NCT03394196|Tenofovir|tenofovir|mesh-list
102107649|NCT03394196|Lamivudine|lamivudine|mesh-list
102107650|NCT03394196|Emtricitabine|emtricitabine|mesh-list
102107651|NCT03394196|Zidovudine|zidovudine|mesh-list
102107652|NCT03394196|Raltegravir Potassium|raltegravir potassium|mesh-list
102107653|NCT03394196|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102107654|NCT03394196|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102107655|NCT03394196|Protease Inhibitors|protease inhibitors|mesh-ancestor
102107656|NCT03394196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102107657|NCT03394196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107658|NCT03394196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102107659|NCT03394196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102107660|NCT03394196|Antiviral Agents|antiviral agents|mesh-ancestor
102107661|NCT03394196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102107662|NCT03394196|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102107663|NCT03394196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102107664|NCT03394196|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102107665|NCT03394196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102107666|NCT03394196|Antimetabolites|antimetabolites|mesh-ancestor
102107667|NCT03394196|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102107668|NCT03394196|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102107669|NCT03398018|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102107670|NCT03398018|Hormones|hormones|mesh-ancestor
102107671|NCT03398018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102107672|NCT03398018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107673|NCT03411434|Methylphenidate|methylphenidate|mesh-list
102107674|NCT03411434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102107675|NCT03411434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954133|NCT05688111|Hemostatics|hemostatics|mesh-ancestor
102107676|NCT03411434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102107677|NCT03411434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102107678|NCT03411434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102107679|NCT03411434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107680|NCT03411434|Dopamine Agents|dopamine agents|mesh-ancestor
102107681|NCT03411434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102107682|NCT03126656|Methyltestosterone|methyltestosterone|mesh-list
102107683|NCT03126656|Testosterone|testosterone|mesh-list
102107684|NCT03126656|Testosterone undecanoate|testosterone undecanoate|mesh-list
102107685|NCT03126656|Testosterone enanthate|testosterone enanthate|mesh-list
102107686|NCT03126656|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102107687|NCT03126656|Androgens|androgens|mesh-ancestor
102107689|NCT03126656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102107690|NCT03126656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107691|NCT03126656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102107692|NCT03126656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102107693|NCT03126656|Anabolic Agents|anabolic agents|mesh-ancestor
102107694|NCT03385382|Dexamethasone|dexamethasone|mesh-list
102107695|NCT03385382|Ranibizumab|ranibizumab|mesh-list
102107696|NCT03385382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102107697|NCT03385382|Antiemetics|antiemetics|mesh-ancestor
102107698|NCT03385382|Autonomic Agents|autonomic agents|mesh-ancestor
102107699|NCT03385382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102107700|NCT03385382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107701|NCT03385382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102107702|NCT03385382|Glucocorticoids|glucocorticoids|mesh-ancestor
102107704|NCT03385382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102107705|NCT03385382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102107706|NCT03385382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102107707|NCT03385382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102107708|NCT03385382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102107709|NCT03385382|Growth Substances|growth substances|mesh-ancestor
102107710|NCT03385382|Growth Inhibitors|growth inhibitors|mesh-ancestor
102107711|NCT03394118|Osimertinib|osimertinib|mesh-list
102107712|NCT03394118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102107713|NCT03394118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102107714|NCT03394118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102107715|NCT03394118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107716|NCT03389672|Anesthetics|anesthetics|mesh-list
102107717|NCT03389672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102107718|NCT03389672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107719|NCT01941446|Moxifloxacin|moxifloxacin|mesh-list
102107720|NCT01941446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102107721|NCT01941446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102107722|NCT01941446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102107723|NCT01941446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102107724|NCT01941446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102107725|NCT01941446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107726|NCT01941446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102107727|NCT01907360|Methylphenidate|methylphenidate|mesh-list
102107728|NCT01907360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102107729|NCT01907360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107730|NCT01907360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102107731|NCT01907360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102107732|NCT01907360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102107733|NCT01907360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107734|NCT01907360|Dopamine Agents|dopamine agents|mesh-ancestor
102107735|NCT01907360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102107736|NCT03126188|Sertraline|sertraline|mesh-list
102107737|NCT03126188|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102107738|NCT03126188|Antidepressive Agents|antidepressive agents|mesh-ancestor
102107739|NCT03126188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102107740|NCT03126188|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102107741|NCT03126188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102107742|NCT03126188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102107743|NCT03126188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107744|NCT03126188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102107745|NCT03126188|Serotonin Agents|serotonin agents|mesh-ancestor
102107746|NCT03126188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107747|NCT03126188|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102107748|NCT03126188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102107749|NCT04446338|Antibodies|antibodies|mesh-list
102107750|NCT04446338|Immunologic Factors|immunologic factors|mesh-ancestor
102107751|NCT04446338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107752|NCT03393728|Propranolol|propranolol|mesh-list
102107753|NCT03393728|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102107754|NCT03393728|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102107755|NCT03393728|Adrenergic Agents|adrenergic agents|mesh-ancestor
102107756|NCT03393728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102107757|NCT03393728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107758|NCT03393728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107759|NCT03393728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102107760|NCT03393728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102107761|NCT03393728|Vasodilator Agents|vasodilator agents|mesh-ancestor
102107762|NCT03393572|Magnesium Sulfate|magnesium sulfate|mesh-list
102107763|NCT03393572|Nalbuphine|nalbuphine|mesh-list
102107764|NCT03393572|Bupivacaine|bupivacaine|mesh-list
102107765|NCT03393572|Anesthetics, Local|anesthetics, local|mesh-ancestor
102107766|NCT03393572|Anesthetics|anesthetics|mesh-ancestor
102107767|NCT03393572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102107768|NCT03393572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107769|NCT03393572|Sensory System Agents|sensory system agents|mesh-ancestor
102107770|NCT03393572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102107771|NCT03393572|Analgesics|analgesics|mesh-ancestor
102107772|NCT03393572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102107773|NCT03393572|Anticonvulsants|anticonvulsants|mesh-ancestor
102107774|NCT03393572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102107775|NCT03393572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102107776|NCT03393572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107777|NCT03393572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102107778|NCT03393572|Tocolytic Agents|tocolytic agents|mesh-ancestor
102107779|NCT03393572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102107780|NCT03393572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102107781|NCT03393572|Narcotics|narcotics|mesh-ancestor
102107782|NCT03393416|Antibodies|antibodies|mesh-list
102107783|NCT03393416|Immunologic Factors|immunologic factors|mesh-ancestor
102107784|NCT03393416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107785|NCT04445948|Amoxicillin|amoxicillin|mesh-list
102107786|NCT04445948|Metronidazole|metronidazole|mesh-list
102107787|NCT04445948|Clarithromycin|clarithromycin|mesh-list
102107788|NCT04445948|Lactoferrin|lactoferrin|mesh-list
102107789|NCT04445948|Esomeprazole|esomeprazole|mesh-list
102107790|NCT04445948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102107791|NCT04445948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102107792|NCT04445948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102107793|NCT04445948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102107794|NCT04445948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102107795|NCT04445948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102107796|NCT04445948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102107797|NCT04445948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102107798|NCT04445948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107799|NCT04445948|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102107800|NCT04445948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102107801|NCT04445948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102107802|NCT02479646|Lenograstim|lenograstim|mesh-list
102107803|NCT02479646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102107804|NCT02479646|Immunologic Factors|immunologic factors|mesh-ancestor
102107805|NCT02479646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107806|NCT02467868|Lenograstim|lenograstim|mesh-list
102107807|NCT02467868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102107808|NCT02467868|Immunologic Factors|immunologic factors|mesh-ancestor
102107809|NCT02467868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107810|NCT02103465|Rotigotine|rotigotine|mesh-list
102107811|NCT02103465|Dopamine Agonists|dopamine agonists|mesh-ancestor
102107812|NCT02103465|Dopamine Agents|dopamine agents|mesh-ancestor
102107813|NCT02103465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102107814|NCT02103465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101954142|NCT02059018|Analgesics|analgesics|mesh-ancestor
102107815|NCT02103465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107816|NCT02102139|Propofol|propofol|mesh-list
102107817|NCT02102139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102107818|NCT02102139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102107819|NCT02102139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107820|NCT02102139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102107821|NCT02102139|Anesthetics, General|anesthetics, general|mesh-ancestor
102107822|NCT02102139|Anesthetics|anesthetics|mesh-ancestor
102107823|NCT02102295|Ascorbic Acid|ascorbic acid|mesh-list
102107824|NCT02102295|Ascorbate-2-phosphate|ascorbate-2-phosphate|mesh-list
102107825|NCT02102295|Fluorides|fluorides|mesh-list
102107826|NCT02102295|Cariostatic Agents|cariostatic agents|mesh-ancestor
102107827|NCT02102295|Protective Agents|protective agents|mesh-ancestor
102107828|NCT02102295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107829|NCT02102295|Antioxidants|antioxidants|mesh-ancestor
102107830|NCT02102295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107831|NCT02102295|Vitamins|vitamins|mesh-ancestor
102107832|NCT02102295|Micronutrients|micronutrients|mesh-ancestor
102107833|NCT02102295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102107834|NCT02102373|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
102107835|NCT02102373|Laxatives|laxatives|mesh-ancestor
102107836|NCT02102373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102107837|NCT02103777|Caffeine|caffeine|mesh-list
102107838|NCT02103777|Caffeine citrate|caffeine citrate|mesh-list
102107839|NCT02103777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107840|NCT02103777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102107841|NCT02103777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107842|NCT02103777|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102107843|NCT02103777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102107844|NCT02103777|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102107845|NCT02103777|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102107846|NCT02103777|Purinergic Agents|purinergic agents|mesh-ancestor
102107847|NCT02103777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102107848|NCT02104011|Propranolol|propranolol|mesh-list
102107849|NCT02104011|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101836460|NCT00483756|Immunologic Factors|immunologic factors|mesh-ancestor
102107850|NCT02104011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102107851|NCT02104011|Adrenergic Agents|adrenergic agents|mesh-ancestor
102107852|NCT02104011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102107853|NCT02104011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107854|NCT02104011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107855|NCT02104011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102107856|NCT02104011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102107857|NCT02104011|Vasodilator Agents|vasodilator agents|mesh-ancestor
102107858|NCT03554889|Nimotuzumab|nimotuzumab|mesh-list
102107859|NCT03554889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102107860|NCT03554889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102107861|NCT02251041|Tocopherols|tocopherols|mesh-list
102107862|NCT02251041|Vitamin E|vitamin e|mesh-list
102107863|NCT02251041|alpha-Tocopherol|alpha-tocopherol|mesh-list
102107864|NCT02251041|Infliximab|infliximab|mesh-list
102107865|NCT02251041|Epoprostenol|epoprostenol|mesh-list
102107866|NCT02251041|Tezosentan|tezosentan|mesh-list
102107867|NCT02251041|Melatonin|melatonin|mesh-list
102107868|NCT02251041|Antithrombins|antithrombins|mesh-list
102107869|NCT02251041|Antithrombin III|antithrombin iii|mesh-list
102107870|NCT02251041|Epoetin Alfa|epoetin alfa|mesh-list
102107871|NCT02251041|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
102107872|NCT02251041|Antioxidants|antioxidants|mesh-ancestor
102107873|NCT02251041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107874|NCT02251041|Protective Agents|protective agents|mesh-ancestor
102107875|NCT02251041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107876|NCT02251041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102107877|NCT02251041|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102107878|NCT02251041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102107879|NCT02251041|Dermatologic Agents|dermatologic agents|mesh-ancestor
102107880|NCT02251041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102107881|NCT02251041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102107882|NCT02251041|Hematinics|hematinics|mesh-ancestor
102107883|NCT02251041|Vitamins|vitamins|mesh-ancestor
102107884|NCT02251041|Micronutrients|micronutrients|mesh-ancestor
102107885|NCT02251041|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102107886|NCT02251041|Protease Inhibitors|protease inhibitors|mesh-ancestor
102107887|NCT02251041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102107888|NCT02251041|Anticoagulants|anticoagulants|mesh-ancestor
102107889|NCT02251041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102107890|NCT02251041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102107891|NCT02251041|Vasodilator Agents|vasodilator agents|mesh-ancestor
102107892|NCT02251041|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102107893|NCT02251041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102107894|NCT02251041|Immunologic Factors|immunologic factors|mesh-ancestor
102107895|NCT02104323|Endostatins|endostatins|mesh-list
102107896|NCT02104323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102107897|NCT02104323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102107898|NCT02104323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102107899|NCT02104323|Growth Substances|growth substances|mesh-ancestor
102107900|NCT02104323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107901|NCT02104323|Growth Inhibitors|growth inhibitors|mesh-ancestor
102107902|NCT02107365|Interferons|interferons|mesh-list
102107903|NCT02107365|Ribavirin|ribavirin|mesh-list
102107904|NCT02107365|Interferon-alpha|interferon-alpha|mesh-list
102107905|NCT02107365|Interferon alpha-2|interferon alpha-2|mesh-list
102107906|NCT02107365|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102107907|NCT02107365|Asunaprevir|asunaprevir|mesh-list
102107908|NCT02107365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102107909|NCT02107365|Antiviral Agents|antiviral agents|mesh-ancestor
102107910|NCT02107365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102107911|NCT02107365|Antimetabolites|antimetabolites|mesh-ancestor
102107912|NCT02107365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107913|NCT02107365|Immunologic Factors|immunologic factors|mesh-ancestor
102107914|NCT02107365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107915|NCT02107365|Protease Inhibitors|protease inhibitors|mesh-ancestor
102107916|NCT02107365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102107917|NCT02110719|Acetaminophen|acetaminophen|mesh-list
102107918|NCT02110719|Dexamethasone|dexamethasone|mesh-list
102107919|NCT02110719|Ibuprofen|ibuprofen|mesh-list
102107920|NCT02110719|Celecoxib|celecoxib|mesh-list
102107921|NCT02110719|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
102107922|NCT02110719|Oxycodone|oxycodone|mesh-list
102107923|NCT02110719|Gabapentin|gabapentin|mesh-list
102107924|NCT02110719|Hydromorphone|hydromorphone|mesh-list
102107925|NCT02110719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102107926|NCT02110719|Antiemetics|antiemetics|mesh-ancestor
102107927|NCT02110719|Autonomic Agents|autonomic agents|mesh-ancestor
102107928|NCT02110719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102107929|NCT02110719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107930|NCT02110719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102107931|NCT02110719|Glucocorticoids|glucocorticoids|mesh-ancestor
102107932|NCT02110719|Hormones|hormones|mesh-ancestor
102107933|NCT02110719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102107934|NCT02110719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102107935|NCT02110719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102107936|NCT02110719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102107937|NCT02110719|Analgesics|analgesics|mesh-ancestor
102107938|NCT02110719|Sensory System Agents|sensory system agents|mesh-ancestor
102107939|NCT02110719|Antipyretics|antipyretics|mesh-ancestor
102107940|NCT02110719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102107941|NCT02110719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102107942|NCT02110719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102107943|NCT02110719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102107944|NCT02110719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107945|NCT02110719|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102107946|NCT02110719|Narcotics|narcotics|mesh-ancestor
102107947|NCT02110719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102107948|NCT02110719|Anticonvulsants|anticonvulsants|mesh-ancestor
102107949|NCT02110719|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102107950|NCT02110719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102107951|NCT02110719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102107952|NCT02110719|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102107953|NCT02110719|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102107954|NCT02110719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102107955|NCT02110719|Antimanic Agents|antimanic agents|mesh-ancestor
102107956|NCT02110719|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102107957|NCT02105103|Insulin|insulin|mesh-list
102107958|NCT02105103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102107959|NCT02105103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107960|NCT03012165|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102107961|NCT03012165|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102107962|NCT02107755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102107963|NCT02107755|Ipilimumab|ipilimumab|mesh-list
102107964|NCT02107755|Antibodies|antibodies|mesh-list
102107965|NCT02107755|Immunoglobulins|immunoglobulins|mesh-list
102107966|NCT02107755|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102107967|NCT02107755|Immunologic Factors|immunologic factors|mesh-ancestor
102107968|NCT02107755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107969|NCT02107755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102107970|NCT02107755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102107971|NCT02107755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107972|NCT02110953|Irinotecan|irinotecan|mesh-list
102107973|NCT02110953|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102107974|NCT02110953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102107975|NCT02110953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102107976|NCT02110953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107977|NCT02110953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102107978|NCT03554109|Leucovorin|leucovorin|mesh-list
102107979|NCT03554109|Paclitaxel|paclitaxel|mesh-list
102107980|NCT03554109|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102107981|NCT03554109|Cyclophosphamide|cyclophosphamide|mesh-list
102107982|NCT03554109|Doxorubicin|doxorubicin|mesh-list
102107983|NCT03554109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102107984|NCT03554109|Fluorouracil|fluorouracil|mesh-list
102107985|NCT03554109|Avelumab|avelumab|mesh-list
102107986|NCT03554109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102107987|NCT03554109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102107988|NCT03554109|Tubulin Modulators|tubulin modulators|mesh-ancestor
102107989|NCT03554109|Antimitotic Agents|antimitotic agents|mesh-ancestor
102107990|NCT03554109|Mitosis Modulators|mitosis modulators|mesh-ancestor
102107991|NCT03554109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102107992|NCT03554109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102107993|NCT03554109|Immunologic Factors|immunologic factors|mesh-ancestor
102107994|NCT03554109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102107995|NCT03554109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102107996|NCT03554109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102107997|NCT03554109|Alkylating Agents|alkylating agents|mesh-ancestor
102107998|NCT03554109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102107999|NCT03554109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102108000|NCT03554109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102108001|NCT03554109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102108002|NCT03554109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102108003|NCT03554109|Antimetabolites|antimetabolites|mesh-ancestor
102108004|NCT03554109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102108005|NCT03554109|Antidotes|antidotes|mesh-ancestor
102108006|NCT03554109|Protective Agents|protective agents|mesh-ancestor
102108007|NCT03554109|Vitamin B Complex|vitamin b complex|mesh-ancestor
102108008|NCT03554109|Vitamins|vitamins|mesh-ancestor
102108009|NCT03554109|Micronutrients|micronutrients|mesh-ancestor
102108010|NCT03554109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102108011|NCT03554031|Hormones|hormones|mesh-list
102108012|NCT03554031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102108013|NCT03554031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108014|NCT02111265|Sufentanil|sufentanil|mesh-list
102108015|NCT02111265|Remifentanil|remifentanil|mesh-list
102108016|NCT02111265|Cisatracurium|cisatracurium|mesh-list
102108017|NCT02111265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102108018|NCT02111265|Narcotics|narcotics|mesh-ancestor
102108019|NCT02111265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102108020|NCT02111265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108021|NCT02111265|Analgesics|analgesics|mesh-ancestor
102108022|NCT02111265|Sensory System Agents|sensory system agents|mesh-ancestor
102108023|NCT02111265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102108024|NCT02111265|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102108025|NCT02111265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102108026|NCT02111265|Anesthetics, General|anesthetics, general|mesh-ancestor
102108027|NCT02111265|Anesthetics|anesthetics|mesh-ancestor
102108028|NCT02111265|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102108029|NCT02111265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102108030|NCT02251119|Ritonavir|ritonavir|mesh-list
102108031|NCT02251119|Tipranavir|tipranavir|mesh-list
102108032|NCT02251119|Loperamide|loperamide|mesh-list
102108033|NCT02251119|Antidiarrheals|antidiarrheals|mesh-list
102108034|NCT02251119|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102108035|NCT02251119|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102108036|NCT02251119|Protease Inhibitors|protease inhibitors|mesh-ancestor
102108037|NCT02251119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102108038|NCT02251119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108039|NCT02251119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102108040|NCT02251119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102108041|NCT02251119|Antiviral Agents|antiviral agents|mesh-ancestor
102108042|NCT02251119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102108043|NCT02251119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102108044|NCT02251119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102108045|NCT02251119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102108046|NCT02105493|Nitroglycerin|nitroglycerin|mesh-list
102108047|NCT02105493|Vasodilator Agents|vasodilator agents|mesh-ancestor
102108048|NCT02111421|Dexmedetomidine|dexmedetomidine|mesh-list
102108049|NCT02111421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102108050|NCT02111421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102108051|NCT02111421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108052|NCT02111421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102108053|NCT02111421|Analgesics|analgesics|mesh-ancestor
102108054|NCT02111421|Sensory System Agents|sensory system agents|mesh-ancestor
102108055|NCT02111421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102108056|NCT02111421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102108057|NCT02111421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102108058|NCT02111421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102108059|NCT02111421|Adrenergic Agents|adrenergic agents|mesh-ancestor
102108060|NCT02111421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102108061|NCT02111421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108062|NCT02108301|Cyclosporine|cyclosporine|mesh-list
102108064|NCT02108301|Cyclosporins|cyclosporins|mesh-list
102108065|NCT02108301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102108066|NCT02108301|Immunologic Factors|immunologic factors|mesh-ancestor
102108067|NCT02108301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108068|NCT02108301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102108069|NCT02108301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102108070|NCT02108301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108071|NCT02108301|Antifungal Agents|antifungal agents|mesh-ancestor
102108072|NCT02108301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102108073|NCT02108301|Dermatologic Agents|dermatologic agents|mesh-ancestor
102108074|NCT02108301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101561518|NCT05246111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102108075|NCT02108535|Sulfadiazine|sulfadiazine|mesh-list
102108076|NCT02108535|Silver Sulfadiazine|silver sulfadiazine|mesh-list
102108077|NCT02108535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102108078|NCT02108535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102108079|NCT02108535|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102108080|NCT02108535|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102108081|NCT02108535|Coccidiostats|coccidiostats|mesh-ancestor
102108082|NCT02108535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102108083|NCT02114073|Cyclosporine|cyclosporine|mesh-list
102108084|NCT02114073|Betamethasone|betamethasone|mesh-list
102108085|NCT02114073|Cyclosporins|cyclosporins|mesh-list
102108086|NCT02114073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102108087|NCT02114073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108088|NCT02114073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102108089|NCT02114073|Immunologic Factors|immunologic factors|mesh-ancestor
102108090|NCT02114073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108091|NCT02114073|Antifungal Agents|antifungal agents|mesh-ancestor
102108092|NCT02114073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102108093|NCT02114073|Dermatologic Agents|dermatologic agents|mesh-ancestor
102108094|NCT02114073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102108095|NCT02114073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102108096|NCT02114073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102108097|NCT02114073|Glucocorticoids|glucocorticoids|mesh-ancestor
102108098|NCT02114073|Hormones|hormones|mesh-ancestor
102108099|NCT02114073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102108100|NCT02114073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102108101|NCT02114073|Respiratory System Agents|respiratory system agents|mesh-ancestor
102108102|NCT02114463|Flurbiprofen|flurbiprofen|mesh-list
102108103|NCT02114463|Analgesics|analgesics|mesh-list
102108104|NCT02114463|Ropivacaine|ropivacaine|mesh-list
102108105|NCT02114463|Anesthetics, Local|anesthetics, local|mesh-ancestor
102108106|NCT02114463|Anesthetics|anesthetics|mesh-ancestor
102108107|NCT02114463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102108108|NCT02114463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108109|NCT02114463|Sensory System Agents|sensory system agents|mesh-ancestor
102108110|NCT02114463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102108111|NCT02114463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102108112|NCT02114463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102108113|NCT02114463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102108114|NCT02114463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102108115|NCT02114463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102108116|NCT02114463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102108117|NCT02114463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108118|NCT02114697|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102108119|NCT02114697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102108120|NCT02114697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102108121|NCT02114697|Antimetabolites|antimetabolites|mesh-ancestor
102108122|NCT02114697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108123|NCT02114697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102108124|NCT02114697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102108125|NCT02114697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102108126|NCT02114775|Sildenafil Citrate|sildenafil citrate|mesh-list
102108127|NCT02114775|Hormones|hormones|mesh-list
102108128|NCT02114775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102108129|NCT02114775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108130|NCT02114775|Vasodilator Agents|vasodilator agents|mesh-ancestor
102108131|NCT02114775|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102108132|NCT02114775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102108133|NCT02114775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102108134|NCT02114775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108135|NCT02114775|Urological Agents|urological agents|mesh-ancestor
102108136|NCT02108847|Ropivacaine|ropivacaine|mesh-list
102108137|NCT02108847|Anesthetics, Local|anesthetics, local|mesh-ancestor
102108138|NCT02108847|Anesthetics|anesthetics|mesh-ancestor
102108139|NCT02108847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102108140|NCT02108847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108141|NCT02108847|Sensory System Agents|sensory system agents|mesh-ancestor
102108142|NCT02108847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102108143|NCT03553329|Trametinib|trametinib|mesh-list
102108144|NCT03553329|Dabrafenib|dabrafenib|mesh-list
102108145|NCT03553329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102108146|NCT03553329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102108147|NCT03553329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102108148|NCT03553329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108149|NCT02115087|Morphine|morphine|mesh-list
102108150|NCT02115087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102108151|NCT02115087|Narcotics|narcotics|mesh-ancestor
102108152|NCT02115087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102108153|NCT02115087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108154|NCT02115087|Analgesics|analgesics|mesh-ancestor
102108155|NCT02115087|Sensory System Agents|sensory system agents|mesh-ancestor
102108156|NCT02115087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102108157|NCT02115243|Ipilimumab|ipilimumab|mesh-list
102108158|NCT02115243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102108159|NCT02115243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102108160|NCT02115243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102108161|NCT02115243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108162|NCT02109315|Liraglutide|liraglutide|mesh-list
102108163|NCT02109315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108164|NCT02109315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102108165|NCT02109315|Incretins|incretins|mesh-ancestor
102108166|NCT02109315|Hormones|hormones|mesh-ancestor
102108167|NCT02109315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102108168|NCT02112903|Vortioxetine|vortioxetine|mesh-list
102108169|NCT02112903|Antidepressive Agents|antidepressive agents|mesh-ancestor
102108170|NCT02112903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102108171|NCT02112903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102108172|NCT02112903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102108173|NCT02112903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102108174|NCT02112903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108175|NCT02112903|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102108176|NCT02112903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102108177|NCT02112903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102108178|NCT02112903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108179|NCT02112903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102108181|NCT02112903|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102108182|NCT02112903|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102108183|NCT02112903|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102108184|NCT02112903|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102108185|NCT02112981|Sirolimus|sirolimus|mesh-list
102108186|NCT02112981|Everolimus|everolimus|mesh-list
102108187|NCT02112981|MTOR Inhibitors|mtor inhibitors|mesh-list
102108188|NCT02112981|Temsirolimus|temsirolimus|mesh-list
102108189|NCT02112981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102108190|NCT02112981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102108191|NCT02112981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108192|NCT02112981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102108193|NCT02112981|Immunologic Factors|immunologic factors|mesh-ancestor
102108194|NCT02112981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108195|NCT02112981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102108196|NCT02112981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102108197|NCT02112981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102108198|NCT02112981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102108199|NCT02112981|Antifungal Agents|antifungal agents|mesh-ancestor
102108200|NCT02113137|Chlorine dioxide|chlorine dioxide|mesh-list
102108201|NCT02113137|Dental Disinfectants|dental disinfectants|mesh-ancestor
102108202|NCT02113137|Disinfectants|disinfectants|mesh-ancestor
102108203|NCT02113137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102108204|NCT02116257|Propacetamol|propacetamol|mesh-list
102108205|NCT02116257|Analgesics|analgesics|mesh-ancestor
102108206|NCT02116257|Sensory System Agents|sensory system agents|mesh-ancestor
102108207|NCT02116257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102108208|NCT02116257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108209|NCT02116257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102108210|NCT02116257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102108211|NCT02116257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102108212|NCT02116257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102108213|NCT02109627|Cytarabine|cytarabine|mesh-list
102108214|NCT02109627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102108215|NCT02109627|Antimetabolites|antimetabolites|mesh-ancestor
102108216|NCT02109627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108217|NCT02109627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102108218|NCT02109627|Antiviral Agents|antiviral agents|mesh-ancestor
102108219|NCT02109627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102108220|NCT02109627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102108221|NCT02109627|Immunologic Factors|immunologic factors|mesh-ancestor
102108222|NCT02109627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108223|NCT02116569|Daratumumab|daratumumab|mesh-list
102108224|NCT02116569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102108225|NCT02109783|Caffeine|caffeine|mesh-list
102108226|NCT02109783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102108227|NCT02109783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108228|NCT02109783|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102108229|NCT02109783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102108230|NCT02109783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108231|NCT02109783|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102108232|NCT02109783|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102108233|NCT02109783|Purinergic Agents|purinergic agents|mesh-ancestor
102108234|NCT02109783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102108235|NCT02109861|Dexamethasone|dexamethasone|mesh-list
102108236|NCT02109861|Bortezomib|bortezomib|mesh-list
102108237|NCT02109861|Melphalan|melphalan|mesh-list
102108238|NCT02109861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102108239|NCT02109861|Antiemetics|antiemetics|mesh-ancestor
102108240|NCT02109861|Autonomic Agents|autonomic agents|mesh-ancestor
102108241|NCT02109861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102108242|NCT02109861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108243|NCT02109861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102108244|NCT02109861|Glucocorticoids|glucocorticoids|mesh-ancestor
102108245|NCT02109861|Hormones|hormones|mesh-ancestor
102108246|NCT02109861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102108247|NCT02109861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102108248|NCT02109861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102108249|NCT02109861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102108250|NCT02109861|Alkylating Agents|alkylating agents|mesh-ancestor
102108251|NCT02109861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108252|NCT02109861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102108253|NCT02109861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102108254|NCT02109861|Immunologic Factors|immunologic factors|mesh-ancestor
102108256|NCT02118753|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102108257|NCT02118753|Hormone Antagonists|hormone antagonists|mesh-ancestor
102108258|NCT02118753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102108259|NCT02118753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108260|NCT02118753|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102108261|NCT02118753|Diuretics|diuretics|mesh-ancestor
102108262|NCT02118753|Natriuretic Agents|natriuretic agents|mesh-ancestor
102108263|NCT02118753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102108264|NCT02118909|Itraconazole|itraconazole|mesh-list
102108265|NCT02118909|Ciprofloxacin|ciprofloxacin|mesh-list
102108266|NCT02118909|Antifungal Agents|antifungal agents|mesh-ancestor
102108267|NCT02118909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102108268|NCT02118909|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102108269|NCT02118909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102108270|NCT02118909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102108271|NCT02118909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108272|NCT02118909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102108273|NCT02118909|Hormone Antagonists|hormone antagonists|mesh-ancestor
101226527|NCT01535092|Silybin|silybin|mesh-list
102108274|NCT02118909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102108275|NCT02118909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108276|NCT02118909|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102108277|NCT02118909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102108278|NCT02118909|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102108279|NCT02118909|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102108280|NCT02118909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102108281|NCT02118909|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102108282|NCT02118987|Omalizumab|omalizumab|mesh-list
102108283|NCT02118987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102108284|NCT02118987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102108285|NCT02118987|Respiratory System Agents|respiratory system agents|mesh-ancestor
102108286|NCT02119143|Vitamins|vitamins|mesh-list
102108287|NCT02119143|Micronutrients|micronutrients|mesh-ancestor
102108288|NCT02119143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108289|NCT02116959|Carboplatin|carboplatin|mesh-list
102108290|NCT02116959|Etoposide|etoposide|mesh-list
102108291|NCT02116959|Vincristine|vincristine|mesh-list
102108292|NCT02116959|Melphalan|melphalan|mesh-list
102108293|NCT02116959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102108294|NCT02116959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102108295|NCT02116959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102108296|NCT02116959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102108297|NCT02116959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102108298|NCT02116959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108299|NCT02116959|Tubulin Modulators|tubulin modulators|mesh-ancestor
102108300|NCT02116959|Antimitotic Agents|antimitotic agents|mesh-ancestor
102108301|NCT02116959|Mitosis Modulators|mitosis modulators|mesh-ancestor
102108302|NCT02116959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102108303|NCT02116959|Alkylating Agents|alkylating agents|mesh-ancestor
102108304|NCT02116959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102108305|NCT02116959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102108306|NCT02116959|Immunologic Factors|immunologic factors|mesh-ancestor
102108307|NCT02116959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108308|NCT03553173|Bupropion|bupropion|mesh-list
102108309|NCT03553173|Varenicline|varenicline|mesh-list
102108310|NCT03553173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102108311|NCT03553173|Antidepressive Agents|antidepressive agents|mesh-ancestor
102108312|NCT03553173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102108313|NCT03553173|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101954164|NCT01561209|Adrenergic Agents|adrenergic agents|mesh-ancestor
102108314|NCT03553173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102108315|NCT03553173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102108316|NCT03553173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108317|NCT03553173|Dopamine Agents|dopamine agents|mesh-ancestor
102108318|NCT03553173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102108319|NCT03553173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108320|NCT03553173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102108321|NCT03553173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102108322|NCT03553173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102108323|NCT03553173|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102108324|NCT03553173|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102108325|NCT03553173|Cholinergic Agents|cholinergic agents|mesh-ancestor
102108327|NCT01330017|Phenylephrine|phenylephrine|mesh-list
102108328|NCT01330017|Oxymetazoline|oxymetazoline|mesh-list
102108329|NCT01330017|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102108330|NCT01330017|Mydriatics|mydriatics|mesh-ancestor
102108331|NCT01330017|Autonomic Agents|autonomic agents|mesh-ancestor
102108332|NCT01330017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102108333|NCT01330017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108334|NCT01330017|Sympathomimetics|sympathomimetics|mesh-ancestor
102108335|NCT01330017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102108336|NCT01330017|Nasal Decongestants|nasal decongestants|mesh-ancestor
102108337|NCT01330017|Respiratory System Agents|respiratory system agents|mesh-ancestor
102108338|NCT01330017|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102108339|NCT01330017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102108340|NCT01330017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102108341|NCT01330017|Adrenergic Agents|adrenergic agents|mesh-ancestor
102108342|NCT01330017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102108343|NCT01330017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108344|NCT01330017|Protective Agents|protective agents|mesh-ancestor
102108345|NCT01330017|Antipruritics|antipruritics|mesh-ancestor
102108346|NCT01330017|Dermatologic Agents|dermatologic agents|mesh-ancestor
102108347|NCT01330017|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102108348|NCT01330017|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102108349|NCT01330017|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102108350|NCT01330017|Histamine Antagonists|histamine antagonists|mesh-ancestor
102108351|NCT01330017|Histamine Agents|histamine agents|mesh-ancestor
102108352|NCT02117583|Oxycodone|oxycodone|mesh-list
102108353|NCT02117583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102108354|NCT02117583|Narcotics|narcotics|mesh-ancestor
102108355|NCT02117583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102108356|NCT02117583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108357|NCT02117583|Analgesics|analgesics|mesh-ancestor
102108358|NCT02117583|Sensory System Agents|sensory system agents|mesh-ancestor
102108359|NCT02117583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102108360|NCT02117739|Dapsone|dapsone|mesh-list
102108361|NCT02117739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102108362|NCT02117739|Antimalarials|antimalarials|mesh-ancestor
102108363|NCT02117739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102108364|NCT02117739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102108365|NCT02117739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102108366|NCT02117739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102108367|NCT02117739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108368|NCT02117739|Leprostatic Agents|leprostatic agents|mesh-ancestor
102108369|NCT02117739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102108370|NCT02251509|Metoprolol|metoprolol|mesh-list
102108371|NCT02251509|Carvedilol|carvedilol|mesh-list
101561820|NCT04220931|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101561821|NCT04220931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101561822|NCT04220931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561823|NCT04220931|Cholinergic Agents|cholinergic agents|mesh-ancestor
101561824|NCT04220931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101561825|NCT04220931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108372|NCT02251509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102108373|NCT02251509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102108374|NCT02251509|Sympatholytics|sympatholytics|mesh-ancestor
102108375|NCT02251509|Autonomic Agents|autonomic agents|mesh-ancestor
102108376|NCT02251509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102108377|NCT02251509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101954171|NCT02800642|Growth Inhibitors|growth inhibitors|mesh-ancestor
102108378|NCT02251509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102108379|NCT02251509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102108380|NCT02251509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102108381|NCT02251509|Adrenergic Agents|adrenergic agents|mesh-ancestor
102108382|NCT02251509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102108383|NCT02251509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108384|NCT02251509|Antioxidants|antioxidants|mesh-ancestor
102108385|NCT02251509|Protective Agents|protective agents|mesh-ancestor
102108386|NCT02251509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102108387|NCT02251509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102108388|NCT02251509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102108389|NCT02251509|Vasodilator Agents|vasodilator agents|mesh-ancestor
102108390|NCT02251509|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102108391|NCT02251509|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102108393|NCT02986659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102108394|NCT02986659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108395|NCT02118051|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102108396|NCT02118051|Progesterone|progesterone|mesh-list
102108397|NCT02118051|Ganirelix|ganirelix|mesh-list
102108398|NCT02118051|Progestins|progestins|mesh-ancestor
102108399|NCT02118051|Hormones|hormones|mesh-ancestor
101226556|NCT01535183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102108400|NCT02118051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102108401|NCT02118051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108402|NCT02118051|Hormone Antagonists|hormone antagonists|mesh-ancestor
102108403|NCT02118051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102108404|NCT02123355|Dexmedetomidine|dexmedetomidine|mesh-list
102108405|NCT02123355|Remifentanil|remifentanil|mesh-list
102108406|NCT02123355|Sevoflurane|sevoflurane|mesh-list
102108407|NCT02123355|Vecuronium Bromide|vecuronium bromide|mesh-list
102108408|NCT02123355|Anesthetics|anesthetics|mesh-ancestor
102108409|NCT02123355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102108410|NCT02123355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108411|NCT02123355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102108412|NCT02123355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102108413|NCT02123355|Analgesics|analgesics|mesh-ancestor
102108414|NCT02123355|Sensory System Agents|sensory system agents|mesh-ancestor
102108415|NCT02123355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102108416|NCT02123355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102108417|NCT02123355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102108418|NCT02123355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102108419|NCT02123355|Adrenergic Agents|adrenergic agents|mesh-ancestor
102108420|NCT02123355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102108421|NCT02123355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108422|NCT02123355|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102108423|NCT02123355|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102108424|NCT02123355|Anesthetics, General|anesthetics, general|mesh-ancestor
102108425|NCT02123355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102108426|NCT02123355|Narcotics|narcotics|mesh-ancestor
102108427|NCT02123355|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102108428|NCT02123355|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102108429|NCT02123355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102108430|NCT02123355|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102108431|NCT02123355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102108432|NCT02123355|Cholinergic Agents|cholinergic agents|mesh-ancestor
102108433|NCT02123433|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102108434|NCT02123433|Immunologic Factors|immunologic factors|mesh-ancestor
102108435|NCT02123433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108436|NCT02123589|Fentanyl|fentanyl|mesh-list
102108437|NCT02123589|Midazolam|midazolam|mesh-list
102108438|NCT02123589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102108439|NCT02123589|Narcotics|narcotics|mesh-ancestor
102108440|NCT02123589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102108441|NCT02123589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108442|NCT02123589|Analgesics|analgesics|mesh-ancestor
102108443|NCT02123589|Sensory System Agents|sensory system agents|mesh-ancestor
102108444|NCT02123589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101836461|NCT00483756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108445|NCT02123589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102108446|NCT02123589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102108447|NCT02123589|Anesthetics, General|anesthetics, general|mesh-ancestor
102108449|NCT02123589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102108450|NCT02123589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102108451|NCT02123589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102108452|NCT02123589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102108453|NCT02123589|GABA Modulators|gaba modulators|mesh-ancestor
102108454|NCT02123589|GABA Agents|gaba agents|mesh-ancestor
102108455|NCT02123589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102108456|NCT02123589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108457|NCT02120547|Cenicriviroc|cenicriviroc|mesh-list
102108458|NCT02120547|Liver Extracts|liver extracts|mesh-list
102108459|NCT02120547|Hematinics|hematinics|mesh-ancestor
102108460|NCT02120547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102108461|NCT02120547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108462|NCT02120547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102108463|NCT02120547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102108464|NCT02120547|Antiviral Agents|antiviral agents|mesh-ancestor
102108465|NCT02120547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102108466|NCT02120703|Pregabalin|pregabalin|mesh-list
102108467|NCT02120703|Gabapentin|gabapentin|mesh-list
102108468|NCT02120703|Analgesics|analgesics|mesh-ancestor
102108469|NCT02120703|Sensory System Agents|sensory system agents|mesh-ancestor
102108470|NCT02120703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102108471|NCT02120703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108472|NCT02120703|Anticonvulsants|anticonvulsants|mesh-ancestor
102108473|NCT02120703|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102108474|NCT02120703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102108475|NCT02120703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108476|NCT02120703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102108477|NCT02120703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102108478|NCT02120703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102108479|NCT02120703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102108480|NCT02120703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102108481|NCT02120703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102108482|NCT02120703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102108483|NCT02120703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102108484|NCT02120703|Antimanic Agents|antimanic agents|mesh-ancestor
102108485|NCT02118285|Cyclophosphamide|cyclophosphamide|mesh-list
102108486|NCT02118285|Fludarabine|fludarabine|mesh-list
102108487|NCT02118285|Interleukin-2|interleukin-2|mesh-list
102108488|NCT02118285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102108489|NCT02118285|Immunologic Factors|immunologic factors|mesh-ancestor
102108490|NCT02118285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108491|NCT02118285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102108492|NCT02118285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102108493|NCT02118285|Alkylating Agents|alkylating agents|mesh-ancestor
102108494|NCT02118285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108495|NCT02118285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102108496|NCT02118285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102108497|NCT02118285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102108498|NCT02118285|Analgesics|analgesics|mesh-ancestor
102108499|NCT02118285|Sensory System Agents|sensory system agents|mesh-ancestor
102108500|NCT02118285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102108501|NCT03552705|Tranexamic Acid|tranexamic acid|mesh-list
102108502|NCT03552705|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102108503|NCT03552705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102108504|NCT03552705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108505|NCT03552705|Hemostatics|hemostatics|mesh-ancestor
102108506|NCT03552705|Coagulants|coagulants|mesh-ancestor
102108507|NCT02118675|Deuterium Oxide|deuterium oxide|mesh-list
102108508|NCT02118675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102108509|NCT02118675|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102108510|NCT02118675|Protective Agents|protective agents|mesh-ancestor
102108511|NCT02118675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108512|NCT02123979|Rotigotine|rotigotine|mesh-list
102108513|NCT02123979|Dopamine Agonists|dopamine agonists|mesh-ancestor
102108514|NCT02123979|Dopamine Agents|dopamine agents|mesh-ancestor
101954182|NCT02056678|Antipyretics|antipyretics|mesh-ancestor
102108515|NCT02123979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102108516|NCT02123979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108517|NCT02123979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108518|NCT03552315|Chromium|chromium|mesh-list
102108519|NCT03552315|Trace Elements|trace elements|mesh-ancestor
102108520|NCT03552315|Micronutrients|micronutrients|mesh-ancestor
102108521|NCT03552315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108523|NCT02120859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102108524|NCT02120859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102108525|NCT02120859|Tubulin Modulators|tubulin modulators|mesh-ancestor
102108526|NCT02120859|Antimitotic Agents|antimitotic agents|mesh-ancestor
102108527|NCT02120859|Mitosis Modulators|mitosis modulators|mesh-ancestor
102108528|NCT02120859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108529|NCT02126943|Macitentan|macitentan|mesh-list
102108530|NCT02126943|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
102108531|NCT02126943|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102108532|NCT02126943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108533|NCT02126943|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
102108534|NCT03551847|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102108535|NCT03551847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102108536|NCT03551847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102108537|NCT03551847|Antitubercular Agents|antitubercular agents|mesh-ancestor
102108538|NCT00150462|Dexamethasone|dexamethasone|mesh-list
102108539|NCT00150462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102108540|NCT00150462|Antiemetics|antiemetics|mesh-ancestor
102108541|NCT00150462|Autonomic Agents|autonomic agents|mesh-ancestor
102108542|NCT00150462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102108543|NCT00150462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108544|NCT00150462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102108545|NCT00150462|Glucocorticoids|glucocorticoids|mesh-ancestor
102108546|NCT00150462|Hormones|hormones|mesh-ancestor
102108547|NCT00150462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102108548|NCT00150462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102108549|NCT00150462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102108550|NCT00095550|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102108551|NCT00095550|Irbesartan|irbesartan|mesh-list
102108552|NCT00095550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102108553|NCT00095550|Diuretics|diuretics|mesh-ancestor
102108554|NCT00095550|Natriuretic Agents|natriuretic agents|mesh-ancestor
102108555|NCT00095550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108556|NCT00095550|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102108557|NCT00095550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102108558|NCT00095550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108559|NCT00095550|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102108560|NCT00095550|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102108561|NCT00095394|Irbesartan|irbesartan|mesh-list
102108562|NCT00095394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102108563|NCT00095394|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102108564|NCT00095394|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102108565|NCT00095394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108566|NCT00093132|Satraplatin|satraplatin|mesh-list
102108567|NCT00093132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102108568|NCT05717400|Ribavirin|ribavirin|mesh-list
102108569|NCT05717400|Sofosbuvir|sofosbuvir|mesh-list
102108570|NCT05717400|Velpatasvir|velpatasvir|mesh-list
102108571|NCT05717400|Bevacizumab|bevacizumab|mesh-list
102108572|NCT05717400|Atezolizumab|atezolizumab|mesh-list
102108573|NCT05717400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102108574|NCT05717400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102108575|NCT05717400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102108576|NCT05717400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102108577|NCT05717400|Growth Substances|growth substances|mesh-ancestor
102108578|NCT05717400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108579|NCT05717400|Growth Inhibitors|growth inhibitors|mesh-ancestor
102108580|NCT05717400|Antimetabolites|antimetabolites|mesh-ancestor
101226586|NCT01535495|Adrenergic Agents|adrenergic agents|mesh-ancestor
102108581|NCT05717400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108582|NCT05717400|Antiviral Agents|antiviral agents|mesh-ancestor
102108583|NCT05717400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102108584|NCT05717400|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102108585|NCT00080106|Vaccines|vaccines|mesh-list
102108586|NCT00080106|Immunologic Factors|immunologic factors|mesh-ancestor
102108587|NCT00080106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108588|NCT00333216|Hydrocortisone|hydrocortisone|mesh-list
102108589|NCT00333216|Anecortave|anecortave|mesh-list
102108590|NCT00333216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102108591|NCT00333216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102108592|NCT00333216|Growth Substances|growth substances|mesh-ancestor
102108593|NCT00333216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562063|NCT03222076|Nivolumab|nivolumab|mesh-list
102108594|NCT00333216|Growth Inhibitors|growth inhibitors|mesh-ancestor
102108595|NCT00333216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102108596|NCT00333216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102108598|NCT00332748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102108599|NCT03530436|Curcumin|curcumin|mesh-list
102108600|NCT03530436|Turmeric extract|turmeric extract|mesh-list
102108601|NCT03530436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102108602|NCT03530436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102108603|NCT03530436|Analgesics|analgesics|mesh-ancestor
102108604|NCT03530436|Sensory System Agents|sensory system agents|mesh-ancestor
102108605|NCT03530436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102108606|NCT03530436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108607|NCT03530436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102108608|NCT03530436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102108609|NCT03530436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102108610|NCT03530436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102108611|NCT03530436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108612|NCT03530436|Antioxidants|antioxidants|mesh-ancestor
102108613|NCT03530436|Protective Agents|protective agents|mesh-ancestor
102108614|NCT03530280|Pregabalin|pregabalin|mesh-list
102108615|NCT03530280|Bupivacaine|bupivacaine|mesh-list
102108616|NCT03530280|Anesthetics, Local|anesthetics, local|mesh-ancestor
102108617|NCT03530280|Anesthetics|anesthetics|mesh-ancestor
102108618|NCT03530280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102108619|NCT03530280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108620|NCT03530280|Sensory System Agents|sensory system agents|mesh-ancestor
102108621|NCT03530280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102108622|NCT03530280|Analgesics|analgesics|mesh-ancestor
102108623|NCT03530280|Anticonvulsants|anticonvulsants|mesh-ancestor
102108624|NCT03530280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102108625|NCT03530280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102108626|NCT03530280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108627|NCT03530280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102108628|NCT03530280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102108629|NCT03530280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102108630|NCT03530280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102108631|NCT00079482|Cytarabine|cytarabine|mesh-list
102108632|NCT00079482|Etoposide|etoposide|mesh-list
102108633|NCT00079482|Mitoxantrone|mitoxantrone|mesh-list
102108634|NCT00079482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102108635|NCT00079482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102108636|NCT00079482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102108637|NCT00079482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102108638|NCT00079482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102108639|NCT00079482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108640|NCT00079482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102108641|NCT00079482|Antimetabolites|antimetabolites|mesh-ancestor
102108642|NCT00079482|Antiviral Agents|antiviral agents|mesh-ancestor
102108643|NCT00079482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102108644|NCT00079482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102108645|NCT00079482|Immunologic Factors|immunologic factors|mesh-ancestor
102108646|NCT00079482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108647|NCT00079482|Analgesics|analgesics|mesh-ancestor
102108648|NCT00079482|Sensory System Agents|sensory system agents|mesh-ancestor
102108649|NCT00079482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102108650|NCT00073866|Celecoxib|celecoxib|mesh-list
102108651|NCT00073866|Docetaxel|docetaxel|mesh-list
102108652|NCT00073866|Irinotecan|irinotecan|mesh-list
102108653|NCT00073866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102108654|NCT00073866|Tubulin Modulators|tubulin modulators|mesh-ancestor
102108655|NCT00073866|Antimitotic Agents|antimitotic agents|mesh-ancestor
102108656|NCT00073866|Mitosis Modulators|mitosis modulators|mesh-ancestor
102108657|NCT00073866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108658|NCT00073866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102108659|NCT00073866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102108660|NCT00073866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102108661|NCT00073866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102108662|NCT00073866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102108663|NCT00073866|Analgesics|analgesics|mesh-ancestor
102108664|NCT00073866|Sensory System Agents|sensory system agents|mesh-ancestor
102108665|NCT00073866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102108666|NCT00073866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836463|NCT00483756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102108667|NCT00073866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102108668|NCT00073866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102108669|NCT00073866|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102108670|NCT00073866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102108672|NCT00325650|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102108673|NCT00325650|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
102108674|NCT00325650|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102108675|NCT00325650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102108676|NCT00325650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108677|NCT00325650|Hormones|hormones|mesh-ancestor
102108678|NCT00325650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102108679|NCT00325650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108680|NCT00070590|Bosentan|bosentan|mesh-list
102108681|NCT00070590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102108682|NCT00070590|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102108683|NCT00070590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108684|NCT00067782|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102108685|NCT00067782|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102108686|NCT00067782|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102108687|NCT00067782|Protease Inhibitors|protease inhibitors|mesh-ancestor
102108688|NCT00067782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102108689|NCT00067782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108690|NCT00067782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102108691|NCT00067782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102108692|NCT00067782|Antiviral Agents|antiviral agents|mesh-ancestor
102108693|NCT00067782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102108694|NCT00058266|Genistein|genistein|mesh-list
102108695|NCT00058266|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102108696|NCT00058266|Protective Agents|protective agents|mesh-ancestor
102108697|NCT00058266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108698|NCT00058266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102108699|NCT00058266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102108700|NCT00058266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102108701|NCT00058266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108702|NCT00058266|Phytoestrogens|phytoestrogens|mesh-ancestor
102108703|NCT00058266|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102108704|NCT00058266|Estrogens|estrogens|mesh-ancestor
102108705|NCT00058266|Hormones|hormones|mesh-ancestor
102108706|NCT00058266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102108707|NCT00313794|Tremelimumab|tremelimumab|mesh-list
102108708|NCT00313794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102108709|NCT00313248|Sagopilone|sagopilone|mesh-list
102108710|NCT00313248|Epothilones|epothilones|mesh-list
102108711|NCT00313248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102108712|NCT00313248|Tubulin Modulators|tubulin modulators|mesh-ancestor
102108713|NCT00313248|Antimitotic Agents|antimitotic agents|mesh-ancestor
102108714|NCT00313248|Mitosis Modulators|mitosis modulators|mesh-ancestor
102108715|NCT00313248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108716|NCT00310830|Bosentan|bosentan|mesh-list
102108717|NCT00310830|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102108718|NCT00310830|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102108719|NCT00310830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108720|NCT00035568|Metformin|metformin|mesh-list
102108721|NCT00035568|Glyburide|glyburide|mesh-list
102108722|NCT00035568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101226606|NCT01535677|Metformin|metformin|mesh-list
102108723|NCT00035568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108724|NCT00031512|Pleconaril|pleconaril|mesh-list
102108725|NCT00031512|Antiviral Agents|antiviral agents|mesh-ancestor
102108726|NCT00031512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102108727|NCT00307398|Hydrocortisone|hydrocortisone|mesh-list
102108728|NCT00307398|Anecortave|anecortave|mesh-list
102108729|NCT00307398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101954195|NCT02799784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102108730|NCT00307398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102108731|NCT00307398|Growth Substances|growth substances|mesh-ancestor
102108732|NCT00307398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108733|NCT00307398|Growth Inhibitors|growth inhibitors|mesh-ancestor
102108734|NCT00307398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102108735|NCT00307398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102108737|NCT01368081|Empagliflozin|empagliflozin|mesh-list
102108738|NCT01368081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102108739|NCT01368081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108740|NCT01368081|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102108741|NCT01368081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108742|NCT02127489|Bupivacaine|bupivacaine|mesh-list
101562230|NCT02623426|Dermatologic Agents|dermatologic agents|mesh-ancestor
102108743|NCT02127489|Anesthetics, Local|anesthetics, local|mesh-ancestor
102108745|NCT02127489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102108746|NCT02127489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108747|NCT02127489|Sensory System Agents|sensory system agents|mesh-ancestor
102108748|NCT02127489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102108749|NCT00004914|Epoetin Alfa|epoetin alfa|mesh-list
102108750|NCT00004914|Hematinics|hematinics|mesh-ancestor
102108751|NCT00286806|Gossypol acetic acid|gossypol acetic acid|mesh-list
102108752|NCT00286806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102108753|NCT00286806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102108754|NCT00286806|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102108755|NCT00286806|Contraceptive Agents|contraceptive agents|mesh-ancestor
102108756|NCT00286806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102108757|NCT00286806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108758|NCT00286806|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
102108759|NCT00286806|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
102108760|NCT00286806|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102108761|NCT00004908|Cyclophosphamide|cyclophosphamide|mesh-list
102108762|NCT00004908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102108763|NCT00004908|Immunologic Factors|immunologic factors|mesh-ancestor
102108764|NCT00004908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108765|NCT00004908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102108766|NCT00004908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102108767|NCT00004908|Alkylating Agents|alkylating agents|mesh-ancestor
102108768|NCT00004908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108769|NCT00004908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102108770|NCT00004908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102108771|NCT00004902|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
102108772|NCT00004902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102108773|NCT00004902|Immunologic Factors|immunologic factors|mesh-ancestor
102108774|NCT00004902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108775|NCT04441398|Nitazoxanide|nitazoxanide|mesh-list
102108776|NCT04441398|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102108777|NCT04441398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102108778|NCT03551067|Midazolam|midazolam|mesh-list
102108779|NCT03551067|Dexmedetomidine|dexmedetomidine|mesh-list
102108780|NCT03551067|Ketamine|ketamine|mesh-list
102108781|NCT03551067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102108782|NCT03551067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102108783|NCT03551067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108784|NCT03551067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102108785|NCT03551067|Analgesics|analgesics|mesh-ancestor
102108786|NCT03551067|Sensory System Agents|sensory system agents|mesh-ancestor
102108787|NCT03551067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102108788|NCT03551067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102108789|NCT03551067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102108790|NCT03551067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102108791|NCT03551067|Adrenergic Agents|adrenergic agents|mesh-ancestor
102108792|NCT03551067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102108793|NCT03551067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108794|NCT03551067|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102108795|NCT03551067|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102108796|NCT03551067|Anesthetics, General|anesthetics, general|mesh-ancestor
102108798|NCT03551067|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102108799|NCT03551067|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102108800|NCT03551067|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102108801|NCT03551067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102108802|NCT03551067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102108803|NCT03551067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102108804|NCT03551067|GABA Modulators|gaba modulators|mesh-ancestor
102108805|NCT03551067|GABA Agents|gaba agents|mesh-ancestor
102108806|NCT03529266|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102108807|NCT03529266|Hemostatics|hemostatics|mesh-ancestor
102108808|NCT03529266|Coagulants|coagulants|mesh-ancestor
102108809|NCT02128191|Ibuprofen|ibuprofen|mesh-list
102108810|NCT02128191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102108811|NCT02128191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102108812|NCT02128191|Analgesics|analgesics|mesh-ancestor
102108813|NCT02128191|Sensory System Agents|sensory system agents|mesh-ancestor
102108814|NCT02128191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102108815|NCT02128191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108816|NCT02128191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102108817|NCT02128191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102108818|NCT02128191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102108820|NCT02128191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108821|NCT00004896|Cyclophosphamide|cyclophosphamide|mesh-list
102108822|NCT00004896|Busulfan|busulfan|mesh-list
102108823|NCT00004896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102108824|NCT00004896|Immunologic Factors|immunologic factors|mesh-ancestor
102108825|NCT00004896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108826|NCT00004896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102108827|NCT00004896|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102108828|NCT00004896|Alkylating Agents|alkylating agents|mesh-ancestor
102108829|NCT00004896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108830|NCT00004896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102108831|NCT00004896|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102108832|NCT02121951|Lidocaine|lidocaine|mesh-list
102108833|NCT02121951|Fentanyl|fentanyl|mesh-list
102108834|NCT02121951|Midazolam|midazolam|mesh-list
102108835|NCT02121951|Anesthetics|anesthetics|mesh-list
102108836|NCT02121951|Levobupivacaine|levobupivacaine|mesh-list
102108837|NCT02121951|Anesthetics, Local|anesthetics, local|mesh-list
102108838|NCT02121951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102108839|NCT02121951|Narcotics|narcotics|mesh-ancestor
102108840|NCT02121951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102108841|NCT02121951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108842|NCT02121951|Analgesics|analgesics|mesh-ancestor
102108843|NCT02121951|Sensory System Agents|sensory system agents|mesh-ancestor
102108844|NCT02121951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102108845|NCT02121951|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102108846|NCT02121951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102108847|NCT02121951|Anesthetics, General|anesthetics, general|mesh-ancestor
102108848|NCT02121951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102108849|NCT02121951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102108850|NCT02121951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102108851|NCT02121951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102108852|NCT02121951|GABA Modulators|gaba modulators|mesh-ancestor
102108853|NCT02121951|GABA Agents|gaba agents|mesh-ancestor
102108854|NCT02121951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102108855|NCT02121951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108856|NCT02121951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102108857|NCT02121951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102108858|NCT02121951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102108859|NCT02121951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102108860|NCT05473858|Phentolamine|phentolamine|mesh-list
102108861|NCT05473858|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102108862|NCT05473858|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102108863|NCT05473858|Adrenergic Agents|adrenergic agents|mesh-ancestor
102108864|NCT05473858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102108865|NCT05473858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108866|NCT05473858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108867|NCT05473858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102108868|NCT00004584|Ritonavir|ritonavir|mesh-list
102108869|NCT00004584|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102108870|NCT00004584|Saquinavir|saquinavir|mesh-list
102108871|NCT00004584|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102108872|NCT00004584|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102108873|NCT00004584|Protease Inhibitors|protease inhibitors|mesh-ancestor
102108874|NCT00004584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102108875|NCT00004584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108876|NCT00004584|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102108877|NCT00004584|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102108878|NCT00004584|Antiviral Agents|antiviral agents|mesh-ancestor
102108879|NCT00004584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102108880|NCT00004584|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102108881|NCT00004584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102108882|NCT00004230|Cyclophosphamide|cyclophosphamide|mesh-list
102108883|NCT00004230|Captopril|captopril|mesh-list
102108884|NCT00004230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102108885|NCT00004230|Immunologic Factors|immunologic factors|mesh-ancestor
102108886|NCT00004230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108887|NCT00004230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102108888|NCT00004230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102108889|NCT00004230|Alkylating Agents|alkylating agents|mesh-ancestor
102108890|NCT00004230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108891|NCT00004230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102108892|NCT00004230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102108893|NCT00004230|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102108894|NCT00004230|Protease Inhibitors|protease inhibitors|mesh-ancestor
102108895|NCT00004230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102108896|NCT00004230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102108897|NCT02252367|Tadalafil|tadalafil|mesh-list
102108898|NCT02252367|Vasodilator Agents|vasodilator agents|mesh-ancestor
102108899|NCT02252367|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102108900|NCT02252367|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102108901|NCT02252367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102108902|NCT02252367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108903|NCT02252367|Urological Agents|urological agents|mesh-ancestor
102108904|NCT00004182|Irinotecan|irinotecan|mesh-list
102108905|NCT00004182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102108906|NCT00004182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102108907|NCT00004182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102108908|NCT00004182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108909|NCT00004182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102108910|NCT02124525|Acetylcysteine|acetylcysteine|mesh-list
102108911|NCT02124525|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102108912|NCT02124525|Antiviral Agents|antiviral agents|mesh-ancestor
102108913|NCT02124525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102108914|NCT02124525|Expectorants|expectorants|mesh-ancestor
102108915|NCT02124525|Respiratory System Agents|respiratory system agents|mesh-ancestor
102108916|NCT02124525|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102108917|NCT02124525|Antioxidants|antioxidants|mesh-ancestor
102108918|NCT02124525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108919|NCT02124525|Protective Agents|protective agents|mesh-ancestor
102108920|NCT02124525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108921|NCT02124525|Antidotes|antidotes|mesh-ancestor
102108922|NCT05725512|Prednisolone|prednisolone|mesh-list
102108923|NCT05725512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102108924|NCT05725512|Glucocorticoids|glucocorticoids|mesh-ancestor
102108925|NCT05725512|Hormones|hormones|mesh-ancestor
102108926|NCT05725512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102108927|NCT05725512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108928|NCT05725512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102108929|NCT05725512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102108930|NCT02124681|Hydroxychloroquine|hydroxychloroquine|mesh-list
102108931|NCT02124681|Antimalarials|antimalarials|mesh-ancestor
102108932|NCT02124681|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102108933|NCT02124681|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102108934|NCT02124681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102108935|NCT02124681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102108936|NCT02124681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108937|NCT02124681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102108938|NCT02128425|Leucovorin|leucovorin|mesh-list
102108939|NCT02128425|Fluorouracil|fluorouracil|mesh-list
102108940|NCT02128425|Oxaliplatin|oxaliplatin|mesh-list
102108941|NCT02128425|Irinotecan|irinotecan|mesh-list
102108942|NCT02128425|Levoleucovorin|levoleucovorin|mesh-list
102108943|NCT02128425|Antimetabolites|antimetabolites|mesh-ancestor
102108944|NCT02128425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108945|NCT02128425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102108946|NCT02128425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102108947|NCT02128425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102108948|NCT02128425|Immunologic Factors|immunologic factors|mesh-ancestor
102108949|NCT02128425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108950|NCT02128425|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102108951|NCT02128425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102108952|NCT02128425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102108953|NCT02128425|Antidotes|antidotes|mesh-ancestor
102108954|NCT02128425|Protective Agents|protective agents|mesh-ancestor
102108955|NCT02128425|Vitamin B Complex|vitamin b complex|mesh-ancestor
102108956|NCT02128425|Vitamins|vitamins|mesh-ancestor
102108957|NCT02128425|Micronutrients|micronutrients|mesh-ancestor
102108958|NCT05641194|Caffeine|caffeine|mesh-list
102108959|NCT05641194|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102108960|NCT05641194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108961|NCT05641194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102108962|NCT05641194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102108963|NCT05641194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108964|NCT05641194|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102108965|NCT05641194|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101836464|NCT00483756|Dermatologic Agents|dermatologic agents|mesh-ancestor
102108966|NCT05641194|Purinergic Agents|purinergic agents|mesh-ancestor
102108967|NCT05641194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102108968|NCT03532620|Calcium, Dietary|calcium, dietary|mesh-list
102108969|NCT03532620|Atorvastatin|atorvastatin|mesh-list
102108970|NCT03532620|Pitavastatin|pitavastatin|mesh-list
102108971|NCT03532620|Calcium|calcium|mesh-list
102108972|NCT03532620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102108973|NCT03532620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108974|NCT03532620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102108975|NCT03532620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102108976|NCT03532620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102108977|NCT03532620|Antimetabolites|antimetabolites|mesh-ancestor
102108978|NCT03532620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102108979|NCT03532620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102108980|NCT03532620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102108981|NCT03532620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102108982|NCT02288130|Ulipristal acetate|ulipristal acetate|mesh-list
102108983|NCT02288130|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102108984|NCT02288130|Contraceptive Agents|contraceptive agents|mesh-ancestor
102108985|NCT02288130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102108986|NCT02288130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108987|NCT02288130|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102108988|NCT03529032|Methadone|methadone|mesh-list
102108989|NCT03529032|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102108990|NCT03529032|Narcotics|narcotics|mesh-ancestor
102108991|NCT03529032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102108992|NCT03529032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102108993|NCT03529032|Analgesics|analgesics|mesh-ancestor
102108994|NCT03529032|Sensory System Agents|sensory system agents|mesh-ancestor
102108995|NCT03529032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102108996|NCT03529032|Antitussive Agents|antitussive agents|mesh-ancestor
102108997|NCT03529032|Respiratory System Agents|respiratory system agents|mesh-ancestor
102108998|NCT02122731|Amiloride|amiloride|mesh-list
102108999|NCT02122731|Diuretics|diuretics|mesh-ancestor
102109000|NCT02122731|Natriuretic Agents|natriuretic agents|mesh-ancestor
102109001|NCT02122731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109002|NCT02122731|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
102109003|NCT02122731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102109004|NCT02122731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102109005|NCT02122731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109006|NCT02122731|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
102109007|NCT02122731|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102109008|NCT05458726|Paclitaxel|paclitaxel|mesh-list
102109009|NCT05458726|Carboplatin|carboplatin|mesh-list
102109010|NCT05458726|Pemetrexed|pemetrexed|mesh-list
102109011|NCT05458726|Osimertinib|osimertinib|mesh-list
102109012|NCT05458726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102109013|NCT05458726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102109014|NCT05458726|Tubulin Modulators|tubulin modulators|mesh-ancestor
102109015|NCT05458726|Antimitotic Agents|antimitotic agents|mesh-ancestor
102109016|NCT05458726|Mitosis Modulators|mitosis modulators|mesh-ancestor
102109017|NCT05458726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109018|NCT05458726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102109019|NCT05458726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102109020|NCT05458726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102109021|NCT05458726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102109023|NCT02122809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102109024|NCT02122809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102109025|NCT02122809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102109026|NCT02122809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109027|NCT00150618|Guanfacine|guanfacine|mesh-list
102109028|NCT00150618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102109029|NCT00150618|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102109030|NCT00150618|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102109031|NCT00150618|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102109032|NCT00150618|Adrenergic Agents|adrenergic agents|mesh-ancestor
102109033|NCT00150618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102109034|NCT00150618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109035|NCT00150618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109036|NCT03532464|Azithromycin|azithromycin|mesh-list
102109037|NCT03532464|Doxycycline|doxycycline|mesh-list
102109038|NCT03532464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102109039|NCT03532464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102109040|NCT03532464|Antimalarials|antimalarials|mesh-ancestor
102109041|NCT03532464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102109042|NCT03532464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102109043|NCT02128893|Isavuconazole|isavuconazole|mesh-list
102109044|NCT02128893|Esomeprazole|esomeprazole|mesh-list
102109045|NCT02128893|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102109046|NCT02128893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102109047|NCT02128893|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102109048|NCT02128893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102109049|NCT02128893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109050|NCT02128893|Antifungal Agents|antifungal agents|mesh-ancestor
102109051|NCT02128893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102109052|NCT02124369|Paclitaxel|paclitaxel|mesh-list
102109053|NCT02124369|Gemcitabine|gemcitabine|mesh-list
102109054|NCT02124369|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102109055|NCT02124369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102109056|NCT02124369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102109057|NCT02124369|Tubulin Modulators|tubulin modulators|mesh-ancestor
102109058|NCT02124369|Antimitotic Agents|antimitotic agents|mesh-ancestor
102109059|NCT02124369|Mitosis Modulators|mitosis modulators|mesh-ancestor
102109060|NCT02124369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109061|NCT02124369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102109062|NCT02124369|Antimetabolites|antimetabolites|mesh-ancestor
102109063|NCT02128971|Ferrous fumarate|ferrous fumarate|mesh-list
102109064|NCT02128971|Trace Elements|trace elements|mesh-ancestor
102109065|NCT02128971|Micronutrients|micronutrients|mesh-ancestor
102109066|NCT02128971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109067|NCT02288208|Tenofovir|tenofovir|mesh-list
102109068|NCT02288208|Entecavir|entecavir|mesh-list
102109069|NCT02288208|Antiviral Agents|antiviral agents|mesh-list
102109070|NCT02288208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102109071|NCT02288208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102109072|NCT02288208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102109073|NCT02288208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102109074|NCT02288208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109075|NCT02288208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102109076|NCT02288208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102109077|NCT02288286|Vaccines|vaccines|mesh-list
102109078|NCT02288286|Immunologic Factors|immunologic factors|mesh-ancestor
102109079|NCT02288286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109080|NCT02251977|Leucovorin|leucovorin|mesh-list
102109081|NCT02251977|Fluorouracil|fluorouracil|mesh-list
102109082|NCT02251977|Capecitabine|capecitabine|mesh-list
102109083|NCT02251977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109084|NCT02251977|Antimetabolites|antimetabolites|mesh-ancestor
102109085|NCT02251977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109086|NCT02251977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102109087|NCT02251977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102109088|NCT02251977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102109089|NCT02251977|Immunologic Factors|immunologic factors|mesh-ancestor
102109090|NCT02251977|Antidotes|antidotes|mesh-ancestor
102109091|NCT02251977|Protective Agents|protective agents|mesh-ancestor
102109092|NCT02251977|Vitamin B Complex|vitamin b complex|mesh-ancestor
102109093|NCT02251977|Vitamins|vitamins|mesh-ancestor
102109094|NCT02251977|Micronutrients|micronutrients|mesh-ancestor
102109095|NCT03528954|Propofol|propofol|mesh-list
102109096|NCT03528954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102109097|NCT03528954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102109098|NCT03528954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109099|NCT03528954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102109100|NCT03528954|Anesthetics, General|anesthetics, general|mesh-ancestor
102109101|NCT03528954|Anesthetics|anesthetics|mesh-ancestor
102109102|NCT02125227|Metformin|metformin|mesh-list
102109103|NCT02125227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102109104|NCT02125227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102109105|NCT02125227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109106|NCT02125227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102109107|NCT02125227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102109108|NCT02125227|Antimetabolites|antimetabolites|mesh-ancestor
102109109|NCT02125227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109110|NCT02125227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102109111|NCT02125227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102109112|NCT02125227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102109113|NCT02129127|Paclitaxel|paclitaxel|mesh-list
102109114|NCT02129127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102109115|NCT02129127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102109116|NCT02129127|Tubulin Modulators|tubulin modulators|mesh-ancestor
102109117|NCT02129127|Antimitotic Agents|antimitotic agents|mesh-ancestor
102109118|NCT02129127|Mitosis Modulators|mitosis modulators|mesh-ancestor
102109119|NCT02129127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109120|NCT05554822|Aspirin|aspirin|mesh-list
102109121|NCT05554822|Clopidogrel|clopidogrel|mesh-list
102109122|NCT05554822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102109123|NCT05554822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102109124|NCT05554822|Analgesics|analgesics|mesh-ancestor
102109125|NCT05554822|Sensory System Agents|sensory system agents|mesh-ancestor
102109126|NCT05554822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102109127|NCT05554822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109128|NCT05554822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102109129|NCT05554822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102109130|NCT05554822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102109131|NCT05554822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102109132|NCT05554822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109133|NCT05554822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102109134|NCT05554822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102109135|NCT05554822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102109136|NCT05554822|Antipyretics|antipyretics|mesh-ancestor
102109137|NCT05554822|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102109138|NCT05554822|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102109139|NCT05554822|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102109140|NCT05554822|Purinergic Agents|purinergic agents|mesh-ancestor
102109141|NCT05554822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102109142|NCT02125305|Metformin|metformin|mesh-list
102109143|NCT02125305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102109144|NCT02125305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109145|NCT00254904|Cisplatin|cisplatin|mesh-list
102109146|NCT00254904|Gemcitabine|gemcitabine|mesh-list
102109147|NCT00254904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102109148|NCT00254904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102109149|NCT00254904|Antimetabolites|antimetabolites|mesh-ancestor
102109150|NCT00254904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109151|NCT05725122|Tamsulosin|tamsulosin|mesh-list
102109152|NCT05725122|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102109153|NCT05725122|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102109154|NCT05725122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102109155|NCT05725122|Adrenergic Agents|adrenergic agents|mesh-ancestor
102109156|NCT05725122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102109157|NCT05725122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109158|NCT05725122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109159|NCT05725122|Urological Agents|urological agents|mesh-ancestor
102109160|NCT03880396|Cisplatin|cisplatin|mesh-list
102109161|NCT03880396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102109162|NCT00253968|SR 46349B|sr 46349b|mesh-list
102109163|NCT00253968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102109164|NCT00253968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102109165|NCT00253968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109166|NCT00253968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102109167|NCT00253968|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102109168|NCT00253968|Serotonin Agents|serotonin agents|mesh-ancestor
102109169|NCT00253968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102109170|NCT00253968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109171|NCT03544606|Pyridoxine|pyridoxine|mesh-list
102109172|NCT03544606|Isosorbide|isosorbide|mesh-list
102109173|NCT03544606|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
102109174|NCT03544606|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
102109175|NCT03544606|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102109176|NCT03544606|Diuretics|diuretics|mesh-ancestor
102109177|NCT03544606|Natriuretic Agents|natriuretic agents|mesh-ancestor
102109178|NCT03544606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109179|NCT03544606|Vasodilator Agents|vasodilator agents|mesh-ancestor
102109180|NCT03544606|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102109181|NCT03544606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109182|NCT03544606|Vitamin B Complex|vitamin b complex|mesh-ancestor
102109183|NCT03544606|Vitamins|vitamins|mesh-ancestor
102109184|NCT03544606|Micronutrients|micronutrients|mesh-ancestor
102109185|NCT02741310|Sumatriptan|sumatriptan|mesh-list
102109186|NCT02741310|Erenumab|erenumab|mesh-list
102109187|NCT02741310|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102109188|NCT02741310|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102109189|NCT02741310|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102109190|NCT02741310|Serotonin Agents|serotonin agents|mesh-ancestor
102109191|NCT02741310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102109192|NCT02741310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109193|NCT02741310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109194|NCT02741310|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
102109196|NCT02741310|Sensory System Agents|sensory system agents|mesh-ancestor
102109197|NCT02741310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102109198|NCT05700448|Gemcitabine|gemcitabine|mesh-list
102109199|NCT05700448|Oxaliplatin|oxaliplatin|mesh-list
102109200|NCT05700448|Pegaspargase|pegaspargase|mesh-list
102109201|NCT05700448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102109202|NCT05700448|Antimetabolites|antimetabolites|mesh-ancestor
102109203|NCT05700448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109204|NCT05700448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102109205|NCT00243906|Plasminogen|plasminogen|mesh-list
102109206|NCT00243906|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102109207|NCT00243906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102109208|NCT00243906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102109209|NCT00243906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109210|NCT03532360|Immunomodulating Agents|immunomodulating agents|mesh-list
102109211|NCT03532360|Immunologic Factors|immunologic factors|mesh-ancestor
102109212|NCT03532360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109213|NCT01367457|Sirolimus|sirolimus|mesh-list
102109214|NCT01367457|Temsirolimus|temsirolimus|mesh-list
102109215|NCT01367457|MTOR Inhibitors|mtor inhibitors|mesh-list
102109216|NCT01367457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102109217|NCT01367457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102109218|NCT01367457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109219|NCT01367457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102109220|NCT01367457|Immunologic Factors|immunologic factors|mesh-ancestor
102109221|NCT01367457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109222|NCT01367457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102109223|NCT01367457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102109224|NCT01367457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102109225|NCT01367457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102109226|NCT01367457|Antifungal Agents|antifungal agents|mesh-ancestor
102109227|NCT05553496|Cyclosporine|cyclosporine|mesh-list
102109228|NCT05553496|Dexamethasone|dexamethasone|mesh-list
102109229|NCT05553496|Dexamethasone acetate|dexamethasone acetate|mesh-list
102109230|NCT05553496|Cyclophosphamide|cyclophosphamide|mesh-list
102109231|NCT05553496|Rituximab|rituximab|mesh-list
102109232|NCT05553496|Tacrolimus|tacrolimus|mesh-list
102109233|NCT05553496|Cyclosporins|cyclosporins|mesh-list
102109234|NCT05553496|BB 1101|bb 1101|mesh-list
102109235|NCT05553496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102109236|NCT05553496|Immunologic Factors|immunologic factors|mesh-ancestor
102109237|NCT05553496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109238|NCT05553496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102109239|NCT05553496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102109240|NCT05553496|Alkylating Agents|alkylating agents|mesh-ancestor
102109241|NCT05553496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109242|NCT05553496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102109243|NCT05553496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102109244|NCT05553496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102109245|NCT05553496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102109246|NCT05553496|Antiemetics|antiemetics|mesh-ancestor
102109247|NCT05553496|Autonomic Agents|autonomic agents|mesh-ancestor
102109248|NCT05553496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102109249|NCT05553496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102109250|NCT05553496|Glucocorticoids|glucocorticoids|mesh-ancestor
102109251|NCT05553496|Hormones|hormones|mesh-ancestor
102109252|NCT05553496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102109253|NCT05553496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102109254|NCT05553496|Protease Inhibitors|protease inhibitors|mesh-ancestor
102109255|NCT05553496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102109256|NCT05553496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102109257|NCT05553496|Antifungal Agents|antifungal agents|mesh-ancestor
102109258|NCT05553496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102109259|NCT05553496|Dermatologic Agents|dermatologic agents|mesh-ancestor
102109260|NCT00239694|Vaccines|vaccines|mesh-list
102109261|NCT00239694|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102109262|NCT00239694|Immunologic Factors|immunologic factors|mesh-ancestor
102109263|NCT00239694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109264|NCT05549284|Rituximab|rituximab|mesh-list
102109265|NCT05549284|Methotrexate|methotrexate|mesh-list
102109266|NCT05549284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102109267|NCT05549284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102109268|NCT05549284|Immunologic Factors|immunologic factors|mesh-ancestor
102109269|NCT05549284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109270|NCT05549284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102109271|NCT05549284|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102109272|NCT05549284|Abortifacient Agents|abortifacient agents|mesh-ancestor
102109273|NCT05549284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102109274|NCT05549284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102109275|NCT05549284|Antimetabolites|antimetabolites|mesh-ancestor
102109276|NCT05549284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109277|NCT05549284|Dermatologic Agents|dermatologic agents|mesh-ancestor
102109278|NCT05549284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102109279|NCT05549284|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102109280|NCT05549284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102109281|NCT05549284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102109282|NCT03065218|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
102109283|NCT03065218|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102109284|NCT03065218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109285|NCT00232752|Sirolimus|sirolimus|mesh-list
102109286|NCT00232752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102109287|NCT00232752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102109288|NCT00232752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102109289|NCT00232752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102109290|NCT00232752|Antifungal Agents|antifungal agents|mesh-ancestor
102109291|NCT00232752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102109292|NCT00232752|Immunologic Factors|immunologic factors|mesh-ancestor
102109293|NCT00232752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109294|NCT02125617|Prednisolone|prednisolone|mesh-list
102109295|NCT02125617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102109296|NCT02125617|Glucocorticoids|glucocorticoids|mesh-ancestor
102109297|NCT02125617|Hormones|hormones|mesh-ancestor
102109298|NCT02125617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102109299|NCT02125617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109300|NCT02125617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102109301|NCT02125617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102109302|NCT02131545|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102109303|NCT02131545|Antidepressive Agents|antidepressive agents|mesh-ancestor
102109304|NCT02131545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102109305|NCT02131545|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102109306|NCT02131545|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102109307|NCT02131545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102109308|NCT02131545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109309|NCT00229008|Linezolid|linezolid|mesh-list
102109310|NCT00229008|Ceftazidime|ceftazidime|mesh-list
102109311|NCT00229008|Ceftobiprole|ceftobiprole|mesh-list
102109312|NCT00229008|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
102109313|NCT00229008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102109314|NCT00229008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102109315|NCT00229008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102109316|NCT00229008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102109317|NCT00229008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109318|NCT05553184|Niacin|niacin|mesh-list
102109319|NCT05553184|Nicotinic Acids|nicotinic acids|mesh-list
102109320|NCT05553184|Niacinamide|niacinamide|mesh-list
102109321|NCT05553184|Formoterol Fumarate|formoterol fumarate|mesh-list
102109322|NCT05553184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102109323|NCT05553184|Autonomic Agents|autonomic agents|mesh-ancestor
102109324|NCT05553184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102109325|NCT05553184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109326|NCT05553184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102109327|NCT05553184|Respiratory System Agents|respiratory system agents|mesh-ancestor
102109328|NCT05553184|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102109329|NCT05553184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102109330|NCT05553184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102109331|NCT05553184|Adrenergic Agents|adrenergic agents|mesh-ancestor
102109332|NCT05553184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102109333|NCT05553184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109334|NCT05553184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102109335|NCT05553184|Antimetabolites|antimetabolites|mesh-ancestor
102109336|NCT05553184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102109337|NCT05553184|Vasodilator Agents|vasodilator agents|mesh-ancestor
102109338|NCT05553184|Vitamin B Complex|vitamin b complex|mesh-ancestor
102109339|NCT05553184|Vitamins|vitamins|mesh-ancestor
102109340|NCT05553184|Micronutrients|micronutrients|mesh-ancestor
102109341|NCT03059992|Ibrexafungerp|ibrexafungerp|mesh-list
102109342|NCT03059992|Antifungal Agents|antifungal agents|mesh-ancestor
101562831|NCT05875961|Immunologic Factors|immunologic factors|mesh-ancestor
101562832|NCT05875961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562833|NCT05870683|Amoxicillin|amoxicillin|mesh-list
101562834|NCT05870683|Esomeprazole|esomeprazole|mesh-list
102109343|NCT03059992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102109345|NCT05242029|Hallucinogens|hallucinogens|mesh-ancestor
102109346|NCT05242029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109347|NCT05242029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102109348|NCT03528564|Epoetin Alfa|epoetin alfa|mesh-list
102109349|NCT03528564|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102109350|NCT03528564|Hematinics|hematinics|mesh-ancestor
102109351|NCT03531372|Antacids|antacids|mesh-list
102109352|NCT03531372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109353|NCT03531372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102109354|NCT02129595|Resveratrol|resveratrol|mesh-list
102109355|NCT02129595|Antioxidants|antioxidants|mesh-ancestor
102109356|NCT02129595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109357|NCT02129595|Protective Agents|protective agents|mesh-ancestor
102109358|NCT02129595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109359|NCT02129595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102109360|NCT02129595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102109361|NCT02129673|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102109362|NCT02129673|Latanoprost|latanoprost|mesh-list
102109363|NCT02129673|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102109364|NCT02260557|Selexipag|selexipag|mesh-list
102109365|NCT02260557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102109366|NCT02129829|Tenofovir|tenofovir|mesh-list
102109367|NCT02129829|Antiviral Agents|antiviral agents|mesh-ancestor
102109368|NCT02129829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102109369|NCT02129829|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102109370|NCT02129829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102109371|NCT02129829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102109372|NCT02129829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109373|NCT02129829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102109374|NCT02129829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102109376|NCT02129985|Exenatide|exenatide|mesh-list
102109377|NCT02129985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102109378|NCT02129985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109379|NCT02129985|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102109380|NCT02129985|Incretins|incretins|mesh-ancestor
102109381|NCT02129985|Hormones|hormones|mesh-ancestor
102109382|NCT02129985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102109383|NCT01730638|Histamine|histamine|mesh-list
102109384|NCT01730638|Glycine|glycine|mesh-list
102109385|NCT01730638|Histamine Agonists|histamine agonists|mesh-ancestor
102109386|NCT01730638|Histamine Agents|histamine agents|mesh-ancestor
102109387|NCT01730638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102109388|NCT01730638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109389|NCT01730638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109390|NCT01730638|Glycine Agents|glycine agents|mesh-ancestor
102109391|NCT02252523|Dexmedetomidine|dexmedetomidine|mesh-list
102109392|NCT02252523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102109393|NCT02252523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102109394|NCT02252523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109395|NCT02252523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102109396|NCT02252523|Analgesics|analgesics|mesh-ancestor
102109397|NCT02252523|Sensory System Agents|sensory system agents|mesh-ancestor
102109398|NCT02252523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102109399|NCT02252523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102109400|NCT02252523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102109401|NCT02252523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102109402|NCT02252523|Adrenergic Agents|adrenergic agents|mesh-ancestor
102109403|NCT02252523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102109404|NCT02252523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109405|NCT02132091|Vitamins|vitamins|mesh-list
102109406|NCT02132091|Vitamin E|vitamin e|mesh-list
102109407|NCT02132091|Micronutrients|micronutrients|mesh-ancestor
102109408|NCT02132091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109409|NCT02132091|Antioxidants|antioxidants|mesh-ancestor
102109410|NCT02132091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109411|NCT02132091|Protective Agents|protective agents|mesh-ancestor
102109412|NCT05548348|Aflutinib|aflutinib|mesh-list
102109413|NCT05548348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102109414|NCT05548348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101836465|NCT00483756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102109415|NCT05548348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109416|NCT05726370|Carboplatin|carboplatin|mesh-list
102109417|NCT05726370|Docetaxel|docetaxel|mesh-list
102109418|NCT05726370|Pembrolizumab|pembrolizumab|mesh-list
102109420|NCT05726370|Tubulin Modulators|tubulin modulators|mesh-ancestor
102109421|NCT05726370|Antimitotic Agents|antimitotic agents|mesh-ancestor
102109422|NCT05726370|Mitosis Modulators|mitosis modulators|mesh-ancestor
102109423|NCT05726370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109424|NCT05726370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102109425|NCT05726370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102109426|NCT04469010|Iron|iron|mesh-list
102109427|NCT04469010|Chelating Agents|chelating agents|mesh-list
102109428|NCT04469010|Micronutrients|micronutrients|mesh-ancestor
102109429|NCT04469010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109430|NCT04469010|Trace Elements|trace elements|mesh-ancestor
102109431|NCT04469010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109432|NCT04469010|Sequestering Agents|sequestering agents|mesh-ancestor
102109433|NCT01121224|Clopidogrel|clopidogrel|mesh-list
102109434|NCT01121224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102109435|NCT01121224|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102109436|NCT01121224|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102109437|NCT01121224|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102109438|NCT01121224|Purinergic Agents|purinergic agents|mesh-ancestor
102109439|NCT01121224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102109440|NCT01121224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109441|NCT01121224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109442|NCT00138762|Atorvastatin|atorvastatin|mesh-list
102109443|NCT00138762|Torcetrapib|torcetrapib|mesh-list
102109444|NCT00138762|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102109445|NCT00138762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102109446|NCT00138762|Antimetabolites|antimetabolites|mesh-ancestor
102109447|NCT00138762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109448|NCT00138762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102109449|NCT00138762|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102109450|NCT00138762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102109451|NCT03531294|Aflibercept|aflibercept|mesh-list
102109452|NCT03531294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102109453|NCT03531294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102109454|NCT03531294|Growth Substances|growth substances|mesh-ancestor
102109455|NCT03531294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109456|NCT03531294|Growth Inhibitors|growth inhibitors|mesh-ancestor
102109457|NCT03531294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102109458|NCT03549975|Botulinum Toxins|botulinum toxins|mesh-list
102109459|NCT03549975|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102109460|NCT03549975|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102109461|NCT03549975|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102109462|NCT03549975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102109463|NCT03549975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109464|NCT03549975|Cholinergic Agents|cholinergic agents|mesh-ancestor
102109465|NCT03549975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102109466|NCT03549975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109467|NCT03549975|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102109468|NCT03549975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102109469|NCT05551624|Acetylcysteine|acetylcysteine|mesh-list
102109470|NCT05551624|Atorvastatin|atorvastatin|mesh-list
102109471|NCT05551624|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102109472|NCT05551624|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102109473|NCT05551624|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102109474|NCT05551624|Antimetabolites|antimetabolites|mesh-ancestor
102109475|NCT05551624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109476|NCT05551624|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102109477|NCT05551624|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102109478|NCT05551624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102109479|NCT05551624|Antiviral Agents|antiviral agents|mesh-ancestor
102109480|NCT05551624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102109481|NCT05551624|Expectorants|expectorants|mesh-ancestor
102109482|NCT05551624|Respiratory System Agents|respiratory system agents|mesh-ancestor
102109483|NCT05551624|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102109484|NCT05551624|Antioxidants|antioxidants|mesh-ancestor
102109485|NCT05551624|Protective Agents|protective agents|mesh-ancestor
102109486|NCT05551624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109487|NCT05551624|Antidotes|antidotes|mesh-ancestor
102109488|NCT00134238|Atorvastatin|atorvastatin|mesh-list
102109489|NCT00134238|Torcetrapib|torcetrapib|mesh-list
102109490|NCT00134238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102109491|NCT00134238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102109492|NCT00134238|Antimetabolites|antimetabolites|mesh-ancestor
102109493|NCT00134238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109494|NCT00134238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102109495|NCT00134238|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102109496|NCT00134238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102109497|NCT02786901|Loteprednol Etabonate|loteprednol etabonate|mesh-list
102109498|NCT02786901|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102109499|NCT03550677|Anesthetics|anesthetics|mesh-list
102109500|NCT03550677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102109501|NCT03550677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109502|NCT03634488|Hydroxyurea|hydroxyurea|mesh-list
102109503|NCT03634488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102109504|NCT03634488|Antisickling Agents|antisickling agents|mesh-ancestor
102109505|NCT03634488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102109506|NCT03634488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109507|NCT03634488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102109508|NCT02132403|Milk fat globule|milk fat globule|mesh-list
102109509|NCT02132403|Gemcitabine|gemcitabine|mesh-list
102109510|NCT02132403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102109511|NCT02132403|Antimetabolites|antimetabolites|mesh-ancestor
102109512|NCT02132403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109513|NCT02132403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102109514|NCT02132403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102109515|NCT04264806|Azacitidine|azacitidine|mesh-list
102109516|NCT04264806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102109517|NCT04264806|Antimetabolites|antimetabolites|mesh-ancestor
102109518|NCT04264806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109519|NCT04264806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102109520|NCT04264806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102109521|NCT02132559|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
102109522|NCT02132559|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102109523|NCT02132559|Immunologic Factors|immunologic factors|mesh-ancestor
102109524|NCT02132559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109525|NCT00126984|Vaccines|vaccines|mesh-list
102109526|NCT00126984|Immunologic Factors|immunologic factors|mesh-ancestor
101226684|NCT01536054|Sirolimus|sirolimus|mesh-list
102109527|NCT00126984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109528|NCT02136147|Guanfacine|guanfacine|mesh-list
102109529|NCT02136147|Methylphenidate|methylphenidate|mesh-list
102109530|NCT02136147|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102109531|NCT02136147|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102109532|NCT02136147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102109533|NCT02136147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109534|NCT02136147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102109535|NCT02136147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102109536|NCT02136147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102109537|NCT02136147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109538|NCT02136147|Dopamine Agents|dopamine agents|mesh-ancestor
102109539|NCT02136147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102109540|NCT02136147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102109541|NCT02136147|Adrenergic Agents|adrenergic agents|mesh-ancestor
102109542|NCT02136147|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102109543|NCT02136147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102109544|NCT02136147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102109545|NCT02136147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102109546|NCT05699746|Capecitabine|capecitabine|mesh-list
102109547|NCT05699746|Oxaliplatin|oxaliplatin|mesh-list
102109548|NCT05699746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102109549|NCT05699746|Antimetabolites|antimetabolites|mesh-ancestor
102109550|NCT05699746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109551|NCT05699746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102109552|NCT03549897|Albuterol|albuterol|mesh-list
102109553|NCT03549897|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102109554|NCT03549897|Autonomic Agents|autonomic agents|mesh-ancestor
102109555|NCT03549897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102109556|NCT03549897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109557|NCT03549897|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102109558|NCT03549897|Respiratory System Agents|respiratory system agents|mesh-ancestor
102109559|NCT03549897|Tocolytic Agents|tocolytic agents|mesh-ancestor
102109560|NCT03549897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102109561|NCT03549897|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102109562|NCT03549897|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102109563|NCT03549897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102109564|NCT03549897|Adrenergic Agents|adrenergic agents|mesh-ancestor
101836466|NCT00483756|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102109565|NCT03549897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102109566|NCT03549897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109568|NCT02133105|Dobutamine|dobutamine|mesh-list
102109569|NCT02133105|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102109570|NCT02133105|Vasodilator Agents|vasodilator agents|mesh-ancestor
102109571|NCT02133105|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102109572|NCT02133105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102109573|NCT02133105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102109574|NCT02133105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109575|NCT02133105|Protective Agents|protective agents|mesh-ancestor
102109576|NCT02133105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109577|NCT02133105|Sympathomimetics|sympathomimetics|mesh-ancestor
102109578|NCT02133105|Autonomic Agents|autonomic agents|mesh-ancestor
102109579|NCT02133105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102109580|NCT02133105|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102109581|NCT02133105|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102109582|NCT02133105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102109583|NCT02133105|Adrenergic Agents|adrenergic agents|mesh-ancestor
102109584|NCT02133105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102109586|NCT04468464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102109587|NCT04468464|Antifungal Agents|antifungal agents|mesh-ancestor
102109588|NCT04468464|Keratolytic Agents|keratolytic agents|mesh-ancestor
102109589|NCT04468464|Dermatologic Agents|dermatologic agents|mesh-ancestor
102109590|NCT02136693|Psyllium|psyllium|mesh-list
102109591|NCT02136693|Cathartics|cathartics|mesh-ancestor
102109592|NCT02136693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102109593|NCT02136771|Vitamin D|vitamin d|mesh-list
102109594|NCT02136771|Cholecalciferol|cholecalciferol|mesh-list
102109595|NCT02136771|Vitamins|vitamins|mesh-ancestor
102109596|NCT02136771|Micronutrients|micronutrients|mesh-ancestor
102109597|NCT02136771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109598|NCT02136771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102109599|NCT02136771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102109600|NCT00125970|Vaccines|vaccines|mesh-list
102109601|NCT00125970|Immunologic Factors|immunologic factors|mesh-ancestor
102109602|NCT00125970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109603|NCT03549663|Prednisone|prednisone|mesh-list
102109604|NCT03549663|Glucocorticoids|glucocorticoids|mesh-list
102109605|NCT03549663|Tacrolimus|tacrolimus|mesh-list
102109606|NCT03549663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102109607|NCT03549663|Hormones|hormones|mesh-ancestor
102109608|NCT03549663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102109609|NCT03549663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109610|NCT03549663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102109611|NCT03549663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102109612|NCT03549663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102109613|NCT03549663|Immunologic Factors|immunologic factors|mesh-ancestor
102109614|NCT03549663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102109615|NCT03549663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102109616|NCT03549663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109617|NCT02137083|Docetaxel|docetaxel|mesh-list
102109618|NCT02137083|Fulvestrant|fulvestrant|mesh-list
102109619|NCT02137083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102109620|NCT02137083|Tubulin Modulators|tubulin modulators|mesh-ancestor
102109621|NCT02137083|Antimitotic Agents|antimitotic agents|mesh-ancestor
102109622|NCT02137083|Mitosis Modulators|mitosis modulators|mesh-ancestor
102109623|NCT02137083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109624|NCT02137083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102109625|NCT02137083|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102109626|NCT02137083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102109627|NCT02137083|Hormone Antagonists|hormone antagonists|mesh-ancestor
102109628|NCT02137083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102109629|NCT02137083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109630|NCT02137161|Tobramycin|tobramycin|mesh-list
102109631|NCT02137161|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
102109632|NCT02137161|Dexamethasone|dexamethasone|mesh-list
102109633|NCT02137161|Bromfenac|bromfenac|mesh-list
102109634|NCT02137161|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102109635|NCT02137161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102109636|NCT02137161|Antiemetics|antiemetics|mesh-ancestor
102109637|NCT02137161|Autonomic Agents|autonomic agents|mesh-ancestor
102109638|NCT02137161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102109639|NCT02137161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109640|NCT02137161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102109643|NCT02137161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102109644|NCT02137161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102109645|NCT02137161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102109646|NCT02137161|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102109647|NCT02137161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102109648|NCT02137161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102109649|NCT02137161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102109650|NCT02137161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102109651|NCT02137161|Analgesics|analgesics|mesh-ancestor
102109652|NCT02137161|Sensory System Agents|sensory system agents|mesh-ancestor
102109653|NCT02137161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102109654|NCT02253069|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
102109655|NCT02253069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102109656|NCT03527628|Cyclophosphamide|cyclophosphamide|mesh-list
102109657|NCT03527628|Dacarbazine|dacarbazine|mesh-list
102109658|NCT03527628|Doxorubicin|doxorubicin|mesh-list
102109659|NCT03527628|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102109660|NCT03527628|Bleomycin|bleomycin|mesh-list
102109661|NCT03527628|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102109662|NCT03527628|Vinblastine|vinblastine|mesh-list
102109663|NCT03527628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102109664|NCT03527628|Immunologic Factors|immunologic factors|mesh-ancestor
102109665|NCT03527628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109666|NCT03527628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102109667|NCT03527628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102109668|NCT03527628|Alkylating Agents|alkylating agents|mesh-ancestor
102109669|NCT03527628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109670|NCT03527628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102109671|NCT03527628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102109672|NCT03527628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102109673|NCT03527628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102109674|NCT03527628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102109675|NCT03527628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102109676|NCT03527628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102109677|NCT03527628|Immunotoxins|immunotoxins|mesh-ancestor
102109678|NCT03527628|Immunoconjugates|immunoconjugates|mesh-ancestor
102109679|NCT03527628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102109680|NCT03527628|Tubulin Modulators|tubulin modulators|mesh-ancestor
102109681|NCT03527628|Antimitotic Agents|antimitotic agents|mesh-ancestor
102109682|NCT03527628|Mitosis Modulators|mitosis modulators|mesh-ancestor
102109683|NCT04466670|Aspirin|aspirin|mesh-list
102109684|NCT04466670|Heparin|heparin|mesh-list
102109685|NCT04466670|Calcium heparin|calcium heparin|mesh-list
102109686|NCT04466670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102109687|NCT04466670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102109688|NCT04466670|Analgesics|analgesics|mesh-ancestor
102109689|NCT04466670|Sensory System Agents|sensory system agents|mesh-ancestor
102109690|NCT04466670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102109691|NCT04466670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109692|NCT04466670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102109693|NCT04466670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102109694|NCT04466670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102109695|NCT04466670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102109696|NCT04466670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109697|NCT04466670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102109698|NCT04466670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102109699|NCT04466670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102109700|NCT04466670|Antipyretics|antipyretics|mesh-ancestor
102109701|NCT04466670|Anticoagulants|anticoagulants|mesh-ancestor
102109702|NCT04468542|Triamcinolone|triamcinolone|mesh-list
102109703|NCT04468542|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102109704|NCT04468542|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102109705|NCT04468542|Bupivacaine|bupivacaine|mesh-list
102109706|NCT04468542|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102109707|NCT04468542|Anesthetics, Local|anesthetics, local|mesh-ancestor
102109708|NCT04468542|Anesthetics|anesthetics|mesh-ancestor
102109709|NCT04468542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102109710|NCT04468542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109711|NCT04468542|Sensory System Agents|sensory system agents|mesh-ancestor
101954263|NCT01560663|Docetaxel|docetaxel|mesh-list
102109712|NCT04468542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102109713|NCT04468542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102109715|NCT04468542|Hormones|hormones|mesh-ancestor
101836467|NCT00483756|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102109716|NCT04468542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102109717|NCT04468542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102109719|NCT04468542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102109720|NCT04468542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109721|NCT03525522|Betamethasone|betamethasone|mesh-list
102109722|NCT03525522|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102109723|NCT03525522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102109724|NCT03525522|Glucocorticoids|glucocorticoids|mesh-ancestor
102109725|NCT03525522|Hormones|hormones|mesh-ancestor
102109726|NCT03525522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102109727|NCT03525522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109728|NCT03525522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102109729|NCT03525522|Respiratory System Agents|respiratory system agents|mesh-ancestor
102109730|NCT03228732|Fluoxetine|fluoxetine|mesh-list
102109731|NCT03228732|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
102109732|NCT03228732|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102109733|NCT03228732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102109734|NCT03228732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102109735|NCT03228732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109736|NCT03228732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102109737|NCT03228732|Serotonin Agents|serotonin agents|mesh-ancestor
102109738|NCT03228732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109739|NCT03228732|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102109740|NCT03228732|Antidepressive Agents|antidepressive agents|mesh-ancestor
102109741|NCT03228732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102109742|NCT03228732|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102109743|NCT03228732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102109744|NCT03228732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102109745|NCT03228732|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102109746|NCT03228732|Immunologic Factors|immunologic factors|mesh-ancestor
102109747|NCT03222492|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102109748|NCT03222492|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102109749|NCT03222492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102109750|NCT03222492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102109751|NCT03222492|Immunotoxins|immunotoxins|mesh-ancestor
102109752|NCT03222492|Immunoconjugates|immunoconjugates|mesh-ancestor
102109753|NCT03222492|Immunologic Factors|immunologic factors|mesh-ancestor
102109754|NCT03222492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109755|NCT04466436|Tryptophan|tryptophan|mesh-list
102109756|NCT04466436|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102109757|NCT04466436|Antidepressive Agents|antidepressive agents|mesh-ancestor
102109758|NCT04466436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102109759|NCT04467450|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102109760|NCT04467450|Botulinum Toxins|botulinum toxins|mesh-list
102109761|NCT04467450|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102109762|NCT04467450|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102109763|NCT04467450|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102109764|NCT04467450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102109765|NCT04467450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109766|NCT04467450|Cholinergic Agents|cholinergic agents|mesh-ancestor
102109767|NCT04467450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102109768|NCT04467450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109769|NCT04467450|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102109770|NCT04467450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102109771|NCT04467450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102109773|NCT05230758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102109774|NCT05230758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109775|NCT03008382|Metoprolol|metoprolol|mesh-list
102109776|NCT03008382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102109777|NCT03008382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102109778|NCT03008382|Sympatholytics|sympatholytics|mesh-ancestor
102109779|NCT03008382|Autonomic Agents|autonomic agents|mesh-ancestor
102109780|NCT03008382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102109781|NCT03008382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109782|NCT03008382|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102109783|NCT03008382|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102109784|NCT03008382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102109785|NCT03008382|Adrenergic Agents|adrenergic agents|mesh-ancestor
102109786|NCT03008382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101563322|NCT05198609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102109787|NCT03008382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109788|NCT02137239|Mycophenolic Acid|mycophenolic acid|mesh-list
102109789|NCT02137239|Prednisone|prednisone|mesh-list
102109790|NCT02137239|Methylprednisolone|methylprednisolone|mesh-list
102109791|NCT02137239|Everolimus|everolimus|mesh-list
102109792|NCT02137239|Abatacept|abatacept|mesh-list
102109793|NCT02137239|Tacrolimus|tacrolimus|mesh-list
102109794|NCT02137239|Thymoglobulin|thymoglobulin|mesh-list
102109795|NCT02137239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102109796|NCT02137239|Glucocorticoids|glucocorticoids|mesh-ancestor
102109797|NCT02137239|Hormones|hormones|mesh-ancestor
102109798|NCT02137239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102109799|NCT02137239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109800|NCT02137239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102109801|NCT02137239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102109802|NCT02137239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102109803|NCT02137239|Immunologic Factors|immunologic factors|mesh-ancestor
102109804|NCT02137239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102109805|NCT02137239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102109806|NCT02137239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109807|NCT02137239|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102109808|NCT02137239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102109809|NCT02137239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102109810|NCT02137239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102109811|NCT02137239|Antitubercular Agents|antitubercular agents|mesh-ancestor
102109812|NCT02137239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102109813|NCT02137239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102109814|NCT02137239|Antiemetics|antiemetics|mesh-ancestor
102109815|NCT02137239|Autonomic Agents|autonomic agents|mesh-ancestor
102109816|NCT02137239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102109817|NCT02137239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102109818|NCT02137239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102109819|NCT02137239|Protective Agents|protective agents|mesh-ancestor
102109820|NCT02137239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102109821|NCT02137239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102109822|NCT02137239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102109823|NCT02137395|Dexamethasone|dexamethasone|mesh-list
102109824|NCT02137395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102109825|NCT02137395|Antiemetics|antiemetics|mesh-ancestor
102109826|NCT02137395|Autonomic Agents|autonomic agents|mesh-ancestor
102109827|NCT02137395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102109828|NCT02137395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109829|NCT02137395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102109830|NCT02137395|Glucocorticoids|glucocorticoids|mesh-ancestor
102109831|NCT02137395|Hormones|hormones|mesh-ancestor
102109832|NCT02137395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102109833|NCT02137395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102109834|NCT02137395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102109835|NCT02137629|Azacitidine|azacitidine|mesh-list
102109836|NCT02137629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102109837|NCT02137629|Antimetabolites|antimetabolites|mesh-ancestor
102109838|NCT02137629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109839|NCT02137629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102109840|NCT02137629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102109841|NCT02137707|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102109842|NCT02137707|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102109843|NCT02137707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109844|NCT02137707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102109845|NCT02137707|Immunologic Factors|immunologic factors|mesh-ancestor
102109846|NCT02137707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109847|NCT02261025|Aspirin|aspirin|mesh-list
102109848|NCT02261025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102109849|NCT02261025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102109850|NCT02261025|Analgesics|analgesics|mesh-ancestor
102109851|NCT02261025|Sensory System Agents|sensory system agents|mesh-ancestor
102109852|NCT02261025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102109853|NCT02261025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109854|NCT02261025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102109855|NCT02261025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102109856|NCT02261025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102109857|NCT02261025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102109858|NCT02261025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109859|NCT02261025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101563396|NCT05007522|Antipruritics|antipruritics|mesh-ancestor
102109860|NCT02261025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102109861|NCT02261025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102109862|NCT02261025|Antipyretics|antipyretics|mesh-ancestor
102109863|NCT02925234|Bevacizumab|bevacizumab|mesh-list
102109864|NCT02925234|Pembrolizumab|pembrolizumab|mesh-list
102109865|NCT02925234|Nivolumab|nivolumab|mesh-list
102109866|NCT02925234|Trastuzumab|trastuzumab|mesh-list
102109867|NCT02925234|Ipilimumab|ipilimumab|mesh-list
102109868|NCT02925234|Atezolizumab|atezolizumab|mesh-list
102109869|NCT02925234|Durvalumab|durvalumab|mesh-list
102109870|NCT02925234|Pertuzumab|pertuzumab|mesh-list
102109871|NCT02925234|Panitumumab|panitumumab|mesh-list
102109872|NCT02925234|Sunitinib|sunitinib|mesh-list
102109873|NCT02925234|Lenvatinib|lenvatinib|mesh-list
102109874|NCT02925234|Olaparib|olaparib|mesh-list
102109875|NCT02925234|Palbociclib|palbociclib|mesh-list
102109876|NCT02925234|Trametinib|trametinib|mesh-list
102109877|NCT02925234|Axitinib|axitinib|mesh-list
102109878|NCT02925234|Afatinib|afatinib|mesh-list
102109879|NCT02925234|Vemurafenib|vemurafenib|mesh-list
102109880|NCT02925234|Dabrafenib|dabrafenib|mesh-list
102109881|NCT02925234|Crizotinib|crizotinib|mesh-list
102109882|NCT02925234|Talazoparib|talazoparib|mesh-list
102109883|NCT02925234|Rucaparib|rucaparib|mesh-list
102109884|NCT02925234|Entrectinib|entrectinib|mesh-list
102109885|NCT02925234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102109886|NCT02925234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102109887|NCT02925234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102109888|NCT02925234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102109889|NCT02925234|Growth Substances|growth substances|mesh-ancestor
102109890|NCT02925234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109891|NCT02925234|Growth Inhibitors|growth inhibitors|mesh-ancestor
102109892|NCT02925234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102109893|NCT02925234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109894|NCT02925234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102109895|NCT02925234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102109896|NCT02925234|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102109897|NCT02137863|Dexmedetomidine|dexmedetomidine|mesh-list
102109898|NCT02137863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102109899|NCT02137863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102109900|NCT02137863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109901|NCT02137863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102109902|NCT02137863|Analgesics|analgesics|mesh-ancestor
101954290|NCT05622058|Antimitotic Agents|antimitotic agents|mesh-ancestor
102109903|NCT02137863|Sensory System Agents|sensory system agents|mesh-ancestor
102109904|NCT02137863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102109905|NCT02137863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102109906|NCT02137863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102109907|NCT02137863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102109908|NCT02137863|Adrenergic Agents|adrenergic agents|mesh-ancestor
102109909|NCT02137863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102109910|NCT02137863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109911|NCT02138019|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
102109912|NCT02138019|Hemostatics|hemostatics|mesh-ancestor
102109913|NCT02138019|Coagulants|coagulants|mesh-ancestor
102109914|NCT02133885|Minocycline|minocycline|mesh-list
102109915|NCT02133885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102109916|NCT02133885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102109917|NCT02138409|Fentanyl|fentanyl|mesh-list
102109918|NCT02138409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102109919|NCT02138409|Narcotics|narcotics|mesh-ancestor
102109920|NCT02138409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102109921|NCT02138409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109922|NCT02138409|Analgesics|analgesics|mesh-ancestor
102109923|NCT02138409|Sensory System Agents|sensory system agents|mesh-ancestor
102109924|NCT02138409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102109925|NCT02138409|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102109926|NCT02138409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102109927|NCT02138409|Anesthetics, General|anesthetics, general|mesh-ancestor
102109928|NCT02138409|Anesthetics|anesthetics|mesh-ancestor
102109929|NCT02138799|Rifampin|rifampin|mesh-list
102109930|NCT02138799|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102109931|NCT02138799|Antitubercular Agents|antitubercular agents|mesh-ancestor
102109932|NCT02138799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102109933|NCT02138799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102109934|NCT02138799|Leprostatic Agents|leprostatic agents|mesh-ancestor
101836468|NCT00483756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102109935|NCT02138799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102109936|NCT02138799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102109937|NCT02138799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109938|NCT02138799|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102109939|NCT02138799|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102109940|NCT02138799|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102109941|NCT02138799|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102109942|NCT02138799|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102109943|NCT02138799|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102109945|NCT05578287|Tislelizumab|tislelizumab|mesh-list
102109946|NCT05578287|Disitamab vedotin|disitamab vedotin|mesh-list
102109947|NCT05578287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102109948|NCT05578287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102109949|NCT05578287|Analgesics|analgesics|mesh-ancestor
102109950|NCT05578287|Sensory System Agents|sensory system agents|mesh-ancestor
102109951|NCT05578287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102109952|NCT05578287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109953|NCT05578287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102109954|NCT05578287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102109955|NCT05578287|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102109956|NCT05578287|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102109957|NCT05578287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102109958|NCT05578287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109959|NCT05578287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102109960|NCT05578287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102109961|NCT05578287|Immunoconjugates|immunoconjugates|mesh-ancestor
102109962|NCT05578287|Immunologic Factors|immunologic factors|mesh-ancestor
102109963|NCT02975271|Serlopitant|serlopitant|mesh-list
102109964|NCT02975271|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102109965|NCT02975271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102109966|NCT02975271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109967|NCT02975271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109968|NCT02741076|Oxymorphone|oxymorphone|mesh-list
102109969|NCT02741076|Morphine|morphine|mesh-list
102109970|NCT02741076|Oxycodone|oxycodone|mesh-list
102109971|NCT02741076|Analgesics, Opioid|analgesics, opioid|mesh-list
102109972|NCT02741076|Narcotics|narcotics|mesh-ancestor
102109973|NCT02741076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102109974|NCT02741076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102109975|NCT02741076|Analgesics|analgesics|mesh-ancestor
102109976|NCT02741076|Sensory System Agents|sensory system agents|mesh-ancestor
102109977|NCT02741076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102109978|NCT02741076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102109979|NCT02973633|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
102109980|NCT02973633|Chelating Agents|chelating agents|mesh-ancestor
102109981|NCT02973633|Sequestering Agents|sequestering agents|mesh-ancestor
102109982|NCT02973633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109983|NCT01666444|Doxorubicin|doxorubicin|mesh-list
102109984|NCT01666444|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102109985|NCT01666444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102109986|NCT01666444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102109987|NCT01666444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102109988|NCT01666444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102109989|NCT01666444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102109990|NCT01666444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102109991|NCT05543122|Fluconazole|fluconazole|mesh-list
102109992|NCT05543122|Methotrexate|methotrexate|mesh-list
102109993|NCT05543122|Atenolol|atenolol|mesh-list
102109994|NCT05543122|Lamotrigine|lamotrigine|mesh-list
102109995|NCT05543122|Lacosamide|lacosamide|mesh-list
102109996|NCT05543122|Levetiracetam|levetiracetam|mesh-list
102109997|NCT05543122|Brivaracetam|brivaracetam|mesh-list
102109998|NCT05543122|Bupropion|bupropion|mesh-list
102109999|NCT05543122|Ezetimibe|ezetimibe|mesh-list
102110000|NCT05543122|Escitalopram|escitalopram|mesh-list
102110001|NCT05543122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102110002|NCT05543122|Abortifacient Agents|abortifacient agents|mesh-ancestor
102110003|NCT05543122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102110004|NCT05543122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110005|NCT05543122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102110006|NCT05543122|Antimetabolites|antimetabolites|mesh-ancestor
102110007|NCT05543122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110008|NCT05543122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102110009|NCT05543122|Dermatologic Agents|dermatologic agents|mesh-ancestor
101563559|NCT04499950|Dopamine Agents|dopamine agents|mesh-ancestor
102110010|NCT05543122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102110011|NCT05543122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102110012|NCT05543122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102110013|NCT05543122|Immunologic Factors|immunologic factors|mesh-ancestor
102110014|NCT05543122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102110015|NCT05543122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102110016|NCT05543122|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102110017|NCT05543122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102110018|NCT05543122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102110019|NCT05543122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102110020|NCT05543122|Serotonin Agents|serotonin agents|mesh-ancestor
102110021|NCT05543122|Autonomic Agents|autonomic agents|mesh-ancestor
102110022|NCT05543122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102110023|NCT05543122|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102110024|NCT05543122|Antidepressive Agents|antidepressive agents|mesh-ancestor
102110025|NCT05543122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102110026|NCT05543122|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102110027|NCT05543122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102110028|NCT05543122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102110029|NCT05543122|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102110030|NCT05543122|Dopamine Agents|dopamine agents|mesh-ancestor
102110031|NCT05543122|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102110032|NCT05543122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102110033|NCT05543122|Anticonvulsants|anticonvulsants|mesh-ancestor
102110034|NCT05543122|Nootropic Agents|nootropic agents|mesh-ancestor
102110035|NCT05543122|Antifungal Agents|antifungal agents|mesh-ancestor
102110036|NCT05543122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102110037|NCT05543122|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102110038|NCT05543122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102110039|NCT05543122|Hormone Antagonists|hormone antagonists|mesh-ancestor
102110040|NCT05543122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102110041|NCT05543122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102110042|NCT05543122|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102110043|NCT05543122|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102110044|NCT05543122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102110045|NCT05543122|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102110046|NCT05543122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102110047|NCT05543122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102110048|NCT05543122|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102110049|NCT05543122|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102110050|NCT05543122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102110051|NCT05543122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102110052|NCT05543122|Sympatholytics|sympatholytics|mesh-ancestor
102110053|NCT05543122|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102110054|NCT05543122|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102110055|NCT05543122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102110056|NCT05543122|Adrenergic Agents|adrenergic agents|mesh-ancestor
102110057|NCT05120934|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102110058|NCT05120934|Amitriptyline|amitriptyline|mesh-list
102110059|NCT05120934|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102110060|NCT05120934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102110061|NCT05120934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102110062|NCT05120934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110063|NCT05120934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102110064|NCT05120934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110065|NCT05120934|Analgesics|analgesics|mesh-ancestor
102110066|NCT05120934|Sensory System Agents|sensory system agents|mesh-ancestor
102110067|NCT05120934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102110068|NCT05120934|Antidepressive Agents|antidepressive agents|mesh-ancestor
102110069|NCT05120934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102110070|NCT05120934|Dopamine Agents|dopamine agents|mesh-ancestor
102110071|NCT05120934|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102110072|NCT05120934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102110073|NCT05120934|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102110074|NCT05120934|Adrenergic Agents|adrenergic agents|mesh-ancestor
102110075|NCT03548493|Magnesium Sulfate|magnesium sulfate|mesh-list
102110076|NCT03548493|Fentanyl|fentanyl|mesh-list
102110077|NCT03548493|Propofol|propofol|mesh-list
102110078|NCT03548493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102110079|NCT03548493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102110080|NCT03548493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110081|NCT03548493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102110082|NCT03548493|Anesthetics, General|anesthetics, general|mesh-ancestor
102110083|NCT03548493|Anesthetics|anesthetics|mesh-ancestor
102110084|NCT03548493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102110085|NCT03548493|Narcotics|narcotics|mesh-ancestor
102110086|NCT03548493|Analgesics|analgesics|mesh-ancestor
102110087|NCT03548493|Sensory System Agents|sensory system agents|mesh-ancestor
102110088|NCT03548493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102110089|NCT03548493|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102110090|NCT03548493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102110091|NCT03548493|Anticonvulsants|anticonvulsants|mesh-ancestor
102110092|NCT03548493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102110093|NCT03548493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102110094|NCT03548493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110095|NCT03548493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102110096|NCT03548493|Tocolytic Agents|tocolytic agents|mesh-ancestor
102110097|NCT03548493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102110098|NCT02139267|Vaccines|vaccines|mesh-list
102110099|NCT02139267|Immunologic Factors|immunologic factors|mesh-ancestor
102110100|NCT02139267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110101|NCT02139345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102110102|NCT03549819|Cannabidiol|cannabidiol|mesh-list
102110103|NCT03549819|Anticonvulsants|anticonvulsants|mesh-ancestor
102110104|NCT03549741|Cabergoline|cabergoline|mesh-list
102110105|NCT03549741|Clomiphene|clomiphene|mesh-list
102110106|NCT03549741|Enclomiphene|enclomiphene|mesh-list
102110107|NCT03549741|Zuclomiphene|zuclomiphene|mesh-list
102110108|NCT03549741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110109|NCT03549741|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102110110|NCT03549741|Hormone Antagonists|hormone antagonists|mesh-ancestor
102110111|NCT03549741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102110112|NCT03549741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110113|NCT03549741|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102110114|NCT03549741|Fertility Agents|fertility agents|mesh-ancestor
102110115|NCT03549741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102110116|NCT03549741|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102110117|NCT03549741|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102110118|NCT03549741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102110119|NCT03549741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102110120|NCT03549741|Dopamine Agonists|dopamine agonists|mesh-ancestor
102110121|NCT03549741|Dopamine Agents|dopamine agents|mesh-ancestor
102110122|NCT03549741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102110123|NCT03522402|Sevoflurane|sevoflurane|mesh-list
102110124|NCT03522402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102110125|NCT03522402|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102110126|NCT03522402|Anesthetics, General|anesthetics, general|mesh-ancestor
102110127|NCT03522402|Anesthetics|anesthetics|mesh-ancestor
102110128|NCT03522402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102110129|NCT03522402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110130|NCT02134899|Everolimus|everolimus|mesh-list
102110131|NCT02134899|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
102110132|NCT02134899|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102110133|NCT02134899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102110134|NCT02134899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102110135|NCT02134899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110136|NCT02134899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102110137|NCT02134899|Immunologic Factors|immunologic factors|mesh-ancestor
102110138|NCT02134899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110139|NCT02134899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102110140|NCT05577819|Technetium Tc 99m Pyrophosphate|technetium tc 99m pyrophosphate|mesh-list
102110141|NCT05577819|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102110142|NCT05577819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110143|NCT02135055|Midazolam|midazolam|mesh-list
102110144|NCT02135055|Morphine|morphine|mesh-list
102110145|NCT02135055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102110146|NCT02135055|Narcotics|narcotics|mesh-ancestor
102110147|NCT02135055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102110148|NCT02135055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110149|NCT02135055|Analgesics|analgesics|mesh-ancestor
102110150|NCT02135055|Sensory System Agents|sensory system agents|mesh-ancestor
102110151|NCT02135055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102110152|NCT02135055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102110153|NCT02135055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102110154|NCT02135055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102110155|NCT02135055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102110156|NCT02135055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102110157|NCT02135055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102110158|NCT02135055|Anesthetics, General|anesthetics, general|mesh-ancestor
102110159|NCT02135055|Anesthetics|anesthetics|mesh-ancestor
102110160|NCT02135055|GABA Modulators|gaba modulators|mesh-ancestor
102110161|NCT02135055|GABA Agents|gaba agents|mesh-ancestor
102110162|NCT02135055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102110163|NCT02135055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110164|NCT05546710|Anesthetics|anesthetics|mesh-list
102110165|NCT05546710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102110166|NCT05546710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110167|NCT02139579|Bevacizumab|bevacizumab|mesh-list
102110168|NCT02139579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102110169|NCT02139579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102110170|NCT02139579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102110171|NCT02139579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102110172|NCT02139579|Growth Substances|growth substances|mesh-ancestor
102110173|NCT02139579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110174|NCT02139579|Growth Inhibitors|growth inhibitors|mesh-ancestor
102110175|NCT02139657|Immunoglobulins|immunoglobulins|mesh-list
102110176|NCT02139657|Immunologic Factors|immunologic factors|mesh-ancestor
102110177|NCT02139657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110178|NCT05550064|Contraceptive Agents|contraceptive agents|mesh-list
102110179|NCT05550064|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102110180|NCT05550064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110181|NCT04076826|Midazolam|midazolam|mesh-list
102110182|NCT04076826|Dexmedetomidine|dexmedetomidine|mesh-list
102110183|NCT04076826|Propofol|propofol|mesh-list
102110184|NCT04076826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102110185|NCT04076826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102110186|NCT04076826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110187|NCT04076826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102110188|NCT04076826|Analgesics|analgesics|mesh-ancestor
102110189|NCT04076826|Sensory System Agents|sensory system agents|mesh-ancestor
102110190|NCT04076826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102110191|NCT04076826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102110192|NCT04076826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102110193|NCT04076826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102110194|NCT04076826|Adrenergic Agents|adrenergic agents|mesh-ancestor
102110195|NCT04076826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102110196|NCT04076826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110197|NCT04076826|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102110198|NCT04076826|Anesthetics, General|anesthetics, general|mesh-ancestor
102110199|NCT04076826|Anesthetics|anesthetics|mesh-ancestor
102110200|NCT04076826|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102110201|NCT04076826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102110202|NCT04076826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102110203|NCT04076826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102110204|NCT04076826|GABA Modulators|gaba modulators|mesh-ancestor
102110205|NCT04076826|GABA Agents|gaba agents|mesh-ancestor
102110206|NCT05577585|Midazolam|midazolam|mesh-list
102110207|NCT05577585|Ketamine|ketamine|mesh-list
102110208|NCT05577585|Analgesics|analgesics|mesh-ancestor
102110209|NCT05577585|Sensory System Agents|sensory system agents|mesh-ancestor
102110210|NCT05577585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102110211|NCT05577585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110212|NCT05577585|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102110213|NCT05577585|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102110214|NCT05577585|Anesthetics, General|anesthetics, general|mesh-ancestor
102110215|NCT05577585|Anesthetics|anesthetics|mesh-ancestor
102110216|NCT05577585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102110217|NCT05577585|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102110218|NCT05577585|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102110219|NCT05577585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102110220|NCT05577585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110221|NCT05577585|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102110222|NCT05577585|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102110223|NCT05577585|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102110224|NCT05577585|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102110225|NCT05577585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102110226|NCT05577585|GABA Modulators|gaba modulators|mesh-ancestor
102110227|NCT05577585|GABA Agents|gaba agents|mesh-ancestor
102110228|NCT04465968|Durvalumab|durvalumab|mesh-list
102110229|NCT04465968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102110230|NCT04465968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102110231|NCT04465968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102110232|NCT04465968|Immunologic Factors|immunologic factors|mesh-ancestor
101836469|NCT00309166|Vaccines|vaccines|mesh-list
102110233|NCT04465968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110234|NCT03526770|Chlorhexidine|chlorhexidine|mesh-list
102110235|NCT03526770|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102110236|NCT03526770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102110237|NCT03526770|Disinfectants|disinfectants|mesh-ancestor
102110238|NCT05577507|Calcium Carbonate|calcium carbonate|mesh-list
102110239|NCT05577507|Cholestyramine Resin|cholestyramine resin|mesh-list
102110240|NCT05577507|Calcium|calcium|mesh-list
102110241|NCT05577507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102110242|NCT05577507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110243|NCT05577507|Antacids|antacids|mesh-ancestor
102110244|NCT05577507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110245|NCT05577507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102110246|NCT05577507|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102110247|NCT05577507|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102110248|NCT05577507|Antimetabolites|antimetabolites|mesh-ancestor
102110249|NCT05577507|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102110250|NCT01565655|Peficitinib|peficitinib|mesh-list
102110251|NCT01565655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102110252|NCT01565655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110253|NCT01565655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102110254|NCT01565655|Immunologic Factors|immunologic factors|mesh-ancestor
102110255|NCT01565655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110256|NCT05535322|Insulin|insulin|mesh-list
102110257|NCT05535322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102110258|NCT05535322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110259|NCT05577273|Trimethoprim|trimethoprim|mesh-list
102110260|NCT05577273|Sulfamethoxazole|sulfamethoxazole|mesh-list
102110261|NCT05577273|Penicillins|penicillins|mesh-list
102110262|NCT05577273|Cefuroxime|cefuroxime|mesh-list
102110263|NCT05577273|Cefuroxime axetil|cefuroxime axetil|mesh-list
102110264|NCT05577273|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102110265|NCT05577273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102110266|NCT05577273|Antimalarials|antimalarials|mesh-ancestor
102110267|NCT05577273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102110268|NCT05577273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102110269|NCT05577273|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102110270|NCT05577273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102110271|NCT05577273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110272|NCT05577273|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102110273|NCT05577273|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102110274|NCT05577273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102110275|NCT05577273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102110276|NCT02252913|Docetaxel|docetaxel|mesh-list
102110277|NCT02252913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102110278|NCT02252913|Tubulin Modulators|tubulin modulators|mesh-ancestor
102110279|NCT02252913|Antimitotic Agents|antimitotic agents|mesh-ancestor
102110280|NCT02252913|Mitosis Modulators|mitosis modulators|mesh-ancestor
102110281|NCT02252913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110282|NCT02253459|Capecitabine|capecitabine|mesh-list
102110283|NCT02253459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102110284|NCT02253459|Antimetabolites|antimetabolites|mesh-ancestor
102110285|NCT02253459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110286|NCT02253459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102110287|NCT02140047|Vaccines|vaccines|mesh-list
102110288|NCT02140047|Immunologic Factors|immunologic factors|mesh-ancestor
102110289|NCT02140047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110290|NCT02135913|Vitamin D|vitamin d|mesh-list
102110291|NCT02135913|Vitamins|vitamins|mesh-ancestor
102110292|NCT02135913|Micronutrients|micronutrients|mesh-ancestor
102110293|NCT02135913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110294|NCT02135913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102110295|NCT02140125|ASP2408|asp2408|mesh-list
102110296|NCT02140125|Immunoconjugates|immunoconjugates|mesh-ancestor
102110297|NCT02140125|Immunologic Factors|immunologic factors|mesh-ancestor
102110298|NCT02140125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110299|NCT05505279|Nicotine|nicotine|mesh-list
102110300|NCT05505279|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102110301|NCT05505279|Autonomic Agents|autonomic agents|mesh-ancestor
102110302|NCT05505279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102110303|NCT05505279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110304|NCT05505279|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102110305|NCT05505279|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102110306|NCT05505279|Cholinergic Agents|cholinergic agents|mesh-ancestor
102110307|NCT05505279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102110308|NCT05505279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110309|NCT05541640|Lidocaine|lidocaine|mesh-list
102110310|NCT05541640|Anesthetics, Local|anesthetics, local|mesh-ancestor
102110311|NCT05541640|Anesthetics|anesthetics|mesh-ancestor
102110312|NCT05541640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102110313|NCT05541640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110314|NCT05541640|Sensory System Agents|sensory system agents|mesh-ancestor
102110315|NCT05541640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102110316|NCT05541640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102110317|NCT05541640|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102110318|NCT05541640|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102110319|NCT05541640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102110320|NCT05541640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110321|NCT02739594|Ibandronic Acid|ibandronic acid|mesh-list
102110322|NCT02739594|Zoledronic Acid|zoledronic acid|mesh-list
102110323|NCT02739594|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102110324|NCT02739594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110325|NCT05545618|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102110326|NCT05545618|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102110327|NCT05545618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110328|NCT02140281|Cefadroxil|cefadroxil|mesh-list
102110329|NCT02140281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102110330|NCT02140281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102110331|NCT05541328|Tisagenlecleucel|tisagenlecleucel|mesh-list
102110332|NCT05541328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102110333|NCT05541328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102110334|NCT05545462|Doxycycline|doxycycline|mesh-list
102110335|NCT05545462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102110336|NCT05545462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102110337|NCT05545462|Antimalarials|antimalarials|mesh-ancestor
102110338|NCT05545462|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102110339|NCT05545462|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102110340|NCT05541172|Methyltestosterone|methyltestosterone|mesh-list
102110341|NCT05541172|Testosterone|testosterone|mesh-list
102110342|NCT05541172|Testosterone undecanoate|testosterone undecanoate|mesh-list
101226799|NCT01536639|Insulin Aspart|insulin aspart|mesh-list
102110343|NCT05541172|Testosterone enanthate|testosterone enanthate|mesh-list
102110344|NCT05541172|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102110345|NCT05541172|Androgens|androgens|mesh-ancestor
102110346|NCT05541172|Hormones|hormones|mesh-ancestor
102110347|NCT05541172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102110348|NCT05541172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110349|NCT05541172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102110350|NCT05541172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102110351|NCT05541172|Anabolic Agents|anabolic agents|mesh-ancestor
102110352|NCT05478993|Dexamethasone|dexamethasone|mesh-list
102110353|NCT05478993|Pomalidomide|pomalidomide|mesh-list
102110354|NCT05478993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102110355|NCT05478993|Antiemetics|antiemetics|mesh-ancestor
102110356|NCT05478993|Autonomic Agents|autonomic agents|mesh-ancestor
102110357|NCT05478993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102110358|NCT05478993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110359|NCT05478993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102110360|NCT05478993|Glucocorticoids|glucocorticoids|mesh-ancestor
102110361|NCT05478993|Hormones|hormones|mesh-ancestor
102110362|NCT05478993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102110363|NCT05478993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102110364|NCT05478993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102110365|NCT05478993|Immunologic Factors|immunologic factors|mesh-ancestor
102110366|NCT05478993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102110367|NCT05478993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102110368|NCT05478993|Growth Substances|growth substances|mesh-ancestor
102110369|NCT05478993|Growth Inhibitors|growth inhibitors|mesh-ancestor
102110370|NCT05699356|Estrogens|estrogens|mesh-list
102110371|NCT05699356|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102110372|NCT05699356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110373|NCT05699356|Hormones|hormones|mesh-ancestor
102110374|NCT05699356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102110375|NCT05699356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102110376|NCT05699356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102110377|NCT05699356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110378|NCT05699356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102110379|NCT05699356|Hormone Antagonists|hormone antagonists|mesh-ancestor
102110380|NCT02140437|Fulvestrant|fulvestrant|mesh-list
102110381|NCT02140437|Anastrozole|anastrozole|mesh-list
102110382|NCT02140437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102110383|NCT02140437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102110384|NCT02140437|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102110385|NCT02140437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102110386|NCT02140437|Hormone Antagonists|hormone antagonists|mesh-ancestor
102110387|NCT02140437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102110388|NCT02140437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110389|NCT02140437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102110390|NCT02140437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102110391|NCT02140437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102110392|NCT02140437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110393|NCT05591560|Itraconazole|itraconazole|mesh-list
102110394|NCT05591560|Antifungal Agents|antifungal agents|mesh-ancestor
102110395|NCT05591560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102110396|NCT05591560|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102110397|NCT05591560|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102110398|NCT05591560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102110399|NCT05591560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110400|NCT05591560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102110401|NCT05591560|Hormone Antagonists|hormone antagonists|mesh-ancestor
102110402|NCT05591560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102110403|NCT05591560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110404|NCT05591560|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102110406|NCT05540470|Primaquine|primaquine|mesh-list
102110407|NCT05540470|Tafenoquine|tafenoquine|mesh-list
102110408|NCT05540470|Amebicides|amebicides|mesh-ancestor
102110409|NCT05540470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102110410|NCT05540470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102110411|NCT05540470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102110412|NCT05540470|Antimalarials|antimalarials|mesh-ancestor
102110413|NCT05540470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102110414|NCT05575167|Vitamin D|vitamin d|mesh-list
102110415|NCT05575167|Alendronate|alendronate|mesh-list
102110416|NCT05575167|Zoledronic Acid|zoledronic acid|mesh-list
102110417|NCT05575167|Vitamins|vitamins|mesh-ancestor
102110418|NCT05575167|Micronutrients|micronutrients|mesh-ancestor
102110419|NCT05575167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110420|NCT05575167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102110421|NCT02140515|Hormones|hormones|mesh-list
102110422|NCT02140515|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102110423|NCT02140515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102110424|NCT02140515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110425|NCT02260947|Ibuprofen|ibuprofen|mesh-list
102110426|NCT02260947|Pregabalin|pregabalin|mesh-list
102110427|NCT02260947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102110428|NCT02260947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102110429|NCT02260947|Analgesics|analgesics|mesh-ancestor
102110430|NCT02260947|Sensory System Agents|sensory system agents|mesh-ancestor
102110431|NCT02260947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102110432|NCT02260947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110433|NCT02260947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102110434|NCT02260947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102110435|NCT02260947|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102110436|NCT02260947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102110437|NCT02260947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110438|NCT02260947|Anticonvulsants|anticonvulsants|mesh-ancestor
102110439|NCT02260947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102110440|NCT02260947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102110441|NCT02260947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102110442|NCT02260947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102110443|NCT02260947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102110444|NCT02260947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102110445|NCT02260947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102110446|NCT03547791|Betamethasone|betamethasone|mesh-list
102110447|NCT03547791|Betamethasone Valerate|betamethasone valerate|mesh-list
102110448|NCT03547791|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102110449|NCT03547791|Betamethasone benzoate|betamethasone benzoate|mesh-list
102110450|NCT03547791|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
102110451|NCT03547791|Glucocorticoids|glucocorticoids|mesh-ancestor
102110452|NCT03547791|Hormones|hormones|mesh-ancestor
102110453|NCT03547791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102110454|NCT03547791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110455|NCT03547791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102110456|NCT03547791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102110457|NCT03547791|Respiratory System Agents|respiratory system agents|mesh-ancestor
102110458|NCT04818177|Immunoglobulins|immunoglobulins|mesh-list
102110459|NCT04818177|Antibodies|antibodies|mesh-list
102110460|NCT04818177|gamma-Globulins|gamma-globulins|mesh-list
102110461|NCT04818177|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102110462|NCT04818177|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102110463|NCT04818177|Immunologic Factors|immunologic factors|mesh-ancestor
102110464|NCT04818177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110465|NCT05544292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
102110466|NCT04425460|Favipiravir|favipiravir|mesh-list
102110467|NCT04425460|Antiviral Agents|antiviral agents|mesh-ancestor
102110468|NCT04425460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102110469|NCT05576272|Gemcitabine|gemcitabine|mesh-list
102110470|NCT05576272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102110471|NCT05576272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102110472|NCT05576272|Antimetabolites|antimetabolites|mesh-ancestor
102110473|NCT05576272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110474|NCT05576116|Pancrelipase|pancrelipase|mesh-list
102110475|NCT05576116|Pancreatin|pancreatin|mesh-list
102110476|NCT05576116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102110477|NCT04765137|Atorvastatin|atorvastatin|mesh-list
102110478|NCT04765137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102110479|NCT04765137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102110480|NCT04765137|Antimetabolites|antimetabolites|mesh-ancestor
102110481|NCT04765137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110482|NCT04765137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102110483|NCT04765137|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102110484|NCT04765137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102110485|NCT05543824|Levobupivacaine|levobupivacaine|mesh-list
102110486|NCT05543824|Anesthetics, Local|anesthetics, local|mesh-ancestor
102110487|NCT05543824|Anesthetics|anesthetics|mesh-ancestor
102110488|NCT05543824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102110489|NCT05543824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110490|NCT05543824|Sensory System Agents|sensory system agents|mesh-ancestor
102110491|NCT05543824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102110492|NCT04703673|Nasal Decongestants|nasal decongestants|mesh-list
102110493|NCT04703673|Pseudoephedrine|pseudoephedrine|mesh-list
102110494|NCT04703673|Ephedrine|ephedrine|mesh-list
102110495|NCT04703673|Sympathomimetics|sympathomimetics|mesh-list
102110496|NCT04703673|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102110497|NCT04703673|Respiratory System Agents|respiratory system agents|mesh-ancestor
102110498|NCT04703673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102110499|NCT04703673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110500|NCT04703673|Autonomic Agents|autonomic agents|mesh-ancestor
102110501|NCT04703673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102110502|NCT04703673|Adrenergic Agents|adrenergic agents|mesh-ancestor
102110503|NCT04703673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102110504|NCT04703673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110505|NCT04703673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102110506|NCT04703673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102110507|NCT05543746|Brexanolone|brexanolone|mesh-list
102110508|NCT05543746|Neurosteroids|neurosteroids|mesh-ancestor
102110509|NCT05543746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102110510|NCT05543746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110511|NCT05543746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110512|NCT05543746|GABA Modulators|gaba modulators|mesh-ancestor
102110513|NCT05543746|GABA Agents|gaba agents|mesh-ancestor
102110514|NCT03526536|Insulin|insulin|mesh-list
102110515|NCT03526536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102110516|NCT03526536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102110517|NCT03526536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110518|NCT05306301|Ponatinib|ponatinib|mesh-list
102110519|NCT05306301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102110520|NCT05306301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102110521|NCT05306301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102110522|NCT05306301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110523|NCT05543434|Hyaluronic Acid|hyaluronic acid|mesh-list
102110524|NCT05543434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102110525|NCT05543434|Immunologic Factors|immunologic factors|mesh-ancestor
102110526|NCT05543434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110527|NCT05543434|Viscosupplements|viscosupplements|mesh-ancestor
102110528|NCT05543434|Protective Agents|protective agents|mesh-ancestor
102110529|NCT01858896|Glucagon|glucagon|mesh-list
102110530|NCT01858896|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102110531|NCT01858896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102110532|NCT01858896|Hormones|hormones|mesh-ancestor
102110533|NCT01858896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102110534|NCT01858896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110535|NCT01858896|Incretins|incretins|mesh-ancestor
102110536|NCT04940286|Paclitaxel|paclitaxel|mesh-list
102110537|NCT04940286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102110538|NCT04940286|Gemcitabine|gemcitabine|mesh-list
102110539|NCT04940286|Durvalumab|durvalumab|mesh-list
102110540|NCT04940286|Immunoglobulins|immunoglobulins|mesh-list
102110541|NCT04940286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102110542|NCT04940286|Immunoglobulin G|immunoglobulin g|mesh-list
102110543|NCT04940286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102110544|NCT04940286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102110545|NCT04940286|Tubulin Modulators|tubulin modulators|mesh-ancestor
102110546|NCT04940286|Antimitotic Agents|antimitotic agents|mesh-ancestor
102110547|NCT04940286|Mitosis Modulators|mitosis modulators|mesh-ancestor
102110548|NCT04940286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110549|NCT04940286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102110550|NCT04940286|Antimetabolites|antimetabolites|mesh-ancestor
102110551|NCT04940286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102110552|NCT04940286|Immunologic Factors|immunologic factors|mesh-ancestor
102110553|NCT04940286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110554|NCT05538988|Cemiplimab|cemiplimab|mesh-list
102110555|NCT05538988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102110556|NCT05538988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102110557|NCT04667637|Edaravone|edaravone|mesh-list
102110558|NCT04667637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102110559|NCT04667637|Antioxidants|antioxidants|mesh-ancestor
102110560|NCT04667637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110561|NCT04667637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102110562|NCT04667637|Protective Agents|protective agents|mesh-ancestor
102110563|NCT04667637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110564|NCT02253927|Ritonavir|ritonavir|mesh-list
102110565|NCT02253927|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102110566|NCT02253927|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102110567|NCT02253927|Protease Inhibitors|protease inhibitors|mesh-ancestor
102110568|NCT02253927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102110569|NCT02253927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110570|NCT02253927|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102110571|NCT02253927|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102110572|NCT02253927|Antiviral Agents|antiviral agents|mesh-ancestor
102110573|NCT02253927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102110574|NCT02253927|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102110575|NCT02253927|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102110576|NCT03745144|Cladribine|cladribine|mesh-list
102110577|NCT03745144|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
102110578|NCT03745144|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
102110579|NCT03745144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102110580|NCT03745144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102110581|NCT03745144|Immunologic Factors|immunologic factors|mesh-ancestor
102110582|NCT03745144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110583|NCT03745144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102110584|NCT03745144|Contraceptive Agents|contraceptive agents|mesh-ancestor
102110585|NCT03745144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102110586|NCT03745144|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102110587|NCT03745144|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102110588|NCT03745144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102110589|NCT03745144|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102110590|NCT03745144|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102110591|NCT03745144|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
102110592|NCT03745144|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102110593|NCT03745144|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
102110594|NCT05697016|Sivelestat|sivelestat|mesh-list
102110595|NCT05697016|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102110596|NCT05697016|Protease Inhibitors|protease inhibitors|mesh-ancestor
102110597|NCT05697016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102110598|NCT05697016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110599|NCT04634877|Paclitaxel|paclitaxel|mesh-list
102110600|NCT04634877|Docetaxel|docetaxel|mesh-list
102110601|NCT04634877|Cisplatin|cisplatin|mesh-list
102110602|NCT04634877|Carboplatin|carboplatin|mesh-list
102110603|NCT04634877|Pembrolizumab|pembrolizumab|mesh-list
102110604|NCT04634877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102110605|NCT04634877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102110606|NCT04634877|Tubulin Modulators|tubulin modulators|mesh-ancestor
102110607|NCT04634877|Antimitotic Agents|antimitotic agents|mesh-ancestor
102110608|NCT04634877|Mitosis Modulators|mitosis modulators|mesh-ancestor
102110609|NCT04634877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110610|NCT04634877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102110611|NCT04634877|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102110612|NCT04629495|Sirolimus|sirolimus|mesh-list
102110613|NCT04629495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102110614|NCT04629495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102110615|NCT04629495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102110616|NCT04629495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102110617|NCT04629495|Antifungal Agents|antifungal agents|mesh-ancestor
102110618|NCT04629495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102110619|NCT04629495|Immunologic Factors|immunologic factors|mesh-ancestor
102110620|NCT04629495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110621|NCT01567995|Clobetasone butyrate|clobetasone butyrate|mesh-list
102110622|NCT01567995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102110623|NCT01567995|Glucocorticoids|glucocorticoids|mesh-ancestor
102110624|NCT01567995|Hormones|hormones|mesh-ancestor
102110625|NCT01567995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102110626|NCT01567995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110627|NCT05567523|Midazolam|midazolam|mesh-list
102110628|NCT05567523|Dexmedetomidine|dexmedetomidine|mesh-list
102110629|NCT05567523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102110630|NCT05567523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102110631|NCT05567523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110632|NCT05567523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102110633|NCT05567523|Analgesics|analgesics|mesh-ancestor
102110634|NCT05567523|Sensory System Agents|sensory system agents|mesh-ancestor
102110635|NCT05567523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102110636|NCT05567523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102110637|NCT05567523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102110638|NCT05567523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102110639|NCT05567523|Adrenergic Agents|adrenergic agents|mesh-ancestor
102110640|NCT05567523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102110641|NCT05567523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110642|NCT05567523|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102110643|NCT05567523|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102110644|NCT05567523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102110645|NCT05567523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102110646|NCT05567523|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102110647|NCT05567523|Anesthetics, General|anesthetics, general|mesh-ancestor
102110648|NCT05567523|Anesthetics|anesthetics|mesh-ancestor
102110649|NCT05567523|GABA Modulators|gaba modulators|mesh-ancestor
102110650|NCT05567523|GABA Agents|gaba agents|mesh-ancestor
102110651|NCT02584504|Atorvastatin|atorvastatin|mesh-list
102110652|NCT02584504|Alirocumab|alirocumab|mesh-list
102110653|NCT02584504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102110654|NCT02584504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102110655|NCT02584504|Antimetabolites|antimetabolites|mesh-ancestor
102110656|NCT02584504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110657|NCT02584504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102110658|NCT02584504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102110659|NCT02584504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102110660|NCT02584504|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102110661|NCT02584504|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102110662|NCT02584504|Protease Inhibitors|protease inhibitors|mesh-ancestor
102110663|NCT04599777|Sorafenib|sorafenib|mesh-list
102110664|NCT04599777|Tislelizumab|tislelizumab|mesh-list
102110665|NCT04599777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102110666|NCT04599777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102110667|NCT04599777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102110668|NCT04599777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110669|NCT04599777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102110670|NCT05044468|Lidocaine|lidocaine|mesh-list
102110671|NCT05044468|Bupivacaine|bupivacaine|mesh-list
102110672|NCT05044468|Anesthetics, Local|anesthetics, local|mesh-ancestor
102110673|NCT05044468|Anesthetics|anesthetics|mesh-ancestor
102110674|NCT05044468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102110675|NCT05044468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110676|NCT05044468|Sensory System Agents|sensory system agents|mesh-ancestor
102110677|NCT05044468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102110678|NCT05044468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102110679|NCT05044468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102110680|NCT05044468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102110681|NCT05044468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102110682|NCT05044468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110683|NCT05176509|Pembrolizumab|pembrolizumab|mesh-list
102110684|NCT05176509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102110685|NCT05176509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102110687|NCT05176509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110688|NCT05007262|Calcium Dobesilate|calcium dobesilate|mesh-list
102110689|NCT05007262|Calcium|calcium|mesh-list
102110690|NCT05007262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102110691|NCT05007262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110692|NCT05007262|Hemostatics|hemostatics|mesh-ancestor
102110693|NCT05007262|Coagulants|coagulants|mesh-ancestor
102110694|NCT03546075|Resveratrol|resveratrol|mesh-list
102110695|NCT03546075|Antioxidants|antioxidants|mesh-ancestor
102110696|NCT03546075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110697|NCT03546075|Protective Agents|protective agents|mesh-ancestor
102110698|NCT03546075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110699|NCT03546075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102110700|NCT03546075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102110701|NCT05537584|Bupropion|bupropion|mesh-list
102110702|NCT05537584|Sertraline|sertraline|mesh-list
102110703|NCT05537584|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102110704|NCT05537584|Antidepressive Agents|antidepressive agents|mesh-ancestor
102110705|NCT05537584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102110706|NCT05537584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102110707|NCT05537584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102110708|NCT05537584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102110709|NCT05537584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110711|NCT05537584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102110712|NCT05537584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110713|NCT05537584|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102110714|NCT05537584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102110715|NCT05537584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102110716|NCT05537584|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102110717|NCT05537584|Serotonin Agents|serotonin agents|mesh-ancestor
102110718|NCT01801072|Levetiracetam|levetiracetam|mesh-list
102110719|NCT01801072|Anticonvulsants|anticonvulsants|mesh-ancestor
102110720|NCT01801072|Nootropic Agents|nootropic agents|mesh-ancestor
102110721|NCT04459377|Ketamine|ketamine|mesh-list
102110722|NCT04459377|Esketamine|esketamine|mesh-list
102110723|NCT04459377|Analgesics|analgesics|mesh-ancestor
102110724|NCT04459377|Sensory System Agents|sensory system agents|mesh-ancestor
102110725|NCT04459377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102110726|NCT04459377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110727|NCT04459377|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102110728|NCT04459377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102110729|NCT04459377|Anesthetics, General|anesthetics, general|mesh-ancestor
102110730|NCT04459377|Anesthetics|anesthetics|mesh-ancestor
102110731|NCT04459377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102110732|NCT04459377|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102110733|NCT04459377|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102110734|NCT04459377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102110735|NCT04459377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110736|NCT04459377|Antidepressive Agents|antidepressive agents|mesh-ancestor
102110738|NCT00748618|Vitamin D|vitamin d|mesh-list
102110739|NCT00748618|Ergocalciferols|ergocalciferols|mesh-list
102110740|NCT00748618|Cholecalciferol|cholecalciferol|mesh-list
102110741|NCT00748618|Vitamins|vitamins|mesh-list
102110742|NCT00748618|Micronutrients|micronutrients|mesh-ancestor
102110743|NCT00748618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110744|NCT00748618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102110745|NCT00748618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102110746|NCT04447755|Lenvatinib|lenvatinib|mesh-list
102110747|NCT04447755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102110748|NCT04447755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102110749|NCT04447755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102110750|NCT04447755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110751|NCT02254005|Maytansine|maytansine|mesh-list
102110752|NCT02254005|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
102110753|NCT02254005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102110754|NCT02254005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102110755|NCT02254005|Tubulin Modulators|tubulin modulators|mesh-ancestor
102110756|NCT02254005|Antimitotic Agents|antimitotic agents|mesh-ancestor
102110757|NCT02254005|Mitosis Modulators|mitosis modulators|mesh-ancestor
102110758|NCT02254005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564316|NCT00609817|Hormones|hormones|mesh-ancestor
102110759|NCT02254005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102110760|NCT02254005|Immunotoxins|immunotoxins|mesh-ancestor
102110761|NCT02254005|Immunoconjugates|immunoconjugates|mesh-ancestor
102110762|NCT02254005|Immunologic Factors|immunologic factors|mesh-ancestor
102110763|NCT02254005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110764|NCT04404387|Ascorbic Acid|ascorbic acid|mesh-list
102110765|NCT04404387|Vitamins|vitamins|mesh-ancestor
102110766|NCT04404387|Micronutrients|micronutrients|mesh-ancestor
101954574|NCT03776955|Antioxidants|antioxidants|mesh-ancestor
102110767|NCT04404387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110768|NCT04404387|Antioxidants|antioxidants|mesh-ancestor
102110769|NCT04404387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110770|NCT04404387|Protective Agents|protective agents|mesh-ancestor
102110771|NCT03546855|Apatinib|apatinib|mesh-list
102110772|NCT03546855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102110773|NCT03546855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102110774|NCT03546855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102110775|NCT03546855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110777|NCT05679310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102110778|NCT05679310|Antioxidants|antioxidants|mesh-ancestor
101226868|NCT01537055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102110779|NCT05679310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110780|NCT05679310|Protective Agents|protective agents|mesh-ancestor
102110781|NCT05679310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110782|NCT05679310|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102110783|NCT05537272|Ascorbic Acid|ascorbic acid|mesh-list
102110784|NCT05537272|Tadalafil|tadalafil|mesh-list
102110785|NCT05537272|Tamsulosin|tamsulosin|mesh-list
102110786|NCT05537272|Vitamins|vitamins|mesh-ancestor
102110787|NCT05537272|Micronutrients|micronutrients|mesh-ancestor
102110788|NCT05537272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110789|NCT05537272|Antioxidants|antioxidants|mesh-ancestor
102110790|NCT05537272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110791|NCT05537272|Protective Agents|protective agents|mesh-ancestor
102110792|NCT05537272|Vasodilator Agents|vasodilator agents|mesh-ancestor
102110793|NCT05537272|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102110794|NCT05537272|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102110795|NCT05537272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102110796|NCT05537272|Urological Agents|urological agents|mesh-ancestor
102110797|NCT05537272|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102110798|NCT05537272|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102110799|NCT05537272|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102110800|NCT05537272|Adrenergic Agents|adrenergic agents|mesh-ancestor
102110801|NCT05537272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102110802|NCT05537194|1,4-dihydropyridine|1,4-dihydropyridine|mesh-list
102110803|NCT05537194|Calcium|calcium|mesh-list
102110804|NCT05537194|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102110805|NCT05537194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110806|NCT05537194|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102110807|NCT05537194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102110808|NCT05537194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110809|NCT05536882|Adapalene|adapalene|mesh-list
102110813|NCT05536882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102110814|NCT05536882|Analgesics|analgesics|mesh-ancestor
102110815|NCT05536882|Sensory System Agents|sensory system agents|mesh-ancestor
102110816|NCT05536882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102110817|NCT05536882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110818|NCT05536882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102110819|NCT05536882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102110823|NCT03931161|Evolocumab|evolocumab|mesh-list
102110824|NCT03931161|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102110825|NCT03931161|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102110826|NCT03931161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102110827|NCT03931161|Antimetabolites|antimetabolites|mesh-ancestor
102110828|NCT03931161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110829|NCT03931161|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102110830|NCT03931161|Protease Inhibitors|protease inhibitors|mesh-ancestor
102110831|NCT03931161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102110832|NCT03931161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102110833|NCT05037123|Ketamine|ketamine|mesh-list
102110834|NCT05037123|Analgesics|analgesics|mesh-ancestor
102110835|NCT05037123|Sensory System Agents|sensory system agents|mesh-ancestor
102110836|NCT05037123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102110837|NCT05037123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110838|NCT05037123|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102110839|NCT05037123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102110840|NCT05037123|Anesthetics, General|anesthetics, general|mesh-ancestor
102110842|NCT05037123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102110843|NCT05037123|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102110844|NCT05037123|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102110845|NCT05037123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102110846|NCT05037123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110847|NCT04354155|Enoxaparin|enoxaparin|mesh-list
102110848|NCT04354155|Anticoagulants|anticoagulants|mesh-ancestor
102110849|NCT04354155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102110850|NCT04354155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101226893|NCT01537146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102110851|NCT04354155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110852|NCT04450654|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102110853|NCT04450654|Immunologic Factors|immunologic factors|mesh-ancestor
102110854|NCT04450654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110855|NCT04350021|Cyclophosphamide|cyclophosphamide|mesh-list
102110856|NCT04350021|Capecitabine|capecitabine|mesh-list
102110857|NCT04350021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102110858|NCT04350021|Immunologic Factors|immunologic factors|mesh-ancestor
102110859|NCT04350021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110860|NCT04350021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102110861|NCT04350021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102110862|NCT04350021|Alkylating Agents|alkylating agents|mesh-ancestor
102110863|NCT04350021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110864|NCT04350021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102110865|NCT04350021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102110866|NCT04350021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102110867|NCT04350021|Antimetabolites|antimetabolites|mesh-ancestor
102110868|NCT05536570|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102110869|NCT05536570|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102110870|NCT05536570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102110871|NCT05536570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110872|NCT05536570|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102110873|NCT05536570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101954747|NCT02060656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102110874|NCT05536570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110875|NCT05536570|Cholinergic Agents|cholinergic agents|mesh-ancestor
102110876|NCT05536570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102110877|NCT03877965|Digoxin|digoxin|mesh-list
102110878|NCT03877965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102110879|NCT03877965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102110880|NCT03877965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102110881|NCT03877965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110882|NCT03877965|Protective Agents|protective agents|mesh-ancestor
102110883|NCT03877965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110884|NCT02253849|Ritonavir|ritonavir|mesh-list
102110885|NCT02253849|Tipranavir|tipranavir|mesh-list
102110886|NCT02253849|Carbamazepine|carbamazepine|mesh-list
102110887|NCT02253849|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102110888|NCT02253849|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102110889|NCT02253849|Protease Inhibitors|protease inhibitors|mesh-ancestor
102110890|NCT02253849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102110891|NCT02253849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110892|NCT02253849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102110893|NCT02253849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102110894|NCT02253849|Antiviral Agents|antiviral agents|mesh-ancestor
102110895|NCT02253849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102110896|NCT02253849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102110897|NCT02253849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102110898|NCT02253849|Anticonvulsants|anticonvulsants|mesh-ancestor
102110899|NCT02253849|Antimanic Agents|antimanic agents|mesh-ancestor
102110900|NCT02253849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102110901|NCT02253849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102110902|NCT02253849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110903|NCT02253849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102110904|NCT02253849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102110905|NCT02253849|Analgesics|analgesics|mesh-ancestor
102110906|NCT02253849|Sensory System Agents|sensory system agents|mesh-ancestor
102110907|NCT02253849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102110908|NCT02253849|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102110909|NCT02253849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102110910|NCT02253849|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102110911|NCT02253849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102110912|NCT03545997|Montelukast|montelukast|mesh-list
102110913|NCT03545997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102110914|NCT03545997|Respiratory System Agents|respiratory system agents|mesh-ancestor
102110915|NCT03545997|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102110916|NCT03545997|Hormone Antagonists|hormone antagonists|mesh-ancestor
102110917|NCT03545997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102110918|NCT03545997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110919|NCT03545997|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102110920|NCT03545997|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102110921|NCT03545997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110922|NCT05696548|Nivolumab|nivolumab|mesh-list
102110923|NCT05696548|Lenvatinib|lenvatinib|mesh-list
102110924|NCT05696548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102110925|NCT05696548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102110926|NCT05696548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102110927|NCT05696548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110928|NCT05696548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102110929|NCT05696548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102110930|NCT03810495|Naltrexone|naltrexone|mesh-list
102110931|NCT03810495|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102110932|NCT03810495|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102110933|NCT03810495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110934|NCT03810495|Sensory System Agents|sensory system agents|mesh-ancestor
102110935|NCT03810495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102110936|NCT04980885|Azacitidine|azacitidine|mesh-list
102110937|NCT04980885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102110938|NCT04980885|Antimetabolites|antimetabolites|mesh-ancestor
102110939|NCT04980885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110940|NCT04980885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102110941|NCT04980885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102110942|NCT04184505|Azacitidine|azacitidine|mesh-list
102110943|NCT04184505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102110944|NCT04184505|Antimetabolites|antimetabolites|mesh-ancestor
102110945|NCT04184505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110946|NCT04184505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102110947|NCT04184505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102110948|NCT03691935|Ropivacaine|ropivacaine|mesh-list
102110949|NCT03691935|Anesthetics|anesthetics|mesh-list
102110950|NCT03691935|Anesthetics, Local|anesthetics, local|mesh-ancestor
102110951|NCT03691935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102110952|NCT03691935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110953|NCT03691935|Sensory System Agents|sensory system agents|mesh-ancestor
102110954|NCT03691935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102110955|NCT03760458|Lamivudine|lamivudine|mesh-list
102110956|NCT03760458|Abacavir|abacavir|mesh-list
102110957|NCT03760458|Dideoxynucleosides|dideoxynucleosides|mesh-list
102110958|NCT03760458|Dolutegravir|dolutegravir|mesh-list
102110959|NCT03760458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102110960|NCT03760458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102110961|NCT03760458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102110962|NCT03760458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110963|NCT03760458|Antiviral Agents|antiviral agents|mesh-ancestor
102110964|NCT03760458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102110965|NCT03760458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102110966|NCT03760458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102110967|NCT03760458|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102110968|NCT03760458|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102110969|NCT03760458|Antimetabolites|antimetabolites|mesh-ancestor
102110970|NCT02066415|Erenumab|erenumab|mesh-list
101226915|NCT01537380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102110971|NCT02066415|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
102110972|NCT02066415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110973|NCT02066415|Analgesics|analgesics|mesh-ancestor
102110974|NCT02066415|Sensory System Agents|sensory system agents|mesh-ancestor
102110975|NCT02066415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102110976|NCT02066415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110977|NCT04467918|Cannabidiol|cannabidiol|mesh-list
102110978|NCT04467918|Anticonvulsants|anticonvulsants|mesh-ancestor
102110979|NCT04720612|Omalizumab|omalizumab|mesh-list
102110980|NCT04720612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102110981|NCT04720612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102110982|NCT04720612|Respiratory System Agents|respiratory system agents|mesh-ancestor
102110983|NCT01981551|Nirogacestat|nirogacestat|mesh-list
102110984|NCT01981551|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
102110985|NCT01981551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102110986|NCT01981551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110987|NCT02584660|Rivaroxaban|rivaroxaban|mesh-list
102110988|NCT02584660|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102110989|NCT02584660|Antithrombins|antithrombins|mesh-ancestor
102110990|NCT02584660|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102110991|NCT02584660|Protease Inhibitors|protease inhibitors|mesh-ancestor
102110992|NCT02584660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102110993|NCT02584660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102110994|NCT02584660|Anticoagulants|anticoagulants|mesh-ancestor
102110995|NCT04862286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102110996|NCT04862286|Immunologic Factors|immunologic factors|mesh-ancestor
102110997|NCT04862286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102110998|NCT02143323|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102110999|NCT02143323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102111000|NCT02143323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102111001|NCT02143323|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102111002|NCT02143323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102111003|NCT02143323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111004|NCT04315558|Bromides|bromides|mesh-list
102111005|NCT04315558|Ipratropium|ipratropium|mesh-list
102111006|NCT04315558|Anticonvulsants|anticonvulsants|mesh-ancestor
102111007|NCT04315558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102111008|NCT04315558|Autonomic Agents|autonomic agents|mesh-ancestor
102111009|NCT04315558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102111010|NCT04315558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111011|NCT04315558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102111012|NCT04315558|Respiratory System Agents|respiratory system agents|mesh-ancestor
102111013|NCT04315558|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102111014|NCT04315558|Cholinergic Agents|cholinergic agents|mesh-ancestor
102111015|NCT04315558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102111016|NCT04315558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111017|NCT04466904|Dulaglutide|dulaglutide|mesh-list
102111018|NCT04466904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102111019|NCT04466904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111020|NCT03524274|Antibodies|antibodies|mesh-list
102111021|NCT03524274|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102111022|NCT03524274|Immunologic Factors|immunologic factors|mesh-ancestor
102111023|NCT03524274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111024|NCT02143479|Tacrolimus|tacrolimus|mesh-list
102111025|NCT02143479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102111026|NCT02143479|Immunologic Factors|immunologic factors|mesh-ancestor
102111027|NCT02143479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111028|NCT02143479|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102111029|NCT02143479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102111030|NCT02143479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111031|NCT02254239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102111032|NCT02254239|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102111033|NCT02254239|Everolimus|everolimus|mesh-list
102111034|NCT02254239|Antibodies|antibodies|mesh-list
102111035|NCT02254239|Immunoglobulins|immunoglobulins|mesh-list
102111036|NCT02254239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102111037|NCT02254239|Immunoconjugates|immunoconjugates|mesh-list
102111038|NCT02254239|Immunologic Factors|immunologic factors|mesh-ancestor
102111039|NCT02254239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111040|NCT02254239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102111041|NCT02254239|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102111042|NCT02254239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102111043|NCT02254239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102111044|NCT02254239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111045|NCT02254239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102111046|NCT02254239|Immunotoxins|immunotoxins|mesh-ancestor
102111047|NCT05088369|Adrenomedullin|adrenomedullin|mesh-list
102111048|NCT05088369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102111049|NCT05088369|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102111050|NCT05088369|Autonomic Agents|autonomic agents|mesh-ancestor
102111051|NCT05088369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102111052|NCT05088369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111053|NCT05088369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102111054|NCT05088369|Respiratory System Agents|respiratory system agents|mesh-ancestor
102111055|NCT05088369|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102111056|NCT05088369|Vasodilator Agents|vasodilator agents|mesh-ancestor
102111057|NCT05088369|Protective Agents|protective agents|mesh-ancestor
102111058|NCT05681182|Amiodarone|amiodarone|mesh-list
102111059|NCT05681182|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102111060|NCT05681182|Vasodilator Agents|vasodilator agents|mesh-ancestor
102111061|NCT05681182|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102111062|NCT05681182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102111063|NCT05681182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111064|NCT05681182|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102111065|NCT05681182|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102111066|NCT05681182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102111067|NCT05681182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102111068|NCT05681182|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102111069|NCT05681182|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102111070|NCT05681182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102111071|NCT03521700|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102111072|NCT03521700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102111073|NCT03521700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102111074|NCT03521700|Antimetabolites|antimetabolites|mesh-ancestor
102111075|NCT03521700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111076|NCT03521700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102111077|NCT03521700|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102111078|NCT03521700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102111079|NCT02144025|Cyclosporine|cyclosporine|mesh-list
102111080|NCT02144025|Cyclosporins|cyclosporins|mesh-list
102111081|NCT02144025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102111082|NCT02144025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111083|NCT02144025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102111084|NCT02144025|Immunologic Factors|immunologic factors|mesh-ancestor
102111085|NCT02144025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111086|NCT02144025|Antifungal Agents|antifungal agents|mesh-ancestor
102111087|NCT02144025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102111088|NCT02144025|Dermatologic Agents|dermatologic agents|mesh-ancestor
102111089|NCT02144025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102111090|NCT02144025|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102111091|NCT03523650|Propranolol|propranolol|mesh-list
102111092|NCT03523650|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102111093|NCT03523650|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102111094|NCT03523650|Adrenergic Agents|adrenergic agents|mesh-ancestor
102111095|NCT03523650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102111096|NCT03523650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111097|NCT03523650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111098|NCT03523650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102111099|NCT03523650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102111100|NCT03523650|Vasodilator Agents|vasodilator agents|mesh-ancestor
102111101|NCT01025505|Imatinib Mesylate|imatinib mesylate|mesh-list
102111102|NCT01025505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102111103|NCT01025505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102111104|NCT01025505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102111105|NCT01025505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111106|NCT02582632|Ritonavir|ritonavir|mesh-list
102111107|NCT02582632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102111108|NCT02582632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102111109|NCT02582632|Protease Inhibitors|protease inhibitors|mesh-ancestor
102111110|NCT02582632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102111111|NCT02582632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111112|NCT02582632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102111113|NCT02582632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102111114|NCT02582632|Antiviral Agents|antiviral agents|mesh-ancestor
102111115|NCT02582632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102111116|NCT02582632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102111117|NCT02582632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102111118|NCT03656562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102111119|NCT03656562|Immunologic Factors|immunologic factors|mesh-ancestor
102111120|NCT03656562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111121|NCT05381974|Psilocybin|psilocybin|mesh-list
102111122|NCT05381974|Hallucinogens|hallucinogens|mesh-ancestor
102111123|NCT05381974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111124|NCT05381974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102111125|NCT02178722|Pembrolizumab|pembrolizumab|mesh-list
102111126|NCT02178722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102111127|NCT02178722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102111128|NCT02178722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101564688|NCT05154669|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102111129|NCT02178722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111130|NCT03523572|Nivolumab|nivolumab|mesh-list
102111131|NCT03523572|Trastuzumab|trastuzumab|mesh-list
102111132|NCT03523572|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
102111133|NCT03523572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102111134|NCT03523572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102111135|NCT03523572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102111136|NCT03523572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111137|NCT03523572|Immunoconjugates|immunoconjugates|mesh-ancestor
102111138|NCT03523572|Immunologic Factors|immunologic factors|mesh-ancestor
102111139|NCT03523572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111140|NCT00972309|Vaccines|vaccines|mesh-list
102111141|NCT00972309|Immunologic Factors|immunologic factors|mesh-ancestor
102111142|NCT00972309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111143|NCT03526224|Teriflunomide|teriflunomide|mesh-list
102111144|NCT03526224|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102111145|NCT03526224|Dermatologic Agents|dermatologic agents|mesh-ancestor
102111146|NCT03526224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102111147|NCT03526224|Immunologic Factors|immunologic factors|mesh-ancestor
102111148|NCT03526224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111149|NCT03526224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102111150|NCT03526224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102111151|NCT03526224|Analgesics|analgesics|mesh-ancestor
102111152|NCT03526224|Sensory System Agents|sensory system agents|mesh-ancestor
102111153|NCT03526224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102111154|NCT03526224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102111155|NCT03526224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102111156|NCT03639246|Paclitaxel|paclitaxel|mesh-list
102111157|NCT03639246|Doxorubicin|doxorubicin|mesh-list
102111158|NCT03639246|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102111159|NCT03639246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102111160|NCT03639246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102111161|NCT03639246|Tubulin Modulators|tubulin modulators|mesh-ancestor
102111162|NCT03639246|Antimitotic Agents|antimitotic agents|mesh-ancestor
102111163|NCT03639246|Mitosis Modulators|mitosis modulators|mesh-ancestor
102111164|NCT03639246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226948|NCT01537744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102111165|NCT03639246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102111166|NCT03639246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102111167|NCT03639246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102111168|NCT03639246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102111169|NCT00545324|Fluticasone|fluticasone|mesh-list
102111170|NCT00545324|Montelukast|montelukast|mesh-list
102111171|NCT00545324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102111172|NCT00545324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102111173|NCT00545324|Autonomic Agents|autonomic agents|mesh-ancestor
102111174|NCT00545324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102111175|NCT00545324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111176|NCT00545324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102111177|NCT00545324|Respiratory System Agents|respiratory system agents|mesh-ancestor
102111178|NCT00545324|Dermatologic Agents|dermatologic agents|mesh-ancestor
102111179|NCT00545324|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102111180|NCT00545324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111181|NCT00545324|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102111182|NCT00545324|Hormone Antagonists|hormone antagonists|mesh-ancestor
102111183|NCT00545324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102111184|NCT00545324|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102111185|NCT00545324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102111186|NCT02582242|Insulin Aspart|insulin aspart|mesh-list
102111187|NCT02582242|Biphasic Insulins|biphasic insulins|mesh-list
102111188|NCT02582242|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
102111189|NCT02582242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102111190|NCT02582242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111191|NCT05004038|BCG Vaccine|bcg vaccine|mesh-list
102111192|NCT05004038|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102111193|NCT05004038|Immunologic Factors|immunologic factors|mesh-ancestor
102111194|NCT05004038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111195|NCT04217356|Hydroxyurea|hydroxyurea|mesh-list
102111196|NCT04217356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102111197|NCT04217356|Antisickling Agents|antisickling agents|mesh-ancestor
102111198|NCT04217356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102111199|NCT04217356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111200|NCT04217356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102111201|NCT03609840|Thiotepa|thiotepa|mesh-list
102111202|NCT03609840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-list
102111204|NCT03609840|Alkylating Agents|alkylating agents|mesh-ancestor
102111205|NCT03609840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111206|NCT03609840|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102111207|NCT03609840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102111208|NCT03609840|Immunologic Factors|immunologic factors|mesh-ancestor
102111209|NCT03609840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111210|NCT03389126|Avelumab|avelumab|mesh-list
102111211|NCT03389126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102111212|NCT03389126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102111213|NCT04212364|Naloxone|naloxone|mesh-list
102111214|NCT04212364|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102111215|NCT04212364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111216|NCT04212364|Sensory System Agents|sensory system agents|mesh-ancestor
102111217|NCT04212364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102111218|NCT04446104|Hydroxychloroquine|hydroxychloroquine|mesh-list
102111219|NCT04446104|Ivermectin|ivermectin|mesh-list
102111220|NCT04446104|Povidone-Iodine|povidone-iodine|mesh-list
102111221|NCT04446104|Povidone|povidone|mesh-list
102111222|NCT04446104|Antimalarials|antimalarials|mesh-ancestor
102111223|NCT04446104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102111224|NCT04446104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102111225|NCT04446104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102111226|NCT04446104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102111227|NCT04446104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111228|NCT04446104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102111229|NCT04446104|Plasma Substitutes|plasma substitutes|mesh-ancestor
102111230|NCT04446104|Blood Substitutes|blood substitutes|mesh-ancestor
102111231|NCT04446104|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102111232|NCT03388970|Vitamin K|vitamin k|mesh-list
102111233|NCT03388970|Vitamin K 1|vitamin k 1|mesh-list
102111234|NCT03388970|Vitamins|vitamins|mesh-ancestor
102111235|NCT03388970|Micronutrients|micronutrients|mesh-ancestor
102111236|NCT03388970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111237|NCT03388970|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102111238|NCT03388970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102111239|NCT03388970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111240|NCT03388970|Hemostatics|hemostatics|mesh-ancestor
102111241|NCT03388970|Coagulants|coagulants|mesh-ancestor
102111242|NCT00616941|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
102111243|NCT00616941|Poly ICLC|poly iclc|mesh-list
102111244|NCT00616941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102111245|NCT00616941|Immunologic Factors|immunologic factors|mesh-ancestor
102111246|NCT00616941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111247|NCT00616941|Interferon Inducers|interferon inducers|mesh-ancestor
102111248|NCT03388892|Paclitaxel|paclitaxel|mesh-list
102111249|NCT03388892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102111250|NCT03388892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102111251|NCT03388892|Tubulin Modulators|tubulin modulators|mesh-ancestor
102111252|NCT03388892|Antimitotic Agents|antimitotic agents|mesh-ancestor
102111253|NCT03388892|Mitosis Modulators|mitosis modulators|mesh-ancestor
102111254|NCT03388892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111255|NCT02577718|Ethanol|ethanol|mesh-list
102111256|NCT02577718|Nitroglycerin|nitroglycerin|mesh-list
102111257|NCT02577718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102111258|NCT02577718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102111259|NCT02577718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102111260|NCT02577718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111261|NCT02577718|Vasodilator Agents|vasodilator agents|mesh-ancestor
102111262|NCT00520533|Sunitinib|sunitinib|mesh-list
102111263|NCT00520533|Antibodies|antibodies|mesh-list
102111264|NCT00520533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102111265|NCT00520533|Immunologic Factors|immunologic factors|mesh-ancestor
102111266|NCT00520533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111267|NCT00520533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102111268|NCT00520533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102111269|NCT00520533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102111270|NCT00520533|Growth Substances|growth substances|mesh-ancestor
102111271|NCT00520533|Growth Inhibitors|growth inhibitors|mesh-ancestor
102111272|NCT00520533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101836470|NCT00309166|Immunologic Factors|immunologic factors|mesh-ancestor
102111273|NCT00520533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102111274|NCT00520533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111275|NCT03388814|Bupivacaine|bupivacaine|mesh-list
102111276|NCT03388814|Anesthetics, Local|anesthetics, local|mesh-ancestor
102111277|NCT03388814|Anesthetics|anesthetics|mesh-ancestor
102111278|NCT03388814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102111279|NCT03388814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111280|NCT03388814|Sensory System Agents|sensory system agents|mesh-ancestor
102111281|NCT03388814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102111282|NCT04680988|Paclitaxel|paclitaxel|mesh-list
102111283|NCT04680988|Gemcitabine|gemcitabine|mesh-list
102111284|NCT04680988|Pemetrexed|pemetrexed|mesh-list
102111285|NCT04680988|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102111286|NCT04680988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102111287|NCT04680988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102111288|NCT04680988|Tubulin Modulators|tubulin modulators|mesh-ancestor
102111289|NCT04680988|Antimitotic Agents|antimitotic agents|mesh-ancestor
101954783|NCT03774615|Ferric maltol|ferric maltol|mesh-list
102111290|NCT04680988|Mitosis Modulators|mitosis modulators|mesh-ancestor
102111291|NCT04680988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111292|NCT04680988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102111293|NCT04680988|Antimetabolites|antimetabolites|mesh-ancestor
102111294|NCT04680988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102111295|NCT04680988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102111296|NCT04680988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102111297|NCT02289144|Ceritinib|ceritinib|mesh-list
102111298|NCT02289144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102111299|NCT02289144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102111300|NCT02289144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102111301|NCT02289144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111302|NCT03393026|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102111303|NCT03393026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102111304|NCT03393026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102111305|NCT03393026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102111306|NCT03393026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111307|NCT03393026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102111308|NCT03393026|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102111309|NCT03393026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102111310|NCT03393026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102111311|NCT03393026|Adrenergic Agents|adrenergic agents|mesh-ancestor
102111312|NCT03393026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102111313|NCT03393026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111314|NCT03393026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102111315|NCT03393026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102111316|NCT03393026|Serotonin Agents|serotonin agents|mesh-ancestor
102111317|NCT03393026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102111318|NCT03393026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102111319|NCT03393026|Dopamine Agents|dopamine agents|mesh-ancestor
102111320|NCT02144415|Amphetamine|amphetamine|mesh-list
102111321|NCT02144415|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102111322|NCT02144415|Dextroamphetamine|dextroamphetamine|mesh-list
102111323|NCT02144415|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102111324|NCT02144415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111325|NCT02144415|Sympathomimetics|sympathomimetics|mesh-ancestor
102111326|NCT02144415|Autonomic Agents|autonomic agents|mesh-ancestor
102111327|NCT02144415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102111328|NCT02144415|Dopamine Agents|dopamine agents|mesh-ancestor
102111329|NCT02144415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102111330|NCT02144415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111331|NCT02144415|Adrenergic Agents|adrenergic agents|mesh-ancestor
102111332|NCT02144415|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102111333|NCT02144415|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102111334|NCT02144415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102111335|NCT02144415|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102111336|NCT02739984|Evolocumab|evolocumab|mesh-list
102111337|NCT02739984|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102111338|NCT02739984|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102111339|NCT02739984|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102111340|NCT02739984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102111341|NCT02739984|Antimetabolites|antimetabolites|mesh-ancestor
102111342|NCT02739984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111343|NCT02739984|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102111344|NCT02739984|Protease Inhibitors|protease inhibitors|mesh-ancestor
102111345|NCT02739984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102111346|NCT02739984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102111347|NCT02739984|Immunologic Factors|immunologic factors|mesh-ancestor
102111348|NCT02739984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111349|NCT00496730|Atorvastatin|atorvastatin|mesh-list
102111350|NCT00496730|Simvastatin|simvastatin|mesh-list
102111351|NCT00496730|Ezetimibe|ezetimibe|mesh-list
102111352|NCT00496730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101564916|NCT00919867|Guanfacine|guanfacine|mesh-list
102111353|NCT00496730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102111354|NCT00496730|Antimetabolites|antimetabolites|mesh-ancestor
102111355|NCT00496730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111356|NCT00496730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102111357|NCT00496730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102111358|NCT00496730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102111359|NCT00446186|Montelukast|montelukast|mesh-list
102111360|NCT00446186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111361|NCT00446186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111362|NCT00446186|Respiratory System Agents|respiratory system agents|mesh-ancestor
102111363|NCT00446186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102111364|NCT00446186|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102111365|NCT00446186|Hormone Antagonists|hormone antagonists|mesh-ancestor
102111366|NCT00446186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102111367|NCT00446186|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102111368|NCT00446186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102111369|NCT02140983|Liraglutide|liraglutide|mesh-list
102111370|NCT02140983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102111371|NCT02140983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111372|NCT02140983|Incretins|incretins|mesh-ancestor
102111373|NCT02140983|Hormones|hormones|mesh-ancestor
102111374|NCT02140983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102111375|NCT00394160|Montelukast|montelukast|mesh-list
102111376|NCT00394160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102111377|NCT00394160|Respiratory System Agents|respiratory system agents|mesh-ancestor
102111378|NCT00394160|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102111379|NCT00394160|Hormone Antagonists|hormone antagonists|mesh-ancestor
102111380|NCT00394160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102111381|NCT00394160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111382|NCT00394160|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102111383|NCT00394160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102111384|NCT00394160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111385|NCT03392792|Plasminogen|plasminogen|mesh-list
102111386|NCT03392792|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
102111387|NCT03392792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102111388|NCT03392792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102111389|NCT03392792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111390|NCT02739828|Adalimumab|adalimumab|mesh-list
102111391|NCT02739828|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102111392|NCT02739828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102111393|NCT02739828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102111394|NCT02141139|Ibuprofen|ibuprofen|mesh-list
102111395|NCT02141139|Ketorolac|ketorolac|mesh-list
102111396|NCT02141139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102111397|NCT02141139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102111398|NCT02141139|Analgesics|analgesics|mesh-ancestor
102111399|NCT02141139|Sensory System Agents|sensory system agents|mesh-ancestor
102111400|NCT02141139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102111401|NCT02141139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111402|NCT02141139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102111403|NCT02141139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102111404|NCT02141139|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102111405|NCT02141139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102111406|NCT02141139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111407|NCT03108495|Pembrolizumab|pembrolizumab|mesh-list
102111408|NCT03108495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102111409|NCT03108495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102111410|NCT03108495|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102111411|NCT03108495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111412|NCT05297032|Quercetin|quercetin|mesh-list
102111413|NCT05297032|Antioxidants|antioxidants|mesh-ancestor
102111414|NCT05297032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111415|NCT05297032|Protective Agents|protective agents|mesh-ancestor
102111416|NCT05297032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111417|NCT03388580|Dimercaprol|dimercaprol|mesh-list
102111418|NCT03388580|Chelating Agents|chelating agents|mesh-ancestor
102111419|NCT03388580|Sequestering Agents|sequestering agents|mesh-ancestor
102111420|NCT03388580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111421|NCT03525912|Ketamine|ketamine|mesh-list
102111423|NCT03525912|Sensory System Agents|sensory system agents|mesh-ancestor
102111424|NCT03525912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102111425|NCT03525912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111426|NCT03525912|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102111427|NCT03525912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102111428|NCT03525912|Anesthetics, General|anesthetics, general|mesh-ancestor
102111430|NCT03525912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102111431|NCT03525912|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102111432|NCT03525912|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102111433|NCT03525912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102111434|NCT03525912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111435|NCT02289378|Docetaxel|docetaxel|mesh-list
102111436|NCT02289378|Oxaliplatin|oxaliplatin|mesh-list
102111437|NCT02289378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102111438|NCT02289378|Tubulin Modulators|tubulin modulators|mesh-ancestor
102111439|NCT02289378|Antimitotic Agents|antimitotic agents|mesh-ancestor
102111440|NCT02289378|Mitosis Modulators|mitosis modulators|mesh-ancestor
102111441|NCT02289378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111442|NCT03851614|Durvalumab|durvalumab|mesh-list
102111443|NCT03851614|Olaparib|olaparib|mesh-list
102111444|NCT03851614|Cediranib|cediranib|mesh-list
102111445|NCT03851614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102111446|NCT03851614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102111447|NCT03851614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102111448|NCT03851614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102111449|NCT03851614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111450|NCT03851614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102111451|NCT04565600|Etoricoxib|etoricoxib|mesh-list
102111452|NCT04565600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102111453|NCT04565600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102111454|NCT04565600|Analgesics|analgesics|mesh-ancestor
102111455|NCT04565600|Sensory System Agents|sensory system agents|mesh-ancestor
102111456|NCT04565600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102111457|NCT04565600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111458|NCT04565600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102111459|NCT04565600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102111460|NCT04565600|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102111461|NCT04565600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102111462|NCT04565600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102111463|NCT04565600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111464|NCT04435808|Hydroxychloroquine|hydroxychloroquine|mesh-list
102111465|NCT04435808|Antimalarials|antimalarials|mesh-ancestor
102111466|NCT04435808|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102111467|NCT04435808|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102111468|NCT04435808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102111469|NCT04435808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102111470|NCT04435808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111471|NCT04435808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102111472|NCT03388346|Edetic Acid|edetic acid|mesh-list
102111473|NCT03388346|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102111474|NCT03388346|Chelating Agents|chelating agents|mesh-ancestor
102111475|NCT03388346|Sequestering Agents|sequestering agents|mesh-ancestor
102111476|NCT03388346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111477|NCT03388346|Anticoagulants|anticoagulants|mesh-ancestor
102111478|NCT03388346|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102111479|NCT03388346|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102111480|NCT05631730|Metoprolol|metoprolol|mesh-list
102111481|NCT05631730|Flecainide|flecainide|mesh-list
102111482|NCT05631730|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102111483|NCT05631730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102111484|NCT05631730|Sympatholytics|sympatholytics|mesh-ancestor
102111485|NCT05631730|Autonomic Agents|autonomic agents|mesh-ancestor
102111486|NCT05631730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102111487|NCT05631730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111488|NCT05631730|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102111489|NCT05631730|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102111490|NCT05631730|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102111492|NCT05631730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102111493|NCT05631730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111494|NCT05631730|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102111495|NCT05631730|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102111496|NCT05631730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102111497|NCT00092144|Montelukast|montelukast|mesh-list
101565065|NCT01212588|Mifepristone|mifepristone|mesh-list
102111498|NCT00092144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111499|NCT00092144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111500|NCT00092144|Respiratory System Agents|respiratory system agents|mesh-ancestor
102111501|NCT00092144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102111502|NCT00092144|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102111503|NCT00092144|Hormone Antagonists|hormone antagonists|mesh-ancestor
102111504|NCT00092144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102111505|NCT00092144|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102111506|NCT00092144|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102111507|NCT02289768|Salicylic Acid|salicylic acid|mesh-list
102111508|NCT02289768|Salicylates|salicylates|mesh-list
102111509|NCT02289768|Fluorouracil|fluorouracil|mesh-list
102111510|NCT02289768|Antimetabolites|antimetabolites|mesh-ancestor
102111511|NCT02289768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111512|NCT02289768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102111513|NCT02289768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102111514|NCT02289768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102111515|NCT02289768|Immunologic Factors|immunologic factors|mesh-ancestor
102111516|NCT02289768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111517|NCT02289768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102111518|NCT02289768|Antifungal Agents|antifungal agents|mesh-ancestor
102111519|NCT02289768|Keratolytic Agents|keratolytic agents|mesh-ancestor
102111520|NCT02289768|Dermatologic Agents|dermatologic agents|mesh-ancestor
102111521|NCT02289768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102111522|NCT02289768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102111523|NCT02289768|Analgesics|analgesics|mesh-ancestor
102111524|NCT02289768|Sensory System Agents|sensory system agents|mesh-ancestor
102111525|NCT02289768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102111526|NCT02289768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102111527|NCT02289768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102111528|NCT02289768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102111529|NCT02289768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102111530|NCT05526586|Ethanol|ethanol|mesh-list
102111531|NCT05526586|Listerine|listerine|mesh-list
102111532|NCT05526586|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
102111533|NCT05526586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102111534|NCT05526586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102111535|NCT05526586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111536|NCT04330430|Nivolumab|nivolumab|mesh-list
102111537|NCT04330430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102111538|NCT04330430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102111539|NCT04330430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102111540|NCT04330430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111541|NCT03387956|Dexamethasone|dexamethasone|mesh-list
102111542|NCT03387956|Atropine|atropine|mesh-list
102111543|NCT03387956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102111544|NCT03387956|Antiemetics|antiemetics|mesh-ancestor
102111545|NCT03387956|Autonomic Agents|autonomic agents|mesh-ancestor
102111546|NCT03387956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102111547|NCT03387956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111548|NCT03387956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102111549|NCT03387956|Glucocorticoids|glucocorticoids|mesh-ancestor
102111550|NCT03387956|Hormones|hormones|mesh-ancestor
102111551|NCT03387956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102111552|NCT03387956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102111553|NCT03387956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102111554|NCT03387956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102111555|NCT03387956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102111556|NCT03387956|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101954810|NCT03773991|Antioxidants|antioxidants|mesh-ancestor
102111557|NCT03387956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102111558|NCT03387956|Respiratory System Agents|respiratory system agents|mesh-ancestor
102111559|NCT03387956|Mydriatics|mydriatics|mesh-ancestor
102111560|NCT03387956|Parasympatholytics|parasympatholytics|mesh-ancestor
102111561|NCT03387956|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102111562|NCT03387956|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102111563|NCT03387956|Cholinergic Agents|cholinergic agents|mesh-ancestor
102111564|NCT03387956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102111565|NCT03387956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111566|NCT03384524|Metoprolol|metoprolol|mesh-list
102111567|NCT03384524|Bromocriptine|bromocriptine|mesh-list
102111568|NCT03384524|Tamsulosin|tamsulosin|mesh-list
102111569|NCT03384524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102111570|NCT03384524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102111571|NCT03384524|Sympatholytics|sympatholytics|mesh-ancestor
102111572|NCT03384524|Autonomic Agents|autonomic agents|mesh-ancestor
102111573|NCT03384524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102111574|NCT03384524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111575|NCT03384524|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102111576|NCT03384524|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102111577|NCT03384524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102111578|NCT03384524|Adrenergic Agents|adrenergic agents|mesh-ancestor
102111579|NCT03384524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102111580|NCT03384524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111581|NCT03384524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102111582|NCT03384524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102111583|NCT03384524|Urological Agents|urological agents|mesh-ancestor
102111584|NCT03384524|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102111585|NCT03384524|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102111586|NCT03384524|Hormone Antagonists|hormone antagonists|mesh-ancestor
102111587|NCT03384524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102111588|NCT03384524|Dopamine Agonists|dopamine agonists|mesh-ancestor
102111589|NCT03384524|Dopamine Agents|dopamine agents|mesh-ancestor
102111590|NCT02289924|Aflibercept|aflibercept|mesh-list
102111591|NCT02289924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102111592|NCT02289924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102111593|NCT02289924|Growth Substances|growth substances|mesh-ancestor
102111594|NCT02289924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111595|NCT02289924|Growth Inhibitors|growth inhibitors|mesh-ancestor
102111596|NCT02289924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102111597|NCT03387644|Pregabalin|pregabalin|mesh-list
102111598|NCT03387644|Analgesics|analgesics|mesh-ancestor
102111599|NCT03387644|Sensory System Agents|sensory system agents|mesh-ancestor
102111600|NCT03387644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102111601|NCT03387644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111602|NCT03387644|Anticonvulsants|anticonvulsants|mesh-ancestor
102111603|NCT03387644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102111604|NCT03387644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102111605|NCT03387644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111606|NCT03387644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102111607|NCT03387644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102111608|NCT03387644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102111609|NCT03387644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102111610|NCT03387644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102111611|NCT02290002|Calcium Dobesilate|calcium dobesilate|mesh-list
102111612|NCT02290002|Calcium|calcium|mesh-list
102111613|NCT02290002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102111614|NCT02290002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111615|NCT02290002|Hemostatics|hemostatics|mesh-ancestor
102111616|NCT02290002|Coagulants|coagulants|mesh-ancestor
102111617|NCT02294292|Carvedilol|carvedilol|mesh-list
102111618|NCT02294292|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102111619|NCT02294292|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102111620|NCT02294292|Adrenergic Agents|adrenergic agents|mesh-ancestor
102111621|NCT02294292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102111622|NCT02294292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111623|NCT02294292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111624|NCT02294292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102111625|NCT02294292|Antioxidants|antioxidants|mesh-ancestor
102111626|NCT02294292|Protective Agents|protective agents|mesh-ancestor
102111627|NCT02294292|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102111628|NCT02294292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102111629|NCT02294292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102111630|NCT02294292|Vasodilator Agents|vasodilator agents|mesh-ancestor
102111631|NCT02294292|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102111632|NCT02294292|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102111633|NCT03387566|Immunoglobulins|immunoglobulins|mesh-list
102111634|NCT03387566|Endothelial Growth Factors|endothelial growth factors|mesh-list
102111635|NCT03387566|Immunologic Factors|immunologic factors|mesh-ancestor
102111636|NCT03387566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111637|NCT03387566|Growth Substances|growth substances|mesh-ancestor
102111638|NCT03391856|Acetylcysteine|acetylcysteine|mesh-list
102111639|NCT03391856|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102111640|NCT03391856|Antiviral Agents|antiviral agents|mesh-ancestor
102111641|NCT03391856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102111642|NCT03391856|Expectorants|expectorants|mesh-ancestor
102111643|NCT03391856|Respiratory System Agents|respiratory system agents|mesh-ancestor
102111644|NCT03391856|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102111645|NCT03391856|Antioxidants|antioxidants|mesh-ancestor
101565212|NCT04404049|UB-421|ub-421|mesh-list
102111646|NCT03391856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111647|NCT03391856|Protective Agents|protective agents|mesh-ancestor
102111648|NCT03391856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111649|NCT03391856|Antidotes|antidotes|mesh-ancestor
102111650|NCT01664494|Capecitabine|capecitabine|mesh-list
102111651|NCT01664494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102111652|NCT01664494|Antimetabolites|antimetabolites|mesh-ancestor
102111653|NCT01664494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111654|NCT01664494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102111655|NCT02290470|Dexamethasone|dexamethasone|mesh-list
102111656|NCT02290470|Dexamethasone acetate|dexamethasone acetate|mesh-list
102111657|NCT02290470|Paclitaxel|paclitaxel|mesh-list
102111658|NCT02290470|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102111659|NCT02290470|Carboplatin|carboplatin|mesh-list
102111660|NCT02290470|Olanzapine|olanzapine|mesh-list
102111661|NCT02290470|Palonosetron|palonosetron|mesh-list
102111662|NCT02290470|BB 1101|bb 1101|mesh-list
102111663|NCT02290470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102111664|NCT02290470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102111665|NCT02290470|Tubulin Modulators|tubulin modulators|mesh-ancestor
102111666|NCT02290470|Antimitotic Agents|antimitotic agents|mesh-ancestor
102111667|NCT02290470|Mitosis Modulators|mitosis modulators|mesh-ancestor
102111668|NCT02290470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111669|NCT02290470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102111670|NCT02290470|Antiemetics|antiemetics|mesh-ancestor
102111671|NCT02290470|Autonomic Agents|autonomic agents|mesh-ancestor
102111672|NCT02290470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102111673|NCT02290470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111674|NCT02290470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102111675|NCT02290470|Glucocorticoids|glucocorticoids|mesh-ancestor
102111676|NCT02290470|Hormones|hormones|mesh-ancestor
102111677|NCT02290470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102111678|NCT02290470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101227033|NCT01538316|Phytoestrogens|phytoestrogens|mesh-ancestor
102111679|NCT02290470|Protease Inhibitors|protease inhibitors|mesh-ancestor
102111680|NCT02290470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102111681|NCT02290470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102111682|NCT02290470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102111683|NCT02290470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102111684|NCT02290470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102111685|NCT02290470|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102111686|NCT02290470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102111687|NCT02290470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102111688|NCT02290470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102111689|NCT02290470|Serotonin Agents|serotonin agents|mesh-ancestor
102111690|NCT02290470|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102111691|NCT02290470|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102111692|NCT05172518|Capecitabine|capecitabine|mesh-list
102111693|NCT05172518|Taxane|taxane|mesh-list
102111694|NCT05172518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102111695|NCT05172518|Antimetabolites|antimetabolites|mesh-ancestor
102111696|NCT05172518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111697|NCT05172518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102111698|NCT03724084|Cytarabine|cytarabine|mesh-list
102111699|NCT03724084|Daunorubicin|daunorubicin|mesh-list
102111700|NCT03724084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102111702|NCT03724084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111703|NCT03724084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102111704|NCT03724084|Antiviral Agents|antiviral agents|mesh-ancestor
102111705|NCT03724084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102111706|NCT03724084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102111707|NCT03724084|Immunologic Factors|immunologic factors|mesh-ancestor
102111708|NCT03724084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111709|NCT03724084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102111710|NCT03724084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102111711|NCT03724084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102111712|NCT03724084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102111713|NCT05172440|Tislelizumab|tislelizumab|mesh-list
102111714|NCT05172440|Axitinib|axitinib|mesh-list
102111715|NCT05172440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102111716|NCT05172440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102111717|NCT05172440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102111718|NCT05172440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102111719|NCT05172440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565288|NCT00910273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102111721|NCT02298582|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102111722|NCT02298582|Narcotics|narcotics|mesh-ancestor
102111723|NCT02298582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102111724|NCT02298582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111725|NCT02298582|Analgesics|analgesics|mesh-ancestor
102111726|NCT02298582|Sensory System Agents|sensory system agents|mesh-ancestor
102111727|NCT02298582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102111728|NCT02298582|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102111729|NCT02298582|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102111730|NCT02298582|Anesthetics, General|anesthetics, general|mesh-ancestor
102111731|NCT02298582|Anesthetics|anesthetics|mesh-ancestor
102111732|NCT04446416|Bevacizumab|bevacizumab|mesh-list
102111733|NCT04446416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102111734|NCT04446416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102111735|NCT04446416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102111736|NCT04446416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102111737|NCT04446416|Growth Substances|growth substances|mesh-ancestor
102111738|NCT04446416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111739|NCT04446416|Growth Inhibitors|growth inhibitors|mesh-ancestor
102111740|NCT02298660|Botulinum Toxins|botulinum toxins|mesh-list
102111741|NCT02298660|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102111742|NCT02298660|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102111743|NCT02298660|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102111744|NCT02298660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101227040|NCT01538329|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102111745|NCT02298660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111746|NCT02298660|Cholinergic Agents|cholinergic agents|mesh-ancestor
102111747|NCT02298660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102111748|NCT02298660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111749|NCT02298660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102111750|NCT02298660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102111751|NCT01396408|Sirolimus|sirolimus|mesh-list
102111752|NCT01396408|Sunitinib|sunitinib|mesh-list
102111753|NCT01396408|Temsirolimus|temsirolimus|mesh-list
102111754|NCT01396408|MTOR Inhibitors|mtor inhibitors|mesh-list
102111755|NCT01396408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102111756|NCT01396408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102111757|NCT01396408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102111758|NCT01396408|Growth Substances|growth substances|mesh-ancestor
102111759|NCT01396408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111760|NCT01396408|Growth Inhibitors|growth inhibitors|mesh-ancestor
102111761|NCT01396408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102111762|NCT01396408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102111763|NCT01396408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111764|NCT01396408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102111765|NCT01396408|Immunologic Factors|immunologic factors|mesh-ancestor
102111766|NCT01396408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102111767|NCT01396408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102111768|NCT01396408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102111769|NCT01396408|Antifungal Agents|antifungal agents|mesh-ancestor
102111770|NCT03571334|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102111771|NCT03571334|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102111772|NCT03571334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102111773|NCT03571334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111774|NCT03571334|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102111775|NCT03571334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102111776|NCT03571334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111777|NCT03571334|Cholinergic Agents|cholinergic agents|mesh-ancestor
102111778|NCT03571334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102111779|NCT05440942|Trametinib|trametinib|mesh-list
102111780|NCT05440942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102111781|NCT05440942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102111782|NCT05440942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102111783|NCT05440942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111784|NCT02291094|Lidocaine|lidocaine|mesh-list
102111785|NCT02291094|Remifentanil|remifentanil|mesh-list
102111786|NCT02291094|Anesthetics, Local|anesthetics, local|mesh-ancestor
102111787|NCT02291094|Anesthetics|anesthetics|mesh-ancestor
102111788|NCT02291094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102111789|NCT02291094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111790|NCT02291094|Sensory System Agents|sensory system agents|mesh-ancestor
102111791|NCT02291094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102111792|NCT02291094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102111793|NCT02291094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101565440|NCT05566223|Analgesics|analgesics|mesh-ancestor
102111794|NCT02291094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102111795|NCT02291094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102111796|NCT02291094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111797|NCT02291094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102111798|NCT02291094|Narcotics|narcotics|mesh-ancestor
102111799|NCT02291094|Analgesics|analgesics|mesh-ancestor
102111800|NCT03387098|Leucovorin|leucovorin|mesh-list
102111801|NCT03387098|Paclitaxel|paclitaxel|mesh-list
102111802|NCT03387098|Cyclophosphamide|cyclophosphamide|mesh-list
102111803|NCT03387098|Bevacizumab|bevacizumab|mesh-list
102111804|NCT03387098|Fluorouracil|fluorouracil|mesh-list
102111805|NCT03387098|Capecitabine|capecitabine|mesh-list
102111806|NCT03387098|Oxaliplatin|oxaliplatin|mesh-list
102111807|NCT03387098|Avelumab|avelumab|mesh-list
102111808|NCT03387098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102111809|NCT03387098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102111810|NCT03387098|Tubulin Modulators|tubulin modulators|mesh-ancestor
102111811|NCT03387098|Antimitotic Agents|antimitotic agents|mesh-ancestor
102111812|NCT03387098|Mitosis Modulators|mitosis modulators|mesh-ancestor
102111813|NCT03387098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111814|NCT03387098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102111815|NCT03387098|Immunologic Factors|immunologic factors|mesh-ancestor
102111816|NCT03387098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111817|NCT03387098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102111818|NCT03387098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102111819|NCT03387098|Alkylating Agents|alkylating agents|mesh-ancestor
102111820|NCT03387098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102111821|NCT03387098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102111822|NCT03387098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102111823|NCT03387098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102111824|NCT03387098|Growth Substances|growth substances|mesh-ancestor
102111825|NCT03387098|Growth Inhibitors|growth inhibitors|mesh-ancestor
102111826|NCT03387098|Antimetabolites|antimetabolites|mesh-ancestor
102111827|NCT03387098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102111828|NCT03387098|Antidotes|antidotes|mesh-ancestor
102111829|NCT03387098|Protective Agents|protective agents|mesh-ancestor
102111830|NCT03387098|Vitamin B Complex|vitamin b complex|mesh-ancestor
102111831|NCT03387098|Vitamins|vitamins|mesh-ancestor
102111832|NCT03387098|Micronutrients|micronutrients|mesh-ancestor
102111833|NCT02577016|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102111834|NCT02577016|Ipragliflozin|ipragliflozin|mesh-list
102111835|NCT02577016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102111836|NCT02577016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111837|NCT02577016|Incretins|incretins|mesh-ancestor
102111838|NCT02577016|Hormones|hormones|mesh-ancestor
102111839|NCT02577016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101954828|NCT05435313|Antimetabolites|antimetabolites|mesh-ancestor
102111840|NCT02577016|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102111841|NCT02577016|Protease Inhibitors|protease inhibitors|mesh-ancestor
102111842|NCT02577016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102111843|NCT02577016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111844|NCT02577016|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102111845|NCT04465110|Grape Seed Extract|grape seed extract|mesh-list
102111846|NCT04465110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102111847|NCT04465110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102111848|NCT04465110|Antioxidants|antioxidants|mesh-ancestor
102111849|NCT04465110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111850|NCT04465110|Protective Agents|protective agents|mesh-ancestor
102111851|NCT04465110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111852|NCT03391700|Rocuronium|rocuronium|mesh-list
102111853|NCT03391700|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102111854|NCT03391700|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102111855|NCT03391700|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102111856|NCT03391700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102111857|NCT03391700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111858|NCT02294838|Citric Acid|citric acid|mesh-list
102111859|NCT02294838|Sodium Citrate|sodium citrate|mesh-list
102111860|NCT02294838|Anticoagulants|anticoagulants|mesh-ancestor
102111861|NCT02294838|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102111862|NCT02294838|Chelating Agents|chelating agents|mesh-ancestor
102111863|NCT02294838|Sequestering Agents|sequestering agents|mesh-ancestor
102111864|NCT02294838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111865|NCT03383822|Insulin|insulin|mesh-list
102111866|NCT03383822|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102111867|NCT03383822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102111868|NCT03383822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111869|NCT03514446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102111870|NCT03514446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102111871|NCT03383744|Vitamin A|vitamin a|mesh-list
102111872|NCT03383744|Vitamins|vitamins|mesh-ancestor
102111873|NCT03383744|Micronutrients|micronutrients|mesh-ancestor
102111874|NCT03383744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111875|NCT05662358|Denosumab|denosumab|mesh-list
102111876|NCT05662358|Alendronate|alendronate|mesh-list
102111877|NCT05662358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102111878|NCT05662358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111879|NCT02294994|Tirofiban|tirofiban|mesh-list
102111880|NCT02294994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102111881|NCT02294994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102111882|NCT02294994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111883|NCT02294994|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102111884|NCT03386630|Sufentanil|sufentanil|mesh-list
102111885|NCT03386630|Morphine|morphine|mesh-list
102111886|NCT03386630|Dsuvia|dsuvia|mesh-list
102111887|NCT03386630|Bupivacaine|bupivacaine|mesh-list
102111888|NCT03386630|Anesthetics, Local|anesthetics, local|mesh-ancestor
102111889|NCT03386630|Anesthetics|anesthetics|mesh-ancestor
102111890|NCT03386630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102111891|NCT03386630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111892|NCT03386630|Sensory System Agents|sensory system agents|mesh-ancestor
102111893|NCT03386630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102111894|NCT03386630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102111895|NCT03386630|Narcotics|narcotics|mesh-ancestor
102111896|NCT03386630|Analgesics|analgesics|mesh-ancestor
102111897|NCT03386630|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102111898|NCT03386630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102111899|NCT03386630|Anesthetics, General|anesthetics, general|mesh-ancestor
102111900|NCT03132714|Amoxicillin|amoxicillin|mesh-list
102111901|NCT03132714|Metronidazole|metronidazole|mesh-list
102111902|NCT03132714|Clarithromycin|clarithromycin|mesh-list
102111903|NCT03132714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102111904|NCT03132714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102111905|NCT03132714|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102111906|NCT03132714|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102111907|NCT03132714|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102111908|NCT03132714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101954829|NCT05435313|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102111909|NCT03132714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111910|NCT03132714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102111911|NCT03132714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102111912|NCT03386318|Oxycodone|oxycodone|mesh-list
102111913|NCT03386318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102111914|NCT03386318|Narcotics|narcotics|mesh-ancestor
102111915|NCT03386318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102111916|NCT03386318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111917|NCT03386318|Analgesics|analgesics|mesh-ancestor
102111918|NCT03386318|Sensory System Agents|sensory system agents|mesh-ancestor
102111919|NCT03386318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102111920|NCT03339284|Dexamethasone|dexamethasone|mesh-list
102111921|NCT03339284|Dexamethasone acetate|dexamethasone acetate|mesh-list
102111922|NCT03339284|Ropivacaine|ropivacaine|mesh-list
102111923|NCT03339284|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102111924|NCT03339284|BB 1101|bb 1101|mesh-list
102111925|NCT03339284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102111926|NCT03339284|Antiemetics|antiemetics|mesh-ancestor
102111927|NCT03339284|Autonomic Agents|autonomic agents|mesh-ancestor
102111928|NCT03339284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102111929|NCT03339284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111930|NCT03339284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102111931|NCT03339284|Glucocorticoids|glucocorticoids|mesh-ancestor
102111932|NCT03339284|Hormones|hormones|mesh-ancestor
102111933|NCT03339284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102111934|NCT03339284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102111935|NCT03339284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102111936|NCT03339284|Anesthetics, Local|anesthetics, local|mesh-ancestor
102111937|NCT03339284|Anesthetics|anesthetics|mesh-ancestor
102111938|NCT03339284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102111939|NCT03339284|Sensory System Agents|sensory system agents|mesh-ancestor
102111940|NCT03339284|Protease Inhibitors|protease inhibitors|mesh-ancestor
102111941|NCT03339284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102111942|NCT03339284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111943|NCT02291562|Dronabinol|dronabinol|mesh-list
102111944|NCT02291562|Cannabidiol|cannabidiol|mesh-list
102111945|NCT02291562|Anticonvulsants|anticonvulsants|mesh-ancestor
102111946|NCT02291562|Hallucinogens|hallucinogens|mesh-ancestor
102111947|NCT02291562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111948|NCT02291562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102111949|NCT02291562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102111950|NCT02291562|Analgesics|analgesics|mesh-ancestor
102111951|NCT02291562|Sensory System Agents|sensory system agents|mesh-ancestor
102111952|NCT02291562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102111953|NCT02291562|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102111954|NCT02291562|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102111955|NCT02291562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102111956|NCT02291562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111957|NCT02291562|Hormones|hormones|mesh-ancestor
102111958|NCT02291562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102111959|NCT03316586|Nivolumab|nivolumab|mesh-list
102111960|NCT03316586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102111961|NCT03316586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102111962|NCT03316586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102111963|NCT03316586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111964|NCT02994927|Prednisone|prednisone|mesh-list
102111965|NCT02994927|Cyclophosphamide|cyclophosphamide|mesh-list
102111966|NCT02994927|Rituximab|rituximab|mesh-list
102111967|NCT02994927|Azathioprine|azathioprine|mesh-list
102111968|NCT02994927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102111969|NCT02994927|Immunologic Factors|immunologic factors|mesh-ancestor
102111970|NCT02994927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111971|NCT02994927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102111972|NCT02994927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102111973|NCT02994927|Alkylating Agents|alkylating agents|mesh-ancestor
102111974|NCT02994927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111975|NCT02994927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102111976|NCT02994927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102111977|NCT02994927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102111978|NCT02994927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102111979|NCT02994927|Glucocorticoids|glucocorticoids|mesh-ancestor
102111980|NCT02994927|Hormones|hormones|mesh-ancestor
102111981|NCT02994927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102111982|NCT02994927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102111983|NCT02994927|Antimetabolites|antimetabolites|mesh-ancestor
102111984|NCT02994927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102111985|NCT03383276|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102111986|NCT03383276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102111987|NCT02295150|Nadroparin|nadroparin|mesh-list
102111988|NCT02295150|Anticoagulants|anticoagulants|mesh-ancestor
102111989|NCT02295150|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102111990|NCT02295150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102111991|NCT02295150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102111992|NCT03390608|Trastuzumab|trastuzumab|mesh-list
102111993|NCT03390608|Estrogens|estrogens|mesh-list
102111994|NCT03390608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102111995|NCT03390608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102111996|NCT03390608|Hormones|hormones|mesh-ancestor
102111997|NCT03390608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102111998|NCT03390608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102111999|NCT03513822|Midazolam|midazolam|mesh-list
102112000|NCT03513822|Ketamine|ketamine|mesh-list
102112001|NCT03513822|Analgesics|analgesics|mesh-ancestor
102112002|NCT03513822|Sensory System Agents|sensory system agents|mesh-ancestor
102112003|NCT03513822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102112004|NCT03513822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112005|NCT03513822|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102112006|NCT03513822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102112007|NCT03513822|Anesthetics, General|anesthetics, general|mesh-ancestor
102112008|NCT03513822|Anesthetics|anesthetics|mesh-ancestor
102112009|NCT03513822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102112010|NCT03513822|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102112011|NCT03513822|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102112012|NCT03513822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102112013|NCT03513822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112014|NCT03513822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102112015|NCT03513822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102112016|NCT03513822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102112017|NCT03513822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102112018|NCT03513822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102112019|NCT03513822|GABA Modulators|gaba modulators|mesh-ancestor
102112020|NCT03513822|GABA Agents|gaba agents|mesh-ancestor
102112021|NCT03383120|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102112022|NCT03383120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102112023|NCT03513432|Ethanol|ethanol|mesh-list
102112024|NCT03513432|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102112025|NCT03513432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102112026|NCT03513432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102112027|NCT03513432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112028|NCT02299440|Ketamine|ketamine|mesh-list
102112029|NCT02299440|Analgesics|analgesics|mesh-ancestor
102112030|NCT02299440|Sensory System Agents|sensory system agents|mesh-ancestor
102112031|NCT02299440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102112032|NCT02299440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112033|NCT02299440|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102112034|NCT02299440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102112035|NCT02299440|Anesthetics, General|anesthetics, general|mesh-ancestor
102112036|NCT02299440|Anesthetics|anesthetics|mesh-ancestor
102112037|NCT02299440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102112038|NCT02299440|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102112039|NCT02299440|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102112040|NCT02299440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102112041|NCT02299440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112042|NCT02145195|Vitamin D|vitamin d|mesh-list
102112043|NCT02145195|Cholecalciferol|cholecalciferol|mesh-list
102112044|NCT02145195|Vitamins|vitamins|mesh-ancestor
102112046|NCT02145195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112047|NCT02145195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102112048|NCT02145195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102112049|NCT03517020|Nebivolol|nebivolol|mesh-list
102112050|NCT03517020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102112051|NCT03517020|Vasodilator Agents|vasodilator agents|mesh-ancestor
102112052|NCT03517020|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102112053|NCT03517020|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102112054|NCT03517020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102112055|NCT03517020|Adrenergic Agents|adrenergic agents|mesh-ancestor
102112056|NCT03517020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102112057|NCT03517020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112058|NCT03517020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112059|NCT02254629|Laxatives|laxatives|mesh-list
102112060|NCT02254629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102112061|NCT02145585|Anesthetics|anesthetics|mesh-list
102112062|NCT02145585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102112063|NCT02145585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112064|NCT02291796|Bezafibrate|bezafibrate|mesh-list
102112065|NCT02291796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102112066|NCT02291796|Antimetabolites|antimetabolites|mesh-ancestor
102112067|NCT02291796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112068|NCT02291796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102112069|NCT03544827|Atropine|atropine|mesh-list
102112070|NCT03544827|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102112071|NCT03544827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102112072|NCT03544827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102112073|NCT03544827|Autonomic Agents|autonomic agents|mesh-ancestor
102112074|NCT03544827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102112075|NCT03544827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112076|NCT03544827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102112077|NCT03544827|Respiratory System Agents|respiratory system agents|mesh-ancestor
102112078|NCT03544827|Mydriatics|mydriatics|mesh-ancestor
102112079|NCT03544827|Parasympatholytics|parasympatholytics|mesh-ancestor
102112080|NCT03544827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102112081|NCT03544827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102112082|NCT03544827|Cholinergic Agents|cholinergic agents|mesh-ancestor
102112083|NCT03544827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102112084|NCT03544827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112085|NCT00107991|Etanercept|etanercept|mesh-list
102112086|NCT00107991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102112087|NCT00107991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102112088|NCT00107991|Analgesics|analgesics|mesh-ancestor
102112089|NCT00107991|Sensory System Agents|sensory system agents|mesh-ancestor
102112090|NCT00107991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102112091|NCT00107991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112092|NCT00107991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102112093|NCT00107991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102112094|NCT00107991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102112095|NCT00107991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102112096|NCT00107991|Immunologic Factors|immunologic factors|mesh-ancestor
102112097|NCT03513276|Epinephrine|epinephrine|mesh-list
102112099|NCT03513276|Ropivacaine|ropivacaine|mesh-list
102112100|NCT03513276|Epinephryl borate|epinephryl borate|mesh-list
102112101|NCT03513276|Anesthetics, Local|anesthetics, local|mesh-ancestor
102112102|NCT03513276|Anesthetics|anesthetics|mesh-ancestor
102112103|NCT03513276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102112104|NCT03513276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112105|NCT03513276|Sensory System Agents|sensory system agents|mesh-ancestor
102112106|NCT03513276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102112107|NCT03513276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102112108|NCT03513276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102112109|NCT03513276|Adrenergic Agents|adrenergic agents|mesh-ancestor
102112110|NCT03513276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102112111|NCT03513276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112112|NCT03513276|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102112113|NCT03513276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102112114|NCT03513276|Autonomic Agents|autonomic agents|mesh-ancestor
102112115|NCT03513276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101954850|NCT04570670|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102112116|NCT03513276|Respiratory System Agents|respiratory system agents|mesh-ancestor
102112117|NCT03513276|Mydriatics|mydriatics|mesh-ancestor
102112118|NCT03513276|Sympathomimetics|sympathomimetics|mesh-ancestor
102112119|NCT03513276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102112120|NCT02291874|Ipragliflozin|ipragliflozin|mesh-list
102112121|NCT02291874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102112122|NCT02291874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112123|NCT02291874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102112124|NCT02291874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112125|NCT03516630|Moxifloxacin|moxifloxacin|mesh-list
102112126|NCT03516630|Trazodone|trazodone|mesh-list
102112127|NCT03516630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102112128|NCT03516630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102112129|NCT03516630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102112130|NCT03516630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102112131|NCT03516630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102112132|NCT03516630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112133|NCT03516630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102112134|NCT03516630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112135|NCT03516630|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102112136|NCT03516630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102112137|NCT03516630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102112138|NCT03516630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102112139|NCT03516630|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102112140|NCT03516630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102112141|NCT03516630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102112142|NCT03516630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102112143|NCT03516630|Serotonin Agents|serotonin agents|mesh-ancestor
102112144|NCT03516630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102112145|NCT03516630|Antidepressive Agents|antidepressive agents|mesh-ancestor
102112146|NCT02142075|Daptomycin|daptomycin|mesh-list
102112147|NCT02142075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102112148|NCT02142075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102112149|NCT02145975|Fentanyl|fentanyl|mesh-list
102112150|NCT02145975|Morphine|morphine|mesh-list
102112151|NCT02145975|Analgesics, Opioid|analgesics, opioid|mesh-list
102112152|NCT02145975|Narcotics|narcotics|mesh-ancestor
102112153|NCT02145975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102112154|NCT02145975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112155|NCT02145975|Analgesics|analgesics|mesh-ancestor
102112156|NCT02145975|Sensory System Agents|sensory system agents|mesh-ancestor
102112157|NCT02145975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102112158|NCT02145975|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102112159|NCT02145975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102112160|NCT02145975|Anesthetics, General|anesthetics, general|mesh-ancestor
102112161|NCT02145975|Anesthetics|anesthetics|mesh-ancestor
102112162|NCT02295852|Calcium|calcium|mesh-list
102112163|NCT02295852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102112164|NCT02295852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112165|NCT02295930|Bevacizumab|bevacizumab|mesh-list
102112166|NCT02295930|Cetuximab|cetuximab|mesh-list
102112167|NCT02295930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102112168|NCT02295930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102112169|NCT02295930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102112170|NCT02295930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102112171|NCT02295930|Growth Substances|growth substances|mesh-ancestor
101565739|NCT00694733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102112172|NCT02295930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227110|NCT01538537|ON 01910|on 01910|mesh-list
102112173|NCT02295930|Growth Inhibitors|growth inhibitors|mesh-ancestor
102112174|NCT02142309|Pioglitazone|pioglitazone|mesh-list
102112175|NCT02142309|Glimepiride|glimepiride|mesh-list
102112176|NCT02142309|Canagliflozin|canagliflozin|mesh-list
102112177|NCT02142309|Vildagliptin|vildagliptin|mesh-list
102112178|NCT02142309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102112179|NCT02142309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112180|NCT02142309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102112181|NCT02142309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102112182|NCT02142309|Immunologic Factors|immunologic factors|mesh-ancestor
102112183|NCT02142309|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102112184|NCT02142309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112185|NCT02142309|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102112186|NCT02142309|Protease Inhibitors|protease inhibitors|mesh-ancestor
102112187|NCT02142309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102112188|NCT02146209|Metronidazole|metronidazole|mesh-list
102112189|NCT02146209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102112190|NCT02146209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102112191|NCT02146209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102112192|NCT02146209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102112193|NCT02299908|Bupivacaine|bupivacaine|mesh-list
102112194|NCT02299908|Anesthetics, Local|anesthetics, local|mesh-list
102112195|NCT02299908|Anesthetics|anesthetics|mesh-list
102112196|NCT02299908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102112197|NCT02299908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102112198|NCT02299908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112199|NCT02299908|Sensory System Agents|sensory system agents|mesh-ancestor
102112200|NCT02299908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102112201|NCT02142543|Zinc Oxide|zinc oxide|mesh-list
102112202|NCT02142543|Dermatologic Agents|dermatologic agents|mesh-ancestor
102112203|NCT02142543|Sunscreening Agents|sunscreening agents|mesh-ancestor
102112204|NCT02142543|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102112205|NCT02142543|Protective Agents|protective agents|mesh-ancestor
102112206|NCT02142543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112207|NCT03390374|Nystatin|nystatin|mesh-list
102112208|NCT03390374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102112209|NCT03390374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102112210|NCT03390374|Antifungal Agents|antifungal agents|mesh-ancestor
102112211|NCT03390374|Ionophores|ionophores|mesh-ancestor
102112212|NCT03390374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102112213|NCT03390374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112214|NCT03545373|Amoxicillin|amoxicillin|mesh-list
102112215|NCT03545373|Azithromycin|azithromycin|mesh-list
102112216|NCT03545373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102112217|NCT03545373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102112218|NCT00492856|Methotrexate|methotrexate|mesh-list
102112219|NCT00492856|Mercaptopurine|mercaptopurine|mesh-list
102112220|NCT00492856|Tretinoin|tretinoin|mesh-list
102112221|NCT00492856|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102112222|NCT00492856|Abortifacient Agents|abortifacient agents|mesh-ancestor
102112223|NCT00492856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102112224|NCT00492856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112225|NCT00492856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102112226|NCT00492856|Antimetabolites|antimetabolites|mesh-ancestor
102112227|NCT00492856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112228|NCT00492856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102112229|NCT00492856|Dermatologic Agents|dermatologic agents|mesh-ancestor
102112230|NCT00492856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102112231|NCT00492856|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102112232|NCT00492856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102112233|NCT00492856|Immunologic Factors|immunologic factors|mesh-ancestor
102112234|NCT00492856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102112235|NCT00492856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102112236|NCT00492856|Keratolytic Agents|keratolytic agents|mesh-ancestor
102112237|NCT02142777|Equol|equol|mesh-list
102112238|NCT02142777|Phytoestrogens|phytoestrogens|mesh-ancestor
102112239|NCT02142777|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102112240|NCT02142777|Estrogens|estrogens|mesh-ancestor
102112241|NCT02142777|Hormones|hormones|mesh-ancestor
102112242|NCT02142777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102112243|NCT02142777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112244|NCT02143167|4-Aminopyridine|4-aminopyridine|mesh-list
101565819|NCT00995566|Sitaxsentan|sitaxsentan|mesh-list
102112245|NCT02143167|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102112246|NCT02143167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102112247|NCT02143167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836471|NCT00309166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112248|NCT03544671|Vitamin D|vitamin d|mesh-list
102112249|NCT03544671|Vitamins|vitamins|mesh-ancestor
102112250|NCT03544671|Micronutrients|micronutrients|mesh-ancestor
102112251|NCT03544671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112252|NCT03544671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102112253|NCT03390062|Apatinib|apatinib|mesh-list
102112254|NCT03390062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102112255|NCT03390062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102112256|NCT03390062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102112257|NCT03390062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112258|NCT03382886|Bevacizumab|bevacizumab|mesh-list
102112260|NCT03382886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102112261|NCT03382886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102112262|NCT03382886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102112263|NCT03382886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102112264|NCT03382886|Growth Substances|growth substances|mesh-ancestor
102112265|NCT03382886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112266|NCT03382886|Growth Inhibitors|growth inhibitors|mesh-ancestor
102112267|NCT03382886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102112268|NCT03382886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112269|NCT03125486|Belimumab|belimumab|mesh-list
102112270|NCT03125486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102112271|NCT03125486|Immunologic Factors|immunologic factors|mesh-ancestor
102112272|NCT03125486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112273|NCT02147925|Metformin|metformin|mesh-list
102112274|NCT02147925|Insulin Glargine|insulin glargine|mesh-list
102112275|NCT02147925|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102112276|NCT02147925|Liraglutide|liraglutide|mesh-list
102112277|NCT02147925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102112278|NCT02147925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112279|NCT02147925|Incretins|incretins|mesh-ancestor
102112280|NCT02147925|Hormones|hormones|mesh-ancestor
102112281|NCT02147925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102112282|NCT02147925|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102112283|NCT02147925|Protease Inhibitors|protease inhibitors|mesh-ancestor
102112284|NCT02147925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102112285|NCT02147925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112286|NCT03544047|Paclitaxel|paclitaxel|mesh-list
102112287|NCT03544047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102112288|NCT03544047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102112289|NCT03544047|Tubulin Modulators|tubulin modulators|mesh-ancestor
102112290|NCT03544047|Antimitotic Agents|antimitotic agents|mesh-ancestor
102112291|NCT03544047|Mitosis Modulators|mitosis modulators|mesh-ancestor
102112292|NCT03544047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112293|NCT03544125|Durvalumab|durvalumab|mesh-list
102112294|NCT03544125|Olaparib|olaparib|mesh-list
102112295|NCT03544125|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102112296|NCT03544125|Immunoglobulins|immunoglobulins|mesh-list
102112297|NCT03544125|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102112298|NCT03544125|Immunoglobulin G|immunoglobulin g|mesh-list
102112299|NCT03544125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102112300|NCT03544125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102112301|NCT03544125|Immunologic Factors|immunologic factors|mesh-ancestor
102112302|NCT03544125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112303|NCT03544125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102112304|NCT03544125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112305|NCT02146911|Bupropion|bupropion|mesh-list
102112306|NCT02146911|Varenicline|varenicline|mesh-list
102112307|NCT02146911|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102112308|NCT02146911|Antidepressive Agents|antidepressive agents|mesh-ancestor
102112309|NCT02146911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102112310|NCT02146911|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102112311|NCT02146911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102112312|NCT02146911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102112313|NCT02146911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112314|NCT02146911|Dopamine Agents|dopamine agents|mesh-ancestor
102112315|NCT02146911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102112316|NCT02146911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112317|NCT02146911|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102112318|NCT02146911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102112319|NCT02146911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102112320|NCT02146911|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102112322|NCT02146911|Cholinergic Agents|cholinergic agents|mesh-ancestor
102112323|NCT02776683|Bevacizumab|bevacizumab|mesh-list
102112324|NCT02776683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102112325|NCT02776683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102112326|NCT02776683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102112327|NCT02776683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102112328|NCT02776683|Growth Substances|growth substances|mesh-ancestor
102112329|NCT02776683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112330|NCT02776683|Growth Inhibitors|growth inhibitors|mesh-ancestor
102112331|NCT02963714|Vaccines|vaccines|mesh-list
102112332|NCT02963714|Immunologic Factors|immunologic factors|mesh-ancestor
102112333|NCT02963714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112334|NCT02148393|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
102112335|NCT02148393|Estradiol|estradiol|mesh-list
102112336|NCT02148393|Progesterone|progesterone|mesh-list
102112337|NCT02148393|Estrogens|estrogens|mesh-ancestor
102112338|NCT02148393|Hormones|hormones|mesh-ancestor
102112339|NCT02148393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102112340|NCT02148393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112341|NCT02148393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102112342|NCT02148393|Progestins|progestins|mesh-ancestor
102112343|NCT00104871|Bortezomib|bortezomib|mesh-list
102112344|NCT00104871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102112345|NCT03385538|Clopidogrel|clopidogrel|mesh-list
102112346|NCT03385538|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102112347|NCT03385538|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102112348|NCT03385538|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102112349|NCT03385538|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102112350|NCT03385538|Purinergic Agents|purinergic agents|mesh-ancestor
102112351|NCT03385538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102112352|NCT03385538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112353|NCT03385538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112354|NCT02147379|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
102112355|NCT02147379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102112356|NCT02147379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102112357|NCT02147379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102112358|NCT02147379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112359|NCT02147379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102112360|NCT02147379|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102112361|NCT02147379|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102112362|NCT02147379|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102112363|NCT02147379|Adrenergic Agents|adrenergic agents|mesh-ancestor
102112364|NCT02147379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102112365|NCT02147379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112366|NCT02147379|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102112367|NCT02147379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102112368|NCT02147379|Serotonin Agents|serotonin agents|mesh-ancestor
102112369|NCT02147379|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102112370|NCT02147379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102112371|NCT02147379|Dopamine Agents|dopamine agents|mesh-ancestor
102112372|NCT02148549|Oxaliplatin|oxaliplatin|mesh-list
102112373|NCT02148549|Irinotecan|irinotecan|mesh-list
102112374|NCT02148549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102112375|NCT02148549|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102112376|NCT02148549|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102112377|NCT02148549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102112378|NCT02148549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112379|NCT03375398|PAZ320|paz320|mesh-list
102112380|NCT03375398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102112381|NCT03375398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112382|NCT02147535|Methylphenidate|methylphenidate|mesh-list
102112383|NCT02147535|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102112384|NCT02147535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112385|NCT02147535|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102112386|NCT02147535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102112387|NCT02147535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102112388|NCT02147535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112389|NCT02147535|Dopamine Agents|dopamine agents|mesh-ancestor
102112390|NCT02147535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102112391|NCT03446612|Nitroprusside|nitroprusside|mesh-list
102112392|NCT03446612|Acetylcholine|acetylcholine|mesh-list
101565955|NCT02882451|Pinaverium|pinaverium|mesh-list
102112393|NCT03446612|Darbepoetin alfa|darbepoetin alfa|mesh-list
102112394|NCT03446612|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
102112396|NCT03446612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102112397|NCT03446612|Vasodilator Agents|vasodilator agents|mesh-ancestor
102112398|NCT03446612|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102112399|NCT03446612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112400|NCT03446612|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102112401|NCT03446612|Cholinergic Agents|cholinergic agents|mesh-ancestor
102112402|NCT03446612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102112403|NCT03446612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112404|NCT03446612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102112405|NCT02148783|Methylphenidate|methylphenidate|mesh-list
102112406|NCT02148783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102112407|NCT02148783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112408|NCT02148783|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102112409|NCT02148783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102112410|NCT02148783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102112411|NCT02148783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112412|NCT02148783|Dopamine Agents|dopamine agents|mesh-ancestor
102112413|NCT02148783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102112414|NCT02155803|Hormones|hormones|mesh-list
102112415|NCT02155803|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102112416|NCT02155803|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
102112417|NCT02155803|beta-Endorphin|beta-endorphin|mesh-list
102112418|NCT02155803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102112419|NCT02155803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112420|NCT02155803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102112421|NCT02155803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112422|NCT02148861|Insulin|insulin|mesh-list
102112423|NCT02148861|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102112424|NCT02148861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102112425|NCT02148861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112426|NCT02152059|Nintedanib|nintedanib|mesh-list
102112427|NCT02152059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102112428|NCT02152059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102112429|NCT02152059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102112430|NCT02152059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112431|NCT02149095|Treprostinil|treprostinil|mesh-list
102112432|NCT02149095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102112433|NCT02149329|Meropenem|meropenem|mesh-list
102112434|NCT02149329|Imipenem|imipenem|mesh-list
102112435|NCT02149329|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
102112436|NCT02149329|Cilastatin|cilastatin|mesh-list
102112437|NCT02149329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102112438|NCT02149329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102112439|NCT02149329|Protease Inhibitors|protease inhibitors|mesh-ancestor
102112440|NCT02149329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102112441|NCT02149329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112442|NCT03255512|Isosorbide|isosorbide|mesh-list
102112443|NCT03255512|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
102112444|NCT03255512|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
102112445|NCT03255512|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102112446|NCT03255512|Diuretics|diuretics|mesh-ancestor
102112447|NCT03255512|Natriuretic Agents|natriuretic agents|mesh-ancestor
102112448|NCT03255512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112449|NCT03255512|Vasodilator Agents|vasodilator agents|mesh-ancestor
102112450|NCT03255512|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102112451|NCT03255512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112452|NCT02149407|Glycerol|glycerol|mesh-list
102112453|NCT02149407|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102112454|NCT02149407|Protective Agents|protective agents|mesh-ancestor
102112455|NCT02149407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112456|NCT03543657|Darbepoetin alfa|darbepoetin alfa|mesh-list
102112457|NCT03543657|Hematinics|hematinics|mesh-ancestor
102112458|NCT04925193|Dexamethasone|dexamethasone|mesh-list
102112459|NCT04925193|Daratumumab|daratumumab|mesh-list
102112460|NCT04925193|Pomalidomide|pomalidomide|mesh-list
102112461|NCT04925193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102112462|NCT04925193|Antiemetics|antiemetics|mesh-ancestor
102112463|NCT04925193|Autonomic Agents|autonomic agents|mesh-ancestor
102112464|NCT04925193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102112465|NCT04925193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112466|NCT04925193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102112467|NCT04925193|Glucocorticoids|glucocorticoids|mesh-ancestor
102112468|NCT04925193|Hormones|hormones|mesh-ancestor
101566030|NCT01255163|Incretins|incretins|mesh-ancestor
101836472|NCT01063816|Carboplatin|carboplatin|mesh-list
102112469|NCT04925193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102112470|NCT04925193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102112471|NCT04925193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102112472|NCT04925193|Immunologic Factors|immunologic factors|mesh-ancestor
102112473|NCT04925193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102112474|NCT04925193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102112475|NCT04925193|Growth Substances|growth substances|mesh-ancestor
102112476|NCT04925193|Growth Inhibitors|growth inhibitors|mesh-ancestor
102112477|NCT03542955|Etoricoxib|etoricoxib|mesh-list
102112478|NCT03542955|Analgesics|analgesics|mesh-list
102112479|NCT03542955|Sensory System Agents|sensory system agents|mesh-ancestor
102112480|NCT03542955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102112481|NCT03542955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112482|NCT03542955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102112483|NCT03542955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102112484|NCT03542955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102112485|NCT03542955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102112486|NCT03542955|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102112487|NCT03542955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102112488|NCT03542955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101227201|NCT01538875|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102112489|NCT03542955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112490|NCT03542331|Ethiodized Oil|ethiodized oil|mesh-list
102112491|NCT03542331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102112492|NCT03458260|Rituximab|rituximab|mesh-list
102112493|NCT03458260|Etoposide|etoposide|mesh-list
102112494|NCT03458260|Ifosfamide|ifosfamide|mesh-list
102112495|NCT03458260|Pixantrone|pixantrone|mesh-list
102112496|NCT03458260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102112497|NCT03458260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102112498|NCT03458260|Immunologic Factors|immunologic factors|mesh-ancestor
102112499|NCT03458260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112500|NCT03458260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102112501|NCT03458260|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102112502|NCT03458260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102112503|NCT03458260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102112504|NCT03458260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102112505|NCT03458260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112506|NCT03458260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102112507|NCT03458260|Alkylating Agents|alkylating agents|mesh-ancestor
102112508|NCT04988074|Cemiplimab|cemiplimab|mesh-list
102112509|NCT04988074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102112510|NCT04988074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102112511|NCT00104637|Sildenafil Citrate|sildenafil citrate|mesh-list
102112512|NCT00104637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112513|NCT00104637|Vasodilator Agents|vasodilator agents|mesh-ancestor
102112514|NCT00104637|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102112515|NCT00104637|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102112516|NCT00104637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102112517|NCT00104637|Urological Agents|urological agents|mesh-ancestor
102112518|NCT04810208|Docetaxel|docetaxel|mesh-list
102112519|NCT04810208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102112520|NCT04810208|Tubulin Modulators|tubulin modulators|mesh-ancestor
102112521|NCT04810208|Antimitotic Agents|antimitotic agents|mesh-ancestor
102112522|NCT04810208|Mitosis Modulators|mitosis modulators|mesh-ancestor
102112523|NCT04810208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112524|NCT04445636|Dexmedetomidine|dexmedetomidine|mesh-list
102112525|NCT04445636|Morphine|morphine|mesh-list
102112526|NCT04445636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102112527|NCT04445636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102112528|NCT04445636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112529|NCT04445636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102112530|NCT04445636|Analgesics|analgesics|mesh-ancestor
102112531|NCT04445636|Sensory System Agents|sensory system agents|mesh-ancestor
102112532|NCT04445636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101954880|NCT02060734|Sensory System Agents|sensory system agents|mesh-ancestor
102112533|NCT04445636|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102112534|NCT04445636|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102112535|NCT04445636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102112536|NCT04445636|Adrenergic Agents|adrenergic agents|mesh-ancestor
102112537|NCT04445636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102112538|NCT04445636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112539|NCT04445636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102112540|NCT04445636|Narcotics|narcotics|mesh-ancestor
101566105|NCT01121991|Hormones|hormones|mesh-list
102112541|NCT02152917|Tranexamic Acid|tranexamic acid|mesh-list
102112542|NCT02152917|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102112543|NCT02152917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101227212|NCT01538875|Vasodilator Agents|vasodilator agents|mesh-ancestor
102112544|NCT02152917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112546|NCT02152917|Coagulants|coagulants|mesh-ancestor
102112547|NCT03111212|Iloprost|iloprost|mesh-list
102112548|NCT03111212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102112549|NCT03111212|Vasodilator Agents|vasodilator agents|mesh-ancestor
102112550|NCT03170206|Palbociclib|palbociclib|mesh-list
102112551|NCT03170206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102112552|NCT03170206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102112553|NCT03170206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102112554|NCT03170206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112555|NCT05424016|Propranolol|propranolol|mesh-list
102112556|NCT05424016|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102112557|NCT05424016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102112558|NCT05424016|Adrenergic Agents|adrenergic agents|mesh-ancestor
102112559|NCT05424016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102112560|NCT05424016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112561|NCT05424016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112562|NCT05424016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102112563|NCT05424016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102112564|NCT05424016|Vasodilator Agents|vasodilator agents|mesh-ancestor
102112565|NCT02149953|Glycine|glycine|mesh-list
102112566|NCT02149953|Glycine Agents|glycine agents|mesh-ancestor
102112567|NCT02149953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102112568|NCT02149953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112569|NCT02149953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112570|NCT03380936|Tacrolimus|tacrolimus|mesh-list
102112571|NCT03380936|Immunoglobulins|immunoglobulins|mesh-list
102112572|NCT03380936|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102112573|NCT03380936|Antibodies|antibodies|mesh-list
102112574|NCT03380936|gamma-Globulins|gamma-globulins|mesh-list
102112575|NCT03380936|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102112576|NCT03380936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102112577|NCT03380936|Immunologic Factors|immunologic factors|mesh-ancestor
102112578|NCT03380936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112579|NCT03380936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102112580|NCT03380936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102112581|NCT03380936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112582|NCT02150031|Chlorhexidine|chlorhexidine|mesh-list
102112583|NCT02150031|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102112584|NCT02150031|Lidocaine|lidocaine|mesh-list
102112585|NCT02150031|Epinephrine|epinephrine|mesh-list
102112586|NCT02150031|Racepinephrine|racepinephrine|mesh-list
102112587|NCT02150031|Epinephryl borate|epinephryl borate|mesh-list
102112588|NCT02150031|Anesthetics, Local|anesthetics, local|mesh-ancestor
102112589|NCT02150031|Anesthetics|anesthetics|mesh-ancestor
102112590|NCT02150031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102112591|NCT02150031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112592|NCT02150031|Sensory System Agents|sensory system agents|mesh-ancestor
102112593|NCT02150031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102112594|NCT02150031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102112595|NCT02150031|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102112596|NCT02150031|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102112597|NCT02150031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102112598|NCT02150031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112599|NCT02150031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102112600|NCT02150031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102112601|NCT02150031|Disinfectants|disinfectants|mesh-ancestor
102112602|NCT02150031|Dermatologic Agents|dermatologic agents|mesh-ancestor
102112603|NCT02150031|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102112604|NCT02150031|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102112605|NCT02150031|Adrenergic Agents|adrenergic agents|mesh-ancestor
102112606|NCT02150031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102112607|NCT02150031|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102112608|NCT02150031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102112609|NCT02150031|Autonomic Agents|autonomic agents|mesh-ancestor
102112610|NCT02150031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101227236|NCT01539018|Antimetabolites|antimetabolites|mesh-ancestor
102112611|NCT02150031|Respiratory System Agents|respiratory system agents|mesh-ancestor
102112612|NCT02150031|Mydriatics|mydriatics|mesh-ancestor
102112613|NCT02150031|Sympathomimetics|sympathomimetics|mesh-ancestor
102112614|NCT02150031|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102112615|NCT04655170|Albuterol|albuterol|mesh-list
102112616|NCT04655170|Formoterol Fumarate|formoterol fumarate|mesh-list
102112617|NCT04655170|Ipratropium|ipratropium|mesh-list
102112618|NCT04655170|Cholinergic Antagonists|cholinergic antagonists|mesh-list
102112619|NCT04655170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102112620|NCT04655170|Autonomic Agents|autonomic agents|mesh-ancestor
102112621|NCT04655170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102112622|NCT04655170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112623|NCT04655170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102112624|NCT04655170|Respiratory System Agents|respiratory system agents|mesh-ancestor
102112625|NCT04655170|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102112626|NCT04655170|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102112627|NCT04655170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102112628|NCT04655170|Adrenergic Agents|adrenergic agents|mesh-ancestor
102112629|NCT04655170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102112630|NCT04655170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112631|NCT04655170|Tocolytic Agents|tocolytic agents|mesh-ancestor
102112632|NCT04655170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102112633|NCT04655170|Cholinergic Agents|cholinergic agents|mesh-ancestor
102112634|NCT02156661|Oxytocin|oxytocin|mesh-list
102112635|NCT02156661|Oxytocics|oxytocics|mesh-ancestor
102112636|NCT02156661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102112637|NCT02156661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112638|NCT03065062|Palbociclib|palbociclib|mesh-list
102112639|NCT03065062|Gedatolisib|gedatolisib|mesh-list
102112640|NCT03065062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102112641|NCT03065062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102112642|NCT03065062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102112643|NCT03065062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112644|NCT03374774|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
102112645|NCT03374774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102112646|NCT03374774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112647|NCT04827862|Pembrolizumab|pembrolizumab|mesh-list
102112648|NCT04827862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102112649|NCT04827862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102112650|NCT04827862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102112651|NCT04827862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112652|NCT03374540|Vitamin K|vitamin k|mesh-list
102112653|NCT03374540|Rivaroxaban|rivaroxaban|mesh-list
102112654|NCT03374540|Vitamins|vitamins|mesh-ancestor
102112655|NCT03374540|Micronutrients|micronutrients|mesh-ancestor
102112656|NCT03374540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112657|NCT03374540|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102112658|NCT03374540|Antithrombins|antithrombins|mesh-ancestor
102112659|NCT03374540|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102112660|NCT03374540|Protease Inhibitors|protease inhibitors|mesh-ancestor
102112661|NCT03374540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102112662|NCT03374540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112663|NCT03374540|Anticoagulants|anticoagulants|mesh-ancestor
102112664|NCT03374540|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102112665|NCT03374540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102112666|NCT03374540|Hemostatics|hemostatics|mesh-ancestor
102112667|NCT03374540|Coagulants|coagulants|mesh-ancestor
102112668|NCT02780115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102112669|NCT02780115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102112670|NCT03378674|Remifentanil|remifentanil|mesh-list
102112671|NCT03378674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102112672|NCT03378674|Narcotics|narcotics|mesh-ancestor
102112673|NCT03378674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102112674|NCT03378674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112675|NCT03378674|Analgesics|analgesics|mesh-ancestor
102112676|NCT03378674|Sensory System Agents|sensory system agents|mesh-ancestor
101227240|NCT01539044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102112677|NCT03378674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102112678|NCT02157207|Vitamins|vitamins|mesh-list
102112679|NCT02157207|Vitamin E|vitamin e|mesh-list
102112680|NCT02157207|Antioxidants|antioxidants|mesh-list
102112681|NCT02157207|Micronutrients|micronutrients|mesh-ancestor
102112682|NCT02157207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112683|NCT02157207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112684|NCT02157207|Protective Agents|protective agents|mesh-ancestor
102112685|NCT02261103|Pramipexole|pramipexole|mesh-list
102112686|NCT02261103|Antioxidants|antioxidants|mesh-ancestor
102112687|NCT02261103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112688|NCT02261103|Protective Agents|protective agents|mesh-ancestor
102112689|NCT02261103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112690|NCT02261103|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102112691|NCT02261103|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102112692|NCT02261103|Dopamine Agonists|dopamine agonists|mesh-ancestor
102112693|NCT02261103|Dopamine Agents|dopamine agents|mesh-ancestor
102112694|NCT02261103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102112695|NCT04703686|Obinutuzumab|obinutuzumab|mesh-list
102112696|NCT04703686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102112697|NCT04703686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102112698|NCT02766777|Lubiprostone|lubiprostone|mesh-list
102112699|NCT02766777|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102112700|NCT02766777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102112701|NCT02766777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112702|NCT03374306|Atropine|atropine|mesh-list
102112703|NCT03374306|Lubricant Eye Drops|lubricant eye drops|mesh-list
102112704|NCT03374306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102112705|NCT03374306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102112706|NCT03374306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102112707|NCT03374306|Autonomic Agents|autonomic agents|mesh-ancestor
102112708|NCT03374306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102112709|NCT03374306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112710|NCT03374306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102112711|NCT03374306|Respiratory System Agents|respiratory system agents|mesh-ancestor
102112712|NCT03374306|Mydriatics|mydriatics|mesh-ancestor
102112713|NCT03374306|Parasympatholytics|parasympatholytics|mesh-ancestor
102112714|NCT03374306|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102112715|NCT03374306|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102112716|NCT03374306|Cholinergic Agents|cholinergic agents|mesh-ancestor
102112717|NCT03374306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102112718|NCT03374306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112719|NCT03374306|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102112720|NCT03374306|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102112721|NCT05534230|Dexmedetomidine|dexmedetomidine|mesh-list
102112722|NCT05534230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102112723|NCT05534230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102112724|NCT05534230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102112725|NCT05534230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112726|NCT05534230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102112727|NCT05534230|Analgesics|analgesics|mesh-ancestor
102112728|NCT05534230|Sensory System Agents|sensory system agents|mesh-ancestor
102112729|NCT05534230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102112730|NCT05534230|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102112731|NCT05534230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102112732|NCT05534230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102112733|NCT05534230|Adrenergic Agents|adrenergic agents|mesh-ancestor
102112734|NCT05534230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102112735|NCT05534230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112736|NCT03369782|Rocuronium|rocuronium|mesh-list
102112737|NCT03369782|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102112738|NCT03369782|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102112739|NCT03369782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102112740|NCT03369782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102112741|NCT03369782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112742|NCT00157014|Cyclosporine|cyclosporine|mesh-list
102112743|NCT00157014|Mycophenolic Acid|mycophenolic acid|mesh-list
102112744|NCT00157014|Prednisone|prednisone|mesh-list
102112745|NCT00157014|Methylprednisolone|methylprednisolone|mesh-list
102112746|NCT00157014|Tacrolimus|tacrolimus|mesh-list
102112747|NCT00157014|Cyclosporins|cyclosporins|mesh-list
102112748|NCT00157014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102112749|NCT00157014|Glucocorticoids|glucocorticoids|mesh-ancestor
102112750|NCT00157014|Hormones|hormones|mesh-ancestor
102112751|NCT00157014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102112752|NCT00157014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112753|NCT00157014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102112754|NCT00157014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102112755|NCT00157014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102112756|NCT00157014|Immunologic Factors|immunologic factors|mesh-ancestor
102112757|NCT00157014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102112758|NCT00157014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102112759|NCT00157014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112760|NCT00157014|Antifungal Agents|antifungal agents|mesh-ancestor
102112761|NCT00157014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102112762|NCT00157014|Dermatologic Agents|dermatologic agents|mesh-ancestor
102112763|NCT00157014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102112764|NCT00157014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102112765|NCT00157014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102112766|NCT00157014|Antitubercular Agents|antitubercular agents|mesh-ancestor
102112767|NCT00157014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102112768|NCT00157014|Antiemetics|antiemetics|mesh-ancestor
102112769|NCT00157014|Autonomic Agents|autonomic agents|mesh-ancestor
102112770|NCT00157014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102112771|NCT00157014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102112772|NCT00157014|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102112773|NCT00157014|Protective Agents|protective agents|mesh-ancestor
102112774|NCT03374228|Linrodostat|linrodostat|mesh-list
102112775|NCT03374228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102112776|NCT03374228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112777|NCT02778867|Fluticasone|fluticasone|mesh-list
102112778|NCT02778867|Xhance|xhance|mesh-list
102112779|NCT02778867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102112780|NCT02778867|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102112781|NCT02778867|Autonomic Agents|autonomic agents|mesh-ancestor
102112782|NCT02778867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102112783|NCT02778867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112784|NCT02778867|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102112785|NCT02778867|Respiratory System Agents|respiratory system agents|mesh-ancestor
102112786|NCT02778867|Dermatologic Agents|dermatologic agents|mesh-ancestor
102112787|NCT02778867|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102112788|NCT04232072|Ibuprofen|ibuprofen|mesh-list
102112789|NCT04232072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102112790|NCT04232072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102112791|NCT04232072|Analgesics|analgesics|mesh-ancestor
102112792|NCT04232072|Sensory System Agents|sensory system agents|mesh-ancestor
102112793|NCT04232072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102112794|NCT04232072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112795|NCT04232072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102112796|NCT04232072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102112797|NCT04232072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102112798|NCT04232072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102112799|NCT04232072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112800|NCT02300064|Antioxidants|antioxidants|mesh-list
102112801|NCT02300064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112802|NCT02300064|Protective Agents|protective agents|mesh-ancestor
102112803|NCT02300064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112804|NCT02688712|Fluorouracil|fluorouracil|mesh-list
102112805|NCT02688712|Capecitabine|capecitabine|mesh-list
102112806|NCT02688712|Antimetabolites|antimetabolites|mesh-ancestor
102112807|NCT02688712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112808|NCT02688712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102112809|NCT02688712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102112810|NCT02688712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102112811|NCT02688712|Immunologic Factors|immunologic factors|mesh-ancestor
102112812|NCT02688712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112813|NCT03373994|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102112814|NCT03373994|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102112815|NCT03373994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112816|NCT02617550|Nitroglycerin|nitroglycerin|mesh-list
102112817|NCT02617550|Vasodilator Agents|vasodilator agents|mesh-ancestor
102112818|NCT03512808|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102112819|NCT03512808|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102112820|NCT03512808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102112821|NCT02519582|Niclosamide|niclosamide|mesh-list
102112822|NCT02519582|Anticestodal Agents|anticestodal agents|mesh-ancestor
102112823|NCT02519582|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102112824|NCT02519582|Anthelmintics|anthelmintics|mesh-ancestor
102112825|NCT02519582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102112826|NCT02519582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102112827|NCT02519582|Antinematodal Agents|antinematodal agents|mesh-ancestor
102112828|NCT02467582|Aspirin|aspirin|mesh-list
102112829|NCT02467582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102112830|NCT02467582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102112831|NCT02467582|Analgesics|analgesics|mesh-ancestor
102112832|NCT02467582|Sensory System Agents|sensory system agents|mesh-ancestor
102112833|NCT02467582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102112834|NCT02467582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112835|NCT02467582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102112836|NCT02467582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102112837|NCT02467582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102112838|NCT02467582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102112839|NCT02467582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112840|NCT02467582|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102112841|NCT02467582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102112842|NCT02467582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101836473|NCT01063816|Gemcitabine|gemcitabine|mesh-list
102112843|NCT02467582|Antipyretics|antipyretics|mesh-ancestor
102112844|NCT05467462|Tranexamic Acid|tranexamic acid|mesh-list
102112845|NCT05467462|Oxytocin|oxytocin|mesh-list
102112846|NCT05467462|Carbetocin|carbetocin|mesh-list
102112847|NCT05467462|Oxytocics|oxytocics|mesh-ancestor
102112848|NCT05467462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102112849|NCT05467462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112850|NCT05467462|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102112851|NCT05467462|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102112852|NCT05467462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112853|NCT05467462|Hemostatics|hemostatics|mesh-ancestor
102112854|NCT05467462|Coagulants|coagulants|mesh-ancestor
102112855|NCT03369002|Seladelpar|seladelpar|mesh-list
102112856|NCT03369002|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102112857|NCT03369002|Antimetabolites|antimetabolites|mesh-ancestor
102112858|NCT03369002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112859|NCT03369002|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102112860|NCT05533606|Lactams|lactams|mesh-list
102112861|NCT05533606|beta-Lactams|beta-lactams|mesh-list
102112862|NCT05533606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102112863|NCT05533606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102112864|NCT02300376|Edetic Acid|edetic acid|mesh-list
102112865|NCT02300376|Calcium|calcium|mesh-list
102112866|NCT02300376|Pentetic Acid|pentetic acid|mesh-list
102112867|NCT02300376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102112868|NCT02300376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112869|NCT02300376|Anticoagulants|anticoagulants|mesh-ancestor
102112870|NCT02300376|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102112871|NCT02300376|Chelating Agents|chelating agents|mesh-ancestor
102112872|NCT02300376|Sequestering Agents|sequestering agents|mesh-ancestor
102112873|NCT02300376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112874|NCT02300376|Antidotes|antidotes|mesh-ancestor
102112875|NCT02300376|Protective Agents|protective agents|mesh-ancestor
102112876|NCT02300376|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102112877|NCT02296398|Romidepsin|romidepsin|mesh-list
102112878|NCT02296398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102112879|NCT02296398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102112880|NCT02296398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102112881|NCT02296398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102112882|NCT02296398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112883|NCT03520062|Liraglutide|liraglutide|mesh-list
102112884|NCT03520062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102112885|NCT03520062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112886|NCT03520062|Incretins|incretins|mesh-ancestor
102112887|NCT03520062|Hormones|hormones|mesh-ancestor
102112888|NCT03520062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102112889|NCT02206984|Tamoxifen|tamoxifen|mesh-list
102112890|NCT02206984|Fulvestrant|fulvestrant|mesh-list
102112891|NCT02206984|Anastrozole|anastrozole|mesh-list
102112892|NCT02206984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102112893|NCT02206984|Hormone Antagonists|hormone antagonists|mesh-ancestor
102112894|NCT02206984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102112895|NCT02206984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112896|NCT02206984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102112897|NCT02206984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102112898|NCT02206984|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102112899|NCT02206984|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102112900|NCT02206984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102112901|NCT02206984|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102112902|NCT02206984|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102112903|NCT02206984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102112904|NCT02206984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102112905|NCT02206984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112906|NCT03512574|Pregabalin|pregabalin|mesh-list
102112907|NCT03512574|Dexmedetomidine|dexmedetomidine|mesh-list
102112908|NCT03512574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102112909|NCT03512574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102112910|NCT03512574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112911|NCT03512574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102112912|NCT03512574|Analgesics|analgesics|mesh-ancestor
102112913|NCT03512574|Sensory System Agents|sensory system agents|mesh-ancestor
102112914|NCT03512574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102112915|NCT03512574|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102112916|NCT03512574|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102112917|NCT03512574|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102112918|NCT03512574|Adrenergic Agents|adrenergic agents|mesh-ancestor
102112919|NCT03512574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102112920|NCT03512574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112921|NCT03512574|Anticonvulsants|anticonvulsants|mesh-ancestor
102112922|NCT03512574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102112923|NCT03512574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102112924|NCT03512574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102112925|NCT03512574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102112926|NCT03512574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102112927|NCT03512574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102112928|NCT01994980|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102112929|NCT01994980|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102112930|NCT01994980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102112931|NCT01994980|Antitubercular Agents|antitubercular agents|mesh-ancestor
102112932|NCT03377348|Triamcinolone|triamcinolone|mesh-list
102112933|NCT03377348|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102112934|NCT03377348|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102112935|NCT03377348|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102112936|NCT03377348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102112937|NCT03377348|Glucocorticoids|glucocorticoids|mesh-ancestor
102112938|NCT03377348|Hormones|hormones|mesh-ancestor
102112939|NCT03377348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102112940|NCT03377348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112941|NCT03377348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102112942|NCT03377348|Immunologic Factors|immunologic factors|mesh-ancestor
102112943|NCT03377348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101227273|NCT01539174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102112944|NCT03377348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112945|NCT02255253|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102112946|NCT02255253|Telmisartan|telmisartan|mesh-list
102112947|NCT02255253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102112948|NCT02255253|Diuretics|diuretics|mesh-ancestor
102112949|NCT02255253|Natriuretic Agents|natriuretic agents|mesh-ancestor
102112950|NCT02255253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112951|NCT02255253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101954907|NCT03768609|Cyclosporine|cyclosporine|mesh-list
102112952|NCT02255253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102112953|NCT02255253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112954|NCT02255253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102112955|NCT02255253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102112956|NCT02300688|Maleic acid|maleic acid|mesh-list
102112957|NCT02300688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102112958|NCT02300688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112959|NCT03896984|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
102112960|NCT03896984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102112961|NCT02151279|Chitosan|chitosan|mesh-list
102112962|NCT02151279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102112963|NCT02151279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102112964|NCT02151279|Antimetabolites|antimetabolites|mesh-ancestor
102112965|NCT02151279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112966|NCT02151279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102112967|NCT02151279|Chelating Agents|chelating agents|mesh-ancestor
102112968|NCT02151279|Sequestering Agents|sequestering agents|mesh-ancestor
102112969|NCT02151279|Hemostatics|hemostatics|mesh-ancestor
102112970|NCT02151279|Coagulants|coagulants|mesh-ancestor
102112971|NCT02159313|Riociguat|riociguat|mesh-list
102112972|NCT02159313|Enzyme Activators|enzyme activators|mesh-ancestor
102112973|NCT02159313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112974|NCT03515772|Darunavir|darunavir|mesh-list
102112975|NCT03515772|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102112976|NCT03515772|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102112977|NCT03515772|Protease Inhibitors|protease inhibitors|mesh-ancestor
102112978|NCT03515772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102112979|NCT03515772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112980|NCT03515772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102112981|NCT03515772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102112982|NCT03515772|Antiviral Agents|antiviral agents|mesh-ancestor
102112983|NCT03515772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102112984|NCT03519750|Melatonin|melatonin|mesh-list
102112985|NCT03519750|Antioxidants|antioxidants|mesh-ancestor
102112986|NCT03519750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102112987|NCT03519750|Protective Agents|protective agents|mesh-ancestor
102112988|NCT03519750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112989|NCT03519750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102112990|NCT02158143|Vitamin D|vitamin d|mesh-list
102112991|NCT02158143|Cholecalciferol|cholecalciferol|mesh-list
102112992|NCT02158143|Vitamins|vitamins|mesh-ancestor
102112993|NCT02158143|Micronutrients|micronutrients|mesh-ancestor
102112994|NCT02158143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102112995|NCT02158143|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102112996|NCT02158143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102112997|NCT02158221|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
102112998|NCT02158221|Growth Substances|growth substances|mesh-ancestor
102112999|NCT02158221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113000|NCT02158221|Vasodilator Agents|vasodilator agents|mesh-ancestor
102113001|NCT02158221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102113002|NCT02158221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113003|NCT02519816|Plasma-lyte 148|plasma-lyte 148|mesh-list
102113004|NCT02519816|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102113005|NCT02519816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102113006|NCT02301000|Metronidazole|metronidazole|mesh-list
102113007|NCT02301000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102113008|NCT02301000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102113009|NCT02301000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102113010|NCT02301000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102113011|NCT02292732|Trametinib|trametinib|mesh-list
102113012|NCT02292732|Norinyl|norinyl|mesh-list
102113013|NCT02292732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102113014|NCT02292732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102113015|NCT02292732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102113016|NCT02292732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113017|NCT02292732|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102113018|NCT02292732|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102113019|NCT02292732|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102113020|NCT02292732|Contraceptive Agents|contraceptive agents|mesh-ancestor
102113021|NCT02292732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102113022|NCT02292732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113023|NCT02292732|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102113024|NCT02292732|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102113025|NCT03376958|Apatinib|apatinib|mesh-list
102113026|NCT03376958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102113027|NCT03376958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102113028|NCT03376958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102113029|NCT03376958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113030|NCT03367676|Docetaxel|docetaxel|mesh-list
102113031|NCT03367676|Trastuzumab|trastuzumab|mesh-list
102113032|NCT03367676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102113033|NCT03367676|Tubulin Modulators|tubulin modulators|mesh-ancestor
102113034|NCT03367676|Antimitotic Agents|antimitotic agents|mesh-ancestor
102113035|NCT03367676|Mitosis Modulators|mitosis modulators|mesh-ancestor
102113036|NCT03367676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113037|NCT03367676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102113038|NCT03515538|Cisplatin|cisplatin|mesh-list
102113039|NCT03515538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102113040|NCT02158689|Letrozole|letrozole|mesh-list
102113041|NCT02158689|Menotropins|menotropins|mesh-list
102113042|NCT02158689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102113043|NCT02158689|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102113044|NCT02158689|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102113045|NCT02158689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102113046|NCT02158689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113047|NCT02158689|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102113048|NCT02158689|Hormone Antagonists|hormone antagonists|mesh-ancestor
102113049|NCT02158689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102113050|NCT02158689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113051|NCT02158689|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102113052|NCT02158689|Fertility Agents|fertility agents|mesh-ancestor
102113053|NCT02158689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102113054|NCT03372200|Febuxostat|febuxostat|mesh-list
102113055|NCT03372200|Dotinurad|dotinurad|mesh-list
102113056|NCT03372200|Gout Suppressants|gout suppressants|mesh-ancestor
102113057|NCT03372200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102113058|NCT03372200|Uricosuric Agents|uricosuric agents|mesh-ancestor
102113059|NCT03372122|Chlorhexidine|chlorhexidine|mesh-list
102113060|NCT03372122|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102113061|NCT03372122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102113062|NCT03372122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102113063|NCT03372122|Disinfectants|disinfectants|mesh-ancestor
102113064|NCT03372122|Dermatologic Agents|dermatologic agents|mesh-ancestor
102113065|NCT02158845|Leuprolide|leuprolide|mesh-list
102113066|NCT02158845|Levonorgestrel|levonorgestrel|mesh-list
102113067|NCT02158845|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102113068|NCT02158845|Fertility Agents|fertility agents|mesh-ancestor
102113069|NCT02158845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102113070|NCT02158845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113071|NCT02158845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102113072|NCT02158845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102113073|NCT02158845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102113074|NCT02158845|Contraceptive Agents|contraceptive agents|mesh-ancestor
102113075|NCT02158845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102113076|NCT02158845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102113077|NCT02158845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102113078|NCT02292966|Asunaprevir|asunaprevir|mesh-list
102113079|NCT02292966|Protease Inhibitors|protease inhibitors|mesh-ancestor
102113080|NCT02292966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102113081|NCT02292966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113082|NCT02519660|Lidocaine|lidocaine|mesh-list
102113083|NCT02519660|Tetracaine|tetracaine|mesh-list
102113084|NCT02519660|Prilocaine|prilocaine|mesh-list
102113085|NCT02519660|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
102113086|NCT02519660|Anesthetics, Local|anesthetics, local|mesh-ancestor
102113087|NCT02519660|Anesthetics|anesthetics|mesh-ancestor
102113088|NCT02519660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102113089|NCT02519660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113090|NCT02519660|Sensory System Agents|sensory system agents|mesh-ancestor
102113091|NCT02519660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102113092|NCT02519660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102113093|NCT02519660|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102113094|NCT02519660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102113095|NCT02519660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102113096|NCT02519660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113097|NCT02519660|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
102113098|NCT02297490|Immunomodulating Agents|immunomodulating agents|mesh-list
102113099|NCT02297490|Immunologic Factors|immunologic factors|mesh-ancestor
102113100|NCT02297490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113102|NCT02297568|Ergocalciferols|ergocalciferols|mesh-list
102113103|NCT02297568|Vitamins|vitamins|mesh-ancestor
102113104|NCT02297568|Micronutrients|micronutrients|mesh-ancestor
102113105|NCT02297568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113106|NCT02297568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102113107|NCT02297568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102113108|NCT03515382|Itraconazole|itraconazole|mesh-list
102113109|NCT03515382|Voriconazole|voriconazole|mesh-list
102113110|NCT03515382|Antifungal Agents|antifungal agents|mesh-ancestor
102113111|NCT03515382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102113112|NCT03515382|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102113113|NCT03515382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102113114|NCT03515382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102113115|NCT03515382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113116|NCT03515382|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102113117|NCT03515382|Hormone Antagonists|hormone antagonists|mesh-ancestor
102113118|NCT03515382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102113119|NCT03515382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113120|NCT03515382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102113121|NCT03511560|Tacrolimus|tacrolimus|mesh-list
102113122|NCT03511560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102113123|NCT03511560|Immunologic Factors|immunologic factors|mesh-ancestor
102113124|NCT03511560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113125|NCT03511560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102113126|NCT03511560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102113127|NCT03511560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113128|NCT03688802|Varenicline|varenicline|mesh-list
102113129|NCT03688802|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102113130|NCT03688802|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102113131|NCT03688802|Cholinergic Agents|cholinergic agents|mesh-ancestor
102113132|NCT03688802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102113133|NCT03688802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113134|NCT03688802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113135|NCT02293356|Nimotuzumab|nimotuzumab|mesh-list
102113136|NCT02293356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102113137|NCT02293356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102113138|NCT03616418|Antihypertensive Agents|antihypertensive agents|mesh-list
102113139|NCT03616418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
102113140|NCT03371498|Methylprednisolone|methylprednisolone|mesh-list
102113141|NCT03371498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102113142|NCT03371498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102113143|NCT03371498|Prednisolone|prednisolone|mesh-list
102113144|NCT03371498|Prednisolone acetate|prednisolone acetate|mesh-list
102113145|NCT03371498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102113146|NCT03371498|Prednisolone phosphate|prednisolone phosphate|mesh-list
102113147|NCT03371498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102113148|NCT03371498|Antiemetics|antiemetics|mesh-ancestor
102113149|NCT03371498|Autonomic Agents|autonomic agents|mesh-ancestor
102113150|NCT03371498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102113151|NCT03371498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113152|NCT03371498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102113153|NCT03371498|Glucocorticoids|glucocorticoids|mesh-ancestor
102113154|NCT03371498|Hormones|hormones|mesh-ancestor
102113155|NCT03371498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102113156|NCT03371498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102113157|NCT03371498|Protective Agents|protective agents|mesh-ancestor
102113158|NCT03371498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102113159|NCT03371498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102113160|NCT03376178|Lidocaine|lidocaine|mesh-list
102113161|NCT03376178|Ropivacaine|ropivacaine|mesh-list
102113162|NCT03376178|Anesthetics, Local|anesthetics, local|mesh-ancestor
102113163|NCT03376178|Anesthetics|anesthetics|mesh-ancestor
102113164|NCT03376178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102113165|NCT03376178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113166|NCT03376178|Sensory System Agents|sensory system agents|mesh-ancestor
102113167|NCT03376178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102113168|NCT03376178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102113169|NCT03376178|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102113170|NCT03376178|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102113171|NCT03376178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102113172|NCT03376178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113173|NCT03514836|Cyclophosphamide|cyclophosphamide|mesh-list
102113174|NCT03514836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102113175|NCT03514836|Immunologic Factors|immunologic factors|mesh-ancestor
102113176|NCT03514836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113177|NCT03514836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102113178|NCT03514836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102113179|NCT03514836|Alkylating Agents|alkylating agents|mesh-ancestor
102113180|NCT03514836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113181|NCT03514836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102113182|NCT03514836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102113183|NCT03371342|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102113184|NCT03371342|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102113185|NCT03371342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102113186|NCT03371342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113187|NCT03371342|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102113188|NCT03371342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102113189|NCT03371342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113190|NCT03371342|Cholinergic Agents|cholinergic agents|mesh-ancestor
102113191|NCT03371342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102113192|NCT02302326|Folic Acid|folic acid|mesh-list
102113193|NCT02302326|Inositol|inositol|mesh-list
102113194|NCT02302326|Metformin|metformin|mesh-list
102113195|NCT02302326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102113196|NCT02302326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113197|NCT02302326|Hematinics|hematinics|mesh-ancestor
102113198|NCT02302326|Vitamin B Complex|vitamin b complex|mesh-ancestor
102113199|NCT02302326|Vitamins|vitamins|mesh-ancestor
102113200|NCT02302326|Micronutrients|micronutrients|mesh-ancestor
102113201|NCT02293590|Sulfasalazine|sulfasalazine|mesh-list
102113202|NCT02293590|Certolizumab Pegol|certolizumab pegol|mesh-list
102113203|NCT02293590|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102113204|NCT02293590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102113205|NCT02293590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102113206|NCT02293590|Immunologic Factors|immunologic factors|mesh-ancestor
102113207|NCT02293590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113208|NCT02293590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102113209|NCT02293590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102113210|NCT02293590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102113211|NCT02293590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102113212|NCT02293590|Analgesics|analgesics|mesh-ancestor
102113213|NCT02293590|Sensory System Agents|sensory system agents|mesh-ancestor
102113214|NCT02293590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102113215|NCT02293590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102113216|NCT02302404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102113217|NCT03124082|Lidocaine|lidocaine|mesh-list
102113218|NCT03124082|Clonidine|clonidine|mesh-list
102113219|NCT03124082|Ketamine|ketamine|mesh-list
102113220|NCT03124082|Remifentanil|remifentanil|mesh-list
102113221|NCT03124082|Anesthetics, Local|anesthetics, local|mesh-ancestor
102113222|NCT03124082|Anesthetics|anesthetics|mesh-ancestor
102113223|NCT03124082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102113224|NCT03124082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113225|NCT03124082|Sensory System Agents|sensory system agents|mesh-ancestor
102113226|NCT03124082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102113227|NCT03124082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102113228|NCT03124082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102113229|NCT03124082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102113230|NCT03124082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102113231|NCT03124082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113232|NCT03124082|Analgesics|analgesics|mesh-ancestor
102113233|NCT03124082|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102113234|NCT03124082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102113235|NCT03124082|Anesthetics, General|anesthetics, general|mesh-ancestor
102113236|NCT03124082|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102113237|NCT03124082|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102113238|NCT03124082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102113239|NCT03124082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102113240|NCT03124082|Narcotics|narcotics|mesh-ancestor
102113241|NCT03124082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102113242|NCT03124082|Sympatholytics|sympatholytics|mesh-ancestor
102113243|NCT03124082|Autonomic Agents|autonomic agents|mesh-ancestor
102113244|NCT03124082|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102113245|NCT03124082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102113246|NCT03124082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102113247|NCT03124082|Adrenergic Agents|adrenergic agents|mesh-ancestor
102113248|NCT03518502|Sorafenib|sorafenib|mesh-list
102113249|NCT03518502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102113250|NCT03518502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102113251|NCT03518502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102113252|NCT03518502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113253|NCT02301780|Aspirin|aspirin|mesh-list
102113254|NCT02301780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102113255|NCT02301780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102113256|NCT02301780|Analgesics|analgesics|mesh-ancestor
102113257|NCT02301780|Sensory System Agents|sensory system agents|mesh-ancestor
102113258|NCT02301780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102113259|NCT02301780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113260|NCT02301780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102113261|NCT02301780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102113262|NCT02301780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102113263|NCT02301780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102113264|NCT02301780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113265|NCT02301780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102113266|NCT02301780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102113267|NCT02301780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102113268|NCT02301780|Antipyretics|antipyretics|mesh-ancestor
102113269|NCT04527068|Bevacizumab|bevacizumab|mesh-list
102113270|NCT04527068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102113271|NCT04527068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102113272|NCT04527068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102113273|NCT04527068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102113274|NCT04527068|Growth Substances|growth substances|mesh-ancestor
102113275|NCT04527068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113276|NCT04527068|Growth Inhibitors|growth inhibitors|mesh-ancestor
102113277|NCT02739360|Idelalisib|idelalisib|mesh-list
102113278|NCT02739360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102113279|NCT02739360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102113280|NCT02739360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113281|NCT03123770|Cyclophosphamide|cyclophosphamide|mesh-list
102113282|NCT03123770|Docetaxel|docetaxel|mesh-list
102113283|NCT03123770|Doxorubicin|doxorubicin|mesh-list
102113284|NCT03123770|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102113285|NCT03123770|Epirubicin|epirubicin|mesh-list
102113286|NCT03123770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102113287|NCT03123770|Immunologic Factors|immunologic factors|mesh-ancestor
102113288|NCT03123770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113289|NCT03123770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102113290|NCT03123770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102113291|NCT03123770|Alkylating Agents|alkylating agents|mesh-ancestor
102113292|NCT03123770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113293|NCT03123770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102113294|NCT03123770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102113295|NCT03123770|Tubulin Modulators|tubulin modulators|mesh-ancestor
102113296|NCT03123770|Antimitotic Agents|antimitotic agents|mesh-ancestor
102113297|NCT03123770|Mitosis Modulators|mitosis modulators|mesh-ancestor
102113298|NCT03123770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102113299|NCT03123770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102113300|NCT03123770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102113301|NCT03123770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102113302|NCT04464642|Methotrexate|methotrexate|mesh-list
102113303|NCT04464642|Tofacitinib|tofacitinib|mesh-list
102113304|NCT04464642|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102113305|NCT04464642|Abortifacient Agents|abortifacient agents|mesh-ancestor
102113306|NCT04464642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102113307|NCT04464642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113308|NCT04464642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102113309|NCT04464642|Antimetabolites|antimetabolites|mesh-ancestor
102113310|NCT04464642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113311|NCT04464642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102113312|NCT04464642|Dermatologic Agents|dermatologic agents|mesh-ancestor
102113313|NCT04464642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102113314|NCT04464642|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102113315|NCT04464642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102113316|NCT04464642|Immunologic Factors|immunologic factors|mesh-ancestor
102113317|NCT04464642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102113318|NCT04464642|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102113319|NCT04464642|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102113320|NCT04464642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102113321|NCT02293668|Letrozole|letrozole|mesh-list
102113322|NCT02293668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102113323|NCT02293668|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102113324|NCT02293668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102113325|NCT02293668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102113326|NCT02293668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113327|NCT02293668|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102113328|NCT02293668|Hormone Antagonists|hormone antagonists|mesh-ancestor
102113329|NCT02293668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102113330|NCT02293668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113331|NCT03123692|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
102113332|NCT03123692|Chelating Agents|chelating agents|mesh-ancestor
102113333|NCT03123692|Sequestering Agents|sequestering agents|mesh-ancestor
102113334|NCT03123692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113364|NCT03375632|Dotinurad|dotinurad|mesh-list
101836474|NCT01063816|Veliparib|veliparib|mesh-list
102113365|NCT03375632|Uricosuric Agents|uricosuric agents|mesh-ancestor
102113366|NCT03375632|Gout Suppressants|gout suppressants|mesh-ancestor
102113367|NCT03375632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102113368|NCT02302170|Vaccines|vaccines|mesh-list
102113369|NCT02302170|Immunologic Factors|immunologic factors|mesh-ancestor
102113370|NCT02302170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113371|NCT03371186|Contraceptive Agents|contraceptive agents|mesh-list
102113372|NCT03371186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102113373|NCT03371186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113374|NCT02302950|Raltegravir Potassium|raltegravir potassium|mesh-list
102113375|NCT02302950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102113376|NCT02302950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102113377|NCT02302950|Antiviral Agents|antiviral agents|mesh-ancestor
102113378|NCT02302950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102113379|NCT02302950|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102113380|NCT02302950|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102113381|NCT02302950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102113382|NCT02302950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113384|NCT02293824|Caffeine citrate|caffeine citrate|mesh-list
102113385|NCT02293824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113386|NCT02293824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102113387|NCT02293824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113388|NCT02293824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102113389|NCT02293824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102113390|NCT02293824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102113391|NCT02293824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102113392|NCT02293824|Purinergic Agents|purinergic agents|mesh-ancestor
102113393|NCT02293824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102113394|NCT03366584|Vitamin D|vitamin d|mesh-list
102113395|NCT03366584|Cholecalciferol|cholecalciferol|mesh-list
102113396|NCT03366584|Beta Carotene|beta carotene|mesh-list
102113397|NCT03366584|Zinc|zinc|mesh-list
102113398|NCT03366584|Dexamethasone|dexamethasone|mesh-list
102113399|NCT03366584|Carotenoids|carotenoids|mesh-list
102113400|NCT03366584|Picolinic acid|picolinic acid|mesh-list
102113401|NCT03366584|Vitamins|vitamins|mesh-ancestor
102113402|NCT03366584|Micronutrients|micronutrients|mesh-ancestor
102113403|NCT03366584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113404|NCT03366584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102113405|NCT03366584|Antiemetics|antiemetics|mesh-ancestor
102113406|NCT03366584|Autonomic Agents|autonomic agents|mesh-ancestor
102113407|NCT03366584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102113408|NCT03366584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102113409|NCT03366584|Glucocorticoids|glucocorticoids|mesh-ancestor
102113410|NCT03366584|Hormones|hormones|mesh-ancestor
102113411|NCT03366584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102113412|NCT03366584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102113413|NCT03366584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102113414|NCT03366584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102113415|NCT03366584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102113416|NCT03366584|Trace Elements|trace elements|mesh-ancestor
102113417|NCT03366584|Antioxidants|antioxidants|mesh-ancestor
102113418|NCT03366584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113419|NCT03366584|Protective Agents|protective agents|mesh-ancestor
102113420|NCT03366584|Provitamins|provitamins|mesh-ancestor
102113421|NCT03366584|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102113422|NCT03366584|Chelating Agents|chelating agents|mesh-ancestor
102113423|NCT03366584|Sequestering Agents|sequestering agents|mesh-ancestor
102113424|NCT03370562|Dexmedetomidine|dexmedetomidine|mesh-list
102113425|NCT03370562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102113426|NCT03370562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102113427|NCT03370562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113428|NCT03370562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102113429|NCT03370562|Analgesics|analgesics|mesh-ancestor
102113430|NCT03370562|Sensory System Agents|sensory system agents|mesh-ancestor
102113431|NCT03370562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102113432|NCT03370562|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102113433|NCT03370562|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102113434|NCT03370562|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102113435|NCT03370562|Adrenergic Agents|adrenergic agents|mesh-ancestor
102113436|NCT03370562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102113437|NCT03370562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113438|NCT03370328|Peppermint oil|peppermint oil|mesh-list
102113439|NCT03370328|Antiemetics|antiemetics|mesh-ancestor
102113440|NCT03370328|Autonomic Agents|autonomic agents|mesh-ancestor
101227332|NCT01539564|Minocycline|minocycline|mesh-list
102113441|NCT03370328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102113442|NCT03370328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113443|NCT03370328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102113444|NCT03370328|Parasympatholytics|parasympatholytics|mesh-ancestor
102113445|NCT02303106|Lamotrigine|lamotrigine|mesh-list
102113446|NCT02303106|Anticonvulsants|anticonvulsants|mesh-ancestor
102113447|NCT02303106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102113448|NCT02303106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102113449|NCT02303106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113450|NCT02303106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102113451|NCT02303106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113452|NCT02303106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102113453|NCT02303106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102113454|NCT02303106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102113455|NCT02303106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102113456|NCT02303106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102113457|NCT04525664|Amoxicillin|amoxicillin|mesh-list
102113458|NCT04525664|Clarithromycin|clarithromycin|mesh-list
102113459|NCT04525664|Omeprazole|omeprazole|mesh-list
102113460|NCT04525664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102113461|NCT04525664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102113462|NCT04525664|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102113463|NCT04525664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102113464|NCT04525664|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102113465|NCT04525664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102113466|NCT04525664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113467|NCT04525664|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102113468|NCT04525664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102113469|NCT04525664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102113470|NCT03510546|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
102113471|NCT03510546|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102113472|NCT03510546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102113473|NCT03510546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113474|NCT03510546|Cholinergic Agents|cholinergic agents|mesh-ancestor
102113475|NCT03510546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102113476|NCT03510546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113477|NCT03505008|Adalimumab|adalimumab|mesh-list
102113478|NCT03505008|Methotrexate|methotrexate|mesh-list
102113479|NCT03505008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102113480|NCT03505008|Abortifacient Agents|abortifacient agents|mesh-ancestor
102113481|NCT03505008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102113482|NCT03505008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113483|NCT03505008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102113484|NCT03505008|Antimetabolites|antimetabolites|mesh-ancestor
102113485|NCT03505008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113486|NCT03505008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102113487|NCT03505008|Dermatologic Agents|dermatologic agents|mesh-ancestor
102113488|NCT03505008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102113489|NCT03505008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102113490|NCT03505008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102113491|NCT03505008|Immunologic Factors|immunologic factors|mesh-ancestor
102113492|NCT03505008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102113493|NCT03505008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102113494|NCT03505008|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102113495|NCT03505008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102113496|NCT03507426|Ketamine|ketamine|mesh-list
102113497|NCT03507426|Analgesics|analgesics|mesh-ancestor
102113498|NCT03507426|Sensory System Agents|sensory system agents|mesh-ancestor
102113499|NCT03507426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102113500|NCT03507426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113501|NCT03507426|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102113502|NCT03507426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102113503|NCT03507426|Anesthetics, General|anesthetics, general|mesh-ancestor
102113504|NCT03507426|Anesthetics|anesthetics|mesh-ancestor
102113505|NCT03507426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102113506|NCT03507426|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102113507|NCT03507426|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102113508|NCT03507426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102113509|NCT03507426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113510|NCT02311530|Felodipine|felodipine|mesh-list
102113511|NCT02311530|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102113512|NCT02311530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102113513|NCT02311530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102113514|NCT02311530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102113515|NCT02311530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113516|NCT02311530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102113517|NCT02311530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113518|NCT02311530|Vasodilator Agents|vasodilator agents|mesh-ancestor
102113519|NCT04522466|Hydroxychloroquine|hydroxychloroquine|mesh-list
102113520|NCT04522466|Antimalarials|antimalarials|mesh-ancestor
102113521|NCT04522466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102113522|NCT04522466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102113523|NCT04522466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102113524|NCT04522466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102113525|NCT04522466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113526|NCT04522466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102113527|NCT02306772|Mesalamine|mesalamine|mesh-list
102113528|NCT02306772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102113529|NCT02306772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102113530|NCT02306772|Analgesics|analgesics|mesh-ancestor
102113531|NCT02306772|Sensory System Agents|sensory system agents|mesh-ancestor
102113532|NCT02306772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102113533|NCT02306772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113534|NCT02306772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102113535|NCT02306772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102113536|NCT03507348|Rituximab|rituximab|mesh-list
102113537|NCT03507348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102113538|NCT03507348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102113539|NCT03507348|Immunologic Factors|immunologic factors|mesh-ancestor
102113540|NCT03507348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113541|NCT03507348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102113542|NCT02518802|Pemetrexed|pemetrexed|mesh-list
102113543|NCT02518802|Gefitinib|gefitinib|mesh-list
102113544|NCT02518802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102113545|NCT02518802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102113546|NCT02518802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113547|NCT02518802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102113548|NCT02518802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102113549|NCT02518802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102113550|NCT04524026|Letrozole|letrozole|mesh-list
102113551|NCT04524026|Aromatase Inhibitors|aromatase inhibitors|mesh-list
102113552|NCT04524026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102113553|NCT04524026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102113554|NCT04524026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102113555|NCT04524026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102113556|NCT04524026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102113557|NCT04524026|Hormone Antagonists|hormone antagonists|mesh-ancestor
102113558|NCT04524026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102113559|NCT04524026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113560|NCT02311608|Octreotide|octreotide|mesh-list
102113561|NCT02311608|Terlipressin|terlipressin|mesh-list
102113562|NCT02311608|Somatostatin|somatostatin|mesh-list
102113563|NCT02311608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102113564|NCT02311608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102113565|NCT02311608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101227347|NCT01539603|Sirolimus|sirolimus|mesh-list
102113566|NCT02311608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102113567|NCT02311608|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102113568|NCT02311608|Hormones|hormones|mesh-ancestor
102113569|NCT02311608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102113570|NCT02311608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113571|NCT02307006|Vancomycin|vancomycin|mesh-list
102113572|NCT02307006|Cefazolin|cefazolin|mesh-list
102113573|NCT02307006|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
102113574|NCT02307006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102113575|NCT02307006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102113576|NCT03362684|Cetuximab|cetuximab|mesh-list
102113577|NCT03362684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102113578|NCT03362684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102113579|NCT02311686|Ethanol|ethanol|mesh-list
101954949|NCT03560362|Autonomic Agents|autonomic agents|mesh-ancestor
102113580|NCT02311686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102113581|NCT02311686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102113582|NCT02311686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102113583|NCT02311686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102113585|NCT02311764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102113586|NCT03365726|Dobutamine|dobutamine|mesh-list
102113587|NCT03365726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102113588|NCT03365726|Sympathomimetics|sympathomimetics|mesh-ancestor
101567150|NCT01254344|Ceftriaxone|ceftriaxone|mesh-list
102113589|NCT03365726|Autonomic Agents|autonomic agents|mesh-ancestor
101902698|NCT05177926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902700|NCT05177926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101902701|NCT01193192|Vitamins|vitamins|mesh-list
101902702|NCT01193192|Micronutrients|micronutrients|mesh-ancestor
101902703|NCT01193192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902704|NCT01193270|Vitamin E|vitamin e|mesh-list
101902705|NCT01193270|Vitamins|vitamins|mesh-ancestor
101902706|NCT01193270|Micronutrients|micronutrients|mesh-ancestor
101902707|NCT01193270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902708|NCT01193270|Antioxidants|antioxidants|mesh-ancestor
101902709|NCT01193270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902710|NCT01193270|Protective Agents|protective agents|mesh-ancestor
101902711|NCT01189214|Memantine|memantine|mesh-list
101902712|NCT01189214|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101902713|NCT01189214|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101902714|NCT01189214|Dopamine Agents|dopamine agents|mesh-ancestor
101902715|NCT01189214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101902716|NCT01189214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902717|NCT01189214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902718|NCT01189214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101902719|NCT01189214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101902720|NCT01193504|Loteprednol Etabonate|loteprednol etabonate|mesh-list
101902721|NCT01193504|Prednisolone acetate|prednisolone acetate|mesh-list
101902722|NCT01193504|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101902723|NCT01193504|Methylprednisolone|methylprednisolone|mesh-list
101902724|NCT01193504|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101902725|NCT01193504|Prednisolone|prednisolone|mesh-list
101902726|NCT01193504|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101902727|NCT01193504|Prednisolone phosphate|prednisolone phosphate|mesh-list
101902728|NCT01193504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101902729|NCT01193504|Antiemetics|antiemetics|mesh-ancestor
101902730|NCT01193504|Autonomic Agents|autonomic agents|mesh-ancestor
101902731|NCT01193504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101902732|NCT01193504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902733|NCT01193504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101902734|NCT01193504|Glucocorticoids|glucocorticoids|mesh-ancestor
101902735|NCT01193504|Hormones|hormones|mesh-ancestor
101902736|NCT01193504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101902737|NCT01193504|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101902738|NCT01193504|Protective Agents|protective agents|mesh-ancestor
101902739|NCT01193504|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101902740|NCT01193504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101902741|NCT01193504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101902742|NCT03848780|Desflurane|desflurane|mesh-list
101902743|NCT03848780|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101902744|NCT03848780|Anesthetics, General|anesthetics, general|mesh-ancestor
101902745|NCT03848780|Anesthetics|anesthetics|mesh-ancestor
101902746|NCT03848780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101902747|NCT03848780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902748|NCT05599802|Vaccines|vaccines|mesh-list
101902749|NCT05599802|Immunologic Factors|immunologic factors|mesh-ancestor
101902750|NCT05599802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902751|NCT00051558|Alendronate|alendronate|mesh-list
101902752|NCT00051558|Teriparatide|teriparatide|mesh-list
101902753|NCT00051558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101902754|NCT00051558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902755|NCT00051558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101902756|NCT03848234|Estradiol|estradiol|mesh-list
101902757|NCT03848234|Estrogens|estrogens|mesh-ancestor
101902758|NCT03848234|Hormones|hormones|mesh-ancestor
101902759|NCT03848234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101902760|NCT03848234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902761|NCT01295918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101902762|NCT01295918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101902763|NCT01195298|Bevacizumab|bevacizumab|mesh-list
101902764|NCT01195298|Capecitabine|capecitabine|mesh-list
101902765|NCT01195298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101622589|NCT04302116|GABA Agents|gaba agents|mesh-ancestor
101902766|NCT01195298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101902767|NCT01195298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101902768|NCT01195298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101902769|NCT01195298|Growth Substances|growth substances|mesh-ancestor
101902770|NCT01195298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902771|NCT01195298|Growth Inhibitors|growth inhibitors|mesh-ancestor
101265357|NCT01773044|Anesthetics|anesthetics|mesh-ancestor
101902772|NCT01195298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101902773|NCT01195298|Antimetabolites|antimetabolites|mesh-ancestor
101902774|NCT01195298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902775|NCT01296074|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101902776|NCT01296074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101902777|NCT01296074|Glucocorticoids|glucocorticoids|mesh-ancestor
101902778|NCT01296074|Hormones|hormones|mesh-ancestor
101902779|NCT01296074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101902780|NCT01296074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902781|NCT01296074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101902782|NCT01296074|Protective Agents|protective agents|mesh-ancestor
101902783|NCT01296074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101902784|NCT01296074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101902785|NCT01189448|Pyrimethamine|pyrimethamine|mesh-list
101902786|NCT01189448|Sulfadiazine|sulfadiazine|mesh-list
101902787|NCT01189448|Spiramycin|spiramycin|mesh-list
101902788|NCT01189448|Antimalarials|antimalarials|mesh-ancestor
101902789|NCT01189448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101902790|NCT01189448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101902791|NCT01189448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101902792|NCT01189448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101902793|NCT01189448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101902794|NCT01189448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902795|NCT01189448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101902796|NCT01189448|Coccidiostats|coccidiostats|mesh-ancestor
101902797|NCT01195376|Dactolisib|dactolisib|mesh-list
101902798|NCT01195376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101902799|NCT01189526|Ranibizumab|ranibizumab|mesh-list
101902800|NCT01189526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101902801|NCT01189526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101902802|NCT01189526|Growth Substances|growth substances|mesh-ancestor
101902803|NCT01189526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902804|NCT01189526|Growth Inhibitors|growth inhibitors|mesh-ancestor
101902805|NCT01189526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101902806|NCT01296230|Hormones|hormones|mesh-list
101902807|NCT01296230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101902808|NCT01296230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902809|NCT01580696|Molgramostim|molgramostim|mesh-list
101902810|NCT01580696|Vaccines|vaccines|mesh-list
101902811|NCT01580696|Sargramostim|sargramostim|mesh-list
101902812|NCT01580696|Immunologic Factors|immunologic factors|mesh-ancestor
101902813|NCT01580696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902814|NCT01580696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101902815|NCT01197014|Losartan|losartan|mesh-list
101902816|NCT01197014|Amlodipine|amlodipine|mesh-list
101902817|NCT01197014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101902818|NCT01197014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101902819|NCT01197014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101902820|NCT01197014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902821|NCT01197014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101902822|NCT01197014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902823|NCT01197014|Vasodilator Agents|vasodilator agents|mesh-ancestor
101902824|NCT01197014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101902825|NCT01197014|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101902826|NCT01197014|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101902827|NCT01195454|Insulin|insulin|mesh-list
101902828|NCT01195454|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101902829|NCT01195454|Insulin Glargine|insulin glargine|mesh-list
101902830|NCT01195454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101902831|NCT01195454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902832|NCT01197170|Bevacizumab|bevacizumab|mesh-list
101902833|NCT01197170|Everolimus|everolimus|mesh-list
101902834|NCT01197170|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101902835|NCT01197170|Sorafenib|sorafenib|mesh-list
101902836|NCT01197170|Anastrozole|anastrozole|mesh-list
101902837|NCT01197170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101902838|NCT01197170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101902839|NCT01197170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101902840|NCT01197170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101902841|NCT01197170|Growth Substances|growth substances|mesh-ancestor
101902842|NCT01197170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902843|NCT01197170|Growth Inhibitors|growth inhibitors|mesh-ancestor
101902844|NCT01197170|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101902845|NCT01197170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101902846|NCT01197170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101902847|NCT01197170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902848|NCT01197170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101902849|NCT01197170|Immunologic Factors|immunologic factors|mesh-ancestor
101902850|NCT01197170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101902851|NCT01197170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101902852|NCT01197170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101902853|NCT01197170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101902854|NCT01197170|Hormone Antagonists|hormone antagonists|mesh-ancestor
101902855|NCT01197170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101902857|NCT05516966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101902858|NCT05516966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902859|NCT01195766|Ofatumumab|ofatumumab|mesh-list
101902860|NCT01195766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101902861|NCT03850886|Niacinamide|niacinamide|mesh-list
101902862|NCT03850886|Niacin|niacin|mesh-list
101902863|NCT03850886|Nicotinic Acids|nicotinic acids|mesh-list
101902864|NCT03850886|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101902865|NCT03850886|Vitamins|vitamins|mesh-ancestor
101902866|NCT03850886|Micronutrients|micronutrients|mesh-ancestor
101902867|NCT03850886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902868|NCT03850886|Vitamin B Complex|vitamin b complex|mesh-ancestor
101902869|NCT03850886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101902870|NCT03850886|Antimetabolites|antimetabolites|mesh-ancestor
101902871|NCT03850886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902872|NCT03850886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101902873|NCT03850886|Vasodilator Agents|vasodilator agents|mesh-ancestor
101902874|NCT03251482|Apixaban|apixaban|mesh-list
101902875|NCT03251482|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101902876|NCT03251482|Antithrombins|antithrombins|mesh-ancestor
101902877|NCT03251482|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101902878|NCT03251482|Protease Inhibitors|protease inhibitors|mesh-ancestor
101902879|NCT03251482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101902880|NCT03251482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902881|NCT03251482|Anticoagulants|anticoagulants|mesh-ancestor
101902882|NCT03732248|Sirolimus|sirolimus|mesh-list
101902883|NCT03732248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101902884|NCT03732248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101902885|NCT03732248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101902886|NCT03732248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101902887|NCT03732248|Antifungal Agents|antifungal agents|mesh-ancestor
101902888|NCT03732248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101902889|NCT03732248|Immunologic Factors|immunologic factors|mesh-ancestor
101902890|NCT03732248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902891|NCT00310037|Bortezomib|bortezomib|mesh-list
101902892|NCT00310037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101902893|NCT01196234|Paclitaxel|paclitaxel|mesh-list
101902894|NCT01196234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101902895|NCT01196234|Carboplatin|carboplatin|mesh-list
101902896|NCT01196234|Gefitinib|gefitinib|mesh-list
101902897|NCT01196234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101902898|NCT01196234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101902899|NCT01196234|Tubulin Modulators|tubulin modulators|mesh-ancestor
101902900|NCT01196234|Antimitotic Agents|antimitotic agents|mesh-ancestor
101902901|NCT01196234|Mitosis Modulators|mitosis modulators|mesh-ancestor
101954960|NCT01322061|Ascorbic Acid|ascorbic acid|mesh-list
101902902|NCT01196234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902903|NCT01196234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101902904|NCT01196234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101902905|NCT05292404|Alirocumab|alirocumab|mesh-list
101902906|NCT05292404|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101902907|NCT05292404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101902908|NCT05292404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101902909|NCT05292404|Antimetabolites|antimetabolites|mesh-ancestor
101902910|NCT05292404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902911|NCT05292404|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101902912|NCT05292404|Protease Inhibitors|protease inhibitors|mesh-ancestor
101902913|NCT05292404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101902914|NCT05292404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101902915|NCT00309959|Paclitaxel|paclitaxel|mesh-list
101902916|NCT00309959|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101902917|NCT00309959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101902918|NCT00309959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101902919|NCT00309959|Tubulin Modulators|tubulin modulators|mesh-ancestor
101902920|NCT00309959|Antimitotic Agents|antimitotic agents|mesh-ancestor
101902921|NCT00309959|Mitosis Modulators|mitosis modulators|mesh-ancestor
101902922|NCT00309959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902924|NCT03238924|Oxytocics|oxytocics|mesh-ancestor
101902925|NCT03238924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101902926|NCT03238924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902927|NCT01190384|Grape Seed Extract|grape seed extract|mesh-list
101902928|NCT01190384|Antioxidants|antioxidants|mesh-list
101902929|NCT01190384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902930|NCT01190384|Protective Agents|protective agents|mesh-ancestor
101902931|NCT01190384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902932|NCT01190384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101902933|NCT01190384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101902934|NCT02532413|Entecavir|entecavir|mesh-list
101902935|NCT02532413|Poly I-C|poly i-c|mesh-list
101902936|NCT02532413|Antiviral Agents|antiviral agents|mesh-ancestor
101902937|NCT02532413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101902938|NCT02532413|Interferon Inducers|interferon inducers|mesh-ancestor
101902939|NCT02532413|Immunologic Factors|immunologic factors|mesh-ancestor
101902940|NCT02532413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902941|NCT01190462|Cetuximab|cetuximab|mesh-list
101902942|NCT01190462|Simvastatin|simvastatin|mesh-list
101902943|NCT01190462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101902944|NCT01190462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101902945|NCT01190462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101902946|NCT01190462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101902947|NCT01190462|Antimetabolites|antimetabolites|mesh-ancestor
101902948|NCT01190462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902949|NCT01190462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101902950|NCT01190462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101902951|NCT01190462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101902952|NCT01198106|Cinnarizine|cinnarizine|mesh-list
101902953|NCT01198106|Scopolamine|scopolamine|mesh-list
101902954|NCT01198106|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101902955|NCT01198106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101902956|NCT01198106|Antiemetics|antiemetics|mesh-ancestor
101902957|NCT01198106|Autonomic Agents|autonomic agents|mesh-ancestor
101902958|NCT01198106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101902959|NCT01198106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902960|NCT01198106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101902961|NCT01198106|Mydriatics|mydriatics|mesh-ancestor
101902962|NCT01198106|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101902963|NCT01198106|Cholinergic Agents|cholinergic agents|mesh-ancestor
101902964|NCT01198106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101902965|NCT01198106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902966|NCT01198106|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101902967|NCT01198106|Parasympatholytics|parasympatholytics|mesh-ancestor
101902968|NCT01198106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101902969|NCT01198106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101902970|NCT01198106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101902971|NCT01198106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101902972|NCT01198106|Histamine Antagonists|histamine antagonists|mesh-ancestor
101902973|NCT01198106|Histamine Agents|histamine agents|mesh-ancestor
101902974|NCT02918500|Nicotine|nicotine|mesh-list
101902975|NCT02918500|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101902976|NCT02918500|Autonomic Agents|autonomic agents|mesh-ancestor
101902977|NCT02918500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101902978|NCT02918500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902979|NCT02918500|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101902980|NCT02918500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101902981|NCT02918500|Cholinergic Agents|cholinergic agents|mesh-ancestor
101902982|NCT02918500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101902983|NCT02918500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902984|NCT03850652|Iron|iron|mesh-list
101902985|NCT03850652|Trace Elements|trace elements|mesh-ancestor
101902986|NCT03850652|Micronutrients|micronutrients|mesh-ancestor
101902987|NCT03850652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902988|NCT01198184|Sirolimus|sirolimus|mesh-list
101902989|NCT01198184|Temsirolimus|temsirolimus|mesh-list
101902990|NCT01198184|MTOR Inhibitors|mtor inhibitors|mesh-list
101902991|NCT01198184|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
101902992|NCT01198184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101622828|NCT02848950|Metformin|metformin|mesh-list
101902993|NCT01198184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101902994|NCT01198184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101902995|NCT01198184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101902996|NCT01198184|Immunologic Factors|immunologic factors|mesh-ancestor
101902997|NCT01198184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101902998|NCT01198184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101902999|NCT01198184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101903000|NCT01198184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101903001|NCT01198184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101903002|NCT01198184|Antifungal Agents|antifungal agents|mesh-ancestor
101903003|NCT01198184|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101903005|NCT00333359|Analgesics|analgesics|mesh-ancestor
101903006|NCT00333359|Sensory System Agents|sensory system agents|mesh-ancestor
101903007|NCT00333359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101903008|NCT00333359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903009|NCT00333359|Anticonvulsants|anticonvulsants|mesh-ancestor
101903010|NCT00333359|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101903011|NCT00333359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101903012|NCT00333359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101903013|NCT00333359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101903014|NCT00333359|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101903015|NCT00333359|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101903016|NCT00333359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101903017|NCT00333359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903018|NCT00333359|Antimanic Agents|antimanic agents|mesh-ancestor
101903019|NCT03246724|Midazolam|midazolam|mesh-list
101903020|NCT03246724|Triazolam|triazolam|mesh-list
101903021|NCT03246724|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101903022|NCT03246724|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101903023|NCT03246724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101903024|NCT03246724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903025|NCT03246724|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101903026|NCT03246724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101903027|NCT03246724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101903028|NCT03246724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101903029|NCT03246724|Anesthetics, General|anesthetics, general|mesh-ancestor
101903030|NCT03246724|Anesthetics|anesthetics|mesh-ancestor
101903031|NCT03246724|GABA Modulators|gaba modulators|mesh-ancestor
101903032|NCT03246724|GABA Agents|gaba agents|mesh-ancestor
101903033|NCT03246724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101903034|NCT03246724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903035|NCT01196546|Metformin|metformin|mesh-list
101903036|NCT01196546|Vildagliptin|vildagliptin|mesh-list
101903037|NCT01196546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101903038|NCT01196546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903039|NCT01196546|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101903040|NCT01196546|Protease Inhibitors|protease inhibitors|mesh-ancestor
101903041|NCT01196546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101903042|NCT01196546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903043|NCT01293266|Propofol|propofol|mesh-list
101903044|NCT01293266|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101903045|NCT01293266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101903046|NCT01293266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903047|NCT01293266|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101903048|NCT01293266|Anesthetics, General|anesthetics, general|mesh-ancestor
101903049|NCT01293266|Anesthetics|anesthetics|mesh-ancestor
101903050|NCT03948646|Bromides|bromides|mesh-list
101903051|NCT03948646|Anticonvulsants|anticonvulsants|mesh-ancestor
101903052|NCT01198340|Ropivacaine|ropivacaine|mesh-list
101903053|NCT01198340|Anesthetics, Local|anesthetics, local|mesh-list
101903054|NCT01198340|Anesthetics|anesthetics|mesh-list
101903055|NCT01198340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101903056|NCT01198340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903057|NCT01198340|Sensory System Agents|sensory system agents|mesh-ancestor
101903058|NCT01198340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101903059|NCT01347112|Varenicline|varenicline|mesh-list
101903060|NCT01347112|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101903061|NCT01347112|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101903062|NCT01347112|Cholinergic Agents|cholinergic agents|mesh-ancestor
101903063|NCT01347112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101903064|NCT01347112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903065|NCT01347112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903066|NCT00308711|Misoprostol|misoprostol|mesh-list
101903067|NCT00308711|Dinoprostone|dinoprostone|mesh-list
101622903|NCT05756764|Topiramate|topiramate|mesh-list
101903068|NCT00308711|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101903069|NCT00308711|Abortifacient Agents|abortifacient agents|mesh-ancestor
101903070|NCT00308711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101903071|NCT00308711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265667|NCT01775891|Flecainide|flecainide|mesh-list
101903072|NCT00308711|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101903073|NCT00308711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101903074|NCT00308711|Oxytocics|oxytocics|mesh-ancestor
101903075|NCT04057456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101903076|NCT04057456|Nabilone|nabilone|mesh-list
101903077|NCT04057456|Antiemetics|antiemetics|mesh-ancestor
101903078|NCT04057456|Autonomic Agents|autonomic agents|mesh-ancestor
101903079|NCT04057456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101903080|NCT04057456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903081|NCT04057456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101903082|NCT04057456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101903083|NCT04057456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101903084|NCT04057456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101903085|NCT04057456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101903086|NCT01198496|Losartan|losartan|mesh-list
101903087|NCT01198496|Amlodipine|amlodipine|mesh-list
101903088|NCT01198496|Valsartan|valsartan|mesh-list
101903089|NCT01198496|Telmisartan|telmisartan|mesh-list
101903090|NCT01198496|Candesartan|candesartan|mesh-list
101903091|NCT01198496|Candesartan cilexetil|candesartan cilexetil|mesh-list
101903092|NCT01198496|Olmesartan|olmesartan|mesh-list
101903093|NCT01198496|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101903094|NCT01198496|Spironolactone|spironolactone|mesh-list
101903095|NCT01198496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101903096|NCT01198496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101903097|NCT01198496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101903098|NCT01198496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903099|NCT01198496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101903100|NCT01198496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903101|NCT01198496|Vasodilator Agents|vasodilator agents|mesh-ancestor
101903102|NCT01198496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101903103|NCT01198496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101903104|NCT01198496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101903105|NCT01198496|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101903106|NCT01198496|Hormone Antagonists|hormone antagonists|mesh-ancestor
101903107|NCT01198496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101903108|NCT01198496|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101903109|NCT01198496|Diuretics|diuretics|mesh-ancestor
101903110|NCT01198496|Natriuretic Agents|natriuretic agents|mesh-ancestor
101903111|NCT01066013|Anti-Infective Agents|anti-infective agents|mesh-list
101903112|NCT01066013|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101903113|NCT01066091|Palmitic Acid|palmitic acid|mesh-list
101903114|NCT01066091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101903115|NCT01066091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903116|NCT03846284|Magnesium Sulfate|magnesium sulfate|mesh-list
101903117|NCT03846284|Bupivacaine|bupivacaine|mesh-list
101903118|NCT03846284|Anesthetics, Local|anesthetics, local|mesh-list
101903119|NCT03846284|Anesthetics|anesthetics|mesh-list
101903120|NCT03846284|N-Methylaspartate|n-methylaspartate|mesh-list
101903121|NCT03846284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101903122|NCT03846284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903123|NCT03846284|Sensory System Agents|sensory system agents|mesh-ancestor
101903124|NCT03846284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101903125|NCT03846284|Analgesics|analgesics|mesh-ancestor
101903126|NCT03846284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101903127|NCT03846284|Anticonvulsants|anticonvulsants|mesh-ancestor
101903128|NCT03846284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101903129|NCT03846284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101903130|NCT03846284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903131|NCT03846284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101903132|NCT03846284|Tocolytic Agents|tocolytic agents|mesh-ancestor
101903133|NCT03846284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101903134|NCT03846284|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
101903135|NCT03846284|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101903136|NCT03846284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101903137|NCT01066169|Lactitol|lactitol|mesh-list
101903138|NCT01066169|Cathartics|cathartics|mesh-ancestor
101903139|NCT01066169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101903140|NCT05572060|Metformin|metformin|mesh-list
101903141|NCT05572060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101903142|NCT05572060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903143|NCT05431244|Antiviral Agents|antiviral agents|mesh-list
101903144|NCT05431244|Gemcitabine|gemcitabine|mesh-list
101903145|NCT05431244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101903146|NCT05431244|Antimetabolites|antimetabolites|mesh-ancestor
101903147|NCT05431244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903148|NCT05431244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101903149|NCT05431244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101903150|NCT01199432|Cyclophosphamide|cyclophosphamide|mesh-list
101903152|NCT01199432|Epirubicin|epirubicin|mesh-list
101903153|NCT01199432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101903154|NCT01199432|Immunologic Factors|immunologic factors|mesh-ancestor
101903155|NCT01199432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903156|NCT01199432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101903157|NCT01199432|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101903158|NCT01199432|Alkylating Agents|alkylating agents|mesh-ancestor
101903159|NCT01199432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903160|NCT01199432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101903161|NCT01199432|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101903162|NCT01199432|Antimetabolites|antimetabolites|mesh-ancestor
101903163|NCT01199432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101903164|NCT01199432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101903165|NCT01199432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101903166|NCT01199432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101903167|NCT01199432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101903168|NCT05064020|Tenofovir|tenofovir|mesh-list
101903169|NCT05064020|Emtricitabine|emtricitabine|mesh-list
101903170|NCT05064020|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
101903171|NCT05064020|Antiviral Agents|antiviral agents|mesh-ancestor
101954999|NCT04233879|Tenofovir|tenofovir|mesh-list
101903172|NCT05064020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101903173|NCT05064020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101903174|NCT05064020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101903175|NCT05064020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101903176|NCT05064020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903178|NCT05064020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101903179|NCT05058560|Tislelizumab|tislelizumab|mesh-list
101903180|NCT05058560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101903181|NCT05058560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101903182|NCT01293422|Rifampin|rifampin|mesh-list
101903183|NCT01293422|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101903184|NCT01293422|Antitubercular Agents|antitubercular agents|mesh-ancestor
101903185|NCT01293422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101903186|NCT01293422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101903187|NCT01293422|Leprostatic Agents|leprostatic agents|mesh-ancestor
101903188|NCT01293422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101903189|NCT01293422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101903190|NCT01293422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903191|NCT01293422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101903192|NCT01293422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101903193|NCT01293422|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101903194|NCT01293422|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101903195|NCT01293422|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101903196|NCT01293422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101903197|NCT01566656|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101903198|NCT01566656|Immunologic Factors|immunologic factors|mesh-ancestor
101903199|NCT01566656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903200|NCT01566656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101903201|NCT01566734|Cefazolin|cefazolin|mesh-list
101903202|NCT01566734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101903203|NCT01566734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101903204|NCT00050778|Interferons|interferons|mesh-list
101903205|NCT00050778|Interferon-beta|interferon-beta|mesh-list
101903206|NCT00050778|Interferon beta-1a|interferon beta-1a|mesh-list
101903207|NCT00050778|Alemtuzumab|alemtuzumab|mesh-list
101903208|NCT00050778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101903209|NCT00050778|Antiviral Agents|antiviral agents|mesh-ancestor
101903210|NCT00050778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101903211|NCT00050778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101903212|NCT00050778|Immunologic Factors|immunologic factors|mesh-ancestor
101903213|NCT00050778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903214|NCT00050778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101903215|NCT01199510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101903216|NCT01199510|Lubricant Eye Drops|lubricant eye drops|mesh-list
101903217|NCT01199510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101903218|NCT04153682|Anti-Infective Agents|anti-infective agents|mesh-list
101903219|NCT04153682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101903220|NCT00050622|Methylphenidate|methylphenidate|mesh-list
101903221|NCT00050622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101903222|NCT00050622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903223|NCT00050622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101903224|NCT00050622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101903225|NCT00050622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101903226|NCT00050622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903227|NCT00050622|Dopamine Agents|dopamine agents|mesh-ancestor
101903228|NCT00050622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101903230|NCT00308087|Molgramostim|molgramostim|mesh-list
101903231|NCT00308087|Sargramostim|sargramostim|mesh-list
101903232|NCT00308087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101903233|NCT00308087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101903234|NCT00308087|Immunologic Factors|immunologic factors|mesh-ancestor
101903235|NCT00308087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903236|NCT00308087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101903237|NCT04942184|Complement Factor H|complement factor h|mesh-list
101903238|NCT04942184|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101903239|NCT04942184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101903240|NCT04942184|Immunologic Factors|immunologic factors|mesh-ancestor
101903241|NCT04942184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903242|NCT00307931|Certolizumab Pegol|certolizumab pegol|mesh-list
101903243|NCT00307931|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101903244|NCT00307931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101903245|NCT00307931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101903246|NCT00307931|Immunologic Factors|immunologic factors|mesh-ancestor
101903247|NCT00307931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903248|NCT00307931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101903249|NCT01097148|Atracurium|atracurium|mesh-list
101903250|NCT01097148|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101903251|NCT01097148|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101903252|NCT01097148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101903253|NCT01097148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101903254|NCT01097148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903255|NCT01097148|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101903256|NCT01097148|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101903257|NCT01097148|Cholinergic Agents|cholinergic agents|mesh-ancestor
101903258|NCT01097148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101903259|NCT01097148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903260|NCT01199276|Sevoflurane|sevoflurane|mesh-list
101903261|NCT01199276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101903262|NCT01199276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101903263|NCT01199276|Anesthetics, General|anesthetics, general|mesh-ancestor
101903264|NCT01199276|Anesthetics|anesthetics|mesh-ancestor
101903265|NCT01199276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101903266|NCT01199276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903267|NCT01202084|Fluticasone|fluticasone|mesh-list
101903268|NCT01202084|Xhance|xhance|mesh-list
101903269|NCT01202084|Formoterol Fumarate|formoterol fumarate|mesh-list
101903270|NCT01202084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101903271|NCT01202084|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101903272|NCT01202084|Autonomic Agents|autonomic agents|mesh-ancestor
101903273|NCT01202084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101903274|NCT01202084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903275|NCT01202084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101903276|NCT01202084|Respiratory System Agents|respiratory system agents|mesh-ancestor
101903277|NCT01202084|Dermatologic Agents|dermatologic agents|mesh-ancestor
101903278|NCT01202084|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101903279|NCT01202084|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101903280|NCT01202084|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101903281|NCT01202084|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101903282|NCT01202084|Adrenergic Agents|adrenergic agents|mesh-ancestor
101903283|NCT01202084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101903284|NCT01202084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903285|NCT04133792|Simvastatin|simvastatin|mesh-list
101903286|NCT04133792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101903287|NCT04133792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101903288|NCT04133792|Antimetabolites|antimetabolites|mesh-ancestor
101903289|NCT04133792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903290|NCT04133792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101903291|NCT04133792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101623117|NCT02601235|Naphazoline|naphazoline|mesh-list
101903292|NCT04133792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101903293|NCT01202240|Ketoconazole|ketoconazole|mesh-list
101903294|NCT01202240|Tofacitinib|tofacitinib|mesh-list
101903295|NCT01202240|Antifungal Agents|antifungal agents|mesh-ancestor
101903296|NCT01202240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101903297|NCT01202240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101903298|NCT01202240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101903299|NCT01202240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101903300|NCT01202240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903301|NCT01202240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101903302|NCT01202240|Hormone Antagonists|hormone antagonists|mesh-ancestor
101903303|NCT01202240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101903304|NCT01202240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903305|NCT01202240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101903306|NCT01202240|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101903307|NCT01202240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101903309|NCT01204112|Tofacitinib|tofacitinib|mesh-list
101903310|NCT01204112|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101903311|NCT01204112|Antitubercular Agents|antitubercular agents|mesh-ancestor
101903312|NCT01204112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101903313|NCT01204112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101903314|NCT01204112|Leprostatic Agents|leprostatic agents|mesh-ancestor
101903315|NCT01204112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101903316|NCT01204112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101903317|NCT01204112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903318|NCT01204112|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101903319|NCT01204112|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101903320|NCT01204112|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101903321|NCT01204112|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101903322|NCT01204112|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101903323|NCT01204112|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101903324|NCT01204112|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101903325|NCT01204112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101903326|NCT01204190|Gestodene|gestodene|mesh-list
101903327|NCT01204190|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101903328|NCT01204190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101903329|NCT01204190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101903330|NCT01204190|Contraceptive Agents|contraceptive agents|mesh-ancestor
101903331|NCT01204190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101903332|NCT01204190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903333|NCT01204190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101903334|NCT01204190|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101903335|NCT01204190|Progestins|progestins|mesh-ancestor
101903336|NCT01204190|Hormones|hormones|mesh-ancestor
101903337|NCT01204190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101903338|NCT01204268|Sevoflurane|sevoflurane|mesh-list
101903339|NCT01204268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101903340|NCT01204268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101903341|NCT01204268|Anesthetics, General|anesthetics, general|mesh-ancestor
101903342|NCT01204268|Anesthetics|anesthetics|mesh-ancestor
101903343|NCT01204268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101903344|NCT01204268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903345|NCT02965898|Vitamin D|vitamin d|mesh-list
101903346|NCT02965898|Ergocalciferols|ergocalciferols|mesh-list
101903347|NCT02965898|Cholecalciferol|cholecalciferol|mesh-list
101903348|NCT02965898|Vitamins|vitamins|mesh-list
101903349|NCT02965898|Micronutrients|micronutrients|mesh-ancestor
101903350|NCT02965898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903351|NCT02965898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101903352|NCT02965898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101903353|NCT01204346|Psychotropic Drugs|psychotropic drugs|mesh-list
101903354|NCT02796170|Dapagliflozin|dapagliflozin|mesh-list
101903355|NCT02796170|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101903356|NCT02796170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903357|NCT02796170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101903358|NCT02796170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903359|NCT03844178|Tetracaine|tetracaine|mesh-list
101903360|NCT03844178|Anesthetics, Local|anesthetics, local|mesh-ancestor
101903361|NCT03844178|Anesthetics|anesthetics|mesh-ancestor
101616718|NCT02617810|Warfarin|warfarin|mesh-list
101903362|NCT03844178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101903363|NCT03844178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903364|NCT03844178|Sensory System Agents|sensory system agents|mesh-ancestor
101903365|NCT03844178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101903366|NCT00049842|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101903367|NCT00049842|Antiviral Agents|antiviral agents|mesh-ancestor
101903368|NCT00049842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101903369|NCT00307151|Ritonavir|ritonavir|mesh-list
101903370|NCT00307151|Lopinavir|lopinavir|mesh-list
101903371|NCT00307151|Lamivudine|lamivudine|mesh-list
101903372|NCT00307151|Zidovudine|zidovudine|mesh-list
101903373|NCT00307151|Nevirapine|nevirapine|mesh-list
101903374|NCT00307151|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101903375|NCT00307151|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101955018|NCT03792334|Anesthetics|anesthetics|mesh-list
101903376|NCT00307151|Protease Inhibitors|protease inhibitors|mesh-ancestor
101903377|NCT00307151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101903378|NCT00307151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903379|NCT00307151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101903380|NCT00307151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101903381|NCT00307151|Antiviral Agents|antiviral agents|mesh-ancestor
101903382|NCT00307151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101903383|NCT00307151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101903384|NCT00307151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101903385|NCT00307151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101903386|NCT00307151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101903387|NCT00307151|Antimetabolites|antimetabolites|mesh-ancestor
101903388|NCT00307151|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101903389|NCT00307151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101903390|NCT03981029|Folic Acid|folic acid|mesh-list
101903391|NCT03981029|Hematinics|hematinics|mesh-ancestor
101903392|NCT03981029|Vitamin B Complex|vitamin b complex|mesh-ancestor
101903393|NCT03981029|Vitamins|vitamins|mesh-ancestor
101903394|NCT03981029|Micronutrients|micronutrients|mesh-ancestor
101903395|NCT03981029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903396|NCT02654132|Dexamethasone|dexamethasone|mesh-list
101903397|NCT02654132|Dexamethasone acetate|dexamethasone acetate|mesh-list
101903398|NCT02654132|Pomalidomide|pomalidomide|mesh-list
101903399|NCT02654132|Elotuzumab|elotuzumab|mesh-list
101903400|NCT02654132|BB 1101|bb 1101|mesh-list
101903401|NCT02654132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101903402|NCT02654132|Antiemetics|antiemetics|mesh-ancestor
101903403|NCT02654132|Autonomic Agents|autonomic agents|mesh-ancestor
101903404|NCT02654132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101903405|NCT02654132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903406|NCT02654132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101903407|NCT02654132|Glucocorticoids|glucocorticoids|mesh-ancestor
101903408|NCT02654132|Hormones|hormones|mesh-ancestor
101903409|NCT02654132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101903410|NCT02654132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101903411|NCT02654132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101903412|NCT02654132|Protease Inhibitors|protease inhibitors|mesh-ancestor
101903413|NCT02654132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101903414|NCT02654132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903415|NCT02654132|Immunologic Factors|immunologic factors|mesh-ancestor
101903416|NCT02654132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101903417|NCT02654132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101903418|NCT02654132|Growth Substances|growth substances|mesh-ancestor
101903419|NCT02654132|Growth Inhibitors|growth inhibitors|mesh-ancestor
101903420|NCT01064141|Vaccines|vaccines|mesh-list
101903421|NCT01064141|Immunologic Factors|immunologic factors|mesh-ancestor
101903422|NCT01064141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903423|NCT03837470|Furosemide|furosemide|mesh-list
101903424|NCT03837470|Diuretics|diuretics|mesh-ancestor
101903425|NCT03837470|Natriuretic Agents|natriuretic agents|mesh-ancestor
101903426|NCT03837470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903427|NCT03837470|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101903428|NCT03837470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101903429|NCT03837470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903430|NCT01199900|Prednisone|prednisone|mesh-list
101903431|NCT01199900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101903432|NCT01199900|Glucocorticoids|glucocorticoids|mesh-ancestor
101903433|NCT01199900|Hormones|hormones|mesh-ancestor
101903434|NCT01199900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101903435|NCT01199900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903436|NCT01199900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101903437|NCT01199900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101903438|NCT01200056|Atorvastatin|atorvastatin|mesh-list
101903439|NCT01200056|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101903440|NCT01200056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101903441|NCT01200056|Antimetabolites|antimetabolites|mesh-ancestor
101903442|NCT01200056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903443|NCT01200056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101903444|NCT01200056|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101903445|NCT01200056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101903447|NCT01200212|Taxane|taxane|mesh-list
101903448|NCT01200212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101903450|NCT01200212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101903451|NCT01200212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101903452|NCT01200212|Growth Substances|growth substances|mesh-ancestor
101903453|NCT01200212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903454|NCT01200212|Growth Inhibitors|growth inhibitors|mesh-ancestor
101903455|NCT03978845|Lidocaine|lidocaine|mesh-list
101903456|NCT03978845|Anesthetics, Local|anesthetics, local|mesh-list
101903457|NCT03978845|Anesthetics|anesthetics|mesh-list
101903458|NCT03978845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101903459|NCT03978845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903460|NCT03978845|Sensory System Agents|sensory system agents|mesh-ancestor
101903461|NCT03978845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101903462|NCT03978845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101903463|NCT03978845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101903464|NCT03978845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101903465|NCT03978845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101903466|NCT03978845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903467|NCT02387996|Nivolumab|nivolumab|mesh-list
101903468|NCT02387996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101903469|NCT02387996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101903470|NCT02387996|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101903471|NCT02387996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903472|NCT01204580|Metformin|metformin|mesh-list
101903473|NCT01204580|Glimepiride|glimepiride|mesh-list
101903474|NCT01204580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101903475|NCT01204580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903476|NCT01204580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101903477|NCT01204580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101903478|NCT01204580|Immunologic Factors|immunologic factors|mesh-ancestor
101903479|NCT03850366|Cyclophosphamide|cyclophosphamide|mesh-list
101903480|NCT03850366|Bortezomib|bortezomib|mesh-list
101903481|NCT03850366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101903482|NCT03850366|Immunologic Factors|immunologic factors|mesh-ancestor
101903483|NCT03850366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903484|NCT03850366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101903485|NCT03850366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101903486|NCT03850366|Alkylating Agents|alkylating agents|mesh-ancestor
101903487|NCT03850366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903488|NCT03850366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101903489|NCT03850366|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101903490|NCT05181592|Luspatercept|luspatercept|mesh-list
101903491|NCT05181592|Hematinics|hematinics|mesh-ancestor
101903492|NCT05181514|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101903493|NCT05181514|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101903494|NCT05181514|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101903495|NCT05181514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101903496|NCT03229486|Glycopyrrolate|glycopyrrolate|mesh-list
101903497|NCT03229486|Neostigmine|neostigmine|mesh-list
101903498|NCT03229486|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101903499|NCT03229486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101903500|NCT03229486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903501|NCT03229486|Cholinergic Agents|cholinergic agents|mesh-ancestor
101903502|NCT03229486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101903503|NCT03229486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903504|NCT03229486|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101903505|NCT03229486|Autonomic Agents|autonomic agents|mesh-ancestor
101903506|NCT03229486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101903507|NCT03229486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101903508|NCT03229486|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101903509|NCT03229486|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101903510|NCT05153668|Everolimus|everolimus|mesh-list
101903511|NCT05153668|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101903512|NCT05153668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101903513|NCT05153668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101903514|NCT05153668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903515|NCT05153668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101903516|NCT05153668|Immunologic Factors|immunologic factors|mesh-ancestor
101903517|NCT05153668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903518|NCT05153668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101903520|NCT03833570|Antioxidants|antioxidants|mesh-ancestor
101903521|NCT03833570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903522|NCT03833570|Protective Agents|protective agents|mesh-ancestor
101903523|NCT03833570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903524|NCT03833570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101903525|NCT01779050|Paclitaxel|paclitaxel|mesh-list
101903526|NCT01779050|Docetaxel|docetaxel|mesh-list
101903527|NCT01779050|Cyclophosphamide|cyclophosphamide|mesh-list
101903528|NCT01779050|Carboplatin|carboplatin|mesh-list
101903529|NCT01779050|Doxorubicin|doxorubicin|mesh-list
101903530|NCT01779050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101903531|NCT01779050|Fluorouracil|fluorouracil|mesh-list
101903532|NCT01779050|Trastuzumab|trastuzumab|mesh-list
101903533|NCT01779050|Epirubicin|epirubicin|mesh-list
101903534|NCT01779050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101903535|NCT01779050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101903536|NCT01779050|Tubulin Modulators|tubulin modulators|mesh-ancestor
101903537|NCT01779050|Antimitotic Agents|antimitotic agents|mesh-ancestor
101903538|NCT01779050|Mitosis Modulators|mitosis modulators|mesh-ancestor
101903539|NCT01779050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903540|NCT01779050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101903541|NCT01779050|Immunologic Factors|immunologic factors|mesh-ancestor
101903542|NCT01779050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903543|NCT01779050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101903544|NCT01779050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101903545|NCT01779050|Alkylating Agents|alkylating agents|mesh-ancestor
101903546|NCT01779050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101903547|NCT01779050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101903548|NCT01779050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101903549|NCT01779050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101903550|NCT01779050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101903551|NCT01779050|Antimetabolites|antimetabolites|mesh-ancestor
101903552|NCT01779050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101903553|NCT01779050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101903554|NCT03841136|Etoposide|etoposide|mesh-list
101903555|NCT03841136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101903556|NCT03841136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101903557|NCT03841136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101227448|NCT01540110|Docetaxel|docetaxel|mesh-list
101903558|NCT03841136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101903559|NCT03841136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101903560|NCT03841136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903561|NCT05669768|Tamoxifen|tamoxifen|mesh-list
101903562|NCT05669768|Pamiparib|pamiparib|mesh-list
101903563|NCT05669768|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101903564|NCT05669768|Hormone Antagonists|hormone antagonists|mesh-ancestor
101903565|NCT05669768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101903566|NCT05669768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903567|NCT05669768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101903568|NCT05669768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101903569|NCT05669768|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101903570|NCT05669768|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101903571|NCT05669768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101903572|NCT05669768|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101903573|NCT05669768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101903574|NCT05669768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903575|NCT00306527|Vaccines|vaccines|mesh-list
101903576|NCT00306527|Immunologic Factors|immunologic factors|mesh-ancestor
101903577|NCT00306527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903578|NCT01066247|Midazolam|midazolam|mesh-list
101903579|NCT01066247|Morphine|morphine|mesh-list
101903580|NCT01066247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101903581|NCT01066247|Narcotics|narcotics|mesh-ancestor
101903582|NCT01066247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101903583|NCT01066247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903584|NCT01066247|Analgesics|analgesics|mesh-ancestor
101521201|NCT04640324|Vitamin E|vitamin e|mesh-list
101903585|NCT01066247|Sensory System Agents|sensory system agents|mesh-ancestor
101903586|NCT01066247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101903587|NCT01066247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101903588|NCT01066247|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101903589|NCT01066247|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101623421|NCT05340153|Artemether|artemether|mesh-list
101903590|NCT01066247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101903591|NCT01066247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101903592|NCT01066247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101903593|NCT01066247|Anesthetics, General|anesthetics, general|mesh-ancestor
101903594|NCT01066247|Anesthetics|anesthetics|mesh-ancestor
101903595|NCT01066247|GABA Modulators|gaba modulators|mesh-ancestor
101903596|NCT01066247|GABA Agents|gaba agents|mesh-ancestor
101903597|NCT01066247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101903598|NCT01066247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903599|NCT00306293|Valacyclovir|valacyclovir|mesh-list
101903600|NCT00306293|Antiviral Agents|antiviral agents|mesh-ancestor
101903601|NCT00306293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101903602|NCT03980951|Analgesics, Opioid|analgesics, opioid|mesh-list
101903603|NCT03980951|Narcotics|narcotics|mesh-ancestor
101903604|NCT03980951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101903605|NCT03980951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903606|NCT03980951|Analgesics|analgesics|mesh-ancestor
101903607|NCT03980951|Sensory System Agents|sensory system agents|mesh-ancestor
101903608|NCT03980951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101903609|NCT02532491|Risperidone|risperidone|mesh-list
101903610|NCT02532491|Aripiprazole|aripiprazole|mesh-list
101903611|NCT02532491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101903612|NCT02532491|Serotonin Agents|serotonin agents|mesh-ancestor
101903613|NCT02532491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101903614|NCT02532491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903615|NCT02532491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903616|NCT02532491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101903617|NCT02532491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101903618|NCT02532491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101903619|NCT02532491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101903620|NCT02532491|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101903621|NCT02532491|Dopamine Agents|dopamine agents|mesh-ancestor
101903622|NCT02532491|Antidepressive Agents|antidepressive agents|mesh-ancestor
101903623|NCT02532491|Dopamine Agonists|dopamine agonists|mesh-ancestor
101903624|NCT02532491|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101903625|NCT02532491|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101903626|NCT02532491|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101903627|NCT02532491|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101903628|NCT01066403|Pergolide|pergolide|mesh-list
101903629|NCT01066403|Dopamine Agonists|dopamine agonists|mesh-ancestor
101903630|NCT01066403|Dopamine Agents|dopamine agents|mesh-ancestor
101903631|NCT01066403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101903632|NCT01066403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903633|NCT01066403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903634|NCT01064219|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101903635|NCT01064219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101903636|NCT01064219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903637|NCT00294671|Diflunisal|diflunisal|mesh-list
101903638|NCT00294671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101903639|NCT00294671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101903640|NCT00294671|Analgesics|analgesics|mesh-ancestor
101903641|NCT00294671|Sensory System Agents|sensory system agents|mesh-ancestor
101903642|NCT00294671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101903643|NCT00294671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903644|NCT00294671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101903645|NCT00294671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101903646|NCT00294671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101903647|NCT00294671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101903648|NCT00294671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903649|NCT01064453|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
101903650|NCT01064453|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101903651|NCT01064453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903652|NCT03980249|Carvedilol|carvedilol|mesh-list
101903653|NCT03980249|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101903655|NCT03980249|Adrenergic Agents|adrenergic agents|mesh-ancestor
101903656|NCT03980249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101903657|NCT03980249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903658|NCT03980249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903659|NCT03980249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101903660|NCT03980249|Antioxidants|antioxidants|mesh-ancestor
101903661|NCT03980249|Protective Agents|protective agents|mesh-ancestor
101903662|NCT03980249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101903663|NCT03980249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101903664|NCT03980249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101903665|NCT03980249|Vasodilator Agents|vasodilator agents|mesh-ancestor
101903666|NCT03980249|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101903667|NCT03980249|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101903668|NCT01495598|Pomalidomide|pomalidomide|mesh-list
101903669|NCT01495598|Immunologic Factors|immunologic factors|mesh-ancestor
101903670|NCT01495598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903671|NCT01495598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101903672|NCT01495598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101903673|NCT01495598|Growth Substances|growth substances|mesh-ancestor
101903674|NCT01495598|Growth Inhibitors|growth inhibitors|mesh-ancestor
101903675|NCT01495598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101903676|NCT01297166|Calcitriol|calcitriol|mesh-list
101903677|NCT01297166|Calcipotriene|calcipotriene|mesh-list
101903678|NCT01297166|Dermatologic Agents|dermatologic agents|mesh-ancestor
101903679|NCT01297166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101903680|NCT01297166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903681|NCT01297166|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101903682|NCT01297166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101903683|NCT01297166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903684|NCT01297166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101903685|NCT01297166|Vitamins|vitamins|mesh-ancestor
101903686|NCT01297166|Micronutrients|micronutrients|mesh-ancestor
101903687|NCT01297166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101903688|NCT01202474|Insulin|insulin|mesh-list
101903689|NCT01202474|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101903690|NCT01202474|Insulin Glargine|insulin glargine|mesh-list
101903691|NCT01202474|Insulin glulisine|insulin glulisine|mesh-list
101903692|NCT01202474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101903693|NCT01202474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903694|NCT05667818|Norfloxacin|norfloxacin|mesh-list
101903695|NCT05667818|Amlodipine|amlodipine|mesh-list
101903696|NCT05667818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101903697|NCT05667818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101903698|NCT05667818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101903699|NCT05667818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903700|NCT05667818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101903701|NCT05667818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903702|NCT05667818|Vasodilator Agents|vasodilator agents|mesh-ancestor
101903703|NCT05667818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101903704|NCT05667818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101903705|NCT05667818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101903706|NCT05667818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101903707|NCT05667818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101903708|NCT05667818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101903709|NCT05667818|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101903710|NCT05667818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101903711|NCT01205204|Clonidine|clonidine|mesh-list
101903712|NCT01205204|Fentanyl|fentanyl|mesh-list
101903713|NCT01205204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101903714|NCT01205204|Narcotics|narcotics|mesh-ancestor
101903715|NCT01205204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101903716|NCT01205204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903717|NCT01205204|Analgesics|analgesics|mesh-ancestor
101903718|NCT01205204|Sensory System Agents|sensory system agents|mesh-ancestor
101903719|NCT01205204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101903720|NCT01205204|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101903721|NCT01205204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101903722|NCT01205204|Anesthetics, General|anesthetics, general|mesh-ancestor
101903723|NCT01205204|Anesthetics|anesthetics|mesh-ancestor
101903724|NCT01205204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101903725|NCT01205204|Sympatholytics|sympatholytics|mesh-ancestor
101903726|NCT01205204|Autonomic Agents|autonomic agents|mesh-ancestor
101903727|NCT01205204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101903728|NCT01205204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101903729|NCT01205204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101903730|NCT01205204|Adrenergic Agents|adrenergic agents|mesh-ancestor
101903731|NCT01205204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101903732|NCT01205204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903733|NCT01205282|Pioglitazone|pioglitazone|mesh-list
101903734|NCT01205282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101903735|NCT01205282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903736|NCT03902912|Prednisolone|prednisolone|mesh-list
101903737|NCT03902912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101903738|NCT03902912|Glucocorticoids|glucocorticoids|mesh-ancestor
101623568|NCT00779532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101903740|NCT03902912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101903741|NCT03902912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903742|NCT03902912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101903743|NCT03902912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101903744|NCT01205360|Fentanyl|fentanyl|mesh-list
101903745|NCT01205360|Bupivacaine|bupivacaine|mesh-list
101903746|NCT01205360|Anesthetics, Local|anesthetics, local|mesh-ancestor
101903747|NCT01205360|Anesthetics|anesthetics|mesh-ancestor
101903748|NCT01205360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101903749|NCT01205360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903750|NCT01205360|Sensory System Agents|sensory system agents|mesh-ancestor
101903751|NCT01205360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101903752|NCT01205360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101903753|NCT01205360|Narcotics|narcotics|mesh-ancestor
101903754|NCT01205360|Analgesics|analgesics|mesh-ancestor
101903755|NCT01205360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101903756|NCT01205360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101903757|NCT01205360|Anesthetics, General|anesthetics, general|mesh-ancestor
101903758|NCT01200914|Heparin|heparin|mesh-list
101903759|NCT01200914|Anticoagulants|anticoagulants|mesh-ancestor
101903760|NCT01200914|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101227468|NCT01540240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101903761|NCT01200914|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101903762|NCT01200914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903763|NCT01205516|Morphine|morphine|mesh-list
101903764|NCT01205516|Methadone|methadone|mesh-list
101903765|NCT01205516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101903766|NCT01205516|Narcotics|narcotics|mesh-ancestor
101903767|NCT01205516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101903768|NCT01205516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903769|NCT01205516|Analgesics|analgesics|mesh-ancestor
101903770|NCT01205516|Sensory System Agents|sensory system agents|mesh-ancestor
101903771|NCT01205516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101903772|NCT01205516|Antitussive Agents|antitussive agents|mesh-ancestor
101903773|NCT01205516|Respiratory System Agents|respiratory system agents|mesh-ancestor
101903774|NCT01297634|Botulinum Toxins|botulinum toxins|mesh-list
101903775|NCT01297634|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101903776|NCT01297634|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101903777|NCT01297634|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101903778|NCT01297634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101903779|NCT01297634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903780|NCT01297634|Cholinergic Agents|cholinergic agents|mesh-ancestor
101903781|NCT01297634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101903782|NCT01297634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903783|NCT01297634|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101903784|NCT01297634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101903785|NCT01201070|Antithrombins|antithrombins|mesh-list
101903786|NCT01201070|Antithrombin III|antithrombin iii|mesh-list
101903787|NCT01201070|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101903788|NCT01201070|Protease Inhibitors|protease inhibitors|mesh-ancestor
101903789|NCT01201070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101903790|NCT01201070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903791|NCT01201070|Anticoagulants|anticoagulants|mesh-ancestor
101903793|NCT01205672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101903794|NCT01205672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903795|NCT03817970|Ondansetron|ondansetron|mesh-list
101903796|NCT03817970|Palonosetron|palonosetron|mesh-list
101903797|NCT03817970|Granisetron|granisetron|mesh-list
101903798|NCT03817970|Antiemetics|antiemetics|mesh-ancestor
101903799|NCT03817970|Autonomic Agents|autonomic agents|mesh-ancestor
101903800|NCT03817970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101903801|NCT03817970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903802|NCT03817970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101903803|NCT03817970|Antipruritics|antipruritics|mesh-ancestor
101903805|NCT03817970|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101903806|NCT03817970|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101903807|NCT03817970|Serotonin Agents|serotonin agents|mesh-ancestor
101903808|NCT03817970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101903809|NCT03817970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903810|NCT01205750|Insulin|insulin|mesh-list
101903811|NCT01205750|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101903812|NCT01205750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101903813|NCT01205750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903814|NCT03012386|Sildenafil Citrate|sildenafil citrate|mesh-list
101903815|NCT03012386|Citric Acid|citric acid|mesh-list
101903816|NCT03012386|Sodium Citrate|sodium citrate|mesh-list
101903817|NCT03012386|Anticoagulants|anticoagulants|mesh-ancestor
101903818|NCT03012386|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101903819|NCT03012386|Chelating Agents|chelating agents|mesh-ancestor
101903820|NCT03012386|Sequestering Agents|sequestering agents|mesh-ancestor
101903821|NCT03012386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903822|NCT03012386|Vasodilator Agents|vasodilator agents|mesh-ancestor
101903823|NCT03012386|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101903824|NCT03012386|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101903825|NCT03012386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101903826|NCT03012386|Urological Agents|urological agents|mesh-ancestor
101903827|NCT01202552|Vaccines|vaccines|mesh-list
101903828|NCT01202552|Immunologic Factors|immunologic factors|mesh-ancestor
101903829|NCT01202552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227469|NCT01540240|Antiviral Agents|antiviral agents|mesh-ancestor
101903830|NCT01205984|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101903831|NCT01205984|Methylprednisolone|methylprednisolone|mesh-list
101903832|NCT01205984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101903833|NCT01205984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101903834|NCT01205984|Prednisolone|prednisolone|mesh-list
101903835|NCT01205984|Prednisolone acetate|prednisolone acetate|mesh-list
101903836|NCT01205984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101903837|NCT01205984|Prednisolone phosphate|prednisolone phosphate|mesh-list
101574898|NCT04219579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574899|NCT04219579|Anticoagulants|anticoagulants|mesh-ancestor
101574900|NCT00635401|Varenicline|varenicline|mesh-list
101574901|NCT00635401|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101574902|NCT00635401|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101574903|NCT00635401|Cholinergic Agents|cholinergic agents|mesh-ancestor
101574904|NCT00635401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101574905|NCT00635401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574906|NCT00635401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574907|NCT02753725|Fentanyl|fentanyl|mesh-list
101574908|NCT02753725|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101574909|NCT02753725|Narcotics|narcotics|mesh-ancestor
101574910|NCT02753725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101574911|NCT02753725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574912|NCT02753725|Analgesics|analgesics|mesh-ancestor
101574913|NCT02753725|Sensory System Agents|sensory system agents|mesh-ancestor
101574914|NCT02753725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101574915|NCT02753725|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101574916|NCT02753725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101574917|NCT02753725|Anesthetics, General|anesthetics, general|mesh-ancestor
101574918|NCT02753725|Anesthetics|anesthetics|mesh-ancestor
101574919|NCT01020123|Glipizide|glipizide|mesh-list
101574920|NCT01020123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101574921|NCT01020123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574922|NCT04300959|Cisplatin|cisplatin|mesh-list
101574923|NCT04300959|Gemcitabine|gemcitabine|mesh-list
101574924|NCT04300959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101574925|NCT04300959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101574926|NCT04300959|Antimetabolites|antimetabolites|mesh-ancestor
101623718|NCT00311844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903839|NCT01205984|Antiemetics|antiemetics|mesh-ancestor
101903840|NCT01205984|Autonomic Agents|autonomic agents|mesh-ancestor
101903841|NCT01205984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101903842|NCT01205984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903843|NCT01205984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101903844|NCT01205984|Glucocorticoids|glucocorticoids|mesh-ancestor
101903845|NCT01205984|Hormones|hormones|mesh-ancestor
101903846|NCT01205984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101903847|NCT01205984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101903848|NCT01205984|Protective Agents|protective agents|mesh-ancestor
101903849|NCT01205984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101903850|NCT01205984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101903851|NCT01205984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101903852|NCT01205984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101903853|NCT01205984|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101903854|NCT01205984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101903855|NCT01205984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903856|NCT01297946|Hormones|hormones|mesh-list
101903857|NCT01297946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903858|NCT01297946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101903859|NCT03211858|Insulin|insulin|mesh-list
101903860|NCT03211858|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101903861|NCT03211858|Insulin Glargine|insulin glargine|mesh-list
101903862|NCT03211858|Insulin Aspart|insulin aspart|mesh-list
101903863|NCT03211858|Insulin, Long-Acting|insulin, long-acting|mesh-list
101903864|NCT03211858|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101903865|NCT03211858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101903866|NCT03211858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903867|NCT01298180|Hormones|hormones|mesh-list
101903868|NCT01298180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101903869|NCT01298180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903870|NCT03211156|Amoxicillin|amoxicillin|mesh-list
101903871|NCT03211156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101903872|NCT03211156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101903873|NCT01298336|Moxifloxacin|moxifloxacin|mesh-list
101903874|NCT01298336|Clarithromycin|clarithromycin|mesh-list
101903875|NCT01298336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101903876|NCT01298336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101903877|NCT01298336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101903878|NCT01298336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101903879|NCT01298336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101903880|NCT01298336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903881|NCT01298336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101903882|NCT01298336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101903883|NCT01298336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101903884|NCT01298336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101903885|NCT04472494|Abatacept|abatacept|mesh-list
101903886|NCT04472494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101903887|NCT04472494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903888|NCT04472494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101903889|NCT04472494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101903890|NCT04472494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101903891|NCT04472494|Immunologic Factors|immunologic factors|mesh-ancestor
101903892|NCT04472494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903893|NCT04472494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101903894|NCT04568200|Paclitaxel|paclitaxel|mesh-list
101903895|NCT04568200|Carboplatin|carboplatin|mesh-list
101903896|NCT04568200|Durvalumab|durvalumab|mesh-list
101903897|NCT04568200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101903898|NCT04568200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101903899|NCT04568200|Tubulin Modulators|tubulin modulators|mesh-ancestor
101903900|NCT04568200|Antimitotic Agents|antimitotic agents|mesh-ancestor
101903901|NCT04568200|Mitosis Modulators|mitosis modulators|mesh-ancestor
101903902|NCT04568200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903903|NCT04568200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101903904|NCT03236506|Sofosbuvir|sofosbuvir|mesh-list
101903905|NCT03236506|Grazoprevir|grazoprevir|mesh-list
101955052|NCT03767439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101903906|NCT03236506|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
101903907|NCT03236506|Antiviral Agents|antiviral agents|mesh-ancestor
101903908|NCT03236506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101903909|NCT01298882|Diacerein|diacerein|mesh-list
101903910|NCT01298882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101903911|NCT01206530|Leucovorin|leucovorin|mesh-list
101903912|NCT01206530|Hydroxychloroquine|hydroxychloroquine|mesh-list
101903913|NCT01206530|Bevacizumab|bevacizumab|mesh-list
101903914|NCT01206530|Fluorouracil|fluorouracil|mesh-list
101903915|NCT01206530|Oxaliplatin|oxaliplatin|mesh-list
101903916|NCT01206530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101903917|NCT01206530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101903918|NCT01206530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101903919|NCT01206530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101903920|NCT01206530|Growth Substances|growth substances|mesh-ancestor
101903921|NCT01206530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903922|NCT01206530|Growth Inhibitors|growth inhibitors|mesh-ancestor
101903923|NCT01206530|Antimetabolites|antimetabolites|mesh-ancestor
101903924|NCT01206530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903925|NCT01206530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101903926|NCT01206530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101903927|NCT01206530|Immunologic Factors|immunologic factors|mesh-ancestor
101903928|NCT01206530|Antidotes|antidotes|mesh-ancestor
101903929|NCT01206530|Protective Agents|protective agents|mesh-ancestor
101903930|NCT01206530|Vitamin B Complex|vitamin b complex|mesh-ancestor
101903931|NCT01206530|Vitamins|vitamins|mesh-ancestor
101903932|NCT01206530|Micronutrients|micronutrients|mesh-ancestor
101903933|NCT01206530|Antimalarials|antimalarials|mesh-ancestor
101903934|NCT01206530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101903935|NCT01206530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101903936|NCT01206530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101903937|NCT01206530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101903938|NCT01206530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101903939|NCT03209518|Leuprolide|leuprolide|mesh-list
101903940|NCT03209518|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101903941|NCT03209518|Fertility Agents|fertility agents|mesh-ancestor
101903942|NCT03209518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101903943|NCT03209518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903944|NCT03209518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101903945|NCT03209518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101903946|NCT05282420|Ranibizumab|ranibizumab|mesh-list
101903947|NCT05282420|Aflibercept|aflibercept|mesh-list
101903948|NCT05282420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101903949|NCT05282420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101903950|NCT05282420|Growth Substances|growth substances|mesh-ancestor
101903951|NCT05282420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903952|NCT05282420|Growth Inhibitors|growth inhibitors|mesh-ancestor
101903953|NCT05282420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101903954|NCT00304031|Temozolomide|temozolomide|mesh-list
101903955|NCT00304031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101903956|NCT00304031|Alkylating Agents|alkylating agents|mesh-ancestor
101903957|NCT00304031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903958|NCT00304031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101903959|NCT01567124|Moxonidine|moxonidine|mesh-list
101903960|NCT01567124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101903961|NCT03617666|Avelumab|avelumab|mesh-list
101903962|NCT03617666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101903963|NCT03617666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101903964|NCT01299194|Atorvastatin|atorvastatin|mesh-list
101903965|NCT01299194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101903966|NCT01299194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101903967|NCT01299194|Antimetabolites|antimetabolites|mesh-ancestor
101903968|NCT01299194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903969|NCT01299194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101903970|NCT01299194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101903971|NCT01299194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101903972|NCT03827408|Midazolam|midazolam|mesh-list
101903973|NCT03827408|Dexmedetomidine|dexmedetomidine|mesh-list
101903974|NCT03827408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101903975|NCT03827408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101903976|NCT03827408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101903977|NCT03827408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101903978|NCT03827408|Analgesics|analgesics|mesh-ancestor
101903979|NCT03827408|Sensory System Agents|sensory system agents|mesh-ancestor
101903980|NCT03827408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101903981|NCT03827408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101903982|NCT03827408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101903983|NCT03827408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101903984|NCT03827408|Adrenergic Agents|adrenergic agents|mesh-ancestor
101903985|NCT03827408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101903986|NCT03827408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101903987|NCT03827408|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101903988|NCT03827408|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101903989|NCT03827408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101903990|NCT03827408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101903991|NCT03827408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101903992|NCT03827408|Anesthetics, General|anesthetics, general|mesh-ancestor
101903993|NCT03827408|Anesthetics|anesthetics|mesh-ancestor
101903994|NCT03827408|GABA Modulators|gaba modulators|mesh-ancestor
101903995|NCT03827408|GABA Agents|gaba agents|mesh-ancestor
101903997|NCT03556904|Hormones|hormones|mesh-list
101903998|NCT03556904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101903999|NCT03556904|Tubulin Modulators|tubulin modulators|mesh-ancestor
101904000|NCT03556904|Antimitotic Agents|antimitotic agents|mesh-ancestor
101904001|NCT03556904|Mitosis Modulators|mitosis modulators|mesh-ancestor
101904002|NCT03556904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904003|NCT03556904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101904004|NCT03556904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904005|NCT00332189|Verapamil|verapamil|mesh-list
101904006|NCT00332189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101904007|NCT00332189|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101904008|NCT00332189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101904009|NCT00332189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904010|NCT00332189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101904011|NCT00332189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904012|NCT00332189|Vasodilator Agents|vasodilator agents|mesh-ancestor
101904013|NCT01206998|Progesterone|progesterone|mesh-list
101904014|NCT01206998|Progestins|progestins|mesh-ancestor
101904015|NCT01206998|Hormones|hormones|mesh-ancestor
101904016|NCT01206998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101904017|NCT01206998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904018|NCT00331799|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101904019|NCT00331799|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101904020|NCT00331799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101904021|NCT00331799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101904022|NCT00331799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904023|NCT00331799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101904024|NCT00331799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904025|NCT00331799|Analgesics|analgesics|mesh-ancestor
101904026|NCT00331799|Sensory System Agents|sensory system agents|mesh-ancestor
101904027|NCT00331799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101904028|NCT00331799|Antidepressive Agents|antidepressive agents|mesh-ancestor
101904029|NCT00331799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101904030|NCT00331799|Dopamine Agents|dopamine agents|mesh-ancestor
101904031|NCT03826940|Lovastatin|lovastatin|mesh-list
101904032|NCT03826940|L 647318|l 647318|mesh-list
101904033|NCT03826940|Dihydromevinolin|dihydromevinolin|mesh-list
101904034|NCT03826940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101904035|NCT03826940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101904036|NCT03826940|Antimetabolites|antimetabolites|mesh-ancestor
101904037|NCT03826940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904038|NCT03826940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101904039|NCT03826940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101904040|NCT03826940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101904041|NCT01201694|Curcumin|curcumin|mesh-list
101904042|NCT01201694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101904043|NCT01201694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101904044|NCT01201694|Analgesics|analgesics|mesh-ancestor
101904045|NCT01201694|Sensory System Agents|sensory system agents|mesh-ancestor
101904046|NCT01201694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101955059|NCT04539405|Anesthetics|anesthetics|mesh-ancestor
101904047|NCT01201694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904048|NCT01201694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101904049|NCT01201694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101904050|NCT01201694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101904051|NCT01201694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101904052|NCT01201694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904053|NCT01201928|Insulin|insulin|mesh-list
101904054|NCT01201928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101904055|NCT01201928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904056|NCT00303719|Cyclosporine|cyclosporine|mesh-list
101904057|NCT00303719|Mycophenolic Acid|mycophenolic acid|mesh-list
101904058|NCT00303719|Cyclophosphamide|cyclophosphamide|mesh-list
101904059|NCT00303719|Fludarabine|fludarabine|mesh-list
101904060|NCT00303719|Cyclosporins|cyclosporins|mesh-list
101904061|NCT00303719|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101904062|NCT00303719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101904063|NCT00303719|Immunologic Factors|immunologic factors|mesh-ancestor
101904064|NCT00303719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904065|NCT00303719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101904066|NCT00303719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101904067|NCT00303719|Alkylating Agents|alkylating agents|mesh-ancestor
101904068|NCT00303719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904069|NCT00303719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101904070|NCT00303719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101904071|NCT00303719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101904072|NCT00303719|Antifungal Agents|antifungal agents|mesh-ancestor
101904073|NCT00303719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101904074|NCT00303719|Dermatologic Agents|dermatologic agents|mesh-ancestor
101904075|NCT00303719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101904076|NCT00303719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101904077|NCT00303719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101904078|NCT00303719|Antitubercular Agents|antitubercular agents|mesh-ancestor
101904079|NCT00303719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101904080|NCT01207310|Nicotine|nicotine|mesh-list
101904081|NCT01207310|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101904082|NCT01207310|Autonomic Agents|autonomic agents|mesh-ancestor
101904083|NCT01207310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101904084|NCT01207310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904085|NCT01207310|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101904086|NCT01207310|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101904087|NCT01207310|Cholinergic Agents|cholinergic agents|mesh-ancestor
101904088|NCT01207310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101904089|NCT01207310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904090|NCT00331409|Everolimus|everolimus|mesh-list
101904091|NCT00331409|Imatinib Mesylate|imatinib mesylate|mesh-list
101904092|NCT00331409|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101904093|NCT00331409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101904094|NCT00331409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101904095|NCT00331409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904096|NCT00331409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101904097|NCT00331409|Immunologic Factors|immunologic factors|mesh-ancestor
101904098|NCT00331409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904099|NCT00331409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101904100|NCT01203254|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
101904101|NCT01203254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101904102|NCT01203254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101904103|NCT01203254|Antimetabolites|antimetabolites|mesh-ancestor
101904104|NCT01203254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904105|NCT01203254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101904106|NCT01064921|Vorinostat|vorinostat|mesh-list
101904107|NCT01064921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101904108|NCT01064921|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101904109|NCT01064921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101904110|NCT01064921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904111|NCT01299662|Poly ICLC|poly iclc|mesh-list
101904112|NCT01299662|Interferon Inducers|interferon inducers|mesh-ancestor
101904113|NCT01299662|Immunologic Factors|immunologic factors|mesh-ancestor
101904114|NCT01299662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904115|NCT00303485|Vitamin D|vitamin d|mesh-list
101904116|NCT00303485|Ibandronic Acid|ibandronic acid|mesh-list
101904118|NCT00303485|Vitamins|vitamins|mesh-ancestor
101904119|NCT00303485|Micronutrients|micronutrients|mesh-ancestor
101904120|NCT00303485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904121|NCT00303485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101904122|NCT00303485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101904123|NCT03983915|Dexmedetomidine|dexmedetomidine|mesh-list
101904124|NCT03983915|Remifentanil|remifentanil|mesh-list
101904125|NCT03983915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101904126|NCT03983915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101904127|NCT03983915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904128|NCT03983915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101904129|NCT03983915|Analgesics|analgesics|mesh-ancestor
101904130|NCT03983915|Sensory System Agents|sensory system agents|mesh-ancestor
101904131|NCT03983915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101904132|NCT03983915|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101904133|NCT03983915|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101904134|NCT03983915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101904135|NCT03983915|Adrenergic Agents|adrenergic agents|mesh-ancestor
101904136|NCT03983915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101904137|NCT03983915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904138|NCT03983915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101904139|NCT03983915|Narcotics|narcotics|mesh-ancestor
101623990|NCT02771925|Anticonvulsants|anticonvulsants|mesh-ancestor
101904140|NCT01300754|Lidocaine|lidocaine|mesh-list
101904141|NCT01300754|Anesthetics, Local|anesthetics, local|mesh-ancestor
101904142|NCT01300754|Anesthetics|anesthetics|mesh-ancestor
101904143|NCT01300754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101904144|NCT01300754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904145|NCT01300754|Sensory System Agents|sensory system agents|mesh-ancestor
101904146|NCT01300754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101904147|NCT01300754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101904148|NCT01300754|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101904149|NCT01300754|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101904150|NCT01300754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101904151|NCT01300754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904152|NCT00303953|Belinostat|belinostat|mesh-list
101904153|NCT00303953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101904154|NCT00303953|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101904155|NCT00303953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101904156|NCT00303953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904157|NCT03840122|Anesthetics|anesthetics|mesh-list
101904158|NCT03840122|Anesthetics, Local|anesthetics, local|mesh-list
101904159|NCT03840122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101904160|NCT03840122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904161|NCT03840122|Sensory System Agents|sensory system agents|mesh-ancestor
101904162|NCT03840122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101904163|NCT03723590|Hyaluronic Acid|hyaluronic acid|mesh-list
101904164|NCT03723590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101904165|NCT03723590|Immunologic Factors|immunologic factors|mesh-ancestor
101904166|NCT03723590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904167|NCT03723590|Viscosupplements|viscosupplements|mesh-ancestor
101904168|NCT03723590|Protective Agents|protective agents|mesh-ancestor
101904169|NCT04343872|Metformin|metformin|mesh-list
101904170|NCT04343872|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101904171|NCT04343872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904172|NCT01314274|Bevacizumab|bevacizumab|mesh-list
101904173|NCT01314274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101955070|NCT02064010|Acamprosate|acamprosate|mesh-list
101904174|NCT01314274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101904175|NCT01314274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101904176|NCT01314274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101904177|NCT01314274|Growth Substances|growth substances|mesh-ancestor
101904178|NCT01314274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904179|NCT01314274|Growth Inhibitors|growth inhibitors|mesh-ancestor
101904180|NCT02935894|Ibuprofen|ibuprofen|mesh-list
101904181|NCT02935894|Pilocarpine|pilocarpine|mesh-list
101904182|NCT02935894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101904183|NCT02935894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101904184|NCT02935894|Analgesics|analgesics|mesh-ancestor
101904185|NCT02935894|Sensory System Agents|sensory system agents|mesh-ancestor
101904186|NCT02935894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101904187|NCT02935894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904188|NCT02935894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101904189|NCT02935894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101904190|NCT02935894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101904191|NCT02935894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101904192|NCT02935894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904193|NCT02935894|Miotics|miotics|mesh-ancestor
101904194|NCT02935894|Autonomic Agents|autonomic agents|mesh-ancestor
101904195|NCT02935894|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101904196|NCT02935894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101904197|NCT02935894|Cholinergic Agents|cholinergic agents|mesh-ancestor
101904198|NCT02935894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101904199|NCT03224182|Apaziquone|apaziquone|mesh-list
101904200|NCT03224182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101904201|NCT03821480|Fluconazole|fluconazole|mesh-list
101904202|NCT03821480|Antifungal Agents|antifungal agents|mesh-ancestor
101904203|NCT03821480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101904204|NCT03821480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101904205|NCT03821480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101904206|NCT03821480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101904207|NCT03821480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904208|NCT03821480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101904209|NCT03821480|Hormone Antagonists|hormone antagonists|mesh-ancestor
101904210|NCT03821480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101904211|NCT03821480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904212|NCT03821480|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101904213|NCT03821480|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101904215|NCT01203488|Vitamins|vitamins|mesh-ancestor
101904216|NCT01203488|Micronutrients|micronutrients|mesh-ancestor
101904217|NCT01203488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904218|NCT03697720|Naproxen|naproxen|mesh-list
101904219|NCT03697720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101904220|NCT03697720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101904221|NCT03697720|Analgesics|analgesics|mesh-ancestor
101904222|NCT03697720|Sensory System Agents|sensory system agents|mesh-ancestor
101904223|NCT03697720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101904224|NCT03697720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904225|NCT03697720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101904226|NCT03697720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101904227|NCT03697720|Gout Suppressants|gout suppressants|mesh-ancestor
101904228|NCT03697720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101904229|NCT03697720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101904230|NCT03697720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904231|NCT01314352|Desloratadine|desloratadine|mesh-list
101904232|NCT01314352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101904233|NCT01314352|Cholinergic Agents|cholinergic agents|mesh-ancestor
101904234|NCT01314352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101904235|NCT01314352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904236|NCT01314352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904237|NCT01314352|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101904238|NCT01314352|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101904239|NCT01314352|Histamine Antagonists|histamine antagonists|mesh-ancestor
101904240|NCT01314352|Histamine Agents|histamine agents|mesh-ancestor
101904241|NCT03818282|Paclitaxel|paclitaxel|mesh-list
101904242|NCT03818282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101904243|NCT03818282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101904244|NCT03818282|Tubulin Modulators|tubulin modulators|mesh-ancestor
101904245|NCT03818282|Antimitotic Agents|antimitotic agents|mesh-ancestor
101904246|NCT03818282|Mitosis Modulators|mitosis modulators|mesh-ancestor
101904247|NCT03818282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904248|NCT01300364|Citalopram|citalopram|mesh-list
101904249|NCT01300364|Reboxetine|reboxetine|mesh-list
101904250|NCT01300364|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101904251|NCT01300364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101904252|NCT01300364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101904253|NCT01300364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904254|NCT01300364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101904255|NCT01300364|Serotonin Agents|serotonin agents|mesh-ancestor
101904256|NCT01300364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904257|NCT01300364|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101904258|NCT01300364|Antidepressive Agents|antidepressive agents|mesh-ancestor
101904259|NCT01300364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101904260|NCT01300364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101904261|NCT01300364|Adrenergic Agents|adrenergic agents|mesh-ancestor
101904262|NCT03221842|Complement C1s|complement c1s|mesh-list
101904263|NCT03221842|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
101904264|NCT03221842|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
101904265|NCT03221842|Immunologic Factors|immunologic factors|mesh-ancestor
101904266|NCT03221842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904267|NCT03221842|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101904268|NCT03221842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101904269|NCT05622890|Maytansine|maytansine|mesh-list
101904270|NCT05622890|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
101904271|NCT05622890|Immunoconjugates|immunoconjugates|mesh-ancestor
101904272|NCT05622890|Immunologic Factors|immunologic factors|mesh-ancestor
101904273|NCT05622890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904274|NCT05622890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101904275|NCT05622890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101904276|NCT05622890|Tubulin Modulators|tubulin modulators|mesh-ancestor
101904277|NCT05622890|Antimitotic Agents|antimitotic agents|mesh-ancestor
101904278|NCT05622890|Mitosis Modulators|mitosis modulators|mesh-ancestor
101904279|NCT05622890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904280|NCT00303329|Deferasirox|deferasirox|mesh-list
101904281|NCT00303329|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101904282|NCT00303329|Chelating Agents|chelating agents|mesh-ancestor
101904283|NCT00303329|Sequestering Agents|sequestering agents|mesh-ancestor
101904284|NCT00303329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904285|NCT01300988|Aprepitant|aprepitant|mesh-list
101904286|NCT01300988|Fosaprepitant|fosaprepitant|mesh-list
101904287|NCT01300988|Antiemetics|antiemetics|mesh-ancestor
101904288|NCT01300988|Autonomic Agents|autonomic agents|mesh-ancestor
101904289|NCT01300988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101904290|NCT01300988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904291|NCT01300988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101904292|NCT01300988|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101904293|NCT01300988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101904294|NCT01300988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904295|NCT01064999|Capecitabine|capecitabine|mesh-list
101904296|NCT01064999|Oxaliplatin|oxaliplatin|mesh-list
101904297|NCT01064999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101904298|NCT01064999|Antimetabolites|antimetabolites|mesh-ancestor
101904299|NCT01064999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904300|NCT01064999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101904301|NCT03818048|Propofol|propofol|mesh-list
101904302|NCT03818048|Sevoflurane|sevoflurane|mesh-list
101904303|NCT03818048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101904304|NCT03818048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101904305|NCT03818048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904306|NCT03818048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101904307|NCT03818048|Anesthetics, General|anesthetics, general|mesh-ancestor
101904308|NCT03818048|Anesthetics|anesthetics|mesh-ancestor
101904309|NCT03818048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101904310|NCT03818048|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101904311|NCT01301924|Meglumine Antimoniate|meglumine antimoniate|mesh-list
101955093|NCT03766893|Narcotics|narcotics|mesh-ancestor
101904312|NCT01301924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101904313|NCT01301924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101904314|NCT01301924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101904316|NCT00329849|Immunologic Factors|immunologic factors|mesh-ancestor
101904317|NCT00329849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904318|NCT05655806|Aminophylline|aminophylline|mesh-list
101904319|NCT05655806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101904320|NCT05655806|Autonomic Agents|autonomic agents|mesh-ancestor
101904321|NCT05655806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101904322|NCT05655806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904323|NCT05655806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101904324|NCT05655806|Respiratory System Agents|respiratory system agents|mesh-ancestor
101904325|NCT05655806|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101904326|NCT05655806|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101904327|NCT05655806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101904328|NCT05655806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904329|NCT05655806|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101904330|NCT05655806|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101904331|NCT05655806|Purinergic Agents|purinergic agents|mesh-ancestor
101904332|NCT05655806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101904333|NCT05655806|Protective Agents|protective agents|mesh-ancestor
101904334|NCT01300676|Estradiol|estradiol|mesh-list
101904335|NCT01300676|Dydrogesterone|dydrogesterone|mesh-list
101904336|NCT01300676|Estrogens|estrogens|mesh-ancestor
101904337|NCT01300676|Hormones|hormones|mesh-ancestor
101904338|NCT01300676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101904339|NCT01300676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904340|NCT01300676|Progestins|progestins|mesh-ancestor
101904341|NCT00329303|Certolizumab Pegol|certolizumab pegol|mesh-list
101904342|NCT00329303|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101904343|NCT00329303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101904344|NCT00329303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101904345|NCT00329303|Immunologic Factors|immunologic factors|mesh-ancestor
101904346|NCT00329303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904347|NCT00329303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101904348|NCT03806816|Melatonin|melatonin|mesh-list
101904349|NCT03806816|Antioxidants|antioxidants|mesh-ancestor
101904350|NCT03806816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904351|NCT03806816|Protective Agents|protective agents|mesh-ancestor
101904352|NCT03806816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904353|NCT03806816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101904354|NCT01301222|Octreotide|octreotide|mesh-list
101904355|NCT01301222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101904356|NCT01301222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101904357|NCT01301222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101904358|NCT02532569|Vaccines|vaccines|mesh-list
101904359|NCT02532569|Immunologic Factors|immunologic factors|mesh-ancestor
101904360|NCT02532569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904361|NCT01302002|Metformin|metformin|mesh-list
101904362|NCT01302002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101904363|NCT01302002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904364|NCT01303250|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
101904365|NCT01303250|Plasma Substitutes|plasma substitutes|mesh-ancestor
101904366|NCT01303250|Blood Substitutes|blood substitutes|mesh-ancestor
101904368|NCT03814616|Pyronaridine|pyronaridine|mesh-list
101904369|NCT03814616|Antimalarials|antimalarials|mesh-ancestor
101904370|NCT03814616|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101904371|NCT03814616|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101904372|NCT03814616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101904373|NCT03814616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101904374|NCT03814616|Antiviral Agents|antiviral agents|mesh-ancestor
101904375|NCT03814616|Schistosomicides|schistosomicides|mesh-ancestor
101904376|NCT03814616|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101904377|NCT03814616|Anthelmintics|anthelmintics|mesh-ancestor
101904378|NCT00302159|Temozolomide|temozolomide|mesh-list
101904379|NCT00302159|Valproic Acid|valproic acid|mesh-list
101904380|NCT00302159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101904381|NCT00302159|Alkylating Agents|alkylating agents|mesh-ancestor
101904382|NCT00302159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904383|NCT00302159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101904384|NCT00302159|Anticonvulsants|anticonvulsants|mesh-ancestor
101904385|NCT00302159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101904386|NCT00302159|GABA Agents|gaba agents|mesh-ancestor
101904387|NCT00302159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101904388|NCT00302159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904389|NCT00302159|Antimanic Agents|antimanic agents|mesh-ancestor
101904390|NCT00302159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101904391|NCT00302159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101904392|NCT00302159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101904393|NCT03814226|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
101904394|NCT03814226|Growth Substances|growth substances|mesh-ancestor
101904395|NCT03814226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904396|NCT03814226|Vasodilator Agents|vasodilator agents|mesh-ancestor
101904397|NCT03814226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101904398|NCT03814226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904399|NCT00302081|Ribavirin|ribavirin|mesh-list
101904400|NCT00302081|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101904401|NCT00302081|Interferon-alpha|interferon-alpha|mesh-list
101904402|NCT00302081|Antimetabolites|antimetabolites|mesh-ancestor
101904403|NCT00302081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904404|NCT00302081|Antiviral Agents|antiviral agents|mesh-ancestor
101904405|NCT00302081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101904406|NCT00302081|Immunologic Factors|immunologic factors|mesh-ancestor
101904407|NCT00302081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904408|NCT00302003|Cytarabine|cytarabine|mesh-list
101904409|NCT00302003|Dexamethasone|dexamethasone|mesh-list
101904410|NCT00302003|Prednisone|prednisone|mesh-list
101904411|NCT00302003|Cyclophosphamide|cyclophosphamide|mesh-list
101904412|NCT00302003|Ifosfamide|ifosfamide|mesh-list
101227536|NCT01540747|Folic Acid|folic acid|mesh-list
101904413|NCT00302003|Doxorubicin|doxorubicin|mesh-list
101904414|NCT00302003|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101904415|NCT00302003|Etoposide|etoposide|mesh-list
101904416|NCT00302003|Vincristine|vincristine|mesh-list
101904417|NCT00302003|Vinorelbine|vinorelbine|mesh-list
101904418|NCT00302003|Etoposide phosphate|etoposide phosphate|mesh-list
101904419|NCT00302003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101904420|NCT00302003|Immunologic Factors|immunologic factors|mesh-ancestor
101904421|NCT00302003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904422|NCT00302003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101904423|NCT00302003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101904424|NCT00302003|Alkylating Agents|alkylating agents|mesh-ancestor
101904425|NCT00302003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904426|NCT00302003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101904427|NCT00302003|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101904428|NCT00302003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101904429|NCT00302003|Antiemetics|antiemetics|mesh-ancestor
101904430|NCT00302003|Autonomic Agents|autonomic agents|mesh-ancestor
101904431|NCT00302003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101904432|NCT00302003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101904433|NCT00302003|Glucocorticoids|glucocorticoids|mesh-ancestor
101904434|NCT00302003|Hormones|hormones|mesh-ancestor
101904435|NCT00302003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101904436|NCT00302003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101904437|NCT00302003|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101904438|NCT00302003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101904439|NCT00302003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101904440|NCT00302003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101904441|NCT00302003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101904442|NCT00302003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101904443|NCT00302003|Antimetabolites|antimetabolites|mesh-ancestor
101904444|NCT00302003|Antiviral Agents|antiviral agents|mesh-ancestor
101904445|NCT00302003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101904446|NCT00302003|Tubulin Modulators|tubulin modulators|mesh-ancestor
101904447|NCT00302003|Antimitotic Agents|antimitotic agents|mesh-ancestor
101904448|NCT00302003|Mitosis Modulators|mitosis modulators|mesh-ancestor
101904450|NCT00036270|Exemestane|exemestane|mesh-list
101904451|NCT00036270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101904452|NCT00036270|Hormone Antagonists|hormone antagonists|mesh-ancestor
101904453|NCT00036270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101904454|NCT00036270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904455|NCT00036270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101904456|NCT00036270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101955099|NCT03766893|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101904457|NCT00036270|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101904458|NCT00036270|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101904459|NCT00036270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101904460|NCT00036270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101904461|NCT00036270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101904462|NCT00036270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101904463|NCT00036270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904464|NCT01097382|Zolpidem|zolpidem|mesh-list
101904465|NCT01097382|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101904466|NCT01097382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101904467|NCT01097382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101904468|NCT01097382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904469|NCT01097382|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101904470|NCT01097382|GABA Agonists|gaba agonists|mesh-ancestor
101904471|NCT01097382|GABA Agents|gaba agents|mesh-ancestor
101904472|NCT01097382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101904473|NCT01097382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904474|NCT00301067|Calcitriol|calcitriol|mesh-list
101904475|NCT00301067|Temozolomide|temozolomide|mesh-list
101904476|NCT00301067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101904477|NCT00301067|Alkylating Agents|alkylating agents|mesh-ancestor
101904478|NCT00301067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904479|NCT00301067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101904480|NCT00301067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101904481|NCT00301067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904482|NCT00301067|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101904483|NCT00301067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101904484|NCT00301067|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101904485|NCT00301067|Vitamins|vitamins|mesh-ancestor
101904486|NCT00301067|Micronutrients|micronutrients|mesh-ancestor
101904487|NCT00301067|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101904488|NCT03979859|Nafithromycin|nafithromycin|mesh-list
101904489|NCT03979859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101904490|NCT03979859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101904491|NCT03979859|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101904492|NCT03979859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101904493|NCT03979859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904494|NCT03955458|Bupivacaine|bupivacaine|mesh-list
101904495|NCT03955458|Ropivacaine|ropivacaine|mesh-list
101904496|NCT03955458|Anesthetics, Local|anesthetics, local|mesh-ancestor
101904497|NCT03955458|Anesthetics|anesthetics|mesh-ancestor
101904498|NCT03955458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101904499|NCT03955458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904500|NCT03955458|Sensory System Agents|sensory system agents|mesh-ancestor
101904501|NCT03955458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101904502|NCT00007020|Cholic Acids|cholic acids|mesh-list
101904503|NCT00007020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101904504|NCT00300755|Pantoprazole|pantoprazole|mesh-list
101904505|NCT00300755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101904506|NCT00300755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101904507|NCT00300755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101904508|NCT00300755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101904509|NCT00300755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904510|NCT00033540|Gemcitabine|gemcitabine|mesh-list
101904511|NCT00033540|Capecitabine|capecitabine|mesh-list
101904512|NCT00033540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101624365|NCT04224441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101904514|NCT00033540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904515|NCT00033540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101904516|NCT00300365|Aspirin|aspirin|mesh-list
101904518|NCT00300365|Pioglitazone|pioglitazone|mesh-list
101904519|NCT00300365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101904520|NCT00300365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101904521|NCT00300365|Analgesics|analgesics|mesh-ancestor
101904522|NCT00300365|Sensory System Agents|sensory system agents|mesh-ancestor
101904523|NCT00300365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101904524|NCT00300365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904525|NCT00300365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101904526|NCT00300365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101904527|NCT00300365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101904528|NCT00300365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101904529|NCT00300365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904531|NCT00300365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101904532|NCT00300365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101904533|NCT00300365|Antipyretics|antipyretics|mesh-ancestor
101904534|NCT00300365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101904535|NCT00300365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101904536|NCT00300365|Antimetabolites|antimetabolites|mesh-ancestor
101904537|NCT00300365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101904538|NCT00300365|Vasodilator Agents|vasodilator agents|mesh-ancestor
101904539|NCT00300365|Vitamin B Complex|vitamin b complex|mesh-ancestor
101904540|NCT00300365|Vitamins|vitamins|mesh-ancestor
101904541|NCT00300365|Micronutrients|micronutrients|mesh-ancestor
101904542|NCT03980015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101904543|NCT03980015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101904544|NCT00048048|Epoetin Alfa|epoetin alfa|mesh-list
101904545|NCT00048048|Hematinics|hematinics|mesh-ancestor
101904546|NCT03953118|Azithromycin|azithromycin|mesh-list
101904547|NCT03953118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101904548|NCT03953118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101904549|NCT01101204|Metformin|metformin|mesh-list
101904550|NCT01101204|Simvastatin|simvastatin|mesh-list
101904551|NCT01101204|Fenofibrate|fenofibrate|mesh-list
101904552|NCT01101204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101904553|NCT01101204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904554|NCT01101204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101904555|NCT01101204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101904556|NCT01101204|Antimetabolites|antimetabolites|mesh-ancestor
101904557|NCT01101204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904558|NCT01101204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101904559|NCT01101204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101904560|NCT01101204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101904561|NCT01095822|Valsartan|valsartan|mesh-list
101904562|NCT01095822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101904563|NCT01095822|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101904564|NCT01095822|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101904565|NCT01095822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904566|NCT01095900|Botulinum Toxins|botulinum toxins|mesh-list
101904567|NCT01095900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101904568|NCT01095900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101904569|NCT01095900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904570|NCT01095900|Cholinergic Agents|cholinergic agents|mesh-ancestor
101904571|NCT01095900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101904572|NCT01095900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904573|NCT00300053|Lenograstim|lenograstim|mesh-list
101904574|NCT00300053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101904575|NCT00300053|Immunologic Factors|immunologic factors|mesh-ancestor
101904576|NCT00300053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904577|NCT01098084|Decitabine|decitabine|mesh-list
101904578|NCT01098084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101904579|NCT01098084|Antimetabolites|antimetabolites|mesh-ancestor
101904580|NCT01098084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904581|NCT01098084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101904582|NCT01098084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101904583|NCT03952572|Prednisone|prednisone|mesh-list
101904584|NCT03952572|Cyclophosphamide|cyclophosphamide|mesh-list
101904585|NCT03952572|Doxorubicin|doxorubicin|mesh-list
101624440|NCT04091815|Anesthetics|anesthetics|mesh-list
101904587|NCT03952572|Vincristine|vincristine|mesh-list
101904588|NCT03952572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101904589|NCT03952572|Immunologic Factors|immunologic factors|mesh-ancestor
101904590|NCT03952572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904591|NCT03952572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101904592|NCT03952572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101904593|NCT03952572|Alkylating Agents|alkylating agents|mesh-ancestor
101904594|NCT03952572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904595|NCT03952572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101904596|NCT03952572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101904597|NCT03952572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101904598|NCT03952572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101904599|NCT03952572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101904600|NCT03952572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101904601|NCT03952572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101904602|NCT03952572|Glucocorticoids|glucocorticoids|mesh-ancestor
101904603|NCT03952572|Hormones|hormones|mesh-ancestor
101904604|NCT03952572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101904605|NCT03952572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101904606|NCT03952572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101904607|NCT03952572|Tubulin Modulators|tubulin modulators|mesh-ancestor
101904608|NCT03952572|Antimitotic Agents|antimitotic agents|mesh-ancestor
101904609|NCT03952572|Mitosis Modulators|mitosis modulators|mesh-ancestor
101904610|NCT03954756|Apatinib|apatinib|mesh-list
101904611|NCT03954756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101904612|NCT03954756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101904613|NCT03954756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101904614|NCT03954756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904615|NCT00326963|Enfuvirtide|enfuvirtide|mesh-list
101904616|NCT00326963|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101904617|NCT00326963|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101904618|NCT00326963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904619|NCT00326963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101904620|NCT00326963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101904621|NCT00326963|Antiviral Agents|antiviral agents|mesh-ancestor
101904622|NCT00326963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101904623|NCT00326885|Catumaxomab|catumaxomab|mesh-list
101904624|NCT00326885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101904625|NCT00326495|Cetuximab|cetuximab|mesh-list
101904626|NCT00326495|Sorafenib|sorafenib|mesh-list
101904627|NCT00326495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101904628|NCT00326495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101904629|NCT00326495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101904630|NCT00326495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101904631|NCT00326495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904632|NCT00326417|Cyclophosphamide|cyclophosphamide|mesh-list
101904633|NCT00326417|Fludarabine|fludarabine|mesh-list
101904634|NCT00326417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101904635|NCT00326417|Immunologic Factors|immunologic factors|mesh-ancestor
101904636|NCT00326417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904637|NCT00326417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101904638|NCT00326417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101904639|NCT00326417|Alkylating Agents|alkylating agents|mesh-ancestor
101904640|NCT00326417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904641|NCT00326417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101904642|NCT00326417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101904643|NCT01060787|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
101904644|NCT01060787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101904645|NCT01060787|Glucocorticoids|glucocorticoids|mesh-ancestor
101904646|NCT01060787|Hormones|hormones|mesh-ancestor
101904647|NCT01060787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101904648|NCT01060787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904649|NCT01065467|Panobinostat|panobinostat|mesh-list
101904650|NCT01065467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101904651|NCT01065467|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101904652|NCT01065467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101904653|NCT01065467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904654|NCT01065545|Clofarabine|clofarabine|mesh-list
101904655|NCT01065545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101904656|NCT01065545|Antimetabolites|antimetabolites|mesh-ancestor
101904657|NCT01065545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904658|NCT01065545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101904659|NCT03979469|Fentanyl|fentanyl|mesh-list
101904660|NCT03979469|Dexmedetomidine|dexmedetomidine|mesh-list
101904661|NCT03979469|Ketamine|ketamine|mesh-list
101904662|NCT03979469|Remifentanil|remifentanil|mesh-list
101904664|NCT03979469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101904665|NCT03979469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904666|NCT03979469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101904667|NCT03979469|Analgesics|analgesics|mesh-ancestor
101904668|NCT03979469|Sensory System Agents|sensory system agents|mesh-ancestor
101904669|NCT03979469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101904670|NCT03979469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101904671|NCT03979469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101904672|NCT03979469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101904673|NCT03979469|Adrenergic Agents|adrenergic agents|mesh-ancestor
101904674|NCT03979469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101904675|NCT03979469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904676|NCT03979469|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101227576|NCT01540812|Antimetabolites|antimetabolites|mesh-ancestor
101904677|NCT03979469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101904679|NCT03979469|Anesthetics|anesthetics|mesh-ancestor
101904680|NCT03979469|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101904681|NCT03979469|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101904682|NCT03979469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101904683|NCT03979469|Narcotics|narcotics|mesh-ancestor
101904684|NCT03979469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101904685|NCT01065701|Dexmedetomidine|dexmedetomidine|mesh-list
101904686|NCT01065701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101904687|NCT01065701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101904688|NCT01065701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904689|NCT01065701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101904690|NCT01065701|Analgesics|analgesics|mesh-ancestor
101904691|NCT01065701|Sensory System Agents|sensory system agents|mesh-ancestor
101904692|NCT01065701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101904693|NCT01065701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101904694|NCT01065701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101904695|NCT01065701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101904696|NCT01065701|Adrenergic Agents|adrenergic agents|mesh-ancestor
101904697|NCT01065701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101904698|NCT01065701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904699|NCT03825341|Hydroxyurea|hydroxyurea|mesh-list
101904700|NCT03825341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101904701|NCT03825341|Antisickling Agents|antisickling agents|mesh-ancestor
101904702|NCT03825341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101904703|NCT03825341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904704|NCT03825341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101904705|NCT01065857|Picosulfate sodium|picosulfate sodium|mesh-list
101904706|NCT01065857|Sodium sulfate|sodium sulfate|mesh-list
101904707|NCT01065857|Magnesium Oxide|magnesium oxide|mesh-list
101904708|NCT01065857|Citric Acid|citric acid|mesh-list
101904709|NCT01065857|Sodium Citrate|sodium citrate|mesh-list
101904710|NCT01065857|Cathartics|cathartics|mesh-ancestor
101904711|NCT01065857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101904712|NCT01065857|Anticoagulants|anticoagulants|mesh-ancestor
101904713|NCT01065857|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101904714|NCT01065857|Chelating Agents|chelating agents|mesh-ancestor
101904715|NCT01065857|Sequestering Agents|sequestering agents|mesh-ancestor
101904716|NCT01065857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904717|NCT01065857|Antacids|antacids|mesh-ancestor
101904718|NCT00297479|Nicotine|nicotine|mesh-list
101904719|NCT00297479|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101904720|NCT00297479|Autonomic Agents|autonomic agents|mesh-ancestor
101904721|NCT00297479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101904722|NCT00297479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904723|NCT00297479|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101904724|NCT00297479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101904725|NCT00297479|Cholinergic Agents|cholinergic agents|mesh-ancestor
101904726|NCT00297479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101904727|NCT00297479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904728|NCT00688870|Vaccines|vaccines|mesh-list
101904729|NCT00688870|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101904730|NCT00688870|Immunologic Factors|immunologic factors|mesh-ancestor
101904731|NCT00688870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904732|NCT02532335|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
101904733|NCT02532335|Cathartics|cathartics|mesh-ancestor
101904734|NCT02532335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101904736|NCT03216226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101904737|NCT03216226|Hormones|hormones|mesh-ancestor
101904738|NCT03216226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101904739|NCT03216226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904740|NCT00290771|Imatinib Mesylate|imatinib mesylate|mesh-list
101904741|NCT00290771|Hydroxyurea|hydroxyurea|mesh-list
101904742|NCT00290771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101904743|NCT00290771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101904744|NCT00290771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101955115|NCT01370590|Atorvastatin|atorvastatin|mesh-list
101904745|NCT00290771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904746|NCT00290771|Antisickling Agents|antisickling agents|mesh-ancestor
101904747|NCT00290771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101904748|NCT00290693|Docetaxel|docetaxel|mesh-list
101904749|NCT00290693|Capecitabine|capecitabine|mesh-list
101904750|NCT00290693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101904751|NCT00290693|Tubulin Modulators|tubulin modulators|mesh-ancestor
101904752|NCT00290693|Antimitotic Agents|antimitotic agents|mesh-ancestor
101904753|NCT00290693|Mitosis Modulators|mitosis modulators|mesh-ancestor
101904754|NCT00290693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904755|NCT00290693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101904756|NCT00290693|Antimetabolites|antimetabolites|mesh-ancestor
101904757|NCT00274469|Fulvestrant|fulvestrant|mesh-list
101904758|NCT00274469|Anastrozole|anastrozole|mesh-list
101904759|NCT00274469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101904760|NCT00274469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101904761|NCT00274469|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101904762|NCT00274469|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101904763|NCT00274469|Hormone Antagonists|hormone antagonists|mesh-ancestor
101904764|NCT00274469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101904765|NCT00274469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904766|NCT00274469|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101904767|NCT00274469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101904768|NCT00274469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101904769|NCT00274469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904770|NCT01556776|Lenalidomide|lenalidomide|mesh-list
101904771|NCT01556776|Immunologic Factors|immunologic factors|mesh-ancestor
101904772|NCT01556776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904773|NCT01556776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101904774|NCT01556776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101904775|NCT01556776|Growth Substances|growth substances|mesh-ancestor
101904776|NCT01556776|Growth Inhibitors|growth inhibitors|mesh-ancestor
101904777|NCT01556776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101904778|NCT05180422|Sotorasib|sotorasib|mesh-list
101904779|NCT05180422|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101904780|NCT05180422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904781|NCT05180422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101904782|NCT05180422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101904783|NCT02422498|Cisplatin|cisplatin|mesh-list
101904784|NCT02422498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101904785|NCT01314976|Metronidazole|metronidazole|mesh-list
101904786|NCT01314976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101904787|NCT01314976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101904788|NCT01314976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101904789|NCT01314976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101904790|NCT02379520|Cyclophosphamide|cyclophosphamide|mesh-list
101904791|NCT02379520|Nivolumab|nivolumab|mesh-list
101904792|NCT02379520|Fludarabine|fludarabine|mesh-list
101904793|NCT02379520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101904794|NCT02379520|Immunologic Factors|immunologic factors|mesh-ancestor
101904795|NCT02379520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904796|NCT02379520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101904797|NCT02379520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101904798|NCT02379520|Alkylating Agents|alkylating agents|mesh-ancestor
101904799|NCT02379520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904800|NCT02379520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101904801|NCT02379520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101904802|NCT02379520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101904803|NCT02379520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101904804|NCT01973452|Dexmedetomidine|dexmedetomidine|mesh-list
101904805|NCT01973452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101904806|NCT01973452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101904807|NCT01973452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904808|NCT01973452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101904809|NCT01973452|Analgesics|analgesics|mesh-ancestor
101904810|NCT01973452|Sensory System Agents|sensory system agents|mesh-ancestor
101904811|NCT01973452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101904812|NCT01973452|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101904813|NCT01973452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101904814|NCT01973452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101904815|NCT01973452|Adrenergic Agents|adrenergic agents|mesh-ancestor
101904816|NCT01973452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101904817|NCT01973452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904818|NCT04504942|Leronlimab|leronlimab|mesh-list
101904819|NCT04504942|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101904820|NCT04504942|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101904821|NCT04504942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904822|NCT04504942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101904823|NCT04504942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101904824|NCT04504942|Antiviral Agents|antiviral agents|mesh-ancestor
101904825|NCT04504942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101904826|NCT01882816|Doxorubicin|doxorubicin|mesh-list
101904827|NCT01882816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101904828|NCT01882816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101904829|NCT01882816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101904830|NCT01882816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101904831|NCT01882816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101904832|NCT01882816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904833|NCT00272987|Paclitaxel|paclitaxel|mesh-list
101904834|NCT00272987|Trastuzumab|trastuzumab|mesh-list
101904835|NCT00272987|Lapatinib|lapatinib|mesh-list
101904836|NCT00272987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101904837|NCT00272987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101904838|NCT00272987|Tubulin Modulators|tubulin modulators|mesh-ancestor
101904839|NCT00272987|Antimitotic Agents|antimitotic agents|mesh-ancestor
101904840|NCT00272987|Mitosis Modulators|mitosis modulators|mesh-ancestor
101904841|NCT00272987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904842|NCT00272987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101904843|NCT00272987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101904844|NCT00272987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101904845|NCT01069757|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101904846|NCT01069757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101904847|NCT01069757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101904848|NCT01069757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101904849|NCT01069757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904850|NCT01070927|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
101904851|NCT01070927|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101904852|NCT01070927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101904853|NCT01070927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904854|NCT03976271|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101904855|NCT03976271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904856|NCT01069913|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101904857|NCT01069913|Dermatologic Agents|dermatologic agents|mesh-ancestor
101904858|NCT01069913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101904859|NCT01069913|Immunologic Factors|immunologic factors|mesh-ancestor
101904860|NCT01069913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904861|NCT01730950|Bevacizumab|bevacizumab|mesh-list
101904862|NCT01730950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101904863|NCT01730950|Antibodies|antibodies|mesh-list
101904864|NCT01730950|Immunoglobulins|immunoglobulins|mesh-list
101904865|NCT01730950|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101904866|NCT01730950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101904867|NCT01730950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101904868|NCT01730950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101904869|NCT01730950|Growth Substances|growth substances|mesh-ancestor
101904870|NCT01730950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904871|NCT01730950|Growth Inhibitors|growth inhibitors|mesh-ancestor
101904872|NCT01730950|Immunologic Factors|immunologic factors|mesh-ancestor
101904873|NCT00271505|Bevacizumab|bevacizumab|mesh-list
101904874|NCT00271505|Carboplatin|carboplatin|mesh-list
101904875|NCT00271505|Docetaxel|docetaxel|mesh-list
101904876|NCT00271505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101904877|NCT00271505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101904878|NCT00271505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101904879|NCT00271505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101904880|NCT00271505|Growth Substances|growth substances|mesh-ancestor
101904881|NCT00271505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904882|NCT00271505|Growth Inhibitors|growth inhibitors|mesh-ancestor
101904883|NCT00271505|Tubulin Modulators|tubulin modulators|mesh-ancestor
101904884|NCT00271505|Antimitotic Agents|antimitotic agents|mesh-ancestor
101904885|NCT00271505|Mitosis Modulators|mitosis modulators|mesh-ancestor
101904886|NCT00271505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904887|NCT01642186|Everolimus|everolimus|mesh-list
101904888|NCT01642186|Letrozole|letrozole|mesh-list
101904889|NCT01642186|Leuprolide|leuprolide|mesh-list
101904890|NCT01642186|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101904891|NCT01642186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101904892|NCT01642186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101904893|NCT01642186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904894|NCT01642186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101904895|NCT01642186|Immunologic Factors|immunologic factors|mesh-ancestor
101904896|NCT01642186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904897|NCT01642186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101904898|NCT01642186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101904899|NCT01642186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101904900|NCT01642186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101904901|NCT01642186|Hormone Antagonists|hormone antagonists|mesh-ancestor
101904902|NCT01642186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101904903|NCT01642186|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101904904|NCT01642186|Fertility Agents|fertility agents|mesh-ancestor
101904905|NCT01642186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101904906|NCT01642186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101904907|NCT00423514|Mycophenolic Acid|mycophenolic acid|mesh-list
101904908|NCT00423514|Melphalan|melphalan|mesh-list
101904909|NCT00423514|Thiotepa|thiotepa|mesh-list
101904910|NCT00423514|Clofarabine|clofarabine|mesh-list
101904911|NCT00423514|Tacrolimus|tacrolimus|mesh-list
101904912|NCT00423514|Immunologic Factors|immunologic factors|mesh-ancestor
101904913|NCT00423514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904914|NCT00423514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101904915|NCT00423514|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101904916|NCT00423514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101904917|NCT00423514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904918|NCT00423514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101904919|NCT00423514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101904920|NCT00423514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101904921|NCT00423514|Antitubercular Agents|antitubercular agents|mesh-ancestor
101904922|NCT00423514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101904923|NCT00423514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101904924|NCT00423514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101904925|NCT00423514|Alkylating Agents|alkylating agents|mesh-ancestor
101904926|NCT00423514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101904927|NCT00423514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101904928|NCT00423514|Antimetabolites|antimetabolites|mesh-ancestor
101904930|NCT00120952|Chromium|chromium|mesh-list
101904931|NCT00120952|Trace Elements|trace elements|mesh-ancestor
101904932|NCT00120952|Micronutrients|micronutrients|mesh-ancestor
101904933|NCT00120952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904934|NCT00289991|Itraconazole|itraconazole|mesh-list
101904935|NCT00289991|Voriconazole|voriconazole|mesh-list
101904936|NCT00289991|Antifungal Agents|antifungal agents|mesh-ancestor
101904937|NCT00289991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101904938|NCT00289991|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101904939|NCT00289991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101904940|NCT00289991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101904941|NCT00289991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904942|NCT00289991|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101904943|NCT00289991|Hormone Antagonists|hormone antagonists|mesh-ancestor
101904944|NCT00289991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101904945|NCT00289991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904946|NCT00289991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101904947|NCT00270413|Sunitinib|sunitinib|mesh-list
101904948|NCT00270413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101904949|NCT00270413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101616747|NCT02614612|Hormones|hormones|mesh-ancestor
101904950|NCT00270413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101904951|NCT00270413|Growth Substances|growth substances|mesh-ancestor
101904952|NCT00270413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904953|NCT00270413|Growth Inhibitors|growth inhibitors|mesh-ancestor
101904954|NCT00270413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101904955|NCT00270413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101904956|NCT00270413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904957|NCT00270257|Buprenorphine|buprenorphine|mesh-list
101904958|NCT00270257|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101904959|NCT00270257|Naloxone|naloxone|mesh-list
101904960|NCT00270257|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101904961|NCT00270257|Narcotics|narcotics|mesh-ancestor
101904962|NCT00270257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101904963|NCT00270257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904964|NCT00270257|Analgesics|analgesics|mesh-ancestor
101904965|NCT00270257|Sensory System Agents|sensory system agents|mesh-ancestor
101904966|NCT00270257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101904967|NCT00270257|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101904968|NCT00269399|Vancomycin|vancomycin|mesh-list
101904969|NCT00269399|Rifaximin|rifaximin|mesh-list
101904970|NCT00269399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101904971|NCT00269399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101904972|NCT00269399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101904973|NCT00269087|Fluticasone|fluticasone|mesh-list
101904974|NCT00269087|Xhance|xhance|mesh-list
101904975|NCT00269087|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101904976|NCT00269087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101904977|NCT00269087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101904978|NCT00269087|Autonomic Agents|autonomic agents|mesh-ancestor
101904979|NCT00269087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101904980|NCT00269087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904981|NCT00269087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101904982|NCT00269087|Respiratory System Agents|respiratory system agents|mesh-ancestor
101904983|NCT00269087|Dermatologic Agents|dermatologic agents|mesh-ancestor
101904984|NCT00269087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101904985|NCT00269087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101904986|NCT00269087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101904987|NCT00269087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101904988|NCT00269087|Adrenergic Agents|adrenergic agents|mesh-ancestor
101904989|NCT00269087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101904990|NCT00269087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904991|NCT00288587|Diuretics|diuretics|mesh-list
101904992|NCT00288587|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
101904993|NCT00288587|Natriuretic Agents|natriuretic agents|mesh-ancestor
101904994|NCT00288587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101904995|NCT00288587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101904996|NCT00288587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101904997|NCT00268463|Capecitabine|capecitabine|mesh-list
101904998|NCT00268463|Floxuridine|floxuridine|mesh-list
101904999|NCT00268463|Oxaliplatin|oxaliplatin|mesh-list
101905000|NCT00268463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101905001|NCT00268463|Antimetabolites|antimetabolites|mesh-ancestor
101905002|NCT00268463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905003|NCT00268463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101905004|NCT00288509|Botulinum Toxins|botulinum toxins|mesh-list
101905005|NCT00288509|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101905006|NCT00288509|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101905007|NCT00288509|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101905008|NCT00288509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101905009|NCT00288509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905010|NCT00288509|Cholinergic Agents|cholinergic agents|mesh-ancestor
101905011|NCT00288509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101955130|NCT03766425|Aflibercept|aflibercept|mesh-list
101905012|NCT00288509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905013|NCT00288509|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101905014|NCT00288509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101905015|NCT01071005|Leuprolide|leuprolide|mesh-list
101227613|NCT01541072|Lenograstim|lenograstim|mesh-list
101905016|NCT01071005|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101905017|NCT01071005|Fertility Agents|fertility agents|mesh-ancestor
101905018|NCT01071005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101905019|NCT01071005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905020|NCT01071005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101905021|NCT01071005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101905022|NCT03976037|Misoprostol|misoprostol|mesh-list
101905023|NCT03976037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101905024|NCT03976037|Abortifacient Agents|abortifacient agents|mesh-ancestor
101905025|NCT03976037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101905026|NCT03976037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905027|NCT03976037|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101905028|NCT03976037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101905029|NCT03976037|Oxytocics|oxytocics|mesh-ancestor
101905030|NCT00265889|Cyclophosphamide|cyclophosphamide|mesh-list
101905031|NCT00265889|Melphalan|melphalan|mesh-list
101905032|NCT00265889|Busulfan|busulfan|mesh-list
101624889|NCT02752113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905033|NCT00265889|Etoposide|etoposide|mesh-list
101905034|NCT00265889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101905035|NCT00265889|Immunologic Factors|immunologic factors|mesh-ancestor
101905036|NCT00265889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905037|NCT00265889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101905038|NCT00265889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101905039|NCT00265889|Alkylating Agents|alkylating agents|mesh-ancestor
101905040|NCT00265889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905041|NCT00265889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101905042|NCT00265889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101905043|NCT00265889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101905044|NCT00265889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101905045|NCT00265889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101905046|NCT00265889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101905048|NCT01333696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101905049|NCT01333696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101905050|NCT01333696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905051|NCT01333696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101905052|NCT01333696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101905053|NCT01333774|Acarbose|acarbose|mesh-list
101905054|NCT01333774|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101905055|NCT01333774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101905056|NCT01333774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905057|NCT01333774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101905058|NCT01333774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905059|NCT01333852|Metformin|metformin|mesh-list
101905060|NCT01333852|Paclitaxel|paclitaxel|mesh-list
101905061|NCT01333852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101905062|NCT01333852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101905063|NCT01333852|Tubulin Modulators|tubulin modulators|mesh-ancestor
101905064|NCT01333852|Antimitotic Agents|antimitotic agents|mesh-ancestor
101905065|NCT01333852|Mitosis Modulators|mitosis modulators|mesh-ancestor
101905066|NCT01333852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905067|NCT01333852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101905068|NCT01333852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905069|NCT03365362|Varenicline|varenicline|mesh-list
101905070|NCT03365362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101905071|NCT03365362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101905072|NCT03365362|Cholinergic Agents|cholinergic agents|mesh-ancestor
101905073|NCT03365362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101905074|NCT03365362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905075|NCT03365362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905076|NCT03206788|Losartan|losartan|mesh-list
101905077|NCT03206788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101905078|NCT03206788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101905079|NCT03206788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101905080|NCT03206788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101955148|NCT03770637|Glucagon|glucagon|mesh-list
101905081|NCT03206788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905082|NCT03205150|Licogliflozin|licogliflozin|mesh-list
101905083|NCT03205150|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101905084|NCT03205150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905085|NCT03205150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101905086|NCT03205150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905087|NCT04936984|Abaloparatide|abaloparatide|mesh-list
101905088|NCT04936984|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
101905089|NCT04936984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101905090|NCT04936984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905091|NCT04936984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101905092|NCT02931838|Deucravacitinib|deucravacitinib|mesh-list
101905093|NCT02931838|Dermatologic Agents|dermatologic agents|mesh-ancestor
101905094|NCT02931838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101905095|NCT02931838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101905096|NCT02931838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905097|NCT03201562|Tropicamide|tropicamide|mesh-list
101905098|NCT03201562|Aceclidine|aceclidine|mesh-list
101905099|NCT03201562|Mydriatics|mydriatics|mesh-ancestor
101905100|NCT03201562|Autonomic Agents|autonomic agents|mesh-ancestor
101905101|NCT03201562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101905102|NCT03201562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905103|NCT03201562|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101905104|NCT03201562|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101905105|NCT03201562|Cholinergic Agents|cholinergic agents|mesh-ancestor
101905106|NCT03201562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101905107|NCT03201562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905109|NCT03201562|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101905110|NCT03200860|Empagliflozin|empagliflozin|mesh-list
101905111|NCT03200860|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101905112|NCT03200860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905113|NCT03200860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101905114|NCT03200860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905115|NCT01314508|Mecasermin|mecasermin|mesh-list
101905116|NCT01314508|Growth Substances|growth substances|mesh-ancestor
101905117|NCT01314508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905118|NCT03268954|Azacitidine|azacitidine|mesh-list
101905119|NCT03268954|Pevonedistat|pevonedistat|mesh-list
101905120|NCT03268954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101905121|NCT03268954|Antimetabolites|antimetabolites|mesh-ancestor
101905122|NCT03268954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905123|NCT03268954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101905124|NCT03268954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101905125|NCT01314586|Secoisolariciresinol|secoisolariciresinol|mesh-list
101905126|NCT01314586|Phytoestrogens|phytoestrogens|mesh-ancestor
101905127|NCT01314586|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101905128|NCT01314586|Estrogens|estrogens|mesh-ancestor
101905129|NCT01314586|Hormones|hormones|mesh-ancestor
101905130|NCT01314586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101905131|NCT01314586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905132|NCT03187756|Cyclophosphamide|cyclophosphamide|mesh-list
101905133|NCT03187756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101905134|NCT03187756|Immunologic Factors|immunologic factors|mesh-ancestor
101905135|NCT03187756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905136|NCT03187756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101905137|NCT03187756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101905138|NCT03187756|Alkylating Agents|alkylating agents|mesh-ancestor
101905139|NCT03187756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905140|NCT03187756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101905141|NCT03187756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101905142|NCT03184558|Pembrolizumab|pembrolizumab|mesh-list
101905143|NCT03184558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101905144|NCT03184558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101905145|NCT03184558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101905146|NCT03184558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905147|NCT03180736|Dexamethasone|dexamethasone|mesh-list
101905148|NCT03180736|Daratumumab|daratumumab|mesh-list
101905149|NCT03180736|Pomalidomide|pomalidomide|mesh-list
101905150|NCT03180736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101905151|NCT03180736|Antiemetics|antiemetics|mesh-ancestor
101905153|NCT03180736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101905154|NCT03180736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905155|NCT03180736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101905156|NCT03180736|Glucocorticoids|glucocorticoids|mesh-ancestor
101905157|NCT03180736|Hormones|hormones|mesh-ancestor
101905158|NCT03180736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101905159|NCT03180736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101905160|NCT03180736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101905161|NCT03180736|Immunologic Factors|immunologic factors|mesh-ancestor
101905162|NCT03180736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101905163|NCT03180736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101905164|NCT03180736|Growth Substances|growth substances|mesh-ancestor
101905165|NCT03180736|Growth Inhibitors|growth inhibitors|mesh-ancestor
101905166|NCT03178942|Permethrin|permethrin|mesh-list
101905167|NCT03178942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101905168|NCT03178942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905169|NCT03093922|Gemcitabine|gemcitabine|mesh-list
101905170|NCT03093922|Atezolizumab|atezolizumab|mesh-list
101905171|NCT03093922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101905172|NCT03093922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101905173|NCT03093922|Antimetabolites|antimetabolites|mesh-ancestor
101905174|NCT03093922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905175|NCT03093922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101905176|NCT03093922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101905177|NCT03175198|Dabigatran|dabigatran|mesh-list
101905178|NCT03175198|Antithrombins|antithrombins|mesh-ancestor
101905179|NCT03175198|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101905180|NCT03175198|Protease Inhibitors|protease inhibitors|mesh-ancestor
101905181|NCT03175198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101905182|NCT03175198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905183|NCT03175198|Anticoagulants|anticoagulants|mesh-ancestor
101905184|NCT03087448|Trametinib|trametinib|mesh-list
101905185|NCT03087448|Ceritinib|ceritinib|mesh-list
101905186|NCT03087448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101905187|NCT03087448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101905188|NCT03087448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101905189|NCT03087448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905190|NCT03175120|Insulin|insulin|mesh-list
101905191|NCT03175120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101905192|NCT03175120|Liraglutide|liraglutide|mesh-list
101905193|NCT03175120|Insulin, Long-Acting|insulin, long-acting|mesh-list
101905194|NCT03175120|Xultophy|xultophy|mesh-list
101905195|NCT03175120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101905196|NCT03175120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905197|NCT03175120|Incretins|incretins|mesh-ancestor
101905198|NCT03175120|Hormones|hormones|mesh-ancestor
101905199|NCT03175120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101905200|NCT02795182|Tislelizumab|tislelizumab|mesh-list
101905201|NCT02795182|Zanubrutinib|zanubrutinib|mesh-list
101905202|NCT02795182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101905203|NCT02795182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101905204|NCT02795182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101905205|NCT02795182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101905206|NCT02795182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905207|NCT03054766|Ranibizumab|ranibizumab|mesh-list
101905208|NCT03054766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101905209|NCT03054766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101905210|NCT03054766|Growth Substances|growth substances|mesh-ancestor
101905211|NCT03054766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905212|NCT03054766|Growth Inhibitors|growth inhibitors|mesh-ancestor
101905213|NCT03054766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101905214|NCT05118724|Atezolizumab|atezolizumab|mesh-list
101905215|NCT05118724|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101227632|NCT01541137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101905216|NCT05118724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905217|NCT05118724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101905218|NCT05118724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101905219|NCT03036748|Amiloride|amiloride|mesh-list
101905220|NCT03036748|Diuretics|diuretics|mesh-ancestor
101905221|NCT03036748|Natriuretic Agents|natriuretic agents|mesh-ancestor
101905222|NCT03036748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905223|NCT03036748|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
101905224|NCT03036748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101905225|NCT03036748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101905226|NCT03036748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905227|NCT03036748|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101905228|NCT03036748|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101905229|NCT03167242|Lumefantrine|lumefantrine|mesh-list
101905230|NCT03167242|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101905231|NCT03167242|Antimalarials|antimalarials|mesh-ancestor
101905232|NCT03167242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101905233|NCT03167242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101905234|NCT03167242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101905235|NCT03636178|Daminozide|daminozide|mesh-list
101905236|NCT03636178|Plant Growth Regulators|plant growth regulators|mesh-ancestor
101905237|NCT03636178|Growth Substances|growth substances|mesh-ancestor
101905238|NCT03636178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905239|NCT01330654|Metoprolol|metoprolol|mesh-list
101905240|NCT01330654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101905241|NCT01330654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101905242|NCT01330654|Sympatholytics|sympatholytics|mesh-ancestor
101905243|NCT01330654|Autonomic Agents|autonomic agents|mesh-ancestor
101905244|NCT01330654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101905245|NCT01330654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905246|NCT01330654|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101905247|NCT01330654|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101905248|NCT01330654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101905249|NCT01330654|Adrenergic Agents|adrenergic agents|mesh-ancestor
101905250|NCT01330654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101905251|NCT01330654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905253|NCT01330810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101625125|NCT04217265|Oxytocics|oxytocics|mesh-ancestor
101905254|NCT01330810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101905255|NCT01330810|Analgesics|analgesics|mesh-ancestor
101905256|NCT01330810|Sensory System Agents|sensory system agents|mesh-ancestor
101905257|NCT01330810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101905258|NCT01330810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905259|NCT01330810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101905260|NCT01330810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101905261|NCT01330810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101905262|NCT01330810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101905263|NCT01330810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905264|NCT01331122|Droxidopa|droxidopa|mesh-list
101905265|NCT01331122|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101905266|NCT01331122|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101905267|NCT01320280|Afatinib|afatinib|mesh-list
101905268|NCT01320280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101905269|NCT01320280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101905270|NCT01320280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101905271|NCT01320280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905272|NCT01331434|Exemestane|exemestane|mesh-list
101905273|NCT01331434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101905274|NCT01331434|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101905275|NCT01331434|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101905276|NCT01331434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101905277|NCT01331434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905278|NCT01331434|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101905279|NCT01331434|Hormone Antagonists|hormone antagonists|mesh-ancestor
101905280|NCT01331434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101905281|NCT01331434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905282|NCT01331590|Dexamethasone|dexamethasone|mesh-list
101905283|NCT01331590|Etoposide|etoposide|mesh-list
101905284|NCT01331590|Ifosfamide|ifosfamide|mesh-list
101905285|NCT01331590|Lenograstim|lenograstim|mesh-list
101905286|NCT01331590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101905287|NCT01331590|Antiemetics|antiemetics|mesh-ancestor
101905288|NCT01331590|Autonomic Agents|autonomic agents|mesh-ancestor
101905289|NCT01331590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101905290|NCT01331590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905291|NCT01331590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101905292|NCT01331590|Glucocorticoids|glucocorticoids|mesh-ancestor
101905293|NCT01331590|Hormones|hormones|mesh-ancestor
101905294|NCT01331590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101905295|NCT01331590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101905296|NCT01331590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101905297|NCT01331590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101905298|NCT01331590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101905299|NCT01331590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101905300|NCT01331590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101905301|NCT01331590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905302|NCT01331590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101905303|NCT01331590|Immunologic Factors|immunologic factors|mesh-ancestor
101905304|NCT01331590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101905305|NCT01331590|Alkylating Agents|alkylating agents|mesh-ancestor
101905306|NCT01331902|Nicorandil|nicorandil|mesh-list
101905307|NCT01331902|Adenosine|adenosine|mesh-list
101905308|NCT01331902|Analgesics|analgesics|mesh-ancestor
101905309|NCT01331902|Sensory System Agents|sensory system agents|mesh-ancestor
101905310|NCT01331902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101905311|NCT01331902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905312|NCT01331902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101905313|NCT01331902|Vasodilator Agents|vasodilator agents|mesh-ancestor
101905314|NCT01331902|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101905315|NCT01331902|Purinergic Agonists|purinergic agonists|mesh-ancestor
101905316|NCT01331902|Purinergic Agents|purinergic agents|mesh-ancestor
101905317|NCT01331902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101905318|NCT01331902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905319|NCT01331902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101905320|NCT01331902|Vitamin B Complex|vitamin b complex|mesh-ancestor
101905321|NCT01331902|Vitamins|vitamins|mesh-ancestor
101905322|NCT01331902|Micronutrients|micronutrients|mesh-ancestor
101905323|NCT04245748|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101905324|NCT04245748|Escitalopram|escitalopram|mesh-list
101905325|NCT04245748|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101905326|NCT04245748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101905327|NCT04245748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101625196|NCT04218513|Edaravone|edaravone|mesh-list
101905328|NCT04245748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905329|NCT04245748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101905330|NCT04245748|Serotonin Agents|serotonin agents|mesh-ancestor
101905331|NCT04245748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905332|NCT04245748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101905333|NCT04245748|Antidepressive Agents|antidepressive agents|mesh-ancestor
101905334|NCT04245748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101905335|NCT04245748|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101905336|NCT04245748|Analgesics|analgesics|mesh-ancestor
101905337|NCT04245748|Sensory System Agents|sensory system agents|mesh-ancestor
101905338|NCT04245748|Dopamine Agents|dopamine agents|mesh-ancestor
101905339|NCT04245436|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101905340|NCT04245436|Escitalopram|escitalopram|mesh-list
101905341|NCT04245436|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101905342|NCT04245436|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101227652|NCT01541280|Antimetabolites|antimetabolites|mesh-ancestor
101905343|NCT04245436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101905344|NCT04245436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905345|NCT04245436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101905346|NCT04245436|Serotonin Agents|serotonin agents|mesh-ancestor
101905347|NCT04245436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905348|NCT04245436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101905349|NCT04245436|Antidepressive Agents|antidepressive agents|mesh-ancestor
101905350|NCT04245436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101905351|NCT04245436|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101905352|NCT04245436|Analgesics|analgesics|mesh-ancestor
101905353|NCT04245436|Sensory System Agents|sensory system agents|mesh-ancestor
101905354|NCT04245436|Dopamine Agents|dopamine agents|mesh-ancestor
101905355|NCT01332370|Metformin|metformin|mesh-list
101905356|NCT01332370|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101905357|NCT01332370|Rosiglitazone|rosiglitazone|mesh-list
101905358|NCT01332370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101905359|NCT01332370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905361|NCT01332370|Hormones|hormones|mesh-ancestor
101905362|NCT01332370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101905363|NCT01332370|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101905364|NCT01332370|Protease Inhibitors|protease inhibitors|mesh-ancestor
101905365|NCT01332370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101905366|NCT01332370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905367|NCT01332448|Orlistat|orlistat|mesh-list
101905368|NCT01332448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101905369|NCT01332448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905370|NCT01332448|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101905371|NCT01332448|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101905372|NCT04484428|Menthol|menthol|mesh-list
101905373|NCT04484428|Antipruritics|antipruritics|mesh-ancestor
101905374|NCT04484428|Dermatologic Agents|dermatologic agents|mesh-ancestor
101905375|NCT01332604|Bevacizumab|bevacizumab|mesh-list
101905376|NCT01332604|Capecitabine|capecitabine|mesh-list
101905377|NCT01332604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101905378|NCT01332604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101905379|NCT01332604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101905380|NCT01332604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101905381|NCT01332604|Growth Substances|growth substances|mesh-ancestor
101905382|NCT01332604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905383|NCT01332604|Growth Inhibitors|growth inhibitors|mesh-ancestor
101905384|NCT01332604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101905385|NCT01332604|Antimetabolites|antimetabolites|mesh-ancestor
101905386|NCT01332604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905387|NCT03445858|Pembrolizumab|pembrolizumab|mesh-list
101905389|NCT03445858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101905390|NCT03445858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101905391|NCT03445858|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101905392|NCT03445858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905393|NCT03445858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101905394|NCT03445858|Antimetabolites|antimetabolites|mesh-ancestor
101905395|NCT03445858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101905396|NCT01333150|Propranolol|propranolol|mesh-list
101905397|NCT01333150|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101905398|NCT01333150|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101905399|NCT01333150|Adrenergic Agents|adrenergic agents|mesh-ancestor
101905400|NCT01333150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101905401|NCT01333150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905402|NCT01333150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905403|NCT01333150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101905404|NCT01333150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101905405|NCT01333150|Vasodilator Agents|vasodilator agents|mesh-ancestor
101905406|NCT02913664|Losartan|losartan|mesh-list
101905407|NCT02913664|Amlodipine|amlodipine|mesh-list
101905408|NCT02913664|Calcium Channel Blockers|calcium channel blockers|mesh-list
101905409|NCT02913664|Angiotensin II|angiotensin ii|mesh-list
101905410|NCT02913664|Giapreza|giapreza|mesh-list
101905411|NCT02913664|Calcium|calcium|mesh-list
101905412|NCT02913664|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
101905413|NCT02913664|Angiotensinogen|angiotensinogen|mesh-list
101905414|NCT02913664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101905415|NCT02913664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905416|NCT02913664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101905417|NCT02913664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101955169|NCT03894891|Docetaxel|docetaxel|mesh-list
101905418|NCT02913664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905419|NCT02913664|Vasodilator Agents|vasodilator agents|mesh-ancestor
101905420|NCT02913664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101905421|NCT02913664|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101905422|NCT02913664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101905423|NCT02913664|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101905424|NCT02913664|Protease Inhibitors|protease inhibitors|mesh-ancestor
101905425|NCT02913664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101905427|NCT02818582|Antimetabolites|antimetabolites|mesh-ancestor
101905428|NCT02818582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905429|NCT02818582|Antiviral Agents|antiviral agents|mesh-ancestor
101905430|NCT02818582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101905431|NCT01337440|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101905432|NCT01337440|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101905433|NCT01337440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101905434|NCT01337440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905435|NCT01337440|Incretins|incretins|mesh-ancestor
101905436|NCT01337440|Hormones|hormones|mesh-ancestor
101905437|NCT01337440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101905438|NCT01337440|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101905439|NCT01337440|Protease Inhibitors|protease inhibitors|mesh-ancestor
101905440|NCT01337440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101905441|NCT01337440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905442|NCT01337440|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101905443|NCT01337440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101905444|NCT01337518|Androgens|androgens|mesh-list
101905445|NCT01337518|Hormones|hormones|mesh-ancestor
101905446|NCT01337518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101905447|NCT01337518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905448|NCT05186194|Vitamin D|vitamin d|mesh-list
101905449|NCT05186194|Calcium|calcium|mesh-list
101905450|NCT05186194|Vitamins|vitamins|mesh-ancestor
101905451|NCT05186194|Micronutrients|micronutrients|mesh-ancestor
101905452|NCT05186194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905453|NCT05186194|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101905454|NCT05186194|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101905455|NCT01338454|Tranexamic Acid|tranexamic acid|mesh-list
101905456|NCT01338454|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101905457|NCT01338454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101905458|NCT01338454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905459|NCT01338454|Hemostatics|hemostatics|mesh-ancestor
101905460|NCT01338454|Coagulants|coagulants|mesh-ancestor
101905461|NCT02882152|Morphine|morphine|mesh-list
101905462|NCT02882152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101905463|NCT02882152|Narcotics|narcotics|mesh-ancestor
101905464|NCT02882152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101905465|NCT02882152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905466|NCT02882152|Analgesics|analgesics|mesh-ancestor
101905467|NCT02882152|Sensory System Agents|sensory system agents|mesh-ancestor
101905468|NCT02882152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101905469|NCT05185804|Enoxaparin|enoxaparin|mesh-list
101905470|NCT05185804|Enoxaparin sodium|enoxaparin sodium|mesh-list
101905471|NCT05185804|Anticoagulants|anticoagulants|mesh-ancestor
101905472|NCT05185804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101905473|NCT05185804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101905474|NCT05185804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905475|NCT01338844|Inositol|inositol|mesh-list
101905476|NCT01338844|Vitamin B Complex|vitamin b complex|mesh-ancestor
101905477|NCT01338844|Vitamins|vitamins|mesh-ancestor
101905478|NCT01338844|Micronutrients|micronutrients|mesh-ancestor
101955183|NCT03765645|Tazobactam|tazobactam|mesh-list
101905479|NCT01338844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905481|NCT01338922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101905482|NCT01338922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905483|NCT01339312|Vaccines|vaccines|mesh-list
101905484|NCT01339312|Immunologic Factors|immunologic factors|mesh-ancestor
101905485|NCT01339312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905486|NCT01339468|Tacrolimus|tacrolimus|mesh-list
101905487|NCT01339468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101905488|NCT01339468|Immunologic Factors|immunologic factors|mesh-ancestor
101905489|NCT01339468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905490|NCT01339468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101905491|NCT01339468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101905492|NCT01339468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905493|NCT01339624|Ketorolac|ketorolac|mesh-list
101905494|NCT01339624|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101905495|NCT01339624|Fentanyl|fentanyl|mesh-list
101905496|NCT01339624|Morphine|morphine|mesh-list
101905497|NCT01339624|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101905498|NCT01339624|Narcotics|narcotics|mesh-ancestor
101905499|NCT01339624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101905500|NCT01339624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905501|NCT01339624|Analgesics|analgesics|mesh-ancestor
101905502|NCT01339624|Sensory System Agents|sensory system agents|mesh-ancestor
101905503|NCT01339624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101905504|NCT01339624|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101905505|NCT01339624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101905506|NCT01339624|Anesthetics, General|anesthetics, general|mesh-ancestor
101905507|NCT01339624|Anesthetics|anesthetics|mesh-ancestor
101905508|NCT01339624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101905509|NCT01339624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101905510|NCT01339624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101905511|NCT01339624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101905512|NCT01339624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101905513|NCT01339624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101905514|NCT01339624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905515|NCT01340248|Carvedilol|carvedilol|mesh-list
101905516|NCT01340248|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101905517|NCT01340248|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101905518|NCT01340248|Adrenergic Agents|adrenergic agents|mesh-ancestor
101905519|NCT01340248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101905520|NCT01340248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905521|NCT01340248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905522|NCT01340248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101905523|NCT01340248|Antioxidants|antioxidants|mesh-ancestor
101905524|NCT01340248|Protective Agents|protective agents|mesh-ancestor
101905525|NCT01340248|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101905526|NCT01340248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101905527|NCT01340248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101905528|NCT01340248|Vasodilator Agents|vasodilator agents|mesh-ancestor
101905529|NCT01340248|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101905530|NCT01340248|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101905531|NCT01340326|Valsartan|valsartan|mesh-list
101905532|NCT01340326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101905533|NCT01340326|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101905534|NCT01340326|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101905535|NCT01340326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905536|NCT00286091|Denosumab|denosumab|mesh-list
101905537|NCT00286091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101905538|NCT00286091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905539|NCT01340950|Tenofovir|tenofovir|mesh-list
101905540|NCT01340950|Lamivudine|lamivudine|mesh-list
101905541|NCT01340950|Zidovudine|zidovudine|mesh-list
101905542|NCT01340950|Efavirenz|efavirenz|mesh-list
101905543|NCT01340950|Nevirapine|nevirapine|mesh-list
101905544|NCT01340950|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101905545|NCT01340950|Antiviral Agents|antiviral agents|mesh-ancestor
101905546|NCT01340950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101905547|NCT01340950|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101905548|NCT01340950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101905549|NCT01340950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101905550|NCT01340950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905551|NCT01340950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101905552|NCT01340950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101905553|NCT01340950|Antimetabolites|antimetabolites|mesh-ancestor
101905554|NCT01340950|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101905555|NCT01340950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101905556|NCT01340950|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101905557|NCT01340950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101905558|NCT01340950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101905559|NCT01340950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101905560|NCT01341106|Entecavir|entecavir|mesh-list
101905561|NCT01341106|Antiviral Agents|antiviral agents|mesh-ancestor
101905562|NCT01341106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101905563|NCT01341184|Rifampin|rifampin|mesh-list
101905564|NCT01341184|Rifabutin|rifabutin|mesh-list
101905565|NCT01341184|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101905566|NCT01341184|Antitubercular Agents|antitubercular agents|mesh-ancestor
101905567|NCT01341184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101905568|NCT01341184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101905569|NCT01341184|Leprostatic Agents|leprostatic agents|mesh-ancestor
101905570|NCT01341184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101905571|NCT01341184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101905572|NCT01341184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905573|NCT01341184|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101905574|NCT01341184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101905575|NCT01341184|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101905576|NCT01341184|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101905577|NCT01341184|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101905578|NCT01341184|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101905579|NCT00285857|Lovastatin|lovastatin|mesh-list
101905580|NCT00285857|L 647318|l 647318|mesh-list
101905581|NCT00285857|Dihydromevinolin|dihydromevinolin|mesh-list
101905582|NCT00285857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101905583|NCT00285857|Antimetabolites|antimetabolites|mesh-ancestor
101905584|NCT00285857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905585|NCT00285857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101905586|NCT00285857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101905587|NCT00285857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101905588|NCT00285857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101905589|NCT01341262|Zoledronic Acid|zoledronic acid|mesh-list
101905590|NCT01341262|Thalidomide|thalidomide|mesh-list
101905591|NCT01341262|Dexamethasone|dexamethasone|mesh-list
101905592|NCT01341262|Cyclophosphamide|cyclophosphamide|mesh-list
101905593|NCT01341262|Melphalan|melphalan|mesh-list
101905594|NCT01341262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101905595|NCT01341262|Immunologic Factors|immunologic factors|mesh-ancestor
101905596|NCT01341262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905597|NCT01341262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101955204|NCT01321671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101905598|NCT01341262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101905599|NCT01341262|Alkylating Agents|alkylating agents|mesh-ancestor
101905600|NCT01341262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905601|NCT01341262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101905602|NCT01341262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101905603|NCT01341262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101905604|NCT01341262|Antiemetics|antiemetics|mesh-ancestor
101905605|NCT01341262|Autonomic Agents|autonomic agents|mesh-ancestor
101905606|NCT01341262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101905607|NCT01341262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101905608|NCT01341262|Glucocorticoids|glucocorticoids|mesh-ancestor
101905610|NCT01341262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101905611|NCT01341262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101905612|NCT01341262|Leprostatic Agents|leprostatic agents|mesh-ancestor
101905613|NCT01341262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101905614|NCT01341262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101905615|NCT01341262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101905616|NCT01341262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101905617|NCT01341262|Growth Substances|growth substances|mesh-ancestor
101905618|NCT01341262|Growth Inhibitors|growth inhibitors|mesh-ancestor
101905619|NCT01341262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101905620|NCT01341340|Everolimus|everolimus|mesh-list
101905621|NCT01341340|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101905622|NCT01341340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101905623|NCT01341340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101905624|NCT01341340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905625|NCT01341340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101905626|NCT01341340|Immunologic Factors|immunologic factors|mesh-ancestor
101905627|NCT01341340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905628|NCT01341340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101905630|NCT01341496|Cyclophosphamide|cyclophosphamide|mesh-list
101905631|NCT01341496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101905632|NCT01341496|Immunologic Factors|immunologic factors|mesh-ancestor
101905633|NCT01341496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905634|NCT01341496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101905635|NCT01341496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101905636|NCT01341496|Alkylating Agents|alkylating agents|mesh-ancestor
101905637|NCT01341496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905638|NCT01341496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101905639|NCT01341496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101905640|NCT01341496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101905641|NCT01341496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101905642|NCT01341496|Analgesics|analgesics|mesh-ancestor
101905643|NCT01341496|Sensory System Agents|sensory system agents|mesh-ancestor
101905644|NCT01341496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101905645|NCT01341496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101905646|NCT01341496|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101905647|NCT01341496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101905648|NCT01341496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101905649|NCT00284141|Aflibercept|aflibercept|mesh-list
101905650|NCT00284141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101905651|NCT00284141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101905652|NCT00284141|Growth Substances|growth substances|mesh-ancestor
101905653|NCT00284141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905654|NCT00284141|Growth Inhibitors|growth inhibitors|mesh-ancestor
101905655|NCT00284141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101905656|NCT05182138|Zinc|zinc|mesh-list
101905657|NCT05182138|Trace Elements|trace elements|mesh-ancestor
101905658|NCT05182138|Micronutrients|micronutrients|mesh-ancestor
101905659|NCT05182138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905660|NCT01315990|Cetuximab|cetuximab|mesh-list
101905661|NCT01315990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101905662|NCT01315990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101905663|NCT00265343|Olanzapine|olanzapine|mesh-list
101905664|NCT00265343|Asenapine|asenapine|mesh-list
101905665|NCT00265343|Antiemetics|antiemetics|mesh-ancestor
101905666|NCT00265343|Autonomic Agents|autonomic agents|mesh-ancestor
101905667|NCT00265343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101905668|NCT00265343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905669|NCT00265343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101905670|NCT00265343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101905671|NCT00265343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101905672|NCT00265343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101905673|NCT00265343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101905674|NCT00265343|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101905675|NCT00265343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101905676|NCT00265343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101905677|NCT00265343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905678|NCT00265343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101905679|NCT00265343|Serotonin Agents|serotonin agents|mesh-ancestor
101905681|NCT01341886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101905682|NCT01341886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905683|NCT00283595|Hormones|hormones|mesh-list
101268331|NCT01803659|Vitamin A|vitamin a|mesh-list
101905684|NCT00283595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101905685|NCT00283595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905686|NCT00265109|Levetiracetam|levetiracetam|mesh-list
101905687|NCT00265109|Anticonvulsants|anticonvulsants|mesh-ancestor
101905688|NCT00265109|Nootropic Agents|nootropic agents|mesh-ancestor
101905689|NCT01342198|Erythromycin|erythromycin|mesh-list
101905690|NCT01342198|Erythromycin Estolate|erythromycin estolate|mesh-list
101905691|NCT01342198|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101905692|NCT01342198|Erythromycin stearate|erythromycin stearate|mesh-list
101905693|NCT01342198|Pregabalin|pregabalin|mesh-list
101905694|NCT01342198|Analgesics|analgesics|mesh-ancestor
101905695|NCT01342198|Sensory System Agents|sensory system agents|mesh-ancestor
101905696|NCT01342198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101905697|NCT01342198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905698|NCT01342198|Anticonvulsants|anticonvulsants|mesh-ancestor
101905699|NCT01342198|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101905700|NCT01342198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101905701|NCT01342198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905702|NCT01342198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101905703|NCT01342198|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101905704|NCT01342198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101905705|NCT01342198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101905706|NCT01342198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101905707|NCT01342198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101905708|NCT01342198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101905709|NCT01342198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101905710|NCT01342198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101905711|NCT01342198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101905713|NCT01342744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101905714|NCT01342744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905715|NCT05150782|Ascorbic Acid|ascorbic acid|mesh-list
101905716|NCT05150782|Curcumin|curcumin|mesh-list
101905717|NCT05150782|Antioxidants|antioxidants|mesh-ancestor
101905718|NCT05150782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905719|NCT05150782|Protective Agents|protective agents|mesh-ancestor
101905720|NCT05150782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905721|NCT05150782|Vitamins|vitamins|mesh-ancestor
101905722|NCT05150782|Micronutrients|micronutrients|mesh-ancestor
101905723|NCT05150782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101905724|NCT05150782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101905725|NCT05150782|Analgesics|analgesics|mesh-ancestor
101905726|NCT05150782|Sensory System Agents|sensory system agents|mesh-ancestor
101905727|NCT05150782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101905728|NCT05150782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101905729|NCT05150782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101905730|NCT05150782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101905731|NCT05150782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101905732|NCT01316068|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
101905733|NCT01316068|Anticoagulants|anticoagulants|mesh-ancestor
101905734|NCT01316068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101905735|NCT01316068|Antimetabolites|antimetabolites|mesh-ancestor
101905736|NCT01316068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101955234|NCT03765021|Tranexamic Acid|tranexamic acid|mesh-list
101905737|NCT01316068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101905738|NCT01316068|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101905739|NCT01316068|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101905740|NCT01316068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101905741|NCT01316068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905742|NCT03233308|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101905743|NCT03233308|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101905744|NCT00283049|Insulin|insulin|mesh-list
101905745|NCT00283049|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101905746|NCT00283049|Insulin Glargine|insulin glargine|mesh-list
101905747|NCT00283049|Insulin glulisine|insulin glulisine|mesh-list
101905748|NCT00283049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101905749|NCT00283049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905750|NCT00264875|Pregabalin|pregabalin|mesh-list
101905751|NCT00264875|Analgesics|analgesics|mesh-ancestor
101905752|NCT00264875|Sensory System Agents|sensory system agents|mesh-ancestor
101905753|NCT00264875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101905754|NCT00264875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905755|NCT00264875|Anticonvulsants|anticonvulsants|mesh-ancestor
101905756|NCT00264875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101905757|NCT00264875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101905758|NCT00264875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905759|NCT00264875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101905760|NCT00264875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101905761|NCT00264875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101905762|NCT00264875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101905763|NCT00264875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101905764|NCT03635398|Midazolam|midazolam|mesh-list
101905765|NCT03635398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101905766|NCT03635398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101905767|NCT03635398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101905768|NCT03635398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905769|NCT03635398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101905770|NCT03635398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101905771|NCT03635398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101905772|NCT03635398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101905773|NCT03635398|Anesthetics, General|anesthetics, general|mesh-ancestor
101905774|NCT03635398|Anesthetics|anesthetics|mesh-ancestor
101905775|NCT03635398|GABA Modulators|gaba modulators|mesh-ancestor
101905776|NCT03635398|GABA Agents|gaba agents|mesh-ancestor
101905777|NCT03635398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101905778|NCT03635398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905779|NCT03151408|Azacitidine|azacitidine|mesh-list
101905780|NCT03151408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101905781|NCT03151408|Antimetabolites|antimetabolites|mesh-ancestor
101905782|NCT03151408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905783|NCT03151408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101905784|NCT03151408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101905785|NCT05226442|Heparin|heparin|mesh-list
101905786|NCT05226442|Calcium heparin|calcium heparin|mesh-list
101905787|NCT05226442|Argatroban|argatroban|mesh-list
101905788|NCT05226442|Anticoagulants|anticoagulants|mesh-ancestor
101905789|NCT05226442|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101905790|NCT05226442|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101905791|NCT05226442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905792|NCT05226442|Antithrombins|antithrombins|mesh-ancestor
101905793|NCT05226442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101905794|NCT05226442|Protease Inhibitors|protease inhibitors|mesh-ancestor
101905795|NCT05226442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101905796|NCT05226442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101905797|NCT01316458|Imatinib Mesylate|imatinib mesylate|mesh-list
101905798|NCT01316458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101905799|NCT01316458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101905800|NCT01316458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101905801|NCT01316458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905802|NCT05198128|Calcium|calcium|mesh-list
101905803|NCT05198128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101905804|NCT05198128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905805|NCT01316848|Tivozanib|tivozanib|mesh-list
101905806|NCT01316848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101905807|NCT01316848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101905808|NCT01316848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905810|NCT02121184|Oxytocics|oxytocics|mesh-ancestor
101905811|NCT02121184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101905812|NCT02121184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905813|NCT01485874|Doxorubicin|doxorubicin|mesh-list
101905814|NCT01485874|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101905815|NCT01485874|Nintedanib|nintedanib|mesh-list
101905816|NCT01485874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101905817|NCT01485874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101905818|NCT01485874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101905819|NCT01485874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101905820|NCT01485874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101905821|NCT01485874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905822|NCT01485874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101905823|NCT05000710|Durvalumab|durvalumab|mesh-list
101905824|NCT05000710|Tremelimumab|tremelimumab|mesh-list
101905825|NCT05000710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101905826|NCT05000710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101905827|NCT04786756|Bupivacaine|bupivacaine|mesh-list
101905828|NCT04786756|Anesthetics, Local|anesthetics, local|mesh-ancestor
101905829|NCT04786756|Anesthetics|anesthetics|mesh-ancestor
101905830|NCT04786756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101905831|NCT04786756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905832|NCT04786756|Sensory System Agents|sensory system agents|mesh-ancestor
101905833|NCT04786756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101905835|NCT00546754|Valsartan|valsartan|mesh-list
101905836|NCT00546754|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101905837|NCT00546754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101905838|NCT00546754|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101905839|NCT00546754|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101905840|NCT00546754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905841|NCT00546754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101905842|NCT00546754|Diuretics|diuretics|mesh-ancestor
101905843|NCT00546754|Natriuretic Agents|natriuretic agents|mesh-ancestor
101905844|NCT00546754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905845|NCT00546754|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101905846|NCT00546754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101905847|NCT04768426|Capecitabine|capecitabine|mesh-list
101905848|NCT04768426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101905849|NCT04768426|Antimetabolites|antimetabolites|mesh-ancestor
101905850|NCT04768426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905851|NCT04768426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101905852|NCT04473508|Ropivacaine|ropivacaine|mesh-list
101905853|NCT04473508|Anesthetics, Local|anesthetics, local|mesh-ancestor
101905855|NCT04473508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101905856|NCT04473508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905857|NCT04473508|Sensory System Agents|sensory system agents|mesh-ancestor
101905858|NCT04473508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101905859|NCT04471402|Dexmedetomidine|dexmedetomidine|mesh-list
101905860|NCT04471402|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101905861|NCT04471402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101905862|NCT04471402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905863|NCT04471402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101905864|NCT04471402|Analgesics|analgesics|mesh-ancestor
101905865|NCT04471402|Sensory System Agents|sensory system agents|mesh-ancestor
101905866|NCT04471402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101905867|NCT04471402|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101905868|NCT04471402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101905869|NCT04471402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101905870|NCT04471402|Adrenergic Agents|adrenergic agents|mesh-ancestor
101905871|NCT04471402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101905872|NCT04471402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905873|NCT00282347|Acetaminophen|acetaminophen|mesh-list
101905874|NCT00282347|Diphenhydramine|diphenhydramine|mesh-list
101905875|NCT00282347|Promethazine|promethazine|mesh-list
101905876|NCT00282347|Mycophenolic Acid|mycophenolic acid|mesh-list
101905877|NCT00282347|Prednisone|prednisone|mesh-list
101905878|NCT00282347|Methylprednisolone|methylprednisolone|mesh-list
101905879|NCT00282347|Rituximab|rituximab|mesh-list
101905880|NCT00282347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101905881|NCT00282347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101905882|NCT00282347|Immunologic Factors|immunologic factors|mesh-ancestor
101905883|NCT00282347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905884|NCT00282347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101905885|NCT00282347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101905886|NCT00282347|Glucocorticoids|glucocorticoids|mesh-ancestor
101905887|NCT00282347|Hormones|hormones|mesh-ancestor
101905888|NCT00282347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101905889|NCT00282347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101905890|NCT00282347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101905891|NCT00282347|Analgesics|analgesics|mesh-ancestor
101905892|NCT00282347|Sensory System Agents|sensory system agents|mesh-ancestor
101905893|NCT00282347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101905894|NCT00282347|Antipyretics|antipyretics|mesh-ancestor
101905895|NCT00282347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101905896|NCT00282347|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101905897|NCT00282347|Antitubercular Agents|antitubercular agents|mesh-ancestor
101905898|NCT00282347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101905899|NCT00282347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101905900|NCT00282347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101905901|NCT00282347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905902|NCT00282347|Antiemetics|antiemetics|mesh-ancestor
101905903|NCT00282347|Autonomic Agents|autonomic agents|mesh-ancestor
101905904|NCT00282347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101905905|NCT00282347|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101905906|NCT00282347|Protective Agents|protective agents|mesh-ancestor
101905907|NCT00282347|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101905908|NCT00282347|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101905909|NCT00282347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101905910|NCT00282347|Anesthetics, Local|anesthetics, local|mesh-ancestor
101905912|NCT00282347|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101905913|NCT00282347|Histamine Antagonists|histamine antagonists|mesh-ancestor
101905914|NCT00282347|Histamine Agents|histamine agents|mesh-ancestor
101905915|NCT00282347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101905916|NCT00282347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101905917|NCT00282347|Antipruritics|antipruritics|mesh-ancestor
101905918|NCT00282347|Dermatologic Agents|dermatologic agents|mesh-ancestor
101905919|NCT01334632|Morphine|morphine|mesh-list
101905920|NCT01334632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101905921|NCT01334632|Narcotics|narcotics|mesh-ancestor
101905922|NCT01334632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101905923|NCT01334632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905924|NCT01334632|Analgesics|analgesics|mesh-ancestor
101905925|NCT01334632|Sensory System Agents|sensory system agents|mesh-ancestor
101625787|NCT02737605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101905926|NCT01334632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101905927|NCT00405964|Desloratadine|desloratadine|mesh-list
101905928|NCT00405964|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101905929|NCT00405964|Cholinergic Agents|cholinergic agents|mesh-ancestor
101905930|NCT00405964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101905931|NCT00405964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905932|NCT00405964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905933|NCT00405964|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101905934|NCT00405964|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101905935|NCT00405964|Histamine Antagonists|histamine antagonists|mesh-ancestor
101905936|NCT00405964|Histamine Agents|histamine agents|mesh-ancestor
101905937|NCT00264797|Methylphenidate|methylphenidate|mesh-list
101905938|NCT00264797|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101905939|NCT00264797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905940|NCT00264797|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101905941|NCT00264797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101905942|NCT00264797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101905943|NCT00264797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905944|NCT00264797|Dopamine Agents|dopamine agents|mesh-ancestor
101905945|NCT00264797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101905946|NCT03148756|Dalbavancin|dalbavancin|mesh-list
101905947|NCT03148756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101905948|NCT03148756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101905950|NCT01343680|Anticoagulants|anticoagulants|mesh-ancestor
101905951|NCT01343680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101905952|NCT01343680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101905953|NCT01343680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905954|NCT00281957|Sirolimus|sirolimus|mesh-list
101905955|NCT00281957|Sorafenib|sorafenib|mesh-list
101905956|NCT00281957|Temsirolimus|temsirolimus|mesh-list
101905957|NCT00281957|Tipifarnib|tipifarnib|mesh-list
101905958|NCT00281957|MTOR Inhibitors|mtor inhibitors|mesh-list
101905959|NCT00281957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101905960|NCT00281957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101905961|NCT00281957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101905962|NCT00281957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905963|NCT00281957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101905964|NCT00281957|Immunologic Factors|immunologic factors|mesh-ancestor
101905965|NCT00281957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905966|NCT00281957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101905967|NCT00281957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101905968|NCT00281957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101905969|NCT00281957|Antifungal Agents|antifungal agents|mesh-ancestor
101905970|NCT01071161|Azithromycin|azithromycin|mesh-list
101905971|NCT01071161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101905972|NCT01071161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101905973|NCT01070225|Hydrocortisone|hydrocortisone|mesh-list
101905974|NCT01070225|Propranolol|propranolol|mesh-list
101905975|NCT01070225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101905976|NCT01070225|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101905977|NCT01070225|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101905978|NCT01070225|Adrenergic Agents|adrenergic agents|mesh-ancestor
101905979|NCT01070225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101905980|NCT01070225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905981|NCT01070225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905982|NCT01070225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101905983|NCT01070225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101905984|NCT01070225|Vasodilator Agents|vasodilator agents|mesh-ancestor
101905985|NCT01070615|Prucalopride|prucalopride|mesh-list
101905986|NCT01070615|Laxatives|laxatives|mesh-ancestor
101905987|NCT01070615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101905988|NCT01070615|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101905989|NCT01070615|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101905990|NCT01070615|Serotonin Agents|serotonin agents|mesh-ancestor
101905991|NCT01070615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101905992|NCT01070615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101905993|NCT01070615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101905994|NCT00262925|Leucovorin|leucovorin|mesh-list
101905995|NCT00262925|Dexamethasone|dexamethasone|mesh-list
101905996|NCT00262925|Methotrexate|methotrexate|mesh-list
101905997|NCT00262925|Vincristine|vincristine|mesh-list
101905998|NCT00262925|Asparaginase|asparaginase|mesh-list
101905999|NCT00262925|Mercaptopurine|mercaptopurine|mesh-list
101906000|NCT00262925|Alemtuzumab|alemtuzumab|mesh-list
101906001|NCT00262925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101906002|NCT00262925|Antibodies|antibodies|mesh-list
101906003|NCT00262925|Immunoglobulins|immunoglobulins|mesh-list
101906004|NCT00262925|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101906005|NCT00262925|Levoleucovorin|levoleucovorin|mesh-list
101906006|NCT00262925|Immunologic Factors|immunologic factors|mesh-ancestor
101906007|NCT00262925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906008|NCT00262925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101906009|NCT00262925|Antiemetics|antiemetics|mesh-ancestor
101906010|NCT00262925|Autonomic Agents|autonomic agents|mesh-ancestor
101906011|NCT00262925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101906012|NCT00262925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101906013|NCT00262925|Glucocorticoids|glucocorticoids|mesh-ancestor
101906014|NCT00262925|Hormones|hormones|mesh-ancestor
101906015|NCT00262925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101906016|NCT00262925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101906017|NCT00262925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101906018|NCT00262925|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101906019|NCT00262925|Abortifacient Agents|abortifacient agents|mesh-ancestor
101906020|NCT00262925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101906021|NCT00262925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101906022|NCT00262925|Antimetabolites|antimetabolites|mesh-ancestor
101906023|NCT00262925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906024|NCT00262925|Dermatologic Agents|dermatologic agents|mesh-ancestor
101906025|NCT00262925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101906026|NCT00262925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101906027|NCT00262925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101906028|NCT00262925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101906029|NCT00262925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101906030|NCT00262925|Antidotes|antidotes|mesh-ancestor
101906031|NCT00262925|Protective Agents|protective agents|mesh-ancestor
101906032|NCT00262925|Vitamin B Complex|vitamin b complex|mesh-ancestor
101906033|NCT00262925|Vitamins|vitamins|mesh-ancestor
101906034|NCT00262925|Micronutrients|micronutrients|mesh-ancestor
101906035|NCT00262925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101906036|NCT00262925|Tubulin Modulators|tubulin modulators|mesh-ancestor
101906037|NCT00262925|Antimitotic Agents|antimitotic agents|mesh-ancestor
101906038|NCT00262925|Mitosis Modulators|mitosis modulators|mesh-ancestor
101906039|NCT01581515|Everolimus|everolimus|mesh-list
101906040|NCT01581515|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101906041|NCT01581515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101906042|NCT01581515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101906043|NCT01581515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906044|NCT01581515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101906045|NCT01581515|Immunologic Factors|immunologic factors|mesh-ancestor
101906046|NCT01581515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906047|NCT01581515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101906048|NCT03720470|Abrocitinib|abrocitinib|mesh-list
101906049|NCT03720470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101906050|NCT03720470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101906051|NCT03720470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906052|NCT00262847|Paclitaxel|paclitaxel|mesh-list
101906053|NCT00262847|Bevacizumab|bevacizumab|mesh-list
101906054|NCT00262847|Carboplatin|carboplatin|mesh-list
101906055|NCT00262847|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101906056|NCT00262847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101906057|NCT00262847|Endothelial Growth Factors|endothelial growth factors|mesh-list
101906058|NCT00262847|Antibodies|antibodies|mesh-list
101906059|NCT00262847|Immunoglobulins|immunoglobulins|mesh-list
101906060|NCT00262847|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101906061|NCT00262847|Immunoglobulin G|immunoglobulin g|mesh-list
101906062|NCT00262847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101906063|NCT00262847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101906064|NCT00262847|Tubulin Modulators|tubulin modulators|mesh-ancestor
101906065|NCT00262847|Antimitotic Agents|antimitotic agents|mesh-ancestor
101906066|NCT00262847|Mitosis Modulators|mitosis modulators|mesh-ancestor
101906067|NCT00262847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906068|NCT00262847|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101906069|NCT00262847|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101906070|NCT00262847|Growth Substances|growth substances|mesh-ancestor
101906071|NCT00262847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906072|NCT00262847|Growth Inhibitors|growth inhibitors|mesh-ancestor
101906073|NCT00262847|Immunologic Factors|immunologic factors|mesh-ancestor
101906074|NCT05329532|Pembrolizumab|pembrolizumab|mesh-list
101625929|NCT02735343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101906075|NCT05329532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101906076|NCT05329532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101906077|NCT05329532|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101906078|NCT05329532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906079|NCT01303640|Everolimus|everolimus|mesh-list
101906080|NCT01303640|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101906081|NCT01303640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101906082|NCT01303640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101906083|NCT01303640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906084|NCT01303640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101906085|NCT01303640|Immunologic Factors|immunologic factors|mesh-ancestor
101906086|NCT01303640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906087|NCT01303640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101906088|NCT03817268|Capecitabine|capecitabine|mesh-list
101906089|NCT03817268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101906090|NCT03817268|Antimetabolites|antimetabolites|mesh-ancestor
101906091|NCT03817268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906092|NCT03817268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101906093|NCT00280397|Lenvatinib|lenvatinib|mesh-list
101906094|NCT00280397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101906095|NCT00280397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101906096|NCT00280397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101906097|NCT00280397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906098|NCT03817112|Dexmedetomidine|dexmedetomidine|mesh-list
101906099|NCT03817112|Propofol|propofol|mesh-list
101906100|NCT03817112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101906101|NCT03817112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101906102|NCT03817112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906103|NCT03817112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101906104|NCT03817112|Analgesics|analgesics|mesh-ancestor
101906105|NCT03817112|Sensory System Agents|sensory system agents|mesh-ancestor
101906106|NCT03817112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101906107|NCT03817112|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101906108|NCT03817112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101906109|NCT03817112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101906110|NCT03817112|Adrenergic Agents|adrenergic agents|mesh-ancestor
101906111|NCT03817112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101906112|NCT03817112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906113|NCT03817112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101906114|NCT03817112|Anesthetics, General|anesthetics, general|mesh-ancestor
101906115|NCT03817112|Anesthetics|anesthetics|mesh-ancestor
101906116|NCT00262301|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
101906117|NCT00262301|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101906118|NCT00262301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101906119|NCT00262301|Immunologic Factors|immunologic factors|mesh-ancestor
101906120|NCT00262301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906121|NCT03814148|Indapamide|indapamide|mesh-list
101906122|NCT03814148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101906123|NCT03814148|Diuretics|diuretics|mesh-ancestor
101906124|NCT03814148|Natriuretic Agents|natriuretic agents|mesh-ancestor
101906125|NCT03814148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906126|NCT03814148|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101906127|NCT03814148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101616762|NCT01689909|Zolpidem|zolpidem|mesh-list
101906128|NCT03814148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906129|NCT00279305|Rituximab|rituximab|mesh-list
101906130|NCT00279305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101906131|NCT00279305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101906132|NCT00279305|Immunologic Factors|immunologic factors|mesh-ancestor
101906133|NCT00279305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906134|NCT00279305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101906135|NCT03800810|Hyaluronic Acid|hyaluronic acid|mesh-list
101906136|NCT03800810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101906137|NCT03800810|Immunologic Factors|immunologic factors|mesh-ancestor
101906138|NCT03800810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906139|NCT03800810|Viscosupplements|viscosupplements|mesh-ancestor
101906140|NCT03800810|Protective Agents|protective agents|mesh-ancestor
101906141|NCT03974867|Prednisone|prednisone|mesh-list
101906142|NCT03974867|Methylprednisolone|methylprednisolone|mesh-list
101906143|NCT03974867|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101906144|NCT03974867|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101906146|NCT03974867|Prednisolone acetate|prednisolone acetate|mesh-list
101906147|NCT03974867|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101906148|NCT03974867|Prednisolone phosphate|prednisolone phosphate|mesh-list
101906149|NCT03974867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101906150|NCT03974867|Glucocorticoids|glucocorticoids|mesh-ancestor
101906151|NCT03974867|Hormones|hormones|mesh-ancestor
101626018|NCT02595463|Lidocaine|lidocaine|mesh-list
101906152|NCT03974867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101906153|NCT03974867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906154|NCT03974867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101906155|NCT03974867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101906156|NCT03974867|Antiemetics|antiemetics|mesh-ancestor
101906157|NCT03974867|Autonomic Agents|autonomic agents|mesh-ancestor
101906158|NCT03974867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101906159|NCT03974867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101906160|NCT03974867|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101906161|NCT03974867|Protective Agents|protective agents|mesh-ancestor
101906162|NCT03799406|Vitamin D|vitamin d|mesh-list
101906163|NCT03799406|Cholecalciferol|cholecalciferol|mesh-list
101906164|NCT03799406|Vitamins|vitamins|mesh-ancestor
101906165|NCT03799406|Micronutrients|micronutrients|mesh-ancestor
101906166|NCT03799406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906167|NCT03799406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101906168|NCT03799406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101906169|NCT03799172|Echinocandins|echinocandins|mesh-list
101906170|NCT03799172|Antifungal Agents|antifungal agents|mesh-ancestor
101906171|NCT03799172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101906172|NCT03799094|Ascorbic Acid|ascorbic acid|mesh-list
101906173|NCT03799094|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101906174|NCT03799094|Vitamins|vitamins|mesh-ancestor
101906175|NCT03799094|Micronutrients|micronutrients|mesh-ancestor
101906176|NCT03799094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906177|NCT03799094|Antioxidants|antioxidants|mesh-ancestor
101906178|NCT03799094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906179|NCT03799094|Protective Agents|protective agents|mesh-ancestor
101906180|NCT03799094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101906181|NCT03799094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101906182|NCT00277355|Minocycline|minocycline|mesh-list
101906183|NCT00277355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101906184|NCT00277355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101906185|NCT00262223|Sertraline|sertraline|mesh-list
101906186|NCT00262223|Antidepressive Agents|antidepressive agents|mesh-ancestor
101906187|NCT00262223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101906188|NCT00262223|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101906189|NCT00262223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101906190|NCT00262223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101906191|NCT00262223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906192|NCT00262223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101906193|NCT00262223|Serotonin Agents|serotonin agents|mesh-ancestor
101906194|NCT00262223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906195|NCT05575700|Ibuprofen|ibuprofen|mesh-list
101906196|NCT05575700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101906197|NCT05575700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101906198|NCT05575700|Analgesics|analgesics|mesh-ancestor
101906199|NCT05575700|Sensory System Agents|sensory system agents|mesh-ancestor
101906200|NCT05575700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101906201|NCT05575700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906202|NCT05575700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101906203|NCT05575700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101906204|NCT05575700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101906205|NCT05575700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101906206|NCT05575700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906207|NCT00276419|Diclofenac|diclofenac|mesh-list
101906208|NCT00276419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101906209|NCT00276419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101906210|NCT00276419|Analgesics|analgesics|mesh-ancestor
101906211|NCT00276419|Sensory System Agents|sensory system agents|mesh-ancestor
101906212|NCT00276419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101906213|NCT00276419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906214|NCT00276419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101906215|NCT00276419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101906216|NCT00276419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101906217|NCT00276419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101906218|NCT00276419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906219|NCT03798392|Anesthetics|anesthetics|mesh-list
101906220|NCT03798392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101906221|NCT03798392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906222|NCT03816020|Niacinamide|niacinamide|mesh-list
101906224|NCT03816020|Nicotinic Acids|nicotinic acids|mesh-list
101906225|NCT03816020|Vitamin B Complex|vitamin b complex|mesh-ancestor
101906226|NCT03816020|Vitamins|vitamins|mesh-ancestor
101906227|NCT03816020|Micronutrients|micronutrients|mesh-ancestor
101906228|NCT03816020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906229|NCT03816020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101906230|NCT03816020|Antimetabolites|antimetabolites|mesh-ancestor
101906231|NCT03816020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906232|NCT03816020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101906233|NCT03816020|Vasodilator Agents|vasodilator agents|mesh-ancestor
101906234|NCT03815864|Antibodies|antibodies|mesh-list
101906235|NCT03815864|Immunoglobulins|immunoglobulins|mesh-list
101906236|NCT03815864|Immunologic Factors|immunologic factors|mesh-ancestor
101906237|NCT03815864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906238|NCT04151342|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101906239|NCT04151342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101906240|NCT04151342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101906241|NCT04151342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906242|NCT03815942|Nivolumab|nivolumab|mesh-list
101906243|NCT03815942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101906244|NCT03815942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101906245|NCT03815942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101906246|NCT03815942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906247|NCT01303874|Etanercept|etanercept|mesh-list
101906248|NCT01303874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101906249|NCT01303874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101906250|NCT01303874|Analgesics|analgesics|mesh-ancestor
101906251|NCT01303874|Sensory System Agents|sensory system agents|mesh-ancestor
101906252|NCT01303874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101906253|NCT01303874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906254|NCT01303874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101906255|NCT01303874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101906256|NCT01303874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101906257|NCT01303874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101906258|NCT01303874|Immunologic Factors|immunologic factors|mesh-ancestor
101906259|NCT03813056|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101906260|NCT03813056|Lubricant Eye Drops|lubricant eye drops|mesh-list
101906261|NCT03813056|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101906262|NCT04070768|Venetoclax|venetoclax|mesh-list
101906263|NCT04070768|Gemtuzumab|gemtuzumab|mesh-list
101906264|NCT04070768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101906265|NCT04070768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101906266|NCT04070768|Immunotoxins|immunotoxins|mesh-ancestor
101906267|NCT04070768|Immunoconjugates|immunoconjugates|mesh-ancestor
101906268|NCT04070768|Immunologic Factors|immunologic factors|mesh-ancestor
101906269|NCT04070768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906270|NCT01301612|Cisplatin|cisplatin|mesh-list
101906271|NCT01301612|Nimotuzumab|nimotuzumab|mesh-list
101906272|NCT01301612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101906273|NCT01301612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101906274|NCT01303952|Eculizumab|eculizumab|mesh-list
101906275|NCT01303952|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101906276|NCT01303952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101906277|NCT01303952|Immunologic Factors|immunologic factors|mesh-ancestor
101906278|NCT01303952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906279|NCT03970616|Durvalumab|durvalumab|mesh-list
101906280|NCT03970616|Tivozanib|tivozanib|mesh-list
101906281|NCT03970616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101906282|NCT03970616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101906283|NCT03970616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101906284|NCT03970616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101906285|NCT03970616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906287|NCT03815474|Ifosfamide|ifosfamide|mesh-list
101906288|NCT03815474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101906289|NCT03815474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101906290|NCT03815474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101906291|NCT03815474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101906292|NCT03815474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101906293|NCT03815474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906294|NCT03815474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101906295|NCT03815474|Alkylating Agents|alkylating agents|mesh-ancestor
101906296|NCT01302158|Glimepiride|glimepiride|mesh-list
101906297|NCT01302158|Ipragliflozin|ipragliflozin|mesh-list
101906298|NCT01302158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101906299|NCT01302158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101906300|NCT01302158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906301|NCT01302158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101906302|NCT01302158|Immunologic Factors|immunologic factors|mesh-ancestor
101906303|NCT01302158|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101906304|NCT01302158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906306|NCT01302236|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101906307|NCT01302236|Hormone Antagonists|hormone antagonists|mesh-ancestor
101906308|NCT01302236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101906309|NCT01302236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906310|NCT01302236|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101906311|NCT01302236|Diuretics|diuretics|mesh-ancestor
101906312|NCT01302236|Natriuretic Agents|natriuretic agents|mesh-ancestor
101906313|NCT01302236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101906314|NCT01304264|Maleic acid|maleic acid|mesh-list
101906315|NCT01304264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101906316|NCT01304264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906317|NCT01304342|Fentanyl|fentanyl|mesh-list
101906318|NCT01304342|Remifentanil|remifentanil|mesh-list
101906319|NCT01304342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101906320|NCT01304342|Narcotics|narcotics|mesh-ancestor
101906321|NCT01304342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101906322|NCT01304342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906323|NCT01304342|Analgesics|analgesics|mesh-ancestor
101906324|NCT01304342|Sensory System Agents|sensory system agents|mesh-ancestor
101906325|NCT01304342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101906326|NCT01304342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101906327|NCT01304342|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101906328|NCT01304342|Anesthetics, General|anesthetics, general|mesh-ancestor
101906329|NCT01304342|Anesthetics|anesthetics|mesh-ancestor
101906330|NCT03653546|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101906331|NCT03653546|Gefitinib|gefitinib|mesh-list
101906332|NCT03653546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101906333|NCT03653546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101906334|NCT03653546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101906335|NCT03653546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906336|NCT03812354|Nicotine|nicotine|mesh-list
101906337|NCT03812354|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101906338|NCT03812354|Autonomic Agents|autonomic agents|mesh-ancestor
101906339|NCT03812354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101906340|NCT03812354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906341|NCT03812354|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101906342|NCT03812354|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101906343|NCT03812354|Cholinergic Agents|cholinergic agents|mesh-ancestor
101906344|NCT03812354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101227783|NCT01541943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101906345|NCT03812354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906346|NCT03812120|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101906347|NCT03812120|Hemostatics|hemostatics|mesh-ancestor
101906348|NCT03812120|Coagulants|coagulants|mesh-ancestor
101906349|NCT03796364|Endostar protein|endostar protein|mesh-list
101906350|NCT03796364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101906351|NCT03796364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101906352|NCT03796364|Growth Substances|growth substances|mesh-ancestor
101906353|NCT03796364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906354|NCT03796364|Growth Inhibitors|growth inhibitors|mesh-ancestor
101906355|NCT03796364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101906356|NCT03795584|Hemostatics|hemostatics|mesh-list
101906357|NCT03795584|Coagulants|coagulants|mesh-ancestor
101906358|NCT03792776|Lidocaine|lidocaine|mesh-list
101906359|NCT03792776|Anesthetics|anesthetics|mesh-list
101906360|NCT03792776|Anesthetics, Local|anesthetics, local|mesh-ancestor
101906361|NCT03792776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101906362|NCT03792776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906363|NCT03792776|Sensory System Agents|sensory system agents|mesh-ancestor
101906364|NCT03792776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101906365|NCT03792776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101906366|NCT03792776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101906367|NCT03792776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101906368|NCT03792776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101906369|NCT03792776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906370|NCT03795272|Rucaparib|rucaparib|mesh-list
101906371|NCT03795272|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101906372|NCT03795272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101906373|NCT03795272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906374|NCT03795272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101906375|NCT00956930|Doxorubicin|doxorubicin|mesh-list
101906376|NCT00956930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101906377|NCT00956930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101906378|NCT00956930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101906379|NCT00956930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101906380|NCT00956930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101906381|NCT00956930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101906382|NCT00956930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906383|NCT03792620|Daratumumab|daratumumab|mesh-list
101906384|NCT03792620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101906385|NCT05027594|Dexamethasone|dexamethasone|mesh-list
101906386|NCT05027594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101906387|NCT05027594|Antiemetics|antiemetics|mesh-ancestor
101906388|NCT05027594|Autonomic Agents|autonomic agents|mesh-ancestor
101906389|NCT05027594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101906390|NCT05027594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906391|NCT05027594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101906392|NCT05027594|Glucocorticoids|glucocorticoids|mesh-ancestor
101906393|NCT05027594|Hormones|hormones|mesh-ancestor
101906394|NCT05027594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101906395|NCT05027594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101906396|NCT05027594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101906397|NCT03811418|Docetaxel|docetaxel|mesh-list
101906398|NCT03811418|Trastuzumab|trastuzumab|mesh-list
101906399|NCT03811418|Vinorelbine|vinorelbine|mesh-list
101906400|NCT03811418|Pertuzumab|pertuzumab|mesh-list
101906401|NCT03811418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101906402|NCT03811418|Tubulin Modulators|tubulin modulators|mesh-ancestor
101906403|NCT03811418|Antimitotic Agents|antimitotic agents|mesh-ancestor
101906404|NCT03811418|Mitosis Modulators|mitosis modulators|mesh-ancestor
101906405|NCT03811418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906406|NCT03811418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101906407|NCT03811418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101906408|NCT03794492|Mycophenolic Acid|mycophenolic acid|mesh-list
101906409|NCT03794492|Methylprednisolone|methylprednisolone|mesh-list
101906410|NCT03794492|Prednisolone|prednisolone|mesh-list
101906411|NCT03794492|Tacrolimus|tacrolimus|mesh-list
101906412|NCT03794492|Basiliximab|basiliximab|mesh-list
101906413|NCT03794492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101906414|NCT03794492|Immunologic Factors|immunologic factors|mesh-ancestor
101906415|NCT03794492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906416|NCT03794492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101906417|NCT03794492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101906418|NCT03794492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906419|NCT03794492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101906420|NCT03794492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101906421|NCT03794492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101906422|NCT03794492|Antitubercular Agents|antitubercular agents|mesh-ancestor
101906423|NCT03794492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101906424|NCT03794492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101906425|NCT03794492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101906426|NCT03794492|Antiemetics|antiemetics|mesh-ancestor
101906427|NCT03794492|Autonomic Agents|autonomic agents|mesh-ancestor
101906428|NCT03794492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101906429|NCT03794492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101906430|NCT03794492|Glucocorticoids|glucocorticoids|mesh-ancestor
101906431|NCT03794492|Hormones|hormones|mesh-ancestor
101906432|NCT03794492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101906433|NCT03794492|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101906434|NCT03794492|Protective Agents|protective agents|mesh-ancestor
101906435|NCT03794492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101906436|NCT03792152|Warfarin|warfarin|mesh-list
101906437|NCT03792152|Rivaroxaban|rivaroxaban|mesh-list
101906438|NCT03792152|Anticoagulants|anticoagulants|mesh-ancestor
101906439|NCT03792152|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101906440|NCT03792152|Antithrombins|antithrombins|mesh-ancestor
101906441|NCT03792152|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101906442|NCT03792152|Protease Inhibitors|protease inhibitors|mesh-ancestor
101906443|NCT03792152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101906444|NCT03792152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906445|NCT00262067|Bevacizumab|bevacizumab|mesh-list
101906446|NCT00262067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101626301|NCT00811720|Sensory System Agents|sensory system agents|mesh-ancestor
101906447|NCT00262067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101906448|NCT00262067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101906449|NCT00262067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101906450|NCT00262067|Growth Substances|growth substances|mesh-ancestor
101906451|NCT00262067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906453|NCT00275561|Fluticasone|fluticasone|mesh-list
101906454|NCT00275561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101906455|NCT00275561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101906456|NCT00275561|Autonomic Agents|autonomic agents|mesh-ancestor
101906457|NCT00275561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101906458|NCT00275561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906459|NCT00275561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101906460|NCT00275561|Respiratory System Agents|respiratory system agents|mesh-ancestor
101906461|NCT00275561|Dermatologic Agents|dermatologic agents|mesh-ancestor
101906462|NCT00275561|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101906463|NCT03810872|Paclitaxel|paclitaxel|mesh-list
101906464|NCT03810872|Afatinib|afatinib|mesh-list
101906465|NCT03810872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101906466|NCT03810872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101906467|NCT03810872|Tubulin Modulators|tubulin modulators|mesh-ancestor
101906468|NCT03810872|Antimitotic Agents|antimitotic agents|mesh-ancestor
101906469|NCT03810872|Mitosis Modulators|mitosis modulators|mesh-ancestor
101227791|NCT01541956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906470|NCT03810872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906471|NCT03810872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101906472|NCT03810872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101906473|NCT05569148|Faricimab|faricimab|mesh-list
101906474|NCT05569148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101906475|NCT05569148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101906476|NCT05569148|Growth Substances|growth substances|mesh-ancestor
101906477|NCT05569148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906478|NCT05569148|Growth Inhibitors|growth inhibitors|mesh-ancestor
101906479|NCT05569148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101906480|NCT03794180|Plonmarlimab|plonmarlimab|mesh-list
101906481|NCT03794180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101906482|NCT03794180|Antiviral Agents|antiviral agents|mesh-ancestor
101906483|NCT03794180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101906484|NCT00274937|Cisplatin|cisplatin|mesh-list
101906485|NCT00274937|Fluorouracil|fluorouracil|mesh-list
101906486|NCT00274937|Amifostine|amifostine|mesh-list
101906487|NCT00274937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101906488|NCT00274937|Antimetabolites|antimetabolites|mesh-ancestor
101906489|NCT00274937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906490|NCT00274937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101906491|NCT00274937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101906492|NCT00274937|Immunologic Factors|immunologic factors|mesh-ancestor
101906493|NCT00274937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906494|NCT00274937|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101906495|NCT00274937|Protective Agents|protective agents|mesh-ancestor
101906496|NCT03792074|Paclitaxel|paclitaxel|mesh-list
101906497|NCT03792074|Bevacizumab|bevacizumab|mesh-list
101906498|NCT03792074|Carboplatin|carboplatin|mesh-list
101906499|NCT03792074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101906500|NCT03792074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101906501|NCT03792074|Tubulin Modulators|tubulin modulators|mesh-ancestor
101906502|NCT03792074|Antimitotic Agents|antimitotic agents|mesh-ancestor
101906503|NCT03792074|Mitosis Modulators|mitosis modulators|mesh-ancestor
101906504|NCT03792074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906505|NCT03792074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101906506|NCT03792074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101906507|NCT03792074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101906508|NCT03792074|Growth Substances|growth substances|mesh-ancestor
101906509|NCT03792074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906510|NCT03792074|Growth Inhibitors|growth inhibitors|mesh-ancestor
101906511|NCT00251693|Lansoprazole|lansoprazole|mesh-list
101906512|NCT00251693|Dexlansoprazole|dexlansoprazole|mesh-list
101906513|NCT00251693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101906514|NCT00251693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101906515|NCT00251693|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101906516|NCT00251693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101906517|NCT00251693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906518|NCT03791918|Lenvatinib|lenvatinib|mesh-list
101906519|NCT03791918|Chlorotrianisene|chlorotrianisene|mesh-list
101906520|NCT03791918|Antibodies|antibodies|mesh-list
101906521|NCT03791918|Immunoglobulins|immunoglobulins|mesh-list
101906522|NCT03791918|Immunologic Factors|immunologic factors|mesh-ancestor
101906523|NCT03791918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906524|NCT03791918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101626370|NCT02727621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101906525|NCT03791918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101906526|NCT03791918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101906527|NCT03791918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906528|NCT03791918|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101906529|NCT03791918|Estrogens|estrogens|mesh-ancestor
101906530|NCT03791918|Hormones|hormones|mesh-ancestor
101906531|NCT03791918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101906532|NCT03791918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101906533|NCT00250835|Celecoxib|celecoxib|mesh-list
101906534|NCT00250835|Capecitabine|capecitabine|mesh-list
101906535|NCT00250835|Oxaliplatin|oxaliplatin|mesh-list
101906536|NCT00250835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101906537|NCT00250835|Antimetabolites|antimetabolites|mesh-ancestor
101227799|NCT01542060|Biphasic Insulins|biphasic insulins|mesh-list
101906538|NCT00250835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906539|NCT00250835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101906540|NCT00250835|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101906541|NCT00250835|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101906542|NCT00250835|Analgesics|analgesics|mesh-ancestor
101906543|NCT00250835|Sensory System Agents|sensory system agents|mesh-ancestor
101906544|NCT00250835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101906545|NCT00250835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906546|NCT00250835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101906547|NCT00250835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101906548|NCT00250835|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101906549|NCT00250835|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101906550|NCT00250835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101906551|NCT01303094|Trabectedin|trabectedin|mesh-list
101906552|NCT01303094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101906553|NCT01303094|Alkylating Agents|alkylating agents|mesh-ancestor
101906554|NCT01303094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906555|NCT01303094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101906556|NCT04785326|Ustekinumab|ustekinumab|mesh-list
101906557|NCT04785326|Dermatologic Agents|dermatologic agents|mesh-ancestor
101906558|NCT03791762|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
101906559|NCT03791762|Vasodilator Agents|vasodilator agents|mesh-ancestor
101906560|NCT03791762|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101906561|NCT03791762|Protective Agents|protective agents|mesh-ancestor
101906562|NCT03791762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906563|NCT04663568|Levonorgestrel|levonorgestrel|mesh-list
101906564|NCT04663568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101906565|NCT04663568|Contraceptive Agents|contraceptive agents|mesh-ancestor
101906566|NCT04663568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101906567|NCT04663568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906568|NCT04663568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101906569|NCT04663568|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101906570|NCT04663568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101906571|NCT03789032|Rabeprazole|rabeprazole|mesh-list
101906572|NCT03789032|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101906574|NCT03789032|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101906575|NCT03789032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101955300|NCT03764163|Xenon|xenon|mesh-list
101906576|NCT03789032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906577|NCT01306370|Tranexamic Acid|tranexamic acid|mesh-list
101906578|NCT01306370|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101906579|NCT01306370|Hemostatics|hemostatics|mesh-list
101906580|NCT01306370|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101906581|NCT01306370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101906582|NCT01306370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906583|NCT01306370|Coagulants|coagulants|mesh-ancestor
101906584|NCT03716024|Linezolid|linezolid|mesh-list
101906585|NCT03716024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101906586|NCT03716024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101906587|NCT03716024|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101906588|NCT03716024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101906589|NCT03716024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906590|NCT00250679|Formoterol Fumarate|formoterol fumarate|mesh-list
101906591|NCT00250679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101906592|NCT00250679|Autonomic Agents|autonomic agents|mesh-ancestor
101906593|NCT00250679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101906594|NCT00250679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906595|NCT00250679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101906596|NCT00250679|Respiratory System Agents|respiratory system agents|mesh-ancestor
101906597|NCT00250679|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101906598|NCT00250679|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101906599|NCT00250679|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101906600|NCT00250679|Adrenergic Agents|adrenergic agents|mesh-ancestor
101906601|NCT00250679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101906602|NCT00250679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906603|NCT03791294|Titanium dioxide|titanium dioxide|mesh-list
101906604|NCT03791294|Hyaluronic Acid|hyaluronic acid|mesh-list
101906605|NCT03791294|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101906606|NCT03791294|Immunologic Factors|immunologic factors|mesh-ancestor
101906607|NCT03791294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906608|NCT03791294|Viscosupplements|viscosupplements|mesh-ancestor
101906609|NCT03791294|Protective Agents|protective agents|mesh-ancestor
101906610|NCT03791294|Sunscreening Agents|sunscreening agents|mesh-ancestor
101906611|NCT03791294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101906612|NCT03791294|Dermatologic Agents|dermatologic agents|mesh-ancestor
101906613|NCT03791294|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101906614|NCT01567358|Infliximab|infliximab|mesh-list
101906615|NCT01567358|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101906616|NCT01567358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101906617|NCT01567358|Dermatologic Agents|dermatologic agents|mesh-ancestor
101906618|NCT01567358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101906619|NCT01567358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101906620|NCT00261833|Protease Inhibitors|protease inhibitors|mesh-list
101906621|NCT00261833|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
101906622|NCT00261833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101906623|NCT00261833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906624|NCT00261833|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101906625|NCT00261833|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101906626|NCT01308242|Sevelamer|sevelamer|mesh-list
101906627|NCT01308242|Chelating Agents|chelating agents|mesh-ancestor
101906628|NCT01308242|Sequestering Agents|sequestering agents|mesh-ancestor
101906629|NCT01308242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906630|NCT01308320|Fentanyl|fentanyl|mesh-list
101906631|NCT01308320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101906632|NCT01308320|Narcotics|narcotics|mesh-ancestor
101906633|NCT01308320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101906634|NCT01308320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906635|NCT01308320|Analgesics|analgesics|mesh-ancestor
101906636|NCT01308320|Sensory System Agents|sensory system agents|mesh-ancestor
101906637|NCT01308320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101906638|NCT01308320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101906639|NCT01308320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101906640|NCT01308320|Anesthetics, General|anesthetics, general|mesh-ancestor
101906641|NCT01308320|Anesthetics|anesthetics|mesh-ancestor
101906642|NCT01306760|Ketamine|ketamine|mesh-list
101906643|NCT01306760|Propofol|propofol|mesh-list
101906644|NCT01306760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101906645|NCT01306760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101906646|NCT01306760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101955306|NCT02556099|Hydroxyurea|hydroxyurea|mesh-list
101906647|NCT01306760|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101906648|NCT01306760|Anesthetics, General|anesthetics, general|mesh-ancestor
101906650|NCT01306760|Analgesics|analgesics|mesh-ancestor
101906651|NCT01306760|Sensory System Agents|sensory system agents|mesh-ancestor
101906652|NCT01306760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101906653|NCT01306760|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101906654|NCT01306760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101906655|NCT01306760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101906656|NCT01306760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101906657|NCT01306760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906658|NCT03787940|Isoniazid|isoniazid|mesh-list
101906659|NCT03787940|Antitubercular Agents|antitubercular agents|mesh-ancestor
101906660|NCT03787940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101906661|NCT03787940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101906662|NCT03787940|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101906663|NCT03787940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101906664|NCT03787940|Antimetabolites|antimetabolites|mesh-ancestor
101906665|NCT03787940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906666|NCT03787940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101906667|NCT03788018|Lidocaine|lidocaine|mesh-list
101906668|NCT03788018|Dexmedetomidine|dexmedetomidine|mesh-list
101906669|NCT03788018|Anesthetics, Local|anesthetics, local|mesh-ancestor
101906670|NCT03788018|Anesthetics|anesthetics|mesh-ancestor
101906671|NCT03788018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101906672|NCT03788018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906673|NCT03788018|Sensory System Agents|sensory system agents|mesh-ancestor
101906674|NCT03788018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101906675|NCT03788018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101906676|NCT03788018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101906677|NCT03788018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101906678|NCT03788018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101906679|NCT03788018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906680|NCT03788018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101906681|NCT03788018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101906682|NCT03788018|Analgesics|analgesics|mesh-ancestor
101906683|NCT03788018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101906684|NCT03788018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101906685|NCT03788018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101906686|NCT03788018|Adrenergic Agents|adrenergic agents|mesh-ancestor
101906687|NCT03788018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101906688|NCT03785756|Ibuprofen|ibuprofen|mesh-list
101906689|NCT03785756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101906690|NCT03785756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101906691|NCT03785756|Analgesics|analgesics|mesh-ancestor
101906692|NCT03785756|Sensory System Agents|sensory system agents|mesh-ancestor
101906693|NCT03785756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101906694|NCT03785756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906695|NCT03785756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101906696|NCT03785756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101906697|NCT03785756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101906698|NCT03785756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101906699|NCT03785756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906700|NCT03788174|Apatinib|apatinib|mesh-list
101906701|NCT03788174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101906702|NCT03788174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101906703|NCT03788174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101906704|NCT03788174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906705|NCT03787550|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101906706|NCT03787550|Analgesics|analgesics|mesh-list
101906707|NCT03787550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
101906708|NCT03787550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101906709|NCT03787550|Sensory System Agents|sensory system agents|mesh-ancestor
101906710|NCT03787550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101906711|NCT03787550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906712|NCT03787550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101906713|NCT03790358|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
101906714|NCT03790358|Hallucinogens|hallucinogens|mesh-ancestor
101906715|NCT03790358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906716|NCT03790358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101906717|NCT03790358|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101906718|NCT03790358|Serotonin Agents|serotonin agents|mesh-ancestor
101906719|NCT03790358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101906720|NCT03790358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906721|NCT03790358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101906722|NCT03789890|Itraconazole|itraconazole|mesh-list
101906723|NCT03789890|Antifungal Agents|antifungal agents|mesh-ancestor
101906724|NCT03789890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101906725|NCT03789890|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101906726|NCT03789890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101906727|NCT03789890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101906728|NCT03789890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906729|NCT03789890|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101906730|NCT03789890|Hormone Antagonists|hormone antagonists|mesh-ancestor
101906731|NCT03789890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101906732|NCT03789890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906733|NCT03789890|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101906734|NCT01308554|Bupivacaine|bupivacaine|mesh-list
101906735|NCT01308554|Anesthetics, Local|anesthetics, local|mesh-ancestor
101906736|NCT01308554|Anesthetics|anesthetics|mesh-ancestor
101906737|NCT01308554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101906738|NCT01308554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906739|NCT01308554|Sensory System Agents|sensory system agents|mesh-ancestor
101906740|NCT01308554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101906741|NCT05693402|Analgesics, Opioid|analgesics, opioid|mesh-list
101906742|NCT05693402|Anesthetics|anesthetics|mesh-list
101906743|NCT05693402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101906744|NCT05693402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906745|NCT05693402|Narcotics|narcotics|mesh-ancestor
101906746|NCT05693402|Analgesics|analgesics|mesh-ancestor
101906747|NCT05693402|Sensory System Agents|sensory system agents|mesh-ancestor
101906748|NCT05693402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101906749|NCT05694728|Vaccines|vaccines|mesh-list
101906750|NCT05694728|Immunologic Factors|immunologic factors|mesh-ancestor
101906751|NCT05694728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906752|NCT01308632|Irinotecan|irinotecan|mesh-list
101906753|NCT01308632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101906754|NCT01308632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101906755|NCT01308632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101906756|NCT01308632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906757|NCT01308632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101906758|NCT03713684|Efpeglenatide|efpeglenatide|mesh-list
101906759|NCT03713684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101906760|NCT03713684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906761|NCT03785522|Insulin|insulin|mesh-list
101906762|NCT03785522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101906763|NCT03785522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906764|NCT05694416|Etoposide|etoposide|mesh-list
101906765|NCT05694416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101906766|NCT05694416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101906767|NCT05694416|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101906768|NCT05694416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101906769|NCT05694416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101906770|NCT05694416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906771|NCT03789422|Cetirizine|cetirizine|mesh-list
101906772|NCT03789422|Tranexamic Acid|tranexamic acid|mesh-list
101906773|NCT03789422|Levocetirizine|levocetirizine|mesh-list
101906774|NCT03789422|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101906775|NCT03789422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101906776|NCT03789422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906777|NCT03789422|Hemostatics|hemostatics|mesh-ancestor
101906778|NCT03789422|Coagulants|coagulants|mesh-ancestor
101227846|NCT01542268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101906779|NCT03789422|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101906780|NCT03789422|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101906781|NCT03789422|Histamine Antagonists|histamine antagonists|mesh-ancestor
101906782|NCT03789422|Histamine Agents|histamine agents|mesh-ancestor
101906783|NCT03789422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101906784|NCT03789422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906785|NCT03789422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101906786|NCT04751084|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101906787|NCT04751084|Parasympatholytics|parasympatholytics|mesh-ancestor
101906788|NCT04751084|Autonomic Agents|autonomic agents|mesh-ancestor
101906789|NCT04751084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101906790|NCT04751084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906791|NCT04751084|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101906792|NCT04751084|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101906793|NCT04751084|Cholinergic Agents|cholinergic agents|mesh-ancestor
101906794|NCT04751084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101906795|NCT04751084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906796|NCT05690048|Vancomycin|vancomycin|mesh-list
101906797|NCT05690048|Bevacizumab|bevacizumab|mesh-list
101906798|NCT05690048|Atezolizumab|atezolizumab|mesh-list
101906799|NCT05690048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101906800|NCT05690048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101906801|NCT05690048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101906802|NCT05690048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101906803|NCT05690048|Growth Substances|growth substances|mesh-ancestor
101906804|NCT05690048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906805|NCT05690048|Growth Inhibitors|growth inhibitors|mesh-ancestor
101906806|NCT05690048|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101906807|NCT05690048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906808|NCT05690048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101906809|NCT05690048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101906810|NCT01308086|Leucovorin|leucovorin|mesh-list
101906811|NCT01308086|Fluorouracil|fluorouracil|mesh-list
101906812|NCT01308086|Capecitabine|capecitabine|mesh-list
101906813|NCT01308086|Oxaliplatin|oxaliplatin|mesh-list
101906814|NCT01308086|Levoleucovorin|levoleucovorin|mesh-list
101906815|NCT01308086|Antimetabolites|antimetabolites|mesh-ancestor
101906816|NCT01308086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906817|NCT01308086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101906818|NCT01308086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101906819|NCT01308086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101906820|NCT01308086|Immunologic Factors|immunologic factors|mesh-ancestor
101906821|NCT01308086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906822|NCT01308086|Antidotes|antidotes|mesh-ancestor
101906823|NCT01308086|Protective Agents|protective agents|mesh-ancestor
101906824|NCT01308086|Vitamin B Complex|vitamin b complex|mesh-ancestor
101906825|NCT01308086|Vitamins|vitamins|mesh-ancestor
101906827|NCT05443802|Insulin|insulin|mesh-list
101906828|NCT05443802|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101906829|NCT05443802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101906830|NCT05443802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906831|NCT01308944|Propranolol|propranolol|mesh-list
101906832|NCT01308944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101906833|NCT01308944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101906834|NCT01308944|Adrenergic Agents|adrenergic agents|mesh-ancestor
101906835|NCT01308944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101906836|NCT01308944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906837|NCT01308944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906838|NCT01308944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101906839|NCT01308944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101906840|NCT01308944|Vasodilator Agents|vasodilator agents|mesh-ancestor
101906841|NCT03777488|Tranexamic Acid|tranexamic acid|mesh-list
101906842|NCT03777488|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101906843|NCT03777488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101906844|NCT03777488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906845|NCT03777488|Hemostatics|hemostatics|mesh-ancestor
101906846|NCT03777488|Coagulants|coagulants|mesh-ancestor
101906847|NCT03777254|RC28-E protein|rc28-e protein|mesh-list
101906848|NCT03777254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101906849|NCT03777254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101906850|NCT03777254|Growth Substances|growth substances|mesh-ancestor
101906851|NCT03777254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906852|NCT03777254|Growth Inhibitors|growth inhibitors|mesh-ancestor
101906853|NCT03777254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101906854|NCT01312298|Bupivacaine|bupivacaine|mesh-list
101906855|NCT01312298|Anesthetics|anesthetics|mesh-list
101906856|NCT01312298|Propofol|propofol|mesh-list
101906857|NCT01312298|Succinylcholine|succinylcholine|mesh-list
101906858|NCT01312298|Anesthetics, Local|anesthetics, local|mesh-ancestor
101906859|NCT01312298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101955315|NCT01321827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101906860|NCT01312298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906861|NCT01312298|Sensory System Agents|sensory system agents|mesh-ancestor
101906862|NCT01312298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101906863|NCT01312298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101906864|NCT01312298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101906865|NCT01312298|Anesthetics, General|anesthetics, general|mesh-ancestor
101906866|NCT01312298|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
101906867|NCT01312298|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101906868|NCT01312298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101906869|NCT01309022|Mycophenolic Acid|mycophenolic acid|mesh-list
101906870|NCT01309022|Sirolimus|sirolimus|mesh-list
101906871|NCT01309022|Tacrolimus|tacrolimus|mesh-list
101906872|NCT01309022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101906873|NCT01309022|Immunologic Factors|immunologic factors|mesh-ancestor
101906874|NCT01309022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906875|NCT01309022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101906876|NCT01309022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101906877|NCT01309022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906878|NCT01309022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101906879|NCT01309022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101906880|NCT01309022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101906881|NCT01309022|Antitubercular Agents|antitubercular agents|mesh-ancestor
101906882|NCT01309022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101906883|NCT01309022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101906884|NCT01309022|Antifungal Agents|antifungal agents|mesh-ancestor
101906885|NCT01560962|Azithromycin|azithromycin|mesh-list
101906886|NCT01560962|Tobramycin|tobramycin|mesh-list
101906887|NCT01560962|Povidone-Iodine|povidone-iodine|mesh-list
101906888|NCT01560962|Povidone|povidone|mesh-list
101906889|NCT01560962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101906890|NCT01560962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101906891|NCT01560962|Plasma Substitutes|plasma substitutes|mesh-ancestor
101906892|NCT01560962|Blood Substitutes|blood substitutes|mesh-ancestor
101906893|NCT01560962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101906894|NCT05401058|Droperidol|droperidol|mesh-list
101906895|NCT05401058|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101906896|NCT05401058|Antiemetics|antiemetics|mesh-ancestor
101906897|NCT05401058|Autonomic Agents|autonomic agents|mesh-ancestor
101906898|NCT05401058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101906899|NCT05401058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906900|NCT05401058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101906901|NCT05401058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101906902|NCT05401058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101906903|NCT05401058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101906904|NCT05401058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101906905|NCT05401058|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101906906|NCT05401058|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101906907|NCT05401058|Dopamine Agents|dopamine agents|mesh-ancestor
101906908|NCT05401058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101906909|NCT05401058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906910|NCT03781466|Progesterone|progesterone|mesh-list
101906911|NCT03781466|Progestins|progestins|mesh-ancestor
101906912|NCT03781466|Hormones|hormones|mesh-ancestor
101906913|NCT03781466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101906914|NCT03781466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906915|NCT03150862|Pamiparib|pamiparib|mesh-list
101227863|NCT01542424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101906916|NCT03150862|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101906917|NCT03150862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101906918|NCT03150862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906919|NCT03150862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101906920|NCT01318928|Metronidazole|metronidazole|mesh-list
101906921|NCT01318928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101906922|NCT01318928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101906923|NCT01318928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101906924|NCT01318928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101906925|NCT01309178|Mannitol|mannitol|mesh-list
101906926|NCT01309178|Amitriptyline|amitriptyline|mesh-list
101906927|NCT01309178|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101906928|NCT01309178|Antidepressive Agents|antidepressive agents|mesh-ancestor
101906929|NCT01309178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101906930|NCT01309178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101906931|NCT01309178|Analgesics|analgesics|mesh-ancestor
101955321|NCT01321827|Antifungal Agents|antifungal agents|mesh-ancestor
101906932|NCT01309178|Sensory System Agents|sensory system agents|mesh-ancestor
101906933|NCT01309178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101906934|NCT01309178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906935|NCT01309178|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101906936|NCT01309178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101906937|NCT01309178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101906938|NCT01309178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906939|NCT01309178|Adrenergic Agents|adrenergic agents|mesh-ancestor
101906940|NCT01309178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101906941|NCT01309178|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101906942|NCT01309178|Diuretics|diuretics|mesh-ancestor
101906944|NCT01335334|Metronidazole|metronidazole|mesh-list
101906945|NCT01335334|Tetracycline|tetracycline|mesh-list
101906946|NCT01335334|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
101906947|NCT01335334|Omeprazole|omeprazole|mesh-list
101906948|NCT01335334|Bismuth|bismuth|mesh-list
101906949|NCT01335334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101906950|NCT01335334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101906951|NCT01335334|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101906952|NCT01335334|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101906953|NCT01335334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101906954|NCT01335334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101906955|NCT01335334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101906956|NCT01335334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101906957|NCT01335334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906958|NCT01335334|Antacids|antacids|mesh-ancestor
101906959|NCT01335334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101906960|NCT01344304|Aprepitant|aprepitant|mesh-list
101906961|NCT01344304|Fosaprepitant|fosaprepitant|mesh-list
101906962|NCT01344304|Antiemetics|antiemetics|mesh-ancestor
101906963|NCT01344304|Autonomic Agents|autonomic agents|mesh-ancestor
101906964|NCT01344304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101906965|NCT01344304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906966|NCT01344304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101906967|NCT01344304|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101906968|NCT01344304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101906969|NCT01344304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101906970|NCT01320020|Catumaxomab|catumaxomab|mesh-list
101906971|NCT01320020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101906972|NCT05312762|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101906973|NCT05312762|Chitosan|chitosan|mesh-list
101906974|NCT05312762|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101227886|NCT01542489|Insulin Aspart|insulin aspart|mesh-list
101906975|NCT05312762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101906976|NCT05312762|Antimetabolites|antimetabolites|mesh-ancestor
101906977|NCT05312762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626822|NCT02715531|Antimetabolites|antimetabolites|mesh-ancestor
101906978|NCT05312762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101906979|NCT05312762|Chelating Agents|chelating agents|mesh-ancestor
101906980|NCT05312762|Sequestering Agents|sequestering agents|mesh-ancestor
101906981|NCT05312762|Hemostatics|hemostatics|mesh-ancestor
101906982|NCT05312762|Coagulants|coagulants|mesh-ancestor
101906983|NCT05312762|Laxatives|laxatives|mesh-ancestor
101906984|NCT05312762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101906985|NCT00379288|Fluticasone|fluticasone|mesh-list
101906987|NCT00379288|Mometasone Furoate|mometasone furoate|mesh-list
101906988|NCT00379288|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101906989|NCT00379288|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101906990|NCT00379288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101906991|NCT00379288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101906992|NCT00379288|Autonomic Agents|autonomic agents|mesh-ancestor
101906993|NCT00379288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101906994|NCT00379288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101906995|NCT00379288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101906996|NCT00379288|Respiratory System Agents|respiratory system agents|mesh-ancestor
101906997|NCT00379288|Dermatologic Agents|dermatologic agents|mesh-ancestor
101906998|NCT00379288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101906999|NCT00379288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101907000|NCT00379288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101907001|NCT00379288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101907002|NCT00379288|Adrenergic Agents|adrenergic agents|mesh-ancestor
101907003|NCT00379288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101907004|NCT00379288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907005|NCT00379288|Glucocorticoids|glucocorticoids|mesh-ancestor
101907006|NCT00379288|Hormones|hormones|mesh-ancestor
101907007|NCT00379288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101907008|NCT00379288|Sympathomimetics|sympathomimetics|mesh-ancestor
101907009|NCT03784040|Nivolumab|nivolumab|mesh-list
101907010|NCT03784040|Ipilimumab|ipilimumab|mesh-list
101907011|NCT03784040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101907012|NCT03784040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101907013|NCT03784040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101907014|NCT03784040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907015|NCT00243503|Trastuzumab|trastuzumab|mesh-list
101907016|NCT00243503|Sunitinib|sunitinib|mesh-list
101907017|NCT00243503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101907019|NCT00243503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101907020|NCT00243503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101907021|NCT00243503|Growth Substances|growth substances|mesh-ancestor
101907022|NCT00243503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907023|NCT00243503|Growth Inhibitors|growth inhibitors|mesh-ancestor
101907024|NCT00243503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101907025|NCT00243503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101907026|NCT00243503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907027|NCT03780686|Dopamine|dopamine|mesh-list
101907028|NCT03780686|Norepinephrine|norepinephrine|mesh-list
101907029|NCT03780686|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101907030|NCT03780686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101907031|NCT03780686|Adrenergic Agents|adrenergic agents|mesh-ancestor
101907032|NCT03780686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101907033|NCT03780686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907034|NCT03780686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907035|NCT03780686|Sympathomimetics|sympathomimetics|mesh-ancestor
101907036|NCT03780686|Autonomic Agents|autonomic agents|mesh-ancestor
101907037|NCT03780686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101907038|NCT03780686|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101907039|NCT03780686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101907040|NCT03780686|Dopamine Agents|dopamine agents|mesh-ancestor
101227891|NCT01542697|Analgesics|analgesics|mesh-ancestor
101907041|NCT03780686|Protective Agents|protective agents|mesh-ancestor
101907042|NCT00338260|Atenolol|atenolol|mesh-list
101907043|NCT00338260|Adrenergic Agents|adrenergic agents|mesh-ancestor
101907044|NCT00338260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101907045|NCT00338260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907046|NCT00338260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907047|NCT00338260|Autonomic Agents|autonomic agents|mesh-ancestor
101907048|NCT00338260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101907049|NCT00338260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101907050|NCT00338260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101907051|NCT00338260|Sympatholytics|sympatholytics|mesh-ancestor
101907052|NCT00338260|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101907053|NCT00338260|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101907054|NCT00338260|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101907056|NCT03775928|Apatinib|apatinib|mesh-list
101907057|NCT03775928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101907058|NCT03775928|Antimetabolites|antimetabolites|mesh-ancestor
101907059|NCT03775928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907060|NCT03775928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101907061|NCT03775928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101907062|NCT03775928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101907063|NCT03775538|Dopamine|dopamine|mesh-list
101907064|NCT03775538|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101907065|NCT03775538|Sympathomimetics|sympathomimetics|mesh-ancestor
101907066|NCT03775538|Autonomic Agents|autonomic agents|mesh-ancestor
101907067|NCT03775538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101907068|NCT03775538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907069|NCT03775538|Dopamine Agents|dopamine agents|mesh-ancestor
101907070|NCT03775538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101907071|NCT03775538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907072|NCT03775538|Protective Agents|protective agents|mesh-ancestor
101907073|NCT00259649|Eletriptan|eletriptan|mesh-list
101907074|NCT00259649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101907075|NCT00259649|Serotonin Agents|serotonin agents|mesh-ancestor
101907076|NCT00259649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101907077|NCT00259649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907078|NCT00259649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907079|NCT05668988|Carboplatin|carboplatin|mesh-list
101907080|NCT05668988|Pemetrexed|pemetrexed|mesh-list
101907081|NCT05668988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101907082|NCT05668988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101907083|NCT05668988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907084|NCT05668988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101907085|NCT05668988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101907086|NCT01320176|Vaccines|vaccines|mesh-list
101907087|NCT01320176|Immunologic Factors|immunologic factors|mesh-ancestor
101907088|NCT01320176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907089|NCT01335646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101907090|NCT01335646|Analgesics|analgesics|mesh-list
101907091|NCT01335646|Sensory System Agents|sensory system agents|mesh-ancestor
101907092|NCT01335646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101907093|NCT01335646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907094|NCT01309412|Siltuximab|siltuximab|mesh-list
101907095|NCT01309412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101907096|NCT00307060|Losartan|losartan|mesh-list
101907097|NCT00307060|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101907098|NCT00307060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101907099|NCT00307060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101907100|NCT00307060|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101227903|NCT01542697|Tocolytic Agents|tocolytic agents|mesh-ancestor
101907101|NCT00307060|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101907102|NCT00307060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907103|NCT00307060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907104|NCT00307060|Diuretics|diuretics|mesh-ancestor
101907105|NCT00307060|Natriuretic Agents|natriuretic agents|mesh-ancestor
101907106|NCT00307060|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101907107|NCT00307060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101907108|NCT01320254|Cisplatin|cisplatin|mesh-list
101907109|NCT01320254|Gemcitabine|gemcitabine|mesh-list
101907110|NCT01320254|Panitumumab|panitumumab|mesh-list
101907111|NCT01320254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101907112|NCT01320254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101907113|NCT01320254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101907114|NCT01320254|Antimetabolites|antimetabolites|mesh-ancestor
101907115|NCT01320254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907116|NCT01320254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101907117|NCT00092638|Ezetimibe|ezetimibe|mesh-list
101907118|NCT00092638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101907119|NCT00092638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101907120|NCT00092638|Antimetabolites|antimetabolites|mesh-ancestor
101907121|NCT00092638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907122|NCT00092638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101907123|NCT03783728|Pyridoxine|pyridoxine|mesh-list
101907124|NCT03783728|Vitamin B 6|vitamin b 6|mesh-list
101907125|NCT03783728|Isoniazid|isoniazid|mesh-list
101907126|NCT03783728|Rifapentine|rifapentine|mesh-list
101907127|NCT03783728|Vitamins|vitamins|mesh-ancestor
101907128|NCT03783728|Micronutrients|micronutrients|mesh-ancestor
101907129|NCT03783728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907130|NCT03783728|Vitamin B Complex|vitamin b complex|mesh-ancestor
101907131|NCT03783728|Antitubercular Agents|antitubercular agents|mesh-ancestor
101907132|NCT03783728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101907133|NCT03783728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101907134|NCT03783728|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101907135|NCT03783728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101907136|NCT03783728|Antimetabolites|antimetabolites|mesh-ancestor
101907137|NCT03783728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524808|NCT04693169|Choline|choline|mesh-list
101907138|NCT03783728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101907139|NCT03783728|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101907140|NCT03783728|Leprostatic Agents|leprostatic agents|mesh-ancestor
101907142|NCT03620422|Albuterol|albuterol|mesh-list
101907143|NCT03620422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101907144|NCT03620422|Autonomic Agents|autonomic agents|mesh-ancestor
101907145|NCT03620422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101907146|NCT03620422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907147|NCT03620422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101907148|NCT03620422|Respiratory System Agents|respiratory system agents|mesh-ancestor
101907149|NCT03620422|Tocolytic Agents|tocolytic agents|mesh-ancestor
101907150|NCT03620422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101907151|NCT03620422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101907152|NCT03620422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101907153|NCT03620422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101907154|NCT03620422|Adrenergic Agents|adrenergic agents|mesh-ancestor
101907155|NCT03620422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101907156|NCT03620422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907157|NCT03620422|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101907158|NCT03620422|Diuretics|diuretics|mesh-ancestor
101907159|NCT03620422|Natriuretic Agents|natriuretic agents|mesh-ancestor
101907160|NCT01309490|Ribavirin|ribavirin|mesh-list
101907161|NCT01309490|Antimetabolites|antimetabolites|mesh-ancestor
101907162|NCT01309490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907163|NCT01309490|Antiviral Agents|antiviral agents|mesh-ancestor
101907164|NCT01309490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101907165|NCT04883840|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101907166|NCT04883840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101907167|NCT04883840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101907169|NCT04883840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907170|NCT04883840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101907171|NCT04883840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101907172|NCT04883840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101907173|NCT01345084|Nimotuzumab|nimotuzumab|mesh-list
101907174|NCT01345084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101907175|NCT01345084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101907176|NCT03783494|Propofol|propofol|mesh-list
101907177|NCT03783494|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101907178|NCT03783494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101907179|NCT03783494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907180|NCT03783494|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101907181|NCT03783494|Anesthetics, General|anesthetics, general|mesh-ancestor
101907182|NCT03783494|Anesthetics|anesthetics|mesh-ancestor
101907183|NCT03774836|Morphine|morphine|mesh-list
101907184|NCT03774836|Tramadol|tramadol|mesh-list
101907185|NCT03774836|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101907186|NCT03774836|Narcotics|narcotics|mesh-ancestor
101907187|NCT03774836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101907188|NCT03774836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907189|NCT03774836|Analgesics|analgesics|mesh-ancestor
101907190|NCT03774836|Sensory System Agents|sensory system agents|mesh-ancestor
101907191|NCT03774836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101907192|NCT03774680|Cetuximab|cetuximab|mesh-list
101907193|NCT03774680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101907194|NCT03774680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101907195|NCT03783338|Vitamin D|vitamin d|mesh-list
101907196|NCT03783338|Vitamins|vitamins|mesh-ancestor
101907197|NCT03783338|Micronutrients|micronutrients|mesh-ancestor
101907198|NCT03783338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907199|NCT03783338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101907200|NCT03774524|Misoprostol|misoprostol|mesh-list
101907201|NCT03774524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101907202|NCT03774524|Abortifacient Agents|abortifacient agents|mesh-ancestor
101907203|NCT03774524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101907204|NCT03774524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907205|NCT03774524|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101907207|NCT03774524|Oxytocics|oxytocics|mesh-ancestor
101907208|NCT03773744|Cyclophosphamide|cyclophosphamide|mesh-list
101907209|NCT03773744|Pembrolizumab|pembrolizumab|mesh-list
101907210|NCT03773744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101907211|NCT03773744|Immunologic Factors|immunologic factors|mesh-ancestor
101907212|NCT03773744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907213|NCT03773744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101907214|NCT03773744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101907215|NCT03773744|Alkylating Agents|alkylating agents|mesh-ancestor
101907216|NCT03773744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907217|NCT03773744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101907218|NCT03773744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101907219|NCT03773744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101907220|NCT03773744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101907221|NCT03779516|Lidocaine|lidocaine|mesh-list
101907222|NCT03779516|Anesthetics, Local|anesthetics, local|mesh-ancestor
101907223|NCT03779516|Anesthetics|anesthetics|mesh-ancestor
101907224|NCT03779516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101907225|NCT03779516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907226|NCT03779516|Sensory System Agents|sensory system agents|mesh-ancestor
101907227|NCT03779516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101907228|NCT03779516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101907229|NCT03779516|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101907230|NCT03779516|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101907231|NCT03779516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101907232|NCT03779516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907233|NCT03779594|Acetazolamide|acetazolamide|mesh-list
101907234|NCT03779594|Anticonvulsants|anticonvulsants|mesh-ancestor
101907235|NCT03779594|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101907236|NCT03779594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101907237|NCT03779594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907238|NCT03779594|Diuretics|diuretics|mesh-ancestor
101907239|NCT03779594|Natriuretic Agents|natriuretic agents|mesh-ancestor
101907240|NCT03779594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907241|NCT03779672|Memantine|memantine|mesh-list
101616777|NCT00592852|Fluoxetine|fluoxetine|mesh-list
101907243|NCT03779672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101907244|NCT03779672|Dopamine Agents|dopamine agents|mesh-ancestor
101907245|NCT03779672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101907246|NCT03779672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907247|NCT03779672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907248|NCT03779672|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101907249|NCT03779672|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101907250|NCT03779282|Dexmedetomidine|dexmedetomidine|mesh-list
101907251|NCT03779282|Ketamine|ketamine|mesh-list
101907252|NCT03779282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101907253|NCT03779282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101907254|NCT03779282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907255|NCT03779282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101907256|NCT03779282|Analgesics|analgesics|mesh-ancestor
101907257|NCT03779282|Sensory System Agents|sensory system agents|mesh-ancestor
101907258|NCT03779282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101907259|NCT03779282|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101907260|NCT03779282|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101907261|NCT03779282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101907262|NCT03779282|Adrenergic Agents|adrenergic agents|mesh-ancestor
101907263|NCT03779282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101907264|NCT03779282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907265|NCT03779282|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101907266|NCT03779282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101907267|NCT03779282|Anesthetics, General|anesthetics, general|mesh-ancestor
101907268|NCT03779282|Anesthetics|anesthetics|mesh-ancestor
101907269|NCT03779282|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101907270|NCT03779282|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101907271|NCT03773588|Propofol|propofol|mesh-list
101907272|NCT03773588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101907273|NCT03773588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101907274|NCT03773588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907275|NCT03773588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101907276|NCT03773588|Anesthetics, General|anesthetics, general|mesh-ancestor
101907277|NCT03773588|Anesthetics|anesthetics|mesh-ancestor
101907278|NCT03773510|Trabectedin|trabectedin|mesh-list
101907279|NCT03773510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101907280|NCT03773510|Alkylating Agents|alkylating agents|mesh-ancestor
101907281|NCT03773510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907282|NCT03773510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101907283|NCT03779360|Clindamycin|clindamycin|mesh-list
101907284|NCT03779360|Clindamycin palmitate|clindamycin palmitate|mesh-list
101907285|NCT03779360|Clindamycin phosphate|clindamycin phosphate|mesh-list
101907286|NCT03779360|Erythromycin|erythromycin|mesh-list
101907287|NCT03779360|Erythromycin Estolate|erythromycin estolate|mesh-list
101907288|NCT03779360|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101907289|NCT03779360|Erythromycin stearate|erythromycin stearate|mesh-list
101907290|NCT03779360|Prednisolone|prednisolone|mesh-list
101907291|NCT03779360|Clobetasol|clobetasol|mesh-list
101907292|NCT03779360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101907293|NCT03779360|Glucocorticoids|glucocorticoids|mesh-ancestor
101907294|NCT03779360|Hormones|hormones|mesh-ancestor
101907295|NCT03779360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101907296|NCT03779360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907297|NCT03779360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101907298|NCT03779360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101907299|NCT03779360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101907300|NCT03779360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101907301|NCT03779360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101907302|NCT03779360|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101907303|NCT03779360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101907304|NCT03779360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907305|NCT01320878|Iloprost|iloprost|mesh-list
101907306|NCT01320878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101907307|NCT01320878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101907308|NCT01320878|Vasodilator Agents|vasodilator agents|mesh-ancestor
101907309|NCT01321034|Niacin|niacin|mesh-list
101907310|NCT01321034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101907311|NCT01321034|Antimetabolites|antimetabolites|mesh-ancestor
101907312|NCT01321034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907313|NCT01321034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101907314|NCT01321034|Vasodilator Agents|vasodilator agents|mesh-ancestor
101907315|NCT01321034|Vitamin B Complex|vitamin b complex|mesh-ancestor
101907317|NCT01321034|Micronutrients|micronutrients|mesh-ancestor
101907318|NCT01321034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907319|NCT05254184|Nivolumab|nivolumab|mesh-list
101907320|NCT05254184|Ipilimumab|ipilimumab|mesh-list
101907321|NCT05254184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101907322|NCT05254184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101907323|NCT05254184|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101907324|NCT05254184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907325|NCT03773042|Propofol|propofol|mesh-list
101907326|NCT03773042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101907327|NCT03773042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101907328|NCT03773042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907329|NCT03773042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101907330|NCT03773042|Anesthetics, General|anesthetics, general|mesh-ancestor
101907331|NCT03773042|Anesthetics|anesthetics|mesh-ancestor
101907332|NCT03782480|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101907333|NCT03782480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101907334|NCT03782480|Immunologic Factors|immunologic factors|mesh-ancestor
101907335|NCT03782480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907336|NCT03712280|Rifaximin|rifaximin|mesh-list
101907337|NCT03712280|Phenylacetic acid|phenylacetic acid|mesh-list
101907338|NCT03712280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101907339|NCT03712280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101907340|NCT03712280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101907341|NCT03712280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101907342|NCT03712280|Antimetabolites|antimetabolites|mesh-ancestor
101907343|NCT03712280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907344|NCT03712280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101907345|NCT01561508|Butyric Acid|butyric acid|mesh-list
101907346|NCT01561508|Histamine Antagonists|histamine antagonists|mesh-ancestor
101907347|NCT01561508|Histamine Agents|histamine agents|mesh-ancestor
101907348|NCT01561508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101907349|NCT01561508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907350|NCT01561508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907352|NCT03772262|Furosemide|furosemide|mesh-list
101907353|NCT03772262|Midazolam|midazolam|mesh-list
101907354|NCT03772262|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101907355|NCT03772262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101907356|NCT03772262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907357|NCT03772262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101907358|NCT03772262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101907359|NCT03772262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101907360|NCT03772262|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101907361|NCT03772262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101907362|NCT03772262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101907363|NCT03772262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101907364|NCT03772262|Anesthetics, General|anesthetics, general|mesh-ancestor
101907365|NCT03772262|Anesthetics|anesthetics|mesh-ancestor
101907366|NCT03772262|GABA Modulators|gaba modulators|mesh-ancestor
101907367|NCT03772262|GABA Agents|gaba agents|mesh-ancestor
101907368|NCT03772262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101907369|NCT03772262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907370|NCT03772262|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101907371|NCT03772262|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101907372|NCT03772262|Antimetabolites|antimetabolites|mesh-ancestor
101907373|NCT03772262|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101907374|NCT03772262|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101907375|NCT03772262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101907376|NCT03772262|Diuretics|diuretics|mesh-ancestor
101907377|NCT03772262|Natriuretic Agents|natriuretic agents|mesh-ancestor
101907378|NCT03772262|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101907379|NCT03772262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101907380|NCT03772106|Propofol|propofol|mesh-list
101907381|NCT03772106|Sevoflurane|sevoflurane|mesh-list
101907382|NCT03772106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101907383|NCT03772106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101907384|NCT03772106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907385|NCT03772106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101907386|NCT03772106|Anesthetics, General|anesthetics, general|mesh-ancestor
101907387|NCT03772106|Anesthetics|anesthetics|mesh-ancestor
101907388|NCT03772106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101907389|NCT03772106|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101907390|NCT01345240|Vaccines|vaccines|mesh-list
101907391|NCT01345240|Immunologic Factors|immunologic factors|mesh-ancestor
101907392|NCT01345240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907393|NCT03771638|Tenofovir|tenofovir|mesh-list
101907394|NCT03771638|Emtricitabine|emtricitabine|mesh-list
101907395|NCT03771638|Antiviral Agents|antiviral agents|mesh-ancestor
101907396|NCT03771638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101907397|NCT03771638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101907398|NCT03771638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101907399|NCT03771638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101907400|NCT03771638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907401|NCT03771638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101907402|NCT03771638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101907403|NCT00092560|Ezetimibe|ezetimibe|mesh-list
101907404|NCT00092560|Fenofibrate|fenofibrate|mesh-list
101907405|NCT00092560|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101907406|NCT00092560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101907407|NCT00092560|Antimetabolites|antimetabolites|mesh-ancestor
101907408|NCT00092560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907409|NCT00092560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101907410|NCT03769064|Methylphenidate|methylphenidate|mesh-list
101907411|NCT03769064|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101907412|NCT03769064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907413|NCT03769064|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101907414|NCT03769064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101907415|NCT03769064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101907416|NCT03769064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907417|NCT03769064|Dopamine Agents|dopamine agents|mesh-ancestor
101907418|NCT03769064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101907419|NCT00090298|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101907420|NCT00090298|Simvastatin|simvastatin|mesh-list
101907421|NCT00090298|Ezetimibe|ezetimibe|mesh-list
101907422|NCT00090298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101907423|NCT00090298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101907424|NCT00090298|Antimetabolites|antimetabolites|mesh-ancestor
101907425|NCT00090298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907426|NCT00090298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101907427|NCT00090298|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101907428|NCT00090298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101907429|NCT03771092|Ferric gluconate|ferric gluconate|mesh-list
101907430|NCT03771092|Hematinics|hematinics|mesh-ancestor
101907431|NCT03768908|Artesunate|artesunate|mesh-list
101907432|NCT03768908|Lumefantrine|lumefantrine|mesh-list
101907433|NCT03768908|Artemether|artemether|mesh-list
101907434|NCT03768908|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101907435|NCT03768908|Amodiaquine|amodiaquine|mesh-list
101907436|NCT03768908|Antimalarials|antimalarials|mesh-ancestor
101907437|NCT03768908|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101907438|NCT03768908|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101907439|NCT03768908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101907440|NCT03768908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101907441|NCT03768908|Antiviral Agents|antiviral agents|mesh-ancestor
101907442|NCT03768908|Schistosomicides|schistosomicides|mesh-ancestor
101907443|NCT03768908|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101907444|NCT03768908|Anthelmintics|anthelmintics|mesh-ancestor
101907445|NCT03777878|Oxytocin|oxytocin|mesh-list
101907446|NCT03777878|Carbetocin|carbetocin|mesh-list
101907447|NCT03777878|Oxytocics|oxytocics|mesh-ancestor
101907448|NCT03777878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101907449|NCT03777878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907450|NCT03246958|Nivolumab|nivolumab|mesh-list
101907451|NCT03246958|Ipilimumab|ipilimumab|mesh-list
101907452|NCT03246958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101907453|NCT03246958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101907454|NCT03246958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101907455|NCT03246958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907456|NCT01321268|Beta Carotene|beta carotene|mesh-list
101907457|NCT01321268|Lycopene|lycopene|mesh-list
101907458|NCT01321268|Resveratrol|resveratrol|mesh-list
101907459|NCT01321268|Carotenoids|carotenoids|mesh-list
101907460|NCT01321268|Antioxidants|antioxidants|mesh-ancestor
101907461|NCT01321268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907462|NCT01321268|Protective Agents|protective agents|mesh-ancestor
101907463|NCT01321268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907464|NCT01321268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101907465|NCT01321268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101907466|NCT01321268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101907467|NCT01321268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101907468|NCT01321268|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101907469|NCT01321268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101907470|NCT01321268|Provitamins|provitamins|mesh-ancestor
101907471|NCT01321268|Vitamins|vitamins|mesh-ancestor
101907472|NCT01321268|Micronutrients|micronutrients|mesh-ancestor
101907473|NCT01335958|DMUC5754A|dmuc5754a|mesh-list
101907474|NCT01335958|Immunoconjugates|immunoconjugates|mesh-ancestor
101907475|NCT01335958|Immunologic Factors|immunologic factors|mesh-ancestor
101907476|NCT01335958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907477|NCT01561274|Bupivacaine|bupivacaine|mesh-list
101907478|NCT01561274|Anesthetics, Local|anesthetics, local|mesh-ancestor
101907479|NCT01561274|Anesthetics|anesthetics|mesh-ancestor
101907480|NCT01561274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101907481|NCT01561274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907482|NCT01561274|Sensory System Agents|sensory system agents|mesh-ancestor
101227986|NCT01543321|Tetrabenazine|tetrabenazine|mesh-list
101907483|NCT01561274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101907484|NCT02882854|Guanfacine|guanfacine|mesh-list
101907485|NCT02882854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101907486|NCT02882854|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101907487|NCT02882854|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101907488|NCT02882854|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101907489|NCT02882854|Adrenergic Agents|adrenergic agents|mesh-ancestor
101907490|NCT02882854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101907491|NCT02882854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907492|NCT02882854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907493|NCT03770936|Candesartan|candesartan|mesh-list
101907494|NCT03770936|Candesartan cilexetil|candesartan cilexetil|mesh-list
101907496|NCT03770936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101907497|NCT03770936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101907498|NCT03770936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101907499|NCT03770936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907500|NCT03770936|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101907501|NCT03770936|Protease Inhibitors|protease inhibitors|mesh-ancestor
101907502|NCT03770936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101907503|NCT03150082|Ciprofloxacin|ciprofloxacin|mesh-list
101907504|NCT03150082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101907505|NCT03150082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101907506|NCT03150082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101907507|NCT03150082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101907508|NCT03150082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101907509|NCT03150082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907510|NCT03150082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101907511|NCT03150082|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101907512|NCT03150082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101907513|NCT01321346|Cytarabine|cytarabine|mesh-list
101907514|NCT01321346|Panobinostat|panobinostat|mesh-list
101907515|NCT01321346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101907516|NCT01321346|Antimetabolites|antimetabolites|mesh-ancestor
101907517|NCT01321346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907518|NCT01321346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101907519|NCT01321346|Antiviral Agents|antiviral agents|mesh-ancestor
101907520|NCT01321346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101907521|NCT01321346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101907522|NCT01321346|Immunologic Factors|immunologic factors|mesh-ancestor
101907523|NCT01321346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907524|NCT01321346|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101907525|NCT01321346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101907526|NCT04058366|Ivacaftor|ivacaftor|mesh-list
101907527|NCT04058366|Elexacaftor|elexacaftor|mesh-list
101907528|NCT04058366|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101907529|NCT04058366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101907530|NCT04058366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907531|NCT02118610|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
101907532|NCT02118610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101907533|NCT02118610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101907534|NCT02118610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101907535|NCT02118610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101907536|NCT02118610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907537|NCT02118610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101907538|NCT02118610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907539|NCT02118610|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101907541|NCT02118610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101907542|NCT02118610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101907543|NCT02118610|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101907544|NCT02118610|Dopamine Agents|dopamine agents|mesh-ancestor
101907545|NCT02118610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101907546|NCT02118610|Adrenergic Agents|adrenergic agents|mesh-ancestor
101907547|NCT02118610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101907548|NCT02118610|Analgesics|analgesics|mesh-ancestor
101907549|NCT02118610|Sensory System Agents|sensory system agents|mesh-ancestor
101907550|NCT02118610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101907551|NCT01561742|Minocycline|minocycline|mesh-list
101907552|NCT01561742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101907553|NCT01561742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101907554|NCT03770702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
101907555|NCT03770702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907556|NCT01345708|Prednisone|prednisone|mesh-list
101907557|NCT01345708|Rituximab|rituximab|mesh-list
101907558|NCT01345708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101907559|NCT01345708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101907560|NCT01345708|Immunologic Factors|immunologic factors|mesh-ancestor
101907561|NCT01345708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907562|NCT01345708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101907563|NCT01345708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101907564|NCT01345708|Glucocorticoids|glucocorticoids|mesh-ancestor
101907565|NCT01345708|Hormones|hormones|mesh-ancestor
101907566|NCT01345708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101907567|NCT01345708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101907568|NCT01345864|Scopolamine|scopolamine|mesh-list
101907569|NCT01345864|Donepezil|donepezil|mesh-list
101907570|NCT01345864|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101907571|NCT01345864|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101907572|NCT01345864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101907573|NCT01345864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907574|NCT01345864|Cholinergic Agents|cholinergic agents|mesh-ancestor
101907575|NCT01345864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101907576|NCT01345864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907577|NCT01345864|Nootropic Agents|nootropic agents|mesh-ancestor
101907578|NCT01345864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101907579|NCT01345864|Antiemetics|antiemetics|mesh-ancestor
101907580|NCT01345864|Autonomic Agents|autonomic agents|mesh-ancestor
101907581|NCT01345864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101907582|NCT01345864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101907583|NCT01345864|Mydriatics|mydriatics|mesh-ancestor
101907584|NCT01345864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101907585|NCT01345864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101907586|NCT01345864|Parasympatholytics|parasympatholytics|mesh-ancestor
101907587|NCT04320602|Eculizumab|eculizumab|mesh-list
101907588|NCT04320602|Ravulizumab|ravulizumab|mesh-list
101907589|NCT04320602|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101907590|NCT04320602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101907591|NCT04320602|Immunologic Factors|immunologic factors|mesh-ancestor
101907592|NCT04320602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907593|NCT03948022|Progesterone|progesterone|mesh-list
101907594|NCT03948022|Dydrogesterone|dydrogesterone|mesh-list
101907595|NCT03948022|Progestins|progestins|mesh-ancestor
101907596|NCT03948022|Hormones|hormones|mesh-ancestor
101907597|NCT03948022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101907598|NCT03948022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907599|NCT03777644|Morphine|morphine|mesh-list
101907600|NCT03777644|Ropivacaine|ropivacaine|mesh-list
101907601|NCT03777644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101907602|NCT03777644|Narcotics|narcotics|mesh-ancestor
101907603|NCT03777644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101907604|NCT03777644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907605|NCT03777644|Analgesics|analgesics|mesh-ancestor
101907606|NCT03777644|Sensory System Agents|sensory system agents|mesh-ancestor
101907607|NCT03777644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101907608|NCT03777644|Anesthetics, Local|anesthetics, local|mesh-ancestor
101907609|NCT03777644|Anesthetics|anesthetics|mesh-ancestor
101907610|NCT04345666|Methyltestosterone|methyltestosterone|mesh-list
101907611|NCT04345666|Testosterone|testosterone|mesh-list
101907612|NCT04345666|Testosterone undecanoate|testosterone undecanoate|mesh-list
101907613|NCT04345666|Testosterone enanthate|testosterone enanthate|mesh-list
101907614|NCT04345666|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101907615|NCT04345666|Androgens|androgens|mesh-ancestor
101907616|NCT04345666|Hormones|hormones|mesh-ancestor
101907617|NCT04345666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101907618|NCT04345666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907619|NCT04345666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101907620|NCT04345666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101907621|NCT04345666|Anabolic Agents|anabolic agents|mesh-ancestor
101907622|NCT01336192|Gemcitabine|gemcitabine|mesh-list
101907623|NCT01336192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101907624|NCT01336192|Antimetabolites|antimetabolites|mesh-ancestor
101907625|NCT01336192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907626|NCT01336192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101907627|NCT04459234|Ketamine|ketamine|mesh-list
101907628|NCT04459234|Analgesics|analgesics|mesh-ancestor
101907629|NCT04459234|Sensory System Agents|sensory system agents|mesh-ancestor
101907630|NCT04459234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101907631|NCT04459234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907632|NCT04459234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101907633|NCT04459234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101907634|NCT04459234|Anesthetics, General|anesthetics, general|mesh-ancestor
101907635|NCT04459234|Anesthetics|anesthetics|mesh-ancestor
101907636|NCT04459234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101907637|NCT04459234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101907638|NCT04459234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101907639|NCT04459234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101907640|NCT04459234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907642|NCT01336348|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101907643|NCT01336348|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101907644|NCT01336348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101907645|NCT01336348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101907646|NCT01336348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907647|NCT01346254|Pioglitazone|pioglitazone|mesh-list
101907648|NCT01346254|Vildagliptin|vildagliptin|mesh-list
101907649|NCT01346254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101907650|NCT01346254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907651|NCT01346254|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101907652|NCT01346254|Protease Inhibitors|protease inhibitors|mesh-ancestor
101907653|NCT01346254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101907654|NCT01346254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907655|NCT04592536|Alprazolam|alprazolam|mesh-list
101907656|NCT04592536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101907657|NCT04592536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101907658|NCT04592536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907659|NCT04592536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101907660|NCT04592536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101907661|NCT04592536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101907662|NCT04592536|GABA Modulators|gaba modulators|mesh-ancestor
101907663|NCT04592536|GABA Agents|gaba agents|mesh-ancestor
101907664|NCT04592536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101907665|NCT04592536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907666|NCT01336582|Docetaxel|docetaxel|mesh-list
101907667|NCT01336582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101907668|NCT01336582|Tubulin Modulators|tubulin modulators|mesh-ancestor
101907669|NCT01336582|Antimitotic Agents|antimitotic agents|mesh-ancestor
101907670|NCT01336582|Mitosis Modulators|mitosis modulators|mesh-ancestor
101907671|NCT01336582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907672|NCT03149848|Rifabutin|rifabutin|mesh-list
101907673|NCT03149848|Cabotegravir|cabotegravir|mesh-list
101907674|NCT03149848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101907675|NCT03149848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101907676|NCT03149848|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101907677|NCT03149848|Antitubercular Agents|antitubercular agents|mesh-ancestor
101907678|NCT03149848|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101907679|NCT03149848|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101907680|NCT03149848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101907681|NCT03149848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907682|NCT03149848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101907683|NCT03149848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101907684|NCT03149848|Antiviral Agents|antiviral agents|mesh-ancestor
101907685|NCT01346800|Ritonavir|ritonavir|mesh-list
101907686|NCT01346800|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101907687|NCT01346800|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101907688|NCT01346800|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101907689|NCT01346800|Protease Inhibitors|protease inhibitors|mesh-ancestor
101907690|NCT01346800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101907691|NCT01346800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907692|NCT01346800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101907693|NCT01346800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101907694|NCT01346800|Antiviral Agents|antiviral agents|mesh-ancestor
101907695|NCT01346800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101907696|NCT01346800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101907697|NCT01346800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101907698|NCT01346800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101907699|NCT03902314|Lidocaine|lidocaine|mesh-list
101907700|NCT03902314|Anesthetics, Local|anesthetics, local|mesh-ancestor
101907701|NCT03902314|Anesthetics|anesthetics|mesh-ancestor
101907702|NCT03902314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101907703|NCT03902314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907704|NCT03902314|Sensory System Agents|sensory system agents|mesh-ancestor
101907705|NCT03902314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101955374|NCT04646109|Hydroxychloroquine|hydroxychloroquine|mesh-list
101907706|NCT03902314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101907707|NCT03902314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101907708|NCT03902314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101907709|NCT03902314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101907710|NCT03902314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907711|NCT01336660|Antivenins|antivenins|mesh-list
101907712|NCT01336660|Immunologic Factors|immunologic factors|mesh-ancestor
101907713|NCT01336660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907714|NCT03768518|Exenatide|exenatide|mesh-list
101907715|NCT03768518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101907716|NCT03768518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907717|NCT03768518|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101907718|NCT03768518|Incretins|incretins|mesh-ancestor
101907719|NCT03768518|Hormones|hormones|mesh-ancestor
101907720|NCT03768518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101907721|NCT04276376|Atezolizumab|atezolizumab|mesh-list
101907722|NCT04276376|Rucaparib|rucaparib|mesh-list
101907723|NCT04276376|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101907724|NCT04276376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907725|NCT04276376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101907726|NCT04276376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101907727|NCT04276376|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101907728|NCT04276376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101907729|NCT04254692|Bupivacaine|bupivacaine|mesh-list
101907730|NCT04254692|Anesthetics, Local|anesthetics, local|mesh-ancestor
101907731|NCT04254692|Anesthetics|anesthetics|mesh-ancestor
101907732|NCT04254692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101907733|NCT04254692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907734|NCT04254692|Sensory System Agents|sensory system agents|mesh-ancestor
101907735|NCT04254692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101907736|NCT03770000|Romidepsin|romidepsin|mesh-list
101907737|NCT03770000|Tenalisib|tenalisib|mesh-list
101907738|NCT03770000|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101907739|NCT03770000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101907740|NCT03770000|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101907741|NCT03770000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101907742|NCT03770000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907743|NCT03770000|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
101907744|NCT03770312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
101907745|NCT03770312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101907746|NCT03770312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101907747|NCT03770312|Antimetabolites|antimetabolites|mesh-ancestor
101907748|NCT03770312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907749|NCT03770312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101907750|NCT03770312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101907751|NCT03158272|Nivolumab|nivolumab|mesh-list
101907752|NCT03158272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101907753|NCT03158272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101907754|NCT03158272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101907755|NCT03158272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907756|NCT01431508|Losartan|losartan|mesh-list
101907757|NCT01431508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101907758|NCT01431508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101907759|NCT01431508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101907760|NCT01431508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101907761|NCT01431508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907762|NCT01321502|Famciclovir|famciclovir|mesh-list
101907763|NCT01321502|Antiviral Agents|antiviral agents|mesh-ancestor
101907764|NCT01321502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101907765|NCT01321502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101907766|NCT01321502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101907767|NCT01321502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907768|NCT01347268|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101907769|NCT01347268|Hormones|hormones|mesh-ancestor
101907770|NCT01347268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101907771|NCT01347268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907772|NCT01347424|Paclitaxel|paclitaxel|mesh-list
101907773|NCT01347424|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101907774|NCT01347424|Carboplatin|carboplatin|mesh-list
101907775|NCT01347424|Endostatins|endostatins|mesh-list
101907776|NCT01347424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101907777|NCT01347424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101907778|NCT01347424|Tubulin Modulators|tubulin modulators|mesh-ancestor
101907779|NCT01347424|Antimitotic Agents|antimitotic agents|mesh-ancestor
101907780|NCT01347424|Mitosis Modulators|mitosis modulators|mesh-ancestor
101907781|NCT01347424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907782|NCT01347424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101907783|NCT01347424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101907784|NCT01347424|Growth Substances|growth substances|mesh-ancestor
101907785|NCT01347424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907786|NCT01347424|Growth Inhibitors|growth inhibitors|mesh-ancestor
101907787|NCT01322438|Rifampin|rifampin|mesh-list
101907788|NCT01322438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101907789|NCT01322438|Antitubercular Agents|antitubercular agents|mesh-ancestor
101907790|NCT01322438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101907791|NCT01322438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101907792|NCT01322438|Leprostatic Agents|leprostatic agents|mesh-ancestor
101907793|NCT01322438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101907794|NCT01322438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101907795|NCT01322438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907796|NCT01322438|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101907797|NCT01322438|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101907798|NCT01322438|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101907799|NCT01322438|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101907800|NCT01322438|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101907801|NCT01322438|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101907802|NCT00654628|Simvastatin|simvastatin|mesh-list
101907803|NCT00654628|Ezetimibe|ezetimibe|mesh-list
101907804|NCT00654628|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101907805|NCT00654628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101907806|NCT00654628|Antimetabolites|antimetabolites|mesh-ancestor
101907807|NCT00654628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907808|NCT00654628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101907809|NCT00654628|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101907810|NCT00654628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101907812|NCT00536380|Desloratadine|desloratadine|mesh-list
101907813|NCT00536380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101907814|NCT00536380|Cholinergic Agents|cholinergic agents|mesh-ancestor
101907815|NCT00536380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101907816|NCT00536380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907817|NCT00536380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907818|NCT00536380|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101907819|NCT00536380|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101907820|NCT00536380|Histamine Antagonists|histamine antagonists|mesh-ancestor
101907821|NCT00536380|Histamine Agents|histamine agents|mesh-ancestor
101907822|NCT00536380|Antipruritics|antipruritics|mesh-ancestor
101907823|NCT00536380|Dermatologic Agents|dermatologic agents|mesh-ancestor
101907824|NCT00536380|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101907825|NCT01337362|Insulin|insulin|mesh-list
101907826|NCT01337362|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101907827|NCT01337362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101907828|NCT01337362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907829|NCT03762824|Vaccines|vaccines|mesh-list
101907830|NCT03762824|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101907831|NCT03762824|Immunologic Factors|immunologic factors|mesh-ancestor
101907832|NCT03762824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907833|NCT00496834|Losartan|losartan|mesh-list
101907834|NCT00496834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101907835|NCT00496834|Carvedilol|carvedilol|mesh-list
101907836|NCT00496834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101907837|NCT00496834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101907838|NCT00496834|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101907839|NCT00496834|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101907840|NCT00496834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907842|NCT00496834|Natriuretic Agents|natriuretic agents|mesh-ancestor
101907843|NCT00496834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907844|NCT00496834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101907845|NCT00496834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101907846|NCT00496834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101907847|NCT00496834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101907848|NCT00496834|Adrenergic Agents|adrenergic agents|mesh-ancestor
101907849|NCT00496834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101907850|NCT00496834|Antioxidants|antioxidants|mesh-ancestor
101907851|NCT00496834|Protective Agents|protective agents|mesh-ancestor
101907852|NCT00496834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101907853|NCT00496834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101907854|NCT00496834|Vasodilator Agents|vasodilator agents|mesh-ancestor
101907855|NCT00496834|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101907856|NCT00496834|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101907857|NCT00189280|Imiquimod|imiquimod|mesh-list
101907858|NCT00189280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101907859|NCT00189280|Immunologic Factors|immunologic factors|mesh-ancestor
101907860|NCT00189280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907861|NCT00189280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101907862|NCT00189280|Interferon Inducers|interferon inducers|mesh-ancestor
101907863|NCT01352494|Gemcitabine|gemcitabine|mesh-list
101907864|NCT01352494|Docetaxel|docetaxel|mesh-list
101907865|NCT01352494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101907866|NCT01352494|Antimetabolites|antimetabolites|mesh-ancestor
101907867|NCT01352494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907868|NCT01352494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101907869|NCT01352494|Tubulin Modulators|tubulin modulators|mesh-ancestor
101907870|NCT01352494|Antimitotic Agents|antimitotic agents|mesh-ancestor
101907871|NCT01352494|Mitosis Modulators|mitosis modulators|mesh-ancestor
101907872|NCT01347814|Domperidone|domperidone|mesh-list
101907873|NCT01347814|Antiemetics|antiemetics|mesh-ancestor
101907874|NCT01347814|Autonomic Agents|autonomic agents|mesh-ancestor
101907875|NCT01347814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101907876|NCT01347814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907877|NCT01347814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101907878|NCT01347814|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101907879|NCT01347814|Dopamine Agents|dopamine agents|mesh-ancestor
101907880|NCT01347814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101907881|NCT01347814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907882|NCT01348126|Docetaxel|docetaxel|mesh-list
101907883|NCT01348126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101907884|NCT01348126|Tubulin Modulators|tubulin modulators|mesh-ancestor
101907885|NCT01348126|Antimitotic Agents|antimitotic agents|mesh-ancestor
101907886|NCT01348126|Mitosis Modulators|mitosis modulators|mesh-ancestor
101907887|NCT01348126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907888|NCT01348204|Quercetin|quercetin|mesh-list
101907889|NCT01348204|Antioxidants|antioxidants|mesh-ancestor
101907890|NCT01348204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907891|NCT01348204|Protective Agents|protective agents|mesh-ancestor
101907892|NCT01348204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907893|NCT00166504|Atorvastatin|atorvastatin|mesh-list
101907894|NCT00166504|Simvastatin|simvastatin|mesh-list
101907895|NCT00166504|Ezetimibe|ezetimibe|mesh-list
101907896|NCT00166504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101907897|NCT00166504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101907898|NCT00166504|Antimetabolites|antimetabolites|mesh-ancestor
101907899|NCT00166504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907900|NCT00166504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101907901|NCT00166504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101907902|NCT00166504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101907903|NCT01348282|Rivastigmine|rivastigmine|mesh-list
101907904|NCT01348282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101907905|NCT01348282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907906|NCT01348282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907907|NCT01348282|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101907908|NCT01348282|Cholinergic Agents|cholinergic agents|mesh-ancestor
101907909|NCT01348282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101907910|NCT01348282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101907911|NCT01348282|Protective Agents|protective agents|mesh-ancestor
101907912|NCT03137992|Bromides|bromides|mesh-list
101955394|NCT05320107|Anesthetics|anesthetics|mesh-ancestor
101907913|NCT03137992|Tiotropium Bromide|tiotropium bromide|mesh-list
101907914|NCT03137992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101907915|NCT03137992|Autonomic Agents|autonomic agents|mesh-ancestor
101907916|NCT03137992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101907917|NCT03137992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907918|NCT03137992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101907919|NCT03137992|Respiratory System Agents|respiratory system agents|mesh-ancestor
101907920|NCT03137992|Parasympatholytics|parasympatholytics|mesh-ancestor
101907921|NCT03137992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101907922|NCT03137992|Cholinergic Agents|cholinergic agents|mesh-ancestor
101907923|NCT03137992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101907924|NCT03137992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907925|NCT03137992|Anticonvulsants|anticonvulsants|mesh-ancestor
101907926|NCT04470778|Famotidine|famotidine|mesh-list
101907927|NCT04470778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101907928|NCT04470778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101907929|NCT04470778|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101907930|NCT04470778|Histamine Antagonists|histamine antagonists|mesh-ancestor
101907931|NCT04470778|Histamine Agents|histamine agents|mesh-ancestor
101907932|NCT04470778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101907933|NCT04470778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907934|NCT04470778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907935|NCT01352572|Milnacipran|milnacipran|mesh-list
101907936|NCT01352572|Mirtazapine|mirtazapine|mesh-list
101907937|NCT01352572|Sertraline|sertraline|mesh-list
101907938|NCT01352572|Fluoxetine|fluoxetine|mesh-list
101907939|NCT01352572|Paroxetine|paroxetine|mesh-list
101907940|NCT01352572|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101907941|NCT01352572|Antidepressive Agents|antidepressive agents|mesh-list
101907942|NCT01352572|Levomilnacipran|levomilnacipran|mesh-list
101907943|NCT01352572|Nortriptyline|nortriptyline|mesh-list
101907944|NCT01352572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101907945|NCT01352572|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101907946|NCT01352572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101907947|NCT01352572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101907948|NCT01352572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907949|NCT01352572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101907950|NCT01352572|Serotonin Agents|serotonin agents|mesh-ancestor
101907951|NCT01352572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101907952|NCT01352572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101907953|NCT01352572|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101627800|NCT02607592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101907954|NCT01352572|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101907955|NCT01352572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101907956|NCT01352572|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101907957|NCT01352572|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101907958|NCT01352572|Histamine Antagonists|histamine antagonists|mesh-ancestor
101907959|NCT01352572|Histamine Agents|histamine agents|mesh-ancestor
101907960|NCT01352572|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101907961|NCT01352572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101907962|NCT01352572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101907963|NCT01352572|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101907964|NCT01352572|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101907965|NCT01352572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101907966|NCT01352572|Adrenergic Agents|adrenergic agents|mesh-ancestor
101907967|NCT01352572|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101907968|NCT01352572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101907969|NCT01352572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101907970|NCT01352572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101907971|NCT01352572|Analgesics|analgesics|mesh-ancestor
101907972|NCT01352572|Sensory System Agents|sensory system agents|mesh-ancestor
101907973|NCT01352572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101907974|NCT01352572|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101907975|NCT01352572|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101907976|NCT01352650|Plerixafor|plerixafor|mesh-list
101907977|NCT01352650|Decitabine|decitabine|mesh-list
101907978|NCT01352650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101907979|NCT01352650|Antimetabolites|antimetabolites|mesh-ancestor
101907980|NCT01352650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907981|NCT01352650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101907982|NCT01352650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101907983|NCT01352650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101907984|NCT01352650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101907985|NCT01352650|Antiviral Agents|antiviral agents|mesh-ancestor
101907986|NCT01352650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101907987|NCT01352728|Axitinib|axitinib|mesh-list
101907988|NCT01352728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101907989|NCT01352728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101907990|NCT01352728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101907991|NCT01352728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907992|NCT03997448|Pembrolizumab|pembrolizumab|mesh-list
101907993|NCT03997448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101907994|NCT03997448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101907995|NCT03997448|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101907996|NCT03997448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101907997|NCT03767660|Sirolimus|sirolimus|mesh-list
101907998|NCT03767660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101907999|NCT03767660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101908000|NCT03767660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101908001|NCT03767660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101908002|NCT03767660|Antifungal Agents|antifungal agents|mesh-ancestor
101908003|NCT03767660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101908004|NCT03767660|Immunologic Factors|immunologic factors|mesh-ancestor
101908005|NCT03767660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908006|NCT03767504|Thymol|thymol|mesh-list
101908007|NCT03767504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101908008|NCT03767504|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101908009|NCT03767504|Antifungal Agents|antifungal agents|mesh-ancestor
101908010|NCT01343290|Canagliflozin|canagliflozin|mesh-list
101908011|NCT01343290|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101908012|NCT01343290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908013|NCT01343290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101908014|NCT01343290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908015|NCT03761264|Amoxicillin|amoxicillin|mesh-list
101908016|NCT03761264|Zinc Oxide|zinc oxide|mesh-list
101908017|NCT03761264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908018|NCT03761264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101908019|NCT03761264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101908020|NCT03761264|Dermatologic Agents|dermatologic agents|mesh-ancestor
101908021|NCT03761264|Sunscreening Agents|sunscreening agents|mesh-ancestor
101908022|NCT03761264|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101908023|NCT03761264|Protective Agents|protective agents|mesh-ancestor
101908024|NCT05096312|Zinc|zinc|mesh-list
101908025|NCT05096312|Adapalene|adapalene|mesh-list
101908026|NCT05096312|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
101908027|NCT05096312|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101908028|NCT05096312|Trace Elements|trace elements|mesh-ancestor
101908029|NCT05096312|Micronutrients|micronutrients|mesh-ancestor
101908030|NCT05096312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908031|NCT05096312|Dermatologic Agents|dermatologic agents|mesh-ancestor
101908032|NCT05096312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101908033|NCT05096312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101908034|NCT05096312|Analgesics|analgesics|mesh-ancestor
101908035|NCT05096312|Sensory System Agents|sensory system agents|mesh-ancestor
101908036|NCT05096312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101908037|NCT05096312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101908038|NCT05096312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101908040|NCT03767036|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101908041|NCT03767036|Tramadol|tramadol|mesh-list
101908042|NCT03767036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101908043|NCT03767036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101908044|NCT03767036|Analgesics|analgesics|mesh-ancestor
101908045|NCT03767036|Sensory System Agents|sensory system agents|mesh-ancestor
101908046|NCT03767036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101908047|NCT03767036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908048|NCT03767036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101908049|NCT03767036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101908050|NCT03767036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101908051|NCT03767036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101908052|NCT03767036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908053|NCT03767036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101908054|NCT03767036|Narcotics|narcotics|mesh-ancestor
101955397|NCT05320107|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101908055|NCT03767036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101908056|NCT03758144|Rifaximin|rifaximin|mesh-list
101908057|NCT03758144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101908058|NCT03758144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101908059|NCT03758144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101908060|NCT03766724|Dapagliflozin|dapagliflozin|mesh-list
101908061|NCT03766724|Empagliflozin|empagliflozin|mesh-list
101908062|NCT03766724|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101908063|NCT03766724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908064|NCT03766724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101908065|NCT03766724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908066|NCT04860518|Dexamethasone|dexamethasone|mesh-list
101908067|NCT04860518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101908068|NCT04860518|Antiemetics|antiemetics|mesh-ancestor
101908069|NCT04860518|Autonomic Agents|autonomic agents|mesh-ancestor
101908070|NCT04860518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101908071|NCT04860518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908072|NCT04860518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101908073|NCT04860518|Glucocorticoids|glucocorticoids|mesh-ancestor
101908074|NCT04860518|Hormones|hormones|mesh-ancestor
101908075|NCT04860518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101228052|NCT01543906|Retinol acetate|retinol acetate|mesh-list
101908076|NCT04860518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101908077|NCT04860518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101908078|NCT03110380|Dolutegravir|dolutegravir|mesh-list
101908079|NCT03110380|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
101908080|NCT03110380|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101908081|NCT03110380|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101908082|NCT03110380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101908083|NCT03110380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908084|NCT03110380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101908085|NCT03110380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101908086|NCT03110380|Antiviral Agents|antiviral agents|mesh-ancestor
101908087|NCT03110380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101908088|NCT03110380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101908089|NCT03110380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101908090|NCT03757910|Corticosterone|corticosterone|mesh-list
101908091|NCT03757910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101908092|NCT01322204|Codeine|codeine|mesh-list
101908093|NCT01322204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101908094|NCT01322204|Narcotics|narcotics|mesh-ancestor
101908095|NCT01322204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101908096|NCT01322204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908097|NCT01322204|Analgesics|analgesics|mesh-ancestor
101908098|NCT01322204|Sensory System Agents|sensory system agents|mesh-ancestor
101908099|NCT01322204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101908100|NCT01322204|Antitussive Agents|antitussive agents|mesh-ancestor
101908101|NCT01322204|Respiratory System Agents|respiratory system agents|mesh-ancestor
101908102|NCT03766490|Gefitinib|gefitinib|mesh-list
101908103|NCT03766490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101908104|NCT03766490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101908106|NCT03766490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908107|NCT01348984|Fentanyl|fentanyl|mesh-list
101908108|NCT01348984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101908109|NCT01348984|Narcotics|narcotics|mesh-ancestor
101908110|NCT01348984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101908111|NCT01348984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908112|NCT01348984|Analgesics|analgesics|mesh-ancestor
101908113|NCT01348984|Sensory System Agents|sensory system agents|mesh-ancestor
101908114|NCT01348984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101908115|NCT01348984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101908116|NCT01348984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101908117|NCT01348984|Anesthetics, General|anesthetics, general|mesh-ancestor
101908118|NCT01348984|Anesthetics|anesthetics|mesh-ancestor
101908119|NCT01567670|Naloxone|naloxone|mesh-list
101908120|NCT01567670|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101908121|NCT01567670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908122|NCT01567670|Sensory System Agents|sensory system agents|mesh-ancestor
101908123|NCT01567670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101908124|NCT01349062|Immunomodulating Agents|immunomodulating agents|mesh-list
101908125|NCT01349062|Immunologic Factors|immunologic factors|mesh-ancestor
101908126|NCT01349062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908127|NCT04848662|Budesonide|budesonide|mesh-list
101908128|NCT04848662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101908129|NCT04848662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101908130|NCT04848662|Autonomic Agents|autonomic agents|mesh-ancestor
101908131|NCT04848662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101908132|NCT04848662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908133|NCT04848662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101908134|NCT04848662|Respiratory System Agents|respiratory system agents|mesh-ancestor
101908135|NCT04848662|Glucocorticoids|glucocorticoids|mesh-ancestor
101908136|NCT04848662|Hormones|hormones|mesh-ancestor
101908137|NCT04848662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101908138|NCT04351256|Durvalumab|durvalumab|mesh-list
101908139|NCT04351256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101908140|NCT04351256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101908141|NCT03700892|Cinnamaldehyde|cinnamaldehyde|mesh-list
101908142|NCT03700892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101908143|NCT03700892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101908144|NCT03700892|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101908145|NCT03700892|Protective Agents|protective agents|mesh-ancestor
101908146|NCT03700892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908147|NCT01322282|Cetirizine|cetirizine|mesh-list
101908148|NCT01322282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101908149|NCT01322282|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101908150|NCT01322282|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101908151|NCT01322282|Histamine Antagonists|histamine antagonists|mesh-ancestor
101908152|NCT01322282|Histamine Agents|histamine agents|mesh-ancestor
101908153|NCT01322282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101908154|NCT01322282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908155|NCT01322282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908156|NCT03757364|Methotrexate|methotrexate|mesh-list
101908157|NCT03757364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101908158|NCT03757364|Abortifacient Agents|abortifacient agents|mesh-ancestor
101908159|NCT03757364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101908160|NCT03757364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908161|NCT03757364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101908162|NCT03757364|Antimetabolites|antimetabolites|mesh-ancestor
101908163|NCT03757364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908164|NCT03757364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101908165|NCT03757364|Dermatologic Agents|dermatologic agents|mesh-ancestor
101908166|NCT03757364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101908167|NCT03757364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101908168|NCT03757364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101908169|NCT03757364|Immunologic Factors|immunologic factors|mesh-ancestor
101908170|NCT03757364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101908171|NCT03757364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101908172|NCT03766178|Nimotuzumab|nimotuzumab|mesh-list
101908173|NCT03766178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101908174|NCT03766178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101908175|NCT04737278|Nicotinic Acids|nicotinic acids|mesh-list
101908177|NCT04737278|Vitamin B Complex|vitamin b complex|mesh-ancestor
101908178|NCT04737278|Vitamins|vitamins|mesh-ancestor
101908179|NCT04737278|Micronutrients|micronutrients|mesh-ancestor
101908180|NCT04737278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908182|NCT04737278|Antimetabolites|antimetabolites|mesh-ancestor
101908183|NCT04737278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908184|NCT04737278|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101908185|NCT04737278|Vasodilator Agents|vasodilator agents|mesh-ancestor
101908186|NCT03759860|Ranibizumab|ranibizumab|mesh-list
101908187|NCT03759860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101908188|NCT03759860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101908189|NCT03759860|Growth Substances|growth substances|mesh-ancestor
101908190|NCT03759860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908191|NCT03759860|Growth Inhibitors|growth inhibitors|mesh-ancestor
101908192|NCT03759860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101908194|NCT03759782|Ribavirin|ribavirin|mesh-list
101908195|NCT03759782|Antiviral Agents|antiviral agents|mesh-ancestor
101908196|NCT03759782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101908197|NCT03759782|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101908198|NCT03759782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101908199|NCT03759782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101908200|NCT03759782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908201|NCT03759782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101908202|NCT03759782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101908203|NCT03759782|Antimetabolites|antimetabolites|mesh-ancestor
101908204|NCT03757052|Amoxicillin|amoxicillin|mesh-list
101908205|NCT03757052|Penicillins|penicillins|mesh-list
101908206|NCT03757052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101908207|NCT03757052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101908208|NCT03765944|Sirolimus|sirolimus|mesh-list
101908209|NCT03765944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101908210|NCT03765944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101908211|NCT03765944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101908212|NCT03765944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101908213|NCT03765944|Antifungal Agents|antifungal agents|mesh-ancestor
101908214|NCT03765944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101908215|NCT03765944|Immunologic Factors|immunologic factors|mesh-ancestor
101908216|NCT03765944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908217|NCT04684394|Aflibercept|aflibercept|mesh-list
101908218|NCT04684394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101908219|NCT04684394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101908220|NCT04684394|Growth Substances|growth substances|mesh-ancestor
101908221|NCT04684394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908222|NCT04684394|Growth Inhibitors|growth inhibitors|mesh-ancestor
101908223|NCT04684394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101908224|NCT03765554|PF-06700841|pf-06700841|mesh-list
101908225|NCT03765554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101908226|NCT03765554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101908227|NCT03765554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908228|NCT04668950|Fluvoxamine|fluvoxamine|mesh-list
101908229|NCT04668950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101908230|NCT04668950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101908231|NCT04668950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101908232|NCT04668950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908233|NCT04668950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101908234|NCT04668950|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101908235|NCT04668950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101908236|NCT04668950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101908237|NCT04668950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908238|NCT04668950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101908239|NCT04668950|Serotonin Agents|serotonin agents|mesh-ancestor
101908240|NCT04668950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101908241|NCT04668950|Antidepressive Agents|antidepressive agents|mesh-ancestor
101908242|NCT04668950|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101908243|NCT04668950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101955431|NCT02064946|Vitamin D|vitamin d|mesh-list
101908244|NCT04668950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101908245|NCT04668950|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101908246|NCT03078478|Insulin|insulin|mesh-list
101908247|NCT03078478|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101908248|NCT03078478|Insulin Glargine|insulin glargine|mesh-list
101908249|NCT03078478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101908250|NCT03078478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908251|NCT01349296|Everolimus|everolimus|mesh-list
101628104|NCT03822507|Cinacalcet|cinacalcet|mesh-list
101908252|NCT01349296|Nintedanib|nintedanib|mesh-list
101908253|NCT01349296|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101908254|NCT01349296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101908255|NCT01349296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101908256|NCT01349296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908257|NCT01349296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101908258|NCT01349296|Immunologic Factors|immunologic factors|mesh-ancestor
101908259|NCT01349296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908260|NCT01349296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101908261|NCT03522844|Escitalopram|escitalopram|mesh-list
101908262|NCT03522844|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101908263|NCT03522844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101908264|NCT03522844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101908265|NCT03522844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908266|NCT03522844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101908267|NCT03522844|Serotonin Agents|serotonin agents|mesh-ancestor
101908268|NCT03522844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908269|NCT00045942|Itraconazole|itraconazole|mesh-list
101908270|NCT00045942|Midostaurin|midostaurin|mesh-list
101908271|NCT00045942|Antifungal Agents|antifungal agents|mesh-ancestor
101908272|NCT00045942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101908273|NCT00045942|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101908274|NCT00045942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101908275|NCT00045942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101908276|NCT00045942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908277|NCT00045942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101908278|NCT00045942|Hormone Antagonists|hormone antagonists|mesh-ancestor
101616782|NCT00592852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101908279|NCT00045942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101908280|NCT00045942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908281|NCT00045942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101908282|NCT00045942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101908283|NCT00045942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101908285|NCT04386616|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101908286|NCT04386616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101908287|NCT04386616|Antiviral Agents|antiviral agents|mesh-ancestor
101908288|NCT04386616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101908289|NCT00045708|Epothilones|epothilones|mesh-list
101908290|NCT00045708|Epothilone B|epothilone b|mesh-list
101908291|NCT00045708|Anticonvulsants|anticonvulsants|mesh-list
101908292|NCT00045708|Tubulin Modulators|tubulin modulators|mesh-ancestor
101908293|NCT00045708|Antimitotic Agents|antimitotic agents|mesh-ancestor
101908294|NCT00045708|Mitosis Modulators|mitosis modulators|mesh-ancestor
101908295|NCT00045708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908296|NCT00045708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101908298|NCT01349452|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101908299|NCT01349452|Lubricant Eye Drops|lubricant eye drops|mesh-list
101908300|NCT01349452|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101908301|NCT01349452|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101908302|NCT01349452|Antiviral Agents|antiviral agents|mesh-ancestor
101908303|NCT01349452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101908304|NCT01349452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101908305|NCT01349452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101908306|NCT01349452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908307|NCT00045630|Paclitaxel|paclitaxel|mesh-list
101908308|NCT00045630|Carboplatin|carboplatin|mesh-list
101908309|NCT00045630|Gemcitabine|gemcitabine|mesh-list
101908310|NCT00045630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101908311|NCT00045630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101908312|NCT00045630|Tubulin Modulators|tubulin modulators|mesh-ancestor
101908313|NCT00045630|Antimitotic Agents|antimitotic agents|mesh-ancestor
101908314|NCT00045630|Mitosis Modulators|mitosis modulators|mesh-ancestor
101908315|NCT00045630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908316|NCT00045630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101908317|NCT00045630|Antimetabolites|antimetabolites|mesh-ancestor
101908318|NCT01357252|Vildagliptin|vildagliptin|mesh-list
101908319|NCT01357252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101908320|NCT01357252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908321|NCT01357252|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101908322|NCT01357252|Protease Inhibitors|protease inhibitors|mesh-ancestor
101908323|NCT01357252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101908324|NCT01357252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228105|NCT01544140|Midazolam|midazolam|mesh-list
101908325|NCT03465280|Interferons|interferons|mesh-list
101908326|NCT03465280|Acyclovir|acyclovir|mesh-list
101908327|NCT03465280|Cidofovir|cidofovir|mesh-list
101908328|NCT03465280|Interferon-alpha|interferon-alpha|mesh-list
101908329|NCT03465280|Artemisinins|artemisinins|mesh-list
101908330|NCT03465280|Artemisinin|artemisinin|mesh-list
101908331|NCT03465280|Celecoxib|celecoxib|mesh-list
101908332|NCT03465280|Methotrexate|methotrexate|mesh-list
101908333|NCT03465280|Indole-3-carbinol|indole-3-carbinol|mesh-list
101908334|NCT03465280|Isotretinoin|isotretinoin|mesh-list
101908335|NCT03465280|Cimetidine|cimetidine|mesh-list
101908336|NCT03465280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101908337|NCT03465280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908338|NCT03465280|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101908339|NCT03465280|Abortifacient Agents|abortifacient agents|mesh-ancestor
101908340|NCT03465280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101908341|NCT03465280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101908342|NCT03465280|Antimetabolites|antimetabolites|mesh-ancestor
101908343|NCT03465280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908344|NCT03465280|Dermatologic Agents|dermatologic agents|mesh-ancestor
101908345|NCT03465280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101908346|NCT03465280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101908347|NCT03465280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101908348|NCT03465280|Immunologic Factors|immunologic factors|mesh-ancestor
101908349|NCT03465280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101908350|NCT03465280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101908351|NCT03465280|Antiviral Agents|antiviral agents|mesh-ancestor
101908352|NCT03465280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101908353|NCT03465280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101616783|NCT00592852|Serotonin Agents|serotonin agents|mesh-ancestor
101908354|NCT03465280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101908355|NCT03465280|Analgesics|analgesics|mesh-ancestor
101908356|NCT03465280|Sensory System Agents|sensory system agents|mesh-ancestor
101908357|NCT03465280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101908358|NCT03465280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101908359|NCT03465280|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101908360|NCT03465280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101908361|NCT03465280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101908362|NCT03465280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101908363|NCT03465280|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101908364|NCT03465280|Histamine Antagonists|histamine antagonists|mesh-ancestor
101908365|NCT03465280|Histamine Agents|histamine agents|mesh-ancestor
101908366|NCT03465280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101955458|NCT05041647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101908367|NCT03465280|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101908368|NCT03465280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101908369|NCT03465280|Antimalarials|antimalarials|mesh-ancestor
101908370|NCT03465280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101908371|NCT03465280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101908372|NCT03465280|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101908373|NCT03465280|Protective Agents|protective agents|mesh-ancestor
101908374|NCT01349764|Vitamin D|vitamin d|mesh-list
101908375|NCT01349764|Cholecalciferol|cholecalciferol|mesh-list
101908376|NCT01349764|Vitamins|vitamins|mesh-ancestor
101908377|NCT01349764|Micronutrients|micronutrients|mesh-ancestor
101908378|NCT01349764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908379|NCT01349764|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101908380|NCT01349764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101908381|NCT02924272|Ixazomib|ixazomib|mesh-list
101908382|NCT02924272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101908383|NCT02924272|Protease Inhibitors|protease inhibitors|mesh-ancestor
101908384|NCT02924272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101908385|NCT02924272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908386|NCT01353742|Lamivudine|lamivudine|mesh-list
101908387|NCT01353742|Adefovir|adefovir|mesh-list
101908388|NCT01353742|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101908389|NCT01353742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101908390|NCT01353742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101908391|NCT01353742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101908392|NCT01353742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908393|NCT01353742|Antiviral Agents|antiviral agents|mesh-ancestor
101908394|NCT01353742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101908395|NCT01353742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101908396|NCT01353742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101908397|NCT00003702|Dactinomycin|dactinomycin|mesh-list
101908398|NCT00003702|Cactinomycin|cactinomycin|mesh-list
101908399|NCT00003702|Methotrexate|methotrexate|mesh-list
101908400|NCT00003702|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101908401|NCT00003702|Abortifacient Agents|abortifacient agents|mesh-ancestor
101908402|NCT00003702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101908403|NCT00003702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908404|NCT00003702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101908405|NCT00003702|Antimetabolites|antimetabolites|mesh-ancestor
101908406|NCT00003702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908407|NCT00003702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101908408|NCT00003702|Dermatologic Agents|dermatologic agents|mesh-ancestor
101908409|NCT00003702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101908410|NCT00003702|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101908411|NCT00003702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101908412|NCT00003702|Immunologic Factors|immunologic factors|mesh-ancestor
101908413|NCT00003702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101908414|NCT00003702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101908415|NCT00003702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101908416|NCT00003702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101908417|NCT00003702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101908418|NCT00003702|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101908419|NCT01350154|Sildenafil Citrate|sildenafil citrate|mesh-list
101908420|NCT01350154|Vasodilator Agents|vasodilator agents|mesh-ancestor
101908421|NCT01350154|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101908422|NCT01350154|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101908423|NCT01350154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101908424|NCT01350154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908425|NCT01350154|Urological Agents|urological agents|mesh-ancestor
101908426|NCT00031590|Cyclophosphamide|cyclophosphamide|mesh-list
101908427|NCT00031590|Lomustine|lomustine|mesh-list
101908428|NCT00031590|Etoposide|etoposide|mesh-list
101908429|NCT00031590|Vincristine|vincristine|mesh-list
101908430|NCT00031590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101908431|NCT00031590|Immunologic Factors|immunologic factors|mesh-ancestor
101908432|NCT00031590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908433|NCT00031590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101908434|NCT00031590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101908435|NCT00031590|Alkylating Agents|alkylating agents|mesh-ancestor
101908436|NCT00031590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908437|NCT00031590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101908438|NCT00031590|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101908439|NCT00031590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101908440|NCT00031590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101908441|NCT00031590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101908442|NCT00031590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101908443|NCT00031590|Tubulin Modulators|tubulin modulators|mesh-ancestor
101908444|NCT00031590|Antimitotic Agents|antimitotic agents|mesh-ancestor
101908445|NCT00031590|Mitosis Modulators|mitosis modulators|mesh-ancestor
101908446|NCT01318096|Tenofovir|tenofovir|mesh-list
101908447|NCT01318096|Lamivudine|lamivudine|mesh-list
101908448|NCT01318096|Efavirenz|efavirenz|mesh-list
101908449|NCT01318096|Raltegravir Potassium|raltegravir potassium|mesh-list
101908450|NCT01318096|Antiviral Agents|antiviral agents|mesh-ancestor
101908451|NCT01318096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101908452|NCT01318096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101908453|NCT01318096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101908454|NCT01318096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101908455|NCT01318096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908456|NCT01318096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101228115|NCT01544140|Anesthetics|anesthetics|mesh-ancestor
101908457|NCT01318096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101908458|NCT01318096|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101908459|NCT01318096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101908460|NCT01318096|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101908461|NCT01318096|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101908462|NCT01318096|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101908463|NCT01318096|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101908464|NCT01318096|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101908465|NCT01318096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101908466|NCT02530320|Palbociclib|palbociclib|mesh-list
101908467|NCT02530320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101908468|NCT02530320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101908469|NCT02530320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101908470|NCT02530320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908471|NCT00239681|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101908472|NCT00239681|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101908473|NCT00239681|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101908474|NCT00239681|Antimetabolites|antimetabolites|mesh-ancestor
101908475|NCT00239681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908476|NCT00239681|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101908477|NCT00239681|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101908478|NCT00239681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101908479|NCT00238433|Melphalan|melphalan|mesh-list
101908480|NCT00238433|Busulfan|busulfan|mesh-list
101908481|NCT00238433|Thiotepa|thiotepa|mesh-list
101908482|NCT00238433|Immunologic Factors|immunologic factors|mesh-ancestor
101908483|NCT00238433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908484|NCT00238433|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101908485|NCT00238433|Alkylating Agents|alkylating agents|mesh-ancestor
101908486|NCT00238433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908487|NCT00238433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101908488|NCT00238433|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101908489|NCT00238433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101908490|NCT02532023|Curcumin|curcumin|mesh-list
101908491|NCT02532023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101908492|NCT02532023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101908493|NCT02532023|Analgesics|analgesics|mesh-ancestor
101908494|NCT02532023|Sensory System Agents|sensory system agents|mesh-ancestor
101908495|NCT02532023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101908496|NCT02532023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908497|NCT02532023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101908498|NCT02532023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101908499|NCT02532023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101955479|NCT03752229|Anesthetics|anesthetics|mesh-ancestor
101908501|NCT02532023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908502|NCT01354522|Cyclophosphamide|cyclophosphamide|mesh-list
101908504|NCT01354522|Doxorubicin|doxorubicin|mesh-list
101908505|NCT01354522|Capecitabine|capecitabine|mesh-list
101908506|NCT01354522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101908507|NCT01354522|Immunologic Factors|immunologic factors|mesh-ancestor
101908508|NCT01354522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908509|NCT01354522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101908510|NCT01354522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101908511|NCT01354522|Alkylating Agents|alkylating agents|mesh-ancestor
101908512|NCT01354522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908513|NCT01354522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101908514|NCT01354522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101908515|NCT01354522|Tubulin Modulators|tubulin modulators|mesh-ancestor
101908516|NCT01354522|Antimitotic Agents|antimitotic agents|mesh-ancestor
101908517|NCT01354522|Mitosis Modulators|mitosis modulators|mesh-ancestor
101908518|NCT01354522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101908519|NCT01354522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101908520|NCT01354522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101908521|NCT01354522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101908522|NCT01354522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101908523|NCT01354522|Antimetabolites|antimetabolites|mesh-ancestor
101908524|NCT00045162|Irinotecan|irinotecan|mesh-list
101908525|NCT00045162|Etoposide|etoposide|mesh-list
101908526|NCT00045162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101908527|NCT00045162|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101908528|NCT00045162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101908529|NCT00045162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101908530|NCT00045162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908531|NCT00045162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101908532|NCT00045162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101908533|NCT02748616|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101908534|NCT02748616|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101908535|NCT02748616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101908536|NCT00238121|Sorafenib|sorafenib|mesh-list
101908537|NCT00238121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101908538|NCT00238121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101908539|NCT00238121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101908540|NCT00238121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908541|NCT01350622|Diclofenac|diclofenac|mesh-list
101908542|NCT01350622|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
101908543|NCT01350622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101908544|NCT01350622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101908545|NCT01350622|Analgesics|analgesics|mesh-ancestor
101908546|NCT01350622|Sensory System Agents|sensory system agents|mesh-ancestor
101908547|NCT01350622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101908548|NCT01350622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908549|NCT01350622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101908550|NCT01350622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101908551|NCT01350622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101908552|NCT01350622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101908553|NCT01350622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908554|NCT01096212|Sevoflurane|sevoflurane|mesh-list
101908555|NCT01096212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101908556|NCT01096212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101908557|NCT01096212|Anesthetics, General|anesthetics, general|mesh-ancestor
101908558|NCT01096212|Anesthetics|anesthetics|mesh-ancestor
101908559|NCT01096212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101955481|NCT03752229|GABA Agents|gaba agents|mesh-ancestor
101908560|NCT01096212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908561|NCT03139240|Oxycodone|oxycodone|mesh-list
101908562|NCT03139240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101908563|NCT03139240|Narcotics|narcotics|mesh-ancestor
101908564|NCT03139240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101908565|NCT03139240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908566|NCT03139240|Analgesics|analgesics|mesh-ancestor
101908567|NCT03139240|Sensory System Agents|sensory system agents|mesh-ancestor
101908568|NCT03139240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101908569|NCT01350856|Artesunate|artesunate|mesh-list
101908570|NCT01350856|Antimalarials|antimalarials|mesh-ancestor
101908571|NCT01350856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101908572|NCT01350856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101908573|NCT01350856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101908574|NCT01350856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101908575|NCT01350856|Antiviral Agents|antiviral agents|mesh-ancestor
101908576|NCT01350856|Schistosomicides|schistosomicides|mesh-ancestor
101908577|NCT01350856|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101908578|NCT01350856|Anthelmintics|anthelmintics|mesh-ancestor
101908579|NCT03973775|Permethrin|permethrin|mesh-list
101908580|NCT03973775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101908581|NCT03973775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908582|NCT01351168|Levodopa|levodopa|mesh-list
101908583|NCT01351168|Zolpidem|zolpidem|mesh-list
101908584|NCT01351168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101908585|NCT01351168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101908586|NCT01351168|Dopamine Agents|dopamine agents|mesh-ancestor
101908587|NCT01351168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101908588|NCT01351168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908589|NCT01351168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908590|NCT01351168|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101908591|NCT01351168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101908592|NCT01351168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101908593|NCT01351168|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101908594|NCT01351168|GABA Agonists|gaba agonists|mesh-ancestor
101908595|NCT01351168|GABA Agents|gaba agents|mesh-ancestor
101908596|NCT01351636|Arotinolol|arotinolol|mesh-list
101908597|NCT01351636|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101908598|NCT01351636|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101908599|NCT01351636|Adrenergic Agents|adrenergic agents|mesh-ancestor
101908600|NCT01351636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101908601|NCT01351636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908602|NCT01351636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908603|NCT01351636|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101908604|NCT01351792|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101908605|NCT01351792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101908606|NCT01351792|Respiratory System Agents|respiratory system agents|mesh-ancestor
101908607|NCT03952260|Anesthetics|anesthetics|mesh-list
101908608|NCT03952260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101908609|NCT03952260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908610|NCT01351948|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101908611|NCT01351948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101908612|NCT01351948|Immunologic Factors|immunologic factors|mesh-ancestor
101908613|NCT01351948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908614|NCT01351948|Antacids|antacids|mesh-ancestor
101908615|NCT01351948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908616|NCT01351948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101908617|NCT01352026|Metformin|metformin|mesh-list
101908618|NCT01352026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101908619|NCT01352026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908620|NCT03136198|Vasodilator Agents|vasodilator agents|mesh-list
101908621|NCT03136198|Diuretics|diuretics|mesh-list
101908622|NCT03136198|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
101908623|NCT03136198|Natriuretic Agents|natriuretic agents|mesh-ancestor
101908624|NCT03136198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908625|NCT03136198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101908626|NCT03136198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908627|NCT01357486|Sorafenib|sorafenib|mesh-list
101908629|NCT01357486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101908630|NCT01357486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101908631|NCT01357486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101908632|NCT01357486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908633|NCT01357486|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101908634|NCT01357486|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101908635|NCT01357486|Antimetabolites|antimetabolites|mesh-ancestor
101908636|NCT01357486|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101908637|NCT01357486|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101908638|NCT01318564|Metformin|metformin|mesh-list
101908639|NCT01318564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101908640|NCT01318564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908641|NCT00042432|Cinacalcet|cinacalcet|mesh-list
101908642|NCT00042432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101908643|NCT00042432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908644|NCT00042432|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101908645|NCT00042432|Hormone Antagonists|hormone antagonists|mesh-ancestor
101908646|NCT00042432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101908647|NCT01352338|Prednisone|prednisone|mesh-list
101908648|NCT01352338|Cyclophosphamide|cyclophosphamide|mesh-list
101908649|NCT01352338|Lenalidomide|lenalidomide|mesh-list
101908650|NCT01352338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101908651|NCT01352338|Immunologic Factors|immunologic factors|mesh-ancestor
101908652|NCT01352338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908653|NCT01352338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101908654|NCT01352338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101908655|NCT01352338|Alkylating Agents|alkylating agents|mesh-ancestor
101908656|NCT01352338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228149|NCT01544283|Hormones|hormones|mesh-ancestor
101908657|NCT01352338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101908658|NCT01352338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101908659|NCT01352338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101908661|NCT01352338|Hormones|hormones|mesh-ancestor
101908662|NCT01352338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101908663|NCT01352338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101908664|NCT01352338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101908665|NCT01352338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101908666|NCT01352338|Growth Substances|growth substances|mesh-ancestor
101908667|NCT01352338|Growth Inhibitors|growth inhibitors|mesh-ancestor
101908668|NCT01542736|Carboplatin|carboplatin|mesh-list
101908669|NCT01542736|Vincristine|vincristine|mesh-list
101908670|NCT01542736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101908671|NCT01542736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101908672|NCT01542736|Tubulin Modulators|tubulin modulators|mesh-ancestor
101908673|NCT01542736|Antimitotic Agents|antimitotic agents|mesh-ancestor
101908674|NCT01542736|Mitosis Modulators|mitosis modulators|mesh-ancestor
101908675|NCT01542736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908676|NCT01099566|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101908677|NCT01099566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101908678|NCT01099722|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101908679|NCT01099722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101908680|NCT01099722|Respiratory System Agents|respiratory system agents|mesh-ancestor
101908681|NCT01361542|Infliximab|infliximab|mesh-list
101908682|NCT01361542|Etanercept|etanercept|mesh-list
101908683|NCT01361542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101908684|NCT01361542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101908685|NCT01361542|Dermatologic Agents|dermatologic agents|mesh-ancestor
101908686|NCT01361542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101908687|NCT01361542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101908688|NCT01361542|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101908689|NCT01361542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101908690|NCT01361542|Analgesics|analgesics|mesh-ancestor
101908691|NCT01361542|Sensory System Agents|sensory system agents|mesh-ancestor
101908692|NCT01361542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101908693|NCT01361542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908694|NCT01361542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101908695|NCT01361542|Immunologic Factors|immunologic factors|mesh-ancestor
101908696|NCT03950700|Epinephrine|epinephrine|mesh-list
101908697|NCT03950700|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
101908698|NCT03950700|Bupivacaine|bupivacaine|mesh-list
101908699|NCT03950700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101908700|NCT03950700|Anesthetics, Local|anesthetics, local|mesh-ancestor
101908701|NCT03950700|Anesthetics|anesthetics|mesh-ancestor
101908702|NCT03950700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101908703|NCT03950700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908705|NCT03950700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101908706|NCT03950700|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101908707|NCT03950700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101908708|NCT03950700|Adrenergic Agents|adrenergic agents|mesh-ancestor
101908709|NCT03950700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101908710|NCT03950700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908711|NCT03950700|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101908712|NCT03950700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101908713|NCT03950700|Autonomic Agents|autonomic agents|mesh-ancestor
101908714|NCT03950700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101908715|NCT03950700|Respiratory System Agents|respiratory system agents|mesh-ancestor
101908716|NCT03950700|Mydriatics|mydriatics|mesh-ancestor
101908717|NCT03950700|Sympathomimetics|sympathomimetics|mesh-ancestor
101908718|NCT00237185|Imatinib Mesylate|imatinib mesylate|mesh-list
101908719|NCT00237185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101908720|NCT00237185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101908721|NCT00237185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101908722|NCT00237185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908723|NCT01357798|Botulinum Toxins|botulinum toxins|mesh-list
101908724|NCT01357798|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101908725|NCT01357798|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101908726|NCT01357798|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101908727|NCT01357798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101908728|NCT01357798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908729|NCT01357798|Cholinergic Agents|cholinergic agents|mesh-ancestor
101908730|NCT01357798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101908731|NCT01357798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908732|NCT01357798|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101908733|NCT01357798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101908734|NCT00003222|Aldesleukin|aldesleukin|mesh-list
101908735|NCT00003222|Interleukin-2|interleukin-2|mesh-list
101908736|NCT00003222|Sargramostim|sargramostim|mesh-list
101908737|NCT00003222|Freund's Adjuvant|freund's adjuvant|mesh-list
101908738|NCT00003222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101908739|NCT00003222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101908740|NCT00003222|Analgesics|analgesics|mesh-ancestor
101908741|NCT00003222|Sensory System Agents|sensory system agents|mesh-ancestor
101908742|NCT00003222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101908743|NCT00003222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908744|NCT00003222|Immunologic Factors|immunologic factors|mesh-ancestor
101908745|NCT00003222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101908746|NCT00003222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101908747|NCT00003222|Antiviral Agents|antiviral agents|mesh-ancestor
101908748|NCT00003222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101908749|NCT00003222|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101908750|NCT01357876|Metformin|metformin|mesh-list
101908751|NCT01357876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101908752|NCT01357876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908753|NCT02877082|Bortezomib|bortezomib|mesh-list
101908754|NCT02877082|Tacrolimus|tacrolimus|mesh-list
101908755|NCT02877082|Thymoglobulin|thymoglobulin|mesh-list
101908756|NCT02877082|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101908757|NCT02877082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101908758|NCT02877082|Immunologic Factors|immunologic factors|mesh-ancestor
101908759|NCT02877082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908760|NCT02877082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101908761|NCT02877082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101908762|NCT02877082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908763|NCT02877082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101908764|NCT03951558|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101908765|NCT03951558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101908766|NCT03951558|Diuretics|diuretics|mesh-ancestor
101908768|NCT03951558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908769|NCT03951558|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101908770|NCT03951558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101908771|NCT03951558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908772|NCT01362010|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101908773|NCT01362010|Minocycline|minocycline|mesh-list
101908774|NCT01362010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101908775|NCT02875366|Ivacaftor|ivacaftor|mesh-list
101908776|NCT02875366|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101908777|NCT02875366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101908778|NCT02875366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908779|NCT01362400|Docetaxel|docetaxel|mesh-list
101908780|NCT01362400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101908781|NCT01362400|Tubulin Modulators|tubulin modulators|mesh-ancestor
101908782|NCT01362400|Antimitotic Agents|antimitotic agents|mesh-ancestor
101908783|NCT01362400|Mitosis Modulators|mitosis modulators|mesh-ancestor
101908784|NCT01362400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908785|NCT00003102|Antibodies|antibodies|mesh-list
101908786|NCT00003102|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101908787|NCT00003102|Immunologic Factors|immunologic factors|mesh-ancestor
101908788|NCT00003102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908789|NCT00002850|Ciprofloxacin|ciprofloxacin|mesh-list
101908790|NCT00002850|Ofloxacin|ofloxacin|mesh-list
101908791|NCT00002850|Trimethoprim|trimethoprim|mesh-list
101908792|NCT00002850|Sulfamethoxazole|sulfamethoxazole|mesh-list
101908793|NCT00002850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101908794|NCT00002850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101908795|NCT00002850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101908796|NCT00002850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101908797|NCT00002850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101908798|NCT00002850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908799|NCT00002850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101908800|NCT00002850|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101908801|NCT00002850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101908802|NCT00002850|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101908803|NCT00002850|Antimalarials|antimalarials|mesh-ancestor
101908804|NCT00002850|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101908805|NCT00002850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101908806|NCT00002850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101908807|NCT00002850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101908808|NCT00002850|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101908809|NCT04234906|Magnesium Sulfate|magnesium sulfate|mesh-list
101908810|NCT04234906|Amiodarone|amiodarone|mesh-list
101908811|NCT04234906|Procainamide|procainamide|mesh-list
101908812|NCT04234906|Dexmedetomidine|dexmedetomidine|mesh-list
101908813|NCT04234906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101908814|NCT04234906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101908815|NCT04234906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908816|NCT04234906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101908817|NCT04234906|Analgesics|analgesics|mesh-ancestor
101908818|NCT04234906|Sensory System Agents|sensory system agents|mesh-ancestor
101908819|NCT04234906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101908820|NCT04234906|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101908821|NCT04234906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101908822|NCT04234906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101908823|NCT04234906|Adrenergic Agents|adrenergic agents|mesh-ancestor
101908824|NCT04234906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101908825|NCT04234906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908826|NCT04234906|Anesthetics|anesthetics|mesh-ancestor
101908827|NCT04234906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101908828|NCT04234906|Anticonvulsants|anticonvulsants|mesh-ancestor
101908829|NCT04234906|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101908830|NCT04234906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101908831|NCT04234906|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101908832|NCT04234906|Tocolytic Agents|tocolytic agents|mesh-ancestor
101908833|NCT04234906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101908834|NCT04234906|Vasodilator Agents|vasodilator agents|mesh-ancestor
101908835|NCT04234906|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101908836|NCT04234906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101908837|NCT04234906|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101908838|NCT04234906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101908839|NCT04234906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101908840|NCT04234906|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101908841|NCT04234906|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101908842|NCT04234906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101908843|NCT04234906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101908845|NCT00002766|Dactinomycin|dactinomycin|mesh-list
101908846|NCT00002766|Prednisone|prednisone|mesh-list
101908847|NCT00002766|Cyclophosphamide|cyclophosphamide|mesh-list
101908848|NCT00002766|Carmustine|carmustine|mesh-list
101908849|NCT00002766|Doxorubicin|doxorubicin|mesh-list
101908850|NCT00002766|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101908851|NCT00002766|Methotrexate|methotrexate|mesh-list
101908852|NCT00002766|Etoposide|etoposide|mesh-list
101908853|NCT00002766|Vincristine|vincristine|mesh-list
101908854|NCT00002766|Daunorubicin|daunorubicin|mesh-list
101908855|NCT00002766|Mitoxantrone|mitoxantrone|mesh-list
101908856|NCT00002766|Mercaptopurine|mercaptopurine|mesh-list
101908857|NCT00002766|Pegaspargase|pegaspargase|mesh-list
101908858|NCT00002766|Sargramostim|sargramostim|mesh-list
101908859|NCT00002766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101908860|NCT00002766|Immunologic Factors|immunologic factors|mesh-ancestor
101228167|NCT01544504|Autonomic Agents|autonomic agents|mesh-ancestor
101908861|NCT00002766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908862|NCT00002766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101908863|NCT00002766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101908864|NCT00002766|Alkylating Agents|alkylating agents|mesh-ancestor
101908865|NCT00002766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908866|NCT00002766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101908867|NCT00002766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101908868|NCT00002766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101908869|NCT00002766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101908870|NCT00002766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101908871|NCT00002766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101908872|NCT00002766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101908873|NCT00002766|Glucocorticoids|glucocorticoids|mesh-ancestor
101908874|NCT00002766|Hormones|hormones|mesh-ancestor
101908875|NCT00002766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101908876|NCT00002766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101908877|NCT00002766|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101908878|NCT00002766|Abortifacient Agents|abortifacient agents|mesh-ancestor
101908879|NCT00002766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101908880|NCT00002766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101908881|NCT00002766|Antimetabolites|antimetabolites|mesh-ancestor
101908882|NCT00002766|Dermatologic Agents|dermatologic agents|mesh-ancestor
101908883|NCT00002766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101908884|NCT00002766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101908885|NCT00002766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101908886|NCT00002766|Antiviral Agents|antiviral agents|mesh-ancestor
101908887|NCT00002766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101908888|NCT00002766|Tubulin Modulators|tubulin modulators|mesh-ancestor
101908889|NCT00002766|Antimitotic Agents|antimitotic agents|mesh-ancestor
101908890|NCT00002766|Mitosis Modulators|mitosis modulators|mesh-ancestor
101908891|NCT00002766|Analgesics|analgesics|mesh-ancestor
101908892|NCT00002766|Sensory System Agents|sensory system agents|mesh-ancestor
101908893|NCT00002766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101908894|NCT00002766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101908895|NCT00002766|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101908896|NCT01355380|Iloprost|iloprost|mesh-list
101908897|NCT01355380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101908898|NCT01355380|Vasodilator Agents|vasodilator agents|mesh-ancestor
101908899|NCT01355614|Infliximab|infliximab|mesh-list
101908900|NCT01355614|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101908901|NCT01355614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101908902|NCT01355614|Dermatologic Agents|dermatologic agents|mesh-ancestor
101908903|NCT01355614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101908904|NCT01355614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101908905|NCT01584492|Beclomethasone|beclomethasone|mesh-list
101908906|NCT01584492|Albuterol|albuterol|mesh-list
101908907|NCT01584492|Formoterol Fumarate|formoterol fumarate|mesh-list
101908908|NCT01584492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101908909|NCT01584492|Autonomic Agents|autonomic agents|mesh-ancestor
101908910|NCT01584492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101908911|NCT01584492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908912|NCT01584492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101908913|NCT01584492|Respiratory System Agents|respiratory system agents|mesh-ancestor
101908914|NCT01584492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101908915|NCT01584492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101908916|NCT01584492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101908917|NCT01584492|Adrenergic Agents|adrenergic agents|mesh-ancestor
101908918|NCT01584492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101908919|NCT01584492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908920|NCT01584492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101908921|NCT01584492|Glucocorticoids|glucocorticoids|mesh-ancestor
101908922|NCT01584492|Hormones|hormones|mesh-ancestor
101908923|NCT01584492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101908924|NCT01584492|Tocolytic Agents|tocolytic agents|mesh-ancestor
101908925|NCT01584492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101908926|NCT00001962|Daclizumab|daclizumab|mesh-list
101908927|NCT00001962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101908928|NCT00001962|Immunologic Factors|immunologic factors|mesh-ancestor
101908929|NCT00001962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908930|NCT01101984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101908931|NCT01101984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101908932|NCT01101984|Hyaluronic Acid|hyaluronic acid|mesh-list
101908933|NCT01101984|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101908934|NCT01101984|Immunologic Factors|immunologic factors|mesh-ancestor
101908935|NCT01101984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908936|NCT01101984|Viscosupplements|viscosupplements|mesh-ancestor
101908937|NCT01101984|Protective Agents|protective agents|mesh-ancestor
101908938|NCT01103154|Nadolol|nadolol|mesh-list
101908939|NCT01103154|Carvedilol|carvedilol|mesh-list
101908940|NCT01103154|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101908941|NCT01103154|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101908942|NCT01103154|Adrenergic Agents|adrenergic agents|mesh-ancestor
101908943|NCT01103154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101908944|NCT01103154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908945|NCT01103154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908946|NCT01103154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101908947|NCT01103154|Antioxidants|antioxidants|mesh-ancestor
101908948|NCT01103154|Protective Agents|protective agents|mesh-ancestor
101908949|NCT01103154|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101908950|NCT01103154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101908951|NCT01103154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101908952|NCT01103154|Vasodilator Agents|vasodilator agents|mesh-ancestor
101908953|NCT01103154|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101908954|NCT01103154|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101908955|NCT01103154|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101908956|NCT01103154|Sympatholytics|sympatholytics|mesh-ancestor
101908957|NCT01103154|Autonomic Agents|autonomic agents|mesh-ancestor
101908958|NCT01103154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101908959|NCT01100346|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101908960|NCT01100346|Hormones|hormones|mesh-ancestor
101908961|NCT01100346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101908962|NCT01100346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908963|NCT01103388|Rituximab|rituximab|mesh-list
101908964|NCT01103388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101908965|NCT01103388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101908966|NCT01103388|Immunologic Factors|immunologic factors|mesh-ancestor
101908967|NCT01103388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908968|NCT01103388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101908969|NCT01327326|Naltrexone|naltrexone|mesh-list
101908970|NCT01327326|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101908971|NCT01327326|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101908972|NCT01327326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908973|NCT01327326|Sensory System Agents|sensory system agents|mesh-ancestor
101955529|NCT03758079|Anticonvulsants|anticonvulsants|mesh-ancestor
101908974|NCT01327326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101908976|NCT03950544|Fosfomycin|fosfomycin|mesh-list
101908977|NCT03950544|Tigecycline|tigecycline|mesh-list
101908978|NCT03950544|Polymyxins|polymyxins|mesh-list
101908979|NCT03950544|Polymyxin B|polymyxin b|mesh-list
101908980|NCT03950544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101908981|NCT03950544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101908982|NCT03950544|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101908983|NCT03950544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101908984|NCT03950544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908985|NCT00028002|Imatinib Mesylate|imatinib mesylate|mesh-list
101908986|NCT00028002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101908987|NCT00028002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101908988|NCT00028002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101908989|NCT00028002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908990|NCT00256997|Risperidone|risperidone|mesh-list
101908991|NCT00256997|Antipsychotic Agents|antipsychotic agents|mesh-list
101908992|NCT00256997|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101908993|NCT00256997|Serotonin Agents|serotonin agents|mesh-ancestor
101908994|NCT00256997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101908995|NCT00256997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101908996|NCT00256997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101908997|NCT00256997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101908998|NCT00256997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101908999|NCT00256997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101909000|NCT00256997|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101909001|NCT00256997|Dopamine Agents|dopamine agents|mesh-ancestor
101909002|NCT00027846|Cyclophosphamide|cyclophosphamide|mesh-list
101909003|NCT00027846|Carboplatin|carboplatin|mesh-list
101909004|NCT00027846|Etoposide|etoposide|mesh-list
101909006|NCT00027846|Podophyllotoxin|podophyllotoxin|mesh-list
101909007|NCT00027846|Lenograstim|lenograstim|mesh-list
101909008|NCT00027846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101909009|NCT00027846|Immunologic Factors|immunologic factors|mesh-ancestor
101909010|NCT00027846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909011|NCT00027846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101909012|NCT00027846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101909013|NCT00027846|Alkylating Agents|alkylating agents|mesh-ancestor
101909014|NCT00027846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909015|NCT00027846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101909016|NCT00027846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101909017|NCT00027846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101909018|NCT00027846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101909019|NCT00027846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101909020|NCT00027846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101909021|NCT00027846|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101909022|NCT00027846|Tubulin Modulators|tubulin modulators|mesh-ancestor
101909023|NCT00027846|Antimitotic Agents|antimitotic agents|mesh-ancestor
101909024|NCT00027846|Mitosis Modulators|mitosis modulators|mesh-ancestor
101909025|NCT00027846|Keratolytic Agents|keratolytic agents|mesh-ancestor
101909026|NCT00027846|Dermatologic Agents|dermatologic agents|mesh-ancestor
101909028|NCT00027378|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101909029|NCT00027378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101909030|NCT00027378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101909031|NCT00027378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909032|NCT00027378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101955545|NCT02067910|Abatacept|abatacept|mesh-list
101909034|NCT00027378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909035|NCT00027378|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101909036|NCT00027378|Antidepressive Agents|antidepressive agents|mesh-ancestor
101909037|NCT00027378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101909038|NCT00027378|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101909039|NCT00027378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101909040|NCT00027378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101909041|NCT03949062|Rituximab|rituximab|mesh-list
101909042|NCT03949062|Lenalidomide|lenalidomide|mesh-list
101909043|NCT03949062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101909044|NCT03949062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101909045|NCT03949062|Immunologic Factors|immunologic factors|mesh-ancestor
101909046|NCT03949062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909047|NCT03949062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101909048|NCT03949062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101909049|NCT03949062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101909050|NCT03949062|Growth Substances|growth substances|mesh-ancestor
101909051|NCT03949062|Growth Inhibitors|growth inhibitors|mesh-ancestor
101909052|NCT00235391|Deferasirox|deferasirox|mesh-list
101909053|NCT00235391|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101909054|NCT00235391|Chelating Agents|chelating agents|mesh-ancestor
101909055|NCT00235391|Sequestering Agents|sequestering agents|mesh-ancestor
101909056|NCT00235391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909057|NCT01103622|Digoxin|digoxin|mesh-list
101909058|NCT01103622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101909059|NCT01103622|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101909060|NCT01103622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101909061|NCT01103622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909062|NCT01103622|Protective Agents|protective agents|mesh-ancestor
101909063|NCT01103622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909064|NCT01072955|Heparin|heparin|mesh-list
101909065|NCT01072955|Calcium heparin|calcium heparin|mesh-list
101909066|NCT01072955|Anticoagulants|anticoagulants|mesh-ancestor
101909067|NCT01072955|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101909068|NCT01072955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101909069|NCT01072955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909070|NCT00026208|Prednisone|prednisone|mesh-list
101909071|NCT00026208|Cyclophosphamide|cyclophosphamide|mesh-list
101909072|NCT00026208|Doxorubicin|doxorubicin|mesh-list
101909073|NCT00026208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101909074|NCT00026208|Etoposide|etoposide|mesh-list
101909075|NCT00026208|Etoposide phosphate|etoposide phosphate|mesh-list
101909076|NCT00026208|Vincristine|vincristine|mesh-list
101909077|NCT00026208|Bleomycin|bleomycin|mesh-list
101909078|NCT00026208|Vinblastine|vinblastine|mesh-list
101909079|NCT00026208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101628932|NCT00714259|Fludarabine|fludarabine|mesh-list
101909081|NCT00026208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909082|NCT00026208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101909083|NCT00026208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101909084|NCT00026208|Alkylating Agents|alkylating agents|mesh-ancestor
101909085|NCT00026208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909086|NCT00026208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101909087|NCT00026208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101909088|NCT00026208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101909089|NCT00026208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101909090|NCT00026208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101909091|NCT00026208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101909092|NCT00026208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101909094|NCT00026208|Hormones|hormones|mesh-ancestor
101909095|NCT00026208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101909096|NCT00026208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101909097|NCT00026208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101909098|NCT00026208|Tubulin Modulators|tubulin modulators|mesh-ancestor
101909099|NCT00026208|Antimitotic Agents|antimitotic agents|mesh-ancestor
101909100|NCT00026208|Mitosis Modulators|mitosis modulators|mesh-ancestor
101909102|NCT00025662|Immunotoxins|immunotoxins|mesh-list
101909103|NCT00025662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101909104|NCT00025662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101909105|NCT00025662|Analgesics|analgesics|mesh-ancestor
101909106|NCT00025662|Sensory System Agents|sensory system agents|mesh-ancestor
101909107|NCT00025662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101909108|NCT00025662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909109|NCT00025662|Immunoconjugates|immunoconjugates|mesh-ancestor
101909110|NCT00025662|Immunologic Factors|immunologic factors|mesh-ancestor
101909111|NCT03759158|Acetylcysteine|acetylcysteine|mesh-list
101909112|NCT03759158|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101909113|NCT03759158|Antiviral Agents|antiviral agents|mesh-ancestor
101909114|NCT03759158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101909115|NCT03759158|Expectorants|expectorants|mesh-ancestor
101909116|NCT03759158|Respiratory System Agents|respiratory system agents|mesh-ancestor
101909117|NCT03759158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101909118|NCT03759158|Antioxidants|antioxidants|mesh-ancestor
101909119|NCT03759158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909120|NCT03759158|Protective Agents|protective agents|mesh-ancestor
101909121|NCT03759158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909122|NCT03759158|Antidotes|antidotes|mesh-ancestor
101909123|NCT00025506|Thalidomide|thalidomide|mesh-list
101909124|NCT00025506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101955674|NCT02260336|Celecoxib|celecoxib|mesh-list
101909125|NCT00025506|Immunologic Factors|immunologic factors|mesh-ancestor
101909126|NCT00025506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909127|NCT00025506|Leprostatic Agents|leprostatic agents|mesh-ancestor
101909128|NCT00025506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101909129|NCT00025506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101909130|NCT00025506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101228203|NCT01544634|Glucocorticoids|glucocorticoids|mesh-ancestor
101909131|NCT00025506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101909132|NCT00025506|Growth Substances|growth substances|mesh-ancestor
101909133|NCT00025506|Growth Inhibitors|growth inhibitors|mesh-ancestor
101909134|NCT00025506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101909135|NCT00024258|Arsenic Trioxide|arsenic trioxide|mesh-list
101909136|NCT00024258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101909137|NCT03756272|Bupivacaine|bupivacaine|mesh-list
101909138|NCT03756272|Anesthetics, Local|anesthetics, local|mesh-ancestor
101909139|NCT03756272|Anesthetics|anesthetics|mesh-ancestor
101909140|NCT03756272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101909141|NCT03756272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909142|NCT03756272|Sensory System Agents|sensory system agents|mesh-ancestor
101909143|NCT03756272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101909144|NCT03756194|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101909145|NCT03756116|Epinephrine|epinephrine|mesh-list
101909146|NCT03756116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101909147|NCT03756116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101909148|NCT03756116|Adrenergic Agents|adrenergic agents|mesh-ancestor
101909149|NCT03756116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101909150|NCT03756116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909151|NCT03756116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909152|NCT03756116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101909153|NCT03756116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101909154|NCT03756116|Autonomic Agents|autonomic agents|mesh-ancestor
101909155|NCT03756116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101909156|NCT03756116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101909157|NCT03756116|Respiratory System Agents|respiratory system agents|mesh-ancestor
101909158|NCT03756116|Mydriatics|mydriatics|mesh-ancestor
101909159|NCT03756116|Sympathomimetics|sympathomimetics|mesh-ancestor
101909160|NCT03756116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101909161|NCT00023712|Bortezomib|bortezomib|mesh-list
101909162|NCT00023712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101909163|NCT00023322|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101909164|NCT00023322|Antiviral Agents|antiviral agents|mesh-ancestor
101909165|NCT00023322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101909166|NCT04640168|Remdesivir|remdesivir|mesh-list
101909167|NCT04640168|Dexamethasone|dexamethasone|mesh-list
101909168|NCT04640168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101909169|NCT04640168|Antiemetics|antiemetics|mesh-ancestor
101909170|NCT04640168|Autonomic Agents|autonomic agents|mesh-ancestor
101909171|NCT04640168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101909172|NCT04640168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909173|NCT04640168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101909174|NCT04640168|Glucocorticoids|glucocorticoids|mesh-ancestor
101909175|NCT04640168|Hormones|hormones|mesh-ancestor
101909176|NCT04640168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101909177|NCT04640168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101909178|NCT04640168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101909179|NCT04640168|Antimetabolites|antimetabolites|mesh-ancestor
101955687|NCT04948203|Sirolimus|sirolimus|mesh-list
101909180|NCT04640168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909181|NCT04640168|Antiviral Agents|antiviral agents|mesh-ancestor
101909182|NCT04640168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101909183|NCT00022698|Capecitabine|capecitabine|mesh-list
101909184|NCT00022698|Irinotecan|irinotecan|mesh-list
101909185|NCT00022698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101909186|NCT00022698|Antimetabolites|antimetabolites|mesh-ancestor
101909187|NCT00022698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909188|NCT00022698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101909189|NCT00022698|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101909190|NCT00022698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101909191|NCT00022698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101909192|NCT03951402|Moxifloxacin|moxifloxacin|mesh-list
101909193|NCT03951402|Tapentadol|tapentadol|mesh-list
101909194|NCT03951402|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101909195|NCT03951402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101909196|NCT03951402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101909197|NCT03951402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101909198|NCT03951402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101909199|NCT03951402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101909200|NCT03951402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909201|NCT03951402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101909202|NCT03951402|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101909203|NCT03951402|Contraceptive Agents|contraceptive agents|mesh-ancestor
101909204|NCT03951402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101909205|NCT03951402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909206|NCT03951402|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101909207|NCT03951402|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101909208|NCT03951402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101955707|NCT03755037|Estradiol|estradiol|mesh-list
101909209|NCT03951402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101909210|NCT03951402|Narcotics|narcotics|mesh-ancestor
101909211|NCT03951402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101909212|NCT03951402|Analgesics|analgesics|mesh-ancestor
101909213|NCT03951402|Sensory System Agents|sensory system agents|mesh-ancestor
101909214|NCT03951402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101909215|NCT03951402|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101909216|NCT03951402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101909217|NCT03951402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101909218|NCT03951402|Adrenergic Agents|adrenergic agents|mesh-ancestor
101909219|NCT03951402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101909220|NCT01100736|Bosentan|bosentan|mesh-list
101909221|NCT01100736|Sitaxsentan|sitaxsentan|mesh-list
101909222|NCT01100736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101909223|NCT01100736|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101909224|NCT01100736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909225|NCT01584726|Magnesium Sulfate|magnesium sulfate|mesh-list
101909226|NCT01584726|Analgesics|analgesics|mesh-ancestor
101909227|NCT01584726|Sensory System Agents|sensory system agents|mesh-ancestor
101909228|NCT01584726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101909229|NCT01584726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909231|NCT01584726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101909232|NCT01584726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101909233|NCT01584726|Anticonvulsants|anticonvulsants|mesh-ancestor
101909234|NCT01584726|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101909235|NCT01584726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101909236|NCT01584726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909237|NCT01584726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101909238|NCT01584726|Tocolytic Agents|tocolytic agents|mesh-ancestor
101909239|NCT01584726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101909240|NCT01584804|Antitussive Agents|antitussive agents|mesh-list
101909241|NCT01584804|Respiratory System Agents|respiratory system agents|mesh-ancestor
101909242|NCT01105494|Epoetin Alfa|epoetin alfa|mesh-list
101909243|NCT01105494|Hematinics|hematinics|mesh-ancestor
101909244|NCT03949686|Bupivacaine|bupivacaine|mesh-list
101909245|NCT03949686|Anesthetics, Local|anesthetics, local|mesh-ancestor
101909246|NCT03949686|Anesthetics|anesthetics|mesh-ancestor
101909247|NCT03949686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101909248|NCT03949686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909249|NCT03949686|Sensory System Agents|sensory system agents|mesh-ancestor
101909250|NCT03949686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101909251|NCT03949842|Fluticasone|fluticasone|mesh-list
101909252|NCT03949842|Xhance|xhance|mesh-list
101909253|NCT03949842|Adrenergic Agents|adrenergic agents|mesh-list
101909254|NCT03949842|Cholinergic Agents|cholinergic agents|mesh-list
101909255|NCT03949842|Muscarinic Antagonists|muscarinic antagonists|mesh-list
101909256|NCT03949842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101909257|NCT03949842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101909258|NCT03949842|Autonomic Agents|autonomic agents|mesh-ancestor
101909259|NCT03949842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101909260|NCT03949842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909261|NCT03949842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101909262|NCT03949842|Respiratory System Agents|respiratory system agents|mesh-ancestor
101909263|NCT03949842|Dermatologic Agents|dermatologic agents|mesh-ancestor
101909264|NCT03949842|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101909265|NCT03949842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101909266|NCT03949842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909267|NCT03949842|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101909268|NCT01102608|Ifosfamide|ifosfamide|mesh-list
101909269|NCT01102608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101909270|NCT01102608|Alkylating Agents|alkylating agents|mesh-ancestor
101909271|NCT01102608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909272|NCT01102608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101909273|NCT01102686|Leucovorin|leucovorin|mesh-list
101909274|NCT01102686|Pyrimethamine|pyrimethamine|mesh-list
101909275|NCT01102686|Antidotes|antidotes|mesh-ancestor
101909276|NCT01102686|Protective Agents|protective agents|mesh-ancestor
101909277|NCT01102686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909278|NCT01102686|Vitamin B Complex|vitamin b complex|mesh-ancestor
101909279|NCT01102686|Vitamins|vitamins|mesh-ancestor
101909280|NCT01102686|Micronutrients|micronutrients|mesh-ancestor
101909281|NCT01102686|Antimalarials|antimalarials|mesh-ancestor
101909282|NCT01102686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101909283|NCT01102686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101909284|NCT01102686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101909285|NCT01102686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101909286|NCT01102686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101909287|NCT01102686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909288|NCT03949374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101909289|NCT03949374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101909290|NCT03949374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101909291|NCT03949374|Antimetabolites|antimetabolites|mesh-ancestor
101909292|NCT03949374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909293|NCT03949374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101909294|NCT03949374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101909295|NCT03949374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101909296|NCT04625972|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
101909297|NCT04625972|Antiviral Agents|antiviral agents|mesh-ancestor
101909298|NCT04625972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101909299|NCT05626140|Diclofenac|diclofenac|mesh-list
101909300|NCT05626140|Lacosamide|lacosamide|mesh-list
101909301|NCT05626140|Codeine|codeine|mesh-list
101909302|NCT05626140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101909303|NCT05626140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101909304|NCT05626140|Analgesics|analgesics|mesh-ancestor
101909305|NCT05626140|Sensory System Agents|sensory system agents|mesh-ancestor
101909306|NCT05626140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101909307|NCT05626140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909308|NCT05626140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101909309|NCT05626140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101909310|NCT05626140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101909311|NCT05626140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101909312|NCT05626140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909313|NCT05626140|Anticonvulsants|anticonvulsants|mesh-ancestor
101909314|NCT05626140|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101909315|NCT05626140|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101909316|NCT05626140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101909317|NCT05626140|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101909318|NCT05626140|Narcotics|narcotics|mesh-ancestor
101909319|NCT05626140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101909320|NCT05626140|Antitussive Agents|antitussive agents|mesh-ancestor
101909321|NCT05626140|Respiratory System Agents|respiratory system agents|mesh-ancestor
101909322|NCT04878042|Hydrogen Peroxide|hydrogen peroxide|mesh-list
101616790|NCT00592852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101909323|NCT04878042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101909324|NCT04878042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101909325|NCT04813614|Lidocaine|lidocaine|mesh-list
101909326|NCT04813614|Anesthetics, Local|anesthetics, local|mesh-ancestor
101909327|NCT04813614|Anesthetics|anesthetics|mesh-ancestor
101909328|NCT04813614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101909329|NCT04813614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228230|NCT01544751|Metformin|metformin|mesh-list
101909330|NCT04813614|Sensory System Agents|sensory system agents|mesh-ancestor
101909331|NCT04813614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101909332|NCT04813614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101909333|NCT04813614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101909334|NCT04813614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101909335|NCT04813614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101909336|NCT04813614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909337|NCT01106118|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101909338|NCT01106118|Vasodilator Agents|vasodilator agents|mesh-ancestor
101909339|NCT01106118|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101909340|NCT01106118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101909341|NCT01106118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101909342|NCT01106118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909343|NCT01106118|Urological Agents|urological agents|mesh-ancestor
101909344|NCT00234065|Aspirin|aspirin|mesh-list
101909345|NCT00234065|Cilostazol|cilostazol|mesh-list
101909346|NCT00234065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101909347|NCT00234065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101909348|NCT00234065|Analgesics|analgesics|mesh-ancestor
101909349|NCT00234065|Sensory System Agents|sensory system agents|mesh-ancestor
101909350|NCT00234065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101909351|NCT00234065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909352|NCT00234065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101909353|NCT00234065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101909354|NCT00234065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101909355|NCT00234065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101909356|NCT00234065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909357|NCT00234065|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101909358|NCT00234065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101909359|NCT00234065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101909360|NCT00234065|Antipyretics|antipyretics|mesh-ancestor
101909361|NCT00234065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101909362|NCT00234065|Autonomic Agents|autonomic agents|mesh-ancestor
101909363|NCT00234065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101909364|NCT00234065|Respiratory System Agents|respiratory system agents|mesh-ancestor
101909365|NCT00234065|Vasodilator Agents|vasodilator agents|mesh-ancestor
101909366|NCT00234065|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101909367|NCT00234065|Protective Agents|protective agents|mesh-ancestor
101909368|NCT00234065|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101909369|NCT00234065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101909370|NCT01108848|Complement C1s|complement c1s|mesh-list
101909371|NCT01108848|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
101909372|NCT01108848|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
101909373|NCT01108848|Immunologic Factors|immunologic factors|mesh-ancestor
101909374|NCT01108848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909375|NCT01108848|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101629225|NCT01029717|Antitubercular Agents|antitubercular agents|mesh-ancestor
101909376|NCT01108848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101909377|NCT00233987|Cyclophosphamide|cyclophosphamide|mesh-list
101909379|NCT00233987|Carmustine|carmustine|mesh-list
101909380|NCT00233987|Etoposide|etoposide|mesh-list
101909381|NCT00233987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101909382|NCT00233987|Immunologic Factors|immunologic factors|mesh-ancestor
101955944|NCT02070718|Naloxone|naloxone|mesh-list
101909383|NCT00233987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909384|NCT00233987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101909385|NCT00233987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101909386|NCT00233987|Alkylating Agents|alkylating agents|mesh-ancestor
101909387|NCT00233987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909388|NCT00233987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101909389|NCT00233987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101909390|NCT00233987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101909391|NCT00233987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101909392|NCT00233987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101909393|NCT00233987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101909394|NCT01108926|Tenofovir|tenofovir|mesh-list
101909396|NCT01108926|Efavirenz|efavirenz|mesh-list
101909397|NCT01108926|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101909398|NCT01108926|Antiviral Agents|antiviral agents|mesh-ancestor
101909399|NCT01108926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101909400|NCT01108926|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101909401|NCT01108926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101909402|NCT01108926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101909403|NCT01108926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909404|NCT01108926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101909405|NCT01108926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101909406|NCT01108926|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101909407|NCT01108926|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101909408|NCT01108926|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101909409|NCT01108926|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101909410|NCT01108926|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101909411|NCT01108926|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101909412|NCT04623242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101909413|NCT04623242|Immunologic Factors|immunologic factors|mesh-ancestor
101909414|NCT04623242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909415|NCT00233363|Rebamipide|rebamipide|mesh-list
101909416|NCT00233363|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101909417|NCT00233363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101909418|NCT00233363|Antioxidants|antioxidants|mesh-ancestor
101909419|NCT00233363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909420|NCT00233363|Protective Agents|protective agents|mesh-ancestor
101909421|NCT00233363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909422|NCT00233363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101909423|NCT01147666|Epoetin Alfa|epoetin alfa|mesh-list
101909424|NCT01147666|Hematinics|hematinics|mesh-ancestor
101909425|NCT01073111|Sirolimus|sirolimus|mesh-list
101909426|NCT01073111|Everolimus|everolimus|mesh-list
101909427|NCT01073111|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101909428|NCT01073111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101909429|NCT01073111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101909430|NCT01073111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909431|NCT01073111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101909432|NCT01073111|Immunologic Factors|immunologic factors|mesh-ancestor
101955956|NCT02070796|Dopamine Agents|dopamine agents|mesh-ancestor
101909433|NCT01073111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909435|NCT01073111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101909436|NCT01073111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101909437|NCT01073111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101909438|NCT01073111|Antifungal Agents|antifungal agents|mesh-ancestor
101909439|NCT01325987|Vitamin D|vitamin d|mesh-list
101909440|NCT01325987|Ergocalciferols|ergocalciferols|mesh-list
101909441|NCT01325987|Cholecalciferol|cholecalciferol|mesh-list
101909442|NCT01325987|Vitamins|vitamins|mesh-list
101909443|NCT01325987|Micronutrients|micronutrients|mesh-ancestor
101909444|NCT01325987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909445|NCT01325987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101909446|NCT01325987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101909447|NCT05321394|Ritonavir|ritonavir|mesh-list
101909448|NCT05321394|Nirmatrelvir|nirmatrelvir|mesh-list
101909449|NCT05321394|Sotrovimab|sotrovimab|mesh-list
101909450|NCT05321394|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
101909451|NCT05321394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101909452|NCT05321394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101909454|NCT05321394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101909455|NCT05321394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909456|NCT05321394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101909457|NCT05321394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101909458|NCT05321394|Antiviral Agents|antiviral agents|mesh-ancestor
101909459|NCT05321394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101909460|NCT05321394|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101909461|NCT05321394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101909462|NCT00256295|Gemcitabine|gemcitabine|mesh-list
101909463|NCT00256295|Oxaliplatin|oxaliplatin|mesh-list
101909464|NCT00256295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101909465|NCT00256295|Antimetabolites|antimetabolites|mesh-ancestor
101909466|NCT00256295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909467|NCT00256295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101909468|NCT04410562|Hydroxychloroquine|hydroxychloroquine|mesh-list
101909469|NCT04410562|Antimalarials|antimalarials|mesh-ancestor
101909470|NCT04410562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101909471|NCT04410562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101909472|NCT04410562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101909473|NCT04410562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101909474|NCT04410562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909475|NCT04410562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101909476|NCT01109160|Azithromycin|azithromycin|mesh-list
101909477|NCT01109160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101909478|NCT01109160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101909480|NCT01363336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101909481|NCT01363336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101909482|NCT01363336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909483|NCT01363336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101909484|NCT01363336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909485|NCT01363336|Vasodilator Agents|vasodilator agents|mesh-ancestor
101909486|NCT01363336|Tocolytic Agents|tocolytic agents|mesh-ancestor
101909487|NCT01363336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101909488|NCT01363414|Hyaluronic Acid|hyaluronic acid|mesh-list
101909489|NCT01363414|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101909490|NCT01363414|Immunologic Factors|immunologic factors|mesh-ancestor
101909491|NCT01363414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909492|NCT01363414|Viscosupplements|viscosupplements|mesh-ancestor
101909493|NCT01363414|Protective Agents|protective agents|mesh-ancestor
101909494|NCT02223520|Chlorhexidine|chlorhexidine|mesh-list
101909495|NCT02223520|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101909497|NCT02223520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101909498|NCT02223520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101909499|NCT02223520|Disinfectants|disinfectants|mesh-ancestor
101909500|NCT02223520|Dermatologic Agents|dermatologic agents|mesh-ancestor
101909501|NCT02223520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101909502|NCT02223520|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101909503|NCT02223520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101909504|NCT02223520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909505|NCT01356472|Imipenem|imipenem|mesh-list
101909506|NCT01356472|Cilastatin|cilastatin|mesh-list
101909507|NCT01356472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101909508|NCT01356472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101909509|NCT01356472|Protease Inhibitors|protease inhibitors|mesh-ancestor
101909510|NCT01356472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101909511|NCT01356472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909512|NCT02122198|Leuprolide|leuprolide|mesh-list
101909513|NCT02122198|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101909514|NCT02122198|Medroxyprogesterone|medroxyprogesterone|mesh-list
101909515|NCT02122198|Estradiol|estradiol|mesh-list
101909516|NCT02122198|Estrogens|estrogens|mesh-ancestor
101909517|NCT02122198|Hormones|hormones|mesh-ancestor
101909518|NCT02122198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101909519|NCT02122198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909520|NCT02122198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101909521|NCT02122198|Contraceptive Agents|contraceptive agents|mesh-ancestor
101909522|NCT02122198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101909523|NCT02122198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101909524|NCT02122198|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101909525|NCT02122198|Fertility Agents|fertility agents|mesh-ancestor
101909526|NCT02122198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101909527|NCT02122198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101228252|NCT01544842|Tacrolimus|tacrolimus|mesh-list
101909528|NCT02122198|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101909529|NCT02122198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101909530|NCT02122198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101909531|NCT02122198|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101909532|NCT01363570|Ranibizumab|ranibizumab|mesh-list
101909533|NCT01363570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101909534|NCT01363570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101909535|NCT01363570|Growth Substances|growth substances|mesh-ancestor
101909536|NCT01363570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909537|NCT01363570|Growth Inhibitors|growth inhibitors|mesh-ancestor
101909538|NCT01363570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101909539|NCT04608500|Minocycline|minocycline|mesh-list
101909540|NCT04608500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101909541|NCT04608500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101909542|NCT01363648|Choline|choline|mesh-list
101909543|NCT01363648|Lipotropic Agents|lipotropic agents|mesh-ancestor
101909544|NCT01363648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101616794|NCT00895245|Aprepitant|aprepitant|mesh-list
101909545|NCT01363648|Antimetabolites|antimetabolites|mesh-ancestor
101909546|NCT01363648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909547|NCT01363648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101909548|NCT01363648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101909549|NCT01363648|Nootropic Agents|nootropic agents|mesh-ancestor
101909550|NCT01107054|Moxifloxacin|moxifloxacin|mesh-list
101909551|NCT01107054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101909552|NCT01107054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101909553|NCT01107054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101909554|NCT01107054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101909555|NCT01107054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101909556|NCT01107054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909557|NCT01107054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101909558|NCT03944070|Ranibizumab|ranibizumab|mesh-list
101909559|NCT03944070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101909560|NCT03944070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101909561|NCT03944070|Growth Substances|growth substances|mesh-ancestor
101909562|NCT03944070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909563|NCT03944070|Growth Inhibitors|growth inhibitors|mesh-ancestor
101909564|NCT03944070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101909566|NCT01363804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101909567|NCT01363804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101909568|NCT01363804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909569|NCT03764462|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101909571|NCT03764462|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101909572|NCT03764462|Hormone Antagonists|hormone antagonists|mesh-ancestor
101909573|NCT03764462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101909574|NCT03764462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909575|NCT03764462|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101909576|NCT03764462|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101909577|NCT03764462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101909578|NCT03764462|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101909579|NCT03764462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909580|NCT03764462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101909581|NCT03764462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101909582|NCT03764462|Antiviral Agents|antiviral agents|mesh-ancestor
101909583|NCT03764462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101909584|NCT05460416|Aspirin|aspirin|mesh-list
101909585|NCT05460416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101909586|NCT05460416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101909587|NCT05460416|Analgesics|analgesics|mesh-ancestor
101909588|NCT05460416|Sensory System Agents|sensory system agents|mesh-ancestor
101956019|NCT02080078|Autonomic Agents|autonomic agents|mesh-ancestor
101909589|NCT05460416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101909590|NCT05460416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909591|NCT05460416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101909592|NCT05460416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101909593|NCT05460416|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101909594|NCT05460416|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101909595|NCT05460416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909596|NCT05460416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101909597|NCT05460416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101909598|NCT05460416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101909599|NCT05460416|Antipyretics|antipyretics|mesh-ancestor
101909600|NCT01364194|Bupivacaine|bupivacaine|mesh-list
101909601|NCT01364194|Anesthetics, Local|anesthetics, local|mesh-ancestor
101909602|NCT01364194|Anesthetics|anesthetics|mesh-ancestor
101909603|NCT01364194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101909604|NCT01364194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909605|NCT01364194|Sensory System Agents|sensory system agents|mesh-ancestor
101909606|NCT01364194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101909607|NCT04575038|Brequinar|brequinar|mesh-list
101909608|NCT04575038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101909609|NCT04575038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101909610|NCT04575038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909611|NCT04575038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101909612|NCT04575038|Immunologic Factors|immunologic factors|mesh-ancestor
101909613|NCT04575038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909614|NCT03066622|Olanzapine|olanzapine|mesh-list
101909615|NCT03066622|Antiemetics|antiemetics|mesh-ancestor
101909616|NCT03066622|Autonomic Agents|autonomic agents|mesh-ancestor
101909617|NCT03066622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101909618|NCT03066622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909619|NCT03066622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101909620|NCT03066622|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101909621|NCT03066622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101909622|NCT03066622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101909623|NCT03066622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101909624|NCT03066622|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101909625|NCT03066622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101909626|NCT03066622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101909627|NCT03066622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909628|NCT03066622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101909629|NCT03066622|Serotonin Agents|serotonin agents|mesh-ancestor
101909630|NCT01364974|Peficitinib|peficitinib|mesh-list
101909631|NCT01364974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101909632|NCT01364974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909633|NCT01364974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101909634|NCT01364974|Immunologic Factors|immunologic factors|mesh-ancestor
101909635|NCT01364974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909636|NCT05323214|Fentanyl|fentanyl|mesh-list
101909637|NCT05323214|Dexmedetomidine|dexmedetomidine|mesh-list
101909638|NCT05323214|Analgesics|analgesics|mesh-list
101909639|NCT05323214|Bupivacaine|bupivacaine|mesh-list
101909640|NCT05323214|Anesthetics, Local|anesthetics, local|mesh-ancestor
101909641|NCT05323214|Anesthetics|anesthetics|mesh-ancestor
101909642|NCT05323214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101909643|NCT05323214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909644|NCT05323214|Sensory System Agents|sensory system agents|mesh-ancestor
101909645|NCT05323214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101909646|NCT05323214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101909647|NCT05323214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101909648|NCT05323214|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101909649|NCT05323214|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101909650|NCT05323214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101909651|NCT05323214|Adrenergic Agents|adrenergic agents|mesh-ancestor
101909652|NCT05323214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101909653|NCT05323214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909654|NCT05323214|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101909655|NCT05323214|Narcotics|narcotics|mesh-ancestor
101909656|NCT05323214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101909657|NCT05323214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101909658|NCT05323214|Anesthetics, General|anesthetics, general|mesh-ancestor
101909659|NCT01936480|Moxifloxacin|moxifloxacin|mesh-list
101909660|NCT01936480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101909661|NCT01936480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101909662|NCT01936480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101909663|NCT01936480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101909664|NCT01936480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101909665|NCT01936480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909666|NCT01936480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101909667|NCT02060188|Nivolumab|nivolumab|mesh-list
101909668|NCT02060188|Ipilimumab|ipilimumab|mesh-list
101909669|NCT02060188|Relatlimab|relatlimab|mesh-list
101909670|NCT02060188|Daratumumab|daratumumab|mesh-list
101909671|NCT02060188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101909672|NCT02060188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101909673|NCT02060188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101909674|NCT02060188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629519|NCT02604004|Lamivudine|lamivudine|mesh-list
101909675|NCT01356862|Pasireotide|pasireotide|mesh-list
101909677|NCT01356862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101909678|NCT01356862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909679|NCT03763760|Dexamethasone|dexamethasone|mesh-list
101909680|NCT03763760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101909681|NCT03763760|Antiemetics|antiemetics|mesh-ancestor
101909682|NCT03763760|Autonomic Agents|autonomic agents|mesh-ancestor
101909683|NCT03763760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101909684|NCT03763760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909685|NCT03763760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101909686|NCT03763760|Glucocorticoids|glucocorticoids|mesh-ancestor
101909687|NCT03763760|Hormones|hormones|mesh-ancestor
101909688|NCT03763760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101909689|NCT03763760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101909690|NCT03763760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101909691|NCT04501952|Remdesivir|remdesivir|mesh-list
101909692|NCT04501952|Antimetabolites|antimetabolites|mesh-ancestor
101909693|NCT04501952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909694|NCT04501952|Antiviral Agents|antiviral agents|mesh-ancestor
101909695|NCT04501952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101909696|NCT00321100|Bevacizumab|bevacizumab|mesh-list
101909697|NCT00321100|Cetuximab|cetuximab|mesh-list
101909698|NCT00321100|Capecitabine|capecitabine|mesh-list
101909699|NCT00321100|Oxaliplatin|oxaliplatin|mesh-list
101909700|NCT00321100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101909701|NCT00321100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101909702|NCT00321100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101909703|NCT00321100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101909704|NCT00321100|Growth Substances|growth substances|mesh-ancestor
101909705|NCT00321100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909706|NCT00321100|Growth Inhibitors|growth inhibitors|mesh-ancestor
101909707|NCT00321100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101909708|NCT00321100|Antimetabolites|antimetabolites|mesh-ancestor
101909709|NCT00321100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909710|NCT02930122|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101909711|NCT02930122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101909712|NCT01365598|Primaquine|primaquine|mesh-list
101909713|NCT01365598|Antimalarials|antimalarials|mesh-ancestor
101909714|NCT01365598|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101909715|NCT01365598|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101909716|NCT01365598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101909717|NCT01365676|Hypericin|hypericin|mesh-list
101909718|NCT01365676|Antidepressive Agents|antidepressive agents|mesh-ancestor
101909719|NCT01365676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101909720|NCT01365676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101909721|NCT01365676|Antiviral Agents|antiviral agents|mesh-ancestor
101909722|NCT01365676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101909723|NCT01365676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101909724|NCT01365676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909725|NCT01365676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101909726|NCT01365676|Immunologic Factors|immunologic factors|mesh-ancestor
101909727|NCT01365676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909728|NCT03754712|Vitamin D|vitamin d|mesh-list
101909729|NCT03754712|Cholecalciferol|cholecalciferol|mesh-list
101909730|NCT03754712|Vitamins|vitamins|mesh-ancestor
101909731|NCT03754712|Micronutrients|micronutrients|mesh-ancestor
101909732|NCT03754712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909733|NCT03754712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101909734|NCT03754712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101909735|NCT01318954|Immunomodulating Agents|immunomodulating agents|mesh-list
101909736|NCT01318954|Immunologic Factors|immunologic factors|mesh-ancestor
101909737|NCT01318954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909738|NCT03754634|Diacerein|diacerein|mesh-list
101909739|NCT03754634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101909740|NCT00070018|Prednisone|prednisone|mesh-list
101909741|NCT00070018|Cyclophosphamide|cyclophosphamide|mesh-list
101909742|NCT00070018|Rituximab|rituximab|mesh-list
101909743|NCT00070018|Doxorubicin|doxorubicin|mesh-list
101909744|NCT00070018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101909745|NCT00070018|Vincristine|vincristine|mesh-list
101909746|NCT00070018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101909747|NCT00070018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101909748|NCT00070018|Immunologic Factors|immunologic factors|mesh-ancestor
101909749|NCT00070018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909750|NCT00070018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101909751|NCT00070018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101629596|NCT02587273|Anesthetics|anesthetics|mesh-ancestor
101909753|NCT00070018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909754|NCT00070018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101909755|NCT00070018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101909756|NCT00070018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101909757|NCT00070018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101909758|NCT00070018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101909759|NCT00070018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101909760|NCT00070018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101909761|NCT00070018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101909762|NCT00070018|Glucocorticoids|glucocorticoids|mesh-ancestor
101909763|NCT00070018|Hormones|hormones|mesh-ancestor
101909764|NCT00070018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101909765|NCT00070018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101909766|NCT00070018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101909768|NCT00070018|Antimitotic Agents|antimitotic agents|mesh-ancestor
101909769|NCT00070018|Mitosis Modulators|mitosis modulators|mesh-ancestor
101909770|NCT03991988|Montelukast|montelukast|mesh-list
101909771|NCT03991988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101909772|NCT03991988|Respiratory System Agents|respiratory system agents|mesh-ancestor
101909773|NCT03991988|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101909774|NCT03991988|Hormone Antagonists|hormone antagonists|mesh-ancestor
101909775|NCT03991988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101909776|NCT03991988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909777|NCT03991988|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101909778|NCT03991988|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101909779|NCT03991988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909780|NCT01073189|Fenoldopam|fenoldopam|mesh-list
101909781|NCT01073189|Furosemide|furosemide|mesh-list
101909782|NCT01073189|Diuretics|diuretics|mesh-ancestor
101909783|NCT01073189|Natriuretic Agents|natriuretic agents|mesh-ancestor
101909784|NCT01073189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909785|NCT01073189|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101909786|NCT01073189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101956065|NCT05459649|Immunologic Factors|immunologic factors|mesh-ancestor
101909787|NCT01073189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909788|NCT01073189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101909789|NCT01073189|Vasodilator Agents|vasodilator agents|mesh-ancestor
101909790|NCT01073189|Dopamine Agonists|dopamine agonists|mesh-ancestor
101909791|NCT01073189|Dopamine Agents|dopamine agents|mesh-ancestor
101909792|NCT01073189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101909793|NCT05191186|Immunomodulating Agents|immunomodulating agents|mesh-list
101909794|NCT05191186|Immunologic Factors|immunologic factors|mesh-ancestor
101909795|NCT05191186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909796|NCT03750656|Hyoscyamine|hyoscyamine|mesh-list
101909797|NCT03750656|Tamsulosin|tamsulosin|mesh-list
101909798|NCT03750656|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101909799|NCT03750656|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101909800|NCT03750656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101909801|NCT03750656|Adrenergic Agents|adrenergic agents|mesh-ancestor
101909802|NCT03750656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101909803|NCT03750656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909804|NCT03750656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909805|NCT03750656|Urological Agents|urological agents|mesh-ancestor
101909806|NCT03750656|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101909807|NCT03750656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101909808|NCT03750656|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101909809|NCT03750656|Autonomic Agents|autonomic agents|mesh-ancestor
101909810|NCT03750656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101909811|NCT03750656|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101909812|NCT03750656|Respiratory System Agents|respiratory system agents|mesh-ancestor
101909813|NCT03750656|Mydriatics|mydriatics|mesh-ancestor
101909814|NCT03750656|Parasympatholytics|parasympatholytics|mesh-ancestor
101909815|NCT03750656|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101909816|NCT03750656|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101909817|NCT03750656|Cholinergic Agents|cholinergic agents|mesh-ancestor
101909818|NCT00229931|Triamcinolone|triamcinolone|mesh-list
101909819|NCT00229931|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101909820|NCT00229931|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101909821|NCT00229931|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101909822|NCT00229931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101909823|NCT00229931|Glucocorticoids|glucocorticoids|mesh-ancestor
101909824|NCT00229931|Hormones|hormones|mesh-ancestor
101909825|NCT00229931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101909826|NCT00229931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909827|NCT00229931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101909828|NCT00229931|Immunologic Factors|immunologic factors|mesh-ancestor
101909829|NCT00229931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101909830|NCT00229931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909831|NCT03752294|Dabigatran|dabigatran|mesh-list
101909832|NCT03752294|Antithrombins|antithrombins|mesh-ancestor
101909833|NCT03752294|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101909834|NCT03752294|Protease Inhibitors|protease inhibitors|mesh-ancestor
101909835|NCT03752294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101909836|NCT03752294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909837|NCT03752294|Anticoagulants|anticoagulants|mesh-ancestor
101909838|NCT03135028|Cytarabine|cytarabine|mesh-list
101909839|NCT03135028|Daunorubicin|daunorubicin|mesh-list
101272473|NCT01843829|Paclitaxel|paclitaxel|mesh-list
101909840|NCT03135028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101909841|NCT03135028|Antimetabolites|antimetabolites|mesh-ancestor
101909842|NCT03135028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909843|NCT03135028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101909844|NCT03135028|Antiviral Agents|antiviral agents|mesh-ancestor
101909845|NCT03135028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101909846|NCT03135028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101909847|NCT03135028|Immunologic Factors|immunologic factors|mesh-ancestor
101909848|NCT03135028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909849|NCT03135028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101909850|NCT03135028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101909851|NCT03135028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101909852|NCT03135028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101909854|NCT03752138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101909855|NCT03752138|Antimetabolites|antimetabolites|mesh-ancestor
101909856|NCT03752138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909857|NCT03752138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101909858|NCT03752138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101909859|NCT01370434|Dexamethasone|dexamethasone|mesh-list
101909860|NCT01370434|Doxorubicin|doxorubicin|mesh-list
101909861|NCT01370434|Vincristine|vincristine|mesh-list
101909862|NCT01370434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101909863|NCT01370434|Antiemetics|antiemetics|mesh-ancestor
101909864|NCT01370434|Autonomic Agents|autonomic agents|mesh-ancestor
101909865|NCT01370434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101909866|NCT01370434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909867|NCT01370434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101909868|NCT01370434|Glucocorticoids|glucocorticoids|mesh-ancestor
101228283|NCT01544959|Fentanyl|fentanyl|mesh-list
101909870|NCT01370434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101909871|NCT01370434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101909872|NCT01370434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101909873|NCT01370434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101909874|NCT01370434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909875|NCT01370434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101909876|NCT01370434|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101909877|NCT01370434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101909878|NCT01370434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101909879|NCT01370434|Tubulin Modulators|tubulin modulators|mesh-ancestor
101909880|NCT01370434|Antimitotic Agents|antimitotic agents|mesh-ancestor
101909881|NCT01370434|Mitosis Modulators|mitosis modulators|mesh-ancestor
101909883|NCT05190952|Ketamine|ketamine|mesh-list
101909884|NCT05190952|Bupivacaine|bupivacaine|mesh-list
101909885|NCT05190952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101909886|NCT05190952|Antiemetics|antiemetics|mesh-ancestor
101909887|NCT05190952|Autonomic Agents|autonomic agents|mesh-ancestor
101909888|NCT05190952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101909889|NCT05190952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909890|NCT05190952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101909891|NCT05190952|Glucocorticoids|glucocorticoids|mesh-ancestor
101909892|NCT05190952|Hormones|hormones|mesh-ancestor
101909893|NCT05190952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101909894|NCT05190952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101909895|NCT05190952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101909896|NCT05190952|Anesthetics, Local|anesthetics, local|mesh-ancestor
101909897|NCT05190952|Anesthetics|anesthetics|mesh-ancestor
101909898|NCT05190952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101909899|NCT05190952|Sensory System Agents|sensory system agents|mesh-ancestor
101909901|NCT05190952|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101909902|NCT05190952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101909903|NCT05190952|Anesthetics, General|anesthetics, general|mesh-ancestor
101909904|NCT05190952|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101909905|NCT05190952|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101909906|NCT05190952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101909907|NCT05190952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909908|NCT03972683|Atropine|atropine|mesh-list
101909909|NCT03972683|Adenosine|adenosine|mesh-list
101909910|NCT03972683|Nitroprusside|nitroprusside|mesh-list
101909911|NCT03972683|Phenylephrine|phenylephrine|mesh-list
101909912|NCT03972683|Oxymetazoline|oxymetazoline|mesh-list
101909913|NCT03972683|Acetylcholine|acetylcholine|mesh-list
101909914|NCT03972683|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101909915|NCT03972683|Mydriatics|mydriatics|mesh-ancestor
101909916|NCT03972683|Autonomic Agents|autonomic agents|mesh-ancestor
101909917|NCT03972683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101909918|NCT03972683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909919|NCT03972683|Sympathomimetics|sympathomimetics|mesh-ancestor
101909920|NCT03972683|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101909921|NCT03972683|Nasal Decongestants|nasal decongestants|mesh-ancestor
101909922|NCT03972683|Respiratory System Agents|respiratory system agents|mesh-ancestor
101909923|NCT03972683|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101909924|NCT03972683|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101909925|NCT03972683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101909926|NCT03972683|Adrenergic Agents|adrenergic agents|mesh-ancestor
101909927|NCT03972683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101909928|NCT03972683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909929|NCT03972683|Protective Agents|protective agents|mesh-ancestor
101909930|NCT03972683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101909931|NCT03972683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101909932|NCT03972683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101909933|NCT03972683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101909934|NCT03972683|Parasympatholytics|parasympatholytics|mesh-ancestor
101956143|NCT03757143|Disinfectants|disinfectants|mesh-ancestor
101909935|NCT03972683|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101909936|NCT03972683|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101909937|NCT03972683|Cholinergic Agents|cholinergic agents|mesh-ancestor
101909938|NCT03972683|Analgesics|analgesics|mesh-ancestor
101909939|NCT03972683|Sensory System Agents|sensory system agents|mesh-ancestor
101909940|NCT03972683|Vasodilator Agents|vasodilator agents|mesh-ancestor
101909941|NCT03972683|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101909942|NCT03972683|Purinergic Agonists|purinergic agonists|mesh-ancestor
101909943|NCT03972683|Purinergic Agents|purinergic agents|mesh-ancestor
101909944|NCT03972683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101909945|NCT03972683|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101909946|NCT03972683|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101909947|NCT04411628|Bamlanivimab|bamlanivimab|mesh-list
101909948|NCT04411628|Antiviral Agents|antiviral agents|mesh-ancestor
101909949|NCT04411628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101909950|NCT03754010|Hyaluronic Acid|hyaluronic acid|mesh-list
101909951|NCT03754010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101909952|NCT03754010|Immunologic Factors|immunologic factors|mesh-ancestor
101909953|NCT03754010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909954|NCT03754010|Viscosupplements|viscosupplements|mesh-ancestor
101909955|NCT03754010|Protective Agents|protective agents|mesh-ancestor
101909956|NCT00227591|Prednisone|prednisone|mesh-list
101909957|NCT00227591|Lenalidomide|lenalidomide|mesh-list
101909958|NCT00227591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101909959|NCT00227591|Glucocorticoids|glucocorticoids|mesh-ancestor
101909960|NCT00227591|Hormones|hormones|mesh-ancestor
101909961|NCT00227591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101909962|NCT00227591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909963|NCT00227591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101909964|NCT00227591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101909965|NCT00227591|Immunologic Factors|immunologic factors|mesh-ancestor
101909966|NCT00227591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101909967|NCT00227591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101909968|NCT00227591|Growth Substances|growth substances|mesh-ancestor
101909969|NCT00227591|Growth Inhibitors|growth inhibitors|mesh-ancestor
101909970|NCT01358344|Pantoprazole|pantoprazole|mesh-list
101909971|NCT01358344|Vorapaxar|vorapaxar|mesh-list
101909972|NCT01358344|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101909973|NCT01358344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101909974|NCT01358344|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101909975|NCT01358344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101909976|NCT01358344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909977|NCT01358344|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101909978|NCT01366300|Lidocaine|lidocaine|mesh-list
101909979|NCT01366300|Propofol|propofol|mesh-list
101909980|NCT01366300|Anesthetics, Local|anesthetics, local|mesh-ancestor
101909981|NCT01366300|Anesthetics|anesthetics|mesh-ancestor
101909982|NCT01366300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101909983|NCT01366300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101909984|NCT01366300|Sensory System Agents|sensory system agents|mesh-ancestor
101909985|NCT01366300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101909986|NCT01366300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101909987|NCT01366300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101909988|NCT01366300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101909989|NCT01366300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101909990|NCT01366300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101909992|NCT01366300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101909993|NCT01366300|Anesthetics, General|anesthetics, general|mesh-ancestor
101909994|NCT00226811|Sunitinib|sunitinib|mesh-list
101909995|NCT00226811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101909996|NCT00226811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101909997|NCT00226811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101909998|NCT00226811|Growth Substances|growth substances|mesh-ancestor
101909999|NCT00226811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910000|NCT00226811|Growth Inhibitors|growth inhibitors|mesh-ancestor
101910001|NCT00226811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101910002|NCT00226811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101910003|NCT00226811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910004|NCT02951052|Rilpivirine|rilpivirine|mesh-list
101910005|NCT02951052|Cabotegravir|cabotegravir|mesh-list
101910006|NCT02951052|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101910007|NCT02951052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101228302|NCT01544972|Acetaminophen|acetaminophen|mesh-list
101910008|NCT02951052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101956157|NCT04428411|Immunologic Factors|immunologic factors|mesh-ancestor
101910009|NCT02951052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910010|NCT02951052|Antiviral Agents|antiviral agents|mesh-ancestor
101910011|NCT02951052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101910012|NCT02951052|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101910013|NCT02951052|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101910014|NCT02951052|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101910015|NCT02951052|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101910016|NCT05261516|Magnesium Sulfate|magnesium sulfate|mesh-list
101910017|NCT05261516|Analgesics|analgesics|mesh-ancestor
101910018|NCT05261516|Sensory System Agents|sensory system agents|mesh-ancestor
101910019|NCT05261516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101910020|NCT05261516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910021|NCT05261516|Anesthetics|anesthetics|mesh-ancestor
101910022|NCT05261516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101910023|NCT05261516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101910024|NCT05261516|Anticonvulsants|anticonvulsants|mesh-ancestor
101910025|NCT05261516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101910026|NCT05261516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101910027|NCT05261516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910028|NCT05261516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101910029|NCT05261516|Tocolytic Agents|tocolytic agents|mesh-ancestor
101910030|NCT05261516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101910031|NCT00226655|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
101910032|NCT00226655|Hormones|hormones|mesh-ancestor
101910033|NCT00226655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101910034|NCT00226655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910035|NCT01371058|Clopidogrel|clopidogrel|mesh-list
101910036|NCT01371058|Policosanol|policosanol|mesh-list
101910037|NCT01371058|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101910038|NCT01371058|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101910039|NCT01371058|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101910040|NCT01371058|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101910041|NCT01371058|Purinergic Agents|purinergic agents|mesh-ancestor
101910042|NCT01371058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101910043|NCT01371058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910044|NCT01371058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910045|NCT01371058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101910046|NCT01371058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101910047|NCT01371058|Antimetabolites|antimetabolites|mesh-ancestor
101910048|NCT01371058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101910049|NCT01105338|Lycopene|lycopene|mesh-list
101910050|NCT01105338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101910051|NCT01105338|Antioxidants|antioxidants|mesh-ancestor
101910052|NCT01105338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910053|NCT01105338|Protective Agents|protective agents|mesh-ancestor
101910054|NCT01105338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910055|NCT01105338|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101910056|NCT01105338|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101910057|NCT01105338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101910058|NCT03747614|Fluorometholone|fluorometholone|mesh-list
101910059|NCT03747614|Tacrolimus|tacrolimus|mesh-list
101910060|NCT03747614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101910061|NCT03747614|Immunologic Factors|immunologic factors|mesh-ancestor
101910062|NCT03747614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910063|NCT03747614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101910064|NCT03747614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101910065|NCT03747614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910066|NCT03747614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101910067|NCT03747614|Glucocorticoids|glucocorticoids|mesh-ancestor
101910069|NCT03747614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101910070|NCT03747614|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101910071|NCT05347004|BI 425809|bi 425809|mesh-list
101910072|NCT05347004|Nootropic Agents|nootropic agents|mesh-ancestor
101910073|NCT04353596|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101910074|NCT04353596|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
101910075|NCT04353596|Protease Inhibitors|protease inhibitors|mesh-ancestor
101910076|NCT04353596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101910077|NCT04353596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910078|NCT01366378|Methylnaltrexone|methylnaltrexone|mesh-list
101910079|NCT01366378|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101910080|NCT01366378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910081|NCT01366378|Sensory System Agents|sensory system agents|mesh-ancestor
101910082|NCT01366378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101910083|NCT03747536|Bromides|bromides|mesh-list
101910084|NCT03747536|Ipratropium|ipratropium|mesh-list
101910085|NCT03747536|Anticonvulsants|anticonvulsants|mesh-ancestor
101910086|NCT03747536|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101910087|NCT03747536|Autonomic Agents|autonomic agents|mesh-ancestor
101910088|NCT03747536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101910089|NCT03747536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910090|NCT03747536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101910091|NCT03747536|Respiratory System Agents|respiratory system agents|mesh-ancestor
101910092|NCT03747536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101910093|NCT03747536|Cholinergic Agents|cholinergic agents|mesh-ancestor
101910094|NCT03747536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101910095|NCT03747536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910096|NCT01358500|Fentanyl|fentanyl|mesh-list
101910097|NCT01358500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101910098|NCT01358500|Narcotics|narcotics|mesh-ancestor
101910099|NCT01358500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101910100|NCT01358500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910101|NCT01358500|Analgesics|analgesics|mesh-ancestor
101910102|NCT01358500|Sensory System Agents|sensory system agents|mesh-ancestor
101910103|NCT01358500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101910104|NCT01358500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101910105|NCT01358500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101910106|NCT01358500|Anesthetics, General|anesthetics, general|mesh-ancestor
101910107|NCT01358500|Anesthetics|anesthetics|mesh-ancestor
101910108|NCT03724942|Brexpiprazole|brexpiprazole|mesh-list
101910109|NCT03724942|Serotonin Agents|serotonin agents|mesh-ancestor
101910110|NCT03724942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101956171|NCT03751059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101910111|NCT03724942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910112|NCT03724942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910113|NCT03724942|Dopamine Agonists|dopamine agonists|mesh-ancestor
101910114|NCT03724942|Dopamine Agents|dopamine agents|mesh-ancestor
101910115|NCT03751514|Azithromycin|azithromycin|mesh-list
101910116|NCT03751514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101910117|NCT03751514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101910118|NCT03615664|Dexamethasone|dexamethasone|mesh-list
101910119|NCT03615664|Gemcitabine|gemcitabine|mesh-list
101910120|NCT03615664|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101910121|NCT03615664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101910122|NCT03615664|Antiemetics|antiemetics|mesh-ancestor
101910123|NCT03615664|Autonomic Agents|autonomic agents|mesh-ancestor
101910124|NCT03615664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101910125|NCT03615664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910126|NCT03615664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101910127|NCT03615664|Glucocorticoids|glucocorticoids|mesh-ancestor
101910128|NCT03615664|Hormones|hormones|mesh-ancestor
101910129|NCT03615664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101910130|NCT03615664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101910131|NCT03615664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101910132|NCT03615664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101910133|NCT03615664|Antimetabolites|antimetabolites|mesh-ancestor
101910134|NCT03615664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910135|NCT03615664|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101910136|NCT03615664|Alkylating Agents|alkylating agents|mesh-ancestor
101910137|NCT03513250|Scopolamine|scopolamine|mesh-list
101272782|NCT01845298|Rifampin|rifampin|mesh-list
101910138|NCT03513250|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101910139|NCT03513250|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101910140|NCT03513250|Antiemetics|antiemetics|mesh-ancestor
101910141|NCT03513250|Autonomic Agents|autonomic agents|mesh-ancestor
101910142|NCT03513250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101910143|NCT03513250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910144|NCT03513250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101910145|NCT03513250|Mydriatics|mydriatics|mesh-ancestor
101910146|NCT03513250|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101910147|NCT03513250|Cholinergic Agents|cholinergic agents|mesh-ancestor
101910148|NCT03513250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101910149|NCT03513250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910150|NCT03513250|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101910151|NCT03513250|Parasympatholytics|parasympatholytics|mesh-ancestor
101910152|NCT01358812|Panitumumab|panitumumab|mesh-list
101910153|NCT01358812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101910154|NCT01358812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101910155|NCT01107522|Temozolomide|temozolomide|mesh-list
101910156|NCT01107522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101910157|NCT01107522|Alkylating Agents|alkylating agents|mesh-ancestor
101910158|NCT01107522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910159|NCT01107522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101910161|NCT01371448|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101910162|NCT01371448|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101910163|NCT01371448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101910164|NCT01371448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910165|NCT01371448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101910166|NCT01371448|Serotonin Agents|serotonin agents|mesh-ancestor
101910167|NCT01371448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910168|NCT01371448|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101910169|NCT01371448|Antidepressive Agents|antidepressive agents|mesh-ancestor
101910170|NCT01371448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101910171|NCT01371448|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101910172|NCT01371448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101910173|NCT01371448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101910174|NCT01371526|Cosyntropin|cosyntropin|mesh-list
101910175|NCT01371526|Hormones|hormones|mesh-ancestor
101910176|NCT01371526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101910177|NCT01371526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910178|NCT03943992|Esomeprazole|esomeprazole|mesh-list
101910179|NCT03943992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101910180|NCT03943992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101910181|NCT03943992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101910182|NCT03943992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101910183|NCT03943992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910184|NCT01371604|Ribavirin|ribavirin|mesh-list
101910185|NCT01371604|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101910186|NCT01371604|Antimetabolites|antimetabolites|mesh-ancestor
101910187|NCT01371604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910188|NCT01371604|Antiviral Agents|antiviral agents|mesh-ancestor
101910189|NCT01371604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101910190|NCT01371682|Ropinirole|ropinirole|mesh-list
101910191|NCT01371682|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101910192|NCT01371682|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101910193|NCT01371682|Dopamine Agonists|dopamine agonists|mesh-ancestor
101910194|NCT01371682|Dopamine Agents|dopamine agents|mesh-ancestor
101910195|NCT01371682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101910196|NCT01371682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910197|NCT01371682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630044|NCT04215159|Irinotecan|irinotecan|mesh-list
101910198|NCT01107756|Lenograstim|lenograstim|mesh-list
101910199|NCT01107756|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101910200|NCT01107756|Immunologic Factors|immunologic factors|mesh-ancestor
101910201|NCT01107756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910203|NCT03127384|Anesthetics, Local|anesthetics, local|mesh-ancestor
101910204|NCT03127384|Anesthetics|anesthetics|mesh-ancestor
101910205|NCT03127384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101910206|NCT03127384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910207|NCT03127384|Sensory System Agents|sensory system agents|mesh-ancestor
101910208|NCT03127384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101910209|NCT03127384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101910210|NCT03127384|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101910212|NCT03127384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101910213|NCT03127384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910214|NCT01111656|Interferons|interferons|mesh-list
101910215|NCT01111656|Interferon-beta|interferon-beta|mesh-list
101910216|NCT01111656|Atorvastatin|atorvastatin|mesh-list
101910217|NCT01111656|Interferon beta-1b|interferon beta-1b|mesh-list
101910218|NCT01111656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101910220|NCT01111656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101910221|NCT01111656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101910222|NCT01111656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101910223|NCT01111656|Antimetabolites|antimetabolites|mesh-ancestor
101910224|NCT01111656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910225|NCT01111656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101910226|NCT01111656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101910227|NCT01111656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101910228|NCT01111656|Immunologic Factors|immunologic factors|mesh-ancestor
101910229|NCT01111656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910230|NCT01111656|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101910231|NCT02819752|Pembrolizumab|pembrolizumab|mesh-list
101910232|NCT02819752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101910233|NCT02819752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101910234|NCT02819752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101910235|NCT02819752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910236|NCT02567578|YH12852|yh12852|mesh-list
101910237|NCT02567578|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101910238|NCT02567578|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101910239|NCT02567578|Serotonin Agents|serotonin agents|mesh-ancestor
101910240|NCT02567578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101910241|NCT02567578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910242|NCT02567578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910243|NCT02523274|Resveratrol|resveratrol|mesh-list
101910244|NCT02523274|Antioxidants|antioxidants|mesh-ancestor
101910245|NCT02523274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910246|NCT02523274|Protective Agents|protective agents|mesh-ancestor
101910247|NCT02523274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910248|NCT02523274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101910249|NCT02523274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101910250|NCT02432560|Sirolimus|sirolimus|mesh-list
101910251|NCT02432560|Everolimus|everolimus|mesh-list
101910252|NCT02432560|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101910253|NCT02432560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101910254|NCT02432560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101910255|NCT02432560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910256|NCT02432560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101910257|NCT02432560|Immunologic Factors|immunologic factors|mesh-ancestor
101910258|NCT02432560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910259|NCT02432560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101910260|NCT02432560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101910261|NCT02432560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101956334|NCT02084602|Artesunate|artesunate|mesh-list
101910262|NCT02432560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101910263|NCT02432560|Antifungal Agents|antifungal agents|mesh-ancestor
101910264|NCT01111734|Acetylcysteine|acetylcysteine|mesh-list
101910265|NCT01111734|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101910266|NCT01111734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910267|NCT01111734|Antiviral Agents|antiviral agents|mesh-ancestor
101910268|NCT01111734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101321718|NCT00085969|Exenatide|exenatide|mesh-list
101910269|NCT01111734|Expectorants|expectorants|mesh-ancestor
101910270|NCT01111734|Respiratory System Agents|respiratory system agents|mesh-ancestor
101910271|NCT01111734|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101910272|NCT01111734|Antioxidants|antioxidants|mesh-ancestor
101910273|NCT01111734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910274|NCT01111734|Protective Agents|protective agents|mesh-ancestor
101910275|NCT01111734|Antidotes|antidotes|mesh-ancestor
101910276|NCT01698138|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101910277|NCT01698138|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101910278|NCT01698138|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101910279|NCT01698138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101910280|NCT01698138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910281|NCT01698138|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101910282|NCT01698138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101910283|NCT01698138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910284|NCT01698138|Cholinergic Agents|cholinergic agents|mesh-ancestor
101910285|NCT01698138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101910286|NCT01111890|Timolol|timolol|mesh-list
101910287|NCT01111890|Dorzolamide|dorzolamide|mesh-list
101910288|NCT01111890|Brinzolamide|brinzolamide|mesh-list
101910289|NCT01111890|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101910290|NCT01111890|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101910291|NCT01111890|Adrenergic Agents|adrenergic agents|mesh-ancestor
101910292|NCT01111890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101910293|NCT01111890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910294|NCT01111890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910295|NCT01111890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101910296|NCT01111890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101910297|NCT01111890|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101910298|NCT01111890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101910299|NCT00745134|Curcumin|curcumin|mesh-list
101910300|NCT00745134|Capecitabine|capecitabine|mesh-list
101910301|NCT00745134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101910302|NCT00745134|Antimetabolites|antimetabolites|mesh-ancestor
101910303|NCT00745134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910304|NCT00745134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101910305|NCT00745134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101910306|NCT00745134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101910307|NCT00745134|Analgesics|analgesics|mesh-ancestor
101910308|NCT00745134|Sensory System Agents|sensory system agents|mesh-ancestor
101910309|NCT00745134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101910310|NCT00745134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910311|NCT00745134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101910312|NCT00745134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101910313|NCT00745134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101910314|NCT01111968|Vaccines|vaccines|mesh-list
101910315|NCT01111968|Immunologic Factors|immunologic factors|mesh-ancestor
101910316|NCT01111968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910317|NCT04398134|Entecavir|entecavir|mesh-list
101910318|NCT04398134|Antiviral Agents|antiviral agents|mesh-ancestor
101910319|NCT04398134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101910320|NCT04281342|Moxifloxacin|moxifloxacin|mesh-list
101910321|NCT04281342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101910322|NCT04281342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101910323|NCT04281342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101910324|NCT04281342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101910325|NCT04281342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101910326|NCT04281342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910327|NCT04281342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101910328|NCT01108146|Hydrocortisone|hydrocortisone|mesh-list
101910329|NCT01108146|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101910330|NCT01108146|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101910331|NCT01108146|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101910332|NCT01108146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101910333|NCT01108302|Oxytocin|oxytocin|mesh-list
101910335|NCT01108302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101910336|NCT01108302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910337|NCT03122860|Lorecivivint|lorecivivint|mesh-list
101910338|NCT03122860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101910339|NCT01319188|Ranibizumab|ranibizumab|mesh-list
101910340|NCT01319188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101910341|NCT01319188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101910342|NCT01319188|Growth Substances|growth substances|mesh-ancestor
101910343|NCT01319188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910344|NCT01319188|Growth Inhibitors|growth inhibitors|mesh-ancestor
101910345|NCT01319188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101910346|NCT05167084|Hydrocortisone|hydrocortisone|mesh-list
101910347|NCT05167084|Metyrapone|metyrapone|mesh-list
101910348|NCT05167084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101910349|NCT05167084|Antimetabolites|antimetabolites|mesh-ancestor
101910350|NCT05167084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910351|NCT05167084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101910352|NCT00867178|Vitamin A|vitamin a|mesh-list
101910353|NCT00867178|Cyclophosphamide|cyclophosphamide|mesh-list
101910354|NCT00867178|Thiotepa|thiotepa|mesh-list
101910355|NCT00867178|Cisplatin|cisplatin|mesh-list
101910356|NCT00867178|Carboplatin|carboplatin|mesh-list
101910357|NCT00867178|Etoposide|etoposide|mesh-list
101910358|NCT00867178|Vincristine|vincristine|mesh-list
101910359|NCT00867178|Vorinostat|vorinostat|mesh-list
101910360|NCT00867178|Tretinoin|tretinoin|mesh-list
101910361|NCT00867178|Etoposide phosphate|etoposide phosphate|mesh-list
101910362|NCT00867178|Isotretinoin|isotretinoin|mesh-list
101910363|NCT00867178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101910364|NCT00867178|Immunologic Factors|immunologic factors|mesh-ancestor
101910365|NCT00867178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910366|NCT00867178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101910367|NCT00867178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101910368|NCT00867178|Alkylating Agents|alkylating agents|mesh-ancestor
101910369|NCT00867178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910370|NCT00867178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101910371|NCT00867178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101910372|NCT00867178|Vitamins|vitamins|mesh-ancestor
101910373|NCT00867178|Micronutrients|micronutrients|mesh-ancestor
101910374|NCT00867178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101910375|NCT00867178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101956367|NCT04346199|Acalabrutinib|acalabrutinib|mesh-list
101910376|NCT00867178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101910377|NCT00867178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101910378|NCT00867178|Tubulin Modulators|tubulin modulators|mesh-ancestor
101910379|NCT00867178|Antimitotic Agents|antimitotic agents|mesh-ancestor
101910380|NCT00867178|Mitosis Modulators|mitosis modulators|mesh-ancestor
101910381|NCT00867178|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101910382|NCT00867178|Keratolytic Agents|keratolytic agents|mesh-ancestor
101910383|NCT00867178|Dermatologic Agents|dermatologic agents|mesh-ancestor
101910384|NCT03945396|Calcium Carbonate|calcium carbonate|mesh-list
101910385|NCT03945396|Antacids|antacids|mesh-ancestor
101910386|NCT03945396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910387|NCT03945396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101910388|NCT01109784|Clopidogrel|clopidogrel|mesh-list
101910389|NCT01109784|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101910390|NCT01109784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101910391|NCT01109784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101910392|NCT01109784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101910393|NCT01109784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101910394|NCT01109784|Purinergic Agents|purinergic agents|mesh-ancestor
101910395|NCT01109784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101910396|NCT01109784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910397|NCT01109784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910398|NCT01328340|Methamphetamine|methamphetamine|mesh-list
101910399|NCT01328340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101910400|NCT01328340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910401|NCT01328340|Sympathomimetics|sympathomimetics|mesh-ancestor
101910402|NCT01328340|Autonomic Agents|autonomic agents|mesh-ancestor
101910403|NCT01328340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101910404|NCT01328340|Dopamine Agents|dopamine agents|mesh-ancestor
101910405|NCT01328340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101910406|NCT01328340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910407|NCT01328340|Adrenergic Agents|adrenergic agents|mesh-ancestor
101910408|NCT01328340|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101910409|NCT01328340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101910410|NCT01328340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101910411|NCT01328340|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101910412|NCT03796728|Lidocaine|lidocaine|mesh-list
101910413|NCT03796728|Anesthetics, Local|anesthetics, local|mesh-ancestor
101910414|NCT03796728|Anesthetics|anesthetics|mesh-ancestor
101910415|NCT03796728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101910416|NCT03796728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910417|NCT03796728|Sensory System Agents|sensory system agents|mesh-ancestor
101910418|NCT03796728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101910419|NCT03796728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101910420|NCT03796728|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101630276|NCT00617253|Sunitinib|sunitinib|mesh-list
101910421|NCT03796728|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101910422|NCT03796728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101910423|NCT03796728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910424|NCT00352534|Dactinomycin|dactinomycin|mesh-list
101910425|NCT00352534|Cactinomycin|cactinomycin|mesh-list
101910426|NCT00352534|Doxorubicin|doxorubicin|mesh-list
101910427|NCT00352534|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101910428|NCT00352534|Vincristine|vincristine|mesh-list
101910429|NCT00352534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101910430|NCT00352534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101910431|NCT00352534|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101910432|NCT00352534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101910434|NCT00352534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910435|NCT00352534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101910436|NCT00352534|Tubulin Modulators|tubulin modulators|mesh-ancestor
101910437|NCT00352534|Antimitotic Agents|antimitotic agents|mesh-ancestor
101910438|NCT00352534|Mitosis Modulators|mitosis modulators|mesh-ancestor
101910439|NCT00352534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101910440|NCT00352534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101910441|NCT00352534|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101910442|NCT00352534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101910443|NCT01328106|Trametinib|trametinib|mesh-list
101910444|NCT01328106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101910445|NCT01328106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101910446|NCT01328106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101910447|NCT01328106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910448|NCT03122548|Pembrolizumab|pembrolizumab|mesh-list
101910449|NCT03122548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101910450|NCT03122548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101910451|NCT03122548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101910452|NCT03122548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910453|NCT03749642|Gabapentin|gabapentin|mesh-list
101910454|NCT03749642|Trazodone|trazodone|mesh-list
101910455|NCT03749642|Analgesics|analgesics|mesh-ancestor
101910456|NCT03749642|Sensory System Agents|sensory system agents|mesh-ancestor
101910457|NCT03749642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101910458|NCT03749642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910459|NCT03749642|Anticonvulsants|anticonvulsants|mesh-ancestor
101910460|NCT03749642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101910461|NCT03749642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101910462|NCT03749642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101910463|NCT03749642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101910464|NCT03749642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101910465|NCT03749642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101910466|NCT03749642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101956434|NCT02082418|Caseins|caseins|mesh-list
101910467|NCT03749642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910468|NCT03749642|Antimanic Agents|antimanic agents|mesh-ancestor
101910469|NCT03749642|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101910470|NCT03749642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101910471|NCT03749642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101910472|NCT03749642|Serotonin Agents|serotonin agents|mesh-ancestor
101910473|NCT03749642|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101910474|NCT03749642|Antidepressive Agents|antidepressive agents|mesh-ancestor
101910475|NCT03751358|Anesthetics|anesthetics|mesh-list
101910476|NCT03751358|Anesthetics, Local|anesthetics, local|mesh-list
101228347|NCT01545297|Anesthetics|anesthetics|mesh-ancestor
101910477|NCT03751358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101910478|NCT03751358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910479|NCT03751358|Sensory System Agents|sensory system agents|mesh-ancestor
101910480|NCT03751358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101910481|NCT05193292|Trastuzumab|trastuzumab|mesh-list
101910482|NCT05193292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101910483|NCT05193292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101910484|NCT05193214|Antibodies|antibodies|mesh-list
101910485|NCT05193214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101910486|NCT05193214|Immunologic Factors|immunologic factors|mesh-ancestor
101910487|NCT05193214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910488|NCT02529774|Leucovorin|leucovorin|mesh-list
101910489|NCT02529774|Dexamethasone|dexamethasone|mesh-list
101910490|NCT02529774|Capecitabine|capecitabine|mesh-list
101910491|NCT02529774|Oxaliplatin|oxaliplatin|mesh-list
101910492|NCT02529774|Fluorouracil|fluorouracil|mesh-list
101910493|NCT02529774|Floxuridine|floxuridine|mesh-list
101910494|NCT02529774|Heparin|heparin|mesh-list
101910495|NCT02529774|Levoleucovorin|levoleucovorin|mesh-list
101910496|NCT02529774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101910497|NCT02529774|Antiemetics|antiemetics|mesh-ancestor
101630343|NCT00617565|Insulin|insulin|mesh-list
101910498|NCT02529774|Autonomic Agents|autonomic agents|mesh-ancestor
101910499|NCT02529774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101910500|NCT02529774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910501|NCT02529774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101910502|NCT02529774|Glucocorticoids|glucocorticoids|mesh-ancestor
101910503|NCT02529774|Hormones|hormones|mesh-ancestor
101910504|NCT02529774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101910505|NCT02529774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101616802|NCT00895245|Hormones|hormones|mesh-ancestor
101910506|NCT02529774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101910507|NCT02529774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101910508|NCT02529774|Antimetabolites|antimetabolites|mesh-ancestor
101910509|NCT02529774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910510|NCT02529774|Antidotes|antidotes|mesh-ancestor
101910511|NCT02529774|Protective Agents|protective agents|mesh-ancestor
101910512|NCT02529774|Vitamin B Complex|vitamin b complex|mesh-ancestor
101910513|NCT02529774|Vitamins|vitamins|mesh-ancestor
101910514|NCT02529774|Micronutrients|micronutrients|mesh-ancestor
101910515|NCT02529774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101910516|NCT02529774|Immunologic Factors|immunologic factors|mesh-ancestor
101910517|NCT02529774|Anticoagulants|anticoagulants|mesh-ancestor
101910518|NCT02529774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101910519|NCT02529774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101910520|NCT04459598|Efavirenz|efavirenz|mesh-list
101910521|NCT04459598|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101910522|NCT04459598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101910523|NCT04459598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101910524|NCT04459598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910525|NCT04459598|Antiviral Agents|antiviral agents|mesh-ancestor
101910526|NCT04459598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101910527|NCT04459598|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101910528|NCT04459598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101910529|NCT04459598|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101910530|NCT04459598|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101910531|NCT04459598|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101910532|NCT04459598|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101910533|NCT03942354|Moxifloxacin|moxifloxacin|mesh-list
101910534|NCT03942354|Linezolid|linezolid|mesh-list
101910535|NCT03942354|Bedaquiline|bedaquiline|mesh-list
101910536|NCT03942354|Clofazimine|clofazimine|mesh-list
101910537|NCT03942354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101910538|NCT03942354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101910539|NCT03942354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101910540|NCT03942354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101910541|NCT03942354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101910542|NCT03942354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910543|NCT03942354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101910544|NCT03942354|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101910545|NCT03942354|Antitubercular Agents|antitubercular agents|mesh-ancestor
101910546|NCT03942354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101910547|NCT03942354|Leprostatic Agents|leprostatic agents|mesh-ancestor
101910548|NCT05165992|Fentanyl|fentanyl|mesh-list
101910549|NCT05165992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101910550|NCT05165992|Narcotics|narcotics|mesh-ancestor
101910551|NCT05165992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101910552|NCT05165992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910553|NCT05165992|Analgesics|analgesics|mesh-ancestor
101910554|NCT05165992|Sensory System Agents|sensory system agents|mesh-ancestor
101910555|NCT05165992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101910556|NCT05165992|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101910557|NCT05165992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101910558|NCT05165992|Anesthetics, General|anesthetics, general|mesh-ancestor
101910559|NCT05165992|Anesthetics|anesthetics|mesh-ancestor
101910560|NCT01359202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101910561|NCT01367548|Methylnaltrexone|methylnaltrexone|mesh-list
101910562|NCT01367548|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101910563|NCT01367548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910564|NCT01367548|Sensory System Agents|sensory system agents|mesh-ancestor
101910565|NCT01367548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101910566|NCT01367626|Letrozole|letrozole|mesh-list
101910567|NCT01367626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101910568|NCT01367626|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101910569|NCT01367626|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101910570|NCT01367626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101910571|NCT01367626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910572|NCT01367626|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101910573|NCT01367626|Hormone Antagonists|hormone antagonists|mesh-ancestor
101910574|NCT01367626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101910575|NCT01367626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910577|NCT01112748|Anesthetics, Local|anesthetics, local|mesh-ancestor
101910578|NCT01112748|Anesthetics|anesthetics|mesh-ancestor
101910579|NCT01112748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101910580|NCT01112748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910581|NCT01112748|Sensory System Agents|sensory system agents|mesh-ancestor
101910582|NCT01112748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101910583|NCT01112748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101910584|NCT01112748|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101910585|NCT01112748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101910586|NCT01112748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101910587|NCT01112748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910589|NCT05192902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101910590|NCT05192902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910591|NCT01211808|Diltiazem|diltiazem|mesh-list
101910592|NCT01211808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101910593|NCT01211808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101910594|NCT01211808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101910595|NCT01211808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910596|NCT01211808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101910597|NCT01211808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910598|NCT01211808|Vasodilator Agents|vasodilator agents|mesh-ancestor
101910599|NCT01209858|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
101910600|NCT01209858|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
101910601|NCT01209858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101910602|NCT01209858|Contraceptive Agents|contraceptive agents|mesh-ancestor
101910603|NCT01209858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101910604|NCT01209858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910605|NCT01209858|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101910606|NCT01209858|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101910607|NCT01209858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101910608|NCT01209858|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101910609|NCT01209858|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101910610|NCT01209858|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
101910611|NCT01209858|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101910612|NCT01209858|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101910613|NCT05191888|Amoxicillin|amoxicillin|mesh-list
101910614|NCT05191888|Metronidazole|metronidazole|mesh-list
101910615|NCT05191888|Clarithromycin|clarithromycin|mesh-list
101910616|NCT05191888|Rabeprazole|rabeprazole|mesh-list
101910617|NCT05191888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101910618|NCT05191888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101910619|NCT05191888|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101910620|NCT05191888|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101910621|NCT05191888|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101910622|NCT05191888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101910623|NCT05191888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910624|NCT05191888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101910625|NCT05191888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101910626|NCT05191888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101910627|NCT05191888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101910628|NCT05191888|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101910629|NCT01112826|Capecitabine|capecitabine|mesh-list
101910630|NCT01112826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101910631|NCT01112826|Antimetabolites|antimetabolites|mesh-ancestor
101910632|NCT01112826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910633|NCT01112826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101910634|NCT01210014|Zinc Sulfate|zinc sulfate|mesh-list
101910635|NCT01210014|Astringents|astringents|mesh-ancestor
101910636|NCT01210014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910637|NCT01210014|Dermatologic Agents|dermatologic agents|mesh-ancestor
101910638|NCT05118256|Pirfenidone|pirfenidone|mesh-list
101910639|NCT05118256|Analgesics|analgesics|mesh-ancestor
101910640|NCT05118256|Sensory System Agents|sensory system agents|mesh-ancestor
101910641|NCT05118256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101910642|NCT05118256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630494|NCT04472299|Ropivacaine|ropivacaine|mesh-list
101910643|NCT05118256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101910644|NCT05118256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101910645|NCT05118256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101910646|NCT05118256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101910647|NCT05118256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101910648|NCT01114542|Insulin|insulin|mesh-list
101910649|NCT01114542|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101910651|NCT01114542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101910652|NCT01114542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910653|NCT02529540|Methamphetamine|methamphetamine|mesh-list
101910654|NCT02529540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101910655|NCT02529540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910656|NCT02529540|Sympathomimetics|sympathomimetics|mesh-ancestor
101910657|NCT02529540|Autonomic Agents|autonomic agents|mesh-ancestor
101910658|NCT02529540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101910659|NCT02529540|Dopamine Agents|dopamine agents|mesh-ancestor
101910660|NCT02529540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101910661|NCT02529540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910662|NCT02529540|Adrenergic Agents|adrenergic agents|mesh-ancestor
101910663|NCT02529540|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101910664|NCT02529540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101910665|NCT02529540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101910666|NCT02529540|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101910667|NCT01359436|Antibodies|antibodies|mesh-list
101910668|NCT01359436|Immunologic Factors|immunologic factors|mesh-ancestor
101910669|NCT01359436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910670|NCT01359514|Pregabalin|pregabalin|mesh-list
101228373|NCT01545778|Analgesics|analgesics|mesh-ancestor
101910671|NCT01359514|Calcium Channel Blockers|calcium channel blockers|mesh-list
101910672|NCT01359514|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101910673|NCT01359514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101910674|NCT01359514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910675|NCT01359514|Analgesics|analgesics|mesh-ancestor
101910676|NCT01359514|Sensory System Agents|sensory system agents|mesh-ancestor
101910677|NCT01359514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101910678|NCT01359514|Anticonvulsants|anticonvulsants|mesh-ancestor
101910679|NCT01359514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101910680|NCT01359514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910681|NCT01359514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101910682|NCT01359514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101910683|NCT01359514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101910684|NCT01359514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101910685|NCT01359514|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101910686|NCT01359514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101910687|NCT01359514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101910688|NCT01359514|Antidepressive Agents|antidepressive agents|mesh-ancestor
101910689|NCT01359514|Dopamine Agents|dopamine agents|mesh-ancestor
101910690|NCT01368016|Nicotine|nicotine|mesh-list
101910691|NCT01368016|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101910692|NCT01368016|Autonomic Agents|autonomic agents|mesh-ancestor
101910693|NCT01368016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101910694|NCT01368016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910695|NCT01368016|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101910696|NCT01368016|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101910697|NCT01368016|Cholinergic Agents|cholinergic agents|mesh-ancestor
101910698|NCT01368016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101910699|NCT01368016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910700|NCT01208454|Vitamin A|vitamin a|mesh-list
101910701|NCT01208454|Vorinostat|vorinostat|mesh-list
101910702|NCT01208454|Tretinoin|tretinoin|mesh-list
101910703|NCT01208454|Isotretinoin|isotretinoin|mesh-list
101910704|NCT01208454|Vitamins|vitamins|mesh-ancestor
101910705|NCT01208454|Micronutrients|micronutrients|mesh-ancestor
101910706|NCT01208454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910707|NCT01208454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101910708|NCT01208454|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101910709|NCT01208454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101910710|NCT01208454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910711|NCT01208454|Keratolytic Agents|keratolytic agents|mesh-ancestor
101910712|NCT01208454|Dermatologic Agents|dermatologic agents|mesh-ancestor
101910713|NCT01110486|Carboplatin|carboplatin|mesh-list
101910714|NCT01110486|Docetaxel|docetaxel|mesh-list
101910715|NCT01110486|Ilorasertib|ilorasertib|mesh-list
101910716|NCT01110486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101910717|NCT01110486|Tubulin Modulators|tubulin modulators|mesh-ancestor
101630568|NCT04116073|Antibodies|antibodies|mesh-list
101910718|NCT01110486|Antimitotic Agents|antimitotic agents|mesh-ancestor
101910719|NCT01110486|Mitosis Modulators|mitosis modulators|mesh-ancestor
101910720|NCT01110486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910721|NCT01110486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101910722|NCT01110486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101910723|NCT01372306|Galantamine|galantamine|mesh-list
101910724|NCT01372306|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101910725|NCT01372306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101910726|NCT01372306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910727|NCT01372306|Cholinergic Agents|cholinergic agents|mesh-ancestor
101910728|NCT01372306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101910729|NCT01372306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910730|NCT01372306|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101910731|NCT01372306|Autonomic Agents|autonomic agents|mesh-ancestor
101910732|NCT01372306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101910733|NCT01372306|Nootropic Agents|nootropic agents|mesh-ancestor
101910734|NCT01114854|Topiramate|topiramate|mesh-list
101910735|NCT01114854|Anticonvulsants|anticonvulsants|mesh-ancestor
101910736|NCT01114854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101910737|NCT01114854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910738|NCT01359670|Sildenafil Citrate|sildenafil citrate|mesh-list
101910739|NCT01359670|Tadalafil|tadalafil|mesh-list
101910740|NCT01359670|Vasodilator Agents|vasodilator agents|mesh-ancestor
101910741|NCT01359670|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101910742|NCT01359670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101910743|NCT01359670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101910744|NCT01359670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910745|NCT01359670|Urological Agents|urological agents|mesh-ancestor
101910746|NCT05188768|Mitogens|mitogens|mesh-list
101910747|NCT05188768|Mitosis Modulators|mitosis modulators|mesh-ancestor
101910748|NCT05188768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910749|NCT01368328|Chromium|chromium|mesh-list
101910751|NCT01368328|Trace Elements|trace elements|mesh-ancestor
101910752|NCT01368328|Micronutrients|micronutrients|mesh-ancestor
101910753|NCT01368328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910754|NCT01368328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101910755|NCT01368328|Antimetabolites|antimetabolites|mesh-ancestor
101910756|NCT01368328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910757|NCT01368328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101910758|NCT01368328|Vasodilator Agents|vasodilator agents|mesh-ancestor
101910759|NCT01368328|Vitamin B Complex|vitamin b complex|mesh-ancestor
101910760|NCT01368328|Vitamins|vitamins|mesh-ancestor
101910761|NCT01110642|Lovastatin|lovastatin|mesh-list
101910762|NCT01110642|L 647318|l 647318|mesh-list
101910763|NCT01110642|Dihydromevinolin|dihydromevinolin|mesh-list
101910764|NCT01110642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101910765|NCT01110642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101910766|NCT01110642|Antimetabolites|antimetabolites|mesh-ancestor
101910767|NCT01110642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910768|NCT01110642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101910769|NCT01110642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101910770|NCT01110642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101910771|NCT02929498|Azacitidine|azacitidine|mesh-list
101910772|NCT02929498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101910773|NCT02929498|Antimetabolites|antimetabolites|mesh-ancestor
101910774|NCT02929498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910775|NCT02929498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101910776|NCT02929498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101910778|NCT01359826|Levomilnacipran|levomilnacipran|mesh-list
101910779|NCT01359826|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101910780|NCT01359826|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101910781|NCT01359826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101910782|NCT01359826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910783|NCT01359826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101910784|NCT01359826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910785|NCT01359826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101910786|NCT01359826|Analgesics|analgesics|mesh-ancestor
101910787|NCT01359826|Sensory System Agents|sensory system agents|mesh-ancestor
101910788|NCT01359826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101910789|NCT01359826|Antidepressive Agents|antidepressive agents|mesh-ancestor
101910790|NCT01359826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101910791|NCT03792672|Ketamine|ketamine|mesh-list
101630657|NCT02583217|Ketamine|ketamine|mesh-list
101910792|NCT03792672|Analgesics|analgesics|mesh-ancestor
101910793|NCT03792672|Sensory System Agents|sensory system agents|mesh-ancestor
101910794|NCT03792672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101910795|NCT03792672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910797|NCT03792672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101910798|NCT03792672|Anesthetics, General|anesthetics, general|mesh-ancestor
101910799|NCT03792672|Anesthetics|anesthetics|mesh-ancestor
101910800|NCT03792672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101910801|NCT03792672|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101910802|NCT03792672|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101910803|NCT03792672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101910804|NCT03792672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910805|NCT01372540|Filanesib|filanesib|mesh-list
101910806|NCT01372540|Antimitotic Agents|antimitotic agents|mesh-ancestor
101910807|NCT01372540|Mitosis Modulators|mitosis modulators|mesh-ancestor
101910808|NCT01372540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910809|NCT01372540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101910810|NCT01113138|Magnesium Sulfate|magnesium sulfate|mesh-list
101910811|NCT01113138|Analgesics|analgesics|mesh-ancestor
101910812|NCT01113138|Sensory System Agents|sensory system agents|mesh-ancestor
101910813|NCT01113138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101910814|NCT01113138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910815|NCT01113138|Anesthetics|anesthetics|mesh-ancestor
101910816|NCT01113138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101910817|NCT01113138|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101910818|NCT01113138|Anticonvulsants|anticonvulsants|mesh-ancestor
101910819|NCT01113138|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101910820|NCT01113138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101910821|NCT01113138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910822|NCT01113138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101910823|NCT01113138|Tocolytic Agents|tocolytic agents|mesh-ancestor
101910824|NCT01113138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101910825|NCT01115322|Nicotinic Acids|nicotinic acids|mesh-list
101910826|NCT01115322|Tazarotene|tazarotene|mesh-list
101910827|NCT01115322|Dermatologic Agents|dermatologic agents|mesh-ancestor
101910828|NCT01115322|Keratolytic Agents|keratolytic agents|mesh-ancestor
101910829|NCT01115322|Vitamin B Complex|vitamin b complex|mesh-ancestor
101910830|NCT01115322|Vitamins|vitamins|mesh-ancestor
101910831|NCT01115322|Micronutrients|micronutrients|mesh-ancestor
101910832|NCT01115322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910833|NCT01111188|Bortezomib|bortezomib|mesh-list
101910834|NCT01111188|Palbociclib|palbociclib|mesh-list
101910835|NCT01111188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101910836|NCT01111188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101910837|NCT01111188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101910838|NCT01111188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910839|NCT01210482|Sirolimus|sirolimus|mesh-list
101910840|NCT01210482|Temsirolimus|temsirolimus|mesh-list
101910841|NCT01210482|MTOR Inhibitors|mtor inhibitors|mesh-list
101910842|NCT01210482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101910843|NCT01210482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101910844|NCT01210482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910845|NCT01210482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101910846|NCT01210482|Immunologic Factors|immunologic factors|mesh-ancestor
101910847|NCT01210482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910848|NCT01210482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101910849|NCT01210482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101910850|NCT01210482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101910851|NCT01210482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101910852|NCT01210482|Antifungal Agents|antifungal agents|mesh-ancestor
101910853|NCT01360060|Magnesium Sulfate|magnesium sulfate|mesh-list
101910854|NCT01360060|Analgesics|analgesics|mesh-ancestor
101910855|NCT01360060|Sensory System Agents|sensory system agents|mesh-ancestor
101910856|NCT01360060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101910857|NCT01360060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910858|NCT01360060|Anesthetics|anesthetics|mesh-ancestor
101910859|NCT01360060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101910860|NCT01360060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101910861|NCT01360060|Anticonvulsants|anticonvulsants|mesh-ancestor
101910862|NCT01360060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101910863|NCT01360060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101910864|NCT01360060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910865|NCT01360060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101910866|NCT01360060|Tocolytic Agents|tocolytic agents|mesh-ancestor
101910867|NCT01360060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101910869|NCT01210638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101910870|NCT01210638|Narcotics|narcotics|mesh-ancestor
101910871|NCT01210638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101910872|NCT01210638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910873|NCT01210638|Analgesics|analgesics|mesh-ancestor
101910874|NCT01210638|Sensory System Agents|sensory system agents|mesh-ancestor
101910875|NCT01210638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101910876|NCT01210638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101910877|NCT03120676|Atezolizumab|atezolizumab|mesh-list
101910878|NCT03120676|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101910879|NCT03120676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910880|NCT03120676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101910881|NCT03120676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101910882|NCT01115478|Vitamin A|vitamin a|mesh-list
101910883|NCT01115478|Vitamins|vitamins|mesh-ancestor
101910884|NCT01115478|Micronutrients|micronutrients|mesh-ancestor
101910885|NCT01115478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910886|NCT01111422|Acetylcysteine|acetylcysteine|mesh-list
101910887|NCT01111422|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101910888|NCT01111422|Antiviral Agents|antiviral agents|mesh-ancestor
101910889|NCT01111422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101910890|NCT01111422|Expectorants|expectorants|mesh-ancestor
101910891|NCT01111422|Respiratory System Agents|respiratory system agents|mesh-ancestor
101910892|NCT01111422|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101910893|NCT01111422|Antioxidants|antioxidants|mesh-ancestor
101910894|NCT01111422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910895|NCT01111422|Protective Agents|protective agents|mesh-ancestor
101910896|NCT01111422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910897|NCT01111422|Antidotes|antidotes|mesh-ancestor
101910898|NCT01212432|Daptomycin|daptomycin|mesh-list
101910899|NCT01212432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101910900|NCT01212432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101910901|NCT01213368|Dronedarone|dronedarone|mesh-list
101910902|NCT01213368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101910903|NCT01369186|Morphine|morphine|mesh-list
101910904|NCT01369186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101910905|NCT01369186|Narcotics|narcotics|mesh-ancestor
101910906|NCT01369186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101910907|NCT01369186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910908|NCT01369186|Analgesics|analgesics|mesh-ancestor
101910909|NCT01369186|Sensory System Agents|sensory system agents|mesh-ancestor
101910910|NCT01369186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101910911|NCT01115712|Pioglitazone|pioglitazone|mesh-list
101910912|NCT01115712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101910913|NCT01115712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910914|NCT01117662|Rituximab|rituximab|mesh-list
101910915|NCT01117662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101910916|NCT01117662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101910917|NCT01117662|Immunologic Factors|immunologic factors|mesh-ancestor
101910918|NCT01117662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910919|NCT01117662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101910920|NCT01319266|Hydrocodone|hydrocodone|mesh-list
101910921|NCT01319266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101910922|NCT01319266|Narcotics|narcotics|mesh-ancestor
101910923|NCT01319266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101910924|NCT01319266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910925|NCT01319266|Analgesics|analgesics|mesh-ancestor
101910926|NCT01319266|Sensory System Agents|sensory system agents|mesh-ancestor
101910927|NCT01319266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101910928|NCT01319266|Antitussive Agents|antitussive agents|mesh-ancestor
101910929|NCT01319266|Respiratory System Agents|respiratory system agents|mesh-ancestor
101910930|NCT01115790|Prexasertib|prexasertib|mesh-list
101910931|NCT01115790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101910932|NCT01115790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101910933|NCT01115790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910934|NCT01115946|Enalapril|enalapril|mesh-list
101910935|NCT01115946|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101910936|NCT01115946|Protease Inhibitors|protease inhibitors|mesh-ancestor
101910937|NCT01115946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101910938|NCT01115946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910939|NCT01115946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101910940|NCT01113372|Clopidogrel|clopidogrel|mesh-list
101910941|NCT01113372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101910942|NCT01113372|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101910943|NCT01113372|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101910944|NCT01113372|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101910945|NCT01113372|Purinergic Agents|purinergic agents|mesh-ancestor
101910947|NCT01113372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910948|NCT01113372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910949|NCT03120520|Plecanatide|plecanatide|mesh-list
101910950|NCT03120520|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
101910951|NCT03120520|Enzyme Activators|enzyme activators|mesh-ancestor
101910952|NCT03120520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910953|NCT03120520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101910954|NCT03941340|Aflutinib|aflutinib|mesh-list
101910955|NCT03941340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101910956|NCT03941340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101910957|NCT03941340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910958|NCT01372930|Etanercept|etanercept|mesh-list
101910959|NCT01372930|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101910960|NCT01372930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101910961|NCT01372930|Analgesics|analgesics|mesh-ancestor
101910962|NCT01372930|Sensory System Agents|sensory system agents|mesh-ancestor
101910963|NCT01372930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101910964|NCT01372930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910965|NCT01372930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101910966|NCT01372930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101910967|NCT01372930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101910968|NCT01372930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101910969|NCT01372930|Immunologic Factors|immunologic factors|mesh-ancestor
101910970|NCT01328652|Dexlansoprazole|dexlansoprazole|mesh-list
101910971|NCT01328652|Lansoprazole|lansoprazole|mesh-list
101910972|NCT01328652|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101910973|NCT01328652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101910974|NCT01328652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910975|NCT01328652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101910976|NCT01328652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101910977|NCT01373008|Beclomethasone|beclomethasone|mesh-list
101910978|NCT01373008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101910979|NCT01373008|Glucocorticoids|glucocorticoids|mesh-ancestor
101910980|NCT01373008|Hormones|hormones|mesh-ancestor
101910981|NCT01373008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101910982|NCT01373008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101910983|NCT01373008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101910984|NCT01373008|Respiratory System Agents|respiratory system agents|mesh-ancestor
101910985|NCT01116180|Candesartan|candesartan|mesh-list
101910986|NCT01116180|Candesartan cilexetil|candesartan cilexetil|mesh-list
101910987|NCT01116180|Angiotensin II|angiotensin ii|mesh-list
101910988|NCT01116180|Giapreza|giapreza|mesh-list
101910989|NCT01116180|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
101910990|NCT01116180|Angiotensinogen|angiotensinogen|mesh-list
101910991|NCT01116180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101910992|NCT01116180|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101910993|NCT01116180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101910994|NCT01116180|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101910995|NCT01116180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101910996|NCT01116180|Protease Inhibitors|protease inhibitors|mesh-ancestor
101910997|NCT01116180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101910999|NCT05067166|Antiviral Agents|antiviral agents|mesh-ancestor
101911000|NCT05067166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101911001|NCT01113528|Aspirin|aspirin|mesh-list
101911002|NCT01113528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101911003|NCT01113528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101911004|NCT01113528|Analgesics|analgesics|mesh-ancestor
101911005|NCT01113528|Sensory System Agents|sensory system agents|mesh-ancestor
101911006|NCT01113528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101911007|NCT01113528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911008|NCT01113528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101911009|NCT01113528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101911010|NCT01113528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101911011|NCT01113528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101911012|NCT01113528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911013|NCT01113528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101911014|NCT01113528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101911015|NCT01113528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101911016|NCT01113528|Antipyretics|antipyretics|mesh-ancestor
101630870|NCT04076137|Decitabine|decitabine|mesh-list
101911018|NCT01369576|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101911019|NCT01369576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101911020|NCT01369576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911021|NCT01113762|Cimetidine|cimetidine|mesh-list
101911022|NCT01113762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101911023|NCT01113762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101911024|NCT01113762|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101911025|NCT01113762|Histamine Antagonists|histamine antagonists|mesh-ancestor
101911026|NCT01113762|Histamine Agents|histamine agents|mesh-ancestor
101911027|NCT01113762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101911028|NCT01113762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911029|NCT01113762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911030|NCT01113762|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101911031|NCT01113762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101911032|NCT01113762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101911033|NCT01212666|Ropivacaine|ropivacaine|mesh-list
101911034|NCT01212666|Anesthetics, Local|anesthetics, local|mesh-ancestor
101911035|NCT01212666|Anesthetics|anesthetics|mesh-ancestor
101911036|NCT01212666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101911037|NCT01212666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911038|NCT01212666|Sensory System Agents|sensory system agents|mesh-ancestor
101911039|NCT01212666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101911040|NCT01116336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101911041|NCT01116336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101911042|NCT01116336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101911043|NCT01116336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101911044|NCT01116336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911045|NCT01213680|Ferric Compounds|ferric compounds|mesh-list
101911046|NCT01213680|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
101911047|NCT01213680|Hematinics|hematinics|mesh-ancestor
101911048|NCT03937518|Strontium ranelate|strontium ranelate|mesh-list
101911049|NCT03937518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101911050|NCT03937518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911051|NCT01211496|Methamphetamine|methamphetamine|mesh-list
101911052|NCT01211496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101911053|NCT01211496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911054|NCT01211496|Sympathomimetics|sympathomimetics|mesh-ancestor
101911055|NCT01211496|Autonomic Agents|autonomic agents|mesh-ancestor
101956678|NCT02088502|Protective Agents|protective agents|mesh-ancestor
101911056|NCT01211496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101911057|NCT01211496|Dopamine Agents|dopamine agents|mesh-ancestor
101911058|NCT01211496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101911059|NCT01211496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911060|NCT01211496|Adrenergic Agents|adrenergic agents|mesh-ancestor
101911061|NCT01211496|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101911062|NCT01211496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101911063|NCT01211496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101911064|NCT01211496|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101911066|NCT01118286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101911067|NCT01118286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101911068|NCT01118286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911069|NCT01118286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101911070|NCT01118286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911071|NCT01118286|Vasodilator Agents|vasodilator agents|mesh-ancestor
101911072|NCT01118286|Tocolytic Agents|tocolytic agents|mesh-ancestor
101911073|NCT01118286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101911074|NCT01585350|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101911075|NCT01585350|Freund's Adjuvant|freund's adjuvant|mesh-list
101911076|NCT01585350|Poly ICLC|poly iclc|mesh-list
101911077|NCT01585350|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101911078|NCT01585350|Immunologic Factors|immunologic factors|mesh-ancestor
101911079|NCT01585350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911080|NCT01585350|Interferon Inducers|interferon inducers|mesh-ancestor
101911081|NCT01118598|Nicotinic Acids|nicotinic acids|mesh-list
101911082|NCT01118598|Niacin|niacin|mesh-list
101911083|NCT01118598|Niacinamide|niacinamide|mesh-list
101911084|NCT01118598|Vitamin B Complex|vitamin b complex|mesh-ancestor
101911085|NCT01118598|Vitamins|vitamins|mesh-ancestor
101911086|NCT01118598|Micronutrients|micronutrients|mesh-ancestor
101911087|NCT01118598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911088|NCT01118598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101911089|NCT01118598|Antimetabolites|antimetabolites|mesh-ancestor
101911090|NCT01118598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911091|NCT01118598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101911092|NCT01118598|Vasodilator Agents|vasodilator agents|mesh-ancestor
101911093|NCT01216020|Cisplatin|cisplatin|mesh-list
101911094|NCT01216020|Cetuximab|cetuximab|mesh-list
101911095|NCT01216020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101956692|NCT02087098|Solifenacin Succinate|solifenacin succinate|mesh-list
101911096|NCT01216020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101911097|NCT01121796|Vitamin D|vitamin d|mesh-list
101911098|NCT01121796|Ergocalciferols|ergocalciferols|mesh-list
101911099|NCT01121796|Cholecalciferol|cholecalciferol|mesh-list
101911100|NCT01121796|Vitamins|vitamins|mesh-list
101911101|NCT01121796|Micronutrients|micronutrients|mesh-ancestor
101911102|NCT01121796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911103|NCT01121796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101911104|NCT01121796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101911105|NCT03939624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
101911106|NCT03939624|Protease Inhibitors|protease inhibitors|mesh-ancestor
101911107|NCT03939624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101911108|NCT03939624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911109|NCT03939624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101911110|NCT03939624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911111|NCT01119144|Calcium, Dietary|calcium, dietary|mesh-list
101911112|NCT01119144|Calcium|calcium|mesh-list
101911113|NCT01119144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101911114|NCT01119144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911115|NCT01119144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101911116|NCT01117038|Amlodipine|amlodipine|mesh-list
101911117|NCT01117038|Enalapril|enalapril|mesh-list
101911118|NCT01117038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101911119|NCT01117038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101911120|NCT01117038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101911121|NCT01117038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911122|NCT01117038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101911123|NCT01117038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911124|NCT01117038|Vasodilator Agents|vasodilator agents|mesh-ancestor
101911125|NCT01117038|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101911126|NCT01117038|Protease Inhibitors|protease inhibitors|mesh-ancestor
101911127|NCT01117038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101911128|NCT01119534|Camphor|camphor|mesh-list
101911129|NCT01119534|Eucalyptol|eucalyptol|mesh-list
101911130|NCT01119534|Phenylpropanolamine|phenylpropanolamine|mesh-list
101911131|NCT01119534|Menthol|menthol|mesh-list
101911132|NCT01119534|Guaifenesin|guaifenesin|mesh-list
101911133|NCT01119534|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
101911134|NCT01119534|Antipruritics|antipruritics|mesh-ancestor
101911135|NCT01119534|Dermatologic Agents|dermatologic agents|mesh-ancestor
101911136|NCT01119534|Expectorants|expectorants|mesh-ancestor
101911137|NCT01119534|Respiratory System Agents|respiratory system agents|mesh-ancestor
101911138|NCT01119534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101911139|NCT01119534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101911140|NCT01119534|Adrenergic Agents|adrenergic agents|mesh-ancestor
101911141|NCT01119534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101911142|NCT01119534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911143|NCT01119534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911144|NCT01119534|Appetite Depressants|appetite depressants|mesh-ancestor
101228428|NCT01546090|GABA Modulators|gaba modulators|mesh-ancestor
101911145|NCT01119534|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101911146|NCT01119534|Sympathomimetics|sympathomimetics|mesh-ancestor
101911147|NCT01119534|Autonomic Agents|autonomic agents|mesh-ancestor
101911148|NCT01119534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101911149|NCT01119534|Nasal Decongestants|nasal decongestants|mesh-ancestor
101911150|NCT01119534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101911151|NCT01119534|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101911152|NCT01119534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101911153|NCT01119534|Antitussive Agents|antitussive agents|mesh-ancestor
101911154|NCT01119534|Insect Repellents|insect repellents|mesh-ancestor
101911155|NCT01119534|Protective Agents|protective agents|mesh-ancestor
101911156|NCT01117116|Fluticasone|fluticasone|mesh-list
101911158|NCT01117116|Budesonide|budesonide|mesh-list
101911159|NCT01117116|Formoterol Fumarate|formoterol fumarate|mesh-list
101911160|NCT01117116|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101911161|NCT01117116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101911162|NCT01117116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101911163|NCT01117116|Autonomic Agents|autonomic agents|mesh-ancestor
101911164|NCT01117116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101911165|NCT01117116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911166|NCT01117116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101911167|NCT01117116|Respiratory System Agents|respiratory system agents|mesh-ancestor
101911168|NCT01117116|Dermatologic Agents|dermatologic agents|mesh-ancestor
101911169|NCT01117116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101911170|NCT01117116|Glucocorticoids|glucocorticoids|mesh-ancestor
101911171|NCT01117116|Hormones|hormones|mesh-ancestor
101911172|NCT01117116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101911173|NCT01117116|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101911174|NCT01117116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101911175|NCT01117116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101911176|NCT01117116|Adrenergic Agents|adrenergic agents|mesh-ancestor
101911177|NCT01117116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101911178|NCT01117116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911179|NCT01216488|Lidocaine|lidocaine|mesh-list
101911180|NCT01216488|Anesthetics, Local|anesthetics, local|mesh-ancestor
101911181|NCT01216488|Anesthetics|anesthetics|mesh-ancestor
101911182|NCT01216488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101911183|NCT01216488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911184|NCT01216488|Sensory System Agents|sensory system agents|mesh-ancestor
101911185|NCT01216488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101911186|NCT01216488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101911187|NCT01216488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101911188|NCT01216488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101911189|NCT01216488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101911190|NCT01216488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911191|NCT01122342|Methyltestosterone|methyltestosterone|mesh-list
101911192|NCT01122342|Testosterone|testosterone|mesh-list
101911193|NCT01122342|Testosterone undecanoate|testosterone undecanoate|mesh-list
101911194|NCT01122342|Testosterone enanthate|testosterone enanthate|mesh-list
101911195|NCT01122342|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101911196|NCT01122342|Androgens|androgens|mesh-ancestor
101911197|NCT01122342|Hormones|hormones|mesh-ancestor
101956735|NCT00187889|Hormone Antagonists|hormone antagonists|mesh-ancestor
101911198|NCT01122342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101911199|NCT01122342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911200|NCT01122342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101911201|NCT01122342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101911202|NCT01122342|Anabolic Agents|anabolic agents|mesh-ancestor
101911203|NCT01213992|Iron|iron|mesh-list
101911204|NCT01213992|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
101911205|NCT01213992|Ferric Compounds|ferric compounds|mesh-list
101911206|NCT01213992|Trace Elements|trace elements|mesh-ancestor
101911207|NCT01213992|Micronutrients|micronutrients|mesh-ancestor
101911208|NCT01213992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911209|NCT01213992|Hematinics|hematinics|mesh-ancestor
101911210|NCT01216644|Leucovorin|leucovorin|mesh-list
101911211|NCT01216644|Docetaxel|docetaxel|mesh-list
101911212|NCT01216644|Fluorouracil|fluorouracil|mesh-list
101911213|NCT01216644|Oxaliplatin|oxaliplatin|mesh-list
101911214|NCT01216644|Epirubicin|epirubicin|mesh-list
101911215|NCT01216644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101911216|NCT01216644|Tubulin Modulators|tubulin modulators|mesh-ancestor
101911217|NCT01216644|Antimitotic Agents|antimitotic agents|mesh-ancestor
101911218|NCT01216644|Mitosis Modulators|mitosis modulators|mesh-ancestor
101911219|NCT01216644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911220|NCT01216644|Antimetabolites|antimetabolites|mesh-ancestor
101911221|NCT01216644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101911222|NCT01216644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101911223|NCT01216644|Immunologic Factors|immunologic factors|mesh-ancestor
101911224|NCT01216644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911225|NCT01216644|Antidotes|antidotes|mesh-ancestor
101911226|NCT01216644|Protective Agents|protective agents|mesh-ancestor
101911227|NCT01216644|Vitamin B Complex|vitamin b complex|mesh-ancestor
101911228|NCT01216644|Vitamins|vitamins|mesh-ancestor
101911229|NCT01216644|Micronutrients|micronutrients|mesh-ancestor
101956771|NCT03746223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101911230|NCT01216644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101911231|NCT01216644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101911232|NCT01216644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101911234|NCT04959760|Antibodies|antibodies|mesh-list
101911235|NCT04959760|Immunoglobulins|immunoglobulins|mesh-list
101911236|NCT04959760|Immunoglobulin G|immunoglobulin g|mesh-list
101911237|NCT04959760|Immunologic Factors|immunologic factors|mesh-ancestor
101911238|NCT04959760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911239|NCT01214226|Pentoxifylline|pentoxifylline|mesh-list
101911240|NCT01214226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101911241|NCT01214226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101911242|NCT01214226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911243|NCT01214226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101911244|NCT01214226|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101911245|NCT01214226|Protective Agents|protective agents|mesh-ancestor
101911246|NCT01214226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911247|NCT01214226|Vasodilator Agents|vasodilator agents|mesh-ancestor
101911248|NCT01214226|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101911249|NCT01214226|Antioxidants|antioxidants|mesh-ancestor
101911250|NCT01360372|Methylnaltrexone|methylnaltrexone|mesh-list
101911251|NCT01360372|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101911252|NCT01360372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911253|NCT01360372|Sensory System Agents|sensory system agents|mesh-ancestor
101911254|NCT01360372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101911255|NCT01219062|Morphine|morphine|mesh-list
101911256|NCT01219062|Bupivacaine|bupivacaine|mesh-list
101911257|NCT01219062|Anesthetics, Local|anesthetics, local|mesh-ancestor
101911258|NCT01219062|Anesthetics|anesthetics|mesh-ancestor
101911259|NCT01219062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101911260|NCT01219062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911261|NCT01219062|Sensory System Agents|sensory system agents|mesh-ancestor
101911262|NCT01219062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101911263|NCT01219062|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101911264|NCT01219062|Narcotics|narcotics|mesh-ancestor
101911265|NCT01219062|Analgesics|analgesics|mesh-ancestor
101911266|NCT01120158|Paclitaxel|paclitaxel|mesh-list
101911267|NCT01120158|Bevacizumab|bevacizumab|mesh-list
101911268|NCT01120158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101911269|NCT01120158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101911270|NCT01120158|Tubulin Modulators|tubulin modulators|mesh-ancestor
101911271|NCT01120158|Antimitotic Agents|antimitotic agents|mesh-ancestor
101911272|NCT01120158|Mitosis Modulators|mitosis modulators|mesh-ancestor
101911273|NCT01120158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911274|NCT01120158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101911275|NCT01120158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101911276|NCT01120158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101911277|NCT01120158|Growth Substances|growth substances|mesh-ancestor
101911278|NCT01120158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911279|NCT01120158|Growth Inhibitors|growth inhibitors|mesh-ancestor
101911281|NCT01373398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101911282|NCT01124526|Cyclophosphamide|cyclophosphamide|mesh-list
101911283|NCT01124526|Rituximab|rituximab|mesh-list
101911284|NCT01124526|Fludarabine|fludarabine|mesh-list
101911285|NCT01124526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101911286|NCT01124526|Immunologic Factors|immunologic factors|mesh-ancestor
101911287|NCT01124526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911288|NCT01124526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101911289|NCT01124526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101911290|NCT01124526|Alkylating Agents|alkylating agents|mesh-ancestor
101911291|NCT01124526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911292|NCT01124526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101911293|NCT01124526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101911294|NCT01124526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101911295|NCT01120314|Otamixaban|otamixaban|mesh-list
101911296|NCT01120314|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101911297|NCT01120314|Antithrombins|antithrombins|mesh-ancestor
101911298|NCT01120314|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101911299|NCT01120314|Protease Inhibitors|protease inhibitors|mesh-ancestor
101911300|NCT01120314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101911301|NCT01120314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911302|NCT01120314|Anticoagulants|anticoagulants|mesh-ancestor
101911303|NCT03633994|Heparin|heparin|mesh-list
101911304|NCT03633994|Anticoagulants|anticoagulants|mesh-ancestor
101911305|NCT03633994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101911306|NCT03633994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101911307|NCT03633994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911308|NCT01328886|Omalizumab|omalizumab|mesh-list
101911309|NCT01328886|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101911310|NCT01328886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101911311|NCT01328886|Respiratory System Agents|respiratory system agents|mesh-ancestor
101911312|NCT01216878|Losartan|losartan|mesh-list
101911313|NCT01216878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101911314|NCT01216878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101911315|NCT01216878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101911316|NCT01216878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101911317|NCT01216878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911318|NCT04624984|Gemcitabine|gemcitabine|mesh-list
101911319|NCT04624984|Doxorubicin|doxorubicin|mesh-list
101911320|NCT04624984|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101911321|NCT04624984|Vinorelbine|vinorelbine|mesh-list
101911322|NCT04624984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101911323|NCT04624984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101911324|NCT04624984|Antimetabolites|antimetabolites|mesh-ancestor
101911325|NCT04624984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911326|NCT04624984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101911327|NCT04624984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101911328|NCT04624984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101911329|NCT04624984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101911330|NCT04624984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101911331|NCT04624984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101911332|NCT04624984|Tubulin Modulators|tubulin modulators|mesh-ancestor
101911333|NCT04624984|Antimitotic Agents|antimitotic agents|mesh-ancestor
101911334|NCT04624984|Mitosis Modulators|mitosis modulators|mesh-ancestor
101911335|NCT04624984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101911336|NCT01214382|Sertraline|sertraline|mesh-list
101911337|NCT01214382|Antidepressive Agents|antidepressive agents|mesh-ancestor
101911338|NCT01214382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101911339|NCT01214382|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101911340|NCT01214382|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101911341|NCT01214382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101911342|NCT01214382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911343|NCT01214382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101911344|NCT01214382|Serotonin Agents|serotonin agents|mesh-ancestor
101911345|NCT01214382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911346|NCT01216956|Nicotinic Acids|nicotinic acids|mesh-list
101911348|NCT01216956|Niacinamide|niacinamide|mesh-list
101911349|NCT01216956|Vitamin B Complex|vitamin b complex|mesh-ancestor
101911350|NCT01216956|Vitamins|vitamins|mesh-ancestor
101911351|NCT01216956|Micronutrients|micronutrients|mesh-ancestor
101911352|NCT01216956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911353|NCT01216956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101911354|NCT01216956|Antimetabolites|antimetabolites|mesh-ancestor
101228454|NCT01546389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101911355|NCT01216956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911356|NCT01216956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101911357|NCT01216956|Vasodilator Agents|vasodilator agents|mesh-ancestor
101911358|NCT01217034|Sorafenib|sorafenib|mesh-list
101911359|NCT01217034|Chlorotrianisene|chlorotrianisene|mesh-list
101911360|NCT01217034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101911361|NCT01217034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101911362|NCT01217034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101911363|NCT01217034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911364|NCT01217034|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101911365|NCT01217034|Estrogens|estrogens|mesh-ancestor
101911366|NCT01217034|Hormones|hormones|mesh-ancestor
101911367|NCT01217034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101911368|NCT01217034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911369|NCT01217034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101911370|NCT01373554|Oltipraz|oltipraz|mesh-list
101911371|NCT01373554|Antiviral Agents|antiviral agents|mesh-ancestor
101911372|NCT01373554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101911373|NCT01373554|Schistosomicides|schistosomicides|mesh-ancestor
101911374|NCT01373554|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101911375|NCT01373554|Anthelmintics|anthelmintics|mesh-ancestor
101911376|NCT01373554|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101911377|NCT01373554|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101911378|NCT01373554|Protective Agents|protective agents|mesh-ancestor
101911379|NCT01373554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911380|NCT01373554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101911381|NCT01373554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101911382|NCT01373554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101911383|NCT01373554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101911384|NCT01373554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911385|NCT01319344|Eplerenone|eplerenone|mesh-list
101911386|NCT01319344|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101911387|NCT01319344|Hormone Antagonists|hormone antagonists|mesh-ancestor
101911388|NCT01319344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101911389|NCT01319344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911390|NCT01319344|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101911391|NCT01319344|Diuretics|diuretics|mesh-ancestor
101911392|NCT01319344|Natriuretic Agents|natriuretic agents|mesh-ancestor
101911393|NCT01319344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101911395|NCT01373632|Temsirolimus|temsirolimus|mesh-list
101911396|NCT01373632|MTOR Inhibitors|mtor inhibitors|mesh-list
101911397|NCT01373632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101911398|NCT01373632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101911399|NCT01373632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101911400|NCT01373632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101911401|NCT01373632|Antifungal Agents|antifungal agents|mesh-ancestor
101911402|NCT01373632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101911403|NCT01373632|Immunologic Factors|immunologic factors|mesh-ancestor
101911404|NCT01373632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911405|NCT01373632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101911406|NCT01373632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101911407|NCT01373632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911408|NCT01124760|Ketoconazole|ketoconazole|mesh-list
101911409|NCT01124760|Diltiazem|diltiazem|mesh-list
101911410|NCT01124760|Antifungal Agents|antifungal agents|mesh-ancestor
101911411|NCT01124760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101911412|NCT01124760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101911413|NCT01124760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101911414|NCT01124760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101911415|NCT01124760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911416|NCT01124760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101911417|NCT01124760|Hormone Antagonists|hormone antagonists|mesh-ancestor
101911418|NCT01124760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101911419|NCT01124760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911420|NCT01124760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101911421|NCT01124760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101911422|NCT01124760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101911423|NCT01124760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101911424|NCT01124760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101911425|NCT01124760|Vasodilator Agents|vasodilator agents|mesh-ancestor
101911426|NCT01214772|Heparin|heparin|mesh-list
101911427|NCT01214772|Anticoagulants|anticoagulants|mesh-ancestor
101911428|NCT01214772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101911429|NCT01214772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101911430|NCT01214772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911431|NCT01125150|Metformin|metformin|mesh-list
101911432|NCT01125150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101911433|NCT01125150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911434|NCT01373710|Trastuzumab|trastuzumab|mesh-list
101911435|NCT01373710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101911436|NCT01373710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101911437|NCT03935256|Paclitaxel|paclitaxel|mesh-list
101911438|NCT03935256|Carboplatin|carboplatin|mesh-list
101911439|NCT03935256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101911440|NCT03935256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101911441|NCT03935256|Tubulin Modulators|tubulin modulators|mesh-ancestor
101911442|NCT03935256|Antimitotic Agents|antimitotic agents|mesh-ancestor
101911443|NCT03935256|Mitosis Modulators|mitosis modulators|mesh-ancestor
101911444|NCT03935256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911445|NCT03869866|Vaccines|vaccines|mesh-list
101911446|NCT03869866|Immunologic Factors|immunologic factors|mesh-ancestor
101911447|NCT03869866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911448|NCT03783702|Acetaminophen|acetaminophen|mesh-list
101911449|NCT03783702|Ibuprofen|ibuprofen|mesh-list
101911450|NCT03783702|Oxycodone|oxycodone|mesh-list
101911451|NCT03783702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101911452|NCT03783702|Analgesics|analgesics|mesh-ancestor
101911453|NCT03783702|Sensory System Agents|sensory system agents|mesh-ancestor
101911454|NCT03783702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101911455|NCT03783702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911456|NCT03783702|Antipyretics|antipyretics|mesh-ancestor
101911457|NCT03783702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101911458|NCT03783702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101911459|NCT03783702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101911460|NCT03783702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101911461|NCT03783702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101911462|NCT03783702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911463|NCT03783702|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101911464|NCT03783702|Narcotics|narcotics|mesh-ancestor
101911465|NCT03783702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101911466|NCT01319734|Glyburide|glyburide|mesh-list
101911467|NCT01319734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911470|NCT01121016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101911471|NCT01121016|Respiratory System Agents|respiratory system agents|mesh-ancestor
101911472|NCT01121016|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101911473|NCT01121016|Hormone Antagonists|hormone antagonists|mesh-ancestor
101911474|NCT01121016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101911475|NCT01121016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911476|NCT01121016|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101911477|NCT01121016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101911478|NCT01121016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911480|NCT03575572|Gout Suppressants|gout suppressants|mesh-ancestor
101911481|NCT03575572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101911482|NCT03575572|Tubulin Modulators|tubulin modulators|mesh-ancestor
101911483|NCT03575572|Antimitotic Agents|antimitotic agents|mesh-ancestor
101911484|NCT03575572|Mitosis Modulators|mitosis modulators|mesh-ancestor
101911485|NCT03575572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911486|NCT03575572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101911487|NCT01214928|Vitamin D|vitamin d|mesh-list
101911488|NCT01214928|Cholecalciferol|cholecalciferol|mesh-list
101911489|NCT01214928|Vitamins|vitamins|mesh-ancestor
101911490|NCT01214928|Micronutrients|micronutrients|mesh-ancestor
101911491|NCT01214928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911492|NCT01214928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101911493|NCT01214928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101911494|NCT01122966|Bevacizumab|bevacizumab|mesh-list
101911495|NCT01122966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101911496|NCT01122966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101911497|NCT01122966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101911498|NCT01122966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101911499|NCT01122966|Growth Substances|growth substances|mesh-ancestor
101911500|NCT01122966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911501|NCT01122966|Growth Inhibitors|growth inhibitors|mesh-ancestor
101911502|NCT01219686|Pindolol|pindolol|mesh-list
101911503|NCT01219686|Dexetimide|dexetimide|mesh-list
101911504|NCT01219686|Citalopram|citalopram|mesh-list
101911505|NCT01219686|Escitalopram|escitalopram|mesh-list
101911506|NCT01219686|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101911507|NCT01219686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101911508|NCT01219686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101911509|NCT01219686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911510|NCT01219686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101911511|NCT01219686|Serotonin Agents|serotonin agents|mesh-ancestor
101911512|NCT01219686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911513|NCT01219686|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101911514|NCT01219686|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101911515|NCT01219686|Parasympatholytics|parasympatholytics|mesh-ancestor
101911516|NCT01219686|Autonomic Agents|autonomic agents|mesh-ancestor
101911517|NCT01219686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101911518|NCT01219686|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101911519|NCT01219686|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101911520|NCT01219686|Cholinergic Agents|cholinergic agents|mesh-ancestor
101911521|NCT01219686|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101911522|NCT01219686|Antidepressive Agents|antidepressive agents|mesh-ancestor
101911523|NCT01219686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101911524|NCT01219686|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101911525|NCT01219686|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101911526|NCT01219686|Adrenergic Agents|adrenergic agents|mesh-ancestor
101911527|NCT01219686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101911528|NCT01219686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101911529|NCT01219686|Vasodilator Agents|vasodilator agents|mesh-ancestor
101911530|NCT01219764|Amoxicillin|amoxicillin|mesh-list
101911531|NCT01219764|Metronidazole|metronidazole|mesh-list
101911532|NCT01219764|Clarithromycin|clarithromycin|mesh-list
101911533|NCT01219764|Rabeprazole|rabeprazole|mesh-list
101911534|NCT01219764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101911535|NCT01219764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101911536|NCT01219764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101911537|NCT01219764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101911538|NCT01219764|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101911539|NCT01219764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101911540|NCT01219764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616817|NCT02617654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101911541|NCT01219764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101911542|NCT01219764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101911543|NCT01219764|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101631396|NCT01064297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101911545|NCT01219764|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101911546|NCT03936426|Copper|copper|mesh-list
101911547|NCT03936426|Trace Elements|trace elements|mesh-ancestor
101911548|NCT03936426|Micronutrients|micronutrients|mesh-ancestor
101911549|NCT03936426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911550|NCT01215084|4-Aminopyridine|4-aminopyridine|mesh-list
101911551|NCT01215084|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101911552|NCT01215084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101911553|NCT01215084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911554|NCT01125696|Ritonavir|ritonavir|mesh-list
101911555|NCT01125696|Lopinavir|lopinavir|mesh-list
101911556|NCT01125696|Tenofovir|tenofovir|mesh-list
101911557|NCT01125696|Lamivudine|lamivudine|mesh-list
101911558|NCT01125696|Zidovudine|zidovudine|mesh-list
101911559|NCT01125696|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101911560|NCT01125696|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101911561|NCT01125696|Protease Inhibitors|protease inhibitors|mesh-ancestor
101911562|NCT01125696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101911563|NCT01125696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911564|NCT01125696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101911565|NCT01125696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101911566|NCT01125696|Antiviral Agents|antiviral agents|mesh-ancestor
101911567|NCT01125696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101911568|NCT01125696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101911569|NCT01125696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101911570|NCT01125696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101911571|NCT01125696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101911572|NCT01125696|Antimetabolites|antimetabolites|mesh-ancestor
101911573|NCT03932916|Donepezil|donepezil|mesh-list
101911574|NCT03932916|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101911575|NCT03932916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101911576|NCT03932916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911577|NCT03932916|Cholinergic Agents|cholinergic agents|mesh-ancestor
101911578|NCT03932916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101911579|NCT03932916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911580|NCT03932916|Nootropic Agents|nootropic agents|mesh-ancestor
101911581|NCT03116152|Paclitaxel|paclitaxel|mesh-list
101911582|NCT03116152|Irinotecan|irinotecan|mesh-list
101911583|NCT03116152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101911584|NCT03116152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101911585|NCT03116152|Tubulin Modulators|tubulin modulators|mesh-ancestor
101911586|NCT03116152|Antimitotic Agents|antimitotic agents|mesh-ancestor
101911587|NCT03116152|Mitosis Modulators|mitosis modulators|mesh-ancestor
101911588|NCT03116152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911589|NCT03116152|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101911590|NCT03116152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101911591|NCT03116152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101911592|NCT01123278|Testosterone|testosterone|mesh-list
101911593|NCT01123278|Androgens|androgens|mesh-ancestor
101911594|NCT01123278|Hormones|hormones|mesh-ancestor
101911595|NCT01123278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101911596|NCT01123278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911597|NCT01219920|Leucovorin|leucovorin|mesh-list
101911598|NCT01219920|Irinotecan|irinotecan|mesh-list
101911599|NCT01219920|Antidotes|antidotes|mesh-ancestor
101911600|NCT01219920|Protective Agents|protective agents|mesh-ancestor
101911601|NCT01219920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911602|NCT01219920|Vitamin B Complex|vitamin b complex|mesh-ancestor
101911603|NCT01219920|Vitamins|vitamins|mesh-ancestor
101911604|NCT01219920|Micronutrients|micronutrients|mesh-ancestor
101911605|NCT01219920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911606|NCT01219920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101911607|NCT01219920|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101911608|NCT01219920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101911609|NCT01219920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101911611|NCT01400776|Estrogens|estrogens|mesh-ancestor
101911612|NCT01400776|Hormones|hormones|mesh-ancestor
101911613|NCT01400776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101911614|NCT01400776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911615|NCT01220076|Tamoxifen|tamoxifen|mesh-list
101911616|NCT01220076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101911617|NCT01220076|Hormone Antagonists|hormone antagonists|mesh-ancestor
101911618|NCT01220076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101911619|NCT01220076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911620|NCT01220076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101911621|NCT01220076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101911622|NCT01220076|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101911623|NCT01220076|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101911624|NCT01220076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101911625|NCT01220154|Paclitaxel|paclitaxel|mesh-list
101911626|NCT01220154|Bevacizumab|bevacizumab|mesh-list
101911627|NCT01220154|Carboplatin|carboplatin|mesh-list
101911628|NCT01220154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101911629|NCT01220154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101911630|NCT01220154|Tubulin Modulators|tubulin modulators|mesh-ancestor
101911631|NCT01220154|Antimitotic Agents|antimitotic agents|mesh-ancestor
101911632|NCT01220154|Mitosis Modulators|mitosis modulators|mesh-ancestor
101911633|NCT01220154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911634|NCT01220154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101911635|NCT01220154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101911636|NCT01220154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101911637|NCT01220154|Growth Substances|growth substances|mesh-ancestor
101911638|NCT01220154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911639|NCT01220154|Growth Inhibitors|growth inhibitors|mesh-ancestor
101911640|NCT01182766|Topiramate|topiramate|mesh-list
101911641|NCT01182766|Anticonvulsants|anticonvulsants|mesh-ancestor
101911642|NCT01182766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101911643|NCT01182766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911644|NCT01220232|Lamivudine|lamivudine|mesh-list
101911645|NCT01220232|Abacavir|abacavir|mesh-list
101911646|NCT01220232|Dideoxynucleosides|dideoxynucleosides|mesh-list
101911647|NCT01220232|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101911648|NCT01220232|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101911649|NCT01220232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101911650|NCT01220232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911651|NCT01220232|Antiviral Agents|antiviral agents|mesh-ancestor
101911652|NCT01220232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101911653|NCT01220232|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101911654|NCT01220232|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101911655|NCT01220232|Antimetabolites|antimetabolites|mesh-ancestor
101911656|NCT01126008|Docetaxel|docetaxel|mesh-list
101911657|NCT01126008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101911658|NCT01126008|Tubulin Modulators|tubulin modulators|mesh-ancestor
101911659|NCT01126008|Antimitotic Agents|antimitotic agents|mesh-ancestor
101911660|NCT01126008|Mitosis Modulators|mitosis modulators|mesh-ancestor
101911661|NCT01126008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911662|NCT03934710|Serotonin|serotonin|mesh-list
101911663|NCT03934710|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-list
101911664|NCT03934710|Serotonin Agents|serotonin agents|mesh-ancestor
101911665|NCT03934710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101911666|NCT03934710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911667|NCT03934710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911668|NCT05169424|Fluticasone|fluticasone|mesh-list
101911669|NCT05169424|Xhance|xhance|mesh-list
101911670|NCT05169424|Tiotropium Bromide|tiotropium bromide|mesh-list
101911671|NCT05169424|Olodaterol|olodaterol|mesh-list
101911672|NCT05169424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101911673|NCT05169424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101911674|NCT05169424|Autonomic Agents|autonomic agents|mesh-ancestor
101911675|NCT05169424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101911676|NCT05169424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911677|NCT05169424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101911678|NCT05169424|Respiratory System Agents|respiratory system agents|mesh-ancestor
101911679|NCT05169424|Dermatologic Agents|dermatologic agents|mesh-ancestor
101911680|NCT05169424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101911681|NCT05169424|Parasympatholytics|parasympatholytics|mesh-ancestor
101911682|NCT05169424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101911683|NCT05169424|Cholinergic Agents|cholinergic agents|mesh-ancestor
101911684|NCT05169424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101911685|NCT05169424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911686|NCT03117010|Dexamethasone|dexamethasone|mesh-list
101911687|NCT03117010|Etoposide|etoposide|mesh-list
101911688|NCT03117010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101911689|NCT03117010|Antiemetics|antiemetics|mesh-ancestor
101911690|NCT03117010|Autonomic Agents|autonomic agents|mesh-ancestor
101911691|NCT03117010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101911692|NCT03117010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631553|NCT02705287|Vitamin D|vitamin d|mesh-list
101911693|NCT03117010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101911694|NCT03117010|Glucocorticoids|glucocorticoids|mesh-ancestor
101911695|NCT03117010|Hormones|hormones|mesh-ancestor
101911696|NCT03117010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101911697|NCT03117010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101911698|NCT03117010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101911699|NCT03117010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101911700|NCT03117010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911701|NCT03117010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101911702|NCT03117010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101911703|NCT03117010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101911704|NCT01123824|Clopidogrel|clopidogrel|mesh-list
101911705|NCT01123824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101911706|NCT01123824|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101911707|NCT01123824|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101911708|NCT01123824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101911709|NCT01123824|Purinergic Agents|purinergic agents|mesh-ancestor
101911710|NCT01123824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101911711|NCT01123824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911712|NCT01123824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911713|NCT01126086|Otamixaban|otamixaban|mesh-list
101911714|NCT01126086|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101911715|NCT01126086|Antithrombins|antithrombins|mesh-ancestor
101911716|NCT01126086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101911717|NCT01126086|Protease Inhibitors|protease inhibitors|mesh-ancestor
101911718|NCT01126086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101911719|NCT01126086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911720|NCT01126086|Anticoagulants|anticoagulants|mesh-ancestor
101911721|NCT03009838|Letrozole|letrozole|mesh-list
101911722|NCT03009838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101911723|NCT03009838|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101911724|NCT03009838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101911725|NCT03009838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101911726|NCT03009838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911727|NCT03009838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101911728|NCT03009838|Hormone Antagonists|hormone antagonists|mesh-ancestor
101911729|NCT03009838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101911730|NCT03009838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911731|NCT01124058|Heparin|heparin|mesh-list
101911732|NCT01124058|Calcium heparin|calcium heparin|mesh-list
101911733|NCT01124058|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101911734|NCT01124058|Tinzaparin|tinzaparin|mesh-list
101911735|NCT01124058|Dalteparin|dalteparin|mesh-list
101911736|NCT01124058|Warfarin|warfarin|mesh-list
101911737|NCT01124058|Anticoagulants|anticoagulants|mesh-ancestor
101911738|NCT01124058|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101911739|NCT01124058|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101911740|NCT01124058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911741|NCT01375972|Cisplatin|cisplatin|mesh-list
101911742|NCT01375972|Gemcitabine|gemcitabine|mesh-list
101911743|NCT01375972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101911744|NCT01375972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101911745|NCT01375972|Antimetabolites|antimetabolites|mesh-ancestor
101911746|NCT01375972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911747|NCT05129644|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101911748|NCT05129644|Antiviral Agents|antiviral agents|mesh-ancestor
101911749|NCT05129644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101911750|NCT01220622|Nimodipine|nimodipine|mesh-list
101911751|NCT01220622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101911752|NCT01220622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101911753|NCT01220622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101911754|NCT01220622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911755|NCT01220622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101911756|NCT01220622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911757|NCT01220622|Vasodilator Agents|vasodilator agents|mesh-ancestor
101911758|NCT05123170|Lidocaine|lidocaine|mesh-list
101911759|NCT05123170|Dexmedetomidine|dexmedetomidine|mesh-list
101911760|NCT05123170|Anesthetics, Local|anesthetics, local|mesh-ancestor
101911761|NCT05123170|Anesthetics|anesthetics|mesh-ancestor
101911762|NCT05123170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101911763|NCT05123170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911764|NCT05123170|Sensory System Agents|sensory system agents|mesh-ancestor
101911765|NCT05123170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101911766|NCT05123170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101911767|NCT05123170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101911768|NCT05123170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101911769|NCT05123170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101911770|NCT05123170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911772|NCT05123170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101911773|NCT05123170|Analgesics|analgesics|mesh-ancestor
101911774|NCT05123170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101911775|NCT05123170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101911776|NCT05123170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101911777|NCT05123170|Adrenergic Agents|adrenergic agents|mesh-ancestor
101911778|NCT05123170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101911779|NCT01215708|Tamsulosin|tamsulosin|mesh-list
101911780|NCT01215708|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101911781|NCT01215708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101911782|NCT01215708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101911783|NCT01215708|Adrenergic Agents|adrenergic agents|mesh-ancestor
101911784|NCT01215708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101911785|NCT01215708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911786|NCT01215708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911787|NCT01215708|Urological Agents|urological agents|mesh-ancestor
101911788|NCT01222026|Vitamin D|vitamin d|mesh-list
101911789|NCT01222026|Strontium ranelate|strontium ranelate|mesh-list
101911790|NCT01222026|Vitamins|vitamins|mesh-ancestor
101911791|NCT01222026|Micronutrients|micronutrients|mesh-ancestor
101911792|NCT01222026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911793|NCT01222026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101911794|NCT00225251|Bupropion|bupropion|mesh-list
101911795|NCT00225251|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101911796|NCT00225251|Antidepressive Agents|antidepressive agents|mesh-ancestor
101911797|NCT00225251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101911798|NCT00225251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101911799|NCT00225251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101911800|NCT00225251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101911801|NCT00225251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911802|NCT00225251|Dopamine Agents|dopamine agents|mesh-ancestor
101911803|NCT00225251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101911804|NCT00225251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911805|NCT00225251|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101911806|NCT00225251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101911807|NCT00225251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101911808|NCT01376128|Paroxetine|paroxetine|mesh-list
101911809|NCT01376128|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101911810|NCT01376128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101911811|NCT01376128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101911812|NCT01376128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911813|NCT01376128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101911814|NCT01376128|Serotonin Agents|serotonin agents|mesh-ancestor
101911815|NCT01376128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911816|NCT01376128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101911817|NCT01376128|Antidepressive Agents|antidepressive agents|mesh-ancestor
101911818|NCT01376128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101911819|NCT01376128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101911820|NCT01376128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101911821|NCT01376128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101911822|NCT01376206|Fluticasone|fluticasone|mesh-list
101911823|NCT01376206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101911824|NCT01376206|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101911825|NCT01376206|Autonomic Agents|autonomic agents|mesh-ancestor
101911826|NCT01376206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101911827|NCT01376206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911828|NCT01376206|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101911829|NCT01376206|Respiratory System Agents|respiratory system agents|mesh-ancestor
101911830|NCT01376206|Dermatologic Agents|dermatologic agents|mesh-ancestor
101911831|NCT01376206|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101911833|NCT01073501|Analgesics|analgesics|mesh-ancestor
101911834|NCT01073501|Sensory System Agents|sensory system agents|mesh-ancestor
101911835|NCT01073501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101911836|NCT01073501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911837|NCT01073501|Anticonvulsants|anticonvulsants|mesh-ancestor
101911838|NCT01073501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101911839|NCT01073501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101631702|NCT01000610|Antiemetics|antiemetics|mesh-ancestor
101911840|NCT01073501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911841|NCT01073501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101911842|NCT01073501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101911843|NCT01073501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101911844|NCT01073501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101911845|NCT01073501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101911846|NCT05005312|Ritonavir|ritonavir|mesh-list
101911847|NCT05005312|Nirmatrelvir|nirmatrelvir|mesh-list
101911848|NCT05005312|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101911849|NCT05005312|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101911850|NCT05005312|Protease Inhibitors|protease inhibitors|mesh-ancestor
101911851|NCT05005312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101911852|NCT05005312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911853|NCT05005312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101911854|NCT05005312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101911855|NCT05005312|Antiviral Agents|antiviral agents|mesh-ancestor
101911856|NCT05005312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101911857|NCT05005312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101911858|NCT05005312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101911859|NCT01222182|Atorvastatin|atorvastatin|mesh-list
101911860|NCT01222182|Simvastatin|simvastatin|mesh-list
101911861|NCT01222182|Pravastatin|pravastatin|mesh-list
101911862|NCT01222182|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101911863|NCT01222182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101911864|NCT01222182|Antimetabolites|antimetabolites|mesh-ancestor
101911865|NCT01222182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911866|NCT01222182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101911867|NCT01222182|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101911868|NCT01222182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101911869|NCT01218750|Bevacizumab|bevacizumab|mesh-list
101911870|NCT01218750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101911871|NCT01218750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101911872|NCT01218750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101911873|NCT01218750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101911874|NCT01218750|Growth Substances|growth substances|mesh-ancestor
101911875|NCT01218750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911876|NCT01218750|Growth Inhibitors|growth inhibitors|mesh-ancestor
101911877|NCT01376284|Dutasteride|dutasteride|mesh-list
101911878|NCT01376284|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101911879|NCT01376284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101911880|NCT01376284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101911881|NCT01376284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911882|NCT01376284|Hormone Antagonists|hormone antagonists|mesh-ancestor
101911883|NCT01376284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101911884|NCT01376284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911885|NCT01376440|Sodium Hypochlorite|sodium hypochlorite|mesh-list
101911886|NCT01376440|Eusol|eusol|mesh-list
101911887|NCT01376440|Disinfectants|disinfectants|mesh-ancestor
101911888|NCT01376440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101911889|NCT01329042|Citric Acid|citric acid|mesh-list
101911890|NCT01329042|Sodium Citrate|sodium citrate|mesh-list
101911891|NCT01329042|Anticoagulants|anticoagulants|mesh-ancestor
101911892|NCT01329042|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101911893|NCT01329042|Chelating Agents|chelating agents|mesh-ancestor
101911894|NCT01329042|Sequestering Agents|sequestering agents|mesh-ancestor
101911895|NCT01329042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911896|NCT00253643|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
101911897|NCT00253643|Antioxidants|antioxidants|mesh-ancestor
101911898|NCT00253643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911899|NCT00253643|Protective Agents|protective agents|mesh-ancestor
101911900|NCT00253643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911901|NCT00253643|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101911902|NCT00253643|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101911903|NCT00253643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101911904|NCT00253643|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101911905|NCT01222650|Silodosin|silodosin|mesh-list
101911906|NCT01222650|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101911907|NCT01222650|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101911908|NCT01222650|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101911909|NCT01222650|Adrenergic Agents|adrenergic agents|mesh-ancestor
101911910|NCT01222650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101911911|NCT01222650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911912|NCT01222650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631773|NCT04072471|Lesinurad|lesinurad|mesh-list
101911914|NCT04856488|Lugol's solution|lugol's solution|mesh-list
101911915|NCT04856488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101911916|NCT04856488|Hemostatics|hemostatics|mesh-ancestor
101911917|NCT04856488|Coagulants|coagulants|mesh-ancestor
101911918|NCT01073579|Vigabatrin|vigabatrin|mesh-list
101911919|NCT01073579|Anticonvulsants|anticonvulsants|mesh-ancestor
101911920|NCT01073579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101911921|NCT01073579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911922|NCT01073579|GABA Agents|gaba agents|mesh-ancestor
101911923|NCT01073579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101911924|NCT01073579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911925|NCT00221195|Thrombin|thrombin|mesh-list
101911926|NCT00221195|Hemostatics|hemostatics|mesh-ancestor
101911927|NCT00221195|Coagulants|coagulants|mesh-ancestor
101911928|NCT04646590|Vaccines|vaccines|mesh-list
101911929|NCT04646590|Immunologic Factors|immunologic factors|mesh-ancestor
101911930|NCT04646590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911931|NCT03931668|Maleic acid|maleic acid|mesh-list
101911932|NCT03931668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101911933|NCT03931668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911934|NCT00220805|Immunoglobulins|immunoglobulins|mesh-list
101911935|NCT00220805|Antibodies|antibodies|mesh-list
101911936|NCT00220805|gamma-Globulins|gamma-globulins|mesh-list
101911937|NCT00220805|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101911938|NCT00220805|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101911939|NCT00220805|Immunoglobulin G|immunoglobulin g|mesh-list
101911940|NCT00220805|Immunologic Factors|immunologic factors|mesh-ancestor
101911941|NCT00220805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911942|NCT00220727|Immunoglobulins|immunoglobulins|mesh-list
101911943|NCT00220727|Antibodies|antibodies|mesh-list
101911944|NCT00220727|gamma-Globulins|gamma-globulins|mesh-list
101911945|NCT00220727|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101911946|NCT00220727|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101911947|NCT00220727|Immunoglobulin G|immunoglobulin g|mesh-list
101911948|NCT00220727|Immunologic Factors|immunologic factors|mesh-ancestor
101911949|NCT00220727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911950|NCT01072097|Atorvastatin|atorvastatin|mesh-list
101911952|NCT01072097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101911953|NCT01072097|Antimetabolites|antimetabolites|mesh-ancestor
101911954|NCT01072097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911955|NCT01072097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101911956|NCT01072097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101911957|NCT01072097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101911958|NCT05760430|Bevacizumab|bevacizumab|mesh-list
101911959|NCT05760430|Apatinib|apatinib|mesh-list
101911960|NCT05760430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101911961|NCT05760430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101911962|NCT05760430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101911963|NCT05760430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101911964|NCT05760430|Growth Substances|growth substances|mesh-ancestor
101911965|NCT05760430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911966|NCT05760430|Growth Inhibitors|growth inhibitors|mesh-ancestor
101911967|NCT05760430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101911968|NCT05760430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101911969|NCT05760430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911970|NCT01221402|Niacin|niacin|mesh-list
101911971|NCT01221402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101911972|NCT01221402|Antimetabolites|antimetabolites|mesh-ancestor
101911973|NCT01221402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911974|NCT01221402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101911976|NCT01221402|Vitamin B Complex|vitamin b complex|mesh-ancestor
101911977|NCT01221402|Vitamins|vitamins|mesh-ancestor
101911978|NCT01221402|Micronutrients|micronutrients|mesh-ancestor
101911979|NCT01221402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911980|NCT04214860|Azacitidine|azacitidine|mesh-list
101911981|NCT04214860|Venetoclax|venetoclax|mesh-list
101911982|NCT04214860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101911983|NCT04214860|Antimetabolites|antimetabolites|mesh-ancestor
101228637|NCT01547546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101911984|NCT04214860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911985|NCT04214860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101911986|NCT04214860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101911987|NCT01127490|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101911988|NCT01127490|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101911989|NCT01127490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101911990|NCT01127490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101911991|NCT01127490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101911992|NCT01127490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101911993|NCT01127490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101911995|NCT01127490|Sensory System Agents|sensory system agents|mesh-ancestor
101911996|NCT01127490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101911997|NCT01127490|Antidepressive Agents|antidepressive agents|mesh-ancestor
101911998|NCT01127490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101911999|NCT01127490|Dopamine Agents|dopamine agents|mesh-ancestor
101912000|NCT01223040|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101912001|NCT01223040|Lubricant Eye Drops|lubricant eye drops|mesh-list
101912002|NCT01223040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101912003|NCT01126866|Bevacizumab|bevacizumab|mesh-list
101912004|NCT01126866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101912005|NCT01126866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101912006|NCT01126866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101912007|NCT01126866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101912008|NCT01126866|Growth Substances|growth substances|mesh-ancestor
101912009|NCT01126866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912010|NCT01126866|Growth Inhibitors|growth inhibitors|mesh-ancestor
101912011|NCT04103554|Valsartan|valsartan|mesh-list
101912012|NCT04103554|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101912013|NCT04103554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101912014|NCT04103554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101912015|NCT04103554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101912016|NCT04103554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912017|NCT03740568|Progesterone|progesterone|mesh-list
101912018|NCT03740568|Progestins|progestins|mesh-ancestor
101912019|NCT03740568|Hormones|hormones|mesh-ancestor
101912020|NCT03740568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101912021|NCT03740568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912022|NCT00252239|Plasminogen|plasminogen|mesh-list
101912023|NCT00252239|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101912024|NCT00252239|Tenecteplase|tenecteplase|mesh-list
101912025|NCT00252239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101912026|NCT00252239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101912027|NCT00252239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912028|NCT01127022|Choline|choline|mesh-list
101912029|NCT01127022|Lipotropic Agents|lipotropic agents|mesh-ancestor
101912030|NCT01127022|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101912031|NCT01127022|Antimetabolites|antimetabolites|mesh-ancestor
101912032|NCT01127022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912033|NCT01127022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101912034|NCT01127022|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101912035|NCT01127022|Nootropic Agents|nootropic agents|mesh-ancestor
101912036|NCT01221558|Lycopene|lycopene|mesh-list
101912037|NCT01221558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101912038|NCT01221558|Antioxidants|antioxidants|mesh-ancestor
101912039|NCT01221558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912040|NCT01221558|Protective Agents|protective agents|mesh-ancestor
101912041|NCT01221558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912042|NCT01221558|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101228666|NCT01548066|Anticonvulsants|anticonvulsants|mesh-ancestor
101912043|NCT01221558|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101912044|NCT01221558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101912045|NCT01221636|Abatacept|abatacept|mesh-list
101912046|NCT01221636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101912047|NCT01221636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912048|NCT01221636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101912049|NCT01221636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101912050|NCT01221636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101912051|NCT01221636|Immunologic Factors|immunologic factors|mesh-ancestor
101912052|NCT01221636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912053|NCT01221636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101912054|NCT05731804|Ritonavir|ritonavir|mesh-list
101912055|NCT05731804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101912056|NCT05731804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101912057|NCT05731804|Protease Inhibitors|protease inhibitors|mesh-ancestor
101912058|NCT05731804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101912059|NCT05731804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912060|NCT05731804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101912061|NCT05731804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101631930|NCT00770224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101912062|NCT05731804|Antiviral Agents|antiviral agents|mesh-ancestor
101912063|NCT05731804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101912064|NCT05731804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101912065|NCT05731804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101912066|NCT01127568|Propranolol|propranolol|mesh-list
101912067|NCT01127568|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101912068|NCT01127568|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101912069|NCT01127568|Adrenergic Agents|adrenergic agents|mesh-ancestor
101912070|NCT01127568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101912071|NCT01127568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912072|NCT01127568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912073|NCT01127568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101912074|NCT01127568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101912075|NCT01127568|Vasodilator Agents|vasodilator agents|mesh-ancestor
101912076|NCT03932292|Calcium|calcium|mesh-list
101912077|NCT03932292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101912078|NCT03932292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912079|NCT01127100|Fentanyl|fentanyl|mesh-list
101912080|NCT01127100|Gabapentin|gabapentin|mesh-list
101912081|NCT01127100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101912082|NCT01127100|Narcotics|narcotics|mesh-ancestor
101912083|NCT01127100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101912084|NCT01127100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912085|NCT01127100|Analgesics|analgesics|mesh-ancestor
101912086|NCT01127100|Sensory System Agents|sensory system agents|mesh-ancestor
101912087|NCT01127100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101912088|NCT01127100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101912089|NCT01127100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101912090|NCT01127100|Anesthetics, General|anesthetics, general|mesh-ancestor
101912092|NCT01127100|Anticonvulsants|anticonvulsants|mesh-ancestor
101912093|NCT01127100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101912094|NCT01127100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101228679|NCT01548118|Vaccines|vaccines|mesh-list
101912095|NCT01127100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101912096|NCT01127100|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101912097|NCT01127100|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101912098|NCT01127100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101912099|NCT01127100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912100|NCT01127100|Antimanic Agents|antimanic agents|mesh-ancestor
101912101|NCT01127178|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2H)-one|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2h)-one|mesh-list
101912102|NCT01127178|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101912103|NCT01127178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101912104|NCT01127178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912105|NCT01127178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101912106|NCT01221792|Carvedilol|carvedilol|mesh-list
101912107|NCT01221792|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101912108|NCT01221792|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101912109|NCT01221792|Adrenergic Agents|adrenergic agents|mesh-ancestor
101912110|NCT01221792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101912111|NCT01221792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912112|NCT01221792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912113|NCT01221792|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101912114|NCT01221792|Antioxidants|antioxidants|mesh-ancestor
101912115|NCT01221792|Protective Agents|protective agents|mesh-ancestor
101616833|NCT00700024|Anabolic Agents|anabolic agents|mesh-ancestor
101912116|NCT01221792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101912117|NCT01221792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101912118|NCT01221792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101912119|NCT01221792|Vasodilator Agents|vasodilator agents|mesh-ancestor
101912120|NCT01221792|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101912121|NCT01221792|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101912122|NCT03932526|Apatinib|apatinib|mesh-list
101912123|NCT03932526|Vinorelbine|vinorelbine|mesh-list
101912124|NCT03932526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101912125|NCT03932526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101912126|NCT03932526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101912127|NCT03932526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912128|NCT03932526|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101912129|NCT03932526|Tubulin Modulators|tubulin modulators|mesh-ancestor
101912130|NCT03932526|Antimitotic Agents|antimitotic agents|mesh-ancestor
101912131|NCT03932526|Mitosis Modulators|mitosis modulators|mesh-ancestor
101912132|NCT01127724|Vitamins|vitamins|mesh-list
101912133|NCT01127724|Vitamin B 12|vitamin b 12|mesh-list
101912134|NCT01127724|Hydroxocobalamin|hydroxocobalamin|mesh-list
101912135|NCT01127724|Vitamin B Complex|vitamin b complex|mesh-list
101912137|NCT01127724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912138|NCT01127724|Hematinics|hematinics|mesh-ancestor
101912139|NCT03103906|Sunscreening Agents|sunscreening agents|mesh-list
101912140|NCT03103906|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101912141|NCT03103906|Protective Agents|protective agents|mesh-ancestor
101912142|NCT03103906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912143|NCT03103906|Dermatologic Agents|dermatologic agents|mesh-ancestor
101912144|NCT05675098|Methylphenidate|methylphenidate|mesh-list
101912145|NCT05675098|Modafinil|modafinil|mesh-list
101912146|NCT05675098|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101912147|NCT05675098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912148|NCT05675098|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101912149|NCT05675098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101912150|NCT05675098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101912151|NCT05675098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912152|NCT05675098|Dopamine Agents|dopamine agents|mesh-ancestor
101912153|NCT05675098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101912154|NCT05675098|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101912155|NCT05675098|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101912156|NCT05675098|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101912157|NCT01223742|Acetylcarnitine|acetylcarnitine|mesh-list
101912158|NCT01223742|Vitamin B Complex|vitamin b complex|mesh-ancestor
101912159|NCT01223742|Vitamins|vitamins|mesh-ancestor
101912160|NCT01223742|Micronutrients|micronutrients|mesh-ancestor
101912161|NCT01223742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912162|NCT01223742|Nootropic Agents|nootropic agents|mesh-ancestor
101912163|NCT01129518|Vaccines|vaccines|mesh-list
101912164|NCT01129518|Immunologic Factors|immunologic factors|mesh-ancestor
101912165|NCT01129518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912166|NCT01223820|Capsaicin|capsaicin|mesh-list
101912167|NCT01223820|Antipruritics|antipruritics|mesh-ancestor
101912168|NCT01223820|Dermatologic Agents|dermatologic agents|mesh-ancestor
101912169|NCT01223820|Sensory System Agents|sensory system agents|mesh-ancestor
101912170|NCT01223820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101912171|NCT01223820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912172|NCT01131234|Cediranib|cediranib|mesh-list
101912173|NCT01131234|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
101912174|NCT01131234|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
101912175|NCT01131234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101912176|NCT01131234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912177|NCT01131234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101912178|NCT01131234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101912179|NCT01129596|Donepezil|donepezil|mesh-list
101912180|NCT01129596|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101912181|NCT01129596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101912182|NCT01129596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912183|NCT01129596|Cholinergic Agents|cholinergic agents|mesh-ancestor
101912184|NCT01129596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101912185|NCT01129596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912186|NCT01129596|Nootropic Agents|nootropic agents|mesh-ancestor
101912187|NCT01127880|Clindamycin|clindamycin|mesh-list
101912188|NCT01127880|Clindamycin palmitate|clindamycin palmitate|mesh-list
101912189|NCT01127880|Clindamycin phosphate|clindamycin phosphate|mesh-list
101912190|NCT01127880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101912191|NCT01127880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101912192|NCT01127880|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101912193|NCT01127880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101912194|NCT01127880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912195|NCT01228344|Lumefantrine|lumefantrine|mesh-list
101912196|NCT01228344|Artemether|artemether|mesh-list
101912197|NCT01228344|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101912198|NCT01228344|Antimalarials|antimalarials|mesh-ancestor
101912199|NCT01228344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101912200|NCT01228344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101912201|NCT01228344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101912202|NCT03927456|Fulvestrant|fulvestrant|mesh-list
101912203|NCT03927456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101912204|NCT03927456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101912205|NCT03927456|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101912206|NCT03927456|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101912207|NCT03927456|Hormone Antagonists|hormone antagonists|mesh-ancestor
101912208|NCT03927456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101912209|NCT03927456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912210|NCT01129830|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101912211|NCT01129830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101912212|NCT01129830|Immunologic Factors|immunologic factors|mesh-ancestor
101912213|NCT01129830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912214|NCT01228422|Interferons|interferons|mesh-list
101912215|NCT01228422|Interferon-alpha|interferon-alpha|mesh-list
101912216|NCT01228422|Interferon alpha-2|interferon alpha-2|mesh-list
101912217|NCT01228422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101912218|NCT01228422|Antiviral Agents|antiviral agents|mesh-ancestor
101912219|NCT01228422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101912220|NCT01228422|Immunologic Factors|immunologic factors|mesh-ancestor
101912221|NCT01228422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912222|NCT01319422|Pomalidomide|pomalidomide|mesh-list
101912223|NCT01319422|Immunologic Factors|immunologic factors|mesh-ancestor
101912224|NCT01319422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912225|NCT01319422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101912226|NCT01319422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101912227|NCT01319422|Growth Substances|growth substances|mesh-ancestor
101912228|NCT01319422|Growth Inhibitors|growth inhibitors|mesh-ancestor
101912229|NCT01319422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101912230|NCT01227174|Propofol|propofol|mesh-list
101912231|NCT01227174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101912232|NCT01227174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101912233|NCT01227174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912234|NCT01227174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101912235|NCT01227174|Anesthetics, General|anesthetics, general|mesh-ancestor
101912236|NCT01227174|Anesthetics|anesthetics|mesh-ancestor
101912237|NCT05615974|Rituximab|rituximab|mesh-list
101912238|NCT05615974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101912239|NCT05615974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101912240|NCT05615974|Immunologic Factors|immunologic factors|mesh-ancestor
101912241|NCT05615974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912242|NCT05615974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101912243|NCT03924492|Pregnanolone|pregnanolone|mesh-list
101912244|NCT03924492|Brexanolone|brexanolone|mesh-list
101912245|NCT03924492|Neurosteroids|neurosteroids|mesh-ancestor
101912246|NCT03924492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101912247|NCT03924492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912248|NCT03924492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912249|NCT03924492|GABA Modulators|gaba modulators|mesh-ancestor
101912250|NCT03924492|GABA Agents|gaba agents|mesh-ancestor
101912251|NCT03924492|Anesthetics|anesthetics|mesh-ancestor
101912252|NCT03924492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101912253|NCT01329276|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101912254|NCT01329276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101912255|NCT01329276|Respiratory System Agents|respiratory system agents|mesh-ancestor
101912256|NCT01224366|Vildagliptin|vildagliptin|mesh-list
101912257|NCT01224366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101912258|NCT01224366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912259|NCT01224366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101912260|NCT01224366|Protease Inhibitors|protease inhibitors|mesh-ancestor
101912261|NCT01224366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101912262|NCT01224366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912263|NCT05415826|Dexamethasone|dexamethasone|mesh-list
101912264|NCT05415826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101912265|NCT05415826|Antiemetics|antiemetics|mesh-ancestor
101912266|NCT05415826|Autonomic Agents|autonomic agents|mesh-ancestor
101912267|NCT05415826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101912268|NCT05415826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912269|NCT05415826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101912270|NCT05415826|Glucocorticoids|glucocorticoids|mesh-ancestor
101912272|NCT05415826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101912273|NCT05415826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101912274|NCT05415826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101912275|NCT05415748|Tamsulosin|tamsulosin|mesh-list
101912276|NCT05415748|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101912277|NCT05415748|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101912278|NCT05415748|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101912279|NCT05415748|Adrenergic Agents|adrenergic agents|mesh-ancestor
101912280|NCT05415748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101912281|NCT05415748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912282|NCT05415748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912283|NCT05415748|Urological Agents|urological agents|mesh-ancestor
101912284|NCT03774576|Itraconazole|itraconazole|mesh-list
101912285|NCT03774576|Antifungal Agents|antifungal agents|mesh-ancestor
101912286|NCT03774576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101912287|NCT03774576|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101912288|NCT03774576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101912289|NCT03774576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101912290|NCT03774576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912291|NCT03774576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101912292|NCT03774576|Hormone Antagonists|hormone antagonists|mesh-ancestor
101228714|NCT01548170|Hormone Antagonists|hormone antagonists|mesh-ancestor
101912293|NCT03774576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101912294|NCT03774576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912295|NCT03774576|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101912296|NCT05415436|Propofol|propofol|mesh-list
101912297|NCT05415436|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101912298|NCT05415436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101912299|NCT05415436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912300|NCT05415436|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101912301|NCT05415436|Anesthetics, General|anesthetics, general|mesh-ancestor
101912302|NCT05415436|Anesthetics|anesthetics|mesh-ancestor
101912304|NCT01227408|Cyclophosphamide|cyclophosphamide|mesh-list
101912305|NCT01227408|Doxorubicin|doxorubicin|mesh-list
101912306|NCT01227408|Capecitabine|capecitabine|mesh-list
101912307|NCT01227408|Methotrexate|methotrexate|mesh-list
101912308|NCT01227408|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
101912309|NCT01227408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101912310|NCT01227408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101912311|NCT01227408|Tubulin Modulators|tubulin modulators|mesh-ancestor
101912312|NCT01227408|Antimitotic Agents|antimitotic agents|mesh-ancestor
101912313|NCT01227408|Mitosis Modulators|mitosis modulators|mesh-ancestor
101912314|NCT01227408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912315|NCT01227408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101912316|NCT01227408|Immunologic Factors|immunologic factors|mesh-ancestor
101912317|NCT01227408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912318|NCT01227408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101912319|NCT01227408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101912320|NCT01227408|Alkylating Agents|alkylating agents|mesh-ancestor
101912321|NCT01227408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101912322|NCT01227408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101912323|NCT01227408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101912324|NCT01227408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101912325|NCT01227408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101912326|NCT01227408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101912327|NCT01227408|Antimetabolites|antimetabolites|mesh-ancestor
101912328|NCT01227408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101912329|NCT01227408|Abortifacient Agents|abortifacient agents|mesh-ancestor
101912330|NCT01227408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101912331|NCT01227408|Dermatologic Agents|dermatologic agents|mesh-ancestor
101912332|NCT01227408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101912333|NCT01227408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101912334|NCT03773796|Nabilone|nabilone|mesh-list
101912335|NCT03773796|Antiemetics|antiemetics|mesh-ancestor
101912336|NCT03773796|Autonomic Agents|autonomic agents|mesh-ancestor
101912338|NCT03773796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912339|NCT03773796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101912340|NCT03773796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101912341|NCT03773796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101912342|NCT03773796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101912343|NCT03773796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101912344|NCT02927938|Cytarabine|cytarabine|mesh-list
101912345|NCT02927938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101912346|NCT02927938|Antimetabolites|antimetabolites|mesh-ancestor
101912347|NCT02927938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912348|NCT02927938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101912349|NCT02927938|Antiviral Agents|antiviral agents|mesh-ancestor
101912350|NCT02927938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101912351|NCT02927938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101912352|NCT02927938|Immunologic Factors|immunologic factors|mesh-ancestor
101912353|NCT02927938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912354|NCT05370820|Tranexamic Acid|tranexamic acid|mesh-list
101912355|NCT05370820|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101912356|NCT05370820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101912357|NCT05370820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912358|NCT05370820|Hemostatics|hemostatics|mesh-ancestor
101912359|NCT05370820|Coagulants|coagulants|mesh-ancestor
101912360|NCT03863860|Fluzoparib|fluzoparib|mesh-list
101912361|NCT03863860|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101912362|NCT03863860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101228724|NCT01548209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101912363|NCT03863860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912364|NCT03863860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101912365|NCT03923166|Capecitabine|capecitabine|mesh-list
101912366|NCT03923166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101912367|NCT03923166|Antimetabolites|antimetabolites|mesh-ancestor
101912368|NCT03923166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912369|NCT03923166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101912370|NCT01224756|Tinoridine|tinoridine|mesh-list
101956947|NCT02095834|Glucocorticoids|glucocorticoids|mesh-ancestor
101912371|NCT01224756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101912372|NCT01224756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101912373|NCT01224756|Analgesics|analgesics|mesh-ancestor
101912374|NCT01224756|Sensory System Agents|sensory system agents|mesh-ancestor
101912375|NCT01224756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101912376|NCT01224756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912377|NCT01224756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101912378|NCT01224756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101912379|NCT03392428|177Lu-PSMA-617|177lu-psma-617|mesh-list
101912380|NCT03392428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101912381|NCT03392428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912382|NCT03222856|Pembrolizumab|pembrolizumab|mesh-list
101912383|NCT03222856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101912384|NCT03222856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101912385|NCT03222856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101912386|NCT03222856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912387|NCT01130298|Testosterone|testosterone|mesh-list
101912388|NCT01130298|Androgens|androgens|mesh-ancestor
101912390|NCT01130298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101912391|NCT01130298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912392|NCT01227720|Nicotine|nicotine|mesh-list
101912393|NCT01227720|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101912394|NCT01227720|Autonomic Agents|autonomic agents|mesh-ancestor
101912395|NCT01227720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101912396|NCT01227720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912397|NCT01227720|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101912398|NCT01227720|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101912399|NCT01227720|Cholinergic Agents|cholinergic agents|mesh-ancestor
101912400|NCT01227720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101912401|NCT01227720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912402|NCT03175978|Methotrexate|methotrexate|mesh-list
101912403|NCT03175978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912404|NCT03175978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101912405|NCT03175978|Abortifacient Agents|abortifacient agents|mesh-ancestor
101912406|NCT03175978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101912407|NCT03175978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101912408|NCT03175978|Antimetabolites|antimetabolites|mesh-ancestor
101616837|NCT00796003|Decitabine|decitabine|mesh-list
101912409|NCT03175978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912410|NCT03175978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101912411|NCT03175978|Dermatologic Agents|dermatologic agents|mesh-ancestor
101912412|NCT03175978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101912413|NCT03175978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101912414|NCT03175978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101912415|NCT03175978|Immunologic Factors|immunologic factors|mesh-ancestor
101912416|NCT03175978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101912417|NCT03175978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101912418|NCT03923010|Itraconazole|itraconazole|mesh-list
101912419|NCT03923010|Antifungal Agents|antifungal agents|mesh-ancestor
101912420|NCT03923010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101912421|NCT03923010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101228729|NCT01548209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101912422|NCT03923010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101912423|NCT03923010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101912424|NCT03923010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912425|NCT03923010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101912426|NCT03923010|Hormone Antagonists|hormone antagonists|mesh-ancestor
101912427|NCT03923010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101912428|NCT03923010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912429|NCT03923010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101912430|NCT01227798|Interferons|interferons|mesh-list
101912431|NCT01227798|Interferon alfacon-1|interferon alfacon-1|mesh-list
101912432|NCT01227798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101912433|NCT01227798|Antiviral Agents|antiviral agents|mesh-ancestor
101912434|NCT01227798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101912435|NCT01130376|Aldesleukin|aldesleukin|mesh-list
101912436|NCT01130376|Interleukin-2|interleukin-2|mesh-list
101912437|NCT01130376|Hormones|hormones|mesh-list
101912438|NCT01130376|Sargramostim|sargramostim|mesh-list
101956951|NCT02095834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101912439|NCT01130376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101912440|NCT01130376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912441|NCT01130376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101912442|NCT01130376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101912443|NCT01130376|Analgesics|analgesics|mesh-ancestor
101912444|NCT01130376|Sensory System Agents|sensory system agents|mesh-ancestor
101912445|NCT01130376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101912446|NCT01130376|Immunologic Factors|immunologic factors|mesh-ancestor
101912447|NCT01130376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101912448|NCT01130376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101912449|NCT01130376|Antiviral Agents|antiviral agents|mesh-ancestor
101912450|NCT01130376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101912451|NCT03740178|Donepezil|donepezil|mesh-list
101912452|NCT03740178|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101912453|NCT03740178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101912454|NCT03740178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912455|NCT03740178|Cholinergic Agents|cholinergic agents|mesh-ancestor
101912456|NCT03740178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101912457|NCT03740178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912458|NCT03740178|Nootropic Agents|nootropic agents|mesh-ancestor
101912459|NCT01131468|Acetylcysteine|acetylcysteine|mesh-list
101912460|NCT01131468|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101912461|NCT01131468|Antiviral Agents|antiviral agents|mesh-ancestor
101912462|NCT01131468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101912463|NCT01131468|Expectorants|expectorants|mesh-ancestor
101912464|NCT01131468|Respiratory System Agents|respiratory system agents|mesh-ancestor
101912465|NCT01131468|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101912466|NCT01131468|Antioxidants|antioxidants|mesh-ancestor
101912467|NCT01131468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912468|NCT01131468|Protective Agents|protective agents|mesh-ancestor
101912469|NCT01131468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912470|NCT01131468|Antidotes|antidotes|mesh-ancestor
101912471|NCT01225224|Peficitinib|peficitinib|mesh-list
101912472|NCT01225224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101912473|NCT01225224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912474|NCT01225224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101912475|NCT01225224|Immunologic Factors|immunologic factors|mesh-ancestor
101912476|NCT01225224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912477|NCT01131546|Amlodipine|amlodipine|mesh-list
101912478|NCT01131546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101912479|NCT01131546|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101912480|NCT01131546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101616838|NCT00796003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101912482|NCT01131546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101912483|NCT01131546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912484|NCT01131546|Vasodilator Agents|vasodilator agents|mesh-ancestor
101912485|NCT01225302|Paclitaxel|paclitaxel|mesh-list
101912486|NCT01225302|Carboplatin|carboplatin|mesh-list
101912487|NCT01225302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101912488|NCT01225302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101912489|NCT01225302|Tubulin Modulators|tubulin modulators|mesh-ancestor
101912490|NCT01225302|Antimitotic Agents|antimitotic agents|mesh-ancestor
101912491|NCT01225302|Mitosis Modulators|mitosis modulators|mesh-ancestor
101912492|NCT01225302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912493|NCT01229046|Clavulanic Acids|clavulanic acids|mesh-list
101912494|NCT01229046|Clavulanic Acid|clavulanic acid|mesh-list
101912495|NCT01229046|Ticarcillin|ticarcillin|mesh-list
101912496|NCT01229046|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
101912497|NCT01229046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101912498|NCT01229046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101912499|NCT01229046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101912500|NCT01229046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912501|NCT01229046|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101912502|NCT03921684|Capecitabine|capecitabine|mesh-list
101912503|NCT03921684|Nivolumab|nivolumab|mesh-list
101912504|NCT03921684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101912505|NCT03921684|Antimetabolites|antimetabolites|mesh-ancestor
101912506|NCT03921684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912507|NCT03921684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101912508|NCT03921684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101912509|NCT03921684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101912510|NCT03929094|Paclitaxel|paclitaxel|mesh-list
101912511|NCT03929094|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101912512|NCT03929094|Gemcitabine|gemcitabine|mesh-list
101912513|NCT03929094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101912514|NCT03929094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101912515|NCT03929094|Tubulin Modulators|tubulin modulators|mesh-ancestor
101912516|NCT03929094|Antimitotic Agents|antimitotic agents|mesh-ancestor
101912517|NCT03929094|Mitosis Modulators|mitosis modulators|mesh-ancestor
101912518|NCT03929094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912519|NCT03929094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101912520|NCT03929094|Antimetabolites|antimetabolites|mesh-ancestor
101912521|NCT01131702|Ranitidine|ranitidine|mesh-list
101912522|NCT01131702|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
101912523|NCT01131702|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101912524|NCT01131702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101912525|NCT01131702|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101912526|NCT01131702|Histamine Antagonists|histamine antagonists|mesh-ancestor
101912527|NCT01131702|Histamine Agents|histamine agents|mesh-ancestor
101912528|NCT01131702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101912529|NCT01131702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912530|NCT01131702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912531|NCT01228110|Hydrocortisone|hydrocortisone|mesh-list
101912532|NCT01228110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101912533|NCT03925818|Metronidazole|metronidazole|mesh-list
101912534|NCT03925818|Tetracycline|tetracycline|mesh-list
101912535|NCT03925818|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
101912536|NCT03925818|Pantoprazole|pantoprazole|mesh-list
101912537|NCT03925818|Bismuth|bismuth|mesh-list
101912538|NCT03925818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101912539|NCT03925818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101912540|NCT03925818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101912541|NCT03925818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101912542|NCT03925818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101912543|NCT03925818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101912544|NCT03925818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101912545|NCT03925818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101912546|NCT03925818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912547|NCT03925818|Antacids|antacids|mesh-ancestor
101912548|NCT03925818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101912549|NCT03925740|Listerine|listerine|mesh-list
101912550|NCT03925740|Fluorides|fluorides|mesh-list
101912551|NCT03925740|Sodium Fluoride|sodium fluoride|mesh-list
101912552|NCT03925740|Cariostatic Agents|cariostatic agents|mesh-ancestor
101912553|NCT03925740|Protective Agents|protective agents|mesh-ancestor
101912554|NCT03925740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912555|NCT03925740|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101912557|NCT01130688|Zileuton|zileuton|mesh-list
101912558|NCT01130688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101912559|NCT01130688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101912560|NCT01130688|Analgesics|analgesics|mesh-ancestor
101912561|NCT01130688|Sensory System Agents|sensory system agents|mesh-ancestor
101912562|NCT01130688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101912563|NCT01130688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912564|NCT01130688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101912565|NCT01130688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101912566|NCT01130688|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101912567|NCT01130688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101912568|NCT01130688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912569|NCT01130688|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101912570|NCT01130688|Hormone Antagonists|hormone antagonists|mesh-ancestor
101912571|NCT01130688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101912572|NCT03925662|Mebendazole|mebendazole|mesh-list
101912573|NCT03925662|Piperazine|piperazine|mesh-list
101912574|NCT03925662|Piperazine citrate|piperazine citrate|mesh-list
101912575|NCT03925662|Bevacizumab|bevacizumab|mesh-list
101912576|NCT03925662|DMP 777|dmp 777|mesh-list
101912577|NCT03925662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101912578|NCT03925662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101912579|NCT03925662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101956959|NCT03556852|Carbetocin|carbetocin|mesh-list
101912580|NCT03925662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101632461|NCT02697045|Aripiprazole|aripiprazole|mesh-list
101912582|NCT03925662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912583|NCT03925662|Growth Inhibitors|growth inhibitors|mesh-ancestor
101912584|NCT03925662|Antinematodal Agents|antinematodal agents|mesh-ancestor
101912585|NCT03925662|Anthelmintics|anthelmintics|mesh-ancestor
101912586|NCT03925662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101912587|NCT03925662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101912588|NCT03925662|Tubulin Modulators|tubulin modulators|mesh-ancestor
101912589|NCT03925662|Antimitotic Agents|antimitotic agents|mesh-ancestor
101912590|NCT03925662|Mitosis Modulators|mitosis modulators|mesh-ancestor
101912591|NCT03925662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912592|NCT03925662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101912593|NCT01229202|Bevacizumab|bevacizumab|mesh-list
101912594|NCT01229202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101912595|NCT01229202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101912596|NCT01229202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101912597|NCT01229202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101912598|NCT01229202|Growth Substances|growth substances|mesh-ancestor
101912599|NCT01229202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912600|NCT01229202|Growth Inhibitors|growth inhibitors|mesh-ancestor
101912601|NCT01229280|Darifenacin|darifenacin|mesh-list
101912602|NCT01229280|Muscarinic Antagonists|muscarinic antagonists|mesh-list
101912603|NCT01229280|Cholinergic Agents|cholinergic agents|mesh-list
101912604|NCT01229280|Cholinergic Antagonists|cholinergic antagonists|mesh-list
101912605|NCT01229280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101912606|NCT01229280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912607|NCT01229280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912608|NCT01229280|Urological Agents|urological agents|mesh-ancestor
101912609|NCT01131780|Ibuprofen|ibuprofen|mesh-list
101912610|NCT01131780|Pseudoephedrine|pseudoephedrine|mesh-list
101912611|NCT01131780|Ephedrine|ephedrine|mesh-list
101912612|NCT01131780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101912613|NCT01131780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101912614|NCT01131780|Analgesics|analgesics|mesh-ancestor
101912615|NCT01131780|Sensory System Agents|sensory system agents|mesh-ancestor
101912616|NCT01131780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101912617|NCT01131780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912618|NCT01131780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101912619|NCT01131780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101912620|NCT01131780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101912621|NCT01131780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101912622|NCT01131780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912623|NCT01131780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101912624|NCT01131780|Autonomic Agents|autonomic agents|mesh-ancestor
101912625|NCT01131780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101912626|NCT01131780|Respiratory System Agents|respiratory system agents|mesh-ancestor
101912627|NCT01131780|Nasal Decongestants|nasal decongestants|mesh-ancestor
101912628|NCT01131780|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101275299|NCT01861535|Imiquimod|imiquimod|mesh-list
101912629|NCT01131780|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101912630|NCT01131780|Sympathomimetics|sympathomimetics|mesh-ancestor
101912631|NCT01131780|Adrenergic Agents|adrenergic agents|mesh-ancestor
101912632|NCT01131780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101912633|NCT01130922|Moxifloxacin|moxifloxacin|mesh-list
101912634|NCT01130922|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101912635|NCT01130922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101912636|NCT01130922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101912637|NCT01130922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101912638|NCT01130922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101912639|NCT01130922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101912640|NCT01130922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912641|NCT01130922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101912642|NCT01130922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101912643|NCT01130922|Contraceptive Agents|contraceptive agents|mesh-ancestor
101912644|NCT01130922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101912645|NCT01130922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912646|NCT01130922|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101912647|NCT01130922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101912648|NCT01130922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101956967|NCT02808572|Mitogens|mitogens|mesh-list
101912651|NCT01131000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101912652|NCT01131000|Analgesics|analgesics|mesh-ancestor
101912653|NCT01131000|Sensory System Agents|sensory system agents|mesh-ancestor
101912654|NCT01131000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101912655|NCT01131000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912656|NCT01131000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101912657|NCT01131000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101912658|NCT01131000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101912659|NCT01131000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101912660|NCT01131000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912661|NCT01132170|Valproic Acid|valproic acid|mesh-list
101912662|NCT01132170|Anticonvulsants|anticonvulsants|mesh-ancestor
101912663|NCT01132170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101912664|NCT01132170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912665|NCT01132170|GABA Agents|gaba agents|mesh-ancestor
101912666|NCT01132170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101912667|NCT01132170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912668|NCT01132170|Antimanic Agents|antimanic agents|mesh-ancestor
101912669|NCT01132170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101912670|NCT01132170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101912671|NCT01132170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101912672|NCT03925428|Entinostat|entinostat|mesh-list
101912673|NCT03925428|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
101912674|NCT03925428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101912675|NCT03925428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101912676|NCT03925428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912677|NCT03920514|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101912678|NCT03920514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101912679|NCT03920514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912680|NCT03919812|Cholecalciferol|cholecalciferol|mesh-list
101912681|NCT03919812|Vitamin D|vitamin d|mesh-list
101912682|NCT03919812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101912683|NCT03919812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912684|NCT03919812|Vitamins|vitamins|mesh-ancestor
101912685|NCT03919812|Micronutrients|micronutrients|mesh-ancestor
101912686|NCT03919812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101912687|NCT03919656|Dapagliflozin|dapagliflozin|mesh-list
101912688|NCT03919656|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101912689|NCT03919656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912690|NCT03919656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101912691|NCT03919656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912692|NCT01132248|Mefloquine|mefloquine|mesh-list
101912693|NCT01132248|Antimalarials|antimalarials|mesh-ancestor
101912694|NCT01132248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101912695|NCT01132248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101912696|NCT01132248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101912697|NCT01229592|Ethanol|ethanol|mesh-list
101912698|NCT01229592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101912699|NCT01229592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101912700|NCT01229592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101912701|NCT01229592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912703|NCT01131936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101912704|NCT01131936|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101912705|NCT01131936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101912706|NCT01131936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912707|NCT01131936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101912708|NCT01131936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912709|NCT01131936|Vasodilator Agents|vasodilator agents|mesh-ancestor
101912710|NCT01132404|Leuprolide|leuprolide|mesh-list
101912711|NCT01132404|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101912712|NCT01132404|Fertility Agents|fertility agents|mesh-ancestor
101912713|NCT01132404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101912714|NCT01132404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912715|NCT01132404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101912716|NCT01132404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101912717|NCT01231854|Cyclosporine|cyclosporine|mesh-list
101912718|NCT01231854|Alitretinoin|alitretinoin|mesh-list
101912719|NCT01231854|Cyclosporins|cyclosporins|mesh-list
101912720|NCT01231854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101912721|NCT01231854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912722|NCT01231854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101912723|NCT01231854|Immunologic Factors|immunologic factors|mesh-ancestor
101912724|NCT01231854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912725|NCT01231854|Antifungal Agents|antifungal agents|mesh-ancestor
101912726|NCT01231854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101912727|NCT01231854|Dermatologic Agents|dermatologic agents|mesh-ancestor
101912728|NCT01231854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101912729|NCT01231854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101912730|NCT01231854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101912731|NCT01132638|Esomeprazole|esomeprazole|mesh-list
101912732|NCT01132638|Pantoprazole|pantoprazole|mesh-list
101912733|NCT01132638|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101912734|NCT01132638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101912735|NCT01132638|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101912736|NCT01132638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101912737|NCT01132638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912738|NCT05402124|Aspirin|aspirin|mesh-list
101912739|NCT05402124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101912740|NCT05402124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101912741|NCT05402124|Analgesics|analgesics|mesh-ancestor
101912742|NCT05402124|Sensory System Agents|sensory system agents|mesh-ancestor
101912743|NCT05402124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101912744|NCT05402124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912745|NCT05402124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101912746|NCT05402124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101912747|NCT05402124|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101912748|NCT05402124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101912749|NCT05402124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912750|NCT05402124|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101912751|NCT05402124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101912752|NCT05402124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101912753|NCT05402124|Antipyretics|antipyretics|mesh-ancestor
101912754|NCT01134432|Prednisolone|prednisolone|mesh-list
101912755|NCT01134432|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101912756|NCT01134432|Methylprednisolone|methylprednisolone|mesh-list
101912757|NCT01134432|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101912758|NCT01134432|Prednisolone acetate|prednisolone acetate|mesh-list
101912759|NCT01134432|Rituximab|rituximab|mesh-list
101912760|NCT01134432|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101912761|NCT01134432|Prednisolone phosphate|prednisolone phosphate|mesh-list
101912762|NCT01134432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101912763|NCT01134432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101912764|NCT01134432|Immunologic Factors|immunologic factors|mesh-ancestor
101912765|NCT01134432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912766|NCT01134432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101912767|NCT01134432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101912768|NCT01134432|Glucocorticoids|glucocorticoids|mesh-ancestor
101912769|NCT01134432|Hormones|hormones|mesh-ancestor
101912770|NCT01134432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101912771|NCT01134432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101912772|NCT01134432|Antiemetics|antiemetics|mesh-ancestor
101912773|NCT01134432|Autonomic Agents|autonomic agents|mesh-ancestor
101616842|NCT00796003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101912774|NCT01134432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101912775|NCT01134432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101912776|NCT01134432|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101912777|NCT01134432|Protective Agents|protective agents|mesh-ancestor
101912778|NCT01232010|Mirodenafil|mirodenafil|mesh-list
101912779|NCT01232010|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101912780|NCT01232010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101912781|NCT01232010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101912782|NCT01232010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912783|NCT01132716|Valacyclovir|valacyclovir|mesh-list
101912784|NCT01132716|Antiviral Agents|antiviral agents|mesh-ancestor
101912785|NCT01132716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101912786|NCT05401812|Glucocorticoids|glucocorticoids|mesh-list
101912788|NCT05401812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101912789|NCT05401812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912790|NCT01137708|Levonorgestrel|levonorgestrel|mesh-list
101912791|NCT01137708|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101912792|NCT01137708|Tofacitinib|tofacitinib|mesh-list
101912793|NCT01137708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101912794|NCT01137708|Contraceptive Agents|contraceptive agents|mesh-ancestor
101912795|NCT01137708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101912796|NCT01137708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912797|NCT01137708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101912798|NCT01137708|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101912799|NCT01137708|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101912800|NCT01137708|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101912801|NCT01137708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101912802|NCT01137708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101912803|NCT01137708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912804|NCT01137708|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101912805|NCT01137708|Estrogens|estrogens|mesh-ancestor
101912806|NCT01137708|Hormones|hormones|mesh-ancestor
101912807|NCT01137708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101912809|NCT03765138|Antioxidants|antioxidants|mesh-ancestor
101912810|NCT03765138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912811|NCT03765138|Protective Agents|protective agents|mesh-ancestor
101912812|NCT03765138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912813|NCT03765138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101912814|NCT03765138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101912815|NCT03765138|Dopamine Agonists|dopamine agonists|mesh-ancestor
101912816|NCT03765138|Dopamine Agents|dopamine agents|mesh-ancestor
101912817|NCT03765138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101912818|NCT01134666|Cetuximab|cetuximab|mesh-list
101912819|NCT01134666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101912820|NCT01134666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101912821|NCT03739788|Deucravacitinib|deucravacitinib|mesh-list
101912822|NCT03739788|Dermatologic Agents|dermatologic agents|mesh-ancestor
101912823|NCT03739788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101912824|NCT03739788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101912825|NCT03739788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912826|NCT01137942|Metronidazole|metronidazole|mesh-list
101912827|NCT01137942|Clarithromycin|clarithromycin|mesh-list
101912828|NCT01137942|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101912829|NCT01137942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101912830|NCT01137942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101912831|NCT01137942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101912832|NCT01137942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101912833|NCT01137942|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101912834|NCT01137942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101912835|NCT01137942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912836|NCT01137942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101912837|NCT01137942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101912838|NCT01233492|Mannitol|mannitol|mesh-list
101912839|NCT01233492|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101912840|NCT01233492|Diuretics|diuretics|mesh-ancestor
101912841|NCT01233492|Natriuretic Agents|natriuretic agents|mesh-ancestor
101912842|NCT01233492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912843|NCT01135056|Sorafenib|sorafenib|mesh-list
101912844|NCT01135056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101912845|NCT01135056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101912846|NCT01135056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101912847|NCT01135056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912848|NCT01132794|Dexmedetomidine|dexmedetomidine|mesh-list
101912849|NCT01132794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101912850|NCT01132794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101912851|NCT01132794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912852|NCT01132794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101912853|NCT01132794|Analgesics|analgesics|mesh-ancestor
101912854|NCT01132794|Sensory System Agents|sensory system agents|mesh-ancestor
101912855|NCT01132794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101912856|NCT01132794|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101912857|NCT01132794|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101912858|NCT01132794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101912859|NCT01132794|Adrenergic Agents|adrenergic agents|mesh-ancestor
101912860|NCT01132794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101912861|NCT01132794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912862|NCT01135212|Candesartan|candesartan|mesh-list
101912863|NCT01135212|Candesartan cilexetil|candesartan cilexetil|mesh-list
101912864|NCT01135212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101912865|NCT01135212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101912866|NCT01135212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101912867|NCT01135212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912868|NCT01233570|Tacrolimus|tacrolimus|mesh-list
101912869|NCT01233570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101912870|NCT01233570|Immunologic Factors|immunologic factors|mesh-ancestor
101912871|NCT01233570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912872|NCT01233570|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101912873|NCT01233570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101912874|NCT01233570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912875|NCT01135290|Petrolatum|petrolatum|mesh-list
101912876|NCT01135290|Emollients|emollients|mesh-ancestor
101912877|NCT01135290|Dermatologic Agents|dermatologic agents|mesh-ancestor
101912878|NCT01135446|Dapagliflozin|dapagliflozin|mesh-list
101912879|NCT01135446|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101912880|NCT01135446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912881|NCT01135446|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101912882|NCT01135446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912884|NCT01135602|Anticonvulsants|anticonvulsants|mesh-ancestor
101912885|NCT01135602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101912886|NCT01135602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912887|NCT05308212|Vaccines|vaccines|mesh-list
101912888|NCT05308212|Immunologic Factors|immunologic factors|mesh-ancestor
101912889|NCT05308212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912890|NCT01138488|Insulin|insulin|mesh-list
101912891|NCT01138488|Insulin Aspart|insulin aspart|mesh-list
101912892|NCT01138488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101912893|NCT01138488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912894|NCT01135680|Moxifloxacin|moxifloxacin|mesh-list
101912895|NCT01135680|Glycerol|glycerol|mesh-list
101912896|NCT01135680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101912897|NCT01135680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101912898|NCT01135680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101912899|NCT01135680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101912900|NCT01135680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101912901|NCT01135680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912902|NCT01135680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101912903|NCT01135680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912904|NCT01135680|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101912905|NCT01135680|Protective Agents|protective agents|mesh-ancestor
101912906|NCT01135758|Ketamine|ketamine|mesh-list
101912907|NCT01135758|Analgesics|analgesics|mesh-ancestor
101912908|NCT01135758|Sensory System Agents|sensory system agents|mesh-ancestor
101912909|NCT01135758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101912910|NCT01135758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912911|NCT01135758|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101912912|NCT01135758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101912913|NCT01135758|Anesthetics, General|anesthetics, general|mesh-ancestor
101912914|NCT01135758|Anesthetics|anesthetics|mesh-ancestor
101912915|NCT01135758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101912916|NCT01135758|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101912917|NCT01135758|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101912918|NCT01135758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101912919|NCT01135758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912920|NCT05401032|Tamsulosin|tamsulosin|mesh-list
101912921|NCT05401032|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101912922|NCT05401032|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101912923|NCT05401032|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101912924|NCT05401032|Adrenergic Agents|adrenergic agents|mesh-ancestor
101912925|NCT05401032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101912926|NCT05401032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912927|NCT05401032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912928|NCT05401032|Urological Agents|urological agents|mesh-ancestor
101912929|NCT03768726|Ziprasidone|ziprasidone|mesh-list
101912930|NCT03768726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101912931|NCT03768726|Serotonin Agents|serotonin agents|mesh-ancestor
101912932|NCT03768726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101912933|NCT03768726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912934|NCT03768726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912935|NCT03768726|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101912936|NCT03768726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101912937|NCT03768726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101912938|NCT03768726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101912939|NCT03768726|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101912940|NCT03768726|Dopamine Agents|dopamine agents|mesh-ancestor
101912941|NCT01138956|Acetylcysteine|acetylcysteine|mesh-list
101912942|NCT01138956|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101912943|NCT01138956|Antiviral Agents|antiviral agents|mesh-ancestor
101912944|NCT01138956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101912945|NCT01138956|Expectorants|expectorants|mesh-ancestor
101912946|NCT01138956|Respiratory System Agents|respiratory system agents|mesh-ancestor
101912947|NCT01138956|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101912948|NCT01138956|Antioxidants|antioxidants|mesh-ancestor
101912949|NCT01138956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912950|NCT01138956|Protective Agents|protective agents|mesh-ancestor
101912951|NCT01138956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912952|NCT01138956|Antidotes|antidotes|mesh-ancestor
101912953|NCT03917940|Glimepiride|glimepiride|mesh-list
101912954|NCT03917940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101912955|NCT03917940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101912956|NCT03917940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912957|NCT03917940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101912958|NCT03917940|Immunologic Factors|immunologic factors|mesh-ancestor
101912959|NCT05287542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
101912960|NCT05287542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101912961|NCT05287542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912963|NCT01232244|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101912964|NCT01232244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101912966|NCT01232244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101912967|NCT01232244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912968|NCT01232244|Incretins|incretins|mesh-ancestor
101912970|NCT03917784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101912971|NCT03917784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101912972|NCT03917784|Analgesics|analgesics|mesh-ancestor
101912973|NCT03917784|Sensory System Agents|sensory system agents|mesh-ancestor
101912974|NCT03917784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101912975|NCT03917784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912976|NCT03917784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101912977|NCT03917784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101912978|NCT03917784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101912979|NCT03917784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101912980|NCT03917784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912981|NCT01133496|Alendronate|alendronate|mesh-list
101912982|NCT01133496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101912983|NCT01133496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912984|NCT01232400|Esmolol|esmolol|mesh-list
101912985|NCT01232400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101912986|NCT01232400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101912987|NCT01232400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101912988|NCT01232400|Adrenergic Agents|adrenergic agents|mesh-ancestor
101912989|NCT01232400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101912990|NCT01232400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101912991|NCT01232400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101912992|NCT02528760|Erythromycin|erythromycin|mesh-list
101912993|NCT02528760|Erythromycin Estolate|erythromycin estolate|mesh-list
101912994|NCT02528760|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101912995|NCT02528760|Erythromycin stearate|erythromycin stearate|mesh-list
101912996|NCT02528760|Metoclopramide|metoclopramide|mesh-list
101912998|NCT02528760|Autonomic Agents|autonomic agents|mesh-ancestor
101912999|NCT02528760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101913000|NCT02528760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913001|NCT02528760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101913002|NCT02528760|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101913003|NCT02528760|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101913004|NCT02528760|Dopamine Agents|dopamine agents|mesh-ancestor
101913005|NCT02528760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101913006|NCT02528760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913007|NCT02528760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101913008|NCT02528760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101913009|NCT02528760|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101913010|NCT02528760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101913011|NCT05594472|Gentamicins|gentamicins|mesh-list
101913012|NCT05594472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101913013|NCT05594472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101913014|NCT05594472|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101913015|NCT05594472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101913016|NCT05594472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913017|NCT01136538|Valacyclovir|valacyclovir|mesh-list
101913018|NCT01136538|Antiviral Agents|antiviral agents|mesh-ancestor
101913019|NCT01136538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101913020|NCT03917628|Adalimumab|adalimumab|mesh-list
101913021|NCT03917628|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101913022|NCT03917628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101913023|NCT03917628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101913024|NCT01329588|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101913025|NCT01329588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101913026|NCT01136850|Azithromycin|azithromycin|mesh-list
101913027|NCT01136850|Chloroquine|chloroquine|mesh-list
101913028|NCT01136850|Pyrimethamine|pyrimethamine|mesh-list
101913029|NCT01136850|Sulfadoxine|sulfadoxine|mesh-list
101913030|NCT01136850|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101913031|NCT01136850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101913032|NCT01136850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101913034|NCT01136850|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101913035|NCT01136850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101913036|NCT01136850|Antimalarials|antimalarials|mesh-ancestor
101913037|NCT01136850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101913038|NCT01136850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101913039|NCT01136850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101913040|NCT01136850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913041|NCT01136850|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101913042|NCT01234116|Tenofovir|tenofovir|mesh-list
101913043|NCT01234116|Emtricitabine|emtricitabine|mesh-list
101913044|NCT01234116|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101913045|NCT01234116|Antiviral Agents|antiviral agents|mesh-ancestor
101913046|NCT01234116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101913047|NCT01234116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101913048|NCT01234116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101913049|NCT01234116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101913050|NCT01234116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913051|NCT01234116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101913052|NCT01234116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101913053|NCT03917004|Nitroglycerin|nitroglycerin|mesh-list
101913054|NCT03917004|Vasodilator Agents|vasodilator agents|mesh-ancestor
101913055|NCT01230996|Cisplatin|cisplatin|mesh-list
101913056|NCT01230996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101913057|NCT01137084|Methylprednisolone|methylprednisolone|mesh-list
101913058|NCT01137084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101913059|NCT01137084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101913060|NCT01137084|Prednisolone|prednisolone|mesh-list
101913061|NCT01137084|Prednisolone acetate|prednisolone acetate|mesh-list
101913062|NCT01137084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101913063|NCT01137084|Prednisolone phosphate|prednisolone phosphate|mesh-list
101913064|NCT01137084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101913065|NCT01137084|Antiemetics|antiemetics|mesh-ancestor
101913066|NCT01137084|Autonomic Agents|autonomic agents|mesh-ancestor
101913067|NCT01137084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101913068|NCT01137084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913069|NCT01137084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101913070|NCT01137084|Glucocorticoids|glucocorticoids|mesh-ancestor
101913071|NCT01137084|Hormones|hormones|mesh-ancestor
101913072|NCT01137084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101913073|NCT01137084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101913074|NCT01137084|Protective Agents|protective agents|mesh-ancestor
101913075|NCT01137084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101956991|NCT02089204|Antimetabolites|antimetabolites|mesh-ancestor
101913076|NCT01137084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101913077|NCT01133886|Decitabine|decitabine|mesh-list
101913078|NCT01133886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101913079|NCT01133886|Antimetabolites|antimetabolites|mesh-ancestor
101913080|NCT01133886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913081|NCT01133886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101913082|NCT01133886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101913083|NCT01140126|UB-421|ub-421|mesh-list
101913084|NCT01140126|Antibodies|antibodies|mesh-list
101913085|NCT01140126|Immunologic Factors|immunologic factors|mesh-ancestor
101913086|NCT01140126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913087|NCT01140126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101913088|NCT01140126|Antiviral Agents|antiviral agents|mesh-ancestor
101913089|NCT01140126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101913090|NCT01231074|Metformin|metformin|mesh-list
101913091|NCT01231074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101913092|NCT01231074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913093|NCT03917394|Iron|iron|mesh-list
101913094|NCT03917394|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101913095|NCT03917394|Trace Elements|trace elements|mesh-ancestor
101913096|NCT03917394|Micronutrients|micronutrients|mesh-ancestor
101913097|NCT03917394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913098|NCT03917394|Hematinics|hematinics|mesh-ancestor
101913099|NCT03769896|Nabilone|nabilone|mesh-list
101913100|NCT03769896|Antiemetics|antiemetics|mesh-ancestor
101913101|NCT03769896|Autonomic Agents|autonomic agents|mesh-ancestor
101913102|NCT03769896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101913103|NCT03769896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913104|NCT03769896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101913105|NCT03769896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101913106|NCT03769896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101913107|NCT03769896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101913108|NCT03769896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101913109|NCT01234194|Remifentanil|remifentanil|mesh-list
101913110|NCT01234194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101913111|NCT01234194|Narcotics|narcotics|mesh-ancestor
101913112|NCT01234194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101913113|NCT01234194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913114|NCT01234194|Analgesics|analgesics|mesh-ancestor
101913115|NCT01234194|Sensory System Agents|sensory system agents|mesh-ancestor
101913116|NCT01234194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101913117|NCT04913922|Nivolumab|nivolumab|mesh-list
101913118|NCT04913922|Relatlimab|relatlimab|mesh-list
101913119|NCT04913922|Azacitidine|azacitidine|mesh-list
101913120|NCT04913922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101913121|NCT04913922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101913122|NCT04913922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101913123|NCT04913922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913124|NCT04913922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101913125|NCT04913922|Antimetabolites|antimetabolites|mesh-ancestor
101913126|NCT04913922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101913127|NCT04910022|Lomustine|lomustine|mesh-list
101228860|NCT01548950|Sildenafil Citrate|sildenafil citrate|mesh-list
101913128|NCT04910022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101913129|NCT04910022|Alkylating Agents|alkylating agents|mesh-ancestor
101913130|NCT04910022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913131|NCT04910022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101913132|NCT05485662|Listerine|listerine|mesh-list
101913133|NCT05485662|Fluorides|fluorides|mesh-list
101913134|NCT05485662|Sodium Fluoride|sodium fluoride|mesh-list
101913135|NCT05485662|Cariostatic Agents|cariostatic agents|mesh-ancestor
101913136|NCT05485662|Protective Agents|protective agents|mesh-ancestor
101913137|NCT05485662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913138|NCT05485662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101913139|NCT05485662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101913140|NCT01234272|Morphine|morphine|mesh-list
101913141|NCT01234272|Ropivacaine|ropivacaine|mesh-list
101913142|NCT01234272|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101913143|NCT01234272|Narcotics|narcotics|mesh-ancestor
101913144|NCT01234272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101913145|NCT01234272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913146|NCT01234272|Analgesics|analgesics|mesh-ancestor
101913147|NCT01234272|Sensory System Agents|sensory system agents|mesh-ancestor
101913149|NCT01234272|Anesthetics, Local|anesthetics, local|mesh-ancestor
101913150|NCT01234272|Anesthetics|anesthetics|mesh-ancestor
101913151|NCT01140438|Metformin|metformin|mesh-list
101913152|NCT01140438|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101913153|NCT01140438|Repaglinide|repaglinide|mesh-list
101913154|NCT01140438|Insulin, Isophane|insulin, isophane|mesh-list
101913155|NCT01140438|Isophane Insulin, Human|isophane insulin, human|mesh-list
101913156|NCT01140438|Isophane insulin, beef|isophane insulin, beef|mesh-list
101913157|NCT01140438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101913158|NCT01140438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913159|NCT01140438|Incretins|incretins|mesh-ancestor
101913160|NCT01140438|Hormones|hormones|mesh-ancestor
101913161|NCT01140438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101913162|NCT01140438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101913163|NCT01140438|Protease Inhibitors|protease inhibitors|mesh-ancestor
101913164|NCT01140438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101913165|NCT01140438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913166|NCT01234506|Vitamin D|vitamin d|mesh-list
101913167|NCT01234506|Secoisolariciresinol|secoisolariciresinol|mesh-list
101913168|NCT01234506|Vitamins|vitamins|mesh-ancestor
101913169|NCT01234506|Micronutrients|micronutrients|mesh-ancestor
101913170|NCT01234506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913171|NCT01234506|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101913172|NCT01234506|Phytoestrogens|phytoestrogens|mesh-ancestor
101913173|NCT01234506|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101913174|NCT01234506|Estrogens|estrogens|mesh-ancestor
101913175|NCT01234506|Hormones|hormones|mesh-ancestor
101913176|NCT01234506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101913177|NCT04751604|Niacinamide|niacinamide|mesh-list
101913178|NCT04751604|Niacin|niacin|mesh-list
101913179|NCT04751604|Nicotinic Acids|nicotinic acids|mesh-list
101913180|NCT04751604|Vitamin B Complex|vitamin b complex|mesh-ancestor
101913181|NCT04751604|Vitamins|vitamins|mesh-ancestor
101913182|NCT04751604|Micronutrients|micronutrients|mesh-ancestor
101633049|NCT01016015|Sirolimus|sirolimus|mesh-list
101913183|NCT04751604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913184|NCT04751604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101913185|NCT04751604|Antimetabolites|antimetabolites|mesh-ancestor
101913186|NCT04751604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913187|NCT04751604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101913188|NCT04751604|Vasodilator Agents|vasodilator agents|mesh-ancestor
101913189|NCT01231542|Rifampin|rifampin|mesh-list
101913190|NCT01231542|Rifabutin|rifabutin|mesh-list
101913191|NCT01231542|Dolutegravir|dolutegravir|mesh-list
101913192|NCT01231542|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101913193|NCT01231542|Antitubercular Agents|antitubercular agents|mesh-ancestor
101913194|NCT01231542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101913195|NCT01231542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101913196|NCT01231542|Leprostatic Agents|leprostatic agents|mesh-ancestor
101913197|NCT01231542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101913198|NCT01231542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101913199|NCT01231542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913200|NCT01231542|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101913201|NCT01231542|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101913202|NCT01231542|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101913203|NCT01231542|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101913204|NCT01231542|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101913205|NCT01231542|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101913206|NCT01231542|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101913207|NCT01231542|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101913208|NCT01231542|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101913209|NCT01231542|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101913210|NCT01231542|Antiviral Agents|antiviral agents|mesh-ancestor
101913211|NCT01231698|Esmolol|esmolol|mesh-list
101913212|NCT01231698|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101913213|NCT01231698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101913214|NCT01231698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101913215|NCT01231698|Adrenergic Agents|adrenergic agents|mesh-ancestor
101913216|NCT01231698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101913217|NCT01231698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913218|NCT01231698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913219|NCT01142778|Bevacizumab|bevacizumab|mesh-list
101913220|NCT01142778|Trastuzumab|trastuzumab|mesh-list
101913221|NCT01142778|Docetaxel|docetaxel|mesh-list
101913222|NCT01142778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101913223|NCT01142778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101913224|NCT01142778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101913225|NCT01142778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101913226|NCT01142778|Growth Substances|growth substances|mesh-ancestor
101913227|NCT01142778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913228|NCT01142778|Growth Inhibitors|growth inhibitors|mesh-ancestor
101913229|NCT01142778|Tubulin Modulators|tubulin modulators|mesh-ancestor
101913230|NCT01142778|Antimitotic Agents|antimitotic agents|mesh-ancestor
101913231|NCT01142778|Mitosis Modulators|mitosis modulators|mesh-ancestor
101913232|NCT01142778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913233|NCT01142934|Chlorhexidine|chlorhexidine|mesh-list
101913234|NCT01142934|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101913235|NCT01142934|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101913236|NCT01142934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101913237|NCT01142934|Disinfectants|disinfectants|mesh-ancestor
101913238|NCT01142934|Dermatologic Agents|dermatologic agents|mesh-ancestor
101913239|NCT04722978|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101913240|NCT04722978|Moxifloxacin|moxifloxacin|mesh-list
101913241|NCT04722978|Carboplatin|carboplatin|mesh-list
101913242|NCT04722978|Gemcitabine|gemcitabine|mesh-list
101913243|NCT04722978|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101913244|NCT04722978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101913245|NCT04722978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101913246|NCT04722978|Antimetabolites|antimetabolites|mesh-ancestor
101913247|NCT04722978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913248|NCT04722978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101913249|NCT04722978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101913250|NCT04722978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101913251|NCT04722978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101913252|NCT04722978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101913253|NCT04722978|Contraceptive Agents|contraceptive agents|mesh-ancestor
101913254|NCT04722978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101913255|NCT04722978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913256|NCT04722978|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101913257|NCT04722978|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101913258|NCT04722978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101913260|NCT01140828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101913261|NCT01140828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101913262|NCT01140828|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101913263|NCT01140828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101913264|NCT01140828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913265|NCT01234740|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101913266|NCT01234740|Bafetinib|bafetinib|mesh-list
101913267|NCT01234740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101913268|NCT01234740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101913269|NCT01234740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913270|NCT01234818|Levonorgestrel|levonorgestrel|mesh-list
101913271|NCT01234818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101913272|NCT01234818|Contraceptive Agents|contraceptive agents|mesh-ancestor
101913273|NCT01234818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101913274|NCT01234818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913275|NCT01234818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101913276|NCT01234818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101913277|NCT01234818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101913278|NCT03714594|Dapagliflozin|dapagliflozin|mesh-list
101913279|NCT03714594|Saxagliptin|saxagliptin|mesh-list
101913280|NCT03714594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101913281|NCT03714594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913282|NCT03714594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101913283|NCT03714594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913284|NCT03714594|Incretins|incretins|mesh-ancestor
101913285|NCT03714594|Hormones|hormones|mesh-ancestor
101913286|NCT03714594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101913287|NCT03714594|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101913288|NCT03714594|Protease Inhibitors|protease inhibitors|mesh-ancestor
101913289|NCT03714594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101913290|NCT04624776|Methylprednisolone|methylprednisolone|mesh-list
101913291|NCT04624776|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101913292|NCT04624776|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101913293|NCT04624776|Prednisolone|prednisolone|mesh-list
101913294|NCT04624776|Prednisolone acetate|prednisolone acetate|mesh-list
101913295|NCT04624776|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101913296|NCT04624776|Prednisolone phosphate|prednisolone phosphate|mesh-list
101913297|NCT04624776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101913300|NCT04624776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101913301|NCT04624776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913302|NCT04624776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101913303|NCT04624776|Glucocorticoids|glucocorticoids|mesh-ancestor
101913304|NCT04624776|Hormones|hormones|mesh-ancestor
101913305|NCT04624776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101913306|NCT04624776|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101913307|NCT04624776|Protective Agents|protective agents|mesh-ancestor
101913308|NCT04624776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101913309|NCT04624776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101913310|NCT01234896|Nicotine|nicotine|mesh-list
101913311|NCT01234896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101913312|NCT01234896|Autonomic Agents|autonomic agents|mesh-ancestor
101913313|NCT01234896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101913314|NCT01234896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913315|NCT01234896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101913316|NCT01234896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101913317|NCT01234896|Cholinergic Agents|cholinergic agents|mesh-ancestor
101913318|NCT01234896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101913319|NCT01234896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913320|NCT01238094|Simvastatin|simvastatin|mesh-list
101913321|NCT01238094|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101913322|NCT01238094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101913323|NCT01238094|Antimetabolites|antimetabolites|mesh-ancestor
101913324|NCT01238094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913325|NCT01238094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101913326|NCT01238094|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101913327|NCT01238094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101913328|NCT01236612|Chloroquine|chloroquine|mesh-list
101913329|NCT01236612|Proguanil|proguanil|mesh-list
101228882|NCT01549158|Furosemide|furosemide|mesh-list
101913330|NCT01236612|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
101913331|NCT01236612|Amebicides|amebicides|mesh-ancestor
101913332|NCT01236612|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101913333|NCT01236612|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101913334|NCT01236612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101913335|NCT01236612|Antimalarials|antimalarials|mesh-ancestor
101913336|NCT01236612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101913337|NCT01236612|Antimetabolites|antimetabolites|mesh-ancestor
101913338|NCT01236612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913339|NCT03633630|Magnesium Oxide|magnesium oxide|mesh-list
101913340|NCT03633630|Antacids|antacids|mesh-ancestor
101913341|NCT03633630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913342|NCT03633630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101913343|NCT01234974|Everolimus|everolimus|mesh-list
101913344|NCT01234974|Pasireotide|pasireotide|mesh-list
101913345|NCT01234974|Somatostatin|somatostatin|mesh-list
101913346|NCT01234974|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101913347|NCT01234974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101913348|NCT01234974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101913349|NCT01234974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913350|NCT01234974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101913351|NCT01234974|Immunologic Factors|immunologic factors|mesh-ancestor
101913352|NCT01234974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913353|NCT01234974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101913354|NCT01234974|Hormones|hormones|mesh-ancestor
101913355|NCT01234974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101913356|NCT01140984|Methylprednisolone|methylprednisolone|mesh-list
101913357|NCT01140984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101913358|NCT01140984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101913359|NCT01140984|Prednisolone|prednisolone|mesh-list
101913360|NCT01140984|Prednisolone acetate|prednisolone acetate|mesh-list
101913361|NCT01140984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101913362|NCT01140984|Prednisolone phosphate|prednisolone phosphate|mesh-list
101913363|NCT01140984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101913364|NCT01140984|Antiemetics|antiemetics|mesh-ancestor
101913365|NCT01140984|Autonomic Agents|autonomic agents|mesh-ancestor
101957000|NCT02095990|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101913366|NCT01140984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101913367|NCT01140984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913368|NCT01140984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101913370|NCT01140984|Hormones|hormones|mesh-ancestor
101276042|NCT01867268|Acetazolamide|acetazolamide|mesh-list
101913371|NCT01140984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101913373|NCT01140984|Protective Agents|protective agents|mesh-ancestor
101913374|NCT01140984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101913375|NCT01140984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101913376|NCT01145430|Doxorubicin|doxorubicin|mesh-list
101913377|NCT01145430|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101913378|NCT01145430|Veliparib|veliparib|mesh-list
101913379|NCT01145430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101913380|NCT01145430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101913381|NCT01145430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101913382|NCT01145430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101913383|NCT01145430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101913384|NCT01145430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913385|NCT01145430|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101913386|NCT03389724|Captopril|captopril|mesh-list
101913387|NCT03389724|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101913388|NCT03389724|Protease Inhibitors|protease inhibitors|mesh-ancestor
101913389|NCT03389724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101913390|NCT03389724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913391|NCT03389724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101913392|NCT01586052|Epoetin Alfa|epoetin alfa|mesh-list
101913393|NCT01586052|Hematinics|hematinics|mesh-ancestor
101913394|NCT03684564|Warfarin|warfarin|mesh-list
101913395|NCT03684564|Rivaroxaban|rivaroxaban|mesh-list
101913396|NCT03684564|Anticoagulants|anticoagulants|mesh-ancestor
101913397|NCT03684564|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101913398|NCT03684564|Antithrombins|antithrombins|mesh-ancestor
101913399|NCT03684564|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101913400|NCT03684564|Protease Inhibitors|protease inhibitors|mesh-ancestor
101913401|NCT03684564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101913402|NCT03684564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913403|NCT05796635|Allantoin|allantoin|mesh-list
101633276|NCT02013427|Sensory System Agents|sensory system agents|mesh-ancestor
101913404|NCT05796635|Dermatologic Agents|dermatologic agents|mesh-ancestor
101913405|NCT05796362|Azithromycin|azithromycin|mesh-list
101913406|NCT05796362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101913407|NCT05796362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101913408|NCT05796115|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101913409|NCT05796115|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101913410|NCT05796115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101913411|NCT05796115|Antitubercular Agents|antitubercular agents|mesh-ancestor
101913412|NCT05795946|Vitamin D|vitamin d|mesh-list
101913413|NCT05795946|Vitamins|vitamins|mesh-ancestor
101913414|NCT05795946|Micronutrients|micronutrients|mesh-ancestor
101913415|NCT05795946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913416|NCT05795946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101913417|NCT05795920|Gemcitabine|gemcitabine|mesh-list
101913418|NCT05795920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101913419|NCT05795920|Antimetabolites|antimetabolites|mesh-ancestor
101913420|NCT05795920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913421|NCT05795920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101913422|NCT05849246|Cisplatin|cisplatin|mesh-list
101913423|NCT05849246|Carboplatin|carboplatin|mesh-list
101913424|NCT05849246|Pemetrexed|pemetrexed|mesh-list
101913425|NCT05849246|Maytansine|maytansine|mesh-list
101913426|NCT05849246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101913427|NCT05849246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101913428|NCT05849246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913429|NCT05849246|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101913430|NCT05849246|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101913431|NCT05849246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101913432|NCT05849246|Tubulin Modulators|tubulin modulators|mesh-ancestor
101913433|NCT05849246|Antimitotic Agents|antimitotic agents|mesh-ancestor
101913434|NCT05849246|Mitosis Modulators|mitosis modulators|mesh-ancestor
101913435|NCT05849220|Dapagliflozin|dapagliflozin|mesh-list
101913436|NCT05849220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101913437|NCT05849220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913439|NCT05849220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913440|NCT05849090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101913441|NCT05849090|Vancomycin|vancomycin|mesh-list
101913442|NCT05849090|Clindamycin|clindamycin|mesh-list
101913443|NCT05849090|Clindamycin palmitate|clindamycin palmitate|mesh-list
101913444|NCT05849090|Clindamycin phosphate|clindamycin phosphate|mesh-list
101913445|NCT05849090|Cefazolin|cefazolin|mesh-list
101913446|NCT05849090|Ceftriaxone|ceftriaxone|mesh-list
101913447|NCT05849090|Tobramycin|tobramycin|mesh-list
101913448|NCT05849090|Cephalosporins|cephalosporins|mesh-list
101913449|NCT05849090|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101913450|NCT05849090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101913451|NCT05849090|Antitubercular Agents|antitubercular agents|mesh-ancestor
101913452|NCT05849090|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101913453|NCT05849090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101913454|NCT05849090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913455|NCT05848869|Misoprostol|misoprostol|mesh-list
101913456|NCT05848869|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101913457|NCT05848869|Abortifacient Agents|abortifacient agents|mesh-ancestor
101913458|NCT05848869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101913459|NCT05848869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913460|NCT05848869|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101913461|NCT05848869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101913462|NCT05848869|Oxytocics|oxytocics|mesh-ancestor
101913463|NCT05848713|Heparin|heparin|mesh-list
101913464|NCT05848713|Anticoagulants|anticoagulants|mesh-ancestor
101913465|NCT05848713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101913466|NCT05848713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101913467|NCT05848713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913468|NCT05848687|Dexamethasone|dexamethasone|mesh-list
101913469|NCT05848687|Methotrexate|methotrexate|mesh-list
101913470|NCT05848687|Bortezomib|bortezomib|mesh-list
101913471|NCT05848687|Asparaginase|asparaginase|mesh-list
101913472|NCT05848687|Mitoxantrone|mitoxantrone|mesh-list
101913473|NCT05848687|Mercaptopurine|mercaptopurine|mesh-list
101913474|NCT05848687|Vorinostat|vorinostat|mesh-list
101913475|NCT05848687|Blinatumomab|blinatumomab|mesh-list
101913476|NCT05848687|Pegaspargase|pegaspargase|mesh-list
101913477|NCT05848687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101913478|NCT05848687|Antiemetics|antiemetics|mesh-ancestor
101913479|NCT05848687|Autonomic Agents|autonomic agents|mesh-ancestor
101913480|NCT05848687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101913481|NCT05848687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913482|NCT05848687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101913483|NCT05848687|Glucocorticoids|glucocorticoids|mesh-ancestor
101913484|NCT05848687|Hormones|hormones|mesh-ancestor
101913485|NCT05848687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101913486|NCT05848687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101913487|NCT05848687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101913488|NCT05848687|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101913489|NCT05848687|Abortifacient Agents|abortifacient agents|mesh-ancestor
101913490|NCT05848687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101913491|NCT05848687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101913492|NCT05848687|Antimetabolites|antimetabolites|mesh-ancestor
101913493|NCT05848687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913494|NCT05848687|Dermatologic Agents|dermatologic agents|mesh-ancestor
101913495|NCT05848687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101913496|NCT05848687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101913497|NCT05848687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101913498|NCT05848687|Immunologic Factors|immunologic factors|mesh-ancestor
101913499|NCT05848687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101913500|NCT05848687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101913501|NCT05848687|Analgesics|analgesics|mesh-ancestor
101913502|NCT05848687|Sensory System Agents|sensory system agents|mesh-ancestor
101913503|NCT05848687|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101913504|NCT05848687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101913505|NCT05848687|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101913506|NCT05848635|Morphine|morphine|mesh-list
101913507|NCT05848635|Hydromorphone|hydromorphone|mesh-list
101913508|NCT05848635|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101913509|NCT05848635|Narcotics|narcotics|mesh-ancestor
101913510|NCT05848635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101913511|NCT05848635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913512|NCT05848635|Analgesics|analgesics|mesh-ancestor
101913513|NCT05848635|Sensory System Agents|sensory system agents|mesh-ancestor
101913514|NCT05848635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101913516|NCT05848531|Analgesics|analgesics|mesh-ancestor
101913517|NCT05848531|Sensory System Agents|sensory system agents|mesh-ancestor
101913518|NCT05848531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101913519|NCT05848531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616853|NCT04110535|Anesthetics|anesthetics|mesh-ancestor
101913521|NCT05848531|Sympatholytics|sympatholytics|mesh-ancestor
101913522|NCT05848531|Autonomic Agents|autonomic agents|mesh-ancestor
101913523|NCT05848531|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101913524|NCT05848531|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101913525|NCT05848531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101913526|NCT05848531|Adrenergic Agents|adrenergic agents|mesh-ancestor
101913527|NCT05848531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101913528|NCT05848531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913529|NCT05848505|Dexmedetomidine|dexmedetomidine|mesh-list
101913530|NCT05848505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101913531|NCT05848505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101913532|NCT05848505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913533|NCT05848505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101913534|NCT05848505|Analgesics|analgesics|mesh-ancestor
101913535|NCT05848505|Sensory System Agents|sensory system agents|mesh-ancestor
101913536|NCT05848505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101913537|NCT05848505|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101913538|NCT05848505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101913539|NCT05848505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101913540|NCT05848505|Adrenergic Agents|adrenergic agents|mesh-ancestor
101913541|NCT05848505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101913542|NCT05848505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913543|NCT05848492|Fluconazole|fluconazole|mesh-list
101913544|NCT05848492|Antifungal Agents|antifungal agents|mesh-ancestor
101913545|NCT05848492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101913546|NCT05848492|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101913547|NCT05848492|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101913548|NCT05848492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101913549|NCT05848492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913550|NCT05848492|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101913551|NCT05848492|Hormone Antagonists|hormone antagonists|mesh-ancestor
101913552|NCT05848492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101913553|NCT05848492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913554|NCT05848492|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101913555|NCT05848492|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101913556|NCT05848336|Caseins|caseins|mesh-list
101913557|NCT05848336|Chelating Agents|chelating agents|mesh-ancestor
101913558|NCT05848336|Sequestering Agents|sequestering agents|mesh-ancestor
101913559|NCT05848336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913560|NCT05848102|Dapagliflozin|dapagliflozin|mesh-list
101913561|NCT05848102|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101913562|NCT05848102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913563|NCT05848102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101228951|NCT01549574|Crizotinib|crizotinib|mesh-list
101913564|NCT05848102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913565|NCT05848011|Prednisone|prednisone|mesh-list
101913566|NCT05848011|Docetaxel|docetaxel|mesh-list
101913567|NCT05848011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101913568|NCT05848011|Tubulin Modulators|tubulin modulators|mesh-ancestor
101913569|NCT05848011|Antimitotic Agents|antimitotic agents|mesh-ancestor
101913570|NCT05848011|Mitosis Modulators|mitosis modulators|mesh-ancestor
101913571|NCT05848011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913572|NCT05848011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101913573|NCT05848011|Glucocorticoids|glucocorticoids|mesh-ancestor
101913574|NCT05848011|Hormones|hormones|mesh-ancestor
101913575|NCT05848011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101913576|NCT05848011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913577|NCT05848011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101913578|NCT05847764|Carboplatin|carboplatin|mesh-list
101913579|NCT05847764|Tislelizumab|tislelizumab|mesh-list
101913581|NCT05847764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101913582|NCT05847764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101913583|NCT05847764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101913584|NCT05847764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101913585|NCT05847764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913586|NCT05846568|Immunoglobulins|immunoglobulins|mesh-list
101913587|NCT05846568|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101913588|NCT05846568|Antibodies|antibodies|mesh-list
101913589|NCT05846568|Immunologic Factors|immunologic factors|mesh-ancestor
101913590|NCT05846568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913591|NCT05846399|Amoxicillin|amoxicillin|mesh-list
101913592|NCT05846399|Ciprofloxacin|ciprofloxacin|mesh-list
101913593|NCT05846399|Clindamycin|clindamycin|mesh-list
101913594|NCT05846399|Clindamycin palmitate|clindamycin palmitate|mesh-list
101913595|NCT05846399|Clindamycin phosphate|clindamycin phosphate|mesh-list
101913596|NCT05846399|Clavulanic Acid|clavulanic acid|mesh-list
101913597|NCT05846399|Clavulanic Acids|clavulanic acids|mesh-list
101913598|NCT05846399|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101913599|NCT05846399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101913600|NCT05846399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101913601|NCT05846399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101913602|NCT05846399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101913603|NCT05846399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101913604|NCT05846399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913605|NCT05846399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101913606|NCT05846399|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101913607|NCT05846399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101913608|NCT05846399|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101913609|NCT05846399|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101913611|NCT05846373|Niacinamide|niacinamide|mesh-list
101913612|NCT05846373|Nicotinic Acids|nicotinic acids|mesh-list
101913613|NCT05846373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101913614|NCT05846373|Antimetabolites|antimetabolites|mesh-ancestor
101913615|NCT05846373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913616|NCT05846373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101913617|NCT05846373|Vasodilator Agents|vasodilator agents|mesh-ancestor
101913618|NCT05846373|Vitamin B Complex|vitamin b complex|mesh-ancestor
101913619|NCT05846373|Vitamins|vitamins|mesh-ancestor
101913620|NCT05846373|Micronutrients|micronutrients|mesh-ancestor
101913621|NCT05846373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913622|NCT05846243|Vaccines|vaccines|mesh-list
101913623|NCT05846243|Immunologic Factors|immunologic factors|mesh-ancestor
101913624|NCT05846243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913625|NCT05846139|Chlorhexidine|chlorhexidine|mesh-list
101913626|NCT05846139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101913627|NCT05846139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101913628|NCT05846139|Disinfectants|disinfectants|mesh-ancestor
101913629|NCT05845996|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
101913630|NCT05845996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101913631|NCT05845996|Immunologic Factors|immunologic factors|mesh-ancestor
101913632|NCT05845996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913633|NCT05845723|Cyclophosphamide|cyclophosphamide|mesh-list
101913634|NCT05845723|Tofacitinib|tofacitinib|mesh-list
101913635|NCT05845723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101913636|NCT05845723|Immunologic Factors|immunologic factors|mesh-ancestor
101913637|NCT05845723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913639|NCT05845723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101913640|NCT05845723|Alkylating Agents|alkylating agents|mesh-ancestor
101913641|NCT05845723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913642|NCT05845723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101913643|NCT05845723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101913644|NCT05845723|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101913645|NCT05845723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101913646|NCT05845723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101913647|NCT05845671|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
101913648|NCT05845671|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101913649|NCT05845671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101913650|NCT05845671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101913651|NCT05845671|Immunologic Factors|immunologic factors|mesh-ancestor
101913652|NCT05845671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913653|NCT05845567|Clarithromycin|clarithromycin|mesh-list
101913654|NCT05845567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101913655|NCT05845567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101913656|NCT05845567|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101913657|NCT05845567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101913658|NCT05845567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913659|NCT05845567|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101913660|NCT05845567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101913661|NCT05845424|Ezetimibe|ezetimibe|mesh-list
101913662|NCT05845424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
101913663|NCT05845424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101913664|NCT05845424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101913665|NCT05845424|Antimetabolites|antimetabolites|mesh-ancestor
101913666|NCT05845424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913667|NCT05845424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101913668|NCT05845424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101913669|NCT05845385|Analgesics|analgesics|mesh-list
101913670|NCT05845385|Sensory System Agents|sensory system agents|mesh-ancestor
101913671|NCT05845385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101913672|NCT05845385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913673|NCT05845268|Tislelizumab|tislelizumab|mesh-list
101913674|NCT05845268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101913675|NCT05845268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101913676|NCT05845268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101913677|NCT05845268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913678|NCT05845125|Triamcinolone|triamcinolone|mesh-list
101913679|NCT05845125|Bupivacaine|bupivacaine|mesh-list
101913680|NCT05845125|Anesthetics, Local|anesthetics, local|mesh-ancestor
101913681|NCT05845125|Anesthetics|anesthetics|mesh-ancestor
101913682|NCT05845125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101913683|NCT05845125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913684|NCT05845125|Sensory System Agents|sensory system agents|mesh-ancestor
101913685|NCT05845125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101913686|NCT05845125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101913687|NCT05845125|Glucocorticoids|glucocorticoids|mesh-ancestor
101913688|NCT05845125|Hormones|hormones|mesh-ancestor
101913689|NCT05845125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101913690|NCT05844982|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
101913691|NCT05844982|Faricimab|faricimab|mesh-list
101913692|NCT05844982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101913693|NCT05844982|Glucocorticoids|glucocorticoids|mesh-ancestor
101913694|NCT05844982|Hormones|hormones|mesh-ancestor
101913695|NCT05844982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101913696|NCT05844982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913697|NCT05844982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101913698|NCT05844982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101913699|NCT05844982|Growth Substances|growth substances|mesh-ancestor
101913700|NCT05844982|Growth Inhibitors|growth inhibitors|mesh-ancestor
101957047|NCT02250118|Bevacizumab|bevacizumab|mesh-list
101913701|NCT05844982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101913702|NCT05844930|Triamcinolone|triamcinolone|mesh-list
101913703|NCT05844930|Lidocaine|lidocaine|mesh-list
101913704|NCT05844930|Anesthetics, Local|anesthetics, local|mesh-ancestor
101913705|NCT05844930|Anesthetics|anesthetics|mesh-ancestor
101913706|NCT05844930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101913707|NCT05844930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913708|NCT05844930|Sensory System Agents|sensory system agents|mesh-ancestor
101633574|NCT00713011|Vasodilator Agents|vasodilator agents|mesh-ancestor
101913709|NCT05844930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101913710|NCT05844930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101913711|NCT05844930|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101913712|NCT05844930|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101913713|NCT05844930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101913714|NCT05844930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913715|NCT05844930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101913716|NCT05844930|Glucocorticoids|glucocorticoids|mesh-ancestor
101913717|NCT05844930|Hormones|hormones|mesh-ancestor
101913718|NCT05844930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101913719|NCT05844800|Bupivacaine|bupivacaine|mesh-list
101913720|NCT05844800|Anesthetics, Local|anesthetics, local|mesh-ancestor
101913721|NCT05844800|Anesthetics|anesthetics|mesh-ancestor
101913722|NCT05844800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101913723|NCT05844800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913724|NCT05844800|Sensory System Agents|sensory system agents|mesh-ancestor
101913725|NCT05844800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101913726|NCT05844683|Chlorhexidine|chlorhexidine|mesh-list
101913727|NCT05844683|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101913728|NCT05844683|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101913729|NCT05844683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101913730|NCT05844683|Disinfectants|disinfectants|mesh-ancestor
101913731|NCT05844683|Dermatologic Agents|dermatologic agents|mesh-ancestor
101913732|NCT05844670|Vincristine|vincristine|mesh-list
101913733|NCT05844670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101913734|NCT05844670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101913735|NCT05844670|Tubulin Modulators|tubulin modulators|mesh-ancestor
101616860|NCT04025203|Gabapentin|gabapentin|mesh-list
101913736|NCT05844670|Antimitotic Agents|antimitotic agents|mesh-ancestor
101913737|NCT05844670|Mitosis Modulators|mitosis modulators|mesh-ancestor
101913738|NCT05844670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913739|NCT05844657|Ferrous fumarate|ferrous fumarate|mesh-list
101913740|NCT05844657|Trace Elements|trace elements|mesh-ancestor
101913741|NCT05844657|Micronutrients|micronutrients|mesh-ancestor
101913742|NCT05844657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913743|NCT05844553|Hydrogen Peroxide|hydrogen peroxide|mesh-list
101913744|NCT05844553|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101913745|NCT05844553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101913746|NCT05844436|Pritelivir|pritelivir|mesh-list
101913747|NCT05844436|Antiviral Agents|antiviral agents|mesh-ancestor
101913748|NCT05844436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101913749|NCT05844436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101913750|NCT05844436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913751|NCT05844371|Oxaliplatin|oxaliplatin|mesh-list
101913752|NCT05844371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101913753|NCT05844306|Deoxyglucose|deoxyglucose|mesh-list
101913754|NCT05844306|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101913755|NCT05844306|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101913756|NCT05844306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913757|NCT05844306|Antimetabolites|antimetabolites|mesh-ancestor
101913758|NCT05844306|Antiviral Agents|antiviral agents|mesh-ancestor
101913759|NCT05844306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101913760|NCT05844150|Etoposide|etoposide|mesh-list
101913761|NCT05844150|Atezolizumab|atezolizumab|mesh-list
101913762|NCT05844150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101913763|NCT05844150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101913764|NCT05844150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101913765|NCT05844150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101913766|NCT05844150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101913767|NCT05844150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913768|NCT05844150|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101913769|NCT05844150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101913770|NCT05844046|Bevacizumab|bevacizumab|mesh-list
101913771|NCT05844046|Durvalumab|durvalumab|mesh-list
101913772|NCT05844046|Tremelimumab|tremelimumab|mesh-list
101913773|NCT05844046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101913774|NCT05844046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101913775|NCT05844046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101913776|NCT05844046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101913777|NCT05844046|Growth Substances|growth substances|mesh-ancestor
101913778|NCT05844046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913779|NCT05844046|Growth Inhibitors|growth inhibitors|mesh-ancestor
101913780|NCT05843838|Anesthetics|anesthetics|mesh-list
101913781|NCT05843838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101913782|NCT05843838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913783|NCT05843812|Magnesium Sulfate|magnesium sulfate|mesh-list
101913784|NCT05843812|Analgesics|analgesics|mesh-ancestor
101913785|NCT05843812|Sensory System Agents|sensory system agents|mesh-ancestor
101913786|NCT05843812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101913787|NCT05843812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913788|NCT05843812|Anesthetics|anesthetics|mesh-ancestor
101913789|NCT05843812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101913790|NCT05843812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101913791|NCT05843812|Anticonvulsants|anticonvulsants|mesh-ancestor
101913792|NCT05843812|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101913793|NCT05843812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101913794|NCT05843812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913795|NCT05843812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101913796|NCT05843812|Tocolytic Agents|tocolytic agents|mesh-ancestor
101913797|NCT05843812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101913798|NCT05843786|Interferons|interferons|mesh-list
101913799|NCT05843786|Interferon-gamma|interferon-gamma|mesh-list
101913800|NCT05843786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101913801|NCT05843786|Antiviral Agents|antiviral agents|mesh-ancestor
101913802|NCT05843786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101913803|NCT05843617|Vitamins|vitamins|mesh-list
101913804|NCT05843617|Ascorbic Acid|ascorbic acid|mesh-list
101913805|NCT05843617|Micronutrients|micronutrients|mesh-ancestor
101913806|NCT05843617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913807|NCT05843617|Antioxidants|antioxidants|mesh-ancestor
101913808|NCT05843617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913809|NCT05843617|Protective Agents|protective agents|mesh-ancestor
101913811|NCT05843344|Morphine|morphine|mesh-list
101913812|NCT05843344|Ropivacaine|ropivacaine|mesh-list
101913813|NCT05843344|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101913814|NCT05843344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101913815|NCT05843344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913816|NCT05843344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101913817|NCT05843344|Analgesics|analgesics|mesh-ancestor
101913818|NCT05843344|Sensory System Agents|sensory system agents|mesh-ancestor
101913819|NCT05843344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101913820|NCT05843344|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101913821|NCT05843344|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101913822|NCT05843344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101913823|NCT05843344|Adrenergic Agents|adrenergic agents|mesh-ancestor
101913824|NCT05843344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101913825|NCT05843344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913826|NCT05843344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101913827|NCT05843344|Narcotics|narcotics|mesh-ancestor
101913828|NCT05843344|Anesthetics, Local|anesthetics, local|mesh-ancestor
101913829|NCT05843344|Anesthetics|anesthetics|mesh-ancestor
101913830|NCT05843292|Carboplatin|carboplatin|mesh-list
101913832|NCT05843292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101913833|NCT05843253|Everolimus|everolimus|mesh-list
101913834|NCT05843253|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101913835|NCT05843253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101913836|NCT05843253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101913837|NCT05843253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913838|NCT05843253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101913839|NCT05843253|Immunologic Factors|immunologic factors|mesh-ancestor
101957055|NCT03060772|Pioglitazone|pioglitazone|mesh-list
101913840|NCT05843253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913841|NCT05843253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101913842|NCT05843162|Losartan|losartan|mesh-list
101913843|NCT05843162|Telmisartan|telmisartan|mesh-list
101913844|NCT05843162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101913845|NCT05843162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101913846|NCT05843162|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101913847|NCT05843162|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101913848|NCT05843162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913849|NCT05842954|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101913850|NCT05842954|Antimalarials|antimalarials|mesh-ancestor
101913851|NCT05842954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101913852|NCT05842954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101913853|NCT05842954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101913854|NCT05842759|Norepinephrine|norepinephrine|mesh-list
101913855|NCT05842759|Propofol|propofol|mesh-list
101913856|NCT05842759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101913857|NCT05842759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101913858|NCT05842759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633728|NCT00778102|Antidotes|antidotes|mesh-ancestor
101913859|NCT05842759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101913860|NCT05842759|Anesthetics, General|anesthetics, general|mesh-ancestor
101913861|NCT05842759|Anesthetics|anesthetics|mesh-ancestor
101913862|NCT05842759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101913863|NCT05842759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101913864|NCT05842759|Adrenergic Agents|adrenergic agents|mesh-ancestor
101913865|NCT05842759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101913866|NCT05842759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913867|NCT05842759|Sympathomimetics|sympathomimetics|mesh-ancestor
101913868|NCT05842759|Autonomic Agents|autonomic agents|mesh-ancestor
101913869|NCT05842759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101913870|NCT05842759|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101913871|NCT05842681|Azithromycin|azithromycin|mesh-list
101913872|NCT05842681|Methylprednisolone|methylprednisolone|mesh-list
101913873|NCT05842681|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101913874|NCT05842681|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101913875|NCT05842681|Prednisolone|prednisolone|mesh-list
101913876|NCT05842681|Prednisolone acetate|prednisolone acetate|mesh-list
101913877|NCT05842681|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101913878|NCT05842681|Prednisolone phosphate|prednisolone phosphate|mesh-list
101913879|NCT05842681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101913880|NCT05842681|Antiemetics|antiemetics|mesh-ancestor
101913881|NCT05842681|Autonomic Agents|autonomic agents|mesh-ancestor
101913882|NCT05842681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101913883|NCT05842681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913884|NCT05842681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101913885|NCT05842681|Glucocorticoids|glucocorticoids|mesh-ancestor
101913887|NCT05842681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101913888|NCT05842681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101913889|NCT05842681|Protective Agents|protective agents|mesh-ancestor
101913890|NCT05842681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101913891|NCT05842681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101913892|NCT05842681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101913893|NCT05842681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101913894|NCT05842486|Antibodies|antibodies|mesh-list
101913895|NCT05842486|Immunologic Factors|immunologic factors|mesh-ancestor
101913896|NCT05842486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913897|NCT05842330|Methylphenidate|methylphenidate|mesh-list
101913898|NCT05842330|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101913899|NCT05842330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913900|NCT05842330|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101913901|NCT05842330|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101913902|NCT05842330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101913903|NCT05842330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913904|NCT05842330|Dopamine Agents|dopamine agents|mesh-ancestor
101913905|NCT05842330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101913907|NCT05842317|Tislelizumab|tislelizumab|mesh-list
101913908|NCT05842317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101913909|NCT05842317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101913910|NCT05842317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101913911|NCT05842317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913912|NCT05842317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101913913|NCT05840848|Beta Carotene|beta carotene|mesh-list
101913914|NCT05840848|Carotenoids|carotenoids|mesh-list
101913915|NCT05840848|Antioxidants|antioxidants|mesh-ancestor
101913916|NCT05840848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913917|NCT05840848|Protective Agents|protective agents|mesh-ancestor
101913918|NCT05840848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913919|NCT05840848|Provitamins|provitamins|mesh-ancestor
101913920|NCT05840848|Vitamins|vitamins|mesh-ancestor
101913921|NCT05840848|Micronutrients|micronutrients|mesh-ancestor
101913922|NCT05840835|Tislelizumab|tislelizumab|mesh-list
101913923|NCT05840835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101913924|NCT05840835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101913925|NCT05840562|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101913926|NCT05840562|Capsaicin|capsaicin|mesh-list
101913927|NCT05840562|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101913928|NCT05840562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101913929|NCT05840562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101913930|NCT05840562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913931|NCT05840562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101913932|NCT05840562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913933|NCT05840562|Analgesics|analgesics|mesh-ancestor
101913945|NCT05840471|Hemostatics|hemostatics|mesh-ancestor
101913946|NCT05840471|Coagulants|coagulants|mesh-ancestor
101913947|NCT05840289|Rituximab|rituximab|mesh-list
101913948|NCT05840289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101913949|NCT05840289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101913950|NCT05840289|Immunologic Factors|immunologic factors|mesh-ancestor
101913951|NCT05840289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913952|NCT05840289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101913953|NCT05839938|Vitamin D|vitamin d|mesh-list
101913954|NCT05839938|Vitamins|vitamins|mesh-ancestor
101913955|NCT05839938|Micronutrients|micronutrients|mesh-ancestor
101913956|NCT05839938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913957|NCT05839938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101913958|NCT05839756|Budesonide|budesonide|mesh-list
101913959|NCT05839756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101913960|NCT05839756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101913961|NCT05839756|Autonomic Agents|autonomic agents|mesh-ancestor
101913962|NCT05839756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101913963|NCT05839756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913964|NCT05839756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101913965|NCT05839756|Respiratory System Agents|respiratory system agents|mesh-ancestor
101913966|NCT05839756|Glucocorticoids|glucocorticoids|mesh-ancestor
101913967|NCT05839756|Hormones|hormones|mesh-ancestor
101913968|NCT05839756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101913969|NCT05839314|Cyclosporine|cyclosporine|mesh-list
101913970|NCT05839314|Cyclosporins|cyclosporins|mesh-list
101276626|NCT01870674|YH12852|yh12852|mesh-list
101913972|NCT05839314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913973|NCT05839314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101913974|NCT05839314|Immunologic Factors|immunologic factors|mesh-ancestor
101913975|NCT05839314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101913976|NCT05839314|Antifungal Agents|antifungal agents|mesh-ancestor
101913977|NCT05839314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101913978|NCT05839314|Dermatologic Agents|dermatologic agents|mesh-ancestor
101913979|NCT05839314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101913980|NCT05839314|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101913981|NCT05836571|Nivolumab|nivolumab|mesh-list
101913982|NCT05836571|Ipilimumab|ipilimumab|mesh-list
101913983|NCT05836571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101913984|NCT05836571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101913985|NCT05836571|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101913986|NCT05836571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101913998|NCT05829499|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101913999|NCT05829499|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101914000|NCT05828095|MEDI9197|medi9197|mesh-list
101914001|NCT05828095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101914002|NCT05828095|Immunologic Factors|immunologic factors|mesh-ancestor
101914003|NCT05828095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914004|NCT05825573|Vitamin K|vitamin k|mesh-list
101914005|NCT05825573|Anticoagulants|anticoagulants|mesh-list
101914006|NCT05825573|Vitamins|vitamins|mesh-ancestor
101914007|NCT05825573|Micronutrients|micronutrients|mesh-ancestor
101914008|NCT05825573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914009|NCT05825573|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101914010|NCT05825573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101914011|NCT05825573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914012|NCT05825573|Hemostatics|hemostatics|mesh-ancestor
101914013|NCT05825573|Coagulants|coagulants|mesh-ancestor
101914014|NCT05825352|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101914015|NCT05825352|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101914016|NCT05824494|Paclitaxel|paclitaxel|mesh-list
101914017|NCT05824494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101914018|NCT05824494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101914019|NCT05824494|Tubulin Modulators|tubulin modulators|mesh-ancestor
101914020|NCT05824494|Antimitotic Agents|antimitotic agents|mesh-ancestor
101914021|NCT05824494|Mitosis Modulators|mitosis modulators|mesh-ancestor
101914022|NCT05824494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914023|NCT05824000|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101914024|NCT05824000|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101914025|NCT05823961|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101914026|NCT05823961|Hyaluronic Acid|hyaluronic acid|mesh-list
101914027|NCT05823961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101914028|NCT05823961|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101914029|NCT05823961|Immunologic Factors|immunologic factors|mesh-ancestor
101914030|NCT05823961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914031|NCT05823961|Viscosupplements|viscosupplements|mesh-ancestor
101914032|NCT05823961|Protective Agents|protective agents|mesh-ancestor
101914033|NCT05823506|Tadalafil|tadalafil|mesh-list
101914034|NCT05823506|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
101914035|NCT05823506|Vasodilator Agents|vasodilator agents|mesh-ancestor
101914036|NCT05823506|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101914037|NCT05823506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101914038|NCT05823506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229112|NCT01550653|Hormones|hormones|mesh-ancestor
101914039|NCT05823506|Urological Agents|urological agents|mesh-ancestor
101914040|NCT05822817|Propofol|propofol|mesh-list
101914041|NCT05822817|Sevoflurane|sevoflurane|mesh-list
101914042|NCT05822817|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101914043|NCT05822817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101914044|NCT05822817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914045|NCT05822817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101914046|NCT05822817|Anesthetics, General|anesthetics, general|mesh-ancestor
101914047|NCT05822817|Anesthetics|anesthetics|mesh-ancestor
101914048|NCT05822817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101914049|NCT05822817|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101914050|NCT05821075|Prednisolone|prednisolone|mesh-list
101914051|NCT05821075|Cerebrolysin|cerebrolysin|mesh-list
101914052|NCT05821075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101914053|NCT05821075|Glucocorticoids|glucocorticoids|mesh-ancestor
101914054|NCT05821075|Hormones|hormones|mesh-ancestor
101914055|NCT05821075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101914056|NCT05821075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276699|NCT01871454|Vasodilator Agents|vasodilator agents|mesh-ancestor
101914057|NCT05821075|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101914058|NCT05821075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101914059|NCT05821075|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101914060|NCT05821075|Protective Agents|protective agents|mesh-ancestor
101914061|NCT05821075|Nootropic Agents|nootropic agents|mesh-ancestor
101914062|NCT05817903|Nivolumab|nivolumab|mesh-list
101914063|NCT05817903|Axitinib|axitinib|mesh-list
101914064|NCT05817903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101914065|NCT05817903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101914066|NCT05817903|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101914067|NCT05817903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957078|NCT02094274|Xhance|xhance|mesh-list
101914069|NCT05817903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101914070|NCT05806931|Bevacizumab|bevacizumab|mesh-list
101914071|NCT05806931|Oxaliplatin|oxaliplatin|mesh-list
101914072|NCT05806931|Irinotecan|irinotecan|mesh-list
101914073|NCT05806931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101914074|NCT05806931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101914075|NCT05806931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101914076|NCT05806931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101914077|NCT05806931|Growth Substances|growth substances|mesh-ancestor
101914078|NCT05806931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914079|NCT05806931|Growth Inhibitors|growth inhibitors|mesh-ancestor
101914080|NCT05806931|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101914081|NCT05806931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101914082|NCT05806931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101914083|NCT05806931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914084|NCT05806021|Triamcinolone|triamcinolone|mesh-list
101914085|NCT05806021|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101914086|NCT05806021|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101914087|NCT05806021|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101914088|NCT05806021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101914089|NCT05806021|Glucocorticoids|glucocorticoids|mesh-ancestor
101914090|NCT05806021|Hormones|hormones|mesh-ancestor
101914091|NCT05806021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101914092|NCT05806021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914093|NCT05806021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101914094|NCT05806021|Immunologic Factors|immunologic factors|mesh-ancestor
101914095|NCT05806021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101914096|NCT05806021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914097|NCT05805605|Mycophenolic Acid|mycophenolic acid|mesh-list
101914098|NCT05805605|Sirolimus|sirolimus|mesh-list
101914099|NCT05805605|Cyclophosphamide|cyclophosphamide|mesh-list
101914100|NCT05805605|Fludarabine|fludarabine|mesh-list
101914101|NCT05805605|Allopurinol|allopurinol|mesh-list
101914102|NCT05805605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101914103|NCT05805605|Immunologic Factors|immunologic factors|mesh-ancestor
101914104|NCT05805605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914105|NCT05805605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101914106|NCT05805605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101914107|NCT05805605|Alkylating Agents|alkylating agents|mesh-ancestor
101914108|NCT05805605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914109|NCT05805605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101914110|NCT05805605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101914111|NCT05805605|Antimetabolites|antimetabolites|mesh-ancestor
101914112|NCT05805605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101914113|NCT05805605|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101914114|NCT05805605|Antitubercular Agents|antitubercular agents|mesh-ancestor
101914115|NCT05805605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101914116|NCT05805605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101914117|NCT05805605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101914118|NCT05805605|Antifungal Agents|antifungal agents|mesh-ancestor
101914119|NCT05805605|Gout Suppressants|gout suppressants|mesh-ancestor
101914120|NCT05805605|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101914121|NCT05805605|Antioxidants|antioxidants|mesh-ancestor
101914122|NCT05805605|Protective Agents|protective agents|mesh-ancestor
101914123|NCT05805436|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101914124|NCT05805436|Laxatives|laxatives|mesh-ancestor
101914125|NCT05805436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101914126|NCT05805072|Cytarabine|cytarabine|mesh-list
101914127|NCT05805072|Azacitidine|azacitidine|mesh-list
101914128|NCT05805072|Decitabine|decitabine|mesh-list
101914129|NCT05805072|Homoharringtonine|homoharringtonine|mesh-list
101914130|NCT05805072|Aclacinomycins|aclacinomycins|mesh-list
101914131|NCT05805072|Lenograstim|lenograstim|mesh-list
101914132|NCT05805072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101914133|NCT05805072|Antimetabolites|antimetabolites|mesh-ancestor
101914134|NCT05805072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914135|NCT05805072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101914136|NCT05805072|Antiviral Agents|antiviral agents|mesh-ancestor
101914137|NCT05805072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101914138|NCT05805072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101914139|NCT05805072|Immunologic Factors|immunologic factors|mesh-ancestor
101914140|NCT05805072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914141|NCT05805072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101914142|NCT05805072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101914143|NCT05805072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101914144|NCT05805072|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101914145|NCT05805072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101914147|NCT05804032|Lenalidomide|lenalidomide|mesh-list
101914148|NCT05804032|Bortezomib|bortezomib|mesh-list
101914149|NCT05804032|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101914150|NCT05804032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101914151|NCT05804032|Antiemetics|antiemetics|mesh-ancestor
101914152|NCT05804032|Autonomic Agents|autonomic agents|mesh-ancestor
101914153|NCT05804032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101914154|NCT05804032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914155|NCT05804032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101914156|NCT05804032|Glucocorticoids|glucocorticoids|mesh-ancestor
101914157|NCT05804032|Hormones|hormones|mesh-ancestor
101914158|NCT05804032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101914159|NCT05804032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101914160|NCT05804032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101914161|NCT05804032|Immunologic Factors|immunologic factors|mesh-ancestor
101914162|NCT05804032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101914163|NCT05804032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101914178|NCT05795101|Trastuzumab|trastuzumab|mesh-list
101914179|NCT05795101|Durvalumab|durvalumab|mesh-list
101914180|NCT05795101|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
101914181|NCT05795101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101914182|NCT05795101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101914183|NCT05795101|Immunoconjugates|immunoconjugates|mesh-ancestor
101914184|NCT05795101|Immunologic Factors|immunologic factors|mesh-ancestor
101914185|NCT05795101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914186|NCT05782907|Upadacitinib|upadacitinib|mesh-list
101914187|NCT05782907|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101914188|NCT05782907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101914189|NCT05782907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101914190|NCT05782907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914191|NCT05782907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101914192|NCT05772364|Calcium|calcium|mesh-list
101914193|NCT05772364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101914194|NCT05772364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914195|NCT05770180|Vaccines|vaccines|mesh-list
101914196|NCT05770180|Immunologic Factors|immunologic factors|mesh-ancestor
101914197|NCT05770180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914198|NCT05767749|Lidocaine|lidocaine|mesh-list
101914199|NCT05767749|Epinephrine|epinephrine|mesh-list
101914200|NCT05767749|Racepinephrine|racepinephrine|mesh-list
101914201|NCT05767749|Bupivacaine|bupivacaine|mesh-list
101914202|NCT05767749|Ropivacaine|ropivacaine|mesh-list
101914203|NCT05767749|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101914204|NCT05767749|Epinephryl borate|epinephryl borate|mesh-list
101914205|NCT05767749|Anesthetics, Local|anesthetics, local|mesh-ancestor
101914206|NCT05767749|Anesthetics|anesthetics|mesh-ancestor
101914207|NCT05767749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101914208|NCT05767749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914209|NCT05767749|Sensory System Agents|sensory system agents|mesh-ancestor
101914210|NCT05767749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101914211|NCT05767749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101914212|NCT05767749|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101914213|NCT05767749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101914214|NCT05767749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101914215|NCT05767749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914216|NCT05767749|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101914217|NCT05767749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101914218|NCT05767749|Adrenergic Agents|adrenergic agents|mesh-ancestor
101914219|NCT05767749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101914220|NCT05767749|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101914221|NCT05767749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101914222|NCT05767749|Autonomic Agents|autonomic agents|mesh-ancestor
101914223|NCT05767749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101914224|NCT05767749|Respiratory System Agents|respiratory system agents|mesh-ancestor
101914225|NCT05767749|Mydriatics|mydriatics|mesh-ancestor
101914226|NCT05767749|Sympathomimetics|sympathomimetics|mesh-ancestor
101914227|NCT05767749|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101914229|NCT05765682|Mepivacaine|mepivacaine|mesh-list
101914230|NCT05765682|Anesthetics, Local|anesthetics, local|mesh-ancestor
101914231|NCT05765682|Anesthetics|anesthetics|mesh-ancestor
101914232|NCT05765682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101914233|NCT05765682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914234|NCT05765682|Sensory System Agents|sensory system agents|mesh-ancestor
101914235|NCT05765682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101914236|NCT05765604|Vaccines|vaccines|mesh-list
101914237|NCT05765604|Immunologic Factors|immunologic factors|mesh-ancestor
101914238|NCT05765604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914239|NCT05753592|Remibrutinib|remibrutinib|mesh-list
101914240|NCT05753592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101634105|NCT00639873|Doxycycline|doxycycline|mesh-list
101914241|NCT05753592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101914242|NCT05753592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914243|NCT05735431|Fluticasone|fluticasone|mesh-list
101914244|NCT05735431|Formoterol Fumarate|formoterol fumarate|mesh-list
101914245|NCT05735431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101914246|NCT05735431|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101914247|NCT05735431|Autonomic Agents|autonomic agents|mesh-ancestor
101914248|NCT05735431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101914249|NCT05735431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914250|NCT05735431|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101914251|NCT05735431|Respiratory System Agents|respiratory system agents|mesh-ancestor
101914252|NCT05735431|Dermatologic Agents|dermatologic agents|mesh-ancestor
101914253|NCT05735431|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101914254|NCT05735431|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101914255|NCT05735431|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101914256|NCT05735431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101914257|NCT05735431|Adrenergic Agents|adrenergic agents|mesh-ancestor
101914258|NCT05735431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101914259|NCT05735431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914260|NCT05704673|Morphine|morphine|mesh-list
101914261|NCT05704673|Nalbuphine|nalbuphine|mesh-list
101914262|NCT05704673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101914263|NCT05704673|Narcotics|narcotics|mesh-ancestor
101914264|NCT05704673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101914265|NCT05704673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914266|NCT05704673|Analgesics|analgesics|mesh-ancestor
101914267|NCT05704673|Sensory System Agents|sensory system agents|mesh-ancestor
101914268|NCT05704673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101914269|NCT05702671|Immunoglobulins|immunoglobulins|mesh-list
101914270|NCT05702671|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101914271|NCT05702671|Antibodies|antibodies|mesh-list
101914272|NCT05702671|Immunologic Factors|immunologic factors|mesh-ancestor
101914273|NCT05702671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914274|NCT05693545|Penicillins|penicillins|mesh-list
101914275|NCT05693545|Penicillin G|penicillin g|mesh-list
101914276|NCT05693545|Penicillin G Benzathine|penicillin g benzathine|mesh-list
101914277|NCT05693545|Penicillin G Procaine|penicillin g procaine|mesh-list
101914278|NCT05693545|Penicillin V|penicillin v|mesh-list
101914279|NCT05693545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101914280|NCT05693545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101914281|NCT05683574|Etoricoxib|etoricoxib|mesh-list
101914282|NCT05683574|Amitriptyline|amitriptyline|mesh-list
101914283|NCT05683574|Cyclobenzaprine|cyclobenzaprine|mesh-list
101914284|NCT05683574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101914285|NCT05683574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101914286|NCT05683574|Analgesics|analgesics|mesh-ancestor
101914287|NCT05683574|Sensory System Agents|sensory system agents|mesh-ancestor
101914288|NCT05683574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101914289|NCT05683574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914290|NCT05683574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101914291|NCT05683574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101914292|NCT05683574|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101914293|NCT05683574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101914294|NCT05683574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101914295|NCT05683574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914296|NCT05683574|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101914297|NCT05683574|Antidepressive Agents|antidepressive agents|mesh-ancestor
101914298|NCT05683574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101914299|NCT05683574|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101914300|NCT05683574|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101914301|NCT05683574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101914302|NCT05683574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101914303|NCT05683574|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101914304|NCT05683574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101914305|NCT05683574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101914306|NCT05683574|Adrenergic Agents|adrenergic agents|mesh-ancestor
101914307|NCT05683574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101914308|NCT05681780|Cyclophosphamide|cyclophosphamide|mesh-list
101914310|NCT05681780|Fludarabine|fludarabine|mesh-list
101914311|NCT05681780|Interleukin-2|interleukin-2|mesh-list
101914312|NCT05681780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101914313|NCT05681780|Immunologic Factors|immunologic factors|mesh-ancestor
101914314|NCT05681780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914315|NCT05681780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101914316|NCT05681780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101914317|NCT05681780|Alkylating Agents|alkylating agents|mesh-ancestor
101914318|NCT05681780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914319|NCT05681780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101914320|NCT05681780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101914321|NCT05681780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101914322|NCT05681780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101914323|NCT05681780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101914325|NCT05681780|Sensory System Agents|sensory system agents|mesh-ancestor
101914326|NCT05681780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101914327|NCT05678205|Cyclophosphamide|cyclophosphamide|mesh-list
101914328|NCT05678205|Fludarabine|fludarabine|mesh-list
101914329|NCT05678205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101914330|NCT05678205|Immunologic Factors|immunologic factors|mesh-ancestor
101914331|NCT05678205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914332|NCT05678205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101914333|NCT05678205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101914334|NCT05678205|Alkylating Agents|alkylating agents|mesh-ancestor
101914335|NCT05678205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914336|NCT05678205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101914337|NCT05678205|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101914338|NCT05673811|Paclitaxel|paclitaxel|mesh-list
101914339|NCT05673811|Gemcitabine|gemcitabine|mesh-list
101914340|NCT05673811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101914341|NCT05673811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101914342|NCT05673811|Tubulin Modulators|tubulin modulators|mesh-ancestor
101914343|NCT05673811|Antimitotic Agents|antimitotic agents|mesh-ancestor
101914344|NCT05673811|Mitosis Modulators|mitosis modulators|mesh-ancestor
101914345|NCT05673811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914346|NCT05673811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101957114|NCT02090296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101914347|NCT05673811|Antimetabolites|antimetabolites|mesh-ancestor
101914348|NCT05671562|Lycopene|lycopene|mesh-list
101914349|NCT05671562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101914350|NCT05671562|Antioxidants|antioxidants|mesh-ancestor
101914351|NCT05671562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914352|NCT05671562|Protective Agents|protective agents|mesh-ancestor
101914353|NCT05671562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914354|NCT05671562|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101914355|NCT05671562|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101914356|NCT05671562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101914357|NCT05669846|Pembrolizumab|pembrolizumab|mesh-list
101914358|NCT05669846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101914359|NCT05669846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101914360|NCT05669846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101914361|NCT05669846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914362|NCT05654818|Vitamin D|vitamin d|mesh-list
101914363|NCT05654818|Vitamins|vitamins|mesh-ancestor
101914364|NCT05654818|Micronutrients|micronutrients|mesh-ancestor
101914365|NCT05654818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914366|NCT05654818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101914367|NCT05634525|Adagrasib|adagrasib|mesh-list
101914368|NCT05634525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101914369|NCT05634369|Dexamethasone|dexamethasone|mesh-list
101914370|NCT05634369|Gemcitabine|gemcitabine|mesh-list
101914371|NCT05634369|Docetaxel|docetaxel|mesh-list
101914372|NCT05634369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101914373|NCT05634369|Antiemetics|antiemetics|mesh-ancestor
101914374|NCT05634369|Autonomic Agents|autonomic agents|mesh-ancestor
101914375|NCT05634369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101914376|NCT05634369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914377|NCT05634369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101914378|NCT05634369|Glucocorticoids|glucocorticoids|mesh-ancestor
101914379|NCT05634369|Hormones|hormones|mesh-ancestor
101914380|NCT05634369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101914381|NCT05634369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101914382|NCT05634369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101914383|NCT05634369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914384|NCT05634369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101914385|NCT05634369|Antimetabolites|antimetabolites|mesh-ancestor
101914386|NCT05634369|Tubulin Modulators|tubulin modulators|mesh-ancestor
101914387|NCT05634369|Antimitotic Agents|antimitotic agents|mesh-ancestor
101914388|NCT05634369|Mitosis Modulators|mitosis modulators|mesh-ancestor
101914389|NCT05613205|Vaccines|vaccines|mesh-list
101914390|NCT05613205|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
101914391|NCT05613205|Immunologic Factors|immunologic factors|mesh-ancestor
101914393|NCT05613205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101914394|NCT05589181|Buprenorphine|buprenorphine|mesh-list
101914395|NCT05589181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101914396|NCT05589181|Narcotics|narcotics|mesh-ancestor
101914397|NCT05589181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101914398|NCT05589181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914399|NCT05589181|Analgesics|analgesics|mesh-ancestor
101914400|NCT05589181|Sensory System Agents|sensory system agents|mesh-ancestor
101914401|NCT05589181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101914402|NCT05589181|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101914403|NCT05562349|Clavulanic Acids|clavulanic acids|mesh-list
101914404|NCT05562349|Clavulanic Acid|clavulanic acid|mesh-list
101914405|NCT05562349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101914406|NCT05562349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101914407|NCT05562349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101914408|NCT05562349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914409|NCT05562349|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101914410|NCT05561673|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101914411|NCT05561673|Vaccines|vaccines|mesh-list
101914412|NCT05561673|Immunologic Factors|immunologic factors|mesh-ancestor
101914413|NCT05561673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914414|NCT05561673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101914415|NCT05561673|Antacids|antacids|mesh-ancestor
101914416|NCT05561673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914417|NCT05561673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101914418|NCT05550714|Anesthetics|anesthetics|mesh-list
101914419|NCT05550714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101914420|NCT05550714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914421|NCT05542264|Olanzapine|olanzapine|mesh-list
101914422|NCT05542264|Risperidone|risperidone|mesh-list
101914423|NCT05542264|Aripiprazole|aripiprazole|mesh-list
101914424|NCT05542264|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101914425|NCT05542264|Antipsychotic Agents|antipsychotic agents|mesh-list
101914426|NCT05542264|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101914427|NCT05542264|Serotonin Agents|serotonin agents|mesh-ancestor
101914428|NCT05542264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101914429|NCT05542264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914430|NCT05542264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914431|NCT05542264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101914432|NCT05542264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101914433|NCT05542264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101914434|NCT05542264|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101914435|NCT05542264|Dopamine Agents|dopamine agents|mesh-ancestor
101914436|NCT05542264|Antiemetics|antiemetics|mesh-ancestor
101914437|NCT05542264|Autonomic Agents|autonomic agents|mesh-ancestor
101914438|NCT05542264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101914439|NCT05542264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101914440|NCT05542264|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101914441|NCT05542264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101914442|NCT05542264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101914443|NCT05542264|Antidepressive Agents|antidepressive agents|mesh-ancestor
101914444|NCT05542264|Dopamine Agonists|dopamine agonists|mesh-ancestor
101914445|NCT05542264|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101914446|NCT05542264|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101914447|NCT05542264|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101914448|NCT05542264|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101914449|NCT05523323|Pembrolizumab|pembrolizumab|mesh-list
101914451|NCT05523323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101914452|NCT05523323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101914453|NCT05523323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101914454|NCT05523323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914455|NCT05523323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101914456|NCT05523323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101914457|NCT05505617|Nitric Oxide|nitric oxide|mesh-list
101914458|NCT05505617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101914459|NCT05505617|Autonomic Agents|autonomic agents|mesh-ancestor
101914460|NCT05505617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101914461|NCT05505617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914462|NCT05505617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101914463|NCT05505617|Respiratory System Agents|respiratory system agents|mesh-ancestor
101914464|NCT05505617|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101914465|NCT05505617|Antioxidants|antioxidants|mesh-ancestor
101914466|NCT05505617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914467|NCT05505617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101914468|NCT05505617|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101914469|NCT05505617|Vasodilator Agents|vasodilator agents|mesh-ancestor
101914470|NCT05505617|Gasotransmitters|gasotransmitters|mesh-ancestor
101914471|NCT05505617|Protective Agents|protective agents|mesh-ancestor
101914472|NCT05487040|Ritonavir|ritonavir|mesh-list
101914473|NCT05487040|Nirmatrelvir|nirmatrelvir|mesh-list
101914474|NCT05487040|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101914475|NCT05487040|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101914476|NCT05487040|Protease Inhibitors|protease inhibitors|mesh-ancestor
101914477|NCT05487040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101914478|NCT05487040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914479|NCT05487040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101914480|NCT05487040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101914481|NCT05487040|Antiviral Agents|antiviral agents|mesh-ancestor
101914482|NCT05487040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101914483|NCT05487040|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101914484|NCT05487040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101914485|NCT05484466|Entecavir|entecavir|mesh-list
101914486|NCT05484466|Antiviral Agents|antiviral agents|mesh-ancestor
101914487|NCT05484466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101914488|NCT05466747|Protease Inhibitors|protease inhibitors|mesh-list
101914489|NCT05466747|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
101914490|NCT05466747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101957120|NCT03691779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101914491|NCT05466747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914492|NCT05466747|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101914493|NCT05466747|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101914494|NCT05408988|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101914495|NCT05408988|Natriuretic Agents|natriuretic agents|mesh-ancestor
101914496|NCT05408988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914498|NCT05402111|Risperidone|risperidone|mesh-list
101914499|NCT05402111|Aripiprazole|aripiprazole|mesh-list
101914500|NCT05402111|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101914501|NCT05402111|Antipsychotic Agents|antipsychotic agents|mesh-list
101914502|NCT05402111|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101914503|NCT05402111|Serotonin Agents|serotonin agents|mesh-ancestor
101914504|NCT05402111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101914505|NCT05402111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914506|NCT05402111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914507|NCT05402111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101914508|NCT05402111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101914509|NCT05402111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101914510|NCT05402111|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101914511|NCT05402111|Dopamine Agents|dopamine agents|mesh-ancestor
101914512|NCT05402111|Antiemetics|antiemetics|mesh-ancestor
101914513|NCT05402111|Autonomic Agents|autonomic agents|mesh-ancestor
101914514|NCT05402111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101914515|NCT05402111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101914516|NCT05402111|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101914517|NCT05402111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101616870|NCT04025203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101914518|NCT05402111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101914519|NCT05402111|Antidepressive Agents|antidepressive agents|mesh-ancestor
101914520|NCT05402111|Dopamine Agonists|dopamine agonists|mesh-ancestor
101914521|NCT05402111|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101914522|NCT05402111|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101914523|NCT05402111|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101914524|NCT05402111|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101914531|NCT05393791|Abiraterone Acetate|abiraterone acetate|mesh-list
101914532|NCT05393791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101914533|NCT05393791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101914534|NCT05393791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101914535|NCT05393791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914536|NCT05393791|Hormone Antagonists|hormone antagonists|mesh-ancestor
101914537|NCT05393791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101914538|NCT05393791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634408|NCT02684019|Analgesics|analgesics|mesh-ancestor
101914539|NCT05393791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101914540|NCT05388773|Carboplatin|carboplatin|mesh-list
101914541|NCT05388773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101914542|NCT05383521|Tinidazole|tinidazole|mesh-list
101914543|NCT05383521|Alkylating Agents|alkylating agents|mesh-ancestor
101914544|NCT05383521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914545|NCT05383521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101914546|NCT05383521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101914547|NCT05383521|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
101914548|NCT05383521|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101914549|NCT05383521|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101914556|NCT05361382|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
101914557|NCT05361382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914558|NCT05359211|Cyclophosphamide|cyclophosphamide|mesh-list
101914559|NCT05359211|Fludarabine|fludarabine|mesh-list
101914560|NCT05359211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101914561|NCT05359211|Immunologic Factors|immunologic factors|mesh-ancestor
101914562|NCT05359211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914563|NCT05359211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101914564|NCT05359211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101914565|NCT05359211|Alkylating Agents|alkylating agents|mesh-ancestor
101914566|NCT05359211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914567|NCT05359211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101914568|NCT05359211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101914569|NCT05358938|Pembrolizumab|pembrolizumab|mesh-list
101914570|NCT05358938|Nivolumab|nivolumab|mesh-list
101914571|NCT05358938|Ipilimumab|ipilimumab|mesh-list
101914572|NCT05358938|Avelumab|avelumab|mesh-list
101914573|NCT05358938|Cemiplimab|cemiplimab|mesh-list
101914574|NCT05358938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101914575|NCT05358938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101914576|NCT05358938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101914577|NCT05358938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914578|NCT05349474|Metformin|metformin|mesh-list
101914579|NCT05349474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101914580|NCT05349474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914581|NCT05343481|Nivolumab|nivolumab|mesh-list
101914582|NCT05343481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101914583|NCT05343481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101914584|NCT05343481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101914585|NCT05343481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914586|NCT05340764|Infliximab|infliximab|mesh-list
101914587|NCT05340764|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101914588|NCT05340764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101914589|NCT05340764|Dermatologic Agents|dermatologic agents|mesh-ancestor
101914590|NCT05340764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101914591|NCT05340764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101914592|NCT05327361|Sunscreening Agents|sunscreening agents|mesh-list
101914593|NCT05327361|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101914594|NCT05327361|Protective Agents|protective agents|mesh-ancestor
101914595|NCT05327361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914596|NCT05327361|Dermatologic Agents|dermatologic agents|mesh-ancestor
101914597|NCT05305014|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101914598|NCT05305014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101914599|NCT05302986|Tranexamic Acid|tranexamic acid|mesh-list
101914600|NCT05302986|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101914601|NCT05302986|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101914602|NCT05302986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914603|NCT05302986|Hemostatics|hemostatics|mesh-ancestor
101914604|NCT05302986|Coagulants|coagulants|mesh-ancestor
101914605|NCT05301192|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
101914606|NCT05301192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101914607|NCT05301192|Vasodilator Agents|vasodilator agents|mesh-ancestor
101914608|NCT05300451|Daratumumab|daratumumab|mesh-list
101914609|NCT05300451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101914610|NCT05287321|Hydroxychloroquine|hydroxychloroquine|mesh-list
101914611|NCT05287321|Antimalarials|antimalarials|mesh-ancestor
101914612|NCT05287321|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101914613|NCT05287321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101914614|NCT05287321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101914615|NCT05287321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101914616|NCT05287321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914617|NCT05287321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101914618|NCT05285904|Ofatumumab|ofatumumab|mesh-list
101914619|NCT05285904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101914620|NCT05283083|Dexmedetomidine|dexmedetomidine|mesh-list
101914621|NCT05283083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101462371|NCT00199277|Iron|iron|mesh-list
101914622|NCT05283083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101914623|NCT05283083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914624|NCT05283083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101914625|NCT05283083|Analgesics|analgesics|mesh-ancestor
101914626|NCT05283083|Sensory System Agents|sensory system agents|mesh-ancestor
101914627|NCT05283083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101914628|NCT05283083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101914629|NCT05283083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101914630|NCT05283083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101914631|NCT05283083|Adrenergic Agents|adrenergic agents|mesh-ancestor
101914632|NCT05283083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101914633|NCT05283083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914634|NCT05262777|Lidocaine|lidocaine|mesh-list
101914635|NCT05262777|Anesthetics, Local|anesthetics, local|mesh-ancestor
101914636|NCT05262777|Anesthetics|anesthetics|mesh-ancestor
101914637|NCT05262777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101914638|NCT05262777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914639|NCT05262777|Sensory System Agents|sensory system agents|mesh-ancestor
101914640|NCT05262777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101914641|NCT05262777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101914642|NCT05262777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101914643|NCT05262777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101914644|NCT05262777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101914645|NCT05262777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914646|NCT05248321|Tranexamic Acid|tranexamic acid|mesh-list
101914647|NCT05248321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101914648|NCT05248321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101914649|NCT05248321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914650|NCT05248321|Hemostatics|hemostatics|mesh-ancestor
101914651|NCT05248321|Coagulants|coagulants|mesh-ancestor
101914652|NCT05241093|Cytarabine|cytarabine|mesh-list
101914653|NCT05241093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101914654|NCT05241093|Antimetabolites|antimetabolites|mesh-ancestor
101914655|NCT05241093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914656|NCT05241093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101914657|NCT05241093|Antiviral Agents|antiviral agents|mesh-ancestor
101914658|NCT05241093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101914659|NCT05241093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101914660|NCT05241093|Immunologic Factors|immunologic factors|mesh-ancestor
101914661|NCT05241093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914662|NCT05233163|Empagliflozin|empagliflozin|mesh-list
101914663|NCT05233163|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101914664|NCT05233163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914665|NCT05233163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101914666|NCT05233163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914667|NCT05229991|Ritonavir|ritonavir|mesh-list
101914668|NCT05229991|Lonafarnib|lonafarnib|mesh-list
101914669|NCT05229991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101914670|NCT05229991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101914671|NCT05229991|Protease Inhibitors|protease inhibitors|mesh-ancestor
101914672|NCT05229991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101914673|NCT05229991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914674|NCT05229991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101914675|NCT05229991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101914676|NCT05229991|Antiviral Agents|antiviral agents|mesh-ancestor
101914677|NCT05229991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101914678|NCT05229991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101914679|NCT05229991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101914680|NCT05214911|Loratadine|loratadine|mesh-list
101914681|NCT05214911|Prednisolone|prednisolone|mesh-list
101914682|NCT05214911|Desloratadine|desloratadine|mesh-list
101914683|NCT05214911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101914684|NCT05214911|Glucocorticoids|glucocorticoids|mesh-ancestor
101914685|NCT05214911|Hormones|hormones|mesh-ancestor
101229226|NCT01551485|Zolpidem|zolpidem|mesh-list
101914686|NCT05214911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101914687|NCT05214911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634555|NCT02867930|Anesthetics, General|anesthetics, general|mesh-ancestor
101914688|NCT05214911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101914689|NCT05214911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101914690|NCT05214911|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101914691|NCT05214911|Cholinergic Agents|cholinergic agents|mesh-ancestor
101914692|NCT05214911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101914693|NCT05214911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914694|NCT05214911|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101914695|NCT05214911|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101914696|NCT05214911|Histamine Antagonists|histamine antagonists|mesh-ancestor
101914697|NCT05214911|Histamine Agents|histamine agents|mesh-ancestor
101914698|NCT05214911|Antipruritics|antipruritics|mesh-ancestor
101914699|NCT05214911|Dermatologic Agents|dermatologic agents|mesh-ancestor
101914700|NCT05214911|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101914701|NCT05213884|Cisplatin|cisplatin|mesh-list
101914702|NCT05213884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101914703|NCT05211024|Penicillins|penicillins|mesh-list
101914704|NCT05211024|Penicillin G|penicillin g|mesh-list
101914705|NCT05211024|Penicillin G Benzathine|penicillin g benzathine|mesh-list
101914706|NCT05211024|Penicillin G Procaine|penicillin g procaine|mesh-list
101914707|NCT05211024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101914708|NCT05211024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101914709|NCT05210439|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101914710|NCT05210439|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101914711|NCT05210439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101957131|NCT02095366|Sufentanil|sufentanil|mesh-list
101914712|NCT05210439|Antitubercular Agents|antitubercular agents|mesh-ancestor
101914713|NCT05209984|Topiramate|topiramate|mesh-list
101914714|NCT05209984|Sibutramine|sibutramine|mesh-list
101914715|NCT05209984|Anticonvulsants|anticonvulsants|mesh-ancestor
101914716|NCT05209984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101914717|NCT05209984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914718|NCT05209984|Antidepressive Agents|antidepressive agents|mesh-ancestor
101914719|NCT05209984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101914720|NCT05209984|Appetite Depressants|appetite depressants|mesh-ancestor
101914721|NCT05209984|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101914722|NCT05204290|Pembrolizumab|pembrolizumab|mesh-list
101914723|NCT05204290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101914724|NCT05204290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101914725|NCT05204290|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101914726|NCT05204290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914727|NCT05199311|Dexamethasone|dexamethasone|mesh-list
101914728|NCT05199311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101914729|NCT05199311|Antiemetics|antiemetics|mesh-ancestor
101914730|NCT05199311|Autonomic Agents|autonomic agents|mesh-ancestor
101914731|NCT05199311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101914732|NCT05199311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914733|NCT05199311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101914734|NCT05199311|Glucocorticoids|glucocorticoids|mesh-ancestor
101914735|NCT05199311|Hormones|hormones|mesh-ancestor
101914736|NCT05199311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101914737|NCT05199311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101914738|NCT05199311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101914739|NCT05179005|Imidacloprid|imidacloprid|mesh-list
101914740|NCT05179005|Cholinergic Agents|cholinergic agents|mesh-ancestor
101914741|NCT05179005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101914742|NCT05179005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914743|NCT05179005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914744|NCT05176080|Fulvestrant|fulvestrant|mesh-list
101914745|NCT05176080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101914746|NCT05176080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101914747|NCT05176080|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101914748|NCT05176080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101914749|NCT05176080|Hormone Antagonists|hormone antagonists|mesh-ancestor
101914750|NCT05176080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101914751|NCT05176080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914752|NCT05165082|Timolol|timolol|mesh-list
101914753|NCT05165082|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101914754|NCT05165082|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101914755|NCT05165082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914756|NCT05165082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101914757|NCT05165082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101914758|NCT05165082|Adrenergic Agents|adrenergic agents|mesh-ancestor
101914759|NCT05165082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101914760|NCT05165082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914761|NCT05165082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101914762|NCT05165082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101914763|NCT05159531|Tenofovir|tenofovir|mesh-list
101914764|NCT05159531|Emtricitabine|emtricitabine|mesh-list
101914765|NCT05159531|Antiviral Agents|antiviral agents|mesh-ancestor
101914766|NCT05159531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101914767|NCT05159531|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101914768|NCT05159531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101914769|NCT05159531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101914770|NCT05159531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914771|NCT05159531|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101914772|NCT05159531|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101914773|NCT05141149|Gemcitabine|gemcitabine|mesh-list
101914774|NCT05141149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101914775|NCT05141149|Antimetabolites|antimetabolites|mesh-ancestor
101914776|NCT05141149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914777|NCT05141149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101914778|NCT05139316|Prednisolone|prednisolone|mesh-list
101914779|NCT05139316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101914780|NCT05139316|Glucocorticoids|glucocorticoids|mesh-ancestor
101914781|NCT05139316|Hormones|hormones|mesh-ancestor
101914782|NCT05139316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101914783|NCT05139316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914784|NCT05139316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101914785|NCT05139316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101914786|NCT05132504|Pembrolizumab|pembrolizumab|mesh-list
101914787|NCT05132504|Folfirinox|folfirinox|mesh-list
101914788|NCT05132504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101914789|NCT05132504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101914790|NCT05132504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101914791|NCT05132504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914792|NCT05128071|Progesterone|progesterone|mesh-list
101914793|NCT05128071|Progestins|progestins|mesh-ancestor
101914794|NCT05128071|Hormones|hormones|mesh-ancestor
101914795|NCT05128071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101914796|NCT05128071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914797|NCT05121324|Midazolam|midazolam|mesh-list
101914798|NCT05121324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101914799|NCT05121324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101914800|NCT05121324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101914801|NCT05121324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914802|NCT05121324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101914803|NCT05121324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101914804|NCT05121324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101914805|NCT05121324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101914806|NCT05121324|Anesthetics, General|anesthetics, general|mesh-ancestor
101914807|NCT05121324|Anesthetics|anesthetics|mesh-ancestor
101914808|NCT05121324|GABA Modulators|gaba modulators|mesh-ancestor
101914809|NCT05121324|GABA Agents|gaba agents|mesh-ancestor
101914810|NCT05121324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101914811|NCT05121324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914813|NCT05118672|Fexofenadine|fexofenadine|mesh-list
101914814|NCT05118672|Phenylephrine|phenylephrine|mesh-list
101914815|NCT05118672|Oxymetazoline|oxymetazoline|mesh-list
101914816|NCT05118672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101914817|NCT05118672|Analgesics|analgesics|mesh-ancestor
101914818|NCT05118672|Sensory System Agents|sensory system agents|mesh-ancestor
101914819|NCT05118672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101914820|NCT05118672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914821|NCT05118672|Antipyretics|antipyretics|mesh-ancestor
101914822|NCT05118672|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101914823|NCT05118672|Mydriatics|mydriatics|mesh-ancestor
101914824|NCT05118672|Autonomic Agents|autonomic agents|mesh-ancestor
101914825|NCT05118672|Sympathomimetics|sympathomimetics|mesh-ancestor
101914826|NCT05118672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101914827|NCT05118672|Nasal Decongestants|nasal decongestants|mesh-ancestor
101914828|NCT05118672|Respiratory System Agents|respiratory system agents|mesh-ancestor
101914829|NCT05118672|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101914830|NCT05118672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101914831|NCT05118672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101914832|NCT05118672|Adrenergic Agents|adrenergic agents|mesh-ancestor
101914833|NCT05118672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101914834|NCT05118672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914835|NCT05118672|Protective Agents|protective agents|mesh-ancestor
101914836|NCT05118672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101914837|NCT05118672|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101914838|NCT05118672|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101914839|NCT05118672|Histamine Antagonists|histamine antagonists|mesh-ancestor
101914841|NCT05114096|Betamethasone|betamethasone|mesh-list
101914842|NCT05114096|Betamethasone Valerate|betamethasone valerate|mesh-list
101914843|NCT05114096|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101914844|NCT05114096|Betamethasone benzoate|betamethasone benzoate|mesh-list
101914845|NCT05114096|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101914846|NCT05114096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101914847|NCT05114096|Glucocorticoids|glucocorticoids|mesh-ancestor
101914848|NCT05114096|Hormones|hormones|mesh-ancestor
101914849|NCT05114096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101914850|NCT05114096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914851|NCT05114096|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101914852|NCT05114096|Respiratory System Agents|respiratory system agents|mesh-ancestor
101914854|NCT05109611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101914855|NCT05109611|Autonomic Agents|autonomic agents|mesh-ancestor
101914856|NCT05109611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101914857|NCT05109611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914858|NCT05109611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101914859|NCT05109611|Respiratory System Agents|respiratory system agents|mesh-ancestor
101914860|NCT05109611|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101914861|NCT05109611|Antioxidants|antioxidants|mesh-ancestor
101914862|NCT05109611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914863|NCT05109611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101914864|NCT05109611|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101914865|NCT05109611|Vasodilator Agents|vasodilator agents|mesh-ancestor
101914866|NCT05109611|Gasotransmitters|gasotransmitters|mesh-ancestor
101914867|NCT05109611|Protective Agents|protective agents|mesh-ancestor
101914868|NCT05106153|Zolpidem|zolpidem|mesh-list
101914869|NCT05106153|Suvorexant|suvorexant|mesh-list
101914870|NCT05106153|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101914871|NCT05106153|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101914872|NCT05106153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101914873|NCT05106153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914874|NCT05106153|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101914875|NCT05106153|GABA Agonists|gaba agonists|mesh-ancestor
101914876|NCT05106153|GABA Agents|gaba agents|mesh-ancestor
101914877|NCT05106153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101914878|NCT05106153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914879|NCT05106153|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
101914880|NCT05102591|Ketorolac|ketorolac|mesh-list
101914881|NCT05102591|Metoclopramide|metoclopramide|mesh-list
101914882|NCT05102591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101914883|NCT05102591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101914884|NCT05102591|Analgesics|analgesics|mesh-ancestor
101914885|NCT05102591|Sensory System Agents|sensory system agents|mesh-ancestor
101914886|NCT05102591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101914887|NCT05102591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914889|NCT05102591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101914890|NCT05102591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101914891|NCT05102591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101914892|NCT05102591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914893|NCT05102591|Antiemetics|antiemetics|mesh-ancestor
101914894|NCT05102591|Autonomic Agents|autonomic agents|mesh-ancestor
101914895|NCT05102591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101914896|NCT05102591|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101914897|NCT05102591|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101914898|NCT05102591|Dopamine Agents|dopamine agents|mesh-ancestor
101914899|NCT05102591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101914900|NCT05097326|Misoprostol|misoprostol|mesh-list
101914901|NCT05097326|Mifepristone|mifepristone|mesh-list
101914902|NCT05097326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101914903|NCT05097326|Abortifacient Agents|abortifacient agents|mesh-ancestor
101914904|NCT05097326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101914905|NCT05097326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914906|NCT05097326|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101914907|NCT05097326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101914908|NCT05097326|Oxytocics|oxytocics|mesh-ancestor
101914909|NCT05097326|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101914910|NCT05097326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101914911|NCT05097326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101914912|NCT05097326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101634783|NCT00629642|Oxybutynin|oxybutynin|mesh-list
101914913|NCT05097326|Contraceptive Agents|contraceptive agents|mesh-ancestor
101914914|NCT05097326|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101914915|NCT05097326|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101914916|NCT05097326|Hormone Antagonists|hormone antagonists|mesh-ancestor
101914917|NCT05097326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101914918|NCT05097326|Luteolytic Agents|luteolytic agents|mesh-ancestor
101914919|NCT05097326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101914920|NCT05097326|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101914921|NCT05081492|Antibodies|antibodies|mesh-list
101914922|NCT05081492|Immunoglobulins|immunoglobulins|mesh-list
101914923|NCT05081492|Immunologic Factors|immunologic factors|mesh-ancestor
101914924|NCT05081492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914925|NCT05081102|Ibuprofen|ibuprofen|mesh-list
101914926|NCT05081102|Oxycodone|oxycodone|mesh-list
101914927|NCT05081102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101914928|NCT05081102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101914929|NCT05081102|Analgesics|analgesics|mesh-ancestor
101914930|NCT05081102|Sensory System Agents|sensory system agents|mesh-ancestor
101914931|NCT05081102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101914932|NCT05081102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914933|NCT05081102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101914934|NCT05081102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101914935|NCT05081102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101914936|NCT05081102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101914937|NCT05081102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914938|NCT05081102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101914939|NCT05081102|Narcotics|narcotics|mesh-ancestor
101914940|NCT05081102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101914941|NCT05074992|Ipilimumab|ipilimumab|mesh-list
101914942|NCT05074992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101914943|NCT05074992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101914944|NCT05074992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101914945|NCT05074992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914946|NCT05070403|Afatinib|afatinib|mesh-list
101914947|NCT05070403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101914948|NCT05070403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101914949|NCT05070403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101914950|NCT05070403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914951|NCT05063656|Gabapentin|gabapentin|mesh-list
101914952|NCT05063656|Analgesics|analgesics|mesh-ancestor
101914953|NCT05063656|Sensory System Agents|sensory system agents|mesh-ancestor
101914954|NCT05063656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101914955|NCT05063656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914956|NCT05063656|Anticonvulsants|anticonvulsants|mesh-ancestor
101914957|NCT05063656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101914958|NCT05063656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101914959|NCT05063656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101914960|NCT05063656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101914961|NCT05063656|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101914962|NCT05063656|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101914963|NCT05063656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101914964|NCT05063656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914965|NCT05063656|Antimanic Agents|antimanic agents|mesh-ancestor
101914966|NCT05060237|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101914967|NCT05060237|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101914968|NCT05060237|Dermatologic Agents|dermatologic agents|mesh-ancestor
101914969|NCT05047601|Ritonavir|ritonavir|mesh-list
101914970|NCT05047601|Nirmatrelvir|nirmatrelvir|mesh-list
101914971|NCT05047601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101914972|NCT05047601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101914973|NCT05047601|Protease Inhibitors|protease inhibitors|mesh-ancestor
101914974|NCT05047601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101914975|NCT05047601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914976|NCT05047601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101914977|NCT05047601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101914978|NCT05047601|Antiviral Agents|antiviral agents|mesh-ancestor
101914979|NCT05047601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101914980|NCT05047601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101914981|NCT05047601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101914982|NCT05043506|Palbociclib|palbociclib|mesh-list
101914983|NCT05043506|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101914984|NCT05043506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101914985|NCT05043506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101914986|NCT05043506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101914987|NCT05043506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101914988|NCT05043506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101914989|NCT05043506|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101914990|NCT05043506|Hormone Antagonists|hormone antagonists|mesh-ancestor
101914991|NCT05043506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101914992|NCT05043506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914993|NCT05022329|Vaccines|vaccines|mesh-list
101914994|NCT05022329|Immunologic Factors|immunologic factors|mesh-ancestor
101914995|NCT05022329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101914996|NCT05012371|Everolimus|everolimus|mesh-list
101914997|NCT05012371|Lenvatinib|lenvatinib|mesh-list
101914998|NCT05012371|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101914999|NCT05012371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101915000|NCT05012371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101915001|NCT05012371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915002|NCT05012371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101915003|NCT05012371|Immunologic Factors|immunologic factors|mesh-ancestor
101915004|NCT05012371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915005|NCT05012371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101915006|NCT05011760|Amphetamine|amphetamine|mesh-list
101915007|NCT05011760|Dextroamphetamine|dextroamphetamine|mesh-list
101915008|NCT05011760|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101915009|NCT05011760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915010|NCT05011760|Sympathomimetics|sympathomimetics|mesh-ancestor
101915011|NCT05011760|Autonomic Agents|autonomic agents|mesh-ancestor
101915012|NCT05011760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101915013|NCT05011760|Dopamine Agents|dopamine agents|mesh-ancestor
101915014|NCT05011760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101915015|NCT05011760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915016|NCT05011760|Adrenergic Agents|adrenergic agents|mesh-ancestor
101915017|NCT05011760|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101915018|NCT05011760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101915019|NCT05011760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101915020|NCT05011760|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101915021|NCT05008146|Hydrocortisone|hydrocortisone|mesh-list
101915022|NCT05008146|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101915023|NCT05008146|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101915024|NCT05008146|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101915025|NCT05008146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101915026|NCT05006599|Insulin|insulin|mesh-list
101915027|NCT05006599|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101915028|NCT05006599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101915029|NCT05006599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915030|NCT04998669|Rituximab|rituximab|mesh-list
101915031|NCT04998669|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
101915032|NCT04998669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101915033|NCT04998669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101915034|NCT04998669|Immunologic Factors|immunologic factors|mesh-ancestor
101915035|NCT04998669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915036|NCT04998669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101915037|NCT04998604|Omalizumab|omalizumab|mesh-list
101915038|NCT04998604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101915039|NCT04998604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101915040|NCT04998604|Respiratory System Agents|respiratory system agents|mesh-ancestor
101915041|NCT04996030|Arsenic Trioxide|arsenic trioxide|mesh-list
101915042|NCT04996030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101915043|NCT04978545|Chlorhexidine|chlorhexidine|mesh-list
101915044|NCT04978545|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101915045|NCT04978545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101915046|NCT04978545|Disinfectants|disinfectants|mesh-ancestor
101915047|NCT04972292|Dipyrone|dipyrone|mesh-list
101915048|NCT04972292|Codeine|codeine|mesh-list
101915049|NCT04972292|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101915050|NCT04972292|Narcotics|narcotics|mesh-ancestor
101915051|NCT04972292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101915052|NCT04972292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915053|NCT04972292|Analgesics|analgesics|mesh-ancestor
101915054|NCT04972292|Sensory System Agents|sensory system agents|mesh-ancestor
101915055|NCT04972292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101915056|NCT04972292|Antitussive Agents|antitussive agents|mesh-ancestor
101915057|NCT04972292|Respiratory System Agents|respiratory system agents|mesh-ancestor
101915058|NCT04972292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101915059|NCT04972292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101915060|NCT04972292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101915061|NCT04972292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101915062|NCT04972292|Antipyretics|antipyretics|mesh-ancestor
101915063|NCT04958811|Bevacizumab|bevacizumab|mesh-list
101915064|NCT04958811|Atezolizumab|atezolizumab|mesh-list
101915065|NCT04958811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101915066|NCT04958811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101915067|NCT04958811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101915068|NCT04958811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101915069|NCT04958811|Growth Substances|growth substances|mesh-ancestor
101915070|NCT04958811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915071|NCT04958811|Growth Inhibitors|growth inhibitors|mesh-ancestor
101915072|NCT04958811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101915073|NCT04958811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915074|NCT04950530|Emtricitabine|emtricitabine|mesh-list
101915075|NCT04950530|Antiviral Agents|antiviral agents|mesh-ancestor
101915076|NCT04950530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101915077|NCT04950530|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101915078|NCT04950530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101915079|NCT04950530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101915080|NCT04950530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915081|NCT04950530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101915082|NCT04950530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101915084|NCT04937699|Clopidogrel|clopidogrel|mesh-list
101915085|NCT04937699|Ticagrelor|ticagrelor|mesh-list
101915086|NCT04937699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101915087|NCT04937699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101915088|NCT04937699|Analgesics|analgesics|mesh-ancestor
101915089|NCT04937699|Sensory System Agents|sensory system agents|mesh-ancestor
101915090|NCT04937699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101915091|NCT04937699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915092|NCT04937699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101915093|NCT04937699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101915094|NCT04937699|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101915095|NCT04937699|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101915096|NCT04937699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915097|NCT04937699|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101915098|NCT04937699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101915099|NCT04937699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101915100|NCT04937699|Antipyretics|antipyretics|mesh-ancestor
101957184|NCT03555526|Metronidazole|metronidazole|mesh-list
101915101|NCT04937699|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101915102|NCT04937699|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101915103|NCT04937699|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101915104|NCT04937699|Purinergic Agents|purinergic agents|mesh-ancestor
101915105|NCT04937699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101915107|NCT04925375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101915108|NCT04925375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915109|NCT04925375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101915110|NCT04925375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101915111|NCT04925375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101915112|NCT04925375|Immunologic Factors|immunologic factors|mesh-ancestor
101915113|NCT04925375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915114|NCT04925375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101915115|NCT04920708|Fulvestrant|fulvestrant|mesh-list
101915116|NCT04920708|Palbociclib|palbociclib|mesh-list
101915117|NCT04920708|Ipatasertib|ipatasertib|mesh-list
101915118|NCT04920708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101915119|NCT04920708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101915120|NCT04920708|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101915121|NCT04920708|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101915122|NCT04920708|Hormone Antagonists|hormone antagonists|mesh-ancestor
101915123|NCT04920708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101915124|NCT04920708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915125|NCT04920708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101915126|NCT04920708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101915127|NCT04920708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915128|NCT04908956|Osimertinib|osimertinib|mesh-list
101915129|NCT04908956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101915130|NCT04908956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101915131|NCT04908956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101915132|NCT04908956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915133|NCT04891068|Azacitidine|azacitidine|mesh-list
101915134|NCT04891068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101915135|NCT04891068|Antimetabolites|antimetabolites|mesh-ancestor
101915136|NCT04891068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915137|NCT04891068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101915138|NCT04891068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101915139|NCT04889716|Obinutuzumab|obinutuzumab|mesh-list
101915140|NCT04889716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101915141|NCT04889716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101915142|NCT04883645|Imiquimod|imiquimod|mesh-list
101915143|NCT04883645|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101915144|NCT04883645|Immunologic Factors|immunologic factors|mesh-ancestor
101915145|NCT04883645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915146|NCT04883645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101915147|NCT04883645|Interferon Inducers|interferon inducers|mesh-ancestor
101915148|NCT04880499|Folic Acid|folic acid|mesh-list
101915149|NCT04880499|Riboflavin|riboflavin|mesh-list
101915150|NCT04880499|Vitamins|vitamins|mesh-ancestor
101915151|NCT04880499|Micronutrients|micronutrients|mesh-ancestor
101915152|NCT04880499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915153|NCT04880499|Hematinics|hematinics|mesh-ancestor
101915154|NCT04880499|Vitamin B Complex|vitamin b complex|mesh-ancestor
101915155|NCT04880499|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101915156|NCT04880499|Dermatologic Agents|dermatologic agents|mesh-ancestor
101915157|NCT04853719|Rivaroxaban|rivaroxaban|mesh-list
101915158|NCT04853719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915159|NCT04853719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101915160|NCT04853719|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101915161|NCT04853719|Antithrombins|antithrombins|mesh-ancestor
101915162|NCT04853719|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101915163|NCT04853719|Protease Inhibitors|protease inhibitors|mesh-ancestor
101915164|NCT04853719|Anticoagulants|anticoagulants|mesh-ancestor
101915165|NCT04852484|Ketamine|ketamine|mesh-list
101915166|NCT04852484|Morphine|morphine|mesh-list
101915167|NCT04852484|Anesthetics|anesthetics|mesh-list
101915168|NCT04852484|Anesthetics, Local|anesthetics, local|mesh-list
101915169|NCT04852484|Analgesics|analgesics|mesh-ancestor
101915170|NCT04852484|Sensory System Agents|sensory system agents|mesh-ancestor
101915171|NCT04852484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101915172|NCT04852484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915173|NCT04852484|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101915174|NCT04852484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101915175|NCT04852484|Anesthetics, General|anesthetics, general|mesh-ancestor
101915176|NCT04852484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101915177|NCT04852484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101915178|NCT04852484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101915179|NCT04852484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101915180|NCT04852484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915181|NCT04852484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101915182|NCT04852484|Narcotics|narcotics|mesh-ancestor
101915183|NCT04848480|Insulin|insulin|mesh-list
101915184|NCT04848480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101915185|NCT04848480|Insulin Aspart|insulin aspart|mesh-list
101915186|NCT04848480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101915187|NCT04848480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915188|NCT04838223|Proxymetacaine|proxymetacaine|mesh-list
101915189|NCT04838223|Anesthetics, Local|anesthetics, local|mesh-ancestor
101915190|NCT04838223|Anesthetics|anesthetics|mesh-ancestor
101915191|NCT04838223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101915192|NCT04838223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915193|NCT04838223|Sensory System Agents|sensory system agents|mesh-ancestor
101915194|NCT04838223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101915195|NCT04829604|Immunoconjugates|immunoconjugates|mesh-list
101915196|NCT04829604|Immunologic Factors|immunologic factors|mesh-ancestor
101915197|NCT04829604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915198|NCT04827147|Methamphetamine|methamphetamine|mesh-list
101915199|NCT04827147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101915200|NCT04827147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915201|NCT04827147|Sympathomimetics|sympathomimetics|mesh-ancestor
101915202|NCT04827147|Autonomic Agents|autonomic agents|mesh-ancestor
101915203|NCT04827147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101915204|NCT04827147|Dopamine Agents|dopamine agents|mesh-ancestor
101915205|NCT04827147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101915206|NCT04827147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915207|NCT04827147|Adrenergic Agents|adrenergic agents|mesh-ancestor
101915208|NCT04827147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101915209|NCT04827147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101915210|NCT04827147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101635086|NCT04144465|Phenylephrine|phenylephrine|mesh-list
101915211|NCT04827147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101915212|NCT04786873|Clonidine|clonidine|mesh-list
101915213|NCT04786873|Analgesics|analgesics|mesh-ancestor
101915214|NCT04786873|Sensory System Agents|sensory system agents|mesh-ancestor
101915215|NCT04786873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101915216|NCT04786873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915217|NCT04786873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101915218|NCT04786873|Sympatholytics|sympatholytics|mesh-ancestor
101915219|NCT04786873|Autonomic Agents|autonomic agents|mesh-ancestor
101915220|NCT04786873|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101915221|NCT04786873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101915222|NCT04786873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101915223|NCT04786873|Adrenergic Agents|adrenergic agents|mesh-ancestor
101915224|NCT04786873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101915225|NCT04786873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915226|NCT04781881|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101915227|NCT04781881|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101915228|NCT04781881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915229|NCT04771728|Metronidazole|metronidazole|mesh-list
101915230|NCT04771728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101915231|NCT04771728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101915232|NCT04771728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101915233|NCT04771728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101915234|NCT04767074|Phenylpropanolamine|phenylpropanolamine|mesh-list
101915235|NCT04767074|Guaifenesin|guaifenesin|mesh-list
101915236|NCT04767074|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
101915237|NCT04767074|Expectorants|expectorants|mesh-ancestor
101915238|NCT04767074|Respiratory System Agents|respiratory system agents|mesh-ancestor
101915239|NCT04767074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101915241|NCT04767074|Adrenergic Agents|adrenergic agents|mesh-ancestor
101915242|NCT04767074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101915243|NCT04767074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915244|NCT04767074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915245|NCT04767074|Appetite Depressants|appetite depressants|mesh-ancestor
101915246|NCT04767074|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101915247|NCT04767074|Sympathomimetics|sympathomimetics|mesh-ancestor
101915248|NCT04767074|Autonomic Agents|autonomic agents|mesh-ancestor
101915249|NCT04767074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101915250|NCT04767074|Nasal Decongestants|nasal decongestants|mesh-ancestor
101915251|NCT04767074|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101915252|NCT04764942|Dexamethasone|dexamethasone|mesh-list
101915253|NCT04764942|Dexamethasone acetate|dexamethasone acetate|mesh-list
101915254|NCT04764942|Pomalidomide|pomalidomide|mesh-list
101915255|NCT04764942|Ichthammol|ichthammol|mesh-list
101915256|NCT04764942|BB 1101|bb 1101|mesh-list
101915257|NCT04764942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101915258|NCT04764942|Antiemetics|antiemetics|mesh-ancestor
101915259|NCT04764942|Autonomic Agents|autonomic agents|mesh-ancestor
101915260|NCT04764942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101915261|NCT04764942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915262|NCT04764942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101915263|NCT04764942|Glucocorticoids|glucocorticoids|mesh-ancestor
101915264|NCT04764942|Hormones|hormones|mesh-ancestor
101915265|NCT04764942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101915266|NCT04764942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101915267|NCT04764942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101915268|NCT04764942|Protease Inhibitors|protease inhibitors|mesh-ancestor
101915269|NCT04764942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101915270|NCT04764942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915271|NCT04764942|Immunologic Factors|immunologic factors|mesh-ancestor
101915272|NCT04764942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101915273|NCT04764942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101915274|NCT04764942|Growth Substances|growth substances|mesh-ancestor
101915275|NCT04764942|Growth Inhibitors|growth inhibitors|mesh-ancestor
101915276|NCT04764942|Dermatologic Agents|dermatologic agents|mesh-ancestor
101915277|NCT04761614|Calcium, Dietary|calcium, dietary|mesh-list
101915278|NCT04761614|Leucovorin|leucovorin|mesh-list
101915279|NCT04761614|Folic Acid|folic acid|mesh-list
101915280|NCT04761614|Bevacizumab|bevacizumab|mesh-list
101915281|NCT04761614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101915282|NCT04761614|Fluorouracil|fluorouracil|mesh-list
101915283|NCT04761614|Oxaliplatin|oxaliplatin|mesh-list
101915284|NCT04761614|Riluzole|riluzole|mesh-list
101915285|NCT04761614|Endothelial Growth Factors|endothelial growth factors|mesh-list
101915286|NCT04761614|Antibodies|antibodies|mesh-list
101915287|NCT04761614|Immunoglobulins|immunoglobulins|mesh-list
101915288|NCT04761614|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101915289|NCT04761614|Immunoglobulin G|immunoglobulin g|mesh-list
101915290|NCT04761614|Calcium|calcium|mesh-list
101915291|NCT04761614|Levoleucovorin|levoleucovorin|mesh-list
101915292|NCT04761614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101915293|NCT04761614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101915294|NCT04761614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101915295|NCT04761614|Growth Substances|growth substances|mesh-ancestor
101229374|NCT01552330|Antimalarials|antimalarials|mesh-ancestor
101915296|NCT04761614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915297|NCT04761614|Growth Inhibitors|growth inhibitors|mesh-ancestor
101915298|NCT04761614|Immunologic Factors|immunologic factors|mesh-ancestor
101915299|NCT04761614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101915300|NCT04761614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101915301|NCT04761614|Antimetabolites|antimetabolites|mesh-ancestor
101915302|NCT04761614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915303|NCT04761614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101915304|NCT04761614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101915305|NCT04761614|Antidotes|antidotes|mesh-ancestor
101915306|NCT04761614|Protective Agents|protective agents|mesh-ancestor
101915307|NCT04761614|Vitamin B Complex|vitamin b complex|mesh-ancestor
101915308|NCT04761614|Vitamins|vitamins|mesh-ancestor
101915309|NCT04761614|Micronutrients|micronutrients|mesh-ancestor
101915310|NCT04761614|Hematinics|hematinics|mesh-ancestor
101915311|NCT04761614|Anticonvulsants|anticonvulsants|mesh-ancestor
101915312|NCT04761614|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101915313|NCT04761614|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101915314|NCT04761614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101915315|NCT04761614|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101915316|NCT04760860|Prazosin|prazosin|mesh-list
101915317|NCT04760860|Terazosin|terazosin|mesh-list
101915318|NCT04760860|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101915319|NCT04760860|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101915320|NCT04760860|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101915321|NCT04760860|Adrenergic Agents|adrenergic agents|mesh-ancestor
101915322|NCT04760860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101915323|NCT04760860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915324|NCT04760860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915325|NCT04760860|Urological Agents|urological agents|mesh-ancestor
101616882|NCT02843607|Immunologic Factors|immunologic factors|mesh-ancestor
101915326|NCT04760860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101915327|NCT04710199|Maraviroc|maraviroc|mesh-list
101915328|NCT04710199|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101915329|NCT04710199|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101915330|NCT04710199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915331|NCT04710199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101915332|NCT04710199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101915333|NCT04710199|Antiviral Agents|antiviral agents|mesh-ancestor
101915334|NCT04710199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101915335|NCT04710199|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101915336|NCT04700176|Dexamethasone|dexamethasone|mesh-list
101915337|NCT04700176|Daratumumab|daratumumab|mesh-list
101915338|NCT04700176|Pomalidomide|pomalidomide|mesh-list
101915339|NCT04700176|Tretinoin|tretinoin|mesh-list
101915340|NCT04700176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101915341|NCT04700176|Antiemetics|antiemetics|mesh-ancestor
101915342|NCT04700176|Autonomic Agents|autonomic agents|mesh-ancestor
101915343|NCT04700176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101915344|NCT04700176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915345|NCT04700176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101915346|NCT04700176|Glucocorticoids|glucocorticoids|mesh-ancestor
101915347|NCT04700176|Hormones|hormones|mesh-ancestor
101915348|NCT04700176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101915349|NCT04700176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101915350|NCT04700176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101915351|NCT04700176|Immunologic Factors|immunologic factors|mesh-ancestor
101915352|NCT04700176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101229384|NCT01552629|Cyclosporins|cyclosporins|mesh-list
101915353|NCT04700176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101915354|NCT04700176|Growth Substances|growth substances|mesh-ancestor
101915355|NCT04700176|Growth Inhibitors|growth inhibitors|mesh-ancestor
101915356|NCT04700176|Keratolytic Agents|keratolytic agents|mesh-ancestor
101915357|NCT04700176|Dermatologic Agents|dermatologic agents|mesh-ancestor
101915358|NCT04699240|Clotrimazole|clotrimazole|mesh-list
101915359|NCT04699240|Miconazole|miconazole|mesh-list
101915360|NCT04699240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101915361|NCT04699240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101915362|NCT04699240|Antifungal Agents|antifungal agents|mesh-ancestor
101915363|NCT04699240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101915364|NCT04699240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101915365|NCT04699240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101915366|NCT04699240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915367|NCT04699240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101915368|NCT04699240|Hormone Antagonists|hormone antagonists|mesh-ancestor
101915369|NCT04699240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101915370|NCT04699240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915371|NCT04699240|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101915372|NCT04699240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101915373|NCT04688658|Nivolumab|nivolumab|mesh-list
101915374|NCT04688658|Axitinib|axitinib|mesh-list
101915375|NCT04688658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101915376|NCT04688658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101915377|NCT04688658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101957220|NCT02102698|Ecopipam|ecopipam|mesh-list
101915378|NCT04688658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915379|NCT04688658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101915380|NCT04688658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101915381|NCT04666454|Adenosine|adenosine|mesh-list
101915382|NCT04666454|Dipyridamole|dipyridamole|mesh-list
101915383|NCT04666454|Apixaban|apixaban|mesh-list
101915384|NCT04666454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101915385|NCT04666454|Antithrombins|antithrombins|mesh-ancestor
101915386|NCT04666454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101915387|NCT04666454|Protease Inhibitors|protease inhibitors|mesh-ancestor
101915388|NCT04666454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101915389|NCT04666454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915390|NCT04666454|Anticoagulants|anticoagulants|mesh-ancestor
101915391|NCT04666454|Analgesics|analgesics|mesh-ancestor
101915392|NCT04666454|Sensory System Agents|sensory system agents|mesh-ancestor
101915393|NCT04666454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101915394|NCT04666454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915395|NCT04666454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101915396|NCT04666454|Vasodilator Agents|vasodilator agents|mesh-ancestor
101915397|NCT04666454|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101915398|NCT04666454|Purinergic Agonists|purinergic agonists|mesh-ancestor
101915399|NCT04666454|Purinergic Agents|purinergic agents|mesh-ancestor
101915400|NCT04666454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101915401|NCT04666454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101915402|NCT04666454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101915403|NCT04665856|Carboplatin|carboplatin|mesh-list
101915404|NCT04665856|Etoposide|etoposide|mesh-list
101915405|NCT04665856|Atezolizumab|atezolizumab|mesh-list
101915406|NCT04665856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101915407|NCT04665856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101915408|NCT04665856|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101915409|NCT04665856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101915410|NCT04665856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101915411|NCT04665856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915412|NCT04665856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101915413|NCT04665856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101915414|NCT04658784|Cyclopropane|cyclopropane|mesh-list
101915415|NCT04658784|Anesthetics|anesthetics|mesh-ancestor
101915416|NCT04658784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101229402|NCT01552798|Analgesics|analgesics|mesh-ancestor
101915417|NCT04658784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915418|NCT04657640|Iron|iron|mesh-list
101915419|NCT04657640|Trace Elements|trace elements|mesh-list
101915420|NCT04657640|Folic Acid|folic acid|mesh-list
101915421|NCT04657640|Micronutrients|micronutrients|mesh-list
101915422|NCT04657640|Vitamin B Complex|vitamin b complex|mesh-list
101915423|NCT04657640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915424|NCT04657640|Hematinics|hematinics|mesh-ancestor
101915425|NCT04657640|Vitamins|vitamins|mesh-ancestor
101915426|NCT04622813|Acetaminophen|acetaminophen|mesh-list
101915427|NCT04622813|Ketoprofen|ketoprofen|mesh-list
101915428|NCT04622813|Nefopam|nefopam|mesh-list
101915429|NCT04622813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101915430|NCT04622813|Analgesics|analgesics|mesh-ancestor
101915431|NCT04622813|Sensory System Agents|sensory system agents|mesh-ancestor
101915432|NCT04622813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101915433|NCT04622813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915434|NCT04622813|Antipyretics|antipyretics|mesh-ancestor
101915435|NCT04622813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101915436|NCT04622813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101915437|NCT04622813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101915438|NCT04622813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101915439|NCT04622813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101915440|NCT04622813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635306|NCT02620579|Propranolol|propranolol|mesh-list
101915441|NCT04616963|Tenofovir|tenofovir|mesh-list
101915442|NCT04616963|Emtricitabine|emtricitabine|mesh-list
101915443|NCT04616963|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
101915444|NCT04616963|Antiviral Agents|antiviral agents|mesh-ancestor
101915445|NCT04616963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101915446|NCT04616963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101915447|NCT04616963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101915448|NCT04616963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101915449|NCT04616963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915450|NCT04616963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101915451|NCT04616963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101915452|NCT04606394|Albuterol|albuterol|mesh-list
101915453|NCT04606394|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101915454|NCT04606394|Autonomic Agents|autonomic agents|mesh-ancestor
101915455|NCT04606394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101915456|NCT04606394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915457|NCT04606394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101915458|NCT04606394|Respiratory System Agents|respiratory system agents|mesh-ancestor
101915459|NCT04606394|Tocolytic Agents|tocolytic agents|mesh-ancestor
101915460|NCT04606394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101915461|NCT04606394|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101915462|NCT04606394|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101915463|NCT04606394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101915464|NCT04606394|Adrenergic Agents|adrenergic agents|mesh-ancestor
101915465|NCT04606394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101915466|NCT04606394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915467|NCT04588545|Trastuzumab|trastuzumab|mesh-list
101915468|NCT04588545|Pertuzumab|pertuzumab|mesh-list
101915469|NCT04588545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101915470|NCT04588545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101915471|NCT04586088|Apatinib|apatinib|mesh-list
101915472|NCT04586088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101915473|NCT04586088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101915474|NCT04586088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101915475|NCT04586088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915476|NCT04579523|Cyclophosphamide|cyclophosphamide|mesh-list
101915477|NCT04579523|Fludarabine|fludarabine|mesh-list
101915478|NCT04579523|Fludarabine phosphate|fludarabine phosphate|mesh-list
101915479|NCT04579523|Daratumumab|daratumumab|mesh-list
101915480|NCT04579523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101915482|NCT04579523|Immunoglobulins|immunoglobulins|mesh-list
101915483|NCT04579523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101915484|NCT04579523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101915485|NCT04579523|Immunologic Factors|immunologic factors|mesh-ancestor
101915486|NCT04579523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915487|NCT04579523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101915488|NCT04579523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101915489|NCT04579523|Alkylating Agents|alkylating agents|mesh-ancestor
101915490|NCT04579523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915491|NCT04579523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101915492|NCT04579523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101915493|NCT04579523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101915494|NCT04579523|Antimetabolites|antimetabolites|mesh-ancestor
101915495|NCT04579510|Vaccines|vaccines|mesh-list
101915496|NCT04579510|Immunologic Factors|immunologic factors|mesh-ancestor
101915497|NCT04579510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915498|NCT04579120|Corticosterone|corticosterone|mesh-list
101915499|NCT04579120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101915500|NCT04564547|Islatravir|islatravir|mesh-list
101915501|NCT04564547|Antiviral Agents|antiviral agents|mesh-ancestor
101915502|NCT04564547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101915503|NCT04564547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101915504|NCT04564547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915505|NCT04564547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101915506|NCT04564547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101915507|NCT04564547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101915508|NCT04557735|Ravulizumab|ravulizumab|mesh-list
101915509|NCT04557735|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101915510|NCT04557735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101915511|NCT04557735|Immunologic Factors|immunologic factors|mesh-ancestor
101915512|NCT04557735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915513|NCT04552223|Nivolumab|nivolumab|mesh-list
101915514|NCT04552223|Relatlimab|relatlimab|mesh-list
101915515|NCT04552223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101915516|NCT04552223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101915517|NCT04552223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101915518|NCT04552223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915520|NCT04550442|Venetoclax|venetoclax|mesh-list
101915521|NCT04550442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101915522|NCT04550442|Antimetabolites|antimetabolites|mesh-ancestor
101915523|NCT04550442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915524|NCT04550442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101915525|NCT04550442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101915526|NCT04527900|Paclitaxel|paclitaxel|mesh-list
101915527|NCT04527900|Carboplatin|carboplatin|mesh-list
101915528|NCT04527900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101915529|NCT04527900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101915530|NCT04527900|Tubulin Modulators|tubulin modulators|mesh-ancestor
101915531|NCT04527900|Antimitotic Agents|antimitotic agents|mesh-ancestor
101915532|NCT04527900|Mitosis Modulators|mitosis modulators|mesh-ancestor
101915533|NCT04527900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915534|NCT04549168|Lemborexant|lemborexant|mesh-list
101915535|NCT04549168|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
101915536|NCT04549168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101915537|NCT04549168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915538|NCT04549168|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101915539|NCT04549168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101915540|NCT04549168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101915541|NCT04549168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915542|NCT04509050|Ivacaftor|ivacaftor|mesh-list
101915543|NCT04509050|Elexacaftor|elexacaftor|mesh-list
101915544|NCT04509050|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101915545|NCT04509050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101915546|NCT04509050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915547|NCT04499248|Bimatoprost|bimatoprost|mesh-list
101915549|NCT04478734|Thiamine|thiamine|mesh-list
101915550|NCT04478734|Biotin|biotin|mesh-list
101915551|NCT04478734|Vitamin B Complex|vitamin b complex|mesh-ancestor
101915552|NCT04478734|Vitamins|vitamins|mesh-ancestor
101915553|NCT04478734|Micronutrients|micronutrients|mesh-ancestor
101915554|NCT04478734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915555|NCT04459117|Acetaminophen|acetaminophen|mesh-list
101915556|NCT04459117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101915557|NCT04459117|Analgesics|analgesics|mesh-ancestor
101915558|NCT04459117|Sensory System Agents|sensory system agents|mesh-ancestor
101915559|NCT04459117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101915560|NCT04459117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915561|NCT04459117|Antipyretics|antipyretics|mesh-ancestor
101915562|NCT04456439|Diphenhydramine|diphenhydramine|mesh-list
101915563|NCT04456439|Promethazine|promethazine|mesh-list
101915564|NCT04456439|Remestemcel-l|remestemcel-l|mesh-list
101915565|NCT04456439|Hydrocortisone|hydrocortisone|mesh-list
101915566|NCT04456439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101915567|NCT04456439|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101915568|NCT04456439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101915569|NCT04456439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101915570|NCT04456439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915571|NCT04456439|Anesthetics, Local|anesthetics, local|mesh-ancestor
101915572|NCT04456439|Anesthetics|anesthetics|mesh-ancestor
101915573|NCT04456439|Sensory System Agents|sensory system agents|mesh-ancestor
101915574|NCT04456439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101915575|NCT04456439|Antiemetics|antiemetics|mesh-ancestor
101915576|NCT04456439|Autonomic Agents|autonomic agents|mesh-ancestor
101915577|NCT04456439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101915578|NCT04456439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101915579|NCT04456439|Histamine Antagonists|histamine antagonists|mesh-ancestor
101915580|NCT04456439|Histamine Agents|histamine agents|mesh-ancestor
101915581|NCT04456439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101915582|NCT04456439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915583|NCT04456439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101915584|NCT04456439|Antipruritics|antipruritics|mesh-ancestor
101915585|NCT04456439|Dermatologic Agents|dermatologic agents|mesh-ancestor
101915586|NCT04456439|Antiviral Agents|antiviral agents|mesh-ancestor
101915587|NCT04456439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101915588|NCT04445714|Dapagliflozin|dapagliflozin|mesh-list
101915589|NCT04445714|Saxagliptin|saxagliptin|mesh-list
101915590|NCT04445714|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101915591|NCT04445714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915592|NCT04445714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101915593|NCT04445714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915594|NCT04445714|Incretins|incretins|mesh-ancestor
101915595|NCT04445714|Hormones|hormones|mesh-ancestor
101915596|NCT04445714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101915597|NCT04445714|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101915598|NCT04445714|Protease Inhibitors|protease inhibitors|mesh-ancestor
101915599|NCT04445714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101915600|NCT04435704|Oxytocin|oxytocin|mesh-list
101915601|NCT04435704|Oxytocics|oxytocics|mesh-ancestor
101915602|NCT04435704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101915603|NCT04435704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915604|NCT04433741|Oxytocin|oxytocin|mesh-list
101915605|NCT04433741|Oxytocics|oxytocics|mesh-ancestor
101915606|NCT04433741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101915607|NCT04433741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915608|NCT04431700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101915609|NCT04431206|Oxytocin|oxytocin|mesh-list
101915610|NCT04431206|Oxytocics|oxytocics|mesh-ancestor
101915611|NCT04431206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101915612|NCT04431206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915613|NCT04427709|Oxytocin|oxytocin|mesh-list
101915614|NCT04427709|Oxytocics|oxytocics|mesh-ancestor
101915615|NCT04427709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101915616|NCT04427709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915617|NCT04415476|Mycophenolic Acid|mycophenolic acid|mesh-list
101915618|NCT04415476|Sirolimus|sirolimus|mesh-list
101915619|NCT04415476|Prednisone|prednisone|mesh-list
101915620|NCT04415476|Tacrolimus|tacrolimus|mesh-list
101915621|NCT04415476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101915622|NCT04415476|Glucocorticoids|glucocorticoids|mesh-ancestor
101915623|NCT04415476|Hormones|hormones|mesh-ancestor
101915624|NCT04415476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101915625|NCT04415476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915627|NCT04415476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101915628|NCT04415476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101915629|NCT04415476|Immunologic Factors|immunologic factors|mesh-ancestor
101915630|NCT04415476|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101915631|NCT04415476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101915632|NCT04415476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915633|NCT04415476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101915634|NCT04415476|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101915635|NCT04415476|Antitubercular Agents|antitubercular agents|mesh-ancestor
101915636|NCT04415476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101915637|NCT04415476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101915638|NCT04415476|Antifungal Agents|antifungal agents|mesh-ancestor
101915639|NCT04389567|Famotidine|famotidine|mesh-list
101915640|NCT04389567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101915641|NCT04389567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101915642|NCT04389567|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101915643|NCT04389567|Histamine Antagonists|histamine antagonists|mesh-ancestor
101915644|NCT04389567|Histamine Agents|histamine agents|mesh-ancestor
101915645|NCT04389567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101915646|NCT04389567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915647|NCT04389567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915648|NCT04386967|Pembrolizumab|pembrolizumab|mesh-list
101915649|NCT04386967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101915650|NCT04386967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101915651|NCT04386967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101915652|NCT04386967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915653|NCT04384367|Naproxen|naproxen|mesh-list
101915654|NCT04384367|Rizatriptan|rizatriptan|mesh-list
101915655|NCT04384367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101915656|NCT04384367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101915657|NCT04384367|Analgesics|analgesics|mesh-ancestor
101915658|NCT04384367|Sensory System Agents|sensory system agents|mesh-ancestor
101915659|NCT04384367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101915660|NCT04384367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915661|NCT04384367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101915662|NCT04384367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101915663|NCT04384367|Gout Suppressants|gout suppressants|mesh-ancestor
101915664|NCT04384367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101915665|NCT04384367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101915666|NCT04384367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915667|NCT04384367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101915668|NCT04384367|Serotonin Agents|serotonin agents|mesh-ancestor
101915741|NCT04318548|Immunologic Factors|immunologic factors|mesh-ancestor
101915742|NCT04318548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915744|NCT04315233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101915745|NCT04315233|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101915746|NCT04315233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101915747|NCT04315233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915748|NCT04313088|Eluxadoline|eluxadoline|mesh-list
101915749|NCT04313088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101915750|NCT04301843|Eflornithine|eflornithine|mesh-list
101915751|NCT04301843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101915752|NCT04301843|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101915753|NCT04301843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101915754|NCT04301843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101915755|NCT04301843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101915756|NCT04301843|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
101915757|NCT04301843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101915758|NCT04301843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915759|NCT04299373|Ethanol|ethanol|mesh-list
101915760|NCT04299373|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101915761|NCT04299373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101915762|NCT04299373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101915763|NCT04299373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915764|NCT04294264|Trifluridine|trifluridine|mesh-list
101915765|NCT04294264|Oxaliplatin|oxaliplatin|mesh-list
101915766|NCT04294264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101915767|NCT04294264|Antimetabolites|antimetabolites|mesh-ancestor
101915768|NCT04294264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915769|NCT04294264|Antiviral Agents|antiviral agents|mesh-ancestor
101915770|NCT04294264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101915772|NCT04292808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101915773|NCT04292808|Anesthetics, General|anesthetics, general|mesh-ancestor
101915774|NCT04292808|Anesthetics|anesthetics|mesh-ancestor
101915775|NCT04292808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101915776|NCT04292808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915777|NCT04250805|Lidocaine|lidocaine|mesh-list
101915778|NCT04250805|Ropivacaine|ropivacaine|mesh-list
101915779|NCT04250805|Anesthetics, Local|anesthetics, local|mesh-ancestor
101915780|NCT04250805|Anesthetics|anesthetics|mesh-ancestor
101915781|NCT04250805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101915782|NCT04250805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915783|NCT04250805|Sensory System Agents|sensory system agents|mesh-ancestor
101915784|NCT04250805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101915785|NCT04250805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101915786|NCT04250805|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101915787|NCT04250805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101915788|NCT04250805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101915789|NCT04250805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915790|NCT04233190|Budesonide|budesonide|mesh-list
101915791|NCT04233190|Formoterol Fumarate|formoterol fumarate|mesh-list
101915792|NCT04233190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101915793|NCT04233190|Autonomic Agents|autonomic agents|mesh-ancestor
101915794|NCT04233190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101915795|NCT04233190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915796|NCT04233190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101915797|NCT04233190|Respiratory System Agents|respiratory system agents|mesh-ancestor
101957252|NCT02307656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101915798|NCT04233190|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101915799|NCT04233190|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101915800|NCT04233190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101915801|NCT04233190|Adrenergic Agents|adrenergic agents|mesh-ancestor
101915802|NCT04233190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101915803|NCT04233190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915804|NCT04233190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101915805|NCT04233190|Glucocorticoids|glucocorticoids|mesh-ancestor
101915806|NCT04233190|Hormones|hormones|mesh-ancestor
101915807|NCT04233190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101915808|NCT04214834|Morphine|morphine|mesh-list
101915809|NCT04214834|Methadone|methadone|mesh-list
101915810|NCT04214834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101915811|NCT04214834|Narcotics|narcotics|mesh-ancestor
101915812|NCT04214834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101915813|NCT04214834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915814|NCT04214834|Analgesics|analgesics|mesh-ancestor
101915815|NCT04214834|Sensory System Agents|sensory system agents|mesh-ancestor
101915816|NCT04214834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101915817|NCT04214834|Antitussive Agents|antitussive agents|mesh-ancestor
101915818|NCT04214834|Respiratory System Agents|respiratory system agents|mesh-ancestor
101915819|NCT04161118|Tisagenlecleucel|tisagenlecleucel|mesh-list
101915820|NCT04161118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101915821|NCT04161118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101915822|NCT04134884|Talazoparib|talazoparib|mesh-list
101915823|NCT04134884|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
101915824|NCT04134884|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101915825|NCT04134884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101915826|NCT04134884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915827|NCT04134884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101915828|NCT04134884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101915829|NCT04134884|Antimetabolites|antimetabolites|mesh-ancestor
101915830|NCT04119037|Morphine|morphine|mesh-list
101915831|NCT04119037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101915832|NCT04119037|Narcotics|narcotics|mesh-ancestor
101915833|NCT04119037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101915834|NCT04119037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915835|NCT04119037|Analgesics|analgesics|mesh-ancestor
101915836|NCT04119037|Sensory System Agents|sensory system agents|mesh-ancestor
101915837|NCT04119037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101915838|NCT04117087|Nivolumab|nivolumab|mesh-list
101915839|NCT04117087|Ipilimumab|ipilimumab|mesh-list
101915840|NCT04117087|Poly ICLC|poly iclc|mesh-list
101915841|NCT04117087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101915842|NCT04117087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101915843|NCT04117087|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101915844|NCT04117087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915845|NCT04117087|Interferon Inducers|interferon inducers|mesh-ancestor
101915846|NCT04117087|Immunologic Factors|immunologic factors|mesh-ancestor
101915847|NCT04117087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915849|NCT04071769|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101915850|NCT04071769|Anesthetics, General|anesthetics, general|mesh-ancestor
101915851|NCT04071769|Anesthetics|anesthetics|mesh-ancestor
101915852|NCT04071769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101915853|NCT04071769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915854|NCT04052568|Psilocybin|psilocybin|mesh-list
101915855|NCT04052568|Hallucinogens|hallucinogens|mesh-ancestor
101915856|NCT04052568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915857|NCT04052568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101915858|NCT04050670|Tirzepatide|tirzepatide|mesh-list
101915859|NCT04050670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101915860|NCT04050670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915861|NCT04050670|Incretins|incretins|mesh-ancestor
101915862|NCT04050670|Hormones|hormones|mesh-ancestor
101915863|NCT04050670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101915864|NCT04049084|Adenosine|adenosine|mesh-list
101915865|NCT04049084|Analgesics|analgesics|mesh-ancestor
101915866|NCT04049084|Sensory System Agents|sensory system agents|mesh-ancestor
101915867|NCT04049084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101915868|NCT04049084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915869|NCT04049084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101915870|NCT04049084|Vasodilator Agents|vasodilator agents|mesh-ancestor
101915871|NCT04049084|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101915872|NCT04049084|Purinergic Agonists|purinergic agonists|mesh-ancestor
101915873|NCT04049084|Purinergic Agents|purinergic agents|mesh-ancestor
101915874|NCT04049084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101915875|NCT04049084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915876|NCT04022967|Ritonavir|ritonavir|mesh-list
101915877|NCT04022967|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101915878|NCT04022967|Tenofovir|tenofovir|mesh-list
101915879|NCT04022967|Lamivudine|lamivudine|mesh-list
101915880|NCT04022967|Dolutegravir|dolutegravir|mesh-list
101915881|NCT04022967|Efavirenz|efavirenz|mesh-list
101915882|NCT04022967|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101915883|NCT04022967|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101915884|NCT04022967|Protease Inhibitors|protease inhibitors|mesh-ancestor
101915885|NCT04022967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101915886|NCT04022967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915887|NCT04022967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101915888|NCT04022967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101915889|NCT04022967|Antiviral Agents|antiviral agents|mesh-ancestor
101915890|NCT04022967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101915891|NCT04022967|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101915892|NCT04022967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101915893|NCT04022967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101915894|NCT04022967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101915895|NCT04022967|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101915896|NCT04022967|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101915897|NCT04022967|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101915898|NCT04022967|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101915899|NCT04022967|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101915900|NCT04022967|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101915901|NCT04022967|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101915903|NCT04016714|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101915904|NCT04016714|Immunologic Factors|immunologic factors|mesh-ancestor
101915905|NCT04016714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915906|NCT03988530|Scopolamine|scopolamine|mesh-list
101915907|NCT03988530|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101915908|NCT03988530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101915909|NCT03988530|Antiemetics|antiemetics|mesh-ancestor
101915910|NCT03988530|Autonomic Agents|autonomic agents|mesh-ancestor
101915911|NCT03988530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101915912|NCT03988530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915913|NCT03988530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101915914|NCT03988530|Mydriatics|mydriatics|mesh-ancestor
101915915|NCT03988530|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101915916|NCT03988530|Cholinergic Agents|cholinergic agents|mesh-ancestor
101915917|NCT03988530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101915918|NCT03988530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915920|NCT03988530|Parasympatholytics|parasympatholytics|mesh-ancestor
101915921|NCT03983824|Cytarabine|cytarabine|mesh-list
101915922|NCT03983824|Etoposide|etoposide|mesh-list
101915923|NCT03983824|Mitoxantrone|mitoxantrone|mesh-list
101915924|NCT03983824|Etoposide phosphate|etoposide phosphate|mesh-list
101915925|NCT03983824|Peposertib|peposertib|mesh-list
101915926|NCT03983824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101915927|NCT03983824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101915928|NCT03983824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101915929|NCT03983824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101915930|NCT03983824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101915931|NCT03983824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915932|NCT03983824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101915933|NCT03983824|Antimetabolites|antimetabolites|mesh-ancestor
101915934|NCT03983824|Antiviral Agents|antiviral agents|mesh-ancestor
101915935|NCT03983824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101915936|NCT03983824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101915937|NCT03983824|Immunologic Factors|immunologic factors|mesh-ancestor
101957269|NCT02098330|Antiemetics|antiemetics|mesh-ancestor
101915938|NCT03983824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915939|NCT03983824|Analgesics|analgesics|mesh-ancestor
101915940|NCT03983824|Sensory System Agents|sensory system agents|mesh-ancestor
101915941|NCT03983824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101915942|NCT03983824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101915943|NCT03980769|Fludarabine|fludarabine|mesh-list
101915944|NCT03980769|Fludarabine phosphate|fludarabine phosphate|mesh-list
101915945|NCT03980769|Thiotepa|thiotepa|mesh-list
101915946|NCT03980769|Treosulfan|treosulfan|mesh-list
101915947|NCT03980769|Busulfan|busulfan|mesh-list
101915948|NCT03980769|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101915949|NCT03980769|Thymoglobulin|thymoglobulin|mesh-list
101915950|NCT03980769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101915951|NCT03980769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101915952|NCT03980769|Antimetabolites|antimetabolites|mesh-ancestor
101915953|NCT03980769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915954|NCT03980769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101915955|NCT03980769|Immunologic Factors|immunologic factors|mesh-ancestor
101915956|NCT03980769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915957|NCT03980769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101915958|NCT03980769|Alkylating Agents|alkylating agents|mesh-ancestor
101915959|NCT03980769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101915960|NCT03972657|Cemiplimab|cemiplimab|mesh-list
101915961|NCT03972657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101915962|NCT03972657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101915963|NCT03948243|Tolbutamide|tolbutamide|mesh-list
101915964|NCT03948243|Dextromethorphan|dextromethorphan|mesh-list
101915965|NCT03948243|Alprazolam|alprazolam|mesh-list
101915966|NCT03948243|Caffeine|caffeine|mesh-list
101915967|NCT03948243|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101915968|NCT03948243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915969|NCT03948243|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101915970|NCT03948243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101915971|NCT03948243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101915972|NCT03948243|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101915973|NCT03948243|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101915974|NCT03948243|Purinergic Agents|purinergic agents|mesh-ancestor
101915975|NCT03948243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101915976|NCT03948243|Antitussive Agents|antitussive agents|mesh-ancestor
101915977|NCT03948243|Respiratory System Agents|respiratory system agents|mesh-ancestor
101915978|NCT03948243|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101915979|NCT03948243|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101915980|NCT03948243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101915981|NCT03948243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101915982|NCT03948243|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101915983|NCT03948243|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101915984|NCT03948243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101915985|NCT03948243|GABA Modulators|gaba modulators|mesh-ancestor
101915986|NCT03948243|GABA Agents|gaba agents|mesh-ancestor
101915987|NCT03948243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101915988|NCT03948035|Dexamethasone|dexamethasone|mesh-list
101915989|NCT03948035|Dexamethasone acetate|dexamethasone acetate|mesh-list
101915990|NCT03948035|Lenalidomide|lenalidomide|mesh-list
101915991|NCT03948035|Elotuzumab|elotuzumab|mesh-list
101915992|NCT03948035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101915993|NCT03948035|Antiemetics|antiemetics|mesh-ancestor
101915994|NCT03948035|Autonomic Agents|autonomic agents|mesh-ancestor
101915995|NCT03948035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101915996|NCT03948035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101915997|NCT03948035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101915998|NCT03948035|Glucocorticoids|glucocorticoids|mesh-ancestor
101916000|NCT03948035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101916001|NCT03948035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101916002|NCT03948035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916003|NCT03948035|Immunologic Factors|immunologic factors|mesh-ancestor
101916004|NCT03948035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101916005|NCT03948035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101916006|NCT03948035|Growth Substances|growth substances|mesh-ancestor
101916007|NCT03948035|Growth Inhibitors|growth inhibitors|mesh-ancestor
101916008|NCT03946124|Fesoterodine|fesoterodine|mesh-list
101916009|NCT03946124|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101916010|NCT03946124|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101916011|NCT03946124|Cholinergic Agents|cholinergic agents|mesh-ancestor
101916012|NCT03946124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101916013|NCT03946124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916014|NCT03946124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916015|NCT03946124|Urological Agents|urological agents|mesh-ancestor
101916016|NCT03942224|Dexamethasone|dexamethasone|mesh-list
101916017|NCT03942224|Bortezomib|bortezomib|mesh-list
101916018|NCT03942224|Daratumumab|daratumumab|mesh-list
101916019|NCT03942224|Ixazomib|ixazomib|mesh-list
101916020|NCT03942224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101916021|NCT03942224|Antiemetics|antiemetics|mesh-ancestor
101916022|NCT03942224|Autonomic Agents|autonomic agents|mesh-ancestor
101916023|NCT03942224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101916024|NCT03942224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916025|NCT03942224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101916026|NCT03942224|Glucocorticoids|glucocorticoids|mesh-ancestor
101916027|NCT03942224|Hormones|hormones|mesh-ancestor
101916028|NCT03942224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101916029|NCT03942224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101916030|NCT03942224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916031|NCT03942224|Protease Inhibitors|protease inhibitors|mesh-ancestor
101916032|NCT03942224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101916033|NCT03942224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916034|NCT03938701|Adalimumab|adalimumab|mesh-list
101916035|NCT03938701|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101916036|NCT03938701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101916037|NCT03938701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101916038|NCT03936933|Goserelin|goserelin|mesh-list
101916039|NCT03936933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101916040|NCT03936933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916041|NCT03936218|Goserelin|goserelin|mesh-list
101916042|NCT03936218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101916043|NCT03936218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916044|NCT03895099|Desogestrel|desogestrel|mesh-list
101916045|NCT03895099|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101916046|NCT03895099|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101635914|NCT00644085|Aspirin|aspirin|mesh-list
101916047|NCT03895099|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101916048|NCT03895099|Contraceptive Agents|contraceptive agents|mesh-ancestor
101916049|NCT03895099|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101916050|NCT03895099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916051|NCT03895099|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101916052|NCT03895099|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101916053|NCT03895099|Progestins|progestins|mesh-ancestor
101916055|NCT03895099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101916056|NCT03879798|Irinotecan|irinotecan|mesh-list
101916057|NCT03879798|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101916058|NCT03879798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101916059|NCT03879798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101916060|NCT03879798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916061|NCT03879798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916062|NCT03818685|Capecitabine|capecitabine|mesh-list
101916063|NCT03818685|Nivolumab|nivolumab|mesh-list
101916064|NCT03818685|Ipilimumab|ipilimumab|mesh-list
101916065|NCT03818685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101916066|NCT03818685|Antimetabolites|antimetabolites|mesh-ancestor
101916067|NCT03818685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916068|NCT03818685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916069|NCT03818685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101916070|NCT03818685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101916071|NCT03815058|Pembrolizumab|pembrolizumab|mesh-list
101229506|NCT01553773|Hormones|hormones|mesh-ancestor
101916072|NCT03815058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101916073|NCT03815058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916074|NCT03815058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101916075|NCT03815058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916076|NCT03801122|Tranexamic Acid|tranexamic acid|mesh-list
101916077|NCT03801122|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101916078|NCT03801122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101916079|NCT03801122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916080|NCT03801122|Hemostatics|hemostatics|mesh-ancestor
101916081|NCT03801122|Coagulants|coagulants|mesh-ancestor
101916082|NCT03797066|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
101916083|NCT03797066|Antiviral Agents|antiviral agents|mesh-ancestor
101916084|NCT03797066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101916085|NCT03771677|Interferons|interferons|mesh-list
101916086|NCT03771677|Interferon-alpha|interferon-alpha|mesh-list
101916087|NCT03771677|Interferon alpha-2|interferon alpha-2|mesh-list
101916088|NCT03771677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916089|NCT03771677|Antiviral Agents|antiviral agents|mesh-ancestor
101916090|NCT03771677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101916091|NCT03771677|Immunologic Factors|immunologic factors|mesh-ancestor
101916092|NCT03771677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916093|NCT03771651|Aspirin|aspirin|mesh-list
101916094|NCT03771651|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101916095|NCT03771651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101916096|NCT03771651|Analgesics|analgesics|mesh-ancestor
101916097|NCT03771651|Sensory System Agents|sensory system agents|mesh-ancestor
101916098|NCT03771651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101916099|NCT03771651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916100|NCT03771651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101916101|NCT03771651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101916102|NCT03771651|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101916103|NCT03771651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101916104|NCT03771651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916105|NCT03771651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101916106|NCT03771651|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101916107|NCT03771651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101916108|NCT03771651|Antipyretics|antipyretics|mesh-ancestor
101916109|NCT03770767|Insulin|insulin|mesh-list
101916110|NCT03770767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101916111|NCT03770767|Insulin Aspart|insulin aspart|mesh-list
101916112|NCT03770767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101916113|NCT03770767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916114|NCT03769155|Nivolumab|nivolumab|mesh-list
101916115|NCT03769155|Ipilimumab|ipilimumab|mesh-list
101916116|NCT03769155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101916117|NCT03769155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916118|NCT03769155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101916119|NCT03769155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916120|NCT03756896|Dexamethasone|dexamethasone|mesh-list
101916121|NCT03756896|Pomalidomide|pomalidomide|mesh-list
101916122|NCT03756896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101916123|NCT03756896|Antiemetics|antiemetics|mesh-ancestor
101916124|NCT03756896|Autonomic Agents|autonomic agents|mesh-ancestor
101916125|NCT03756896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101916126|NCT03756896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916127|NCT03756896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101916128|NCT03756896|Glucocorticoids|glucocorticoids|mesh-ancestor
101916129|NCT03756896|Hormones|hormones|mesh-ancestor
101916130|NCT03756896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101916131|NCT03756896|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101916132|NCT03756896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916133|NCT03756896|Immunologic Factors|immunologic factors|mesh-ancestor
101916134|NCT03756896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101916135|NCT03756896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101916136|NCT03756896|Growth Substances|growth substances|mesh-ancestor
101916137|NCT03756896|Growth Inhibitors|growth inhibitors|mesh-ancestor
101916138|NCT03747575|Astegolimab|astegolimab|mesh-list
101916139|NCT03747575|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101916140|NCT03747575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101916141|NCT03747575|Antiviral Agents|antiviral agents|mesh-ancestor
101916142|NCT03747575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101916143|NCT03747419|Avelumab|avelumab|mesh-list
101916144|NCT03747419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101916145|NCT03747419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916146|NCT03733145|Angiotensin II|angiotensin ii|mesh-list
101916147|NCT03733145|Giapreza|giapreza|mesh-list
101916148|NCT03733145|Angiotensinogen|angiotensinogen|mesh-list
101916149|NCT03733145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101916150|NCT03733145|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101916151|NCT03733145|Protease Inhibitors|protease inhibitors|mesh-ancestor
101916152|NCT03733145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101916153|NCT03733145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916154|NCT03715972|Hydroxyurea|hydroxyurea|mesh-list
101916155|NCT03715972|Acetazolamide|acetazolamide|mesh-list
101916156|NCT03715972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916157|NCT03715972|Antisickling Agents|antisickling agents|mesh-ancestor
101916158|NCT03715972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101916159|NCT03715972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916160|NCT03715972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101916161|NCT03715972|Anticonvulsants|anticonvulsants|mesh-ancestor
101916162|NCT03715972|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101916163|NCT03715972|Diuretics|diuretics|mesh-ancestor
101916164|NCT03715972|Natriuretic Agents|natriuretic agents|mesh-ancestor
101916165|NCT03715972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916166|NCT03702218|Antiviral Agents|antiviral agents|mesh-list
101916167|NCT03702218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101916168|NCT03691714|Cetuximab|cetuximab|mesh-list
101916169|NCT03691714|Durvalumab|durvalumab|mesh-list
101916170|NCT03691714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101916171|NCT03691714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916172|NCT03691493|Tamoxifen|tamoxifen|mesh-list
101916173|NCT03691493|Letrozole|letrozole|mesh-list
101916174|NCT03691493|Fulvestrant|fulvestrant|mesh-list
101916175|NCT03691493|Palbociclib|palbociclib|mesh-list
101916176|NCT03691493|Anastrozole|anastrozole|mesh-list
101916177|NCT03691493|Exemestane|exemestane|mesh-list
101916178|NCT03691493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916179|NCT03691493|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101916180|NCT03691493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101916181|NCT03691493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101916182|NCT03691493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916183|NCT03691493|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101916184|NCT03691493|Hormone Antagonists|hormone antagonists|mesh-ancestor
101916185|NCT03691493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101916186|NCT03691493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916187|NCT03691493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101916188|NCT03691493|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101916189|NCT03691493|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101916190|NCT03691493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101916191|NCT03691493|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101916192|NCT03691493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101916193|NCT03657043|Tisotumab vedotin|tisotumab vedotin|mesh-list
101916194|NCT03657043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101916195|NCT03657043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916196|NCT03634540|Belzutifan|belzutifan|mesh-list
101574927|NCT04300959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916197|NCT03634540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916199|NCT03631706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101916200|NCT03631706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916201|NCT03631706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101916202|NCT03631706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916203|NCT03619876|Adalimumab|adalimumab|mesh-list
101916204|NCT03619876|Abatacept|abatacept|mesh-list
101916205|NCT03619876|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101916206|NCT03619876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101916207|NCT03619876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101916208|NCT03619876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101916209|NCT03619876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916210|NCT03619876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101916211|NCT03619876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916212|NCT03619876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101916213|NCT03619876|Immunologic Factors|immunologic factors|mesh-ancestor
101957292|NCT02103166|Cholinergic Agents|cholinergic agents|mesh-ancestor
101916214|NCT03619876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916215|NCT03605901|Methadone|methadone|mesh-list
101916216|NCT03605901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101916217|NCT03605901|Narcotics|narcotics|mesh-ancestor
101916218|NCT03605901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101916219|NCT03605901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916220|NCT03605901|Analgesics|analgesics|mesh-ancestor
101916221|NCT03605901|Sensory System Agents|sensory system agents|mesh-ancestor
101916222|NCT03605901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101916223|NCT03605901|Antitussive Agents|antitussive agents|mesh-ancestor
101916224|NCT03605901|Respiratory System Agents|respiratory system agents|mesh-ancestor
101916225|NCT03583255|Dexamethasone|dexamethasone|mesh-list
101916226|NCT03583255|Dexamethasone acetate|dexamethasone acetate|mesh-list
101916227|NCT03583255|Ichthammol|ichthammol|mesh-list
101916228|NCT03583255|BB 1101|bb 1101|mesh-list
101916229|NCT03583255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101916230|NCT03583255|Antiemetics|antiemetics|mesh-ancestor
101916231|NCT03583255|Autonomic Agents|autonomic agents|mesh-ancestor
101916232|NCT03583255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101916233|NCT03583255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916234|NCT03583255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101916235|NCT03583255|Glucocorticoids|glucocorticoids|mesh-ancestor
101916236|NCT03583255|Hormones|hormones|mesh-ancestor
101916237|NCT03583255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101916238|NCT03583255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101916239|NCT03583255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916240|NCT03583255|Protease Inhibitors|protease inhibitors|mesh-ancestor
101916241|NCT03583255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101916242|NCT03583255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916243|NCT03583255|Dermatologic Agents|dermatologic agents|mesh-ancestor
101916244|NCT03579771|Paclitaxel|paclitaxel|mesh-list
101916245|NCT03579771|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101916246|NCT03579771|Gemcitabine|gemcitabine|mesh-list
101916247|NCT03579771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101916248|NCT03579771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916249|NCT03579771|Tubulin Modulators|tubulin modulators|mesh-ancestor
101916250|NCT03579771|Antimitotic Agents|antimitotic agents|mesh-ancestor
101916251|NCT03579771|Mitosis Modulators|mitosis modulators|mesh-ancestor
101916252|NCT03579771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916253|NCT03579771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101916254|NCT03579771|Antimetabolites|antimetabolites|mesh-ancestor
101916255|NCT03578081|Dexamethasone|dexamethasone|mesh-list
101916256|NCT03578081|Ondansetron|ondansetron|mesh-list
101916257|NCT03578081|Olanzapine|olanzapine|mesh-list
101916258|NCT03578081|Palonosetron|palonosetron|mesh-list
101916259|NCT03578081|Fosaprepitant|fosaprepitant|mesh-list
101916260|NCT03578081|Aprepitant|aprepitant|mesh-list
101916261|NCT03578081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101916262|NCT03578081|Antiemetics|antiemetics|mesh-ancestor
101916263|NCT03578081|Autonomic Agents|autonomic agents|mesh-ancestor
101916264|NCT03578081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101916265|NCT03578081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916266|NCT03578081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101916267|NCT03578081|Glucocorticoids|glucocorticoids|mesh-ancestor
101916268|NCT03578081|Hormones|hormones|mesh-ancestor
101916269|NCT03578081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101916270|NCT03578081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101916271|NCT03578081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916272|NCT03578081|Antipruritics|antipruritics|mesh-ancestor
101916273|NCT03578081|Dermatologic Agents|dermatologic agents|mesh-ancestor
101916274|NCT03578081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101916275|NCT03578081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101916277|NCT03578081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101916278|NCT03578081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916279|NCT03578081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101916280|NCT03578081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101916281|NCT03578081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101916282|NCT03578081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101916283|NCT03578081|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101916284|NCT03578081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101916285|NCT03578081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101916286|NCT03578081|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101916287|NCT03540420|Atezolizumab|atezolizumab|mesh-list
101916288|NCT03540420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101916289|NCT03540420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916290|NCT03540420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101916291|NCT03540420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916292|NCT03510884|Nicotinic Acids|nicotinic acids|mesh-list
101916293|NCT03510884|Niacin|niacin|mesh-list
101916294|NCT03510884|Niacinamide|niacinamide|mesh-list
101916295|NCT03510884|Atorvastatin|atorvastatin|mesh-list
101916296|NCT03510884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101916297|NCT03510884|Simvastatin|simvastatin|mesh-list
101916298|NCT03510884|Ezetimibe|ezetimibe|mesh-list
101916299|NCT03510884|Pravastatin|pravastatin|mesh-list
101916300|NCT03510884|Alirocumab|alirocumab|mesh-list
101916301|NCT03510884|Lovastatin|lovastatin|mesh-list
101916302|NCT03510884|Cholestyramine Resin|cholestyramine resin|mesh-list
101916303|NCT03510884|Fenofibrate|fenofibrate|mesh-list
101916304|NCT03510884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101916305|NCT03510884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101916306|NCT03510884|Antimetabolites|antimetabolites|mesh-ancestor
101916307|NCT03510884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916308|NCT03510884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101916309|NCT03510884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101916310|NCT03510884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101916311|NCT03510884|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101916312|NCT03510884|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101916313|NCT03510884|Protease Inhibitors|protease inhibitors|mesh-ancestor
101916314|NCT03510884|Vitamin B Complex|vitamin b complex|mesh-ancestor
101916315|NCT03510884|Vitamins|vitamins|mesh-ancestor
101916316|NCT03510884|Micronutrients|micronutrients|mesh-ancestor
101916317|NCT03510884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916318|NCT03510884|Vasodilator Agents|vasodilator agents|mesh-ancestor
101916319|NCT03506360|Dexamethasone|dexamethasone|mesh-list
101916320|NCT03506360|Dexamethasone acetate|dexamethasone acetate|mesh-list
101916321|NCT03506360|Pembrolizumab|pembrolizumab|mesh-list
101916322|NCT03506360|Ixazomib|ixazomib|mesh-list
101916323|NCT03506360|Ichthammol|ichthammol|mesh-list
101916324|NCT03506360|BB 1101|bb 1101|mesh-list
101916325|NCT03506360|Glycine|glycine|mesh-list
101916326|NCT03506360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101916327|NCT03506360|Antiemetics|antiemetics|mesh-ancestor
101916328|NCT03506360|Autonomic Agents|autonomic agents|mesh-ancestor
101916329|NCT03506360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101916330|NCT03506360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916331|NCT03506360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101916332|NCT03506360|Glucocorticoids|glucocorticoids|mesh-ancestor
101916333|NCT03506360|Hormones|hormones|mesh-ancestor
101916334|NCT03506360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101916335|NCT03506360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101916336|NCT03506360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916337|NCT03506360|Protease Inhibitors|protease inhibitors|mesh-ancestor
101916338|NCT03506360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101916339|NCT03506360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916340|NCT03506360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101916341|NCT03506360|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101916342|NCT03506360|Dermatologic Agents|dermatologic agents|mesh-ancestor
101916343|NCT03506360|Glycine Agents|glycine agents|mesh-ancestor
101916344|NCT03506360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101916346|NCT03497975|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101916347|NCT03497975|Narcotics|narcotics|mesh-ancestor
101916348|NCT03497975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101916349|NCT03497975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916350|NCT03497975|Analgesics|analgesics|mesh-ancestor
101916351|NCT03497975|Sensory System Agents|sensory system agents|mesh-ancestor
101916352|NCT03497975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101916353|NCT03497169|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101916354|NCT03497169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101916355|NCT03497169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616905|NCT00899847|Cyclosporins|cyclosporins|mesh-list
101916356|NCT03497169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101916357|NCT03497169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101916358|NCT03497169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101916359|NCT03497169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916361|NCT03497169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101916362|NCT03497143|Lamotrigine|lamotrigine|mesh-list
101916363|NCT03497143|Anticonvulsants|anticonvulsants|mesh-ancestor
101916364|NCT03497143|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101916365|NCT03497143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101916366|NCT03497143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916367|NCT03497143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101916368|NCT03497143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916369|NCT03497143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101916370|NCT03497143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101916371|NCT03497143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101916372|NCT03497143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101916373|NCT03497143|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101916374|NCT03478514|Palbociclib|palbociclib|mesh-list
101916375|NCT03478514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916376|NCT03478514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101916377|NCT03478514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101916378|NCT03478514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916379|NCT03456843|Ascorbic Acid|ascorbic acid|mesh-list
101916381|NCT03456843|Methyltestosterone|methyltestosterone|mesh-list
101916382|NCT03456843|Hormones|hormones|mesh-list
101916383|NCT03456843|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101916384|NCT03456843|Androgens|androgens|mesh-list
101916385|NCT03456843|Androgen Antagonists|androgen antagonists|mesh-list
101916386|NCT03456843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916387|NCT03456843|Tubulin Modulators|tubulin modulators|mesh-ancestor
101916388|NCT03456843|Antimitotic Agents|antimitotic agents|mesh-ancestor
101916389|NCT03456843|Mitosis Modulators|mitosis modulators|mesh-ancestor
101916390|NCT03456843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916391|NCT03456843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101916392|NCT03456843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916393|NCT03456843|Antioxidants|antioxidants|mesh-ancestor
101916394|NCT03456843|Protective Agents|protective agents|mesh-ancestor
101916395|NCT03456843|Vitamins|vitamins|mesh-ancestor
101916396|NCT03456843|Micronutrients|micronutrients|mesh-ancestor
101916397|NCT03456843|Estrogens|estrogens|mesh-ancestor
101916398|NCT03456843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101916399|NCT03456843|Anabolic Agents|anabolic agents|mesh-ancestor
101916400|NCT03456843|Hormone Antagonists|hormone antagonists|mesh-ancestor
101916401|NCT03455829|Osimertinib|osimertinib|mesh-list
101916402|NCT03455829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916403|NCT03455829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101916404|NCT03455829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101916405|NCT03455829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916406|NCT03453489|Tryptophan|tryptophan|mesh-list
101916407|NCT03453489|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101916408|NCT03453489|Antidepressive Agents|antidepressive agents|mesh-ancestor
101916409|NCT03453489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101916410|NCT03440190|Methylphenidate|methylphenidate|mesh-list
101916411|NCT03440190|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101916412|NCT03440190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916413|NCT03440190|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101916414|NCT03440190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101916415|NCT03440190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101916416|NCT03440190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916417|NCT03440190|Dopamine Agents|dopamine agents|mesh-ancestor
101916418|NCT03440190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101916419|NCT03434262|Gemcitabine|gemcitabine|mesh-list
101916420|NCT03434262|Trametinib|trametinib|mesh-list
101916421|NCT03434262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101916422|NCT03434262|Antimetabolites|antimetabolites|mesh-ancestor
101916423|NCT03434262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916424|NCT03434262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916425|NCT03434262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101916426|NCT03434262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101916428|NCT03429244|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101916429|NCT03429244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916430|NCT03408587|Ipilimumab|ipilimumab|mesh-list
101916431|NCT03408587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101916432|NCT03408587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916433|NCT03408587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101916434|NCT03408587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916435|NCT03387553|Immunomodulating Agents|immunomodulating agents|mesh-list
101916436|NCT03387553|Immunologic Factors|immunologic factors|mesh-ancestor
101916437|NCT03387553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916438|NCT03370276|Nivolumab|nivolumab|mesh-list
101916439|NCT03370276|Cetuximab|cetuximab|mesh-list
101916440|NCT03370276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101916441|NCT03370276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916442|NCT03370276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101916443|NCT03370276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916444|NCT03331341|Doxorubicin|doxorubicin|mesh-list
101916445|NCT03331341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101916446|NCT03331341|Pembrolizumab|pembrolizumab|mesh-list
101916447|NCT03331341|Dacarbazine|dacarbazine|mesh-list
101916448|NCT03331341|Vinblastine|vinblastine|mesh-list
101916449|NCT03331341|Imidazole|imidazole|mesh-list
101916450|NCT03331341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101916451|NCT03331341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916452|NCT03331341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101916453|NCT03331341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101916454|NCT03331341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101916455|NCT03331341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916456|NCT03331341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101916457|NCT03331341|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101916458|NCT03331341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101916459|NCT03331341|Alkylating Agents|alkylating agents|mesh-ancestor
101916460|NCT03331341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101916461|NCT03331341|Tubulin Modulators|tubulin modulators|mesh-ancestor
101916462|NCT03331341|Antimitotic Agents|antimitotic agents|mesh-ancestor
101916463|NCT03331341|Mitosis Modulators|mitosis modulators|mesh-ancestor
101916464|NCT03319745|Pembrolizumab|pembrolizumab|mesh-list
101916465|NCT03319745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101916466|NCT03319745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916467|NCT03319745|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101916468|NCT03319745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916469|NCT03314636|Dexamethasone|dexamethasone|mesh-list
101916470|NCT03314636|Lenalidomide|lenalidomide|mesh-list
101916471|NCT03314636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101916472|NCT03314636|Antiemetics|antiemetics|mesh-ancestor
101916473|NCT03314636|Autonomic Agents|autonomic agents|mesh-ancestor
101916474|NCT03314636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101916475|NCT03314636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916476|NCT03314636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101916477|NCT03314636|Glucocorticoids|glucocorticoids|mesh-ancestor
101916478|NCT03314636|Hormones|hormones|mesh-ancestor
101916479|NCT03314636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101916480|NCT03314636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101957325|NCT02100046|Ethosuximide|ethosuximide|mesh-list
101916481|NCT03314636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916482|NCT03314636|Immunologic Factors|immunologic factors|mesh-ancestor
101916483|NCT03314636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101916484|NCT03314636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101916485|NCT03314636|Growth Substances|growth substances|mesh-ancestor
101229607|NCT01554852|Melphalan|melphalan|mesh-list
101916486|NCT03314636|Growth Inhibitors|growth inhibitors|mesh-ancestor
101916488|NCT03310541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101916489|NCT03310541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916490|NCT03310541|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101916491|NCT03310541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101916492|NCT03310541|Hormone Antagonists|hormone antagonists|mesh-ancestor
101916493|NCT03310541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101916494|NCT03310541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916495|NCT03279861|Valsartan|valsartan|mesh-list
101916496|NCT03279861|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101916497|NCT03279861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101916498|NCT03279861|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101916499|NCT03279861|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101916500|NCT03279861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916501|NCT03277729|Cyclophosphamide|cyclophosphamide|mesh-list
101916502|NCT03277729|Fludarabine|fludarabine|mesh-list
101916503|NCT03277729|Fludarabine phosphate|fludarabine phosphate|mesh-list
101916504|NCT03277729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101916505|NCT03277729|Immunologic Factors|immunologic factors|mesh-ancestor
101916506|NCT03277729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916507|NCT03277729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101916508|NCT03277729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101916509|NCT03277729|Alkylating Agents|alkylating agents|mesh-ancestor
101916510|NCT03277729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916511|NCT03277729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916512|NCT03277729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101916513|NCT03277729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101916514|NCT03277729|Antimetabolites|antimetabolites|mesh-ancestor
101916515|NCT03250832|Bevacizumab|bevacizumab|mesh-list
101916516|NCT03250832|Dostarlimab|dostarlimab|mesh-list
101916517|NCT03250832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101916518|NCT03250832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916519|NCT03250832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101916520|NCT03250832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101916521|NCT03250832|Growth Substances|growth substances|mesh-ancestor
101916522|NCT03250832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916523|NCT03250832|Growth Inhibitors|growth inhibitors|mesh-ancestor
101916524|NCT03250117|Ropinirole|ropinirole|mesh-list
101916525|NCT03250117|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101916526|NCT03250117|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101916527|NCT03250117|Dopamine Agonists|dopamine agonists|mesh-ancestor
101916528|NCT03250117|Dopamine Agents|dopamine agents|mesh-ancestor
101916529|NCT03250117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101916530|NCT03250117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916531|NCT03250117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916532|NCT03236935|Pembrolizumab|pembrolizumab|mesh-list
101916533|NCT03236935|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
101916534|NCT03236935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101916535|NCT03236935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916536|NCT03236935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101916537|NCT03236935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916538|NCT03236935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101916539|NCT03230838|Meropenem|meropenem|mesh-list
101916540|NCT03230838|Tazobactam|tazobactam|mesh-list
101916541|NCT03230838|Ceftolozane|ceftolozane|mesh-list
101916542|NCT03230838|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
101916543|NCT03230838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101916544|NCT03230838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101916545|NCT03230838|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101916546|NCT03230838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101916547|NCT03230838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916548|NCT03230838|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101916549|NCT03217136|Metronidazole|metronidazole|mesh-list
101916550|NCT03217136|Meropenem|meropenem|mesh-list
101916551|NCT03217136|Tazobactam|tazobactam|mesh-list
101916552|NCT03217136|Ceftolozane|ceftolozane|mesh-list
101916553|NCT03217136|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
101916554|NCT03217136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101916555|NCT03217136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101916556|NCT03217136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101916557|NCT03217136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101916558|NCT03217136|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101916559|NCT03217136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101916560|NCT03217136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916561|NCT03217136|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101916562|NCT03201939|Lisinopril|lisinopril|mesh-list
101916563|NCT03201939|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101916564|NCT03201939|Protease Inhibitors|protease inhibitors|mesh-ancestor
101916565|NCT03201939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101916566|NCT03201939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916567|NCT03201939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101916568|NCT03201939|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101916569|NCT03201939|Protective Agents|protective agents|mesh-ancestor
101636431|NCT00646191|Adalimumab|adalimumab|mesh-list
101916570|NCT03201939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916572|NCT03179761|Immunologic Factors|immunologic factors|mesh-ancestor
101916573|NCT03179761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916574|NCT03173248|Azacitidine|azacitidine|mesh-list
101916575|NCT03173248|Ivosidenib|ivosidenib|mesh-list
101775298|NCT00936195|Lopinavir|lopinavir|mesh-list
101916576|NCT03173248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101916577|NCT03173248|Antimetabolites|antimetabolites|mesh-ancestor
101916578|NCT03173248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916579|NCT03173248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916580|NCT03173248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101916581|NCT03158064|Durvalumab|durvalumab|mesh-list
101916582|NCT03158064|Tremelimumab|tremelimumab|mesh-list
101916583|NCT03158064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101916584|NCT03158064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916585|NCT03122886|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101916586|NCT03122886|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
101916587|NCT03122886|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101916588|NCT03122886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101916589|NCT03090165|Bicalutamide|bicalutamide|mesh-list
101916590|NCT03090165|Androgen Antagonists|androgen antagonists|mesh-ancestor
101916591|NCT03090165|Hormone Antagonists|hormone antagonists|mesh-ancestor
101916592|NCT03090165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101916593|NCT03090165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916594|NCT03090165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916595|NCT03087708|Naloxegol|naloxegol|mesh-list
101916596|NCT03087708|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101916597|NCT03087708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916598|NCT03087708|Sensory System Agents|sensory system agents|mesh-ancestor
101916599|NCT03087708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101916600|NCT03059563|Varenicline|varenicline|mesh-list
101916601|NCT03059563|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101916602|NCT03059563|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101916603|NCT03059563|Cholinergic Agents|cholinergic agents|mesh-ancestor
101916604|NCT03059563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101916605|NCT03059563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916606|NCT03059563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916607|NCT03057847|Sofosbuvir|sofosbuvir|mesh-list
101916608|NCT03057847|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
101916609|NCT03057847|Velpatasvir|velpatasvir|mesh-list
101916610|NCT03057847|Antiviral Agents|antiviral agents|mesh-ancestor
101916611|NCT03057847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101916612|NCT03043599|Nivolumab|nivolumab|mesh-list
101916613|NCT03043599|Ipilimumab|ipilimumab|mesh-list
101916614|NCT03043599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101957345|NCT02103556|Mineral Oil|mineral oil|mesh-list
101916615|NCT03043599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916616|NCT03043599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101916617|NCT03043599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916618|NCT03042143|Plasma-lyte 148|plasma-lyte 148|mesh-list
101916619|NCT03042143|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101916620|NCT03042143|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101916621|NCT03040973|Gefitinib|gefitinib|mesh-list
101916622|NCT03040973|Osimertinib|osimertinib|mesh-list
101916623|NCT03040973|Nazartinib|nazartinib|mesh-list
101916624|NCT03040973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916625|NCT03040973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101916626|NCT03040973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101916627|NCT03040973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916628|NCT03022773|Carotenoids|carotenoids|mesh-list
101916629|NCT03022773|Antioxidants|antioxidants|mesh-ancestor
101916630|NCT03022773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916631|NCT03022773|Protective Agents|protective agents|mesh-ancestor
101916632|NCT03022773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916633|NCT02946463|Eculizumab|eculizumab|mesh-list
101916634|NCT02946463|Ravulizumab|ravulizumab|mesh-list
101916635|NCT02946463|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101916636|NCT02946463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101916637|NCT02946463|Immunologic Factors|immunologic factors|mesh-ancestor
101916638|NCT02946463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916639|NCT02928224|Leucovorin|leucovorin|mesh-list
101916640|NCT02928224|Folic Acid|folic acid|mesh-list
101916641|NCT02928224|Fluorouracil|fluorouracil|mesh-list
101916642|NCT02928224|Irinotecan|irinotecan|mesh-list
101916643|NCT02928224|Cetuximab|cetuximab|mesh-list
101916644|NCT02928224|Levoleucovorin|levoleucovorin|mesh-list
101916645|NCT02928224|Antimetabolites|antimetabolites|mesh-ancestor
101916646|NCT02928224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916647|NCT02928224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101916648|NCT02928224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916649|NCT02928224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101916650|NCT02928224|Immunologic Factors|immunologic factors|mesh-ancestor
101916651|NCT02928224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916652|NCT02928224|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101916653|NCT02928224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101916654|NCT02928224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101916655|NCT02928224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101916656|NCT02928224|Antidotes|antidotes|mesh-ancestor
101916657|NCT02928224|Protective Agents|protective agents|mesh-ancestor
101916658|NCT02928224|Vitamin B Complex|vitamin b complex|mesh-ancestor
101916659|NCT02928224|Vitamins|vitamins|mesh-ancestor
101916660|NCT02928224|Micronutrients|micronutrients|mesh-ancestor
101916661|NCT02928224|Hematinics|hematinics|mesh-ancestor
101916662|NCT02897375|Carboplatin|carboplatin|mesh-list
101916663|NCT02897375|Palbociclib|palbociclib|mesh-list
101916664|NCT02897375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916665|NCT02897375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101916666|NCT02897375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101916667|NCT02897375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916668|NCT02891603|Sirolimus|sirolimus|mesh-list
101916669|NCT02891603|Tacrolimus|tacrolimus|mesh-list
101916670|NCT02891603|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101916671|NCT02891603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101916672|NCT02891603|Immunologic Factors|immunologic factors|mesh-ancestor
101916673|NCT02891603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916674|NCT02891603|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101916675|NCT02891603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101916676|NCT02891603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916677|NCT02891603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101916678|NCT02891603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101916679|NCT02891603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101916680|NCT02891603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916681|NCT02891603|Antifungal Agents|antifungal agents|mesh-ancestor
101916682|NCT02891603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101916683|NCT02875314|Cyclophosphamide|cyclophosphamide|mesh-list
101916684|NCT02875314|Thiotepa|thiotepa|mesh-list
101916685|NCT02875314|Cisplatin|cisplatin|mesh-list
101916686|NCT02875314|Carboplatin|carboplatin|mesh-list
101916687|NCT02875314|Methotrexate|methotrexate|mesh-list
101916688|NCT02875314|Etoposide|etoposide|mesh-list
101916689|NCT02875314|Etoposide phosphate|etoposide phosphate|mesh-list
101916690|NCT02875314|Vincristine|vincristine|mesh-list
101916691|NCT02875314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101916692|NCT02875314|Immunologic Factors|immunologic factors|mesh-ancestor
101916693|NCT02875314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916694|NCT02875314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101916695|NCT02875314|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101916696|NCT02875314|Alkylating Agents|alkylating agents|mesh-ancestor
101916697|NCT02875314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916698|NCT02875314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916699|NCT02875314|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101916700|NCT02875314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101916701|NCT02875314|Abortifacient Agents|abortifacient agents|mesh-ancestor
101916702|NCT02875314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101916703|NCT02875314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101916704|NCT02875314|Antimetabolites|antimetabolites|mesh-ancestor
101916705|NCT02875314|Dermatologic Agents|dermatologic agents|mesh-ancestor
101916706|NCT02875314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101916707|NCT02875314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101916708|NCT02875314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101916709|NCT02875314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101916710|NCT02875314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101916711|NCT02875314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101916712|NCT02875314|Tubulin Modulators|tubulin modulators|mesh-ancestor
101916713|NCT02875314|Antimitotic Agents|antimitotic agents|mesh-ancestor
101916714|NCT02875314|Mitosis Modulators|mitosis modulators|mesh-ancestor
101916715|NCT02872116|Leucovorin|leucovorin|mesh-list
101916716|NCT02872116|Fluorouracil|fluorouracil|mesh-list
101916717|NCT02872116|Capecitabine|capecitabine|mesh-list
101916718|NCT02872116|Oxaliplatin|oxaliplatin|mesh-list
101916719|NCT02872116|Nivolumab|nivolumab|mesh-list
101916720|NCT02872116|Ipilimumab|ipilimumab|mesh-list
101916721|NCT02872116|Antimetabolites|antimetabolites|mesh-ancestor
101916722|NCT02872116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916723|NCT02872116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101916724|NCT02872116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916725|NCT02872116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101916726|NCT02872116|Immunologic Factors|immunologic factors|mesh-ancestor
101916727|NCT02872116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916728|NCT02872116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101916729|NCT02872116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101916730|NCT02872116|Antidotes|antidotes|mesh-ancestor
101916731|NCT02872116|Protective Agents|protective agents|mesh-ancestor
101916732|NCT02872116|Vitamin B Complex|vitamin b complex|mesh-ancestor
101916733|NCT02872116|Vitamins|vitamins|mesh-ancestor
101916734|NCT02872116|Micronutrients|micronutrients|mesh-ancestor
101916735|NCT02860039|Vaccines|vaccines|mesh-list
101916736|NCT02860039|Immunologic Factors|immunologic factors|mesh-ancestor
101916737|NCT02860039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916738|NCT02819024|Alovudine|alovudine|mesh-list
101916739|NCT02819024|Dideoxynucleosides|dideoxynucleosides|mesh-list
101916740|NCT02819024|Dexamethasone|dexamethasone|mesh-list
101916741|NCT02819024|Dexamethasone acetate|dexamethasone acetate|mesh-list
101916742|NCT02819024|Ichthammol|ichthammol|mesh-list
101916743|NCT02819024|BB 1101|bb 1101|mesh-list
101916744|NCT02819024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101916745|NCT02819024|Antiemetics|antiemetics|mesh-ancestor
101916746|NCT02819024|Autonomic Agents|autonomic agents|mesh-ancestor
101916747|NCT02819024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101916748|NCT02819024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916749|NCT02819024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101916750|NCT02819024|Glucocorticoids|glucocorticoids|mesh-ancestor
101916751|NCT02819024|Hormones|hormones|mesh-ancestor
101916752|NCT02819024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101916753|NCT02819024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101916754|NCT02819024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916755|NCT02819024|Protease Inhibitors|protease inhibitors|mesh-ancestor
101916756|NCT02819024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101916757|NCT02819024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916758|NCT02819024|Dermatologic Agents|dermatologic agents|mesh-ancestor
101916759|NCT02819024|Antiviral Agents|antiviral agents|mesh-ancestor
101916760|NCT02819024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101916761|NCT02819024|Antimetabolites|antimetabolites|mesh-ancestor
101916762|NCT02819024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101916763|NCT02819024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101916764|NCT02800785|Moxifloxacin|moxifloxacin|mesh-list
101916765|NCT02800785|Metronidazole|metronidazole|mesh-list
101916766|NCT02800785|Ciprofloxacin|ciprofloxacin|mesh-list
101916767|NCT02800785|Levofloxacin|levofloxacin|mesh-list
101916768|NCT02800785|Cefazolin|cefazolin|mesh-list
101916769|NCT02800785|Ceftriaxone|ceftriaxone|mesh-list
101916770|NCT02800785|Clavulanic Acids|clavulanic acids|mesh-list
101916771|NCT02800785|Clavulanic Acid|clavulanic acid|mesh-list
101916772|NCT02800785|Ertapenem|ertapenem|mesh-list
101916773|NCT02800785|Cefuroxime|cefuroxime|mesh-list
101916774|NCT02800785|Tigecycline|tigecycline|mesh-list
101916775|NCT02800785|Cefotaxime|cefotaxime|mesh-list
101916776|NCT02800785|Cefoxitin|cefoxitin|mesh-list
101916777|NCT02800785|Ticarcillin|ticarcillin|mesh-list
101916778|NCT02800785|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
101916779|NCT02800785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101916780|NCT02800785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101916781|NCT02800785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101229701|NCT01555190|Folic Acid|folic acid|mesh-list
101916782|NCT02800785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101916783|NCT02800785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101916784|NCT02800785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916785|NCT02800785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916786|NCT02800785|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101916787|NCT02800785|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101916788|NCT02800785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101916789|NCT02800785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101916790|NCT02800785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101916791|NCT02800785|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101916792|NCT02800785|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101916793|NCT02796937|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
101916794|NCT02796937|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101916795|NCT02796937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101916796|NCT02796937|Protease Inhibitors|protease inhibitors|mesh-ancestor
101916797|NCT02796937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101916798|NCT02796937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916799|NCT02792257|Dronabinol|dronabinol|mesh-list
101916800|NCT02792257|Hallucinogens|hallucinogens|mesh-ancestor
101916801|NCT02792257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916802|NCT02792257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101916803|NCT02792257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101916804|NCT02792257|Analgesics|analgesics|mesh-ancestor
101916805|NCT02792257|Sensory System Agents|sensory system agents|mesh-ancestor
101916806|NCT02792257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101916807|NCT02792257|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101916808|NCT02792257|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101916809|NCT02792257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101916810|NCT02792257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916811|NCT02792257|Hormones|hormones|mesh-ancestor
101916812|NCT02792257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101916813|NCT02782663|Upadacitinib|upadacitinib|mesh-list
101916814|NCT02782663|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101916815|NCT02782663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101916816|NCT02782663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101916817|NCT02782663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916818|NCT02782663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101916819|NCT02765854|Dexamethasone|dexamethasone|mesh-list
101916820|NCT02765854|Lenalidomide|lenalidomide|mesh-list
101916821|NCT02765854|Ixazomib|ixazomib|mesh-list
101916822|NCT02765854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101916823|NCT02765854|Antiemetics|antiemetics|mesh-ancestor
101916824|NCT02765854|Autonomic Agents|autonomic agents|mesh-ancestor
101916825|NCT02765854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101916826|NCT02765854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916827|NCT02765854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101916828|NCT02765854|Glucocorticoids|glucocorticoids|mesh-ancestor
101916829|NCT02765854|Hormones|hormones|mesh-ancestor
101916830|NCT02765854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101916831|NCT02765854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101916832|NCT02765854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916833|NCT02765854|Immunologic Factors|immunologic factors|mesh-ancestor
101916834|NCT02765854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101916835|NCT02765854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101916836|NCT02765854|Growth Substances|growth substances|mesh-ancestor
101229710|NCT01555216|Anesthetics|anesthetics|mesh-ancestor
101916837|NCT02765854|Growth Inhibitors|growth inhibitors|mesh-ancestor
101916838|NCT02765854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916839|NCT02765854|Protease Inhibitors|protease inhibitors|mesh-ancestor
101916840|NCT02765854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101916841|NCT02761694|Paclitaxel|paclitaxel|mesh-list
101916842|NCT02761694|Fulvestrant|fulvestrant|mesh-list
101916843|NCT02761694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101916844|NCT02761694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916845|NCT02761694|Tubulin Modulators|tubulin modulators|mesh-ancestor
101916846|NCT02761694|Antimitotic Agents|antimitotic agents|mesh-ancestor
101916847|NCT02761694|Mitosis Modulators|mitosis modulators|mesh-ancestor
101916848|NCT02761694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916849|NCT02761694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101916850|NCT02761694|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101916851|NCT02761694|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101916852|NCT02761694|Hormone Antagonists|hormone antagonists|mesh-ancestor
101916853|NCT02761694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101916854|NCT02761694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916855|NCT02760030|Fulvestrant|fulvestrant|mesh-list
101916856|NCT02760030|Palbociclib|palbociclib|mesh-list
101916857|NCT02760030|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101916858|NCT02760030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101916859|NCT02760030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916860|NCT02760030|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101916861|NCT02760030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101916862|NCT02760030|Hormone Antagonists|hormone antagonists|mesh-ancestor
101916863|NCT02760030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101916864|NCT02760030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916865|NCT02760030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101916866|NCT02760030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101916867|NCT02760030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916868|NCT02760030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101916869|NCT02641093|Pembrolizumab|pembrolizumab|mesh-list
101916870|NCT02641093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916871|NCT02641093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101916872|NCT02641093|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101616918|NCT00899847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101916873|NCT02641093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916874|NCT02584309|Doxorubicin|doxorubicin|mesh-list
101916875|NCT02584309|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101916876|NCT02584309|Dexrazoxane|dexrazoxane|mesh-list
101916877|NCT02584309|Razoxane|razoxane|mesh-list
101916878|NCT02584309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101916879|NCT02584309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916880|NCT02584309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101916881|NCT02584309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101916882|NCT02584309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101916883|NCT02584309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916884|NCT02584309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101916885|NCT02584309|Protective Agents|protective agents|mesh-ancestor
101916886|NCT02584309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916887|NCT02584309|Antimitotic Agents|antimitotic agents|mesh-ancestor
101916888|NCT02584309|Mitosis Modulators|mitosis modulators|mesh-ancestor
101916889|NCT02578732|Leucovorin|leucovorin|mesh-list
101916890|NCT02578732|Oxaliplatin|oxaliplatin|mesh-list
101916891|NCT02578732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916892|NCT02578732|Antidotes|antidotes|mesh-ancestor
101916893|NCT02578732|Protective Agents|protective agents|mesh-ancestor
101916894|NCT02578732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916895|NCT02578732|Vitamin B Complex|vitamin b complex|mesh-ancestor
101916896|NCT02578732|Vitamins|vitamins|mesh-ancestor
101916897|NCT02578732|Micronutrients|micronutrients|mesh-ancestor
101916898|NCT02525757|Paclitaxel|paclitaxel|mesh-list
101916899|NCT02525757|Carboplatin|carboplatin|mesh-list
101916900|NCT02525757|Atezolizumab|atezolizumab|mesh-list
101916901|NCT02525757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101916902|NCT02525757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916903|NCT02525757|Tubulin Modulators|tubulin modulators|mesh-ancestor
101916904|NCT02525757|Antimitotic Agents|antimitotic agents|mesh-ancestor
101916905|NCT02525757|Mitosis Modulators|mitosis modulators|mesh-ancestor
101916906|NCT02525757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916907|NCT02525757|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101916908|NCT02525757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101916910|NCT02519452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916911|NCT02505984|Oxytocin|oxytocin|mesh-list
101916912|NCT02505984|Oxytocics|oxytocics|mesh-ancestor
101916913|NCT02505984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101916914|NCT02505984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916915|NCT02477280|Methylphenidate|methylphenidate|mesh-list
101916916|NCT02477280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101916917|NCT02477280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916918|NCT02477280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101916919|NCT02477280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101916920|NCT02477280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101916921|NCT02477280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916922|NCT02477280|Dopamine Agents|dopamine agents|mesh-ancestor
101916923|NCT02477280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101916924|NCT02438722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101916925|NCT02438722|Cetuximab|cetuximab|mesh-list
101916926|NCT02438722|Afatinib|afatinib|mesh-list
101916927|NCT02438722|Antibodies|antibodies|mesh-list
101916928|NCT02438722|Immunoglobulins|immunoglobulins|mesh-list
101916929|NCT02438722|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101916930|NCT02438722|Immunologic Factors|immunologic factors|mesh-ancestor
101916931|NCT02438722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916932|NCT02438722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916933|NCT02438722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101916934|NCT02438722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101916935|NCT02438722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916936|NCT02435212|Deferasirox|deferasirox|mesh-list
101916937|NCT02435212|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101916938|NCT02435212|Chelating Agents|chelating agents|mesh-ancestor
101916939|NCT02435212|Sequestering Agents|sequestering agents|mesh-ancestor
101916940|NCT02435212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916948|NCT02408770|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101916949|NCT02408770|Contraceptive Agents|contraceptive agents|mesh-ancestor
101916950|NCT02408770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101916951|NCT02408770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916952|NCT02408770|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101916954|NCT02403323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101916955|NCT02403323|Immunologic Factors|immunologic factors|mesh-ancestor
101916956|NCT02403323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916957|NCT02368665|Amlodipine|amlodipine|mesh-list
101916958|NCT02368665|Candesartan|candesartan|mesh-list
101916959|NCT02368665|Candesartan cilexetil|candesartan cilexetil|mesh-list
101916960|NCT02368665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101916961|NCT02368665|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101916962|NCT02368665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101916963|NCT02368665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916964|NCT02368665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101229749|NCT01555710|Etoposide|etoposide|mesh-list
101916965|NCT02368665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916966|NCT02368665|Vasodilator Agents|vasodilator agents|mesh-ancestor
101916967|NCT02368665|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101916968|NCT02368665|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101916969|NCT02368652|Amlodipine|amlodipine|mesh-list
101916970|NCT02368652|Candesartan|candesartan|mesh-list
101916971|NCT02368652|Candesartan cilexetil|candesartan cilexetil|mesh-list
101916972|NCT02368652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101916973|NCT02368652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101916974|NCT02368652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101916975|NCT02368652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916976|NCT02368652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101916977|NCT02368652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916978|NCT02368652|Vasodilator Agents|vasodilator agents|mesh-ancestor
101916979|NCT02368652|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101916980|NCT02368652|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101916981|NCT02339922|Rituximab|rituximab|mesh-list
101916982|NCT02339922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101916983|NCT02339922|Ixazomib|ixazomib|mesh-list
101916984|NCT02339922|Antibodies|antibodies|mesh-list
101916985|NCT02339922|Immunoglobulins|immunoglobulins|mesh-list
101916986|NCT02339922|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101916987|NCT02339922|Glycine|glycine|mesh-list
101916988|NCT02339922|Immunologic Factors|immunologic factors|mesh-ancestor
101916989|NCT02339922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101916990|NCT02339922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101916991|NCT02339922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101916992|NCT02339922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101916993|NCT02339922|Protease Inhibitors|protease inhibitors|mesh-ancestor
101916994|NCT02339922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101916995|NCT02339922|Glycine Agents|glycine agents|mesh-ancestor
101916996|NCT02339922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101916997|NCT02332577|Amoxicillin|amoxicillin|mesh-list
101916998|NCT02332577|Pristinamycin|pristinamycin|mesh-list
101916999|NCT02332577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101917000|NCT02332577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101917001|NCT02330926|Ibuprofen|ibuprofen|mesh-list
101917002|NCT02330926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101917003|NCT02330926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101917004|NCT02330926|Analgesics|analgesics|mesh-ancestor
101917005|NCT02330926|Sensory System Agents|sensory system agents|mesh-ancestor
101917006|NCT02330926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101917007|NCT02330926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917008|NCT02330926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101917009|NCT02330926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101917010|NCT02330926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101917011|NCT02330926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101917012|NCT02330926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917013|NCT02312245|Paclitaxel|paclitaxel|mesh-list
101917014|NCT02312245|Bevacizumab|bevacizumab|mesh-list
101917015|NCT02312245|Gemcitabine|gemcitabine|mesh-list
101917016|NCT02312245|Doxorubicin|doxorubicin|mesh-list
101917017|NCT02312245|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101917018|NCT02312245|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101917019|NCT02312245|Topotecan|topotecan|mesh-list
101917020|NCT02312245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101917021|NCT02312245|Endothelial Growth Factors|endothelial growth factors|mesh-list
101917022|NCT02312245|Antibodies|antibodies|mesh-list
101917023|NCT02312245|Immunoglobulins|immunoglobulins|mesh-list
101917024|NCT02312245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101917025|NCT02312245|Immunoglobulin G|immunoglobulin g|mesh-list
101917026|NCT02312245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101917027|NCT02312245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101917028|NCT02312245|Tubulin Modulators|tubulin modulators|mesh-ancestor
101917030|NCT02312245|Mitosis Modulators|mitosis modulators|mesh-ancestor
101917031|NCT02312245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917032|NCT02312245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101917033|NCT02312245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101917034|NCT02312245|Growth Substances|growth substances|mesh-ancestor
101917035|NCT02312245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917036|NCT02312245|Growth Inhibitors|growth inhibitors|mesh-ancestor
101917037|NCT02312245|Immunologic Factors|immunologic factors|mesh-ancestor
101917038|NCT02312245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101917039|NCT02312245|Antimetabolites|antimetabolites|mesh-ancestor
101917040|NCT02312245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101917041|NCT02312245|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101917042|NCT02312245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101917043|NCT02312245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101917044|NCT02312245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101917045|NCT02297438|Letrozole|letrozole|mesh-list
101917046|NCT02297438|Palbociclib|palbociclib|mesh-list
101917047|NCT02297438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101229504|NCT01553773|Estradiol|estradiol|mesh-list
101917048|NCT02297438|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101917049|NCT02297438|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101917050|NCT02297438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101917051|NCT02297438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917052|NCT02297438|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101917053|NCT02297438|Hormone Antagonists|hormone antagonists|mesh-ancestor
101917054|NCT02297438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101917055|NCT02297438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917056|NCT02297438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101917057|NCT02297139|Dasatinib|dasatinib|mesh-list
101917058|NCT02297139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101917059|NCT02297139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101917060|NCT02297139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101917061|NCT02297139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917062|NCT02137759|Temozolomide|temozolomide|mesh-list
101917063|NCT02137759|Belinostat|belinostat|mesh-list
101917064|NCT02137759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101917065|NCT02137759|Alkylating Agents|alkylating agents|mesh-ancestor
101917066|NCT02137759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917067|NCT02137759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101917068|NCT02137759|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101917069|NCT02137759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101917070|NCT02115295|Cytarabine|cytarabine|mesh-list
101917071|NCT02115295|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
101917072|NCT02115295|Venetoclax|venetoclax|mesh-list
101917073|NCT02115295|Idarubicin|idarubicin|mesh-list
101917074|NCT02115295|Cladribine|cladribine|mesh-list
101917075|NCT02115295|Midostaurin|midostaurin|mesh-list
101917076|NCT02115295|Staurosporine|staurosporine|mesh-list
101917077|NCT02115295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101917078|NCT02115295|Antimetabolites|antimetabolites|mesh-ancestor
101917079|NCT02115295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917080|NCT02115295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101917081|NCT02115295|Antiviral Agents|antiviral agents|mesh-ancestor
101917082|NCT02115295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101917083|NCT02115295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101917084|NCT02115295|Immunologic Factors|immunologic factors|mesh-ancestor
101917085|NCT02115295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917086|NCT02115295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101917087|NCT02115295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101917088|NCT02115295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101917089|NCT02115295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101917090|NCT02115295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101917091|NCT02090998|Lidocaine|lidocaine|mesh-list
101917092|NCT02090998|Amitriptyline|amitriptyline|mesh-list
101917093|NCT02090998|Anesthetics, Local|anesthetics, local|mesh-ancestor
101917094|NCT02090998|Anesthetics|anesthetics|mesh-ancestor
101917095|NCT02090998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101917096|NCT02090998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917097|NCT02090998|Sensory System Agents|sensory system agents|mesh-ancestor
101917098|NCT02090998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101917099|NCT02090998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101917100|NCT02090998|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101917101|NCT02090998|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101917102|NCT02090998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101917103|NCT02090998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917104|NCT02090998|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101917105|NCT02090998|Antidepressive Agents|antidepressive agents|mesh-ancestor
101917106|NCT02090998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101917107|NCT02090998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101917108|NCT02090998|Analgesics|analgesics|mesh-ancestor
101917109|NCT02090998|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101917110|NCT02090998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101917111|NCT02090998|Adrenergic Agents|adrenergic agents|mesh-ancestor
101917112|NCT02090998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101917113|NCT02043665|Pembrolizumab|pembrolizumab|mesh-list
101917114|NCT02043665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101917115|NCT02043665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101917116|NCT02043665|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101917117|NCT02043665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917118|NCT01989585|Trametinib|trametinib|mesh-list
101917119|NCT01989585|Dabrafenib|dabrafenib|mesh-list
101917120|NCT01989585|Navitoclax|navitoclax|mesh-list
101917121|NCT01989585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101917122|NCT01989585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101917123|NCT01989585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101917124|NCT01989585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917125|NCT01974440|Prednisone|prednisone|mesh-list
101917126|NCT01974440|Cyclophosphamide|cyclophosphamide|mesh-list
101917127|NCT01974440|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101917128|NCT01974440|Rituximab|rituximab|mesh-list
101917129|NCT01974440|Doxorubicin|doxorubicin|mesh-list
101917130|NCT01974440|Vincristine|vincristine|mesh-list
101917131|NCT01974440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101917132|NCT01974440|Immunologic Factors|immunologic factors|mesh-ancestor
101917133|NCT01974440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917134|NCT01974440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101917135|NCT01974440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101917136|NCT01974440|Alkylating Agents|alkylating agents|mesh-ancestor
101917137|NCT01974440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917138|NCT01974440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101917139|NCT01974440|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101917140|NCT01974440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101917141|NCT01974440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101917142|NCT01974440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101917143|NCT01974440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101917144|NCT01974440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101917145|NCT01974440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101917146|NCT01974440|Glucocorticoids|glucocorticoids|mesh-ancestor
101917147|NCT01974440|Hormones|hormones|mesh-ancestor
101917148|NCT01974440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101917149|NCT01974440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101917150|NCT01974440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101917151|NCT01974440|Tubulin Modulators|tubulin modulators|mesh-ancestor
101917152|NCT01974440|Antimitotic Agents|antimitotic agents|mesh-ancestor
101917153|NCT01974440|Mitosis Modulators|mitosis modulators|mesh-ancestor
101917154|NCT01959139|Leucovorin|leucovorin|mesh-list
101917155|NCT01959139|Fluorouracil|fluorouracil|mesh-list
101917156|NCT01959139|Oxaliplatin|oxaliplatin|mesh-list
101917157|NCT01959139|Irinotecan|irinotecan|mesh-list
101917158|NCT01959139|Levoleucovorin|levoleucovorin|mesh-list
101917159|NCT01959139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917160|NCT01959139|Antimetabolites|antimetabolites|mesh-ancestor
101917161|NCT01959139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917162|NCT01959139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101917163|NCT01959139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101917164|NCT01959139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101917165|NCT01959139|Immunologic Factors|immunologic factors|mesh-ancestor
101917166|NCT01959139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101917167|NCT01959139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101917168|NCT01959139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101917169|NCT01959139|Antidotes|antidotes|mesh-ancestor
101917171|NCT01959139|Vitamin B Complex|vitamin b complex|mesh-ancestor
101917172|NCT01959139|Vitamins|vitamins|mesh-ancestor
101917173|NCT01959139|Micronutrients|micronutrients|mesh-ancestor
101917174|NCT01912651|Cephalexin|cephalexin|mesh-list
101917175|NCT01912651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101917176|NCT01912651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101917177|NCT01912625|Paclitaxel|paclitaxel|mesh-list
101917178|NCT01912625|Carboplatin|carboplatin|mesh-list
101917179|NCT01912625|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101917180|NCT01912625|Trametinib|trametinib|mesh-list
101917181|NCT01912625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101917182|NCT01912625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101917183|NCT01912625|Tubulin Modulators|tubulin modulators|mesh-ancestor
101917184|NCT01912625|Antimitotic Agents|antimitotic agents|mesh-ancestor
101917185|NCT01912625|Mitosis Modulators|mitosis modulators|mesh-ancestor
101917186|NCT01912625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917187|NCT01912625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101917188|NCT01912625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101917189|NCT01817166|Vitamin D|vitamin d|mesh-list
101917190|NCT01817166|Cholecalciferol|cholecalciferol|mesh-list
101917191|NCT01817166|Vitamins|vitamins|mesh-ancestor
101917192|NCT01817166|Micronutrients|micronutrients|mesh-ancestor
101917193|NCT01817166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917194|NCT01817166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101917195|NCT01817166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101917196|NCT01814813|Bevacizumab|bevacizumab|mesh-list
101917197|NCT01814813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101917198|NCT01814813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101917199|NCT01814813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101917200|NCT01814813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101917201|NCT01814813|Growth Substances|growth substances|mesh-ancestor
101917202|NCT01814813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917203|NCT01814813|Growth Inhibitors|growth inhibitors|mesh-ancestor
101917204|NCT01720836|Poly ICLC|poly iclc|mesh-list
101917205|NCT01720836|Interferon Inducers|interferon inducers|mesh-ancestor
101917206|NCT01720836|Immunologic Factors|immunologic factors|mesh-ancestor
101917207|NCT01720836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917208|NCT01667120|Ketorolac|ketorolac|mesh-list
101917209|NCT01667120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101917210|NCT01667120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101917211|NCT01667120|Analgesics|analgesics|mesh-ancestor
101917212|NCT01667120|Sensory System Agents|sensory system agents|mesh-ancestor
101917213|NCT01667120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101229800|NCT01555970|Protective Agents|protective agents|mesh-ancestor
101917214|NCT01667120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917215|NCT01667120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101917216|NCT01667120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101917217|NCT01667120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101917218|NCT01667120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101917219|NCT01667120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917220|NCT01642251|Cisplatin|cisplatin|mesh-list
101917221|NCT01642251|Etoposide|etoposide|mesh-list
101917222|NCT01642251|Etoposide phosphate|etoposide phosphate|mesh-list
101917223|NCT01642251|Veliparib|veliparib|mesh-list
101917224|NCT01642251|Podophyllotoxin|podophyllotoxin|mesh-list
101917225|NCT01642251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101917226|NCT01642251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101917227|NCT01642251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101917228|NCT01642251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101917229|NCT01642251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101917230|NCT01642251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917231|NCT01642251|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101917232|NCT01642251|Keratolytic Agents|keratolytic agents|mesh-ancestor
101917233|NCT01642251|Dermatologic Agents|dermatologic agents|mesh-ancestor
101917234|NCT01642251|Tubulin Modulators|tubulin modulators|mesh-ancestor
101917235|NCT01642251|Antimitotic Agents|antimitotic agents|mesh-ancestor
101917236|NCT01642251|Mitosis Modulators|mitosis modulators|mesh-ancestor
101917237|NCT01606137|Nabiximols|nabiximols|mesh-list
101917238|NCT01606137|Analgesics|analgesics|mesh-ancestor
101917239|NCT01606137|Sensory System Agents|sensory system agents|mesh-ancestor
101917240|NCT01606137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101917241|NCT01606137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917242|NCT01532518|MEN 11420|men 11420|mesh-list
101917243|NCT01532518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101917244|NCT01532518|Autonomic Agents|autonomic agents|mesh-ancestor
101957383|NCT03554980|Cariostatic Agents|cariostatic agents|mesh-ancestor
101917245|NCT01532518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101917246|NCT01532518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917247|NCT01532518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101917248|NCT01532518|Respiratory System Agents|respiratory system agents|mesh-ancestor
101917249|NCT01489813|Genistein|genistein|mesh-list
101917250|NCT01489813|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101917251|NCT01489813|Protective Agents|protective agents|mesh-ancestor
101917252|NCT01489813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917253|NCT01489813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101917254|NCT01489813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101917255|NCT01489813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101917256|NCT01489813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917258|NCT01489813|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101917259|NCT01489813|Estrogens|estrogens|mesh-ancestor
101917260|NCT01489813|Hormones|hormones|mesh-ancestor
101917261|NCT01489813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101917262|NCT01420874|Leucovorin|leucovorin|mesh-list
101917263|NCT01420874|Fluorouracil|fluorouracil|mesh-list
101917264|NCT01420874|Oxaliplatin|oxaliplatin|mesh-list
101917265|NCT01420874|Antimetabolites|antimetabolites|mesh-ancestor
101917266|NCT01420874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917267|NCT01420874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101917268|NCT01420874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101917269|NCT01420874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101917270|NCT01420874|Immunologic Factors|immunologic factors|mesh-ancestor
101917271|NCT01420874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917272|NCT01420874|Antidotes|antidotes|mesh-ancestor
101917273|NCT01420874|Protective Agents|protective agents|mesh-ancestor
101917274|NCT01420874|Vitamin B Complex|vitamin b complex|mesh-ancestor
101917275|NCT01420874|Vitamins|vitamins|mesh-ancestor
101917276|NCT01420874|Micronutrients|micronutrients|mesh-ancestor
101917277|NCT01405521|Vaccines|vaccines|mesh-list
101917278|NCT01405521|Immunologic Factors|immunologic factors|mesh-ancestor
101917279|NCT01405521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917280|NCT01027000|Sirolimus|sirolimus|mesh-list
101917281|NCT01027000|Cyclophosphamide|cyclophosphamide|mesh-list
101917282|NCT01027000|Busulfan|busulfan|mesh-list
101917283|NCT01027000|Rituximab|rituximab|mesh-list
101917284|NCT01027000|Methotrexate|methotrexate|mesh-list
101917285|NCT01027000|Fludarabine|fludarabine|mesh-list
101917286|NCT01027000|Fludarabine phosphate|fludarabine phosphate|mesh-list
101917287|NCT01027000|Tacrolimus|tacrolimus|mesh-list
101917288|NCT01027000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101917289|NCT01027000|Immunologic Factors|immunologic factors|mesh-ancestor
101917290|NCT01027000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917291|NCT01027000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101917292|NCT01027000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101917293|NCT01027000|Alkylating Agents|alkylating agents|mesh-ancestor
101917294|NCT01027000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917295|NCT01027000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101917296|NCT01027000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101917297|NCT01027000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101917298|NCT01027000|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101917299|NCT01027000|Abortifacient Agents|abortifacient agents|mesh-ancestor
101917300|NCT01027000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101917301|NCT01027000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101917302|NCT01027000|Antimetabolites|antimetabolites|mesh-ancestor
101917303|NCT01027000|Dermatologic Agents|dermatologic agents|mesh-ancestor
101917304|NCT01027000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101917305|NCT01027000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101917306|NCT01027000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101917307|NCT01027000|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101917308|NCT01027000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101917309|NCT01027000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101917310|NCT01027000|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101917311|NCT01027000|Antifungal Agents|antifungal agents|mesh-ancestor
101917312|NCT00861068|Lacosamide|lacosamide|mesh-list
101917313|NCT00861068|Anticonvulsants|anticonvulsants|mesh-ancestor
101917314|NCT00861068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101917315|NCT00861068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101917316|NCT00861068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101917317|NCT00861068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917318|NCT00844285|Certolizumab Pegol|certolizumab pegol|mesh-list
101917319|NCT00844285|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101917320|NCT00844285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101917321|NCT00844285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101917322|NCT00844285|Immunologic Factors|immunologic factors|mesh-ancestor
101917323|NCT00844285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917324|NCT00844285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101917326|NCT00841789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101917327|NCT00841789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101917328|NCT00841789|Analgesics|analgesics|mesh-ancestor
101917329|NCT00841789|Sensory System Agents|sensory system agents|mesh-ancestor
101917330|NCT00841789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101637183|NCT02646111|Ribavirin|ribavirin|mesh-list
101917331|NCT00841789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917332|NCT00841789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101917333|NCT00841789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101917334|NCT00841789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101917335|NCT00841789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101917336|NCT00841789|Immunologic Factors|immunologic factors|mesh-ancestor
101917337|NCT00711646|Nabiximols|nabiximols|mesh-list
101917338|NCT00711646|Analgesics|analgesics|mesh-ancestor
101917339|NCT00711646|Sensory System Agents|sensory system agents|mesh-ancestor
101917340|NCT00711646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101917341|NCT00711646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917342|NCT00702468|Nabiximols|nabiximols|mesh-list
101917343|NCT00702468|Analgesics|analgesics|mesh-ancestor
101917344|NCT00702468|Sensory System Agents|sensory system agents|mesh-ancestor
101917345|NCT00702468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101917346|NCT00702468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917347|NCT00681538|Nabiximols|nabiximols|mesh-list
101917348|NCT00681538|Analgesics|analgesics|mesh-ancestor
101917349|NCT00681538|Sensory System Agents|sensory system agents|mesh-ancestor
101917350|NCT00681538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101917351|NCT00681538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917352|NCT00634634|Sorafenib|sorafenib|mesh-list
101917353|NCT00634634|Letrozole|letrozole|mesh-list
101917354|NCT00634634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101917355|NCT00634634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101917356|NCT00634634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101917357|NCT00634634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917358|NCT00634634|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101917359|NCT00634634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101917360|NCT00634634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101917361|NCT00634634|Hormone Antagonists|hormone antagonists|mesh-ancestor
101917362|NCT00634634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101917363|NCT00634634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917364|NCT00497029|Fluorides|fluorides|mesh-list
101917365|NCT00497029|Fluorides, Topical|fluorides, topical|mesh-list
101917366|NCT00497029|Cariostatic Agents|cariostatic agents|mesh-ancestor
101917367|NCT00497029|Protective Agents|protective agents|mesh-ancestor
101917368|NCT00497029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917369|NCT00455351|Vorinostat|vorinostat|mesh-list
101917370|NCT00455351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101917371|NCT00455351|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101917372|NCT00455351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101917373|NCT00455351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917374|NCT00379340|Dactinomycin|dactinomycin|mesh-list
101917375|NCT00379340|Cactinomycin|cactinomycin|mesh-list
101917376|NCT00379340|Cyclophosphamide|cyclophosphamide|mesh-list
101917377|NCT00379340|Doxorubicin|doxorubicin|mesh-list
101917378|NCT00379340|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101917379|NCT00379340|Etoposide|etoposide|mesh-list
101917380|NCT00379340|Vincristine|vincristine|mesh-list
101917381|NCT00379340|Etoposide phosphate|etoposide phosphate|mesh-list
101917382|NCT00379340|Podophyllotoxin|podophyllotoxin|mesh-list
101917383|NCT00379340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101917384|NCT00379340|Immunologic Factors|immunologic factors|mesh-ancestor
101917385|NCT00379340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917386|NCT00379340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101917387|NCT00379340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101917388|NCT00379340|Alkylating Agents|alkylating agents|mesh-ancestor
101917389|NCT00379340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917390|NCT00379340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101917391|NCT00379340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101917392|NCT00379340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101917393|NCT00379340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101917394|NCT00379340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101917395|NCT00379340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101917396|NCT00379340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101917397|NCT00379340|Tubulin Modulators|tubulin modulators|mesh-ancestor
101917398|NCT00379340|Antimitotic Agents|antimitotic agents|mesh-ancestor
101917399|NCT00379340|Mitosis Modulators|mitosis modulators|mesh-ancestor
101917400|NCT00379340|Keratolytic Agents|keratolytic agents|mesh-ancestor
101917401|NCT00379340|Dermatologic Agents|dermatologic agents|mesh-ancestor
101917402|NCT00379340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101917403|NCT00379340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101917404|NCT00379340|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101917405|NCT00379340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101917406|NCT00301808|Docetaxel|docetaxel|mesh-list
101917407|NCT00301808|Pemetrexed|pemetrexed|mesh-list
101917408|NCT00301808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101917409|NCT00301808|Tubulin Modulators|tubulin modulators|mesh-ancestor
101917410|NCT00301808|Antimitotic Agents|antimitotic agents|mesh-ancestor
101917411|NCT00301808|Mitosis Modulators|mitosis modulators|mesh-ancestor
101917412|NCT00301808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917413|NCT00301808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101917414|NCT00301808|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101917415|NCT00301808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101917416|NCT00254670|Naltrexone|naltrexone|mesh-list
101917417|NCT00254670|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101917418|NCT00254670|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101917419|NCT00254670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917420|NCT00254670|Sensory System Agents|sensory system agents|mesh-ancestor
101917421|NCT00254670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101917422|NCT00138801|Doxycycline|doxycycline|mesh-list
101917423|NCT00138801|Ceftriaxone|ceftriaxone|mesh-list
101917424|NCT00138801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101917425|NCT00138801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101917426|NCT00138801|Antimalarials|antimalarials|mesh-ancestor
101917427|NCT00138801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101917428|NCT00138801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101917429|NCT05795478|Pregabalin|pregabalin|mesh-list
101917430|NCT05795478|Oxycodone|oxycodone|mesh-list
101917431|NCT05795478|Analgesics|analgesics|mesh-ancestor
101917432|NCT05795478|Sensory System Agents|sensory system agents|mesh-ancestor
101917433|NCT05795478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101917434|NCT05795478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917435|NCT05795478|Anticonvulsants|anticonvulsants|mesh-ancestor
101917436|NCT05795478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101917437|NCT05795478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101917438|NCT05795478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917439|NCT05795478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101917440|NCT05795478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101917441|NCT05795478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101917442|NCT05795478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101917443|NCT05795478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101917444|NCT05795478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101917445|NCT05795478|Narcotics|narcotics|mesh-ancestor
101917446|NCT05795413|Bupivacaine|bupivacaine|mesh-list
101917447|NCT05795413|Anesthetics, Local|anesthetics, local|mesh-ancestor
101917448|NCT05795413|Anesthetics|anesthetics|mesh-ancestor
101917449|NCT05795413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101917450|NCT05795413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917451|NCT05795413|Sensory System Agents|sensory system agents|mesh-ancestor
101917452|NCT05795413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101917453|NCT05795400|Dapagliflozin|dapagliflozin|mesh-list
101917454|NCT05795400|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101917455|NCT05795400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917456|NCT05795400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101917457|NCT05795400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917458|NCT05795283|Dexetimide|dexetimide|mesh-list
101917459|NCT05795283|Citalopram|citalopram|mesh-list
101917460|NCT05795283|Escitalopram|escitalopram|mesh-list
101917461|NCT05795283|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101917462|NCT05795283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101917463|NCT05795283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101917464|NCT05795283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917465|NCT05795283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101917466|NCT05795283|Serotonin Agents|serotonin agents|mesh-ancestor
101917467|NCT05795283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229848|NCT01556477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917468|NCT05795283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101917469|NCT05795283|Antidepressive Agents|antidepressive agents|mesh-ancestor
101917471|NCT05795283|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101917472|NCT05795283|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101917473|NCT05795283|Parasympatholytics|parasympatholytics|mesh-ancestor
101917474|NCT05795283|Autonomic Agents|autonomic agents|mesh-ancestor
101917475|NCT05795283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101917476|NCT05795283|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101917477|NCT05795283|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101917478|NCT05795283|Cholinergic Agents|cholinergic agents|mesh-ancestor
101917479|NCT05795244|Nivolumab|nivolumab|mesh-list
101917480|NCT05795244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101917481|NCT05795244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101637331|NCT02567149|Cidofovir|cidofovir|mesh-list
101917482|NCT05795244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101917483|NCT05795244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917484|NCT05794919|Calcium, Dietary|calcium, dietary|mesh-list
101917486|NCT05794919|Calcium|calcium|mesh-list
101917487|NCT05794919|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101917488|NCT05794919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917489|NCT05794919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101917490|NCT05794919|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101917491|NCT05794919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101917492|NCT05794919|Disinfectants|disinfectants|mesh-ancestor
101917493|NCT05794919|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
101917494|NCT05794919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101917495|NCT05794425|Cyclosporine|cyclosporine|mesh-list
101917496|NCT05794425|Cyclosporins|cyclosporins|mesh-list
101917497|NCT05794425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101917498|NCT05794425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917499|NCT05794425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101917500|NCT05794425|Immunologic Factors|immunologic factors|mesh-ancestor
101917501|NCT05794425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917502|NCT05794425|Antifungal Agents|antifungal agents|mesh-ancestor
101917503|NCT05794425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101917504|NCT05794425|Dermatologic Agents|dermatologic agents|mesh-ancestor
101917505|NCT05794425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101917506|NCT05794425|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101917507|NCT05726097|Ascorbic Acid|ascorbic acid|mesh-list
101917508|NCT05726097|Prucalopride|prucalopride|mesh-list
101917509|NCT05726097|Picosulfate sodium|picosulfate sodium|mesh-list
101917510|NCT05726097|Antioxidants|antioxidants|mesh-ancestor
101917511|NCT05726097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917512|NCT05726097|Protective Agents|protective agents|mesh-ancestor
101917513|NCT05726097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917514|NCT05726097|Vitamins|vitamins|mesh-ancestor
101917515|NCT05726097|Micronutrients|micronutrients|mesh-ancestor
101917516|NCT05726097|Laxatives|laxatives|mesh-ancestor
101917517|NCT05726097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101917518|NCT05726097|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101917519|NCT05726097|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101917520|NCT05726097|Serotonin Agents|serotonin agents|mesh-ancestor
101917521|NCT05726097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101917522|NCT05726097|Cathartics|cathartics|mesh-ancestor
101917523|NCT05712343|Valacyclovir|valacyclovir|mesh-list
101917524|NCT05712343|Antiviral Agents|antiviral agents|mesh-ancestor
101917525|NCT05712343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101917526|NCT05703425|Sulfasalazine|sulfasalazine|mesh-list
101917527|NCT05703425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101917528|NCT05703425|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101917529|NCT05703425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101917530|NCT05703425|Analgesics|analgesics|mesh-ancestor
101917531|NCT05703425|Sensory System Agents|sensory system agents|mesh-ancestor
101917532|NCT05703425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101917533|NCT05703425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917534|NCT05703425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101917535|NCT05703425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101917536|NCT05703425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101917537|NCT05690503|Ketamine|ketamine|mesh-list
101917538|NCT05690503|Analgesics|analgesics|mesh-ancestor
101917539|NCT05690503|Sensory System Agents|sensory system agents|mesh-ancestor
101917540|NCT05690503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101917541|NCT05690503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917542|NCT05690503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101917543|NCT05690503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101917544|NCT05690503|Anesthetics, General|anesthetics, general|mesh-ancestor
101917545|NCT05690503|Anesthetics|anesthetics|mesh-ancestor
101775300|NCT00936195|Lamivudine|lamivudine|mesh-list
101917546|NCT05690503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101917547|NCT05690503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101917548|NCT05690503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101917550|NCT05690503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917551|NCT05663515|Insulin|insulin|mesh-list
101917552|NCT05663515|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101917553|NCT05663515|Exenatide|exenatide|mesh-list
101917554|NCT05663515|Biguanides|biguanides|mesh-list
101917555|NCT05663515|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
101917556|NCT05663515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101917557|NCT05663515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637408|NCT00967616|Leucovorin|leucovorin|mesh-list
101917558|NCT05663515|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101917559|NCT05663515|Incretins|incretins|mesh-ancestor
101917561|NCT05663515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101917562|NCT05624606|Vaccines|vaccines|mesh-list
101917563|NCT05624606|Immunologic Factors|immunologic factors|mesh-ancestor
101917564|NCT05624606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917565|NCT05600062|Racecadotril|racecadotril|mesh-list
101917566|NCT05600062|Antidiarrheals|antidiarrheals|mesh-ancestor
101917567|NCT05600062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101917568|NCT05600062|Protease Inhibitors|protease inhibitors|mesh-ancestor
101917569|NCT05600062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101917570|NCT05600062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917571|NCT05588648|Vactosertib|vactosertib|mesh-list
101917572|NCT05588648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101917573|NCT05588648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101917574|NCT05588648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917575|NCT05571267|Bevacizumab|bevacizumab|mesh-list
101917576|NCT05571267|Ranibizumab|ranibizumab|mesh-list
101917577|NCT05571267|Aflibercept|aflibercept|mesh-list
101917578|NCT05571267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101917579|NCT05571267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101917580|NCT05571267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101917581|NCT05571267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101917582|NCT05571267|Growth Substances|growth substances|mesh-ancestor
101917583|NCT05571267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917584|NCT05571267|Growth Inhibitors|growth inhibitors|mesh-ancestor
101917585|NCT05550194|Valacyclovir|valacyclovir|mesh-list
101917586|NCT05550194|Antiviral Agents|antiviral agents|mesh-ancestor
101917587|NCT05550194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101917588|NCT05477459|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
101917589|NCT05477459|Hallucinogens|hallucinogens|mesh-ancestor
101917590|NCT05477459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229880|NCT05847660|Fertility Agents|fertility agents|mesh-ancestor
101917591|NCT05477459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101917592|NCT05477459|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101917593|NCT05477459|Serotonin Agents|serotonin agents|mesh-ancestor
101917594|NCT05477459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101917595|NCT05477459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917596|NCT05477459|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101917597|NCT05426486|Carboplatin|carboplatin|mesh-list
101917598|NCT05426486|Docetaxel|docetaxel|mesh-list
101917599|NCT05426486|Trastuzumab|trastuzumab|mesh-list
101917600|NCT05426486|Pertuzumab|pertuzumab|mesh-list
101917601|NCT05426486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101917602|NCT05426486|Tubulin Modulators|tubulin modulators|mesh-ancestor
101917603|NCT05426486|Antimitotic Agents|antimitotic agents|mesh-ancestor
101917604|NCT05426486|Mitosis Modulators|mitosis modulators|mesh-ancestor
101917605|NCT05426486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917606|NCT05426486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101917607|NCT05399290|Doxycycline|doxycycline|mesh-list
101917608|NCT05399290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101917609|NCT05399290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101917610|NCT05399290|Antimalarials|antimalarials|mesh-ancestor
101917611|NCT05399290|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101917612|NCT05399290|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101917613|NCT05389852|Dexmedetomidine|dexmedetomidine|mesh-list
101917614|NCT05389852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101917615|NCT05389852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101917616|NCT05389852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917617|NCT05389852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101917618|NCT05389852|Analgesics|analgesics|mesh-ancestor
101917619|NCT05389852|Sensory System Agents|sensory system agents|mesh-ancestor
101917620|NCT05389852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101616932|NCT00899847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101917621|NCT05389852|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101917622|NCT05389852|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101917623|NCT05389852|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101917624|NCT05389852|Adrenergic Agents|adrenergic agents|mesh-ancestor
101917625|NCT05389852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101917626|NCT05389852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917627|NCT05386914|Sirolimus|sirolimus|mesh-list
101917628|NCT05386914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101917629|NCT05386914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101917630|NCT05386914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101917631|NCT05386914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101917632|NCT05386914|Antifungal Agents|antifungal agents|mesh-ancestor
101917633|NCT05386914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101917634|NCT05386914|Immunologic Factors|immunologic factors|mesh-ancestor
101917635|NCT05386914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917637|NCT05352828|Fludarabine|fludarabine|mesh-list
101917638|NCT05352828|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101917639|NCT05352828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101917640|NCT05352828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101917641|NCT05352828|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101917642|NCT05352828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917643|NCT05352828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101917644|NCT05352828|Alkylating Agents|alkylating agents|mesh-ancestor
101917645|NCT05318469|Ivermectin|ivermectin|mesh-list
101917646|NCT05318469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101917647|NCT05318469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101917648|NCT05318248|Clonidine|clonidine|mesh-list
101917649|NCT05318248|Analgesics|analgesics|mesh-ancestor
101917650|NCT05318248|Sensory System Agents|sensory system agents|mesh-ancestor
101917651|NCT05318248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101917652|NCT05318248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917653|NCT05318248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101917654|NCT05318248|Sympatholytics|sympatholytics|mesh-ancestor
101917655|NCT05318248|Autonomic Agents|autonomic agents|mesh-ancestor
101917656|NCT05318248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101917657|NCT05318248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101917658|NCT05318248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101917659|NCT05318248|Adrenergic Agents|adrenergic agents|mesh-ancestor
101917660|NCT05318248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101917661|NCT05318248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917662|NCT05290493|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
101917663|NCT05290493|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
101917664|NCT05290493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101917665|NCT05290493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917666|NCT05287256|Dronabinol|dronabinol|mesh-list
101917667|NCT05287256|Hallucinogens|hallucinogens|mesh-ancestor
101917668|NCT05287256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917669|NCT05287256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101917670|NCT05287256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101917671|NCT05287256|Analgesics|analgesics|mesh-ancestor
101917672|NCT05287256|Sensory System Agents|sensory system agents|mesh-ancestor
101917673|NCT05287256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101917674|NCT05287256|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101917675|NCT05287256|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101917676|NCT05287256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101917677|NCT05287256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917678|NCT05287256|Hormones|hormones|mesh-ancestor
101917679|NCT05287256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101917680|NCT05219266|Midostaurin|midostaurin|mesh-list
101917681|NCT05219266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101917682|NCT05219266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101917683|NCT05219266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101917684|NCT05219266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917685|NCT05204862|Antibodies|antibodies|mesh-list
101917686|NCT05204862|Immunologic Factors|immunologic factors|mesh-ancestor
101917687|NCT05204862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917688|NCT05193851|Ricolinostat|ricolinostat|mesh-list
101917689|NCT05193851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101917690|NCT05193851|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101917691|NCT05193851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101917692|NCT05193851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917693|NCT05193318|Ketamine|ketamine|mesh-list
101917694|NCT05193318|Analgesics|analgesics|mesh-ancestor
101917695|NCT05193318|Sensory System Agents|sensory system agents|mesh-ancestor
101917696|NCT05193318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101917697|NCT05193318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917698|NCT05193318|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101917699|NCT05193318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101917701|NCT05193318|Anesthetics|anesthetics|mesh-ancestor
101917702|NCT05193318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101917703|NCT05193318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101917704|NCT05193318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101917705|NCT05193318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101637563|NCT00970502|Celecoxib|celecoxib|mesh-list
101917711|NCT05163041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917712|NCT05138575|Empagliflozin|empagliflozin|mesh-list
101917713|NCT05138575|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101917714|NCT05138575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917715|NCT05138575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101917716|NCT05138575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917717|NCT05122559|Acetylcysteine|acetylcysteine|mesh-list
101917718|NCT05122559|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101917719|NCT05122559|Antiviral Agents|antiviral agents|mesh-ancestor
101917720|NCT05122559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101917721|NCT05122559|Expectorants|expectorants|mesh-ancestor
101917722|NCT05122559|Respiratory System Agents|respiratory system agents|mesh-ancestor
101917723|NCT05122559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101917724|NCT05122559|Antioxidants|antioxidants|mesh-ancestor
101917725|NCT05122559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917726|NCT05122559|Protective Agents|protective agents|mesh-ancestor
101917727|NCT05122559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917728|NCT05122559|Antidotes|antidotes|mesh-ancestor
101917729|NCT05112666|Rivaroxaban|rivaroxaban|mesh-list
101917730|NCT05112666|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101917731|NCT05112666|Antithrombins|antithrombins|mesh-ancestor
101917732|NCT05112666|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101917733|NCT05112666|Protease Inhibitors|protease inhibitors|mesh-ancestor
101917734|NCT05112666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101957439|NCT02106364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917735|NCT05112666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917736|NCT05112666|Anticoagulants|anticoagulants|mesh-ancestor
101917737|NCT05080764|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101917738|NCT05080764|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101917739|NCT05080764|Dermatologic Agents|dermatologic agents|mesh-ancestor
101917740|NCT05054725|Sotorasib|sotorasib|mesh-list
101917741|NCT05054725|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101917742|NCT05054725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917743|NCT05054725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101917744|NCT05054725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101917751|NCT05046522|Palmidrol|palmidrol|mesh-list
101917752|NCT05046522|Analgesics|analgesics|mesh-ancestor
101917753|NCT05046522|Sensory System Agents|sensory system agents|mesh-ancestor
101917754|NCT05046522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101917755|NCT05046522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917756|NCT05046522|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101917757|NCT05046522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101917758|NCT05046522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101917759|NCT05046522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101917760|NCT05046522|Antiviral Agents|antiviral agents|mesh-ancestor
101917761|NCT05046522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101917762|NCT05046522|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101917763|NCT05046522|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101917764|NCT05046522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101917765|NCT05046522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917766|NCT05046522|Hormones|hormones|mesh-ancestor
101917767|NCT05046522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101917768|NCT05046132|Moxifloxacin|moxifloxacin|mesh-list
101917769|NCT05046132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101917770|NCT05046132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101917771|NCT05046132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101917772|NCT05046132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101917773|NCT05046132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101917774|NCT05046132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917775|NCT05046132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101917776|NCT04915482|Antibodies|antibodies|mesh-list
101917777|NCT04915482|Immunologic Factors|immunologic factors|mesh-ancestor
101917778|NCT04915482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637640|NCT00964886|Autonomic Agents|autonomic agents|mesh-ancestor
101917780|NCT04897971|Immunologic Factors|immunologic factors|mesh-ancestor
101917781|NCT04897971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917782|NCT04857827|Timolol|timolol|mesh-list
101229922|NCT05847088|Antiemetics|antiemetics|mesh-ancestor
101917783|NCT04857827|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101917784|NCT04857827|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101917785|NCT04857827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917786|NCT04857827|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101917787|NCT04857827|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101917788|NCT04857827|Adrenergic Agents|adrenergic agents|mesh-ancestor
101917789|NCT04857827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101917790|NCT04857827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917791|NCT04857827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101917792|NCT04857827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101917793|NCT04796584|Antibodies|antibodies|mesh-list
101917794|NCT04796584|Immunologic Factors|immunologic factors|mesh-ancestor
101917795|NCT04796584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917796|NCT04725149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101917797|NCT04716075|Acalabrutinib|acalabrutinib|mesh-list
101917798|NCT04716075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101917799|NCT04712539|Oseltamivir|oseltamivir|mesh-list
101917800|NCT04712539|Baloxavir|baloxavir|mesh-list
101917801|NCT04712539|Antiviral Agents|antiviral agents|mesh-ancestor
101917802|NCT04712539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101917803|NCT04712539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101917804|NCT04712539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917805|NCT04688931|Mitomycins|mitomycins|mesh-list
101917806|NCT04688931|Mitomycin|mitomycin|mesh-list
101917807|NCT04688931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101917808|NCT04688931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101917809|NCT04688931|Alkylating Agents|alkylating agents|mesh-ancestor
101917810|NCT04688931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917811|NCT04688931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101917812|NCT04688931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101917813|NCT04630769|Interleukin-2|interleukin-2|mesh-list
101917814|NCT04630769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101917815|NCT04630769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101917816|NCT04630769|Analgesics|analgesics|mesh-ancestor
101917817|NCT04630769|Sensory System Agents|sensory system agents|mesh-ancestor
101917818|NCT04630769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101917819|NCT04630769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917820|NCT04543188|Midazolam|midazolam|mesh-list
101917821|NCT04543188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101917822|NCT04543188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101917823|NCT04543188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101917824|NCT04543188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917825|NCT04543188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101917826|NCT04543188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101917827|NCT04543188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101917828|NCT04543188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101917829|NCT04543188|Anesthetics, General|anesthetics, general|mesh-ancestor
101917830|NCT04543188|Anesthetics|anesthetics|mesh-ancestor
101917831|NCT04543188|GABA Modulators|gaba modulators|mesh-ancestor
101917832|NCT04543188|GABA Agents|gaba agents|mesh-ancestor
101917833|NCT04543188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101917834|NCT04543188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917835|NCT04477512|Prednisone|prednisone|mesh-list
101917836|NCT04477512|Nivolumab|nivolumab|mesh-list
101917837|NCT04477512|Abiraterone Acetate|abiraterone acetate|mesh-list
101917838|NCT04477512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101917839|NCT04477512|Glucocorticoids|glucocorticoids|mesh-ancestor
101917840|NCT04477512|Hormones|hormones|mesh-ancestor
101917841|NCT04477512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101917842|NCT04477512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917843|NCT04477512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101917844|NCT04477512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101917845|NCT04477512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101917846|NCT04477512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101917847|NCT04477512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917848|NCT04477512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101917849|NCT04477512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101917850|NCT04477512|Hormone Antagonists|hormone antagonists|mesh-ancestor
101917851|NCT04477512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101637714|NCT03588884|Vitamin D|vitamin d|mesh-list
101917852|NCT04459273|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101917853|NCT04459273|FAPI-46|fapi-46|mesh-list
101917854|NCT04459273|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101917855|NCT04459273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917857|NCT04457232|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101917858|NCT04457232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917859|NCT04407247|Infliximab|infliximab|mesh-list
101917860|NCT04407247|Vedolizumab|vedolizumab|mesh-list
101917861|NCT04407247|Immunoglobulins|immunoglobulins|mesh-list
101917862|NCT04407247|Immunoglobulin G|immunoglobulin g|mesh-list
101917863|NCT04407247|Immunologic Factors|immunologic factors|mesh-ancestor
101917864|NCT04407247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917865|NCT04407247|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101917866|NCT04407247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101917867|NCT04407247|Dermatologic Agents|dermatologic agents|mesh-ancestor
101917868|NCT04407247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101917869|NCT04407247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101917870|NCT04349124|Nifedipine|nifedipine|mesh-list
101917871|NCT04349124|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101917872|NCT04349124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101917873|NCT04349124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917874|NCT04349124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101917875|NCT04349124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917876|NCT04349124|Vasodilator Agents|vasodilator agents|mesh-ancestor
101917877|NCT04349124|Tocolytic Agents|tocolytic agents|mesh-ancestor
101917878|NCT04349124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101917879|NCT04348292|Sirolimus|sirolimus|mesh-list
101917880|NCT04348292|Durvalumab|durvalumab|mesh-list
101917881|NCT04348292|Immunoglobulins|immunoglobulins|mesh-list
101917882|NCT04348292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101917883|NCT04348292|Immunoglobulin G|immunoglobulin g|mesh-list
101917884|NCT04348292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101917885|NCT04348292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101917886|NCT04348292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101917887|NCT04348292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101917888|NCT04348292|Antifungal Agents|antifungal agents|mesh-ancestor
101917889|NCT04348292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101917890|NCT04348292|Immunologic Factors|immunologic factors|mesh-ancestor
101917891|NCT04348292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917892|NCT04348292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101917894|NCT04316676|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
101917895|NCT04316676|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101917896|NCT04316676|Purinergic Agonists|purinergic agonists|mesh-ancestor
101917897|NCT04316676|Purinergic Agents|purinergic agents|mesh-ancestor
101917898|NCT04316676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101917899|NCT04316676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917900|NCT04316676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917901|NCT04147494|Edetic Acid|edetic acid|mesh-list
101917902|NCT04147494|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101917903|NCT04147494|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101917904|NCT04147494|FAPI-46|fapi-46|mesh-list
101917905|NCT04147494|Chelating Agents|chelating agents|mesh-ancestor
101917906|NCT04147494|Sequestering Agents|sequestering agents|mesh-ancestor
101917907|NCT04147494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917908|NCT04147494|Anticoagulants|anticoagulants|mesh-ancestor
101917909|NCT04147494|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101917910|NCT04147494|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101917911|NCT04138706|Vancomycin|vancomycin|mesh-list
101917912|NCT04138706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101917913|NCT04138706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101917914|NCT03991403|Paclitaxel|paclitaxel|mesh-list
101917915|NCT03991403|Bevacizumab|bevacizumab|mesh-list
101917916|NCT03991403|Carboplatin|carboplatin|mesh-list
101917917|NCT03991403|Pemetrexed|pemetrexed|mesh-list
101917918|NCT03991403|Atezolizumab|atezolizumab|mesh-list
101917919|NCT03991403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101917920|NCT03991403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101917921|NCT03991403|Tubulin Modulators|tubulin modulators|mesh-ancestor
101917922|NCT03991403|Antimitotic Agents|antimitotic agents|mesh-ancestor
101917923|NCT03991403|Mitosis Modulators|mitosis modulators|mesh-ancestor
101917924|NCT03991403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917925|NCT03991403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101917926|NCT03991403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101917927|NCT03991403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101917928|NCT03991403|Growth Substances|growth substances|mesh-ancestor
101917929|NCT03991403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917930|NCT03991403|Growth Inhibitors|growth inhibitors|mesh-ancestor
101917931|NCT03991403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101917932|NCT03991403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101917933|NCT03991403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101917934|NCT03991403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101917936|NCT03930680|Razoxane|razoxane|mesh-list
101917937|NCT03930680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101917938|NCT03930680|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101917939|NCT03930680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101917940|NCT03930680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101917941|NCT03930680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101917942|NCT03930680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917943|NCT03930680|Protective Agents|protective agents|mesh-ancestor
101917944|NCT03930680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917945|NCT03930680|Antimitotic Agents|antimitotic agents|mesh-ancestor
101917946|NCT03930680|Mitosis Modulators|mitosis modulators|mesh-ancestor
101917947|NCT03897439|Bupropion|bupropion|mesh-list
101917948|NCT03897439|Nicotine|nicotine|mesh-list
101917949|NCT03897439|Varenicline|varenicline|mesh-list
101917950|NCT03897439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101917951|NCT03897439|Autonomic Agents|autonomic agents|mesh-ancestor
101917952|NCT03897439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101917953|NCT03897439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917954|NCT03897439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101917955|NCT03897439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101917956|NCT03897439|Cholinergic Agents|cholinergic agents|mesh-ancestor
101917957|NCT03897439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101917958|NCT03897439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917959|NCT03897439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101917960|NCT03897439|Antidepressive Agents|antidepressive agents|mesh-ancestor
101917961|NCT03897439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101917962|NCT03897439|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101917963|NCT03897439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101917964|NCT03897439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101917965|NCT03897439|Dopamine Agents|dopamine agents|mesh-ancestor
101917966|NCT03897439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101917967|NCT03897439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101917968|NCT03897439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101917969|NCT03830164|Vitamins|vitamins|mesh-list
101917970|NCT03830164|Vitamin E|vitamin e|mesh-list
101917971|NCT03830164|Tocopherols|tocopherols|mesh-list
101917972|NCT03830164|Tocotrienols|tocotrienols|mesh-list
101917973|NCT03830164|alpha-Tocopherol|alpha-tocopherol|mesh-list
101917974|NCT03830164|Pentoxifylline|pentoxifylline|mesh-list
101917975|NCT03830164|Atorvastatin|atorvastatin|mesh-list
101917976|NCT03830164|Micronutrients|micronutrients|mesh-ancestor
101917977|NCT03830164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917978|NCT03830164|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101917979|NCT03830164|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101917980|NCT03830164|Antimetabolites|antimetabolites|mesh-ancestor
101917981|NCT03830164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101917982|NCT03830164|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101917983|NCT03830164|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101917984|NCT03830164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101917985|NCT03830164|Antioxidants|antioxidants|mesh-ancestor
101917986|NCT03830164|Protective Agents|protective agents|mesh-ancestor
101917987|NCT03830164|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101917988|NCT03830164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101917989|NCT03830164|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101917990|NCT03830164|Vasodilator Agents|vasodilator agents|mesh-ancestor
101917991|NCT03830164|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101917992|NCT03777436|Apremilast|apremilast|mesh-list
101917993|NCT03777436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101917994|NCT03777436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101917995|NCT03777436|Analgesics|analgesics|mesh-ancestor
101917996|NCT03777436|Sensory System Agents|sensory system agents|mesh-ancestor
101917997|NCT03777436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101917998|NCT03777436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101917999|NCT03777436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101918000|NCT03777436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101918001|NCT03777436|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101918002|NCT03777436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101918003|NCT03777436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101918004|NCT03777436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918005|NCT03773302|Gemcitabine|gemcitabine|mesh-list
101918006|NCT03773302|Infigratinib|infigratinib|mesh-list
101918007|NCT03773302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101918008|NCT03773302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101918009|NCT03773302|Antimetabolites|antimetabolites|mesh-ancestor
101918010|NCT03773302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918011|NCT03701763|Apremilast|apremilast|mesh-list
101918012|NCT03701763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101918013|NCT03701763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101918014|NCT03701763|Analgesics|analgesics|mesh-ancestor
101918015|NCT03701763|Sensory System Agents|sensory system agents|mesh-ancestor
101918016|NCT03701763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101918017|NCT03701763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918018|NCT03701763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101918019|NCT03701763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101918020|NCT03701763|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101918021|NCT03701763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101918022|NCT03701763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101918023|NCT03701763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918025|NCT03673462|Immunologic Factors|immunologic factors|mesh-ancestor
101918026|NCT03673462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918027|NCT03592992|Morphine|morphine|mesh-list
101918028|NCT03592992|Hydromorphone|hydromorphone|mesh-list
101918029|NCT03592992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101918030|NCT03592992|Narcotics|narcotics|mesh-ancestor
101918031|NCT03592992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101918032|NCT03592992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918033|NCT03592992|Analgesics|analgesics|mesh-ancestor
101918034|NCT03592992|Sensory System Agents|sensory system agents|mesh-ancestor
101918035|NCT03592992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101918036|NCT03447808|Daratumumab|daratumumab|mesh-list
101918037|NCT03447808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101918038|NCT03386240|Triclosan|triclosan|mesh-list
101918039|NCT03386240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101918040|NCT03386240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101918041|NCT03386240|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101918042|NCT03386240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101918043|NCT03386240|Antimetabolites|antimetabolites|mesh-ancestor
101918044|NCT03386240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918045|NCT03386240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101918046|NCT03366766|Cisplatin|cisplatin|mesh-list
101918047|NCT03366766|Gemcitabine|gemcitabine|mesh-list
101918048|NCT03366766|Nivolumab|nivolumab|mesh-list
101918049|NCT03366766|Pemetrexed|pemetrexed|mesh-list
101918050|NCT03366766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101918051|NCT03366766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101918052|NCT03366766|Antimetabolites|antimetabolites|mesh-ancestor
101918053|NCT03366766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918054|NCT03366766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101918055|NCT03366766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101918056|NCT03366766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101918057|NCT03366766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101918058|NCT03366766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101918059|NCT03308448|Epoetin Alfa|epoetin alfa|mesh-list
101918060|NCT03308448|Hematinics|hematinics|mesh-ancestor
101918061|NCT03299309|Vaccines|vaccines|mesh-list
101918062|NCT03299309|Immunologic Factors|immunologic factors|mesh-ancestor
101918063|NCT03299309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918064|NCT03254927|Cetuximab|cetuximab|mesh-list
101918065|NCT03254927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101918066|NCT03254927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101918067|NCT03039036|Misoprostol|misoprostol|mesh-list
101918068|NCT03039036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101918069|NCT03039036|Abortifacient Agents|abortifacient agents|mesh-ancestor
101918070|NCT03039036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101918071|NCT03039036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918072|NCT03039036|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101918073|NCT03039036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101918074|NCT03039036|Oxytocics|oxytocics|mesh-ancestor
101918075|NCT03025880|Gemcitabine|gemcitabine|mesh-list
101918076|NCT03025880|Pembrolizumab|pembrolizumab|mesh-list
101918077|NCT03025880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101918078|NCT03025880|Antimetabolites|antimetabolites|mesh-ancestor
101918079|NCT03025880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918080|NCT03025880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101918081|NCT03025880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101918082|NCT03025880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101918083|NCT02962297|Vitamin E|vitamin e|mesh-list
101918084|NCT02962297|Vitamins|vitamins|mesh-ancestor
101918085|NCT02962297|Micronutrients|micronutrients|mesh-ancestor
101918086|NCT02962297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918087|NCT02962297|Antioxidants|antioxidants|mesh-ancestor
101918088|NCT02962297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918089|NCT02962297|Protective Agents|protective agents|mesh-ancestor
101918090|NCT02939742|Betamethasone|betamethasone|mesh-list
101918091|NCT02939742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101918092|NCT02939742|Glucocorticoids|glucocorticoids|mesh-ancestor
101918093|NCT02939742|Hormones|hormones|mesh-ancestor
101918094|NCT02939742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101918095|NCT02939742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918096|NCT02939742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101918097|NCT02939742|Respiratory System Agents|respiratory system agents|mesh-ancestor
101918098|NCT02678572|Melphalan|melphalan|mesh-list
101918099|NCT02678572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101918100|NCT02678572|Alkylating Agents|alkylating agents|mesh-ancestor
101918101|NCT02678572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918102|NCT02678572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101918103|NCT02678572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101918104|NCT02678572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101918105|NCT02678572|Immunologic Factors|immunologic factors|mesh-ancestor
101918106|NCT02678572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918107|NCT02581787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101918108|NCT02581787|Antibodies|antibodies|mesh-list
101918109|NCT02581787|Immunoglobulins|immunoglobulins|mesh-list
101918110|NCT02581787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101918111|NCT02581787|Immunoglobulin G|immunoglobulin g|mesh-list
101918112|NCT02581787|Immunologic Factors|immunologic factors|mesh-ancestor
101918113|NCT02581787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918114|NCT02581787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101918115|NCT02518555|Vaccines|vaccines|mesh-list
101918116|NCT02518555|Immunologic Factors|immunologic factors|mesh-ancestor
101918117|NCT02518555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918118|NCT02027376|Docetaxel|docetaxel|mesh-list
101918119|NCT02027376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101918120|NCT02027376|Tubulin Modulators|tubulin modulators|mesh-ancestor
101918121|NCT02027376|Antimitotic Agents|antimitotic agents|mesh-ancestor
101918122|NCT02027376|Mitosis Modulators|mitosis modulators|mesh-ancestor
101918123|NCT02027376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918124|NCT02005289|Lenalidomide|lenalidomide|mesh-list
101918125|NCT02005289|Immunologic Factors|immunologic factors|mesh-ancestor
101918126|NCT02005289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918127|NCT02005289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101918128|NCT02005289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101918129|NCT02005289|Growth Substances|growth substances|mesh-ancestor
101918130|NCT02005289|Growth Inhibitors|growth inhibitors|mesh-ancestor
101918131|NCT02005289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101918132|NCT01924533|Paclitaxel|paclitaxel|mesh-list
101918133|NCT01924533|Olaparib|olaparib|mesh-list
101918134|NCT01924533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101918135|NCT01924533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101918136|NCT01924533|Tubulin Modulators|tubulin modulators|mesh-ancestor
101918137|NCT01924533|Antimitotic Agents|antimitotic agents|mesh-ancestor
101918138|NCT01924533|Mitosis Modulators|mitosis modulators|mesh-ancestor
101918139|NCT01924533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918140|NCT01924533|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101918141|NCT01924533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101918142|NCT01683955|Tranexamic Acid|tranexamic acid|mesh-list
101918143|NCT01683955|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101918144|NCT01683955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101918145|NCT01683955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918146|NCT01683955|Hemostatics|hemostatics|mesh-ancestor
101918147|NCT01683955|Coagulants|coagulants|mesh-ancestor
101918148|NCT01606436|Moxifloxacin|moxifloxacin|mesh-list
101918149|NCT01606436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101918150|NCT01606436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101918151|NCT01606436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101918152|NCT01606436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101918153|NCT01606436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101957462|NCT02106520|Growth Inhibitors|growth inhibitors|mesh-ancestor
101918154|NCT01606436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918155|NCT01606436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101918156|NCT01453088|Bortezomib|bortezomib|mesh-list
101918157|NCT01453088|Melphalan|melphalan|mesh-list
101574928|NCT02760355|Ribavirin|ribavirin|mesh-list
101918158|NCT01453088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101918159|NCT01453088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101918160|NCT01453088|Alkylating Agents|alkylating agents|mesh-ancestor
101918161|NCT01453088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918162|NCT01453088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101918163|NCT01453088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101918164|NCT01453088|Immunologic Factors|immunologic factors|mesh-ancestor
101918165|NCT01453088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918166|NCT01345175|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101918167|NCT01345175|Metronidazole|metronidazole|mesh-list
101918168|NCT01345175|Rifaximin|rifaximin|mesh-list
101918169|NCT01345175|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101918170|NCT01345175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101918171|NCT01345175|Antitubercular Agents|antitubercular agents|mesh-ancestor
101918172|NCT01345175|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101918173|NCT01345175|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101918174|NCT01345175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101918175|NCT01295645|Cidofovir|cidofovir|mesh-list
101918176|NCT01295645|Antiviral Agents|antiviral agents|mesh-ancestor
101918177|NCT01295645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101918178|NCT01295645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101918179|NCT01295645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918180|NCT01257139|Docetaxel|docetaxel|mesh-list
101918181|NCT01257139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101918182|NCT01257139|Tubulin Modulators|tubulin modulators|mesh-ancestor
101918183|NCT01257139|Antimitotic Agents|antimitotic agents|mesh-ancestor
101918184|NCT01257139|Mitosis Modulators|mitosis modulators|mesh-ancestor
101918185|NCT01257139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918186|NCT01243190|Ofatumumab|ofatumumab|mesh-list
101918187|NCT01243190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101918188|NCT01046825|Leucovorin|leucovorin|mesh-list
101918189|NCT01046825|Folic Acid|folic acid|mesh-list
101918190|NCT01046825|Cytarabine|cytarabine|mesh-list
101918191|NCT01046825|Prednisone|prednisone|mesh-list
101918192|NCT01046825|Cyclophosphamide|cyclophosphamide|mesh-list
101918193|NCT01046825|Doxorubicin|doxorubicin|mesh-list
101918194|NCT01046825|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101918195|NCT01046825|Rituximab|rituximab|mesh-list
101918196|NCT01046825|Rasburicase|rasburicase|mesh-list
101918197|NCT01046825|Lenograstim|lenograstim|mesh-list
101918198|NCT01046825|Levoleucovorin|levoleucovorin|mesh-list
101918199|NCT01046825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101918200|NCT01046825|Glucocorticoids|glucocorticoids|mesh-ancestor
101918201|NCT01046825|Hormones|hormones|mesh-ancestor
101918202|NCT01046825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101918203|NCT01046825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918204|NCT01046825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101918205|NCT01046825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101918206|NCT01046825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101918207|NCT01046825|Immunologic Factors|immunologic factors|mesh-ancestor
101918208|NCT01046825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101918209|NCT01046825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101918210|NCT01046825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101918211|NCT01046825|Alkylating Agents|alkylating agents|mesh-ancestor
101918212|NCT01046825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918213|NCT01046825|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101918214|NCT01046825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101918215|NCT01046825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101918216|NCT01046825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101918217|NCT01046825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101918218|NCT01046825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101918219|NCT01046825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101918220|NCT01046825|Antimetabolites|antimetabolites|mesh-ancestor
101918221|NCT01046825|Antiviral Agents|antiviral agents|mesh-ancestor
101918222|NCT01046825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101918223|NCT01046825|Antidotes|antidotes|mesh-ancestor
101918224|NCT01046825|Protective Agents|protective agents|mesh-ancestor
101918225|NCT01046825|Vitamin B Complex|vitamin b complex|mesh-ancestor
101918226|NCT01046825|Vitamins|vitamins|mesh-ancestor
101230672|NCT04710368|Evolocumab|evolocumab|mesh-list
101918227|NCT01046825|Micronutrients|micronutrients|mesh-ancestor
101918228|NCT01046825|Hematinics|hematinics|mesh-ancestor
101918229|NCT01046825|Gout Suppressants|gout suppressants|mesh-ancestor
101918230|NCT00936936|Carboplatin|carboplatin|mesh-list
101918231|NCT00936936|Gemcitabine|gemcitabine|mesh-list
101918232|NCT00936936|Docetaxel|docetaxel|mesh-list
101918233|NCT00936936|Etoposide|etoposide|mesh-list
101918234|NCT00936936|Melphalan|melphalan|mesh-list
101918235|NCT00936936|Ifosfamide|ifosfamide|mesh-list
101918236|NCT00936936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101918237|NCT00936936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101918238|NCT00936936|Antimetabolites|antimetabolites|mesh-ancestor
101918239|NCT00936936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918240|NCT00936936|Tubulin Modulators|tubulin modulators|mesh-ancestor
101918241|NCT00936936|Antimitotic Agents|antimitotic agents|mesh-ancestor
101918242|NCT00936936|Mitosis Modulators|mitosis modulators|mesh-ancestor
101918243|NCT00936936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101918244|NCT00936936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101918245|NCT00936936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101918246|NCT00936936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101918247|NCT00936936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101918248|NCT00936936|Alkylating Agents|alkylating agents|mesh-ancestor
101918249|NCT00936936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101918250|NCT00936936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101918251|NCT00936936|Immunologic Factors|immunologic factors|mesh-ancestor
101918252|NCT00936936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918253|NCT04478292|Sodium thiosulfate|sodium thiosulfate|mesh-list
101918254|NCT04478292|Cisplatin|cisplatin|mesh-list
101918255|NCT04478292|Carboplatin|carboplatin|mesh-list
101918256|NCT04478292|Doxorubicin|doxorubicin|mesh-list
101918257|NCT04478292|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101918258|NCT04478292|Fluorouracil|fluorouracil|mesh-list
101918259|NCT04478292|Irinotecan|irinotecan|mesh-list
101918260|NCT04478292|Vincristine|vincristine|mesh-list
101918261|NCT04478292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101918262|NCT04478292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101918263|NCT04478292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101918264|NCT04478292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101918265|NCT04478292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101918266|NCT04478292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918267|NCT04478292|Antimetabolites|antimetabolites|mesh-ancestor
101918268|NCT04478292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101918269|NCT04478292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101918270|NCT04478292|Immunologic Factors|immunologic factors|mesh-ancestor
101918271|NCT04478292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918272|NCT04478292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101918273|NCT04478292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101918274|NCT04478292|Tubulin Modulators|tubulin modulators|mesh-ancestor
101918275|NCT04478292|Antimitotic Agents|antimitotic agents|mesh-ancestor
101918276|NCT04478292|Mitosis Modulators|mitosis modulators|mesh-ancestor
101918277|NCT04478292|Antidotes|antidotes|mesh-ancestor
101918278|NCT04478292|Protective Agents|protective agents|mesh-ancestor
101918279|NCT04478292|Antioxidants|antioxidants|mesh-ancestor
101918280|NCT04478292|Antitubercular Agents|antitubercular agents|mesh-ancestor
101918281|NCT04478292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101918282|NCT04478292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101918283|NCT04478292|Chelating Agents|chelating agents|mesh-ancestor
101918284|NCT04478292|Sequestering Agents|sequestering agents|mesh-ancestor
101918285|NCT01141296|Fenofibrate|fenofibrate|mesh-list
101918286|NCT01141296|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101918287|NCT01141296|Antimetabolites|antimetabolites|mesh-ancestor
101918288|NCT01141296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918289|NCT01141296|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101918290|NCT01238328|Thymoglobulin|thymoglobulin|mesh-list
101918291|NCT01238328|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101918292|NCT01238328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101230013|NCT05840406|Ibuprofen|ibuprofen|mesh-list
101918293|NCT01238328|Immunologic Factors|immunologic factors|mesh-ancestor
101918294|NCT01238328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918295|NCT01238406|Pancrelipase|pancrelipase|mesh-list
101918296|NCT01238406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101918297|NCT03724890|Avelumab|avelumab|mesh-list
101918298|NCT03724890|Peposertib|peposertib|mesh-list
101918299|NCT03724890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101918300|NCT03724890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101918301|NCT03724890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101918303|NCT03724890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918304|NCT01141452|Fluticasone|fluticasone|mesh-list
101918305|NCT01141452|Xhance|xhance|mesh-list
101918306|NCT01141452|Beclomethasone|beclomethasone|mesh-list
101918307|NCT01141452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101918308|NCT01141452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101918309|NCT01141452|Autonomic Agents|autonomic agents|mesh-ancestor
101918310|NCT01141452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101918311|NCT01141452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918312|NCT01141452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101918313|NCT01141452|Respiratory System Agents|respiratory system agents|mesh-ancestor
101918314|NCT01141452|Dermatologic Agents|dermatologic agents|mesh-ancestor
101918315|NCT01141452|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101918316|NCT01141452|Glucocorticoids|glucocorticoids|mesh-ancestor
101918317|NCT01141452|Hormones|hormones|mesh-ancestor
101918318|NCT01141452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101918319|NCT00219557|Gemcitabine|gemcitabine|mesh-list
101918320|NCT00219557|Axitinib|axitinib|mesh-list
101918321|NCT00219557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101918322|NCT00219557|Antimetabolites|antimetabolites|mesh-ancestor
101918323|NCT00219557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918324|NCT00219557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101918325|NCT00219557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101918326|NCT00219557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101918327|NCT05282940|Levonorgestrel|levonorgestrel|mesh-list
101918328|NCT05282940|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101918329|NCT05282940|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
101918330|NCT05282940|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
101918331|NCT05282940|Estradiol|estradiol|mesh-list
101918332|NCT05282940|Estrogens|estrogens|mesh-ancestor
101918333|NCT05282940|Hormones|hormones|mesh-ancestor
101918334|NCT05282940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101918335|NCT05282940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918336|NCT05282940|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101918337|NCT05282940|Contraceptive Agents|contraceptive agents|mesh-ancestor
101918338|NCT05282940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101918339|NCT05282940|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101918340|NCT05282940|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101918341|NCT05282940|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101918342|NCT05282940|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101918343|NCT05282940|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101918344|NCT05282940|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
101918345|NCT05282940|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101918346|NCT05282940|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101918347|NCT01238562|Lenograstim|lenograstim|mesh-list
101918348|NCT01238562|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101918349|NCT01238562|Immunologic Factors|immunologic factors|mesh-ancestor
101918350|NCT01238562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918351|NCT01329666|Vitamin D|vitamin d|mesh-list
101918352|NCT01329666|Cholecalciferol|cholecalciferol|mesh-list
101918353|NCT01329666|Vitamins|vitamins|mesh-ancestor
101918354|NCT01329666|Micronutrients|micronutrients|mesh-ancestor
101918355|NCT01329666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918356|NCT01329666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101918357|NCT01329666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101918358|NCT05255484|Antibodies|antibodies|mesh-list
101918359|NCT05255484|Immunologic Factors|immunologic factors|mesh-ancestor
101918360|NCT05255484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918361|NCT01141998|Cholecalciferol|cholecalciferol|mesh-list
101918362|NCT01141998|Vitamin D|vitamin d|mesh-list
101918363|NCT01141998|Calcium, Dietary|calcium, dietary|mesh-list
101918364|NCT01141998|Calcium|calcium|mesh-list
101918365|NCT01141998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101918366|NCT01141998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918367|NCT01141998|Vitamins|vitamins|mesh-ancestor
101918368|NCT01141998|Micronutrients|micronutrients|mesh-ancestor
101918369|NCT01141998|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101918370|NCT01238718|Lidocaine|lidocaine|mesh-list
101918371|NCT01238718|Anesthetics, Local|anesthetics, local|mesh-ancestor
101918372|NCT01238718|Anesthetics|anesthetics|mesh-ancestor
101918373|NCT01238718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101918374|NCT01238718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918376|NCT01238718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101918377|NCT01238718|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101918378|NCT01238718|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101918379|NCT01238718|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101918380|NCT01238718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101918381|NCT01238718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918382|NCT01238796|Telavancin|telavancin|mesh-list
101918383|NCT01238796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101918384|NCT01238796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101918385|NCT01143948|Insulin|insulin|mesh-list
101918386|NCT01143948|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101918387|NCT01143948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101918388|NCT01143948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918389|NCT01145976|Cyclophosphamide|cyclophosphamide|mesh-list
101918390|NCT01145976|Fludarabine|fludarabine|mesh-list
101918391|NCT01145976|Thymoglobulin|thymoglobulin|mesh-list
101918392|NCT01145976|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101918393|NCT01145976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101918394|NCT01145976|Immunologic Factors|immunologic factors|mesh-ancestor
101918395|NCT01145976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918396|NCT01145976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101918397|NCT01145976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101918398|NCT01145976|Alkylating Agents|alkylating agents|mesh-ancestor
101918399|NCT01145976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918400|NCT01145976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101918401|NCT01145976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101918402|NCT01238952|Carboplatin|carboplatin|mesh-list
101918403|NCT01238952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101918405|NCT05158998|Sevoflurane|sevoflurane|mesh-list
101918406|NCT05158998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101918407|NCT05158998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101918408|NCT05158998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918409|NCT05158998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101918410|NCT05158998|Anesthetics, General|anesthetics, general|mesh-ancestor
101918411|NCT05158998|Anesthetics|anesthetics|mesh-ancestor
101918412|NCT05158998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101918413|NCT05158998|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101918414|NCT01144260|Bafetinib|bafetinib|mesh-list
101918415|NCT01144260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101918416|NCT01144260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101918417|NCT01144260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918418|NCT01239498|Lidocaine|lidocaine|mesh-list
101918419|NCT01239498|Epinephrine|epinephrine|mesh-list
101918420|NCT01239498|Racepinephrine|racepinephrine|mesh-list
101918421|NCT01239498|Anesthetics|anesthetics|mesh-list
101918422|NCT01239498|Epinephryl borate|epinephryl borate|mesh-list
101918423|NCT01239498|Anesthetics, Local|anesthetics, local|mesh-ancestor
101230047|NCT05840328|Sensory System Agents|sensory system agents|mesh-ancestor
101918424|NCT01239498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101918425|NCT01239498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918426|NCT01239498|Sensory System Agents|sensory system agents|mesh-ancestor
101918427|NCT01239498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101918428|NCT01239498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101918429|NCT01239498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101918430|NCT01239498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101918431|NCT01239498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101918432|NCT01239498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918433|NCT01239498|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101918434|NCT01239498|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101918435|NCT01239498|Adrenergic Agents|adrenergic agents|mesh-ancestor
101918436|NCT01239498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101918437|NCT01239498|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101918438|NCT01239498|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101918439|NCT01239498|Autonomic Agents|autonomic agents|mesh-ancestor
101918440|NCT01239498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101918441|NCT01239498|Respiratory System Agents|respiratory system agents|mesh-ancestor
101918443|NCT01239498|Sympathomimetics|sympathomimetics|mesh-ancestor
101918444|NCT01239498|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101918445|NCT00251927|Esomeprazole|esomeprazole|mesh-list
101918446|NCT00251927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101918447|NCT00251927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101918448|NCT00251927|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101918449|NCT00251927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101616948|NCT00899847|Glucocorticoids|glucocorticoids|mesh-ancestor
101918450|NCT00251927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918452|NCT03790800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101918453|NCT03790800|Vasodilator Agents|vasodilator agents|mesh-ancestor
101918454|NCT03790800|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101918455|NCT03790800|Serotonin Agents|serotonin agents|mesh-ancestor
101918456|NCT03790800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101918457|NCT03790800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918458|NCT03790800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918459|NCT03790800|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101918460|NCT03790800|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101918461|NCT03790800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101918462|NCT03790800|Adrenergic Agents|adrenergic agents|mesh-ancestor
101918464|NCT03971201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101918465|NCT03971201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101918466|NCT03971201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101918467|NCT03971201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918468|NCT01236144|Plerixafor|plerixafor|mesh-list
101918469|NCT01236144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101918470|NCT01236144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101918471|NCT01236144|Antiviral Agents|antiviral agents|mesh-ancestor
101918472|NCT01236144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101918473|NCT02528526|Inositol|inositol|mesh-list
101918474|NCT02528526|Vitamin B Complex|vitamin b complex|mesh-ancestor
101918475|NCT02528526|Vitamins|vitamins|mesh-ancestor
101918476|NCT02528526|Micronutrients|micronutrients|mesh-ancestor
101918477|NCT02528526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918478|NCT03971279|Dexamethasone|dexamethasone|mesh-list
101918479|NCT03971279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101918480|NCT03971279|Antiemetics|antiemetics|mesh-ancestor
101918481|NCT03971279|Autonomic Agents|autonomic agents|mesh-ancestor
101918482|NCT03971279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101918483|NCT03971279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918484|NCT03971279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101918485|NCT03971279|Glucocorticoids|glucocorticoids|mesh-ancestor
101918486|NCT03971279|Hormones|hormones|mesh-ancestor
101918487|NCT03971279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101918488|NCT03971279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101918489|NCT03971279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101918490|NCT01329744|Mecasermin|mecasermin|mesh-list
101918491|NCT01329744|Growth Substances|growth substances|mesh-ancestor
101918492|NCT01329744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918493|NCT00165503|Sodium thiosulfate|sodium thiosulfate|mesh-list
101918494|NCT00165503|Pemetrexed|pemetrexed|mesh-list
101918495|NCT00165503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101918496|NCT00165503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101918497|NCT00165503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918498|NCT00165503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101918499|NCT00165503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101918500|NCT00165503|Antidotes|antidotes|mesh-ancestor
101918501|NCT00165503|Protective Agents|protective agents|mesh-ancestor
101918502|NCT00165503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918503|NCT00165503|Antioxidants|antioxidants|mesh-ancestor
101918504|NCT00165503|Antitubercular Agents|antitubercular agents|mesh-ancestor
101918505|NCT00165503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101918506|NCT00165503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101918507|NCT00165503|Chelating Agents|chelating agents|mesh-ancestor
101918508|NCT00165503|Sequestering Agents|sequestering agents|mesh-ancestor
101918509|NCT01144650|Dapsone|dapsone|mesh-list
101918510|NCT01144650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101918511|NCT01144650|Antimalarials|antimalarials|mesh-ancestor
101918512|NCT01144650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101918513|NCT01144650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101918514|NCT01144650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101918515|NCT01144650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101957499|NCT01562301|Carboplatin|carboplatin|mesh-list
101918516|NCT01144650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918517|NCT01144650|Leprostatic Agents|leprostatic agents|mesh-ancestor
101918518|NCT01144650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101918520|NCT00162773|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101918521|NCT00162773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101918522|NCT00162773|Respiratory System Agents|respiratory system agents|mesh-ancestor
101918523|NCT03970577|Prednisone|prednisone|mesh-list
101918524|NCT03970577|Rituximab|rituximab|mesh-list
101918525|NCT03970577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101918527|NCT03970577|Immunologic Factors|immunologic factors|mesh-ancestor
101918528|NCT03970577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918529|NCT03970577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101918530|NCT03970577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101918531|NCT03970577|Glucocorticoids|glucocorticoids|mesh-ancestor
101918532|NCT03970577|Hormones|hormones|mesh-ancestor
101918533|NCT03970577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101918534|NCT03970577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101918535|NCT01073813|Minocycline|minocycline|mesh-list
101918536|NCT01073813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101918537|NCT01073813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101918538|NCT03823391|Adalimumab|adalimumab|mesh-list
101918539|NCT03823391|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101918540|NCT03823391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101918541|NCT03823391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101918542|NCT01075529|Fluoxetine|fluoxetine|mesh-list
101918543|NCT01075529|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101918544|NCT01075529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101918545|NCT01075529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101918546|NCT01075529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918547|NCT01075529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101918549|NCT01075529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918550|NCT01075529|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101918551|NCT01075529|Antidepressive Agents|antidepressive agents|mesh-ancestor
101918552|NCT01075529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101918553|NCT01075529|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101918554|NCT01075529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101918555|NCT01075529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101918556|NCT01073891|Moxifloxacin|moxifloxacin|mesh-list
101918557|NCT01073891|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101918558|NCT01073891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101918559|NCT01073891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101918560|NCT01073891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101918561|NCT01073891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101918562|NCT01073891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101918563|NCT01073891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918564|NCT01073891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101918565|NCT01073891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101918566|NCT01073891|Contraceptive Agents|contraceptive agents|mesh-ancestor
101918567|NCT01073891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101918568|NCT01073891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918569|NCT01073891|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101918570|NCT01073891|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101918571|NCT01073891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101918572|NCT00209027|Aripiprazole|aripiprazole|mesh-list
101918573|NCT00209027|Antidepressive Agents|antidepressive agents|mesh-ancestor
101918574|NCT00209027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101918575|NCT00209027|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101918576|NCT00209027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101918577|NCT00209027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101918578|NCT00209027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918579|NCT00209027|Dopamine Agonists|dopamine agonists|mesh-ancestor
101918580|NCT00209027|Dopamine Agents|dopamine agents|mesh-ancestor
101918581|NCT00209027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101918582|NCT00209027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918583|NCT00209027|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101918584|NCT00209027|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101918586|NCT00209027|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101918587|NCT00209027|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101918588|NCT00209027|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101918589|NCT00209027|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101918590|NCT00160667|Brivaracetam|brivaracetam|mesh-list
101918591|NCT00160667|Anticonvulsants|anticonvulsants|mesh-ancestor
101918592|NCT00206375|Hormones|hormones|mesh-list
101918593|NCT00206375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101918594|NCT00206375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918595|NCT00160199|Progesterone|progesterone|mesh-list
101918596|NCT00160199|Progestins|progestins|mesh-ancestor
101918597|NCT00160199|Hormones|hormones|mesh-ancestor
101775302|NCT00936195|Zidovudine|zidovudine|mesh-list
101918598|NCT00160199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101918599|NCT00160199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918600|NCT00157157|Factor VIII|factor viii|mesh-list
101918601|NCT00157157|Coagulants|coagulants|mesh-ancestor
101918602|NCT00203411|Bevacizumab|bevacizumab|mesh-list
101918603|NCT00203411|Capecitabine|capecitabine|mesh-list
101918604|NCT00203411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101918605|NCT00203411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101918606|NCT00203411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101918607|NCT00203411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101918608|NCT00203411|Growth Substances|growth substances|mesh-ancestor
101918609|NCT00203411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918610|NCT00203411|Growth Inhibitors|growth inhibitors|mesh-ancestor
101918611|NCT00203411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101918612|NCT00203411|Antimetabolites|antimetabolites|mesh-ancestor
101918613|NCT00203411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918614|NCT00203021|Glatiramer Acetate|glatiramer acetate|mesh-list
101918616|NCT00203021|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101918618|NCT00203021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918619|NCT00203021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101918620|NCT00203021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101918621|NCT00201851|Tamoxifen|tamoxifen|mesh-list
101918622|NCT00201851|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101918623|NCT00201851|Hormone Antagonists|hormone antagonists|mesh-ancestor
101918624|NCT00201851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101918625|NCT00201851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918626|NCT00201851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101918627|NCT00201851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101918628|NCT00201851|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101918629|NCT00201851|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101918630|NCT00201851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101918631|NCT01074203|Nitazoxanide|nitazoxanide|mesh-list
101918632|NCT01074203|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101918633|NCT01074203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101918634|NCT01074281|Enalapril|enalapril|mesh-list
101918635|NCT01074281|Enalaprilat|enalaprilat|mesh-list
101918636|NCT01074281|Nitrendipine|nitrendipine|mesh-list
101918637|NCT01074281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101918638|NCT01074281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918639|NCT01074281|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101918640|NCT01074281|Protease Inhibitors|protease inhibitors|mesh-ancestor
101918641|NCT01074281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101918642|NCT01074281|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101918643|NCT01074281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101918644|NCT01074281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101918645|NCT01074281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918646|NCT01074281|Vasodilator Agents|vasodilator agents|mesh-ancestor
101918647|NCT03129100|Ixekizumab|ixekizumab|mesh-list
101918648|NCT03129100|Dermatologic Agents|dermatologic agents|mesh-ancestor
101918649|NCT03100006|Nivolumab|nivolumab|mesh-list
101918650|NCT03100006|Oregovomab|oregovomab|mesh-list
101918651|NCT03100006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101918652|NCT03100006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101918653|NCT03100006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101918654|NCT03100006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918655|NCT03099538|Ixekizumab|ixekizumab|mesh-list
101918656|NCT03099538|Dermatologic Agents|dermatologic agents|mesh-ancestor
101918657|NCT00883480|Gemcitabine|gemcitabine|mesh-list
101918658|NCT00883480|Docetaxel|docetaxel|mesh-list
101918659|NCT00883480|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101918660|NCT00883480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101918661|NCT00883480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101918662|NCT00883480|Antimetabolites|antimetabolites|mesh-ancestor
101918663|NCT00883480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918664|NCT00883480|Tubulin Modulators|tubulin modulators|mesh-ancestor
101918665|NCT00883480|Antimitotic Agents|antimitotic agents|mesh-ancestor
101918666|NCT00883480|Mitosis Modulators|mitosis modulators|mesh-ancestor
101918667|NCT00883480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101918668|NCT00883480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101918669|NCT05418946|Dapagliflozin|dapagliflozin|mesh-list
101918670|NCT05418946|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101918671|NCT05418946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918672|NCT05418946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101918673|NCT05418946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918674|NCT03097588|Palonosetron|palonosetron|mesh-list
101918675|NCT03097588|Antiemetics|antiemetics|mesh-ancestor
101918676|NCT03097588|Autonomic Agents|autonomic agents|mesh-ancestor
101918677|NCT03097588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101918678|NCT03097588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918679|NCT03097588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101918680|NCT03097588|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101918681|NCT03097588|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101918682|NCT03097588|Serotonin Agents|serotonin agents|mesh-ancestor
101918683|NCT03097588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101918684|NCT03097588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918685|NCT05418244|Ondansetron|ondansetron|mesh-list
101918686|NCT05418244|Antiemetics|antiemetics|mesh-ancestor
101918687|NCT05418244|Autonomic Agents|autonomic agents|mesh-ancestor
101918688|NCT05418244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101918689|NCT05418244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918690|NCT05418244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101918691|NCT05418244|Antipruritics|antipruritics|mesh-ancestor
101918692|NCT05418244|Dermatologic Agents|dermatologic agents|mesh-ancestor
101918693|NCT05418244|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101918694|NCT05418244|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101918695|NCT05418244|Serotonin Agents|serotonin agents|mesh-ancestor
101918696|NCT05418244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101360053|NCT00212680|Landiolol|landiolol|mesh-list
101918697|NCT05418244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918699|NCT05418166|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101918700|NCT05418166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101918701|NCT05418166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101918702|NCT05418166|Antimetabolites|antimetabolites|mesh-ancestor
101918703|NCT05418166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918704|NCT05418166|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101918705|NCT05418166|Protease Inhibitors|protease inhibitors|mesh-ancestor
101918706|NCT05418166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101918707|NCT05418166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101918708|NCT01631214|Alendronate|alendronate|mesh-list
101918709|NCT01631214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101918710|NCT01631214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101918711|NCT01631214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918712|NCT01631214|Immunologic Factors|immunologic factors|mesh-ancestor
101918713|NCT01567774|Atorvastatin|atorvastatin|mesh-list
101918714|NCT01567774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101918715|NCT01567774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101918716|NCT01567774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101918717|NCT01567774|Antimetabolites|antimetabolites|mesh-ancestor
101918718|NCT01567774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918719|NCT01567774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101918720|NCT01567774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101918721|NCT01567774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101918722|NCT01567930|Sirolimus|sirolimus|mesh-list
101918723|NCT01567930|Temsirolimus|temsirolimus|mesh-list
101918724|NCT01567930|MTOR Inhibitors|mtor inhibitors|mesh-list
101918725|NCT01567930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101918726|NCT01567930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101918727|NCT01567930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918728|NCT01567930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101918729|NCT01567930|Immunologic Factors|immunologic factors|mesh-ancestor
101918730|NCT01567930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918732|NCT01567930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101918733|NCT01567930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101918734|NCT01567930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101918735|NCT01567930|Antifungal Agents|antifungal agents|mesh-ancestor
101918736|NCT04604548|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
101918737|NCT04604548|Antioxidants|antioxidants|mesh-ancestor
101918738|NCT04604548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918739|NCT04604548|Protective Agents|protective agents|mesh-ancestor
101918740|NCT04604548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918741|NCT01142622|Ropivacaine|ropivacaine|mesh-list
101918742|NCT01142622|Anesthetics, Local|anesthetics, local|mesh-ancestor
101918743|NCT01142622|Anesthetics|anesthetics|mesh-ancestor
101918744|NCT01142622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101918745|NCT01142622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918746|NCT01142622|Sensory System Agents|sensory system agents|mesh-ancestor
101918747|NCT01142622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101918748|NCT01142700|Ribavirin|ribavirin|mesh-list
101918749|NCT01142700|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101918750|NCT01142700|Antimetabolites|antimetabolites|mesh-ancestor
101918751|NCT01142700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918752|NCT01142700|Antiviral Agents|antiviral agents|mesh-ancestor
101918753|NCT01142700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101918754|NCT01144728|Metformin|metformin|mesh-list
101918755|NCT01144728|Glimepiride|glimepiride|mesh-list
101918756|NCT01144728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101918757|NCT01144728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918758|NCT01144728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101918759|NCT01144728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101918760|NCT01144728|Immunologic Factors|immunologic factors|mesh-ancestor
101918761|NCT01239810|Hyaluronic Acid|hyaluronic acid|mesh-list
101918762|NCT01239810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101918763|NCT01239810|Immunologic Factors|immunologic factors|mesh-ancestor
101918764|NCT01239810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918766|NCT01239810|Protective Agents|protective agents|mesh-ancestor
101918767|NCT01239888|Tibolone|tibolone|mesh-list
101918768|NCT01239888|Oxytocin|oxytocin|mesh-list
101918769|NCT01239888|Oxytocics|oxytocics|mesh-ancestor
101918770|NCT01239888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101918771|NCT01239888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918772|NCT01239888|Androgen Antagonists|androgen antagonists|mesh-ancestor
101918773|NCT01239888|Hormone Antagonists|hormone antagonists|mesh-ancestor
101918774|NCT01239888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101918775|NCT01239888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101918776|NCT01239888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101918777|NCT01239888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101918778|NCT01239888|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101918779|NCT01239888|Anabolic Agents|anabolic agents|mesh-ancestor
101918780|NCT01239888|Hormones|hormones|mesh-ancestor
101918781|NCT01318486|Heparin|heparin|mesh-list
101918782|NCT01318486|Anticoagulants|anticoagulants|mesh-ancestor
101918783|NCT01318486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101918784|NCT01318486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101918785|NCT01318486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918786|NCT03436108|Bisphenol A|bisphenol a|mesh-list
101918787|NCT03436108|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101918788|NCT03436108|Estrogens|estrogens|mesh-ancestor
101918789|NCT03436108|Hormones|hormones|mesh-ancestor
101918790|NCT03436108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101918791|NCT03436108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918792|NCT03436108|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101918793|NCT03436108|Antioxidants|antioxidants|mesh-ancestor
101918794|NCT03436108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918795|NCT03436108|Protective Agents|protective agents|mesh-ancestor
101918796|NCT02870218|Nicotine|nicotine|mesh-list
101918797|NCT02870218|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101918798|NCT02870218|Autonomic Agents|autonomic agents|mesh-ancestor
101918799|NCT02870218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101918800|NCT02870218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918801|NCT02870218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101918802|NCT02870218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101918803|NCT02870218|Cholinergic Agents|cholinergic agents|mesh-ancestor
101918804|NCT02870218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101918805|NCT02870218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918806|NCT02614690|Calpastatin|calpastatin|mesh-list
101918807|NCT02614690|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
101918808|NCT02614690|Protease Inhibitors|protease inhibitors|mesh-ancestor
101918809|NCT02614690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101918810|NCT02614690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918811|NCT01442194|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101918812|NCT01442194|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101918813|NCT01442194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918814|NCT01442194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101918815|NCT01442194|Immunologic Factors|immunologic factors|mesh-ancestor
101918816|NCT01442194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918817|NCT00468130|Aripiprazole|aripiprazole|mesh-list
101918818|NCT00468130|Antidepressive Agents|antidepressive agents|mesh-ancestor
101918819|NCT00468130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101918820|NCT00468130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101918821|NCT00468130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101918822|NCT00468130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101918823|NCT00468130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918824|NCT00468130|Dopamine Agonists|dopamine agonists|mesh-ancestor
101918825|NCT00468130|Dopamine Agents|dopamine agents|mesh-ancestor
101918826|NCT00468130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101918827|NCT00468130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918828|NCT00468130|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101918829|NCT00468130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101918830|NCT00468130|Serotonin Agents|serotonin agents|mesh-ancestor
101230095|NCT05839652|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101918831|NCT00468130|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101918832|NCT00468130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101918833|NCT00468130|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101918834|NCT00468130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101918835|NCT05196256|Sufentanil|sufentanil|mesh-list
101918836|NCT05196256|Levobupivacaine|levobupivacaine|mesh-list
101918837|NCT05196256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101918838|NCT05196256|Narcotics|narcotics|mesh-ancestor
101918839|NCT05196256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101918840|NCT05196256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918841|NCT05196256|Analgesics|analgesics|mesh-ancestor
101918842|NCT05196256|Sensory System Agents|sensory system agents|mesh-ancestor
101918843|NCT05196256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101918844|NCT05196256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101918845|NCT05196256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101918846|NCT05196256|Anesthetics, General|anesthetics, general|mesh-ancestor
101918847|NCT05196256|Anesthetics|anesthetics|mesh-ancestor
101918848|NCT05196256|Anesthetics, Local|anesthetics, local|mesh-ancestor
101918849|NCT01375348|Remifentanil|remifentanil|mesh-list
101918850|NCT01375348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101918851|NCT01375348|Narcotics|narcotics|mesh-ancestor
101918852|NCT01375348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101918853|NCT01375348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918854|NCT01375348|Analgesics|analgesics|mesh-ancestor
101918855|NCT01375348|Sensory System Agents|sensory system agents|mesh-ancestor
101918856|NCT01375348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101918857|NCT05195086|Mycophenolic Acid|mycophenolic acid|mesh-list
101918858|NCT05195086|Cyclophosphamide|cyclophosphamide|mesh-list
101918859|NCT05195086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101918860|NCT05195086|Immunologic Factors|immunologic factors|mesh-ancestor
101918861|NCT05195086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918862|NCT05195086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101918863|NCT05195086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101918864|NCT05195086|Alkylating Agents|alkylating agents|mesh-ancestor
101957516|NCT02101840|Narcotics|narcotics|mesh-ancestor
101918865|NCT05195086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918866|NCT05195086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101918867|NCT05195086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101918868|NCT05195086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101918869|NCT05195086|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101918870|NCT05195086|Antitubercular Agents|antitubercular agents|mesh-ancestor
101918871|NCT05195086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101918872|NCT05195086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101918873|NCT05195086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101918875|NCT05194852|Anesthetics, Local|anesthetics, local|mesh-list
101918876|NCT05194852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101918877|NCT05194852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918878|NCT05194852|Sensory System Agents|sensory system agents|mesh-ancestor
101918879|NCT05194852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101918880|NCT01375426|Amoxicillin|amoxicillin|mesh-list
101918881|NCT01375426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101918882|NCT01375426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101918883|NCT05193838|Allopurinol|allopurinol|mesh-list
101918884|NCT05193838|Antimetabolites|antimetabolites|mesh-ancestor
101918885|NCT05193838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918886|NCT05193838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101918887|NCT05193838|Gout Suppressants|gout suppressants|mesh-ancestor
101918888|NCT05193838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101918889|NCT05193838|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101918890|NCT05193838|Antioxidants|antioxidants|mesh-ancestor
101918891|NCT05193838|Protective Agents|protective agents|mesh-ancestor
101918892|NCT05193838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918893|NCT05193604|Paclitaxel|paclitaxel|mesh-list
101918894|NCT05193604|Gemcitabine|gemcitabine|mesh-list
101918895|NCT05193604|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101918896|NCT05193604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101918897|NCT05193604|Tubulin Modulators|tubulin modulators|mesh-ancestor
101918898|NCT05193604|Antimitotic Agents|antimitotic agents|mesh-ancestor
101918899|NCT05193604|Mitosis Modulators|mitosis modulators|mesh-ancestor
101918900|NCT05193604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918901|NCT05193604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101918902|NCT05193604|Antimetabolites|antimetabolites|mesh-ancestor
101918903|NCT01375816|Leucovorin|leucovorin|mesh-list
101918904|NCT01375816|Bevacizumab|bevacizumab|mesh-list
101918905|NCT01375816|Fluorouracil|fluorouracil|mesh-list
101918906|NCT01375816|Irinotecan|irinotecan|mesh-list
101918907|NCT01375816|Calcium|calcium|mesh-list
101918908|NCT01375816|Levoleucovorin|levoleucovorin|mesh-list
101918909|NCT01375816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101918910|NCT01375816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101918911|NCT01375816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101918912|NCT01375816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101918913|NCT01375816|Growth Substances|growth substances|mesh-ancestor
101918914|NCT01375816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918915|NCT01375816|Growth Inhibitors|growth inhibitors|mesh-ancestor
101918916|NCT01375816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101918918|NCT01375816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957538|NCT02105350|Gemcitabine|gemcitabine|mesh-list
101918919|NCT01375816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101918920|NCT01375816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101918921|NCT01375816|Immunologic Factors|immunologic factors|mesh-ancestor
101918922|NCT01375816|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101918923|NCT01375816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101918924|NCT01375816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101918925|NCT01375816|Antidotes|antidotes|mesh-ancestor
101918926|NCT01375816|Protective Agents|protective agents|mesh-ancestor
101918927|NCT01375816|Vitamin B Complex|vitamin b complex|mesh-ancestor
101918928|NCT01375816|Vitamins|vitamins|mesh-ancestor
101918929|NCT01375816|Micronutrients|micronutrients|mesh-ancestor
101918930|NCT03632824|Tranexamic Acid|tranexamic acid|mesh-list
101918931|NCT03632824|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101918932|NCT03632824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101918933|NCT03632824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918934|NCT03632824|Hemostatics|hemostatics|mesh-ancestor
101918935|NCT03632824|Coagulants|coagulants|mesh-ancestor
101918936|NCT00911820|Bevacizumab|bevacizumab|mesh-list
101918937|NCT00911820|Cisplatin|cisplatin|mesh-list
101918938|NCT00911820|Docetaxel|docetaxel|mesh-list
101918939|NCT00911820|Irinotecan|irinotecan|mesh-list
101918940|NCT00911820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101918941|NCT00911820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101918942|NCT00911820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101918943|NCT00911820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101918944|NCT00911820|Growth Substances|growth substances|mesh-ancestor
101918945|NCT00911820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918946|NCT00911820|Growth Inhibitors|growth inhibitors|mesh-ancestor
101918947|NCT00911820|Tubulin Modulators|tubulin modulators|mesh-ancestor
101918948|NCT00911820|Antimitotic Agents|antimitotic agents|mesh-ancestor
101918949|NCT00911820|Mitosis Modulators|mitosis modulators|mesh-ancestor
101918950|NCT00911820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918951|NCT00911820|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101918952|NCT00911820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101918953|NCT00911820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101918954|NCT05348122|Dulaglutide|dulaglutide|mesh-list
101918955|NCT05348122|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
101918956|NCT05348122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101918957|NCT05348122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918958|NCT05348122|Immunologic Factors|immunologic factors|mesh-ancestor
101918959|NCT05038618|Somatomedin B|somatomedin b|mesh-list
101918960|NCT05038618|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101918961|NCT05038618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101918962|NCT05038618|Protease Inhibitors|protease inhibitors|mesh-ancestor
101918963|NCT05038618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101918964|NCT05038618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918965|NCT01244880|Ketamine|ketamine|mesh-list
101918966|NCT01244880|Analgesics|analgesics|mesh-ancestor
101918967|NCT01244880|Sensory System Agents|sensory system agents|mesh-ancestor
101918968|NCT01244880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101918969|NCT01244880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918970|NCT01244880|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101918971|NCT01244880|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101918973|NCT01244880|Anesthetics|anesthetics|mesh-ancestor
101230106|NCT05839574|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101918974|NCT01244880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101918975|NCT01244880|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101918976|NCT01244880|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101918977|NCT01244880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101918978|NCT01244880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101918979|NCT01244958|Rituximab|rituximab|mesh-list
101918980|NCT01244958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101918981|NCT01244958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101918982|NCT01244958|Immunologic Factors|immunologic factors|mesh-ancestor
101918983|NCT01244958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918984|NCT01244958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101918985|NCT00246324|Interferons|interferons|mesh-list
101918986|NCT00246324|Interferon-beta|interferon-beta|mesh-list
101918987|NCT00246324|Interferon beta-1a|interferon beta-1a|mesh-list
101918988|NCT00246324|Doxycycline|doxycycline|mesh-list
101918989|NCT00246324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101918990|NCT00246324|Antiviral Agents|antiviral agents|mesh-ancestor
101918991|NCT00246324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101918992|NCT00246324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101918993|NCT00246324|Antimalarials|antimalarials|mesh-ancestor
101918994|NCT00246324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101918995|NCT00246324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101918996|NCT00246324|Immunologic Factors|immunologic factors|mesh-ancestor
101918997|NCT00246324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101918998|NCT00246324|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101918999|NCT01237782|Propolis|propolis|mesh-list
101919000|NCT01237782|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101919001|NCT01237782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101919002|NCT01245660|Lapatinib|lapatinib|mesh-list
101919003|NCT01245660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101919004|NCT01245660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101919005|NCT01245660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101919006|NCT01245660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919007|NCT03686904|Benzalkonium Compounds|benzalkonium compounds|mesh-list
101919008|NCT03686904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101919009|NCT03686904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101919010|NCT03913806|Bevacizumab|bevacizumab|mesh-list
101919011|NCT03913806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101919012|NCT03913806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101919013|NCT03913806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101919014|NCT03913806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101919015|NCT03913806|Growth Substances|growth substances|mesh-ancestor
101919016|NCT03913806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919017|NCT03913806|Growth Inhibitors|growth inhibitors|mesh-ancestor
101919018|NCT01250808|Dexamethasone|dexamethasone|mesh-list
101919019|NCT01250808|Bortezomib|bortezomib|mesh-list
101919020|NCT01250808|Melphalan|melphalan|mesh-list
101919021|NCT01250808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101919022|NCT01250808|Antiemetics|antiemetics|mesh-ancestor
101919023|NCT01250808|Autonomic Agents|autonomic agents|mesh-ancestor
101919024|NCT01250808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101919025|NCT01250808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919026|NCT01250808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101919027|NCT01250808|Glucocorticoids|glucocorticoids|mesh-ancestor
101919028|NCT01250808|Hormones|hormones|mesh-ancestor
101919029|NCT01250808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101919030|NCT01250808|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101919031|NCT01250808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101919032|NCT01250808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101919033|NCT01250808|Alkylating Agents|alkylating agents|mesh-ancestor
101919034|NCT01250808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919035|NCT01250808|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101919036|NCT01250808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101919037|NCT01250808|Immunologic Factors|immunologic factors|mesh-ancestor
101919038|NCT01146678|Insulin Glargine|insulin glargine|mesh-list
101919039|NCT01146678|Lixisenatide|lixisenatide|mesh-list
101919040|NCT01146678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101919041|NCT01146678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919042|NCT05429866|Nivolumab|nivolumab|mesh-list
101919043|NCT05429866|Atezolizumab|atezolizumab|mesh-list
101919044|NCT05429866|Durvalumab|durvalumab|mesh-list
101919045|NCT05429866|Avelumab|avelumab|mesh-list
101919046|NCT05429866|Cemiplimab|cemiplimab|mesh-list
101919047|NCT05429866|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101919048|NCT05429866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101919049|NCT05429866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101919050|NCT05429866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919051|NCT01250886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101919052|NCT03632590|Magnesium Sulfate|magnesium sulfate|mesh-list
101919053|NCT03632590|Magnesium citrate|magnesium citrate|mesh-list
101919054|NCT03632590|Magnesium Oxide|magnesium oxide|mesh-list
101919055|NCT03632590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919056|NCT03632590|Analgesics|analgesics|mesh-ancestor
101919057|NCT03632590|Sensory System Agents|sensory system agents|mesh-ancestor
101919058|NCT03632590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101919059|NCT03632590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919060|NCT03632590|Anesthetics|anesthetics|mesh-ancestor
101919061|NCT03632590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101919063|NCT03632590|Anticonvulsants|anticonvulsants|mesh-ancestor
101919064|NCT03632590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101919065|NCT03632590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101919066|NCT03632590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101919067|NCT03632590|Tocolytic Agents|tocolytic agents|mesh-ancestor
101919068|NCT03632590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101919069|NCT03632590|Cathartics|cathartics|mesh-ancestor
101919070|NCT03632590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101919071|NCT03632590|Antacids|antacids|mesh-ancestor
101919072|NCT05376670|Gentamicins|gentamicins|mesh-list
101919073|NCT05376670|Tobramycin|tobramycin|mesh-list
101919074|NCT05376670|Amikacin|amikacin|mesh-list
101919075|NCT05376670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101919076|NCT05376670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101919077|NCT05376670|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101919078|NCT05376670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101919079|NCT05376670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919080|NCT01242774|Panobinostat|panobinostat|mesh-list
101919081|NCT01242774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101919082|NCT01242774|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101919083|NCT01242774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101919084|NCT01242774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919085|NCT01243086|Dexamethasone|dexamethasone|mesh-list
101919086|NCT01243086|Ranibizumab|ranibizumab|mesh-list
101919087|NCT01243086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101919088|NCT01243086|Antiemetics|antiemetics|mesh-ancestor
101919089|NCT01243086|Autonomic Agents|autonomic agents|mesh-ancestor
101919090|NCT01243086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101919091|NCT01243086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919092|NCT01243086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101919093|NCT01243086|Glucocorticoids|glucocorticoids|mesh-ancestor
101919094|NCT01243086|Hormones|hormones|mesh-ancestor
101919095|NCT01243086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101919096|NCT01243086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101919097|NCT01243086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101919098|NCT01243086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101919099|NCT01243086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101919100|NCT01243086|Growth Substances|growth substances|mesh-ancestor
101919101|NCT01243086|Growth Inhibitors|growth inhibitors|mesh-ancestor
101919102|NCT03908814|Antibodies|antibodies|mesh-list
101919103|NCT03908814|Immunologic Factors|immunologic factors|mesh-ancestor
101919104|NCT03908814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919105|NCT01253382|Ecallantide|ecallantide|mesh-list
101919106|NCT01253382|Analgesics|analgesics|mesh-ancestor
101919107|NCT01253382|Sensory System Agents|sensory system agents|mesh-ancestor
101919108|NCT01253382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101919109|NCT01253382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919110|NCT01253382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101919111|NCT01253382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101919112|NCT01253382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101919113|NCT01253382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101919114|NCT01148160|Voriconazole|voriconazole|mesh-list
101919115|NCT01148160|Antifungal Agents|antifungal agents|mesh-ancestor
101919116|NCT01148160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101919117|NCT01148160|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101919118|NCT01148160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101919119|NCT01148160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101919120|NCT01148160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919121|NCT01148160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101919122|NCT01148160|Hormone Antagonists|hormone antagonists|mesh-ancestor
101919123|NCT01148160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101919124|NCT01148160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919125|NCT01148160|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101919126|NCT01147692|Simvastatin|simvastatin|mesh-list
101919127|NCT01147692|rGLP-1 protein|rglp-1 protein|mesh-list
101919128|NCT01147692|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101919129|NCT01147692|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101919130|NCT01147692|Antimetabolites|antimetabolites|mesh-ancestor
101919131|NCT01147692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919132|NCT01147692|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101919133|NCT01147692|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101919134|NCT01147692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101919136|NCT01147692|Hormones|hormones|mesh-ancestor
101919137|NCT01147692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101919138|NCT01147692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919139|NCT03913182|Apatinib|apatinib|mesh-list
101919140|NCT03913182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101919141|NCT03913182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101919142|NCT03913182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101919143|NCT03913182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919144|NCT02713386|Paclitaxel|paclitaxel|mesh-list
101919145|NCT02713386|Carboplatin|carboplatin|mesh-list
101919146|NCT02713386|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101919147|NCT02713386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101919148|NCT02713386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101919149|NCT02713386|Tubulin Modulators|tubulin modulators|mesh-ancestor
101919150|NCT02713386|Antimitotic Agents|antimitotic agents|mesh-ancestor
101919151|NCT02713386|Mitosis Modulators|mitosis modulators|mesh-ancestor
101919152|NCT02713386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919153|NCT01967238|Vaccines|vaccines|mesh-list
101919154|NCT01967238|Immunologic Factors|immunologic factors|mesh-ancestor
101919155|NCT01967238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919156|NCT05616000|Folic Acid|folic acid|mesh-list
101919157|NCT05616000|Acetylcarnitine|acetylcarnitine|mesh-list
101919158|NCT05616000|Hematinics|hematinics|mesh-ancestor
101919159|NCT05616000|Vitamin B Complex|vitamin b complex|mesh-ancestor
101919160|NCT05616000|Vitamins|vitamins|mesh-ancestor
101919161|NCT05616000|Micronutrients|micronutrients|mesh-ancestor
101919162|NCT05616000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919163|NCT05616000|Nootropic Agents|nootropic agents|mesh-ancestor
101919164|NCT03912402|Paclitaxel|paclitaxel|mesh-list
101919165|NCT03912402|Bevacizumab|bevacizumab|mesh-list
101919166|NCT03912402|Carboplatin|carboplatin|mesh-list
101919167|NCT03912402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101919168|NCT03912402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101919169|NCT03912402|Tubulin Modulators|tubulin modulators|mesh-ancestor
101919170|NCT03912402|Antimitotic Agents|antimitotic agents|mesh-ancestor
101919171|NCT03912402|Mitosis Modulators|mitosis modulators|mesh-ancestor
101919172|NCT03912402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919173|NCT03912402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101919174|NCT03912402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101919175|NCT03912402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101919176|NCT03912402|Growth Substances|growth substances|mesh-ancestor
101919177|NCT03912402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919178|NCT03912402|Growth Inhibitors|growth inhibitors|mesh-ancestor
101919179|NCT01147770|Progesterone|progesterone|mesh-list
101919180|NCT01147770|Progestins|progestins|mesh-ancestor
101919181|NCT01147770|Hormones|hormones|mesh-ancestor
101230127|NCT05839548|Carticaine|carticaine|mesh-list
101919182|NCT01147770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101919183|NCT01147770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919184|NCT01148316|Fluoxetine|fluoxetine|mesh-list
101919185|NCT01148316|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101919186|NCT01148316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101919187|NCT01148316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101919188|NCT01148316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919189|NCT01148316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101919190|NCT01148316|Serotonin Agents|serotonin agents|mesh-ancestor
101919191|NCT01148316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919192|NCT01148316|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101919194|NCT01148316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101919195|NCT01148316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101919196|NCT01148316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101919197|NCT01148316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101919198|NCT01249638|Bevacizumab|bevacizumab|mesh-list
101919199|NCT01249638|Capecitabine|capecitabine|mesh-list
101919200|NCT01249638|Irinotecan|irinotecan|mesh-list
101919201|NCT01249638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101919202|NCT01249638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101919203|NCT01249638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101919204|NCT01249638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101919205|NCT01249638|Growth Substances|growth substances|mesh-ancestor
101919206|NCT01249638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919207|NCT01249638|Growth Inhibitors|growth inhibitors|mesh-ancestor
101919208|NCT01249638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101919209|NCT01249638|Antimetabolites|antimetabolites|mesh-ancestor
101919210|NCT01249638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919211|NCT01249638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101919212|NCT01249638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101919213|NCT01249638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101919214|NCT03907098|Endostar protein|endostar protein|mesh-list
101919215|NCT03907098|Endostatins|endostatins|mesh-list
101919216|NCT03907098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101919217|NCT03907098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101919218|NCT03907098|Growth Substances|growth substances|mesh-ancestor
101919219|NCT03907098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919220|NCT03907098|Growth Inhibitors|growth inhibitors|mesh-ancestor
101919221|NCT03907098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101919222|NCT01251822|Prucalopride|prucalopride|mesh-list
101919223|NCT01251822|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101919224|NCT01251822|Laxatives|laxatives|mesh-ancestor
101919225|NCT01251822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101919226|NCT01251822|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101919227|NCT01251822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101919228|NCT01251822|Serotonin Agents|serotonin agents|mesh-ancestor
101919229|NCT01251822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101919230|NCT01251822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919231|NCT01251822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919232|NCT01253694|Ranibizumab|ranibizumab|mesh-list
101919233|NCT01253694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101919234|NCT01253694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101919235|NCT01253694|Growth Substances|growth substances|mesh-ancestor
101919236|NCT01253694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919237|NCT01253694|Growth Inhibitors|growth inhibitors|mesh-ancestor
101919238|NCT01253694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101919239|NCT01148004|Ritonavir|ritonavir|mesh-list
101919240|NCT01148004|Lopinavir|lopinavir|mesh-list
101919241|NCT01148004|Fenofibrate|fenofibrate|mesh-list
101919242|NCT01148004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101919243|NCT01148004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101919244|NCT01148004|Protease Inhibitors|protease inhibitors|mesh-ancestor
101919245|NCT01148004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101919246|NCT01148004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919247|NCT01148004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101919248|NCT01148004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101919249|NCT01148004|Antiviral Agents|antiviral agents|mesh-ancestor
101919250|NCT01148004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101919251|NCT01148004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101919252|NCT01148004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101919253|NCT01148004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101919254|NCT01148004|Antimetabolites|antimetabolites|mesh-ancestor
101919255|NCT01148004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101919256|NCT01252056|Cilostazol|cilostazol|mesh-list
101919257|NCT01252056|Probucol|probucol|mesh-list
101919258|NCT01252056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101919259|NCT01252056|Autonomic Agents|autonomic agents|mesh-ancestor
101919260|NCT01252056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101919261|NCT01252056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919262|NCT01252056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101919263|NCT01252056|Respiratory System Agents|respiratory system agents|mesh-ancestor
101919264|NCT01252056|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101919265|NCT01252056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101919266|NCT01252056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919268|NCT01252056|Vasodilator Agents|vasodilator agents|mesh-ancestor
101919269|NCT01252056|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101919270|NCT01252056|Protective Agents|protective agents|mesh-ancestor
101919271|NCT01252056|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101919272|NCT01252056|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101919273|NCT01252056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101919274|NCT01252056|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101919275|NCT01252056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101919276|NCT01252056|Antimetabolites|antimetabolites|mesh-ancestor
101919277|NCT01252056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101919278|NCT01252056|Antioxidants|antioxidants|mesh-ancestor
101919279|NCT02528448|Plasma-lyte 148|plasma-lyte 148|mesh-list
101919280|NCT02528448|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101919281|NCT02528448|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101919282|NCT01148472|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101919283|NCT01148472|Escitalopram|escitalopram|mesh-list
101919284|NCT01148472|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101919285|NCT01148472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101919286|NCT01148472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101919287|NCT01148472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919288|NCT01148472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101919289|NCT01148472|Serotonin Agents|serotonin agents|mesh-ancestor
101919290|NCT01148472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919291|NCT01148472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101639138|NCT04145258|Antipyretics|antipyretics|mesh-ancestor
101919292|NCT01148472|Antidepressive Agents|antidepressive agents|mesh-ancestor
101919293|NCT01148472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101919294|NCT01148472|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101919295|NCT01148472|Analgesics|analgesics|mesh-ancestor
101919296|NCT01148472|Sensory System Agents|sensory system agents|mesh-ancestor
101919297|NCT01148472|Dopamine Agents|dopamine agents|mesh-ancestor
101919299|NCT01147146|Midazolam|midazolam|mesh-list
101919300|NCT01147146|Bupivacaine|bupivacaine|mesh-list
101919301|NCT01147146|Propofol|propofol|mesh-list
101919302|NCT01147146|Atracurium|atracurium|mesh-list
101919303|NCT01147146|Anesthetics, Local|anesthetics, local|mesh-ancestor
101919304|NCT01147146|Anesthetics|anesthetics|mesh-ancestor
101919305|NCT01147146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101919306|NCT01147146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919307|NCT01147146|Sensory System Agents|sensory system agents|mesh-ancestor
101919308|NCT01147146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101919309|NCT01147146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101919310|NCT01147146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101919311|NCT01147146|Anesthetics, General|anesthetics, general|mesh-ancestor
101919312|NCT01147146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101919313|NCT01147146|Narcotics|narcotics|mesh-ancestor
101919314|NCT01147146|Analgesics|analgesics|mesh-ancestor
101919315|NCT01147146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101919316|NCT01147146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101919317|NCT01147146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101919318|NCT01147146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101919319|NCT01147146|GABA Modulators|gaba modulators|mesh-ancestor
101919320|NCT01147146|GABA Agents|gaba agents|mesh-ancestor
101919321|NCT01147146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101919322|NCT01147146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919323|NCT01147146|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101919324|NCT01147146|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101919325|NCT01147146|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101919326|NCT01147146|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101919327|NCT01147146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101919328|NCT01147146|Cholinergic Agents|cholinergic agents|mesh-ancestor
101919329|NCT01250340|Aspirin|aspirin|mesh-list
101919330|NCT01250340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101919331|NCT01250340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101919332|NCT01250340|Analgesics|analgesics|mesh-ancestor
101919333|NCT01250340|Sensory System Agents|sensory system agents|mesh-ancestor
101919334|NCT01250340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101919335|NCT01250340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919336|NCT01250340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101919337|NCT01250340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101919338|NCT01250340|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101919339|NCT01250340|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101281864|NCT01903785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919340|NCT01250340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919341|NCT01250340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101919342|NCT01250340|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101919343|NCT01250340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101919344|NCT01250340|Antipyretics|antipyretics|mesh-ancestor
101919345|NCT03915132|Nimotuzumab|nimotuzumab|mesh-list
101919346|NCT03915132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101919347|NCT03915132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101919348|NCT01250652|Cetirizine|cetirizine|mesh-list
101919349|NCT01250652|Hydroxyzine|hydroxyzine|mesh-list
101919350|NCT01250652|Levocetirizine|levocetirizine|mesh-list
101919351|NCT01250652|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101919352|NCT01250652|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101919353|NCT01250652|Histamine Antagonists|histamine antagonists|mesh-ancestor
101919354|NCT01250652|Histamine Agents|histamine agents|mesh-ancestor
101919355|NCT01250652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101919356|NCT01250652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919357|NCT01250652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919358|NCT01250652|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101919359|NCT01250652|Antipruritics|antipruritics|mesh-ancestor
101919360|NCT01250652|Dermatologic Agents|dermatologic agents|mesh-ancestor
101919361|NCT01253928|Pioglitazone|pioglitazone|mesh-list
101919362|NCT01253928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101919363|NCT01253928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919364|NCT01252524|Calcium polycarbophil|calcium polycarbophil|mesh-list
101919365|NCT01252524|Psyllium|psyllium|mesh-list
101919366|NCT01252524|Calcium|calcium|mesh-list
101919367|NCT01252524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101919368|NCT01252524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919369|NCT01252524|Antidiarrheals|antidiarrheals|mesh-ancestor
101919370|NCT01252524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101919371|NCT01252524|Cathartics|cathartics|mesh-ancestor
101919372|NCT03914352|Antibodies|antibodies|mesh-list
101919373|NCT03914352|Immunologic Factors|immunologic factors|mesh-ancestor
101919374|NCT03914352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919375|NCT01254006|Thiamine|thiamine|mesh-list
101919376|NCT01254006|Vitamins|vitamins|mesh-ancestor
101919377|NCT01254006|Micronutrients|micronutrients|mesh-ancestor
101919378|NCT01254006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919379|NCT01254006|Vitamin B Complex|vitamin b complex|mesh-ancestor
101919380|NCT03914118|Modafinil|modafinil|mesh-list
101919381|NCT03914118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101919382|NCT03914118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919383|NCT03914118|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101919384|NCT03914118|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101919385|NCT03914118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101919386|NCT03914118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919387|NCT02528136|Oxytocin|oxytocin|mesh-list
101919388|NCT02528136|Carbetocin|carbetocin|mesh-list
101919389|NCT02528136|Oxytocics|oxytocics|mesh-ancestor
101919390|NCT02528136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101919391|NCT02528136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919392|NCT01252680|Vaccines|vaccines|mesh-list
101919393|NCT01252680|Immunologic Factors|immunologic factors|mesh-ancestor
101919394|NCT01252680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919395|NCT01252758|Albuterol|albuterol|mesh-list
101919396|NCT01252758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101919397|NCT01252758|Autonomic Agents|autonomic agents|mesh-ancestor
101919398|NCT01252758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101919399|NCT01252758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919400|NCT01252758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101919401|NCT01252758|Respiratory System Agents|respiratory system agents|mesh-ancestor
101919402|NCT01252758|Tocolytic Agents|tocolytic agents|mesh-ancestor
101919403|NCT01252758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101919404|NCT01252758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101919405|NCT01252758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101919406|NCT01252758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101919407|NCT01252758|Adrenergic Agents|adrenergic agents|mesh-ancestor
101919408|NCT01252758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101919409|NCT01252758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919410|NCT03913884|Mitogens|mitogens|mesh-list
101919411|NCT03913884|Mitosis Modulators|mitosis modulators|mesh-ancestor
101919412|NCT03913884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919413|NCT01147224|Ciclesonide|ciclesonide|mesh-list
101919414|NCT01147224|Glucocorticoids|glucocorticoids|mesh-ancestor
101919415|NCT01147224|Hormones|hormones|mesh-ancestor
101919416|NCT01147224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101919417|NCT01147224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919418|NCT01147224|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101919419|NCT03913650|Bupivacaine|bupivacaine|mesh-list
101919420|NCT03913650|Anesthetics, Local|anesthetics, local|mesh-ancestor
101919421|NCT03913650|Anesthetics|anesthetics|mesh-ancestor
101919422|NCT03913650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101919423|NCT03913650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919424|NCT03913650|Sensory System Agents|sensory system agents|mesh-ancestor
101919425|NCT03913650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101919427|NCT01149174|Mitomycin|mitomycin|mesh-list
101919428|NCT01149174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101919429|NCT01149174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101919430|NCT01149174|Alkylating Agents|alkylating agents|mesh-ancestor
101919431|NCT01149174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919432|NCT01149174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101919433|NCT01149174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101919434|NCT04353778|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
101919435|NCT04353778|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101919436|NCT04353778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101919437|NCT04353778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919438|NCT04353778|Cholinergic Agents|cholinergic agents|mesh-ancestor
101919439|NCT04353778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101919440|NCT04353778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919441|NCT01148628|Everolimus|everolimus|mesh-list
101639290|NCT03715933|Temozolomide|temozolomide|mesh-list
101919442|NCT01148628|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101919443|NCT01148628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101919444|NCT01148628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101919445|NCT01148628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919446|NCT01148628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101919447|NCT01148628|Immunologic Factors|immunologic factors|mesh-ancestor
101919448|NCT01148628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919449|NCT01148628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101919450|NCT01254708|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101919451|NCT01254708|Antifungal Agents|antifungal agents|mesh-ancestor
101919452|NCT01254708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101919453|NCT01254708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101360124|NCT00213694|Analgesics|analgesics|mesh-ancestor
101919454|NCT01254708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101919455|NCT03909594|Ketamine|ketamine|mesh-list
101919456|NCT03909594|Bupivacaine|bupivacaine|mesh-list
101919457|NCT03909594|Anesthetics, Local|anesthetics, local|mesh-ancestor
101919458|NCT03909594|Anesthetics|anesthetics|mesh-ancestor
101919459|NCT03909594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101919460|NCT03909594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919461|NCT03909594|Sensory System Agents|sensory system agents|mesh-ancestor
101919462|NCT03909594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101919463|NCT03909594|Analgesics|analgesics|mesh-ancestor
101919464|NCT03909594|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101919465|NCT03909594|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101919466|NCT03909594|Anesthetics, General|anesthetics, general|mesh-ancestor
101919467|NCT03909594|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101919468|NCT03909594|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101919469|NCT03909594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101919470|NCT03909594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919471|NCT04492072|Misoprostol|misoprostol|mesh-list
101919472|NCT04492072|Oxytocin|oxytocin|mesh-list
101919473|NCT04492072|Oxytocics|oxytocics|mesh-ancestor
101919474|NCT04492072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101919475|NCT04492072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919476|NCT04492072|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101919477|NCT04492072|Abortifacient Agents|abortifacient agents|mesh-ancestor
101919478|NCT04492072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101919479|NCT04492072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101919480|NCT04181008|Amiloride|amiloride|mesh-list
101919481|NCT04181008|Diuretics|diuretics|mesh-ancestor
101919482|NCT04181008|Natriuretic Agents|natriuretic agents|mesh-ancestor
101919483|NCT04181008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919484|NCT04181008|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
101919485|NCT04181008|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101919486|NCT04181008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101282014|NCT01904734|Clomiphene|clomiphene|mesh-list
101919487|NCT04181008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919488|NCT04181008|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101919489|NCT04181008|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101919490|NCT03629340|Metformin|metformin|mesh-list
101919491|NCT03629340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101919492|NCT03629340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919493|NCT03904836|Tobramycin|tobramycin|mesh-list
101919494|NCT03904836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101919495|NCT03904836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101919496|NCT03908580|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101919497|NCT03908580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101919498|NCT03908580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101919499|NCT03908580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919500|NCT03908580|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101919501|NCT03908580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101919502|NCT03908580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919503|NCT03908580|Cholinergic Agents|cholinergic agents|mesh-ancestor
101919504|NCT03908580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101919505|NCT03904680|Vitamin D|vitamin d|mesh-list
101919506|NCT03904680|Methotrexate|methotrexate|mesh-list
101919507|NCT03904680|Vitamins|vitamins|mesh-ancestor
101919508|NCT03904680|Micronutrients|micronutrients|mesh-ancestor
101919509|NCT03904680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919510|NCT03904680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101919511|NCT03904680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101919512|NCT03904680|Abortifacient Agents|abortifacient agents|mesh-ancestor
101919513|NCT03904680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101919514|NCT03904680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101919515|NCT03904680|Antimetabolites|antimetabolites|mesh-ancestor
101919516|NCT03904680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919517|NCT03904680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101919518|NCT03904680|Dermatologic Agents|dermatologic agents|mesh-ancestor
101919519|NCT03904680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101919520|NCT03904680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101919521|NCT03904680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101919522|NCT03904680|Immunologic Factors|immunologic factors|mesh-ancestor
101919523|NCT03904680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101919524|NCT03904680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101919525|NCT01150266|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101919526|NCT01150266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101919527|NCT01150266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101919528|NCT01150266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919529|NCT01256268|Paclitaxel|paclitaxel|mesh-list
101919530|NCT01256268|Carboplatin|carboplatin|mesh-list
101919531|NCT01256268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101919532|NCT01256268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101919533|NCT01256268|Tubulin Modulators|tubulin modulators|mesh-ancestor
101919534|NCT01256268|Antimitotic Agents|antimitotic agents|mesh-ancestor
101919535|NCT01256268|Mitosis Modulators|mitosis modulators|mesh-ancestor
101919536|NCT01256268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919537|NCT03902106|Albuterol|albuterol|mesh-list
101919538|NCT03902106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101919539|NCT03902106|Autonomic Agents|autonomic agents|mesh-ancestor
101919540|NCT03902106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101919541|NCT03902106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919542|NCT03902106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101919543|NCT03902106|Respiratory System Agents|respiratory system agents|mesh-ancestor
101919544|NCT03902106|Tocolytic Agents|tocolytic agents|mesh-ancestor
101919545|NCT03902106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101919546|NCT03902106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101919547|NCT03902106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101919548|NCT03902106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101919549|NCT03902106|Adrenergic Agents|adrenergic agents|mesh-ancestor
101919550|NCT03902106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101919551|NCT03902106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919552|NCT03902340|Analgesics|analgesics|mesh-list
101919553|NCT03902340|Sensory System Agents|sensory system agents|mesh-ancestor
101919554|NCT03902340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101919555|NCT03902340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919557|NCT01149330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101919558|NCT01149330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101919559|NCT01149330|Analgesics|analgesics|mesh-ancestor
101919560|NCT01149330|Sensory System Agents|sensory system agents|mesh-ancestor
101919561|NCT01149330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101919562|NCT01149330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919563|NCT01149330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101919564|NCT01149330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101919565|NCT01149330|Dermatologic Agents|dermatologic agents|mesh-ancestor
101919566|NCT03984214|Dronabinol|dronabinol|mesh-list
101919567|NCT03984214|Hallucinogens|hallucinogens|mesh-ancestor
101919568|NCT03984214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919569|NCT03984214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101919570|NCT03984214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101919571|NCT03984214|Analgesics|analgesics|mesh-ancestor
101919572|NCT03984214|Sensory System Agents|sensory system agents|mesh-ancestor
101919573|NCT03984214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101919574|NCT03984214|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101919575|NCT03984214|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101919576|NCT03984214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101919577|NCT03984214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919578|NCT03984214|Hormones|hormones|mesh-ancestor
101919579|NCT03984214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101919580|NCT01150344|Artemether|artemether|mesh-list
101919581|NCT01150344|Atovaquone|atovaquone|mesh-list
101919582|NCT01150344|Proguanil|proguanil|mesh-list
101919583|NCT01150344|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
101919584|NCT01150344|Antimalarials|antimalarials|mesh-ancestor
101919585|NCT01150344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101919586|NCT01150344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101919587|NCT01150344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101919588|NCT01150344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101919589|NCT01150344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919590|NCT01150344|Antimetabolites|antimetabolites|mesh-ancestor
101919591|NCT01256580|Dexamethasone|dexamethasone|mesh-list
101919592|NCT01256580|Bevacizumab|bevacizumab|mesh-list
101919593|NCT01256580|Verteporfin|verteporfin|mesh-list
101919594|NCT01256580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101919595|NCT01256580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101919596|NCT01256580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101919597|NCT01256580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101919598|NCT01256580|Growth Substances|growth substances|mesh-ancestor
101919599|NCT01256580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919600|NCT01256580|Growth Inhibitors|growth inhibitors|mesh-ancestor
101919601|NCT01256580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101919602|NCT01256580|Antiemetics|antiemetics|mesh-ancestor
101919603|NCT01256580|Autonomic Agents|autonomic agents|mesh-ancestor
101919604|NCT01256580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101919605|NCT01256580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101919606|NCT01256580|Glucocorticoids|glucocorticoids|mesh-ancestor
101919608|NCT01256580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101919609|NCT01256580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101919610|NCT01256580|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101919611|NCT01256580|Dermatologic Agents|dermatologic agents|mesh-ancestor
101919612|NCT03901716|Fentanyl|fentanyl|mesh-list
101919613|NCT03901716|Midazolam|midazolam|mesh-list
101919614|NCT03901716|Sufentanil|sufentanil|mesh-list
101919615|NCT03901716|Remifentanil|remifentanil|mesh-list
101919616|NCT03901716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101919617|NCT03901716|Narcotics|narcotics|mesh-ancestor
101919618|NCT03901716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101919619|NCT03901716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919620|NCT03901716|Analgesics|analgesics|mesh-ancestor
101919621|NCT03901716|Sensory System Agents|sensory system agents|mesh-ancestor
101919622|NCT03901716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101919623|NCT03901716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101919624|NCT03901716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101919625|NCT03901716|Anesthetics, General|anesthetics, general|mesh-ancestor
101919626|NCT03901716|Anesthetics|anesthetics|mesh-ancestor
101919627|NCT03901716|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101919628|NCT03901716|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101919629|NCT03901716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101919630|NCT03901716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101919631|NCT03901716|GABA Modulators|gaba modulators|mesh-ancestor
101919632|NCT03901716|GABA Agents|gaba agents|mesh-ancestor
101919633|NCT03901716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101919634|NCT03901716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919635|NCT04113538|Aflibercept|aflibercept|mesh-list
101919636|NCT04113538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101919637|NCT04113538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101919639|NCT04113538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919640|NCT04113538|Growth Inhibitors|growth inhibitors|mesh-ancestor
101919641|NCT04113538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101919642|NCT03904368|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101919643|NCT03904368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101919644|NCT03904368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919645|NCT03922750|Insulin|insulin|mesh-list
101919646|NCT03922750|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101919647|NCT03922750|Insulin Glargine|insulin glargine|mesh-list
101919648|NCT03922750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101919649|NCT03922750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919650|NCT03898128|Immunotoxins|immunotoxins|mesh-list
101919651|NCT03898128|Immunoconjugates|immunoconjugates|mesh-ancestor
101919652|NCT03898128|Immunologic Factors|immunologic factors|mesh-ancestor
101919653|NCT03898128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919654|NCT01149408|Decitabine|decitabine|mesh-list
101919655|NCT01149408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101919656|NCT01149408|Antimetabolites|antimetabolites|mesh-ancestor
101919657|NCT01149408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919658|NCT01149408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101919659|NCT01149408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101919660|NCT03631966|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101919661|NCT03631966|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101919662|NCT03631966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101919663|NCT03631966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919664|NCT03631966|Cholinergic Agents|cholinergic agents|mesh-ancestor
101919665|NCT03631966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101919666|NCT03631966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919667|NCT01149018|Dronabinol|dronabinol|mesh-list
101574929|NCT02760355|Sofosbuvir|sofosbuvir|mesh-list
101919668|NCT01149018|Hallucinogens|hallucinogens|mesh-ancestor
101919669|NCT01149018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919670|NCT01149018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101919671|NCT01149018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101919672|NCT01149018|Analgesics|analgesics|mesh-ancestor
101919673|NCT01149018|Sensory System Agents|sensory system agents|mesh-ancestor
101919674|NCT01149018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101919675|NCT01149018|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101919676|NCT01149018|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101919677|NCT01149018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101919678|NCT01149018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919679|NCT01149018|Hormones|hormones|mesh-ancestor
101919680|NCT01149018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101919681|NCT03904056|Ranibizumab|ranibizumab|mesh-list
101919682|NCT03904056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101919683|NCT03904056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101919684|NCT03904056|Growth Substances|growth substances|mesh-ancestor
101919685|NCT03904056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919686|NCT03904056|Growth Inhibitors|growth inhibitors|mesh-ancestor
101919687|NCT03904056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101919688|NCT03897660|Vitamins|vitamins|mesh-list
101919689|NCT03897660|Vitamin K|vitamin k|mesh-list
101919690|NCT03897660|Vitamin K 2|vitamin k 2|mesh-list
101919691|NCT03897660|Micronutrients|micronutrients|mesh-ancestor
101919692|NCT03897660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919693|NCT03897660|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101919694|NCT03897660|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101919695|NCT03897660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919696|NCT03897660|Hemostatics|hemostatics|mesh-ancestor
101919697|NCT03897660|Coagulants|coagulants|mesh-ancestor
101919698|NCT03901170|Letrozole|letrozole|mesh-list
101919699|NCT03901170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101919700|NCT03901170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101919701|NCT03901170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101919702|NCT03901170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101919703|NCT03901170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919704|NCT03901170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101919705|NCT03901170|Hormone Antagonists|hormone antagonists|mesh-ancestor
101919706|NCT03901170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101919707|NCT03901170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919708|NCT03900858|Isoniazid|isoniazid|mesh-list
101919709|NCT03900858|Rifapentine|rifapentine|mesh-list
101919710|NCT03900858|Rifampin|rifampin|mesh-list
101919711|NCT03900858|Antitubercular Agents|antitubercular agents|mesh-ancestor
101919712|NCT03900858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101919713|NCT03900858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101919714|NCT03900858|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101919715|NCT03900858|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101919716|NCT03900858|Antimetabolites|antimetabolites|mesh-ancestor
101919717|NCT03900858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919718|NCT03900858|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101919719|NCT03900858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101919720|NCT03900858|Leprostatic Agents|leprostatic agents|mesh-ancestor
101919721|NCT03900858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101919722|NCT03900858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101919723|NCT03900858|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101919724|NCT03900858|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101919725|NCT03900858|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101919726|NCT03900858|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101919727|NCT03900858|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101919728|NCT03900858|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101919729|NCT01149564|Ibuprofen|ibuprofen|mesh-list
101919730|NCT01149564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101919731|NCT01149564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101919732|NCT01149564|Analgesics|analgesics|mesh-ancestor
101919733|NCT01149564|Sensory System Agents|sensory system agents|mesh-ancestor
101919734|NCT01149564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101919735|NCT01149564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919736|NCT01149564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101919737|NCT01149564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101919738|NCT01149564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101919739|NCT01149564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101919740|NCT01149564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919741|NCT02527746|Cyclophosphamide|cyclophosphamide|mesh-list
101919742|NCT02527746|Epirubicin|epirubicin|mesh-list
101919743|NCT02527746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101919744|NCT02527746|Immunologic Factors|immunologic factors|mesh-ancestor
101919745|NCT02527746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919746|NCT02527746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101919747|NCT02527746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101919748|NCT02527746|Alkylating Agents|alkylating agents|mesh-ancestor
101919749|NCT02527746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919750|NCT02527746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101919751|NCT02527746|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101919752|NCT02527746|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101919753|NCT02527746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101919754|NCT02527746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101919755|NCT02527746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101919756|NCT01586286|Nifedipine|nifedipine|mesh-list
101919757|NCT01586286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101919758|NCT01586286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101919759|NCT01586286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919760|NCT01586286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101919761|NCT01586286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919762|NCT01586286|Vasodilator Agents|vasodilator agents|mesh-ancestor
101919763|NCT01586286|Tocolytic Agents|tocolytic agents|mesh-ancestor
101919764|NCT01586286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101919765|NCT01257048|Budesonide|budesonide|mesh-list
101919766|NCT01257048|Formoterol Fumarate|formoterol fumarate|mesh-list
101919767|NCT01257048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101919768|NCT01257048|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101919769|NCT01257048|Autonomic Agents|autonomic agents|mesh-ancestor
101919770|NCT01257048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101919771|NCT01257048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919772|NCT01257048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101919773|NCT01257048|Respiratory System Agents|respiratory system agents|mesh-ancestor
101919775|NCT01257048|Hormones|hormones|mesh-ancestor
101919776|NCT01257048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101919777|NCT01257048|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101919778|NCT01257048|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101919779|NCT01257048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101919780|NCT01257048|Adrenergic Agents|adrenergic agents|mesh-ancestor
101919781|NCT01257048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101919782|NCT01257048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919784|NCT01258296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101919785|NCT01258296|Narcotics|narcotics|mesh-ancestor
101919786|NCT01258296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101919787|NCT01258296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919788|NCT01258296|Analgesics|analgesics|mesh-ancestor
101919789|NCT01258296|Sensory System Agents|sensory system agents|mesh-ancestor
101919790|NCT01258296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101919791|NCT01258296|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101919792|NCT01258296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101919793|NCT01258296|Anesthetics, General|anesthetics, general|mesh-ancestor
101919794|NCT01258296|Anesthetics|anesthetics|mesh-ancestor
101919795|NCT01257126|Diclofenac|diclofenac|mesh-list
101919796|NCT01257126|Nimesulide|nimesulide|mesh-list
101919797|NCT01257126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101919798|NCT01257126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101919799|NCT01257126|Analgesics|analgesics|mesh-ancestor
101919800|NCT01257126|Sensory System Agents|sensory system agents|mesh-ancestor
101919801|NCT01257126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101919802|NCT01257126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919803|NCT01257126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101919804|NCT01257126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101919805|NCT01257126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101919806|NCT01257126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101919807|NCT01257126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919808|NCT02527824|Oxaliplatin|oxaliplatin|mesh-list
101919809|NCT02527824|Irinotecan|irinotecan|mesh-list
101919810|NCT02527824|Tegafur|tegafur|mesh-list
101919811|NCT02527824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101919812|NCT02527824|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101919813|NCT02527824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101919814|NCT02527824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101919815|NCT02527824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919816|NCT02527824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101919817|NCT02527824|Antimetabolites|antimetabolites|mesh-ancestor
101919818|NCT01586208|Phenytoin|phenytoin|mesh-list
101919819|NCT01586208|Valproic Acid|valproic acid|mesh-list
101919820|NCT01586208|Anticonvulsants|anticonvulsants|mesh-ancestor
101919821|NCT01586208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101919822|NCT01586208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919823|NCT01586208|GABA Agents|gaba agents|mesh-ancestor
101919824|NCT01586208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101919825|NCT01586208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919826|NCT01586208|Antimanic Agents|antimanic agents|mesh-ancestor
101919827|NCT01586208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101919828|NCT01586208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101919829|NCT01586208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101919830|NCT01586208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101919831|NCT01586208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101919832|NCT01586208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101919833|NCT01586208|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101919834|NCT01586208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101919835|NCT03893526|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101230211|NCT05839054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101230212|NCT05839054|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101919836|NCT03893526|Valsartan|valsartan|mesh-list
101919837|NCT03893526|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101919838|NCT03893526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101919839|NCT03893526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919840|NCT03893526|Incretins|incretins|mesh-ancestor
101919841|NCT03893526|Hormones|hormones|mesh-ancestor
101919842|NCT03893526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101919843|NCT03893526|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101919844|NCT03893526|Protease Inhibitors|protease inhibitors|mesh-ancestor
101919845|NCT03893526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101919846|NCT03893526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919847|NCT03893526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101919848|NCT03893526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101919849|NCT03893526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101919850|NCT01149798|Cisplatin|cisplatin|mesh-list
101919851|NCT01149798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101919852|NCT01149798|Paclitaxel|paclitaxel|mesh-list
101919853|NCT01149798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101919854|NCT01149798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101919855|NCT01149798|Tubulin Modulators|tubulin modulators|mesh-ancestor
101919856|NCT01149798|Antimitotic Agents|antimitotic agents|mesh-ancestor
101919857|NCT01149798|Mitosis Modulators|mitosis modulators|mesh-ancestor
101919858|NCT01149798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919859|NCT01257360|Panitumumab|panitumumab|mesh-list
101919860|NCT01257360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101919861|NCT01257360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101919862|NCT01258452|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
101919863|NCT01258452|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101919864|NCT01258452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101919865|NCT01258452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919866|NCT05943028|Esketamine|esketamine|mesh-list
101919867|NCT05943028|Antidepressive Agents|antidepressive agents|mesh-ancestor
101919868|NCT05943028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101919869|NCT05942963|Metformin|metformin|mesh-list
101919870|NCT05942963|Pioglitazone|pioglitazone|mesh-list
101919871|NCT05942963|Empagliflozin|empagliflozin|mesh-list
101919872|NCT05942963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101919873|NCT05942963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919874|NCT05942963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101919875|NCT05942963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919876|NCT05942911|Hydroxychloroquine|hydroxychloroquine|mesh-list
101919877|NCT05942911|Cannabidiol|cannabidiol|mesh-list
101919878|NCT05942911|Antimalarials|antimalarials|mesh-ancestor
101919879|NCT05942911|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101919880|NCT05942911|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101919881|NCT05942911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101919882|NCT05942911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101919883|NCT05942911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919884|NCT05942911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101919885|NCT05942911|Anticonvulsants|anticonvulsants|mesh-ancestor
101919886|NCT05942768|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101919887|NCT05942768|Antibodies|antibodies|mesh-list
101919888|NCT05942768|Immunologic Factors|immunologic factors|mesh-ancestor
101919889|NCT05942768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919890|NCT05942768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919891|NCT05942768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101919892|NCT05942768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101919894|NCT05942573|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101919895|NCT05942573|Apatinib|apatinib|mesh-list
101919896|NCT05942573|Ramucirumab|ramucirumab|mesh-list
101919897|NCT05942573|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101919898|NCT05942573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101919899|NCT05942573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101919900|NCT05942573|Tubulin Modulators|tubulin modulators|mesh-ancestor
101919901|NCT05942573|Antimitotic Agents|antimitotic agents|mesh-ancestor
101919902|NCT05942573|Mitosis Modulators|mitosis modulators|mesh-ancestor
101919903|NCT05942573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919904|NCT05942573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101919905|NCT05942573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101919906|NCT05942573|Immunologic Factors|immunologic factors|mesh-ancestor
101919907|NCT05942573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919908|NCT05942378|Vaccines|vaccines|mesh-list
101919909|NCT05942378|Immunologic Factors|immunologic factors|mesh-ancestor
101919910|NCT05942378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232355|NCT01559480|Desogestrel|desogestrel|mesh-list
101919911|NCT05942352|Tetramethylpyrazine|tetramethylpyrazine|mesh-list
101919912|NCT05942352|Vasodilator Agents|vasodilator agents|mesh-ancestor
101919913|NCT05942313|Buprenorphine|buprenorphine|mesh-list
101919914|NCT05942313|Methadone|methadone|mesh-list
101919915|NCT05942313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101919916|NCT05942313|Narcotics|narcotics|mesh-ancestor
101919917|NCT05942313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101919918|NCT05942313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919919|NCT05942313|Analgesics|analgesics|mesh-ancestor
101919920|NCT05942313|Sensory System Agents|sensory system agents|mesh-ancestor
101919921|NCT05942313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101919922|NCT05942313|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101919923|NCT05942313|Antitussive Agents|antitussive agents|mesh-ancestor
101919924|NCT05942313|Respiratory System Agents|respiratory system agents|mesh-ancestor
101919925|NCT05942300|Carboplatin|carboplatin|mesh-list
101919926|NCT05942300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101919927|NCT05942053|Vitamin K|vitamin k|mesh-list
101919928|NCT05942053|Vitamin K 2|vitamin k 2|mesh-list
101919929|NCT05942053|Menaquinone 7|menaquinone 7|mesh-list
101919930|NCT05942053|Vitamins|vitamins|mesh-ancestor
101919931|NCT05942053|Micronutrients|micronutrients|mesh-ancestor
101919932|NCT05942053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919933|NCT05942053|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101919934|NCT05942053|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101919935|NCT05942053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919936|NCT05942053|Hemostatics|hemostatics|mesh-ancestor
101919937|NCT05942053|Coagulants|coagulants|mesh-ancestor
101919938|NCT05942027|Ubiquinone|ubiquinone|mesh-list
101919939|NCT05942027|Coenzyme Q10|coenzyme q10|mesh-list
101919940|NCT05942027|Micronutrients|micronutrients|mesh-ancestor
101919941|NCT05942027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919942|NCT05942027|Vitamins|vitamins|mesh-ancestor
101919943|NCT05941897|Durvalumab|durvalumab|mesh-list
101919944|NCT05941897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101919945|NCT05941897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101919946|NCT05941845|Interferons|interferons|mesh-list
101919947|NCT05941845|Interferon-alpha|interferon-alpha|mesh-list
101919948|NCT05941845|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101919949|NCT05941845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101919950|NCT05941845|Antiviral Agents|antiviral agents|mesh-ancestor
101919951|NCT05941845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101919952|NCT05941845|Immunologic Factors|immunologic factors|mesh-ancestor
101919953|NCT05941845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919954|NCT05941806|Tamsulosin|tamsulosin|mesh-list
101919955|NCT05941806|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101919956|NCT05941806|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101919957|NCT05941806|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101919958|NCT05941806|Adrenergic Agents|adrenergic agents|mesh-ancestor
101919959|NCT05941806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101919960|NCT05941806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919961|NCT05941806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919962|NCT05941806|Urological Agents|urological agents|mesh-ancestor
101919963|NCT05941767|Lidocaine|lidocaine|mesh-list
101919964|NCT05941767|Dexmedetomidine|dexmedetomidine|mesh-list
101919965|NCT05941767|Anesthetics, Local|anesthetics, local|mesh-ancestor
101919966|NCT05941767|Anesthetics|anesthetics|mesh-ancestor
101919967|NCT05941767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101919968|NCT05941767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101919969|NCT05941767|Sensory System Agents|sensory system agents|mesh-ancestor
101919970|NCT05941767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101919971|NCT05941767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101919972|NCT05941767|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101919973|NCT05941767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101230242|NCT05830630|Bupivacaine|bupivacaine|mesh-list
101230243|NCT05830630|Methylene Blue|methylene blue|mesh-list
101919974|NCT05941767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101919975|NCT05941767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919976|NCT05941767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101919977|NCT05941767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101919978|NCT05941767|Analgesics|analgesics|mesh-ancestor
101919979|NCT05941767|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101919980|NCT05941767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101919981|NCT05941767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101919982|NCT05941767|Adrenergic Agents|adrenergic agents|mesh-ancestor
101919983|NCT05941767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101919984|NCT05941741|Cisplatin|cisplatin|mesh-list
101919985|NCT05941741|Gemcitabine|gemcitabine|mesh-list
101232428|NCT05570669|Simethicone|simethicone|mesh-list
101919986|NCT05941741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101919987|NCT05941741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101919988|NCT05941741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101919989|NCT05941741|Antimetabolites|antimetabolites|mesh-ancestor
101919990|NCT05941741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919991|NCT05941741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101919992|NCT05941637|Axitinib|axitinib|mesh-list
101919993|NCT05941637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101919994|NCT05941637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101919995|NCT05941637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101919996|NCT05941637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101919997|NCT05941585|Cytarabine|cytarabine|mesh-list
101919998|NCT05941585|Venetoclax|venetoclax|mesh-list
101919999|NCT05941585|Mitoxantrone|mitoxantrone|mesh-list
101920000|NCT05941585|Homoharringtonine|homoharringtonine|mesh-list
101920001|NCT05941585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101920002|NCT05941585|Antimetabolites|antimetabolites|mesh-ancestor
101920003|NCT05941585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920004|NCT05941585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920005|NCT05941585|Antiviral Agents|antiviral agents|mesh-ancestor
101920006|NCT05941585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101920007|NCT05941585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101920008|NCT05941585|Immunologic Factors|immunologic factors|mesh-ancestor
101920009|NCT05941585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920010|NCT05941585|Analgesics|analgesics|mesh-ancestor
101920011|NCT05941585|Sensory System Agents|sensory system agents|mesh-ancestor
101920012|NCT05941585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101920013|NCT05941585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101920014|NCT05941585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101920015|NCT05941585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101920016|NCT05941585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101920017|NCT05941585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101920018|NCT05941507|Antibodies|antibodies|mesh-list
101920019|NCT05941507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101920020|NCT05941507|Immunologic Factors|immunologic factors|mesh-ancestor
101920021|NCT05941507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920022|NCT05941494|Phenylephrine|phenylephrine|mesh-list
101920023|NCT05941494|Oxymetazoline|oxymetazoline|mesh-list
101920024|NCT05941494|Ephedrine|ephedrine|mesh-list
101920025|NCT05941494|Pseudoephedrine|pseudoephedrine|mesh-list
101920026|NCT05941494|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
101920027|NCT05941494|Anesthetics|anesthetics|mesh-list
101920028|NCT05941494|Propofol|propofol|mesh-list
101920029|NCT05941494|Sevoflurane|sevoflurane|mesh-list
101920030|NCT05941494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101920031|NCT05941494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920032|NCT05941494|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101920033|NCT05941494|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101920034|NCT05941494|Anesthetics, General|anesthetics, general|mesh-ancestor
101920035|NCT05941494|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101920036|NCT05941494|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101920037|NCT05941494|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101920038|NCT05941494|Mydriatics|mydriatics|mesh-ancestor
101920039|NCT05941494|Autonomic Agents|autonomic agents|mesh-ancestor
101920040|NCT05941494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101920041|NCT05941494|Sympathomimetics|sympathomimetics|mesh-ancestor
101920042|NCT05941494|Nasal Decongestants|nasal decongestants|mesh-ancestor
101920043|NCT05941494|Respiratory System Agents|respiratory system agents|mesh-ancestor
101920045|NCT05941494|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101920046|NCT05941494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101920047|NCT05941494|Adrenergic Agents|adrenergic agents|mesh-ancestor
101920048|NCT05941494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101920049|NCT05941494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920050|NCT05941494|Protective Agents|protective agents|mesh-ancestor
101920051|NCT05941494|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101920052|NCT05941494|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101920053|NCT05941494|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101920054|NCT05941481|Tislelizumab|tislelizumab|mesh-list
101920055|NCT05941481|Antibodies|antibodies|mesh-list
101920056|NCT05941481|Immunologic Factors|immunologic factors|mesh-ancestor
101920057|NCT05941481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920058|NCT05941481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101920059|NCT05941481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920061|NCT05941429|Cariostatic Agents|cariostatic agents|mesh-ancestor
101920062|NCT05941429|Protective Agents|protective agents|mesh-ancestor
101920063|NCT05941429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920064|NCT05941338|Paclitaxel|paclitaxel|mesh-list
101920065|NCT05941338|Carboplatin|carboplatin|mesh-list
101920066|NCT05941338|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101920067|NCT05941338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101920068|NCT05941338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920069|NCT05941338|Tubulin Modulators|tubulin modulators|mesh-ancestor
101920070|NCT05941338|Antimitotic Agents|antimitotic agents|mesh-ancestor
101920071|NCT05941338|Mitosis Modulators|mitosis modulators|mesh-ancestor
101920072|NCT05941338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920073|NCT05941247|Hemay005|hemay005|mesh-list
101920074|NCT05941247|Dermatologic Agents|dermatologic agents|mesh-ancestor
101920075|NCT05941247|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101920076|NCT05941247|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101920077|NCT05941247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101920078|NCT05941247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920079|NCT05941130|Ibuprofen|ibuprofen|mesh-list
101920080|NCT05941130|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101920081|NCT05941130|Methylprednisolone|methylprednisolone|mesh-list
101920082|NCT05941130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101920083|NCT05941130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101920084|NCT05941130|Analgesics|analgesics|mesh-ancestor
101920085|NCT05941130|Sensory System Agents|sensory system agents|mesh-ancestor
101920086|NCT05941130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101920087|NCT05941130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920088|NCT05941130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101920089|NCT05941130|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101920090|NCT05941130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101920091|NCT05941130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920092|NCT05941130|Antiemetics|antiemetics|mesh-ancestor
101920093|NCT05941130|Autonomic Agents|autonomic agents|mesh-ancestor
101920094|NCT05941130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101920095|NCT05941130|Glucocorticoids|glucocorticoids|mesh-ancestor
101920097|NCT05941130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101920098|NCT05941130|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101920099|NCT05941130|Protective Agents|protective agents|mesh-ancestor
101920100|NCT05939921|Metformin|metformin|mesh-list
101920101|NCT05939921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101920102|NCT05939921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920103|NCT05939518|Anesthetics|anesthetics|mesh-list
101920104|NCT05939518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101920105|NCT05939518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920106|NCT05939219|Vaccines|vaccines|mesh-list
101920107|NCT05939219|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101920108|NCT05939219|Immunologic Factors|immunologic factors|mesh-ancestor
101920109|NCT05939219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920110|NCT05938517|Betahistine|betahistine|mesh-list
101920111|NCT05938517|Selegiline|selegiline|mesh-list
101920112|NCT05938517|Antidepressive Agents|antidepressive agents|mesh-ancestor
101920113|NCT05938517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101920114|NCT05938517|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101920115|NCT05938517|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101920116|NCT05938517|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101920117|NCT05938517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101574930|NCT02760355|Ledipasvir|ledipasvir|mesh-list
101920118|NCT05938517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920119|NCT05938517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101920120|NCT05938517|Protective Agents|protective agents|mesh-ancestor
101920121|NCT05938517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920122|NCT05938517|Vasodilator Agents|vasodilator agents|mesh-ancestor
101920123|NCT05938517|Histamine Agonists|histamine agonists|mesh-ancestor
101920124|NCT05938517|Histamine Agents|histamine agents|mesh-ancestor
101920125|NCT05938517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101920126|NCT05935657|Dexmedetomidine|dexmedetomidine|mesh-list
101920127|NCT05935657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101920128|NCT05935657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101920129|NCT05935657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920130|NCT05935657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101920131|NCT05935657|Analgesics|analgesics|mesh-ancestor
101920132|NCT05935657|Sensory System Agents|sensory system agents|mesh-ancestor
101920133|NCT05935657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101920134|NCT05935657|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101920135|NCT05935657|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101920136|NCT05935657|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101920137|NCT05935657|Adrenergic Agents|adrenergic agents|mesh-ancestor
101920138|NCT05935657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101920139|NCT05935657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920140|NCT05922982|Norepinephrine|norepinephrine|mesh-list
101920141|NCT05922982|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101920142|NCT05922982|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101920143|NCT05922982|Adrenergic Agents|adrenergic agents|mesh-ancestor
101920144|NCT05922982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101920145|NCT05922982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920146|NCT05922982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920147|NCT05922982|Sympathomimetics|sympathomimetics|mesh-ancestor
101920148|NCT05922982|Autonomic Agents|autonomic agents|mesh-ancestor
101920149|NCT05922982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101920150|NCT05922982|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101920151|NCT05911321|Dexamethasone|dexamethasone|mesh-list
101920152|NCT05911321|Pomalidomide|pomalidomide|mesh-list
101920153|NCT05911321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101920154|NCT05911321|Antiemetics|antiemetics|mesh-ancestor
101920155|NCT05911321|Autonomic Agents|autonomic agents|mesh-ancestor
101920156|NCT05911321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101920157|NCT05911321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920158|NCT05911321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101920159|NCT05911321|Glucocorticoids|glucocorticoids|mesh-ancestor
101920160|NCT05911321|Hormones|hormones|mesh-ancestor
101920161|NCT05911321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101920162|NCT05911321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101920163|NCT05911321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920164|NCT05911321|Immunologic Factors|immunologic factors|mesh-ancestor
101920165|NCT05911321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101920166|NCT05911321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101920167|NCT05911321|Growth Substances|growth substances|mesh-ancestor
101920168|NCT05911321|Growth Inhibitors|growth inhibitors|mesh-ancestor
101920169|NCT05907850|Riboflavin|riboflavin|mesh-list
101920170|NCT05907850|Vitamin B Complex|vitamin b complex|mesh-ancestor
101920171|NCT05907850|Vitamins|vitamins|mesh-ancestor
101920172|NCT05907850|Micronutrients|micronutrients|mesh-ancestor
101920173|NCT05907850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920174|NCT05907850|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101920175|NCT05907850|Dermatologic Agents|dermatologic agents|mesh-ancestor
101920176|NCT05906836|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101920177|NCT05906836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101920178|NCT05906836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101920179|NCT05906836|Antimetabolites|antimetabolites|mesh-ancestor
101920180|NCT05906836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920181|NCT05906836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101920182|NCT05906836|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101920183|NCT05906836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101920184|NCT05904730|Axitinib|axitinib|mesh-list
101920185|NCT05904730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920186|NCT05904730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101920187|NCT05904730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101920188|NCT05904730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920189|NCT05903859|Probenecid|probenecid|mesh-list
101920190|NCT05903859|Uricosuric Agents|uricosuric agents|mesh-ancestor
101920191|NCT05903859|Gout Suppressants|gout suppressants|mesh-ancestor
101920192|NCT05903859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101920193|NCT05896384|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
101920194|NCT05896384|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
101920195|NCT05896384|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101920196|NCT05896384|Contraceptive Agents|contraceptive agents|mesh-ancestor
101920197|NCT05896384|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101920198|NCT05896384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920199|NCT05896384|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101920200|NCT05896384|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101920201|NCT05896384|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101920202|NCT05896384|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101920203|NCT05896384|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101920204|NCT05896384|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
101920205|NCT05896384|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101920206|NCT05896384|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101920207|NCT05893797|Insulin Lispro|insulin lispro|mesh-list
101920209|NCT05893797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101920210|NCT05893797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920211|NCT05893797|Antioxidants|antioxidants|mesh-ancestor
101920212|NCT05893797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920213|NCT05893797|Protective Agents|protective agents|mesh-ancestor
101920214|NCT05889793|Emetine|emetine|mesh-list
101920215|NCT05889793|Amebicides|amebicides|mesh-ancestor
101920216|NCT05889793|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101920217|NCT05889793|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101920218|NCT05889793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101920219|NCT05889793|Antinematodal Agents|antinematodal agents|mesh-ancestor
101920220|NCT05889793|Anthelmintics|anthelmintics|mesh-ancestor
101920221|NCT05889793|Cathartics|cathartics|mesh-ancestor
101920222|NCT05889793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101920223|NCT05889793|Emetics|emetics|mesh-ancestor
101920224|NCT05889793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920225|NCT05889793|Autonomic Agents|autonomic agents|mesh-ancestor
101920226|NCT05889793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101920227|NCT05889793|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101616965|NCT04106557|Anticonvulsants|anticonvulsants|mesh-ancestor
101920228|NCT05889793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101920229|NCT05889793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920230|NCT05860270|Vitamin D|vitamin d|mesh-list
101920231|NCT05860270|Cholecalciferol|cholecalciferol|mesh-list
101920232|NCT05860270|Vitamins|vitamins|mesh-ancestor
101920233|NCT05860270|Micronutrients|micronutrients|mesh-ancestor
101920234|NCT05860270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920235|NCT05860270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101920236|NCT05860270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101920237|NCT05855395|Dexamethasone|dexamethasone|mesh-list
101920238|NCT05855395|Prednisone|prednisone|mesh-list
101920239|NCT05855395|Methylprednisolone|methylprednisolone|mesh-list
101920240|NCT05855395|Glucocorticoids|glucocorticoids|mesh-list
101920241|NCT05855395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101920242|NCT05855395|Antiemetics|antiemetics|mesh-ancestor
101920243|NCT05855395|Autonomic Agents|autonomic agents|mesh-ancestor
101920244|NCT05855395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101920245|NCT05855395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920246|NCT05855395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101920247|NCT05855395|Hormones|hormones|mesh-ancestor
101920248|NCT05855395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101920249|NCT05855395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101920250|NCT05855395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920251|NCT05855395|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101920252|NCT05855395|Protective Agents|protective agents|mesh-ancestor
101920253|NCT05853354|Denosumab|denosumab|mesh-list
101920254|NCT05853354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101920255|NCT05853354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920256|NCT05833867|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
101920257|NCT05833867|Immunoconjugates|immunoconjugates|mesh-ancestor
101920258|NCT05833867|Immunologic Factors|immunologic factors|mesh-ancestor
101920259|NCT05833867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920260|NCT05822830|Tirzepatide|tirzepatide|mesh-list
101920261|NCT05822830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101920262|NCT05822830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920263|NCT05822830|Incretins|incretins|mesh-ancestor
101920264|NCT05822830|Hormones|hormones|mesh-ancestor
101957630|NCT02110654|Montelukast|montelukast|mesh-list
101920265|NCT05822830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101920267|NCT05818826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101920268|NCT05818826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101920269|NCT05808881|Naloxone|naloxone|mesh-list
101920270|NCT05808881|Nalmefene|nalmefene|mesh-list
101920271|NCT05808881|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101920272|NCT05808881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920273|NCT05808881|Sensory System Agents|sensory system agents|mesh-ancestor
101920274|NCT05808881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101920275|NCT05807139|Spironolactone|spironolactone|mesh-list
101920276|NCT05807139|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101920277|NCT05807139|Hormone Antagonists|hormone antagonists|mesh-ancestor
101920278|NCT05807139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101920279|NCT05807139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920280|NCT05807139|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101920281|NCT05807139|Diuretics|diuretics|mesh-ancestor
101920282|NCT05807139|Natriuretic Agents|natriuretic agents|mesh-ancestor
101920283|NCT05802628|Cetylpyridinium|cetylpyridinium|mesh-list
101920284|NCT05802628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101920285|NCT05802628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101920286|NCT05776888|Ofatumumab|ofatumumab|mesh-list
101920287|NCT05776888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920288|NCT05767021|Mirikizumab|mirikizumab|mesh-list
101920289|NCT05767021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101920290|NCT05767021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101920291|NCT05767021|Analgesics|analgesics|mesh-ancestor
101920292|NCT05767021|Sensory System Agents|sensory system agents|mesh-ancestor
101920293|NCT05767021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101920294|NCT05767021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920295|NCT05767021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101920296|NCT05767021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101920297|NCT05767021|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101920298|NCT05767021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101920299|NCT05751187|Folic Acid|folic acid|mesh-list
101920300|NCT05751187|Vitamin B 12|vitamin b 12|mesh-list
101920301|NCT05751187|Dexamethasone|dexamethasone|mesh-list
101920302|NCT05751187|Bevacizumab|bevacizumab|mesh-list
101920303|NCT05751187|Pembrolizumab|pembrolizumab|mesh-list
101920304|NCT05751187|Carboplatin|carboplatin|mesh-list
101920306|NCT05751187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101920307|NCT05751187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920308|NCT05751187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101920309|NCT05751187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101920310|NCT05751187|Growth Substances|growth substances|mesh-ancestor
101920311|NCT05751187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920312|NCT05751187|Growth Inhibitors|growth inhibitors|mesh-ancestor
101920313|NCT05751187|Vitamins|vitamins|mesh-ancestor
101920314|NCT05751187|Micronutrients|micronutrients|mesh-ancestor
101920315|NCT05751187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101920316|NCT05751187|Antiemetics|antiemetics|mesh-ancestor
101920317|NCT05751187|Autonomic Agents|autonomic agents|mesh-ancestor
101920318|NCT05751187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101920319|NCT05751187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101920320|NCT05751187|Glucocorticoids|glucocorticoids|mesh-ancestor
101920321|NCT05751187|Hormones|hormones|mesh-ancestor
101920322|NCT05751187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101920323|NCT05751187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101920324|NCT05751187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101920325|NCT05751187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920326|NCT05751187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101920327|NCT05751187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101920328|NCT05751187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101920329|NCT05751187|Hematinics|hematinics|mesh-ancestor
101920330|NCT05751187|Vitamin B Complex|vitamin b complex|mesh-ancestor
101920334|NCT05701241|Octreotide|octreotide|mesh-list
101920335|NCT05701241|Lanreotide|lanreotide|mesh-list
101920336|NCT05701241|Somatostatin|somatostatin|mesh-list
101920337|NCT05701241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101232783|NCT03710590|Nicotine|nicotine|mesh-list
101920339|NCT05701241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920340|NCT05701241|Hormones|hormones|mesh-ancestor
101920341|NCT05701241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101920342|NCT05701241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920343|NCT05698979|Botulinum Toxins|botulinum toxins|mesh-list
101920344|NCT05698979|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101920345|NCT05698979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101920350|NCT05696847|Tirzepatide|tirzepatide|mesh-list
101920351|NCT05696847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101920352|NCT05696847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920353|NCT05696847|Incretins|incretins|mesh-ancestor
101920354|NCT05696847|Hormones|hormones|mesh-ancestor
101920355|NCT05696847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101920356|NCT05691712|Tirzepatide|tirzepatide|mesh-list
101920357|NCT05691712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101920358|NCT05691712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920359|NCT05691712|Incretins|incretins|mesh-ancestor
101920360|NCT05691712|Hormones|hormones|mesh-ancestor
101920361|NCT05691712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101920362|NCT05676216|Diphenhydramine|diphenhydramine|mesh-list
101920363|NCT05676216|Promethazine|promethazine|mesh-list
101920364|NCT05676216|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101920365|NCT05676216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101920366|NCT05676216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101920367|NCT05676216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920368|NCT05676216|Anesthetics, Local|anesthetics, local|mesh-ancestor
101920369|NCT05676216|Anesthetics|anesthetics|mesh-ancestor
101920370|NCT05676216|Sensory System Agents|sensory system agents|mesh-ancestor
101920371|NCT05676216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101920372|NCT05676216|Antiemetics|antiemetics|mesh-ancestor
101920373|NCT05676216|Autonomic Agents|autonomic agents|mesh-ancestor
101920374|NCT05676216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101920375|NCT05676216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101920376|NCT05676216|Histamine Antagonists|histamine antagonists|mesh-ancestor
101920377|NCT05676216|Histamine Agents|histamine agents|mesh-ancestor
101920378|NCT05676216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101920379|NCT05676216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920380|NCT05676216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101920381|NCT05676216|Antipruritics|antipruritics|mesh-ancestor
101920382|NCT05676216|Dermatologic Agents|dermatologic agents|mesh-ancestor
101920388|NCT05647889|Lidocaine|lidocaine|mesh-list
101920389|NCT05647889|Anesthetics, Local|anesthetics, local|mesh-ancestor
101920390|NCT05647889|Anesthetics|anesthetics|mesh-ancestor
101920391|NCT05647889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101920392|NCT05647889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920393|NCT05647889|Sensory System Agents|sensory system agents|mesh-ancestor
101920394|NCT05647889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101920395|NCT05647889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101920396|NCT05647889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101920397|NCT05647889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101920398|NCT05647889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101920399|NCT05647889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920400|NCT05613777|BI 425809|bi 425809|mesh-list
101920401|NCT05613777|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
101920402|NCT05613777|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
101920403|NCT05613777|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101920404|NCT05613777|Contraceptive Agents|contraceptive agents|mesh-ancestor
101920405|NCT05613777|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101920406|NCT05613777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920407|NCT05613777|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101920408|NCT05613777|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101230339|NCT05585151|Evolocumab|evolocumab|mesh-list
101920409|NCT05613777|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101920410|NCT05613777|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101920411|NCT05613777|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101957643|NCT03258710|Tenofovir|tenofovir|mesh-list
101920412|NCT05613777|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
101920413|NCT05613777|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101920414|NCT05613777|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101920415|NCT05613777|Nootropic Agents|nootropic agents|mesh-ancestor
101920416|NCT05571592|Cannabidiol|cannabidiol|mesh-list
101920417|NCT05571592|Anticonvulsants|anticonvulsants|mesh-ancestor
101920418|NCT05564039|Dulaglutide|dulaglutide|mesh-list
101920419|NCT05564039|Tirzepatide|tirzepatide|mesh-list
101920420|NCT05564039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101920421|NCT05564039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920422|NCT05564039|Incretins|incretins|mesh-ancestor
101920423|NCT05564039|Hormones|hormones|mesh-ancestor
101920424|NCT05564039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101920425|NCT05562947|Ranibizumab|ranibizumab|mesh-list
101920426|NCT05562947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101920427|NCT05562947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101920428|NCT05562947|Growth Substances|growth substances|mesh-ancestor
101920429|NCT05562947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920430|NCT05562947|Growth Inhibitors|growth inhibitors|mesh-ancestor
101920431|NCT05562947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920432|NCT05559905|Molnupiravir|molnupiravir|mesh-list
101920433|NCT05559905|Antiviral Agents|antiviral agents|mesh-ancestor
101920434|NCT05559905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101920435|NCT05538663|Gemcitabine|gemcitabine|mesh-list
101920436|NCT05538663|Docetaxel|docetaxel|mesh-list
101920437|NCT05538663|BCG Vaccine|bcg vaccine|mesh-list
101920438|NCT05538663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101920439|NCT05538663|Antimetabolites|antimetabolites|mesh-ancestor
101920440|NCT05538663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920441|NCT05538663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920442|NCT05538663|Tubulin Modulators|tubulin modulators|mesh-ancestor
101920443|NCT05538663|Antimitotic Agents|antimitotic agents|mesh-ancestor
101920444|NCT05538663|Mitosis Modulators|mitosis modulators|mesh-ancestor
101920445|NCT05538663|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101920446|NCT05538663|Immunologic Factors|immunologic factors|mesh-ancestor
101920447|NCT05538663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920448|NCT05536791|Dabigatran|dabigatran|mesh-list
101920449|NCT05536791|Antithrombins|antithrombins|mesh-ancestor
101920450|NCT05536791|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101920451|NCT05536791|Protease Inhibitors|protease inhibitors|mesh-ancestor
101920452|NCT05536791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101920453|NCT05536791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920454|NCT05536791|Anticoagulants|anticoagulants|mesh-ancestor
101920455|NCT05526989|Niraparib|niraparib|mesh-list
101920456|NCT05526989|Dostarlimab|dostarlimab|mesh-list
101920457|NCT05526989|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101920458|NCT05526989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101920459|NCT05526989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920460|NCT05526989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920461|NCT05522231|Everolimus|everolimus|mesh-list
101920462|NCT05522231|Axitinib|axitinib|mesh-list
101920463|NCT05522231|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101920464|NCT05522231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101920465|NCT05522231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101920466|NCT05522231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920467|NCT05522231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101920468|NCT05522231|Immunologic Factors|immunologic factors|mesh-ancestor
101920469|NCT05522231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920470|NCT05522231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920471|NCT05484154|Protein C|protein c|mesh-list
101920472|NCT05484154|Anticoagulants|anticoagulants|mesh-ancestor
101920473|NCT05484154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101920474|NCT05484154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101920475|NCT05484154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920476|NCT05481736|Psilocybin|psilocybin|mesh-list
101920477|NCT05481736|Hallucinogens|hallucinogens|mesh-ancestor
101920478|NCT05481736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920479|NCT05481736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101920480|NCT05446298|Pembrolizumab|pembrolizumab|mesh-list
101920481|NCT05446298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101920482|NCT05446298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101957648|NCT03258710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101920483|NCT05446298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101920484|NCT05446298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920485|NCT05440786|Irinotecan|irinotecan|mesh-list
101920486|NCT05440786|Temozolomide|temozolomide|mesh-list
101920487|NCT05440786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101920488|NCT05440786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101920489|NCT05440786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101920490|NCT05440786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920491|NCT05440786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920492|NCT05440786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101920493|NCT05440786|Alkylating Agents|alkylating agents|mesh-ancestor
101920494|NCT05433584|Tirzepatide|tirzepatide|mesh-list
101640365|NCT04063189|Hormones|hormones|mesh-ancestor
101920495|NCT05433584|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101920503|NCT05377424|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101920504|NCT05377424|Purinergic Agents|purinergic agents|mesh-ancestor
101920505|NCT05377424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101920506|NCT05377424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920507|NCT05377424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920508|NCT05371964|Imetelstat|imetelstat|mesh-list
101920509|NCT05371964|Motesanib diphosphate|motesanib diphosphate|mesh-list
101920510|NCT05371964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101920511|NCT05371964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920512|NCT05371964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101920524|NCT05321043|Riboflavin|riboflavin|mesh-list
101920525|NCT05321043|Vitamins|vitamins|mesh-ancestor
101920526|NCT05321043|Micronutrients|micronutrients|mesh-ancestor
101920527|NCT05321043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920528|NCT05321043|Vitamin B Complex|vitamin b complex|mesh-ancestor
101920529|NCT05321043|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101920530|NCT05321043|Dermatologic Agents|dermatologic agents|mesh-ancestor
101920531|NCT05318105|Diuretics|diuretics|mesh-list
101920532|NCT05318105|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
101920533|NCT05318105|Natriuretic Agents|natriuretic agents|mesh-ancestor
101920534|NCT05318105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920535|NCT05318105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101920536|NCT05318105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920537|NCT05303311|Dexamethasone|dexamethasone|mesh-list
101920538|NCT05303311|Meperidine|meperidine|mesh-list
101920539|NCT05303311|Bupivacaine|bupivacaine|mesh-list
101920540|NCT05303311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101920541|NCT05303311|Antiemetics|antiemetics|mesh-ancestor
101920542|NCT05303311|Autonomic Agents|autonomic agents|mesh-ancestor
101920543|NCT05303311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101920544|NCT05303311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920545|NCT05303311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101920546|NCT05303311|Glucocorticoids|glucocorticoids|mesh-ancestor
101920547|NCT05303311|Hormones|hormones|mesh-ancestor
101920548|NCT05303311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101920549|NCT05303311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101920550|NCT05303311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920551|NCT05303311|Anesthetics, Local|anesthetics, local|mesh-ancestor
101920553|NCT05303311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101920554|NCT05303311|Sensory System Agents|sensory system agents|mesh-ancestor
101920555|NCT05303311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101920556|NCT05303311|Narcotics|narcotics|mesh-ancestor
101920557|NCT05303311|Analgesics|analgesics|mesh-ancestor
101920558|NCT05303311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101920559|NCT05285982|Nintedanib|nintedanib|mesh-list
101920560|NCT05285982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920561|NCT05285982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101920562|NCT05285982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101920563|NCT05285982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920564|NCT05275374|Trametinib|trametinib|mesh-list
101920565|NCT05275374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920566|NCT05275374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101920567|NCT05275374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101920568|NCT05275374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920569|NCT05262764|Empagliflozin|empagliflozin|mesh-list
101957652|NCT02110810|Indomethacin|indomethacin|mesh-list
101920570|NCT05262764|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101920571|NCT05262764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920572|NCT05262764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101920573|NCT05262764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920574|NCT05233579|Sulforaphane|sulforaphane|mesh-list
101920575|NCT05233579|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101920576|NCT05233579|Protective Agents|protective agents|mesh-ancestor
101920577|NCT05233579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920578|NCT05233579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920579|NCT05227612|Psilocybin|psilocybin|mesh-list
101920580|NCT05227612|Hallucinogens|hallucinogens|mesh-ancestor
101920581|NCT05227612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920582|NCT05227612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101920583|NCT05208892|Dexmedetomidine|dexmedetomidine|mesh-list
101920584|NCT05208892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101920585|NCT05208892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101920586|NCT05208892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920587|NCT05208892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101920588|NCT05208892|Analgesics|analgesics|mesh-ancestor
101920589|NCT05208892|Sensory System Agents|sensory system agents|mesh-ancestor
101920590|NCT05208892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101920591|NCT05208892|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101920592|NCT05208892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101920593|NCT05208892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101920594|NCT05208892|Adrenergic Agents|adrenergic agents|mesh-ancestor
101920595|NCT05208892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101920596|NCT05208892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920597|NCT05154955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101920598|NCT05147402|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
101920599|NCT05147402|Hallucinogens|hallucinogens|mesh-ancestor
101920600|NCT05147402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920601|NCT05147402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101920602|NCT05147402|Serotonin Agents|serotonin agents|mesh-ancestor
101920603|NCT05147402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101920604|NCT05147402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920605|NCT05147402|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101920606|NCT05147402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101920607|NCT05147402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101920608|NCT05147402|Adrenergic Agents|adrenergic agents|mesh-ancestor
101920609|NCT05147376|Curcumin|curcumin|mesh-list
101230378|NCT05527470|Cisplatin|cisplatin|mesh-list
101920610|NCT05147376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101920611|NCT05147376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101920612|NCT05147376|Analgesics|analgesics|mesh-ancestor
101920613|NCT05147376|Sensory System Agents|sensory system agents|mesh-ancestor
101920614|NCT05147376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101920615|NCT05147376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920616|NCT05147376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101920617|NCT05147376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101616971|NCT04117750|Vitamin D|vitamin d|mesh-list
101920618|NCT05147376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920619|NCT05147376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101920620|NCT05147376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920621|NCT05130463|Empagliflozin|empagliflozin|mesh-list
101920622|NCT05130463|Linagliptin|linagliptin|mesh-list
101920623|NCT05130463|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101920624|NCT05130463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920625|NCT05130463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101920626|NCT05130463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920627|NCT05130463|Incretins|incretins|mesh-ancestor
101920628|NCT05130463|Hormones|hormones|mesh-ancestor
101920629|NCT05130463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101920630|NCT05130463|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101920631|NCT05130463|Protease Inhibitors|protease inhibitors|mesh-ancestor
101920632|NCT05130463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101920633|NCT05123703|Ocrelizumab|ocrelizumab|mesh-list
101920634|NCT05123703|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101920635|NCT05123703|Immunologic Factors|immunologic factors|mesh-ancestor
101920636|NCT05123703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957655|NCT02110810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101920637|NCT05123703|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101920638|NCT05123703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920640|NCT05119920|Pilocarpine|pilocarpine|mesh-list
101920641|NCT05119920|Miotics|miotics|mesh-ancestor
101920642|NCT05119920|Autonomic Agents|autonomic agents|mesh-ancestor
101640500|NCT04342975|Niacin|niacin|mesh-list
101920643|NCT05119920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101920644|NCT05119920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920645|NCT05119920|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101920646|NCT05119920|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101920647|NCT05119920|Cholinergic Agents|cholinergic agents|mesh-ancestor
101920648|NCT05119920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101920649|NCT05119920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920650|NCT05090371|Ofatumumab|ofatumumab|mesh-list
101920651|NCT05090371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920652|NCT05084638|Ofatumumab|ofatumumab|mesh-list
101920653|NCT05084638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920654|NCT05065736|Clofarabine|clofarabine|mesh-list
101920655|NCT05065736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101920656|NCT05065736|Antimetabolites|antimetabolites|mesh-ancestor
101920657|NCT05065736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920658|NCT05065736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920659|NCT05065190|Nintedanib|nintedanib|mesh-list
101920660|NCT05065190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920661|NCT05065190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101920662|NCT05065190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101920663|NCT05065190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920664|NCT05054868|Ketorolac|ketorolac|mesh-list
101920665|NCT05054868|Oxycodone|oxycodone|mesh-list
101920666|NCT05054868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101920667|NCT05054868|Narcotics|narcotics|mesh-ancestor
101920668|NCT05054868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101920669|NCT05054868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920670|NCT05054868|Analgesics|analgesics|mesh-ancestor
101920671|NCT05054868|Sensory System Agents|sensory system agents|mesh-ancestor
101920672|NCT05054868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101920673|NCT05054868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101920674|NCT05054868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101920675|NCT05054868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101920676|NCT05054868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101920677|NCT05054868|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101920678|NCT05054868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101920679|NCT05054868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920680|NCT05048342|Remibrutinib|remibrutinib|mesh-list
101920681|NCT05048342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101920682|NCT05048342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101920683|NCT05048342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920684|NCT05046535|Nicotine|nicotine|mesh-list
101920685|NCT05046535|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101920686|NCT05046535|Autonomic Agents|autonomic agents|mesh-ancestor
101920687|NCT05046535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101920688|NCT05046535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920689|NCT05046535|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101920690|NCT05046535|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101920691|NCT05046535|Cholinergic Agents|cholinergic agents|mesh-ancestor
101920692|NCT05046535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101920693|NCT05046535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920694|NCT05009342|Calpastatin|calpastatin|mesh-list
101920695|NCT05009342|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
101920696|NCT05009342|Protease Inhibitors|protease inhibitors|mesh-ancestor
101920697|NCT05009342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101920698|NCT05009342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920699|NCT04987775|Acetylcysteine|acetylcysteine|mesh-list
101920700|NCT04987775|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101920701|NCT04987775|Antiviral Agents|antiviral agents|mesh-ancestor
101920702|NCT04987775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101920703|NCT04987775|Expectorants|expectorants|mesh-ancestor
101920704|NCT04987775|Respiratory System Agents|respiratory system agents|mesh-ancestor
101920705|NCT04987775|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101920706|NCT04987775|Antioxidants|antioxidants|mesh-ancestor
101920707|NCT04987775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920708|NCT04987775|Protective Agents|protective agents|mesh-ancestor
101920709|NCT04987775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920710|NCT04987775|Antidotes|antidotes|mesh-ancestor
101920711|NCT04965597|Methotrexate|methotrexate|mesh-list
101920712|NCT04965597|Fludarabine phosphate|fludarabine phosphate|mesh-list
101920713|NCT04965597|Fludarabine|fludarabine|mesh-list
101920714|NCT04965597|Treosulfan|treosulfan|mesh-list
101920715|NCT04965597|Busulfan|busulfan|mesh-list
101920716|NCT04965597|Tacrolimus|tacrolimus|mesh-list
101920717|NCT04965597|Thymoglobulin|thymoglobulin|mesh-list
101920718|NCT04965597|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101920719|NCT04965597|Immunoglobulins|immunoglobulins|mesh-list
101920720|NCT04965597|Antibodies|antibodies|mesh-list
101920721|NCT04965597|gamma-Globulins|gamma-globulins|mesh-list
101920722|NCT04965597|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101920723|NCT04965597|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101920724|NCT04965597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101920725|NCT04965597|Abortifacient Agents|abortifacient agents|mesh-ancestor
101920726|NCT04965597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101920727|NCT04965597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920728|NCT04965597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101920729|NCT04965597|Antimetabolites|antimetabolites|mesh-ancestor
101920730|NCT04965597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920731|NCT04965597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920732|NCT04965597|Dermatologic Agents|dermatologic agents|mesh-ancestor
101920733|NCT04965597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101920734|NCT04965597|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101920735|NCT04965597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101920736|NCT04965597|Immunologic Factors|immunologic factors|mesh-ancestor
101920737|NCT04965597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101920738|NCT04965597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101920739|NCT04965597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101920740|NCT04965597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101920741|NCT04965597|Alkylating Agents|alkylating agents|mesh-ancestor
101920742|NCT04965597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101920743|NCT04922827|Infliximab|infliximab|mesh-list
101920744|NCT04922827|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101920745|NCT04922827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101920746|NCT04922827|Dermatologic Agents|dermatologic agents|mesh-ancestor
101920747|NCT04922827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101920748|NCT04922827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101920749|NCT04921930|Artesunate|artesunate|mesh-list
101920750|NCT04921930|Antimalarials|antimalarials|mesh-ancestor
101920751|NCT04921930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101920752|NCT04921930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101920753|NCT04921930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101920754|NCT04921930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920755|NCT04921930|Antiviral Agents|antiviral agents|mesh-ancestor
101920756|NCT04921930|Schistosomicides|schistosomicides|mesh-ancestor
101920757|NCT04921930|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101920758|NCT04921930|Anthelmintics|anthelmintics|mesh-ancestor
101920759|NCT04909684|Pembrolizumab|pembrolizumab|mesh-list
101920760|NCT04909684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101920761|NCT04909684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920762|NCT04909684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101920763|NCT04909684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920764|NCT04877457|Ocrelizumab|ocrelizumab|mesh-list
101920765|NCT04877457|Immunologic Factors|immunologic factors|mesh-ancestor
101920766|NCT04877457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920767|NCT04869358|Ofatumumab|ofatumumab|mesh-list
101920768|NCT04869358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920769|NCT04751383|Dinutuximab|dinutuximab|mesh-list
101920770|NCT04751383|Magrolimab|magrolimab|mesh-list
101920771|NCT04751383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101920772|NCT04751383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920773|NCT04751383|Immunologic Factors|immunologic factors|mesh-ancestor
101920774|NCT04751383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920775|NCT04751383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101920776|NCT04719273|Anastrozole|anastrozole|mesh-list
101920777|NCT04719273|Onapristone|onapristone|mesh-list
101920778|NCT04719273|Progesterone|progesterone|mesh-list
101920779|NCT04719273|Estrogens|estrogens|mesh-list
101920780|NCT04719273|Progestins|progestins|mesh-ancestor
101920781|NCT04719273|Hormones|hormones|mesh-ancestor
101920782|NCT04719273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101920783|NCT04719273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920784|NCT04719273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101920785|NCT04719273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920786|NCT04719273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101920787|NCT04719273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101920788|NCT04719273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101920789|NCT04719273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920790|NCT04719273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101920791|NCT04719273|Hormone Antagonists|hormone antagonists|mesh-ancestor
101920792|NCT04719273|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101920793|NCT04719273|Fertility Agents|fertility agents|mesh-ancestor
101920794|NCT04719273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101920795|NCT04670679|Pembrolizumab|pembrolizumab|mesh-list
101920796|NCT04670679|Cetuximab|cetuximab|mesh-list
101920810|NCT04631510|Sensory System Agents|sensory system agents|mesh-ancestor
101920811|NCT04631510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101920812|NCT04631510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920814|NCT04631510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101920815|NCT04631510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101920816|NCT04631510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101920817|NCT04631510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101920818|NCT04631510|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101920819|NCT04631510|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101920820|NCT04631510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101920821|NCT04631510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920822|NCT04631510|Antimanic Agents|antimanic agents|mesh-ancestor
101920823|NCT04612257|Insulin|insulin|mesh-list
101920824|NCT04612257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101920825|NCT04612257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920826|NCT04571619|Buprenorphine|buprenorphine|mesh-list
101920827|NCT04571619|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101920828|NCT04571619|Narcotics|narcotics|mesh-ancestor
101920829|NCT04571619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101920830|NCT04571619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920831|NCT04571619|Analgesics|analgesics|mesh-ancestor
101920832|NCT04571619|Sensory System Agents|sensory system agents|mesh-ancestor
101920833|NCT04571619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101920834|NCT04571619|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101920835|NCT04559581|Nintedanib|nintedanib|mesh-list
101920836|NCT04559581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920837|NCT04559581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101920838|NCT04559581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101920839|NCT04559581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920840|NCT04527380|Adalimumab|adalimumab|mesh-list
101920841|NCT04527380|Ixekizumab|ixekizumab|mesh-list
101920842|NCT04527380|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101920843|NCT04527380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101920844|NCT04527380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101920845|NCT04527380|Dermatologic Agents|dermatologic agents|mesh-ancestor
101920846|NCT04522050|Gemcitabine|gemcitabine|mesh-list
101920847|NCT04522050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920848|NCT04522050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101957680|NCT02114476|Hormones|hormones|mesh-ancestor
101920849|NCT04522050|Antimetabolites|antimetabolites|mesh-ancestor
101920850|NCT04522050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920851|NCT04509674|Empagliflozin|empagliflozin|mesh-list
101920852|NCT04509674|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101920853|NCT04509674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920854|NCT04509674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101920855|NCT04509674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920856|NCT04485013|Pembrolizumab|pembrolizumab|mesh-list
101920857|NCT04485013|Cetuximab|cetuximab|mesh-list
101920858|NCT04485013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101920859|NCT04485013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920860|NCT04485013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101920861|NCT04485013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920862|NCT04481048|Acetylcysteine|acetylcysteine|mesh-list
101920863|NCT04481048|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101920864|NCT04481048|Antiviral Agents|antiviral agents|mesh-ancestor
101920865|NCT04481048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101920866|NCT04481048|Expectorants|expectorants|mesh-ancestor
101920867|NCT04481048|Respiratory System Agents|respiratory system agents|mesh-ancestor
101920868|NCT04481048|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101920869|NCT04481048|Antioxidants|antioxidants|mesh-ancestor
101920870|NCT04481048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640718|NCT00962390|Equol|equol|mesh-list
101920871|NCT04481048|Protective Agents|protective agents|mesh-ancestor
101920872|NCT04481048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920873|NCT04481048|Antidotes|antidotes|mesh-ancestor
101920874|NCT04472429|Paclitaxel|paclitaxel|mesh-list
101920875|NCT04472429|Carboplatin|carboplatin|mesh-list
101920876|NCT04472429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101920877|NCT04472429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920878|NCT04472429|Tubulin Modulators|tubulin modulators|mesh-ancestor
101920879|NCT04472429|Antimitotic Agents|antimitotic agents|mesh-ancestor
101920880|NCT04472429|Mitosis Modulators|mitosis modulators|mesh-ancestor
101920881|NCT04472429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920882|NCT04471597|Bupivacaine|bupivacaine|mesh-list
101920883|NCT04471597|Anesthetics, Local|anesthetics, local|mesh-ancestor
101920884|NCT04471597|Anesthetics|anesthetics|mesh-ancestor
101920885|NCT04471597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101920886|NCT04471597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920887|NCT04471597|Sensory System Agents|sensory system agents|mesh-ancestor
101920888|NCT04471597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101920889|NCT04464798|Rituximab|rituximab|mesh-list
101920890|NCT04464798|Obinutuzumab|obinutuzumab|mesh-list
101920891|NCT04464798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101920892|NCT04464798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920893|NCT04464798|Immunologic Factors|immunologic factors|mesh-ancestor
101920894|NCT04464798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920895|NCT04464798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101920896|NCT04375631|Cytarabine|cytarabine|mesh-list
101920897|NCT04375631|Cyclosporine|cyclosporine|mesh-list
101920898|NCT04375631|Mycophenolic Acid|mycophenolic acid|mesh-list
101920899|NCT04375631|Cyclophosphamide|cyclophosphamide|mesh-list
101920900|NCT04375631|Fludarabine|fludarabine|mesh-list
101920901|NCT04375631|Fludarabine phosphate|fludarabine phosphate|mesh-list
101920902|NCT04375631|Mitoxantrone|mitoxantrone|mesh-list
101920903|NCT04375631|Idarubicin|idarubicin|mesh-list
101920904|NCT04375631|Cladribine|cladribine|mesh-list
101920905|NCT04375631|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
101920906|NCT04375631|Cyclosporins|cyclosporins|mesh-list
101920907|NCT04375631|Lenograstim|lenograstim|mesh-list
101920908|NCT04375631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101920909|NCT04375631|Immunologic Factors|immunologic factors|mesh-ancestor
101957689|NCT02110966|Analgesics|analgesics|mesh-ancestor
101920910|NCT04375631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920911|NCT04375631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101920912|NCT04375631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101920913|NCT04375631|Alkylating Agents|alkylating agents|mesh-ancestor
101920914|NCT04375631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920915|NCT04375631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920916|NCT04375631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101920917|NCT04375631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101920918|NCT04375631|Antimetabolites|antimetabolites|mesh-ancestor
101920919|NCT04375631|Antiviral Agents|antiviral agents|mesh-ancestor
101920920|NCT04375631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101920921|NCT04375631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101920922|NCT04375631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101920923|NCT04375631|Antifungal Agents|antifungal agents|mesh-ancestor
101920924|NCT04375631|Dermatologic Agents|dermatologic agents|mesh-ancestor
101920925|NCT04375631|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101920926|NCT04375631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101920927|NCT04375631|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101920928|NCT04375631|Antitubercular Agents|antitubercular agents|mesh-ancestor
101920929|NCT04375631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101920930|NCT04375631|Analgesics|analgesics|mesh-ancestor
101920931|NCT04375631|Sensory System Agents|sensory system agents|mesh-ancestor
101920932|NCT04375631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101920933|NCT04375631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101920934|NCT04375631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101920935|NCT04357587|Pembrolizumab|pembrolizumab|mesh-list
101920936|NCT04357587|Capecitabine|capecitabine|mesh-list
101920937|NCT04357587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101920938|NCT04357587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920939|NCT04357587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101920940|NCT04357587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230443|NCT05254418|Dulaglutide|dulaglutide|mesh-list
101920941|NCT04357587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101920942|NCT04357587|Antimetabolites|antimetabolites|mesh-ancestor
101920943|NCT04353492|Ofatumumab|ofatumumab|mesh-list
101640791|NCT00958724|Vinorelbine|vinorelbine|mesh-list
101920944|NCT04353492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920945|NCT04325217|Nintedanib|nintedanib|mesh-list
101920946|NCT04325217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920947|NCT04325217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101920951|NCT04269408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101920952|NCT04269408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101920953|NCT04269408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101920954|NCT04269408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920955|NCT04269408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101920956|NCT04269408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920957|NCT04269408|Vasodilator Agents|vasodilator agents|mesh-ancestor
101920958|NCT04248829|Gefitinib|gefitinib|mesh-list
101920959|NCT04248829|Lazertinib|lazertinib|mesh-list
101920960|NCT04248829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920961|NCT04248829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101920962|NCT04248829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101920963|NCT04248829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920970|NCT04187833|Nivolumab|nivolumab|mesh-list
101920971|NCT04187833|Talazoparib|talazoparib|mesh-list
101920972|NCT04187833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101920973|NCT04187833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920974|NCT04187833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101920975|NCT04187833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920976|NCT04187833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101920977|NCT04187833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101920978|NCT04184401|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101920979|NCT04145349|Cyclophosphamide|cyclophosphamide|mesh-list
101920980|NCT04145349|Vinorelbine|vinorelbine|mesh-list
101920981|NCT04145349|Ramucirumab|ramucirumab|mesh-list
101920982|NCT04145349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101920983|NCT04145349|Immunologic Factors|immunologic factors|mesh-ancestor
101920984|NCT04145349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101920985|NCT04145349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101920986|NCT04145349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101920987|NCT04145349|Alkylating Agents|alkylating agents|mesh-ancestor
101920988|NCT04145349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101920989|NCT04145349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101920990|NCT04145349|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101920991|NCT04145349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101920992|NCT04145349|Tubulin Modulators|tubulin modulators|mesh-ancestor
101920993|NCT04145349|Antimitotic Agents|antimitotic agents|mesh-ancestor
101920994|NCT04145349|Mitosis Modulators|mitosis modulators|mesh-ancestor
101920995|NCT04122170|Aspirin|aspirin|mesh-list
101920996|NCT04122170|Ticagrelor|ticagrelor|mesh-list
101920997|NCT04122170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101920998|NCT04122170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101920999|NCT04122170|Analgesics|analgesics|mesh-ancestor
101921000|NCT04122170|Sensory System Agents|sensory system agents|mesh-ancestor
101921001|NCT04122170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101921002|NCT04122170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921003|NCT04122170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101921004|NCT04122170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101921005|NCT04122170|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101921006|NCT04122170|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101921007|NCT04122170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921008|NCT04122170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101921009|NCT04122170|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101921010|NCT04122170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101921011|NCT04122170|Antipyretics|antipyretics|mesh-ancestor
101921012|NCT04122170|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101921013|NCT04122170|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101921014|NCT04122170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101921015|NCT04122170|Purinergic Agents|purinergic agents|mesh-ancestor
101921016|NCT04122170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101574931|NCT02760355|Antimetabolites|antimetabolites|mesh-ancestor
101921044|NCT04073433|Adrenergic Agents|adrenergic agents|mesh-ancestor
101921046|NCT04038515|Nicotine|nicotine|mesh-list
101921047|NCT04038515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101921048|NCT04038515|Autonomic Agents|autonomic agents|mesh-ancestor
101921049|NCT04038515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101921050|NCT04038515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921051|NCT04038515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101921052|NCT04038515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101921053|NCT04038515|Cholinergic Agents|cholinergic agents|mesh-ancestor
101921054|NCT04038515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101921055|NCT04038515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921056|NCT04038515|Antipruritics|antipruritics|mesh-ancestor
101921057|NCT04038515|Dermatologic Agents|dermatologic agents|mesh-ancestor
101921058|NCT03997266|Gentamicins|gentamicins|mesh-list
101921059|NCT03997266|Ampicillin|ampicillin|mesh-list
101921060|NCT03997266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101921061|NCT03997266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101921062|NCT03997266|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101921063|NCT03997266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101921064|NCT03997266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921065|NCT03970096|Cyclosporine|cyclosporine|mesh-list
101921066|NCT03970096|Sirolimus|sirolimus|mesh-list
101921067|NCT03970096|Cyclophosphamide|cyclophosphamide|mesh-list
101921068|NCT03970096|Busulfan|busulfan|mesh-list
101921069|NCT03970096|Thiotepa|thiotepa|mesh-list
101921070|NCT03970096|Methotrexate|methotrexate|mesh-list
101921071|NCT03970096|Fludarabine|fludarabine|mesh-list
101921072|NCT03970096|Tacrolimus|tacrolimus|mesh-list
101921073|NCT03970096|Cyclosporins|cyclosporins|mesh-list
101921074|NCT03970096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101921075|NCT03970096|Immunologic Factors|immunologic factors|mesh-ancestor
101921076|NCT03970096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921077|NCT03970096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101921078|NCT03970096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101921079|NCT03970096|Alkylating Agents|alkylating agents|mesh-ancestor
101921080|NCT03970096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921081|NCT03970096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101921082|NCT03970096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101921083|NCT03970096|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101921084|NCT03970096|Abortifacient Agents|abortifacient agents|mesh-ancestor
101921085|NCT03970096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101921086|NCT03970096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101921087|NCT03970096|Antimetabolites|antimetabolites|mesh-ancestor
101921088|NCT03970096|Dermatologic Agents|dermatologic agents|mesh-ancestor
101921089|NCT03970096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101921090|NCT03970096|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101921091|NCT03970096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101921092|NCT03970096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101921093|NCT03970096|Antifungal Agents|antifungal agents|mesh-ancestor
101921094|NCT03970096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101640941|NCT04295993|Sympathomimetics|sympathomimetics|mesh-ancestor
101921095|NCT03970096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101921096|NCT03970096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101921097|NCT03959293|Durvalumab|durvalumab|mesh-list
101921098|NCT03959293|Tremelimumab|tremelimumab|mesh-list
101921099|NCT03959293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101921100|NCT03959293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101921101|NCT03936153|Abexinostat|abexinostat|mesh-list
101921102|NCT03936153|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101921103|NCT03936153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101230468|NCT05150704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101921104|NCT03936153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921105|NCT03792841|Etanercept|etanercept|mesh-list
101921106|NCT03792841|Pembrolizumab|pembrolizumab|mesh-list
101921107|NCT03792841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101921108|NCT03792841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101921109|NCT03792841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101921110|NCT03792841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921111|NCT03792841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101921112|NCT03792841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101921113|NCT03792841|Analgesics|analgesics|mesh-ancestor
101921114|NCT03792841|Sensory System Agents|sensory system agents|mesh-ancestor
101921115|NCT03792841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101921116|NCT03792841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921117|NCT03792841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101921118|NCT03792841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101921119|NCT03792841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101921120|NCT03792841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101921121|NCT03792841|Immunologic Factors|immunologic factors|mesh-ancestor
101921122|NCT03782987|Itraconazole|itraconazole|mesh-list
101921123|NCT03782987|Antifungal Agents|antifungal agents|mesh-ancestor
101921124|NCT03782987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101921125|NCT03782987|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101921126|NCT03782987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101921127|NCT03782987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101921128|NCT03782987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921129|NCT03782987|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101921130|NCT03782987|Hormone Antagonists|hormone antagonists|mesh-ancestor
101921131|NCT03782987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101921132|NCT03782987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921133|NCT03782987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101921134|NCT03755791|Sorafenib|sorafenib|mesh-list
101921135|NCT03755791|Atezolizumab|atezolizumab|mesh-list
101921136|NCT03755791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101921137|NCT03755791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101921138|NCT03755791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101921139|NCT03755791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921140|NCT03755791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101921141|NCT03755791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101921142|NCT03755102|Osimertinib|osimertinib|mesh-list
101921143|NCT03755102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101921144|NCT03755102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101921145|NCT03755102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101921146|NCT03755102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921147|NCT03742986|Paclitaxel|paclitaxel|mesh-list
101921148|NCT03742986|Docetaxel|docetaxel|mesh-list
101921149|NCT03742986|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101921150|NCT03742986|Cyclophosphamide|cyclophosphamide|mesh-list
101921151|NCT03742986|Doxorubicin|doxorubicin|mesh-list
101921152|NCT03742986|Nivolumab|nivolumab|mesh-list
101921153|NCT03742986|Trastuzumab|trastuzumab|mesh-list
101921154|NCT03742986|Pertuzumab|pertuzumab|mesh-list
101921155|NCT03742986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101921156|NCT03742986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101921157|NCT03742986|Tubulin Modulators|tubulin modulators|mesh-ancestor
101921158|NCT03742986|Antimitotic Agents|antimitotic agents|mesh-ancestor
101921159|NCT03742986|Mitosis Modulators|mitosis modulators|mesh-ancestor
101921160|NCT03742986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921161|NCT03742986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101921162|NCT03742986|Immunologic Factors|immunologic factors|mesh-ancestor
101921163|NCT03742986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921164|NCT03742986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101230481|NCT05095259|Insulin|insulin|mesh-list
101921165|NCT03742986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101921166|NCT03742986|Alkylating Agents|alkylating agents|mesh-ancestor
101921167|NCT03742986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101641017|NCT01005719|Omeprazole|omeprazole|mesh-list
101921168|NCT03742986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101921169|NCT03742986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101921170|NCT03742986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101921171|NCT03742986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101921172|NCT03742986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101921173|NCT03742986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101921174|NCT03713580|Venetoclax|venetoclax|mesh-list
101921175|NCT03713580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101921176|NCT03713437|Insulin|insulin|mesh-list
101921177|NCT03713437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101921178|NCT03713437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921179|NCT03706365|Prednisone|prednisone|mesh-list
101921180|NCT03706365|Abiraterone Acetate|abiraterone acetate|mesh-list
101921181|NCT03706365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101921182|NCT03706365|Glucocorticoids|glucocorticoids|mesh-ancestor
101921183|NCT03706365|Hormones|hormones|mesh-ancestor
101921184|NCT03706365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101921185|NCT03706365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921186|NCT03706365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101921187|NCT03706365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101921188|NCT03706365|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101921189|NCT03706365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101921190|NCT03706365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921191|NCT03706365|Hormone Antagonists|hormone antagonists|mesh-ancestor
101921192|NCT03706365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101921193|NCT03594747|Paclitaxel|paclitaxel|mesh-list
101921194|NCT03594747|Carboplatin|carboplatin|mesh-list
101921195|NCT03594747|Tislelizumab|tislelizumab|mesh-list
101921196|NCT03594747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101921197|NCT03594747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101921198|NCT03594747|Tubulin Modulators|tubulin modulators|mesh-ancestor
101921199|NCT03594747|Antimitotic Agents|antimitotic agents|mesh-ancestor
101921200|NCT03594747|Mitosis Modulators|mitosis modulators|mesh-ancestor
101921201|NCT03594747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921202|NCT03594747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101921203|NCT03575403|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101921204|NCT03575403|Methylphenidate|methylphenidate|mesh-list
101921205|NCT03575403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101921206|NCT03575403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921207|NCT03575403|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101921208|NCT03575403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101921209|NCT03575403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101921210|NCT03575403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921211|NCT03575403|Dopamine Agents|dopamine agents|mesh-ancestor
101921212|NCT03575403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101921213|NCT03575403|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101921214|NCT03575403|Analgesics|analgesics|mesh-ancestor
101921215|NCT03575403|Sensory System Agents|sensory system agents|mesh-ancestor
101921216|NCT03575403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101921217|NCT03575403|Antidepressive Agents|antidepressive agents|mesh-ancestor
101921218|NCT03575403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101921219|NCT03485287|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
101921220|NCT03485287|Hallucinogens|hallucinogens|mesh-ancestor
101921221|NCT03485287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921222|NCT03485287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101921223|NCT03485287|Serotonin Agents|serotonin agents|mesh-ancestor
101921224|NCT03485287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101921225|NCT03485287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921226|NCT03485287|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101921227|NCT03485287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101921228|NCT03485287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101921229|NCT03485287|Adrenergic Agents|adrenergic agents|mesh-ancestor
101921230|NCT03474029|Rifampin|rifampin|mesh-list
101921231|NCT03474029|Rifapentine|rifapentine|mesh-list
101921232|NCT03474029|Isoniazid|isoniazid|mesh-list
101921233|NCT03474029|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101921234|NCT03474029|Antitubercular Agents|antitubercular agents|mesh-ancestor
101921235|NCT03474029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101921236|NCT03474029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101921237|NCT03474029|Leprostatic Agents|leprostatic agents|mesh-ancestor
101921238|NCT03474029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101921239|NCT03474029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101921240|NCT03474029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921241|NCT03474029|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101921242|NCT03474029|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101921243|NCT03474029|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101921244|NCT03474029|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101921245|NCT03474029|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101921246|NCT03474029|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101921247|NCT03474029|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101921248|NCT03474029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101921249|NCT03474029|Antimetabolites|antimetabolites|mesh-ancestor
101921250|NCT03474029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101921251|NCT03395080|Paclitaxel|paclitaxel|mesh-list
101921252|NCT03395080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101921253|NCT03395080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101921254|NCT03395080|Tubulin Modulators|tubulin modulators|mesh-ancestor
101921255|NCT03395080|Antimitotic Agents|antimitotic agents|mesh-ancestor
101921256|NCT03395080|Mitosis Modulators|mitosis modulators|mesh-ancestor
101921257|NCT03395080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921258|NCT03356860|Paclitaxel|paclitaxel|mesh-list
101921259|NCT03356860|Cyclophosphamide|cyclophosphamide|mesh-list
101921260|NCT03356860|Durvalumab|durvalumab|mesh-list
101921261|NCT03356860|Epirubicin|epirubicin|mesh-list
101921262|NCT03356860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101921263|NCT03356860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101921264|NCT03356860|Tubulin Modulators|tubulin modulators|mesh-ancestor
101921265|NCT03356860|Antimitotic Agents|antimitotic agents|mesh-ancestor
101921266|NCT03356860|Mitosis Modulators|mitosis modulators|mesh-ancestor
101921267|NCT03356860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921268|NCT03356860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101921269|NCT03356860|Immunologic Factors|immunologic factors|mesh-ancestor
101921270|NCT03356860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921271|NCT03356860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101921272|NCT03356860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101921273|NCT03356860|Alkylating Agents|alkylating agents|mesh-ancestor
101921274|NCT03356860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101921275|NCT03356860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101921276|NCT03356860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101921277|NCT03356860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101921278|NCT03356860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101921279|NCT03356860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101921280|NCT03313778|Pembrolizumab|pembrolizumab|mesh-list
101921281|NCT03313778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101921282|NCT03313778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101921283|NCT03313778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101921284|NCT03313778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921285|NCT03282123|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
101921286|NCT03282123|Hallucinogens|hallucinogens|mesh-ancestor
101921287|NCT03282123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921288|NCT03282123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101921289|NCT03282123|Serotonin Agents|serotonin agents|mesh-ancestor
101921290|NCT03282123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101921291|NCT03282123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921292|NCT03282123|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101921293|NCT03282123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101921294|NCT03282123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101921295|NCT03282123|Adrenergic Agents|adrenergic agents|mesh-ancestor
101921296|NCT03245437|Oxytocin|oxytocin|mesh-list
101921297|NCT03245437|Oxytocics|oxytocics|mesh-ancestor
101921298|NCT03245437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101921299|NCT03245437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921300|NCT03229057|Metformin|metformin|mesh-list
101921301|NCT03229057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101921302|NCT03229057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921303|NCT03217643|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101921304|NCT03217643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101921305|NCT03217643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101921306|NCT03217643|Immunotoxins|immunotoxins|mesh-ancestor
101921307|NCT03217643|Immunoconjugates|immunoconjugates|mesh-ancestor
101921308|NCT03217643|Immunologic Factors|immunologic factors|mesh-ancestor
101921309|NCT03217643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921310|NCT03207529|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
101921311|NCT03207529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101921312|NCT03207529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921313|NCT03181763|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
101921314|NCT03181763|Hallucinogens|hallucinogens|mesh-ancestor
101921315|NCT03181763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921316|NCT03181763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101921317|NCT03181763|Serotonin Agents|serotonin agents|mesh-ancestor
101921318|NCT03181763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101921319|NCT03181763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921320|NCT03181763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101921321|NCT03181763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101921322|NCT03181763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101921323|NCT03181763|Adrenergic Agents|adrenergic agents|mesh-ancestor
101921324|NCT03175432|Bevacizumab|bevacizumab|mesh-list
101921325|NCT03175432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101921327|NCT03175432|Endothelial Growth Factors|endothelial growth factors|mesh-list
101921328|NCT03175432|Antibodies|antibodies|mesh-list
101921329|NCT03175432|Immunoglobulins|immunoglobulins|mesh-list
101921330|NCT03175432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101921331|NCT03175432|Immunoglobulin G|immunoglobulin g|mesh-list
101921332|NCT03175432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101921333|NCT03175432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101921334|NCT03175432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101921335|NCT03175432|Growth Substances|growth substances|mesh-ancestor
101921336|NCT03175432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921337|NCT03175432|Growth Inhibitors|growth inhibitors|mesh-ancestor
101921338|NCT03175432|Immunologic Factors|immunologic factors|mesh-ancestor
101921339|NCT03175432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101921340|NCT03175432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921341|NCT03092323|Pembrolizumab|pembrolizumab|mesh-list
101921342|NCT03092323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101921343|NCT03092323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101921344|NCT03092323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101921345|NCT03092323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921346|NCT03006432|Leucovorin|leucovorin|mesh-list
101921347|NCT03006432|Folic Acid|folic acid|mesh-list
101921348|NCT03006432|Docetaxel|docetaxel|mesh-list
101921349|NCT03006432|Fluorouracil|fluorouracil|mesh-list
101921350|NCT03006432|Oxaliplatin|oxaliplatin|mesh-list
101921351|NCT03006432|Levoleucovorin|levoleucovorin|mesh-list
101921352|NCT03006432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101921353|NCT03006432|Tubulin Modulators|tubulin modulators|mesh-ancestor
101230512|NCT05049278|Phenylephrine|phenylephrine|mesh-list
101921354|NCT03006432|Antimitotic Agents|antimitotic agents|mesh-ancestor
101921355|NCT03006432|Mitosis Modulators|mitosis modulators|mesh-ancestor
101921356|NCT03006432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921357|NCT03006432|Antimetabolites|antimetabolites|mesh-ancestor
101921358|NCT03006432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101921359|NCT03006432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101921360|NCT03006432|Immunologic Factors|immunologic factors|mesh-ancestor
101921361|NCT03006432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921362|NCT03006432|Antidotes|antidotes|mesh-ancestor
101921363|NCT03006432|Protective Agents|protective agents|mesh-ancestor
101921364|NCT03006432|Vitamin B Complex|vitamin b complex|mesh-ancestor
101921365|NCT03006432|Vitamins|vitamins|mesh-ancestor
101921366|NCT03006432|Micronutrients|micronutrients|mesh-ancestor
101921367|NCT03006432|Hematinics|hematinics|mesh-ancestor
101921368|NCT02999022|Lithium Carbonate|lithium carbonate|mesh-list
101921369|NCT02999022|Antidepressive Agents|antidepressive agents|mesh-ancestor
101921370|NCT02999022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101921371|NCT02999022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101921372|NCT02999022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921373|NCT02999022|Antimanic Agents|antimanic agents|mesh-ancestor
101921374|NCT02999022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101921375|NCT02999022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101921376|NCT02999022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921377|NCT02759185|Dronabinol|dronabinol|mesh-list
101921378|NCT02759185|Cannabidiol|cannabidiol|mesh-list
101921379|NCT02759185|Anticonvulsants|anticonvulsants|mesh-ancestor
101921380|NCT02759185|Hallucinogens|hallucinogens|mesh-ancestor
101921381|NCT02759185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921382|NCT02759185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101921383|NCT02759185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101921384|NCT02759185|Analgesics|analgesics|mesh-ancestor
101921385|NCT02759185|Sensory System Agents|sensory system agents|mesh-ancestor
101921386|NCT02759185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101641249|NCT03881917|Cystatins|cystatins|mesh-list
101921387|NCT02759185|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101921388|NCT02759185|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101921389|NCT02759185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101921390|NCT02759185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921392|NCT02759185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101921393|NCT02619253|Pembrolizumab|pembrolizumab|mesh-list
101921394|NCT02619253|Vorinostat|vorinostat|mesh-list
101921395|NCT02619253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101921396|NCT02619253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101921397|NCT02619253|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101921398|NCT02619253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921399|NCT02619253|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101283871|NCT01916954|Artemether|artemether|mesh-list
101921400|NCT02619253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101921402|NCT02584478|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101921403|NCT02584478|Carboplatin|carboplatin|mesh-list
101921404|NCT02584478|Doxorubicin|doxorubicin|mesh-list
101921405|NCT02584478|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101921406|NCT02584478|Topotecan|topotecan|mesh-list
101921407|NCT02584478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101921408|NCT02584478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101921409|NCT02584478|Tubulin Modulators|tubulin modulators|mesh-ancestor
101921410|NCT02584478|Antimitotic Agents|antimitotic agents|mesh-ancestor
101921411|NCT02584478|Mitosis Modulators|mitosis modulators|mesh-ancestor
101921412|NCT02584478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921413|NCT02584478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101921414|NCT02584478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101921415|NCT02584478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101921416|NCT02584478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101921417|NCT02584478|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101921418|NCT02502786|Antibodies|antibodies|mesh-list
101921419|NCT02502786|Immunologic Factors|immunologic factors|mesh-ancestor
101921420|NCT02502786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921421|NCT02436993|Paclitaxel|paclitaxel|mesh-list
101921422|NCT02436993|Bevacizumab|bevacizumab|mesh-list
101921423|NCT02436993|Carboplatin|carboplatin|mesh-list
101921424|NCT02436993|Trastuzumab|trastuzumab|mesh-list
101921425|NCT02436993|Pertuzumab|pertuzumab|mesh-list
101921426|NCT02436993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101921427|NCT02436993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101921428|NCT02436993|Tubulin Modulators|tubulin modulators|mesh-ancestor
101921429|NCT02436993|Antimitotic Agents|antimitotic agents|mesh-ancestor
101921430|NCT02436993|Mitosis Modulators|mitosis modulators|mesh-ancestor
101921431|NCT02436993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921432|NCT02436993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101921492|NCT02102802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101921493|NCT02102802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101921494|NCT02102802|Adrenergic Agents|adrenergic agents|mesh-ancestor
101921495|NCT02011971|Vinpocetine|vinpocetine|mesh-list
101957729|NCT02111122|Sodium Oxybate|sodium oxybate|mesh-list
101921496|NCT02011971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101921498|NCT02011971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921499|NCT02011971|Vasodilator Agents|vasodilator agents|mesh-ancestor
101921500|NCT02011971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101921501|NCT02011971|Protective Agents|protective agents|mesh-ancestor
101921502|NCT02011971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921503|NCT02011971|Nootropic Agents|nootropic agents|mesh-ancestor
101921504|NCT02008396|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
101921505|NCT02008396|Hallucinogens|hallucinogens|mesh-ancestor
101921506|NCT02008396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921507|NCT02008396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101921508|NCT02008396|Serotonin Agents|serotonin agents|mesh-ancestor
101921509|NCT02008396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101921510|NCT02008396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921511|NCT02008396|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101921512|NCT02008396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101921513|NCT02008396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101921514|NCT02008396|Adrenergic Agents|adrenergic agents|mesh-ancestor
101921515|NCT01951339|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101921516|NCT01951339|Glimepiride|glimepiride|mesh-list
101921517|NCT01951339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101921518|NCT01951339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921519|NCT01951339|Incretins|incretins|mesh-ancestor
101921520|NCT01951339|Hormones|hormones|mesh-ancestor
101921521|NCT01951339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101921522|NCT01951339|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101921523|NCT01951339|Protease Inhibitors|protease inhibitors|mesh-ancestor
101921524|NCT01951339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101921525|NCT01951339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921526|NCT01951339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101921527|NCT01951339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101921528|NCT01951339|Immunologic Factors|immunologic factors|mesh-ancestor
101921529|NCT01856478|Methotrexate|methotrexate|mesh-list
101921530|NCT01856478|Afatinib|afatinib|mesh-list
101921531|NCT01856478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101921532|NCT01856478|Abortifacient Agents|abortifacient agents|mesh-ancestor
101921533|NCT01856478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101921534|NCT01856478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921535|NCT01856478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101921536|NCT01856478|Antimetabolites|antimetabolites|mesh-ancestor
101641387|NCT00948428|Imiquimod|imiquimod|mesh-list
101921537|NCT01856478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921538|NCT01856478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101921539|NCT01856478|Dermatologic Agents|dermatologic agents|mesh-ancestor
101921540|NCT01856478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101921541|NCT01856478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101921542|NCT01856478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101921543|NCT01856478|Immunologic Factors|immunologic factors|mesh-ancestor
101921544|NCT01856478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101616986|NCT02840175|Adalimumab|adalimumab|mesh-list
101921545|NCT01856478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101921546|NCT01856478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101921548|NCT01853826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101921549|NCT01853826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101921550|NCT01853826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101921551|NCT01853826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921552|NCT01844518|Abatacept|abatacept|mesh-list
101921553|NCT01844518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101921554|NCT01844518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921555|NCT01844518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101921556|NCT01844518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101921557|NCT01844518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101921558|NCT01844518|Immunologic Factors|immunologic factors|mesh-ancestor
101921559|NCT01844518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921560|NCT01844518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101921561|NCT01835041|Leucovorin|leucovorin|mesh-list
101921562|NCT01835041|Thioctic Acid|thioctic acid|mesh-list
101921563|NCT01835041|Fluorouracil|fluorouracil|mesh-list
101921564|NCT01835041|Oxaliplatin|oxaliplatin|mesh-list
101921565|NCT01835041|Irinotecan|irinotecan|mesh-list
101921566|NCT01835041|Calcium|calcium|mesh-list
101921567|NCT01835041|Levoleucovorin|levoleucovorin|mesh-list
101921568|NCT01835041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101921569|NCT01835041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921570|NCT01835041|Antimetabolites|antimetabolites|mesh-ancestor
101921571|NCT01835041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921572|NCT01835041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101921573|NCT01835041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101921574|NCT01835041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101921575|NCT01835041|Immunologic Factors|immunologic factors|mesh-ancestor
101921576|NCT01835041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101921577|NCT01835041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101921578|NCT01835041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101921579|NCT01835041|Antidotes|antidotes|mesh-ancestor
101921580|NCT01835041|Protective Agents|protective agents|mesh-ancestor
101921581|NCT01835041|Vitamin B Complex|vitamin b complex|mesh-ancestor
101921583|NCT01835041|Micronutrients|micronutrients|mesh-ancestor
101921584|NCT01835041|Antioxidants|antioxidants|mesh-ancestor
101921585|NCT01833572|Gefitinib|gefitinib|mesh-list
101921586|NCT01833572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101921587|NCT01833572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101921588|NCT01833572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101921589|NCT01833572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921590|NCT01793610|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
101921591|NCT01793610|Hallucinogens|hallucinogens|mesh-ancestor
101921592|NCT01793610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921593|NCT01793610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101921594|NCT01793610|Serotonin Agents|serotonin agents|mesh-ancestor
101921595|NCT01793610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101921596|NCT01793610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921597|NCT01793610|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101921598|NCT01793610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101921599|NCT01793610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101921600|NCT01793610|Adrenergic Agents|adrenergic agents|mesh-ancestor
101921601|NCT01639690|Busulfan|busulfan|mesh-list
101921602|NCT01639690|Alkylating Agents|alkylating agents|mesh-ancestor
101921603|NCT01639690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921604|NCT01639690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101921605|NCT01639690|Immunologic Factors|immunologic factors|mesh-ancestor
101921606|NCT01639690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921607|NCT01639690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101921608|NCT01639690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101921609|NCT01639690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101921610|NCT01591577|Temozolomide|temozolomide|mesh-list
101921611|NCT01591577|Lapatinib|lapatinib|mesh-list
101921612|NCT01591577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101921613|NCT01591577|Alkylating Agents|alkylating agents|mesh-ancestor
101921614|NCT01591577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101957751|NCT05431322|Analgesics|analgesics|mesh-ancestor
101921615|NCT01591577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101921616|NCT01591577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101921617|NCT01591577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101921619|NCT01509586|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101921620|NCT01509586|Autonomic Agents|autonomic agents|mesh-ancestor
101921621|NCT01509586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101921622|NCT01509586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921623|NCT01509586|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101921624|NCT01509586|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101921625|NCT01509586|Cholinergic Agents|cholinergic agents|mesh-ancestor
101921626|NCT01509586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101921627|NCT01509586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921628|NCT01509586|Respiratory System Agents|respiratory system agents|mesh-ancestor
101921629|NCT01364584|Exenatide|exenatide|mesh-list
101921630|NCT01364584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101921631|NCT01364584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921632|NCT01364584|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101921633|NCT01364584|Incretins|incretins|mesh-ancestor
101921634|NCT01364584|Hormones|hormones|mesh-ancestor
101921635|NCT01364584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101921636|NCT01163383|Iodine|iodine|mesh-list
101921637|NCT01163383|Cadexomer iodine|cadexomer iodine|mesh-list
101921638|NCT01163383|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
101921639|NCT01163383|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101921640|NCT01163383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101921641|NCT01163383|Trace Elements|trace elements|mesh-ancestor
101921642|NCT01163383|Micronutrients|micronutrients|mesh-ancestor
101921643|NCT01163383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921644|NCT01163383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101921645|NCT01163383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101921646|NCT01163383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921647|NCT01163383|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101921648|NCT01044264|Clindamycin|clindamycin|mesh-list
101921649|NCT01044264|Clindamycin palmitate|clindamycin palmitate|mesh-list
101921650|NCT01044264|Clindamycin phosphate|clindamycin phosphate|mesh-list
101921651|NCT01044264|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101921652|NCT01044264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101921653|NCT01044264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101921654|NCT01044264|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101921655|NCT01044264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101921656|NCT01044264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921657|NCT01044264|Dermatologic Agents|dermatologic agents|mesh-ancestor
101921658|NCT01039584|Butoconazole|butoconazole|mesh-list
101921659|NCT01039584|Antifungal Agents|antifungal agents|mesh-ancestor
101921660|NCT01039584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101921661|NCT00979693|Psilocybin|psilocybin|mesh-list
101921662|NCT00979693|Hallucinogens|hallucinogens|mesh-ancestor
101921663|NCT00979693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921664|NCT00979693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101921665|NCT00920387|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
101921666|NCT00920387|Hallucinogens|hallucinogens|mesh-ancestor
101921667|NCT00920387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921668|NCT00920387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101921669|NCT00920387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101921670|NCT00920387|Serotonin Agents|serotonin agents|mesh-ancestor
101921671|NCT00920387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101921672|NCT00920387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921673|NCT00920387|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101921674|NCT00786019|Vitamins|vitamins|mesh-list
101921675|NCT00786019|Ascorbic Acid|ascorbic acid|mesh-list
101921676|NCT00786019|Micronutrients|micronutrients|mesh-ancestor
101921677|NCT00786019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921678|NCT00786019|Antioxidants|antioxidants|mesh-ancestor
101921679|NCT00786019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921680|NCT00786019|Protective Agents|protective agents|mesh-ancestor
101921681|NCT00692484|Chlorhexidine|chlorhexidine|mesh-list
101921682|NCT00692484|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101921683|NCT00692484|Povidone-Iodine|povidone-iodine|mesh-list
101921684|NCT00692484|Povidone|povidone|mesh-list
101921685|NCT00692484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101921686|NCT00692484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101921687|NCT00692484|Disinfectants|disinfectants|mesh-ancestor
101921688|NCT00692484|Dermatologic Agents|dermatologic agents|mesh-ancestor
101921689|NCT00692484|Plasma Substitutes|plasma substitutes|mesh-ancestor
101921690|NCT00692484|Blood Substitutes|blood substitutes|mesh-ancestor
101921691|NCT00679783|Olaparib|olaparib|mesh-list
101921692|NCT00679783|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101921693|NCT00679783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101921694|NCT00679783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921695|NCT00679783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101921696|NCT00152698|Irbesartan|irbesartan|mesh-list
101921697|NCT00152698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101921698|NCT00152698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101921699|NCT00152698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101921700|NCT00152698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921701|NCT01257516|Pregabalin|pregabalin|mesh-list
101921702|NCT01257516|Analgesics|analgesics|mesh-ancestor
101921703|NCT01257516|Sensory System Agents|sensory system agents|mesh-ancestor
101921704|NCT01257516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101921705|NCT01257516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921706|NCT01257516|Anticonvulsants|anticonvulsants|mesh-ancestor
101921707|NCT01257516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101921708|NCT01257516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101921709|NCT01257516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921710|NCT01257516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101921711|NCT01257516|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101921712|NCT01257516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101921713|NCT01257516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101921714|NCT01257516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101921715|NCT01149954|Ibuprofen|ibuprofen|mesh-list
101921716|NCT01149954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101921717|NCT01149954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101921718|NCT01149954|Analgesics|analgesics|mesh-ancestor
101921719|NCT01149954|Sensory System Agents|sensory system agents|mesh-ancestor
101921720|NCT01149954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101921721|NCT01149954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921722|NCT01149954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101921723|NCT01149954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101921724|NCT01149954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101921725|NCT01149954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101921726|NCT01149954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921727|NCT03899610|Durvalumab|durvalumab|mesh-list
101921728|NCT03899610|Tremelimumab|tremelimumab|mesh-list
101921729|NCT03899610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101921730|NCT03899610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101921731|NCT02527668|Vitamin D|vitamin d|mesh-list
101921732|NCT02527668|Cholecalciferol|cholecalciferol|mesh-list
101921733|NCT02527668|Calcifediol|calcifediol|mesh-list
101921734|NCT02527668|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
101921735|NCT02527668|Vitamins|vitamins|mesh-ancestor
101921736|NCT02527668|Micronutrients|micronutrients|mesh-ancestor
101921737|NCT02527668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921738|NCT02527668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101921739|NCT02527668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101921740|NCT03896646|Iminodiacetic acid|iminodiacetic acid|mesh-list
101921741|NCT03896646|Chelating Agents|chelating agents|mesh-ancestor
101921742|NCT03896646|Sequestering Agents|sequestering agents|mesh-ancestor
101921743|NCT03896646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921744|NCT03896256|Ketamine|ketamine|mesh-list
101921745|NCT03896256|Analgesics|analgesics|mesh-ancestor
101921746|NCT03896256|Sensory System Agents|sensory system agents|mesh-ancestor
101921747|NCT03896256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101921748|NCT03896256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921749|NCT03896256|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101921750|NCT03896256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101921751|NCT03896256|Anesthetics, General|anesthetics, general|mesh-ancestor
101921752|NCT03896256|Anesthetics|anesthetics|mesh-ancestor
101921753|NCT03896256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101921754|NCT03896256|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101921755|NCT03896256|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101921756|NCT03896256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101921757|NCT03896256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921758|NCT03893136|Leflunomide|leflunomide|mesh-list
101921759|NCT03893136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101921760|NCT03893136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921761|NCT03893136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101921762|NCT03893136|Immunologic Factors|immunologic factors|mesh-ancestor
101921763|NCT03893136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921764|NCT01258530|Oseltamivir|oseltamivir|mesh-list
101921765|NCT01258530|Antiviral Agents|antiviral agents|mesh-ancestor
101921766|NCT01258530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101921767|NCT01258530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101921768|NCT01258530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921770|NCT01255410|Immunologic Factors|immunologic factors|mesh-ancestor
101921771|NCT01255410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921772|NCT01150110|Salicylic Acid|salicylic acid|mesh-list
101921773|NCT01150110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101921774|NCT01150110|Antifungal Agents|antifungal agents|mesh-ancestor
101921775|NCT01150110|Keratolytic Agents|keratolytic agents|mesh-ancestor
101921776|NCT01150110|Dermatologic Agents|dermatologic agents|mesh-ancestor
101921777|NCT01257672|Ondansetron|ondansetron|mesh-list
101921778|NCT01257672|Domperidone|domperidone|mesh-list
101921779|NCT01257672|Antiemetics|antiemetics|mesh-ancestor
101921780|NCT01257672|Autonomic Agents|autonomic agents|mesh-ancestor
101921781|NCT01257672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101921782|NCT01257672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921783|NCT01257672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101921784|NCT01257672|Antipruritics|antipruritics|mesh-ancestor
101921785|NCT01257672|Dermatologic Agents|dermatologic agents|mesh-ancestor
101921786|NCT01257672|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101921787|NCT01257672|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101921788|NCT01257672|Serotonin Agents|serotonin agents|mesh-ancestor
101921789|NCT01257672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101921790|NCT01257672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921791|NCT01257672|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101921792|NCT01257672|Dopamine Agents|dopamine agents|mesh-ancestor
101921793|NCT01258686|Silymarin|silymarin|mesh-list
101921794|NCT01258686|Antioxidants|antioxidants|mesh-ancestor
101921795|NCT01258686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921796|NCT01258686|Protective Agents|protective agents|mesh-ancestor
101921797|NCT01258686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921798|NCT01258764|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101921799|NCT01258764|Lisinopril|lisinopril|mesh-list
101921800|NCT01258764|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101921801|NCT01258764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101921802|NCT01258764|Diuretics|diuretics|mesh-ancestor
101921803|NCT01258764|Natriuretic Agents|natriuretic agents|mesh-ancestor
101921804|NCT01258764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921805|NCT01258764|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101921806|NCT01258764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101921807|NCT01258764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921808|NCT01258764|Protease Inhibitors|protease inhibitors|mesh-ancestor
101921809|NCT01258764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101921810|NCT01258764|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101921811|NCT01258764|Protective Agents|protective agents|mesh-ancestor
101921812|NCT03895788|Niraparib|niraparib|mesh-list
101921813|NCT03895788|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101921814|NCT03895788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101921815|NCT03895788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921816|NCT03895788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101921817|NCT01257828|Riluzole|riluzole|mesh-list
101921818|NCT01257828|Anticonvulsants|anticonvulsants|mesh-ancestor
101921819|NCT01257828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101921820|NCT01257828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101921821|NCT01257828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101921822|NCT01257828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921823|NCT01257828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921824|NCT01257828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101921825|NCT01257828|Protective Agents|protective agents|mesh-ancestor
101921826|NCT03899142|Immunoglobulins|immunoglobulins|mesh-list
101921827|NCT03899142|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101921828|NCT03899142|Antibodies|antibodies|mesh-list
101921829|NCT03899142|Immunologic Factors|immunologic factors|mesh-ancestor
101921830|NCT03899142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921832|NCT03892902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101921833|NCT03892902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101921834|NCT03892902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921835|NCT03892668|Tranexamic Acid|tranexamic acid|mesh-list
101921836|NCT03892668|Oxytocin|oxytocin|mesh-list
101921837|NCT03892668|Oxytocics|oxytocics|mesh-ancestor
101641691|NCT02593474|Naltrexone|naltrexone|mesh-list
101921838|NCT03892668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101921839|NCT03892668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921840|NCT03892668|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101921841|NCT03892668|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101921842|NCT03892668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921845|NCT01258920|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101921846|NCT01258920|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101921847|NCT01258920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101921848|NCT01258920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101921849|NCT01258920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921850|NCT01258920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101921851|NCT01258920|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101921852|NCT01258920|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101921853|NCT01258920|Serotonin Agents|serotonin agents|mesh-ancestor
101921854|NCT01258920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101921855|NCT01258920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921856|NCT01258920|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101921857|NCT01258920|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101921858|NCT01258920|Dopamine Agents|dopamine agents|mesh-ancestor
101921859|NCT03898752|Coenzyme Q10|coenzyme q10|mesh-list
101921860|NCT03898752|Vitamins|vitamins|mesh-ancestor
101921861|NCT03898752|Micronutrients|micronutrients|mesh-ancestor
101921862|NCT03898752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921863|NCT01255644|Valganciclovir|valganciclovir|mesh-list
101921864|NCT01255644|Antiviral Agents|antiviral agents|mesh-ancestor
101921865|NCT01255644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101921866|NCT01255800|Cetuximab|cetuximab|mesh-list
101921867|NCT01255800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101921868|NCT01255800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101921869|NCT01257906|Tretinoin|tretinoin|mesh-list
101921870|NCT01257906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101921871|NCT01257906|Keratolytic Agents|keratolytic agents|mesh-ancestor
101921872|NCT01257906|Dermatologic Agents|dermatologic agents|mesh-ancestor
101921873|NCT03892512|Dexmedetomidine|dexmedetomidine|mesh-list
101921874|NCT03892512|Esmolol|esmolol|mesh-list
101921875|NCT03892512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101921876|NCT03892512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101921877|NCT03892512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921878|NCT03892512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101921879|NCT03892512|Analgesics|analgesics|mesh-ancestor
101921880|NCT03892512|Sensory System Agents|sensory system agents|mesh-ancestor
101921881|NCT03892512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101921882|NCT03892512|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101921883|NCT03892512|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101921884|NCT03892512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101921885|NCT03892512|Adrenergic Agents|adrenergic agents|mesh-ancestor
101921886|NCT03892512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101921887|NCT03892512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921888|NCT03892512|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101921889|NCT03892512|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101921890|NCT03892512|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101921891|NCT01255878|Gabapentin|gabapentin|mesh-list
101921892|NCT01255878|Analgesics|analgesics|mesh-ancestor
101921893|NCT01255878|Sensory System Agents|sensory system agents|mesh-ancestor
101921894|NCT01255878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101921895|NCT01255878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921896|NCT01255878|Anticonvulsants|anticonvulsants|mesh-ancestor
101921897|NCT01255878|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101921898|NCT01255878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101921899|NCT01255878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101921900|NCT01255878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101957783|NCT03230864|Olanzapine|olanzapine|mesh-list
101921901|NCT01255878|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101921902|NCT01255878|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101921903|NCT01255878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101921904|NCT01255878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921905|NCT01255878|Antimanic Agents|antimanic agents|mesh-ancestor
101921906|NCT01255956|Sirolimus|sirolimus|mesh-list
101921907|NCT01255956|Paclitaxel|paclitaxel|mesh-list
101921908|NCT01255956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101921909|NCT01255956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101921910|NCT01255956|Tubulin Modulators|tubulin modulators|mesh-ancestor
101921911|NCT01255956|Antimitotic Agents|antimitotic agents|mesh-ancestor
101921912|NCT01255956|Mitosis Modulators|mitosis modulators|mesh-ancestor
101921913|NCT01255956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921914|NCT01255956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101921915|NCT01255956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101921916|NCT01255956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101921918|NCT01255956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101921919|NCT01255956|Immunologic Factors|immunologic factors|mesh-ancestor
101921920|NCT01255956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230607|NCT04895592|Ichthammol|ichthammol|mesh-list
101921921|NCT03892434|Dexamethasone|dexamethasone|mesh-list
101921922|NCT03892434|Dexamethasone acetate|dexamethasone acetate|mesh-list
101921923|NCT03892434|Bevacizumab|bevacizumab|mesh-list
101921924|NCT03892434|BB 1101|bb 1101|mesh-list
101921925|NCT03892434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101921926|NCT03892434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101921927|NCT03892434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101921928|NCT03892434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101921929|NCT03892434|Growth Substances|growth substances|mesh-ancestor
101921930|NCT03892434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921931|NCT03892434|Growth Inhibitors|growth inhibitors|mesh-ancestor
101921932|NCT03892434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101921933|NCT03892434|Antiemetics|antiemetics|mesh-ancestor
101921934|NCT03892434|Autonomic Agents|autonomic agents|mesh-ancestor
101921935|NCT03892434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101921936|NCT03892434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101921937|NCT03892434|Glucocorticoids|glucocorticoids|mesh-ancestor
101921938|NCT03892434|Hormones|hormones|mesh-ancestor
101921939|NCT03892434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101921940|NCT03892434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101921941|NCT03892434|Protease Inhibitors|protease inhibitors|mesh-ancestor
101921942|NCT03892434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101921943|NCT03892434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921944|NCT03889626|Capecitabine|capecitabine|mesh-list
101921945|NCT03889626|Apatinib|apatinib|mesh-list
101921946|NCT03889626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101921947|NCT03889626|Antimetabolites|antimetabolites|mesh-ancestor
101921948|NCT03889626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921949|NCT03889626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101921950|NCT03889626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101921951|NCT03889626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101921952|NCT03892122|Dexmedetomidine|dexmedetomidine|mesh-list
101921953|NCT03892122|Propofol|propofol|mesh-list
101921954|NCT03892122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101921955|NCT03892122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101921956|NCT03892122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921957|NCT03892122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101921958|NCT03892122|Analgesics|analgesics|mesh-ancestor
101921959|NCT03892122|Sensory System Agents|sensory system agents|mesh-ancestor
101921960|NCT03892122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101921961|NCT03892122|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101921962|NCT03892122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101921963|NCT03892122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101921964|NCT03892122|Adrenergic Agents|adrenergic agents|mesh-ancestor
101921965|NCT03892122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101921966|NCT03892122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101921967|NCT03892122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101921968|NCT03892122|Anesthetics, General|anesthetics, general|mesh-ancestor
101921969|NCT03892122|Anesthetics|anesthetics|mesh-ancestor
101921970|NCT01589562|Megestrol|megestrol|mesh-list
101921971|NCT01589562|Megestrol Acetate|megestrol acetate|mesh-list
101957786|NCT03230864|Serotonin Agents|serotonin agents|mesh-ancestor
101921972|NCT01589562|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101921973|NCT01589562|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101921974|NCT01589562|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101921975|NCT01589562|Contraceptive Agents|contraceptive agents|mesh-ancestor
101921976|NCT01589562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101921977|NCT01589562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921978|NCT01589562|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101921979|NCT01589562|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101921980|NCT01589562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101921981|NCT01589562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101921982|NCT01589562|Appetite Stimulants|appetite stimulants|mesh-ancestor
101921983|NCT01589562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101921985|NCT01152372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101641845|NCT00749359|Paroxetine|paroxetine|mesh-list
101921986|NCT01152372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921987|NCT01589640|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101921988|NCT01589640|Lubricant Eye Drops|lubricant eye drops|mesh-list
101921989|NCT01589640|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101921991|NCT01259934|Interferon-alpha|interferon-alpha|mesh-list
101921993|NCT01259934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101921994|NCT01259934|Antiviral Agents|antiviral agents|mesh-ancestor
101921995|NCT01259934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101921996|NCT01259934|Immunologic Factors|immunologic factors|mesh-ancestor
101921997|NCT01259934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101921998|NCT01153386|Treprostinil|treprostinil|mesh-list
101921999|NCT01153386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101922000|NCT01260012|Praziquantel|praziquantel|mesh-list
101922001|NCT01260012|Antioxidants|antioxidants|mesh-list
101922002|NCT01260012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922003|NCT01260012|Protective Agents|protective agents|mesh-ancestor
101922004|NCT01260012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922005|NCT01260012|Anthelmintics|anthelmintics|mesh-ancestor
101922006|NCT01260012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101922007|NCT01260012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101922008|NCT03888924|Vaccines|vaccines|mesh-list
101922009|NCT03888924|BCG Vaccine|bcg vaccine|mesh-list
101922010|NCT03888924|Immunologic Factors|immunologic factors|mesh-ancestor
101922011|NCT03888924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922012|NCT03888924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101922013|NCT01151592|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101922014|NCT01151592|Hematinics|hematinics|mesh-ancestor
101922015|NCT01151670|Pioglitazone|pioglitazone|mesh-list
101922016|NCT01151670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101922017|NCT01151670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922018|NCT03888846|Colchicine|colchicine|mesh-list
101922019|NCT03888846|Pentoxifylline|pentoxifylline|mesh-list
101922020|NCT03888846|Gout Suppressants|gout suppressants|mesh-ancestor
101922021|NCT03888846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101922022|NCT03888846|Tubulin Modulators|tubulin modulators|mesh-ancestor
101922023|NCT03888846|Antimitotic Agents|antimitotic agents|mesh-ancestor
101922024|NCT03888846|Mitosis Modulators|mitosis modulators|mesh-ancestor
101922025|NCT03888846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922026|NCT03888846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101922027|NCT03888846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101922028|NCT03888846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101922029|NCT03888846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101922030|NCT03888846|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101922031|NCT03888846|Protective Agents|protective agents|mesh-ancestor
101922032|NCT03888846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922033|NCT03888846|Vasodilator Agents|vasodilator agents|mesh-ancestor
101922034|NCT03888846|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101922035|NCT03888846|Antioxidants|antioxidants|mesh-ancestor
101922036|NCT03891420|Galidesivir|galidesivir|mesh-list
101922037|NCT03891420|Antiviral Agents|antiviral agents|mesh-ancestor
101922038|NCT03891420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101922039|NCT01153542|Ivacaftor|ivacaftor|mesh-list
101922040|NCT01153542|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101922041|NCT01153542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101922042|NCT01153542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922043|NCT01152606|Trastuzumab|trastuzumab|mesh-list
101922044|NCT01152606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101922045|NCT01152606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101922046|NCT01153854|Racecadotril|racecadotril|mesh-list
101922047|NCT01153854|Antidiarrheals|antidiarrheals|mesh-ancestor
101922048|NCT01153854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101922049|NCT01153854|Protease Inhibitors|protease inhibitors|mesh-ancestor
101922050|NCT01153854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101922051|NCT01153854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922052|NCT01260246|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101230629|NCT04843761|Remdesivir|remdesivir|mesh-list
101922053|NCT01260246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101922054|NCT01260246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922055|NCT01260246|Incretins|incretins|mesh-ancestor
101922056|NCT01260246|Hormones|hormones|mesh-ancestor
101922057|NCT01260246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101922058|NCT01260246|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101922059|NCT01260246|Protease Inhibitors|protease inhibitors|mesh-ancestor
101922060|NCT01260246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101922061|NCT01260246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922062|NCT03888534|Ixazomib|ixazomib|mesh-list
101922063|NCT03888534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101922064|NCT03888534|Protease Inhibitors|protease inhibitors|mesh-ancestor
101922065|NCT03888534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101922066|NCT03888534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922068|NCT03885804|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101922069|NCT03885804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101922070|NCT03885804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922071|NCT03885804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101922072|NCT03885804|Analgesics|analgesics|mesh-ancestor
101922073|NCT03885804|Sensory System Agents|sensory system agents|mesh-ancestor
101922074|NCT03885804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101922075|NCT03885804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101922076|NCT03885804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101922077|NCT03885804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101922078|NCT03885804|Adrenergic Agents|adrenergic agents|mesh-ancestor
101922079|NCT03885804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101922080|NCT03885804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922081|NCT03885258|Melatonin|melatonin|mesh-list
101922082|NCT03885258|Antioxidants|antioxidants|mesh-ancestor
101922083|NCT03885258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922084|NCT03885258|Protective Agents|protective agents|mesh-ancestor
101922085|NCT03885258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922086|NCT03885258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101922087|NCT01262196|Chrysarobin|chrysarobin|mesh-list
101922088|NCT01262196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101922089|NCT01262196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101922090|NCT01262196|Analgesics|analgesics|mesh-ancestor
101922091|NCT01262196|Sensory System Agents|sensory system agents|mesh-ancestor
101922092|NCT01262196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101922093|NCT01262196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922094|NCT01262196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101922095|NCT01262196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101922096|NCT03885180|Warfarin|warfarin|mesh-list
101922097|NCT03885180|Anticoagulants|anticoagulants|mesh-ancestor
101922098|NCT03888144|Ketorolac|ketorolac|mesh-list
101922099|NCT03888144|Oxycodone|oxycodone|mesh-list
101922100|NCT03888144|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101922101|NCT03888144|Narcotics|narcotics|mesh-ancestor
101922102|NCT03888144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101922103|NCT03888144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922104|NCT03888144|Analgesics|analgesics|mesh-ancestor
101922105|NCT03888144|Sensory System Agents|sensory system agents|mesh-ancestor
101922106|NCT03888144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101922107|NCT03888144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101922108|NCT03888144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101922109|NCT03888144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101922110|NCT03888144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101922111|NCT03888144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101922112|NCT03888144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101957791|NCT03230864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101922113|NCT03888144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922115|NCT03890406|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101922116|NCT03890406|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101922117|NCT03890406|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101922118|NCT03890406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101922119|NCT03890406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922120|NCT01154400|Caseins|caseins|mesh-list
101922121|NCT01154400|Chelating Agents|chelating agents|mesh-ancestor
101922122|NCT01154400|Sequestering Agents|sequestering agents|mesh-ancestor
101922123|NCT01154400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922124|NCT01152840|Everolimus|everolimus|mesh-list
101922125|NCT01152840|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101922126|NCT01152840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101922127|NCT01152840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101922128|NCT01152840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922129|NCT01152840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101922130|NCT01152840|Immunologic Factors|immunologic factors|mesh-ancestor
101922131|NCT01152840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922132|NCT01152840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101922133|NCT01262274|Anastrozole|anastrozole|mesh-list
101922134|NCT01262274|Tegafur|tegafur|mesh-list
101922135|NCT01262274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101922136|NCT01262274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101642001|NCT00736450|Glucocorticoids|glucocorticoids|mesh-ancestor
101922137|NCT01262274|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101922138|NCT01262274|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101922139|NCT01262274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101922140|NCT01262274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922141|NCT01262274|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101922142|NCT01262274|Hormone Antagonists|hormone antagonists|mesh-ancestor
101922143|NCT01262274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101922144|NCT01262274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922145|NCT01262274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101922146|NCT01262274|Antimetabolites|antimetabolites|mesh-ancestor
101922148|NCT01260558|Temsirolimus|temsirolimus|mesh-list
101922149|NCT01260558|MTOR Inhibitors|mtor inhibitors|mesh-list
101922150|NCT01260558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101922151|NCT01260558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101922152|NCT01260558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101922153|NCT01260558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101922154|NCT01260558|Antifungal Agents|antifungal agents|mesh-ancestor
101922155|NCT01260558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101922156|NCT01260558|Immunologic Factors|immunologic factors|mesh-ancestor
101922157|NCT01260558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922158|NCT01260558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101922159|NCT01260558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101922160|NCT01260558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922161|NCT01260714|Etoposide|etoposide|mesh-list
101922162|NCT01260714|Podophyllotoxin|podophyllotoxin|mesh-list
101922163|NCT01260714|Mitoxantrone|mitoxantrone|mesh-list
101922164|NCT01260714|Azacitidine|azacitidine|mesh-list
101922165|NCT01260714|Etoposide phosphate|etoposide phosphate|mesh-list
101922166|NCT01260714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101922167|NCT01260714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101922168|NCT01260714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101922169|NCT01260714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101922170|NCT01260714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101922171|NCT01260714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922172|NCT01260714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101922173|NCT01260714|Antimetabolites|antimetabolites|mesh-ancestor
101922174|NCT01260714|Analgesics|analgesics|mesh-ancestor
101922175|NCT01260714|Sensory System Agents|sensory system agents|mesh-ancestor
101922176|NCT01260714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101922177|NCT01260714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922178|NCT01260714|Keratolytic Agents|keratolytic agents|mesh-ancestor
101922179|NCT01260714|Dermatologic Agents|dermatologic agents|mesh-ancestor
101922180|NCT01260714|Tubulin Modulators|tubulin modulators|mesh-ancestor
101922181|NCT01260714|Antimitotic Agents|antimitotic agents|mesh-ancestor
101922182|NCT01260714|Mitosis Modulators|mitosis modulators|mesh-ancestor
101922183|NCT03890094|Sufentanil|sufentanil|mesh-list
101922184|NCT03890094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101922185|NCT03890094|Narcotics|narcotics|mesh-ancestor
101922186|NCT03890094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101922187|NCT03890094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922188|NCT03890094|Analgesics|analgesics|mesh-ancestor
101922189|NCT03890094|Sensory System Agents|sensory system agents|mesh-ancestor
101922190|NCT03890094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101922191|NCT03890094|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101922192|NCT03890094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101922193|NCT03890094|Anesthetics, General|anesthetics, general|mesh-ancestor
101922194|NCT03890094|Anesthetics|anesthetics|mesh-ancestor
101922195|NCT03887754|Risperidone|risperidone|mesh-list
101922196|NCT03887754|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101922197|NCT03887754|Serotonin Agents|serotonin agents|mesh-ancestor
101922198|NCT03887754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101922199|NCT03887754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922200|NCT03887754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922201|NCT03887754|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101922202|NCT03887754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101922203|NCT03887754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101922204|NCT03887754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101922205|NCT03887754|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101922206|NCT03887754|Dopamine Agents|dopamine agents|mesh-ancestor
101922207|NCT03889470|Nitroglycerin|nitroglycerin|mesh-list
101922208|NCT03889470|Vasodilator Agents|vasodilator agents|mesh-ancestor
101922209|NCT01262586|Glimepiride|glimepiride|mesh-list
101922210|NCT01262586|Vildagliptin|vildagliptin|mesh-list
101922211|NCT01262586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101922212|NCT01262586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101922213|NCT01262586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922214|NCT01262586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101922215|NCT01262586|Immunologic Factors|immunologic factors|mesh-ancestor
101922216|NCT01262586|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101922217|NCT01262586|Protease Inhibitors|protease inhibitors|mesh-ancestor
101922218|NCT01262586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101922219|NCT01262586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922220|NCT01157052|Capecitabine|capecitabine|mesh-list
101922221|NCT01157052|Oxaliplatin|oxaliplatin|mesh-list
101922223|NCT01157052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101922224|NCT01157052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922225|NCT01157052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101922226|NCT01157052|Antimetabolites|antimetabolites|mesh-ancestor
101922227|NCT01157052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922228|NCT01157052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101922229|NCT03887130|Paclitaxel|paclitaxel|mesh-list
101922230|NCT03887130|Vinorelbine|vinorelbine|mesh-list
101922231|NCT03887130|Docetaxel|docetaxel|mesh-list
101922232|NCT03887130|Gemcitabine|gemcitabine|mesh-list
101922233|NCT03887130|Capecitabine|capecitabine|mesh-list
101922234|NCT03887130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101922235|NCT03887130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101922236|NCT03887130|Tubulin Modulators|tubulin modulators|mesh-ancestor
101922237|NCT03887130|Antimitotic Agents|antimitotic agents|mesh-ancestor
101922238|NCT03887130|Mitosis Modulators|mitosis modulators|mesh-ancestor
101922239|NCT03887130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922240|NCT03887130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101922241|NCT03887130|Antimetabolites|antimetabolites|mesh-ancestor
101922242|NCT01155960|Anastrozole|anastrozole|mesh-list
101922243|NCT01155960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101922244|NCT01155960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101922245|NCT01155960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101922246|NCT01155960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101922247|NCT01155960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101922248|NCT01155960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922249|NCT01155960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101922250|NCT01155960|Hormone Antagonists|hormone antagonists|mesh-ancestor
101922251|NCT01155960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101922252|NCT01155960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922253|NCT03883776|Octreotide|octreotide|mesh-list
101922254|NCT03883776|Al18F-NOTA-octreotide|al18f-nota-octreotide|mesh-list
101922255|NCT03883776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101922256|NCT03883776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101922257|NCT03883776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101922258|NCT03883776|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101922259|NCT03883776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922260|NCT03886896|Lidocaine|lidocaine|mesh-list
101922261|NCT03886896|Anesthetics, Local|anesthetics, local|mesh-ancestor
101922262|NCT03886896|Anesthetics|anesthetics|mesh-ancestor
101922263|NCT03886896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101922264|NCT03886896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922265|NCT03886896|Sensory System Agents|sensory system agents|mesh-ancestor
101922266|NCT03886896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101922267|NCT03886896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101922268|NCT03886896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101922269|NCT03886896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101922270|NCT03886896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101922271|NCT03886896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922272|NCT03881904|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101922273|NCT03881904|Gestodene|gestodene|mesh-list
101922274|NCT03881904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101922275|NCT03881904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101922276|NCT03881904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101922277|NCT03881904|Contraceptive Agents|contraceptive agents|mesh-ancestor
101922278|NCT03881904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101922279|NCT03881904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922280|NCT03881904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101922281|NCT03881904|Estrogens|estrogens|mesh-ancestor
101922282|NCT03881904|Hormones|hormones|mesh-ancestor
101922283|NCT03881904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101922284|NCT03881904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101922285|NCT03881904|Progestins|progestins|mesh-ancestor
101642159|NCT00918034|Talaporfin|talaporfin|mesh-list
101922286|NCT01262742|Carbetocin|carbetocin|mesh-list
101922287|NCT01262742|Oxytocin|oxytocin|mesh-list
101922288|NCT01262742|Oxytocics|oxytocics|mesh-ancestor
101922289|NCT01262742|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101922290|NCT01262742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922291|NCT01261416|Levetiracetam|levetiracetam|mesh-list
101922292|NCT01261416|Anticonvulsants|anticonvulsants|mesh-ancestor
101922293|NCT01261416|Nootropic Agents|nootropic agents|mesh-ancestor
101922294|NCT03617172|Misoprostol|misoprostol|mesh-list
101922295|NCT03617172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101922296|NCT03617172|Abortifacient Agents|abortifacient agents|mesh-ancestor
101922297|NCT03617172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101922298|NCT03617172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922299|NCT03617172|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101922300|NCT03617172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101922301|NCT03617172|Oxytocics|oxytocics|mesh-ancestor
101922302|NCT01154790|Naproxen|naproxen|mesh-list
101922303|NCT01154790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101922304|NCT01154790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101922305|NCT01154790|Analgesics|analgesics|mesh-ancestor
101922306|NCT01154790|Sensory System Agents|sensory system agents|mesh-ancestor
101922307|NCT01154790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101922308|NCT01154790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922309|NCT01154790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101922310|NCT01154790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101922311|NCT01154790|Gout Suppressants|gout suppressants|mesh-ancestor
101922312|NCT01154790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101922313|NCT01154790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101922314|NCT01154790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922315|NCT03883698|Sofosbuvir|sofosbuvir|mesh-list
101922316|NCT03883698|Antiviral Agents|antiviral agents|mesh-ancestor
101922317|NCT03883698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101922318|NCT01263210|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101922319|NCT01263210|Immunologic Factors|immunologic factors|mesh-ancestor
101922320|NCT01263210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922321|NCT01263288|Cholecalciferol|cholecalciferol|mesh-list
101922322|NCT01263288|Vitamin D|vitamin d|mesh-list
101922323|NCT01263288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101922324|NCT01263288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922325|NCT01263288|Vitamins|vitamins|mesh-ancestor
101922326|NCT01263288|Micronutrients|micronutrients|mesh-ancestor
101922327|NCT01263288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101922328|NCT01263834|Bevacizumab|bevacizumab|mesh-list
101922329|NCT01263834|Mitomycins|mitomycins|mesh-list
101922330|NCT01263834|Mitomycin|mitomycin|mesh-list
101922331|NCT01263834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101922332|NCT01263834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101922333|NCT01263834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101922334|NCT01263834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101922335|NCT01263834|Growth Substances|growth substances|mesh-ancestor
101922336|NCT01263834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922337|NCT01263834|Growth Inhibitors|growth inhibitors|mesh-ancestor
101922338|NCT01263834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101922339|NCT01263834|Alkylating Agents|alkylating agents|mesh-ancestor
101922340|NCT01263834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922341|NCT01263834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101922342|NCT01263834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101922343|NCT01263366|Norepinephrine|norepinephrine|mesh-list
101922344|NCT01263366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101922345|NCT01263366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101922346|NCT01263366|Adrenergic Agents|adrenergic agents|mesh-ancestor
101922347|NCT01263366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101922348|NCT01263366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922349|NCT01263366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922350|NCT01263366|Sympathomimetics|sympathomimetics|mesh-ancestor
101922351|NCT01263366|Autonomic Agents|autonomic agents|mesh-ancestor
101922352|NCT01263366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101922353|NCT01263366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101922354|NCT01155102|Anastrozole|anastrozole|mesh-list
101922355|NCT01155102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101922356|NCT01155102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101922357|NCT01155102|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101922358|NCT01155102|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101922359|NCT01155102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101922360|NCT01155102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922361|NCT01155102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101922362|NCT01155102|Hormone Antagonists|hormone antagonists|mesh-ancestor
101922363|NCT01155102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101922364|NCT01155102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922365|NCT01156350|Fludarabine|fludarabine|mesh-list
101922367|NCT01156350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101922368|NCT01156350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922369|NCT01156350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101922370|NCT01156350|Immunologic Factors|immunologic factors|mesh-ancestor
101922371|NCT01156350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922372|NCT01156350|Alkylating Agents|alkylating agents|mesh-ancestor
101922373|NCT01156350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101922374|NCT01156350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101922375|NCT03886662|LB100|lb100|mesh-list
101922376|NCT03886662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101922377|NCT03886662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101922378|NCT03886662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922379|NCT01155258|Sirolimus|sirolimus|mesh-list
101922380|NCT01155258|Vinorelbine|vinorelbine|mesh-list
101922381|NCT01155258|Temsirolimus|temsirolimus|mesh-list
101922382|NCT01155258|MTOR Inhibitors|mtor inhibitors|mesh-list
101922383|NCT01155258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101922384|NCT01155258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101922385|NCT01155258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101922386|NCT01155258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101922387|NCT01155258|Antifungal Agents|antifungal agents|mesh-ancestor
101922388|NCT01155258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101922389|NCT01155258|Immunologic Factors|immunologic factors|mesh-ancestor
101922390|NCT01155258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922391|NCT01155258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101922392|NCT01155258|Tubulin Modulators|tubulin modulators|mesh-ancestor
101922393|NCT01155258|Antimitotic Agents|antimitotic agents|mesh-ancestor
101922394|NCT01155258|Mitosis Modulators|mitosis modulators|mesh-ancestor
101922395|NCT01155258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922396|NCT01155258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101922397|NCT01155258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101922398|NCT01156584|Flucytosine|flucytosine|mesh-list
101922399|NCT01156584|Antifungal Agents|antifungal agents|mesh-ancestor
101922400|NCT01156584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101922401|NCT01156584|Antimetabolites|antimetabolites|mesh-ancestor
101922402|NCT01156584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922403|NCT03879174|Tamoxifen|tamoxifen|mesh-list
101922404|NCT03879174|Pembrolizumab|pembrolizumab|mesh-list
101922405|NCT03879174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101922406|NCT03879174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101922407|NCT03879174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101922408|NCT03879174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922409|NCT03879174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101922410|NCT03879174|Hormone Antagonists|hormone antagonists|mesh-ancestor
101922411|NCT03879174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101922412|NCT03879174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922413|NCT03879174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101922414|NCT03879174|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101922415|NCT03879174|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101922416|NCT03879174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101922417|NCT01159548|Promethazine|promethazine|mesh-list
101922418|NCT01159548|Diphenhydramine|diphenhydramine|mesh-list
101922419|NCT01159548|Antipruritics|antipruritics|mesh-ancestor
101922420|NCT01159548|Dermatologic Agents|dermatologic agents|mesh-ancestor
101922421|NCT01159548|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101922422|NCT01159548|Histamine Antagonists|histamine antagonists|mesh-ancestor
101922423|NCT01159548|Histamine Agents|histamine agents|mesh-ancestor
101922424|NCT01159548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101922425|NCT01159548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922426|NCT01159548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922427|NCT01159548|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101922428|NCT01159548|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101922429|NCT01159548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101922430|NCT01159548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101922431|NCT01159548|Anesthetics, Local|anesthetics, local|mesh-ancestor
101922432|NCT01159548|Anesthetics|anesthetics|mesh-ancestor
101922433|NCT01159548|Sensory System Agents|sensory system agents|mesh-ancestor
101922434|NCT01159548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101922435|NCT01159548|Antiemetics|antiemetics|mesh-ancestor
101922436|NCT01159548|Autonomic Agents|autonomic agents|mesh-ancestor
101922437|NCT01159548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101922438|NCT01156740|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101922439|NCT01156740|Amoxicillin|amoxicillin|mesh-list
101922440|NCT01156740|Penicillins|penicillins|mesh-list
101922441|NCT01156740|beta-Lactams|beta-lactams|mesh-list
101922442|NCT01156740|Penicillin G|penicillin g|mesh-list
101922443|NCT01156740|Penicillin G Benzathine|penicillin g benzathine|mesh-list
101922444|NCT01156740|Penicillin G Procaine|penicillin g procaine|mesh-list
101922445|NCT01156740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101922446|NCT03880968|Etanercept|etanercept|mesh-list
101922447|NCT03880968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101922448|NCT03880968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101922449|NCT03880968|Analgesics|analgesics|mesh-ancestor
101922450|NCT03880968|Sensory System Agents|sensory system agents|mesh-ancestor
101922451|NCT03880968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101922452|NCT03880968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922453|NCT03880968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101922454|NCT03880968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101922455|NCT03880968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101922456|NCT03880968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101922457|NCT03880968|Immunologic Factors|immunologic factors|mesh-ancestor
101922458|NCT03880734|Cholecalciferol|cholecalciferol|mesh-list
101922459|NCT03880734|Vitamin D|vitamin d|mesh-list
101922460|NCT03880734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101922461|NCT03880734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922462|NCT03880734|Vitamins|vitamins|mesh-ancestor
101922463|NCT03880734|Micronutrients|micronutrients|mesh-ancestor
101922464|NCT03880734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101922465|NCT01157754|Levonorgestrel|levonorgestrel|mesh-list
101922466|NCT01157754|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101922467|NCT01157754|Contraceptive Agents|contraceptive agents|mesh-ancestor
101922468|NCT01157754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101922469|NCT01157754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922470|NCT01157754|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101922471|NCT01157754|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101922472|NCT01157754|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101922473|NCT01265940|Vinblastine|vinblastine|mesh-list
101922474|NCT01265940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101922475|NCT01265940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101922476|NCT01265940|Tubulin Modulators|tubulin modulators|mesh-ancestor
101922477|NCT01265940|Antimitotic Agents|antimitotic agents|mesh-ancestor
101922478|NCT01265940|Mitosis Modulators|mitosis modulators|mesh-ancestor
101922479|NCT01265940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922480|NCT01264302|Finasteride|finasteride|mesh-list
101922481|NCT01264302|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101922482|NCT01264302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101922483|NCT01264302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101922484|NCT01264302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922485|NCT01264302|Hormone Antagonists|hormone antagonists|mesh-ancestor
101922486|NCT01264302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101922487|NCT01264302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922488|NCT01264302|Urological Agents|urological agents|mesh-ancestor
101922489|NCT03760146|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101922490|NCT03760146|Immunologic Factors|immunologic factors|mesh-ancestor
101922491|NCT03760146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922492|NCT01161654|Naratriptan|naratriptan|mesh-list
101922493|NCT01161654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101922494|NCT01161654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101922495|NCT01161654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101922496|NCT01161654|Serotonin Agents|serotonin agents|mesh-ancestor
101922497|NCT01161654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101922498|NCT01161654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922499|NCT01161654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922500|NCT01266174|Eltoprazine|eltoprazine|mesh-list
101922501|NCT01266174|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101922502|NCT01266174|Serotonin Agents|serotonin agents|mesh-ancestor
101922503|NCT01266174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101922504|NCT01266174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922505|NCT01266174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922506|NCT01266252|Dexmedetomidine|dexmedetomidine|mesh-list
101922507|NCT01266252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101922508|NCT01266252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101922509|NCT01266252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922510|NCT01266252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101922512|NCT01266252|Sensory System Agents|sensory system agents|mesh-ancestor
101922513|NCT01266252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101922514|NCT01266252|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101922515|NCT01266252|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101922517|NCT01266252|Adrenergic Agents|adrenergic agents|mesh-ancestor
101922518|NCT01266252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101922519|NCT01266252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922520|NCT01266486|Metformin|metformin|mesh-list
101922521|NCT01266486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101922522|NCT01266486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922523|NCT01161888|Imiquimod|imiquimod|mesh-list
101922524|NCT01161888|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101922525|NCT01161888|Immunologic Factors|immunologic factors|mesh-ancestor
101922526|NCT01161888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922527|NCT01161888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101922528|NCT01161888|Interferon Inducers|interferon inducers|mesh-ancestor
101922529|NCT03760068|Insulin Aspart|insulin aspart|mesh-list
101922530|NCT03760068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101922531|NCT03760068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922532|NCT03759600|Niraparib|niraparib|mesh-list
101957824|NCT02251288|Vaccines|vaccines|mesh-list
101922533|NCT03759600|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101922534|NCT03759600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101922535|NCT03759600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922536|NCT03759600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101922537|NCT01161966|Zonisamide|zonisamide|mesh-list
101922538|NCT01161966|Anticonvulsants|anticonvulsants|mesh-ancestor
101922539|NCT01161966|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101922540|NCT01161966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101922541|NCT01161966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922542|NCT01161966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101922543|NCT01161966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922544|NCT01158144|Paclitaxel|paclitaxel|mesh-list
101922545|NCT01158144|Carboplatin|carboplatin|mesh-list
101922546|NCT01158144|Endostar protein|endostar protein|mesh-list
101922547|NCT01158144|Endostatins|endostatins|mesh-list
101922548|NCT01158144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101922549|NCT01158144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101922550|NCT01158144|Tubulin Modulators|tubulin modulators|mesh-ancestor
101922551|NCT01158144|Antimitotic Agents|antimitotic agents|mesh-ancestor
101922552|NCT01158144|Mitosis Modulators|mitosis modulators|mesh-ancestor
101922553|NCT01158144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922554|NCT01158144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101922555|NCT01158144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101922556|NCT01158144|Growth Substances|growth substances|mesh-ancestor
101922557|NCT01158144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922558|NCT01158144|Growth Inhibitors|growth inhibitors|mesh-ancestor
101922559|NCT01264536|Lactoferrin|lactoferrin|mesh-list
101922560|NCT01264536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101922561|NCT01160172|Vaccines|vaccines|mesh-list
101922562|NCT01160172|Immunologic Factors|immunologic factors|mesh-ancestor
101922563|NCT01160172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922564|NCT03878784|Sumatriptan|sumatriptan|mesh-list
101922565|NCT03878784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101922566|NCT03878784|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101922567|NCT03878784|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101922568|NCT03878784|Serotonin Agents|serotonin agents|mesh-ancestor
101922569|NCT03878784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101922570|NCT03878784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922571|NCT03878784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922572|NCT01266720|Gemcitabine|gemcitabine|mesh-list
101922573|NCT01266720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101922574|NCT01266720|Antimetabolites|antimetabolites|mesh-ancestor
101922575|NCT01266720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922576|NCT01266720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101922577|NCT01589952|Interferons|interferons|mesh-list
101922578|NCT01589952|Entecavir|entecavir|mesh-list
101922579|NCT01589952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101922580|NCT01589952|Antiviral Agents|antiviral agents|mesh-ancestor
101922581|NCT01589952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101922583|NCT03876444|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101642440|NCT00943670|Maytansine|maytansine|mesh-list
101922584|NCT03876444|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101922585|NCT03876444|Prednisolone|prednisolone|mesh-list
101922586|NCT03876444|Prednisolone acetate|prednisolone acetate|mesh-list
101922587|NCT03876444|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101922588|NCT03876444|Prednisolone phosphate|prednisolone phosphate|mesh-list
101922589|NCT03876444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101922590|NCT03876444|Antiemetics|antiemetics|mesh-ancestor
101922591|NCT03876444|Autonomic Agents|autonomic agents|mesh-ancestor
101922592|NCT03876444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101922593|NCT03876444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922594|NCT03876444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101922595|NCT03876444|Glucocorticoids|glucocorticoids|mesh-ancestor
101922596|NCT03876444|Hormones|hormones|mesh-ancestor
101922597|NCT03876444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101922598|NCT03876444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101922599|NCT03876444|Protective Agents|protective agents|mesh-ancestor
101922600|NCT03876444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101922601|NCT03876444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101922602|NCT01264692|Amlodipine|amlodipine|mesh-list
101922603|NCT01264692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101922605|NCT01264692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101922606|NCT01264692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922607|NCT01264692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101922608|NCT01264692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922609|NCT01264692|Vasodilator Agents|vasodilator agents|mesh-ancestor
101922610|NCT01160328|Leuprolide|leuprolide|mesh-list
101922611|NCT01160328|Testosterone|testosterone|mesh-list
101922612|NCT01160328|Androgens|androgens|mesh-ancestor
101922613|NCT01160328|Hormones|hormones|mesh-ancestor
101922614|NCT01160328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101922615|NCT01160328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922616|NCT01160328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101922617|NCT01160328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101922618|NCT01160328|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101922619|NCT01160328|Fertility Agents|fertility agents|mesh-ancestor
101922620|NCT01160328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101922621|NCT01162746|Dexamethasone|dexamethasone|mesh-list
101922622|NCT01162746|Ranibizumab|ranibizumab|mesh-list
101922623|NCT01162746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101922624|NCT01162746|Antiemetics|antiemetics|mesh-ancestor
101922625|NCT01162746|Autonomic Agents|autonomic agents|mesh-ancestor
101922626|NCT01162746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101922627|NCT01162746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922628|NCT01162746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101922629|NCT01162746|Glucocorticoids|glucocorticoids|mesh-ancestor
101922630|NCT01162746|Hormones|hormones|mesh-ancestor
101922631|NCT01162746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101922632|NCT01162746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101922633|NCT01162746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101922634|NCT01162746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101922635|NCT01162746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101922636|NCT01162746|Growth Substances|growth substances|mesh-ancestor
101922637|NCT01162746|Growth Inhibitors|growth inhibitors|mesh-ancestor
101922638|NCT01268202|Pravastatin|pravastatin|mesh-list
101922639|NCT01268202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101922640|NCT01268202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101922641|NCT01268202|Antimetabolites|antimetabolites|mesh-ancestor
101230719|NCT04591431|Ipilimumab|ipilimumab|mesh-list
101922642|NCT01268202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922643|NCT01268202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101922644|NCT01268202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101922645|NCT01268202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101922646|NCT01162824|Adenosine|adenosine|mesh-list
101922647|NCT01162824|Acetylcholine|acetylcholine|mesh-list
101922648|NCT01162824|Analgesics|analgesics|mesh-ancestor
101922649|NCT01162824|Sensory System Agents|sensory system agents|mesh-ancestor
101922650|NCT01162824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101922651|NCT01162824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922652|NCT01162824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101922653|NCT01162824|Vasodilator Agents|vasodilator agents|mesh-ancestor
101922654|NCT01162824|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101922655|NCT01162824|Purinergic Agonists|purinergic agonists|mesh-ancestor
101922656|NCT01162824|Purinergic Agents|purinergic agents|mesh-ancestor
101922657|NCT01162824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101922658|NCT01162824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922659|NCT01162824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101922660|NCT01162824|Cholinergic Agents|cholinergic agents|mesh-ancestor
101922661|NCT01265004|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101922662|NCT01265004|Hemostatics|hemostatics|mesh-ancestor
101922663|NCT01265004|Coagulants|coagulants|mesh-ancestor
101922664|NCT01162902|Candesartan|candesartan|mesh-list
101922665|NCT01162902|Candesartan cilexetil|candesartan cilexetil|mesh-list
101922666|NCT01162902|Bisoprolol|bisoprolol|mesh-list
101922667|NCT01162902|Diltiazem|diltiazem|mesh-list
101922668|NCT01162902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101922669|NCT01162902|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101922670|NCT01162902|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101922671|NCT01162902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922672|NCT01162902|Sympatholytics|sympatholytics|mesh-ancestor
101922673|NCT01162902|Autonomic Agents|autonomic agents|mesh-ancestor
101922674|NCT01162902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101922675|NCT01162902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922676|NCT01162902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101922677|NCT01162902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101922678|NCT01162902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101922679|NCT01162902|Adrenergic Agents|adrenergic agents|mesh-ancestor
101922680|NCT01162902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101922681|NCT01162902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101922682|NCT01162902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101922683|NCT01162902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101922684|NCT01162902|Vasodilator Agents|vasodilator agents|mesh-ancestor
101922685|NCT03877536|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101922686|NCT03877536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101922687|NCT03877536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101922688|NCT03877536|Antiviral Agents|antiviral agents|mesh-ancestor
101922689|NCT03877536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101922690|NCT02526888|Diltiazem|diltiazem|mesh-list
101922691|NCT02526888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101922692|NCT02526888|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101922693|NCT02526888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101922694|NCT02526888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922695|NCT02526888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101922696|NCT02526888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922697|NCT02526888|Vasodilator Agents|vasodilator agents|mesh-ancestor
101922698|NCT01158612|Hormones|hormones|mesh-list
101922699|NCT01158612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101922700|NCT01158612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922701|NCT03877692|Labetalol|labetalol|mesh-list
101922702|NCT03877692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101922703|NCT03877692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101922704|NCT03877692|Adrenergic Agents|adrenergic agents|mesh-ancestor
101922705|NCT03877692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101922706|NCT03877692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922707|NCT03877692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922708|NCT03877692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101922709|NCT03877692|Sympathomimetics|sympathomimetics|mesh-ancestor
101922710|NCT03877692|Autonomic Agents|autonomic agents|mesh-ancestor
101922711|NCT03877692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101922712|NCT03877692|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101922713|NCT03877692|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101922714|NCT01158846|Bivalirudin|bivalirudin|mesh-list
101922715|NCT01158846|Abciximab|abciximab|mesh-list
101922716|NCT01158846|Clopidogrel|clopidogrel|mesh-list
101922717|NCT01158846|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101922718|NCT01158846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101922719|NCT01158846|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101922720|NCT01158846|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101922721|NCT01158846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101922722|NCT01158846|Purinergic Agents|purinergic agents|mesh-ancestor
101922723|NCT01158846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101922724|NCT01158846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922725|NCT01158846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922726|NCT01158846|Antithrombins|antithrombins|mesh-ancestor
101922727|NCT01158846|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101922728|NCT01158846|Protease Inhibitors|protease inhibitors|mesh-ancestor
101922729|NCT01158846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101922730|NCT01158846|Anticoagulants|anticoagulants|mesh-ancestor
101642591|NCT00687739|Estradiol|estradiol|mesh-list
101922731|NCT01268670|Ibuprofen|ibuprofen|mesh-list
101922732|NCT01268670|Oxycodone|oxycodone|mesh-list
101922733|NCT01268670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101922734|NCT01268670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101922735|NCT01268670|Analgesics|analgesics|mesh-ancestor
101922736|NCT01268670|Sensory System Agents|sensory system agents|mesh-ancestor
101922737|NCT01268670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101957841|NCT02112214|Bismuth|bismuth|mesh-list
101922738|NCT01268670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922739|NCT01268670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101922741|NCT01268670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101922742|NCT01268670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101922743|NCT01268670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922744|NCT01268670|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101922745|NCT01268670|Narcotics|narcotics|mesh-ancestor
101922746|NCT01268670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101922747|NCT01160718|Fulvestrant|fulvestrant|mesh-list
101922748|NCT01160718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101922749|NCT01160718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101922750|NCT01160718|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101922751|NCT01160718|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101922752|NCT01160718|Hormone Antagonists|hormone antagonists|mesh-ancestor
101922753|NCT01160718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101922754|NCT01160718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922755|NCT01159080|Mycophenolic Acid|mycophenolic acid|mesh-list
101922756|NCT01159080|Tacrolimus|tacrolimus|mesh-list
101922757|NCT01159080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101922758|NCT01159080|Immunologic Factors|immunologic factors|mesh-ancestor
101922759|NCT01159080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922760|NCT01159080|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101922761|NCT01159080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101922762|NCT01159080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922763|NCT01159080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101922764|NCT01159080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101922765|NCT01159080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101922766|NCT01159080|Antitubercular Agents|antitubercular agents|mesh-ancestor
101922767|NCT01159080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101922768|NCT01159080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101922769|NCT01160952|Itraconazole|itraconazole|mesh-list
101922770|NCT01160952|Antifungal Agents|antifungal agents|mesh-ancestor
101922771|NCT01160952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101922772|NCT01160952|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101922773|NCT01160952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101922774|NCT01160952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101922775|NCT01160952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922776|NCT01160952|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101922777|NCT01160952|Hormone Antagonists|hormone antagonists|mesh-ancestor
101922778|NCT01160952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101922779|NCT01160952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922780|NCT01160952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101922781|NCT01159158|Nateglinide|nateglinide|mesh-list
101922782|NCT01159158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101922783|NCT01159158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922784|NCT01161108|Melatonin|melatonin|mesh-list
101922785|NCT01161108|Antioxidants|antioxidants|mesh-ancestor
101922786|NCT01161108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922787|NCT01161108|Protective Agents|protective agents|mesh-ancestor
101922788|NCT01161108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922789|NCT01161108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101922790|NCT01161186|Paclitaxel|paclitaxel|mesh-list
101922791|NCT01161186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101922792|NCT01161186|Gemcitabine|gemcitabine|mesh-list
101922793|NCT01161186|Capecitabine|capecitabine|mesh-list
101922794|NCT01161186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101922795|NCT01161186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101922796|NCT01161186|Tubulin Modulators|tubulin modulators|mesh-ancestor
101922797|NCT01161186|Antimitotic Agents|antimitotic agents|mesh-ancestor
101922798|NCT01161186|Mitosis Modulators|mitosis modulators|mesh-ancestor
101922799|NCT01161186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922800|NCT01161186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101922801|NCT01161186|Antimetabolites|antimetabolites|mesh-ancestor
101922802|NCT01159236|Paclitaxel|paclitaxel|mesh-list
101922803|NCT01159236|Cyclophosphamide|cyclophosphamide|mesh-list
101642675|NCT01001429|Dexmedetomidine|dexmedetomidine|mesh-list
101922804|NCT01159236|Bevacizumab|bevacizumab|mesh-list
101922805|NCT01159236|Doxorubicin|doxorubicin|mesh-list
101922806|NCT01159236|Fluorouracil|fluorouracil|mesh-list
101922807|NCT01159236|Epirubicin|epirubicin|mesh-list
101922808|NCT01159236|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101922809|NCT01159236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101922810|NCT01159236|Tubulin Modulators|tubulin modulators|mesh-ancestor
101922811|NCT01159236|Antimitotic Agents|antimitotic agents|mesh-ancestor
101922812|NCT01159236|Mitosis Modulators|mitosis modulators|mesh-ancestor
101922813|NCT01159236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922814|NCT01159236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101922815|NCT01159236|Immunologic Factors|immunologic factors|mesh-ancestor
101922816|NCT01159236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922817|NCT01159236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101922818|NCT01159236|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101922819|NCT01159236|Alkylating Agents|alkylating agents|mesh-ancestor
101922820|NCT01159236|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101922821|NCT01159236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101922822|NCT01159236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101922823|NCT01159236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101922824|NCT01159236|Growth Substances|growth substances|mesh-ancestor
101922825|NCT01159236|Growth Inhibitors|growth inhibitors|mesh-ancestor
101922826|NCT01159236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101922827|NCT01159236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101922828|NCT01159236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101922829|NCT01159236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101922830|NCT01159236|Antimetabolites|antimetabolites|mesh-ancestor
101922831|NCT01159236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101922832|NCT01267344|Gemcitabine|gemcitabine|mesh-list
101922833|NCT01267344|Oxaliplatin|oxaliplatin|mesh-list
101922834|NCT01267344|Cetuximab|cetuximab|mesh-list
101922835|NCT01267344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101922836|NCT01267344|Antimetabolites|antimetabolites|mesh-ancestor
101922837|NCT01267344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922838|NCT01267344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101922839|NCT01267344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101922840|NCT03879564|Ketamine|ketamine|mesh-list
101922841|NCT03879564|Analgesics|analgesics|mesh-ancestor
101922842|NCT03879564|Sensory System Agents|sensory system agents|mesh-ancestor
101922843|NCT03879564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101922844|NCT03879564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922845|NCT03879564|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101922846|NCT03879564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101922847|NCT03879564|Anesthetics, General|anesthetics, general|mesh-ancestor
101922848|NCT03879564|Anesthetics|anesthetics|mesh-ancestor
101922849|NCT03879564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101922850|NCT03879564|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101922851|NCT03879564|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101922852|NCT03879564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101922853|NCT03879564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922854|NCT01581840|Panitumumab|panitumumab|mesh-list
101922855|NCT01581840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101922856|NCT01581840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101922857|NCT03879486|Povidone-Iodine|povidone-iodine|mesh-list
101922858|NCT03879486|Formaldehyde|formaldehyde|mesh-list
101922859|NCT03879486|Povidone|povidone|mesh-list
101922860|NCT03879486|Plasma Substitutes|plasma substitutes|mesh-ancestor
101922861|NCT03879486|Blood Substitutes|blood substitutes|mesh-ancestor
101922862|NCT03879486|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101922863|NCT03879486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101922864|NCT03879486|Disinfectants|disinfectants|mesh-ancestor
101922865|NCT01269294|Moxifloxacin|moxifloxacin|mesh-list
101922866|NCT01269294|Simeprevir|simeprevir|mesh-list
101922867|NCT01269294|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101922868|NCT01269294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101922869|NCT01269294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101922870|NCT01269294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101922872|NCT01269294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101922873|NCT01269294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922874|NCT01269294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101922875|NCT01269294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101922876|NCT01269294|Contraceptive Agents|contraceptive agents|mesh-ancestor
101922877|NCT01269294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101922878|NCT01269294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922879|NCT01269294|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101922880|NCT01269294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101922881|NCT01269294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101922882|NCT01269294|Antiviral Agents|antiviral agents|mesh-ancestor
101922883|NCT01269294|Protease Inhibitors|protease inhibitors|mesh-ancestor
101922885|NCT01163994|Ceftriaxone|ceftriaxone|mesh-list
101922886|NCT01163994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101922887|NCT01163994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101922888|NCT01163994|Antimalarials|antimalarials|mesh-ancestor
101922889|NCT01163994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101922890|NCT01163994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101922891|NCT01267734|Everolimus|everolimus|mesh-list
101922892|NCT01267734|Clopidogrel|clopidogrel|mesh-list
101922893|NCT01267734|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101922894|NCT01267734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101922895|NCT01267734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101922896|NCT01267734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922897|NCT01267734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101922898|NCT01267734|Immunologic Factors|immunologic factors|mesh-ancestor
101922899|NCT01267734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922900|NCT01267734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101922901|NCT01267734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101922902|NCT01267734|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101922903|NCT01267734|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101922904|NCT01267734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101922905|NCT01267734|Purinergic Agents|purinergic agents|mesh-ancestor
101922906|NCT01267734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101922907|NCT01164306|Nicotine|nicotine|mesh-list
101922908|NCT01164306|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101922909|NCT01164306|Autonomic Agents|autonomic agents|mesh-ancestor
101922910|NCT01164306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101922911|NCT01164306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922912|NCT01164306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101922913|NCT01164306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101922914|NCT01164306|Cholinergic Agents|cholinergic agents|mesh-ancestor
101922915|NCT01164306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101922916|NCT01164306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922917|NCT01269450|Progesterone|progesterone|mesh-list
101922918|NCT01269450|Progestins|progestins|mesh-ancestor
101922919|NCT01269450|Hormones|hormones|mesh-ancestor
101922920|NCT01269450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101922921|NCT01269450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922922|NCT01269528|Nitric Oxide|nitric oxide|mesh-list
101922923|NCT01269528|Methacholine Chloride|methacholine chloride|mesh-list
101922924|NCT01269528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101922925|NCT01269528|Autonomic Agents|autonomic agents|mesh-ancestor
101922926|NCT01269528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101922927|NCT01269528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922928|NCT01269528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101922929|NCT01269528|Respiratory System Agents|respiratory system agents|mesh-ancestor
101922930|NCT01269528|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101922931|NCT01269528|Antioxidants|antioxidants|mesh-ancestor
101922932|NCT01269528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922933|NCT01269528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101922934|NCT01269528|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101922935|NCT01269528|Vasodilator Agents|vasodilator agents|mesh-ancestor
101922936|NCT01269528|Gasotransmitters|gasotransmitters|mesh-ancestor
101922937|NCT01269528|Protective Agents|protective agents|mesh-ancestor
101922938|NCT01269528|Miotics|miotics|mesh-ancestor
101922939|NCT01269528|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101922940|NCT01269528|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
101922941|NCT01269528|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101922942|NCT01269528|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101922943|NCT01269528|Cholinergic Agents|cholinergic agents|mesh-ancestor
101922944|NCT01268904|Valproic Acid|valproic acid|mesh-list
101922945|NCT01268904|Anticonvulsants|anticonvulsants|mesh-ancestor
101922946|NCT01268904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101957857|NCT02112292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101922947|NCT01268904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922948|NCT01268904|GABA Agents|gaba agents|mesh-ancestor
101922949|NCT01268904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101922950|NCT01268904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922951|NCT01268904|Antimanic Agents|antimanic agents|mesh-ancestor
101922952|NCT01268904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101922953|NCT01268904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101922954|NCT01268904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101922955|NCT01269606|Insulin|insulin|mesh-list
101922956|NCT01269606|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101922957|NCT01269606|Insulin Aspart|insulin aspart|mesh-list
101922958|NCT01269606|Insulin, Long-Acting|insulin, long-acting|mesh-list
101922959|NCT01269606|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101922960|NCT01269606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101922961|NCT01269606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922962|NCT03872232|Telmisartan|telmisartan|mesh-list
101922963|NCT03872232|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101922964|NCT03872232|Ezetimibe|ezetimibe|mesh-list
101922965|NCT03872232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101922966|NCT03872232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101922967|NCT03872232|Antimetabolites|antimetabolites|mesh-ancestor
101922968|NCT03872232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922969|NCT03872232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101922970|NCT03872232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101922971|NCT03872232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101922972|NCT03872232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101922973|NCT03872232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101922974|NCT03872232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101922975|NCT01280214|Triamcinolone|triamcinolone|mesh-list
101922976|NCT01280214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101922977|NCT01280214|Glucocorticoids|glucocorticoids|mesh-ancestor
101922978|NCT01280214|Hormones|hormones|mesh-ancestor
101922979|NCT01280214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101922980|NCT01280214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922981|NCT01165008|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101922982|NCT01165008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101922983|NCT01164540|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101922984|NCT01164540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101922985|NCT01164540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101922986|NCT01164540|Antimetabolites|antimetabolites|mesh-ancestor
101922987|NCT01164540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922988|NCT01164540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101922989|NCT01164540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101922990|NCT01164540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101922991|NCT01269684|Everolimus|everolimus|mesh-list
101922992|NCT01269684|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101922993|NCT01269684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101922994|NCT01269684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101922995|NCT01269684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101922996|NCT01269684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101922997|NCT01269684|Immunologic Factors|immunologic factors|mesh-ancestor
101922998|NCT01269684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101922999|NCT01269684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923000|NCT01165164|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101923001|NCT01165164|Lubricant Eye Drops|lubricant eye drops|mesh-list
101923002|NCT01165164|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101923003|NCT01280526|Romidepsin|romidepsin|mesh-list
101923004|NCT01280526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101923005|NCT01280526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923006|NCT01280526|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101923007|NCT01280526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101923008|NCT01280526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923009|NCT01164774|Ramipril|ramipril|mesh-list
101923010|NCT01164774|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101923011|NCT01164774|Protease Inhibitors|protease inhibitors|mesh-ancestor
101923012|NCT01164774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101923013|NCT01164774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923014|NCT01164774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101923015|NCT01269138|Thrombin|thrombin|mesh-list
101923016|NCT01269138|Hemostatics|hemostatics|mesh-ancestor
101923017|NCT01269138|Coagulants|coagulants|mesh-ancestor
101923018|NCT02526810|Insulin|insulin|mesh-list
101923019|NCT02526810|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101923020|NCT02526810|Insulin Glargine|insulin glargine|mesh-list
101923021|NCT02526810|Insulin Lispro|insulin lispro|mesh-list
101923022|NCT02526810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101923023|NCT02526810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923024|NCT01280682|Rituximab|rituximab|mesh-list
101923025|NCT01280682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101923026|NCT01280682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923027|NCT01280682|Immunologic Factors|immunologic factors|mesh-ancestor
101923028|NCT01280682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923029|NCT01280682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101923030|NCT01269216|Leucovorin|leucovorin|mesh-list
101923031|NCT01269216|Irinotecan|irinotecan|mesh-list
101923032|NCT01269216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101923033|NCT01269216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101923034|NCT01269216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101923035|NCT01269216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923036|NCT01269216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923037|NCT01269216|Antidotes|antidotes|mesh-ancestor
101923038|NCT01269216|Protective Agents|protective agents|mesh-ancestor
101923039|NCT01269216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923040|NCT01269216|Vitamin B Complex|vitamin b complex|mesh-ancestor
101923041|NCT01269216|Vitamins|vitamins|mesh-ancestor
101923042|NCT01269216|Micronutrients|micronutrients|mesh-ancestor
101923043|NCT03874806|Ropivacaine|ropivacaine|mesh-list
101923044|NCT03874806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101923045|NCT03874806|Anesthetics, Local|anesthetics, local|mesh-ancestor
101923046|NCT03874806|Anesthetics|anesthetics|mesh-ancestor
101923047|NCT03874806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101923048|NCT03874806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923049|NCT03874806|Sensory System Agents|sensory system agents|mesh-ancestor
101923050|NCT03874806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101923051|NCT01165476|Treprostinil|treprostinil|mesh-list
101923052|NCT01165476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101923053|NCT01169922|Ethanol|ethanol|mesh-list
101923054|NCT01169922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101923055|NCT01169922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101923056|NCT01169922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101923057|NCT01169922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923058|NCT01283100|Dolutegravir|dolutegravir|mesh-list
101923059|NCT01283100|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101923060|NCT01283100|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101923061|NCT01283100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101923062|NCT01283100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923063|NCT01283100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101923064|NCT01283100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101923065|NCT01283100|Antiviral Agents|antiviral agents|mesh-ancestor
101923066|NCT01283100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101923067|NCT01269996|Metformin|metformin|mesh-list
101923068|NCT01269996|Gliclazide|gliclazide|mesh-list
101923069|NCT01269996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101923070|NCT01269996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923071|NCT01283178|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101923072|NCT01283178|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101923073|NCT01283178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923074|NCT01281150|Paclitaxel|paclitaxel|mesh-list
101923075|NCT01281150|Carboplatin|carboplatin|mesh-list
101923076|NCT01281150|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101923077|NCT01281150|Veliparib|veliparib|mesh-list
101923078|NCT01281150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101923079|NCT01281150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923080|NCT01281150|Tubulin Modulators|tubulin modulators|mesh-ancestor
101923081|NCT01281150|Antimitotic Agents|antimitotic agents|mesh-ancestor
101923082|NCT01281150|Mitosis Modulators|mitosis modulators|mesh-ancestor
101923083|NCT01281150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923084|NCT01281150|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101923085|NCT01281150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101923086|NCT03871218|Hyaluronic Acid|hyaluronic acid|mesh-list
101923087|NCT03871218|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101923088|NCT03871218|Immunologic Factors|immunologic factors|mesh-ancestor
101923089|NCT03871218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923090|NCT03871218|Viscosupplements|viscosupplements|mesh-ancestor
101923092|NCT01281228|Exenatide|exenatide|mesh-list
101923093|NCT01281228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101923094|NCT01281228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923095|NCT01281228|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101923096|NCT01281228|Incretins|incretins|mesh-ancestor
101923097|NCT01281228|Hormones|hormones|mesh-ancestor
101923098|NCT01281228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101923099|NCT01283256|Zonisamide|zonisamide|mesh-list
101923100|NCT01283256|Anticonvulsants|anticonvulsants|mesh-ancestor
101923101|NCT01283256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101923102|NCT01283256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101923103|NCT01283256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923104|NCT01283256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101923105|NCT01283256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923106|NCT01270776|Chlorhexidine|chlorhexidine|mesh-list
101923107|NCT01270776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101923108|NCT01270776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101923109|NCT01270776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101923110|NCT01270776|Disinfectants|disinfectants|mesh-ancestor
101923111|NCT01270776|Dermatologic Agents|dermatologic agents|mesh-ancestor
101923112|NCT03874260|Fenofibrate|fenofibrate|mesh-list
101923113|NCT03874260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101923114|NCT03874260|Antimetabolites|antimetabolites|mesh-ancestor
101923115|NCT03874260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923116|NCT03874260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101923117|NCT01281540|Cisapride|cisapride|mesh-list
101923118|NCT01281540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101923119|NCT01281540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101923120|NCT01281540|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101923121|NCT01281540|Serotonin Agents|serotonin agents|mesh-ancestor
101923122|NCT01281540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101923123|NCT01281540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923124|NCT01281540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923125|NCT03874026|Cetuximab|cetuximab|mesh-list
101923126|NCT03874026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101923127|NCT03874026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923128|NCT01283412|Dexmedetomidine|dexmedetomidine|mesh-list
101923129|NCT01283412|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101923130|NCT01283412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101923131|NCT01283412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923132|NCT01283412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101923133|NCT01283412|Analgesics|analgesics|mesh-ancestor
101923134|NCT01283412|Sensory System Agents|sensory system agents|mesh-ancestor
101923135|NCT01283412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101923136|NCT01283412|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101923137|NCT01283412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101923138|NCT01283412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101923139|NCT01283412|Adrenergic Agents|adrenergic agents|mesh-ancestor
101923140|NCT01283412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101923141|NCT01283412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923142|NCT01271478|Telmisartan|telmisartan|mesh-list
101923143|NCT01271478|Captopril|captopril|mesh-list
101923144|NCT01271478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101923145|NCT01271478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101923146|NCT01271478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101923147|NCT01271478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923148|NCT01271478|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101923149|NCT01271478|Protease Inhibitors|protease inhibitors|mesh-ancestor
101923150|NCT01271478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101923151|NCT03871062|Anesthetics|anesthetics|mesh-list
101617005|NCT02603497|Peficitinib|peficitinib|mesh-list
101923152|NCT03871062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101923153|NCT03871062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923154|NCT01281696|Bevacizumab|bevacizumab|mesh-list
101923155|NCT01281696|Methotrexate|methotrexate|mesh-list
101923156|NCT01281696|Etoposide|etoposide|mesh-list
101923157|NCT01281696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101923158|NCT01281696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923159|NCT01281696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101923160|NCT01281696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101923161|NCT01281696|Growth Substances|growth substances|mesh-ancestor
101923162|NCT01281696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923163|NCT01281696|Growth Inhibitors|growth inhibitors|mesh-ancestor
101923164|NCT01281696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101923165|NCT01281696|Abortifacient Agents|abortifacient agents|mesh-ancestor
101923166|NCT01281696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101923167|NCT01281696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101923168|NCT01281696|Antimetabolites|antimetabolites|mesh-ancestor
101923169|NCT01281696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923170|NCT01281696|Dermatologic Agents|dermatologic agents|mesh-ancestor
101923171|NCT01281696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101923172|NCT01281696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101923173|NCT01281696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101923174|NCT01281696|Immunologic Factors|immunologic factors|mesh-ancestor
101923175|NCT01281696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101923176|NCT01281696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101923177|NCT01281696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101923178|NCT01281696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101923179|NCT01281696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101923180|NCT05835713|Propofol|propofol|mesh-list
101923181|NCT05835713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101923182|NCT05835713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101923183|NCT05835713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923184|NCT05835713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101923185|NCT05835713|Anesthetics, General|anesthetics, general|mesh-ancestor
101923186|NCT05835713|Anesthetics|anesthetics|mesh-ancestor
101923187|NCT05835479|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101923188|NCT05835479|Rezafungin|rezafungin|mesh-list
101923189|NCT05835479|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101923190|NCT05835479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101923191|NCT05835479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101923192|NCT05835479|Antimalarials|antimalarials|mesh-ancestor
101923193|NCT05835479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101923194|NCT05835479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101923195|NCT05835479|Antifungal Agents|antifungal agents|mesh-ancestor
101923196|NCT05835089|Estradiol|estradiol|mesh-list
101923197|NCT05835089|Testosterone|testosterone|mesh-list
101923198|NCT05835089|Estrogens|estrogens|mesh-ancestor
101923199|NCT05835089|Hormones|hormones|mesh-ancestor
101923200|NCT05835089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101923201|NCT05835089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923202|NCT05835089|Androgens|androgens|mesh-ancestor
101923203|NCT05834868|Insulin Lispro|insulin lispro|mesh-list
101923204|NCT05834868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101923205|NCT05834868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923206|NCT05834855|Rituximab|rituximab|mesh-list
101923207|NCT05834855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101923208|NCT05834855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923209|NCT05834855|Immunologic Factors|immunologic factors|mesh-ancestor
101923210|NCT05834855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923211|NCT05834855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101923212|NCT05834764|Maleic acid|maleic acid|mesh-list
101923213|NCT05834764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101923214|NCT05834764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923215|NCT05834647|Lidocaine|lidocaine|mesh-list
101923216|NCT05834647|Prilocaine|prilocaine|mesh-list
101923217|NCT05834647|Anesthetics, Local|anesthetics, local|mesh-ancestor
101923218|NCT05834647|Anesthetics|anesthetics|mesh-ancestor
101923219|NCT05834647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101923220|NCT05834647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923221|NCT05834647|Sensory System Agents|sensory system agents|mesh-ancestor
101923222|NCT05834647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101923223|NCT05834647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101923224|NCT05834647|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101923225|NCT05834647|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101923226|NCT05834647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101923227|NCT05834647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923228|NCT05834582|Paclitaxel|paclitaxel|mesh-list
101923229|NCT05834582|Cyclophosphamide|cyclophosphamide|mesh-list
101923230|NCT05834582|Epirubicin|epirubicin|mesh-list
101923232|NCT05834582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101923233|NCT05834582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923234|NCT05834582|Tubulin Modulators|tubulin modulators|mesh-ancestor
101923235|NCT05834582|Antimitotic Agents|antimitotic agents|mesh-ancestor
101923236|NCT05834582|Mitosis Modulators|mitosis modulators|mesh-ancestor
101923237|NCT05834582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923238|NCT05834582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101923239|NCT05834582|Immunologic Factors|immunologic factors|mesh-ancestor
101923240|NCT05834582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923241|NCT05834582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101923242|NCT05834582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101923243|NCT05834582|Alkylating Agents|alkylating agents|mesh-ancestor
101923244|NCT05834582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101923245|NCT05834582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101923246|NCT05834582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101923247|NCT05834582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101923248|NCT05834582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101923249|NCT05834582|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101923250|NCT05834543|Paclitaxel|paclitaxel|mesh-list
101923251|NCT05834543|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101923252|NCT05834543|Cisplatin|cisplatin|mesh-list
101923253|NCT05834543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101923254|NCT05834543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923255|NCT05834543|Tubulin Modulators|tubulin modulators|mesh-ancestor
101923256|NCT05834543|Antimitotic Agents|antimitotic agents|mesh-ancestor
101923257|NCT05834543|Mitosis Modulators|mitosis modulators|mesh-ancestor
101923258|NCT05834543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923260|NCT05834517|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101923261|NCT05834517|Immunologic Factors|immunologic factors|mesh-ancestor
101923262|NCT05834517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923263|NCT05834517|Viscosupplements|viscosupplements|mesh-ancestor
101923264|NCT05834517|Protective Agents|protective agents|mesh-ancestor
101923265|NCT05834478|Fallypride|fallypride|mesh-list
101923266|NCT05834478|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101923267|NCT05834478|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101923268|NCT05834478|Dopamine Agents|dopamine agents|mesh-ancestor
101923269|NCT05834478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101923270|NCT05834478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923271|NCT05834478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923272|NCT05834361|Carboprost|carboprost|mesh-list
101923273|NCT05834361|Carboprost tromethamine|carboprost tromethamine|mesh-list
101923274|NCT05834361|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101923275|NCT05834361|Abortifacient Agents|abortifacient agents|mesh-ancestor
101923276|NCT05834361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101923277|NCT05834361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923278|NCT05834361|Oxytocics|oxytocics|mesh-ancestor
101923279|NCT05834348|Docetaxel|docetaxel|mesh-list
101923280|NCT05834348|Bevacizumab|bevacizumab|mesh-list
101923281|NCT05834348|Carboplatin|carboplatin|mesh-list
101923282|NCT05834348|Pembrolizumab|pembrolizumab|mesh-list
101923283|NCT05834348|Nivolumab|nivolumab|mesh-list
101923284|NCT05834348|Atezolizumab|atezolizumab|mesh-list
101923285|NCT05834348|Gefitinib|gefitinib|mesh-list
101923286|NCT05834348|Osimertinib|osimertinib|mesh-list
101923287|NCT05834348|Afatinib|afatinib|mesh-list
101923288|NCT05834348|Crizotinib|crizotinib|mesh-list
101923289|NCT05834348|Ceritinib|ceritinib|mesh-list
101923290|NCT05834348|Entrectinib|entrectinib|mesh-list
101923291|NCT05834348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923292|NCT05834348|Tubulin Modulators|tubulin modulators|mesh-ancestor
101923293|NCT05834348|Antimitotic Agents|antimitotic agents|mesh-ancestor
101923294|NCT05834348|Mitosis Modulators|mitosis modulators|mesh-ancestor
101923295|NCT05834348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923296|NCT05834348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101923297|NCT05834348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101923298|NCT05834348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101923299|NCT05834348|Growth Substances|growth substances|mesh-ancestor
101923300|NCT05834348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923301|NCT05834348|Growth Inhibitors|growth inhibitors|mesh-ancestor
101923302|NCT05834348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101923303|NCT05834348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101923304|NCT05834348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101923305|NCT05834270|Tamsulosin|tamsulosin|mesh-list
101923306|NCT05834270|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101923307|NCT05834270|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101923308|NCT05834270|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101923309|NCT05834270|Adrenergic Agents|adrenergic agents|mesh-ancestor
101923310|NCT05834270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101923311|NCT05834270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923312|NCT05834270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923313|NCT05834270|Urological Agents|urological agents|mesh-ancestor
101923314|NCT05834244|Azacitidine|azacitidine|mesh-list
101923315|NCT05834244|Venetoclax|venetoclax|mesh-list
101923316|NCT05834244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101230860|NCT04273776|Zolpidem|zolpidem|mesh-list
101923317|NCT05834244|Antimetabolites|antimetabolites|mesh-ancestor
101923318|NCT05834244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923319|NCT05834244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923320|NCT05834244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101923321|NCT05834231|Memantine|memantine|mesh-list
101923322|NCT05834231|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101923323|NCT05834231|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101923324|NCT05834231|Dopamine Agents|dopamine agents|mesh-ancestor
101923325|NCT05834231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101923326|NCT05834231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923327|NCT05834231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923328|NCT05834231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101923329|NCT05834231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101923330|NCT05833958|Metformin|metformin|mesh-list
101923331|NCT05833958|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101643189|NCT00757393|Ergocalciferols|ergocalciferols|mesh-list
101923332|NCT05833958|Dapagliflozin|dapagliflozin|mesh-list
101923333|NCT05833958|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101923334|NCT05833958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923335|NCT05833958|Incretins|incretins|mesh-ancestor
101923337|NCT05833958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101923338|NCT05833958|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101923339|NCT05833958|Protease Inhibitors|protease inhibitors|mesh-ancestor
101923340|NCT05833958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101923341|NCT05833958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923342|NCT05833958|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101923343|NCT05830162|Amoxicillin|amoxicillin|mesh-list
101923344|NCT05830162|Clavulanic Acids|clavulanic acids|mesh-list
101923345|NCT05830162|Clavulanic Acid|clavulanic acid|mesh-list
101923346|NCT05830162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101923347|NCT05830162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101923348|NCT05830162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101923349|NCT05830162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923350|NCT05830162|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101923351|NCT05829707|Diclofenac|diclofenac|mesh-list
101923352|NCT05829707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101923353|NCT05829707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101923354|NCT05829707|Anesthetics|anesthetics|mesh-list
101923355|NCT05829707|Levobupivacaine|levobupivacaine|mesh-list
101923356|NCT05829707|Anesthetics, Local|anesthetics, local|mesh-list
101923357|NCT05829707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101923358|NCT05829707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923359|NCT05829707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101923360|NCT05829707|Analgesics|analgesics|mesh-ancestor
101923361|NCT05829707|Sensory System Agents|sensory system agents|mesh-ancestor
101923362|NCT05829707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101923363|NCT05829707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101923364|NCT05829707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101923365|NCT05829707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101923366|NCT05829707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923367|NCT05823948|Insulin|insulin|mesh-list
101923368|NCT05823948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101923369|NCT05823948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923370|NCT05819918|Calcifediol|calcifediol|mesh-list
101923371|NCT05819918|Vitamins|vitamins|mesh-ancestor
101923372|NCT05819918|Micronutrients|micronutrients|mesh-ancestor
101957881|NCT02118844|Rocuronium|rocuronium|mesh-list
101923373|NCT05819918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923374|NCT05819918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101923375|NCT05810883|Insulin|insulin|mesh-list
101923376|NCT05810883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101923377|NCT05810883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923378|NCT05807074|Tranexamic Acid|tranexamic acid|mesh-list
101923379|NCT05807074|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101923380|NCT05807074|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101230886|NCT04245722|Rituximab|rituximab|mesh-list
101923381|NCT05807074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923382|NCT05807074|Hemostatics|hemostatics|mesh-ancestor
101923383|NCT05807074|Coagulants|coagulants|mesh-ancestor
101923384|NCT05789303|Dexamethasone|dexamethasone|mesh-list
101923385|NCT05789303|Pomalidomide|pomalidomide|mesh-list
101923386|NCT05789303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101923387|NCT05789303|Antiemetics|antiemetics|mesh-ancestor
101923388|NCT05789303|Autonomic Agents|autonomic agents|mesh-ancestor
101923389|NCT05789303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101923390|NCT05789303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923391|NCT05789303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101923392|NCT05789303|Glucocorticoids|glucocorticoids|mesh-ancestor
101923393|NCT05789303|Hormones|hormones|mesh-ancestor
101923394|NCT05789303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101923395|NCT05789303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101923396|NCT05789303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923397|NCT05789303|Immunologic Factors|immunologic factors|mesh-ancestor
101923398|NCT05789303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101923399|NCT05789303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101923400|NCT05789303|Growth Substances|growth substances|mesh-ancestor
101923401|NCT05789303|Growth Inhibitors|growth inhibitors|mesh-ancestor
101923402|NCT05772273|Azacitidine|azacitidine|mesh-list
101923403|NCT05772273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101923404|NCT05772273|Antimetabolites|antimetabolites|mesh-ancestor
101923405|NCT05772273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923406|NCT05772273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923407|NCT05772273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101923408|NCT05753098|Sildenafil Citrate|sildenafil citrate|mesh-list
101923409|NCT05753098|Clomiphene|clomiphene|mesh-list
101923410|NCT05753098|Enclomiphene|enclomiphene|mesh-list
101923411|NCT05753098|Zuclomiphene|zuclomiphene|mesh-list
101923412|NCT05753098|Estrogens|estrogens|mesh-list
101923413|NCT05753098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923414|NCT05753098|Vasodilator Agents|vasodilator agents|mesh-ancestor
101923415|NCT05753098|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101923416|NCT05753098|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101923417|NCT05753098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101923418|NCT05753098|Urological Agents|urological agents|mesh-ancestor
101923419|NCT05753098|Hormones|hormones|mesh-ancestor
101923420|NCT05753098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101923421|NCT05753098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923422|NCT05753098|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101923423|NCT05753098|Hormone Antagonists|hormone antagonists|mesh-ancestor
101923424|NCT05753098|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101923425|NCT05753098|Fertility Agents|fertility agents|mesh-ancestor
101923426|NCT05753098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101923427|NCT05753098|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101923428|NCT05753098|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101923429|NCT05726292|Androgens|androgens|mesh-list
101923430|NCT05726292|Hormones|hormones|mesh-ancestor
101923431|NCT05726292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101923432|NCT05726292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923433|NCT05699811|Paclitaxel|paclitaxel|mesh-list
101923434|NCT05699811|Cyclophosphamide|cyclophosphamide|mesh-list
101923435|NCT05699811|Tislelizumab|tislelizumab|mesh-list
101923436|NCT05699811|Antibodies|antibodies|mesh-list
101923437|NCT05699811|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101923438|NCT05699811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101923439|NCT05699811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923440|NCT05699811|Tubulin Modulators|tubulin modulators|mesh-ancestor
101923441|NCT05699811|Antimitotic Agents|antimitotic agents|mesh-ancestor
101923442|NCT05699811|Mitosis Modulators|mitosis modulators|mesh-ancestor
101923443|NCT05699811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923444|NCT05699811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101923445|NCT05699811|Immunologic Factors|immunologic factors|mesh-ancestor
101923446|NCT05699811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923447|NCT05699811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101923448|NCT05699811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101923449|NCT05699811|Alkylating Agents|alkylating agents|mesh-ancestor
101923450|NCT05699811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101923451|NCT05699811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101923452|NCT05692908|Immunoconjugates|immunoconjugates|mesh-list
101923453|NCT05692908|Immunologic Factors|immunologic factors|mesh-ancestor
101923454|NCT05692908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923455|NCT05692843|Cyclosporine|cyclosporine|mesh-list
101923456|NCT05692843|Cyclosporins|cyclosporins|mesh-list
101923457|NCT05692843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101923458|NCT05692843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923459|NCT05692843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101923460|NCT05692843|Immunologic Factors|immunologic factors|mesh-ancestor
101923461|NCT05692843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923462|NCT05692843|Antifungal Agents|antifungal agents|mesh-ancestor
101923463|NCT05692843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101923464|NCT05692843|Dermatologic Agents|dermatologic agents|mesh-ancestor
101923465|NCT05692843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101923466|NCT05692843|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101923467|NCT05662865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
101923468|NCT05662865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923469|NCT05662865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101923470|NCT05662865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923471|NCT05660616|Gemcitabine|gemcitabine|mesh-list
101923472|NCT05660616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101923473|NCT05660616|Antimetabolites|antimetabolites|mesh-ancestor
101923474|NCT05660616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923475|NCT05660616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923477|NCT05659810|Analgesics|analgesics|mesh-ancestor
101923478|NCT05659810|Sensory System Agents|sensory system agents|mesh-ancestor
101923479|NCT05659810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101923480|NCT05659810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923481|NCT05659810|Anticonvulsants|anticonvulsants|mesh-ancestor
101923482|NCT05659810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101923483|NCT05659810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101923484|NCT05659810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101923485|NCT05659810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101923486|NCT05659810|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101923487|NCT05659810|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101923488|NCT05659810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101923489|NCT05659810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923490|NCT05659810|Antimanic Agents|antimanic agents|mesh-ancestor
101923491|NCT05658497|Interferons|interferons|mesh-list
101923492|NCT05658497|Interferon-beta|interferon-beta|mesh-list
101923493|NCT05658497|Interferon beta-1a|interferon beta-1a|mesh-list
101923494|NCT05658497|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101923495|NCT05658497|Natalizumab|natalizumab|mesh-list
101923496|NCT05658497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923497|NCT05658497|Antiviral Agents|antiviral agents|mesh-ancestor
101923498|NCT05658497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101923499|NCT05658497|Immunologic Factors|immunologic factors|mesh-ancestor
101923500|NCT05658497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923501|NCT05658497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101923502|NCT05658497|Dermatologic Agents|dermatologic agents|mesh-ancestor
101923503|NCT05658497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101923504|NCT05645757|Ertapenem|ertapenem|mesh-list
101923505|NCT05645757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101923506|NCT05645757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101923507|NCT05625347|Aspirin|aspirin|mesh-list
101923508|NCT05625347|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101923509|NCT05625347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101923510|NCT05625347|Analgesics|analgesics|mesh-ancestor
101923511|NCT05625347|Sensory System Agents|sensory system agents|mesh-ancestor
101923512|NCT05625347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101923513|NCT05625347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923514|NCT05625347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101923515|NCT05625347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101923516|NCT05625347|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101923517|NCT05625347|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101923518|NCT05625347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923519|NCT05625347|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101923520|NCT05625347|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101923521|NCT05625347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101923522|NCT05625347|Antipyretics|antipyretics|mesh-ancestor
101923523|NCT05619913|Pembrolizumab|pembrolizumab|mesh-list
101923524|NCT05619913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101923525|NCT05619913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923526|NCT05619913|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101923527|NCT05619913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923529|NCT05594680|Cilostazol|cilostazol|mesh-list
101923530|NCT05594680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101923531|NCT05594680|Abortifacient Agents|abortifacient agents|mesh-ancestor
101923532|NCT05594680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101923533|NCT05594680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923534|NCT05594680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101923535|NCT05594680|Antimetabolites|antimetabolites|mesh-ancestor
101923536|NCT05594680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923537|NCT05594680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923538|NCT05594680|Dermatologic Agents|dermatologic agents|mesh-ancestor
101923539|NCT05594680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101923540|NCT05594680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101923541|NCT05594680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101923542|NCT05594680|Immunologic Factors|immunologic factors|mesh-ancestor
101923543|NCT05594680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101923544|NCT05594680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101923545|NCT05594680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101923546|NCT05594680|Autonomic Agents|autonomic agents|mesh-ancestor
101923547|NCT05594680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101923548|NCT05594680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101923549|NCT05594680|Respiratory System Agents|respiratory system agents|mesh-ancestor
101923550|NCT05594680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101923551|NCT05594680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101923552|NCT05594680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101923553|NCT05594680|Vasodilator Agents|vasodilator agents|mesh-ancestor
101923554|NCT05594680|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101923555|NCT05594680|Protective Agents|protective agents|mesh-ancestor
101923556|NCT05594680|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101923557|NCT05594680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101923559|NCT05594563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923560|NCT05594563|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101923561|NCT05594563|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101923562|NCT05594563|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101923563|NCT05594563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101923564|NCT05594563|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
101923565|NCT05594563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101923566|NCT05594563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923568|NCT05567029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101923569|NCT05567029|Immunologic Factors|immunologic factors|mesh-ancestor
101923570|NCT05567029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923572|NCT05557643|Hallucinogens|hallucinogens|mesh-ancestor
101923573|NCT05557643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923574|NCT05557643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101923575|NCT05526443|Antineoplastic Agents|antineoplastic agents|mesh-list
101923576|NCT05325593|Dexamethasone|dexamethasone|mesh-list
101923577|NCT05325593|Dexamethasone acetate|dexamethasone acetate|mesh-list
101923578|NCT05325593|BB 1101|bb 1101|mesh-list
101923579|NCT05325593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101923580|NCT05325593|Antiemetics|antiemetics|mesh-ancestor
101923581|NCT05325593|Autonomic Agents|autonomic agents|mesh-ancestor
101923582|NCT05325593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101923583|NCT05325593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923584|NCT05325593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101923585|NCT05325593|Glucocorticoids|glucocorticoids|mesh-ancestor
101923586|NCT05325593|Hormones|hormones|mesh-ancestor
101923587|NCT05325593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101923588|NCT05325593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101923589|NCT05325593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923590|NCT05325593|Protease Inhibitors|protease inhibitors|mesh-ancestor
101923591|NCT05325593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101923592|NCT05325593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923593|NCT05322967|Antihypertensive Agents|antihypertensive agents|mesh-list
101923594|NCT05321121|Dexmedetomidine|dexmedetomidine|mesh-list
101923595|NCT05321121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101923596|NCT05321121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101923597|NCT05321121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923598|NCT05321121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101923599|NCT05321121|Analgesics|analgesics|mesh-ancestor
101923600|NCT05321121|Sensory System Agents|sensory system agents|mesh-ancestor
101923601|NCT05321121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101923602|NCT05321121|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101923603|NCT05321121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101923604|NCT05321121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101923605|NCT05321121|Adrenergic Agents|adrenergic agents|mesh-ancestor
101923606|NCT05321121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101923607|NCT05321121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923609|NCT05310734|Anesthetics, Local|anesthetics, local|mesh-ancestor
101923610|NCT05310734|Anesthetics|anesthetics|mesh-ancestor
101923611|NCT05310734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101923612|NCT05310734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923613|NCT05310734|Sensory System Agents|sensory system agents|mesh-ancestor
101923614|NCT05310734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101923615|NCT05284552|Tinzaparin|tinzaparin|mesh-list
101923616|NCT05284552|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101923617|NCT05284552|Dalteparin|dalteparin|mesh-list
101923618|NCT05284552|Anticoagulants|anticoagulants|mesh-ancestor
101923619|NCT05284552|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101923620|NCT05284552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101923621|NCT05284552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923622|NCT05281614|Etanercept|etanercept|mesh-list
101923623|NCT05281614|Vedolizumab|vedolizumab|mesh-list
101923624|NCT05281614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101923625|NCT05281614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101923626|NCT05281614|Analgesics|analgesics|mesh-ancestor
101923627|NCT05281614|Sensory System Agents|sensory system agents|mesh-ancestor
101923628|NCT05281614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101923629|NCT05281614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923631|NCT05281614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101923632|NCT05281614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101923633|NCT05281614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101923634|NCT05281614|Immunologic Factors|immunologic factors|mesh-ancestor
101230933|NCT04192955|Salicylates|salicylates|mesh-list
101923635|NCT05228288|Pyrithione zinc|pyrithione zinc|mesh-list
101923636|NCT05228288|Keratolytic Agents|keratolytic agents|mesh-ancestor
101923637|NCT05228288|Dermatologic Agents|dermatologic agents|mesh-ancestor
101923638|NCT05215574|Pembrolizumab|pembrolizumab|mesh-list
101923639|NCT05215574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101923640|NCT05215574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923641|NCT05215574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101923642|NCT05215574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923643|NCT05215418|Topiramate|topiramate|mesh-list
101923644|NCT05215418|Phentermine|phentermine|mesh-list
101923645|NCT05215418|Anticonvulsants|anticonvulsants|mesh-ancestor
101923646|NCT05215418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101923647|NCT05215418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923648|NCT05215418|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101923649|NCT05215418|Appetite Depressants|appetite depressants|mesh-ancestor
101923650|NCT05215418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101923651|NCT05215418|Sympathomimetics|sympathomimetics|mesh-ancestor
101923652|NCT05215418|Autonomic Agents|autonomic agents|mesh-ancestor
101923653|NCT05215418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101923654|NCT05215418|Adrenergic Agents|adrenergic agents|mesh-ancestor
101923655|NCT05215418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101923656|NCT05215418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923657|NCT05053737|Atezolizumab|atezolizumab|mesh-list
101923658|NCT05053737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101923659|NCT05053737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923660|NCT05053737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101923661|NCT05053737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923662|NCT05041153|Pembrolizumab|pembrolizumab|mesh-list
101923663|NCT05041153|Lenvatinib|lenvatinib|mesh-list
101923664|NCT05041153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101923665|NCT05041153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923666|NCT05041153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101923667|NCT05041153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923668|NCT05041153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101923669|NCT05041153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101923670|NCT05019703|Atezolizumab|atezolizumab|mesh-list
101923671|NCT05019703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101923672|NCT05019703|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101923673|NCT05019703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923674|NCT05019703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101923675|NCT05019703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923676|NCT05019703|Immunologic Factors|immunologic factors|mesh-ancestor
101923677|NCT05019703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923679|NCT04955938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923680|NCT04955938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101923681|NCT04955938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923682|NCT04907851|Denosumab|denosumab|mesh-list
101923683|NCT04907851|Pembrolizumab|pembrolizumab|mesh-list
101923684|NCT04907851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101923685|NCT04907851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923686|NCT04907851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101923687|NCT04907851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923688|NCT04907851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101923689|NCT04907851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923690|NCT04879589|Abiraterone Acetate|abiraterone acetate|mesh-list
101923691|NCT04879589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923692|NCT04879589|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101923693|NCT04879589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101923694|NCT04879589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923695|NCT04879589|Hormone Antagonists|hormone antagonists|mesh-ancestor
101957932|NCT03694197|Protease Inhibitors|protease inhibitors|mesh-ancestor
101230937|NCT04192955|Sensory System Agents|sensory system agents|mesh-ancestor
101923696|NCT04879589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101923697|NCT04879589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923698|NCT04879589|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101923700|NCT04872608|Palbociclib|palbociclib|mesh-list
101923701|NCT04872608|Onapristone|onapristone|mesh-list
101923702|NCT04872608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923703|NCT04872608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101923704|NCT04872608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101923705|NCT04872608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101923706|NCT04872608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923707|NCT04872608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101923708|NCT04872608|Hormone Antagonists|hormone antagonists|mesh-ancestor
101923709|NCT04872608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101923710|NCT04872608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923711|NCT04872608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101923712|NCT04872608|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101923713|NCT04872608|Fertility Agents|fertility agents|mesh-ancestor
101923714|NCT04872608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101923715|NCT04869501|Atezolizumab|atezolizumab|mesh-list
101923716|NCT04869501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101923717|NCT04869501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923718|NCT04869501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101923719|NCT04869501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923720|NCT04831398|Melatonin|melatonin|mesh-list
101923721|NCT04831398|Antioxidants|antioxidants|mesh-ancestor
101923722|NCT04831398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923723|NCT04831398|Protective Agents|protective agents|mesh-ancestor
101923724|NCT04831398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923725|NCT04831398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101923726|NCT04826484|Bupivacaine|bupivacaine|mesh-list
101923727|NCT04826484|Anesthetics, Local|anesthetics, local|mesh-ancestor
101923728|NCT04826484|Anesthetics|anesthetics|mesh-ancestor
101923729|NCT04826484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101923730|NCT04826484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923731|NCT04826484|Sensory System Agents|sensory system agents|mesh-ancestor
101923732|NCT04826484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101923733|NCT04801849|Vitamin E|vitamin e|mesh-list
101923734|NCT04801849|Tocopherols|tocopherols|mesh-list
101923735|NCT04801849|alpha-Tocopherol|alpha-tocopherol|mesh-list
101923736|NCT04801849|Vitamins|vitamins|mesh-ancestor
101923737|NCT04801849|Micronutrients|micronutrients|mesh-ancestor
101923738|NCT04801849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923739|NCT04801849|Antioxidants|antioxidants|mesh-ancestor
101923740|NCT04801849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923741|NCT04801849|Protective Agents|protective agents|mesh-ancestor
101923742|NCT04714359|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
101923743|NCT04714359|Hallucinogens|hallucinogens|mesh-ancestor
101923744|NCT04714359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923745|NCT04714359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101923746|NCT04714359|Serotonin Agents|serotonin agents|mesh-ancestor
101923747|NCT04714359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101923748|NCT04714359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923749|NCT04714359|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101923750|NCT04714359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101923751|NCT04714359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101923752|NCT04714359|Adrenergic Agents|adrenergic agents|mesh-ancestor
101923753|NCT04635839|Heparin|heparin|mesh-list
101923754|NCT04635839|Calcium heparin|calcium heparin|mesh-list
101923755|NCT04635839|Anticoagulants|anticoagulants|mesh-ancestor
101923756|NCT04635839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101923757|NCT04635839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101923758|NCT04635839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923759|NCT04591275|Denosumab|denosumab|mesh-list
101923760|NCT04591275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101923761|NCT04591275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923762|NCT04560179|Tobramycin|tobramycin|mesh-list
101923763|NCT04560179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101923764|NCT04560179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101923765|NCT04560179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101923766|NCT04543591|Ravulizumab|ravulizumab|mesh-list
101923767|NCT04543591|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101923768|NCT04543591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101923769|NCT04543591|Immunologic Factors|immunologic factors|mesh-ancestor
101923770|NCT04543591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923771|NCT04536337|Entecavir|entecavir|mesh-list
101923772|NCT04536337|Antiviral Agents|antiviral agents|mesh-ancestor
101923773|NCT04536337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101923774|NCT04515836|Olaparib|olaparib|mesh-list
101923775|NCT04515836|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101923776|NCT04515836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101923777|NCT04515836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923778|NCT04515836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101643642|NCT00755521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101923779|NCT04441034|Anticonvulsants|anticonvulsants|mesh-list
101923780|NCT04441034|Convulsants|convulsants|mesh-list
101923781|NCT04441034|Antidepressive Agents|antidepressive agents|mesh-list
101923782|NCT04441034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101923783|NCT04441034|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101923784|NCT04441034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923785|NCT04438824|Palbociclib|palbociclib|mesh-list
101923786|NCT04438824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923787|NCT04438824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101923788|NCT04438824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101923789|NCT04438824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923790|NCT04348006|Dexamethasone|dexamethasone|mesh-list
101923791|NCT04348006|Cyclophosphamide|cyclophosphamide|mesh-list
101923792|NCT04348006|Lenalidomide|lenalidomide|mesh-list
101923793|NCT04348006|Bortezomib|bortezomib|mesh-list
101923794|NCT04348006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101923795|NCT04348006|Immunologic Factors|immunologic factors|mesh-ancestor
101923796|NCT04348006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923797|NCT04348006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101923798|NCT04348006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101923799|NCT04348006|Alkylating Agents|alkylating agents|mesh-ancestor
101923800|NCT04348006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923801|NCT04348006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923802|NCT04348006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101923803|NCT04348006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101923804|NCT04348006|Antiemetics|antiemetics|mesh-ancestor
101923805|NCT04348006|Autonomic Agents|autonomic agents|mesh-ancestor
101923806|NCT04348006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101923807|NCT04348006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101923808|NCT04348006|Glucocorticoids|glucocorticoids|mesh-ancestor
101923809|NCT04348006|Hormones|hormones|mesh-ancestor
101923810|NCT04348006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101923811|NCT04348006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101923812|NCT04348006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101923813|NCT04348006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101923814|NCT04348006|Growth Substances|growth substances|mesh-ancestor
101923815|NCT04348006|Growth Inhibitors|growth inhibitors|mesh-ancestor
101923817|NCT04313972|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101923818|NCT04313972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101923819|NCT04313972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923820|NCT04313972|Sensory System Agents|sensory system agents|mesh-ancestor
101923821|NCT04313972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101923822|NCT04304625|Tranexamic Acid|tranexamic acid|mesh-list
101923823|NCT04304625|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101923824|NCT04304625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101923825|NCT04304625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923826|NCT04304625|Hemostatics|hemostatics|mesh-ancestor
101923827|NCT04304625|Coagulants|coagulants|mesh-ancestor
101923828|NCT04295863|Pembrolizumab|pembrolizumab|mesh-list
101923829|NCT04295863|Nivolumab|nivolumab|mesh-list
101923830|NCT04295863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101923831|NCT04295863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923832|NCT04295863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101923833|NCT04295863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923834|NCT04231526|Pembrolizumab|pembrolizumab|mesh-list
101923835|NCT04231526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101923836|NCT04231526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923837|NCT04231526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101923838|NCT04231526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923839|NCT04201873|Poly I-C|poly i-c|mesh-list
101923840|NCT04201873|Pembrolizumab|pembrolizumab|mesh-list
101923841|NCT04201873|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101923842|NCT04201873|Vaccines|vaccines|mesh-list
101923843|NCT04201873|Poly ICLC|poly iclc|mesh-list
101923844|NCT04201873|Immunologic Factors|immunologic factors|mesh-ancestor
101923845|NCT04201873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923846|NCT04201873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101923847|NCT04201873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923848|NCT04201873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101923849|NCT04201873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923850|NCT04201873|Interferon Inducers|interferon inducers|mesh-ancestor
101923851|NCT04201873|Laxatives|laxatives|mesh-ancestor
101923852|NCT04201873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101923853|NCT04201873|Antiviral Agents|antiviral agents|mesh-ancestor
101923854|NCT04201873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101923855|NCT03873883|Pembrolizumab|pembrolizumab|mesh-list
101923856|NCT03873883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101923857|NCT03873883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923858|NCT03873883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101923859|NCT03873883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923860|NCT03785678|Tenecteplase|tenecteplase|mesh-list
101923861|NCT03785678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101923862|NCT03785678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101923863|NCT03785678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923864|NCT03729804|Dexamethasone|dexamethasone|mesh-list
101923865|NCT03729804|Lenalidomide|lenalidomide|mesh-list
101923866|NCT03729804|Bortezomib|bortezomib|mesh-list
101923867|NCT03729804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101923868|NCT03729804|Antiemetics|antiemetics|mesh-ancestor
101923869|NCT03729804|Autonomic Agents|autonomic agents|mesh-ancestor
101923870|NCT03729804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101923871|NCT03729804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923872|NCT03729804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101923873|NCT03729804|Glucocorticoids|glucocorticoids|mesh-ancestor
101923874|NCT03729804|Hormones|hormones|mesh-ancestor
101923875|NCT03729804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101923876|NCT03729804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101923877|NCT03729804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923878|NCT03729804|Immunologic Factors|immunologic factors|mesh-ancestor
101923879|NCT03729804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101923880|NCT03729804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101923881|NCT03729804|Growth Substances|growth substances|mesh-ancestor
101923882|NCT03729804|Growth Inhibitors|growth inhibitors|mesh-ancestor
101923883|NCT03697564|Gemcitabine|gemcitabine|mesh-list
101923884|NCT03697564|Nivolumab|nivolumab|mesh-list
101923885|NCT03697564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101923886|NCT03697564|Antimetabolites|antimetabolites|mesh-ancestor
101923887|NCT03697564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923888|NCT03697564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923889|NCT03697564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101286390|NCT01940653|Progestins|progestins|mesh-ancestor
101923890|NCT03697564|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101923891|NCT03595683|Pembrolizumab|pembrolizumab|mesh-list
101923892|NCT03595683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101923893|NCT03595683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923894|NCT03595683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101923895|NCT03595683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923896|NCT03571321|Cytarabine|cytarabine|mesh-list
101923897|NCT03571321|Dexamethasone|dexamethasone|mesh-list
101923898|NCT03571321|Cyclophosphamide|cyclophosphamide|mesh-list
101923899|NCT03571321|Rituximab|rituximab|mesh-list
101923900|NCT03571321|Doxorubicin|doxorubicin|mesh-list
101923901|NCT03571321|Methotrexate|methotrexate|mesh-list
101923902|NCT03571321|Vincristine|vincristine|mesh-list
101923903|NCT03571321|Mercaptopurine|mercaptopurine|mesh-list
101923904|NCT03571321|Pegaspargase|pegaspargase|mesh-list
101923905|NCT03571321|Thioguanine|thioguanine|mesh-list
101923906|NCT03571321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101923907|NCT03571321|Immunologic Factors|immunologic factors|mesh-ancestor
101236284|NCT01596998|Racepinephrine|racepinephrine|mesh-list
101923908|NCT03571321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923909|NCT03571321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101923910|NCT03571321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101923911|NCT03571321|Alkylating Agents|alkylating agents|mesh-ancestor
101923912|NCT03571321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923913|NCT03571321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923914|NCT03571321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101923915|NCT03571321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101923916|NCT03571321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101923917|NCT03571321|Antiemetics|antiemetics|mesh-ancestor
101923918|NCT03571321|Autonomic Agents|autonomic agents|mesh-ancestor
101923919|NCT03571321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101923920|NCT03571321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101923921|NCT03571321|Glucocorticoids|glucocorticoids|mesh-ancestor
101923922|NCT03571321|Hormones|hormones|mesh-ancestor
101923923|NCT03571321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101923924|NCT03571321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101923925|NCT03571321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101923926|NCT03571321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101923927|NCT03571321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101923928|NCT03571321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101923929|NCT03571321|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101643788|NCT04082260|Alemtuzumab|alemtuzumab|mesh-list
101923930|NCT03571321|Abortifacient Agents|abortifacient agents|mesh-ancestor
101923931|NCT03571321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101923932|NCT03571321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101923933|NCT03571321|Antimetabolites|antimetabolites|mesh-ancestor
101923934|NCT03571321|Dermatologic Agents|dermatologic agents|mesh-ancestor
101923935|NCT03571321|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101923936|NCT03571321|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101923937|NCT03571321|Antiviral Agents|antiviral agents|mesh-ancestor
101923938|NCT03571321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101923939|NCT03571321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101923940|NCT03571321|Tubulin Modulators|tubulin modulators|mesh-ancestor
101923941|NCT03571321|Antimitotic Agents|antimitotic agents|mesh-ancestor
101923942|NCT03571321|Mitosis Modulators|mitosis modulators|mesh-ancestor
101923943|NCT03565445|Pembrolizumab|pembrolizumab|mesh-list
101923944|NCT03565445|Nivolumab|nivolumab|mesh-list
101923945|NCT03565445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101923946|NCT03565445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923947|NCT03565445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101923948|NCT03565445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923949|NCT03516812|Methyltestosterone|methyltestosterone|mesh-list
101923950|NCT03516812|Olaparib|olaparib|mesh-list
101923951|NCT03516812|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
101923952|NCT03516812|Testosterone|testosterone|mesh-list
101923953|NCT03516812|Testosterone undecanoate|testosterone undecanoate|mesh-list
101923954|NCT03516812|Testosterone enanthate|testosterone enanthate|mesh-list
101923955|NCT03516812|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101923956|NCT03516812|Androgens|androgens|mesh-ancestor
101923957|NCT03516812|Hormones|hormones|mesh-ancestor
101923958|NCT03516812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101923959|NCT03516812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923960|NCT03516812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101923961|NCT03516812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923962|NCT03516812|Anabolic Agents|anabolic agents|mesh-ancestor
101923963|NCT03516812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101923964|NCT03516812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923966|NCT03500445|Lenalidomide|lenalidomide|mesh-list
101923967|NCT03500445|Daratumumab|daratumumab|mesh-list
101923968|NCT03500445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101923969|NCT03500445|Antiemetics|antiemetics|mesh-ancestor
101923970|NCT03500445|Autonomic Agents|autonomic agents|mesh-ancestor
101923971|NCT03500445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101923972|NCT03500445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101923973|NCT03500445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101923974|NCT03500445|Glucocorticoids|glucocorticoids|mesh-ancestor
101923975|NCT03500445|Hormones|hormones|mesh-ancestor
101957946|NCT04000815|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
101923976|NCT03500445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101923977|NCT03500445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101923978|NCT03500445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101923979|NCT03500445|Immunologic Factors|immunologic factors|mesh-ancestor
101923980|NCT03500445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101923981|NCT03500445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101923982|NCT03500445|Growth Substances|growth substances|mesh-ancestor
101923983|NCT03500445|Growth Inhibitors|growth inhibitors|mesh-ancestor
101923985|NCT03494530|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101923986|NCT03494530|Antithrombins|antithrombins|mesh-ancestor
101923987|NCT03494530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101923988|NCT03494530|Protease Inhibitors|protease inhibitors|mesh-ancestor
101923989|NCT03494530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101923990|NCT03494530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923991|NCT03494530|Anticoagulants|anticoagulants|mesh-ancestor
101923992|NCT03466736|Flutemetamol|flutemetamol|mesh-list
101923993|NCT03466736|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101923994|NCT03466736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101923995|NCT03423264|Gabapentin|gabapentin|mesh-list
101923996|NCT03423264|Analgesics|analgesics|mesh-ancestor
101923997|NCT03423264|Sensory System Agents|sensory system agents|mesh-ancestor
101923998|NCT03423264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101923999|NCT03423264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924000|NCT03423264|Anticonvulsants|anticonvulsants|mesh-ancestor
101924001|NCT03423264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101924002|NCT03423264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101924003|NCT03423264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101924004|NCT03423264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101924005|NCT03423264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101924006|NCT03423264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101924007|NCT03423264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101924008|NCT03423264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924009|NCT03423264|Antimanic Agents|antimanic agents|mesh-ancestor
101924010|NCT03225547|Pembrolizumab|pembrolizumab|mesh-list
101924011|NCT03225547|Mifepristone|mifepristone|mesh-list
101924012|NCT03225547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101924013|NCT03225547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924014|NCT03225547|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101924015|NCT03225547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924016|NCT03225547|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101924017|NCT03225547|Abortifacient Agents|abortifacient agents|mesh-ancestor
101924018|NCT03225547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101924019|NCT03225547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924020|NCT03225547|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101924021|NCT03225547|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101924022|NCT03225547|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101924023|NCT03225547|Contraceptive Agents|contraceptive agents|mesh-ancestor
101924024|NCT03225547|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101924025|NCT03225547|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101924026|NCT03225547|Hormone Antagonists|hormone antagonists|mesh-ancestor
101924027|NCT03225547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101924028|NCT03225547|Luteolytic Agents|luteolytic agents|mesh-ancestor
101924029|NCT03225547|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101924030|NCT03225547|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101924031|NCT02990533|Methyltestosterone|methyltestosterone|mesh-list
101924032|NCT02990533|Testosterone|testosterone|mesh-list
101924033|NCT02990533|Testosterone undecanoate|testosterone undecanoate|mesh-list
101924034|NCT02990533|Testosterone enanthate|testosterone enanthate|mesh-list
101924035|NCT02990533|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101924036|NCT02990533|Androgens|androgens|mesh-ancestor
101924037|NCT02990533|Hormones|hormones|mesh-ancestor
101924038|NCT02990533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101924039|NCT02990533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924040|NCT02990533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101924041|NCT02990533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924042|NCT02990533|Anabolic Agents|anabolic agents|mesh-ancestor
101924044|NCT02969837|Lenalidomide|lenalidomide|mesh-list
101924046|NCT02969837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101924047|NCT02969837|Antiemetics|antiemetics|mesh-ancestor
101924048|NCT02969837|Autonomic Agents|autonomic agents|mesh-ancestor
101924049|NCT02969837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101924050|NCT02969837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924051|NCT02969837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101924052|NCT02969837|Glucocorticoids|glucocorticoids|mesh-ancestor
101924053|NCT02969837|Hormones|hormones|mesh-ancestor
101924054|NCT02969837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101924055|NCT02969837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101924056|NCT02969837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924057|NCT02969837|Immunologic Factors|immunologic factors|mesh-ancestor
101924058|NCT02969837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101924059|NCT02969837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101924060|NCT02969837|Growth Substances|growth substances|mesh-ancestor
101924061|NCT02969837|Growth Inhibitors|growth inhibitors|mesh-ancestor
101924062|NCT02776917|Paclitaxel|paclitaxel|mesh-list
101924063|NCT02776917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101924064|NCT02776917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924065|NCT02776917|Tubulin Modulators|tubulin modulators|mesh-ancestor
101924066|NCT02776917|Antimitotic Agents|antimitotic agents|mesh-ancestor
101924067|NCT02776917|Mitosis Modulators|mitosis modulators|mesh-ancestor
101924068|NCT02776917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924069|NCT02751255|Tretinoin|tretinoin|mesh-list
101924070|NCT02751255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924071|NCT02751255|Keratolytic Agents|keratolytic agents|mesh-ancestor
101924072|NCT02751255|Dermatologic Agents|dermatologic agents|mesh-ancestor
101924073|NCT02707666|Pembrolizumab|pembrolizumab|mesh-list
101924074|NCT02707666|Pemetrexed|pemetrexed|mesh-list
101924075|NCT02707666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924076|NCT02707666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101924077|NCT02707666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101924078|NCT02707666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924079|NCT02707666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101924080|NCT02707666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101924081|NCT02707666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101924083|NCT02668770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101924084|NCT02668770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924085|NCT02668770|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101924086|NCT02668770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924087|NCT02659293|Dexamethasone|dexamethasone|mesh-list
101924088|NCT02659293|Lenalidomide|lenalidomide|mesh-list
101924089|NCT02659293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101924090|NCT02659293|Antiemetics|antiemetics|mesh-ancestor
101924091|NCT02659293|Autonomic Agents|autonomic agents|mesh-ancestor
101924092|NCT02659293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101924093|NCT02659293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924094|NCT02659293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101924095|NCT02659293|Glucocorticoids|glucocorticoids|mesh-ancestor
101924096|NCT02659293|Hormones|hormones|mesh-ancestor
101924097|NCT02659293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101924098|NCT02659293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101924099|NCT02659293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924100|NCT02659293|Immunologic Factors|immunologic factors|mesh-ancestor
101924101|NCT02659293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101924102|NCT02659293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101924103|NCT02659293|Growth Substances|growth substances|mesh-ancestor
101924104|NCT02659293|Growth Inhibitors|growth inhibitors|mesh-ancestor
101924105|NCT02656511|Tenofovir|tenofovir|mesh-list
101924106|NCT02656511|Emtricitabine|emtricitabine|mesh-list
101924107|NCT02656511|Dolutegravir|dolutegravir|mesh-list
101924108|NCT02656511|Antiviral Agents|antiviral agents|mesh-ancestor
101924109|NCT02656511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101924110|NCT02656511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101924111|NCT02656511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101957960|NCT03743883|Aspirin|aspirin|mesh-list
101924112|NCT02656511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101286620|NCT01941979|Leucovorin|leucovorin|mesh-list
101924113|NCT02656511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924114|NCT02656511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101924115|NCT02656511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101924116|NCT02656511|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101924117|NCT02656511|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101924118|NCT02613169|Isoniazid|isoniazid|mesh-list
101924119|NCT02613169|Antitubercular Agents|antitubercular agents|mesh-ancestor
101924120|NCT02613169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101924121|NCT02613169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101924122|NCT02613169|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101924123|NCT02613169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101924124|NCT02613169|Antimetabolites|antimetabolites|mesh-ancestor
101924125|NCT02613169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924126|NCT02613169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101924127|NCT02572323|Tesamorelin|tesamorelin|mesh-list
101924128|NCT02572323|Growth Substances|growth substances|mesh-ancestor
101924129|NCT02572323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924130|NCT02513186|Dexamethasone|dexamethasone|mesh-list
101924131|NCT02513186|Cyclophosphamide|cyclophosphamide|mesh-list
101924132|NCT02513186|Lenalidomide|lenalidomide|mesh-list
101924133|NCT02513186|Bortezomib|bortezomib|mesh-list
101924134|NCT02513186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101924135|NCT02513186|Immunologic Factors|immunologic factors|mesh-ancestor
101924136|NCT02513186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924137|NCT02513186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101924138|NCT02513186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101924139|NCT02513186|Alkylating Agents|alkylating agents|mesh-ancestor
101924140|NCT02513186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924141|NCT02513186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924142|NCT02513186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101924143|NCT02513186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101924144|NCT02513186|Antiemetics|antiemetics|mesh-ancestor
101924145|NCT02513186|Autonomic Agents|autonomic agents|mesh-ancestor
101924146|NCT02513186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101924147|NCT02513186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101924148|NCT02513186|Glucocorticoids|glucocorticoids|mesh-ancestor
101924149|NCT02513186|Hormones|hormones|mesh-ancestor
101924150|NCT02513186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101924151|NCT02513186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101924152|NCT02513186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101924153|NCT02513186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101924154|NCT02513186|Growth Substances|growth substances|mesh-ancestor
101924155|NCT02513186|Growth Inhibitors|growth inhibitors|mesh-ancestor
101924156|NCT02441491|Cyclophosphamide|cyclophosphamide|mesh-list
101924157|NCT02441491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101924158|NCT02441491|Immunologic Factors|immunologic factors|mesh-ancestor
101924159|NCT02441491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924160|NCT02441491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101924161|NCT02441491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101924162|NCT02441491|Alkylating Agents|alkylating agents|mesh-ancestor
101924163|NCT02441491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924164|NCT02441491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924165|NCT02441491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101924166|NCT02431988|Cyclophosphamide|cyclophosphamide|mesh-list
101924167|NCT02431988|Fludarabine|fludarabine|mesh-list
101924168|NCT02431988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101924169|NCT02431988|Immunologic Factors|immunologic factors|mesh-ancestor
101230990|NCT04023071|Cyclophosphamide|cyclophosphamide|mesh-list
101924170|NCT02431988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924171|NCT02431988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101924172|NCT02431988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101924173|NCT02431988|Alkylating Agents|alkylating agents|mesh-ancestor
101924174|NCT02431988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924175|NCT02431988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924176|NCT02431988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101924177|NCT02399371|Pembrolizumab|pembrolizumab|mesh-list
101924178|NCT02399371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101924179|NCT02399371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924180|NCT02399371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101924181|NCT02399371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924182|NCT02389517|Dexamethasone|dexamethasone|mesh-list
101924183|NCT02389517|Lenalidomide|lenalidomide|mesh-list
101924184|NCT02389517|Ixazomib|ixazomib|mesh-list
101924185|NCT02389517|Glycine|glycine|mesh-list
101924186|NCT02389517|Proteasome Inhibitors|proteasome inhibitors|mesh-list
101924187|NCT02389517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101924188|NCT02389517|Antiemetics|antiemetics|mesh-ancestor
101924189|NCT02389517|Autonomic Agents|autonomic agents|mesh-ancestor
101924190|NCT02389517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101924191|NCT02389517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924192|NCT02389517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101924193|NCT02389517|Glucocorticoids|glucocorticoids|mesh-ancestor
101924194|NCT02389517|Hormones|hormones|mesh-ancestor
101924195|NCT02389517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101924196|NCT02389517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101924197|NCT02389517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924198|NCT02389517|Immunologic Factors|immunologic factors|mesh-ancestor
101924199|NCT02389517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101924200|NCT02389517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101924201|NCT02389517|Growth Substances|growth substances|mesh-ancestor
101924202|NCT02389517|Growth Inhibitors|growth inhibitors|mesh-ancestor
101924203|NCT02389517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924204|NCT02389517|Protease Inhibitors|protease inhibitors|mesh-ancestor
101924205|NCT02389517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101924206|NCT02389517|Glycine Agents|glycine agents|mesh-ancestor
101924207|NCT02389517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101924208|NCT02366819|Leucovorin|leucovorin|mesh-list
101924209|NCT02366819|Fluorouracil|fluorouracil|mesh-list
101924210|NCT02366819|Oxaliplatin|oxaliplatin|mesh-list
101924211|NCT02366819|Irinotecan|irinotecan|mesh-list
101924212|NCT02366819|Calcium|calcium|mesh-list
101924213|NCT02366819|Levoleucovorin|levoleucovorin|mesh-list
101924214|NCT02366819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101924215|NCT02366819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924216|NCT02366819|Antimetabolites|antimetabolites|mesh-ancestor
101924217|NCT02366819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924218|NCT02366819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101924219|NCT02366819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924220|NCT02366819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101924221|NCT02366819|Immunologic Factors|immunologic factors|mesh-ancestor
101924222|NCT02366819|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101924223|NCT02366819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101924224|NCT02366819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101924225|NCT02366819|Antidotes|antidotes|mesh-ancestor
101924226|NCT02366819|Protective Agents|protective agents|mesh-ancestor
101924227|NCT02366819|Vitamin B Complex|vitamin b complex|mesh-ancestor
101924228|NCT02366819|Vitamins|vitamins|mesh-ancestor
101924229|NCT02366819|Micronutrients|micronutrients|mesh-ancestor
101644092|NCT02586454|Analgesics|analgesics|mesh-ancestor
101924230|NCT02352948|Gemcitabine|gemcitabine|mesh-list
101924231|NCT02352948|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101924232|NCT02352948|Durvalumab|durvalumab|mesh-list
101924233|NCT02352948|Vinorelbine|vinorelbine|mesh-list
101924234|NCT02352948|Tremelimumab|tremelimumab|mesh-list
101924235|NCT02352948|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101924236|NCT02352948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101924237|NCT02352948|Antimetabolites|antimetabolites|mesh-ancestor
101924238|NCT02352948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924239|NCT02352948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924240|NCT02352948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101924241|NCT02352948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101924242|NCT02352948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101924243|NCT02352948|Immunologic Factors|immunologic factors|mesh-ancestor
101924244|NCT02352948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101957973|NCT03743883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101924245|NCT02352948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101924246|NCT02352948|Tubulin Modulators|tubulin modulators|mesh-ancestor
101924247|NCT02352948|Antimitotic Agents|antimitotic agents|mesh-ancestor
101924248|NCT02352948|Mitosis Modulators|mitosis modulators|mesh-ancestor
101924249|NCT02333162|Mycophenolic Acid|mycophenolic acid|mesh-list
101924250|NCT02333162|Fludarabine|fludarabine|mesh-list
101924251|NCT02333162|Fludarabine phosphate|fludarabine phosphate|mesh-list
101924252|NCT02333162|Melphalan|melphalan|mesh-list
101924253|NCT02333162|Tacrolimus|tacrolimus|mesh-list
101924254|NCT02333162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924255|NCT02333162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101924256|NCT02333162|Antimetabolites|antimetabolites|mesh-ancestor
101924257|NCT02333162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924258|NCT02333162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101924259|NCT02333162|Immunologic Factors|immunologic factors|mesh-ancestor
101924260|NCT02333162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924261|NCT02333162|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101924262|NCT02333162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101924263|NCT02333162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101924264|NCT02333162|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101924265|NCT02333162|Antitubercular Agents|antitubercular agents|mesh-ancestor
101924266|NCT02333162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101924267|NCT02333162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101924268|NCT02333162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101924269|NCT02333162|Alkylating Agents|alkylating agents|mesh-ancestor
101924270|NCT02333162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101924271|NCT02281838|Enalapril|enalapril|mesh-list
101924272|NCT02281838|Labetalol|labetalol|mesh-list
101924273|NCT02281838|Hydralazine|hydralazine|mesh-list
101924274|NCT02281838|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101924275|NCT02281838|Protease Inhibitors|protease inhibitors|mesh-ancestor
101924276|NCT02281838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101924277|NCT02281838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924278|NCT02281838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101924279|NCT02281838|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101924280|NCT02281838|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101924281|NCT02281838|Adrenergic Agents|adrenergic agents|mesh-ancestor
101924282|NCT02281838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101924283|NCT02281838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924284|NCT02281838|Sympathomimetics|sympathomimetics|mesh-ancestor
101924285|NCT02281838|Autonomic Agents|autonomic agents|mesh-ancestor
101924286|NCT02281838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101924287|NCT02281838|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101924288|NCT02281838|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101924289|NCT02281838|Vasodilator Agents|vasodilator agents|mesh-ancestor
101924290|NCT02213913|Prednisone|prednisone|mesh-list
101924291|NCT02213913|Cyclophosphamide|cyclophosphamide|mesh-list
101924292|NCT02213913|Rituximab|rituximab|mesh-list
101924293|NCT02213913|Doxorubicin|doxorubicin|mesh-list
101924294|NCT02213913|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101924295|NCT02213913|Etoposide|etoposide|mesh-list
101924296|NCT02213913|Vincristine|vincristine|mesh-list
101924297|NCT02213913|Lenalidomide|lenalidomide|mesh-list
101924298|NCT02213913|Etoposide phosphate|etoposide phosphate|mesh-list
101924299|NCT02213913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101924300|NCT02213913|Immunologic Factors|immunologic factors|mesh-ancestor
101924301|NCT02213913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924302|NCT02213913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101924303|NCT02213913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101924304|NCT02213913|Alkylating Agents|alkylating agents|mesh-ancestor
101924305|NCT02213913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924306|NCT02213913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924307|NCT02213913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101924308|NCT02213913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101924309|NCT02213913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101924310|NCT02213913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101924311|NCT02213913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101924313|NCT02213913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101924314|NCT02213913|Glucocorticoids|glucocorticoids|mesh-ancestor
101924315|NCT02213913|Hormones|hormones|mesh-ancestor
101924316|NCT02213913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101236704|NCT01599117|Udenafil|udenafil|mesh-list
101924317|NCT02213913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101924318|NCT02213913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101924319|NCT02213913|Tubulin Modulators|tubulin modulators|mesh-ancestor
101924320|NCT02213913|Antimitotic Agents|antimitotic agents|mesh-ancestor
101924321|NCT02213913|Mitosis Modulators|mitosis modulators|mesh-ancestor
101924322|NCT02213913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101924323|NCT02213913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101924324|NCT02213913|Growth Substances|growth substances|mesh-ancestor
101924325|NCT02213913|Growth Inhibitors|growth inhibitors|mesh-ancestor
101924326|NCT01847326|Paclitaxel|paclitaxel|mesh-list
101924327|NCT01847326|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101924328|NCT01847326|Carboplatin|carboplatin|mesh-list
101924329|NCT01847326|Fluorouracil|fluorouracil|mesh-list
101924330|NCT01847326|Hydroxyurea|hydroxyurea|mesh-list
101924331|NCT01847326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101924332|NCT01847326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924333|NCT01847326|Tubulin Modulators|tubulin modulators|mesh-ancestor
101924334|NCT01847326|Antimitotic Agents|antimitotic agents|mesh-ancestor
101924335|NCT01847326|Mitosis Modulators|mitosis modulators|mesh-ancestor
101924336|NCT01847326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924337|NCT01847326|Antimetabolites|antimetabolites|mesh-ancestor
101924338|NCT01847326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101924339|NCT01847326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101924340|NCT01847326|Immunologic Factors|immunologic factors|mesh-ancestor
101924341|NCT01847326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924342|NCT01847326|Antisickling Agents|antisickling agents|mesh-ancestor
101924343|NCT01847326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101924344|NCT01847326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101924345|NCT01665794|Dexamethasone|dexamethasone|mesh-list
101924346|NCT01665794|Daratumumab|daratumumab|mesh-list
101924347|NCT01665794|Pomalidomide|pomalidomide|mesh-list
101924348|NCT01665794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101924349|NCT01665794|Antiemetics|antiemetics|mesh-ancestor
101924350|NCT01665794|Autonomic Agents|autonomic agents|mesh-ancestor
101924351|NCT01665794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101924352|NCT01665794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924353|NCT01665794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101924354|NCT01665794|Glucocorticoids|glucocorticoids|mesh-ancestor
101924355|NCT01665794|Hormones|hormones|mesh-ancestor
101924356|NCT01665794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101924357|NCT01665794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101924358|NCT01665794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924359|NCT01665794|Immunologic Factors|immunologic factors|mesh-ancestor
101924360|NCT01665794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101924361|NCT01665794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101924362|NCT01665794|Growth Substances|growth substances|mesh-ancestor
101924363|NCT01665794|Growth Inhibitors|growth inhibitors|mesh-ancestor
101924364|NCT01526096|Plerixafor|plerixafor|mesh-list
101924365|NCT01526096|Melphalan|melphalan|mesh-list
101924366|NCT01526096|Basiliximab|basiliximab|mesh-list
101924367|NCT01526096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101924368|NCT01526096|Alkylating Agents|alkylating agents|mesh-ancestor
101924369|NCT01526096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924370|NCT01526096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924371|NCT01526096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101924372|NCT01526096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101924373|NCT01526096|Immunologic Factors|immunologic factors|mesh-ancestor
101924374|NCT01526096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924375|NCT01526096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101924376|NCT01526096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101924377|NCT01526096|Antiviral Agents|antiviral agents|mesh-ancestor
101924378|NCT01526096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101924379|NCT01369212|Tenofovir|tenofovir|mesh-list
101924380|NCT01369212|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101924381|NCT01369212|Antiviral Agents|antiviral agents|mesh-ancestor
101924382|NCT01369212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101644240|NCT00603824|Anticoagulants|anticoagulants|mesh-ancestor
101924383|NCT01369212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101924384|NCT01369212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101924385|NCT01369212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101924386|NCT01369212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924387|NCT01369212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101957986|NCT03988803|Nootropic Agents|nootropic agents|mesh-ancestor
101924388|NCT01369212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101924390|NCT00800215|Anticonvulsants|anticonvulsants|mesh-ancestor
101924391|NCT00800215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101924392|NCT00800215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101924393|NCT00800215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101924394|NCT00800215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924395|NCT00669734|Metronidazole|metronidazole|mesh-list
101924396|NCT00669734|Tricyclodecane-9-yl-xanthogenate|tricyclodecane-9-yl-xanthogenate|mesh-list
101924397|NCT00669734|Vaccines|vaccines|mesh-list
101924398|NCT00669734|Sargramostim|sargramostim|mesh-list
101924399|NCT00669734|Immunologic Factors|immunologic factors|mesh-ancestor
101924400|NCT00669734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924401|NCT00669734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924402|NCT00669734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101924403|NCT00669734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101924404|NCT00669734|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101924405|NCT00669734|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101924406|NCT00669734|Antioxidants|antioxidants|mesh-ancestor
101924407|NCT00669734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924408|NCT00669734|Protective Agents|protective agents|mesh-ancestor
101924409|NCT00669734|Antiviral Agents|antiviral agents|mesh-ancestor
101924410|NCT00669734|Growth Inhibitors|growth inhibitors|mesh-ancestor
101924411|NCT00669734|Growth Substances|growth substances|mesh-ancestor
101924412|NCT00669734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101924413|NCT00669734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101924414|NCT00337649|Trastuzumab|trastuzumab|mesh-list
101924415|NCT00337649|Epothilones|epothilones|mesh-list
101924416|NCT00337649|Desoxyepothilone B|desoxyepothilone b|mesh-list
101924417|NCT00337649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101924418|NCT00337649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924419|NCT00337649|Tubulin Modulators|tubulin modulators|mesh-ancestor
101924420|NCT00337649|Antimitotic Agents|antimitotic agents|mesh-ancestor
101924421|NCT00337649|Mitosis Modulators|mitosis modulators|mesh-ancestor
101924422|NCT00337649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924423|NCT00071084|Zanolimumab|zanolimumab|mesh-list
101924424|NCT00071084|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101924425|NCT00071084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101924426|NCT00071084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924427|NCT00071084|Immunologic Factors|immunologic factors|mesh-ancestor
101924428|NCT00071084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924429|NCT00042406|Zanolimumab|zanolimumab|mesh-list
101924430|NCT00042406|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101924431|NCT00042406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101924432|NCT00042406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924433|NCT00042406|Immunologic Factors|immunologic factors|mesh-ancestor
101924434|NCT00042406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924435|NCT01170078|Epoetin Alfa|epoetin alfa|mesh-list
101924436|NCT01170078|Hematinics|hematinics|mesh-ancestor
101924437|NCT01283646|Vitamins|vitamins|mesh-list
101924438|NCT01283646|Folic Acid|folic acid|mesh-list
101924439|NCT01283646|Vitamin B Complex|vitamin b complex|mesh-list
101924440|NCT01283646|Micronutrients|micronutrients|mesh-ancestor
101924441|NCT01283646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924442|NCT01283646|Hematinics|hematinics|mesh-ancestor
101924443|NCT01283724|Dienogest|dienogest|mesh-list
101924444|NCT01283724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101924445|NCT01283724|Contraceptive Agents|contraceptive agents|mesh-ancestor
101924446|NCT01283724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101924447|NCT01283724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924448|NCT01283724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101924449|NCT01283724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101924450|NCT01283724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101924451|NCT01283724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101924452|NCT01283724|Hormone Antagonists|hormone antagonists|mesh-ancestor
101924453|NCT01283724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101924454|NCT01283724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101924455|NCT01283724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924456|NCT01586442|Eplerenone|eplerenone|mesh-list
101924457|NCT01586442|Spironolactone|spironolactone|mesh-list
101924458|NCT01586442|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101924460|NCT01586442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101924461|NCT01586442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924462|NCT01586442|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101924463|NCT01586442|Diuretics|diuretics|mesh-ancestor
101924464|NCT01586442|Natriuretic Agents|natriuretic agents|mesh-ancestor
101924465|NCT01586442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101924466|NCT01587066|Valproic Acid|valproic acid|mesh-list
101924467|NCT01587066|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101924468|NCT01587066|Antidepressive Agents|antidepressive agents|mesh-ancestor
101924469|NCT01587066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101924470|NCT01587066|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101924471|NCT01587066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101924472|NCT01587066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101924473|NCT01587066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924474|NCT01587066|Anticonvulsants|anticonvulsants|mesh-ancestor
101924475|NCT01587066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101924476|NCT01587066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924477|NCT01587066|GABA Agents|gaba agents|mesh-ancestor
101924478|NCT01587066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101924479|NCT01587066|Antimanic Agents|antimanic agents|mesh-ancestor
101924480|NCT01587144|Lucanthone|lucanthone|mesh-list
101924481|NCT01587144|Temozolomide|temozolomide|mesh-list
101924482|NCT01587144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101924483|NCT01587144|Alkylating Agents|alkylating agents|mesh-ancestor
101924484|NCT01587144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924485|NCT01587144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924486|NCT01587144|Schistosomicides|schistosomicides|mesh-ancestor
101924487|NCT01587144|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101924488|NCT01587144|Anthelmintics|anthelmintics|mesh-ancestor
101924489|NCT01587144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101924490|NCT01587144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101924492|NCT01587222|Midodrine|midodrine|mesh-list
101924493|NCT01587222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101924494|NCT01587222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101924495|NCT01587222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924496|NCT01587222|Sympathomimetics|sympathomimetics|mesh-ancestor
101924497|NCT01587222|Autonomic Agents|autonomic agents|mesh-ancestor
101924498|NCT01587222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101924499|NCT01587222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924500|NCT01587222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101924501|NCT01587222|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101924502|NCT01587222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101924503|NCT01587222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101924504|NCT01587222|Adrenergic Agents|adrenergic agents|mesh-ancestor
101924505|NCT01587222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101924506|NCT01587222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924507|NCT01167738|Metformin|metformin|mesh-list
101924508|NCT01167738|Gemcitabine|gemcitabine|mesh-list
101924509|NCT01167738|Capecitabine|capecitabine|mesh-list
101924510|NCT01167738|Epirubicin|epirubicin|mesh-list
101924511|NCT01167738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924512|NCT01167738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101924513|NCT01167738|Antimetabolites|antimetabolites|mesh-ancestor
101924514|NCT01167738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924515|NCT01167738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101924516|NCT01167738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924517|NCT01167738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101957999|NCT00180713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101924518|NCT01167738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101924519|NCT01167738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101924520|NCT01167738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101924521|NCT01167816|Azacitidine|azacitidine|mesh-list
101924522|NCT01167816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101924523|NCT01167816|Antimetabolites|antimetabolites|mesh-ancestor
101924524|NCT01167816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924525|NCT01167816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924526|NCT01167816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101924527|NCT01167894|Simvastatin|simvastatin|mesh-list
101924528|NCT01167894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101924529|NCT01167894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101924530|NCT01167894|Antimetabolites|antimetabolites|mesh-ancestor
101924531|NCT01167894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924532|NCT01167894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101644389|NCT00673465|Metformin|metformin|mesh-list
101924533|NCT01167894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101924535|NCT03870828|Dimercaprol|dimercaprol|mesh-list
101924536|NCT03870828|Chelating Agents|chelating agents|mesh-ancestor
101924537|NCT03870828|Sequestering Agents|sequestering agents|mesh-ancestor
101924538|NCT03870828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924539|NCT03870594|Chrysarobin|chrysarobin|mesh-list
101924540|NCT03870594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101924541|NCT03870594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101924542|NCT03870594|Analgesics|analgesics|mesh-ancestor
101924543|NCT03870594|Sensory System Agents|sensory system agents|mesh-ancestor
101924544|NCT03870594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101924545|NCT03870594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924546|NCT03870594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101924547|NCT03870594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101924548|NCT01165866|Ondansetron|ondansetron|mesh-list
101924549|NCT01165866|Metoclopramide|metoclopramide|mesh-list
101924550|NCT01165866|Antiemetics|antiemetics|mesh-ancestor
101924551|NCT01165866|Autonomic Agents|autonomic agents|mesh-ancestor
101924552|NCT01165866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101924553|NCT01165866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924554|NCT01165866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101924555|NCT01165866|Antipruritics|antipruritics|mesh-ancestor
101924556|NCT01165866|Dermatologic Agents|dermatologic agents|mesh-ancestor
101924557|NCT01165866|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101924558|NCT01165866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101924559|NCT01165866|Serotonin Agents|serotonin agents|mesh-ancestor
101924560|NCT01165866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101924561|NCT01165866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924562|NCT01165866|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101924563|NCT01165866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101924564|NCT01165866|Dopamine Agents|dopamine agents|mesh-ancestor
101924565|NCT01170468|Vitamin D|vitamin d|mesh-list
101924566|NCT01170468|Cholecalciferol|cholecalciferol|mesh-list
101924567|NCT01170468|Vitamins|vitamins|mesh-ancestor
101924568|NCT01170468|Micronutrients|micronutrients|mesh-ancestor
101924569|NCT01170468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924570|NCT01170468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101924571|NCT01170468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101924572|NCT01273584|Metformin|metformin|mesh-list
101924573|NCT01273584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101924574|NCT01273584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924575|NCT01281852|Paclitaxel|paclitaxel|mesh-list
101924576|NCT01281852|Cisplatin|cisplatin|mesh-list
101924577|NCT01281852|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101924578|NCT01281852|Veliparib|veliparib|mesh-list
101924579|NCT01281852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101924580|NCT01281852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924581|NCT01281852|Tubulin Modulators|tubulin modulators|mesh-ancestor
101924582|NCT01281852|Antimitotic Agents|antimitotic agents|mesh-ancestor
101924583|NCT01281852|Mitosis Modulators|mitosis modulators|mesh-ancestor
101924584|NCT01281852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924585|NCT01281852|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101924586|NCT01281852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101924587|NCT01168440|Sunitinib|sunitinib|mesh-list
101924588|NCT01168440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924589|NCT01168440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101924590|NCT01168440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101924591|NCT01168440|Growth Substances|growth substances|mesh-ancestor
101924592|NCT01168440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924593|NCT01168440|Growth Inhibitors|growth inhibitors|mesh-ancestor
101924594|NCT01168440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101924595|NCT01168440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101924596|NCT01168440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924597|NCT01170780|Dexamethasone|dexamethasone|mesh-list
101924598|NCT01170780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101924599|NCT01170780|Antiemetics|antiemetics|mesh-ancestor
101924600|NCT01170780|Autonomic Agents|autonomic agents|mesh-ancestor
101924601|NCT01170780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101924602|NCT01170780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924603|NCT01170780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101924604|NCT01170780|Glucocorticoids|glucocorticoids|mesh-ancestor
101924605|NCT01170780|Hormones|hormones|mesh-ancestor
101924606|NCT01170780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101924607|NCT01170780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101924608|NCT01170780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924609|NCT01165944|Pramlintide|pramlintide|mesh-list
101924610|NCT01165944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101924611|NCT01165944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924612|NCT01170858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101924613|NCT01170858|Icodextrin|icodextrin|mesh-list
101924614|NCT01170858|Dialysis Solutions|dialysis solutions|mesh-ancestor
101924615|NCT01171092|Bortezomib|bortezomib|mesh-list
101924616|NCT01171092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924617|NCT03753204|Furosemide|furosemide|mesh-list
101924618|NCT03753204|Diuretics|diuretics|mesh-ancestor
101924619|NCT03753204|Natriuretic Agents|natriuretic agents|mesh-ancestor
101924620|NCT03753204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924621|NCT03753204|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101924622|NCT03753204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101924623|NCT03753204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924624|NCT01171170|Paclitaxel|paclitaxel|mesh-list
101924625|NCT01171170|Bevacizumab|bevacizumab|mesh-list
101924626|NCT01171170|Carboplatin|carboplatin|mesh-list
101924627|NCT01171170|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101924628|NCT01171170|Nitroglycerin|nitroglycerin|mesh-list
101924629|NCT01171170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101924630|NCT01171170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924631|NCT01171170|Tubulin Modulators|tubulin modulators|mesh-ancestor
101924632|NCT01171170|Antimitotic Agents|antimitotic agents|mesh-ancestor
101924633|NCT01171170|Mitosis Modulators|mitosis modulators|mesh-ancestor
101924634|NCT01171170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924635|NCT01171170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101924636|NCT01171170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101924637|NCT01171170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101924638|NCT01171170|Growth Substances|growth substances|mesh-ancestor
101924639|NCT01171170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924640|NCT01171170|Growth Inhibitors|growth inhibitors|mesh-ancestor
101924641|NCT01171170|Vasodilator Agents|vasodilator agents|mesh-ancestor
101924643|NCT01166100|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101924644|NCT01166100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101924645|NCT01166100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101924646|NCT01166100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924647|NCT01166100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101924648|NCT01166100|Serotonin Agents|serotonin agents|mesh-ancestor
101924649|NCT01166100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924650|NCT01166100|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101924651|NCT01166100|Antidepressive Agents|antidepressive agents|mesh-ancestor
101924652|NCT01166100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101924653|NCT01166100|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101924654|NCT01166100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101924655|NCT01166100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101924656|NCT01277016|Melphalan|melphalan|mesh-list
101924657|NCT01277016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101924658|NCT01277016|Alkylating Agents|alkylating agents|mesh-ancestor
101924659|NCT01277016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924660|NCT01277016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924661|NCT01277016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101924662|NCT01277016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101924663|NCT01277016|Immunologic Factors|immunologic factors|mesh-ancestor
101924664|NCT01277016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924665|NCT01171326|Minocycline|minocycline|mesh-list
101924666|NCT01171326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101924667|NCT01171326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101924668|NCT01171482|Fluorouracil|fluorouracil|mesh-list
101924669|NCT01171482|Sorafenib|sorafenib|mesh-list
101924670|NCT01171482|Mitomycins|mitomycins|mesh-list
101924671|NCT01171482|Mitomycin|mitomycin|mesh-list
101924672|NCT01171482|Antimetabolites|antimetabolites|mesh-ancestor
101924673|NCT01171482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924674|NCT01171482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101924675|NCT01171482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924676|NCT01171482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101924677|NCT01171482|Immunologic Factors|immunologic factors|mesh-ancestor
101924678|NCT01171482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924679|NCT01171482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101924680|NCT01171482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101924681|NCT01171482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101924682|NCT01171482|Alkylating Agents|alkylating agents|mesh-ancestor
101924683|NCT01171482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101924684|NCT01282398|Simvastatin|simvastatin|mesh-list
101924685|NCT01282398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101924686|NCT01282398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101924687|NCT01282398|Antimetabolites|antimetabolites|mesh-ancestor
101924688|NCT01282398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924689|NCT01282398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101924690|NCT01282398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101924691|NCT01282398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101924692|NCT01169142|Vitamin D|vitamin d|mesh-list
101924693|NCT01169142|Ergocalciferols|ergocalciferols|mesh-list
101924694|NCT01169142|Cholecalciferol|cholecalciferol|mesh-list
101924695|NCT01169142|Vitamins|vitamins|mesh-list
101924696|NCT01169142|Micronutrients|micronutrients|mesh-ancestor
101924697|NCT01169142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924698|NCT01169142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101924699|NCT01169142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101924700|NCT01169298|Lenalidomide|lenalidomide|mesh-list
101924701|NCT01169298|Immunologic Factors|immunologic factors|mesh-ancestor
101924702|NCT01169298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924703|NCT01169298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101924704|NCT01169298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101924705|NCT01169298|Growth Substances|growth substances|mesh-ancestor
101924706|NCT01169298|Growth Inhibitors|growth inhibitors|mesh-ancestor
101924707|NCT01169298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924708|NCT01277484|Decitabine|decitabine|mesh-list
101924709|NCT01277484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101924710|NCT01277484|Antimetabolites|antimetabolites|mesh-ancestor
101924711|NCT01277484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924712|NCT01277484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924713|NCT01277484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101924714|NCT01282632|Olanzapine|olanzapine|mesh-list
101924715|NCT01282632|Risperidone|risperidone|mesh-list
101924716|NCT01282632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101924717|NCT01282632|Serotonin Agents|serotonin agents|mesh-ancestor
101924718|NCT01282632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101924719|NCT01282632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924720|NCT01282632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924721|NCT01282632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101924722|NCT01282632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101924723|NCT01282632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101924724|NCT01282632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101924725|NCT01282632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101924726|NCT01282632|Dopamine Agents|dopamine agents|mesh-ancestor
101924727|NCT01282632|Antiemetics|antiemetics|mesh-ancestor
101924728|NCT01282632|Autonomic Agents|autonomic agents|mesh-ancestor
101924729|NCT01282632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101958024|NCT04052139|Antimanic Agents|antimanic agents|mesh-ancestor
101924731|NCT01282632|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101924732|NCT01282632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101924733|NCT01282632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101924734|NCT01172028|Docetaxel|docetaxel|mesh-list
101924735|NCT01172028|Pemetrexed|pemetrexed|mesh-list
101924736|NCT01172028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924737|NCT01172028|Tubulin Modulators|tubulin modulators|mesh-ancestor
101924738|NCT01172028|Antimitotic Agents|antimitotic agents|mesh-ancestor
101924739|NCT01172028|Mitosis Modulators|mitosis modulators|mesh-ancestor
101924740|NCT01172028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924741|NCT01172028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101924742|NCT01172028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101924743|NCT01172028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101924744|NCT01278186|Paclitaxel|paclitaxel|mesh-list
101924745|NCT01278186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101924746|NCT01278186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924747|NCT01278186|Tubulin Modulators|tubulin modulators|mesh-ancestor
101924748|NCT01278186|Antimitotic Agents|antimitotic agents|mesh-ancestor
101924749|NCT01278186|Mitosis Modulators|mitosis modulators|mesh-ancestor
101924750|NCT01278186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924751|NCT01169688|Phenylephrine|phenylephrine|mesh-list
101924752|NCT01169688|Oxymetazoline|oxymetazoline|mesh-list
101924753|NCT01169688|Cyclopentolate|cyclopentolate|mesh-list
101924754|NCT01169688|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101924755|NCT01169688|Mydriatics|mydriatics|mesh-ancestor
101924756|NCT01169688|Autonomic Agents|autonomic agents|mesh-ancestor
101924757|NCT01169688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101924758|NCT01169688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924759|NCT01169688|Sympathomimetics|sympathomimetics|mesh-ancestor
101924760|NCT01169688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101924761|NCT01169688|Nasal Decongestants|nasal decongestants|mesh-ancestor
101924762|NCT01169688|Respiratory System Agents|respiratory system agents|mesh-ancestor
101924763|NCT01169688|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101924764|NCT01169688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101924765|NCT01169688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101924766|NCT01169688|Adrenergic Agents|adrenergic agents|mesh-ancestor
101924767|NCT01169688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101924768|NCT01169688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924769|NCT01169688|Protective Agents|protective agents|mesh-ancestor
101924770|NCT01169688|Parasympatholytics|parasympatholytics|mesh-ancestor
101924771|NCT01169688|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101924772|NCT01169688|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101924773|NCT01169688|Cholinergic Agents|cholinergic agents|mesh-ancestor
101924774|NCT01278264|Ropivacaine|ropivacaine|mesh-list
101924775|NCT01278264|Anesthetics, Local|anesthetics, local|mesh-ancestor
101924776|NCT01278264|Anesthetics|anesthetics|mesh-ancestor
101924777|NCT01278264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101924778|NCT01278264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924779|NCT01278264|Sensory System Agents|sensory system agents|mesh-ancestor
101924780|NCT01278264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101924781|NCT01172652|Ziprasidone|ziprasidone|mesh-list
101924782|NCT01172652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101924783|NCT01172652|Serotonin Agents|serotonin agents|mesh-ancestor
101924784|NCT01172652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101924785|NCT01172652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924786|NCT01172652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924787|NCT01172652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101924788|NCT01172652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101924789|NCT01172652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101924790|NCT01172652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101924791|NCT01172652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101924792|NCT01172652|Dopamine Agents|dopamine agents|mesh-ancestor
101924793|NCT02526030|Aripiprazole|aripiprazole|mesh-list
101924794|NCT02526030|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101924795|NCT02526030|Ziprasidone|ziprasidone|mesh-list
101924796|NCT02526030|Antidepressive Agents|antidepressive agents|mesh-ancestor
101924797|NCT02526030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101924798|NCT02526030|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101924799|NCT02526030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101924800|NCT02526030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101924801|NCT02526030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924802|NCT02526030|Dopamine Agonists|dopamine agonists|mesh-ancestor
101924803|NCT02526030|Dopamine Agents|dopamine agents|mesh-ancestor
101924804|NCT02526030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101924805|NCT02526030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924806|NCT02526030|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101924807|NCT02526030|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101924808|NCT02526030|Serotonin Agents|serotonin agents|mesh-ancestor
101924809|NCT02526030|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101924810|NCT02526030|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101924811|NCT02526030|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101924812|NCT02526030|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101924813|NCT03867240|Gabapentin|gabapentin|mesh-list
101924814|NCT03867240|Analgesics|analgesics|mesh-ancestor
101924815|NCT03867240|Sensory System Agents|sensory system agents|mesh-ancestor
101924816|NCT03867240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101924817|NCT03867240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924818|NCT03867240|Anticonvulsants|anticonvulsants|mesh-ancestor
101924819|NCT03867240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101924820|NCT03867240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101924821|NCT03867240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101924822|NCT03867240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101924823|NCT03867240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101924824|NCT03867240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101924825|NCT03867240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101924826|NCT03867240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924827|NCT03867240|Antimanic Agents|antimanic agents|mesh-ancestor
101924828|NCT01172964|Flucytosine|flucytosine|mesh-list
101924829|NCT01172964|Antifungal Agents|antifungal agents|mesh-ancestor
101924830|NCT01172964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101924831|NCT01172964|Antimetabolites|antimetabolites|mesh-ancestor
101924832|NCT01172964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924833|NCT03866928|Stiripentol|stiripentol|mesh-list
101471767|NCT00287781|Lidocaine|lidocaine|mesh-list
101924834|NCT03866928|Anticonvulsants|anticonvulsants|mesh-ancestor
101924835|NCT01172496|Treprostinil|treprostinil|mesh-list
101924836|NCT01172496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101924837|NCT01178034|Warfarin|warfarin|mesh-list
101924838|NCT01178034|Anticoagulants|anticoagulants|mesh-ancestor
101924839|NCT01288170|Tobramycin|tobramycin|mesh-list
101924840|NCT01288170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101924841|NCT01288170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101924842|NCT01178112|Carboplatin|carboplatin|mesh-list
101924843|NCT01178112|Trientine|trientine|mesh-list
101924844|NCT01178112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924845|NCT01178112|Chelating Agents|chelating agents|mesh-ancestor
101924846|NCT01178112|Sequestering Agents|sequestering agents|mesh-ancestor
101924847|NCT01178112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924848|NCT01175460|Nedaplatin|nedaplatin|mesh-list
101924849|NCT01175460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924850|NCT01175538|Lactulose|lactulose|mesh-list
101924851|NCT01175538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101924852|NCT01288326|Liraglutide|liraglutide|mesh-list
101924853|NCT01288326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101924854|NCT01288326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924855|NCT01288326|Incretins|incretins|mesh-ancestor
101924856|NCT01288326|Hormones|hormones|mesh-ancestor
101924857|NCT01288326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101924858|NCT01173510|Raltegravir Potassium|raltegravir potassium|mesh-list
101924859|NCT01173510|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101924860|NCT01173510|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101924861|NCT01173510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101924863|NCT01173510|Antiviral Agents|antiviral agents|mesh-ancestor
101924864|NCT01173510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101924865|NCT01173510|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101924866|NCT01173510|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101924867|NCT01173510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101924868|NCT01173510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924869|NCT01173510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101924870|NCT01173510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101924871|NCT03435640|Nivolumab|nivolumab|mesh-list
101924872|NCT03435640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101924873|NCT03435640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924874|NCT03435640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101924875|NCT03435640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924876|NCT01175772|Celecoxib|celecoxib|mesh-list
101924877|NCT01175772|Methotrexate|methotrexate|mesh-list
101924878|NCT01175772|Cyclophosphamide|cyclophosphamide|mesh-list
101924879|NCT01175772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101924880|NCT01175772|Abortifacient Agents|abortifacient agents|mesh-ancestor
101924881|NCT01175772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101924882|NCT01175772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924883|NCT01175772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101924884|NCT01175772|Antimetabolites|antimetabolites|mesh-ancestor
101924885|NCT01175772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924886|NCT01175772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924887|NCT01175772|Dermatologic Agents|dermatologic agents|mesh-ancestor
101924888|NCT01175772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101924889|NCT01175772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101924890|NCT01175772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101924891|NCT01175772|Immunologic Factors|immunologic factors|mesh-ancestor
101924892|NCT01175772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101924893|NCT01175772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101924894|NCT01175772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101924895|NCT01175772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101924896|NCT01175772|Analgesics|analgesics|mesh-ancestor
101924897|NCT01175772|Sensory System Agents|sensory system agents|mesh-ancestor
101924898|NCT01175772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101924899|NCT01175772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101231089|NCT03797001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101924900|NCT01175772|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101924901|NCT01175772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101924902|NCT01175772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101924903|NCT01175772|Alkylating Agents|alkylating agents|mesh-ancestor
101924904|NCT01175772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101924905|NCT03395392|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
101924906|NCT03395392|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101924907|NCT03395392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101644766|NCT05248984|Ketorolac|ketorolac|mesh-list
101924908|NCT03395392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101924909|NCT03395392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924910|NCT03395392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101924911|NCT03395392|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101924912|NCT03395392|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101924913|NCT03395392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101924914|NCT03395392|Adrenergic Agents|adrenergic agents|mesh-ancestor
101924915|NCT03395392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101924916|NCT03395392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924917|NCT03395392|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101924918|NCT03395392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101924919|NCT03395392|Serotonin Agents|serotonin agents|mesh-ancestor
101924920|NCT03395392|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101924921|NCT03395392|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101924922|NCT03395392|Dopamine Agents|dopamine agents|mesh-ancestor
101924923|NCT01536964|Morphine|morphine|mesh-list
101958045|NCT03981861|Spironolactone|spironolactone|mesh-list
101924925|NCT01536964|Narcotics|narcotics|mesh-ancestor
101924926|NCT01536964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101924927|NCT01536964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924928|NCT01536964|Analgesics|analgesics|mesh-ancestor
101924929|NCT01536964|Sensory System Agents|sensory system agents|mesh-ancestor
101924930|NCT01536964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101924931|NCT01288404|Fluorometholone|fluorometholone|mesh-list
101924932|NCT01288404|Bevacizumab|bevacizumab|mesh-list
101617035|NCT02839941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924933|NCT01288404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101924935|NCT01288404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101924936|NCT01288404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101924937|NCT01288404|Growth Substances|growth substances|mesh-ancestor
101924938|NCT01288404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924939|NCT01288404|Growth Inhibitors|growth inhibitors|mesh-ancestor
101924940|NCT01288404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101924941|NCT01288404|Glucocorticoids|glucocorticoids|mesh-ancestor
101924942|NCT01288404|Hormones|hormones|mesh-ancestor
101924943|NCT01288404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101924944|NCT01288404|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101924945|NCT03860220|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
101924946|NCT03860220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101924947|NCT03860220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101924948|NCT03860220|Antimetabolites|antimetabolites|mesh-ancestor
101924949|NCT03860220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924950|NCT03860220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101924951|NCT03860220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101924952|NCT03860220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101924953|NCT03860220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101924954|NCT03860220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101924955|NCT03860220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924956|NCT03860220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101924957|NCT03860220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101924958|NCT01286688|Terbinafine|terbinafine|mesh-list
101924959|NCT01286688|Antifungal Agents|antifungal agents|mesh-ancestor
101924960|NCT01286688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101924961|NCT01286688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101924962|NCT01286688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924963|NCT01286766|Cisplatin|cisplatin|mesh-list
101924964|NCT01286766|Docetaxel|docetaxel|mesh-list
101924965|NCT01286766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924966|NCT01286766|Tubulin Modulators|tubulin modulators|mesh-ancestor
101924967|NCT01286766|Antimitotic Agents|antimitotic agents|mesh-ancestor
101924968|NCT01286766|Mitosis Modulators|mitosis modulators|mesh-ancestor
101924969|NCT01286766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101924970|NCT02525484|Pirfenidone|pirfenidone|mesh-list
101924971|NCT02525484|Analgesics|analgesics|mesh-ancestor
101924972|NCT02525484|Sensory System Agents|sensory system agents|mesh-ancestor
101924973|NCT02525484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101924974|NCT02525484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924975|NCT02525484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101924976|NCT02525484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101924977|NCT02525484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101924978|NCT02525484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101924979|NCT02525484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924980|NCT01173978|Prednisolone|prednisolone|mesh-list
101644844|NCT05073250|Rituximab|rituximab|mesh-list
101924982|NCT01173978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101924983|NCT01173978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924984|NCT01173978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101924985|NCT01173978|Glucocorticoids|glucocorticoids|mesh-ancestor
101924986|NCT01173978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101924987|NCT01173978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101924988|NCT01174056|Pioglitazone|pioglitazone|mesh-list
101924989|NCT01174056|Zileuton|zileuton|mesh-list
101924990|NCT01174056|Hydroxyurea|hydroxyurea|mesh-list
101924991|NCT01174056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101924992|NCT01174056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101924993|NCT01174056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101924994|NCT01174056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101924995|NCT01174056|Analgesics|analgesics|mesh-ancestor
101924996|NCT01174056|Sensory System Agents|sensory system agents|mesh-ancestor
101924997|NCT01174056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101924998|NCT01174056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101924999|NCT01174056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101925000|NCT01174056|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101925001|NCT01174056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101925002|NCT01174056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925003|NCT01174056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101925004|NCT01174056|Hormone Antagonists|hormone antagonists|mesh-ancestor
101287501|NCT03069703|Rituximab|rituximab|mesh-list
101925005|NCT01174056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101925007|NCT01174056|Antisickling Agents|antisickling agents|mesh-ancestor
101925008|NCT01174056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101925009|NCT01174212|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101925010|NCT01174212|Vancomycin|vancomycin|mesh-list
101925011|NCT01174212|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101925012|NCT01174212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101925013|NCT01174212|Antitubercular Agents|antitubercular agents|mesh-ancestor
101925014|NCT01174290|Haloperidol|haloperidol|mesh-list
101925015|NCT01174290|Haloperidol decanoate|haloperidol decanoate|mesh-list
101925016|NCT01174290|Antiemetics|antiemetics|mesh-ancestor
101925017|NCT01174290|Autonomic Agents|autonomic agents|mesh-ancestor
101925018|NCT01174290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101925019|NCT01174290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925020|NCT01174290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101925021|NCT01174290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101925022|NCT01174290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101925023|NCT01174290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101925024|NCT01174290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101925025|NCT01174290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101925026|NCT01174290|Dopamine Agents|dopamine agents|mesh-ancestor
101925027|NCT01174290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101231105|NCT03776864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231106|NCT03776864|Immunologic Factors|immunologic factors|mesh-ancestor
101231107|NCT03776864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925028|NCT01174290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925029|NCT01174290|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101925030|NCT03862404|Epinephrine|epinephrine|mesh-list
101925031|NCT03862404|Bupivacaine|bupivacaine|mesh-list
101925032|NCT03862404|Anesthetics, Local|anesthetics, local|mesh-ancestor
101925033|NCT03862404|Anesthetics|anesthetics|mesh-ancestor
101925034|NCT03862404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101925035|NCT03862404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925036|NCT03862404|Sensory System Agents|sensory system agents|mesh-ancestor
101925037|NCT03862404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101925038|NCT03862404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101925039|NCT03862404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101925040|NCT03862404|Adrenergic Agents|adrenergic agents|mesh-ancestor
101925041|NCT03862404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101925042|NCT03862404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925043|NCT03862404|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101925044|NCT03862404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101925045|NCT03862404|Autonomic Agents|autonomic agents|mesh-ancestor
101925046|NCT03862404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101925047|NCT03862404|Respiratory System Agents|respiratory system agents|mesh-ancestor
101925048|NCT03862404|Mydriatics|mydriatics|mesh-ancestor
101925049|NCT03862404|Sympathomimetics|sympathomimetics|mesh-ancestor
101925050|NCT03862404|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101925051|NCT03865680|Fluorides|fluorides|mesh-list
101925052|NCT03865680|Sodium Fluoride|sodium fluoride|mesh-list
101925053|NCT03865680|Fluorides, Topical|fluorides, topical|mesh-list
101925054|NCT03865680|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
101644929|NCT04881682|Antibodies|antibodies|mesh-list
101925055|NCT03865680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925056|NCT03865680|Cariostatic Agents|cariostatic agents|mesh-ancestor
101925057|NCT03865680|Protective Agents|protective agents|mesh-ancestor
101925059|NCT01288716|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101925060|NCT01288716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925061|NCT01288716|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101925062|NCT01288716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101925063|NCT01288716|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101925064|NCT01288716|GABA Agonists|gaba agonists|mesh-ancestor
101925065|NCT01288716|GABA Agents|gaba agents|mesh-ancestor
101925066|NCT01288716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101925067|NCT01288716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925068|NCT01285596|Mirabegron|mirabegron|mesh-list
101925069|NCT01285596|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101925070|NCT01285596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101925071|NCT01285596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101925072|NCT01285596|Adrenergic Agents|adrenergic agents|mesh-ancestor
101925073|NCT01285596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101925074|NCT01285596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925075|NCT01285596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925076|NCT01285596|Urological Agents|urological agents|mesh-ancestor
101925077|NCT00655876|Paclitaxel|paclitaxel|mesh-list
101925078|NCT00655876|Cetuximab|cetuximab|mesh-list
101617036|NCT02839941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101925079|NCT00655876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101925080|NCT00655876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101925081|NCT00655876|Tubulin Modulators|tubulin modulators|mesh-ancestor
101925082|NCT00655876|Antimitotic Agents|antimitotic agents|mesh-ancestor
101925083|NCT00655876|Mitosis Modulators|mitosis modulators|mesh-ancestor
101925084|NCT00655876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925085|NCT00655876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101925086|NCT01176318|Erdosteine|erdosteine|mesh-list
101925087|NCT01176318|Expectorants|expectorants|mesh-ancestor
101925088|NCT01176318|Respiratory System Agents|respiratory system agents|mesh-ancestor
101925089|NCT01178658|Cytarabine|cytarabine|mesh-list
101925090|NCT01178658|Etoposide|etoposide|mesh-list
101925091|NCT01178658|Melphalan|melphalan|mesh-list
101925092|NCT01178658|Busulfan|busulfan|mesh-list
101925093|NCT01178658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101925094|NCT01178658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101231120|NCT03675412|Caffeine|caffeine|mesh-list
101231121|NCT03675412|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101231122|NCT03675412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925095|NCT01178658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101925096|NCT01178658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101925097|NCT01178658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101925098|NCT01178658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925099|NCT01178658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101925100|NCT01178658|Antimetabolites|antimetabolites|mesh-ancestor
101925101|NCT01178658|Antiviral Agents|antiviral agents|mesh-ancestor
101925102|NCT01178658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101925103|NCT01178658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101925104|NCT01178658|Immunologic Factors|immunologic factors|mesh-ancestor
101925105|NCT01178658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925106|NCT01178658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101925107|NCT01178658|Alkylating Agents|alkylating agents|mesh-ancestor
101925108|NCT01178658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101925109|NCT03092752|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101925110|NCT03092752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925111|NCT01174524|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101925112|NCT01174524|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101925113|NCT01174524|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101925114|NCT01174524|Gestodene|gestodene|mesh-list
101925115|NCT01174524|Femovan|femovan|mesh-list
101925116|NCT01174524|Contraceptive Agents|contraceptive agents|mesh-list
101925117|NCT01174524|Contraceptives, Oral|contraceptives, oral|mesh-list
101925118|NCT01174524|Estradiol|estradiol|mesh-list
101925119|NCT01174524|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101925120|NCT01174524|Estrogens|estrogens|mesh-ancestor
101925121|NCT01174524|Hormones|hormones|mesh-ancestor
101925122|NCT01174524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101925123|NCT01174524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925124|NCT01174524|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101925125|NCT01174524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101925126|NCT01174524|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101925127|NCT01174524|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101925128|NCT01174524|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101925129|NCT01174524|Progestins|progestins|mesh-ancestor
101644988|NCT04750473|Edetic Acid|edetic acid|mesh-list
101925130|NCT01174524|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101925131|NCT02525172|Rituximab|rituximab|mesh-list
101925132|NCT02525172|Methotrexate|methotrexate|mesh-list
101925134|NCT02525172|Immunoglobulins|immunoglobulins|mesh-list
101925135|NCT02525172|Antibodies|antibodies|mesh-list
101925136|NCT02525172|gamma-Globulins|gamma-globulins|mesh-list
101231130|NCT03664180|Heparin|heparin|mesh-list
101925137|NCT02525172|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101925138|NCT02525172|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101925139|NCT02525172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101925140|NCT02525172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101925141|NCT02525172|Immunologic Factors|immunologic factors|mesh-ancestor
101925142|NCT02525172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925143|NCT02525172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101925144|NCT02525172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101925145|NCT02525172|Abortifacient Agents|abortifacient agents|mesh-ancestor
101925146|NCT02525172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101925147|NCT02525172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101925148|NCT02525172|Antimetabolites|antimetabolites|mesh-ancestor
101925149|NCT02525172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925150|NCT02525172|Dermatologic Agents|dermatologic agents|mesh-ancestor
101925151|NCT02525172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101925152|NCT02525172|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101925153|NCT02525172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101925154|NCT02525172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101925155|NCT01285674|Cisplatin|cisplatin|mesh-list
101925156|NCT01285674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101925157|NCT03859362|Ertapenem|ertapenem|mesh-list
101925158|NCT03859362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101925159|NCT03859362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101925160|NCT05598580|Lenalidomide|lenalidomide|mesh-list
101925161|NCT05598580|Immunologic Factors|immunologic factors|mesh-ancestor
101925162|NCT05598580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925163|NCT05598580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101925164|NCT05598580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101925165|NCT05598580|Growth Substances|growth substances|mesh-ancestor
101925166|NCT05598580|Growth Inhibitors|growth inhibitors|mesh-ancestor
101925167|NCT05598580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101925168|NCT01287546|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101925169|NCT01287546|Trametinib|trametinib|mesh-list
101925170|NCT01287546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101925171|NCT01287546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101925172|NCT01287546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101925173|NCT01287546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925174|NCT03182166|Golimumab|golimumab|mesh-list
101925175|NCT03182166|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101925176|NCT03182166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101925177|NCT03182166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101925178|NCT03182166|Immunologic Factors|immunologic factors|mesh-ancestor
101925179|NCT03182166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925180|NCT03193216|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
101925181|NCT03193216|Antacids|antacids|mesh-ancestor
101925182|NCT03193216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925183|NCT03193216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101925184|NCT03864978|Rifaximin|rifaximin|mesh-list
101925185|NCT03864978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101925186|NCT03864978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101925187|NCT03864978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101925188|NCT01568788|Vaccines|vaccines|mesh-list
101925189|NCT01568788|Immunologic Factors|immunologic factors|mesh-ancestor
101925190|NCT01568788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925191|NCT01287624|Paclitaxel|paclitaxel|mesh-list
101925192|NCT01287624|Gemcitabine|gemcitabine|mesh-list
101925193|NCT01287624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101925194|NCT01287624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101925195|NCT01287624|Tubulin Modulators|tubulin modulators|mesh-ancestor
101925196|NCT01287624|Antimitotic Agents|antimitotic agents|mesh-ancestor
101925197|NCT01287624|Mitosis Modulators|mitosis modulators|mesh-ancestor
101925198|NCT01287624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925199|NCT01287624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101925200|NCT01287624|Antimetabolites|antimetabolites|mesh-ancestor
101925201|NCT05597800|Nivolumab|nivolumab|mesh-list
101925202|NCT05597800|Ipilimumab|ipilimumab|mesh-list
101925203|NCT05597800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101925204|NCT05597800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101925205|NCT05597800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101958071|NCT03743649|Anticonvulsants|anticonvulsants|mesh-ancestor
101925206|NCT05597800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925207|NCT01176552|Interferon-alpha|interferon-alpha|mesh-list
101925208|NCT01176552|Interferon alpha-2|interferon alpha-2|mesh-list
101925209|NCT01176552|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
101925210|NCT01176552|Antiviral Agents|antiviral agents|mesh-ancestor
101925211|NCT01176552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101925212|NCT01176552|Immunologic Factors|immunologic factors|mesh-ancestor
101925213|NCT01176552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925214|NCT01176552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101925215|NCT01179438|Dexmedetomidine|dexmedetomidine|mesh-list
101925216|NCT01179438|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101925217|NCT01179438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101925218|NCT01179438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925219|NCT01179438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101925220|NCT01179438|Analgesics|analgesics|mesh-ancestor
101925221|NCT01179438|Sensory System Agents|sensory system agents|mesh-ancestor
101925222|NCT01179438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101925223|NCT01179438|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101925224|NCT01179438|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101925225|NCT01179438|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101925226|NCT01179438|Adrenergic Agents|adrenergic agents|mesh-ancestor
101925227|NCT01179438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101925228|NCT01179438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925229|NCT03864666|Cilostazol|cilostazol|mesh-list
101925230|NCT03864666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101925231|NCT03864666|Autonomic Agents|autonomic agents|mesh-ancestor
101925232|NCT03864666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101925233|NCT03864666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925234|NCT03864666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101925235|NCT03864666|Respiratory System Agents|respiratory system agents|mesh-ancestor
101925236|NCT03864666|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101925237|NCT03864666|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101925238|NCT03864666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925239|NCT03864666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101925240|NCT03864666|Vasodilator Agents|vasodilator agents|mesh-ancestor
101925241|NCT03864666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101925242|NCT03864666|Protective Agents|protective agents|mesh-ancestor
101925243|NCT03864666|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101925244|NCT03864666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101925245|NCT03864666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101925246|NCT03858972|Capecitabine|capecitabine|mesh-list
101925247|NCT03858972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101925248|NCT03858972|Antimetabolites|antimetabolites|mesh-ancestor
101925249|NCT03858972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925250|NCT03858972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101925251|NCT03091348|Methyltestosterone|methyltestosterone|mesh-list
101925252|NCT03091348|Testosterone|testosterone|mesh-list
101925253|NCT03091348|Testosterone undecanoate|testosterone undecanoate|mesh-list
101925254|NCT03091348|Testosterone enanthate|testosterone enanthate|mesh-list
101925255|NCT03091348|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101925256|NCT03091348|Androgens|androgens|mesh-ancestor
101925257|NCT03091348|Hormones|hormones|mesh-ancestor
101925258|NCT03091348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101925259|NCT03091348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925260|NCT03091348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101925261|NCT03091348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101925262|NCT03091348|Anabolic Agents|anabolic agents|mesh-ancestor
101925263|NCT02525016|Lidocaine|lidocaine|mesh-list
101925264|NCT02525016|Anesthetics, Local|anesthetics, local|mesh-ancestor
101925265|NCT02525016|Anesthetics|anesthetics|mesh-ancestor
101925266|NCT02525016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101925267|NCT02525016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925268|NCT02525016|Sensory System Agents|sensory system agents|mesh-ancestor
101925269|NCT02525016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101925270|NCT02525016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101925271|NCT02525016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101925272|NCT02525016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101925273|NCT02525016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101925274|NCT02525016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925275|NCT01179594|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101925276|NCT01179594|Interferon-alpha|interferon-alpha|mesh-list
101925277|NCT01179594|Entecavir|entecavir|mesh-list
101925278|NCT01179594|Antiviral Agents|antiviral agents|mesh-ancestor
101925279|NCT01179594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101925280|NCT01179594|Immunologic Factors|immunologic factors|mesh-ancestor
101925281|NCT01179594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925282|NCT03751098|Phenylephrine|phenylephrine|mesh-list
101925283|NCT03751098|Oxymetazoline|oxymetazoline|mesh-list
101925284|NCT03751098|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101925285|NCT03751098|Tropicamide|tropicamide|mesh-list
101925286|NCT03751098|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101925287|NCT03751098|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101925288|NCT03751098|Mydriatics|mydriatics|mesh-ancestor
101925289|NCT03751098|Autonomic Agents|autonomic agents|mesh-ancestor
101925290|NCT03751098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101925291|NCT03751098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925292|NCT03751098|Sympathomimetics|sympathomimetics|mesh-ancestor
101925293|NCT03751098|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101925294|NCT03751098|Nasal Decongestants|nasal decongestants|mesh-ancestor
101925295|NCT03751098|Respiratory System Agents|respiratory system agents|mesh-ancestor
101925296|NCT03751098|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101925297|NCT03751098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101925298|NCT03751098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101925299|NCT03751098|Adrenergic Agents|adrenergic agents|mesh-ancestor
101925300|NCT03751098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101925301|NCT03751098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925302|NCT03751098|Protective Agents|protective agents|mesh-ancestor
101925303|NCT03751098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101925304|NCT03751098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101925305|NCT03751098|Cholinergic Agents|cholinergic agents|mesh-ancestor
101925306|NCT01176708|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
101925307|NCT01176708|Protease Inhibitors|protease inhibitors|mesh-ancestor
101925308|NCT01176708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101925309|NCT01176708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925310|NCT01176708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101925311|NCT01176708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925312|NCT01288794|Furosemide|furosemide|mesh-list
101925313|NCT01288794|Diuretics|diuretics|mesh-list
101231194|NCT03634852|Hormones|hormones|mesh-ancestor
101925314|NCT01288794|Natriuretic Agents|natriuretic agents|mesh-ancestor
101925315|NCT01288794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925316|NCT01288794|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101925317|NCT01288794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101925318|NCT01288794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925319|NCT01288872|Praziquantel|praziquantel|mesh-list
101925320|NCT01288872|Anthelmintics|anthelmintics|mesh-ancestor
101925321|NCT01288872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101925322|NCT01288872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101925323|NCT03864588|Ropivacaine|ropivacaine|mesh-list
101925324|NCT03864588|Anesthetics, Local|anesthetics, local|mesh-ancestor
101925325|NCT03864588|Anesthetics|anesthetics|mesh-ancestor
101925326|NCT03864588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101925327|NCT03864588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925328|NCT03864588|Sensory System Agents|sensory system agents|mesh-ancestor
101925329|NCT03864588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101925330|NCT01288950|Vitamin D|vitamin d|mesh-list
101925331|NCT01288950|Ergocalciferols|ergocalciferols|mesh-list
101925332|NCT01288950|Cholecalciferol|cholecalciferol|mesh-list
101925333|NCT01288950|Vitamins|vitamins|mesh-list
101925334|NCT01288950|Micronutrients|micronutrients|mesh-ancestor
101925335|NCT01288950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925336|NCT01288950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101925337|NCT01288950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101925338|NCT01174914|Tenofovir|tenofovir|mesh-list
101925339|NCT01174914|Lamivudine|lamivudine|mesh-list
101925340|NCT01174914|Emtricitabine|emtricitabine|mesh-list
101925341|NCT01174914|Efavirenz|efavirenz|mesh-list
101925342|NCT01174914|Lopinavir|lopinavir|mesh-list
101925343|NCT01174914|Nevirapine|nevirapine|mesh-list
101925344|NCT01174914|Stavudine|stavudine|mesh-list
101925345|NCT01174914|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
101925346|NCT01174914|Naltrexone|naltrexone|mesh-list
101925347|NCT01174914|Antiviral Agents|antiviral agents|mesh-ancestor
101925348|NCT01174914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101925349|NCT01174914|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101925350|NCT01174914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101925351|NCT01174914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101925352|NCT01174914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925353|NCT01174914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101925354|NCT01174914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101925355|NCT01174914|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101925356|NCT01174914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101925357|NCT01174914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925359|NCT01174914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101925360|NCT01174914|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101925361|NCT01174914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101925362|NCT01174914|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101925363|NCT01174914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101925364|NCT01174914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101925365|NCT01174914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101925366|NCT01174914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101925367|NCT01174914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101925368|NCT01174914|Protease Inhibitors|protease inhibitors|mesh-ancestor
101925369|NCT01174914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101925370|NCT01174914|Antimetabolites|antimetabolites|mesh-ancestor
101925371|NCT05548426|Linezolid|linezolid|mesh-list
101925372|NCT05548426|Penicillins|penicillins|mesh-list
101925373|NCT05548426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101925374|NCT05548426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101925375|NCT05548426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101925376|NCT05548426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101925377|NCT05548426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925378|NCT03102892|Anti-Infective Agents|anti-infective agents|mesh-list
101925379|NCT03102892|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101925381|NCT01177176|Nicotine|nicotine|mesh-list
101925382|NCT01177176|Varenicline|varenicline|mesh-list
101925383|NCT01177176|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101925384|NCT01177176|Autonomic Agents|autonomic agents|mesh-ancestor
101925385|NCT01177176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101925386|NCT01177176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925387|NCT01177176|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101925388|NCT01177176|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101925389|NCT01177176|Cholinergic Agents|cholinergic agents|mesh-ancestor
101925390|NCT01177176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101925391|NCT01177176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925392|NCT01177176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101925393|NCT01177176|Antidepressive Agents|antidepressive agents|mesh-ancestor
101925394|NCT01177176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101925395|NCT01177176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101925396|NCT01177176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101925397|NCT01177176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101925398|NCT01177176|Dopamine Agents|dopamine agents|mesh-ancestor
101925399|NCT01177176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101925400|NCT01177176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101925401|NCT01177176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101925402|NCT01287780|Gentamicins|gentamicins|mesh-list
101925403|NCT01287780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101925404|NCT01287780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101925405|NCT01287780|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101925406|NCT01287780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101925407|NCT01287780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925408|NCT01179828|Oxycodone|oxycodone|mesh-list
101925409|NCT01179828|Clobazam|clobazam|mesh-list
101925410|NCT01179828|Imipramine|imipramine|mesh-list
101925411|NCT01179828|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101925412|NCT01179828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101925413|NCT01179828|Narcotics|narcotics|mesh-ancestor
101677873|NCT05133518|Anesthetics|anesthetics|mesh-ancestor
101925414|NCT01179828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101925415|NCT01179828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925416|NCT01179828|Analgesics|analgesics|mesh-ancestor
101925417|NCT01179828|Sensory System Agents|sensory system agents|mesh-ancestor
101925418|NCT01179828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101925419|NCT01179828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101925420|NCT01179828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101925421|NCT01179828|Cholinergic Agents|cholinergic agents|mesh-ancestor
101925422|NCT01179828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101925423|NCT01179828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925424|NCT01179828|Urological Agents|urological agents|mesh-ancestor
101925425|NCT01179828|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101925426|NCT01179828|Antidepressive Agents|antidepressive agents|mesh-ancestor
101925427|NCT01179828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101925428|NCT01179828|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101925429|NCT01179828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101925430|NCT01179828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101925431|NCT01179828|Adrenergic Agents|adrenergic agents|mesh-ancestor
101925432|NCT01179828|Anticonvulsants|anticonvulsants|mesh-ancestor
101925433|NCT01179828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101925434|NCT01179828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101925435|NCT01179828|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101925436|NCT01179828|GABA Agonists|gaba agonists|mesh-ancestor
101925437|NCT01179828|GABA Agents|gaba agents|mesh-ancestor
101925438|NCT01180062|Latanoprost|latanoprost|mesh-list
101925439|NCT01180062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101925440|NCT01180062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101925441|NCT03858582|Pembrolizumab|pembrolizumab|mesh-list
101925442|NCT03858582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101925443|NCT03858582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101925444|NCT03858582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101925445|NCT03858582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925446|NCT01177566|Pimecrolimus|pimecrolimus|mesh-list
101925447|NCT01177566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101925449|NCT01177566|Analgesics|analgesics|mesh-ancestor
101925450|NCT01177566|Sensory System Agents|sensory system agents|mesh-ancestor
101925451|NCT01177566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101925452|NCT01177566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925453|NCT01177566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101925454|NCT01177566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101925455|NCT01177566|Dermatologic Agents|dermatologic agents|mesh-ancestor
101925456|NCT01177566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101925457|NCT01177566|Immunologic Factors|immunologic factors|mesh-ancestor
101925458|NCT01177566|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101925459|NCT01177566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101925460|NCT01177566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925461|NCT01181154|Rituximab|rituximab|mesh-list
101925462|NCT01181154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101925463|NCT01181154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101925464|NCT01181154|Immunologic Factors|immunologic factors|mesh-ancestor
101925465|NCT01181154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925466|NCT01181154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101925467|NCT03101566|Gemcitabine|gemcitabine|mesh-list
101925468|NCT03101566|Nivolumab|nivolumab|mesh-list
101925469|NCT03101566|Ipilimumab|ipilimumab|mesh-list
101925470|NCT03101566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101925471|NCT03101566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101925472|NCT03101566|Antimetabolites|antimetabolites|mesh-ancestor
101925473|NCT03101566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925474|NCT03101566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101925475|NCT03101566|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101925476|NCT01289496|Interferons|interferons|mesh-list
101925477|NCT01289496|Ribavirin|ribavirin|mesh-list
101925478|NCT01289496|Interferon-alpha|interferon-alpha|mesh-list
101925479|NCT01289496|Interferon alpha-2|interferon alpha-2|mesh-list
101925480|NCT01289496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101925481|NCT01289496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101925482|NCT01289496|Antiviral Agents|antiviral agents|mesh-ancestor
101925483|NCT01289496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101925484|NCT01289496|Antimetabolites|antimetabolites|mesh-ancestor
101925485|NCT01289496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925486|NCT01289496|Immunologic Factors|immunologic factors|mesh-ancestor
101925487|NCT01289496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925488|NCT01181232|Zolpidem|zolpidem|mesh-list
101925489|NCT01181232|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101925490|NCT01181232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101925491|NCT01181232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101925492|NCT01181232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925493|NCT01181232|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101925494|NCT01181232|GABA Agonists|gaba agonists|mesh-ancestor
101925495|NCT01181232|GABA Agents|gaba agents|mesh-ancestor
101925496|NCT01181232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101925497|NCT01181232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925498|NCT01181310|Scopolamine|scopolamine|mesh-list
101925499|NCT01181310|Donepezil|donepezil|mesh-list
101925500|NCT01181310|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101925501|NCT01181310|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101925502|NCT01181310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101925503|NCT01181310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925504|NCT01181310|Cholinergic Agents|cholinergic agents|mesh-ancestor
101925505|NCT01181310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101925506|NCT01181310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925508|NCT01181310|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101925509|NCT01181310|Antiemetics|antiemetics|mesh-ancestor
101925510|NCT01181310|Autonomic Agents|autonomic agents|mesh-ancestor
101925511|NCT01181310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101925512|NCT01181310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101925513|NCT01181310|Mydriatics|mydriatics|mesh-ancestor
101925514|NCT01181310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101925515|NCT01181310|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101925516|NCT01181310|Parasympatholytics|parasympatholytics|mesh-ancestor
101925517|NCT02525250|Lenalidomide|lenalidomide|mesh-list
101925518|NCT02525250|Immunologic Factors|immunologic factors|mesh-ancestor
101925519|NCT02525250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925520|NCT02525250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101925521|NCT02525250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101925522|NCT02525250|Growth Substances|growth substances|mesh-ancestor
101925523|NCT02525250|Growth Inhibitors|growth inhibitors|mesh-ancestor
101925524|NCT02525250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101925525|NCT01288092|Dactolisib|dactolisib|mesh-list
101925526|NCT01288092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101925527|NCT01290744|Clofazimine|clofazimine|mesh-list
101925528|NCT01290744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101925529|NCT01290744|Leprostatic Agents|leprostatic agents|mesh-ancestor
101925530|NCT01290744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101925531|NCT01290744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101925532|NCT01181388|Tirofiban|tirofiban|mesh-list
101925533|NCT01181388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101925534|NCT01181388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101925535|NCT01181388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925536|NCT01181388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101925537|NCT01181544|Heparin|heparin|mesh-list
101925538|NCT01181544|Anticoagulants|anticoagulants|mesh-ancestor
101925539|NCT01181544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101925540|NCT01181544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101925541|NCT01181544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925542|NCT01184664|Nicotine|nicotine|mesh-list
101925543|NCT01184664|Varenicline|varenicline|mesh-list
101925544|NCT01184664|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101925545|NCT01184664|Autonomic Agents|autonomic agents|mesh-ancestor
101925546|NCT01184664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101925547|NCT01184664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925548|NCT01184664|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101925549|NCT01184664|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101925550|NCT01184664|Cholinergic Agents|cholinergic agents|mesh-ancestor
101925551|NCT01184664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101925552|NCT01184664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925553|NCT03858192|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101925554|NCT03858192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101925555|NCT01184820|Factor VIII|factor viii|mesh-list
101925556|NCT01184820|Coagulants|coagulants|mesh-ancestor
101925558|NCT03858270|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101925559|NCT03858270|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101925560|NCT03858270|Dopamine Agents|dopamine agents|mesh-ancestor
101925561|NCT03858270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101925562|NCT03858270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925563|NCT03858270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925564|NCT03858270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101925565|NCT03858270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101925566|NCT01289730|Etanercept|etanercept|mesh-list
101925567|NCT01289730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101925568|NCT01289730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101925569|NCT01289730|Analgesics|analgesics|mesh-ancestor
101925570|NCT01289730|Sensory System Agents|sensory system agents|mesh-ancestor
101925571|NCT01289730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101925572|NCT01289730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925573|NCT01289730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101925574|NCT01289730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101925575|NCT01289730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101925576|NCT01289730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101925577|NCT01289730|Immunologic Factors|immunologic factors|mesh-ancestor
101925578|NCT01290900|Moxifloxacin|moxifloxacin|mesh-list
101925579|NCT01290900|Ceftazidime|ceftazidime|mesh-list
101925580|NCT01290900|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
101925581|NCT01290900|Avibactam|avibactam|mesh-list
101925582|NCT01290900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101925583|NCT01290900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101925584|NCT01290900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101925585|NCT01290900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101925586|NCT01290900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101925587|NCT01290900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925588|NCT01290900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101925589|NCT01290900|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101925590|NCT03855306|Glyburide|glyburide|mesh-list
101925591|NCT03855306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101925592|NCT03855306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925593|NCT03855384|Cisplatin|cisplatin|mesh-list
101925594|NCT03855384|Carboplatin|carboplatin|mesh-list
101925595|NCT03855384|Fluorouracil|fluorouracil|mesh-list
101925596|NCT03855384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101925597|NCT03855384|Antimetabolites|antimetabolites|mesh-ancestor
101288097|NCT05352178|Hormones|hormones|mesh-ancestor
101925598|NCT03855384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925599|NCT03855384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101925600|NCT03855384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101925601|NCT03855384|Immunologic Factors|immunologic factors|mesh-ancestor
101925602|NCT03855384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925603|NCT01181934|Nicotine|nicotine|mesh-list
101925604|NCT01181934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101925605|NCT01181934|Autonomic Agents|autonomic agents|mesh-ancestor
101925606|NCT01181934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101925607|NCT01181934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925608|NCT01181934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101925609|NCT01181934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101925610|NCT01181934|Cholinergic Agents|cholinergic agents|mesh-ancestor
101925611|NCT01181934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101925612|NCT01181934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925613|NCT01187862|Efavirenz|efavirenz|mesh-list
101925614|NCT01187862|Losartan|losartan|mesh-list
101925615|NCT01187862|Metoprolol|metoprolol|mesh-list
101925616|NCT01187862|Midazolam|midazolam|mesh-list
101925617|NCT01187862|Caffeine|caffeine|mesh-list
101925618|NCT01187862|Chlorzoxazone|chlorzoxazone|mesh-list
101925619|NCT01187862|Omeprazole|omeprazole|mesh-list
101925620|NCT01187862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101925621|NCT01187862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101925622|NCT01187862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101925623|NCT01187862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925624|NCT01187862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101925625|NCT01187862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101925626|NCT01187862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101925627|NCT01187862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101925628|NCT01187862|Anesthetics, General|anesthetics, general|mesh-ancestor
101925629|NCT01187862|Anesthetics|anesthetics|mesh-ancestor
101925630|NCT01187862|GABA Modulators|gaba modulators|mesh-ancestor
101925631|NCT01187862|GABA Agents|gaba agents|mesh-ancestor
101925632|NCT01187862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101925633|NCT01187862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925634|NCT01187862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101925635|NCT01187862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101925636|NCT01187862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101925637|NCT01187862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101925638|NCT01187862|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101925639|NCT01187862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101925640|NCT01187862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101925641|NCT01187862|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101925642|NCT01187862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101925643|NCT01187862|Purinergic Agents|purinergic agents|mesh-ancestor
101925644|NCT01187862|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101925645|NCT01187862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101925646|NCT01187862|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101925647|NCT01187862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101925648|NCT01187862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101925649|NCT01187862|Antiviral Agents|antiviral agents|mesh-ancestor
101925650|NCT01187862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101925651|NCT01187862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101925652|NCT01187862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101925653|NCT01187862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101925654|NCT01187862|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101925655|NCT01187862|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101925656|NCT01187862|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101925657|NCT01187862|Sympatholytics|sympatholytics|mesh-ancestor
101925658|NCT01187862|Autonomic Agents|autonomic agents|mesh-ancestor
101925659|NCT01187862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101925660|NCT01187862|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101925661|NCT01187862|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101925662|NCT01187862|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101925663|NCT01187862|Adrenergic Agents|adrenergic agents|mesh-ancestor
101925664|NCT01187862|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101925665|NCT01187862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101925666|NCT01290042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101925667|NCT01290042|Immunologic Factors|immunologic factors|mesh-ancestor
101925668|NCT01290042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925669|NCT01185444|Hyaluronic Acid|hyaluronic acid|mesh-list
101925670|NCT01185444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101925671|NCT01185444|Immunologic Factors|immunologic factors|mesh-ancestor
101925672|NCT01185444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925673|NCT01185444|Viscosupplements|viscosupplements|mesh-ancestor
101925674|NCT01185444|Protective Agents|protective agents|mesh-ancestor
101925676|NCT03857334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101925677|NCT01185678|Contraceptive Agents|contraceptive agents|mesh-list
101925679|NCT01185678|Contraceptives, Oral|contraceptives, oral|mesh-list
101925680|NCT01185678|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
101925681|NCT01185678|Progestins|progestins|mesh-list
101925682|NCT01185678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101925683|NCT01185678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925684|NCT01185678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101925685|NCT01185678|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101925686|NCT01185678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101925687|NCT01185678|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101925688|NCT01185678|Hormones|hormones|mesh-ancestor
101925689|NCT01185678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101925690|NCT01188174|Clofarabine|clofarabine|mesh-list
101925691|NCT01188174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101925692|NCT01188174|Antimetabolites|antimetabolites|mesh-ancestor
101925693|NCT01188174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925694|NCT01188174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101925695|NCT01588002|Ritonavir|ritonavir|mesh-list
101925696|NCT01588002|Efavirenz|efavirenz|mesh-list
101925697|NCT01588002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101925698|NCT01588002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101925699|NCT01588002|Protease Inhibitors|protease inhibitors|mesh-ancestor
101925700|NCT01588002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101925701|NCT01588002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925702|NCT01588002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101925703|NCT01588002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101925704|NCT01588002|Antiviral Agents|antiviral agents|mesh-ancestor
101925705|NCT01588002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101925706|NCT01588002|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101925707|NCT01588002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101925708|NCT01588002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101925709|NCT01588002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101925710|NCT01588002|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101925711|NCT01588002|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101925712|NCT01588002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101925713|NCT01588002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101925714|NCT01588002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101925715|NCT01291212|Methyltestosterone|methyltestosterone|mesh-list
101925716|NCT01291212|Testosterone|testosterone|mesh-list
101925717|NCT01291212|Testosterone undecanoate|testosterone undecanoate|mesh-list
101925718|NCT01291212|Testosterone enanthate|testosterone enanthate|mesh-list
101925719|NCT01291212|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101925720|NCT01291212|Androgens|androgens|mesh-ancestor
101925721|NCT01291212|Hormones|hormones|mesh-ancestor
101925722|NCT01291212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101925723|NCT01291212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925724|NCT01291212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101925725|NCT01291212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101925726|NCT01291212|Anabolic Agents|anabolic agents|mesh-ancestor
101925727|NCT01182168|Gemcitabine|gemcitabine|mesh-list
101925728|NCT01182168|Everolimus|everolimus|mesh-list
101925729|NCT01182168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101925730|NCT01182168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101925731|NCT01182168|Antimetabolites|antimetabolites|mesh-ancestor
101925732|NCT01182168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925734|NCT01182168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101925735|NCT01182168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101925736|NCT01182168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101925737|NCT01182168|Immunologic Factors|immunologic factors|mesh-ancestor
101925738|NCT01182168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925739|NCT01182246|Genistein|genistein|mesh-list
101925740|NCT01182246|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101925741|NCT01182246|Protective Agents|protective agents|mesh-ancestor
101925742|NCT01182246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925743|NCT01182246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101925744|NCT01182246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101925745|NCT01182246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101925746|NCT01182246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925747|NCT01182246|Phytoestrogens|phytoestrogens|mesh-ancestor
101925748|NCT01182246|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101925750|NCT01182246|Hormones|hormones|mesh-ancestor
101925751|NCT01182246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101925752|NCT01588626|Ticagrelor|ticagrelor|mesh-list
101925753|NCT01588626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101925754|NCT01588626|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101925755|NCT01588626|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101925756|NCT01588626|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101925757|NCT01588626|Purinergic Agents|purinergic agents|mesh-ancestor
101925758|NCT01588626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101238160|NCT02702492|Niacin|niacin|mesh-list
101925759|NCT01588626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231281|NCT03523156|Azithromycin|azithromycin|mesh-list
101925760|NCT01588626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925761|NCT01290120|Rituximab|rituximab|mesh-list
101925762|NCT01290120|Doxorubicin|doxorubicin|mesh-list
101925763|NCT01290120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101925764|NCT01290120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101925765|NCT01290120|Immunologic Factors|immunologic factors|mesh-ancestor
101925766|NCT01290120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925767|NCT01290120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101925768|NCT01290120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101925769|NCT01290120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101925770|NCT01290120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101925771|NCT01290120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101925772|NCT01290120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925773|NCT01290198|Fluconazole|fluconazole|mesh-list
101925774|NCT01290198|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
101925775|NCT01290198|Antifungal Agents|antifungal agents|mesh-ancestor
101925776|NCT01290198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101925777|NCT01290198|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101925778|NCT01290198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101925779|NCT01290198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101925780|NCT01290198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925781|NCT01290198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101925782|NCT01290198|Hormone Antagonists|hormone antagonists|mesh-ancestor
101925783|NCT01290198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101925784|NCT01290198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925785|NCT01290198|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101925786|NCT01290198|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101925787|NCT01290276|Ondansetron|ondansetron|mesh-list
101925788|NCT01290276|Methylphenidate|methylphenidate|mesh-list
101925789|NCT01290276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101925790|NCT01290276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925791|NCT01290276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101925792|NCT01290276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101925793|NCT01290276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101925794|NCT01290276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925795|NCT01290276|Dopamine Agents|dopamine agents|mesh-ancestor
101925796|NCT01290276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101925797|NCT01290276|Antiemetics|antiemetics|mesh-ancestor
101925798|NCT01290276|Autonomic Agents|autonomic agents|mesh-ancestor
101925799|NCT01290276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101925800|NCT01290276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101925801|NCT01290276|Antipruritics|antipruritics|mesh-ancestor
101925802|NCT01290276|Dermatologic Agents|dermatologic agents|mesh-ancestor
101925803|NCT01290276|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101925804|NCT01290276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101925805|NCT01290276|Serotonin Agents|serotonin agents|mesh-ancestor
101925806|NCT03856866|Hydroxychloroquine|hydroxychloroquine|mesh-list
101925807|NCT03856866|Antimalarials|antimalarials|mesh-ancestor
101925808|NCT03856866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101925809|NCT03856866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101925810|NCT03856866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101925811|NCT03856866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101925812|NCT03856866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925813|NCT03856866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101925814|NCT01587768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101925815|NCT01587768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101925816|NCT01182636|Adapalene|adapalene|mesh-list
101925817|NCT01182636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101925818|NCT01182636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101925819|NCT01182636|Analgesics|analgesics|mesh-ancestor
101925820|NCT01182636|Sensory System Agents|sensory system agents|mesh-ancestor
101925821|NCT01182636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101925822|NCT01182636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925823|NCT01182636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101231292|NCT03463408|Nivolumab|nivolumab|mesh-list
101925824|NCT01182636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101925825|NCT01182636|Dermatologic Agents|dermatologic agents|mesh-ancestor
101925826|NCT01290354|Lapatinib|lapatinib|mesh-list
101925827|NCT01290354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101925828|NCT01290354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101925829|NCT01290354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101925830|NCT01290354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925831|NCT01188408|Docetaxel|docetaxel|mesh-list
101925832|NCT01188408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101925833|NCT01188408|Tubulin Modulators|tubulin modulators|mesh-ancestor
101925834|NCT01188408|Antimitotic Agents|antimitotic agents|mesh-ancestor
101925835|NCT01188408|Mitosis Modulators|mitosis modulators|mesh-ancestor
101925836|NCT01188408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925837|NCT01186146|Aspirin|aspirin|mesh-list
101925838|NCT01186146|Clopidogrel|clopidogrel|mesh-list
101925839|NCT01186146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101925840|NCT01186146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101925841|NCT01186146|Analgesics|analgesics|mesh-ancestor
101925842|NCT01186146|Sensory System Agents|sensory system agents|mesh-ancestor
101925843|NCT01186146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101925844|NCT01186146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925845|NCT01186146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101925846|NCT01186146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101925847|NCT01186146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101925848|NCT01186146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101925849|NCT01186146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925850|NCT01186146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101925851|NCT01186146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101925852|NCT01186146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101925853|NCT01186146|Antipyretics|antipyretics|mesh-ancestor
101925854|NCT01186146|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101925855|NCT01186146|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101925856|NCT01186146|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101925857|NCT01186146|Purinergic Agents|purinergic agents|mesh-ancestor
101925858|NCT01186146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101925859|NCT01186224|Plerixafor|plerixafor|mesh-list
101925860|NCT01186224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101925861|NCT01186224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101925862|NCT01186224|Antiviral Agents|antiviral agents|mesh-ancestor
101925863|NCT01186224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101925864|NCT01183494|Irinotecan|irinotecan|mesh-list
101925865|NCT01183494|Bevacizumab|bevacizumab|mesh-list
101925866|NCT01183494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101925867|NCT01183494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101925868|NCT01183494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101925869|NCT01183494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925870|NCT01183494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101925871|NCT01183494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101925872|NCT01183494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101925873|NCT01183494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101925874|NCT01183494|Growth Substances|growth substances|mesh-ancestor
101925875|NCT01183494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925876|NCT01183494|Growth Inhibitors|growth inhibitors|mesh-ancestor
101645737|NCT00765271|Abacavir|abacavir|mesh-list
101925877|NCT01183572|Iron|iron|mesh-list
101925878|NCT01183572|Folic Acid|folic acid|mesh-list
101925879|NCT01183572|Vitamin B Complex|vitamin b complex|mesh-list
101925880|NCT01183572|Trace Elements|trace elements|mesh-ancestor
101925881|NCT01183572|Micronutrients|micronutrients|mesh-ancestor
101925882|NCT01183572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925883|NCT01183572|Hematinics|hematinics|mesh-ancestor
101925884|NCT01183572|Vitamins|vitamins|mesh-ancestor
101925885|NCT03856242|Tamsulosin|tamsulosin|mesh-list
101925886|NCT03856242|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101925887|NCT03856242|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101925888|NCT03856242|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101925889|NCT03856242|Adrenergic Agents|adrenergic agents|mesh-ancestor
101925890|NCT03856242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101925891|NCT03856242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925892|NCT03856242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925893|NCT03856242|Urological Agents|urological agents|mesh-ancestor
101925895|NCT01291524|Analgesics|analgesics|mesh-ancestor
101925896|NCT01291524|Sensory System Agents|sensory system agents|mesh-ancestor
101925897|NCT01291524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101925898|NCT01291524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925899|NCT01291524|Anticonvulsants|anticonvulsants|mesh-ancestor
101925900|NCT01291524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101958132|NCT05256914|Disinfectants|disinfectants|mesh-ancestor
101925901|NCT01291524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101925902|NCT01291524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925903|NCT01291524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101925904|NCT01291524|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101925905|NCT01291524|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101925906|NCT01291524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101925907|NCT01291524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101925908|NCT01183806|Rivastigmine|rivastigmine|mesh-list
101925909|NCT01183806|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101925910|NCT01183806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101925911|NCT01183806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925912|NCT01183806|Cholinergic Agents|cholinergic agents|mesh-ancestor
101925913|NCT01183806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101925914|NCT01183806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925915|NCT01183806|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101925916|NCT01183806|Protective Agents|protective agents|mesh-ancestor
101925917|NCT01188954|Doxycycline|doxycycline|mesh-list
101925918|NCT01188954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101925919|NCT01188954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101925920|NCT01188954|Antimalarials|antimalarials|mesh-ancestor
101925921|NCT01188954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101925922|NCT01188954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101925923|NCT01183962|Vitamin D|vitamin d|mesh-list
101925924|NCT01183962|Vitamins|vitamins|mesh-ancestor
101925925|NCT01183962|Micronutrients|micronutrients|mesh-ancestor
101925926|NCT01183962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925927|NCT01183962|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101925928|NCT01187238|Cisplatin|cisplatin|mesh-list
101925929|NCT01187238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101925930|NCT01588314|Gabapentin|gabapentin|mesh-list
101925931|NCT01588314|Analgesics|analgesics|mesh-ancestor
101925932|NCT01588314|Sensory System Agents|sensory system agents|mesh-ancestor
101925933|NCT01588314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101925934|NCT01588314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925935|NCT01588314|Anticonvulsants|anticonvulsants|mesh-ancestor
101925936|NCT01588314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101925937|NCT01588314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101925938|NCT01588314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101925939|NCT01588314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101925940|NCT01588314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101925941|NCT01588314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101925942|NCT01588314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101925943|NCT01588314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925944|NCT01588314|Antimanic Agents|antimanic agents|mesh-ancestor
101925945|NCT01290432|Folic Acid|folic acid|mesh-list
101925946|NCT01290432|Melatonin|melatonin|mesh-list
101925947|NCT01290432|Antioxidants|antioxidants|mesh-ancestor
101925948|NCT01290432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925949|NCT01290432|Protective Agents|protective agents|mesh-ancestor
101925950|NCT01290432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925951|NCT01290432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101925952|NCT01290432|Hematinics|hematinics|mesh-ancestor
101925953|NCT01290432|Vitamin B Complex|vitamin b complex|mesh-ancestor
101925954|NCT01290432|Vitamins|vitamins|mesh-ancestor
101925955|NCT01290432|Micronutrients|micronutrients|mesh-ancestor
101925956|NCT01290510|Hyaluronic Acid|hyaluronic acid|mesh-list
101925957|NCT01290510|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101925958|NCT01290510|Immunologic Factors|immunologic factors|mesh-ancestor
101925959|NCT01290510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925960|NCT01290510|Viscosupplements|viscosupplements|mesh-ancestor
101925961|NCT01290510|Protective Agents|protective agents|mesh-ancestor
101925962|NCT01184196|Povidone-Iodine|povidone-iodine|mesh-list
101925963|NCT01184196|Povidone|povidone|mesh-list
101925964|NCT01184196|Plasma Substitutes|plasma substitutes|mesh-ancestor
101925965|NCT01184196|Blood Substitutes|blood substitutes|mesh-ancestor
101925966|NCT01184196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101925967|NCT01184196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101925968|NCT01292460|Timolol|timolol|mesh-list
101925969|NCT01292460|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101925970|NCT01292460|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101925971|NCT01292460|Adrenergic Agents|adrenergic agents|mesh-ancestor
101925972|NCT01292460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101925973|NCT01292460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925974|NCT01292460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101925975|NCT01292460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101925976|NCT01292460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101925977|NCT01292616|Antirheumatic Agents|antirheumatic agents|mesh-list
101925979|NCT01292694|Captopril|captopril|mesh-list
101925980|NCT01292694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101925981|NCT01292694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101925982|NCT01292694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101925983|NCT01292694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101925984|NCT01292694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101925985|NCT01292694|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101925986|NCT01292694|Protease Inhibitors|protease inhibitors|mesh-ancestor
101925987|NCT01292694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101925988|NCT03851562|Alprostadil|alprostadil|mesh-list
101925989|NCT03851562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101925990|NCT03851562|Vasodilator Agents|vasodilator agents|mesh-ancestor
101925991|NCT03851562|Urological Agents|urological agents|mesh-ancestor
101925992|NCT01293630|Paclitaxel|paclitaxel|mesh-list
101925993|NCT01293630|Carboplatin|carboplatin|mesh-list
101925994|NCT01293630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101925995|NCT01293630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101925996|NCT01293630|Tubulin Modulators|tubulin modulators|mesh-ancestor
101925997|NCT01293630|Antimitotic Agents|antimitotic agents|mesh-ancestor
101925998|NCT01293630|Mitosis Modulators|mitosis modulators|mesh-ancestor
101925999|NCT01293630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926000|NCT01191060|Lenalidomide|lenalidomide|mesh-list
101926001|NCT01191060|Bortezomib|bortezomib|mesh-list
101926002|NCT01191060|Immunologic Factors|immunologic factors|mesh-ancestor
101926003|NCT01191060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926004|NCT01191060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101926005|NCT01191060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101926006|NCT01191060|Growth Substances|growth substances|mesh-ancestor
101926007|NCT01191060|Growth Inhibitors|growth inhibitors|mesh-ancestor
101926008|NCT01191060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101926009|NCT01291602|Avibactam|avibactam|mesh-list
101926010|NCT01291602|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101926011|NCT01291602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101926012|NCT01291602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926013|NCT01291602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101926014|NCT01291602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101926015|NCT03851172|Ketorolac|ketorolac|mesh-list
101926016|NCT03851172|Nepafenac|nepafenac|mesh-list
101926017|NCT03851172|Cyclopentolate|cyclopentolate|mesh-list
101926018|NCT03851172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101926019|NCT03851172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101926020|NCT03851172|Analgesics|analgesics|mesh-ancestor
101926021|NCT03851172|Sensory System Agents|sensory system agents|mesh-ancestor
101926022|NCT03851172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101926023|NCT03851172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926024|NCT03851172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101926025|NCT03851172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101926026|NCT03851172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101926027|NCT03851172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101926028|NCT03851172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926029|NCT03851172|Mydriatics|mydriatics|mesh-ancestor
101926030|NCT03851172|Autonomic Agents|autonomic agents|mesh-ancestor
101926031|NCT03851172|Parasympatholytics|parasympatholytics|mesh-ancestor
101926032|NCT03851172|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101926033|NCT03851172|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101926034|NCT03851172|Cholinergic Agents|cholinergic agents|mesh-ancestor
101926035|NCT03851172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101926036|NCT03853512|Petrolatum|petrolatum|mesh-list
101926037|NCT03853512|Emollients|emollients|mesh-ancestor
101926038|NCT03853512|Dermatologic Agents|dermatologic agents|mesh-ancestor
101926039|NCT03849612|Insulin Lispro|insulin lispro|mesh-list
101926040|NCT03849612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101926041|NCT03849612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926042|NCT03853200|Chlorhexidine|chlorhexidine|mesh-list
101926043|NCT03853200|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101926044|NCT03853200|Acetic Acid|acetic acid|mesh-list
101926045|NCT03853200|Root Canal Irrigants|root canal irrigants|mesh-list
101926046|NCT03853200|Edetic Acid|edetic acid|mesh-list
101926048|NCT03853200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101926049|NCT03853200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101926050|NCT03853200|Disinfectants|disinfectants|mesh-ancestor
101926051|NCT03853200|Dermatologic Agents|dermatologic agents|mesh-ancestor
101926052|NCT03853200|Anticoagulants|anticoagulants|mesh-ancestor
101926053|NCT03853200|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101926054|NCT03853200|Chelating Agents|chelating agents|mesh-ancestor
101926055|NCT03853200|Sequestering Agents|sequestering agents|mesh-ancestor
101926056|NCT03853200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926057|NCT03853200|Antidotes|antidotes|mesh-ancestor
101926058|NCT03853200|Protective Agents|protective agents|mesh-ancestor
101926059|NCT03853200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926060|NCT03853200|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101926061|NCT03853200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101926062|NCT03853200|Dental Disinfectants|dental disinfectants|mesh-ancestor
101926063|NCT01293942|Bevacizumab|bevacizumab|mesh-list
101926064|NCT01293942|Capecitabine|capecitabine|mesh-list
101926065|NCT01293942|Oxaliplatin|oxaliplatin|mesh-list
101926066|NCT01293942|Irinotecan|irinotecan|mesh-list
101926067|NCT01293942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101926068|NCT01293942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101926069|NCT01293942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101926070|NCT01293942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101926071|NCT01293942|Growth Substances|growth substances|mesh-ancestor
101926072|NCT01293942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926073|NCT01293942|Growth Inhibitors|growth inhibitors|mesh-ancestor
101926074|NCT01293942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101926075|NCT01293942|Antimetabolites|antimetabolites|mesh-ancestor
101926076|NCT01293942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926077|NCT01293942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101926078|NCT01293942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101926079|NCT01293942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101926080|NCT01189656|Vaccines|vaccines|mesh-list
101926081|NCT01189656|Immunologic Factors|immunologic factors|mesh-ancestor
101926082|NCT01189656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926083|NCT01581138|Ribavirin|ribavirin|mesh-list
101926084|NCT01581138|Antimetabolites|antimetabolites|mesh-ancestor
101926085|NCT01581138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926086|NCT01581138|Antiviral Agents|antiviral agents|mesh-ancestor
101926087|NCT01581138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101926088|NCT01191216|Docetaxel|docetaxel|mesh-list
101926089|NCT01191216|Tryptophan|tryptophan|mesh-list
101926090|NCT01191216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101926091|NCT01191216|Tubulin Modulators|tubulin modulators|mesh-ancestor
101926092|NCT01191216|Antimitotic Agents|antimitotic agents|mesh-ancestor
101926093|NCT01191216|Mitosis Modulators|mitosis modulators|mesh-ancestor
101926094|NCT01191216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926095|NCT01191216|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101926096|NCT01191216|Antidepressive Agents|antidepressive agents|mesh-ancestor
101926097|NCT01191216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101926098|NCT01294176|Thioctic Acid|thioctic acid|mesh-list
101926099|NCT01294176|Antioxidants|antioxidants|mesh-ancestor
101926100|NCT01294176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926101|NCT01294176|Protective Agents|protective agents|mesh-ancestor
101926102|NCT01294176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926103|NCT01294176|Vitamin B Complex|vitamin b complex|mesh-ancestor
101926104|NCT01294176|Vitamins|vitamins|mesh-ancestor
101926105|NCT01294176|Micronutrients|micronutrients|mesh-ancestor
101926106|NCT03847818|Carboplatin|carboplatin|mesh-list
101926107|NCT03847818|Docetaxel|docetaxel|mesh-list
101926108|NCT03847818|Trastuzumab|trastuzumab|mesh-list
101926109|NCT03847818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101926110|NCT03847818|Tubulin Modulators|tubulin modulators|mesh-ancestor
101926111|NCT03847818|Antimitotic Agents|antimitotic agents|mesh-ancestor
101926112|NCT03847818|Mitosis Modulators|mitosis modulators|mesh-ancestor
101926113|NCT03847818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926114|NCT03847818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101926115|NCT01294410|Antibodies|antibodies|mesh-list
101926116|NCT01294410|Immunoglobulins|immunoglobulins|mesh-list
101926117|NCT01294410|Immunologic Factors|immunologic factors|mesh-ancestor
101926118|NCT01294410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926119|NCT01191450|Chlorthalidone|chlorthalidone|mesh-list
101926120|NCT01191450|Amiloride|amiloride|mesh-list
101926121|NCT01191450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101926122|NCT01191450|Diuretics|diuretics|mesh-ancestor
101926123|NCT01191450|Natriuretic Agents|natriuretic agents|mesh-ancestor
101926124|NCT01191450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926125|NCT01191450|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101926126|NCT01191450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101926127|NCT01191450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926128|NCT01191450|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
101926129|NCT01191450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101926130|NCT01191450|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101926131|NCT01191450|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101926132|NCT01194336|Huperzine A|huperzine a|mesh-list
101926133|NCT01194336|Donepezil|donepezil|mesh-list
101926134|NCT01194336|Galantamine|galantamine|mesh-list
101926135|NCT01194336|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101926136|NCT01194336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101926137|NCT01194336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926138|NCT01194336|Cholinergic Agents|cholinergic agents|mesh-ancestor
101926139|NCT01194336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101926140|NCT01194336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926141|NCT01194336|Nootropic Agents|nootropic agents|mesh-ancestor
101926142|NCT01194336|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101926143|NCT01194336|Autonomic Agents|autonomic agents|mesh-ancestor
101926144|NCT01194336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101926145|NCT01194336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101926146|NCT01194336|Protective Agents|protective agents|mesh-ancestor
101926147|NCT02660710|Rituximab|rituximab|mesh-list
101926148|NCT02660710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101926149|NCT02660710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101926150|NCT02660710|Immunologic Factors|immunologic factors|mesh-ancestor
101926151|NCT02660710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926152|NCT02660710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101926153|NCT01294878|Omalizumab|omalizumab|mesh-list
101926154|NCT01294878|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101926155|NCT01294878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101926156|NCT01294878|Respiratory System Agents|respiratory system agents|mesh-ancestor
101926157|NCT01296438|Insulin|insulin|mesh-list
101926158|NCT01296438|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101926159|NCT01296438|Insulin Aspart|insulin aspart|mesh-list
101926160|NCT01296438|Insulin, Long-Acting|insulin, long-acting|mesh-list
101926161|NCT01296438|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101926162|NCT01296438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101926163|NCT01296438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926164|NCT03847272|Prednisone|prednisone|mesh-list
101926165|NCT03847272|Ustekinumab|ustekinumab|mesh-list
101926166|NCT03847272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101926167|NCT03847272|Glucocorticoids|glucocorticoids|mesh-ancestor
101926168|NCT03847272|Hormones|hormones|mesh-ancestor
101926169|NCT03847272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101926170|NCT03847272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926171|NCT03847272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101926172|NCT03847272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101926173|NCT03847272|Dermatologic Agents|dermatologic agents|mesh-ancestor
101926174|NCT03850626|Immunomodulating Agents|immunomodulating agents|mesh-list
101926175|NCT03850626|Immunologic Factors|immunologic factors|mesh-ancestor
101926176|NCT03850626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926177|NCT01294956|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101926178|NCT01294956|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101926179|NCT01294956|Lubricant Eye Drops|lubricant eye drops|mesh-list
101926180|NCT01294956|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101926181|NCT01294956|Laxatives|laxatives|mesh-ancestor
101926182|NCT01294956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101926183|NCT01190358|Grape Seed Extract|grape seed extract|mesh-list
101926184|NCT01190358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101926185|NCT01190358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101926186|NCT01190358|Antioxidants|antioxidants|mesh-ancestor
101926187|NCT01190358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926188|NCT01190358|Protective Agents|protective agents|mesh-ancestor
101926189|NCT01190358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926190|NCT01293162|Folic Acid|folic acid|mesh-list
101926191|NCT01293162|Policosanol|policosanol|mesh-list
101926192|NCT01293162|Hematinics|hematinics|mesh-ancestor
101926193|NCT01293162|Vitamin B Complex|vitamin b complex|mesh-ancestor
101926194|NCT01293162|Vitamins|vitamins|mesh-ancestor
101926195|NCT01293162|Micronutrients|micronutrients|mesh-ancestor
101926196|NCT01293162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926197|NCT01293162|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101926198|NCT01293162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101926199|NCT01293162|Antimetabolites|antimetabolites|mesh-ancestor
101926200|NCT01293162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926201|NCT01293162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101926202|NCT01293162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101926203|NCT01190670|Tacrolimus|tacrolimus|mesh-list
101926204|NCT01190670|Peficitinib|peficitinib|mesh-list
101926205|NCT01190670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101926206|NCT01190670|Immunologic Factors|immunologic factors|mesh-ancestor
101926207|NCT01190670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926208|NCT01190670|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101926209|NCT01190670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101926210|NCT01190670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926211|NCT01194882|Insulin|insulin|mesh-list
101926212|NCT01194882|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101926213|NCT01194882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101926214|NCT01194882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926215|NCT01191684|Vaccines|vaccines|mesh-list
101926216|NCT01191684|Immunologic Factors|immunologic factors|mesh-ancestor
101926217|NCT01191684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926218|NCT02659540|Nivolumab|nivolumab|mesh-list
101926219|NCT02659540|Ipilimumab|ipilimumab|mesh-list
101926220|NCT02659540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101926221|NCT02659540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101926222|NCT02659540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101926223|NCT02659540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926224|NCT01295268|Emu Oil|emu oil|mesh-list
101926225|NCT01295268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101926226|NCT01295268|Dermatologic Agents|dermatologic agents|mesh-ancestor
101926227|NCT01383694|Piperine|piperine|mesh-list
101926228|NCT01383694|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101926229|NCT01383694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101926230|NCT01383694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926231|NCT01191918|Lithium Carbonate|lithium carbonate|mesh-list
101926232|NCT01191918|Donepezil|donepezil|mesh-list
101926233|NCT01191918|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101926234|NCT01191918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101926235|NCT01191918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926236|NCT01191918|Cholinergic Agents|cholinergic agents|mesh-ancestor
101926237|NCT01191918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101926238|NCT01191918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926239|NCT01191918|Nootropic Agents|nootropic agents|mesh-ancestor
101926240|NCT01191918|Antidepressive Agents|antidepressive agents|mesh-ancestor
101926241|NCT01191918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101926242|NCT01191918|Antimanic Agents|antimanic agents|mesh-ancestor
101926243|NCT01191918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101926244|NCT01191918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101926245|NCT03850314|Glycine|glycine|mesh-list
101926246|NCT03850314|Glycine Agents|glycine agents|mesh-ancestor
101926247|NCT03850314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101926248|NCT03850314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926249|NCT03850314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926250|NCT01097746|Paclitaxel|paclitaxel|mesh-list
101926251|NCT01097746|Bevacizumab|bevacizumab|mesh-list
101926252|NCT01097746|Carboplatin|carboplatin|mesh-list
101926253|NCT01097746|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101926254|NCT01097746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101926255|NCT01097746|Endothelial Growth Factors|endothelial growth factors|mesh-list
101926256|NCT01097746|Antibodies|antibodies|mesh-list
101926257|NCT01097746|Immunoglobulins|immunoglobulins|mesh-list
101926258|NCT01097746|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101926259|NCT01097746|Immunoglobulin G|immunoglobulin g|mesh-list
101926260|NCT01097746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101926261|NCT01097746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101926262|NCT01097746|Tubulin Modulators|tubulin modulators|mesh-ancestor
101926263|NCT01097746|Antimitotic Agents|antimitotic agents|mesh-ancestor
101926265|NCT01097746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926266|NCT01097746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101926267|NCT01097746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101926268|NCT01097746|Growth Substances|growth substances|mesh-ancestor
101926269|NCT01097746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926270|NCT01097746|Growth Inhibitors|growth inhibitors|mesh-ancestor
101926271|NCT01097746|Immunologic Factors|immunologic factors|mesh-ancestor
101926272|NCT01190748|Galantamine|galantamine|mesh-list
101926273|NCT01190748|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101926274|NCT01190748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101926275|NCT01190748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926276|NCT01190748|Cholinergic Agents|cholinergic agents|mesh-ancestor
101926277|NCT01190748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101231372|NCT03384784|Galantamine|galantamine|mesh-list
101926278|NCT01190748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926279|NCT01190748|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101926280|NCT01190748|Autonomic Agents|autonomic agents|mesh-ancestor
101926281|NCT01190748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101926282|NCT01190748|Nootropic Agents|nootropic agents|mesh-ancestor
101926283|NCT01383538|Leucovorin|leucovorin|mesh-list
101926284|NCT01383538|Oxaliplatin|oxaliplatin|mesh-list
101926285|NCT01383538|Irinotecan|irinotecan|mesh-list
101926286|NCT01383538|Folfirinox|folfirinox|mesh-list
101926287|NCT01383538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101926288|NCT01383538|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101926289|NCT01383538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101926290|NCT01383538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101926291|NCT01383538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926292|NCT01383538|Antidotes|antidotes|mesh-ancestor
101926293|NCT01383538|Protective Agents|protective agents|mesh-ancestor
101926294|NCT01383538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926295|NCT01383538|Vitamin B Complex|vitamin b complex|mesh-ancestor
101926296|NCT01383538|Vitamins|vitamins|mesh-ancestor
101926297|NCT01383538|Micronutrients|micronutrients|mesh-ancestor
101926298|NCT01383460|Epoetin Alfa|epoetin alfa|mesh-list
101926299|NCT01383460|Lenograstim|lenograstim|mesh-list
101926300|NCT01383460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101926301|NCT01383460|Immunologic Factors|immunologic factors|mesh-ancestor
101926302|NCT01383460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926303|NCT01383460|Hematinics|hematinics|mesh-ancestor
101926304|NCT01192230|Docetaxel|docetaxel|mesh-list
101926305|NCT01192230|Endostatins|endostatins|mesh-list
101926306|NCT01192230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101926307|NCT01192230|Tubulin Modulators|tubulin modulators|mesh-ancestor
101926308|NCT01192230|Antimitotic Agents|antimitotic agents|mesh-ancestor
101926309|NCT01192230|Mitosis Modulators|mitosis modulators|mesh-ancestor
101926310|NCT01192230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926311|NCT01192230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101926312|NCT01192230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101926313|NCT01192230|Growth Substances|growth substances|mesh-ancestor
101926314|NCT01192230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926315|NCT01192230|Growth Inhibitors|growth inhibitors|mesh-ancestor
101926316|NCT05416840|Amlodipine|amlodipine|mesh-list
101926317|NCT05416840|Clonidine|clonidine|mesh-list
101926318|NCT05416840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101926319|NCT05416840|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101926320|NCT05416840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101926321|NCT05416840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926322|NCT05416840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101926323|NCT05416840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926324|NCT05416840|Vasodilator Agents|vasodilator agents|mesh-ancestor
101926325|NCT05416840|Analgesics|analgesics|mesh-ancestor
101926326|NCT05416840|Sensory System Agents|sensory system agents|mesh-ancestor
101926327|NCT05416840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101926328|NCT05416840|Sympatholytics|sympatholytics|mesh-ancestor
101926329|NCT05416840|Autonomic Agents|autonomic agents|mesh-ancestor
101926330|NCT05416840|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101926331|NCT05416840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101926332|NCT05416840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101926333|NCT05416840|Adrenergic Agents|adrenergic agents|mesh-ancestor
101926334|NCT05416840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101926335|NCT01192308|Tamoxifen|tamoxifen|mesh-list
101926336|NCT01192308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101646190|NCT00766909|Cyclosporins|cyclosporins|mesh-list
101926337|NCT01192308|Hormone Antagonists|hormone antagonists|mesh-ancestor
101926338|NCT01192308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101926339|NCT01192308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926340|NCT01192308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101926341|NCT01192308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101926342|NCT01192308|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101926343|NCT01192308|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101926344|NCT01192308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101926345|NCT01190982|Paclitaxel|paclitaxel|mesh-list
101926346|NCT01190982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101926347|NCT01190982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101926348|NCT01190982|Tubulin Modulators|tubulin modulators|mesh-ancestor
101926349|NCT01190982|Antimitotic Agents|antimitotic agents|mesh-ancestor
101926350|NCT01190982|Mitosis Modulators|mitosis modulators|mesh-ancestor
101926351|NCT01190982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926352|NCT04170556|Nivolumab|nivolumab|mesh-list
101926353|NCT04170556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101926354|NCT04170556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101926355|NCT04170556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101926356|NCT04170556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926357|NCT03846960|Pulmonary Surfactants|pulmonary surfactants|mesh-list
101926358|NCT03846960|Respiratory System Agents|respiratory system agents|mesh-ancestor
101926359|NCT01196754|Sevoflurane|sevoflurane|mesh-list
101926360|NCT01196754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101926361|NCT01196754|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101926362|NCT01196754|Anesthetics, General|anesthetics, general|mesh-ancestor
101926363|NCT01196754|Anesthetics|anesthetics|mesh-ancestor
101926364|NCT01196754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101926365|NCT01196754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926366|NCT01295502|Paclitaxel|paclitaxel|mesh-list
101926367|NCT01295502|Cisplatin|cisplatin|mesh-list
101926368|NCT01295502|Carboplatin|carboplatin|mesh-list
101926369|NCT01295502|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101926370|NCT01295502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101926371|NCT01295502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101926372|NCT01295502|Tubulin Modulators|tubulin modulators|mesh-ancestor
101926373|NCT01295502|Antimitotic Agents|antimitotic agents|mesh-ancestor
101926374|NCT01295502|Mitosis Modulators|mitosis modulators|mesh-ancestor
101926375|NCT01295502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926376|NCT05207644|Letrozole|letrozole|mesh-list
101926377|NCT05207644|Misoprostol|misoprostol|mesh-list
101926378|NCT05207644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101926379|NCT05207644|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101926380|NCT05207644|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101926381|NCT05207644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101926382|NCT05207644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926383|NCT05207644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101926384|NCT05207644|Hormone Antagonists|hormone antagonists|mesh-ancestor
101926385|NCT05207644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101926386|NCT05207644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926387|NCT05207644|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101926388|NCT05207644|Abortifacient Agents|abortifacient agents|mesh-ancestor
101926389|NCT05207644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101926390|NCT05207644|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101926391|NCT05207644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101926393|NCT03846102|Acetaminophen|acetaminophen|mesh-list
101926394|NCT03846102|Morphine|morphine|mesh-list
101926395|NCT03846102|Levobupivacaine|levobupivacaine|mesh-list
101926396|NCT03846102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101926397|NCT03846102|Narcotics|narcotics|mesh-ancestor
101926398|NCT03846102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101926399|NCT03846102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926400|NCT03846102|Analgesics|analgesics|mesh-ancestor
101926401|NCT03846102|Sensory System Agents|sensory system agents|mesh-ancestor
101926402|NCT03846102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101926403|NCT03846102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101926404|NCT03846102|Antipyretics|antipyretics|mesh-ancestor
101926405|NCT03846102|Anesthetics, Local|anesthetics, local|mesh-ancestor
101926406|NCT03846102|Anesthetics|anesthetics|mesh-ancestor
101926407|NCT01383148|Paclitaxel|paclitaxel|mesh-list
101926408|NCT01383148|Cisplatin|cisplatin|mesh-list
101926409|NCT01383148|Carboplatin|carboplatin|mesh-list
101926410|NCT01383148|Gemcitabine|gemcitabine|mesh-list
101926411|NCT01383148|Pemetrexed|pemetrexed|mesh-list
101926412|NCT01383148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101926413|NCT01383148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101926414|NCT01383148|Tubulin Modulators|tubulin modulators|mesh-ancestor
101926416|NCT01383148|Mitosis Modulators|mitosis modulators|mesh-ancestor
101926417|NCT01383148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926418|NCT01383148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101926419|NCT01383148|Antimetabolites|antimetabolites|mesh-ancestor
101926420|NCT01383148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101926421|NCT01383148|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101926422|NCT01383148|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101926423|NCT01192854|Adefovir|adefovir|mesh-list
101926424|NCT01192854|Clevudine|clevudine|mesh-list
101926425|NCT01192854|Antiviral Agents|antiviral agents|mesh-ancestor
101926426|NCT01192854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101926427|NCT01192854|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101926428|NCT01192854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101926429|NCT01192854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101926430|NCT01192854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926431|NCT01382914|Chlorhexidine|chlorhexidine|mesh-list
101926432|NCT01382914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101926433|NCT01382914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101926434|NCT01382914|Disinfectants|disinfectants|mesh-ancestor
101926435|NCT01195428|Simvastatin|simvastatin|mesh-list
101926436|NCT01195428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101926437|NCT01195428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101926438|NCT01195428|Antimetabolites|antimetabolites|mesh-ancestor
101926439|NCT01195428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926440|NCT01195428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101926441|NCT01195428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101926442|NCT01195428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101926443|NCT03439462|Sirolimus|sirolimus|mesh-list
101926444|NCT03439462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101926445|NCT03439462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926446|NCT03439462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101926447|NCT03439462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101926448|NCT03439462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101926449|NCT03439462|Antifungal Agents|antifungal agents|mesh-ancestor
101926450|NCT03439462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101926451|NCT03439462|Immunologic Factors|immunologic factors|mesh-ancestor
101926452|NCT01193166|Olanzapine|olanzapine|mesh-list
101926453|NCT01193166|Risperidone|risperidone|mesh-list
101926454|NCT01193166|Aripiprazole|aripiprazole|mesh-list
101926455|NCT01193166|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101926456|NCT01193166|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101926457|NCT01193166|Perphenazine|perphenazine|mesh-list
101926458|NCT01193166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101926459|NCT01193166|Serotonin Agents|serotonin agents|mesh-ancestor
101926460|NCT01193166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101926461|NCT01193166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926462|NCT01193166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926463|NCT01193166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101926464|NCT01193166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101926465|NCT01193166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101926466|NCT01193166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101926467|NCT01193166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101926468|NCT01193166|Dopamine Agents|dopamine agents|mesh-ancestor
101926469|NCT01193166|Antiemetics|antiemetics|mesh-ancestor
101926470|NCT01193166|Autonomic Agents|autonomic agents|mesh-ancestor
101926471|NCT01193166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101926472|NCT01193166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101926473|NCT01193166|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101926474|NCT01193166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101926475|NCT01193166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101926476|NCT01193166|Antidepressive Agents|antidepressive agents|mesh-ancestor
101926477|NCT01193166|Dopamine Agonists|dopamine agonists|mesh-ancestor
101926478|NCT01193166|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101926479|NCT01193166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101926480|NCT01193166|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101926481|NCT01193166|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101926483|NCT01197144|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101926484|NCT01197144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101926485|NCT01197144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101926486|NCT01193400|Cytarabine|cytarabine|mesh-list
101926487|NCT01193400|Clofarabine|clofarabine|mesh-list
101926488|NCT01193400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101926489|NCT01193400|Antimetabolites|antimetabolites|mesh-ancestor
101926490|NCT01193400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926492|NCT01193400|Antiviral Agents|antiviral agents|mesh-ancestor
101926493|NCT01193400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101926494|NCT01193400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101926495|NCT01193400|Immunologic Factors|immunologic factors|mesh-ancestor
101926496|NCT01193400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926497|NCT03904888|Anesthetics|anesthetics|mesh-list
101926498|NCT03904888|Anesthetics, Local|anesthetics, local|mesh-list
101926499|NCT03904888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101926500|NCT03904888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926501|NCT03904888|Sensory System Agents|sensory system agents|mesh-ancestor
101926502|NCT03904888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101926503|NCT03846258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101926504|NCT01193478|Ledipasvir|ledipasvir|mesh-list
101926505|NCT01193478|Antiviral Agents|antiviral agents|mesh-ancestor
101926506|NCT01193478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101926507|NCT01295736|Sildenafil Citrate|sildenafil citrate|mesh-list
101926508|NCT01295736|Vasodilator Agents|vasodilator agents|mesh-ancestor
101926509|NCT01295736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101926510|NCT01295736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101926511|NCT01295736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101926512|NCT01295736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926513|NCT01295736|Urological Agents|urological agents|mesh-ancestor
101926514|NCT03733470|Sildenafil Citrate|sildenafil citrate|mesh-list
101926515|NCT03733470|Vasodilator Agents|vasodilator agents|mesh-ancestor
101926516|NCT03733470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101926517|NCT03733470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101926518|NCT03733470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101926519|NCT03733470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926520|NCT03733470|Urological Agents|urological agents|mesh-ancestor
101926521|NCT01195974|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
101926522|NCT01195974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101926523|NCT01195974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926524|NCT04731376|Methyltestosterone|methyltestosterone|mesh-list
101926525|NCT04731376|Testosterone|testosterone|mesh-list
101926526|NCT04731376|Testosterone undecanoate|testosterone undecanoate|mesh-list
101926527|NCT04731376|Testosterone enanthate|testosterone enanthate|mesh-list
101926528|NCT04731376|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101926529|NCT04731376|Androgens|androgens|mesh-ancestor
101926530|NCT04731376|Hormones|hormones|mesh-ancestor
101926531|NCT04731376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101926532|NCT04731376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926533|NCT04731376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101926534|NCT04731376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101926535|NCT04731376|Anabolic Agents|anabolic agents|mesh-ancestor
101926536|NCT01196208|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101926537|NCT01196208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101926538|NCT01196208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101926539|NCT01196208|Immunotoxins|immunotoxins|mesh-ancestor
101926540|NCT01196208|Immunoconjugates|immunoconjugates|mesh-ancestor
101926541|NCT01196208|Immunologic Factors|immunologic factors|mesh-ancestor
101231408|NCT03321526|Antidepressive Agents|antidepressive agents|mesh-ancestor
101926542|NCT01196208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926543|NCT01295892|Estrogens|estrogens|mesh-list
101926544|NCT01295892|Hormones|hormones|mesh-ancestor
101926545|NCT01295892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101926546|NCT01295892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926547|NCT03018418|Mitomycins|mitomycins|mesh-list
101926548|NCT03018418|Mitomycin|mitomycin|mesh-list
101926549|NCT03018418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101926550|NCT03018418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101926551|NCT03018418|Alkylating Agents|alkylating agents|mesh-ancestor
101926552|NCT03018418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926553|NCT03018418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101926554|NCT03018418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101926555|NCT01296204|Antibodies|antibodies|mesh-list
101926556|NCT01296204|Immunologic Factors|immunologic factors|mesh-ancestor
101926557|NCT01296204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926558|NCT01197846|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101926559|NCT01197846|Antidepressive Agents|antidepressive agents|mesh-ancestor
101926560|NCT01197846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101926561|NCT01197846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101926562|NCT01197846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101646414|NCT00772135|Sildenafil Citrate|sildenafil citrate|mesh-list
101926563|NCT01197846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101926564|NCT01197846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926565|NCT05670678|Lactoferrin|lactoferrin|mesh-list
101926566|NCT05670678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101926567|NCT02914366|Ambroxol|ambroxol|mesh-list
101926568|NCT02914366|Expectorants|expectorants|mesh-ancestor
101926569|NCT02914366|Respiratory System Agents|respiratory system agents|mesh-ancestor
101926570|NCT03846180|Octreotide|octreotide|mesh-list
101926571|NCT03846180|Terlipressin|terlipressin|mesh-list
101926573|NCT03846180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101926574|NCT03846180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101926575|NCT03846180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101926576|NCT03846180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101926577|NCT03846180|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101926578|NCT03846180|Hormones|hormones|mesh-ancestor
101926579|NCT03846180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101926580|NCT03846180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926581|NCT01199406|Levobupivacaine|levobupivacaine|mesh-list
101926582|NCT01199406|Anesthetics, Local|anesthetics, local|mesh-ancestor
101926583|NCT01199406|Anesthetics|anesthetics|mesh-ancestor
101926584|NCT01199406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101926585|NCT01199406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926586|NCT01199406|Sensory System Agents|sensory system agents|mesh-ancestor
101926587|NCT01199406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101926588|NCT02729116|Ertapenem|ertapenem|mesh-list
101926589|NCT02729116|Sitafloxacin|sitafloxacin|mesh-list
101926590|NCT02729116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101926591|NCT02729116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101926592|NCT02729116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101926593|NCT02729116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101926594|NCT02729116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101926595|NCT02729116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926596|NCT02729116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101926597|NCT02627092|Copper|copper|mesh-list
101926598|NCT02627092|Trace Elements|trace elements|mesh-ancestor
101926599|NCT02627092|Micronutrients|micronutrients|mesh-ancestor
101926600|NCT02627092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926601|NCT05289648|Niraparib|niraparib|mesh-list
101926602|NCT05289648|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101926603|NCT05289648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101926604|NCT05289648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926605|NCT05289648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101926606|NCT01199562|Valganciclovir|valganciclovir|mesh-list
101926607|NCT01199562|Ganciclovir|ganciclovir|mesh-list
101926608|NCT01199562|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101926609|NCT01199562|Antiviral Agents|antiviral agents|mesh-list
101926610|NCT01199562|Foscarnet|foscarnet|mesh-list
101926611|NCT01199562|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
101926612|NCT01199562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101926613|NCT01199562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101926614|NCT01199562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101926615|NCT01199562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926616|NCT01199562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101926617|NCT03845322|Curcumin|curcumin|mesh-list
101926618|NCT03845322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101926619|NCT03845322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101926620|NCT03845322|Analgesics|analgesics|mesh-ancestor
101926621|NCT03845322|Sensory System Agents|sensory system agents|mesh-ancestor
101926622|NCT03845322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101926623|NCT03845322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926624|NCT03845322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101926625|NCT03845322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101926626|NCT03845322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101926627|NCT03845322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101926628|NCT03845322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926629|NCT03844932|Cyclosporine|cyclosporine|mesh-list
101926630|NCT03844932|Cyclosporins|cyclosporins|mesh-list
101926631|NCT03844932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101926632|NCT03844932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926633|NCT03844932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101926634|NCT03844932|Immunologic Factors|immunologic factors|mesh-ancestor
101926635|NCT03844932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926636|NCT03844932|Antifungal Agents|antifungal agents|mesh-ancestor
101926637|NCT03844932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101926638|NCT03844932|Dermatologic Agents|dermatologic agents|mesh-ancestor
101926639|NCT03844932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101926640|NCT03844932|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101926641|NCT03726996|Desipramine|desipramine|mesh-list
101926642|NCT03726996|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101926643|NCT03726996|Antidepressive Agents|antidepressive agents|mesh-ancestor
101926644|NCT03726996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101926645|NCT03726996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101926646|NCT03726996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926647|NCT03726996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101926648|NCT03726996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101926649|NCT03726996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101926650|NCT03726996|Adrenergic Agents|adrenergic agents|mesh-ancestor
101926651|NCT03726996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101926652|NCT03726996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926653|NCT01202058|Sirolimus|sirolimus|mesh-list
101926654|NCT01202058|Everolimus|everolimus|mesh-list
101926655|NCT01202058|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101926656|NCT01202058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101926657|NCT01202058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101926658|NCT01202058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926659|NCT01202058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101926660|NCT01202058|Immunologic Factors|immunologic factors|mesh-ancestor
101926661|NCT01202058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926662|NCT01202058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101926663|NCT01202058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101926664|NCT01202058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101926665|NCT01202058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101926666|NCT01202058|Antifungal Agents|antifungal agents|mesh-ancestor
101926667|NCT03844854|Salicylic Acid|salicylic acid|mesh-list
101926668|NCT03844854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101926669|NCT03844854|Antifungal Agents|antifungal agents|mesh-ancestor
101926670|NCT03844854|Keratolytic Agents|keratolytic agents|mesh-ancestor
101926671|NCT03844854|Dermatologic Agents|dermatologic agents|mesh-ancestor
101926672|NCT03842046|Phenylephrine|phenylephrine|mesh-list
101926673|NCT03842046|Oxymetazoline|oxymetazoline|mesh-list
101926674|NCT03842046|Norepinephrine|norepinephrine|mesh-list
101926675|NCT03842046|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101926676|NCT03842046|Mydriatics|mydriatics|mesh-ancestor
101926677|NCT03842046|Autonomic Agents|autonomic agents|mesh-ancestor
101926678|NCT03842046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101926679|NCT03842046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926680|NCT03842046|Sympathomimetics|sympathomimetics|mesh-ancestor
101926681|NCT03842046|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101926682|NCT03842046|Nasal Decongestants|nasal decongestants|mesh-ancestor
101926683|NCT03842046|Respiratory System Agents|respiratory system agents|mesh-ancestor
101926684|NCT03842046|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101926685|NCT03842046|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101926686|NCT03842046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101926687|NCT03842046|Adrenergic Agents|adrenergic agents|mesh-ancestor
101926688|NCT03842046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101926689|NCT03842046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926690|NCT03842046|Protective Agents|protective agents|mesh-ancestor
101926691|NCT01198236|Itraconazole|itraconazole|mesh-list
101926692|NCT01198236|Antifungal Agents|antifungal agents|mesh-ancestor
101926693|NCT01198236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101926694|NCT01198236|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101926695|NCT01198236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101926696|NCT01198236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101926697|NCT01198236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926698|NCT01198236|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101926699|NCT01198236|Hormone Antagonists|hormone antagonists|mesh-ancestor
101926700|NCT01198236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101926701|NCT01198236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926702|NCT01198236|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101926703|NCT01198314|Immunosuppressive Agents|immunosuppressive agents|mesh-list
101926704|NCT01198314|Immunologic Factors|immunologic factors|mesh-ancestor
101926705|NCT01198314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926706|NCT04091490|Nivolumab|nivolumab|mesh-list
101926707|NCT04091490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101926708|NCT04091490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101926709|NCT04091490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101926710|NCT04091490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926711|NCT05184816|Deferoxamine|deferoxamine|mesh-list
101926712|NCT05184816|Siderophores|siderophores|mesh-ancestor
101926713|NCT05184816|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101926714|NCT05184816|Chelating Agents|chelating agents|mesh-ancestor
101926715|NCT05184816|Sequestering Agents|sequestering agents|mesh-ancestor
101926716|NCT05184816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926717|NCT03841890|Tolnaftate|tolnaftate|mesh-list
101926718|NCT03841890|Antifungal Agents|antifungal agents|mesh-ancestor
101926720|NCT01200108|Budesonide|budesonide|mesh-list
101926721|NCT01200108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101926722|NCT01200108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101926723|NCT01200108|Autonomic Agents|autonomic agents|mesh-ancestor
101926724|NCT01200108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101926725|NCT01200108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926726|NCT01200108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101926727|NCT01200108|Respiratory System Agents|respiratory system agents|mesh-ancestor
101926728|NCT01200108|Glucocorticoids|glucocorticoids|mesh-ancestor
101926729|NCT01200108|Hormones|hormones|mesh-ancestor
101926730|NCT01200108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101926731|NCT01200186|Progestins|progestins|mesh-list
101926732|NCT01200186|Hormones|hormones|mesh-ancestor
101926733|NCT01200186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101926734|NCT01200186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926735|NCT03841812|Propofol|propofol|mesh-list
101926736|NCT03841812|Sevoflurane|sevoflurane|mesh-list
101926737|NCT03841812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101926738|NCT03841812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101926739|NCT03841812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926740|NCT03841812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101926741|NCT03841812|Anesthetics, General|anesthetics, general|mesh-ancestor
101926742|NCT03841812|Anesthetics|anesthetics|mesh-ancestor
101926743|NCT03841812|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101926744|NCT03841812|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101926745|NCT03882970|Tirzepatide|tirzepatide|mesh-list
101926746|NCT03882970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101926747|NCT03882970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926748|NCT03882970|Incretins|incretins|mesh-ancestor
101926749|NCT03882970|Hormones|hormones|mesh-ancestor
101926750|NCT03882970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101926751|NCT05111808|Methylene Blue|methylene blue|mesh-list
101926752|NCT05111808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101926753|NCT05111808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926754|NCT01198392|Cisplatin|cisplatin|mesh-list
101926755|NCT01198392|Tegafur|tegafur|mesh-list
101926756|NCT01198392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101926757|NCT01198392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101926758|NCT01198392|Antimetabolites|antimetabolites|mesh-ancestor
101926759|NCT01198392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926760|NCT01200264|Apremilast|apremilast|mesh-list
101926761|NCT01200264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101926762|NCT01200264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101926763|NCT01200264|Analgesics|analgesics|mesh-ancestor
101926764|NCT01200264|Sensory System Agents|sensory system agents|mesh-ancestor
101926765|NCT01200264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101926766|NCT01200264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926767|NCT01200264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101926768|NCT01200264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101926769|NCT01200264|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101926770|NCT01200264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101926771|NCT01200264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101926772|NCT01200264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926773|NCT04799236|Amphotericin B|amphotericin b|mesh-list
101926774|NCT04799236|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101926775|NCT04799236|Miltefosine|miltefosine|mesh-list
101926776|NCT04799236|Amebicides|amebicides|mesh-ancestor
101926777|NCT04799236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101926778|NCT04799236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101926779|NCT04799236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101926780|NCT04799236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101926781|NCT04799236|Antifungal Agents|antifungal agents|mesh-ancestor
101926782|NCT04799236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101926783|NCT01202370|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
101926784|NCT01202370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101926785|NCT01202370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101926786|NCT03630952|Aflibercept|aflibercept|mesh-list
101926787|NCT03630952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101926788|NCT03630952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101926789|NCT03630952|Growth Substances|growth substances|mesh-ancestor
101926790|NCT03630952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926791|NCT03630952|Growth Inhibitors|growth inhibitors|mesh-ancestor
101926792|NCT03630952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101926793|NCT01198782|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101926794|NCT01198782|Lubricant Eye Drops|lubricant eye drops|mesh-list
101926795|NCT01198782|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101926796|NCT01200654|Linezolid|linezolid|mesh-list
101926797|NCT01200654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101926798|NCT01200654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101926799|NCT01200654|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101926800|NCT01200654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101926801|NCT01200654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926802|NCT01200732|Tadalafil|tadalafil|mesh-list
101926803|NCT01200732|Vasodilator Agents|vasodilator agents|mesh-ancestor
101926804|NCT01200732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101926805|NCT01200732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101926806|NCT01200732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101926807|NCT01200732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926808|NCT01200732|Urological Agents|urological agents|mesh-ancestor
101926809|NCT01198860|Ascorbic Acid|ascorbic acid|mesh-list
101926810|NCT01198860|Tenofovir|tenofovir|mesh-list
101926811|NCT01198860|Antiviral Agents|antiviral agents|mesh-ancestor
101926812|NCT01198860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101926813|NCT01198860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101926814|NCT01198860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101926815|NCT01198860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101926816|NCT01198860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926817|NCT01198860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101926818|NCT01198860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101926820|NCT01198860|Protective Agents|protective agents|mesh-ancestor
101926821|NCT01198860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926822|NCT01198860|Vitamins|vitamins|mesh-ancestor
101926823|NCT01198860|Micronutrients|micronutrients|mesh-ancestor
101926824|NCT01198938|Melatonin|melatonin|mesh-list
101926825|NCT01198938|Antioxidants|antioxidants|mesh-ancestor
101926826|NCT01198938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926827|NCT01198938|Protective Agents|protective agents|mesh-ancestor
101926828|NCT01198938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926829|NCT01198938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101926830|NCT01201044|Gemcitabine|gemcitabine|mesh-list
101926831|NCT01201044|Nedaplatin|nedaplatin|mesh-list
101926832|NCT01201044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101926833|NCT01201044|Antimetabolites|antimetabolites|mesh-ancestor
101926834|NCT01201044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926835|NCT01201044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101926836|NCT03843060|Itraconazole|itraconazole|mesh-list
101926837|NCT03843060|Antifungal Agents|antifungal agents|mesh-ancestor
101926838|NCT03843060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101926839|NCT03843060|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101926840|NCT03843060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101926841|NCT03843060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101926842|NCT03843060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926843|NCT03843060|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101926844|NCT03843060|Hormone Antagonists|hormone antagonists|mesh-ancestor
101926845|NCT03843060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101926846|NCT03843060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926847|NCT03843060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101926848|NCT04427904|Lidocaine|lidocaine|mesh-list
101926849|NCT04427904|Epinephrine|epinephrine|mesh-list
101926850|NCT04427904|Racepinephrine|racepinephrine|mesh-list
101926851|NCT04427904|Bupivacaine|bupivacaine|mesh-list
101926852|NCT04427904|Epinephryl borate|epinephryl borate|mesh-list
101926853|NCT04427904|Anesthetics, Local|anesthetics, local|mesh-ancestor
101926854|NCT04427904|Anesthetics|anesthetics|mesh-ancestor
101926855|NCT04427904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101926856|NCT04427904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926857|NCT04427904|Sensory System Agents|sensory system agents|mesh-ancestor
101926858|NCT04427904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101926859|NCT04427904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101926860|NCT04427904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101926861|NCT04427904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101926862|NCT04427904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101646715|NCT00769405|Antidotes|antidotes|mesh-ancestor
101926863|NCT04427904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926865|NCT04427904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101926866|NCT04427904|Adrenergic Agents|adrenergic agents|mesh-ancestor
101926867|NCT04427904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101926868|NCT04427904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101926869|NCT04427904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101926870|NCT04427904|Autonomic Agents|autonomic agents|mesh-ancestor
101926871|NCT04427904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101926872|NCT04427904|Respiratory System Agents|respiratory system agents|mesh-ancestor
101926873|NCT04427904|Mydriatics|mydriatics|mesh-ancestor
101926874|NCT04427904|Sympathomimetics|sympathomimetics|mesh-ancestor
101926875|NCT04427904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101926876|NCT03792516|Artesunate|artesunate|mesh-list
101926877|NCT03792516|Antimalarials|antimalarials|mesh-ancestor
101926878|NCT03792516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101926879|NCT03792516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101926880|NCT03792516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101926881|NCT03792516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101926882|NCT03792516|Antiviral Agents|antiviral agents|mesh-ancestor
101926883|NCT03792516|Schistosomicides|schistosomicides|mesh-ancestor
101926884|NCT03792516|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101926885|NCT03792516|Anthelmintics|anthelmintics|mesh-ancestor
101926886|NCT01201122|Mesalamine|mesalamine|mesh-list
101926887|NCT01201122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101926888|NCT01201122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101926889|NCT01201122|Analgesics|analgesics|mesh-ancestor
101926890|NCT01201122|Sensory System Agents|sensory system agents|mesh-ancestor
101926891|NCT01201122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101926892|NCT01201122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926893|NCT01201122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101926894|NCT01201122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101926895|NCT03674112|Trastuzumab|trastuzumab|mesh-list
101926896|NCT03674112|Pertuzumab|pertuzumab|mesh-list
101926897|NCT03674112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101926898|NCT03674112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101926899|NCT03668808|Insulin|insulin|mesh-list
101926900|NCT03668808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101926901|NCT03668808|Insulin Glargine|insulin glargine|mesh-list
101926902|NCT03668808|Insulin, Long-Acting|insulin, long-acting|mesh-list
101926903|NCT03668808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101926904|NCT03668808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926905|NCT05281926|Nivolumab|nivolumab|mesh-list
101926906|NCT05281926|Poly ICLC|poly iclc|mesh-list
101926907|NCT05281926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101926908|NCT05281926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101926909|NCT05281926|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101926910|NCT05281926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926911|NCT05281926|Interferon Inducers|interferon inducers|mesh-ancestor
101926912|NCT05281926|Immunologic Factors|immunologic factors|mesh-ancestor
101926913|NCT05281926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926914|NCT03844776|Acetaminophen|acetaminophen|mesh-list
101926915|NCT03844776|Amoxicillin|amoxicillin|mesh-list
101926916|NCT03844776|Metronidazole|metronidazole|mesh-list
101926917|NCT03844776|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101926918|NCT03844776|Chlorhexidine|chlorhexidine|mesh-list
101926919|NCT03844776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101926920|NCT03844776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101926921|NCT03844776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101926922|NCT03844776|Disinfectants|disinfectants|mesh-ancestor
101926923|NCT03844776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101926924|NCT03844776|Analgesics|analgesics|mesh-ancestor
101926925|NCT03844776|Sensory System Agents|sensory system agents|mesh-ancestor
101926926|NCT03844776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101926927|NCT03844776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926928|NCT03844776|Antipyretics|antipyretics|mesh-ancestor
101926929|NCT03844776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101926930|NCT03844776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101926931|NCT03844776|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101926932|NCT03844776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101926933|NCT03844776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926934|NCT01566942|Oxaliplatin|oxaliplatin|mesh-list
101926935|NCT01566942|Irinotecan|irinotecan|mesh-list
101926936|NCT01566942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101926937|NCT01566942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101926938|NCT01566942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101926939|NCT01566942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101926940|NCT01566942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926941|NCT01201278|Insulin|insulin|mesh-list
101926942|NCT01201278|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101926943|NCT01201278|Insulin Lispro|insulin lispro|mesh-list
101926944|NCT01201278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101926945|NCT01201278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926946|NCT05667948|Immunomodulating Agents|immunomodulating agents|mesh-list
101926947|NCT05667948|Immunologic Factors|immunologic factors|mesh-ancestor
101926948|NCT05667948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926949|NCT01199328|Aspirin|aspirin|mesh-list
101926950|NCT01199328|Esomeprazole|esomeprazole|mesh-list
101926951|NCT01199328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101926952|NCT01199328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101926953|NCT01199328|Analgesics|analgesics|mesh-ancestor
101926954|NCT01199328|Sensory System Agents|sensory system agents|mesh-ancestor
101926955|NCT01199328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101926956|NCT01199328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926957|NCT01199328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101926958|NCT01199328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101926959|NCT01199328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101926960|NCT01199328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101926961|NCT01199328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926962|NCT01199328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101926963|NCT01199328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101926964|NCT01199328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101926965|NCT01199328|Antipyretics|antipyretics|mesh-ancestor
101926966|NCT01199328|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101926967|NCT01199328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101926968|NCT01199328|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101926969|NCT02982954|Nivolumab|nivolumab|mesh-list
101926970|NCT02982954|Ipilimumab|ipilimumab|mesh-list
101926971|NCT02982954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101926972|NCT02982954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101926973|NCT02982954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101926974|NCT02982954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926975|NCT01203228|Cyclophosphamide|cyclophosphamide|mesh-list
101926976|NCT01203228|Busulfan|busulfan|mesh-list
101926977|NCT01203228|Fludarabine phosphate|fludarabine phosphate|mesh-list
101926978|NCT01203228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101926979|NCT01203228|Immunologic Factors|immunologic factors|mesh-ancestor
101926980|NCT01203228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926981|NCT01203228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101926982|NCT01203228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101926983|NCT01203228|Alkylating Agents|alkylating agents|mesh-ancestor
101926984|NCT01203228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926985|NCT01203228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101926986|NCT01203228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101926987|NCT01203228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101926988|NCT01203228|Antimetabolites|antimetabolites|mesh-ancestor
101926989|NCT01203696|Amlodipine|amlodipine|mesh-list
101926990|NCT01203696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101926991|NCT01203696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101926992|NCT01203696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101926993|NCT01203696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101926994|NCT01203696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101926995|NCT01203696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101926996|NCT01203696|Vasodilator Agents|vasodilator agents|mesh-ancestor
101926997|NCT01203306|Bevacizumab|bevacizumab|mesh-list
101926998|NCT01203306|Capecitabine|capecitabine|mesh-list
101926999|NCT01203306|Octreotide|octreotide|mesh-list
101927000|NCT01203306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101927001|NCT01203306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927002|NCT01203306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101927003|NCT01203306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101927004|NCT01203306|Growth Substances|growth substances|mesh-ancestor
101927005|NCT01203306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927006|NCT01203306|Growth Inhibitors|growth inhibitors|mesh-ancestor
101927007|NCT01203306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101927008|NCT01203306|Antimetabolites|antimetabolites|mesh-ancestor
101927009|NCT01203306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927010|NCT01203306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101927011|NCT01203306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101646868|NCT00769873|Heparin|heparin|mesh-list
101927012|NCT01203384|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
101927013|NCT01203384|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101927014|NCT01203384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101927015|NCT01203384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927016|NCT03724968|Nivolumab|nivolumab|mesh-list
101927017|NCT03724968|Ipilimumab|ipilimumab|mesh-list
101927018|NCT03724968|Relatlimab|relatlimab|mesh-list
101927019|NCT03724968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101927020|NCT03724968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927021|NCT03724968|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101927022|NCT03724968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927023|NCT01204086|Fluoxetine|fluoxetine|mesh-list
101927024|NCT01204086|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101927025|NCT01204086|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101927026|NCT01204086|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101927027|NCT01204086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101927028|NCT01204086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927029|NCT01204086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101927030|NCT01204086|Serotonin Agents|serotonin agents|mesh-ancestor
101927031|NCT01204086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927032|NCT01204086|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101927033|NCT01204086|Antidepressive Agents|antidepressive agents|mesh-ancestor
101927034|NCT01204086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101927035|NCT01204086|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101927036|NCT01204086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101927037|NCT01204086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101927038|NCT01204086|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101927039|NCT01201902|Vaccines|vaccines|mesh-list
101927040|NCT01201902|Immunologic Factors|immunologic factors|mesh-ancestor
101927041|NCT01201902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927042|NCT01204164|Dexamethasone|dexamethasone|mesh-list
101927043|NCT01204164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101927044|NCT01204164|Antiemetics|antiemetics|mesh-ancestor
101927045|NCT01204164|Autonomic Agents|autonomic agents|mesh-ancestor
101927046|NCT01204164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101927047|NCT01204164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927048|NCT01204164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101927049|NCT01204164|Glucocorticoids|glucocorticoids|mesh-ancestor
101927050|NCT01204164|Hormones|hormones|mesh-ancestor
101387660|NCT00322660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927051|NCT01204164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101927052|NCT01204164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101927053|NCT01204164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927054|NCT01206036|Sirolimus|sirolimus|mesh-list
101927055|NCT01206036|Docetaxel|docetaxel|mesh-list
101927056|NCT01206036|Temsirolimus|temsirolimus|mesh-list
101927057|NCT01206036|MTOR Inhibitors|mtor inhibitors|mesh-list
101927058|NCT01206036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927059|NCT01206036|Tubulin Modulators|tubulin modulators|mesh-ancestor
101927060|NCT01206036|Antimitotic Agents|antimitotic agents|mesh-ancestor
101927061|NCT01206036|Mitosis Modulators|mitosis modulators|mesh-ancestor
101927062|NCT01206036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927063|NCT01206036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101927064|NCT01206036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101927065|NCT01206036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101927066|NCT01206036|Immunologic Factors|immunologic factors|mesh-ancestor
101927067|NCT01206036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927068|NCT01206036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101927069|NCT01206036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101927070|NCT01206036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101927071|NCT01206036|Antifungal Agents|antifungal agents|mesh-ancestor
101927072|NCT01204320|Paclitaxel|paclitaxel|mesh-list
101927073|NCT01204320|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101927074|NCT01204320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101927075|NCT01204320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927076|NCT01204320|Tubulin Modulators|tubulin modulators|mesh-ancestor
101927077|NCT01204320|Antimitotic Agents|antimitotic agents|mesh-ancestor
101927078|NCT01204320|Mitosis Modulators|mitosis modulators|mesh-ancestor
101927079|NCT01204320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927080|NCT03722238|Ibuprofen|ibuprofen|mesh-list
101927081|NCT03722238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101927082|NCT03722238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101927083|NCT03722238|Analgesics|analgesics|mesh-ancestor
101927084|NCT03722238|Sensory System Agents|sensory system agents|mesh-ancestor
101927090|NCT03722238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101927091|NCT03722238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927092|NCT01203540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101927093|NCT01203540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101927094|NCT01203618|Farletuzumab|farletuzumab|mesh-list
101927095|NCT01203618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927096|NCT01206270|Methyltestosterone|methyltestosterone|mesh-list
101927097|NCT01206270|Castor Oil|castor oil|mesh-list
101927098|NCT01206270|Testosterone|testosterone|mesh-list
101927099|NCT01206270|Testosterone undecanoate|testosterone undecanoate|mesh-list
101927100|NCT01206270|Testosterone enanthate|testosterone enanthate|mesh-list
101927101|NCT01206270|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101927102|NCT01206270|Androgens|androgens|mesh-ancestor
101927103|NCT01206270|Hormones|hormones|mesh-ancestor
101927104|NCT01206270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101927105|NCT01206270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927106|NCT01206270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101927107|NCT01206270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927108|NCT01206270|Anabolic Agents|anabolic agents|mesh-ancestor
101927109|NCT01206270|Cathartics|cathartics|mesh-ancestor
101927110|NCT01206270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101927111|NCT01298310|Lidocaine|lidocaine|mesh-list
101927112|NCT01298310|Anesthetics, Local|anesthetics, local|mesh-ancestor
101927113|NCT01298310|Anesthetics|anesthetics|mesh-ancestor
101927114|NCT01298310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101927115|NCT01298310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927116|NCT01298310|Sensory System Agents|sensory system agents|mesh-ancestor
101927117|NCT01298310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101927118|NCT01298310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101927119|NCT01298310|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101927120|NCT01298310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101927121|NCT01298310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101927122|NCT01298310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927123|NCT01298466|Pregabalin|pregabalin|mesh-list
101927124|NCT01298466|Analgesics|analgesics|mesh-ancestor
101231511|NCT03084939|Lapatinib|lapatinib|mesh-list
101927125|NCT01298466|Sensory System Agents|sensory system agents|mesh-ancestor
101927126|NCT01298466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101927127|NCT01298466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927128|NCT01298466|Anticonvulsants|anticonvulsants|mesh-ancestor
101927129|NCT01298466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101927130|NCT01298466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101927131|NCT01298466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927132|NCT01298466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101927133|NCT01298466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101927134|NCT01298466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101927135|NCT01298466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101927136|NCT01298466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101927137|NCT01206348|Minocycline|minocycline|mesh-list
101927138|NCT01206348|Clindamycin|clindamycin|mesh-list
101927139|NCT01206348|Clindamycin palmitate|clindamycin palmitate|mesh-list
101927140|NCT01206348|Clindamycin phosphate|clindamycin phosphate|mesh-list
101927141|NCT01206348|Tretinoin|tretinoin|mesh-list
101927142|NCT01206348|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101927143|NCT01206348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101927144|NCT01206348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101927145|NCT01206348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101927146|NCT01206348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101927147|NCT01206348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927148|NCT01206348|Dermatologic Agents|dermatologic agents|mesh-ancestor
101927149|NCT01206348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927150|NCT01206348|Keratolytic Agents|keratolytic agents|mesh-ancestor
101927157|NCT01204476|Octreotide|octreotide|mesh-list
101927158|NCT01204476|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101927159|NCT01204476|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101927160|NCT01204476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101927161|NCT01204476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101927162|NCT01204476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927163|NCT01204476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101927164|NCT01204476|Immunologic Factors|immunologic factors|mesh-ancestor
101927165|NCT01204476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927166|NCT01204476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927167|NCT01204476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101927168|NCT01204476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101927169|NCT03633292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
101927170|NCT03633292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101927171|NCT04630210|Atezolizumab|atezolizumab|mesh-list
101927172|NCT04630210|Letrozole|letrozole|mesh-list
101927173|NCT04630210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101927174|NCT04630210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927175|NCT04630210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101927176|NCT04630210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927177|NCT04630210|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101927178|NCT04630210|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101927179|NCT04630210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101927180|NCT04630210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101927181|NCT04630210|Hormone Antagonists|hormone antagonists|mesh-ancestor
101927182|NCT04630210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101927183|NCT04630210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927184|NCT01382368|Sildenafil Citrate|sildenafil citrate|mesh-list
101927185|NCT01382368|Vasodilator Agents|vasodilator agents|mesh-ancestor
101927186|NCT01382368|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101927187|NCT01382368|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101927188|NCT01382368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101927189|NCT01382368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927190|NCT01382368|Urological Agents|urological agents|mesh-ancestor
101927191|NCT04546828|Gemcitabine|gemcitabine|mesh-list
101927192|NCT04546828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927193|NCT04546828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101927194|NCT04546828|Antimetabolites|antimetabolites|mesh-ancestor
101927195|NCT04546828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927196|NCT01382134|Aspirin|aspirin|mesh-list
101927197|NCT01382134|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101927198|NCT01382134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101927199|NCT01382134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101927200|NCT01382134|Analgesics|analgesics|mesh-ancestor
101927201|NCT01382134|Sensory System Agents|sensory system agents|mesh-ancestor
101927202|NCT01382134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101927203|NCT01382134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927204|NCT01382134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101927205|NCT01382134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101927206|NCT01382134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101927207|NCT01382134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101927208|NCT01382134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927209|NCT01382134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101927210|NCT01382134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101927211|NCT01382134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101927212|NCT01382134|Antipyretics|antipyretics|mesh-ancestor
101927213|NCT01382134|Hemostatics|hemostatics|mesh-ancestor
101927214|NCT01382134|Coagulants|coagulants|mesh-ancestor
101927215|NCT01382134|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101927216|NCT01382134|Natriuretic Agents|natriuretic agents|mesh-ancestor
101927217|NCT05077488|Lidocaine|lidocaine|mesh-list
101927218|NCT05077488|Anesthetics, Local|anesthetics, local|mesh-ancestor
101927219|NCT05077488|Anesthetics|anesthetics|mesh-ancestor
101927220|NCT05077488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101927221|NCT05077488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927222|NCT05077488|Sensory System Agents|sensory system agents|mesh-ancestor
101927223|NCT05077488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101927224|NCT05077488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101927225|NCT05077488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101927226|NCT05077488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101927227|NCT05077488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101927228|NCT05077488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927229|NCT05668572|Vaccines|vaccines|mesh-list
101927230|NCT05668572|Immunologic Factors|immunologic factors|mesh-ancestor
101927231|NCT05668572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927232|NCT02410980|Tretinoin|tretinoin|mesh-list
101927233|NCT02410980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927234|NCT02410980|Keratolytic Agents|keratolytic agents|mesh-ancestor
101927235|NCT02410980|Dermatologic Agents|dermatologic agents|mesh-ancestor
101927236|NCT01298934|Panobinostat|panobinostat|mesh-list
101927237|NCT01298934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927238|NCT01298934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101927239|NCT01298934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101927240|NCT01298934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927241|NCT01300962|Capecitabine|capecitabine|mesh-list
101927242|NCT01300962|Trastuzumab|trastuzumab|mesh-list
101927243|NCT01300962|Lapatinib|lapatinib|mesh-list
101927244|NCT01300962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101927245|NCT01300962|Antimetabolites|antimetabolites|mesh-ancestor
101927246|NCT01300962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927247|NCT01300962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927248|NCT01300962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101927249|NCT01300962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101927250|NCT01300962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101927251|NCT01299012|Liraglutide|liraglutide|mesh-list
101927252|NCT01299012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101927253|NCT01299012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927254|NCT01299012|Incretins|incretins|mesh-ancestor
101927255|NCT01299012|Hormones|hormones|mesh-ancestor
101927256|NCT01299012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101927257|NCT02155920|Everolimus|everolimus|mesh-list
101927258|NCT02155920|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101927259|NCT02155920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101231525|NCT03084939|Immunotoxins|immunotoxins|mesh-ancestor
101927260|NCT02155920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101927261|NCT02155920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927262|NCT02155920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101927263|NCT02155920|Immunologic Factors|immunologic factors|mesh-ancestor
101927264|NCT02155920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927265|NCT02155920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927266|NCT01301040|Cyclophosphamide|cyclophosphamide|mesh-list
101927267|NCT01301040|Docetaxel|docetaxel|mesh-list
101927268|NCT01301040|Epirubicin|epirubicin|mesh-list
101927269|NCT01301040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101927270|NCT01301040|Immunologic Factors|immunologic factors|mesh-ancestor
101927271|NCT01301040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927272|NCT01301040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101927273|NCT01301040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101927274|NCT01301040|Alkylating Agents|alkylating agents|mesh-ancestor
101927275|NCT01301040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927276|NCT01301040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927277|NCT01301040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101927278|NCT01301040|Tubulin Modulators|tubulin modulators|mesh-ancestor
101927279|NCT01301040|Antimitotic Agents|antimitotic agents|mesh-ancestor
101927280|NCT01301040|Mitosis Modulators|mitosis modulators|mesh-ancestor
101927281|NCT01301040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101927282|NCT01301040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101927283|NCT01301040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101927284|NCT01301040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101927285|NCT03818334|Cyclophosphamide|cyclophosphamide|mesh-list
101927286|NCT03818334|Thymoglobulin|thymoglobulin|mesh-list
101927287|NCT03818334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101927288|NCT03818334|Immunologic Factors|immunologic factors|mesh-ancestor
101927289|NCT03818334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927290|NCT03818334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101927291|NCT03818334|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101927292|NCT03818334|Alkylating Agents|alkylating agents|mesh-ancestor
101927293|NCT03818334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927294|NCT03818334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927295|NCT03818334|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101927296|NCT01206972|Enoxaparin|enoxaparin|mesh-list
101927297|NCT01206972|Rivaroxaban|rivaroxaban|mesh-list
101927298|NCT01206972|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101927299|NCT01206972|Antithrombins|antithrombins|mesh-ancestor
101927300|NCT01206972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101927301|NCT01206972|Protease Inhibitors|protease inhibitors|mesh-ancestor
101927302|NCT01206972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101927303|NCT01206972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927304|NCT01206972|Anticoagulants|anticoagulants|mesh-ancestor
101927305|NCT01206972|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101927306|NCT01206972|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101927307|NCT03817476|BI 425809|bi 425809|mesh-list
101927308|NCT03817476|Nootropic Agents|nootropic agents|mesh-ancestor
101927309|NCT02918292|Mycophenolic Acid|mycophenolic acid|mesh-list
101927310|NCT02918292|Cyclophosphamide|cyclophosphamide|mesh-list
101927311|NCT02918292|Fludarabine|fludarabine|mesh-list
101927312|NCT02918292|Tacrolimus|tacrolimus|mesh-list
101927313|NCT02918292|Thymoglobulin|thymoglobulin|mesh-list
101927314|NCT02918292|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101927315|NCT02918292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101927316|NCT02918292|Immunologic Factors|immunologic factors|mesh-ancestor
101927317|NCT02918292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927318|NCT02918292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101927319|NCT02918292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101927320|NCT02918292|Alkylating Agents|alkylating agents|mesh-ancestor
101927321|NCT02918292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927322|NCT02918292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927323|NCT02918292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101927324|NCT02918292|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101927325|NCT02918292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101927326|NCT02918292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101231534|NCT03047005|Sensory System Agents|sensory system agents|mesh-ancestor
101927327|NCT02918292|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101927328|NCT02918292|Antitubercular Agents|antitubercular agents|mesh-ancestor
101927329|NCT02918292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101927330|NCT02918292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101927331|NCT01207128|Voriconazole|voriconazole|mesh-list
101927332|NCT01207128|Micafungin|micafungin|mesh-list
101927333|NCT01207128|Antifungal Agents|antifungal agents|mesh-ancestor
101927334|NCT01207128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101927335|NCT01207128|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101927336|NCT01207128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101927337|NCT01207128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101927338|NCT01207128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927339|NCT01207128|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101927340|NCT01207128|Hormone Antagonists|hormone antagonists|mesh-ancestor
101927341|NCT01207128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101927342|NCT01207128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927343|NCT01207128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101927344|NCT01299558|Fluticasone|fluticasone|mesh-list
101927345|NCT01299558|Xhance|xhance|mesh-list
101927346|NCT01299558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101927347|NCT01299558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101927348|NCT01299558|Autonomic Agents|autonomic agents|mesh-ancestor
101927349|NCT01299558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101927350|NCT01299558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927351|NCT01299558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101927352|NCT01299558|Respiratory System Agents|respiratory system agents|mesh-ancestor
101927353|NCT01299558|Dermatologic Agents|dermatologic agents|mesh-ancestor
101927354|NCT01299558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101927355|NCT01207206|Ketamine|ketamine|mesh-list
101927356|NCT01207206|Analgesics|analgesics|mesh-ancestor
101927357|NCT01207206|Sensory System Agents|sensory system agents|mesh-ancestor
101927358|NCT01207206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101927359|NCT01207206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927360|NCT01207206|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101927361|NCT01207206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101927362|NCT01207206|Anesthetics, General|anesthetics, general|mesh-ancestor
101927363|NCT01207206|Anesthetics|anesthetics|mesh-ancestor
101927364|NCT01207206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101927365|NCT01207206|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101927366|NCT01207206|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101958256|NCT04862780|Osimertinib|osimertinib|mesh-list
101927367|NCT01207206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101927368|NCT01207206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927370|NCT03719586|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
101927371|NCT03719586|Antimetabolites|antimetabolites|mesh-ancestor
101927372|NCT03719586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927373|NCT03719586|Antiviral Agents|antiviral agents|mesh-ancestor
101927374|NCT03719586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101927375|NCT01205022|Calcium, Dietary|calcium, dietary|mesh-list
101927376|NCT01205022|Leucovorin|leucovorin|mesh-list
101927377|NCT01205022|Bevacizumab|bevacizumab|mesh-list
101927378|NCT01205022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101927379|NCT01205022|Fluorouracil|fluorouracil|mesh-list
101927380|NCT01205022|Irinotecan|irinotecan|mesh-list
101927381|NCT01205022|Camptothecin|camptothecin|mesh-list
101647242|NCT04156425|Serotonin Agents|serotonin agents|mesh-ancestor
101927383|NCT01205022|Immunoglobulins|immunoglobulins|mesh-list
101927384|NCT01205022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101927386|NCT01205022|Levoleucovorin|levoleucovorin|mesh-list
101927387|NCT01205022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927388|NCT01205022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101927389|NCT01205022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101927390|NCT01205022|Growth Substances|growth substances|mesh-ancestor
101927391|NCT01205022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927392|NCT01205022|Growth Inhibitors|growth inhibitors|mesh-ancestor
101927393|NCT01205022|Immunologic Factors|immunologic factors|mesh-ancestor
101927394|NCT01205022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101927395|NCT01205022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101927396|NCT01205022|Antimetabolites|antimetabolites|mesh-ancestor
101927397|NCT01205022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927398|NCT01205022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101927399|NCT01205022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101927400|NCT01205022|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101927401|NCT01205022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101927402|NCT01205022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101927403|NCT01205022|Antidotes|antidotes|mesh-ancestor
101927404|NCT01205022|Protective Agents|protective agents|mesh-ancestor
101927405|NCT01205022|Vitamin B Complex|vitamin b complex|mesh-ancestor
101927406|NCT01205022|Vitamins|vitamins|mesh-ancestor
101927407|NCT01205022|Micronutrients|micronutrients|mesh-ancestor
101927408|NCT01205022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101927409|NCT01205178|Chloroquine|chloroquine|mesh-list
101927410|NCT01205178|Primaquine|primaquine|mesh-list
101927411|NCT01205178|Tafenoquine|tafenoquine|mesh-list
101927412|NCT01205178|Amebicides|amebicides|mesh-ancestor
101927413|NCT01205178|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101927414|NCT01205178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101927415|NCT01205178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101927416|NCT01205178|Antimalarials|antimalarials|mesh-ancestor
101927417|NCT01205178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101927418|NCT01205256|Methadone|methadone|mesh-list
101927419|NCT01205256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101927420|NCT01205256|Narcotics|narcotics|mesh-ancestor
101927421|NCT01205256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101927422|NCT01205256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927423|NCT01205256|Analgesics|analgesics|mesh-ancestor
101927424|NCT01205256|Sensory System Agents|sensory system agents|mesh-ancestor
101927425|NCT01205256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101927426|NCT01205256|Antitussive Agents|antitussive agents|mesh-ancestor
101927427|NCT01205256|Respiratory System Agents|respiratory system agents|mesh-ancestor
101927428|NCT03823482|Lidocaine|lidocaine|mesh-list
101927429|NCT03823482|Anesthetics, Local|anesthetics, local|mesh-ancestor
101927430|NCT03823482|Anesthetics|anesthetics|mesh-ancestor
101927431|NCT03823482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101927432|NCT03823482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927433|NCT03823482|Sensory System Agents|sensory system agents|mesh-ancestor
101927434|NCT03823482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101927435|NCT03823482|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101927436|NCT03823482|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101927437|NCT03823482|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101927438|NCT03823482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101927439|NCT03823482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927440|NCT03816306|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101927442|NCT03816306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927443|NCT03816072|Phenylephrine|phenylephrine|mesh-list
101927444|NCT03816072|Oxymetazoline|oxymetazoline|mesh-list
101927445|NCT03816072|Propofol|propofol|mesh-list
101927446|NCT03816072|Sevoflurane|sevoflurane|mesh-list
101927447|NCT03816072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101927448|NCT03816072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101927449|NCT03816072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927450|NCT03816072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101927451|NCT03816072|Anesthetics, General|anesthetics, general|mesh-ancestor
101927452|NCT03816072|Anesthetics|anesthetics|mesh-ancestor
101927453|NCT03816072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101927454|NCT03816072|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101927455|NCT03816072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101927456|NCT03816072|Mydriatics|mydriatics|mesh-ancestor
101927457|NCT03816072|Autonomic Agents|autonomic agents|mesh-ancestor
101647317|NCT04156035|Ketamine|ketamine|mesh-list
101927458|NCT03816072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101927459|NCT03816072|Sympathomimetics|sympathomimetics|mesh-ancestor
101927460|NCT03816072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101927461|NCT03816072|Nasal Decongestants|nasal decongestants|mesh-ancestor
101231548|NCT03020030|Leucovorin|leucovorin|mesh-list
101927462|NCT03816072|Respiratory System Agents|respiratory system agents|mesh-ancestor
101927463|NCT03816072|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101927464|NCT03816072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101927465|NCT03816072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101927466|NCT03816072|Adrenergic Agents|adrenergic agents|mesh-ancestor
101927467|NCT03816072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101927468|NCT03816072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927469|NCT03816072|Protective Agents|protective agents|mesh-ancestor
101927470|NCT01299948|Prednisolone|prednisolone|mesh-list
101927471|NCT01299948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101927472|NCT01299948|Glucocorticoids|glucocorticoids|mesh-ancestor
101927473|NCT01299948|Hormones|hormones|mesh-ancestor
101927474|NCT01299948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101927475|NCT01299948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927476|NCT01299948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101927477|NCT01299948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927478|NCT01300026|N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine|n-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9h-purin-6-amine|mesh-list
101927479|NCT01300026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101927480|NCT01300026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927481|NCT01297452|Paclitaxel|paclitaxel|mesh-list
101927482|NCT01297452|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101927483|NCT01297452|Carboplatin|carboplatin|mesh-list
101927484|NCT01297452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101927485|NCT01297452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927486|NCT01297452|Tubulin Modulators|tubulin modulators|mesh-ancestor
101927487|NCT01297452|Antimitotic Agents|antimitotic agents|mesh-ancestor
101927488|NCT01297452|Mitosis Modulators|mitosis modulators|mesh-ancestor
101927489|NCT01297452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927490|NCT01301586|Doxycycline|doxycycline|mesh-list
101927491|NCT01301586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101927492|NCT01301586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101927493|NCT01301586|Antimalarials|antimalarials|mesh-ancestor
101927494|NCT01301586|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101927495|NCT01301586|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101927496|NCT03815838|Fallypride|fallypride|mesh-list
101927497|NCT03815838|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101927498|NCT03815838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101927499|NCT03815838|Dopamine Agents|dopamine agents|mesh-ancestor
101927500|NCT03815838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101927501|NCT03815838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927502|NCT03815838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927503|NCT01205724|Factor VIII|factor viii|mesh-list
101927504|NCT01205724|Coagulants|coagulants|mesh-ancestor
101927505|NCT01301820|Lenalidomide|lenalidomide|mesh-list
101927506|NCT01301820|Azacitidine|azacitidine|mesh-list
101927507|NCT01301820|Immunologic Factors|immunologic factors|mesh-ancestor
101927508|NCT01301820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927509|NCT01301820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101927510|NCT01301820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101927511|NCT01301820|Growth Substances|growth substances|mesh-ancestor
101927512|NCT01301820|Growth Inhibitors|growth inhibitors|mesh-ancestor
101927513|NCT01301820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927514|NCT01301820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101927515|NCT01301820|Antimetabolites|antimetabolites|mesh-ancestor
101927516|NCT01301820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927517|NCT01301820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101927518|NCT01297686|Dexamethasone|dexamethasone|mesh-list
101927519|NCT01297686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101927520|NCT01297686|Antiemetics|antiemetics|mesh-ancestor
101927521|NCT01297686|Autonomic Agents|autonomic agents|mesh-ancestor
101927522|NCT01297686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101927523|NCT01297686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927524|NCT01297686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101927525|NCT01297686|Glucocorticoids|glucocorticoids|mesh-ancestor
101927526|NCT01297686|Hormones|hormones|mesh-ancestor
101927527|NCT01297686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101927528|NCT01297686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101927529|NCT01297686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927530|NCT01205880|Calcitriol|calcitriol|mesh-list
101927531|NCT01205880|Clobetasol|clobetasol|mesh-list
101927532|NCT01205880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101647407|NCT00662805|Xhance|xhance|mesh-list
101927533|NCT01205880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927534|NCT01205880|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101927535|NCT01205880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101927536|NCT01205880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927537|NCT01205880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101927538|NCT01205880|Vitamins|vitamins|mesh-ancestor
101927539|NCT01205880|Micronutrients|micronutrients|mesh-ancestor
101927540|NCT01205880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101927541|NCT01205880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101927542|NCT01205880|Glucocorticoids|glucocorticoids|mesh-ancestor
101927543|NCT01205880|Hormones|hormones|mesh-ancestor
101927544|NCT01205880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101927545|NCT01205958|Pyranoprofen|pyranoprofen|mesh-list
101927546|NCT01205958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101927547|NCT01205958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101927548|NCT01205958|Analgesics|analgesics|mesh-ancestor
101927549|NCT01205958|Sensory System Agents|sensory system agents|mesh-ancestor
101927550|NCT01205958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101927551|NCT01205958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927552|NCT01205958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101927553|NCT01205958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101927554|NCT01205958|Gout Suppressants|gout suppressants|mesh-ancestor
101927555|NCT01297842|Meropenem|meropenem|mesh-list
101927556|NCT01297842|Imipenem|imipenem|mesh-list
101927557|NCT01297842|Ertapenem|ertapenem|mesh-list
101927558|NCT01297842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101927559|NCT01297842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101927560|NCT01297998|Cisplatin|cisplatin|mesh-list
101927561|NCT01297998|Gemcitabine|gemcitabine|mesh-list
101927562|NCT01297998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927563|NCT01297998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101927564|NCT01297998|Antimetabolites|antimetabolites|mesh-ancestor
101927565|NCT01297998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927566|NCT01298076|Dexamethasone|dexamethasone|mesh-list
101927567|NCT01298076|Bevacizumab|bevacizumab|mesh-list
101927568|NCT01298076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101927569|NCT01298076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927570|NCT01298076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101927571|NCT01298076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101927572|NCT01298076|Growth Substances|growth substances|mesh-ancestor
101927573|NCT01298076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927574|NCT01298076|Growth Inhibitors|growth inhibitors|mesh-ancestor
101927575|NCT01298076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101927576|NCT01298076|Antiemetics|antiemetics|mesh-ancestor
101927577|NCT01298076|Autonomic Agents|autonomic agents|mesh-ancestor
101927578|NCT01298076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101958271|NCT00177671|Donepezil|donepezil|mesh-list
101927579|NCT01298076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101927580|NCT01298076|Glucocorticoids|glucocorticoids|mesh-ancestor
101927581|NCT01298076|Hormones|hormones|mesh-ancestor
101927582|NCT01298076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101927583|NCT01298076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101927584|NCT03819348|Antifungal Agents|antifungal agents|mesh-list
101927585|NCT03819348|Clotrimazole|clotrimazole|mesh-list
101927586|NCT03819348|Miconazole|miconazole|mesh-list
101927587|NCT03819348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101927588|NCT03819348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101231574|NCT03020030|Antiemetics|antiemetics|mesh-ancestor
101927589|NCT03819348|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101927590|NCT03819348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101927591|NCT03819348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101927592|NCT03819348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927593|NCT03819348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101927594|NCT03819348|Hormone Antagonists|hormone antagonists|mesh-ancestor
101927595|NCT03819348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101927596|NCT03819348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927597|NCT03819348|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101927598|NCT03819348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101927599|NCT01560390|Ketamine|ketamine|mesh-list
101927600|NCT01560390|Analgesics|analgesics|mesh-ancestor
101927601|NCT01560390|Sensory System Agents|sensory system agents|mesh-ancestor
101927602|NCT01560390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101927603|NCT01560390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927604|NCT01560390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101927605|NCT01560390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101647474|NCT00790777|Serotonin Agents|serotonin agents|mesh-ancestor
101927606|NCT01560390|Anesthetics, General|anesthetics, general|mesh-ancestor
101927607|NCT01560390|Anesthetics|anesthetics|mesh-ancestor
101927608|NCT01560390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101927609|NCT01560390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101927610|NCT01560390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101927611|NCT01560390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101927612|NCT01560390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927613|NCT03807882|Clozapine|clozapine|mesh-list
101927614|NCT03807882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101927615|NCT03807882|Serotonin Agents|serotonin agents|mesh-ancestor
101927616|NCT03807882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101927617|NCT03807882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927618|NCT03807882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927619|NCT03807882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101927620|NCT03807882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101927621|NCT03807882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101927622|NCT03807882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101927623|NCT03807882|GABA Antagonists|gaba antagonists|mesh-ancestor
101927624|NCT03807882|GABA Agents|gaba agents|mesh-ancestor
101927625|NCT03796572|Ropivacaine|ropivacaine|mesh-list
101927626|NCT03796572|Anesthetics, Local|anesthetics, local|mesh-ancestor
101927627|NCT03796572|Anesthetics|anesthetics|mesh-ancestor
101927628|NCT03796572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101927629|NCT03796572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927630|NCT03796572|Sensory System Agents|sensory system agents|mesh-ancestor
101927631|NCT03796572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101927632|NCT01304472|Clopidogrel|clopidogrel|mesh-list
101927633|NCT01304472|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101927634|NCT01304472|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101927635|NCT01304472|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101927636|NCT01304472|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101927637|NCT01304472|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101927638|NCT01304472|Purinergic Agents|purinergic agents|mesh-ancestor
101927639|NCT01304472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101927640|NCT01304472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927641|NCT01304472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927642|NCT03795792|Curcumin|curcumin|mesh-list
101927643|NCT03795792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101927644|NCT03795792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101927645|NCT03795792|Analgesics|analgesics|mesh-ancestor
101927646|NCT03795792|Sensory System Agents|sensory system agents|mesh-ancestor
101927647|NCT03795792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101927648|NCT03795792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927649|NCT03795792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101927650|NCT03795792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101927651|NCT03795792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927652|NCT03795792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101927653|NCT03795792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927654|NCT01303536|Ondansetron|ondansetron|mesh-list
101927655|NCT01303536|Antiemetics|antiemetics|mesh-ancestor
101927656|NCT01303536|Autonomic Agents|autonomic agents|mesh-ancestor
101927657|NCT01303536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101927658|NCT01303536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927659|NCT01303536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101927660|NCT01303536|Antipruritics|antipruritics|mesh-ancestor
101927661|NCT01303536|Dermatologic Agents|dermatologic agents|mesh-ancestor
101927662|NCT01303536|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101927663|NCT01303536|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101927664|NCT01303536|Serotonin Agents|serotonin agents|mesh-ancestor
101927665|NCT01303536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101927666|NCT01303536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927667|NCT01303614|Lidocaine|lidocaine|mesh-list
101927668|NCT01303614|Prilocaine|prilocaine|mesh-list
101927669|NCT01303614|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
101927670|NCT01303614|Anesthetics, Local|anesthetics, local|mesh-ancestor
101927671|NCT01303614|Anesthetics|anesthetics|mesh-ancestor
101927672|NCT01303614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101927673|NCT01303614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927674|NCT01303614|Sensory System Agents|sensory system agents|mesh-ancestor
101927675|NCT01303614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101927676|NCT01303614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101927677|NCT01303614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101927678|NCT01303614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101927679|NCT01303614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101927680|NCT01303614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927681|NCT01303614|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
101927682|NCT03347838|Nivolumab|nivolumab|mesh-list
101927683|NCT03347838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101927684|NCT03347838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927685|NCT03347838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101927686|NCT03347838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927687|NCT03795090|Anti-Infective Agents|anti-infective agents|mesh-list
101927688|NCT03795090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101927689|NCT03802422|Vitamin B 12|vitamin b 12|mesh-list
101927690|NCT03802422|Hydroxocobalamin|hydroxocobalamin|mesh-list
101927691|NCT03802422|Vitamins|vitamins|mesh-ancestor
101927692|NCT03802422|Micronutrients|micronutrients|mesh-ancestor
101927693|NCT03802422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927694|NCT03802422|Vitamin B Complex|vitamin b complex|mesh-ancestor
101927695|NCT03802422|Hematinics|hematinics|mesh-ancestor
101927696|NCT03801564|Hyaluronic Acid|hyaluronic acid|mesh-list
101927697|NCT03801564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101927698|NCT03801564|Immunologic Factors|immunologic factors|mesh-ancestor
101927699|NCT03801564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927700|NCT03801564|Viscosupplements|viscosupplements|mesh-ancestor
101927701|NCT03801564|Protective Agents|protective agents|mesh-ancestor
101927702|NCT03813186|Decitabine|decitabine|mesh-list
101927703|NCT03813186|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
101927704|NCT03813186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101927705|NCT03813186|Antimetabolites|antimetabolites|mesh-ancestor
101927706|NCT03813186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927707|NCT03813186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927708|NCT03813186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101927710|NCT03353350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101927711|NCT03353350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927712|NCT01302132|Ipragliflozin|ipragliflozin|mesh-list
101927713|NCT01302132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101927714|NCT01302132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927715|NCT01302132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101927716|NCT01302132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927717|NCT03799536|Sotalol|sotalol|mesh-list
101927718|NCT03799536|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101927719|NCT03799536|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101927720|NCT03799536|Adrenergic Agents|adrenergic agents|mesh-ancestor
101927721|NCT03799536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101927722|NCT03799536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927723|NCT03799536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927724|NCT03799536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101927725|NCT03799536|Sympatholytics|sympatholytics|mesh-ancestor
101927726|NCT03799536|Autonomic Agents|autonomic agents|mesh-ancestor
101927727|NCT03799536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101927728|NCT03229278|Pembrolizumab|pembrolizumab|mesh-list
101927729|NCT03229278|Nivolumab|nivolumab|mesh-list
101927730|NCT03229278|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101927731|NCT03229278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101927732|NCT03229278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927733|NCT03229278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101927734|NCT03229278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927735|NCT03812796|Avelumab|avelumab|mesh-list
101927736|NCT03812796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101927737|NCT03812796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927738|NCT05759104|Adalimumab|adalimumab|mesh-list
101927739|NCT05759104|Infliximab|infliximab|mesh-list
101927740|NCT05759104|Ustekinumab|ustekinumab|mesh-list
101927741|NCT05759104|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101927742|NCT05759104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101927743|NCT05759104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101927744|NCT05759104|Dermatologic Agents|dermatologic agents|mesh-ancestor
101927745|NCT05759104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101927746|NCT01384240|Proflavine|proflavine|mesh-list
101927747|NCT01384240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101927748|NCT01384240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101927749|NCT01381510|Finasteride|finasteride|mesh-list
101927750|NCT01381510|Dutasteride|dutasteride|mesh-list
101927751|NCT01381510|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
101927752|NCT01381510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101647617|NCT02631135|Propofol|propofol|mesh-list
101927753|NCT01381510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101927754|NCT01381510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927755|NCT01381510|Hormone Antagonists|hormone antagonists|mesh-ancestor
101927756|NCT01381510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101927757|NCT01381510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927758|NCT01381510|Urological Agents|urological agents|mesh-ancestor
101927759|NCT04258072|Vactosertib|vactosertib|mesh-list
101927760|NCT04258072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101927761|NCT04258072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101927762|NCT04258072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927763|NCT02984800|Anesthetics|anesthetics|mesh-list
101927764|NCT02984800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101927765|NCT02984800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927766|NCT04188730|Lofexidine|lofexidine|mesh-list
101927767|NCT04188730|Clonidine|clonidine|mesh-list
101927768|NCT04188730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101927769|NCT04188730|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101927770|NCT04188730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927771|NCT04188730|Sensory System Agents|sensory system agents|mesh-ancestor
101927772|NCT04188730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101927773|NCT04188730|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101927774|NCT04188730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101927775|NCT04188730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101927776|NCT04188730|Adrenergic Agents|adrenergic agents|mesh-ancestor
101927777|NCT04188730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101927778|NCT04188730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927779|NCT04188730|Analgesics|analgesics|mesh-ancestor
101927780|NCT04188730|Sympatholytics|sympatholytics|mesh-ancestor
101927781|NCT04188730|Autonomic Agents|autonomic agents|mesh-ancestor
101927782|NCT01381432|Azathioprine|azathioprine|mesh-list
101927783|NCT01381432|Antimetabolites|antimetabolites|mesh-ancestor
101927784|NCT01381432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927785|NCT01381432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101927786|NCT01381432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927787|NCT01381432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101927788|NCT01381432|Immunologic Factors|immunologic factors|mesh-ancestor
101927789|NCT01381432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927790|NCT01381432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101927791|NCT01381354|Thioctic Acid|thioctic acid|mesh-list
101927792|NCT01381354|Riboflavin|riboflavin|mesh-list
101927793|NCT01381354|Thiamine|thiamine|mesh-list
101927794|NCT01381354|Niacinamide|niacinamide|mesh-list
101927795|NCT01381354|Niacin|niacin|mesh-list
101927796|NCT01381354|Nicotinic Acids|nicotinic acids|mesh-list
101927797|NCT01381354|Acetylcarnitine|acetylcarnitine|mesh-list
101927798|NCT01381354|Ubiquinone|ubiquinone|mesh-list
101927799|NCT01381354|Acetylcysteine|acetylcysteine|mesh-list
101927800|NCT01381354|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
101927801|NCT01381354|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101927802|NCT01381354|Vitamins|vitamins|mesh-ancestor
101927803|NCT01381354|Micronutrients|micronutrients|mesh-ancestor
101927804|NCT01381354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927805|NCT01381354|Antiviral Agents|antiviral agents|mesh-ancestor
101927806|NCT01381354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101927807|NCT01381354|Expectorants|expectorants|mesh-ancestor
101927808|NCT01381354|Respiratory System Agents|respiratory system agents|mesh-ancestor
101927809|NCT01381354|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101927811|NCT01381354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927812|NCT01381354|Protective Agents|protective agents|mesh-ancestor
101927813|NCT01381354|Antidotes|antidotes|mesh-ancestor
101927814|NCT01381354|Vitamin B Complex|vitamin b complex|mesh-ancestor
101927815|NCT01381354|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101927816|NCT01381354|Dermatologic Agents|dermatologic agents|mesh-ancestor
101927817|NCT01381354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101927818|NCT01381354|Antimetabolites|antimetabolites|mesh-ancestor
101927819|NCT01381354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101927820|NCT01381354|Vasodilator Agents|vasodilator agents|mesh-ancestor
101927821|NCT01381354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101927822|NCT01381354|Nootropic Agents|nootropic agents|mesh-ancestor
101927823|NCT01381276|Beta Carotene|beta carotene|mesh-list
101927824|NCT01381276|Vitamin A|vitamin a|mesh-list
101927825|NCT01381276|Retinol palmitate|retinol palmitate|mesh-list
101927826|NCT01381276|Carotenoids|carotenoids|mesh-list
101647685|NCT00664833|Urological Agents|urological agents|mesh-ancestor
101927827|NCT01381276|Antioxidants|antioxidants|mesh-ancestor
101927828|NCT01381276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927829|NCT01381276|Protective Agents|protective agents|mesh-ancestor
101927830|NCT01381276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927831|NCT01381276|Provitamins|provitamins|mesh-ancestor
101927832|NCT01381276|Vitamins|vitamins|mesh-ancestor
101927833|NCT01381276|Micronutrients|micronutrients|mesh-ancestor
101927834|NCT01381276|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101927835|NCT01381276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927836|NCT02661022|Dexamethasone|dexamethasone|mesh-list
101927837|NCT02661022|Pomalidomide|pomalidomide|mesh-list
101927838|NCT02661022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101927839|NCT02661022|Antiemetics|antiemetics|mesh-ancestor
101927840|NCT02661022|Autonomic Agents|autonomic agents|mesh-ancestor
101927841|NCT02661022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101927842|NCT02661022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927843|NCT02661022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101927844|NCT02661022|Glucocorticoids|glucocorticoids|mesh-ancestor
101927845|NCT02661022|Hormones|hormones|mesh-ancestor
101231621|NCT03011684|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101927846|NCT02661022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101927847|NCT02661022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101927848|NCT02661022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927849|NCT02661022|Immunologic Factors|immunologic factors|mesh-ancestor
101927850|NCT02661022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101927851|NCT02661022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101927852|NCT02661022|Growth Substances|growth substances|mesh-ancestor
101927853|NCT02661022|Growth Inhibitors|growth inhibitors|mesh-ancestor
101927854|NCT01569256|Cabergoline|cabergoline|mesh-list
101927855|NCT01569256|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101927856|NCT01569256|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101927857|NCT01569256|Dopamine Agonists|dopamine agonists|mesh-ancestor
101927858|NCT01569256|Dopamine Agents|dopamine agents|mesh-ancestor
101927859|NCT01569256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101927860|NCT01569256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927861|NCT01569256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927862|NCT03794544|Durvalumab|durvalumab|mesh-list
101927863|NCT03794544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101927864|NCT03794544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927865|NCT01380808|Capecitabine|capecitabine|mesh-list
101927866|NCT01380808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101927867|NCT01380808|Antimetabolites|antimetabolites|mesh-ancestor
101927868|NCT01380808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927869|NCT01380808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927870|NCT03799224|Decitabine|decitabine|mesh-list
101927871|NCT03799224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101927872|NCT03799224|Antimetabolites|antimetabolites|mesh-ancestor
101927873|NCT03799224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927874|NCT03799224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927875|NCT03799224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101927876|NCT03798912|Octreotide|octreotide|mesh-list
101927877|NCT03798912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101927878|NCT03798912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101927879|NCT03798912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927880|NCT03798834|Anesthetics|anesthetics|mesh-list
101927881|NCT03798834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101290373|NCT04226690|Dronabinol|dronabinol|mesh-list
101927882|NCT03798834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927883|NCT03812562|Nivolumab|nivolumab|mesh-list
101927884|NCT03812562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101927885|NCT03812562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927886|NCT03812562|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101927887|NCT03812562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927888|NCT01304784|Paclitaxel|paclitaxel|mesh-list
101927889|NCT01304784|Docetaxel|docetaxel|mesh-list
101927890|NCT01304784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101927891|NCT01304784|Capecitabine|capecitabine|mesh-list
101927892|NCT01304784|Trastuzumab|trastuzumab|mesh-list
101927893|NCT01304784|Lapatinib|lapatinib|mesh-list
101927894|NCT01304784|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101927895|NCT01304784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101927896|NCT01304784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927897|NCT01304784|Tubulin Modulators|tubulin modulators|mesh-ancestor
101927898|NCT01304784|Antimitotic Agents|antimitotic agents|mesh-ancestor
101927899|NCT01304784|Mitosis Modulators|mitosis modulators|mesh-ancestor
101927900|NCT01304784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927901|NCT01304784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101927902|NCT01304784|Antimetabolites|antimetabolites|mesh-ancestor
101927903|NCT01304784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101927904|NCT01304784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101927905|NCT01304784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101231632|NCT02968108|Ustekinumab|ustekinumab|mesh-list
101231633|NCT02968108|Dermatologic Agents|dermatologic agents|mesh-ancestor
101231634|NCT02947347|Rituximab|rituximab|mesh-list
101231635|NCT02947347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101927906|NCT01304784|Immunologic Factors|immunologic factors|mesh-ancestor
101927907|NCT01304784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927908|NCT03798600|Caspofungin|caspofungin|mesh-list
101927910|NCT03798600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101927911|NCT03798600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101927912|NCT03798600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927913|NCT03798522|Nalbuphine|nalbuphine|mesh-list
101927914|NCT03798522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101927915|NCT03798522|Narcotics|narcotics|mesh-ancestor
101927916|NCT03798522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101927917|NCT03798522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927918|NCT03798522|Analgesics|analgesics|mesh-ancestor
101927919|NCT03798522|Sensory System Agents|sensory system agents|mesh-ancestor
101927920|NCT03798522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101927921|NCT01308034|Sunitinib|sunitinib|mesh-list
101927922|NCT01308034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927923|NCT01308034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101927924|NCT01308034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101927925|NCT01308034|Growth Substances|growth substances|mesh-ancestor
101927926|NCT01308034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927927|NCT01308034|Growth Inhibitors|growth inhibitors|mesh-ancestor
101927928|NCT01308034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101927929|NCT01308034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101927930|NCT01308034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927931|NCT01302210|Mupirocin|mupirocin|mesh-list
101927932|NCT01302210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101927933|NCT01302210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101927934|NCT01302210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101927935|NCT01302210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101927936|NCT01302210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927937|NCT00005044|Bicalutamide|bicalutamide|mesh-list
101927938|NCT00005044|Flutamide|flutamide|mesh-list
101927939|NCT00005044|Hormones|hormones|mesh-list
101927940|NCT00005044|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101927941|NCT00005044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101927942|NCT00005044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927943|NCT00005044|Androgen Antagonists|androgen antagonists|mesh-ancestor
101927944|NCT00005044|Hormone Antagonists|hormone antagonists|mesh-ancestor
101927945|NCT00005044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927946|NCT00005044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101927947|NCT03794154|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101927948|NCT03794154|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101927949|NCT03794154|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101927950|NCT03794154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101927951|NCT03794154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927952|NCT03794154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101927953|NCT03794154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927954|NCT03794154|Analgesics|analgesics|mesh-ancestor
101927955|NCT03794154|Sensory System Agents|sensory system agents|mesh-ancestor
101927956|NCT03794154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101927957|NCT03794154|Antidepressive Agents|antidepressive agents|mesh-ancestor
101927958|NCT03794154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101927959|NCT03794154|Dopamine Agents|dopamine agents|mesh-ancestor
101927960|NCT03811860|Lithium Carbonate|lithium carbonate|mesh-list
101927961|NCT03811860|Antidepressive Agents|antidepressive agents|mesh-ancestor
101927962|NCT03811860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101927963|NCT03811860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101927964|NCT03811860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927965|NCT03811860|Antimanic Agents|antimanic agents|mesh-ancestor
101927966|NCT03811860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101927967|NCT03811860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101927968|NCT03811860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927969|NCT02722668|Mycophenolic Acid|mycophenolic acid|mesh-list
101927970|NCT02722668|Sirolimus|sirolimus|mesh-list
101927971|NCT02722668|Cyclophosphamide|cyclophosphamide|mesh-list
101927972|NCT02722668|Fludarabine|fludarabine|mesh-list
101927973|NCT02722668|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101927974|NCT02722668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101927975|NCT02722668|Immunologic Factors|immunologic factors|mesh-ancestor
101927976|NCT02722668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101927977|NCT02722668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101927978|NCT02722668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101927979|NCT02722668|Alkylating Agents|alkylating agents|mesh-ancestor
101927980|NCT02722668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101927981|NCT02722668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927982|NCT02722668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101927983|NCT02722668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101927984|NCT02722668|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101927985|NCT02722668|Antitubercular Agents|antitubercular agents|mesh-ancestor
101927986|NCT02722668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101927987|NCT02722668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101927988|NCT02722668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101927989|NCT02722668|Antifungal Agents|antifungal agents|mesh-ancestor
101927991|NCT01303926|Bevacizumab|bevacizumab|mesh-list
101927992|NCT01303926|Carboplatin|carboplatin|mesh-list
101927993|NCT01303926|Pemetrexed|pemetrexed|mesh-list
101927994|NCT01303926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101927995|NCT01303926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101927996|NCT01303926|Tubulin Modulators|tubulin modulators|mesh-ancestor
101927997|NCT01303926|Antimitotic Agents|antimitotic agents|mesh-ancestor
101927998|NCT01303926|Mitosis Modulators|mitosis modulators|mesh-ancestor
101927999|NCT01303926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928000|NCT01303926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101928001|NCT01303926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101928002|NCT01303926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101928003|NCT01303926|Growth Substances|growth substances|mesh-ancestor
101928004|NCT01303926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928005|NCT01303926|Growth Inhibitors|growth inhibitors|mesh-ancestor
101928006|NCT01303926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101928007|NCT01303926|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101928008|NCT01303926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101928009|NCT03084796|Bromides|bromides|mesh-list
101928010|NCT03084796|Tiotropium Bromide|tiotropium bromide|mesh-list
101928011|NCT03084796|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101928012|NCT03084796|Autonomic Agents|autonomic agents|mesh-ancestor
101928013|NCT03084796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101928014|NCT03084796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928015|NCT03084796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101928016|NCT03084796|Respiratory System Agents|respiratory system agents|mesh-ancestor
101928017|NCT03084796|Parasympatholytics|parasympatholytics|mesh-ancestor
101928018|NCT03084796|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101928019|NCT03084796|Cholinergic Agents|cholinergic agents|mesh-ancestor
101928020|NCT03084796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101928021|NCT03084796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928022|NCT03084796|Anticonvulsants|anticonvulsants|mesh-ancestor
101928023|NCT03717012|Nintedanib|nintedanib|mesh-list
101928024|NCT03717012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101928025|NCT03717012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101928026|NCT03717012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101928027|NCT03717012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928028|NCT01302756|Folic Acid|folic acid|mesh-list
101928029|NCT01302756|Hematinics|hematinics|mesh-ancestor
101928030|NCT01302756|Vitamin B Complex|vitamin b complex|mesh-ancestor
101928031|NCT01302756|Vitamins|vitamins|mesh-ancestor
101928032|NCT01302756|Micronutrients|micronutrients|mesh-ancestor
101928033|NCT01302756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928034|NCT04893252|Durvalumab|durvalumab|mesh-list
101928035|NCT04893252|Vactosertib|vactosertib|mesh-list
101928036|NCT04893252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101928037|NCT04893252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101928038|NCT04893252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101928039|NCT04893252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101928040|NCT04893252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928041|NCT03797508|Progesterone|progesterone|mesh-list
101928042|NCT03797508|Progestins|progestins|mesh-ancestor
101928043|NCT03797508|Hormones|hormones|mesh-ancestor
101928044|NCT03797508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101928045|NCT03797508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928046|NCT01380496|Doxycycline|doxycycline|mesh-list
101928047|NCT01380496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101928048|NCT01380496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101928049|NCT01380496|Antimalarials|antimalarials|mesh-ancestor
101928050|NCT01380496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101958315|NCT02113150|Remifentanil|remifentanil|mesh-list
101928051|NCT01380496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101928052|NCT01304316|Phenylephrine|phenylephrine|mesh-list
101928053|NCT01304316|Oxymetazoline|oxymetazoline|mesh-list
101928054|NCT01304316|Tetracaine|tetracaine|mesh-list
101928055|NCT01304316|Anesthetics, Local|anesthetics, local|mesh-ancestor
101928056|NCT01304316|Anesthetics|anesthetics|mesh-ancestor
101928057|NCT01304316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101928058|NCT01304316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928059|NCT01304316|Sensory System Agents|sensory system agents|mesh-ancestor
101928060|NCT01304316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101928061|NCT01304316|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101928062|NCT01304316|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101928063|NCT01304316|Adrenergic Agents|adrenergic agents|mesh-ancestor
101928064|NCT01304316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101928065|NCT01304316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928066|NCT01304316|Sympathomimetics|sympathomimetics|mesh-ancestor
101928067|NCT01304316|Autonomic Agents|autonomic agents|mesh-ancestor
101928068|NCT01304316|Nasal Decongestants|nasal decongestants|mesh-ancestor
101928069|NCT01304316|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101928070|NCT01304316|Respiratory System Agents|respiratory system agents|mesh-ancestor
101928071|NCT01304316|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101928072|NCT01304316|Mydriatics|mydriatics|mesh-ancestor
101928073|NCT01304316|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101928074|NCT01304316|Protective Agents|protective agents|mesh-ancestor
101928075|NCT03792828|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101928076|NCT03792828|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101928077|NCT03792828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101928078|NCT03792828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101928079|NCT03792828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928080|NCT03792828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101928081|NCT03792828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928082|NCT03792828|Analgesics|analgesics|mesh-ancestor
101928083|NCT03792828|Sensory System Agents|sensory system agents|mesh-ancestor
101928084|NCT03792828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101928085|NCT03792828|Antidepressive Agents|antidepressive agents|mesh-ancestor
101928086|NCT03792828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101928087|NCT03792828|Dopamine Agents|dopamine agents|mesh-ancestor
101928088|NCT01379326|Mebendazole|mebendazole|mesh-list
101928090|NCT01379326|Piperazine citrate|piperazine citrate|mesh-list
101928091|NCT01379326|DMP 777|dmp 777|mesh-list
101231676|NCT02525796|Eplerenone|eplerenone|mesh-list
101928092|NCT01379326|Antinematodal Agents|antinematodal agents|mesh-ancestor
101928093|NCT01379326|Anthelmintics|anthelmintics|mesh-ancestor
101928094|NCT01379326|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101928095|NCT01379326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101928096|NCT01379326|Tubulin Modulators|tubulin modulators|mesh-ancestor
101928097|NCT01379326|Antimitotic Agents|antimitotic agents|mesh-ancestor
101928098|NCT01379326|Mitosis Modulators|mitosis modulators|mesh-ancestor
101928099|NCT01379326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928100|NCT01379326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101928101|NCT01379326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101928102|NCT01560546|Testosterone|testosterone|mesh-list
101928103|NCT01560546|Androgens|androgens|mesh-ancestor
101928104|NCT01560546|Hormones|hormones|mesh-ancestor
101928105|NCT01560546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101928106|NCT01560546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928107|NCT03792984|Vitamin D|vitamin d|mesh-list
101928108|NCT03792984|Cholecalciferol|cholecalciferol|mesh-list
101928109|NCT03792984|Metformin|metformin|mesh-list
101928110|NCT03792984|Calcium Carbonate|calcium carbonate|mesh-list
101928111|NCT03792984|Calcium|calcium|mesh-list
101928112|NCT03792984|Vitamins|vitamins|mesh-ancestor
101928113|NCT03792984|Micronutrients|micronutrients|mesh-ancestor
101928114|NCT03792984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928115|NCT03792984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101928116|NCT03792984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101928117|NCT03792984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101928118|NCT03792984|Antacids|antacids|mesh-ancestor
101928119|NCT03792984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928120|NCT03792984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101928121|NCT03792906|Norepinephrine|norepinephrine|mesh-list
101928122|NCT03792906|Bupivacaine|bupivacaine|mesh-list
101928123|NCT03792906|Anesthetics, Local|anesthetics, local|mesh-ancestor
101928124|NCT03792906|Anesthetics|anesthetics|mesh-ancestor
101928126|NCT03792906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928127|NCT03792906|Sensory System Agents|sensory system agents|mesh-ancestor
101928128|NCT03792906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101928129|NCT03792906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101928130|NCT03792906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101928131|NCT03792906|Adrenergic Agents|adrenergic agents|mesh-ancestor
101928132|NCT03792906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101928133|NCT03792906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648043|NCT00996593|Iodine|iodine|mesh-list
101928134|NCT03792906|Sympathomimetics|sympathomimetics|mesh-ancestor
101928135|NCT03792906|Autonomic Agents|autonomic agents|mesh-ancestor
101928136|NCT03792906|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101928137|NCT03078556|Lamivudine|lamivudine|mesh-list
101928138|NCT03078556|Dolutegravir|dolutegravir|mesh-list
101928139|NCT03078556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101928140|NCT03078556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101928141|NCT03078556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101928142|NCT03078556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928143|NCT03078556|Antiviral Agents|antiviral agents|mesh-ancestor
101928144|NCT03078556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101928145|NCT03078556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101928146|NCT03078556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101928147|NCT03078556|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101928148|NCT03078556|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101928149|NCT03949894|Tolvaptan|tolvaptan|mesh-list
101928150|NCT03949894|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101928151|NCT03949894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928152|NCT03949894|Natriuretic Agents|natriuretic agents|mesh-ancestor
101928153|NCT03949894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928154|NCT03714672|Diclofenac|diclofenac|mesh-list
101928155|NCT03714672|Tramadol|tramadol|mesh-list
101928156|NCT03714672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101928157|NCT03714672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101928158|NCT03714672|Analgesics|analgesics|mesh-ancestor
101928159|NCT03714672|Sensory System Agents|sensory system agents|mesh-ancestor
101928160|NCT03714672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101928161|NCT03714672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928162|NCT03714672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101928163|NCT03714672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101928164|NCT03714672|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101928165|NCT03714672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101928166|NCT03714672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928167|NCT03714672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101928168|NCT03714672|Narcotics|narcotics|mesh-ancestor
101928169|NCT03714672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101928170|NCT03083470|Paclitaxel|paclitaxel|mesh-list
101928171|NCT03083470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101928172|NCT03083470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101928173|NCT03083470|Tubulin Modulators|tubulin modulators|mesh-ancestor
101928174|NCT03083470|Antimitotic Agents|antimitotic agents|mesh-ancestor
101928175|NCT03083470|Mitosis Modulators|mitosis modulators|mesh-ancestor
101928176|NCT03083470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928177|NCT01377610|Naltrexone|naltrexone|mesh-list
101928178|NCT01377610|Buprenorphine|buprenorphine|mesh-list
101928179|NCT01377610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101928180|NCT01377610|Narcotics|narcotics|mesh-ancestor
101928181|NCT01377610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101928182|NCT01377610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928183|NCT01377610|Analgesics|analgesics|mesh-ancestor
101928184|NCT01377610|Sensory System Agents|sensory system agents|mesh-ancestor
101928185|NCT01377610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101928186|NCT01377610|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101928187|NCT01377610|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101928188|NCT03811080|Fexuprazan|fexuprazan|mesh-list
101928189|NCT03811080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101928190|NCT01377532|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
101928191|NCT01377532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101928192|NCT01377532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101928193|NCT01377532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928194|NCT01377532|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101928195|NCT03810976|Gemcitabine|gemcitabine|mesh-list
101928196|NCT03810976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101928197|NCT03810976|Antimetabolites|antimetabolites|mesh-ancestor
101928198|NCT03810976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928199|NCT03810976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101928200|NCT05405244|Bromocriptine|bromocriptine|mesh-list
101928201|NCT05405244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928202|NCT05405244|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101928203|NCT05405244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101928204|NCT05405244|Hormone Antagonists|hormone antagonists|mesh-ancestor
101928205|NCT05405244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101928206|NCT05405244|Dopamine Agonists|dopamine agonists|mesh-ancestor
101928207|NCT05405244|Dopamine Agents|dopamine agents|mesh-ancestor
101928208|NCT05405244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101928209|NCT05405244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928210|NCT03789006|Interleukin-2|interleukin-2|mesh-list
101928211|NCT03789006|Immunoglobulins|immunoglobulins|mesh-list
101928212|NCT03789006|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101928213|NCT03789006|Antibodies|antibodies|mesh-list
101928214|NCT03789006|Basiliximab|basiliximab|mesh-list
101928215|NCT03789006|Thymoglobulin|thymoglobulin|mesh-list
101928216|NCT03789006|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101928217|NCT03789006|Immunologic Factors|immunologic factors|mesh-ancestor
101928218|NCT03789006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928219|NCT03789006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101928220|NCT03789006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101928221|NCT03789006|Analgesics|analgesics|mesh-ancestor
101928222|NCT03789006|Sensory System Agents|sensory system agents|mesh-ancestor
101928223|NCT03789006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101928224|NCT03789006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101928225|NCT01306266|Rizatriptan|rizatriptan|mesh-list
101928226|NCT01306266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101928227|NCT01306266|Serotonin Agents|serotonin agents|mesh-ancestor
101928228|NCT01306266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101928229|NCT01306266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928230|NCT01306266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928231|NCT03516214|Trametinib|trametinib|mesh-list
101928232|NCT03516214|Nazartinib|nazartinib|mesh-list
101928233|NCT03516214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101928234|NCT03516214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101928235|NCT03516214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101928236|NCT03516214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928237|NCT03630796|Sevoflurane|sevoflurane|mesh-list
101928238|NCT03630796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101928239|NCT03630796|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101928240|NCT03630796|Anesthetics, General|anesthetics, general|mesh-ancestor
101928241|NCT03630796|Anesthetics|anesthetics|mesh-ancestor
101928242|NCT03630796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101928243|NCT03630796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928244|NCT05202964|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101928245|NCT05202964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101928246|NCT01096966|Bupivacaine|bupivacaine|mesh-list
101928247|NCT01096966|Anesthetics, Local|anesthetics, local|mesh-ancestor
101928248|NCT01096966|Anesthetics|anesthetics|mesh-ancestor
101928249|NCT01096966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101928250|NCT01096966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928251|NCT01096966|Sensory System Agents|sensory system agents|mesh-ancestor
101928252|NCT01096966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101928253|NCT01379560|Isopropyl unoprostone|isopropyl unoprostone|mesh-list
101928254|NCT01379560|Dinoprost|dinoprost|mesh-list
101928255|NCT01379560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101928256|NCT01379560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101928257|NCT01379560|Abortifacient Agents|abortifacient agents|mesh-ancestor
101928258|NCT01379560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101928259|NCT01379560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928260|NCT01379560|Oxytocics|oxytocics|mesh-ancestor
101928261|NCT01379482|Paclitaxel|paclitaxel|mesh-list
101928262|NCT01379482|Docetaxel|docetaxel|mesh-list
101928263|NCT01379482|Cisplatin|cisplatin|mesh-list
101928264|NCT01379482|Doxorubicin|doxorubicin|mesh-list
101928265|NCT01379482|Oxaliplatin|oxaliplatin|mesh-list
101928266|NCT01379482|Irinotecan|irinotecan|mesh-list
101928267|NCT01379482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101928268|NCT01379482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101928269|NCT01379482|Tubulin Modulators|tubulin modulators|mesh-ancestor
101928270|NCT01379482|Antimitotic Agents|antimitotic agents|mesh-ancestor
101928271|NCT01379482|Mitosis Modulators|mitosis modulators|mesh-ancestor
101928272|NCT01379482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928273|NCT01379482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101928274|NCT01379482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101928275|NCT01379482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101928276|NCT01379482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101928277|NCT01379482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101928278|NCT05624424|Sufentanil|sufentanil|mesh-list
101928279|NCT05624424|Remifentanil|remifentanil|mesh-list
101928280|NCT05624424|Propofol|propofol|mesh-list
101928281|NCT05624424|Sevoflurane|sevoflurane|mesh-list
101928282|NCT05624424|Cisatracurium|cisatracurium|mesh-list
101928283|NCT05624424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101928284|NCT05624424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101928285|NCT05624424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928286|NCT05624424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101928287|NCT05624424|Anesthetics, General|anesthetics, general|mesh-ancestor
101928288|NCT05624424|Anesthetics|anesthetics|mesh-ancestor
101928289|NCT05624424|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101928290|NCT05624424|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101928291|NCT05624424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101928292|NCT05624424|Narcotics|narcotics|mesh-ancestor
101928293|NCT05624424|Analgesics|analgesics|mesh-ancestor
101928294|NCT05624424|Sensory System Agents|sensory system agents|mesh-ancestor
101928295|NCT05624424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101928296|NCT05624424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101928297|NCT05624424|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101928298|NCT05624424|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101928300|NCT05461690|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101928301|NCT05461690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101928302|NCT05461690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928303|NCT05461690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101928304|NCT05456230|Midazolam|midazolam|mesh-list
101928305|NCT05456230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101928306|NCT05456230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101928307|NCT05456230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101928308|NCT05456230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928309|NCT05456230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101928310|NCT05456230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101928311|NCT05456230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101928312|NCT05456230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101928313|NCT05456230|Anesthetics, General|anesthetics, general|mesh-ancestor
101928314|NCT05456230|Anesthetics|anesthetics|mesh-ancestor
101928315|NCT05456230|GABA Modulators|gaba modulators|mesh-ancestor
101928316|NCT05456230|GABA Agents|gaba agents|mesh-ancestor
101928317|NCT05456230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101928318|NCT05456230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928319|NCT03791814|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
101928320|NCT03791814|Antiviral Agents|antiviral agents|mesh-ancestor
101928321|NCT03791814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101928322|NCT05404048|Atezolizumab|atezolizumab|mesh-list
101928323|NCT05404048|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101928324|NCT05404048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928325|NCT05404048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101928326|NCT05404048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101928327|NCT01377376|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101928328|NCT01377376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101928329|NCT01377376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101928330|NCT01377376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101928331|NCT01377376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928332|NCT03788538|Dexmedetomidine|dexmedetomidine|mesh-list
101928333|NCT03788538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101928334|NCT03788538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101928335|NCT03788538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928336|NCT03788538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101928337|NCT03788538|Analgesics|analgesics|mesh-ancestor
101928338|NCT03788538|Sensory System Agents|sensory system agents|mesh-ancestor
101928339|NCT03788538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101928340|NCT03788538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101928341|NCT03788538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101928342|NCT03788538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101928343|NCT03788538|Adrenergic Agents|adrenergic agents|mesh-ancestor
101928344|NCT03788538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101928345|NCT03788538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928346|NCT05320120|Esketamine|esketamine|mesh-list
101928347|NCT05320120|Antidepressive Agents|antidepressive agents|mesh-ancestor
101928348|NCT05320120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101928349|NCT03077698|Megestrol|megestrol|mesh-list
101928350|NCT03077698|Megestrol Acetate|megestrol acetate|mesh-list
101928351|NCT03077698|Progestins|progestins|mesh-list
101928352|NCT03077698|10-carboxymethyl-9-acridanone|10-carboxymethyl-9-acridanone|mesh-list
101928353|NCT03077698|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101928354|NCT03077698|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101928355|NCT03077698|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101928356|NCT03077698|Contraceptive Agents|contraceptive agents|mesh-ancestor
101928357|NCT03077698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101928358|NCT03077698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928359|NCT03077698|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101928360|NCT03077698|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101928361|NCT03077698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101928362|NCT03077698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101928363|NCT03077698|Appetite Stimulants|appetite stimulants|mesh-ancestor
101928364|NCT03077698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101928365|NCT03077698|Hormones|hormones|mesh-ancestor
101928366|NCT03077698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101928367|NCT03077698|Interferon Inducers|interferon inducers|mesh-ancestor
101928368|NCT03077698|Immunologic Factors|immunologic factors|mesh-ancestor
101928369|NCT01377220|Choline|choline|mesh-list
101928370|NCT01377220|Lipotropic Agents|lipotropic agents|mesh-ancestor
101928371|NCT01377220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101928372|NCT01377220|Antimetabolites|antimetabolites|mesh-ancestor
101928373|NCT01377220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928374|NCT01377220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101928375|NCT01377220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101928376|NCT01377220|Nootropic Agents|nootropic agents|mesh-ancestor
101928377|NCT03079102|Nitric Oxide|nitric oxide|mesh-list
101928378|NCT03079102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101928379|NCT03079102|Autonomic Agents|autonomic agents|mesh-ancestor
101928380|NCT03079102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101928381|NCT03079102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928382|NCT03079102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101928383|NCT03079102|Respiratory System Agents|respiratory system agents|mesh-ancestor
101928384|NCT03079102|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101928385|NCT03079102|Antioxidants|antioxidants|mesh-ancestor
101928386|NCT03079102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928387|NCT03079102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101928388|NCT03079102|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101928389|NCT03079102|Vasodilator Agents|vasodilator agents|mesh-ancestor
101928390|NCT03079102|Gasotransmitters|gasotransmitters|mesh-ancestor
101928391|NCT03079102|Protective Agents|protective agents|mesh-ancestor
101928392|NCT03791424|Midazolam|midazolam|mesh-list
101928393|NCT03791424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101928394|NCT03791424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101928395|NCT03791424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101928396|NCT03791424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928397|NCT03791424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101928398|NCT03791424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101928399|NCT03791424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101928400|NCT03791424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101928401|NCT03791424|Anesthetics, General|anesthetics, general|mesh-ancestor
101928402|NCT03791424|Anesthetics|anesthetics|mesh-ancestor
101928403|NCT03791424|GABA Modulators|gaba modulators|mesh-ancestor
101928404|NCT03791424|GABA Agents|gaba agents|mesh-ancestor
101928405|NCT03791424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101928406|NCT03791424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928407|NCT03787992|Gefitinib|gefitinib|mesh-list
101928408|NCT03787992|Aflutinib|aflutinib|mesh-list
101928409|NCT03787992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101928410|NCT03787992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101928411|NCT03787992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101958340|NCT03553108|Olaparib|olaparib|mesh-list
101928412|NCT03787992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928413|NCT02434354|Pembrolizumab|pembrolizumab|mesh-list
101928414|NCT02434354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101928415|NCT02434354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101928416|NCT02434354|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101928417|NCT02434354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928418|NCT05764018|Caffeine|caffeine|mesh-list
101928419|NCT05764018|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101928420|NCT05764018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928421|NCT05764018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101928422|NCT05764018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101928423|NCT05764018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928424|NCT05764018|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101928425|NCT05764018|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101928426|NCT05764018|Purinergic Agents|purinergic agents|mesh-ancestor
101928427|NCT05764018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101928428|NCT01308528|Enoxaparin|enoxaparin|mesh-list
101928429|NCT01308528|Enoxaparin sodium|enoxaparin sodium|mesh-list
101928430|NCT01308528|Anticoagulants|anticoagulants|mesh-ancestor
101928431|NCT01308528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101928432|NCT01308528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101928433|NCT01308528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648280|NCT00788749|Hormones|hormones|mesh-ancestor
101648287|NCT00609752|Hormones|hormones|mesh-ancestor
101928434|NCT04839328|Hemay005|hemay005|mesh-list
101928435|NCT04839328|Dermatologic Agents|dermatologic agents|mesh-ancestor
101928436|NCT04839328|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101928437|NCT04839328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101928438|NCT04839328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101928439|NCT04839328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928440|NCT03785496|Spartalizumab|spartalizumab|mesh-list
101928441|NCT03785496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101928442|NCT03785496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928443|NCT03785496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101928444|NCT03785496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101928445|NCT01307202|Gabapentin|gabapentin|mesh-list
101928446|NCT01307202|Analgesics|analgesics|mesh-ancestor
101231751|NCT01840592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101928447|NCT01307202|Sensory System Agents|sensory system agents|mesh-ancestor
101928448|NCT01307202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101928449|NCT01307202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928450|NCT01307202|Anticonvulsants|anticonvulsants|mesh-ancestor
101928451|NCT01307202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101928452|NCT01307202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101928453|NCT01307202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101928454|NCT01307202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101928455|NCT01307202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101928456|NCT01307202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101928457|NCT01307202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101928458|NCT01307202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928459|NCT01307202|Antimanic Agents|antimanic agents|mesh-ancestor
101928460|NCT04294576|Pembrolizumab|pembrolizumab|mesh-list
101928461|NCT04294576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101928462|NCT04294576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101928463|NCT04294576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101928464|NCT04294576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928465|NCT01308606|Simeprevir|simeprevir|mesh-list
101928466|NCT01308606|Antiviral Agents|antiviral agents|mesh-ancestor
101928467|NCT01308606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101928468|NCT01308606|Protease Inhibitors|protease inhibitors|mesh-ancestor
101928469|NCT01308606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101928470|NCT01308606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928471|NCT04637386|Anesthetics|anesthetics|mesh-list
101928472|NCT04637386|Anesthetics, Local|anesthetics, local|mesh-list
101928473|NCT04637386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101928474|NCT04637386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928475|NCT04637386|Sensory System Agents|sensory system agents|mesh-ancestor
101928476|NCT04637386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101928477|NCT01308684|Bevacizumab|bevacizumab|mesh-list
101928478|NCT01308684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101928480|NCT01308684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101928481|NCT01308684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101928482|NCT01308684|Growth Substances|growth substances|mesh-ancestor
101928483|NCT01308684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928484|NCT01308684|Growth Inhibitors|growth inhibitors|mesh-ancestor
101928485|NCT05613114|4-Aminopyridine|4-aminopyridine|mesh-list
101928486|NCT05613114|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101928487|NCT05613114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101928488|NCT05613114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928489|NCT03790566|Bupivacaine|bupivacaine|mesh-list
101928490|NCT03790566|Anesthetics, Local|anesthetics, local|mesh-ancestor
101928491|NCT03790566|Anesthetics|anesthetics|mesh-ancestor
101928492|NCT03790566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101928493|NCT03790566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928494|NCT03790566|Sensory System Agents|sensory system agents|mesh-ancestor
101928495|NCT03790566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101928496|NCT04436224|Fentanyl|fentanyl|mesh-list
101928497|NCT04436224|Hydromorphone|hydromorphone|mesh-list
101928498|NCT04436224|Butorphanol|butorphanol|mesh-list
101928499|NCT04436224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101928500|NCT04436224|Narcotics|narcotics|mesh-ancestor
101928501|NCT04436224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101928502|NCT04436224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928503|NCT04436224|Analgesics|analgesics|mesh-ancestor
101928504|NCT04436224|Sensory System Agents|sensory system agents|mesh-ancestor
101928505|NCT04436224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101928506|NCT04436224|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101648356|NCT00996281|Olmesartan|olmesartan|mesh-list
101928507|NCT04436224|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101928508|NCT04436224|Anesthetics, General|anesthetics, general|mesh-ancestor
101928510|NCT04436224|Antitussive Agents|antitussive agents|mesh-ancestor
101928511|NCT04436224|Respiratory System Agents|respiratory system agents|mesh-ancestor
101928512|NCT04436224|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101928513|NCT03785184|Dexamethasone|dexamethasone|mesh-list
101928514|NCT03785184|Lenalidomide|lenalidomide|mesh-list
101928515|NCT03785184|Venetoclax|venetoclax|mesh-list
101928516|NCT03785184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101928517|NCT03785184|Antiemetics|antiemetics|mesh-ancestor
101928518|NCT03785184|Autonomic Agents|autonomic agents|mesh-ancestor
101928519|NCT03785184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101928520|NCT03785184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928521|NCT03785184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101928522|NCT03785184|Glucocorticoids|glucocorticoids|mesh-ancestor
101928523|NCT03785184|Hormones|hormones|mesh-ancestor
101928524|NCT03785184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101928525|NCT03785184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101928526|NCT03785184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101928527|NCT03785184|Immunologic Factors|immunologic factors|mesh-ancestor
101928528|NCT03785184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101928529|NCT03785184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101928530|NCT03785184|Growth Substances|growth substances|mesh-ancestor
101928531|NCT03785184|Growth Inhibitors|growth inhibitors|mesh-ancestor
101928532|NCT03784794|Thrombin|thrombin|mesh-list
101928533|NCT03784794|Hemostatics|hemostatics|mesh-ancestor
101928534|NCT03784794|Coagulants|coagulants|mesh-ancestor
101928535|NCT01378546|Amifampridine|amifampridine|mesh-list
101928536|NCT01378546|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101928537|NCT01378546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101928538|NCT01378546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928539|NCT01378546|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101928540|NCT01378546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101928541|NCT01378546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928542|NCT05688384|Alfentanil|alfentanil|mesh-list
101928543|NCT05688384|Propofol|propofol|mesh-list
101928544|NCT05688384|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101928545|NCT05688384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101928546|NCT05688384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928547|NCT05688384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101928548|NCT05688384|Anesthetics, General|anesthetics, general|mesh-ancestor
101928549|NCT05688384|Anesthetics|anesthetics|mesh-ancestor
101928550|NCT05688384|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101928551|NCT05688384|Narcotics|narcotics|mesh-ancestor
101928552|NCT05688384|Analgesics|analgesics|mesh-ancestor
101928553|NCT05688384|Sensory System Agents|sensory system agents|mesh-ancestor
101928554|NCT05688384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101928555|NCT01307592|Rituximab|rituximab|mesh-list
101928556|NCT01307592|Gemcitabine|gemcitabine|mesh-list
101928557|NCT01307592|Oxaliplatin|oxaliplatin|mesh-list
101928558|NCT01307592|Lenalidomide|lenalidomide|mesh-list
101928559|NCT01307592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101928560|NCT01307592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101928561|NCT01307592|Immunologic Factors|immunologic factors|mesh-ancestor
101928562|NCT01307592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928563|NCT01307592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101928564|NCT01307592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101928565|NCT01307592|Antimetabolites|antimetabolites|mesh-ancestor
101928566|NCT01307592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928567|NCT01307592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101928568|NCT01307592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101928569|NCT01307592|Growth Substances|growth substances|mesh-ancestor
101928570|NCT01307592|Growth Inhibitors|growth inhibitors|mesh-ancestor
101231797|NCT01251861|Hormone Antagonists|hormone antagonists|mesh-ancestor
101231798|NCT01251861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101231799|NCT01251861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231800|NCT01251861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101928571|NCT03790020|Bupivacaine|bupivacaine|mesh-list
101928572|NCT03790020|Anesthetics, Local|anesthetics, local|mesh-ancestor
101928573|NCT03790020|Anesthetics|anesthetics|mesh-ancestor
101928574|NCT03790020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101928575|NCT03790020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928576|NCT03790020|Sensory System Agents|sensory system agents|mesh-ancestor
101928577|NCT03790020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101928578|NCT03075826|Guadecitabine|guadecitabine|mesh-list
101928579|NCT03075826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101928580|NCT01378156|Vaccines|vaccines|mesh-list
101928581|NCT01378156|Immunologic Factors|immunologic factors|mesh-ancestor
101928582|NCT01378156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928583|NCT04108234|Ketamine|ketamine|mesh-list
101928584|NCT04108234|Analgesics|analgesics|mesh-ancestor
101928585|NCT04108234|Sensory System Agents|sensory system agents|mesh-ancestor
101928586|NCT04108234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101928587|NCT04108234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928588|NCT04108234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101928589|NCT04108234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101928590|NCT04108234|Anesthetics, General|anesthetics, general|mesh-ancestor
101928591|NCT04108234|Anesthetics|anesthetics|mesh-ancestor
101928592|NCT04108234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101928593|NCT04108234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101928594|NCT04108234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101928595|NCT04108234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101928596|NCT04108234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928597|NCT03687814|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101928598|NCT03687814|Laxatives|laxatives|mesh-ancestor
101928599|NCT03687814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101928600|NCT05763550|Pregabalin|pregabalin|mesh-list
101928601|NCT05763550|Analgesics|analgesics|mesh-ancestor
101928602|NCT05763550|Sensory System Agents|sensory system agents|mesh-ancestor
101928603|NCT05763550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101928604|NCT05763550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928605|NCT05763550|Anticonvulsants|anticonvulsants|mesh-ancestor
101928606|NCT05763550|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101928607|NCT05763550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101928608|NCT05763550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928609|NCT05763550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101928610|NCT05763550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101928611|NCT05763550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101928612|NCT05763550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101928613|NCT05763550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101928614|NCT03783936|Leucovorin|leucovorin|mesh-list
101928615|NCT03783936|Fluorouracil|fluorouracil|mesh-list
101928616|NCT03783936|Oxaliplatin|oxaliplatin|mesh-list
101928617|NCT03783936|Trastuzumab|trastuzumab|mesh-list
101928618|NCT03783936|Avelumab|avelumab|mesh-list
101928619|NCT03783936|Antimetabolites|antimetabolites|mesh-ancestor
101928620|NCT03783936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928621|NCT03783936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101928622|NCT03783936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101928623|NCT03783936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101928624|NCT03783936|Immunologic Factors|immunologic factors|mesh-ancestor
101928625|NCT03783936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928626|NCT03783936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101928627|NCT03783936|Antidotes|antidotes|mesh-ancestor
101928628|NCT03783936|Protective Agents|protective agents|mesh-ancestor
101928629|NCT03783936|Vitamin B Complex|vitamin b complex|mesh-ancestor
101928630|NCT03783936|Vitamins|vitamins|mesh-ancestor
101928631|NCT03783936|Micronutrients|micronutrients|mesh-ancestor
101928632|NCT03781908|Silver Nitrate|silver nitrate|mesh-list
101928633|NCT03781908|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101928634|NCT03781908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101928635|NCT03781596|Fluticasone|fluticasone|mesh-list
101475472|NCT00301002|Alefacept|alefacept|mesh-list
101928636|NCT03781596|Omeprazole|omeprazole|mesh-list
101928637|NCT03781596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101928638|NCT03781596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101928639|NCT03781596|Autonomic Agents|autonomic agents|mesh-ancestor
101928640|NCT03781596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101928641|NCT03781596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928642|NCT03781596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101928643|NCT03781596|Respiratory System Agents|respiratory system agents|mesh-ancestor
101928644|NCT03781596|Dermatologic Agents|dermatologic agents|mesh-ancestor
101928645|NCT03781596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101928646|NCT03781596|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101928647|NCT03781596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101928648|NCT03781596|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101928649|NCT03781596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101928650|NCT03781596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928651|NCT03781674|Progesterone|progesterone|mesh-list
101928652|NCT03781674|Progestins|progestins|mesh-ancestor
101928653|NCT03781674|Hormones|hormones|mesh-ancestor
101928654|NCT03781674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101928655|NCT03781674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928656|NCT03786120|Zolpidem|zolpidem|mesh-list
101928657|NCT03786120|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101648505|NCT00800761|Siderophores|siderophores|mesh-ancestor
101928658|NCT03786120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101928659|NCT03786120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101928660|NCT03786120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928661|NCT03786120|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101928662|NCT03786120|GABA Agonists|gaba agonists|mesh-ancestor
101928664|NCT03786120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101928665|NCT03786120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928666|NCT01561014|Fluorouracil|fluorouracil|mesh-list
101928667|NCT01561014|Oxaliplatin|oxaliplatin|mesh-list
101928668|NCT01561014|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101928669|NCT01561014|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101928670|NCT01561014|Antimetabolites|antimetabolites|mesh-ancestor
101928671|NCT01561014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928672|NCT01561014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101928673|NCT01561014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101928674|NCT01561014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101928675|NCT01561014|Immunologic Factors|immunologic factors|mesh-ancestor
101928676|NCT01561014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928677|NCT01561014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101928678|NCT01561014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101928679|NCT01561014|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101928680|NCT01561092|Escitalopram|escitalopram|mesh-list
101928681|NCT01561092|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101928682|NCT01561092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101928683|NCT01561092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101928684|NCT01561092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928685|NCT01561092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101928686|NCT01561092|Serotonin Agents|serotonin agents|mesh-ancestor
101928687|NCT01561092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928688|NCT05494866|Cobicistat|cobicistat|mesh-list
101928689|NCT05494866|Paclitaxel|paclitaxel|mesh-list
101928690|NCT05494866|Gemcitabine|gemcitabine|mesh-list
101928691|NCT05494866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101928692|NCT05494866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101928693|NCT05494866|Tubulin Modulators|tubulin modulators|mesh-ancestor
101928694|NCT05494866|Antimitotic Agents|antimitotic agents|mesh-ancestor
101928695|NCT05494866|Mitosis Modulators|mitosis modulators|mesh-ancestor
101958354|NCT00175877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101928696|NCT05494866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928697|NCT05494866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101928698|NCT05494866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101928699|NCT05494866|Antiviral Agents|antiviral agents|mesh-ancestor
101928700|NCT05494866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101928701|NCT05494866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101928702|NCT05494866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101231822|NCT00843882|Lenalidomide|lenalidomide|mesh-list
101231823|NCT00843882|Epoetin Alfa|epoetin alfa|mesh-list
101928703|NCT05494866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101928704|NCT05494866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101928705|NCT05494866|Antimetabolites|antimetabolites|mesh-ancestor
101928706|NCT01316874|Valrubicin|valrubicin|mesh-list
101928707|NCT01316874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101928708|NCT01316874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101928709|NCT01316874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101928710|NCT01316874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101928711|NCT01316874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928712|NCT01309542|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101928713|NCT01309542|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101928714|NCT01309542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101928715|NCT01309542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101928716|NCT01309542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928717|NCT01309542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101928718|NCT01309542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928719|NCT01309542|Antidepressive Agents|antidepressive agents|mesh-ancestor
101928720|NCT01309542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101928722|NCT01309620|Trace Elements|trace elements|mesh-ancestor
101928723|NCT01309620|Micronutrients|micronutrients|mesh-ancestor
101928724|NCT01309620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928725|NCT03783312|Acetaminophen|acetaminophen|mesh-list
101928726|NCT03783312|Ibuprofen|ibuprofen|mesh-list
101928727|NCT03783312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101928728|NCT03783312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101928729|NCT03783312|Analgesics|analgesics|mesh-ancestor
101928730|NCT03783312|Sensory System Agents|sensory system agents|mesh-ancestor
101928731|NCT03783312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101648579|NCT00676845|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101928732|NCT03783312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928733|NCT03783312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101928734|NCT03783312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101928735|NCT03783312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101928736|NCT03783312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101928737|NCT03783312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928739|NCT03776916|Simethicone|simethicone|mesh-list
101928740|NCT03776916|Antifoaming Agents|antifoaming agents|mesh-ancestor
101928741|NCT03776916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928742|NCT03776916|Emollients|emollients|mesh-ancestor
101928743|NCT03776916|Dermatologic Agents|dermatologic agents|mesh-ancestor
101928744|NCT01560702|Epinephrine|epinephrine|mesh-list
101928745|NCT01560702|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101928746|NCT01560702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101928747|NCT01560702|Adrenergic Agents|adrenergic agents|mesh-ancestor
101928748|NCT01560702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101928749|NCT01560702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928750|NCT01560702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928751|NCT01560702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101928752|NCT01560702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101928753|NCT01560702|Autonomic Agents|autonomic agents|mesh-ancestor
101928754|NCT01560702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101928755|NCT01560702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101928756|NCT01560702|Respiratory System Agents|respiratory system agents|mesh-ancestor
101928757|NCT01560702|Mydriatics|mydriatics|mesh-ancestor
101928758|NCT01560702|Sympathomimetics|sympathomimetics|mesh-ancestor
101928759|NCT01560702|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101928760|NCT03776838|Fentanyl|fentanyl|mesh-list
101928761|NCT03776838|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101928762|NCT03776838|Narcotics|narcotics|mesh-ancestor
101928763|NCT03776838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101928764|NCT03776838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928765|NCT03776838|Analgesics|analgesics|mesh-ancestor
101958359|NCT02117362|Ipilimumab|ipilimumab|mesh-list
101928766|NCT03776838|Sensory System Agents|sensory system agents|mesh-ancestor
101928767|NCT03776838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101928768|NCT03776838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101928769|NCT03776838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101928770|NCT03776838|Anesthetics, General|anesthetics, general|mesh-ancestor
101928771|NCT03776838|Anesthetics|anesthetics|mesh-ancestor
101928772|NCT03781050|Sirolimus|sirolimus|mesh-list
101928773|NCT03781050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101928774|NCT03781050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101928775|NCT03781050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101928776|NCT03781050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101928777|NCT03781050|Antifungal Agents|antifungal agents|mesh-ancestor
101928778|NCT03781050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101928779|NCT03781050|Immunologic Factors|immunologic factors|mesh-ancestor
101928780|NCT03781050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928781|NCT02865850|Darbepoetin alfa|darbepoetin alfa|mesh-list
101928782|NCT02865850|Hematinics|hematinics|mesh-ancestor
101928783|NCT01309698|Inositol|inositol|mesh-list
101928784|NCT01309698|Vildagliptin|vildagliptin|mesh-list
101928785|NCT01309698|Voglibose|voglibose|mesh-list
101928786|NCT01309698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101928787|NCT01309698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928788|NCT01309698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101928789|NCT01309698|Protease Inhibitors|protease inhibitors|mesh-ancestor
101928790|NCT01309698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101928791|NCT01309698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928792|NCT01309698|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101928793|NCT01309698|Vitamin B Complex|vitamin b complex|mesh-ancestor
101928794|NCT01309698|Vitamins|vitamins|mesh-ancestor
101928795|NCT01309698|Micronutrients|micronutrients|mesh-ancestor
101928796|NCT01142284|Cilostazol|cilostazol|mesh-list
101928797|NCT01142284|Probucol|probucol|mesh-list
101928798|NCT01142284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101928799|NCT01142284|Autonomic Agents|autonomic agents|mesh-ancestor
101928800|NCT01142284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101928801|NCT01142284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928802|NCT01142284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101928803|NCT01142284|Respiratory System Agents|respiratory system agents|mesh-ancestor
101928804|NCT01142284|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101928805|NCT01142284|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101928806|NCT01142284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648662|NCT04031703|Antimetabolites|antimetabolites|mesh-ancestor
101928807|NCT01142284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101928808|NCT01142284|Vasodilator Agents|vasodilator agents|mesh-ancestor
101928809|NCT01142284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101928810|NCT01142284|Protective Agents|protective agents|mesh-ancestor
101928811|NCT01142284|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101928812|NCT01142284|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101928813|NCT01142284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101928814|NCT01142284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101928815|NCT01142284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101928816|NCT01142284|Antimetabolites|antimetabolites|mesh-ancestor
101928817|NCT01142284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101928818|NCT01142284|Antioxidants|antioxidants|mesh-ancestor
101928819|NCT01309776|Tianeptine|tianeptine|mesh-list
101928820|NCT01309776|Escitalopram|escitalopram|mesh-list
101928821|NCT01309776|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101928822|NCT01309776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101928823|NCT01309776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101928824|NCT01309776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928825|NCT01309776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101928826|NCT01309776|Serotonin Agents|serotonin agents|mesh-ancestor
101928827|NCT01309776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928828|NCT01309776|Antidepressive Agents|antidepressive agents|mesh-ancestor
101928829|NCT01309776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101928830|NCT01309776|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101928831|NCT03783000|BI 425809|bi 425809|mesh-list
101928832|NCT03783000|Nootropic Agents|nootropic agents|mesh-ancestor
101928833|NCT01309854|Pioglitazone|pioglitazone|mesh-list
101928834|NCT01309854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101928835|NCT01309854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928836|NCT03780192|Sirolimus|sirolimus|mesh-list
101928837|NCT03780192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101928838|NCT03780192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101928839|NCT03780192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101928840|NCT03780192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101928841|NCT03780192|Antifungal Agents|antifungal agents|mesh-ancestor
101928842|NCT03780192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101928843|NCT03780192|Immunologic Factors|immunologic factors|mesh-ancestor
101928844|NCT03780192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928846|NCT05305560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101928847|NCT05305560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101928848|NCT03776448|Charcoal|charcoal|mesh-list
101928849|NCT03776448|Antidotes|antidotes|mesh-ancestor
101928850|NCT03776448|Protective Agents|protective agents|mesh-ancestor
101928851|NCT03776448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928852|NCT03780270|Fluorides|fluorides|mesh-list
101928853|NCT03780270|Fluorides, Topical|fluorides, topical|mesh-list
101928854|NCT03780270|Cariostatic Agents|cariostatic agents|mesh-ancestor
101928855|NCT03780270|Protective Agents|protective agents|mesh-ancestor
101928856|NCT03780270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928857|NCT03072160|Pembrolizumab|pembrolizumab|mesh-list
101928858|NCT03072160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101928859|NCT03072160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101928860|NCT03072160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101928861|NCT03072160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928862|NCT05517486|Bupivacaine|bupivacaine|mesh-list
101928863|NCT05517486|Anesthetics, Local|anesthetics, local|mesh-ancestor
101928864|NCT05517486|Anesthetics|anesthetics|mesh-ancestor
101928865|NCT05517486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101928866|NCT05517486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928867|NCT05517486|Sensory System Agents|sensory system agents|mesh-ancestor
101928868|NCT05517486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101928869|NCT01019356|Rosiglitazone|rosiglitazone|mesh-list
101928870|NCT01019356|Acarbose|acarbose|mesh-list
101928871|NCT01019356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101928872|NCT01019356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928873|NCT01019356|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101928874|NCT01019356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101928875|NCT01019356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928876|NCT01314066|Bevacizumab|bevacizumab|mesh-list
101928877|NCT01314066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101928878|NCT01314066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101928879|NCT01314066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101928880|NCT01314066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101928881|NCT01314066|Growth Substances|growth substances|mesh-ancestor
101928882|NCT01314066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928883|NCT01314066|Growth Inhibitors|growth inhibitors|mesh-ancestor
101928884|NCT01314300|Lidocaine|lidocaine|mesh-list
101928885|NCT01314300|Anesthetics, Local|anesthetics, local|mesh-ancestor
101928886|NCT01314300|Anesthetics|anesthetics|mesh-ancestor
101928887|NCT01314300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101928888|NCT01314300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928889|NCT01314300|Sensory System Agents|sensory system agents|mesh-ancestor
101928890|NCT01314300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101928891|NCT01314300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101928892|NCT01314300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101928893|NCT01314300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101928894|NCT01314300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101928895|NCT01314300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928896|NCT05762536|Docetaxel|docetaxel|mesh-list
101928897|NCT05762536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101928898|NCT05762536|Tubulin Modulators|tubulin modulators|mesh-ancestor
101928899|NCT05762536|Antimitotic Agents|antimitotic agents|mesh-ancestor
101928900|NCT05762536|Mitosis Modulators|mitosis modulators|mesh-ancestor
101928901|NCT05762536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928902|NCT03776058|Cinacalcet|cinacalcet|mesh-list
101928903|NCT03776058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101928904|NCT03776058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928905|NCT03776058|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101928906|NCT03776058|Hormone Antagonists|hormone antagonists|mesh-ancestor
101928907|NCT03776058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101928908|NCT05202496|Calcitriol|calcitriol|mesh-list
101928909|NCT05202496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101928911|NCT05202496|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101928912|NCT05202496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101928913|NCT05202496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928914|NCT05202496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101928915|NCT05202496|Vitamins|vitamins|mesh-ancestor
101928916|NCT05202496|Micronutrients|micronutrients|mesh-ancestor
101928917|NCT05202496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101928918|NCT03779568|Bupivacaine|bupivacaine|mesh-list
101928919|NCT03779568|Anesthetics, Local|anesthetics, local|mesh-ancestor
101928920|NCT03779568|Anesthetics|anesthetics|mesh-ancestor
101928921|NCT03779568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101928922|NCT03779568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928923|NCT03779568|Sensory System Agents|sensory system agents|mesh-ancestor
101928924|NCT03779568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101928925|NCT05201560|Fentanyl|fentanyl|mesh-list
101928926|NCT05201560|Butorphanol|butorphanol|mesh-list
101928927|NCT05201560|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101928928|NCT05201560|Narcotics|narcotics|mesh-ancestor
101928929|NCT05201560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101928930|NCT05201560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928931|NCT05201560|Analgesics|analgesics|mesh-ancestor
101928932|NCT05201560|Sensory System Agents|sensory system agents|mesh-ancestor
101928933|NCT05201560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101928934|NCT05201560|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101928935|NCT05201560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101928936|NCT05201560|Anesthetics, General|anesthetics, general|mesh-ancestor
101928937|NCT05201560|Anesthetics|anesthetics|mesh-ancestor
101928938|NCT05201560|Antitussive Agents|antitussive agents|mesh-ancestor
101928939|NCT05201560|Respiratory System Agents|respiratory system agents|mesh-ancestor
101928940|NCT05201560|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101928941|NCT05201326|Bevacizumab|bevacizumab|mesh-list
101928942|NCT05201326|Irinotecan|irinotecan|mesh-list
101928943|NCT05201326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101928944|NCT05201326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101928945|NCT05201326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101928946|NCT05201326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101231876|NCT00710424|Nabiximols|nabiximols|mesh-list
101928947|NCT05201326|Growth Substances|growth substances|mesh-ancestor
101928948|NCT05201326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928949|NCT05201326|Growth Inhibitors|growth inhibitors|mesh-ancestor
101928950|NCT05201326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101928951|NCT05201326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101928952|NCT05201326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101928953|NCT05201326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928954|NCT03775668|Enmetazobactam|enmetazobactam|mesh-list
101928955|NCT03775668|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101928956|NCT03775668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101928957|NCT03775668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648817|NCT00796081|Serotonin Agents|serotonin agents|mesh-ancestor
101928958|NCT03775668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101928959|NCT03775668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101617144|NCT00610584|Cetirizine|cetirizine|mesh-list
101928961|NCT01561404|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101928962|NCT01561404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101928963|NCT01561404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101928964|NCT01561404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928965|NCT01561404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101928966|NCT01561404|Immunologic Factors|immunologic factors|mesh-ancestor
101928967|NCT01561404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928968|NCT01561404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101928969|NCT03775590|Acetic Acid|acetic acid|mesh-list
101928970|NCT03775590|Retinol acetate|retinol acetate|mesh-list
101928971|NCT03775590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101928972|NCT03775590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101928973|NCT03775590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101928974|NCT03775590|Immunologic Factors|immunologic factors|mesh-ancestor
101928975|NCT03775590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928976|NCT03775590|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101928977|NCT03775590|Protective Agents|protective agents|mesh-ancestor
101928978|NCT03775590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101928979|NCT03775746|Rivaroxaban|rivaroxaban|mesh-list
101928980|NCT03775746|Clopidogrel|clopidogrel|mesh-list
101928981|NCT03775746|Ticagrelor|ticagrelor|mesh-list
101928982|NCT03775746|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101928983|NCT03775746|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101928984|NCT03775746|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101928986|NCT03775746|Purinergic Agents|purinergic agents|mesh-ancestor
101928987|NCT03775746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101928988|NCT03775746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101928989|NCT03775746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101928990|NCT03775746|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101928991|NCT03775746|Antithrombins|antithrombins|mesh-ancestor
101928992|NCT03775746|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101928993|NCT03775746|Protease Inhibitors|protease inhibitors|mesh-ancestor
101928994|NCT03775746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101928995|NCT03775746|Anticoagulants|anticoagulants|mesh-ancestor
101928996|NCT03779178|Landiolol|landiolol|mesh-list
101928997|NCT03779178|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101928998|NCT03779178|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101928999|NCT03779178|Adrenergic Agents|adrenergic agents|mesh-ancestor
101929000|NCT03779178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101929001|NCT03779178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929002|NCT03779178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231889|NCT00026312|Tretinoin|tretinoin|mesh-list
101929003|NCT03779178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101929004|NCT03779100|Lenvatinib|lenvatinib|mesh-list
101929005|NCT03779100|Antibodies|antibodies|mesh-list
101929006|NCT03779100|Immunoglobulins|immunoglobulins|mesh-list
101929007|NCT03779100|Immunologic Factors|immunologic factors|mesh-ancestor
101929008|NCT03779100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929009|NCT03779100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101929010|NCT03779100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101929011|NCT03779100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101929012|NCT03779100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929013|NCT05711212|Xanthohumol|xanthohumol|mesh-list
101929014|NCT05711212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101929015|NCT05711212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101929016|NCT05711212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101929017|NCT05711212|Growth Substances|growth substances|mesh-ancestor
101929018|NCT05711212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929019|NCT05711212|Growth Inhibitors|growth inhibitors|mesh-ancestor
101929020|NCT05212636|Antidepressive Agents|antidepressive agents|mesh-list
101929021|NCT05212636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101929022|NCT03773094|Chlorhexidine|chlorhexidine|mesh-list
101929023|NCT03773094|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101929024|NCT03773094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101929025|NCT03773094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101929026|NCT03773094|Disinfectants|disinfectants|mesh-ancestor
101929027|NCT03773094|Dermatologic Agents|dermatologic agents|mesh-ancestor
101929028|NCT03775356|Anesthetics|anesthetics|mesh-list
101929029|NCT03775356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101929030|NCT03775356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929031|NCT05211622|Thioctic Acid|thioctic acid|mesh-list
101929032|NCT05211622|Chlorhexidine|chlorhexidine|mesh-list
101929033|NCT05211622|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101929034|NCT05211622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101929035|NCT05211622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101929036|NCT05211622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101929037|NCT05211622|Disinfectants|disinfectants|mesh-ancestor
101929038|NCT05211622|Dermatologic Agents|dermatologic agents|mesh-ancestor
101929039|NCT05211622|Antioxidants|antioxidants|mesh-ancestor
101929040|NCT05211622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929041|NCT05211622|Protective Agents|protective agents|mesh-ancestor
101929042|NCT05211622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929043|NCT05211622|Vitamin B Complex|vitamin b complex|mesh-ancestor
101929045|NCT05211622|Micronutrients|micronutrients|mesh-ancestor
101929046|NCT05705518|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101929047|NCT05705518|Lubricant Eye Drops|lubricant eye drops|mesh-list
101929048|NCT05705518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101929050|NCT05191264|Sensory System Agents|sensory system agents|mesh-ancestor
101929051|NCT05191264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101929052|NCT05191264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929053|NCT03778008|Vitamin B 12|vitamin b 12|mesh-list
101929054|NCT03778008|Gentamicins|gentamicins|mesh-list
101929055|NCT03778008|Dexamethasone|dexamethasone|mesh-list
101929056|NCT03778008|Lidocaine|lidocaine|mesh-list
101929057|NCT03778008|Mitogens|mitogens|mesh-list
101929058|NCT03778008|Vitamins|vitamins|mesh-ancestor
101929059|NCT03778008|Micronutrients|micronutrients|mesh-ancestor
101929060|NCT03778008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929061|NCT03778008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101929062|NCT03778008|Antiemetics|antiemetics|mesh-ancestor
101929063|NCT03778008|Autonomic Agents|autonomic agents|mesh-ancestor
101929064|NCT03778008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101929065|NCT03778008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101929066|NCT03778008|Glucocorticoids|glucocorticoids|mesh-ancestor
101929067|NCT03778008|Hormones|hormones|mesh-ancestor
101929068|NCT03778008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101929069|NCT03778008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101929070|NCT03778008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101929071|NCT03778008|Anesthetics, Local|anesthetics, local|mesh-ancestor
101929072|NCT03778008|Anesthetics|anesthetics|mesh-ancestor
101929073|NCT03778008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101929074|NCT03778008|Sensory System Agents|sensory system agents|mesh-ancestor
101929075|NCT03778008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101929076|NCT03778008|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101929077|NCT03778008|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101929078|NCT03778008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101929079|NCT03778008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929080|NCT03778008|Mitosis Modulators|mitosis modulators|mesh-ancestor
101929081|NCT03778008|Vitamin B Complex|vitamin b complex|mesh-ancestor
101929082|NCT03778008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101929083|NCT03778008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101929084|NCT03778008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101929085|NCT03778008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101929086|NCT05697328|Pseudoephedrine|pseudoephedrine|mesh-list
101929087|NCT05697328|Ephedrine|ephedrine|mesh-list
101929088|NCT05697328|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101929089|NCT05697328|Autonomic Agents|autonomic agents|mesh-ancestor
101929090|NCT05697328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101929091|NCT05697328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929092|NCT05697328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101929093|NCT05697328|Respiratory System Agents|respiratory system agents|mesh-ancestor
101929094|NCT05697328|Nasal Decongestants|nasal decongestants|mesh-ancestor
101929095|NCT05697328|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101929096|NCT05697328|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101929097|NCT05697328|Sympathomimetics|sympathomimetics|mesh-ancestor
101929098|NCT05697328|Adrenergic Agents|adrenergic agents|mesh-ancestor
101929099|NCT05697328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101929100|NCT05697328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929101|NCT03777930|Thalidomide|thalidomide|mesh-list
101929102|NCT03777930|Megestrol|megestrol|mesh-list
101929103|NCT03777930|Megestrol Acetate|megestrol acetate|mesh-list
101929104|NCT03777930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101648950|NCT02868827|Vitamin D|vitamin d|mesh-list
101929105|NCT03777930|Immunologic Factors|immunologic factors|mesh-ancestor
101929106|NCT03777930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929107|NCT03777930|Leprostatic Agents|leprostatic agents|mesh-ancestor
101929108|NCT03777930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101929109|NCT03777930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101291600|NCT01956591|Oxybutynin|oxybutynin|mesh-list
101929110|NCT03777930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101929111|NCT03777930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101929113|NCT03777930|Growth Inhibitors|growth inhibitors|mesh-ancestor
101929114|NCT03777930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101929115|NCT03777930|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101929116|NCT03777930|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101929117|NCT03777930|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101929118|NCT03777930|Contraceptive Agents|contraceptive agents|mesh-ancestor
101929119|NCT03777930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101929120|NCT03777930|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101929121|NCT03777930|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101929122|NCT03777930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101929123|NCT03777930|Appetite Stimulants|appetite stimulants|mesh-ancestor
101929124|NCT03777930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101929126|NCT03777696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101929127|NCT03777696|Abortifacient Agents|abortifacient agents|mesh-ancestor
101929128|NCT03777696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101929129|NCT03777696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929130|NCT03777696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101929131|NCT03777696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101929132|NCT03777696|Oxytocics|oxytocics|mesh-ancestor
101929134|NCT04581148|Immunoglobulins|immunoglobulins|mesh-list
101929135|NCT04581148|Immunologic Factors|immunologic factors|mesh-ancestor
101929136|NCT04581148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929137|NCT03708744|Oxazolidinones|oxazolidinones|mesh-list
101929138|NCT03708744|Zolmitriptan|zolmitriptan|mesh-list
101929139|NCT03708744|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101929140|NCT03708744|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101929141|NCT03708744|Serotonin Agents|serotonin agents|mesh-ancestor
101929142|NCT03708744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101929143|NCT03708744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929144|NCT03708744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929145|NCT03708744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101929146|NCT03708744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101929147|NCT03708744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101929148|NCT03774108|Metformin|metformin|mesh-list
101929149|NCT03774108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101929150|NCT03774108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929151|NCT03438526|Melatonin|melatonin|mesh-list
101929152|NCT03438526|Antioxidants|antioxidants|mesh-ancestor
101929153|NCT03438526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929154|NCT03438526|Protective Agents|protective agents|mesh-ancestor
101929155|NCT03438526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929156|NCT03438526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101929157|NCT02575144|Clarithromycin|clarithromycin|mesh-list
101929158|NCT02575144|Dexamethasone|dexamethasone|mesh-list
101929159|NCT02575144|Lenalidomide|lenalidomide|mesh-list
101929160|NCT02575144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101929161|NCT02575144|Antiemetics|antiemetics|mesh-ancestor
101929162|NCT02575144|Autonomic Agents|autonomic agents|mesh-ancestor
101929163|NCT02575144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101929164|NCT02575144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929165|NCT02575144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101929166|NCT02575144|Glucocorticoids|glucocorticoids|mesh-ancestor
101929167|NCT02575144|Hormones|hormones|mesh-ancestor
101929168|NCT02575144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101929169|NCT02575144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101929170|NCT02575144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101929171|NCT02575144|Immunologic Factors|immunologic factors|mesh-ancestor
101929172|NCT02575144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101929173|NCT02575144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101929174|NCT02575144|Growth Substances|growth substances|mesh-ancestor
101929175|NCT02575144|Growth Inhibitors|growth inhibitors|mesh-ancestor
101929176|NCT02575144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101929177|NCT02575144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101929178|NCT02575144|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101929179|NCT02575144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101929180|NCT02575144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929181|NCT02575144|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101929182|NCT02575144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101929183|NCT03768882|Acetaminophen|acetaminophen|mesh-list
101929184|NCT03768882|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
101241550|NCT01629394|Neostigmine|neostigmine|mesh-list
101929185|NCT03768882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101929186|NCT03768882|Analgesics|analgesics|mesh-ancestor
101929187|NCT03768882|Sensory System Agents|sensory system agents|mesh-ancestor
101929188|NCT03768882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101231935|NCT01556737|Genistein|genistein|mesh-list
101929189|NCT03768882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929190|NCT03768882|Antipyretics|antipyretics|mesh-ancestor
101929191|NCT03768882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101929192|NCT03768882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101929193|NCT03768882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101929194|NCT02574286|Vitamin D|vitamin d|mesh-list
101929195|NCT02574286|Vitamins|vitamins|mesh-ancestor
101929196|NCT02574286|Micronutrients|micronutrients|mesh-ancestor
101929197|NCT02574286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929198|NCT02574286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101929199|NCT01321944|Nicotine|nicotine|mesh-list
101929200|NCT01321944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101929201|NCT01321944|Autonomic Agents|autonomic agents|mesh-ancestor
101929202|NCT01321944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101929203|NCT01321944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929204|NCT01321944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101929205|NCT01321944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101929206|NCT01321944|Cholinergic Agents|cholinergic agents|mesh-ancestor
101929207|NCT01321944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101929208|NCT01321944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929209|NCT03771846|Leucovorin|leucovorin|mesh-list
101929210|NCT03771846|Gemcitabine|gemcitabine|mesh-list
101929211|NCT03771846|Fluorouracil|fluorouracil|mesh-list
101929212|NCT03771846|Oxaliplatin|oxaliplatin|mesh-list
101929213|NCT03771846|Irinotecan|irinotecan|mesh-list
101929214|NCT03771846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101929215|NCT03771846|Antimetabolites|antimetabolites|mesh-ancestor
101929216|NCT03771846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929217|NCT03771846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101929218|NCT03771846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101929219|NCT03771846|Immunologic Factors|immunologic factors|mesh-ancestor
101929220|NCT03771846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929221|NCT03771846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101929222|NCT03771846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101929223|NCT03771846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101929224|NCT03771846|Antidotes|antidotes|mesh-ancestor
101929225|NCT03771846|Protective Agents|protective agents|mesh-ancestor
101929226|NCT03771846|Vitamin B Complex|vitamin b complex|mesh-ancestor
101929227|NCT03771846|Vitamins|vitamins|mesh-ancestor
101929228|NCT03771846|Micronutrients|micronutrients|mesh-ancestor
101929229|NCT03763110|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101929230|NCT03763110|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101929231|NCT03763110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101929232|NCT03763110|Antitubercular Agents|antitubercular agents|mesh-ancestor
101929233|NCT03771768|Triamcinolone|triamcinolone|mesh-list
101929234|NCT03771768|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101929235|NCT03771768|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101929236|NCT03771768|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101929237|NCT03771768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101929238|NCT03771768|Glucocorticoids|glucocorticoids|mesh-ancestor
101929239|NCT03771768|Hormones|hormones|mesh-ancestor
101929240|NCT03771768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101929241|NCT03771768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929242|NCT03771768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101929243|NCT03771768|Immunologic Factors|immunologic factors|mesh-ancestor
101929244|NCT03771768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101929245|NCT03771768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929246|NCT04393350|Pembrolizumab|pembrolizumab|mesh-list
101929247|NCT04393350|Lenvatinib|lenvatinib|mesh-list
101929248|NCT04393350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101929249|NCT04393350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101929250|NCT04393350|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101231957|NCT01556815|Hormones|hormones|mesh-ancestor
101929251|NCT04393350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929252|NCT04393350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101929253|NCT04393350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101929254|NCT03768258|Methyltestosterone|methyltestosterone|mesh-list
101929255|NCT03768258|Anastrozole|anastrozole|mesh-list
101929256|NCT03768258|Testosterone|testosterone|mesh-list
101929257|NCT03768258|Testosterone undecanoate|testosterone undecanoate|mesh-list
101929258|NCT03768258|Testosterone enanthate|testosterone enanthate|mesh-list
101929259|NCT03768258|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101929261|NCT03768258|Hormones|hormones|mesh-ancestor
101929262|NCT03768258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101929263|NCT03768258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929264|NCT03768258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101929265|NCT03768258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101929266|NCT03768258|Anabolic Agents|anabolic agents|mesh-ancestor
101929267|NCT03768258|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101929268|NCT03768258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101929269|NCT03768258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101929270|NCT03768258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929271|NCT03768258|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101929272|NCT03768258|Hormone Antagonists|hormone antagonists|mesh-ancestor
101929274|NCT03771222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101929275|NCT03771222|Antimetabolites|antimetabolites|mesh-ancestor
101929276|NCT03771222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929277|NCT03771222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101929278|NCT03771222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101929279|NCT03771066|Bisphenol A|bisphenol a|mesh-list
101929280|NCT03771066|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101929281|NCT03771066|Estrogens|estrogens|mesh-ancestor
101929282|NCT03771066|Hormones|hormones|mesh-ancestor
101929283|NCT03771066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101929284|NCT03771066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929285|NCT03771066|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101929286|NCT03771066|Antioxidants|antioxidants|mesh-ancestor
101929287|NCT03771066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929288|NCT03771066|Protective Agents|protective agents|mesh-ancestor
101929289|NCT04478838|Olanzapine|olanzapine|mesh-list
101929290|NCT04478838|Risperidone|risperidone|mesh-list
101929291|NCT04478838|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101929292|NCT04478838|Serotonin Agents|serotonin agents|mesh-ancestor
101929293|NCT04478838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101929294|NCT04478838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929295|NCT04478838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929296|NCT04478838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101929297|NCT04478838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101929298|NCT04478838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101929299|NCT04478838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101929300|NCT04478838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101929301|NCT04478838|Dopamine Agents|dopamine agents|mesh-ancestor
101929302|NCT04478838|Antiemetics|antiemetics|mesh-ancestor
101929303|NCT04478838|Autonomic Agents|autonomic agents|mesh-ancestor
101929304|NCT04478838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101929305|NCT04478838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101929306|NCT04478838|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101929307|NCT04478838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101929308|NCT04478838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101929309|NCT03768024|Hydromorphone|hydromorphone|mesh-list
101929310|NCT03768024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101929311|NCT03768024|Narcotics|narcotics|mesh-ancestor
101929312|NCT03768024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101929313|NCT03768024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929314|NCT03768024|Analgesics|analgesics|mesh-ancestor
101929315|NCT03768024|Sensory System Agents|sensory system agents|mesh-ancestor
101929316|NCT03768024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101929317|NCT03999684|Tretinoin|tretinoin|mesh-list
101929318|NCT03999684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101929319|NCT03999684|Keratolytic Agents|keratolytic agents|mesh-ancestor
101929320|NCT03999684|Dermatologic Agents|dermatologic agents|mesh-ancestor
101929321|NCT02083354|Trametinib|trametinib|mesh-list
101929322|NCT02083354|Dabrafenib|dabrafenib|mesh-list
101929323|NCT02083354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101929324|NCT02083354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101929325|NCT02083354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101929326|NCT02083354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929327|NCT01399918|Bevacizumab|bevacizumab|mesh-list
101929328|NCT01399918|Everolimus|everolimus|mesh-list
101929329|NCT01399918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101929330|NCT01399918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101929331|NCT01399918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101929332|NCT01399918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101929333|NCT01399918|Growth Substances|growth substances|mesh-ancestor
101929335|NCT01399918|Growth Inhibitors|growth inhibitors|mesh-ancestor
101929336|NCT01399918|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101241695|NCT01630343|Acetaminophen|acetaminophen|mesh-list
101929337|NCT01399918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101929338|NCT01399918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101929339|NCT01399918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929340|NCT01399918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101929341|NCT01399918|Immunologic Factors|immunologic factors|mesh-ancestor
101929342|NCT03761472|Hyaluronic Acid|hyaluronic acid|mesh-list
101929343|NCT03761472|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101929344|NCT03761472|Immunologic Factors|immunologic factors|mesh-ancestor
101929345|NCT03761472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929346|NCT03761472|Viscosupplements|viscosupplements|mesh-ancestor
101929347|NCT03761472|Protective Agents|protective agents|mesh-ancestor
101929348|NCT03767322|Allopurinol|allopurinol|mesh-list
101929350|NCT03767322|Antimetabolites|antimetabolites|mesh-ancestor
101929351|NCT03767322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929352|NCT03767322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101929353|NCT03767322|Gout Suppressants|gout suppressants|mesh-ancestor
101929354|NCT03767322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101929355|NCT03767322|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101929356|NCT03767322|Antioxidants|antioxidants|mesh-ancestor
101929357|NCT03767322|Protective Agents|protective agents|mesh-ancestor
101929358|NCT03767322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929359|NCT03761004|Levodopa|levodopa|mesh-list
101929360|NCT03761004|Carbidopa|carbidopa|mesh-list
101929361|NCT03761004|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101929362|NCT03761004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101929363|NCT03761004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101929364|NCT03761004|Dopamine Agents|dopamine agents|mesh-ancestor
101929365|NCT03761004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101929366|NCT03761004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929367|NCT03761004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929368|NCT03761004|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101929369|NCT03761004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101929370|NCT03761004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101929371|NCT03761004|Immunologic Factors|immunologic factors|mesh-ancestor
101929372|NCT03761004|Dopamine Agonists|dopamine agonists|mesh-ancestor
101929373|NCT03770208|Lidocaine|lidocaine|mesh-list
101929374|NCT03770208|Anesthetics, Local|anesthetics, local|mesh-ancestor
101929375|NCT03770208|Anesthetics|anesthetics|mesh-ancestor
101929376|NCT03770208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101929377|NCT03770208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929378|NCT03770208|Sensory System Agents|sensory system agents|mesh-ancestor
101929379|NCT03770208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101929380|NCT03770208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101231977|NCT01557127|Sorafenib|sorafenib|mesh-list
101929381|NCT03770208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101929382|NCT03770208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101929383|NCT03770208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101929384|NCT03770208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929385|NCT03766854|Insulin|insulin|mesh-list
101929386|NCT03766854|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101929387|NCT03766854|Insulin Glargine|insulin glargine|mesh-list
101929388|NCT03766854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101929389|NCT03766854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929390|NCT01322100|Bleomycin|bleomycin|mesh-list
101929391|NCT01322100|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101929392|NCT01322100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101929393|NCT03760848|Midazolam|midazolam|mesh-list
101929394|NCT03760848|Atorvastatin|atorvastatin|mesh-list
101929395|NCT03760848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101929396|NCT03760848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101929397|NCT03760848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101929398|NCT03760848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929399|NCT03760848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101929400|NCT03760848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101929401|NCT03760848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101929402|NCT03760848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101929403|NCT03760848|Anesthetics, General|anesthetics, general|mesh-ancestor
101929404|NCT03760848|Anesthetics|anesthetics|mesh-ancestor
101929405|NCT03760848|GABA Modulators|gaba modulators|mesh-ancestor
101929406|NCT03760848|GABA Agents|gaba agents|mesh-ancestor
101929407|NCT03760848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101929408|NCT03760848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929409|NCT03760848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101929410|NCT03760848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101929411|NCT03760848|Antimetabolites|antimetabolites|mesh-ancestor
101929412|NCT03760848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101929413|NCT03760848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101929414|NCT03760848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101929415|NCT01567488|Everolimus|everolimus|mesh-list
101929416|NCT01567488|Octreotide|octreotide|mesh-list
101929417|NCT01567488|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101929418|NCT01567488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101929419|NCT01567488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101929420|NCT01567488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929421|NCT01567488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101929422|NCT01567488|Immunologic Factors|immunologic factors|mesh-ancestor
101929423|NCT01567488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929424|NCT01567488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101929425|NCT01567488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101929426|NCT01567488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101929427|NCT03760770|Riboflavin|riboflavin|mesh-list
101929428|NCT03760770|Vitamin B Complex|vitamin b complex|mesh-ancestor
101929429|NCT03760770|Vitamins|vitamins|mesh-ancestor
101929430|NCT03760770|Micronutrients|micronutrients|mesh-ancestor
101929431|NCT03760770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929432|NCT03760770|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101929433|NCT03760770|Dermatologic Agents|dermatologic agents|mesh-ancestor
101929434|NCT01561794|Ciprofloxacin|ciprofloxacin|mesh-list
101929435|NCT01561794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101929436|NCT01561794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101929437|NCT01561794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101929438|NCT01561794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101929439|NCT01561794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101929440|NCT01561794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929441|NCT01561794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101929442|NCT01561794|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101929443|NCT01561794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101929444|NCT01322178|Cetuximab|cetuximab|mesh-list
101929445|NCT01322178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101929446|NCT01322178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101929447|NCT03760614|Entinostat|entinostat|mesh-list
101929448|NCT03760614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101929449|NCT03760614|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101929450|NCT03760614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101929451|NCT03760614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929452|NCT00112840|Bevacizumab|bevacizumab|mesh-list
101929453|NCT00112840|Temsirolimus|temsirolimus|mesh-list
101929454|NCT00112840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101929455|NCT00112840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101929456|NCT00112840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101929457|NCT00112840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101929458|NCT00112840|Growth Substances|growth substances|mesh-ancestor
101929459|NCT00112840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929460|NCT00112840|Growth Inhibitors|growth inhibitors|mesh-ancestor
101929461|NCT00112840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101929462|NCT00112840|Immunologic Factors|immunologic factors|mesh-ancestor
101929463|NCT00112840|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101929464|NCT00112840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101929465|NCT00112840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101929466|NCT00112840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929467|NCT03769818|Dexamethasone|dexamethasone|mesh-list
101929468|NCT03769818|Dexamethasone acetate|dexamethasone acetate|mesh-list
101929469|NCT03769818|Bupivacaine|bupivacaine|mesh-list
101929470|NCT03769818|BB 1101|bb 1101|mesh-list
101929471|NCT03769818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101929472|NCT03769818|Antiemetics|antiemetics|mesh-ancestor
101929473|NCT03769818|Autonomic Agents|autonomic agents|mesh-ancestor
101929474|NCT03769818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101929475|NCT03769818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929476|NCT03769818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101929477|NCT03769818|Glucocorticoids|glucocorticoids|mesh-ancestor
101929478|NCT03769818|Hormones|hormones|mesh-ancestor
101929479|NCT03769818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101929480|NCT03769818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101929481|NCT03769818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101958395|NCT02117596|Sirolimus|sirolimus|mesh-list
101929484|NCT03769818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929485|NCT03769818|Anesthetics, Local|anesthetics, local|mesh-ancestor
101929486|NCT03769818|Anesthetics|anesthetics|mesh-ancestor
101929487|NCT03769818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101929488|NCT03769818|Sensory System Agents|sensory system agents|mesh-ancestor
101929489|NCT05223244|Triamcinolone|triamcinolone|mesh-list
101929490|NCT05223244|Heparin|heparin|mesh-list
101929491|NCT05223244|Bupivacaine|bupivacaine|mesh-list
101929492|NCT05223244|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
101929493|NCT05223244|Anesthetics, Local|anesthetics, local|mesh-ancestor
101929494|NCT05223244|Anesthetics|anesthetics|mesh-ancestor
101929495|NCT05223244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101929496|NCT05223244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929497|NCT05223244|Sensory System Agents|sensory system agents|mesh-ancestor
101929498|NCT05223244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101929499|NCT05223244|Anticoagulants|anticoagulants|mesh-ancestor
101929500|NCT05223244|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101929501|NCT05223244|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101929502|NCT05223244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929503|NCT05223244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101929504|NCT05223244|Glucocorticoids|glucocorticoids|mesh-ancestor
101929505|NCT05223244|Hormones|hormones|mesh-ancestor
101929506|NCT05223244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101929507|NCT05223244|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101929508|NCT05223244|Protective Agents|protective agents|mesh-ancestor
101929509|NCT05223244|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101929510|NCT05223244|Antioxidants|antioxidants|mesh-ancestor
101929511|NCT05223010|Sevoflurane|sevoflurane|mesh-list
101929512|NCT05223010|Melatonin|melatonin|mesh-list
101929513|NCT05223010|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101929514|NCT05223010|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101929515|NCT05223010|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101929516|NCT05223010|Anesthetics, General|anesthetics, general|mesh-ancestor
101929517|NCT05223010|Anesthetics|anesthetics|mesh-ancestor
101929518|NCT05223010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101929519|NCT05223010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929520|NCT05223010|Antioxidants|antioxidants|mesh-ancestor
101929521|NCT05223010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929522|NCT05223010|Protective Agents|protective agents|mesh-ancestor
101929523|NCT03760302|Analgesics|analgesics|mesh-list
101929524|NCT03760302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
101929525|NCT03760302|Sensory System Agents|sensory system agents|mesh-ancestor
101929526|NCT03760302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101929527|NCT03760302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929528|NCT03760302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101929529|NCT03766074|Vitamin D|vitamin d|mesh-list
101929530|NCT03766074|Vitamins|vitamins|mesh-ancestor
101929531|NCT03766074|Micronutrients|micronutrients|mesh-ancestor
101929532|NCT03766074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929533|NCT03766074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101929534|NCT05219656|Cyclosporine|cyclosporine|mesh-list
101929535|NCT05219656|Cyclosporins|cyclosporins|mesh-list
101929536|NCT05219656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101929537|NCT05219656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929538|NCT05219656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101929539|NCT05219656|Immunologic Factors|immunologic factors|mesh-ancestor
101929540|NCT05219656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929541|NCT05219656|Antifungal Agents|antifungal agents|mesh-ancestor
101929542|NCT05219656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101929543|NCT05219656|Dermatologic Agents|dermatologic agents|mesh-ancestor
101929544|NCT05219656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101929545|NCT05219656|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101929546|NCT05168644|Niclosamide|niclosamide|mesh-list
101929547|NCT05168644|Anticestodal Agents|anticestodal agents|mesh-ancestor
101929548|NCT05168644|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101929549|NCT05168644|Anthelmintics|anthelmintics|mesh-ancestor
101929550|NCT05168644|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101929551|NCT05168644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101929552|NCT05168644|Antinematodal Agents|antinematodal agents|mesh-ancestor
101929553|NCT05412888|Coenzyme Q10|coenzyme q10|mesh-list
101929554|NCT05412888|Ubiquinone|ubiquinone|mesh-list
101929555|NCT05412888|Vitamins|vitamins|mesh-ancestor
101929556|NCT05412888|Micronutrients|micronutrients|mesh-ancestor
101929557|NCT05412888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929558|NCT05558410|Acetaminophen|acetaminophen|mesh-list
101929559|NCT05558410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101929560|NCT05558410|Analgesics|analgesics|mesh-ancestor
101929561|NCT05558410|Sensory System Agents|sensory system agents|mesh-ancestor
101929562|NCT05558410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101649407|NCT00685971|Vitamin D|vitamin d|mesh-list
101929563|NCT05558410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929564|NCT05558410|Antipyretics|antipyretics|mesh-ancestor
101929565|NCT05087212|Plerixafor|plerixafor|mesh-list
101929566|NCT05087212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101929567|NCT05087212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101929568|NCT05087212|Antiviral Agents|antiviral agents|mesh-ancestor
101929569|NCT05087212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101929570|NCT01532310|Belimumab|belimumab|mesh-list
101929571|NCT01532310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101929572|NCT01532310|Immunologic Factors|immunologic factors|mesh-ancestor
101929573|NCT01532310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929574|NCT01321788|Tinzaparin|tinzaparin|mesh-list
101929575|NCT01321788|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101929576|NCT01321788|Dalteparin|dalteparin|mesh-list
101929577|NCT01321788|Anticoagulants|anticoagulants|mesh-ancestor
101929578|NCT01321788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101929579|NCT01321788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101929580|NCT01321788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929581|NCT05053828|Clopidogrel|clopidogrel|mesh-list
101929582|NCT05053828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
101929583|NCT05053828|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101929584|NCT05053828|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101929585|NCT05053828|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101929586|NCT05053828|Purinergic Agents|purinergic agents|mesh-ancestor
101929587|NCT05053828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101929588|NCT05053828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929589|NCT05053828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929590|NCT03120780|Fentanyl|fentanyl|mesh-list
101929591|NCT03120780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101929592|NCT03120780|Narcotics|narcotics|mesh-ancestor
101929593|NCT03120780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101929594|NCT03120780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929595|NCT03120780|Analgesics|analgesics|mesh-ancestor
101929596|NCT03120780|Sensory System Agents|sensory system agents|mesh-ancestor
101929597|NCT03120780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101929598|NCT03120780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101929599|NCT03120780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101929600|NCT03120780|Anesthetics, General|anesthetics, general|mesh-ancestor
101929601|NCT03120780|Anesthetics|anesthetics|mesh-ancestor
101929602|NCT04920838|Acetaminophen|acetaminophen|mesh-list
101929603|NCT04920838|Ciclesonide|ciclesonide|mesh-list
101929604|NCT04920838|Nitazoxanide|nitazoxanide|mesh-list
101929605|NCT04920838|Budesonide|budesonide|mesh-list
101929606|NCT04920838|Telmisartan|telmisartan|mesh-list
101929607|NCT04920838|Fluoxetine|fluoxetine|mesh-list
101929608|NCT04920838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101929609|NCT04920838|Analgesics|analgesics|mesh-ancestor
101929610|NCT04920838|Sensory System Agents|sensory system agents|mesh-ancestor
101929611|NCT04920838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101929612|NCT04920838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929613|NCT04920838|Antipyretics|antipyretics|mesh-ancestor
101929614|NCT04920838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101929615|NCT04920838|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101929616|NCT04920838|Autonomic Agents|autonomic agents|mesh-ancestor
101929617|NCT04920838|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101929618|NCT04920838|Respiratory System Agents|respiratory system agents|mesh-ancestor
101929619|NCT04920838|Glucocorticoids|glucocorticoids|mesh-ancestor
101929620|NCT04920838|Hormones|hormones|mesh-ancestor
101929621|NCT04920838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101929622|NCT04920838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101929623|NCT04920838|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101929624|NCT04920838|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101929625|NCT04920838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929626|NCT04920838|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101958404|NCT02117752|Dapsone|dapsone|mesh-list
101929627|NCT04920838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101929628|NCT04920838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101929629|NCT04920838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101929630|NCT04920838|Serotonin Agents|serotonin agents|mesh-ancestor
101929631|NCT04920838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101929632|NCT04920838|Antidepressive Agents|antidepressive agents|mesh-ancestor
101929633|NCT04920838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101929634|NCT04920838|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101929635|NCT04920838|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101929636|NCT04920838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101929637|NCT04920838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101929638|NCT04920838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101929639|NCT04920838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101929640|NCT03764280|Insulin|insulin|mesh-list
101929641|NCT03764280|Insulin, Short-Acting|insulin, short-acting|mesh-list
101929642|NCT03764280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101929643|NCT03764280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929644|NCT05133804|Methylphenidate|methylphenidate|mesh-list
101929646|NCT05133804|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101929647|NCT05133804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929648|NCT05133804|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101929649|NCT05133804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101929650|NCT05133804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101929651|NCT05133804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929652|NCT05133804|Dopamine Agents|dopamine agents|mesh-ancestor
101929653|NCT05133804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101929654|NCT05133804|Antidepressive Agents|antidepressive agents|mesh-ancestor
101929655|NCT05133804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101929656|NCT05133804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101929657|NCT05133804|Adrenergic Agents|adrenergic agents|mesh-ancestor
101929658|NCT03764202|Sufentanil|sufentanil|mesh-list
101929659|NCT03764202|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101929660|NCT03764202|Narcotics|narcotics|mesh-ancestor
101929661|NCT03764202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101929662|NCT03764202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929663|NCT03764202|Analgesics|analgesics|mesh-ancestor
101929664|NCT03764202|Sensory System Agents|sensory system agents|mesh-ancestor
101929665|NCT03764202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101929666|NCT03764202|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101929667|NCT03764202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101929668|NCT03764202|Anesthetics, General|anesthetics, general|mesh-ancestor
101929669|NCT03764202|Anesthetics|anesthetics|mesh-ancestor
101929670|NCT04678492|Amoxicillin|amoxicillin|mesh-list
101929671|NCT04678492|Tetracycline|tetracycline|mesh-list
101929672|NCT04678492|Furazolidone|furazolidone|mesh-list
101929673|NCT04678492|Esomeprazole|esomeprazole|mesh-list
101929674|NCT04678492|Bismuth|bismuth|mesh-list
101929675|NCT04678492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101929676|NCT04678492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101929677|NCT04678492|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101929678|NCT04678492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101929679|NCT04678492|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101929680|NCT04678492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101929681|NCT04678492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929682|NCT04678492|Antacids|antacids|mesh-ancestor
101929683|NCT04678492|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101929684|NCT04678492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101929685|NCT04678492|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101929686|NCT04678492|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
101929687|NCT04678492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101929688|NCT04678492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101929689|NCT04678492|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101929690|NCT03176784|Nicotine|nicotine|mesh-list
101929691|NCT03176784|Varenicline|varenicline|mesh-list
101929692|NCT03176784|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101929693|NCT03176784|Autonomic Agents|autonomic agents|mesh-ancestor
101929694|NCT03176784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101929695|NCT03176784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929696|NCT03176784|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101929697|NCT03176784|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101929698|NCT03176784|Cholinergic Agents|cholinergic agents|mesh-ancestor
101929699|NCT03176784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101929700|NCT03176784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929701|NCT05091528|Capecitabine|capecitabine|mesh-list
101929702|NCT05091528|Trastuzumab|trastuzumab|mesh-list
101929703|NCT05091528|Tucatinib|tucatinib|mesh-list
101929704|NCT05091528|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
101929705|NCT05091528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101929706|NCT05091528|Antimetabolites|antimetabolites|mesh-ancestor
101929707|NCT05091528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929708|NCT05091528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101929709|NCT05091528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101929710|NCT05091528|Immunoconjugates|immunoconjugates|mesh-ancestor
101929711|NCT05091528|Immunologic Factors|immunologic factors|mesh-ancestor
101929712|NCT05091528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929713|NCT05091528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101929714|NCT05091528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101929715|NCT04236258|Enalapril|enalapril|mesh-list
101649555|NCT00688857|Diazoxide|diazoxide|mesh-list
101929716|NCT04236258|Nifedipine|nifedipine|mesh-list
101929717|NCT04236258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101929718|NCT04236258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101929719|NCT04236258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929720|NCT04236258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101929721|NCT04236258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929723|NCT04236258|Tocolytic Agents|tocolytic agents|mesh-ancestor
101929724|NCT04236258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101929725|NCT04236258|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101929726|NCT04236258|Protease Inhibitors|protease inhibitors|mesh-ancestor
101929727|NCT04236258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101929728|NCT04236258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101929729|NCT01317004|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101929730|NCT01317004|Interferon beta-1b|interferon beta-1b|mesh-list
101929731|NCT01317004|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101929732|NCT01317004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929733|NCT01317004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101929734|NCT01317004|Immunologic Factors|immunologic factors|mesh-ancestor
101929735|NCT01317004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929736|NCT01317004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101929737|NCT03049618|Pembrolizumab|pembrolizumab|mesh-list
101929738|NCT03049618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101929739|NCT03049618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101929740|NCT03049618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101929741|NCT03049618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929742|NCT05536102|Doxorubicin|doxorubicin|mesh-list
101929743|NCT05536102|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101929744|NCT05536102|Capecitabine|capecitabine|mesh-list
101929745|NCT05536102|Oxaliplatin|oxaliplatin|mesh-list
101929746|NCT05536102|Tislelizumab|tislelizumab|mesh-list
101929747|NCT05536102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101929748|NCT05536102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101929749|NCT05536102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101929750|NCT05536102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101929751|NCT05536102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101929752|NCT05536102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929753|NCT05536102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101929754|NCT05536102|Antimetabolites|antimetabolites|mesh-ancestor
101929755|NCT05536102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101929756|NCT05524714|Xanthohumol|xanthohumol|mesh-list
101929757|NCT05524714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101929758|NCT05524714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101929759|NCT05524714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101929760|NCT05524714|Growth Substances|growth substances|mesh-ancestor
101929761|NCT05524714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929762|NCT05524714|Growth Inhibitors|growth inhibitors|mesh-ancestor
101929763|NCT05692804|Protein S|protein s|mesh-list
101929764|NCT05692804|Anticoagulants|anticoagulants|mesh-ancestor
101929765|NCT01316380|Tiotropium Bromide|tiotropium bromide|mesh-list
101929766|NCT01316380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101929767|NCT01316380|Autonomic Agents|autonomic agents|mesh-ancestor
101232048|NCT01557335|Antipyretics|antipyretics|mesh-ancestor
101929768|NCT01316380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101929769|NCT01316380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929770|NCT01316380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101929771|NCT01316380|Respiratory System Agents|respiratory system agents|mesh-ancestor
101929772|NCT01316380|Parasympatholytics|parasympatholytics|mesh-ancestor
101929773|NCT01316380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101929774|NCT01316380|Cholinergic Agents|cholinergic agents|mesh-ancestor
101929775|NCT01316380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101929776|NCT01316380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929777|NCT05692570|Ritonavir|ritonavir|mesh-list
101929778|NCT05692570|Cobicistat|cobicistat|mesh-list
101929779|NCT05692570|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101929780|NCT05692570|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101929781|NCT05692570|Protease Inhibitors|protease inhibitors|mesh-ancestor
101929782|NCT05692570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101929783|NCT05692570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929784|NCT05692570|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101929785|NCT05692570|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101929786|NCT05692570|Antiviral Agents|antiviral agents|mesh-ancestor
101929787|NCT05692570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101929788|NCT05692570|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101929789|NCT05692570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101929790|NCT05691556|Botulinum Toxins|botulinum toxins|mesh-list
101929791|NCT05691556|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101929792|NCT05691556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101929793|NCT05691556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929794|NCT05691556|Cholinergic Agents|cholinergic agents|mesh-ancestor
101929795|NCT05691556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101929796|NCT05691556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929797|NCT05689450|Amikacin|amikacin|mesh-list
101929798|NCT05689450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101929799|NCT05689450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101929800|NCT05417308|Minoxidil|minoxidil|mesh-list
101929801|NCT05417308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101929802|NCT05417308|Vasodilator Agents|vasodilator agents|mesh-ancestor
101929803|NCT04650542|Paroxetine|paroxetine|mesh-list
101929804|NCT04650542|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101929805|NCT04650542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101929806|NCT04650542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101929807|NCT04650542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929808|NCT04650542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101929809|NCT04650542|Serotonin Agents|serotonin agents|mesh-ancestor
101929810|NCT04650542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929811|NCT04650542|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101929812|NCT04650542|Antidepressive Agents|antidepressive agents|mesh-ancestor
101929813|NCT04650542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101929814|NCT04650542|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101929815|NCT04650542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101929816|NCT04650542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101929817|NCT04621058|Vitamin D|vitamin d|mesh-list
101929818|NCT04621058|Vitamins|vitamins|mesh-list
101929819|NCT04621058|Micronutrients|micronutrients|mesh-ancestor
101929820|NCT04621058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929821|NCT04621058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101929822|NCT04308668|Hydroxychloroquine|hydroxychloroquine|mesh-list
101929823|NCT04308668|Antimalarials|antimalarials|mesh-ancestor
101929824|NCT04308668|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101929825|NCT04308668|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101929826|NCT04308668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101929827|NCT04308668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101929828|NCT04308668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929829|NCT04308668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101929830|NCT04451330|Doxycycline|doxycycline|mesh-list
101929831|NCT04451330|Trifarotene|trifarotene|mesh-list
101242206|NCT01634061|Dactolisib|dactolisib|mesh-list
101929832|NCT04451330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101929833|NCT04451330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101929835|NCT04451330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101929836|NCT04451330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101929837|NCT04451330|Dermatologic Agents|dermatologic agents|mesh-ancestor
101929838|NCT02493426|Oxytocin|oxytocin|mesh-list
101929839|NCT02493426|Oxytocics|oxytocics|mesh-ancestor
101929840|NCT02493426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101929841|NCT02493426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929842|NCT03763734|Dexamethasone|dexamethasone|mesh-list
101929843|NCT03763734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101929844|NCT03763734|Antiemetics|antiemetics|mesh-ancestor
101929845|NCT03763734|Autonomic Agents|autonomic agents|mesh-ancestor
101929846|NCT03763734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101929847|NCT03763734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929848|NCT03763734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101929849|NCT03763734|Glucocorticoids|glucocorticoids|mesh-ancestor
101929850|NCT03763734|Hormones|hormones|mesh-ancestor
101929851|NCT03763734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101929852|NCT03763734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101929853|NCT03763734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101929854|NCT05063136|Capecitabine|capecitabine|mesh-list
101929855|NCT05063136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101929856|NCT05063136|Antimetabolites|antimetabolites|mesh-ancestor
101929857|NCT05063136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929858|NCT05063136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101929859|NCT03756324|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101929860|NCT03756324|Cefdinir|cefdinir|mesh-list
101929861|NCT03756324|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101929862|NCT03756324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101929863|NCT03756324|Antitubercular Agents|antitubercular agents|mesh-ancestor
101929864|NCT03751202|Fluticasone|fluticasone|mesh-list
101929865|NCT03751202|Xhance|xhance|mesh-list
101929866|NCT03751202|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101929867|NCT03751202|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101929868|NCT03751202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101929869|NCT03751202|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101929870|NCT03751202|Autonomic Agents|autonomic agents|mesh-ancestor
101929871|NCT03751202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101929872|NCT03751202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929873|NCT03751202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101929874|NCT03751202|Respiratory System Agents|respiratory system agents|mesh-ancestor
101929875|NCT03751202|Dermatologic Agents|dermatologic agents|mesh-ancestor
101929876|NCT03751202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101929877|NCT03751202|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101929878|NCT03751202|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101929879|NCT03751202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101929880|NCT03751202|Adrenergic Agents|adrenergic agents|mesh-ancestor
101929881|NCT03751202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101929882|NCT03751202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929883|NCT03751202|Glucocorticoids|glucocorticoids|mesh-ancestor
101929884|NCT03751202|Hormones|hormones|mesh-ancestor
101929885|NCT03751202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101929886|NCT03751202|Sympathomimetics|sympathomimetics|mesh-ancestor
101929887|NCT03749408|Mannitol|mannitol|mesh-list
101929888|NCT03749408|Bupivacaine|bupivacaine|mesh-list
101929889|NCT03749408|Anesthetics, Local|anesthetics, local|mesh-ancestor
101929890|NCT03749408|Anesthetics|anesthetics|mesh-ancestor
101929891|NCT03749408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101929892|NCT03749408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929893|NCT03749408|Sensory System Agents|sensory system agents|mesh-ancestor
101929894|NCT03749408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101929895|NCT03749408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101929896|NCT03749408|Diuretics|diuretics|mesh-ancestor
101929897|NCT03749408|Natriuretic Agents|natriuretic agents|mesh-ancestor
101929898|NCT04387136|Sufentanil|sufentanil|mesh-list
101929899|NCT04387136|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101929900|NCT04387136|Narcotics|narcotics|mesh-ancestor
101929901|NCT04387136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101929902|NCT04387136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242286|NCT01634438|Heparin|heparin|mesh-list
101929903|NCT04387136|Analgesics|analgesics|mesh-ancestor
101929904|NCT04387136|Sensory System Agents|sensory system agents|mesh-ancestor
101929905|NCT04387136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101929906|NCT04387136|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101929907|NCT04387136|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101929908|NCT04387136|Anesthetics, General|anesthetics, general|mesh-ancestor
101929909|NCT04387136|Anesthetics|anesthetics|mesh-ancestor
101929910|NCT04252586|Cannabidiol|cannabidiol|mesh-list
101929911|NCT04252586|Anticonvulsants|anticonvulsants|mesh-ancestor
101929912|NCT04507776|Etanercept|etanercept|mesh-list
101929913|NCT04507776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101929914|NCT04507776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101929915|NCT04507776|Analgesics|analgesics|mesh-ancestor
101929916|NCT04507776|Sensory System Agents|sensory system agents|mesh-ancestor
101929917|NCT04507776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101929918|NCT04507776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929919|NCT04507776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101929920|NCT04507776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101929921|NCT04507776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101929922|NCT04507776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101929923|NCT04507776|Immunologic Factors|immunologic factors|mesh-ancestor
101929924|NCT04504032|Rivaroxaban|rivaroxaban|mesh-list
101929925|NCT04504032|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101929926|NCT04504032|Antithrombins|antithrombins|mesh-ancestor
101929927|NCT04504032|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101929928|NCT04504032|Protease Inhibitors|protease inhibitors|mesh-ancestor
101929929|NCT04504032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101929930|NCT04504032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929931|NCT04504032|Anticoagulants|anticoagulants|mesh-ancestor
101929932|NCT03756246|Vaccines|vaccines|mesh-list
101929933|NCT03756246|Immunologic Factors|immunologic factors|mesh-ancestor
101929934|NCT03756246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929935|NCT05460858|Acetylcysteine|acetylcysteine|mesh-list
101929936|NCT05460858|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101929937|NCT05460858|Antiviral Agents|antiviral agents|mesh-ancestor
101929938|NCT05460858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101929939|NCT05460858|Expectorants|expectorants|mesh-ancestor
101929940|NCT05460858|Respiratory System Agents|respiratory system agents|mesh-ancestor
101929941|NCT05460858|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101929942|NCT05460858|Antioxidants|antioxidants|mesh-ancestor
101929943|NCT05460858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929944|NCT05460858|Protective Agents|protective agents|mesh-ancestor
101929945|NCT05460858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929946|NCT05460858|Antidotes|antidotes|mesh-ancestor
101929947|NCT05359224|Clopidogrel|clopidogrel|mesh-list
101929948|NCT05359224|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101929949|NCT05359224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101929950|NCT05359224|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101929951|NCT05359224|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101929952|NCT05359224|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101929953|NCT05359224|Purinergic Agents|purinergic agents|mesh-ancestor
101929954|NCT05359224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101929955|NCT05359224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929956|NCT05359224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929957|NCT03758118|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
101929958|NCT03758118|Nootropic Agents|nootropic agents|mesh-ancestor
101929959|NCT03756090|Paclitaxel|paclitaxel|mesh-list
101929960|NCT03756090|Cyclophosphamide|cyclophosphamide|mesh-list
101929961|NCT03756090|Epirubicin|epirubicin|mesh-list
101929962|NCT03756090|Palbociclib|palbociclib|mesh-list
101232077|NCT01557478|Protective Agents|protective agents|mesh-ancestor
101929963|NCT03756090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101929964|NCT03756090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101929965|NCT03756090|Tubulin Modulators|tubulin modulators|mesh-ancestor
101929966|NCT03756090|Antimitotic Agents|antimitotic agents|mesh-ancestor
101929967|NCT03756090|Mitosis Modulators|mitosis modulators|mesh-ancestor
101929968|NCT03756090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929969|NCT03756090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101929970|NCT03756090|Immunologic Factors|immunologic factors|mesh-ancestor
101929971|NCT03756090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929972|NCT03756090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101929973|NCT03756090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101929974|NCT03756090|Alkylating Agents|alkylating agents|mesh-ancestor
101929975|NCT03756090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101929976|NCT03756090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101929977|NCT03756090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101929978|NCT03756090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101929979|NCT03756090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101929980|NCT03756090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101929981|NCT04605588|Ribavirin|ribavirin|mesh-list
101929982|NCT04605588|Hydroxychloroquine|hydroxychloroquine|mesh-list
101929983|NCT04605588|Nitazoxanide|nitazoxanide|mesh-list
101929984|NCT04605588|Antimetabolites|antimetabolites|mesh-ancestor
101929985|NCT04605588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101929986|NCT04605588|Antiviral Agents|antiviral agents|mesh-ancestor
101929987|NCT04605588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101929988|NCT04605588|Antimalarials|antimalarials|mesh-ancestor
101929989|NCT04605588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101929990|NCT04605588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101929991|NCT04605588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101929992|NCT04605588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101929993|NCT03752736|Sunscreening Agents|sunscreening agents|mesh-list
101929994|NCT03752736|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101929995|NCT03752736|Protective Agents|protective agents|mesh-ancestor
101929996|NCT03752736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101929997|NCT03752736|Dermatologic Agents|dermatologic agents|mesh-ancestor
101929998|NCT03752658|Tenofovir|tenofovir|mesh-list
101929999|NCT03752658|Antiviral Agents|antiviral agents|mesh-ancestor
101930000|NCT03752658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101930001|NCT03752658|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101930002|NCT03752658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101930003|NCT03752658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101930004|NCT03752658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930005|NCT03752658|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101930006|NCT03752658|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101930007|NCT03752424|Anti-Infective Agents|anti-infective agents|mesh-list
101930008|NCT03752424|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101930009|NCT03755778|Itraconazole|itraconazole|mesh-list
101930010|NCT03755778|Rifampin|rifampin|mesh-list
101930011|NCT03755778|Quinidine|quinidine|mesh-list
101930012|NCT03755778|Antifungal Agents|antifungal agents|mesh-ancestor
101930013|NCT03755778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101930014|NCT03755778|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101930015|NCT03755778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101930016|NCT03755778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101930017|NCT03755778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930018|NCT03755778|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101930019|NCT03755778|Hormone Antagonists|hormone antagonists|mesh-ancestor
101930020|NCT03755778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101930021|NCT03755778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232085|NCT01557660|Treprostinil|treprostinil|mesh-list
101930022|NCT03755778|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101930023|NCT03755778|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101958459|NCT02118064|Irinotecan|irinotecan|mesh-list
101930024|NCT03755778|Antitubercular Agents|antitubercular agents|mesh-ancestor
101930025|NCT03755778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101930026|NCT03755778|Leprostatic Agents|leprostatic agents|mesh-ancestor
101930027|NCT03755778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101930028|NCT03755778|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101930029|NCT03755778|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101930030|NCT03755778|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101930031|NCT03755778|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101930032|NCT03755778|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101930033|NCT03755778|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101930034|NCT03755778|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101930035|NCT03755778|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101930036|NCT03755778|Adrenergic Agents|adrenergic agents|mesh-ancestor
101930037|NCT03755778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101930038|NCT03755778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101930039|NCT03755778|Antimalarials|antimalarials|mesh-ancestor
101930040|NCT03755778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101930041|NCT03755778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101930042|NCT03755778|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101930043|NCT03755778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101930044|NCT03755778|Cholinergic Agents|cholinergic agents|mesh-ancestor
101930045|NCT03755778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101930046|NCT03755778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101930047|NCT03755778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101930048|NCT03755778|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101930049|NCT03779074|Amoxicillin|amoxicillin|mesh-list
101930050|NCT03779074|Metronidazole|metronidazole|mesh-list
101930051|NCT03779074|Clarithromycin|clarithromycin|mesh-list
101930052|NCT03779074|Tetracycline|tetracycline|mesh-list
101930053|NCT03779074|Rabeprazole|rabeprazole|mesh-list
101930054|NCT03779074|Bismuth|bismuth|mesh-list
101930055|NCT03779074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101930056|NCT03779074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101930057|NCT03779074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101930058|NCT03779074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101930059|NCT03779074|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101930060|NCT03779074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101930061|NCT03779074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930062|NCT03779074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101930063|NCT03779074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101930064|NCT03779074|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101930065|NCT03779074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101930066|NCT03779074|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101930067|NCT03779074|Antacids|antacids|mesh-ancestor
101930068|NCT03755700|Vitamin E|vitamin e|mesh-list
101930069|NCT03755700|Acetylcysteine|acetylcysteine|mesh-list
101930070|NCT03755700|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101930071|NCT03755700|Vitamins|vitamins|mesh-ancestor
101930072|NCT03755700|Micronutrients|micronutrients|mesh-ancestor
101930073|NCT03755700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930074|NCT03755700|Antioxidants|antioxidants|mesh-ancestor
101617158|NCT00894543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101930075|NCT03755700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930076|NCT03755700|Protective Agents|protective agents|mesh-ancestor
101930078|NCT03755700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101930079|NCT03755700|Expectorants|expectorants|mesh-ancestor
101930080|NCT03755700|Respiratory System Agents|respiratory system agents|mesh-ancestor
101930081|NCT03755700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101930082|NCT03755700|Antidotes|antidotes|mesh-ancestor
101930083|NCT03757650|Amoxicillin|amoxicillin|mesh-list
101930084|NCT03757650|Clarithromycin|clarithromycin|mesh-list
101930085|NCT03757650|Omeprazole|omeprazole|mesh-list
101930086|NCT03757650|Bismuth|bismuth|mesh-list
101930087|NCT03757650|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
101930088|NCT03757650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101930089|NCT03757650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101930090|NCT03757650|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101930091|NCT03757650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101930092|NCT03757650|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101930093|NCT03757650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101930094|NCT03757650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649925|NCT05832333|Vaccines|vaccines|mesh-list
101930095|NCT03757650|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101930096|NCT03757650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101930097|NCT03757650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101930099|NCT03757650|Antidiarrheals|antidiarrheals|mesh-ancestor
101930100|NCT04432376|Miconazole|miconazole|mesh-list
101930101|NCT04432376|Antifungal Agents|antifungal agents|mesh-ancestor
101930102|NCT04432376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101930103|NCT04432376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101930104|NCT04432376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101930105|NCT04432376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101930106|NCT04432376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930107|NCT04432376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101930108|NCT04432376|Hormone Antagonists|hormone antagonists|mesh-ancestor
101930109|NCT04432376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101930110|NCT04432376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930111|NCT04432376|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101930112|NCT04432376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101930113|NCT05180968|Dronabinol|dronabinol|mesh-list
101930114|NCT05180968|Nabilone|nabilone|mesh-list
101930115|NCT05180968|Antiemetics|antiemetics|mesh-ancestor
101930116|NCT05180968|Autonomic Agents|autonomic agents|mesh-ancestor
101930117|NCT05180968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101930118|NCT05180968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930119|NCT05180968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101930120|NCT05180968|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101930121|NCT05180968|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101930122|NCT05180968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101930123|NCT05180968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101930124|NCT05180968|Hallucinogens|hallucinogens|mesh-ancestor
101930125|NCT05180968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101930126|NCT05180968|Analgesics|analgesics|mesh-ancestor
101930127|NCT05180968|Sensory System Agents|sensory system agents|mesh-ancestor
101930128|NCT05180968|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101930129|NCT05180968|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101930130|NCT05180968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101930131|NCT05180968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930132|NCT05180968|Hormones|hormones|mesh-ancestor
101930133|NCT05180968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101930134|NCT03693404|Ketorolac|ketorolac|mesh-list
101930135|NCT03693404|Morphine|morphine|mesh-list
101930136|NCT03693404|Bupivacaine|bupivacaine|mesh-list
101930137|NCT03693404|Anesthetics|anesthetics|mesh-list
101930138|NCT03693404|Anesthetics, General|anesthetics, general|mesh-list
101930139|NCT03693404|Anesthetics, Local|anesthetics, local|mesh-ancestor
101930140|NCT03693404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101930141|NCT03693404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930142|NCT03693404|Sensory System Agents|sensory system agents|mesh-ancestor
101930143|NCT03693404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101930144|NCT03693404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101930145|NCT03693404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101930146|NCT03693404|Analgesics|analgesics|mesh-ancestor
101930147|NCT03693404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101930148|NCT03693404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101930149|NCT03693404|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101930150|NCT03693404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101958464|NCT02118064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101232109|NCT01557764|Lapatinib|lapatinib|mesh-list
101930151|NCT03693404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930152|NCT03693404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101930153|NCT03693404|Narcotics|narcotics|mesh-ancestor
101930154|NCT04219358|Imiquimod|imiquimod|mesh-list
101930155|NCT04219358|Sunscreening Agents|sunscreening agents|mesh-list
101930156|NCT04219358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101930157|NCT04219358|Immunologic Factors|immunologic factors|mesh-ancestor
101930158|NCT04219358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930159|NCT04219358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101930160|NCT04219358|Interferon Inducers|interferon inducers|mesh-ancestor
101930161|NCT04219358|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101930162|NCT04219358|Protective Agents|protective agents|mesh-ancestor
101930163|NCT04219358|Dermatologic Agents|dermatologic agents|mesh-ancestor
101930164|NCT04218110|Ethanol|ethanol|mesh-list
101930165|NCT04218110|Chlorhexidine|chlorhexidine|mesh-list
101930166|NCT04218110|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101930167|NCT04218110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
101930168|NCT04218110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101930169|NCT04218110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101930170|NCT04218110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930171|NCT04218110|Disinfectants|disinfectants|mesh-ancestor
101930172|NCT04218110|Dermatologic Agents|dermatologic agents|mesh-ancestor
101930174|NCT05154994|Ipilimumab|ipilimumab|mesh-list
101930175|NCT05154994|Tremelimumab|tremelimumab|mesh-list
101930176|NCT05154994|Belinostat|belinostat|mesh-list
101930177|NCT05154994|Immunoglobulins|immunoglobulins|mesh-list
101930178|NCT05154994|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101930179|NCT05154994|Immunoglobulin G|immunoglobulin g|mesh-list
101930180|NCT05154994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101930181|NCT05154994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101930182|NCT05154994|Immunologic Factors|immunologic factors|mesh-ancestor
101930183|NCT05154994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930184|NCT05154994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101930185|NCT05154994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930186|NCT05154994|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101930187|NCT05154994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101930188|NCT03752190|Cosyntropin|cosyntropin|mesh-list
101930189|NCT03752190|Hormones|hormones|mesh-ancestor
101930190|NCT03752190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101930191|NCT03752190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930192|NCT04210310|Oxytocin|oxytocin|mesh-list
101930193|NCT04210310|Oxytocics|oxytocics|mesh-ancestor
101930194|NCT04210310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101930195|NCT04210310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930196|NCT03755466|Tofacitinib|tofacitinib|mesh-list
101930197|NCT03755466|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101930198|NCT03755466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101930199|NCT03755466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101930200|NCT03755466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930201|NCT03755310|Suvorexant|suvorexant|mesh-list
101930202|NCT03755310|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101930203|NCT03755310|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101930204|NCT03755310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101930205|NCT03755310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930206|NCT03755310|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
101930207|NCT03755310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101930208|NCT03755310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930209|NCT04381988|Hydroxychloroquine|hydroxychloroquine|mesh-list
101930210|NCT04381988|Antimalarials|antimalarials|mesh-ancestor
101930211|NCT04381988|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101930212|NCT04381988|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101930213|NCT04381988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101930214|NCT04381988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101930215|NCT04381988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930216|NCT04381988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101930217|NCT03668392|Asparaginase|asparaginase|mesh-list
101930218|NCT03668392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101930219|NCT04176016|Edetic Acid|edetic acid|mesh-list
101930220|NCT04176016|Pentetic Acid|pentetic acid|mesh-list
101930221|NCT04176016|Antidotes|antidotes|mesh-ancestor
101930222|NCT04176016|Protective Agents|protective agents|mesh-ancestor
101958485|NCT02118142|Betaine|betaine|mesh-list
101930223|NCT04176016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930225|NCT04176016|Sequestering Agents|sequestering agents|mesh-ancestor
101930226|NCT04176016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930227|NCT04176016|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101930228|NCT04176016|Anticoagulants|anticoagulants|mesh-ancestor
101930229|NCT04176016|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101930230|NCT03695094|Lamotrigine|lamotrigine|mesh-list
101930231|NCT03695094|Oxcarbazepine|oxcarbazepine|mesh-list
101930232|NCT03695094|Levetiracetam|levetiracetam|mesh-list
101930233|NCT03695094|Brivaracetam|brivaracetam|mesh-list
101930234|NCT03695094|Padsevonil|padsevonil|mesh-list
101930235|NCT03695094|Anticonvulsants|anticonvulsants|mesh-ancestor
101930236|NCT03695094|Nootropic Agents|nootropic agents|mesh-ancestor
101930237|NCT03695094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101930238|NCT03695094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101930239|NCT03695094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930240|NCT03695094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101930241|NCT03695094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930242|NCT03695094|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101930243|NCT03695094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101930244|NCT03695094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101930245|NCT03695094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101930246|NCT03695094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101930247|NCT03695094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101930248|NCT03695094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101930249|NCT03695094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101930251|NCT04497948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101930252|NCT04495374|Pregabalin|pregabalin|mesh-list
101930253|NCT04495374|Analgesics|analgesics|mesh-ancestor
101930254|NCT04495374|Sensory System Agents|sensory system agents|mesh-ancestor
101930255|NCT04495374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101930256|NCT04495374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930257|NCT04495374|Anticonvulsants|anticonvulsants|mesh-ancestor
101930258|NCT04495374|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101930259|NCT04495374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101930260|NCT04495374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930261|NCT04495374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101930262|NCT04495374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101930263|NCT04495374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101930264|NCT04495374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101930265|NCT04495374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101930266|NCT03752112|Penicillins|penicillins|mesh-list
101930267|NCT03752112|Cefixime|cefixime|mesh-list
101930268|NCT03752112|Penicillin G Benzathine|penicillin g benzathine|mesh-list
101930269|NCT03752112|Penicillin G|penicillin g|mesh-list
101930270|NCT03752112|Penicillin G Procaine|penicillin g procaine|mesh-list
101930271|NCT03752112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101930272|NCT03752112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101930273|NCT03757338|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101930274|NCT03757338|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101930275|NCT03757338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930276|NCT03757338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101930277|NCT03757338|Immunologic Factors|immunologic factors|mesh-ancestor
101930278|NCT03757338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930279|NCT03757260|Anti-Infective Agents|anti-infective agents|mesh-list
101930280|NCT03757260|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101930281|NCT04168190|Vaccines|vaccines|mesh-list
101930282|NCT04168190|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101930283|NCT04168190|Immunologic Factors|immunologic factors|mesh-ancestor
101930284|NCT04168190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930286|NCT03529942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101930287|NCT03529942|Glucocorticoids|glucocorticoids|mesh-ancestor
101930288|NCT03529942|Hormones|hormones|mesh-ancestor
101930289|NCT03529942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101930290|NCT03529942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930291|NCT03529942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101930292|NCT03529942|Immunologic Factors|immunologic factors|mesh-ancestor
101930293|NCT03501940|Fluorides|fluorides|mesh-list
101930294|NCT03501940|Cariostatic Agents|cariostatic agents|mesh-ancestor
101930295|NCT03501940|Protective Agents|protective agents|mesh-ancestor
101930296|NCT03501940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930297|NCT03754842|Niacinamide|niacinamide|mesh-list
101930298|NCT03754842|Niacin|niacin|mesh-list
101930299|NCT03754842|Nicotinic Acids|nicotinic acids|mesh-list
101930300|NCT03754842|Vitamin B Complex|vitamin b complex|mesh-ancestor
101930301|NCT03754842|Vitamins|vitamins|mesh-ancestor
101930302|NCT03754842|Micronutrients|micronutrients|mesh-ancestor
101930303|NCT03754842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930304|NCT03754842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101930305|NCT03754842|Antimetabolites|antimetabolites|mesh-ancestor
101930306|NCT03754842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930307|NCT03754842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101930308|NCT03754842|Vasodilator Agents|vasodilator agents|mesh-ancestor
101930309|NCT01562210|Olaparib|olaparib|mesh-list
101930310|NCT01562210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101930311|NCT01562210|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101930312|NCT01562210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101930313|NCT01562210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930314|NCT04189952|Rituximab|rituximab|mesh-list
101930315|NCT04189952|Carboplatin|carboplatin|mesh-list
101930316|NCT04189952|Etoposide|etoposide|mesh-list
101930317|NCT04189952|Ifosfamide|ifosfamide|mesh-list
101930318|NCT04189952|Acalabrutinib|acalabrutinib|mesh-list
101930319|NCT04189952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101930320|NCT04189952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101930321|NCT04189952|Immunologic Factors|immunologic factors|mesh-ancestor
101930322|NCT04189952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930323|NCT04189952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101930324|NCT04189952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101930325|NCT04189952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101930326|NCT04189952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101930327|NCT04189952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101930328|NCT04189952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930329|NCT04189952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101930330|NCT04189952|Alkylating Agents|alkylating agents|mesh-ancestor
101930331|NCT04716426|Tetracycline|tetracycline|mesh-list
101930332|NCT04716426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101930333|NCT04716426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101930334|NCT04716426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101930335|NCT04716426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101930336|NCT04716426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930337|NCT05761756|Caffeine|caffeine|mesh-list
101930338|NCT05761756|Methylphenidate|methylphenidate|mesh-list
101930339|NCT05761756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101930340|NCT05761756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930341|NCT05761756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101930342|NCT05761756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101930343|NCT05761756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930344|NCT05761756|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101930345|NCT05761756|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101930346|NCT05761756|Purinergic Agents|purinergic agents|mesh-ancestor
101930347|NCT05761756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101930348|NCT05761756|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101930349|NCT05761756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101930350|NCT05761756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101930351|NCT05761756|Dopamine Agents|dopamine agents|mesh-ancestor
101930352|NCT04164758|Pimavanserin|pimavanserin|mesh-list
101930353|NCT04164758|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101930354|NCT04164758|Antidepressive Agents|antidepressive agents|mesh-ancestor
101930355|NCT04164758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101930356|NCT04164758|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101930357|NCT04164758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101930358|NCT04164758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101930359|NCT04164758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930360|NCT04164758|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101930361|NCT04164758|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101930362|NCT04164758|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101930363|NCT04164758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101930364|NCT04164758|Serotonin Agents|serotonin agents|mesh-ancestor
101930365|NCT04164758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101930366|NCT04164758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930367|NCT03754686|Acetaminophen|acetaminophen|mesh-list
101930368|NCT03754686|Oseltamivir|oseltamivir|mesh-list
101930369|NCT03754686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101930370|NCT03754686|Analgesics|analgesics|mesh-ancestor
101930371|NCT03754686|Sensory System Agents|sensory system agents|mesh-ancestor
101930372|NCT03754686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101930373|NCT03754686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930374|NCT03754686|Antipyretics|antipyretics|mesh-ancestor
101930375|NCT03754686|Antiviral Agents|antiviral agents|mesh-ancestor
101930376|NCT03754686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101930377|NCT03754686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101930378|NCT03754686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930379|NCT05200884|Lidocaine|lidocaine|mesh-list
101930380|NCT05200884|Carticaine|carticaine|mesh-list
101930381|NCT05200884|Anesthetics, Local|anesthetics, local|mesh-ancestor
101930382|NCT05200884|Anesthetics|anesthetics|mesh-ancestor
101930383|NCT05200884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101930384|NCT05200884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930385|NCT05200884|Sensory System Agents|sensory system agents|mesh-ancestor
101930386|NCT05200884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101930387|NCT05200884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101930388|NCT05200884|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101930389|NCT05200884|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101930390|NCT05200884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101930391|NCT05200884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930392|NCT03746444|Anesthetics|anesthetics|mesh-list
101930393|NCT03746444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101650227|NCT05485519|Analgesics|analgesics|mesh-ancestor
101930394|NCT03746444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930395|NCT03749096|Immunoglobulins|immunoglobulins|mesh-list
101930396|NCT03749096|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101930397|NCT03749096|Antibodies|antibodies|mesh-list
101930398|NCT03749096|gamma-Globulins|gamma-globulins|mesh-list
101930399|NCT03749096|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101930400|NCT03749096|Immunologic Factors|immunologic factors|mesh-ancestor
101930401|NCT03749096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930402|NCT03748940|Mirikizumab|mirikizumab|mesh-list
101930403|NCT03748940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101930404|NCT03748940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101930405|NCT03748940|Analgesics|analgesics|mesh-ancestor
101930406|NCT03748940|Sensory System Agents|sensory system agents|mesh-ancestor
101930407|NCT03748940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101930408|NCT03748940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930409|NCT03748940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101930410|NCT03748940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101930411|NCT03748940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101930412|NCT03748940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101930413|NCT04177862|Fentanyl|fentanyl|mesh-list
101930414|NCT04177862|Sufentanil|sufentanil|mesh-list
101930415|NCT04177862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101930416|NCT04177862|Narcotics|narcotics|mesh-ancestor
101930417|NCT04177862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101930418|NCT04177862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930419|NCT04177862|Analgesics|analgesics|mesh-ancestor
101930420|NCT04177862|Sensory System Agents|sensory system agents|mesh-ancestor
101930421|NCT04177862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101930422|NCT04177862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101930423|NCT04177862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101930424|NCT04177862|Anesthetics, General|anesthetics, general|mesh-ancestor
101930425|NCT04177862|Anesthetics|anesthetics|mesh-ancestor
101930426|NCT03746366|Corticosterone|corticosterone|mesh-list
101930427|NCT03746366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101930428|NCT04157738|Insulin|insulin|mesh-list
101930429|NCT04157738|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101930430|NCT04157738|Insulin, Short-Acting|insulin, short-acting|mesh-list
101930431|NCT04157738|Insulin, Long-Acting|insulin, long-acting|mesh-list
101930432|NCT04157738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101930433|NCT04157738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930434|NCT04156646|Balovaptan|balovaptan|mesh-list
101930435|NCT04156646|Esomeprazole|esomeprazole|mesh-list
101930436|NCT04156646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101930437|NCT04156646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101930438|NCT04156646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101930439|NCT04156646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101930440|NCT04156646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930441|NCT04156646|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101930442|NCT04156646|Natriuretic Agents|natriuretic agents|mesh-ancestor
101930443|NCT04156646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930445|NCT04676412|Lenvatinib|lenvatinib|mesh-list
101930446|NCT04676412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101930447|NCT04676412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101930448|NCT04676412|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101930449|NCT04676412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930450|NCT04676412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101930451|NCT04676412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101930452|NCT03751488|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101930453|NCT03751488|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101930454|NCT03751488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101930455|NCT03751488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101930456|NCT03751488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930457|NCT03751488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101930458|NCT03751488|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101930459|NCT03751488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101930460|NCT03751488|Serotonin Agents|serotonin agents|mesh-ancestor
101930461|NCT03751488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101930462|NCT03751488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930463|NCT03751488|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101930464|NCT03751488|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101930465|NCT03751488|Dopamine Agents|dopamine agents|mesh-ancestor
101930466|NCT04150250|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101930467|NCT04150250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101930468|NCT04537806|Pregnanolone|pregnanolone|mesh-list
101930469|NCT04537806|Brexanolone|brexanolone|mesh-list
101930470|NCT04537806|Anesthetics|anesthetics|mesh-ancestor
101930471|NCT04537806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101930472|NCT04537806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930473|NCT04537806|Neurosteroids|neurosteroids|mesh-ancestor
101930474|NCT04537806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101930475|NCT04537806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930476|NCT04537806|GABA Modulators|gaba modulators|mesh-ancestor
101930477|NCT04537806|GABA Agents|gaba agents|mesh-ancestor
101930478|NCT03744806|Bevacizumab|bevacizumab|mesh-list
101930479|NCT03744806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101930480|NCT03744806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101930481|NCT03744806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101930482|NCT03744806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101930483|NCT03744806|Growth Substances|growth substances|mesh-ancestor
101930484|NCT03744806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930485|NCT03744806|Growth Inhibitors|growth inhibitors|mesh-ancestor
101930486|NCT04531098|Vaccines|vaccines|mesh-list
101930487|NCT04531098|Immunologic Factors|immunologic factors|mesh-ancestor
101930488|NCT04531098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930489|NCT04529850|Avasopasem manganese|avasopasem manganese|mesh-list
101930490|NCT04529850|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101930491|NCT04529850|Antioxidants|antioxidants|mesh-ancestor
101930492|NCT04529850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930493|NCT04529850|Protective Agents|protective agents|mesh-ancestor
101930494|NCT04529850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930495|NCT04225676|Tisagenlecleucel|tisagenlecleucel|mesh-list
101930496|NCT04225676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101930497|NCT04225676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101930498|NCT01561950|Clopidogrel|clopidogrel|mesh-list
101930499|NCT01561950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101930500|NCT01561950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101930501|NCT01561950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101930502|NCT01561950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101930503|NCT01561950|Purinergic Agents|purinergic agents|mesh-ancestor
101930504|NCT01561950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101930505|NCT01561950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930506|NCT01561950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930507|NCT04139018|Timolol|timolol|mesh-list
101930508|NCT04139018|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101930509|NCT04139018|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101930510|NCT04139018|Adrenergic Agents|adrenergic agents|mesh-ancestor
101930511|NCT04139018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101930512|NCT04139018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930513|NCT04139018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930514|NCT04139018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101930515|NCT04139018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101930517|NCT05206318|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
101930518|NCT05206318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930520|NCT04136444|Anticonvulsants|anticonvulsants|mesh-ancestor
101930521|NCT05027048|Calcium|calcium|mesh-list
101930522|NCT05027048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101930523|NCT05027048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930524|NCT03751332|Tacrolimus|tacrolimus|mesh-list
101930525|NCT03751332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101930526|NCT03751332|Immunologic Factors|immunologic factors|mesh-ancestor
101930527|NCT03751332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930528|NCT03751332|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101930529|NCT03751332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101930530|NCT03751332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930531|NCT04425252|Brequinar|brequinar|mesh-list
101930532|NCT04425252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101930533|NCT04425252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101930534|NCT04425252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930535|NCT04425252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101930536|NCT04425252|Immunologic Factors|immunologic factors|mesh-ancestor
101930537|NCT04425252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930538|NCT04003610|Carboplatin|carboplatin|mesh-list
101930539|NCT04003610|Gemcitabine|gemcitabine|mesh-list
101930540|NCT04003610|Pembrolizumab|pembrolizumab|mesh-list
101930541|NCT04003610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101930542|NCT04003610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101930543|NCT04003610|Antimetabolites|antimetabolites|mesh-ancestor
101930544|NCT04003610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930545|NCT04003610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101930546|NCT04003610|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101930547|NCT03744104|Vaccines|vaccines|mesh-list
101930548|NCT03744104|Immunologic Factors|immunologic factors|mesh-ancestor
101930549|NCT03744104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930550|NCT03999554|Vaccines|vaccines|mesh-list
101930551|NCT03999554|Immunologic Factors|immunologic factors|mesh-ancestor
101930552|NCT03999554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930553|NCT05280626|Prednisolone|prednisolone|mesh-list
101930554|NCT05280626|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101930555|NCT05280626|Methylprednisolone|methylprednisolone|mesh-list
101930556|NCT05280626|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101930557|NCT05280626|Prednisolone acetate|prednisolone acetate|mesh-list
101930558|NCT05280626|Cyclophosphamide|cyclophosphamide|mesh-list
101930559|NCT05280626|Rituximab|rituximab|mesh-list
101930560|NCT05280626|Doxorubicin|doxorubicin|mesh-list
101930561|NCT05280626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101930562|NCT05280626|Vincristine|vincristine|mesh-list
101930563|NCT05280626|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101930564|NCT05280626|Prednisolone phosphate|prednisolone phosphate|mesh-list
101930565|NCT05280626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101930566|NCT05280626|Immunologic Factors|immunologic factors|mesh-ancestor
101930567|NCT05280626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930568|NCT05280626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101930569|NCT05280626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101930570|NCT05280626|Alkylating Agents|alkylating agents|mesh-ancestor
101930571|NCT05280626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930572|NCT05280626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101930573|NCT05280626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101930574|NCT05280626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101930575|NCT05280626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101930576|NCT05280626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101930577|NCT05280626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101930578|NCT05280626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101930579|NCT05280626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101930580|NCT05280626|Glucocorticoids|glucocorticoids|mesh-ancestor
101930581|NCT05280626|Hormones|hormones|mesh-ancestor
101930582|NCT05280626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101930583|NCT05280626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101930584|NCT05280626|Antiemetics|antiemetics|mesh-ancestor
101930585|NCT05280626|Autonomic Agents|autonomic agents|mesh-ancestor
101930586|NCT05280626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101930587|NCT05280626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101930588|NCT05280626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101930589|NCT05280626|Protective Agents|protective agents|mesh-ancestor
101930590|NCT05280626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101930591|NCT05280626|Tubulin Modulators|tubulin modulators|mesh-ancestor
101930592|NCT05280626|Antimitotic Agents|antimitotic agents|mesh-ancestor
101930593|NCT05280626|Mitosis Modulators|mitosis modulators|mesh-ancestor
101930594|NCT04526574|Vaccines|vaccines|mesh-list
101930595|NCT04526574|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101930596|NCT04526574|Immunologic Factors|immunologic factors|mesh-ancestor
101930597|NCT04526574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930598|NCT03993392|Buprenorphine|buprenorphine|mesh-list
101930599|NCT03993392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101930600|NCT03993392|Narcotics|narcotics|mesh-ancestor
101930601|NCT03993392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101930602|NCT03993392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930603|NCT03993392|Analgesics|analgesics|mesh-ancestor
101930604|NCT03993392|Sensory System Agents|sensory system agents|mesh-ancestor
101930605|NCT03993392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101930606|NCT03993392|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101930607|NCT03751176|Leucovorin|leucovorin|mesh-list
101930608|NCT03751176|Folic Acid|folic acid|mesh-list
101930609|NCT03751176|Fluorouracil|fluorouracil|mesh-list
101930610|NCT03751176|Irinotecan|irinotecan|mesh-list
101930611|NCT03751176|Panitumumab|panitumumab|mesh-list
101930612|NCT03751176|Levoleucovorin|levoleucovorin|mesh-list
101930613|NCT03751176|Antimetabolites|antimetabolites|mesh-ancestor
101930614|NCT03751176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930615|NCT03751176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101930616|NCT03751176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101930617|NCT03751176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101930618|NCT03751176|Immunologic Factors|immunologic factors|mesh-ancestor
101930619|NCT03751176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930620|NCT03751176|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101930621|NCT03751176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101930622|NCT03751176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101930623|NCT03751176|Antidotes|antidotes|mesh-ancestor
101930624|NCT03751176|Protective Agents|protective agents|mesh-ancestor
101930625|NCT03751176|Vitamin B Complex|vitamin b complex|mesh-ancestor
101930626|NCT03751176|Vitamins|vitamins|mesh-ancestor
101930627|NCT03751176|Micronutrients|micronutrients|mesh-ancestor
101930628|NCT03751176|Hematinics|hematinics|mesh-ancestor
101930629|NCT03751176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101930630|NCT04377308|Fluoxetine|fluoxetine|mesh-list
101930631|NCT04377308|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101930632|NCT04377308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101930633|NCT04377308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101930634|NCT04377308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930635|NCT04377308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101930636|NCT04377308|Serotonin Agents|serotonin agents|mesh-ancestor
101930637|NCT04377308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930638|NCT04377308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101930639|NCT04377308|Antidepressive Agents|antidepressive agents|mesh-ancestor
101930640|NCT04377308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101930641|NCT04377308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101930642|NCT04377308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101930643|NCT04377308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101930644|NCT03743870|Bupivacaine|bupivacaine|mesh-list
101930645|NCT03743870|Levobupivacaine|levobupivacaine|mesh-list
101930646|NCT03743870|Anesthetics, Local|anesthetics, local|mesh-ancestor
101930647|NCT03743870|Anesthetics|anesthetics|mesh-ancestor
101930648|NCT03743870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101930649|NCT03743870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930650|NCT03743870|Sensory System Agents|sensory system agents|mesh-ancestor
101930651|NCT03743870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101930652|NCT03988088|Lasmiditan|lasmiditan|mesh-list
101930653|NCT03988088|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101930654|NCT03988088|Serotonin Agents|serotonin agents|mesh-ancestor
101930655|NCT03988088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101930656|NCT03988088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930657|NCT03988088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930658|NCT03987620|Ibrexafungerp|ibrexafungerp|mesh-list
101930659|NCT03987620|Antifungal Agents|antifungal agents|mesh-ancestor
101958499|NCT02124070|Hormones|hormones|mesh-list
101930660|NCT03987620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101930661|NCT05204524|Temozolomide|temozolomide|mesh-list
101930662|NCT05204524|Epirubicin|epirubicin|mesh-list
101930663|NCT05204524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101930664|NCT05204524|Alkylating Agents|alkylating agents|mesh-ancestor
101930665|NCT05204524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930666|NCT05204524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101930667|NCT05204524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101232196|NCT01558336|Praziquantel|praziquantel|mesh-list
101930668|NCT05204524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101930669|NCT05204524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101930670|NCT05204524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101930671|NCT05204056|Epinephrine|epinephrine|mesh-list
101930672|NCT05204056|Morphine|morphine|mesh-list
101930673|NCT05204056|Ropivacaine|ropivacaine|mesh-list
101930674|NCT05204056|Tranexamic Acid|tranexamic acid|mesh-list
101930675|NCT05204056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101930676|NCT05204056|Narcotics|narcotics|mesh-ancestor
101930677|NCT05204056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101930678|NCT05204056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930679|NCT05204056|Analgesics|analgesics|mesh-ancestor
101930680|NCT05204056|Sensory System Agents|sensory system agents|mesh-ancestor
101930681|NCT05204056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101930682|NCT05204056|Anesthetics, Local|anesthetics, local|mesh-ancestor
101930683|NCT05204056|Anesthetics|anesthetics|mesh-ancestor
101930684|NCT05204056|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101930685|NCT05204056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101930686|NCT05204056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930687|NCT05204056|Hemostatics|hemostatics|mesh-ancestor
101930688|NCT05204056|Coagulants|coagulants|mesh-ancestor
101930689|NCT05204056|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101930690|NCT05204056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101930691|NCT05204056|Adrenergic Agents|adrenergic agents|mesh-ancestor
101930692|NCT05204056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101930693|NCT05204056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101930694|NCT05204056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101930695|NCT05204056|Autonomic Agents|autonomic agents|mesh-ancestor
101930696|NCT05204056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101930697|NCT05204056|Respiratory System Agents|respiratory system agents|mesh-ancestor
101930698|NCT05204056|Mydriatics|mydriatics|mesh-ancestor
101930699|NCT05204056|Sympathomimetics|sympathomimetics|mesh-ancestor
101930700|NCT05204056|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101930701|NCT05203744|Tafenoquine|tafenoquine|mesh-list
101930702|NCT05203744|Antimalarials|antimalarials|mesh-ancestor
101930703|NCT05203744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101930704|NCT05203744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101930705|NCT05203744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101930706|NCT03987074|Firsocostat|firsocostat|mesh-list
101930707|NCT03987074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101930708|NCT03987074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930709|NCT05761366|PSMA-BCH|psma-bch|mesh-list
101930710|NCT05761366|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101930711|NCT05761366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930712|NCT05302466|Silicon|silicon|mesh-list
101930713|NCT05302466|Trace Elements|trace elements|mesh-ancestor
101930714|NCT05302466|Micronutrients|micronutrients|mesh-ancestor
101930715|NCT05302466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930716|NCT05203588|Vitamin D|vitamin d|mesh-list
101930717|NCT05203588|Denosumab|denosumab|mesh-list
101930718|NCT05203588|Calcium|calcium|mesh-list
101930719|NCT05203588|Vitamins|vitamins|mesh-ancestor
101930720|NCT05203588|Micronutrients|micronutrients|mesh-ancestor
101930721|NCT05203588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930722|NCT05203588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101930723|NCT05203588|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101930724|NCT05203354|Acitretin|acitretin|mesh-list
101930725|NCT05203354|Keratolytic Agents|keratolytic agents|mesh-ancestor
101930726|NCT05203354|Dermatologic Agents|dermatologic agents|mesh-ancestor
101930727|NCT04439214|Nivolumab|nivolumab|mesh-list
101930728|NCT04439214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101930729|NCT04439214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101930730|NCT04439214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101930731|NCT04439214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930732|NCT03754062|Haloperidol|haloperidol|mesh-list
101930733|NCT03754062|Haloperidol decanoate|haloperidol decanoate|mesh-list
101930734|NCT03754062|Antiemetics|antiemetics|mesh-ancestor
101930735|NCT03754062|Autonomic Agents|autonomic agents|mesh-ancestor
101930736|NCT03754062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101930737|NCT03754062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930738|NCT03754062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101930739|NCT03754062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101930740|NCT03754062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101930741|NCT03754062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101930742|NCT03754062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101930743|NCT03754062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101930744|NCT03754062|Dopamine Agents|dopamine agents|mesh-ancestor
101930745|NCT03754062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101293234|NCT01968005|Etodolac|etodolac|mesh-list
101930746|NCT03754062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930747|NCT03754062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101930749|NCT03696342|Pazufloxacin|pazufloxacin|mesh-list
101930750|NCT03696342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101930751|NCT03696342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101930752|NCT03696342|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101930753|NCT03696342|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101930754|NCT03696342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101930755|NCT03696342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101930756|NCT03696342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101930757|NCT03696342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930758|NCT03696342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101930759|NCT03696342|Antitubercular Agents|antitubercular agents|mesh-ancestor
101930760|NCT05180032|Denosumab|denosumab|mesh-list
101930761|NCT05180032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101930762|NCT05180032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930763|NCT05761132|Pembrolizumab|pembrolizumab|mesh-list
101930764|NCT05761132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101930765|NCT05761132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101930766|NCT05761132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101930767|NCT05761132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930768|NCT04411680|Sargramostim|sargramostim|mesh-list
101930769|NCT04411680|Immunologic Factors|immunologic factors|mesh-ancestor
101930770|NCT04411680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930771|NCT05760976|Cisatracurium|cisatracurium|mesh-list
101930772|NCT05760976|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101930773|NCT05760976|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101930774|NCT05760976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101930775|NCT05760976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930776|NCT05324358|Ketorolac|ketorolac|mesh-list
101930777|NCT05324358|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101930778|NCT05324358|Morphine|morphine|mesh-list
101930779|NCT05324358|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101930780|NCT05324358|Narcotics|narcotics|mesh-ancestor
101930781|NCT05324358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101930782|NCT05324358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930783|NCT05324358|Analgesics|analgesics|mesh-ancestor
101930784|NCT05324358|Sensory System Agents|sensory system agents|mesh-ancestor
101930785|NCT05324358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101930786|NCT05324358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101930787|NCT05324358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101930788|NCT05324358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101930789|NCT05324358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101930790|NCT05324358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101930791|NCT05324358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101930792|NCT05324358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930793|NCT03747978|Amlodipine|amlodipine|mesh-list
101930794|NCT03747978|Perindopril|perindopril|mesh-list
101930795|NCT03747978|Indapamide|indapamide|mesh-list
101930796|NCT03747978|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
101930797|NCT03747978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101930798|NCT03747978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101930799|NCT03747978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101930800|NCT03747978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930801|NCT03747978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101930802|NCT03747978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930803|NCT03747978|Vasodilator Agents|vasodilator agents|mesh-ancestor
101930804|NCT03747978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101930805|NCT03747978|Protease Inhibitors|protease inhibitors|mesh-ancestor
101930806|NCT03747978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101930807|NCT03747978|Diuretics|diuretics|mesh-ancestor
101930808|NCT03747978|Natriuretic Agents|natriuretic agents|mesh-ancestor
101930809|NCT03747978|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101930810|NCT04603846|Paclitaxel|paclitaxel|mesh-list
101930811|NCT04603846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101930812|NCT04603846|Antibodies|antibodies|mesh-list
101930813|NCT04603846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101930814|NCT04603846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101930815|NCT04603846|Tubulin Modulators|tubulin modulators|mesh-ancestor
101930816|NCT04603846|Antimitotic Agents|antimitotic agents|mesh-ancestor
101930817|NCT04603846|Mitosis Modulators|mitosis modulators|mesh-ancestor
101293292|NCT01968395|Caspofungin|caspofungin|mesh-list
101930818|NCT04603846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930819|NCT04603846|Immunologic Factors|immunologic factors|mesh-ancestor
101930820|NCT04603846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930821|NCT03747900|Botulinum Toxins|botulinum toxins|mesh-list
101930822|NCT03747900|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101930823|NCT03747900|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101930824|NCT03747900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101930825|NCT03747900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101930826|NCT03747900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930827|NCT03747900|Cholinergic Agents|cholinergic agents|mesh-ancestor
101930828|NCT03747900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101930829|NCT03747900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930830|NCT03747900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101930831|NCT03747900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101930832|NCT04578106|Trastuzumab|trastuzumab|mesh-list
101930833|NCT04578106|Pertuzumab|pertuzumab|mesh-list
101930834|NCT04578106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101930835|NCT04578106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101930836|NCT04472182|Calcium|calcium|mesh-list
101930837|NCT04472182|Fluorides|fluorides|mesh-list
101930838|NCT04472182|Fluorides, Topical|fluorides, topical|mesh-list
101930839|NCT04472182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101930840|NCT04472182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930841|NCT04472182|Cariostatic Agents|cariostatic agents|mesh-ancestor
101930842|NCT04472182|Protective Agents|protective agents|mesh-ancestor
101930843|NCT04423744|Moxifloxacin|moxifloxacin|mesh-list
101930844|NCT04423744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101930845|NCT04423744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101930846|NCT04423744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101930847|NCT04423744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101930848|NCT04423744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101930849|NCT04423744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930850|NCT04423744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101930851|NCT05759416|Melatonin|melatonin|mesh-list
101930852|NCT05759416|Antioxidants|antioxidants|mesh-ancestor
101930853|NCT05759416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930854|NCT05759416|Protective Agents|protective agents|mesh-ancestor
101930855|NCT05759416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930856|NCT05759416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101930857|NCT03746340|Propofol|propofol|mesh-list
101930858|NCT03746340|Sevoflurane|sevoflurane|mesh-list
101930859|NCT03746340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101930860|NCT03746340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101930861|NCT03746340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930862|NCT03746340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101930863|NCT03746340|Anesthetics, General|anesthetics, general|mesh-ancestor
101930864|NCT03746340|Anesthetics|anesthetics|mesh-ancestor
101930865|NCT03746340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101930866|NCT03746340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101930867|NCT04222816|Lithium Carbonate|lithium carbonate|mesh-list
101930868|NCT04222816|Antidepressive Agents|antidepressive agents|mesh-ancestor
101930869|NCT04222816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101930870|NCT04222816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101930871|NCT04222816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930872|NCT04222816|Antimanic Agents|antimanic agents|mesh-ancestor
101930873|NCT04222816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101930874|NCT04222816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101930875|NCT04222816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930876|NCT04161144|Sirolimus|sirolimus|mesh-list
101930877|NCT04161144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101930878|NCT04161144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101930879|NCT04161144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101930880|NCT04161144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101930881|NCT04161144|Antifungal Agents|antifungal agents|mesh-ancestor
101930882|NCT04161144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101930883|NCT04161144|Immunologic Factors|immunologic factors|mesh-ancestor
101930884|NCT04161144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930885|NCT03747744|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
101930886|NCT03747744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101930887|NCT03747744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101930888|NCT04823364|Neurotransmitter Agents|neurotransmitter agents|mesh-list
101930889|NCT04823364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930890|NCT04823364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930891|NCT04764630|Naloxone|naloxone|mesh-list
101930892|NCT04764630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101930893|NCT04764630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930894|NCT04764630|Sensory System Agents|sensory system agents|mesh-ancestor
101930895|NCT04764630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101930896|NCT04153188|Phenylephrine|phenylephrine|mesh-list
101930897|NCT04153188|Oxymetazoline|oxymetazoline|mesh-list
101930898|NCT04153188|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101930899|NCT04153188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101930900|NCT04153188|Adrenergic Agents|adrenergic agents|mesh-ancestor
101930901|NCT04153188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101930902|NCT04153188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930903|NCT04153188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930904|NCT04153188|Sympathomimetics|sympathomimetics|mesh-ancestor
101930905|NCT04153188|Autonomic Agents|autonomic agents|mesh-ancestor
101930906|NCT04153188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101930907|NCT04153188|Nasal Decongestants|nasal decongestants|mesh-ancestor
101930908|NCT04153188|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101930909|NCT04153188|Respiratory System Agents|respiratory system agents|mesh-ancestor
101930910|NCT04153188|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101930911|NCT04153188|Mydriatics|mydriatics|mesh-ancestor
101930912|NCT04153188|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101930913|NCT04153188|Protective Agents|protective agents|mesh-ancestor
101930914|NCT03611010|Atorvastatin|atorvastatin|mesh-list
101930915|NCT03611010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101930916|NCT03611010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101930917|NCT03611010|Antimetabolites|antimetabolites|mesh-ancestor
101930918|NCT03611010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930919|NCT03611010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101930920|NCT03611010|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101930921|NCT03611010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101930922|NCT03749850|Cyclophosphamide|cyclophosphamide|mesh-list
101930923|NCT03749850|Doxorubicin|doxorubicin|mesh-list
101930924|NCT03749850|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101930925|NCT03749850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101930926|NCT03749850|Immunologic Factors|immunologic factors|mesh-ancestor
101930927|NCT03749850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930928|NCT03749850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101930929|NCT03749850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101930930|NCT03749850|Alkylating Agents|alkylating agents|mesh-ancestor
101930931|NCT03749850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930932|NCT03749850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101930933|NCT03749850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101930934|NCT03749850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101930935|NCT03749850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101930936|NCT03749850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101930937|NCT03749850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101930938|NCT04357782|Ascorbic Acid|ascorbic acid|mesh-list
101930940|NCT04357782|Micronutrients|micronutrients|mesh-ancestor
101930941|NCT04357782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930942|NCT04357782|Antioxidants|antioxidants|mesh-ancestor
101930943|NCT04357782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930944|NCT04357782|Protective Agents|protective agents|mesh-ancestor
101930945|NCT03980522|Rilonacept|rilonacept|mesh-list
101930946|NCT03980522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101930947|NCT04400682|Favipiravir|favipiravir|mesh-list
101930948|NCT04400682|Antiviral Agents|antiviral agents|mesh-ancestor
101930949|NCT04400682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101930950|NCT03066778|Carboplatin|carboplatin|mesh-list
101930951|NCT03066778|Pembrolizumab|pembrolizumab|mesh-list
101930952|NCT03066778|Etoposide|etoposide|mesh-list
101930953|NCT03066778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101930954|NCT03066778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101930955|NCT03066778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101930956|NCT03066778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930957|NCT03066778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101930958|NCT03066778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101930959|NCT03066778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101930960|NCT03066778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101930961|NCT04136548|Fentanyl|fentanyl|mesh-list
101930962|NCT04136548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101930963|NCT04136548|Narcotics|narcotics|mesh-ancestor
101930964|NCT04136548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101930965|NCT04136548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930966|NCT04136548|Analgesics|analgesics|mesh-ancestor
101930967|NCT04136548|Sensory System Agents|sensory system agents|mesh-ancestor
101930968|NCT04136548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101930969|NCT04136548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101930970|NCT04136548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101930971|NCT04136548|Anesthetics, General|anesthetics, general|mesh-ancestor
101930972|NCT04136548|Anesthetics|anesthetics|mesh-ancestor
101930973|NCT04347954|Iodine|iodine|mesh-list
101930974|NCT04347954|Cadexomer iodine|cadexomer iodine|mesh-list
101930975|NCT04347954|Povidone-Iodine|povidone-iodine|mesh-list
101930976|NCT04347954|Povidone|povidone|mesh-list
101930977|NCT04347954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101930978|NCT04347954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101930979|NCT04347954|Trace Elements|trace elements|mesh-ancestor
101232264|NCT01558934|Lofexidine|lofexidine|mesh-list
101930980|NCT04347954|Micronutrients|micronutrients|mesh-ancestor
101930981|NCT04347954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930982|NCT04347954|Plasma Substitutes|plasma substitutes|mesh-ancestor
101930983|NCT04347954|Blood Substitutes|blood substitutes|mesh-ancestor
101930984|NCT03065530|Dexmedetomidine|dexmedetomidine|mesh-list
101930985|NCT03065530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101930986|NCT03065530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101930987|NCT03065530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101930988|NCT03065530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101930989|NCT03065530|Analgesics|analgesics|mesh-ancestor
101930990|NCT03065530|Sensory System Agents|sensory system agents|mesh-ancestor
101930991|NCT03065530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101930992|NCT03065530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101930993|NCT03065530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101930994|NCT03065530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101930995|NCT03065530|Adrenergic Agents|adrenergic agents|mesh-ancestor
101930996|NCT03065530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101930997|NCT03065530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101930998|NCT03979820|Phenelzine|phenelzine|mesh-list
101930999|NCT03979820|Tyramine|tyramine|mesh-list
101931000|NCT03979820|Antidepressive Agents|antidepressive agents|mesh-ancestor
101931001|NCT03979820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101931002|NCT03979820|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101931003|NCT03979820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101931004|NCT03979820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931006|NCT03979820|Autonomic Agents|autonomic agents|mesh-ancestor
101931007|NCT03979820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101931008|NCT03979820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931009|NCT03979820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101931010|NCT03979820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101931011|NCT03979820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101931012|NCT03979820|Adrenergic Agents|adrenergic agents|mesh-ancestor
101931013|NCT03979820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101931014|NCT03647488|Docetaxel|docetaxel|mesh-list
101931015|NCT03647488|Spartalizumab|spartalizumab|mesh-list
101931016|NCT03647488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101931017|NCT03647488|Tubulin Modulators|tubulin modulators|mesh-ancestor
101931018|NCT03647488|Antimitotic Agents|antimitotic agents|mesh-ancestor
101958521|NCT02118688|Dopamine Agents|dopamine agents|mesh-ancestor
101931019|NCT03647488|Mitosis Modulators|mitosis modulators|mesh-ancestor
101931020|NCT03647488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931021|NCT03647488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101931022|NCT03647488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101931023|NCT03693950|Darbepoetin alfa|darbepoetin alfa|mesh-list
101931024|NCT03693950|Hematinics|hematinics|mesh-ancestor
101931025|NCT03579160|Timolol|timolol|mesh-list
101931026|NCT03579160|Petrolatum|petrolatum|mesh-list
101931027|NCT03579160|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101931028|NCT03579160|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101931029|NCT03579160|Adrenergic Agents|adrenergic agents|mesh-ancestor
101931030|NCT03579160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101931031|NCT03579160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931032|NCT03579160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931033|NCT03579160|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101931034|NCT03579160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101931035|NCT03579160|Emollients|emollients|mesh-ancestor
101931036|NCT03579160|Dermatologic Agents|dermatologic agents|mesh-ancestor
101931037|NCT04109456|Atezolizumab|atezolizumab|mesh-list
101931038|NCT04109456|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101931039|NCT04109456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931040|NCT04109456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101931041|NCT04109456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101931043|NCT04109222|Immunologic Factors|immunologic factors|mesh-ancestor
101931044|NCT04109222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931045|NCT03745664|Methylprednisolone|methylprednisolone|mesh-list
101931046|NCT03745664|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101931047|NCT03745664|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101931048|NCT03745664|Prednisolone|prednisolone|mesh-list
101931049|NCT03745664|Prednisolone acetate|prednisolone acetate|mesh-list
101931050|NCT03745664|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101931051|NCT03745664|Prednisolone phosphate|prednisolone phosphate|mesh-list
101931052|NCT03745664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101931053|NCT03745664|Antiemetics|antiemetics|mesh-ancestor
101931054|NCT03745664|Autonomic Agents|autonomic agents|mesh-ancestor
101931055|NCT03745664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101931056|NCT03745664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931057|NCT03745664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101931058|NCT03745664|Glucocorticoids|glucocorticoids|mesh-ancestor
101931059|NCT03745664|Hormones|hormones|mesh-ancestor
101931060|NCT03745664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101931061|NCT03745664|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101931062|NCT03745664|Protective Agents|protective agents|mesh-ancestor
101931063|NCT03745664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101931064|NCT03745664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101931065|NCT03447262|Ivacaftor|ivacaftor|mesh-list
101931066|NCT03447262|VX-659|vx-659|mesh-list
101931067|NCT03447262|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101931068|NCT03447262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101931069|NCT03447262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931070|NCT04094870|Sertraline|sertraline|mesh-list
101931071|NCT04094870|Antidepressive Agents|antidepressive agents|mesh-ancestor
101931072|NCT04094870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101650903|NCT00106587|Paclitaxel|paclitaxel|mesh-list
101931073|NCT04094870|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101931074|NCT04094870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101931075|NCT04094870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101931076|NCT04094870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931077|NCT04094870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101931078|NCT04094870|Serotonin Agents|serotonin agents|mesh-ancestor
101931079|NCT04094870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931080|NCT04399356|Niclosamide|niclosamide|mesh-list
101931081|NCT04399356|Anticestodal Agents|anticestodal agents|mesh-ancestor
101931082|NCT04399356|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101931083|NCT04399356|Anthelmintics|anthelmintics|mesh-ancestor
101931084|NCT04399356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101931085|NCT04399356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101931086|NCT04399356|Antinematodal Agents|antinematodal agents|mesh-ancestor
101931087|NCT03692676|Tiotropium Bromide|tiotropium bromide|mesh-list
101931088|NCT03692676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101931089|NCT03692676|Autonomic Agents|autonomic agents|mesh-ancestor
101931090|NCT03692676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101931091|NCT03692676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931092|NCT03692676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101931093|NCT03692676|Respiratory System Agents|respiratory system agents|mesh-ancestor
101931094|NCT03692676|Parasympatholytics|parasympatholytics|mesh-ancestor
101931095|NCT03692676|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101931096|NCT03692676|Cholinergic Agents|cholinergic agents|mesh-ancestor
101931097|NCT03692676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101931098|NCT03692676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931099|NCT04118166|Nivolumab|nivolumab|mesh-list
101931100|NCT04118166|Ipilimumab|ipilimumab|mesh-list
101931101|NCT04118166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101931102|NCT04118166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101931103|NCT04118166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101931104|NCT04118166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931105|NCT04346628|Favipiravir|favipiravir|mesh-list
101931106|NCT04346628|Antiviral Agents|antiviral agents|mesh-ancestor
101931107|NCT04346628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101931108|NCT03681470|Dapsone|dapsone|mesh-list
101931109|NCT03681470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101931110|NCT03681470|Antimalarials|antimalarials|mesh-ancestor
101931111|NCT03681470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101931112|NCT03681470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101931113|NCT03681470|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101931114|NCT03681470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101931115|NCT03681470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931116|NCT03681470|Leprostatic Agents|leprostatic agents|mesh-ancestor
101931117|NCT03681470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101931118|NCT02414750|Vemurafenib|vemurafenib|mesh-list
101931119|NCT02414750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101931120|NCT02414750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101931121|NCT02414750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101931122|NCT02414750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931123|NCT04343976|Interferons|interferons|mesh-list
101931124|NCT04343976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101931125|NCT04343976|Antiviral Agents|antiviral agents|mesh-ancestor
101931126|NCT04343976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101931127|NCT03322540|Pembrolizumab|pembrolizumab|mesh-list
101931128|NCT03322540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101931129|NCT03322540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101931130|NCT03322540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101931131|NCT03322540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931132|NCT02909452|Pembrolizumab|pembrolizumab|mesh-list
101931133|NCT02909452|Entinostat|entinostat|mesh-list
101931134|NCT02909452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101931135|NCT02909452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101931136|NCT02909452|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101931137|NCT02909452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931138|NCT02909452|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101931139|NCT02909452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101931140|NCT02025556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101931141|NCT02025556|Immunologic Factors|immunologic factors|mesh-ancestor
101931142|NCT02025556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931143|NCT01935466|Pioglitazone|pioglitazone|mesh-list
101931144|NCT01935466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101931145|NCT01935466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931146|NCT04334148|Hydroxychloroquine|hydroxychloroquine|mesh-list
101931147|NCT04334148|Antimalarials|antimalarials|mesh-ancestor
101650983|NCT00696033|Diazepam|diazepam|mesh-list
101931148|NCT04334148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101931149|NCT04334148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101931150|NCT04334148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101931151|NCT04334148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101931152|NCT04334148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931153|NCT04334148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101931154|NCT04399122|Acetaminophen|acetaminophen|mesh-list
101931155|NCT04399122|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
101931156|NCT04399122|Oxycodone|oxycodone|mesh-list
101931157|NCT04399122|Codeine|codeine|mesh-list
101931158|NCT04399122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101931159|NCT04399122|Analgesics|analgesics|mesh-ancestor
101931160|NCT04399122|Sensory System Agents|sensory system agents|mesh-ancestor
101931161|NCT04399122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101931162|NCT04399122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931164|NCT04399122|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101931165|NCT04399122|Narcotics|narcotics|mesh-ancestor
101931166|NCT04399122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101931167|NCT04399122|Antitussive Agents|antitussive agents|mesh-ancestor
101931168|NCT04399122|Respiratory System Agents|respiratory system agents|mesh-ancestor
101931169|NCT04399122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101931170|NCT04399122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101931171|NCT04399122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101931172|NCT00826462|Triamcinolone|triamcinolone|mesh-list
101931173|NCT00826462|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101931174|NCT00826462|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101931175|NCT00826462|Naproxen|naproxen|mesh-list
101931176|NCT00826462|Lidocaine|lidocaine|mesh-list
101931177|NCT00826462|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101931178|NCT00826462|Anesthetics, Local|anesthetics, local|mesh-ancestor
101931179|NCT00826462|Anesthetics|anesthetics|mesh-ancestor
101931180|NCT00826462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101931181|NCT00826462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931182|NCT00826462|Sensory System Agents|sensory system agents|mesh-ancestor
101931183|NCT00826462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101931184|NCT00826462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101931185|NCT00826462|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101931186|NCT00826462|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101931187|NCT00826462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101931188|NCT00826462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931189|NCT00826462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101931190|NCT00826462|Glucocorticoids|glucocorticoids|mesh-ancestor
101931191|NCT00826462|Hormones|hormones|mesh-ancestor
101931192|NCT00826462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101931193|NCT00826462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101931194|NCT00826462|Immunologic Factors|immunologic factors|mesh-ancestor
101931195|NCT00826462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101931196|NCT00826462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101931197|NCT00826462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101931198|NCT00826462|Analgesics|analgesics|mesh-ancestor
101931199|NCT00826462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101931200|NCT00826462|Gout Suppressants|gout suppressants|mesh-ancestor
101931201|NCT00826462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101931202|NCT04398732|Etanercept|etanercept|mesh-list
101931203|NCT04398732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101931204|NCT04398732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101931205|NCT04398732|Analgesics|analgesics|mesh-ancestor
101931206|NCT04398732|Sensory System Agents|sensory system agents|mesh-ancestor
101931207|NCT04398732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101931208|NCT04398732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931209|NCT04398732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101931210|NCT04398732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101931211|NCT04398732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101931212|NCT04398732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101931213|NCT04398732|Immunologic Factors|immunologic factors|mesh-ancestor
101931214|NCT04322682|Colchicine|colchicine|mesh-list
101931215|NCT04322682|Gout Suppressants|gout suppressants|mesh-ancestor
101931217|NCT04322682|Tubulin Modulators|tubulin modulators|mesh-ancestor
101931218|NCT04322682|Antimitotic Agents|antimitotic agents|mesh-ancestor
101651051|NCT00928070|Fesoterodine|fesoterodine|mesh-list
101931219|NCT04322682|Mitosis Modulators|mitosis modulators|mesh-ancestor
101232365|NCT01559480|Hormones|hormones|mesh-ancestor
101931220|NCT04322682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931221|NCT04322682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101931222|NCT04322526|Naltrexone|naltrexone|mesh-list
101931223|NCT04322526|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101931224|NCT04322526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101931225|NCT04322526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931226|NCT04322526|Sensory System Agents|sensory system agents|mesh-ancestor
101931227|NCT04322526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101931228|NCT04115358|Hyaluronic Acid|hyaluronic acid|mesh-list
101931229|NCT04115358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101931230|NCT04115358|Immunologic Factors|immunologic factors|mesh-ancestor
101931231|NCT04115358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931232|NCT04115358|Viscosupplements|viscosupplements|mesh-ancestor
101931233|NCT04115358|Protective Agents|protective agents|mesh-ancestor
101931234|NCT05668884|Gemcitabine|gemcitabine|mesh-list
101931235|NCT05668884|Oxaliplatin|oxaliplatin|mesh-list
101931236|NCT05668884|Tislelizumab|tislelizumab|mesh-list
101931237|NCT05668884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101931238|NCT05668884|Antimetabolites|antimetabolites|mesh-ancestor
101931239|NCT05668884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931240|NCT05668884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101931241|NCT05668884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101931242|NCT05187208|Niraparib|niraparib|mesh-list
101931243|NCT05187208|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101931244|NCT05187208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101931245|NCT05187208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931246|NCT05187208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101931247|NCT05081206|Propofol|propofol|mesh-list
101931248|NCT05081206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101931249|NCT05081206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101931250|NCT05081206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931251|NCT05081206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101931252|NCT05081206|Anesthetics, General|anesthetics, general|mesh-ancestor
101931253|NCT05081206|Anesthetics|anesthetics|mesh-ancestor
101931254|NCT04105998|Oxytocin|oxytocin|mesh-list
101931255|NCT04105998|Oxytocics|oxytocics|mesh-ancestor
101931256|NCT04105998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101931257|NCT04105998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931258|NCT04543968|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
101931259|NCT04543968|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
101931260|NCT04543968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101931261|NCT04543968|Antioxidants|antioxidants|mesh-ancestor
101931262|NCT04543968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931263|NCT04543968|Protective Agents|protective agents|mesh-ancestor
101931264|NCT04543968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931265|NCT04543968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101931266|NCT04543968|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101931267|NCT04543968|Disinfectants|disinfectants|mesh-ancestor
101931268|NCT04368910|Artesunate|artesunate|mesh-list
101931269|NCT04368910|Chloroquine|chloroquine|mesh-list
101931270|NCT04368910|Pyronaridine|pyronaridine|mesh-list
101931271|NCT04368910|Antimalarials|antimalarials|mesh-ancestor
101931272|NCT04368910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101931273|NCT04368910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101931274|NCT04368910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101931275|NCT04368910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101931276|NCT04368910|Antiviral Agents|antiviral agents|mesh-ancestor
101931277|NCT04368910|Schistosomicides|schistosomicides|mesh-ancestor
101931278|NCT04368910|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101931279|NCT04368910|Anthelmintics|anthelmintics|mesh-ancestor
101931280|NCT04368910|Amebicides|amebicides|mesh-ancestor
101931281|NCT04368910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101931282|NCT04249258|Dobutamine|dobutamine|mesh-list
101931283|NCT04249258|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101931284|NCT04249258|Sympathomimetics|sympathomimetics|mesh-ancestor
101931285|NCT04249258|Autonomic Agents|autonomic agents|mesh-ancestor
101931286|NCT04249258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101931287|NCT04249258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931288|NCT04249258|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101931289|NCT04249258|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101931291|NCT04249258|Adrenergic Agents|adrenergic agents|mesh-ancestor
101931292|NCT04249258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101931293|NCT04249258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931294|NCT04249258|Protective Agents|protective agents|mesh-ancestor
101931295|NCT03938584|Ascorbic Acid|ascorbic acid|mesh-list
101931296|NCT03938584|Vitamins|vitamins|mesh-ancestor
101931297|NCT03938584|Micronutrients|micronutrients|mesh-ancestor
101931298|NCT03938584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931299|NCT03938584|Antioxidants|antioxidants|mesh-ancestor
101931300|NCT03938584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931301|NCT03938584|Protective Agents|protective agents|mesh-ancestor
101931302|NCT03269344|Gabapentin|gabapentin|mesh-list
101931303|NCT03269344|Analgesics|analgesics|mesh-ancestor
101931304|NCT03269344|Sensory System Agents|sensory system agents|mesh-ancestor
101931305|NCT03269344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101931306|NCT03269344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931307|NCT03269344|Anticonvulsants|anticonvulsants|mesh-ancestor
101931308|NCT03269344|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101931309|NCT03269344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101931310|NCT03269344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101931311|NCT03269344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101931312|NCT03269344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101931313|NCT03269344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101931314|NCT03269344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101931315|NCT03269344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931316|NCT03269344|Antimanic Agents|antimanic agents|mesh-ancestor
101931317|NCT04389840|Heparin|heparin|mesh-list
101931318|NCT04389840|Anticoagulants|anticoagulants|mesh-ancestor
101931319|NCT04389840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101931320|NCT04389840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101931321|NCT04389840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931322|NCT03747198|Dimethyl sulfone|dimethyl sulfone|mesh-list
101931323|NCT03747198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101931324|NCT02933944|Pembrolizumab|pembrolizumab|mesh-list
101931325|NCT02933944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101931326|NCT02933944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101931327|NCT02933944|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101931328|NCT02933944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931329|NCT04307940|Acetaminophen|acetaminophen|mesh-list
101931330|NCT04307940|Naproxen|naproxen|mesh-list
101931331|NCT04307940|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
101931332|NCT04307940|Hydrocodone|hydrocodone|mesh-list
101931334|NCT04307940|Analgesics|analgesics|mesh-ancestor
101931335|NCT04307940|Sensory System Agents|sensory system agents|mesh-ancestor
101931336|NCT04307940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101931337|NCT04307940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931338|NCT04307940|Antipyretics|antipyretics|mesh-ancestor
101232429|NCT05570669|Sodium sulfate|sodium sulfate|mesh-list
101931339|NCT04307940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101931340|NCT04307940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101931341|NCT04307940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101931342|NCT04307940|Gout Suppressants|gout suppressants|mesh-ancestor
101931343|NCT04307940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101931344|NCT04307940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101931345|NCT04307940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931346|NCT04307940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101931347|NCT04307940|Narcotics|narcotics|mesh-ancestor
101931348|NCT04307940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101931349|NCT04307940|Antitussive Agents|antitussive agents|mesh-ancestor
101931350|NCT04307940|Respiratory System Agents|respiratory system agents|mesh-ancestor
101931351|NCT02717416|Hemostatics|hemostatics|mesh-list
101931352|NCT02717416|Coagulants|coagulants|mesh-ancestor
101931353|NCT02054104|Celecoxib|celecoxib|mesh-list
101931354|NCT02054104|Cyclophosphamide|cyclophosphamide|mesh-list
101931355|NCT02054104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101931356|NCT02054104|Immunologic Factors|immunologic factors|mesh-ancestor
101931357|NCT02054104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931358|NCT02054104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101931359|NCT02054104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101931360|NCT02054104|Alkylating Agents|alkylating agents|mesh-ancestor
101931361|NCT02054104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931362|NCT02054104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101931363|NCT02054104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101931364|NCT02054104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101931365|NCT02054104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101931366|NCT02054104|Analgesics|analgesics|mesh-ancestor
101931367|NCT02054104|Sensory System Agents|sensory system agents|mesh-ancestor
101931368|NCT02054104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101931369|NCT02054104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101931370|NCT02054104|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101931371|NCT02054104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101931372|NCT02054104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101931373|NCT04331704|Tenofovir|tenofovir|mesh-list
101931374|NCT04331704|Emtricitabine|emtricitabine|mesh-list
101931375|NCT04331704|Antiviral Agents|antiviral agents|mesh-ancestor
101931376|NCT04331704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101931377|NCT04331704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101931378|NCT04331704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101931379|NCT04331704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101931380|NCT04331704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931381|NCT04331704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101931382|NCT04331704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101931383|NCT04229290|Dolutegravir|dolutegravir|mesh-list
101931384|NCT04229290|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101931385|NCT04229290|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101931386|NCT04229290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101931387|NCT04229290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931388|NCT04229290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101931389|NCT04229290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101931390|NCT04229290|Antiviral Agents|antiviral agents|mesh-ancestor
101931391|NCT04229290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101931392|NCT04181476|Sunscreening Agents|sunscreening agents|mesh-list
101931393|NCT04181476|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101931394|NCT04181476|Protective Agents|protective agents|mesh-ancestor
101931395|NCT04181476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931396|NCT04181476|Dermatologic Agents|dermatologic agents|mesh-ancestor
101931397|NCT03855046|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
101931398|NCT03855046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101931399|NCT03855046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101931400|NCT03855046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931401|NCT03855046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101931402|NCT03855046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101931403|NCT03855046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931404|NCT03855046|Cholinergic Agents|cholinergic agents|mesh-ancestor
101931405|NCT03855046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101931407|NCT03854110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101931408|NCT03854110|Antimetabolites|antimetabolites|mesh-ancestor
101931409|NCT03854110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931410|NCT03854110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101931412|NCT04292730|Antimetabolites|antimetabolites|mesh-ancestor
101931413|NCT04292730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931414|NCT04292730|Antiviral Agents|antiviral agents|mesh-ancestor
101931415|NCT04292730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101931416|NCT02861014|Ocrelizumab|ocrelizumab|mesh-list
101931417|NCT02861014|Immunologic Factors|immunologic factors|mesh-ancestor
101931418|NCT02861014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931419|NCT04382586|Zanubrutinib|zanubrutinib|mesh-list
101931420|NCT04382586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101931421|NCT04382586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101931422|NCT04382586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101931423|NCT04382586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931424|NCT02737306|Leronlimab|leronlimab|mesh-list
101931425|NCT02737306|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101931426|NCT02737306|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101931427|NCT02737306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931428|NCT02737306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101931429|NCT02737306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101931430|NCT02737306|Antiviral Agents|antiviral agents|mesh-ancestor
101931431|NCT02737306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101931432|NCT02728648|Oxycodone|oxycodone|mesh-list
101931433|NCT02728648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101931434|NCT02728648|Narcotics|narcotics|mesh-ancestor
101931435|NCT02728648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101931436|NCT02728648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931437|NCT02728648|Analgesics|analgesics|mesh-ancestor
101931438|NCT02728648|Sensory System Agents|sensory system agents|mesh-ancestor
101931439|NCT02728648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101931440|NCT04275336|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
101931441|NCT04275336|Anesthetics, Local|anesthetics, local|mesh-ancestor
101931442|NCT04275336|Anesthetics|anesthetics|mesh-ancestor
101931443|NCT04275336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101931444|NCT04275336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931445|NCT04275336|Sensory System Agents|sensory system agents|mesh-ancestor
101931446|NCT04275336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101931447|NCT04275336|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
101651272|NCT00696969|Miltefosine|miltefosine|mesh-list
101931449|NCT01971970|Infliximab|infliximab|mesh-list
101931450|NCT01971970|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101931451|NCT01971970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101931452|NCT01971970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101931453|NCT01971970|Dermatologic Agents|dermatologic agents|mesh-ancestor
101931454|NCT01971970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101931455|NCT01161394|Pioglitazone|pioglitazone|mesh-list
101931456|NCT01161394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101931457|NCT01161394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931458|NCT04079790|Gepotidacin|gepotidacin|mesh-list
101931459|NCT04079790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101931460|NCT04079790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101931461|NCT04079790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931462|NCT04079790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101931463|NCT03749226|Aztreonam|aztreonam|mesh-list
101931464|NCT03749226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101931465|NCT03749226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101931466|NCT04259346|Ixekizumab|ixekizumab|mesh-list
101931467|NCT04259346|Dermatologic Agents|dermatologic agents|mesh-ancestor
101931468|NCT03748836|ALPN-101|alpn-101|mesh-list
101931469|NCT03748836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101931470|NCT03748836|Immunologic Factors|immunologic factors|mesh-ancestor
101931471|NCT03748836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931472|NCT03745404|Lidocaine|lidocaine|mesh-list
101931473|NCT03745404|Anesthetics, Local|anesthetics, local|mesh-ancestor
101931474|NCT03745404|Anesthetics|anesthetics|mesh-ancestor
101931475|NCT03745404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101931476|NCT03745404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931477|NCT03745404|Sensory System Agents|sensory system agents|mesh-ancestor
101931478|NCT03745404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101931479|NCT03745404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101931480|NCT03745404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101931481|NCT03745404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101931482|NCT03745404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101931483|NCT03745404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931485|NCT01348100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101931486|NCT01348100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101931487|NCT01348100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101931488|NCT01348100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931489|NCT01348100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101931490|NCT03673670|Tiotropium Bromide|tiotropium bromide|mesh-list
101931491|NCT03673670|Olodaterol|olodaterol|mesh-list
101931492|NCT03673670|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101931493|NCT03673670|Autonomic Agents|autonomic agents|mesh-ancestor
101931494|NCT03673670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101931495|NCT03673670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931496|NCT03673670|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101931497|NCT03673670|Respiratory System Agents|respiratory system agents|mesh-ancestor
101931498|NCT03673670|Parasympatholytics|parasympatholytics|mesh-ancestor
101931499|NCT03673670|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101931500|NCT03673670|Cholinergic Agents|cholinergic agents|mesh-ancestor
101931501|NCT03673670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101931502|NCT03673670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931503|NCT04369742|Hydroxychloroquine|hydroxychloroquine|mesh-list
101931504|NCT04369742|Calcium|calcium|mesh-list
101931505|NCT04369742|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101931506|NCT04369742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931507|NCT04369742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931508|NCT04369742|Antimalarials|antimalarials|mesh-ancestor
101931509|NCT04369742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101931510|NCT04369742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101931511|NCT04369742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101931512|NCT04369742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101931513|NCT04369742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101931514|NCT03745586|Glucocorticoids|glucocorticoids|mesh-list
101931516|NCT03745586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101931517|NCT03745586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931518|NCT03055936|Levodopa|levodopa|mesh-list
101931519|NCT03055936|Carbidopa|carbidopa|mesh-list
101931520|NCT03055936|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101931521|NCT03055936|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101931522|NCT03055936|Dopamine Agents|dopamine agents|mesh-ancestor
101931523|NCT03055936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101931524|NCT03055936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931525|NCT03055936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931526|NCT03055936|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101931527|NCT03055936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101931528|NCT05215366|Arginine Vasopressin|arginine vasopressin|mesh-list
101931529|NCT05215366|Hemostatics|hemostatics|mesh-ancestor
101931530|NCT05215366|Coagulants|coagulants|mesh-ancestor
101931531|NCT05215366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101931532|NCT05215366|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101931533|NCT05215366|Natriuretic Agents|natriuretic agents|mesh-ancestor
101931534|NCT05215366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931535|NCT05201170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101931536|NCT03891524|Enoxaparin|enoxaparin|mesh-list
101931537|NCT03891524|Anticoagulants|anticoagulants|mesh-ancestor
101931538|NCT03891524|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101931539|NCT03891524|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101931540|NCT03891524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931541|NCT04695652|Somatomedin B|somatomedin b|mesh-list
101931542|NCT04695652|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101931543|NCT04695652|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101931544|NCT04695652|Protease Inhibitors|protease inhibitors|mesh-ancestor
101931545|NCT04695652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101931546|NCT04695652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931547|NCT04489108|Tranexamic Acid|tranexamic acid|mesh-list
101931548|NCT04489108|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101931549|NCT04489108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101931550|NCT04489108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931551|NCT04489108|Hemostatics|hemostatics|mesh-ancestor
101931552|NCT04489108|Coagulants|coagulants|mesh-ancestor
101931553|NCT03771586|Ketamine|ketamine|mesh-list
101931554|NCT03771586|Analgesics|analgesics|mesh-ancestor
101931555|NCT03771586|Sensory System Agents|sensory system agents|mesh-ancestor
101931556|NCT03771586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101931557|NCT03771586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931558|NCT03771586|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101931560|NCT03771586|Anesthetics, General|anesthetics, general|mesh-ancestor
101931561|NCT03771586|Anesthetics|anesthetics|mesh-ancestor
101931562|NCT03771586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101931563|NCT03771586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101931564|NCT03771586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101931565|NCT03771586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101931566|NCT03771586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931567|NCT02335060|Acetylcysteine|acetylcysteine|mesh-list
101931568|NCT02335060|Dronabinol|dronabinol|mesh-list
101931569|NCT02335060|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101931570|NCT02335060|Antiviral Agents|antiviral agents|mesh-ancestor
101931571|NCT02335060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101931572|NCT02335060|Expectorants|expectorants|mesh-ancestor
101931573|NCT02335060|Respiratory System Agents|respiratory system agents|mesh-ancestor
101931574|NCT02335060|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101931575|NCT02335060|Antioxidants|antioxidants|mesh-ancestor
101931576|NCT02335060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931577|NCT02335060|Protective Agents|protective agents|mesh-ancestor
101931578|NCT02335060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931579|NCT02335060|Antidotes|antidotes|mesh-ancestor
101931580|NCT02335060|Hallucinogens|hallucinogens|mesh-ancestor
101931581|NCT02335060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101931582|NCT02335060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101931583|NCT02335060|Analgesics|analgesics|mesh-ancestor
101931584|NCT02335060|Sensory System Agents|sensory system agents|mesh-ancestor
101931585|NCT02335060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101931586|NCT02335060|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101931587|NCT02335060|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101931588|NCT02335060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101931590|NCT02335060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101931591|NCT00284986|Remestemcel-l|remestemcel-l|mesh-list
101931592|NCT00284986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101931593|NCT00284986|Antiviral Agents|antiviral agents|mesh-ancestor
101931594|NCT00284986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101931595|NCT04075604|Nivolumab|nivolumab|mesh-list
101931596|NCT04075604|Palbociclib|palbociclib|mesh-list
101931597|NCT04075604|Anastrozole|anastrozole|mesh-list
101931598|NCT04075604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101931599|NCT04075604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101931600|NCT04075604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101931601|NCT04075604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931602|NCT04075604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101931603|NCT04075604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101931604|NCT04075604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101931605|NCT04075604|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101931606|NCT04075604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101931607|NCT04075604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101931608|NCT04075604|Hormone Antagonists|hormone antagonists|mesh-ancestor
101931609|NCT04075604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101931610|NCT04075604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931611|NCT01765400|Clopidogrel|clopidogrel|mesh-list
101931612|NCT01765400|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101931613|NCT01765400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101931614|NCT01765400|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101931615|NCT01765400|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101931616|NCT01765400|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101931617|NCT01765400|Purinergic Agents|purinergic agents|mesh-ancestor
101931618|NCT01765400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101931619|NCT01765400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931620|NCT01765400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931621|NCT05217238|Remifentanil|remifentanil|mesh-list
101931622|NCT05217238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101931623|NCT05217238|Narcotics|narcotics|mesh-ancestor
101931624|NCT05217238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101931625|NCT05217238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931626|NCT05217238|Analgesics|analgesics|mesh-ancestor
101931627|NCT05217238|Sensory System Agents|sensory system agents|mesh-ancestor
101931628|NCT05217238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101931630|NCT05217160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101931631|NCT05217160|Narcotics|narcotics|mesh-ancestor
101931632|NCT05217160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101931633|NCT05217160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931634|NCT05217160|Analgesics|analgesics|mesh-ancestor
101931635|NCT05217160|Sensory System Agents|sensory system agents|mesh-ancestor
101931636|NCT05217160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101931637|NCT01495676|Cisplatin|cisplatin|mesh-list
101931638|NCT01495676|Gemcitabine|gemcitabine|mesh-list
101931639|NCT01495676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101931640|NCT01495676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101931642|NCT01495676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931643|NCT05052970|Dexamethasone|dexamethasone|mesh-list
101931644|NCT05052970|Dexamethasone acetate|dexamethasone acetate|mesh-list
101931645|NCT05052970|Bortezomib|bortezomib|mesh-list
101931646|NCT05052970|Mitoxantrone|mitoxantrone|mesh-list
101931647|NCT05052970|BB 1101|bb 1101|mesh-list
101931648|NCT05052970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101931649|NCT05052970|Antiemetics|antiemetics|mesh-ancestor
101931650|NCT05052970|Autonomic Agents|autonomic agents|mesh-ancestor
101931651|NCT05052970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101931652|NCT05052970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931653|NCT05052970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101931654|NCT05052970|Glucocorticoids|glucocorticoids|mesh-ancestor
101931655|NCT05052970|Hormones|hormones|mesh-ancestor
101931656|NCT05052970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101931657|NCT05052970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101931658|NCT05052970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101931659|NCT05052970|Protease Inhibitors|protease inhibitors|mesh-ancestor
101931660|NCT05052970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101931661|NCT05052970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931662|NCT05052970|Analgesics|analgesics|mesh-ancestor
101931663|NCT05052970|Sensory System Agents|sensory system agents|mesh-ancestor
101931664|NCT05052970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101931665|NCT05052970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101931666|NCT04903210|Niacinamide|niacinamide|mesh-list
101931667|NCT04903210|Niacin|niacin|mesh-list
101931668|NCT04903210|Nicotinic Acids|nicotinic acids|mesh-list
101931669|NCT04903210|Vitamin B Complex|vitamin b complex|mesh-ancestor
101931670|NCT04903210|Vitamins|vitamins|mesh-ancestor
101931671|NCT04903210|Micronutrients|micronutrients|mesh-ancestor
101931672|NCT04903210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931673|NCT04903210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101931674|NCT04903210|Antimetabolites|antimetabolites|mesh-ancestor
101931675|NCT04903210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931676|NCT04903210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101931677|NCT04903210|Vasodilator Agents|vasodilator agents|mesh-ancestor
101931678|NCT04719208|Chlorhexidine|chlorhexidine|mesh-list
101931679|NCT04719208|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101931680|NCT04719208|Hydrogen Peroxide|hydrogen peroxide|mesh-list
101931681|NCT04719208|Povidone-Iodine|povidone-iodine|mesh-list
101931682|NCT04719208|Listerine|listerine|mesh-list
101931683|NCT04719208|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101931684|NCT04719208|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101931685|NCT04719208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101931686|NCT04719208|Disinfectants|disinfectants|mesh-ancestor
101931687|NCT04719208|Dermatologic Agents|dermatologic agents|mesh-ancestor
101931688|NCT04701190|Norepinephrine|norepinephrine|mesh-list
101931689|NCT04701190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931690|NCT04701190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101931691|NCT04701190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101931692|NCT04701190|Adrenergic Agents|adrenergic agents|mesh-ancestor
101931693|NCT04701190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101931694|NCT04701190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931695|NCT04701190|Sympathomimetics|sympathomimetics|mesh-ancestor
101931696|NCT04701190|Autonomic Agents|autonomic agents|mesh-ancestor
101931697|NCT04701190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101931698|NCT04701190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101931699|NCT04496362|Heparin|heparin|mesh-list
101931700|NCT04496362|Anticoagulants|anticoagulants|mesh-ancestor
101931701|NCT04496362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101931702|NCT04496362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101931703|NCT04496362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931704|NCT04423588|Dexlansoprazole|dexlansoprazole|mesh-list
101931705|NCT04423588|Lansoprazole|lansoprazole|mesh-list
101931706|NCT04423588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101931707|NCT04423588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101931708|NCT04423588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101931709|NCT04423588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101931710|NCT04423588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931711|NCT04090684|Ciprofloxacin|ciprofloxacin|mesh-list
101931712|NCT04090684|Celecoxib|celecoxib|mesh-list
101931713|NCT04090684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101931714|NCT04090684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101931715|NCT04090684|Analgesics|analgesics|mesh-ancestor
101931716|NCT04090684|Sensory System Agents|sensory system agents|mesh-ancestor
101931717|NCT04090684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101931718|NCT04090684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931719|NCT04090684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101931720|NCT04090684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101931721|NCT04090684|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101931722|NCT04090684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101931723|NCT04090684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101931724|NCT04090684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931725|NCT04090684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101931726|NCT04090684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101931727|NCT04090684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101931728|NCT04090684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101931729|NCT04090684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101931730|NCT04090684|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101931731|NCT04090684|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101931732|NCT04963816|Dexamethasone|dexamethasone|mesh-list
101931733|NCT04963816|Dexamethasone acetate|dexamethasone acetate|mesh-list
101931734|NCT04963816|Bupivacaine|bupivacaine|mesh-list
101931735|NCT04963816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101931736|NCT04963816|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101931737|NCT04963816|BB 1101|bb 1101|mesh-list
101931738|NCT04963816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101931739|NCT04963816|Antiemetics|antiemetics|mesh-ancestor
101931740|NCT04963816|Autonomic Agents|autonomic agents|mesh-ancestor
101931741|NCT04963816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101931742|NCT04963816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931743|NCT04963816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101931744|NCT04963816|Glucocorticoids|glucocorticoids|mesh-ancestor
101931745|NCT04963816|Hormones|hormones|mesh-ancestor
101931746|NCT04963816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101651571|NCT02617485|Hormones|hormones|mesh-ancestor
101931747|NCT04963816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101931748|NCT04963816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101931749|NCT04963816|Protease Inhibitors|protease inhibitors|mesh-ancestor
101931750|NCT04963816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101931751|NCT04963816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931752|NCT04963816|Anesthetics, Local|anesthetics, local|mesh-ancestor
101931753|NCT04963816|Anesthetics|anesthetics|mesh-ancestor
101931754|NCT04963816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101931755|NCT04963816|Sensory System Agents|sensory system agents|mesh-ancestor
101931756|NCT04933240|Tamoxifen|tamoxifen|mesh-list
101931757|NCT04933240|Estradiol|estradiol|mesh-list
101931758|NCT04933240|Estrogens|estrogens|mesh-ancestor
101931759|NCT04933240|Hormones|hormones|mesh-ancestor
101931760|NCT04933240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101931761|NCT04933240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931762|NCT04933240|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101931763|NCT04933240|Hormone Antagonists|hormone antagonists|mesh-ancestor
101931764|NCT04933240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101931765|NCT04933240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101931766|NCT04933240|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101931767|NCT04933240|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101931768|NCT04933240|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101931769|NCT01317940|Calcium, Dietary|calcium, dietary|mesh-list
101931770|NCT01317940|Vitamin D|vitamin d|mesh-list
101931771|NCT01317940|Calcitriol|calcitriol|mesh-list
101931772|NCT01317940|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
101931773|NCT01317940|Calcium Carbonate|calcium carbonate|mesh-list
101931774|NCT01317940|Calcium|calcium|mesh-list
101931775|NCT01317940|Vitamins|vitamins|mesh-ancestor
101931776|NCT01317940|Micronutrients|micronutrients|mesh-ancestor
101931777|NCT01317940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931778|NCT01317940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101931779|NCT01317940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101931780|NCT01317940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931781|NCT01317940|Antacids|antacids|mesh-ancestor
101931782|NCT01317940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101931783|NCT01317940|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101931784|NCT01317940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101931785|NCT01317940|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101931786|NCT05706688|Anesthetics|anesthetics|mesh-list
101931787|NCT05706688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101931788|NCT05706688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931789|NCT05706454|Ramatroban|ramatroban|mesh-list
101931790|NCT05706454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101931791|NCT01317550|Minocycline|minocycline|mesh-list
101931792|NCT01317550|Modafinil|modafinil|mesh-list
101931793|NCT01317550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101931794|NCT01317550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101931795|NCT01317550|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101931796|NCT01317550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931797|NCT01317550|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101931798|NCT01317550|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101931799|NCT01317550|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101931800|NCT01317550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931801|NCT01317472|Dexlansoprazole|dexlansoprazole|mesh-list
101931802|NCT01317472|Lansoprazole|lansoprazole|mesh-list
101931803|NCT01317472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101931804|NCT01317472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101931805|NCT01317472|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101931806|NCT01317472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101931807|NCT01317472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931808|NCT01345630|Ritonavir|ritonavir|mesh-list
101931809|NCT01345630|Darunavir|darunavir|mesh-list
101931810|NCT01345630|Tenofovir|tenofovir|mesh-list
101931811|NCT01345630|Emtricitabine|emtricitabine|mesh-list
101931812|NCT01345630|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101931813|NCT01345630|Maraviroc|maraviroc|mesh-list
101931814|NCT01345630|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101931815|NCT01345630|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101931816|NCT01345630|Protease Inhibitors|protease inhibitors|mesh-ancestor
101931817|NCT01345630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101931818|NCT01345630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931819|NCT01345630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101931820|NCT01345630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101931821|NCT01345630|Antiviral Agents|antiviral agents|mesh-ancestor
101931822|NCT01345630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101931823|NCT01345630|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101931824|NCT01345630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101931825|NCT01345630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101931826|NCT01345630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101931827|NCT01345630|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101931828|NCT01345630|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101931829|NCT01345630|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101931830|NCT03693612|Paclitaxel|paclitaxel|mesh-list
101931831|NCT03693612|Docetaxel|docetaxel|mesh-list
101931832|NCT03693612|Cetuximab|cetuximab|mesh-list
101931833|NCT03693612|Tremelimumab|tremelimumab|mesh-list
101931834|NCT03693612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101931835|NCT03693612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101931836|NCT03693612|Tubulin Modulators|tubulin modulators|mesh-ancestor
101931837|NCT03693612|Antimitotic Agents|antimitotic agents|mesh-ancestor
101931838|NCT03693612|Mitosis Modulators|mitosis modulators|mesh-ancestor
101931839|NCT03693612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931840|NCT03693612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101931841|NCT03746652|Dexamethasone|dexamethasone|mesh-list
101931842|NCT03746652|Daratumumab|daratumumab|mesh-list
101931843|NCT03746652|Ixazomib|ixazomib|mesh-list
101931844|NCT03746652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101931845|NCT03746652|Antiemetics|antiemetics|mesh-ancestor
101931846|NCT03746652|Autonomic Agents|autonomic agents|mesh-ancestor
101931847|NCT03746652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101931848|NCT03746652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931849|NCT03746652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101931850|NCT03746652|Glucocorticoids|glucocorticoids|mesh-ancestor
101931851|NCT03746652|Hormones|hormones|mesh-ancestor
101931852|NCT03746652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101931853|NCT03746652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101931854|NCT03746652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101931855|NCT03746652|Protease Inhibitors|protease inhibitors|mesh-ancestor
101931856|NCT03746652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101931857|NCT03746652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931858|NCT01562808|Aripiprazole|aripiprazole|mesh-list
101931859|NCT01562808|Antidepressive Agents|antidepressive agents|mesh-ancestor
101931860|NCT01562808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101931861|NCT01562808|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101931862|NCT01562808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101931863|NCT01562808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101931864|NCT01562808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931865|NCT01562808|Dopamine Agonists|dopamine agonists|mesh-ancestor
101931866|NCT01562808|Dopamine Agents|dopamine agents|mesh-ancestor
101931867|NCT01562808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101931868|NCT01562808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931869|NCT01562808|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101931870|NCT01562808|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101931871|NCT01562808|Serotonin Agents|serotonin agents|mesh-ancestor
101931872|NCT01562808|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101931873|NCT01562808|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101931874|NCT01562808|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101931875|NCT01562808|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101931876|NCT04051944|Rozanolixizumab|rozanolixizumab|mesh-list
101931877|NCT04051944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101931878|NCT04051944|Immunologic Factors|immunologic factors|mesh-ancestor
101931879|NCT04051944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931880|NCT04067492|Diclofenac|diclofenac|mesh-list
101931881|NCT04067492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101931882|NCT04067492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101931883|NCT04067492|Analgesics|analgesics|mesh-ancestor
101931884|NCT04067492|Sensory System Agents|sensory system agents|mesh-ancestor
101931885|NCT04067492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101931886|NCT04067492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931887|NCT04067492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101931888|NCT04067492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101931889|NCT04067492|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101931890|NCT04067492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101931891|NCT04067492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931892|NCT04186806|Muramidase|muramidase|mesh-list
101931893|NCT04186806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101931894|NCT03748446|Xenon|xenon|mesh-list
101931895|NCT03748446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101931896|NCT03748446|Anesthetics, General|anesthetics, general|mesh-ancestor
101931897|NCT03748446|Anesthetics|anesthetics|mesh-ancestor
101931898|NCT03748446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101651718|NCT00803335|Estrogens|estrogens|mesh-list
101931899|NCT03748446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931900|NCT04036110|Vitamins|vitamins|mesh-list
101931901|NCT04036110|Ascorbic Acid|ascorbic acid|mesh-list
101931902|NCT04036110|Micronutrients|micronutrients|mesh-ancestor
101931903|NCT04036110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931904|NCT04036110|Antioxidants|antioxidants|mesh-ancestor
101931905|NCT04036110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931906|NCT04036110|Protective Agents|protective agents|mesh-ancestor
101931907|NCT03053050|Selonsertib|selonsertib|mesh-list
101931908|NCT03053050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101931909|NCT03053050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101931910|NCT03053050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931911|NCT04369950|Lidocaine|lidocaine|mesh-list
101931912|NCT04369950|Epinephrine|epinephrine|mesh-list
101931913|NCT04369950|Morphine|morphine|mesh-list
101931914|NCT04369950|Chloroprocaine|chloroprocaine|mesh-list
101931915|NCT04369950|Anesthetics, Local|anesthetics, local|mesh-ancestor
101931916|NCT04369950|Anesthetics|anesthetics|mesh-ancestor
101931917|NCT04369950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101931918|NCT04369950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931919|NCT04369950|Sensory System Agents|sensory system agents|mesh-ancestor
101931920|NCT04369950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101931921|NCT04369950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101931922|NCT04369950|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101617186|NCT04988256|Cyclosporine|cyclosporine|mesh-list
101958596|NCT00574496|Cyclosporine|cyclosporine|mesh-list
101931923|NCT04369950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101931924|NCT04369950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101931925|NCT04369950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931926|NCT04369950|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101931927|NCT04369950|Narcotics|narcotics|mesh-ancestor
101931928|NCT04369950|Analgesics|analgesics|mesh-ancestor
101931929|NCT04369950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101931930|NCT04369950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101931931|NCT04369950|Adrenergic Agents|adrenergic agents|mesh-ancestor
101931932|NCT04369950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101931933|NCT04369950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101931934|NCT04369950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101931935|NCT04369950|Autonomic Agents|autonomic agents|mesh-ancestor
101931936|NCT04369950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101931937|NCT04369950|Respiratory System Agents|respiratory system agents|mesh-ancestor
101931938|NCT04369950|Mydriatics|mydriatics|mesh-ancestor
101931939|NCT04369950|Sympathomimetics|sympathomimetics|mesh-ancestor
101931940|NCT04369950|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101931941|NCT02955602|Seladelpar|seladelpar|mesh-list
101931942|NCT02955602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101931943|NCT02955602|Antimetabolites|antimetabolites|mesh-ancestor
101931944|NCT02955602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931945|NCT02955602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101931946|NCT03748290|Pregabalin|pregabalin|mesh-list
101931947|NCT03748290|Analgesics|analgesics|mesh-ancestor
101931948|NCT03748290|Sensory System Agents|sensory system agents|mesh-ancestor
101931949|NCT03748290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101931950|NCT03748290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931951|NCT03748290|Anticonvulsants|anticonvulsants|mesh-ancestor
101931952|NCT03748290|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101931953|NCT03748290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101931954|NCT03748290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931955|NCT03748290|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101931956|NCT03748290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101931957|NCT03748290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101931958|NCT03748290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101931959|NCT03748290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101931960|NCT05651074|Omeprazole|omeprazole|mesh-list
101931961|NCT05651074|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101931962|NCT05651074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101931963|NCT05651074|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101931964|NCT05651074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101931965|NCT05651074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931966|NCT03738956|Tofacitinib|tofacitinib|mesh-list
101931967|NCT03738956|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101931968|NCT03738956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101931969|NCT03738956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101931970|NCT03738956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931971|NCT05609656|Pembrolizumab|pembrolizumab|mesh-list
101931972|NCT05609656|Calcium|calcium|mesh-list
101931973|NCT05609656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101931974|NCT05609656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101931975|NCT05609656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101931976|NCT05609656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931977|NCT05609656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101931978|NCT05609656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931980|NCT04175808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101931981|NCT04175808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101931982|NCT04175808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101931983|NCT04175808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101931984|NCT04175808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101931985|NCT04175808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101931986|NCT04175808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101931987|NCT05598424|Methylprednisolone|methylprednisolone|mesh-list
101931988|NCT05598424|Glucocorticoids|glucocorticoids|mesh-list
101931989|NCT05598424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101931991|NCT05598424|Autonomic Agents|autonomic agents|mesh-ancestor
101931992|NCT05598424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101931993|NCT05598424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101931994|NCT05598424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101931995|NCT05598424|Hormones|hormones|mesh-ancestor
101931996|NCT05598424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101931997|NCT05598424|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101931998|NCT05598424|Protective Agents|protective agents|mesh-ancestor
101932000|NCT05501860|Anesthetics, Local|anesthetics, local|mesh-ancestor
101932001|NCT05501860|Anesthetics|anesthetics|mesh-ancestor
101932002|NCT05501860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101932003|NCT05501860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932004|NCT05501860|Sensory System Agents|sensory system agents|mesh-ancestor
101932005|NCT05501860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101932006|NCT03738176|Triamcinolone|triamcinolone|mesh-list
101932007|NCT03738176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101932008|NCT03738176|Glucocorticoids|glucocorticoids|mesh-ancestor
101932009|NCT03738176|Hormones|hormones|mesh-ancestor
101932010|NCT03738176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101932011|NCT03738176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932012|NCT03051100|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
101932013|NCT03051100|Atorvastatin|atorvastatin|mesh-list
101932014|NCT03051100|Ezetimibe|ezetimibe|mesh-list
101932015|NCT03051100|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101932016|NCT03051100|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101932017|NCT03051100|Antimetabolites|antimetabolites|mesh-ancestor
101932018|NCT03051100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932019|NCT03051100|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101932020|NCT03051100|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101932021|NCT03051100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101932022|NCT03051100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101932023|NCT03051100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932024|NCT05280028|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101932025|NCT05280028|Tibolone|tibolone|mesh-list
101932026|NCT05280028|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101932027|NCT05280028|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101932028|NCT05280028|Medroxyprogesterone|medroxyprogesterone|mesh-list
101932029|NCT05280028|Estradiol|estradiol|mesh-list
101932030|NCT05280028|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101932031|NCT05280028|Estrogens|estrogens|mesh-ancestor
101932032|NCT05280028|Hormones|hormones|mesh-ancestor
101932033|NCT05280028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101932034|NCT05280028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932035|NCT05280028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101932036|NCT05280028|Contraceptive Agents|contraceptive agents|mesh-ancestor
101932037|NCT05280028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101932038|NCT05280028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101932039|NCT05280028|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101932040|NCT05280028|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101932041|NCT05280028|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101932042|NCT05280028|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101932043|NCT05280028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101932044|NCT05280028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101932045|NCT05280028|Androgen Antagonists|androgen antagonists|mesh-ancestor
101932046|NCT05280028|Hormone Antagonists|hormone antagonists|mesh-ancestor
101932047|NCT05280028|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101932048|NCT05280028|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101932049|NCT05280028|Anabolic Agents|anabolic agents|mesh-ancestor
101932050|NCT05569876|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101932051|NCT05569876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932052|NCT01343368|Leuprolide|leuprolide|mesh-list
101932053|NCT01343368|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101932054|NCT01343368|Fertility Agents|fertility agents|mesh-ancestor
101932055|NCT01343368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101932056|NCT01343368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932057|NCT01343368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101932058|NCT01343368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101932059|NCT02955212|Upadacitinib|upadacitinib|mesh-list
101932060|NCT02955212|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101932061|NCT02955212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101932062|NCT02955212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101932063|NCT02955212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932064|NCT02955212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101932065|NCT03050398|Letrozole|letrozole|mesh-list
101932066|NCT03050398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101932067|NCT03050398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101932068|NCT03050398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101932069|NCT03050398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101932070|NCT03050398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932071|NCT03050398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101932072|NCT03050398|Hormone Antagonists|hormone antagonists|mesh-ancestor
101932073|NCT03050398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101932074|NCT03050398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932075|NCT03626506|Amlodipine|amlodipine|mesh-list
101932076|NCT03626506|Indapamide|indapamide|mesh-list
101932077|NCT03626506|Spironolactone|spironolactone|mesh-list
101932078|NCT03626506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101932079|NCT03626506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101932080|NCT03626506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101932081|NCT03626506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932082|NCT03626506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101932083|NCT03626506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932084|NCT03626506|Vasodilator Agents|vasodilator agents|mesh-ancestor
101932085|NCT03626506|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101932086|NCT03626506|Hormone Antagonists|hormone antagonists|mesh-ancestor
101932087|NCT03626506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101932088|NCT03626506|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101932089|NCT03626506|Diuretics|diuretics|mesh-ancestor
101932090|NCT03626506|Natriuretic Agents|natriuretic agents|mesh-ancestor
101932091|NCT03626506|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101932092|NCT03737708|Adalimumab|adalimumab|mesh-list
101932093|NCT03737708|Methotrexate|methotrexate|mesh-list
101932094|NCT03737708|Abatacept|abatacept|mesh-list
101932095|NCT03737708|Tacrolimus|tacrolimus|mesh-list
101932096|NCT03737708|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101932097|NCT03737708|Abortifacient Agents|abortifacient agents|mesh-ancestor
101932098|NCT03737708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101932099|NCT03737708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932100|NCT03737708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101932101|NCT03737708|Antimetabolites|antimetabolites|mesh-ancestor
101932102|NCT03737708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932103|NCT03737708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101932104|NCT03737708|Dermatologic Agents|dermatologic agents|mesh-ancestor
101932105|NCT03737708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101932106|NCT03737708|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101932107|NCT03737708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101932108|NCT03737708|Immunologic Factors|immunologic factors|mesh-ancestor
101932109|NCT03737708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101932110|NCT03737708|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101932111|NCT03737708|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101932112|NCT03737708|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101932113|NCT03737708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101932114|NCT03737708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101932115|NCT03737708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101932116|NCT05517928|Omeprazole|omeprazole|mesh-list
101932117|NCT05517928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101932118|NCT05517928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101932119|NCT05517928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101932120|NCT05517928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101232611|NCT04873323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101932121|NCT05517928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932122|NCT04052204|Avelumab|avelumab|mesh-list
101932123|NCT04052204|Talazoparib|talazoparib|mesh-list
101932124|NCT04052204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101932125|NCT04052204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101932126|NCT04052204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101932127|NCT04052204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101932128|NCT04052204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932129|NCT04050722|Listerine|listerine|mesh-list
101932130|NCT04050722|Sodium Fluoride|sodium fluoride|mesh-list
101932131|NCT04050722|Cariostatic Agents|cariostatic agents|mesh-ancestor
101932132|NCT04050722|Protective Agents|protective agents|mesh-ancestor
101932133|NCT04050722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932134|NCT04050722|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101932135|NCT04050722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101932137|NCT04049552|Temsirolimus|temsirolimus|mesh-list
101932138|NCT04049552|MTOR Inhibitors|mtor inhibitors|mesh-list
101932139|NCT04049552|Petrolatum|petrolatum|mesh-list
101932140|NCT04049552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101932141|NCT04049552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101932142|NCT04049552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101932143|NCT04049552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101932144|NCT04049552|Antifungal Agents|antifungal agents|mesh-ancestor
101932145|NCT04049552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101932146|NCT04049552|Immunologic Factors|immunologic factors|mesh-ancestor
101932147|NCT04049552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932148|NCT04049552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101932149|NCT04049552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101932150|NCT04049552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932151|NCT04049552|Emollients|emollients|mesh-ancestor
101932152|NCT04049552|Dermatologic Agents|dermatologic agents|mesh-ancestor
101932153|NCT03737474|Brexpiprazole|brexpiprazole|mesh-list
101932154|NCT03737474|Serotonin Agents|serotonin agents|mesh-ancestor
101932155|NCT03737474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101932156|NCT03737474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932157|NCT03737474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932158|NCT03737474|Dopamine Agonists|dopamine agonists|mesh-ancestor
101932159|NCT03737474|Dopamine Agents|dopamine agents|mesh-ancestor
101932160|NCT03048058|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101932161|NCT03048058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101932162|NCT03048058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101932163|NCT03048058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101932164|NCT03048058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101932165|NCT03048058|Adrenergic Agents|adrenergic agents|mesh-ancestor
101932166|NCT03048058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101932167|NCT03048058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932168|NCT03048058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932169|NCT03047980|Sirolimus|sirolimus|mesh-list
101932170|NCT03047980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101932171|NCT03047980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101932172|NCT03047980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101932173|NCT03047980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101932174|NCT03047980|Antifungal Agents|antifungal agents|mesh-ancestor
101932175|NCT03047980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101932176|NCT03047980|Immunologic Factors|immunologic factors|mesh-ancestor
101932177|NCT03047980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932178|NCT04022980|Nivolumab|nivolumab|mesh-list
101932179|NCT04022980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101932180|NCT04022980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101232633|NCT04696952|Zopiclone|zopiclone|mesh-list
101932181|NCT04022980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101932182|NCT04022980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932183|NCT03876028|Tisagenlecleucel|tisagenlecleucel|mesh-list
101932184|NCT03876028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101932185|NCT03876028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101932186|NCT03732482|Temozolomide|temozolomide|mesh-list
101932187|NCT03732482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101932188|NCT03732482|Alkylating Agents|alkylating agents|mesh-ancestor
101932189|NCT03732482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932190|NCT03732482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101932191|NCT04047446|Dexamethasone|dexamethasone|mesh-list
101932192|NCT04047446|Bupivacaine|bupivacaine|mesh-list
101932193|NCT04047446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101932194|NCT04047446|Antiemetics|antiemetics|mesh-ancestor
101932195|NCT04047446|Autonomic Agents|autonomic agents|mesh-ancestor
101932196|NCT04047446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101932197|NCT04047446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932198|NCT04047446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101932199|NCT04047446|Glucocorticoids|glucocorticoids|mesh-ancestor
101932201|NCT04047446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101932202|NCT04047446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101932203|NCT04047446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101932204|NCT04047446|Anesthetics, Local|anesthetics, local|mesh-ancestor
101932205|NCT04047446|Anesthetics|anesthetics|mesh-ancestor
101932206|NCT04047446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101932207|NCT04047446|Sensory System Agents|sensory system agents|mesh-ancestor
101932208|NCT03629054|Metformin|metformin|mesh-list
101932209|NCT03629054|Empagliflozin|empagliflozin|mesh-list
101932210|NCT03629054|Linagliptin|linagliptin|mesh-list
101932211|NCT03629054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101932212|NCT03629054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932213|NCT03629054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101932214|NCT03629054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932215|NCT03629054|Incretins|incretins|mesh-ancestor
101932217|NCT03629054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101932218|NCT03629054|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101932219|NCT03629054|Protease Inhibitors|protease inhibitors|mesh-ancestor
101932220|NCT03629054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101932221|NCT02754856|Durvalumab|durvalumab|mesh-list
101932222|NCT02754856|Ipilimumab|ipilimumab|mesh-list
101932223|NCT02754856|Tremelimumab|tremelimumab|mesh-list
101932224|NCT02754856|Immunoglobulins|immunoglobulins|mesh-list
101932225|NCT02754856|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101932226|NCT02754856|Immunoglobulin G|immunoglobulin g|mesh-list
101932227|NCT02754856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101932228|NCT02754856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101932229|NCT02754856|Immunologic Factors|immunologic factors|mesh-ancestor
101932230|NCT02754856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932231|NCT02754856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101932232|NCT02754856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932233|NCT02573896|Lenalidomide|lenalidomide|mesh-list
101932234|NCT02573896|Dinutuximab|dinutuximab|mesh-list
101932235|NCT02573896|Immunologic Factors|immunologic factors|mesh-ancestor
101932236|NCT02573896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932237|NCT02573896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101932238|NCT02573896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101932239|NCT02573896|Growth Substances|growth substances|mesh-ancestor
101932240|NCT02573896|Growth Inhibitors|growth inhibitors|mesh-ancestor
101932241|NCT02573896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101932242|NCT03045328|Venetoclax|venetoclax|mesh-list
101932243|NCT03045328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101932244|NCT02154490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101932245|NCT02154490|Nivolumab|nivolumab|mesh-list
101932246|NCT02154490|Ipilimumab|ipilimumab|mesh-list
101932247|NCT02154490|Durvalumab|durvalumab|mesh-list
101932248|NCT02154490|Rilotumumab|rilotumumab|mesh-list
101932249|NCT02154490|Docetaxel|docetaxel|mesh-list
101932250|NCT02154490|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101932251|NCT02154490|Palbociclib|palbociclib|mesh-list
101932252|NCT02154490|Tremelimumab|tremelimumab|mesh-list
101932253|NCT02154490|Talazoparib|talazoparib|mesh-list
101932254|NCT02154490|Antibodies|antibodies|mesh-list
101932255|NCT02154490|Immunoglobulins|immunoglobulins|mesh-list
101932256|NCT02154490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101932257|NCT02154490|Immunoglobulin G|immunoglobulin g|mesh-list
101932258|NCT02154490|Immunologic Factors|immunologic factors|mesh-ancestor
101932259|NCT02154490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932260|NCT02154490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101932261|NCT02154490|Tubulin Modulators|tubulin modulators|mesh-ancestor
101932262|NCT02154490|Antimitotic Agents|antimitotic agents|mesh-ancestor
101932263|NCT02154490|Mitosis Modulators|mitosis modulators|mesh-ancestor
101932264|NCT02154490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932265|NCT02154490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101932266|NCT02154490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101932267|NCT02154490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101932268|NCT02154490|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101932269|NCT01512316|Cycloserine|cycloserine|mesh-list
101932270|NCT01512316|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101932271|NCT01512316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101932272|NCT01512316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101932273|NCT01512316|Antitubercular Agents|antitubercular agents|mesh-ancestor
101932274|NCT01512316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101932275|NCT01512316|Antimetabolites|antimetabolites|mesh-ancestor
101232676|NCT04410406|Antimitotic Agents|antimitotic agents|mesh-ancestor
101932276|NCT01512316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932277|NCT03639740|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101958621|NCT00574496|Antimetabolites|antimetabolites|mesh-ancestor
101932278|NCT03639740|Immunologic Factors|immunologic factors|mesh-ancestor
101932279|NCT03639740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932280|NCT01048138|Biperiden|biperiden|mesh-list
101932281|NCT01048138|Biperiden lactate|biperiden lactate|mesh-list
101932282|NCT01048138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101932283|NCT01048138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101932285|NCT01048138|Autonomic Agents|autonomic agents|mesh-ancestor
101932286|NCT01048138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101932287|NCT01048138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932288|NCT01048138|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101932289|NCT01048138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101932290|NCT01048138|Cholinergic Agents|cholinergic agents|mesh-ancestor
101932291|NCT01048138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101932292|NCT01048138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932293|NCT00972478|Prednisone|prednisone|mesh-list
101932294|NCT00972478|Cortisone|cortisone|mesh-list
101932295|NCT00972478|Cyclophosphamide|cyclophosphamide|mesh-list
101932296|NCT00972478|Rituximab|rituximab|mesh-list
101932297|NCT00972478|Doxorubicin|doxorubicin|mesh-list
101932298|NCT00972478|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101932299|NCT00972478|Vincristine|vincristine|mesh-list
101932300|NCT00972478|Vorinostat|vorinostat|mesh-list
101932301|NCT00972478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101932302|NCT00972478|Antibodies|antibodies|mesh-list
101932303|NCT00972478|Immunoglobulins|immunoglobulins|mesh-list
101932304|NCT00972478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101932305|NCT00972478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101932306|NCT00972478|Immunologic Factors|immunologic factors|mesh-ancestor
101932307|NCT00972478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932308|NCT00972478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101932309|NCT00972478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101932310|NCT00972478|Alkylating Agents|alkylating agents|mesh-ancestor
101932311|NCT00972478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932312|NCT00972478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101932313|NCT00972478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101932314|NCT00972478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101932315|NCT00972478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101932316|NCT00972478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101932317|NCT00972478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101932318|NCT00972478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101932319|NCT00972478|Glucocorticoids|glucocorticoids|mesh-ancestor
101932320|NCT00972478|Hormones|hormones|mesh-ancestor
101932321|NCT00972478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101932322|NCT00972478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101932323|NCT00972478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101932324|NCT00972478|Tubulin Modulators|tubulin modulators|mesh-ancestor
101932325|NCT00972478|Antimitotic Agents|antimitotic agents|mesh-ancestor
101932326|NCT00972478|Mitosis Modulators|mitosis modulators|mesh-ancestor
101932327|NCT00972478|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101932328|NCT00823342|Tenofovir|tenofovir|mesh-list
101932329|NCT00823342|Clevudine|clevudine|mesh-list
101932330|NCT00823342|Antiviral Agents|antiviral agents|mesh-ancestor
101932331|NCT00823342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101932332|NCT00823342|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101932333|NCT00823342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101932334|NCT00823342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101932335|NCT00823342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932336|NCT00823342|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101932337|NCT00823342|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101932338|NCT01082445|Acetylcysteine|acetylcysteine|mesh-list
101932339|NCT01082445|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101932340|NCT01082445|Antiviral Agents|antiviral agents|mesh-ancestor
101932341|NCT01082445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101932342|NCT01082445|Expectorants|expectorants|mesh-ancestor
101932343|NCT01082445|Respiratory System Agents|respiratory system agents|mesh-ancestor
101932344|NCT01082445|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101932345|NCT01082445|Antioxidants|antioxidants|mesh-ancestor
101932346|NCT01082445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932347|NCT01082445|Protective Agents|protective agents|mesh-ancestor
101932348|NCT01082445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652175|NCT04116255|Salicylic Acid|salicylic acid|mesh-list
101932349|NCT01082445|Antidotes|antidotes|mesh-ancestor
101932350|NCT01085877|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101932351|NCT01085877|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101932353|NCT01085877|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101932354|NCT01085877|Estrogens|estrogens|mesh-ancestor
101932355|NCT01085877|Hormones|hormones|mesh-ancestor
101932356|NCT01085877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101932357|NCT01085877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932358|NCT01085877|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101932359|NCT01085877|Contraceptive Agents|contraceptive agents|mesh-ancestor
101932360|NCT01085877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101932361|NCT01085877|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101932363|NCT01089855|Anticonvulsants|anticonvulsants|mesh-ancestor
101932364|NCT01089855|Antimanic Agents|antimanic agents|mesh-ancestor
101932365|NCT01089855|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101932366|NCT01089855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101932367|NCT01089855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932368|NCT01089855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101932369|NCT01089855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101932370|NCT01089855|Analgesics|analgesics|mesh-ancestor
101932371|NCT01089855|Sensory System Agents|sensory system agents|mesh-ancestor
101932372|NCT01089855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101932373|NCT01089855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101932374|NCT01089855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101932375|NCT01089855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932376|NCT01089855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101932377|NCT01089855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101932378|NCT04132960|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
101932379|NCT04132960|Immunoconjugates|immunoconjugates|mesh-ancestor
101932380|NCT04132960|Immunologic Factors|immunologic factors|mesh-ancestor
101932381|NCT04132960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932382|NCT03980314|Nivolumab|nivolumab|mesh-list
101932383|NCT03980314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101932384|NCT03980314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101932385|NCT03980314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101932386|NCT03980314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932387|NCT03674320|Methyltestosterone|methyltestosterone|mesh-list
101932388|NCT03674320|Testosterone|testosterone|mesh-list
101932389|NCT03674320|Testosterone undecanoate|testosterone undecanoate|mesh-list
101932390|NCT03674320|Testosterone enanthate|testosterone enanthate|mesh-list
101932391|NCT03674320|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101932392|NCT03674320|Androgens|androgens|mesh-ancestor
101932393|NCT03674320|Hormones|hormones|mesh-ancestor
101932394|NCT03674320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101932395|NCT03674320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932396|NCT03674320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101932397|NCT03674320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101932398|NCT03674320|Anabolic Agents|anabolic agents|mesh-ancestor
101932399|NCT05457946|Vaccines|vaccines|mesh-list
101932400|NCT05457946|Immunologic Factors|immunologic factors|mesh-ancestor
101932401|NCT05457946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932402|NCT03625960|Cantharidin|cantharidin|mesh-list
101932403|NCT03625960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101932404|NCT03625960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932405|NCT03042910|Talazoparib|talazoparib|mesh-list
101932406|NCT03042910|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101932407|NCT03042910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101932408|NCT03042910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932409|NCT03042910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101932410|NCT03243838|Apatinib|apatinib|mesh-list
101932411|NCT03243838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101932412|NCT03243838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101932413|NCT03243838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101932414|NCT03243838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932415|NCT03059446|Cenicriviroc|cenicriviroc|mesh-list
101932416|NCT03059446|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101932417|NCT03059446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932418|NCT03059446|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101932419|NCT03059446|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101932420|NCT03059446|Antiviral Agents|antiviral agents|mesh-ancestor
101932421|NCT03059446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101932422|NCT00090519|Ruboxistaurin|ruboxistaurin|mesh-list
101932423|NCT00090519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101932424|NCT00090519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932425|NCT02980666|Teduglutide|teduglutide|mesh-list
101932426|NCT02980666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101932427|NCT02980666|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101932428|NCT02980666|Protective Agents|protective agents|mesh-ancestor
101932429|NCT02980666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932430|NCT02962102|Calcitriol|calcitriol|mesh-list
101932431|NCT02962102|Calcifediol|calcifediol|mesh-list
101932432|NCT02962102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101932433|NCT02962102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932434|NCT02962102|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101932435|NCT02962102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101932436|NCT02962102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932437|NCT02962102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101932439|NCT02962102|Micronutrients|micronutrients|mesh-ancestor
101932440|NCT02962102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101932441|NCT02947750|Folic Acid|folic acid|mesh-list
101932442|NCT02947750|Hematinics|hematinics|mesh-ancestor
101932443|NCT02947750|Vitamin B Complex|vitamin b complex|mesh-ancestor
101932444|NCT02947750|Vitamins|vitamins|mesh-ancestor
101932445|NCT02947750|Micronutrients|micronutrients|mesh-ancestor
101932446|NCT02947750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932447|NCT02630368|Cyclophosphamide|cyclophosphamide|mesh-list
101932448|NCT02630368|Avelumab|avelumab|mesh-list
101932449|NCT02630368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101932450|NCT02630368|Immunologic Factors|immunologic factors|mesh-ancestor
101932451|NCT02630368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932452|NCT02630368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101932453|NCT02630368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101932454|NCT02630368|Alkylating Agents|alkylating agents|mesh-ancestor
101932455|NCT02630368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932456|NCT02630368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101932457|NCT02630368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101932458|NCT02630368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101932459|NCT05244460|Diphenhydramine|diphenhydramine|mesh-list
101932460|NCT05244460|Promethazine|promethazine|mesh-list
101932461|NCT05244460|Droperidol|droperidol|mesh-list
101479123|NCT00285896|Incretins|incretins|mesh-ancestor
101932462|NCT05244460|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101932463|NCT05244460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101932464|NCT05244460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101932465|NCT05244460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932466|NCT05244460|Anesthetics, Local|anesthetics, local|mesh-ancestor
101932467|NCT05244460|Anesthetics|anesthetics|mesh-ancestor
101932468|NCT05244460|Sensory System Agents|sensory system agents|mesh-ancestor
101932469|NCT05244460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101932470|NCT05244460|Antiemetics|antiemetics|mesh-ancestor
101932471|NCT05244460|Autonomic Agents|autonomic agents|mesh-ancestor
101932472|NCT05244460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101932473|NCT05244460|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101932474|NCT05244460|Histamine Antagonists|histamine antagonists|mesh-ancestor
101932475|NCT05244460|Histamine Agents|histamine agents|mesh-ancestor
101932476|NCT05244460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101932477|NCT05244460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932478|NCT05244460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101932479|NCT05244460|Antipruritics|antipruritics|mesh-ancestor
101932480|NCT05244460|Dermatologic Agents|dermatologic agents|mesh-ancestor
101932481|NCT05244460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101932482|NCT05244460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101932483|NCT05244460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101932484|NCT05244460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101932485|NCT05244460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101932486|NCT05244460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101932487|NCT05244460|Dopamine Agents|dopamine agents|mesh-ancestor
101932488|NCT00096993|Gemcitabine|gemcitabine|mesh-list
101932489|NCT00096993|Pertuzumab|pertuzumab|mesh-list
101932490|NCT00096993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101932491|NCT00096993|Antimetabolites|antimetabolites|mesh-ancestor
101932492|NCT00096993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932493|NCT00096993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101932494|NCT00096993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101932495|NCT05172700|Pirtobrutinib|pirtobrutinib|mesh-list
101932496|NCT05172700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101932497|NCT05172700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101932498|NCT05172700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932499|NCT00072189|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
101932500|NCT00072189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101932501|NCT00072189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101932502|NCT00072189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101932503|NCT00072189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932505|NCT03040024|Analgesics|analgesics|mesh-ancestor
101932506|NCT03040024|Sensory System Agents|sensory system agents|mesh-ancestor
101617203|NCT04988256|Dermatologic Agents|dermatologic agents|mesh-ancestor
101932507|NCT03040024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101932508|NCT03040024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932509|NCT03040024|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101932511|NCT03040024|Anesthetics, General|anesthetics, general|mesh-ancestor
101932512|NCT03040024|Anesthetics|anesthetics|mesh-ancestor
101932513|NCT03040024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101932514|NCT03040024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101932515|NCT03040024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101932516|NCT03040024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101932517|NCT03040024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932518|NCT04716946|Durvalumab|durvalumab|mesh-list
101932519|NCT04716946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101932520|NCT04716946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101932521|NCT03038620|Liraglutide|liraglutide|mesh-list
101932522|NCT03038620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101932523|NCT03038620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932524|NCT03038620|Incretins|incretins|mesh-ancestor
101932525|NCT03038620|Hormones|hormones|mesh-ancestor
101932526|NCT03038620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101932527|NCT02032810|Ipilimumab|ipilimumab|mesh-list
101932528|NCT02032810|Panobinostat|panobinostat|mesh-list
101932529|NCT02032810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101932530|NCT02032810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101932531|NCT02032810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101932532|NCT02032810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932533|NCT02032810|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101932534|NCT02032810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101932535|NCT01415674|Afatinib|afatinib|mesh-list
101932536|NCT01415674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101932537|NCT01415674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101932538|NCT01415674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101932539|NCT01415674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932540|NCT01350934|Vitamin D|vitamin d|mesh-list
101932541|NCT01350934|Cholecalciferol|cholecalciferol|mesh-list
101932542|NCT01350934|Alendronate|alendronate|mesh-list
101932543|NCT01350934|Calcitriol|calcitriol|mesh-list
101932544|NCT01350934|Calcium|calcium|mesh-list
101932545|NCT01350934|Vitamins|vitamins|mesh-ancestor
101932546|NCT01350934|Micronutrients|micronutrients|mesh-ancestor
101932547|NCT01350934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932548|NCT01350934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101932549|NCT01350934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101932550|NCT01350934|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101932551|NCT01350934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101932552|NCT01350934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932553|NCT01350934|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101932554|NCT01146418|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101932555|NCT01146418|Hormones|hormones|mesh-ancestor
101932556|NCT01146418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101932557|NCT01146418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932558|NCT05654896|Ceftriaxone|ceftriaxone|mesh-list
101932559|NCT05654896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101932560|NCT05654896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101932561|NCT00745108|Tibolone|tibolone|mesh-list
101932562|NCT00745108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932563|NCT00745108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101932564|NCT00745108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101932565|NCT00745108|Hormones|hormones|mesh-ancestor
101932566|NCT00745108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101932567|NCT00745108|Androgen Antagonists|androgen antagonists|mesh-ancestor
101932568|NCT00745108|Hormone Antagonists|hormone antagonists|mesh-ancestor
101932569|NCT00745108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101932570|NCT00745108|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101932572|NCT00725374|Tibolone|tibolone|mesh-list
101932573|NCT00725374|Androgen Antagonists|androgen antagonists|mesh-ancestor
101932574|NCT00725374|Hormone Antagonists|hormone antagonists|mesh-ancestor
101932575|NCT00725374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101932576|NCT00725374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932577|NCT00725374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101932578|NCT00725374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101932579|NCT00725374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101932580|NCT00725374|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101932581|NCT00725374|Anabolic Agents|anabolic agents|mesh-ancestor
101932583|NCT03622580|Aflibercept|aflibercept|mesh-list
101932584|NCT03622580|Faricimab|faricimab|mesh-list
101932585|NCT03622580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101932586|NCT03622580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101932587|NCT03622580|Growth Substances|growth substances|mesh-ancestor
101932588|NCT03622580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932589|NCT03622580|Growth Inhibitors|growth inhibitors|mesh-ancestor
101232761|NCT03813121|Midazolam|midazolam|mesh-list
101932590|NCT03622580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101932591|NCT00461032|Montelukast|montelukast|mesh-list
101932592|NCT00461032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101932593|NCT00461032|Respiratory System Agents|respiratory system agents|mesh-ancestor
101932594|NCT00461032|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101932595|NCT00461032|Hormone Antagonists|hormone antagonists|mesh-ancestor
101932596|NCT00461032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101932597|NCT00461032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932598|NCT00461032|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101932599|NCT00461032|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101932600|NCT00461032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932601|NCT00446056|Ketotifen|ketotifen|mesh-list
101932602|NCT00446056|Montelukast|montelukast|mesh-list
101932603|NCT00446056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101932604|NCT00446056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932605|NCT00446056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932606|NCT00446056|Respiratory System Agents|respiratory system agents|mesh-ancestor
101932607|NCT00446056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101932608|NCT00446056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101932609|NCT00446056|Hormone Antagonists|hormone antagonists|mesh-ancestor
101932610|NCT00446056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101932611|NCT00446056|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101932612|NCT00446056|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101932613|NCT00446056|Antipruritics|antipruritics|mesh-ancestor
101932614|NCT00446056|Dermatologic Agents|dermatologic agents|mesh-ancestor
101932615|NCT00446056|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101932616|NCT00446056|Histamine Antagonists|histamine antagonists|mesh-ancestor
101932617|NCT00446056|Histamine Agents|histamine agents|mesh-ancestor
101932618|NCT00446056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101932619|NCT00389740|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101932620|NCT00389740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932621|NCT00389740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101932622|NCT00389740|Hormone Antagonists|hormone antagonists|mesh-ancestor
101932623|NCT00389740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101932624|NCT00389740|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101932625|NCT00389740|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101932626|NCT00389740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101932627|NCT00092092|Budesonide|budesonide|mesh-list
101932628|NCT00092092|Montelukast|montelukast|mesh-list
101958645|NCT02127190|CXA-10|cxa-10|mesh-list
101932629|NCT00092092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101932630|NCT00092092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101932631|NCT00092092|Autonomic Agents|autonomic agents|mesh-ancestor
101932632|NCT00092092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101932633|NCT00092092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932634|NCT00092092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101932635|NCT00092092|Respiratory System Agents|respiratory system agents|mesh-ancestor
101932636|NCT00092092|Glucocorticoids|glucocorticoids|mesh-ancestor
101932637|NCT00092092|Hormones|hormones|mesh-ancestor
101932638|NCT00092092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101932639|NCT00092092|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101932640|NCT00092092|Hormone Antagonists|hormone antagonists|mesh-ancestor
101932641|NCT00092092|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101932642|NCT00092092|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101932643|NCT00092092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932644|NCT00092014|Vitamin D|vitamin d|mesh-list
101932645|NCT00092014|Alendronate|alendronate|mesh-list
101932646|NCT00092014|Risedronic Acid|risedronic acid|mesh-list
101932647|NCT00092014|Calcium|calcium|mesh-list
101932648|NCT00092014|Vitamins|vitamins|mesh-ancestor
101932649|NCT00092014|Micronutrients|micronutrients|mesh-ancestor
101932650|NCT00092014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932651|NCT00092014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101932652|NCT00092014|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101932653|NCT00092014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101932654|NCT00092014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101932655|NCT00092014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932656|NCT00090142|Montelukast|montelukast|mesh-list
101932657|NCT00090142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101932658|NCT00090142|Respiratory System Agents|respiratory system agents|mesh-ancestor
101932659|NCT00090142|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101932660|NCT00090142|Hormone Antagonists|hormone antagonists|mesh-ancestor
101932661|NCT00090142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101932662|NCT00090142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932663|NCT00090142|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101932664|NCT00090142|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101932665|NCT00090142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932666|NCT00043108|Paclitaxel|paclitaxel|mesh-list
101932667|NCT00043108|Carboplatin|carboplatin|mesh-list
101932668|NCT00043108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101932669|NCT00043108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101932670|NCT00043108|Tubulin Modulators|tubulin modulators|mesh-ancestor
101932671|NCT00043108|Antimitotic Agents|antimitotic agents|mesh-ancestor
101932672|NCT00043108|Mitosis Modulators|mitosis modulators|mesh-ancestor
101932673|NCT00043108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932674|NCT03619408|Antacids|antacids|mesh-list
101932675|NCT03619408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932676|NCT03619408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101932677|NCT04032158|Interferon beta-1a|interferon beta-1a|mesh-list
101932678|NCT04032158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101932679|NCT04032158|Immunologic Factors|immunologic factors|mesh-ancestor
101932680|NCT04032158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932681|NCT04032158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101932682|NCT04032158|Antiviral Agents|antiviral agents|mesh-ancestor
101932683|NCT04032158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101932684|NCT03620708|Nicotine|nicotine|mesh-list
101932685|NCT03620708|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101932686|NCT03620708|Autonomic Agents|autonomic agents|mesh-ancestor
101932688|NCT03620708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932689|NCT03620708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101932690|NCT03620708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101932691|NCT03620708|Cholinergic Agents|cholinergic agents|mesh-ancestor
101932692|NCT03620708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101932693|NCT03620708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932694|NCT03654326|Naproxen|naproxen|mesh-list
101932695|NCT03654326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101932696|NCT03654326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101932697|NCT03654326|Analgesics|analgesics|mesh-ancestor
101932698|NCT03654326|Sensory System Agents|sensory system agents|mesh-ancestor
101932699|NCT03654326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101932700|NCT03654326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932701|NCT03654326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101932702|NCT03654326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101932703|NCT03654326|Gout Suppressants|gout suppressants|mesh-ancestor
101932704|NCT03654326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101932705|NCT03654326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101932706|NCT03654326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932707|NCT03735446|Cytarabine|cytarabine|mesh-list
101932708|NCT03735446|Etoposide|etoposide|mesh-list
101932709|NCT03735446|Mitoxantrone|mitoxantrone|mesh-list
101932710|NCT03735446|Prexasertib|prexasertib|mesh-list
101932711|NCT03735446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101932712|NCT03735446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101932713|NCT03735446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101932714|NCT03735446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101932715|NCT03735446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101932716|NCT03735446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932717|NCT03735446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101932718|NCT03735446|Antimetabolites|antimetabolites|mesh-ancestor
101932719|NCT03735446|Antiviral Agents|antiviral agents|mesh-ancestor
101932720|NCT03735446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101932721|NCT03735446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101932722|NCT03735446|Immunologic Factors|immunologic factors|mesh-ancestor
101932723|NCT03735446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932724|NCT03735446|Analgesics|analgesics|mesh-ancestor
101932725|NCT03735446|Sensory System Agents|sensory system agents|mesh-ancestor
101932726|NCT03735446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101932727|NCT03735446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101932728|NCT03735368|Pregabalin|pregabalin|mesh-list
101932729|NCT03735368|Dexmedetomidine|dexmedetomidine|mesh-list
101932730|NCT03735368|Benoxinate|benoxinate|mesh-list
101932731|NCT03735368|Anesthetics|anesthetics|mesh-ancestor
101932732|NCT03735368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101932733|NCT03735368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932734|NCT03735368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101932735|NCT03735368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101932736|NCT03735368|Analgesics|analgesics|mesh-ancestor
101932737|NCT03735368|Sensory System Agents|sensory system agents|mesh-ancestor
101932738|NCT03735368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101932739|NCT03735368|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101932740|NCT03735368|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101932741|NCT03735368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101932742|NCT03735368|Adrenergic Agents|adrenergic agents|mesh-ancestor
101932743|NCT03735368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101932744|NCT03735368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932745|NCT03735368|Anticonvulsants|anticonvulsants|mesh-ancestor
101932746|NCT03735368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101932747|NCT03735368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101932748|NCT03735368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101932749|NCT03735368|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101932750|NCT03735368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101932751|NCT03735368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101932752|NCT03735368|Anesthetics, Local|anesthetics, local|mesh-ancestor
101932753|NCT00071799|Cytarabine|cytarabine|mesh-list
101932754|NCT00071799|Azacitidine|azacitidine|mesh-list
101932755|NCT00071799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101932756|NCT00071799|Antimetabolites|antimetabolites|mesh-ancestor
101932757|NCT00071799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932758|NCT00071799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101932759|NCT00071799|Antiviral Agents|antiviral agents|mesh-ancestor
101932760|NCT00071799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101932761|NCT00071799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101932762|NCT00071799|Immunologic Factors|immunologic factors|mesh-ancestor
101932763|NCT00071799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932764|NCT00071799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101932765|NCT03615482|Vaccines|vaccines|mesh-list
101932766|NCT03615482|Immunologic Factors|immunologic factors|mesh-ancestor
101932767|NCT03615482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932768|NCT03652610|Vaccines|vaccines|mesh-list
101932769|NCT03652610|Immunologic Factors|immunologic factors|mesh-ancestor
101932770|NCT03652610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932771|NCT03615404|Molgramostim|molgramostim|mesh-list
101932772|NCT03615404|Sargramostim|sargramostim|mesh-list
101932773|NCT03615404|Immunologic Factors|immunologic factors|mesh-ancestor
101932774|NCT03615404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932775|NCT03615404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101932776|NCT03730064|Acetylcysteine|acetylcysteine|mesh-list
101932777|NCT03730064|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101932778|NCT03730064|Antiviral Agents|antiviral agents|mesh-ancestor
101932779|NCT03730064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101932780|NCT03730064|Expectorants|expectorants|mesh-ancestor
101932781|NCT03730064|Respiratory System Agents|respiratory system agents|mesh-ancestor
101932782|NCT03730064|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101932783|NCT03730064|Antioxidants|antioxidants|mesh-ancestor
101932784|NCT03730064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932785|NCT03730064|Protective Agents|protective agents|mesh-ancestor
101932786|NCT03730064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932787|NCT03730064|Antidotes|antidotes|mesh-ancestor
101932788|NCT03580382|Trametinib|trametinib|mesh-list
101932789|NCT03580382|Antibodies|antibodies|mesh-list
101932790|NCT03580382|Immunologic Factors|immunologic factors|mesh-ancestor
101932791|NCT03580382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932792|NCT03580382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101932793|NCT03580382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101932794|NCT03580382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101932795|NCT03580382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932796|NCT03577730|Caffeine|caffeine|mesh-list
101932797|NCT03577730|Caffeine citrate|caffeine citrate|mesh-list
101932798|NCT03577730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932799|NCT03577730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101932800|NCT03577730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932801|NCT03577730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101932802|NCT03577730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101932803|NCT03577730|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101932804|NCT03577730|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101932805|NCT03577730|Purinergic Agents|purinergic agents|mesh-ancestor
101932806|NCT03577730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101932808|NCT03731780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101932809|NCT03731780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101932810|NCT03731780|Disinfectants|disinfectants|mesh-ancestor
101932811|NCT03735134|Colchicine|colchicine|mesh-list
101932812|NCT03735134|Gout Suppressants|gout suppressants|mesh-ancestor
101932813|NCT03735134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101932814|NCT03735134|Tubulin Modulators|tubulin modulators|mesh-ancestor
101932815|NCT03735134|Antimitotic Agents|antimitotic agents|mesh-ancestor
101932816|NCT03735134|Mitosis Modulators|mitosis modulators|mesh-ancestor
101932817|NCT03735134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932818|NCT03735134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101932819|NCT03608774|Azithromycin|azithromycin|mesh-list
101932820|NCT03608774|Doxycycline|doxycycline|mesh-list
101932821|NCT03608774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101932822|NCT03608774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101932823|NCT03608774|Antimalarials|antimalarials|mesh-ancestor
101932824|NCT03608774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101932825|NCT03608774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101932826|NCT04021524|Chlorhexidine|chlorhexidine|mesh-list
101932827|NCT04021524|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101932828|NCT04021524|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101932829|NCT04021524|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101932830|NCT04021524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101932831|NCT04021524|Disinfectants|disinfectants|mesh-ancestor
101958669|NCT02127736|Amitriptyline|amitriptyline|mesh-list
101932833|NCT03729674|Infliximab|infliximab|mesh-list
101932834|NCT03729674|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101932835|NCT03729674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101932836|NCT03729674|Dermatologic Agents|dermatologic agents|mesh-ancestor
101932837|NCT03729674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101932838|NCT03729674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101932839|NCT03731468|Dexamethasone|dexamethasone|mesh-list
101932840|NCT03731468|Anesthetics|anesthetics|mesh-list
101932841|NCT03731468|Anesthetics, Local|anesthetics, local|mesh-list
101932842|NCT03731468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101932843|NCT03731468|Antiemetics|antiemetics|mesh-ancestor
101932844|NCT03731468|Autonomic Agents|autonomic agents|mesh-ancestor
101932845|NCT03731468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101232805|NCT03471507|Diclofenac|diclofenac|mesh-list
101932846|NCT03731468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932847|NCT03731468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101932848|NCT03731468|Glucocorticoids|glucocorticoids|mesh-ancestor
101932849|NCT03731468|Hormones|hormones|mesh-ancestor
101932850|NCT03731468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101932851|NCT03731468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101932852|NCT03731468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101932853|NCT03731468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101932854|NCT03731468|Sensory System Agents|sensory system agents|mesh-ancestor
101932855|NCT03600428|Vaccines|vaccines|mesh-list
101932856|NCT03600428|Immunologic Factors|immunologic factors|mesh-ancestor
101932857|NCT03600428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932858|NCT03575702|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101932859|NCT03575702|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101932860|NCT03575702|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101932861|NCT03575702|Cholinergic Agents|cholinergic agents|mesh-ancestor
101932862|NCT03575702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101932863|NCT03575702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932864|NCT03575702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932865|NCT03575702|Urological Agents|urological agents|mesh-ancestor
101932866|NCT03639896|Dexmedetomidine|dexmedetomidine|mesh-list
101932867|NCT03639896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101932868|NCT03639896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101932869|NCT03639896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932870|NCT03639896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101932871|NCT03639896|Analgesics|analgesics|mesh-ancestor
101932872|NCT03639896|Sensory System Agents|sensory system agents|mesh-ancestor
101932873|NCT03639896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101932874|NCT03639896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101932875|NCT03639896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101932876|NCT03639896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101932877|NCT03639896|Adrenergic Agents|adrenergic agents|mesh-ancestor
101932878|NCT03639896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101932879|NCT03639896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932880|NCT03573908|Linaclotide|linaclotide|mesh-list
101932881|NCT03573908|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
101932882|NCT03573908|Enzyme Activators|enzyme activators|mesh-ancestor
101932883|NCT03573908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932884|NCT03573908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101932885|NCT03729284|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101932886|NCT03729284|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101932887|NCT03729284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101932888|NCT03729284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101932889|NCT03729284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932890|NCT03729284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101932891|NCT03729284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932892|NCT03729284|Analgesics|analgesics|mesh-ancestor
101932893|NCT03729284|Sensory System Agents|sensory system agents|mesh-ancestor
101932894|NCT03729284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101932895|NCT03729284|Antidepressive Agents|antidepressive agents|mesh-ancestor
101958674|NCT02127736|Analgesics|analgesics|mesh-ancestor
101932896|NCT03729284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101932897|NCT03729284|Dopamine Agents|dopamine agents|mesh-ancestor
101932898|NCT03729128|Memantine|memantine|mesh-list
101932899|NCT03729128|Dextromethorphan|dextromethorphan|mesh-list
101932900|NCT03729128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101932901|NCT03729128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101932902|NCT03729128|Dopamine Agents|dopamine agents|mesh-ancestor
101932903|NCT03729128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101932904|NCT03729128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932905|NCT03729128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932906|NCT03729128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101932907|NCT03729128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101932908|NCT03729128|Antitussive Agents|antitussive agents|mesh-ancestor
101932909|NCT03729128|Respiratory System Agents|respiratory system agents|mesh-ancestor
101932910|NCT03734354|Brexpiprazole|brexpiprazole|mesh-list
101932911|NCT03734354|Serotonin Agents|serotonin agents|mesh-ancestor
101932912|NCT03734354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101932913|NCT03734354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932914|NCT03734354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932915|NCT03734354|Dopamine Agonists|dopamine agonists|mesh-ancestor
101932916|NCT03734354|Dopamine Agents|dopamine agents|mesh-ancestor
101932917|NCT03728894|Midazolam|midazolam|mesh-list
101932918|NCT03728894|Hydroxyzine|hydroxyzine|mesh-list
101932919|NCT03728894|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101932920|NCT03728894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101932921|NCT03728894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101932922|NCT03728894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932923|NCT03728894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101932924|NCT03728894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101932925|NCT03728894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101932926|NCT03728894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101932927|NCT03728894|Anesthetics, General|anesthetics, general|mesh-ancestor
101932928|NCT03728894|Anesthetics|anesthetics|mesh-ancestor
101932929|NCT03728894|GABA Modulators|gaba modulators|mesh-ancestor
101932930|NCT03728894|GABA Agents|gaba agents|mesh-ancestor
101932931|NCT03728894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101932932|NCT03728894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932933|NCT03728894|Antipruritics|antipruritics|mesh-ancestor
101932934|NCT03728894|Dermatologic Agents|dermatologic agents|mesh-ancestor
101932935|NCT03728894|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101932936|NCT03728894|Histamine Antagonists|histamine antagonists|mesh-ancestor
101932937|NCT03728894|Histamine Agents|histamine agents|mesh-ancestor
101932938|NCT03730766|Amoxicillin|amoxicillin|mesh-list
101932939|NCT03730766|Metronidazole|metronidazole|mesh-list
101932940|NCT03730766|Potassium Citrate|potassium citrate|mesh-list
101932941|NCT03730766|Esomeprazole|esomeprazole|mesh-list
101932942|NCT03730766|Bismuth|bismuth|mesh-list
101932943|NCT03730766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932944|NCT03730766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101932945|NCT03730766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101932946|NCT03730766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101932947|NCT03730766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101932948|NCT03730766|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101932949|NCT03730766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101932950|NCT03730766|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101932951|NCT03730766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101932953|NCT03730766|Diuretics|diuretics|mesh-ancestor
101932954|NCT03730766|Natriuretic Agents|natriuretic agents|mesh-ancestor
101932955|NCT03730766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932956|NCT03730766|Expectorants|expectorants|mesh-ancestor
101932957|NCT03730766|Respiratory System Agents|respiratory system agents|mesh-ancestor
101932958|NCT00071487|Belimumab|belimumab|mesh-list
101932959|NCT00071487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101932960|NCT00071487|Immunologic Factors|immunologic factors|mesh-ancestor
101932961|NCT00071487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932962|NCT03962283|Rifaximin|rifaximin|mesh-list
101932963|NCT03962283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101932964|NCT03962283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101932965|NCT03962283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101932966|NCT03591146|Ropivacaine|ropivacaine|mesh-list
101932967|NCT03591146|Anesthetics, Local|anesthetics, local|mesh-ancestor
101932968|NCT03591146|Anesthetics|anesthetics|mesh-ancestor
101932969|NCT03591146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101232823|NCT03468335|Irinotecan|irinotecan|mesh-list
101932970|NCT03591146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932971|NCT03591146|Sensory System Agents|sensory system agents|mesh-ancestor
101932972|NCT03591146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101932973|NCT00096447|Lapatinib|lapatinib|mesh-list
101932974|NCT00096447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101932975|NCT00096447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101932976|NCT00096447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101932977|NCT00096447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932978|NCT03588572|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101932979|NCT03588572|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101932980|NCT03588572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101932981|NCT03588572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101932982|NCT03588572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932983|NCT03588572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101932984|NCT03588572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932985|NCT03588572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101932986|NCT03588572|Antidepressive Agents|antidepressive agents|mesh-ancestor
101932987|NCT03588572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101932988|NCT00070941|Escitalopram|escitalopram|mesh-list
101932989|NCT00070941|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101932990|NCT00070941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101932991|NCT00070941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101932992|NCT00070941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101932993|NCT00070941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101932994|NCT00070941|Serotonin Agents|serotonin agents|mesh-ancestor
101932995|NCT00070941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101932996|NCT00070707|Mometasone Furoate|mometasone furoate|mesh-list
101932997|NCT00070707|Albuterol|albuterol|mesh-list
101932998|NCT00070707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101932999|NCT00070707|Autonomic Agents|autonomic agents|mesh-ancestor
101933000|NCT00070707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101933001|NCT00070707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933002|NCT00070707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101933003|NCT00070707|Respiratory System Agents|respiratory system agents|mesh-ancestor
101933004|NCT00070707|Tocolytic Agents|tocolytic agents|mesh-ancestor
101933005|NCT00070707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101933006|NCT00070707|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101933007|NCT00070707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101933008|NCT00070707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101933009|NCT00070707|Adrenergic Agents|adrenergic agents|mesh-ancestor
101933010|NCT00070707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101958708|NCT02122510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101933011|NCT00070707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933012|NCT00070707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101933013|NCT00070707|Dermatologic Agents|dermatologic agents|mesh-ancestor
101933014|NCT00070707|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101933015|NCT03036124|Dapagliflozin|dapagliflozin|mesh-list
101933016|NCT03036124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101933017|NCT03036124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933018|NCT03036124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101933019|NCT03036124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933020|NCT00070317|Methylene Blue|methylene blue|mesh-list
101933021|NCT00070317|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
101933022|NCT00070317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101933023|NCT00070317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933024|NCT00070317|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101933025|NCT01086345|Bevacizumab|bevacizumab|mesh-list
101933026|NCT01086345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101933027|NCT01086345|Irinotecan|irinotecan|mesh-list
101933028|NCT01086345|Camptothecin|camptothecin|mesh-list
101933029|NCT01086345|Antibodies|antibodies|mesh-list
101933030|NCT01086345|Immunoglobulins|immunoglobulins|mesh-list
101933031|NCT01086345|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101933032|NCT01086345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101933033|NCT01086345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101933034|NCT01086345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101933035|NCT01086345|Growth Substances|growth substances|mesh-ancestor
101933036|NCT01086345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933037|NCT01086345|Growth Inhibitors|growth inhibitors|mesh-ancestor
101933038|NCT01086345|Immunologic Factors|immunologic factors|mesh-ancestor
101933039|NCT01086345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101933040|NCT01086345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101933041|NCT01086345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101933042|NCT01086345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933043|NCT01086345|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101933044|NCT01089933|Anesthetics|anesthetics|mesh-list
101933045|NCT01089933|Anesthetics, Local|anesthetics, local|mesh-list
101933046|NCT01089933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101933047|NCT01089933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933048|NCT01089933|Sensory System Agents|sensory system agents|mesh-ancestor
101933049|NCT01089933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101933050|NCT03960411|Doxycycline|doxycycline|mesh-list
101933051|NCT03960411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101933052|NCT03960411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101933053|NCT03960411|Antimalarials|antimalarials|mesh-ancestor
101933054|NCT03960411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101933055|NCT03960411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101933056|NCT01090167|Clofarabine|clofarabine|mesh-list
101933057|NCT01090167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101933058|NCT01090167|Antimetabolites|antimetabolites|mesh-ancestor
101933059|NCT01090167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933060|NCT01090167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101933061|NCT03587636|Bupivacaine|bupivacaine|mesh-list
101933062|NCT03587636|Anesthetics, Local|anesthetics, local|mesh-ancestor
101933063|NCT03587636|Anesthetics|anesthetics|mesh-ancestor
101933064|NCT03587636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101933065|NCT03587636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933066|NCT03587636|Sensory System Agents|sensory system agents|mesh-ancestor
101933067|NCT03587636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101933068|NCT03053362|Vortioxetine|vortioxetine|mesh-list
101933069|NCT03053362|Antidepressive Agents|antidepressive agents|mesh-ancestor
101933070|NCT03053362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101933071|NCT03053362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101933072|NCT03053362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101933073|NCT03053362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101933074|NCT03053362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933075|NCT03053362|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101933076|NCT03053362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101933077|NCT03053362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101933078|NCT03053362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933079|NCT03053362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101933081|NCT03053362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101933082|NCT03053362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101933083|NCT03053362|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101933084|NCT03053362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101933085|NCT03733652|Interferons|interferons|mesh-list
101933086|NCT03733652|Interferon-alpha|interferon-alpha|mesh-list
101933087|NCT03733652|Interferon alpha-2|interferon alpha-2|mesh-list
101933088|NCT03733652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101933089|NCT03733652|Antiviral Agents|antiviral agents|mesh-ancestor
101933090|NCT03733652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101933091|NCT03733652|Immunologic Factors|immunologic factors|mesh-ancestor
101933092|NCT03733652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933093|NCT03586544|Albuterol|albuterol|mesh-list
101933094|NCT03586544|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101933095|NCT03586544|Autonomic Agents|autonomic agents|mesh-ancestor
101933096|NCT03586544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101933097|NCT03586544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933098|NCT03586544|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101933099|NCT03586544|Respiratory System Agents|respiratory system agents|mesh-ancestor
101933100|NCT03586544|Tocolytic Agents|tocolytic agents|mesh-ancestor
101933101|NCT03586544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101933102|NCT03586544|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101933103|NCT03586544|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101933104|NCT03586544|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101933105|NCT03586544|Adrenergic Agents|adrenergic agents|mesh-ancestor
101933106|NCT03586544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101933107|NCT03586544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933108|NCT03737448|Trimetazidine|trimetazidine|mesh-list
101933109|NCT03737448|Vasodilator Agents|vasodilator agents|mesh-ancestor
101933110|NCT03733574|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101933111|NCT03733574|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101933112|NCT03733574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101933113|NCT03733574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101933114|NCT03733574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933115|NCT03733574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101933116|NCT03733574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933117|NCT03733574|Antidepressive Agents|antidepressive agents|mesh-ancestor
101933118|NCT03733574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101933119|NCT03728192|Camptothecin|camptothecin|mesh-list
101933120|NCT03728192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101933121|NCT03728192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101933122|NCT03728192|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101933123|NCT03728192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101933124|NCT03728192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101933125|NCT03728192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933126|NCT03589768|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101933127|NCT03589768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101933128|NCT03589768|Immunologic Factors|immunologic factors|mesh-ancestor
101933129|NCT03589768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933130|NCT03589768|Antacids|antacids|mesh-ancestor
101933131|NCT03589768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933132|NCT03589768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101933133|NCT03733340|Imipenem|imipenem|mesh-list
101933134|NCT03733340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101933135|NCT03733340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101933136|NCT05183308|Clodronic Acid|clodronic acid|mesh-list
101933137|NCT05183308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101933138|NCT05183308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933139|NCT05137600|Clarithromycin|clarithromycin|mesh-list
101933140|NCT05137600|Midazolam|midazolam|mesh-list
101933141|NCT05137600|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101933142|NCT05137600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101933143|NCT05137600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101933144|NCT05137600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933145|NCT05137600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101933146|NCT05137600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101933147|NCT05137600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101933148|NCT05137600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101232866|NCT02965716|Pembrolizumab|pembrolizumab|mesh-list
101933149|NCT05137600|Anesthetics, General|anesthetics, general|mesh-ancestor
101933150|NCT05137600|Anesthetics|anesthetics|mesh-ancestor
101933151|NCT05137600|GABA Modulators|gaba modulators|mesh-ancestor
101933152|NCT05137600|GABA Agents|gaba agents|mesh-ancestor
101933153|NCT05137600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101933154|NCT05137600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933155|NCT05137600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101933156|NCT05137600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101933157|NCT05137600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101933158|NCT05137600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101933159|NCT05137600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101933160|NCT05137600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101933161|NCT00089505|Ritonavir|ritonavir|mesh-list
101933162|NCT00089505|Lopinavir|lopinavir|mesh-list
101933163|NCT00089505|Tenofovir|tenofovir|mesh-list
101933164|NCT00089505|Emtricitabine|emtricitabine|mesh-list
101933165|NCT00089505|Nevirapine|nevirapine|mesh-list
101933166|NCT00089505|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101933167|NCT00089505|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101933168|NCT00089505|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101933169|NCT00089505|Protease Inhibitors|protease inhibitors|mesh-ancestor
101933170|NCT00089505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101933171|NCT00089505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933172|NCT00089505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101933173|NCT00089505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101933174|NCT00089505|Antiviral Agents|antiviral agents|mesh-ancestor
101933175|NCT00089505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101933176|NCT00089505|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101933177|NCT00089505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101933178|NCT00089505|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101933179|NCT00089505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101933180|NCT00089505|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101933181|NCT00089505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101933182|NCT04009824|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101933183|NCT04009824|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101933184|NCT04009824|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101933185|NCT04009824|Immunologic Factors|immunologic factors|mesh-ancestor
101933186|NCT04009824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933188|NCT04009824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933189|NCT04009824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101933190|NCT05041426|Valganciclovir|valganciclovir|mesh-list
101933191|NCT05041426|Letermovir|letermovir|mesh-list
101933192|NCT05041426|Antiviral Agents|antiviral agents|mesh-ancestor
101933193|NCT05041426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101933194|NCT05041426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101933195|NCT05041426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101933196|NCT05041426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933197|NCT05041426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101933198|NCT04987372|Lidocaine|lidocaine|mesh-list
101933199|NCT04987372|Magnesium Sulfate|magnesium sulfate|mesh-list
101933200|NCT04987372|Pregabalin|pregabalin|mesh-list
101933201|NCT04987372|Dexmedetomidine|dexmedetomidine|mesh-list
101933202|NCT04987372|Ketamine|ketamine|mesh-list
101933203|NCT04987372|Anesthetics, Local|anesthetics, local|mesh-ancestor
101933204|NCT04987372|Anesthetics|anesthetics|mesh-ancestor
101933205|NCT04987372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101933206|NCT04987372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933207|NCT04987372|Sensory System Agents|sensory system agents|mesh-ancestor
101933208|NCT04987372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101933209|NCT04987372|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101933210|NCT04987372|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101933211|NCT04987372|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101933212|NCT04987372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101933213|NCT04987372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232881|NCT02909686|Curcumin|curcumin|mesh-list
101933214|NCT04987372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101933215|NCT04987372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101933216|NCT04987372|Analgesics|analgesics|mesh-ancestor
101933217|NCT04987372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101933218|NCT04987372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101933219|NCT04987372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101933220|NCT04987372|Adrenergic Agents|adrenergic agents|mesh-ancestor
101933221|NCT04987372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101958719|NCT02128126|Immunologic Factors|immunologic factors|mesh-ancestor
101933222|NCT04987372|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101933223|NCT04987372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101933224|NCT04987372|Anesthetics, General|anesthetics, general|mesh-ancestor
101933225|NCT04987372|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101933226|NCT04987372|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101933227|NCT04987372|Anticonvulsants|anticonvulsants|mesh-ancestor
101933228|NCT04987372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101933229|NCT04987372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101933230|NCT04987372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101933231|NCT04987372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101933232|NCT04987372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101933233|NCT04987372|Tocolytic Agents|tocolytic agents|mesh-ancestor
101933234|NCT04987372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101933235|NCT03555890|Cetirizine|cetirizine|mesh-list
101933236|NCT03555890|Levocetirizine|levocetirizine|mesh-list
101933237|NCT03555890|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101933238|NCT03555890|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101933239|NCT03555890|Histamine Antagonists|histamine antagonists|mesh-ancestor
101933240|NCT03555890|Histamine Agents|histamine agents|mesh-ancestor
101933241|NCT03555890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101933242|NCT03555890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933243|NCT03555890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933244|NCT03555890|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101933245|NCT04905862|Antipyretics|antipyretics|mesh-list
101933246|NCT04905862|Analgesics|analgesics|mesh-list
101933247|NCT04905862|Sensory System Agents|sensory system agents|mesh-ancestor
101933248|NCT04905862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101933249|NCT04905862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933250|NCT03630120|Sorafenib|sorafenib|mesh-list
101933251|NCT03630120|Lenvatinib|lenvatinib|mesh-list
101933252|NCT03630120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101933253|NCT03630120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101933254|NCT03630120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101933255|NCT03630120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933256|NCT03744702|Ascorbic Acid|ascorbic acid|mesh-list
101933257|NCT03744702|Antioxidants|antioxidants|mesh-ancestor
101933258|NCT03744702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933259|NCT03744702|Protective Agents|protective agents|mesh-ancestor
101933260|NCT03744702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933261|NCT03744702|Vitamins|vitamins|mesh-ancestor
101933262|NCT03744702|Micronutrients|micronutrients|mesh-ancestor
101933263|NCT03736980|Psilocybin|psilocybin|mesh-list
101933264|NCT03736980|Hallucinogens|hallucinogens|mesh-ancestor
101933265|NCT03736980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933266|NCT03736980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101933267|NCT03727646|Niacinamide|niacinamide|mesh-list
101933268|NCT03727646|Niacin|niacin|mesh-list
101933269|NCT03727646|Nicotinic Acids|nicotinic acids|mesh-list
101933270|NCT03727646|Vitamin B Complex|vitamin b complex|mesh-ancestor
101933271|NCT03727646|Vitamins|vitamins|mesh-ancestor
101933272|NCT03727646|Micronutrients|micronutrients|mesh-ancestor
101933273|NCT03727646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933274|NCT03727646|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101933275|NCT03727646|Antimetabolites|antimetabolites|mesh-ancestor
101933276|NCT03727646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933277|NCT03727646|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101933278|NCT03727646|Vasodilator Agents|vasodilator agents|mesh-ancestor
101933279|NCT05666336|Mycophenolic Acid|mycophenolic acid|mesh-list
101933280|NCT05666336|Hydroxychloroquine|hydroxychloroquine|mesh-list
101933281|NCT05666336|Prednisone|prednisone|mesh-list
101933282|NCT05666336|Methylprednisolone|methylprednisolone|mesh-list
101933283|NCT05666336|Cyclophosphamide|cyclophosphamide|mesh-list
101933284|NCT05666336|Tacrolimus|tacrolimus|mesh-list
101933285|NCT05666336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101933286|NCT05666336|Immunologic Factors|immunologic factors|mesh-ancestor
101933287|NCT05666336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933288|NCT05666336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101933289|NCT05666336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101933290|NCT05666336|Alkylating Agents|alkylating agents|mesh-ancestor
101933291|NCT05666336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933292|NCT05666336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101933293|NCT05666336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101958722|NCT02128204|Anesthetics, Local|anesthetics, local|mesh-ancestor
101933294|NCT05666336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101933295|NCT05666336|Glucocorticoids|glucocorticoids|mesh-ancestor
101933296|NCT05666336|Hormones|hormones|mesh-ancestor
101933297|NCT05666336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101933298|NCT05666336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101933299|NCT05666336|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101933300|NCT05666336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101933301|NCT05666336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101933302|NCT05666336|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101933303|NCT05666336|Antitubercular Agents|antitubercular agents|mesh-ancestor
101933304|NCT05666336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101933305|NCT05666336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101933306|NCT05666336|Antiemetics|antiemetics|mesh-ancestor
101933307|NCT05666336|Autonomic Agents|autonomic agents|mesh-ancestor
101933308|NCT05666336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101933309|NCT05666336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101933310|NCT05666336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101933311|NCT05666336|Protective Agents|protective agents|mesh-ancestor
101933312|NCT05666336|Antimalarials|antimalarials|mesh-ancestor
101933313|NCT05666336|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101933314|NCT05666336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101933315|NCT03554486|Insulin|insulin|mesh-list
101933316|NCT03554486|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101933317|NCT03554486|Insulin Aspart|insulin aspart|mesh-list
101933318|NCT03554486|Insulin, Long-Acting|insulin, long-acting|mesh-list
101933319|NCT03554486|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101933320|NCT03554486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101653149|NCT00910988|Olanzapine|olanzapine|mesh-list
101933321|NCT03554486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933322|NCT03554018|Acetaminophen|acetaminophen|mesh-list
101933323|NCT03554018|Ibuprofen|ibuprofen|mesh-list
101933324|NCT03554018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101933325|NCT03554018|Analgesics|analgesics|mesh-ancestor
101933326|NCT03554018|Sensory System Agents|sensory system agents|mesh-ancestor
101933327|NCT03554018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101933328|NCT03554018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933329|NCT03554018|Antipyretics|antipyretics|mesh-ancestor
101933330|NCT03554018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101933331|NCT03554018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101933332|NCT03554018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101933333|NCT03554018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101933334|NCT03554018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101933335|NCT03554018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933336|NCT05462938|Dexmedetomidine|dexmedetomidine|mesh-list
101933337|NCT05462938|Propofol|propofol|mesh-list
101933338|NCT05462938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101933339|NCT05462938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101933340|NCT05462938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933341|NCT05462938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101933342|NCT05462938|Analgesics|analgesics|mesh-ancestor
101933343|NCT05462938|Sensory System Agents|sensory system agents|mesh-ancestor
101933344|NCT05462938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101933345|NCT05462938|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101933346|NCT05462938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101933347|NCT05462938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101933348|NCT05462938|Adrenergic Agents|adrenergic agents|mesh-ancestor
101933349|NCT05462938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101933350|NCT05462938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933351|NCT05462938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101933352|NCT05462938|Anesthetics, General|anesthetics, general|mesh-ancestor
101933353|NCT05462938|Anesthetics|anesthetics|mesh-ancestor
101933354|NCT04787692|Analgesics, Opioid|analgesics, opioid|mesh-list
101933355|NCT04787692|Narcotics|narcotics|mesh-ancestor
101933356|NCT04787692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101933357|NCT04787692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933358|NCT04787692|Analgesics|analgesics|mesh-ancestor
101933359|NCT04787692|Sensory System Agents|sensory system agents|mesh-ancestor
101933360|NCT04787692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101933361|NCT05462548|Luspatercept|luspatercept|mesh-list
101933362|NCT05462548|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
101933363|NCT05462548|Hematinics|hematinics|mesh-ancestor
101933364|NCT05462548|Immunologic Factors|immunologic factors|mesh-ancestor
101933365|NCT05462548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933366|NCT03408340|Fentanyl|fentanyl|mesh-list
101933367|NCT03408340|Ketamine|ketamine|mesh-list
101933368|NCT03408340|Propofol|propofol|mesh-list
101933369|NCT03408340|Sevoflurane|sevoflurane|mesh-list
101933370|NCT03408340|Rocuronium|rocuronium|mesh-list
101933371|NCT03408340|Anesthetics|anesthetics|mesh-ancestor
101933372|NCT03408340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101933373|NCT03408340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933374|NCT03408340|Sensory System Agents|sensory system agents|mesh-ancestor
101933375|NCT03408340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101933376|NCT03408340|Analgesics|analgesics|mesh-ancestor
101933377|NCT03408340|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101933378|NCT03408340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101933379|NCT03408340|Anesthetics, General|anesthetics, general|mesh-ancestor
101933380|NCT03408340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101933381|NCT03408340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101933382|NCT03408340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101933383|NCT03408340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933384|NCT03408340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101933385|NCT03408340|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101933386|NCT03408340|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101933387|NCT03408340|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101933388|NCT03408340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101933389|NCT03408340|Narcotics|narcotics|mesh-ancestor
101933390|NCT03408340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101933391|NCT03408340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101933393|NCT03570554|Acetaminophen|acetaminophen|mesh-list
101933394|NCT03570554|Celecoxib|celecoxib|mesh-list
101933395|NCT03570554|Naproxen|naproxen|mesh-list
101933396|NCT03570554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101933397|NCT03570554|Analgesics|analgesics|mesh-ancestor
101933398|NCT03570554|Sensory System Agents|sensory system agents|mesh-ancestor
101933399|NCT03570554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101933400|NCT03570554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933401|NCT03570554|Antipyretics|antipyretics|mesh-ancestor
101933402|NCT03570554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101933403|NCT03570554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101933404|NCT03570554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101933405|NCT03570554|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101933406|NCT03570554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101933407|NCT03570554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101933408|NCT03570554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933409|NCT03570554|Gout Suppressants|gout suppressants|mesh-ancestor
101933410|NCT04004208|Aflibercept|aflibercept|mesh-list
101933411|NCT04004208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101933412|NCT04004208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101933413|NCT04004208|Growth Substances|growth substances|mesh-ancestor
101933414|NCT04004208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933415|NCT04004208|Growth Inhibitors|growth inhibitors|mesh-ancestor
101933416|NCT04004208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101933417|NCT03727412|Naproxen|naproxen|mesh-list
101933418|NCT03727412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101933419|NCT03727412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101933420|NCT03727412|Analgesics|analgesics|mesh-ancestor
101933421|NCT03727412|Sensory System Agents|sensory system agents|mesh-ancestor
101933422|NCT03727412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101933423|NCT03727412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933424|NCT03727412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101933425|NCT03727412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101933426|NCT03727412|Gout Suppressants|gout suppressants|mesh-ancestor
101933427|NCT03727412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101933428|NCT03727412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101933429|NCT03727412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933430|NCT03643952|Daptomycin|daptomycin|mesh-list
101933431|NCT03643952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101933432|NCT03643952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101933433|NCT03035032|Leuprolide|leuprolide|mesh-list
101933434|NCT03035032|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101933435|NCT03035032|Fertility Agents|fertility agents|mesh-ancestor
101933436|NCT03035032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101933437|NCT03035032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933438|NCT03035032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101933439|NCT03035032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101933440|NCT03629184|Oseltamivir|oseltamivir|mesh-list
101933441|NCT03629184|Baloxavir|baloxavir|mesh-list
101933442|NCT03629184|Antiviral Agents|antiviral agents|mesh-ancestor
101933443|NCT03629184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101933444|NCT03629184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101933445|NCT03629184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933446|NCT03725228|Lidocaine|lidocaine|mesh-list
101933447|NCT03725228|Magnesium Sulfate|magnesium sulfate|mesh-list
101933448|NCT03725228|Anesthetics, Local|anesthetics, local|mesh-ancestor
101933449|NCT03725228|Anesthetics|anesthetics|mesh-ancestor
101933450|NCT03725228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101933451|NCT03725228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933452|NCT03725228|Sensory System Agents|sensory system agents|mesh-ancestor
101933453|NCT03725228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101933454|NCT03725228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101933455|NCT03725228|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101933456|NCT03725228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101933457|NCT03725228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101933458|NCT03725228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933459|NCT03725228|Analgesics|analgesics|mesh-ancestor
101933460|NCT03725228|Anticonvulsants|anticonvulsants|mesh-ancestor
101933461|NCT03725228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101933462|NCT03725228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101933463|NCT03725228|Tocolytic Agents|tocolytic agents|mesh-ancestor
101933464|NCT03725228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101933465|NCT03724838|Sildenafil Citrate|sildenafil citrate|mesh-list
101933466|NCT03724838|Esomeprazole|esomeprazole|mesh-list
101933467|NCT03724838|Citric Acid|citric acid|mesh-list
101933468|NCT03724838|Sodium Citrate|sodium citrate|mesh-list
101933469|NCT03724838|Anticoagulants|anticoagulants|mesh-ancestor
101933470|NCT03724838|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101933471|NCT03724838|Chelating Agents|chelating agents|mesh-ancestor
101933472|NCT03724838|Sequestering Agents|sequestering agents|mesh-ancestor
101653332|NCT04449536|Mesna|mesna|mesh-list
101933473|NCT03724838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933474|NCT03724838|Vasodilator Agents|vasodilator agents|mesh-ancestor
101933475|NCT03724838|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101933476|NCT03724838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101933477|NCT03724838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101933478|NCT03724838|Urological Agents|urological agents|mesh-ancestor
101933479|NCT03724838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101933480|NCT03724838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101933481|NCT03724838|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101933482|NCT02892344|Mometasone Furoate|mometasone furoate|mesh-list
101933483|NCT02892344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101933484|NCT02892344|Dermatologic Agents|dermatologic agents|mesh-ancestor
101933485|NCT02892344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101933487|NCT03727100|Analgesics|analgesics|mesh-ancestor
101933488|NCT03727100|Sensory System Agents|sensory system agents|mesh-ancestor
101933489|NCT03727100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101933490|NCT03727100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933491|NCT03727100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101933492|NCT03727100|Sympatholytics|sympatholytics|mesh-ancestor
101933493|NCT03727100|Autonomic Agents|autonomic agents|mesh-ancestor
101933494|NCT03727100|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101933495|NCT03727100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101933496|NCT03727100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101933497|NCT03727100|Adrenergic Agents|adrenergic agents|mesh-ancestor
101933498|NCT03727100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101933499|NCT03727100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933500|NCT03358030|Riboflavin|riboflavin|mesh-list
101933501|NCT03358030|Vitamin B Complex|vitamin b complex|mesh-ancestor
101933502|NCT03358030|Vitamins|vitamins|mesh-ancestor
101933503|NCT03358030|Micronutrients|micronutrients|mesh-ancestor
101933504|NCT03358030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933505|NCT03358030|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101933506|NCT03358030|Dermatologic Agents|dermatologic agents|mesh-ancestor
101933507|NCT03566810|Metformin|metformin|mesh-list
101933508|NCT03566810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101933509|NCT03566810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933510|NCT03628716|Atezolizumab|atezolizumab|mesh-list
101933511|NCT03628716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101933512|NCT03628716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933513|NCT03628716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101933514|NCT03628716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101933515|NCT03840616|Fluconazole|fluconazole|mesh-list
101933516|NCT03840616|Antifungal Agents|antifungal agents|mesh-ancestor
101933517|NCT03840616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101933518|NCT03840616|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101933519|NCT03840616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101933520|NCT03840616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101933521|NCT03840616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933522|NCT03840616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101933523|NCT03840616|Hormone Antagonists|hormone antagonists|mesh-ancestor
101933524|NCT03840616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101933525|NCT03840616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933526|NCT03840616|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101933527|NCT03840616|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101933528|NCT00088413|Molgramostim|molgramostim|mesh-list
101933529|NCT00088413|Sargramostim|sargramostim|mesh-list
101933530|NCT00088413|Immunologic Factors|immunologic factors|mesh-ancestor
101933531|NCT00088413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933532|NCT00088413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101933533|NCT03787654|Solifenacin Succinate|solifenacin succinate|mesh-list
101933534|NCT03787654|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101933535|NCT03787654|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101933536|NCT03787654|Cholinergic Agents|cholinergic agents|mesh-ancestor
101933537|NCT03787654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101933538|NCT03787654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933539|NCT03787654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933540|NCT03787654|Urological Agents|urological agents|mesh-ancestor
101933541|NCT00086385|Bupropion|bupropion|mesh-list
101933543|NCT00086385|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101933544|NCT00086385|Autonomic Agents|autonomic agents|mesh-ancestor
101933545|NCT00086385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101933546|NCT00086385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933547|NCT00086385|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101933548|NCT00086385|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101933549|NCT00086385|Cholinergic Agents|cholinergic agents|mesh-ancestor
101933550|NCT00086385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101933551|NCT00086385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933552|NCT00086385|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101933553|NCT00086385|Antidepressive Agents|antidepressive agents|mesh-ancestor
101933554|NCT00086385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101933555|NCT00086385|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101933556|NCT00086385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101933557|NCT00086385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101933558|NCT00086385|Dopamine Agents|dopamine agents|mesh-ancestor
101933559|NCT00086385|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101933560|NCT00086385|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101933561|NCT00086385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101933562|NCT03993288|Iron|iron|mesh-list
101933563|NCT03993288|Trace Elements|trace elements|mesh-ancestor
101933564|NCT03993288|Micronutrients|micronutrients|mesh-ancestor
101933565|NCT03993288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933566|NCT05093608|Bevacizumab|bevacizumab|mesh-list
101933567|NCT05093608|Atezolizumab|atezolizumab|mesh-list
101933568|NCT05093608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101933569|NCT05093608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101933570|NCT05093608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101933571|NCT05093608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101933572|NCT05093608|Growth Substances|growth substances|mesh-ancestor
101933573|NCT05093608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933574|NCT05093608|Growth Inhibitors|growth inhibitors|mesh-ancestor
101933575|NCT05093608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101933576|NCT05093608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933577|NCT03991494|Pamiparib|pamiparib|mesh-list
101933578|NCT03991494|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101933579|NCT03991494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101933580|NCT03991494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933581|NCT03991494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101232955|NCT02527564|Suvorexant|suvorexant|mesh-list
101232956|NCT02527564|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101933582|NCT03736044|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
101933583|NCT03736044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101933584|NCT03383770|Anesthetics|anesthetics|mesh-list
101933585|NCT03383770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101933586|NCT03383770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933587|NCT00086307|Pramipexole|pramipexole|mesh-list
101933588|NCT00086307|Escitalopram|escitalopram|mesh-list
101933589|NCT00086307|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101933590|NCT00086307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101933591|NCT00086307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101933592|NCT00086307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933593|NCT00086307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101933594|NCT00086307|Serotonin Agents|serotonin agents|mesh-ancestor
101933595|NCT00086307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933596|NCT00086307|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101933597|NCT00086307|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101933598|NCT00086307|Antioxidants|antioxidants|mesh-ancestor
101933599|NCT00086307|Protective Agents|protective agents|mesh-ancestor
101933600|NCT00086307|Dopamine Agonists|dopamine agonists|mesh-ancestor
101933601|NCT00086307|Dopamine Agents|dopamine agents|mesh-ancestor
101933602|NCT01086579|Paclitaxel|paclitaxel|mesh-list
101933603|NCT01086579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101933604|NCT01086579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101933605|NCT01086579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101933606|NCT01086579|Tubulin Modulators|tubulin modulators|mesh-ancestor
101933607|NCT01086579|Antimitotic Agents|antimitotic agents|mesh-ancestor
101933608|NCT01086579|Mitosis Modulators|mitosis modulators|mesh-ancestor
101933609|NCT01086579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933610|NCT03743922|Ergocalciferols|ergocalciferols|mesh-list
101933611|NCT03743922|Cholecalciferol|cholecalciferol|mesh-list
101933612|NCT03743922|Vitamin D|vitamin d|mesh-list
101933613|NCT03743922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101617214|NCT00848536|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101933614|NCT03743922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933616|NCT03743922|Micronutrients|micronutrients|mesh-ancestor
101933617|NCT03743922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101933618|NCT03988842|Heparin|heparin|mesh-list
101933619|NCT03988842|Calcium heparin|calcium heparin|mesh-list
101933620|NCT03988842|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101933621|NCT03988842|Plasminogen|plasminogen|mesh-list
101933622|NCT03988842|Apixaban|apixaban|mesh-list
101933623|NCT03988842|Anticoagulants|anticoagulants|mesh-ancestor
101933624|NCT03988842|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101933625|NCT03988842|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101933626|NCT03988842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958765|NCT00688376|Donepezil|donepezil|mesh-list
101933627|NCT03988842|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101232966|NCT02179749|Mifepristone|mifepristone|mesh-list
101232967|NCT02179749|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101933628|NCT03988842|Antithrombins|antithrombins|mesh-ancestor
101933629|NCT03988842|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101933630|NCT03988842|Protease Inhibitors|protease inhibitors|mesh-ancestor
101933631|NCT03988842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101933632|NCT02668822|Ibuprofen|ibuprofen|mesh-list
101933633|NCT02668822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101933634|NCT02668822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101933635|NCT02668822|Analgesics|analgesics|mesh-ancestor
101933636|NCT02668822|Sensory System Agents|sensory system agents|mesh-ancestor
101933637|NCT02668822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101933638|NCT02668822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933639|NCT02668822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101933640|NCT02668822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101933641|NCT02668822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101933642|NCT02668822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101933643|NCT02668822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933644|NCT04112589|Cytarabine|cytarabine|mesh-list
101933645|NCT04112589|Fludarabine|fludarabine|mesh-list
101933646|NCT04112589|Idarubicin|idarubicin|mesh-list
101933647|NCT04112589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101933648|NCT04112589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101933649|NCT04112589|Antimetabolites|antimetabolites|mesh-ancestor
101933650|NCT04112589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933651|NCT04112589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101933652|NCT04112589|Immunologic Factors|immunologic factors|mesh-ancestor
101933653|NCT04112589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933654|NCT04112589|Antiviral Agents|antiviral agents|mesh-ancestor
101933655|NCT04112589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101933656|NCT04112589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101933657|NCT04112589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101933658|NCT04112589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101933659|NCT04112589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101933660|NCT03547154|Interferons|interferons|mesh-list
101933661|NCT03547154|Interferon-alpha|interferon-alpha|mesh-list
101933662|NCT03547154|Interferon alpha-2|interferon alpha-2|mesh-list
101933663|NCT03547154|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101933664|NCT03547154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101933665|NCT03547154|Antiviral Agents|antiviral agents|mesh-ancestor
101933666|NCT03547154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101933667|NCT03547154|Immunologic Factors|immunologic factors|mesh-ancestor
101933668|NCT03547154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933669|NCT02275546|NuvaRing|nuvaring|mesh-list
101933670|NCT02275546|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101933671|NCT02275546|Desogestrel|desogestrel|mesh-list
101933672|NCT02275546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101933673|NCT02275546|Contraceptive Agents|contraceptive agents|mesh-ancestor
101933674|NCT02275546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101933675|NCT02275546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933676|NCT02275546|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101933677|NCT02275546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101933678|NCT02275546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101933679|NCT02275546|Estrogens|estrogens|mesh-ancestor
101933680|NCT02275546|Hormones|hormones|mesh-ancestor
101933681|NCT02275546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101933682|NCT02275546|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101933683|NCT02275546|Progestins|progestins|mesh-ancestor
101933684|NCT01090713|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101933685|NCT01090713|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101933686|NCT01090713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933687|NCT01090713|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101933688|NCT01090713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101958769|NCT00688376|Cholinergic Agents|cholinergic agents|mesh-ancestor
101933689|NCT01090713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101933690|NCT01090713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933692|NCT01090713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101933693|NCT01096797|Sevoflurane|sevoflurane|mesh-list
101933694|NCT01096797|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101933695|NCT01096797|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101653536|NCT03396926|Antibodies|antibodies|mesh-list
101933696|NCT01096797|Anesthetics, General|anesthetics, general|mesh-ancestor
101933697|NCT01096797|Anesthetics|anesthetics|mesh-ancestor
101933698|NCT01096797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101933699|NCT01096797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933700|NCT00068601|Cyclophosphamide|cyclophosphamide|mesh-list
101933701|NCT00068601|Goserelin|goserelin|mesh-list
101933702|NCT00068601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101933703|NCT00068601|Immunologic Factors|immunologic factors|mesh-ancestor
101933704|NCT00068601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933705|NCT00068601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101933706|NCT00068601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101933707|NCT00068601|Alkylating Agents|alkylating agents|mesh-ancestor
101933708|NCT00068601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933709|NCT00068601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101933710|NCT00068601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101933711|NCT00068601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101933712|NCT01670656|Ibuprofen|ibuprofen|mesh-list
101933713|NCT01670656|Contraceptive Agents|contraceptive agents|mesh-list
101933714|NCT01670656|Etonogestrel|etonogestrel|mesh-list
101933715|NCT01670656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101933716|NCT01670656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101933717|NCT01670656|Analgesics|analgesics|mesh-ancestor
101933718|NCT01670656|Sensory System Agents|sensory system agents|mesh-ancestor
101933719|NCT01670656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101933720|NCT01670656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933721|NCT01670656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101933722|NCT01670656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101933723|NCT01670656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101933724|NCT01670656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101933725|NCT01670656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933726|NCT01670656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101933727|NCT01670656|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101933728|NCT01670656|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101933729|NCT03621696|Cisplatin|cisplatin|mesh-list
101933730|NCT03621696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101933731|NCT00068445|Lamotrigine|lamotrigine|mesh-list
101933732|NCT00068445|Anticonvulsants|anticonvulsants|mesh-ancestor
101933733|NCT00068445|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101933734|NCT00068445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101933735|NCT00068445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933736|NCT00068445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101933737|NCT00068445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933738|NCT00068445|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101933739|NCT00068445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101933740|NCT00068445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101933741|NCT00068445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101933742|NCT00068445|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101933743|NCT03033784|Oxytocin|oxytocin|mesh-list
101933744|NCT03033784|Oxytocics|oxytocics|mesh-ancestor
101933745|NCT03033784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101933746|NCT03033784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933747|NCT00038649|Imatinib Mesylate|imatinib mesylate|mesh-list
101933748|NCT00038649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101933749|NCT00038649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101933750|NCT00038649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101933751|NCT00038649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933752|NCT02926690|OTS167|ots167|mesh-list
101933753|NCT02926690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101933754|NCT02926690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101233056|NCT01565239|Coagulants|coagulants|mesh-ancestor
101933755|NCT02926690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933756|NCT03652818|Acetaminophen|acetaminophen|mesh-list
101933757|NCT03652818|Pregabalin|pregabalin|mesh-list
101933758|NCT03652818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101933759|NCT03652818|Analgesics|analgesics|mesh-ancestor
101933760|NCT03652818|Sensory System Agents|sensory system agents|mesh-ancestor
101933761|NCT03652818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101933762|NCT03652818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933764|NCT03652818|Anticonvulsants|anticonvulsants|mesh-ancestor
101933765|NCT03652818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101933766|NCT03652818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101933767|NCT03652818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653600|NCT00648037|Rituximab|rituximab|mesh-list
101933768|NCT03652818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101933769|NCT03652818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101933770|NCT03652818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101933771|NCT03652818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101933772|NCT03652818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101933773|NCT03723824|Grazoprevir|grazoprevir|mesh-list
101933774|NCT03723824|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
101933775|NCT03723824|Antiviral Agents|antiviral agents|mesh-ancestor
101933776|NCT03723824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101933777|NCT00620464|Etonogestrel|etonogestrel|mesh-list
101933778|NCT00620464|Desogestrel|desogestrel|mesh-list
101933779|NCT00620464|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101933780|NCT00620464|Contraceptive Agents|contraceptive agents|mesh-ancestor
101933781|NCT00620464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101933782|NCT00620464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933783|NCT00620464|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101933784|NCT00620464|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101933785|NCT00620464|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101933786|NCT00620464|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101933787|NCT00620464|Progestins|progestins|mesh-ancestor
101933789|NCT00620464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101933790|NCT00541684|Atenolol|atenolol|mesh-list
101933791|NCT00541684|Adrenergic Agents|adrenergic agents|mesh-ancestor
101933792|NCT00541684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101933793|NCT00541684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933794|NCT00541684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933795|NCT00541684|Autonomic Agents|autonomic agents|mesh-ancestor
101933796|NCT00541684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101933797|NCT00541684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101933798|NCT00541684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101933799|NCT00541684|Sympatholytics|sympatholytics|mesh-ancestor
101933800|NCT00541684|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101933801|NCT00541684|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101933802|NCT00541684|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101933803|NCT00413764|Tibolone|tibolone|mesh-list
101933804|NCT00413764|Norethindrone|norethindrone|mesh-list
101933805|NCT00413764|Norethindrone Acetate|norethindrone acetate|mesh-list
101933806|NCT00413764|Estradiol|estradiol|mesh-list
101933807|NCT00413764|Estrogens|estrogens|mesh-ancestor
101933808|NCT00413764|Hormones|hormones|mesh-ancestor
101933809|NCT00413764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101933810|NCT00413764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933811|NCT00413764|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101933812|NCT00413764|Contraceptive Agents|contraceptive agents|mesh-ancestor
101933813|NCT00413764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101933814|NCT00413764|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101933815|NCT00413764|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101933816|NCT00413764|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101933817|NCT00413764|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101933818|NCT00413764|Androgen Antagonists|androgen antagonists|mesh-ancestor
101933819|NCT00413764|Hormone Antagonists|hormone antagonists|mesh-ancestor
101933820|NCT00413764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101933821|NCT00413764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101933822|NCT00413764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101933823|NCT00413764|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101933824|NCT00413764|Anabolic Agents|anabolic agents|mesh-ancestor
101933825|NCT03726788|Triamcinolone|triamcinolone|mesh-list
101933826|NCT03726788|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101933827|NCT03726788|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101933828|NCT03726788|Botulinum Toxins|botulinum toxins|mesh-list
101933829|NCT03726788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101933830|NCT03726788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101933831|NCT03726788|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101933832|NCT03726788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101933833|NCT03726788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101617218|NCT04260516|Acetylcysteine|acetylcysteine|mesh-list
101933834|NCT03726788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933835|NCT03726788|Cholinergic Agents|cholinergic agents|mesh-ancestor
101933836|NCT03726788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101933837|NCT03726788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933838|NCT03726788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101933839|NCT03726788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101933840|NCT03726788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101933841|NCT03726788|Glucocorticoids|glucocorticoids|mesh-ancestor
101933842|NCT03726788|Hormones|hormones|mesh-ancestor
101653672|NCT00640393|Analgesics|analgesics|mesh-ancestor
101933843|NCT03726788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101933844|NCT03726788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101933845|NCT03726788|Immunologic Factors|immunologic factors|mesh-ancestor
101933846|NCT03726788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101933847|NCT03735264|Docetaxel|docetaxel|mesh-list
101933848|NCT03735264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101933849|NCT03735264|Tubulin Modulators|tubulin modulators|mesh-ancestor
101933850|NCT03735264|Antimitotic Agents|antimitotic agents|mesh-ancestor
101933851|NCT03735264|Mitosis Modulators|mitosis modulators|mesh-ancestor
101933852|NCT03735264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933853|NCT03560258|Vaccines|vaccines|mesh-list
101933854|NCT03560258|Immunologic Factors|immunologic factors|mesh-ancestor
101933855|NCT03560258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933856|NCT02759380|Phytoestrogens|phytoestrogens|mesh-list
101933857|NCT02759380|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101933858|NCT02759380|Estrogens|estrogens|mesh-ancestor
101933859|NCT02759380|Hormones|hormones|mesh-ancestor
101933860|NCT02759380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101933861|NCT02759380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933862|NCT03539432|Gemfibrozil|gemfibrozil|mesh-list
101933863|NCT03539432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101933864|NCT03539432|Antimetabolites|antimetabolites|mesh-ancestor
101933865|NCT03539432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933866|NCT03539432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101933867|NCT03539432|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101933868|NCT03539432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101933869|NCT03539432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101933870|NCT03615924|Ticagrelor|ticagrelor|mesh-list
101933871|NCT03615924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101933872|NCT03615924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101933873|NCT03615924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101933874|NCT03615924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101933875|NCT03615924|Purinergic Agents|purinergic agents|mesh-ancestor
101933876|NCT03615924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101933877|NCT03615924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933878|NCT03615924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933879|NCT05576038|Tryptophan|tryptophan|mesh-list
101933880|NCT05576038|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101933881|NCT05576038|Antidepressive Agents|antidepressive agents|mesh-ancestor
101933882|NCT05576038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101933883|NCT04660240|Sirolimus|sirolimus|mesh-list
101933884|NCT04660240|Temsirolimus|temsirolimus|mesh-list
101933885|NCT04660240|MTOR Inhibitors|mtor inhibitors|mesh-list
101933886|NCT04660240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101933887|NCT04660240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101933888|NCT04660240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101933889|NCT04660240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101933890|NCT04660240|Antifungal Agents|antifungal agents|mesh-ancestor
101933891|NCT04660240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101933892|NCT04660240|Immunologic Factors|immunologic factors|mesh-ancestor
101933893|NCT04660240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933894|NCT04660240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101933895|NCT04660240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101933896|NCT04660240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933897|NCT03033394|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101933898|NCT03033394|Penicillins|penicillins|mesh-list
101933899|NCT03033394|Lactams|lactams|mesh-list
101933900|NCT03033394|beta-Lactams|beta-lactams|mesh-list
101933901|NCT03033394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101933902|NCT03639428|Midazolam|midazolam|mesh-list
101933903|NCT03639428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101933904|NCT03639428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101933905|NCT03639428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101933906|NCT03639428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933907|NCT03639428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101933908|NCT03639428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101933909|NCT03639428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101933910|NCT03639428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101933911|NCT03639428|Anesthetics, General|anesthetics, general|mesh-ancestor
101933912|NCT03639428|Anesthetics|anesthetics|mesh-ancestor
101933913|NCT03639428|GABA Modulators|gaba modulators|mesh-ancestor
101933914|NCT03639428|GABA Agents|gaba agents|mesh-ancestor
101933915|NCT03639428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101933916|NCT03639428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933917|NCT04575688|Bupivacaine|bupivacaine|mesh-list
101933918|NCT04575688|Anesthetics, Local|anesthetics, local|mesh-ancestor
101933919|NCT04575688|Anesthetics|anesthetics|mesh-ancestor
101933920|NCT04575688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101933921|NCT04575688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933922|NCT04575688|Sensory System Agents|sensory system agents|mesh-ancestor
101933923|NCT04575688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101933939|NCT04561648|Heparin|heparin|mesh-list
101933940|NCT04561648|Calcium heparin|calcium heparin|mesh-list
101933941|NCT04561648|Anticoagulants|anticoagulants|mesh-ancestor
101933942|NCT04561648|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101933943|NCT04561648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101933944|NCT04561648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933945|NCT03981822|Cantharidin|cantharidin|mesh-list
101933946|NCT03981822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101933947|NCT03981822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933948|NCT03704818|Dapagliflozin|dapagliflozin|mesh-list
101933949|NCT03704818|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101933950|NCT03704818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933951|NCT03704818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101933952|NCT03704818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933953|NCT05506930|Morphine|morphine|mesh-list
101933954|NCT05506930|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101933955|NCT05506930|Narcotics|narcotics|mesh-ancestor
101933956|NCT05506930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101933957|NCT05506930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933958|NCT05506930|Analgesics|analgesics|mesh-ancestor
101933959|NCT05506930|Sensory System Agents|sensory system agents|mesh-ancestor
101933960|NCT05506930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101933961|NCT05464264|Ketamine|ketamine|mesh-list
101933962|NCT05464264|Analgesics|analgesics|mesh-ancestor
101933963|NCT05464264|Sensory System Agents|sensory system agents|mesh-ancestor
101933964|NCT05464264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101933965|NCT05464264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101933966|NCT05464264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101933967|NCT05464264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101933968|NCT05464264|Anesthetics, General|anesthetics, general|mesh-ancestor
101933969|NCT05464264|Anesthetics|anesthetics|mesh-ancestor
101933970|NCT05464264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101933971|NCT05464264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101933972|NCT05464264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101933973|NCT05464264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101958790|NCT02126332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101933974|NCT05464264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101933975|NCT01310738|Amphotericin B|amphotericin b|mesh-list
101933976|NCT01310738|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101933977|NCT01310738|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
101933978|NCT01310738|Meglumine Antimoniate|meglumine antimoniate|mesh-list
101933979|NCT01310738|Deoxycholic Acid|deoxycholic acid|mesh-list
101933980|NCT01310738|Amebicides|amebicides|mesh-ancestor
101933981|NCT01310738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101933982|NCT01310738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101933983|NCT01310738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101933984|NCT01310738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101933985|NCT01310738|Antifungal Agents|antifungal agents|mesh-ancestor
101933986|NCT01310738|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101933987|NCT01310738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101933988|NCT03704506|Amoxicillin|amoxicillin|mesh-list
101933989|NCT03704506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101933990|NCT03704506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101933991|NCT03615144|Fludarabine|fludarabine|mesh-list
101933992|NCT03615144|Melphalan|melphalan|mesh-list
101653819|NCT00826969|Ciclesonide|ciclesonide|mesh-list
101933993|NCT03615144|Thiotepa|thiotepa|mesh-list
101933994|NCT03615144|Clofarabine|clofarabine|mesh-list
101933995|NCT03615144|Thymoglobulin|thymoglobulin|mesh-list
101933996|NCT03615144|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101933997|NCT03615144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101933998|NCT03615144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101933999|NCT03615144|Antimetabolites|antimetabolites|mesh-ancestor
101934000|NCT03615144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934001|NCT03615144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101934002|NCT03615144|Immunologic Factors|immunologic factors|mesh-ancestor
101934003|NCT03615144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934004|NCT03615144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101934005|NCT03615144|Alkylating Agents|alkylating agents|mesh-ancestor
101934006|NCT03615144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101934007|NCT05340790|Anti-Infective Agents|anti-infective agents|mesh-list
101934008|NCT05340790|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101934009|NCT03682302|Bupivacaine|bupivacaine|mesh-list
101934010|NCT03682302|Anesthetics, Local|anesthetics, local|mesh-ancestor
101934011|NCT03682302|Anesthetics|anesthetics|mesh-ancestor
101934012|NCT03682302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101934013|NCT03682302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934014|NCT03682302|Sensory System Agents|sensory system agents|mesh-ancestor
101934015|NCT03682302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101934017|NCT03522506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101934018|NCT03522506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934019|NCT03522506|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101934020|NCT03522506|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101934021|NCT03522506|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101934022|NCT03522506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934023|NCT03320434|Prednisolone acetate|prednisolone acetate|mesh-list
101934024|NCT03320434|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101934025|NCT03320434|Methylprednisolone|methylprednisolone|mesh-list
101934026|NCT03320434|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101934027|NCT03320434|Prednisolone|prednisolone|mesh-list
101934028|NCT03320434|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101934029|NCT03320434|Prednisolone phosphate|prednisolone phosphate|mesh-list
101934030|NCT03320434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101934031|NCT03320434|Antiemetics|antiemetics|mesh-ancestor
101934032|NCT03320434|Autonomic Agents|autonomic agents|mesh-ancestor
101934033|NCT03320434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101233168|NCT01570088|Folic Acid|folic acid|mesh-list
101934034|NCT03320434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934035|NCT03320434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101934036|NCT03320434|Glucocorticoids|glucocorticoids|mesh-ancestor
101934037|NCT03320434|Hormones|hormones|mesh-ancestor
101934038|NCT03320434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101934039|NCT03320434|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101934040|NCT03320434|Protective Agents|protective agents|mesh-ancestor
101934041|NCT03320434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101934042|NCT03320434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101934043|NCT02892734|Nivolumab|nivolumab|mesh-list
101934044|NCT02892734|Ipilimumab|ipilimumab|mesh-list
101934045|NCT02892734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101934046|NCT02892734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101934047|NCT02892734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101934048|NCT02892734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934049|NCT05231590|Myeloma Proteins|myeloma proteins|mesh-list
101934050|NCT05231590|Paraproteins|paraproteins|mesh-list
101934051|NCT05231590|Immunologic Factors|immunologic factors|mesh-ancestor
101934052|NCT05231590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934053|NCT00055497|Adalimumab|adalimumab|mesh-list
101934054|NCT00055497|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101934055|NCT00055497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101934056|NCT00055497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101934058|NCT03726398|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101934059|NCT03726398|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101934060|NCT03726398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934061|NCT03726398|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
101934062|NCT04050592|Estradiol|estradiol|mesh-list
101934063|NCT04050592|Estrogens|estrogens|mesh-ancestor
101934064|NCT04050592|Hormones|hormones|mesh-ancestor
101934065|NCT04050592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101934066|NCT04050592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934067|NCT03726242|Cromakalim|cromakalim|mesh-list
101934068|NCT03726242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101934069|NCT03726242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101934071|NCT03726242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101934072|NCT03726242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934073|NCT03726242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101934074|NCT03726242|Respiratory System Agents|respiratory system agents|mesh-ancestor
101934075|NCT03726242|Parasympatholytics|parasympatholytics|mesh-ancestor
101934076|NCT03726242|Vasodilator Agents|vasodilator agents|mesh-ancestor
101934077|NCT03731988|Lidocaine|lidocaine|mesh-list
101934078|NCT03731988|Prilocaine|prilocaine|mesh-list
101934079|NCT03731988|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
101934080|NCT03731988|Anesthetics, Local|anesthetics, local|mesh-ancestor
101934081|NCT03731988|Anesthetics|anesthetics|mesh-ancestor
101934082|NCT03731988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101934083|NCT03731988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934084|NCT03731988|Sensory System Agents|sensory system agents|mesh-ancestor
101934085|NCT03731988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101934086|NCT03731988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101934087|NCT03731988|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101934088|NCT03731988|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101934089|NCT03731988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101934090|NCT03731988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934091|NCT03731988|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
101934092|NCT01094457|Aspirin|aspirin|mesh-list
101934093|NCT01094457|Cilostazol|cilostazol|mesh-list
101934094|NCT01094457|Clopidogrel|clopidogrel|mesh-list
101934095|NCT01094457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101934096|NCT01094457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101934097|NCT01094457|Analgesics|analgesics|mesh-ancestor
101934098|NCT01094457|Sensory System Agents|sensory system agents|mesh-ancestor
101934099|NCT01094457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101934100|NCT01094457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934101|NCT01094457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101934102|NCT01094457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101934103|NCT01094457|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101934104|NCT01094457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101934105|NCT01094457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934106|NCT01094457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101934107|NCT01094457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101934108|NCT01094457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101934109|NCT01094457|Antipyretics|antipyretics|mesh-ancestor
101934110|NCT01094457|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101934111|NCT01094457|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101934112|NCT01094457|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101934113|NCT01094457|Purinergic Agents|purinergic agents|mesh-ancestor
101934114|NCT01094457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101934115|NCT01094457|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101934116|NCT01094457|Autonomic Agents|autonomic agents|mesh-ancestor
101934117|NCT01094457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101934118|NCT01094457|Respiratory System Agents|respiratory system agents|mesh-ancestor
101934119|NCT01094457|Vasodilator Agents|vasodilator agents|mesh-ancestor
101934120|NCT01094457|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101934121|NCT01094457|Protective Agents|protective agents|mesh-ancestor
101934122|NCT01094457|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101934123|NCT01094457|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101934124|NCT03701698|Methylprednisolone|methylprednisolone|mesh-list
101934125|NCT03701698|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101934126|NCT03701698|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101934127|NCT03701698|Prednisolone|prednisolone|mesh-list
101934128|NCT03701698|Prednisolone acetate|prednisolone acetate|mesh-list
101934129|NCT03701698|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101934130|NCT03701698|Prednisolone phosphate|prednisolone phosphate|mesh-list
101934131|NCT03701698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101934132|NCT03701698|Antiemetics|antiemetics|mesh-ancestor
101934133|NCT03701698|Autonomic Agents|autonomic agents|mesh-ancestor
101934134|NCT03701698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101934135|NCT03701698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934136|NCT03701698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101934137|NCT03701698|Glucocorticoids|glucocorticoids|mesh-ancestor
101934138|NCT03701698|Hormones|hormones|mesh-ancestor
101934139|NCT03701698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101934140|NCT03701698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101934141|NCT03701698|Protective Agents|protective agents|mesh-ancestor
101934142|NCT03701698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101934143|NCT03701698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101934144|NCT03734562|Amiodarone|amiodarone|mesh-list
101934145|NCT03734562|Sotalol|sotalol|mesh-list
101934146|NCT03734562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
101934147|NCT03734562|Vasodilator Agents|vasodilator agents|mesh-ancestor
101934148|NCT03734562|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101934149|NCT03734562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101934150|NCT03734562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934151|NCT03734562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101934152|NCT03734562|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101934153|NCT03734562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101934154|NCT03734562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101934155|NCT03734562|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101934156|NCT03734562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101934157|NCT03734562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101934158|NCT03734562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101934159|NCT03734562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101934160|NCT03734562|Adrenergic Agents|adrenergic agents|mesh-ancestor
101934161|NCT03734562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101934162|NCT03734562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934163|NCT03734562|Sympatholytics|sympatholytics|mesh-ancestor
101934164|NCT03734562|Autonomic Agents|autonomic agents|mesh-ancestor
101934165|NCT03734562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101934166|NCT03034096|Propofol|propofol|mesh-list
101934167|NCT03034096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101934168|NCT03034096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101934169|NCT03034096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934170|NCT03034096|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101934171|NCT03034096|Anesthetics, General|anesthetics, general|mesh-ancestor
101934172|NCT03034096|Anesthetics|anesthetics|mesh-ancestor
101934173|NCT03722420|Imatinib Mesylate|imatinib mesylate|mesh-list
101934174|NCT03722420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101934175|NCT03722420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101934176|NCT03722420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101934177|NCT03722420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934178|NCT03721874|Dapagliflozin|dapagliflozin|mesh-list
101934179|NCT03721874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101934180|NCT03721874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934181|NCT03721874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101934182|NCT03721874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934183|NCT03807843|Vaccines|vaccines|mesh-list
101934184|NCT03807843|Immunologic Factors|immunologic factors|mesh-ancestor
101934185|NCT03807843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934186|NCT01094535|Secretin|secretin|mesh-list
101934187|NCT01094535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101934188|NCT01094535|Hormones|hormones|mesh-ancestor
101934189|NCT01094535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101934191|NCT02843074|Dexamethasone|dexamethasone|mesh-list
101934192|NCT02843074|Lenalidomide|lenalidomide|mesh-list
101934193|NCT02843074|Elotuzumab|elotuzumab|mesh-list
101934194|NCT02843074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101934195|NCT02843074|Antiemetics|antiemetics|mesh-ancestor
101934196|NCT02843074|Autonomic Agents|autonomic agents|mesh-ancestor
101934197|NCT02843074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101934198|NCT02843074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934199|NCT02843074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101934200|NCT02843074|Glucocorticoids|glucocorticoids|mesh-ancestor
101934201|NCT02843074|Hormones|hormones|mesh-ancestor
101934202|NCT02843074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101934203|NCT02843074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101934204|NCT02843074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101934205|NCT02843074|Immunologic Factors|immunologic factors|mesh-ancestor
101934206|NCT02843074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101934207|NCT02843074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101934208|NCT02843074|Growth Substances|growth substances|mesh-ancestor
101934209|NCT02843074|Growth Inhibitors|growth inhibitors|mesh-ancestor
101934210|NCT00038103|Celecoxib|celecoxib|mesh-list
101934211|NCT00038103|Exemestane|exemestane|mesh-list
101934212|NCT00038103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101934213|NCT00038103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101934214|NCT00038103|Analgesics|analgesics|mesh-ancestor
101934215|NCT00038103|Sensory System Agents|sensory system agents|mesh-ancestor
101934216|NCT00038103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101654047|NCT00967499|Antipruritics|antipruritics|mesh-ancestor
101934217|NCT00038103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934218|NCT00038103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101934219|NCT00038103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101934220|NCT00038103|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101934221|NCT00038103|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101934222|NCT00038103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101934223|NCT00038103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934224|NCT00038103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101934225|NCT00038103|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101934226|NCT00038103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101934227|NCT00038103|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101934228|NCT00038103|Hormone Antagonists|hormone antagonists|mesh-ancestor
101934229|NCT00038103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101934230|NCT03678870|Analgesics, Opioid|analgesics, opioid|mesh-list
101934231|NCT03678870|Narcotics|narcotics|mesh-ancestor
101934232|NCT03678870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101934233|NCT03678870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934234|NCT03678870|Analgesics|analgesics|mesh-ancestor
101934235|NCT03678870|Sensory System Agents|sensory system agents|mesh-ancestor
101934236|NCT03678870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101934237|NCT03032380|Meropenem|meropenem|mesh-list
101934238|NCT03032380|Linezolid|linezolid|mesh-list
101934239|NCT03032380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101934240|NCT03032380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101934241|NCT03032380|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101934242|NCT03032380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387661|NCT00322660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934243|NCT03032380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934244|NCT03519854|Bromides|bromides|mesh-list
101934245|NCT03519854|Rocuronium|rocuronium|mesh-list
101934246|NCT03519854|Anticonvulsants|anticonvulsants|mesh-ancestor
101934247|NCT03519854|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101934248|NCT03519854|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101934249|NCT03519854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101934250|NCT03519854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101934251|NCT03519854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934252|NCT03703960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
101934253|NCT03703960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101934254|NCT03703960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934255|NCT03479216|Magnesium Sulfate|magnesium sulfate|mesh-list
101934256|NCT03479216|Dexmedetomidine|dexmedetomidine|mesh-list
101934257|NCT03479216|Bupivacaine|bupivacaine|mesh-list
101934258|NCT03479216|Anesthetics, Local|anesthetics, local|mesh-ancestor
101934259|NCT03479216|Anesthetics|anesthetics|mesh-ancestor
101934260|NCT03479216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101934261|NCT03479216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934262|NCT03479216|Sensory System Agents|sensory system agents|mesh-ancestor
101934263|NCT03479216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101934264|NCT03479216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101934265|NCT03479216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101934266|NCT03479216|Analgesics|analgesics|mesh-ancestor
101934267|NCT03479216|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101934268|NCT03479216|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101934269|NCT03479216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101934270|NCT03479216|Adrenergic Agents|adrenergic agents|mesh-ancestor
101934271|NCT03479216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101934272|NCT03479216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934273|NCT03479216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101934274|NCT03479216|Anticonvulsants|anticonvulsants|mesh-ancestor
101934276|NCT03479216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101934277|NCT03479216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101934278|NCT03479216|Tocolytic Agents|tocolytic agents|mesh-ancestor
101934279|NCT03479216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101934280|NCT03717116|Parathyroid Hormone|parathyroid hormone|mesh-list
101934281|NCT03717116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101934282|NCT03717116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934283|NCT03717038|Trifluridine|trifluridine|mesh-list
101934284|NCT03717038|Antimetabolites|antimetabolites|mesh-ancestor
101934285|NCT03717038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934286|NCT03717038|Antiviral Agents|antiviral agents|mesh-ancestor
101934287|NCT03717038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101934288|NCT00143182|Olanzapine|olanzapine|mesh-list
101934289|NCT00143182|Asenapine|asenapine|mesh-list
101654126|NCT02862509|Hormones|hormones|mesh-ancestor
101934290|NCT00143182|Antiemetics|antiemetics|mesh-ancestor
101934291|NCT00143182|Autonomic Agents|autonomic agents|mesh-ancestor
101934292|NCT00143182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101934293|NCT00143182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934294|NCT00143182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101934295|NCT00143182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101934296|NCT00143182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101934297|NCT00143182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101934298|NCT00143182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101934299|NCT00143182|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101934300|NCT00143182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101934301|NCT00143182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101934302|NCT00143182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934303|NCT00143182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101934304|NCT00143182|Serotonin Agents|serotonin agents|mesh-ancestor
101934305|NCT03677934|Ranibizumab|ranibizumab|mesh-list
101934306|NCT03677934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101934307|NCT03677934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101934308|NCT03677934|Growth Substances|growth substances|mesh-ancestor
101934309|NCT03677934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934310|NCT03677934|Growth Inhibitors|growth inhibitors|mesh-ancestor
101934311|NCT03677934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101934312|NCT03435692|Acetaminophen|acetaminophen|mesh-list
101934313|NCT03435692|Diphenhydramine|diphenhydramine|mesh-list
101934314|NCT03435692|Promethazine|promethazine|mesh-list
101934315|NCT03435692|Fentanyl|fentanyl|mesh-list
101934316|NCT03435692|Morphine|morphine|mesh-list
101934317|NCT03435692|Oxycodone|oxycodone|mesh-list
101934318|NCT03435692|Lorazepam|lorazepam|mesh-list
101934319|NCT03435692|Ondansetron|ondansetron|mesh-list
101934320|NCT03435692|Ropivacaine|ropivacaine|mesh-list
101934321|NCT03435692|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101934322|NCT03435692|Narcotics|narcotics|mesh-ancestor
101934323|NCT03435692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101934324|NCT03435692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934325|NCT03435692|Analgesics|analgesics|mesh-ancestor
101934326|NCT03435692|Sensory System Agents|sensory system agents|mesh-ancestor
101934327|NCT03435692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101934328|NCT03435692|Anesthetics, Local|anesthetics, local|mesh-ancestor
101934329|NCT03435692|Anesthetics|anesthetics|mesh-ancestor
101934330|NCT03435692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101934331|NCT03435692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101934332|NCT03435692|Anesthetics, General|anesthetics, general|mesh-ancestor
101934333|NCT03435692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101934334|NCT03435692|Antipyretics|antipyretics|mesh-ancestor
101934335|NCT03435692|Antiemetics|antiemetics|mesh-ancestor
101934336|NCT03435692|Autonomic Agents|autonomic agents|mesh-ancestor
101934337|NCT03435692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101934338|NCT03435692|Antipruritics|antipruritics|mesh-ancestor
101934339|NCT03435692|Dermatologic Agents|dermatologic agents|mesh-ancestor
101934340|NCT03435692|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101934341|NCT03435692|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101934342|NCT03435692|Serotonin Agents|serotonin agents|mesh-ancestor
101934343|NCT03435692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101934344|NCT03435692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934345|NCT03435692|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101934346|NCT03435692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101934347|NCT03435692|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101934348|NCT03435692|Histamine Antagonists|histamine antagonists|mesh-ancestor
101934349|NCT03435692|Histamine Agents|histamine agents|mesh-ancestor
101934350|NCT03435692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101934351|NCT03435692|Anticonvulsants|anticonvulsants|mesh-ancestor
101934352|NCT03435692|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101934353|NCT03435692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101934354|NCT03435692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101934355|NCT03435692|GABA Modulators|gaba modulators|mesh-ancestor
101934356|NCT03435692|GABA Agents|gaba agents|mesh-ancestor
101934357|NCT03705442|Loperamide|loperamide|mesh-list
101934358|NCT03705442|Antidiarrheals|antidiarrheals|mesh-list
101934359|NCT03705442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101934360|NCT04817410|Naltrexone|naltrexone|mesh-list
101934361|NCT04817410|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101934362|NCT04817410|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101934363|NCT04817410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934364|NCT04817410|Sensory System Agents|sensory system agents|mesh-ancestor
101934365|NCT04817410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101654194|NCT04283435|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101934366|NCT03673956|Vancomycin|vancomycin|mesh-list
101934367|NCT03673956|Levofloxacin|levofloxacin|mesh-list
101934368|NCT03673956|Tobramycin|tobramycin|mesh-list
101934369|NCT03673956|Mupirocin|mupirocin|mesh-list
101934370|NCT03673956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101934371|NCT03673956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101934372|NCT03673956|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101934373|NCT03673956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101934374|NCT03673956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101934375|NCT03673956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101934376|NCT03673956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934377|NCT03673956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101934378|NCT03673956|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101934379|NCT03673956|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101934380|NCT03673956|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101934381|NCT03716804|Ciprofloxacin|ciprofloxacin|mesh-list
101934382|NCT03716804|Cefuroxime|cefuroxime|mesh-list
101934383|NCT03716804|Cefuroxime axetil|cefuroxime axetil|mesh-list
101934384|NCT03716804|Nitrofurantoin|nitrofurantoin|mesh-list
101934385|NCT03716804|Cefixime|cefixime|mesh-list
101934386|NCT03716804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101934387|NCT03716804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101934388|NCT03716804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101934389|NCT03716804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101934390|NCT03716804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101934391|NCT03716804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233334|NCT01571063|Vitamins|vitamins|mesh-ancestor
101934392|NCT03716804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101934393|NCT03716804|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101934394|NCT03716804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101934395|NCT03716804|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101934396|NCT01310166|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101934397|NCT01310166|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101934398|NCT01310166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934399|NCT01310166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101934400|NCT01310166|Immunologic Factors|immunologic factors|mesh-ancestor
101934401|NCT01310166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934402|NCT03733860|Alprostadil|alprostadil|mesh-list
101934403|NCT03733860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101934404|NCT03733860|Vasodilator Agents|vasodilator agents|mesh-ancestor
101934405|NCT03733860|Urological Agents|urological agents|mesh-ancestor
101934406|NCT03605862|Nitazoxanide|nitazoxanide|mesh-list
101934407|NCT03605862|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101934408|NCT03605862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101934410|NCT01310244|Carboplatin|carboplatin|mesh-list
101934411|NCT01310244|Belinostat|belinostat|mesh-list
101934412|NCT01310244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101934413|NCT01310244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101934414|NCT01310244|Tubulin Modulators|tubulin modulators|mesh-ancestor
101934415|NCT01310244|Antimitotic Agents|antimitotic agents|mesh-ancestor
101934416|NCT01310244|Mitosis Modulators|mitosis modulators|mesh-ancestor
101934417|NCT01310244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934418|NCT01310244|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101934419|NCT01310244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101934420|NCT03672006|Heparin|heparin|mesh-list
101934421|NCT03672006|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101934422|NCT03672006|Anticoagulants|anticoagulants|mesh-ancestor
101934423|NCT03672006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101934424|NCT03672006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101934425|NCT03672006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934426|NCT03621072|Fluconazole|fluconazole|mesh-list
101934427|NCT03621072|Antifungal Agents|antifungal agents|mesh-ancestor
101934428|NCT03621072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101934429|NCT03621072|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101934430|NCT03621072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101934431|NCT03621072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101934432|NCT03621072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934433|NCT03621072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101934434|NCT03621072|Hormone Antagonists|hormone antagonists|mesh-ancestor
101934435|NCT03621072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101934436|NCT03621072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934437|NCT03621072|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101934438|NCT03621072|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101934439|NCT03512288|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101934440|NCT03512288|Immunologic Factors|immunologic factors|mesh-ancestor
101934441|NCT03512288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934442|NCT01311050|Bevacizumab|bevacizumab|mesh-list
101934443|NCT01311050|Capecitabine|capecitabine|mesh-list
101934444|NCT01311050|Oxaliplatin|oxaliplatin|mesh-list
101934445|NCT01311050|Irinotecan|irinotecan|mesh-list
101934446|NCT01311050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101934447|NCT01311050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101934448|NCT01311050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101934449|NCT01311050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101934450|NCT01311050|Growth Substances|growth substances|mesh-ancestor
101934451|NCT01311050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934452|NCT01311050|Growth Inhibitors|growth inhibitors|mesh-ancestor
101934453|NCT01311050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101934454|NCT01311050|Antimetabolites|antimetabolites|mesh-ancestor
101934455|NCT01311050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934456|NCT01311050|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101934457|NCT01311050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101934458|NCT01311050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101934459|NCT03700450|Cyclophosphamide|cyclophosphamide|mesh-list
101934460|NCT03700450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101934461|NCT03700450|Immunologic Factors|immunologic factors|mesh-ancestor
101934462|NCT03700450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934463|NCT03700450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101934464|NCT03700450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101934465|NCT03700450|Alkylating Agents|alkylating agents|mesh-ancestor
101934466|NCT03700450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934467|NCT03700450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101934468|NCT03700450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101934469|NCT03702946|Oxytocin|oxytocin|mesh-list
101934470|NCT03702946|Oxytocics|oxytocics|mesh-ancestor
101934471|NCT03702946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101934472|NCT03702946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934473|NCT04491526|Tamsulosin|tamsulosin|mesh-list
101934474|NCT04491526|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101934475|NCT04491526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101934476|NCT04491526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101934477|NCT04491526|Adrenergic Agents|adrenergic agents|mesh-ancestor
101934478|NCT04491526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101934479|NCT04491526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934480|NCT04491526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934481|NCT04491526|Urological Agents|urological agents|mesh-ancestor
101934482|NCT04484350|Enalapril|enalapril|mesh-list
101934483|NCT04484350|Labetalol|labetalol|mesh-list
101934484|NCT04484350|Hydralazine|hydralazine|mesh-list
101934485|NCT04484350|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101934486|NCT04484350|Protease Inhibitors|protease inhibitors|mesh-ancestor
101934487|NCT04484350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101934488|NCT04484350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934489|NCT04484350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101934490|NCT04484350|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101934491|NCT04484350|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101934492|NCT04484350|Adrenergic Agents|adrenergic agents|mesh-ancestor
101934493|NCT04484350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101934494|NCT04484350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934496|NCT04484350|Autonomic Agents|autonomic agents|mesh-ancestor
101934497|NCT04484350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101934498|NCT04484350|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101934499|NCT04484350|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101934500|NCT04484350|Vasodilator Agents|vasodilator agents|mesh-ancestor
101934501|NCT03699904|Valacyclovir|valacyclovir|mesh-list
101934502|NCT03699904|Antiviral Agents|antiviral agents|mesh-ancestor
101934503|NCT03699904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101934504|NCT03697018|Lithium Carbonate|lithium carbonate|mesh-list
101934505|NCT03697018|Antidepressive Agents|antidepressive agents|mesh-ancestor
101934506|NCT03697018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101934507|NCT03697018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101934508|NCT03697018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934509|NCT03697018|Antimanic Agents|antimanic agents|mesh-ancestor
101934510|NCT03697018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101934511|NCT03697018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101934512|NCT03697018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934513|NCT03696940|Atorvastatin|atorvastatin|mesh-list
101934514|NCT03696940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101934515|NCT03696940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101934516|NCT03696940|Antimetabolites|antimetabolites|mesh-ancestor
101934517|NCT03696940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934518|NCT03696940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101934519|NCT03696940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101934520|NCT03696940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101934521|NCT03731442|Paclitaxel|paclitaxel|mesh-list
101934522|NCT03731442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101934523|NCT03731442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101934524|NCT03731442|Tubulin Modulators|tubulin modulators|mesh-ancestor
101934525|NCT03731442|Antimitotic Agents|antimitotic agents|mesh-ancestor
101934526|NCT03731442|Mitosis Modulators|mitosis modulators|mesh-ancestor
101233421|NCT01571648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101934527|NCT03731442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934528|NCT03702400|Phenylephrine|phenylephrine|mesh-list
101934529|NCT03702400|Oxymetazoline|oxymetazoline|mesh-list
101934530|NCT03702400|Norepinephrine|norepinephrine|mesh-list
101934531|NCT03702400|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101934532|NCT03702400|Mydriatics|mydriatics|mesh-ancestor
101934533|NCT03702400|Autonomic Agents|autonomic agents|mesh-ancestor
101934534|NCT03702400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101934535|NCT03702400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934536|NCT03702400|Sympathomimetics|sympathomimetics|mesh-ancestor
101958819|NCT02128906|Docetaxel|docetaxel|mesh-list
101934537|NCT03702400|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101934538|NCT03702400|Nasal Decongestants|nasal decongestants|mesh-ancestor
101934539|NCT03702400|Respiratory System Agents|respiratory system agents|mesh-ancestor
101934540|NCT03702400|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101934541|NCT03702400|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101934542|NCT03702400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101934543|NCT03702400|Adrenergic Agents|adrenergic agents|mesh-ancestor
101934544|NCT03702400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101934545|NCT03702400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934546|NCT03702400|Protective Agents|protective agents|mesh-ancestor
101934547|NCT03699202|Ziresovir|ziresovir|mesh-list
101934548|NCT03699202|Antiviral Agents|antiviral agents|mesh-ancestor
101934549|NCT03699202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101934550|NCT03598140|Sildenafil Citrate|sildenafil citrate|mesh-list
101934551|NCT03598140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934552|NCT03598140|Vasodilator Agents|vasodilator agents|mesh-ancestor
101934553|NCT03598140|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101934554|NCT03598140|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101934555|NCT03598140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101934556|NCT03598140|Urological Agents|urological agents|mesh-ancestor
101934574|NCT03644550|Pembrolizumab|pembrolizumab|mesh-list
101934575|NCT03644550|LMB-100|lmb-100|mesh-list
101934576|NCT03644550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101934577|NCT03644550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101934578|NCT03644550|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101934579|NCT03644550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934580|NCT03644550|Immunoconjugates|immunoconjugates|mesh-ancestor
101934581|NCT03644550|Immunologic Factors|immunologic factors|mesh-ancestor
101934582|NCT03644550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934583|NCT03511664|177Lu-PSMA-617|177lu-psma-617|mesh-list
101934584|NCT03511664|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101934585|NCT03511664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934586|NCT00054717|Ritonavir|ritonavir|mesh-list
101934587|NCT00054717|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
101934588|NCT00054717|Tipranavir|tipranavir|mesh-list
101934589|NCT00054717|Protease Inhibitors|protease inhibitors|mesh-list
101934590|NCT00054717|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101934591|NCT00054717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101934592|NCT00054717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934593|NCT00054717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101934594|NCT00054717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101934595|NCT00054717|Antiviral Agents|antiviral agents|mesh-ancestor
101934596|NCT00054717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101934597|NCT00054717|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101934598|NCT00054717|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101233447|NCT01571804|Pregabalin|pregabalin|mesh-list
101934600|NCT03430856|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101934601|NCT03430856|Insulin Aspart|insulin aspart|mesh-list
101934602|NCT03430856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101934603|NCT03430856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934604|NCT01097265|Capecitabine|capecitabine|mesh-list
101934605|NCT01097265|Oxaliplatin|oxaliplatin|mesh-list
101934606|NCT01097265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101934607|NCT01097265|Antimetabolites|antimetabolites|mesh-ancestor
101934608|NCT01097265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101958831|NCT02252302|Albuterol|albuterol|mesh-list
101934609|NCT01097265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101934611|NCT03731286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101934612|NCT03731286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934613|NCT03731286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101934614|NCT03731286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101934615|NCT03731286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934616|NCT03731286|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101934617|NCT03731286|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101934618|NCT03731286|Purinergic Agents|purinergic agents|mesh-ancestor
101934619|NCT03731286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101934620|NCT00066807|Tamoxifen|tamoxifen|mesh-list
101934621|NCT00066807|Epirubicin|epirubicin|mesh-list
101934622|NCT00066807|Exemestane|exemestane|mesh-list
101934623|NCT00066807|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101934624|NCT00066807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101934625|NCT00066807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101934626|NCT00066807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101934627|NCT00066807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101934628|NCT00066807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101934629|NCT00066807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934630|NCT00066807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101934631|NCT00066807|Hormone Antagonists|hormone antagonists|mesh-ancestor
101934632|NCT00066807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101934633|NCT00066807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934634|NCT00066807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101934635|NCT00066807|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101934636|NCT00066807|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101934637|NCT00066807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101934638|NCT00066807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101934639|NCT00066807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101934640|NCT00066807|Luteolytic Agents|luteolytic agents|mesh-ancestor
101934641|NCT00066807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101934642|NCT00066807|Contraceptive Agents|contraceptive agents|mesh-ancestor
101934643|NCT00066807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101934644|NCT00066807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101934645|NCT03619330|Liraglutide|liraglutide|mesh-list
101934646|NCT03619330|Testosterone|testosterone|mesh-list
101934647|NCT03619330|Androgens|androgens|mesh-ancestor
101934648|NCT03619330|Hormones|hormones|mesh-ancestor
101934649|NCT03619330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101934650|NCT03619330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934651|NCT03619330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101934652|NCT03619330|Incretins|incretins|mesh-ancestor
101934653|NCT04457284|Nivolumab|nivolumab|mesh-list
101934654|NCT04457284|Temozolomide|temozolomide|mesh-list
101934655|NCT04457284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101934656|NCT04457284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101934657|NCT04457284|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101934658|NCT04457284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934659|NCT04457284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101934660|NCT04457284|Alkylating Agents|alkylating agents|mesh-ancestor
101934661|NCT00054639|Rituximab|rituximab|mesh-list
101934662|NCT00054639|Oblimersen|oblimersen|mesh-list
101934663|NCT00054639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101934664|NCT00054639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101654496|NCT00824707|Entecavir|entecavir|mesh-list
101934665|NCT00054639|Immunologic Factors|immunologic factors|mesh-ancestor
101934666|NCT00054639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934667|NCT00054639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101934668|NCT02530359|Pirfenidone|pirfenidone|mesh-list
101934669|NCT02530359|Analgesics|analgesics|mesh-ancestor
101934670|NCT02530359|Sensory System Agents|sensory system agents|mesh-ancestor
101934671|NCT02530359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101934672|NCT02530359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934673|NCT02530359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101934674|NCT02530359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101934675|NCT02530359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101934676|NCT02530359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101934677|NCT02530359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101934679|NCT03428360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101934680|NCT03428360|Anticonvulsants|anticonvulsants|mesh-ancestor
101934681|NCT03428360|Antiemetics|antiemetics|mesh-ancestor
101934682|NCT03428360|Autonomic Agents|autonomic agents|mesh-ancestor
101934683|NCT03428360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101934684|NCT03428360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934685|NCT03428360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101934686|NCT03428360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101934687|NCT03428360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101934688|NCT03428360|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101934689|NCT03428360|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101934690|NCT03428360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101934691|NCT03428360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101934692|NCT03428360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101934693|NCT03428360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101934694|NCT03428360|Anesthetics, General|anesthetics, general|mesh-ancestor
101934695|NCT03428360|Anesthetics|anesthetics|mesh-ancestor
101934696|NCT03428360|GABA Modulators|gaba modulators|mesh-ancestor
101934697|NCT03428360|GABA Agents|gaba agents|mesh-ancestor
101934698|NCT03428360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101233503|NCT01571908|Rocuronium|rocuronium|mesh-list
101934699|NCT03428360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934700|NCT03427892|Brexpiprazole|brexpiprazole|mesh-list
101934701|NCT03427892|Serotonin Agents|serotonin agents|mesh-ancestor
101934702|NCT03427892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101934703|NCT03427892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934704|NCT03427892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934705|NCT03427892|Dopamine Agonists|dopamine agonists|mesh-ancestor
101934706|NCT03427892|Dopamine Agents|dopamine agents|mesh-ancestor
101934707|NCT03466658|Anti-Infective Agents|anti-infective agents|mesh-list
101934708|NCT03466658|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101934709|NCT04867928|Azacitidine|azacitidine|mesh-list
101934710|NCT04867928|Venetoclax|venetoclax|mesh-list
101934711|NCT04867928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101934712|NCT04867928|Antimetabolites|antimetabolites|mesh-ancestor
101934713|NCT04867928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934714|NCT04867928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101934715|NCT04867928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101934716|NCT03425396|Nitrofurantoin|nitrofurantoin|mesh-list
101934717|NCT03425396|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101934719|NCT03425396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101934720|NCT03698734|Evening primrose oil|evening primrose oil|mesh-list
101934721|NCT03698734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101934722|NCT03698734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101934723|NCT03698734|Analgesics|analgesics|mesh-ancestor
101934724|NCT03698734|Sensory System Agents|sensory system agents|mesh-ancestor
101934725|NCT03698734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101934726|NCT03698734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934727|NCT03698734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101934728|NCT03698734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101934729|NCT03698734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101934730|NCT03698734|Antimetabolites|antimetabolites|mesh-ancestor
101934731|NCT03698734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934732|NCT03698734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101934733|NCT03698734|Dermatologic Agents|dermatologic agents|mesh-ancestor
101934734|NCT04070157|Lofexidine|lofexidine|mesh-list
101934735|NCT04070157|Clonidine|clonidine|mesh-list
101934736|NCT04070157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101654570|NCT00825019|Serotonin Agents|serotonin agents|mesh-ancestor
101934737|NCT04070157|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101934738|NCT04070157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934739|NCT04070157|Sensory System Agents|sensory system agents|mesh-ancestor
101934740|NCT04070157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101934741|NCT04070157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101934742|NCT04070157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101934743|NCT04070157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101934744|NCT04070157|Adrenergic Agents|adrenergic agents|mesh-ancestor
101934745|NCT04070157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101934746|NCT04070157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934747|NCT04070157|Analgesics|analgesics|mesh-ancestor
101934748|NCT04070157|Sympatholytics|sympatholytics|mesh-ancestor
101934749|NCT04070157|Autonomic Agents|autonomic agents|mesh-ancestor
101934750|NCT01091337|Albuterol|albuterol|mesh-list
101934751|NCT01091337|Procaterol|procaterol|mesh-list
101934752|NCT01091337|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101934753|NCT01091337|Autonomic Agents|autonomic agents|mesh-ancestor
101247121|NCT01673737|Vemurafenib|vemurafenib|mesh-list
101934754|NCT01091337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101934755|NCT01091337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934756|NCT01091337|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101934757|NCT01091337|Respiratory System Agents|respiratory system agents|mesh-ancestor
101934758|NCT01091337|Tocolytic Agents|tocolytic agents|mesh-ancestor
101934759|NCT01091337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101934760|NCT01091337|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101934761|NCT01091337|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101934762|NCT01091337|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101934763|NCT01091337|Adrenergic Agents|adrenergic agents|mesh-ancestor
101934764|NCT01091337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101934765|NCT01091337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934766|NCT01091337|Sympathomimetics|sympathomimetics|mesh-ancestor
101934767|NCT03955809|Ketamine|ketamine|mesh-list
101934768|NCT03955809|Analgesics|analgesics|mesh-ancestor
101934769|NCT03955809|Sensory System Agents|sensory system agents|mesh-ancestor
101934770|NCT03955809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101934771|NCT03955809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934772|NCT03955809|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101934773|NCT03955809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101934774|NCT03955809|Anesthetics, General|anesthetics, general|mesh-ancestor
101934775|NCT03955809|Anesthetics|anesthetics|mesh-ancestor
101934776|NCT03955809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101934777|NCT03955809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101934778|NCT03955809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101934779|NCT03955809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101934780|NCT03955809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934781|NCT01094613|Mercaptopurine|mercaptopurine|mesh-list
101934782|NCT01094613|Antimetabolites|antimetabolites|mesh-ancestor
101934783|NCT01094613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934784|NCT01094613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101934785|NCT01094613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101934786|NCT01094613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101934787|NCT01094613|Immunologic Factors|immunologic factors|mesh-ancestor
101934788|NCT01094613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934789|NCT01094613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101934790|NCT01094613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101934791|NCT03953001|Lidocaine|lidocaine|mesh-list
101934792|NCT03953001|Epinephrine|epinephrine|mesh-list
101934793|NCT03953001|Anesthetics, Local|anesthetics, local|mesh-list
101934794|NCT03953001|Anesthetics|anesthetics|mesh-list
101934795|NCT03953001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101934796|NCT03953001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934797|NCT03953001|Sensory System Agents|sensory system agents|mesh-ancestor
101934798|NCT03953001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101934799|NCT03953001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101934800|NCT03953001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101934801|NCT03953001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101934802|NCT03953001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101934803|NCT03953001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934804|NCT03953001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101934805|NCT03953001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101934806|NCT03953001|Adrenergic Agents|adrenergic agents|mesh-ancestor
101934807|NCT03953001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101934808|NCT03953001|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101934809|NCT03953001|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101934810|NCT03953001|Autonomic Agents|autonomic agents|mesh-ancestor
101934811|NCT03953001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101934812|NCT03953001|Respiratory System Agents|respiratory system agents|mesh-ancestor
101934813|NCT03953001|Mydriatics|mydriatics|mesh-ancestor
101934814|NCT03953001|Sympathomimetics|sympathomimetics|mesh-ancestor
101934815|NCT03953001|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101934816|NCT01094769|Moxonidine|moxonidine|mesh-list
101934817|NCT01094769|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101934818|NCT01091415|Calcium|calcium|mesh-list
101934819|NCT01091415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101934820|NCT01091415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934821|NCT00032487|Metformin|metformin|mesh-list
101934822|NCT00032487|Glimepiride|glimepiride|mesh-list
101934823|NCT00032487|Rosiglitazone|rosiglitazone|mesh-list
101934824|NCT00032487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101934825|NCT00032487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101958838|NCT02252302|Tocolytic Agents|tocolytic agents|mesh-ancestor
101934826|NCT00032487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101934827|NCT00032487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101934828|NCT00032487|Immunologic Factors|immunologic factors|mesh-ancestor
101934829|NCT01091493|Moxifloxacin|moxifloxacin|mesh-list
101934830|NCT01091493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101934831|NCT01091493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101934832|NCT01091493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101934833|NCT01091493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101934834|NCT01091493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101934835|NCT01091493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934836|NCT01091493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101934837|NCT03692416|Prednisone|prednisone|mesh-list
101934838|NCT03692416|Ibuprofen|ibuprofen|mesh-list
101934839|NCT03692416|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101934840|NCT03692416|Methotrexate|methotrexate|mesh-list
101934841|NCT03692416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101934842|NCT03692416|Glucocorticoids|glucocorticoids|mesh-ancestor
101934843|NCT03692416|Hormones|hormones|mesh-ancestor
101934844|NCT03692416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101934845|NCT03692416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934846|NCT03692416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101934847|NCT03692416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101934848|NCT03692416|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101934849|NCT03692416|Abortifacient Agents|abortifacient agents|mesh-ancestor
101934850|NCT03692416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101934851|NCT03692416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101934852|NCT03692416|Antimetabolites|antimetabolites|mesh-ancestor
101934853|NCT03692416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934854|NCT03692416|Dermatologic Agents|dermatologic agents|mesh-ancestor
101934855|NCT03692416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101934856|NCT03692416|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101934857|NCT03692416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101934858|NCT03692416|Immunologic Factors|immunologic factors|mesh-ancestor
101934859|NCT03692416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101934860|NCT03692416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101934861|NCT03692416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101617234|NCT00928668|Olodaterol|olodaterol|mesh-list
101934862|NCT03692416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101934863|NCT03692416|Analgesics|analgesics|mesh-ancestor
101934864|NCT03692416|Sensory System Agents|sensory system agents|mesh-ancestor
101934865|NCT03692416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101934866|NCT03692416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101934867|NCT03692416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101934868|NCT03692416|Protective Agents|protective agents|mesh-ancestor
101934869|NCT03594552|Baclofen|baclofen|mesh-list
101934870|NCT03594552|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101934871|NCT03594552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934872|NCT03594552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101934873|NCT03594552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101934874|NCT03594552|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101934875|NCT03594552|GABA Agonists|gaba agonists|mesh-ancestor
101934876|NCT03594552|GABA Agents|gaba agents|mesh-ancestor
101934877|NCT03594552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101934878|NCT03594552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934879|NCT03641508|Dexamethasone|dexamethasone|mesh-list
101934880|NCT03641508|Triamcinolone|triamcinolone|mesh-list
101934881|NCT03641508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101934882|NCT03641508|Antiemetics|antiemetics|mesh-ancestor
101934883|NCT03641508|Autonomic Agents|autonomic agents|mesh-ancestor
101934884|NCT03641508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101934885|NCT03641508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934886|NCT03641508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101934887|NCT03641508|Glucocorticoids|glucocorticoids|mesh-ancestor
101934888|NCT03641508|Hormones|hormones|mesh-ancestor
101934889|NCT03641508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101934890|NCT03641508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101934891|NCT03641508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101934892|NCT03624244|Letrozole|letrozole|mesh-list
101934893|NCT03624244|Exemestane|exemestane|mesh-list
101934894|NCT03624244|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101934895|NCT03624244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101958842|NCT02252302|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101934896|NCT03624244|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101934897|NCT03624244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101934898|NCT03624244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934899|NCT03624244|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101934900|NCT03624244|Hormone Antagonists|hormone antagonists|mesh-ancestor
101934901|NCT03624244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101934902|NCT03624244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934903|NCT03465878|Insulin Lispro|insulin lispro|mesh-list
101934904|NCT03465878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101934905|NCT03465878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934906|NCT01091571|Dipyridamole|dipyridamole|mesh-list
101934907|NCT01091571|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101934908|NCT01091571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101934909|NCT01091571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934910|NCT01091571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101934911|NCT01091571|Vasodilator Agents|vasodilator agents|mesh-ancestor
101934912|NCT01091649|Ritonavir|ritonavir|mesh-list
101934913|NCT01091649|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101934914|NCT01091649|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101934915|NCT01091649|Protease Inhibitors|protease inhibitors|mesh-ancestor
101934916|NCT01091649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101934917|NCT01091649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934918|NCT01091649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101934919|NCT01091649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101934920|NCT01091649|Antiviral Agents|antiviral agents|mesh-ancestor
101934921|NCT01091649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101934922|NCT01091649|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101934923|NCT01091649|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101934924|NCT01091727|Botulinum Toxins|botulinum toxins|mesh-list
101934925|NCT01091727|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101934926|NCT01091727|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101934927|NCT01091727|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101233565|NCT01572259|Hormones|hormones|mesh-list
101934928|NCT01091727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101934929|NCT01091727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934930|NCT01091727|Cholinergic Agents|cholinergic agents|mesh-ancestor
101934931|NCT01091727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101934932|NCT01091727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934933|NCT01091727|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101934934|NCT01091727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101934935|NCT03421730|Budesonide|budesonide|mesh-list
101934936|NCT03421730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101934937|NCT03421730|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101934938|NCT03421730|Autonomic Agents|autonomic agents|mesh-ancestor
101934939|NCT03421730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101934940|NCT03421730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934941|NCT03421730|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101934942|NCT03421730|Respiratory System Agents|respiratory system agents|mesh-ancestor
101934943|NCT03421730|Glucocorticoids|glucocorticoids|mesh-ancestor
101934944|NCT03421730|Hormones|hormones|mesh-ancestor
101934945|NCT03421730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101934946|NCT01094925|Gabapentin|gabapentin|mesh-list
101934947|NCT01094925|Analgesics|analgesics|mesh-ancestor
101934948|NCT01094925|Sensory System Agents|sensory system agents|mesh-ancestor
101934949|NCT01094925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101934950|NCT01094925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934951|NCT01094925|Anticonvulsants|anticonvulsants|mesh-ancestor
101934952|NCT01094925|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101934953|NCT01094925|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101934954|NCT01094925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101934955|NCT01094925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101934956|NCT01094925|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101934957|NCT01094925|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101934958|NCT01094925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101934959|NCT01094925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934960|NCT01094925|Antimanic Agents|antimanic agents|mesh-ancestor
101934961|NCT03718676|Pemetrexed|pemetrexed|mesh-list
101934962|NCT03718676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101934963|NCT03718676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101934964|NCT03718676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934965|NCT03718676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101934966|NCT03718676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101934968|NCT00054327|Cyclophosphamide|cyclophosphamide|mesh-list
101934969|NCT00054327|Busulfan|busulfan|mesh-list
101934970|NCT00054327|Etoposide|etoposide|mesh-list
101934971|NCT00054327|Etoposide phosphate|etoposide phosphate|mesh-list
101934972|NCT00054327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101934973|NCT00054327|Immunologic Factors|immunologic factors|mesh-ancestor
101934974|NCT00054327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934975|NCT00054327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101934976|NCT00054327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101934977|NCT00054327|Alkylating Agents|alkylating agents|mesh-ancestor
101934978|NCT00054327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101934979|NCT00054327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101934980|NCT00054327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101934981|NCT00054327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101934982|NCT00054327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101934983|NCT00054327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101934984|NCT00054327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101934985|NCT00054327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101934986|NCT00054327|Antimetabolites|antimetabolites|mesh-ancestor
101934987|NCT00054327|Antiviral Agents|antiviral agents|mesh-ancestor
101934988|NCT00054327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101934989|NCT03029650|Scopolamine|scopolamine|mesh-list
101934990|NCT03029650|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101934991|NCT03029650|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101934992|NCT03029650|Antiemetics|antiemetics|mesh-ancestor
101934993|NCT03029650|Autonomic Agents|autonomic agents|mesh-ancestor
101934994|NCT03029650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101934995|NCT03029650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101934996|NCT03029650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101934997|NCT03029650|Mydriatics|mydriatics|mesh-ancestor
101934998|NCT03029650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101934999|NCT03029650|Cholinergic Agents|cholinergic agents|mesh-ancestor
101935000|NCT03029650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101935001|NCT03029650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935002|NCT03029650|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101935003|NCT03029650|Parasympatholytics|parasympatholytics|mesh-ancestor
101935004|NCT03462680|Niacin|niacin|mesh-list
101935005|NCT03462680|Vitamins|vitamins|mesh-ancestor
101935006|NCT03462680|Micronutrients|micronutrients|mesh-ancestor
101935007|NCT03462680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935008|NCT03462680|Vitamin B Complex|vitamin b complex|mesh-ancestor
101935009|NCT03462680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101935010|NCT03462680|Antimetabolites|antimetabolites|mesh-ancestor
101935011|NCT03462680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935012|NCT03462680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101935013|NCT03462680|Vasodilator Agents|vasodilator agents|mesh-ancestor
101935014|NCT03692026|Melatonin|melatonin|mesh-list
101935015|NCT03692026|Hyaluronic Acid|hyaluronic acid|mesh-list
101935016|NCT03692026|Antioxidants|antioxidants|mesh-ancestor
101935017|NCT03692026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935018|NCT03692026|Protective Agents|protective agents|mesh-ancestor
101935019|NCT03692026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935020|NCT03692026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101935021|NCT03692026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101935022|NCT03692026|Immunologic Factors|immunologic factors|mesh-ancestor
101935023|NCT03692026|Viscosupplements|viscosupplements|mesh-ancestor
101935024|NCT03624322|Olanzapine|olanzapine|mesh-list
101935025|NCT03624322|Antiemetics|antiemetics|mesh-ancestor
101935026|NCT03624322|Autonomic Agents|autonomic agents|mesh-ancestor
101935027|NCT03624322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101935028|NCT03624322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935029|NCT03624322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101935030|NCT03624322|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101935031|NCT03624322|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101935032|NCT03624322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101935033|NCT03624322|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101935034|NCT03624322|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101935035|NCT03624322|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101935036|NCT03624322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101935037|NCT03624322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654871|NCT02839668|Analgesics|analgesics|mesh-ancestor
101935038|NCT03624322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101935039|NCT03624322|Serotonin Agents|serotonin agents|mesh-ancestor
101935040|NCT01097811|Erythromycin|erythromycin|mesh-list
101935041|NCT01097811|Erythromycin Estolate|erythromycin estolate|mesh-list
101935042|NCT01097811|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101935043|NCT01097811|Erythromycin stearate|erythromycin stearate|mesh-list
101935044|NCT01097811|Neomycin|neomycin|mesh-list
101935045|NCT01097811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101935046|NCT01097811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101935047|NCT01097811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101935048|NCT01097811|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101935049|NCT01097811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101935050|NCT01097811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935051|NCT03957291|Chlorhexidine|chlorhexidine|mesh-list
101935052|NCT03957291|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101935053|NCT03957291|Povidone-Iodine|povidone-iodine|mesh-list
101935054|NCT03957291|Povidone|povidone|mesh-list
101935055|NCT03957291|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101935056|NCT03957291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101935057|NCT03957291|Disinfectants|disinfectants|mesh-ancestor
101935058|NCT03957291|Dermatologic Agents|dermatologic agents|mesh-ancestor
101935059|NCT03957291|Plasma Substitutes|plasma substitutes|mesh-ancestor
101935060|NCT03957291|Blood Substitutes|blood substitutes|mesh-ancestor
101935061|NCT04044976|Caffeine|caffeine|mesh-list
101935062|NCT04044976|Caffeine citrate|caffeine citrate|mesh-list
101935063|NCT04044976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935064|NCT04044976|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101935065|NCT04044976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935066|NCT04044976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101935067|NCT04044976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101935068|NCT04044976|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101935069|NCT04044976|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101935070|NCT04044976|Purinergic Agents|purinergic agents|mesh-ancestor
101935071|NCT04044976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101935072|NCT03691636|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101935073|NCT03691636|Lifitegrast|lifitegrast|mesh-list
101935074|NCT03691636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101935075|NCT04295902|Pyrithione zinc|pyrithione zinc|mesh-list
101935076|NCT04295902|Keratolytic Agents|keratolytic agents|mesh-ancestor
101935077|NCT04295902|Dermatologic Agents|dermatologic agents|mesh-ancestor
101935078|NCT03956121|Magnesium Sulfate|magnesium sulfate|mesh-list
101935079|NCT03956121|Analgesics|analgesics|mesh-ancestor
101935080|NCT03956121|Sensory System Agents|sensory system agents|mesh-ancestor
101935081|NCT03956121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101297580|NCT01999686|Metformin|metformin|mesh-list
101935082|NCT03956121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935083|NCT03956121|Anesthetics|anesthetics|mesh-ancestor
101935084|NCT03956121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101935085|NCT03956121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101935086|NCT03956121|Anticonvulsants|anticonvulsants|mesh-ancestor
101935087|NCT03956121|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101935088|NCT03956121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101935089|NCT03956121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935090|NCT03956121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101935091|NCT03956121|Tocolytic Agents|tocolytic agents|mesh-ancestor
101935092|NCT03956121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101935093|NCT03636906|Vaccines|vaccines|mesh-list
101935094|NCT03636906|Immunologic Factors|immunologic factors|mesh-ancestor
101935095|NCT03636906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935096|NCT03028870|Naproxen|naproxen|mesh-list
101935097|NCT03028870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101935098|NCT03028870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101935099|NCT03028870|Analgesics|analgesics|mesh-ancestor
101935100|NCT03028870|Sensory System Agents|sensory system agents|mesh-ancestor
101935101|NCT03028870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101935102|NCT03028870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935103|NCT03028870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101935104|NCT03028870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101935105|NCT03028870|Gout Suppressants|gout suppressants|mesh-ancestor
101935106|NCT03028870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101935107|NCT03028870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101958847|NCT02252614|Naproxen|naproxen|mesh-list
101935108|NCT03028870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935110|NCT01098201|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101935111|NCT01098201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101935112|NCT01098201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101654941|NCT02342444|Enoxaparin|enoxaparin|mesh-list
101935113|NCT01098201|Immunologic Factors|immunologic factors|mesh-ancestor
101935114|NCT01098201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935115|NCT01098201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101935117|NCT01092039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101935118|NCT03663582|Teduglutide|teduglutide|mesh-list
101935119|NCT03663582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101935120|NCT03663582|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101935121|NCT03663582|Protective Agents|protective agents|mesh-ancestor
101935122|NCT03663582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935123|NCT01098357|Becaplermin|becaplermin|mesh-list
101935124|NCT01098357|Anticoagulants|anticoagulants|mesh-ancestor
101935125|NCT01098357|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
101935126|NCT01098357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101935127|NCT01098357|Growth Substances|growth substances|mesh-ancestor
101935128|NCT01098357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935129|NCT03730740|Lenalidomide|lenalidomide|mesh-list
101935130|NCT03730740|Immunologic Factors|immunologic factors|mesh-ancestor
101935131|NCT03730740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935132|NCT03730740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101935133|NCT03730740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101935134|NCT03730740|Growth Substances|growth substances|mesh-ancestor
101935135|NCT03730740|Growth Inhibitors|growth inhibitors|mesh-ancestor
101935136|NCT03730740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101935137|NCT01098513|Dolutegravir|dolutegravir|mesh-list
101935138|NCT01098513|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101935139|NCT01098513|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101935140|NCT01098513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101935141|NCT01098513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935142|NCT01098513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101935143|NCT01098513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101935144|NCT01098513|Antiviral Agents|antiviral agents|mesh-ancestor
101935145|NCT01098513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101935146|NCT03693976|Xylometazoline|xylometazoline|mesh-list
101935147|NCT03693976|Nasal Decongestants|nasal decongestants|mesh-ancestor
101935148|NCT03693976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101935149|NCT03693976|Respiratory System Agents|respiratory system agents|mesh-ancestor
101935150|NCT03730584|Ropivacaine|ropivacaine|mesh-list
101935151|NCT03730584|Anesthetics, Local|anesthetics, local|mesh-ancestor
101935152|NCT03730584|Anesthetics|anesthetics|mesh-ancestor
101935153|NCT03730584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101935154|NCT03730584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935155|NCT03730584|Sensory System Agents|sensory system agents|mesh-ancestor
101297653|NCT02000336|Glucocorticoids|glucocorticoids|mesh-ancestor
101935156|NCT03730584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101935157|NCT03502616|Tofacitinib|tofacitinib|mesh-list
101935158|NCT03502616|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101935159|NCT03502616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101935160|NCT03502616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101935161|NCT03502616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935162|NCT04003012|Lidocaine|lidocaine|mesh-list
101935163|NCT04003012|Anesthetics, Local|anesthetics, local|mesh-ancestor
101935164|NCT04003012|Anesthetics|anesthetics|mesh-ancestor
101935165|NCT04003012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101935166|NCT04003012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935167|NCT04003012|Sensory System Agents|sensory system agents|mesh-ancestor
101935168|NCT04003012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101935169|NCT04003012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101935170|NCT04003012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101935171|NCT04003012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101935172|NCT04003012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101935173|NCT04003012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935174|NCT05666076|Bupivacaine|bupivacaine|mesh-list
101935175|NCT05666076|Prilocaine|prilocaine|mesh-list
101935176|NCT05666076|Anesthetics, Local|anesthetics, local|mesh-ancestor
101935177|NCT05666076|Anesthetics|anesthetics|mesh-ancestor
101935178|NCT05666076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101935179|NCT05666076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935180|NCT05666076|Sensory System Agents|sensory system agents|mesh-ancestor
101935181|NCT05666076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101935183|NCT03028012|Ketorolac|ketorolac|mesh-list
101935184|NCT03028012|Lidocaine|lidocaine|mesh-list
101935185|NCT03028012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101935186|NCT03028012|Antiemetics|antiemetics|mesh-ancestor
101935187|NCT03028012|Autonomic Agents|autonomic agents|mesh-ancestor
101935188|NCT03028012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101935189|NCT03028012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935190|NCT03028012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101935191|NCT03028012|Glucocorticoids|glucocorticoids|mesh-ancestor
101935192|NCT03028012|Hormones|hormones|mesh-ancestor
101935193|NCT03028012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101935194|NCT03028012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101935195|NCT03028012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101935196|NCT03028012|Anesthetics, Local|anesthetics, local|mesh-ancestor
101935197|NCT03028012|Anesthetics|anesthetics|mesh-ancestor
101935198|NCT03028012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101935199|NCT03028012|Sensory System Agents|sensory system agents|mesh-ancestor
101935200|NCT03028012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101935201|NCT03028012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101935202|NCT03028012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101935203|NCT03028012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101935204|NCT03028012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935205|NCT03028012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101935206|NCT03028012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101935207|NCT03028012|Analgesics|analgesics|mesh-ancestor
101935208|NCT03028012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101935209|NCT03028012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101935210|NCT03028012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101935211|NCT03634800|Nivolumab|nivolumab|mesh-list
101935212|NCT03634800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101935213|NCT03634800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101935214|NCT03634800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101935215|NCT03634800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935216|NCT03662334|Insulin, Short-Acting|insulin, short-acting|mesh-list
101935217|NCT03662334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101935218|NCT03662334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935219|NCT02955186|Saracatinib|saracatinib|mesh-list
101935220|NCT02955186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101935221|NCT02955186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101935222|NCT02955186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935223|NCT03693508|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101935224|NCT03693508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101935225|NCT03693508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101935226|NCT03693508|Antiviral Agents|antiviral agents|mesh-ancestor
101935227|NCT03693508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101935229|NCT03690778|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101935230|NCT03690778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101935231|NCT03690778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935232|NCT03690778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101935233|NCT03690778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101935234|NCT03690778|Antimetabolites|antimetabolites|mesh-ancestor
101935235|NCT03690778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935236|NCT03690778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101935237|NCT03690778|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101935238|NCT03690778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101935239|NCT03715634|Buprenorphine|buprenorphine|mesh-list
101935240|NCT03715634|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101935241|NCT03715634|Narcotics|narcotics|mesh-ancestor
101935242|NCT03715634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101935243|NCT03715634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935244|NCT03715634|Analgesics|analgesics|mesh-ancestor
101935245|NCT03715634|Sensory System Agents|sensory system agents|mesh-ancestor
101935246|NCT03715634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101935247|NCT03715634|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101935248|NCT03502070|Tobramycin|tobramycin|mesh-list
101935249|NCT03502070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101247631|NCT04886297|Resveratrol|resveratrol|mesh-list
101935251|NCT04158934|Factor VIII|factor viii|mesh-list
101935252|NCT04158934|BAX 855|bax 855|mesh-list
101935253|NCT04158934|Coagulants|coagulants|mesh-ancestor
101935254|NCT03715556|Amiodarone|amiodarone|mesh-list
101935255|NCT03715556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101935256|NCT03715556|Vasodilator Agents|vasodilator agents|mesh-ancestor
101935257|NCT03715556|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101935258|NCT03715556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101935259|NCT03715556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935260|NCT03715556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101655092|NCT02837640|Dopamine Agents|dopamine agents|mesh-ancestor
101935261|NCT03715556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101935262|NCT03715556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101935263|NCT03715556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101935264|NCT03715556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101935265|NCT03715556|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101935266|NCT03715556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101935267|NCT03730038|Pitavastatin|pitavastatin|mesh-list
101935268|NCT03730038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101935269|NCT03730038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101935270|NCT03730038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101935271|NCT03730038|Antimetabolites|antimetabolites|mesh-ancestor
101935272|NCT03730038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935273|NCT03730038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101935274|NCT03730038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101935275|NCT03725904|Progesterone|progesterone|mesh-list
101935276|NCT03725904|Progestins|progestins|mesh-ancestor
101935277|NCT03725904|Hormones|hormones|mesh-ancestor
101935278|NCT03725904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101935279|NCT03725904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935280|NCT03730272|Analgesics|analgesics|mesh-list
101935281|NCT03730272|Sensory System Agents|sensory system agents|mesh-ancestor
101935282|NCT03730272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101935283|NCT03730272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935284|NCT03585504|Contraceptive Agents|contraceptive agents|mesh-list
101935285|NCT03585504|Etonogestrel|etonogestrel|mesh-list
101935286|NCT03585504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101935287|NCT03585504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935288|NCT03585504|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101935289|NCT03585504|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101935290|NCT03690622|Dexmedetomidine|dexmedetomidine|mesh-list
101935291|NCT03690622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101935292|NCT03690622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101935293|NCT03690622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935294|NCT03690622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101935295|NCT03690622|Analgesics|analgesics|mesh-ancestor
101935296|NCT03690622|Sensory System Agents|sensory system agents|mesh-ancestor
101935297|NCT03690622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101935298|NCT03690622|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101935299|NCT03690622|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101935301|NCT03690622|Adrenergic Agents|adrenergic agents|mesh-ancestor
101935302|NCT03690622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101935303|NCT03690622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935304|NCT03715322|Tobramycin|tobramycin|mesh-list
101935305|NCT03715322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101935306|NCT03715322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101935307|NCT03687268|Naloxone|naloxone|mesh-list
101935308|NCT03687268|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101935309|NCT03687268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935310|NCT03687268|Sensory System Agents|sensory system agents|mesh-ancestor
101935311|NCT03687268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101935312|NCT03576066|Tenofovir|tenofovir|mesh-list
101935313|NCT03576066|Entecavir|entecavir|mesh-list
101935314|NCT03576066|Antiviral Agents|antiviral agents|mesh-ancestor
101935315|NCT03576066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101935316|NCT03576066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101935317|NCT03576066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101935318|NCT03576066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101935319|NCT03576066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935320|NCT03576066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101935321|NCT03576066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101935322|NCT03639480|Amlodipine|amlodipine|mesh-list
101935323|NCT03639480|Valsartan|valsartan|mesh-list
101935324|NCT03639480|Atorvastatin|atorvastatin|mesh-list
101935325|NCT03639480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101935326|NCT03639480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101935327|NCT03639480|Antimetabolites|antimetabolites|mesh-ancestor
101935328|NCT03639480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935329|NCT03639480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101935330|NCT03639480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101935331|NCT03639480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101935332|NCT03639480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101935333|NCT03639480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101655169|NCT02833584|Acetaminophen|acetaminophen|mesh-list
101935334|NCT03639480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101935335|NCT03639480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101935336|NCT03639480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935337|NCT03639480|Vasodilator Agents|vasodilator agents|mesh-ancestor
101935338|NCT03639480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101935339|NCT03639480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101935341|NCT03689998|Antioxidants|antioxidants|mesh-ancestor
101935342|NCT03689998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935343|NCT03689998|Protective Agents|protective agents|mesh-ancestor
101935344|NCT03689998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935345|NCT03689998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101935346|NCT03948178|Simendan|simendan|mesh-list
101935347|NCT03948178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101935348|NCT03948178|Vasodilator Agents|vasodilator agents|mesh-ancestor
101935349|NCT03948178|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101935350|NCT03948178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101935351|NCT03948178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101935352|NCT03948178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935353|NCT03948178|Protective Agents|protective agents|mesh-ancestor
101935354|NCT03948178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935355|NCT03687034|Temozolomide|temozolomide|mesh-list
101935356|NCT03687034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101935357|NCT03687034|Alkylating Agents|alkylating agents|mesh-ancestor
101935358|NCT03687034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935359|NCT03687034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101935360|NCT03520920|Rituximab|rituximab|mesh-list
101935361|NCT03520920|Zanubrutinib|zanubrutinib|mesh-list
101935362|NCT03520920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101935363|NCT03520920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101935364|NCT03520920|Immunologic Factors|immunologic factors|mesh-ancestor
101935365|NCT03520920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935366|NCT03520920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101935367|NCT03520920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101935368|NCT03520920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101935369|NCT03520920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935370|NCT03686878|Lifitegrast|lifitegrast|mesh-list
101935371|NCT03686878|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101935372|NCT03686878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101935373|NCT03682198|Phenylephrine|phenylephrine|mesh-list
101935374|NCT03682198|Oxymetazoline|oxymetazoline|mesh-list
101935375|NCT03682198|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101935376|NCT03682198|Mydriatics|mydriatics|mesh-ancestor
101935377|NCT03682198|Autonomic Agents|autonomic agents|mesh-ancestor
101958873|NCT03681951|Pembrolizumab|pembrolizumab|mesh-list
101935378|NCT03682198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101935379|NCT03682198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935381|NCT03682198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101935382|NCT03682198|Nasal Decongestants|nasal decongestants|mesh-ancestor
101935383|NCT03682198|Respiratory System Agents|respiratory system agents|mesh-ancestor
101935384|NCT03682198|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101935385|NCT03682198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101935386|NCT03682198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101935387|NCT03682198|Adrenergic Agents|adrenergic agents|mesh-ancestor
101935388|NCT03682198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101935389|NCT03682198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935390|NCT03682198|Protective Agents|protective agents|mesh-ancestor
101935391|NCT02953340|Cyclophosphamide|cyclophosphamide|mesh-list
101935392|NCT02953340|Docetaxel|docetaxel|mesh-list
101935393|NCT02953340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101935394|NCT02953340|Immunologic Factors|immunologic factors|mesh-ancestor
101935395|NCT02953340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935396|NCT02953340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101935397|NCT02953340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101935398|NCT02953340|Alkylating Agents|alkylating agents|mesh-ancestor
101935399|NCT02953340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935400|NCT02953340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101935401|NCT02953340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101935402|NCT02953340|Tubulin Modulators|tubulin modulators|mesh-ancestor
101935403|NCT02953340|Antimitotic Agents|antimitotic agents|mesh-ancestor
101935404|NCT02953340|Mitosis Modulators|mitosis modulators|mesh-ancestor
101935405|NCT03554772|Celecoxib|celecoxib|mesh-list
101935406|NCT03554772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101655246|NCT05878249|Eusol|eusol|mesh-list
101935407|NCT03554772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101935408|NCT03554772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101935409|NCT03554772|Analgesics|analgesics|mesh-ancestor
101935410|NCT03554772|Sensory System Agents|sensory system agents|mesh-ancestor
101935411|NCT03554772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101935412|NCT03554772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935413|NCT03554772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101935414|NCT03554772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101935415|NCT03554772|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101935416|NCT03554772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101935417|NCT03554772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101935418|NCT03554772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935419|NCT03624010|Simendan|simendan|mesh-list
101233683|NCT01572623|Clopidogrel|clopidogrel|mesh-list
101935420|NCT03624010|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101935421|NCT03624010|Vasodilator Agents|vasodilator agents|mesh-ancestor
101935422|NCT03624010|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101935423|NCT03624010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101935424|NCT03624010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101935425|NCT03624010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935426|NCT03624010|Protective Agents|protective agents|mesh-ancestor
101935427|NCT03624010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935428|NCT03686722|Metformin|metformin|mesh-list
101935429|NCT03686722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101935430|NCT03686722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935431|NCT04629976|Tenofovir|tenofovir|mesh-list
101935432|NCT04629976|Antiviral Agents|antiviral agents|mesh-ancestor
101935433|NCT04629976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101935434|NCT04629976|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101935435|NCT04629976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101935436|NCT04629976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101935437|NCT04629976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935438|NCT04629976|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101935439|NCT04629976|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101935440|NCT03728946|Bupivacaine|bupivacaine|mesh-list
101935441|NCT03728946|Anesthetics, Local|anesthetics, local|mesh-ancestor
101935442|NCT03728946|Anesthetics|anesthetics|mesh-ancestor
101935443|NCT03728946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101935444|NCT03728946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935445|NCT03728946|Sensory System Agents|sensory system agents|mesh-ancestor
101935446|NCT03728946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101935447|NCT03553758|Ketamine|ketamine|mesh-list
101935448|NCT03553758|Analgesics|analgesics|mesh-ancestor
101935449|NCT03553758|Sensory System Agents|sensory system agents|mesh-ancestor
101935450|NCT03553758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101935451|NCT03553758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935452|NCT03553758|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101935453|NCT03553758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101935454|NCT03553758|Anesthetics, General|anesthetics, general|mesh-ancestor
101935455|NCT03553758|Anesthetics|anesthetics|mesh-ancestor
101935456|NCT03553758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101935457|NCT03553758|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101935458|NCT03553758|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101935459|NCT03553758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101935460|NCT03553758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935461|NCT02954354|Oseltamivir|oseltamivir|mesh-list
101935462|NCT02954354|Baloxavir|baloxavir|mesh-list
101935463|NCT02954354|Antiviral Agents|antiviral agents|mesh-ancestor
101935464|NCT02954354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101935465|NCT02954354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101935466|NCT02954354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935467|NCT03519516|Ciprofloxacin|ciprofloxacin|mesh-list
101935468|NCT03519516|Levofloxacin|levofloxacin|mesh-list
101935469|NCT03519516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101935470|NCT03519516|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101935471|NCT03519516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101935472|NCT03519516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101935473|NCT03519516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101935474|NCT03519516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101935475|NCT03519516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101935476|NCT03519516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935477|NCT03519516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101935478|NCT03519516|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101935479|NCT03519516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101935480|NCT03519516|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101935481|NCT03681574|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
101935482|NCT03681574|GABA Agents|gaba agents|mesh-ancestor
101935483|NCT03681574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101935484|NCT03681574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935485|NCT03681574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935486|NCT03519204|Lidocaine|lidocaine|mesh-list
101935487|NCT03519204|Anesthetics, Local|anesthetics, local|mesh-ancestor
101935488|NCT03519204|Anesthetics|anesthetics|mesh-ancestor
101935489|NCT03519204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101935490|NCT03519204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935491|NCT03519204|Sensory System Agents|sensory system agents|mesh-ancestor
101935492|NCT03519204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101935493|NCT03519204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101935494|NCT03519204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101935495|NCT03519204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101935496|NCT03519204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101935497|NCT03519204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935498|NCT03624166|Ketamine|ketamine|mesh-list
101935499|NCT03624166|Anesthetics|anesthetics|mesh-list
101935500|NCT03624166|Anesthetics, General|anesthetics, general|mesh-list
101935501|NCT03624166|Analgesics|analgesics|mesh-ancestor
101935502|NCT03624166|Sensory System Agents|sensory system agents|mesh-ancestor
101935503|NCT03624166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101935504|NCT03624166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935505|NCT03624166|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101935506|NCT03624166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101935507|NCT03624166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101935508|NCT03624166|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101935509|NCT03624166|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101935510|NCT03624166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101935511|NCT03624166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935512|NCT03518112|Calcium, Dietary|calcium, dietary|mesh-list
101935513|NCT03518112|Leucovorin|leucovorin|mesh-list
101935514|NCT03518112|Folic Acid|folic acid|mesh-list
101935515|NCT03518112|Cytarabine|cytarabine|mesh-list
101935516|NCT03518112|Dexamethasone|dexamethasone|mesh-list
101935517|NCT03518112|Dexamethasone acetate|dexamethasone acetate|mesh-list
101935518|NCT03518112|Cyclophosphamide|cyclophosphamide|mesh-list
101935519|NCT03518112|Rituximab|rituximab|mesh-list
101935520|NCT03518112|Methotrexate|methotrexate|mesh-list
101935521|NCT03518112|Vincristine|vincristine|mesh-list
101935522|NCT03518112|Mercaptopurine|mercaptopurine|mesh-list
101935523|NCT03518112|Blinatumomab|blinatumomab|mesh-list
101935524|NCT03518112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101935525|NCT03518112|Muromonab-CD3|muromonab-cd3|mesh-list
101935526|NCT03518112|Antibodies|antibodies|mesh-list
101935527|NCT03518112|Immunoglobulins|immunoglobulins|mesh-list
101935528|NCT03518112|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101935529|NCT03518112|Lenograstim|lenograstim|mesh-list
101935530|NCT03518112|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101935531|NCT03518112|BB 1101|bb 1101|mesh-list
101935532|NCT03518112|Calcium|calcium|mesh-list
101935533|NCT03518112|Levoleucovorin|levoleucovorin|mesh-list
101935534|NCT03518112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101935535|NCT03518112|Immunologic Factors|immunologic factors|mesh-ancestor
101935536|NCT03518112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935537|NCT03518112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101935538|NCT03518112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101935539|NCT03518112|Alkylating Agents|alkylating agents|mesh-ancestor
101935540|NCT03518112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935541|NCT03518112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101935542|NCT03518112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101935543|NCT03518112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101935544|NCT03518112|Antiemetics|antiemetics|mesh-ancestor
101935545|NCT03518112|Autonomic Agents|autonomic agents|mesh-ancestor
101935546|NCT03518112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101935547|NCT03518112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101935548|NCT03518112|Glucocorticoids|glucocorticoids|mesh-ancestor
101935549|NCT03518112|Hormones|hormones|mesh-ancestor
101935550|NCT03518112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101935551|NCT03518112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101935552|NCT03518112|Protease Inhibitors|protease inhibitors|mesh-ancestor
101935553|NCT03518112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101935554|NCT03518112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101935555|NCT03518112|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101935556|NCT03518112|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101935557|NCT03518112|Abortifacient Agents|abortifacient agents|mesh-ancestor
101935558|NCT03518112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101935559|NCT03518112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101935560|NCT03518112|Antimetabolites|antimetabolites|mesh-ancestor
101935561|NCT03518112|Dermatologic Agents|dermatologic agents|mesh-ancestor
101935562|NCT03518112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101935563|NCT03518112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101935564|NCT03518112|Antiviral Agents|antiviral agents|mesh-ancestor
101935565|NCT03518112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101935566|NCT03518112|Antidotes|antidotes|mesh-ancestor
101935567|NCT03518112|Protective Agents|protective agents|mesh-ancestor
101935568|NCT03518112|Vitamin B Complex|vitamin b complex|mesh-ancestor
101935569|NCT03518112|Vitamins|vitamins|mesh-ancestor
101935570|NCT03518112|Micronutrients|micronutrients|mesh-ancestor
101935571|NCT03518112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101935572|NCT03518112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101935573|NCT03518112|Tubulin Modulators|tubulin modulators|mesh-ancestor
101935574|NCT03518112|Antimitotic Agents|antimitotic agents|mesh-ancestor
101935575|NCT03518112|Mitosis Modulators|mitosis modulators|mesh-ancestor
101935576|NCT03518112|Hematinics|hematinics|mesh-ancestor
101935577|NCT03686254|Bevacizumab|bevacizumab|mesh-list
101935578|NCT03686254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101935579|NCT03686254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101935580|NCT03686254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101935581|NCT03686254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101935582|NCT03686254|Growth Substances|growth substances|mesh-ancestor
101935583|NCT03686254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935584|NCT03686254|Growth Inhibitors|growth inhibitors|mesh-ancestor
101935585|NCT03679780|Nitroprusside|nitroprusside|mesh-list
101935586|NCT03679780|BQ 788|bq 788|mesh-list
101935587|NCT03679780|Nitroarginine|nitroarginine|mesh-list
101935588|NCT03679780|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
101935590|NCT03679780|Vasodilator Agents|vasodilator agents|mesh-ancestor
101935591|NCT03679780|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101935592|NCT03679780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935593|NCT03679780|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101935594|NCT03679780|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
101935595|NCT03679780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101935596|NCT03659734|Analgesics, Opioid|analgesics, opioid|mesh-list
101935597|NCT03659734|Narcotics|narcotics|mesh-ancestor
101935598|NCT03659734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101935599|NCT03659734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935600|NCT03659734|Analgesics|analgesics|mesh-ancestor
101935601|NCT03659734|Sensory System Agents|sensory system agents|mesh-ancestor
101935602|NCT03659734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101935603|NCT03680716|Ropivacaine|ropivacaine|mesh-list
101935604|NCT03680716|Anesthetics, Local|anesthetics, local|mesh-ancestor
101935605|NCT03680716|Anesthetics|anesthetics|mesh-ancestor
101935606|NCT03680716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101935607|NCT03680716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935608|NCT03680716|Sensory System Agents|sensory system agents|mesh-ancestor
101935609|NCT03680716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101935610|NCT03680638|Allopurinol|allopurinol|mesh-list
101935611|NCT03680638|Tempol|tempol|mesh-list
101935612|NCT03680638|Antimetabolites|antimetabolites|mesh-ancestor
101935613|NCT03680638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935614|NCT03680638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101935615|NCT03680638|Gout Suppressants|gout suppressants|mesh-ancestor
101935616|NCT03680638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101935617|NCT03680638|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101935618|NCT03680638|Antioxidants|antioxidants|mesh-ancestor
101935619|NCT03680638|Protective Agents|protective agents|mesh-ancestor
101935620|NCT03680638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935621|NCT03680638|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101935622|NCT03680638|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101935623|NCT03680638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101935624|NCT03680560|Trastuzumab|trastuzumab|mesh-list
101935625|NCT03680560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101935626|NCT03680560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101935627|NCT03444298|Vitamin E|vitamin e|mesh-list
101935628|NCT03444298|Tocopherols|tocopherols|mesh-list
101935629|NCT03444298|Tocotrienols|tocotrienols|mesh-list
101935630|NCT03444298|alpha-Tocopherol|alpha-tocopherol|mesh-list
101935631|NCT03444298|gamma-Tocopherol|gamma-tocopherol|mesh-list
101935632|NCT03444298|Vitamins|vitamins|mesh-ancestor
101935633|NCT03444298|Micronutrients|micronutrients|mesh-ancestor
101935634|NCT03444298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935635|NCT03444298|Antioxidants|antioxidants|mesh-ancestor
101935636|NCT03444298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935637|NCT03444298|Protective Agents|protective agents|mesh-ancestor
101935638|NCT03640312|Candesartan|candesartan|mesh-list
101935639|NCT03640312|Candesartan cilexetil|candesartan cilexetil|mesh-list
101935640|NCT03640312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101935641|NCT03640312|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101935642|NCT03640312|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101935643|NCT03640312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935644|NCT03639610|Dexamethasone|dexamethasone|mesh-list
101935645|NCT03639610|Melphalan|melphalan|mesh-list
101935646|NCT03639610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101935647|NCT03639610|Antiemetics|antiemetics|mesh-ancestor
101935648|NCT03639610|Autonomic Agents|autonomic agents|mesh-ancestor
101935649|NCT03639610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101935650|NCT03639610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935651|NCT03639610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101935652|NCT03639610|Glucocorticoids|glucocorticoids|mesh-ancestor
101935653|NCT03639610|Hormones|hormones|mesh-ancestor
101935654|NCT03639610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101935655|NCT03639610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101935656|NCT03639610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101935657|NCT03639610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101935658|NCT03639610|Alkylating Agents|alkylating agents|mesh-ancestor
101935659|NCT03639610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935660|NCT03639610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101935661|NCT03639610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101935662|NCT03639610|Immunologic Factors|immunologic factors|mesh-ancestor
101935663|NCT03680404|Allopurinol|allopurinol|mesh-list
101935664|NCT03680404|Phenylephrine|phenylephrine|mesh-list
101935665|NCT03680404|Oxymetazoline|oxymetazoline|mesh-list
101935667|NCT03680404|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101935668|NCT03680404|Mydriatics|mydriatics|mesh-ancestor
101935669|NCT03680404|Autonomic Agents|autonomic agents|mesh-ancestor
101935670|NCT03680404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101935671|NCT03680404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935672|NCT03680404|Sympathomimetics|sympathomimetics|mesh-ancestor
101935673|NCT03680404|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101935674|NCT03680404|Nasal Decongestants|nasal decongestants|mesh-ancestor
101935675|NCT03680404|Respiratory System Agents|respiratory system agents|mesh-ancestor
101935676|NCT03680404|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101935677|NCT03680404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101935678|NCT03680404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101935679|NCT03680404|Adrenergic Agents|adrenergic agents|mesh-ancestor
101935680|NCT03680404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101935681|NCT03680404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935682|NCT03680404|Protective Agents|protective agents|mesh-ancestor
101935683|NCT03680404|Antimetabolites|antimetabolites|mesh-ancestor
101935684|NCT03680404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101935685|NCT03680404|Gout Suppressants|gout suppressants|mesh-ancestor
101935686|NCT03680404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101935687|NCT03680404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101935688|NCT03680404|Antioxidants|antioxidants|mesh-ancestor
101935689|NCT03680404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101935690|NCT03680404|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101935691|NCT03680404|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101935692|NCT03685630|Brivaracetam|brivaracetam|mesh-list
101935693|NCT03685630|Anticonvulsants|anticonvulsants|mesh-ancestor
101935694|NCT02954406|Rituximab|rituximab|mesh-list
101935695|NCT02954406|Gemcitabine|gemcitabine|mesh-list
101935696|NCT02954406|Lenalidomide|lenalidomide|mesh-list
101935697|NCT02954406|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101935698|NCT02954406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101935699|NCT02954406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101935700|NCT02954406|Immunologic Factors|immunologic factors|mesh-ancestor
101935701|NCT02954406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935702|NCT02954406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101935703|NCT02954406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101935704|NCT02954406|Antimetabolites|antimetabolites|mesh-ancestor
101935705|NCT02954406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935706|NCT02954406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101935707|NCT02954406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101655543|NCT05462613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101935708|NCT02954406|Growth Substances|growth substances|mesh-ancestor
101935709|NCT02954406|Growth Inhibitors|growth inhibitors|mesh-ancestor
101935710|NCT02954406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101935711|NCT02954406|Alkylating Agents|alkylating agents|mesh-ancestor
101935712|NCT01310478|Endostatins|endostatins|mesh-list
101935713|NCT01310478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101935714|NCT01310478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101935715|NCT01310478|Growth Substances|growth substances|mesh-ancestor
101935716|NCT01310478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935717|NCT01310478|Growth Inhibitors|growth inhibitors|mesh-ancestor
101935718|NCT01310478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101935719|NCT03728244|Hyaluronic Acid|hyaluronic acid|mesh-list
101935720|NCT03728244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101935721|NCT03728244|Immunologic Factors|immunologic factors|mesh-ancestor
101935722|NCT03728244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935723|NCT03728244|Viscosupplements|viscosupplements|mesh-ancestor
101935724|NCT03728244|Protective Agents|protective agents|mesh-ancestor
101935725|NCT03511326|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101935726|NCT03511326|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
101935727|NCT03511326|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101935728|NCT03511326|Dermatologic Agents|dermatologic agents|mesh-ancestor
101935729|NCT03721614|Sirolimus|sirolimus|mesh-list
101935730|NCT03721614|Everolimus|everolimus|mesh-list
101935731|NCT03721614|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101935732|NCT03721614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101935733|NCT03721614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101935734|NCT03721614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935735|NCT03721614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101935736|NCT03721614|Immunologic Factors|immunologic factors|mesh-ancestor
101935737|NCT03721614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935738|NCT03721614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101935739|NCT03721614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101935740|NCT03721614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101935741|NCT03721614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101935742|NCT03721614|Antifungal Agents|antifungal agents|mesh-ancestor
101935743|NCT03727620|Amoxicillin|amoxicillin|mesh-list
101935744|NCT03727620|Metronidazole|metronidazole|mesh-list
101935745|NCT03727620|Doxycycline|doxycycline|mesh-list
101935746|NCT03727620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101935747|NCT03727620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101935748|NCT03727620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101935749|NCT03727620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101935750|NCT03727620|Antimalarials|antimalarials|mesh-ancestor
101935751|NCT03727464|Propofol|propofol|mesh-list
101935752|NCT03727464|Sevoflurane|sevoflurane|mesh-list
101935753|NCT03727464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101935754|NCT03727464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101935755|NCT03727464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935756|NCT03727464|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101935757|NCT03727464|Anesthetics, General|anesthetics, general|mesh-ancestor
101935758|NCT03727464|Anesthetics|anesthetics|mesh-ancestor
101935759|NCT03727464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101935760|NCT03727464|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101935761|NCT03508830|Bupivacaine|bupivacaine|mesh-list
101935762|NCT03508830|Anesthetics, Local|anesthetics, local|mesh-ancestor
101935763|NCT03508830|Anesthetics|anesthetics|mesh-ancestor
101935764|NCT03508830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101935765|NCT03508830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935766|NCT03508830|Sensory System Agents|sensory system agents|mesh-ancestor
101935767|NCT03508830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101935768|NCT03569202|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101935769|NCT03569202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101935770|NCT03724578|Anti-Infective Agents|anti-infective agents|mesh-list
101935771|NCT03724578|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101935772|NCT03724578|Grape Seed Extract|grape seed extract|mesh-list
101935773|NCT03724578|Fluorides|fluorides|mesh-list
101935774|NCT03724578|Cariostatic Agents|cariostatic agents|mesh-ancestor
101935775|NCT03724578|Protective Agents|protective agents|mesh-ancestor
101935776|NCT03724578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935777|NCT03724578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101935778|NCT03724578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101935779|NCT03724578|Antioxidants|antioxidants|mesh-ancestor
101935780|NCT03724578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935781|NCT03721380|Methadone|methadone|mesh-list
101655619|NCT05198934|Antiviral Agents|antiviral agents|mesh-ancestor
101935782|NCT03721380|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101935783|NCT03721380|Narcotics|narcotics|mesh-ancestor
101935784|NCT03721380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101935785|NCT03721380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935786|NCT03721380|Analgesics|analgesics|mesh-ancestor
101935787|NCT03721380|Sensory System Agents|sensory system agents|mesh-ancestor
101935788|NCT03721380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101935789|NCT03721380|Antitussive Agents|antitussive agents|mesh-ancestor
101935790|NCT03721380|Respiratory System Agents|respiratory system agents|mesh-ancestor
101935791|NCT03568500|Olanzapine|olanzapine|mesh-list
101935792|NCT03568500|Risperidone|risperidone|mesh-list
101935793|NCT03568500|Aripiprazole|aripiprazole|mesh-list
101935794|NCT03568500|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101935795|NCT03568500|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101935796|NCT03568500|Serotonin Agents|serotonin agents|mesh-ancestor
101935797|NCT03568500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101935798|NCT03568500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935799|NCT03568500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935800|NCT03568500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101935801|NCT03568500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101935802|NCT03568500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101935803|NCT03568500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101935804|NCT03568500|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101935805|NCT03568500|Dopamine Agents|dopamine agents|mesh-ancestor
101935806|NCT03568500|Antiemetics|antiemetics|mesh-ancestor
101935807|NCT03568500|Autonomic Agents|autonomic agents|mesh-ancestor
101935808|NCT03568500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101935809|NCT03568500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101935810|NCT03568500|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101935811|NCT03568500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101935812|NCT03568500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101935813|NCT03568500|Antidepressive Agents|antidepressive agents|mesh-ancestor
101935814|NCT03568500|Dopamine Agonists|dopamine agonists|mesh-ancestor
101935815|NCT03568500|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101935816|NCT03568500|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101935817|NCT03568500|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101935818|NCT03568500|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101935819|NCT03910738|Methyltestosterone|methyltestosterone|mesh-list
101935820|NCT03910738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101935821|NCT03910738|Testosterone|testosterone|mesh-list
101935822|NCT03910738|Testosterone undecanoate|testosterone undecanoate|mesh-list
101935823|NCT03910738|Testosterone enanthate|testosterone enanthate|mesh-list
101935824|NCT03910738|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101935825|NCT03910738|Androgens|androgens|mesh-ancestor
101935826|NCT03910738|Hormones|hormones|mesh-ancestor
101935827|NCT03910738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101935828|NCT03910738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935829|NCT03910738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101935830|NCT03910738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101935831|NCT03910738|Anabolic Agents|anabolic agents|mesh-ancestor
101935832|NCT03685084|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101935833|NCT03685084|Piperacillin|piperacillin|mesh-list
101935834|NCT03685084|Cefepime|cefepime|mesh-list
101935835|NCT03685084|Lactams|lactams|mesh-list
101935836|NCT03685084|beta-Lactams|beta-lactams|mesh-list
101935837|NCT03685084|Enmetazobactam|enmetazobactam|mesh-list
101935838|NCT03685084|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101935839|NCT03685084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101935840|NCT03685084|Antitubercular Agents|antitubercular agents|mesh-ancestor
101935841|NCT03685084|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101935842|NCT03685084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101935843|NCT03685084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935844|NCT03724266|Chitosan|chitosan|mesh-list
101935845|NCT03724266|Calcium|calcium|mesh-list
101935846|NCT03724266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101935847|NCT03724266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935848|NCT03724266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101935849|NCT03724266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101935850|NCT03724266|Antimetabolites|antimetabolites|mesh-ancestor
101935851|NCT03724266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935852|NCT03724266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101935853|NCT03724266|Chelating Agents|chelating agents|mesh-ancestor
101935854|NCT03724266|Sequestering Agents|sequestering agents|mesh-ancestor
101935855|NCT03724266|Hemostatics|hemostatics|mesh-ancestor
101935856|NCT03724266|Coagulants|coagulants|mesh-ancestor
101935857|NCT03679390|Ketamine|ketamine|mesh-list
101935858|NCT03679390|Analgesics|analgesics|mesh-ancestor
101935859|NCT03679390|Sensory System Agents|sensory system agents|mesh-ancestor
101935860|NCT03679390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101935861|NCT03679390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935862|NCT03679390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101935863|NCT03679390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101935864|NCT03679390|Anesthetics, General|anesthetics, general|mesh-ancestor
101935865|NCT03679390|Anesthetics|anesthetics|mesh-ancestor
101935866|NCT03679390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101935867|NCT03679390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101935868|NCT03679390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101935869|NCT03679390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101233763|NCT01573338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101935870|NCT03679390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935872|NCT03684772|Furosemide|furosemide|mesh-list
101935873|NCT03684772|Diuretics|diuretics|mesh-ancestor
101935874|NCT03684772|Natriuretic Agents|natriuretic agents|mesh-ancestor
101935875|NCT03684772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935876|NCT03684772|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101935877|NCT03684772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101935878|NCT03684772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935879|NCT03684772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101935880|NCT03684772|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101935881|NCT03684772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101935882|NCT03684772|Protective Agents|protective agents|mesh-ancestor
101935883|NCT03676114|Ketamine|ketamine|mesh-list
101935884|NCT03676114|Analgesics|analgesics|mesh-ancestor
101935885|NCT03676114|Sensory System Agents|sensory system agents|mesh-ancestor
101935886|NCT03676114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101935887|NCT03676114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935888|NCT03676114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101935889|NCT03676114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101935890|NCT03676114|Anesthetics, General|anesthetics, general|mesh-ancestor
101935891|NCT03676114|Anesthetics|anesthetics|mesh-ancestor
101935892|NCT03676114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101935893|NCT03676114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101935894|NCT03676114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101935895|NCT03676114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101935896|NCT03676114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935897|NCT03676036|Mometasone Furoate|mometasone furoate|mesh-list
101935898|NCT03676036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101935899|NCT03676036|Dermatologic Agents|dermatologic agents|mesh-ancestor
101935900|NCT03676036|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101935901|NCT03025828|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101935902|NCT03025828|Hormones|hormones|mesh-ancestor
101935903|NCT03025828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101935904|NCT03025828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935905|NCT03546816|Serlopitant|serlopitant|mesh-list
101935906|NCT03546816|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101935907|NCT03546816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101935908|NCT03546816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935909|NCT03546816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935910|NCT03675802|Misoprostol|misoprostol|mesh-list
101935911|NCT03675802|Dinoprostone|dinoprostone|mesh-list
101935912|NCT03675802|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101935913|NCT03675802|Abortifacient Agents|abortifacient agents|mesh-ancestor
101935914|NCT03675802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101935915|NCT03675802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935916|NCT03675802|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101935917|NCT03675802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101935918|NCT03675802|Oxytocics|oxytocics|mesh-ancestor
101935919|NCT03678610|Ionomycin|ionomycin|mesh-list
101935920|NCT03678610|Calcium Ionophores|calcium ionophores|mesh-ancestor
101935921|NCT03678610|Ionophores|ionophores|mesh-ancestor
101935922|NCT03678610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101935923|NCT03678610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935924|NCT03675646|Morphine|morphine|mesh-list
101935925|NCT03675646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101935927|NCT03675646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101935928|NCT03675646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935929|NCT03675646|Analgesics|analgesics|mesh-ancestor
101935930|NCT03675646|Sensory System Agents|sensory system agents|mesh-ancestor
101935931|NCT03675646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101935932|NCT03678532|Midazolam|midazolam|mesh-list
101935933|NCT03678532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101935934|NCT03678532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101655786|NCT04532528|Dabigatran|dabigatran|mesh-list
101935935|NCT03678532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101935936|NCT03678532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935937|NCT03678532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101935938|NCT03678532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101935939|NCT03678532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101935940|NCT03678532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101935941|NCT03678532|Anesthetics, General|anesthetics, general|mesh-ancestor
101935943|NCT03678532|GABA Modulators|gaba modulators|mesh-ancestor
101935944|NCT03678532|GABA Agents|gaba agents|mesh-ancestor
101935945|NCT03678532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101935946|NCT03678532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935947|NCT03675178|Ceftriaxone|ceftriaxone|mesh-list
101935948|NCT03675178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101935949|NCT03675178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101935950|NCT03678142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101935951|NCT03678142|Vancomycin|vancomycin|mesh-list
101935952|NCT03678142|Imipenem|imipenem|mesh-list
101935953|NCT03678142|Floxacillin|floxacillin|mesh-list
101935954|NCT03678142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101935955|NCT03522298|GDC-0084|gdc-0084|mesh-list
101935956|NCT03522298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101935957|NCT03522298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935958|NCT03674866|Insulin|insulin|mesh-list
101935959|NCT03674866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101935960|NCT03674866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935961|NCT03623776|Carboplatin|carboplatin|mesh-list
101935962|NCT03623776|Pemetrexed|pemetrexed|mesh-list
101935963|NCT03623776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101935964|NCT03623776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101935965|NCT03623776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935966|NCT03623776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101935967|NCT03623776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101935968|NCT03683914|Dinoprostone|dinoprostone|mesh-list
101935969|NCT03683914|Oxytocics|oxytocics|mesh-ancestor
101935970|NCT03683914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101935971|NCT03683914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935973|NCT03448406|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101935974|NCT03448406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935975|NCT03448406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101935976|NCT03448406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935977|NCT00064701|Cyclosporine|cyclosporine|mesh-list
101935978|NCT00064701|Mycophenolic Acid|mycophenolic acid|mesh-list
101935979|NCT00064701|Tacrolimus|tacrolimus|mesh-list
101935980|NCT00064701|Cyclosporins|cyclosporins|mesh-list
101935981|NCT00064701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101935982|NCT00064701|Immunologic Factors|immunologic factors|mesh-ancestor
101935983|NCT00064701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101935984|NCT00064701|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101935985|NCT00064701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101935986|NCT00064701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101935987|NCT00064701|Antifungal Agents|antifungal agents|mesh-ancestor
101935988|NCT00064701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101935989|NCT00064701|Dermatologic Agents|dermatologic agents|mesh-ancestor
101935990|NCT00064701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101935991|NCT00064701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101935992|NCT00064701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101935993|NCT00064701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101935994|NCT00064701|Antitubercular Agents|antitubercular agents|mesh-ancestor
101935995|NCT00064701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101935996|NCT00064077|Paclitaxel|paclitaxel|mesh-list
101935997|NCT00064077|Vinorelbine|vinorelbine|mesh-list
101935998|NCT00064077|Cisplatin|cisplatin|mesh-list
101935999|NCT00064077|Gemcitabine|gemcitabine|mesh-list
101936000|NCT00064077|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101936001|NCT00064077|Topotecan|topotecan|mesh-list
101233788|NCT01573468|Capecitabine|capecitabine|mesh-list
101936002|NCT00064077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101936003|NCT00064077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101936004|NCT00064077|Tubulin Modulators|tubulin modulators|mesh-ancestor
101936005|NCT00064077|Antimitotic Agents|antimitotic agents|mesh-ancestor
101936006|NCT00064077|Mitosis Modulators|mitosis modulators|mesh-ancestor
101936007|NCT00064077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936008|NCT00064077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101936009|NCT00064077|Antimetabolites|antimetabolites|mesh-ancestor
101936010|NCT00064077|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101936011|NCT00064077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101936012|NCT00064077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101936013|NCT03674008|Propofol|propofol|mesh-list
101936014|NCT03674008|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101936015|NCT03674008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101936016|NCT03674008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936017|NCT03674008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101936018|NCT03674008|Anesthetics, General|anesthetics, general|mesh-ancestor
101936019|NCT03674008|Anesthetics|anesthetics|mesh-ancestor
101936020|NCT00063999|Paclitaxel|paclitaxel|mesh-list
101936021|NCT00063999|Cisplatin|cisplatin|mesh-list
101936022|NCT00063999|Carboplatin|carboplatin|mesh-list
101936023|NCT00063999|Doxorubicin|doxorubicin|mesh-list
101936024|NCT00063999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101936025|NCT00063999|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101936026|NCT00063999|Lenograstim|lenograstim|mesh-list
101936027|NCT00063999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101936028|NCT00063999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101936029|NCT00063999|Tubulin Modulators|tubulin modulators|mesh-ancestor
101936030|NCT00063999|Antimitotic Agents|antimitotic agents|mesh-ancestor
101936031|NCT00063999|Mitosis Modulators|mitosis modulators|mesh-ancestor
101936032|NCT00063999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936033|NCT00063999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101936034|NCT00063999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101936035|NCT00063999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101936036|NCT00063999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101936037|NCT00063999|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101936038|NCT00063999|Immunologic Factors|immunologic factors|mesh-ancestor
101936039|NCT00063999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936040|NCT01092351|Nitrofurantoin|nitrofurantoin|mesh-list
101936041|NCT01092351|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101936042|NCT01092351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101936043|NCT01092351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101936044|NCT02878798|Topiramate|topiramate|mesh-list
101936045|NCT02878798|Anticonvulsants|anticonvulsants|mesh-ancestor
101936046|NCT02878798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101617246|NCT00700492|Hormones|hormones|mesh-ancestor
101936047|NCT02878798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936049|NCT03673384|Xhance|xhance|mesh-list
101936050|NCT03673384|Histamine|histamine|mesh-list
101936051|NCT03673384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101936052|NCT03673384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101936053|NCT03673384|Autonomic Agents|autonomic agents|mesh-ancestor
101936054|NCT03673384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101936055|NCT03673384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936056|NCT03673384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101936057|NCT03673384|Respiratory System Agents|respiratory system agents|mesh-ancestor
101936058|NCT03673384|Dermatologic Agents|dermatologic agents|mesh-ancestor
101936059|NCT03673384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101936060|NCT03673384|Histamine Agonists|histamine agonists|mesh-ancestor
101936061|NCT03673384|Histamine Agents|histamine agents|mesh-ancestor
101936062|NCT03673384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101936063|NCT03673384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936064|NCT02915302|Vaccines|vaccines|mesh-list
101936065|NCT02915302|Immunologic Factors|immunologic factors|mesh-ancestor
101959026|NCT00130247|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101936066|NCT02915302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936067|NCT03023878|Dexamethasone|dexamethasone|mesh-list
101936068|NCT03023878|Blinatumomab|blinatumomab|mesh-list
101936069|NCT03023878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101936070|NCT03023878|Antiemetics|antiemetics|mesh-ancestor
101936071|NCT03023878|Autonomic Agents|autonomic agents|mesh-ancestor
101936072|NCT03023878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101936073|NCT03023878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936074|NCT03023878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101936075|NCT03023878|Glucocorticoids|glucocorticoids|mesh-ancestor
101936076|NCT03023878|Hormones|hormones|mesh-ancestor
101936077|NCT03023878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101936078|NCT03023878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101936079|NCT03023878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101936080|NCT03670888|Rituximab|rituximab|mesh-list
101936081|NCT03670888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101936082|NCT03670888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101936083|NCT03670888|Immunologic Factors|immunologic factors|mesh-ancestor
101936084|NCT03670888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936085|NCT03670888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101936086|NCT03023722|Maytansine|maytansine|mesh-list
101936087|NCT03023722|Anetumab ravtansine|anetumab ravtansine|mesh-list
101936088|NCT03023722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101936089|NCT03023722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101936090|NCT03023722|Tubulin Modulators|tubulin modulators|mesh-ancestor
101936091|NCT03023722|Antimitotic Agents|antimitotic agents|mesh-ancestor
101936092|NCT03023722|Mitosis Modulators|mitosis modulators|mesh-ancestor
101936093|NCT03023722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936094|NCT03023722|Immunoconjugates|immunoconjugates|mesh-ancestor
101936095|NCT03023722|Immunologic Factors|immunologic factors|mesh-ancestor
101936096|NCT03023722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936097|NCT03623230|Bupivacaine|bupivacaine|mesh-list
101936098|NCT03623230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101936099|NCT03623230|Anesthetics, Local|anesthetics, local|mesh-ancestor
101936100|NCT03623230|Anesthetics|anesthetics|mesh-ancestor
101936101|NCT03623230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101936102|NCT03623230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936103|NCT03623230|Sensory System Agents|sensory system agents|mesh-ancestor
101936104|NCT03623230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101936105|NCT02624596|Midazolam|midazolam|mesh-list
101936106|NCT02624596|Ketamine|ketamine|mesh-list
101936107|NCT02624596|Analgesics|analgesics|mesh-ancestor
101936108|NCT02624596|Sensory System Agents|sensory system agents|mesh-ancestor
101936109|NCT02624596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101936110|NCT02624596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936111|NCT02624596|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101936112|NCT02624596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101936113|NCT02624596|Anesthetics, General|anesthetics, general|mesh-ancestor
101936114|NCT02624596|Anesthetics|anesthetics|mesh-ancestor
101936115|NCT02624596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101936116|NCT02624596|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101936117|NCT02624596|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101936118|NCT02624596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101936119|NCT02624596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936120|NCT02624596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101936121|NCT02624596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101936122|NCT02624596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101936123|NCT02624596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101936124|NCT02624596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101936125|NCT02624596|GABA Modulators|gaba modulators|mesh-ancestor
101936126|NCT02624596|GABA Agents|gaba agents|mesh-ancestor
101936127|NCT03669562|Alprostadil|alprostadil|mesh-list
101936128|NCT03669562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101936129|NCT03669562|Vasodilator Agents|vasodilator agents|mesh-ancestor
101936130|NCT03669562|Urological Agents|urological agents|mesh-ancestor
101936132|NCT03669484|Bromides|bromides|mesh-list
101936133|NCT03669484|Propofol|propofol|mesh-list
101936134|NCT03669484|Rocuronium|rocuronium|mesh-list
101936135|NCT03669484|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101936136|NCT03669484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101936137|NCT03669484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936138|NCT03669484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101936139|NCT03669484|Anesthetics, General|anesthetics, general|mesh-ancestor
101936140|NCT03669484|Anesthetics|anesthetics|mesh-ancestor
101936141|NCT03669484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101936142|NCT03669484|Narcotics|narcotics|mesh-ancestor
101936143|NCT03669484|Analgesics|analgesics|mesh-ancestor
101936144|NCT03669484|Sensory System Agents|sensory system agents|mesh-ancestor
101936145|NCT03669484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101936146|NCT03669484|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101936147|NCT03669484|Anticonvulsants|anticonvulsants|mesh-ancestor
101936148|NCT03669484|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101936149|NCT03669484|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101936150|NCT03669484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101936151|NCT02159404|Immunomodulating Agents|immunomodulating agents|mesh-list
101936152|NCT02159404|Immunologic Factors|immunologic factors|mesh-ancestor
101936153|NCT02159404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936154|NCT01979536|Cytarabine|cytarabine|mesh-list
101936155|NCT01979536|Dexamethasone|dexamethasone|mesh-list
101936156|NCT01979536|Dexamethasone acetate|dexamethasone acetate|mesh-list
101936157|NCT01979536|Cyclophosphamide|cyclophosphamide|mesh-list
101936158|NCT01979536|Ifosfamide|ifosfamide|mesh-list
101936159|NCT01979536|Isophosphamide mustard|isophosphamide mustard|mesh-list
101936160|NCT01979536|Doxorubicin|doxorubicin|mesh-list
101936161|NCT01979536|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101936162|NCT01979536|Methotrexate|methotrexate|mesh-list
101936163|NCT01979536|Etoposide|etoposide|mesh-list
101936164|NCT01979536|Etoposide phosphate|etoposide phosphate|mesh-list
101936165|NCT01979536|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101936166|NCT01979536|Podophyllotoxin|podophyllotoxin|mesh-list
101936167|NCT01979536|Crizotinib|crizotinib|mesh-list
101936168|NCT01979536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101936169|NCT01979536|Antibodies|antibodies|mesh-list
101936170|NCT01979536|Immunoglobulins|immunoglobulins|mesh-list
101936171|NCT01979536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101936172|NCT01979536|BB 1101|bb 1101|mesh-list
101936173|NCT01979536|Immunoconjugates|immunoconjugates|mesh-list
101936174|NCT01979536|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101936175|NCT01979536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101936176|NCT01979536|Immunologic Factors|immunologic factors|mesh-ancestor
101936177|NCT01979536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936178|NCT01979536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101936179|NCT01979536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101936180|NCT01979536|Alkylating Agents|alkylating agents|mesh-ancestor
101936181|NCT01979536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936182|NCT01979536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101936183|NCT01979536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101936184|NCT01979536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101936185|NCT01979536|Antiemetics|antiemetics|mesh-ancestor
101936186|NCT01979536|Autonomic Agents|autonomic agents|mesh-ancestor
101936187|NCT01979536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101936188|NCT01979536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101936189|NCT01979536|Glucocorticoids|glucocorticoids|mesh-ancestor
101936190|NCT01979536|Hormones|hormones|mesh-ancestor
101936191|NCT01979536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101936192|NCT01979536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101936193|NCT01979536|Protease Inhibitors|protease inhibitors|mesh-ancestor
101936194|NCT01979536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101936195|NCT01979536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101936196|NCT01979536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101936197|NCT01979536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101936198|NCT01979536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101936199|NCT01979536|Abortifacient Agents|abortifacient agents|mesh-ancestor
101936200|NCT01979536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101936201|NCT01979536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101936202|NCT01979536|Antimetabolites|antimetabolites|mesh-ancestor
101936203|NCT01979536|Dermatologic Agents|dermatologic agents|mesh-ancestor
101936204|NCT01979536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101936205|NCT01979536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101936206|NCT01979536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101936207|NCT01979536|Antiviral Agents|antiviral agents|mesh-ancestor
101936208|NCT01979536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101936209|NCT01979536|Immunotoxins|immunotoxins|mesh-ancestor
101936210|NCT01979536|Keratolytic Agents|keratolytic agents|mesh-ancestor
101936211|NCT01979536|Tubulin Modulators|tubulin modulators|mesh-ancestor
101936212|NCT01979536|Antimitotic Agents|antimitotic agents|mesh-ancestor
101936213|NCT01979536|Mitosis Modulators|mitosis modulators|mesh-ancestor
101936214|NCT01979536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101936215|NCT03496298|Efpeglenatide|efpeglenatide|mesh-list
101936216|NCT03496298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101936217|NCT03496298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936218|NCT03668860|Dexamethasone|dexamethasone|mesh-list
101936219|NCT03668860|Dexamethasone acetate|dexamethasone acetate|mesh-list
101936220|NCT03668860|Betamethasone|betamethasone|mesh-list
101936221|NCT03668860|Betamethasone Valerate|betamethasone valerate|mesh-list
101936222|NCT03668860|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101936223|NCT03668860|Betamethasone benzoate|betamethasone benzoate|mesh-list
101936224|NCT03668860|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
101936225|NCT03668860|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101936226|NCT03668860|BB 1101|bb 1101|mesh-list
101936227|NCT03668860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101936228|NCT03668860|Antiemetics|antiemetics|mesh-ancestor
101936229|NCT03668860|Autonomic Agents|autonomic agents|mesh-ancestor
101936230|NCT03668860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101936231|NCT03668860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936232|NCT03668860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101936233|NCT03668860|Glucocorticoids|glucocorticoids|mesh-ancestor
101936234|NCT03668860|Hormones|hormones|mesh-ancestor
101936235|NCT03668860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101936236|NCT03668860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101936237|NCT03668860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101936238|NCT03668860|Protease Inhibitors|protease inhibitors|mesh-ancestor
101936239|NCT03668860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101936240|NCT03668860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936241|NCT03668860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101936242|NCT03668860|Respiratory System Agents|respiratory system agents|mesh-ancestor
101936243|NCT03668860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101936244|NCT00062751|Sirolimus|sirolimus|mesh-list
101936245|NCT00062751|Letrozole|letrozole|mesh-list
101936246|NCT00062751|Temsirolimus|temsirolimus|mesh-list
101936247|NCT00062751|MTOR Inhibitors|mtor inhibitors|mesh-list
101936248|NCT00062751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101936249|NCT00062751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101936250|NCT00062751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101936251|NCT00062751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101936252|NCT00062751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936253|NCT00062751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101936254|NCT00062751|Hormone Antagonists|hormone antagonists|mesh-ancestor
101936255|NCT00062751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101936256|NCT00062751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936257|NCT00062751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101936258|NCT00062751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101936259|NCT00062751|Immunologic Factors|immunologic factors|mesh-ancestor
101936260|NCT00062751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101936261|NCT00062751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101936262|NCT00062751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101936263|NCT00062751|Antifungal Agents|antifungal agents|mesh-ancestor
101936264|NCT00945724|Cytarabine|cytarabine|mesh-list
101936265|NCT00945724|Prednisolone|prednisolone|mesh-list
101936266|NCT00945724|Cyclophosphamide|cyclophosphamide|mesh-list
101936267|NCT00945724|Rituximab|rituximab|mesh-list
101936268|NCT00945724|Doxorubicin|doxorubicin|mesh-list
101936269|NCT00945724|Methotrexate|methotrexate|mesh-list
101936270|NCT00945724|Vincristine|vincristine|mesh-list
101936271|NCT00945724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101936272|NCT00945724|Immunologic Factors|immunologic factors|mesh-ancestor
101936273|NCT00945724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936274|NCT00945724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101936275|NCT00945724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101936276|NCT00945724|Alkylating Agents|alkylating agents|mesh-ancestor
101936277|NCT00945724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936278|NCT00945724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101936279|NCT00945724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101936280|NCT00945724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101936281|NCT00945724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101936282|NCT00945724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101936283|NCT00945724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101936284|NCT00945724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101936285|NCT00945724|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101936286|NCT00945724|Abortifacient Agents|abortifacient agents|mesh-ancestor
101936287|NCT00945724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101936288|NCT00945724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101936289|NCT00945724|Antimetabolites|antimetabolites|mesh-ancestor
101936290|NCT00945724|Dermatologic Agents|dermatologic agents|mesh-ancestor
101936291|NCT00945724|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101936292|NCT00945724|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101936293|NCT00945724|Antiviral Agents|antiviral agents|mesh-ancestor
101936294|NCT00945724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101233872|NCT01574092|Irinotecan|irinotecan|mesh-list
101936295|NCT00945724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101936296|NCT00945724|Tubulin Modulators|tubulin modulators|mesh-ancestor
101936297|NCT00945724|Antimitotic Agents|antimitotic agents|mesh-ancestor
101936298|NCT00945724|Mitosis Modulators|mitosis modulators|mesh-ancestor
101936299|NCT00945724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101936300|NCT00945724|Glucocorticoids|glucocorticoids|mesh-ancestor
101936301|NCT00945724|Hormones|hormones|mesh-ancestor
101936302|NCT00945724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101936303|NCT00945724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101936304|NCT00258310|Capecitabine|capecitabine|mesh-list
101936305|NCT00258310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101936306|NCT00258310|Antimetabolites|antimetabolites|mesh-ancestor
101936307|NCT00258310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936308|NCT00258310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101936309|NCT00062439|Docetaxel|docetaxel|mesh-list
101936310|NCT00062439|Etoposide|etoposide|mesh-list
101936311|NCT00062439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101936312|NCT00062439|Tubulin Modulators|tubulin modulators|mesh-ancestor
101936313|NCT00062439|Antimitotic Agents|antimitotic agents|mesh-ancestor
101936314|NCT00062439|Mitosis Modulators|mitosis modulators|mesh-ancestor
101936315|NCT00062439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936316|NCT00062439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101936317|NCT00062439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101936318|NCT00062439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101936319|NCT00062439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101936320|NCT01099059|Amantadine|amantadine|mesh-list
101936321|NCT01099059|Methylphenidate|methylphenidate|mesh-list
101936322|NCT01099059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101936323|NCT01099059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936324|NCT01099059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101936325|NCT01099059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101936326|NCT01099059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101936327|NCT01099059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936328|NCT01099059|Dopamine Agents|dopamine agents|mesh-ancestor
101936329|NCT01099059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101936330|NCT01099059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101936331|NCT01099059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101936332|NCT01099059|Antiviral Agents|antiviral agents|mesh-ancestor
101936333|NCT01099059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101936334|NCT01099059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101936335|NCT01099059|Analgesics|analgesics|mesh-ancestor
101936336|NCT01099059|Sensory System Agents|sensory system agents|mesh-ancestor
101936337|NCT01099059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101936338|NCT01092741|Imatinib Mesylate|imatinib mesylate|mesh-list
101936339|NCT01092741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101936340|NCT01092741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101936341|NCT01092741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101936342|NCT01092741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936343|NCT01095471|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101936344|NCT01095471|Immunologic Factors|immunologic factors|mesh-ancestor
101936345|NCT01095471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936347|NCT03955341|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101936348|NCT03955341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101936349|NCT03955341|Disinfectants|disinfectants|mesh-ancestor
101936350|NCT00031551|Etanercept|etanercept|mesh-list
101936351|NCT00031551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101936352|NCT00031551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101936353|NCT00031551|Analgesics|analgesics|mesh-ancestor
101936354|NCT00031551|Sensory System Agents|sensory system agents|mesh-ancestor
101936355|NCT00031551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101936356|NCT00031551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936357|NCT00031551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101936358|NCT00031551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101936359|NCT00031551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101936360|NCT00031551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101936361|NCT00031551|Immunologic Factors|immunologic factors|mesh-ancestor
101936362|NCT01099137|Vildagliptin|vildagliptin|mesh-list
101936363|NCT01099137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101936364|NCT01099137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936365|NCT01099137|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101936366|NCT01099137|Protease Inhibitors|protease inhibitors|mesh-ancestor
101936367|NCT01099137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101936368|NCT01099137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936369|NCT01092975|Phenylephrine|phenylephrine|mesh-list
101936370|NCT01092975|Oxymetazoline|oxymetazoline|mesh-list
101936371|NCT01092975|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101936372|NCT01092975|Mydriatics|mydriatics|mesh-ancestor
101936373|NCT01092975|Autonomic Agents|autonomic agents|mesh-ancestor
101936374|NCT01092975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101936375|NCT01092975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936376|NCT01092975|Sympathomimetics|sympathomimetics|mesh-ancestor
101936377|NCT01092975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101936378|NCT01092975|Nasal Decongestants|nasal decongestants|mesh-ancestor
101936379|NCT01092975|Respiratory System Agents|respiratory system agents|mesh-ancestor
101936380|NCT01092975|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101936381|NCT01092975|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101936382|NCT01092975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101936383|NCT01092975|Adrenergic Agents|adrenergic agents|mesh-ancestor
101936384|NCT01092975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101936385|NCT01092975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936386|NCT01092975|Protective Agents|protective agents|mesh-ancestor
101936387|NCT01584297|Ketoconazole|ketoconazole|mesh-list
101936388|NCT01584297|Antifungal Agents|antifungal agents|mesh-ancestor
101936389|NCT01584297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101936390|NCT01584297|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101936391|NCT01584297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101936392|NCT01584297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101936393|NCT01584297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936394|NCT01584297|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101936395|NCT01584297|Hormone Antagonists|hormone antagonists|mesh-ancestor
101936396|NCT01584297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101936397|NCT01584297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936398|NCT01584297|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101936400|NCT00049257|Carboplatin|carboplatin|mesh-list
101936401|NCT00049257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101936402|NCT00049257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101936403|NCT00049257|Tubulin Modulators|tubulin modulators|mesh-ancestor
101936404|NCT00049257|Antimitotic Agents|antimitotic agents|mesh-ancestor
101936405|NCT00049257|Mitosis Modulators|mitosis modulators|mesh-ancestor
101936406|NCT00049257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936407|NCT03951987|Charcoal|charcoal|mesh-list
101936408|NCT03951987|Antidotes|antidotes|mesh-ancestor
101936409|NCT03951987|Protective Agents|protective agents|mesh-ancestor
101936410|NCT03951987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936411|NCT03668470|Dulaglutide|dulaglutide|mesh-list
101936412|NCT03668470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101936413|NCT03668470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936414|NCT03020992|Certolizumab Pegol|certolizumab pegol|mesh-list
101936415|NCT03020992|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101936416|NCT03020992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101936417|NCT03020992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101936418|NCT03020992|Immunologic Factors|immunologic factors|mesh-ancestor
101936419|NCT03020992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936420|NCT03020992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101936421|NCT03020914|Methamphetamine|methamphetamine|mesh-list
101936422|NCT03020914|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101936423|NCT03020914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936424|NCT03020914|Sympathomimetics|sympathomimetics|mesh-ancestor
101936425|NCT03020914|Autonomic Agents|autonomic agents|mesh-ancestor
101936426|NCT03020914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101936427|NCT03020914|Dopamine Agents|dopamine agents|mesh-ancestor
101936428|NCT03020914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101936429|NCT03020914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936430|NCT03020914|Adrenergic Agents|adrenergic agents|mesh-ancestor
101936431|NCT03020914|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101936432|NCT03020914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101936433|NCT03020914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101936434|NCT03020914|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101936435|NCT03018340|Pimavanserin|pimavanserin|mesh-list
101936436|NCT03018340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101936437|NCT03018340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101936438|NCT03018340|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101936439|NCT03018340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101936440|NCT03018340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101936441|NCT03018340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936442|NCT03018340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101936443|NCT03018340|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101936444|NCT03018340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101936445|NCT03018340|Serotonin Agents|serotonin agents|mesh-ancestor
101936446|NCT03018340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101936447|NCT03018340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936448|NCT00048165|Cyclosporine|cyclosporine|mesh-list
101936449|NCT00048165|Mycophenolic Acid|mycophenolic acid|mesh-list
101936450|NCT00048165|Methylprednisolone|methylprednisolone|mesh-list
101936451|NCT00048165|Cyclosporins|cyclosporins|mesh-list
101936452|NCT00048165|Daclizumab|daclizumab|mesh-list
101936453|NCT00048165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101936454|NCT00048165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936455|NCT00048165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101936456|NCT00048165|Immunologic Factors|immunologic factors|mesh-ancestor
101936457|NCT00048165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936458|NCT00048165|Antifungal Agents|antifungal agents|mesh-ancestor
101936459|NCT00048165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101936460|NCT00048165|Dermatologic Agents|dermatologic agents|mesh-ancestor
101936461|NCT00048165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101936462|NCT00048165|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101936463|NCT00048165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101936464|NCT00048165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101936465|NCT00048165|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101936466|NCT00048165|Antitubercular Agents|antitubercular agents|mesh-ancestor
101936467|NCT00048165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101936468|NCT00048165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101936469|NCT00048165|Antiemetics|antiemetics|mesh-ancestor
101936470|NCT00048165|Autonomic Agents|autonomic agents|mesh-ancestor
101936471|NCT00048165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101936472|NCT00048165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101936473|NCT00048165|Glucocorticoids|glucocorticoids|mesh-ancestor
101936474|NCT00048165|Hormones|hormones|mesh-ancestor
101936475|NCT00048165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101936476|NCT00048165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101936477|NCT00048165|Protective Agents|protective agents|mesh-ancestor
101936478|NCT01099527|Capecitabine|capecitabine|mesh-list
101936479|NCT01099527|Everolimus|everolimus|mesh-list
101936480|NCT01099527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101936481|NCT01099527|Antimetabolites|antimetabolites|mesh-ancestor
101936482|NCT01099527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936483|NCT01099527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101936484|NCT01099527|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101936485|NCT01099527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101936486|NCT01099527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101936487|NCT01099527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101936488|NCT01099527|Immunologic Factors|immunologic factors|mesh-ancestor
101936489|NCT01099527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936490|NCT01093365|Varenicline|varenicline|mesh-list
101936491|NCT01093365|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101298988|NCT05965908|Metformin|metformin|mesh-list
101936492|NCT01093365|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101936493|NCT01093365|Cholinergic Agents|cholinergic agents|mesh-ancestor
101936494|NCT01093365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101936495|NCT01093365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936496|NCT01093365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936497|NCT03955497|Hyaluronic Acid|hyaluronic acid|mesh-list
101936498|NCT03955497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101936499|NCT03955497|Immunologic Factors|immunologic factors|mesh-ancestor
101936500|NCT03955497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936501|NCT03955497|Viscosupplements|viscosupplements|mesh-ancestor
101936502|NCT03955497|Protective Agents|protective agents|mesh-ancestor
101936503|NCT01099605|Bupivacaine|bupivacaine|mesh-list
101936504|NCT01099605|Anesthetics, Local|anesthetics, local|mesh-ancestor
101936505|NCT01099605|Anesthetics|anesthetics|mesh-ancestor
101936506|NCT01099605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101936507|NCT01099605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936508|NCT01099605|Sensory System Agents|sensory system agents|mesh-ancestor
101936509|NCT01099605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101936510|NCT00059787|Paclitaxel|paclitaxel|mesh-list
101936511|NCT00059787|Carboplatin|carboplatin|mesh-list
101936512|NCT00059787|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101936513|NCT00059787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101936514|NCT00059787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101936515|NCT00059787|Tubulin Modulators|tubulin modulators|mesh-ancestor
101936516|NCT00059787|Antimitotic Agents|antimitotic agents|mesh-ancestor
101936517|NCT00059787|Mitosis Modulators|mitosis modulators|mesh-ancestor
101936518|NCT00059787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936519|NCT00059787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101936520|NCT00059787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101936521|NCT01099839|Ipragliflozin|ipragliflozin|mesh-list
101936522|NCT01099839|Miglitol|miglitol|mesh-list
101936523|NCT01099839|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101936524|NCT01099839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936525|NCT01099839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101936526|NCT01099839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936527|NCT01099839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101936528|NCT01099839|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101936529|NCT00058539|Pertuzumab|pertuzumab|mesh-list
101936530|NCT00058539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101936531|NCT00058539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101936532|NCT03956823|Amlodipine|amlodipine|mesh-list
101936533|NCT03956823|Telmisartan|telmisartan|mesh-list
101936534|NCT03956823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101936535|NCT03956823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101936536|NCT03956823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101936537|NCT03956823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959082|NCT02252458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101936538|NCT03956823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101936539|NCT03956823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936540|NCT03956823|Vasodilator Agents|vasodilator agents|mesh-ancestor
101936541|NCT03956823|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101656371|NCT02838264|Itraconazole|itraconazole|mesh-list
101936542|NCT03956823|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101936543|NCT03015532|Bupivacaine|bupivacaine|mesh-list
101936544|NCT03015532|Ropivacaine|ropivacaine|mesh-list
101936545|NCT03015532|Anesthetics, Local|anesthetics, local|mesh-ancestor
101936546|NCT03015532|Anesthetics|anesthetics|mesh-ancestor
101936547|NCT03015532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101936548|NCT03015532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936549|NCT03015532|Sensory System Agents|sensory system agents|mesh-ancestor
101936550|NCT03015532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101936551|NCT03954873|Glucagon|glucagon|mesh-list
101936552|NCT03954873|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101936553|NCT03954873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936554|NCT03954873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101936555|NCT03954873|Hormones|hormones|mesh-ancestor
101936556|NCT03954873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101936557|NCT03954873|Incretins|incretins|mesh-ancestor
101936558|NCT03951831|Docetaxel|docetaxel|mesh-list
101936559|NCT03951831|Leuprolide|leuprolide|mesh-list
101936560|NCT03951831|Cemiplimab|cemiplimab|mesh-list
101936561|NCT03951831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101936562|NCT03951831|Tubulin Modulators|tubulin modulators|mesh-ancestor
101936563|NCT03951831|Antimitotic Agents|antimitotic agents|mesh-ancestor
101936564|NCT03951831|Mitosis Modulators|mitosis modulators|mesh-ancestor
101936565|NCT03951831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936566|NCT03951831|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101936567|NCT03951831|Fertility Agents|fertility agents|mesh-ancestor
101936568|NCT03951831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101936569|NCT03951831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936570|NCT03951831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101936571|NCT03951831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101936572|NCT03954639|Bupivacaine|bupivacaine|mesh-list
101936573|NCT03954639|Anesthetics, Local|anesthetics, local|mesh-ancestor
101936574|NCT03954639|Anesthetics|anesthetics|mesh-ancestor
101936575|NCT03954639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101936576|NCT03954639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936577|NCT03954639|Sensory System Agents|sensory system agents|mesh-ancestor
101936578|NCT03954639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101936579|NCT01095939|Benazepril|benazepril|mesh-list
101936580|NCT01095939|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101936581|NCT01095939|Protease Inhibitors|protease inhibitors|mesh-ancestor
101936582|NCT01095939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101936583|NCT01095939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936584|NCT01095939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101936585|NCT03015220|Dulaglutide|dulaglutide|mesh-list
101936586|NCT03015220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101936587|NCT03015220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936588|NCT00022659|Bevacizumab|bevacizumab|mesh-list
101936589|NCT00022659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101936590|NCT00022659|Antibodies|antibodies|mesh-list
101936591|NCT00022659|Immunoglobulins|immunoglobulins|mesh-list
101936592|NCT00022659|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101936593|NCT00022659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101936594|NCT00022659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101936595|NCT00022659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101936596|NCT00022659|Growth Substances|growth substances|mesh-ancestor
101936597|NCT00022659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936598|NCT00022659|Growth Inhibitors|growth inhibitors|mesh-ancestor
101233938|NCT01575236|Chlorhexidine|chlorhexidine|mesh-list
101936599|NCT00022659|Immunologic Factors|immunologic factors|mesh-ancestor
101936600|NCT03018106|Estrogens|estrogens|mesh-list
101936601|NCT03018106|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101936602|NCT03018106|Hormones|hormones|mesh-ancestor
101936603|NCT03018106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101936604|NCT03018106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936605|NCT03018028|Liraglutide|liraglutide|mesh-list
101936606|NCT03018028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101936607|NCT03018028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936608|NCT03018028|Incretins|incretins|mesh-ancestor
101936609|NCT03018028|Hormones|hormones|mesh-ancestor
101936610|NCT03018028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101936611|NCT03667222|Minocycline|minocycline|mesh-list
101936612|NCT03667222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101936613|NCT03667222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101936614|NCT03667300|Linagliptin|linagliptin|mesh-list
101936615|NCT03667300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101936616|NCT03667300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936617|NCT03667300|Incretins|incretins|mesh-ancestor
101936618|NCT03667300|Hormones|hormones|mesh-ancestor
101936619|NCT03667300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101936620|NCT03667300|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101936621|NCT03667300|Protease Inhibitors|protease inhibitors|mesh-ancestor
101936622|NCT03667300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101936623|NCT03667300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936624|NCT03667066|Clopidogrel|clopidogrel|mesh-list
101936625|NCT03667066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101936626|NCT03667066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101936627|NCT03667066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101936628|NCT03667066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101936629|NCT03667066|Purinergic Agents|purinergic agents|mesh-ancestor
101936630|NCT03667066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101936631|NCT03667066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936632|NCT03667066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936633|NCT00021255|Cyclophosphamide|cyclophosphamide|mesh-list
101936634|NCT00021255|Carboplatin|carboplatin|mesh-list
101936635|NCT00021255|Docetaxel|docetaxel|mesh-list
101936636|NCT00021255|Doxorubicin|doxorubicin|mesh-list
101936637|NCT00021255|Trastuzumab|trastuzumab|mesh-list
101936638|NCT00021255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101936639|NCT00021255|Immunologic Factors|immunologic factors|mesh-ancestor
101936640|NCT00021255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936641|NCT00021255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101936642|NCT00021255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101936643|NCT00021255|Alkylating Agents|alkylating agents|mesh-ancestor
101936644|NCT00021255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936645|NCT00021255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101936646|NCT00021255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101936647|NCT00021255|Tubulin Modulators|tubulin modulators|mesh-ancestor
101936648|NCT00021255|Antimitotic Agents|antimitotic agents|mesh-ancestor
101936649|NCT00021255|Mitosis Modulators|mitosis modulators|mesh-ancestor
101936650|NCT00021255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101233963|NCT01575418|Tenofovir|tenofovir|mesh-list
101936651|NCT00021255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101936652|NCT00021255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101936653|NCT00021255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101936654|NCT00021255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101936655|NCT03012334|Alprazolam|alprazolam|mesh-list
101936656|NCT03012334|Lasmiditan|lasmiditan|mesh-list
101936657|NCT03012334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101936658|NCT03012334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101936659|NCT03012334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936660|NCT03012334|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101936661|NCT03012334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101936662|NCT03012334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101936663|NCT03012334|GABA Modulators|gaba modulators|mesh-ancestor
101936664|NCT03012334|GABA Agents|gaba agents|mesh-ancestor
101936665|NCT03012334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101936666|NCT03012334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936667|NCT03012334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101936668|NCT03012334|Serotonin Agents|serotonin agents|mesh-ancestor
101936669|NCT03951285|Niacinamide|niacinamide|mesh-list
101936670|NCT03951285|Vitamin B Complex|vitamin b complex|mesh-ancestor
101936671|NCT03951285|Vitamins|vitamins|mesh-ancestor
101936672|NCT03951285|Micronutrients|micronutrients|mesh-ancestor
101936673|NCT03951285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936674|NCT04571944|Suvorexant|suvorexant|mesh-list
101936675|NCT04571944|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101936676|NCT04571944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101936677|NCT04571944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101959092|NCT04032171|Antiviral Agents|antiviral agents|mesh-ancestor
101936678|NCT04571944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936679|NCT04571944|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
101936680|NCT04571944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101936681|NCT04571944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936682|NCT04052932|Allopurinol|allopurinol|mesh-list
101936683|NCT04052932|Antimetabolites|antimetabolites|mesh-ancestor
101936684|NCT04052932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936685|NCT04052932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101936686|NCT04052932|Gout Suppressants|gout suppressants|mesh-ancestor
101936687|NCT04052932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101936688|NCT04052932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101936689|NCT04052932|Antioxidants|antioxidants|mesh-ancestor
101936690|NCT04052932|Protective Agents|protective agents|mesh-ancestor
101936691|NCT04052932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936693|NCT03006562|Anticoagulants|anticoagulants|mesh-ancestor
101936694|NCT03006562|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101936695|NCT03006562|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101936696|NCT03006562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936698|NCT03666208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101936699|NCT03666208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101936700|NCT03666208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101936701|NCT03666208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101936702|NCT03666208|Antifungal Agents|antifungal agents|mesh-ancestor
101936703|NCT03666208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101936704|NCT03666208|Immunologic Factors|immunologic factors|mesh-ancestor
101936705|NCT03666208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936706|NCT03007966|Clonidine|clonidine|mesh-list
101936707|NCT03007966|Epinephrine|epinephrine|mesh-list
101936708|NCT03007966|Bupivacaine|bupivacaine|mesh-list
101936709|NCT03007966|Anesthetics, Local|anesthetics, local|mesh-ancestor
101936710|NCT03007966|Anesthetics|anesthetics|mesh-ancestor
101936711|NCT03007966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101936712|NCT03007966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936713|NCT03007966|Sensory System Agents|sensory system agents|mesh-ancestor
101233974|NCT01575418|Protective Agents|protective agents|mesh-ancestor
101936714|NCT03007966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101936715|NCT03007966|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101936716|NCT03007966|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101936717|NCT03007966|Adrenergic Agents|adrenergic agents|mesh-ancestor
101936718|NCT03007966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101936719|NCT03007966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936720|NCT03007966|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101936721|NCT03007966|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101936722|NCT03007966|Autonomic Agents|autonomic agents|mesh-ancestor
101936723|NCT03007966|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101936724|NCT03007966|Respiratory System Agents|respiratory system agents|mesh-ancestor
101936725|NCT03007966|Mydriatics|mydriatics|mesh-ancestor
101936726|NCT03007966|Sympathomimetics|sympathomimetics|mesh-ancestor
101936727|NCT03007966|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101936728|NCT03007966|Analgesics|analgesics|mesh-ancestor
101936729|NCT03007966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101936730|NCT03007966|Sympatholytics|sympatholytics|mesh-ancestor
101936731|NCT03007966|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101936732|NCT03007888|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101936733|NCT03007888|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101936734|NCT03007888|Immunologic Factors|immunologic factors|mesh-ancestor
101936735|NCT03007888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936736|NCT03007888|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101936737|NCT03007888|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101936738|NCT03007888|Dopamine Agonists|dopamine agonists|mesh-ancestor
101936739|NCT03007888|Dopamine Agents|dopamine agents|mesh-ancestor
101936740|NCT03007888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101936741|NCT03007888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936742|NCT03541044|Nicotine|nicotine|mesh-list
101936743|NCT03541044|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101936744|NCT03541044|Autonomic Agents|autonomic agents|mesh-ancestor
101936745|NCT03541044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101936746|NCT03541044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936747|NCT03541044|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101936748|NCT03541044|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101936749|NCT03541044|Cholinergic Agents|cholinergic agents|mesh-ancestor
101936750|NCT03541044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101936751|NCT03541044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936752|NCT00009945|Clodronic Acid|clodronic acid|mesh-list
101936753|NCT00009945|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101936754|NCT00009945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936755|NCT03540030|Acetaminophen|acetaminophen|mesh-list
101936756|NCT03540030|Celecoxib|celecoxib|mesh-list
101936757|NCT03540030|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101936759|NCT03540030|Gabapentin|gabapentin|mesh-list
101936760|NCT03540030|Propofol|propofol|mesh-list
101936761|NCT03540030|Sevoflurane|sevoflurane|mesh-list
101936762|NCT03540030|Desflurane|desflurane|mesh-list
101936763|NCT03540030|Rocuronium|rocuronium|mesh-list
101936764|NCT03540030|Vecuronium Bromide|vecuronium bromide|mesh-list
101936765|NCT03540030|Anesthetics, Local|anesthetics, local|mesh-ancestor
101936766|NCT03540030|Anesthetics|anesthetics|mesh-ancestor
101936767|NCT03540030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101936768|NCT03540030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936769|NCT03540030|Sensory System Agents|sensory system agents|mesh-ancestor
101936770|NCT03540030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101936771|NCT03540030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101936772|NCT03540030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101936773|NCT03540030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101936774|NCT03540030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101936775|NCT03540030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936776|NCT03540030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101936777|NCT03540030|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101936778|NCT03540030|Anesthetics, General|anesthetics, general|mesh-ancestor
101936779|NCT03540030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101936780|NCT03540030|Analgesics|analgesics|mesh-ancestor
101936781|NCT03540030|Antipyretics|antipyretics|mesh-ancestor
101936782|NCT03540030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101936783|NCT03540030|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101936784|NCT03540030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101936785|NCT03540030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101936786|NCT03540030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101936787|NCT03540030|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101936788|NCT03540030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101936789|NCT03540030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101936790|NCT03540030|Anticonvulsants|anticonvulsants|mesh-ancestor
101936791|NCT03540030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101936792|NCT03540030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101936793|NCT03540030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101936794|NCT03540030|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101936795|NCT03540030|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101936796|NCT03540030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101936797|NCT03540030|Antimanic Agents|antimanic agents|mesh-ancestor
101936798|NCT03540030|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101936799|NCT03540030|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101936800|NCT03540030|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101936801|NCT03540030|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101936802|NCT03540030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101936803|NCT03540030|Cholinergic Agents|cholinergic agents|mesh-ancestor
101936804|NCT03003676|Cyclophosphamide|cyclophosphamide|mesh-list
101936806|NCT03003676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101936807|NCT03003676|Immunologic Factors|immunologic factors|mesh-ancestor
101936808|NCT03003676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936809|NCT03003676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101936810|NCT03003676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101936811|NCT03003676|Alkylating Agents|alkylating agents|mesh-ancestor
101936812|NCT03003676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936813|NCT03003676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101936814|NCT03003676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101936815|NCT03003676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101936816|NCT03003676|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101936817|NCT03665740|Resveratrol|resveratrol|mesh-list
101936818|NCT03665740|Antioxidants|antioxidants|mesh-ancestor
101936819|NCT03665740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936820|NCT03665740|Protective Agents|protective agents|mesh-ancestor
101936821|NCT03665740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936822|NCT03665740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101936823|NCT03665740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101936824|NCT03665350|Insulin|insulin|mesh-list
101936825|NCT03665350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101936826|NCT03665350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936827|NCT03665428|Bismuth|bismuth|mesh-list
101936828|NCT03665428|Antacids|antacids|mesh-ancestor
101936829|NCT03665428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936830|NCT03665428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101936831|NCT03669328|Anesthetics|anesthetics|mesh-list
101936832|NCT03669328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101936833|NCT03669328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936835|NCT02912650|Ibuprofen|ibuprofen|mesh-list
101936836|NCT02912650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101936837|NCT02912650|Analgesics|analgesics|mesh-ancestor
101936838|NCT02912650|Sensory System Agents|sensory system agents|mesh-ancestor
101936839|NCT02912650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101936840|NCT02912650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936841|NCT02912650|Antipyretics|antipyretics|mesh-ancestor
101936842|NCT02912650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101936843|NCT02912650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101656669|NCT00843661|Fenofibrate|fenofibrate|mesh-list
101936844|NCT02912650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101936845|NCT02912650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101936846|NCT02912650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101936847|NCT02912650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936849|NCT03002038|Azathioprine|azathioprine|mesh-list
101936850|NCT03002038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101936851|NCT03002038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101936852|NCT03002038|Immunologic Factors|immunologic factors|mesh-ancestor
101936853|NCT03002038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936854|NCT03002038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101936855|NCT03002038|Antimetabolites|antimetabolites|mesh-ancestor
101936856|NCT03002038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936857|NCT03002038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101936858|NCT03002038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101936859|NCT03664414|Pentoxifylline|pentoxifylline|mesh-list
101936860|NCT03664414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101936861|NCT03664414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101936862|NCT03664414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936863|NCT03664414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101936864|NCT03664414|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101936865|NCT03664414|Protective Agents|protective agents|mesh-ancestor
101936866|NCT03664414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936867|NCT03664414|Vasodilator Agents|vasodilator agents|mesh-ancestor
101936868|NCT03664414|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101936869|NCT03664414|Antioxidants|antioxidants|mesh-ancestor
101936870|NCT02911948|Insulin|insulin|mesh-list
101936871|NCT02911948|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101936872|NCT02911948|Liraglutide|liraglutide|mesh-list
101936874|NCT02911948|Xultophy|xultophy|mesh-list
101936875|NCT02911948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101936876|NCT02911948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936877|NCT02911948|Incretins|incretins|mesh-ancestor
101936878|NCT02911948|Hormones|hormones|mesh-ancestor
101936879|NCT02911948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101936880|NCT03622918|Rifampin|rifampin|mesh-list
101936881|NCT03622918|Colistin|colistin|mesh-list
101936882|NCT03622918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101936883|NCT03622918|Antitubercular Agents|antitubercular agents|mesh-ancestor
101936884|NCT03622918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101936885|NCT03622918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101936886|NCT03622918|Leprostatic Agents|leprostatic agents|mesh-ancestor
101936887|NCT03622918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101936888|NCT03622918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101936889|NCT03622918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936890|NCT03622918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101936891|NCT03622918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101936892|NCT03622918|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101936893|NCT03622918|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101936894|NCT03622918|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101936895|NCT03622918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101936896|NCT03487666|Capecitabine|capecitabine|mesh-list
101936897|NCT03487666|Nivolumab|nivolumab|mesh-list
101936898|NCT03487666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101936899|NCT03487666|Antimetabolites|antimetabolites|mesh-ancestor
101936900|NCT03487666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936901|NCT03487666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101936902|NCT03487666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101936903|NCT03487666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101936904|NCT03376672|Dexamethasone|dexamethasone|mesh-list
101936905|NCT03376672|Lenalidomide|lenalidomide|mesh-list
101936906|NCT03376672|Ixazomib|ixazomib|mesh-list
101936907|NCT03376672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101936908|NCT03376672|Antiemetics|antiemetics|mesh-ancestor
101936909|NCT03376672|Autonomic Agents|autonomic agents|mesh-ancestor
101936910|NCT03376672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101936911|NCT03376672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936912|NCT03376672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101936913|NCT03376672|Glucocorticoids|glucocorticoids|mesh-ancestor
101936914|NCT03376672|Hormones|hormones|mesh-ancestor
101936915|NCT03376672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101936916|NCT03376672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101936917|NCT03376672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101656745|NCT02841488|Sensory System Agents|sensory system agents|mesh-ancestor
101936918|NCT03376672|Immunologic Factors|immunologic factors|mesh-ancestor
101936919|NCT03376672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101936920|NCT03376672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101936921|NCT03376672|Growth Substances|growth substances|mesh-ancestor
101936922|NCT03376672|Growth Inhibitors|growth inhibitors|mesh-ancestor
101936923|NCT03376672|Protease Inhibitors|protease inhibitors|mesh-ancestor
101234066|NCT01576185|Sorafenib|sorafenib|mesh-list
101936924|NCT03376672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101936925|NCT03376672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936927|NCT03367312|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101936928|NCT03367312|Anesthetics, General|anesthetics, general|mesh-ancestor
101936930|NCT03367312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101936931|NCT03367312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936932|NCT00027027|Pertuzumab|pertuzumab|mesh-list
101936933|NCT00027027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101936934|NCT00027027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101936935|NCT00046839|Celecoxib|celecoxib|mesh-list
101936936|NCT00046839|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
101936937|NCT00046839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101936938|NCT00046839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101936939|NCT00046839|Analgesics|analgesics|mesh-ancestor
101936940|NCT00046839|Sensory System Agents|sensory system agents|mesh-ancestor
101936941|NCT00046839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101936942|NCT00046839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936943|NCT00046839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101936944|NCT00046839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101936945|NCT00046839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101936946|NCT00046839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101936947|NCT00046839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936948|NCT00006903|Fulvestrant|fulvestrant|mesh-list
101936949|NCT00006903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101936950|NCT00006903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101936951|NCT00006903|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101936952|NCT00006903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101936953|NCT00006903|Hormone Antagonists|hormone antagonists|mesh-ancestor
101936954|NCT00006903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101936955|NCT00006903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936956|NCT03951597|Gemcitabine|gemcitabine|mesh-list
101936957|NCT03951597|Oxaliplatin|oxaliplatin|mesh-list
101936958|NCT03951597|Lenvatinib|lenvatinib|mesh-list
101936959|NCT03951597|Antibodies|antibodies|mesh-list
101936960|NCT03951597|Immunologic Factors|immunologic factors|mesh-ancestor
101936961|NCT03951597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936962|NCT03951597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101936963|NCT03951597|Antimetabolites|antimetabolites|mesh-ancestor
101936964|NCT03951597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936965|NCT03951597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101936966|NCT03951597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101936967|NCT03951597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101936968|NCT03539484|Obinutuzumab|obinutuzumab|mesh-list
101936969|NCT03539484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101936970|NCT03539484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101936971|NCT01101009|Amlodipine|amlodipine|mesh-list
101936972|NCT01101009|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101936973|NCT01101009|Olmesartan|olmesartan|mesh-list
101936974|NCT01101009|Perindopril|perindopril|mesh-list
101936975|NCT01101009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101936976|NCT01101009|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101936977|NCT01101009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101936978|NCT01101009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617286|NCT01074008|Antimetabolites|antimetabolites|mesh-ancestor
101936979|NCT01101009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101936980|NCT01101009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936981|NCT01101009|Vasodilator Agents|vasodilator agents|mesh-ancestor
101936982|NCT01101009|Diuretics|diuretics|mesh-ancestor
101936983|NCT01101009|Natriuretic Agents|natriuretic agents|mesh-ancestor
101936984|NCT01101009|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101936985|NCT01101009|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101936986|NCT01101009|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101936987|NCT01101009|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101936988|NCT01101009|Protease Inhibitors|protease inhibitors|mesh-ancestor
101936989|NCT01101009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101936990|NCT02996500|Tofacitinib|tofacitinib|mesh-list
101656821|NCT02841800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101936991|NCT02996500|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101936992|NCT02996500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101936993|NCT02996500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101936994|NCT02996500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101936996|NCT00006489|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101936997|NCT00006489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101936998|NCT00006489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101936999|NCT00006489|Sensory System Agents|sensory system agents|mesh-ancestor
101937000|NCT00006489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101937001|NCT01096095|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
101937002|NCT01096095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937003|NCT03720756|Nickel|nickel|mesh-list
101937004|NCT03720756|Trace Elements|trace elements|mesh-ancestor
101937005|NCT03720756|Micronutrients|micronutrients|mesh-ancestor
101937006|NCT03720756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937007|NCT00025233|Bevacizumab|bevacizumab|mesh-list
101937008|NCT00025233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101937009|NCT00025233|Antibodies|antibodies|mesh-list
101937010|NCT00025233|Immunoglobulins|immunoglobulins|mesh-list
101937011|NCT00025233|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101937012|NCT00025233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937013|NCT00025233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101937014|NCT00025233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101937015|NCT00025233|Growth Substances|growth substances|mesh-ancestor
101937016|NCT00025233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937017|NCT00025233|Growth Inhibitors|growth inhibitors|mesh-ancestor
101937018|NCT00025233|Immunologic Factors|immunologic factors|mesh-ancestor
101937019|NCT00025155|Epothilones|epothilones|mesh-list
101937020|NCT00025155|Epothilone B|epothilone b|mesh-list
101937021|NCT00025155|Tubulin Modulators|tubulin modulators|mesh-ancestor
101937022|NCT00025155|Antimitotic Agents|antimitotic agents|mesh-ancestor
101937023|NCT00025155|Mitosis Modulators|mitosis modulators|mesh-ancestor
101937024|NCT00025155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937025|NCT00025155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937026|NCT02998996|Endocine|endocine|mesh-list
101937027|NCT02998996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101937028|NCT02998996|Immunologic Factors|immunologic factors|mesh-ancestor
101937029|NCT02998996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937030|NCT03663478|Ropivacaine|ropivacaine|mesh-list
101937031|NCT03663478|Anesthetics, Local|anesthetics, local|mesh-ancestor
101937032|NCT03663478|Anesthetics|anesthetics|mesh-ancestor
101937033|NCT03663478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101937034|NCT03663478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937035|NCT03663478|Sensory System Agents|sensory system agents|mesh-ancestor
101937036|NCT03663478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101937037|NCT02994940|Acetaminophen|acetaminophen|mesh-list
101937038|NCT02994940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101937039|NCT02994940|Analgesics|analgesics|mesh-ancestor
101937040|NCT02994940|Sensory System Agents|sensory system agents|mesh-ancestor
101937041|NCT02994940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101937042|NCT02994940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937043|NCT02994940|Antipyretics|antipyretics|mesh-ancestor
101937073|NCT01063270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101937074|NCT01063270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937075|NCT01063270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101937076|NCT01063270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101937077|NCT01063270|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101937078|NCT01063270|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101937079|NCT01063270|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101937080|NCT01063270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101937081|NCT01063270|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101937082|NCT00023673|Paclitaxel|paclitaxel|mesh-list
101937083|NCT00023673|Carboplatin|carboplatin|mesh-list
101937084|NCT00023673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101937085|NCT00023673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937086|NCT00023673|Tubulin Modulators|tubulin modulators|mesh-ancestor
101937087|NCT00023673|Antimitotic Agents|antimitotic agents|mesh-ancestor
101937088|NCT00023673|Mitosis Modulators|mitosis modulators|mesh-ancestor
101937089|NCT00023673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937090|NCT01069900|Amoxicillin|amoxicillin|mesh-list
101937091|NCT01069900|Moxifloxacin|moxifloxacin|mesh-list
101937092|NCT01069900|Clavulanic Acid|clavulanic acid|mesh-list
101937093|NCT01069900|Clavulanic Acids|clavulanic acids|mesh-list
101937094|NCT01069900|Ertapenem|ertapenem|mesh-list
101937095|NCT01069900|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101937096|NCT01069900|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101937097|NCT01069900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101937098|NCT01069900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101937099|NCT01069900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101937100|NCT01069900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101937101|NCT01069900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101937102|NCT01069900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937103|NCT01069900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937104|NCT01069900|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101937105|NCT01069900|Contraceptive Agents|contraceptive agents|mesh-ancestor
101937106|NCT01069900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101937107|NCT01069900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937108|NCT01069900|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101937109|NCT01069900|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101937110|NCT01069900|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101937111|NCT01069900|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101937112|NCT00006237|Interferons|interferons|mesh-list
101937113|NCT00006237|Interferon-alpha|interferon-alpha|mesh-list
101937114|NCT00006237|Aldesleukin|aldesleukin|mesh-list
101937115|NCT00006237|Interleukin-2|interleukin-2|mesh-list
101937116|NCT00006237|Dacarbazine|dacarbazine|mesh-list
101937117|NCT00006237|Vinblastine|vinblastine|mesh-list
101937118|NCT00006237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937119|NCT00006237|Antiviral Agents|antiviral agents|mesh-ancestor
101937120|NCT00006237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101937121|NCT00006237|Immunologic Factors|immunologic factors|mesh-ancestor
101937122|NCT00006237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937123|NCT00006237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101937124|NCT00006237|Analgesics|analgesics|mesh-ancestor
101937125|NCT00006237|Sensory System Agents|sensory system agents|mesh-ancestor
101937126|NCT00006237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101937127|NCT00006237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101937128|NCT00006237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101937129|NCT00006237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101937130|NCT00006237|Alkylating Agents|alkylating agents|mesh-ancestor
101937131|NCT00006237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937132|NCT00006237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101937133|NCT00006237|Tubulin Modulators|tubulin modulators|mesh-ancestor
101937134|NCT00006237|Antimitotic Agents|antimitotic agents|mesh-ancestor
101937135|NCT00006237|Mitosis Modulators|mitosis modulators|mesh-ancestor
101937137|NCT04056754|Abiraterone Acetate|abiraterone acetate|mesh-list
101937138|NCT04056754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101937139|NCT04056754|Glucocorticoids|glucocorticoids|mesh-ancestor
101937140|NCT04056754|Hormones|hormones|mesh-ancestor
101656968|NCT04245774|Anesthetics|anesthetics|mesh-ancestor
101937141|NCT04056754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101937142|NCT04056754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937143|NCT04056754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101937144|NCT04056754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937145|NCT04056754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101937146|NCT04056754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101937147|NCT04056754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937148|NCT04056754|Hormone Antagonists|hormone antagonists|mesh-ancestor
101937149|NCT04056754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101937150|NCT04056442|Cannabidiol|cannabidiol|mesh-list
101937151|NCT04056442|Anticonvulsants|anticonvulsants|mesh-ancestor
101937152|NCT03661684|Prednisone|prednisone|mesh-list
101937153|NCT03661684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101937154|NCT03661684|Glucocorticoids|glucocorticoids|mesh-ancestor
101937155|NCT03661684|Hormones|hormones|mesh-ancestor
101937156|NCT03661684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101937157|NCT03661684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937158|NCT03661684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101937159|NCT03661684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937160|NCT02993926|Leuprolide|leuprolide|mesh-list
101937161|NCT02993926|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101937162|NCT02993926|Fertility Agents|fertility agents|mesh-ancestor
101937163|NCT02993926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101937164|NCT02993926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937165|NCT02993926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101937166|NCT02993926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937167|NCT04055506|Ritonavir|ritonavir|mesh-list
101937168|NCT04055506|Deucravacitinib|deucravacitinib|mesh-list
101937169|NCT04055506|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101937170|NCT04055506|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101937171|NCT04055506|Protease Inhibitors|protease inhibitors|mesh-ancestor
101937172|NCT04055506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101937173|NCT04055506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937174|NCT04055506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101937175|NCT04055506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101937176|NCT04055506|Antiviral Agents|antiviral agents|mesh-ancestor
101937177|NCT04055506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101937178|NCT04055506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101937179|NCT04055506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101937180|NCT04055506|Dermatologic Agents|dermatologic agents|mesh-ancestor
101937181|NCT04055506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101937182|NCT02993224|Deferasirox|deferasirox|mesh-list
101937183|NCT02993224|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101937184|NCT02993224|Chelating Agents|chelating agents|mesh-ancestor
101937185|NCT02993224|Sequestering Agents|sequestering agents|mesh-ancestor
101937186|NCT02993224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937187|NCT02992132|Pimavanserin|pimavanserin|mesh-list
101937188|NCT02992132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101937189|NCT02992132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101937190|NCT02992132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101937191|NCT02992132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101937192|NCT02992132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101937193|NCT02992132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937194|NCT02992132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101937195|NCT02992132|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101937196|NCT02992132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101937198|NCT02992132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101937199|NCT02992132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937200|NCT03444584|Metformin|metformin|mesh-list
101937201|NCT03444584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101937202|NCT03444584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937203|NCT03717740|Esomeprazole|esomeprazole|mesh-list
101959226|NCT02133118|Pioglitazone|pioglitazone|mesh-list
101937204|NCT03717740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101937205|NCT03717740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101937206|NCT03717740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101937207|NCT03717740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101937208|NCT03717740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937209|NCT03411902|Risedronic Acid|risedronic acid|mesh-list
101937210|NCT03411902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101937211|NCT03411902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101937212|NCT03411902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937213|NCT03411902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101937214|NCT03411902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937215|NCT03411902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101937217|NCT03717662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101937218|NCT03717662|Autonomic Agents|autonomic agents|mesh-ancestor
101937219|NCT03717662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101937220|NCT03717662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937221|NCT03717662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101937222|NCT03717662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101937223|NCT03717662|Cholinergic Agents|cholinergic agents|mesh-ancestor
101937224|NCT03717662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101937225|NCT03717662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937226|NCT03494816|Axitinib|axitinib|mesh-list
101937227|NCT03494816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937228|NCT03494816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101937229|NCT03494816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101937230|NCT03494816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937231|NCT03713918|Lithium Carbonate|lithium carbonate|mesh-list
101937232|NCT03713918|Antidepressive Agents|antidepressive agents|mesh-ancestor
101937233|NCT03713918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101937234|NCT03713918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101937235|NCT03713918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937236|NCT03713918|Antimanic Agents|antimanic agents|mesh-ancestor
101937237|NCT03713918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101937238|NCT03713918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101937239|NCT03713918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937240|NCT03713762|Lidocaine|lidocaine|mesh-list
101937241|NCT03713762|Fentanyl|fentanyl|mesh-list
101937242|NCT03713762|Bupivacaine|bupivacaine|mesh-list
101937243|NCT03713762|Anesthetics, Local|anesthetics, local|mesh-ancestor
101937244|NCT03713762|Anesthetics|anesthetics|mesh-ancestor
101937245|NCT03713762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101937246|NCT03713762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937247|NCT03713762|Sensory System Agents|sensory system agents|mesh-ancestor
101937248|NCT03713762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101937249|NCT03713762|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101937250|NCT03713762|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101937251|NCT03713762|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101937252|NCT03713762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101937253|NCT03713762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937254|NCT03713762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101937255|NCT03713762|Narcotics|narcotics|mesh-ancestor
101937256|NCT03713762|Analgesics|analgesics|mesh-ancestor
101937257|NCT03713762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101234137|NCT01576731|Tenofovir|tenofovir|mesh-list
101937258|NCT03713762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101937259|NCT03713762|Anesthetics, General|anesthetics, general|mesh-ancestor
101937260|NCT05975450|Abatacept|abatacept|mesh-list
101937261|NCT05975450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101937262|NCT05975450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959256|NCT02252692|Enalapril|enalapril|mesh-list
101937263|NCT05975450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101937264|NCT05975450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937265|NCT05975450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101937266|NCT05975450|Immunologic Factors|immunologic factors|mesh-ancestor
101937267|NCT05975450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937268|NCT05975450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101937269|NCT05975411|Anesthetics|anesthetics|mesh-list
101937271|NCT05975411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937272|NCT05975346|Ketamine|ketamine|mesh-list
101937273|NCT05975346|Analgesics|analgesics|mesh-ancestor
101937274|NCT05975346|Sensory System Agents|sensory system agents|mesh-ancestor
101937275|NCT05975346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101937276|NCT05975346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937277|NCT05975346|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101937278|NCT05975346|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101937279|NCT05975346|Anesthetics, General|anesthetics, general|mesh-ancestor
101937280|NCT05975346|Anesthetics|anesthetics|mesh-ancestor
101937281|NCT05975346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101937282|NCT05975346|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101937283|NCT05975346|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101937284|NCT05975346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101937285|NCT05975346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937286|NCT05975320|Warfarin|warfarin|mesh-list
101937287|NCT05975320|Apixaban|apixaban|mesh-list
101937288|NCT05975320|Anticoagulants|anticoagulants|mesh-ancestor
101937289|NCT05975320|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101937290|NCT05975320|Antithrombins|antithrombins|mesh-ancestor
101937291|NCT05975320|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101937292|NCT05975320|Protease Inhibitors|protease inhibitors|mesh-ancestor
101937293|NCT05975320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101937294|NCT05975320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937295|NCT05975294|Dexamethasone|dexamethasone|mesh-list
101937296|NCT05975294|Ketorolac|ketorolac|mesh-list
101937297|NCT05975294|Fentanyl|fentanyl|mesh-list
101937298|NCT05975294|Nalbuphine|nalbuphine|mesh-list
101937299|NCT05975294|Bupivacaine|bupivacaine|mesh-list
101937300|NCT05975294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101937301|NCT05975294|Antiemetics|antiemetics|mesh-ancestor
101937302|NCT05975294|Autonomic Agents|autonomic agents|mesh-ancestor
101937303|NCT05975294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101937304|NCT05975294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937305|NCT05975294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101937306|NCT05975294|Glucocorticoids|glucocorticoids|mesh-ancestor
101937307|NCT05975294|Hormones|hormones|mesh-ancestor
101937308|NCT05975294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101937309|NCT05975294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101937310|NCT05975294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937311|NCT05975294|Anesthetics, Local|anesthetics, local|mesh-ancestor
101937312|NCT05975294|Anesthetics|anesthetics|mesh-ancestor
101937313|NCT05975294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101937314|NCT05975294|Sensory System Agents|sensory system agents|mesh-ancestor
101937315|NCT05975294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101937316|NCT05975294|Narcotics|narcotics|mesh-ancestor
101937317|NCT05975294|Analgesics|analgesics|mesh-ancestor
101937318|NCT05975294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101937319|NCT05975294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101937320|NCT05975294|Anesthetics, General|anesthetics, general|mesh-ancestor
101937321|NCT05975294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101937322|NCT05975294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101937323|NCT05975294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101937324|NCT05975294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101937325|NCT05975294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101937326|NCT05975294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937327|NCT05975268|Antibodies|antibodies|mesh-list
101937328|NCT05975268|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101937329|NCT05975268|Immunologic Factors|immunologic factors|mesh-ancestor
101937330|NCT05975268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937331|NCT05975112|Plasminogen|plasminogen|mesh-list
101937332|NCT05975112|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101937333|NCT05975112|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101937334|NCT05975112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937335|NCT05974969|Daratumumab|daratumumab|mesh-list
101937336|NCT05974969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937337|NCT05974852|Ocrelizumab|ocrelizumab|mesh-list
101937338|NCT05974852|Immunologic Factors|immunologic factors|mesh-ancestor
101937339|NCT05974852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937340|NCT05974839|Ocrelizumab|ocrelizumab|mesh-list
101937341|NCT05974839|Immunologic Factors|immunologic factors|mesh-ancestor
101937342|NCT05974839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937343|NCT05974774|Ascorbic Acid|ascorbic acid|mesh-list
101937344|NCT05974774|Methyltestosterone|methyltestosterone|mesh-list
101937345|NCT05974774|Androgens|androgens|mesh-list
101937346|NCT05974774|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101937347|NCT05974774|Micronutrients|micronutrients|mesh-ancestor
101937348|NCT05974774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937349|NCT05974774|Hormones|hormones|mesh-ancestor
101937350|NCT05974774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101937351|NCT05974774|Antioxidants|antioxidants|mesh-ancestor
101937352|NCT05974774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937353|NCT05974774|Protective Agents|protective agents|mesh-ancestor
101937354|NCT05974774|Vitamins|vitamins|mesh-ancestor
101937355|NCT05974774|Estrogens|estrogens|mesh-ancestor
101937356|NCT05974774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101937357|NCT05974774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937358|NCT05974774|Anabolic Agents|anabolic agents|mesh-ancestor
101937359|NCT05974748|Propolis|propolis|mesh-list
101937360|NCT05974748|Sodium Hypochlorite|sodium hypochlorite|mesh-list
101937361|NCT05974748|Eusol|eusol|mesh-list
101937362|NCT05974748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101937363|NCT05974748|Disinfectants|disinfectants|mesh-ancestor
101937364|NCT05974683|Mycophenolic Acid|mycophenolic acid|mesh-list
101937365|NCT05974683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101937366|NCT05974683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937367|NCT05974683|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101937368|NCT05974683|Antitubercular Agents|antitubercular agents|mesh-ancestor
101937369|NCT05974683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101937370|NCT05974683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101937371|NCT05974683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101937372|NCT05974683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937373|NCT05974527|Dexmedetomidine|dexmedetomidine|mesh-list
101937374|NCT05974527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101937375|NCT05974527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101937376|NCT05974527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937377|NCT05974527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101937378|NCT05974527|Analgesics|analgesics|mesh-ancestor
101937379|NCT05974527|Sensory System Agents|sensory system agents|mesh-ancestor
101937380|NCT05974527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101937381|NCT05974527|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101937382|NCT05974527|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101937383|NCT05974527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101937384|NCT05974527|Adrenergic Agents|adrenergic agents|mesh-ancestor
101937385|NCT05974527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101937386|NCT05974527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937387|NCT05974501|Acetaminophen|acetaminophen|mesh-list
101937388|NCT05974501|Dexamethasone|dexamethasone|mesh-list
101937389|NCT05974501|Celecoxib|celecoxib|mesh-list
101937390|NCT05974501|Meloxicam|meloxicam|mesh-list
101937391|NCT05974501|Oxycodone|oxycodone|mesh-list
101937392|NCT05974501|Ropivacaine|ropivacaine|mesh-list
101937393|NCT05974501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101937394|NCT05974501|Antiemetics|antiemetics|mesh-ancestor
101937395|NCT05974501|Autonomic Agents|autonomic agents|mesh-ancestor
101937396|NCT05974501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101937397|NCT05974501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937398|NCT05974501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101937399|NCT05974501|Glucocorticoids|glucocorticoids|mesh-ancestor
101937400|NCT05974501|Hormones|hormones|mesh-ancestor
101937401|NCT05974501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101937402|NCT05974501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101937403|NCT05974501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937404|NCT05974501|Anesthetics, Local|anesthetics, local|mesh-ancestor
101937405|NCT05974501|Anesthetics|anesthetics|mesh-ancestor
101937406|NCT05974501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101937407|NCT05974501|Sensory System Agents|sensory system agents|mesh-ancestor
101937408|NCT05974501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101937409|NCT05974501|Analgesics|analgesics|mesh-ancestor
101937410|NCT05974501|Antipyretics|antipyretics|mesh-ancestor
101937411|NCT05974501|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101937412|NCT05974501|Narcotics|narcotics|mesh-ancestor
101937413|NCT05974501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101937414|NCT05974501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101937415|NCT05974501|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101937416|NCT05974501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101937417|NCT05974501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101937419|NCT05974462|Methylprednisolone|methylprednisolone|mesh-list
101937420|NCT05974462|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101937421|NCT05974462|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101937422|NCT05974462|Prednisolone|prednisolone|mesh-list
101937423|NCT05974462|Prednisolone acetate|prednisolone acetate|mesh-list
101937424|NCT05974462|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101937425|NCT05974462|Prednisolone phosphate|prednisolone phosphate|mesh-list
101937426|NCT05974462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101937427|NCT05974462|Antiemetics|antiemetics|mesh-ancestor
101937428|NCT05974462|Autonomic Agents|autonomic agents|mesh-ancestor
101937429|NCT05974462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101937430|NCT05974462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937431|NCT05974462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101937432|NCT05974462|Glucocorticoids|glucocorticoids|mesh-ancestor
101937433|NCT05974462|Hormones|hormones|mesh-ancestor
101937434|NCT05974462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101937435|NCT05974462|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101937436|NCT05974462|Protective Agents|protective agents|mesh-ancestor
101937437|NCT05974462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101937438|NCT05974462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937439|NCT05974436|Dialysis Solutions|dialysis solutions|mesh-list
101657267|NCT00838669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101937440|NCT05974436|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101937441|NCT05974423|Acetaminophen|acetaminophen|mesh-list
101937443|NCT05974423|Oxycodone|oxycodone|mesh-list
101937444|NCT05974423|Narcotics|narcotics|mesh-list
101937445|NCT05974423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101937446|NCT05974423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101937447|NCT05974423|Analgesics|analgesics|mesh-ancestor
101937448|NCT05974423|Sensory System Agents|sensory system agents|mesh-ancestor
101937449|NCT05974423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101937450|NCT05974423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937451|NCT05974423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101937452|NCT05974423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101937453|NCT05974423|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101937454|NCT05974423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101937455|NCT05974423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937456|NCT05974423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101937457|NCT05974423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101937458|NCT05974423|Antipyretics|antipyretics|mesh-ancestor
101937459|NCT05974410|Hydrocortisone|hydrocortisone|mesh-list
101937460|NCT05974410|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101937461|NCT05974410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101937462|NCT05974410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101937463|NCT05974410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937464|NCT05974345|Ezetimibe|ezetimibe|mesh-list
101937465|NCT05974345|Evolocumab|evolocumab|mesh-list
101937466|NCT05974345|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101937467|NCT05974345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101937468|NCT05974345|Antimetabolites|antimetabolites|mesh-ancestor
101937469|NCT05974345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937470|NCT05974345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101937471|NCT05974345|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101937472|NCT05974345|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101937473|NCT05974345|Protease Inhibitors|protease inhibitors|mesh-ancestor
101937474|NCT05974345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101937475|NCT05974332|Oncostatin M|oncostatin m|mesh-list
101937476|NCT05974332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937477|NCT05974332|Growth Inhibitors|growth inhibitors|mesh-ancestor
101937478|NCT05974332|Growth Substances|growth substances|mesh-ancestor
101937479|NCT05974332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937480|NCT05974293|Nabiximols|nabiximols|mesh-list
101937481|NCT05974293|Analgesics|analgesics|mesh-ancestor
101937482|NCT05974293|Sensory System Agents|sensory system agents|mesh-ancestor
101937483|NCT05974293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101937484|NCT05974293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937485|NCT05974267|Atovaquone|atovaquone|mesh-list
101937486|NCT05974267|Pyronaridine|pyronaridine|mesh-list
101937487|NCT05974267|Proguanil|proguanil|mesh-list
101937488|NCT05974267|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
101937489|NCT05974267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101937490|NCT05974267|Antimalarials|antimalarials|mesh-ancestor
101937491|NCT05974267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101937492|NCT05974267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101937493|NCT05974267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101937494|NCT05974267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937496|NCT05974059|Capecitabine|capecitabine|mesh-list
101937497|NCT05974059|Oxaliplatin|oxaliplatin|mesh-list
101937498|NCT05974059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101937499|NCT05974059|Antimetabolites|antimetabolites|mesh-ancestor
101937500|NCT05974059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937501|NCT05974059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937502|NCT05974007|Immunomodulating Agents|immunomodulating agents|mesh-list
101937503|NCT05974007|Immunologic Factors|immunologic factors|mesh-ancestor
101937504|NCT05974007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937505|NCT05973903|Pembrolizumab|pembrolizumab|mesh-list
101937506|NCT05973903|Lenvatinib|lenvatinib|mesh-list
101937507|NCT05973903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101937508|NCT05973903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937509|NCT05973903|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101937510|NCT05973903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937511|NCT05973903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101937512|NCT05973903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101937513|NCT05973864|Pembrolizumab|pembrolizumab|mesh-list
101937514|NCT05973864|Capecitabine|capecitabine|mesh-list
101937515|NCT05973864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101937516|NCT05973864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937517|NCT05973864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101937518|NCT05973864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937519|NCT05973864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101937520|NCT05973864|Antimetabolites|antimetabolites|mesh-ancestor
101937521|NCT05973747|Calcium, Dietary|calcium, dietary|mesh-list
101937523|NCT05973747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101937524|NCT05973747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937525|NCT05973747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101937526|NCT05973552|Iron|iron|mesh-list
101937527|NCT05973552|Trace Elements|trace elements|mesh-ancestor
101937528|NCT05973552|Micronutrients|micronutrients|mesh-ancestor
101937529|NCT05973552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937530|NCT05973487|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
101937531|NCT05973487|Antioxidants|antioxidants|mesh-ancestor
101937532|NCT05973487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937533|NCT05973487|Protective Agents|protective agents|mesh-ancestor
101937534|NCT05973487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937535|NCT05973487|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101937536|NCT05973487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937537|NCT05971667|Sildenafil Citrate|sildenafil citrate|mesh-list
101937538|NCT05971667|Tadalafil|tadalafil|mesh-list
101937539|NCT05971667|Pentoxifylline|pentoxifylline|mesh-list
101937540|NCT05971667|Vasodilator Agents|vasodilator agents|mesh-ancestor
101937541|NCT05971667|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101937542|NCT05971667|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101937543|NCT05971667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101937544|NCT05971667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937545|NCT05971667|Urological Agents|urological agents|mesh-ancestor
101937546|NCT05971667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101937547|NCT05971667|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101937548|NCT05971667|Protective Agents|protective agents|mesh-ancestor
101937549|NCT05971667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937550|NCT05971667|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101937551|NCT05971667|Antioxidants|antioxidants|mesh-ancestor
101937552|NCT05970770|Norepinephrine|norepinephrine|mesh-list
101937553|NCT05970770|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101937554|NCT05970770|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101937555|NCT05970770|Adrenergic Agents|adrenergic agents|mesh-ancestor
101937556|NCT05970770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101937557|NCT05970770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937558|NCT05970770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937559|NCT05970770|Sympathomimetics|sympathomimetics|mesh-ancestor
101937560|NCT05970770|Autonomic Agents|autonomic agents|mesh-ancestor
101937561|NCT05970770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101937562|NCT05970770|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101937563|NCT05969431|Hydrocortisone|hydrocortisone|mesh-list
101937564|NCT05969431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101937565|NCT05957367|Cetuximab|cetuximab|mesh-list
101937566|NCT05957367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101937567|NCT05957367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937568|NCT05953766|Ropivacaine|ropivacaine|mesh-list
101937570|NCT05953766|Anesthetics|anesthetics|mesh-ancestor
101937571|NCT05953766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101937572|NCT05953766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937573|NCT05953766|Sensory System Agents|sensory system agents|mesh-ancestor
101937574|NCT05953766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101937575|NCT05951400|Cetrorelix|cetrorelix|mesh-list
101937576|NCT05951400|Dydrogesterone|dydrogesterone|mesh-list
101937577|NCT05951400|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101937578|NCT05951400|Fertility Agents|fertility agents|mesh-ancestor
101937579|NCT05951400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101937580|NCT05951400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937581|NCT05951400|Hormone Antagonists|hormone antagonists|mesh-ancestor
101937582|NCT05951400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101937583|NCT05951400|Progestins|progestins|mesh-ancestor
101937584|NCT05951400|Hormones|hormones|mesh-ancestor
101937585|NCT05905341|Fulvestrant|fulvestrant|mesh-list
101937586|NCT05905341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101937587|NCT05905341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937588|NCT05905341|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101937589|NCT05905341|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101937590|NCT05905341|Hormone Antagonists|hormone antagonists|mesh-ancestor
101657414|NCT02837978|Methotrexate|methotrexate|mesh-list
101937591|NCT05905341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101937592|NCT05905341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937593|NCT05898672|Ritonavir|ritonavir|mesh-list
101937594|NCT05898672|Nirmatrelvir|nirmatrelvir|mesh-list
101937595|NCT05898672|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
101937596|NCT05898672|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101937597|NCT05898672|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101937598|NCT05898672|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101937599|NCT05898672|Protease Inhibitors|protease inhibitors|mesh-ancestor
101937600|NCT05898672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101937601|NCT05898672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937602|NCT05898672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101937603|NCT05898672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101937604|NCT05898672|Antiviral Agents|antiviral agents|mesh-ancestor
101937605|NCT05898672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101937606|NCT05898672|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101937607|NCT05898672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101937608|NCT05898672|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101937609|NCT05898672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101937610|NCT05898672|Antimetabolites|antimetabolites|mesh-ancestor
101937611|NCT05898672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101937612|NCT05898672|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101937613|NCT05896683|Lazertinib|lazertinib|mesh-list
101937614|NCT05896683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101937615|NCT05896683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101937616|NCT05896683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937617|NCT05853458|Hydroxyurea|hydroxyurea|mesh-list
101937618|NCT05853458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937619|NCT05853458|Antisickling Agents|antisickling agents|mesh-ancestor
101937620|NCT05853458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101937621|NCT05853458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937622|NCT05853458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101937623|NCT05826015|Paclitaxel|paclitaxel|mesh-list
101937624|NCT05826015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101937625|NCT05826015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937626|NCT05826015|Tubulin Modulators|tubulin modulators|mesh-ancestor
101937627|NCT05826015|Antimitotic Agents|antimitotic agents|mesh-ancestor
101937628|NCT05826015|Mitosis Modulators|mitosis modulators|mesh-ancestor
101937629|NCT05826015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937630|NCT05812807|Pembrolizumab|pembrolizumab|mesh-list
101937631|NCT05812807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101937632|NCT05812807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937633|NCT05812807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101937634|NCT05812807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937635|NCT05806164|Mirabegron|mirabegron|mesh-list
101937636|NCT05806164|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101937637|NCT05806164|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101937638|NCT05806164|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-list
101937639|NCT05806164|Adrenergic Agents|adrenergic agents|mesh-list
101937640|NCT05806164|Adrenergic Agonists|adrenergic agonists|mesh-list
101937641|NCT05806164|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101937642|NCT05806164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101937643|NCT05806164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937644|NCT05806164|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101937645|NCT05806164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101937646|NCT05806164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937647|NCT05806164|Cholinergic Agents|cholinergic agents|mesh-ancestor
101937648|NCT05806164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101937649|NCT05806164|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101937650|NCT05806164|Urological Agents|urological agents|mesh-ancestor
101937651|NCT05805761|Anti-Infective Agents|anti-infective agents|mesh-list
101937652|NCT05805761|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101937653|NCT05742841|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101937654|NCT05742841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101937655|NCT05742841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101937656|NCT05742841|Antimetabolites|antimetabolites|mesh-ancestor
101937657|NCT05742841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937658|NCT05742841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101937659|NCT05742841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101937660|NCT05742841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101937661|NCT05722418|Cyclophosphamide|cyclophosphamide|mesh-list
101937662|NCT05722418|Fludarabine|fludarabine|mesh-list
101937663|NCT05722418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101937664|NCT05722418|Immunologic Factors|immunologic factors|mesh-ancestor
101937665|NCT05722418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937666|NCT05722418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101937667|NCT05722418|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101937668|NCT05722418|Alkylating Agents|alkylating agents|mesh-ancestor
101937669|NCT05722418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937670|NCT05722418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937671|NCT05722418|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101937672|NCT05701540|Esomeprazole|esomeprazole|mesh-list
101937673|NCT05701540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101937674|NCT05701540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101937675|NCT05701540|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101937676|NCT05701540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101937677|NCT05701540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937678|NCT05688371|Dexmedetomidine|dexmedetomidine|mesh-list
101937679|NCT05688371|Morphine|morphine|mesh-list
101937680|NCT05688371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101937681|NCT05688371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101937682|NCT05688371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937683|NCT05688371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101937684|NCT05688371|Analgesics|analgesics|mesh-ancestor
101937685|NCT05688371|Sensory System Agents|sensory system agents|mesh-ancestor
101937686|NCT05688371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101937687|NCT05688371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101937688|NCT05688371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101937689|NCT05688371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101937690|NCT05688371|Adrenergic Agents|adrenergic agents|mesh-ancestor
101937691|NCT05688371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101937692|NCT05688371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937693|NCT05688371|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101937694|NCT05688371|Narcotics|narcotics|mesh-ancestor
101937695|NCT05680818|Vitamin D|vitamin d|mesh-list
101937696|NCT05680818|Calcitriol|calcitriol|mesh-list
101937697|NCT05680818|Alfacalcidol|alfacalcidol|mesh-list
101937698|NCT05680818|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
101937699|NCT05680818|26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3|26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin d3|mesh-list
101937700|NCT05680818|Calcium|calcium|mesh-list
101937701|NCT05680818|Vitamins|vitamins|mesh-ancestor
101937702|NCT05680818|Micronutrients|micronutrients|mesh-ancestor
101937703|NCT05680818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937704|NCT05680818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101937705|NCT05680818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101937706|NCT05680818|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101937707|NCT05680818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101959336|NCT00129623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937708|NCT05680818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937709|NCT05680818|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101937710|NCT05680818|Dermatologic Agents|dermatologic agents|mesh-ancestor
101937711|NCT05668949|Pembrolizumab|pembrolizumab|mesh-list
101937712|NCT05668949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101937713|NCT05668949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937714|NCT05668949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101937715|NCT05668949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937716|NCT05662332|Insulin|insulin|mesh-list
101937717|NCT05662332|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101937718|NCT05662332|Insulin Glargine|insulin glargine|mesh-list
101937719|NCT05662332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101937720|NCT05662332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937721|NCT05633654|Pembrolizumab|pembrolizumab|mesh-list
101937722|NCT05633654|Capecitabine|capecitabine|mesh-list
101937723|NCT05633654|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
101937724|NCT05633654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101937725|NCT05633654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937726|NCT05633654|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101937727|NCT05633654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937728|NCT05633654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101937729|NCT05633654|Antimetabolites|antimetabolites|mesh-ancestor
101937730|NCT05633654|Immunoconjugates|immunoconjugates|mesh-ancestor
101937731|NCT05633654|Immunologic Factors|immunologic factors|mesh-ancestor
101937732|NCT05633654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937733|NCT05618353|Colchicine|colchicine|mesh-list
101937734|NCT05618353|Gout Suppressants|gout suppressants|mesh-ancestor
101937735|NCT05618353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101937736|NCT05618353|Tubulin Modulators|tubulin modulators|mesh-ancestor
101937737|NCT05618353|Antimitotic Agents|antimitotic agents|mesh-ancestor
101937738|NCT05618353|Mitosis Modulators|mitosis modulators|mesh-ancestor
101657559|NCT00573937|Morphine|morphine|mesh-list
101937739|NCT05618353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937740|NCT05618353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937741|NCT05595044|Vitamin D|vitamin d|mesh-list
101937742|NCT05595044|Vitamins|vitamins|mesh-ancestor
101937743|NCT05595044|Micronutrients|micronutrients|mesh-ancestor
101937744|NCT05595044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937745|NCT05595044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101937746|NCT05563766|Itraconazole|itraconazole|mesh-list
101937747|NCT05563766|Antifungal Agents|antifungal agents|mesh-ancestor
101937748|NCT05563766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101937749|NCT05563766|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101937750|NCT05563766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101937751|NCT05563766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101937752|NCT05563766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937753|NCT05563766|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101937754|NCT05563766|Hormone Antagonists|hormone antagonists|mesh-ancestor
101937755|NCT05563766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101937756|NCT05563766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937757|NCT05563766|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101937758|NCT05556265|Deucravacitinib|deucravacitinib|mesh-list
101937759|NCT05556265|Dermatologic Agents|dermatologic agents|mesh-ancestor
101937760|NCT05556265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101937761|NCT05556265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101937762|NCT05556265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937763|NCT05545280|Glycopyrrolate|glycopyrrolate|mesh-list
101937764|NCT05545280|Neostigmine|neostigmine|mesh-list
101937765|NCT05545280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101937766|NCT05545280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101937767|NCT05545280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937768|NCT05545280|Cholinergic Agents|cholinergic agents|mesh-ancestor
101937769|NCT05545280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101937770|NCT05545280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937771|NCT05545280|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101937772|NCT05545280|Autonomic Agents|autonomic agents|mesh-ancestor
101937773|NCT05545280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101937774|NCT05545280|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101937775|NCT05545280|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101937776|NCT05545280|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101937777|NCT05535764|Interferons|interferons|mesh-list
101937785|NCT05535764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937794|NCT05416125|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101937795|NCT05416125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101937796|NCT05416125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937797|NCT05416125|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101937798|NCT05416125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101937799|NCT05416125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101937800|NCT05416125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937801|NCT05416125|Dopamine Agents|dopamine agents|mesh-ancestor
101937802|NCT05416125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101937803|NCT05377905|Doxorubicin|doxorubicin|mesh-list
101937804|NCT05377905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101937805|NCT05377905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101937806|NCT05377905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937807|NCT05377905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101937808|NCT05377905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101937809|NCT05377905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101937810|NCT05377905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937818|NCT05372133|Morphine|morphine|mesh-list
101937819|NCT05372133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101937820|NCT05372133|Narcotics|narcotics|mesh-ancestor
101937821|NCT05372133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101937822|NCT05372133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937823|NCT05372133|Analgesics|analgesics|mesh-ancestor
101937824|NCT05372133|Sensory System Agents|sensory system agents|mesh-ancestor
101937825|NCT05372133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101937826|NCT05347212|Nivolumab|nivolumab|mesh-list
101937827|NCT05347212|Relatlimab|relatlimab|mesh-list
101937828|NCT05347212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101937829|NCT05347212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937830|NCT05347212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101937831|NCT05347212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937832|NCT05250011|Dapagliflozin|dapagliflozin|mesh-list
101937833|NCT05250011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101937834|NCT05250011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937835|NCT05250011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101937836|NCT05250011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937837|NCT05144009|Rituximab|rituximab|mesh-list
101937838|NCT05144009|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
101937839|NCT05144009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101937840|NCT05144009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937841|NCT05144009|Immunologic Factors|immunologic factors|mesh-ancestor
101937842|NCT05144009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937843|NCT05144009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101937844|NCT05110742|Cyclophosphamide|cyclophosphamide|mesh-list
101937845|NCT05110742|Fludarabine|fludarabine|mesh-list
101937846|NCT05110742|Fludarabine phosphate|fludarabine phosphate|mesh-list
101937847|NCT05110742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101937848|NCT05110742|Immunologic Factors|immunologic factors|mesh-ancestor
101937849|NCT05110742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937850|NCT05110742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101937851|NCT05110742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101937852|NCT05110742|Alkylating Agents|alkylating agents|mesh-ancestor
101937853|NCT05110742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937854|NCT05110742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937855|NCT05110742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101937856|NCT05110742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101937857|NCT05110742|Antimetabolites|antimetabolites|mesh-ancestor
101937858|NCT05076006|PF-06700841|pf-06700841|mesh-list
101937859|NCT05076006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101937860|NCT05076006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101937861|NCT05076006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937862|NCT05064631|Broncho-Vaxom|broncho-vaxom|mesh-list
101937863|NCT05064631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101937864|NCT05064631|Immunologic Factors|immunologic factors|mesh-ancestor
101937865|NCT05064631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937866|NCT05042440|Factor VIII|factor viii|mesh-list
101937867|NCT05042440|BAX 855|bax 855|mesh-list
101937868|NCT05042440|Coagulants|coagulants|mesh-ancestor
101937869|NCT05022563|Warfarin|warfarin|mesh-list
101937870|NCT05022563|Rivaroxaban|rivaroxaban|mesh-list
101937871|NCT05022563|Dabigatran|dabigatran|mesh-list
101937872|NCT05022563|Apixaban|apixaban|mesh-list
101937873|NCT05022563|Anticoagulants|anticoagulants|mesh-list
101937874|NCT05022563|Edoxaban|edoxaban|mesh-list
101937875|NCT05022563|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101937876|NCT05022563|Antithrombins|antithrombins|mesh-ancestor
101937877|NCT05022563|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101937878|NCT05022563|Protease Inhibitors|protease inhibitors|mesh-ancestor
101937879|NCT05022563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101937880|NCT05022563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937881|NCT05009069|Fluorouracil|fluorouracil|mesh-list
101937882|NCT05009069|Capecitabine|capecitabine|mesh-list
101937883|NCT05009069|Atezolizumab|atezolizumab|mesh-list
101937884|NCT05009069|Antimetabolites|antimetabolites|mesh-ancestor
101937885|NCT05009069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937886|NCT05009069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101937887|NCT05009069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937888|NCT05009069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101937889|NCT05009069|Immunologic Factors|immunologic factors|mesh-ancestor
101937890|NCT05009069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937891|NCT05009069|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101937892|NCT05009069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101937893|NCT05004116|Irinotecan|irinotecan|mesh-list
101937894|NCT05004116|Temozolomide|temozolomide|mesh-list
101937895|NCT05004116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101937896|NCT05004116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101937897|NCT05004116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101937898|NCT05004116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937899|NCT05004116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937900|NCT05004116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101937901|NCT05004116|Alkylating Agents|alkylating agents|mesh-ancestor
101937902|NCT04972110|Olaparib|olaparib|mesh-list
101937903|NCT04972110|Niraparib|niraparib|mesh-list
101937904|NCT04972110|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101937905|NCT04972110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101937906|NCT04972110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937907|NCT04972110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937908|NCT04968951|Metronidazole|metronidazole|mesh-list
101937910|NCT04968951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101937911|NCT04968951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101937912|NCT04968951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101937913|NCT04968951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101937914|NCT04950426|Propranolol|propranolol|mesh-list
101937915|NCT04950426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101937916|NCT04950426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101937917|NCT04950426|Adrenergic Agents|adrenergic agents|mesh-ancestor
101937918|NCT04950426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101937919|NCT04950426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937920|NCT04950426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937921|NCT04950426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101937922|NCT04950426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101937923|NCT04950426|Vasodilator Agents|vasodilator agents|mesh-ancestor
101937924|NCT04940546|Bevacizumab|bevacizumab|mesh-list
101937925|NCT04940546|Capecitabine|capecitabine|mesh-list
101937926|NCT04940546|Oxaliplatin|oxaliplatin|mesh-list
101937927|NCT04940546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101937928|NCT04940546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937929|NCT04940546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101937930|NCT04940546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101937931|NCT04940546|Growth Substances|growth substances|mesh-ancestor
101937932|NCT04940546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937933|NCT04940546|Growth Inhibitors|growth inhibitors|mesh-ancestor
101937934|NCT04940546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101937935|NCT04940546|Antimetabolites|antimetabolites|mesh-ancestor
101937936|NCT04940546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937937|NCT04936334|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101937938|NCT04936334|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101937939|NCT04936334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937940|NCT04892017|Trametinib|trametinib|mesh-list
101937941|NCT04892017|Sotorasib|sotorasib|mesh-list
101937942|NCT04892017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937943|NCT04892017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101937944|NCT04892017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101937945|NCT04892017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937946|NCT04892017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101937947|NCT04892017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101937948|NCT04884412|Anesthetics|anesthetics|mesh-list
101937949|NCT04884412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101937950|NCT04884412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937951|NCT04863950|Lomustine|lomustine|mesh-list
101937952|NCT04863950|Imipramine|imipramine|mesh-list
101937953|NCT04863950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101937954|NCT04863950|Alkylating Agents|alkylating agents|mesh-ancestor
101937955|NCT04863950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937956|NCT04863950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937957|NCT04863950|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101937958|NCT04863950|Antidepressive Agents|antidepressive agents|mesh-ancestor
101937959|NCT04863950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101937960|NCT04863950|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101937961|NCT04863950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101937962|NCT04863950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101937963|NCT04863950|Adrenergic Agents|adrenergic agents|mesh-ancestor
101937964|NCT04863950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101937965|NCT04863950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937967|NCT04826393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101937968|NCT04826393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937969|NCT04824391|Vaccines|vaccines|mesh-list
101937970|NCT04824391|Immunologic Factors|immunologic factors|mesh-ancestor
101937971|NCT04824391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937972|NCT04822597|Lidocaine|lidocaine|mesh-list
101937973|NCT04822597|Anesthetics, Local|anesthetics, local|mesh-ancestor
101937974|NCT04822597|Anesthetics|anesthetics|mesh-ancestor
101937975|NCT04822597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101937976|NCT04822597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101937977|NCT04822597|Sensory System Agents|sensory system agents|mesh-ancestor
101937978|NCT04822597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101937979|NCT04822597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101937980|NCT04822597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101937981|NCT04822597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101937982|NCT04822597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101937983|NCT04822597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937984|NCT04821856|Cannabidiol|cannabidiol|mesh-list
101937985|NCT04821856|Anticonvulsants|anticonvulsants|mesh-ancestor
101959370|NCT00129467|Serotonin|serotonin|mesh-list
101937987|NCT04808999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101937988|NCT04808999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937989|NCT04808999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101937990|NCT04808999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937991|NCT04764227|Paclitaxel|paclitaxel|mesh-list
101937992|NCT04764227|Carboplatin|carboplatin|mesh-list
101937993|NCT04764227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101937994|NCT04764227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101937995|NCT04764227|Tubulin Modulators|tubulin modulators|mesh-ancestor
101937996|NCT04764227|Antimitotic Agents|antimitotic agents|mesh-ancestor
101937997|NCT04764227|Mitosis Modulators|mitosis modulators|mesh-ancestor
101937998|NCT04764227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101937999|NCT04762498|Methotrexate|methotrexate|mesh-list
101938000|NCT04762498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101938001|NCT04762498|Abortifacient Agents|abortifacient agents|mesh-ancestor
101938002|NCT04762498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101938003|NCT04762498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938004|NCT04762498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101938005|NCT04762498|Antimetabolites|antimetabolites|mesh-ancestor
101938006|NCT04762498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938007|NCT04762498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938008|NCT04762498|Dermatologic Agents|dermatologic agents|mesh-ancestor
101938009|NCT04762498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101938010|NCT04762498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101938011|NCT04762498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101938012|NCT04762498|Immunologic Factors|immunologic factors|mesh-ancestor
101938013|NCT04762498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101938014|NCT04762498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101938015|NCT04733092|Ethiodized Oil|ethiodized oil|mesh-list
101938016|NCT04733092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938017|NCT04722887|Protease Inhibitors|protease inhibitors|mesh-list
101938018|NCT04722887|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
101938019|NCT04722887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101938020|NCT04722887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938021|NCT04722887|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101938022|NCT04722887|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101938023|NCT04706026|Anesthetics|anesthetics|mesh-list
101938024|NCT04706026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101938025|NCT04706026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938026|NCT04695340|Psyllium|psyllium|mesh-list
101938027|NCT04695340|Cathartics|cathartics|mesh-ancestor
101938028|NCT04695340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101938029|NCT04657991|Pembrolizumab|pembrolizumab|mesh-list
101938030|NCT04657991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101938031|NCT04657991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938032|NCT04657991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101938033|NCT04657991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938034|NCT04639245|Cyclophosphamide|cyclophosphamide|mesh-list
101938035|NCT04639245|Fludarabine|fludarabine|mesh-list
101938036|NCT04639245|Atezolizumab|atezolizumab|mesh-list
101938037|NCT04639245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101938038|NCT04639245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101938039|NCT04639245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101938040|NCT04639245|Immunologic Factors|immunologic factors|mesh-ancestor
101938041|NCT04639245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938042|NCT04639245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101938043|NCT04639245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101938044|NCT04639245|Alkylating Agents|alkylating agents|mesh-ancestor
101300615|NCT04642547|Lenvatinib|lenvatinib|mesh-list
101938045|NCT04639245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938046|NCT04639245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938047|NCT04639245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101938048|NCT04639245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101938049|NCT04599465|Ivacaftor|ivacaftor|mesh-list
101938050|NCT04599465|Elexacaftor|elexacaftor|mesh-list
101938051|NCT04599465|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101938052|NCT04599465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101938053|NCT04599465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938054|NCT04589130|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
101938055|NCT04589130|Naltrexone|naltrexone|mesh-list
101938056|NCT04589130|Bupropion|bupropion|mesh-list
101938057|NCT04589130|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101938058|NCT04589130|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101938059|NCT04589130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938060|NCT04589130|Sensory System Agents|sensory system agents|mesh-ancestor
101938061|NCT04589130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101938062|NCT04589130|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101938063|NCT04589130|Antidepressive Agents|antidepressive agents|mesh-ancestor
101938064|NCT04589130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101938065|NCT04589130|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101938066|NCT04589130|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101938067|NCT04589130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101938068|NCT04589130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938069|NCT04589130|Dopamine Agents|dopamine agents|mesh-ancestor
101938070|NCT04589130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101938071|NCT04589130|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101938072|NCT04589130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101938073|NCT04589130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101938074|NCT04589130|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101938075|NCT04587843|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
101938076|NCT04587843|Naltrexone|naltrexone|mesh-list
101938077|NCT04587843|Bupropion|bupropion|mesh-list
101938078|NCT04587843|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101938079|NCT04587843|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101938080|NCT04587843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938081|NCT04587843|Sensory System Agents|sensory system agents|mesh-ancestor
101938082|NCT04587843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101938083|NCT04587843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101938084|NCT04587843|Antidepressive Agents|antidepressive agents|mesh-ancestor
101938085|NCT04587843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101938086|NCT04587843|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101938087|NCT04587843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101938088|NCT04587843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101938089|NCT04587843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938090|NCT04587843|Dopamine Agents|dopamine agents|mesh-ancestor
101938091|NCT04587843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101938092|NCT04587843|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101938093|NCT04587843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101938094|NCT04587843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101938095|NCT04587843|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101938096|NCT04562441|Avelumab|avelumab|mesh-list
101938097|NCT04562441|Axitinib|axitinib|mesh-list
101938098|NCT04562441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101938099|NCT04562441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938100|NCT04562441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101938101|NCT04562441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387662|NCT00322660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101938102|NCT04562441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938103|NCT04553692|Leucovorin|leucovorin|mesh-list
101938104|NCT04553692|Bevacizumab|bevacizumab|mesh-list
101938105|NCT04553692|Gemcitabine|gemcitabine|mesh-list
101938106|NCT04553692|Docetaxel|docetaxel|mesh-list
101938107|NCT04553692|Fluorouracil|fluorouracil|mesh-list
101938108|NCT04553692|Irinotecan|irinotecan|mesh-list
101938109|NCT04553692|Azacitidine|azacitidine|mesh-list
101938110|NCT04553692|Venetoclax|venetoclax|mesh-list
101938111|NCT04553692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101938112|NCT04553692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938113|NCT04553692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101938114|NCT04553692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101938115|NCT04553692|Growth Substances|growth substances|mesh-ancestor
101938116|NCT04553692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938117|NCT04553692|Growth Inhibitors|growth inhibitors|mesh-ancestor
101938118|NCT04553692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101938119|NCT04553692|Antimetabolites|antimetabolites|mesh-ancestor
101938120|NCT04553692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938121|NCT04553692|Tubulin Modulators|tubulin modulators|mesh-ancestor
101938122|NCT04553692|Antimitotic Agents|antimitotic agents|mesh-ancestor
101938123|NCT04553692|Mitosis Modulators|mitosis modulators|mesh-ancestor
101938124|NCT04553692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101938125|NCT04553692|Immunologic Factors|immunologic factors|mesh-ancestor
101938126|NCT04553692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101938127|NCT04553692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101938128|NCT04553692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101938129|NCT04553692|Antidotes|antidotes|mesh-ancestor
101938130|NCT04553692|Protective Agents|protective agents|mesh-ancestor
101938131|NCT04553692|Vitamin B Complex|vitamin b complex|mesh-ancestor
101938132|NCT04553692|Vitamins|vitamins|mesh-ancestor
101938133|NCT04553692|Micronutrients|micronutrients|mesh-ancestor
101938134|NCT04497116|Gemcitabine|gemcitabine|mesh-list
101938135|NCT04497116|Talazoparib|talazoparib|mesh-list
101938136|NCT04497116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101938137|NCT04497116|Antimetabolites|antimetabolites|mesh-ancestor
101938138|NCT04497116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938139|NCT04497116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938140|NCT04497116|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101938141|NCT04497116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101938142|NCT04433780|Tenofovir|tenofovir|mesh-list
101938143|NCT04433780|Lamivudine|lamivudine|mesh-list
101234443|NCT01578434|Vitamin D|vitamin d|mesh-list
101938144|NCT04433780|Antiviral Agents|antiviral agents|mesh-ancestor
101938145|NCT04433780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101938146|NCT04433780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101938147|NCT04433780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101938148|NCT04433780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101938149|NCT04433780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938150|NCT04433780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101938151|NCT04433780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101938152|NCT04408664|Cromolyn Sodium|cromolyn sodium|mesh-list
101938153|NCT04408664|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
101938154|NCT04408664|Immunologic Factors|immunologic factors|mesh-ancestor
101938155|NCT04408664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938156|NCT04408664|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101938157|NCT04408664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101938158|NCT04408664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101938159|NCT04408664|Respiratory System Agents|respiratory system agents|mesh-ancestor
101938160|NCT04401761|Aspirin|aspirin|mesh-list
101938161|NCT04401761|Rivaroxaban|rivaroxaban|mesh-list
101938162|NCT04401761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101938163|NCT04401761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101938164|NCT04401761|Analgesics|analgesics|mesh-ancestor
101938165|NCT04401761|Sensory System Agents|sensory system agents|mesh-ancestor
101938166|NCT04401761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101938167|NCT04401761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938168|NCT04401761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101938169|NCT04401761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101938170|NCT04401761|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101938171|NCT04401761|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101938172|NCT04401761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938173|NCT04401761|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101938174|NCT04401761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101938175|NCT04401761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101938176|NCT04401761|Antipyretics|antipyretics|mesh-ancestor
101938177|NCT04401761|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101938178|NCT04401761|Antithrombins|antithrombins|mesh-ancestor
101938179|NCT04401761|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101938180|NCT04401761|Protease Inhibitors|protease inhibitors|mesh-ancestor
101938181|NCT04401761|Anticoagulants|anticoagulants|mesh-ancestor
101938182|NCT04373265|Pembrolizumab|pembrolizumab|mesh-list
101938183|NCT04373265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101938184|NCT04373265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938185|NCT04373265|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101938186|NCT04373265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938187|NCT04362293|Sirolimus|sirolimus|mesh-list
101938188|NCT04362293|Plerixafor|plerixafor|mesh-list
101938189|NCT04362293|Cyclophosphamide|cyclophosphamide|mesh-list
101938190|NCT04362293|Thiotepa|thiotepa|mesh-list
101938191|NCT04362293|Temsirolimus|temsirolimus|mesh-list
101938192|NCT04362293|Alemtuzumab|alemtuzumab|mesh-list
101938193|NCT04362293|Hydroxyurea|hydroxyurea|mesh-list
101938194|NCT04362293|Azathioprine|azathioprine|mesh-list
101938195|NCT04362293|MTOR Inhibitors|mtor inhibitors|mesh-list
101938196|NCT04362293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101938197|NCT04362293|Immunologic Factors|immunologic factors|mesh-ancestor
101938198|NCT04362293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938199|NCT04362293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101938200|NCT04362293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101938201|NCT04362293|Alkylating Agents|alkylating agents|mesh-ancestor
101938202|NCT04362293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938203|NCT04362293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938204|NCT04362293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101938205|NCT04362293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101938206|NCT04362293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101938207|NCT04362293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101938208|NCT04362293|Antifungal Agents|antifungal agents|mesh-ancestor
101938209|NCT04362293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101938210|NCT04362293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101938211|NCT04362293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101938212|NCT04362293|Antisickling Agents|antisickling agents|mesh-ancestor
101938213|NCT04362293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101234536|NCT01578720|Aflibercept|aflibercept|mesh-list
101938214|NCT04362293|Antimetabolites|antimetabolites|mesh-ancestor
101938215|NCT04362293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101938216|NCT04362293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101938217|NCT04362293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101938218|NCT04362293|Antiviral Agents|antiviral agents|mesh-ancestor
101938219|NCT04337450|Lamivudine|lamivudine|mesh-list
101938220|NCT04337450|Dolutegravir|dolutegravir|mesh-list
101938221|NCT04337450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101938222|NCT04337450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101938223|NCT04337450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101938224|NCT04337450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938225|NCT04337450|Antiviral Agents|antiviral agents|mesh-ancestor
101938226|NCT04337450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101938227|NCT04337450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101938228|NCT04337450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101938229|NCT04337450|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101938230|NCT04337450|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101938231|NCT04332367|Paclitaxel|paclitaxel|mesh-list
101938232|NCT04332367|Carboplatin|carboplatin|mesh-list
101938233|NCT04332367|Ramucirumab|ramucirumab|mesh-list
101938234|NCT04332367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101938235|NCT04332367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938236|NCT04332367|Tubulin Modulators|tubulin modulators|mesh-ancestor
101938237|NCT04332367|Antimitotic Agents|antimitotic agents|mesh-ancestor
101938238|NCT04332367|Mitosis Modulators|mitosis modulators|mesh-ancestor
101938239|NCT04332367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938240|NCT04290546|Cetuximab|cetuximab|mesh-list
101938241|NCT04290546|Ipilimumab|ipilimumab|mesh-list
101938242|NCT04290546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101938243|NCT04290546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101938244|NCT04290546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938245|NCT04290546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938246|NCT04212013|Rituximab|rituximab|mesh-list
101938247|NCT04212013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101938248|NCT04212013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938249|NCT04212013|Immunologic Factors|immunologic factors|mesh-ancestor
101938250|NCT04212013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938251|NCT04212013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101938252|NCT04209595|Rucaparib|rucaparib|mesh-list
101938253|NCT04209595|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101938254|NCT04209595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101938255|NCT04209595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938256|NCT04209595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938257|NCT04186559|Pentoxifylline|pentoxifylline|mesh-list
101938258|NCT04186559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101938259|NCT04186559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101938260|NCT04186559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938261|NCT04186559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101938262|NCT04186559|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101938263|NCT04186559|Protective Agents|protective agents|mesh-ancestor
101234559|NCT01578928|Pasireotide|pasireotide|mesh-list
101938264|NCT04186559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938265|NCT04186559|Vasodilator Agents|vasodilator agents|mesh-ancestor
101938266|NCT04186559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101938268|NCT04183452|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
101938269|NCT04183452|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
101938270|NCT04183452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101938271|NCT04183452|Hormone Antagonists|hormone antagonists|mesh-ancestor
101938272|NCT04183452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101938273|NCT04183452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938274|NCT04183452|Progestins|progestins|mesh-ancestor
101938275|NCT04183452|Hormones|hormones|mesh-ancestor
101938276|NCT04104646|Morphine|morphine|mesh-list
101938277|NCT04104646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101938278|NCT04104646|Narcotics|narcotics|mesh-ancestor
101938279|NCT04104646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101938280|NCT04104646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938281|NCT04104646|Analgesics|analgesics|mesh-ancestor
101938282|NCT04104646|Sensory System Agents|sensory system agents|mesh-ancestor
101938283|NCT04104646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101938284|NCT04098874|Bupropion|bupropion|mesh-list
101938285|NCT04098874|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101938286|NCT04098874|Antidepressive Agents|antidepressive agents|mesh-ancestor
101938287|NCT04098874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101938288|NCT04098874|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101938289|NCT04098874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101938290|NCT04098874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101938291|NCT04098874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938292|NCT04098874|Dopamine Agents|dopamine agents|mesh-ancestor
101938293|NCT04098874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101938294|NCT04098874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938295|NCT04098874|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101938296|NCT04098874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101938297|NCT04098874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101938298|NCT03841357|Abatacept|abatacept|mesh-list
101938299|NCT03841357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101938300|NCT03841357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938301|NCT03841357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101938302|NCT03841357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938303|NCT03841357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101938304|NCT03841357|Immunologic Factors|immunologic factors|mesh-ancestor
101938305|NCT03841357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938306|NCT03841357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101938307|NCT03818191|Acamprosate|acamprosate|mesh-list
101938308|NCT03818191|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101938309|NCT03640481|Belumosudil|belumosudil|mesh-list
101938310|NCT03640481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101234590|NCT01579110|Levamisole|levamisole|mesh-list
101938311|NCT03640481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101938312|NCT03640481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938313|NCT03622788|Cyclophosphamide|cyclophosphamide|mesh-list
101938314|NCT03622788|Fludarabine|fludarabine|mesh-list
101938315|NCT03622788|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101938316|NCT03622788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101938317|NCT03622788|Immunologic Factors|immunologic factors|mesh-ancestor
101938318|NCT03622788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938319|NCT03622788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101938320|NCT03622788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101938321|NCT03622788|Alkylating Agents|alkylating agents|mesh-ancestor
101938322|NCT03622788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938323|NCT03622788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938324|NCT03622788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101938325|NCT03594110|Empagliflozin|empagliflozin|mesh-list
101938326|NCT03594110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101938327|NCT03594110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938328|NCT03594110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101938329|NCT03594110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938330|NCT03580824|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
101938331|NCT03580824|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101938332|NCT03580824|Immunologic Factors|immunologic factors|mesh-ancestor
101938333|NCT03580824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938334|NCT03532295|Bevacizumab|bevacizumab|mesh-list
101938335|NCT03532295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101938336|NCT03532295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938337|NCT03532295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101938338|NCT03532295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101938339|NCT03532295|Growth Substances|growth substances|mesh-ancestor
101938340|NCT03532295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938341|NCT03532295|Growth Inhibitors|growth inhibitors|mesh-ancestor
101938342|NCT03497676|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101938343|NCT03497676|Rilpivirine|rilpivirine|mesh-list
101938344|NCT03497676|Cabotegravir|cabotegravir|mesh-list
101938345|NCT03497676|Antiviral Agents|antiviral agents|mesh-ancestor
101938346|NCT03497676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101938347|NCT03497676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101938348|NCT03497676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101938349|NCT03497676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101938350|NCT03497676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938351|NCT03497676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101938352|NCT03497676|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101938353|NCT03497676|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101938354|NCT03403205|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
101938355|NCT03403205|Choline|choline|mesh-list
101938356|NCT03403205|Lipotropic Agents|lipotropic agents|mesh-ancestor
101938357|NCT03403205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101938358|NCT03403205|Antimetabolites|antimetabolites|mesh-ancestor
101938359|NCT03403205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234611|NCT01579201|Carbetocin|carbetocin|mesh-list
101938360|NCT03403205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101938361|NCT03403205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101938362|NCT03403205|Nootropic Agents|nootropic agents|mesh-ancestor
101938363|NCT03403205|Chelating Agents|chelating agents|mesh-ancestor
101938364|NCT03403205|Sequestering Agents|sequestering agents|mesh-ancestor
101938365|NCT03403205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101938366|NCT03403205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101938367|NCT03403205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101938368|NCT03403205|Growth Substances|growth substances|mesh-ancestor
101938369|NCT03403205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938370|NCT03403205|Growth Inhibitors|growth inhibitors|mesh-ancestor
101938371|NCT03403205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938372|NCT03366142|Ustekinumab|ustekinumab|mesh-list
101938373|NCT03366142|Dermatologic Agents|dermatologic agents|mesh-ancestor
101938374|NCT03311126|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101938375|NCT03311126|Obinutuzumab|obinutuzumab|mesh-list
101938376|NCT03311126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101938377|NCT03311126|Alkylating Agents|alkylating agents|mesh-ancestor
101938378|NCT03311126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938379|NCT03311126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938380|NCT03311126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101938381|NCT03304418|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
101938382|NCT03304418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938383|NCT03300947|Lorazepam|lorazepam|mesh-list
101938384|NCT03300947|Psilocybin|psilocybin|mesh-list
101938385|NCT03300947|Hallucinogens|hallucinogens|mesh-ancestor
101938386|NCT03300947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938387|NCT03300947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101938388|NCT03300947|Anticonvulsants|anticonvulsants|mesh-ancestor
101938389|NCT03300947|Antiemetics|antiemetics|mesh-ancestor
101938390|NCT03300947|Autonomic Agents|autonomic agents|mesh-ancestor
101938391|NCT03300947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101938392|NCT03300947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101938393|NCT03300947|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101938394|NCT03300947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101938395|NCT03300947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101938396|NCT03300947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101938397|NCT03300947|GABA Modulators|gaba modulators|mesh-ancestor
101938398|NCT03300947|GABA Agents|gaba agents|mesh-ancestor
101938399|NCT03300947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101938400|NCT03300947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938404|NCT03278925|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
101938406|NCT03278925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938407|NCT03278925|Protective Agents|protective agents|mesh-ancestor
101938408|NCT03278925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938409|NCT03278925|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101938410|NCT03278925|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101938412|NCT03278925|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101938413|NCT03238326|Brexpiprazole|brexpiprazole|mesh-list
101938414|NCT03238326|Serotonin Agents|serotonin agents|mesh-ancestor
101938415|NCT03238326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101938416|NCT03238326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938417|NCT03238326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938418|NCT03238326|Dopamine Agonists|dopamine agonists|mesh-ancestor
101938419|NCT03238326|Dopamine Agents|dopamine agents|mesh-ancestor
101938420|NCT03206047|Poly I-C|poly i-c|mesh-list
101938421|NCT03206047|Atezolizumab|atezolizumab|mesh-list
101938422|NCT03206047|Guadecitabine|guadecitabine|mesh-list
101938423|NCT03206047|Azacitidine|azacitidine|mesh-list
101938424|NCT03206047|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101938425|NCT03206047|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101938426|NCT03206047|Poly ICLC|poly iclc|mesh-list
101938427|NCT03206047|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101938428|NCT03206047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938429|NCT03206047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101938430|NCT03206047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938431|NCT03206047|Immunologic Factors|immunologic factors|mesh-ancestor
101938432|NCT03206047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938433|NCT03206047|Interferon Inducers|interferon inducers|mesh-ancestor
101938434|NCT03206047|Laxatives|laxatives|mesh-ancestor
101938435|NCT03206047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101938436|NCT03206047|Antiviral Agents|antiviral agents|mesh-ancestor
101938437|NCT03206047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101938438|NCT03206047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101938439|NCT03206047|Antimetabolites|antimetabolites|mesh-ancestor
101938440|NCT03206047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101938441|NCT03190941|Aldesleukin|aldesleukin|mesh-list
101938442|NCT03190941|Cyclophosphamide|cyclophosphamide|mesh-list
101938443|NCT03190941|Fludarabine|fludarabine|mesh-list
101938444|NCT03190941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101938445|NCT03190941|Immunologic Factors|immunologic factors|mesh-ancestor
101938446|NCT03190941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938447|NCT03190941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101938448|NCT03190941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101938449|NCT03190941|Alkylating Agents|alkylating agents|mesh-ancestor
101938450|NCT03190941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938451|NCT03190941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938452|NCT03190941|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101938453|NCT03190941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101938454|NCT03190941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101938455|NCT03190941|Antiviral Agents|antiviral agents|mesh-ancestor
101938456|NCT03190941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101938458|NCT03107884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101938459|NCT03107884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938460|NCT03106415|Pembrolizumab|pembrolizumab|mesh-list
101938461|NCT03106415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101938462|NCT03106415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938463|NCT03106415|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101938464|NCT03106415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938465|NCT03024996|Atezolizumab|atezolizumab|mesh-list
101938466|NCT03024996|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101938467|NCT03024996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938468|NCT03024996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101938469|NCT03024996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938470|NCT03003325|Aspirin|aspirin|mesh-list
101938471|NCT03003325|Interferons|interferons|mesh-list
101938472|NCT03003325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938473|NCT03003325|Antiviral Agents|antiviral agents|mesh-ancestor
101938474|NCT03003325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101938475|NCT03003325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101938476|NCT03003325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101938478|NCT03003325|Sensory System Agents|sensory system agents|mesh-ancestor
101938479|NCT03003325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101938480|NCT03003325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938481|NCT03003325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101938482|NCT03003325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101938483|NCT03003325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101938484|NCT03003325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101938485|NCT03003325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938486|NCT03003325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101938487|NCT03003325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101938488|NCT03003325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101938489|NCT03003325|Antipyretics|antipyretics|mesh-ancestor
101938490|NCT02969798|Metformin|metformin|mesh-list
101938491|NCT02969798|Pioglitazone|pioglitazone|mesh-list
101938492|NCT02969798|Dapagliflozin|dapagliflozin|mesh-list
101938493|NCT02969798|Saxagliptin|saxagliptin|mesh-list
101938494|NCT02969798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101938495|NCT02969798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938496|NCT02969798|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101938497|NCT02969798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938498|NCT02969798|Incretins|incretins|mesh-ancestor
101938499|NCT02969798|Hormones|hormones|mesh-ancestor
101938500|NCT02969798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101959442|NCT00133991|Rituximab|rituximab|mesh-list
101938501|NCT02969798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101938502|NCT02969798|Protease Inhibitors|protease inhibitors|mesh-ancestor
101938503|NCT02969798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101938504|NCT02967692|Trametinib|trametinib|mesh-list
101938505|NCT02967692|Dabrafenib|dabrafenib|mesh-list
101938506|NCT02967692|Spartalizumab|spartalizumab|mesh-list
101938507|NCT02967692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938508|NCT02967692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101938509|NCT02967692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101938510|NCT02967692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938511|NCT02967692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101938512|NCT02967692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101938513|NCT02917993|Osimertinib|osimertinib|mesh-list
101938514|NCT02917993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938515|NCT02917993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101938516|NCT02917993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101938517|NCT02917993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938518|NCT02855203|Pembrolizumab|pembrolizumab|mesh-list
101938519|NCT02855203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101938520|NCT02855203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938521|NCT02855203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101938522|NCT02855203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938523|NCT02753283|Vitamin D|vitamin d|mesh-list
101938524|NCT02753283|Zoledronic Acid|zoledronic acid|mesh-list
101938525|NCT02753283|Denosumab|denosumab|mesh-list
101938526|NCT02753283|Calcium|calcium|mesh-list
101938527|NCT02753283|Vitamins|vitamins|mesh-ancestor
101938528|NCT02753283|Micronutrients|micronutrients|mesh-ancestor
101938529|NCT02753283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938530|NCT02753283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101938531|NCT02753283|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101938532|NCT02748564|Aldesleukin|aldesleukin|mesh-list
101938533|NCT02748564|Pembrolizumab|pembrolizumab|mesh-list
101938534|NCT02748564|Interleukin-2|interleukin-2|mesh-list
101938535|NCT02748564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101938536|NCT02748564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938537|NCT02748564|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101938538|NCT02748564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938539|NCT02748564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101938540|NCT02748564|Analgesics|analgesics|mesh-ancestor
101938541|NCT02748564|Sensory System Agents|sensory system agents|mesh-ancestor
101938542|NCT02748564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101938543|NCT02748564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938544|NCT02748564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101938545|NCT02748564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101938546|NCT02748564|Antiviral Agents|antiviral agents|mesh-ancestor
101938547|NCT02748564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101938548|NCT02672917|Paclitaxel|paclitaxel|mesh-list
101938549|NCT02672917|Gemcitabine|gemcitabine|mesh-list
101938550|NCT02672917|Folfirinox|folfirinox|mesh-list
101938551|NCT02672917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101938552|NCT02672917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938553|NCT02672917|Tubulin Modulators|tubulin modulators|mesh-ancestor
101938554|NCT02672917|Antimitotic Agents|antimitotic agents|mesh-ancestor
101938555|NCT02672917|Mitosis Modulators|mitosis modulators|mesh-ancestor
101938556|NCT02672917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938557|NCT02672917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101938558|NCT02672917|Antimetabolites|antimetabolites|mesh-ancestor
101938559|NCT02642965|Cytarabine|cytarabine|mesh-list
101658392|NCT04519476|Prednisolone|prednisolone|mesh-list
101938560|NCT02642965|Fludarabine|fludarabine|mesh-list
101938561|NCT02642965|Fludarabine phosphate|fludarabine phosphate|mesh-list
101938570|NCT02642965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938572|NCT02642965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101938573|NCT02642965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101938574|NCT02642965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101938575|NCT02642965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101938601|NCT02461927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101938602|NCT02461927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938603|NCT02461927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101938604|NCT02461927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101938605|NCT02461927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101938606|NCT02461927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101938607|NCT02461927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101938608|NCT02461927|GABA Modulators|gaba modulators|mesh-ancestor
101938609|NCT02461927|GABA Agents|gaba agents|mesh-ancestor
101938610|NCT02461927|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101938611|NCT02461927|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101617349|NCT01067144|Lorazepam|lorazepam|mesh-list
101938647|NCT01936532|Lenalidomide|lenalidomide|mesh-list
101938648|NCT01936532|Ixazomib|ixazomib|mesh-list
101938649|NCT01936532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101938650|NCT01936532|Antiemetics|antiemetics|mesh-ancestor
101938651|NCT01936532|Autonomic Agents|autonomic agents|mesh-ancestor
101938652|NCT01936532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101938653|NCT01936532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938654|NCT01936532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101938655|NCT01936532|Glucocorticoids|glucocorticoids|mesh-ancestor
101938656|NCT01936532|Hormones|hormones|mesh-ancestor
101938657|NCT01936532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101938658|NCT01936532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101938659|NCT01936532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938660|NCT01936532|Immunologic Factors|immunologic factors|mesh-ancestor
101938661|NCT01936532|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101938662|NCT01936532|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101938663|NCT01936532|Growth Substances|growth substances|mesh-ancestor
101938664|NCT01936532|Growth Inhibitors|growth inhibitors|mesh-ancestor
101938665|NCT01936532|Protease Inhibitors|protease inhibitors|mesh-ancestor
101938666|NCT01936532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101938667|NCT01936532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938668|NCT01920932|Prednisone|prednisone|mesh-list
101938669|NCT01920932|Prednisolone|prednisolone|mesh-list
101938670|NCT01920932|Cyclophosphamide|cyclophosphamide|mesh-list
101938671|NCT01920932|Dacarbazine|dacarbazine|mesh-list
101938672|NCT01920932|Doxorubicin|doxorubicin|mesh-list
101938673|NCT01920932|Etoposide|etoposide|mesh-list
101938674|NCT01920932|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101938675|NCT01920932|Imidazole|imidazole|mesh-list
101938676|NCT01920932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101938677|NCT01920932|Immunologic Factors|immunologic factors|mesh-ancestor
101938678|NCT01920932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938679|NCT01920932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101938680|NCT01920932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101938681|NCT01920932|Alkylating Agents|alkylating agents|mesh-ancestor
101938682|NCT01920932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938683|NCT01920932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938684|NCT01920932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101938685|NCT01920932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101938686|NCT01920932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101938687|NCT01920932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101938688|NCT01920932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101938689|NCT01920932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101938690|NCT01920932|Glucocorticoids|glucocorticoids|mesh-ancestor
101938691|NCT01920932|Hormones|hormones|mesh-ancestor
101938692|NCT01920932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101938693|NCT01920932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101938694|NCT01920932|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101938695|NCT01920932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101938696|NCT01920932|Immunotoxins|immunotoxins|mesh-ancestor
101938697|NCT01920932|Immunoconjugates|immunoconjugates|mesh-ancestor
101938698|NCT01054625|Zalutumumab|zalutumumab|mesh-list
101938699|NCT01054625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101938700|NCT01054625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938701|NCT01038778|Aldesleukin|aldesleukin|mesh-list
101938702|NCT01038778|Deoxyglucose|deoxyglucose|mesh-list
101938703|NCT01038778|Interleukin-2|interleukin-2|mesh-list
101938704|NCT01038778|Entinostat|entinostat|mesh-list
101938705|NCT01038778|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101938706|NCT01038778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
101938707|NCT01038778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938708|NCT01038778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101938709|NCT01038778|Analgesics|analgesics|mesh-ancestor
101938710|NCT01038778|Sensory System Agents|sensory system agents|mesh-ancestor
101938711|NCT01038778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101938712|NCT01038778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658533|NCT00851929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101938726|NCT00542308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938727|NCT00488605|Leucovorin|leucovorin|mesh-list
101938728|NCT00488605|Prednisone|prednisone|mesh-list
101938729|NCT00488605|Methotrexate|methotrexate|mesh-list
101938730|NCT00488605|Vinblastine|vinblastine|mesh-list
101938731|NCT00488605|Levoleucovorin|levoleucovorin|mesh-list
101938732|NCT00488605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101938733|NCT00488605|Glucocorticoids|glucocorticoids|mesh-ancestor
101938734|NCT00488605|Hormones|hormones|mesh-ancestor
101938735|NCT00488605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101938736|NCT00488605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938737|NCT00488605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101938738|NCT00488605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938739|NCT00488605|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101938740|NCT00488605|Abortifacient Agents|abortifacient agents|mesh-ancestor
101938741|NCT00488605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101938742|NCT00488605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101938743|NCT00488605|Antimetabolites|antimetabolites|mesh-ancestor
101938744|NCT00488605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938745|NCT00488605|Dermatologic Agents|dermatologic agents|mesh-ancestor
101938746|NCT00488605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101938747|NCT00488605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101938748|NCT00488605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101938749|NCT00488605|Immunologic Factors|immunologic factors|mesh-ancestor
101938750|NCT00488605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101938751|NCT00488605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101938752|NCT00488605|Antidotes|antidotes|mesh-ancestor
101938753|NCT00488605|Protective Agents|protective agents|mesh-ancestor
101938754|NCT00488605|Vitamin B Complex|vitamin b complex|mesh-ancestor
101938755|NCT00488605|Vitamins|vitamins|mesh-ancestor
101938756|NCT00488605|Micronutrients|micronutrients|mesh-ancestor
101938757|NCT00488605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101938758|NCT00488605|Tubulin Modulators|tubulin modulators|mesh-ancestor
101938759|NCT00488605|Antimitotic Agents|antimitotic agents|mesh-ancestor
101938760|NCT00488605|Mitosis Modulators|mitosis modulators|mesh-ancestor
101938796|NCT00006734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101938797|NCT00006734|Alkylating Agents|alkylating agents|mesh-ancestor
101938798|NCT00006734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938799|NCT00006734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938800|NCT00006734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101938801|NCT00006734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101938802|NCT00006734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101938803|NCT00006734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101938804|NCT00006734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101938805|NCT00006734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101234680|NCT01579539|Prednisolone|prednisolone|mesh-list
101938806|NCT00006734|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101938807|NCT00006734|Tubulin Modulators|tubulin modulators|mesh-ancestor
101938808|NCT00006734|Antimitotic Agents|antimitotic agents|mesh-ancestor
101938809|NCT00006734|Mitosis Modulators|mitosis modulators|mesh-ancestor
101938810|NCT02991118|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
101938811|NCT02991118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101938812|NCT02991118|Antimetabolites|antimetabolites|mesh-ancestor
101938813|NCT02991118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938814|NCT02991118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101938815|NCT02991118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101938816|NCT02991118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101938817|NCT02991118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938818|NCT02991040|Lidocaine|lidocaine|mesh-list
101938819|NCT02991040|Anesthetics, Local|anesthetics, local|mesh-ancestor
101938820|NCT02991040|Anesthetics|anesthetics|mesh-ancestor
101938821|NCT02991040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101938822|NCT02991040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938823|NCT02991040|Sensory System Agents|sensory system agents|mesh-ancestor
101938824|NCT02991040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101938825|NCT02991040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101938826|NCT02991040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101938827|NCT02991040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101938828|NCT02991040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101938829|NCT02991040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938830|NCT03660436|Mycophenolic Acid|mycophenolic acid|mesh-list
101938831|NCT03660436|Deucravacitinib|deucravacitinib|mesh-list
101938832|NCT03660436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101959504|NCT05577676|Triamcinolone|triamcinolone|mesh-list
101938833|NCT03660436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938834|NCT03660436|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101938835|NCT03660436|Antitubercular Agents|antitubercular agents|mesh-ancestor
101938836|NCT03660436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101938837|NCT03660436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101938838|NCT03660436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101938839|NCT03660436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938840|NCT03660436|Dermatologic Agents|dermatologic agents|mesh-ancestor
101938841|NCT03660436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101938843|NCT03662620|Telmisartan|telmisartan|mesh-list
101938844|NCT03662620|Chlorthalidone|chlorthalidone|mesh-list
101938845|NCT03662620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101938846|NCT03662620|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101938847|NCT03662620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101938848|NCT03662620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938849|NCT03662620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101938850|NCT03662620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938851|NCT03662620|Vasodilator Agents|vasodilator agents|mesh-ancestor
101938852|NCT03662620|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101301430|NCT03631199|Paclitaxel|paclitaxel|mesh-list
101938853|NCT03662620|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101938854|NCT03662620|Diuretics|diuretics|mesh-ancestor
101938855|NCT03662620|Natriuretic Agents|natriuretic agents|mesh-ancestor
101938856|NCT03662620|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101938857|NCT03415178|Atorvastatin|atorvastatin|mesh-list
101938858|NCT03415178|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101938859|NCT03415178|Alirocumab|alirocumab|mesh-list
101938860|NCT03415178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101938861|NCT03415178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101938862|NCT03415178|Antimetabolites|antimetabolites|mesh-ancestor
101658685|NCT00621985|Dexamethasone|dexamethasone|mesh-list
101938863|NCT03415178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938864|NCT03415178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101234690|NCT01579539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101938865|NCT03415178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101938866|NCT03415178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101938867|NCT03415178|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101938868|NCT03415178|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101938869|NCT03415178|Protease Inhibitors|protease inhibitors|mesh-ancestor
101938870|NCT01068730|Metformin|metformin|mesh-list
101938871|NCT01068730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101938872|NCT01068730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938873|NCT01068652|Insulin|insulin|mesh-list
101938874|NCT01068652|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101938875|NCT01068652|Metformin|metformin|mesh-list
101938876|NCT01068652|Insulin Aspart|insulin aspart|mesh-list
101938877|NCT01068652|Insulin, Long-Acting|insulin, long-acting|mesh-list
101938878|NCT01068652|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101938879|NCT01068652|Insulin Detemir|insulin detemir|mesh-list
101938880|NCT01068652|Biphasic Insulins|biphasic insulins|mesh-list
101938881|NCT01068652|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101938882|NCT01068652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101938883|NCT01068652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938884|NCT03658720|Ibuprofen|ibuprofen|mesh-list
101938885|NCT03658720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101938886|NCT03658720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101938887|NCT03658720|Analgesics|analgesics|mesh-ancestor
101938888|NCT03658720|Sensory System Agents|sensory system agents|mesh-ancestor
101938889|NCT03658720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101938890|NCT03658720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938891|NCT03658720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101938892|NCT03658720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101938893|NCT03658720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101938894|NCT03658720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101938895|NCT03658720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938896|NCT03658408|4-Aminopyridine|4-aminopyridine|mesh-list
101959518|NCT03549832|Ribavirin|ribavirin|mesh-list
101938897|NCT03658408|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101938898|NCT03658408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101938899|NCT03658408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938900|NCT03658330|Naltrexone|naltrexone|mesh-list
101938901|NCT03658330|Ketamine|ketamine|mesh-list
101938902|NCT03658330|Analgesics|analgesics|mesh-ancestor
101938903|NCT03658330|Sensory System Agents|sensory system agents|mesh-ancestor
101938904|NCT03658330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101938905|NCT03658330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938906|NCT03658330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101938907|NCT03658330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101938908|NCT03658330|Anesthetics, General|anesthetics, general|mesh-ancestor
101938909|NCT03658330|Anesthetics|anesthetics|mesh-ancestor
101938910|NCT03658330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101938911|NCT03658330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101938912|NCT03658330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101938913|NCT03658330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101938914|NCT03658330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938915|NCT03658330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101938916|NCT03658330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101938917|NCT02920528|Ketamine|ketamine|mesh-list
101938918|NCT02920528|Analgesics|analgesics|mesh-ancestor
101938919|NCT02920528|Sensory System Agents|sensory system agents|mesh-ancestor
101938920|NCT02920528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101938921|NCT02920528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234700|NCT01579539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101938922|NCT02920528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101938923|NCT02920528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101938924|NCT02920528|Anesthetics, General|anesthetics, general|mesh-ancestor
101938925|NCT02920528|Anesthetics|anesthetics|mesh-ancestor
101938926|NCT02920528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101938927|NCT02920528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101938928|NCT02920528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101938929|NCT02920528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101938930|NCT02920528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938931|NCT01068418|Vitamin D|vitamin d|mesh-list
101938932|NCT01068418|Cholecalciferol|cholecalciferol|mesh-list
101938933|NCT01068418|Vitamins|vitamins|mesh-ancestor
101938934|NCT01068418|Micronutrients|micronutrients|mesh-ancestor
101938935|NCT01068418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658758|NCT00861367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101938936|NCT01068418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101938937|NCT01068418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101938938|NCT01100619|Rosiglitazone|rosiglitazone|mesh-list
101938939|NCT01100619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101938940|NCT01100619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938941|NCT03657550|Niacin|niacin|mesh-list
101938942|NCT03657550|Amlodipine|amlodipine|mesh-list
101938943|NCT03657550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101938944|NCT03657550|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101938945|NCT03657550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101938946|NCT03657550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938947|NCT03657550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101938948|NCT03657550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938949|NCT03657550|Vasodilator Agents|vasodilator agents|mesh-ancestor
101938950|NCT03657550|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101938951|NCT03657550|Antimetabolites|antimetabolites|mesh-ancestor
101938952|NCT03657550|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101938953|NCT03657550|Vitamin B Complex|vitamin b complex|mesh-ancestor
101938954|NCT03657550|Vitamins|vitamins|mesh-ancestor
101938955|NCT03657550|Micronutrients|micronutrients|mesh-ancestor
101938956|NCT02920450|Paclitaxel|paclitaxel|mesh-list
101938957|NCT02920450|Carboplatin|carboplatin|mesh-list
101938958|NCT02920450|Gedatolisib|gedatolisib|mesh-list
101938959|NCT02920450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101938960|NCT02920450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938961|NCT02920450|Tubulin Modulators|tubulin modulators|mesh-ancestor
101938962|NCT02920450|Antimitotic Agents|antimitotic agents|mesh-ancestor
101938963|NCT02920450|Mitosis Modulators|mitosis modulators|mesh-ancestor
101938964|NCT02920450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938965|NCT02920450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101938966|NCT02920450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101938967|NCT03622450|Ciprofloxacin|ciprofloxacin|mesh-list
101938968|NCT03622450|Levofloxacin|levofloxacin|mesh-list
101938969|NCT03622450|Gentamicins|gentamicins|mesh-list
101938970|NCT03622450|Meropenem|meropenem|mesh-list
101938971|NCT03622450|Amikacin|amikacin|mesh-list
101938972|NCT03622450|Colistin|colistin|mesh-list
101938973|NCT03622450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101938974|NCT03622450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101938975|NCT03622450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101938976|NCT03622450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101938977|NCT03622450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101938978|NCT03622450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938979|NCT03622450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938980|NCT03622450|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101938981|NCT03622450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101938982|NCT03622450|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101234716|NCT01579760|Growth Substances|growth substances|mesh-ancestor
101938983|NCT03622450|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101938984|NCT03657862|Fluorides|fluorides|mesh-list
101938985|NCT03657862|Cariostatic Agents|cariostatic agents|mesh-ancestor
101938986|NCT03657862|Protective Agents|protective agents|mesh-ancestor
101938987|NCT03657862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101938988|NCT02730130|Pembrolizumab|pembrolizumab|mesh-list
101938989|NCT02730130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101938990|NCT02730130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101938991|NCT02730130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101617364|NCT01067144|Antiemetics|antiemetics|mesh-ancestor
101938992|NCT02730130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101938993|NCT02919436|Tamsulosin|tamsulosin|mesh-list
101938994|NCT02919436|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101938995|NCT02919436|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101938996|NCT02919436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101938997|NCT02919436|Adrenergic Agents|adrenergic agents|mesh-ancestor
101938998|NCT02919436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101938999|NCT02919436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939000|NCT02919436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939001|NCT02919436|Urological Agents|urological agents|mesh-ancestor
101939002|NCT03657472|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
101939003|NCT03657472|Atorvastatin|atorvastatin|mesh-list
101939004|NCT03657472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101939005|NCT03657472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101939006|NCT03657472|Antimetabolites|antimetabolites|mesh-ancestor
101939007|NCT03657472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939008|NCT03657472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101939009|NCT03657472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101658835|NCT04204577|Apatinib|apatinib|mesh-list
101939010|NCT03657472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101939011|NCT03657472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101939013|NCT04440358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101939015|NCT04438330|Trace Elements|trace elements|mesh-ancestor
101939016|NCT04438330|Micronutrients|micronutrients|mesh-ancestor
101939017|NCT04438330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939018|NCT03803475|Edetic Acid|edetic acid|mesh-list
101939019|NCT03803475|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101939020|NCT03803475|Chelating Agents|chelating agents|mesh-ancestor
101939021|NCT03803475|Sequestering Agents|sequestering agents|mesh-ancestor
101939022|NCT03803475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939024|NCT03803475|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101939025|NCT03803475|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101939026|NCT02682004|Serotonin|serotonin|mesh-list
101939027|NCT02682004|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101939028|NCT02682004|Serotonin Agents|serotonin agents|mesh-ancestor
101939029|NCT02682004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101939030|NCT02682004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939031|NCT02682004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939032|NCT00005937|Cyclosporine|cyclosporine|mesh-list
101939033|NCT00005937|Cyclosporins|cyclosporins|mesh-list
101939034|NCT00005937|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101939035|NCT00005937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101939036|NCT00005937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939037|NCT00005937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101939038|NCT00005937|Immunologic Factors|immunologic factors|mesh-ancestor
101939039|NCT00005937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234732|NCT01579864|Rocuronium|rocuronium|mesh-list
101939040|NCT00005937|Antifungal Agents|antifungal agents|mesh-ancestor
101939041|NCT00005937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101939042|NCT00005937|Dermatologic Agents|dermatologic agents|mesh-ancestor
101939043|NCT00005937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101939044|NCT00005937|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101939045|NCT01096329|Methyltestosterone|methyltestosterone|mesh-list
101939046|NCT01096329|Testosterone|testosterone|mesh-list
101939047|NCT01096329|Testosterone undecanoate|testosterone undecanoate|mesh-list
101939048|NCT01096329|Testosterone enanthate|testosterone enanthate|mesh-list
101939049|NCT01096329|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101939050|NCT01096329|Androgens|androgens|mesh-ancestor
101939051|NCT01096329|Hormones|hormones|mesh-ancestor
101939052|NCT01096329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101939053|NCT01096329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939054|NCT01096329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101939055|NCT01096329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101939056|NCT01096329|Anabolic Agents|anabolic agents|mesh-ancestor
101939057|NCT02908516|Tranexamic Acid|tranexamic acid|mesh-list
101939058|NCT02908516|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101939059|NCT02908516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101939060|NCT02908516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939061|NCT02908516|Hemostatics|hemostatics|mesh-ancestor
101939062|NCT02908516|Coagulants|coagulants|mesh-ancestor
101939063|NCT03717350|Meropenem|meropenem|mesh-list
101939064|NCT03717350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101939065|NCT03717350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101939067|NCT03713372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101939068|NCT03713372|Immunologic Factors|immunologic factors|mesh-ancestor
101939069|NCT03713372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939070|NCT03656614|Neostigmine|neostigmine|mesh-list
101939071|NCT03656614|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101939072|NCT03656614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101939073|NCT03656614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939074|NCT03656614|Cholinergic Agents|cholinergic agents|mesh-ancestor
101939075|NCT03656614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101939076|NCT03656614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939077|NCT03656614|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101939078|NCT03656614|Autonomic Agents|autonomic agents|mesh-ancestor
101939079|NCT03656614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101939080|NCT02906644|Nicotine|nicotine|mesh-list
101939081|NCT02906644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101939082|NCT02906644|Autonomic Agents|autonomic agents|mesh-ancestor
101939083|NCT02906644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101939084|NCT02906644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939085|NCT02906644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101939086|NCT02906644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101939087|NCT02906644|Cholinergic Agents|cholinergic agents|mesh-ancestor
101939088|NCT02906644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101939089|NCT02906644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939090|NCT02982772|Nicotine|nicotine|mesh-list
101939091|NCT02982772|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101939092|NCT02982772|Autonomic Agents|autonomic agents|mesh-ancestor
101939093|NCT02982772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101939094|NCT02982772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939095|NCT02982772|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101939096|NCT02982772|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101939097|NCT02982772|Cholinergic Agents|cholinergic agents|mesh-ancestor
101939098|NCT02982772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101939099|NCT02982772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939100|NCT03713216|Morphine|morphine|mesh-list
101939101|NCT03713216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101939102|NCT03713216|Narcotics|narcotics|mesh-ancestor
101939103|NCT03713216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101939104|NCT03713216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939105|NCT03713216|Analgesics|analgesics|mesh-ancestor
101939106|NCT03713216|Sensory System Agents|sensory system agents|mesh-ancestor
101939107|NCT03713216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101939108|NCT02098954|Gemcitabine|gemcitabine|mesh-list
101939109|NCT02098954|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101939110|NCT02098954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101939111|NCT02098954|Antimetabolites|antimetabolites|mesh-ancestor
101939112|NCT02098954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939113|NCT02098954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101939114|NCT02098954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101939115|NCT02098954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101939116|NCT03655834|Pemetrexed|pemetrexed|mesh-list
101939117|NCT03655834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101939118|NCT03655834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101939119|NCT03655834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939120|NCT03655834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101939121|NCT03655834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101939122|NCT03488108|Minoxidil|minoxidil|mesh-list
101939123|NCT03488108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101939124|NCT03488108|Vasodilator Agents|vasodilator agents|mesh-ancestor
101939125|NCT03712670|Pyranoprofen|pyranoprofen|mesh-list
101939126|NCT03712670|Aflibercept|aflibercept|mesh-list
101939127|NCT03712670|Carotenoids|carotenoids|mesh-list
101939128|NCT03712670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101939129|NCT03712670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101939130|NCT03712670|Growth Substances|growth substances|mesh-ancestor
101939131|NCT03712670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939132|NCT03712670|Growth Inhibitors|growth inhibitors|mesh-ancestor
101939133|NCT03712670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101939134|NCT03712670|Antioxidants|antioxidants|mesh-ancestor
101939135|NCT03712670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939136|NCT03712670|Protective Agents|protective agents|mesh-ancestor
101939137|NCT03712670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101939138|NCT03712670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101939139|NCT03712670|Analgesics|analgesics|mesh-ancestor
101939140|NCT03712670|Sensory System Agents|sensory system agents|mesh-ancestor
101939141|NCT03712670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101939142|NCT03712670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101939143|NCT03712670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101939144|NCT03712670|Gout Suppressants|gout suppressants|mesh-ancestor
101939145|NCT03440918|Anti-Infective Agents|anti-infective agents|mesh-list
101939146|NCT03440918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101939147|NCT03486392|Liraglutide|liraglutide|mesh-list
101939148|NCT03486392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101939149|NCT03486392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939150|NCT03486392|Incretins|incretins|mesh-ancestor
101939151|NCT03486392|Hormones|hormones|mesh-ancestor
101939152|NCT03486392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101939153|NCT02981524|Cyclophosphamide|cyclophosphamide|mesh-list
101939154|NCT02981524|Pembrolizumab|pembrolizumab|mesh-list
101939155|NCT02981524|Immunologic Factors|immunologic factors|mesh-ancestor
101939156|NCT02981524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939157|NCT02981524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101939158|NCT02981524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101939159|NCT02981524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101939160|NCT02981524|Alkylating Agents|alkylating agents|mesh-ancestor
101939161|NCT02981524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939162|NCT02981524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101939163|NCT02981524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101939164|NCT02981524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101939165|NCT02981524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101939166|NCT04297150|Rivaroxaban|rivaroxaban|mesh-list
101939168|NCT04297150|Edoxaban|edoxaban|mesh-list
101939169|NCT04297150|Dabigatran|dabigatran|mesh-list
101939170|NCT04297150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101939171|NCT04297150|Antithrombins|antithrombins|mesh-ancestor
101939172|NCT04297150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101939173|NCT04297150|Protease Inhibitors|protease inhibitors|mesh-ancestor
101939174|NCT04297150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101939175|NCT04297150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939176|NCT04297150|Anticoagulants|anticoagulants|mesh-ancestor
101939177|NCT03486314|Rifampin|rifampin|mesh-list
101939178|NCT03486314|Paclitaxel|paclitaxel|mesh-list
101939179|NCT03486314|Docetaxel|docetaxel|mesh-list
101939180|NCT03486314|Carboplatin|carboplatin|mesh-list
101939181|NCT03486314|Pevonedistat|pevonedistat|mesh-list
101939182|NCT03486314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101939183|NCT03486314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101939184|NCT03486314|Tubulin Modulators|tubulin modulators|mesh-ancestor
101939185|NCT03486314|Antimitotic Agents|antimitotic agents|mesh-ancestor
101939186|NCT03486314|Mitosis Modulators|mitosis modulators|mesh-ancestor
101939187|NCT03486314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939188|NCT03486314|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101939189|NCT03486314|Antitubercular Agents|antitubercular agents|mesh-ancestor
101939190|NCT03486314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101939191|NCT03486314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101939192|NCT03486314|Leprostatic Agents|leprostatic agents|mesh-ancestor
101939193|NCT03486314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101939194|NCT03486314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101939195|NCT03486314|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101939196|NCT03486314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101939197|NCT03486314|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101939198|NCT03486314|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101939199|NCT03486314|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101939200|NCT03486314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101939201|NCT02975206|Serlopitant|serlopitant|mesh-list
101939202|NCT02975206|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101939203|NCT02975206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101939204|NCT02975206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939205|NCT02975206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939206|NCT03654820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101939207|NCT01066156|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101939208|NCT01066156|Antidepressive Agents|antidepressive agents|mesh-ancestor
101939209|NCT01066156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101939210|NCT01066156|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101939211|NCT01066156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101939212|NCT01066156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101939213|NCT01066156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939214|NCT02980042|Rituximab|rituximab|mesh-list
101939215|NCT02980042|Ocrelizumab|ocrelizumab|mesh-list
101939216|NCT02980042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101939217|NCT02980042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101939218|NCT02980042|Immunologic Factors|immunologic factors|mesh-ancestor
101939219|NCT02980042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939220|NCT02980042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101939222|NCT01066000|Hematinics|hematinics|mesh-ancestor
101939223|NCT01065844|Nelfinavir|nelfinavir|mesh-list
101939224|NCT01065844|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101939225|NCT01065844|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101939226|NCT01065844|Protease Inhibitors|protease inhibitors|mesh-ancestor
101939227|NCT01065844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101939228|NCT01065844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939229|NCT01065844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101939230|NCT01065844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101939231|NCT01065844|Antiviral Agents|antiviral agents|mesh-ancestor
101939232|NCT01065844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101939233|NCT00004635|Thalidomide|thalidomide|mesh-list
101939234|NCT00004635|Leuprolide|leuprolide|mesh-list
101939235|NCT00004635|Goserelin|goserelin|mesh-list
101939236|NCT00004635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101659060|NCT05758389|Paclitaxel|paclitaxel|mesh-list
101939237|NCT00004635|Immunologic Factors|immunologic factors|mesh-ancestor
101939238|NCT00004635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939240|NCT00004635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101939241|NCT00004635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101939242|NCT00004635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101939243|NCT00004635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101939244|NCT00004635|Growth Substances|growth substances|mesh-ancestor
101939245|NCT00004635|Growth Inhibitors|growth inhibitors|mesh-ancestor
101939246|NCT00004635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101939247|NCT00004635|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101939248|NCT00004635|Fertility Agents|fertility agents|mesh-ancestor
101939249|NCT00004635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101939250|NCT00004635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101939251|NCT00004563|Cyclophosphamide|cyclophosphamide|mesh-list
101939252|NCT00004563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101939253|NCT00004563|Immunologic Factors|immunologic factors|mesh-ancestor
101939254|NCT00004563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939255|NCT00004563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101939256|NCT00004563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101939257|NCT00004563|Alkylating Agents|alkylating agents|mesh-ancestor
101939258|NCT00004563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939259|NCT00004563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101939260|NCT00004563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101939261|NCT03951051|Olmesartan|olmesartan|mesh-list
101939262|NCT03951051|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101939263|NCT03951051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101939264|NCT03951051|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101939265|NCT03951051|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101939266|NCT03951051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939267|NCT01103115|Calcium, Dietary|calcium, dietary|mesh-list
101939268|NCT01103115|Vitamin D|vitamin d|mesh-list
101939269|NCT01103115|Calcium Carbonate|calcium carbonate|mesh-list
101939270|NCT01103115|Calcium|calcium|mesh-list
101939271|NCT01103115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101939272|NCT01103115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939273|NCT01103115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101939274|NCT01103115|Vitamins|vitamins|mesh-ancestor
101939275|NCT01103115|Micronutrients|micronutrients|mesh-ancestor
101939276|NCT01103115|Antacids|antacids|mesh-ancestor
101939277|NCT01103115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939278|NCT01103115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101939279|NCT01103193|Remifentanil|remifentanil|mesh-list
101939280|NCT01103193|Sevoflurane|sevoflurane|mesh-list
101939281|NCT01103193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101939282|NCT01103193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101939283|NCT01103193|Anesthetics, General|anesthetics, general|mesh-ancestor
101939284|NCT01103193|Anesthetics|anesthetics|mesh-ancestor
101939285|NCT01103193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101939286|NCT01103193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939287|NCT01103193|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101939288|NCT01103193|Narcotics|narcotics|mesh-ancestor
101939289|NCT01103193|Analgesics|analgesics|mesh-ancestor
101939290|NCT01103193|Sensory System Agents|sensory system agents|mesh-ancestor
101939291|NCT01103193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101939292|NCT03949101|Atropine|atropine|mesh-list
101939293|NCT03949101|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101939294|NCT03949101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101939295|NCT03949101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101939296|NCT03949101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101939297|NCT03949101|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101939298|NCT03949101|Autonomic Agents|autonomic agents|mesh-ancestor
101939299|NCT03949101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101939300|NCT03949101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939301|NCT03949101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101939302|NCT03949101|Respiratory System Agents|respiratory system agents|mesh-ancestor
101939303|NCT03949101|Mydriatics|mydriatics|mesh-ancestor
101939304|NCT03949101|Parasympatholytics|parasympatholytics|mesh-ancestor
101939305|NCT03949101|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101939306|NCT03949101|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101939307|NCT03949101|Cholinergic Agents|cholinergic agents|mesh-ancestor
101939308|NCT03949101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101939309|NCT03949101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939310|NCT01096485|Levonorgestrel|levonorgestrel|mesh-list
101939311|NCT01096485|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101939312|NCT01096485|Contraceptive Agents|contraceptive agents|mesh-ancestor
101939313|NCT01096485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101939314|NCT01096485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939315|NCT01096485|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101939316|NCT01096485|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101939317|NCT01096485|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101939319|NCT00003645|Goserelin|goserelin|mesh-list
101939320|NCT00003645|Flutamide|flutamide|mesh-list
101939321|NCT00003645|Bicalutamide|bicalutamide|mesh-list
101939322|NCT00003645|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101939323|NCT00003645|Fertility Agents|fertility agents|mesh-ancestor
101939324|NCT00003645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101234827|NCT01583426|Paclitaxel|paclitaxel|mesh-list
101939325|NCT00003645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939326|NCT00003645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101939327|NCT00003645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101939328|NCT00003645|Androgen Antagonists|androgen antagonists|mesh-ancestor
101939329|NCT00003645|Hormone Antagonists|hormone antagonists|mesh-ancestor
101939330|NCT00003645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101939331|NCT02918968|Flutamide|flutamide|mesh-list
101939332|NCT02918968|Androgens|androgens|mesh-list
101939333|NCT02918968|Hormones|hormones|mesh-ancestor
101939334|NCT02918968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101939335|NCT02918968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939336|NCT02918968|Androgen Antagonists|androgen antagonists|mesh-ancestor
101939337|NCT02918968|Hormone Antagonists|hormone antagonists|mesh-ancestor
101939338|NCT02918968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101939339|NCT02918968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101939340|NCT01065766|Metformin|metformin|mesh-list
101939341|NCT01065766|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101939342|NCT01065766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101939343|NCT01065766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939344|NCT01065766|Incretins|incretins|mesh-ancestor
101939345|NCT01065766|Hormones|hormones|mesh-ancestor
101939346|NCT01065766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101939347|NCT01065766|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101939348|NCT01065766|Protease Inhibitors|protease inhibitors|mesh-ancestor
101939349|NCT01065766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101939350|NCT01065766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939351|NCT03653260|Lidocaine|lidocaine|mesh-list
101939352|NCT03653260|Anesthetics, Local|anesthetics, local|mesh-ancestor
101939353|NCT03653260|Anesthetics|anesthetics|mesh-ancestor
101939354|NCT03653260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101939355|NCT03653260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939356|NCT03653260|Sensory System Agents|sensory system agents|mesh-ancestor
101939357|NCT03653260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101939358|NCT03653260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101939359|NCT03653260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101939360|NCT03653260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101939361|NCT03653260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101939362|NCT03653260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939363|NCT03652792|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
101939364|NCT03652792|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101939365|NCT03652792|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101939366|NCT03652792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939367|NCT04054960|Levodopa|levodopa|mesh-list
101939368|NCT04054960|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101939369|NCT04054960|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101939370|NCT04054960|Dopamine Agents|dopamine agents|mesh-ancestor
101939371|NCT04054960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101939372|NCT04054960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939373|NCT04054960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939374|NCT04055194|Tranexamic Acid|tranexamic acid|mesh-list
101939375|NCT04055194|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101939376|NCT04055194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101939377|NCT04055194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939378|NCT04055194|Hemostatics|hemostatics|mesh-ancestor
101939379|NCT04055194|Coagulants|coagulants|mesh-ancestor
101939380|NCT01103583|Hydroxyurea|hydroxyurea|mesh-list
101939381|NCT01103583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101939382|NCT01103583|Antisickling Agents|antisickling agents|mesh-ancestor
101939383|NCT01103583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387663|NCT00322660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101939384|NCT01103583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939385|NCT01103583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101939387|NCT02530047|Interferon-beta|interferon-beta|mesh-list
101939388|NCT02530047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101939389|NCT02530047|Antiviral Agents|antiviral agents|mesh-ancestor
101939390|NCT02530047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101939391|NCT02530047|Immunologic Factors|immunologic factors|mesh-ancestor
101939392|NCT02530047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939393|NCT02529969|Curcumin|curcumin|mesh-list
101939394|NCT02529969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101939395|NCT02529969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101939396|NCT02529969|Analgesics|analgesics|mesh-ancestor
101939397|NCT02529969|Sensory System Agents|sensory system agents|mesh-ancestor
101939398|NCT02529969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101939399|NCT02529969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939400|NCT02529969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101939401|NCT02529969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101939402|NCT02529969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101939403|NCT02529969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101939404|NCT02529969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939405|NCT01584687|Omalizumab|omalizumab|mesh-list
101939406|NCT01584687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101939407|NCT01584687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101939408|NCT01584687|Respiratory System Agents|respiratory system agents|mesh-ancestor
101939409|NCT01101789|Triclosan|triclosan|mesh-list
101939410|NCT01101789|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101939411|NCT01101789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101939412|NCT01101789|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101939413|NCT01101789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101939414|NCT01101789|Antimetabolites|antimetabolites|mesh-ancestor
101939415|NCT01101789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939416|NCT01101789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101939417|NCT04185220|Mogamulizumab|mogamulizumab|mesh-list
101939418|NCT04185220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101939419|NCT01103739|Simvastatin|simvastatin|mesh-list
101939420|NCT01103739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101939421|NCT01103739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101939422|NCT01103739|Antimetabolites|antimetabolites|mesh-ancestor
101939423|NCT01103739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939424|NCT01103739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101939425|NCT01103739|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101939426|NCT01103739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101939427|NCT04054024|Erenumab|erenumab|mesh-list
101939428|NCT04054024|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
101939429|NCT04054024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939430|NCT04054024|Analgesics|analgesics|mesh-ancestor
101939431|NCT04054024|Sensory System Agents|sensory system agents|mesh-ancestor
101939432|NCT04054024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101939433|NCT04054024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939434|NCT00002931|Paclitaxel|paclitaxel|mesh-list
101939435|NCT00002931|Etoposide|etoposide|mesh-list
101939436|NCT00002931|Carboplatin|carboplatin|mesh-list
101939437|NCT00002931|Ifosfamide|ifosfamide|mesh-list
101617377|NCT00788593|Pancreatin|pancreatin|mesh-list
101939438|NCT00002931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101939439|NCT00002931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101939440|NCT00002931|Tubulin Modulators|tubulin modulators|mesh-ancestor
101939441|NCT00002931|Antimitotic Agents|antimitotic agents|mesh-ancestor
101939442|NCT00002931|Mitosis Modulators|mitosis modulators|mesh-ancestor
101939443|NCT00002931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939444|NCT00002931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101939445|NCT00002931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101939446|NCT00002931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101939447|NCT00002931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101939448|NCT00002931|Alkylating Agents|alkylating agents|mesh-ancestor
101939449|NCT02918266|Scopolamine|scopolamine|mesh-list
101939451|NCT02918266|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101939452|NCT02918266|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101939453|NCT02918266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101939454|NCT02918266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939455|NCT02918266|Cholinergic Agents|cholinergic agents|mesh-ancestor
101939456|NCT02918266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101939457|NCT02918266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939458|NCT02918266|Nootropic Agents|nootropic agents|mesh-ancestor
101939459|NCT02918266|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101939460|NCT02918266|Antiemetics|antiemetics|mesh-ancestor
101939461|NCT02918266|Autonomic Agents|autonomic agents|mesh-ancestor
101939462|NCT02918266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101939463|NCT02918266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101939464|NCT02918266|Mydriatics|mydriatics|mesh-ancestor
101939465|NCT02918266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101939466|NCT02918266|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101939467|NCT02918266|Parasympatholytics|parasympatholytics|mesh-ancestor
101939468|NCT00041067|Docetaxel|docetaxel|mesh-list
101939469|NCT00041067|Trastuzumab|trastuzumab|mesh-list
101939470|NCT00041067|Vinorelbine|vinorelbine|mesh-list
101939471|NCT00041067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101939472|NCT00041067|Tubulin Modulators|tubulin modulators|mesh-ancestor
101939473|NCT00041067|Antimitotic Agents|antimitotic agents|mesh-ancestor
101939474|NCT00041067|Mitosis Modulators|mitosis modulators|mesh-ancestor
101939475|NCT00041067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939476|NCT00041067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101939477|NCT00041067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101939478|NCT01063036|Tenofovir|tenofovir|mesh-list
101939479|NCT01063036|Entecavir|entecavir|mesh-list
101939480|NCT01063036|Antiviral Agents|antiviral agents|mesh-ancestor
101939481|NCT01063036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101939482|NCT01063036|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101939483|NCT01063036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101939484|NCT01063036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101939485|NCT01063036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939486|NCT01063036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101939487|NCT01063036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101939488|NCT03652480|Methylprednisolone|methylprednisolone|mesh-list
101939489|NCT03652480|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101939490|NCT03652480|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101939491|NCT03652480|Prednisolone|prednisolone|mesh-list
101939492|NCT03652480|Prednisolone acetate|prednisolone acetate|mesh-list
101939493|NCT03652480|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101939494|NCT03652480|Prednisolone phosphate|prednisolone phosphate|mesh-list
101939495|NCT03652480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101939496|NCT03652480|Antiemetics|antiemetics|mesh-ancestor
101939497|NCT03652480|Autonomic Agents|autonomic agents|mesh-ancestor
101939498|NCT03652480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101939499|NCT03652480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939500|NCT03652480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101939501|NCT03652480|Glucocorticoids|glucocorticoids|mesh-ancestor
101939502|NCT03652480|Hormones|hormones|mesh-ancestor
101939503|NCT03652480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101939504|NCT03652480|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101939505|NCT03652480|Protective Agents|protective agents|mesh-ancestor
101939506|NCT03652480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101939507|NCT03652480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101939508|NCT03622060|Nicardipine|nicardipine|mesh-list
101939509|NCT03622060|Nitroglycerin|nitroglycerin|mesh-list
101939510|NCT03622060|Vasodilator Agents|vasodilator agents|mesh-ancestor
101939511|NCT03622060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101939512|NCT03622060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101939513|NCT03622060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101939514|NCT03622060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939515|NCT03622060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101939516|NCT03622060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939517|NCT00040365|Amifostine|amifostine|mesh-list
101939518|NCT00040365|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101939519|NCT00040365|Protective Agents|protective agents|mesh-ancestor
101939520|NCT00040365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939521|NCT02974114|Acetaminophen|acetaminophen|mesh-list
101939522|NCT02974114|Caffeine|caffeine|mesh-list
101939523|NCT02974114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101939524|NCT02974114|Analgesics|analgesics|mesh-ancestor
101939525|NCT02974114|Sensory System Agents|sensory system agents|mesh-ancestor
101939526|NCT02974114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101939527|NCT02974114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939528|NCT02974114|Antipyretics|antipyretics|mesh-ancestor
101939529|NCT02974114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101939530|NCT02974114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101939531|NCT02974114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101939532|NCT02974114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939533|NCT02974114|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101939534|NCT02974114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101939535|NCT02974114|Purinergic Agents|purinergic agents|mesh-ancestor
101659380|NCT00859105|Imiquimod|imiquimod|mesh-list
101939536|NCT02974114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101939537|NCT00001959|Pirfenidone|pirfenidone|mesh-list
101939538|NCT00001959|Analgesics|analgesics|mesh-ancestor
101939539|NCT00001959|Sensory System Agents|sensory system agents|mesh-ancestor
101939540|NCT00001959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101939541|NCT00001959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939542|NCT00001959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101939543|NCT00001959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101939544|NCT00001959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101939545|NCT00001959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101939546|NCT00001959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101939547|NCT03950505|Pioglitazone|pioglitazone|mesh-list
101939548|NCT03950505|Alogliptin|alogliptin|mesh-list
101939549|NCT03950505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101939550|NCT03950505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939551|NCT03950505|Incretins|incretins|mesh-ancestor
101939552|NCT03950505|Hormones|hormones|mesh-ancestor
101939553|NCT03950505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101939554|NCT03950505|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101939555|NCT03950505|Protease Inhibitors|protease inhibitors|mesh-ancestor
101939556|NCT03950505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101939557|NCT03950505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939558|NCT00001941|Daclizumab|daclizumab|mesh-list
101939559|NCT00001941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101939560|NCT00001941|Immunologic Factors|immunologic factors|mesh-ancestor
101939561|NCT00001941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939562|NCT01061866|Thalidomide|thalidomide|mesh-list
101251926|NCT03769285|Niacin|niacin|mesh-list
101939563|NCT01061866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101939564|NCT01061866|Immunologic Factors|immunologic factors|mesh-ancestor
101939565|NCT01061866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939566|NCT01061866|Leprostatic Agents|leprostatic agents|mesh-ancestor
101939567|NCT01061866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101939568|NCT01061866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101939569|NCT01061866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101939570|NCT01061866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101939571|NCT01061866|Growth Substances|growth substances|mesh-ancestor
101939572|NCT01061866|Growth Inhibitors|growth inhibitors|mesh-ancestor
101939573|NCT01061866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101939574|NCT03652714|Anesthetics|anesthetics|mesh-list
101939575|NCT03652714|Anesthetics, Local|anesthetics, local|mesh-list
101939576|NCT03652714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101939577|NCT03652714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939578|NCT03652714|Sensory System Agents|sensory system agents|mesh-ancestor
101939579|NCT03652714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101939580|NCT03948477|Pantoprazole|pantoprazole|mesh-list
101939581|NCT03948477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101939582|NCT03948477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101939583|NCT03948477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101939584|NCT03948477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101939585|NCT03948477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939586|NCT03953781|Levetiracetam|levetiracetam|mesh-list
101939587|NCT03953781|Anticonvulsants|anticonvulsants|mesh-ancestor
101939588|NCT03953781|Nootropic Agents|nootropic agents|mesh-ancestor
101939589|NCT01103817|Vitamin D|vitamin d|mesh-list
101939590|NCT01103817|Vitamins|vitamins|mesh-ancestor
101939591|NCT01103817|Micronutrients|micronutrients|mesh-ancestor
101939592|NCT01103817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939593|NCT01103817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101939594|NCT01102101|Remifentanil|remifentanil|mesh-list
101939595|NCT01102101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101939596|NCT01102101|Narcotics|narcotics|mesh-ancestor
101939597|NCT01102101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101939598|NCT01102101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939599|NCT01102101|Analgesics|analgesics|mesh-ancestor
101939600|NCT01102101|Sensory System Agents|sensory system agents|mesh-ancestor
101939601|NCT01102101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101939602|NCT03950271|Capecitabine|capecitabine|mesh-list
101939603|NCT03950271|Oxaliplatin|oxaliplatin|mesh-list
101939604|NCT03950271|Trastuzumab|trastuzumab|mesh-list
101939605|NCT03950271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101939606|NCT03950271|Antimetabolites|antimetabolites|mesh-ancestor
101939607|NCT03950271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939608|NCT03950271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101939609|NCT03950271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101939610|NCT01102335|Telbivudine|telbivudine|mesh-list
101659448|NCT05979961|Cisplatin|cisplatin|mesh-list
101939611|NCT01102335|Antiviral Agents|antiviral agents|mesh-ancestor
101939612|NCT01102335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101939613|NCT01102335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101939614|NCT01102335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101939615|NCT01102335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939616|NCT02973100|Dulaglutide|dulaglutide|mesh-list
101939617|NCT02973100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101939618|NCT02973100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939619|NCT01105611|Ritonavir|ritonavir|mesh-list
101939620|NCT01105611|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101939621|NCT01105611|Raltegravir Potassium|raltegravir potassium|mesh-list
101939622|NCT01105611|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101939623|NCT01105611|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101939624|NCT01105611|Protease Inhibitors|protease inhibitors|mesh-ancestor
101939625|NCT01105611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101939626|NCT01105611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939627|NCT01105611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101939628|NCT01105611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101939629|NCT01105611|Antiviral Agents|antiviral agents|mesh-ancestor
101939630|NCT01105611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101939631|NCT01105611|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101939632|NCT01105611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101939633|NCT01105611|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101939634|NCT01105611|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101939635|NCT05497557|Sotorasib|sotorasib|mesh-list
101939636|NCT05497557|Omeprazole|omeprazole|mesh-list
101939637|NCT05497557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101939638|NCT05497557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101939639|NCT05497557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101939640|NCT05497557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101939641|NCT05497557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939642|NCT05497557|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101939643|NCT05497557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101939644|NCT05497557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101939645|NCT03948321|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101939646|NCT03948321|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101939647|NCT03948321|Dermatologic Agents|dermatologic agents|mesh-ancestor
101939648|NCT05415267|Vaccines|vaccines|mesh-list
101939649|NCT05415267|Immunologic Factors|immunologic factors|mesh-ancestor
101939650|NCT05415267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939651|NCT01482286|Metformin|metformin|mesh-list
101939652|NCT01482286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101939653|NCT01482286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939654|NCT03651934|Iron|iron|mesh-list
101939655|NCT03651934|Selenium|selenium|mesh-list
101939656|NCT03651934|Trace Elements|trace elements|mesh-ancestor
101939657|NCT03651934|Micronutrients|micronutrients|mesh-ancestor
101939658|NCT03651934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939659|NCT03651934|Antioxidants|antioxidants|mesh-ancestor
101939660|NCT03651934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939661|NCT03651934|Protective Agents|protective agents|mesh-ancestor
101939662|NCT02972632|Vortioxetine|vortioxetine|mesh-list
101939663|NCT02972632|Antidepressive Agents|antidepressive agents|mesh-ancestor
101939664|NCT02972632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101939665|NCT02972632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101939666|NCT02972632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101939667|NCT02972632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101939668|NCT02972632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939669|NCT02972632|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101939670|NCT02972632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101939671|NCT02972632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101939672|NCT02972632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939673|NCT02972632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101939674|NCT02972632|Serotonin Agents|serotonin agents|mesh-ancestor
101939675|NCT02972632|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101939676|NCT02972632|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101939677|NCT02972632|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101939678|NCT02972632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101939679|NCT01106001|Levobupivacaine|levobupivacaine|mesh-list
101939680|NCT01106001|Anesthetics, Local|anesthetics, local|mesh-ancestor
101939681|NCT01106001|Anesthetics|anesthetics|mesh-ancestor
101939682|NCT01106001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101939683|NCT01106001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939684|NCT01106001|Sensory System Agents|sensory system agents|mesh-ancestor
101387664|NCT00322660|Autonomic Agents|autonomic agents|mesh-ancestor
101939685|NCT01106001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101659518|NCT05979415|Emetics|emetics|mesh-ancestor
101939686|NCT01327521|Cisplatin|cisplatin|mesh-list
101939687|NCT01327521|Gemcitabine|gemcitabine|mesh-list
101939688|NCT01327521|Doxorubicin|doxorubicin|mesh-list
101939689|NCT01327521|Fluorouracil|fluorouracil|mesh-list
101939690|NCT01327521|Epirubicin|epirubicin|mesh-list
101939691|NCT01327521|Mitomycins|mitomycins|mesh-list
101939692|NCT01327521|Mitomycin|mitomycin|mesh-list
101939693|NCT01327521|Maleic acid|maleic acid|mesh-list
101939694|NCT01327521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101939695|NCT01327521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101939696|NCT01327521|Antimetabolites|antimetabolites|mesh-ancestor
101939697|NCT01327521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939698|NCT01327521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101939699|NCT01327521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101939700|NCT01327521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101939701|NCT01327521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101939702|NCT01327521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101939703|NCT01327521|Immunologic Factors|immunologic factors|mesh-ancestor
101939704|NCT01327521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939705|NCT01327521|Alkylating Agents|alkylating agents|mesh-ancestor
101939706|NCT01327521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101939707|NCT04899921|Nivolumab|nivolumab|mesh-list
101939708|NCT04899921|Ipilimumab|ipilimumab|mesh-list
101939709|NCT04899921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101939710|NCT04899921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101939711|NCT04899921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101939712|NCT04899921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939714|NCT01104519|Nicotinic Acids|nicotinic acids|mesh-list
101939715|NCT01104519|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101939716|NCT01104519|Antimetabolites|antimetabolites|mesh-ancestor
101939717|NCT01104519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939718|NCT01104519|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101939719|NCT01104519|Vasodilator Agents|vasodilator agents|mesh-ancestor
101939720|NCT01104519|Vitamin B Complex|vitamin b complex|mesh-ancestor
101939721|NCT01104519|Vitamins|vitamins|mesh-ancestor
101939722|NCT01104519|Micronutrients|micronutrients|mesh-ancestor
101939723|NCT01104519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939724|NCT03944733|Iron|iron|mesh-list
101939725|NCT03944733|Trace Elements|trace elements|mesh-ancestor
101939726|NCT03944733|Micronutrients|micronutrients|mesh-ancestor
101939727|NCT03944733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939728|NCT01060384|Lenalidomide|lenalidomide|mesh-list
101939729|NCT01060384|Ofatumumab|ofatumumab|mesh-list
101939730|NCT01060384|Immunologic Factors|immunologic factors|mesh-ancestor
101939731|NCT01060384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939732|NCT01060384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101939733|NCT01060384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101939734|NCT01060384|Growth Substances|growth substances|mesh-ancestor
101939735|NCT01060384|Growth Inhibitors|growth inhibitors|mesh-ancestor
101939736|NCT01060384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101939737|NCT01060150|Methylphenidate|methylphenidate|mesh-list
101939738|NCT01060150|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101939739|NCT01060150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234942|NCT01589432|Lidocaine|lidocaine|mesh-list
101939740|NCT01060150|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101939741|NCT01060150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101939742|NCT01060150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101939743|NCT01060150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939744|NCT01060150|Dopamine Agents|dopamine agents|mesh-ancestor
101939745|NCT01060150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101939746|NCT03863223|Docetaxel|docetaxel|mesh-list
101939747|NCT03863223|Trastuzumab|trastuzumab|mesh-list
101939748|NCT03863223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101939749|NCT03863223|Tubulin Modulators|tubulin modulators|mesh-ancestor
101939750|NCT03863223|Antimitotic Agents|antimitotic agents|mesh-ancestor
101939751|NCT03863223|Mitosis Modulators|mitosis modulators|mesh-ancestor
101939752|NCT03863223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939753|NCT03863223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101939754|NCT01104597|Nitroglycerin|nitroglycerin|mesh-list
101939755|NCT01104597|Vasodilator Agents|vasodilator agents|mesh-ancestor
101939756|NCT02970292|Pimavanserin|pimavanserin|mesh-list
101939757|NCT02970292|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101939758|NCT02970292|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101939759|NCT02970292|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101939760|NCT02970292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101939761|NCT02970292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101939762|NCT02970292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939763|NCT02970292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101939764|NCT02970292|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101939765|NCT02970292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101939766|NCT02970292|Serotonin Agents|serotonin agents|mesh-ancestor
101939767|NCT02970292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101939768|NCT02970292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939769|NCT03944655|Anesthetics|anesthetics|mesh-list
101939770|NCT03944655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101939771|NCT03944655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939772|NCT05276895|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
101939773|NCT05276895|Quercetin|quercetin|mesh-list
101939774|NCT05276895|Antioxidants|antioxidants|mesh-ancestor
101939775|NCT05276895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939776|NCT05276895|Protective Agents|protective agents|mesh-ancestor
101939777|NCT05276895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939778|NCT05276895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101939779|NCT02971228|Insulin Lispro|insulin lispro|mesh-list
101939780|NCT02971228|Glucagon|glucagon|mesh-list
101939781|NCT02971228|Pancrelipase|pancrelipase|mesh-list
101939782|NCT02971228|Pancreatin|pancreatin|mesh-list
101939783|NCT02971228|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101939784|NCT02971228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101939785|NCT02971228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939786|NCT02971228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101939787|NCT02971228|Hormones|hormones|mesh-ancestor
101939788|NCT02971228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101939789|NCT02971228|Incretins|incretins|mesh-ancestor
101939790|NCT01060072|Loteprednol Etabonate|loteprednol etabonate|mesh-list
101939791|NCT01060072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101939792|NCT03741075|Tranexamic Acid|tranexamic acid|mesh-list
101939793|NCT03741075|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101939794|NCT03741075|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101939795|NCT03741075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939796|NCT03741075|Hemostatics|hemostatics|mesh-ancestor
101939797|NCT03741075|Coagulants|coagulants|mesh-ancestor
101939798|NCT01328223|Sorafenib|sorafenib|mesh-list
101939799|NCT01328223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101939800|NCT01328223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101939801|NCT01328223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101939802|NCT01328223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939803|NCT01104987|Alendronate|alendronate|mesh-list
101939804|NCT01104987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101939805|NCT01104987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939806|NCT01106235|Aldesleukin|aldesleukin|mesh-list
101939807|NCT01106235|Cyclophosphamide|cyclophosphamide|mesh-list
101939808|NCT01106235|Interleukin-2|interleukin-2|mesh-list
101939809|NCT01106235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101939810|NCT01106235|Immunologic Factors|immunologic factors|mesh-ancestor
101939811|NCT01106235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939812|NCT01106235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101939813|NCT01106235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101939814|NCT01106235|Alkylating Agents|alkylating agents|mesh-ancestor
101939815|NCT01106235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939816|NCT01106235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101939817|NCT01106235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101939818|NCT01106235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101939819|NCT01106235|Analgesics|analgesics|mesh-ancestor
101939820|NCT01106235|Sensory System Agents|sensory system agents|mesh-ancestor
101939821|NCT01106235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101939822|NCT01106235|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101939823|NCT01106235|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101939824|NCT01106235|Antiviral Agents|antiviral agents|mesh-ancestor
101939825|NCT01106235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101939826|NCT02969590|Leuprolide|leuprolide|mesh-list
101939827|NCT02969590|Norethindrone|norethindrone|mesh-list
101939828|NCT02969590|Estradiol|estradiol|mesh-list
101939829|NCT02969590|Estrogens|estrogens|mesh-list
101939830|NCT02969590|Progesterone|progesterone|mesh-list
101939831|NCT02969590|Progestins|progestins|mesh-list
101939832|NCT02969590|Hormones|hormones|mesh-ancestor
101939833|NCT02969590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101939834|NCT02969590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939835|NCT02969590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101939836|NCT02969590|Contraceptive Agents|contraceptive agents|mesh-ancestor
101939837|NCT02969590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101939838|NCT02969590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101939839|NCT02969590|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101939840|NCT02969590|Fertility Agents|fertility agents|mesh-ancestor
101939841|NCT02969590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101939842|NCT02969590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101939843|NCT02969590|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101939844|NCT02969590|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101939845|NCT02969590|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101939846|NCT03650998|Ropivacaine|ropivacaine|mesh-list
101939847|NCT03650998|Anesthetics, Local|anesthetics, local|mesh-ancestor
101939848|NCT03650998|Anesthetics|anesthetics|mesh-ancestor
101939849|NCT03650998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101939850|NCT03650998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939851|NCT03650998|Sensory System Agents|sensory system agents|mesh-ancestor
101939852|NCT03650998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101939853|NCT04053400|Ketamine|ketamine|mesh-list
101939854|NCT04053400|Analgesics|analgesics|mesh-ancestor
101939855|NCT04053400|Sensory System Agents|sensory system agents|mesh-ancestor
101939856|NCT04053400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101939857|NCT04053400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939858|NCT04053400|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101939859|NCT04053400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101939860|NCT04053400|Anesthetics, General|anesthetics, general|mesh-ancestor
101939861|NCT04053400|Anesthetics|anesthetics|mesh-ancestor
101939862|NCT04053400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101939863|NCT04053400|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101939864|NCT04053400|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101939865|NCT04053400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101939866|NCT04053400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939867|NCT03345849|Upadacitinib|upadacitinib|mesh-list
101939868|NCT03345849|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101939869|NCT03345849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101939870|NCT03345849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101939871|NCT03345849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939872|NCT03345849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101939873|NCT01109043|Bisoprolol|bisoprolol|mesh-list
101939874|NCT01109043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101939875|NCT01109043|Sympatholytics|sympatholytics|mesh-ancestor
101959661|NCT02253940|Ritonavir|ritonavir|mesh-list
101939876|NCT01109043|Autonomic Agents|autonomic agents|mesh-ancestor
101939877|NCT01109043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101939878|NCT01109043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939879|NCT01109043|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101939880|NCT01109043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101939881|NCT01109043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101939890|NCT01109121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101939891|NCT01109121|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101939892|NCT01109121|Antioxidants|antioxidants|mesh-ancestor
101939893|NCT01109121|Protective Agents|protective agents|mesh-ancestor
101939894|NCT01109121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939895|NCT01106547|Methylprednisolone|methylprednisolone|mesh-list
101939896|NCT01106547|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101939897|NCT01106547|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101939898|NCT01106547|Prednisolone|prednisolone|mesh-list
101939899|NCT01106547|Prednisolone acetate|prednisolone acetate|mesh-list
101939900|NCT01106547|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101939901|NCT01106547|Prednisolone phosphate|prednisolone phosphate|mesh-list
101939902|NCT01106547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101939903|NCT01106547|Antiemetics|antiemetics|mesh-ancestor
101939904|NCT01106547|Autonomic Agents|autonomic agents|mesh-ancestor
101939905|NCT01106547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101939906|NCT01106547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939907|NCT01106547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101939908|NCT01106547|Glucocorticoids|glucocorticoids|mesh-ancestor
101939909|NCT01106547|Hormones|hormones|mesh-ancestor
101939910|NCT01106547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101939911|NCT01106547|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101939912|NCT01106547|Protective Agents|protective agents|mesh-ancestor
101939913|NCT01106547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101939914|NCT01106547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101939915|NCT01105299|Anastrozole|anastrozole|mesh-list
101939916|NCT01105299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101939917|NCT01105299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101939918|NCT01105299|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101939919|NCT01105299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101939920|NCT01105299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101939921|NCT01105299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939922|NCT01105299|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101939923|NCT01105299|Hormone Antagonists|hormone antagonists|mesh-ancestor
101939924|NCT01105299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101939925|NCT01105299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939926|NCT03947229|Clopidogrel|clopidogrel|mesh-list
101939927|NCT03947229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101939928|NCT03947229|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101939929|NCT03947229|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101939930|NCT03947229|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101939931|NCT03947229|Purinergic Agents|purinergic agents|mesh-ancestor
101939932|NCT03947229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101939933|NCT03947229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939934|NCT03947229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939935|NCT03011307|Oxytocin|oxytocin|mesh-list
101939936|NCT03011307|Oxytocics|oxytocics|mesh-ancestor
101939937|NCT03011307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101939938|NCT03011307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939939|NCT01327755|Selenium|selenium|mesh-list
101939940|NCT01327755|Antioxidants|antioxidants|mesh-ancestor
101939941|NCT01327755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939942|NCT01327755|Protective Agents|protective agents|mesh-ancestor
101939943|NCT01327755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939944|NCT01327755|Trace Elements|trace elements|mesh-ancestor
101939945|NCT01327755|Micronutrients|micronutrients|mesh-ancestor
101939954|NCT04537923|Insulin|insulin|mesh-list
101939955|NCT04537923|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101939956|NCT04537923|Insulin Glargine|insulin glargine|mesh-list
101939958|NCT04537923|Tirzepatide|tirzepatide|mesh-list
101939959|NCT04537923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101939960|NCT04537923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939961|NCT04537923|Incretins|incretins|mesh-ancestor
101939962|NCT04537923|Hormones|hormones|mesh-ancestor
101939963|NCT04537923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101939964|NCT01107093|Ulipristal acetate|ulipristal acetate|mesh-list
101939965|NCT01107093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101939966|NCT01107093|Contraceptive Agents|contraceptive agents|mesh-ancestor
101939967|NCT01107093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101939968|NCT01107093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939969|NCT01107093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101939970|NCT01118793|Clopidogrel|clopidogrel|mesh-list
101939971|NCT01118793|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101939972|NCT01118793|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101939973|NCT01118793|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101939974|NCT01118793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101939975|NCT01118793|Purinergic Agents|purinergic agents|mesh-ancestor
101939976|NCT01118793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101939977|NCT01118793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939978|NCT01118793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939979|NCT00127335|Atorvastatin|atorvastatin|mesh-list
101939980|NCT00127335|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101939981|NCT00127335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101939982|NCT00127335|Antimetabolites|antimetabolites|mesh-ancestor
101939983|NCT00127335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101939984|NCT00127335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101939985|NCT00127335|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101939986|NCT00127335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101939987|NCT01109511|Oxycodone|oxycodone|mesh-list
101939988|NCT01109511|Naloxone|naloxone|mesh-list
101939989|NCT01109511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101939990|NCT01109511|Narcotics|narcotics|mesh-ancestor
101939991|NCT01109511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101939992|NCT01109511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101939993|NCT01109511|Analgesics|analgesics|mesh-ancestor
101939994|NCT01109511|Sensory System Agents|sensory system agents|mesh-ancestor
101939995|NCT01109511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101939996|NCT01109511|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101939997|NCT01112085|Ranibizumab|ranibizumab|mesh-list
101939998|NCT01112085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101939999|NCT01112085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101940000|NCT01112085|Growth Substances|growth substances|mesh-ancestor
101940001|NCT01112085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940002|NCT01112085|Growth Inhibitors|growth inhibitors|mesh-ancestor
101940003|NCT01112085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101940004|NCT01328301|Methamphetamine|methamphetamine|mesh-list
101940005|NCT01328301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101940006|NCT01328301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940007|NCT01328301|Sympathomimetics|sympathomimetics|mesh-ancestor
101940008|NCT01328301|Autonomic Agents|autonomic agents|mesh-ancestor
101940009|NCT01328301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101940010|NCT01328301|Dopamine Agents|dopamine agents|mesh-ancestor
101940011|NCT01328301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101940012|NCT01328301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940013|NCT01328301|Adrenergic Agents|adrenergic agents|mesh-ancestor
101940014|NCT01328301|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101940015|NCT01328301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101234982|NCT01590199|Everolimus|everolimus|mesh-list
101940016|NCT01328301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101940017|NCT01328301|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101940018|NCT01328457|Paromomycin|paromomycin|mesh-list
101940019|NCT01328457|Neomycin|neomycin|mesh-list
101940020|NCT01328457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101940021|NCT01328457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101940022|NCT01328457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101940023|NCT01328457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101940024|NCT01328457|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101940025|NCT01328457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101940026|NCT01328457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940027|NCT01109823|Levofloxacin|levofloxacin|mesh-list
101940028|NCT01109823|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101940029|NCT01109823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101940030|NCT01109823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101940031|NCT01109823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101940032|NCT01109823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101940033|NCT01109823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101940034|NCT01109823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940035|NCT01109823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101940036|NCT01109823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101940037|NCT01109823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101940039|NCT03943407|Cinnamaldehyde|cinnamaldehyde|mesh-list
101940040|NCT03943407|Doxepin|doxepin|mesh-list
101940041|NCT03943407|Menthol|menthol|mesh-list
101940042|NCT03943407|Histamine|histamine|mesh-list
101940043|NCT03943407|Antipruritics|antipruritics|mesh-ancestor
101940044|NCT03943407|Dermatologic Agents|dermatologic agents|mesh-ancestor
101940045|NCT03943407|Histamine Agonists|histamine agonists|mesh-ancestor
101940046|NCT03943407|Histamine Agents|histamine agents|mesh-ancestor
101940047|NCT03943407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101940048|NCT03943407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940049|NCT03943407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940050|NCT03943407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101940051|NCT03943407|Immunologic Factors|immunologic factors|mesh-ancestor
101940052|NCT03943407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101940053|NCT03943407|Interferon Inducers|interferon inducers|mesh-ancestor
101940054|NCT03943407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101940055|NCT03943407|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101940056|NCT03943407|Protective Agents|protective agents|mesh-ancestor
101940057|NCT03943407|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101940058|NCT03943407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101940059|NCT03943407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101940060|NCT03943407|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101940061|NCT03943407|Antidepressive Agents|antidepressive agents|mesh-ancestor
101940062|NCT03943407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101940063|NCT03943407|Histamine Antagonists|histamine antagonists|mesh-ancestor
101940065|NCT01209351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101940066|NCT01209351|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101940067|NCT01209351|Protective Agents|protective agents|mesh-ancestor
101940068|NCT01209351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940069|NCT02529579|Gemcitabine|gemcitabine|mesh-list
101940070|NCT02529579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101940071|NCT02529579|Antimetabolites|antimetabolites|mesh-ancestor
101940072|NCT02529579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940073|NCT02529579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101940074|NCT01209429|Hormones|hormones|mesh-list
101940075|NCT01209429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101940076|NCT01209429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940077|NCT01110291|Docetaxel|docetaxel|mesh-list
101940078|NCT01110291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101940079|NCT01110291|Tubulin Modulators|tubulin modulators|mesh-ancestor
101940080|NCT01110291|Antimitotic Agents|antimitotic agents|mesh-ancestor
101940081|NCT01110291|Mitosis Modulators|mitosis modulators|mesh-ancestor
101940082|NCT01110291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940083|NCT01207947|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101940084|NCT01207947|Vasodilator Agents|vasodilator agents|mesh-ancestor
101940085|NCT01207947|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101940086|NCT01207947|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101940087|NCT01207947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101940088|NCT01207947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940089|NCT01207947|Urological Agents|urological agents|mesh-ancestor
101940090|NCT01107639|Docetaxel|docetaxel|mesh-list
101940091|NCT01107639|Cetuximab|cetuximab|mesh-list
101940092|NCT01107639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101940093|NCT01107639|Tubulin Modulators|tubulin modulators|mesh-ancestor
101940094|NCT01107639|Antimitotic Agents|antimitotic agents|mesh-ancestor
101940095|NCT01107639|Mitosis Modulators|mitosis modulators|mesh-ancestor
101940096|NCT01107639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940097|NCT01107639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101940098|NCT03942861|Methylprednisolone|methylprednisolone|mesh-list
101940099|NCT03942861|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101940100|NCT03942861|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101940101|NCT03942861|Prednisolone|prednisolone|mesh-list
101940102|NCT03942861|Prednisolone acetate|prednisolone acetate|mesh-list
101940103|NCT03942861|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101940105|NCT03942861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101940106|NCT03942861|Antiemetics|antiemetics|mesh-ancestor
101940107|NCT03942861|Autonomic Agents|autonomic agents|mesh-ancestor
101940108|NCT03942861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101940109|NCT03942861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940110|NCT03942861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101940111|NCT03942861|Glucocorticoids|glucocorticoids|mesh-ancestor
101940112|NCT03942861|Hormones|hormones|mesh-ancestor
101940113|NCT03942861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101940114|NCT03942861|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101940115|NCT03942861|Protective Agents|protective agents|mesh-ancestor
101940116|NCT03942861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101940117|NCT03942861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101940118|NCT01107951|Dexamethasone|dexamethasone|mesh-list
101940119|NCT01107951|Rituximab|rituximab|mesh-list
101940120|NCT01107951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101940121|NCT01107951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101940122|NCT01107951|Immunologic Factors|immunologic factors|mesh-ancestor
101940123|NCT01107951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940124|NCT01107951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101940125|NCT01107951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101940126|NCT01107951|Antiemetics|antiemetics|mesh-ancestor
101940127|NCT01107951|Autonomic Agents|autonomic agents|mesh-ancestor
101940128|NCT01107951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101940129|NCT01107951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101940130|NCT01107951|Glucocorticoids|glucocorticoids|mesh-ancestor
101940131|NCT01107951|Hormones|hormones|mesh-ancestor
101940132|NCT01107951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101940133|NCT01107951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101940134|NCT01108029|Memantine|memantine|mesh-list
101940135|NCT01108029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101940136|NCT01108029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101940137|NCT01108029|Dopamine Agents|dopamine agents|mesh-ancestor
101940138|NCT01108029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101940139|NCT01108029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940140|NCT01108029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940141|NCT01108029|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101940142|NCT01108029|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101940144|NCT03941925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101940145|NCT01110603|Paclitaxel|paclitaxel|mesh-list
101940146|NCT01110603|Carboplatin|carboplatin|mesh-list
101940147|NCT01110603|Doxorubicin|doxorubicin|mesh-list
101940148|NCT01110603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101940149|NCT01110603|Niraparib|niraparib|mesh-list
101940150|NCT01110603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101940151|NCT01110603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101940152|NCT01110603|Tubulin Modulators|tubulin modulators|mesh-ancestor
101940153|NCT01110603|Antimitotic Agents|antimitotic agents|mesh-ancestor
101940154|NCT01110603|Mitosis Modulators|mitosis modulators|mesh-ancestor
101940155|NCT01110603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940156|NCT01110603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101940157|NCT01110603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101940158|NCT01110603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101940159|NCT01110603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101940160|NCT01110603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101940161|NCT04258683|Pembrolizumab|pembrolizumab|mesh-list
101940162|NCT04258683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101940163|NCT04258683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101940164|NCT04258683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101940165|NCT04258683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940166|NCT01112787|Tazarotene|tazarotene|mesh-list
101940167|NCT01112787|Dermatologic Agents|dermatologic agents|mesh-ancestor
101940168|NCT01112787|Keratolytic Agents|keratolytic agents|mesh-ancestor
101940169|NCT01108107|Capecitabine|capecitabine|mesh-list
101940170|NCT01108107|Oxaliplatin|oxaliplatin|mesh-list
101940171|NCT01108107|Panitumumab|panitumumab|mesh-list
101940172|NCT01108107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101940173|NCT01108107|Antimetabolites|antimetabolites|mesh-ancestor
101940174|NCT01108107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940175|NCT01108107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101940176|NCT01108107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101940177|NCT01111227|Propofol|propofol|mesh-list
101940178|NCT01111227|Isoflurane|isoflurane|mesh-list
101940179|NCT01111227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101940181|NCT01111227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101959689|NCT05203432|Mydriatics|mydriatics|mesh-ancestor
101940183|NCT01111227|Anesthetics, General|anesthetics, general|mesh-ancestor
101940184|NCT01111227|Anesthetics|anesthetics|mesh-ancestor
101940185|NCT01111227|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101940186|NCT01111383|Tobramycin|tobramycin|mesh-list
101940187|NCT01111383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101940188|NCT01111383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101940189|NCT01208649|Exenatide|exenatide|mesh-list
101940190|NCT01208649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101940191|NCT01208649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940192|NCT01208649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101940193|NCT01208649|Incretins|incretins|mesh-ancestor
101940194|NCT01208649|Hormones|hormones|mesh-ancestor
101940195|NCT01208649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101940196|NCT01211847|Diazoxide|diazoxide|mesh-list
101940197|NCT01211847|Choline|choline|mesh-list
101940198|NCT01211847|Lipotropic Agents|lipotropic agents|mesh-ancestor
101940199|NCT01211847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101940200|NCT01211847|Antimetabolites|antimetabolites|mesh-ancestor
101940201|NCT01211847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940202|NCT01211847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101940203|NCT01211847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101940204|NCT01211847|Nootropic Agents|nootropic agents|mesh-ancestor
101940205|NCT01211847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101940206|NCT01211847|Vasodilator Agents|vasodilator agents|mesh-ancestor
101940207|NCT01210287|Lamivudine|lamivudine|mesh-list
101940208|NCT01210287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
101235224|NCT01591889|Tinidazole|tinidazole|mesh-list
101940209|NCT01210287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101940210|NCT01210287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101940211|NCT01210287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940212|NCT01210287|Antiviral Agents|antiviral agents|mesh-ancestor
101940213|NCT01210287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101940214|NCT01210287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101940215|NCT01210287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101940216|NCT01211925|Aspirin|aspirin|mesh-list
101940217|NCT01211925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101940218|NCT01211925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101940219|NCT01211925|Analgesics|analgesics|mesh-ancestor
101940220|NCT01211925|Sensory System Agents|sensory system agents|mesh-ancestor
101940221|NCT01211925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101940222|NCT01211925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940223|NCT01211925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101940224|NCT01211925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101940225|NCT01211925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101940226|NCT01211925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101940227|NCT01211925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940228|NCT01211925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101940229|NCT01211925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101940230|NCT01211925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101940231|NCT01211925|Antipyretics|antipyretics|mesh-ancestor
101940232|NCT01114425|Raltegravir Potassium|raltegravir potassium|mesh-list
101940233|NCT01114425|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101940234|NCT01114425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101940235|NCT01114425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101940236|NCT01114425|Antiviral Agents|antiviral agents|mesh-ancestor
101940237|NCT01114425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101940238|NCT01114425|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101940239|NCT01114425|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101940240|NCT01114425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101940241|NCT01114425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940242|NCT01114425|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101940243|NCT01114425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101940244|NCT01328145|Aspirin|aspirin|mesh-list
101940245|NCT01328145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101940246|NCT01328145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101940248|NCT01328145|Sensory System Agents|sensory system agents|mesh-ancestor
101940249|NCT01328145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101940250|NCT01328145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940251|NCT01328145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101940252|NCT01328145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101940253|NCT01328145|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101940254|NCT01328145|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101940255|NCT01328145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940256|NCT01328145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101940257|NCT01328145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101940258|NCT01328145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101940259|NCT01328145|Antipyretics|antipyretics|mesh-ancestor
101940260|NCT01210521|Vitamin D|vitamin d|mesh-list
101940261|NCT01210521|Vitamins|vitamins|mesh-ancestor
101940262|NCT01210521|Micronutrients|micronutrients|mesh-ancestor
101940263|NCT01210521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940264|NCT01210521|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101940265|NCT01210599|Pamidronate|pamidronate|mesh-list
101940266|NCT01210599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101940267|NCT01210599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940268|NCT03944889|Capsaicin|capsaicin|mesh-list
101940269|NCT03944889|Antipruritics|antipruritics|mesh-ancestor
101940270|NCT03944889|Dermatologic Agents|dermatologic agents|mesh-ancestor
101940271|NCT03944889|Sensory System Agents|sensory system agents|mesh-ancestor
101940272|NCT03944889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101940273|NCT03944889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940274|NCT01210677|Prednisone|prednisone|mesh-list
101940275|NCT01210677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101940276|NCT01210677|Glucocorticoids|glucocorticoids|mesh-ancestor
101940277|NCT01210677|Hormones|hormones|mesh-ancestor
101940278|NCT01210677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101940279|NCT01210677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940280|NCT01210677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101940281|NCT01210677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101940282|NCT01210755|Rivaroxaban|rivaroxaban|mesh-list
101940283|NCT01210755|Dabigatran|dabigatran|mesh-list
101940284|NCT01210755|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101940285|NCT01210755|Antithrombins|antithrombins|mesh-ancestor
101940286|NCT01210755|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101940287|NCT01210755|Protease Inhibitors|protease inhibitors|mesh-ancestor
101940288|NCT01210755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101235375|NCT01592318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101940289|NCT01210755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940290|NCT01210755|Anticoagulants|anticoagulants|mesh-ancestor
101940291|NCT01210911|Metformin|metformin|mesh-list
101940292|NCT01210911|Gemcitabine|gemcitabine|mesh-list
101940293|NCT01210911|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101940294|NCT01210911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101940295|NCT01210911|Antimetabolites|antimetabolites|mesh-ancestor
101940296|NCT01210911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940297|NCT01210911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101940298|NCT01210911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101940299|NCT01210911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940300|NCT01210911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101940301|NCT01210911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101940302|NCT01115049|Chlorhexidine|chlorhexidine|mesh-list
101940303|NCT01115049|Hexetidine|hexetidine|mesh-list
101940304|NCT01115049|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101940305|NCT01115049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101940306|NCT01115049|Disinfectants|disinfectants|mesh-ancestor
101940307|NCT01115049|Antifungal Agents|antifungal agents|mesh-ancestor
101940308|NCT03941535|Vitamin K|vitamin k|mesh-list
101940309|NCT03941535|Vitamins|vitamins|mesh-ancestor
101940310|NCT03941535|Micronutrients|micronutrients|mesh-ancestor
101940311|NCT03941535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940312|NCT03941535|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101940313|NCT03941535|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101940314|NCT03941535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940315|NCT03941535|Hemostatics|hemostatics|mesh-ancestor
101940316|NCT03941535|Coagulants|coagulants|mesh-ancestor
101940317|NCT01115127|Inositol|inositol|mesh-list
101940318|NCT01115127|Melatonin|melatonin|mesh-list
101940319|NCT01115127|Antioxidants|antioxidants|mesh-ancestor
101940320|NCT01115127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940321|NCT01115127|Protective Agents|protective agents|mesh-ancestor
101940322|NCT01115127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940323|NCT01115127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101940324|NCT01115127|Vitamin B Complex|vitamin b complex|mesh-ancestor
101940325|NCT01115127|Vitamins|vitamins|mesh-ancestor
101940326|NCT01115127|Micronutrients|micronutrients|mesh-ancestor
101940327|NCT01211223|Amoxicillin|amoxicillin|mesh-list
101940328|NCT01211223|Metronidazole|metronidazole|mesh-list
101940329|NCT01211223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101940330|NCT01211223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101940331|NCT01211223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101940332|NCT01211223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101940333|NCT01113489|Beclomethasone|beclomethasone|mesh-list
101940334|NCT01113489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101940335|NCT01113489|Glucocorticoids|glucocorticoids|mesh-ancestor
101940336|NCT01113489|Hormones|hormones|mesh-ancestor
101940337|NCT01113489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101940338|NCT01113489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940339|NCT01113489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101940340|NCT01113489|Respiratory System Agents|respiratory system agents|mesh-ancestor
101940341|NCT01115439|Artesunate|artesunate|mesh-list
101940342|NCT01115439|Pyrimethamine|pyrimethamine|mesh-list
101940343|NCT01115439|Sulfadoxine|sulfadoxine|mesh-list
101940344|NCT01115439|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101940345|NCT01115439|Antimalarials|antimalarials|mesh-ancestor
101940346|NCT01115439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101940347|NCT01115439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101940348|NCT01115439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101940349|NCT01115439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101940350|NCT01115439|Antiviral Agents|antiviral agents|mesh-ancestor
101940351|NCT01115439|Schistosomicides|schistosomicides|mesh-ancestor
101940352|NCT01115439|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101940353|NCT01115439|Anthelmintics|anthelmintics|mesh-ancestor
101940354|NCT01115439|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101940355|NCT01115439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101940356|NCT01115439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940357|NCT01115439|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101940358|NCT01212315|Triclosan|triclosan|mesh-list
101940359|NCT01212315|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101940360|NCT01212315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101940361|NCT01212315|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101940362|NCT01212315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101940363|NCT01212315|Antimetabolites|antimetabolites|mesh-ancestor
101940364|NCT01212315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940365|NCT01212315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101940367|NCT03938259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101940368|NCT03938259|Narcotics|narcotics|mesh-ancestor
101940369|NCT03938259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101940370|NCT03938259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940371|NCT03938259|Analgesics|analgesics|mesh-ancestor
101940372|NCT03938259|Sensory System Agents|sensory system agents|mesh-ancestor
101940373|NCT03938259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101940374|NCT03938259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101940375|NCT03938259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101940376|NCT03938259|Anesthetics, General|anesthetics, general|mesh-ancestor
101940377|NCT03938259|Anesthetics|anesthetics|mesh-ancestor
101940378|NCT03939663|Misoprostol|misoprostol|mesh-list
101940379|NCT03939663|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101940380|NCT03939663|Abortifacient Agents|abortifacient agents|mesh-ancestor
101940381|NCT03939663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101940382|NCT03939663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940383|NCT03939663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101940384|NCT03939663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101940385|NCT03939663|Oxytocics|oxytocics|mesh-ancestor
101940386|NCT01213407|Temozolomide|temozolomide|mesh-list
101940387|NCT01213407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101940388|NCT01213407|Alkylating Agents|alkylating agents|mesh-ancestor
101940389|NCT01213407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940390|NCT01213407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101940391|NCT01211457|Decitabine|decitabine|mesh-list
101940392|NCT01211457|Venetoclax|venetoclax|mesh-list
101940393|NCT01211457|Sapacitabine|sapacitabine|mesh-list
101940394|NCT01211457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101940395|NCT01211457|Antimetabolites|antimetabolites|mesh-ancestor
101940396|NCT01211457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940397|NCT01211457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101940398|NCT01211457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101940399|NCT01213563|Insulin|insulin|mesh-list
101940400|NCT01213563|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101940401|NCT01213563|Insulin, neutral|insulin, neutral|mesh-list
101940402|NCT01213563|Insulin, Regular, Pork|insulin, regular, pork|mesh-list
101940403|NCT01213563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101940404|NCT01213563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940405|NCT01115985|Atorvastatin|atorvastatin|mesh-list
101940406|NCT01115985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101940407|NCT01115985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101940409|NCT01115985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940410|NCT01115985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101940411|NCT01115985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101235422|NCT01593046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101940412|NCT01115985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101940413|NCT01116063|Iloprost|iloprost|mesh-list
101940414|NCT01116063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101940415|NCT01116063|Vasodilator Agents|vasodilator agents|mesh-ancestor
101940416|NCT01116219|Bevacizumab|bevacizumab|mesh-list
101940417|NCT01116219|Pemetrexed|pemetrexed|mesh-list
101940418|NCT01116219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101940419|NCT01116219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101940420|NCT01116219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101940421|NCT01116219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101940422|NCT01116219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101940423|NCT01116219|Growth Substances|growth substances|mesh-ancestor
101940424|NCT01116219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940425|NCT01116219|Growth Inhibitors|growth inhibitors|mesh-ancestor
101940426|NCT01116219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101940427|NCT01116219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940428|NCT01116219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101940429|NCT01116219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101940430|NCT01116219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101940431|NCT01213719|Betaine|betaine|mesh-list
101940432|NCT01213719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101940433|NCT01213719|Lipotropic Agents|lipotropic agents|mesh-ancestor
101940434|NCT01213719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101940435|NCT01213719|Antimetabolites|antimetabolites|mesh-ancestor
101940436|NCT01213719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940437|NCT01213719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101940438|NCT01114191|Ketoconazole|ketoconazole|mesh-list
101940439|NCT01114191|Antifungal Agents|antifungal agents|mesh-ancestor
101660266|NCT05231629|Melphalan|melphalan|mesh-list
101940440|NCT01114191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101940441|NCT01114191|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101940442|NCT01114191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101940443|NCT01114191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101940444|NCT01114191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940445|NCT01114191|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101940446|NCT01114191|Hormone Antagonists|hormone antagonists|mesh-ancestor
101940447|NCT01114191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101940448|NCT01114191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940449|NCT01114191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101940450|NCT01211691|Antibodies|antibodies|mesh-list
101940451|NCT01211691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101940452|NCT01211691|Immunologic Factors|immunologic factors|mesh-ancestor
101940453|NCT01211691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940454|NCT03937869|Secnidazole|secnidazole|mesh-list
101940455|NCT03937869|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101940456|NCT03937869|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101940457|NCT03937869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101940458|NCT01116531|Pregabalin|pregabalin|mesh-list
101940459|NCT01116531|Tramadol|tramadol|mesh-list
101940460|NCT01116531|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101940461|NCT01116531|Analgesics|analgesics|mesh-ancestor
101940462|NCT01116531|Sensory System Agents|sensory system agents|mesh-ancestor
101940463|NCT01116531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101940464|NCT01116531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940465|NCT01116531|Anticonvulsants|anticonvulsants|mesh-ancestor
101940466|NCT01116531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101940467|NCT01116531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101940468|NCT01116531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940469|NCT01116531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101940470|NCT01116531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101940471|NCT01116531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101940472|NCT01116531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101940473|NCT01116531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101940474|NCT01116531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101940475|NCT01116531|Narcotics|narcotics|mesh-ancestor
101940476|NCT01116531|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101940477|NCT01116531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101940479|NCT01116531|Antidepressive Agents|antidepressive agents|mesh-ancestor
101940480|NCT01116531|Dopamine Agents|dopamine agents|mesh-ancestor
101940481|NCT03939975|Pembrolizumab|pembrolizumab|mesh-list
101940482|NCT03939975|Nivolumab|nivolumab|mesh-list
101940483|NCT03939975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101940484|NCT03939975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101940485|NCT03939975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101940486|NCT03939975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940487|NCT01116609|Epinephrine|epinephrine|mesh-list
101940488|NCT01116609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101940489|NCT01116609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101940490|NCT01116609|Adrenergic Agents|adrenergic agents|mesh-ancestor
101940491|NCT01116609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101940492|NCT01116609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940493|NCT01116609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940494|NCT01116609|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101940495|NCT01116609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101940496|NCT01116609|Autonomic Agents|autonomic agents|mesh-ancestor
101940497|NCT01116609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101940498|NCT01116609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101940499|NCT01116609|Respiratory System Agents|respiratory system agents|mesh-ancestor
101940500|NCT01116609|Mydriatics|mydriatics|mesh-ancestor
101940501|NCT01116609|Sympathomimetics|sympathomimetics|mesh-ancestor
101940502|NCT01116609|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101940503|NCT01118403|Ampicillin|ampicillin|mesh-list
101940504|NCT01118403|Sulbactam|sulbactam|mesh-list
101940505|NCT01118403|Sultamicillin|sultamicillin|mesh-list
101940506|NCT01118403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101940507|NCT01118403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101940508|NCT01118403|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101940509|NCT01118403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101940510|NCT01118403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940511|NCT01121835|Insulin|insulin|mesh-list
101940512|NCT01121835|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101940513|NCT01121835|Insulin Glargine|insulin glargine|mesh-list
101940514|NCT01121835|Insulin glulisine|insulin glulisine|mesh-list
101940515|NCT01121835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101940516|NCT01121835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940517|NCT03788967|Ertapenem|ertapenem|mesh-list
101940518|NCT03788967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101940519|NCT03788967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101940520|NCT01118559|Darexaban|darexaban|mesh-list
101940521|NCT01118559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101940522|NCT01118559|Antithrombins|antithrombins|mesh-ancestor
101940523|NCT01118559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101940524|NCT01118559|Protease Inhibitors|protease inhibitors|mesh-ancestor
101940525|NCT01118559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101940526|NCT01118559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940527|NCT01118559|Anticoagulants|anticoagulants|mesh-ancestor
101940528|NCT01216293|Esomeprazole|esomeprazole|mesh-list
101940529|NCT01216293|Dexlansoprazole|dexlansoprazole|mesh-list
101940530|NCT01216293|Lansoprazole|lansoprazole|mesh-list
101940531|NCT01216293|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101940532|NCT01216293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101940533|NCT01216293|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101940534|NCT01216293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101940535|NCT01216293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940536|NCT01216371|Sunitinib|sunitinib|mesh-list
101940537|NCT01216371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101940538|NCT01216371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101940539|NCT01216371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101940540|NCT01216371|Growth Substances|growth substances|mesh-ancestor
101940541|NCT01216371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940542|NCT01216371|Growth Inhibitors|growth inhibitors|mesh-ancestor
101940543|NCT01216371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101940544|NCT01216371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101940545|NCT01216371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940546|NCT01118871|Ritonavir|ritonavir|mesh-list
101940547|NCT01118871|Darunavir|darunavir|mesh-list
101940548|NCT01118871|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101940549|NCT01118871|Etravirine|etravirine|mesh-list
101940550|NCT01118871|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101940551|NCT01118871|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101940552|NCT01118871|Protease Inhibitors|protease inhibitors|mesh-ancestor
101940553|NCT01118871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101940554|NCT01118871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940555|NCT01118871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101940556|NCT01118871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101940557|NCT01118871|Antiviral Agents|antiviral agents|mesh-ancestor
101940558|NCT01118871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101940559|NCT01118871|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101940560|NCT01118871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101940561|NCT01118871|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101940562|NCT01118871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101940563|NCT01216449|Citalopram|citalopram|mesh-list
101940564|NCT01216449|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101940565|NCT01216449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101940566|NCT01216449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101940567|NCT01216449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940568|NCT01216449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101940569|NCT01216449|Serotonin Agents|serotonin agents|mesh-ancestor
101940570|NCT01216449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940571|NCT01216449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101940572|NCT01216449|Antidepressive Agents|antidepressive agents|mesh-ancestor
101940573|NCT01216449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101940574|NCT03937401|Oxytocin|oxytocin|mesh-list
101940575|NCT03937401|Oxytocics|oxytocics|mesh-ancestor
101940576|NCT03937401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101940577|NCT03937401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940578|NCT03939273|Metronidazole|metronidazole|mesh-list
101940579|NCT03939273|Vancomycin|vancomycin|mesh-list
101940580|NCT03939273|Ciprofloxacin|ciprofloxacin|mesh-list
101940581|NCT03939273|Fluconazole|fluconazole|mesh-list
101940582|NCT03939273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101940583|NCT03939273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101940584|NCT03939273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101940585|NCT03939273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101940586|NCT03939273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101940587|NCT03939273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101940588|NCT03939273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101940589|NCT03939273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940590|NCT03939273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101940591|NCT03939273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101940592|NCT03939273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101940593|NCT03939273|Antifungal Agents|antifungal agents|mesh-ancestor
101940594|NCT03939273|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101940595|NCT03939273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101940596|NCT03939273|Hormone Antagonists|hormone antagonists|mesh-ancestor
101387665|NCT00322660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101940597|NCT03939273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101940598|NCT03939273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940599|NCT03939273|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101940600|NCT03939273|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101940601|NCT01213017|Certolizumab Pegol|certolizumab pegol|mesh-list
101940602|NCT01213017|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101940603|NCT01213017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101940604|NCT01213017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101940605|NCT01213017|Immunologic Factors|immunologic factors|mesh-ancestor
101940606|NCT01213017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940607|NCT01213017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101940608|NCT01119417|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
101940609|NCT01119417|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101940610|NCT01119417|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101940611|NCT01119417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940612|NCT01216605|Oxytocin|oxytocin|mesh-list
101940613|NCT01216605|Oxytocics|oxytocics|mesh-ancestor
101940614|NCT01216605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101940615|NCT01216605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940616|NCT01213095|Rituximab|rituximab|mesh-list
101940617|NCT01213095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101940618|NCT01213095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101940619|NCT01213095|Immunologic Factors|immunologic factors|mesh-ancestor
101940620|NCT01213095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940621|NCT01213095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101940622|NCT03938883|Hyaluronic Acid|hyaluronic acid|mesh-list
101940623|NCT03938883|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101940624|NCT03938883|Immunologic Factors|immunologic factors|mesh-ancestor
101940625|NCT03938883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940626|NCT03938883|Viscosupplements|viscosupplements|mesh-ancestor
101940627|NCT03938883|Protective Agents|protective agents|mesh-ancestor
101940628|NCT01216839|Everolimus|everolimus|mesh-list
101940629|NCT01216839|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101940630|NCT01216839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101940631|NCT01216839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101940632|NCT01216839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940633|NCT01216839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101940634|NCT01216839|Immunologic Factors|immunologic factors|mesh-ancestor
101940635|NCT01216839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940636|NCT01216839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101940637|NCT01119651|Tazarotene|tazarotene|mesh-list
101940638|NCT01119651|Dermatologic Agents|dermatologic agents|mesh-ancestor
101940639|NCT01119651|Keratolytic Agents|keratolytic agents|mesh-ancestor
101940640|NCT03971877|Polymyxins|polymyxins|mesh-list
101940641|NCT03971877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101940642|NCT03971877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101940643|NCT01328925|Nitazoxanide|nitazoxanide|mesh-list
101940644|NCT01328925|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101940645|NCT01328925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101940646|NCT01119885|Fentanyl|fentanyl|mesh-list
101940647|NCT01119885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101940648|NCT01119885|Narcotics|narcotics|mesh-ancestor
101940649|NCT01119885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101940650|NCT01119885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940651|NCT01119885|Analgesics|analgesics|mesh-ancestor
101940652|NCT01119885|Sensory System Agents|sensory system agents|mesh-ancestor
101940653|NCT01119885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101940654|NCT01119885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101940655|NCT01119885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101940656|NCT01119885|Anesthetics, General|anesthetics, general|mesh-ancestor
101940657|NCT01119885|Anesthetics|anesthetics|mesh-ancestor
101940658|NCT03935217|Secnidazole|secnidazole|mesh-list
101940659|NCT03935217|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101940660|NCT03935217|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101940661|NCT03935217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101940662|NCT01219023|Sildenafil Citrate|sildenafil citrate|mesh-list
101940663|NCT01219023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940664|NCT01219023|Vasodilator Agents|vasodilator agents|mesh-ancestor
101940665|NCT01219023|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101940667|NCT01219023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101940668|NCT01219023|Urological Agents|urological agents|mesh-ancestor
101940669|NCT01124487|Insulin|insulin|mesh-list
101940670|NCT01124487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101940671|NCT01124487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940672|NCT01120119|Calcitriol|calcitriol|mesh-list
101940673|NCT01120119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101940674|NCT01120119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940675|NCT01120119|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101940676|NCT01120119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101940677|NCT01120119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940678|NCT01120119|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101940679|NCT01120119|Vitamins|vitamins|mesh-ancestor
101940680|NCT01120119|Micronutrients|micronutrients|mesh-ancestor
101940681|NCT01120119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101940682|NCT01219101|Citric Acid|citric acid|mesh-list
101940683|NCT01219101|Sodium Citrate|sodium citrate|mesh-list
101940684|NCT01219101|Clomiphene|clomiphene|mesh-list
101940685|NCT01219101|Enclomiphene|enclomiphene|mesh-list
101940686|NCT01219101|Zuclomiphene|zuclomiphene|mesh-list
101940687|NCT01219101|Anticoagulants|anticoagulants|mesh-ancestor
101940688|NCT01219101|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101940689|NCT01219101|Chelating Agents|chelating agents|mesh-ancestor
101940690|NCT01219101|Sequestering Agents|sequestering agents|mesh-ancestor
101940691|NCT01219101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940692|NCT01219101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101940693|NCT01219101|Hormone Antagonists|hormone antagonists|mesh-ancestor
101940694|NCT01219101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101940695|NCT01219101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940696|NCT01219101|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101940697|NCT01219101|Fertility Agents|fertility agents|mesh-ancestor
101940698|NCT01219101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101940699|NCT01219101|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101940700|NCT01219101|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101940701|NCT01217619|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101940702|NCT01217619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101940703|NCT01217619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101940704|NCT01217619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101940705|NCT01217619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940707|NCT01122615|Sunitinib|sunitinib|mesh-list
101940708|NCT01122615|Temsirolimus|temsirolimus|mesh-list
101940709|NCT01122615|MTOR Inhibitors|mtor inhibitors|mesh-list
101940710|NCT01122615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101940711|NCT01122615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101940712|NCT01122615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101940713|NCT01122615|Growth Substances|growth substances|mesh-ancestor
101940714|NCT01122615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940715|NCT01122615|Growth Inhibitors|growth inhibitors|mesh-ancestor
101940716|NCT01122615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101940717|NCT01122615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101940718|NCT01122615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940719|NCT01122615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101940720|NCT01122615|Immunologic Factors|immunologic factors|mesh-ancestor
101940721|NCT01122615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101940722|NCT01122615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101940723|NCT01122615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101940724|NCT01122615|Antifungal Agents|antifungal agents|mesh-ancestor
101940725|NCT01217697|Prednisone|prednisone|mesh-list
101940726|NCT01217697|Prednisolone|prednisolone|mesh-list
101940727|NCT01217697|Abiraterone Acetate|abiraterone acetate|mesh-list
101940728|NCT01217697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101940729|NCT01217697|Glucocorticoids|glucocorticoids|mesh-ancestor
101940730|NCT01217697|Hormones|hormones|mesh-ancestor
101940731|NCT01217697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101940732|NCT01217697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940733|NCT01217697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101940734|NCT01217697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101940735|NCT01217697|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101940736|NCT01217697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101940737|NCT01217697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940738|NCT01217697|Hormone Antagonists|hormone antagonists|mesh-ancestor
101940739|NCT01217697|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101940740|NCT01214343|Sorafenib|sorafenib|mesh-list
101940741|NCT01214343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101940742|NCT01214343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101940743|NCT01214343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101940744|NCT01214343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940745|NCT01120431|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101940746|NCT01124799|Ciprofloxacin|ciprofloxacin|mesh-list
101940747|NCT01124799|Simeprevir|simeprevir|mesh-list
101940748|NCT01124799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101940749|NCT01124799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101940750|NCT01124799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101940751|NCT01124799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101940752|NCT01124799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101940753|NCT01124799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940754|NCT01124799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101940755|NCT01124799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101940756|NCT01124799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101940757|NCT01124799|Antiviral Agents|antiviral agents|mesh-ancestor
101940758|NCT01124799|Protease Inhibitors|protease inhibitors|mesh-ancestor
101940759|NCT01124877|Ziprasidone|ziprasidone|mesh-list
101940760|NCT01124877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101940761|NCT01124877|Serotonin Agents|serotonin agents|mesh-ancestor
101940762|NCT01124877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101940763|NCT01124877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940764|NCT01124877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940765|NCT01124877|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101940766|NCT01124877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101940767|NCT01124877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101940768|NCT01124877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101940769|NCT01124877|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101940770|NCT01124877|Dopamine Agents|dopamine agents|mesh-ancestor
101940771|NCT01219413|Perindopril|perindopril|mesh-list
101940772|NCT01219413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101235510|NCT01593397|Fentanyl|fentanyl|mesh-list
101940773|NCT01219413|Protease Inhibitors|protease inhibitors|mesh-ancestor
101940774|NCT01219413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101940775|NCT01219413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940776|NCT01219413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101940777|NCT03783039|Cellulose, Oxidized|cellulose, oxidized|mesh-list
101940778|NCT03783039|Hemostatics|hemostatics|mesh-ancestor
101940779|NCT03783039|Coagulants|coagulants|mesh-ancestor
101940780|NCT03933501|Amoxicillin|amoxicillin|mesh-list
101940781|NCT03933501|Metronidazole|metronidazole|mesh-list
101940782|NCT03933501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101940783|NCT03933501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101940784|NCT03933501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101940785|NCT03933501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101940786|NCT01122771|Amphotericin B|amphotericin b|mesh-list
101940787|NCT01122771|Paromomycin|paromomycin|mesh-list
101940788|NCT01122771|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101940789|NCT01122771|Miltefosine|miltefosine|mesh-list
101940790|NCT01122771|Amebicides|amebicides|mesh-ancestor
101940791|NCT01122771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101940792|NCT01122771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101940793|NCT01122771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101940794|NCT01122771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101940795|NCT01122771|Antifungal Agents|antifungal agents|mesh-ancestor
101940796|NCT01122771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101940797|NCT01125033|Vitamins|vitamins|mesh-list
101940798|NCT01125033|Ascorbic Acid|ascorbic acid|mesh-list
101940799|NCT01125033|Vitamin E|vitamin e|mesh-list
101940800|NCT01125033|Tocopherols|tocopherols|mesh-list
101940801|NCT01125033|Tocotrienols|tocotrienols|mesh-list
101940802|NCT01125033|alpha-Tocopherol|alpha-tocopherol|mesh-list
101940803|NCT01125033|Micronutrients|micronutrients|mesh-ancestor
101940804|NCT01125033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940805|NCT01125033|Antioxidants|antioxidants|mesh-ancestor
101940806|NCT01125033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940807|NCT01125033|Protective Agents|protective agents|mesh-ancestor
101940808|NCT01120665|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101940809|NCT01120665|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101940810|NCT01120665|Estradiol|estradiol|mesh-list
101940811|NCT01120665|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101940812|NCT01120665|Hormones|hormones|mesh-ancestor
101940813|NCT01120665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101940814|NCT01120665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940815|NCT01120665|Estrogens|estrogens|mesh-ancestor
101940816|NCT01120665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101940817|NCT01120665|Contraceptive Agents|contraceptive agents|mesh-ancestor
101940818|NCT01120665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101940819|NCT01120665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101940820|NCT01120821|Imatinib Mesylate|imatinib mesylate|mesh-list
101940821|NCT01120821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101940822|NCT01120821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101940823|NCT01120821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101940824|NCT01120821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940825|NCT01125423|Milnacipran|milnacipran|mesh-list
101940826|NCT01125423|Levomilnacipran|levomilnacipran|mesh-list
101940827|NCT01125423|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101940828|NCT01125423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101940829|NCT01125423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101940830|NCT01125423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940831|NCT01125423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101940832|NCT01125423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940833|NCT01125423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101940834|NCT01125423|Analgesics|analgesics|mesh-ancestor
101940835|NCT01125423|Sensory System Agents|sensory system agents|mesh-ancestor
101940836|NCT01125423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101940837|NCT01125423|Antidepressive Agents|antidepressive agents|mesh-ancestor
101940838|NCT01125423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101940839|NCT01219569|Propofol|propofol|mesh-list
101940840|NCT01219569|Sevoflurane|sevoflurane|mesh-list
101940841|NCT01219569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101940842|NCT01219569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101940843|NCT01219569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940844|NCT01219569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101940845|NCT01219569|Anesthetics, General|anesthetics, general|mesh-ancestor
101940846|NCT01219569|Anesthetics|anesthetics|mesh-ancestor
101940847|NCT01219569|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101940848|NCT01219569|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101940849|NCT03933345|Naloxone|naloxone|mesh-list
101940850|NCT03933345|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101940851|NCT03933345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940852|NCT03933345|Sensory System Agents|sensory system agents|mesh-ancestor
101940853|NCT03933345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101940854|NCT01121055|Lorazepam|lorazepam|mesh-list
101940855|NCT01121055|Anticonvulsants|anticonvulsants|mesh-ancestor
101940856|NCT01121055|Antiemetics|antiemetics|mesh-ancestor
101940857|NCT01121055|Autonomic Agents|autonomic agents|mesh-ancestor
101940858|NCT01121055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101940859|NCT01121055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940860|NCT01121055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101940861|NCT01121055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101940862|NCT01121055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101940863|NCT01121055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101940864|NCT01121055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101940865|NCT01121055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101940866|NCT01121055|GABA Modulators|gaba modulators|mesh-ancestor
101940867|NCT01121055|GABA Agents|gaba agents|mesh-ancestor
101940868|NCT01121055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101940869|NCT01121055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940870|NCT01121133|Rifampin|rifampin|mesh-list
101940871|NCT01121133|Navitoclax|navitoclax|mesh-list
101940872|NCT01121133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101940873|NCT01121133|Antitubercular Agents|antitubercular agents|mesh-ancestor
101940874|NCT01121133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101940875|NCT01121133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101940876|NCT01121133|Leprostatic Agents|leprostatic agents|mesh-ancestor
101940877|NCT01121133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101940878|NCT01121133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101940879|NCT01121133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940880|NCT01121133|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101940881|NCT01121133|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101940882|NCT01121133|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101940883|NCT01121133|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101940884|NCT01121133|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101940885|NCT01121133|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101940887|NCT01218321|Anticonvulsants|anticonvulsants|mesh-list
101940888|NCT01214889|Vaccines|vaccines|mesh-list
101940889|NCT01214889|Immunologic Factors|immunologic factors|mesh-ancestor
101940890|NCT01214889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940891|NCT01123317|Oxytocin|oxytocin|mesh-list
101940892|NCT01123317|Oxytocics|oxytocics|mesh-ancestor
101940893|NCT01123317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101940894|NCT01123317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940895|NCT01121289|Insulin Aspart|insulin aspart|mesh-list
101940896|NCT01121289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101940897|NCT01121289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940898|NCT01123473|Fluorouracil|fluorouracil|mesh-list
101940899|NCT01123473|Capecitabine|capecitabine|mesh-list
101940900|NCT01123473|Epirubicin|epirubicin|mesh-list
101940901|NCT01123473|Lapatinib|lapatinib|mesh-list
101940902|NCT01123473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101940903|NCT01123473|Antimetabolites|antimetabolites|mesh-ancestor
101940904|NCT01123473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940905|NCT01123473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101940906|NCT01123473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101940907|NCT01123473|Immunologic Factors|immunologic factors|mesh-ancestor
101940908|NCT01123473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940909|NCT01123473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101940910|NCT01123473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101940911|NCT01123473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101940912|NCT01123473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101940913|NCT01123473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101940914|NCT01123551|Morphine|morphine|mesh-list
101940915|NCT01123551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101940916|NCT01123551|Narcotics|narcotics|mesh-ancestor
101940917|NCT01123551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101940918|NCT01123551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940920|NCT01123551|Sensory System Agents|sensory system agents|mesh-ancestor
101940921|NCT01123551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101940922|NCT01125657|Darexaban|darexaban|mesh-list
101940923|NCT01125657|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101940924|NCT01125657|Antithrombins|antithrombins|mesh-ancestor
101940925|NCT01125657|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101940926|NCT01125657|Protease Inhibitors|protease inhibitors|mesh-ancestor
101940927|NCT01125657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101940928|NCT01125657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940929|NCT01125657|Anticoagulants|anticoagulants|mesh-ancestor
101940930|NCT03934203|Moxifloxacin|moxifloxacin|mesh-list
101940931|NCT03934203|BI 409306|bi 409306|mesh-list
101940932|NCT03934203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101940933|NCT03934203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101940934|NCT03934203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101940935|NCT03934203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101940936|NCT03934203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101940937|NCT03934203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940938|NCT03934203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101940939|NCT03934203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101940940|NCT03934047|Tranexamic Acid|tranexamic acid|mesh-list
101940941|NCT03934047|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101940942|NCT03934047|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101940943|NCT03934047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101959870|NCT00126581|Paclitaxel|paclitaxel|mesh-list
101940945|NCT03934047|Coagulants|coagulants|mesh-ancestor
101940946|NCT01218711|Losartan|losartan|mesh-list
101940947|NCT01218711|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101940948|NCT01218711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101235562|NCT01593605|Resveratrol|resveratrol|mesh-list
101940949|NCT01218711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101940950|NCT01218711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101940951|NCT01218711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101940952|NCT01218711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940953|NCT01218711|Diuretics|diuretics|mesh-ancestor
101940954|NCT01218711|Natriuretic Agents|natriuretic agents|mesh-ancestor
101940955|NCT01218711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940956|NCT01218711|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101940957|NCT01218711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101940958|NCT01125891|Gemcitabine|gemcitabine|mesh-list
101940959|NCT01125891|ON 01910|on 01910|mesh-list
101940960|NCT01125891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101940961|NCT01125891|Antimetabolites|antimetabolites|mesh-ancestor
101940962|NCT01125891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940963|NCT01125891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101940964|NCT01125891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101940965|NCT01125891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101940966|NCT01124253|Endostatins|endostatins|mesh-list
101940967|NCT01124253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101940968|NCT01124253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101940969|NCT01124253|Growth Substances|growth substances|mesh-ancestor
101940970|NCT01124253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940971|NCT01124253|Growth Inhibitors|growth inhibitors|mesh-ancestor
101940972|NCT01124253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101940974|NCT01215669|Immunologic Factors|immunologic factors|mesh-ancestor
101940975|NCT01215669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940976|NCT01222221|Temozolomide|temozolomide|mesh-list
101940977|NCT01222221|Sargramostim|sargramostim|mesh-list
101940978|NCT01222221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101940979|NCT01222221|Alkylating Agents|alkylating agents|mesh-ancestor
101940980|NCT01222221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940981|NCT01222221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101940982|NCT01222221|Immunologic Factors|immunologic factors|mesh-ancestor
101940983|NCT01222221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101940984|NCT01220661|Cefotetan|cefotetan|mesh-list
101940985|NCT01220661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101940986|NCT01220661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101940987|NCT02903914|Pembrolizumab|pembrolizumab|mesh-list
101940988|NCT02903914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101940989|NCT02903914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101940990|NCT02903914|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101303583|NCT03581877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101940991|NCT02903914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940992|NCT01222611|Fosamprenavir|fosamprenavir|mesh-list
101940993|NCT01222611|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101940994|NCT01222611|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101940995|NCT01222611|Protease Inhibitors|protease inhibitors|mesh-ancestor
101940996|NCT01222611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101940997|NCT01222611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101940998|NCT01222611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101940999|NCT01222611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101941000|NCT01222611|Antiviral Agents|antiviral agents|mesh-ancestor
101941001|NCT01222611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101941002|NCT03928353|Ticagrelor|ticagrelor|mesh-list
101235582|NCT01593644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101941003|NCT03928353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101941004|NCT03928353|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101941005|NCT03928353|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101941006|NCT03928353|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101941007|NCT03928353|Purinergic Agents|purinergic agents|mesh-ancestor
101941008|NCT03928353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101941009|NCT03928353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941010|NCT03928353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941011|NCT03931863|Ondansetron|ondansetron|mesh-list
101941012|NCT03931863|Antiemetics|antiemetics|mesh-ancestor
101941013|NCT03931863|Autonomic Agents|autonomic agents|mesh-ancestor
101941014|NCT03931863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101941015|NCT03931863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941016|NCT03931863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101941017|NCT03931863|Antipruritics|antipruritics|mesh-ancestor
101941018|NCT03931863|Dermatologic Agents|dermatologic agents|mesh-ancestor
101941019|NCT03931863|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101941020|NCT03931863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101941021|NCT03931863|Serotonin Agents|serotonin agents|mesh-ancestor
101941022|NCT03931863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101941023|NCT03931863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941024|NCT03650608|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101941025|NCT03650608|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101941026|NCT01226355|Sirolimus|sirolimus|mesh-list
101941027|NCT01226355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101941028|NCT01226355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101941029|NCT01226355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101941030|NCT01226355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101941031|NCT01226355|Antifungal Agents|antifungal agents|mesh-ancestor
101941032|NCT01226355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101941033|NCT01226355|Immunologic Factors|immunologic factors|mesh-ancestor
101941034|NCT01226355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941035|NCT01129089|Micronutrients|micronutrients|mesh-list
101941036|NCT01129089|Trace Elements|trace elements|mesh-list
101941037|NCT01129089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941038|NCT01129323|Cyclophosphamide|cyclophosphamide|mesh-list
101941040|NCT01129323|Thymoglobulin|thymoglobulin|mesh-list
101941041|NCT01129323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101941042|NCT01129323|Immunologic Factors|immunologic factors|mesh-ancestor
101941043|NCT01129323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941044|NCT01129323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101941045|NCT01129323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101941046|NCT01129323|Alkylating Agents|alkylating agents|mesh-ancestor
101941047|NCT01129323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941048|NCT01129323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101941049|NCT01129323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101941050|NCT01221129|Zinc|zinc|mesh-list
101941051|NCT01221129|Trace Elements|trace elements|mesh-ancestor
101941052|NCT01221129|Micronutrients|micronutrients|mesh-ancestor
101941053|NCT01221129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941054|NCT01222923|Risperidone|risperidone|mesh-list
101941055|NCT01222923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101941056|NCT01222923|Serotonin Agents|serotonin agents|mesh-ancestor
101941057|NCT01222923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101941058|NCT01222923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101960480|NCT02147548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101941059|NCT01222923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941061|NCT01222923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101941062|NCT01222923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101941063|NCT01222923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101941064|NCT01222923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101941065|NCT01222923|Dopamine Agents|dopamine agents|mesh-ancestor
101941066|NCT01223079|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101941067|NCT01223079|Hormones|hormones|mesh-ancestor
101941068|NCT01223079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101941069|NCT01223079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941070|NCT03648970|Pravastatin|pravastatin|mesh-list
101941071|NCT03648970|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101941072|NCT03648970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101941073|NCT03648970|Antimetabolites|antimetabolites|mesh-ancestor
101941074|NCT03648970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941075|NCT03648970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101941076|NCT03648970|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101941077|NCT03648970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101941078|NCT03927963|Dexmedetomidine|dexmedetomidine|mesh-list
101941079|NCT03927963|Propofol|propofol|mesh-list
101941080|NCT03927963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101960542|NCT05665881|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101941081|NCT03927963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101941082|NCT03927963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941083|NCT03927963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101941084|NCT03927963|Analgesics|analgesics|mesh-ancestor
101941085|NCT03927963|Sensory System Agents|sensory system agents|mesh-ancestor
101941086|NCT03927963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101941087|NCT03927963|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101941088|NCT03927963|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101941089|NCT03927963|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101941090|NCT03927963|Adrenergic Agents|adrenergic agents|mesh-ancestor
101941091|NCT03927963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101941092|NCT03927963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941093|NCT03927963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101941094|NCT03927963|Anesthetics, General|anesthetics, general|mesh-ancestor
101941095|NCT03927963|Anesthetics|anesthetics|mesh-ancestor
101941096|NCT03648346|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101941097|NCT01127529|Protein C|protein c|mesh-list
101941098|NCT01127529|Anticoagulants|anticoagulants|mesh-ancestor
101941099|NCT01127529|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101941100|NCT01127529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101941101|NCT01127529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941102|NCT01226667|Pregabalin|pregabalin|mesh-list
101941103|NCT01226667|Analgesics|analgesics|mesh-ancestor
101941104|NCT01226667|Sensory System Agents|sensory system agents|mesh-ancestor
101941105|NCT01226667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101941106|NCT01226667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941107|NCT01226667|Anticonvulsants|anticonvulsants|mesh-ancestor
101941108|NCT01226667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101941109|NCT01226667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101941110|NCT01226667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941111|NCT01226667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101941112|NCT01226667|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101941113|NCT01226667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101941114|NCT01226667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101941115|NCT01226667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101941116|NCT03927807|Misoprostol|misoprostol|mesh-list
101941117|NCT03927807|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101941118|NCT03927807|Abortifacient Agents|abortifacient agents|mesh-ancestor
101941119|NCT03927807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101941120|NCT03927807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941121|NCT03927807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101941122|NCT03927807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101941123|NCT03927807|Oxytocics|oxytocics|mesh-ancestor
101941124|NCT05284942|Mycophenolic Acid|mycophenolic acid|mesh-list
101941126|NCT05284942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101941127|NCT05284942|Glucocorticoids|glucocorticoids|mesh-ancestor
101941128|NCT05284942|Hormones|hormones|mesh-ancestor
101941129|NCT05284942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101941130|NCT05284942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941131|NCT05284942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101941132|NCT05284942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101941133|NCT05284942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101941134|NCT05284942|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101941135|NCT05284942|Antitubercular Agents|antitubercular agents|mesh-ancestor
101941136|NCT05284942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101941137|NCT05284942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101941138|NCT05284942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101941139|NCT05284942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941140|NCT03648034|Ropivacaine|ropivacaine|mesh-list
101941141|NCT03648034|Anesthetics, Local|anesthetics, local|mesh-ancestor
101941142|NCT03648034|Anesthetics|anesthetics|mesh-ancestor
101941143|NCT03648034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101941144|NCT03648034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941145|NCT03648034|Sensory System Agents|sensory system agents|mesh-ancestor
101941146|NCT03648034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101941147|NCT01129479|Galantamine|galantamine|mesh-list
101941148|NCT01129479|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101941149|NCT01129479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101941150|NCT01129479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941151|NCT01129479|Cholinergic Agents|cholinergic agents|mesh-ancestor
101941152|NCT01129479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101941153|NCT01129479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941154|NCT01129479|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101941155|NCT01129479|Autonomic Agents|autonomic agents|mesh-ancestor
101941156|NCT01129479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101941157|NCT01129479|Nootropic Agents|nootropic agents|mesh-ancestor
101941158|NCT03647956|Bevacizumab|bevacizumab|mesh-list
101941159|NCT03647956|Atezolizumab|atezolizumab|mesh-list
101941160|NCT03647956|Carboplatin|carboplatin|mesh-list
101941162|NCT03647956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101941163|NCT03647956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101941164|NCT03647956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101941165|NCT03647956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101941166|NCT03647956|Growth Substances|growth substances|mesh-ancestor
101941167|NCT03647956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941168|NCT03647956|Growth Inhibitors|growth inhibitors|mesh-ancestor
101941169|NCT03647956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101941170|NCT03647956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941171|NCT03647956|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101941172|NCT03647956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101941173|NCT03647956|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101941175|NCT01221675|Immunologic Factors|immunologic factors|mesh-ancestor
101941176|NCT01221675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941177|NCT03927729|Methoxyflurane|methoxyflurane|mesh-list
101941178|NCT03927729|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101941179|NCT03927729|Anesthetics, General|anesthetics, general|mesh-ancestor
101941180|NCT03927729|Anesthetics|anesthetics|mesh-ancestor
101941181|NCT03927729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101941182|NCT03927729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941183|NCT01226823|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101941184|NCT01226823|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101941185|NCT01226823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101941186|NCT02968576|Tenofovir|tenofovir|mesh-list
101941187|NCT02968576|Emtricitabine|emtricitabine|mesh-list
101941188|NCT02968576|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101941189|NCT02968576|Antiviral Agents|antiviral agents|mesh-ancestor
101941190|NCT02968576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101941191|NCT02968576|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101661017|NCT03471182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101941192|NCT02968576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101941194|NCT02968576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941195|NCT02968576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101941196|NCT02968576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101941198|NCT01127217|Amlodipine|amlodipine|mesh-list
101941199|NCT01127217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101941200|NCT01127217|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101941201|NCT01127217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101941202|NCT01127217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941203|NCT01127217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101941204|NCT01127217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941205|NCT01127217|Vasodilator Agents|vasodilator agents|mesh-ancestor
101941206|NCT01127217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101941207|NCT01127217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101941208|NCT01127217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101941209|NCT01226901|Niraparib|niraparib|mesh-list
101303806|NCT01748448|Cholecalciferol|cholecalciferol|mesh-list
101941210|NCT01226901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101941211|NCT01226901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101235671|NCT01594177|Mitosis Modulators|mitosis modulators|mesh-ancestor
101941212|NCT01226901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941213|NCT01226901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101941215|NCT03648658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101941216|NCT03648658|Analgesics|analgesics|mesh-ancestor
101941217|NCT03648658|Sensory System Agents|sensory system agents|mesh-ancestor
101941218|NCT03648658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101941219|NCT03648658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941220|NCT03648658|Antipyretics|antipyretics|mesh-ancestor
101941221|NCT03931239|Vaccines|vaccines|mesh-list
101941222|NCT03931239|Immunologic Factors|immunologic factors|mesh-ancestor
101941223|NCT03931239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941224|NCT03927495|Paclitaxel|paclitaxel|mesh-list
101941225|NCT03927495|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101941226|NCT03927495|Cisplatin|cisplatin|mesh-list
101941227|NCT03927495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101961071|NCT04804696|Paclitaxel|paclitaxel|mesh-list
101941228|NCT03927495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101941229|NCT03927495|Tubulin Modulators|tubulin modulators|mesh-ancestor
101941230|NCT03927495|Antimitotic Agents|antimitotic agents|mesh-ancestor
101941231|NCT03927495|Mitosis Modulators|mitosis modulators|mesh-ancestor
101941232|NCT03927495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941233|NCT02966002|Aspirin|aspirin|mesh-list
101941234|NCT02966002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101941235|NCT02966002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101941236|NCT02966002|Analgesics|analgesics|mesh-ancestor
101941237|NCT02966002|Sensory System Agents|sensory system agents|mesh-ancestor
101941238|NCT02966002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101941239|NCT02966002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941240|NCT02966002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101941241|NCT02966002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101941242|NCT02966002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101941243|NCT02966002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101941244|NCT02966002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941245|NCT02966002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101941246|NCT02966002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101941247|NCT02966002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101941248|NCT02966002|Antipyretics|antipyretics|mesh-ancestor
101941249|NCT01127295|Tamoxifen|tamoxifen|mesh-list
101941250|NCT01127295|Letrozole|letrozole|mesh-list
101941251|NCT01127295|Anastrozole|anastrozole|mesh-list
101941252|NCT01127295|Exemestane|exemestane|mesh-list
101941253|NCT01127295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101941254|NCT01127295|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101941255|NCT01127295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101941256|NCT01127295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101941257|NCT01127295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941258|NCT01127295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101941259|NCT01127295|Hormone Antagonists|hormone antagonists|mesh-ancestor
101961118|NCT02160574|Chlorhexidine|chlorhexidine|mesh-list
101235691|NCT01594229|Immunologic Factors|immunologic factors|mesh-ancestor
101941260|NCT01127295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101941261|NCT01127295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941262|NCT01127295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101941263|NCT01127295|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101941264|NCT01127295|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101941265|NCT01127295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101941267|NCT01129713|Omeprazole|omeprazole|mesh-list
101941268|NCT01129713|Lansoprazole|lansoprazole|mesh-list
101941269|NCT01129713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101941270|NCT01129713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101941271|NCT01129713|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101941272|NCT01129713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101941273|NCT01129713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941274|NCT01221831|Dienogest|dienogest|mesh-list
101941275|NCT01221831|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101941276|NCT01221831|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101941277|NCT01221831|Estradiol|estradiol|mesh-list
101941278|NCT01221831|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101941279|NCT01221831|Estrogens|estrogens|mesh-ancestor
101941280|NCT01221831|Hormones|hormones|mesh-ancestor
101941281|NCT01221831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101941282|NCT01221831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617408|NCT00793819|Silodosin|silodosin|mesh-list
101941283|NCT01221831|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101941284|NCT01221831|Contraceptive Agents|contraceptive agents|mesh-ancestor
101941285|NCT01221831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101941286|NCT01221831|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101941287|NCT01221831|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101941288|NCT01221831|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101941289|NCT01221831|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101941290|NCT01221831|Hormone Antagonists|hormone antagonists|mesh-ancestor
101941291|NCT01221831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101941292|NCT01221831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101941293|NCT03931317|Timolol|timolol|mesh-list
101941294|NCT03931317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941295|NCT03931317|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101941296|NCT03931317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101941297|NCT03931317|Adrenergic Agents|adrenergic agents|mesh-ancestor
101941298|NCT03931317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101941299|NCT03931317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941300|NCT03931317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101941301|NCT03931317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101941302|NCT01221909|Tranexamic Acid|tranexamic acid|mesh-list
101941303|NCT01221909|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101941304|NCT01221909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101941305|NCT01221909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941306|NCT01221909|Hemostatics|hemostatics|mesh-ancestor
101941307|NCT01221909|Coagulants|coagulants|mesh-ancestor
101941308|NCT02900092|Ganaxolone|ganaxolone|mesh-list
101941309|NCT02900092|Neurosteroids|neurosteroids|mesh-ancestor
101941310|NCT02900092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101941311|NCT02900092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941312|NCT02900092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941313|NCT02900092|GABA Modulators|gaba modulators|mesh-ancestor
101941314|NCT02900092|GABA Agents|gaba agents|mesh-ancestor
101941315|NCT01130025|Tinzaparin|tinzaparin|mesh-list
101941316|NCT01130025|Warfarin|warfarin|mesh-list
101941317|NCT01130025|Anticoagulants|anticoagulants|mesh-ancestor
101941318|NCT01130025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101941319|NCT01130025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101941320|NCT01130025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941322|NCT03925155|Chlorhexidine|chlorhexidine|mesh-list
101941323|NCT03925155|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101941325|NCT03925155|Disinfectants|disinfectants|mesh-ancestor
101941326|NCT03925155|Trace Elements|trace elements|mesh-ancestor
101941327|NCT03925155|Micronutrients|micronutrients|mesh-ancestor
101941328|NCT03925155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941329|NCT01131195|Paclitaxel|paclitaxel|mesh-list
101941330|NCT01131195|Cyclophosphamide|cyclophosphamide|mesh-list
101941331|NCT01131195|Bevacizumab|bevacizumab|mesh-list
101941332|NCT01131195|Capecitabine|capecitabine|mesh-list
101941333|NCT01131195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101941334|NCT01131195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101941335|NCT01131195|Tubulin Modulators|tubulin modulators|mesh-ancestor
101941336|NCT01131195|Antimitotic Agents|antimitotic agents|mesh-ancestor
101941337|NCT01131195|Mitosis Modulators|mitosis modulators|mesh-ancestor
101941338|NCT01131195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941339|NCT01131195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101941340|NCT01131195|Immunologic Factors|immunologic factors|mesh-ancestor
101941341|NCT01131195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941342|NCT01131195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101941343|NCT01131195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101941344|NCT01131195|Alkylating Agents|alkylating agents|mesh-ancestor
101941345|NCT01131195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101941346|NCT01131195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101941347|NCT01131195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101941348|NCT01131195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101941350|NCT01131195|Growth Inhibitors|growth inhibitors|mesh-ancestor
101941351|NCT01131195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101941352|NCT01131195|Antimetabolites|antimetabolites|mesh-ancestor
101941353|NCT01227135|Hydroxychloroquine|hydroxychloroquine|mesh-list
101941354|NCT01227135|Imatinib Mesylate|imatinib mesylate|mesh-list
101941355|NCT01227135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101941356|NCT01227135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101941357|NCT01227135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101941358|NCT01227135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941359|NCT01227135|Antimalarials|antimalarials|mesh-ancestor
101941360|NCT01227135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101941361|NCT01227135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101941362|NCT01227135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101941363|NCT01227135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101941364|NCT01223625|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101941365|NCT01223625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101941366|NCT01223625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101941367|NCT01223625|Antimetabolites|antimetabolites|mesh-ancestor
101941368|NCT01223625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941369|NCT01223625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101941370|NCT01223625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101941371|NCT01223625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101941372|NCT01228227|Atorvastatin|atorvastatin|mesh-list
101941373|NCT01228227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101941374|NCT01228227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101941375|NCT01228227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101941376|NCT01228227|Antimetabolites|antimetabolites|mesh-ancestor
101941377|NCT01228227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941378|NCT01228227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101941379|NCT01228227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101941380|NCT01228227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101941381|NCT04052854|Zanubrutinib|zanubrutinib|mesh-list
101941382|NCT04052854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101941383|NCT04052854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101961222|NCT00118157|Tamoxifen|tamoxifen|mesh-list
101941384|NCT04052854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101941385|NCT04052854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941386|NCT03740373|Budesonide|budesonide|mesh-list
101941387|NCT03740373|Glycopyrrolate|glycopyrrolate|mesh-list
101941388|NCT03740373|Formoterol Fumarate|formoterol fumarate|mesh-list
101941389|NCT03740373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101941390|NCT03740373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101941391|NCT03740373|Autonomic Agents|autonomic agents|mesh-ancestor
101941392|NCT03740373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101941393|NCT03740373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941394|NCT03740373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101941395|NCT03740373|Respiratory System Agents|respiratory system agents|mesh-ancestor
101941396|NCT03740373|Glucocorticoids|glucocorticoids|mesh-ancestor
101941397|NCT03740373|Hormones|hormones|mesh-ancestor
101941398|NCT03740373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101941399|NCT03740373|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101941400|NCT03740373|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101941401|NCT03740373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101941402|NCT03740373|Adrenergic Agents|adrenergic agents|mesh-ancestor
101941403|NCT03740373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101941404|NCT03740373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941405|NCT03740373|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101941406|NCT03740373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101941407|NCT03740373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101941408|NCT03740373|Cholinergic Agents|cholinergic agents|mesh-ancestor
101941409|NCT01228305|Acetaminophen|acetaminophen|mesh-list
101941410|NCT01228305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101941411|NCT01228305|Analgesics|analgesics|mesh-ancestor
101941412|NCT01228305|Sensory System Agents|sensory system agents|mesh-ancestor
101941413|NCT01228305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101941414|NCT01228305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661246|NCT01950520|Analgesics|analgesics|mesh-ancestor
101941415|NCT01228305|Antipyretics|antipyretics|mesh-ancestor
101941416|NCT02902120|Grazoprevir|grazoprevir|mesh-list
101941417|NCT02902120|Antiviral Agents|antiviral agents|mesh-ancestor
101941418|NCT02902120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101941419|NCT03646396|Sofosbuvir|sofosbuvir|mesh-list
101941420|NCT03646396|Antiviral Agents|antiviral agents|mesh-ancestor
101941421|NCT03646396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101941422|NCT01131273|Buprenorphine|buprenorphine|mesh-list
101941423|NCT01131273|Methadone|methadone|mesh-list
101941424|NCT01131273|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101941425|NCT01131273|Naloxone|naloxone|mesh-list
101941426|NCT01131273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101941427|NCT01131273|Narcotics|narcotics|mesh-ancestor
101941428|NCT01131273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101941429|NCT01131273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941430|NCT01131273|Analgesics|analgesics|mesh-ancestor
101941431|NCT01131273|Sensory System Agents|sensory system agents|mesh-ancestor
101941432|NCT01131273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101941433|NCT01131273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101941434|NCT01131273|Antitussive Agents|antitussive agents|mesh-ancestor
101941435|NCT01131273|Respiratory System Agents|respiratory system agents|mesh-ancestor
101941437|NCT03646318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101941438|NCT03646318|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101941439|NCT03646318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101941440|NCT03646318|Serotonin Agents|serotonin agents|mesh-ancestor
101941441|NCT03646318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101941442|NCT03646318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941443|NCT03646318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941444|NCT01130181|Cholecalciferol|cholecalciferol|mesh-list
101941445|NCT01130181|Vitamin D|vitamin d|mesh-list
101941446|NCT01130181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101941447|NCT01130181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941448|NCT01130181|Vitamins|vitamins|mesh-ancestor
101941449|NCT01130181|Micronutrients|micronutrients|mesh-ancestor
101941450|NCT01130181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101941451|NCT03621514|Lidocaine|lidocaine|mesh-list
101941452|NCT03621514|Anesthetics, Local|anesthetics, local|mesh-ancestor
101941453|NCT03621514|Anesthetics|anesthetics|mesh-ancestor
101941454|NCT03621514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101941455|NCT03621514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941456|NCT03621514|Sensory System Agents|sensory system agents|mesh-ancestor
101941457|NCT03621514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101941458|NCT03621514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101941459|NCT03621514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101941460|NCT03621514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101941461|NCT03621514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101941462|NCT03621514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941463|NCT01127841|Rituximab|rituximab|mesh-list
101941464|NCT01127841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101941465|NCT01127841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101941466|NCT01127841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101941467|NCT01127841|Immunologic Factors|immunologic factors|mesh-ancestor
101941468|NCT01127841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941469|NCT01127841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101941470|NCT01127841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101941471|NCT01127841|Alkylating Agents|alkylating agents|mesh-ancestor
101941472|NCT01127841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941473|NCT01227603|Candesartan|candesartan|mesh-list
101941474|NCT01227603|Candesartan cilexetil|candesartan cilexetil|mesh-list
101941475|NCT01227603|Nifedipine|nifedipine|mesh-list
101941476|NCT01227603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101941477|NCT01227603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101941478|NCT01227603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101941479|NCT01227603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941480|NCT01227603|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101941481|NCT01227603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101941482|NCT01227603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101941483|NCT01227603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941484|NCT01227603|Vasodilator Agents|vasodilator agents|mesh-ancestor
101941485|NCT01227603|Tocolytic Agents|tocolytic agents|mesh-ancestor
101941486|NCT01227603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101941487|NCT01130259|Iniparib|iniparib|mesh-list
101941488|NCT01130259|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101941489|NCT01130259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101941490|NCT01130259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941491|NCT01130259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101941493|NCT01585623|Midazolam|midazolam|mesh-list
101941494|NCT01585623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101941495|NCT01585623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101941496|NCT01585623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101941497|NCT01585623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941498|NCT01585623|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101941499|NCT01585623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101941500|NCT01585623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101941501|NCT01585623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101941502|NCT01585623|Anesthetics, General|anesthetics, general|mesh-ancestor
101941503|NCT01585623|Anesthetics|anesthetics|mesh-ancestor
101941504|NCT01585623|GABA Modulators|gaba modulators|mesh-ancestor
101941505|NCT01585623|GABA Agents|gaba agents|mesh-ancestor
101618348|NCT02876822|Vitamin D|vitamin d|mesh-list
101941506|NCT01585623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101618418|NCT02611336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101618639|NCT04203342|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101619543|NCT00766363|Nootropic Agents|nootropic agents|mesh-ancestor
101619618|NCT04238169|Bevacizumab|bevacizumab|mesh-list
101619987|NCT00819910|Rosiglitazone|rosiglitazone|mesh-list
101620134|NCT03409848|Nivolumab|nivolumab|mesh-list
101620211|NCT05477589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620285|NCT00770341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101620286|NCT05472753|Selenium|selenium|mesh-list
101620287|NCT05472753|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
101620288|NCT05472753|Curcumin|curcumin|mesh-list
101620289|NCT05472753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101620290|NCT05472753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101620291|NCT05472753|Analgesics|analgesics|mesh-ancestor
101620360|NCT05511909|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101620508|NCT02797587|Nicotine|nicotine|mesh-list
101620584|NCT05805098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101620887|NCT05701917|Rivaroxaban|rivaroxaban|mesh-list
101620888|NCT05701917|Apixaban|apixaban|mesh-list
101620889|NCT05701917|Warfarin|warfarin|mesh-list
101620890|NCT05701917|Anticoagulants|anticoagulants|mesh-ancestor
101620891|NCT05701917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101620892|NCT05701917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101620893|NCT05701917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620974|NCT05515978|Metformin|metformin|mesh-list
101620975|NCT05515978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101620976|NCT05515978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620977|NCT05513469|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
101620978|NCT05513469|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101620979|NCT05513469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620980|NCT05494593|Rituximab|rituximab|mesh-list
101620981|NCT05494593|Methotrexate|methotrexate|mesh-list
101620982|NCT05494593|Immunoglobulins|immunoglobulins|mesh-list
101620983|NCT05494593|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101620984|NCT05494593|Antibodies|antibodies|mesh-list
101620985|NCT05494593|gamma-Globulins|gamma-globulins|mesh-list
101620986|NCT05494593|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101621038|NCT05438264|Cholinergic Agents|cholinergic agents|mesh-ancestor
101621131|NCT05163223|Antimetabolites|antimetabolites|mesh-ancestor
101621279|NCT04817345|Antiviral Agents|antiviral agents|mesh-ancestor
101622109|NCT02794077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101622408|NCT02611492|Abortifacient Agents|abortifacient agents|mesh-ancestor
101622637|NCT02785653|Rocuronium|rocuronium|mesh-list
101622715|NCT03936192|Meloxicam|meloxicam|mesh-list
101622864|NCT00839800|Terbutaline|terbutaline|mesh-list
101623014|NCT04216134|Edetic Acid|edetic acid|mesh-list
101941507|NCT01585623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623391|NCT02848170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101623771|NCT02778945|Rocuronium|rocuronium|mesh-list
101623845|NCT04228263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101624143|NCT02774187|Sorafenib|sorafenib|mesh-list
101624371|NCT02767089|Prednisone|prednisone|mesh-list
101624671|NCT00744757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101624820|NCT02758509|Sofosbuvir|sofosbuvir|mesh-list
101941508|NCT01585623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101625044|NCT04219995|Prednisolone|prednisolone|mesh-list
101941509|NCT01585623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101941510|NCT01585623|Sympatholytics|sympatholytics|mesh-ancestor
101625639|NCT02736123|Nivolumab|nivolumab|mesh-list
101941512|NCT01585623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101625791|NCT02737605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101625868|NCT04089163|Flucytosine|flucytosine|mesh-list
101626020|NCT02595463|Anesthetics|anesthetics|mesh-ancestor
101626306|NCT00811642|Posaconazole|posaconazole|mesh-list
101626376|NCT02727621|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101626475|NCT02720601|Irinotecan|irinotecan|mesh-list
101941513|NCT01585623|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101941514|NCT01585623|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101626823|NCT02715531|Antidotes|antidotes|mesh-ancestor
101626898|NCT00805792|Cholinergic Agents|cholinergic agents|mesh-ancestor
101627343|NCT02710305|Bromides|bromides|mesh-list
101941516|NCT01585623|Adrenergic Agents|adrenergic agents|mesh-ancestor
101941517|NCT03926559|Morphine|morphine|mesh-list
101941519|NCT03926559|Narcotics|narcotics|mesh-ancestor
101627870|NCT04885257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101941520|NCT03926559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101628018|NCT04371393|Remestemcel-l|remestemcel-l|mesh-list
101941521|NCT03926559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628162|NCT00724711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101628307|NCT00720343|Choline|choline|mesh-list
101628468|NCT00614835|Docetaxel|docetaxel|mesh-list
101941523|NCT03926559|Sensory System Agents|sensory system agents|mesh-ancestor
101628835|NCT01016912|Ribavirin|ribavirin|mesh-list
101941524|NCT03926559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101629289|NCT04106752|Caffeine|caffeine|mesh-list
101941525|NCT01228617|Nicotine|nicotine|mesh-list
101629582|NCT02704767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101941526|NCT01228617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101629894|NCT00776230|Vaccines|vaccines|mesh-list
101941527|NCT01228617|Autonomic Agents|autonomic agents|mesh-ancestor
101630114|NCT03236805|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101630406|NCT02584231|Coagulants|coagulants|mesh-ancestor
101287668|NCT04917055|Antiemetics|antiemetics|mesh-ancestor
101630709|NCT04102072|Sympathomimetics|sympathomimetics|mesh-ancestor
101630788|NCT04076371|Antiemetics|antiemetics|mesh-ancestor
101631766|NCT00619203|Analgesics|analgesics|mesh-ancestor
101941528|NCT01228617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101632146|NCT04208763|Imipenem|imipenem|mesh-list
101941529|NCT01228617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941530|NCT01228617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101633267|NCT02013427|Omeprazole|omeprazole|mesh-list
101941532|NCT01228617|Cholinergic Agents|cholinergic agents|mesh-ancestor
101633494|NCT02572687|Durvalumab|durvalumab|mesh-list
101633874|NCT00777946|Amlodipine|amlodipine|mesh-list
101941533|NCT01228617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101634171|NCT00719797|Levoleucovorin|levoleucovorin|mesh-list
101634246|NCT02684799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101634319|NCT00755716|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101634394|NCT00754936|Escitalopram|escitalopram|mesh-list
101634467|NCT02570581|Ramipril|ramipril|mesh-list
101634544|NCT02867930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101635294|NCT00727207|Immunologic Factors|immunologic factors|mesh-ancestor
101635446|NCT00641433|Coccidiostats|coccidiostats|mesh-ancestor
101635596|NCT00735241|Levoleucovorin|levoleucovorin|mesh-list
101635896|NCT04179045|Sirolimus|sirolimus|mesh-list
101635970|NCT02674191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101636125|NCT00738751|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101636349|NCT00711529|Antimanic Agents|antimanic agents|mesh-ancestor
101636423|NCT04174131|Viscosupplements|viscosupplements|mesh-ancestor
101636945|NCT02652507|Dexmedetomidine|dexmedetomidine|mesh-list
101637168|NCT02646657|Vedolizumab|vedolizumab|mesh-list
101637336|NCT00707239|Imipenem|imipenem|mesh-list
101637393|NCT02863406|Chelating Agents|chelating agents|mesh-ancestor
101961373|NCT02161354|Buprenorphine|buprenorphine|mesh-list
101637775|NCT00705679|Tenofovir|tenofovir|mesh-list
101637844|NCT05973370|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101637918|NCT05972785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101638290|NCT05766631|Analgesics|analgesics|mesh-ancestor
101638291|NCT05766631|Sensory System Agents|sensory system agents|mesh-ancestor
101638292|NCT05766631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101638293|NCT05766631|Antitussive Agents|antitussive agents|mesh-ancestor
101638294|NCT05766631|Respiratory System Agents|respiratory system agents|mesh-ancestor
101638304|NCT05748834|Tucatinib|tucatinib|mesh-list
101638381|NCT05631795|Fulvestrant|fulvestrant|mesh-list
101638382|NCT05631795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101638383|NCT05631795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101638384|NCT05631795|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101638385|NCT05631795|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101638386|NCT05631795|Hormone Antagonists|hormone antagonists|mesh-ancestor
101638387|NCT05631795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101638388|NCT05631795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638389|NCT05630976|Isavuconazole|isavuconazole|mesh-list
101638390|NCT05630976|Antifungal Agents|antifungal agents|mesh-ancestor
101638391|NCT05630976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101638392|NCT05630183|Paclitaxel|paclitaxel|mesh-list
101638393|NCT05630183|Gemcitabine|gemcitabine|mesh-list
101638394|NCT05630183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101638395|NCT05630183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101638443|NCT05624996|Pemetrexed|pemetrexed|mesh-list
101638444|NCT05624996|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101638445|NCT05624996|Etoposide phosphate|etoposide phosphate|mesh-list
101638446|NCT05624996|Durvalumab|durvalumab|mesh-list
101638447|NCT05624996|Immunoglobulins|immunoglobulins|mesh-list
101638448|NCT05624996|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101638449|NCT05624996|Immunoglobulin G|immunoglobulin g|mesh-list
101638450|NCT05624996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101638451|NCT05624996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101638452|NCT05624996|Tubulin Modulators|tubulin modulators|mesh-ancestor
101638453|NCT05624996|Antimitotic Agents|antimitotic agents|mesh-ancestor
101638454|NCT05624996|Mitosis Modulators|mitosis modulators|mesh-ancestor
101638455|NCT05624996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638466|NCT05612594|Ertugliflozin|ertugliflozin|mesh-list
101638520|NCT05440708|Bevacizumab|bevacizumab|mesh-list
101638521|NCT05440708|Pembrolizumab|pembrolizumab|mesh-list
101638522|NCT05440708|Atezolizumab|atezolizumab|mesh-list
101295626|NCT01985789|Histamine Agents|histamine agents|mesh-ancestor
101638899|NCT04683939|Paclitaxel|paclitaxel|mesh-list
101638967|NCT04588246|Dopamine Agents|dopamine agents|mesh-ancestor
101638968|NCT04588246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101638969|NCT04588246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638970|NCT04588246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638971|NCT04588246|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101638972|NCT04588246|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101639120|NCT04154982|Protective Agents|protective agents|mesh-ancestor
101639195|NCT04037254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101639348|NCT03505762|Alkylating Agents|alkylating agents|mesh-ancestor
101639495|NCT03212742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639569|NCT03000439|Tofacitinib|tofacitinib|mesh-list
101639719|NCT02566304|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101639795|NCT01946529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101640092|NCT00749398|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101640249|NCT00699283|Brivaracetam|brivaracetam|mesh-list
101640320|NCT02567461|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101941534|NCT01228617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640620|NCT00921505|Acetaminophen|acetaminophen|mesh-list
101640914|NCT05141552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101941536|NCT01227759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101641067|NCT02563951|Granisetron|granisetron|mesh-list
101941537|NCT01227759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101641212|NCT00689611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101941538|NCT01227759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101641737|NCT00729586|Temsirolimus|temsirolimus|mesh-list
101941540|NCT03923829|Zinc Sulfate|zinc sulfate|mesh-list
101642036|NCT02857244|Nootropic Agents|nootropic agents|mesh-ancestor
101642412|NCT02851394|Levobupivacaine|levobupivacaine|mesh-list
101941541|NCT03923829|Trace Elements|trace elements|mesh-ancestor
101941542|NCT03923829|Micronutrients|micronutrients|mesh-ancestor
101941543|NCT03923829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941544|NCT03923829|Astringents|astringents|mesh-ancestor
101643013|NCT00753727|Growth Substances|growth substances|mesh-ancestor
101941545|NCT03923829|Dermatologic Agents|dermatologic agents|mesh-ancestor
101643413|NCT00716092|Hormones|hormones|mesh-ancestor
101643536|NCT00714688|Dopamine Agents|dopamine agents|mesh-ancestor
101643835|NCT00571519|Metformin|metformin|mesh-list
101644061|NCT04115956|Dexamethasone|dexamethasone|mesh-list
101644138|NCT04674514|Glucocorticoids|glucocorticoids|mesh-ancestor
101644290|NCT04079374|Etanercept|etanercept|mesh-list
101941547|NCT01128075|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101644513|NCT05857059|Misoprostol|misoprostol|mesh-list
101644669|NCT05678647|Iron|iron|mesh-list
101941548|NCT01128075|Immunologic Factors|immunologic factors|mesh-ancestor
101941549|NCT01128075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941550|NCT01128075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101235796|NCT01594879|Levonorgestrel|levonorgestrel|mesh-list
101645560|NCT00572169|Glucocorticoids|glucocorticoids|mesh-ancestor
101941552|NCT01128075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101941553|NCT03923751|Anesthetics|anesthetics|mesh-list
101941554|NCT03923751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101646313|NCT03955042|Pemetrexed|pemetrexed|mesh-list
101646383|NCT03913702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101646694|NCT00777595|Moxifloxacin|moxifloxacin|mesh-list
101941555|NCT03923751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647137|NCT00597753|Epoetin Alfa|epoetin alfa|mesh-list
101647217|NCT00879879|Losartan|losartan|mesh-list
101647360|NCT00665353|Pioglitazone|pioglitazone|mesh-list
101647440|NCT00662883|Dermatologic Agents|dermatologic agents|mesh-ancestor
101647707|NCT00666757|Sertraline|sertraline|mesh-list
101647806|NCT00786331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101647879|NCT00672399|Incretins|incretins|mesh-ancestor
101941557|NCT03923361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101647958|NCT00792025|Sunitinib|sunitinib|mesh-list
101648029|NCT00787111|Antidepressive Agents|antidepressive agents|mesh-ancestor
101648182|NCT00609596|Dutasteride|dutasteride|mesh-list
101648249|NCT04259684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101941558|NCT03923361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101648627|NCT04992572|Anesthetics, Local|anesthetics, local|mesh-ancestor
101648704|NCT00994643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101941559|NCT03923361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941560|NCT03923361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101941562|NCT03923361|Anesthetics|anesthetics|mesh-ancestor
101649073|NCT00991289|Nitazoxanide|nitazoxanide|mesh-list
101649305|NCT00802009|Hormones|hormones|mesh-ancestor
101941563|NCT03740295|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
101649450|NCT00686439|Adalimumab|adalimumab|mesh-list
101649522|NCT04257656|Antiviral Agents|antiviral agents|mesh-ancestor
101941564|NCT03740295|Antioxidants|antioxidants|mesh-ancestor
101650274|NCT05400603|Alkylating Agents|alkylating agents|mesh-ancestor
101650494|NCT04472611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101650592|NCT03842696|Vorinostat|vorinostat|mesh-list
101650718|NCT02859896|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
101941565|NCT03740295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650939|NCT00695331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651014|NCT02623569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101651237|NCT02620995|Sildenafil Citrate|sildenafil citrate|mesh-list
101941566|NCT03740295|Protective Agents|protective agents|mesh-ancestor
101651536|NCT00629681|Pregabalin|pregabalin|mesh-list
101651684|NCT00631514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101651768|NCT04775329|Rifaximin|rifaximin|mesh-list
101651921|NCT00806923|Bevacizumab|bevacizumab|mesh-list
101652444|NCT00808171|Lidocaine|lidocaine|mesh-list
101652519|NCT04286711|Apatinib|apatinib|mesh-list
101652662|NCT04253132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101652887|NCT00642811|Aspirin|aspirin|mesh-list
101941568|NCT03740295|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101653260|NCT00910910|Growth Inhibitors|growth inhibitors|mesh-ancestor
101653486|NCT00648895|Metoprolol|metoprolol|mesh-list
101941569|NCT03740295|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101653641|NCT00817375|Analgesics|analgesics|mesh-ancestor
101653784|NCT02992964|Nivolumab|nivolumab|mesh-list
101653862|NCT00574405|Insulin|insulin|mesh-list
101653948|NCT00638443|Anesthetics|anesthetics|mesh-ancestor
101654009|NCT03667313|Antifungal Agents|antifungal agents|mesh-ancestor
101235804|NCT01594905|Tenofovir|tenofovir|mesh-list
101941570|NCT03740295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101654386|NCT00824239|Fentanyl|fentanyl|mesh-list
101654610|NCT05242718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101941571|NCT03740295|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101941572|NCT02965378|Docetaxel|docetaxel|mesh-list
101654763|NCT00623623|Anticoagulants|anticoagulants|mesh-ancestor
101654829|NCT00901628|Sympathomimetics|sympathomimetics|mesh-ancestor
101655137|NCT02838576|Estrogens|estrogens|mesh-list
101655213|NCT05878561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101655290|NCT05877846|Ergocalciferols|ergocalciferols|mesh-list
101655513|NCT05474846|Protective Agents|protective agents|mesh-ancestor
101655587|NCT05307770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655589|NCT05307770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655590|NCT05307770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101655591|NCT05307458|Buprenorphine|buprenorphine|mesh-list
101941573|NCT02965378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101941574|NCT02965378|Tubulin Modulators|tubulin modulators|mesh-ancestor
101941575|NCT02965378|Antimitotic Agents|antimitotic agents|mesh-ancestor
101656116|NCT02593526|Bumetanide|bumetanide|mesh-list
101656185|NCT02106507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101941576|NCT02965378|Mitosis Modulators|mitosis modulators|mesh-ancestor
101656497|NCT00835731|Vitamins|vitamins|mesh-ancestor
101656715|NCT00892008|Anticonvulsants|anticonvulsants|mesh-ancestor
101941577|NCT02965378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657086|NCT00888654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101657162|NCT02827656|Contraceptive Agents|contraceptive agents|mesh-ancestor
101657309|NCT02839928|Anesthetics|anesthetics|mesh-ancestor
101657455|NCT00621517|Dopamine Agents|dopamine agents|mesh-ancestor
101941579|NCT01224093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101657680|NCT05660694|Micronutrients|micronutrients|mesh-ancestor
101657756|NCT05659992|Antimetabolites|antimetabolites|mesh-ancestor
101657831|NCT00705549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101658057|NCT00849511|Protective Agents|protective agents|mesh-ancestor
101658504|NCT00619801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941580|NCT01224093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101658678|NCT00962585|Equol|equol|mesh-list
101941582|NCT01224093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941583|NCT01224093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101941584|NCT03772041|Tolvaptan|tolvaptan|mesh-list
101659326|NCT00858715|Antipyretics|antipyretics|mesh-ancestor
101659719|NCT05977868|Vancomycin|vancomycin|mesh-list
101659786|NCT05975307|Antimetabolites|antimetabolites|mesh-ancestor
101660011|NCT05698524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101660235|NCT05345171|Hormones|hormones|mesh-ancestor
101941585|NCT03772041|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101941586|NCT03772041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660537|NCT04665037|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101660538|NCT04665037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101660539|NCT04665037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101660540|NCT04665037|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101660541|NCT04665037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101660542|NCT04665037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101660543|NCT04665037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660544|NCT04665037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101660545|NCT04665037|Hormone Antagonists|hormone antagonists|mesh-ancestor
101660546|NCT04665037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101660547|NCT04665037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660614|NCT04586504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101941587|NCT03772041|Natriuretic Agents|natriuretic agents|mesh-ancestor
101941588|NCT03772041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941590|NCT03922815|Propofol|propofol|mesh-list
101941591|NCT03922815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101941592|NCT03922815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101941593|NCT03922815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941594|NCT03922815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101941595|NCT03922815|Anesthetics, General|anesthetics, general|mesh-ancestor
101941596|NCT03922815|Anesthetics|anesthetics|mesh-ancestor
101941597|NCT03922815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101660774|NCT04158258|Pertuzumab|pertuzumab|mesh-list
101941598|NCT03922815|Narcotics|narcotics|mesh-ancestor
101660990|NCT03492437|Tepotinib|tepotinib|mesh-list
101661137|NCT02738866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101661520|NCT00855205|Rituximab|rituximab|mesh-list
101661662|NCT02798250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101941599|NCT03922815|Analgesics|analgesics|mesh-ancestor
101661740|NCT00865501|Diuretics|diuretics|mesh-ancestor
101941600|NCT03922815|Sensory System Agents|sensory system agents|mesh-ancestor
101662259|NCT00871039|GABA Agents|gaba agents|mesh-ancestor
101662419|NCT03637062|Hormones|hormones|mesh-ancestor
101662629|NCT00868153|Levonorgestrel|levonorgestrel|mesh-list
101662721|NCT00616603|BB 1101|bb 1101|mesh-list
101941601|NCT03922815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101662929|NCT02785146|Calcium, Dietary|calcium, dietary|mesh-list
101663006|NCT00874393|Hydrocortisone|hydrocortisone|mesh-list
101663160|NCT04029831|Ketamine|ketamine|mesh-list
101663235|NCT00590577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101663536|NCT00880867|Poly ICLC|poly iclc|mesh-list
101663614|NCT00881179|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101941602|NCT03922815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101663910|NCT02838992|Alkylating Agents|alkylating agents|mesh-ancestor
101664132|NCT02779530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101664207|NCT02778906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101664290|NCT02836184|Niacin|niacin|mesh-list
101664506|NCT02772822|Rituximab|rituximab|mesh-list
101664579|NCT02835404|Nedaplatin|nedaplatin|mesh-list
101941603|NCT01227915|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
101941604|NCT01227915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101665256|NCT00890539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101941605|NCT01227915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101665627|NCT00799383|Micronutrients|micronutrients|mesh-ancestor
101665704|NCT04222686|Losartan|losartan|mesh-list
101665851|NCT00945815|Antiviral Agents|antiviral agents|mesh-ancestor
101666148|NCT02752308|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101941606|NCT01227915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101941607|NCT01227915|Glucocorticoids|glucocorticoids|mesh-ancestor
101941608|NCT01227915|Hormones|hormones|mesh-ancestor
101666446|NCT02751294|Antimalarials|antimalarials|mesh-ancestor
101666821|NCT00905905|Antimetabolites|antimetabolites|mesh-ancestor
101667122|NCT04220892|Pembrolizumab|pembrolizumab|mesh-list
101667340|NCT00605891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101667486|NCT04242914|Anesthetics, General|anesthetics, general|mesh-ancestor
101667644|NCT00900445|Prednisone|prednisone|mesh-list
101668164|NCT00908089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101668468|NCT02744196|Methotrexate|methotrexate|mesh-list
101668693|NCT05629260|Immunologic Factors|immunologic factors|mesh-ancestor
101668994|NCT02731950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669229|NCT00939341|Budesonide|budesonide|mesh-list
101669364|NCT05788094|Tafenoquine|tafenoquine|mesh-list
101669515|NCT05739136|Norethindrone Acetate|norethindrone acetate|mesh-list
101669516|NCT05739136|Estradiol|estradiol|mesh-list
101669517|NCT05739136|Relugolix|relugolix|mesh-list
101669518|NCT05739136|Estrogens|estrogens|mesh-ancestor
101669519|NCT05739136|Hormones|hormones|mesh-ancestor
101669520|NCT05739136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101669521|NCT05739136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669522|NCT05739136|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101669523|NCT05739136|Contraceptive Agents|contraceptive agents|mesh-ancestor
101961556|NCT03560739|Ofatumumab|ofatumumab|mesh-list
101669524|NCT05739136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101669525|NCT05739136|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101669526|NCT05739136|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101669527|NCT05739136|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101669528|NCT05739136|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101669529|NCT05739136|Androgen Antagonists|androgen antagonists|mesh-ancestor
101669530|NCT05739136|Hormone Antagonists|hormone antagonists|mesh-ancestor
101669531|NCT05737030|N-Methylaspartate|n-methylaspartate|mesh-list
101669532|NCT05737030|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
101669533|NCT05737030|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101669534|NCT05737030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101669535|NCT05737030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669565|NCT05702827|Meloxicam|meloxicam|mesh-list
101669593|NCT05654298|Sumatriptan|sumatriptan|mesh-list
101669663|NCT05506046|Cholinergic Agents|cholinergic agents|mesh-ancestor
101669739|NCT05411718|Antipyretics|antipyretics|mesh-ancestor
101669960|NCT04637282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101669961|NCT04598477|Prednisone|prednisone|mesh-list
101669962|NCT04598477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101669963|NCT04598477|Glucocorticoids|glucocorticoids|mesh-ancestor
101669964|NCT04598477|Hormones|hormones|mesh-ancestor
101669965|NCT04598477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101669966|NCT04598477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669967|NCT04598477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101669968|NCT04598477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101669969|NCT04594408|Epinephrine|epinephrine|mesh-list
101670041|NCT04423627|Analgesics|analgesics|mesh-ancestor
101670111|NCT04292470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101670185|NCT04046549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101670259|NCT03644667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101670260|NCT03644667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670261|NCT03644667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101670262|NCT03644667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670263|NCT03644667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101670264|NCT03644667|Immunologic Factors|immunologic factors|mesh-ancestor
101670265|NCT03644667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101670266|NCT03644667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235872|NCT01595399|Mydriatics|mydriatics|mesh-ancestor
101670267|NCT03644667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101670408|NCT02772003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670482|NCT02337829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670495|NCT02257528|Nivolumab|nivolumab|mesh-list
101670496|NCT02257528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101670497|NCT02257528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670498|NCT02257528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101670499|NCT02257528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670500|NCT02179086|Temozolomide|temozolomide|mesh-list
101670501|NCT02179086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101670502|NCT02179086|Alkylating Agents|alkylating agents|mesh-ancestor
101670503|NCT02179086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670504|NCT02179086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670555|NCT01375829|MTOR Inhibitors|mtor inhibitors|mesh-list
101670629|NCT02730624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101670705|NCT04253964|Tubulin Modulators|tubulin modulators|mesh-ancestor
101670785|NCT02729766|Empagliflozin|empagliflozin|mesh-list
101670921|NCT00926653|Serotonin Agents|serotonin agents|mesh-ancestor
101671013|NCT02738814|Propofol|propofol|mesh-list
101671295|NCT05906225|Anesthetics|anesthetics|mesh-list
101671677|NCT05488847|Mydriatics|mydriatics|mesh-ancestor
101671830|NCT05159453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101671906|NCT04544436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101941609|NCT01227915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101941610|NCT01227915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672282|NCT03593590|Ocrelizumab|ocrelizumab|mesh-list
101941612|NCT01227915|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101941613|NCT01224405|Docetaxel|docetaxel|mesh-list
101941614|NCT01224405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101673034|NCT00003519|Docetaxel|docetaxel|mesh-list
101673341|NCT04004078|Miconazole|miconazole|mesh-list
101941615|NCT01224405|Tubulin Modulators|tubulin modulators|mesh-ancestor
101941616|NCT01224405|Antimitotic Agents|antimitotic agents|mesh-ancestor
101941617|NCT01224405|Mitosis Modulators|mitosis modulators|mesh-ancestor
101539735|NCT01128595|Xhance|xhance|mesh-list
101674454|NCT00637988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101674907|NCT06005259|Spironolactone|spironolactone|mesh-list
101674975|NCT06004947|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101675276|NCT05884528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675426|NCT05765851|Immunoconjugates|immunoconjugates|mesh-ancestor
101675576|NCT05600894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675577|NCT05600894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101675579|NCT05568888|Hemostatics|hemostatics|mesh-ancestor
101675580|NCT05568888|Coagulants|coagulants|mesh-ancestor
101675581|NCT05553834|Cemiplimab|cemiplimab|mesh-list
101675582|NCT05553834|Alirocumab|alirocumab|mesh-list
101675583|NCT05553834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101675950|NCT05193071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101676025|NCT05063565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101676026|NCT05063565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676027|NCT05063565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676028|NCT05042505|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101676029|NCT05042505|Dapagliflozin|dapagliflozin|mesh-list
101676030|NCT05042505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101676264|NCT04458259|Axitinib|axitinib|mesh-list
101676324|NCT04310007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676325|NCT04310007|Tubulin Modulators|tubulin modulators|mesh-ancestor
101676326|NCT04310007|Antimitotic Agents|antimitotic agents|mesh-ancestor
101676327|NCT04310007|Mitosis Modulators|mitosis modulators|mesh-ancestor
101676328|NCT04310007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676400|NCT04194203|Carboplatin|carboplatin|mesh-list
101676401|NCT04194203|Pemetrexed|pemetrexed|mesh-list
101676402|NCT04194203|Atezolizumab|atezolizumab|mesh-list
101676403|NCT04194203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101676404|NCT04194203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676405|NCT04194203|Tubulin Modulators|tubulin modulators|mesh-ancestor
101676406|NCT04194203|Antimitotic Agents|antimitotic agents|mesh-ancestor
101676407|NCT04194203|Mitosis Modulators|mitosis modulators|mesh-ancestor
101676408|NCT04194203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676409|NCT04194203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101676410|NCT04194203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101676411|NCT04194203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101676412|NCT04194203|Growth Substances|growth substances|mesh-ancestor
101676413|NCT04194203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676414|NCT04194203|Growth Inhibitors|growth inhibitors|mesh-ancestor
101676415|NCT04194203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101676416|NCT04194203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101676417|NCT04194203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101676418|NCT04194203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101676419|NCT04172532|Peposertib|peposertib|mesh-list
101676420|NCT04172532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101676421|NCT04172532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101676422|NCT04172532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676423|NCT04164082|Gemcitabine|gemcitabine|mesh-list
101676552|NCT03971253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101676857|NCT03250975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676932|NCT03049189|Edotreotide|edotreotide|mesh-list
101677010|NCT02823665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101677239|NCT00999336|Anticoagulants|anticoagulants|mesh-ancestor
101677462|NCT02788058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101677541|NCT04094805|Vitamins|vitamins|mesh-ancestor
101677611|NCT02787356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101677757|NCT02783222|Paclitaxel|paclitaxel|mesh-list
101677906|NCT05131178|Bupivacaine|bupivacaine|mesh-list
101677999|NCT05453253|Vaccines|vaccines|mesh-list
101678133|NCT02714010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101678208|NCT04908605|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101678353|NCT00634790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101678517|NCT00940693|Analgesics|analgesics|mesh-ancestor
101941618|NCT01224405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101941619|NCT02899156|Flumazenil|flumazenil|mesh-list
101941620|NCT02899156|Antidotes|antidotes|mesh-ancestor
101679265|NCT05387031|Ustekinumab|ustekinumab|mesh-list
101679559|NCT00637871|Tamoxifen|tamoxifen|mesh-list
101679704|NCT02767154|Mannitol|mannitol|mesh-list
101679779|NCT00644319|Analgesics|analgesics|mesh-ancestor
101679932|NCT00644475|Protease Inhibitors|protease inhibitors|mesh-ancestor
101680303|NCT00646737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101680456|NCT04172259|Cyclophosphamide|cyclophosphamide|mesh-list
101941622|NCT02899156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680675|NCT02768168|Narcotics|narcotics|mesh-ancestor
101941623|NCT02899156|GABA Modulators|gaba modulators|mesh-ancestor
101681674|NCT00913835|Olaratumab|olaratumab|mesh-list
101681722|NCT04218500|Niacin|niacin|mesh-list
101941624|NCT02899156|GABA Agents|gaba agents|mesh-ancestor
101682092|NCT00911807|Nootropic Agents|nootropic agents|mesh-ancestor
101682316|NCT02735798|Gancotamab|gancotamab|mesh-list
101682394|NCT02740166|Propranolol|propranolol|mesh-list
101941625|NCT02899156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101941626|NCT02899156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682691|NCT02728622|Antimitotic Agents|antimitotic agents|mesh-ancestor
101941628|NCT01131429|Docetaxel|docetaxel|mesh-list
101683293|NCT00650481|Autonomic Agents|autonomic agents|mesh-ancestor
101683444|NCT02722694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101683518|NCT00302744|Niacin|niacin|mesh-list
101683599|NCT04005872|Calcium|calcium|mesh-list
101941629|NCT01131429|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101941631|NCT01131429|Tubulin Modulators|tubulin modulators|mesh-ancestor
101684931|NCT00670293|Dopamine Agents|dopamine agents|mesh-ancestor
101685154|NCT03094052|Narcotics|narcotics|mesh-ancestor
101685312|NCT02702960|Mycophenolic Acid|mycophenolic acid|mesh-list
101685459|NCT03739853|Antimetabolites|antimetabolites|mesh-ancestor
101836653|NCT00308074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836654|NCT00308074|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101836655|NCT00308074|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101836656|NCT00308074|Serotonin Agents|serotonin agents|mesh-ancestor
101836657|NCT00308074|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101836658|NCT00308074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101836659|NCT00308074|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101836660|NCT00308074|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101836661|NCT03997058|Estazolam|estazolam|mesh-list
101836662|NCT03997058|Anticonvulsants|anticonvulsants|mesh-ancestor
101836663|NCT03997058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101836664|NCT03997058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101836665|NCT03997058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101836666|NCT03997058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836667|NCT03997058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101836668|NCT03997058|GABA Modulators|gaba modulators|mesh-ancestor
101836669|NCT03997058|GABA Agents|gaba agents|mesh-ancestor
101836670|NCT03997058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101836671|NCT03997058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836672|NCT00500760|Panitumumab|panitumumab|mesh-list
101836673|NCT00500760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101836674|NCT00500760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101836675|NCT01016730|Bortezomib|bortezomib|mesh-list
101836676|NCT01016730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101836677|NCT01012934|Alendronate|alendronate|mesh-list
101836678|NCT01012934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101836679|NCT01012934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836680|NCT04334330|Trastuzumab|trastuzumab|mesh-list
101836681|NCT04334330|Fulvestrant|fulvestrant|mesh-list
101836682|NCT04334330|Palbociclib|palbociclib|mesh-list
101836683|NCT04334330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101836684|NCT04334330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101836685|NCT04334330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101836686|NCT04334330|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101836687|NCT04334330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101836688|NCT04334330|Hormone Antagonists|hormone antagonists|mesh-ancestor
101836689|NCT04334330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101836690|NCT04334330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235940|NCT01595789|Hormones|hormones|mesh-ancestor
101836691|NCT04334330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101836692|NCT04334330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101836693|NCT04334330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836694|NCT01015196|Daunorubicin|daunorubicin|mesh-list
101836695|NCT01015196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101836696|NCT01015196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101836697|NCT01015196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101836698|NCT01015196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101836699|NCT01015196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101836700|NCT01015196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836701|NCT01009892|Codeine|codeine|mesh-list
101836702|NCT01009892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101836703|NCT01009892|Narcotics|narcotics|mesh-ancestor
101836704|NCT01009892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101836705|NCT01009892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836706|NCT01009892|Analgesics|analgesics|mesh-ancestor
101836707|NCT01009892|Sensory System Agents|sensory system agents|mesh-ancestor
101836708|NCT01009892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101836709|NCT01009892|Antitussive Agents|antitussive agents|mesh-ancestor
101836710|NCT01009892|Respiratory System Agents|respiratory system agents|mesh-ancestor
101836711|NCT00307684|Methylphenidate|methylphenidate|mesh-list
101836712|NCT00307684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101836713|NCT00307684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836714|NCT00307684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101556485|NCT05920798|Immunologic Factors|immunologic factors|mesh-ancestor
101556486|NCT05920798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556487|NCT05920798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101836715|NCT00307684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101836716|NCT00307684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101836717|NCT00307684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836719|NCT00307684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101836721|NCT00489918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101836722|NCT00489918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836723|NCT00489918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101836724|NCT01061788|Everolimus|everolimus|mesh-list
101836725|NCT01061788|Panitumumab|panitumumab|mesh-list
101836726|NCT01061788|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101836727|NCT01061788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101836728|NCT01061788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101836729|NCT01061788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836730|NCT01061788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101836731|NCT01061788|Immunologic Factors|immunologic factors|mesh-ancestor
101836732|NCT01061788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836733|NCT01061788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101836734|NCT01061788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101961703|NCT03726177|Aspirin|aspirin|mesh-list
101836735|NCT00307294|Thalidomide|thalidomide|mesh-list
101836736|NCT00307294|Doxorubicin|doxorubicin|mesh-list
101836737|NCT00307294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101836738|NCT00307294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101836739|NCT00307294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101836740|NCT00307294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101836741|NCT00307294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101836742|NCT00307294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836743|NCT00307294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101836744|NCT00307294|Immunologic Factors|immunologic factors|mesh-ancestor
101836745|NCT00307294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836746|NCT00307294|Leprostatic Agents|leprostatic agents|mesh-ancestor
101836747|NCT00307294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101836748|NCT00307294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101836749|NCT00307294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101836750|NCT00307294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101836751|NCT00307294|Growth Substances|growth substances|mesh-ancestor
101836752|NCT00307294|Growth Inhibitors|growth inhibitors|mesh-ancestor
101836753|NCT03981094|Pirfenidone|pirfenidone|mesh-list
101836754|NCT03981094|Analgesics|analgesics|mesh-ancestor
101836755|NCT03981094|Sensory System Agents|sensory system agents|mesh-ancestor
101836756|NCT03981094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101836757|NCT03981094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836758|NCT03981094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101836759|NCT03981094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101836760|NCT03981094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101836761|NCT03981094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101836762|NCT03981094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101836763|NCT03963401|PF-06700841|pf-06700841|mesh-list
101836764|NCT03963401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101836765|NCT03963401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101836766|NCT03963401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836767|NCT04410965|Teriflunomide|teriflunomide|mesh-list
101836768|NCT04410965|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101836769|NCT04410965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101836770|NCT04410965|Analgesics|analgesics|mesh-ancestor
101836771|NCT04410965|Sensory System Agents|sensory system agents|mesh-ancestor
101836772|NCT04410965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101836773|NCT04410965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836774|NCT04410965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101836775|NCT04410965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101836776|NCT04410965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101836777|NCT04410965|Immunologic Factors|immunologic factors|mesh-ancestor
101836778|NCT04012775|Insulin|insulin|mesh-list
101836779|NCT04012775|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101836780|NCT04012775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101836781|NCT04012775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836782|NCT00944723|Vitamins|vitamins|mesh-list
101836783|NCT00944723|Zinc|zinc|mesh-list
101836784|NCT00944723|Vitamin B Complex|vitamin b complex|mesh-list
101836785|NCT00944723|Zinc Sulfate|zinc sulfate|mesh-list
101836786|NCT00944723|Micronutrients|micronutrients|mesh-ancestor
101836787|NCT00944723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836788|NCT00944723|Trace Elements|trace elements|mesh-ancestor
101836789|NCT00944723|Astringents|astringents|mesh-ancestor
101836791|NCT00944801|Doxorubicin|doxorubicin|mesh-list
101836792|NCT00944801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101836793|NCT00944801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101504534|NCT00509184|Rituximab|rituximab|mesh-list
101836794|NCT00944801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101836795|NCT00944801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101836796|NCT00944801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101836797|NCT00944801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101836798|NCT00944801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836799|NCT01060228|Valproic Acid|valproic acid|mesh-list
101836800|NCT01060228|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101836801|NCT01060228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101836802|NCT01060228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101836803|NCT01060228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101836804|NCT01060228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836805|NCT01060228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101836806|NCT01060228|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101836807|NCT01060228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101836808|NCT01060228|Serotonin Agents|serotonin agents|mesh-ancestor
101836809|NCT01060228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101836810|NCT01060228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836811|NCT01060228|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101836812|NCT01060228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101836813|NCT01060228|Dopamine Agents|dopamine agents|mesh-ancestor
101836814|NCT01060228|Anticonvulsants|anticonvulsants|mesh-ancestor
101836815|NCT01060228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101836816|NCT01060228|GABA Agents|gaba agents|mesh-ancestor
101836817|NCT01060228|Antimanic Agents|antimanic agents|mesh-ancestor
101836818|NCT00306670|Prednisone|prednisone|mesh-list
101836819|NCT00306670|Rituximab|rituximab|mesh-list
101836820|NCT00306670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101836821|NCT00306670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101836822|NCT00306670|Immunologic Factors|immunologic factors|mesh-ancestor
101836823|NCT00306670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836824|NCT00306670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101836825|NCT00306670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101836826|NCT00306670|Glucocorticoids|glucocorticoids|mesh-ancestor
101836827|NCT00306670|Hormones|hormones|mesh-ancestor
101836828|NCT00306670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101836829|NCT00306670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101836830|NCT00306592|Natalizumab|natalizumab|mesh-list
101836831|NCT00306592|Immunologic Factors|immunologic factors|mesh-ancestor
101836832|NCT00306592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836833|NCT00321646|Bevacizumab|bevacizumab|mesh-list
101836834|NCT00321646|Docetaxel|docetaxel|mesh-list
101836835|NCT00321646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101836836|NCT00321646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101836837|NCT00321646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101836838|NCT00321646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101836839|NCT00321646|Growth Substances|growth substances|mesh-ancestor
101836840|NCT00321646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836841|NCT00321646|Growth Inhibitors|growth inhibitors|mesh-ancestor
101836842|NCT00321646|Tubulin Modulators|tubulin modulators|mesh-ancestor
101836843|NCT00321646|Antimitotic Agents|antimitotic agents|mesh-ancestor
101836844|NCT00321646|Mitosis Modulators|mitosis modulators|mesh-ancestor
101836845|NCT00321646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836846|NCT00403767|Warfarin|warfarin|mesh-list
101836847|NCT00403767|Rivaroxaban|rivaroxaban|mesh-list
101836848|NCT00403767|Anticoagulants|anticoagulants|mesh-ancestor
101836849|NCT00403767|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101836850|NCT00403767|Antithrombins|antithrombins|mesh-ancestor
101836851|NCT00403767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101836852|NCT00403767|Protease Inhibitors|protease inhibitors|mesh-ancestor
101836853|NCT00403767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101836854|NCT00403767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836856|NCT00492284|Ranibizumab|ranibizumab|mesh-list
101836857|NCT00492284|Verteporfin|verteporfin|mesh-list
101836858|NCT00492284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101836859|NCT00492284|Antiemetics|antiemetics|mesh-ancestor
101836860|NCT00492284|Autonomic Agents|autonomic agents|mesh-ancestor
101836861|NCT00492284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101836862|NCT00492284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836863|NCT00492284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101836864|NCT00492284|Glucocorticoids|glucocorticoids|mesh-ancestor
101836865|NCT00492284|Hormones|hormones|mesh-ancestor
101836866|NCT00492284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101836867|NCT00492284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101941633|NCT01131429|Mitosis Modulators|mitosis modulators|mesh-ancestor
101836868|NCT00492284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101836869|NCT00492284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101836870|NCT00492284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101836871|NCT00492284|Growth Substances|growth substances|mesh-ancestor
101836872|NCT00492284|Growth Inhibitors|growth inhibitors|mesh-ancestor
101836873|NCT00492284|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101836874|NCT00492284|Dermatologic Agents|dermatologic agents|mesh-ancestor
101836876|NCT01013012|Ramosetron|ramosetron|mesh-list
101836877|NCT01013012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101836878|NCT01013012|Antiemetics|antiemetics|mesh-ancestor
101836879|NCT01013012|Autonomic Agents|autonomic agents|mesh-ancestor
101836880|NCT01013012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101836881|NCT01013012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836882|NCT01013012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101836883|NCT01013012|Glucocorticoids|glucocorticoids|mesh-ancestor
101836884|NCT01013012|Hormones|hormones|mesh-ancestor
101836885|NCT01013012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101836886|NCT01013012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101836887|NCT01013012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101836888|NCT01013012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101836889|NCT01013012|Serotonin Agents|serotonin agents|mesh-ancestor
101836890|NCT01013012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101836891|NCT01013012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836892|NCT01009970|Prednisone|prednisone|mesh-list
101836893|NCT01009970|Cyclophosphamide|cyclophosphamide|mesh-list
101836894|NCT01009970|Rituximab|rituximab|mesh-list
101836895|NCT01009970|Doxorubicin|doxorubicin|mesh-list
101836896|NCT01009970|Vincristine|vincristine|mesh-list
101836897|NCT01009970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101836898|NCT01009970|Immunologic Factors|immunologic factors|mesh-ancestor
101836899|NCT01009970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836900|NCT01009970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101836901|NCT01009970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101836902|NCT01009970|Alkylating Agents|alkylating agents|mesh-ancestor
101836903|NCT01009970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836904|NCT01009970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101961750|NCT03726021|Irinotecan|irinotecan|mesh-list
101836905|NCT01009970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101836906|NCT01009970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101836907|NCT01009970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101836908|NCT01009970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101836909|NCT01009970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101836910|NCT01009970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101836911|NCT01009970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101836912|NCT01009970|Glucocorticoids|glucocorticoids|mesh-ancestor
101836913|NCT01009970|Hormones|hormones|mesh-ancestor
101836914|NCT01009970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101836915|NCT01009970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101836916|NCT01009970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101836917|NCT01009970|Tubulin Modulators|tubulin modulators|mesh-ancestor
101836918|NCT01009970|Antimitotic Agents|antimitotic agents|mesh-ancestor
101836919|NCT01009970|Mitosis Modulators|mitosis modulators|mesh-ancestor
101836920|NCT01015352|Azacitidine|azacitidine|mesh-list
101836921|NCT01015352|Epoetin Alfa|epoetin alfa|mesh-list
101836922|NCT01015352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101836923|NCT01015352|Antimetabolites|antimetabolites|mesh-ancestor
101836924|NCT01015352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836925|NCT01015352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101836926|NCT01015352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101836927|NCT01015352|Hematinics|hematinics|mesh-ancestor
101836928|NCT03563157|Leucovorin|leucovorin|mesh-list
101836929|NCT03563157|Paclitaxel|paclitaxel|mesh-list
101836930|NCT03563157|Cyclophosphamide|cyclophosphamide|mesh-list
101836931|NCT03563157|Fluorouracil|fluorouracil|mesh-list
101836932|NCT03563157|Capecitabine|capecitabine|mesh-list
101836933|NCT03563157|Oxaliplatin|oxaliplatin|mesh-list
101836934|NCT03563157|Cetuximab|cetuximab|mesh-list
101836935|NCT03563157|Avelumab|avelumab|mesh-list
101836936|NCT03563157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101836937|NCT03563157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101836938|NCT03563157|Tubulin Modulators|tubulin modulators|mesh-ancestor
101836939|NCT03563157|Antimitotic Agents|antimitotic agents|mesh-ancestor
101836940|NCT03563157|Mitosis Modulators|mitosis modulators|mesh-ancestor
101836941|NCT03563157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836943|NCT03563157|Immunologic Factors|immunologic factors|mesh-ancestor
101836944|NCT03563157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836945|NCT03563157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101836946|NCT03563157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101836947|NCT03563157|Alkylating Agents|alkylating agents|mesh-ancestor
101836948|NCT03563157|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101836949|NCT03563157|Antimetabolites|antimetabolites|mesh-ancestor
101836950|NCT03563157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101836951|NCT03563157|Antidotes|antidotes|mesh-ancestor
101836952|NCT03563157|Protective Agents|protective agents|mesh-ancestor
101836953|NCT03563157|Vitamin B Complex|vitamin b complex|mesh-ancestor
101836954|NCT03563157|Vitamins|vitamins|mesh-ancestor
101836955|NCT03563157|Micronutrients|micronutrients|mesh-ancestor
101836956|NCT03563157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101836957|NCT01010048|Nifedipine|nifedipine|mesh-list
101836958|NCT01010048|Bromides|bromides|mesh-list
101836959|NCT01010048|Propantheline|propantheline|mesh-list
101836960|NCT01010048|Tamsulosin|tamsulosin|mesh-list
101836961|NCT01010048|Progesterone|progesterone|mesh-list
101836962|NCT01010048|Progestins|progestins|mesh-ancestor
101836963|NCT01010048|Hormones|hormones|mesh-ancestor
101836964|NCT01010048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101961783|NCT03557931|Dopamine Agents|dopamine agents|mesh-ancestor
101836965|NCT01010048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836966|NCT01010048|Anticonvulsants|anticonvulsants|mesh-ancestor
101836967|NCT01010048|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101836968|NCT01010048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101836969|NCT01010048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101836970|NCT01010048|Adrenergic Agents|adrenergic agents|mesh-ancestor
101836971|NCT01010048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101836972|NCT01010048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836973|NCT01010048|Urological Agents|urological agents|mesh-ancestor
101836974|NCT01010048|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101836975|NCT01010048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101836976|NCT01010048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101836977|NCT01010048|Vasodilator Agents|vasodilator agents|mesh-ancestor
101836978|NCT01010048|Tocolytic Agents|tocolytic agents|mesh-ancestor
101836979|NCT01010048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101836980|NCT01010048|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101836981|NCT01010048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101836982|NCT01010048|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101836983|NCT01010048|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101836984|NCT01010048|Cholinergic Agents|cholinergic agents|mesh-ancestor
101836985|NCT01589055|Nicotine|nicotine|mesh-list
101836986|NCT01589055|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101836987|NCT01589055|Autonomic Agents|autonomic agents|mesh-ancestor
101836988|NCT01589055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101836989|NCT01589055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101836990|NCT01589055|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101836991|NCT01589055|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101836992|NCT01589055|Cholinergic Agents|cholinergic agents|mesh-ancestor
101836993|NCT01589055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101836994|NCT01589055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101836995|NCT00414765|Aldesleukin|aldesleukin|mesh-list
101836996|NCT00414765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101836997|NCT00414765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101836998|NCT00414765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101836999|NCT00414765|Antiviral Agents|antiviral agents|mesh-ancestor
101837000|NCT00414765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101837001|NCT03997292|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101837002|NCT03997292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101837003|NCT03997292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101837004|NCT03997292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837005|NCT01013402|Insulin|insulin|mesh-list
101837006|NCT01013402|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101837007|NCT01013402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101837008|NCT01013402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837009|NCT01013480|Baclofen|baclofen|mesh-list
101837010|NCT01013480|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101837011|NCT01013480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837012|NCT01013480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101837013|NCT01013480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101837014|NCT01013480|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101837015|NCT01013480|GABA Agonists|gaba agonists|mesh-ancestor
101837016|NCT01013480|GABA Agents|gaba agents|mesh-ancestor
101837017|NCT01013480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101837018|NCT01013480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837019|NCT00500370|Exenatide|exenatide|mesh-list
101837020|NCT00500370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101837021|NCT00500370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837022|NCT00500370|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101837023|NCT00500370|Incretins|incretins|mesh-ancestor
101837024|NCT00500370|Hormones|hormones|mesh-ancestor
101837025|NCT00500370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101837026|NCT00320788|Aflibercept|aflibercept|mesh-list
101837027|NCT00320788|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101837028|NCT00320788|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101837029|NCT00320788|Growth Substances|growth substances|mesh-ancestor
101837030|NCT00320788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837031|NCT00320788|Growth Inhibitors|growth inhibitors|mesh-ancestor
101837032|NCT00320788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101837033|NCT03996486|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
101837034|NCT03996486|Immunoglobulins|immunoglobulins|mesh-list
101837035|NCT03996486|Immunoglobulin G|immunoglobulin g|mesh-list
101837036|NCT03996486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101837037|NCT03996486|Myeloma Proteins|myeloma proteins|mesh-list
101837038|NCT03996486|Paraproteins|paraproteins|mesh-list
101837039|NCT03996486|Immunologic Factors|immunologic factors|mesh-ancestor
101837040|NCT03996486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837041|NCT03996486|Anticoagulants|anticoagulants|mesh-ancestor
101837042|NCT03996486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101837043|NCT03996486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101837044|NCT03996486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837045|NCT03996486|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101837046|NCT03996486|Protease Inhibitors|protease inhibitors|mesh-ancestor
101837047|NCT03996486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101837048|NCT03996486|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101837049|NCT03996486|Antithrombins|antithrombins|mesh-ancestor
101837050|NCT01014468|Bevacizumab|bevacizumab|mesh-list
101837051|NCT01014468|Ranibizumab|ranibizumab|mesh-list
101837052|NCT01014468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101837053|NCT01014468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101837054|NCT01014468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101837055|NCT01014468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101837056|NCT01014468|Growth Substances|growth substances|mesh-ancestor
101837057|NCT01014468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837058|NCT01014468|Growth Inhibitors|growth inhibitors|mesh-ancestor
101837059|NCT00503984|Prednisone|prednisone|mesh-list
101837060|NCT00503984|Docetaxel|docetaxel|mesh-list
101837061|NCT00503984|Azacitidine|azacitidine|mesh-list
101837062|NCT00503984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101837063|NCT00503984|Tubulin Modulators|tubulin modulators|mesh-ancestor
101837064|NCT00503984|Antimitotic Agents|antimitotic agents|mesh-ancestor
101837065|NCT00503984|Mitosis Modulators|mitosis modulators|mesh-ancestor
101837066|NCT00503984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837067|NCT00503984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101961820|NCT00293813|Denosumab|denosumab|mesh-list
101837068|NCT00503984|Glucocorticoids|glucocorticoids|mesh-ancestor
101837069|NCT00503984|Hormones|hormones|mesh-ancestor
101837070|NCT00503984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101837071|NCT00503984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837072|NCT00503984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101837073|NCT00503984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101837074|NCT00503984|Antimetabolites|antimetabolites|mesh-ancestor
101837075|NCT00503984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101837076|NCT03996564|Acetaminophen|acetaminophen|mesh-list
101837077|NCT03996564|Diclofenac|diclofenac|mesh-list
101837078|NCT03996564|Ketorolac|ketorolac|mesh-list
101837079|NCT03996564|Diazepam|diazepam|mesh-list
101837080|NCT03996564|Hydrocodone|hydrocodone|mesh-list
101837081|NCT03996564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101837082|NCT03996564|Analgesics|analgesics|mesh-ancestor
101837083|NCT03996564|Sensory System Agents|sensory system agents|mesh-ancestor
101837084|NCT03996564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101837085|NCT03996564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837086|NCT03996564|Antipyretics|antipyretics|mesh-ancestor
101837087|NCT03996564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101837088|NCT03996564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101837089|NCT03996564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101837090|NCT03996564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101837091|NCT03996564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101837092|NCT03996564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837093|NCT03996564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101837094|NCT03996564|Narcotics|narcotics|mesh-ancestor
101837095|NCT03996564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101837096|NCT03996564|Antitussive Agents|antitussive agents|mesh-ancestor
101837097|NCT03996564|Respiratory System Agents|respiratory system agents|mesh-ancestor
101837098|NCT03996564|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101837099|NCT03996564|Anticonvulsants|anticonvulsants|mesh-ancestor
101837100|NCT03996564|Antiemetics|antiemetics|mesh-ancestor
101837101|NCT03996564|Autonomic Agents|autonomic agents|mesh-ancestor
101837102|NCT03996564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101837103|NCT03996564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101837104|NCT03996564|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101837105|NCT03996564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101837106|NCT03996564|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101837107|NCT03996564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101837108|NCT03996564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101837109|NCT03996564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101837110|NCT03996564|Anesthetics, General|anesthetics, general|mesh-ancestor
101837111|NCT03996564|Anesthetics|anesthetics|mesh-ancestor
101837112|NCT03996564|GABA Modulators|gaba modulators|mesh-ancestor
101837113|NCT03996564|GABA Agents|gaba agents|mesh-ancestor
101837114|NCT03996564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101837115|NCT00565409|Etanercept|etanercept|mesh-list
101837116|NCT00565409|Methotrexate|methotrexate|mesh-list
101837117|NCT00565409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101837118|NCT00565409|Abortifacient Agents|abortifacient agents|mesh-ancestor
101837119|NCT00565409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101837120|NCT00565409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837121|NCT00565409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101837122|NCT00565409|Antimetabolites|antimetabolites|mesh-ancestor
101837123|NCT00565409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837124|NCT00565409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101837125|NCT00565409|Dermatologic Agents|dermatologic agents|mesh-ancestor
101837126|NCT00565409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101837127|NCT00565409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101837128|NCT00565409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101837129|NCT00565409|Immunologic Factors|immunologic factors|mesh-ancestor
101837130|NCT00565409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101837131|NCT00565409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101837132|NCT00565409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101837133|NCT00565409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101837134|NCT00565409|Analgesics|analgesics|mesh-ancestor
101837135|NCT00565409|Sensory System Agents|sensory system agents|mesh-ancestor
101837136|NCT00565409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101837137|NCT00565409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101837138|NCT00565409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101837140|NCT00394251|Cyclophosphamide|cyclophosphamide|mesh-list
101837141|NCT00394251|Bevacizumab|bevacizumab|mesh-list
101837142|NCT00394251|Doxorubicin|doxorubicin|mesh-list
101837143|NCT00394251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101837144|NCT00394251|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101837145|NCT00394251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101837146|NCT00394251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101837147|NCT00394251|Tubulin Modulators|tubulin modulators|mesh-ancestor
101837148|NCT00394251|Antimitotic Agents|antimitotic agents|mesh-ancestor
101837149|NCT00394251|Mitosis Modulators|mitosis modulators|mesh-ancestor
101685566|NCT00615212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101837150|NCT00394251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101961905|NCT00111917|Infliximab|infliximab|mesh-list
101837151|NCT00394251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101837152|NCT00394251|Immunologic Factors|immunologic factors|mesh-ancestor
101837153|NCT00394251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837154|NCT00394251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101837155|NCT00394251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101837156|NCT00394251|Alkylating Agents|alkylating agents|mesh-ancestor
101837157|NCT00394251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101837158|NCT00394251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101837159|NCT00394251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101837160|NCT00394251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101837161|NCT00394251|Growth Substances|growth substances|mesh-ancestor
101837162|NCT00394251|Growth Inhibitors|growth inhibitors|mesh-ancestor
101837163|NCT00394251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101837164|NCT00394251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101837165|NCT00394251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101837166|NCT00394251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101837168|NCT02532400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101556940|NCT04767061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101837169|NCT02532400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101837171|NCT00394095|Anticonvulsants|anticonvulsants|mesh-ancestor
101837172|NCT00394095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101837173|NCT00394095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837174|NCT00503906|Paclitaxel|paclitaxel|mesh-list
101837175|NCT00503906|Bevacizumab|bevacizumab|mesh-list
101837176|NCT00503906|Gemcitabine|gemcitabine|mesh-list
101837177|NCT00503906|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101837178|NCT00503906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101837179|NCT00503906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101837180|NCT00503906|Tubulin Modulators|tubulin modulators|mesh-ancestor
101837181|NCT00503906|Antimitotic Agents|antimitotic agents|mesh-ancestor
101837182|NCT00503906|Mitosis Modulators|mitosis modulators|mesh-ancestor
101837183|NCT00503906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837184|NCT00503906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101837185|NCT00503906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101837186|NCT00503906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101837187|NCT00503906|Growth Substances|growth substances|mesh-ancestor
101837188|NCT00503906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837189|NCT00503906|Growth Inhibitors|growth inhibitors|mesh-ancestor
101837190|NCT00503906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101837191|NCT00503906|Antimetabolites|antimetabolites|mesh-ancestor
101837192|NCT00305110|Hydromorphone|hydromorphone|mesh-list
101837193|NCT00305110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101837194|NCT00305110|Narcotics|narcotics|mesh-ancestor
101837195|NCT00305110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101837196|NCT00305110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837197|NCT00305110|Analgesics|analgesics|mesh-ancestor
101837198|NCT00305110|Sensory System Agents|sensory system agents|mesh-ancestor
101837199|NCT00305110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101837200|NCT03984760|Sevelamer|sevelamer|mesh-list
101837201|NCT03984760|Chelating Agents|chelating agents|mesh-ancestor
101837202|NCT03984760|Sequestering Agents|sequestering agents|mesh-ancestor
101837203|NCT03984760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837204|NCT00491894|Glycopyrrolate|glycopyrrolate|mesh-list
101837205|NCT00491894|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101837206|NCT00491894|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101837207|NCT00491894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101837208|NCT00491894|Cholinergic Agents|cholinergic agents|mesh-ancestor
101837209|NCT00491894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101961919|NCT03520569|Octreotide|octreotide|mesh-list
101837210|NCT00491894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837211|NCT00491894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837212|NCT01060618|Maraviroc|maraviroc|mesh-list
101837213|NCT01060618|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101837214|NCT01060618|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101837215|NCT01060618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837216|NCT01060618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101837217|NCT01060618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101837219|NCT01060618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101837220|NCT01060618|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101837221|NCT00491504|Mometasone Furoate|mometasone furoate|mesh-list
101837222|NCT00491504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101837223|NCT00491504|Dermatologic Agents|dermatologic agents|mesh-ancestor
101837224|NCT00491504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101837225|NCT00500292|Leucovorin|leucovorin|mesh-list
101837226|NCT00500292|Folic Acid|folic acid|mesh-list
101837227|NCT00500292|Fluorouracil|fluorouracil|mesh-list
101837228|NCT00500292|Oxaliplatin|oxaliplatin|mesh-list
101837229|NCT00500292|Levoleucovorin|levoleucovorin|mesh-list
101837230|NCT00500292|Antimetabolites|antimetabolites|mesh-ancestor
101837231|NCT00500292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837232|NCT00500292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101837233|NCT00500292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101837234|NCT00500292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101837235|NCT00500292|Immunologic Factors|immunologic factors|mesh-ancestor
101837236|NCT00500292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837237|NCT00500292|Antidotes|antidotes|mesh-ancestor
101837238|NCT00500292|Protective Agents|protective agents|mesh-ancestor
101837239|NCT00500292|Vitamin B Complex|vitamin b complex|mesh-ancestor
101837240|NCT00500292|Vitamins|vitamins|mesh-ancestor
101837241|NCT00500292|Micronutrients|micronutrients|mesh-ancestor
101837242|NCT00500292|Hematinics|hematinics|mesh-ancestor
101837243|NCT01013558|Remifentanil|remifentanil|mesh-list
101837244|NCT01013558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101837245|NCT01013558|Narcotics|narcotics|mesh-ancestor
101837246|NCT01013558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101837247|NCT01013558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837248|NCT01013558|Analgesics|analgesics|mesh-ancestor
101837249|NCT01013558|Sensory System Agents|sensory system agents|mesh-ancestor
101837250|NCT01013558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101837251|NCT00499746|Tramadol|tramadol|mesh-list
101837252|NCT00499746|Hydromorphone|hydromorphone|mesh-list
101837253|NCT00499746|Methylphenidate|methylphenidate|mesh-list
101837254|NCT00499746|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101837255|NCT00499746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837256|NCT00499746|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101961930|NCT03723291|Vitamin E|vitamin e|mesh-list
101837257|NCT00499746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101837258|NCT00499746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101837259|NCT00499746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837260|NCT00499746|Dopamine Agents|dopamine agents|mesh-ancestor
101837261|NCT00499746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101837262|NCT00499746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101837263|NCT00499746|Narcotics|narcotics|mesh-ancestor
101837264|NCT00499746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101837265|NCT00499746|Analgesics|analgesics|mesh-ancestor
101837266|NCT00499746|Sensory System Agents|sensory system agents|mesh-ancestor
101837267|NCT00499746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101837269|NCT01010516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101837270|NCT01010516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
101837271|NCT01010516|Fenofibrate|fenofibrate|mesh-list
101837272|NCT01010516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101837273|NCT01010516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101837274|NCT01010516|Antimetabolites|antimetabolites|mesh-ancestor
101837275|NCT01010516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837276|NCT01010516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101837277|NCT01010516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101837278|NCT01010516|Vasodilator Agents|vasodilator agents|mesh-ancestor
101837279|NCT01010516|Vitamin B Complex|vitamin b complex|mesh-ancestor
101837280|NCT01010516|Vitamins|vitamins|mesh-ancestor
101837281|NCT01010516|Micronutrients|micronutrients|mesh-ancestor
101837282|NCT01010516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837283|NCT01020162|Gabapentin|gabapentin|mesh-list
101837284|NCT01020162|Amitriptyline|amitriptyline|mesh-list
101837285|NCT01020162|Analgesics|analgesics|mesh-ancestor
101837286|NCT01020162|Sensory System Agents|sensory system agents|mesh-ancestor
101837287|NCT01020162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101837288|NCT01020162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837289|NCT01020162|Anticonvulsants|anticonvulsants|mesh-ancestor
101837290|NCT01020162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101837291|NCT01020162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101961955|NCT00111761|Immunologic Factors|immunologic factors|mesh-ancestor
101837292|NCT01020162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101837293|NCT01020162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101837294|NCT01020162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101837295|NCT01020162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101837296|NCT01020162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101837297|NCT01020162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837298|NCT01020162|Antimanic Agents|antimanic agents|mesh-ancestor
101837299|NCT01020162|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101837300|NCT01020162|Antidepressive Agents|antidepressive agents|mesh-ancestor
101837301|NCT01020162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101837302|NCT01020162|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101837303|NCT01020162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101837304|NCT01020162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101837305|NCT01020162|Adrenergic Agents|adrenergic agents|mesh-ancestor
101837306|NCT01016886|Bisoprolol|bisoprolol|mesh-list
101837307|NCT01016886|Perindopril|perindopril|mesh-list
101837308|NCT01016886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101837309|NCT01016886|Sympatholytics|sympatholytics|mesh-ancestor
101837310|NCT01016886|Autonomic Agents|autonomic agents|mesh-ancestor
101837311|NCT01016886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101837312|NCT01016886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837313|NCT01016886|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101837314|NCT01016886|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101837315|NCT01016886|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101837316|NCT01016886|Adrenergic Agents|adrenergic agents|mesh-ancestor
101837317|NCT01016886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101837318|NCT01016886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837319|NCT01016886|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101837320|NCT01016886|Protease Inhibitors|protease inhibitors|mesh-ancestor
101837321|NCT01016886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101837322|NCT00499590|Ranibizumab|ranibizumab|mesh-list
101837323|NCT00499590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101837324|NCT00499590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101837325|NCT00499590|Growth Substances|growth substances|mesh-ancestor
101837326|NCT00499590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837327|NCT00499590|Growth Inhibitors|growth inhibitors|mesh-ancestor
101837328|NCT00499590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101837329|NCT00510146|Olanzapine|olanzapine|mesh-list
101837330|NCT00510146|Antiemetics|antiemetics|mesh-ancestor
101837331|NCT00510146|Autonomic Agents|autonomic agents|mesh-ancestor
101837332|NCT00510146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101837333|NCT00510146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837334|NCT00510146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101837335|NCT00510146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101837336|NCT00510146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101837337|NCT00510146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101837338|NCT00510146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101837339|NCT00510146|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101837340|NCT00510146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101837341|NCT00510146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101837342|NCT00510146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837344|NCT00510146|Serotonin Agents|serotonin agents|mesh-ancestor
101837345|NCT04250064|Bevacizumab|bevacizumab|mesh-list
101837346|NCT04250064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101837347|NCT04250064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101837348|NCT04250064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101837349|NCT04250064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101837350|NCT04250064|Growth Substances|growth substances|mesh-ancestor
101837351|NCT04250064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837352|NCT04250064|Growth Inhibitors|growth inhibitors|mesh-ancestor
101837353|NCT00480636|Dalteparin|dalteparin|mesh-list
101837354|NCT00480636|Tinzaparin|tinzaparin|mesh-list
101837355|NCT00480636|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101837356|NCT00480636|Anticoagulants|anticoagulants|mesh-ancestor
101837357|NCT00480636|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101837358|NCT00480636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101236171|NCT01596647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101837359|NCT00480636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837360|NCT01017198|Antacids|antacids|mesh-list
101837361|NCT01017198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837362|NCT01017198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101837363|NCT00499122|Cyclophosphamide|cyclophosphamide|mesh-list
101837364|NCT00499122|Docetaxel|docetaxel|mesh-list
101837365|NCT00499122|Doxorubicin|doxorubicin|mesh-list
101837366|NCT00499122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101837367|NCT00499122|Immunologic Factors|immunologic factors|mesh-ancestor
101837368|NCT00499122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837369|NCT00499122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101837370|NCT00499122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101837371|NCT00499122|Alkylating Agents|alkylating agents|mesh-ancestor
101837372|NCT00499122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837373|NCT00499122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101837374|NCT00499122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101837375|NCT00499122|Tubulin Modulators|tubulin modulators|mesh-ancestor
101837376|NCT00499122|Antimitotic Agents|antimitotic agents|mesh-ancestor
101837377|NCT00499122|Mitosis Modulators|mitosis modulators|mesh-ancestor
101837378|NCT00499122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101837379|NCT00499122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101837380|NCT00499122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101837381|NCT00499122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101837382|NCT00393939|Docetaxel|docetaxel|mesh-list
101837383|NCT00393939|Sunitinib|sunitinib|mesh-list
101837384|NCT00393939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101837385|NCT00393939|Tubulin Modulators|tubulin modulators|mesh-ancestor
101837386|NCT00393939|Antimitotic Agents|antimitotic agents|mesh-ancestor
101837387|NCT00393939|Mitosis Modulators|mitosis modulators|mesh-ancestor
101837388|NCT00393939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837389|NCT00393939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101837390|NCT00393939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101837391|NCT00393939|Growth Substances|growth substances|mesh-ancestor
101837392|NCT00393939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837393|NCT00393939|Growth Inhibitors|growth inhibitors|mesh-ancestor
101837394|NCT00393939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101837395|NCT00393939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101837396|NCT00488982|Docetaxel|docetaxel|mesh-list
101837397|NCT00488982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101837398|NCT00488982|Tubulin Modulators|tubulin modulators|mesh-ancestor
101837399|NCT00488982|Antimitotic Agents|antimitotic agents|mesh-ancestor
101837400|NCT00488982|Mitosis Modulators|mitosis modulators|mesh-ancestor
101837401|NCT00488982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837402|NCT00488826|Vaccines|vaccines|mesh-list
101837403|NCT00488826|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101837404|NCT00488826|Immunologic Factors|immunologic factors|mesh-ancestor
101837405|NCT00488826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837406|NCT01017354|Calcifediol|calcifediol|mesh-list
101837407|NCT01017354|Vitamins|vitamins|mesh-ancestor
101837408|NCT01017354|Micronutrients|micronutrients|mesh-ancestor
101837409|NCT01017354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837410|NCT01017354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101837411|NCT00393861|Bevacizumab|bevacizumab|mesh-list
101837412|NCT00393861|Oxaliplatin|oxaliplatin|mesh-list
101837413|NCT00393861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101837414|NCT00393861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101837415|NCT00393861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101837416|NCT00393861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101837417|NCT00393861|Growth Substances|growth substances|mesh-ancestor
101837418|NCT00393861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837419|NCT00393861|Growth Inhibitors|growth inhibitors|mesh-ancestor
101837420|NCT01040559|Idarubicin|idarubicin|mesh-list
101837421|NCT01040559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101837422|NCT01040559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101837423|NCT01040559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101837424|NCT01040559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101837425|NCT01040559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101837426|NCT01040559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837427|NCT01020396|Metronidazole|metronidazole|mesh-list
101837428|NCT01020396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101837429|NCT01020396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101837430|NCT01020396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101837431|NCT01020396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101837432|NCT00488592|Molgramostim|molgramostim|mesh-list
101837433|NCT00488592|Sargramostim|sargramostim|mesh-list
101837434|NCT00488592|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101837435|NCT00488592|Immunologic Factors|immunologic factors|mesh-ancestor
101837436|NCT00488592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837437|NCT00488592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101837438|NCT00488592|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101837439|NCT00488514|Naproxen|naproxen|mesh-list
101837440|NCT00488514|Sumatriptan|sumatriptan|mesh-list
101837441|NCT00488514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101837442|NCT00488514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101837443|NCT00488514|Analgesics|analgesics|mesh-ancestor
101837444|NCT00488514|Sensory System Agents|sensory system agents|mesh-ancestor
101837445|NCT00488514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101837446|NCT00488514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837447|NCT00488514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101837448|NCT00488514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101837449|NCT00488514|Gout Suppressants|gout suppressants|mesh-ancestor
101837450|NCT00488514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101837451|NCT00488514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101837452|NCT00488514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837453|NCT00488514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101837454|NCT00488514|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101837455|NCT00488514|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101837456|NCT00488514|Serotonin Agents|serotonin agents|mesh-ancestor
101837457|NCT00488514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101837458|NCT00320710|Zoledronic Acid|zoledronic acid|mesh-list
101837459|NCT00320710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101837460|NCT00320710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837461|NCT00320398|PENTA|penta|mesh-list
101837462|NCT00320398|Fondaparinux|fondaparinux|mesh-list
101837463|NCT00320398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101837464|NCT00320398|Antithrombins|antithrombins|mesh-ancestor
101837465|NCT00320398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101837466|NCT00320398|Protease Inhibitors|protease inhibitors|mesh-ancestor
101837467|NCT00320398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101837468|NCT00320398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837469|NCT00320398|Anticoagulants|anticoagulants|mesh-ancestor
101837470|NCT00320398|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101837471|NCT00320398|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101837472|NCT00498186|Rotigotine|rotigotine|mesh-list
101837473|NCT00498186|Dopamine Agonists|dopamine agonists|mesh-ancestor
101837474|NCT00498186|Dopamine Agents|dopamine agents|mesh-ancestor
101837475|NCT00498186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101837476|NCT00498186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837477|NCT00498186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837478|NCT03984526|Atropine|atropine|mesh-list
101837479|NCT03984526|Ephedrine|ephedrine|mesh-list
101837480|NCT03984526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101837481|NCT03984526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101837482|NCT03984526|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101837483|NCT03984526|Autonomic Agents|autonomic agents|mesh-ancestor
101837484|NCT03984526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101837485|NCT03984526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837486|NCT03984526|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101837487|NCT03984526|Respiratory System Agents|respiratory system agents|mesh-ancestor
101837488|NCT03984526|Mydriatics|mydriatics|mesh-ancestor
101837489|NCT03984526|Parasympatholytics|parasympatholytics|mesh-ancestor
101837490|NCT03984526|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101837491|NCT03984526|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101837492|NCT03984526|Cholinergic Agents|cholinergic agents|mesh-ancestor
101837493|NCT03984526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101837494|NCT03984526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837495|NCT03984526|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101837496|NCT03984526|Sympathomimetics|sympathomimetics|mesh-ancestor
101837497|NCT03984526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101837498|NCT03984526|Adrenergic Agents|adrenergic agents|mesh-ancestor
101837499|NCT01017666|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
101837500|NCT01017666|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
101837501|NCT01017666|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101837502|NCT01017666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101837503|NCT01017666|Purinergic Agents|purinergic agents|mesh-ancestor
101837504|NCT01017666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101837505|NCT01017666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962124|NCT02171572|Dabigatran|dabigatran|mesh-list
101837506|NCT01017666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837507|NCT01017744|Anesthetics|anesthetics|mesh-list
101837508|NCT01017744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101837509|NCT01017744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837510|NCT00477594|Mipomersen|mipomersen|mesh-list
101837511|NCT00477594|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101837512|NCT00477594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101837513|NCT00477594|Antimetabolites|antimetabolites|mesh-ancestor
101837514|NCT00477594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837515|NCT00477594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101837516|NCT00304954|Sirolimus|sirolimus|mesh-list
101837517|NCT00304954|Infliximab|infliximab|mesh-list
101837518|NCT00304954|Daclizumab|daclizumab|mesh-list
101837519|NCT00304954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101837520|NCT00304954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101837521|NCT00304954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101837522|NCT00304954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101837523|NCT00304954|Antifungal Agents|antifungal agents|mesh-ancestor
101837524|NCT00304954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101837525|NCT00304954|Immunologic Factors|immunologic factors|mesh-ancestor
101837526|NCT00304954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837527|NCT00304954|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101837528|NCT00304954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101837529|NCT00304954|Dermatologic Agents|dermatologic agents|mesh-ancestor
101837530|NCT00304954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101837531|NCT00304954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101837532|NCT00475176|Ribavirin|ribavirin|mesh-list
101837533|NCT00475176|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101837534|NCT00475176|Antimetabolites|antimetabolites|mesh-ancestor
101837535|NCT00475176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837536|NCT00475176|Antiviral Agents|antiviral agents|mesh-ancestor
101837537|NCT00475176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101837538|NCT00393705|Insulin|insulin|mesh-list
101837539|NCT00393705|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101837540|NCT00393705|Insulin Lispro|insulin lispro|mesh-list
101837541|NCT00393705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101837542|NCT00393705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837543|NCT00303628|Leucovorin|leucovorin|mesh-list
101837544|NCT00303628|Bevacizumab|bevacizumab|mesh-list
101837545|NCT00303628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101837546|NCT00303628|Fluorouracil|fluorouracil|mesh-list
101837547|NCT00303628|Oxaliplatin|oxaliplatin|mesh-list
101837548|NCT00303628|Antibodies|antibodies|mesh-list
101837549|NCT00303628|Immunoglobulins|immunoglobulins|mesh-list
101837550|NCT00303628|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101837552|NCT00303628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101837553|NCT00303628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101685616|NCT00616070|Hormones|hormones|mesh-ancestor
101837554|NCT00303628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101837555|NCT00303628|Growth Substances|growth substances|mesh-ancestor
101837556|NCT00303628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837557|NCT00303628|Growth Inhibitors|growth inhibitors|mesh-ancestor
101837558|NCT00303628|Immunologic Factors|immunologic factors|mesh-ancestor
101837559|NCT00303628|Antimetabolites|antimetabolites|mesh-ancestor
101837560|NCT00303628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837561|NCT00303628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101837562|NCT00303628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101837563|NCT00303628|Antidotes|antidotes|mesh-ancestor
101837564|NCT00303628|Protective Agents|protective agents|mesh-ancestor
101837565|NCT00303628|Vitamin B Complex|vitamin b complex|mesh-ancestor
101837566|NCT00303628|Vitamins|vitamins|mesh-ancestor
101837567|NCT00303628|Micronutrients|micronutrients|mesh-ancestor
101837568|NCT00414453|Lidocaine|lidocaine|mesh-list
101837569|NCT00414453|Oxycodone|oxycodone|mesh-list
101837570|NCT00414453|Anesthetics, Local|anesthetics, local|mesh-ancestor
101837571|NCT00414453|Anesthetics|anesthetics|mesh-ancestor
101837572|NCT00414453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101837573|NCT00414453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837574|NCT00414453|Sensory System Agents|sensory system agents|mesh-ancestor
101837575|NCT00414453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101837576|NCT00414453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101837577|NCT00414453|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101837578|NCT00414453|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101837579|NCT00414453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101837580|NCT00414453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837581|NCT00414453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101837582|NCT00414453|Narcotics|narcotics|mesh-ancestor
101837583|NCT00414453|Analgesics|analgesics|mesh-ancestor
101837584|NCT01037595|Turmeric extract|turmeric extract|mesh-list
101837585|NCT01037595|Antioxidants|antioxidants|mesh-ancestor
101837586|NCT01037595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837587|NCT01037595|Protective Agents|protective agents|mesh-ancestor
101837588|NCT01037595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837589|NCT01041027|Paclitaxel|paclitaxel|mesh-list
101837590|NCT01041027|Carboplatin|carboplatin|mesh-list
101837591|NCT01041027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101837592|NCT01041027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101837593|NCT01041027|Tubulin Modulators|tubulin modulators|mesh-ancestor
101837594|NCT01041027|Antimitotic Agents|antimitotic agents|mesh-ancestor
101837595|NCT01041027|Mitosis Modulators|mitosis modulators|mesh-ancestor
101837596|NCT01041027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837597|NCT00332488|Insulin|insulin|mesh-list
101837598|NCT00332488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101837599|NCT00332488|Metformin|metformin|mesh-list
101837600|NCT00332488|Secretagogues|secretagogues|mesh-list
101837601|NCT00332488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101837602|NCT00332488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837603|NCT00332332|Etanercept|etanercept|mesh-list
101837604|NCT00332332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101837605|NCT00332332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101837606|NCT00332332|Analgesics|analgesics|mesh-ancestor
101837607|NCT00332332|Sensory System Agents|sensory system agents|mesh-ancestor
101837608|NCT00332332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101837609|NCT00332332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837610|NCT00332332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101837611|NCT00332332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101837612|NCT00332332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101837613|NCT00332332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101837614|NCT00332332|Immunologic Factors|immunologic factors|mesh-ancestor
101837615|NCT00392925|Pramlintide|pramlintide|mesh-list
101837616|NCT00392925|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
101837617|NCT00392925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101837618|NCT00392925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837619|NCT00392925|Appetite Depressants|appetite depressants|mesh-ancestor
101837620|NCT00392925|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101837621|NCT00392925|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
101837622|NCT00392925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837623|NCT00474786|Sirolimus|sirolimus|mesh-list
101837624|NCT00474786|Sorafenib|sorafenib|mesh-list
101837625|NCT00474786|Temsirolimus|temsirolimus|mesh-list
101837626|NCT00474786|MTOR Inhibitors|mtor inhibitors|mesh-list
101837627|NCT00474786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101837628|NCT00474786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101837629|NCT00474786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101837630|NCT00474786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837631|NCT00474786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101837632|NCT00474786|Immunologic Factors|immunologic factors|mesh-ancestor
101837633|NCT00474786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837634|NCT00474786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101837635|NCT00474786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101837636|NCT00474786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101837637|NCT00474786|Antifungal Agents|antifungal agents|mesh-ancestor
101837638|NCT00392769|Cetuximab|cetuximab|mesh-list
101837639|NCT00392769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101837640|NCT00392769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101837641|NCT01041183|Ramosetron|ramosetron|mesh-list
101837642|NCT01041183|Antiemetics|antiemetics|mesh-ancestor
101837643|NCT01041183|Autonomic Agents|autonomic agents|mesh-ancestor
101837644|NCT01041183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101837645|NCT01041183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837646|NCT01041183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101837647|NCT01041183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101837648|NCT01041183|Serotonin Agents|serotonin agents|mesh-ancestor
101837649|NCT01041183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101837650|NCT01041183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837651|NCT00319696|Bosentan|bosentan|mesh-list
101837652|NCT00319696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101837653|NCT00319696|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101837654|NCT00319696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837655|NCT00474630|Naltrexone|naltrexone|mesh-list
101837656|NCT00474630|Bupropion|bupropion|mesh-list
101837657|NCT00474630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101837658|NCT00474630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101837659|NCT00474630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837660|NCT00474630|Sensory System Agents|sensory system agents|mesh-ancestor
101837661|NCT00474630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101837662|NCT00474630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101837663|NCT00474630|Antidepressive Agents|antidepressive agents|mesh-ancestor
101837664|NCT00474630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101837665|NCT00474630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101962253|NCT02169856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101837666|NCT00474630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101837667|NCT00474630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101837668|NCT00474630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837669|NCT00474630|Dopamine Agents|dopamine agents|mesh-ancestor
101837670|NCT00474630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101837671|NCT00474630|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101837672|NCT00474630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101837673|NCT00474630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101837674|NCT01064752|Minocycline|minocycline|mesh-list
101837675|NCT01064752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101837676|NCT01064752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101837677|NCT00392379|Nicotine|nicotine|mesh-list
101837678|NCT00392379|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101837679|NCT00392379|Autonomic Agents|autonomic agents|mesh-ancestor
101837680|NCT00392379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101837681|NCT00392379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837682|NCT00392379|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101837683|NCT00392379|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101837684|NCT00392379|Cholinergic Agents|cholinergic agents|mesh-ancestor
101837685|NCT00392379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101837686|NCT00392379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837687|NCT01038063|Lumefantrine|lumefantrine|mesh-list
101837688|NCT01038063|Artemether|artemether|mesh-list
101837689|NCT01038063|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101837690|NCT01038063|Antimalarials|antimalarials|mesh-ancestor
101837691|NCT01038063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101837692|NCT01038063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101837693|NCT01038063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101837694|NCT01043991|Darbepoetin alfa|darbepoetin alfa|mesh-list
101837695|NCT01043991|Hematinics|hematinics|mesh-ancestor
101837696|NCT01020630|Sunitinib|sunitinib|mesh-list
101837697|NCT01020630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101837698|NCT01020630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101837699|NCT01020630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101837700|NCT01020630|Growth Substances|growth substances|mesh-ancestor
101837701|NCT01020630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837702|NCT01020630|Growth Inhibitors|growth inhibitors|mesh-ancestor
101837704|NCT01020630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101962306|NCT02757352|Ixekizumab|ixekizumab|mesh-list
101837705|NCT01020630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837706|NCT00403455|Paroxetine|paroxetine|mesh-list
101837707|NCT00403455|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101837708|NCT00403455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101837709|NCT00403455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101837710|NCT00403455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837711|NCT00403455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101837712|NCT00403455|Serotonin Agents|serotonin agents|mesh-ancestor
101837713|NCT00403455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837714|NCT00403455|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101837715|NCT00403455|Antidepressive Agents|antidepressive agents|mesh-ancestor
101837716|NCT00403455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101837717|NCT00403455|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101837718|NCT00403455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101837719|NCT00403455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101837720|NCT00318370|Farletuzumab|farletuzumab|mesh-list
101837721|NCT00318370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101837722|NCT00510068|Everolimus|everolimus|mesh-list
101837723|NCT00510068|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101837724|NCT00510068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101837725|NCT00510068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101837726|NCT00510068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837727|NCT00510068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101837728|NCT00510068|Immunologic Factors|immunologic factors|mesh-ancestor
101837729|NCT00510068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837730|NCT00510068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101837731|NCT00509600|Etanercept|etanercept|mesh-list
101837732|NCT00509600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101837733|NCT00509600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101837734|NCT00509600|Analgesics|analgesics|mesh-ancestor
101837735|NCT00509600|Sensory System Agents|sensory system agents|mesh-ancestor
101837736|NCT00509600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101837737|NCT00509600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837738|NCT00509600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101837739|NCT00509600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101837740|NCT00509600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101837741|NCT00509600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101837742|NCT00509600|Immunologic Factors|immunologic factors|mesh-ancestor
101837744|NCT01014104|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101837745|NCT01014104|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101837746|NCT01014104|Prednisolone|prednisolone|mesh-list
101837747|NCT01014104|Prednisolone acetate|prednisolone acetate|mesh-list
101837748|NCT01014104|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101837749|NCT01014104|Prednisolone phosphate|prednisolone phosphate|mesh-list
101837750|NCT01014104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101837751|NCT01014104|Antiemetics|antiemetics|mesh-ancestor
101837752|NCT01014104|Autonomic Agents|autonomic agents|mesh-ancestor
101837753|NCT01014104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101837754|NCT01014104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837755|NCT01014104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101837756|NCT01014104|Glucocorticoids|glucocorticoids|mesh-ancestor
101837757|NCT01014104|Hormones|hormones|mesh-ancestor
101837758|NCT01014104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101837759|NCT01014104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101837760|NCT01014104|Protective Agents|protective agents|mesh-ancestor
101837761|NCT01014104|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101837762|NCT01014104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101837763|NCT00402987|Celecoxib|celecoxib|mesh-list
101837764|NCT00402987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101837765|NCT00402987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101837766|NCT00402987|Analgesics|analgesics|mesh-ancestor
101837767|NCT00402987|Sensory System Agents|sensory system agents|mesh-ancestor
101837768|NCT00402987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101837769|NCT00402987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837771|NCT00402987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101837772|NCT00402987|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101837773|NCT00402987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101837774|NCT00402987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101557540|NCT02605486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101837775|NCT00402987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837777|NCT01015664|Cetuximab|cetuximab|mesh-list
101837778|NCT01015664|Temsirolimus|temsirolimus|mesh-list
101837779|NCT01015664|MTOR Inhibitors|mtor inhibitors|mesh-list
101837780|NCT01015664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101837781|NCT01015664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101837782|NCT01015664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101837783|NCT01015664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101837784|NCT01015664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837785|NCT01015664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101837786|NCT01015664|Immunologic Factors|immunologic factors|mesh-ancestor
101837787|NCT01015664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837788|NCT01015664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101837789|NCT01015664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101837790|NCT01015664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101837791|NCT01015664|Antifungal Agents|antifungal agents|mesh-ancestor
101837792|NCT00501644|Interferons|interferons|mesh-list
101837793|NCT00501644|Interferon-gamma|interferon-gamma|mesh-list
101837794|NCT00501644|Carboplatin|carboplatin|mesh-list
101837795|NCT00501644|Molgramostim|molgramostim|mesh-list
101837796|NCT00501644|Sargramostim|sargramostim|mesh-list
101837797|NCT00501644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101837798|NCT00501644|Antiviral Agents|antiviral agents|mesh-ancestor
101837799|NCT00501644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101837800|NCT00501644|Immunologic Factors|immunologic factors|mesh-ancestor
101837801|NCT00501644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837802|NCT01014260|Doxycycline|doxycycline|mesh-list
101837803|NCT01014260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101837804|NCT01014260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101837805|NCT01014260|Antimalarials|antimalarials|mesh-ancestor
101837806|NCT01014260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101962425|NCT02175394|Hormones|hormones|mesh-ancestor
101837807|NCT01014260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101837808|NCT01010672|Sirolimus|sirolimus|mesh-list
101837809|NCT01010672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101837810|NCT01010672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101837811|NCT01010672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101837812|NCT01010672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101837813|NCT01010672|Antifungal Agents|antifungal agents|mesh-ancestor
101837814|NCT01010672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101837815|NCT01010672|Immunologic Factors|immunologic factors|mesh-ancestor
101837816|NCT01010672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837817|NCT01014338|Fosinopril|fosinopril|mesh-list
101837818|NCT01014338|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101837819|NCT01014338|Protease Inhibitors|protease inhibitors|mesh-ancestor
101837820|NCT01014338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101837821|NCT01014338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837822|NCT01014338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101837823|NCT01014416|Tolvaptan|tolvaptan|mesh-list
101837824|NCT01014416|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101837825|NCT01014416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837826|NCT01014416|Natriuretic Agents|natriuretic agents|mesh-ancestor
101837827|NCT01014416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837828|NCT00497796|Ganciclovir|ganciclovir|mesh-list
101837829|NCT00497796|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101837830|NCT00497796|Maribavir|maribavir|mesh-list
101837831|NCT00497796|Antiviral Agents|antiviral agents|mesh-ancestor
101837832|NCT00497796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101837833|NCT00497796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101837834|NCT00497796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101837835|NCT00497796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837836|NCT01017822|Gemcitabine|gemcitabine|mesh-list
101837837|NCT01017822|Capecitabine|capecitabine|mesh-list
101837838|NCT01017822|Conatumumab|conatumumab|mesh-list
101837839|NCT01017822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101837840|NCT01017822|Antimetabolites|antimetabolites|mesh-ancestor
101837841|NCT01017822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837842|NCT01017822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101837843|NCT01017822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101837844|NCT00496782|Maraviroc|maraviroc|mesh-list
101837845|NCT00496782|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101837846|NCT00496782|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101837847|NCT00496782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837848|NCT00496782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101837849|NCT00496782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101837850|NCT00496782|Antiviral Agents|antiviral agents|mesh-ancestor
101837851|NCT00496782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101837852|NCT00496782|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101837853|NCT01020708|Acetylcysteine|acetylcysteine|mesh-list
101837854|NCT01020708|Aminosalicylic Acid|aminosalicylic acid|mesh-list
101837856|NCT01020708|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101837857|NCT01020708|Antiviral Agents|antiviral agents|mesh-ancestor
101837858|NCT01020708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101837859|NCT01020708|Expectorants|expectorants|mesh-ancestor
101837860|NCT01020708|Respiratory System Agents|respiratory system agents|mesh-ancestor
101837861|NCT01020708|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101837862|NCT01020708|Antioxidants|antioxidants|mesh-ancestor
101962459|NCT02173756|Analgesics|analgesics|mesh-ancestor
101837863|NCT01020708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837864|NCT01020708|Protective Agents|protective agents|mesh-ancestor
101837865|NCT01020708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837866|NCT01020708|Antidotes|antidotes|mesh-ancestor
101837867|NCT01020708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101837868|NCT01020708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101837869|NCT01020708|Analgesics|analgesics|mesh-ancestor
101837870|NCT01020708|Sensory System Agents|sensory system agents|mesh-ancestor
101837871|NCT01020708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101837872|NCT01020708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101837873|NCT01020708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101837874|NCT01020708|Antitubercular Agents|antitubercular agents|mesh-ancestor
101837875|NCT01020708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101837876|NCT01020864|Carboplatin|carboplatin|mesh-list
101837877|NCT01020864|Cetuximab|cetuximab|mesh-list
101837878|NCT01020864|Vinorelbine|vinorelbine|mesh-list
101837879|NCT01020864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101837880|NCT01020864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101837881|NCT01020864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101837882|NCT01020864|Tubulin Modulators|tubulin modulators|mesh-ancestor
101837883|NCT01020864|Antimitotic Agents|antimitotic agents|mesh-ancestor
101837884|NCT01020864|Mitosis Modulators|mitosis modulators|mesh-ancestor
101837885|NCT01020864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837886|NCT04428372|Mannitol|mannitol|mesh-list
101837887|NCT04428372|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101837888|NCT04428372|Diuretics|diuretics|mesh-ancestor
101837889|NCT04428372|Natriuretic Agents|natriuretic agents|mesh-ancestor
101837890|NCT04428372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837891|NCT01014858|Donepezil|donepezil|mesh-list
101837892|NCT01014858|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101837893|NCT01014858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101837894|NCT01014858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837895|NCT01014858|Cholinergic Agents|cholinergic agents|mesh-ancestor
101837896|NCT01014858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101837897|NCT01014858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837898|NCT01014858|Nootropic Agents|nootropic agents|mesh-ancestor
101837899|NCT00471276|Sunitinib|sunitinib|mesh-list
101837900|NCT00471276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101837901|NCT00471276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101837902|NCT00471276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101837903|NCT00471276|Growth Substances|growth substances|mesh-ancestor
101837904|NCT00471276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837905|NCT00471276|Growth Inhibitors|growth inhibitors|mesh-ancestor
101837906|NCT00471276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101837907|NCT00471276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387666|NCT00322660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101837908|NCT00471276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837909|NCT00470262|Pioglitazone|pioglitazone|mesh-list
101837910|NCT00470262|Fenofibrate|fenofibrate|mesh-list
101837911|NCT00470262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101837912|NCT00470262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837913|NCT00470262|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101837914|NCT00470262|Antimetabolites|antimetabolites|mesh-ancestor
101837915|NCT00470262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837916|NCT00470262|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101837917|NCT04034862|Lamivudine|lamivudine|mesh-list
101837918|NCT04034862|Dolutegravir|dolutegravir|mesh-list
101837919|NCT04034862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101685626|NCT03153527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101837921|NCT04034862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101837922|NCT04034862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837923|NCT04034862|Antiviral Agents|antiviral agents|mesh-ancestor
101837924|NCT04034862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101837925|NCT04034862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101837926|NCT04034862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101837927|NCT04034862|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101837928|NCT04034862|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101837929|NCT00496470|Budesonide|budesonide|mesh-list
101837930|NCT00496470|Bromides|bromides|mesh-list
101837931|NCT00496470|Formoterol Fumarate|formoterol fumarate|mesh-list
101837932|NCT00496470|Tiotropium Bromide|tiotropium bromide|mesh-list
101837933|NCT00496470|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101837934|NCT00496470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101837935|NCT00496470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101837936|NCT00496470|Autonomic Agents|autonomic agents|mesh-ancestor
101837937|NCT00496470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101837938|NCT00496470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837939|NCT00496470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101837940|NCT00496470|Respiratory System Agents|respiratory system agents|mesh-ancestor
101837941|NCT00496470|Glucocorticoids|glucocorticoids|mesh-ancestor
101837942|NCT00496470|Hormones|hormones|mesh-ancestor
101837943|NCT00496470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101837944|NCT00496470|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101837945|NCT00496470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101837946|NCT00496470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101837947|NCT00496470|Adrenergic Agents|adrenergic agents|mesh-ancestor
101837948|NCT00496470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101837949|NCT00496470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837950|NCT00496470|Parasympatholytics|parasympatholytics|mesh-ancestor
101837951|NCT00496470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101837952|NCT00496470|Cholinergic Agents|cholinergic agents|mesh-ancestor
101837953|NCT00496470|Anticonvulsants|anticonvulsants|mesh-ancestor
101837954|NCT01021176|Diltiazem|diltiazem|mesh-list
101837955|NCT01021176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101837956|NCT01021176|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101837957|NCT01021176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101837958|NCT01021176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837959|NCT01021176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101837960|NCT01021176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837961|NCT01021176|Vasodilator Agents|vasodilator agents|mesh-ancestor
101837962|NCT01018368|Rifampin|rifampin|mesh-list
101837963|NCT01018368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101837964|NCT01018368|Antitubercular Agents|antitubercular agents|mesh-ancestor
101837965|NCT01018368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101837966|NCT01018368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101837967|NCT01018368|Leprostatic Agents|leprostatic agents|mesh-ancestor
101837968|NCT01018368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101837969|NCT01018368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387667|NCT00322660|Respiratory System Agents|respiratory system agents|mesh-ancestor
101837970|NCT01018368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837971|NCT01018368|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101837972|NCT01018368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101837973|NCT01018368|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101837974|NCT01018368|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101837975|NCT01018368|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101837976|NCT01018368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101837977|NCT00487578|Naratriptan|naratriptan|mesh-list
101837978|NCT00487578|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101837979|NCT00487578|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101837980|NCT00487578|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101837981|NCT00487578|Serotonin Agents|serotonin agents|mesh-ancestor
101837982|NCT00487578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101837983|NCT00487578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837984|NCT00487578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101837985|NCT00495612|Omalizumab|omalizumab|mesh-list
101837986|NCT00495612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101837987|NCT00495612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101837988|NCT00495612|Respiratory System Agents|respiratory system agents|mesh-ancestor
101837989|NCT01021488|Enoxaparin|enoxaparin|mesh-list
101837990|NCT01021488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101837991|NCT01021488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101837992|NCT01021488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101837993|NCT01021488|Antimetabolites|antimetabolites|mesh-ancestor
101837994|NCT01021488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101837995|NCT01021488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101837996|NCT01021488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101837997|NCT01021488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101837998|NCT01021488|Anticoagulants|anticoagulants|mesh-ancestor
101837999|NCT01021488|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101838000|NCT01021488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101838001|NCT00487188|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101838002|NCT00487188|Enfuvirtide|enfuvirtide|mesh-list
101838003|NCT00487188|Antiviral Agents|antiviral agents|mesh-ancestor
101838004|NCT00487188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101838005|NCT00487188|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101838006|NCT00487188|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101838007|NCT00487188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838008|NCT00487188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101838009|NCT00509366|Cisplatin|cisplatin|mesh-list
101838010|NCT00509366|Gemcitabine|gemcitabine|mesh-list
101838011|NCT00509366|Docetaxel|docetaxel|mesh-list
101838012|NCT00509366|Pemetrexed|pemetrexed|mesh-list
101838013|NCT00509366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838014|NCT00509366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101838015|NCT00509366|Antimetabolites|antimetabolites|mesh-ancestor
101838016|NCT00509366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838017|NCT00509366|Tubulin Modulators|tubulin modulators|mesh-ancestor
101838018|NCT00509366|Antimitotic Agents|antimitotic agents|mesh-ancestor
101838019|NCT00509366|Mitosis Modulators|mitosis modulators|mesh-ancestor
101838020|NCT00509366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101838021|NCT00509366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101838022|NCT00509366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101838023|NCT01016054|Carboplatin|carboplatin|mesh-list
101838024|NCT01016054|Gemcitabine|gemcitabine|mesh-list
101838025|NCT01016054|Doxorubicin|doxorubicin|mesh-list
101838026|NCT01016054|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101838027|NCT01016054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838028|NCT01016054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101838029|NCT01016054|Antimetabolites|antimetabolites|mesh-ancestor
101838030|NCT01016054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322400|NCT00087451|Sirolimus|sirolimus|mesh-list
101838031|NCT01016054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101838032|NCT01016054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101838033|NCT01016054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101838034|NCT01016054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101838035|NCT00500318|Bromides|bromides|mesh-list
101838036|NCT00500318|Anticonvulsants|anticonvulsants|mesh-ancestor
101838037|NCT00499694|Bevacizumab|bevacizumab|mesh-list
101838038|NCT00499694|Satraplatin|satraplatin|mesh-list
101838039|NCT00499694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101838040|NCT00499694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838041|NCT00499694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101838042|NCT00499694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101838043|NCT00499694|Growth Substances|growth substances|mesh-ancestor
101838044|NCT00499694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838045|NCT00499694|Growth Inhibitors|growth inhibitors|mesh-ancestor
101838046|NCT00486954|Paclitaxel|paclitaxel|mesh-list
101838047|NCT00486954|Lapatinib|lapatinib|mesh-list
101838048|NCT00486954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101838049|NCT00486954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838050|NCT00486954|Tubulin Modulators|tubulin modulators|mesh-ancestor
101838051|NCT00486954|Antimitotic Agents|antimitotic agents|mesh-ancestor
101838052|NCT00486954|Mitosis Modulators|mitosis modulators|mesh-ancestor
101838053|NCT00486954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838054|NCT00486954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101838055|NCT00486954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101838056|NCT00494676|Methamphetamine|methamphetamine|mesh-list
101838057|NCT00494676|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101838058|NCT00494676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838059|NCT00494676|Sympathomimetics|sympathomimetics|mesh-ancestor
101838060|NCT00494676|Autonomic Agents|autonomic agents|mesh-ancestor
101838061|NCT00494676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101838062|NCT00494676|Dopamine Agents|dopamine agents|mesh-ancestor
101838063|NCT00494676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101838064|NCT00494676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838065|NCT00494676|Adrenergic Agents|adrenergic agents|mesh-ancestor
101838066|NCT00494676|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101838067|NCT00494676|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101838068|NCT00494676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101838069|NCT00494676|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101838070|NCT00486720|Vorinostat|vorinostat|mesh-list
101838071|NCT00486720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838072|NCT00486720|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101838073|NCT00486720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101838074|NCT00486720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838075|NCT00486330|Ritonavir|ritonavir|mesh-list
101838076|NCT00486330|Tipranavir|tipranavir|mesh-list
101838077|NCT00486330|Buprenorphine|buprenorphine|mesh-list
101838078|NCT00486330|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101838079|NCT00486330|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101838080|NCT00486330|Protease Inhibitors|protease inhibitors|mesh-ancestor
101838081|NCT00486330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101838082|NCT00486330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838083|NCT00486330|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101838084|NCT00486330|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101838085|NCT00486330|Antiviral Agents|antiviral agents|mesh-ancestor
101838086|NCT00486330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101838087|NCT00486330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101838088|NCT00486330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101838089|NCT00486330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101838090|NCT00486330|Narcotics|narcotics|mesh-ancestor
101838091|NCT00486330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101838092|NCT00486330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838093|NCT00486330|Analgesics|analgesics|mesh-ancestor
101838094|NCT00486330|Sensory System Agents|sensory system agents|mesh-ancestor
101236441|NCT01597765|Vitamins|vitamins|mesh-list
101838095|NCT00486330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101838096|NCT00486330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101838097|NCT01021566|Methadone|methadone|mesh-list
101838098|NCT01021566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101838099|NCT01021566|Narcotics|narcotics|mesh-ancestor
101838100|NCT01021566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101838101|NCT01021566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838102|NCT01021566|Analgesics|analgesics|mesh-ancestor
101838103|NCT01021566|Sensory System Agents|sensory system agents|mesh-ancestor
101838104|NCT01021566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101838105|NCT01021566|Antitussive Agents|antitussive agents|mesh-ancestor
101838106|NCT01021566|Respiratory System Agents|respiratory system agents|mesh-ancestor
101838107|NCT00494442|Olaparib|olaparib|mesh-list
101838108|NCT00494442|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
101838109|NCT00494442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101838110|NCT00494442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838111|NCT00494442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838112|NCT00493974|Zileuton|zileuton|mesh-list
101838113|NCT00493974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101838114|NCT00493974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101838115|NCT00493974|Analgesics|analgesics|mesh-ancestor
101838116|NCT00493974|Sensory System Agents|sensory system agents|mesh-ancestor
101838117|NCT00493974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101838118|NCT00493974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838119|NCT00493974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101838120|NCT00493974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101838121|NCT00493974|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101838122|NCT00493974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101838123|NCT00493974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838124|NCT00493974|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101838125|NCT00493974|Hormone Antagonists|hormone antagonists|mesh-ancestor
101838126|NCT00493974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101838127|NCT01018446|Busulfan|busulfan|mesh-list
101838128|NCT01018446|Alkylating Agents|alkylating agents|mesh-ancestor
101838129|NCT01018446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838130|NCT01018446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101838131|NCT01018446|Immunologic Factors|immunologic factors|mesh-ancestor
101838132|NCT01018446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838133|NCT01018446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101838134|NCT01018446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838135|NCT01018446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101838136|NCT01018602|Vildagliptin|vildagliptin|mesh-list
101838137|NCT01018602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101838138|NCT01018602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838139|NCT01018602|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101838140|NCT01018602|Protease Inhibitors|protease inhibitors|mesh-ancestor
101838141|NCT01018602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101838142|NCT01018602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838143|NCT01018758|Palonosetron|palonosetron|mesh-list
101838144|NCT01018758|Antiemetics|antiemetics|mesh-ancestor
101838145|NCT01018758|Autonomic Agents|autonomic agents|mesh-ancestor
101838146|NCT01018758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101838147|NCT01018758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838148|NCT01018758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101838149|NCT01018758|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101838150|NCT01018758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101838151|NCT01018758|Serotonin Agents|serotonin agents|mesh-ancestor
101838152|NCT01018758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101838153|NCT01018758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838154|NCT00469092|Insulin|insulin|mesh-list
101838155|NCT00469092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101838156|NCT00469092|Metformin|metformin|mesh-list
101838157|NCT00469092|Insulin Glargine|insulin glargine|mesh-list
101838158|NCT00469092|Insulin Aspart|insulin aspart|mesh-list
101838159|NCT00469092|Glimepiride|glimepiride|mesh-list
101838160|NCT00469092|Biphasic Insulins|biphasic insulins|mesh-list
101838161|NCT00469092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101838162|NCT00469092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838163|NCT00469092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101838164|NCT00469092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101838165|NCT00469092|Immunologic Factors|immunologic factors|mesh-ancestor
101838166|NCT00499616|Cyclophosphamide|cyclophosphamide|mesh-list
101838167|NCT00499616|Carboplatin|carboplatin|mesh-list
101838168|NCT00499616|Doxorubicin|doxorubicin|mesh-list
101838169|NCT00499616|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101838170|NCT00499616|Etoposide|etoposide|mesh-list
101838171|NCT00499616|Topotecan|topotecan|mesh-list
101838172|NCT00499616|Isotretinoin|isotretinoin|mesh-list
101838173|NCT00499616|Lenograstim|lenograstim|mesh-list
101838174|NCT00499616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101838175|NCT00499616|Immunologic Factors|immunologic factors|mesh-ancestor
101838176|NCT00499616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838177|NCT00499616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101838178|NCT00499616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101838179|NCT00499616|Alkylating Agents|alkylating agents|mesh-ancestor
101838180|NCT00499616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838181|NCT00499616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838182|NCT00499616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101838183|NCT00499616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101838184|NCT00499616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101838185|NCT00499616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101838186|NCT00499616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101838187|NCT00499616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101838188|NCT00499616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101838189|NCT00499616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101838190|NCT00499616|Dermatologic Agents|dermatologic agents|mesh-ancestor
101838191|NCT00402597|Rivaroxaban|rivaroxaban|mesh-list
101838192|NCT00402597|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101838193|NCT00402597|Antithrombins|antithrombins|mesh-ancestor
101685653|NCT05320991|Anesthetics|anesthetics|mesh-ancestor
101838194|NCT00402597|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101838195|NCT00402597|Protease Inhibitors|protease inhibitors|mesh-ancestor
101838196|NCT00402597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101838197|NCT00402597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838198|NCT00402597|Anticoagulants|anticoagulants|mesh-ancestor
101838199|NCT00469014|Fludarabine|fludarabine|mesh-list
101838200|NCT00469014|Fludarabine phosphate|fludarabine phosphate|mesh-list
101838201|NCT00469014|Busulfan|busulfan|mesh-list
101838202|NCT00469014|Clofarabine|clofarabine|mesh-list
101838203|NCT00469014|Thymoglobulin|thymoglobulin|mesh-list
101838204|NCT00469014|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101838205|NCT00469014|Lenograstim|lenograstim|mesh-list
101838206|NCT00469014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838207|NCT00469014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101838208|NCT00469014|Antimetabolites|antimetabolites|mesh-ancestor
101838209|NCT00469014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838210|NCT00469014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101838211|NCT00469014|Immunologic Factors|immunologic factors|mesh-ancestor
101838212|NCT00469014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838213|NCT00469014|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101838214|NCT00469014|Alkylating Agents|alkylating agents|mesh-ancestor
101838215|NCT00469014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101838216|NCT00469014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101838217|NCT00493038|Amoxicillin|amoxicillin|mesh-list
101838218|NCT00493038|Moxifloxacin|moxifloxacin|mesh-list
101838219|NCT00493038|Clavulanic Acid|clavulanic acid|mesh-list
101838220|NCT00493038|Clavulanic Acids|clavulanic acids|mesh-list
101838221|NCT00493038|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101838222|NCT00493038|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101838223|NCT00493038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101838224|NCT00493038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101557994|NCT00335140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101838225|NCT00493038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101838226|NCT00493038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101838228|NCT00493038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838229|NCT00493038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838230|NCT00493038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101838231|NCT00493038|Contraceptive Agents|contraceptive agents|mesh-ancestor
101838232|NCT00493038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101838233|NCT00493038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838234|NCT00493038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101838235|NCT00493038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101838236|NCT00493038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101838237|NCT00493038|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101838238|NCT00392223|Azithromycin|azithromycin|mesh-list
101838239|NCT00392223|Minocycline|minocycline|mesh-list
101838240|NCT00392223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101838241|NCT00392223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101838242|NCT00402285|Lycopene|lycopene|mesh-list
101838244|NCT00402285|Antioxidants|antioxidants|mesh-ancestor
101838245|NCT00402285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838246|NCT00402285|Protective Agents|protective agents|mesh-ancestor
101838247|NCT00402285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838248|NCT00402285|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101838249|NCT00402285|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101838250|NCT00402285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838251|NCT03747159|Belimumab|belimumab|mesh-list
101838252|NCT03747159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101838253|NCT03747159|Immunologic Factors|immunologic factors|mesh-ancestor
101838254|NCT03747159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838255|NCT00413283|Carboplatin|carboplatin|mesh-list
101838256|NCT00413283|Gemcitabine|gemcitabine|mesh-list
101838257|NCT00413283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838258|NCT00413283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101838259|NCT00413283|Antimetabolites|antimetabolites|mesh-ancestor
101838260|NCT00413283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838261|NCT00402051|Carboplatin|carboplatin|mesh-list
101838262|NCT00402051|Pemetrexed|pemetrexed|mesh-list
101236500|NCT01597986|Norinyl|norinyl|mesh-list
101838263|NCT00402051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838264|NCT00402051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101838265|NCT00402051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838266|NCT00402051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101838267|NCT00402051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101838268|NCT00401973|Metformin|metformin|mesh-list
101838269|NCT00401973|Amantadine|amantadine|mesh-list
101838270|NCT00401973|Zonisamide|zonisamide|mesh-list
101838271|NCT00401973|Olanzapine|olanzapine|mesh-list
101838272|NCT00401973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101838273|NCT00401973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838274|NCT00401973|Antiemetics|antiemetics|mesh-ancestor
101838275|NCT00401973|Autonomic Agents|autonomic agents|mesh-ancestor
101838276|NCT00401973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101838277|NCT00401973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101838278|NCT00401973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101838279|NCT00401973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101838280|NCT00401973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101838281|NCT00401973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101838282|NCT00401973|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101838283|NCT00401973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101838284|NCT00401973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101838285|NCT00401973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838286|NCT00401973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101838287|NCT00401973|Serotonin Agents|serotonin agents|mesh-ancestor
101838288|NCT00401973|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101838289|NCT00401973|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101838290|NCT00401973|Antiviral Agents|antiviral agents|mesh-ancestor
101838291|NCT00401973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101838292|NCT00401973|Dopamine Agents|dopamine agents|mesh-ancestor
101962700|NCT00110357|Irinotecan|irinotecan|mesh-list
101838293|NCT00401973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101838294|NCT00401973|Analgesics|analgesics|mesh-ancestor
101838295|NCT00401973|Sensory System Agents|sensory system agents|mesh-ancestor
101838296|NCT00401973|Anticonvulsants|anticonvulsants|mesh-ancestor
101838297|NCT00401973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101838298|NCT00401973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101838299|NCT01038453|Vitamin D|vitamin d|mesh-list
101838300|NCT01038453|Cholecalciferol|cholecalciferol|mesh-list
101838301|NCT01038453|Vitamins|vitamins|mesh-ancestor
101838302|NCT01038453|Micronutrients|micronutrients|mesh-ancestor
101838303|NCT01038453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838304|NCT01038453|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101838305|NCT01038453|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101838306|NCT00401193|Tranexamic Acid|tranexamic acid|mesh-list
101838307|NCT00401193|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101838308|NCT00401193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101838309|NCT00401193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838310|NCT00401193|Hemostatics|hemostatics|mesh-ancestor
101838311|NCT00401193|Coagulants|coagulants|mesh-ancestor
101838312|NCT00400569|Sunitinib|sunitinib|mesh-list
101838313|NCT00400569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838314|NCT00400569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101838315|NCT00400569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101838316|NCT00400569|Growth Substances|growth substances|mesh-ancestor
101838317|NCT00400569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838318|NCT00400569|Growth Inhibitors|growth inhibitors|mesh-ancestor
101838319|NCT00400569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101838320|NCT00400569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101838321|NCT00400569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838322|NCT00413049|Amlodipine|amlodipine|mesh-list
101838323|NCT00413049|Valsartan|valsartan|mesh-list
101838324|NCT00413049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101838325|NCT00413049|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101838326|NCT00413049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101838327|NCT00413049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838328|NCT00413049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101838329|NCT00413049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838330|NCT00413049|Vasodilator Agents|vasodilator agents|mesh-ancestor
101838331|NCT00413049|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101838332|NCT00413049|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101838333|NCT03732495|Denosumab|denosumab|mesh-list
101838334|NCT03732495|Lenvatinib|lenvatinib|mesh-list
101838335|NCT03732495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838336|NCT03732495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101838337|NCT03732495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101838338|NCT03732495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838339|NCT03732495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101506071|NCT00516399|Natamycin|natamycin|mesh-list
101838340|NCT03732495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838342|NCT01041729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101838343|NCT01041729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101838344|NCT01041729|Antimetabolites|antimetabolites|mesh-ancestor
101838345|NCT01041729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838346|NCT01041729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101838347|NCT01041729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101838348|NCT01041729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101838349|NCT01324245|Fenoldopam|fenoldopam|mesh-list
101838350|NCT01324245|Enalaprilat|enalaprilat|mesh-list
101838351|NCT01324245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101838352|NCT01324245|Vasodilator Agents|vasodilator agents|mesh-ancestor
101838353|NCT01324245|Dopamine Agonists|dopamine agonists|mesh-ancestor
101838354|NCT01324245|Dopamine Agents|dopamine agents|mesh-ancestor
101838355|NCT01324245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101838356|NCT01324245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838357|NCT01324245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838358|NCT01324245|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101838359|NCT01324245|Protease Inhibitors|protease inhibitors|mesh-ancestor
101838360|NCT01324245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101838361|NCT00454194|Pemetrexed|pemetrexed|mesh-list
101838362|NCT00454194|Sorafenib|sorafenib|mesh-list
101838363|NCT00454194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838364|NCT00454194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101838365|NCT00454194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838366|NCT00454194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101838367|NCT00454194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101838368|NCT00454194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101838369|NCT00468546|Methotrexate|methotrexate|mesh-list
101838370|NCT00468546|Rituximab|rituximab|mesh-list
101838371|NCT00468546|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101838372|NCT00468546|Abortifacient Agents|abortifacient agents|mesh-ancestor
101838373|NCT00468546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101838374|NCT00468546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838375|NCT00468546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101838376|NCT00468546|Antimetabolites|antimetabolites|mesh-ancestor
101838377|NCT00468546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101962751|NCT02183194|Paclitaxel|paclitaxel|mesh-list
101838378|NCT00468546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838380|NCT00468546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101838381|NCT00468546|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101838382|NCT00468546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101838383|NCT00468546|Immunologic Factors|immunologic factors|mesh-ancestor
101838384|NCT00468546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101838385|NCT00468546|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101838386|NCT00468546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101838387|NCT00303316|Vaccines|vaccines|mesh-list
101838388|NCT00303316|Immunologic Factors|immunologic factors|mesh-ancestor
101838389|NCT00303316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838390|NCT01064986|Hydrocortisone|hydrocortisone|mesh-list
101838391|NCT01064986|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101838393|NCT01064986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101838394|NCT01064986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101838395|NCT01064986|Adrenergic Agents|adrenergic agents|mesh-ancestor
101838396|NCT01064986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101838397|NCT01064986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838398|NCT01064986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838399|NCT01064986|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101838400|NCT01064986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101838401|NCT01064986|Autonomic Agents|autonomic agents|mesh-ancestor
101838402|NCT01064986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101838403|NCT01064986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101838404|NCT01064986|Respiratory System Agents|respiratory system agents|mesh-ancestor
101838405|NCT01064986|Mydriatics|mydriatics|mesh-ancestor
101838406|NCT01064986|Sympathomimetics|sympathomimetics|mesh-ancestor
101838407|NCT01064986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101838408|NCT01064986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101838409|NCT00468312|Mometasone Furoate|mometasone furoate|mesh-list
101838410|NCT00468312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101838411|NCT00468312|Dermatologic Agents|dermatologic agents|mesh-ancestor
101838412|NCT00468312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101838414|NCT03980002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101838415|NCT03980002|Immunologic Factors|immunologic factors|mesh-ancestor
101838416|NCT03980002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838417|NCT03980002|Leprostatic Agents|leprostatic agents|mesh-ancestor
101838418|NCT03980002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101838419|NCT03980002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101838420|NCT03980002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101838421|NCT03980002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101838422|NCT03980002|Growth Substances|growth substances|mesh-ancestor
101838423|NCT03980002|Growth Inhibitors|growth inhibitors|mesh-ancestor
101838424|NCT03980002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838425|NCT00331864|Ranibizumab|ranibizumab|mesh-list
101838426|NCT00331864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101838427|NCT00331864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101838428|NCT00331864|Growth Substances|growth substances|mesh-ancestor
101838429|NCT00331864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838430|NCT00331864|Growth Inhibitors|growth inhibitors|mesh-ancestor
101838431|NCT00331864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838432|NCT00331630|Paclitaxel|paclitaxel|mesh-list
101838433|NCT00331630|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101838434|NCT00331630|Lapatinib|lapatinib|mesh-list
101838435|NCT00331630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101838436|NCT00331630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838437|NCT00331630|Tubulin Modulators|tubulin modulators|mesh-ancestor
101838438|NCT00331630|Antimitotic Agents|antimitotic agents|mesh-ancestor
101838439|NCT00331630|Mitosis Modulators|mitosis modulators|mesh-ancestor
101838440|NCT00331630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838441|NCT00331630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101838442|NCT00331630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101838443|NCT00331552|Cyclophosphamide|cyclophosphamide|mesh-list
101838444|NCT00331552|Doxorubicin|doxorubicin|mesh-list
101838445|NCT00331552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101838446|NCT00331552|Trastuzumab|trastuzumab|mesh-list
101838447|NCT00331552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101838448|NCT00331552|Antibodies|antibodies|mesh-list
101838449|NCT00331552|Immunoglobulins|immunoglobulins|mesh-list
101838450|NCT00331552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101838451|NCT00331552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101838452|NCT00331552|Immunologic Factors|immunologic factors|mesh-ancestor
101838453|NCT00331552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838454|NCT00331552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101838455|NCT00331552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101838456|NCT00331552|Alkylating Agents|alkylating agents|mesh-ancestor
101387668|NCT00322660|Mydriatics|mydriatics|mesh-ancestor
101838457|NCT00331552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838458|NCT00331552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838459|NCT00331552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101838460|NCT00331552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101838461|NCT00331552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101838462|NCT00331552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101962893|NCT01083329|Niacin|niacin|mesh-list
101838463|NCT00331552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101838464|NCT04320628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
101838465|NCT04320628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101838466|NCT00331006|Rituximab|rituximab|mesh-list
101838467|NCT00331006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101838468|NCT00331006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838469|NCT00331006|Immunologic Factors|immunologic factors|mesh-ancestor
101838470|NCT00331006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838471|NCT00331006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101838472|NCT00302458|Methylphenidate|methylphenidate|mesh-list
101838473|NCT00302458|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101838474|NCT00302458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838475|NCT00302458|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101838476|NCT00302458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101838477|NCT00302458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101838478|NCT00302458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838479|NCT00302458|Dopamine Agents|dopamine agents|mesh-ancestor
101838480|NCT00302458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101838481|NCT00391053|Vaccines|vaccines|mesh-list
101838482|NCT00391053|Immunologic Factors|immunologic factors|mesh-ancestor
101838483|NCT00391053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838484|NCT00317044|Esomeprazole|esomeprazole|mesh-list
101838485|NCT00317044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101838486|NCT00317044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101838487|NCT00317044|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101838488|NCT00317044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101838489|NCT00317044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838490|NCT00301834|Cyclosporine|cyclosporine|mesh-list
101838491|NCT00301834|Methylprednisolone|methylprednisolone|mesh-list
101838492|NCT00301834|Methotrexate|methotrexate|mesh-list
101838493|NCT00301834|Fludarabine phosphate|fludarabine phosphate|mesh-list
101838494|NCT00301834|Fludarabine|fludarabine|mesh-list
101838495|NCT00301834|Busulfan|busulfan|mesh-list
101838496|NCT00301834|Alemtuzumab|alemtuzumab|mesh-list
101838497|NCT00301834|Cyclosporins|cyclosporins|mesh-list
101838498|NCT00301834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101838499|NCT00301834|Abortifacient Agents|abortifacient agents|mesh-ancestor
101838500|NCT00301834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101838501|NCT00301834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838502|NCT00301834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101838503|NCT00301834|Antimetabolites|antimetabolites|mesh-ancestor
101838504|NCT00301834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838505|NCT00301834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838506|NCT00301834|Dermatologic Agents|dermatologic agents|mesh-ancestor
101838507|NCT00301834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101838508|NCT00301834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101962929|NCT02184286|Antiviral Agents|antiviral agents|mesh-ancestor
101838510|NCT00301834|Immunologic Factors|immunologic factors|mesh-ancestor
101838511|NCT00301834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101838512|NCT00301834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101838513|NCT00301834|Antifungal Agents|antifungal agents|mesh-ancestor
101838514|NCT00301834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101838515|NCT00301834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101838516|NCT00301834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101838517|NCT00301834|Antiemetics|antiemetics|mesh-ancestor
101838518|NCT00301834|Autonomic Agents|autonomic agents|mesh-ancestor
101838519|NCT00301834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101838520|NCT00301834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101838521|NCT00301834|Glucocorticoids|glucocorticoids|mesh-ancestor
101838522|NCT00301834|Hormones|hormones|mesh-ancestor
101838523|NCT00301834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101838524|NCT00301834|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101838525|NCT00301834|Protective Agents|protective agents|mesh-ancestor
101838526|NCT00301834|Alkylating Agents|alkylating agents|mesh-ancestor
101558296|NCT01180647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101838527|NCT00301834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101838528|NCT00301834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101838529|NCT00301834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101838530|NCT00301366|Protease Inhibitors|protease inhibitors|mesh-list
101838531|NCT00301366|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
101838532|NCT00301366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101838533|NCT00301366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838534|NCT00301366|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101838535|NCT00301366|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101838537|NCT00466440|Docetaxel|docetaxel|mesh-list
101838538|NCT00466440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838539|NCT00466440|Tubulin Modulators|tubulin modulators|mesh-ancestor
101838540|NCT00466440|Antimitotic Agents|antimitotic agents|mesh-ancestor
101838541|NCT00466440|Mitosis Modulators|mitosis modulators|mesh-ancestor
101838542|NCT00466440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838543|NCT00466440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101838544|NCT00466440|Glucocorticoids|glucocorticoids|mesh-ancestor
101838545|NCT00466440|Hormones|hormones|mesh-ancestor
101838546|NCT00466440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101838547|NCT00466440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838548|NCT00466440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101838550|NCT00465972|Temazepam|temazepam|mesh-list
101838551|NCT00465972|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101838552|NCT00465972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101838553|NCT00465972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101838554|NCT00465972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838556|NCT00465972|Antidepressive Agents|antidepressive agents|mesh-ancestor
101838557|NCT00465972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101838558|NCT00465972|Histamine Antagonists|histamine antagonists|mesh-ancestor
101838559|NCT00465972|Histamine Agents|histamine agents|mesh-ancestor
101838560|NCT00465972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101838561|NCT00465972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838562|NCT00465972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101838563|NCT00465972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101838564|NCT00465972|GABA Modulators|gaba modulators|mesh-ancestor
101838565|NCT00465972|GABA Agents|gaba agents|mesh-ancestor
101838566|NCT03926754|Mirabegron|mirabegron|mesh-list
101838567|NCT03926754|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101838568|NCT03926754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101838569|NCT03926754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101838570|NCT03926754|Adrenergic Agents|adrenergic agents|mesh-ancestor
101838571|NCT03926754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101838572|NCT03926754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838573|NCT03926754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838574|NCT03926754|Urological Agents|urological agents|mesh-ancestor
101838575|NCT00465894|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101838576|NCT00465894|Estradiol|estradiol|mesh-list
101838577|NCT00465894|Estrogens|estrogens|mesh-ancestor
101838578|NCT00465894|Hormones|hormones|mesh-ancestor
101838579|NCT00465894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101838580|NCT00465894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838581|NCT00465894|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101838582|NCT00465894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101838583|NCT00465894|Cholinergic Agents|cholinergic agents|mesh-ancestor
101838584|NCT00465894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101838585|NCT00465894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838586|NCT00465894|Urological Agents|urological agents|mesh-ancestor
101838587|NCT00330460|Denosumab|denosumab|mesh-list
101838588|NCT00330460|Alendronate|alendronate|mesh-list
101838589|NCT00330460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101838590|NCT00330460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838591|NCT01062490|Treosulfan|treosulfan|mesh-list
101838592|NCT01062490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101838593|NCT01062490|Alkylating Agents|alkylating agents|mesh-ancestor
101838594|NCT01062490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838595|NCT01062490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838596|NCT00465738|Botulinum Toxins|botulinum toxins|mesh-list
101838597|NCT00465738|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101963001|NCT02185690|Pemetrexed|pemetrexed|mesh-list
101838598|NCT00465738|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101838599|NCT00465738|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
101838600|NCT00465738|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101838601|NCT00465738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101838602|NCT00465738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838603|NCT00465738|Cholinergic Agents|cholinergic agents|mesh-ancestor
101838604|NCT00465738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101838605|NCT00465738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838606|NCT00465738|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101838607|NCT00465738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101838609|NCT00400179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838610|NCT00464568|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
101838611|NCT00464568|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101838612|NCT00464568|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101838613|NCT00464568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101838614|NCT00464568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838615|NCT00464490|Dexmedetomidine|dexmedetomidine|mesh-list
101838616|NCT00464490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101838617|NCT00464490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101838618|NCT00464490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838619|NCT00464490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101838620|NCT00464490|Analgesics|analgesics|mesh-ancestor
101838621|NCT00464490|Sensory System Agents|sensory system agents|mesh-ancestor
101838622|NCT00464490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101838623|NCT00464490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101838624|NCT00464490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101838625|NCT00464490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101838626|NCT00464490|Adrenergic Agents|adrenergic agents|mesh-ancestor
101838627|NCT00464490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101838628|NCT00464490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838630|NCT00412893|Isavuconazole|isavuconazole|mesh-list
101838631|NCT00412893|Antifungal Agents|antifungal agents|mesh-ancestor
101838632|NCT00412893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101838633|NCT00412893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101838634|NCT00412893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101838635|NCT00412893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101838636|NCT00412893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838637|NCT00412893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101838638|NCT00412893|Hormone Antagonists|hormone antagonists|mesh-ancestor
101838639|NCT00412893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101838640|NCT00412893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838641|NCT00412893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101838642|NCT00412737|Oseltamivir|oseltamivir|mesh-list
101838643|NCT00412737|Antiviral Agents|antiviral agents|mesh-ancestor
101838644|NCT00412737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101838645|NCT00412737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101838646|NCT00412737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838647|NCT00508742|Vaccines|vaccines|mesh-list
101838648|NCT00508742|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101838649|NCT00508742|Immunologic Factors|immunologic factors|mesh-ancestor
101838650|NCT00508742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838651|NCT01041963|Losartan|losartan|mesh-list
101838652|NCT01041963|Enalapril|enalapril|mesh-list
101838653|NCT01041963|Enalaprilat|enalaprilat|mesh-list
101838654|NCT01041963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101838655|NCT01041963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101838656|NCT01041963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101838657|NCT01041963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101838658|NCT01041963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838659|NCT01041963|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101838660|NCT01041963|Protease Inhibitors|protease inhibitors|mesh-ancestor
101838661|NCT01041963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101838662|NCT01044225|Cetuximab|cetuximab|mesh-list
101838663|NCT01044225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101838664|NCT01044225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838665|NCT00508274|Capecitabine|capecitabine|mesh-list
101838666|NCT00508274|Lapatinib|lapatinib|mesh-list
101838667|NCT00508274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101838668|NCT00508274|Antimetabolites|antimetabolites|mesh-ancestor
101838669|NCT00508274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558446|NCT00998296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838670|NCT00508274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838671|NCT00508274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101838672|NCT00508274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101838673|NCT01042041|Doxorubicin|doxorubicin|mesh-list
101838674|NCT01042041|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101838675|NCT01042041|Sorafenib|sorafenib|mesh-list
101838676|NCT01042041|Mitomycins|mitomycins|mesh-list
101838677|NCT01042041|Mitomycin|mitomycin|mesh-list
101838678|NCT01042041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838679|NCT01042041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101838680|NCT01042041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101838681|NCT01042041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101838683|NCT01042041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838684|NCT01042041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101838685|NCT01042041|Alkylating Agents|alkylating agents|mesh-ancestor
101838686|NCT01042041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101838687|NCT00499460|Oxycodone|oxycodone|mesh-list
101838688|NCT00499460|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101838689|NCT00499460|Narcotics|narcotics|mesh-ancestor
101838690|NCT00499460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101838691|NCT00499460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838692|NCT00499460|Analgesics|analgesics|mesh-ancestor
101838693|NCT00499460|Sensory System Agents|sensory system agents|mesh-ancestor
101838694|NCT00499460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101838695|NCT00412113|Calcium, Dietary|calcium, dietary|mesh-list
101838696|NCT00412113|Amlodipine|amlodipine|mesh-list
101838697|NCT00412113|Atorvastatin|atorvastatin|mesh-list
101838698|NCT00412113|Calcium|calcium|mesh-list
101838699|NCT00412113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101838700|NCT00412113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838701|NCT00412113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101838702|NCT00412113|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101838703|NCT00412113|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101838704|NCT00412113|Antimetabolites|antimetabolites|mesh-ancestor
101387669|NCT00322660|Sympathomimetics|sympathomimetics|mesh-ancestor
101838705|NCT00412113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838706|NCT00412113|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101838707|NCT00412113|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101838708|NCT00412113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101838709|NCT00412113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101838710|NCT00412113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101838711|NCT00412113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101838712|NCT00412113|Vasodilator Agents|vasodilator agents|mesh-ancestor
101838713|NCT01014650|Glycine|glycine|mesh-list
101838714|NCT01014650|Glycine Agents|glycine agents|mesh-ancestor
101838715|NCT01014650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101838716|NCT01014650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838717|NCT01014650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838718|NCT00411645|Maribavir|maribavir|mesh-list
101838719|NCT00411645|Antiviral Agents|antiviral agents|mesh-ancestor
101838720|NCT00411645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101838721|NCT00490724|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101838722|NCT00490724|Natriuretic Agents|natriuretic agents|mesh-ancestor
101838723|NCT00490724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838724|NCT01039155|Oxaliplatin|oxaliplatin|mesh-list
101838725|NCT01039155|Azacitidine|azacitidine|mesh-list
101838726|NCT01039155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838727|NCT01039155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101838728|NCT01039155|Antimetabolites|antimetabolites|mesh-ancestor
101838729|NCT01039155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838730|NCT01039155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101838731|NCT01039233|Bicalutamide|bicalutamide|mesh-list
101838732|NCT01039233|Androgen Antagonists|androgen antagonists|mesh-ancestor
101838733|NCT01039233|Hormone Antagonists|hormone antagonists|mesh-ancestor
101838734|NCT01039233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101838735|NCT01039233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838736|NCT01039233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838737|NCT00490646|Docetaxel|docetaxel|mesh-list
101838738|NCT00490646|Trastuzumab|trastuzumab|mesh-list
101838739|NCT00490646|Epothilones|epothilones|mesh-list
101838740|NCT00490646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838741|NCT00490646|Tubulin Modulators|tubulin modulators|mesh-ancestor
101838742|NCT00490646|Antimitotic Agents|antimitotic agents|mesh-ancestor
101838743|NCT00490646|Mitosis Modulators|mitosis modulators|mesh-ancestor
101963078|NCT01083797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101236595|NCT01598441|Iloprost|iloprost|mesh-list
101838744|NCT00490646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838745|NCT00490646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101838747|NCT03992937|Progesterone|progesterone|mesh-list
101838748|NCT03992937|Progestins|progestins|mesh-ancestor
101838749|NCT03992937|Hormones|hormones|mesh-ancestor
101838750|NCT03992937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101838751|NCT03992937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838752|NCT03992937|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101838753|NCT03992937|Contraceptive Agents|contraceptive agents|mesh-ancestor
101838754|NCT03992937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101838755|NCT03992937|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101838756|NCT03992937|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101838757|NCT03992937|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101838758|NCT01039545|Norfloxacin|norfloxacin|mesh-list
101838759|NCT01039545|Diclofenac|diclofenac|mesh-list
101838760|NCT01039545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101838761|NCT01039545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101838762|NCT01039545|Analgesics|analgesics|mesh-ancestor
101838763|NCT01039545|Sensory System Agents|sensory system agents|mesh-ancestor
101838764|NCT01039545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101838765|NCT01039545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838766|NCT01039545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101838767|NCT01039545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101838768|NCT01039545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101838769|NCT01039545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101838770|NCT01039545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838771|NCT01039545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101838772|NCT01039545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101838773|NCT01039545|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101838774|NCT01039545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101838775|NCT01039545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838776|NCT01039545|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101838777|NCT01039545|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101838778|NCT00490568|Rosiglitazone|rosiglitazone|mesh-list
101838779|NCT00490568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101838780|NCT00490568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838781|NCT00561353|Ribavirin|ribavirin|mesh-list
101838782|NCT00561353|Simeprevir|simeprevir|mesh-list
101838783|NCT00561353|Antimetabolites|antimetabolites|mesh-ancestor
101838784|NCT00561353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838785|NCT00561353|Antiviral Agents|antiviral agents|mesh-ancestor
101838786|NCT00561353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101838787|NCT00561353|Protease Inhibitors|protease inhibitors|mesh-ancestor
101838788|NCT00561353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101838789|NCT00944957|Efavirenz|efavirenz|mesh-list
101838790|NCT00944957|Raltegravir Potassium|raltegravir potassium|mesh-list
101838791|NCT00944957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101838792|NCT00944957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101838793|NCT00944957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101838794|NCT00944957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838795|NCT00944957|Antiviral Agents|antiviral agents|mesh-ancestor
101838796|NCT00944957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101838797|NCT00944957|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101838798|NCT00944957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101838799|NCT00944957|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101838800|NCT00944957|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101838801|NCT00944957|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101236634|NCT01598584|Serotonin Agents|serotonin agents|mesh-ancestor
101838802|NCT00944957|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101838803|NCT00944957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101838804|NCT00944957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101838805|NCT00944957|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101838806|NCT00944957|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101838807|NCT00945347|Miglustat|miglustat|mesh-list
101838808|NCT00945347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101838809|NCT00945347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838810|NCT00945347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101838811|NCT00945347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101838812|NCT00945347|Antiviral Agents|antiviral agents|mesh-ancestor
101838813|NCT00945347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101838814|NCT00945347|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101838815|NCT00945347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101838816|NCT00945347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838817|NCT00941135|Docetaxel|docetaxel|mesh-list
101838818|NCT00941135|Cetuximab|cetuximab|mesh-list
101838819|NCT00941135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838820|NCT00941135|Tubulin Modulators|tubulin modulators|mesh-ancestor
101838821|NCT00941135|Antimitotic Agents|antimitotic agents|mesh-ancestor
101838822|NCT00941135|Mitosis Modulators|mitosis modulators|mesh-ancestor
101838823|NCT00941135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838824|NCT00941135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101838825|NCT00556439|Abatacept|abatacept|mesh-list
101838826|NCT00556439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101838827|NCT00556439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838828|NCT00556439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101838829|NCT00556439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838830|NCT00556439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101838831|NCT00556439|Immunologic Factors|immunologic factors|mesh-ancestor
101838832|NCT00556439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838833|NCT00556439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101838834|NCT04012307|Candesartan|candesartan|mesh-list
101838835|NCT04012307|Candesartan cilexetil|candesartan cilexetil|mesh-list
101838836|NCT04012307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101838837|NCT04012307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101838838|NCT04012307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101838839|NCT04012307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838840|NCT00387465|Azacitidine|azacitidine|mesh-list
101838841|NCT00387465|Entinostat|entinostat|mesh-list
101838842|NCT00387465|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
101838843|NCT00387465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101838844|NCT00387465|Antimetabolites|antimetabolites|mesh-ancestor
101838845|NCT00387465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838846|NCT00387465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838847|NCT00387465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101838848|NCT01042665|Latanoprost|latanoprost|mesh-list
101838849|NCT01042665|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101838850|NCT01042665|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101838851|NCT00949949|Gemcitabine|gemcitabine|mesh-list
101838852|NCT00949949|Everolimus|everolimus|mesh-list
101838853|NCT00949949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838854|NCT00949949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101838855|NCT00949949|Antimetabolites|antimetabolites|mesh-ancestor
101838856|NCT00949949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838857|NCT00949949|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101838858|NCT00949949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101838859|NCT00949949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101838860|NCT00949949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101838861|NCT00949949|Immunologic Factors|immunologic factors|mesh-ancestor
101838862|NCT00949949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838863|NCT00941369|Insulin|insulin|mesh-list
101838864|NCT00941369|Insulin Glargine|insulin glargine|mesh-list
101838865|NCT00941369|Insulin, Isophane|insulin, isophane|mesh-list
101838866|NCT00941369|Isophane Insulin, Human|isophane insulin, human|mesh-list
101838867|NCT00941369|Isophane insulin, beef|isophane insulin, beef|mesh-list
101838868|NCT00941369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101838869|NCT00941369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838870|NCT00950027|Povidone-Iodine|povidone-iodine|mesh-list
101838871|NCT00950027|Povidone|povidone|mesh-list
101838872|NCT00950027|Plasma Substitutes|plasma substitutes|mesh-ancestor
101838873|NCT00950027|Blood Substitutes|blood substitutes|mesh-ancestor
101838874|NCT00950027|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101838875|NCT00950027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101838876|NCT00941525|Latanoprost|latanoprost|mesh-list
101838877|NCT00941525|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101838878|NCT00941525|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101838879|NCT00456261|Bevacizumab|bevacizumab|mesh-list
101838880|NCT00456261|Carboplatin|carboplatin|mesh-list
101838881|NCT00456261|Gemcitabine|gemcitabine|mesh-list
101838882|NCT00456261|Pemetrexed|pemetrexed|mesh-list
101838883|NCT00456261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101838884|NCT00456261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838885|NCT00456261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101838886|NCT00456261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101838887|NCT00456261|Growth Substances|growth substances|mesh-ancestor
101838888|NCT00456261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838889|NCT00456261|Growth Inhibitors|growth inhibitors|mesh-ancestor
101838890|NCT00456261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101838891|NCT00456261|Antimetabolites|antimetabolites|mesh-ancestor
101838892|NCT00456261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838893|NCT00456261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101838894|NCT00456261|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101838895|NCT00456261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101838896|NCT00386607|Valsartan|valsartan|mesh-list
101838897|NCT00386607|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101838898|NCT00386607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101685688|NCT00906035|Antipyretics|antipyretics|mesh-ancestor
101838899|NCT00386607|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101838900|NCT00386607|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101838901|NCT00386607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838902|NCT00386607|Diuretics|diuretics|mesh-ancestor
101838903|NCT00386607|Natriuretic Agents|natriuretic agents|mesh-ancestor
101838904|NCT00386607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838905|NCT00386607|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101838906|NCT00386607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101838907|NCT00410163|Cyclophosphamide|cyclophosphamide|mesh-list
101838908|NCT00410163|Fludarabine|fludarabine|mesh-list
101838910|NCT00410163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101838911|NCT00410163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101838912|NCT00410163|Immunologic Factors|immunologic factors|mesh-ancestor
101838913|NCT00410163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838914|NCT00410163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101838915|NCT00410163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101838916|NCT00410163|Alkylating Agents|alkylating agents|mesh-ancestor
101838917|NCT00410163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838918|NCT00410163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838919|NCT00410163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101838920|NCT03617523|Vaccines|vaccines|mesh-list
101838921|NCT03617523|Immunologic Factors|immunologic factors|mesh-ancestor
101838922|NCT03617523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838924|NCT00409617|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101838925|NCT00409617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101838926|NCT00409617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101838927|NCT00300274|Cyclosporine|cyclosporine|mesh-list
101838928|NCT00300274|Mycophenolic Acid|mycophenolic acid|mesh-list
101838929|NCT00300274|Everolimus|everolimus|mesh-list
101838930|NCT00300274|Cyclosporins|cyclosporins|mesh-list
101838931|NCT00300274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101838932|NCT00300274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838933|NCT00300274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101838934|NCT00300274|Immunologic Factors|immunologic factors|mesh-ancestor
101838935|NCT00300274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838936|NCT00300274|Antifungal Agents|antifungal agents|mesh-ancestor
101838937|NCT00300274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101838938|NCT00300274|Dermatologic Agents|dermatologic agents|mesh-ancestor
101838939|NCT00300274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101838940|NCT00300274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101838941|NCT00300274|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101838942|NCT00300274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101838943|NCT00300274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838944|NCT00300274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101838945|NCT00300274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101838946|NCT00300274|Antitubercular Agents|antitubercular agents|mesh-ancestor
101838947|NCT00300274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101838948|NCT01043211|Lidocaine|lidocaine|mesh-list
101838949|NCT01043211|Epinephrine|epinephrine|mesh-list
101838950|NCT01043211|Anesthetics, Local|anesthetics, local|mesh-ancestor
101838951|NCT01043211|Anesthetics|anesthetics|mesh-ancestor
101838952|NCT01043211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101838953|NCT01043211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838954|NCT01043211|Sensory System Agents|sensory system agents|mesh-ancestor
101838955|NCT01043211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101838956|NCT01043211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101838957|NCT01043211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101838958|NCT01043211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101838959|NCT01043211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101838960|NCT01043211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101838961|NCT01043211|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101838962|NCT01043211|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101838963|NCT01043211|Adrenergic Agents|adrenergic agents|mesh-ancestor
101838964|NCT01043211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101838965|NCT01043211|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101838966|NCT01043211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101838967|NCT01043211|Autonomic Agents|autonomic agents|mesh-ancestor
101838968|NCT01043211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101838969|NCT01043211|Respiratory System Agents|respiratory system agents|mesh-ancestor
101838970|NCT01043211|Mydriatics|mydriatics|mesh-ancestor
101838971|NCT01043211|Sympathomimetics|sympathomimetics|mesh-ancestor
101838972|NCT01043211|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101838973|NCT01043445|Glycerol|glycerol|mesh-list
101838974|NCT01043445|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101838975|NCT01043445|Protective Agents|protective agents|mesh-ancestor
101838976|NCT01043445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838977|NCT00396591|Aflibercept|aflibercept|mesh-list
101838978|NCT00396591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101838979|NCT00396591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101838980|NCT00396591|Growth Substances|growth substances|mesh-ancestor
101838981|NCT00396591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838982|NCT00396591|Growth Inhibitors|growth inhibitors|mesh-ancestor
101838983|NCT00396591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838984|NCT00316264|Palivizumab|palivizumab|mesh-list
101838985|NCT00316264|Antiviral Agents|antiviral agents|mesh-ancestor
101838986|NCT00316264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101838987|NCT00385827|Prednisone|prednisone|mesh-list
101838988|NCT00385827|Mitoxantrone|mitoxantrone|mesh-list
101838989|NCT00385827|Siltuximab|siltuximab|mesh-list
101838990|NCT00385827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101838991|NCT00385827|Glucocorticoids|glucocorticoids|mesh-ancestor
101838992|NCT00385827|Hormones|hormones|mesh-ancestor
101838993|NCT00385827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101838994|NCT00385827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101838995|NCT00385827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101838996|NCT00385827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101838997|NCT00385827|Analgesics|analgesics|mesh-ancestor
101838998|NCT00385827|Sensory System Agents|sensory system agents|mesh-ancestor
101838999|NCT00385827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101839000|NCT00385827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101839001|NCT00385827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101839002|NCT00385827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101839003|NCT00385827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839004|NCT00498602|Saponin QA-21V1|saponin qa-21v1|mesh-list
101839005|NCT00498602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101839006|NCT00498602|Immunologic Factors|immunologic factors|mesh-ancestor
101839007|NCT00498602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839008|NCT00507728|Bupropion|bupropion|mesh-list
101839009|NCT00507728|Varenicline|varenicline|mesh-list
101839010|NCT00507728|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101839011|NCT00507728|Antidepressive Agents|antidepressive agents|mesh-ancestor
101839012|NCT00507728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101839013|NCT00507728|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101839014|NCT00507728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101839015|NCT00507728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101839016|NCT00507728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839017|NCT00507728|Dopamine Agents|dopamine agents|mesh-ancestor
101839018|NCT00507728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101839019|NCT00507728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839020|NCT00507728|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101839021|NCT00507728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101839022|NCT00507728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101839023|NCT00507728|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101839024|NCT00507728|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101839025|NCT00507728|Cholinergic Agents|cholinergic agents|mesh-ancestor
101839026|NCT00498368|Rituximab|rituximab|mesh-list
101839027|NCT00498368|Angiotensin II|angiotensin ii|mesh-list
101839028|NCT00498368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101839029|NCT00498368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101839030|NCT00498368|Immunologic Factors|immunologic factors|mesh-ancestor
101839031|NCT00498368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839032|NCT00498368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101839033|NCT00498368|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101839034|NCT04460066|Paclitaxel|paclitaxel|mesh-list
101839035|NCT04460066|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101839036|NCT04460066|Antibodies|antibodies|mesh-list
101839037|NCT04460066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101839038|NCT04460066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101839039|NCT04460066|Tubulin Modulators|tubulin modulators|mesh-ancestor
101839040|NCT04460066|Antimitotic Agents|antimitotic agents|mesh-ancestor
101839041|NCT04460066|Mitosis Modulators|mitosis modulators|mesh-ancestor
101839042|NCT04460066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839043|NCT04460066|Immunologic Factors|immunologic factors|mesh-ancestor
101839044|NCT04460066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839045|NCT00385671|Pregabalin|pregabalin|mesh-list
101839046|NCT00385671|Gabapentin|gabapentin|mesh-list
101839047|NCT00385671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101839048|NCT00385671|Analgesics|analgesics|mesh-ancestor
101839049|NCT00385671|Sensory System Agents|sensory system agents|mesh-ancestor
101839050|NCT00385671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101839051|NCT00385671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839052|NCT00385671|Anticonvulsants|anticonvulsants|mesh-ancestor
101839053|NCT00385671|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101839054|NCT00385671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101839055|NCT00385671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839056|NCT00385671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101839057|NCT00385671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101839058|NCT00385671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101839059|NCT00385671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101839060|NCT00385671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101839061|NCT00385671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101963262|NCT02193568|Anesthetics|anesthetics|mesh-list
101839062|NCT00385671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101839063|NCT00385671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101839064|NCT00385671|Antimanic Agents|antimanic agents|mesh-ancestor
101839065|NCT00385671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101839066|NCT00385671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101839067|NCT00385671|Antidepressive Agents|antidepressive agents|mesh-ancestor
101839068|NCT00385671|Dopamine Agents|dopamine agents|mesh-ancestor
101839069|NCT00497198|Bile Acids and Salts|bile acids and salts|mesh-list
101839070|NCT00497198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101839071|NCT00496964|Botulinum Toxins|botulinum toxins|mesh-list
101839072|NCT00496964|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101839073|NCT00496964|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101839074|NCT00496964|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101839075|NCT00496964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101839076|NCT00496964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839077|NCT00496964|Cholinergic Agents|cholinergic agents|mesh-ancestor
101839078|NCT00496964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101839079|NCT00496964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839080|NCT00496964|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101839081|NCT00496964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101839082|NCT01011062|Losartan|losartan|mesh-list
101839083|NCT01011062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101839084|NCT01011062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101839085|NCT01011062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101839086|NCT01011062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101685719|NCT02698124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101839087|NCT01011062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839089|NCT00490490|Lugol's solution|lugol's solution|mesh-list
101839090|NCT00490490|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101839091|NCT00490490|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101839092|NCT00490490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101839093|NCT00490490|Trace Elements|trace elements|mesh-ancestor
101839094|NCT00490490|Micronutrients|micronutrients|mesh-ancestor
101839095|NCT00490490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839097|NCT00490490|Coagulants|coagulants|mesh-ancestor
101839098|NCT05049980|Mifepristone|mifepristone|mesh-list
101839099|NCT05049980|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101839100|NCT05049980|Abortifacient Agents|abortifacient agents|mesh-ancestor
101839101|NCT05049980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101839102|NCT05049980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839103|NCT05049980|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101839104|NCT05049980|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101839105|NCT05049980|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101839106|NCT05049980|Contraceptive Agents|contraceptive agents|mesh-ancestor
101839107|NCT05049980|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101839108|NCT05049980|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101839109|NCT05049980|Hormone Antagonists|hormone antagonists|mesh-ancestor
101839110|NCT05049980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101839111|NCT05049980|Luteolytic Agents|luteolytic agents|mesh-ancestor
101839112|NCT05049980|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101839113|NCT05049980|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101839114|NCT05176418|Nicotine|nicotine|mesh-list
101839115|NCT05176418|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101839116|NCT05176418|Autonomic Agents|autonomic agents|mesh-ancestor
101839117|NCT05176418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101839118|NCT05176418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839119|NCT05176418|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101558913|NCT01170663|Paclitaxel|paclitaxel|mesh-list
101839120|NCT05176418|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101839121|NCT05176418|Cholinergic Agents|cholinergic agents|mesh-ancestor
101839122|NCT05176418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101839123|NCT05176418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839124|NCT00385593|Budesonide|budesonide|mesh-list
101839125|NCT00385593|Formoterol Fumarate|formoterol fumarate|mesh-list
101839126|NCT00385593|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101839127|NCT00385593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101839128|NCT00385593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101839129|NCT00385593|Autonomic Agents|autonomic agents|mesh-ancestor
101839130|NCT00385593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101839131|NCT00385593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839132|NCT00385593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101839133|NCT00385593|Respiratory System Agents|respiratory system agents|mesh-ancestor
101839134|NCT00385593|Glucocorticoids|glucocorticoids|mesh-ancestor
101839135|NCT00385593|Hormones|hormones|mesh-ancestor
101839136|NCT00385593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101839137|NCT00385593|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101839138|NCT00385593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101839139|NCT00385593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101839140|NCT00385593|Adrenergic Agents|adrenergic agents|mesh-ancestor
101839141|NCT00385593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101839142|NCT00385593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839143|NCT01015040|Solifenacin Succinate|solifenacin succinate|mesh-list
101839144|NCT01015040|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101839145|NCT01015040|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101839146|NCT01015040|Cholinergic Agents|cholinergic agents|mesh-ancestor
101839147|NCT01015040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101839148|NCT01015040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839149|NCT01015040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839150|NCT01015040|Urological Agents|urological agents|mesh-ancestor
101839151|NCT00495170|Paclitaxel|paclitaxel|mesh-list
101839152|NCT00495170|Carboplatin|carboplatin|mesh-list
101839153|NCT00495170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101839154|NCT00495170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101839155|NCT00495170|Tubulin Modulators|tubulin modulators|mesh-ancestor
101839156|NCT00495170|Antimitotic Agents|antimitotic agents|mesh-ancestor
101839157|NCT00495170|Mitosis Modulators|mitosis modulators|mesh-ancestor
101506876|NCT05146778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101839158|NCT00495170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839159|NCT01011374|Ranibizumab|ranibizumab|mesh-list
101839160|NCT01011374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101839161|NCT01011374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101839162|NCT01011374|Growth Substances|growth substances|mesh-ancestor
101839163|NCT01011374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839164|NCT01011374|Growth Inhibitors|growth inhibitors|mesh-ancestor
101839165|NCT01011374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101839166|NCT00385203|Cediranib|cediranib|mesh-list
101839167|NCT00385203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101839168|NCT00385203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101839169|NCT00385203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101839170|NCT00385203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839171|NCT01043601|Formoterol Fumarate|formoterol fumarate|mesh-list
101839172|NCT01043601|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101839173|NCT01043601|Autonomic Agents|autonomic agents|mesh-ancestor
101839174|NCT01043601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101839175|NCT01043601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839176|NCT01043601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101839177|NCT01043601|Respiratory System Agents|respiratory system agents|mesh-ancestor
101839178|NCT01043601|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101839179|NCT01043601|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101839180|NCT01043601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101839181|NCT01043601|Adrenergic Agents|adrenergic agents|mesh-ancestor
101839182|NCT01043601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101839183|NCT01043601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839184|NCT01043679|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101839185|NCT01043679|Antidepressive Agents|antidepressive agents|mesh-ancestor
101839186|NCT01043679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101839187|NCT01043679|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101839188|NCT01043679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101839189|NCT01043679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101839190|NCT01043679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839191|NCT00408993|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101839192|NCT00408993|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101839193|NCT00408993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101839194|NCT00408993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101839195|NCT00408993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839196|NCT00408993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101839197|NCT00408993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839199|NCT00408993|Sensory System Agents|sensory system agents|mesh-ancestor
101839200|NCT00408993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101839201|NCT00408993|Antidepressive Agents|antidepressive agents|mesh-ancestor
101839202|NCT00408993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101839203|NCT00408993|Dopamine Agents|dopamine agents|mesh-ancestor
101839204|NCT00395967|Plerixafor|plerixafor|mesh-list
101839205|NCT00395967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101839206|NCT00395967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101839207|NCT00395967|Antiviral Agents|antiviral agents|mesh-ancestor
101839208|NCT00395967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101839209|NCT00395343|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101839210|NCT00395343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101839211|NCT00395343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839212|NCT00395343|Incretins|incretins|mesh-ancestor
101839213|NCT00395343|Hormones|hormones|mesh-ancestor
101839214|NCT00395343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101839215|NCT00395343|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101839216|NCT00395343|Protease Inhibitors|protease inhibitors|mesh-ancestor
101839217|NCT00395343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101839218|NCT00395343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839219|NCT00560573|Gemcitabine|gemcitabine|mesh-list
101839220|NCT00560573|Pemetrexed|pemetrexed|mesh-list
101839221|NCT00560573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101839222|NCT00560573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101839223|NCT00560573|Antimetabolites|antimetabolites|mesh-ancestor
101839224|NCT00560573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506952|NCT00521703|Lidocaine|lidocaine|mesh-list
101839226|NCT00560573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101839227|NCT00560573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101839228|NCT00950105|Semapimod|semapimod|mesh-list
101839229|NCT00950105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101839230|NCT00950105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101839231|NCT00950105|Analgesics|analgesics|mesh-ancestor
101839232|NCT00950105|Sensory System Agents|sensory system agents|mesh-ancestor
101839233|NCT00950105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101839234|NCT00950105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839235|NCT00950105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101839236|NCT00950105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101839237|NCT00950105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101839238|NCT00950105|Immunologic Factors|immunologic factors|mesh-ancestor
101839239|NCT00950261|Cisplatin|cisplatin|mesh-list
101839240|NCT00950261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101839241|NCT05280197|Bupivacaine|bupivacaine|mesh-list
101839242|NCT05280197|Anesthetics, Local|anesthetics, local|mesh-ancestor
101839243|NCT05280197|Anesthetics|anesthetics|mesh-ancestor
101839244|NCT05280197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101839245|NCT05280197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839246|NCT05280197|Sensory System Agents|sensory system agents|mesh-ancestor
101839247|NCT05280197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101839248|NCT00946595|Ritonavir|ritonavir|mesh-list
101839249|NCT00946595|Lopinavir|lopinavir|mesh-list
101839250|NCT00946595|Tenofovir|tenofovir|mesh-list
101839251|NCT00946595|Efavirenz|efavirenz|mesh-list
101839252|NCT00946595|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101839253|NCT00946595|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101839254|NCT00946595|Protease Inhibitors|protease inhibitors|mesh-ancestor
101839255|NCT00946595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101839256|NCT00946595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839257|NCT00946595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101839258|NCT00946595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101839259|NCT00946595|Antiviral Agents|antiviral agents|mesh-ancestor
101839260|NCT00946595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101839261|NCT00946595|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101963307|NCT02187250|Metformin|metformin|mesh-list
101839262|NCT00946595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101839263|NCT00946595|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101839264|NCT00946595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101839265|NCT00946595|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101839266|NCT00946595|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101839267|NCT00946595|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101839268|NCT00946595|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101839269|NCT00946595|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101839271|NCT00494780|Prednisolone|prednisolone|mesh-list
101839272|NCT00494780|Cyclophosphamide|cyclophosphamide|mesh-list
101839273|NCT00494780|Doxorubicin|doxorubicin|mesh-list
101839274|NCT00494780|Vincristine|vincristine|mesh-list
101839275|NCT00494780|Ofatumumab|ofatumumab|mesh-list
101839276|NCT00494780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101839277|NCT00494780|Immunologic Factors|immunologic factors|mesh-ancestor
101839278|NCT00494780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839279|NCT00494780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101839280|NCT00494780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101839281|NCT00494780|Alkylating Agents|alkylating agents|mesh-ancestor
101839282|NCT00494780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839283|NCT00494780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101839284|NCT00494780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101839285|NCT00494780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101839286|NCT00494780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101839287|NCT00494780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101839288|NCT00494780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101839289|NCT00494780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101839290|NCT00494780|Glucocorticoids|glucocorticoids|mesh-ancestor
101839291|NCT00494780|Hormones|hormones|mesh-ancestor
101236735|NCT01599364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101839292|NCT00494780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101839293|NCT00494780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101839294|NCT00494780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101839295|NCT00494780|Tubulin Modulators|tubulin modulators|mesh-ancestor
101839296|NCT00494780|Antimitotic Agents|antimitotic agents|mesh-ancestor
101839297|NCT00494780|Mitosis Modulators|mitosis modulators|mesh-ancestor
101839298|NCT01011452|Montelukast|montelukast|mesh-list
101839299|NCT01011452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101839300|NCT01011452|Respiratory System Agents|respiratory system agents|mesh-ancestor
101839301|NCT01011452|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101839302|NCT01011452|Hormone Antagonists|hormone antagonists|mesh-ancestor
101839303|NCT01011452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101839304|NCT01011452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839305|NCT01011452|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101839306|NCT01011452|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101839307|NCT01011452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839308|NCT00490022|Dihydrotestosterone|dihydrotestosterone|mesh-list
101839309|NCT00490022|Androgens|androgens|mesh-ancestor
101839310|NCT00490022|Hormones|hormones|mesh-ancestor
101839311|NCT00490022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101839312|NCT00490022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839313|NCT01011530|Pevonedistat|pevonedistat|mesh-list
101839314|NCT01011530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101839315|NCT01011530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839316|NCT00493454|Rituximab|rituximab|mesh-list
101839317|NCT00493454|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101839318|NCT00493454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101839319|NCT00493454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101839320|NCT00493454|Immunologic Factors|immunologic factors|mesh-ancestor
101839321|NCT00493454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839322|NCT00493454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101839323|NCT00493220|Ceftriaxone|ceftriaxone|mesh-list
101839324|NCT00493220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101839325|NCT00493220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101839326|NCT00950339|Omeprazole|omeprazole|mesh-list
101839327|NCT00950339|Pantoprazole|pantoprazole|mesh-list
101839328|NCT00950339|Famotidine|famotidine|mesh-list
101839329|NCT00950339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101839330|NCT00950339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101839331|NCT00950339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101839332|NCT00950339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101839333|NCT00950339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839334|NCT00950339|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101839335|NCT00950339|Histamine Antagonists|histamine antagonists|mesh-ancestor
101839336|NCT00950339|Histamine Agents|histamine agents|mesh-ancestor
101839337|NCT00950339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101839338|NCT00950339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839339|NCT00950417|Nimotuzumab|nimotuzumab|mesh-list
101839340|NCT00950417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101839341|NCT00950417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101839343|NCT00946673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101839344|NCT00946673|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101839345|NCT00946673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101839346|NCT00946673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839347|NCT00394953|Darbepoetin alfa|darbepoetin alfa|mesh-list
101839348|NCT00394953|Hematinics|hematinics|mesh-ancestor
101839349|NCT00946751|Levetiracetam|levetiracetam|mesh-list
101839350|NCT00946751|Anticonvulsants|anticonvulsants|mesh-ancestor
101839351|NCT00946751|Nootropic Agents|nootropic agents|mesh-ancestor
101839353|NCT00485732|Immunologic Factors|immunologic factors|mesh-ancestor
101839354|NCT00485732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839355|NCT00946829|Telmisartan|telmisartan|mesh-list
101839356|NCT00946829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101839357|NCT00946829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101236757|NCT05690802|Palonosetron|palonosetron|mesh-list
101839358|NCT00946829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101839359|NCT00946829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839360|NCT00489554|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101839361|NCT00489554|Immunologic Factors|immunologic factors|mesh-ancestor
101839362|NCT00489554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839363|NCT00408681|Lithium Carbonate|lithium carbonate|mesh-list
101839364|NCT00408681|Antidepressive Agents|antidepressive agents|mesh-ancestor
101839365|NCT00408681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101839366|NCT00408681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101839367|NCT00408681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839368|NCT00408681|Antimanic Agents|antimanic agents|mesh-ancestor
101839369|NCT00408681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101839370|NCT00408681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101839371|NCT00408681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839372|NCT00560417|Insulin|insulin|mesh-list
101839373|NCT00560417|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101839374|NCT00560417|Insulin Glargine|insulin glargine|mesh-list
101839375|NCT00560417|Insulin Lispro|insulin lispro|mesh-list
101839376|NCT00560417|Protamines|protamines|mesh-list
101839377|NCT00560417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101839378|NCT00560417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839379|NCT00560417|Heparin Antagonists|heparin antagonists|mesh-ancestor
101839380|NCT00560417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839381|NCT00560417|Coagulants|coagulants|mesh-ancestor
101839382|NCT01040091|Tenofovir|tenofovir|mesh-list
101839383|NCT01040091|Emtricitabine|emtricitabine|mesh-list
101839384|NCT01040091|Efavirenz|efavirenz|mesh-list
101839385|NCT01040091|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101839386|NCT01040091|Antiviral Agents|antiviral agents|mesh-ancestor
101839387|NCT01040091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101839388|NCT01040091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101839389|NCT01040091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101839390|NCT01040091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101839391|NCT01040091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839392|NCT01040091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101839393|NCT01040091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101839394|NCT01040091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101839395|NCT01040091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101839396|NCT01040091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101839397|NCT01040091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101839398|NCT01040091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101839399|NCT01040091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101839401|NCT00946907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101839402|NCT00946907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101839403|NCT00946907|Analgesics|analgesics|mesh-ancestor
101839404|NCT00946907|Sensory System Agents|sensory system agents|mesh-ancestor
101839405|NCT00946907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101839406|NCT00946907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839407|NCT00946907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101839408|NCT00946907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101839409|NCT00946907|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101839410|NCT00946907|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101839411|NCT00946907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839412|NCT00946907|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101839413|NCT00946907|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101839414|NCT00946907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101839416|NCT00942539|Midazolam|midazolam|mesh-list
101839417|NCT00942539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101839418|NCT00942539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101839419|NCT00942539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101839420|NCT00942539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839421|NCT00942539|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101839422|NCT00942539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101839423|NCT00942539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101839424|NCT00942539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101839425|NCT00942539|Anesthetics, General|anesthetics, general|mesh-ancestor
101839426|NCT00942539|Anesthetics|anesthetics|mesh-ancestor
101839427|NCT00942539|GABA Modulators|gaba modulators|mesh-ancestor
101839428|NCT00942539|GABA Agents|gaba agents|mesh-ancestor
101839429|NCT00942539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101839430|NCT00942539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839431|NCT00947063|Promethazine|promethazine|mesh-list
101839432|NCT00947063|Diphenhydramine|diphenhydramine|mesh-list
101839433|NCT00947063|Antipruritics|antipruritics|mesh-ancestor
101839434|NCT00947063|Dermatologic Agents|dermatologic agents|mesh-ancestor
101839435|NCT00947063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101839436|NCT00947063|Histamine Antagonists|histamine antagonists|mesh-ancestor
101839437|NCT00947063|Histamine Agents|histamine agents|mesh-ancestor
101839438|NCT00947063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101839439|NCT00947063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839440|NCT00947063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839441|NCT00947063|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101839442|NCT00947063|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101839443|NCT00947063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101839444|NCT00947063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101839445|NCT00947063|Anesthetics, Local|anesthetics, local|mesh-ancestor
101839446|NCT00947063|Anesthetics|anesthetics|mesh-ancestor
101839447|NCT00947063|Sensory System Agents|sensory system agents|mesh-ancestor
101839448|NCT00947063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101839449|NCT00947063|Antiemetics|antiemetics|mesh-ancestor
101839450|NCT00947063|Autonomic Agents|autonomic agents|mesh-ancestor
101839451|NCT00947063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101839453|NCT00942617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101839454|NCT00942617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101839455|NCT00942617|Analgesics|analgesics|mesh-ancestor
101839456|NCT00942617|Sensory System Agents|sensory system agents|mesh-ancestor
101839457|NCT00942617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101839458|NCT00942617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839459|NCT00942617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101839460|NCT00942617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101839461|NCT00942617|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101839462|NCT00942617|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101839463|NCT00942617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839464|NCT00942617|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101839465|NCT00942617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101839466|NCT00942617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101839467|NCT00942617|Antipyretics|antipyretics|mesh-ancestor
101839468|NCT00345345|Alemtuzumab|alemtuzumab|mesh-list
101839469|NCT00345345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101839470|NCT00345345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101839471|NCT03968159|Pimavanserin|pimavanserin|mesh-list
101839472|NCT03968159|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101839473|NCT03968159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101839474|NCT03968159|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101839475|NCT03968159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101839476|NCT03968159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101839477|NCT03968159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839478|NCT03968159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101839479|NCT03968159|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101839480|NCT03968159|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101839481|NCT03968159|Serotonin Agents|serotonin agents|mesh-ancestor
101839482|NCT03968159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101839483|NCT03968159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839484|NCT00947141|Valganciclovir|valganciclovir|mesh-list
101839485|NCT00947141|Ganciclovir|ganciclovir|mesh-list
101839486|NCT00947141|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101839487|NCT00947141|Foscarnet|foscarnet|mesh-list
101839488|NCT00947141|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
101839489|NCT00947141|Antiviral Agents|antiviral agents|mesh-ancestor
101839490|NCT00947141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101839491|NCT00947141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101839492|NCT00947141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101839493|NCT00947141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839494|NCT00947141|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101839495|NCT03966365|Timolol|timolol|mesh-list
101839496|NCT03966365|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101839497|NCT03966365|Dorzolamide|dorzolamide|mesh-list
101839498|NCT03966365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101839499|NCT03966365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101839500|NCT03966365|Adrenergic Agents|adrenergic agents|mesh-ancestor
101839501|NCT03966365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101839502|NCT03966365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839503|NCT03966365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839504|NCT03966365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101839505|NCT03966365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101839506|NCT03966365|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101839507|NCT03966365|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101839508|NCT03966365|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101839509|NCT03966365|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101839510|NCT03966365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101839511|NCT00375219|Homoharringtonine|homoharringtonine|mesh-list
101839512|NCT00375219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101839513|NCT00375219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101839514|NCT00375219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101839515|NCT00375219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101839516|NCT00375219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839517|NCT03965351|Probenecid|probenecid|mesh-list
101839518|NCT03965351|Uricosuric Agents|uricosuric agents|mesh-ancestor
101839519|NCT03965351|Gout Suppressants|gout suppressants|mesh-ancestor
101839520|NCT03965351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101839521|NCT00947375|Lamotrigine|lamotrigine|mesh-list
101839522|NCT00947375|Haloperidol|haloperidol|mesh-list
101839523|NCT00947375|Haloperidol decanoate|haloperidol decanoate|mesh-list
101839524|NCT00947375|Antiemetics|antiemetics|mesh-ancestor
101839525|NCT00947375|Autonomic Agents|autonomic agents|mesh-ancestor
101839526|NCT00947375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101839527|NCT00947375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839528|NCT00947375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101839529|NCT00947375|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101839530|NCT00947375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101839531|NCT00947375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101839532|NCT00947375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101839533|NCT00947375|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101839534|NCT00947375|Dopamine Agents|dopamine agents|mesh-ancestor
101839535|NCT00947375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101387670|NCT00322660|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101839536|NCT00947375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839537|NCT00947375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101839538|NCT00947375|Anticonvulsants|anticonvulsants|mesh-ancestor
101839539|NCT00947375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101839540|NCT00947375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101839541|NCT00947375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101839542|NCT00947375|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101839543|NCT00947453|Montelukast|montelukast|mesh-list
101839544|NCT00947453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101839545|NCT00947453|Respiratory System Agents|respiratory system agents|mesh-ancestor
101839546|NCT00947453|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101839547|NCT00947453|Hormone Antagonists|hormone antagonists|mesh-ancestor
101839548|NCT00947453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101839549|NCT00947453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839550|NCT00947453|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101839551|NCT00947453|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101839552|NCT00947453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839553|NCT00942773|Voriconazole|voriconazole|mesh-list
101839554|NCT00942773|Antifungal Agents|antifungal agents|mesh-ancestor
101839555|NCT00942773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101839556|NCT00942773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101839557|NCT00942773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101839558|NCT00942773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101839559|NCT00942773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839560|NCT00942773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101559340|NCT00957853|Cetuximab|cetuximab|mesh-list
101839561|NCT00942773|Hormone Antagonists|hormone antagonists|mesh-ancestor
101839562|NCT00942773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101839563|NCT00942773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839564|NCT00942773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101839566|NCT00374907|Saxagliptin|saxagliptin|mesh-list
101839567|NCT00374907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101839568|NCT00374907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839569|NCT00374907|Incretins|incretins|mesh-ancestor
101839570|NCT00374907|Hormones|hormones|mesh-ancestor
101839571|NCT00374907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101839572|NCT00374907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101839573|NCT00374907|Protease Inhibitors|protease inhibitors|mesh-ancestor
101839574|NCT00374907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101839575|NCT00374907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839576|NCT01045083|Methylphenidate|methylphenidate|mesh-list
101839577|NCT01045083|Escitalopram|escitalopram|mesh-list
101839578|NCT01045083|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101839579|NCT01045083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101839580|NCT01045083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101839581|NCT01045083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839582|NCT01045083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101839583|NCT01045083|Serotonin Agents|serotonin agents|mesh-ancestor
101839584|NCT01045083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839585|NCT01045083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101839586|NCT01045083|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101839588|NCT01040325|Vaccines|vaccines|mesh-list
101839589|NCT01040325|Immunologic Factors|immunologic factors|mesh-ancestor
101839590|NCT01040325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839591|NCT00947843|Aspirin|aspirin|mesh-list
101839592|NCT00947843|Clopidogrel|clopidogrel|mesh-list
101839593|NCT00947843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101839594|NCT00947843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101839595|NCT00947843|Analgesics|analgesics|mesh-ancestor
101839596|NCT00947843|Sensory System Agents|sensory system agents|mesh-ancestor
101839597|NCT00947843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101839598|NCT00947843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839599|NCT00947843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101839600|NCT00947843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101839601|NCT00947843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101839602|NCT00947843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101839603|NCT00947843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839604|NCT00947843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101839605|NCT00947843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101839607|NCT00947843|Antipyretics|antipyretics|mesh-ancestor
101839608|NCT00947843|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101839609|NCT00947843|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101839610|NCT00947843|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101839611|NCT00947843|Purinergic Agents|purinergic agents|mesh-ancestor
101839612|NCT00947843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101839613|NCT00948077|Isoniazid, pyrazinamide, rifampin drug combination|isoniazid, pyrazinamide, rifampin drug combination|mesh-list
101839614|NCT00948077|Antitubercular Agents|antitubercular agents|mesh-ancestor
101839615|NCT00948077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101839616|NCT00948077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101839617|NCT00407745|Pregabalin|pregabalin|mesh-list
101839618|NCT00407745|Analgesics|analgesics|mesh-ancestor
101839619|NCT00407745|Sensory System Agents|sensory system agents|mesh-ancestor
101839620|NCT00407745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101839621|NCT00407745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839622|NCT00407745|Anticonvulsants|anticonvulsants|mesh-ancestor
101839623|NCT00407745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101839624|NCT00407745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101839625|NCT00407745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839626|NCT00407745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101839627|NCT00407745|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101839628|NCT00407745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101839629|NCT00407745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101839630|NCT00407745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101839631|NCT00951431|Esomeprazole|esomeprazole|mesh-list
101559417|NCT02869009|Antipyretics|antipyretics|mesh-ancestor
101839632|NCT00951431|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101839633|NCT00951431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101839634|NCT00951431|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101839635|NCT00951431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101839636|NCT00951431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839637|NCT00299494|Rituximab|rituximab|mesh-list
101839638|NCT00299494|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
101839639|NCT00299494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101839640|NCT00299494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101839641|NCT00299494|Immunologic Factors|immunologic factors|mesh-ancestor
101839642|NCT00299494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839643|NCT00299494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101839644|NCT00299494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101839645|NCT00299494|Immunotoxins|immunotoxins|mesh-ancestor
101685742|NCT03356834|Tenofovir|tenofovir|mesh-list
101839646|NCT00299494|Immunoconjugates|immunoconjugates|mesh-ancestor
101839647|NCT00943553|Decitabine|decitabine|mesh-list
101839648|NCT00943553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101839649|NCT00943553|Antimetabolites|antimetabolites|mesh-ancestor
101839650|NCT00943553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839651|NCT00943553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101839652|NCT00943553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101839653|NCT00453180|Acetylcysteine|acetylcysteine|mesh-list
101839654|NCT00453180|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101839655|NCT00453180|Antiviral Agents|antiviral agents|mesh-ancestor
101839656|NCT00453180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101839657|NCT00453180|Expectorants|expectorants|mesh-ancestor
101839658|NCT00453180|Respiratory System Agents|respiratory system agents|mesh-ancestor
101839659|NCT00453180|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101839660|NCT00453180|Antioxidants|antioxidants|mesh-ancestor
101839661|NCT00453180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839662|NCT00453180|Protective Agents|protective agents|mesh-ancestor
101839663|NCT00453180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839664|NCT00453180|Antidotes|antidotes|mesh-ancestor
101839665|NCT00943709|Insulin|insulin|mesh-list
101839666|NCT00943709|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101839667|NCT00943709|Insulin Glargine|insulin glargine|mesh-list
101839668|NCT00943709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101839669|NCT00943709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839670|NCT00464178|Bortezomib|bortezomib|mesh-list
101839671|NCT00464178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101839672|NCT00316186|Carboplatin|carboplatin|mesh-list
101839673|NCT00316186|Topotecan|topotecan|mesh-list
101839674|NCT00316186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101839675|NCT00316186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101839676|NCT00316186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101839677|NCT00316186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101839678|NCT00316186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839679|NCT01065220|Cyproterone Acetate|cyproterone acetate|mesh-list
101839680|NCT01065220|Testolactone|testolactone|mesh-list
101839681|NCT01065220|Lynestrenol|lynestrenol|mesh-list
101839682|NCT01065220|Estradiol|estradiol|mesh-list
101839683|NCT01065220|Cyproterone|cyproterone|mesh-list
101839684|NCT01065220|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
101839685|NCT01065220|Estrogens|estrogens|mesh-ancestor
101839686|NCT01065220|Hormones|hormones|mesh-ancestor
101839687|NCT01065220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101839688|NCT01065220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839689|NCT01065220|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101839690|NCT01065220|Contraceptive Agents|contraceptive agents|mesh-ancestor
101839691|NCT01065220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101839692|NCT01065220|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101839693|NCT01065220|Androgen Antagonists|androgen antagonists|mesh-ancestor
101839694|NCT01065220|Hormone Antagonists|hormone antagonists|mesh-ancestor
101839695|NCT01065220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101839696|NCT01065220|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101839697|NCT01065220|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101839698|NCT01065220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101839699|NCT01065220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839700|NCT01065220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101839701|NCT01065220|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101839702|NCT01065220|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101839703|NCT01065220|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101839704|NCT00943943|Plerixafor|plerixafor|mesh-list
101839705|NCT00943943|Sorafenib|sorafenib|mesh-list
101839706|NCT00943943|Lenograstim|lenograstim|mesh-list
101839707|NCT00943943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101839708|NCT00943943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101839710|NCT00943943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839711|NCT00943943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101839712|NCT00943943|Immunologic Factors|immunologic factors|mesh-ancestor
101839713|NCT00943943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839714|NCT00943943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101839715|NCT00943943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101839716|NCT00943943|Antiviral Agents|antiviral agents|mesh-ancestor
101839717|NCT00943943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101839718|NCT00948779|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101839719|NCT00948779|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101839720|NCT00948779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101839721|NCT00948779|Antitubercular Agents|antitubercular agents|mesh-ancestor
101839722|NCT00453102|Rituximab|rituximab|mesh-list
101839723|NCT00453102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101839724|NCT00453102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101839725|NCT00453102|Immunologic Factors|immunologic factors|mesh-ancestor
101839726|NCT00453102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839727|NCT00453102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101839728|NCT00299182|Cytarabine|cytarabine|mesh-list
101839729|NCT00299182|Dexamethasone|dexamethasone|mesh-list
101839730|NCT00299182|Cyclophosphamide|cyclophosphamide|mesh-list
101839731|NCT00299182|Rituximab|rituximab|mesh-list
101839732|NCT00299182|Doxorubicin|doxorubicin|mesh-list
101839733|NCT00299182|Methotrexate|methotrexate|mesh-list
101839734|NCT00299182|Vincristine|vincristine|mesh-list
101839735|NCT00299182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101839736|NCT00299182|Immunologic Factors|immunologic factors|mesh-ancestor
101839737|NCT00299182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839738|NCT00299182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101839739|NCT00299182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101839740|NCT00299182|Alkylating Agents|alkylating agents|mesh-ancestor
101839741|NCT00299182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839742|NCT00299182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101839743|NCT00299182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101839744|NCT00299182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101839745|NCT00299182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101839746|NCT00299182|Antiemetics|antiemetics|mesh-ancestor
101839747|NCT00299182|Autonomic Agents|autonomic agents|mesh-ancestor
101839748|NCT00299182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101839749|NCT00299182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101839750|NCT00299182|Glucocorticoids|glucocorticoids|mesh-ancestor
101839752|NCT00299182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101839753|NCT00299182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101839754|NCT00299182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101839755|NCT00299182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101839756|NCT00299182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101839757|NCT00299182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101839758|NCT00299182|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101839759|NCT00299182|Abortifacient Agents|abortifacient agents|mesh-ancestor
101839760|NCT00299182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101839761|NCT00299182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101839762|NCT00299182|Antimetabolites|antimetabolites|mesh-ancestor
101839763|NCT00299182|Dermatologic Agents|dermatologic agents|mesh-ancestor
101839764|NCT00299182|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101839765|NCT00299182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101839766|NCT00299182|Antiviral Agents|antiviral agents|mesh-ancestor
101839767|NCT00299182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101839768|NCT00299182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101839769|NCT00299182|Tubulin Modulators|tubulin modulators|mesh-ancestor
101839770|NCT00299182|Antimitotic Agents|antimitotic agents|mesh-ancestor
101839771|NCT00299182|Mitosis Modulators|mitosis modulators|mesh-ancestor
101839772|NCT00467142|Leucovorin|leucovorin|mesh-list
101839773|NCT00467142|Bevacizumab|bevacizumab|mesh-list
101839774|NCT00467142|Fluorouracil|fluorouracil|mesh-list
101839775|NCT00467142|Irinotecan|irinotecan|mesh-list
101839776|NCT00467142|Calcium|calcium|mesh-list
101839777|NCT00467142|Levoleucovorin|levoleucovorin|mesh-list
101839778|NCT00467142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101839779|NCT00467142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101839780|NCT00467142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101839781|NCT00467142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101839782|NCT00467142|Growth Substances|growth substances|mesh-ancestor
101839783|NCT00467142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839784|NCT00467142|Growth Inhibitors|growth inhibitors|mesh-ancestor
101839785|NCT00467142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101839786|NCT00467142|Antimetabolites|antimetabolites|mesh-ancestor
101839787|NCT00467142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839788|NCT00467142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101839789|NCT00467142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101839790|NCT00467142|Immunologic Factors|immunologic factors|mesh-ancestor
101839791|NCT00467142|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101839792|NCT00467142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101839793|NCT00467142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101839794|NCT00467142|Antidotes|antidotes|mesh-ancestor
101839795|NCT00467142|Protective Agents|protective agents|mesh-ancestor
101839796|NCT00467142|Vitamin B Complex|vitamin b complex|mesh-ancestor
101839798|NCT00467142|Micronutrients|micronutrients|mesh-ancestor
101839799|NCT01065376|Cabergoline|cabergoline|mesh-list
101839800|NCT01065376|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101839801|NCT01065376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101839802|NCT01065376|Dopamine Agonists|dopamine agonists|mesh-ancestor
101839803|NCT01065376|Dopamine Agents|dopamine agents|mesh-ancestor
101839804|NCT01065376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101839805|NCT01065376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839806|NCT01065376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839807|NCT00944177|Metformin|metformin|mesh-list
101839808|NCT00944177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101839809|NCT00944177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839810|NCT00553475|Pregabalin|pregabalin|mesh-list
101839811|NCT00553475|Analgesics|analgesics|mesh-ancestor
101839812|NCT00553475|Sensory System Agents|sensory system agents|mesh-ancestor
101839813|NCT00553475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101839814|NCT00553475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839815|NCT00553475|Anticonvulsants|anticonvulsants|mesh-ancestor
101839816|NCT00553475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101839817|NCT00553475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101839818|NCT00553475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839819|NCT00553475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101839820|NCT00553475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101839821|NCT00553475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101839822|NCT00553475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101839823|NCT00553475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101839824|NCT00329602|Ropinirole|ropinirole|mesh-list
101839825|NCT00329602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101839826|NCT00329602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101839827|NCT00329602|Dopamine Agonists|dopamine agonists|mesh-ancestor
101839828|NCT00329602|Dopamine Agents|dopamine agents|mesh-ancestor
101839829|NCT00329602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101839830|NCT00329602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839831|NCT00329602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839832|NCT01060696|Mefenamic Acid|mefenamic acid|mesh-list
101839833|NCT01060696|Scopolamine|scopolamine|mesh-list
101839834|NCT01060696|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101839835|NCT01060696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101839836|NCT01060696|Antiemetics|antiemetics|mesh-ancestor
101839837|NCT01060696|Autonomic Agents|autonomic agents|mesh-ancestor
101839838|NCT01060696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101839839|NCT01060696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839840|NCT01060696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101839841|NCT01060696|Mydriatics|mydriatics|mesh-ancestor
101839842|NCT01060696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101839843|NCT01060696|Cholinergic Agents|cholinergic agents|mesh-ancestor
101839844|NCT01060696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101839845|NCT01060696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839846|NCT01060696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101839847|NCT01060696|Parasympatholytics|parasympatholytics|mesh-ancestor
101839848|NCT01060696|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101839849|NCT01060696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101839850|NCT01060696|Analgesics|analgesics|mesh-ancestor
101839851|NCT01060696|Sensory System Agents|sensory system agents|mesh-ancestor
101839852|NCT01060696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101839853|NCT01060696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101839854|NCT01060696|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101839855|NCT01060696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101839856|NCT01065610|Oxytocin|oxytocin|mesh-list
101839857|NCT01065610|Oxytocics|oxytocics|mesh-ancestor
101839858|NCT01065610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101559654|NCT00947011|Hormones|hormones|mesh-ancestor
101839859|NCT01065610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839860|NCT00463866|Budesonide|budesonide|mesh-list
101839861|NCT00463866|Formoterol Fumarate|formoterol fumarate|mesh-list
101839862|NCT00463866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101839863|NCT00463866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101839864|NCT00463866|Autonomic Agents|autonomic agents|mesh-ancestor
101839865|NCT00463866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101839866|NCT00463866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839867|NCT00463866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101839868|NCT00463866|Respiratory System Agents|respiratory system agents|mesh-ancestor
101839869|NCT00463866|Glucocorticoids|glucocorticoids|mesh-ancestor
101839870|NCT00463866|Hormones|hormones|mesh-ancestor
101839871|NCT00463866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101839872|NCT00463866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101839873|NCT00463866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101839874|NCT00463866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101839875|NCT00463866|Adrenergic Agents|adrenergic agents|mesh-ancestor
101839876|NCT00463866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101839877|NCT00463866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839878|NCT00313846|Buprenorphine|buprenorphine|mesh-list
101839879|NCT00313846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101839880|NCT00313846|Narcotics|narcotics|mesh-ancestor
101839881|NCT00313846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101839882|NCT00313846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839883|NCT00313846|Analgesics|analgesics|mesh-ancestor
101839884|NCT00313846|Sensory System Agents|sensory system agents|mesh-ancestor
101839885|NCT00313846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101839886|NCT00313846|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101839887|NCT00949247|Bevacizumab|bevacizumab|mesh-list
101839888|NCT00949247|Trastuzumab|trastuzumab|mesh-list
101839889|NCT00949247|Carboplatin|carboplatin|mesh-list
101839890|NCT00949247|Docetaxel|docetaxel|mesh-list
101839891|NCT00949247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101839892|NCT00949247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101839893|NCT00949247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101839894|NCT00949247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101839895|NCT00949247|Growth Substances|growth substances|mesh-ancestor
101839896|NCT00949247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839897|NCT00949247|Growth Inhibitors|growth inhibitors|mesh-ancestor
101839898|NCT00949247|Tubulin Modulators|tubulin modulators|mesh-ancestor
101839899|NCT00949247|Antimitotic Agents|antimitotic agents|mesh-ancestor
101839900|NCT00949247|Mitosis Modulators|mitosis modulators|mesh-ancestor
101839901|NCT00949247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839902|NCT00551135|Pregabalin|pregabalin|mesh-list
101839903|NCT00551135|Analgesics|analgesics|mesh-ancestor
101839904|NCT00551135|Sensory System Agents|sensory system agents|mesh-ancestor
101839905|NCT00551135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101839906|NCT00551135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839907|NCT00551135|Anticonvulsants|anticonvulsants|mesh-ancestor
101839908|NCT00551135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101839909|NCT00551135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101839910|NCT00551135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839911|NCT00551135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101839912|NCT00551135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101839913|NCT00551135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101839914|NCT00551135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101839915|NCT00551135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101839916|NCT00944333|Clopidogrel|clopidogrel|mesh-list
101839917|NCT00944333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101839918|NCT00944333|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101839919|NCT00944333|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101839920|NCT00944333|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101839921|NCT00944333|Purinergic Agents|purinergic agents|mesh-ancestor
101839922|NCT00944333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101839923|NCT00944333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839924|NCT00944333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839925|NCT00299104|Methylprednisolone|methylprednisolone|mesh-list
101839926|NCT00299104|Rituximab|rituximab|mesh-list
101839927|NCT00299104|Methotrexate|methotrexate|mesh-list
101839928|NCT00299104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101839929|NCT00299104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101839930|NCT00299104|Immunologic Factors|immunologic factors|mesh-ancestor
101839931|NCT00299104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839932|NCT00299104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101839933|NCT00299104|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101839934|NCT00299104|Abortifacient Agents|abortifacient agents|mesh-ancestor
101839935|NCT00299104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101839936|NCT00299104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101839938|NCT00299104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839939|NCT00299104|Dermatologic Agents|dermatologic agents|mesh-ancestor
101839940|NCT00299104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101839941|NCT00299104|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101839942|NCT00299104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101839943|NCT00299104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101839944|NCT00299104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101839945|NCT00299104|Antiemetics|antiemetics|mesh-ancestor
101839946|NCT00299104|Autonomic Agents|autonomic agents|mesh-ancestor
101839947|NCT00299104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101839948|NCT00299104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101839949|NCT00299104|Glucocorticoids|glucocorticoids|mesh-ancestor
101839950|NCT00299104|Hormones|hormones|mesh-ancestor
101839951|NCT00299104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101839952|NCT00299104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101839953|NCT00299104|Protective Agents|protective agents|mesh-ancestor
101839954|NCT03979456|Rituximab|rituximab|mesh-list
101839955|NCT03979456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101963369|NCT03535168|Anesthetics|anesthetics|mesh-ancestor
101839956|NCT03979456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101839957|NCT03979456|Immunologic Factors|immunologic factors|mesh-ancestor
101839958|NCT03979456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839959|NCT03979456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101839960|NCT00313612|Oxaliplatin|oxaliplatin|mesh-list
101839961|NCT00313612|Topotecan|topotecan|mesh-list
101839962|NCT00313612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101839963|NCT00313612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101839964|NCT00313612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101839965|NCT00313612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101839966|NCT00313612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839967|NCT00507416|Thalidomide|thalidomide|mesh-list
101839968|NCT00507416|Dexamethasone|dexamethasone|mesh-list
101839969|NCT00507416|Prednisone|prednisone|mesh-list
101839970|NCT00507416|Bortezomib|bortezomib|mesh-list
101839971|NCT00507416|Melphalan|melphalan|mesh-list
101839972|NCT00507416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101839973|NCT00507416|Antiemetics|antiemetics|mesh-ancestor
101839974|NCT00507416|Autonomic Agents|autonomic agents|mesh-ancestor
101839975|NCT00507416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101839976|NCT00507416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101839977|NCT00507416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101839978|NCT00507416|Glucocorticoids|glucocorticoids|mesh-ancestor
101839979|NCT00507416|Hormones|hormones|mesh-ancestor
101839980|NCT00507416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101839981|NCT00507416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101839982|NCT00507416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101839983|NCT00507416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101839984|NCT00507416|Alkylating Agents|alkylating agents|mesh-ancestor
101839985|NCT00507416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101839986|NCT00507416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101839987|NCT00507416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101839988|NCT00507416|Immunologic Factors|immunologic factors|mesh-ancestor
101839989|NCT00507416|Leprostatic Agents|leprostatic agents|mesh-ancestor
101839990|NCT00507416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101839991|NCT00507416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101839992|NCT00507416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101839993|NCT00507416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101839994|NCT00507416|Growth Substances|growth substances|mesh-ancestor
101839995|NCT00507416|Growth Inhibitors|growth inhibitors|mesh-ancestor
101839996|NCT00489476|Loxapine|loxapine|mesh-list
101839997|NCT00489476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101839998|NCT00489476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101839999|NCT00489476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101840000|NCT00489476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840001|NCT00489476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101840002|NCT00489476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101840003|NCT00489476|Dopamine Agents|dopamine agents|mesh-ancestor
101840004|NCT00489476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101840005|NCT00489476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840006|NCT04216043|Caseins|caseins|mesh-list
101840007|NCT04216043|Chelating Agents|chelating agents|mesh-ancestor
101840008|NCT04216043|Sequestering Agents|sequestering agents|mesh-ancestor
101840009|NCT04216043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840010|NCT00957125|Bevacizumab|bevacizumab|mesh-list
101840011|NCT00957125|Docetaxel|docetaxel|mesh-list
101840012|NCT00957125|Epirubicin|epirubicin|mesh-list
101840013|NCT00957125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101840014|NCT00957125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101840015|NCT00957125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101840016|NCT00957125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101840017|NCT00957125|Growth Substances|growth substances|mesh-ancestor
101840018|NCT00957125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840019|NCT00957125|Growth Inhibitors|growth inhibitors|mesh-ancestor
101840020|NCT00957125|Tubulin Modulators|tubulin modulators|mesh-ancestor
101840021|NCT00957125|Antimitotic Agents|antimitotic agents|mesh-ancestor
101840022|NCT00957125|Mitosis Modulators|mitosis modulators|mesh-ancestor
101840023|NCT00957125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963374|NCT02192320|Dexamethasone|dexamethasone|mesh-list
101840024|NCT00957125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101840025|NCT00957125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101840026|NCT00957125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101840027|NCT00957125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840028|NCT00957203|Istradefylline|istradefylline|mesh-list
101840029|NCT00957203|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
101840030|NCT00957203|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101840031|NCT00957203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101840032|NCT00957203|Purinergic Agents|purinergic agents|mesh-ancestor
101840033|NCT00957203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101840034|NCT00957203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840035|NCT00957203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840036|NCT00952913|Lansoprazole|lansoprazole|mesh-list
101840037|NCT00952913|Dexlansoprazole|dexlansoprazole|mesh-list
101840038|NCT00952913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101840039|NCT00952913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101840040|NCT00952913|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101840041|NCT00952913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840042|NCT00952913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840043|NCT00952991|Vildagliptin|vildagliptin|mesh-list
101840044|NCT00952991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101840045|NCT00952991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840046|NCT00952991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101840047|NCT00952991|Protease Inhibitors|protease inhibitors|mesh-ancestor
101840048|NCT00952991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840049|NCT00952991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840050|NCT00953303|Dexamethasone|dexamethasone|mesh-list
101840051|NCT00953303|Dexamethasone acetate|dexamethasone acetate|mesh-list
101840052|NCT00953303|Prednisone|prednisone|mesh-list
101840053|NCT00953303|Torsemide|torsemide|mesh-list
101840054|NCT00953303|Dobutamine|dobutamine|mesh-list
101840055|NCT00953303|Dopamine|dopamine|mesh-list
101840056|NCT00953303|Furosemide|furosemide|mesh-list
101840057|NCT00953303|Nitroglycerin|nitroglycerin|mesh-list
101840058|NCT00953303|Glucocorticoids|glucocorticoids|mesh-list
101840059|NCT00953303|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101840060|NCT00953303|BB 1101|bb 1101|mesh-list
101840061|NCT00953303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101840062|NCT00953303|Antiemetics|antiemetics|mesh-ancestor
101840063|NCT00953303|Autonomic Agents|autonomic agents|mesh-ancestor
101840064|NCT00953303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101840065|NCT00953303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840066|NCT00953303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101840067|NCT00953303|Hormones|hormones|mesh-ancestor
101840068|NCT00953303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101840069|NCT00953303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101840070|NCT00953303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101840071|NCT00953303|Protease Inhibitors|protease inhibitors|mesh-ancestor
101840072|NCT00953303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840073|NCT00953303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840074|NCT00953303|Diuretics|diuretics|mesh-ancestor
101840075|NCT00953303|Natriuretic Agents|natriuretic agents|mesh-ancestor
101840076|NCT00953303|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101840077|NCT00953303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101840078|NCT00953303|Vasodilator Agents|vasodilator agents|mesh-ancestor
101840079|NCT00953303|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101840080|NCT00953303|Sympathomimetics|sympathomimetics|mesh-ancestor
101840081|NCT00953303|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101840082|NCT00953303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101840083|NCT00953303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101840084|NCT00953303|Adrenergic Agents|adrenergic agents|mesh-ancestor
101559866|NCT01231464|Fluticasone|fluticasone|mesh-list
101840085|NCT00953303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101840086|NCT00953303|Protective Agents|protective agents|mesh-ancestor
101840087|NCT00953303|Dopamine Agents|dopamine agents|mesh-ancestor
101840088|NCT00953303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101840089|NCT05300555|Warfarin|warfarin|mesh-list
101840090|NCT05300555|Rivaroxaban|rivaroxaban|mesh-list
101840091|NCT05300555|Anticoagulants|anticoagulants|mesh-ancestor
101840092|NCT05300555|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101840093|NCT05300555|Antithrombins|antithrombins|mesh-ancestor
101840094|NCT05300555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101840095|NCT05300555|Protease Inhibitors|protease inhibitors|mesh-ancestor
101840096|NCT05300555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840097|NCT05300555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840098|NCT04010669|Somatostatin|somatostatin|mesh-list
101840099|NCT04010669|Hormones|hormones|mesh-ancestor
101840100|NCT04010669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101840101|NCT04010669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840102|NCT00452790|Vaccines|vaccines|mesh-list
101840103|NCT00452790|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101840104|NCT00452790|Immunologic Factors|immunologic factors|mesh-ancestor
101840105|NCT00452790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840106|NCT00953381|Omeprazole|omeprazole|mesh-list
101840107|NCT00953381|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101840108|NCT00953381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101840109|NCT00953381|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101840110|NCT00953381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840111|NCT00953381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840112|NCT05300477|Acetazolamide|acetazolamide|mesh-list
101840113|NCT05300477|Epoetin Alfa|epoetin alfa|mesh-list
101840114|NCT05300477|Hematinics|hematinics|mesh-ancestor
101840115|NCT05300477|Anticonvulsants|anticonvulsants|mesh-ancestor
101840116|NCT05300477|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101840117|NCT05300477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840118|NCT05300477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840119|NCT05300477|Diuretics|diuretics|mesh-ancestor
101840120|NCT05300477|Natriuretic Agents|natriuretic agents|mesh-ancestor
101840121|NCT05300477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840122|NCT00953459|Sunitinib|sunitinib|mesh-list
101840123|NCT00953459|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101840124|NCT00953459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101840125|NCT00953459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101840126|NCT00953459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101840127|NCT00953459|Growth Substances|growth substances|mesh-ancestor
101840128|NCT00953459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840129|NCT00953459|Growth Inhibitors|growth inhibitors|mesh-ancestor
101840130|NCT00953459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101840131|NCT00953459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840132|NCT00953459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840133|NCT00953459|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101840134|NCT00953537|Capecitabine|capecitabine|mesh-list
101840135|NCT00953537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101840136|NCT00953537|Antimetabolites|antimetabolites|mesh-ancestor
101840137|NCT00953537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840138|NCT00953537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101840139|NCT00463788|Cisplatin|cisplatin|mesh-list
101840140|NCT00463788|Cetuximab|cetuximab|mesh-list
101840141|NCT00463788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101840142|NCT00463788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101840143|NCT00548249|Iron|iron|mesh-list
101840144|NCT00548249|Trace Elements|trace elements|mesh-ancestor
101840145|NCT00548249|Micronutrients|micronutrients|mesh-ancestor
101840146|NCT00548249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840147|NCT01025466|Memantine|memantine|mesh-list
101840148|NCT01025466|Rivastigmine|rivastigmine|mesh-list
101840149|NCT01025466|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101840150|NCT01025466|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101840152|NCT01025466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101840153|NCT01025466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840154|NCT01025466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840155|NCT01025466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101840156|NCT01025466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101840157|NCT01025466|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101840158|NCT01025466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840159|NCT01025466|Cholinergic Agents|cholinergic agents|mesh-ancestor
101840160|NCT01025466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101840161|NCT01025466|Protective Agents|protective agents|mesh-ancestor
101840162|NCT01025544|Vaccines|vaccines|mesh-list
101840163|NCT01025544|Immunologic Factors|immunologic factors|mesh-ancestor
101840164|NCT01025544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840165|NCT03839940|Dexamethasone|dexamethasone|mesh-list
101840166|NCT03839940|Everolimus|everolimus|mesh-list
101840167|NCT03839940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101840168|NCT03839940|Antiemetics|antiemetics|mesh-ancestor
101840169|NCT03839940|Autonomic Agents|autonomic agents|mesh-ancestor
101840170|NCT03839940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101840171|NCT03839940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840172|NCT03839940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101840173|NCT03839940|Glucocorticoids|glucocorticoids|mesh-ancestor
101840174|NCT03839940|Hormones|hormones|mesh-ancestor
101840175|NCT03839940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101840176|NCT03839940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101840177|NCT03839940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101840178|NCT03839940|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101840179|NCT03839940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101840180|NCT03839940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840181|NCT03839940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840182|NCT03839940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101840183|NCT03839940|Immunologic Factors|immunologic factors|mesh-ancestor
101840184|NCT01027494|Ciprofloxacin|ciprofloxacin|mesh-list
101840185|NCT01027494|Dexamethasone|dexamethasone|mesh-list
101840186|NCT01027494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101840187|NCT01027494|Antiemetics|antiemetics|mesh-ancestor
101840188|NCT01027494|Autonomic Agents|autonomic agents|mesh-ancestor
101840189|NCT01027494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101840190|NCT01027494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840191|NCT01027494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101840192|NCT01027494|Glucocorticoids|glucocorticoids|mesh-ancestor
101840193|NCT01027494|Hormones|hormones|mesh-ancestor
101840194|NCT01027494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101840195|NCT01027494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101840196|NCT01027494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101840197|NCT01027494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101840198|NCT01027494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101840199|NCT01027494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101840200|NCT01027494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101840201|NCT01027494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840202|NCT01027494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840203|NCT01027494|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101840204|NCT01027494|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101840205|NCT01025700|Nabilone|nabilone|mesh-list
101840206|NCT01025700|Antiemetics|antiemetics|mesh-ancestor
101840207|NCT01025700|Autonomic Agents|autonomic agents|mesh-ancestor
101840208|NCT01025700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101840209|NCT01025700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840210|NCT01025700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101840211|NCT01025700|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101840212|NCT01025700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101840213|NCT01025700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101840214|NCT01025700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101840215|NCT00462462|Ethanol|ethanol|mesh-list
101840216|NCT00462462|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101840217|NCT00462462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101840218|NCT00462462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101840219|NCT00462462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840220|NCT00462384|Epoetin Alfa|epoetin alfa|mesh-list
101840221|NCT00462384|Hematinics|hematinics|mesh-ancestor
101840222|NCT00452400|Olodaterol|olodaterol|mesh-list
101840223|NCT00452400|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101840224|NCT00452400|Autonomic Agents|autonomic agents|mesh-ancestor
101840225|NCT00452400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101685772|NCT04214054|Calcium|calcium|mesh-list
101840226|NCT00452400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840228|NCT00452400|Respiratory System Agents|respiratory system agents|mesh-ancestor
101840229|NCT01566474|Melatonin|melatonin|mesh-list
101840230|NCT01566474|Omeprazole|omeprazole|mesh-list
101840231|NCT01566474|Antioxidants|antioxidants|mesh-ancestor
101840232|NCT01566474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840233|NCT01566474|Protective Agents|protective agents|mesh-ancestor
101840234|NCT01566474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840235|NCT01566474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101840236|NCT01566474|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101840237|NCT01566474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101840238|NCT01566474|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101840239|NCT01566474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840240|NCT01025778|Cyclophosphamide|cyclophosphamide|mesh-list
101840241|NCT01025778|Thiotepa|thiotepa|mesh-list
101840242|NCT01025778|Etoposide|etoposide|mesh-list
101840243|NCT01025778|Clofarabine|clofarabine|mesh-list
101840244|NCT01025778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101840245|NCT01025778|Immunologic Factors|immunologic factors|mesh-ancestor
101840246|NCT01025778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840247|NCT01025778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101840248|NCT01025778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101840249|NCT01025778|Alkylating Agents|alkylating agents|mesh-ancestor
101840250|NCT01025778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840251|NCT01025778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101840252|NCT01025778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101840253|NCT01025778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101840254|NCT01025778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101840255|NCT01025778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101840256|NCT01025778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840257|NCT01025778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101840258|NCT01025778|Antimetabolites|antimetabolites|mesh-ancestor
101840259|NCT00443430|Prednisone|prednisone|mesh-list
101840260|NCT00443430|Prednisolone|prednisolone|mesh-list
101840261|NCT00443430|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101840262|NCT00443430|Methylprednisolone|methylprednisolone|mesh-list
101840263|NCT00443430|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101840264|NCT00443430|Prednisolone acetate|prednisolone acetate|mesh-list
101840265|NCT00443430|Etanercept|etanercept|mesh-list
101840266|NCT00443430|Methotrexate|methotrexate|mesh-list
101840267|NCT00443430|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101840268|NCT00443430|Prednisolone phosphate|prednisolone phosphate|mesh-list
101840269|NCT00443430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101840270|NCT00443430|Glucocorticoids|glucocorticoids|mesh-ancestor
101840271|NCT00443430|Hormones|hormones|mesh-ancestor
101840272|NCT00443430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101840273|NCT00443430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840274|NCT00443430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101840275|NCT00443430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101840276|NCT00443430|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101840277|NCT00443430|Abortifacient Agents|abortifacient agents|mesh-ancestor
101840278|NCT00443430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101840279|NCT00443430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101840280|NCT00443430|Antimetabolites|antimetabolites|mesh-ancestor
101840281|NCT00443430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840282|NCT00443430|Dermatologic Agents|dermatologic agents|mesh-ancestor
101840283|NCT00443430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840284|NCT00443430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101840285|NCT00443430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101840286|NCT00443430|Immunologic Factors|immunologic factors|mesh-ancestor
101840287|NCT00443430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101840288|NCT00443430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101840289|NCT00443430|Antiemetics|antiemetics|mesh-ancestor
101840290|NCT00443430|Autonomic Agents|autonomic agents|mesh-ancestor
101840291|NCT00443430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101840292|NCT00443430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101840293|NCT00443430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101840294|NCT00443430|Protective Agents|protective agents|mesh-ancestor
101840295|NCT00443430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101840296|NCT00443430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101840297|NCT00443430|Analgesics|analgesics|mesh-ancestor
101840298|NCT00443430|Sensory System Agents|sensory system agents|mesh-ancestor
101840299|NCT03898986|Vaccines|vaccines|mesh-list
101840300|NCT03898986|Immunologic Factors|immunologic factors|mesh-ancestor
101840301|NCT03898986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840302|NCT01022658|Insulin|insulin|mesh-list
101840303|NCT01022658|Insulin Detemir|insulin detemir|mesh-list
101840304|NCT01022658|Insulin Aspart|insulin aspart|mesh-list
101840305|NCT01022658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101840306|NCT01022658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840307|NCT01022736|Gabapentin|gabapentin|mesh-list
101840308|NCT01022736|Analgesics|analgesics|mesh-ancestor
101840309|NCT01022736|Sensory System Agents|sensory system agents|mesh-ancestor
101840310|NCT01022736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101840311|NCT01022736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840312|NCT01022736|Anticonvulsants|anticonvulsants|mesh-ancestor
101840313|NCT01022736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101840314|NCT01022736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101840315|NCT01022736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101840316|NCT01022736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101840317|NCT01022736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101840318|NCT01022736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101840319|NCT01022736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101840320|NCT01022736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840321|NCT01022736|Antimanic Agents|antimanic agents|mesh-ancestor
101840322|NCT01025934|Bevacizumab|bevacizumab|mesh-list
101840323|NCT01025934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101840324|NCT01025934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101840325|NCT01025934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101840326|NCT01025934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101840327|NCT01025934|Growth Substances|growth substances|mesh-ancestor
101840328|NCT01025934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840329|NCT01025934|Growth Inhibitors|growth inhibitors|mesh-ancestor
101840330|NCT01026090|Dronedarone|dronedarone|mesh-list
101840331|NCT01026090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101840332|NCT00460746|Ritonavir|ritonavir|mesh-list
101840333|NCT00460746|Darunavir|darunavir|mesh-list
101840334|NCT00460746|Etravirine|etravirine|mesh-list
101840335|NCT00460746|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101840336|NCT00460746|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101840337|NCT00460746|Protease Inhibitors|protease inhibitors|mesh-ancestor
101840338|NCT00460746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840339|NCT00460746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840340|NCT00460746|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101840341|NCT00460746|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101840342|NCT00460746|Antiviral Agents|antiviral agents|mesh-ancestor
101840343|NCT00460746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101840344|NCT00460746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101840345|NCT00460746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101840346|NCT00460746|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101840347|NCT00460746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101840348|NCT01026558|Ceftobiprole|ceftobiprole|mesh-list
101237068|NCT04714619|Letrozole|letrozole|mesh-list
101840349|NCT01026558|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
101840350|NCT01026558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101840351|NCT01026558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101840352|NCT00373425|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101840353|NCT00373425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101840354|NCT00373425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101840355|NCT00373425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840356|NCT00373425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840357|NCT00459342|Dasatinib|dasatinib|mesh-list
101840358|NCT00459342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101840359|NCT00459342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101840360|NCT00459342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840361|NCT00459342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840362|NCT00442962|Tenofovir|tenofovir|mesh-list
101840363|NCT00442962|Emtricitabine|emtricitabine|mesh-list
101840364|NCT00442962|Efavirenz|efavirenz|mesh-list
101840365|NCT00442962|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101840366|NCT00442962|Antiviral Agents|antiviral agents|mesh-ancestor
101840367|NCT00442962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101840368|NCT00442962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101840369|NCT00442962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101840370|NCT00442962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101685777|NCT02909036|Alkylating Agents|alkylating agents|mesh-ancestor
101840371|NCT00442962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840372|NCT00442962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101840373|NCT00442962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101840374|NCT00442962|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101840375|NCT00442962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101840376|NCT00442962|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101840377|NCT00442962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101840378|NCT00442962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101840379|NCT00442962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101840380|NCT01028508|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101840381|NCT01028508|Antidepressive Agents|antidepressive agents|mesh-ancestor
101840382|NCT01028508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101840383|NCT01028508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840384|NCT01028508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840385|NCT01028508|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101840386|NCT01028508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101840387|NCT01028508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101840388|NCT01028508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101840389|NCT01028508|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101840390|NCT01026636|Ceftobiprole|ceftobiprole|mesh-list
101840391|NCT01026636|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
101840392|NCT01026636|Cephalosporins|cephalosporins|mesh-list
101840393|NCT01026636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101840394|NCT01026636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101840395|NCT00313300|Apixaban|apixaban|mesh-list
101840396|NCT00313300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101840397|NCT00313300|Antithrombins|antithrombins|mesh-ancestor
101840398|NCT00313300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101840399|NCT00313300|Protease Inhibitors|protease inhibitors|mesh-ancestor
101840400|NCT00313300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840401|NCT00313300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840402|NCT00313300|Anticoagulants|anticoagulants|mesh-ancestor
101840403|NCT00459186|Prednisone|prednisone|mesh-list
101840404|NCT00459186|Docetaxel|docetaxel|mesh-list
101840405|NCT00459186|Everolimus|everolimus|mesh-list
101840406|NCT00459186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101840407|NCT00459186|Tubulin Modulators|tubulin modulators|mesh-ancestor
101840408|NCT00459186|Antimitotic Agents|antimitotic agents|mesh-ancestor
101840409|NCT00459186|Mitosis Modulators|mitosis modulators|mesh-ancestor
101840410|NCT00459186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840411|NCT00459186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101840412|NCT00459186|Glucocorticoids|glucocorticoids|mesh-ancestor
101840413|NCT00459186|Hormones|hormones|mesh-ancestor
101840414|NCT00459186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101840415|NCT00459186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840416|NCT00459186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101840417|NCT00459186|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101840418|NCT00459186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101840419|NCT00459186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840420|NCT00459186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101840421|NCT00459186|Immunologic Factors|immunologic factors|mesh-ancestor
101840422|NCT01026714|Rifampin|rifampin|mesh-list
101840423|NCT01026714|Fluconazole|fluconazole|mesh-list
101840424|NCT01026714|Flurbiprofen|flurbiprofen|mesh-list
101840425|NCT01026714|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101840426|NCT01026714|Antitubercular Agents|antitubercular agents|mesh-ancestor
101840427|NCT01026714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101840428|NCT01026714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101840429|NCT01026714|Leprostatic Agents|leprostatic agents|mesh-ancestor
101840430|NCT01026714|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101840431|NCT01026714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101963417|NCT02188186|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101840432|NCT01026714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840433|NCT01026714|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101840434|NCT01026714|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101840435|NCT01026714|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101840436|NCT01026714|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101840437|NCT01026714|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101840438|NCT01026714|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101840439|NCT01026714|Antifungal Agents|antifungal agents|mesh-ancestor
101840440|NCT01026714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101840441|NCT01026714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101840442|NCT01026714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101840443|NCT01026714|Hormone Antagonists|hormone antagonists|mesh-ancestor
101840444|NCT01026714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101840445|NCT01026714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840446|NCT01026714|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101840447|NCT01026714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101840449|NCT01026714|Sensory System Agents|sensory system agents|mesh-ancestor
101840450|NCT01026714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101840451|NCT01026714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101840452|NCT01026714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101840453|NCT01026714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101840454|NCT01026714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101840455|NCT01026714|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101840457|NCT03996252|Fluorouracil|fluorouracil|mesh-list
101840458|NCT03996252|Calcipotriene|calcipotriene|mesh-list
101840459|NCT03996252|Antimetabolites|antimetabolites|mesh-ancestor
101840460|NCT03996252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840461|NCT03996252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101840462|NCT03996252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101840463|NCT03996252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101840464|NCT03996252|Immunologic Factors|immunologic factors|mesh-ancestor
101840465|NCT03996252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840466|NCT03996252|Dermatologic Agents|dermatologic agents|mesh-ancestor
101840467|NCT03996252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101840468|NCT03996252|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101840469|NCT03996252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101840470|NCT03996252|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101840471|NCT03996252|Vitamins|vitamins|mesh-ancestor
101840472|NCT03996252|Micronutrients|micronutrients|mesh-ancestor
101840473|NCT03996252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101840474|NCT00313144|Protease Inhibitors|protease inhibitors|mesh-list
101840475|NCT00313144|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
101840476|NCT00313144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840477|NCT00313144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840478|NCT00313144|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101840479|NCT00313144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101840480|NCT00459108|Dasatinib|dasatinib|mesh-list
101840481|NCT00459108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101840482|NCT00459108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101840483|NCT00459108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840484|NCT00459108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840485|NCT00328198|Alemtuzumab|alemtuzumab|mesh-list
101840486|NCT00328198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101840487|NCT00328198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101840488|NCT00450450|Lenograstim|lenograstim|mesh-list
101840489|NCT00450450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101840490|NCT00450450|Immunologic Factors|immunologic factors|mesh-ancestor
101840491|NCT00450450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840492|NCT03440892|Sulfasalazine|sulfasalazine|mesh-list
101840493|NCT03440892|Methotrexate|methotrexate|mesh-list
101840494|NCT03440892|Abatacept|abatacept|mesh-list
101840495|NCT03440892|Tofacitinib|tofacitinib|mesh-list
101840496|NCT03440892|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101840497|NCT03440892|Abortifacient Agents|abortifacient agents|mesh-ancestor
101840498|NCT03440892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101840499|NCT03440892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840500|NCT03440892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101840501|NCT03440892|Antimetabolites|antimetabolites|mesh-ancestor
101840502|NCT03440892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840503|NCT03440892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101840504|NCT03440892|Dermatologic Agents|dermatologic agents|mesh-ancestor
101840505|NCT03440892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840506|NCT03440892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101840507|NCT03440892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101840508|NCT03440892|Immunologic Factors|immunologic factors|mesh-ancestor
101840509|NCT03440892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101840510|NCT03440892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101840511|NCT03440892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101685780|NCT02909036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101840512|NCT03440892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101840513|NCT03440892|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101840514|NCT03440892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101840515|NCT03440892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101840516|NCT03440892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101840517|NCT03440892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101840518|NCT03440892|Analgesics|analgesics|mesh-ancestor
101840519|NCT03440892|Sensory System Agents|sensory system agents|mesh-ancestor
101840520|NCT03440892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101840521|NCT03440892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101840522|NCT03440892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101840523|NCT00442572|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101840524|NCT00442572|Antiviral Agents|antiviral agents|mesh-ancestor
101840525|NCT00442572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101840526|NCT01023360|Esomeprazole|esomeprazole|mesh-list
101840527|NCT01023360|Rabeprazole|rabeprazole|mesh-list
101840528|NCT01023360|Pantoprazole|pantoprazole|mesh-list
101840529|NCT01023360|Clopidogrel|clopidogrel|mesh-list
101840530|NCT01023360|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101840531|NCT01023360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101840532|NCT01023360|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101840533|NCT01023360|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101840534|NCT01023360|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101840535|NCT01023360|Purinergic Agents|purinergic agents|mesh-ancestor
101840536|NCT01023360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101840537|NCT01023360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840538|NCT01023360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840540|NCT01023360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101840541|NCT01023360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840542|NCT03685890|Nivolumab|nivolumab|mesh-list
101840543|NCT03685890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101840544|NCT03685890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101840545|NCT03685890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101840546|NCT03685890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840547|NCT00442416|Epoetin Alfa|epoetin alfa|mesh-list
101840548|NCT00442416|Hematinics|hematinics|mesh-ancestor
101840549|NCT03674424|Avelumab|avelumab|mesh-list
101840550|NCT03674424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101840551|NCT03674424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101840552|NCT00441792|Midazolam|midazolam|mesh-list
101840553|NCT00441792|Etomidate|etomidate|mesh-list
101840554|NCT00441792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101840555|NCT00441792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101840556|NCT00441792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101840557|NCT00441792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840558|NCT00441792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101840559|NCT00441792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101840560|NCT00441792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101840561|NCT00441792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101840562|NCT00441792|Anesthetics, General|anesthetics, general|mesh-ancestor
101840563|NCT00441792|Anesthetics|anesthetics|mesh-ancestor
101840564|NCT00441792|GABA Modulators|gaba modulators|mesh-ancestor
101840565|NCT00441792|GABA Agents|gaba agents|mesh-ancestor
101840566|NCT00441792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101840567|NCT00441792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840568|NCT00312208|Cyclophosphamide|cyclophosphamide|mesh-list
101840569|NCT00312208|Docetaxel|docetaxel|mesh-list
101840570|NCT00312208|Doxorubicin|doxorubicin|mesh-list
101840571|NCT00312208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101840572|NCT00312208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101840573|NCT00312208|Immunologic Factors|immunologic factors|mesh-ancestor
101840574|NCT00312208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840575|NCT00312208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101840576|NCT00312208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101840577|NCT00312208|Alkylating Agents|alkylating agents|mesh-ancestor
101840578|NCT00312208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840579|NCT00312208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237133|NCT04541173|Growth Inhibitors|growth inhibitors|mesh-ancestor
101840580|NCT00312208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101840581|NCT00312208|Tubulin Modulators|tubulin modulators|mesh-ancestor
101840582|NCT00312208|Antimitotic Agents|antimitotic agents|mesh-ancestor
101840583|NCT00312208|Mitosis Modulators|mitosis modulators|mesh-ancestor
101840584|NCT00312208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101685784|NCT04213898|Paclitaxel|paclitaxel|mesh-list
101840585|NCT00312208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101840586|NCT00312208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101840588|NCT00297778|Pramipexole|pramipexole|mesh-list
101840589|NCT00297778|Antioxidants|antioxidants|mesh-ancestor
101840590|NCT00297778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840591|NCT00297778|Protective Agents|protective agents|mesh-ancestor
101840592|NCT00297778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840593|NCT00297778|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101840594|NCT00297778|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101840595|NCT00297778|Dopamine Agonists|dopamine agonists|mesh-ancestor
101840596|NCT00297778|Dopamine Agents|dopamine agents|mesh-ancestor
101840597|NCT00297778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101840598|NCT03848832|Cannabidiol|cannabidiol|mesh-list
101840599|NCT03848832|Anticonvulsants|anticonvulsants|mesh-ancestor
101840600|NCT00327340|Docetaxel|docetaxel|mesh-list
101840601|NCT00327340|Mitoxantrone|mitoxantrone|mesh-list
101840602|NCT00327340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101840603|NCT00327340|Tubulin Modulators|tubulin modulators|mesh-ancestor
101840604|NCT00327340|Antimitotic Agents|antimitotic agents|mesh-ancestor
101840605|NCT00327340|Mitosis Modulators|mitosis modulators|mesh-ancestor
101840606|NCT00327340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840607|NCT00327340|Analgesics|analgesics|mesh-ancestor
101840608|NCT00327340|Sensory System Agents|sensory system agents|mesh-ancestor
101840609|NCT00327340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101840610|NCT00327340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840611|NCT00327340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101840612|NCT00327340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101840613|NCT00327340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840615|NCT00958139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840616|NCT00958139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840617|NCT00450216|Ibuprofen|ibuprofen|mesh-list
101840618|NCT00450216|Famotidine|famotidine|mesh-list
101840619|NCT00450216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101840620|NCT00450216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101840621|NCT00450216|Analgesics|analgesics|mesh-ancestor
101840622|NCT00450216|Sensory System Agents|sensory system agents|mesh-ancestor
101840623|NCT00450216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101840624|NCT00450216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840625|NCT00450216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101840626|NCT00450216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101963444|NCT03535090|Glucocorticoids|glucocorticoids|mesh-ancestor
101840627|NCT00450216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101840628|NCT00450216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840629|NCT00450216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840630|NCT00450216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101840631|NCT00450216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101840632|NCT00450216|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101840633|NCT00450216|Histamine Antagonists|histamine antagonists|mesh-ancestor
101840634|NCT00450216|Histamine Agents|histamine agents|mesh-ancestor
101840635|NCT00450216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101840636|NCT01566006|Mycophenolic Acid|mycophenolic acid|mesh-list
101840637|NCT01566006|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
101840638|NCT01566006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101840639|NCT01566006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101840640|NCT01566006|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101840641|NCT01566006|Antitubercular Agents|antitubercular agents|mesh-ancestor
101840642|NCT01566006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101840643|NCT01566006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101840644|NCT01566006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840645|NCT01566006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840646|NCT01566006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101840647|NCT00958451|Ergocalciferols|ergocalciferols|mesh-list
101840648|NCT00958451|Vitamin D|vitamin d|mesh-list
101840649|NCT00958451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101840650|NCT00958451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840651|NCT00958451|Vitamins|vitamins|mesh-ancestor
101840652|NCT00958451|Micronutrients|micronutrients|mesh-ancestor
101840653|NCT00958451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101840654|NCT05352191|Beclomethasone|beclomethasone|mesh-list
101840655|NCT05352191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101840656|NCT05352191|Glucocorticoids|glucocorticoids|mesh-ancestor
101840657|NCT05352191|Hormones|hormones|mesh-ancestor
101840658|NCT05352191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101840659|NCT05352191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840660|NCT05352191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101840661|NCT05352191|Respiratory System Agents|respiratory system agents|mesh-ancestor
101840662|NCT00954005|Rituximab|rituximab|mesh-list
101840663|NCT00954005|Gemcitabine|gemcitabine|mesh-list
101840664|NCT00954005|Oxaliplatin|oxaliplatin|mesh-list
101840665|NCT00954005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101840666|NCT00954005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101840667|NCT00954005|Immunologic Factors|immunologic factors|mesh-ancestor
101840668|NCT00954005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840669|NCT00954005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101840670|NCT00954005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101840671|NCT00954005|Antimetabolites|antimetabolites|mesh-ancestor
101840672|NCT00954005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840673|NCT01023750|Fenofibrate|fenofibrate|mesh-list
101840674|NCT01023750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101840675|NCT01023750|Antimetabolites|antimetabolites|mesh-ancestor
101840676|NCT01023750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840677|NCT01023750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101840678|NCT05300009|Methotrexate|methotrexate|mesh-list
101840679|NCT05300009|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101840680|NCT05300009|Abortifacient Agents|abortifacient agents|mesh-ancestor
101840681|NCT05300009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101840682|NCT05300009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840683|NCT05300009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101840684|NCT05300009|Antimetabolites|antimetabolites|mesh-ancestor
101840685|NCT05300009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840686|NCT05300009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101840687|NCT05300009|Dermatologic Agents|dermatologic agents|mesh-ancestor
101840688|NCT05300009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840689|NCT05300009|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101840690|NCT05300009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101840691|NCT05300009|Immunologic Factors|immunologic factors|mesh-ancestor
101840692|NCT05300009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101840693|NCT05300009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101840694|NCT05352113|Antidepressive Agents|antidepressive agents|mesh-list
101840695|NCT05352113|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
101963451|NCT03535870|Fluticasone|fluticasone|mesh-list
101840696|NCT05352113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101840697|NCT05352113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101840698|NCT05352113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101840699|NCT05352113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840700|NCT05352113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101840702|NCT05352113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840704|NCT00547703|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101840705|NCT00547703|Antidepressive Agents|antidepressive agents|mesh-ancestor
101840706|NCT00547703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101840707|NCT00547703|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101840708|NCT00547703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101840709|NCT00547703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101840710|NCT00547703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840711|NCT00547703|Adrenergic Agents|adrenergic agents|mesh-ancestor
101840712|NCT00547703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101840713|NCT00547703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840714|NCT00297232|Natalizumab|natalizumab|mesh-list
101840715|NCT00297232|Immunologic Factors|immunologic factors|mesh-ancestor
101840716|NCT00297232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840717|NCT01062802|Atorvastatin|atorvastatin|mesh-list
101840718|NCT01062802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101840719|NCT01062802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101840720|NCT01062802|Antimetabolites|antimetabolites|mesh-ancestor
101840721|NCT01062802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840722|NCT01062802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101840723|NCT01062802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101840724|NCT01062802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840725|NCT03867383|Calcium, Dietary|calcium, dietary|mesh-list
101840726|NCT03867383|Calcium|calcium|mesh-list
101840727|NCT03867383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101840728|NCT03867383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840729|NCT03867383|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101840730|NCT00954395|Fibrin Fibrinogen Degradation Products|fibrin fibrinogen degradation products|mesh-list
101840731|NCT00954395|Fibrin fragment D|fibrin fragment d|mesh-list
101840732|NCT00954395|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101840733|NCT00954395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101840734|NCT00954395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840735|NCT00954395|Hemostatics|hemostatics|mesh-ancestor
101840736|NCT00954395|Coagulants|coagulants|mesh-ancestor
101840737|NCT00954395|Anticoagulants|anticoagulants|mesh-ancestor
101840738|NCT03741101|Trametinib|trametinib|mesh-list
101840739|NCT03741101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101840740|NCT03741101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101840741|NCT03741101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840742|NCT03741101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840743|NCT00449670|Vaccines|vaccines|mesh-list
101840744|NCT00449670|Immunologic Factors|immunologic factors|mesh-ancestor
101237197|NCT04229771|Sensory System Agents|sensory system agents|mesh-ancestor
101840745|NCT00449670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840746|NCT04010903|Insulin|insulin|mesh-list
101840747|NCT04010903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101840748|NCT04010903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840749|NCT05299931|Ustekinumab|ustekinumab|mesh-list
101840750|NCT05299931|Dermatologic Agents|dermatologic agents|mesh-ancestor
101840751|NCT00296374|Atorvastatin|atorvastatin|mesh-list
101840752|NCT00296374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101840753|NCT00296374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101840754|NCT00296374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101840755|NCT00296374|Antimetabolites|antimetabolites|mesh-ancestor
101840756|NCT00296374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840757|NCT00296374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101840758|NCT00296374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101840759|NCT00296374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840760|NCT03387761|Nivolumab|nivolumab|mesh-list
101840761|NCT03387761|Ipilimumab|ipilimumab|mesh-list
101840762|NCT03387761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101963453|NCT03535870|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101840763|NCT03387761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101840764|NCT03387761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101840765|NCT03387761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840766|NCT01060774|Lidocaine|lidocaine|mesh-list
101840767|NCT01060774|Bupivacaine|bupivacaine|mesh-list
101840768|NCT01060774|Anesthetics, Local|anesthetics, local|mesh-ancestor
101840769|NCT01060774|Anesthetics|anesthetics|mesh-ancestor
101840770|NCT01060774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101840771|NCT01060774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840772|NCT01060774|Sensory System Agents|sensory system agents|mesh-ancestor
101840773|NCT01060774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101840774|NCT01060774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101840775|NCT01060774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101840776|NCT01060774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101840777|NCT01060774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101840778|NCT01060774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840779|NCT00954785|Diclofenac|diclofenac|mesh-list
101840780|NCT00954785|Etoricoxib|etoricoxib|mesh-list
101840781|NCT00954785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101840782|NCT00954785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101840783|NCT00954785|Analgesics|analgesics|mesh-ancestor
101840784|NCT00954785|Sensory System Agents|sensory system agents|mesh-ancestor
101840785|NCT00954785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101840786|NCT00954785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840787|NCT00954785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101840788|NCT00954785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101840789|NCT00954785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101840790|NCT00954785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840791|NCT00954785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840792|NCT00954785|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101840793|NCT00548717|Mycophenolic Acid|mycophenolic acid|mesh-list
101840794|NCT00548717|Sirolimus|sirolimus|mesh-list
101840795|NCT00548717|Bortezomib|bortezomib|mesh-list
101840796|NCT00548717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101840797|NCT00548717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101840798|NCT00548717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101840799|NCT00548717|Antitubercular Agents|antitubercular agents|mesh-ancestor
101840800|NCT00548717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101840801|NCT00548717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101840802|NCT00548717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840803|NCT00548717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840804|NCT00548717|Antifungal Agents|antifungal agents|mesh-ancestor
101840805|NCT00548717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101840806|NCT00548717|Immunologic Factors|immunologic factors|mesh-ancestor
101840807|NCT00548717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840808|NCT00441168|Dexamethasone|dexamethasone|mesh-list
101840809|NCT00441168|Vincristine|vincristine|mesh-list
101840810|NCT00441168|Doxorubicin|doxorubicin|mesh-list
101840811|NCT00441168|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101840812|NCT00441168|Bortezomib|bortezomib|mesh-list
101840813|NCT00441168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101840814|NCT00441168|Antiemetics|antiemetics|mesh-ancestor
101840815|NCT00441168|Autonomic Agents|autonomic agents|mesh-ancestor
101840816|NCT00441168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101840817|NCT00441168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840818|NCT00441168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101840819|NCT00441168|Glucocorticoids|glucocorticoids|mesh-ancestor
101840820|NCT00441168|Hormones|hormones|mesh-ancestor
101840821|NCT00441168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101840822|NCT00441168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101840823|NCT00441168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101840824|NCT00441168|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101840825|NCT00441168|Tubulin Modulators|tubulin modulators|mesh-ancestor
101840826|NCT00441168|Antimitotic Agents|antimitotic agents|mesh-ancestor
101840827|NCT00441168|Mitosis Modulators|mitosis modulators|mesh-ancestor
101840828|NCT00441168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840829|NCT00441168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101840830|NCT00441168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101840831|NCT00441168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101560610|NCT00604435|Growth Substances|growth substances|mesh-ancestor
101840832|NCT00441168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840834|NCT01062958|Folic Acid|folic acid|mesh-list
101840835|NCT01062958|Vitamin B 12|vitamin b 12|mesh-list
101840836|NCT01062958|Hydroxocobalamin|hydroxocobalamin|mesh-list
101840837|NCT01062958|Micronutrients|micronutrients|mesh-ancestor
101840838|NCT01062958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840839|NCT01062958|Hematinics|hematinics|mesh-ancestor
101840840|NCT01062958|Vitamin B Complex|vitamin b complex|mesh-ancestor
101840841|NCT01028976|Ascorbic Acid|ascorbic acid|mesh-list
101840842|NCT01028976|Vitamins|vitamins|mesh-ancestor
101840843|NCT01028976|Micronutrients|micronutrients|mesh-ancestor
101840844|NCT01028976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840845|NCT01028976|Antioxidants|antioxidants|mesh-ancestor
101840846|NCT01028976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840847|NCT01028976|Protective Agents|protective agents|mesh-ancestor
101840848|NCT01024140|Escitalopram|escitalopram|mesh-list
101840849|NCT01024140|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101840850|NCT01024140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101840851|NCT01024140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101840852|NCT01024140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840853|NCT01024140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101840854|NCT01024140|Serotonin Agents|serotonin agents|mesh-ancestor
101840855|NCT01024140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840856|NCT00457626|Valsartan|valsartan|mesh-list
101840857|NCT00457626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101237226|NCT03871153|Carboplatin|carboplatin|mesh-list
101840858|NCT00457626|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101840859|NCT00457626|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101840860|NCT00457626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840861|NCT02748707|Celecoxib|celecoxib|mesh-list
101840862|NCT02748707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101840863|NCT02748707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101840864|NCT02748707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101840865|NCT02748707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840866|NCT02748707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840867|NCT02748707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101840868|NCT02748707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101840869|NCT02748707|Analgesics|analgesics|mesh-ancestor
101840870|NCT02748707|Sensory System Agents|sensory system agents|mesh-ancestor
101840871|NCT02748707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101508607|NCT00530361|Natriuretic Agents|natriuretic agents|mesh-ancestor
101840872|NCT02748707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840874|NCT02748707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101840875|NCT02748707|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101840876|NCT02748707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101840877|NCT05014061|Adenosine|adenosine|mesh-list
101840878|NCT05014061|Analgesics|analgesics|mesh-ancestor
101840879|NCT05014061|Sensory System Agents|sensory system agents|mesh-ancestor
101840880|NCT05014061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101840881|NCT05014061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840882|NCT05014061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101840883|NCT05014061|Vasodilator Agents|vasodilator agents|mesh-ancestor
101840884|NCT05014061|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101840885|NCT05014061|Purinergic Agonists|purinergic agonists|mesh-ancestor
101840886|NCT05014061|Purinergic Agents|purinergic agents|mesh-ancestor
101840887|NCT05014061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101840888|NCT05014061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840889|NCT00373113|Capecitabine|capecitabine|mesh-list
101840890|NCT00373113|Sunitinib|sunitinib|mesh-list
101840891|NCT00373113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101840892|NCT00373113|Antimetabolites|antimetabolites|mesh-ancestor
101840893|NCT00373113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840894|NCT00373113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101840895|NCT00373113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101840896|NCT00373113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101840897|NCT00373113|Growth Substances|growth substances|mesh-ancestor
101840898|NCT00373113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840899|NCT00373113|Growth Inhibitors|growth inhibitors|mesh-ancestor
101840900|NCT00373113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101840901|NCT00373113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840903|NCT01045941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101840904|NCT01045941|Antimetabolites|antimetabolites|mesh-ancestor
101840905|NCT01045941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560683|NCT01218438|Antibodies|antibodies|mesh-list
101840906|NCT01045941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101840907|NCT00407511|Pregabalin|pregabalin|mesh-list
101840908|NCT00407511|Analgesics|analgesics|mesh-ancestor
101840909|NCT00407511|Sensory System Agents|sensory system agents|mesh-ancestor
101840910|NCT00407511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101237242|NCT03536728|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101840911|NCT00407511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840912|NCT00407511|Anticonvulsants|anticonvulsants|mesh-ancestor
101840913|NCT00407511|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101840914|NCT00407511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101840915|NCT00407511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840916|NCT00407511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101840917|NCT00407511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101840918|NCT00407511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101840919|NCT00407511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101840920|NCT00407511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101840921|NCT00384189|Ciclesonide|ciclesonide|mesh-list
101840922|NCT00384189|Albuterol|albuterol|mesh-list
101840923|NCT00384189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101840924|NCT00384189|Autonomic Agents|autonomic agents|mesh-ancestor
101840925|NCT00384189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101840926|NCT00384189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840927|NCT00384189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101840928|NCT00384189|Respiratory System Agents|respiratory system agents|mesh-ancestor
101840929|NCT00384189|Tocolytic Agents|tocolytic agents|mesh-ancestor
101840930|NCT00384189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101840931|NCT00384189|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101840932|NCT00384189|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101840933|NCT00384189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101840934|NCT00384189|Adrenergic Agents|adrenergic agents|mesh-ancestor
101840935|NCT00384189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101840936|NCT00384189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840937|NCT00384189|Glucocorticoids|glucocorticoids|mesh-ancestor
101840938|NCT00384189|Hormones|hormones|mesh-ancestor
101840939|NCT00384189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101840940|NCT00384189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101840941|NCT00326716|Ritonavir|ritonavir|mesh-list
101840942|NCT00326716|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101685795|NCT04213898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101840943|NCT00326716|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101840944|NCT00326716|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101840945|NCT00326716|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101840946|NCT00326716|Protease Inhibitors|protease inhibitors|mesh-ancestor
101840947|NCT00326716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840948|NCT00326716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840950|NCT00326716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101840951|NCT00326716|Antiviral Agents|antiviral agents|mesh-ancestor
101840952|NCT00326716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101840953|NCT00326716|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101840954|NCT00326716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101840955|NCT00326716|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101840956|NCT00326716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101840957|NCT01063192|Leucovorin|leucovorin|mesh-list
101840958|NCT01063192|Gemcitabine|gemcitabine|mesh-list
101840959|NCT01063192|Fluorouracil|fluorouracil|mesh-list
101840960|NCT01063192|Oxaliplatin|oxaliplatin|mesh-list
101840961|NCT01063192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101840962|NCT01063192|Antimetabolites|antimetabolites|mesh-ancestor
101840963|NCT01063192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840964|NCT01063192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101840965|NCT01063192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101840966|NCT01063192|Immunologic Factors|immunologic factors|mesh-ancestor
101840967|NCT01063192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840968|NCT01063192|Antidotes|antidotes|mesh-ancestor
101840969|NCT01063192|Protective Agents|protective agents|mesh-ancestor
101840970|NCT01063192|Vitamin B Complex|vitamin b complex|mesh-ancestor
101840971|NCT01063192|Vitamins|vitamins|mesh-ancestor
101840972|NCT01063192|Micronutrients|micronutrients|mesh-ancestor
101840973|NCT03978988|Aspirin|aspirin|mesh-list
101840974|NCT03978988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101840975|NCT03978988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101237268|NCT03462251|Paclitaxel|paclitaxel|mesh-list
101840976|NCT03978988|Analgesics|analgesics|mesh-ancestor
101840977|NCT03978988|Sensory System Agents|sensory system agents|mesh-ancestor
101840978|NCT03978988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101840979|NCT03978988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101840980|NCT03978988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101840981|NCT03978988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101840982|NCT03978988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101840983|NCT03978988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101840984|NCT03978988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840985|NCT03978988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101840986|NCT03978988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101840987|NCT03978988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840989|NCT01063426|Enoxaparin|enoxaparin|mesh-list
101840990|NCT01063426|Enoxaparin sodium|enoxaparin sodium|mesh-list
101840991|NCT01063426|Atorvastatin|atorvastatin|mesh-list
101840992|NCT01063426|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101840993|NCT01063426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101840994|NCT01063426|Antimetabolites|antimetabolites|mesh-ancestor
101840995|NCT01063426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101840996|NCT01063426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101840997|NCT01063426|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101840998|NCT01063426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101840999|NCT01063426|Anticoagulants|anticoagulants|mesh-ancestor
101841000|NCT01063426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101841001|NCT01063426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101841002|NCT00548405|Interferons|interferons|mesh-list
101841003|NCT00548405|Interferon-beta|interferon-beta|mesh-list
101841004|NCT00548405|Interferon beta-1a|interferon beta-1a|mesh-list
101841005|NCT00548405|Alemtuzumab|alemtuzumab|mesh-list
101841006|NCT00548405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841007|NCT00548405|Antiviral Agents|antiviral agents|mesh-ancestor
101841008|NCT00548405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101841009|NCT00548405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101841010|NCT00548405|Immunologic Factors|immunologic factors|mesh-ancestor
101841011|NCT00548405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841012|NCT00548405|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101841013|NCT04919369|Vitamins|vitamins|mesh-list
101841014|NCT04919369|Vitamin A|vitamin a|mesh-list
101841015|NCT04919369|Atezolizumab|atezolizumab|mesh-list
101841016|NCT04919369|Tretinoin|tretinoin|mesh-list
101841017|NCT04919369|Retinol palmitate|retinol palmitate|mesh-list
101841018|NCT04919369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101841019|NCT04919369|Micronutrients|micronutrients|mesh-ancestor
101841020|NCT04919369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841021|NCT04919369|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101841022|NCT04919369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841023|NCT04919369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101841024|NCT04919369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841025|NCT04919369|Immunologic Factors|immunologic factors|mesh-ancestor
101841026|NCT04919369|Keratolytic Agents|keratolytic agents|mesh-ancestor
101841027|NCT04919369|Dermatologic Agents|dermatologic agents|mesh-ancestor
101841028|NCT04919369|Antioxidants|antioxidants|mesh-ancestor
101841029|NCT04919369|Protective Agents|protective agents|mesh-ancestor
101841030|NCT04919369|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101841031|NCT00959075|Thiamine|thiamine|mesh-list
101841032|NCT00959075|Vitamins|vitamins|mesh-ancestor
101841033|NCT00959075|Micronutrients|micronutrients|mesh-ancestor
101841034|NCT00959075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841035|NCT00959075|Vitamin B Complex|vitamin b complex|mesh-ancestor
101841036|NCT00295750|Leuprolide|leuprolide|mesh-list
101841037|NCT00295750|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101841038|NCT00295750|Fertility Agents|fertility agents|mesh-ancestor
101841039|NCT00295750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101841040|NCT00295750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841041|NCT00295750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101841042|NCT00295750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841043|NCT00959231|Cyclosporine|cyclosporine|mesh-list
101841044|NCT00959231|Mycophenolic Acid|mycophenolic acid|mesh-list
101841045|NCT00959231|Cyclophosphamide|cyclophosphamide|mesh-list
101841046|NCT00959231|Fludarabine|fludarabine|mesh-list
101841047|NCT00959231|Fludarabine phosphate|fludarabine phosphate|mesh-list
101841048|NCT00959231|Cyclosporins|cyclosporins|mesh-list
101841049|NCT00959231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101841050|NCT00959231|Immunologic Factors|immunologic factors|mesh-ancestor
101841051|NCT00959231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841052|NCT00959231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101841053|NCT00959231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101841054|NCT00959231|Alkylating Agents|alkylating agents|mesh-ancestor
101841055|NCT00959231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560837|NCT00934843|Prednisolone|prednisolone|mesh-list
101841056|NCT00959231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841057|NCT00959231|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101841058|NCT00959231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101841059|NCT00959231|Antimetabolites|antimetabolites|mesh-ancestor
101841060|NCT00959231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841061|NCT00959231|Antifungal Agents|antifungal agents|mesh-ancestor
101841062|NCT00959231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101841063|NCT00959231|Dermatologic Agents|dermatologic agents|mesh-ancestor
101841064|NCT00959231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101841065|NCT00959231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101841066|NCT00959231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101841067|NCT00959231|Antitubercular Agents|antitubercular agents|mesh-ancestor
101841068|NCT00959231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101841069|NCT03948581|Vedolizumab|vedolizumab|mesh-list
101841070|NCT03948581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101841071|NCT00548327|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101841072|NCT00548327|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101841073|NCT00548327|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101841074|NCT00548327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101841075|NCT00548327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841076|NCT00548327|Adrenergic Agents|adrenergic agents|mesh-ancestor
101841077|NCT00548327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101841078|NCT00548327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841079|NCT04720547|Zolpidem|zolpidem|mesh-list
101841080|NCT04720547|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101841081|NCT04720547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101841082|NCT04720547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101841083|NCT04720547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841084|NCT04720547|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101841085|NCT04720547|GABA Agonists|gaba agonists|mesh-ancestor
101841086|NCT04720547|GABA Agents|gaba agents|mesh-ancestor
101841087|NCT04720547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101841088|NCT04720547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841089|NCT00959387|Paclitaxel|paclitaxel|mesh-list
101841090|NCT00959387|Cisplatin|cisplatin|mesh-list
101841091|NCT00959387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101841092|NCT00959387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841093|NCT00959387|Tubulin Modulators|tubulin modulators|mesh-ancestor
101841094|NCT00959387|Antimitotic Agents|antimitotic agents|mesh-ancestor
101841095|NCT00959387|Mitosis Modulators|mitosis modulators|mesh-ancestor
101841096|NCT00959387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841097|NCT04718285|Favipiravir|favipiravir|mesh-list
101841098|NCT04718285|Montelukast|montelukast|mesh-list
101841099|NCT04718285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101841100|NCT04718285|Respiratory System Agents|respiratory system agents|mesh-ancestor
101841101|NCT04718285|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101841102|NCT04718285|Hormone Antagonists|hormone antagonists|mesh-ancestor
101841103|NCT04718285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101841104|NCT04718285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841105|NCT04718285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101841106|NCT04718285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101841107|NCT04718285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841108|NCT04718285|Antiviral Agents|antiviral agents|mesh-ancestor
101841109|NCT04718285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101841110|NCT00959621|Aspirin|aspirin|mesh-list
101841111|NCT00959621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101841112|NCT00959621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101841113|NCT00959621|Analgesics|analgesics|mesh-ancestor
101841114|NCT00959621|Sensory System Agents|sensory system agents|mesh-ancestor
101841115|NCT00959621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101841116|NCT00959621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841118|NCT00959621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101841119|NCT00959621|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101841120|NCT00959621|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101841121|NCT00959621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841122|NCT00959621|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101841123|NCT00959621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101841124|NCT00959621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841125|NCT00959621|Antipyretics|antipyretics|mesh-ancestor
101841126|NCT00959777|Lenograstim|lenograstim|mesh-list
101841127|NCT00959777|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101841128|NCT00959777|Immunologic Factors|immunologic factors|mesh-ancestor
101841129|NCT00959777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841130|NCT00959933|Ribavirin|ribavirin|mesh-list
101841131|NCT00959933|Antimetabolites|antimetabolites|mesh-ancestor
101841132|NCT00959933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841133|NCT00959933|Antiviral Agents|antiviral agents|mesh-ancestor
101841134|NCT00959933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101841135|NCT00960245|Nadolol|nadolol|mesh-list
101841136|NCT00960245|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101841137|NCT00960245|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101841138|NCT00960245|Adrenergic Agents|adrenergic agents|mesh-ancestor
101841139|NCT00960245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101841140|NCT00960245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841141|NCT00960245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841142|NCT00960245|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101841143|NCT00960245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101841144|NCT00960245|Sympatholytics|sympatholytics|mesh-ancestor
101841145|NCT00960245|Autonomic Agents|autonomic agents|mesh-ancestor
101841146|NCT00960245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101841147|NCT00406653|Abatacept|abatacept|mesh-list
101841148|NCT00406653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101841149|NCT00406653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841150|NCT00406653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101841151|NCT00406653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841152|NCT00406653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101841153|NCT00406653|Immunologic Factors|immunologic factors|mesh-ancestor
101841154|NCT00406653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841155|NCT00406653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101841156|NCT00547157|Cisplatin|cisplatin|mesh-list
101841157|NCT00547157|Panitumumab|panitumumab|mesh-list
101841158|NCT00547157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237293|NCT03462251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841159|NCT00547157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101841160|NCT00960479|Ribavirin|ribavirin|mesh-list
101841161|NCT00960479|Antimetabolites|antimetabolites|mesh-ancestor
101841162|NCT00960479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841163|NCT00960479|Antiviral Agents|antiviral agents|mesh-ancestor
101841164|NCT00960479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101841165|NCT00960557|Combretastatin|combretastatin|mesh-list
101841166|NCT00960557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101841167|NCT00960557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841168|NCT00960557|Tubulin Modulators|tubulin modulators|mesh-ancestor
101841169|NCT00960557|Antimitotic Agents|antimitotic agents|mesh-ancestor
101841170|NCT00960557|Mitosis Modulators|mitosis modulators|mesh-ancestor
101841171|NCT00960557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841172|NCT00960635|Vitamin D|vitamin d|mesh-list
101841173|NCT00960635|Cholecalciferol|cholecalciferol|mesh-list
101841174|NCT00960635|Calcitriol|calcitriol|mesh-list
101841175|NCT00960635|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
101841176|NCT00960635|Vitamins|vitamins|mesh-ancestor
101841177|NCT00960635|Micronutrients|micronutrients|mesh-ancestor
101841178|NCT00960635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841179|NCT00960635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101841180|NCT00960635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101841181|NCT00960635|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101841182|NCT00960635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101841183|NCT00960635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963483|NCT02192710|Anesthetics, General|anesthetics, general|mesh-ancestor
101841184|NCT00960635|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101841185|NCT00960713|Rituximab|rituximab|mesh-list
101841186|NCT00960713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101841187|NCT00960713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841188|NCT00960713|Immunologic Factors|immunologic factors|mesh-ancestor
101841189|NCT00960713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841190|NCT00960713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101841191|NCT04009889|Silicon|silicon|mesh-list
101841192|NCT04009889|Trace Elements|trace elements|mesh-ancestor
101841193|NCT04009889|Micronutrients|micronutrients|mesh-ancestor
101841194|NCT04009889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841195|NCT00962507|Everolimus|everolimus|mesh-list
101841196|NCT00962507|Panobinostat|panobinostat|mesh-list
101841197|NCT00962507|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101841198|NCT00962507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101841199|NCT00962507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841200|NCT00962507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841201|NCT00962507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101841202|NCT00962507|Immunologic Factors|immunologic factors|mesh-ancestor
101841203|NCT00962507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841204|NCT00962507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841205|NCT00962507|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101841206|NCT00384033|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101841207|NCT00384033|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101841208|NCT00384033|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101841209|NCT00384033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101841210|NCT00384033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101841211|NCT00384033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841212|NCT00384033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101841213|NCT00384033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841214|NCT00384033|Analgesics|analgesics|mesh-ancestor
101841215|NCT00384033|Sensory System Agents|sensory system agents|mesh-ancestor
101841216|NCT00384033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101841217|NCT00384033|Antidepressive Agents|antidepressive agents|mesh-ancestor
101841218|NCT00384033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101841219|NCT00384033|Dopamine Agents|dopamine agents|mesh-ancestor
101841220|NCT00962663|Ibuprofen|ibuprofen|mesh-list
101841221|NCT00962663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101841222|NCT00962663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101841223|NCT00962663|Analgesics|analgesics|mesh-ancestor
101841224|NCT00962663|Sensory System Agents|sensory system agents|mesh-ancestor
101841225|NCT00962663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101841226|NCT00962663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841227|NCT00962663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101841228|NCT00962663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101841229|NCT00962663|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101841230|NCT00962663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841231|NCT00962663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841232|NCT00962975|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101841233|NCT00962975|Antiviral Agents|antiviral agents|mesh-ancestor
101841234|NCT00962975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101841235|NCT00075387|Sodium thiosulfate|sodium thiosulfate|mesh-list
101841236|NCT00075387|Cyclophosphamide|cyclophosphamide|mesh-list
101841237|NCT00075387|Carboplatin|carboplatin|mesh-list
101841238|NCT00075387|Etoposide|etoposide|mesh-list
101841239|NCT00075387|Etoposide phosphate|etoposide phosphate|mesh-list
101841240|NCT00075387|Antidotes|antidotes|mesh-list
101841241|NCT00075387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101841242|NCT00075387|Immunologic Factors|immunologic factors|mesh-ancestor
101841243|NCT00075387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841244|NCT00075387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101841245|NCT00075387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101841246|NCT00075387|Alkylating Agents|alkylating agents|mesh-ancestor
101841247|NCT00075387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841248|NCT00075387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841249|NCT00075387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101841250|NCT00075387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101841251|NCT00075387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101841252|NCT00075387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101841253|NCT00075387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841254|NCT00075387|Protective Agents|protective agents|mesh-ancestor
101841255|NCT00075387|Antioxidants|antioxidants|mesh-ancestor
101841256|NCT00075387|Antitubercular Agents|antitubercular agents|mesh-ancestor
101841257|NCT00075387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101841258|NCT00075387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101841259|NCT00075387|Chelating Agents|chelating agents|mesh-ancestor
101841260|NCT00075387|Sequestering Agents|sequestering agents|mesh-ancestor
101841261|NCT00963131|Antioxidants|antioxidants|mesh-list
101841262|NCT00963131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841263|NCT00963131|Protective Agents|protective agents|mesh-ancestor
101841264|NCT00963131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841265|NCT00963209|Tamoxifen|tamoxifen|mesh-list
101841266|NCT00963209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101841267|NCT00963209|Hormone Antagonists|hormone antagonists|mesh-ancestor
101841268|NCT00963209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101841269|NCT00963209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841270|NCT00963209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101237337|NCT03258281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101841271|NCT00963209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841272|NCT00963209|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101841273|NCT00963209|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101841274|NCT00963209|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101841275|NCT00963443|Aspirin|aspirin|mesh-list
101841276|NCT00963443|Pseudoephedrine|pseudoephedrine|mesh-list
101841277|NCT00963443|Ephedrine|ephedrine|mesh-list
101841278|NCT00963443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101841279|NCT00963443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101841280|NCT00963443|Analgesics|analgesics|mesh-ancestor
101841281|NCT00963443|Sensory System Agents|sensory system agents|mesh-ancestor
101841282|NCT00963443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101841283|NCT00963443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841284|NCT00963443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101841285|NCT00963443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101841286|NCT00963443|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101841287|NCT00963443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101841288|NCT00963443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841289|NCT00963443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101841290|NCT00963443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101509027|NCT00515450|Antibodies|antibodies|mesh-list
101841291|NCT00963443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841293|NCT00963443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101841294|NCT00963443|Autonomic Agents|autonomic agents|mesh-ancestor
101841295|NCT00963443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101841296|NCT00963443|Respiratory System Agents|respiratory system agents|mesh-ancestor
101841297|NCT00963443|Nasal Decongestants|nasal decongestants|mesh-ancestor
101841298|NCT00963443|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101841299|NCT00963443|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101841300|NCT00963443|Sympathomimetics|sympathomimetics|mesh-ancestor
101841301|NCT00963443|Adrenergic Agents|adrenergic agents|mesh-ancestor
101841302|NCT00963443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101841303|NCT00963833|Interferons|interferons|mesh-list
101841304|NCT00963833|Interferon-beta|interferon-beta|mesh-list
101841305|NCT00963833|Interferon beta-1b|interferon beta-1b|mesh-list
101841306|NCT00963833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841307|NCT00963833|Antiviral Agents|antiviral agents|mesh-ancestor
101841308|NCT00963833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101841309|NCT00963833|Immunologic Factors|immunologic factors|mesh-ancestor
101841310|NCT00963833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841311|NCT00963833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101841312|NCT00967655|Capecitabine|capecitabine|mesh-list
101841313|NCT00967655|Irinotecan|irinotecan|mesh-list
101841314|NCT00967655|Panitumumab|panitumumab|mesh-list
101841315|NCT00967655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101841316|NCT00967655|Antimetabolites|antimetabolites|mesh-ancestor
101841317|NCT00967655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841318|NCT00967655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841319|NCT00967655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101841320|NCT00967655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101237352|NCT05705388|Incretins|incretins|mesh-ancestor
101841321|NCT00967655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841322|NCT00967655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101841323|NCT00546377|Cyclophosphamide|cyclophosphamide|mesh-list
101841324|NCT00546377|Rituximab|rituximab|mesh-list
101841325|NCT00546377|Mitoxantrone|mitoxantrone|mesh-list
101841326|NCT00546377|Pentostatin|pentostatin|mesh-list
101841327|NCT00546377|Sargramostim|sargramostim|mesh-list
101841328|NCT00546377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101841329|NCT00546377|Immunologic Factors|immunologic factors|mesh-ancestor
101841330|NCT00546377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841331|NCT00546377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101841332|NCT00546377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101841333|NCT00546377|Alkylating Agents|alkylating agents|mesh-ancestor
101841334|NCT00546377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841335|NCT00546377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841336|NCT00546377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101841337|NCT00546377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101841338|NCT00546377|Analgesics|analgesics|mesh-ancestor
101841339|NCT00546377|Sensory System Agents|sensory system agents|mesh-ancestor
101841340|NCT00546377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101841341|NCT00546377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101841342|NCT00546377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101841343|NCT00546377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841344|NCT00546377|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
101841345|NCT00967967|Mometasone Furoate|mometasone furoate|mesh-list
101841346|NCT00967967|Desloratadine|desloratadine|mesh-list
101841347|NCT00967967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101841348|NCT00967967|Dermatologic Agents|dermatologic agents|mesh-ancestor
101841349|NCT00967967|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101841350|NCT00967967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101841351|NCT00967967|Cholinergic Agents|cholinergic agents|mesh-ancestor
101841352|NCT00967967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101841353|NCT00967967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841354|NCT00967967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841355|NCT00967967|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101841356|NCT00967967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101841357|NCT00967967|Histamine Antagonists|histamine antagonists|mesh-ancestor
101841358|NCT00967967|Histamine Agents|histamine agents|mesh-ancestor
101841359|NCT00964457|Cetuximab|cetuximab|mesh-list
101841360|NCT00964457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101841361|NCT00964457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841362|NCT00964535|Budesonide|budesonide|mesh-list
101841363|NCT00964535|Formoterol Fumarate|formoterol fumarate|mesh-list
101685824|NCT00616850|Sensory System Agents|sensory system agents|mesh-ancestor
101841364|NCT00964535|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101841366|NCT00964535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101841367|NCT00964535|Autonomic Agents|autonomic agents|mesh-ancestor
101841368|NCT00964535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101841369|NCT00964535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841370|NCT00964535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101841371|NCT00964535|Respiratory System Agents|respiratory system agents|mesh-ancestor
101841372|NCT00964535|Glucocorticoids|glucocorticoids|mesh-ancestor
101841373|NCT00964535|Hormones|hormones|mesh-ancestor
101841374|NCT00964535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101841375|NCT00964535|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101841376|NCT00964535|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101841377|NCT00964535|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101841378|NCT00964535|Adrenergic Agents|adrenergic agents|mesh-ancestor
101841379|NCT00964535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101841380|NCT00964535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841381|NCT00964691|Chloroquine|chloroquine|mesh-list
101841382|NCT00964691|Pyrimethamine|pyrimethamine|mesh-list
101841383|NCT00964691|Sulfadoxine|sulfadoxine|mesh-list
101841384|NCT00964691|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101841385|NCT00964691|Amebicides|amebicides|mesh-ancestor
101841386|NCT00964691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101841387|NCT00964691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101841388|NCT00964691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101841389|NCT00964691|Antimalarials|antimalarials|mesh-ancestor
101841390|NCT00964691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101841391|NCT00964691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101841392|NCT00964691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841393|NCT00964691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841394|NCT00964691|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101841395|NCT00964769|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101841396|NCT00964769|Immunologic Factors|immunologic factors|mesh-ancestor
101841397|NCT00964769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841398|NCT00968435|Bevacizumab|bevacizumab|mesh-list
101841399|NCT00968435|Cetuximab|cetuximab|mesh-list
101841400|NCT00968435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101841401|NCT00968435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841402|NCT00968435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101841403|NCT00968435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101841404|NCT00968435|Growth Substances|growth substances|mesh-ancestor
101841405|NCT00968435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841406|NCT00968435|Growth Inhibitors|growth inhibitors|mesh-ancestor
101841407|NCT05253287|Hormones|hormones|mesh-list
101841408|NCT05253287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101841409|NCT05253287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841410|NCT00968591|Everolimus|everolimus|mesh-list
101841411|NCT00968591|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101841412|NCT00968591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101841413|NCT00968591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841414|NCT00968591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841415|NCT00968591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101841416|NCT00968591|Immunologic Factors|immunologic factors|mesh-ancestor
101841417|NCT00968591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841418|NCT00968591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841419|NCT00968903|Methylprednisolone|methylprednisolone|mesh-list
101841420|NCT00968903|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101841421|NCT00968903|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101841422|NCT00968903|Prednisolone|prednisolone|mesh-list
101841423|NCT00968903|Prednisolone acetate|prednisolone acetate|mesh-list
101841424|NCT00968903|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101841425|NCT00968903|Prednisolone phosphate|prednisolone phosphate|mesh-list
101841426|NCT00968903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101841427|NCT00968903|Antiemetics|antiemetics|mesh-ancestor
101841428|NCT00968903|Autonomic Agents|autonomic agents|mesh-ancestor
101841429|NCT00968903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101841430|NCT00968903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841431|NCT00968903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101841432|NCT00968903|Glucocorticoids|glucocorticoids|mesh-ancestor
101841433|NCT00968903|Hormones|hormones|mesh-ancestor
101685827|NCT00616850|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101841434|NCT00968903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101841435|NCT00968903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101841436|NCT00968903|Protective Agents|protective agents|mesh-ancestor
101841437|NCT00968903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101841438|NCT00968903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841439|NCT00969137|Nicotine|nicotine|mesh-list
101841440|NCT00969137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101841441|NCT00969137|Autonomic Agents|autonomic agents|mesh-ancestor
101841442|NCT00969137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101841443|NCT00969137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841444|NCT00969137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101841445|NCT00969137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101841446|NCT00969137|Cholinergic Agents|cholinergic agents|mesh-ancestor
101841447|NCT00969137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101841448|NCT00969137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841449|NCT00965315|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101841450|NCT00965315|Fenofibrate|fenofibrate|mesh-list
101841451|NCT00965315|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101841452|NCT00965315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101841453|NCT00965315|Antimetabolites|antimetabolites|mesh-ancestor
101841454|NCT00965315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841455|NCT00965315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101841456|NCT00965315|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101841457|NCT00965315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841458|NCT00969293|Ecallantide|ecallantide|mesh-list
101841459|NCT00969293|Analgesics|analgesics|mesh-ancestor
101841460|NCT00969293|Sensory System Agents|sensory system agents|mesh-ancestor
101841461|NCT00969293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101841462|NCT00969293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841463|NCT00969293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101841464|NCT00969293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101841465|NCT00969293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101841466|NCT00969293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101841467|NCT00969449|Naproxen|naproxen|mesh-list
101841468|NCT00969449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101841469|NCT00969449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101841470|NCT00969449|Analgesics|analgesics|mesh-ancestor
101841471|NCT00969449|Sensory System Agents|sensory system agents|mesh-ancestor
101841472|NCT00969449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101841473|NCT00969449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841474|NCT00969449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101841475|NCT00969449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101841476|NCT00969449|Gout Suppressants|gout suppressants|mesh-ancestor
101841477|NCT00969449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101841478|NCT00969449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841479|NCT00969449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841480|NCT00965393|Bradykinin|bradykinin|mesh-list
101841481|NCT00965393|Kininogens|kininogens|mesh-list
101841482|NCT00965393|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-list
101841483|NCT00965393|Vasodilator Agents|vasodilator agents|mesh-ancestor
101841484|NCT00965393|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
101841485|NCT00965393|Protease Inhibitors|protease inhibitors|mesh-ancestor
101841486|NCT00965393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841487|NCT00965393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841488|NCT00965549|Insulin|insulin|mesh-list
101841489|NCT00965549|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101841490|NCT00965549|Insulin Glargine|insulin glargine|mesh-list
101841491|NCT00965549|Insulin Aspart|insulin aspart|mesh-list
101841492|NCT00965549|Insulin glulisine|insulin glulisine|mesh-list
101841493|NCT00965549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101841494|NCT00965549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841495|NCT00966251|Pidilizumab|pidilizumab|mesh-list
101841496|NCT00966251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101841497|NCT00966251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841498|NCT00966329|Maraviroc|maraviroc|mesh-list
101841499|NCT00966329|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101841500|NCT00966329|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101841501|NCT00966329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841502|NCT00966329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101841503|NCT00966329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101841504|NCT00966329|Antiviral Agents|antiviral agents|mesh-ancestor
101841505|NCT00966329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101841506|NCT00966329|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101841507|NCT00970697|Becaplermin|becaplermin|mesh-list
101841508|NCT00970697|Anticoagulants|anticoagulants|mesh-ancestor
101841509|NCT00970697|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
101841510|NCT00970697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101841511|NCT00970697|Growth Substances|growth substances|mesh-ancestor
101841512|NCT00970697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841513|NCT00967031|Capecitabine|capecitabine|mesh-list
101841514|NCT00967031|Lapatinib|lapatinib|mesh-list
101841515|NCT00967031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101841516|NCT00967031|Antimetabolites|antimetabolites|mesh-ancestor
101841517|NCT00967031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841518|NCT00967031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841519|NCT00967031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101841520|NCT00967031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841521|NCT00967109|Chrysarobin|chrysarobin|mesh-list
101841522|NCT00967109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101841523|NCT00967109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101841524|NCT00967109|Analgesics|analgesics|mesh-ancestor
101841525|NCT00967109|Sensory System Agents|sensory system agents|mesh-ancestor
101841526|NCT00967109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101841527|NCT00967109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841528|NCT00967109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101841529|NCT00967109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101841530|NCT00545753|Permethrin|permethrin|mesh-list
101841531|NCT00545753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841532|NCT00545753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841533|NCT00970931|Chlorthalidone|chlorthalidone|mesh-list
101841534|NCT00970931|Amiloride|amiloride|mesh-list
101841535|NCT00970931|Diuretics|diuretics|mesh-list
101841536|NCT00970931|Natriuretic Agents|natriuretic agents|mesh-ancestor
101841537|NCT00970931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841538|NCT00970931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101841539|NCT00970931|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101841540|NCT00970931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101841541|NCT00970931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841542|NCT00970931|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
101841543|NCT00970931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101841544|NCT00970931|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101841545|NCT00970931|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101841546|NCT00406419|Methotrexate|methotrexate|mesh-list
101841547|NCT00406419|Ocrelizumab|ocrelizumab|mesh-list
101841548|NCT00406419|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101841549|NCT00406419|Abortifacient Agents|abortifacient agents|mesh-ancestor
101841550|NCT00406419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101841551|NCT00406419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841552|NCT00406419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101841553|NCT00406419|Antimetabolites|antimetabolites|mesh-ancestor
101841554|NCT00406419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841555|NCT00406419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841556|NCT00406419|Dermatologic Agents|dermatologic agents|mesh-ancestor
101841557|NCT00406419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841558|NCT00406419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101841559|NCT00406419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101841560|NCT00406419|Immunologic Factors|immunologic factors|mesh-ancestor
101841561|NCT00406419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101841562|NCT00406419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101841563|NCT00967421|Ethanol|ethanol|mesh-list
101841564|NCT00967421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101841565|NCT00967421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101841566|NCT00967421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101841567|NCT00967421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841568|NCT00971165|Losartan|losartan|mesh-list
101841569|NCT00971165|Chlorthalidone|chlorthalidone|mesh-list
101841570|NCT00971165|Amiloride|amiloride|mesh-list
101841571|NCT00971165|Diuretics|diuretics|mesh-list
101841572|NCT00971165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101841573|NCT00971165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101841574|NCT00971165|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101841575|NCT00971165|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101841576|NCT00971165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841577|NCT00971165|Natriuretic Agents|natriuretic agents|mesh-ancestor
101841578|NCT00971165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841579|NCT00971165|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101841580|NCT00971165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101841581|NCT00971165|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
101841582|NCT00971165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101841583|NCT00971165|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101841584|NCT00971165|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101841585|NCT00971399|Ondansetron|ondansetron|mesh-list
101841586|NCT00971399|Ramosetron|ramosetron|mesh-list
101841587|NCT00971399|Antiemetics|antiemetics|mesh-ancestor
101841588|NCT00971399|Autonomic Agents|autonomic agents|mesh-ancestor
101841589|NCT00971399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101841590|NCT00971399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841591|NCT00971399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101841592|NCT00971399|Antipruritics|antipruritics|mesh-ancestor
101841593|NCT00971399|Dermatologic Agents|dermatologic agents|mesh-ancestor
101841594|NCT00971399|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101841595|NCT00971399|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101841596|NCT00971399|Serotonin Agents|serotonin agents|mesh-ancestor
101841597|NCT00971399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101841598|NCT00971399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841599|NCT00973505|Anastrozole|anastrozole|mesh-list
101841600|NCT00973505|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101841601|NCT00973505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841602|NCT00973505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101841603|NCT00973505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841604|NCT00973505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841605|NCT00973505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101841606|NCT00973505|Hormone Antagonists|hormone antagonists|mesh-ancestor
101841607|NCT00973505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101841608|NCT00973505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841609|NCT00973505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101841610|NCT00973583|Vitamin D|vitamin d|mesh-list
101841611|NCT00973583|Vitamins|vitamins|mesh-ancestor
101841612|NCT00973583|Micronutrients|micronutrients|mesh-ancestor
101841613|NCT00973583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841614|NCT00973583|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101841615|NCT00972101|Mycophenolic Acid|mycophenolic acid|mesh-list
101841616|NCT00972101|Rituximab|rituximab|mesh-list
101841617|NCT00972101|Fludarabine|fludarabine|mesh-list
101841618|NCT00972101|Fludarabine phosphate|fludarabine phosphate|mesh-list
101841619|NCT00972101|Etoposide|etoposide|mesh-list
101841620|NCT00972101|Melphalan|melphalan|mesh-list
101841621|NCT00972101|Thiotepa|thiotepa|mesh-list
101841622|NCT00972101|Tacrolimus|tacrolimus|mesh-list
101841623|NCT00972101|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101841624|NCT00972101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101841625|NCT00972101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841626|NCT00972101|Immunologic Factors|immunologic factors|mesh-ancestor
101841627|NCT00972101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841628|NCT00972101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101841629|NCT00972101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101841630|NCT00972101|Antimetabolites|antimetabolites|mesh-ancestor
101841631|NCT00972101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841632|NCT00972101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101841633|NCT00972101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101841634|NCT00972101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101841635|NCT00972101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101841636|NCT00972101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101841637|NCT00972101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841638|NCT00972101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101841639|NCT00972101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101841640|NCT00972101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101841641|NCT00972101|Antitubercular Agents|antitubercular agents|mesh-ancestor
101841642|NCT00972101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101841643|NCT00972101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101841644|NCT00972101|Alkylating Agents|alkylating agents|mesh-ancestor
101841645|NCT00972101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101841646|NCT00325468|Denosumab|denosumab|mesh-list
101841647|NCT00325468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101841648|NCT00325468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841649|NCT00972257|Timolol|timolol|mesh-list
101841650|NCT00972257|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101841651|NCT00972257|Dorzolamide|dorzolamide|mesh-list
101841652|NCT00972257|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101841653|NCT00972257|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101841654|NCT00972257|Adrenergic Agents|adrenergic agents|mesh-ancestor
101841655|NCT00972257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101841656|NCT00972257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841657|NCT00972257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841659|NCT00972257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101841660|NCT00972257|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101841661|NCT00972257|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101841662|NCT00972257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101841663|NCT00972257|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101841664|NCT00972257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841665|NCT00311584|Irinotecan|irinotecan|mesh-list
101841666|NCT00311584|Temozolomide|temozolomide|mesh-list
101841667|NCT00311584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101841668|NCT00311584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101841669|NCT00311584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841670|NCT00311584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841671|NCT00311584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841672|NCT00311584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101841673|NCT00311584|Alkylating Agents|alkylating agents|mesh-ancestor
101841674|NCT00383331|Gemcitabine|gemcitabine|mesh-list
101841675|NCT00383331|Pemetrexed|pemetrexed|mesh-list
101841676|NCT00383331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101841677|NCT00383331|Antimetabolites|antimetabolites|mesh-ancestor
101841678|NCT00383331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841679|NCT00383331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841680|NCT00383331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841681|NCT00383331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101841682|NCT00383331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101841683|NCT03934541|Vaccines|vaccines|mesh-list
101841684|NCT03934541|Immunologic Factors|immunologic factors|mesh-ancestor
101841685|NCT03934541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841686|NCT00325234|Carboplatin|carboplatin|mesh-list
101841687|NCT00325234|Gemcitabine|gemcitabine|mesh-list
101841688|NCT00325234|Pemetrexed|pemetrexed|mesh-list
101841689|NCT00325234|Vinorelbine|vinorelbine|mesh-list
101841690|NCT00325234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841691|NCT00325234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101841692|NCT00325234|Antimetabolites|antimetabolites|mesh-ancestor
101841693|NCT00325234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841694|NCT00325234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841695|NCT00325234|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101841696|NCT00325234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101841697|NCT00325234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101841698|NCT00325234|Tubulin Modulators|tubulin modulators|mesh-ancestor
101841699|NCT00325234|Antimitotic Agents|antimitotic agents|mesh-ancestor
101841700|NCT00325234|Mitosis Modulators|mitosis modulators|mesh-ancestor
101841701|NCT01063504|Teriparatide|teriparatide|mesh-list
101841702|NCT01063504|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101841703|NCT01063504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841704|NCT01063504|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101841705|NCT00366249|Ertapenem|ertapenem|mesh-list
101841706|NCT00366249|Tigecycline|tigecycline|mesh-list
101841707|NCT00366249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101841708|NCT00366249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101841709|NCT00366249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101841710|NCT00366249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841711|NCT00366249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841712|NCT03927911|Bupivacaine|bupivacaine|mesh-list
101841713|NCT03927911|Anesthetics, Local|anesthetics, local|mesh-ancestor
101841714|NCT03927911|Anesthetics|anesthetics|mesh-ancestor
101841715|NCT03927911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101841716|NCT03927911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841717|NCT03927911|Sensory System Agents|sensory system agents|mesh-ancestor
101841718|NCT03927911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101841719|NCT00383019|Latanoprost|latanoprost|mesh-list
101841720|NCT00383019|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101841721|NCT00383019|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101841722|NCT00310804|Vaccines|vaccines|mesh-list
101841723|NCT00310804|Immunologic Factors|immunologic factors|mesh-ancestor
101841724|NCT00310804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841725|NCT00590187|Sapacitabine|sapacitabine|mesh-list
101841726|NCT00590187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841727|NCT03978364|Azacitidine|azacitidine|mesh-list
101561511|NCT05276206|Anesthetics|anesthetics|mesh-list
101841728|NCT03978364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101841729|NCT03978364|Antimetabolites|antimetabolites|mesh-ancestor
101841730|NCT03978364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841731|NCT03978364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841732|NCT03978364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841733|NCT01046487|Cyclophosphamide|cyclophosphamide|mesh-list
101841734|NCT01046487|Imatinib Mesylate|imatinib mesylate|mesh-list
101841735|NCT01046487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101841736|NCT01046487|Immunologic Factors|immunologic factors|mesh-ancestor
101841737|NCT01046487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841738|NCT01046487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101841739|NCT01046487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101841740|NCT01046487|Alkylating Agents|alkylating agents|mesh-ancestor
101841741|NCT01046487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841742|NCT01046487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841743|NCT01046487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101841744|NCT01046487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101841745|NCT01046487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841746|NCT03978286|Vortioxetine|vortioxetine|mesh-list
101841747|NCT03978286|Sertraline|sertraline|mesh-list
101841748|NCT03978286|Antidepressive Agents|antidepressive agents|mesh-ancestor
101841749|NCT03978286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101841750|NCT03978286|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101841751|NCT03978286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101841752|NCT03978286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101841753|NCT03978286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841754|NCT03978286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101841755|NCT03978286|Serotonin Agents|serotonin agents|mesh-ancestor
101841756|NCT03978286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841757|NCT03978286|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101841758|NCT03978286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101841759|NCT03978286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101841760|NCT03978286|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101841761|NCT03978286|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101841762|NCT03978286|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101841763|NCT03978286|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101841764|NCT03933449|Paclitaxel|paclitaxel|mesh-list
101841765|NCT03933449|Docetaxel|docetaxel|mesh-list
101841766|NCT03933449|Pembrolizumab|pembrolizumab|mesh-list
101841767|NCT03933449|Irinotecan|irinotecan|mesh-list
101841768|NCT03933449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101841769|NCT03933449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841770|NCT03933449|Tubulin Modulators|tubulin modulators|mesh-ancestor
101841771|NCT03933449|Antimitotic Agents|antimitotic agents|mesh-ancestor
101841772|NCT03933449|Mitosis Modulators|mitosis modulators|mesh-ancestor
101841773|NCT03933449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841774|NCT03933449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101841775|NCT03933449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101841776|NCT03933449|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101841777|NCT03933449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101841778|NCT03933449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841779|NCT00974441|Valproic Acid|valproic acid|mesh-list
101841780|NCT00974441|Anticonvulsants|anticonvulsants|mesh-ancestor
101841781|NCT00974441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841782|NCT00974441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841783|NCT00974441|GABA Agents|gaba agents|mesh-ancestor
101841784|NCT00974441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101841785|NCT00974441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841786|NCT00974441|Antimanic Agents|antimanic agents|mesh-ancestor
101841787|NCT00974441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101841788|NCT00974441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101841789|NCT00974441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101841790|NCT01049451|Methylprednisolone|methylprednisolone|mesh-list
101841791|NCT01049451|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101841792|NCT01049451|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101841793|NCT01049451|Prednisolone|prednisolone|mesh-list
101841794|NCT01049451|Prednisolone acetate|prednisolone acetate|mesh-list
101841795|NCT01049451|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101841796|NCT01049451|Prednisolone phosphate|prednisolone phosphate|mesh-list
101841797|NCT01049451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101841798|NCT01049451|Antiemetics|antiemetics|mesh-ancestor
101841799|NCT01049451|Autonomic Agents|autonomic agents|mesh-ancestor
101841800|NCT01049451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101841801|NCT01049451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841802|NCT01049451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101561578|NCT05054842|Metformin|metformin|mesh-list
101841803|NCT01049451|Glucocorticoids|glucocorticoids|mesh-ancestor
101841804|NCT01049451|Hormones|hormones|mesh-ancestor
101841805|NCT01049451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101841806|NCT01049451|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101841807|NCT01049451|Protective Agents|protective agents|mesh-ancestor
101841808|NCT01049451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101841809|NCT01049451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841810|NCT00972569|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101841811|NCT00972569|Natriuretic Agents|natriuretic agents|mesh-ancestor
101841812|NCT00972569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841813|NCT00974753|Ketorolac|ketorolac|mesh-list
101841814|NCT00974753|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101841815|NCT00974753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101841816|NCT00974753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101841817|NCT00974753|Analgesics|analgesics|mesh-ancestor
101841818|NCT00974753|Sensory System Agents|sensory system agents|mesh-ancestor
101841819|NCT00974753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101841820|NCT00974753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841821|NCT00974753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101841822|NCT00974753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101841823|NCT00974753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101841824|NCT00974753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841825|NCT00974753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841826|NCT00972803|Chlorhexidine|chlorhexidine|mesh-list
101841827|NCT00972803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101841828|NCT00972803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101841829|NCT00972803|Disinfectants|disinfectants|mesh-ancestor
101841830|NCT02908269|Vaccines|vaccines|mesh-list
101841831|NCT02908269|Immunologic Factors|immunologic factors|mesh-ancestor
101841832|NCT02908269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841833|NCT00974987|Temozolomide|temozolomide|mesh-list
101841834|NCT00974987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101841835|NCT00974987|Alkylating Agents|alkylating agents|mesh-ancestor
101841836|NCT00974987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841837|NCT00974987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841838|NCT00975065|Metformin|metformin|mesh-list
101841839|NCT00975065|Vildagliptin|vildagliptin|mesh-list
101841840|NCT00975065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101841841|NCT00975065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841842|NCT00975065|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101841843|NCT00975065|Protease Inhibitors|protease inhibitors|mesh-ancestor
101841844|NCT00975065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841845|NCT00975065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841846|NCT00972881|Capecitabine|capecitabine|mesh-list
101841847|NCT00972881|Irinotecan|irinotecan|mesh-list
101841848|NCT00972881|Cetuximab|cetuximab|mesh-list
101841849|NCT00972881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101841850|NCT00972881|Antimetabolites|antimetabolites|mesh-ancestor
101841851|NCT00972881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841852|NCT00972881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841853|NCT00972881|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101841854|NCT00972881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101841855|NCT00972881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841856|NCT00972881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101841857|NCT00290758|Genistein|genistein|mesh-list
101841858|NCT00290758|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101841859|NCT00290758|Protective Agents|protective agents|mesh-ancestor
101841860|NCT00290758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841861|NCT00290758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841862|NCT00290758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101841863|NCT00290758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841864|NCT00290758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841865|NCT00290758|Phytoestrogens|phytoestrogens|mesh-ancestor
101841866|NCT00290758|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101841868|NCT00290758|Hormones|hormones|mesh-ancestor
101841869|NCT00290758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101841870|NCT00975299|Bombesin|bombesin|mesh-list
101841871|NCT00975299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101841872|NCT00975299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841873|NCT00975299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841874|NCT01060930|Epinephrine|epinephrine|mesh-list
101841875|NCT01060930|Norepinephrine|norepinephrine|mesh-list
101841876|NCT01060930|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
101841877|NCT01060930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101561653|NCT04616534|Gemcitabine|gemcitabine|mesh-list
101841878|NCT01060930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101841879|NCT01060930|Adrenergic Agents|adrenergic agents|mesh-ancestor
101841880|NCT01060930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101841881|NCT01060930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841882|NCT01060930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841883|NCT01060930|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101841884|NCT01060930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101841885|NCT01060930|Autonomic Agents|autonomic agents|mesh-ancestor
101841886|NCT01060930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101841887|NCT01060930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101841888|NCT01060930|Respiratory System Agents|respiratory system agents|mesh-ancestor
101841889|NCT01060930|Mydriatics|mydriatics|mesh-ancestor
101841890|NCT01060930|Sympathomimetics|sympathomimetics|mesh-ancestor
101841891|NCT01060930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101841892|NCT01060930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841893|NCT00973037|Tamoxifen|tamoxifen|mesh-list
101841894|NCT00973037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101841895|NCT00973037|Hormone Antagonists|hormone antagonists|mesh-ancestor
101841896|NCT00973037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101237546|NCT04551885|Aldesleukin|aldesleukin|mesh-list
101841897|NCT00973037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841898|NCT00973037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101841899|NCT00973037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841900|NCT00973037|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101841901|NCT00973037|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101841902|NCT00973037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101841903|NCT00973115|Simvastatin|simvastatin|mesh-list
101841904|NCT00973115|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101841905|NCT00973115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101841906|NCT00973115|Antimetabolites|antimetabolites|mesh-ancestor
101841907|NCT00973115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841908|NCT00973115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101841909|NCT00973115|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101841910|NCT00973115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841911|NCT00973193|Panitumumab|panitumumab|mesh-list
101841912|NCT00973193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101841913|NCT00973193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841914|NCT00975533|Insulin|insulin|mesh-list
101841915|NCT00975533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101841916|NCT00975533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841917|NCT00372567|Sunitinib|sunitinib|mesh-list
101841918|NCT00372567|Imatinib Mesylate|imatinib mesylate|mesh-list
101841919|NCT00372567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841920|NCT00372567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101841921|NCT00372567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101841922|NCT00372567|Growth Substances|growth substances|mesh-ancestor
101841923|NCT00372567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841924|NCT00372567|Growth Inhibitors|growth inhibitors|mesh-ancestor
101841925|NCT00372567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101841926|NCT00372567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841927|NCT00372567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841928|NCT00973271|Atorvastatin|atorvastatin|mesh-list
101841929|NCT00973271|Fenofibric acid|fenofibric acid|mesh-list
101841930|NCT00973271|Fenofibrate|fenofibrate|mesh-list
101841931|NCT00973271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101841932|NCT00973271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101841933|NCT00973271|Antimetabolites|antimetabolites|mesh-ancestor
101841934|NCT00973271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841935|NCT00973271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101841936|NCT00973271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101841937|NCT00973271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841938|NCT00975767|Docetaxel|docetaxel|mesh-list
101841939|NCT00975767|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101841940|NCT00975767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841942|NCT00975767|Antimitotic Agents|antimitotic agents|mesh-ancestor
101841943|NCT00975767|Mitosis Modulators|mitosis modulators|mesh-ancestor
101841944|NCT00975767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841945|NCT00975767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101841946|NCT00975767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841947|NCT00365547|Bevacizumab|bevacizumab|mesh-list
101841949|NCT00365547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101841950|NCT00365547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841951|NCT00365547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101841952|NCT00365547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101841953|NCT00365547|Growth Substances|growth substances|mesh-ancestor
101841954|NCT00365547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841955|NCT00365547|Growth Inhibitors|growth inhibitors|mesh-ancestor
101841956|NCT00365547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101841957|NCT00365547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101841958|NCT00365547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841959|NCT00365547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841960|NCT00979589|Aspirin|aspirin|mesh-list
101841961|NCT00979589|Clopidogrel|clopidogrel|mesh-list
101841962|NCT00979589|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101841963|NCT00979589|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101841964|NCT00979589|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101841965|NCT00979589|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101841966|NCT00979589|Purinergic Agents|purinergic agents|mesh-ancestor
101841967|NCT00979589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101841968|NCT00979589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841969|NCT00979589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841970|NCT00979589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101841971|NCT00979589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101841972|NCT00979589|Analgesics|analgesics|mesh-ancestor
101841973|NCT00979589|Sensory System Agents|sensory system agents|mesh-ancestor
101841974|NCT00979589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101841975|NCT00979589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101841976|NCT00979589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101841977|NCT00979589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101841978|NCT00979589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101841979|NCT00979589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101841980|NCT00979589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841981|NCT00979589|Antipyretics|antipyretics|mesh-ancestor
101841982|NCT00294658|Prednisone|prednisone|mesh-list
101841983|NCT00294658|Prednisolone|prednisolone|mesh-list
101841984|NCT00294658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101841985|NCT00294658|Glucocorticoids|glucocorticoids|mesh-ancestor
101841986|NCT00294658|Hormones|hormones|mesh-ancestor
101841987|NCT00294658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101841988|NCT00294658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101841989|NCT00294658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101841990|NCT00294658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101841991|NCT00979667|Oseltamivir|oseltamivir|mesh-list
101841992|NCT00979667|Zanamivir|zanamivir|mesh-list
101841993|NCT00979667|Antiviral Agents|antiviral agents|mesh-ancestor
101841994|NCT00979667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101841995|NCT00979667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101841996|NCT00979667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101841997|NCT03978052|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
101841998|NCT03978052|Antioxidants|antioxidants|mesh-ancestor
101841999|NCT03978052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842000|NCT03978052|Protective Agents|protective agents|mesh-ancestor
101842001|NCT03978052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842002|NCT03978052|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101842003|NCT03978052|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101842004|NCT03978052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101842005|NCT03978052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101842006|NCT03923933|Chlorthalidone|chlorthalidone|mesh-list
101842007|NCT03923933|Bumetanide|bumetanide|mesh-list
101842008|NCT03923933|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101842009|NCT03923933|Diuretics|diuretics|mesh-ancestor
101842010|NCT03923933|Natriuretic Agents|natriuretic agents|mesh-ancestor
101842012|NCT03923933|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101842013|NCT03923933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101842014|NCT03923933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842016|NCT01066468|Imatinib Mesylate|imatinib mesylate|mesh-list
101842017|NCT01066468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101842018|NCT01066468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101842019|NCT01066468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101842020|NCT01066468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842021|NCT00980135|Hydrocortisone|hydrocortisone|mesh-list
101842022|NCT00980135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101842023|NCT00980213|Sunitinib|sunitinib|mesh-list
101842024|NCT00980213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561811|NCT04268498|Anesthetics|anesthetics|mesh-ancestor
101842026|NCT00980213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101842027|NCT00980213|Growth Substances|growth substances|mesh-ancestor
101842028|NCT00980213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842029|NCT00980213|Growth Inhibitors|growth inhibitors|mesh-ancestor
101842030|NCT00980213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101842031|NCT00980213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101842032|NCT00980213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842033|NCT00976469|Vaccines|vaccines|mesh-list
101842034|NCT00976469|Immunologic Factors|immunologic factors|mesh-ancestor
101842035|NCT00976469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842036|NCT00980603|Docetaxel|docetaxel|mesh-list
101842037|NCT00980603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101842038|NCT00980603|Tubulin Modulators|tubulin modulators|mesh-ancestor
101842039|NCT00980603|Antimitotic Agents|antimitotic agents|mesh-ancestor
101842040|NCT00980603|Mitosis Modulators|mitosis modulators|mesh-ancestor
101842041|NCT00980603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842042|NCT00274456|Paclitaxel|paclitaxel|mesh-list
101842043|NCT00274456|Docetaxel|docetaxel|mesh-list
101842044|NCT00274456|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101842045|NCT00274456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101842046|NCT00274456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101842047|NCT00274456|Tubulin Modulators|tubulin modulators|mesh-ancestor
101842048|NCT00274456|Antimitotic Agents|antimitotic agents|mesh-ancestor
101842049|NCT00274456|Mitosis Modulators|mitosis modulators|mesh-ancestor
101842050|NCT00274456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842051|NCT00977093|Pentetic Acid|pentetic acid|mesh-list
101842052|NCT00977093|Antidotes|antidotes|mesh-ancestor
101842053|NCT00977093|Protective Agents|protective agents|mesh-ancestor
101842054|NCT00977093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842055|NCT00977093|Chelating Agents|chelating agents|mesh-ancestor
101842056|NCT00977093|Sequestering Agents|sequestering agents|mesh-ancestor
101842057|NCT00977093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842058|NCT00977093|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101842059|NCT00977249|Varenicline|varenicline|mesh-list
101842060|NCT00977249|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101842061|NCT00977249|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101842062|NCT00977249|Cholinergic Agents|cholinergic agents|mesh-ancestor
101842063|NCT00977249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101842064|NCT00977249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842065|NCT00977249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842066|NCT01069822|Midazolam|midazolam|mesh-list
101842067|NCT01069822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101842068|NCT01069822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101842069|NCT01069822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101842070|NCT01069822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842071|NCT01069822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101842072|NCT01069822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101842073|NCT01069822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101842074|NCT01069822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101842075|NCT01069822|Anesthetics, General|anesthetics, general|mesh-ancestor
101842076|NCT01069822|Anesthetics|anesthetics|mesh-ancestor
101842077|NCT01069822|GABA Modulators|gaba modulators|mesh-ancestor
101842078|NCT01069822|GABA Agents|gaba agents|mesh-ancestor
101842079|NCT01069822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101842080|NCT01069822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842081|NCT00364923|10-deazaaminopterin|10-deazaaminopterin|mesh-list
101842082|NCT00364923|Aminopterin|aminopterin|mesh-list
101842083|NCT00364923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101842084|NCT00364923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101963556|NCT02193256|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101842085|NCT00364923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842086|NCT00364923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101842088|NCT00273052|Carvedilol|carvedilol|mesh-list
101842089|NCT00273052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101842090|NCT00273052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101842091|NCT00273052|Sympatholytics|sympatholytics|mesh-ancestor
101842092|NCT00273052|Autonomic Agents|autonomic agents|mesh-ancestor
101842093|NCT00273052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101842094|NCT00273052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842095|NCT00273052|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101842096|NCT00273052|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101842097|NCT00273052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101842098|NCT00273052|Adrenergic Agents|adrenergic agents|mesh-ancestor
101842099|NCT00273052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101842100|NCT00273052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842101|NCT00273052|Antioxidants|antioxidants|mesh-ancestor
101842102|NCT00273052|Protective Agents|protective agents|mesh-ancestor
101842103|NCT00273052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101842104|NCT00273052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101842105|NCT00273052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101842106|NCT00273052|Vasodilator Agents|vasodilator agents|mesh-ancestor
101842107|NCT00273052|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101842108|NCT00273052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101842109|NCT01046721|Exenatide|exenatide|mesh-list
101842110|NCT01046721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101842111|NCT01046721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842112|NCT01046721|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101842113|NCT01046721|Incretins|incretins|mesh-ancestor
101842114|NCT01046721|Hormones|hormones|mesh-ancestor
101842115|NCT01046721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101842116|NCT01046799|Entecavir|entecavir|mesh-list
101842117|NCT01046799|Antiviral Agents|antiviral agents|mesh-ancestor
101842118|NCT01046799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101842119|NCT00290290|Chlorhexidine|chlorhexidine|mesh-list
101842120|NCT00290290|Povidone-Iodine|povidone-iodine|mesh-list
101842121|NCT00290290|Povidone|povidone|mesh-list
101842122|NCT00290290|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101842123|NCT00290290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101842124|NCT00290290|Disinfectants|disinfectants|mesh-ancestor
101842125|NCT00290290|Plasma Substitutes|plasma substitutes|mesh-ancestor
101842126|NCT00290290|Blood Substitutes|blood substitutes|mesh-ancestor
101842127|NCT01049685|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101842128|NCT01049685|Antiviral Agents|antiviral agents|mesh-ancestor
101842129|NCT01049685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101842130|NCT01580943|Chlorhexidine|chlorhexidine|mesh-list
101842131|NCT01580943|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101842132|NCT01580943|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101842133|NCT01580943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101842134|NCT01580943|Disinfectants|disinfectants|mesh-ancestor
101842135|NCT01580943|Dermatologic Agents|dermatologic agents|mesh-ancestor
101842136|NCT02534961|Cefazolin|cefazolin|mesh-list
101842137|NCT02534961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101842138|NCT02534961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101842139|NCT01046955|Alemtuzumab|alemtuzumab|mesh-list
101842140|NCT01046955|Thymoglobulin|thymoglobulin|mesh-list
101842141|NCT01046955|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101842142|NCT01046955|Daclizumab|daclizumab|mesh-list
101842143|NCT01046955|Immunologic Factors|immunologic factors|mesh-ancestor
101842144|NCT01046955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842145|NCT01046955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101842146|NCT01046955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101842147|NCT01046955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101842148|NCT00272038|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101842149|NCT00272038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101842150|NCT00272038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101842151|NCT00272038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101842152|NCT00272038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842153|NCT00271024|Naltrexone|naltrexone|mesh-list
101842154|NCT00271024|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101842155|NCT00271024|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101842156|NCT00271024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259908|NCT01741558|Vitamins|vitamins|mesh-ancestor
101842158|NCT00271024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101842159|NCT00381693|Azacitidine|azacitidine|mesh-list
101842160|NCT00381693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101842161|NCT00381693|Antimetabolites|antimetabolites|mesh-ancestor
101842162|NCT00381693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842163|NCT00381693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101842164|NCT00381693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101842165|NCT00545363|Ibandronic Acid|ibandronic acid|mesh-list
101842166|NCT00545363|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101842167|NCT00545363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842168|NCT00977405|Gentamicins|gentamicins|mesh-list
101842169|NCT00977405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101842170|NCT00977405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101842171|NCT00977405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101842172|NCT00977405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101842173|NCT00977405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561954|NCT03906136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101842174|NCT00977795|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101842175|NCT00977795|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101842176|NCT00977795|Dermatologic Agents|dermatologic agents|mesh-ancestor
101842177|NCT00977873|Cholecalciferol|cholecalciferol|mesh-list
101842178|NCT00977873|Vitamin D|vitamin d|mesh-list
101842179|NCT00977873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101842180|NCT00977873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842181|NCT00977873|Vitamins|vitamins|mesh-ancestor
101842182|NCT00977873|Micronutrients|micronutrients|mesh-ancestor
101842183|NCT00977873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101842184|NCT00457392|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101842185|NCT00457392|Sunitinib|sunitinib|mesh-list
101842186|NCT00457392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101842187|NCT00457392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101842188|NCT00457392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101842189|NCT00457392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842190|NCT00457392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101842191|NCT00457392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101842192|NCT00457392|Growth Substances|growth substances|mesh-ancestor
101842193|NCT00457392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842194|NCT00457392|Growth Inhibitors|growth inhibitors|mesh-ancestor
101842195|NCT00545051|Ibandronic Acid|ibandronic acid|mesh-list
101842196|NCT00545051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101842197|NCT00545051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842198|NCT00381615|Vaccines|vaccines|mesh-list
101842199|NCT00381615|Immunologic Factors|immunologic factors|mesh-ancestor
101842200|NCT00381615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842201|NCT00978107|Flucytosine|flucytosine|mesh-list
101842202|NCT00978107|Antifungal Agents|antifungal agents|mesh-ancestor
101842203|NCT00978107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101842204|NCT00978107|Antimetabolites|antimetabolites|mesh-ancestor
101842205|NCT00978107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842206|NCT01029132|Galantamine|galantamine|mesh-list
101842207|NCT01029132|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101842208|NCT01029132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101237614|NCT03970200|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101842209|NCT01029132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842210|NCT01029132|Cholinergic Agents|cholinergic agents|mesh-ancestor
101842211|NCT01029132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101842212|NCT01029132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842213|NCT01029132|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101842214|NCT01029132|Autonomic Agents|autonomic agents|mesh-ancestor
101842215|NCT01029132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101842216|NCT01029132|Nootropic Agents|nootropic agents|mesh-ancestor
101842217|NCT04008017|Eosinophil Cationic Protein|eosinophil cationic protein|mesh-list
101842218|NCT04008017|Immunologic Factors|immunologic factors|mesh-ancestor
101842219|NCT04008017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842220|NCT01049763|Oseltamivir|oseltamivir|mesh-list
101842221|NCT01049763|Antiviral Agents|antiviral agents|mesh-ancestor
101842222|NCT01049763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101842223|NCT01049763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101842224|NCT01049763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842225|NCT00981773|Maraviroc|maraviroc|mesh-list
101842226|NCT00981773|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101842227|NCT00981773|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101963566|NCT03535558|Antimalarials|antimalarials|mesh-ancestor
101842228|NCT00981773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842230|NCT00981773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101842231|NCT00981773|Antiviral Agents|antiviral agents|mesh-ancestor
101842232|NCT00981773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101842233|NCT00981773|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101562029|NCT03401853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562030|NCT03281369|Leucovorin|leucovorin|mesh-list
101562031|NCT03281369|Linagliptin|linagliptin|mesh-list
101562032|NCT03281369|Paclitaxel|paclitaxel|mesh-list
101562033|NCT03281369|Fluorouracil|fluorouracil|mesh-list
101562034|NCT03281369|Oxaliplatin|oxaliplatin|mesh-list
101562035|NCT03281369|Atezolizumab|atezolizumab|mesh-list
101562036|NCT03281369|Ramucirumab|ramucirumab|mesh-list
101562037|NCT03281369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101562038|NCT03281369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101562039|NCT03281369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101562040|NCT03281369|Tubulin Modulators|tubulin modulators|mesh-ancestor
101562041|NCT03281369|Antimitotic Agents|antimitotic agents|mesh-ancestor
101562042|NCT03281369|Mitosis Modulators|mitosis modulators|mesh-ancestor
101562043|NCT03281369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562044|NCT03281369|Antimetabolites|antimetabolites|mesh-ancestor
101562045|NCT03281369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101842234|NCT01049841|Sirolimus|sirolimus|mesh-list
101842235|NCT01049841|Temsirolimus|temsirolimus|mesh-list
101842236|NCT01049841|MTOR Inhibitors|mtor inhibitors|mesh-list
101842237|NCT01049841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101842238|NCT01049841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101842239|NCT01049841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842240|NCT01049841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101842241|NCT01049841|Immunologic Factors|immunologic factors|mesh-ancestor
101842242|NCT01049841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842243|NCT01049841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101842244|NCT01049841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101842245|NCT01049841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101842246|NCT01049841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101842247|NCT01049841|Antifungal Agents|antifungal agents|mesh-ancestor
101842248|NCT00978263|Metformin|metformin|mesh-list
101842249|NCT00978263|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101842250|NCT00978263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842251|NCT00981851|Albuterol|albuterol|mesh-list
101842252|NCT00981851|Tiotropium Bromide|tiotropium bromide|mesh-list
101842253|NCT00981851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101842254|NCT00981851|Autonomic Agents|autonomic agents|mesh-ancestor
101842255|NCT00981851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101842256|NCT00981851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842257|NCT00981851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101237625|NCT03841110|Pembrolizumab|pembrolizumab|mesh-list
101842258|NCT00981851|Respiratory System Agents|respiratory system agents|mesh-ancestor
101842259|NCT00981851|Parasympatholytics|parasympatholytics|mesh-ancestor
101842260|NCT00981851|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101842261|NCT00981851|Cholinergic Agents|cholinergic agents|mesh-ancestor
101842262|NCT00981851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101842263|NCT00981851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842264|NCT00981851|Tocolytic Agents|tocolytic agents|mesh-ancestor
101842265|NCT00981851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101842266|NCT00981851|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101842267|NCT00981851|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101842268|NCT00981851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101842269|NCT00981851|Adrenergic Agents|adrenergic agents|mesh-ancestor
101842270|NCT00981929|Losartan|losartan|mesh-list
101842271|NCT00981929|Tramadol|tramadol|mesh-list
101842272|NCT00981929|Caffeine|caffeine|mesh-list
101842273|NCT00981929|Omeprazole|omeprazole|mesh-list
101842274|NCT00981929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101842275|NCT00981929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101842276|NCT00981929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101842277|NCT00981929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101842278|NCT00981929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842279|NCT00981929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101842280|NCT00981929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842281|NCT00981929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101842282|NCT00981929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101963569|NCT03535558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101842283|NCT00981929|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101842284|NCT00981929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101842285|NCT00981929|Purinergic Agents|purinergic agents|mesh-ancestor
101842286|NCT00981929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101842287|NCT00981929|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101842288|NCT00981929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101842289|NCT00981929|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101842290|NCT00981929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101842292|NCT00981929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101842293|NCT00981929|Analgesics|analgesics|mesh-ancestor
101842294|NCT00981929|Sensory System Agents|sensory system agents|mesh-ancestor
101842295|NCT00981929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101842296|NCT00364845|Darbepoetin alfa|darbepoetin alfa|mesh-list
101842297|NCT00364845|Hematinics|hematinics|mesh-ancestor
101842298|NCT00978653|Allopurinol|allopurinol|mesh-list
101842299|NCT00978653|Antimetabolites|antimetabolites|mesh-ancestor
101842300|NCT00978653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842301|NCT00978653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101842302|NCT00978653|Gout Suppressants|gout suppressants|mesh-ancestor
101842303|NCT00978653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101842304|NCT00978653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101842305|NCT00978653|Antioxidants|antioxidants|mesh-ancestor
101842306|NCT00978653|Protective Agents|protective agents|mesh-ancestor
101842307|NCT00978653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842308|NCT00293722|Etanercept|etanercept|mesh-list
101842309|NCT00293722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101842311|NCT00293722|Analgesics|analgesics|mesh-ancestor
101842312|NCT00293722|Sensory System Agents|sensory system agents|mesh-ancestor
101237636|NCT03841110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101842313|NCT00293722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101842314|NCT00293722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842315|NCT00293722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101842316|NCT00293722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101842317|NCT00293722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101842318|NCT00293722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101842319|NCT00293722|Immunologic Factors|immunologic factors|mesh-ancestor
101842320|NCT00381303|Ritonavir|ritonavir|mesh-list
101842321|NCT00381303|Darunavir|darunavir|mesh-list
101842322|NCT00381303|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101842323|NCT00381303|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101842324|NCT00381303|Protease Inhibitors|protease inhibitors|mesh-ancestor
101842325|NCT00381303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101842326|NCT00381303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842327|NCT00381303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101842328|NCT00381303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101842329|NCT00381303|Antiviral Agents|antiviral agents|mesh-ancestor
101842330|NCT00381303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101842331|NCT00381303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101842332|NCT00381303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101842333|NCT00364689|Rifaximin|rifaximin|mesh-list
101842334|NCT00364689|Lactulose|lactulose|mesh-list
101842335|NCT00364689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101842336|NCT00364689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101842337|NCT00364689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101842338|NCT00545129|Tanezumab|tanezumab|mesh-list
101842339|NCT00545129|Analgesics|analgesics|mesh-ancestor
101842340|NCT00545129|Sensory System Agents|sensory system agents|mesh-ancestor
101842341|NCT00545129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101842342|NCT00545129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842343|NCT00956111|Vaccines|vaccines|mesh-list
101842344|NCT00956111|Immunologic Factors|immunologic factors|mesh-ancestor
101842345|NCT00956111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842346|NCT00982631|Sirolimus|sirolimus|mesh-list
101842347|NCT00982631|Temsirolimus|temsirolimus|mesh-list
101842348|NCT00982631|MTOR Inhibitors|mtor inhibitors|mesh-list
101842349|NCT00982631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101842350|NCT00982631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101842351|NCT00982631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842352|NCT00982631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101842353|NCT00982631|Immunologic Factors|immunologic factors|mesh-ancestor
101842354|NCT00982631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842355|NCT00982631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101842356|NCT00982631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101842357|NCT00982631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101260123|NCT01742702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101842358|NCT00982631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101842359|NCT00982631|Antifungal Agents|antifungal agents|mesh-ancestor
101842361|NCT00364611|Trastuzumab|trastuzumab|mesh-list
101842362|NCT00364611|Docetaxel|docetaxel|mesh-list
101842363|NCT00364611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101842364|NCT00364611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101842365|NCT00364611|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101842366|NCT00364611|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101842367|NCT00364611|Growth Substances|growth substances|mesh-ancestor
101842368|NCT00364611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842369|NCT00364611|Growth Inhibitors|growth inhibitors|mesh-ancestor
101842370|NCT00364611|Tubulin Modulators|tubulin modulators|mesh-ancestor
101842371|NCT00364611|Antimitotic Agents|antimitotic agents|mesh-ancestor
101842372|NCT00364611|Mitosis Modulators|mitosis modulators|mesh-ancestor
101842373|NCT00364611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842374|NCT00956189|Aripiprazole|aripiprazole|mesh-list
101842375|NCT00956189|Amisulpride|amisulpride|mesh-list
101842376|NCT00956189|Antidepressive Agents|antidepressive agents|mesh-ancestor
101842377|NCT00956189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101842378|NCT00956189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101842379|NCT00956189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101842380|NCT00956189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101842381|NCT00956189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842382|NCT00956189|Dopamine Agonists|dopamine agonists|mesh-ancestor
101842383|NCT00956189|Dopamine Agents|dopamine agents|mesh-ancestor
101842384|NCT00956189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101842385|NCT00956189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842386|NCT00956189|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101842387|NCT00956189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101842388|NCT00956189|Serotonin Agents|serotonin agents|mesh-ancestor
101842389|NCT00956189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101842390|NCT00956189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101842391|NCT00956189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101842392|NCT00956189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101842393|NCT00956189|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101842394|NCT00956267|Letrozole|letrozole|mesh-list
101842395|NCT00956267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101842396|NCT00956267|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101842397|NCT00956267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101842398|NCT00956267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101842399|NCT00956267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842400|NCT00956267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101842401|NCT00956267|Hormone Antagonists|hormone antagonists|mesh-ancestor
101842402|NCT00956267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101842403|NCT00956267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842404|NCT04007003|Insulin|insulin|mesh-list
101842405|NCT04007003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101842406|NCT04007003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842407|NCT00364533|Oxycodone|oxycodone|mesh-list
101842408|NCT00364533|Tapentadol|tapentadol|mesh-list
101842409|NCT00364533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101842410|NCT00364533|Narcotics|narcotics|mesh-ancestor
101842411|NCT00364533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101842412|NCT00364533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842413|NCT00364533|Analgesics|analgesics|mesh-ancestor
101842414|NCT00364533|Sensory System Agents|sensory system agents|mesh-ancestor
101842415|NCT00364533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101842416|NCT00364533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101842417|NCT00364533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101842418|NCT00364533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101842419|NCT00364533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842420|NCT00364533|Adrenergic Agents|adrenergic agents|mesh-ancestor
101842421|NCT00364533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101842422|NCT01047423|Simvastatin|simvastatin|mesh-list
101842423|NCT01047423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101842424|NCT01047423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101842425|NCT01047423|Antimetabolites|antimetabolites|mesh-ancestor
101387671|NCT00322699|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
101842426|NCT01047423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842427|NCT01047423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101963576|NCT02193334|Mitogens|mitogens|mesh-list
101842428|NCT01047423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101842429|NCT01047423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101842430|NCT00984737|Insulin|insulin|mesh-list
101842431|NCT00984737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101842432|NCT00984737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842434|NCT01047579|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101842435|NCT01047579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101842436|NCT01047579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842437|NCT01047579|Cholinergic Agents|cholinergic agents|mesh-ancestor
101842438|NCT01047579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101842439|NCT01047579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842440|NCT01047579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101842441|NCT01047579|Protective Agents|protective agents|mesh-ancestor
101842442|NCT04006847|Dasatinib|dasatinib|mesh-list
101842443|NCT04006847|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101842444|NCT04006847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101842445|NCT04006847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101842446|NCT04006847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101842447|NCT04006847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842448|NCT00984893|Zoledronic Acid|zoledronic acid|mesh-list
101842449|NCT00984893|Diphosphonates|diphosphonates|mesh-list
101842450|NCT00984893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101842451|NCT00984893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842452|NCT00983021|Insulin|insulin|mesh-list
101842453|NCT00983021|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101842454|NCT00983021|Liraglutide|liraglutide|mesh-list
101842455|NCT00983021|Insulin, Long-Acting|insulin, long-acting|mesh-list
101842456|NCT00983021|Xultophy|xultophy|mesh-list
101842457|NCT00983021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101842458|NCT00983021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842459|NCT00983021|Incretins|incretins|mesh-ancestor
101842460|NCT00983021|Hormones|hormones|mesh-ancestor
101842461|NCT00983021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101842462|NCT00984971|Tenofovir|tenofovir|mesh-list
101842463|NCT00984971|Antiviral Agents|antiviral agents|mesh-ancestor
101842464|NCT00984971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101842465|NCT00984971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101842466|NCT00984971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101842467|NCT00984971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101842468|NCT00984971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842469|NCT00984971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101842470|NCT00984971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101842471|NCT00544817|Temozolomide|temozolomide|mesh-list
101842472|NCT00544817|Sorafenib|sorafenib|mesh-list
101842473|NCT00544817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101842474|NCT00544817|Alkylating Agents|alkylating agents|mesh-ancestor
101842475|NCT00544817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842476|NCT00544817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101842477|NCT00544817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101842478|NCT00544817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101842479|NCT00289978|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101842480|NCT00289978|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101842481|NCT00289978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842482|NCT00289978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101842483|NCT00289978|Immunologic Factors|immunologic factors|mesh-ancestor
101842484|NCT00289978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842485|NCT00983177|Colchicine|colchicine|mesh-list
101842486|NCT00983177|Gout Suppressants|gout suppressants|mesh-ancestor
101842487|NCT00983177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101842488|NCT00983177|Tubulin Modulators|tubulin modulators|mesh-ancestor
101842489|NCT00983177|Antimitotic Agents|antimitotic agents|mesh-ancestor
101842490|NCT00983177|Mitosis Modulators|mitosis modulators|mesh-ancestor
101842491|NCT00983177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842492|NCT00983177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101842493|NCT00983255|Tedizolid phosphate|tedizolid phosphate|mesh-list
101842494|NCT00983255|Tedizolid|tedizolid|mesh-list
101842495|NCT00983255|Oxazolidinones|oxazolidinones|mesh-list
101842496|NCT00983255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101842497|NCT00983255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101842498|NCT00983255|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101842499|NCT00983255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101842500|NCT00983255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842501|NCT00988403|Levan|levan|mesh-list
101842502|NCT00988403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101842503|NCT00988481|Topiramate|topiramate|mesh-list
101842504|NCT00988481|Anticonvulsants|anticonvulsants|mesh-ancestor
101842505|NCT00988481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101842506|NCT00988481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842507|NCT00289900|Atorvastatin|atorvastatin|mesh-list
101842508|NCT00289900|Simvastatin|simvastatin|mesh-list
101842509|NCT00289900|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101842510|NCT00289900|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101842511|NCT00289900|Antimetabolites|antimetabolites|mesh-ancestor
101842512|NCT00289900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842513|NCT00289900|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101842514|NCT00289900|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101842515|NCT00289900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101842517|NCT00543725|Rilpivirine|rilpivirine|mesh-list
101842518|NCT00543725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101842519|NCT00543725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101842520|NCT00543725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101842521|NCT00543725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842522|NCT00543725|Antiviral Agents|antiviral agents|mesh-ancestor
101842523|NCT00543725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101842524|NCT00543725|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101842525|NCT00543725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101842526|NCT00543725|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101842527|NCT00543725|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101842528|NCT00543725|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101842529|NCT00543725|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101842530|NCT00543725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101842531|NCT00543725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101842532|NCT00985361|Vitamin D|vitamin d|mesh-list
101842533|NCT00985361|Cholecalciferol|cholecalciferol|mesh-list
101842534|NCT00985361|Vitamins|vitamins|mesh-list
101842535|NCT00985361|Micronutrients|micronutrients|mesh-ancestor
101842536|NCT00985361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842537|NCT00985361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101842538|NCT00985361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101842539|NCT00269152|Carboplatin|carboplatin|mesh-list
101842540|NCT00269152|Pemetrexed|pemetrexed|mesh-list
101842541|NCT00269152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101842542|NCT00269152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101842543|NCT00269152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842544|NCT00269152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101842545|NCT00269152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101842546|NCT00988715|Cyclosporine|cyclosporine|mesh-list
101842547|NCT00988715|Mycophenolic Acid|mycophenolic acid|mesh-list
101842548|NCT00988715|Fludarabine|fludarabine|mesh-list
101842549|NCT00988715|Fludarabine phosphate|fludarabine phosphate|mesh-list
101842550|NCT00988715|Cyclosporins|cyclosporins|mesh-list
101842551|NCT00988715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101842552|NCT00988715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101842553|NCT00988715|Antimetabolites|antimetabolites|mesh-ancestor
101842554|NCT00988715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842555|NCT00988715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101842556|NCT00988715|Immunologic Factors|immunologic factors|mesh-ancestor
101842557|NCT00988715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842558|NCT00988715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101842559|NCT00988715|Antifungal Agents|antifungal agents|mesh-ancestor
101842560|NCT00988715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101842561|NCT00988715|Dermatologic Agents|dermatologic agents|mesh-ancestor
101842562|NCT00988715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101842563|NCT00988715|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101842564|NCT00988715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101842565|NCT00988715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101842566|NCT00988715|Antitubercular Agents|antitubercular agents|mesh-ancestor
101842567|NCT00988715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101842568|NCT03975166|Fluticasone|fluticasone|mesh-list
101842569|NCT03975166|Xhance|xhance|mesh-list
101842570|NCT03975166|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101842571|NCT03975166|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101842572|NCT03975166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101842573|NCT03975166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101842574|NCT03975166|Autonomic Agents|autonomic agents|mesh-ancestor
101842575|NCT03975166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101842576|NCT03975166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842577|NCT03975166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101842578|NCT03975166|Respiratory System Agents|respiratory system agents|mesh-ancestor
101842579|NCT03975166|Dermatologic Agents|dermatologic agents|mesh-ancestor
101842580|NCT03975166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101842581|NCT03975166|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101842582|NCT03975166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101842583|NCT03975166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101842584|NCT03975166|Adrenergic Agents|adrenergic agents|mesh-ancestor
101842585|NCT03975166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101842586|NCT03975166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842587|NCT03975166|Glucocorticoids|glucocorticoids|mesh-ancestor
101842588|NCT03975166|Hormones|hormones|mesh-ancestor
101842589|NCT03975166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101842590|NCT03975166|Sympathomimetics|sympathomimetics|mesh-ancestor
101842591|NCT01325818|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101842592|NCT01325818|Pravastatin|pravastatin|mesh-list
101842593|NCT01325818|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101842594|NCT01325818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101842595|NCT01325818|Antimetabolites|antimetabolites|mesh-ancestor
101842596|NCT01325818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842597|NCT01325818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101842598|NCT01325818|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101842599|NCT01325818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101842600|NCT00379899|Vitamin D|vitamin d|mesh-list
101842601|NCT00379899|Cinacalcet|cinacalcet|mesh-list
101842602|NCT00379899|Vitamins|vitamins|mesh-ancestor
101842603|NCT00379899|Micronutrients|micronutrients|mesh-ancestor
101842604|NCT00379899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842605|NCT00379899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101842606|NCT00379899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101842607|NCT00379899|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101842608|NCT00379899|Hormone Antagonists|hormone antagonists|mesh-ancestor
101842609|NCT00379899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101842610|NCT02535039|Methylprednisolone|methylprednisolone|mesh-list
101842611|NCT02535039|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101842612|NCT02535039|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101842613|NCT02535039|Prednisolone|prednisolone|mesh-list
101842614|NCT02535039|Prednisolone acetate|prednisolone acetate|mesh-list
101842615|NCT02535039|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101842616|NCT02535039|Prednisolone phosphate|prednisolone phosphate|mesh-list
101842617|NCT02535039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101842618|NCT02535039|Antiemetics|antiemetics|mesh-ancestor
101842619|NCT02535039|Autonomic Agents|autonomic agents|mesh-ancestor
101842620|NCT02535039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101842621|NCT02535039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842622|NCT02535039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101842623|NCT02535039|Glucocorticoids|glucocorticoids|mesh-ancestor
101842624|NCT02535039|Hormones|hormones|mesh-ancestor
101842625|NCT02535039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101842626|NCT02535039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101842627|NCT02535039|Protective Agents|protective agents|mesh-ancestor
101842628|NCT02535039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101842629|NCT02535039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101842630|NCT00363129|Vitamin E|vitamin e|mesh-list
101842631|NCT00363129|Vitamins|vitamins|mesh-ancestor
101842632|NCT00363129|Micronutrients|micronutrients|mesh-ancestor
101842633|NCT00363129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842634|NCT00363129|Antioxidants|antioxidants|mesh-ancestor
101842635|NCT00363129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842636|NCT00363129|Protective Agents|protective agents|mesh-ancestor
101842637|NCT00268996|Darapladib|darapladib|mesh-list
101842638|NCT00268996|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
101842639|NCT00268996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101842640|NCT00268996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842641|NCT00379587|Rituximab|rituximab|mesh-list
101842642|NCT00379587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101842643|NCT00379587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101842644|NCT00379587|Immunologic Factors|immunologic factors|mesh-ancestor
101842645|NCT00379587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842646|NCT00379587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101842648|NCT00363051|Octreotide|octreotide|mesh-list
101842649|NCT00363051|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101842650|NCT00363051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101842651|NCT00363051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101842652|NCT00363051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842653|NCT00363051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101842654|NCT00363051|Immunologic Factors|immunologic factors|mesh-ancestor
101842655|NCT00363051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842656|NCT00363051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101842657|NCT00363051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101842658|NCT00363051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101842659|NCT00379353|Thalidomide|thalidomide|mesh-list
101842660|NCT00379353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101842661|NCT00379353|Immunologic Factors|immunologic factors|mesh-ancestor
101842662|NCT00379353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842663|NCT00379353|Leprostatic Agents|leprostatic agents|mesh-ancestor
101842664|NCT00379353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101842665|NCT00379353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101842666|NCT00379353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101842667|NCT00379353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101842668|NCT00379353|Growth Substances|growth substances|mesh-ancestor
101842669|NCT00379353|Growth Inhibitors|growth inhibitors|mesh-ancestor
101842670|NCT00379353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101842671|NCT01047657|Orlistat|orlistat|mesh-list
101842672|NCT01047657|Sibutramine|sibutramine|mesh-list
101842673|NCT01047657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101842674|NCT01047657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842675|NCT01047657|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101842676|NCT01047657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101842677|NCT01047657|Antidepressive Agents|antidepressive agents|mesh-ancestor
101842678|NCT01047657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101842679|NCT01047657|Appetite Depressants|appetite depressants|mesh-ancestor
101842680|NCT00378573|Bevacizumab|bevacizumab|mesh-list
101842681|NCT00378573|Gemcitabine|gemcitabine|mesh-list
101842682|NCT00378573|Docetaxel|docetaxel|mesh-list
101842683|NCT00378573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101842684|NCT00378573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101842685|NCT00378573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101842686|NCT00378573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101842687|NCT00378573|Growth Substances|growth substances|mesh-ancestor
101842688|NCT00378573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842689|NCT00378573|Growth Inhibitors|growth inhibitors|mesh-ancestor
101842690|NCT00378573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101842691|NCT00378573|Antimetabolites|antimetabolites|mesh-ancestor
101842692|NCT00378573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842693|NCT00378573|Tubulin Modulators|tubulin modulators|mesh-ancestor
101842694|NCT00378573|Antimitotic Agents|antimitotic agents|mesh-ancestor
101842695|NCT00378573|Mitosis Modulators|mitosis modulators|mesh-ancestor
101842696|NCT01047891|Sorafenib|sorafenib|mesh-list
101842697|NCT01047891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101842698|NCT01047891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101842699|NCT01047891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101842700|NCT01047891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842701|NCT02534571|Epinephrine|epinephrine|mesh-list
101842702|NCT02534571|Hemostatics|hemostatics|mesh-list
101842703|NCT02534571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101842704|NCT02534571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101842705|NCT02534571|Adrenergic Agents|adrenergic agents|mesh-ancestor
101842706|NCT02534571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101842707|NCT02534571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842708|NCT02534571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842709|NCT02534571|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101842710|NCT02534571|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101842712|NCT02534571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101842713|NCT02534571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101842714|NCT02534571|Respiratory System Agents|respiratory system agents|mesh-ancestor
101842715|NCT02534571|Mydriatics|mydriatics|mesh-ancestor
101842716|NCT02534571|Sympathomimetics|sympathomimetics|mesh-ancestor
101842717|NCT02534571|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101842718|NCT02534571|Coagulants|coagulants|mesh-ancestor
101842719|NCT00457002|Enoxaparin|enoxaparin|mesh-list
101842720|NCT00457002|Apixaban|apixaban|mesh-list
101842721|NCT00457002|Anticoagulants|anticoagulants|mesh-ancestor
101842722|NCT00457002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101842723|NCT00457002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101842724|NCT00457002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842725|NCT00457002|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101842726|NCT00457002|Antithrombins|antithrombins|mesh-ancestor
101842727|NCT00457002|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101842728|NCT00457002|Protease Inhibitors|protease inhibitors|mesh-ancestor
101842729|NCT00457002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101842730|NCT00362115|Olmesartan|olmesartan|mesh-list
101842731|NCT00362115|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
101842732|NCT00362115|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101842733|NCT00362115|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101842734|NCT00362115|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101842735|NCT00362115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842736|NCT00485264|Raltegravir Potassium|raltegravir potassium|mesh-list
101842737|NCT00485264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101842738|NCT00485264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101842739|NCT00485264|Antiviral Agents|antiviral agents|mesh-ancestor
101842740|NCT00485264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101842741|NCT00485264|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101842742|NCT00485264|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101842743|NCT00485264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101842744|NCT00485264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842745|NCT00293254|Raltegravir Potassium|raltegravir potassium|mesh-list
101842746|NCT00293254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101842747|NCT00293254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101842748|NCT00293254|Antiviral Agents|antiviral agents|mesh-ancestor
101842749|NCT00293254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101842750|NCT00293254|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101842751|NCT00293254|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101842752|NCT00293254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101842753|NCT00293254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842754|NCT03975010|Naltrexone|naltrexone|mesh-list
101842755|NCT03975010|Buprenorphine|buprenorphine|mesh-list
101842756|NCT03975010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101842757|NCT03975010|Narcotics|narcotics|mesh-ancestor
101842758|NCT03975010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101842759|NCT03975010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842760|NCT03975010|Analgesics|analgesics|mesh-ancestor
101842761|NCT03975010|Sensory System Agents|sensory system agents|mesh-ancestor
101842762|NCT03975010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101842763|NCT03975010|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101842764|NCT03975010|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101842765|NCT01016990|Valproic Acid|valproic acid|mesh-list
101842766|NCT01016990|Anticonvulsants|anticonvulsants|mesh-ancestor
101842767|NCT01016990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101842768|NCT01016990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842769|NCT01016990|GABA Agents|gaba agents|mesh-ancestor
101842770|NCT01016990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101842771|NCT01016990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842772|NCT01016990|Antimanic Agents|antimanic agents|mesh-ancestor
101842773|NCT01016990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101842774|NCT01016990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101842775|NCT01016990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101842776|NCT01048047|Amlodipine|amlodipine|mesh-list
101842777|NCT01048047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101842778|NCT01048047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101842779|NCT01048047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101842780|NCT01048047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842781|NCT01048047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101842782|NCT01048047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842783|NCT01048047|Vasodilator Agents|vasodilator agents|mesh-ancestor
101842784|NCT01324635|Panobinostat|panobinostat|mesh-list
101842785|NCT01324635|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
101842786|NCT01324635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101842787|NCT01324635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101842788|NCT01324635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842790|NCT00456846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101842791|NCT00456846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101842792|NCT00456846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101842793|NCT00456846|Tubulin Modulators|tubulin modulators|mesh-ancestor
101842794|NCT00456846|Antimitotic Agents|antimitotic agents|mesh-ancestor
101842795|NCT00456846|Mitosis Modulators|mitosis modulators|mesh-ancestor
101842796|NCT00456846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842797|NCT03324282|Avelumab|avelumab|mesh-list
101842798|NCT03324282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101842799|NCT03324282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101842800|NCT00484094|Sirolimus|sirolimus|mesh-list
101842801|NCT00484094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101842802|NCT00484094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101842803|NCT00484094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101842804|NCT00484094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101842805|NCT00484094|Antifungal Agents|antifungal agents|mesh-ancestor
101842806|NCT00484094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101842807|NCT00484094|Immunologic Factors|immunologic factors|mesh-ancestor
101842808|NCT00484094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842809|NCT01029288|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101842810|NCT01029288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842811|NCT01029444|Insulin Aspart|insulin aspart|mesh-list
101842812|NCT01029444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101842813|NCT01029444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842814|NCT01029522|Atorvastatin|atorvastatin|mesh-list
101842815|NCT01029522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101842816|NCT01029522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101842817|NCT01029522|Antimetabolites|antimetabolites|mesh-ancestor
101842818|NCT01029522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842819|NCT01029522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101842820|NCT01029522|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101842821|NCT01029522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101842822|NCT00447876|Botulinum Toxins|botulinum toxins|mesh-list
101842823|NCT00447876|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101842824|NCT00447876|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101842825|NCT00447876|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101842826|NCT00447876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101842827|NCT00447876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842828|NCT00447876|Cholinergic Agents|cholinergic agents|mesh-ancestor
101842829|NCT00447876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101842830|NCT00447876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842831|NCT00447876|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101842832|NCT00447876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101842833|NCT01565772|Etoposide|etoposide|mesh-list
101842834|NCT01565772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101842835|NCT01565772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101842836|NCT01565772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101842837|NCT01565772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101842838|NCT01565772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101842839|NCT01565772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842840|NCT00456300|Exenatide|exenatide|mesh-list
101842841|NCT00456300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101842842|NCT00456300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842843|NCT00456300|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101842844|NCT00456300|Incretins|incretins|mesh-ancestor
101842845|NCT00456300|Hormones|hormones|mesh-ancestor
101963613|NCT02195908|Autonomic Agents|autonomic agents|mesh-ancestor
101842846|NCT00456300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101842848|NCT00267748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101842849|NCT00267748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101842850|NCT00267748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101842851|NCT00267748|Growth Substances|growth substances|mesh-ancestor
101842852|NCT00267748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842853|NCT00267748|Growth Inhibitors|growth inhibitors|mesh-ancestor
101842854|NCT00267748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101842855|NCT00267748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101842856|NCT00267748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842857|NCT00267202|Omalizumab|omalizumab|mesh-list
101842858|NCT00267202|Immunomodulating Agents|immunomodulating agents|mesh-list
101842859|NCT00267202|Immunologic Factors|immunologic factors|mesh-list
101842860|NCT00267202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842861|NCT00267202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101842862|NCT00267202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101842863|NCT00267202|Respiratory System Agents|respiratory system agents|mesh-ancestor
101842864|NCT01067638|Tranexamic Acid|tranexamic acid|mesh-list
101842865|NCT01067638|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101842866|NCT01067638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101842867|NCT01067638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842868|NCT01067638|Hemostatics|hemostatics|mesh-ancestor
101842869|NCT01067638|Coagulants|coagulants|mesh-ancestor
101842870|NCT00267046|Doxorubicin|doxorubicin|mesh-list
101842871|NCT00267046|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101842872|NCT00267046|Vincristine|vincristine|mesh-list
101842873|NCT00267046|Ifosfamide|ifosfamide|mesh-list
101842874|NCT00267046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101842875|NCT00267046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101842876|NCT00267046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101842877|NCT00267046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101842878|NCT00267046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101842879|NCT00267046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842880|NCT00267046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101842881|NCT00267046|Tubulin Modulators|tubulin modulators|mesh-ancestor
101842882|NCT00267046|Antimitotic Agents|antimitotic agents|mesh-ancestor
101842883|NCT00267046|Mitosis Modulators|mitosis modulators|mesh-ancestor
101842884|NCT00267046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101842885|NCT00267046|Alkylating Agents|alkylating agents|mesh-ancestor
101842886|NCT01029678|Vinorelbine|vinorelbine|mesh-list
101842887|NCT01029678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101842888|NCT01029678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101842889|NCT01029678|Tubulin Modulators|tubulin modulators|mesh-ancestor
101842890|NCT01029678|Antimitotic Agents|antimitotic agents|mesh-ancestor
101842891|NCT01029678|Mitosis Modulators|mitosis modulators|mesh-ancestor
101842892|NCT01029678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842893|NCT00286468|Alogliptin|alogliptin|mesh-list
101842894|NCT00286468|Glyburide|glyburide|mesh-list
101842895|NCT00286468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101842896|NCT00286468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842897|NCT00286468|Incretins|incretins|mesh-ancestor
101842898|NCT00286468|Hormones|hormones|mesh-ancestor
101842899|NCT00286468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101842900|NCT00286468|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101842901|NCT00286468|Protease Inhibitors|protease inhibitors|mesh-ancestor
101842902|NCT00286468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101842903|NCT00286468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842904|NCT00507026|Diclofenac|diclofenac|mesh-list
101842905|NCT00507026|Ketorolac|ketorolac|mesh-list
101842906|NCT00507026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101842907|NCT00507026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101842908|NCT00507026|Analgesics|analgesics|mesh-ancestor
101842909|NCT00507026|Sensory System Agents|sensory system agents|mesh-ancestor
101842910|NCT00507026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101842911|NCT00507026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842912|NCT00507026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101842913|NCT00507026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101842914|NCT00507026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101842915|NCT00507026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101963615|NCT02195908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842916|NCT00507026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842917|NCT01019174|Cyclophosphamide|cyclophosphamide|mesh-list
101842918|NCT01019174|Lenalidomide|lenalidomide|mesh-list
101842919|NCT01019174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101842920|NCT01019174|Immunologic Factors|immunologic factors|mesh-ancestor
101842921|NCT01019174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842922|NCT01019174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101842923|NCT01019174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101842924|NCT01019174|Alkylating Agents|alkylating agents|mesh-ancestor
101842925|NCT01019174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842926|NCT01019174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101842927|NCT01019174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101842928|NCT01019174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101842929|NCT01019174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101842930|NCT01019174|Growth Substances|growth substances|mesh-ancestor
101842931|NCT01019174|Growth Inhibitors|growth inhibitors|mesh-ancestor
101842932|NCT01017224|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
101842933|NCT01017224|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101842934|NCT01017224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842935|NCT01011920|Cytarabine|cytarabine|mesh-list
101842936|NCT01011920|Rituximab|rituximab|mesh-list
101842937|NCT01011920|Methotrexate|methotrexate|mesh-list
101842938|NCT01011920|Thiotepa|thiotepa|mesh-list
101842939|NCT01011920|Carmustine|carmustine|mesh-list
101842940|NCT01011920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101842941|NCT01011920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101842942|NCT01011920|Immunologic Factors|immunologic factors|mesh-ancestor
101842943|NCT01011920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842944|NCT01011920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101842945|NCT01011920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101842946|NCT01011920|Abortifacient Agents|abortifacient agents|mesh-ancestor
101842947|NCT01011920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101842948|NCT01011920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101842949|NCT01011920|Antimetabolites|antimetabolites|mesh-ancestor
101842950|NCT01011920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842951|NCT01011920|Dermatologic Agents|dermatologic agents|mesh-ancestor
101842952|NCT01011920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101842953|NCT01011920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101842954|NCT01011920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101842955|NCT01011920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101842956|NCT01011920|Antiviral Agents|antiviral agents|mesh-ancestor
101842957|NCT01011920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101842958|NCT01011920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101842959|NCT01011920|Alkylating Agents|alkylating agents|mesh-ancestor
101842960|NCT01011920|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101842961|NCT03976102|Rituximab|rituximab|mesh-list
101842962|NCT03976102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101842963|NCT03976102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101842964|NCT03976102|Immunologic Factors|immunologic factors|mesh-ancestor
101842965|NCT03976102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842966|NCT03976102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101842967|NCT00506948|Mycophenolic Acid|mycophenolic acid|mesh-list
101842968|NCT00506948|Sirolimus|sirolimus|mesh-list
101842969|NCT00506948|Thymoglobulin|thymoglobulin|mesh-list
101842970|NCT00506948|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101842971|NCT00506948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101842972|NCT00506948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101842973|NCT00506948|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101842974|NCT00506948|Antitubercular Agents|antitubercular agents|mesh-ancestor
101842975|NCT00506948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101842976|NCT00506948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101842977|NCT00506948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101842978|NCT00506948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842979|NCT00506948|Antifungal Agents|antifungal agents|mesh-ancestor
101842980|NCT00506948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101842981|NCT00506948|Immunologic Factors|immunologic factors|mesh-ancestor
101842982|NCT00506948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842984|NCT00286234|Nicotinic Acids|nicotinic acids|mesh-list
101842985|NCT00286234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101562786|NCT05904808|Natriuretic Agents|natriuretic agents|mesh-ancestor
101842986|NCT00286234|Antimetabolites|antimetabolites|mesh-ancestor
101842987|NCT00286234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101842988|NCT00286234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101842989|NCT00286234|Vasodilator Agents|vasodilator agents|mesh-ancestor
101842990|NCT00286234|Vitamin B Complex|vitamin b complex|mesh-ancestor
101842992|NCT00286234|Micronutrients|micronutrients|mesh-ancestor
101842993|NCT00286234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101842994|NCT01019408|Chloroquine|chloroquine|mesh-list
101842995|NCT01019408|Amebicides|amebicides|mesh-ancestor
101842996|NCT01019408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101842997|NCT01019408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101842998|NCT01019408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101842999|NCT01019408|Antimalarials|antimalarials|mesh-ancestor
101843000|NCT01019408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101843001|NCT01067950|Pancrelipase|pancrelipase|mesh-list
101843002|NCT01067950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101843003|NCT00445848|Bevacizumab|bevacizumab|mesh-list
101843004|NCT00445848|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101843005|NCT00445848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101843006|NCT00445848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101843007|NCT00445848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101843008|NCT00445848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101843009|NCT00445848|Growth Substances|growth substances|mesh-ancestor
101843010|NCT00445848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843011|NCT00445848|Growth Inhibitors|growth inhibitors|mesh-ancestor
101843012|NCT00445848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101843013|NCT00445848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101843014|NCT00445848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843015|NCT00286156|Sirolimus|sirolimus|mesh-list
101843016|NCT00286156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101843017|NCT00286156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101843018|NCT00286156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101843019|NCT00286156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101843020|NCT00286156|Antifungal Agents|antifungal agents|mesh-ancestor
101843021|NCT00286156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101843022|NCT00286156|Immunologic Factors|immunologic factors|mesh-ancestor
101843023|NCT00286156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843024|NCT00455520|Tapentadol|tapentadol|mesh-list
101843025|NCT00455520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101843026|NCT00455520|Narcotics|narcotics|mesh-ancestor
101843027|NCT00455520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101843028|NCT00455520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843029|NCT00455520|Analgesics|analgesics|mesh-ancestor
101843030|NCT00455520|Sensory System Agents|sensory system agents|mesh-ancestor
101843031|NCT00455520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101843032|NCT00455520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101843033|NCT00455520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101843034|NCT00455520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101843035|NCT00455520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843036|NCT00455520|Adrenergic Agents|adrenergic agents|mesh-ancestor
101843037|NCT00455520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101843038|NCT00284050|Ranibizumab|ranibizumab|mesh-list
101843039|NCT00284050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101843040|NCT00284050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101843041|NCT00284050|Growth Substances|growth substances|mesh-ancestor
101843042|NCT00284050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843043|NCT00284050|Growth Inhibitors|growth inhibitors|mesh-ancestor
101843044|NCT00284050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101843045|NCT00293020|Fentanyl|fentanyl|mesh-list
101843046|NCT00293020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101843047|NCT00293020|Narcotics|narcotics|mesh-ancestor
101843048|NCT00293020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101843049|NCT00293020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843050|NCT00293020|Analgesics|analgesics|mesh-ancestor
101843051|NCT00293020|Sensory System Agents|sensory system agents|mesh-ancestor
101843052|NCT00293020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101843053|NCT00293020|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101843054|NCT00293020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101843055|NCT00293020|Anesthetics, General|anesthetics, general|mesh-ancestor
101843056|NCT00293020|Anesthetics|anesthetics|mesh-ancestor
101843057|NCT00377637|Mycophenolic Acid|mycophenolic acid|mesh-list
101843058|NCT00377637|Cyclophosphamide|cyclophosphamide|mesh-list
101843059|NCT00377637|Azathioprine|azathioprine|mesh-list
101843060|NCT00377637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101843061|NCT00377637|Immunologic Factors|immunologic factors|mesh-ancestor
101843062|NCT00377637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843063|NCT00377637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101843064|NCT00377637|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101843065|NCT00377637|Alkylating Agents|alkylating agents|mesh-ancestor
101843066|NCT00377637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843067|NCT00377637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101843068|NCT00377637|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101843069|NCT00377637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101843070|NCT00377637|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101843071|NCT00377637|Antitubercular Agents|antitubercular agents|mesh-ancestor
101843072|NCT00377637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101843073|NCT00377637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101843074|NCT00377637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101843075|NCT00377637|Antimetabolites|antimetabolites|mesh-ancestor
101843076|NCT00377637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101843077|NCT00377403|Acetaminophen|acetaminophen|mesh-list
101843078|NCT00377403|Amoxicillin|amoxicillin|mesh-list
101843079|NCT00377403|Phenylpropanolamine|phenylpropanolamine|mesh-list
101843080|NCT00377403|Pseudoephedrine|pseudoephedrine|mesh-list
101843081|NCT00377403|Ephedrine|ephedrine|mesh-list
101843082|NCT00377403|Dextromethorphan|dextromethorphan|mesh-list
101843083|NCT00377403|Guaifenesin|guaifenesin|mesh-list
101843084|NCT00377403|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
101843085|NCT00377403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101843086|NCT00377403|Analgesics|analgesics|mesh-ancestor
101843087|NCT00377403|Sensory System Agents|sensory system agents|mesh-ancestor
101843088|NCT00377403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101843089|NCT00377403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843090|NCT00377403|Antipyretics|antipyretics|mesh-ancestor
101843091|NCT00377403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101843092|NCT00377403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101843093|NCT00377403|Antitussive Agents|antitussive agents|mesh-ancestor
101843094|NCT00377403|Respiratory System Agents|respiratory system agents|mesh-ancestor
101843095|NCT00377403|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101843096|NCT00377403|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101843097|NCT00377403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101843098|NCT00377403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843099|NCT00377403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101843100|NCT00377403|Autonomic Agents|autonomic agents|mesh-ancestor
101843101|NCT00377403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101843102|NCT00377403|Nasal Decongestants|nasal decongestants|mesh-ancestor
101843103|NCT00377403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101843104|NCT00377403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101843105|NCT00377403|Sympathomimetics|sympathomimetics|mesh-ancestor
101843106|NCT00377403|Adrenergic Agents|adrenergic agents|mesh-ancestor
101843107|NCT00377403|Expectorants|expectorants|mesh-ancestor
101843108|NCT00377403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101843109|NCT00377403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101843110|NCT00377403|Appetite Depressants|appetite depressants|mesh-ancestor
101843111|NCT00377403|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101843112|NCT00370149|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101843113|NCT00370149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101843114|NCT00292942|Artesunate|artesunate|mesh-list
101843115|NCT00292942|Mannitol|mannitol|mesh-list
101843116|NCT00292942|Antimalarials|antimalarials|mesh-ancestor
101843117|NCT00292942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101843118|NCT00292942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101843119|NCT00292942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101843120|NCT00292942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101843121|NCT00292942|Antiviral Agents|antiviral agents|mesh-ancestor
101843122|NCT00292942|Schistosomicides|schistosomicides|mesh-ancestor
101843123|NCT00292942|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101843124|NCT00292942|Anthelmintics|anthelmintics|mesh-ancestor
101843125|NCT00292942|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101843126|NCT00292942|Diuretics|diuretics|mesh-ancestor
101843127|NCT00292942|Natriuretic Agents|natriuretic agents|mesh-ancestor
101963634|NCT03534388|Eusol|eusol|mesh-list
101843128|NCT00292942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843130|NCT00483938|Ribavirin|ribavirin|mesh-list
101843131|NCT00483938|Interferon-alpha|interferon-alpha|mesh-list
101843132|NCT00483938|Interferon alpha-2|interferon alpha-2|mesh-list
101843133|NCT00483938|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101843134|NCT00483938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101843135|NCT00483938|Antiviral Agents|antiviral agents|mesh-ancestor
101843136|NCT00483938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101843137|NCT00483938|Antimetabolites|antimetabolites|mesh-ancestor
101843138|NCT00483938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843139|NCT00483938|Immunologic Factors|immunologic factors|mesh-ancestor
101843140|NCT00483938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843141|NCT00370071|Interferons|interferons|mesh-list
101843142|NCT00370071|Interferon-beta|interferon-beta|mesh-list
101843143|NCT00370071|Interferon beta-1b|interferon beta-1b|mesh-list
101843144|NCT00370071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101843145|NCT00370071|Antiviral Agents|antiviral agents|mesh-ancestor
101843146|NCT00370071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101843148|NCT00370071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843149|NCT00370071|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101843150|NCT00369915|Scopolamine|scopolamine|mesh-list
101843151|NCT00369915|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101843152|NCT00369915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101843153|NCT00369915|Antiemetics|antiemetics|mesh-ancestor
101843154|NCT00369915|Autonomic Agents|autonomic agents|mesh-ancestor
101843155|NCT00369915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101843156|NCT00369915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843157|NCT00369915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101843158|NCT00369915|Mydriatics|mydriatics|mesh-ancestor
101843159|NCT00369915|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101843160|NCT00369915|Cholinergic Agents|cholinergic agents|mesh-ancestor
101843161|NCT00369915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101843162|NCT00369915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843163|NCT00369915|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101843164|NCT00369915|Parasympatholytics|parasympatholytics|mesh-ancestor
101843165|NCT03991845|Levocetirizine|levocetirizine|mesh-list
101843166|NCT03991845|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101843167|NCT03991845|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101843168|NCT03991845|Histamine Antagonists|histamine antagonists|mesh-ancestor
101843169|NCT03991845|Histamine Agents|histamine agents|mesh-ancestor
101843170|NCT03991845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101843171|NCT03991845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843172|NCT03991845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843173|NCT01017380|Celecoxib|celecoxib|mesh-list
101843174|NCT01017380|Etoricoxib|etoricoxib|mesh-list
101843175|NCT01017380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101843176|NCT01017380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101843177|NCT01017380|Analgesics|analgesics|mesh-ancestor
101843178|NCT01017380|Sensory System Agents|sensory system agents|mesh-ancestor
101843179|NCT01017380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101843180|NCT01017380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843181|NCT01017380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101843182|NCT01017380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101843183|NCT01017380|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101843184|NCT01017380|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101843185|NCT01017380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101843186|NCT01017380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843187|NCT00369681|Rituximab|rituximab|mesh-list
101843188|NCT00369681|Doxorubicin|doxorubicin|mesh-list
101843189|NCT00369681|Dacarbazine|dacarbazine|mesh-list
101843190|NCT00369681|Bleomycin|bleomycin|mesh-list
101843191|NCT00369681|Vinblastine|vinblastine|mesh-list
101843192|NCT00369681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101843193|NCT00369681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101843194|NCT00369681|Immunologic Factors|immunologic factors|mesh-ancestor
101843195|NCT00369681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563012|NCT05612074|Vasodilator Agents|vasodilator agents|mesh-ancestor
101563013|NCT05612074|Gasotransmitters|gasotransmitters|mesh-ancestor
101563014|NCT05612074|Protective Agents|protective agents|mesh-ancestor
101563015|NCT05610085|Levetiracetam|levetiracetam|mesh-list
101563016|NCT05610085|Phenobarbital|phenobarbital|mesh-list
101563017|NCT05610085|Anticonvulsants|anticonvulsants|mesh-ancestor
101563018|NCT05610085|Nootropic Agents|nootropic agents|mesh-ancestor
101563019|NCT05610085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101563020|NCT05610085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101563021|NCT05610085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563022|NCT05610085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101563023|NCT05610085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101563024|NCT05610085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101563025|NCT05610085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563026|NCT05610085|GABA Modulators|gaba modulators|mesh-ancestor
101563027|NCT05610085|GABA Agents|gaba agents|mesh-ancestor
101563028|NCT05610085|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101563029|NCT05610085|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101563030|NCT05610085|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101563037|NCT05581589|Irinotecan|irinotecan|mesh-list
101843196|NCT00369681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101843197|NCT00369681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101843198|NCT00369681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101843199|NCT00369681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101843200|NCT00369681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101843201|NCT00369681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843202|NCT00369681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101843203|NCT00369681|Alkylating Agents|alkylating agents|mesh-ancestor
101843204|NCT00369681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101843205|NCT00369681|Tubulin Modulators|tubulin modulators|mesh-ancestor
101843206|NCT00369681|Antimitotic Agents|antimitotic agents|mesh-ancestor
101843207|NCT00369681|Mitosis Modulators|mitosis modulators|mesh-ancestor
101843209|NCT00266812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101843210|NCT00266812|Alkylating Agents|alkylating agents|mesh-ancestor
101843211|NCT00266812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843212|NCT00266812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101843213|NCT04249544|Pramipexole|pramipexole|mesh-list
101843214|NCT04249544|Antioxidants|antioxidants|mesh-ancestor
101843215|NCT04249544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843216|NCT04249544|Protective Agents|protective agents|mesh-ancestor
101843217|NCT04249544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843218|NCT04249544|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101843219|NCT04249544|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101843220|NCT04249544|Dopamine Agonists|dopamine agonists|mesh-ancestor
101843221|NCT04249544|Dopamine Agents|dopamine agents|mesh-ancestor
101843222|NCT04249544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101843223|NCT00488774|Golimumab|golimumab|mesh-list
101843224|NCT00488774|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101843225|NCT00488774|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101843226|NCT00488774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101843227|NCT00488774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101843228|NCT00488774|Immunologic Factors|immunologic factors|mesh-ancestor
101843229|NCT00488774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843230|NCT00361569|Estrogens|estrogens|mesh-list
101843231|NCT00361569|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101843232|NCT00361569|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
101843233|NCT00361569|Hormones|hormones|mesh-ancestor
101843234|NCT00361569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101843235|NCT00361569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843236|NCT01011998|Imatinib Mesylate|imatinib mesylate|mesh-list
101843237|NCT01011998|Valproic Acid|valproic acid|mesh-list
101843238|NCT01011998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101843239|NCT01011998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101843240|NCT01011998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101843241|NCT01011998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843242|NCT01011998|Anticonvulsants|anticonvulsants|mesh-ancestor
101843243|NCT01011998|GABA Agents|gaba agents|mesh-ancestor
101843244|NCT01011998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101843245|NCT01011998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843246|NCT01011998|Antimanic Agents|antimanic agents|mesh-ancestor
101843247|NCT01011998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101963643|NCT04308694|Sensory System Agents|sensory system agents|mesh-ancestor
101843248|NCT01011998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101843249|NCT01011998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101843250|NCT01017458|Methyltestosterone|methyltestosterone|mesh-list
101843251|NCT01017458|Testosterone|testosterone|mesh-list
101843252|NCT01017458|Testosterone undecanoate|testosterone undecanoate|mesh-list
101843253|NCT01017458|Testosterone enanthate|testosterone enanthate|mesh-list
101843254|NCT01017458|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101843255|NCT01017458|Androgens|androgens|mesh-ancestor
101843256|NCT01017458|Hormones|hormones|mesh-ancestor
101843257|NCT01017458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101843258|NCT01017458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843259|NCT01017458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101843260|NCT01017458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101843261|NCT01017458|Anabolic Agents|anabolic agents|mesh-ancestor
101843262|NCT02534415|Hyaluronic Acid|hyaluronic acid|mesh-list
101843263|NCT02534415|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101843264|NCT02534415|Immunologic Factors|immunologic factors|mesh-ancestor
101237972|NCT01746173|Hormones|hormones|mesh-ancestor
101843265|NCT02534415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843266|NCT02534415|Viscosupplements|viscosupplements|mesh-ancestor
101843267|NCT02534415|Protective Agents|protective agents|mesh-ancestor
101843268|NCT00488618|Cariprazine|cariprazine|mesh-list
101843269|NCT00488618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101563109|NCT05505630|Midazolam|midazolam|mesh-list
101843270|NCT00488618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101843271|NCT00488618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101843272|NCT00488618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843273|NCT00488618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101843274|NCT01019642|Cholecalciferol|cholecalciferol|mesh-list
101843276|NCT01019642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101843277|NCT01019642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843279|NCT01019642|Micronutrients|micronutrients|mesh-ancestor
101843280|NCT01019642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101843281|NCT00266656|Hormones|hormones|mesh-list
101843282|NCT00266656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101843283|NCT00266656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843284|NCT00483548|Ziprasidone|ziprasidone|mesh-list
101843285|NCT00483548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101843286|NCT00483548|Serotonin Agents|serotonin agents|mesh-ancestor
101843287|NCT00483548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101843288|NCT00483548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843289|NCT00483548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843290|NCT00483548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101843291|NCT00483548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101843292|NCT00483548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101843293|NCT00483548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101843294|NCT00483548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101843295|NCT00483548|Dopamine Agents|dopamine agents|mesh-ancestor
101843296|NCT00445770|Etanercept|etanercept|mesh-list
101843297|NCT00445770|Methotrexate|methotrexate|mesh-list
101843298|NCT00445770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101843299|NCT00445770|Abortifacient Agents|abortifacient agents|mesh-ancestor
101843300|NCT00445770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101843301|NCT00445770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843302|NCT00445770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101843303|NCT00445770|Antimetabolites|antimetabolites|mesh-ancestor
101843304|NCT00445770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843305|NCT00445770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101843306|NCT00445770|Dermatologic Agents|dermatologic agents|mesh-ancestor
101843307|NCT00445770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101843308|NCT00445770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101843309|NCT00445770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101843310|NCT00445770|Immunologic Factors|immunologic factors|mesh-ancestor
101843311|NCT00445770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101843312|NCT00445770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101843313|NCT00445770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101843314|NCT00445770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101843315|NCT00445770|Analgesics|analgesics|mesh-ancestor
101843316|NCT00445770|Sensory System Agents|sensory system agents|mesh-ancestor
101843317|NCT00445770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101843318|NCT00445770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101843319|NCT00445770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101843320|NCT00266032|Drospirenone|drospirenone|mesh-list
101843321|NCT00266032|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101843322|NCT00266032|Hormone Antagonists|hormone antagonists|mesh-ancestor
101843323|NCT00266032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101843324|NCT00266032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843325|NCT00266032|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101843326|NCT00266032|Diuretics|diuretics|mesh-ancestor
101843327|NCT00266032|Natriuretic Agents|natriuretic agents|mesh-ancestor
101843328|NCT01019798|Docetaxel|docetaxel|mesh-list
101843329|NCT01019798|Sunitinib|sunitinib|mesh-list
101843330|NCT01019798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101843331|NCT01019798|Tubulin Modulators|tubulin modulators|mesh-ancestor
101843332|NCT01019798|Antimitotic Agents|antimitotic agents|mesh-ancestor
101843333|NCT01019798|Mitosis Modulators|mitosis modulators|mesh-ancestor
101843334|NCT01019798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843335|NCT01019798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101843336|NCT01019798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101843337|NCT01019798|Growth Substances|growth substances|mesh-ancestor
101843338|NCT01019798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843339|NCT01019798|Growth Inhibitors|growth inhibitors|mesh-ancestor
101843340|NCT01019798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101843341|NCT01019798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101843342|NCT00483002|Varenicline|varenicline|mesh-list
101843343|NCT00483002|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101843344|NCT00483002|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101843345|NCT00483002|Cholinergic Agents|cholinergic agents|mesh-ancestor
101843346|NCT00483002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101843347|NCT00483002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843348|NCT00483002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843349|NCT00482612|Mirtazapine|mirtazapine|mesh-list
101843350|NCT00482612|Antidepressive Agents|antidepressive agents|mesh-ancestor
101843351|NCT00482612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101843352|NCT00482612|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101843353|NCT00482612|Histamine Antagonists|histamine antagonists|mesh-ancestor
101843354|NCT00482612|Histamine Agents|histamine agents|mesh-ancestor
101843355|NCT00482612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101843356|NCT00482612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843357|NCT00482612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843358|NCT00482612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101843359|NCT00482612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101843360|NCT00482612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101843361|NCT00482612|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101843362|NCT00482612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101843363|NCT00482612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101843364|NCT00482612|Adrenergic Agents|adrenergic agents|mesh-ancestor
101843365|NCT00482612|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101843366|NCT00482612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101843367|NCT00482612|Serotonin Agents|serotonin agents|mesh-ancestor
101843368|NCT00482612|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101843369|NCT00282568|Tacrolimus|tacrolimus|mesh-list
101843370|NCT00282568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101843371|NCT00282568|Immunologic Factors|immunologic factors|mesh-ancestor
101843372|NCT00282568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843373|NCT00282568|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101843374|NCT00282568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101843375|NCT00282568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843376|NCT02532322|Acetaminophen|acetaminophen|mesh-list
101843377|NCT02532322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101843378|NCT02532322|Analgesics|analgesics|mesh-ancestor
101843379|NCT02532322|Sensory System Agents|sensory system agents|mesh-ancestor
101843380|NCT02532322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101843381|NCT02532322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843382|NCT02532322|Antipyretics|antipyretics|mesh-ancestor
101843383|NCT00445692|Clarithromycin|clarithromycin|mesh-list
101843384|NCT00445692|Dexamethasone|dexamethasone|mesh-list
101843385|NCT00445692|Dexamethasone acetate|dexamethasone acetate|mesh-list
101843386|NCT00445692|Lenalidomide|lenalidomide|mesh-list
101843387|NCT00445692|Ichthammol|ichthammol|mesh-list
101843388|NCT00445692|BB 1101|bb 1101|mesh-list
101843389|NCT00445692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101843390|NCT00445692|Antiemetics|antiemetics|mesh-ancestor
101843391|NCT00445692|Autonomic Agents|autonomic agents|mesh-ancestor
101843410|NCT00445692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101843411|NCT00445692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101843413|NCT00445692|Dermatologic Agents|dermatologic agents|mesh-ancestor
101843414|NCT00282412|Cyclosporine|cyclosporine|mesh-list
101843415|NCT00282412|Mycophenolic Acid|mycophenolic acid|mesh-list
101843416|NCT00282412|Cyclophosphamide|cyclophosphamide|mesh-list
101843417|NCT00282412|Fludarabine|fludarabine|mesh-list
101843418|NCT00282412|Alemtuzumab|alemtuzumab|mesh-list
101843419|NCT00282412|Cyclosporins|cyclosporins|mesh-list
101843420|NCT00282412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101843421|NCT00282412|Immunologic Factors|immunologic factors|mesh-ancestor
101843422|NCT00282412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843423|NCT00282412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101843424|NCT00282412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101843425|NCT00282412|Alkylating Agents|alkylating agents|mesh-ancestor
101843426|NCT00282412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843427|NCT00282412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101843428|NCT00282412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101843429|NCT00282412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101843430|NCT00282412|Antifungal Agents|antifungal agents|mesh-ancestor
101843431|NCT00282412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101843432|NCT00282412|Dermatologic Agents|dermatologic agents|mesh-ancestor
101843433|NCT00282412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101843434|NCT00282412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101843435|NCT00282412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101843436|NCT00282412|Antitubercular Agents|antitubercular agents|mesh-ancestor
101843437|NCT00282412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101843438|NCT00282412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101843459|NCT00282256|Tacrolimus|tacrolimus|mesh-list
101843460|NCT00282256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101843461|NCT00282256|Immunologic Factors|immunologic factors|mesh-ancestor
101843462|NCT00282256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843463|NCT00282256|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101843464|NCT00282256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101843465|NCT00282256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843466|NCT00265330|Ziprasidone|ziprasidone|mesh-list
101843467|NCT00265330|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101843468|NCT00265330|Serotonin Agents|serotonin agents|mesh-ancestor
101843469|NCT00265330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101843470|NCT00265330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843471|NCT00265330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843472|NCT00265330|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101843473|NCT00265330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101843474|NCT00265330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101843475|NCT00265330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101843476|NCT00265330|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101843477|NCT00265330|Dopamine Agents|dopamine agents|mesh-ancestor
101843478|NCT00543569|Mycophenolic Acid|mycophenolic acid|mesh-list
101843479|NCT00543569|Alefacept|alefacept|mesh-list
101843480|NCT00543569|Tacrolimus|tacrolimus|mesh-list
101843481|NCT00543569|Basiliximab|basiliximab|mesh-list
101843482|NCT00543569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101843483|NCT00543569|Immunologic Factors|immunologic factors|mesh-ancestor
101843484|NCT00543569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843485|NCT00543569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101843486|NCT00543569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101843487|NCT00543569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843488|NCT00543569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101843489|NCT00543569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101843490|NCT00543569|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101843491|NCT00543569|Antitubercular Agents|antitubercular agents|mesh-ancestor
101843492|NCT00543569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101843493|NCT00543569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101843494|NCT00543569|Dermatologic Agents|dermatologic agents|mesh-ancestor
101843496|NCT00984347|Oxytocics|oxytocics|mesh-ancestor
101843497|NCT00984347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101843498|NCT00984347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843499|NCT00984425|Sorafenib|sorafenib|mesh-list
101843500|NCT00984425|Lapatinib|lapatinib|mesh-list
101843501|NCT00984425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101843502|NCT00984425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101843503|NCT00984425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101843504|NCT00984425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843505|NCT05596955|Naltrexone|naltrexone|mesh-list
101843506|NCT05596955|Buprenorphine|buprenorphine|mesh-list
101843507|NCT05596955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101843508|NCT05596955|Narcotics|narcotics|mesh-ancestor
101843509|NCT05596955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101843510|NCT05596955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843511|NCT05596955|Analgesics|analgesics|mesh-ancestor
101843512|NCT05596955|Sensory System Agents|sensory system agents|mesh-ancestor
101843513|NCT05596955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101843514|NCT05596955|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101843515|NCT05596955|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101843516|NCT00445458|Paclitaxel|paclitaxel|mesh-list
101843517|NCT00445458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101843518|NCT00445458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101843519|NCT00445458|Tubulin Modulators|tubulin modulators|mesh-ancestor
101843520|NCT00445458|Antimitotic Agents|antimitotic agents|mesh-ancestor
101843521|NCT00445458|Mitosis Modulators|mitosis modulators|mesh-ancestor
101843522|NCT00445458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843523|NCT03914417|Imiquimod|imiquimod|mesh-list
101843524|NCT03914417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101843525|NCT03914417|Immunologic Factors|immunologic factors|mesh-ancestor
101843526|NCT03914417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843527|NCT03914417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101843528|NCT03914417|Interferon Inducers|interferon inducers|mesh-ancestor
101843529|NCT05586113|Bismuth|bismuth|mesh-list
101843530|NCT05586113|Antacids|antacids|mesh-ancestor
101843531|NCT05586113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843532|NCT05586113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101843533|NCT00541385|Artesunate|artesunate|mesh-list
101843534|NCT00541385|Lumefantrine|lumefantrine|mesh-list
101843535|NCT00541385|Pyronaridine|pyronaridine|mesh-list
101843536|NCT00541385|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
101843538|NCT00541385|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101843539|NCT00541385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101843540|NCT00541385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101843541|NCT00541385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101843542|NCT00541385|Antiviral Agents|antiviral agents|mesh-ancestor
101843543|NCT00541385|Schistosomicides|schistosomicides|mesh-ancestor
101843544|NCT00541385|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101843545|NCT00541385|Anthelmintics|anthelmintics|mesh-ancestor
101843546|NCT00988949|Spiradoline|spiradoline|mesh-list
101843547|NCT00988949|Analgesics|analgesics|mesh-ancestor
101843548|NCT00988949|Sensory System Agents|sensory system agents|mesh-ancestor
101843549|NCT00988949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101843550|NCT00988949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843551|NCT00988949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101843552|NCT00988949|Diuretics|diuretics|mesh-ancestor
101843553|NCT00988949|Natriuretic Agents|natriuretic agents|mesh-ancestor
101843554|NCT00989027|Oxytocin|oxytocin|mesh-list
101843555|NCT00989027|Carboprost|carboprost|mesh-list
101843556|NCT00989027|Carboprost tromethamine|carboprost tromethamine|mesh-list
101843557|NCT00989027|Ergonovine|ergonovine|mesh-list
101843558|NCT00989027|Oxytocics|oxytocics|mesh-ancestor
101843559|NCT00989027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101843560|NCT00989027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843561|NCT00989027|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101843562|NCT00989027|Abortifacient Agents|abortifacient agents|mesh-ancestor
101843563|NCT00265096|Golimumab|golimumab|mesh-list
101843564|NCT00265096|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101843565|NCT00265096|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101843566|NCT00265096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101843567|NCT00265096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101843568|NCT00265096|Immunologic Factors|immunologic factors|mesh-ancestor
101843569|NCT00265096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843570|NCT02201108|Teriflunomide|teriflunomide|mesh-list
101843571|NCT02201108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101843572|NCT02201108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101843573|NCT02201108|Analgesics|analgesics|mesh-ancestor
101563418|NCT04941573|Xenon|xenon|mesh-list
101843574|NCT02201108|Sensory System Agents|sensory system agents|mesh-ancestor
101843575|NCT02201108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101843576|NCT02201108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843577|NCT02201108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101843578|NCT02201108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101843579|NCT02201108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101843580|NCT02201108|Immunologic Factors|immunologic factors|mesh-ancestor
101843581|NCT00986609|Poly I-C|poly i-c|mesh-list
101843582|NCT00986609|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101843583|NCT00986609|Vaccines|vaccines|mesh-list
101843584|NCT00986609|Poly ICLC|poly iclc|mesh-list
101843585|NCT00986609|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
101843586|NCT00986609|Immunologic Factors|immunologic factors|mesh-ancestor
101843587|NCT00986609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843588|NCT00986609|Interferon Inducers|interferon inducers|mesh-ancestor
101843589|NCT00986609|Laxatives|laxatives|mesh-ancestor
101843590|NCT00986609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101843591|NCT00986609|Antiviral Agents|antiviral agents|mesh-ancestor
101843592|NCT00986609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101843593|NCT00986609|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101843594|NCT00281320|Asenapine|asenapine|mesh-list
101843595|NCT00281320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101843596|NCT00281320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101843597|NCT00281320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101843598|NCT00281320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843599|NCT00281320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101843600|NCT00541307|Heparin|heparin|mesh-list
101843601|NCT00541307|Anticoagulants|anticoagulants|mesh-ancestor
101843602|NCT00541307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101843603|NCT00541307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101843604|NCT00541307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843605|NCT05003258|Dexamethasone|dexamethasone|mesh-list
101843606|NCT05003258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101843607|NCT05003258|Antiemetics|antiemetics|mesh-ancestor
101843608|NCT05003258|Autonomic Agents|autonomic agents|mesh-ancestor
101843609|NCT05003258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101843610|NCT05003258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843611|NCT05003258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101843612|NCT05003258|Glucocorticoids|glucocorticoids|mesh-ancestor
101843613|NCT05003258|Hormones|hormones|mesh-ancestor
101843614|NCT05003258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101843615|NCT05003258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101843616|NCT05003258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101843617|NCT05499689|Bupivacaine|bupivacaine|mesh-list
101843618|NCT05499689|Anesthetics, Local|anesthetics, local|mesh-ancestor
101843619|NCT05499689|Anesthetics|anesthetics|mesh-ancestor
101843620|NCT05499689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101843621|NCT05499689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843622|NCT05499689|Sensory System Agents|sensory system agents|mesh-ancestor
101843623|NCT05499689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101843624|NCT01012232|Ropivacaine|ropivacaine|mesh-list
101843625|NCT01012232|Anesthetics, Local|anesthetics, local|mesh-ancestor
101843626|NCT01012232|Anesthetics|anesthetics|mesh-ancestor
101843627|NCT01012232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101843628|NCT01012232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843629|NCT01012232|Sensory System Agents|sensory system agents|mesh-ancestor
101843630|NCT01012232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101843631|NCT00541229|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101843632|NCT00541229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101843633|NCT00541229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843635|NCT00541229|Hormones|hormones|mesh-ancestor
101843636|NCT00541229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101843637|NCT00541229|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101843638|NCT00541229|Protease Inhibitors|protease inhibitors|mesh-ancestor
101843639|NCT00541229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101843640|NCT00541229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843641|NCT04006691|Mitomycins|mitomycins|mesh-list
101843642|NCT04006691|Mitomycin|mitomycin|mesh-list
101843643|NCT04006691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101843644|NCT04006691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101843645|NCT04006691|Alkylating Agents|alkylating agents|mesh-ancestor
101843646|NCT04006691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843647|NCT04006691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101843648|NCT04006691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101563464|NCT04818216|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101843649|NCT00986765|Aspirin|aspirin|mesh-list
101843650|NCT00986765|Enoxaparin|enoxaparin|mesh-list
101843651|NCT00986765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101843652|NCT00986765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101843653|NCT00986765|Analgesics|analgesics|mesh-ancestor
101843654|NCT00986765|Sensory System Agents|sensory system agents|mesh-ancestor
101843655|NCT00986765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101843656|NCT00986765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843657|NCT00986765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101843658|NCT00986765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101843659|NCT00986765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101843660|NCT00986765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101843661|NCT00986765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843662|NCT00986765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101843663|NCT00986765|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101843664|NCT00986765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101843665|NCT00986765|Antipyretics|antipyretics|mesh-ancestor
101843666|NCT00986765|Anticoagulants|anticoagulants|mesh-ancestor
101843667|NCT00986843|Irinotecan|irinotecan|mesh-list
101843668|NCT00986843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101843669|NCT00986843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101843670|NCT00986843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101843671|NCT00986843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843672|NCT00986843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101843673|NCT01019876|Cyclophosphamide|cyclophosphamide|mesh-list
101843674|NCT01019876|Fludarabine|fludarabine|mesh-list
101843675|NCT01019876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101843676|NCT01019876|Immunologic Factors|immunologic factors|mesh-ancestor
101843677|NCT01019876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843678|NCT01019876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101843679|NCT01019876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101843680|NCT01019876|Alkylating Agents|alkylating agents|mesh-ancestor
101963672|NCT02031016|Narcotics|narcotics|mesh-ancestor
101843681|NCT01019876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843682|NCT01019876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101843683|NCT01019876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101843684|NCT05463419|Vaccines|vaccines|mesh-list
101843685|NCT05463419|Immunologic Factors|immunologic factors|mesh-ancestor
101843686|NCT05463419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843687|NCT01017770|Artesunate|artesunate|mesh-list
101843688|NCT01017770|Lumefantrine|lumefantrine|mesh-list
101843689|NCT01017770|Artemether|artemether|mesh-list
101843690|NCT01017770|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101843691|NCT01017770|Amodiaquine|amodiaquine|mesh-list
101843692|NCT01017770|Antimalarials|antimalarials|mesh-ancestor
101843693|NCT01017770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101843694|NCT01017770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101843695|NCT01017770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101843696|NCT01017770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101843697|NCT01017770|Antiviral Agents|antiviral agents|mesh-ancestor
101843698|NCT01017770|Schistosomicides|schistosomicides|mesh-ancestor
101843699|NCT01017770|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101843700|NCT01017770|Anthelmintics|anthelmintics|mesh-ancestor
101843701|NCT01017926|Triazolam|triazolam|mesh-list
101843702|NCT01017926|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101843703|NCT01017926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101843704|NCT01017926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101843705|NCT01017926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101843706|NCT01017926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685923|NCT00632645|Olanzapine|olanzapine|mesh-list
101843708|NCT01017926|GABA Modulators|gaba modulators|mesh-ancestor
101843709|NCT01017926|GABA Agents|gaba agents|mesh-ancestor
101843710|NCT01017926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101843711|NCT01017926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843712|NCT00481832|Cyclosporine|cyclosporine|mesh-list
101843713|NCT00481832|Mycophenolic Acid|mycophenolic acid|mesh-list
101843714|NCT00481832|Methylprednisolone|methylprednisolone|mesh-list
101843715|NCT00481832|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101843716|NCT00481832|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101843717|NCT00481832|Prednisolone|prednisolone|mesh-list
101843718|NCT00481832|Prednisolone acetate|prednisolone acetate|mesh-list
101843719|NCT00481832|Cyclophosphamide|cyclophosphamide|mesh-list
101843720|NCT00481832|Carmustine|carmustine|mesh-list
101843721|NCT00481832|Rituximab|rituximab|mesh-list
101843722|NCT00481832|Etoposide|etoposide|mesh-list
101843723|NCT00481832|Cyclosporins|cyclosporins|mesh-list
101843724|NCT00481832|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101843725|NCT00481832|Lenograstim|lenograstim|mesh-list
101843726|NCT00481832|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101843727|NCT00481832|Prednisolone phosphate|prednisolone phosphate|mesh-list
101843728|NCT00481832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101843729|NCT00481832|Immunologic Factors|immunologic factors|mesh-ancestor
101843730|NCT00481832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843731|NCT00481832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101843732|NCT00481832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101843733|NCT00481832|Alkylating Agents|alkylating agents|mesh-ancestor
101843734|NCT00481832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843735|NCT00481832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101843736|NCT00481832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101843737|NCT00481832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101843738|NCT00481832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101843739|NCT00481832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101843740|NCT00481832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101843741|NCT00481832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101843742|NCT00481832|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101843743|NCT00481832|Antifungal Agents|antifungal agents|mesh-ancestor
101843744|NCT00481832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101843745|NCT00481832|Dermatologic Agents|dermatologic agents|mesh-ancestor
101843746|NCT00481832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101843747|NCT00481832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101843748|NCT00481832|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101843749|NCT00481832|Antitubercular Agents|antitubercular agents|mesh-ancestor
101843750|NCT00481832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101843751|NCT00481832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101843752|NCT00481832|Antiemetics|antiemetics|mesh-ancestor
101843753|NCT00481832|Autonomic Agents|autonomic agents|mesh-ancestor
101843754|NCT00481832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101843755|NCT00481832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101843756|NCT00481832|Glucocorticoids|glucocorticoids|mesh-ancestor
101843757|NCT00481832|Hormones|hormones|mesh-ancestor
101843758|NCT00481832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101843759|NCT00481832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101843760|NCT00481832|Protective Agents|protective agents|mesh-ancestor
101843761|NCT00481832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101843762|NCT00481676|Omalizumab|omalizumab|mesh-list
101843763|NCT00481676|Loratadine|loratadine|mesh-list
101843764|NCT00481676|Clemastine|clemastine|mesh-list
101843765|NCT00481676|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101843766|NCT00481676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101843767|NCT00481676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101238047|NCT03136731|Antibodies|antibodies|mesh-list
101843768|NCT00481676|Respiratory System Agents|respiratory system agents|mesh-ancestor
101843769|NCT00481676|Immunologic Factors|immunologic factors|mesh-ancestor
101843770|NCT00481676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843771|NCT00481676|Antipruritics|antipruritics|mesh-ancestor
101843772|NCT00481676|Dermatologic Agents|dermatologic agents|mesh-ancestor
101843773|NCT00481676|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101843774|NCT00481676|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101843775|NCT00481676|Histamine Antagonists|histamine antagonists|mesh-ancestor
101843776|NCT00481676|Histamine Agents|histamine agents|mesh-ancestor
101843777|NCT00481676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101843778|NCT00481676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843779|NCT00987233|Triamcinolone|triamcinolone|mesh-list
101843780|NCT00987233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101843781|NCT00987233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101843782|NCT00987233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101843783|NCT00987233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101843784|NCT00987233|Glucocorticoids|glucocorticoids|mesh-ancestor
101843785|NCT00987233|Hormones|hormones|mesh-ancestor
101843786|NCT00987233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101843787|NCT00987233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843788|NCT00987233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101843789|NCT00987233|Immunologic Factors|immunologic factors|mesh-ancestor
101843790|NCT00987233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101843791|NCT00987233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843792|NCT04377503|Methylprednisolone|methylprednisolone|mesh-list
101843793|NCT04377503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101843794|NCT04377503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101843795|NCT04377503|Prednisolone|prednisolone|mesh-list
101843796|NCT04377503|Prednisolone acetate|prednisolone acetate|mesh-list
101843797|NCT04377503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101843798|NCT04377503|Prednisolone phosphate|prednisolone phosphate|mesh-list
101843799|NCT04377503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101843800|NCT04377503|Antiemetics|antiemetics|mesh-ancestor
101843801|NCT04377503|Autonomic Agents|autonomic agents|mesh-ancestor
101843802|NCT04377503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101843803|NCT04377503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843805|NCT04377503|Glucocorticoids|glucocorticoids|mesh-ancestor
101843806|NCT04377503|Hormones|hormones|mesh-ancestor
101843807|NCT04377503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101843808|NCT04377503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101843809|NCT04377503|Protective Agents|protective agents|mesh-ancestor
101843810|NCT04377503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101843811|NCT04377503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101843812|NCT00542789|Esomeprazole|esomeprazole|mesh-list
101843813|NCT00542789|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101843814|NCT00542789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101843815|NCT00542789|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101843816|NCT00542789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101843817|NCT00542789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843818|NCT00464672|Vaccines|vaccines|mesh-list
101843819|NCT00464672|Immunologic Factors|immunologic factors|mesh-ancestor
101843820|NCT00464672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843821|NCT03996434|Cetrorelix|cetrorelix|mesh-list
101843822|NCT03996434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101843823|NCT03996434|Fertility Agents|fertility agents|mesh-ancestor
101843824|NCT03996434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101843825|NCT03996434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843826|NCT03996434|Hormone Antagonists|hormone antagonists|mesh-ancestor
101843827|NCT03996434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101843828|NCT00987779|Gabapentin|gabapentin|mesh-list
101843829|NCT00987779|Analgesics|analgesics|mesh-ancestor
101843830|NCT00987779|Sensory System Agents|sensory system agents|mesh-ancestor
101843831|NCT00987779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101843832|NCT00987779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843833|NCT00987779|Anticonvulsants|anticonvulsants|mesh-ancestor
101843834|NCT00987779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101843835|NCT00987779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101843836|NCT00987779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101843837|NCT00987779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101843838|NCT00987779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101843839|NCT00987779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101843840|NCT00987779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101843841|NCT00987779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843842|NCT00987779|Antimanic Agents|antimanic agents|mesh-ancestor
101843843|NCT01018160|Rabeprazole|rabeprazole|mesh-list
101843844|NCT01018160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101843845|NCT01018160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101843846|NCT01018160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101843847|NCT01018160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101843848|NCT01018160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843849|NCT00473876|Metformin|metformin|mesh-list
101843850|NCT00473876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101843851|NCT00473876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843852|NCT00463580|Infliximab|infliximab|mesh-list
101843853|NCT00463580|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101843854|NCT00463580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101843855|NCT00463580|Dermatologic Agents|dermatologic agents|mesh-ancestor
101843856|NCT00463580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101843857|NCT00463580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101843858|NCT01020734|Cyclosporine|cyclosporine|mesh-list
101843859|NCT01020734|Cyclophosphamide|cyclophosphamide|mesh-list
101843860|NCT01020734|Busulfan|busulfan|mesh-list
101843861|NCT01020734|Methotrexate|methotrexate|mesh-list
101843862|NCT01020734|Fludarabine|fludarabine|mesh-list
101843863|NCT01020734|Fludarabine phosphate|fludarabine phosphate|mesh-list
101843864|NCT01020734|Cyclosporins|cyclosporins|mesh-list
101843865|NCT01020734|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101843866|NCT01020734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101843867|NCT01020734|Immunologic Factors|immunologic factors|mesh-ancestor
101843868|NCT01020734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843869|NCT01020734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101843870|NCT01020734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101843871|NCT01020734|Alkylating Agents|alkylating agents|mesh-ancestor
101843872|NCT01020734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843873|NCT01020734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101843874|NCT01020734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101843875|NCT01020734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101843876|NCT01020734|Abortifacient Agents|abortifacient agents|mesh-ancestor
101843877|NCT01020734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101843878|NCT01020734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101843879|NCT01020734|Antimetabolites|antimetabolites|mesh-ancestor
101843880|NCT01020734|Dermatologic Agents|dermatologic agents|mesh-ancestor
101843881|NCT01020734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101843882|NCT01020734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101843883|NCT01020734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101843884|NCT01020734|Antifungal Agents|antifungal agents|mesh-ancestor
101843885|NCT01020734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101843886|NCT01020734|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101843887|NCT00540449|Efavirenz|efavirenz|mesh-list
101843888|NCT00540449|Rilpivirine|rilpivirine|mesh-list
101843889|NCT00540449|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101843890|NCT00540449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101843891|NCT00540449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101238076|NCT02939573|Leprostatic Agents|leprostatic agents|mesh-ancestor
101843892|NCT00540449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843893|NCT00540449|Antiviral Agents|antiviral agents|mesh-ancestor
101843894|NCT00540449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101843895|NCT00540449|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101843896|NCT00540449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101843897|NCT00540449|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101843899|NCT00540449|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101843900|NCT00540449|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101843901|NCT00540449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101843902|NCT00540449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101843903|NCT03911843|Vitamin D|vitamin d|mesh-list
101843904|NCT03911843|Vitamins|vitamins|mesh-ancestor
101843905|NCT03911843|Micronutrients|micronutrients|mesh-ancestor
101843906|NCT03911843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843907|NCT03911843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101843908|NCT00361335|Golimumab|golimumab|mesh-list
101843909|NCT00361335|Methotrexate|methotrexate|mesh-list
101843910|NCT00361335|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101843911|NCT00361335|Abortifacient Agents|abortifacient agents|mesh-ancestor
101843912|NCT00361335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101843913|NCT00361335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843914|NCT00361335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101843915|NCT00361335|Antimetabolites|antimetabolites|mesh-ancestor
101843916|NCT00361335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843917|NCT00361335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101843918|NCT00361335|Dermatologic Agents|dermatologic agents|mesh-ancestor
101843919|NCT00361335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101843920|NCT00361335|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101843921|NCT00361335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101843922|NCT00361335|Immunologic Factors|immunologic factors|mesh-ancestor
101843923|NCT00361335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101843924|NCT00361335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101843925|NCT00361335|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101843926|NCT00361335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101843927|NCT00264550|Golimumab|golimumab|mesh-list
101843928|NCT00264550|Methotrexate|methotrexate|mesh-list
101843929|NCT00264550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101843930|NCT00264550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101843931|NCT00264550|Abortifacient Agents|abortifacient agents|mesh-ancestor
101843932|NCT00264550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101843933|NCT00264550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843934|NCT00264550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101843935|NCT00264550|Antimetabolites|antimetabolites|mesh-ancestor
101238085|NCT02876107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101843936|NCT00264550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843937|NCT00264550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101843938|NCT00264550|Dermatologic Agents|dermatologic agents|mesh-ancestor
101843939|NCT00264550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101843940|NCT00264550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101843941|NCT00264550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101843942|NCT00264550|Immunologic Factors|immunologic factors|mesh-ancestor
101843943|NCT00264550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101843944|NCT00264550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101843945|NCT00264550|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101563763|NCT03735979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101563764|NCT03722498|Leucovorin|leucovorin|mesh-list
101563765|NCT03722498|Fluorouracil|fluorouracil|mesh-list
101563766|NCT03722498|Oxaliplatin|oxaliplatin|mesh-list
101563767|NCT03722498|Sorafenib|sorafenib|mesh-list
101563768|NCT03722498|Antimetabolites|antimetabolites|mesh-ancestor
101563775|NCT03722498|Antidotes|antidotes|mesh-ancestor
101843946|NCT00264550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101843947|NCT04004507|Phentolamine|phentolamine|mesh-list
101843948|NCT04004507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101843949|NCT04004507|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101843950|NCT04004507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101843951|NCT04004507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101843952|NCT04004507|Adrenergic Agents|adrenergic agents|mesh-ancestor
101843953|NCT04004507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101843954|NCT04004507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843955|NCT04004507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843956|NCT04004507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101843957|NCT01070290|Capecitabine|capecitabine|mesh-list
101843958|NCT01070290|Oxaliplatin|oxaliplatin|mesh-list
101843959|NCT01070290|Irinotecan|irinotecan|mesh-list
101843960|NCT01070290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101843962|NCT01070290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843963|NCT01070290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101843964|NCT01070290|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101843965|NCT01070290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101843966|NCT01070290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101843967|NCT01070446|Choline|choline|mesh-list
101843968|NCT01070446|Lipotropic Agents|lipotropic agents|mesh-ancestor
101843969|NCT01070446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101843970|NCT01070446|Antimetabolites|antimetabolites|mesh-ancestor
101843971|NCT01070446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101843972|NCT01070446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101843973|NCT01070446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101843974|NCT01070446|Nootropic Agents|nootropic agents|mesh-ancestor
101843975|NCT01050387|Vitamin D|vitamin d|mesh-list
101843976|NCT01050387|Vitamins|vitamins|mesh-ancestor
101843977|NCT01050387|Micronutrients|micronutrients|mesh-ancestor
101843978|NCT01050387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843979|NCT01050387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101843980|NCT01070524|Budesonide|budesonide|mesh-list
101843981|NCT01070524|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101843982|NCT01070524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101843983|NCT01070524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101843984|NCT01070524|Autonomic Agents|autonomic agents|mesh-ancestor
101843985|NCT01070524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101843986|NCT01070524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843987|NCT01070524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101843988|NCT01070524|Respiratory System Agents|respiratory system agents|mesh-ancestor
101843989|NCT01070524|Glucocorticoids|glucocorticoids|mesh-ancestor
101843990|NCT01070524|Hormones|hormones|mesh-ancestor
101843991|NCT01070524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101843992|NCT01070524|Sympathomimetics|sympathomimetics|mesh-ancestor
101843994|NCT01071304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101843995|NCT01071304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101843996|NCT01071304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101843997|NCT01071304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101843998|NCT01071304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101843999|NCT01071304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101844000|NCT01071304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101844001|NCT01071304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101844002|NCT01071304|Anesthetics, General|anesthetics, general|mesh-ancestor
101844003|NCT01071304|Anesthetics|anesthetics|mesh-ancestor
101844004|NCT01071304|GABA Modulators|gaba modulators|mesh-ancestor
101844005|NCT01071304|GABA Agents|gaba agents|mesh-ancestor
101844006|NCT01071304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101844007|NCT01071304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844008|NCT01069042|Enalapril|enalapril|mesh-list
101844009|NCT01069042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101844010|NCT01069042|Protease Inhibitors|protease inhibitors|mesh-ancestor
101844011|NCT01069042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101844012|NCT01069042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844013|NCT01069042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101844014|NCT00368979|Dutasteride|dutasteride|mesh-list
101844015|NCT00368979|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101844016|NCT00368979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101844017|NCT00368979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101844018|NCT00368979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844019|NCT00368979|Hormone Antagonists|hormone antagonists|mesh-ancestor
101844020|NCT00368979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101844021|NCT00368979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844023|NCT00264238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101844024|NCT00264238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101844025|NCT00264238|Dopamine Agents|dopamine agents|mesh-ancestor
101844026|NCT00264238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101844027|NCT00264238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844028|NCT00264238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844029|NCT00264238|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101238137|NCT02727803|Busulfan|busulfan|mesh-list
101844030|NCT00264238|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101844031|NCT00540293|Atorvastatin|atorvastatin|mesh-list
101844032|NCT00540293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101844033|NCT00540293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101844034|NCT00540293|Antimetabolites|antimetabolites|mesh-ancestor
101844035|NCT00540293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844036|NCT00540293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101844037|NCT00540293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101844038|NCT00540293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101844039|NCT01050621|Ascorbic Acid|ascorbic acid|mesh-list
101844040|NCT01050621|Vitamins|vitamins|mesh-ancestor
101844041|NCT01050621|Micronutrients|micronutrients|mesh-ancestor
101844042|NCT01050621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844043|NCT01050621|Antioxidants|antioxidants|mesh-ancestor
101844044|NCT01050621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844045|NCT01050621|Protective Agents|protective agents|mesh-ancestor
101844046|NCT00359073|Montelukast|montelukast|mesh-list
101844047|NCT00359073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101844048|NCT00359073|Respiratory System Agents|respiratory system agents|mesh-ancestor
101844049|NCT00359073|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101844050|NCT00359073|Hormone Antagonists|hormone antagonists|mesh-ancestor
101844051|NCT00359073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101844052|NCT00359073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844053|NCT00359073|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101844054|NCT00359073|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101844055|NCT00359073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844056|NCT00368745|Pregabalin|pregabalin|mesh-list
101844057|NCT00368745|Analgesics|analgesics|mesh-ancestor
101844058|NCT00368745|Sensory System Agents|sensory system agents|mesh-ancestor
101844059|NCT00368745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101844060|NCT00368745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844061|NCT00368745|Anticonvulsants|anticonvulsants|mesh-ancestor
101844062|NCT00368745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101844063|NCT00368745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101844064|NCT00368745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844065|NCT00368745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101844066|NCT00368745|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101844067|NCT00368745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101844068|NCT00368745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101844069|NCT00368745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101844070|NCT03235739|Naloxegol|naloxegol|mesh-list
101238171|NCT02702492|Vitamins|vitamins|mesh-ancestor
101844071|NCT03235739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101844072|NCT03235739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844073|NCT03235739|Sensory System Agents|sensory system agents|mesh-ancestor
101844074|NCT03235739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101844075|NCT04573673|Emodin|emodin|mesh-list
101844076|NCT04573673|Cathartics|cathartics|mesh-ancestor
101844077|NCT04573673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101844078|NCT04573673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101844079|NCT04573673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101844080|NCT04573673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844081|NCT01050699|Fentanyl|fentanyl|mesh-list
101844082|NCT01050699|Midazolam|midazolam|mesh-list
101844083|NCT01050699|Dexmedetomidine|dexmedetomidine|mesh-list
101844084|NCT01050699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101844085|NCT01050699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101844086|NCT01050699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844087|NCT01050699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101844088|NCT01050699|Analgesics|analgesics|mesh-ancestor
101844089|NCT01050699|Sensory System Agents|sensory system agents|mesh-ancestor
101844090|NCT01050699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101844091|NCT01050699|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101844092|NCT01050699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101844093|NCT01050699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101844094|NCT01050699|Adrenergic Agents|adrenergic agents|mesh-ancestor
101844095|NCT01050699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101844096|NCT01050699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844097|NCT01050699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101844099|NCT01050699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101844100|NCT01050699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101844101|NCT01050699|Anesthetics, General|anesthetics, general|mesh-ancestor
101844102|NCT01050699|Anesthetics|anesthetics|mesh-ancestor
101844103|NCT01050699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101844104|NCT01050699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101844105|NCT01050699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101844106|NCT01050699|GABA Modulators|gaba modulators|mesh-ancestor
101844107|NCT01050699|GABA Agents|gaba agents|mesh-ancestor
101844108|NCT02408315|Misoprostol|misoprostol|mesh-list
101844109|NCT02408315|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101844110|NCT02408315|Abortifacient Agents|abortifacient agents|mesh-ancestor
101844111|NCT02408315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101844112|NCT02408315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844113|NCT02408315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101844114|NCT02408315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101844115|NCT02408315|Oxytocics|oxytocics|mesh-ancestor
101844116|NCT05711693|Bepridil|bepridil|mesh-list
101844117|NCT05711693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101844118|NCT05711693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101844119|NCT05711693|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101844120|NCT05711693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101844121|NCT05711693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844122|NCT05711693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101844123|NCT05711693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844124|NCT05711693|Vasodilator Agents|vasodilator agents|mesh-ancestor
101844125|NCT04005365|Propranolol|propranolol|mesh-list
101844126|NCT04005365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101844127|NCT04005365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101844128|NCT04005365|Adrenergic Agents|adrenergic agents|mesh-ancestor
101844129|NCT04005365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101387672|NCT00322699|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
101844130|NCT04005365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844131|NCT04005365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844132|NCT04005365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101844133|NCT04005365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101844134|NCT04005365|Vasodilator Agents|vasodilator agents|mesh-ancestor
101844135|NCT01027182|Raltegravir Potassium|raltegravir potassium|mesh-list
101844136|NCT01027182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101844137|NCT01027182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101844138|NCT01027182|Antiviral Agents|antiviral agents|mesh-ancestor
101844139|NCT01027182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101844140|NCT01027182|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101844141|NCT01027182|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101844142|NCT01027182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101844143|NCT01027182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844144|NCT00358917|Ritonavir|ritonavir|mesh-list
101844145|NCT00358917|Lopinavir|lopinavir|mesh-list
101844146|NCT00358917|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
101844147|NCT00358917|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101844148|NCT00358917|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101844149|NCT00358917|Protease Inhibitors|protease inhibitors|mesh-ancestor
101844150|NCT00358917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101844151|NCT00358917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844152|NCT00358917|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101844153|NCT00358917|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101844154|NCT00358917|Antiviral Agents|antiviral agents|mesh-ancestor
101844155|NCT00358917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101844156|NCT00358917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101844157|NCT00358917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101844158|NCT00358917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101844159|NCT01048515|Caffeine|caffeine|mesh-list
101844160|NCT01048515|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101844161|NCT01048515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844162|NCT01048515|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101844163|NCT01048515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101844164|NCT01048515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844165|NCT01048515|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101844166|NCT01048515|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101563997|NCT02392429|Cytarabine|cytarabine|mesh-list
101844167|NCT01048515|Purinergic Agents|purinergic agents|mesh-ancestor
101844168|NCT01048515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101844169|NCT01050777|Paromomycin|paromomycin|mesh-list
101844170|NCT01050777|Meglumine Antimoniate|meglumine antimoniate|mesh-list
101844171|NCT01050777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101683481|NCT02694146|Hylan|hylan|mesh-list
101844172|NCT01050777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101844173|NCT01050777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101844174|NCT01050777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101844175|NCT00264004|Cediranib|cediranib|mesh-list
101844176|NCT00264004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101844177|NCT00264004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101844178|NCT00264004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101844179|NCT00264004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844180|NCT01069198|Vitamin A|vitamin a|mesh-list
101844181|NCT01069198|Albendazole|albendazole|mesh-list
101844182|NCT01069198|Vitamins|vitamins|mesh-ancestor
101844183|NCT01069198|Micronutrients|micronutrients|mesh-ancestor
101844184|NCT01069198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844185|NCT01069198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844186|NCT01069198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101844187|NCT01069198|Anthelmintics|anthelmintics|mesh-ancestor
101844188|NCT01069198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101844189|NCT01069198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101844190|NCT01069198|Anticestodal Agents|anticestodal agents|mesh-ancestor
101844191|NCT01069198|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101844192|NCT01069198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101844193|NCT01069198|Tubulin Modulators|tubulin modulators|mesh-ancestor
101844194|NCT01069198|Antimitotic Agents|antimitotic agents|mesh-ancestor
101844195|NCT01069198|Mitosis Modulators|mitosis modulators|mesh-ancestor
101844196|NCT00368355|Cytarabine|cytarabine|mesh-list
101844197|NCT00368355|Cyclophosphamide|cyclophosphamide|mesh-list
101844198|NCT00368355|Alemtuzumab|alemtuzumab|mesh-list
101844199|NCT00368355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101844200|NCT00368355|Immunologic Factors|immunologic factors|mesh-ancestor
101844201|NCT00368355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844202|NCT00368355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101844203|NCT00368355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101844204|NCT00368355|Alkylating Agents|alkylating agents|mesh-ancestor
101844205|NCT00368355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844206|NCT00368355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101844207|NCT00368355|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101844208|NCT00368355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101844209|NCT00368355|Antimetabolites|antimetabolites|mesh-ancestor
101844210|NCT00368355|Antiviral Agents|antiviral agents|mesh-ancestor
101844211|NCT00368355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101844212|NCT00368355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101844213|NCT01070680|Dexmedetomidine|dexmedetomidine|mesh-list
101844214|NCT01070680|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101844215|NCT01070680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101844216|NCT01070680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844217|NCT01070680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101844218|NCT01070680|Analgesics|analgesics|mesh-ancestor
101844219|NCT01070680|Sensory System Agents|sensory system agents|mesh-ancestor
101844220|NCT01070680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101844221|NCT01070680|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101844222|NCT01070680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101844223|NCT01070680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101844224|NCT01070680|Adrenergic Agents|adrenergic agents|mesh-ancestor
101844225|NCT01070680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101844226|NCT01070680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844227|NCT00445146|Elvitegravir|elvitegravir|mesh-list
101844228|NCT00445146|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101844229|NCT00445146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101844230|NCT00445146|Antiviral Agents|antiviral agents|mesh-ancestor
101844231|NCT00445146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101844232|NCT00445146|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101844233|NCT00445146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101844234|NCT00445146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844235|NCT01581736|Insulin|insulin|mesh-list
101844236|NCT01581736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101844237|NCT01581736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101844238|NCT01581736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844239|NCT01030302|Bortezomib|bortezomib|mesh-list
101844240|NCT01030302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101844241|NCT00368277|Amlodipine|amlodipine|mesh-list
101844242|NCT00368277|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101844243|NCT00368277|Ramipril|ramipril|mesh-list
101844244|NCT00368277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101963705|NCT02198170|Ketoconazole|ketoconazole|mesh-list
101844245|NCT00368277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101844246|NCT00368277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101844247|NCT00368277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844248|NCT00368277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101844249|NCT00368277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844250|NCT00368277|Vasodilator Agents|vasodilator agents|mesh-ancestor
101844251|NCT00368277|Diuretics|diuretics|mesh-ancestor
101844252|NCT00368277|Natriuretic Agents|natriuretic agents|mesh-ancestor
101844253|NCT00368277|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101844254|NCT00368277|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101844255|NCT00368277|Protease Inhibitors|protease inhibitors|mesh-ancestor
101844256|NCT00368277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101844257|NCT00280150|Paclitaxel|paclitaxel|mesh-list
101844258|NCT00280150|Bevacizumab|bevacizumab|mesh-list
101844259|NCT00280150|Carboplatin|carboplatin|mesh-list
101844260|NCT00280150|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101844261|NCT00280150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101844262|NCT00280150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101844263|NCT00280150|Tubulin Modulators|tubulin modulators|mesh-ancestor
101844264|NCT00280150|Antimitotic Agents|antimitotic agents|mesh-ancestor
101844265|NCT00280150|Mitosis Modulators|mitosis modulators|mesh-ancestor
101844266|NCT00280150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844267|NCT00280150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101844268|NCT00280150|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101844269|NCT00280150|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101844270|NCT00280150|Growth Substances|growth substances|mesh-ancestor
101844271|NCT00280150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844272|NCT00280150|Growth Inhibitors|growth inhibitors|mesh-ancestor
101844273|NCT00280150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101844274|NCT00280150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101844275|NCT00279916|Triamcinolone|triamcinolone|mesh-list
101844276|NCT00279916|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101844277|NCT00279916|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101844278|NCT00279916|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101844279|NCT00279916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101844280|NCT00279916|Glucocorticoids|glucocorticoids|mesh-ancestor
101844281|NCT00279916|Hormones|hormones|mesh-ancestor
101685942|NCT00632645|Adrenergic Agents|adrenergic agents|mesh-ancestor
101844282|NCT00279916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101844283|NCT00279916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844284|NCT00279916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101844285|NCT00279916|Immunologic Factors|immunologic factors|mesh-ancestor
101844286|NCT00279916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101844287|NCT00279916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844289|NCT02534337|Gemcitabine|gemcitabine|mesh-list
101844290|NCT02534337|Fluorouracil|fluorouracil|mesh-list
101844291|NCT02534337|Oxaliplatin|oxaliplatin|mesh-list
101844292|NCT02534337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101844293|NCT02534337|Antimetabolites|antimetabolites|mesh-ancestor
101844294|NCT02534337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844295|NCT02534337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101844296|NCT02534337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101844297|NCT02534337|Immunologic Factors|immunologic factors|mesh-ancestor
101844298|NCT02534337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844299|NCT02534337|Antidotes|antidotes|mesh-ancestor
101844300|NCT02534337|Protective Agents|protective agents|mesh-ancestor
101844301|NCT02534337|Vitamin B Complex|vitamin b complex|mesh-ancestor
101844302|NCT02534337|Vitamins|vitamins|mesh-ancestor
101844303|NCT02534337|Micronutrients|micronutrients|mesh-ancestor
101844304|NCT01325896|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101844305|NCT01325896|Antiviral Agents|antiviral agents|mesh-ancestor
101844306|NCT01325896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101844307|NCT01050933|Carbon Monoxide|carbon monoxide|mesh-list
101844308|NCT01050933|Antimetabolites|antimetabolites|mesh-ancestor
101844309|NCT01050933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844310|NCT01050933|Gasotransmitters|gasotransmitters|mesh-ancestor
101844311|NCT01050933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101844312|NCT01050933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844313|NCT00358527|Mometasone Furoate|mometasone furoate|mesh-list
101844314|NCT00358527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101844315|NCT00358527|Dermatologic Agents|dermatologic agents|mesh-ancestor
101844316|NCT00358527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101844317|NCT00251758|Dexlansoprazole|dexlansoprazole|mesh-list
101844318|NCT00251758|Lansoprazole|lansoprazole|mesh-list
101844319|NCT00251758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101844320|NCT00251758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101844321|NCT00251758|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101844322|NCT00251758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101844323|NCT00251758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844324|NCT00279214|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
101844325|NCT00279214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101844326|NCT00262834|Vorinostat|vorinostat|mesh-list
101844327|NCT00262834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101844328|NCT00262834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101844329|NCT00262834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101844330|NCT00262834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844331|NCT04417361|Erenumab|erenumab|mesh-list
101844332|NCT04417361|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
101844333|NCT04417361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844334|NCT04417361|Analgesics|analgesics|mesh-ancestor
101844335|NCT04417361|Sensory System Agents|sensory system agents|mesh-ancestor
101844336|NCT04417361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101844337|NCT04417361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844338|NCT00541775|Metformin|metformin|mesh-list
101844339|NCT00541775|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101844340|NCT00541775|Rosiglitazone|rosiglitazone|mesh-list
101844341|NCT00541775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101844342|NCT00541775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844343|NCT00541775|Incretins|incretins|mesh-ancestor
101844344|NCT00541775|Hormones|hormones|mesh-ancestor
101844345|NCT00541775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101844346|NCT00541775|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101844347|NCT00541775|Protease Inhibitors|protease inhibitors|mesh-ancestor
101844348|NCT00541775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101844349|NCT00541775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844350|NCT04004117|Fentanyl|fentanyl|mesh-list
101844351|NCT04004117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101844352|NCT04004117|Narcotics|narcotics|mesh-ancestor
101844353|NCT04004117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101844354|NCT04004117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844355|NCT04004117|Analgesics|analgesics|mesh-ancestor
101844356|NCT04004117|Sensory System Agents|sensory system agents|mesh-ancestor
101844357|NCT04004117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101844358|NCT04004117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101844359|NCT04004117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101844360|NCT04004117|Anesthetics, General|anesthetics, general|mesh-ancestor
101844361|NCT04004117|Anesthetics|anesthetics|mesh-ancestor
101844362|NCT00539513|Acetylcysteine|acetylcysteine|mesh-list
101844363|NCT00539513|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101844364|NCT00539513|Antiviral Agents|antiviral agents|mesh-ancestor
101844365|NCT00539513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101844366|NCT00539513|Expectorants|expectorants|mesh-ancestor
101844367|NCT00539513|Respiratory System Agents|respiratory system agents|mesh-ancestor
101844368|NCT00539513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101844369|NCT00539513|Antioxidants|antioxidants|mesh-ancestor
101844370|NCT00539513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844371|NCT00539513|Protective Agents|protective agents|mesh-ancestor
101844372|NCT00539513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844373|NCT00539513|Antidotes|antidotes|mesh-ancestor
101844374|NCT02997761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101844375|NCT02997761|Blinatumomab|blinatumomab|mesh-list
101844376|NCT02997761|Antibodies|antibodies|mesh-list
101844377|NCT02997761|Immunoglobulins|immunoglobulins|mesh-list
101844378|NCT02997761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101844379|NCT02997761|Muromonab-CD3|muromonab-cd3|mesh-list
101844380|NCT02997761|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101844381|NCT02997761|Immunologic Factors|immunologic factors|mesh-ancestor
101844382|NCT02997761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844383|NCT02997761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101844384|NCT02997761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101844385|NCT00454584|Etanercept|etanercept|mesh-list
101844386|NCT00454584|Ustekinumab|ustekinumab|mesh-list
101844387|NCT00454584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101844388|NCT00454584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101844389|NCT00454584|Analgesics|analgesics|mesh-ancestor
101844390|NCT00454584|Sensory System Agents|sensory system agents|mesh-ancestor
101844391|NCT00454584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101844392|NCT00454584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844393|NCT00454584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101844394|NCT00454584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101844395|NCT00454584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101844396|NCT00454584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101844397|NCT00454584|Immunologic Factors|immunologic factors|mesh-ancestor
101844398|NCT00454584|Dermatologic Agents|dermatologic agents|mesh-ancestor
101844399|NCT04204343|Bupivacaine|bupivacaine|mesh-list
101844400|NCT04204343|Anesthetics, Local|anesthetics, local|mesh-ancestor
101844401|NCT04204343|Anesthetics|anesthetics|mesh-ancestor
101844402|NCT04204343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101844403|NCT04204343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844404|NCT04204343|Sensory System Agents|sensory system agents|mesh-ancestor
101844405|NCT04204343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101844406|NCT02845271|Acetaminophen|acetaminophen|mesh-list
101844408|NCT02845271|Codeine|codeine|mesh-list
101844409|NCT02845271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101844410|NCT02845271|Analgesics|analgesics|mesh-ancestor
101844411|NCT02845271|Sensory System Agents|sensory system agents|mesh-ancestor
101844412|NCT02845271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101844413|NCT02845271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844414|NCT02845271|Antipyretics|antipyretics|mesh-ancestor
101844415|NCT02845271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101844416|NCT02845271|Narcotics|narcotics|mesh-ancestor
101844417|NCT02845271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101844418|NCT02845271|Antitussive Agents|antitussive agents|mesh-ancestor
101844419|NCT02845271|Respiratory System Agents|respiratory system agents|mesh-ancestor
101844420|NCT00445068|Panobinostat|panobinostat|mesh-list
101238287|NCT01599572|Zinc|zinc|mesh-list
101844421|NCT00445068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101844422|NCT00445068|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101844423|NCT00445068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101844424|NCT00445068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844425|NCT02404337|Betaine|betaine|mesh-list
101844426|NCT02404337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101844427|NCT02404337|Lipotropic Agents|lipotropic agents|mesh-ancestor
101844428|NCT02404337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101844429|NCT02404337|Antimetabolites|antimetabolites|mesh-ancestor
101844430|NCT02404337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844431|NCT02404337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101844432|NCT05360147|Metformin|metformin|mesh-list
101844433|NCT05360147|Liraglutide|liraglutide|mesh-list
101844434|NCT05360147|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101844435|NCT05360147|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
101844436|NCT05360147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844437|NCT05360147|Incretins|incretins|mesh-ancestor
101844438|NCT05360147|Hormones|hormones|mesh-ancestor
101844439|NCT05360147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101844440|NCT00444912|Plerixafor|plerixafor|mesh-list
101844441|NCT00444912|Rituximab|rituximab|mesh-list
101844442|NCT00444912|Lenograstim|lenograstim|mesh-list
101844443|NCT00444912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101844444|NCT00444912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101844445|NCT00444912|Immunologic Factors|immunologic factors|mesh-ancestor
101844446|NCT00444912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844447|NCT00444912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101844448|NCT00444912|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101844449|NCT00444912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101844450|NCT00444912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101844451|NCT00444912|Antiviral Agents|antiviral agents|mesh-ancestor
101844452|NCT00444912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101844453|NCT00538733|Clarithromycin|clarithromycin|mesh-list
101844454|NCT00538733|Thalidomide|thalidomide|mesh-list
101844455|NCT00538733|Dexamethasone|dexamethasone|mesh-list
101844456|NCT00538733|Lenalidomide|lenalidomide|mesh-list
101844457|NCT00538733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101844458|NCT00538733|Antiemetics|antiemetics|mesh-ancestor
101844459|NCT00538733|Autonomic Agents|autonomic agents|mesh-ancestor
101844460|NCT00538733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101844461|NCT00538733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844462|NCT00538733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101844463|NCT00538733|Glucocorticoids|glucocorticoids|mesh-ancestor
101844464|NCT00538733|Hormones|hormones|mesh-ancestor
101844465|NCT00538733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101844466|NCT00538733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101844467|NCT00538733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101844468|NCT00538733|Immunologic Factors|immunologic factors|mesh-ancestor
101844469|NCT00538733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101844470|NCT00538733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101844471|NCT00538733|Growth Substances|growth substances|mesh-ancestor
101844472|NCT00538733|Growth Inhibitors|growth inhibitors|mesh-ancestor
101844473|NCT00538733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101844474|NCT00538733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101844475|NCT00538733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101844476|NCT00538733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101844477|NCT00538733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844478|NCT00538733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101844479|NCT00538733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101844480|NCT00538733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101844481|NCT00538733|Leprostatic Agents|leprostatic agents|mesh-ancestor
101844482|NCT00444678|Capecitabine|capecitabine|mesh-list
101844483|NCT00444678|Oxaliplatin|oxaliplatin|mesh-list
101844484|NCT00444678|Cetuximab|cetuximab|mesh-list
101844485|NCT00444678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101844486|NCT00444678|Antimetabolites|antimetabolites|mesh-ancestor
101844487|NCT00444678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238303|NCT01599819|Factor VIII|factor viii|mesh-list
101844488|NCT00444678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101844489|NCT00444678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101844490|NCT00539981|Hemagglutinins|hemagglutinins|mesh-list
101844491|NCT00539981|Immunologic Factors|immunologic factors|mesh-ancestor
101844492|NCT00539981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844493|NCT00539981|Agglutinins|agglutinins|mesh-ancestor
101844494|NCT00539981|Coagulants|coagulants|mesh-ancestor
101844495|NCT00990197|Nicotine|nicotine|mesh-list
101844496|NCT00990197|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101844497|NCT00990197|Autonomic Agents|autonomic agents|mesh-ancestor
101844498|NCT00990197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101844499|NCT00990197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844500|NCT00990197|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101844501|NCT00990197|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101844502|NCT00990197|Cholinergic Agents|cholinergic agents|mesh-ancestor
101844503|NCT00990197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101844504|NCT00990197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844505|NCT01051011|Metformin|metformin|mesh-list
101844506|NCT01051011|Insulin Glargine|insulin glargine|mesh-list
101844507|NCT01051011|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101685948|NCT02304809|Vemurafenib|vemurafenib|mesh-list
101844508|NCT01051011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101844509|NCT01051011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844510|NCT01051011|Incretins|incretins|mesh-ancestor
101844511|NCT01051011|Hormones|hormones|mesh-ancestor
101844512|NCT01051011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101844513|NCT01048827|Busulfan|busulfan|mesh-list
101844514|NCT01048827|Alkylating Agents|alkylating agents|mesh-ancestor
101844515|NCT01048827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844516|NCT01048827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101844517|NCT01048827|Immunologic Factors|immunologic factors|mesh-ancestor
101844518|NCT01048827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844519|NCT01048827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101844520|NCT01048827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101844521|NCT01048827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101844522|NCT02023463|Leuprolide|leuprolide|mesh-list
101844523|NCT02023463|Goserelin|goserelin|mesh-list
101844524|NCT02023463|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101844525|NCT02023463|Fertility Agents|fertility agents|mesh-ancestor
101844526|NCT02023463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101844527|NCT02023463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844528|NCT02023463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101844529|NCT02023463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101844530|NCT01302327|Exenatide|exenatide|mesh-list
101844531|NCT01302327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101844532|NCT01302327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844533|NCT01302327|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101844534|NCT01302327|Incretins|incretins|mesh-ancestor
101844535|NCT01302327|Hormones|hormones|mesh-ancestor
101844536|NCT01302327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101844537|NCT01048983|Minocycline|minocycline|mesh-list
101844538|NCT01048983|Curcumin|curcumin|mesh-list
101844539|NCT01048983|Modafinil|modafinil|mesh-list
101844540|NCT01048983|Bupropion|bupropion|mesh-list
101844541|NCT01048983|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101844542|NCT01048983|Antidepressive Agents|antidepressive agents|mesh-ancestor
101844543|NCT01048983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101844544|NCT01048983|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101844545|NCT01048983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101844546|NCT01048983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101564369|NCT00927355|Pioglitazone|pioglitazone|mesh-list
101844547|NCT01048983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844548|NCT01048983|Dopamine Agents|dopamine agents|mesh-ancestor
101844549|NCT01048983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101844550|NCT01048983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844551|NCT01048983|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101844552|NCT01048983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101844553|NCT01048983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101844554|NCT01048983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101844555|NCT01048983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101844556|NCT01048983|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101844557|NCT01048983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101844558|NCT01048983|Analgesics|analgesics|mesh-ancestor
101844559|NCT01048983|Sensory System Agents|sensory system agents|mesh-ancestor
101844560|NCT01048983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101844561|NCT01048983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101844562|NCT01048983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101844563|NCT01048983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101844564|NCT01048983|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101844565|NCT01048983|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101844566|NCT01048983|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101844567|NCT01048983|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101844568|NCT00990275|Ethanol|ethanol|mesh-list
101844569|NCT00990275|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101844570|NCT00990275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101844571|NCT00990275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101844572|NCT00990275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844573|NCT01340417|Melatonin|melatonin|mesh-list
101844574|NCT01340417|Antioxidants|antioxidants|mesh-ancestor
101844575|NCT01340417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844576|NCT01340417|Protective Agents|protective agents|mesh-ancestor
101844577|NCT01340417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844578|NCT01340417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101844579|NCT01049061|Farletuzumab|farletuzumab|mesh-list
101844580|NCT01049061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101844581|NCT00367341|Escitalopram|escitalopram|mesh-list
101844582|NCT00367341|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101844583|NCT00367341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101844584|NCT00367341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101844585|NCT00367341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844586|NCT00367341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101844587|NCT00367341|Serotonin Agents|serotonin agents|mesh-ancestor
101844588|NCT00367341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844589|NCT01052961|Oseltamivir|oseltamivir|mesh-list
101844590|NCT01052961|Antiviral Agents|antiviral agents|mesh-ancestor
101844591|NCT01052961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101844592|NCT01052961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101844593|NCT01052961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844594|NCT00440466|Epoetin Alfa|epoetin alfa|mesh-list
101844595|NCT00440466|Hematinics|hematinics|mesh-ancestor
101844596|NCT01051167|Cetuximab|cetuximab|mesh-list
101844597|NCT01051167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101844598|NCT01051167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101844599|NCT01325441|Paclitaxel|paclitaxel|mesh-list
101844600|NCT01325441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101844601|NCT01325441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101844602|NCT01325441|Tubulin Modulators|tubulin modulators|mesh-ancestor
101844603|NCT01325441|Antimitotic Agents|antimitotic agents|mesh-ancestor
101844604|NCT01325441|Mitosis Modulators|mitosis modulators|mesh-ancestor
101844605|NCT01325441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844606|NCT00616967|Paclitaxel|paclitaxel|mesh-list
101844607|NCT00616967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101844608|NCT00616967|Carboplatin|carboplatin|mesh-list
101844609|NCT00616967|Vorinostat|vorinostat|mesh-list
101844610|NCT00616967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101844611|NCT00616967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101844612|NCT00616967|Tubulin Modulators|tubulin modulators|mesh-ancestor
101844613|NCT00616967|Antimitotic Agents|antimitotic agents|mesh-ancestor
101844614|NCT00616967|Mitosis Modulators|mitosis modulators|mesh-ancestor
101844615|NCT00616967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844616|NCT00616967|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101844617|NCT00616967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101844618|NCT05360537|Insulin Glargine|insulin glargine|mesh-list
101844619|NCT05360537|Liraglutide|liraglutide|mesh-list
101844620|NCT05360537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101564453|NCT00610909|Paroxetine|paroxetine|mesh-list
101844621|NCT05360537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844622|NCT05360537|Incretins|incretins|mesh-ancestor
101844623|NCT05360537|Hormones|hormones|mesh-ancestor
101844624|NCT05360537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101844625|NCT05590637|Pimavanserin|pimavanserin|mesh-list
101844626|NCT05590637|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101844627|NCT05590637|Antidepressive Agents|antidepressive agents|mesh-ancestor
101844628|NCT05590637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101844629|NCT05590637|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101844630|NCT05590637|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101844631|NCT05590637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101844632|NCT05590637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844633|NCT05590637|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101844634|NCT05590637|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101844635|NCT05590637|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101844636|NCT05590637|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101844637|NCT05590637|Serotonin Agents|serotonin agents|mesh-ancestor
101844638|NCT05590637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101844639|NCT05590637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844640|NCT00989651|Paclitaxel|paclitaxel|mesh-list
101844641|NCT00989651|Bevacizumab|bevacizumab|mesh-list
101844642|NCT00989651|Cisplatin|cisplatin|mesh-list
101844643|NCT00989651|Carboplatin|carboplatin|mesh-list
101844644|NCT00989651|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101844645|NCT00989651|Veliparib|veliparib|mesh-list
101844646|NCT00989651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101844647|NCT00989651|Endothelial Growth Factors|endothelial growth factors|mesh-list
101844648|NCT00989651|Antibodies|antibodies|mesh-list
101844649|NCT00989651|Immunoglobulins|immunoglobulins|mesh-list
101844650|NCT00989651|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101844651|NCT00989651|Immunoglobulin G|immunoglobulin g|mesh-list
101844652|NCT00989651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101844653|NCT00989651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101844654|NCT00989651|Tubulin Modulators|tubulin modulators|mesh-ancestor
101844655|NCT00989651|Antimitotic Agents|antimitotic agents|mesh-ancestor
101844656|NCT00989651|Mitosis Modulators|mitosis modulators|mesh-ancestor
101844657|NCT00989651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844658|NCT00989651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101844659|NCT00989651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101844660|NCT00989651|Growth Substances|growth substances|mesh-ancestor
101844661|NCT00989651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844662|NCT00989651|Growth Inhibitors|growth inhibitors|mesh-ancestor
101238339|NCT01599923|Antivenins|antivenins|mesh-list
101844663|NCT00989651|Immunologic Factors|immunologic factors|mesh-ancestor
101844664|NCT00989651|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101844665|NCT00989651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101844667|NCT05590559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101844668|NCT05590559|Narcotics|narcotics|mesh-ancestor
101963736|NCT02198326|Olcegepant|olcegepant|mesh-list
101844669|NCT05590559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101844670|NCT05590559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844672|NCT05590559|Sensory System Agents|sensory system agents|mesh-ancestor
101844673|NCT05590559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101844674|NCT05590325|Dolutegravir|dolutegravir|mesh-list
101844675|NCT05590325|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101844676|NCT05590325|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101844677|NCT05590325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101844678|NCT05590325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844679|NCT05590325|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101844680|NCT05590325|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101844681|NCT05590325|Antiviral Agents|antiviral agents|mesh-ancestor
101844682|NCT05590325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101844683|NCT00989729|Methylprednisolone|methylprednisolone|mesh-list
101844684|NCT00989729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101844685|NCT00989729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101844686|NCT00989729|Prednisolone|prednisolone|mesh-list
101844687|NCT00989729|Prednisolone acetate|prednisolone acetate|mesh-list
101844688|NCT00989729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101844689|NCT00989729|Prednisolone phosphate|prednisolone phosphate|mesh-list
101844690|NCT00989729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101844691|NCT00989729|Antiemetics|antiemetics|mesh-ancestor
101844692|NCT00989729|Autonomic Agents|autonomic agents|mesh-ancestor
101844693|NCT00989729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101844694|NCT00989729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844695|NCT00989729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101844696|NCT00989729|Glucocorticoids|glucocorticoids|mesh-ancestor
101844697|NCT00989729|Hormones|hormones|mesh-ancestor
101844698|NCT00989729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101844699|NCT00989729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101844700|NCT00989729|Protective Agents|protective agents|mesh-ancestor
101844701|NCT00989729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101844702|NCT00989729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101844703|NCT00989807|Aztreonam|aztreonam|mesh-list
101844704|NCT00989807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101844705|NCT00989807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101844706|NCT00990587|Ciclopirox|ciclopirox|mesh-list
101844707|NCT00990587|Antifungal Agents|antifungal agents|mesh-ancestor
101844708|NCT00990587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101844709|NCT00537329|Anidulafungin|anidulafungin|mesh-list
101844710|NCT00537329|Antifungal Agents|antifungal agents|mesh-ancestor
101844711|NCT00537329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101844712|NCT03905135|Avelumab|avelumab|mesh-list
101844713|NCT03905135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101844714|NCT03905135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101844715|NCT00991055|Pioglitazone|pioglitazone|mesh-list
101844716|NCT00991055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101844717|NCT00991055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844718|NCT00991133|Clofarabine|clofarabine|mesh-list
101844719|NCT00991133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101844720|NCT00991133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844721|NCT00991133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101844722|NCT00991133|Antimetabolites|antimetabolites|mesh-ancestor
101844723|NCT00991211|Cyclophosphamide|cyclophosphamide|mesh-list
101844724|NCT00991211|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101844725|NCT00991211|Doxorubicin|doxorubicin|mesh-list
101844726|NCT00991211|Vincristine|vincristine|mesh-list
101844727|NCT00991211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101844728|NCT00991211|Immunologic Factors|immunologic factors|mesh-ancestor
101844729|NCT00991211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844730|NCT00991211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101844731|NCT00991211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101844732|NCT00991211|Alkylating Agents|alkylating agents|mesh-ancestor
101844733|NCT00991211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844734|NCT00991211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101844735|NCT00991211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101844736|NCT00991211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101844737|NCT00991211|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101844738|NCT00991211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101844739|NCT00991211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101844740|NCT00991211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101844741|NCT00991211|Tubulin Modulators|tubulin modulators|mesh-ancestor
101844742|NCT00991211|Antimitotic Agents|antimitotic agents|mesh-ancestor
101844743|NCT00991211|Mitosis Modulators|mitosis modulators|mesh-ancestor
101844744|NCT00357903|Etanercept|etanercept|mesh-list
101844745|NCT00357903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101844746|NCT00357903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101844747|NCT00357903|Analgesics|analgesics|mesh-ancestor
101844748|NCT00357903|Sensory System Agents|sensory system agents|mesh-ancestor
101844749|NCT00357903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101844750|NCT00357903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844751|NCT00357903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101844752|NCT00357903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101844753|NCT00357903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101844754|NCT00357903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101844755|NCT00357903|Immunologic Factors|immunologic factors|mesh-ancestor
101844756|NCT01053039|Morphine|morphine|mesh-list
101844757|NCT01053039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101844758|NCT01053039|Narcotics|narcotics|mesh-ancestor
101844759|NCT01053039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101844760|NCT01053039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844761|NCT01053039|Analgesics|analgesics|mesh-ancestor
101844762|NCT01053039|Sensory System Agents|sensory system agents|mesh-ancestor
101844763|NCT01053039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101844764|NCT01051401|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101844765|NCT01051401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101844766|NCT01051401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101844767|NCT01051401|Antimetabolites|antimetabolites|mesh-ancestor
101844768|NCT01051401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844769|NCT01051401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101844770|NCT01051401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101844771|NCT01051401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101564590|NCT01134627|Minocycline|minocycline|mesh-list
101844772|NCT00348933|Vitamin B 12|vitamin b 12|mesh-list
101844773|NCT00348933|Hydroxocobalamin|hydroxocobalamin|mesh-list
101844774|NCT00348933|Betaine|betaine|mesh-list
101844776|NCT00348933|Micronutrients|micronutrients|mesh-ancestor
101844777|NCT00348933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844778|NCT00348933|Vitamin B Complex|vitamin b complex|mesh-ancestor
101844779|NCT00348933|Hematinics|hematinics|mesh-ancestor
101844780|NCT00348933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101844781|NCT00348933|Lipotropic Agents|lipotropic agents|mesh-ancestor
101844782|NCT00348933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101844783|NCT00348933|Antimetabolites|antimetabolites|mesh-ancestor
101844784|NCT00348933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844785|NCT00348933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101844786|NCT01051479|Choline|choline|mesh-list
101844787|NCT01051479|Lipotropic Agents|lipotropic agents|mesh-ancestor
101844788|NCT01051479|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101844789|NCT01051479|Antimetabolites|antimetabolites|mesh-ancestor
101844790|NCT01051479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844791|NCT01051479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101844792|NCT01051479|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101844793|NCT01051479|Nootropic Agents|nootropic agents|mesh-ancestor
101844794|NCT01055691|Metformin|metformin|mesh-list
101844795|NCT01055691|Dapagliflozin|dapagliflozin|mesh-list
101844796|NCT01055691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101844797|NCT01055691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844798|NCT01055691|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101844799|NCT01055691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844801|NCT03896477|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101844802|NCT03896477|Immunologic Factors|immunologic factors|mesh-ancestor
101844803|NCT03896477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844804|NCT00444600|Triamcinolone|triamcinolone|mesh-list
101844805|NCT00444600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101844806|NCT00444600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101844807|NCT00444600|Ranibizumab|ranibizumab|mesh-list
101844808|NCT00444600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101844809|NCT00444600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101963743|NCT02198404|Propofol|propofol|mesh-list
101844811|NCT00444600|Growth Substances|growth substances|mesh-ancestor
101844812|NCT00444600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844813|NCT00444600|Growth Inhibitors|growth inhibitors|mesh-ancestor
101844814|NCT00444600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101844815|NCT00444600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101844816|NCT00444600|Glucocorticoids|glucocorticoids|mesh-ancestor
101844817|NCT00444600|Hormones|hormones|mesh-ancestor
101844818|NCT00444600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101844819|NCT00444600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101844820|NCT00444600|Immunologic Factors|immunologic factors|mesh-ancestor
101844821|NCT00444600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101844822|NCT00444600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844823|NCT05357027|Cyclophosphamide|cyclophosphamide|mesh-list
101844824|NCT05357027|Fludarabine|fludarabine|mesh-list
101844825|NCT05357027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101844826|NCT05357027|Immunologic Factors|immunologic factors|mesh-ancestor
101844827|NCT05357027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844828|NCT05357027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101844829|NCT05357027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101844830|NCT05357027|Alkylating Agents|alkylating agents|mesh-ancestor
101844831|NCT05357027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844832|NCT05357027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101844833|NCT05357027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101844834|NCT00443898|Terbinafine|terbinafine|mesh-list
101844835|NCT00443898|Antifungal Agents|antifungal agents|mesh-ancestor
101844836|NCT00443898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101844837|NCT00443898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101844838|NCT00443898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844839|NCT00537017|Levodopa|levodopa|mesh-list
101844840|NCT00537017|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101844841|NCT00537017|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101844842|NCT00537017|Dopamine Agents|dopamine agents|mesh-ancestor
101844843|NCT00537017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101844844|NCT00537017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844845|NCT00537017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844846|NCT00348309|Rosiglitazone|rosiglitazone|mesh-list
101844847|NCT00348309|Donepezil|donepezil|mesh-list
101844848|NCT00348309|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101844849|NCT00348309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101844850|NCT00348309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844851|NCT00348309|Cholinergic Agents|cholinergic agents|mesh-ancestor
101844852|NCT00348309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101844853|NCT00348309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844854|NCT00348309|Nootropic Agents|nootropic agents|mesh-ancestor
101844855|NCT00348309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101844856|NCT04451837|Dapagliflozin|dapagliflozin|mesh-list
101844857|NCT04451837|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101844858|NCT04451837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844859|NCT04451837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101844860|NCT04451837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844861|NCT05493683|Tislelizumab|tislelizumab|mesh-list
101844862|NCT05493683|Disitamab vedotin|disitamab vedotin|mesh-list
101844863|NCT05493683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101844864|NCT05493683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101844865|NCT05493683|Immunoconjugates|immunoconjugates|mesh-ancestor
101844866|NCT05493683|Immunologic Factors|immunologic factors|mesh-ancestor
101844867|NCT05493683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844869|NCT05440487|Sequestering Agents|sequestering agents|mesh-ancestor
101844870|NCT05440487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844871|NCT00440310|Talaporfin|talaporfin|mesh-list
101844872|NCT00440310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101844873|NCT00440310|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101844874|NCT00440310|Dermatologic Agents|dermatologic agents|mesh-ancestor
101844875|NCT01055847|Aztreonam|aztreonam|mesh-list
101844876|NCT01055847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101844877|NCT01055847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101844878|NCT02533791|Vaccines|vaccines|mesh-list
101844879|NCT02533791|Immunologic Factors|immunologic factors|mesh-ancestor
101844880|NCT02533791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844881|NCT05426681|Glyburide|glyburide|mesh-list
101844882|NCT05426681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101844883|NCT05426681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844884|NCT01055925|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101844886|NCT01055925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101844887|NCT00440232|Frovatriptan|frovatriptan|mesh-list
101844888|NCT00440232|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101844889|NCT00440232|Serotonin Agents|serotonin agents|mesh-ancestor
101844890|NCT00440232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101844891|NCT00440232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844892|NCT00440232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844893|NCT01564199|Fluticasone|fluticasone|mesh-list
101844894|NCT01564199|Xhance|xhance|mesh-list
101844895|NCT01564199|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101844896|NCT01564199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101844897|NCT01564199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101844898|NCT01564199|Autonomic Agents|autonomic agents|mesh-ancestor
101844899|NCT01564199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101844900|NCT01564199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844901|NCT01564199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101844902|NCT01564199|Respiratory System Agents|respiratory system agents|mesh-ancestor
101844903|NCT01564199|Dermatologic Agents|dermatologic agents|mesh-ancestor
101844904|NCT01564199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101844905|NCT01564199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101844906|NCT01564199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101844907|NCT01564199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101844908|NCT01564199|Adrenergic Agents|adrenergic agents|mesh-ancestor
101844909|NCT01564199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101844910|NCT01564199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844911|NCT02533323|Gemcitabine|gemcitabine|mesh-list
101844912|NCT02533323|Oxaliplatin|oxaliplatin|mesh-list
101844913|NCT02533323|Pegaspargase|pegaspargase|mesh-list
101844914|NCT02533323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101844915|NCT02533323|Antimetabolites|antimetabolites|mesh-ancestor
101844916|NCT02533323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844917|NCT02533323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101844918|NCT05379959|Methamphetamine|methamphetamine|mesh-list
101844919|NCT05379959|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101844920|NCT05379959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844921|NCT05379959|Sympathomimetics|sympathomimetics|mesh-ancestor
101844922|NCT05379959|Autonomic Agents|autonomic agents|mesh-ancestor
101844923|NCT05379959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101844924|NCT05379959|Dopamine Agents|dopamine agents|mesh-ancestor
101844925|NCT05379959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101844926|NCT05379959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844927|NCT05379959|Adrenergic Agents|adrenergic agents|mesh-ancestor
101844928|NCT05379959|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101844929|NCT05379959|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101844930|NCT05379959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101844931|NCT05379959|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101844933|NCT05357885|Immunologic Factors|immunologic factors|mesh-ancestor
101844934|NCT05357885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844935|NCT04003181|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101844936|NCT04003181|Bile Acids and Salts|bile acids and salts|mesh-list
101844937|NCT04003181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101844938|NCT04003181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101844939|NCT00356889|Bevacizumab|bevacizumab|mesh-list
101844940|NCT00356889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101844941|NCT00356889|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101844942|NCT00356889|Antibodies|antibodies|mesh-list
101844943|NCT00356889|Immunoglobulins|immunoglobulins|mesh-list
101844944|NCT00356889|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101844945|NCT00356889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101844946|NCT00356889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101844947|NCT00356889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101844948|NCT00356889|Growth Substances|growth substances|mesh-ancestor
101844949|NCT00356889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844950|NCT00356889|Growth Inhibitors|growth inhibitors|mesh-ancestor
101844951|NCT00356889|Immunologic Factors|immunologic factors|mesh-ancestor
101844952|NCT00356889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101844953|NCT00356889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101963750|NCT02198482|Cytarabine|cytarabine|mesh-list
101844954|NCT00356889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844955|NCT05186363|Pyrimethamine|pyrimethamine|mesh-list
101844956|NCT05186363|Sulfadoxine|sulfadoxine|mesh-list
101844957|NCT05186363|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101844958|NCT05186363|Amodiaquine|amodiaquine|mesh-list
101844959|NCT05186363|Antimalarials|antimalarials|mesh-ancestor
101844960|NCT05186363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101844961|NCT05186363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101844962|NCT05186363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101844963|NCT05186363|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101844964|NCT05186363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387673|NCT00322699|Trioxsalen|trioxsalen|mesh-list
101844965|NCT05186363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844966|NCT05186363|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101844967|NCT03742323|Idelalisib|idelalisib|mesh-list
101844968|NCT03742323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101844969|NCT03742323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101844970|NCT03742323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844971|NCT04715022|Ascorbic Acid|ascorbic acid|mesh-list
101844972|NCT04715022|Antioxidants|antioxidants|mesh-ancestor
101844973|NCT04715022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844974|NCT04715022|Protective Agents|protective agents|mesh-ancestor
101844975|NCT04715022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844976|NCT04715022|Vitamins|vitamins|mesh-ancestor
101844977|NCT04715022|Micronutrients|micronutrients|mesh-ancestor
101844978|NCT00356811|Paclitaxel|paclitaxel|mesh-list
101844979|NCT00356811|Lapatinib|lapatinib|mesh-list
101844980|NCT00356811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101844981|NCT00356811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101844982|NCT00356811|Tubulin Modulators|tubulin modulators|mesh-ancestor
101844983|NCT00356811|Antimitotic Agents|antimitotic agents|mesh-ancestor
101844984|NCT00356811|Mitosis Modulators|mitosis modulators|mesh-ancestor
101844985|NCT00356811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101844986|NCT00356811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101844987|NCT00356811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101844988|NCT00439218|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
101844989|NCT00439218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101844990|NCT01030614|Dexamethasone|dexamethasone|mesh-list
101844991|NCT01030614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101844992|NCT01030614|Antiemetics|antiemetics|mesh-ancestor
101844993|NCT01030614|Autonomic Agents|autonomic agents|mesh-ancestor
101844994|NCT01030614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101844995|NCT01030614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101844996|NCT01030614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101844997|NCT01030614|Glucocorticoids|glucocorticoids|mesh-ancestor
101844998|NCT01030614|Hormones|hormones|mesh-ancestor
101844999|NCT01030614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101845000|NCT01030614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101845001|NCT01030614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101845002|NCT01030692|Rivastigmine|rivastigmine|mesh-list
101845003|NCT01030692|Huperzine A|huperzine a|mesh-list
101845004|NCT01030692|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101845005|NCT01030692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101845006|NCT01030692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845007|NCT01030692|Cholinergic Agents|cholinergic agents|mesh-ancestor
101845008|NCT01030692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101845009|NCT01030692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845010|NCT01030692|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101845011|NCT01030692|Protective Agents|protective agents|mesh-ancestor
101845012|NCT03138252|Oxytocin|oxytocin|mesh-list
101845013|NCT03138252|Oxytocics|oxytocics|mesh-ancestor
101845014|NCT03138252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101845015|NCT03138252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845017|NCT04994561|Metformin|metformin|mesh-list
101845018|NCT04994561|Dasatinib|dasatinib|mesh-list
101845019|NCT04994561|Resveratrol|resveratrol|mesh-list
101845020|NCT04994561|Quercetin|quercetin|mesh-list
101845021|NCT04994561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101845022|NCT04994561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845023|NCT04994561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101845024|NCT04994561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101845026|NCT04994561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845027|NCT04994561|Antioxidants|antioxidants|mesh-ancestor
101845028|NCT04994561|Protective Agents|protective agents|mesh-ancestor
101845029|NCT04994561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101845030|NCT04994561|Vitamin B Complex|vitamin b complex|mesh-ancestor
101845031|NCT04994561|Vitamins|vitamins|mesh-ancestor
101845032|NCT04994561|Micronutrients|micronutrients|mesh-ancestor
101845033|NCT01030770|Ranibizumab|ranibizumab|mesh-list
101845034|NCT01030770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101845035|NCT01030770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101845036|NCT01030770|Growth Substances|growth substances|mesh-ancestor
101845037|NCT01030770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845038|NCT01030770|Growth Inhibitors|growth inhibitors|mesh-ancestor
101845039|NCT01030770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101845040|NCT04941443|Ibuprofen|ibuprofen|mesh-list
101845041|NCT04941443|Methadone|methadone|mesh-list
101845042|NCT04941443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101845043|NCT04941443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101845044|NCT04941443|Analgesics|analgesics|mesh-ancestor
101845045|NCT04941443|Sensory System Agents|sensory system agents|mesh-ancestor
101845046|NCT04941443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101845047|NCT04941443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845048|NCT04941443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101845049|NCT04941443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101845050|NCT04941443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101845051|NCT04941443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101845052|NCT04941443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845053|NCT04941443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101845054|NCT04941443|Narcotics|narcotics|mesh-ancestor
101845055|NCT04941443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101845056|NCT04941443|Antitussive Agents|antitussive agents|mesh-ancestor
101845057|NCT04941443|Respiratory System Agents|respiratory system agents|mesh-ancestor
101845058|NCT03994692|Ether|ether|mesh-list
101845059|NCT03994692|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101845060|NCT03994692|Anesthetics, General|anesthetics, general|mesh-ancestor
101845061|NCT03994692|Anesthetics|anesthetics|mesh-ancestor
101845062|NCT03994692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101238462|NCT01605279|Dobutamine|dobutamine|mesh-list
101845063|NCT03994692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845064|NCT01030926|Insulin|insulin|mesh-list
101845065|NCT01030926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101845066|NCT01030926|Insulin Glargine|insulin glargine|mesh-list
101845067|NCT01030926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101845068|NCT01030926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845069|NCT00536939|Paclitaxel|paclitaxel|mesh-list
101845070|NCT00536939|Bevacizumab|bevacizumab|mesh-list
101845071|NCT00536939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101845072|NCT00536939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101845073|NCT00536939|Tubulin Modulators|tubulin modulators|mesh-ancestor
101845074|NCT00536939|Antimitotic Agents|antimitotic agents|mesh-ancestor
101564885|NCT04962841|Metformin|metformin|mesh-list
101845075|NCT00536939|Mitosis Modulators|mitosis modulators|mesh-ancestor
101845076|NCT00536939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845077|NCT00536939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101845078|NCT00536939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101845079|NCT00536939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101845080|NCT00536939|Growth Substances|growth substances|mesh-ancestor
101845081|NCT00536939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845082|NCT00536939|Growth Inhibitors|growth inhibitors|mesh-ancestor
101845083|NCT04597697|Insulin|insulin|mesh-list
101845084|NCT04597697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101845085|NCT04597697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845086|NCT00347919|Lapatinib|lapatinib|mesh-list
101845087|NCT00347919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101845088|NCT00347919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101845089|NCT00347919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101845090|NCT00347919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845091|NCT00439140|Botulinum Toxins|botulinum toxins|mesh-list
101845092|NCT00439140|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101845093|NCT00439140|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101845094|NCT00439140|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101845095|NCT00439140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101845096|NCT00439140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845097|NCT00439140|Cholinergic Agents|cholinergic agents|mesh-ancestor
101845098|NCT00439140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101845099|NCT00439140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845100|NCT00439140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101845101|NCT00439140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101845102|NCT00356421|Insulin|insulin|mesh-list
101845103|NCT00356421|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101845104|NCT00356421|Insulin Lispro|insulin lispro|mesh-list
101845105|NCT00356421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101845106|NCT00356421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845107|NCT03990129|Dipyrone|dipyrone|mesh-list
101845108|NCT03990129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101845109|NCT03990129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101845110|NCT03990129|Analgesics|analgesics|mesh-ancestor
101845111|NCT03990129|Sensory System Agents|sensory system agents|mesh-ancestor
101845112|NCT03990129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101845113|NCT03990129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845114|NCT03990129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101845115|NCT03990129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101845116|NCT03990129|Antipyretics|antipyretics|mesh-ancestor
101845117|NCT01051947|Metoprolol|metoprolol|mesh-list
101845118|NCT01051947|Nebivolol|nebivolol|mesh-list
101845119|NCT01051947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101845120|NCT01051947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101845121|NCT01051947|Sympatholytics|sympatholytics|mesh-ancestor
101845122|NCT01051947|Autonomic Agents|autonomic agents|mesh-ancestor
101845123|NCT01051947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101845124|NCT01051947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845125|NCT01051947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101845126|NCT01051947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101845127|NCT01051947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101845128|NCT01051947|Adrenergic Agents|adrenergic agents|mesh-ancestor
101845129|NCT01051947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101238502|NCT01607983|Antioxidants|antioxidants|mesh-ancestor
101845130|NCT01051947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845131|NCT01051947|Vasodilator Agents|vasodilator agents|mesh-ancestor
101845132|NCT01051947|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101845133|NCT01051947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101845134|NCT01051947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101845135|NCT01052025|Curcumin|curcumin|mesh-list
101845136|NCT01052025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101845137|NCT01052025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101845138|NCT01052025|Analgesics|analgesics|mesh-ancestor
101845139|NCT01052025|Sensory System Agents|sensory system agents|mesh-ancestor
101845140|NCT01052025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101845141|NCT01052025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845142|NCT01052025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101845143|NCT01052025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101845144|NCT01052025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101845145|NCT01052025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101845146|NCT01052025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845147|NCT00443820|Terbinafine|terbinafine|mesh-list
101845148|NCT00443820|Antifungal Agents|antifungal agents|mesh-ancestor
101845149|NCT00443820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101564965|NCT00918463|Dasatinib|dasatinib|mesh-list
101845150|NCT00443820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101845151|NCT00443820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845152|NCT00438672|Dexamethasone|dexamethasone|mesh-list
101845153|NCT00438672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101845154|NCT00438672|Antiemetics|antiemetics|mesh-ancestor
101845155|NCT00438672|Autonomic Agents|autonomic agents|mesh-ancestor
101845156|NCT00438672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101845157|NCT00438672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845158|NCT00438672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101963769|NCT03961841|Oxaliplatin|oxaliplatin|mesh-list
101845159|NCT00438672|Glucocorticoids|glucocorticoids|mesh-ancestor
101685971|NCT02849327|Immunomodulating Agents|immunomodulating agents|mesh-list
101845161|NCT00438672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101845162|NCT00438672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101845164|NCT00438360|Cyclosporine|cyclosporine|mesh-list
101845165|NCT00438360|Cyclosporins|cyclosporins|mesh-list
101845166|NCT00438360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101845167|NCT00438360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845168|NCT00438360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101845169|NCT00438360|Immunologic Factors|immunologic factors|mesh-ancestor
101845170|NCT00438360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845171|NCT00438360|Antifungal Agents|antifungal agents|mesh-ancestor
101845172|NCT00438360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101845173|NCT00438360|Dermatologic Agents|dermatologic agents|mesh-ancestor
101845174|NCT00438360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101845175|NCT00438360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101845176|NCT00536471|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101845177|NCT00536471|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101845178|NCT00536471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101845179|NCT00536471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101845180|NCT00536471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845181|NCT00536471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101845182|NCT00536471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845183|NCT00536471|Analgesics|analgesics|mesh-ancestor
101845184|NCT00536471|Sensory System Agents|sensory system agents|mesh-ancestor
101845185|NCT00536471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101845186|NCT00536471|Antidepressive Agents|antidepressive agents|mesh-ancestor
101845187|NCT00536471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101845188|NCT00536471|Dopamine Agents|dopamine agents|mesh-ancestor
101845189|NCT00437658|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101845190|NCT00437658|Medroxyprogesterone|medroxyprogesterone|mesh-list
101845191|NCT00437658|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101845192|NCT00437658|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101845193|NCT00437658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101845194|NCT00437658|Contraceptive Agents|contraceptive agents|mesh-ancestor
101845195|NCT00437658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101845196|NCT00437658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845197|NCT00437658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101845198|NCT00437658|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101845199|NCT00437658|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101845200|NCT00437658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101845201|NCT00437658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101845202|NCT04002635|Letrozole|letrozole|mesh-list
101845203|NCT04002635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101845204|NCT04002635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101845205|NCT04002635|Estradiol|estradiol|mesh-list
101845206|NCT04002635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101845207|NCT04002635|Progesterone|progesterone|mesh-list
101845208|NCT04002635|Estrogens|estrogens|mesh-ancestor
101845209|NCT04002635|Hormones|hormones|mesh-ancestor
101845210|NCT04002635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101845211|NCT04002635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845212|NCT04002635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101845213|NCT04002635|Contraceptive Agents|contraceptive agents|mesh-ancestor
101845214|NCT04002635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101845215|NCT04002635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101845216|NCT04002635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101845217|NCT04002635|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101845218|NCT04002635|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101845219|NCT04002635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101845220|NCT04002635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845221|NCT04002635|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101845222|NCT04002635|Hormone Antagonists|hormone antagonists|mesh-ancestor
101845223|NCT04002635|Progestins|progestins|mesh-ancestor
101845224|NCT01052181|Cholecalciferol|cholecalciferol|mesh-list
101845225|NCT01052181|Vitamin D|vitamin d|mesh-list
101845226|NCT01052181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101845227|NCT01052181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845228|NCT01052181|Vitamins|vitamins|mesh-ancestor
101845229|NCT01052181|Micronutrients|micronutrients|mesh-ancestor
101685975|NCT00618696|Antibodies|antibodies|mesh-list
101845230|NCT01052181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101845231|NCT01056237|Mycophenolic Acid|mycophenolic acid|mesh-list
101845232|NCT01056237|Azathioprine|azathioprine|mesh-list
101845233|NCT01056237|Tacrolimus|tacrolimus|mesh-list
101845234|NCT01056237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101845235|NCT01056237|Immunologic Factors|immunologic factors|mesh-ancestor
101845236|NCT01056237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845237|NCT01056237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101845238|NCT01056237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101845239|NCT01056237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845240|NCT01056237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101845241|NCT01056237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101845242|NCT01056237|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101845243|NCT01056237|Antitubercular Agents|antitubercular agents|mesh-ancestor
101845244|NCT01056237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101845245|NCT01056237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101845246|NCT01056237|Antimetabolites|antimetabolites|mesh-ancestor
101845247|NCT01056237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101845248|NCT01056237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101845249|NCT02533557|Lidocaine|lidocaine|mesh-list
101845250|NCT02533557|Epinephrine|epinephrine|mesh-list
101845251|NCT02533557|Racepinephrine|racepinephrine|mesh-list
101845252|NCT02533557|Epinephryl borate|epinephryl borate|mesh-list
101845253|NCT02533557|Anesthetics, Local|anesthetics, local|mesh-ancestor
101845254|NCT02533557|Anesthetics|anesthetics|mesh-ancestor
101845255|NCT02533557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101845256|NCT02533557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845257|NCT02533557|Sensory System Agents|sensory system agents|mesh-ancestor
101845258|NCT02533557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101845259|NCT02533557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101845260|NCT02533557|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101845261|NCT02533557|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101845262|NCT02533557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101845263|NCT02533557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845264|NCT02533557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101845265|NCT02533557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101845266|NCT02533557|Adrenergic Agents|adrenergic agents|mesh-ancestor
101845267|NCT02533557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101845268|NCT02533557|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101845269|NCT02533557|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101845270|NCT02533557|Autonomic Agents|autonomic agents|mesh-ancestor
101845271|NCT02533557|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101845272|NCT02533557|Respiratory System Agents|respiratory system agents|mesh-ancestor
101845273|NCT02533557|Mydriatics|mydriatics|mesh-ancestor
101845274|NCT02533557|Sympathomimetics|sympathomimetics|mesh-ancestor
101845275|NCT02533557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101845276|NCT00356265|Phenylephrine|phenylephrine|mesh-list
101845277|NCT00356265|Oxymetazoline|oxymetazoline|mesh-list
101845278|NCT00356265|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101845279|NCT00356265|Mydriatics|mydriatics|mesh-ancestor
101845280|NCT00356265|Autonomic Agents|autonomic agents|mesh-ancestor
101845281|NCT00356265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101845282|NCT00356265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845283|NCT00356265|Sympathomimetics|sympathomimetics|mesh-ancestor
101845284|NCT00356265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101845285|NCT00356265|Nasal Decongestants|nasal decongestants|mesh-ancestor
101845286|NCT00356265|Respiratory System Agents|respiratory system agents|mesh-ancestor
101845287|NCT00356265|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101845288|NCT00356265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101845289|NCT00356265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101845290|NCT00356265|Adrenergic Agents|adrenergic agents|mesh-ancestor
101845291|NCT00356265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101845292|NCT00356265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845293|NCT00356265|Protective Agents|protective agents|mesh-ancestor
101845294|NCT01052259|Gusperimus|gusperimus|mesh-list
101845295|NCT01052259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101845296|NCT01052259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101845297|NCT01052259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101845298|NCT01052259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845299|NCT01052259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101845300|NCT01052259|Immunologic Factors|immunologic factors|mesh-ancestor
101565108|NCT04746547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101845301|NCT01052259|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101845302|NCT01052259|Protective Agents|protective agents|mesh-ancestor
101845303|NCT01056549|Exenatide|exenatide|mesh-list
101845304|NCT01056549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101845305|NCT01056549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845306|NCT01056549|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101845307|NCT01056549|Incretins|incretins|mesh-ancestor
101845308|NCT01056549|Hormones|hormones|mesh-ancestor
101845309|NCT01056549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101845310|NCT01052337|Anesthetics|anesthetics|mesh-list
101845311|NCT01052337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101845312|NCT01052337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845313|NCT00535145|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101845314|NCT00535145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101845315|NCT00535145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101845316|NCT00535145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101845317|NCT00535145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845318|NCT00535145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101845319|NCT00535145|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101845320|NCT00535145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101845321|NCT00535145|Serotonin Agents|serotonin agents|mesh-ancestor
101845322|NCT00535145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101845323|NCT00535145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845324|NCT00535145|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101845325|NCT00535145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101845326|NCT00535145|Dopamine Agents|dopamine agents|mesh-ancestor
101845327|NCT01056627|Valproic Acid|valproic acid|mesh-list
101845328|NCT01056627|Anticonvulsants|anticonvulsants|mesh-ancestor
101845329|NCT01056627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101845330|NCT01056627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845331|NCT01056627|GABA Agents|gaba agents|mesh-ancestor
101845332|NCT01056627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101845333|NCT01056627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845334|NCT01056627|Antimanic Agents|antimanic agents|mesh-ancestor
101845335|NCT01056627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101845336|NCT01056627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101845337|NCT01056627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101845338|NCT01053585|Baclofen|baclofen|mesh-list
101845339|NCT01053585|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101845340|NCT01053585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845341|NCT01053585|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101845342|NCT01053585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101845343|NCT01053585|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101845344|NCT01053585|GABA Agonists|gaba agonists|mesh-ancestor
101845345|NCT01053585|GABA Agents|gaba agents|mesh-ancestor
101845346|NCT01053585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101845347|NCT01053585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845348|NCT01564355|Triamcinolone|triamcinolone|mesh-list
101845349|NCT01564355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101845350|NCT01564355|Glucocorticoids|glucocorticoids|mesh-ancestor
101845351|NCT01564355|Hormones|hormones|mesh-ancestor
101845352|NCT01564355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101845353|NCT01564355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845354|NCT01056705|Vaccines|vaccines|mesh-list
101845355|NCT01056705|Immunologic Factors|immunologic factors|mesh-ancestor
101845356|NCT01056705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845357|NCT00437268|Irinotecan|irinotecan|mesh-list
101845358|NCT00437268|Cetuximab|cetuximab|mesh-list
101845359|NCT00437268|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101845360|NCT00437268|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101845361|NCT00437268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101845362|NCT00437268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845363|NCT00437268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101845364|NCT00437268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101845365|NCT04002089|Bupivacaine|bupivacaine|mesh-list
101845366|NCT04002089|Anesthetics, Local|anesthetics, local|mesh-ancestor
101845367|NCT04002089|Anesthetics|anesthetics|mesh-ancestor
101845368|NCT04002089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101845369|NCT04002089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845370|NCT04002089|Sensory System Agents|sensory system agents|mesh-ancestor
101845371|NCT04002089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101845372|NCT04002245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
101845373|NCT04002245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101845374|NCT01056861|Botulinum Toxins|botulinum toxins|mesh-list
101845375|NCT01056861|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101845376|NCT01056861|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101845377|NCT01056861|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101845378|NCT01056861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101845379|NCT01056861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845380|NCT01056861|Cholinergic Agents|cholinergic agents|mesh-ancestor
101845381|NCT01056861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101845382|NCT01056861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845383|NCT01056861|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101845384|NCT01056861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101845385|NCT05355467|Tenofovir|tenofovir|mesh-list
101845386|NCT05355467|Antiviral Agents|antiviral agents|mesh-ancestor
101845387|NCT05355467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101845388|NCT05355467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101845389|NCT05355467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101845390|NCT05355467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101845391|NCT05355467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845392|NCT05355467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101845393|NCT05355467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101845394|NCT04139525|Heparin|heparin|mesh-list
101845395|NCT04139525|Calcium heparin|calcium heparin|mesh-list
101845396|NCT04139525|Citric Acid|citric acid|mesh-list
101845397|NCT04139525|Sodium Citrate|sodium citrate|mesh-list
101845398|NCT04139525|Anticoagulants|anticoagulants|mesh-ancestor
101845399|NCT04139525|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101845400|NCT04139525|Chelating Agents|chelating agents|mesh-ancestor
101845401|NCT04139525|Sequestering Agents|sequestering agents|mesh-ancestor
101845402|NCT04139525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845403|NCT04139525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101845404|NCT04139525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101845405|NCT00437034|Aflibercept|aflibercept|mesh-list
101845406|NCT00437034|Endothelial Growth Factors|endothelial growth factors|mesh-list
101845407|NCT00437034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101845408|NCT00437034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101845409|NCT00437034|Growth Substances|growth substances|mesh-ancestor
101845410|NCT00437034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845411|NCT00437034|Growth Inhibitors|growth inhibitors|mesh-ancestor
101845412|NCT00437034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101845413|NCT00337467|Ritonavir|ritonavir|mesh-list
101845414|NCT00337467|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101845415|NCT00337467|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101845416|NCT00337467|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101845417|NCT00337467|Protease Inhibitors|protease inhibitors|mesh-ancestor
101845418|NCT00337467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101845419|NCT00337467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845420|NCT00337467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101845421|NCT00337467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101845422|NCT00337467|Antiviral Agents|antiviral agents|mesh-ancestor
101845423|NCT00337467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101845424|NCT00337467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101845425|NCT00337467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101845426|NCT00428220|Sunitinib|sunitinib|mesh-list
101845427|NCT00428220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101845428|NCT00428220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101845429|NCT00428220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101845430|NCT00428220|Growth Substances|growth substances|mesh-ancestor
101845431|NCT00428220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845432|NCT00428220|Growth Inhibitors|growth inhibitors|mesh-ancestor
101845433|NCT00428220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101845434|NCT00428220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101845435|NCT00428220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845436|NCT01057329|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101845437|NCT01057329|Olanzapine|olanzapine|mesh-list
101845438|NCT01057329|Aripiprazole|aripiprazole|mesh-list
101845439|NCT01057329|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101845440|NCT01057329|Antiemetics|antiemetics|mesh-ancestor
101845441|NCT01057329|Autonomic Agents|autonomic agents|mesh-ancestor
101845442|NCT01057329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101238554|NCT01609153|Serotonin Agents|serotonin agents|mesh-ancestor
101845443|NCT01057329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845444|NCT01057329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101845445|NCT01057329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101845446|NCT01057329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101845447|NCT01057329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101845448|NCT01057329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101845449|NCT01057329|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101845450|NCT01057329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101845451|NCT01057329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101845452|NCT01057329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845453|NCT01057329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101845454|NCT01057329|Serotonin Agents|serotonin agents|mesh-ancestor
101845455|NCT01057329|Antidepressive Agents|antidepressive agents|mesh-ancestor
101845456|NCT01057329|Dopamine Agonists|dopamine agonists|mesh-ancestor
101845457|NCT01057329|Dopamine Agents|dopamine agents|mesh-ancestor
101845458|NCT01057329|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101845459|NCT01057329|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101845460|NCT01057329|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101845461|NCT01057329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101845462|NCT01057329|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101845463|NCT01057329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101845464|NCT01057329|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101845465|NCT01057329|Analgesics|analgesics|mesh-ancestor
101845466|NCT01057329|Sensory System Agents|sensory system agents|mesh-ancestor
101845467|NCT01057329|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101845468|NCT01057329|Adrenergic Agents|adrenergic agents|mesh-ancestor
101845469|NCT01057407|Sevelamer|sevelamer|mesh-list
101845470|NCT01057407|Chelating Agents|chelating agents|mesh-ancestor
101845471|NCT01057407|Sequestering Agents|sequestering agents|mesh-ancestor
101845472|NCT01057407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845473|NCT02873975|Prexasertib|prexasertib|mesh-list
101845474|NCT02873975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101845475|NCT02873975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101845476|NCT02873975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845477|NCT01057563|Paclitaxel|paclitaxel|mesh-list
101845478|NCT01057563|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101845479|NCT01057563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101845480|NCT01057563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101845481|NCT01057563|Tubulin Modulators|tubulin modulators|mesh-ancestor
101845482|NCT01057563|Antimitotic Agents|antimitotic agents|mesh-ancestor
101845483|NCT01057563|Mitosis Modulators|mitosis modulators|mesh-ancestor
101845484|NCT01057563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845486|NCT00345579|Anticoagulants|anticoagulants|mesh-ancestor
101845487|NCT00345579|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101845488|NCT00345579|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101845489|NCT00345579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845490|NCT04002323|Lamivudine|lamivudine|mesh-list
101845491|NCT04002323|Dolutegravir|dolutegravir|mesh-list
101845492|NCT04002323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101845493|NCT04002323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101845494|NCT04002323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101845495|NCT04002323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845496|NCT04002323|Antiviral Agents|antiviral agents|mesh-ancestor
101845497|NCT04002323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101845498|NCT04002323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101845499|NCT04002323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101845500|NCT04002323|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101845501|NCT04002323|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101845502|NCT04001855|Acetic Acid|acetic acid|mesh-list
101845503|NCT04001855|Retinol acetate|retinol acetate|mesh-list
101845504|NCT04001855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101845505|NCT04001855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101845506|NCT04001855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101845507|NCT04001855|Immunologic Factors|immunologic factors|mesh-ancestor
101845508|NCT04001855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845509|NCT04001855|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101845510|NCT04001855|Protective Agents|protective agents|mesh-ancestor
101845511|NCT04001855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101845512|NCT00335829|Bevacizumab|bevacizumab|mesh-list
101845513|NCT00335829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101845514|NCT00335829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101845515|NCT00335829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101845516|NCT00335829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101845517|NCT00335829|Growth Substances|growth substances|mesh-ancestor
101845518|NCT00335829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845519|NCT00335829|Growth Inhibitors|growth inhibitors|mesh-ancestor
101845520|NCT02533011|Heparin|heparin|mesh-list
101845521|NCT02533011|Anticoagulants|anticoagulants|mesh-ancestor
101845522|NCT02533011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101845523|NCT02533011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101845524|NCT02533011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845525|NCT05262257|Metformin|metformin|mesh-list
101845526|NCT05262257|Dapagliflozin|dapagliflozin|mesh-list
101845527|NCT05262257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101845528|NCT05262257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845529|NCT05262257|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101845530|NCT05262257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845531|NCT03989817|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
101845532|NCT03989817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101845533|NCT03989817|Vasodilator Agents|vasodilator agents|mesh-ancestor
101845534|NCT03989817|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101845535|NCT03989817|Protective Agents|protective agents|mesh-ancestor
101845536|NCT03989817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845537|NCT01059123|Amoxicillin|amoxicillin|mesh-list
101845538|NCT01059123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101845539|NCT01059123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101845540|NCT03986385|Capecitabine|capecitabine|mesh-list
101845541|NCT03986385|Oxaliplatin|oxaliplatin|mesh-list
101845542|NCT03986385|Apatinib|apatinib|mesh-list
101845543|NCT03986385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101845544|NCT03986385|Antimetabolites|antimetabolites|mesh-ancestor
101845545|NCT03986385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845546|NCT03986385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101845547|NCT03986385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101845548|NCT03986385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101845549|NCT00344019|Atorvastatin|atorvastatin|mesh-list
101845550|NCT00344019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101845551|NCT00344019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101845552|NCT00344019|Antimetabolites|antimetabolites|mesh-ancestor
101845553|NCT00344019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845554|NCT00344019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101845555|NCT00344019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101845556|NCT00344019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101845557|NCT00535847|Interferons|interferons|mesh-list
101845558|NCT00535847|Ribavirin|ribavirin|mesh-list
101845559|NCT00535847|Interferon-alpha|interferon-alpha|mesh-list
101845560|NCT00535847|Interferon alpha-2|interferon alpha-2|mesh-list
101845561|NCT00535847|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101845562|NCT00535847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101845563|NCT00535847|Antiviral Agents|antiviral agents|mesh-ancestor
101845564|NCT00535847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101845565|NCT00535847|Antimetabolites|antimetabolites|mesh-ancestor
101845566|NCT00535847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845567|NCT00535847|Immunologic Factors|immunologic factors|mesh-ancestor
101845568|NCT00535847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845569|NCT03606785|Tranexamic Acid|tranexamic acid|mesh-list
101845570|NCT03606785|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101845571|NCT03606785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101845572|NCT03606785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845573|NCT03606785|Hemostatics|hemostatics|mesh-ancestor
101845574|NCT03606785|Coagulants|coagulants|mesh-ancestor
101845576|NCT05356169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101845577|NCT01057875|Caffeine|caffeine|mesh-list
101845578|NCT01057875|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101845579|NCT01057875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845580|NCT01057875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101845581|NCT01057875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101845582|NCT01057875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845583|NCT01057875|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101845584|NCT01057875|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101845585|NCT01057875|Purinergic Agents|purinergic agents|mesh-ancestor
101845586|NCT01057875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101845587|NCT04001387|Anesthetics|anesthetics|mesh-list
101845588|NCT04001387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101845589|NCT04001387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845590|NCT00334737|Epoetin Alfa|epoetin alfa|mesh-list
101845591|NCT00334737|Darbepoetin alfa|darbepoetin alfa|mesh-list
101845592|NCT00334737|Hematinics|hematinics|mesh-ancestor
101845593|NCT03986073|Linagliptin|linagliptin|mesh-list
101845594|NCT03986073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101845595|NCT03986073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845596|NCT03986073|Incretins|incretins|mesh-ancestor
101845597|NCT03986073|Hormones|hormones|mesh-ancestor
101845598|NCT03986073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101845599|NCT03986073|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101845600|NCT03986073|Protease Inhibitors|protease inhibitors|mesh-ancestor
101845601|NCT03986073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101845602|NCT03986073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845603|NCT05347199|Amisulpride|amisulpride|mesh-list
101845604|NCT05347199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101845605|NCT05347199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101845606|NCT05347199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101845607|NCT05347199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845608|NCT05347199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101845609|NCT05347199|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101845610|NCT05347199|Dopamine Agents|dopamine agents|mesh-ancestor
101845611|NCT05347199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101845612|NCT05347199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845613|NCT05347199|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101845614|NCT05347199|Antidepressive Agents|antidepressive agents|mesh-ancestor
101845615|NCT01060137|Fentanyl|fentanyl|mesh-list
101845616|NCT01060137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101845617|NCT01060137|Narcotics|narcotics|mesh-ancestor
101845618|NCT01060137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101845619|NCT01060137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845620|NCT01060137|Analgesics|analgesics|mesh-ancestor
101845621|NCT01060137|Sensory System Agents|sensory system agents|mesh-ancestor
101845622|NCT01060137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101845623|NCT01060137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101845624|NCT01060137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101845625|NCT01060137|Anesthetics, General|anesthetics, general|mesh-ancestor
101845626|NCT01060137|Anesthetics|anesthetics|mesh-ancestor
101845627|NCT01058109|Calcium, Dietary|calcium, dietary|mesh-list
101845628|NCT01058109|Calcium|calcium|mesh-list
101845629|NCT01058109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101845630|NCT01058109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845631|NCT01058109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101845632|NCT00992069|Efavirenz|efavirenz|mesh-list
101686021|NCT01898520|Nabiximols|nabiximols|mesh-list
101845633|NCT00992069|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101845634|NCT00992069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101845635|NCT00992069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101845636|NCT00992069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101963814|NCT02202304|Thymol|thymol|mesh-list
101845637|NCT00992069|Antiviral Agents|antiviral agents|mesh-ancestor
101845638|NCT00992069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101845639|NCT00992069|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101845640|NCT00992069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101845641|NCT00992069|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101845642|NCT00992069|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101845643|NCT00992069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101845644|NCT00992069|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101845645|NCT01060293|Dopamine|dopamine|mesh-list
101845646|NCT01060293|Furosemide|furosemide|mesh-list
101845647|NCT01060293|Diuretics|diuretics|mesh-ancestor
101845648|NCT01060293|Natriuretic Agents|natriuretic agents|mesh-ancestor
101845649|NCT01060293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845650|NCT01060293|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101845651|NCT01060293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101845652|NCT01060293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845653|NCT01060293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101845654|NCT01060293|Sympathomimetics|sympathomimetics|mesh-ancestor
101845655|NCT01060293|Autonomic Agents|autonomic agents|mesh-ancestor
101845656|NCT01060293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101845657|NCT01060293|Dopamine Agents|dopamine agents|mesh-ancestor
101845658|NCT01060293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101845659|NCT01060293|Protective Agents|protective agents|mesh-ancestor
101845660|NCT05343767|Metformin|metformin|mesh-list
101845661|NCT05343767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101845662|NCT05343767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845663|NCT01054677|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101845664|NCT01054677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101845665|NCT03989037|Carboplatin|carboplatin|mesh-list
101845666|NCT03989037|Docetaxel|docetaxel|mesh-list
101845667|NCT03989037|Trastuzumab|trastuzumab|mesh-list
101845668|NCT03989037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101845669|NCT03989037|Tubulin Modulators|tubulin modulators|mesh-ancestor
101845670|NCT03989037|Antimitotic Agents|antimitotic agents|mesh-ancestor
101845671|NCT03989037|Mitosis Modulators|mitosis modulators|mesh-ancestor
101845672|NCT03989037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845673|NCT03989037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101845674|NCT00416598|Cytarabine|cytarabine|mesh-list
101845675|NCT00416598|Etoposide|etoposide|mesh-list
101565485|NCT04323527|Analgesics|analgesics|mesh-ancestor
101845676|NCT00416598|Podophyllotoxin|podophyllotoxin|mesh-list
101845677|NCT00416598|Daunorubicin|daunorubicin|mesh-list
101845678|NCT00416598|Etoposide phosphate|etoposide phosphate|mesh-list
101845679|NCT00416598|Busulfan|busulfan|mesh-list
101845680|NCT00416598|Decitabine|decitabine|mesh-list
101845681|NCT00416598|Lenograstim|lenograstim|mesh-list
101845682|NCT00416598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101845683|NCT00416598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101845684|NCT00416598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101845685|NCT00416598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101845686|NCT00416598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101845687|NCT00416598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845688|NCT00416598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101845689|NCT00416598|Antimetabolites|antimetabolites|mesh-ancestor
101845690|NCT00416598|Antiviral Agents|antiviral agents|mesh-ancestor
101845691|NCT00416598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101845692|NCT00416598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101845693|NCT00416598|Immunologic Factors|immunologic factors|mesh-ancestor
101845694|NCT00416598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845695|NCT00416598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101845696|NCT00416598|Alkylating Agents|alkylating agents|mesh-ancestor
101845697|NCT00416598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101845698|NCT00416598|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101845699|NCT00416598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101845700|NCT00416598|Keratolytic Agents|keratolytic agents|mesh-ancestor
101845701|NCT00416598|Dermatologic Agents|dermatologic agents|mesh-ancestor
101845702|NCT00416598|Tubulin Modulators|tubulin modulators|mesh-ancestor
101845703|NCT00416598|Antimitotic Agents|antimitotic agents|mesh-ancestor
101845704|NCT00416598|Mitosis Modulators|mitosis modulators|mesh-ancestor
101686022|NCT01898520|Analgesics|analgesics|mesh-ancestor
101845705|NCT00534599|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101845706|NCT00534599|Antidepressive Agents|antidepressive agents|mesh-ancestor
101845707|NCT00534599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101845708|NCT00534599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101845709|NCT00534599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101845710|NCT00534599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101845711|NCT00534599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845712|NCT04001465|Methacholine Chloride|methacholine chloride|mesh-list
101845714|NCT04001465|Autonomic Agents|autonomic agents|mesh-ancestor
101845715|NCT04001465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101845716|NCT04001465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845717|NCT04001465|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101845718|NCT04001465|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
101845719|NCT04001465|Respiratory System Agents|respiratory system agents|mesh-ancestor
101845720|NCT04001465|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101845721|NCT04001465|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101845722|NCT04001465|Cholinergic Agents|cholinergic agents|mesh-ancestor
101845723|NCT04001465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101845724|NCT04001465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845725|NCT00992381|Naproxen|naproxen|mesh-list
101845726|NCT00992381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101845727|NCT00992381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101845728|NCT00992381|Analgesics|analgesics|mesh-ancestor
101845729|NCT00992381|Sensory System Agents|sensory system agents|mesh-ancestor
101845730|NCT00992381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101845731|NCT00992381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845732|NCT00992381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101845733|NCT00992381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101845734|NCT00992381|Gout Suppressants|gout suppressants|mesh-ancestor
101845735|NCT00992381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101686027|NCT00903617|Nicotinic Acids|nicotinic acids|mesh-list
101845737|NCT00992381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845738|NCT00992537|Insulin|insulin|mesh-list
101845739|NCT00992537|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101845740|NCT00992537|Insulin Aspart|insulin aspart|mesh-list
101845741|NCT00992537|Insulin, Long-Acting|insulin, long-acting|mesh-list
101845742|NCT00992537|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101845743|NCT00992537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101845744|NCT00992537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845745|NCT00992693|Ribavirin|ribavirin|mesh-list
101845746|NCT00992693|Antimetabolites|antimetabolites|mesh-ancestor
101845747|NCT00992693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845748|NCT00992693|Antiviral Agents|antiviral agents|mesh-ancestor
101845749|NCT00992693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101845750|NCT00992771|Varenicline|varenicline|mesh-list
101845751|NCT00992771|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101845752|NCT00992771|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101845753|NCT00992771|Cholinergic Agents|cholinergic agents|mesh-ancestor
101845754|NCT00992771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101845755|NCT00992771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845756|NCT00992771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845757|NCT00992849|Bevacizumab|bevacizumab|mesh-list
101845758|NCT00992849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101845759|NCT00992849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101845760|NCT00992849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101845761|NCT00992849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101845762|NCT00992849|Growth Substances|growth substances|mesh-ancestor
101845763|NCT00992849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845764|NCT00992849|Growth Inhibitors|growth inhibitors|mesh-ancestor
101845765|NCT04001231|Exenatide|exenatide|mesh-list
101845766|NCT04001231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101845767|NCT04001231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845768|NCT04001231|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101845769|NCT04001231|Incretins|incretins|mesh-ancestor
101845770|NCT04001231|Hormones|hormones|mesh-ancestor
101845771|NCT04001231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101845772|NCT03892889|Aripiprazole|aripiprazole|mesh-list
101845773|NCT03892889|Antidepressive Agents|antidepressive agents|mesh-ancestor
101845774|NCT03892889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101845775|NCT03892889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101845776|NCT03892889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101845777|NCT03892889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101963828|NCT02207452|Tocolytic Agents|tocolytic agents|mesh-ancestor
101845778|NCT03892889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845779|NCT03892889|Dopamine Agonists|dopamine agonists|mesh-ancestor
101845780|NCT03892889|Dopamine Agents|dopamine agents|mesh-ancestor
101845781|NCT03892889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101845782|NCT03892889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845783|NCT03892889|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101845784|NCT03892889|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101845785|NCT03892889|Serotonin Agents|serotonin agents|mesh-ancestor
101845786|NCT03892889|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101845787|NCT03892889|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101845788|NCT03892889|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101845789|NCT03892889|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101845790|NCT00993707|Hyaluronic Acid|hyaluronic acid|mesh-list
101845791|NCT00993707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101845792|NCT00993707|Immunologic Factors|immunologic factors|mesh-ancestor
101845793|NCT00993707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845794|NCT00993707|Viscosupplements|viscosupplements|mesh-ancestor
101845795|NCT00993707|Protective Agents|protective agents|mesh-ancestor
101845796|NCT00473330|Ranibizumab|ranibizumab|mesh-list
101845797|NCT00473330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101845798|NCT00473330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101845799|NCT00473330|Growth Substances|growth substances|mesh-ancestor
101845800|NCT00473330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845801|NCT00473330|Growth Inhibitors|growth inhibitors|mesh-ancestor
101845802|NCT00473330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101845803|NCT00416520|Sevelamer|sevelamer|mesh-list
101845804|NCT00416520|Chelating Agents|chelating agents|mesh-ancestor
101845805|NCT00416520|Sequestering Agents|sequestering agents|mesh-ancestor
101845806|NCT00416520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845807|NCT00533429|Bevacizumab|bevacizumab|mesh-list
101845808|NCT00533429|Carboplatin|carboplatin|mesh-list
101845809|NCT00533429|Pemetrexed|pemetrexed|mesh-list
101845810|NCT00533429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101845811|NCT00533429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101845812|NCT00533429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101845813|NCT00533429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101845814|NCT00533429|Growth Substances|growth substances|mesh-ancestor
101845815|NCT00533429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845816|NCT00533429|Growth Inhibitors|growth inhibitors|mesh-ancestor
101845817|NCT00533429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101845818|NCT00533429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845819|NCT00533429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101845820|NCT00533429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101845821|NCT01034124|Vitamin K|vitamin k|mesh-list
101845822|NCT01034124|Midazolam|midazolam|mesh-list
101845823|NCT01034124|Warfarin|warfarin|mesh-list
101845824|NCT01034124|Vitamins|vitamins|mesh-ancestor
101845825|NCT01034124|Micronutrients|micronutrients|mesh-ancestor
101845826|NCT01034124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845827|NCT01034124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101845828|NCT01034124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101845829|NCT01034124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101845830|NCT01034124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101845831|NCT01034124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101845832|NCT01034124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101845833|NCT01034124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101845834|NCT01034124|Anesthetics, General|anesthetics, general|mesh-ancestor
101845835|NCT01034124|Anesthetics|anesthetics|mesh-ancestor
101845836|NCT01034124|GABA Modulators|gaba modulators|mesh-ancestor
101845837|NCT01034124|GABA Agents|gaba agents|mesh-ancestor
101845838|NCT01034124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101845839|NCT01034124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845840|NCT01034124|Anticoagulants|anticoagulants|mesh-ancestor
101845841|NCT01034124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101845842|NCT01034124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101845843|NCT01034124|Hemostatics|hemostatics|mesh-ancestor
101845844|NCT01034124|Coagulants|coagulants|mesh-ancestor
101845845|NCT00339183|Panitumumab|panitumumab|mesh-list
101845846|NCT00339183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101845847|NCT00339183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101845848|NCT01060605|Sirolimus|sirolimus|mesh-list
101845849|NCT01060605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101845850|NCT01060605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101845851|NCT01060605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101845852|NCT01060605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101845853|NCT01060605|Antifungal Agents|antifungal agents|mesh-ancestor
101845854|NCT01060605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101845855|NCT01060605|Immunologic Factors|immunologic factors|mesh-ancestor
101845856|NCT01060605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845857|NCT00532883|Hydroxyurea|hydroxyurea|mesh-list
101845858|NCT00532883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101845859|NCT00532883|Antisickling Agents|antisickling agents|mesh-ancestor
101845860|NCT00532883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101845861|NCT00532883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845862|NCT00532883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101845863|NCT00993863|Ibuprofen|ibuprofen|mesh-list
101845864|NCT00993863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101845865|NCT00993863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101845866|NCT00993863|Analgesics|analgesics|mesh-ancestor
101845867|NCT00993863|Sensory System Agents|sensory system agents|mesh-ancestor
101686084|NCT00620646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101845868|NCT00993863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101845869|NCT00993863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845870|NCT00993863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101845871|NCT00993863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101845872|NCT00993863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101845873|NCT00993863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101845874|NCT00993863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845876|NCT00995423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101845877|NCT00995423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101845878|NCT00995423|Tubulin Modulators|tubulin modulators|mesh-ancestor
101845879|NCT00995423|Antimitotic Agents|antimitotic agents|mesh-ancestor
101845880|NCT00995423|Mitosis Modulators|mitosis modulators|mesh-ancestor
101845881|NCT00995423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845882|NCT00995657|Fluticasone|fluticasone|mesh-list
101845883|NCT00995657|Xhance|xhance|mesh-list
101845884|NCT00995657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101845885|NCT00995657|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101845886|NCT00995657|Autonomic Agents|autonomic agents|mesh-ancestor
101845887|NCT00995657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101845888|NCT00995657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845889|NCT00995657|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101845890|NCT00995657|Respiratory System Agents|respiratory system agents|mesh-ancestor
101845891|NCT00995657|Dermatologic Agents|dermatologic agents|mesh-ancestor
101845892|NCT00995657|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101845893|NCT00994097|Gemcitabine|gemcitabine|mesh-list
101845894|NCT00994097|Pemetrexed|pemetrexed|mesh-list
101845895|NCT00994097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101845896|NCT00994097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101845897|NCT00994097|Antimetabolites|antimetabolites|mesh-ancestor
101845898|NCT00994097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845899|NCT00994097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101845900|NCT00994097|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101845901|NCT00994097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101565712|NCT02029001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101845902|NCT04000919|Carbidopa|carbidopa|mesh-list
101845903|NCT04000919|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101845904|NCT04000919|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101845905|NCT04000919|Dopamine Agents|dopamine agents|mesh-ancestor
101845906|NCT04000919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101845907|NCT04000919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845908|NCT04000919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845909|NCT04000919|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101845910|NCT04000919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101845911|NCT00994253|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101845912|NCT00994253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101845913|NCT00994253|Diuretics|diuretics|mesh-ancestor
101845914|NCT00994253|Natriuretic Agents|natriuretic agents|mesh-ancestor
101845915|NCT00994253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845916|NCT00994253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101845917|NCT00994253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101845918|NCT00994253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845919|NCT00338949|Olanzapine|olanzapine|mesh-list
101845920|NCT00338949|Risperidone|risperidone|mesh-list
101845921|NCT00338949|Ziprasidone|ziprasidone|mesh-list
101845922|NCT00338949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101845923|NCT00338949|Serotonin Agents|serotonin agents|mesh-ancestor
101845924|NCT00338949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101845925|NCT00338949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686090|NCT00620646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101845926|NCT00338949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845927|NCT00338949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101845928|NCT00338949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101845929|NCT00338949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101845930|NCT00338949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101845931|NCT00338949|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101845932|NCT00338949|Dopamine Agents|dopamine agents|mesh-ancestor
101845933|NCT00338949|Antiemetics|antiemetics|mesh-ancestor
101845934|NCT00338949|Autonomic Agents|autonomic agents|mesh-ancestor
101845935|NCT00338949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101845936|NCT00338949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101845937|NCT00338949|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101845938|NCT00338949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101845939|NCT00338949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101845940|NCT01325259|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101845941|NCT01325259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101845942|NCT01325259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845943|NCT00332709|Zoledronic Acid|zoledronic acid|mesh-list
101845944|NCT00332709|Letrozole|letrozole|mesh-list
101845945|NCT00332709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101845946|NCT00332709|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101845947|NCT00332709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101845948|NCT00332709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101845949|NCT00332709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845950|NCT00332709|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101845951|NCT00332709|Hormone Antagonists|hormone antagonists|mesh-ancestor
101845952|NCT00332709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101845953|NCT00332709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845954|NCT00332709|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101845955|NCT03988725|Vitamin E|vitamin e|mesh-list
101845956|NCT03988725|Vitamins|vitamins|mesh-ancestor
101845957|NCT03988725|Micronutrients|micronutrients|mesh-ancestor
101845958|NCT03988725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845959|NCT03988725|Antioxidants|antioxidants|mesh-ancestor
101845960|NCT03988725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845961|NCT03988725|Protective Agents|protective agents|mesh-ancestor
101845962|NCT00332241|Aripiprazole|aripiprazole|mesh-list
101845963|NCT00332241|Antidepressive Agents|antidepressive agents|mesh-ancestor
101845964|NCT00332241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101845965|NCT00332241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101845966|NCT00332241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101845967|NCT00332241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101845968|NCT00332241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845969|NCT00332241|Dopamine Agonists|dopamine agonists|mesh-ancestor
101845970|NCT00332241|Dopamine Agents|dopamine agents|mesh-ancestor
101845971|NCT00332241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101845972|NCT00332241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101845973|NCT00332241|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101845974|NCT00332241|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101845975|NCT00332241|Serotonin Agents|serotonin agents|mesh-ancestor
101845976|NCT00332241|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101845977|NCT00332241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101845978|NCT00332241|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101845979|NCT00332241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101845980|NCT01058577|Somatostatin|somatostatin|mesh-list
101845981|NCT01058577|Hormones|hormones|mesh-ancestor
101845982|NCT01058577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101845983|NCT01058577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845984|NCT03983889|Fentanyl|fentanyl|mesh-list
101845985|NCT03983889|Midazolam|midazolam|mesh-list
101845986|NCT03983889|Dexmedetomidine|dexmedetomidine|mesh-list
101845987|NCT03983889|Remifentanil|remifentanil|mesh-list
101845988|NCT03983889|Propofol|propofol|mesh-list
101845989|NCT03983889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101845990|NCT03983889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101845991|NCT03983889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101845992|NCT03983889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101845993|NCT03983889|Analgesics|analgesics|mesh-ancestor
101845994|NCT03983889|Sensory System Agents|sensory system agents|mesh-ancestor
101845995|NCT03983889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101845996|NCT03983889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101845997|NCT03983889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101845998|NCT03983889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101845999|NCT03983889|Adrenergic Agents|adrenergic agents|mesh-ancestor
101846000|NCT03983889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101846001|NCT03983889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846002|NCT03983889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101846003|NCT03983889|Anesthetics, General|anesthetics, general|mesh-ancestor
101846004|NCT03983889|Anesthetics|anesthetics|mesh-ancestor
101846005|NCT03983889|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101846006|NCT03983889|Narcotics|narcotics|mesh-ancestor
101846007|NCT03983889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101846008|NCT03983889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101846009|NCT03983889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101846010|NCT03983889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101846011|NCT03983889|GABA Modulators|gaba modulators|mesh-ancestor
101846012|NCT03983889|GABA Agents|gaba agents|mesh-ancestor
101846013|NCT00337935|Epoetin Alfa|epoetin alfa|mesh-list
101846014|NCT00337935|Hematinics|hematinics|mesh-ancestor
101846015|NCT00337779|Glatiramer Acetate|glatiramer acetate|mesh-list
101846017|NCT00337779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101846018|NCT00337779|Immunologic Factors|immunologic factors|mesh-ancestor
101846019|NCT00337779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846020|NCT00337779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101846021|NCT00337779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101846022|NCT00352755|Leucovorin|leucovorin|mesh-list
101846023|NCT00352755|Fluorouracil|fluorouracil|mesh-list
101846024|NCT00352755|Oxaliplatin|oxaliplatin|mesh-list
101846025|NCT00352755|Antimetabolites|antimetabolites|mesh-ancestor
101846026|NCT00352755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846027|NCT00352755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101846028|NCT00352755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846029|NCT00352755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101846030|NCT00352755|Immunologic Factors|immunologic factors|mesh-ancestor
101846031|NCT00352755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846032|NCT00352755|Antidotes|antidotes|mesh-ancestor
101846033|NCT00352755|Protective Agents|protective agents|mesh-ancestor
101846034|NCT00352755|Vitamin B Complex|vitamin b complex|mesh-ancestor
101846035|NCT00352755|Vitamins|vitamins|mesh-ancestor
101846036|NCT00352755|Micronutrients|micronutrients|mesh-ancestor
101846037|NCT00533897|Abatacept|abatacept|mesh-list
101846038|NCT00533897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101846039|NCT00533897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846040|NCT00533897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101846041|NCT00533897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846042|NCT00533897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101846043|NCT00533897|Immunologic Factors|immunologic factors|mesh-ancestor
101846044|NCT00533897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846045|NCT00533897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101846046|NCT00426660|Maraviroc|maraviroc|mesh-list
101846047|NCT00426660|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101846048|NCT00426660|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101846049|NCT00426660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846050|NCT00426660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101846051|NCT00426660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101846052|NCT00426660|Antiviral Agents|antiviral agents|mesh-ancestor
101846053|NCT00426660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101846054|NCT00426660|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101846055|NCT00426270|Immunoglobulins|immunoglobulins|mesh-list
101846056|NCT00426270|Immunologic Factors|immunologic factors|mesh-ancestor
101846057|NCT00426270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846059|NCT00330681|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101846060|NCT00330681|Antioxidants|antioxidants|mesh-ancestor
101238702|NCT01611415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101846061|NCT00330681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846062|NCT00330681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101846063|NCT00330681|Protective Agents|protective agents|mesh-ancestor
101846064|NCT00330681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846065|NCT00329901|Vaccines|vaccines|mesh-list
101846066|NCT00329901|Immunologic Factors|immunologic factors|mesh-ancestor
101846067|NCT00329901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846068|NCT00436956|Prednisone|prednisone|mesh-list
101846069|NCT00436956|Cediranib|cediranib|mesh-list
101846070|NCT00436956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101846071|NCT00436956|Glucocorticoids|glucocorticoids|mesh-ancestor
101846072|NCT00436956|Hormones|hormones|mesh-ancestor
101846073|NCT00436956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101846074|NCT00436956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846075|NCT00436956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101846076|NCT00436956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846077|NCT00436956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101846078|NCT00436956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846079|NCT00436956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846080|NCT00436644|Topotecan|topotecan|mesh-list
101846081|NCT00436644|Lapatinib|lapatinib|mesh-list
101846082|NCT00436644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101846083|NCT00436644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101846084|NCT00436644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846085|NCT00436644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846086|NCT00436644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846087|NCT00436644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101846088|NCT00324987|Bevacizumab|bevacizumab|mesh-list
101846089|NCT00324987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101846090|NCT00324987|Imatinib Mesylate|imatinib mesylate|mesh-list
101846091|NCT00324987|Endothelial Growth Factors|endothelial growth factors|mesh-list
101846092|NCT00324987|Antibodies|antibodies|mesh-list
101846093|NCT00324987|Immunoglobulins|immunoglobulins|mesh-list
101846094|NCT00324987|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101846095|NCT00324987|Immunoglobulin G|immunoglobulin g|mesh-list
101846096|NCT00324987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846097|NCT00324987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101846098|NCT00324987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101846099|NCT00324987|Growth Substances|growth substances|mesh-ancestor
101846100|NCT00324987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846101|NCT00324987|Growth Inhibitors|growth inhibitors|mesh-ancestor
101846102|NCT00324987|Immunologic Factors|immunologic factors|mesh-ancestor
101846103|NCT00324987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101846104|NCT00324987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846105|NCT00324987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846106|NCT00324675|Rosiglitazone|rosiglitazone|mesh-list
101846107|NCT00324675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101846108|NCT00324675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846109|NCT01055145|Moxifloxacin|moxifloxacin|mesh-list
101846110|NCT01055145|Levofloxacin|levofloxacin|mesh-list
101846111|NCT01055145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101846112|NCT01055145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101846113|NCT01055145|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101846114|NCT01055145|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101846115|NCT01055145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846116|NCT01055145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846117|NCT01055145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846118|NCT01055145|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101846119|NCT01055145|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101846120|NCT01055145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101846121|NCT00436566|Paclitaxel|paclitaxel|mesh-list
101846122|NCT00436566|Cyclophosphamide|cyclophosphamide|mesh-list
101846123|NCT00436566|Doxorubicin|doxorubicin|mesh-list
101846124|NCT00436566|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101846125|NCT00436566|Trastuzumab|trastuzumab|mesh-list
101846126|NCT00436566|Lapatinib|lapatinib|mesh-list
101565930|NCT00996580|Estradiol|estradiol|mesh-list
101846127|NCT00436566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101846128|NCT00436566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846129|NCT00436566|Tubulin Modulators|tubulin modulators|mesh-ancestor
101846130|NCT00436566|Antimitotic Agents|antimitotic agents|mesh-ancestor
101846131|NCT00436566|Mitosis Modulators|mitosis modulators|mesh-ancestor
101846132|NCT00436566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846133|NCT00436566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101846134|NCT00436566|Immunologic Factors|immunologic factors|mesh-ancestor
101846135|NCT00436566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846136|NCT00436566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101846137|NCT00436566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101846138|NCT00436566|Alkylating Agents|alkylating agents|mesh-ancestor
101846139|NCT00436566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101846140|NCT00436566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101846141|NCT00436566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101846142|NCT00436566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101846143|NCT00436566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846144|NCT00436566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101846145|NCT00436566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101846147|NCT01060683|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101846148|NCT01060683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101846149|NCT01060683|Analgesics|analgesics|mesh-ancestor
101846150|NCT01060683|Sensory System Agents|sensory system agents|mesh-ancestor
101846151|NCT01060683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101846152|NCT01060683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846153|NCT01060683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101846154|NCT01060683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101846155|NCT01055301|Thalidomide|thalidomide|mesh-list
101846156|NCT01055301|Dexamethasone|dexamethasone|mesh-list
101846157|NCT01055301|Cyclophosphamide|cyclophosphamide|mesh-list
101846158|NCT01055301|Melphalan|melphalan|mesh-list
101846159|NCT01055301|Doxorubicin|doxorubicin|mesh-list
101846160|NCT01055301|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101846161|NCT01055301|Etoposide|etoposide|mesh-list
101846162|NCT01055301|Lenalidomide|lenalidomide|mesh-list
101846163|NCT01055301|Bortezomib|bortezomib|mesh-list
101846164|NCT01055301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101846165|NCT01055301|Immunologic Factors|immunologic factors|mesh-ancestor
101846166|NCT01055301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846167|NCT01055301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101846168|NCT01055301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101846169|NCT01055301|Alkylating Agents|alkylating agents|mesh-ancestor
101846170|NCT01055301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846171|NCT01055301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846172|NCT01055301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101846173|NCT01055301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101846174|NCT01055301|Antiemetics|antiemetics|mesh-ancestor
101846175|NCT01055301|Autonomic Agents|autonomic agents|mesh-ancestor
101846176|NCT01055301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101846177|NCT01055301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101846178|NCT01055301|Glucocorticoids|glucocorticoids|mesh-ancestor
101846179|NCT01055301|Hormones|hormones|mesh-ancestor
101846180|NCT01055301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101846181|NCT01055301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101846182|NCT01055301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101846183|NCT01055301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101846184|NCT01055301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101846185|NCT01055301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846186|NCT01055301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101846187|NCT01055301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101846188|NCT01055301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101846189|NCT01055301|Growth Substances|growth substances|mesh-ancestor
101846190|NCT01055301|Growth Inhibitors|growth inhibitors|mesh-ancestor
101846191|NCT01055301|Leprostatic Agents|leprostatic agents|mesh-ancestor
101846192|NCT01055301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101846193|NCT01055301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101846195|NCT01055379|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101846196|NCT01055379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846197|NCT01055379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686124|NCT04209426|Tacrine|tacrine|mesh-list
101846198|NCT01055379|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101846199|NCT01055379|Protective Agents|protective agents|mesh-ancestor
101846200|NCT01055379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846201|NCT03988101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101566023|NCT04540835|Calcium|calcium|mesh-list
101846202|NCT03988101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101846203|NCT03988101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101846204|NCT03988101|Antimetabolites|antimetabolites|mesh-ancestor
101846205|NCT03988101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846206|NCT03988101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101846207|NCT03988101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101846208|NCT03988101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846209|NCT00352365|Lenalidomide|lenalidomide|mesh-list
101846210|NCT00352365|Immunologic Factors|immunologic factors|mesh-ancestor
101846211|NCT00352365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846212|NCT00352365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101846213|NCT00352365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101846214|NCT00352365|Growth Substances|growth substances|mesh-ancestor
101846215|NCT00352365|Growth Inhibitors|growth inhibitors|mesh-ancestor
101846216|NCT00352365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846217|NCT01055535|Plasminogen|plasminogen|mesh-list
101846218|NCT01055535|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101846219|NCT01055535|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101846220|NCT01055535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846221|NCT03987867|Paclitaxel|paclitaxel|mesh-list
101846222|NCT03987867|Carboplatin|carboplatin|mesh-list
101846223|NCT03987867|Pemetrexed|pemetrexed|mesh-list
101846224|NCT03987867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101846225|NCT03987867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101846226|NCT03987867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846227|NCT03987867|Tubulin Modulators|tubulin modulators|mesh-ancestor
101846228|NCT03987867|Antimitotic Agents|antimitotic agents|mesh-ancestor
101846229|NCT03987867|Mitosis Modulators|mitosis modulators|mesh-ancestor
101846230|NCT03987867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846231|NCT03987867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846232|NCT03987867|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101846233|NCT03987867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101846234|NCT03987867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101846235|NCT00532493|Prazosin|prazosin|mesh-list
101846236|NCT00532493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101846237|NCT00532493|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101846238|NCT00532493|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101846239|NCT00532493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101846240|NCT00532493|Adrenergic Agents|adrenergic agents|mesh-ancestor
101846241|NCT00532493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101846242|NCT00532493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846243|NCT00532493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846244|NCT00996515|Azacitidine|azacitidine|mesh-list
101846245|NCT00996515|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101846246|NCT00996515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101846247|NCT00996515|Antimetabolites|antimetabolites|mesh-ancestor
101846248|NCT00996515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846249|NCT00996515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846250|NCT00996515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846251|NCT00996515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101846252|NCT00994799|Ranibizumab|ranibizumab|mesh-list
101846253|NCT00994799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101846254|NCT00994799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101846255|NCT00994799|Growth Substances|growth substances|mesh-ancestor
101846256|NCT00994799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846257|NCT00994799|Growth Inhibitors|growth inhibitors|mesh-ancestor
101495821|NCT03274700|Tamsulosin|tamsulosin|mesh-list
101846258|NCT00994799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846259|NCT00533507|Vaccines|vaccines|mesh-list
101846260|NCT00533507|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101846261|NCT00533507|Immunologic Factors|immunologic factors|mesh-ancestor
101846262|NCT00533507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846263|NCT00352053|Tenofovir|tenofovir|mesh-list
101846264|NCT00352053|Antiviral Agents|antiviral agents|mesh-ancestor
101846265|NCT00352053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101846266|NCT00352053|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101846267|NCT00352053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101846268|NCT00352053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846269|NCT00352053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846270|NCT00352053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101846271|NCT00352053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101846272|NCT00995033|Varenicline|varenicline|mesh-list
101846273|NCT00995033|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101846274|NCT00995033|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101846275|NCT00995033|Cholinergic Agents|cholinergic agents|mesh-ancestor
101846276|NCT00995033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101566095|NCT00996034|Nicotine|nicotine|mesh-list
101846277|NCT00995033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846279|NCT00997061|Topotecan|topotecan|mesh-list
101846280|NCT00997061|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101846281|NCT00997061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101846282|NCT00997061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846283|NCT00997061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846284|NCT00997061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846285|NCT00351819|Testosterone|testosterone|mesh-list
101846286|NCT00351819|Androgens|androgens|mesh-ancestor
101846287|NCT00351819|Hormones|hormones|mesh-ancestor
101846288|NCT00351819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101846289|NCT00351819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846290|NCT00998933|Testosterone|testosterone|mesh-list
101846291|NCT00998933|Androgens|androgens|mesh-ancestor
101846292|NCT00998933|Hormones|hormones|mesh-ancestor
101846293|NCT00998933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101846294|NCT00998933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846295|NCT00323115|Temozolomide|temozolomide|mesh-list
101846296|NCT00323115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101846297|NCT00323115|Alkylating Agents|alkylating agents|mesh-ancestor
101846298|NCT00323115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846299|NCT00323115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846300|NCT00322881|Paclitaxel|paclitaxel|mesh-list
101846301|NCT00322881|Carboplatin|carboplatin|mesh-list
101846302|NCT00322881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101846303|NCT00322881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846304|NCT00322881|Tubulin Modulators|tubulin modulators|mesh-ancestor
101846305|NCT00322881|Antimitotic Agents|antimitotic agents|mesh-ancestor
101846306|NCT00322881|Mitosis Modulators|mitosis modulators|mesh-ancestor
101846307|NCT00322881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846308|NCT00415194|Pemetrexed|pemetrexed|mesh-list
101846309|NCT00415194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846310|NCT00415194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846311|NCT00415194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846312|NCT00415194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101846313|NCT00415194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101846314|NCT00436332|Bevacizumab|bevacizumab|mesh-list
101846315|NCT00436332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101846316|NCT00436332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101846317|NCT00436332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846318|NCT00436332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101846319|NCT00436332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101846320|NCT00436332|Growth Substances|growth substances|mesh-ancestor
101846321|NCT00436332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846322|NCT00436332|Growth Inhibitors|growth inhibitors|mesh-ancestor
101846323|NCT00436332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101846324|NCT00436332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846325|NCT00436332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846326|NCT00532259|Pidilizumab|pidilizumab|mesh-list
101846327|NCT00532259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101846328|NCT00532259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846329|NCT00322491|Plerixafor|plerixafor|mesh-list
101846330|NCT00322491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101846331|NCT00322491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101846332|NCT00322491|Antiviral Agents|antiviral agents|mesh-ancestor
101846333|NCT00322491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101846334|NCT01034514|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
101846335|NCT01034514|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101846336|NCT01034514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846338|NCT00997607|Immunologic Factors|immunologic factors|mesh-ancestor
101846339|NCT00997607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846340|NCT00997685|Capecitabine|capecitabine|mesh-list
101846341|NCT00997685|Oxaliplatin|oxaliplatin|mesh-list
101846342|NCT00997685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101846343|NCT00997685|Antimetabolites|antimetabolites|mesh-ancestor
101846344|NCT00997685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846345|NCT00997685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846346|NCT00997919|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101846347|NCT00997919|Immunologic Factors|immunologic factors|mesh-ancestor
101846348|NCT00997919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846349|NCT00997997|Moxifloxacin|moxifloxacin|mesh-list
101846350|NCT00997997|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101846351|NCT00997997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101846352|NCT00997997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101846353|NCT00997997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101846354|NCT00997997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101846355|NCT00997997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846356|NCT00997997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846357|NCT00997997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846358|NCT00997997|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101846359|NCT00997997|Contraceptive Agents|contraceptive agents|mesh-ancestor
101846360|NCT00997997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101846361|NCT00997997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846362|NCT00997997|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101846363|NCT00997997|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101846364|NCT00997997|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101846365|NCT00998075|Esomeprazole|esomeprazole|mesh-list
101846366|NCT00998075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846367|NCT00998075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846368|NCT00998075|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101846369|NCT00998075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101846370|NCT00998075|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101846371|NCT00531947|Selegiline|selegiline|mesh-list
101846372|NCT00531947|Antidepressive Agents|antidepressive agents|mesh-ancestor
101846373|NCT00531947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101846374|NCT00531947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101846375|NCT00531947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101846376|NCT00531947|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101846378|NCT00531947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846379|NCT00531947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101846380|NCT00531947|Protective Agents|protective agents|mesh-ancestor
101846381|NCT00531947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846382|NCT01003847|Fenofibrate|fenofibrate|mesh-list
101846383|NCT01003847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101846384|NCT01003847|Antimetabolites|antimetabolites|mesh-ancestor
101846385|NCT01003847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846386|NCT01003847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101846387|NCT00530855|Lacosamide|lacosamide|mesh-list
101846388|NCT00530855|Anticonvulsants|anticonvulsants|mesh-ancestor
101387674|NCT00322699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846389|NCT00530855|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101846390|NCT00530855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101846391|NCT00530855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101846392|NCT00530855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846393|NCT01004237|Valsartan|valsartan|mesh-list
101846394|NCT01004237|Pravastatin|pravastatin|mesh-list
101846395|NCT01004237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101846396|NCT01004237|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101846397|NCT01004237|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101846398|NCT01004237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846399|NCT01004237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101846400|NCT01004237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101846401|NCT01004237|Antimetabolites|antimetabolites|mesh-ancestor
101846402|NCT01004237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101846403|NCT01004237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101846404|NCT01004237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846405|NCT01004315|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101846406|NCT01004315|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101846407|NCT01004315|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101846408|NCT01004315|Cholinergic Agents|cholinergic agents|mesh-ancestor
101846409|NCT01004315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101846410|NCT01004315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846411|NCT01004315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846412|NCT01004315|Urological Agents|urological agents|mesh-ancestor
101846414|NCT05239637|Calcium heparin|calcium heparin|mesh-list
101846415|NCT05239637|Anticoagulants|anticoagulants|mesh-ancestor
101846416|NCT05239637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101846417|NCT05239637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101846418|NCT05239637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846419|NCT01005095|Vitamin D|vitamin d|mesh-list
101846420|NCT01005095|Ergocalciferols|ergocalciferols|mesh-list
101846421|NCT01005095|Cholecalciferol|cholecalciferol|mesh-list
101846422|NCT01005095|Vitamins|vitamins|mesh-list
101846423|NCT01005095|Micronutrients|micronutrients|mesh-ancestor
101846424|NCT01005095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846425|NCT01005095|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101846426|NCT01005095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101846427|NCT01005641|Lapatinib|lapatinib|mesh-list
101846428|NCT01005641|Exemestane|exemestane|mesh-list
101846429|NCT01005641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846430|NCT01005641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101846431|NCT01005641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846432|NCT01005641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846433|NCT01005641|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101846434|NCT01005641|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101846435|NCT01005641|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101846436|NCT01005641|Hormone Antagonists|hormone antagonists|mesh-ancestor
101846437|NCT01005641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101846438|NCT01005641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846439|NCT01005797|Sorafenib|sorafenib|mesh-list
101846440|NCT01005797|Panobinostat|panobinostat|mesh-list
101846441|NCT01005797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846442|NCT01005797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101846443|NCT01005797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846444|NCT01005797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846445|NCT01005797|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101846446|NCT01006031|Interferons|interferons|mesh-list
101846447|NCT01006031|Ribavirin|ribavirin|mesh-list
101846448|NCT01006031|Interferon-alpha|interferon-alpha|mesh-list
101846449|NCT01006031|Interferon alpha-2|interferon alpha-2|mesh-list
101846450|NCT01006031|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101846451|NCT01006031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846452|NCT01006031|Antiviral Agents|antiviral agents|mesh-ancestor
101846453|NCT01006031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101846454|NCT01006031|Antimetabolites|antimetabolites|mesh-ancestor
101846455|NCT01006031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846456|NCT01006031|Immunologic Factors|immunologic factors|mesh-ancestor
101846457|NCT01006031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846458|NCT01006187|Lidocaine|lidocaine|mesh-list
101846459|NCT01006187|Anesthetics, Local|anesthetics, local|mesh-ancestor
101846460|NCT01006187|Anesthetics|anesthetics|mesh-ancestor
101846461|NCT01006187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101846462|NCT01006187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846463|NCT01006187|Sensory System Agents|sensory system agents|mesh-ancestor
101846464|NCT01006187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101846465|NCT01006187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101846466|NCT01006187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101846467|NCT01006187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101846468|NCT01006187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101846469|NCT01006187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846470|NCT00530777|Valacyclovir|valacyclovir|mesh-list
101846471|NCT00530777|Antiviral Agents|antiviral agents|mesh-ancestor
101846473|NCT01006499|Pentoxifylline|pentoxifylline|mesh-list
101846474|NCT01006499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101846475|NCT01006499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846476|NCT01006499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846477|NCT01006499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101846478|NCT01006499|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101846479|NCT01006499|Protective Agents|protective agents|mesh-ancestor
101846480|NCT01006499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846481|NCT01006499|Vasodilator Agents|vasodilator agents|mesh-ancestor
101846482|NCT01006499|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101846483|NCT01006499|Antioxidants|antioxidants|mesh-ancestor
101846484|NCT03882047|Fluticasone|fluticasone|mesh-list
101846485|NCT03882047|Xhance|xhance|mesh-list
101846486|NCT03882047|Mometasone Furoate|mometasone furoate|mesh-list
101846487|NCT03882047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101846488|NCT03882047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101846489|NCT03882047|Autonomic Agents|autonomic agents|mesh-ancestor
101846490|NCT03882047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101846491|NCT03882047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846492|NCT03882047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101846493|NCT03882047|Respiratory System Agents|respiratory system agents|mesh-ancestor
101846494|NCT03882047|Dermatologic Agents|dermatologic agents|mesh-ancestor
101846495|NCT03882047|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101846496|NCT01007279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101846497|NCT01007279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101846498|NCT01007279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101846499|NCT01007279|Antimetabolites|antimetabolites|mesh-ancestor
101846500|NCT01007279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846501|NCT01007279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101846502|NCT01007279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101846503|NCT01007279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846504|NCT00530621|Pemetrexed|pemetrexed|mesh-list
101846505|NCT00530621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846506|NCT00530621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101963909|NCT02203552|Minocycline|minocycline|mesh-list
101963915|NCT02200354|Bevacizumab|bevacizumab|mesh-list
101846507|NCT00530621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846508|NCT00530621|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101846509|NCT00530621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101846511|NCT00531479|Anidulafungin|anidulafungin|mesh-list
101846512|NCT00531479|Antifungal Agents|antifungal agents|mesh-ancestor
101846513|NCT00531479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101846514|NCT00531479|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101846515|NCT00531479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101846516|NCT00531479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846517|NCT00531479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846518|NCT00531479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101846519|NCT00531479|Hormone Antagonists|hormone antagonists|mesh-ancestor
101846520|NCT00531479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101846521|NCT00531479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846522|NCT00531479|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101846523|NCT00999479|Ferrous fumarate|ferrous fumarate|mesh-list
101846524|NCT00999479|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101846525|NCT00999479|Norethindrone|norethindrone|mesh-list
101846526|NCT00999479|Norethindrone Acetate|norethindrone acetate|mesh-list
101846527|NCT00999479|Estradiol|estradiol|mesh-list
101846528|NCT00999479|Estrogens|estrogens|mesh-ancestor
101846529|NCT00999479|Hormones|hormones|mesh-ancestor
101846530|NCT00999479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101846531|NCT00999479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846532|NCT00999479|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101846533|NCT00999479|Contraceptive Agents|contraceptive agents|mesh-ancestor
101846534|NCT00999479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101846535|NCT00999479|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101846536|NCT00999479|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101846537|NCT00999479|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101846538|NCT00999479|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101846539|NCT00999479|Trace Elements|trace elements|mesh-ancestor
101846540|NCT00999479|Micronutrients|micronutrients|mesh-ancestor
101846541|NCT00999557|Bimatoprost|bimatoprost|mesh-list
101846542|NCT00999557|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101846543|NCT00999557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101846544|NCT00999557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101846545|NCT01008137|Vaccines|vaccines|mesh-list
101846546|NCT01008137|Immunologic Factors|immunologic factors|mesh-ancestor
101846547|NCT01008137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846549|NCT00999791|Bevacizumab|bevacizumab|mesh-list
101846550|NCT00999791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101846551|NCT00999791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846552|NCT00999791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101846553|NCT00999791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101846554|NCT00999791|Growth Substances|growth substances|mesh-ancestor
101846555|NCT00999791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846556|NCT00999791|Growth Inhibitors|growth inhibitors|mesh-ancestor
101846557|NCT00999791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101846558|NCT00999791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101846559|NCT00999791|Analgesics|analgesics|mesh-ancestor
101846560|NCT00999791|Sensory System Agents|sensory system agents|mesh-ancestor
101846561|NCT00999791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101846562|NCT00999791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101846563|NCT00999791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101846564|NCT00999791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101846565|NCT00999791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846566|NCT00999791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846567|NCT00999869|Triamcinolone|triamcinolone|mesh-list
101846568|NCT00999869|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101846569|NCT00999869|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101846570|NCT00999869|Botulinum Toxins|botulinum toxins|mesh-list
101846571|NCT00999869|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101846572|NCT00999869|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101846573|NCT00999869|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101846574|NCT00999869|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101846575|NCT00999869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101846576|NCT00999869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846577|NCT00999869|Cholinergic Agents|cholinergic agents|mesh-ancestor
101846578|NCT00999869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101846579|NCT00999869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846580|NCT00999869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101846581|NCT00999869|Glucocorticoids|glucocorticoids|mesh-ancestor
101846583|NCT00999869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101846584|NCT00999869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101846585|NCT00999869|Immunologic Factors|immunologic factors|mesh-ancestor
101846586|NCT00999869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846587|NCT00999869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101846588|NCT00999869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101846589|NCT01008293|Lactulose|lactulose|mesh-list
101846590|NCT01008293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101846591|NCT01008527|Poly ICLC|poly iclc|mesh-list
101846592|NCT01008527|Interferon Inducers|interferon inducers|mesh-ancestor
101846593|NCT01008527|Immunologic Factors|immunologic factors|mesh-ancestor
101846594|NCT01008527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846595|NCT01000415|Cisplatin|cisplatin|mesh-list
101846596|NCT01000415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846597|NCT01008761|Azithromycin|azithromycin|mesh-list
101846598|NCT01008761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101846599|NCT01008761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101846600|NCT01008917|Sirolimus|sirolimus|mesh-list
101846601|NCT01008917|Sorafenib|sorafenib|mesh-list
101846602|NCT01008917|Temsirolimus|temsirolimus|mesh-list
101846603|NCT01008917|MTOR Inhibitors|mtor inhibitors|mesh-list
101846604|NCT01008917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846605|NCT01008917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101846606|NCT01008917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846607|NCT01008917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846608|NCT01008917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101846609|NCT01008917|Immunologic Factors|immunologic factors|mesh-ancestor
101846610|NCT01008917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846611|NCT01008917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101846612|NCT01008917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101846613|NCT01008917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101846614|NCT01008917|Antifungal Agents|antifungal agents|mesh-ancestor
101846615|NCT01009073|Irinotecan|irinotecan|mesh-list
101846616|NCT01009073|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101846617|NCT01009073|Navitoclax|navitoclax|mesh-list
101846618|NCT01009073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101846619|NCT01009073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101846620|NCT01009073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686150|NCT02848157|Analgesics|analgesics|mesh-ancestor
101846621|NCT01009073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846623|NCT01009073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101846624|NCT00530075|Gusperimus|gusperimus|mesh-list
101846625|NCT00530075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101846626|NCT00530075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846627|NCT00530075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101846628|NCT00530075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846629|NCT00530075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101846630|NCT00530075|Immunologic Factors|immunologic factors|mesh-ancestor
101846631|NCT00530075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101846632|NCT00530075|Protective Agents|protective agents|mesh-ancestor
101846633|NCT01001585|Sevoflurane|sevoflurane|mesh-list
101846634|NCT01001585|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101846635|NCT01001585|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101846636|NCT01001585|Anesthetics, General|anesthetics, general|mesh-ancestor
101846637|NCT01001585|Anesthetics|anesthetics|mesh-ancestor
101846638|NCT01001585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101846639|NCT01001585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846640|NCT01001897|Misoprostol|misoprostol|mesh-list
101846641|NCT01001897|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101846642|NCT01001897|Abortifacient Agents|abortifacient agents|mesh-ancestor
101846643|NCT01001897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101846644|NCT01001897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846645|NCT01001897|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101846646|NCT01001897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101846647|NCT01001897|Oxytocics|oxytocics|mesh-ancestor
101566448|NCT02867800|Anesthetics, Local|anesthetics, local|mesh-ancestor
101846649|NCT05734001|Coagulants|coagulants|mesh-ancestor
101846650|NCT01002911|Cefazolin|cefazolin|mesh-list
101846651|NCT01002911|Cephalexin|cephalexin|mesh-list
101846652|NCT01002911|Bacitracin|bacitracin|mesh-list
101846653|NCT01002911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101846654|NCT01002911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101387675|NCT00322699|Dermatologic Agents|dermatologic agents|mesh-ancestor
101846655|NCT01002911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101846656|NCT05059535|Acetaminophen|acetaminophen|mesh-list
101846657|NCT05059535|Analgesics|analgesics|mesh-list
101846658|NCT05059535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101846659|NCT05059535|Sensory System Agents|sensory system agents|mesh-ancestor
101846660|NCT05059535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101846661|NCT05059535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846662|NCT05059535|Antipyretics|antipyretics|mesh-ancestor
101846663|NCT00531011|Paclitaxel|paclitaxel|mesh-list
101846664|NCT00531011|Everolimus|everolimus|mesh-list
101846665|NCT00531011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101846666|NCT00531011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846667|NCT00531011|Tubulin Modulators|tubulin modulators|mesh-ancestor
101846668|NCT00531011|Antimitotic Agents|antimitotic agents|mesh-ancestor
101846669|NCT00531011|Mitosis Modulators|mitosis modulators|mesh-ancestor
101846670|NCT00531011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846671|NCT00531011|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101846672|NCT00531011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101846673|NCT00531011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846674|NCT00531011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101846675|NCT00531011|Immunologic Factors|immunologic factors|mesh-ancestor
101846676|NCT00531011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846677|NCT04000295|Paclitaxel|paclitaxel|mesh-list
101846678|NCT04000295|Etoposide|etoposide|mesh-list
101846679|NCT04000295|Apatinib|apatinib|mesh-list
101846680|NCT04000295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101846681|NCT04000295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846682|NCT04000295|Tubulin Modulators|tubulin modulators|mesh-ancestor
101846683|NCT04000295|Antimitotic Agents|antimitotic agents|mesh-ancestor
101846684|NCT04000295|Mitosis Modulators|mitosis modulators|mesh-ancestor
101846685|NCT04000295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846686|NCT04000295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101846687|NCT04000295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101846688|NCT04000295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846689|NCT04000295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101846690|NCT01003613|Tranilast|tranilast|mesh-list
101846691|NCT01003613|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101514476|NCT05471063|Fluconazole|fluconazole|mesh-list
101846692|NCT01003613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101846693|NCT01003613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101846694|NCT01003613|Analgesics|analgesics|mesh-ancestor
101846695|NCT01003613|Sensory System Agents|sensory system agents|mesh-ancestor
101846696|NCT01003613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101846697|NCT01003613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846698|NCT01003613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101846699|NCT01003613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101846700|NCT01003613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101846701|NCT01003613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101846702|NCT01003613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846703|NCT01003613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101846704|NCT01003613|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101846705|NCT01003613|Histamine Antagonists|histamine antagonists|mesh-ancestor
101846706|NCT01003613|Histamine Agents|histamine agents|mesh-ancestor
101846707|NCT01003613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101846708|NCT01003613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101846709|NCT01003613|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101846710|NCT01003613|Hemostatics|hemostatics|mesh-ancestor
101846711|NCT01003613|Coagulants|coagulants|mesh-ancestor
101846712|NCT00471146|Gemcitabine|gemcitabine|mesh-list
101846713|NCT00471146|Axitinib|axitinib|mesh-list
101846714|NCT00471146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101846715|NCT00471146|Antimetabolites|antimetabolites|mesh-ancestor
101846716|NCT00471146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846718|NCT00471146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101846719|NCT00471146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846720|NCT01021358|Ketoconazole|ketoconazole|mesh-list
101846721|NCT01021358|Navitoclax|navitoclax|mesh-list
101846722|NCT01021358|Antifungal Agents|antifungal agents|mesh-ancestor
101846723|NCT01021358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101846724|NCT01021358|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101846725|NCT01021358|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101846727|NCT01021358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846728|NCT01021358|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101846729|NCT01021358|Hormone Antagonists|hormone antagonists|mesh-ancestor
101846730|NCT01021358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101846731|NCT01021358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846732|NCT01021358|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101846733|NCT01021358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846734|NCT00469898|Carboplatin|carboplatin|mesh-list
101846735|NCT00469898|Irinotecan|irinotecan|mesh-list
101846736|NCT00469898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846737|NCT00469898|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101846738|NCT00469898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101846739|NCT00469898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846740|NCT00469898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846741|NCT01021436|Amikacin|amikacin|mesh-list
101846742|NCT01021436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101846743|NCT01021436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101846744|NCT00529763|Dasatinib|dasatinib|mesh-list
101846745|NCT00529763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846746|NCT00529763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101846747|NCT00529763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846748|NCT00529763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846749|NCT00486902|Ketamine|ketamine|mesh-list
101846750|NCT00486902|N-Methylaspartate|n-methylaspartate|mesh-list
101846751|NCT00486902|Analgesics|analgesics|mesh-ancestor
101846752|NCT00486902|Sensory System Agents|sensory system agents|mesh-ancestor
101846753|NCT00486902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101846754|NCT00486902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846755|NCT00486902|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101846756|NCT00486902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101846757|NCT00486902|Anesthetics, General|anesthetics, general|mesh-ancestor
101846758|NCT00486902|Anesthetics|anesthetics|mesh-ancestor
101846759|NCT00486902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101846760|NCT00486902|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101846761|NCT00486902|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101846762|NCT00486902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101846763|NCT00486902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846764|NCT00486902|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
101846765|NCT03687827|Insulin|insulin|mesh-list
101846766|NCT03687827|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101846767|NCT03687827|Insulin Glargine|insulin glargine|mesh-list
101846768|NCT03687827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101846769|NCT03687827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846770|NCT00529529|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101846771|NCT00529529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101846772|NCT00529529|Autonomic Agents|autonomic agents|mesh-ancestor
101846773|NCT00529529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101846774|NCT00529529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846775|NCT00529529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101846776|NCT00529529|Respiratory System Agents|respiratory system agents|mesh-ancestor
101846777|NCT00529529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101846778|NCT00529529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101846779|NCT00529529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101846780|NCT00529529|Adrenergic Agents|adrenergic agents|mesh-ancestor
101846781|NCT00529529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101846782|NCT00529529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846783|NCT05685953|Vaccines|vaccines|mesh-list
101846784|NCT05685953|Immunologic Factors|immunologic factors|mesh-ancestor
101846785|NCT05685953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846786|NCT00486434|Calcitonin|calcitonin|mesh-list
101846787|NCT00486434|Salmon calcitonin|salmon calcitonin|mesh-list
101238795|NCT01612247|Antipyretics|antipyretics|mesh-ancestor
101846788|NCT00486434|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
101846789|NCT00486434|Katacalcin|katacalcin|mesh-list
101846790|NCT00486434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101846791|NCT00486434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846792|NCT00486434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101846793|NCT00486434|Vasodilator Agents|vasodilator agents|mesh-ancestor
101846794|NCT00529451|Ramipril|ramipril|mesh-list
101846795|NCT00529451|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101846796|NCT00529451|Protease Inhibitors|protease inhibitors|mesh-ancestor
101846797|NCT00529451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846798|NCT00529451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846799|NCT00529451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101846800|NCT05641259|Azacitidine|azacitidine|mesh-list
101846801|NCT05641259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101846802|NCT05641259|Antimetabolites|antimetabolites|mesh-ancestor
101846803|NCT05641259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846804|NCT05641259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846805|NCT05641259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846806|NCT05405387|Budesonide|budesonide|mesh-list
101846807|NCT05405387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101846808|NCT05405387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101846809|NCT05405387|Autonomic Agents|autonomic agents|mesh-ancestor
101846810|NCT05405387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101846811|NCT05405387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846812|NCT05405387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101846813|NCT05405387|Respiratory System Agents|respiratory system agents|mesh-ancestor
101846814|NCT05405387|Glucocorticoids|glucocorticoids|mesh-ancestor
101846815|NCT05405387|Hormones|hormones|mesh-ancestor
101846816|NCT05405387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101846817|NCT03999437|Terbinafine|terbinafine|mesh-list
101846818|NCT03999437|Butenafine|butenafine|mesh-list
101846819|NCT03999437|Antifungal Agents|antifungal agents|mesh-ancestor
101846820|NCT03999437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101846821|NCT03999437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846822|NCT03999437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846823|NCT05638217|Listerine|listerine|mesh-list
101846824|NCT05638217|Fluorides|fluorides|mesh-list
101846825|NCT05638217|Sodium Fluoride|sodium fluoride|mesh-list
101846826|NCT05638217|Fluorides, Topical|fluorides, topical|mesh-list
101846827|NCT05638217|Cariostatic Agents|cariostatic agents|mesh-ancestor
101846828|NCT05638217|Protective Agents|protective agents|mesh-ancestor
101846829|NCT05638217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846830|NCT05638217|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101846831|NCT05638217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101846832|NCT05637281|Indomethacin|indomethacin|mesh-list
101846833|NCT05637281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101846834|NCT05637281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101846835|NCT05637281|Analgesics|analgesics|mesh-ancestor
101846836|NCT05637281|Sensory System Agents|sensory system agents|mesh-ancestor
101846837|NCT05637281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101846838|NCT05637281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846839|NCT05637281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101846840|NCT05637281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101846841|NCT05637281|Gout Suppressants|gout suppressants|mesh-ancestor
101846842|NCT05637281|Tocolytic Agents|tocolytic agents|mesh-ancestor
101846843|NCT05637281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101846844|NCT05637281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101846845|NCT05637281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846846|NCT05637281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846847|NCT00321711|Azacitidine|azacitidine|mesh-list
101846848|NCT00321711|Decitabine|decitabine|mesh-list
101846849|NCT00321711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101846850|NCT00321711|Antimetabolites|antimetabolites|mesh-ancestor
101846851|NCT00321711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846852|NCT00321711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846853|NCT00321711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846854|NCT00486044|Simvastatin|simvastatin|mesh-list
101846855|NCT00486044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101846856|NCT00486044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101846857|NCT00486044|Antimetabolites|antimetabolites|mesh-ancestor
101846858|NCT00486044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846859|NCT00486044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101846860|NCT00486044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101846861|NCT00486044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846862|NCT00351273|Azithromycin|azithromycin|mesh-list
101846863|NCT00351273|Doxycycline|doxycycline|mesh-list
101846864|NCT00351273|Rifampin|rifampin|mesh-list
101846865|NCT00351273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101846866|NCT00351273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101846867|NCT00351273|Antimalarials|antimalarials|mesh-ancestor
101846868|NCT00351273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101846869|NCT00351273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101846870|NCT00351273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101846871|NCT00351273|Antitubercular Agents|antitubercular agents|mesh-ancestor
101846872|NCT00351273|Leprostatic Agents|leprostatic agents|mesh-ancestor
101846873|NCT00351273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101846874|NCT00351273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846875|NCT00351273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846876|NCT00351273|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101846877|NCT00351273|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101846878|NCT00351273|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101846879|NCT00351273|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101846880|NCT00351273|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101846881|NCT00351273|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101846882|NCT00327717|Zonisamide|zonisamide|mesh-list
101846883|NCT00327717|Anticonvulsants|anticonvulsants|mesh-ancestor
101846884|NCT00327717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101846885|NCT00327717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101846886|NCT00327717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846887|NCT00327717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101846888|NCT00327717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846889|NCT00463346|Acamprosate|acamprosate|mesh-list
101846890|NCT00463346|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101846891|NCT01022528|Dexamethasone|dexamethasone|mesh-list
101846892|NCT01022528|Dexamethasone acetate|dexamethasone acetate|mesh-list
101846893|NCT01022528|BB 1101|bb 1101|mesh-list
101846894|NCT01022528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101846895|NCT01022528|Antiemetics|antiemetics|mesh-ancestor
101846896|NCT01022528|Autonomic Agents|autonomic agents|mesh-ancestor
101963976|NCT02210728|Methylphenidate|methylphenidate|mesh-list
101846897|NCT01022528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101846898|NCT01022528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846899|NCT01022528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101846900|NCT01022528|Glucocorticoids|glucocorticoids|mesh-ancestor
101846901|NCT01022528|Hormones|hormones|mesh-ancestor
101846902|NCT01022528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101846903|NCT01022528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101846904|NCT01022528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846905|NCT01022528|Protease Inhibitors|protease inhibitors|mesh-ancestor
101846906|NCT01022528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846907|NCT01022528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846908|NCT01025102|Sufentanil|sufentanil|mesh-list
101846909|NCT01025102|Ropivacaine|ropivacaine|mesh-list
101846910|NCT01025102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101846911|NCT01025102|Narcotics|narcotics|mesh-ancestor
101846912|NCT01025102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101846913|NCT01025102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846914|NCT01025102|Analgesics|analgesics|mesh-ancestor
101846915|NCT01025102|Sensory System Agents|sensory system agents|mesh-ancestor
101846916|NCT01025102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101846917|NCT01025102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101846918|NCT01025102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101846919|NCT01025102|Anesthetics, General|anesthetics, general|mesh-ancestor
101846920|NCT01025102|Anesthetics|anesthetics|mesh-ancestor
101846921|NCT01025102|Anesthetics, Local|anesthetics, local|mesh-ancestor
101846922|NCT00424476|Belimumab|belimumab|mesh-list
101846923|NCT00424476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101846924|NCT00424476|Immunologic Factors|immunologic factors|mesh-ancestor
101846925|NCT00424476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846926|NCT01037634|Oseltamivir|oseltamivir|mesh-list
101846927|NCT01037634|Antiviral Agents|antiviral agents|mesh-ancestor
101846928|NCT01037634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101846929|NCT01037634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846930|NCT01037634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846931|NCT01037712|Valacyclovir|valacyclovir|mesh-list
101846932|NCT01037712|Antiviral Agents|antiviral agents|mesh-ancestor
101846933|NCT01037712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101846934|NCT00453362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101846935|NCT00453362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846936|NCT00453362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101846937|NCT00453362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846938|NCT00453362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846939|NCT00424398|Bepotastine besilate|bepotastine besilate|mesh-list
101846940|NCT00424398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101846941|NCT00461786|Pemetrexed|pemetrexed|mesh-list
101846942|NCT00461786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846943|NCT00461786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846944|NCT00461786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846945|NCT00461786|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101846946|NCT00461786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101846947|NCT01021592|Bortezomib|bortezomib|mesh-list
101846948|NCT01021592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846949|NCT00435162|Valsartan|valsartan|mesh-list
101846950|NCT00435162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101846951|NCT00435162|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101846952|NCT00435162|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101846953|NCT00435162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846954|NCT03836664|Timolol|timolol|mesh-list
101846955|NCT03836664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101846956|NCT03836664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101846957|NCT03836664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101846958|NCT03836664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101846959|NCT03836664|Adrenergic Agents|adrenergic agents|mesh-ancestor
101846960|NCT03836664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101846961|NCT03836664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846962|NCT03836664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846963|NCT03836664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101846964|NCT03836664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101846965|NCT00350727|Lapatinib|lapatinib|mesh-list
101846966|NCT00350727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101846967|NCT00350727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101846968|NCT00350727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686168|NCT00619710|Cilastatin|cilastatin|mesh-list
101846969|NCT00350727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846970|NCT01032486|Rasagiline|rasagiline|mesh-list
101846971|NCT01032486|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101846972|NCT01032486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101846973|NCT01032486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846974|NCT01032486|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101846975|NCT01032486|Protective Agents|protective agents|mesh-ancestor
101846976|NCT01032486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846977|NCT01061697|Pregabalin|pregabalin|mesh-list
101846978|NCT01061697|Analgesics|analgesics|mesh-ancestor
101846979|NCT01061697|Sensory System Agents|sensory system agents|mesh-ancestor
101846980|NCT01061697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101846981|NCT01061697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846982|NCT01061697|Anticonvulsants|anticonvulsants|mesh-ancestor
101846983|NCT01061697|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101846984|NCT01061697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101846985|NCT01061697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238820|NCT01612299|Everolimus|everolimus|mesh-list
101846986|NCT01061697|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101846987|NCT01061697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101846988|NCT01061697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101846989|NCT01061697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101846990|NCT01061697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101846991|NCT00434304|Ropinirole|ropinirole|mesh-list
101846992|NCT00434304|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101846993|NCT00434304|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101846994|NCT00434304|Dopamine Agonists|dopamine agonists|mesh-ancestor
101846995|NCT00434304|Dopamine Agents|dopamine agents|mesh-ancestor
101846996|NCT00434304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101846997|NCT00434304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101846998|NCT00434304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101846999|NCT00424008|Fluticasone|fluticasone|mesh-list
101847000|NCT00424008|Xhance|xhance|mesh-list
101847001|NCT00424008|Mometasone Furoate|mometasone furoate|mesh-list
101847002|NCT00424008|Formoterol Fumarate|formoterol fumarate|mesh-list
101847003|NCT00424008|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101847004|NCT00424008|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101847005|NCT00424008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101847006|NCT00424008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101847007|NCT00424008|Autonomic Agents|autonomic agents|mesh-ancestor
101847008|NCT00424008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101847009|NCT00424008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847010|NCT00424008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101847011|NCT00424008|Respiratory System Agents|respiratory system agents|mesh-ancestor
101847012|NCT00424008|Dermatologic Agents|dermatologic agents|mesh-ancestor
101847013|NCT00424008|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101847014|NCT00424008|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101847015|NCT00424008|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101847016|NCT00424008|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101847017|NCT00424008|Adrenergic Agents|adrenergic agents|mesh-ancestor
101847018|NCT00424008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101847019|NCT00424008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847020|NCT00424008|Glucocorticoids|glucocorticoids|mesh-ancestor
101847021|NCT00424008|Hormones|hormones|mesh-ancestor
101566826|NCT02865616|Vancomycin|vancomycin|mesh-list
101847022|NCT00424008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101847023|NCT00424008|Sympathomimetics|sympathomimetics|mesh-ancestor
101847024|NCT00423930|Bevacizumab|bevacizumab|mesh-list
101847025|NCT00423930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101847026|NCT00423930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101847027|NCT00423930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101847028|NCT00423930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101847029|NCT00423930|Growth Substances|growth substances|mesh-ancestor
101847030|NCT00423930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847031|NCT00423930|Growth Inhibitors|growth inhibitors|mesh-ancestor
101847032|NCT00423852|Paclitaxel|paclitaxel|mesh-list
101847033|NCT00423852|Carboplatin|carboplatin|mesh-list
101847034|NCT00423852|Ifosfamide|ifosfamide|mesh-list
101847035|NCT00423852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101847036|NCT00423852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101847037|NCT00423852|Tubulin Modulators|tubulin modulators|mesh-ancestor
101847038|NCT00423852|Antimitotic Agents|antimitotic agents|mesh-ancestor
101847039|NCT00423852|Mitosis Modulators|mitosis modulators|mesh-ancestor
101847040|NCT00423852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238829|NCT01612377|Prednisone|prednisone|mesh-list
101847041|NCT00423852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101847042|NCT00423852|Alkylating Agents|alkylating agents|mesh-ancestor
101847043|NCT00461708|Gemcitabine|gemcitabine|mesh-list
101847044|NCT00461708|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101847045|NCT00461708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101847046|NCT00461708|Antimetabolites|antimetabolites|mesh-ancestor
101847047|NCT00461708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847048|NCT00461708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101847049|NCT00461708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101847050|NCT00461708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101847051|NCT00327171|Aflibercept|aflibercept|mesh-list
101847052|NCT00327171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101847053|NCT00327171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101847054|NCT00327171|Growth Substances|growth substances|mesh-ancestor
101847055|NCT00327171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847056|NCT00327171|Growth Inhibitors|growth inhibitors|mesh-ancestor
101847057|NCT00327171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101847058|NCT01038024|Antioxidants|antioxidants|mesh-list
101847059|NCT01038024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847060|NCT01038024|Protective Agents|protective agents|mesh-ancestor
101847061|NCT01038024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847062|NCT00461630|Niacin|niacin|mesh-list
101847063|NCT00461630|Simvastatin|simvastatin|mesh-list
101847064|NCT00461630|Ezetimibe|ezetimibe|mesh-list
101847065|NCT00461630|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
101847066|NCT00461630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101847067|NCT00461630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101847068|NCT00461630|Antimetabolites|antimetabolites|mesh-ancestor
101847069|NCT00461630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847070|NCT00461630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101847071|NCT00461630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101847072|NCT00461630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101847073|NCT00461630|Vasodilator Agents|vasodilator agents|mesh-ancestor
101847074|NCT00461630|Vitamin B Complex|vitamin b complex|mesh-ancestor
101847075|NCT00461630|Vitamins|vitamins|mesh-ancestor
101847076|NCT00461630|Micronutrients|micronutrients|mesh-ancestor
101847077|NCT00461630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847078|NCT01061853|Sirolimus|sirolimus|mesh-list
101847079|NCT01061853|Betamethasone|betamethasone|mesh-list
101847080|NCT01061853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101847081|NCT01061853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101847082|NCT01061853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101847083|NCT01061853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101847084|NCT01061853|Antifungal Agents|antifungal agents|mesh-ancestor
101847085|NCT01061853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101847086|NCT01061853|Immunologic Factors|immunologic factors|mesh-ancestor
101847087|NCT01061853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847088|NCT01061853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101847089|NCT01061853|Glucocorticoids|glucocorticoids|mesh-ancestor
101847090|NCT01061853|Hormones|hormones|mesh-ancestor
101847091|NCT01061853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101847092|NCT01061853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101847093|NCT01061853|Respiratory System Agents|respiratory system agents|mesh-ancestor
101847094|NCT01325415|Moxifloxacin|moxifloxacin|mesh-list
101847095|NCT01325415|Naloxegol|naloxegol|mesh-list
101847096|NCT01325415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101847097|NCT01325415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101847099|NCT01325415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101847100|NCT01325415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101847101|NCT01325415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264555|NCT01768377|Lidocaine|lidocaine|mesh-list
101847102|NCT01325415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101847103|NCT01325415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847104|NCT01325415|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101847105|NCT01325415|Sensory System Agents|sensory system agents|mesh-ancestor
101847106|NCT01325415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101847107|NCT01022840|Ketamine|ketamine|mesh-list
101847108|NCT01022840|Esketamine|esketamine|mesh-list
101847109|NCT01022840|Analgesics|analgesics|mesh-ancestor
101847110|NCT01022840|Sensory System Agents|sensory system agents|mesh-ancestor
101847111|NCT01022840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101847112|NCT01022840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847113|NCT01022840|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101847114|NCT01022840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101847115|NCT01022840|Anesthetics, General|anesthetics, general|mesh-ancestor
101847116|NCT01022840|Anesthetics|anesthetics|mesh-ancestor
101847117|NCT01022840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101847118|NCT01022840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101847119|NCT01022840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101847120|NCT01022840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101847121|NCT01022840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847122|NCT01022840|Antidepressive Agents|antidepressive agents|mesh-ancestor
101847123|NCT01022840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101847124|NCT01025570|Gemcitabine|gemcitabine|mesh-list
101847125|NCT01025570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101847126|NCT01025570|Antimetabolites|antimetabolites|mesh-ancestor
101847127|NCT01025570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847128|NCT01025570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101847129|NCT03983876|Adalimumab|adalimumab|mesh-list
101847130|NCT03983876|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101847131|NCT03983876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101847132|NCT03983876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101847133|NCT00327015|Metformin|metformin|mesh-list
101847134|NCT00327015|Pioglitazone|pioglitazone|mesh-list
101847135|NCT00327015|Saxagliptin|saxagliptin|mesh-list
101847136|NCT00327015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101847137|NCT00327015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847138|NCT00327015|Incretins|incretins|mesh-ancestor
101847139|NCT00327015|Hormones|hormones|mesh-ancestor
101847140|NCT00327015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101847141|NCT00327015|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101847142|NCT00327015|Protease Inhibitors|protease inhibitors|mesh-ancestor
101847143|NCT00327015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101847144|NCT00327015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847145|NCT00434148|Pasireotide|pasireotide|mesh-list
101847146|NCT00434148|Hormones|hormones|mesh-ancestor
101847147|NCT00434148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101847148|NCT00434148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847149|NCT01063569|Hydrocortisone|hydrocortisone|mesh-list
101847150|NCT01063569|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101847151|NCT01063569|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101847152|NCT01063569|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101847153|NCT01063569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101847154|NCT01063647|Treosulfan|treosulfan|mesh-list
101847155|NCT01063647|Busulfan|busulfan|mesh-list
101847156|NCT01063647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101847157|NCT01063647|Alkylating Agents|alkylating agents|mesh-ancestor
101847158|NCT01063647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847159|NCT01063647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101847160|NCT01063647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101847161|NCT01063647|Immunologic Factors|immunologic factors|mesh-ancestor
101847162|NCT01063647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847163|NCT01063647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101847164|NCT00468728|Vancomycin|vancomycin|mesh-list
101847165|NCT00468728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101847166|NCT00468728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101847167|NCT00433914|Vaccines|vaccines|mesh-list
101847168|NCT00433914|Immunologic Factors|immunologic factors|mesh-ancestor
101847169|NCT00433914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847170|NCT00468650|Sildenafil Citrate|sildenafil citrate|mesh-list
101566975|NCT01256294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101847171|NCT00468650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847172|NCT00468650|Vasodilator Agents|vasodilator agents|mesh-ancestor
101847173|NCT00468650|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101847174|NCT00468650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101847175|NCT00468650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101847176|NCT00468650|Urological Agents|urological agents|mesh-ancestor
101847177|NCT00423150|Temozolomide|temozolomide|mesh-list
101847178|NCT00423150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101847179|NCT00423150|Alkylating Agents|alkylating agents|mesh-ancestor
101847180|NCT00423150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847181|NCT00423150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101847182|NCT00433836|Valsartan|valsartan|mesh-list
101847183|NCT00433836|Enalapril|enalapril|mesh-list
101847184|NCT00433836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101847185|NCT00433836|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101847186|NCT00433836|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101847187|NCT00433836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847188|NCT00433836|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101847189|NCT00433836|Protease Inhibitors|protease inhibitors|mesh-ancestor
101847190|NCT00433836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101847191|NCT01022918|Bevacizumab|bevacizumab|mesh-list
101847192|NCT01022918|Temozolomide|temozolomide|mesh-list
101847193|NCT01022918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101847194|NCT01022918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101847195|NCT01022918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101847196|NCT01022918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101847197|NCT01022918|Growth Substances|growth substances|mesh-ancestor
101847198|NCT01022918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847199|NCT01022918|Growth Inhibitors|growth inhibitors|mesh-ancestor
101847200|NCT01022918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101847201|NCT01022918|Alkylating Agents|alkylating agents|mesh-ancestor
101847202|NCT01022918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847203|NCT00433446|Siltuximab|siltuximab|mesh-list
101847204|NCT00433446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101847205|NCT00468104|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101847206|NCT00468104|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101847207|NCT00468104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101847208|NCT00468104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847209|NCT00326625|Glatiramer Acetate|glatiramer acetate|mesh-list
101847210|NCT00326625|(T,G)-A-L|(t,g)-a-l|mesh-list
101847211|NCT00326625|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101847212|NCT00326625|Immunologic Factors|immunologic factors|mesh-ancestor
101847213|NCT00326625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847214|NCT00326625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101238886|NCT01612871|Tamoxifen|tamoxifen|mesh-list
101847215|NCT00326625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101847216|NCT00433290|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101847217|NCT00433290|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101847218|NCT00433290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101847219|NCT00433290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101847220|NCT00433290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847221|NCT00433290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101847222|NCT00433290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847223|NCT00433290|Analgesics|analgesics|mesh-ancestor
101847224|NCT00433290|Sensory System Agents|sensory system agents|mesh-ancestor
101847225|NCT00433290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101847226|NCT00433290|Antidepressive Agents|antidepressive agents|mesh-ancestor
101847227|NCT00433290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101847228|NCT00433290|Dopamine Agents|dopamine agents|mesh-ancestor
101847229|NCT00467870|Methyltestosterone|methyltestosterone|mesh-list
101847230|NCT00467870|Testosterone|testosterone|mesh-list
101847231|NCT00467870|Testosterone undecanoate|testosterone undecanoate|mesh-list
101847232|NCT00467870|Testosterone enanthate|testosterone enanthate|mesh-list
101847233|NCT00467870|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101847234|NCT00467870|Androgens|androgens|mesh-ancestor
101847236|NCT00467870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101847237|NCT00467870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847238|NCT00467870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101847239|NCT00467870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101847240|NCT00467870|Anabolic Agents|anabolic agents|mesh-ancestor
101847241|NCT00467558|Naltrexone|naltrexone|mesh-list
101847242|NCT00467558|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101847243|NCT00467558|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101847244|NCT00467558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847245|NCT00467558|Sensory System Agents|sensory system agents|mesh-ancestor
101847246|NCT00467558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101847247|NCT00422292|Vaccines|vaccines|mesh-list
101847248|NCT00422292|Immunologic Factors|immunologic factors|mesh-ancestor
101847249|NCT00422292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847250|NCT00452348|Fluticasone|fluticasone|mesh-list
101847251|NCT00452348|Xhance|xhance|mesh-list
101847252|NCT00452348|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101847253|NCT00452348|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101847254|NCT00452348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101847255|NCT00452348|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101847256|NCT00452348|Autonomic Agents|autonomic agents|mesh-ancestor
101847257|NCT00452348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101847258|NCT00452348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847259|NCT00452348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101847260|NCT00452348|Respiratory System Agents|respiratory system agents|mesh-ancestor
101847261|NCT00452348|Dermatologic Agents|dermatologic agents|mesh-ancestor
101847262|NCT00452348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101847263|NCT00452348|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101847264|NCT00452348|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101847265|NCT00452348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101847266|NCT00452348|Adrenergic Agents|adrenergic agents|mesh-ancestor
101847267|NCT00452348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101847268|NCT00452348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847269|NCT00452348|Glucocorticoids|glucocorticoids|mesh-ancestor
101847270|NCT00452348|Hormones|hormones|mesh-ancestor
101847271|NCT00452348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101847272|NCT00452348|Sympathomimetics|sympathomimetics|mesh-ancestor
101847273|NCT01323062|Bavituximab|bavituximab|mesh-list
101847274|NCT01323062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101847275|NCT01323062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101847276|NCT00320541|Paclitaxel|paclitaxel|mesh-list
101847277|NCT00320541|Bevacizumab|bevacizumab|mesh-list
101847278|NCT00320541|Gemcitabine|gemcitabine|mesh-list
101847279|NCT00320541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101847280|NCT00320541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101847281|NCT00320541|Tubulin Modulators|tubulin modulators|mesh-ancestor
101847282|NCT00320541|Antimitotic Agents|antimitotic agents|mesh-ancestor
101847283|NCT00320541|Mitosis Modulators|mitosis modulators|mesh-ancestor
101847284|NCT00320541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847285|NCT00320541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101847286|NCT00320541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101847287|NCT00320541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101847288|NCT00320541|Growth Substances|growth substances|mesh-ancestor
101847289|NCT00320541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847290|NCT00320541|Growth Inhibitors|growth inhibitors|mesh-ancestor
101847291|NCT00320541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101847292|NCT00320541|Antimetabolites|antimetabolites|mesh-ancestor
101847293|NCT00320385|Trastuzumab|trastuzumab|mesh-list
101847294|NCT00320385|Lapatinib|lapatinib|mesh-list
101847295|NCT00320385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101847296|NCT00320385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101847297|NCT00320385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101847298|NCT00320385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101847299|NCT00320385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847300|NCT00309777|Simvastatin|simvastatin|mesh-list
101847301|NCT00309777|Pitavastatin|pitavastatin|mesh-list
101847302|NCT00309777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101847303|NCT00309777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101847304|NCT00309777|Antimetabolites|antimetabolites|mesh-ancestor
101847305|NCT00309777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847306|NCT00309777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101847307|NCT00309777|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101847308|NCT00309777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101847309|NCT00325143|Edetic Acid|edetic acid|mesh-list
101847310|NCT00325143|Pentetic Acid|pentetic acid|mesh-list
101847311|NCT00325143|Antidotes|antidotes|mesh-ancestor
101847312|NCT00325143|Protective Agents|protective agents|mesh-ancestor
101847313|NCT00325143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847314|NCT00325143|Chelating Agents|chelating agents|mesh-ancestor
101847315|NCT00325143|Sequestering Agents|sequestering agents|mesh-ancestor
101847316|NCT00325143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847317|NCT00325143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101847318|NCT00325143|Anticoagulants|anticoagulants|mesh-ancestor
101847319|NCT00325143|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101847320|NCT00319839|Paclitaxel|paclitaxel|mesh-list
101847321|NCT00319839|Cetuximab|cetuximab|mesh-list
101847322|NCT00319839|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101847323|NCT00319839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101847324|NCT00319839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101847325|NCT00319839|Tubulin Modulators|tubulin modulators|mesh-ancestor
101847326|NCT00319839|Antimitotic Agents|antimitotic agents|mesh-ancestor
101847327|NCT00319839|Mitosis Modulators|mitosis modulators|mesh-ancestor
101686189|NCT02847143|Oxytocin|oxytocin|mesh-list
101847328|NCT00319839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847329|NCT00319839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101847330|NCT01062087|Lidocaine|lidocaine|mesh-list
101847331|NCT01062087|Bupivacaine|bupivacaine|mesh-list
101847332|NCT01062087|Anesthetics, Local|anesthetics, local|mesh-ancestor
101847333|NCT01062087|Anesthetics|anesthetics|mesh-ancestor
101847334|NCT01062087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101847335|NCT01062087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847336|NCT01062087|Sensory System Agents|sensory system agents|mesh-ancestor
101847337|NCT01062087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101847338|NCT01062087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101847339|NCT01062087|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101847340|NCT01062087|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101847341|NCT01062087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101847342|NCT01062087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847343|NCT00319449|Atorvastatin|atorvastatin|mesh-list
101847344|NCT00319449|Ezetimibe|ezetimibe|mesh-list
101847345|NCT00319449|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101847346|NCT00319449|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101847347|NCT00319449|Antimetabolites|antimetabolites|mesh-ancestor
101847348|NCT00319449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847349|NCT00319449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101847350|NCT00319449|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101847351|NCT00319449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101847352|NCT00308685|Albuterol|albuterol|mesh-list
101847353|NCT00308685|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101847354|NCT00308685|Autonomic Agents|autonomic agents|mesh-ancestor
101847355|NCT00308685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101847356|NCT00308685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847357|NCT00308685|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101847358|NCT00308685|Respiratory System Agents|respiratory system agents|mesh-ancestor
101847359|NCT00308685|Tocolytic Agents|tocolytic agents|mesh-ancestor
101847360|NCT00308685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101847361|NCT00308685|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101847362|NCT00308685|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101847363|NCT00308685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101847364|NCT00308685|Adrenergic Agents|adrenergic agents|mesh-ancestor
101847365|NCT00308685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101847366|NCT00308685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847367|NCT01060917|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101847368|NCT01060917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847369|NCT03981081|Prednisone|prednisone|mesh-list
101847370|NCT03981081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101847371|NCT03981081|Glucocorticoids|glucocorticoids|mesh-ancestor
101847372|NCT03981081|Hormones|hormones|mesh-ancestor
101847373|NCT03981081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101847374|NCT03981081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847375|NCT03981081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101847376|NCT03981081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101847377|NCT03979209|Mometasone Furoate|mometasone furoate|mesh-list
101847378|NCT03979209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101847379|NCT03979209|Dermatologic Agents|dermatologic agents|mesh-ancestor
101847380|NCT03979209|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101847381|NCT00316719|Lamivudine|lamivudine|mesh-list
101847382|NCT00316719|Adefovir|adefovir|mesh-list
101847383|NCT00316719|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101847384|NCT00316719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101847385|NCT00316719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101847386|NCT00316719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101847387|NCT00316719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847388|NCT00316719|Antiviral Agents|antiviral agents|mesh-ancestor
101847389|NCT00316719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101847390|NCT00316719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101847391|NCT00316719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101847392|NCT01065987|Tizanidine|tizanidine|mesh-list
101847393|NCT01065987|Analgesics|analgesics|mesh-ancestor
101847394|NCT01065987|Sensory System Agents|sensory system agents|mesh-ancestor
101847395|NCT01065987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101847396|NCT01065987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847397|NCT01065987|Anticonvulsants|anticonvulsants|mesh-ancestor
101847398|NCT01065987|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101847399|NCT01065987|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101847400|NCT01065987|Parasympatholytics|parasympatholytics|mesh-ancestor
101847401|NCT01065987|Autonomic Agents|autonomic agents|mesh-ancestor
101847402|NCT01065987|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101847403|NCT01065987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101847404|NCT01065987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101847405|NCT01065987|Adrenergic Agents|adrenergic agents|mesh-ancestor
101847406|NCT01065987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101847407|NCT01065987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847409|NCT01064115|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101847410|NCT01064115|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101847411|NCT01064115|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101847412|NCT01064115|Histamine Antagonists|histamine antagonists|mesh-ancestor
101847413|NCT01064115|Histamine Agents|histamine agents|mesh-ancestor
101847414|NCT01064115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101847415|NCT01064115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847416|NCT01064115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847417|NCT00422058|Liraglutide|liraglutide|mesh-list
101847418|NCT00422058|Orlistat|orlistat|mesh-list
101847419|NCT00422058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101847420|NCT00422058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847421|NCT00422058|Incretins|incretins|mesh-ancestor
101847422|NCT00422058|Hormones|hormones|mesh-ancestor
101847423|NCT00422058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101847424|NCT00422058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101847425|NCT00422058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847426|NCT00422058|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101847427|NCT00422058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101847428|NCT01032798|Mepivacaine|mepivacaine|mesh-list
101847429|NCT01032798|Anesthetics, Local|anesthetics, local|mesh-ancestor
101847430|NCT01032798|Anesthetics|anesthetics|mesh-ancestor
101847431|NCT01032798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101847432|NCT01032798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847433|NCT01032798|Sensory System Agents|sensory system agents|mesh-ancestor
101847434|NCT01032798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101847435|NCT00413244|Testosterone|testosterone|mesh-list
101847436|NCT00413244|Androgens|androgens|mesh-ancestor
101847437|NCT00413244|Hormones|hormones|mesh-ancestor
101847438|NCT00413244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101847439|NCT00413244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847440|NCT01033032|Amrubicin|amrubicin|mesh-list
101847441|NCT01033032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101847442|NCT01038570|Oxytocin|oxytocin|mesh-list
101847443|NCT01038570|Oxytocics|oxytocics|mesh-ancestor
101847444|NCT01038570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101847445|NCT01038570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847446|NCT00420342|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101847447|NCT00420342|Drospirenone|drospirenone|mesh-list
101847448|NCT00420342|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101847449|NCT00420342|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101847450|NCT00420342|Medroxyprogesterone|medroxyprogesterone|mesh-list
101847451|NCT00420342|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101847452|NCT00420342|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
101847453|NCT00420342|Estradiol|estradiol|mesh-list
101847454|NCT00420342|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101847455|NCT00420342|Estrogens|estrogens|mesh-ancestor
101847456|NCT00420342|Hormones|hormones|mesh-ancestor
101847457|NCT00420342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101847458|NCT00420342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847459|NCT00420342|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101847460|NCT00420342|Contraceptive Agents|contraceptive agents|mesh-ancestor
101847461|NCT00420342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101847462|NCT00420342|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101847463|NCT00420342|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101847464|NCT00420342|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101847465|NCT00420342|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101847466|NCT00420342|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101847467|NCT00420342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101847468|NCT00420342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101847469|NCT00420342|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101847471|NCT00420342|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101847473|NCT00420342|Natriuretic Agents|natriuretic agents|mesh-ancestor
101847474|NCT01038648|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101847475|NCT01038648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101847476|NCT01038648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847477|NCT01038648|Incretins|incretins|mesh-ancestor
101847478|NCT01038648|Hormones|hormones|mesh-ancestor
101847479|NCT01038648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101847480|NCT01038648|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101847481|NCT01038648|Protease Inhibitors|protease inhibitors|mesh-ancestor
101847482|NCT01038648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101847483|NCT01038648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847484|NCT00432666|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
101847485|NCT00432666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101847486|NCT00432666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101847487|NCT00432666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847488|NCT00432666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101847489|NCT00432666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101847490|NCT00432666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847491|NCT00432666|Cholinergic Agents|cholinergic agents|mesh-ancestor
101847492|NCT00432666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101847493|NCT00451958|Leuprolide|leuprolide|mesh-list
101847494|NCT00451958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101847495|NCT00451958|Fertility Agents|fertility agents|mesh-ancestor
101847496|NCT00451958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101847497|NCT00451958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847498|NCT00451958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101847499|NCT00451958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101847500|NCT01025882|Gemcitabine|gemcitabine|mesh-list
101847501|NCT01025882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101847502|NCT01025882|Antimetabolites|antimetabolites|mesh-ancestor
101847503|NCT01025882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847504|NCT01025882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101847505|NCT01026116|Paclitaxel|paclitaxel|mesh-list
101847506|NCT01026116|Cyclophosphamide|cyclophosphamide|mesh-list
101847507|NCT01026116|Epirubicin|epirubicin|mesh-list
101847508|NCT01026116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101847509|NCT01026116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101847510|NCT01026116|Tubulin Modulators|tubulin modulators|mesh-ancestor
101847511|NCT01026116|Antimitotic Agents|antimitotic agents|mesh-ancestor
101847512|NCT01026116|Mitosis Modulators|mitosis modulators|mesh-ancestor
101847513|NCT01026116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847514|NCT01026116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101847515|NCT01026116|Immunologic Factors|immunologic factors|mesh-ancestor
101847516|NCT01026116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847517|NCT01026116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101847518|NCT01026116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101847519|NCT01026116|Alkylating Agents|alkylating agents|mesh-ancestor
101847520|NCT01026116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101847521|NCT01026116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101847522|NCT01026116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101847523|NCT01026116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101847524|NCT01026116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101847525|NCT00432276|Metformin|metformin|mesh-list
101847526|NCT00432276|Pioglitazone|pioglitazone|mesh-list
101847527|NCT00432276|Alogliptin|alogliptin|mesh-list
101847528|NCT00432276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101847529|NCT00432276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847530|NCT00432276|Incretins|incretins|mesh-ancestor
101847531|NCT00432276|Hormones|hormones|mesh-ancestor
101847532|NCT00432276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101847533|NCT00432276|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101847534|NCT00432276|Protease Inhibitors|protease inhibitors|mesh-ancestor
101847535|NCT00432276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101847536|NCT00432276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847537|NCT01027520|Monensin|monensin|mesh-list
101847538|NCT01027520|Antifungal Agents|antifungal agents|mesh-ancestor
101847539|NCT01027520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101847540|NCT01027520|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101847541|NCT01027520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101847542|NCT01027520|Coccidiostats|coccidiostats|mesh-ancestor
101847543|NCT01027520|Proton Ionophores|proton ionophores|mesh-ancestor
101847544|NCT01027520|Uncoupling Agents|uncoupling agents|mesh-ancestor
101847546|NCT01027520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847548|NCT01027520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101847549|NCT01027520|Sodium Ionophores|sodium ionophores|mesh-ancestor
101847550|NCT01023230|Entecavir|entecavir|mesh-list
101847551|NCT01023230|Antiviral Agents|antiviral agents|mesh-ancestor
101847552|NCT01023230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101847553|NCT01027832|Tazobactam|tazobactam|mesh-list
101847554|NCT01027832|Piperacillin|piperacillin|mesh-list
101847555|NCT01027832|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101847556|NCT01027832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101847557|NCT01027832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101847558|NCT01027832|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101847559|NCT01027832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101847560|NCT01027832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847561|NCT00413010|Pregabalin|pregabalin|mesh-list
101847562|NCT00413010|Analgesics|analgesics|mesh-ancestor
101847563|NCT00413010|Sensory System Agents|sensory system agents|mesh-ancestor
101847564|NCT00413010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101847565|NCT00413010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847566|NCT00413010|Anticonvulsants|anticonvulsants|mesh-ancestor
101847567|NCT00413010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101847568|NCT00413010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101847569|NCT00413010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847570|NCT00413010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101847571|NCT00413010|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101847572|NCT00413010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101847573|NCT00413010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101847574|NCT00413010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101847575|NCT00459290|Mifepristone|mifepristone|mesh-list
101847576|NCT00459290|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101847577|NCT00459290|Abortifacient Agents|abortifacient agents|mesh-ancestor
101847578|NCT00459290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101847579|NCT00459290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847580|NCT00459290|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101847581|NCT00459290|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101847582|NCT00459290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101847583|NCT00459290|Contraceptive Agents|contraceptive agents|mesh-ancestor
101847584|NCT00459290|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101847585|NCT00459290|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101847586|NCT00459290|Hormone Antagonists|hormone antagonists|mesh-ancestor
101847587|NCT00459290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101847588|NCT00459290|Luteolytic Agents|luteolytic agents|mesh-ancestor
101847589|NCT00459290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101847590|NCT00459290|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101847591|NCT00443534|Sunitinib|sunitinib|mesh-list
101847592|NCT00443534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101847593|NCT00443534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101847594|NCT00443534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101847595|NCT00443534|Growth Substances|growth substances|mesh-ancestor
101847596|NCT00443534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847597|NCT00443534|Growth Inhibitors|growth inhibitors|mesh-ancestor
101847598|NCT00443534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101847599|NCT00443534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101847600|NCT00443534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847601|NCT00419952|Budesonide|budesonide|mesh-list
101847602|NCT00419952|Formoterol Fumarate|formoterol fumarate|mesh-list
101847603|NCT00419952|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
102074173|NCT03554304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101847604|NCT00419952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101847605|NCT00419952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101847606|NCT00419952|Autonomic Agents|autonomic agents|mesh-ancestor
101847607|NCT00419952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101847608|NCT00419952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265013|NCT01770470|Chitosan|chitosan|mesh-list
101847609|NCT00419952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101847610|NCT00419952|Respiratory System Agents|respiratory system agents|mesh-ancestor
101847611|NCT00419952|Glucocorticoids|glucocorticoids|mesh-ancestor
101847612|NCT00419952|Hormones|hormones|mesh-ancestor
101847613|NCT00419952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101847614|NCT00419952|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101847615|NCT00419952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101847616|NCT00419952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101847617|NCT00419952|Adrenergic Agents|adrenergic agents|mesh-ancestor
101847618|NCT00419952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101847619|NCT00419952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847620|NCT00443456|Amlodipine|amlodipine|mesh-list
101847621|NCT00443456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101847622|NCT00443456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101847623|NCT00443456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101847624|NCT00443456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847625|NCT00443456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101847626|NCT00443456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847627|NCT00443456|Vasodilator Agents|vasodilator agents|mesh-ancestor
101847628|NCT00419562|Insulin|insulin|mesh-list
101847629|NCT00419562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101847630|NCT00419562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847631|NCT03557294|Varenicline|varenicline|mesh-list
101847632|NCT03557294|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101847633|NCT03557294|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101847634|NCT03557294|Cholinergic Agents|cholinergic agents|mesh-ancestor
101847635|NCT03557294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101847636|NCT03557294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847637|NCT03557294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847638|NCT01026350|Antibodies|antibodies|mesh-list
101847639|NCT01026350|Immunologic Factors|immunologic factors|mesh-ancestor
101847640|NCT01026350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847641|NCT01026428|Levodopa|levodopa|mesh-list
101847642|NCT01026428|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101847643|NCT01026428|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101847644|NCT01026428|Dopamine Agents|dopamine agents|mesh-ancestor
101847645|NCT01026428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101847646|NCT01026428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847647|NCT01026428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847648|NCT00308139|Exenatide|exenatide|mesh-list
101847649|NCT00308139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101847650|NCT00308139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847651|NCT00308139|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101847652|NCT00308139|Incretins|incretins|mesh-ancestor
101847653|NCT00308139|Hormones|hormones|mesh-ancestor
101847654|NCT00308139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101847655|NCT00459056|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101847656|NCT00459056|Carvedilol|carvedilol|mesh-list
101847657|NCT00459056|Lisinopril|lisinopril|mesh-list
101847658|NCT00459056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101847659|NCT00459056|Diuretics|diuretics|mesh-ancestor
101847660|NCT00459056|Natriuretic Agents|natriuretic agents|mesh-ancestor
101847661|NCT00459056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847662|NCT00459056|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101847663|NCT00459056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101847664|NCT00459056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847665|NCT00459056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101847666|NCT00459056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101847667|NCT00459056|Adrenergic Agents|adrenergic agents|mesh-ancestor
101847668|NCT00459056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101847669|NCT00459056|Antioxidants|antioxidants|mesh-ancestor
101847670|NCT00459056|Protective Agents|protective agents|mesh-ancestor
101847671|NCT00459056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101847672|NCT00459056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101847673|NCT00459056|Vasodilator Agents|vasodilator agents|mesh-ancestor
101847674|NCT00459056|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101964086|NCT02221492|Plerixafor|plerixafor|mesh-list
101847675|NCT00459056|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101847676|NCT00459056|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101847678|NCT00459056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101847679|NCT00459056|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101847680|NCT01062477|Vaccines|vaccines|mesh-list
101847681|NCT01062477|Immunologic Factors|immunologic factors|mesh-ancestor
101847682|NCT01062477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847683|NCT01323374|Carbidopa|carbidopa|mesh-list
101847684|NCT01323374|Droxidopa|droxidopa|mesh-list
101847685|NCT01323374|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101847686|NCT01323374|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101847688|NCT01323374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101847689|NCT01323374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847690|NCT01323374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847691|NCT01323374|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101847692|NCT01323374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101847693|NCT00431964|Azithromycin|azithromycin|mesh-list
101847694|NCT00431964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101847695|NCT00431964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101847696|NCT00431496|Cinacalcet|cinacalcet|mesh-list
101847697|NCT00431496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101847698|NCT00431496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847699|NCT00431496|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101847700|NCT00431496|Hormone Antagonists|hormone antagonists|mesh-ancestor
101847701|NCT00431496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101847702|NCT00316173|Carboplatin|carboplatin|mesh-list
101847703|NCT00316173|Topotecan|topotecan|mesh-list
101847704|NCT00316173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101847705|NCT00316173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101847706|NCT00316173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101847707|NCT00316173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101847708|NCT00316173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847709|NCT00412542|Thalidomide|thalidomide|mesh-list
101847710|NCT00412542|Irinotecan|irinotecan|mesh-list
101847711|NCT00412542|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101847712|NCT00412542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101847713|NCT00412542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101847714|NCT00412542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847715|NCT00412542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101847716|NCT00412542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101847717|NCT00412542|Immunologic Factors|immunologic factors|mesh-ancestor
101847718|NCT00412542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847719|NCT00412542|Leprostatic Agents|leprostatic agents|mesh-ancestor
101847720|NCT00412542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101847721|NCT00412542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101847722|NCT00412542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101847723|NCT00412542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101847724|NCT00412542|Growth Substances|growth substances|mesh-ancestor
101847725|NCT00412542|Growth Inhibitors|growth inhibitors|mesh-ancestor
101847726|NCT00316017|Dextrans|dextrans|mesh-list
101847727|NCT00316017|Anticoagulants|anticoagulants|mesh-ancestor
101847728|NCT00316017|Plasma Substitutes|plasma substitutes|mesh-ancestor
101847729|NCT00316017|Blood Substitutes|blood substitutes|mesh-ancestor
101847730|NCT00451178|Prednisone|prednisone|mesh-list
101847731|NCT00451178|Cyclophosphamide|cyclophosphamide|mesh-list
101847732|NCT00451178|Rituximab|rituximab|mesh-list
101847733|NCT00451178|Doxorubicin|doxorubicin|mesh-list
101847734|NCT00451178|Vincristine|vincristine|mesh-list
101847735|NCT00451178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101847736|NCT00451178|Immunologic Factors|immunologic factors|mesh-ancestor
101847737|NCT00451178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847738|NCT00451178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101847739|NCT00451178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101847740|NCT00451178|Alkylating Agents|alkylating agents|mesh-ancestor
101847741|NCT00451178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847742|NCT00451178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101847743|NCT00451178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101847744|NCT00451178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101847745|NCT00451178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101847746|NCT00451178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101847747|NCT00451178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101847748|NCT00451178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101847749|NCT00451178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101847750|NCT00451178|Glucocorticoids|glucocorticoids|mesh-ancestor
101847751|NCT00451178|Hormones|hormones|mesh-ancestor
101847752|NCT00451178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101847753|NCT00451178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101847754|NCT00451178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101847755|NCT00451178|Tubulin Modulators|tubulin modulators|mesh-ancestor
101847756|NCT00451178|Antimitotic Agents|antimitotic agents|mesh-ancestor
101847757|NCT00451178|Mitosis Modulators|mitosis modulators|mesh-ancestor
101847758|NCT00450866|Epothilones|epothilones|mesh-list
101847759|NCT00450866|Epothilone B|epothilone b|mesh-list
101847760|NCT00450866|Tubulin Modulators|tubulin modulators|mesh-ancestor
101847761|NCT00450866|Antimitotic Agents|antimitotic agents|mesh-ancestor
101847762|NCT00450866|Mitosis Modulators|mitosis modulators|mesh-ancestor
101847763|NCT00450866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847764|NCT00450866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101847765|NCT01026584|Aripiprazole|aripiprazole|mesh-list
101847766|NCT01026584|Antidepressive Agents|antidepressive agents|mesh-ancestor
101847767|NCT01026584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101847768|NCT01026584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101847769|NCT01026584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101847770|NCT01026584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101847771|NCT01026584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847772|NCT01026584|Dopamine Agonists|dopamine agonists|mesh-ancestor
101847773|NCT01026584|Dopamine Agents|dopamine agents|mesh-ancestor
101847774|NCT01026584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101238990|NCT01613209|Olmesartan|olmesartan|mesh-list
101847775|NCT01026584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847776|NCT01026584|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101847777|NCT01026584|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101847778|NCT01026584|Serotonin Agents|serotonin agents|mesh-ancestor
101847779|NCT01026584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101847780|NCT01026584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101847781|NCT01026584|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101847782|NCT01026584|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101847783|NCT01023464|Emollients|emollients|mesh-list
101847784|NCT01023464|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101847785|NCT01023464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101847786|NCT01023464|Dermatologic Agents|dermatologic agents|mesh-ancestor
101847787|NCT01023542|Everolimus|everolimus|mesh-list
101847788|NCT01023542|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101847789|NCT01023542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101847790|NCT01023542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101847791|NCT01023542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847792|NCT01023542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101847793|NCT01023542|Immunologic Factors|immunologic factors|mesh-ancestor
101847794|NCT01023542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847795|NCT01023542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101847796|NCT01026740|Ceftobiprole|ceftobiprole|mesh-list
101847797|NCT01026740|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
101847798|NCT01026740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101847799|NCT01026740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101847800|NCT01028534|Olmesartan|olmesartan|mesh-list
101847801|NCT01028534|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101847802|NCT01028534|Calcium Channel Blockers|calcium channel blockers|mesh-list
101847803|NCT01028534|Angiotensin II|angiotensin ii|mesh-list
101847804|NCT01028534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
101847805|NCT01028534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101847806|NCT01028534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847807|NCT01028534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101847808|NCT01028534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101847809|NCT01028534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847810|NCT01028534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101847811|NCT01028534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101847812|NCT00441974|Adefovir|adefovir|mesh-list
101847813|NCT00441974|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101847814|NCT00441974|Antiviral Agents|antiviral agents|mesh-ancestor
101847815|NCT00441974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101847816|NCT00441974|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101847817|NCT00441974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101847818|NCT00441974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101847819|NCT00441974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847820|NCT00441584|Ribavirin|ribavirin|mesh-list
101847821|NCT00441584|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101847822|NCT00441584|Interferon-alpha|interferon-alpha|mesh-list
101847823|NCT00441584|Antimetabolites|antimetabolites|mesh-ancestor
101847824|NCT00441584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847825|NCT00441584|Antiviral Agents|antiviral agents|mesh-ancestor
101847826|NCT00441584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101847827|NCT00441584|Immunologic Factors|immunologic factors|mesh-ancestor
101847828|NCT00441584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847829|NCT00430716|Sildenafil Citrate|sildenafil citrate|mesh-list
101847830|NCT00430716|Citric Acid|citric acid|mesh-list
101847831|NCT00430716|Sodium Citrate|sodium citrate|mesh-list
101847832|NCT00430716|Anticoagulants|anticoagulants|mesh-ancestor
101847833|NCT00430716|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101847834|NCT00430716|Chelating Agents|chelating agents|mesh-ancestor
101847835|NCT00430716|Sequestering Agents|sequestering agents|mesh-ancestor
101847836|NCT00430716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239003|NCT01613469|Leucovorin|leucovorin|mesh-list
101847837|NCT00430716|Vasodilator Agents|vasodilator agents|mesh-ancestor
101567642|NCT00626535|Esomeprazole|esomeprazole|mesh-list
101847838|NCT00430716|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101847839|NCT00430716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101847840|NCT00430716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101847841|NCT00430716|Urological Agents|urological agents|mesh-ancestor
101847842|NCT01028768|Teduglutide|teduglutide|mesh-list
101847843|NCT01028768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101847844|NCT01028768|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101847845|NCT01028768|Protective Agents|protective agents|mesh-ancestor
101847846|NCT01028768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847847|NCT00441272|Pioglitazone|pioglitazone|mesh-list
101847848|NCT00441272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101847849|NCT00441272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847850|NCT01566552|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101847851|NCT01566552|Antifungal Agents|antifungal agents|mesh-ancestor
101847852|NCT01566552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101847853|NCT01566552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101847854|NCT01566552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101847855|NCT01028924|Teduglutide|teduglutide|mesh-list
101847856|NCT01028924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101847857|NCT01028924|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101847858|NCT01028924|Protective Agents|protective agents|mesh-ancestor
101847859|NCT01028924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847860|NCT00430638|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101847862|NCT00430638|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101847863|NCT00430638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101847864|NCT00430638|Diuretics|diuretics|mesh-ancestor
101847865|NCT00430638|Natriuretic Agents|natriuretic agents|mesh-ancestor
101847866|NCT00430638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847867|NCT00430638|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101847868|NCT00430638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101847869|NCT00430638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847870|NCT00430638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101847871|NCT00430638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101847872|NCT03671330|Letrozole|letrozole|mesh-list
101847873|NCT03671330|Goserelin|goserelin|mesh-list
101847874|NCT03671330|Anastrozole|anastrozole|mesh-list
101847875|NCT03671330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101847876|NCT03671330|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101847877|NCT03671330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101847878|NCT03671330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101847879|NCT03671330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847880|NCT03671330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101847881|NCT03671330|Hormone Antagonists|hormone antagonists|mesh-ancestor
101847882|NCT03671330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101847883|NCT03671330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847884|NCT03671330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101847885|NCT01038882|Midazolam|midazolam|mesh-list
101847886|NCT01038882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101847887|NCT01038882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101847888|NCT01038882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101847889|NCT01038882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847890|NCT01038882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101847891|NCT01038882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101847892|NCT01038882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101847893|NCT01038882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101847894|NCT01038882|Anesthetics, General|anesthetics, general|mesh-ancestor
101847895|NCT01038882|Anesthetics|anesthetics|mesh-ancestor
101847896|NCT01038882|GABA Modulators|gaba modulators|mesh-ancestor
101847897|NCT01038882|GABA Agents|gaba agents|mesh-ancestor
101847898|NCT01038882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101847899|NCT01038882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847900|NCT00449930|Metformin|metformin|mesh-list
101847901|NCT00449930|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101847902|NCT00449930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101847903|NCT00449930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847905|NCT00449930|Hormones|hormones|mesh-ancestor
101847906|NCT00449930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101847907|NCT00449930|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101847908|NCT00449930|Protease Inhibitors|protease inhibitors|mesh-ancestor
101847909|NCT00449930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101847910|NCT00449930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847911|NCT00441116|Dutasteride|dutasteride|mesh-list
101847912|NCT00441116|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101847913|NCT00441116|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101567724|NCT04290208|Acetaminophen|acetaminophen|mesh-list
101847914|NCT00441116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101847915|NCT00441116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847916|NCT00441116|Hormone Antagonists|hormone antagonists|mesh-ancestor
101847917|NCT00441116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101847918|NCT00441116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847919|NCT01024322|Diclofenac|diclofenac|mesh-list
101847920|NCT01024322|Prednisolone acetate|prednisolone acetate|mesh-list
101847921|NCT01024322|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101847922|NCT01024322|Methylprednisolone|methylprednisolone|mesh-list
101847923|NCT01024322|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101847924|NCT01024322|Prednisolone|prednisolone|mesh-list
101847925|NCT01024322|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101847926|NCT01024322|Prednisolone phosphate|prednisolone phosphate|mesh-list
101847927|NCT01024322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101847928|NCT01024322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101847929|NCT01024322|Analgesics|analgesics|mesh-ancestor
101847930|NCT01024322|Sensory System Agents|sensory system agents|mesh-ancestor
101847931|NCT01024322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101847932|NCT01024322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847933|NCT01024322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101847934|NCT01024322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101847935|NCT01024322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101847936|NCT01024322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101847937|NCT01024322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847938|NCT01024322|Antiemetics|antiemetics|mesh-ancestor
101847939|NCT01024322|Autonomic Agents|autonomic agents|mesh-ancestor
101847940|NCT01024322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101847941|NCT01024322|Glucocorticoids|glucocorticoids|mesh-ancestor
101847942|NCT01024322|Hormones|hormones|mesh-ancestor
101847943|NCT01024322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101847944|NCT01024322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101847945|NCT01024322|Protective Agents|protective agents|mesh-ancestor
101847946|NCT01024322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101847947|NCT01024322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101847948|NCT03320642|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
101847949|NCT03320642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101847950|NCT03320642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847951|NCT01566266|Amoxicillin|amoxicillin|mesh-list
101847952|NCT01566266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101847953|NCT01566266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101847954|NCT00430248|Allopurinol|allopurinol|mesh-list
101847955|NCT00430248|Febuxostat|febuxostat|mesh-list
101847956|NCT00430248|Antimetabolites|antimetabolites|mesh-ancestor
101847957|NCT00430248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847958|NCT00430248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101847959|NCT00430248|Gout Suppressants|gout suppressants|mesh-ancestor
101847960|NCT00430248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101847961|NCT00430248|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101847962|NCT00430248|Antioxidants|antioxidants|mesh-ancestor
101847963|NCT00430248|Protective Agents|protective agents|mesh-ancestor
101847964|NCT00430248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847965|NCT00411762|Capecitabine|capecitabine|mesh-list
101847966|NCT00411762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101847967|NCT00411762|Antimetabolites|antimetabolites|mesh-ancestor
101847968|NCT00411762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847969|NCT00411762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101847970|NCT00429858|Gemcitabine|gemcitabine|mesh-list
101847971|NCT00429858|Tegafur|tegafur|mesh-list
101847972|NCT00429858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101847973|NCT00429858|Antimetabolites|antimetabolites|mesh-ancestor
101686213|NCT03897335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101847974|NCT00429858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101847975|NCT00429858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101847976|NCT01035216|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
101847977|NCT01035216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101847978|NCT01035216|Immunologic Factors|immunologic factors|mesh-ancestor
101847979|NCT01035216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847980|NCT00449150|Cetrorelix|cetrorelix|mesh-list
101847981|NCT00449150|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101847982|NCT00449150|Fertility Agents|fertility agents|mesh-ancestor
101847983|NCT00449150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101847984|NCT00449150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101847985|NCT00449150|Hormone Antagonists|hormone antagonists|mesh-ancestor
101847986|NCT00449150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101847987|NCT00428844|Vancomycin|vancomycin|mesh-list
101847988|NCT00428844|Daptomycin|daptomycin|mesh-list
101847989|NCT00428844|Teicoplanin|teicoplanin|mesh-list
101847990|NCT00428844|Floxacillin|floxacillin|mesh-list
101847992|NCT00428844|Nafcillin|nafcillin|mesh-list
101847993|NCT00428844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101847994|NCT00428844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101847995|NCT00457418|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101847996|NCT00457418|Antiviral Agents|antiviral agents|mesh-ancestor
101847997|NCT00457418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101847998|NCT01039194|Galantamine|galantamine|mesh-list
101847999|NCT01039194|BMS 708163|bms 708163|mesh-list
101848000|NCT01039194|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101848001|NCT01039194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101848002|NCT01039194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848003|NCT01039194|Cholinergic Agents|cholinergic agents|mesh-ancestor
101848004|NCT01039194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101848005|NCT01039194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848006|NCT01039194|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101848007|NCT01039194|Autonomic Agents|autonomic agents|mesh-ancestor
101848008|NCT01039194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101848009|NCT01039194|Nootropic Agents|nootropic agents|mesh-ancestor
101848010|NCT01039194|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101848011|NCT00449072|Loratadine|loratadine|mesh-list
101848012|NCT00449072|Antipruritics|antipruritics|mesh-ancestor
101848013|NCT00449072|Dermatologic Agents|dermatologic agents|mesh-ancestor
101848014|NCT00449072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101848015|NCT00449072|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101848016|NCT00449072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101848017|NCT00449072|Histamine Antagonists|histamine antagonists|mesh-ancestor
101848018|NCT00449072|Histamine Agents|histamine agents|mesh-ancestor
101848019|NCT00449072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101848020|NCT00449072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848021|NCT00449072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848022|NCT00419094|Levetiracetam|levetiracetam|mesh-list
101848023|NCT00419094|Anticonvulsants|anticonvulsants|mesh-ancestor
101848024|NCT00419094|Nootropic Agents|nootropic agents|mesh-ancestor
101848025|NCT00448916|Pregabalin|pregabalin|mesh-list
101848026|NCT00448916|Analgesics|analgesics|mesh-ancestor
101848027|NCT00448916|Sensory System Agents|sensory system agents|mesh-ancestor
101848028|NCT00448916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101848029|NCT00448916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848030|NCT00448916|Anticonvulsants|anticonvulsants|mesh-ancestor
101848031|NCT00448916|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101848032|NCT00448916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101848033|NCT00448916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848034|NCT00448916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101848035|NCT00448916|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101239034|NCT01613755|Dipyridamole|dipyridamole|mesh-list
101848036|NCT00448916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101848037|NCT00448916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101848038|NCT00448916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101848039|NCT00418938|Leucovorin|leucovorin|mesh-list
101848040|NCT00418938|Bevacizumab|bevacizumab|mesh-list
101848041|NCT00418938|Panitumumab|panitumumab|mesh-list
101848042|NCT00418938|Fluorouracil|fluorouracil|mesh-list
101848043|NCT00418938|Irinotecan|irinotecan|mesh-list
101848044|NCT00418938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101848045|NCT00418938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101848046|NCT00418938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101686215|NCT01617096|Dapivirine|dapivirine|mesh-list
101848047|NCT00418938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101848048|NCT00418938|Growth Substances|growth substances|mesh-ancestor
101848049|NCT00418938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848050|NCT00418938|Growth Inhibitors|growth inhibitors|mesh-ancestor
101848051|NCT00418938|Antimetabolites|antimetabolites|mesh-ancestor
101848052|NCT00418938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848053|NCT00418938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101848054|NCT00418938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101848055|NCT00418938|Immunologic Factors|immunologic factors|mesh-ancestor
101848056|NCT00418938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101848057|NCT00418938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101848058|NCT00418938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101848059|NCT00418938|Antidotes|antidotes|mesh-ancestor
101848060|NCT00418938|Protective Agents|protective agents|mesh-ancestor
101848061|NCT00418938|Vitamin B Complex|vitamin b complex|mesh-ancestor
101848063|NCT00418938|Micronutrients|micronutrients|mesh-ancestor
101848064|NCT00448760|Leucovorin|leucovorin|mesh-list
101848065|NCT00448760|Docetaxel|docetaxel|mesh-list
101848066|NCT00448760|Oxaliplatin|oxaliplatin|mesh-list
101848067|NCT00448760|Floxuridine|floxuridine|mesh-list
101848068|NCT00448760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101848069|NCT00448760|Tubulin Modulators|tubulin modulators|mesh-ancestor
101848070|NCT00448760|Antimitotic Agents|antimitotic agents|mesh-ancestor
101848071|NCT00448760|Mitosis Modulators|mitosis modulators|mesh-ancestor
101848072|NCT00448760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848073|NCT00448760|Antidotes|antidotes|mesh-ancestor
101848074|NCT00448760|Protective Agents|protective agents|mesh-ancestor
101848075|NCT00448760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848076|NCT00448760|Vitamin B Complex|vitamin b complex|mesh-ancestor
101848077|NCT00448760|Vitamins|vitamins|mesh-ancestor
101848078|NCT00448760|Micronutrients|micronutrients|mesh-ancestor
101848079|NCT00448760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101848080|NCT00448760|Antimetabolites|antimetabolites|mesh-ancestor
101848081|NCT01039350|Darbepoetin alfa|darbepoetin alfa|mesh-list
101848082|NCT01039350|Hematinics|hematinics|mesh-ancestor
101848083|NCT01039506|Irinotecan|irinotecan|mesh-list
101848084|NCT01039506|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101848085|NCT01039506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101848086|NCT01039506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101848087|NCT01039506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848088|NCT01039506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101848089|NCT01033500|Abatacept|abatacept|mesh-list
101848090|NCT01033500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101848091|NCT01033500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848092|NCT01033500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101848093|NCT01033500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101848094|NCT01033500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101848095|NCT01033500|Immunologic Factors|immunologic factors|mesh-ancestor
101848096|NCT01033500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848097|NCT01033500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101848098|NCT01035450|Sirolimus|sirolimus|mesh-list
101848099|NCT01035450|Everolimus|everolimus|mesh-list
101848100|NCT01035450|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101848101|NCT01035450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101848102|NCT01035450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101848103|NCT01035450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848104|NCT01035450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101848105|NCT01035450|Immunologic Factors|immunologic factors|mesh-ancestor
101848106|NCT01035450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848107|NCT01035450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101848108|NCT01035450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101848109|NCT01035450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101848110|NCT01035450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101848111|NCT01035450|Antifungal Agents|antifungal agents|mesh-ancestor
101848112|NCT01035528|Metformin|metformin|mesh-list
101848113|NCT01035528|Insulin Glargine|insulin glargine|mesh-list
101848114|NCT01035528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101848115|NCT01035528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848116|NCT01033656|Methotrexate|methotrexate|mesh-list
101848117|NCT01033656|Azathioprine|azathioprine|mesh-list
101848118|NCT01033656|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101848119|NCT01033656|Leflunomide|leflunomide|mesh-list
101848120|NCT01033656|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101848121|NCT01033656|Abortifacient Agents|abortifacient agents|mesh-ancestor
101848122|NCT01033656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101848123|NCT01033656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848124|NCT01033656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101848125|NCT01033656|Antimetabolites|antimetabolites|mesh-ancestor
101848126|NCT01033656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848127|NCT01033656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101848128|NCT01033656|Dermatologic Agents|dermatologic agents|mesh-ancestor
101848129|NCT01033656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101848130|NCT01033656|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101848131|NCT01033656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101848132|NCT01033656|Immunologic Factors|immunologic factors|mesh-ancestor
101848133|NCT01033656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101848134|NCT01033656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101848135|NCT01039740|Mirtazapine|mirtazapine|mesh-list
101848136|NCT01039740|Antidepressive Agents|antidepressive agents|mesh-ancestor
101848137|NCT01039740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101848138|NCT01039740|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101848139|NCT01039740|Histamine Antagonists|histamine antagonists|mesh-ancestor
101848140|NCT01039740|Histamine Agents|histamine agents|mesh-ancestor
101848141|NCT01039740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101848142|NCT01039740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848143|NCT01039740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848145|NCT01039740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101848146|NCT01039740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101848147|NCT01039740|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101848148|NCT01039740|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101848149|NCT01039740|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101848150|NCT01039740|Adrenergic Agents|adrenergic agents|mesh-ancestor
101848151|NCT01039740|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101848152|NCT01039740|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101848153|NCT01039740|Serotonin Agents|serotonin agents|mesh-ancestor
101848154|NCT01039740|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101848155|NCT00448136|Bevacizumab|bevacizumab|mesh-list
101848156|NCT00448136|Streptozocin|streptozocin|mesh-list
101848157|NCT00448136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101848158|NCT00448136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101239055|NCT01613807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101848159|NCT00448136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101848160|NCT00448136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101848161|NCT00448136|Growth Substances|growth substances|mesh-ancestor
101848162|NCT00448136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848163|NCT00448136|Growth Inhibitors|growth inhibitors|mesh-ancestor
101848164|NCT00448136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101848165|NCT00447902|Ritonavir|ritonavir|mesh-list
101848166|NCT00447902|Tipranavir|tipranavir|mesh-list
101848167|NCT00447902|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101848168|NCT00447902|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101848169|NCT00447902|Protease Inhibitors|protease inhibitors|mesh-ancestor
101848170|NCT00447902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101848171|NCT00447902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848172|NCT00447902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101848173|NCT00447902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101848174|NCT00447902|Antiviral Agents|antiviral agents|mesh-ancestor
101848175|NCT00447902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101848176|NCT00447902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101848177|NCT00447902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101848178|NCT00307437|Ustekinumab|ustekinumab|mesh-list
101848179|NCT00307437|Dermatologic Agents|dermatologic agents|mesh-ancestor
101848180|NCT00440726|Cytarabine|cytarabine|mesh-list
101848181|NCT00440726|Dexamethasone|dexamethasone|mesh-list
101848182|NCT00440726|Doxorubicin|doxorubicin|mesh-list
101848183|NCT00440726|Methotrexate|methotrexate|mesh-list
101848184|NCT00440726|Vincristine|vincristine|mesh-list
101848185|NCT00440726|Bortezomib|bortezomib|mesh-list
101848186|NCT00440726|Asparaginase|asparaginase|mesh-list
101848187|NCT00440726|Pegaspargase|pegaspargase|mesh-list
101848188|NCT00440726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101848189|NCT00440726|Antiemetics|antiemetics|mesh-ancestor
101848190|NCT00440726|Autonomic Agents|autonomic agents|mesh-ancestor
101848191|NCT00440726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101848192|NCT00440726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848193|NCT00440726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101848194|NCT00440726|Glucocorticoids|glucocorticoids|mesh-ancestor
101848195|NCT00440726|Hormones|hormones|mesh-ancestor
101848196|NCT00440726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101848197|NCT00440726|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101848198|NCT00440726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101848199|NCT00440726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101848200|NCT00440726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101848201|NCT00440726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101848202|NCT00440726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101848203|NCT00440726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848204|NCT00440726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101848205|NCT00440726|Abortifacient Agents|abortifacient agents|mesh-ancestor
101848206|NCT00440726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101848207|NCT00440726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101848208|NCT00440726|Antimetabolites|antimetabolites|mesh-ancestor
101848209|NCT00440726|Dermatologic Agents|dermatologic agents|mesh-ancestor
101848210|NCT00440726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101848211|NCT00440726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101848212|NCT00440726|Immunologic Factors|immunologic factors|mesh-ancestor
101848213|NCT00440726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101848214|NCT00440726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101848215|NCT00440726|Antiviral Agents|antiviral agents|mesh-ancestor
101848216|NCT00440726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101568013|NCT00975286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848217|NCT00440726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101848218|NCT00440726|Tubulin Modulators|tubulin modulators|mesh-ancestor
101848219|NCT00440726|Antimitotic Agents|antimitotic agents|mesh-ancestor
101848220|NCT00440726|Mitosis Modulators|mitosis modulators|mesh-ancestor
101848222|NCT01030016|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101848223|NCT01030016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101848224|NCT01030016|Adrenergic Agents|adrenergic agents|mesh-ancestor
101848225|NCT01030016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101848226|NCT01030016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848227|NCT01030016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848228|NCT01030016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101848229|NCT01030016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101848230|NCT01030016|Sympatholytics|sympatholytics|mesh-ancestor
101848231|NCT01030016|Autonomic Agents|autonomic agents|mesh-ancestor
101848232|NCT01030016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101848233|NCT01030016|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101848234|NCT03996278|Thymoglobulin|thymoglobulin|mesh-list
101848235|NCT03996278|Immunologic Factors|immunologic factors|mesh-ancestor
101848236|NCT03996278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848237|NCT03996278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101848238|NCT00447278|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101848239|NCT00447278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101848240|NCT00447278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101848241|NCT00447278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101848242|NCT00447278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848243|NCT00447278|Adrenergic Agents|adrenergic agents|mesh-ancestor
101848244|NCT00447278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101848245|NCT00447278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848247|NCT01030094|Carbamazepine|carbamazepine|mesh-list
101848248|NCT01030094|Valproic Acid|valproic acid|mesh-list
101848249|NCT01030094|Anticonvulsants|anticonvulsants|mesh-ancestor
101848250|NCT01030094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101848251|NCT01030094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848252|NCT01030094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101848253|NCT01030094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848254|NCT01030094|GABA Agents|gaba agents|mesh-ancestor
101848255|NCT01030094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101848256|NCT01030094|Antimanic Agents|antimanic agents|mesh-ancestor
101848257|NCT01030094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101848258|NCT01030094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101848259|NCT01030094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101848260|NCT01030094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101848261|NCT01030094|Analgesics|analgesics|mesh-ancestor
101848262|NCT01030094|Sensory System Agents|sensory system agents|mesh-ancestor
101848263|NCT01030094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101848264|NCT01030094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101848265|NCT01030094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101848266|NCT01030094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101848267|NCT01030094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101848268|NCT01565798|Copper|copper|mesh-list
101848269|NCT01565798|Trace Elements|trace elements|mesh-ancestor
101848270|NCT01565798|Micronutrients|micronutrients|mesh-ancestor
101848271|NCT01565798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848272|NCT01030328|Fenofibrate|fenofibrate|mesh-list
101848273|NCT01030328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101848274|NCT01030328|Antimetabolites|antimetabolites|mesh-ancestor
101848275|NCT01030328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848276|NCT01030328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101848277|NCT00405756|Aspirin|aspirin|mesh-list
101848278|NCT00405756|Prednisone|prednisone|mesh-list
101848279|NCT00405756|Lenalidomide|lenalidomide|mesh-list
101848280|NCT00405756|Melphalan|melphalan|mesh-list
101848281|NCT00405756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101848282|NCT00405756|Glucocorticoids|glucocorticoids|mesh-ancestor
101848283|NCT00405756|Hormones|hormones|mesh-ancestor
101848284|NCT00405756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101848285|NCT00405756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848286|NCT00405756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101848287|NCT00405756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101848288|NCT00405756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101848289|NCT00405756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101848290|NCT00405756|Analgesics|analgesics|mesh-ancestor
101848291|NCT00405756|Sensory System Agents|sensory system agents|mesh-ancestor
101848292|NCT00405756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101848293|NCT00405756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101848294|NCT00405756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101848295|NCT00405756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101848296|NCT00405756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848297|NCT00405756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101848298|NCT00405756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101848299|NCT00405756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101848300|NCT00405756|Antipyretics|antipyretics|mesh-ancestor
101848301|NCT00405756|Immunologic Factors|immunologic factors|mesh-ancestor
101848302|NCT00405756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101848303|NCT00405756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101848304|NCT00405756|Growth Substances|growth substances|mesh-ancestor
101848305|NCT00405756|Growth Inhibitors|growth inhibitors|mesh-ancestor
101848306|NCT00405756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101848307|NCT00405756|Alkylating Agents|alkylating agents|mesh-ancestor
101848308|NCT00405756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101848309|NCT00405756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101848310|NCT00456092|Apremilast|apremilast|mesh-list
101848311|NCT00456092|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101848312|NCT00456092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101848313|NCT00456092|Analgesics|analgesics|mesh-ancestor
101848314|NCT00456092|Sensory System Agents|sensory system agents|mesh-ancestor
101848315|NCT00456092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101848316|NCT00456092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848317|NCT00456092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101848318|NCT00456092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101848319|NCT00456092|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101848320|NCT00456092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101848321|NCT00456092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101848322|NCT00456092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848323|NCT01030640|Tanezumab|tanezumab|mesh-list
101848324|NCT01030640|Analgesics|analgesics|mesh-ancestor
101848325|NCT01030640|Sensory System Agents|sensory system agents|mesh-ancestor
101848326|NCT01030640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101848327|NCT01030640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848328|NCT00411450|Panitumumab|panitumumab|mesh-list
101848329|NCT00411450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101848330|NCT00411450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101848331|NCT00404820|Vitamin D|vitamin d|mesh-list
101848332|NCT00404820|Zoledronic Acid|zoledronic acid|mesh-list
101848333|NCT00404820|Alendronate|alendronate|mesh-list
101848334|NCT00404820|Calcium|calcium|mesh-list
101848335|NCT00404820|Vitamins|vitamins|mesh-ancestor
101848336|NCT00404820|Micronutrients|micronutrients|mesh-ancestor
101848337|NCT00404820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848338|NCT00404820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101848339|NCT00404820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101848340|NCT00446030|Cyclophosphamide|cyclophosphamide|mesh-list
101848341|NCT00446030|Bevacizumab|bevacizumab|mesh-list
101848342|NCT00446030|Carboplatin|carboplatin|mesh-list
101848343|NCT00446030|Docetaxel|docetaxel|mesh-list
101848344|NCT00446030|Doxorubicin|doxorubicin|mesh-list
101848345|NCT00446030|Trastuzumab|trastuzumab|mesh-list
101848346|NCT00446030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101848347|NCT00446030|Immunologic Factors|immunologic factors|mesh-ancestor
101848348|NCT00446030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848349|NCT00446030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101848350|NCT00446030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101848351|NCT00446030|Alkylating Agents|alkylating agents|mesh-ancestor
101848352|NCT00446030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848353|NCT00446030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101848354|NCT00446030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101848355|NCT00446030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101848356|NCT00446030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101848357|NCT00446030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101848358|NCT00446030|Growth Substances|growth substances|mesh-ancestor
101848359|NCT00446030|Growth Inhibitors|growth inhibitors|mesh-ancestor
101848360|NCT00446030|Tubulin Modulators|tubulin modulators|mesh-ancestor
101848361|NCT00446030|Antimitotic Agents|antimitotic agents|mesh-ancestor
101848362|NCT00446030|Mitosis Modulators|mitosis modulators|mesh-ancestor
101848363|NCT00446030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101848364|NCT00446030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101848365|NCT00446030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101848366|NCT00446030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101848367|NCT00410514|Mirabegron|mirabegron|mesh-list
101848368|NCT00410514|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101848369|NCT00410514|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101848370|NCT00410514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101848371|NCT00410514|Adrenergic Agents|adrenergic agents|mesh-ancestor
101848372|NCT00410514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101848373|NCT00410514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848374|NCT00410514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848375|NCT00410514|Urological Agents|urological agents|mesh-ancestor
101848376|NCT03847610|Penicillins|penicillins|mesh-list
101848377|NCT03847610|Penicillin V|penicillin v|mesh-list
101848378|NCT03847610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101848379|NCT03847610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101848380|NCT01036854|Ondansetron|ondansetron|mesh-list
101848381|NCT01036854|Antiemetics|antiemetics|mesh-ancestor
101848382|NCT01036854|Autonomic Agents|autonomic agents|mesh-ancestor
101848383|NCT01036854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101848384|NCT01036854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848385|NCT01036854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101848386|NCT01036854|Antipruritics|antipruritics|mesh-ancestor
101848387|NCT01036854|Dermatologic Agents|dermatologic agents|mesh-ancestor
101848388|NCT01036854|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101848389|NCT01036854|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101848390|NCT01036854|Serotonin Agents|serotonin agents|mesh-ancestor
101848391|NCT01036854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101848392|NCT01036854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848393|NCT01030796|Caffeine|caffeine|mesh-list
101848394|NCT01030796|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101848395|NCT01030796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848396|NCT01030796|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101848397|NCT01030796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101848398|NCT01030796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848399|NCT01030796|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101848400|NCT01030796|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101848401|NCT01030796|Purinergic Agents|purinergic agents|mesh-ancestor
101848402|NCT01030796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101848403|NCT00455858|Insulin Detemir|insulin detemir|mesh-list
101848404|NCT00455858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101848405|NCT00455858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848406|NCT00439556|Cytarabine|cytarabine|mesh-list
101848407|NCT00439556|Rituximab|rituximab|mesh-list
101848408|NCT00439556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101848409|NCT00439556|Methotrexate|methotrexate|mesh-list
101848410|NCT00439556|Etoposide|etoposide|mesh-list
101848411|NCT00439556|Etoposide phosphate|etoposide phosphate|mesh-list
101848412|NCT00439556|Bortezomib|bortezomib|mesh-list
101848413|NCT00439556|Melphalan|melphalan|mesh-list
101848414|NCT00439556|Mechlorethamine|mechlorethamine|mesh-list
101848415|NCT00439556|Carmustine|carmustine|mesh-list
101848417|NCT00439556|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
101848418|NCT00439556|Antibodies|antibodies|mesh-list
101848419|NCT00439556|Immunoglobulins|immunoglobulins|mesh-list
101848420|NCT00439556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101848421|NCT00439556|Lenograstim|lenograstim|mesh-list
101848422|NCT00439556|Tacrolimus|tacrolimus|mesh-list
101848423|NCT00439556|Thymoglobulin|thymoglobulin|mesh-list
101848424|NCT00439556|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101848425|NCT00439556|Immunologic Factors|immunologic factors|mesh-ancestor
101848426|NCT00439556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848427|NCT00439556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101848428|NCT00439556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101848429|NCT00439556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101848430|NCT00439556|Abortifacient Agents|abortifacient agents|mesh-ancestor
101848431|NCT00439556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101848432|NCT00439556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101848433|NCT00439556|Antimetabolites|antimetabolites|mesh-ancestor
101848434|NCT00439556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848435|NCT00439556|Dermatologic Agents|dermatologic agents|mesh-ancestor
101848436|NCT00439556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101848437|NCT00439556|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101848438|NCT00439556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101848439|NCT00439556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101848440|NCT00439556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101848441|NCT00439556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101848442|NCT00439556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101848444|NCT00439556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101848445|NCT00439556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101848446|NCT00439556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101848447|NCT00439556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101848448|NCT00439556|Alkylating Agents|alkylating agents|mesh-ancestor
101848449|NCT00439556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101848450|NCT00439556|Keratolytic Agents|keratolytic agents|mesh-ancestor
101848451|NCT00439556|Tubulin Modulators|tubulin modulators|mesh-ancestor
101848452|NCT00439556|Antimitotic Agents|antimitotic agents|mesh-ancestor
101848453|NCT00439556|Mitosis Modulators|mitosis modulators|mesh-ancestor
101848454|NCT00410202|Tenofovir|tenofovir|mesh-list
101848455|NCT00410202|Lamivudine|lamivudine|mesh-list
101848456|NCT00410202|Entecavir|entecavir|mesh-list
101848457|NCT00410202|Adefovir|adefovir|mesh-list
101848458|NCT00410202|Antiviral Agents|antiviral agents|mesh-ancestor
101848459|NCT00410202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101848460|NCT00410202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101848461|NCT00410202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101848462|NCT00410202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101848463|NCT00410202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848464|NCT00410202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101848465|NCT00410202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101848466|NCT03802058|Paclitaxel|paclitaxel|mesh-list
101848467|NCT03802058|Carboplatin|carboplatin|mesh-list
101848468|NCT03802058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101848469|NCT03802058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101848470|NCT03802058|Tubulin Modulators|tubulin modulators|mesh-ancestor
101848471|NCT03802058|Antimitotic Agents|antimitotic agents|mesh-ancestor
101848472|NCT03802058|Mitosis Modulators|mitosis modulators|mesh-ancestor
101848473|NCT03802058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848474|NCT00445328|Heparin|heparin|mesh-list
101848475|NCT00445328|Calcium heparin|calcium heparin|mesh-list
101848476|NCT00445328|Dalteparin|dalteparin|mesh-list
101848477|NCT00445328|Tinzaparin|tinzaparin|mesh-list
101848478|NCT00445328|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101848479|NCT00445328|Anticoagulants|anticoagulants|mesh-ancestor
101848480|NCT00445328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101848481|NCT00445328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101848482|NCT00445328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848484|NCT00455312|Cyclophosphamide|cyclophosphamide|mesh-list
101848485|NCT00455312|Fludarabine|fludarabine|mesh-list
101848486|NCT00455312|Alemtuzumab|alemtuzumab|mesh-list
101848487|NCT00455312|Thymoglobulin|thymoglobulin|mesh-list
101848488|NCT00455312|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101848489|NCT00455312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101848490|NCT00455312|Immunologic Factors|immunologic factors|mesh-ancestor
101848491|NCT00455312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848492|NCT00455312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101848493|NCT00455312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101848494|NCT00455312|Alkylating Agents|alkylating agents|mesh-ancestor
101848495|NCT00455312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848496|NCT00455312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101848497|NCT00455312|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101848498|NCT00455312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101848499|NCT00455312|Antiemetics|antiemetics|mesh-ancestor
101848500|NCT00455312|Autonomic Agents|autonomic agents|mesh-ancestor
101848501|NCT00455312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101848502|NCT00455312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101848503|NCT00455312|Glucocorticoids|glucocorticoids|mesh-ancestor
101848504|NCT00455312|Hormones|hormones|mesh-ancestor
101848505|NCT00455312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101848506|NCT00455312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101848507|NCT00455312|Protective Agents|protective agents|mesh-ancestor
101848508|NCT00455312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101848509|NCT01031030|Cyclophosphamide|cyclophosphamide|mesh-list
101848510|NCT01031030|Fluorouracil|fluorouracil|mesh-list
101848511|NCT01031030|Methotrexate|methotrexate|mesh-list
101848512|NCT01031030|Epirubicin|epirubicin|mesh-list
101848513|NCT01031030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101848514|NCT01031030|Immunologic Factors|immunologic factors|mesh-ancestor
101848515|NCT01031030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848516|NCT01031030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101848517|NCT01031030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101848518|NCT01031030|Alkylating Agents|alkylating agents|mesh-ancestor
101568312|NCT05324215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101848519|NCT01031030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848520|NCT01031030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101848521|NCT01031030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101848522|NCT01031030|Antimetabolites|antimetabolites|mesh-ancestor
101848523|NCT01031030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101848524|NCT01031030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101848525|NCT01031030|Abortifacient Agents|abortifacient agents|mesh-ancestor
101848526|NCT01031030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101848527|NCT01031030|Dermatologic Agents|dermatologic agents|mesh-ancestor
101848528|NCT01031030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101848529|NCT01031030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101848530|NCT01031030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101848531|NCT01031030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101848532|NCT01031030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101848533|NCT01031030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101848534|NCT01024712|Paclitaxel|paclitaxel|mesh-list
101848535|NCT01024712|Carboplatin|carboplatin|mesh-list
101848536|NCT01024712|Gefitinib|gefitinib|mesh-list
101848537|NCT01024712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101848538|NCT01024712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101848539|NCT01024712|Tubulin Modulators|tubulin modulators|mesh-ancestor
101848540|NCT01024712|Antimitotic Agents|antimitotic agents|mesh-ancestor
101848541|NCT01024712|Mitosis Modulators|mitosis modulators|mesh-ancestor
101848542|NCT01024712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848543|NCT01024712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101848544|NCT01024712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101848545|NCT01323452|Entecavir|entecavir|mesh-list
101848546|NCT01323452|Antiviral Agents|antiviral agents|mesh-ancestor
101848547|NCT01323452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101848548|NCT00444626|Lidocaine|lidocaine|mesh-list
101848549|NCT00444626|Prilocaine|prilocaine|mesh-list
101848550|NCT00444626|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
101848551|NCT00444626|Hyaluronic Acid|hyaluronic acid|mesh-list
101848552|NCT00444626|Anesthetics, Local|anesthetics, local|mesh-ancestor
101848553|NCT00444626|Anesthetics|anesthetics|mesh-ancestor
101848554|NCT00444626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101686243|NCT00621036|Sargramostim|sargramostim|mesh-list
101848555|NCT00444626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848556|NCT00444626|Sensory System Agents|sensory system agents|mesh-ancestor
101848557|NCT00444626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101848558|NCT00444626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101848559|NCT00444626|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101848560|NCT00444626|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101848561|NCT00444626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101848562|NCT00444626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848563|NCT00444626|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101848565|NCT00444626|Viscosupplements|viscosupplements|mesh-ancestor
101848566|NCT00444626|Protective Agents|protective agents|mesh-ancestor
101848567|NCT00444626|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
101848568|NCT01024868|Ropivacaine|ropivacaine|mesh-list
101848569|NCT01024868|Anesthetics, Local|anesthetics, local|mesh-ancestor
101848570|NCT01024868|Anesthetics|anesthetics|mesh-ancestor
101848571|NCT01024868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101848572|NCT01024868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848573|NCT01024868|Sensory System Agents|sensory system agents|mesh-ancestor
101848574|NCT01024868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101848575|NCT03795194|Clavulanic Acid|clavulanic acid|mesh-list
101848576|NCT03795194|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101848577|NCT03795194|Clavulanic Acids|clavulanic acids|mesh-list
101848578|NCT03795194|Ampicillin|ampicillin|mesh-list
101848579|NCT03795194|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101848580|NCT03795194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101848581|NCT03795194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848582|NCT03795194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101848583|NCT03795194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101848584|NCT00404352|Interferon beta-1a|interferon beta-1a|mesh-list
101848585|NCT00404352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101848586|NCT00404352|Immunologic Factors|immunologic factors|mesh-ancestor
101848587|NCT00404352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848588|NCT00404352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101848589|NCT00404352|Antiviral Agents|antiviral agents|mesh-ancestor
101848590|NCT00404352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101848591|NCT00439244|Zoledronic Acid|zoledronic acid|mesh-list
101848592|NCT00439244|Teriparatide|teriparatide|mesh-list
101848593|NCT00439244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101568389|NCT01237223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848594|NCT00439244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848595|NCT00439244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101848597|NCT04844762|Antipruritics|antipruritics|mesh-ancestor
101848598|NCT04844762|Dermatologic Agents|dermatologic agents|mesh-ancestor
101848599|NCT01323218|Vitamin D|vitamin d|mesh-list
101848600|NCT01323218|Vitamins|vitamins|mesh-ancestor
101848601|NCT01323218|Micronutrients|micronutrients|mesh-ancestor
101848602|NCT01323218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848603|NCT01323218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101848604|NCT01323296|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
101848605|NCT01323296|Hematinics|hematinics|mesh-ancestor
101848606|NCT01323296|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101848607|NCT01323296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101848608|NCT00438464|Finasteride|finasteride|mesh-list
101848609|NCT00438464|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101848610|NCT00438464|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101848611|NCT00438464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101848612|NCT00438464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848613|NCT00438464|Hormone Antagonists|hormone antagonists|mesh-ancestor
101848614|NCT00438464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101848615|NCT00438464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848616|NCT00438464|Urological Agents|urological agents|mesh-ancestor
101848617|NCT00437294|Capecitabine|capecitabine|mesh-list
101848618|NCT00437294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101848619|NCT00437294|Antimetabolites|antimetabolites|mesh-ancestor
101848620|NCT00437294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848621|NCT00437294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101848622|NCT01033760|Ritonavir|ritonavir|mesh-list
101848623|NCT01033760|Darunavir|darunavir|mesh-list
101848624|NCT01033760|Tenofovir|tenofovir|mesh-list
101848625|NCT01033760|Emtricitabine|emtricitabine|mesh-list
101848626|NCT01033760|Raltegravir Potassium|raltegravir potassium|mesh-list
101848627|NCT01033760|Maraviroc|maraviroc|mesh-list
101848628|NCT01033760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101848629|NCT01033760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101848630|NCT01033760|Protease Inhibitors|protease inhibitors|mesh-ancestor
101848631|NCT01033760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101848632|NCT01033760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848633|NCT01033760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101848634|NCT01033760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101848635|NCT01033760|Antiviral Agents|antiviral agents|mesh-ancestor
101848636|NCT01033760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101848637|NCT01033760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101848638|NCT01033760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101848639|NCT01033760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101848640|NCT01033760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101848641|NCT01033760|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101848642|NCT01033760|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101848643|NCT01033760|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101848644|NCT01033760|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101848645|NCT01033760|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101848646|NCT01031732|Tacrine|tacrine|mesh-list
101848647|NCT01031732|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101848648|NCT01031732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101848649|NCT01031732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848650|NCT01031732|Cholinergic Agents|cholinergic agents|mesh-ancestor
101848651|NCT01031732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101848652|NCT01031732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848653|NCT01031732|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101848654|NCT01031732|Autonomic Agents|autonomic agents|mesh-ancestor
101848655|NCT01031732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101848656|NCT01031732|Nootropic Agents|nootropic agents|mesh-ancestor
101848658|NCT01033994|Mitosis Modulators|mitosis modulators|mesh-ancestor
101848659|NCT01033994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848660|NCT01031888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101848661|NCT01031888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101848662|NCT00436826|Interferons|interferons|mesh-list
101848663|NCT00436826|Interferon-beta|interferon-beta|mesh-list
101848664|NCT00436826|Cladribine|cladribine|mesh-list
101848665|NCT00436826|Interferon beta-1b|interferon beta-1b|mesh-list
101848666|NCT00436826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101848667|NCT00436826|Antiviral Agents|antiviral agents|mesh-ancestor
101848668|NCT00436826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101848669|NCT00436826|Immunologic Factors|immunologic factors|mesh-ancestor
101848670|NCT00436826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848671|NCT00436826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101848672|NCT00436826|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101848673|NCT00410124|Everolimus|everolimus|mesh-list
101848674|NCT00410124|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101848675|NCT00410124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101848676|NCT00410124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101848677|NCT00410124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848678|NCT00410124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101848679|NCT00410124|Immunologic Factors|immunologic factors|mesh-ancestor
101516451|NCT00537966|Rilpivirine|rilpivirine|mesh-list
101848680|NCT00410124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848681|NCT00410124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101848682|NCT01036932|Lenograstim|lenograstim|mesh-list
101848683|NCT01036932|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101848684|NCT01036932|Immunologic Factors|immunologic factors|mesh-ancestor
101848685|NCT01036932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848686|NCT00410046|Etanercept|etanercept|mesh-list
101848687|NCT00410046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101848688|NCT00410046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101848689|NCT00410046|Analgesics|analgesics|mesh-ancestor
101848690|NCT00410046|Sensory System Agents|sensory system agents|mesh-ancestor
101848691|NCT00410046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101848692|NCT00410046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848693|NCT00410046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101848694|NCT00410046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101848695|NCT00410046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101848696|NCT00410046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101848697|NCT00410046|Immunologic Factors|immunologic factors|mesh-ancestor
101848698|NCT00416624|Epoetin Alfa|epoetin alfa|mesh-list
101848699|NCT00416624|Darbepoetin alfa|darbepoetin alfa|mesh-list
101848700|NCT00416624|Hematinics|hematinics|mesh-ancestor
101848701|NCT02501954|Paclitaxel|paclitaxel|mesh-list
101848702|NCT02501954|Carboplatin|carboplatin|mesh-list
101848703|NCT02501954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101848704|NCT02501954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101848705|NCT02501954|Tubulin Modulators|tubulin modulators|mesh-ancestor
101848706|NCT02501954|Antimitotic Agents|antimitotic agents|mesh-ancestor
101848707|NCT02501954|Mitosis Modulators|mitosis modulators|mesh-ancestor
101848708|NCT02501954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848709|NCT00262600|Warfarin|warfarin|mesh-list
101848710|NCT00262600|Dabigatran|dabigatran|mesh-list
101848711|NCT00262600|Anticoagulants|anticoagulants|mesh-ancestor
101848712|NCT00262600|Antithrombins|antithrombins|mesh-ancestor
101848714|NCT00262600|Protease Inhibitors|protease inhibitors|mesh-ancestor
101848715|NCT00262600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101848716|NCT00262600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848717|NCT00409578|Valsartan|valsartan|mesh-list
101848718|NCT00409578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101848719|NCT00409578|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101848720|NCT00409578|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101848721|NCT00409578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848722|NCT01037322|Cannabidiol|cannabidiol|mesh-list
101848723|NCT01037322|Anticonvulsants|anticonvulsants|mesh-ancestor
101848724|NCT01070758|Lanreotide|lanreotide|mesh-list
101848725|NCT01070758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101848726|NCT00428090|Rosiglitazone|rosiglitazone|mesh-list
101848727|NCT00428090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101848728|NCT00428090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848729|NCT01031966|Thymalfasin|thymalfasin|mesh-list
101848730|NCT01031966|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101848731|NCT01031966|Immunologic Factors|immunologic factors|mesh-ancestor
101848732|NCT01031966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848733|NCT00436436|Temozolomide|temozolomide|mesh-list
101848734|NCT00436436|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
101848735|NCT00436436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101848736|NCT00436436|Alkylating Agents|alkylating agents|mesh-ancestor
101848737|NCT00436436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848738|NCT00436436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101848739|NCT00436436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101848740|NCT00262522|Ritonavir|ritonavir|mesh-list
101848741|NCT00262522|Lopinavir|lopinavir|mesh-list
101848742|NCT00262522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
101848743|NCT00262522|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101848744|NCT00262522|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101848745|NCT00262522|Protease Inhibitors|protease inhibitors|mesh-ancestor
101848746|NCT00262522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101848747|NCT00262522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848748|NCT00262522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101848749|NCT00262522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101848750|NCT00262522|Antiviral Agents|antiviral agents|mesh-ancestor
101848751|NCT00262522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101848752|NCT00262522|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101848753|NCT00262522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101848754|NCT00262522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101848756|NCT00436280|Gemcitabine|gemcitabine|mesh-list
101848757|NCT00436280|Oxaliplatin|oxaliplatin|mesh-list
101848758|NCT00436280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101848759|NCT00436280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101848760|NCT00436280|Immunologic Factors|immunologic factors|mesh-ancestor
101848761|NCT00436280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964272|NCT02223052|Azacitidine|azacitidine|mesh-list
101848762|NCT00436280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101848763|NCT00436280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101848764|NCT00436280|Antimetabolites|antimetabolites|mesh-ancestor
101848765|NCT00436280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848766|NCT00394836|Ofatumumab|ofatumumab|mesh-list
101848767|NCT00394836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101848768|NCT00394836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101848769|NCT00394836|Immunologic Factors|immunologic factors|mesh-ancestor
101848770|NCT00394836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848771|NCT01040598|Omalizumab|omalizumab|mesh-list
101848772|NCT01040598|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101848773|NCT01040598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101848774|NCT01040598|Respiratory System Agents|respiratory system agents|mesh-ancestor
101848775|NCT01039974|Ketoconazole|ketoconazole|mesh-list
101848776|NCT01039974|Antifungal Agents|antifungal agents|mesh-ancestor
101848777|NCT01039974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101848778|NCT01039974|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101848779|NCT01039974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101848780|NCT01039974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101848781|NCT01039974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848782|NCT01039974|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101848783|NCT01039974|Hormone Antagonists|hormone antagonists|mesh-ancestor
101239197|NCT01614301|Alkylating Agents|alkylating agents|mesh-ancestor
101848784|NCT01039974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101848785|NCT01039974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848786|NCT01039974|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101848787|NCT01032122|Rituximab|rituximab|mesh-list
101848788|NCT01032122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101848789|NCT01032122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101848790|NCT01032122|Immunologic Factors|immunologic factors|mesh-ancestor
101848791|NCT01032122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848792|NCT01032122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101848793|NCT03819660|Amifampridine|amifampridine|mesh-list
101848794|NCT03819660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101848795|NCT03819660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101848796|NCT03819660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848797|NCT03819660|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101848798|NCT03819660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101848799|NCT03819660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848800|NCT00394524|Insulin|insulin|mesh-list
101848801|NCT00394524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101848802|NCT00394524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848803|NCT00409344|Dexmedetomidine|dexmedetomidine|mesh-list
101848804|NCT00409344|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101848805|NCT00409344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101848806|NCT00409344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848807|NCT00409344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101848808|NCT00409344|Analgesics|analgesics|mesh-ancestor
101848809|NCT00409344|Sensory System Agents|sensory system agents|mesh-ancestor
101848810|NCT00409344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101848811|NCT00409344|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101848812|NCT00409344|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101848813|NCT00409344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101848814|NCT00409344|Adrenergic Agents|adrenergic agents|mesh-ancestor
101848815|NCT00409344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101848816|NCT00409344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848817|NCT00415610|Nicardipine|nicardipine|mesh-list
101848818|NCT00415610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101848819|NCT00415610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101848820|NCT00415610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101848821|NCT00415610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848822|NCT00415610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101848823|NCT00415610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848824|NCT00415610|Vasodilator Agents|vasodilator agents|mesh-ancestor
101848825|NCT01722812|Cromolyn Sodium|cromolyn sodium|mesh-list
101848826|NCT01722812|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
101848827|NCT01722812|Immunologic Factors|immunologic factors|mesh-ancestor
101848828|NCT01722812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848829|NCT01722812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101848830|NCT01722812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101848831|NCT01722812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101848832|NCT01722812|Respiratory System Agents|respiratory system agents|mesh-ancestor
101848833|NCT00250432|Caspofungin|caspofungin|mesh-list
101848834|NCT00250432|Antifungal Agents|antifungal agents|mesh-ancestor
101848835|NCT00250432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101848836|NCT00250432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101848837|NCT00250432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848838|NCT00249808|Antibodies|antibodies|mesh-list
101848839|NCT00249808|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101848840|NCT00249808|Immunologic Factors|immunologic factors|mesh-ancestor
101848841|NCT00249808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848842|NCT00278512|Cyclophosphamide|cyclophosphamide|mesh-list
101848843|NCT00278512|Fludarabine|fludarabine|mesh-list
101848844|NCT00278512|Alemtuzumab|alemtuzumab|mesh-list
101848845|NCT00278512|Tacrolimus|tacrolimus|mesh-list
101848846|NCT00278512|Thymoglobulin|thymoglobulin|mesh-list
101848847|NCT00278512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101964316|NCT02223598|Hormones|hormones|mesh-ancestor
101848848|NCT00278512|Immunologic Factors|immunologic factors|mesh-ancestor
101848849|NCT00278512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848850|NCT00278512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101848851|NCT00278512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101848852|NCT00278512|Alkylating Agents|alkylating agents|mesh-ancestor
101848853|NCT00278512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848854|NCT00278512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101848855|NCT00278512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101848856|NCT00278512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101848857|NCT00278512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101848858|NCT00278512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101848859|NCT01072240|Rituximab|rituximab|mesh-list
101848860|NCT01072240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101848861|NCT01072240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101848862|NCT01072240|Immunologic Factors|immunologic factors|mesh-ancestor
101848863|NCT01072240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848864|NCT01072240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101848865|NCT00427934|Maraviroc|maraviroc|mesh-list
101848866|NCT00427934|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101848867|NCT00427934|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101848868|NCT00427934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848869|NCT00427934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101848870|NCT00427934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101848871|NCT00427934|Antiviral Agents|antiviral agents|mesh-ancestor
101848872|NCT00427934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101848873|NCT00427934|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101848874|NCT00427700|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101848875|NCT00427700|Clomiphene|clomiphene|mesh-list
101848876|NCT00427700|Enclomiphene|enclomiphene|mesh-list
101848877|NCT00427700|Zuclomiphene|zuclomiphene|mesh-list
101848878|NCT00427700|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101848879|NCT00427700|Hormone Antagonists|hormone antagonists|mesh-ancestor
101848880|NCT00427700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101848881|NCT00427700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848882|NCT00427700|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101848883|NCT00427700|Fertility Agents|fertility agents|mesh-ancestor
101848884|NCT00427700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101848885|NCT00427700|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101848886|NCT00427700|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101848887|NCT00427700|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101848888|NCT01324076|Doxorubicin|doxorubicin|mesh-list
101848889|NCT01324076|Sorafenib|sorafenib|mesh-list
101848890|NCT01324076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101848891|NCT01324076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101848892|NCT01324076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101848893|NCT01324076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101848894|NCT01324076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101848895|NCT01324076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848896|NCT01324076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101848897|NCT00409188|Cyclophosphamide|cyclophosphamide|mesh-list
101848898|NCT00409188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101848899|NCT00409188|Immunologic Factors|immunologic factors|mesh-ancestor
101848900|NCT00409188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848901|NCT00409188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101848902|NCT00409188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101848903|NCT00409188|Alkylating Agents|alkylating agents|mesh-ancestor
101848904|NCT00409188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848905|NCT00409188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101848906|NCT00409188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101848908|NCT00434954|Exenatide|exenatide|mesh-list
101848909|NCT00434954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101848910|NCT00434954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848911|NCT00434954|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101848912|NCT00434954|Incretins|incretins|mesh-ancestor
101848913|NCT00434954|Hormones|hormones|mesh-ancestor
101848914|NCT00434954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101848915|NCT00276484|Atorvastatin|atorvastatin|mesh-list
101848916|NCT00276484|Ezetimibe|ezetimibe|mesh-list
101848917|NCT00276484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101848918|NCT00276484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101848919|NCT00276484|Antimetabolites|antimetabolites|mesh-ancestor
101848920|NCT00276484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848921|NCT00276484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101848922|NCT00276484|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101848923|NCT00276484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101848924|NCT00426842|Midodrine|midodrine|mesh-list
101848925|NCT00426842|Sympathomimetics|sympathomimetics|mesh-ancestor
101848926|NCT00426842|Autonomic Agents|autonomic agents|mesh-ancestor
101848927|NCT00426842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101848928|NCT00426842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848929|NCT00426842|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101848930|NCT00426842|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101848931|NCT00426842|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101848932|NCT00426842|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101848933|NCT00426842|Adrenergic Agents|adrenergic agents|mesh-ancestor
101848934|NCT00426842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101848935|NCT00426842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848936|NCT00434876|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101848937|NCT00434876|Antidepressive Agents|antidepressive agents|mesh-ancestor
101848938|NCT00434876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101964372|NCT00094757|Incretins|incretins|mesh-ancestor
101848939|NCT00434876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101848940|NCT00434876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101848941|NCT00434876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101848942|NCT00434876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848944|NCT01072318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101848945|NCT01072318|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101848946|NCT01072318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101848947|NCT01072318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101848948|NCT01072318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848949|NCT01072318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101848950|NCT01072318|Hormone Antagonists|hormone antagonists|mesh-ancestor
101848951|NCT01072318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101848952|NCT01072318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848953|NCT00276094|Tamoxifen|tamoxifen|mesh-list
101848954|NCT00276094|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101848955|NCT00276094|Hormone Antagonists|hormone antagonists|mesh-ancestor
101848956|NCT00276094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101848957|NCT00276094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848958|NCT00276094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101848959|NCT00276094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101848960|NCT00276094|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101848961|NCT00276094|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101848962|NCT00276094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101848963|NCT03975088|Ranibizumab|ranibizumab|mesh-list
101848964|NCT03975088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101848965|NCT03975088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101848966|NCT03975088|Growth Substances|growth substances|mesh-ancestor
101964412|NCT04378114|Sensory System Agents|sensory system agents|mesh-ancestor
101848967|NCT03975088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848968|NCT03975088|Growth Inhibitors|growth inhibitors|mesh-ancestor
101848969|NCT03975088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101848970|NCT00276016|Phenylephrine|phenylephrine|mesh-list
101848971|NCT00276016|Oxymetazoline|oxymetazoline|mesh-list
101848972|NCT00276016|Pseudoephedrine|pseudoephedrine|mesh-list
101848974|NCT00276016|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101848975|NCT00276016|Mydriatics|mydriatics|mesh-ancestor
101848976|NCT00276016|Autonomic Agents|autonomic agents|mesh-ancestor
101848977|NCT00276016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101848978|NCT00276016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101848979|NCT00276016|Sympathomimetics|sympathomimetics|mesh-ancestor
101848980|NCT00276016|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101848981|NCT00276016|Nasal Decongestants|nasal decongestants|mesh-ancestor
101848982|NCT00276016|Respiratory System Agents|respiratory system agents|mesh-ancestor
101848983|NCT00276016|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101848984|NCT00276016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101848985|NCT00276016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101848986|NCT00276016|Adrenergic Agents|adrenergic agents|mesh-ancestor
101848987|NCT00276016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101848988|NCT00276016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101848989|NCT00276016|Protective Agents|protective agents|mesh-ancestor
101848990|NCT00276016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101848991|NCT00276016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101848992|NCT00276016|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101848993|NCT00434642|Bevacizumab|bevacizumab|mesh-list
101848994|NCT00434642|Carboplatin|carboplatin|mesh-list
101848995|NCT00434642|Gemcitabine|gemcitabine|mesh-list
101848996|NCT00434642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101848997|NCT00434642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101848998|NCT00434642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101848999|NCT00434642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101849000|NCT00434642|Growth Substances|growth substances|mesh-ancestor
101849001|NCT00434642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849002|NCT00434642|Growth Inhibitors|growth inhibitors|mesh-ancestor
101849003|NCT00434642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101849004|NCT00434642|Antimetabolites|antimetabolites|mesh-ancestor
101849005|NCT00434642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849006|NCT01032434|Sertraline|sertraline|mesh-list
101849007|NCT01032434|Antidepressive Agents|antidepressive agents|mesh-ancestor
101849008|NCT01032434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101849009|NCT01032434|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101849010|NCT01032434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101849011|NCT01032434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101849012|NCT01032434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849013|NCT01032434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101849014|NCT01032434|Serotonin Agents|serotonin agents|mesh-ancestor
101849015|NCT01032434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849016|NCT00426764|Romidepsin|romidepsin|mesh-list
101849017|NCT00426764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101849018|NCT00426764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101849019|NCT00426764|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101849020|NCT00426764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101849021|NCT00426764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849022|NCT01032668|Clopidogrel|clopidogrel|mesh-list
101849023|NCT01032668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101849024|NCT01032668|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101849025|NCT01032668|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101849026|NCT01032668|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101849027|NCT01032668|Purinergic Agents|purinergic agents|mesh-ancestor
101849028|NCT01032668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101849029|NCT01032668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849030|NCT01032668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849031|NCT00434252|Paclitaxel|paclitaxel|mesh-list
101849032|NCT00434252|Bevacizumab|bevacizumab|mesh-list
101849033|NCT00434252|Carboplatin|carboplatin|mesh-list
101849034|NCT00434252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101849035|NCT00434252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101849036|NCT00434252|Tubulin Modulators|tubulin modulators|mesh-ancestor
101849037|NCT00434252|Antimitotic Agents|antimitotic agents|mesh-ancestor
101849038|NCT00434252|Mitosis Modulators|mitosis modulators|mesh-ancestor
101849039|NCT00434252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849040|NCT00434252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101568828|NCT01230827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101849042|NCT00434252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101849043|NCT00434252|Growth Substances|growth substances|mesh-ancestor
101849044|NCT00434252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849045|NCT00434252|Growth Inhibitors|growth inhibitors|mesh-ancestor
101849047|NCT00425750|Bortezomib|bortezomib|mesh-list
101849048|NCT00425750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101849049|NCT00425750|Tubulin Modulators|tubulin modulators|mesh-ancestor
101849050|NCT00425750|Antimitotic Agents|antimitotic agents|mesh-ancestor
101849051|NCT00425750|Mitosis Modulators|mitosis modulators|mesh-ancestor
101849052|NCT00425750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849053|NCT00414908|Pancrelipase|pancrelipase|mesh-list
101849054|NCT00414908|Pancreatin|pancreatin|mesh-list
101849055|NCT00414908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101849056|NCT00242710|Bazedoxifene|bazedoxifene|mesh-list
101849057|NCT00242710|Estrogens|estrogens|mesh-list
101849058|NCT00242710|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101849059|NCT00242710|Hormones|hormones|mesh-ancestor
101849060|NCT00242710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101849061|NCT00242710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849062|NCT00242710|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101849063|NCT00242710|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101849064|NCT00242710|Hormone Antagonists|hormone antagonists|mesh-ancestor
101849065|NCT00242710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101849066|NCT00408876|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101849067|NCT00408876|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101849068|NCT00408876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101849069|NCT00408876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101849070|NCT00408876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849071|NCT00408876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101849072|NCT00408876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849073|NCT00408876|Analgesics|analgesics|mesh-ancestor
101849074|NCT00408876|Sensory System Agents|sensory system agents|mesh-ancestor
101849075|NCT00408876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101849076|NCT00408876|Antidepressive Agents|antidepressive agents|mesh-ancestor
101849077|NCT00408876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101849078|NCT00408876|Dopamine Agents|dopamine agents|mesh-ancestor
101849079|NCT00240994|Mycophenolic Acid|mycophenolic acid|mesh-list
101849080|NCT00240994|Sirolimus|sirolimus|mesh-list
101849081|NCT00240994|Alemtuzumab|alemtuzumab|mesh-list
101849082|NCT00240994|Tacrolimus|tacrolimus|mesh-list
101849083|NCT00240994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101849084|NCT00240994|Immunologic Factors|immunologic factors|mesh-ancestor
101849085|NCT00240994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849086|NCT00240994|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101849087|NCT00240994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101849088|NCT00240994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849089|NCT00240994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101849090|NCT00240994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101849091|NCT00240994|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101849092|NCT00240994|Antitubercular Agents|antitubercular agents|mesh-ancestor
101849093|NCT00240994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101849094|NCT00240994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101849095|NCT00240994|Antifungal Agents|antifungal agents|mesh-ancestor
101849096|NCT00240994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101849097|NCT01070836|Natalizumab|natalizumab|mesh-list
101849098|NCT01070836|Immunologic Factors|immunologic factors|mesh-ancestor
101849099|NCT01070836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849100|NCT00239590|Methyltestosterone|methyltestosterone|mesh-list
101849101|NCT00239590|Testosterone|testosterone|mesh-list
101239244|NCT01614431|Antidotes|antidotes|mesh-ancestor
101849102|NCT00239590|Testosterone undecanoate|testosterone undecanoate|mesh-list
101849103|NCT00239590|Testosterone enanthate|testosterone enanthate|mesh-list
101849104|NCT00239590|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101849105|NCT00239590|Androgens|androgens|mesh-ancestor
101849106|NCT00239590|Hormones|hormones|mesh-ancestor
101516892|NCT00546546|Methotrexate|methotrexate|mesh-list
101849107|NCT00239590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101849108|NCT00239590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849109|NCT00239590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101849110|NCT00239590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101849111|NCT00239590|Anabolic Agents|anabolic agents|mesh-ancestor
101849113|NCT00433160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101849114|NCT00433160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849115|NCT00433160|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101849116|NCT00239356|Aripiprazole|aripiprazole|mesh-list
101849117|NCT00239356|Antidepressive Agents|antidepressive agents|mesh-ancestor
101849118|NCT00239356|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101849119|NCT00239356|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101964479|NCT02531165|Aspirin|aspirin|mesh-list
101849120|NCT00239356|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101849121|NCT00239356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101849122|NCT00239356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849123|NCT00239356|Dopamine Agonists|dopamine agonists|mesh-ancestor
101849124|NCT00239356|Dopamine Agents|dopamine agents|mesh-ancestor
101849125|NCT00239356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101849126|NCT00239356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849127|NCT00239356|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101849128|NCT00239356|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101849129|NCT00239356|Serotonin Agents|serotonin agents|mesh-ancestor
101849130|NCT00239356|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101849131|NCT00239356|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101849132|NCT00239356|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101849133|NCT00239356|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101849134|NCT00425438|Mycophenolic Acid|mycophenolic acid|mesh-list
101849135|NCT00425438|Prednisolone|prednisolone|mesh-list
101849136|NCT00425438|Cyclophosphamide|cyclophosphamide|mesh-list
101849137|NCT00425438|Azathioprine|azathioprine|mesh-list
101849138|NCT00425438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101849139|NCT00425438|Immunologic Factors|immunologic factors|mesh-ancestor
101849140|NCT00425438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849141|NCT00425438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101849142|NCT00425438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101849143|NCT00425438|Alkylating Agents|alkylating agents|mesh-ancestor
101849144|NCT00425438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849145|NCT00425438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101849146|NCT00425438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101849147|NCT00425438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101849148|NCT00425438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101849149|NCT00425438|Antitubercular Agents|antitubercular agents|mesh-ancestor
101849150|NCT00425438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101849151|NCT00425438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101849152|NCT00425438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101849153|NCT00425438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101849154|NCT00425438|Glucocorticoids|glucocorticoids|mesh-ancestor
101849155|NCT00425438|Hormones|hormones|mesh-ancestor
101849156|NCT00425438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101849157|NCT00425438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101849158|NCT00425438|Antimetabolites|antimetabolites|mesh-ancestor
101849159|NCT00425438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101849160|NCT01041066|Labetalol|labetalol|mesh-list
101849161|NCT01041066|Nicardipine|nicardipine|mesh-list
101849162|NCT01041066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101849163|NCT01041066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101239256|NCT01614938|Cisplatin|cisplatin|mesh-list
101849164|NCT01041066|Adrenergic Agents|adrenergic agents|mesh-ancestor
101849165|NCT01041066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101849166|NCT01041066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849167|NCT01041066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849168|NCT01041066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101849169|NCT01041066|Sympathomimetics|sympathomimetics|mesh-ancestor
101849170|NCT01041066|Autonomic Agents|autonomic agents|mesh-ancestor
101849171|NCT01041066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101849172|NCT01041066|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101849173|NCT01041066|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101849174|NCT01041066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101849175|NCT01041066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101849176|NCT01041066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101849177|NCT01041066|Vasodilator Agents|vasodilator agents|mesh-ancestor
101849179|NCT01323608|Cholecalciferol|cholecalciferol|mesh-list
101849180|NCT01323608|Vitamins|vitamins|mesh-ancestor
101849181|NCT01323608|Micronutrients|micronutrients|mesh-ancestor
101849182|NCT01323608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849183|NCT01323608|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101849184|NCT01323608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101849185|NCT00275002|Temozolomide|temozolomide|mesh-list
101849186|NCT00275002|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
101849187|NCT00275002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101849188|NCT00275002|Alkylating Agents|alkylating agents|mesh-ancestor
101849189|NCT00275002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849190|NCT00275002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101849191|NCT00275002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101849192|NCT00433004|Levonorgestrel|levonorgestrel|mesh-list
101849193|NCT00433004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101849194|NCT00433004|Contraceptive Agents|contraceptive agents|mesh-ancestor
101849195|NCT00433004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101849196|NCT00433004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849197|NCT00433004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101849198|NCT00433004|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101849199|NCT00433004|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101849200|NCT00393042|Amphetamine|amphetamine|mesh-list
101849201|NCT00393042|Adderall|adderall|mesh-list
101849202|NCT00393042|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
101849203|NCT00393042|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101849204|NCT00393042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849205|NCT00393042|Sympathomimetics|sympathomimetics|mesh-ancestor
101849206|NCT00393042|Autonomic Agents|autonomic agents|mesh-ancestor
101849207|NCT00393042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101849208|NCT00393042|Dopamine Agents|dopamine agents|mesh-ancestor
101849209|NCT00393042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101849210|NCT00393042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849211|NCT00393042|Adrenergic Agents|adrenergic agents|mesh-ancestor
101849212|NCT00393042|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101849213|NCT00393042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101849214|NCT00393042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101849215|NCT00393042|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101849217|NCT01040286|Flurbiprofen|flurbiprofen|mesh-list
101849218|NCT01040286|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101849219|NCT01040286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101849220|NCT01040286|Disinfectants|disinfectants|mesh-ancestor
101849221|NCT01040286|Analgesics|analgesics|mesh-ancestor
101849222|NCT01040286|Sensory System Agents|sensory system agents|mesh-ancestor
101849223|NCT01040286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101849224|NCT01040286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849225|NCT01040286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101849226|NCT01040286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101849227|NCT01040286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101849228|NCT01040286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101849229|NCT01040286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101849230|NCT01040286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101849231|NCT01040286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849232|NCT01041378|Dexamethasone|dexamethasone|mesh-list
101849233|NCT01041378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101849234|NCT01041378|Antiemetics|antiemetics|mesh-ancestor
101849235|NCT01041378|Autonomic Agents|autonomic agents|mesh-ancestor
101849236|NCT01041378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101849237|NCT01041378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849238|NCT01041378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101849239|NCT01041378|Glucocorticoids|glucocorticoids|mesh-ancestor
101849240|NCT01041378|Hormones|hormones|mesh-ancestor
101849241|NCT01041378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101849242|NCT01041378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101849243|NCT01041378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101849244|NCT03546192|Vaccines|vaccines|mesh-list
101849245|NCT03546192|Immunologic Factors|immunologic factors|mesh-ancestor
101849246|NCT03546192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849247|NCT01043952|Remifentanil|remifentanil|mesh-list
101849248|NCT01043952|Propofol|propofol|mesh-list
101849249|NCT01043952|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101849250|NCT01043952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101849251|NCT01043952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101964580|NCT04772248|Adalimumab|adalimumab|mesh-list
101849252|NCT01043952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101849253|NCT01043952|Anesthetics, General|anesthetics, general|mesh-ancestor
101849254|NCT01043952|Anesthetics|anesthetics|mesh-ancestor
101849255|NCT01043952|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101849256|NCT01043952|Narcotics|narcotics|mesh-ancestor
101849257|NCT01043952|Analgesics|analgesics|mesh-ancestor
101849258|NCT01043952|Sensory System Agents|sensory system agents|mesh-ancestor
101849259|NCT01043952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101849260|NCT00274846|Aldesleukin|aldesleukin|mesh-list
101849261|NCT00274846|Cyclophosphamide|cyclophosphamide|mesh-list
101849262|NCT00274846|Fludarabine|fludarabine|mesh-list
101849263|NCT00274846|Fludarabine phosphate|fludarabine phosphate|mesh-list
101569077|NCT04452565|BB 1101|bb 1101|mesh-list
101849264|NCT00274846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101849265|NCT00274846|Immunologic Factors|immunologic factors|mesh-ancestor
101849266|NCT00274846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849267|NCT00274846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101849268|NCT00274846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101849269|NCT00274846|Alkylating Agents|alkylating agents|mesh-ancestor
101849270|NCT00274846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849271|NCT00274846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101849272|NCT00274846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101849273|NCT00274846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101849274|NCT00274846|Antimetabolites|antimetabolites|mesh-ancestor
101849275|NCT00274846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101849276|NCT00274846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101849277|NCT00274846|Antiviral Agents|antiviral agents|mesh-ancestor
101849278|NCT00274846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101849279|NCT01072786|Vaccines|vaccines|mesh-list
101849280|NCT01072786|Immunologic Factors|immunologic factors|mesh-ancestor
101849281|NCT01072786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849282|NCT03970798|Midazolam|midazolam|mesh-list
101849283|NCT03970798|Caffeine|caffeine|mesh-list
101849284|NCT03970798|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101849285|NCT03970798|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101849286|NCT03970798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101849287|NCT03970798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101849288|NCT03970798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849289|NCT03970798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101849290|NCT03970798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101849291|NCT03970798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101849292|NCT03970798|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101239282|NCT01615042|Lenalidomide|lenalidomide|mesh-list
101849293|NCT03970798|Anesthetics, General|anesthetics, general|mesh-ancestor
101849294|NCT03970798|Anesthetics|anesthetics|mesh-ancestor
101849295|NCT03970798|GABA Modulators|gaba modulators|mesh-ancestor
101849296|NCT03970798|GABA Agents|gaba agents|mesh-ancestor
101849297|NCT03970798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101849298|NCT03970798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849299|NCT03970798|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101849300|NCT03970798|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101849301|NCT03970798|Antimetabolites|antimetabolites|mesh-ancestor
101849302|NCT03970798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101849303|NCT03970798|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101849304|NCT03970798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101849305|NCT03970798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101849306|NCT03970798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101849307|NCT03970798|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101849308|NCT03970798|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101849309|NCT03970798|Purinergic Agents|purinergic agents|mesh-ancestor
101849311|NCT00414440|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101849312|NCT00414440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101849313|NCT00414440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101849314|NCT00414440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849315|NCT00414440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101849316|NCT00414440|Immunologic Factors|immunologic factors|mesh-ancestor
101686296|NCT01497509|Mydriatics|mydriatics|mesh-ancestor
101849317|NCT00414440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849318|NCT00414440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101849319|NCT00209560|Fospropofol|fospropofol|mesh-list
101849320|NCT00209560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101849321|NCT00209560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101849322|NCT00209560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849323|NCT01073800|Atorvastatin|atorvastatin|mesh-list
101849324|NCT01073800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101849325|NCT01073800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101849326|NCT01073800|Antimetabolites|antimetabolites|mesh-ancestor
101849327|NCT01073800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849328|NCT01073800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101849329|NCT01073800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101849330|NCT01073800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101849331|NCT01037660|Metformin|metformin|mesh-list
101849332|NCT01037660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101849333|NCT01037660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849334|NCT00236080|Modafinil|modafinil|mesh-list
101849335|NCT00236080|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101849336|NCT00236080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849337|NCT00236080|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101849338|NCT00236080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101849339|NCT00236080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101849340|NCT00236080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849342|NCT01033058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101849343|NCT01033058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101849344|NCT01033058|Antimetabolites|antimetabolites|mesh-ancestor
101849345|NCT01033058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849346|NCT01033058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101849347|NCT01033058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101849348|NCT01033058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101849349|NCT03973138|Ranibizumab|ranibizumab|mesh-list
101849350|NCT03973138|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101849351|NCT03973138|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101849352|NCT03973138|Growth Substances|growth substances|mesh-ancestor
101849353|NCT03973138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849354|NCT03973138|Growth Inhibitors|growth inhibitors|mesh-ancestor
101849355|NCT03973138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101849356|NCT01072942|Ciprofloxacin|ciprofloxacin|mesh-list
101849357|NCT01072942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101849358|NCT01072942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101849359|NCT01072942|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101849360|NCT01072942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101849361|NCT01072942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101849362|NCT01072942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849363|NCT01072942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101849364|NCT01072942|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101849365|NCT01072942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101849366|NCT00234052|Bevacizumab|bevacizumab|mesh-list
101849367|NCT00234052|Carboplatin|carboplatin|mesh-list
101849368|NCT00234052|Pemetrexed|pemetrexed|mesh-list
101849369|NCT00234052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101849371|NCT00234052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101849372|NCT00234052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101849373|NCT00234052|Growth Substances|growth substances|mesh-ancestor
101849374|NCT00234052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849375|NCT00234052|Growth Inhibitors|growth inhibitors|mesh-ancestor
101849376|NCT00234052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101849377|NCT00234052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849378|NCT00234052|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101849379|NCT00234052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101849380|NCT00408408|Cyclophosphamide|cyclophosphamide|mesh-list
101849381|NCT00408408|Bevacizumab|bevacizumab|mesh-list
101849382|NCT00408408|Gemcitabine|gemcitabine|mesh-list
101849383|NCT00408408|Docetaxel|docetaxel|mesh-list
101849384|NCT00408408|Doxorubicin|doxorubicin|mesh-list
101849385|NCT00408408|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101849386|NCT00408408|Capecitabine|capecitabine|mesh-list
101849387|NCT00408408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101849388|NCT00408408|Immunologic Factors|immunologic factors|mesh-ancestor
101849389|NCT00408408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849391|NCT00408408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101849392|NCT00408408|Alkylating Agents|alkylating agents|mesh-ancestor
101849393|NCT00408408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849394|NCT00408408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101849395|NCT00408408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101849396|NCT00408408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101849397|NCT00408408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101849398|NCT00408408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101849399|NCT00408408|Growth Substances|growth substances|mesh-ancestor
101849400|NCT00408408|Growth Inhibitors|growth inhibitors|mesh-ancestor
101849401|NCT00408408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101849402|NCT00408408|Antimetabolites|antimetabolites|mesh-ancestor
101849403|NCT00408408|Tubulin Modulators|tubulin modulators|mesh-ancestor
101849404|NCT00408408|Antimitotic Agents|antimitotic agents|mesh-ancestor
101849405|NCT00408408|Mitosis Modulators|mitosis modulators|mesh-ancestor
101849406|NCT00408408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101849407|NCT00408408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101849408|NCT00408408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101849409|NCT00408408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101849410|NCT00414050|Vaccines|vaccines|mesh-list
101849411|NCT00414050|Immunologic Factors|immunologic factors|mesh-ancestor
101849412|NCT00414050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849413|NCT03973840|Methyltestosterone|methyltestosterone|mesh-list
101849414|NCT03973840|Testosterone|testosterone|mesh-list
101849415|NCT03973840|Testosterone undecanoate|testosterone undecanoate|mesh-list
101849416|NCT03973840|Testosterone enanthate|testosterone enanthate|mesh-list
101849417|NCT03973840|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101849418|NCT03973840|Androgens|androgens|mesh-ancestor
101849419|NCT03973840|Hormones|hormones|mesh-ancestor
101849420|NCT03973840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101849421|NCT03973840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849422|NCT03973840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101849423|NCT03973840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101849424|NCT03973840|Anabolic Agents|anabolic agents|mesh-ancestor
101849425|NCT00413972|Simvastatin|simvastatin|mesh-list
101849426|NCT00413972|Ezetimibe|ezetimibe|mesh-list
101849427|NCT00413972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101849428|NCT00413972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101849429|NCT00413972|Antimetabolites|antimetabolites|mesh-ancestor
101849430|NCT00413972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849431|NCT00413972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101849432|NCT00413972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101849433|NCT00413972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101849434|NCT00259012|Pantoprazole|pantoprazole|mesh-list
101849435|NCT00259012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101849436|NCT00259012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101849437|NCT00259012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101849438|NCT00259012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101849439|NCT00259012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849440|NCT01044186|Deferasirox|deferasirox|mesh-list
101849441|NCT01044186|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101849442|NCT01044186|Chelating Agents|chelating agents|mesh-ancestor
101849443|NCT01044186|Sequestering Agents|sequestering agents|mesh-ancestor
101849444|NCT01044186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849445|NCT00209170|Escitalopram|escitalopram|mesh-list
101849446|NCT00209170|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101849447|NCT00209170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101849448|NCT00209170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101849449|NCT00209170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849450|NCT00209170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101849451|NCT00209170|Serotonin Agents|serotonin agents|mesh-ancestor
101849452|NCT00209170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849453|NCT01071694|Interferons|interferons|mesh-list
101849454|NCT01071694|Interferon-beta|interferon-beta|mesh-list
101849455|NCT01071694|Interferon beta-1b|interferon beta-1b|mesh-list
101849456|NCT01071694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101849457|NCT01071694|Antiviral Agents|antiviral agents|mesh-ancestor
101849458|NCT01071694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101849459|NCT01071694|Immunologic Factors|immunologic factors|mesh-ancestor
101849460|NCT01071694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849461|NCT01071694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101849462|NCT00413894|Epoetin Alfa|epoetin alfa|mesh-list
101849463|NCT00413894|Hematinics|hematinics|mesh-ancestor
101849464|NCT03972748|Itraconazole|itraconazole|mesh-list
101849465|NCT03972748|Antifungal Agents|antifungal agents|mesh-ancestor
101849466|NCT03972748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101849467|NCT03972748|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101849468|NCT03972748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101849469|NCT03972748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101239323|NCT01615211|Letrozole|letrozole|mesh-list
101849470|NCT03972748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849471|NCT03972748|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101849472|NCT03972748|Hormone Antagonists|hormone antagonists|mesh-ancestor
101849473|NCT03972748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101849474|NCT03972748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849475|NCT03972748|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101849476|NCT01581814|Metformin|metformin|mesh-list
101849477|NCT01581814|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
101849478|NCT01581814|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101849479|NCT01581814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101849480|NCT01581814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849481|NCT01581814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101849482|NCT01581814|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101849483|NCT01581814|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101849484|NCT01581814|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101569277|NCT05337085|Anesthetics, General|anesthetics, general|mesh-ancestor
101849485|NCT01581814|Contraceptive Agents|contraceptive agents|mesh-ancestor
101849486|NCT01581814|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101849487|NCT01581814|Estrogens|estrogens|mesh-ancestor
101849488|NCT01581814|Hormones|hormones|mesh-ancestor
101849489|NCT01581814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101849490|NCT00407550|Gemcitabine|gemcitabine|mesh-list
101849491|NCT00407550|Pemetrexed|pemetrexed|mesh-list
101849492|NCT00407550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101849493|NCT00407550|Antimetabolites|antimetabolites|mesh-ancestor
101849494|NCT00407550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849495|NCT00407550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101849496|NCT00407550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101849497|NCT00407550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101849498|NCT00407550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101849499|NCT00209092|Docetaxel|docetaxel|mesh-list
101849500|NCT00209092|Capecitabine|capecitabine|mesh-list
101849501|NCT00209092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101849502|NCT00209092|Tubulin Modulators|tubulin modulators|mesh-ancestor
101849503|NCT00209092|Antimitotic Agents|antimitotic agents|mesh-ancestor
101849504|NCT00209092|Mitosis Modulators|mitosis modulators|mesh-ancestor
101849505|NCT00209092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849506|NCT00209092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101849507|NCT00209092|Antimetabolites|antimetabolites|mesh-ancestor
101849508|NCT03972982|Insulin|insulin|mesh-list
101849509|NCT03972982|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101849510|NCT03972982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101849511|NCT03972982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849512|NCT00403494|Verapamil|verapamil|mesh-list
101849513|NCT00403494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101849514|NCT00403494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101849515|NCT00403494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101849516|NCT00403494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849517|NCT00403494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101849518|NCT00403494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849519|NCT00403494|Vasodilator Agents|vasodilator agents|mesh-ancestor
101849520|NCT00403260|Artesunate|artesunate|mesh-list
101849521|NCT00403260|Mefloquine|mefloquine|mesh-list
101849522|NCT00403260|Pyronaridine|pyronaridine|mesh-list
101849523|NCT00403260|Antimalarials|antimalarials|mesh-ancestor
101849524|NCT00403260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101849525|NCT00403260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101849526|NCT00403260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101849527|NCT00403260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101849528|NCT00403260|Antiviral Agents|antiviral agents|mesh-ancestor
101849529|NCT00403260|Schistosomicides|schistosomicides|mesh-ancestor
101849530|NCT00403260|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101849531|NCT00403260|Anthelmintics|anthelmintics|mesh-ancestor
101849532|NCT00406848|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101849533|NCT00406848|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101686304|NCT02846519|Rifampin|rifampin|mesh-list
101849534|NCT00406848|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101849535|NCT00406848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101849536|NCT00406848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849537|NCT00406848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101849538|NCT00406848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849539|NCT00406848|Analgesics|analgesics|mesh-ancestor
101849540|NCT00406848|Sensory System Agents|sensory system agents|mesh-ancestor
101849541|NCT00406848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101849542|NCT00406848|Antidepressive Agents|antidepressive agents|mesh-ancestor
101849543|NCT00406848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101849544|NCT00406848|Dopamine Agents|dopamine agents|mesh-ancestor
101849546|NCT00406692|Anticonvulsants|anticonvulsants|mesh-ancestor
101849547|NCT00406692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101849548|NCT00406692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101849549|NCT00406692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849550|NCT00406692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101849551|NCT00406692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849552|NCT00004494|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
101849553|NCT00004494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101849554|NCT00004494|Vasodilator Agents|vasodilator agents|mesh-ancestor
101849555|NCT00004494|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101849556|NCT00004494|Protective Agents|protective agents|mesh-ancestor
101849557|NCT00004494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849558|NCT00315705|Cyclophosphamide|cyclophosphamide|mesh-list
101849559|NCT00315705|Etoposide|etoposide|mesh-list
101849560|NCT00315705|Clofarabine|clofarabine|mesh-list
101849561|NCT00315705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101849562|NCT00315705|Immunologic Factors|immunologic factors|mesh-ancestor
101849563|NCT00315705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849564|NCT00315705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101849565|NCT00315705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101849566|NCT00315705|Alkylating Agents|alkylating agents|mesh-ancestor
101849567|NCT00315705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849568|NCT00315705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101849569|NCT00315705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101849570|NCT00315705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101849571|NCT00315705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101849572|NCT00315705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101849573|NCT00315705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101849574|NCT00315705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101849575|NCT00315705|Antimetabolites|antimetabolites|mesh-ancestor
101849576|NCT03982173|Durvalumab|durvalumab|mesh-list
101849578|NCT03982173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101849579|NCT03982173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101849580|NCT01062633|Erythritol|erythritol|mesh-list
101849581|NCT01062633|Sorbitol|sorbitol|mesh-list
101849582|NCT01062633|Vasodilator Agents|vasodilator agents|mesh-ancestor
101849583|NCT01062633|Cathartics|cathartics|mesh-ancestor
101849584|NCT01062633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101849585|NCT00307125|Rituximab|rituximab|mesh-list
101849586|NCT00307125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101849587|NCT00307125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101849588|NCT00307125|Immunologic Factors|immunologic factors|mesh-ancestor
101849589|NCT00307125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849590|NCT00307125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101849591|NCT01066299|Oxytocin|oxytocin|mesh-list
101849592|NCT01066299|Oxytocics|oxytocics|mesh-ancestor
101849593|NCT01066299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101849594|NCT01066299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849595|NCT00307047|Paclitaxel|paclitaxel|mesh-list
101849596|NCT00307047|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101849597|NCT00307047|Everolimus|everolimus|mesh-list
101849598|NCT00307047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101849599|NCT00307047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101849600|NCT00307047|Tubulin Modulators|tubulin modulators|mesh-ancestor
101849601|NCT00307047|Antimitotic Agents|antimitotic agents|mesh-ancestor
101849602|NCT00307047|Mitosis Modulators|mitosis modulators|mesh-ancestor
101849603|NCT00307047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849604|NCT00307047|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101849605|NCT00307047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101849606|NCT00307047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101849607|NCT00307047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101849608|NCT00307047|Immunologic Factors|immunologic factors|mesh-ancestor
101849609|NCT00307047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849610|NCT01066377|Sulfalene|sulfalene|mesh-list
101849611|NCT01066377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101849612|NCT01066377|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101849613|NCT01066377|Antimalarials|antimalarials|mesh-ancestor
101849614|NCT01066377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101849615|NCT01066377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101849616|NCT00306891|Cediranib|cediranib|mesh-list
101849617|NCT00306891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101849618|NCT00306891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101849619|NCT00306891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101849620|NCT00306891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849621|NCT03980847|Alendronate|alendronate|mesh-list
101849622|NCT03980847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101849623|NCT03980847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849624|NCT00391872|Clopidogrel|clopidogrel|mesh-list
101849625|NCT00391872|Ticagrelor|ticagrelor|mesh-list
101849626|NCT00391872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101849627|NCT00391872|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101849628|NCT00391872|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101849629|NCT00391872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101849630|NCT00391872|Purinergic Agents|purinergic agents|mesh-ancestor
101849631|NCT00391872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101849632|NCT00391872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849633|NCT00391872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849634|NCT00391170|Dexamethasone|dexamethasone|mesh-list
101849635|NCT00391170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101849636|NCT00391170|Antiemetics|antiemetics|mesh-ancestor
101849637|NCT00391170|Autonomic Agents|autonomic agents|mesh-ancestor
101849638|NCT00391170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101849639|NCT00391170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849640|NCT00391170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101849641|NCT00391170|Glucocorticoids|glucocorticoids|mesh-ancestor
101849642|NCT00391170|Hormones|hormones|mesh-ancestor
101849643|NCT00391170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101849644|NCT00391170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101849645|NCT00391170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101849646|NCT00402324|Valproic Acid|valproic acid|mesh-list
101849647|NCT00402324|Olanzapine|olanzapine|mesh-list
101849648|NCT00402324|Antiemetics|antiemetics|mesh-ancestor
101849649|NCT00402324|Autonomic Agents|autonomic agents|mesh-ancestor
101849650|NCT00402324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101849651|NCT00402324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849652|NCT00402324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101849653|NCT00402324|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101849654|NCT00402324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101849655|NCT00402324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101849656|NCT00402324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101849657|NCT00402324|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101849658|NCT00402324|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101849659|NCT00402324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101849660|NCT00402324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849661|NCT00402324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101849662|NCT00402324|Serotonin Agents|serotonin agents|mesh-ancestor
101849663|NCT00402324|Anticonvulsants|anticonvulsants|mesh-ancestor
101849664|NCT00402324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101849665|NCT00402324|GABA Agents|gaba agents|mesh-ancestor
101849666|NCT00402324|Antimanic Agents|antimanic agents|mesh-ancestor
101849667|NCT00294723|Liraglutide|liraglutide|mesh-list
101849668|NCT00294723|Glimepiride|glimepiride|mesh-list
101849669|NCT00294723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101849670|NCT00294723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849671|NCT00294723|Incretins|incretins|mesh-ancestor
101849672|NCT00294723|Hormones|hormones|mesh-ancestor
101849673|NCT00294723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101849674|NCT00294723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101849675|NCT00294723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101849676|NCT00294723|Immunologic Factors|immunologic factors|mesh-ancestor
101849677|NCT00375492|Exenatide|exenatide|mesh-list
101849678|NCT00375492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101849679|NCT00375492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849680|NCT00375492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101849681|NCT00375492|Incretins|incretins|mesh-ancestor
101849682|NCT00375492|Hormones|hormones|mesh-ancestor
101849683|NCT00375492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101849684|NCT00306189|Denosumab|denosumab|mesh-list
101849685|NCT00306189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101849686|NCT00306189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849687|NCT00305877|Bevacizumab|bevacizumab|mesh-list
101849688|NCT00305877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101849689|NCT00305877|Cetuximab|cetuximab|mesh-list
101849690|NCT00305877|Gemcitabine|gemcitabine|mesh-list
101849691|NCT00305877|Capecitabine|capecitabine|mesh-list
101849692|NCT00305877|Antibodies|antibodies|mesh-list
101849693|NCT00305877|Immunoglobulins|immunoglobulins|mesh-list
101849694|NCT00305877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101849695|NCT00305877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101849696|NCT00305877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101849697|NCT00305877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101849698|NCT00305877|Growth Substances|growth substances|mesh-ancestor
101849699|NCT00305877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849700|NCT00305877|Growth Inhibitors|growth inhibitors|mesh-ancestor
101849701|NCT00305877|Immunologic Factors|immunologic factors|mesh-ancestor
101849702|NCT00305877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101849703|NCT00305877|Antimetabolites|antimetabolites|mesh-ancestor
101849704|NCT00305877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849705|NCT00312195|Buprenorphine|buprenorphine|mesh-list
101849706|NCT00312195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101849707|NCT00312195|Narcotics|narcotics|mesh-ancestor
101849708|NCT00312195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101849709|NCT00312195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849710|NCT00312195|Analgesics|analgesics|mesh-ancestor
101849711|NCT00312195|Sensory System Agents|sensory system agents|mesh-ancestor
101849712|NCT00312195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101849713|NCT00312195|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101849714|NCT02532777|Mycophenolic Acid|mycophenolic acid|mesh-list
101849715|NCT02532777|Prednisone|prednisone|mesh-list
101849716|NCT02532777|Methylprednisolone|methylprednisolone|mesh-list
101849717|NCT02532777|Cyclophosphamide|cyclophosphamide|mesh-list
101849718|NCT02532777|Leflunomide|leflunomide|mesh-list
101849719|NCT02532777|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101849720|NCT02532777|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101849721|NCT02532777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101849722|NCT02532777|Immunologic Factors|immunologic factors|mesh-ancestor
101849723|NCT02532777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849724|NCT02532777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101849725|NCT02532777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101849726|NCT02532777|Alkylating Agents|alkylating agents|mesh-ancestor
101849727|NCT02532777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849728|NCT02532777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101849729|NCT02532777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101849730|NCT02532777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101849731|NCT02532777|Glucocorticoids|glucocorticoids|mesh-ancestor
101849733|NCT02532777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101849734|NCT02532777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101849735|NCT02532777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101849736|NCT02532777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101849737|NCT02532777|Antitubercular Agents|antitubercular agents|mesh-ancestor
101849738|NCT02532777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101849739|NCT02532777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101849740|NCT02532777|Antiemetics|antiemetics|mesh-ancestor
101849741|NCT02532777|Autonomic Agents|autonomic agents|mesh-ancestor
101849742|NCT02532777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101849743|NCT02532777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101849744|NCT02532777|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101849745|NCT02532777|Protective Agents|protective agents|mesh-ancestor
101849746|NCT02532777|Protease Inhibitors|protease inhibitors|mesh-ancestor
101849747|NCT01062945|Doxazosin|doxazosin|mesh-list
101849748|NCT01062945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101849749|NCT01062945|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101849750|NCT01062945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101849751|NCT01062945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101849752|NCT01062945|Adrenergic Agents|adrenergic agents|mesh-ancestor
101849753|NCT01062945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101849754|NCT01062945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849755|NCT01062945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849756|NCT01063023|Moxifloxacin|moxifloxacin|mesh-list
101849757|NCT01063023|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101849758|NCT01063023|Asunaprevir|asunaprevir|mesh-list
101849759|NCT01063023|Protease Inhibitors|protease inhibitors|mesh-ancestor
101849760|NCT01063023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101849761|NCT01063023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849762|NCT01063023|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101849763|NCT01063023|Contraceptive Agents|contraceptive agents|mesh-ancestor
101849764|NCT01063023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101849765|NCT01063023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849766|NCT01063023|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101849767|NCT01063023|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101849768|NCT01063023|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101849769|NCT01063023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101849770|NCT01063023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101849771|NCT01063023|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101849772|NCT01063023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101849773|NCT01063023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101849774|NCT01063101|Fucoidan|fucoidan|mesh-list
101849775|NCT01063101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101849776|NCT01063101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101849777|NCT01063101|Anticoagulants|anticoagulants|mesh-ancestor
101849778|NCT01063101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101849779|NCT01066689|Rituximab|rituximab|mesh-list
101849780|NCT01066689|Citric Acid|citric acid|mesh-list
101849781|NCT01066689|Sodium Citrate|sodium citrate|mesh-list
101849782|NCT01066689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101849783|NCT01066689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101849784|NCT01066689|Immunologic Factors|immunologic factors|mesh-ancestor
101849785|NCT01066689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849786|NCT01066689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101849787|NCT01066689|Anticoagulants|anticoagulants|mesh-ancestor
101569577|NCT01228019|Vitamin B Complex|vitamin b complex|mesh-ancestor
101849789|NCT01066689|Chelating Agents|chelating agents|mesh-ancestor
101849790|NCT01066689|Sequestering Agents|sequestering agents|mesh-ancestor
101849791|NCT01066689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849792|NCT00293709|Etanercept|etanercept|mesh-list
101849793|NCT00293709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101849794|NCT00293709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101849795|NCT00293709|Analgesics|analgesics|mesh-ancestor
101849796|NCT00293709|Sensory System Agents|sensory system agents|mesh-ancestor
101849797|NCT00293709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101849798|NCT00293709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849799|NCT00293709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101849800|NCT00293709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101849801|NCT00293709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101849802|NCT00293709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101849803|NCT00293709|Immunologic Factors|immunologic factors|mesh-ancestor
101849804|NCT01063257|Clofarabine|clofarabine|mesh-list
101849805|NCT01063257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101849806|NCT01063257|Antimetabolites|antimetabolites|mesh-ancestor
101849807|NCT01063257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849808|NCT01063257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101849809|NCT03977649|Erenumab|erenumab|mesh-list
101849810|NCT03977649|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
101849811|NCT03977649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849812|NCT03977649|Analgesics|analgesics|mesh-ancestor
101849813|NCT03977649|Sensory System Agents|sensory system agents|mesh-ancestor
101849814|NCT03977649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101849815|NCT03977649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849816|NCT01066767|Fexofenadine|fexofenadine|mesh-list
101849817|NCT01066767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101849818|NCT01066767|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101849819|NCT01066767|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101849820|NCT01066767|Histamine Antagonists|histamine antagonists|mesh-ancestor
101849821|NCT01066767|Histamine Agents|histamine agents|mesh-ancestor
101849822|NCT01066767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101849823|NCT01066767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849824|NCT01066767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849825|NCT03980379|Rituximab|rituximab|mesh-list
101849826|NCT03980379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101849828|NCT03980379|Immunologic Factors|immunologic factors|mesh-ancestor
101849829|NCT03980379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849830|NCT03980379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101849831|NCT01064271|Risperidone|risperidone|mesh-list
101849832|NCT01064271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101849833|NCT01064271|Serotonin Agents|serotonin agents|mesh-ancestor
101849834|NCT01064271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101849835|NCT01064271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849836|NCT01064271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849837|NCT01064271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101849838|NCT01064271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101849839|NCT01064271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101849840|NCT01064271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101849841|NCT01064271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101849842|NCT01064271|Dopamine Agents|dopamine agents|mesh-ancestor
101849843|NCT01066845|Tadalafil|tadalafil|mesh-list
101849844|NCT01066845|Vasodilator Agents|vasodilator agents|mesh-ancestor
101849845|NCT01066845|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101849846|NCT01066845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101849847|NCT01066845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101239396|NCT01615614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101849848|NCT01066845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849849|NCT01066845|Urological Agents|urological agents|mesh-ancestor
101849850|NCT01064349|Trastuzumab|trastuzumab|mesh-list
101849851|NCT01064349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101849852|NCT01064349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101849853|NCT00293397|Doxorubicin|doxorubicin|mesh-list
101849854|NCT00293397|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101849855|NCT00293397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101849856|NCT00293397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101849857|NCT00293397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101849858|NCT00293397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101849859|NCT00293397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101569656|NCT00895843|Analgesics|analgesics|mesh-ancestor
101849860|NCT00293397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849862|NCT03981627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101849863|NCT03981627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849864|NCT01069263|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
101849865|NCT01069263|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101849866|NCT01069263|Protective Agents|protective agents|mesh-ancestor
101849867|NCT01069263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849868|NCT01069263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101849869|NCT01069263|Antioxidants|antioxidants|mesh-ancestor
101849870|NCT01069263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849872|NCT01067235|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101849873|NCT01067235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849874|NCT01067235|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101849875|NCT01067235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101849876|NCT01067235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101849877|NCT01067235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849878|NCT00290745|Tamoxifen|tamoxifen|mesh-list
101849879|NCT00290745|Letrozole|letrozole|mesh-list
101849880|NCT00290745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849881|NCT00290745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101849882|NCT00290745|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101849883|NCT00290745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101849884|NCT00290745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101849885|NCT00290745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101849886|NCT00290745|Hormone Antagonists|hormone antagonists|mesh-ancestor
101849887|NCT00290745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101849888|NCT00290745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849889|NCT00290745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101849890|NCT00290745|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101849891|NCT00290745|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101849892|NCT00290745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101849893|NCT03980223|Doxycycline|doxycycline|mesh-list
101849894|NCT03980223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101849895|NCT03980223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101849896|NCT03980223|Antimalarials|antimalarials|mesh-ancestor
101849897|NCT03980223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101849898|NCT03980223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101849899|NCT01067391|Tadalafil|tadalafil|mesh-list
101849900|NCT01067391|Vasodilator Agents|vasodilator agents|mesh-ancestor
101849901|NCT01067391|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101849902|NCT01067391|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101849903|NCT01067391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101849904|NCT01067391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849905|NCT01067391|Urological Agents|urological agents|mesh-ancestor
101849906|NCT00402168|Cyclosporine|cyclosporine|mesh-list
101849907|NCT00402168|Abatacept|abatacept|mesh-list
101849908|NCT00402168|Tacrolimus|tacrolimus|mesh-list
101849909|NCT00402168|Cyclosporins|cyclosporins|mesh-list
101849910|NCT00402168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101849911|NCT00402168|Immunologic Factors|immunologic factors|mesh-ancestor
101849912|NCT00402168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849913|NCT00402168|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101849914|NCT00402168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101849915|NCT00402168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849916|NCT00402168|Antifungal Agents|antifungal agents|mesh-ancestor
101849917|NCT00402168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101849918|NCT00402168|Dermatologic Agents|dermatologic agents|mesh-ancestor
101849919|NCT00402168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101849920|NCT00402168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101849921|NCT00402168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101849922|NCT00402168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101849923|NCT00290589|Methylprednisolone|methylprednisolone|mesh-list
101849924|NCT00290589|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101849925|NCT00290589|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101849926|NCT00290589|Prednisolone|prednisolone|mesh-list
101849927|NCT00290589|Prednisolone acetate|prednisolone acetate|mesh-list
101964687|NCT04174612|Antiviral Agents|antiviral agents|mesh-ancestor
101849928|NCT00290589|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101849929|NCT00290589|Prednisolone phosphate|prednisolone phosphate|mesh-list
101849930|NCT00290589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101849931|NCT00290589|Antiemetics|antiemetics|mesh-ancestor
101849932|NCT00290589|Autonomic Agents|autonomic agents|mesh-ancestor
101569727|NCT00893113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101849933|NCT00290589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101849934|NCT00290589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849935|NCT00290589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101849936|NCT00290589|Glucocorticoids|glucocorticoids|mesh-ancestor
101849937|NCT00290589|Hormones|hormones|mesh-ancestor
101849938|NCT00290589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101849939|NCT00290589|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101849940|NCT00290589|Protective Agents|protective agents|mesh-ancestor
101849941|NCT00290589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101849942|NCT00290589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101849943|NCT01067547|Iron|iron|mesh-list
101849944|NCT01067547|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101849945|NCT01067547|Trace Elements|trace elements|mesh-ancestor
101849946|NCT01067547|Micronutrients|micronutrients|mesh-ancestor
101849947|NCT01067547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849948|NCT01067547|Hematinics|hematinics|mesh-ancestor
101849949|NCT00290511|Dexamethasone|dexamethasone|mesh-list
101849950|NCT00290511|Rituximab|rituximab|mesh-list
101849951|NCT00290511|Fludarabine|fludarabine|mesh-list
101849952|NCT00290511|Fludarabine phosphate|fludarabine phosphate|mesh-list
101849953|NCT00290511|Mitoxantrone|mitoxantrone|mesh-list
101849954|NCT00290511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101849955|NCT00290511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101849956|NCT00290511|Immunologic Factors|immunologic factors|mesh-ancestor
101849957|NCT00290511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849958|NCT00290511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101849959|NCT00290511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101849960|NCT00290511|Antiemetics|antiemetics|mesh-ancestor
101849961|NCT00290511|Autonomic Agents|autonomic agents|mesh-ancestor
101849962|NCT00290511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101849964|NCT00290511|Glucocorticoids|glucocorticoids|mesh-ancestor
101849965|NCT00290511|Hormones|hormones|mesh-ancestor
101849966|NCT00290511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101849967|NCT00290511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101849968|NCT00290511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101849969|NCT00290511|Antimetabolites|antimetabolites|mesh-ancestor
101849970|NCT00290511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849971|NCT00290511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101849972|NCT00290511|Analgesics|analgesics|mesh-ancestor
101849973|NCT00290511|Sensory System Agents|sensory system agents|mesh-ancestor
101849974|NCT00290511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101849975|NCT00290511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101849976|NCT00290511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101849977|NCT00290433|Cytarabine|cytarabine|mesh-list
101849978|NCT00290433|Dexamethasone|dexamethasone|mesh-list
101849979|NCT00290433|Cyclophosphamide|cyclophosphamide|mesh-list
101849980|NCT00290433|Doxorubicin|doxorubicin|mesh-list
101849981|NCT00290433|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101849982|NCT00290433|Methotrexate|methotrexate|mesh-list
101849983|NCT00290433|Vincristine|vincristine|mesh-list
101849984|NCT00290433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101849985|NCT00290433|Immunologic Factors|immunologic factors|mesh-ancestor
101849986|NCT00290433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101849987|NCT00290433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101849988|NCT00290433|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101849989|NCT00290433|Alkylating Agents|alkylating agents|mesh-ancestor
101849990|NCT00290433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101849991|NCT00290433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101849992|NCT00290433|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101849993|NCT00290433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101849994|NCT00290433|Antiemetics|antiemetics|mesh-ancestor
101849995|NCT00290433|Autonomic Agents|autonomic agents|mesh-ancestor
101849996|NCT00290433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101849997|NCT00290433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101964697|NCT01082003|Pentoxifylline|pentoxifylline|mesh-list
101849999|NCT00290433|Hormones|hormones|mesh-ancestor
101850000|NCT00290433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101850001|NCT00290433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101850002|NCT00290433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101850003|NCT00290433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101850004|NCT00290433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101850005|NCT00290433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101850006|NCT00290433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101850007|NCT00290433|Abortifacient Agents|abortifacient agents|mesh-ancestor
101850008|NCT00290433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101569803|NCT02834845|Sevoflurane|sevoflurane|mesh-list
101850009|NCT00290433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101850010|NCT00290433|Antimetabolites|antimetabolites|mesh-ancestor
101850011|NCT00290433|Dermatologic Agents|dermatologic agents|mesh-ancestor
101850012|NCT00290433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101850013|NCT00290433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101850014|NCT00290433|Antiviral Agents|antiviral agents|mesh-ancestor
101850015|NCT00290433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101850016|NCT00290433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101850017|NCT00290433|Tubulin Modulators|tubulin modulators|mesh-ancestor
101850018|NCT00290433|Antimitotic Agents|antimitotic agents|mesh-ancestor
101850019|NCT00290433|Mitosis Modulators|mitosis modulators|mesh-ancestor
101850020|NCT00304083|Doxorubicin|doxorubicin|mesh-list
101850021|NCT00304083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101850022|NCT00304083|Etoposide|etoposide|mesh-list
101850023|NCT00304083|Ifosfamide|ifosfamide|mesh-list
101850024|NCT00304083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101850025|NCT00304083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101850026|NCT00304083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101850027|NCT00304083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101850028|NCT00304083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101850029|NCT00304083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850030|NCT00304083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101850031|NCT00304083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101850032|NCT00304083|Alkylating Agents|alkylating agents|mesh-ancestor
101850033|NCT01069965|BGP 15|bgp 15|mesh-list
101850034|NCT01069965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686326|NCT00618228|Sensory System Agents|sensory system agents|mesh-ancestor
101850035|NCT01069965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850036|NCT00391092|Bevacizumab|bevacizumab|mesh-list
101850037|NCT00391092|Trastuzumab|trastuzumab|mesh-list
101850038|NCT00391092|Docetaxel|docetaxel|mesh-list
101850039|NCT00391092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101850040|NCT00391092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101850041|NCT00391092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101850042|NCT00391092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101850043|NCT00391092|Growth Substances|growth substances|mesh-ancestor
101850044|NCT00391092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850045|NCT00391092|Growth Inhibitors|growth inhibitors|mesh-ancestor
101850046|NCT00391092|Tubulin Modulators|tubulin modulators|mesh-ancestor
101850047|NCT00391092|Antimitotic Agents|antimitotic agents|mesh-ancestor
101850048|NCT00391092|Mitosis Modulators|mitosis modulators|mesh-ancestor
101850049|NCT00391092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850050|NCT00374868|Pemetrexed|pemetrexed|mesh-list
101850051|NCT00374868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101850052|NCT00374868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101850053|NCT00374868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850054|NCT00374868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101850055|NCT00374868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101850056|NCT01044342|Donepezil|donepezil|mesh-list
101850057|NCT01044342|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101850058|NCT01044342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101850059|NCT01044342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850060|NCT01044342|Cholinergic Agents|cholinergic agents|mesh-ancestor
101850061|NCT01044342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101850062|NCT01044342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850063|NCT01044342|Nootropic Agents|nootropic agents|mesh-ancestor
101850065|NCT00374556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101850066|NCT00374556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101850067|NCT00374556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850068|NCT01064973|Baclofen|baclofen|mesh-list
101850069|NCT01064973|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101850070|NCT01064973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850071|NCT01064973|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101850072|NCT01064973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101850073|NCT01064973|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101850074|NCT01064973|GABA Agonists|gaba agonists|mesh-ancestor
101850075|NCT01064973|GABA Agents|gaba agents|mesh-ancestor
101850076|NCT01064973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101850077|NCT01064973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850078|NCT00374322|Lapatinib|lapatinib|mesh-list
101850079|NCT00374322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101850080|NCT00374322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101850081|NCT00374322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101850082|NCT00374322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850083|NCT00303459|Bosentan|bosentan|mesh-list
101850084|NCT00303459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101850085|NCT00303459|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101850086|NCT00303459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850088|NCT00289887|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101850089|NCT00289887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101850090|NCT00289887|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101850091|NCT00289887|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101850092|NCT00289887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850093|NCT01068093|Ezetimibe|ezetimibe|mesh-list
101850094|NCT01068093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101850095|NCT01068093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101850096|NCT01068093|Antimetabolites|antimetabolites|mesh-ancestor
101850097|NCT01068093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850098|NCT01068093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101850099|NCT00401544|Dextrans|dextrans|mesh-list
101850100|NCT00401544|Darbepoetin alfa|darbepoetin alfa|mesh-list
101850101|NCT00401544|Iron-Dextran Complex|iron-dextran complex|mesh-list
101850102|NCT00401544|Hematinics|hematinics|mesh-ancestor
101850103|NCT00401544|Anticoagulants|anticoagulants|mesh-ancestor
101850104|NCT00401544|Plasma Substitutes|plasma substitutes|mesh-ancestor
101850105|NCT00401544|Blood Substitutes|blood substitutes|mesh-ancestor
101850106|NCT00292461|Lamotrigine|lamotrigine|mesh-list
101850108|NCT00292461|Anticonvulsants|anticonvulsants|mesh-ancestor
101850109|NCT00292461|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101850110|NCT00292461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101850111|NCT00292461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850112|NCT00292461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101850113|NCT00292461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850114|NCT00292461|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101850115|NCT00292461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101850116|NCT00292461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101850117|NCT00292461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101850118|NCT00292461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101850119|NCT00288639|Pregabalin|pregabalin|mesh-list
101850120|NCT00288639|Analgesics|analgesics|mesh-ancestor
101850121|NCT00288639|Sensory System Agents|sensory system agents|mesh-ancestor
101850122|NCT00288639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101850123|NCT00288639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850124|NCT00288639|Anticonvulsants|anticonvulsants|mesh-ancestor
101850125|NCT00288639|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101850126|NCT00288639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101850127|NCT00288639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850128|NCT00288639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101850129|NCT00288639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101850130|NCT00288639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101850131|NCT00288639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101850132|NCT00288639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101850133|NCT00390858|Deferasirox|deferasirox|mesh-list
101850134|NCT00390858|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101850135|NCT00390858|Chelating Agents|chelating agents|mesh-ancestor
101850136|NCT00390858|Sequestering Agents|sequestering agents|mesh-ancestor
101850137|NCT00390858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850139|NCT00390780|Miconazole|miconazole|mesh-list
101850140|NCT00390780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101850141|NCT00390780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101850142|NCT00390780|Antifungal Agents|antifungal agents|mesh-ancestor
101850143|NCT00390780|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101850144|NCT00390780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101850145|NCT00390780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101850146|NCT00390780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850147|NCT00390780|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101850148|NCT00390780|Hormone Antagonists|hormone antagonists|mesh-ancestor
101850149|NCT00390780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101850150|NCT00390780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850151|NCT00390780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101850152|NCT00390780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101850153|NCT00390546|Propranolol|propranolol|mesh-list
101850154|NCT00390546|Digoxin|digoxin|mesh-list
101850155|NCT00390546|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101850156|NCT00390546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101850157|NCT00390546|Adrenergic Agents|adrenergic agents|mesh-ancestor
101850158|NCT00390546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101850159|NCT00390546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850160|NCT00390546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850161|NCT00390546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101850162|NCT00390546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101850163|NCT00390546|Vasodilator Agents|vasodilator agents|mesh-ancestor
101850164|NCT00390546|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101850165|NCT00390546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101850166|NCT00390546|Protective Agents|protective agents|mesh-ancestor
101850167|NCT00400764|Rituximab|rituximab|mesh-list
101850168|NCT00400764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101850169|NCT00400764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101850170|NCT00400764|Immunologic Factors|immunologic factors|mesh-ancestor
101850171|NCT00400764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850172|NCT00400764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101850173|NCT00302211|Bosentan|bosentan|mesh-list
101850174|NCT00302211|Sildenafil Citrate|sildenafil citrate|mesh-list
101850175|NCT00302211|Iloprost|iloprost|mesh-list
101850176|NCT00302211|Vasodilator Agents|vasodilator agents|mesh-ancestor
101850177|NCT00302211|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101850178|NCT00302211|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101850179|NCT00302211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101850180|NCT00302211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850181|NCT00302211|Urological Agents|urological agents|mesh-ancestor
101850182|NCT00302211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101850183|NCT00302211|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101850184|NCT00302211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101850185|NCT01045902|Moxifloxacin|moxifloxacin|mesh-list
101850186|NCT01045902|Ampicillin|ampicillin|mesh-list
101850187|NCT01045902|Sulbactam|sulbactam|mesh-list
101850188|NCT01045902|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101850189|NCT01045902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101850190|NCT01045902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101850191|NCT01045902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101850192|NCT01045902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101850193|NCT01045902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101850194|NCT01045902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850195|NCT01045902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101850196|NCT01045902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101850197|NCT01045902|Contraceptive Agents|contraceptive agents|mesh-ancestor
101850198|NCT01045902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101850199|NCT01045902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850200|NCT01045902|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101850201|NCT01045902|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101850202|NCT01045902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101850203|NCT01045902|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101850204|NCT01041690|Bevacizumab|bevacizumab|mesh-list
101850205|NCT01041690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101850206|NCT01041690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101850207|NCT01041690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101850208|NCT01041690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101850209|NCT01041690|Growth Substances|growth substances|mesh-ancestor
101850210|NCT01041690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850211|NCT01041690|Growth Inhibitors|growth inhibitors|mesh-ancestor
101850212|NCT00288015|Bevacizumab|bevacizumab|mesh-list
101850213|NCT00288015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101850214|NCT00288015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101850215|NCT00288015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101850216|NCT00288015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101850217|NCT00288015|Growth Substances|growth substances|mesh-ancestor
101850218|NCT00288015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850219|NCT00288015|Growth Inhibitors|growth inhibitors|mesh-ancestor
101850220|NCT00389064|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101850221|NCT00389064|Antidepressive Agents|antidepressive agents|mesh-ancestor
101850222|NCT00389064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101850223|NCT00389064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101850224|NCT00389064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101850225|NCT00389064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101850226|NCT00389064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850227|NCT01068327|Leucovorin|leucovorin|mesh-list
101850228|NCT01068327|Nelfinavir|nelfinavir|mesh-list
101850229|NCT01068327|Gemcitabine|gemcitabine|mesh-list
101850230|NCT01068327|Fluorouracil|fluorouracil|mesh-list
101850231|NCT01068327|Calcium|calcium|mesh-list
101850232|NCT01068327|Levoleucovorin|levoleucovorin|mesh-list
101850233|NCT01068327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101850234|NCT01068327|Antimetabolites|antimetabolites|mesh-ancestor
101850235|NCT01068327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850236|NCT01068327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101850237|NCT01068327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101850238|NCT01068327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850239|NCT01068327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101850240|NCT01068327|Immunologic Factors|immunologic factors|mesh-ancestor
101850241|NCT01068327|Antidotes|antidotes|mesh-ancestor
101850242|NCT01068327|Protective Agents|protective agents|mesh-ancestor
101850243|NCT01068327|Vitamin B Complex|vitamin b complex|mesh-ancestor
101850244|NCT01068327|Vitamins|vitamins|mesh-ancestor
101850245|NCT01068327|Micronutrients|micronutrients|mesh-ancestor
101850246|NCT01068327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101850247|NCT01068327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101850248|NCT01068327|Protease Inhibitors|protease inhibitors|mesh-ancestor
101850249|NCT01068327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101850250|NCT01068327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101850251|NCT01068327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101850252|NCT01068327|Antiviral Agents|antiviral agents|mesh-ancestor
101850253|NCT01068327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101850255|NCT01045980|Ergocalciferols|ergocalciferols|mesh-list
101850256|NCT01045980|Cholecalciferol|cholecalciferol|mesh-list
101850257|NCT01045980|Vitamins|vitamins|mesh-list
101850258|NCT01045980|Micronutrients|micronutrients|mesh-ancestor
101850259|NCT01045980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850260|NCT01045980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101850261|NCT01045980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101850262|NCT00388674|Entecavir|entecavir|mesh-list
101850263|NCT00388674|Antiviral Agents|antiviral agents|mesh-ancestor
101850264|NCT00388674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101850265|NCT00388362|Sirolimus|sirolimus|mesh-list
101850266|NCT00388362|Prednisone|prednisone|mesh-list
101850267|NCT00388362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101850268|NCT00388362|Glucocorticoids|glucocorticoids|mesh-ancestor
101850269|NCT00388362|Hormones|hormones|mesh-ancestor
101850270|NCT00388362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101850271|NCT00388362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850272|NCT00388362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101850273|NCT00388362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101850274|NCT00388362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101850275|NCT00388362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101850276|NCT00388362|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101850277|NCT00388362|Antifungal Agents|antifungal agents|mesh-ancestor
101850278|NCT00388362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101850279|NCT00388362|Immunologic Factors|immunologic factors|mesh-ancestor
101850280|NCT01046058|Simeprevir|simeprevir|mesh-list
101850281|NCT01046058|Antiviral Agents|antiviral agents|mesh-ancestor
101850282|NCT01046058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101850283|NCT01046058|Protease Inhibitors|protease inhibitors|mesh-ancestor
101850284|NCT01046058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101850285|NCT01046058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850286|NCT01046214|Bupropion|bupropion|mesh-list
101850287|NCT01046214|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101850288|NCT01046214|Antidepressive Agents|antidepressive agents|mesh-ancestor
101850289|NCT01046214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101850290|NCT01046214|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101850291|NCT01046214|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101850292|NCT01046214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101850293|NCT01046214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850294|NCT01046214|Dopamine Agents|dopamine agents|mesh-ancestor
101850295|NCT01046214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101850296|NCT01046214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850297|NCT01046214|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101850298|NCT01046214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101850299|NCT01046214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101850300|NCT01324284|Lubiprostone|lubiprostone|mesh-list
101850301|NCT01324284|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101850302|NCT01324284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101850303|NCT01324284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850304|NCT00387894|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101850305|NCT00387894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101850306|NCT00387894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101850307|NCT00387894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101850308|NCT00387894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850309|NCT00387426|Sunitinib|sunitinib|mesh-list
101850310|NCT00387426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101850311|NCT00387426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101850312|NCT00387426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101850313|NCT00387426|Growth Substances|growth substances|mesh-ancestor
101850314|NCT00387426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850315|NCT00387426|Growth Inhibitors|growth inhibitors|mesh-ancestor
101850316|NCT00387426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101850317|NCT00387426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101850318|NCT00387426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850319|NCT00387348|Dexetimide|dexetimide|mesh-list
101850320|NCT00387348|Citalopram|citalopram|mesh-list
101850321|NCT00387348|Escitalopram|escitalopram|mesh-list
101850322|NCT00387348|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101686332|NCT03711305|Carboplatin|carboplatin|mesh-list
101850323|NCT00387348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101850324|NCT00387348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101850325|NCT00387348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850326|NCT00387348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101850327|NCT00387348|Serotonin Agents|serotonin agents|mesh-ancestor
101850328|NCT00387348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850329|NCT00387348|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101850330|NCT00387348|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101850331|NCT00387348|Parasympatholytics|parasympatholytics|mesh-ancestor
101850332|NCT00387348|Autonomic Agents|autonomic agents|mesh-ancestor
101850333|NCT00387348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101850334|NCT00387348|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101850335|NCT00387348|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101850336|NCT00387348|Cholinergic Agents|cholinergic agents|mesh-ancestor
101850337|NCT00387348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101850338|NCT00387348|Antidepressive Agents|antidepressive agents|mesh-ancestor
101850339|NCT00387348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101850340|NCT03992820|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
101850341|NCT03992820|Anesthetics, Local|anesthetics, local|mesh-ancestor
101850342|NCT03992820|Anesthetics|anesthetics|mesh-ancestor
101850343|NCT03992820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101850344|NCT03992820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850345|NCT03992820|Sensory System Agents|sensory system agents|mesh-ancestor
101850346|NCT03992820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101850347|NCT03992820|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
101850348|NCT00413660|Tofacitinib|tofacitinib|mesh-list
101850349|NCT00413660|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101850350|NCT00413660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101850351|NCT00413660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101850352|NCT00413660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850353|NCT01234532|Anastrozole|anastrozole|mesh-list
101850355|NCT01234532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101850356|NCT01234532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101850357|NCT01234532|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101850358|NCT01234532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101850359|NCT01234532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101850360|NCT01234532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850361|NCT01234532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101850362|NCT01234532|Hormone Antagonists|hormone antagonists|mesh-ancestor
101850363|NCT01234532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101850364|NCT01234532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850365|NCT01234532|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101850366|NCT00431444|Zoledronic Acid|zoledronic acid|mesh-list
101239470|NCT01616069|Protective Agents|protective agents|mesh-ancestor
101850367|NCT00431444|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101850368|NCT00431444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101850369|NCT00431444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850370|NCT00431444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101850371|NCT00431444|Hormone Antagonists|hormone antagonists|mesh-ancestor
101850372|NCT00431444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101850373|NCT00431444|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101850374|NCT00431444|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101850375|NCT00430352|Rituximab|rituximab|mesh-list
101850376|NCT00430352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101850377|NCT00430352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101850378|NCT00430352|Immunologic Factors|immunologic factors|mesh-ancestor
101850379|NCT00430352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850380|NCT00430352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101850381|NCT01068405|Methotrexate|methotrexate|mesh-list
101850382|NCT01068405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101850383|NCT01068405|Abortifacient Agents|abortifacient agents|mesh-ancestor
101850384|NCT01068405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101850385|NCT01068405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850386|NCT01068405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101850387|NCT01068405|Antimetabolites|antimetabolites|mesh-ancestor
101850388|NCT01068405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850389|NCT01068405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101850390|NCT01068405|Dermatologic Agents|dermatologic agents|mesh-ancestor
101850391|NCT01068405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686338|NCT03711305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101850392|NCT01068405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101850393|NCT01068405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101850394|NCT01068405|Immunologic Factors|immunologic factors|mesh-ancestor
101850395|NCT01068405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101850396|NCT01068405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101850397|NCT00429572|Fludarabine|fludarabine|mesh-list
101850398|NCT00429572|Melphalan|melphalan|mesh-list
101850399|NCT00429572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101850400|NCT00429572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850401|NCT00429572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101850402|NCT00429572|Immunologic Factors|immunologic factors|mesh-ancestor
101850403|NCT00429572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850404|NCT00429572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101850405|NCT00429572|Alkylating Agents|alkylating agents|mesh-ancestor
101850406|NCT00429572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101850407|NCT00429494|Leuprolide|leuprolide|mesh-list
101850408|NCT00429494|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101239493|NCT01616225|Hormones|hormones|mesh-list
101850409|NCT00429494|Fertility Agents|fertility agents|mesh-ancestor
101850410|NCT00429494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101850411|NCT00429494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850412|NCT00429494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101964723|NCT01082471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101964724|NCT01082471|Narcotics|narcotics|mesh-ancestor
101850413|NCT00429494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101850415|NCT00429416|Cyclophosphamide|cyclophosphamide|mesh-list
101850416|NCT00429416|Fludarabine|fludarabine|mesh-list
101850417|NCT00429416|Fludarabine phosphate|fludarabine phosphate|mesh-list
101850418|NCT00429416|Molgramostim|molgramostim|mesh-list
101850419|NCT00429416|Tacrolimus|tacrolimus|mesh-list
101850420|NCT00429416|Sargramostim|sargramostim|mesh-list
101850421|NCT00429416|Mesna|mesna|mesh-list
101850422|NCT00429416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101850423|NCT00429416|Immunologic Factors|immunologic factors|mesh-ancestor
101850424|NCT00429416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850425|NCT00429416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101850426|NCT00429416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101850427|NCT00429416|Alkylating Agents|alkylating agents|mesh-ancestor
101850428|NCT00429416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850429|NCT00429416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101850430|NCT00429416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101850431|NCT00429416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101850432|NCT00429416|Antimetabolites|antimetabolites|mesh-ancestor
101850433|NCT00429416|Antiviral Agents|antiviral agents|mesh-ancestor
101850434|NCT00429416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101850435|NCT00429416|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101850436|NCT00429416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101850437|NCT00429416|Protective Agents|protective agents|mesh-ancestor
101850438|NCT00429182|Cyclophosphamide|cyclophosphamide|mesh-list
101850439|NCT00429182|Thiotepa|thiotepa|mesh-list
101850440|NCT00429182|Carboplatin|carboplatin|mesh-list
101850441|NCT00429182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101850442|NCT00429182|Immunologic Factors|immunologic factors|mesh-ancestor
101850443|NCT00429182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850444|NCT00429182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101850445|NCT00429182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101850446|NCT00429182|Alkylating Agents|alkylating agents|mesh-ancestor
101850447|NCT00429182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850448|NCT00429182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101850449|NCT00429182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101850450|NCT00429104|Trastuzumab|trastuzumab|mesh-list
101850451|NCT00429104|Sargramostim|sargramostim|mesh-list
101850452|NCT00429104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101850453|NCT00429104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101850454|NCT00429104|Immunologic Factors|immunologic factors|mesh-ancestor
101850455|NCT00429104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850456|NCT00429026|Cyclophosphamide|cyclophosphamide|mesh-list
101850457|NCT00429026|Melphalan|melphalan|mesh-list
101850458|NCT00429026|Fludarabine|fludarabine|mesh-list
101850459|NCT00429026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101850460|NCT00429026|Immunologic Factors|immunologic factors|mesh-ancestor
101850461|NCT00429026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850462|NCT00429026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101850463|NCT00429026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101850464|NCT00429026|Alkylating Agents|alkylating agents|mesh-ancestor
101850465|NCT00429026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850466|NCT00429026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101850467|NCT00429026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101850468|NCT00301821|Prednisone|prednisone|mesh-list
101850469|NCT00301821|Cyclophosphamide|cyclophosphamide|mesh-list
101850470|NCT00301821|Rituximab|rituximab|mesh-list
101850471|NCT00301821|Doxorubicin|doxorubicin|mesh-list
101239517|NCT01616407|Hallucinogens|hallucinogens|mesh-ancestor
101850472|NCT00301821|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101850473|NCT00301821|Vincristine|vincristine|mesh-list
101850474|NCT00301821|Epratuzumab|epratuzumab|mesh-list
101850475|NCT00301821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101850476|NCT00301821|Immunologic Factors|immunologic factors|mesh-ancestor
101850477|NCT00301821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850478|NCT00301821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101850479|NCT00301821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101850480|NCT00301821|Alkylating Agents|alkylating agents|mesh-ancestor
101850481|NCT00301821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850482|NCT00301821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101850484|NCT00301821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101850485|NCT00301821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101850486|NCT00301821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101850487|NCT00301821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101850488|NCT00301821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101850489|NCT00301821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101850490|NCT00301821|Glucocorticoids|glucocorticoids|mesh-ancestor
101850491|NCT00301821|Hormones|hormones|mesh-ancestor
101850492|NCT00301821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101850493|NCT00301821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101850494|NCT00301821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101850495|NCT00301821|Tubulin Modulators|tubulin modulators|mesh-ancestor
101850496|NCT00301821|Antimitotic Agents|antimitotic agents|mesh-ancestor
101850497|NCT00301821|Mitosis Modulators|mitosis modulators|mesh-ancestor
101850498|NCT03976713|Bromides|bromides|mesh-list
101850499|NCT03976713|Tiotropium Bromide|tiotropium bromide|mesh-list
101850500|NCT03976713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101850501|NCT03976713|Autonomic Agents|autonomic agents|mesh-ancestor
101850502|NCT03976713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101850503|NCT03976713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850504|NCT03976713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101850505|NCT03976713|Respiratory System Agents|respiratory system agents|mesh-ancestor
101850506|NCT03976713|Parasympatholytics|parasympatholytics|mesh-ancestor
101850507|NCT03976713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101850508|NCT03976713|Cholinergic Agents|cholinergic agents|mesh-ancestor
101850509|NCT03976713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101850510|NCT03976713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850511|NCT03976713|Anticonvulsants|anticonvulsants|mesh-ancestor
101850512|NCT00372996|Fulvestrant|fulvestrant|mesh-list
101850513|NCT00372996|Exemestane|exemestane|mesh-list
101850514|NCT00372996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101850515|NCT00372996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101850516|NCT00372996|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101850517|NCT00372996|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101850518|NCT00372996|Hormone Antagonists|hormone antagonists|mesh-ancestor
101850519|NCT00372996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101850520|NCT00372996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850521|NCT00372996|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101850522|NCT00372996|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101239530|NCT01616615|Aspirin|aspirin|mesh-list
101850523|NCT00372996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101850524|NCT00372996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850525|NCT00399360|Metformin|metformin|mesh-list
101850526|NCT00399360|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101850527|NCT00399360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850528|NCT00428948|Tolvaptan|tolvaptan|mesh-list
101570329|NCT00960934|Vitamins|vitamins|mesh-ancestor
101850529|NCT00428948|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101850530|NCT00428948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850531|NCT00428948|Natriuretic Agents|natriuretic agents|mesh-ancestor
101850532|NCT00428948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850533|NCT00428792|Methylphenidate|methylphenidate|mesh-list
101850534|NCT00428792|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101850535|NCT00428792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850536|NCT00428792|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101850537|NCT00428792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101850538|NCT00428792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101850539|NCT00428792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850540|NCT00428792|Dopamine Agents|dopamine agents|mesh-ancestor
101850541|NCT00428792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101850542|NCT00300885|Paclitaxel|paclitaxel|mesh-list
101850543|NCT00300885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101850544|NCT00300885|Carboplatin|carboplatin|mesh-list
101850545|NCT00300885|Sorafenib|sorafenib|mesh-list
101850546|NCT00300885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101850547|NCT00300885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101850548|NCT00300885|Tubulin Modulators|tubulin modulators|mesh-ancestor
101850549|NCT00300885|Antimitotic Agents|antimitotic agents|mesh-ancestor
101850550|NCT00300885|Mitosis Modulators|mitosis modulators|mesh-ancestor
101964733|NCT03553498|Analgesics|analgesics|mesh-ancestor
101850551|NCT00300885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850552|NCT00300885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101850553|NCT00300885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101850554|NCT00386334|Eszopiclone|eszopiclone|mesh-list
101850555|NCT00386334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101850556|NCT00386334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101850557|NCT00386334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850558|NCT01143116|Silver Nitrate|silver nitrate|mesh-list
101850559|NCT01143116|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101850560|NCT01143116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101850561|NCT00292227|Moxifloxacin|moxifloxacin|mesh-list
101850562|NCT00292227|Rotigotine|rotigotine|mesh-list
101850563|NCT00292227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101850564|NCT00292227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101850565|NCT00292227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101850566|NCT00292227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101850567|NCT00292227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101850568|NCT00292227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850569|NCT00292227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101850570|NCT00292227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850571|NCT00292227|Dopamine Agonists|dopamine agonists|mesh-ancestor
101850572|NCT00292227|Dopamine Agents|dopamine agents|mesh-ancestor
101850573|NCT00292227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101850574|NCT00386100|Metformin|metformin|mesh-list
101850575|NCT00386100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101850576|NCT00386100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850577|NCT00300495|Amiodarone|amiodarone|mesh-list
101850578|NCT00300495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101850579|NCT00300495|Vasodilator Agents|vasodilator agents|mesh-ancestor
101850580|NCT00300495|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101850581|NCT00300495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101850582|NCT00300495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850583|NCT00300495|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101239550|NCT01616680|Immunoconjugates|immunoconjugates|mesh-list
101850584|NCT00300495|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101850585|NCT00300495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101850586|NCT00300495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101850587|NCT00300495|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101850588|NCT00300495|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101850589|NCT00300495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101850590|NCT03979989|Tapentadol|tapentadol|mesh-list
101850591|NCT03979989|Omeprazole|omeprazole|mesh-list
101850592|NCT03979989|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101850593|NCT03979989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101850594|NCT03979989|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101850596|NCT03979989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850597|NCT03979989|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101850598|NCT03979989|Narcotics|narcotics|mesh-ancestor
101850599|NCT03979989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101850600|NCT03979989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850601|NCT03979989|Analgesics|analgesics|mesh-ancestor
101850602|NCT03979989|Sensory System Agents|sensory system agents|mesh-ancestor
101850603|NCT03979989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101850604|NCT03979989|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101850605|NCT03979989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101850606|NCT03979989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101850607|NCT03979989|Adrenergic Agents|adrenergic agents|mesh-ancestor
101850608|NCT03979989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101850610|NCT01325571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101850611|NCT01325571|Immunologic Factors|immunologic factors|mesh-ancestor
101850612|NCT01325571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850613|NCT01325571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101850614|NCT01325571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101850615|NCT01325571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850616|NCT00386022|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101850617|NCT00386022|Estrogens|estrogens|mesh-list
101850618|NCT00386022|LHRH, N-Ac-2-Nal(1)-4-Cl-Phe(2)-3-Pal(3)-Arg(5)-Glu(6)-AlaNH2(10)-|lhrh, n-ac-2-nal(1)-4-cl-phe(2)-3-pal(3)-arg(5)-glu(6)-alanh2(10)-|mesh-list
101850619|NCT00386022|Hormones|hormones|mesh-ancestor
101850620|NCT00386022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101850621|NCT00386022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850622|NCT00386022|Hormone Antagonists|hormone antagonists|mesh-ancestor
101850623|NCT01068795|Enoxaparin|enoxaparin|mesh-list
101850624|NCT01068795|Anticoagulants|anticoagulants|mesh-ancestor
101850625|NCT01068795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101850626|NCT01068795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101850627|NCT01068795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850628|NCT00286455|Alogliptin|alogliptin|mesh-list
101850629|NCT00286455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101850630|NCT00286455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850631|NCT00286455|Incretins|incretins|mesh-ancestor
101850632|NCT00286455|Hormones|hormones|mesh-ancestor
101850633|NCT00286455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101850634|NCT00286455|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101850635|NCT00286455|Protease Inhibitors|protease inhibitors|mesh-ancestor
101850636|NCT00286455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101850637|NCT00286455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850638|NCT00385944|Clopidogrel|clopidogrel|mesh-list
101850639|NCT00385944|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101850640|NCT00385944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101850641|NCT00385944|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101850642|NCT00385944|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101850643|NCT00385944|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101850644|NCT00385944|Purinergic Agents|purinergic agents|mesh-ancestor
101850645|NCT00385944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101850646|NCT00385944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850647|NCT00385944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850648|NCT00286221|Fentanyl|fentanyl|mesh-list
101850649|NCT00286221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101850650|NCT00286221|Narcotics|narcotics|mesh-ancestor
101850651|NCT00286221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101850652|NCT00286221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850653|NCT00286221|Analgesics|analgesics|mesh-ancestor
101850654|NCT00286221|Sensory System Agents|sensory system agents|mesh-ancestor
101850655|NCT00286221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101850656|NCT00286221|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101850657|NCT00286221|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101850658|NCT00286221|Anesthetics, General|anesthetics, general|mesh-ancestor
101850659|NCT00286221|Anesthetics|anesthetics|mesh-ancestor
101850660|NCT00398112|Sunitinib|sunitinib|mesh-list
101850661|NCT00398112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101850662|NCT00398112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101850663|NCT00398112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101850664|NCT00398112|Growth Substances|growth substances|mesh-ancestor
101850665|NCT00398112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850666|NCT00398112|Growth Inhibitors|growth inhibitors|mesh-ancestor
101850667|NCT00398112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101850668|NCT00398112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101850669|NCT00398112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850670|NCT01065129|Plerixafor|plerixafor|mesh-list
101850671|NCT01065129|Azacitidine|azacitidine|mesh-list
101850672|NCT01065129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101850673|NCT01065129|Antimetabolites|antimetabolites|mesh-ancestor
101850674|NCT01065129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850675|NCT01065129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101850676|NCT01065129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101850677|NCT01065129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101850678|NCT01065129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101850679|NCT01065129|Antiviral Agents|antiviral agents|mesh-ancestor
101850680|NCT01065129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101850681|NCT01042314|Donepezil|donepezil|mesh-list
101850682|NCT01042314|BMS 708163|bms 708163|mesh-list
101850683|NCT01042314|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101850684|NCT01042314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101850685|NCT01042314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850686|NCT01042314|Cholinergic Agents|cholinergic agents|mesh-ancestor
101850687|NCT01042314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101850688|NCT01042314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850689|NCT01042314|Nootropic Agents|nootropic agents|mesh-ancestor
101850690|NCT01042314|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101850691|NCT00372528|Pregabalin|pregabalin|mesh-list
101850692|NCT00372528|Analgesics|analgesics|mesh-ancestor
101850693|NCT00372528|Sensory System Agents|sensory system agents|mesh-ancestor
101850694|NCT00372528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101850695|NCT00372528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850696|NCT00372528|Anticonvulsants|anticonvulsants|mesh-ancestor
101850697|NCT00372528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101850698|NCT00372528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101850699|NCT00372528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850700|NCT00372528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101850701|NCT00372528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101850702|NCT00372528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101850703|NCT00372528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101850704|NCT00372528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101850705|NCT00283803|Sulindac sulfone|sulindac sulfone|mesh-list
101850706|NCT00283803|Hormones|hormones|mesh-list
101850707|NCT00283803|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101850708|NCT00283803|Androgen Antagonists|androgen antagonists|mesh-list
101850709|NCT00283803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101850710|NCT00283803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850711|NCT00283803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101850712|NCT00283803|Hormone Antagonists|hormone antagonists|mesh-ancestor
101850713|NCT00283803|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101850714|NCT00283803|Protective Agents|protective agents|mesh-ancestor
101850715|NCT00283803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101850716|NCT00283803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101850717|NCT00283803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850718|NCT00283803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101850719|NCT00283803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101850720|NCT00283803|Analgesics|analgesics|mesh-ancestor
101850721|NCT00283803|Sensory System Agents|sensory system agents|mesh-ancestor
101850722|NCT00283803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101850723|NCT00283803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101850724|NCT00283803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101850725|NCT01044810|Efavirenz|efavirenz|mesh-list
101850726|NCT01044810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101850727|NCT01044810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101850728|NCT01044810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101850729|NCT01044810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850730|NCT01044810|Antiviral Agents|antiviral agents|mesh-ancestor
101850731|NCT01044810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101850732|NCT01044810|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101850733|NCT01044810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101686362|NCT05000658|Autonomic Agents|autonomic agents|mesh-ancestor
101850734|NCT01044810|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101850735|NCT01044810|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101850736|NCT01044810|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101850737|NCT01044810|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101850738|NCT01033370|Clevidipine|clevidipine|mesh-list
101850739|NCT01033370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101850740|NCT01033370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101850741|NCT01033370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850742|NCT01033370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101850743|NCT01033370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850744|NCT01044888|Heparin|heparin|mesh-list
101850745|NCT01044888|Anticoagulants|anticoagulants|mesh-ancestor
101850746|NCT01044888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101850747|NCT01044888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101850748|NCT01044888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101570554|NCT00887809|Gemcitabine|gemcitabine|mesh-list
101850750|NCT03742466|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101850751|NCT03742466|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101850752|NCT03742466|Prednisolone|prednisolone|mesh-list
101850753|NCT03742466|Prednisolone acetate|prednisolone acetate|mesh-list
101850754|NCT03742466|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101850755|NCT03742466|Prednisolone phosphate|prednisolone phosphate|mesh-list
101850756|NCT03742466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101850757|NCT03742466|Antiemetics|antiemetics|mesh-ancestor
101850758|NCT03742466|Autonomic Agents|autonomic agents|mesh-ancestor
101850759|NCT03742466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101850760|NCT03742466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850761|NCT03742466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101850762|NCT03742466|Glucocorticoids|glucocorticoids|mesh-ancestor
101850763|NCT03742466|Hormones|hormones|mesh-ancestor
101850764|NCT03742466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101850765|NCT03742466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101850766|NCT03742466|Protective Agents|protective agents|mesh-ancestor
101850767|NCT03742466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101850768|NCT03742466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101850769|NCT01065285|Vaccines|vaccines|mesh-list
101850770|NCT01065285|Immunologic Factors|immunologic factors|mesh-ancestor
101850771|NCT01065285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850772|NCT01033526|Aspirin|aspirin|mesh-list
101850773|NCT01033526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101850774|NCT01033526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101850775|NCT01033526|Analgesics|analgesics|mesh-ancestor
101850776|NCT01033526|Sensory System Agents|sensory system agents|mesh-ancestor
101239584|NCT01616966|Remifentanil|remifentanil|mesh-list
101850777|NCT01033526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101850778|NCT01033526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850779|NCT01033526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101850780|NCT01033526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101850781|NCT01033526|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101850782|NCT01033526|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101850783|NCT01033526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850784|NCT01033526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101850785|NCT01033526|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101850786|NCT01033526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101850787|NCT01033526|Antipyretics|antipyretics|mesh-ancestor
101850788|NCT00397488|Sunitinib|sunitinib|mesh-list
101850789|NCT00397488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101850790|NCT00397488|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101850791|NCT00397488|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101850792|NCT00397488|Growth Substances|growth substances|mesh-ancestor
101850793|NCT00397488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850794|NCT00397488|Growth Inhibitors|growth inhibitors|mesh-ancestor
101850795|NCT00397488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101850796|NCT00397488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101850797|NCT00397488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850798|NCT01581411|Plasminogen|plasminogen|mesh-list
101850799|NCT01581411|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101850800|NCT01581411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101964776|NCT03963479|Vitamin B 6|vitamin b 6|mesh-list
101850801|NCT01581411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101850802|NCT01581411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850803|NCT02900664|Trametinib|trametinib|mesh-list
101850804|NCT02900664|Spartalizumab|spartalizumab|mesh-list
101850805|NCT02900664|Nazartinib|nazartinib|mesh-list
101850806|NCT02900664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101850807|NCT02900664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101850808|NCT02900664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101850809|NCT02900664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850810|NCT02900664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101850811|NCT02900664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101850812|NCT01324596|Prednisolone|prednisolone|mesh-list
101850813|NCT01324596|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101850814|NCT01324596|Methylprednisolone|methylprednisolone|mesh-list
101239591|NCT01616966|Anesthetics, General|anesthetics, general|mesh-ancestor
101850815|NCT01324596|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101850816|NCT01324596|Prednisolone acetate|prednisolone acetate|mesh-list
101850817|NCT01324596|Cyclophosphamide|cyclophosphamide|mesh-list
101850818|NCT01324596|Rituximab|rituximab|mesh-list
101850819|NCT01324596|Doxorubicin|doxorubicin|mesh-list
101850820|NCT01324596|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101850821|NCT01324596|Vincristine|vincristine|mesh-list
101850822|NCT01324596|Bortezomib|bortezomib|mesh-list
101850823|NCT01324596|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101850824|NCT01324596|Prednisolone phosphate|prednisolone phosphate|mesh-list
101850825|NCT01324596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101850826|NCT01324596|Immunologic Factors|immunologic factors|mesh-ancestor
101850827|NCT01324596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850828|NCT01324596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101850829|NCT01324596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101850830|NCT01324596|Alkylating Agents|alkylating agents|mesh-ancestor
101850831|NCT01324596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850832|NCT01324596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101850833|NCT01324596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101850834|NCT01324596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101850835|NCT01324596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101850836|NCT01324596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101850837|NCT01324596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101850838|NCT01324596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101850839|NCT01324596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101850840|NCT01324596|Tubulin Modulators|tubulin modulators|mesh-ancestor
101850841|NCT01324596|Antimitotic Agents|antimitotic agents|mesh-ancestor
101850842|NCT01324596|Mitosis Modulators|mitosis modulators|mesh-ancestor
101850843|NCT01324596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101850844|NCT01324596|Glucocorticoids|glucocorticoids|mesh-ancestor
101850846|NCT01324596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101850847|NCT01324596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101850848|NCT01324596|Antiemetics|antiemetics|mesh-ancestor
101850849|NCT01324596|Autonomic Agents|autonomic agents|mesh-ancestor
101850850|NCT01324596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101850851|NCT01324596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101850852|NCT01324596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101850853|NCT01324596|Protective Agents|protective agents|mesh-ancestor
101850854|NCT00424190|Vancomycin|vancomycin|mesh-list
101850855|NCT00424190|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
101850856|NCT00424190|Aztreonam|aztreonam|mesh-list
101850857|NCT00424190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101850858|NCT00424190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101850859|NCT02859012|Axitinib|axitinib|mesh-list
101850860|NCT02859012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101850861|NCT02859012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101850862|NCT02859012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101850863|NCT02859012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850864|NCT00274287|Sargramostim|sargramostim|mesh-list
101850865|NCT00274287|Immunologic Factors|immunologic factors|mesh-ancestor
101850866|NCT00274287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850867|NCT01045278|Interferons|interferons|mesh-list
101850868|NCT01045278|Ribavirin|ribavirin|mesh-list
101850869|NCT01045278|Interferon-alpha|interferon-alpha|mesh-list
101850870|NCT01045278|Interferon alpha-2|interferon alpha-2|mesh-list
101850871|NCT01045278|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101850872|NCT01045278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101850873|NCT01045278|Antiviral Agents|antiviral agents|mesh-ancestor
101850874|NCT01045278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101964783|NCT02228512|Prednisone|prednisone|mesh-list
101850875|NCT01045278|Antimetabolites|antimetabolites|mesh-ancestor
101850876|NCT01045278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850877|NCT01045278|Immunologic Factors|immunologic factors|mesh-ancestor
101850878|NCT01045278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850879|NCT00423800|Interferons|interferons|mesh-list
101850880|NCT00423800|Ribavirin|ribavirin|mesh-list
101850881|NCT00423800|Interferon-alpha|interferon-alpha|mesh-list
101850882|NCT00423800|Interferon alpha-2|interferon alpha-2|mesh-list
101850883|NCT00423800|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101850884|NCT00423800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101850885|NCT00423800|Antiviral Agents|antiviral agents|mesh-ancestor
101850886|NCT00423800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101850887|NCT00423800|Antimetabolites|antimetabolites|mesh-ancestor
101850888|NCT00423800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850889|NCT00423800|Immunologic Factors|immunologic factors|mesh-ancestor
101850890|NCT00423800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850891|NCT00405548|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101850892|NCT00405548|Natriuretic Agents|natriuretic agents|mesh-ancestor
101850893|NCT00405548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850894|NCT00405392|Ibandronic Acid|ibandronic acid|mesh-list
101850895|NCT00405392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101850896|NCT00405392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850897|NCT00282243|Tacrolimus|tacrolimus|mesh-list
101850898|NCT00282243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101850899|NCT00282243|Immunologic Factors|immunologic factors|mesh-ancestor
101850900|NCT00282243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850901|NCT00282243|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101850902|NCT00282243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101850903|NCT00282243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850904|NCT00272961|N-(2-acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl)thiophene-2-carboxamide|n-(2-acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl)thiophene-2-carboxamide|mesh-list
101850905|NCT00272961|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101850906|NCT00272961|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101850907|NCT00272961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850909|NCT00282087|Docetaxel|docetaxel|mesh-list
101850910|NCT00282087|Doxorubicin|doxorubicin|mesh-list
101850911|NCT00282087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101850912|NCT00282087|Antimetabolites|antimetabolites|mesh-ancestor
101850913|NCT00282087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850914|NCT00282087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101850915|NCT00282087|Tubulin Modulators|tubulin modulators|mesh-ancestor
101850916|NCT00282087|Antimitotic Agents|antimitotic agents|mesh-ancestor
101850917|NCT00282087|Mitosis Modulators|mitosis modulators|mesh-ancestor
101850918|NCT00282087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101850919|NCT00282087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101850920|NCT00282087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101850921|NCT00282087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101850922|NCT00281697|Bevacizumab|bevacizumab|mesh-list
101850923|NCT00281697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101850924|NCT00281697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101850925|NCT00281697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101850926|NCT00281697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101850927|NCT00281697|Growth Substances|growth substances|mesh-ancestor
101850928|NCT00281697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850929|NCT00281697|Growth Inhibitors|growth inhibitors|mesh-ancestor
101850930|NCT00232180|Eplerenone|eplerenone|mesh-list
101850931|NCT00232180|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101850932|NCT00232180|Hormone Antagonists|hormone antagonists|mesh-ancestor
101850933|NCT00232180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101850934|NCT00232180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850935|NCT00232180|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101850936|NCT00232180|Diuretics|diuretics|mesh-ancestor
101850937|NCT00232180|Natriuretic Agents|natriuretic agents|mesh-ancestor
101850938|NCT00232180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101850939|NCT01070277|Albendazole|albendazole|mesh-list
101850940|NCT01070277|Tinidazole|tinidazole|mesh-list
101850941|NCT01070277|Anthelmintics|anthelmintics|mesh-ancestor
101850942|NCT01070277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101850943|NCT01070277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101850944|NCT01070277|Anticestodal Agents|anticestodal agents|mesh-ancestor
101850945|NCT01070277|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101850946|NCT01070277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101850947|NCT01070277|Tubulin Modulators|tubulin modulators|mesh-ancestor
101850948|NCT01070277|Antimitotic Agents|antimitotic agents|mesh-ancestor
101850949|NCT01070277|Mitosis Modulators|mitosis modulators|mesh-ancestor
101850950|NCT01070277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850951|NCT01070277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101850952|NCT01070277|Alkylating Agents|alkylating agents|mesh-ancestor
101850953|NCT01070277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101850954|NCT01070277|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
101850956|NCT00270231|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101850957|NCT00270231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101850958|NCT00270231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850959|NCT00270231|Sensory System Agents|sensory system agents|mesh-ancestor
101850960|NCT00270231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101850961|NCT02532309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101850962|NCT02532309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101850963|NCT02532309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101850964|NCT02532309|Antimetabolites|antimetabolites|mesh-ancestor
101850965|NCT02532309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850966|NCT02532309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101850967|NCT02532309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101850968|NCT02532309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101850969|NCT00258856|Vaccines|vaccines|mesh-list
101850970|NCT00258856|Immunologic Factors|immunologic factors|mesh-ancestor
101850971|NCT00258856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850972|NCT00269919|Risperidone|risperidone|mesh-list
101850973|NCT00269919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101850974|NCT00269919|Serotonin Agents|serotonin agents|mesh-ancestor
101850975|NCT00269919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101850976|NCT00269919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101850977|NCT00269919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850978|NCT00269919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101850979|NCT00269919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101850980|NCT00269919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101850981|NCT00269919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101850982|NCT00269919|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101850983|NCT00269919|Dopamine Agents|dopamine agents|mesh-ancestor
101850984|NCT00257920|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
101850985|NCT00257920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850986|NCT00257920|Vitamins|vitamins|mesh-ancestor
101850987|NCT00257920|Micronutrients|micronutrients|mesh-ancestor
101850988|NCT00257920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101850990|NCT00268983|Rituximab|rituximab|mesh-list
101850991|NCT00268983|Tositumomab I-131|tositumomab i-131|mesh-list
101850992|NCT00268983|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101850993|NCT00268983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101850994|NCT00268983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101850995|NCT00268983|Immunologic Factors|immunologic factors|mesh-ancestor
101850996|NCT00268983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101850997|NCT00268983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101850998|NCT00268983|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101850999|NCT00268983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101851000|NCT00268983|Trace Elements|trace elements|mesh-ancestor
101851001|NCT00268983|Micronutrients|micronutrients|mesh-ancestor
101851002|NCT01070511|Tadalafil|tadalafil|mesh-list
101851003|NCT01070511|Vasodilator Agents|vasodilator agents|mesh-ancestor
101851004|NCT01070511|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101851005|NCT01070511|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101851006|NCT01070511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101239653|NCT01617213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101851007|NCT01070511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851008|NCT01070511|Urological Agents|urological agents|mesh-ancestor
101851009|NCT01070667|Dronedarone|dronedarone|mesh-list
101851010|NCT01070667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101851011|NCT00257608|Bevacizumab|bevacizumab|mesh-list
101851012|NCT00257608|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101851013|NCT00257608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101851014|NCT00257608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101851015|NCT00257608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101851016|NCT00257608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101851017|NCT00257608|Growth Substances|growth substances|mesh-ancestor
101851018|NCT00257608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851019|NCT00257608|Growth Inhibitors|growth inhibitors|mesh-ancestor
101851022|NCT00257608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851023|NCT00231478|Granisetron|granisetron|mesh-list
101851024|NCT00231478|Antiemetics|antiemetics|mesh-ancestor
101851025|NCT00231478|Autonomic Agents|autonomic agents|mesh-ancestor
101851026|NCT00231478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101851027|NCT00231478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851028|NCT00231478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101851029|NCT00231478|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101851030|NCT00231478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101851031|NCT00231478|Serotonin Agents|serotonin agents|mesh-ancestor
101851032|NCT00231478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101851033|NCT00231478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851034|NCT00207142|Ritonavir|ritonavir|mesh-list
101851035|NCT00207142|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101851036|NCT00207142|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101851037|NCT00207142|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101851038|NCT00207142|Protease Inhibitors|protease inhibitors|mesh-ancestor
101851039|NCT00207142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101851040|NCT00207142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851041|NCT00207142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101851042|NCT00207142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101851043|NCT00207142|Antiviral Agents|antiviral agents|mesh-ancestor
101851044|NCT00207142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101851045|NCT00207142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101851046|NCT00207142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101570852|NCT02823691|Lanreotide|lanreotide|mesh-list
101851047|NCT00268905|Carboplatin|carboplatin|mesh-list
101851048|NCT00268905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101851049|NCT00206518|Docetaxel|docetaxel|mesh-list
101851050|NCT00206518|Doxorubicin|doxorubicin|mesh-list
101851051|NCT00206518|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101851052|NCT00206518|Cyclophosphamide|cyclophosphamide|mesh-list
101851053|NCT00206518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101851054|NCT00206518|Tubulin Modulators|tubulin modulators|mesh-ancestor
101851055|NCT00206518|Antimitotic Agents|antimitotic agents|mesh-ancestor
101851056|NCT00206518|Mitosis Modulators|mitosis modulators|mesh-ancestor
101851057|NCT00206518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851058|NCT00206518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101851059|NCT00206518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101851060|NCT00206518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101851061|NCT00206518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101851062|NCT00206518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101851063|NCT00206518|Immunologic Factors|immunologic factors|mesh-ancestor
101851064|NCT00206518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851065|NCT00206518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101851066|NCT00206518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101851067|NCT00206518|Alkylating Agents|alkylating agents|mesh-ancestor
101851068|NCT00206518|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101851069|NCT00206440|Esomeprazole|esomeprazole|mesh-list
101851070|NCT00206440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101851071|NCT00206440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101851072|NCT00206440|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101851073|NCT00206440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101851074|NCT00206440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851075|NCT00268437|Carboplatin|carboplatin|mesh-list
101851076|NCT00268437|Pemetrexed|pemetrexed|mesh-list
101851077|NCT00268437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101851078|NCT00268437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101851079|NCT00268437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851080|NCT00268437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101851081|NCT00268437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101851082|NCT00423488|Simvastatin|simvastatin|mesh-list
101851083|NCT00423488|Ezetimibe|ezetimibe|mesh-list
101851084|NCT00423488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101851085|NCT00423488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101851086|NCT00423488|Antimetabolites|antimetabolites|mesh-ancestor
101851087|NCT00423488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851088|NCT00423488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101851089|NCT00423488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101851090|NCT00423488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101851091|NCT00404066|Dexamethasone|dexamethasone|mesh-list
101851092|NCT00404066|Cyclophosphamide|cyclophosphamide|mesh-list
101851093|NCT00404066|Docetaxel|docetaxel|mesh-list
101851094|NCT00404066|Doxorubicin|doxorubicin|mesh-list
101851095|NCT00404066|Trastuzumab|trastuzumab|mesh-list
101851096|NCT00404066|Lapatinib|lapatinib|mesh-list
101851097|NCT00404066|Lenograstim|lenograstim|mesh-list
101851098|NCT00404066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101851099|NCT00404066|Immunologic Factors|immunologic factors|mesh-ancestor
101851100|NCT00404066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851101|NCT00404066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101851102|NCT00404066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101851103|NCT00404066|Alkylating Agents|alkylating agents|mesh-ancestor
101851104|NCT00404066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851105|NCT00404066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101851106|NCT00404066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101851107|NCT00404066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101851108|NCT00404066|Antiemetics|antiemetics|mesh-ancestor
101851109|NCT00404066|Autonomic Agents|autonomic agents|mesh-ancestor
101851110|NCT00404066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101851111|NCT00404066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101851112|NCT00404066|Glucocorticoids|glucocorticoids|mesh-ancestor
101851113|NCT00404066|Hormones|hormones|mesh-ancestor
101851114|NCT00404066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101851115|NCT00404066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101851116|NCT00404066|Tubulin Modulators|tubulin modulators|mesh-ancestor
101851117|NCT00404066|Antimitotic Agents|antimitotic agents|mesh-ancestor
101851118|NCT00404066|Mitosis Modulators|mitosis modulators|mesh-ancestor
101851119|NCT00404066|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101851120|NCT00404066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101851121|NCT00404066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101851122|NCT00404066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101851123|NCT00404066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101851124|NCT00404066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101851125|NCT00404066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101851127|NCT00423332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101851128|NCT00423332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101851129|NCT00423332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101851130|NCT00423332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851131|NCT00413036|Lenalidomide|lenalidomide|mesh-list
101851132|NCT00413036|Immunologic Factors|immunologic factors|mesh-ancestor
101851133|NCT00413036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851134|NCT00413036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101851135|NCT00413036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101851136|NCT00413036|Growth Substances|growth substances|mesh-ancestor
101851137|NCT00413036|Growth Inhibitors|growth inhibitors|mesh-ancestor
101851138|NCT00413036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101851139|NCT00412958|Plasminogen|plasminogen|mesh-list
101851140|NCT00412958|Fibrinolysin|fibrinolysin|mesh-list
101851141|NCT00412958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101851142|NCT00412958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101851143|NCT00412958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851144|NCT00423176|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101851145|NCT00423176|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101851146|NCT00423176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101851147|NCT00423176|Antitubercular Agents|antitubercular agents|mesh-ancestor
101851148|NCT01040702|Methylphenidate|methylphenidate|mesh-list
101851149|NCT01040702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101851150|NCT01040702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851151|NCT01040702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101851152|NCT01040702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101851153|NCT01040702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101851154|NCT01040702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851155|NCT01040702|Dopamine Agents|dopamine agents|mesh-ancestor
101851156|NCT01040702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101851157|NCT00268203|Tositumomab I-131|tositumomab i-131|mesh-list
101851158|NCT00268203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101851159|NCT00384930|Tadalafil|tadalafil|mesh-list
101851160|NCT00384930|Vasodilator Agents|vasodilator agents|mesh-ancestor
101851161|NCT00384930|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101851162|NCT00384930|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101851163|NCT00384930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101851164|NCT00384930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851165|NCT00384930|Urological Agents|urological agents|mesh-ancestor
101851166|NCT00423098|Mycophenolic Acid|mycophenolic acid|mesh-list
101851168|NCT00423098|Methylprednisolone|methylprednisolone|mesh-list
101851169|NCT00423098|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101851170|NCT00423098|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101851171|NCT00423098|Prednisolone|prednisolone|mesh-list
101851172|NCT00423098|Prednisolone acetate|prednisolone acetate|mesh-list
101851173|NCT00423098|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101851174|NCT00423098|Prednisolone phosphate|prednisolone phosphate|mesh-list
101851175|NCT00423098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101851176|NCT00423098|Glucocorticoids|glucocorticoids|mesh-ancestor
101851177|NCT00423098|Hormones|hormones|mesh-ancestor
101851178|NCT00423098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101851179|NCT00423098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851180|NCT00423098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101851181|NCT00423098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101851182|NCT00423098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101851183|NCT00423098|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101851184|NCT00423098|Antitubercular Agents|antitubercular agents|mesh-ancestor
101851185|NCT00423098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101851186|NCT00423098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101851187|NCT00423098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101851188|NCT00423098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851189|NCT00423098|Antiemetics|antiemetics|mesh-ancestor
101851190|NCT00423098|Autonomic Agents|autonomic agents|mesh-ancestor
101851191|NCT00423098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101851192|NCT00423098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101851193|NCT00423098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101851194|NCT00423098|Protective Agents|protective agents|mesh-ancestor
101851195|NCT01042704|Aspirin|aspirin|mesh-list
101571000|NCT01061151|Nevirapine|nevirapine|mesh-list
101851196|NCT01042704|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101851197|NCT01042704|Dexamethasone|dexamethasone|mesh-list
101851198|NCT01042704|Lenalidomide|lenalidomide|mesh-list
101851199|NCT01042704|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101851200|NCT01042704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101851202|NCT01042704|Autonomic Agents|autonomic agents|mesh-ancestor
101851203|NCT01042704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101851204|NCT01042704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851205|NCT01042704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101851206|NCT01042704|Glucocorticoids|glucocorticoids|mesh-ancestor
101851207|NCT01042704|Hormones|hormones|mesh-ancestor
101851208|NCT01042704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101851209|NCT01042704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101851210|NCT01042704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101851211|NCT01042704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101851212|NCT01042704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101851213|NCT01042704|Analgesics|analgesics|mesh-ancestor
101851214|NCT01042704|Sensory System Agents|sensory system agents|mesh-ancestor
101851215|NCT01042704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101851216|NCT01042704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101851217|NCT01042704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101851218|NCT01042704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851219|NCT01042704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101851220|NCT01042704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101851221|NCT01042704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101851222|NCT01042704|Antipyretics|antipyretics|mesh-ancestor
101851223|NCT01042704|Immunologic Factors|immunologic factors|mesh-ancestor
101851224|NCT01042704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101851225|NCT01042704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101851226|NCT01042704|Growth Substances|growth substances|mesh-ancestor
101851227|NCT01042704|Growth Inhibitors|growth inhibitors|mesh-ancestor
101851228|NCT01042704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101851229|NCT01042704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101851230|NCT01042704|Alkylating Agents|alkylating agents|mesh-ancestor
101851231|NCT00750698|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101851232|NCT00750698|Entinostat|entinostat|mesh-list
101851233|NCT00750698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101851234|NCT00750698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101851235|NCT00750698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686385|NCT04211298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101851236|NCT00750698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851237|NCT00750698|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101851239|NCT01046838|Vasodilator Agents|vasodilator agents|mesh-ancestor
101851240|NCT01046838|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101851241|NCT01046838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101851242|NCT01046838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101851243|NCT01046838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851244|NCT01046838|Urological Agents|urological agents|mesh-ancestor
101851245|NCT01042782|Everolimus|everolimus|mesh-list
101851246|NCT01042782|Mitomycin|mitomycin|mesh-list
101851247|NCT01042782|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101851248|NCT01042782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101851249|NCT01042782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101851250|NCT01042782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851251|NCT01042782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101851252|NCT01042782|Immunologic Factors|immunologic factors|mesh-ancestor
101851253|NCT01042782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851254|NCT01042782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101851255|NCT01042782|Alkylating Agents|alkylating agents|mesh-ancestor
101851256|NCT01042782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101851257|NCT01042782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101851258|NCT00411788|Sirolimus|sirolimus|mesh-list
101851259|NCT00411788|Trastuzumab|trastuzumab|mesh-list
101851260|NCT00411788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101851261|NCT00411788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101851262|NCT00411788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101851263|NCT00411788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101851264|NCT00411788|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101851265|NCT00411788|Antifungal Agents|antifungal agents|mesh-ancestor
101851266|NCT00411788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101851267|NCT00411788|Immunologic Factors|immunologic factors|mesh-ancestor
101851268|NCT00411788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851269|NCT01046994|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101851270|NCT01046994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851271|NCT01040936|Atorvastatin|atorvastatin|mesh-list
101851272|NCT01040936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101851273|NCT01040936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101851274|NCT01040936|Antimetabolites|antimetabolites|mesh-ancestor
101851275|NCT01040936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851276|NCT01040936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101851277|NCT01040936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101851278|NCT01040936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101851279|NCT01041092|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101851280|NCT01041092|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101851281|NCT01041092|Hormone Antagonists|hormone antagonists|mesh-ancestor
101851282|NCT01041092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101851283|NCT01041092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851284|NCT01041092|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101851285|NCT01041092|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101851286|NCT01041092|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101851287|NCT01041170|Rimonabant|rimonabant|mesh-list
101851288|NCT01041170|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101851289|NCT01041170|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
101851290|NCT01041170|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101851291|NCT01041170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101851292|NCT01041170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851293|NCT01041170|Hormones|hormones|mesh-ancestor
101851294|NCT01041170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101851296|NCT01041482|Sorafenib|sorafenib|mesh-list
101851297|NCT01041482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101851298|NCT01041482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101851299|NCT01041482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101851300|NCT01041482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851301|NCT00422942|Rituximab|rituximab|mesh-list
101851302|NCT00422942|Methotrexate|methotrexate|mesh-list
101851303|NCT00422942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101851304|NCT00422942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101851305|NCT00422942|Immunologic Factors|immunologic factors|mesh-ancestor
101851306|NCT00422942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851307|NCT00422942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101851308|NCT00422942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101851309|NCT00422942|Abortifacient Agents|abortifacient agents|mesh-ancestor
101851310|NCT00422942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101851311|NCT00422942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101851313|NCT00422942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851314|NCT00422942|Dermatologic Agents|dermatologic agents|mesh-ancestor
101851315|NCT00422942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101851316|NCT00422942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101851317|NCT00422942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101851318|NCT00422942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101851319|NCT01039142|Acitretin|acitretin|mesh-list
101851320|NCT01039142|Keratolytic Agents|keratolytic agents|mesh-ancestor
101851321|NCT01039142|Dermatologic Agents|dermatologic agents|mesh-ancestor
101851322|NCT00422162|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101851323|NCT00422162|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101851324|NCT00422162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101851325|NCT00422162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101851326|NCT00422162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851327|NCT00422162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101851328|NCT00422162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851329|NCT00422162|Analgesics|analgesics|mesh-ancestor
101851330|NCT00422162|Sensory System Agents|sensory system agents|mesh-ancestor
101851331|NCT00422162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101851332|NCT00422162|Antidepressive Agents|antidepressive agents|mesh-ancestor
101851333|NCT00422162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101851334|NCT00422162|Dopamine Agents|dopamine agents|mesh-ancestor
101851335|NCT00411632|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101851336|NCT00411632|Bexarotene|bexarotene|mesh-list
101851337|NCT00411632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101851338|NCT00411632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101851339|NCT00411632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101851340|NCT00411632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851341|NCT00422084|Artesunate|artesunate|mesh-list
101851342|NCT00422084|Lumefantrine|lumefantrine|mesh-list
101851343|NCT00422084|Artemether|artemether|mesh-list
101851344|NCT00422084|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101851346|NCT00422084|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
101851347|NCT00422084|Antimalarials|antimalarials|mesh-ancestor
101851348|NCT00422084|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101851349|NCT00422084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101851350|NCT00422084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101851351|NCT00422084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101851352|NCT00422084|Antiviral Agents|antiviral agents|mesh-ancestor
101851353|NCT00422084|Schistosomicides|schistosomicides|mesh-ancestor
101851354|NCT00422084|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101851355|NCT00422084|Anthelmintics|anthelmintics|mesh-ancestor
101851356|NCT00421928|Oxycodone|oxycodone|mesh-list
101851357|NCT00421928|Tapentadol|tapentadol|mesh-list
101851358|NCT00421928|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101851359|NCT00421928|Narcotics|narcotics|mesh-ancestor
101851360|NCT00421928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101851361|NCT00421928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851362|NCT00421928|Analgesics|analgesics|mesh-ancestor
101851363|NCT00421928|Sensory System Agents|sensory system agents|mesh-ancestor
101851364|NCT00421928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101851365|NCT00421928|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101851366|NCT00421928|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101851367|NCT00421928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101851368|NCT00421928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851369|NCT00421928|Adrenergic Agents|adrenergic agents|mesh-ancestor
101851370|NCT00421928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101851371|NCT01047072|Mycophenolic Acid|mycophenolic acid|mesh-list
101851372|NCT01047072|Cyclophosphamide|cyclophosphamide|mesh-list
101851373|NCT01047072|Rituximab|rituximab|mesh-list
101851374|NCT01047072|Fludarabine|fludarabine|mesh-list
101851375|NCT01047072|Fludarabine phosphate|fludarabine phosphate|mesh-list
101851376|NCT01047072|Tacrolimus|tacrolimus|mesh-list
101851377|NCT01047072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101851378|NCT01047072|Immunologic Factors|immunologic factors|mesh-ancestor
101851379|NCT01047072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851380|NCT01047072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101851381|NCT01047072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101851382|NCT01047072|Alkylating Agents|alkylating agents|mesh-ancestor
101851383|NCT01047072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851384|NCT01047072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101851385|NCT01047072|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101851386|NCT01047072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101851387|NCT01047072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101851388|NCT01047072|Antimetabolites|antimetabolites|mesh-ancestor
101851389|NCT01047072|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101851390|NCT01047072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101851391|NCT01047072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101851392|NCT01047072|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101851393|NCT01047072|Antitubercular Agents|antitubercular agents|mesh-ancestor
101851394|NCT01047072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101851395|NCT01047072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101851396|NCT00372060|Pioglitazone|pioglitazone|mesh-list
101851397|NCT00372060|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101851398|NCT00372060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101851399|NCT00372060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851400|NCT00372060|Incretins|incretins|mesh-ancestor
101851401|NCT00372060|Hormones|hormones|mesh-ancestor
101851402|NCT00372060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101239700|NCT01617590|Methotrexate|methotrexate|mesh-list
101851403|NCT00372060|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101851404|NCT00372060|Protease Inhibitors|protease inhibitors|mesh-ancestor
101851405|NCT00372060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101851406|NCT00372060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851407|NCT01043172|Gemcitabine|gemcitabine|mesh-list
101851408|NCT01043172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101851409|NCT01043172|Antimetabolites|antimetabolites|mesh-ancestor
101851410|NCT01043172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851411|NCT01043172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101851412|NCT01045434|Omeprazole|omeprazole|mesh-list
101851413|NCT01045434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101851414|NCT01045434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101851415|NCT01045434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101851416|NCT01045434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101851417|NCT01045434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851418|NCT01043484|Bevacizumab|bevacizumab|mesh-list
101851419|NCT01043484|Capecitabine|capecitabine|mesh-list
101851420|NCT01043484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101851421|NCT01043484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101684595|NCT02632071|Paclitaxel|paclitaxel|mesh-list
101851422|NCT01043484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101851423|NCT01043484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101851424|NCT01043484|Growth Substances|growth substances|mesh-ancestor
101851425|NCT01043484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851426|NCT01043484|Growth Inhibitors|growth inhibitors|mesh-ancestor
101851427|NCT01043484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101851428|NCT01043484|Antimetabolites|antimetabolites|mesh-ancestor
101851429|NCT01043484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851430|NCT00396318|Tenecteplase|tenecteplase|mesh-list
101851431|NCT00396318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101851432|NCT00396318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101851433|NCT00396318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851434|NCT00381888|PENTA|penta|mesh-list
101851435|NCT00381888|Fondaparinux|fondaparinux|mesh-list
101851436|NCT00381888|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101851437|NCT00381888|Antithrombins|antithrombins|mesh-ancestor
101851438|NCT00381888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101851439|NCT00381888|Protease Inhibitors|protease inhibitors|mesh-ancestor
101851440|NCT00381888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101851441|NCT00381888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851442|NCT00381888|Anticoagulants|anticoagulants|mesh-ancestor
101851443|NCT00381888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101851444|NCT00381888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101851445|NCT00267969|Ustekinumab|ustekinumab|mesh-list
101851446|NCT00267969|Dermatologic Agents|dermatologic agents|mesh-ancestor
101851447|NCT00280293|Lamotrigine|lamotrigine|mesh-list
101851448|NCT00280293|Anticonvulsants|anticonvulsants|mesh-ancestor
101851449|NCT00280293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101851450|NCT00280293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101851451|NCT00280293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851452|NCT00280293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101851453|NCT00280293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851454|NCT00280293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101851455|NCT00280293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101851456|NCT00280293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101851457|NCT00280293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101851458|NCT00280293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101851459|NCT00421148|Bromides|bromides|mesh-list
101851460|NCT00421148|Rocuronium|rocuronium|mesh-list
101851461|NCT00421148|Anticonvulsants|anticonvulsants|mesh-ancestor
101851462|NCT00421148|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101851463|NCT00421148|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101851464|NCT00421148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101851465|NCT00421148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101851466|NCT00421148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851467|NCT00403754|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101851468|NCT00403754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101851469|NCT00403754|Autonomic Agents|autonomic agents|mesh-ancestor
101851470|NCT00403754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101851471|NCT00403754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851472|NCT00403754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101851473|NCT00403754|Respiratory System Agents|respiratory system agents|mesh-ancestor
101851474|NCT00403754|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101851475|NCT00403754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101851476|NCT00403754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101851477|NCT00403754|Adrenergic Agents|adrenergic agents|mesh-ancestor
101851478|NCT00403754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101851479|NCT00403754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851480|NCT00280059|Pregabalin|pregabalin|mesh-list
101851481|NCT00280059|Lamotrigine|lamotrigine|mesh-list
101851482|NCT00280059|Analgesics|analgesics|mesh-ancestor
101851483|NCT00280059|Sensory System Agents|sensory system agents|mesh-ancestor
101851484|NCT00280059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101851485|NCT00280059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851486|NCT00280059|Anticonvulsants|anticonvulsants|mesh-ancestor
101851487|NCT00280059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101851488|NCT00280059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101851489|NCT00280059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851490|NCT00280059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101851491|NCT00280059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101851492|NCT00280059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101851493|NCT00280059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101851494|NCT00280059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101851495|NCT00280059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101851496|NCT00280059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101851497|NCT00403130|Paclitaxel|paclitaxel|mesh-list
101851498|NCT00403130|Bevacizumab|bevacizumab|mesh-list
101851499|NCT00403130|Gemcitabine|gemcitabine|mesh-list
101851500|NCT00403130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101851501|NCT00403130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101851502|NCT00403130|Tubulin Modulators|tubulin modulators|mesh-ancestor
101851503|NCT00403130|Antimitotic Agents|antimitotic agents|mesh-ancestor
101851504|NCT00403130|Mitosis Modulators|mitosis modulators|mesh-ancestor
101851505|NCT00403130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686411|NCT02845661|Analgesics|analgesics|mesh-ancestor
101851507|NCT00403130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101851508|NCT00403130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101851509|NCT00403130|Growth Substances|growth substances|mesh-ancestor
101851510|NCT00403130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851511|NCT00403130|Growth Inhibitors|growth inhibitors|mesh-ancestor
101851512|NCT00403130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101851513|NCT00403130|Antimetabolites|antimetabolites|mesh-ancestor
101851514|NCT01039610|Moxifloxacin|moxifloxacin|mesh-list
101851515|NCT01039610|Linezolid|linezolid|mesh-list
101851516|NCT01039610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101851517|NCT01039610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101851518|NCT01039610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101851519|NCT01039610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101851520|NCT01039610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101851521|NCT01039610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851522|NCT01039610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101851523|NCT01039610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101851524|NCT00420290|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101851525|NCT00420290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101851526|NCT00267189|Cyclosporine|cyclosporine|mesh-list
101851527|NCT00267189|Everolimus|everolimus|mesh-list
101851528|NCT00267189|Azathioprine|azathioprine|mesh-list
101851529|NCT00267189|Tacrolimus|tacrolimus|mesh-list
101851530|NCT00267189|Cyclosporins|cyclosporins|mesh-list
101851531|NCT00267189|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
101851532|NCT00267189|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101851533|NCT00267189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101851534|NCT00267189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101851535|NCT00267189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851536|NCT00267189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101851537|NCT00267189|Immunologic Factors|immunologic factors|mesh-ancestor
101851538|NCT00267189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851539|NCT00267189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101851540|NCT00267189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101851541|NCT00267189|Antimetabolites|antimetabolites|mesh-ancestor
101851542|NCT00267189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101851543|NCT00267189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101851544|NCT00267189|Antifungal Agents|antifungal agents|mesh-ancestor
101851545|NCT00267189|Dermatologic Agents|dermatologic agents|mesh-ancestor
101851546|NCT00402116|Temozolomide|temozolomide|mesh-list
101851547|NCT00402116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101851548|NCT00402116|Alkylating Agents|alkylating agents|mesh-ancestor
101851549|NCT00402116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851550|NCT00402116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101851551|NCT00401960|Daptomycin|daptomycin|mesh-list
101851552|NCT00401960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101851553|NCT00401960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101851554|NCT00401726|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101851555|NCT00401726|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101851556|NCT00401726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101851557|NCT00401726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101851558|NCT00401726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851559|NCT00401726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101851560|NCT00401726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851561|NCT00401726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101851562|NCT00401726|Antidepressive Agents|antidepressive agents|mesh-ancestor
101851563|NCT00401726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101851564|NCT00371826|Cyclosporine|cyclosporine|mesh-list
101851565|NCT00371826|Mycophenolic Acid|mycophenolic acid|mesh-list
101851566|NCT00371826|Prednisone|prednisone|mesh-list
101571377|NCT00948688|Vorinostat|vorinostat|mesh-list
101851567|NCT00371826|Everolimus|everolimus|mesh-list
101851568|NCT00371826|Cyclosporins|cyclosporins|mesh-list
101851569|NCT00371826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
101851570|NCT00371826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101851571|NCT00371826|Glucocorticoids|glucocorticoids|mesh-ancestor
101851573|NCT00371826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101851574|NCT00371826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851575|NCT00371826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101851576|NCT00371826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101851577|NCT00371826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101851578|NCT00371826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851580|NCT00371826|Immunologic Factors|immunologic factors|mesh-ancestor
101851581|NCT00371826|Antifungal Agents|antifungal agents|mesh-ancestor
101851582|NCT00371826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101851583|NCT00371826|Dermatologic Agents|dermatologic agents|mesh-ancestor
101851584|NCT00371826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101851585|NCT00371826|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101851586|NCT00371826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101851587|NCT00371826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101851588|NCT00371826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101851589|NCT00371826|Antitubercular Agents|antitubercular agents|mesh-ancestor
101851590|NCT00371826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101851591|NCT03993366|Pramlintide|pramlintide|mesh-list
101851592|NCT03993366|Insulin Aspart|insulin aspart|mesh-list
101851593|NCT03993366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101851594|NCT03993366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851595|NCT02457702|Glycerol|glycerol|mesh-list
101851596|NCT02457702|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101851597|NCT02457702|Protective Agents|protective agents|mesh-ancestor
101851598|NCT02457702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851599|NCT00396084|Moxifloxacin|moxifloxacin|mesh-list
101851600|NCT00396084|Levofloxacin|levofloxacin|mesh-list
101851601|NCT00396084|Isoniazid|isoniazid|mesh-list
101851602|NCT00396084|Linezolid|linezolid|mesh-list
101851603|NCT00396084|Gatifloxacin|gatifloxacin|mesh-list
101851604|NCT00396084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101851605|NCT00396084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101851606|NCT00396084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101851607|NCT00396084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101851608|NCT00396084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101851609|NCT00396084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851610|NCT00396084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101851611|NCT00396084|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101851612|NCT00396084|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101851613|NCT00396084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101851614|NCT00396084|Antitubercular Agents|antitubercular agents|mesh-ancestor
101851615|NCT00396084|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101851616|NCT00396084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101851617|NCT00396084|Antimetabolites|antimetabolites|mesh-ancestor
101964862|NCT02228902|Trace Elements|trace elements|mesh-ancestor
101851618|NCT00396084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101851619|NCT00396084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101851620|NCT00396084|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101851621|NCT00396084|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101851622|NCT00395850|Disulfiram|disulfiram|mesh-list
101851623|NCT00395850|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101851624|NCT00395850|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
101851625|NCT00395850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101851626|NCT00395850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851627|NCT00420212|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101851628|NCT00420212|Dermatologic Agents|dermatologic agents|mesh-ancestor
101851629|NCT00420212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101851630|NCT00420212|Immunologic Factors|immunologic factors|mesh-ancestor
101851631|NCT00420212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851632|NCT00401258|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101851633|NCT00401258|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101851634|NCT00401258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101851635|NCT00401258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101851636|NCT00401258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851637|NCT00401258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101686423|NCT00880074|Alovudine|alovudine|mesh-list
101851638|NCT00401258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851639|NCT00401258|Analgesics|analgesics|mesh-ancestor
101851640|NCT00401258|Sensory System Agents|sensory system agents|mesh-ancestor
101851641|NCT00401258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101851642|NCT00401258|Antidepressive Agents|antidepressive agents|mesh-ancestor
101851643|NCT00401258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101851644|NCT00401258|Dopamine Agents|dopamine agents|mesh-ancestor
101851645|NCT00380874|Pregabalin|pregabalin|mesh-list
101851646|NCT00380874|Analgesics|analgesics|mesh-ancestor
101851647|NCT00380874|Sensory System Agents|sensory system agents|mesh-ancestor
101851648|NCT00380874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101851649|NCT00380874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851650|NCT00380874|Anticonvulsants|anticonvulsants|mesh-ancestor
101851651|NCT00380874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101851652|NCT00380874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101851653|NCT00380874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851654|NCT00380874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101851655|NCT00380874|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101851656|NCT00380874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101851657|NCT00380874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101851658|NCT00380874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101851659|NCT00420056|Palbociclib|palbociclib|mesh-list
101851660|NCT00420056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101851661|NCT00420056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101851662|NCT00420056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101851663|NCT00420056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851664|NCT00411554|Inositol|inositol|mesh-list
101851665|NCT00411554|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101851666|NCT00411554|Voglibose|voglibose|mesh-list
101851667|NCT00411554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101851668|NCT00411554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851669|NCT00411554|Incretins|incretins|mesh-ancestor
101851670|NCT00411554|Hormones|hormones|mesh-ancestor
101851671|NCT00411554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101851672|NCT00411554|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101851673|NCT00411554|Protease Inhibitors|protease inhibitors|mesh-ancestor
101851674|NCT00411554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101851675|NCT00411554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851676|NCT00411554|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101851677|NCT00411554|Vitamin B Complex|vitamin b complex|mesh-ancestor
101851678|NCT00411554|Vitamins|vitamins|mesh-ancestor
101851679|NCT00411554|Micronutrients|micronutrients|mesh-ancestor
101851680|NCT00380718|Pemetrexed|pemetrexed|mesh-list
101851681|NCT00380718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101851682|NCT00380718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101851683|NCT00380718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851684|NCT00380718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101851685|NCT00380718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101851686|NCT00380250|Lubiprostone|lubiprostone|mesh-list
101851687|NCT00380250|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101851688|NCT00380250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101851689|NCT00380250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851690|NCT00400400|Mycophenolic Acid|mycophenolic acid|mesh-list
101851691|NCT00400400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101851692|NCT00400400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101851693|NCT00400400|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101851694|NCT00400400|Antitubercular Agents|antitubercular agents|mesh-ancestor
101851695|NCT00400400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101851696|NCT00400400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101851697|NCT00400400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101851698|NCT00400400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851699|NCT00395694|Lamotrigine|lamotrigine|mesh-list
101851700|NCT00395694|Anticonvulsants|anticonvulsants|mesh-ancestor
101851701|NCT00395694|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101851702|NCT00395694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101851703|NCT00395694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851704|NCT00395694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101851705|NCT00395694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851706|NCT00395694|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101851707|NCT00395694|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101686428|NCT04375787|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101851708|NCT00395694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101851709|NCT00395694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101851710|NCT00395694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101851711|NCT00419744|Budesonide|budesonide|mesh-list
101851712|NCT00419744|Formoterol Fumarate|formoterol fumarate|mesh-list
101851713|NCT00419744|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101851714|NCT00419744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101851715|NCT00419744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101851716|NCT00419744|Autonomic Agents|autonomic agents|mesh-ancestor
101851717|NCT00419744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101851718|NCT00419744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851719|NCT00419744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101851720|NCT00419744|Respiratory System Agents|respiratory system agents|mesh-ancestor
101851721|NCT00419744|Glucocorticoids|glucocorticoids|mesh-ancestor
101851722|NCT00419744|Hormones|hormones|mesh-ancestor
101239753|NCT01617746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101851723|NCT00419744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101851724|NCT00419744|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101851725|NCT00419744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101851726|NCT00419744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101851727|NCT00419744|Adrenergic Agents|adrenergic agents|mesh-ancestor
101851728|NCT00419744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101851729|NCT00419744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851730|NCT01047774|Caseins|caseins|mesh-list
101851731|NCT01047774|Chelating Agents|chelating agents|mesh-ancestor
101851732|NCT01047774|Sequestering Agents|sequestering agents|mesh-ancestor
101851733|NCT01047774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851734|NCT00395304|Fluticasone|fluticasone|mesh-list
101851736|NCT00395304|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101851737|NCT00395304|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101851738|NCT00395304|Montelukast|montelukast|mesh-list
101851739|NCT00395304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101851740|NCT00395304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101851741|NCT00395304|Autonomic Agents|autonomic agents|mesh-ancestor
101851742|NCT00395304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101851743|NCT00395304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851744|NCT00395304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101851745|NCT00395304|Respiratory System Agents|respiratory system agents|mesh-ancestor
101851746|NCT00395304|Dermatologic Agents|dermatologic agents|mesh-ancestor
101851747|NCT00395304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101851748|NCT00395304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101851749|NCT00395304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101851750|NCT00395304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101851751|NCT00395304|Adrenergic Agents|adrenergic agents|mesh-ancestor
101851752|NCT00395304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101851753|NCT00395304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851754|NCT00395304|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101851755|NCT00395304|Hormone Antagonists|hormone antagonists|mesh-ancestor
101851756|NCT00395304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101851757|NCT00395304|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101851758|NCT00395304|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101851759|NCT00395304|Glucocorticoids|glucocorticoids|mesh-ancestor
101851760|NCT00395304|Hormones|hormones|mesh-ancestor
101851761|NCT00395304|Sympathomimetics|sympathomimetics|mesh-ancestor
101851762|NCT00395226|Zinc Sulfate|zinc sulfate|mesh-list
101851763|NCT00395226|Astringents|astringents|mesh-ancestor
101851764|NCT00395226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851765|NCT00395226|Dermatologic Agents|dermatologic agents|mesh-ancestor
101851766|NCT00394914|Pleconaril|pleconaril|mesh-list
101851767|NCT00394914|Antiviral Agents|antiviral agents|mesh-ancestor
101851768|NCT00394914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101851769|NCT00366444|Diclofenac|diclofenac|mesh-list
101851770|NCT00366444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101851771|NCT00366444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101851772|NCT00366444|Analgesics|analgesics|mesh-ancestor
101851773|NCT00366444|Sensory System Agents|sensory system agents|mesh-ancestor
101851774|NCT00366444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101851775|NCT00366444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851776|NCT00366444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101851777|NCT00366444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101851778|NCT00366444|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101851779|NCT00366444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101851780|NCT00366444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851781|NCT00365976|Eszopiclone|eszopiclone|mesh-list
101851782|NCT00365976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101851783|NCT00365976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101851784|NCT00365976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851785|NCT00378534|Cyclosporine|cyclosporine|mesh-list
101851786|NCT00378534|Cyclophosphamide|cyclophosphamide|mesh-list
101851787|NCT00378534|Fludarabine|fludarabine|mesh-list
101851788|NCT00378534|Cyclosporins|cyclosporins|mesh-list
101851789|NCT00378534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101851790|NCT00378534|Immunologic Factors|immunologic factors|mesh-ancestor
101851791|NCT00378534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851792|NCT00378534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101851793|NCT00378534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101851794|NCT00378534|Alkylating Agents|alkylating agents|mesh-ancestor
101851795|NCT00378534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851796|NCT00378534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101851797|NCT00378534|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101851798|NCT00378534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101851799|NCT00378534|Antifungal Agents|antifungal agents|mesh-ancestor
101851800|NCT00378534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101851801|NCT00378534|Dermatologic Agents|dermatologic agents|mesh-ancestor
101851802|NCT00378534|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101851803|NCT00377676|Bromocriptine|bromocriptine|mesh-list
101851804|NCT00377676|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101851805|NCT00377676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101851806|NCT00377676|Hormone Antagonists|hormone antagonists|mesh-ancestor
101851807|NCT00377676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101851808|NCT00377676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851809|NCT00377676|Dopamine Agonists|dopamine agonists|mesh-ancestor
101851810|NCT00377676|Dopamine Agents|dopamine agents|mesh-ancestor
101851811|NCT00377676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101851812|NCT00377676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851813|NCT00377520|Pemetrexed|pemetrexed|mesh-list
101851814|NCT00377520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101851815|NCT00377520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101851816|NCT00377520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851817|NCT00377520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101851818|NCT00377520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101851819|NCT00377364|Acetaminophen|acetaminophen|mesh-list
101851820|NCT00377364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101851821|NCT00377364|Analgesics|analgesics|mesh-ancestor
101851822|NCT00377364|Sensory System Agents|sensory system agents|mesh-ancestor
101851823|NCT00377364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101851824|NCT00377364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851825|NCT00377364|Antipyretics|antipyretics|mesh-ancestor
101851826|NCT00365508|Nicotine|nicotine|mesh-list
101851827|NCT00365508|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101851828|NCT00365508|Autonomic Agents|autonomic agents|mesh-ancestor
101851829|NCT00365508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101851830|NCT00365508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851831|NCT00365508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101851832|NCT00365508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101851833|NCT00365508|Cholinergic Agents|cholinergic agents|mesh-ancestor
101851834|NCT00365508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101851835|NCT00365508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851836|NCT00365352|Gabapentin|gabapentin|mesh-list
101851837|NCT00365352|Analgesics|analgesics|mesh-ancestor
101851838|NCT00365352|Sensory System Agents|sensory system agents|mesh-ancestor
101851839|NCT00365352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101851840|NCT00365352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851841|NCT00365352|Anticonvulsants|anticonvulsants|mesh-ancestor
101851842|NCT00365352|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101851843|NCT00365352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101851844|NCT00365352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101851845|NCT00365352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101851846|NCT00365352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101851847|NCT00365352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101851848|NCT00365352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101851849|NCT00365352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851850|NCT00365352|Antimanic Agents|antimanic agents|mesh-ancestor
101851851|NCT00410384|Belimumab|belimumab|mesh-list
101851852|NCT00410384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101851853|NCT00410384|Immunologic Factors|immunologic factors|mesh-ancestor
101519698|NCT01206439|Nebivolol|nebivolol|mesh-list
101851854|NCT00410384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851855|NCT00370032|Alosetron|alosetron|mesh-list
101851856|NCT00370032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101851857|NCT00370032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101851858|NCT00370032|Serotonin Agents|serotonin agents|mesh-ancestor
101851859|NCT00370032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101851860|NCT00370032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571677|NCT00957034|Hormones|hormones|mesh-ancestor
101851861|NCT00370032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851862|NCT00410072|Tenofovir|tenofovir|mesh-list
101851863|NCT00410072|Entecavir|entecavir|mesh-list
101851864|NCT00410072|Antiviral Agents|antiviral agents|mesh-ancestor
101851865|NCT00410072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101851866|NCT00410072|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101851867|NCT00410072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101851868|NCT00410072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101851869|NCT00410072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851870|NCT00410072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101851871|NCT00410072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101851872|NCT00409838|Methotrexate|methotrexate|mesh-list
101851873|NCT00409838|Abatacept|abatacept|mesh-list
101851874|NCT00409838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101851875|NCT00409838|Abortifacient Agents|abortifacient agents|mesh-ancestor
101851876|NCT00409838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101851877|NCT00409838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851878|NCT00409838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101851879|NCT00409838|Antimetabolites|antimetabolites|mesh-ancestor
101851880|NCT00409838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101964895|NCT02229058|Tubulin Modulators|tubulin modulators|mesh-ancestor
101851881|NCT00409838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101851882|NCT00409838|Dermatologic Agents|dermatologic agents|mesh-ancestor
101851883|NCT00409838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101851884|NCT00409838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101851885|NCT00409838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101851886|NCT00409838|Immunologic Factors|immunologic factors|mesh-ancestor
101851887|NCT00409838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101851888|NCT00409838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101851889|NCT00409838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101851890|NCT00409838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101851891|NCT01041872|Lidocaine|lidocaine|mesh-list
101851892|NCT01041872|Propofol|propofol|mesh-list
101851893|NCT01041872|Anesthetics, Local|anesthetics, local|mesh-ancestor
101851894|NCT01041872|Anesthetics|anesthetics|mesh-ancestor
101851895|NCT01041872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101851896|NCT01041872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851897|NCT01041872|Sensory System Agents|sensory system agents|mesh-ancestor
101851898|NCT01041872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101851899|NCT01041872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101851900|NCT01041872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101851901|NCT01041872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101851902|NCT01041872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101851903|NCT01041872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851904|NCT01041872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101851905|NCT01041872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101851906|NCT01041872|Anesthetics, General|anesthetics, general|mesh-ancestor
101851907|NCT00399542|Lubiprostone|lubiprostone|mesh-list
101851908|NCT00399542|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101851909|NCT00399542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101851910|NCT00399542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851911|NCT01039766|Oxytocin|oxytocin|mesh-list
101851912|NCT01039766|Oxytocics|oxytocics|mesh-ancestor
101851913|NCT01039766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101851914|NCT01039766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851915|NCT00409682|Adalimumab|adalimumab|mesh-list
101851916|NCT00409682|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101851917|NCT00409682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101851918|NCT00409682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101851919|NCT01039844|Paclitaxel|paclitaxel|mesh-list
101851920|NCT01039844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101851921|NCT01039844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101851922|NCT01039844|Tubulin Modulators|tubulin modulators|mesh-ancestor
101851923|NCT01039844|Antimitotic Agents|antimitotic agents|mesh-ancestor
101851924|NCT01039844|Mitosis Modulators|mitosis modulators|mesh-ancestor
101686431|NCT04375787|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101851925|NCT01039844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851926|NCT01042028|Capecitabine|capecitabine|mesh-list
101851927|NCT01042028|Irinotecan|irinotecan|mesh-list
101851928|NCT01042028|Cetuximab|cetuximab|mesh-list
101851929|NCT01042028|Everolimus|everolimus|mesh-list
101851930|NCT01042028|Oxaliplatin|oxaliplatin|mesh-list
101851931|NCT01042028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101851932|NCT01042028|Antimetabolites|antimetabolites|mesh-ancestor
101851933|NCT01042028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851934|NCT01042028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101851935|NCT01042028|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101851936|NCT01042028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101851937|NCT01042028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101571752|NCT04303065|Glucocorticoids|glucocorticoids|mesh-ancestor
101851938|NCT01042028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101851939|NCT01042028|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101851940|NCT01042028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101851941|NCT01042028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101851942|NCT01042028|Immunologic Factors|immunologic factors|mesh-ancestor
101851943|NCT01042028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851945|NCT03993626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101851946|NCT03993626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101851947|NCT03993626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101851948|NCT03993626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851949|NCT00398216|Edoxaban|edoxaban|mesh-list
101851950|NCT00398216|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
101851951|NCT00398216|Antithrombins|antithrombins|mesh-ancestor
101851952|NCT00398216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101851953|NCT00398216|Protease Inhibitors|protease inhibitors|mesh-ancestor
101851954|NCT00398216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101851955|NCT00398216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851956|NCT00398216|Anticoagulants|anticoagulants|mesh-ancestor
101851957|NCT00398138|Sargramostim|sargramostim|mesh-list
101851958|NCT00398138|Freund's Adjuvant|freund's adjuvant|mesh-list
101851959|NCT00398138|Immunologic Factors|immunologic factors|mesh-ancestor
101851960|NCT00398138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239789|NCT01617928|Veliparib|veliparib|mesh-list
101851961|NCT00398138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101851962|NCT00397982|Sirolimus|sirolimus|mesh-list
101851963|NCT00397982|Bevacizumab|bevacizumab|mesh-list
101851964|NCT00397982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101851965|NCT00397982|Temsirolimus|temsirolimus|mesh-list
101851966|NCT00397982|MTOR Inhibitors|mtor inhibitors|mesh-list
101851967|NCT00397982|Endothelial Growth Factors|endothelial growth factors|mesh-list
101851968|NCT00397982|Antibodies|antibodies|mesh-list
101851969|NCT00397982|Immunoglobulins|immunoglobulins|mesh-list
101851970|NCT00397982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101851971|NCT00397982|Immunoglobulin G|immunoglobulin g|mesh-list
101851972|NCT00397982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101851973|NCT00397982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101851974|NCT00397982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101851975|NCT00397982|Growth Substances|growth substances|mesh-ancestor
101851976|NCT00397982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851977|NCT00397982|Growth Inhibitors|growth inhibitors|mesh-ancestor
101851978|NCT00397982|Immunologic Factors|immunologic factors|mesh-ancestor
101851979|NCT00397982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101851980|NCT00397982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101851981|NCT00397982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101851982|NCT00397982|Antifungal Agents|antifungal agents|mesh-ancestor
101851983|NCT00397982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101851984|NCT00397982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101851985|NCT00397982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101851986|NCT00397982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851987|NCT03715166|Bumetanide|bumetanide|mesh-list
101851988|NCT03715166|Diuretics|diuretics|mesh-ancestor
101851989|NCT03715166|Natriuretic Agents|natriuretic agents|mesh-ancestor
101851990|NCT03715166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101851991|NCT03715166|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101851992|NCT03715166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101851993|NCT03715166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101851994|NCT01042574|Clevidipine|clevidipine|mesh-list
101851995|NCT01042574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101851996|NCT01042574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101851997|NCT01042574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775313|NCT00936195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101851998|NCT01042574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101851999|NCT01042574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852000|NCT01042652|Raltegravir Potassium|raltegravir potassium|mesh-list
101852001|NCT01042652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101852002|NCT01042652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101852003|NCT01042652|Antiviral Agents|antiviral agents|mesh-ancestor
101852004|NCT01042652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101852005|NCT01042652|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101852006|NCT01042652|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101852007|NCT01042652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101852008|NCT01042652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852009|NCT01040078|Vaccines|vaccines|mesh-list
101852010|NCT01040078|Immunologic Factors|immunologic factors|mesh-ancestor
101852011|NCT01040078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852012|NCT01035320|Simvastatin|simvastatin|mesh-list
101852013|NCT01035320|Ezetimibe|ezetimibe|mesh-list
101852014|NCT01035320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101852015|NCT01035320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101852016|NCT01035320|Antimetabolites|antimetabolites|mesh-ancestor
101852017|NCT01035320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852018|NCT01035320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101852019|NCT01035320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101852020|NCT01035320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101852021|NCT01042730|Pitavastatin|pitavastatin|mesh-list
101852022|NCT01042730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101852023|NCT01042730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101852024|NCT01042730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101852025|NCT01042730|Antimetabolites|antimetabolites|mesh-ancestor
101852026|NCT01042730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852027|NCT01042730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101852028|NCT01042730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101852029|NCT00396812|Rituximab|rituximab|mesh-list
101852030|NCT00396812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101852031|NCT00396812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101852032|NCT00396812|Immunologic Factors|immunologic factors|mesh-ancestor
101852033|NCT00396812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852034|NCT00396812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101852035|NCT01566578|Mitogens|mitogens|mesh-list
101852036|NCT01566578|Mitosis Modulators|mitosis modulators|mesh-ancestor
101852037|NCT01566578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852038|NCT01040234|Bupivacaine|bupivacaine|mesh-list
101852039|NCT01040234|Anesthetics, Local|anesthetics, local|mesh-ancestor
101852040|NCT01040234|Anesthetics|anesthetics|mesh-ancestor
101852041|NCT01040234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101852042|NCT01040234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852043|NCT01040234|Sensory System Agents|sensory system agents|mesh-ancestor
101852044|NCT01040234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101852045|NCT00396656|Atenolol|atenolol|mesh-list
101852046|NCT00396656|Valsartan|valsartan|mesh-list
101852047|NCT00396656|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101852048|NCT00396656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101852049|NCT00396656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101852050|NCT00396656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101852051|NCT00396656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852052|NCT00396656|Diuretics|diuretics|mesh-ancestor
101852053|NCT00396656|Natriuretic Agents|natriuretic agents|mesh-ancestor
101852054|NCT00396656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852055|NCT00396656|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101852056|NCT00396656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101852057|NCT00396656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101852058|NCT00396656|Sympatholytics|sympatholytics|mesh-ancestor
101852059|NCT00396656|Autonomic Agents|autonomic agents|mesh-ancestor
101852060|NCT00396656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101852061|NCT00396656|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101852062|NCT00396656|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101852063|NCT00396656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101852064|NCT00396656|Adrenergic Agents|adrenergic agents|mesh-ancestor
101852065|NCT00396656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101852066|NCT00408434|Efatutazone|efatutazone|mesh-list
101852067|NCT00408434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101852069|NCT00418886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101852070|NCT00418886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101852071|NCT00418886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852072|NCT00418886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101852073|NCT00418886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101852074|NCT01040312|Cisplatin|cisplatin|mesh-list
101852075|NCT01040312|Carboplatin|carboplatin|mesh-list
101852076|NCT01040312|Nedaplatin|nedaplatin|mesh-list
101852077|NCT01040312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101852078|NCT00407030|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
101852079|NCT00407030|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101852080|NCT00407030|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101852081|NCT00407030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101852082|NCT00407030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852083|NCT00407030|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101852084|NCT00407030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101852085|NCT00407030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101571899|NCT00946114|Sildenafil Citrate|sildenafil citrate|mesh-list
101852086|NCT00407030|Cholinergic Agents|cholinergic agents|mesh-ancestor
101852087|NCT00407030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101852088|NCT00406640|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101852089|NCT00406640|Escitalopram|escitalopram|mesh-list
101852090|NCT00406640|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101852091|NCT00406640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101852092|NCT00406640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101852093|NCT00406640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852094|NCT00406640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101852095|NCT00406640|Serotonin Agents|serotonin agents|mesh-ancestor
101852096|NCT00406640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852097|NCT00406640|Antidepressive Agents|antidepressive agents|mesh-ancestor
101852098|NCT00406640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101852099|NCT00406640|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101852100|NCT01043510|Insulin|insulin|mesh-list
101852101|NCT01043510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101852102|NCT01043510|Insulin Detemir|insulin detemir|mesh-list
101852103|NCT01043510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101852104|NCT01043510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852105|NCT01043666|Mirabegron|mirabegron|mesh-list
101852106|NCT01043666|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101852107|NCT01043666|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101852108|NCT01043666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101852109|NCT01043666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101852110|NCT01043666|Adrenergic Agents|adrenergic agents|mesh-ancestor
101852111|NCT01043666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101852112|NCT01043666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852113|NCT01043666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852114|NCT01043666|Urological Agents|urological agents|mesh-ancestor
101852115|NCT01043666|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101852116|NCT01043666|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101852117|NCT01043666|Cholinergic Agents|cholinergic agents|mesh-ancestor
101852118|NCT00394472|Lesogaberan|lesogaberan|mesh-list
101852119|NCT00394472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101852120|NCT00394472|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101852121|NCT00394472|GABA Agonists|gaba agonists|mesh-ancestor
101852122|NCT00394472|GABA Agents|gaba agents|mesh-ancestor
101852123|NCT00394472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101852124|NCT00394472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852125|NCT00394472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852126|NCT00395486|Atorvastatin|atorvastatin|mesh-list
101852127|NCT00395486|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101852128|NCT00395486|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101852129|NCT00395486|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101852130|NCT00395486|Antimetabolites|antimetabolites|mesh-ancestor
101852131|NCT00395486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852132|NCT00395486|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101852133|NCT00395486|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101852134|NCT00395486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101852135|NCT01043744|Lumefantrine|lumefantrine|mesh-list
101852136|NCT01043744|Artemether|artemether|mesh-list
101852137|NCT01043744|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101852138|NCT01043744|Antimalarials|antimalarials|mesh-ancestor
101852139|NCT01043744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101852140|NCT01043744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101852141|NCT01043744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101852142|NCT00395018|Entecavir|entecavir|mesh-list
101852143|NCT00395018|Antiviral Agents|antiviral agents|mesh-ancestor
101852144|NCT00395018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101852145|NCT01036412|Chlorhexidine|chlorhexidine|mesh-list
101852146|NCT01036412|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101852147|NCT01036412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101852148|NCT01036412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101852149|NCT01036412|Disinfectants|disinfectants|mesh-ancestor
101852150|NCT01036412|Dermatologic Agents|dermatologic agents|mesh-ancestor
101852151|NCT00375518|Atorvastatin|atorvastatin|mesh-list
101852152|NCT00375518|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101852153|NCT00375518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101852154|NCT00375518|Antimetabolites|antimetabolites|mesh-ancestor
101852155|NCT00375518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852156|NCT00375518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101852157|NCT00375518|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101852158|NCT00375518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101852159|NCT01045772|Rilonacept|rilonacept|mesh-list
101852160|NCT01045772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101852161|NCT01045928|Rituximab|rituximab|mesh-list
101852162|NCT01045928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101852164|NCT01045928|Antibodies|antibodies|mesh-list
101852165|NCT01045928|Immunoglobulins|immunoglobulins|mesh-list
101852166|NCT01045928|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101852167|NCT01045928|Immunologic Factors|immunologic factors|mesh-ancestor
101852168|NCT01045928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852169|NCT01045928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101852170|NCT01045928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101852171|NCT01045928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101852172|NCT01045928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101852173|NCT01045928|Growth Substances|growth substances|mesh-ancestor
101852174|NCT01045928|Growth Inhibitors|growth inhibitors|mesh-ancestor
101852175|NCT00256750|Cyclosporine|cyclosporine|mesh-list
101852176|NCT00256750|Abatacept|abatacept|mesh-list
101852177|NCT00256750|Cyclosporins|cyclosporins|mesh-list
101852178|NCT00256750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101852179|NCT00256750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852180|NCT00256750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101852181|NCT00256750|Immunologic Factors|immunologic factors|mesh-ancestor
101852182|NCT00256750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852183|NCT00256750|Antifungal Agents|antifungal agents|mesh-ancestor
101852184|NCT00256750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101852185|NCT00256750|Dermatologic Agents|dermatologic agents|mesh-ancestor
101852186|NCT00256750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101852187|NCT00256750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101852188|NCT00256750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101852189|NCT00256750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101852190|NCT00256750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101852191|NCT00279201|Insulin Glargine|insulin glargine|mesh-list
101852192|NCT00279201|Insulin Lispro|insulin lispro|mesh-list
101852193|NCT00279201|Insulin, Isophane|insulin, isophane|mesh-list
101852194|NCT00279201|Biphasic Insulins|biphasic insulins|mesh-list
101852195|NCT00279201|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
101852196|NCT00279201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101852197|NCT00279201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852198|NCT00203476|Niacin|niacin|mesh-list
101852199|NCT00203476|Ezetimibe|ezetimibe|mesh-list
101852200|NCT00203476|Colestipol|colestipol|mesh-list
101852201|NCT00203476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101852202|NCT00203476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101852203|NCT00203476|Antimetabolites|antimetabolites|mesh-ancestor
101852204|NCT00203476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852205|NCT00203476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101852206|NCT00203476|Vasodilator Agents|vasodilator agents|mesh-ancestor
101852207|NCT00203476|Vitamin B Complex|vitamin b complex|mesh-ancestor
101852208|NCT00203476|Vitamins|vitamins|mesh-ancestor
101852209|NCT00203476|Micronutrients|micronutrients|mesh-ancestor
101852210|NCT00203476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852211|NCT00203476|Sequestering Agents|sequestering agents|mesh-ancestor
101852212|NCT00203242|Valproic Acid|valproic acid|mesh-list
101852213|NCT00203242|Anticonvulsants|anticonvulsants|mesh-ancestor
101852214|NCT00203242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686438|NCT00825630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101852215|NCT00203242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852217|NCT00203242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101852218|NCT00203242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852219|NCT00203242|Antimanic Agents|antimanic agents|mesh-ancestor
101852220|NCT00203242|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101852221|NCT00203242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101852222|NCT00203242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101852223|NCT00200356|Ozagrel|ozagrel|mesh-list
101852224|NCT00200356|Edaravone|edaravone|mesh-list
101852225|NCT00200356|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101852226|NCT00200356|Antioxidants|antioxidants|mesh-ancestor
101852227|NCT00200356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852228|NCT00200356|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101852229|NCT00200356|Protective Agents|protective agents|mesh-ancestor
101852230|NCT00200356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852231|NCT00200356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101852232|NCT00200356|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101852233|NCT00200356|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101852234|NCT00200356|Histamine Antagonists|histamine antagonists|mesh-ancestor
101852235|NCT00200356|Histamine Agents|histamine agents|mesh-ancestor
101852236|NCT00200356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101852237|NCT00227344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
101852238|NCT00227266|Valproic Acid|valproic acid|mesh-list
101852239|NCT00227266|Anticonvulsants|anticonvulsants|mesh-ancestor
101852240|NCT00227266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101852241|NCT00227266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852242|NCT00227266|GABA Agents|gaba agents|mesh-ancestor
101852243|NCT00227266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101852244|NCT00227266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852245|NCT00227266|Antimanic Agents|antimanic agents|mesh-ancestor
101852246|NCT00227266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101852247|NCT00227266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101852248|NCT00227266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101852250|NCT00256282|Vinorelbine|vinorelbine|mesh-list
101852251|NCT00256282|Sargramostim|sargramostim|mesh-list
101852252|NCT00256282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101852253|NCT00256282|Tubulin Modulators|tubulin modulators|mesh-ancestor
101852254|NCT00256282|Antimitotic Agents|antimitotic agents|mesh-ancestor
101852255|NCT00256282|Mitosis Modulators|mitosis modulators|mesh-ancestor
101852256|NCT00256282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852257|NCT00256282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101852258|NCT00256282|Immunologic Factors|immunologic factors|mesh-ancestor
101852259|NCT00256282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852260|NCT00256204|Rasagiline|rasagiline|mesh-list
101852261|NCT00256204|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101852262|NCT00256204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101852263|NCT00256204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852264|NCT00256204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101852265|NCT00256204|Protective Agents|protective agents|mesh-ancestor
101852266|NCT00256204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852267|NCT03972358|Misoprostol|misoprostol|mesh-list
101852268|NCT03972358|Mifepristone|mifepristone|mesh-list
101852269|NCT03972358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101852270|NCT03972358|Abortifacient Agents|abortifacient agents|mesh-ancestor
101852271|NCT03972358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101852272|NCT03972358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852273|NCT03972358|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101852274|NCT03972358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101852275|NCT03972358|Oxytocics|oxytocics|mesh-ancestor
101852276|NCT03972358|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101852277|NCT03972358|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101852278|NCT03972358|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101852279|NCT03972358|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101852280|NCT03972358|Contraceptive Agents|contraceptive agents|mesh-ancestor
101852281|NCT03972358|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101852282|NCT03972358|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101852283|NCT03972358|Hormone Antagonists|hormone antagonists|mesh-ancestor
101852284|NCT03972358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101852285|NCT03972358|Luteolytic Agents|luteolytic agents|mesh-ancestor
101852286|NCT03972358|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101852287|NCT03972358|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101852289|NCT01073332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852290|NCT01073332|Protective Agents|protective agents|mesh-ancestor
101852291|NCT01073332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852292|NCT03972046|Trametinib|trametinib|mesh-list
101852293|NCT03972046|Dabrafenib|dabrafenib|mesh-list
101852294|NCT03972046|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
101852295|NCT03972046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101852296|NCT03972046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101852297|NCT03972046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101852298|NCT03972046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852299|NCT03972046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101852300|NCT01071772|Insulin|insulin|mesh-list
101852301|NCT01071772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101852302|NCT01071772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852303|NCT01074346|Interferons|interferons|mesh-list
101852304|NCT01074346|Interferon-beta|interferon-beta|mesh-list
101852305|NCT01074346|Interferon beta-1a|interferon beta-1a|mesh-list
101852306|NCT01074346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101852307|NCT01074346|Antiviral Agents|antiviral agents|mesh-ancestor
101852308|NCT01074346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101852309|NCT01074346|Immunologic Factors|immunologic factors|mesh-ancestor
101852310|NCT01074346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852311|NCT01074346|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101852312|NCT00278889|Leucovorin|leucovorin|mesh-list
101852313|NCT00278889|Bevacizumab|bevacizumab|mesh-list
101852314|NCT00278889|Fluorouracil|fluorouracil|mesh-list
101852315|NCT00278889|Oxaliplatin|oxaliplatin|mesh-list
101852316|NCT00278889|Cediranib|cediranib|mesh-list
101852317|NCT00278889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101852318|NCT00278889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101852319|NCT00278889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101852320|NCT00278889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101852321|NCT00278889|Growth Substances|growth substances|mesh-ancestor
101852322|NCT00278889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852323|NCT00278889|Growth Inhibitors|growth inhibitors|mesh-ancestor
101852324|NCT00278889|Antimetabolites|antimetabolites|mesh-ancestor
101852325|NCT00278889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852326|NCT00278889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101852327|NCT00278889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101852328|NCT00278889|Immunologic Factors|immunologic factors|mesh-ancestor
101852329|NCT00278889|Antidotes|antidotes|mesh-ancestor
101852330|NCT00278889|Protective Agents|protective agents|mesh-ancestor
101852331|NCT00278889|Vitamin B Complex|vitamin b complex|mesh-ancestor
101852332|NCT00278889|Vitamins|vitamins|mesh-ancestor
101852333|NCT00278889|Micronutrients|micronutrients|mesh-ancestor
101852334|NCT00278889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101852335|NCT00278889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101852336|NCT01070745|Ibuprofen|ibuprofen|mesh-list
101852337|NCT01070745|Indomethacin|indomethacin|mesh-list
101852338|NCT01070745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101852339|NCT01070745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101852340|NCT01070745|Analgesics|analgesics|mesh-ancestor
101852341|NCT01070745|Sensory System Agents|sensory system agents|mesh-ancestor
101852342|NCT01070745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101852343|NCT01070745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852344|NCT01070745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101852345|NCT01070745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101852346|NCT01070745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101852347|NCT01070745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101852348|NCT01070745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852349|NCT01070745|Gout Suppressants|gout suppressants|mesh-ancestor
101852350|NCT01070745|Tocolytic Agents|tocolytic agents|mesh-ancestor
101852351|NCT01070745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101852353|NCT01071057|Naloxone|naloxone|mesh-list
101852354|NCT01071057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101852355|NCT01071057|Narcotics|narcotics|mesh-ancestor
101852356|NCT01071057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101852357|NCT01071057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852358|NCT01071057|Analgesics|analgesics|mesh-ancestor
101852359|NCT01071057|Sensory System Agents|sensory system agents|mesh-ancestor
101852360|NCT01071057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101852361|NCT01071057|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101852362|NCT00278109|Cyclophosphamide|cyclophosphamide|mesh-list
101852363|NCT00278109|Doxorubicin|doxorubicin|mesh-list
101852364|NCT00278109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101852365|NCT00278109|Immunologic Factors|immunologic factors|mesh-ancestor
101852366|NCT00278109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852367|NCT00278109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101852368|NCT00278109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101852369|NCT00278109|Alkylating Agents|alkylating agents|mesh-ancestor
101852370|NCT00278109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852371|NCT00278109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101852372|NCT00278109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101852373|NCT00278109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101852374|NCT00278109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101852375|NCT00278109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101852376|NCT00278109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101852377|NCT00296517|Bupropion|bupropion|mesh-list
101852378|NCT00296517|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101852379|NCT00296517|Antidepressive Agents|antidepressive agents|mesh-ancestor
101852380|NCT00296517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101852381|NCT00296517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101852382|NCT00296517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101852383|NCT00296517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101852384|NCT00296517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852385|NCT00296517|Dopamine Agents|dopamine agents|mesh-ancestor
101852386|NCT00296517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101852387|NCT00296517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852388|NCT00296517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101852389|NCT00296517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101852390|NCT00296517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101852391|NCT00224770|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101852392|NCT00224770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101852393|NCT00224770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101852394|NCT00224770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852395|NCT00266409|Alprazolam|alprazolam|mesh-list
101852396|NCT00266409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101852397|NCT00266409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101852398|NCT00266409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852399|NCT00266409|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101852400|NCT00266409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101852401|NCT00266409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101852402|NCT00266409|GABA Modulators|gaba modulators|mesh-ancestor
101852403|NCT00266409|GABA Agents|gaba agents|mesh-ancestor
101852404|NCT00266409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101852405|NCT00266409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852406|NCT00265785|Pemetrexed|pemetrexed|mesh-list
101964968|NCT02230228|Vitamin A|vitamin a|mesh-list
101852407|NCT00265785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101852408|NCT00265785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101852409|NCT00265785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852410|NCT00265785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101852411|NCT00265785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101852412|NCT02532153|Ketamine|ketamine|mesh-list
101852413|NCT02532153|Analgesics|analgesics|mesh-ancestor
101852414|NCT02532153|Sensory System Agents|sensory system agents|mesh-ancestor
101852415|NCT02532153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101239879|NCT01618591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101852416|NCT02532153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852417|NCT02532153|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101852418|NCT02532153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101852419|NCT02532153|Anesthetics, General|anesthetics, general|mesh-ancestor
101852420|NCT02532153|Anesthetics|anesthetics|mesh-ancestor
101852421|NCT02532153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101852422|NCT02532153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101852423|NCT02532153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101852424|NCT02532153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101852425|NCT02532153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852426|NCT00265395|Interferons|interferons|mesh-list
101852427|NCT00265395|Ribavirin|ribavirin|mesh-list
101852428|NCT00265395|Interferon-alpha|interferon-alpha|mesh-list
101852429|NCT00265395|Interferon alpha-2|interferon alpha-2|mesh-list
101852430|NCT00265395|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101852431|NCT00265395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101852432|NCT00265395|Antiviral Agents|antiviral agents|mesh-ancestor
101852433|NCT00265395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101852434|NCT00265395|Antimetabolites|antimetabolites|mesh-ancestor
101852435|NCT00265395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852436|NCT00265395|Immunologic Factors|immunologic factors|mesh-ancestor
101852437|NCT00265395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852438|NCT01582113|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
101852439|NCT01582113|Nootropic Agents|nootropic agents|mesh-ancestor
101852440|NCT00195442|Factor VIII|factor viii|mesh-list
101852441|NCT00195442|Coagulants|coagulants|mesh-ancestor
101852442|NCT01070823|Natalizumab|natalizumab|mesh-list
101852443|NCT01070823|Immunologic Factors|immunologic factors|mesh-ancestor
101852444|NCT01070823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852445|NCT01071135|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101852446|NCT01071135|Antidepressive Agents|antidepressive agents|mesh-ancestor
101852447|NCT01071135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101852448|NCT01071135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101852449|NCT01071135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101852450|NCT01071135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101852451|NCT01071135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852452|NCT00275301|Olanzapine|olanzapine|mesh-list
101852453|NCT00275301|Antiemetics|antiemetics|mesh-ancestor
101852454|NCT00275301|Autonomic Agents|autonomic agents|mesh-ancestor
101852455|NCT00275301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101852456|NCT00275301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852457|NCT00275301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101852458|NCT00275301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101852459|NCT00275301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101852460|NCT00275301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101852461|NCT00275301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101852462|NCT00275301|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101852463|NCT00275301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101852464|NCT00275301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101852465|NCT00275301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852466|NCT00275301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101852467|NCT00275301|Serotonin Agents|serotonin agents|mesh-ancestor
101852468|NCT02531997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
101852469|NCT02531997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101852470|NCT02531997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852471|NCT00251745|Dexlansoprazole|dexlansoprazole|mesh-list
101852473|NCT00251745|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101852474|NCT00251745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101852475|NCT00251745|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101852476|NCT00251745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101852477|NCT00251745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852478|NCT00255190|Dexlansoprazole|dexlansoprazole|mesh-list
101852479|NCT00255190|Lansoprazole|lansoprazole|mesh-list
101852480|NCT00255190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101852481|NCT00255190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101852482|NCT00255190|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101852483|NCT00255190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101852484|NCT00255190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852485|NCT00359424|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101852486|NCT00359424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101852487|NCT00359424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101852488|NCT00359424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852489|NCT01049646|Angiotensin II|angiotensin ii|mesh-list
101852490|NCT01049646|Giapreza|giapreza|mesh-list
101852491|NCT01049646|Angiotensinogen|angiotensinogen|mesh-list
101852492|NCT01049646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101852493|NCT01049646|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101852494|NCT01049646|Protease Inhibitors|protease inhibitors|mesh-ancestor
101852495|NCT01049646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101852496|NCT01049646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852497|NCT02286414|Vitamins|vitamins|mesh-list
101852498|NCT02286414|Vitamin K|vitamin k|mesh-list
101852499|NCT02286414|Warfarin|warfarin|mesh-list
101852500|NCT02286414|Rivaroxaban|rivaroxaban|mesh-list
101852501|NCT02286414|Dabigatran|dabigatran|mesh-list
101852502|NCT02286414|Apixaban|apixaban|mesh-list
101852503|NCT02286414|Acenocoumarol|acenocoumarol|mesh-list
101852504|NCT02286414|Fluindione|fluindione|mesh-list
101852505|NCT02286414|Micronutrients|micronutrients|mesh-ancestor
101852506|NCT02286414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852508|NCT02286414|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101852509|NCT02286414|Antithrombins|antithrombins|mesh-ancestor
101852510|NCT02286414|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101852511|NCT02286414|Protease Inhibitors|protease inhibitors|mesh-ancestor
101852512|NCT02286414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101852513|NCT02286414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852514|NCT02286414|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101852515|NCT02286414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101852516|NCT02286414|Hemostatics|hemostatics|mesh-ancestor
101852517|NCT02286414|Coagulants|coagulants|mesh-ancestor
101852518|NCT00255034|Ribavirin|ribavirin|mesh-list
101852519|NCT00255034|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101852520|NCT00255034|Interferon-alpha|interferon-alpha|mesh-list
101852521|NCT00255034|Antimetabolites|antimetabolites|mesh-ancestor
101852522|NCT00255034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852523|NCT00255034|Antiviral Agents|antiviral agents|mesh-ancestor
101852524|NCT00255034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101852525|NCT00255034|Immunologic Factors|immunologic factors|mesh-ancestor
101852526|NCT00255034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852527|NCT03991104|Oxaliplatin|oxaliplatin|mesh-list
101852528|NCT03991104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101852529|NCT00254566|Azithromycin|azithromycin|mesh-list
101852530|NCT00254566|Moxifloxacin|moxifloxacin|mesh-list
101852531|NCT00254566|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101852532|NCT00254566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101852533|NCT00254566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101852534|NCT00254566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101852535|NCT00254566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101852536|NCT00254566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101852537|NCT00254566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852538|NCT00254566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101852539|NCT00254566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101572363|NCT02797717|Glucocorticoids|glucocorticoids|mesh-ancestor
101852540|NCT00254566|Contraceptive Agents|contraceptive agents|mesh-ancestor
101852541|NCT00254566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101852542|NCT00254566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852543|NCT00254566|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101852544|NCT00254566|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101852545|NCT00254566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101852546|NCT02531854|Pemetrexed|pemetrexed|mesh-list
101852547|NCT02531854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101852548|NCT02531854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101852549|NCT02531854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852550|NCT02531854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101852551|NCT02531854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101852552|NCT01048086|Tretinoin|tretinoin|mesh-list
101852553|NCT01048086|Isotretinoin|isotretinoin|mesh-list
101852554|NCT01048086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101852555|NCT01048086|Keratolytic Agents|keratolytic agents|mesh-ancestor
101852556|NCT01048086|Dermatologic Agents|dermatologic agents|mesh-ancestor
101852557|NCT03830892|Nicotine|nicotine|mesh-list
101852558|NCT03830892|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101852559|NCT03830892|Autonomic Agents|autonomic agents|mesh-ancestor
101852560|NCT03830892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101852561|NCT03830892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852562|NCT03830892|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101852563|NCT03830892|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101852564|NCT03830892|Cholinergic Agents|cholinergic agents|mesh-ancestor
101852565|NCT03830892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101852566|NCT03830892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852567|NCT01049880|Ascorbic Acid|ascorbic acid|mesh-list
101852568|NCT01049880|Gemcitabine|gemcitabine|mesh-list
101852569|NCT01049880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101852570|NCT01049880|Antimetabolites|antimetabolites|mesh-ancestor
101852571|NCT01049880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852572|NCT01049880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101852573|NCT01049880|Antioxidants|antioxidants|mesh-ancestor
101852574|NCT01049880|Protective Agents|protective agents|mesh-ancestor
101852575|NCT01049880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852576|NCT01049880|Vitamins|vitamins|mesh-ancestor
101852577|NCT01049880|Micronutrients|micronutrients|mesh-ancestor
101852578|NCT00253630|Vorinostat|vorinostat|mesh-list
101852579|NCT00253630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101852580|NCT00253630|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101852581|NCT00253630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101852582|NCT00253630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852583|NCT00358644|Decitabine|decitabine|mesh-list
101852584|NCT00358644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101852585|NCT00358644|Antimetabolites|antimetabolites|mesh-ancestor
101852586|NCT00358644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852587|NCT00358644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101852588|NCT00358644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101852589|NCT01048320|Gemcitabine|gemcitabine|mesh-list
101852590|NCT01048320|Oxaliplatin|oxaliplatin|mesh-list
101852591|NCT01048320|Imatinib Mesylate|imatinib mesylate|mesh-list
101852592|NCT01048320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101852593|NCT01048320|Antimetabolites|antimetabolites|mesh-ancestor
101852594|NCT01048320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852595|NCT01048320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101852596|NCT01048320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101852597|NCT01048320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101852598|NCT03990480|Amlodipine|amlodipine|mesh-list
101852599|NCT03990480|Valsartan|valsartan|mesh-list
101852600|NCT03990480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101852601|NCT03990480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101852602|NCT03990480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101852603|NCT03990480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852604|NCT03990480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101852605|NCT03990480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852606|NCT03990480|Vasodilator Agents|vasodilator agents|mesh-ancestor
101852607|NCT03990480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101852608|NCT03990480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101852609|NCT00369486|Triamcinolone|triamcinolone|mesh-list
101852610|NCT00369486|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101852611|NCT00369486|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101852612|NCT00369486|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101572429|NCT02797249|Antipyretics|antipyretics|mesh-ancestor
101852613|NCT00369486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101852614|NCT00369486|Glucocorticoids|glucocorticoids|mesh-ancestor
101852615|NCT00369486|Hormones|hormones|mesh-ancestor
101852616|NCT00369486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101852617|NCT00369486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852618|NCT00369486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101852619|NCT00369486|Immunologic Factors|immunologic factors|mesh-ancestor
101852620|NCT00369486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101852621|NCT00369486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852622|NCT00363480|Fluticasone|fluticasone|mesh-list
101852623|NCT00363480|Albuterol|albuterol|mesh-list
101852624|NCT00363480|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101852625|NCT00363480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101852626|NCT00363480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101852627|NCT00363480|Autonomic Agents|autonomic agents|mesh-ancestor
101852628|NCT00363480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101852629|NCT00363480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852630|NCT00363480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101852631|NCT00363480|Respiratory System Agents|respiratory system agents|mesh-ancestor
101852632|NCT00363480|Dermatologic Agents|dermatologic agents|mesh-ancestor
101852633|NCT00363480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101852634|NCT00363480|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101852635|NCT00363480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101852636|NCT00363480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101852637|NCT00363480|Adrenergic Agents|adrenergic agents|mesh-ancestor
101852638|NCT00363480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101852639|NCT00363480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852640|NCT00363480|Tocolytic Agents|tocolytic agents|mesh-ancestor
101852641|NCT00363480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101852642|NCT03990636|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101852643|NCT03990636|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101852644|NCT03990636|Dermatologic Agents|dermatologic agents|mesh-ancestor
101852645|NCT01048398|Acetaminophen|acetaminophen|mesh-list
101852646|NCT01048398|Remifentanil|remifentanil|mesh-list
101852647|NCT01048398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101852648|NCT01048398|Analgesics|analgesics|mesh-ancestor
101852649|NCT01048398|Sensory System Agents|sensory system agents|mesh-ancestor
101852650|NCT01048398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101520470|NCT00544128|Ritonavir|ritonavir|mesh-list
101852651|NCT01048398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852652|NCT01048398|Antipyretics|antipyretics|mesh-ancestor
101852653|NCT01048398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101852654|NCT01048398|Narcotics|narcotics|mesh-ancestor
101852655|NCT01048398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101852656|NCT01073644|Sunitinib|sunitinib|mesh-list
101852657|NCT01073644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101852658|NCT01073644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101852659|NCT01073644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101852660|NCT01073644|Growth Substances|growth substances|mesh-ancestor
101852661|NCT01073644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852662|NCT01073644|Growth Inhibitors|growth inhibitors|mesh-ancestor
101852663|NCT01073644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101852664|NCT01073644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101852665|NCT01073644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852666|NCT03992586|Methamphetamine|methamphetamine|mesh-list
101852667|NCT03992586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101852668|NCT03992586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852669|NCT03992586|Sympathomimetics|sympathomimetics|mesh-ancestor
101852670|NCT03992586|Autonomic Agents|autonomic agents|mesh-ancestor
101852671|NCT03992586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101852672|NCT03992586|Dopamine Agents|dopamine agents|mesh-ancestor
101852673|NCT03992586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101852674|NCT03992586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852675|NCT03992586|Adrenergic Agents|adrenergic agents|mesh-ancestor
101852676|NCT03992586|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101852677|NCT03992586|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101852678|NCT03992586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101852679|NCT03992586|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101852680|NCT00221104|Pravastatin|pravastatin|mesh-list
101852681|NCT00221104|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101852682|NCT00221104|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101852683|NCT00221104|Antimetabolites|antimetabolites|mesh-ancestor
101852684|NCT00221104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852685|NCT00221104|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101852686|NCT00221104|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101852687|NCT00221104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101852688|NCT00189202|Sirolimus|sirolimus|mesh-list
101852689|NCT00189202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101852691|NCT00189202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101852692|NCT00189202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101852693|NCT00189202|Antifungal Agents|antifungal agents|mesh-ancestor
101852694|NCT00189202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101852695|NCT00189202|Immunologic Factors|immunologic factors|mesh-ancestor
101852696|NCT00189202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852697|NCT01071928|Docetaxel|docetaxel|mesh-list
101852698|NCT01071928|Vadimezan|vadimezan|mesh-list
101852699|NCT01071928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101852700|NCT01071928|Tubulin Modulators|tubulin modulators|mesh-ancestor
101852701|NCT01071928|Antimitotic Agents|antimitotic agents|mesh-ancestor
101852702|NCT01071928|Mitosis Modulators|mitosis modulators|mesh-ancestor
101852703|NCT01071928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852704|NCT00187486|Temozolomide|temozolomide|mesh-list
101852705|NCT00187486|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101852706|NCT00187486|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101852707|NCT00187486|Alkylating Agents|alkylating agents|mesh-ancestor
101852708|NCT00187486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852709|NCT00187486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101852710|NCT00187486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101852711|NCT00187486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101852712|NCT00220636|Aripiprazole|aripiprazole|mesh-list
101852713|NCT00220636|Antidepressive Agents|antidepressive agents|mesh-ancestor
101852714|NCT00220636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101852715|NCT00220636|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101852716|NCT00220636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101852717|NCT00220636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101852718|NCT00220636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852719|NCT00220636|Dopamine Agonists|dopamine agonists|mesh-ancestor
101852720|NCT00220636|Dopamine Agents|dopamine agents|mesh-ancestor
101852721|NCT00220636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101852722|NCT00220636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852723|NCT00220636|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101852724|NCT00220636|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101852725|NCT00220636|Serotonin Agents|serotonin agents|mesh-ancestor
101852726|NCT00220636|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101852727|NCT00220636|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101852728|NCT00220636|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101852729|NCT00220636|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101852730|NCT00362232|Enoxaparin|enoxaparin|mesh-list
101852731|NCT00362232|Rivaroxaban|rivaroxaban|mesh-list
101852732|NCT00362232|Enoxaparin sodium|enoxaparin sodium|mesh-list
101852733|NCT00362232|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101852734|NCT00362232|Antithrombins|antithrombins|mesh-ancestor
101852735|NCT00362232|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101852736|NCT00362232|Protease Inhibitors|protease inhibitors|mesh-ancestor
101852737|NCT00362232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101396121|NCT00327808|Budesonide|budesonide|mesh-list
101852738|NCT00362232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852739|NCT00362232|Anticoagulants|anticoagulants|mesh-ancestor
101852740|NCT00362232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101852741|NCT00362232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101852742|NCT01048554|Bevacizumab|bevacizumab|mesh-list
101852743|NCT01048554|Temozolomide|temozolomide|mesh-list
101852744|NCT01048554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101852745|NCT01048554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101852746|NCT01048554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101852747|NCT01048554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101852748|NCT01048554|Growth Substances|growth substances|mesh-ancestor
101852749|NCT01048554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852750|NCT01048554|Growth Inhibitors|growth inhibitors|mesh-ancestor
101852751|NCT01048554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101852752|NCT01048554|Alkylating Agents|alkylating agents|mesh-ancestor
101964995|NCT01090661|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101852753|NCT01048554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852754|NCT00219544|Pregabalin|pregabalin|mesh-list
101852755|NCT00219544|Analgesics|analgesics|mesh-ancestor
101852756|NCT00219544|Sensory System Agents|sensory system agents|mesh-ancestor
101852757|NCT00219544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101852758|NCT00219544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852759|NCT00219544|Anticonvulsants|anticonvulsants|mesh-ancestor
101852760|NCT00219544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101852761|NCT00219544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101852762|NCT00219544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101572572|NCT03028519|Vitamins|vitamins|mesh-ancestor
101852763|NCT00219544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101852765|NCT00219544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101852766|NCT00219544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101852767|NCT00219544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101852768|NCT00357552|Ritonavir|ritonavir|mesh-list
101852769|NCT00357552|Lopinavir|lopinavir|mesh-list
101852770|NCT00357552|Tenofovir|tenofovir|mesh-list
101852771|NCT00357552|Emtricitabine|emtricitabine|mesh-list
101852772|NCT00357552|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101852773|NCT00357552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101852774|NCT00357552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101852775|NCT00357552|Protease Inhibitors|protease inhibitors|mesh-ancestor
101852776|NCT00357552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101852777|NCT00357552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852778|NCT00357552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101852779|NCT00357552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101852780|NCT00357552|Antiviral Agents|antiviral agents|mesh-ancestor
101852781|NCT00357552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101852782|NCT00357552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101852783|NCT00357552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101852784|NCT00357552|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101852785|NCT00357552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101852786|NCT00187096|Cyclophosphamide|cyclophosphamide|mesh-list
101852787|NCT00187096|Fludarabine|fludarabine|mesh-list
101852788|NCT00187096|Etoposide|etoposide|mesh-list
101852789|NCT00187096|Interleukin-2|interleukin-2|mesh-list
101852790|NCT00187096|Clofarabine|clofarabine|mesh-list
101852791|NCT00187096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101852792|NCT00187096|Immunologic Factors|immunologic factors|mesh-ancestor
101852793|NCT00187096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852794|NCT00187096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101852795|NCT00187096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101852796|NCT00187096|Alkylating Agents|alkylating agents|mesh-ancestor
101852797|NCT00187096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852798|NCT00187096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101852799|NCT00187096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101852800|NCT00187096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101852801|NCT00187096|Antimetabolites|antimetabolites|mesh-ancestor
101852802|NCT00187096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101852803|NCT00187096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101852804|NCT00187096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101852805|NCT00187096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101852806|NCT00187096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101852807|NCT00187096|Analgesics|analgesics|mesh-ancestor
101852808|NCT00187096|Sensory System Agents|sensory system agents|mesh-ancestor
101852809|NCT00187096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101852810|NCT00357396|Melphalan|melphalan|mesh-list
101852811|NCT00357396|Busulfan|busulfan|mesh-list
101852812|NCT00357396|Thiotepa|thiotepa|mesh-list
101852813|NCT00357396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101852814|NCT00357396|Alkylating Agents|alkylating agents|mesh-ancestor
101852815|NCT00357396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852816|NCT00357396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101852817|NCT00357396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101852818|NCT00357396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101852819|NCT00357396|Immunologic Factors|immunologic factors|mesh-ancestor
101852820|NCT00357396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852821|NCT00186628|Acetaminophen|acetaminophen|mesh-list
101852822|NCT00186628|Diphenhydramine|diphenhydramine|mesh-list
101852823|NCT00186628|Promethazine|promethazine|mesh-list
101852824|NCT00186628|Cyclosporine|cyclosporine|mesh-list
101852825|NCT00186628|Hydrocortisone|hydrocortisone|mesh-list
101852826|NCT00186628|Methylprednisolone|methylprednisolone|mesh-list
101852827|NCT00186628|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101852828|NCT00186628|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101852829|NCT00186628|Prednisolone|prednisolone|mesh-list
101852830|NCT00186628|Prednisolone acetate|prednisolone acetate|mesh-list
101852831|NCT00186628|Rituximab|rituximab|mesh-list
101852832|NCT00186628|Granisetron|granisetron|mesh-list
101852833|NCT00186628|Lenograstim|lenograstim|mesh-list
101852834|NCT00186628|Cyclosporins|cyclosporins|mesh-list
101852835|NCT00186628|Thymoglobulin|thymoglobulin|mesh-list
101852836|NCT00186628|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101852837|NCT00186628|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101852838|NCT00186628|Prednisolone phosphate|prednisolone phosphate|mesh-list
101852839|NCT00186628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101852840|NCT00186628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101852841|NCT00186628|Immunologic Factors|immunologic factors|mesh-ancestor
101852842|NCT00186628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852843|NCT00186628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101852844|NCT00186628|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101852845|NCT00186628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101852846|NCT00186628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852847|NCT00186628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101852848|NCT00186628|Antifungal Agents|antifungal agents|mesh-ancestor
101852849|NCT00186628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101852850|NCT00186628|Dermatologic Agents|dermatologic agents|mesh-ancestor
101852851|NCT00186628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101852852|NCT00186628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101852853|NCT00186628|Analgesics|analgesics|mesh-ancestor
101852854|NCT00186628|Sensory System Agents|sensory system agents|mesh-ancestor
101852855|NCT00186628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101852856|NCT00186628|Antipyretics|antipyretics|mesh-ancestor
101852857|NCT00186628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101852858|NCT00186628|Antiemetics|antiemetics|mesh-ancestor
101852859|NCT00186628|Autonomic Agents|autonomic agents|mesh-ancestor
101852860|NCT00186628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101852861|NCT00186628|Glucocorticoids|glucocorticoids|mesh-ancestor
101852862|NCT00186628|Hormones|hormones|mesh-ancestor
101852863|NCT00186628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101852864|NCT00186628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101852865|NCT00186628|Protective Agents|protective agents|mesh-ancestor
101852866|NCT00186628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101852867|NCT00186628|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101852868|NCT00186628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101686461|NCT02845349|Serotonin Agents|serotonin agents|mesh-ancestor
101852869|NCT00186628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101852870|NCT00186628|Anesthetics, Local|anesthetics, local|mesh-ancestor
101852872|NCT00186628|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101852873|NCT00186628|Histamine Antagonists|histamine antagonists|mesh-ancestor
101852874|NCT00186628|Histamine Agents|histamine agents|mesh-ancestor
101852875|NCT00186628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101852876|NCT00186628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101852877|NCT00186628|Antipruritics|antipruritics|mesh-ancestor
101852878|NCT00186628|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101852879|NCT00186628|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101852880|NCT00186628|Serotonin Agents|serotonin agents|mesh-ancestor
101852881|NCT00368550|Sertraline|sertraline|mesh-list
101852882|NCT00368550|Antidepressive Agents|antidepressive agents|mesh-ancestor
101852883|NCT00368550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101852884|NCT00368550|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101852885|NCT00368550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101852886|NCT00368550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101852887|NCT00368550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852888|NCT00368550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101852889|NCT00368550|Serotonin Agents|serotonin agents|mesh-ancestor
101852890|NCT00368550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852891|NCT01050036|Busulfan|busulfan|mesh-list
101852892|NCT01050036|Alkylating Agents|alkylating agents|mesh-ancestor
101965008|NCT05546398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101852893|NCT01050036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852894|NCT01050036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101852896|NCT01050036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852897|NCT01050036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101852898|NCT01050036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101852899|NCT01050036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101852900|NCT00357006|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101852901|NCT00357006|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101852902|NCT00357006|Estradiol|estradiol|mesh-list
101852903|NCT00357006|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101852904|NCT00357006|Estrogens|estrogens|mesh-ancestor
101852905|NCT00357006|Hormones|hormones|mesh-ancestor
101852906|NCT00357006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101852907|NCT00357006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852908|NCT00357006|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101852909|NCT00357006|Contraceptive Agents|contraceptive agents|mesh-ancestor
101852910|NCT00357006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101852911|NCT00357006|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101852912|NCT01050114|Oxybutynin|oxybutynin|mesh-list
101852913|NCT01050114|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101852914|NCT01050114|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101852915|NCT01050114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101852916|NCT01050114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852917|NCT01050114|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101852918|NCT01050114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101852919|NCT01050114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852920|NCT01050114|Cholinergic Agents|cholinergic agents|mesh-ancestor
101852921|NCT01050114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101852922|NCT01050114|Parasympatholytics|parasympatholytics|mesh-ancestor
101852923|NCT01050114|Autonomic Agents|autonomic agents|mesh-ancestor
101852924|NCT01050114|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101852925|NCT01050114|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101852926|NCT01050114|Urological Agents|urological agents|mesh-ancestor
101852927|NCT01048632|Oxandrolone|oxandrolone|mesh-list
101852928|NCT01048632|Androgens|androgens|mesh-ancestor
101852929|NCT01048632|Hormones|hormones|mesh-ancestor
101852930|NCT01048632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101852931|NCT01048632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852932|NCT01048632|Anabolic Agents|anabolic agents|mesh-ancestor
101852933|NCT00165646|Rabeprazole|rabeprazole|mesh-list
101852934|NCT00165646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101852935|NCT00165646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101852936|NCT00165646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101852937|NCT00165646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101852938|NCT00165646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852939|NCT01050270|Acetylcysteine|acetylcysteine|mesh-list
101852940|NCT01050270|Ondansetron|ondansetron|mesh-list
101852941|NCT01050270|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101852942|NCT01050270|Antiemetics|antiemetics|mesh-ancestor
101852943|NCT01050270|Autonomic Agents|autonomic agents|mesh-ancestor
101852944|NCT01050270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101852945|NCT01050270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852946|NCT01050270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101852947|NCT01050270|Antipruritics|antipruritics|mesh-ancestor
101852948|NCT01050270|Dermatologic Agents|dermatologic agents|mesh-ancestor
101852949|NCT01050270|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101852950|NCT01050270|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101852951|NCT01050270|Serotonin Agents|serotonin agents|mesh-ancestor
101852952|NCT01050270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101852953|NCT01050270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852954|NCT01050270|Antiviral Agents|antiviral agents|mesh-ancestor
101852955|NCT01050270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101852956|NCT01050270|Expectorants|expectorants|mesh-ancestor
101852957|NCT01050270|Respiratory System Agents|respiratory system agents|mesh-ancestor
101852958|NCT01050270|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101852959|NCT01050270|Antioxidants|antioxidants|mesh-ancestor
101852960|NCT01050270|Protective Agents|protective agents|mesh-ancestor
101852961|NCT01050270|Antidotes|antidotes|mesh-ancestor
101852962|NCT00367770|Bosentan|bosentan|mesh-list
101852963|NCT00367770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101852965|NCT00367770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852966|NCT00185614|Cyclosporine|cyclosporine|mesh-list
101852967|NCT00185614|Mycophenolic Acid|mycophenolic acid|mesh-list
101852968|NCT00185614|Cyclophosphamide|cyclophosphamide|mesh-list
101852969|NCT00185614|Melphalan|melphalan|mesh-list
101852970|NCT00185614|Cyclosporins|cyclosporins|mesh-list
101852971|NCT00185614|Lenograstim|lenograstim|mesh-list
101852972|NCT00185614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101852973|NCT00185614|Immunologic Factors|immunologic factors|mesh-ancestor
101852974|NCT00185614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852975|NCT00185614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101852976|NCT00185614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101852977|NCT00185614|Alkylating Agents|alkylating agents|mesh-ancestor
101852978|NCT00185614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101852979|NCT00185614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101852980|NCT00185614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101852981|NCT00185614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101852982|NCT00185614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101852983|NCT00185614|Antifungal Agents|antifungal agents|mesh-ancestor
101852984|NCT00185614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101852985|NCT00185614|Dermatologic Agents|dermatologic agents|mesh-ancestor
101852986|NCT00185614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101852987|NCT00185614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101852988|NCT00185614|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101852989|NCT00185614|Antitubercular Agents|antitubercular agents|mesh-ancestor
101852990|NCT00185614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101852991|NCT01075438|Vaccines|vaccines|mesh-list
101852992|NCT01075438|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101852993|NCT01075438|Immunologic Factors|immunologic factors|mesh-ancestor
101852994|NCT01075438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101852995|NCT00361842|Irinotecan|irinotecan|mesh-list
101852996|NCT00361842|Floxuridine|floxuridine|mesh-list
101852997|NCT00361842|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101852998|NCT00361842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101852999|NCT00361842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101853000|NCT00361842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853001|NCT00361842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101853002|NCT00361842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101853003|NCT00361842|Antimetabolites|antimetabolites|mesh-ancestor
101853004|NCT01324752|Losartan|losartan|mesh-list
101853005|NCT01324752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101853006|NCT01324752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101853007|NCT01324752|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101853008|NCT01324752|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101853009|NCT01324752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853010|NCT01050348|Atorvastatin|atorvastatin|mesh-list
101853011|NCT01050348|Calcium|calcium|mesh-list
101853012|NCT01050348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101853013|NCT01050348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853014|NCT01050348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101853016|NCT01050348|Antimetabolites|antimetabolites|mesh-ancestor
101853017|NCT01050348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853018|NCT01050348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101853019|NCT01050348|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101853020|NCT01050348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101853021|NCT01053390|Leucovorin|leucovorin|mesh-list
101853022|NCT01053390|Fluorouracil|fluorouracil|mesh-list
101853023|NCT01053390|Epirubicin|epirubicin|mesh-list
101853024|NCT01053390|Somatostatin|somatostatin|mesh-list
101853025|NCT01053390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101853026|NCT01053390|Antimetabolites|antimetabolites|mesh-ancestor
101853027|NCT01053390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853028|NCT01053390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101853029|NCT01053390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101853030|NCT01053390|Immunologic Factors|immunologic factors|mesh-ancestor
101853031|NCT01053390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853032|NCT01053390|Antidotes|antidotes|mesh-ancestor
101853033|NCT01053390|Protective Agents|protective agents|mesh-ancestor
101853034|NCT01053390|Vitamin B Complex|vitamin b complex|mesh-ancestor
101853036|NCT01053390|Micronutrients|micronutrients|mesh-ancestor
101853037|NCT01053390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101853038|NCT01053390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101853039|NCT01053390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101853040|NCT01053390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101853041|NCT01053390|Hormones|hormones|mesh-ancestor
101853042|NCT01053390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101853043|NCT00356148|Ampicillin|ampicillin|mesh-list
101853044|NCT00356148|Sulbactam|sulbactam|mesh-list
101853045|NCT00356148|Sultamicillin|sultamicillin|mesh-list
101853046|NCT00356148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101853047|NCT00356148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101853048|NCT00356148|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101853049|NCT00356148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101853050|NCT00356148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853051|NCT00361218|Citalopram|citalopram|mesh-list
101853052|NCT00361218|Escitalopram|escitalopram|mesh-list
101853053|NCT00361218|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
101853054|NCT00361218|Serotonin|serotonin|mesh-list
101853055|NCT00361218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101853056|NCT00361218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101853057|NCT00361218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853058|NCT00361218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101853059|NCT00361218|Serotonin Agents|serotonin agents|mesh-ancestor
101853060|NCT00361218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853061|NCT00361218|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101853062|NCT00361218|Antidepressive Agents|antidepressive agents|mesh-ancestor
101853063|NCT00361218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101853064|NCT00361218|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101853065|NCT01049022|Moxifloxacin|moxifloxacin|mesh-list
101853066|NCT01049022|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101853067|NCT01049022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101853068|NCT01049022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101853069|NCT01049022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101853070|NCT01049022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101853071|NCT01049022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101853072|NCT01049022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853073|NCT01049022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101853074|NCT01049022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101853075|NCT01049022|Contraceptive Agents|contraceptive agents|mesh-ancestor
101853076|NCT01049022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101853077|NCT01049022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853078|NCT01049022|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101853079|NCT01049022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101853080|NCT01049022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101853081|NCT02534610|Etoricoxib|etoricoxib|mesh-list
101853082|NCT02534610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101853083|NCT02534610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101853084|NCT02534610|Analgesics|analgesics|mesh-ancestor
101853085|NCT02534610|Sensory System Agents|sensory system agents|mesh-ancestor
101853086|NCT02534610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101853087|NCT02534610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853088|NCT02534610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101853089|NCT02534610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101853090|NCT02534610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101853091|NCT02534610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101853092|NCT02534610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101853093|NCT02534610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853094|NCT01050426|Leucovorin|leucovorin|mesh-list
101853095|NCT01050426|Cetuximab|cetuximab|mesh-list
101853096|NCT01050426|Levoleucovorin|levoleucovorin|mesh-list
101853097|NCT01050426|Antidotes|antidotes|mesh-ancestor
101853098|NCT01050426|Protective Agents|protective agents|mesh-ancestor
101853099|NCT01050426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853100|NCT01050426|Vitamin B Complex|vitamin b complex|mesh-ancestor
101853101|NCT01050426|Vitamins|vitamins|mesh-ancestor
101853102|NCT01050426|Micronutrients|micronutrients|mesh-ancestor
101965023|NCT03653026|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101853103|NCT01050426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101853104|NCT01050426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101853105|NCT00367458|Atorvastatin|atorvastatin|mesh-list
101853106|NCT00367458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101853107|NCT00367458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101853108|NCT00367458|Antimetabolites|antimetabolites|mesh-ancestor
101853109|NCT00367458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853110|NCT00367458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101853111|NCT00367458|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101853112|NCT00367458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101853113|NCT00252694|Candesartan|candesartan|mesh-list
101853114|NCT00252694|Candesartan cilexetil|candesartan cilexetil|mesh-list
101853115|NCT00252694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101853116|NCT00252694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101853117|NCT00252694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101853118|NCT00252694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853119|NCT00185380|Levonorgestrel|levonorgestrel|mesh-list
101853120|NCT00185380|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101853121|NCT00185380|Contraceptive Agents|contraceptive agents|mesh-ancestor
101853122|NCT00185380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101853123|NCT00185380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853124|NCT00185380|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101853125|NCT00185380|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101853126|NCT00185380|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101853127|NCT01077466|Natalizumab|natalizumab|mesh-list
101853128|NCT01077466|Immunologic Factors|immunologic factors|mesh-ancestor
101853129|NCT01077466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853130|NCT00160654|Levetiracetam|levetiracetam|mesh-list
101853131|NCT00160654|Anticonvulsants|anticonvulsants|mesh-ancestor
101853132|NCT00160654|Nootropic Agents|nootropic agents|mesh-ancestor
101853133|NCT01582672|Sunitinib|sunitinib|mesh-list
101853134|NCT01582672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101853135|NCT01582672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101853136|NCT01582672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101853137|NCT01582672|Growth Substances|growth substances|mesh-ancestor
101853138|NCT01582672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101572945|NCT02173405|Cholinergic Agents|cholinergic agents|mesh-ancestor
101853139|NCT01582672|Growth Inhibitors|growth inhibitors|mesh-ancestor
101853140|NCT01582672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101853141|NCT01582672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101853142|NCT01582672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853143|NCT00366678|Vaccines|vaccines|mesh-list
101853144|NCT00366678|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101853145|NCT00366678|Immunologic Factors|immunologic factors|mesh-ancestor
101853146|NCT00366678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853147|NCT01049178|Silymarin|silymarin|mesh-list
101853148|NCT01049178|Antioxidants|antioxidants|mesh-ancestor
101853149|NCT01049178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853150|NCT01049178|Protective Agents|protective agents|mesh-ancestor
101853151|NCT01049178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853152|NCT02534454|Nicotine|nicotine|mesh-list
101853153|NCT02534454|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101853154|NCT02534454|Autonomic Agents|autonomic agents|mesh-ancestor
101853155|NCT02534454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101853156|NCT02534454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853157|NCT02534454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101853158|NCT02534454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101853159|NCT02534454|Cholinergic Agents|cholinergic agents|mesh-ancestor
101853160|NCT02534454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101853161|NCT02534454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853162|NCT00355368|Rocuronium|rocuronium|mesh-list
101853163|NCT00355368|Succinylcholine|succinylcholine|mesh-list
101853164|NCT00355368|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101853165|NCT00355368|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101853166|NCT00355368|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101853167|NCT00355368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101853168|NCT00355368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965028|NCT02232724|Choline|choline|mesh-list
101853169|NCT00355368|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
101853171|NCT01054092|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101853172|NCT01054092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853173|NCT01054092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101853174|NCT01054092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853175|NCT00360282|Rizatriptan|rizatriptan|mesh-list
101853176|NCT00360282|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101853177|NCT00360282|Serotonin Agents|serotonin agents|mesh-ancestor
101853178|NCT00360282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101853179|NCT00360282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853180|NCT00360282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853181|NCT00373958|Vaccines|vaccines|mesh-list
101853182|NCT00373958|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101853183|NCT00373958|Immunologic Factors|immunologic factors|mesh-ancestor
101853184|NCT00373958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853185|NCT00373880|Cocaine|cocaine|mesh-list
101853186|NCT00373880|Aripiprazole|aripiprazole|mesh-list
101853187|NCT00373880|Antidepressive Agents|antidepressive agents|mesh-ancestor
101853188|NCT00373880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101853189|NCT00373880|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101853190|NCT00373880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101853191|NCT00373880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101853192|NCT00373880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853193|NCT00373880|Dopamine Agonists|dopamine agonists|mesh-ancestor
101853194|NCT00373880|Dopamine Agents|dopamine agents|mesh-ancestor
101853195|NCT00373880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101853196|NCT00373880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853197|NCT00373880|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101853198|NCT00373880|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101853199|NCT00373880|Serotonin Agents|serotonin agents|mesh-ancestor
101853200|NCT00373880|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101853201|NCT00373880|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101853202|NCT00373880|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101853203|NCT00373880|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101853204|NCT00373880|Anesthetics, Local|anesthetics, local|mesh-ancestor
101853205|NCT00373880|Anesthetics|anesthetics|mesh-ancestor
101853206|NCT00373880|Sensory System Agents|sensory system agents|mesh-ancestor
101853207|NCT00373880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101853208|NCT00373880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101853209|NCT00373880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101853210|NCT00373880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101573019|NCT04228393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101853211|NCT00373880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101853213|NCT00184600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101853214|NCT00184600|Insulin Aspart|insulin aspart|mesh-list
101853215|NCT00184600|Insulin, Long-Acting|insulin, long-acting|mesh-list
101853216|NCT00184600|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101853217|NCT00184600|Insulin Detemir|insulin detemir|mesh-list
101853218|NCT00184600|Biphasic Insulins|biphasic insulins|mesh-list
101853219|NCT00184600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101853220|NCT00184600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853221|NCT00265317|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101853222|NCT00265317|Sunitinib|sunitinib|mesh-list
101853223|NCT00265317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101853224|NCT00265317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101853225|NCT00265317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101853226|NCT00265317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853227|NCT00265317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101686471|NCT03852251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101853228|NCT00265317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101853229|NCT00265317|Growth Substances|growth substances|mesh-ancestor
101853230|NCT00265317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853231|NCT00265317|Growth Inhibitors|growth inhibitors|mesh-ancestor
101853232|NCT00373490|Vorinostat|vorinostat|mesh-list
101853233|NCT00373490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101853234|NCT00373490|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101853235|NCT00373490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101853236|NCT00373490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853237|NCT00251589|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101853238|NCT00251589|Vorinostat|vorinostat|mesh-list
101853239|NCT00251589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101853240|NCT00251589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101853241|NCT00251589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101853242|NCT00251589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853243|NCT00251589|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101853244|NCT00265239|Edaravone|edaravone|mesh-list
101853245|NCT00265239|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101853246|NCT00265239|Antioxidants|antioxidants|mesh-ancestor
101853247|NCT00265239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853248|NCT00265239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101853249|NCT00265239|Protective Agents|protective agents|mesh-ancestor
101853250|NCT00265239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853251|NCT00159874|Sildenafil Citrate|sildenafil citrate|mesh-list
101853252|NCT00159874|Citric Acid|citric acid|mesh-list
101853253|NCT00159874|Sodium Citrate|sodium citrate|mesh-list
101853254|NCT00159874|Anticoagulants|anticoagulants|mesh-ancestor
101853255|NCT00159874|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101853256|NCT00159874|Chelating Agents|chelating agents|mesh-ancestor
101853257|NCT00159874|Sequestering Agents|sequestering agents|mesh-ancestor
101853258|NCT00159874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853259|NCT00159874|Vasodilator Agents|vasodilator agents|mesh-ancestor
101853260|NCT00159874|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101853261|NCT00159874|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101853262|NCT00159874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101853263|NCT00159874|Urological Agents|urological agents|mesh-ancestor
101853264|NCT00184054|Ascorbic Acid|ascorbic acid|mesh-list
101853265|NCT00184054|Arsenic Trioxide|arsenic trioxide|mesh-list
101853266|NCT00184054|Vitamins|vitamins|mesh-ancestor
101853267|NCT00184054|Micronutrients|micronutrients|mesh-ancestor
101853268|NCT00184054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853269|NCT00184054|Antioxidants|antioxidants|mesh-ancestor
101853270|NCT00184054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853271|NCT00184054|Protective Agents|protective agents|mesh-ancestor
101853272|NCT00184054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101853273|NCT02533908|Fentanyl|fentanyl|mesh-list
101853274|NCT02533908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101853275|NCT02533908|Narcotics|narcotics|mesh-ancestor
101853276|NCT02533908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101853277|NCT02533908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853278|NCT02533908|Analgesics|analgesics|mesh-ancestor
101853279|NCT02533908|Sensory System Agents|sensory system agents|mesh-ancestor
101853280|NCT02533908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101853281|NCT02533908|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101853282|NCT02533908|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101853283|NCT02533908|Anesthetics, General|anesthetics, general|mesh-ancestor
101853284|NCT02533908|Anesthetics|anesthetics|mesh-ancestor
101853285|NCT00183430|Prazosin|prazosin|mesh-list
101853286|NCT00183430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101853287|NCT00183430|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101853288|NCT00183430|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101853289|NCT00183430|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101853290|NCT00183430|Adrenergic Agents|adrenergic agents|mesh-ancestor
101853291|NCT00183430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101853292|NCT00183430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853293|NCT00183430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853294|NCT00183274|Norepinephrine|norepinephrine|mesh-list
101853295|NCT00183274|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101853296|NCT00183274|Serotonin|serotonin|mesh-list
101853297|NCT00183274|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
101853298|NCT00183274|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101853299|NCT00183274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101853300|NCT00183274|Adrenergic Agents|adrenergic agents|mesh-ancestor
101853301|NCT00183274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101965044|NCT04981678|Analgesics|analgesics|mesh-ancestor
101853302|NCT00183274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853303|NCT00183274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853304|NCT00183274|Sympathomimetics|sympathomimetics|mesh-ancestor
101853305|NCT00183274|Autonomic Agents|autonomic agents|mesh-ancestor
101853306|NCT00183274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101853307|NCT00183274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101853308|NCT00183274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101853309|NCT00183274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101853310|NCT00183274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101853311|NCT00183274|Antidepressive Agents|antidepressive agents|mesh-ancestor
101853312|NCT00183274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101853313|NCT00183274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101853314|NCT00183274|Serotonin Agents|serotonin agents|mesh-ancestor
101853315|NCT00183196|Naltrexone|naltrexone|mesh-list
101853316|NCT00183196|Gabapentin|gabapentin|mesh-list
101853317|NCT00183196|Analgesics|analgesics|mesh-ancestor
101853318|NCT00183196|Sensory System Agents|sensory system agents|mesh-ancestor
101853319|NCT00183196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101853320|NCT00183196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853321|NCT00183196|Anticonvulsants|anticonvulsants|mesh-ancestor
101853322|NCT00183196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101853323|NCT00183196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101853324|NCT00183196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101853325|NCT00183196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101240005|NCT01619163|Prednisolone|prednisolone|mesh-list
101853326|NCT00183196|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101853327|NCT00183196|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101853328|NCT00183196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101853329|NCT00183196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853330|NCT00183196|Antimanic Agents|antimanic agents|mesh-ancestor
101853331|NCT00183196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101853332|NCT00183196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101853333|NCT00349752|Certolizumab Pegol|certolizumab pegol|mesh-list
101853334|NCT00349752|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101853335|NCT00349752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101853336|NCT00349752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101853337|NCT00349752|Immunologic Factors|immunologic factors|mesh-ancestor
101853338|NCT00349752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853339|NCT00349752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101853340|NCT01055652|Dapagliflozin|dapagliflozin|mesh-list
101853341|NCT01055652|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101853342|NCT01055652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853343|NCT01055652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101853344|NCT01055652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853345|NCT00348816|Prednisone|prednisone|mesh-list
101853346|NCT00348816|Docetaxel|docetaxel|mesh-list
101853347|NCT00348816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101853348|NCT00348816|Tubulin Modulators|tubulin modulators|mesh-ancestor
101853349|NCT00348816|Antimitotic Agents|antimitotic agents|mesh-ancestor
101853350|NCT00348816|Mitosis Modulators|mitosis modulators|mesh-ancestor
101853351|NCT00348816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853352|NCT00348816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101853353|NCT00348816|Glucocorticoids|glucocorticoids|mesh-ancestor
101853354|NCT00348816|Hormones|hormones|mesh-ancestor
101853355|NCT00348816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101853356|NCT00348816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853357|NCT00348816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101853358|NCT03989310|Manganese|manganese|mesh-list
101853359|NCT03989310|Paclitaxel|paclitaxel|mesh-list
101853360|NCT03989310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101853361|NCT03989310|Gemcitabine|gemcitabine|mesh-list
101853362|NCT03989310|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101853363|NCT03989310|Antibodies|antibodies|mesh-list
101853364|NCT03989310|Immunoglobulins|immunoglobulins|mesh-list
101853365|NCT03989310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101853366|NCT03989310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101853367|NCT03989310|Tubulin Modulators|tubulin modulators|mesh-ancestor
101853368|NCT03989310|Antimitotic Agents|antimitotic agents|mesh-ancestor
101853369|NCT03989310|Mitosis Modulators|mitosis modulators|mesh-ancestor
101853370|NCT03989310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853371|NCT03989310|Immunologic Factors|immunologic factors|mesh-ancestor
101853372|NCT03989310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853373|NCT03989310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101853374|NCT03989310|Antimetabolites|antimetabolites|mesh-ancestor
101853375|NCT03989310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101853376|NCT03989310|Trace Elements|trace elements|mesh-ancestor
101853377|NCT03989310|Micronutrients|micronutrients|mesh-ancestor
101853379|NCT03966898|Anastrozole|anastrozole|mesh-list
101853380|NCT03966898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101853381|NCT03966898|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101853382|NCT03966898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101853383|NCT03966898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101853384|NCT03966898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853385|NCT03966898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101853386|NCT03966898|Hormone Antagonists|hormone antagonists|mesh-ancestor
101853387|NCT03966898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101853388|NCT03966898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853389|NCT03966898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101853390|NCT03989700|Thiamine|thiamine|mesh-list
101853391|NCT03989700|Vitamins|vitamins|mesh-ancestor
101853392|NCT03989700|Micronutrients|micronutrients|mesh-ancestor
101853393|NCT03989700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853394|NCT03989700|Vitamin B Complex|vitamin b complex|mesh-ancestor
101853395|NCT01051284|Gemcitabine|gemcitabine|mesh-list
101853396|NCT01051284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101853397|NCT01051284|Antimetabolites|antimetabolites|mesh-ancestor
101853398|NCT01051284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853399|NCT01051284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101853400|NCT01051362|Carboplatin|carboplatin|mesh-list
101853401|NCT01051362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101853402|NCT01055808|Insulin|insulin|mesh-list
101853403|NCT01055808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101853404|NCT01055808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853405|NCT00265083|Golimumab|golimumab|mesh-list
101853406|NCT00265083|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101853407|NCT00265083|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101853408|NCT00265083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101853409|NCT00265083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101853410|NCT00265083|Immunologic Factors|immunologic factors|mesh-ancestor
101853411|NCT00265083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853412|NCT00264849|Omalizumab|omalizumab|mesh-list
101853413|NCT00264849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101853414|NCT00264849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101853415|NCT00264849|Respiratory System Agents|respiratory system agents|mesh-ancestor
101853416|NCT01073709|Acetaminophen|acetaminophen|mesh-list
101853417|NCT01073709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101853418|NCT01073709|Analgesics|analgesics|mesh-ancestor
101853419|NCT01073709|Sensory System Agents|sensory system agents|mesh-ancestor
101853420|NCT01073709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101853421|NCT01073709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853422|NCT01073709|Antipyretics|antipyretics|mesh-ancestor
101853423|NCT00211809|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101853424|NCT00211809|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101853425|NCT00211809|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101853426|NCT00211809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101853427|NCT00211809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853428|NCT00211809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101853429|NCT00211809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853430|NCT00211809|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101853431|NCT00211809|Antidepressive Agents|antidepressive agents|mesh-ancestor
101853432|NCT00211809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101853433|NCT01071291|Niacin|niacin|mesh-list
101853434|NCT01071291|Nicotinic Acids|nicotinic acids|mesh-list
101853435|NCT01071291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101573266|NCT02772601|Metoprolol|metoprolol|mesh-list
101853436|NCT01071291|Antimetabolites|antimetabolites|mesh-ancestor
101853437|NCT01071291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853438|NCT01071291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101853439|NCT01071291|Vasodilator Agents|vasodilator agents|mesh-ancestor
101853440|NCT01071291|Vitamin B Complex|vitamin b complex|mesh-ancestor
101853441|NCT01071291|Vitamins|vitamins|mesh-ancestor
101853442|NCT01071291|Micronutrients|micronutrients|mesh-ancestor
101853443|NCT01071291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853444|NCT00129766|Palivizumab|palivizumab|mesh-list
101853445|NCT00129766|Antiviral Agents|antiviral agents|mesh-ancestor
101853446|NCT00129766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101853447|NCT00150592|Guanfacine|guanfacine|mesh-list
101853448|NCT00150592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101853449|NCT00150592|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101853450|NCT00150592|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101853451|NCT00150592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101853452|NCT00150592|Adrenergic Agents|adrenergic agents|mesh-ancestor
101853453|NCT00150592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101853454|NCT00150592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853455|NCT00150592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853456|NCT00149890|Cyclosporine|cyclosporine|mesh-list
101853457|NCT00149890|Cyclosporins|cyclosporins|mesh-list
101853458|NCT00149890|Basiliximab|basiliximab|mesh-list
101853459|NCT00149890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101853460|NCT00149890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853461|NCT00149890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101853462|NCT00149890|Immunologic Factors|immunologic factors|mesh-ancestor
101853463|NCT00149890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853464|NCT00149890|Antifungal Agents|antifungal agents|mesh-ancestor
101853465|NCT00149890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101853466|NCT00149890|Dermatologic Agents|dermatologic agents|mesh-ancestor
101853467|NCT00149890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101853468|NCT00149890|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101853469|NCT00174382|Donepezil|donepezil|mesh-list
101853470|NCT00174382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101853471|NCT00174382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101853472|NCT00174382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853473|NCT00174382|Cholinergic Agents|cholinergic agents|mesh-ancestor
101853474|NCT00174382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101853475|NCT00174382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853476|NCT00174382|Nootropic Agents|nootropic agents|mesh-ancestor
101853477|NCT00355134|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101853478|NCT00355134|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101853479|NCT00355134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853480|NCT00355134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101853481|NCT00355134|Immunologic Factors|immunologic factors|mesh-ancestor
101853482|NCT00355134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853483|NCT00171730|Pasireotide|pasireotide|mesh-list
101853484|NCT00171730|Hormones|hormones|mesh-ancestor
101853485|NCT00171730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101853486|NCT00171730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853487|NCT00348348|Moxifloxacin|moxifloxacin|mesh-list
101853488|NCT00348348|Besifloxacin|besifloxacin|mesh-list
101853489|NCT00348348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101853490|NCT00348348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101853491|NCT00348348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101853492|NCT00348348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101853493|NCT00348348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101853494|NCT00348348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853495|NCT00348348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101853496|NCT00354744|Dactinomycin|dactinomycin|mesh-list
101853497|NCT00354744|Cyclophosphamide|cyclophosphamide|mesh-list
101853498|NCT00354744|Ifosfamide|ifosfamide|mesh-list
101853499|NCT00354744|Isophosphamide mustard|isophosphamide mustard|mesh-list
101853500|NCT00354744|Doxorubicin|doxorubicin|mesh-list
101853501|NCT00354744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101853502|NCT00354744|Irinotecan|irinotecan|mesh-list
101853503|NCT00354744|Etoposide|etoposide|mesh-list
101853504|NCT00354744|Vincristine|vincristine|mesh-list
101853505|NCT00354744|Camptothecin|camptothecin|mesh-list
101853506|NCT00354744|Lenograstim|lenograstim|mesh-list
101853507|NCT00354744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101853508|NCT00354744|Immunologic Factors|immunologic factors|mesh-ancestor
101853509|NCT00354744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853510|NCT00354744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101240033|NCT01619176|Analgesics|analgesics|mesh-ancestor
101853511|NCT00354744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101853512|NCT00354744|Alkylating Agents|alkylating agents|mesh-ancestor
101686484|NCT04349982|Hemostatics|hemostatics|mesh-ancestor
101853513|NCT00354744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853514|NCT00354744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101853515|NCT00354744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101853516|NCT00354744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101853517|NCT00354744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101853518|NCT00354744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101853519|NCT00354744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101853520|NCT00354744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101853521|NCT00354744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101853522|NCT00354744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101853523|NCT00354744|Tubulin Modulators|tubulin modulators|mesh-ancestor
101853524|NCT00354744|Antimitotic Agents|antimitotic agents|mesh-ancestor
101853525|NCT00354744|Mitosis Modulators|mitosis modulators|mesh-ancestor
101853526|NCT00354744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101853527|NCT00354744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101853528|NCT00354744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101853529|NCT00354744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101853531|NCT01055964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101853532|NCT01055964|Immunologic Factors|immunologic factors|mesh-ancestor
101853533|NCT01055964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853534|NCT01055964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101853535|NCT01055964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101853536|NCT01055964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853537|NCT01056042|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101853538|NCT01056042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101853539|NCT01056042|Medroxyprogesterone|medroxyprogesterone|mesh-list
101853540|NCT01056042|Gestodene|gestodene|mesh-list
101853541|NCT01056042|Estradiol|estradiol|mesh-list
101853542|NCT01056042|Estrogens|estrogens|mesh-ancestor
101853543|NCT01056042|Hormones|hormones|mesh-ancestor
101853544|NCT01056042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101853545|NCT01056042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853546|NCT01056042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101853547|NCT01056042|Contraceptive Agents|contraceptive agents|mesh-ancestor
101853548|NCT01056042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101853549|NCT01056042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101853550|NCT01056042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101853551|NCT01056042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101853552|NCT01056042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101853553|NCT01056042|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101853554|NCT01056042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101853555|NCT01056042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101853556|NCT01056042|Progestins|progestins|mesh-ancestor
101853557|NCT00373256|Paclitaxel|paclitaxel|mesh-list
101853558|NCT00373256|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101853559|NCT00373256|Bevacizumab|bevacizumab|mesh-list
101853560|NCT00373256|Sunitinib|sunitinib|mesh-list
101853561|NCT00373256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101853562|NCT00373256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101853563|NCT00373256|Tubulin Modulators|tubulin modulators|mesh-ancestor
101853564|NCT00373256|Antimitotic Agents|antimitotic agents|mesh-ancestor
101853565|NCT00373256|Mitosis Modulators|mitosis modulators|mesh-ancestor
101853566|NCT00373256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853567|NCT00373256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101853568|NCT00373256|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101853569|NCT00373256|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101853570|NCT00373256|Growth Substances|growth substances|mesh-ancestor
101853571|NCT00373256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853572|NCT00373256|Growth Inhibitors|growth inhibitors|mesh-ancestor
101240053|NCT01619436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101853573|NCT00373256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101853574|NCT00373256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101853575|NCT01324544|Buprenorphine|buprenorphine|mesh-list
101853576|NCT01324544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101853578|NCT01324544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101853579|NCT01324544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853580|NCT01324544|Analgesics|analgesics|mesh-ancestor
101853581|NCT01324544|Sensory System Agents|sensory system agents|mesh-ancestor
101853582|NCT01324544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101853583|NCT01324544|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101853584|NCT00394082|Paclitaxel|paclitaxel|mesh-list
101853585|NCT00394082|Bevacizumab|bevacizumab|mesh-list
101686487|NCT04315350|Curcumin|curcumin|mesh-list
101853586|NCT00394082|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101853587|NCT00394082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101853588|NCT00394082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101853589|NCT00394082|Tubulin Modulators|tubulin modulators|mesh-ancestor
101853590|NCT00394082|Antimitotic Agents|antimitotic agents|mesh-ancestor
101853591|NCT00394082|Mitosis Modulators|mitosis modulators|mesh-ancestor
101853592|NCT00394082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853593|NCT00394082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101853594|NCT00394082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101853595|NCT00394082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101853596|NCT00394082|Growth Substances|growth substances|mesh-ancestor
101853597|NCT00394082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853598|NCT00394082|Growth Inhibitors|growth inhibitors|mesh-ancestor
101853599|NCT00393848|Ketoconazole|ketoconazole|mesh-list
101853600|NCT00393848|Antifungal Agents|antifungal agents|mesh-ancestor
101853601|NCT00393848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101853602|NCT00393848|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101853603|NCT00393848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101853604|NCT00393848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101853605|NCT00393848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853606|NCT00393848|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101853607|NCT00393848|Hormone Antagonists|hormone antagonists|mesh-ancestor
101853608|NCT00393848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101853609|NCT00393848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853610|NCT00393848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101853611|NCT00393458|Formoterol Fumarate|formoterol fumarate|mesh-list
101853612|NCT00393458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101853613|NCT00393458|Autonomic Agents|autonomic agents|mesh-ancestor
101853614|NCT00393458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101853615|NCT00393458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853616|NCT00393458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101853617|NCT00393458|Respiratory System Agents|respiratory system agents|mesh-ancestor
101853618|NCT00393458|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101853619|NCT00393458|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101853620|NCT00393458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101853621|NCT00393458|Adrenergic Agents|adrenergic agents|mesh-ancestor
101853622|NCT00393458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101853623|NCT00393458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853624|NCT01046006|Dexamethasone|dexamethasone|mesh-list
101853625|NCT01046006|Rituximab|rituximab|mesh-list
101853626|NCT01046006|Bortezomib|bortezomib|mesh-list
101853627|NCT01046006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101853628|NCT01046006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101853629|NCT01046006|Immunologic Factors|immunologic factors|mesh-ancestor
101853630|NCT01046006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853631|NCT01046006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101853632|NCT01046006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101853633|NCT01046006|Antiemetics|antiemetics|mesh-ancestor
101853634|NCT01046006|Autonomic Agents|autonomic agents|mesh-ancestor
101500560|NCT00504933|Cetirizine|cetirizine|mesh-list
101853635|NCT01046006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101853636|NCT01046006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101853637|NCT01046006|Glucocorticoids|glucocorticoids|mesh-ancestor
101853638|NCT01046006|Hormones|hormones|mesh-ancestor
101853639|NCT01046006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101853640|NCT01046006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101853641|NCT01046162|Alprazolam|alprazolam|mesh-list
101853642|NCT01046162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101853643|NCT01046162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101965077|NCT02262598|Telmisartan|telmisartan|mesh-list
101853644|NCT01046162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853645|NCT01046162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101853646|NCT01046162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101853647|NCT01046162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101853648|NCT01046162|GABA Modulators|gaba modulators|mesh-ancestor
101853649|NCT01046162|GABA Agents|gaba agents|mesh-ancestor
101853650|NCT01046162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101853651|NCT01046162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853652|NCT00417482|Risperidone|risperidone|mesh-list
101853653|NCT00417482|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101853654|NCT00417482|Serotonin Agents|serotonin agents|mesh-ancestor
101853655|NCT00417482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101686489|NCT04315350|Glucocorticoids|glucocorticoids|mesh-ancestor
101853656|NCT00417482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853657|NCT00417482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853658|NCT00417482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101853659|NCT00417482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101853660|NCT00417482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101853661|NCT00417482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101853662|NCT00417482|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101853663|NCT00417482|Dopamine Agents|dopamine agents|mesh-ancestor
101853665|NCT00417248|Sorafenib|sorafenib|mesh-list
101853666|NCT00417248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101853667|NCT00417248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101853668|NCT00417248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101853669|NCT00417248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101853670|NCT00417248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101853671|NCT00417248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853672|NCT00417248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101853673|NCT01046240|Palonosetron|palonosetron|mesh-list
101853674|NCT01046240|Antiemetics|antiemetics|mesh-ancestor
101853675|NCT01046240|Autonomic Agents|autonomic agents|mesh-ancestor
101853676|NCT01046240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101853677|NCT01046240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853678|NCT01046240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101853679|NCT01046240|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101853680|NCT01046240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101853681|NCT01046240|Serotonin Agents|serotonin agents|mesh-ancestor
101853682|NCT01046240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101853683|NCT01046240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853684|NCT00392288|Ciclesonide|ciclesonide|mesh-list
101853685|NCT00392288|Glucocorticoids|glucocorticoids|mesh-ancestor
101853686|NCT00392288|Hormones|hormones|mesh-ancestor
101853687|NCT00392288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101853688|NCT00392288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853689|NCT00392288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101853690|NCT00417170|Amlodipine|amlodipine|mesh-list
101853691|NCT00417170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101853692|NCT00417170|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101853693|NCT00417170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101853694|NCT00417170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853695|NCT00417170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101853696|NCT00417170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240078|NCT01619566|Analgesics|analgesics|mesh-ancestor
101853697|NCT00417170|Vasodilator Agents|vasodilator agents|mesh-ancestor
101853698|NCT00392990|Cytarabine|cytarabine|mesh-list
101853699|NCT00392990|Cyclophosphamide|cyclophosphamide|mesh-list
101853700|NCT00392990|Ifosfamide|ifosfamide|mesh-list
101853701|NCT00392990|Rituximab|rituximab|mesh-list
101853702|NCT00392990|Doxorubicin|doxorubicin|mesh-list
101853703|NCT00392990|Methotrexate|methotrexate|mesh-list
101853704|NCT00392990|Etoposide|etoposide|mesh-list
101853705|NCT00392990|Vincristine|vincristine|mesh-list
101853706|NCT00392990|Etoposide phosphate|etoposide phosphate|mesh-list
101853707|NCT00392990|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101853708|NCT00392990|Podophyllotoxin|podophyllotoxin|mesh-list
101853709|NCT00392990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101853710|NCT00392990|Immunologic Factors|immunologic factors|mesh-ancestor
101853711|NCT00392990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853712|NCT00392990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101853713|NCT00392990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101853714|NCT00392990|Alkylating Agents|alkylating agents|mesh-ancestor
101853715|NCT00392990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853716|NCT00392990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101853717|NCT00392990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101853718|NCT00392990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101853719|NCT00392990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101853720|NCT00392990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101853721|NCT00392990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101853722|NCT00392990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101853723|NCT00392990|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101853724|NCT00392990|Abortifacient Agents|abortifacient agents|mesh-ancestor
101853725|NCT00392990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101853726|NCT00392990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101853727|NCT00392990|Antimetabolites|antimetabolites|mesh-ancestor
101853728|NCT00392990|Dermatologic Agents|dermatologic agents|mesh-ancestor
101521556|NCT01227967|Oseltamivir|oseltamivir|mesh-list
101853729|NCT00392990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101853730|NCT00392990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101853731|NCT00392990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101853732|NCT00392990|Antiviral Agents|antiviral agents|mesh-ancestor
101853733|NCT00392990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101853734|NCT00392990|Tubulin Modulators|tubulin modulators|mesh-ancestor
101853735|NCT00392990|Antimitotic Agents|antimitotic agents|mesh-ancestor
101853736|NCT00392990|Mitosis Modulators|mitosis modulators|mesh-ancestor
101853737|NCT00392990|Keratolytic Agents|keratolytic agents|mesh-ancestor
101853738|NCT00249873|Clopidogrel|clopidogrel|mesh-list
101853739|NCT00249873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101853740|NCT00249873|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101853741|NCT00249873|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101853742|NCT00249873|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101853743|NCT00249873|Purinergic Agents|purinergic agents|mesh-ancestor
101853744|NCT00249873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101853745|NCT00249873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853746|NCT00249873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853747|NCT01037348|Ranibizumab|ranibizumab|mesh-list
101853748|NCT01037348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101853749|NCT01037348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101853750|NCT01037348|Growth Substances|growth substances|mesh-ancestor
101853751|NCT01037348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853752|NCT01037348|Growth Inhibitors|growth inhibitors|mesh-ancestor
101853753|NCT01037348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101853755|NCT03490292|Carboplatin|carboplatin|mesh-list
101853756|NCT03490292|Avelumab|avelumab|mesh-list
101853757|NCT03490292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101853758|NCT03490292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101853759|NCT03490292|Tubulin Modulators|tubulin modulators|mesh-ancestor
101853760|NCT03490292|Antimitotic Agents|antimitotic agents|mesh-ancestor
101853761|NCT03490292|Mitosis Modulators|mitosis modulators|mesh-ancestor
101853762|NCT03490292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853763|NCT03490292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101853764|NCT01046630|Ketamine|ketamine|mesh-list
101853765|NCT01046630|Analgesics|analgesics|mesh-ancestor
101853766|NCT01046630|Sensory System Agents|sensory system agents|mesh-ancestor
101853767|NCT01046630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101853768|NCT01046630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853769|NCT01046630|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101853770|NCT01046630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101853771|NCT01046630|Anesthetics, General|anesthetics, general|mesh-ancestor
101853772|NCT01046630|Anesthetics|anesthetics|mesh-ancestor
101853773|NCT01046630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101853774|NCT01046630|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101853775|NCT01046630|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101853776|NCT01046630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101853777|NCT01046630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853778|NCT01046708|Progesterone|progesterone|mesh-list
101853779|NCT01046708|Progestins|progestins|mesh-ancestor
101853780|NCT01046708|Hormones|hormones|mesh-ancestor
101853781|NCT01046708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101965088|NCT04542382|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101853782|NCT01046708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853783|NCT01046786|Methylprednisolone|methylprednisolone|mesh-list
101853784|NCT01046786|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101853785|NCT01046786|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101853786|NCT01046786|Prednisolone|prednisolone|mesh-list
101853787|NCT01046786|Prednisolone acetate|prednisolone acetate|mesh-list
101853788|NCT01046786|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101853789|NCT01046786|Prednisolone phosphate|prednisolone phosphate|mesh-list
101853790|NCT01046786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101853791|NCT01046786|Antiemetics|antiemetics|mesh-ancestor
101853792|NCT01046786|Autonomic Agents|autonomic agents|mesh-ancestor
101853793|NCT01046786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101853794|NCT01046786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853795|NCT01046786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101853796|NCT01046786|Glucocorticoids|glucocorticoids|mesh-ancestor
101853797|NCT01046786|Hormones|hormones|mesh-ancestor
101853798|NCT01046786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101853799|NCT01046786|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101853800|NCT01046786|Protective Agents|protective agents|mesh-ancestor
101853801|NCT01046786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101853802|NCT01046786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101853803|NCT00391976|Tobramycin|tobramycin|mesh-list
101853804|NCT00391976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101853805|NCT00391976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101853806|NCT00762554|Fentanyl|fentanyl|mesh-list
101853807|NCT00762554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101573619|NCT02769013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101853808|NCT00762554|Narcotics|narcotics|mesh-ancestor
101853809|NCT00762554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101853810|NCT00762554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853812|NCT00762554|Sensory System Agents|sensory system agents|mesh-ancestor
101853813|NCT00762554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101853814|NCT00762554|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101853815|NCT00762554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101853816|NCT00762554|Anesthetics, General|anesthetics, general|mesh-ancestor
101853817|NCT00762554|Anesthetics|anesthetics|mesh-ancestor
101853818|NCT00391898|Levodopa|levodopa|mesh-list
101853819|NCT00391898|Carbidopa|carbidopa|mesh-list
101853820|NCT00391898|Entacapone|entacapone|mesh-list
101853821|NCT00391898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101853822|NCT00391898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101853823|NCT00391898|Dopamine Agents|dopamine agents|mesh-ancestor
101240091|NCT01619644|Antimanic Agents|antimanic agents|mesh-ancestor
101853824|NCT00391898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101853825|NCT00391898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853826|NCT00391898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853827|NCT00391898|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101853828|NCT00391898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101853829|NCT00391898|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101853830|NCT01046864|Leucovorin|leucovorin|mesh-list
101853831|NCT01046864|Fluorouracil|fluorouracil|mesh-list
101853832|NCT01046864|Irinotecan|irinotecan|mesh-list
101853833|NCT01046864|Antimetabolites|antimetabolites|mesh-ancestor
101853834|NCT01046864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853835|NCT01046864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101853836|NCT01046864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101853837|NCT01046864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101853838|NCT01046864|Immunologic Factors|immunologic factors|mesh-ancestor
101853839|NCT01046864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853840|NCT01046864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101853841|NCT01046864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101853842|NCT01046864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101853843|NCT01046864|Antidotes|antidotes|mesh-ancestor
101853844|NCT01046864|Protective Agents|protective agents|mesh-ancestor
101853845|NCT01046864|Vitamin B Complex|vitamin b complex|mesh-ancestor
101853846|NCT01046864|Vitamins|vitamins|mesh-ancestor
101853847|NCT01046864|Micronutrients|micronutrients|mesh-ancestor
101853848|NCT01046942|Aspirin|aspirin|mesh-list
101853849|NCT01046942|Clopidogrel|clopidogrel|mesh-list
101853850|NCT01046942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101853851|NCT01046942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101853852|NCT01046942|Analgesics|analgesics|mesh-ancestor
101853853|NCT01046942|Sensory System Agents|sensory system agents|mesh-ancestor
101853854|NCT01046942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101853855|NCT01046942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853856|NCT01046942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101853857|NCT01046942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101853858|NCT01046942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101853859|NCT01046942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101853860|NCT01046942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853861|NCT01046942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101853862|NCT01046942|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101853863|NCT01046942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101853864|NCT01046942|Antipyretics|antipyretics|mesh-ancestor
101853865|NCT01046942|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101853866|NCT01046942|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101853867|NCT01046942|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101853868|NCT01046942|Purinergic Agents|purinergic agents|mesh-ancestor
101573693|NCT04224337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101573694|NCT04224337|Alkylating Agents|alkylating agents|mesh-ancestor
101573709|NCT02764021|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101573710|NCT02764021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101573711|NCT02762617|Tenofovir|tenofovir|mesh-list
101573712|NCT02762617|Antiviral Agents|antiviral agents|mesh-ancestor
101573713|NCT02762617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101573714|NCT02762617|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101573715|NCT02762617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101573716|NCT02762617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101573717|NCT02762617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101573718|NCT02762617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101573719|NCT02762617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101573720|NCT01192152|Metformin|metformin|mesh-list
101573721|NCT01192152|Saxagliptin|saxagliptin|mesh-list
101853870|NCT01049438|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101853871|NCT01049438|Doxycycline|doxycycline|mesh-list
101853872|NCT01049438|Minocycline|minocycline|mesh-list
101853873|NCT01049438|Mupirocin|mupirocin|mesh-list
101853874|NCT01049438|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101853875|NCT01049438|Trimethoprim|trimethoprim|mesh-list
101853876|NCT01049438|Sulfamethoxazole|sulfamethoxazole|mesh-list
101853877|NCT01049438|Hexachlorophene|hexachlorophene|mesh-list
101853878|NCT01049438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101853879|NCT01049438|Antimalarials|antimalarials|mesh-ancestor
101853880|NCT01049438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101853881|NCT01049438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101853882|NCT01049438|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101853883|NCT01049438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101853884|NCT01049438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101853885|NCT01049438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853886|NCT01049438|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101853887|NCT01049438|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101853888|NCT01049438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101853889|NCT01049438|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101853890|NCT01049438|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101853891|NCT01047098|Iron|iron|mesh-list
101853892|NCT01047098|Trace Elements|trace elements|mesh-ancestor
101853893|NCT01047098|Micronutrients|micronutrients|mesh-ancestor
101853894|NCT01047098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853895|NCT00391586|Paclitaxel|paclitaxel|mesh-list
101853896|NCT00391586|Etoposide|etoposide|mesh-list
101853897|NCT00391586|Vinorelbine|vinorelbine|mesh-list
101853898|NCT00391586|Docetaxel|docetaxel|mesh-list
101853899|NCT00391586|Gemcitabine|gemcitabine|mesh-list
101853900|NCT00391586|Irinotecan|irinotecan|mesh-list
101853901|NCT00391586|Pemetrexed|pemetrexed|mesh-list
101853902|NCT00391586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101853903|NCT00391586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101853904|NCT00391586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101853905|NCT00391586|Tubulin Modulators|tubulin modulators|mesh-ancestor
101853906|NCT00391586|Antimitotic Agents|antimitotic agents|mesh-ancestor
101853907|NCT00391586|Mitosis Modulators|mitosis modulators|mesh-ancestor
101853908|NCT00391586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853909|NCT00391586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101853910|NCT00391586|Antimetabolites|antimetabolites|mesh-ancestor
101853911|NCT00391586|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101853912|NCT00391586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101853913|NCT00391586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101853914|NCT00391586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101853915|NCT00391586|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101853916|NCT00391586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101853918|NCT00391430|Sertraline|sertraline|mesh-list
101853919|NCT00391430|Antidepressive Agents|antidepressive agents|mesh-ancestor
101853920|NCT00391430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101853921|NCT00391430|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101853922|NCT00391430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101853923|NCT00391430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101853924|NCT00391430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853925|NCT00391430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101853926|NCT00391430|Serotonin Agents|serotonin agents|mesh-ancestor
101853927|NCT00391430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853928|NCT00391274|Docetaxel|docetaxel|mesh-list
101853929|NCT00391274|Pemetrexed|pemetrexed|mesh-list
101853930|NCT00391274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101853931|NCT00391274|Tubulin Modulators|tubulin modulators|mesh-ancestor
101853932|NCT00391274|Antimitotic Agents|antimitotic agents|mesh-ancestor
101853933|NCT00391274|Mitosis Modulators|mitosis modulators|mesh-ancestor
101853934|NCT00391274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853935|NCT00391274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101853936|NCT00391274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101853937|NCT00391274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101853938|NCT00391118|Paclitaxel|paclitaxel|mesh-list
101853939|NCT00391118|Carboplatin|carboplatin|mesh-list
101853940|NCT00391118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101853941|NCT00391118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101853942|NCT00391118|Tubulin Modulators|tubulin modulators|mesh-ancestor
101853943|NCT00391118|Antimitotic Agents|antimitotic agents|mesh-ancestor
101853944|NCT00391118|Mitosis Modulators|mitosis modulators|mesh-ancestor
101853945|NCT00391118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853947|NCT00390884|Immunologic Factors|immunologic factors|mesh-ancestor
101853948|NCT00390884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853949|NCT01047488|Pregabalin|pregabalin|mesh-list
101853950|NCT01047488|Imipramine|imipramine|mesh-list
101853951|NCT01047488|Analgesics|analgesics|mesh-ancestor
101853952|NCT01047488|Sensory System Agents|sensory system agents|mesh-ancestor
101853953|NCT01047488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101853954|NCT01047488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853955|NCT01047488|Anticonvulsants|anticonvulsants|mesh-ancestor
101853956|NCT01047488|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101853957|NCT01047488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101853958|NCT01047488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853959|NCT01047488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101853960|NCT01047488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101853961|NCT01047488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101853962|NCT01047488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101853963|NCT01047488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101853964|NCT01047488|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101853965|NCT01047488|Antidepressive Agents|antidepressive agents|mesh-ancestor
101853966|NCT01047488|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101853967|NCT01047488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101853968|NCT01047488|Adrenergic Agents|adrenergic agents|mesh-ancestor
101853969|NCT01047488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101853970|NCT01047566|Digoxin|digoxin|mesh-list
101853971|NCT01047566|Dronedarone|dronedarone|mesh-list
101853972|NCT01047566|Calcium Channel Blockers|calcium channel blockers|mesh-list
101853973|NCT01047566|Calcium|calcium|mesh-list
101853974|NCT01047566|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101853975|NCT01047566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101853976|NCT01047566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853977|NCT01047566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101853978|NCT01047566|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101965101|NCT03723538|Analgesics|analgesics|mesh-ancestor
101853979|NCT01047566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101853980|NCT01047566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853981|NCT01047566|Protective Agents|protective agents|mesh-ancestor
101853982|NCT01047566|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101853983|NCT01047566|Adrenergic Agents|adrenergic agents|mesh-ancestor
101853984|NCT01047566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101853985|NCT01047566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101853986|NCT00365846|Alemtuzumab|alemtuzumab|mesh-list
101853987|NCT00365846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101853988|NCT00365846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101853989|NCT00264537|Golimumab|golimumab|mesh-list
101853990|NCT00264537|Methotrexate|methotrexate|mesh-list
101853991|NCT00264537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101853992|NCT00264537|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101853993|NCT00264537|Abortifacient Agents|abortifacient agents|mesh-ancestor
101853994|NCT00264537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101853995|NCT00264537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101853996|NCT00264537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101853997|NCT00264537|Antimetabolites|antimetabolites|mesh-ancestor
101853998|NCT00264537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101853999|NCT00264537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101854000|NCT00264537|Dermatologic Agents|dermatologic agents|mesh-ancestor
101854001|NCT00264537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854002|NCT00264537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101854003|NCT00264537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101854004|NCT00264537|Immunologic Factors|immunologic factors|mesh-ancestor
101854005|NCT00264537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101854006|NCT00264537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101854007|NCT00264537|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101854008|NCT00264537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101854009|NCT00371150|Entecavir|entecavir|mesh-list
101854010|NCT00371150|Antiviral Agents|antiviral agents|mesh-ancestor
101854011|NCT00371150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101854012|NCT00264303|Levocetirizine|levocetirizine|mesh-list
101854013|NCT00264303|Desloratadine|desloratadine|mesh-list
101854014|NCT00264303|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101854015|NCT00264303|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101854016|NCT00264303|Histamine Antagonists|histamine antagonists|mesh-ancestor
101854017|NCT00264303|Histamine Agents|histamine agents|mesh-ancestor
101854018|NCT00264303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101854019|NCT00264303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854020|NCT00264303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854021|NCT00264303|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101854022|NCT00264303|Cholinergic Agents|cholinergic agents|mesh-ancestor
101854023|NCT01071369|Betamethasone|betamethasone|mesh-list
101854024|NCT01071369|Betamethasone Valerate|betamethasone valerate|mesh-list
101854025|NCT01071369|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101854026|NCT01071369|Betamethasone benzoate|betamethasone benzoate|mesh-list
101854027|NCT01071369|Lidocaine|lidocaine|mesh-list
101854028|NCT01071369|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101854029|NCT01071369|Anesthetics, Local|anesthetics, local|mesh-ancestor
101854030|NCT01071369|Anesthetics|anesthetics|mesh-ancestor
101854031|NCT01071369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101854032|NCT01071369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854033|NCT01071369|Sensory System Agents|sensory system agents|mesh-ancestor
101854034|NCT01071369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101854035|NCT01071369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101854036|NCT01071369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101854037|NCT01071369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101854038|NCT01071369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101854039|NCT01071369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854040|NCT01071369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101854041|NCT01071369|Glucocorticoids|glucocorticoids|mesh-ancestor
101854042|NCT01071369|Hormones|hormones|mesh-ancestor
101854043|NCT01071369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101854044|NCT01071369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101854045|NCT01071369|Respiratory System Agents|respiratory system agents|mesh-ancestor
101854046|NCT00370682|Vaccines|vaccines|mesh-list
101854047|NCT00370682|Immunologic Factors|immunologic factors|mesh-ancestor
101854048|NCT00370682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854049|NCT00264147|Diclofenac|diclofenac|mesh-list
101854050|NCT00264147|Etoricoxib|etoricoxib|mesh-list
101854051|NCT00264147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101854052|NCT00264147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101854053|NCT00264147|Analgesics|analgesics|mesh-ancestor
101854054|NCT00264147|Sensory System Agents|sensory system agents|mesh-ancestor
101854055|NCT00264147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101854056|NCT00264147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854057|NCT00264147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101854058|NCT00264147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101854059|NCT00264147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101854060|NCT00264147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854061|NCT00264147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854062|NCT00264147|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101854063|NCT01044446|Dialysis Solutions|dialysis solutions|mesh-list
101854064|NCT01044446|Icodextrin|icodextrin|mesh-list
101854065|NCT01044446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101854066|NCT03971019|Calcium, Dietary|calcium, dietary|mesh-list
101854067|NCT03971019|Atorvastatin|atorvastatin|mesh-list
101854068|NCT03971019|Simvastatin|simvastatin|mesh-list
101854069|NCT03971019|Calcium|calcium|mesh-list
101854070|NCT03971019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101854071|NCT03971019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854072|NCT03971019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101854073|NCT03971019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101854074|NCT03971019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101854075|NCT03971019|Antimetabolites|antimetabolites|mesh-ancestor
101854076|NCT03971019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854077|NCT03971019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101854078|NCT03971019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101854079|NCT03971019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854080|NCT03974685|Niacinamide|niacinamide|mesh-list
101854081|NCT03974685|Niacin|niacin|mesh-list
101854082|NCT03974685|Nicotinic Acids|nicotinic acids|mesh-list
101854083|NCT03974685|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
101854084|NCT03974685|Vitamin B Complex|vitamin b complex|mesh-ancestor
101854085|NCT03974685|Vitamins|vitamins|mesh-ancestor
101854086|NCT03974685|Micronutrients|micronutrients|mesh-ancestor
101854087|NCT03974685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854088|NCT03974685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101854089|NCT03974685|Antimetabolites|antimetabolites|mesh-ancestor
101854090|NCT03974685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854091|NCT03974685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101854092|NCT03974685|Vasodilator Agents|vasodilator agents|mesh-ancestor
101854093|NCT03974685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101854094|NCT00263211|Aspirin|aspirin|mesh-list
101854095|NCT00263211|Clopidogrel|clopidogrel|mesh-list
101854096|NCT00263211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101854097|NCT00263211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101854098|NCT00263211|Analgesics|analgesics|mesh-ancestor
101854099|NCT00263211|Sensory System Agents|sensory system agents|mesh-ancestor
101854100|NCT00263211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101854101|NCT00263211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854102|NCT00263211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101854103|NCT00263211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101854104|NCT00263211|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101854105|NCT00263211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101854106|NCT00263211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854107|NCT00263211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101854108|NCT00263211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101854109|NCT00263211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854110|NCT00263211|Antipyretics|antipyretics|mesh-ancestor
101854111|NCT00263211|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101854112|NCT00263211|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101854113|NCT00263211|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101854114|NCT00263211|Purinergic Agents|purinergic agents|mesh-ancestor
101854115|NCT00263211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101854116|NCT00248625|Acetylcysteine|acetylcysteine|mesh-list
101854117|NCT00248625|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101854118|NCT00248625|Antiviral Agents|antiviral agents|mesh-ancestor
101854119|NCT00248625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101854120|NCT00248625|Expectorants|expectorants|mesh-ancestor
101854121|NCT00248625|Respiratory System Agents|respiratory system agents|mesh-ancestor
101854122|NCT00248625|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101854123|NCT00248625|Antioxidants|antioxidants|mesh-ancestor
101854124|NCT00248625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854125|NCT00248625|Protective Agents|protective agents|mesh-ancestor
101854126|NCT00248625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854127|NCT00248625|Antidotes|antidotes|mesh-ancestor
101854128|NCT00262821|Tirapazamine|tirapazamine|mesh-list
101854129|NCT00262821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101854130|NCT01326117|Tadalafil|tadalafil|mesh-list
101854131|NCT01326117|Vasodilator Agents|vasodilator agents|mesh-ancestor
101854132|NCT01326117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101854133|NCT01326117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101854134|NCT01326117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854135|NCT01326117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854136|NCT01326117|Urological Agents|urological agents|mesh-ancestor
101854137|NCT03970239|Ketanserin|ketanserin|mesh-list
101854138|NCT03970239|Fluorides|fluorides|mesh-list
101854139|NCT03970239|Altanserin|altanserin|mesh-list
101854140|NCT03970239|Cariostatic Agents|cariostatic agents|mesh-ancestor
101854141|NCT03970239|Protective Agents|protective agents|mesh-ancestor
101854142|NCT03970239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854143|NCT03970239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101854144|NCT03970239|Serotonin Agents|serotonin agents|mesh-ancestor
101854145|NCT03970239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101854146|NCT03970239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854147|NCT03970239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101854148|NCT03970239|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101854149|NCT00170950|Amlodipine|amlodipine|mesh-list
101854150|NCT00170950|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101854151|NCT00170950|Benazepril|benazepril|mesh-list
101854152|NCT00170950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101854153|NCT00170950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101854154|NCT00170950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101854155|NCT00170950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854156|NCT00170950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101854157|NCT00170950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854158|NCT00170950|Vasodilator Agents|vasodilator agents|mesh-ancestor
101854159|NCT00170950|Diuretics|diuretics|mesh-ancestor
101854160|NCT00170950|Natriuretic Agents|natriuretic agents|mesh-ancestor
101854161|NCT00170950|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101854162|NCT00170950|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101854163|NCT00170950|Protease Inhibitors|protease inhibitors|mesh-ancestor
101854164|NCT00170950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854165|NCT00262041|Vaccines|vaccines|mesh-list
101854166|NCT00262041|Immunologic Factors|immunologic factors|mesh-ancestor
101854167|NCT00262041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854168|NCT00208767|Valsartan|valsartan|mesh-list
101854169|NCT00208767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101854170|NCT00208767|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101854171|NCT00208767|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101854172|NCT00208767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854174|NCT02531529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101854175|NCT02531529|Narcotics|narcotics|mesh-ancestor
101854176|NCT02531529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101854177|NCT02531529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854178|NCT02531529|Analgesics|analgesics|mesh-ancestor
101854179|NCT02531529|Sensory System Agents|sensory system agents|mesh-ancestor
101854180|NCT02531529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101854181|NCT02531529|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101854182|NCT02531529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101854183|NCT02531529|Anesthetics, General|anesthetics, general|mesh-ancestor
101854184|NCT02531529|Anesthetics|anesthetics|mesh-ancestor
101854186|NCT01071525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101854187|NCT01071525|Antimetabolites|antimetabolites|mesh-ancestor
101854188|NCT01071525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854189|NCT01071525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101854190|NCT01071525|Vasodilator Agents|vasodilator agents|mesh-ancestor
101854191|NCT01071525|Vitamin B Complex|vitamin b complex|mesh-ancestor
101854192|NCT01071525|Vitamins|vitamins|mesh-ancestor
101854193|NCT01071525|Micronutrients|micronutrients|mesh-ancestor
101854194|NCT01071525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854195|NCT01072695|Ribavirin|ribavirin|mesh-list
101854196|NCT01072695|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101854197|NCT01072695|Antimetabolites|antimetabolites|mesh-ancestor
101240163|NCT01620112|Sympatholytics|sympatholytics|mesh-ancestor
101854198|NCT01072695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854199|NCT01072695|Antiviral Agents|antiviral agents|mesh-ancestor
101854200|NCT01072695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101854201|NCT00390806|Topotecan|topotecan|mesh-list
101854202|NCT00390806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101854203|NCT00390806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101854204|NCT00390806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854205|NCT00390806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854206|NCT00390806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101854207|NCT00135200|Tositumomab I-131|tositumomab i-131|mesh-list
101854208|NCT00135200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101854209|NCT01047722|Aspirin|aspirin|mesh-list
101854210|NCT01047722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101854211|NCT01047722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101854212|NCT01047722|Analgesics|analgesics|mesh-ancestor
101854213|NCT01047722|Sensory System Agents|sensory system agents|mesh-ancestor
101854214|NCT01047722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101854215|NCT01047722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854216|NCT01047722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101854217|NCT01047722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101854218|NCT01047722|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101854219|NCT01047722|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101854220|NCT01047722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854221|NCT01047722|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101854222|NCT01047722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101854223|NCT01047722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854224|NCT01047722|Antipyretics|antipyretics|mesh-ancestor
101854225|NCT00390416|Leucovorin|leucovorin|mesh-list
101854226|NCT00390416|Bevacizumab|bevacizumab|mesh-list
101854227|NCT00390416|Docetaxel|docetaxel|mesh-list
101854228|NCT00390416|Fluorouracil|fluorouracil|mesh-list
101854229|NCT00390416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101854230|NCT00390416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101854231|NCT00390416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101854232|NCT00390416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101854233|NCT00390416|Growth Substances|growth substances|mesh-ancestor
101854234|NCT00390416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854235|NCT00390416|Growth Inhibitors|growth inhibitors|mesh-ancestor
101854236|NCT00390416|Tubulin Modulators|tubulin modulators|mesh-ancestor
101854237|NCT00390416|Antimitotic Agents|antimitotic agents|mesh-ancestor
101854238|NCT00390416|Mitosis Modulators|mitosis modulators|mesh-ancestor
101854239|NCT00390416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854240|NCT00390416|Antimetabolites|antimetabolites|mesh-ancestor
101854241|NCT00390416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101854242|NCT00390416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101854243|NCT00390416|Immunologic Factors|immunologic factors|mesh-ancestor
101574073|NCT02855632|Hormones|hormones|mesh-list
101854245|NCT00390416|Protective Agents|protective agents|mesh-ancestor
101854246|NCT00390416|Vitamin B Complex|vitamin b complex|mesh-ancestor
101854247|NCT00390416|Vitamins|vitamins|mesh-ancestor
101854248|NCT00390416|Micronutrients|micronutrients|mesh-ancestor
101854249|NCT00261495|Oxycodone|oxycodone|mesh-list
101854250|NCT00261495|Hydromorphone|hydromorphone|mesh-list
101854251|NCT00261495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101854252|NCT00261495|Narcotics|narcotics|mesh-ancestor
101965131|NCT02262676|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101854253|NCT00261495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101854254|NCT00261495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854255|NCT00261495|Analgesics|analgesics|mesh-ancestor
101854256|NCT00261495|Sensory System Agents|sensory system agents|mesh-ancestor
101854257|NCT00261495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101854258|NCT00168844|Tiotropium Bromide|tiotropium bromide|mesh-list
101854259|NCT00168844|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101854260|NCT00168844|Autonomic Agents|autonomic agents|mesh-ancestor
101854261|NCT00168844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101854262|NCT00168844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854263|NCT00168844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101854264|NCT00168844|Respiratory System Agents|respiratory system agents|mesh-ancestor
101854265|NCT00168844|Parasympatholytics|parasympatholytics|mesh-ancestor
101854266|NCT00168844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101854267|NCT00168844|Cholinergic Agents|cholinergic agents|mesh-ancestor
101854268|NCT00168844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101854269|NCT00168844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854270|NCT00365456|Risedronic Acid|risedronic acid|mesh-list
101854271|NCT00365456|Hormones|hormones|mesh-list
101854272|NCT00365456|Parathyroid Hormone|parathyroid hormone|mesh-list
101854273|NCT00365456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101854274|NCT00365456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854275|NCT00365456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101854276|NCT00365456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101854277|NCT00365456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854278|NCT00365456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101854279|NCT00365456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101854280|NCT01047956|Methadone|methadone|mesh-list
101854281|NCT01047956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101854282|NCT01047956|Narcotics|narcotics|mesh-ancestor
101854283|NCT01047956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101854284|NCT01047956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854285|NCT01047956|Analgesics|analgesics|mesh-ancestor
101854286|NCT01047956|Sensory System Agents|sensory system agents|mesh-ancestor
101854287|NCT01047956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101854288|NCT01047956|Antitussive Agents|antitussive agents|mesh-ancestor
101854289|NCT01047956|Respiratory System Agents|respiratory system agents|mesh-ancestor
101854290|NCT03480698|Cerebrolysin|cerebrolysin|mesh-list
101854291|NCT03480698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101854292|NCT03480698|Protective Agents|protective agents|mesh-ancestor
101854293|NCT03480698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854294|NCT03480698|Nootropic Agents|nootropic agents|mesh-ancestor
101854295|NCT00206427|Lapatinib|lapatinib|mesh-list
101854296|NCT00206427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101854297|NCT00206427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101854298|NCT00206427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854299|NCT00206427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854300|NCT00389324|Immunoglobulins|immunoglobulins|mesh-list
101854301|NCT00389324|Antibodies|antibodies|mesh-list
101854302|NCT00389324|gamma-Globulins|gamma-globulins|mesh-list
101854303|NCT00389324|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101854304|NCT00389324|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101854305|NCT00389324|Immunoglobulin G|immunoglobulin g|mesh-list
101854306|NCT00389324|Immunologic Factors|immunologic factors|mesh-ancestor
101854307|NCT00389324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854308|NCT00365300|Pantoprazole|pantoprazole|mesh-list
101854309|NCT00365300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101854310|NCT00365300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101854311|NCT00365300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101854312|NCT00365300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854313|NCT00365300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854314|NCT01048034|Azacitidine|azacitidine|mesh-list
101854315|NCT01048034|Epoetin Alfa|epoetin alfa|mesh-list
101854316|NCT01048034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101854317|NCT01048034|Antimetabolites|antimetabolites|mesh-ancestor
101854318|NCT01048034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854319|NCT01048034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101854320|NCT01048034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854322|NCT00370292|Pemetrexed|pemetrexed|mesh-list
101854323|NCT00370292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101854324|NCT00370292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854325|NCT00370292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854326|NCT00370292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101854327|NCT00370292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101854329|NCT01049672|Heroin|heroin|mesh-list
101854330|NCT01049672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101854331|NCT01049672|Narcotics|narcotics|mesh-ancestor
101854332|NCT01049672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101854333|NCT01049672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854334|NCT01049672|Analgesics|analgesics|mesh-ancestor
101854335|NCT01049672|Sensory System Agents|sensory system agents|mesh-ancestor
101854336|NCT01049672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101854337|NCT01049672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101854338|NCT01049672|Anesthetics, General|anesthetics, general|mesh-ancestor
101854339|NCT01049672|Anesthetics|anesthetics|mesh-ancestor
101854340|NCT01048190|Vaccines|vaccines|mesh-list
101854341|NCT01048190|Immunologic Factors|immunologic factors|mesh-ancestor
101854342|NCT01048190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854343|NCT01048268|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
101854344|NCT01048268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101854345|NCT01048268|Incretins|incretins|mesh-ancestor
101854346|NCT01048268|Hormones|hormones|mesh-ancestor
101854347|NCT01048268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101854348|NCT01048268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854349|NCT03993236|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101854350|NCT03993236|Ezetimibe|ezetimibe|mesh-list
101854351|NCT03993236|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101854352|NCT03993236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101854353|NCT03993236|Antimetabolites|antimetabolites|mesh-ancestor
101854354|NCT03993236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854355|NCT03993236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101854356|NCT03993236|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101854357|NCT03993236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854358|NCT00388154|Cisplatin|cisplatin|mesh-list
101854359|NCT00388154|Gemcitabine|gemcitabine|mesh-list
101854360|NCT00388154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101854361|NCT00388154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101854362|NCT00388154|Antimetabolites|antimetabolites|mesh-ancestor
101854363|NCT00388154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854364|NCT02535104|Ranpirnase|ranpirnase|mesh-list
101854365|NCT02535104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101854366|NCT02535104|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101854367|NCT02535104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854368|NCT02535104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854369|NCT00386360|Risedronic Acid|risedronic acid|mesh-list
101854370|NCT00386360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101854371|NCT00386360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101686507|NCT04958772|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101854372|NCT00386360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854373|NCT00386360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101854374|NCT00386360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854375|NCT00386360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101854377|NCT00369278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101854378|NCT00369278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101854379|NCT00369278|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101854380|NCT00369278|Antitubercular Agents|antitubercular agents|mesh-ancestor
101854381|NCT00369278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101854382|NCT00369278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101854383|NCT00369278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854384|NCT00369278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854385|NCT00529373|Calcium, Dietary|calcium, dietary|mesh-list
101854386|NCT00529373|Vitamin D|vitamin d|mesh-list
101854387|NCT00529373|Cholecalciferol|cholecalciferol|mesh-list
101854388|NCT00529373|Calcium Carbonate|calcium carbonate|mesh-list
101854389|NCT00529373|Calcium|calcium|mesh-list
101854390|NCT00529373|Vitamins|vitamins|mesh-ancestor
101854391|NCT00529373|Micronutrients|micronutrients|mesh-ancestor
101854392|NCT00529373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965140|NCT02233582|Sensory System Agents|sensory system agents|mesh-ancestor
101854393|NCT00529373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101854394|NCT00529373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101854396|NCT00529373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854397|NCT00529373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101854398|NCT00369122|Bevacizumab|bevacizumab|mesh-list
101854399|NCT00369122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101854400|NCT00369122|Cisplatin|cisplatin|mesh-list
101854401|NCT00369122|Endothelial Growth Factors|endothelial growth factors|mesh-list
101854402|NCT00369122|Antibodies|antibodies|mesh-list
101854403|NCT00369122|Immunoglobulins|immunoglobulins|mesh-list
101854404|NCT00369122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101854405|NCT00369122|Immunoglobulin G|immunoglobulin g|mesh-list
101854406|NCT00369122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101854407|NCT00369122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101854408|NCT00369122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101854409|NCT00369122|Growth Substances|growth substances|mesh-ancestor
101854410|NCT00369122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854411|NCT00369122|Growth Inhibitors|growth inhibitors|mesh-ancestor
101854412|NCT00369122|Immunologic Factors|immunologic factors|mesh-ancestor
101854413|NCT03999203|Nitric Oxide|nitric oxide|mesh-list
101854414|NCT03999203|Citric Acid|citric acid|mesh-list
101854415|NCT03999203|Sodium Citrate|sodium citrate|mesh-list
101854416|NCT03999203|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101854417|NCT03999203|Autonomic Agents|autonomic agents|mesh-ancestor
101854418|NCT03999203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101854419|NCT03999203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854420|NCT03999203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101854421|NCT03999203|Respiratory System Agents|respiratory system agents|mesh-ancestor
101854422|NCT03999203|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101854423|NCT03999203|Antioxidants|antioxidants|mesh-ancestor
101854424|NCT03999203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854425|NCT03999203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101854426|NCT03999203|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101854427|NCT03999203|Vasodilator Agents|vasodilator agents|mesh-ancestor
101854428|NCT03999203|Gasotransmitters|gasotransmitters|mesh-ancestor
101854429|NCT03999203|Protective Agents|protective agents|mesh-ancestor
101854430|NCT03999203|Anticoagulants|anticoagulants|mesh-ancestor
101854431|NCT03999203|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101854432|NCT03999203|Chelating Agents|chelating agents|mesh-ancestor
101854433|NCT03999203|Sequestering Agents|sequestering agents|mesh-ancestor
101854434|NCT04854395|Bupivacaine|bupivacaine|mesh-list
101854435|NCT04854395|Anesthetics, Local|anesthetics, local|mesh-ancestor
101854436|NCT04854395|Anesthetics|anesthetics|mesh-ancestor
101854437|NCT04854395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101854438|NCT04854395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854439|NCT04854395|Sensory System Agents|sensory system agents|mesh-ancestor
101854440|NCT04854395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101854441|NCT05173493|Amoxicillin|amoxicillin|mesh-list
101854442|NCT05173493|Levofloxacin|levofloxacin|mesh-list
101854443|NCT05173493|Tetracycline|tetracycline|mesh-list
101854444|NCT05173493|Furazolidone|furazolidone|mesh-list
101854445|NCT05173493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101854446|NCT05173493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101854447|NCT05173493|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101854448|NCT05173493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101854449|NCT05173493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101854450|NCT05173493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854451|NCT05173493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854452|NCT05173493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101854453|NCT05173493|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101854454|NCT05173493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101854455|NCT05173493|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101854456|NCT05173493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101240208|NCT01620333|Insulin|insulin|mesh-list
101854457|NCT05173493|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
101854458|NCT05173493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101854459|NCT05173493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101854460|NCT05173493|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101854461|NCT03872843|Ibuprofen|ibuprofen|mesh-list
101854462|NCT03872843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101854463|NCT03872843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101854464|NCT03872843|Analgesics|analgesics|mesh-ancestor
101854465|NCT03872843|Sensory System Agents|sensory system agents|mesh-ancestor
101854466|NCT03872843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101574300|NCT02855788|Antidotes|antidotes|mesh-ancestor
101854467|NCT03872843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854468|NCT03872843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101854469|NCT03872843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101854470|NCT03872843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101854471|NCT03872843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854472|NCT03872843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854473|NCT03966040|Vaccines|vaccines|mesh-list
101854474|NCT03966040|Immunologic Factors|immunologic factors|mesh-ancestor
101854475|NCT03966040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854476|NCT03999125|Dexamethasone|dexamethasone|mesh-list
101854477|NCT03999125|Dexamethasone acetate|dexamethasone acetate|mesh-list
101854478|NCT03999125|Ranibizumab|ranibizumab|mesh-list
101854479|NCT03999125|Aflibercept|aflibercept|mesh-list
101854480|NCT03999125|BB 1101|bb 1101|mesh-list
101854481|NCT03999125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101854482|NCT03999125|Antiemetics|antiemetics|mesh-ancestor
101854483|NCT03999125|Autonomic Agents|autonomic agents|mesh-ancestor
101854484|NCT03999125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101854485|NCT03999125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854486|NCT03999125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101854487|NCT03999125|Glucocorticoids|glucocorticoids|mesh-ancestor
101854488|NCT03999125|Hormones|hormones|mesh-ancestor
101854489|NCT03999125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101854490|NCT03999125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101854491|NCT03999125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101854492|NCT03999125|Protease Inhibitors|protease inhibitors|mesh-ancestor
101854493|NCT03999125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854494|NCT03999125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854495|NCT03999125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101854496|NCT03999125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101854497|NCT03999125|Growth Substances|growth substances|mesh-ancestor
101854498|NCT03999125|Growth Inhibitors|growth inhibitors|mesh-ancestor
101854499|NCT00168064|Mechlorethamine|mechlorethamine|mesh-list
101854500|NCT00168064|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
101854501|NCT00168064|Alkylating Agents|alkylating agents|mesh-ancestor
101854502|NCT00168064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854503|NCT00168064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101854504|NCT00168064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101854505|NCT00166114|Desipramine|desipramine|mesh-list
101854506|NCT00166114|Escitalopram|escitalopram|mesh-list
101854507|NCT00166114|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101854508|NCT00166114|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101854509|NCT00166114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101854510|NCT00166114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854511|NCT00166114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101854512|NCT00166114|Serotonin Agents|serotonin agents|mesh-ancestor
101854513|NCT00166114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854514|NCT00166114|Antidepressive Agents|antidepressive agents|mesh-ancestor
101854515|NCT00166114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101854516|NCT00166114|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101854517|NCT00166114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854518|NCT00166114|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101240213|NCT01620333|Biphasic Insulins|biphasic insulins|mesh-list
101854519|NCT00166114|Adrenergic Agents|adrenergic agents|mesh-ancestor
101854520|NCT05032781|Minocycline|minocycline|mesh-list
101854521|NCT05032781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101854522|NCT05032781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101854523|NCT00129376|Cyclophosphamide|cyclophosphamide|mesh-list
101854524|NCT00129376|Docetaxel|docetaxel|mesh-list
101854525|NCT00129376|Doxorubicin|doxorubicin|mesh-list
101854526|NCT00129376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101854527|NCT00129376|Immunologic Factors|immunologic factors|mesh-ancestor
101854528|NCT00129376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854529|NCT00129376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101854530|NCT00129376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101854531|NCT00129376|Alkylating Agents|alkylating agents|mesh-ancestor
101854532|NCT00129376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854533|NCT00129376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101854534|NCT00129376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101854535|NCT00129376|Tubulin Modulators|tubulin modulators|mesh-ancestor
101854536|NCT00129376|Antimitotic Agents|antimitotic agents|mesh-ancestor
101854537|NCT00129376|Mitosis Modulators|mitosis modulators|mesh-ancestor
101854538|NCT00129376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101854539|NCT00129376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101854540|NCT00129376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101854541|NCT00129376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854542|NCT04878107|Docetaxel|docetaxel|mesh-list
101854543|NCT04878107|Apatinib|apatinib|mesh-list
101854544|NCT04878107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101854545|NCT04878107|Tubulin Modulators|tubulin modulators|mesh-ancestor
101854546|NCT04878107|Antimitotic Agents|antimitotic agents|mesh-ancestor
101854547|NCT04878107|Mitosis Modulators|mitosis modulators|mesh-ancestor
101854548|NCT04878107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854549|NCT04878107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101854550|NCT04878107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854551|NCT03998969|Pantoprazole|pantoprazole|mesh-list
101854552|NCT03998969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101854553|NCT03998969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101854554|NCT03998969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101854555|NCT03998969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854556|NCT03998969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854557|NCT00129220|Haloperidol|haloperidol|mesh-list
101854558|NCT00129220|Olanzapine|olanzapine|mesh-list
101854559|NCT00129220|Haloperidol decanoate|haloperidol decanoate|mesh-list
101854560|NCT00129220|Antiemetics|antiemetics|mesh-ancestor
101854561|NCT00129220|Autonomic Agents|autonomic agents|mesh-ancestor
101854562|NCT00129220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101854563|NCT00129220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854564|NCT00129220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101854565|NCT00129220|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101854566|NCT00129220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101854567|NCT00129220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101854568|NCT00129220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101854569|NCT00129220|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101854570|NCT00129220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101854571|NCT00129220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101854572|NCT00129220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854573|NCT00129220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101854574|NCT00129220|Serotonin Agents|serotonin agents|mesh-ancestor
101854575|NCT00129220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101854576|NCT00129220|Dopamine Agents|dopamine agents|mesh-ancestor
101854577|NCT00129220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101854578|NCT03686813|Sildenafil Citrate|sildenafil citrate|mesh-list
101854579|NCT03686813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854580|NCT03686813|Vasodilator Agents|vasodilator agents|mesh-ancestor
101854581|NCT03686813|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101854582|NCT03686813|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101854583|NCT03686813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854584|NCT03686813|Urological Agents|urological agents|mesh-ancestor
101854585|NCT00128830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
101854586|NCT00128830|Etravirine|etravirine|mesh-list
101854587|NCT00128830|Enfuvirtide|enfuvirtide|mesh-list
101854588|NCT00128830|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
101854589|NCT00128830|Protease Inhibitors|protease inhibitors|mesh-list
101854590|NCT00128830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101854591|NCT00128830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854592|NCT00128830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854593|NCT00128830|Antiviral Agents|antiviral agents|mesh-ancestor
101854594|NCT00128830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101854595|NCT00128830|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101854596|NCT00128830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101854597|NCT00128830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101854598|NCT00128830|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101854599|NCT00128830|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101854600|NCT01074892|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101854601|NCT01074892|Levonorgestrel|levonorgestrel|mesh-list
101854602|NCT01074892|Medroxyprogesterone|medroxyprogesterone|mesh-list
101854603|NCT01074892|Progestins|progestins|mesh-list
101854604|NCT01074892|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101854605|NCT01074892|Contraceptive Agents|contraceptive agents|mesh-ancestor
101854606|NCT01074892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101854607|NCT01074892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854608|NCT01074892|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101854609|NCT01074892|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101854610|NCT01074892|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101854611|NCT01074892|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101854612|NCT01074892|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101854613|NCT01074892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101854614|NCT01074892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101854615|NCT01074892|Hormones|hormones|mesh-ancestor
101854616|NCT01074892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101854617|NCT00128206|Rifampin|rifampin|mesh-list
101854618|NCT00128206|Isoniazid|isoniazid|mesh-list
101854619|NCT00128206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101854620|NCT00128206|Antitubercular Agents|antitubercular agents|mesh-ancestor
101854621|NCT00128206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101854622|NCT00128206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101854623|NCT00128206|Leprostatic Agents|leprostatic agents|mesh-ancestor
101854624|NCT00128206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101854625|NCT00128206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854626|NCT00128206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854627|NCT00128206|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101854628|NCT00128206|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101854629|NCT00128206|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101854630|NCT00128206|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101854631|NCT00128206|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101854632|NCT00128206|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101854633|NCT00128206|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101854634|NCT00128206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101854635|NCT00128206|Antimetabolites|antimetabolites|mesh-ancestor
101854636|NCT00128206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101854637|NCT01075828|Cetuximab|cetuximab|mesh-list
101854638|NCT01075828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101854639|NCT01075828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101854640|NCT01074970|Cisplatin|cisplatin|mesh-list
101854641|NCT01074970|Rucaparib|rucaparib|mesh-list
101854642|NCT01074970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101854643|NCT01074970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101854644|NCT01074970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854645|NCT01074970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854646|NCT03968146|Acetaminophen|acetaminophen|mesh-list
101854647|NCT03968146|Ketorolac|ketorolac|mesh-list
101854648|NCT03968146|Fentanyl|fentanyl|mesh-list
101854649|NCT03968146|Meperidine|meperidine|mesh-list
101854650|NCT03968146|Morphine|morphine|mesh-list
101854651|NCT03968146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101854652|NCT03968146|Narcotics|narcotics|mesh-ancestor
101854653|NCT03968146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101854654|NCT03968146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854655|NCT03968146|Analgesics|analgesics|mesh-ancestor
101854656|NCT03968146|Sensory System Agents|sensory system agents|mesh-ancestor
101854657|NCT03968146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101854658|NCT03968146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101854659|NCT03968146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101854660|NCT03968146|Anesthetics, General|anesthetics, general|mesh-ancestor
101854662|NCT03968146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101854663|NCT03968146|Antipyretics|antipyretics|mesh-ancestor
101854664|NCT03968146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101854665|NCT03968146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101854666|NCT03968146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101854667|NCT03968146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101854668|NCT03968146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854669|NCT03968146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854670|NCT03966118|Paclitaxel|paclitaxel|mesh-list
101854671|NCT03966118|Avelumab|avelumab|mesh-list
101854672|NCT03966118|Ramucirumab|ramucirumab|mesh-list
101854673|NCT03966118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101854674|NCT03966118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101854675|NCT03966118|Tubulin Modulators|tubulin modulators|mesh-ancestor
101854676|NCT03966118|Antimitotic Agents|antimitotic agents|mesh-ancestor
101854677|NCT03966118|Mitosis Modulators|mitosis modulators|mesh-ancestor
101854678|NCT03966118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854679|NCT03966118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101854680|NCT03968224|Metformin|metformin|mesh-list
101854681|NCT03968224|Dapagliflozin|dapagliflozin|mesh-list
101854682|NCT03968224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101854683|NCT03968224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854684|NCT03968224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101854685|NCT03968224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854686|NCT01075126|Valproic Acid|valproic acid|mesh-list
101854687|NCT01075126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101854688|NCT01075126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854689|NCT01075126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854690|NCT01075126|Antimanic Agents|antimanic agents|mesh-ancestor
101854691|NCT01075126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101854692|NCT01075126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101854693|NCT01075126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854694|NCT01075126|Anticonvulsants|anticonvulsants|mesh-ancestor
101574522|NCT01188798|Pentostatin|pentostatin|mesh-list
101854695|NCT01075126|GABA Agents|gaba agents|mesh-ancestor
101854696|NCT01075126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101854697|NCT03823378|Upadacitinib|upadacitinib|mesh-list
101854698|NCT03823378|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101854699|NCT03823378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101854700|NCT03823378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854701|NCT03823378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854702|NCT03823378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101854703|NCT00141778|Ramipril|ramipril|mesh-list
101854704|NCT00141778|Spironolactone|spironolactone|mesh-list
101854705|NCT00141778|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
101854706|NCT00141778|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101854707|NCT00141778|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101854708|NCT00141778|Mineralocorticoids|mineralocorticoids|mesh-list
101854709|NCT00141778|Hormone Antagonists|hormone antagonists|mesh-ancestor
101854710|NCT00141778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101854711|NCT00141778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854712|NCT00141778|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101854713|NCT00141778|Diuretics|diuretics|mesh-ancestor
101854714|NCT00141778|Natriuretic Agents|natriuretic agents|mesh-ancestor
101854715|NCT00141778|Protease Inhibitors|protease inhibitors|mesh-ancestor
101854716|NCT00141778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854717|NCT00141778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101854718|NCT00141778|Hormones|hormones|mesh-ancestor
101854719|NCT01079884|Esomeprazole|esomeprazole|mesh-list
101854720|NCT01079884|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101854721|NCT01079884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101854722|NCT01079884|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101854723|NCT01079884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854724|NCT01079884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854725|NCT01075906|Colchicine|colchicine|mesh-list
101854726|NCT01075906|Gout Suppressants|gout suppressants|mesh-ancestor
101854727|NCT01075906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101854728|NCT01075906|Tubulin Modulators|tubulin modulators|mesh-ancestor
101854729|NCT01075906|Antimitotic Agents|antimitotic agents|mesh-ancestor
101854730|NCT01075906|Mitosis Modulators|mitosis modulators|mesh-ancestor
101854731|NCT01075906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854732|NCT01075906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101854733|NCT01076062|Misoprostol|misoprostol|mesh-list
101854734|NCT01076062|Oxytocin|oxytocin|mesh-list
101854735|NCT01076062|Oxytocics|oxytocics|mesh-ancestor
101854736|NCT01076062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101854737|NCT01076062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854738|NCT01076062|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101854739|NCT01076062|Abortifacient Agents|abortifacient agents|mesh-ancestor
101854740|NCT01076062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101854741|NCT01076062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101854742|NCT00115336|Ibuprofen|ibuprofen|mesh-list
101854743|NCT00115336|Ketorolac|ketorolac|mesh-list
101854744|NCT00115336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101854745|NCT00115336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101854746|NCT00115336|Analgesics|analgesics|mesh-ancestor
101854747|NCT00115336|Sensory System Agents|sensory system agents|mesh-ancestor
101854748|NCT00115336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101854749|NCT00115336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854750|NCT00115336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101854751|NCT00115336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101854752|NCT00115336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101854753|NCT00115336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854754|NCT00115336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854755|NCT01076140|Lisinopril|lisinopril|mesh-list
101854756|NCT01076140|Nebivolol|nebivolol|mesh-list
101854757|NCT01076140|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101854758|NCT01076140|Protease Inhibitors|protease inhibitors|mesh-ancestor
101854759|NCT01076140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854760|NCT01076140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854761|NCT01076140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101854762|NCT01076140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101854763|NCT01076140|Protective Agents|protective agents|mesh-ancestor
101854764|NCT01076140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854765|NCT01076140|Vasodilator Agents|vasodilator agents|mesh-ancestor
101854766|NCT01076140|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101854767|NCT01076140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101574606|NCT01034631|Everolimus|everolimus|mesh-list
101854768|NCT01076140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101854769|NCT01076140|Adrenergic Agents|adrenergic agents|mesh-ancestor
101854770|NCT01076140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101854771|NCT00205803|Vaccines|vaccines|mesh-list
101854772|NCT00205803|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101854773|NCT00205803|Immunologic Factors|immunologic factors|mesh-ancestor
101854774|NCT00205803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854775|NCT00127192|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101854776|NCT00127192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101854777|NCT00127192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854778|NCT00127192|Incretins|incretins|mesh-ancestor
101854779|NCT00127192|Hormones|hormones|mesh-ancestor
101854780|NCT00127192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101854781|NCT00127192|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101854782|NCT00127192|Protease Inhibitors|protease inhibitors|mesh-ancestor
101854783|NCT00127192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854784|NCT00127192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854785|NCT00127036|Bevacizumab|bevacizumab|mesh-list
101854786|NCT00127036|Capecitabine|capecitabine|mesh-list
101854787|NCT00127036|Oxaliplatin|oxaliplatin|mesh-list
101854788|NCT00127036|Irinotecan|irinotecan|mesh-list
101854789|NCT00127036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101854790|NCT00127036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101854791|NCT00127036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101854792|NCT00127036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101854793|NCT00127036|Growth Substances|growth substances|mesh-ancestor
101854794|NCT00127036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854795|NCT00127036|Growth Inhibitors|growth inhibitors|mesh-ancestor
101854796|NCT00127036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101854797|NCT00127036|Antimetabolites|antimetabolites|mesh-ancestor
101854798|NCT00127036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854799|NCT00127036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101854800|NCT00127036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101854801|NCT00127036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854802|NCT00259857|Alendronate|alendronate|mesh-list
101854803|NCT00259857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101854804|NCT00259857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854805|NCT01071681|Telmisartan|telmisartan|mesh-list
101315713|NCT04547530|Vitamin D|vitamin d|mesh-list
101854806|NCT01071681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101854807|NCT01071681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101854808|NCT01071681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101854809|NCT01071681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854810|NCT00203307|Olanzapine|olanzapine|mesh-list
101854811|NCT00203307|Antiemetics|antiemetics|mesh-ancestor
101854812|NCT00203307|Autonomic Agents|autonomic agents|mesh-ancestor
101854813|NCT00203307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101854814|NCT00203307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854815|NCT00203307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101854816|NCT00203307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101854817|NCT00203307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101854818|NCT00203307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101854819|NCT00203307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101854820|NCT00203307|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101854821|NCT00203307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101854822|NCT00203307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101854823|NCT00203307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854824|NCT00203307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101854825|NCT00203307|Serotonin Agents|serotonin agents|mesh-ancestor
101854826|NCT00126568|Sorafenib|sorafenib|mesh-list
101854827|NCT00126568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101854828|NCT00126568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101854829|NCT00126568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854830|NCT00126568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854831|NCT00202839|Ribavirin|ribavirin|mesh-list
101854832|NCT00202839|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101854833|NCT00202839|Interferon-alpha|interferon-alpha|mesh-list
101854834|NCT00202839|Antimetabolites|antimetabolites|mesh-ancestor
101854835|NCT00202839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854836|NCT00202839|Antiviral Agents|antiviral agents|mesh-ancestor
101854837|NCT00202839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101854838|NCT00202839|Immunologic Factors|immunologic factors|mesh-ancestor
101854839|NCT00202839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854840|NCT00126490|Aldesleukin|aldesleukin|mesh-list
101854841|NCT00126490|Bevacizumab|bevacizumab|mesh-list
101854842|NCT00126490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101854843|NCT00126490|Interleukin-2|interleukin-2|mesh-list
101854844|NCT00126490|Endothelial Growth Factors|endothelial growth factors|mesh-list
101854845|NCT00126490|Antibodies|antibodies|mesh-list
101854846|NCT00126490|Immunoglobulins|immunoglobulins|mesh-list
101854847|NCT00126490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101854848|NCT00126490|Immunoglobulin G|immunoglobulin g|mesh-list
101854849|NCT00126490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101854850|NCT00126490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101854851|NCT00126490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101854852|NCT00126490|Growth Substances|growth substances|mesh-ancestor
101854853|NCT00126490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854854|NCT00126490|Growth Inhibitors|growth inhibitors|mesh-ancestor
101854855|NCT00126490|Immunologic Factors|immunologic factors|mesh-ancestor
101854856|NCT00126490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101854857|NCT00126490|Analgesics|analgesics|mesh-ancestor
101854858|NCT00126490|Sensory System Agents|sensory system agents|mesh-ancestor
101854859|NCT00126490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101854860|NCT00126490|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101854861|NCT00126490|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101854862|NCT00126490|Antiviral Agents|antiviral agents|mesh-ancestor
101854863|NCT00126490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101854864|NCT00200967|Beclomethasone|beclomethasone|mesh-list
101854865|NCT00200967|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101854866|NCT00200967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101854867|NCT00200967|Autonomic Agents|autonomic agents|mesh-ancestor
101854868|NCT00200967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101854869|NCT00200967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854870|NCT00200967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101854871|NCT00200967|Respiratory System Agents|respiratory system agents|mesh-ancestor
101854872|NCT00200967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101854873|NCT00200967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101854874|NCT00200967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101854875|NCT00200967|Adrenergic Agents|adrenergic agents|mesh-ancestor
101854876|NCT00200967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101854877|NCT00200967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854878|NCT00200967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101854879|NCT00200967|Glucocorticoids|glucocorticoids|mesh-ancestor
101854880|NCT00200967|Hormones|hormones|mesh-ancestor
101854881|NCT00200967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101854882|NCT02533440|Anesthetics|anesthetics|mesh-list
101854883|NCT02533440|Anesthetics, Local|anesthetics, local|mesh-list
101854884|NCT02533440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101854885|NCT02533440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854886|NCT02533440|Sensory System Agents|sensory system agents|mesh-ancestor
101854887|NCT02533440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101854888|NCT00354432|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101854889|NCT00354432|Caseins|caseins|mesh-list
101854890|NCT00354432|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101854891|NCT00354432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101854892|NCT00354432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101854893|NCT00354432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854894|NCT00354432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101854895|NCT00354432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854896|NCT00354432|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101854897|NCT00354432|Antidepressive Agents|antidepressive agents|mesh-ancestor
101854898|NCT00354432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101854899|NCT00354432|Chelating Agents|chelating agents|mesh-ancestor
101854900|NCT00354432|Sequestering Agents|sequestering agents|mesh-ancestor
101854901|NCT00140140|Paclitaxel|paclitaxel|mesh-list
101854902|NCT00140140|Vinorelbine|vinorelbine|mesh-list
101854903|NCT00140140|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101854904|NCT00140140|Trastuzumab|trastuzumab|mesh-list
101854905|NCT00140140|Lenograstim|lenograstim|mesh-list
101854906|NCT00140140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101854907|NCT00140140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101854908|NCT00140140|Tubulin Modulators|tubulin modulators|mesh-ancestor
101854909|NCT00140140|Antimitotic Agents|antimitotic agents|mesh-ancestor
101854910|NCT00140140|Mitosis Modulators|mitosis modulators|mesh-ancestor
101854911|NCT00140140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854912|NCT00140140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101854913|NCT00140140|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101854914|NCT00140140|Immunologic Factors|immunologic factors|mesh-ancestor
101854915|NCT00140140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854916|NCT00346398|Immunomodulating Agents|immunomodulating agents|mesh-list
101854917|NCT00346398|Immunologic Factors|immunologic factors|mesh-ancestor
101574752|NCT04301739|Paclitaxel|paclitaxel|mesh-list
101854918|NCT00346398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854919|NCT00346164|Doxorubicin|doxorubicin|mesh-list
101854920|NCT00346164|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101854921|NCT00346164|Ifosfamide|ifosfamide|mesh-list
101854922|NCT00346164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101854923|NCT00346164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101854924|NCT00346164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101854925|NCT00346164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101854926|NCT00346164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854927|NCT00346164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854928|NCT00346164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101854929|NCT00346164|Alkylating Agents|alkylating agents|mesh-ancestor
101854930|NCT01052298|Ciprofloxacin|ciprofloxacin|mesh-list
101854931|NCT01052298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101854932|NCT01052298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101854933|NCT01052298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101854934|NCT01052298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101854935|NCT01052298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854936|NCT01052298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854937|NCT01052298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101854938|NCT01052298|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101854939|NCT01052298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101854940|NCT00114244|Gemcitabine|gemcitabine|mesh-list
101854941|NCT00114244|Sorafenib|sorafenib|mesh-list
101854942|NCT00114244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101854943|NCT00114244|Antimetabolites|antimetabolites|mesh-ancestor
101854944|NCT00114244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686529|NCT02771249|Antiviral Agents|antiviral agents|mesh-ancestor
101854945|NCT00114244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101965179|NCT02233972|Midazolam|midazolam|mesh-list
101854946|NCT00114244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101854947|NCT00114244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854949|NCT01054872|Immunologic Factors|immunologic factors|mesh-ancestor
101854950|NCT01054872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854951|NCT00337662|Olanzapine|olanzapine|mesh-list
101854952|NCT00337662|Risperidone|risperidone|mesh-list
101854953|NCT00337662|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101854954|NCT00337662|Serotonin Agents|serotonin agents|mesh-ancestor
101854955|NCT00337662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101854956|NCT00337662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854957|NCT00337662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854958|NCT00337662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101854959|NCT00337662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101854960|NCT00337662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101854961|NCT00337662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101854962|NCT00337662|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101854963|NCT00337662|Dopamine Agents|dopamine agents|mesh-ancestor
101854964|NCT00337662|Antiemetics|antiemetics|mesh-ancestor
101854965|NCT00337662|Autonomic Agents|autonomic agents|mesh-ancestor
101854966|NCT00337662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101854967|NCT00337662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101854968|NCT00337662|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101854969|NCT00337662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101854970|NCT00337662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101854971|NCT00138424|Cidofovir|cidofovir|mesh-list
101854972|NCT00138424|Antiviral Agents|antiviral agents|mesh-ancestor
101854973|NCT00138424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101854974|NCT00138424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854975|NCT00138424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854976|NCT00368966|Vaccines|vaccines|mesh-list
101854977|NCT00368966|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101854978|NCT00368966|Immunologic Factors|immunologic factors|mesh-ancestor
101854979|NCT00368966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854980|NCT00114166|Topotecan|topotecan|mesh-list
101854981|NCT00114166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101854982|NCT00114166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101854983|NCT00114166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101854984|NCT00114166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101854985|NCT00114166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101854986|NCT00337428|Vaccines|vaccines|mesh-list
101854987|NCT00337428|Immunologic Factors|immunologic factors|mesh-ancestor
101854988|NCT00337428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854989|NCT00235989|Interferons|interferons|mesh-list
101854990|NCT00235989|Interferon-beta|interferon-beta|mesh-list
101854991|NCT00235989|Interferon beta-1b|interferon beta-1b|mesh-list
101854992|NCT00235989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101854993|NCT00235989|Antiviral Agents|antiviral agents|mesh-ancestor
101854994|NCT00235989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101854995|NCT00235989|Immunologic Factors|immunologic factors|mesh-ancestor
101854996|NCT00235989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101854997|NCT00235989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101854998|NCT00113386|Docetaxel|docetaxel|mesh-list
101854999|NCT00113386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855000|NCT00113386|Tubulin Modulators|tubulin modulators|mesh-ancestor
101855001|NCT00113386|Antimitotic Agents|antimitotic agents|mesh-ancestor
101855002|NCT00113386|Mitosis Modulators|mitosis modulators|mesh-ancestor
101855003|NCT00113386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855004|NCT00353262|Capecitabine|capecitabine|mesh-list
101855005|NCT00353262|Oxaliplatin|oxaliplatin|mesh-list
101855006|NCT00353262|Bevacizumab|bevacizumab|mesh-list
101855007|NCT00353262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101855008|NCT00353262|Antimetabolites|antimetabolites|mesh-ancestor
101855009|NCT00353262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855010|NCT00353262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855011|NCT00353262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101855012|NCT00353262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101855013|NCT00353262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101855014|NCT00353262|Growth Substances|growth substances|mesh-ancestor
101855015|NCT00353262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855016|NCT00353262|Growth Inhibitors|growth inhibitors|mesh-ancestor
101855018|NCT00125164|Growth Substances|growth substances|mesh-ancestor
101855019|NCT00125164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855020|NCT03985410|Moxifloxacin|moxifloxacin|mesh-list
101855021|NCT03985410|Durlobactam|durlobactam|mesh-list
101855022|NCT03985410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101855023|NCT03985410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101855024|NCT03985410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101855025|NCT03985410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101855026|NCT03985410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101855027|NCT03985410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855028|NCT03985410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855029|NCT03985410|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101855030|NCT00136318|Ribavirin|ribavirin|mesh-list
101855031|NCT00136318|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101855032|NCT00136318|Escitalopram|escitalopram|mesh-list
101855033|NCT00136318|Antimetabolites|antimetabolites|mesh-ancestor
101855034|NCT00136318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855035|NCT00136318|Antiviral Agents|antiviral agents|mesh-ancestor
101855036|NCT00136318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101855037|NCT00136318|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101855038|NCT00136318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101855039|NCT00136318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101855040|NCT00136318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101855041|NCT00136318|Serotonin Agents|serotonin agents|mesh-ancestor
101855042|NCT00136318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855043|NCT01058850|Rindopepimut|rindopepimut|mesh-list
101855044|NCT01058850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101855045|NCT01058850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855046|NCT00136084|Cytarabine|cytarabine|mesh-list
101855047|NCT00136084|Dexamethasone|dexamethasone|mesh-list
101855048|NCT00136084|Prednisone|prednisone|mesh-list
101855049|NCT00136084|Cyclophosphamide|cyclophosphamide|mesh-list
101855050|NCT00136084|Methotrexate|methotrexate|mesh-list
101855051|NCT00136084|Etoposide|etoposide|mesh-list
101855052|NCT00136084|Vincristine|vincristine|mesh-list
101855053|NCT00136084|Daunorubicin|daunorubicin|mesh-list
101855054|NCT00136084|Asparaginase|asparaginase|mesh-list
101855055|NCT00136084|Mitoxantrone|mitoxantrone|mesh-list
101855056|NCT00136084|Mercaptopurine|mercaptopurine|mesh-list
101855057|NCT00136084|Cladribine|cladribine|mesh-list
101855058|NCT00136084|Gemtuzumab|gemtuzumab|mesh-list
101855059|NCT00136084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101855060|NCT00136084|Immunologic Factors|immunologic factors|mesh-ancestor
101855061|NCT00136084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855062|NCT00136084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101855063|NCT00136084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101855064|NCT00136084|Alkylating Agents|alkylating agents|mesh-ancestor
101855065|NCT00136084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855066|NCT00136084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855067|NCT00136084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101855068|NCT00136084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101855069|NCT00136084|Antiemetics|antiemetics|mesh-ancestor
101855070|NCT00136084|Autonomic Agents|autonomic agents|mesh-ancestor
101855071|NCT00136084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101855072|NCT00136084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101855073|NCT00136084|Glucocorticoids|glucocorticoids|mesh-ancestor
101855074|NCT00136084|Hormones|hormones|mesh-ancestor
101855075|NCT00136084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101855076|NCT00136084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101855077|NCT00136084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101855078|NCT00136084|Abortifacient Agents|abortifacient agents|mesh-ancestor
101855079|NCT00136084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101855080|NCT00136084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101855081|NCT00136084|Antimetabolites|antimetabolites|mesh-ancestor
101855082|NCT00136084|Dermatologic Agents|dermatologic agents|mesh-ancestor
101855083|NCT00136084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101855084|NCT00136084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101855085|NCT00136084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101855086|NCT00136084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101855087|NCT00136084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101855088|NCT00136084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101855089|NCT00136084|Antiviral Agents|antiviral agents|mesh-ancestor
101855090|NCT00136084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101855091|NCT00136084|Tubulin Modulators|tubulin modulators|mesh-ancestor
101855092|NCT00136084|Antimitotic Agents|antimitotic agents|mesh-ancestor
101855093|NCT00136084|Mitosis Modulators|mitosis modulators|mesh-ancestor
101855094|NCT00136084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101855095|NCT00136084|Analgesics|analgesics|mesh-ancestor
101855096|NCT00136084|Sensory System Agents|sensory system agents|mesh-ancestor
101855097|NCT00136084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101855098|NCT00136084|Immunotoxins|immunotoxins|mesh-ancestor
101855099|NCT00136084|Immunoconjugates|immunoconjugates|mesh-ancestor
101855100|NCT00364832|Epoetin Alfa|epoetin alfa|mesh-list
101855101|NCT00364832|Hematinics|hematinics|mesh-ancestor
101855102|NCT00235755|Ezogabine|ezogabine|mesh-list
101855103|NCT00235755|Anticonvulsants|anticonvulsants|mesh-ancestor
101855104|NCT00235755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101855105|NCT00235755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855106|NCT01581879|Ziprasidone|ziprasidone|mesh-list
101855107|NCT01581879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101855108|NCT01581879|Serotonin Agents|serotonin agents|mesh-ancestor
101855109|NCT01581879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101855110|NCT01581879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855111|NCT01581879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855112|NCT01581879|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101855113|NCT01581879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101855114|NCT01581879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101855115|NCT01581879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101855116|NCT01581879|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101855117|NCT01581879|Dopamine Agents|dopamine agents|mesh-ancestor
101855118|NCT00337194|Gemcitabine|gemcitabine|mesh-list
101855119|NCT00337194|Doxorubicin|doxorubicin|mesh-list
101855120|NCT00337194|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101855121|NCT00337194|Vinorelbine|vinorelbine|mesh-list
101855122|NCT00337194|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101855123|NCT00337194|Antibodies|antibodies|mesh-list
101855124|NCT00337194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101855125|NCT00337194|Immunologic Factors|immunologic factors|mesh-ancestor
101855126|NCT00337194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855127|NCT00337194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101855128|NCT00337194|Antimetabolites|antimetabolites|mesh-ancestor
101855129|NCT00337194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855130|NCT00337194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855131|NCT00337194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101855132|NCT00337194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101855133|NCT00337194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101855134|NCT00337194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101855135|NCT00337194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101855136|NCT00337194|Tubulin Modulators|tubulin modulators|mesh-ancestor
101855137|NCT00337194|Antimitotic Agents|antimitotic agents|mesh-ancestor
101855138|NCT00337194|Mitosis Modulators|mitosis modulators|mesh-ancestor
101855139|NCT00337194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101855140|NCT00337194|Immunotoxins|immunotoxins|mesh-ancestor
101855141|NCT00337194|Immunoconjugates|immunoconjugates|mesh-ancestor
101855142|NCT01074021|Nimotuzumab|nimotuzumab|mesh-list
101855143|NCT01074021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101855144|NCT01074021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855145|NCT01074333|Cetuximab|cetuximab|mesh-list
101855146|NCT01074333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101855147|NCT01074333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855148|NCT00385736|Adalimumab|adalimumab|mesh-list
101855149|NCT00385736|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101855150|NCT00385736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101855151|NCT00385736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101855152|NCT01057212|Bevacizumab|bevacizumab|mesh-list
101855153|NCT01057212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101855154|NCT01057212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855155|NCT01057212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101855156|NCT01057212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101855157|NCT01057212|Growth Substances|growth substances|mesh-ancestor
101855158|NCT01057212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855159|NCT01057212|Growth Inhibitors|growth inhibitors|mesh-ancestor
101855160|NCT03988452|Ritonavir|ritonavir|mesh-list
101855161|NCT03988452|Darunavir|darunavir|mesh-list
101855162|NCT03988452|Tenofovir|tenofovir|mesh-list
101855163|NCT03988452|Lamivudine|lamivudine|mesh-list
101855164|NCT03988452|Zidovudine|zidovudine|mesh-list
101855165|NCT03988452|Dolutegravir|dolutegravir|mesh-list
101855166|NCT03988452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101855167|NCT03988452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101855168|NCT03988452|Protease Inhibitors|protease inhibitors|mesh-ancestor
101855169|NCT03988452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686533|NCT02771249|Vitamins|vitamins|mesh-ancestor
101855170|NCT03988452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855171|NCT03988452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101855172|NCT03988452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101855173|NCT03988452|Antiviral Agents|antiviral agents|mesh-ancestor
101855174|NCT03988452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101855175|NCT03988452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101855176|NCT03988452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101855177|NCT03988452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101855178|NCT03988452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101855179|NCT03988452|Antimetabolites|antimetabolites|mesh-ancestor
101855180|NCT03988452|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101855181|NCT03988452|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101855182|NCT01048580|Capecitabine|capecitabine|mesh-list
101855183|NCT01048580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101855184|NCT01048580|Antimetabolites|antimetabolites|mesh-ancestor
101855185|NCT01048580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855186|NCT01048580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855187|NCT00195819|Adalimumab|adalimumab|mesh-list
101855188|NCT00195819|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101855189|NCT00195819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101855190|NCT00195819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101855191|NCT00527735|Paclitaxel|paclitaxel|mesh-list
101855192|NCT00527735|Carboplatin|carboplatin|mesh-list
101855193|NCT00527735|Ipilimumab|ipilimumab|mesh-list
101855194|NCT00527735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101855195|NCT00527735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855196|NCT00527735|Tubulin Modulators|tubulin modulators|mesh-ancestor
101855197|NCT00527735|Antimitotic Agents|antimitotic agents|mesh-ancestor
101855198|NCT00527735|Mitosis Modulators|mitosis modulators|mesh-ancestor
101855199|NCT00527735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855200|NCT00527735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101855201|NCT00527735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101855202|NCT00336492|Infliximab|infliximab|mesh-list
101855203|NCT00336492|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101855204|NCT00336492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101855205|NCT00336492|Dermatologic Agents|dermatologic agents|mesh-ancestor
101855206|NCT00336492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101855207|NCT00336492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101855208|NCT00194025|Valproic Acid|valproic acid|mesh-list
101855209|NCT00194025|Anticonvulsants|anticonvulsants|mesh-ancestor
101855210|NCT00194025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101855211|NCT00194025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855212|NCT00194025|GABA Agents|gaba agents|mesh-ancestor
101855213|NCT00194025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101855214|NCT00194025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855215|NCT00194025|Antimanic Agents|antimanic agents|mesh-ancestor
101855216|NCT00194025|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101855217|NCT00194025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101855218|NCT00194025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101855219|NCT00521339|Apremilast|apremilast|mesh-list
101855220|NCT00521339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101855221|NCT00521339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101855222|NCT00521339|Analgesics|analgesics|mesh-ancestor
101855223|NCT00521339|Sensory System Agents|sensory system agents|mesh-ancestor
101855224|NCT00521339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101855225|NCT00521339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855226|NCT00521339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101855227|NCT00521339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101855228|NCT00521339|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101855229|NCT00521339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101855230|NCT00521339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101855231|NCT00521339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855233|NCT00363896|Anticonvulsants|anticonvulsants|mesh-ancestor
101855234|NCT00527423|Aflibercept|aflibercept|mesh-list
101855235|NCT00527423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101855236|NCT00527423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101855237|NCT00527423|Growth Substances|growth substances|mesh-ancestor
101855238|NCT00527423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855239|NCT00527423|Growth Inhibitors|growth inhibitors|mesh-ancestor
101343821|NCT00274989|Rituximab|rituximab|mesh-list
101855240|NCT00527423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855241|NCT00527111|Fluorouracil|fluorouracil|mesh-list
101855242|NCT00527111|Cetuximab|cetuximab|mesh-list
101855243|NCT00527111|Antimetabolites|antimetabolites|mesh-ancestor
101855244|NCT00527111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855245|NCT00527111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101855246|NCT00527111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855247|NCT00527111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101855248|NCT00527111|Immunologic Factors|immunologic factors|mesh-ancestor
101855249|NCT00527111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855250|NCT00527111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101855251|NCT00336024|Leucovorin|leucovorin|mesh-list
101855252|NCT00336024|Cyclophosphamide|cyclophosphamide|mesh-list
101855253|NCT00336024|Thiotepa|thiotepa|mesh-list
101855254|NCT00336024|Carboplatin|carboplatin|mesh-list
101855255|NCT00336024|Methotrexate|methotrexate|mesh-list
101855256|NCT00336024|Etoposide|etoposide|mesh-list
101855257|NCT00336024|Vincristine|vincristine|mesh-list
101855258|NCT00336024|Etoposide phosphate|etoposide phosphate|mesh-list
101855259|NCT00336024|Levoleucovorin|levoleucovorin|mesh-list
101855260|NCT00336024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101855261|NCT00336024|Immunologic Factors|immunologic factors|mesh-ancestor
101855262|NCT00336024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855263|NCT00336024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101855264|NCT00336024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101855265|NCT00336024|Alkylating Agents|alkylating agents|mesh-ancestor
101855266|NCT00336024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855267|NCT00336024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855268|NCT00336024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101855269|NCT00336024|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101855270|NCT00336024|Abortifacient Agents|abortifacient agents|mesh-ancestor
101855271|NCT00336024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101855272|NCT00336024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101855273|NCT00336024|Antimetabolites|antimetabolites|mesh-ancestor
101855274|NCT00336024|Dermatologic Agents|dermatologic agents|mesh-ancestor
101855275|NCT00336024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101855276|NCT00336024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101855277|NCT00336024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101855278|NCT00336024|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101855279|NCT00336024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101855280|NCT00336024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101855281|NCT00336024|Antidotes|antidotes|mesh-ancestor
101855282|NCT00336024|Protective Agents|protective agents|mesh-ancestor
101855283|NCT00336024|Vitamin B Complex|vitamin b complex|mesh-ancestor
101855284|NCT00336024|Vitamins|vitamins|mesh-ancestor
101855285|NCT00336024|Micronutrients|micronutrients|mesh-ancestor
101855286|NCT00336024|Tubulin Modulators|tubulin modulators|mesh-ancestor
101855287|NCT00336024|Antimitotic Agents|antimitotic agents|mesh-ancestor
101855288|NCT00336024|Mitosis Modulators|mitosis modulators|mesh-ancestor
101855289|NCT00384956|Azacitidine|azacitidine|mesh-list
101855290|NCT00384956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101855291|NCT00384956|Antimetabolites|antimetabolites|mesh-ancestor
101855292|NCT00384956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855293|NCT00384956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855294|NCT00384956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101855295|NCT04090697|Oxandrolone|oxandrolone|mesh-list
101855296|NCT04090697|Androgens|androgens|mesh-ancestor
101855297|NCT04090697|Hormones|hormones|mesh-ancestor
101575120|NCT01026831|Timolol|timolol|mesh-list
101855298|NCT04090697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101855299|NCT04090697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855300|NCT04090697|Anabolic Agents|anabolic agents|mesh-ancestor
101855301|NCT00367640|Immunomodulating Agents|immunomodulating agents|mesh-list
101855302|NCT00367640|Immunologic Factors|immunologic factors|mesh-list
101855303|NCT00367640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855304|NCT01325220|Baclofen|baclofen|mesh-list
101855305|NCT01325220|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101855306|NCT01325220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855307|NCT01325220|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101855308|NCT01325220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101855309|NCT01325220|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101855310|NCT01325220|GABA Agonists|gaba agonists|mesh-ancestor
101855311|NCT01325220|GABA Agents|gaba agents|mesh-ancestor
101523163|NCT04689191|Vaccines|vaccines|mesh-list
101855312|NCT01325220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101855313|NCT01325220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855314|NCT00367484|Interferons|interferons|mesh-list
101855315|NCT00367484|Interferon-beta|interferon-beta|mesh-list
101855316|NCT00367484|Interferon beta-1a|interferon beta-1a|mesh-list
101855317|NCT00367484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855318|NCT00367484|Antiviral Agents|antiviral agents|mesh-ancestor
101855319|NCT00367484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101855320|NCT00367484|Immunologic Factors|immunologic factors|mesh-ancestor
101855321|NCT00367484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855322|NCT00367484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101855323|NCT00526799|Sorafenib|sorafenib|mesh-list
101855324|NCT00526799|Topotecan|topotecan|mesh-list
101855325|NCT00526799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855326|NCT00526799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101855327|NCT00526799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101855328|NCT00526799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855329|NCT00526799|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101855330|NCT00526799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101855331|NCT01059084|Valacyclovir|valacyclovir|mesh-list
101855332|NCT01059084|Antiviral Agents|antiviral agents|mesh-ancestor
101855333|NCT01059084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101855334|NCT03992144|Amoxicillin|amoxicillin|mesh-list
101855335|NCT03992144|Metronidazole|metronidazole|mesh-list
101855336|NCT03992144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101855337|NCT03992144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101855338|NCT03992144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101855339|NCT03992144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101855340|NCT02534870|Ritonavir|ritonavir|mesh-list
101855341|NCT02534870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101855342|NCT02534870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101855343|NCT02534870|Protease Inhibitors|protease inhibitors|mesh-ancestor
101855344|NCT02534870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101855345|NCT02534870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855346|NCT02534870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101855347|NCT02534870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101855348|NCT02534870|Antiviral Agents|antiviral agents|mesh-ancestor
101855349|NCT02534870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101855350|NCT02534870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101855351|NCT02534870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101855352|NCT03992066|Epoetin Alfa|epoetin alfa|mesh-list
101855353|NCT03992066|Darbepoetin alfa|darbepoetin alfa|mesh-list
101855354|NCT03992066|Hematinics|hematinics|mesh-ancestor
101855355|NCT03986268|Vitamin D|vitamin d|mesh-list
101855356|NCT03986268|Cholecalciferol|cholecalciferol|mesh-list
101855357|NCT03986268|Vitamins|vitamins|mesh-ancestor
101855359|NCT03986268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855360|NCT03986268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101855361|NCT03986268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101855362|NCT01048892|Cyclophosphamide|cyclophosphamide|mesh-list
101855363|NCT01048892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101855364|NCT01048892|Immunologic Factors|immunologic factors|mesh-ancestor
101855365|NCT01048892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855366|NCT01048892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101855367|NCT01048892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101855368|NCT01048892|Alkylating Agents|alkylating agents|mesh-ancestor
101855369|NCT01048892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855370|NCT01048892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855371|NCT01048892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101855372|NCT01259648|Remifentanil|remifentanil|mesh-list
101855373|NCT01259648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101855374|NCT01259648|Narcotics|narcotics|mesh-ancestor
101855375|NCT01259648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101855376|NCT01259648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855377|NCT01259648|Analgesics|analgesics|mesh-ancestor
101855378|NCT01259648|Sensory System Agents|sensory system agents|mesh-ancestor
101855379|NCT01259648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101855380|NCT01049048|Vitamin D|vitamin d|mesh-list
101855381|NCT01049048|Cholecalciferol|cholecalciferol|mesh-list
101855382|NCT01049048|Vitamins|vitamins|mesh-ancestor
101855383|NCT01049048|Micronutrients|micronutrients|mesh-ancestor
101686544|NCT04048278|Lidocaine|lidocaine|mesh-list
101855384|NCT01049048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855385|NCT01049048|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101855386|NCT01049048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101855387|NCT00520481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101855388|NCT00520481|Immunologic Factors|immunologic factors|mesh-ancestor
101855389|NCT00520481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855390|NCT01044992|Levodopa|levodopa|mesh-list
101855391|NCT01044992|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101855392|NCT01044992|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101855393|NCT01044992|Dopamine Agents|dopamine agents|mesh-ancestor
101855394|NCT01044992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101855395|NCT01044992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855396|NCT01044992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855397|NCT00520403|Interferons|interferons|mesh-list
101855398|NCT00520403|Interferon-alpha|interferon-alpha|mesh-list
101855399|NCT00520403|Interferon alpha-2|interferon alpha-2|mesh-list
101855400|NCT00520403|Bevacizumab|bevacizumab|mesh-list
101855401|NCT00520403|Vinblastine|vinblastine|mesh-list
101855402|NCT00520403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101855403|NCT00520403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855404|NCT00520403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101855405|NCT00520403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101855406|NCT00520403|Growth Substances|growth substances|mesh-ancestor
101855407|NCT00520403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855408|NCT00520403|Growth Inhibitors|growth inhibitors|mesh-ancestor
101855409|NCT00520403|Antiviral Agents|antiviral agents|mesh-ancestor
101855410|NCT00520403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101855411|NCT00520403|Immunologic Factors|immunologic factors|mesh-ancestor
101855412|NCT00520403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101855413|NCT00520403|Tubulin Modulators|tubulin modulators|mesh-ancestor
101855414|NCT00520403|Antimitotic Agents|antimitotic agents|mesh-ancestor
101855415|NCT00520403|Mitosis Modulators|mitosis modulators|mesh-ancestor
101855416|NCT00520403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855417|NCT00520013|Paclitaxel|paclitaxel|mesh-list
101855418|NCT00520013|Bevacizumab|bevacizumab|mesh-list
101855419|NCT00520013|Carboplatin|carboplatin|mesh-list
101855420|NCT00520013|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101855421|NCT00520013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101855422|NCT00520013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855423|NCT00520013|Tubulin Modulators|tubulin modulators|mesh-ancestor
101855424|NCT00520013|Antimitotic Agents|antimitotic agents|mesh-ancestor
101855425|NCT00520013|Mitosis Modulators|mitosis modulators|mesh-ancestor
101855426|NCT00520013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855427|NCT00520013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101855428|NCT00520013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101855429|NCT00520013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101855430|NCT00520013|Growth Substances|growth substances|mesh-ancestor
101855431|NCT00520013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855432|NCT00520013|Growth Inhibitors|growth inhibitors|mesh-ancestor
101855433|NCT00520013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101855434|NCT00520013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101855435|NCT00526097|Bisacodyl|bisacodyl|mesh-list
101855436|NCT00526097|Cathartics|cathartics|mesh-ancestor
101855437|NCT00526097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101855438|NCT00526097|Laxatives|laxatives|mesh-ancestor
101855439|NCT00525785|Leucovorin|leucovorin|mesh-list
101855440|NCT00525785|Folic Acid|folic acid|mesh-list
101855441|NCT00525785|Fluorouracil|fluorouracil|mesh-list
101855442|NCT00525785|Oxaliplatin|oxaliplatin|mesh-list
101855443|NCT00525785|Levoleucovorin|levoleucovorin|mesh-list
101855444|NCT00525785|Antimetabolites|antimetabolites|mesh-ancestor
101855445|NCT00525785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855446|NCT00525785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101855447|NCT00525785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855448|NCT00525785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101855449|NCT00525785|Immunologic Factors|immunologic factors|mesh-ancestor
101855450|NCT00525785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855451|NCT00525785|Antidotes|antidotes|mesh-ancestor
101855452|NCT00525785|Protective Agents|protective agents|mesh-ancestor
101855453|NCT00525785|Vitamin B Complex|vitamin b complex|mesh-ancestor
101855454|NCT00525785|Vitamins|vitamins|mesh-ancestor
101855455|NCT00525785|Micronutrients|micronutrients|mesh-ancestor
101855456|NCT00525785|Hematinics|hematinics|mesh-ancestor
101855457|NCT00525161|Sorafenib|sorafenib|mesh-list
101855458|NCT00525161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855459|NCT00525161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101855460|NCT00525161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101855461|NCT00525161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855462|NCT00135694|Prednisone|prednisone|mesh-list
101855463|NCT00135694|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
101855464|NCT00135694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101855465|NCT00135694|Glucocorticoids|glucocorticoids|mesh-ancestor
101855466|NCT00135694|Hormones|hormones|mesh-ancestor
101855467|NCT00135694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101855468|NCT00135694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855469|NCT00135694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101855470|NCT00135694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855471|NCT00135694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101855472|NCT00135694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855473|NCT00524459|Docetaxel|docetaxel|mesh-list
101855474|NCT00524459|Doxorubicin|doxorubicin|mesh-list
101855475|NCT00524459|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101855476|NCT00524459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855477|NCT00524459|Tubulin Modulators|tubulin modulators|mesh-ancestor
101855478|NCT00524459|Antimitotic Agents|antimitotic agents|mesh-ancestor
101855479|NCT00524459|Mitosis Modulators|mitosis modulators|mesh-ancestor
101855480|NCT00524459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855481|NCT00524459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101855482|NCT00524459|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101855483|NCT00524459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101855484|NCT00524459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101855485|NCT00519623|Insulin|insulin|mesh-list
101855486|NCT00519623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101855487|NCT00519623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855488|NCT01076530|Temozolomide|temozolomide|mesh-list
101855489|NCT01076530|Vorinostat|vorinostat|mesh-list
101855490|NCT01076530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101855491|NCT01076530|Alkylating Agents|alkylating agents|mesh-ancestor
101855492|NCT01076530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855493|NCT01076530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855494|NCT01076530|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101855495|NCT01076530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101855496|NCT00519077|Gefitinib|gefitinib|mesh-list
101855497|NCT00519077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855498|NCT00519077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101855499|NCT00519077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101855500|NCT00519077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855501|NCT00124618|Cetuximab|cetuximab|mesh-list
101855502|NCT00124618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101855503|NCT00124618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855504|NCT00124072|Folic Acid|folic acid|mesh-list
101855505|NCT00124072|Vitamin B 12|vitamin b 12|mesh-list
101855506|NCT00124072|Hydroxocobalamin|hydroxocobalamin|mesh-list
101855507|NCT00124072|Simvastatin|simvastatin|mesh-list
101855508|NCT00124072|Vitamins|vitamins|mesh-ancestor
101855509|NCT00124072|Micronutrients|micronutrients|mesh-ancestor
101855510|NCT00124072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855511|NCT00124072|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101855512|NCT00124072|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101855513|NCT00124072|Antimetabolites|antimetabolites|mesh-ancestor
101855514|NCT00124072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855515|NCT00124072|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101855516|NCT00124072|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101855517|NCT00124072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101855518|NCT00124072|Hematinics|hematinics|mesh-ancestor
101855519|NCT00124072|Vitamin B Complex|vitamin b complex|mesh-ancestor
101855520|NCT01080352|Ascorbic Acid|ascorbic acid|mesh-list
101855521|NCT01080352|Vitamins|vitamins|mesh-ancestor
101855522|NCT01080352|Micronutrients|micronutrients|mesh-ancestor
101855523|NCT01080352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855524|NCT01080352|Antioxidants|antioxidants|mesh-ancestor
101686556|NCT02697318|Timolol|timolol|mesh-list
101855525|NCT01080352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855526|NCT01080352|Protective Agents|protective agents|mesh-ancestor
101855527|NCT00524303|Paclitaxel|paclitaxel|mesh-list
101855528|NCT00524303|Trastuzumab|trastuzumab|mesh-list
101855529|NCT00524303|Lapatinib|lapatinib|mesh-list
101855530|NCT00524303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101855531|NCT00524303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855532|NCT00524303|Tubulin Modulators|tubulin modulators|mesh-ancestor
101855533|NCT00524303|Antimitotic Agents|antimitotic agents|mesh-ancestor
101855534|NCT00524303|Mitosis Modulators|mitosis modulators|mesh-ancestor
101855535|NCT00524303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855536|NCT00524303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101855537|NCT00524303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101855538|NCT00524303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101855539|NCT04461041|Empagliflozin|empagliflozin|mesh-list
101855540|NCT04461041|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101855541|NCT04461041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855542|NCT04461041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101855543|NCT04461041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855544|NCT00335556|Dactinomycin|dactinomycin|mesh-list
101855545|NCT00335556|Cyclophosphamide|cyclophosphamide|mesh-list
101855546|NCT00335556|Carboplatin|carboplatin|mesh-list
101855547|NCT00335556|Doxorubicin|doxorubicin|mesh-list
101855548|NCT00335556|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101855549|NCT00335556|Irinotecan|irinotecan|mesh-list
101855550|NCT00335556|Etoposide|etoposide|mesh-list
101855551|NCT00335556|Vincristine|vincristine|mesh-list
101855552|NCT00335556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101855553|NCT00335556|Immunologic Factors|immunologic factors|mesh-ancestor
101855554|NCT00335556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855555|NCT00335556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101855556|NCT00335556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101855557|NCT00335556|Alkylating Agents|alkylating agents|mesh-ancestor
101855558|NCT00335556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855559|NCT00335556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855560|NCT00335556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101240366|NCT01621308|Insulin|insulin|mesh-list
101855561|NCT00335556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101855562|NCT00335556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101855563|NCT00335556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101855564|NCT00335556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101855565|NCT00335556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101855566|NCT00335556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101855567|NCT00335556|Tubulin Modulators|tubulin modulators|mesh-ancestor
101855568|NCT00335556|Antimitotic Agents|antimitotic agents|mesh-ancestor
101855569|NCT00335556|Mitosis Modulators|mitosis modulators|mesh-ancestor
101855570|NCT00335556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101855571|NCT00335556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101855572|NCT00335556|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101855573|NCT00335556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101855574|NCT00518687|Vaccines|vaccines|mesh-list
101855575|NCT00518687|Immunologic Factors|immunologic factors|mesh-ancestor
101855576|NCT00518687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855577|NCT00134056|Prednisone|prednisone|mesh-list
101855578|NCT00134056|Docetaxel|docetaxel|mesh-list
101855579|NCT00134056|Atrasentan|atrasentan|mesh-list
101855580|NCT00134056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855581|NCT00134056|Tubulin Modulators|tubulin modulators|mesh-ancestor
101855582|NCT00134056|Antimitotic Agents|antimitotic agents|mesh-ancestor
101855583|NCT00134056|Mitosis Modulators|mitosis modulators|mesh-ancestor
101855584|NCT00134056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855585|NCT00134056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101855586|NCT00134056|Glucocorticoids|glucocorticoids|mesh-ancestor
101855587|NCT00134056|Hormones|hormones|mesh-ancestor
101855588|NCT00134056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101855589|NCT00134056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855590|NCT00134056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101855591|NCT00134056|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101855592|NCT00134056|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101855593|NCT00518531|Denosumab|denosumab|mesh-list
101855594|NCT00518531|Alendronate|alendronate|mesh-list
101855595|NCT00518531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101855596|NCT00518531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855597|NCT01326442|Vitamin D|vitamin d|mesh-list
101855598|NCT01326442|Vitamins|vitamins|mesh-ancestor
101855599|NCT01326442|Micronutrients|micronutrients|mesh-ancestor
101855600|NCT01326442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855601|NCT01326442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101855603|NCT00523991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101855604|NCT00523991|Autonomic Agents|autonomic agents|mesh-ancestor
101855605|NCT00523991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101855606|NCT00523991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855607|NCT00523991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101855608|NCT00523991|Respiratory System Agents|respiratory system agents|mesh-ancestor
101855609|NCT00523991|Parasympatholytics|parasympatholytics|mesh-ancestor
101855610|NCT00523991|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101855611|NCT00523991|Cholinergic Agents|cholinergic agents|mesh-ancestor
101855612|NCT00523991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101855613|NCT00523991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855614|NCT00350844|Hydroxyurea|hydroxyurea|mesh-list
101855615|NCT00350844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855616|NCT00350844|Antisickling Agents|antisickling agents|mesh-ancestor
101855617|NCT00350844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101855618|NCT00350844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855619|NCT00350844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101855620|NCT00345540|Carboplatin|carboplatin|mesh-list
101855621|NCT00345540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855622|NCT00335322|Ritonavir|ritonavir|mesh-list
101855623|NCT00335322|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101855624|NCT00335322|Tenofovir|tenofovir|mesh-list
101855625|NCT00335322|Emtricitabine|emtricitabine|mesh-list
101855626|NCT00335322|Zidovudine|zidovudine|mesh-list
101855627|NCT00335322|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101855628|NCT00335322|Abacavir|abacavir|mesh-list
101855629|NCT00335322|Efavirenz|efavirenz|mesh-list
101855630|NCT00335322|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101855631|NCT00335322|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101855632|NCT00335322|Protease Inhibitors|protease inhibitors|mesh-ancestor
101855633|NCT00335322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101855634|NCT00335322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855635|NCT00335322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101855636|NCT00335322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101855637|NCT00335322|Antiviral Agents|antiviral agents|mesh-ancestor
101855638|NCT00335322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101855639|NCT00335322|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101855640|NCT00335322|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101855641|NCT00335322|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101855642|NCT00335322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101855643|NCT00335322|Antimetabolites|antimetabolites|mesh-ancestor
101855644|NCT00335322|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101855645|NCT00335322|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101855646|NCT00335322|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101855647|NCT00335322|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101855648|NCT00335322|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101855649|NCT01059396|Propranolol|propranolol|mesh-list
101855650|NCT01059396|Carvedilol|carvedilol|mesh-list
101855651|NCT01059396|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101855652|NCT01059396|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101855653|NCT01059396|Adrenergic Agents|adrenergic agents|mesh-ancestor
101855654|NCT01059396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101855655|NCT01059396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855656|NCT01059396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855657|NCT01059396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101855658|NCT01059396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101855659|NCT01059396|Vasodilator Agents|vasodilator agents|mesh-ancestor
101855660|NCT01059396|Antioxidants|antioxidants|mesh-ancestor
101855661|NCT01059396|Protective Agents|protective agents|mesh-ancestor
101855662|NCT01059396|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101855663|NCT01059396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101855664|NCT01059396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101855665|NCT01059396|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101855666|NCT01059396|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101855667|NCT01059552|Vorinostat|vorinostat|mesh-list
101855668|NCT01059552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855669|NCT01059552|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101855670|NCT01059552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101855671|NCT01059552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855673|NCT03741894|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101855674|NCT03741894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101855675|NCT03741894|Disinfectants|disinfectants|mesh-ancestor
101855676|NCT03755765|Amoxicillin|amoxicillin|mesh-list
101855677|NCT03755765|Clavulanic Acid|clavulanic acid|mesh-list
101855678|NCT03755765|Clavulanic Acids|clavulanic acids|mesh-list
101855679|NCT03755765|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101855680|NCT03755765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101855681|NCT03755765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101855682|NCT03755765|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101855684|NCT03755765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855685|NCT01061112|Tolbutamide|tolbutamide|mesh-list
101855686|NCT01061112|Fluconazole|fluconazole|mesh-list
101855687|NCT01061112|Ketoprofen|ketoprofen|mesh-list
101855688|NCT01061112|Flurbiprofen|flurbiprofen|mesh-list
101855689|NCT01061112|Antifungal Agents|antifungal agents|mesh-ancestor
101855690|NCT01061112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101855691|NCT01061112|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101855692|NCT01061112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101855693|NCT01061112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101855694|NCT01061112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855695|NCT01061112|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101855696|NCT01061112|Hormone Antagonists|hormone antagonists|mesh-ancestor
101855697|NCT01061112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101855698|NCT01061112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855699|NCT01061112|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101855700|NCT01061112|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101855701|NCT01061112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101855702|NCT01061112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101855703|NCT01061112|Analgesics|analgesics|mesh-ancestor
101855704|NCT01061112|Sensory System Agents|sensory system agents|mesh-ancestor
101855705|NCT01061112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101855706|NCT01061112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101855707|NCT01061112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101855708|NCT01061112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101855709|NCT01061112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101855710|NCT01061190|Propranolol|propranolol|mesh-list
101855711|NCT01061190|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101855712|NCT01061190|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101855713|NCT01061190|Adrenergic Agents|adrenergic agents|mesh-ancestor
101855714|NCT01061190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101855715|NCT01061190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855716|NCT01061190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855717|NCT01061190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101855718|NCT01061190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101855719|NCT01061190|Vasodilator Agents|vasodilator agents|mesh-ancestor
101855720|NCT00324168|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101855721|NCT00324168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101855722|NCT00517829|Docetaxel|docetaxel|mesh-list
101855723|NCT00517829|Oxaliplatin|oxaliplatin|mesh-list
101855724|NCT00517829|Cetuximab|cetuximab|mesh-list
101855725|NCT00517829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855726|NCT00517829|Tubulin Modulators|tubulin modulators|mesh-ancestor
101855727|NCT00517829|Antimitotic Agents|antimitotic agents|mesh-ancestor
101855728|NCT00517829|Mitosis Modulators|mitosis modulators|mesh-ancestor
101855729|NCT00517829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855730|NCT00517829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101855731|NCT00343512|Docetaxel|docetaxel|mesh-list
101855732|NCT00343512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855733|NCT00343512|Tubulin Modulators|tubulin modulators|mesh-ancestor
101855734|NCT00343512|Antimitotic Agents|antimitotic agents|mesh-ancestor
101855735|NCT00343512|Mitosis Modulators|mitosis modulators|mesh-ancestor
101855736|NCT00343512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855737|NCT00334542|Simvastatin|simvastatin|mesh-list
101855738|NCT00334542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101855739|NCT00334542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101855740|NCT00334542|Antimetabolites|antimetabolites|mesh-ancestor
101855741|NCT00334542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855742|NCT00334542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101855743|NCT00334542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101855744|NCT00334542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101855745|NCT00112294|Paclitaxel|paclitaxel|mesh-list
101855746|NCT00112294|Docetaxel|docetaxel|mesh-list
101855748|NCT00112294|Cetuximab|cetuximab|mesh-list
101855749|NCT00112294|Taxane|taxane|mesh-list
101855750|NCT00112294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101855751|NCT00112294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855752|NCT00112294|Tubulin Modulators|tubulin modulators|mesh-ancestor
101855753|NCT00112294|Antimitotic Agents|antimitotic agents|mesh-ancestor
101855754|NCT00112294|Mitosis Modulators|mitosis modulators|mesh-ancestor
101855755|NCT00112294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855756|NCT00112294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101855757|NCT00235443|Lacosamide|lacosamide|mesh-list
101855758|NCT00235443|Anticonvulsants|anticonvulsants|mesh-ancestor
101855759|NCT00235443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101855760|NCT00235443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101855761|NCT00235443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101855762|NCT00235443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855763|NCT00234039|Gemcitabine|gemcitabine|mesh-list
101855764|NCT00234039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101855765|NCT00234039|Antimetabolites|antimetabolites|mesh-ancestor
101855766|NCT00234039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855767|NCT00234039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855768|NCT02531451|Aspirin|aspirin|mesh-list
101855769|NCT02531451|Ibuprofen|ibuprofen|mesh-list
101855770|NCT02531451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101855771|NCT02531451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101855772|NCT02531451|Analgesics|analgesics|mesh-ancestor
101855773|NCT02531451|Sensory System Agents|sensory system agents|mesh-ancestor
101855774|NCT02531451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101855775|NCT02531451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855776|NCT02531451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101855777|NCT02531451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101855778|NCT02531451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101855779|NCT02531451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101855780|NCT02531451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855781|NCT02531451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101855782|NCT02531451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101855783|NCT02531451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101855785|NCT01073007|Simvastatin|simvastatin|mesh-list
101855786|NCT01073007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101855787|NCT01073007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101855788|NCT01073007|Antimetabolites|antimetabolites|mesh-ancestor
101855789|NCT01073007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855790|NCT01073007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101855791|NCT01073007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101855792|NCT01073007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101855793|NCT03741621|Psyllium|psyllium|mesh-list
101855794|NCT03741621|Cathartics|cathartics|mesh-ancestor
101855795|NCT03741621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101855796|NCT00323622|Pyrimethamine|pyrimethamine|mesh-list
101855797|NCT00323622|Sulfadoxine|sulfadoxine|mesh-list
101855798|NCT00323622|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101855799|NCT00323622|Amodiaquine|amodiaquine|mesh-list
101855800|NCT00323622|Vaccines|vaccines|mesh-list
101855801|NCT00323622|Immunologic Factors|immunologic factors|mesh-ancestor
101855802|NCT00323622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855803|NCT00323622|Antimalarials|antimalarials|mesh-ancestor
101855804|NCT00323622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101855805|NCT00323622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101855806|NCT00323622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101855807|NCT00323622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101855808|NCT00323622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101855809|NCT00323622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855810|NCT00323622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101855811|NCT01326039|Bupivacaine|bupivacaine|mesh-list
101855812|NCT01326039|Anesthetics, Local|anesthetics, local|mesh-ancestor
101855813|NCT01326039|Anesthetics|anesthetics|mesh-ancestor
101855814|NCT01326039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101855815|NCT01326039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855816|NCT01326039|Sensory System Agents|sensory system agents|mesh-ancestor
101855817|NCT01326039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101855818|NCT01057758|Simvastatin|simvastatin|mesh-list
101855819|NCT01057758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101855820|NCT01057758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101855821|NCT01057758|Antimetabolites|antimetabolites|mesh-ancestor
101855822|NCT01057758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855823|NCT01057758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101855824|NCT01057758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101855825|NCT01057758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101855826|NCT00186537|Rosiglitazone|rosiglitazone|mesh-list
101855827|NCT00186537|Fenofibrate|fenofibrate|mesh-list
101855828|NCT00186537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101855829|NCT00186537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574889|NCT01031979|Urological Agents|urological agents|mesh-ancestor
101855830|NCT00186537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101855831|NCT00186537|Antimetabolites|antimetabolites|mesh-ancestor
101855832|NCT00186537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855833|NCT00186537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101855834|NCT03968835|Bacitracin|bacitracin|mesh-list
101855835|NCT03968835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101855836|NCT03968835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101855837|NCT03968835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101855838|NCT00322842|Plerixafor|plerixafor|mesh-list
101855839|NCT00322842|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101855840|NCT00322842|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101855841|NCT00322842|Antiviral Agents|antiviral agents|mesh-ancestor
101855842|NCT00322842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101855843|NCT04726085|Ibuprofen|ibuprofen|mesh-list
101855844|NCT04726085|Indomethacin|indomethacin|mesh-list
101855845|NCT04726085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101855846|NCT04726085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101855847|NCT04726085|Analgesics|analgesics|mesh-ancestor
101855848|NCT04726085|Sensory System Agents|sensory system agents|mesh-ancestor
101855849|NCT04726085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101855850|NCT04726085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855851|NCT04726085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101855852|NCT04726085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101855853|NCT04726085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101855854|NCT04726085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101855855|NCT04726085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855856|NCT04726085|Gout Suppressants|gout suppressants|mesh-ancestor
101855857|NCT04726085|Tocolytic Agents|tocolytic agents|mesh-ancestor
101855858|NCT04726085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101855859|NCT00255723|Carboplatin|carboplatin|mesh-list
101855860|NCT00255723|Etoposide|etoposide|mesh-list
101855861|NCT00255723|Ifosfamide|ifosfamide|mesh-list
101855862|NCT00255723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855863|NCT00255723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101855864|NCT00255723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101855865|NCT00255723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101855866|NCT00255723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101855867|NCT00255723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855868|NCT00255723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101855869|NCT00255723|Alkylating Agents|alkylating agents|mesh-ancestor
101855870|NCT01060176|Tranexamic Acid|tranexamic acid|mesh-list
101855871|NCT01060176|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101855872|NCT01060176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101855873|NCT01060176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855874|NCT01060176|Hemostatics|hemostatics|mesh-ancestor
101855875|NCT01060176|Coagulants|coagulants|mesh-ancestor
101855876|NCT00132808|Zoledronic Acid|zoledronic acid|mesh-list
101855877|NCT00132808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101855878|NCT00132808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855879|NCT03982992|Blinatumomab|blinatumomab|mesh-list
101855880|NCT03982992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855881|NCT03695471|Pembrolizumab|pembrolizumab|mesh-list
101855882|NCT03695471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101855883|NCT03695471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855884|NCT03695471|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101855885|NCT03695471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855886|NCT01061268|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101855887|NCT01061268|Lubricant Eye Drops|lubricant eye drops|mesh-list
101855888|NCT01061268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101855889|NCT00517361|Bevacizumab|bevacizumab|mesh-list
101855890|NCT00517361|Carboplatin|carboplatin|mesh-list
101855891|NCT00517361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101855892|NCT00517361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855893|NCT00517361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101855894|NCT00517361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101855895|NCT00517361|Growth Substances|growth substances|mesh-ancestor
101855896|NCT00517361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855897|NCT00517361|Growth Inhibitors|growth inhibitors|mesh-ancestor
101855898|NCT00516893|Natalizumab|natalizumab|mesh-list
101855899|NCT00516893|Immunologic Factors|immunologic factors|mesh-ancestor
101855900|NCT00516893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855901|NCT03657641|Pembrolizumab|pembrolizumab|mesh-list
101855902|NCT03657641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101855903|NCT03657641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855904|NCT03657641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101574890|NCT02753803|Pioglitazone|pioglitazone|mesh-list
101855905|NCT03657641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855907|NCT03649841|Prednisone|prednisone|mesh-list
101855908|NCT03649841|Cortisone|cortisone|mesh-list
101855909|NCT03649841|Methyltestosterone|methyltestosterone|mesh-list
101855910|NCT03649841|Abiraterone Acetate|abiraterone acetate|mesh-list
101855911|NCT03649841|Hormones|hormones|mesh-list
101855912|NCT03649841|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101855913|NCT03649841|Androgens|androgens|mesh-list
101855914|NCT03649841|Androgen Antagonists|androgen antagonists|mesh-list
101855915|NCT03649841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101855916|NCT03649841|Glucocorticoids|glucocorticoids|mesh-ancestor
101855917|NCT03649841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101855918|NCT03649841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855919|NCT03649841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101855920|NCT03649841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855921|NCT03649841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101855922|NCT03649841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101855923|NCT03649841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855924|NCT03649841|Hormone Antagonists|hormone antagonists|mesh-ancestor
101855925|NCT03649841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101855926|NCT03649841|Antioxidants|antioxidants|mesh-ancestor
101855927|NCT03649841|Protective Agents|protective agents|mesh-ancestor
101855928|NCT03649841|Vitamins|vitamins|mesh-ancestor
101855929|NCT03649841|Micronutrients|micronutrients|mesh-ancestor
101855930|NCT03649841|Estrogens|estrogens|mesh-ancestor
101855931|NCT03649841|Anabolic Agents|anabolic agents|mesh-ancestor
101855932|NCT00522431|Testosterone|testosterone|mesh-list
101855933|NCT00522431|Androgens|androgens|mesh-ancestor
101855934|NCT00522431|Hormones|hormones|mesh-ancestor
101855935|NCT00522431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101855936|NCT00522431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855937|NCT00185211|Interferons|interferons|mesh-list
101855938|NCT00185211|Interferon-beta|interferon-beta|mesh-list
101855939|NCT00185211|Interferon beta-1b|interferon beta-1b|mesh-list
101855940|NCT00185211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855941|NCT00185211|Antiviral Agents|antiviral agents|mesh-ancestor
101855942|NCT00185211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101855943|NCT00185211|Immunologic Factors|immunologic factors|mesh-ancestor
101855944|NCT00185211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855945|NCT00185211|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101855946|NCT00516737|Rizatriptan|rizatriptan|mesh-list
101855947|NCT00516737|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101686583|NCT04186026|Glucagon|glucagon|mesh-list
101855948|NCT00516737|Serotonin Agents|serotonin agents|mesh-ancestor
101855949|NCT00516737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101855950|NCT00516737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855951|NCT00516737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855952|NCT03540485|Melatonin|melatonin|mesh-list
101855953|NCT03540485|Antioxidants|antioxidants|mesh-ancestor
101855954|NCT03540485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855955|NCT03540485|Protective Agents|protective agents|mesh-ancestor
101855956|NCT03540485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855957|NCT03540485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101855958|NCT00132730|MK 0873|mk 0873|mesh-list
101855959|NCT00132730|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101855960|NCT00132730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101855961|NCT00132730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101855962|NCT00132730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855963|NCT02531841|Dexamethasone acetate|dexamethasone acetate|mesh-list
101855964|NCT02531841|Dexamethasone|dexamethasone|mesh-list
101855965|NCT02531841|Etoposide phosphate|etoposide phosphate|mesh-list
101855966|NCT02531841|Etoposide|etoposide|mesh-list
101855967|NCT02531841|Ifosfamide|ifosfamide|mesh-list
101855968|NCT02531841|Isophosphamide mustard|isophosphamide mustard|mesh-list
101855969|NCT02531841|Thiotepa|thiotepa|mesh-list
101855970|NCT02531841|Carmustine|carmustine|mesh-list
101855971|NCT02531841|Busulfan|busulfan|mesh-list
101855972|NCT02531841|BB 1101|bb 1101|mesh-list
101855973|NCT02531841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101855974|NCT02531841|Antiemetics|antiemetics|mesh-ancestor
101855975|NCT02531841|Autonomic Agents|autonomic agents|mesh-ancestor
101855976|NCT02531841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101855977|NCT02531841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101855978|NCT02531841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101855979|NCT02531841|Glucocorticoids|glucocorticoids|mesh-ancestor
101575798|NCT02730481|Paclitaxel|paclitaxel|mesh-list
101855980|NCT02531841|Hormones|hormones|mesh-ancestor
101855981|NCT02531841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101855982|NCT02531841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101855983|NCT02531841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855984|NCT02531841|Protease Inhibitors|protease inhibitors|mesh-ancestor
101855985|NCT02531841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101855986|NCT02531841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101855987|NCT02531841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101855988|NCT02531841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101855989|NCT02531841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101855990|NCT02531841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101240469|NCT01621750|Clopidogrel|clopidogrel|mesh-list
101855991|NCT02531841|Alkylating Agents|alkylating agents|mesh-ancestor
101855992|NCT02531841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101855993|NCT02531841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101855994|NCT02531841|Immunologic Factors|immunologic factors|mesh-ancestor
101855995|NCT01074411|Carboplatin|carboplatin|mesh-list
101855996|NCT01074411|Bortezomib|bortezomib|mesh-list
101855997|NCT01074411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101855998|NCT03973047|Ondansetron|ondansetron|mesh-list
101855999|NCT03973047|Antiemetics|antiemetics|mesh-ancestor
101856000|NCT03973047|Autonomic Agents|autonomic agents|mesh-ancestor
101856001|NCT03973047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101856002|NCT03973047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856003|NCT03973047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101856004|NCT03973047|Antipruritics|antipruritics|mesh-ancestor
101856005|NCT03973047|Dermatologic Agents|dermatologic agents|mesh-ancestor
101856006|NCT03973047|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101856007|NCT03973047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101856008|NCT03973047|Serotonin Agents|serotonin agents|mesh-ancestor
101856009|NCT03973047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101856010|NCT03973047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856011|NCT00522275|Lacosamide|lacosamide|mesh-list
101856012|NCT00522275|Anticonvulsants|anticonvulsants|mesh-ancestor
101856013|NCT00522275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101856014|NCT00522275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101856015|NCT00522275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101856016|NCT00522275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856017|NCT01074567|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
101856018|NCT01074567|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101856019|NCT01074567|Protective Agents|protective agents|mesh-ancestor
101856020|NCT01074567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856021|NCT01074567|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101856022|NCT01074567|Antioxidants|antioxidants|mesh-ancestor
101856023|NCT01074567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856024|NCT00522041|Nitroglycerin|nitroglycerin|mesh-list
101856025|NCT00522041|Vasodilator Agents|vasodilator agents|mesh-ancestor
101856026|NCT03519971|Paclitaxel|paclitaxel|mesh-list
101856027|NCT03519971|Etoposide|etoposide|mesh-list
101856028|NCT03519971|Cisplatin|cisplatin|mesh-list
101856029|NCT03519971|Carboplatin|carboplatin|mesh-list
101856030|NCT03519971|Pemetrexed|pemetrexed|mesh-list
101856031|NCT03519971|Durvalumab|durvalumab|mesh-list
101856032|NCT03519971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101856033|NCT03519971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101856034|NCT03519971|Tubulin Modulators|tubulin modulators|mesh-ancestor
101856035|NCT03519971|Antimitotic Agents|antimitotic agents|mesh-ancestor
101856036|NCT03519971|Mitosis Modulators|mitosis modulators|mesh-ancestor
101856037|NCT03519971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856038|NCT03519971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101856039|NCT03519971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101856040|NCT03519971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101856041|NCT03519971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101856042|NCT03519971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101856043|NCT03519971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101856044|NCT00122980|Hydroxyurea|hydroxyurea|mesh-list
101856045|NCT00122980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101856046|NCT00122980|Antisickling Agents|antisickling agents|mesh-ancestor
101856047|NCT00122980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101856048|NCT00122980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322766|NCT00006224|Gemcitabine|gemcitabine|mesh-list
101856049|NCT00122980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101856050|NCT00340704|Tamsulosin|tamsulosin|mesh-list
101856051|NCT00340704|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101856052|NCT00340704|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101856053|NCT00340704|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101856054|NCT00340704|Adrenergic Agents|adrenergic agents|mesh-ancestor
101856055|NCT00340704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101856056|NCT00340704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856057|NCT00340704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856058|NCT00340704|Urological Agents|urological agents|mesh-ancestor
101686608|NCT00650819|Ezetimibe|ezetimibe|mesh-list
101856059|NCT00132496|Rabeprazole|rabeprazole|mesh-list
101856060|NCT00132496|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101856061|NCT00132496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101856062|NCT00132496|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101856063|NCT00132496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101856064|NCT00132496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856065|NCT01080586|Cyclosporine|cyclosporine|mesh-list
101856066|NCT01080586|Cyclosporins|cyclosporins|mesh-list
101856067|NCT01080586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101856068|NCT01080586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856069|NCT01080586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101856070|NCT01080586|Immunologic Factors|immunologic factors|mesh-ancestor
101856071|NCT01080586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856072|NCT01080586|Antifungal Agents|antifungal agents|mesh-ancestor
101856073|NCT01080586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101856074|NCT01080586|Dermatologic Agents|dermatologic agents|mesh-ancestor
101856075|NCT01080586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101856076|NCT01080586|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101856077|NCT00231777|Ondansetron|ondansetron|mesh-list
101856078|NCT00231777|Aprepitant|aprepitant|mesh-list
101856079|NCT00231777|Antiemetics|antiemetics|mesh-ancestor
101856080|NCT00231777|Autonomic Agents|autonomic agents|mesh-ancestor
101856081|NCT00231777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101856082|NCT00231777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856083|NCT00231777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101856084|NCT00231777|Antipruritics|antipruritics|mesh-ancestor
101856085|NCT00231777|Dermatologic Agents|dermatologic agents|mesh-ancestor
101856086|NCT00231777|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101856087|NCT00231777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101856088|NCT00231777|Serotonin Agents|serotonin agents|mesh-ancestor
101856089|NCT00231777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101856090|NCT00231777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856091|NCT00231777|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101856092|NCT01076842|Insulin|insulin|mesh-list
101856093|NCT01076842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101856094|NCT01076842|Exenatide|exenatide|mesh-list
101856095|NCT01076842|Insulin Detemir|insulin detemir|mesh-list
101856096|NCT01076842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101856097|NCT01076842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856098|NCT01076842|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101856099|NCT01076842|Incretins|incretins|mesh-ancestor
101856100|NCT01076842|Hormones|hormones|mesh-ancestor
101856101|NCT01076842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101856102|NCT01060410|Cyclophosphamide|cyclophosphamide|mesh-list
101856103|NCT01060410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101856104|NCT01060410|Immunologic Factors|immunologic factors|mesh-ancestor
101856105|NCT01060410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856106|NCT01060410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101856107|NCT01060410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101856108|NCT01060410|Alkylating Agents|alkylating agents|mesh-ancestor
101856109|NCT01060410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856110|NCT01060410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101856111|NCT01060410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101856112|NCT00231465|Docetaxel|docetaxel|mesh-list
101856113|NCT00231465|Gefitinib|gefitinib|mesh-list
101856114|NCT00231465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101686626|NCT02689362|Incretins|incretins|mesh-ancestor
101856115|NCT00231465|Tubulin Modulators|tubulin modulators|mesh-ancestor
101856116|NCT00231465|Antimitotic Agents|antimitotic agents|mesh-ancestor
101856117|NCT00231465|Mitosis Modulators|mitosis modulators|mesh-ancestor
101856118|NCT00231465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856119|NCT00231465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101856120|NCT00231465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101856121|NCT00254397|Leuprolide|leuprolide|mesh-list
101856122|NCT00254397|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101856123|NCT00254397|Fertility Agents|fertility agents|mesh-ancestor
101856124|NCT00254397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101856125|NCT00254397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856126|NCT00254397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101856127|NCT00254397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101856128|NCT00254163|Cyclophosphamide|cyclophosphamide|mesh-list
101856129|NCT00254163|Rituximab|rituximab|mesh-list
101856130|NCT00254163|Fludarabine|fludarabine|mesh-list
101856131|NCT00254163|Pentostatin|pentostatin|mesh-list
101574891|NCT02753803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101856132|NCT00254163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101856133|NCT00254163|Immunologic Factors|immunologic factors|mesh-ancestor
101856134|NCT00254163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856135|NCT00254163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101856136|NCT00254163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101856137|NCT00254163|Alkylating Agents|alkylating agents|mesh-ancestor
101856138|NCT00254163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856139|NCT00254163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101856140|NCT00254163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101856141|NCT00254163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101856142|NCT00254163|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
101856143|NCT00254163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101856145|NCT00110890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101856146|NCT00110890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856147|NCT00110890|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101856148|NCT00110890|Hormone Antagonists|hormone antagonists|mesh-ancestor
101856149|NCT00110890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101856150|NCT00182637|Bortezomib|bortezomib|mesh-list
101856151|NCT00182637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101856152|NCT01076998|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101856153|NCT01076998|Lubricant Eye Drops|lubricant eye drops|mesh-list
101856154|NCT01076998|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101856155|NCT00122278|Dexamethasone|dexamethasone|mesh-list
101856156|NCT00122278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101856157|NCT00122278|Antiemetics|antiemetics|mesh-ancestor
101856158|NCT00122278|Autonomic Agents|autonomic agents|mesh-ancestor
101856159|NCT00122278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101856160|NCT00122278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856161|NCT00122278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101856162|NCT00122278|Glucocorticoids|glucocorticoids|mesh-ancestor
101856163|NCT00122278|Hormones|hormones|mesh-ancestor
101856164|NCT00122278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101856165|NCT00122278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101856166|NCT00122278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101856167|NCT00182091|Hormones|hormones|mesh-list
101856168|NCT00182091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101856169|NCT00182091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856170|NCT03398135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101856171|NCT03398135|Immunologic Factors|immunologic factors|mesh-ancestor
101856172|NCT03398135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856173|NCT01072071|Furosemide|furosemide|mesh-list
101856174|NCT01072071|Diuretics|diuretics|mesh-ancestor
101856175|NCT01072071|Natriuretic Agents|natriuretic agents|mesh-ancestor
101856176|NCT01072071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856177|NCT01072071|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101856178|NCT01072071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101856179|NCT01072071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856181|NCT00181155|Antimetabolites|antimetabolites|mesh-ancestor
101856182|NCT00181155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856183|NCT00181155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101856184|NCT00181155|Gout Suppressants|gout suppressants|mesh-ancestor
101856185|NCT00181155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101856186|NCT00181155|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101856187|NCT00181155|Antioxidants|antioxidants|mesh-ancestor
101856188|NCT00181155|Protective Agents|protective agents|mesh-ancestor
101856189|NCT00181155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856190|NCT00322452|Paclitaxel|paclitaxel|mesh-list
101856191|NCT00322452|Carboplatin|carboplatin|mesh-list
101856192|NCT00322452|Gefitinib|gefitinib|mesh-list
101856193|NCT00322452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101856194|NCT00322452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101856195|NCT00322452|Tubulin Modulators|tubulin modulators|mesh-ancestor
101856196|NCT00322452|Antimitotic Agents|antimitotic agents|mesh-ancestor
101856197|NCT00322452|Mitosis Modulators|mitosis modulators|mesh-ancestor
101856198|NCT00322452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856199|NCT00322452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101856200|NCT00322452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101856201|NCT00110812|Aldesleukin|aldesleukin|mesh-list
101856202|NCT00110812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101856203|NCT00110812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101856204|NCT00110812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101856205|NCT00110812|Antiviral Agents|antiviral agents|mesh-ancestor
101856206|NCT00110812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101856207|NCT00516269|Methylphenidate|methylphenidate|mesh-list
101856208|NCT00516269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101856209|NCT00516269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856210|NCT00516269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101856211|NCT00516269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101856212|NCT00516269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101856213|NCT00516269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856214|NCT00516269|Dopamine Agents|dopamine agents|mesh-ancestor
101856215|NCT00516269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101856216|NCT04639037|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
101856217|NCT00228813|Lenograstim|lenograstim|mesh-list
101856218|NCT00228813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101856219|NCT00228813|Immunologic Factors|immunologic factors|mesh-ancestor
101856220|NCT00228813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856221|NCT00322374|Epirubicin|epirubicin|mesh-list
101856222|NCT00322374|Epothilones|epothilones|mesh-list
101856223|NCT00322374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101856224|NCT00322374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101856225|NCT00322374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101856226|NCT00322374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101856227|NCT00322374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101856228|NCT00322374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856229|NCT00322374|Tubulin Modulators|tubulin modulators|mesh-ancestor
101856230|NCT00322374|Antimitotic Agents|antimitotic agents|mesh-ancestor
101856231|NCT00322374|Mitosis Modulators|mitosis modulators|mesh-ancestor
101856232|NCT00174447|Ziprasidone|ziprasidone|mesh-list
101856233|NCT00174447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101856234|NCT00174447|Serotonin Agents|serotonin agents|mesh-ancestor
101856235|NCT00174447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101856236|NCT00174447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856237|NCT00174447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856238|NCT00174447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101856239|NCT00174447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101856240|NCT00174447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101856241|NCT00174447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101856242|NCT00174447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101856244|NCT00321984|Dexlansoprazole|dexlansoprazole|mesh-list
101856245|NCT00321984|Lansoprazole|lansoprazole|mesh-list
101856246|NCT00321984|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101856247|NCT00321984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101856248|NCT00321984|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101856249|NCT00321984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101856250|NCT00321984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856251|NCT01060488|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
101856252|NCT01060488|Hormones|hormones|mesh-ancestor
101856253|NCT01060488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101856254|NCT01060488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856255|NCT01060566|Ivacaftor|ivacaftor|mesh-list
101856256|NCT01060566|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101856257|NCT01060566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101856258|NCT01060566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856259|NCT02533284|Magnesium Sulfate|magnesium sulfate|mesh-list
101856260|NCT02533284|Analgesics|analgesics|mesh-ancestor
101856261|NCT02533284|Sensory System Agents|sensory system agents|mesh-ancestor
101856262|NCT02533284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101856263|NCT02533284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856264|NCT02533284|Anesthetics|anesthetics|mesh-ancestor
101856265|NCT02533284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101856266|NCT02533284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101856267|NCT02533284|Anticonvulsants|anticonvulsants|mesh-ancestor
101856268|NCT02533284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101856269|NCT02533284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101856270|NCT02533284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856271|NCT02533284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101856272|NCT02533284|Tocolytic Agents|tocolytic agents|mesh-ancestor
101856273|NCT02533284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101856274|NCT00515099|Thymoglobulin|thymoglobulin|mesh-list
101856275|NCT00515099|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101856276|NCT00515099|Immunologic Factors|immunologic factors|mesh-ancestor
101856277|NCT00515099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856278|NCT00515099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101856279|NCT00110266|Deferasirox|deferasirox|mesh-list
101856280|NCT00110266|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101856282|NCT00110266|Sequestering Agents|sequestering agents|mesh-ancestor
101686661|NCT03574337|Cholinergic Agents|cholinergic agents|mesh-ancestor
101856283|NCT00110266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856284|NCT00366548|Vaccines|vaccines|mesh-list
101856285|NCT00366548|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101856286|NCT00366548|Immunologic Factors|immunologic factors|mesh-ancestor
101856287|NCT00366548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856288|NCT01074645|Tenofovir|tenofovir|mesh-list
101856289|NCT01074645|Antiviral Agents|antiviral agents|mesh-ancestor
101856290|NCT01074645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101856291|NCT01074645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101856292|NCT01074645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101856293|NCT01074645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101856294|NCT01074645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856295|NCT01074645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101856296|NCT01074645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101856297|NCT00132028|Vorinostat|vorinostat|mesh-list
101856298|NCT00132028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101856299|NCT00132028|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101856300|NCT00132028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101856301|NCT00132028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856302|NCT01045304|Carboplatin|carboplatin|mesh-list
101856303|NCT01045304|Gemcitabine|gemcitabine|mesh-list
101856304|NCT01045304|Iniparib|iniparib|mesh-list
101856305|NCT01045304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101856306|NCT01045304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101856307|NCT01045304|Antimetabolites|antimetabolites|mesh-ancestor
101856308|NCT01045304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856309|NCT01045304|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101856310|NCT01045304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101856311|NCT01080742|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101856312|NCT01080742|Bisoprolol|bisoprolol|mesh-list
101856313|NCT01080742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101856314|NCT01080742|Diuretics|diuretics|mesh-ancestor
101856315|NCT01080742|Natriuretic Agents|natriuretic agents|mesh-ancestor
101856316|NCT01080742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856317|NCT01080742|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101856318|NCT01080742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101856319|NCT01080742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856320|NCT01080742|Sympatholytics|sympatholytics|mesh-ancestor
101856321|NCT01080742|Autonomic Agents|autonomic agents|mesh-ancestor
101856322|NCT01080742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101856323|NCT01080742|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101856324|NCT01080742|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101856325|NCT01080742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101856326|NCT01080742|Adrenergic Agents|adrenergic agents|mesh-ancestor
101856327|NCT01080742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101856328|NCT00131248|Metoclopramide|metoclopramide|mesh-list
101856329|NCT00131248|Ranitidine|ranitidine|mesh-list
101856330|NCT00131248|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
101856331|NCT00131248|Antiemetics|antiemetics|mesh-ancestor
101856332|NCT00131248|Autonomic Agents|autonomic agents|mesh-ancestor
101856333|NCT00131248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101856334|NCT00131248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856335|NCT00131248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101856336|NCT00131248|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101856337|NCT00131248|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101856338|NCT00131248|Dopamine Agents|dopamine agents|mesh-ancestor
101856339|NCT00131248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101856340|NCT00131248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856341|NCT00131248|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101686695|NCT00380627|Etoricoxib|etoricoxib|mesh-list
101856342|NCT00131248|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101856343|NCT00131248|Histamine Antagonists|histamine antagonists|mesh-ancestor
101856344|NCT00131248|Histamine Agents|histamine agents|mesh-ancestor
101856345|NCT00362414|Mitogens|mitogens|mesh-list
101856346|NCT00362414|Mitosis Modulators|mitosis modulators|mesh-ancestor
101856347|NCT00362414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856348|NCT01080820|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
101856349|NCT01080820|Antiviral Agents|antiviral agents|mesh-ancestor
101856350|NCT01080820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101856351|NCT01080820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101856352|NCT01080820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101856353|NCT01049204|Maraviroc|maraviroc|mesh-list
101576168|NCT02724163|Immunoconjugates|immunoconjugates|mesh-ancestor
101856354|NCT01049204|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101856355|NCT01049204|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101856356|NCT01049204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856357|NCT01049204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101856358|NCT01049204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101856359|NCT01049204|Antiviral Agents|antiviral agents|mesh-ancestor
101856360|NCT01049204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101856361|NCT01049204|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101856362|NCT00096382|Aldesleukin|aldesleukin|mesh-list
101856363|NCT00096382|Cyclophosphamide|cyclophosphamide|mesh-list
101856364|NCT00096382|Fludarabine|fludarabine|mesh-list
101856365|NCT00096382|Fludarabine phosphate|fludarabine phosphate|mesh-list
101856366|NCT00096382|Interleukin-2|interleukin-2|mesh-list
101856367|NCT00096382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101856368|NCT00096382|Immunologic Factors|immunologic factors|mesh-ancestor
101856369|NCT00096382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856370|NCT00096382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101856371|NCT00096382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101856372|NCT00096382|Alkylating Agents|alkylating agents|mesh-ancestor
101856373|NCT00096382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856374|NCT00096382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101856375|NCT00096382|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101856376|NCT00096382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101856377|NCT00096382|Antimetabolites|antimetabolites|mesh-ancestor
101856378|NCT00096382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101856379|NCT00096382|Analgesics|analgesics|mesh-ancestor
101856380|NCT00096382|Sensory System Agents|sensory system agents|mesh-ancestor
101856381|NCT00096382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101856382|NCT00096382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101856383|NCT00096382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101856384|NCT00096382|Antiviral Agents|antiviral agents|mesh-ancestor
101856385|NCT00096382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101856386|NCT00384332|Olanzapine|olanzapine|mesh-list
101856387|NCT00384332|Antiemetics|antiemetics|mesh-ancestor
101856388|NCT00384332|Autonomic Agents|autonomic agents|mesh-ancestor
101856389|NCT00384332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101856390|NCT00384332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856391|NCT00384332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101856392|NCT00384332|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101856393|NCT00384332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101856394|NCT00384332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101856395|NCT00384332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101856396|NCT00384332|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101856397|NCT00384332|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101856398|NCT00384332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101856399|NCT00384332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856400|NCT00384332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101856401|NCT00384332|Serotonin Agents|serotonin agents|mesh-ancestor
101856402|NCT00096226|Paclitaxel|paclitaxel|mesh-list
101856403|NCT00096226|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101856404|NCT00096226|Carboplatin|carboplatin|mesh-list
101856405|NCT00096226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101856406|NCT00096226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101856407|NCT00096226|Tubulin Modulators|tubulin modulators|mesh-ancestor
101856408|NCT00096226|Antimitotic Agents|antimitotic agents|mesh-ancestor
101856409|NCT00096226|Mitosis Modulators|mitosis modulators|mesh-ancestor
101856410|NCT00096226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856411|NCT01078714|Bumetanide|bumetanide|mesh-list
101856412|NCT01078714|Diuretics|diuretics|mesh-ancestor
101856413|NCT01078714|Natriuretic Agents|natriuretic agents|mesh-ancestor
101856414|NCT01078714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856415|NCT01078714|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101856416|NCT01078714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101856417|NCT01078714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856418|NCT03964324|Nitric Oxide|nitric oxide|mesh-list
101856419|NCT03964324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101856420|NCT03964324|Autonomic Agents|autonomic agents|mesh-ancestor
101856421|NCT03964324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101856422|NCT03964324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856423|NCT03964324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101856424|NCT03964324|Respiratory System Agents|respiratory system agents|mesh-ancestor
101856425|NCT03964324|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101856426|NCT03964324|Antioxidants|antioxidants|mesh-ancestor
101856427|NCT03964324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856428|NCT03964324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101856429|NCT03964324|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101856431|NCT03964324|Gasotransmitters|gasotransmitters|mesh-ancestor
101856432|NCT03964324|Protective Agents|protective agents|mesh-ancestor
101856433|NCT01082848|Aripiprazole|aripiprazole|mesh-list
101856434|NCT01082848|Antidepressive Agents|antidepressive agents|mesh-ancestor
101856435|NCT01082848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101856436|NCT01082848|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101856437|NCT01082848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101856438|NCT01082848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101856439|NCT01082848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856440|NCT01082848|Dopamine Agonists|dopamine agonists|mesh-ancestor
101856441|NCT01082848|Dopamine Agents|dopamine agents|mesh-ancestor
101856442|NCT01082848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101856443|NCT01082848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856444|NCT01082848|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101856445|NCT01082848|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101856446|NCT01082848|Serotonin Agents|serotonin agents|mesh-ancestor
101856447|NCT01082848|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101856448|NCT01082848|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101856449|NCT01082848|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101856450|NCT01082848|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101856452|NCT01082926|Interleukin-2|interleukin-2|mesh-list
101856453|NCT01082926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101856454|NCT01082926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101856455|NCT01082926|Analgesics|analgesics|mesh-ancestor
101856456|NCT01082926|Sensory System Agents|sensory system agents|mesh-ancestor
101856457|NCT01082926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101856458|NCT01082926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856459|NCT01082926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101856460|NCT01082926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101856461|NCT01082926|Antiviral Agents|antiviral agents|mesh-ancestor
101856462|NCT01082926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101856463|NCT03962920|Tigecycline|tigecycline|mesh-list
101856464|NCT03962920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101856465|NCT03962920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101856466|NCT03962920|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101856467|NCT03962920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101856468|NCT03962920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856469|NCT01078870|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101856470|NCT01078870|Escitalopram|escitalopram|mesh-list
101856471|NCT01078870|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101856472|NCT01078870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101856473|NCT01078870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101856474|NCT01078870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856475|NCT01078870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101856476|NCT01078870|Serotonin Agents|serotonin agents|mesh-ancestor
101856477|NCT01078870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856478|NCT01078870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101856479|NCT01078870|Antidepressive Agents|antidepressive agents|mesh-ancestor
101856480|NCT01078870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101856481|NCT01078870|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101856482|NCT01078870|Analgesics|analgesics|mesh-ancestor
101856483|NCT01078870|Sensory System Agents|sensory system agents|mesh-ancestor
101856484|NCT01078870|Dopamine Agents|dopamine agents|mesh-ancestor
101856485|NCT00105196|Aripiprazole|aripiprazole|mesh-list
101856486|NCT00105196|Antidepressive Agents|antidepressive agents|mesh-ancestor
101856487|NCT00105196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101856488|NCT00105196|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101856489|NCT00105196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101856490|NCT00105196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101856491|NCT00105196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856492|NCT00105196|Dopamine Agonists|dopamine agonists|mesh-ancestor
101856493|NCT00105196|Dopamine Agents|dopamine agents|mesh-ancestor
101856494|NCT00105196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101856495|NCT00105196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856496|NCT00105196|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101856497|NCT00105196|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101856498|NCT00105196|Serotonin Agents|serotonin agents|mesh-ancestor
101856499|NCT00105196|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101856500|NCT00105196|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101856501|NCT00105196|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101856502|NCT00105196|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101856504|NCT00104572|Anastrozole|anastrozole|mesh-list
101856505|NCT00104572|Calcium|calcium|mesh-list
101856506|NCT00104572|Testosterone|testosterone|mesh-list
101856507|NCT00104572|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101856508|NCT00104572|Vitamins|vitamins|mesh-ancestor
101856509|NCT00104572|Micronutrients|micronutrients|mesh-ancestor
101856510|NCT00104572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856511|NCT00104572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101856512|NCT00104572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101856513|NCT00104572|Androgens|androgens|mesh-ancestor
101856514|NCT00104572|Hormones|hormones|mesh-ancestor
101856515|NCT00104572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101240537|NCT01622361|Tubulin Modulators|tubulin modulators|mesh-ancestor
101856516|NCT00104572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101856518|NCT00104572|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101856519|NCT00104572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101856520|NCT00104572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856521|NCT00104572|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101856522|NCT00104572|Hormone Antagonists|hormone antagonists|mesh-ancestor
101856523|NCT00514943|Cetuximab|cetuximab|mesh-list
101856524|NCT00514943|Afatinib|afatinib|mesh-list
101856525|NCT00514943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101856526|NCT00514943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101856527|NCT00514943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101856528|NCT00514943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101856529|NCT00514943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856530|NCT00103402|Alfuzosin|alfuzosin|mesh-list
101856531|NCT00103402|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101856532|NCT00103402|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101856533|NCT00103402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101856534|NCT00103402|Adrenergic Agents|adrenergic agents|mesh-ancestor
101856535|NCT00103402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101856536|NCT00103402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856537|NCT00103402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856538|NCT00103402|Urological Agents|urological agents|mesh-ancestor
101856539|NCT00095836|Gefitinib|gefitinib|mesh-list
101856540|NCT00095836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101856541|NCT00095836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101856542|NCT00095836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101856543|NCT00095836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856544|NCT00168831|Tiotropium Bromide|tiotropium bromide|mesh-list
101856545|NCT00168831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101856546|NCT00168831|Autonomic Agents|autonomic agents|mesh-ancestor
101856547|NCT00168831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101856548|NCT00168831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856549|NCT00168831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101856550|NCT00168831|Respiratory System Agents|respiratory system agents|mesh-ancestor
101856551|NCT00168831|Parasympatholytics|parasympatholytics|mesh-ancestor
101856552|NCT00168831|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101856553|NCT00168831|Cholinergic Agents|cholinergic agents|mesh-ancestor
101856554|NCT00168831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101856555|NCT00168831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856556|NCT03330821|Cytarabine|cytarabine|mesh-list
101856557|NCT03330821|Idarubicin|idarubicin|mesh-list
101856558|NCT03330821|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101856559|NCT03330821|Pevonedistat|pevonedistat|mesh-list
101856560|NCT03330821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101856561|NCT03330821|Antimetabolites|antimetabolites|mesh-ancestor
101856562|NCT03330821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856563|NCT03330821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101856564|NCT03330821|Antiviral Agents|antiviral agents|mesh-ancestor
101856565|NCT03330821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101856566|NCT03330821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101856567|NCT03330821|Immunologic Factors|immunologic factors|mesh-ancestor
101856568|NCT03330821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856569|NCT03330821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101856570|NCT03330821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101856571|NCT03330821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101856572|NCT00512135|Botulinum Toxins|botulinum toxins|mesh-list
101856573|NCT00512135|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101856574|NCT00512135|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101576399|NCT02713087|Ephedrine|ephedrine|mesh-list
101856575|NCT00512135|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
101856576|NCT00512135|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101856577|NCT00512135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101856578|NCT00512135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856579|NCT00512135|Cholinergic Agents|cholinergic agents|mesh-ancestor
101856580|NCT00512135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101856581|NCT00512135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856582|NCT00512135|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101856583|NCT00512135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101856584|NCT03235505|Nicotine|nicotine|mesh-list
101856585|NCT03235505|Varenicline|varenicline|mesh-list
101856586|NCT03235505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101856587|NCT03235505|Autonomic Agents|autonomic agents|mesh-ancestor
101856588|NCT03235505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101856589|NCT03235505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856590|NCT03235505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101856591|NCT03235505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101856592|NCT03235505|Cholinergic Agents|cholinergic agents|mesh-ancestor
101856593|NCT03235505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101856594|NCT03235505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856595|NCT00251979|Esomeprazole|esomeprazole|mesh-list
101856596|NCT00251979|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101856597|NCT00251979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101856598|NCT00251979|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101856599|NCT00251979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101856600|NCT00251979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856601|NCT00511901|Epoetin Alfa|epoetin alfa|mesh-list
101856602|NCT00511901|Hematinics|hematinics|mesh-ancestor
101856603|NCT04580147|Aflibercept|aflibercept|mesh-list
101856604|NCT04580147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101856605|NCT04580147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101856606|NCT04580147|Growth Substances|growth substances|mesh-ancestor
101856607|NCT04580147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856608|NCT04580147|Growth Inhibitors|growth inhibitors|mesh-ancestor
101856609|NCT04580147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101856610|NCT03147287|Fulvestrant|fulvestrant|mesh-list
101856611|NCT03147287|Palbociclib|palbociclib|mesh-list
101856612|NCT03147287|Avelumab|avelumab|mesh-list
101856613|NCT03147287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101856614|NCT03147287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101856615|NCT03147287|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101856616|NCT03147287|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101856617|NCT03147287|Hormone Antagonists|hormone antagonists|mesh-ancestor
101856618|NCT03147287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101856619|NCT03147287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856620|NCT03147287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101856621|NCT03147287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101856622|NCT03147287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856623|NCT03147287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101856624|NCT00228423|Clopidogrel|clopidogrel|mesh-list
101856625|NCT00228423|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101856626|NCT00228423|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101856627|NCT00228423|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101856628|NCT00228423|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101856629|NCT00228423|Purinergic Agents|purinergic agents|mesh-ancestor
101856630|NCT00228423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101856631|NCT00228423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686833|NCT02686710|Sevoflurane|sevoflurane|mesh-list
101856632|NCT00228423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856633|NCT00513695|Paclitaxel|paclitaxel|mesh-list
101856634|NCT00513695|Cyclophosphamide|cyclophosphamide|mesh-list
101856635|NCT00513695|Doxorubicin|doxorubicin|mesh-list
101856636|NCT00513695|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101856637|NCT00513695|Sunitinib|sunitinib|mesh-list
101856638|NCT00513695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101856639|NCT00513695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101856640|NCT00513695|Tubulin Modulators|tubulin modulators|mesh-ancestor
101856641|NCT00513695|Antimitotic Agents|antimitotic agents|mesh-ancestor
101856642|NCT00513695|Mitosis Modulators|mitosis modulators|mesh-ancestor
101856643|NCT00513695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856644|NCT00513695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101856645|NCT00513695|Immunologic Factors|immunologic factors|mesh-ancestor
101856646|NCT00513695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856647|NCT00513695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101576484|NCT02721511|Furosemide|furosemide|mesh-list
101856648|NCT00513695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101856649|NCT00513695|Alkylating Agents|alkylating agents|mesh-ancestor
101856650|NCT00513695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101856651|NCT00513695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101856652|NCT00513695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101856653|NCT00513695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101856654|NCT00513695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101856655|NCT00513695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101856656|NCT00513695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101856657|NCT00513695|Growth Substances|growth substances|mesh-ancestor
101856658|NCT00513695|Growth Inhibitors|growth inhibitors|mesh-ancestor
101856659|NCT00513695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101856661|NCT00162981|Anticonvulsants|anticonvulsants|mesh-ancestor
101856662|NCT00162981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101856663|NCT00162981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101856664|NCT00162981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101856665|NCT00162981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856666|NCT00162981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101856667|NCT00162981|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101856668|NCT00162981|GABA Agonists|gaba agonists|mesh-ancestor
101856669|NCT00162981|GABA Agents|gaba agents|mesh-ancestor
101856670|NCT00162981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101856671|NCT00162981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856672|NCT00099268|Levodopa|levodopa|mesh-list
101856673|NCT00099268|Carbidopa|carbidopa|mesh-list
101856674|NCT00099268|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101856675|NCT00099268|Entacapone|entacapone|mesh-list
101856676|NCT00099268|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101856677|NCT00099268|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101856678|NCT00099268|Dopamine Agents|dopamine agents|mesh-ancestor
101856679|NCT00099268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101856680|NCT00099268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856681|NCT00099268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856682|NCT00099268|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101856683|NCT00099268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101856684|NCT00099268|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101856685|NCT00099268|Immunologic Factors|immunologic factors|mesh-ancestor
101856686|NCT00099268|Dopamine Agonists|dopamine agonists|mesh-ancestor
101856687|NCT00099268|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101856688|NCT00511355|Levonorgestrel|levonorgestrel|mesh-list
101856689|NCT00511355|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101856690|NCT00511355|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
101856691|NCT00511355|Estradiol|estradiol|mesh-list
101856692|NCT00511355|Estrogens|estrogens|mesh-ancestor
101856693|NCT00511355|Hormones|hormones|mesh-ancestor
101856694|NCT00511355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101856695|NCT00511355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856696|NCT00511355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101856697|NCT00511355|Contraceptive Agents|contraceptive agents|mesh-ancestor
101856698|NCT00511355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101856699|NCT00511355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101856700|NCT00511355|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101856701|NCT00511355|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101856702|NCT00511355|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101856703|NCT00511355|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101856704|NCT01083784|Valproic Acid|valproic acid|mesh-list
101856705|NCT01083784|Clonazepam|clonazepam|mesh-list
101856706|NCT01083784|Anticonvulsants|anticonvulsants|mesh-list
101856707|NCT01083784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101856708|NCT01083784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856709|NCT01083784|GABA Agents|gaba agents|mesh-ancestor
101856710|NCT01083784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101856711|NCT01083784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856712|NCT01083784|Antimanic Agents|antimanic agents|mesh-ancestor
101856713|NCT01083784|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101856714|NCT01083784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101856715|NCT01083784|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101856716|NCT01083784|GABA Modulators|gaba modulators|mesh-ancestor
101856717|NCT00095212|Testosterone|testosterone|mesh-list
101856718|NCT00095212|Androgens|androgens|mesh-ancestor
101856719|NCT00095212|Hormones|hormones|mesh-ancestor
101965350|NCT01091207|Sorafenib|sorafenib|mesh-list
101856720|NCT00095212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101856721|NCT00095212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856722|NCT02834975|Paclitaxel|paclitaxel|mesh-list
101856723|NCT02834975|Carboplatin|carboplatin|mesh-list
101856724|NCT02834975|Pembrolizumab|pembrolizumab|mesh-list
101856725|NCT02834975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101856726|NCT02834975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101856727|NCT02834975|Tubulin Modulators|tubulin modulators|mesh-ancestor
101856728|NCT02834975|Antimitotic Agents|antimitotic agents|mesh-ancestor
101856729|NCT02834975|Mitosis Modulators|mitosis modulators|mesh-ancestor
101856730|NCT02834975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856731|NCT02834975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101856732|NCT02834975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101856733|NCT00120874|Memantine|memantine|mesh-list
101856734|NCT00120874|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101856735|NCT00120874|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101856736|NCT00120874|Dopamine Agents|dopamine agents|mesh-ancestor
101856737|NCT00120874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101856738|NCT00120874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856739|NCT00120874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856740|NCT00120874|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101856741|NCT00120874|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101856742|NCT00120250|Eszopiclone|eszopiclone|mesh-list
101856743|NCT00120250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101856744|NCT00120250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101856745|NCT00120250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856746|NCT01081600|Trastuzumab|trastuzumab|mesh-list
101856747|NCT01081600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101856748|NCT01081600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101856749|NCT01079338|Caffeine|caffeine|mesh-list
101856750|NCT01079338|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101856751|NCT01079338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856752|NCT01079338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101856753|NCT01079338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101856754|NCT01079338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856755|NCT01079338|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101856756|NCT01079338|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101856757|NCT01079338|Purinergic Agents|purinergic agents|mesh-ancestor
101856758|NCT01079338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101856759|NCT00384176|Leucovorin|leucovorin|mesh-list
101856760|NCT00384176|Bevacizumab|bevacizumab|mesh-list
101856761|NCT00384176|Fluorouracil|fluorouracil|mesh-list
101856762|NCT00384176|Oxaliplatin|oxaliplatin|mesh-list
101856763|NCT00384176|Cediranib|cediranib|mesh-list
101856764|NCT00384176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101856765|NCT00384176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101856766|NCT00384176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101856767|NCT00384176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101240581|NCT01622439|GABA Agents|gaba agents|mesh-ancestor
101856768|NCT00384176|Growth Substances|growth substances|mesh-ancestor
101686871|NCT00093899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101856769|NCT00384176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856770|NCT00384176|Growth Inhibitors|growth inhibitors|mesh-ancestor
101856771|NCT00384176|Antimetabolites|antimetabolites|mesh-ancestor
101856772|NCT00384176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856773|NCT00384176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101856774|NCT00384176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101856775|NCT00384176|Immunologic Factors|immunologic factors|mesh-ancestor
101856777|NCT00384176|Protective Agents|protective agents|mesh-ancestor
101856778|NCT00384176|Vitamin B Complex|vitamin b complex|mesh-ancestor
101856779|NCT00384176|Vitamins|vitamins|mesh-ancestor
101856780|NCT00384176|Micronutrients|micronutrients|mesh-ancestor
101856781|NCT00384176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101856782|NCT00384176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101856783|NCT00513305|Cytarabine|cytarabine|mesh-list
101856784|NCT00513305|Arsenic Trioxide|arsenic trioxide|mesh-list
101856785|NCT00513305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101856786|NCT00513305|Antimetabolites|antimetabolites|mesh-ancestor
101856787|NCT00513305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856788|NCT00513305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101856789|NCT00513305|Antiviral Agents|antiviral agents|mesh-ancestor
101856790|NCT00513305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101856791|NCT00513305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101856793|NCT00513305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856794|NCT00513071|Saracatinib|saracatinib|mesh-list
101856795|NCT00513071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101856796|NCT00513071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101856797|NCT00513071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856798|NCT00510887|Dexamethasone|dexamethasone|mesh-list
101856799|NCT00510887|Rituximab|rituximab|mesh-list
101856800|NCT00510887|Fludarabine|fludarabine|mesh-list
101856801|NCT00510887|Bortezomib|bortezomib|mesh-list
101856802|NCT00510887|Mitoxantrone|mitoxantrone|mesh-list
101856803|NCT00510887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101856804|NCT00510887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101856805|NCT00510887|Immunologic Factors|immunologic factors|mesh-ancestor
101856806|NCT00510887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856807|NCT00510887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101856808|NCT00510887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101856809|NCT00510887|Antiemetics|antiemetics|mesh-ancestor
101856810|NCT00510887|Autonomic Agents|autonomic agents|mesh-ancestor
101856811|NCT00510887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101856812|NCT00510887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101856813|NCT00510887|Glucocorticoids|glucocorticoids|mesh-ancestor
101856814|NCT00510887|Hormones|hormones|mesh-ancestor
101856815|NCT00510887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101856816|NCT00510887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101856817|NCT00510887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856818|NCT00510887|Analgesics|analgesics|mesh-ancestor
101856819|NCT00510887|Sensory System Agents|sensory system agents|mesh-ancestor
101856820|NCT00510887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101856821|NCT00510887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101856822|NCT00510887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101856823|NCT01012349|Aspirin|aspirin|mesh-list
101856824|NCT01012349|Citric Acid|citric acid|mesh-list
101856825|NCT01012349|Sodium Citrate|sodium citrate|mesh-list
101856826|NCT01012349|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101856827|NCT01012349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101856828|NCT01012349|Analgesics|analgesics|mesh-ancestor
101856829|NCT01012349|Sensory System Agents|sensory system agents|mesh-ancestor
101856830|NCT01012349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101856831|NCT01012349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856832|NCT01012349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101856833|NCT01012349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101856834|NCT01012349|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101856835|NCT01012349|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101856836|NCT01012349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856837|NCT01012349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101856838|NCT01012349|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101856839|NCT01012349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101856840|NCT01012349|Antipyretics|antipyretics|mesh-ancestor
101856841|NCT01012349|Anticoagulants|anticoagulants|mesh-ancestor
101856842|NCT01012349|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101856843|NCT01012349|Chelating Agents|chelating agents|mesh-ancestor
101856844|NCT01012349|Sequestering Agents|sequestering agents|mesh-ancestor
101856846|NCT00358826|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101856847|NCT00358826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101856848|NCT00358826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856849|NCT01009541|Pregabalin|pregabalin|mesh-list
101856850|NCT01009541|Analgesics|analgesics|mesh-ancestor
101856851|NCT01009541|Sensory System Agents|sensory system agents|mesh-ancestor
101856852|NCT01009541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101856853|NCT01009541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856854|NCT01009541|Anticonvulsants|anticonvulsants|mesh-ancestor
101856855|NCT01009541|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101856856|NCT01009541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101856857|NCT01009541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856858|NCT01009541|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101856859|NCT01009541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101856860|NCT01009541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101856861|NCT01009541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101856862|NCT01009541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101856863|NCT00510653|Imatinib Mesylate|imatinib mesylate|mesh-list
101856864|NCT00510653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101856865|NCT00510653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101856866|NCT00510653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101856867|NCT00510653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856868|NCT01009697|Codeine|codeine|mesh-list
101856869|NCT01009697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101856870|NCT01009697|Narcotics|narcotics|mesh-ancestor
101856871|NCT01009697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101856872|NCT01009697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856873|NCT01009697|Analgesics|analgesics|mesh-ancestor
101856874|NCT01009697|Sensory System Agents|sensory system agents|mesh-ancestor
101856875|NCT01009697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101856876|NCT01009697|Antitussive Agents|antitussive agents|mesh-ancestor
101856877|NCT01009697|Respiratory System Agents|respiratory system agents|mesh-ancestor
101856878|NCT01009853|Codeine|codeine|mesh-list
101856879|NCT01009853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101856880|NCT01009853|Narcotics|narcotics|mesh-ancestor
101856881|NCT01009853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101856882|NCT01009853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856883|NCT01009853|Analgesics|analgesics|mesh-ancestor
101856884|NCT01009853|Sensory System Agents|sensory system agents|mesh-ancestor
101856885|NCT01009853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101856886|NCT01009853|Antitussive Agents|antitussive agents|mesh-ancestor
101856887|NCT01009853|Respiratory System Agents|respiratory system agents|mesh-ancestor
101856888|NCT00506285|Methylphenidate|methylphenidate|mesh-list
101856889|NCT00506285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101856890|NCT00506285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856891|NCT00506285|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101856892|NCT00506285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101856893|NCT00506285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101686875|NCT00092807|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101856894|NCT00506285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856896|NCT00506285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101856897|NCT00506129|Fludarabine|fludarabine|mesh-list
101856898|NCT00506129|Fludarabine phosphate|fludarabine phosphate|mesh-list
101856899|NCT00506129|Melphalan|melphalan|mesh-list
101856900|NCT00506129|Thymoglobulin|thymoglobulin|mesh-list
101856901|NCT00506129|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101856902|NCT00506129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101856903|NCT00506129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101856904|NCT00506129|Antimetabolites|antimetabolites|mesh-ancestor
101856905|NCT00506129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856906|NCT00506129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101856907|NCT00506129|Immunologic Factors|immunologic factors|mesh-ancestor
101856908|NCT00506129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856909|NCT00506129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101856910|NCT00506129|Alkylating Agents|alkylating agents|mesh-ancestor
101856911|NCT00506129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101856912|NCT00358670|Infliximab|infliximab|mesh-list
101856913|NCT00358670|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101856914|NCT00358670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101856915|NCT00358670|Dermatologic Agents|dermatologic agents|mesh-ancestor
101856916|NCT00358670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101856917|NCT00358670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101856918|NCT01010087|Oseltamivir|oseltamivir|mesh-list
101856919|NCT01010087|Antiviral Agents|antiviral agents|mesh-ancestor
101856920|NCT01010087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101856921|NCT01010087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101856922|NCT01010087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856923|NCT00505661|Letrozole|letrozole|mesh-list
101856924|NCT00505661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101856925|NCT00505661|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101856926|NCT00505661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101856927|NCT00505661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101965372|NCT01583777|Belinostat|belinostat|mesh-list
101856928|NCT00505661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856929|NCT00505661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101856930|NCT00505661|Hormone Antagonists|hormone antagonists|mesh-ancestor
101856931|NCT00505661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101856932|NCT00505661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856933|NCT00383786|Vofopitant|vofopitant|mesh-list
101856934|NCT00383786|Antiemetics|antiemetics|mesh-ancestor
101856935|NCT00383786|Autonomic Agents|autonomic agents|mesh-ancestor
101856936|NCT00383786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101856937|NCT00383786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856938|NCT00383786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101856939|NCT00383786|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101856940|NCT00383786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101856941|NCT00383786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856942|NCT05358977|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101856943|NCT05358977|Hemostatics|hemostatics|mesh-ancestor
101856944|NCT05358977|Coagulants|coagulants|mesh-ancestor
101856945|NCT01010243|Pioglitazone|pioglitazone|mesh-list
101856946|NCT01010243|Dexamethasone|dexamethasone|mesh-list
101856947|NCT01010243|Lenalidomide|lenalidomide|mesh-list
101576781|NCT00612157|Eszopiclone|eszopiclone|mesh-list
101856948|NCT01010243|Treosulfan|treosulfan|mesh-list
101856949|NCT01010243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101856951|NCT01010243|Autonomic Agents|autonomic agents|mesh-ancestor
101856952|NCT01010243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101856953|NCT01010243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856954|NCT01010243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101856955|NCT01010243|Glucocorticoids|glucocorticoids|mesh-ancestor
101856957|NCT01010243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101856958|NCT01010243|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101856959|NCT01010243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101856960|NCT01010243|Immunologic Factors|immunologic factors|mesh-ancestor
101856961|NCT01010243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101856962|NCT01010243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101856963|NCT01010243|Growth Substances|growth substances|mesh-ancestor
101856964|NCT01010243|Growth Inhibitors|growth inhibitors|mesh-ancestor
101856965|NCT01010243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101856966|NCT01010243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101856967|NCT01010243|Alkylating Agents|alkylating agents|mesh-ancestor
101856968|NCT01010243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856969|NCT00383708|Lanreotide|lanreotide|mesh-list
101240611|NCT01622790|Lamivudine|lamivudine|mesh-list
101856970|NCT00383708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101856971|NCT00504881|Brivaracetam|brivaracetam|mesh-list
101856972|NCT00504881|Anticonvulsants|anticonvulsants|mesh-ancestor
101856973|NCT00504725|Ketamine|ketamine|mesh-list
101856974|NCT00504725|Analgesics|analgesics|mesh-ancestor
101856975|NCT00504725|Sensory System Agents|sensory system agents|mesh-ancestor
101856976|NCT00504725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101856977|NCT00504725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856978|NCT00504725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101856979|NCT00504725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101856980|NCT00504725|Anesthetics, General|anesthetics, general|mesh-ancestor
101856981|NCT00504725|Anesthetics|anesthetics|mesh-ancestor
101856982|NCT00504725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101856983|NCT00504725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101856984|NCT00504725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101856985|NCT00504725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101856986|NCT00504725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101856987|NCT00383240|Mometasone Furoate|mometasone furoate|mesh-list
101856988|NCT00383240|Formoterol Fumarate|formoterol fumarate|mesh-list
101856989|NCT00383240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101856990|NCT00383240|Autonomic Agents|autonomic agents|mesh-ancestor
101856991|NCT00383240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101856992|NCT00383240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101856993|NCT00383240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101856994|NCT00383240|Respiratory System Agents|respiratory system agents|mesh-ancestor
101856995|NCT00383240|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101856996|NCT00383240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101856997|NCT00383240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101856998|NCT00383240|Adrenergic Agents|adrenergic agents|mesh-ancestor
101856999|NCT00383240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101857000|NCT00383240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857001|NCT00383240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101857002|NCT00383240|Dermatologic Agents|dermatologic agents|mesh-ancestor
101857003|NCT00383240|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101857004|NCT05130788|Nicotine|nicotine|mesh-list
101857005|NCT05130788|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101857006|NCT05130788|Autonomic Agents|autonomic agents|mesh-ancestor
101857007|NCT05130788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101857008|NCT05130788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857009|NCT05130788|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101857010|NCT05130788|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101857011|NCT05130788|Cholinergic Agents|cholinergic agents|mesh-ancestor
101857012|NCT05130788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101857013|NCT05130788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857014|NCT00362180|Mipomersen|mipomersen|mesh-list
101857015|NCT00362180|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101857016|NCT00362180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101857017|NCT00362180|Antimetabolites|antimetabolites|mesh-ancestor
101857018|NCT00362180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857019|NCT00362180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101857020|NCT00383162|Naproxen|naproxen|mesh-list
101857021|NCT00383162|Sumatriptan|sumatriptan|mesh-list
101857022|NCT00383162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101857023|NCT00383162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101857024|NCT00383162|Analgesics|analgesics|mesh-ancestor
101857025|NCT00383162|Sensory System Agents|sensory system agents|mesh-ancestor
101857026|NCT00383162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101857027|NCT00383162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857028|NCT00383162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101857029|NCT00383162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101857030|NCT00383162|Gout Suppressants|gout suppressants|mesh-ancestor
101857031|NCT00383162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101857032|NCT00383162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101857033|NCT00383162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857034|NCT00383162|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101857035|NCT00383162|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101857036|NCT00383162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101857037|NCT00383162|Serotonin Agents|serotonin agents|mesh-ancestor
101857038|NCT00383162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101857039|NCT01052792|Naproxen|naproxen|mesh-list
101857040|NCT01052792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101857041|NCT01052792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101857042|NCT01052792|Analgesics|analgesics|mesh-ancestor
101857043|NCT01052792|Sensory System Agents|sensory system agents|mesh-ancestor
101857044|NCT01052792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101857045|NCT01052792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857046|NCT01052792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101857047|NCT01052792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101857048|NCT01052792|Gout Suppressants|gout suppressants|mesh-ancestor
101857049|NCT01052792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101857050|NCT01052792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101857051|NCT01052792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857052|NCT01052870|Finasteride|finasteride|mesh-list
101857053|NCT01052870|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101857054|NCT01052870|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101857055|NCT01052870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101857056|NCT01052870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857057|NCT01052870|Hormone Antagonists|hormone antagonists|mesh-ancestor
101857058|NCT01052870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101686939|NCT04212650|Losartan|losartan|mesh-list
101857059|NCT01052870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857060|NCT01052870|Urological Agents|urological agents|mesh-ancestor
101857061|NCT00358436|Bromides|bromides|mesh-list
101857062|NCT00358436|Anticonvulsants|anticonvulsants|mesh-ancestor
101857063|NCT01053026|Olmesartan|olmesartan|mesh-list
101857064|NCT01053026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101857065|NCT01053026|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101857066|NCT01053026|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101857067|NCT01053026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857068|NCT01045538|Capecitabine|capecitabine|mesh-list
101857069|NCT01045538|Vorinostat|vorinostat|mesh-list
101857070|NCT01045538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101857071|NCT01045538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101857072|NCT01045538|Antimetabolites|antimetabolites|mesh-ancestor
101857073|NCT01045538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857074|NCT01045538|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101857075|NCT01045538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101857076|NCT00361634|Etanercept|etanercept|mesh-list
101857077|NCT00361634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101857078|NCT00361634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101857079|NCT00361634|Analgesics|analgesics|mesh-ancestor
101857080|NCT00361634|Sensory System Agents|sensory system agents|mesh-ancestor
101857081|NCT00361634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101857082|NCT00361634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857083|NCT00361634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101857084|NCT00361634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101857085|NCT00361634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101857086|NCT00361634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101857087|NCT00361634|Immunologic Factors|immunologic factors|mesh-ancestor
101857088|NCT00357968|Clopidogrel|clopidogrel|mesh-list
101857089|NCT00357968|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101857090|NCT00357968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101857091|NCT00357968|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101857092|NCT00357968|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101857093|NCT00357968|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101857094|NCT00357968|Purinergic Agents|purinergic agents|mesh-ancestor
101857095|NCT00357968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101857096|NCT00357968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857097|NCT00357968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857098|NCT00357656|Factor VIII|factor viii|mesh-list
101857099|NCT00357656|Coagulants|coagulants|mesh-ancestor
101857100|NCT00357500|Thalidomide|thalidomide|mesh-list
101857101|NCT00357500|Celecoxib|celecoxib|mesh-list
101857102|NCT00357500|Cyclophosphamide|cyclophosphamide|mesh-list
101857103|NCT00357500|Etoposide|etoposide|mesh-list
101857104|NCT00357500|Fenofibrate|fenofibrate|mesh-list
101857105|NCT00357500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101857106|NCT00357500|Immunologic Factors|immunologic factors|mesh-ancestor
101857107|NCT00357500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857108|NCT00357500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101857109|NCT00357500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101857110|NCT00357500|Alkylating Agents|alkylating agents|mesh-ancestor
101857111|NCT00357500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857112|NCT00357500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101857113|NCT00357500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101857114|NCT00357500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101857115|NCT00357500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101857116|NCT00357500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101857117|NCT00357500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101857118|NCT00357500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101857119|NCT00357500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101857120|NCT00357500|Analgesics|analgesics|mesh-ancestor
101857121|NCT00357500|Sensory System Agents|sensory system agents|mesh-ancestor
101857122|NCT00357500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101857123|NCT00357500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101857124|NCT00357500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101857125|NCT00357500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101857126|NCT00357500|Leprostatic Agents|leprostatic agents|mesh-ancestor
101857127|NCT00357500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101857128|NCT00357500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101857129|NCT00357500|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101857130|NCT00357500|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101857132|NCT00357500|Growth Inhibitors|growth inhibitors|mesh-ancestor
101857133|NCT00357500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101857134|NCT00357500|Antimetabolites|antimetabolites|mesh-ancestor
101857135|NCT00357500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101857136|NCT00357110|Fulvestrant|fulvestrant|mesh-list
101857137|NCT00357110|Anastrozole|anastrozole|mesh-list
101857138|NCT00357110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101857139|NCT00357110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101857140|NCT00357110|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101857141|NCT00357110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101857142|NCT00357110|Hormone Antagonists|hormone antagonists|mesh-ancestor
101857143|NCT00357110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101857144|NCT00357110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857145|NCT00357110|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101857146|NCT00357110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101857147|NCT00357110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101857148|NCT00357110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857149|NCT03337646|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101857150|NCT03337646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101857151|NCT03337646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857152|NCT03337646|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101857153|NCT03337646|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101857154|NCT03337646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101857155|NCT03337646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857157|NCT03337646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101857158|NCT00098722|Maraviroc|maraviroc|mesh-list
101857159|NCT00098722|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101857160|NCT00098722|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101857161|NCT00098722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857162|NCT00098722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101857163|NCT00098722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101857164|NCT00098722|Antiviral Agents|antiviral agents|mesh-ancestor
101857165|NCT00098722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101857166|NCT00098722|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101857167|NCT02531152|Latanoprost|latanoprost|mesh-list
101857168|NCT02531152|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101857169|NCT02531152|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101857170|NCT01084408|Paclitaxel|paclitaxel|mesh-list
101857171|NCT01084408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101857172|NCT01084408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101857173|NCT01084408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101857174|NCT01084408|Tubulin Modulators|tubulin modulators|mesh-ancestor
101857175|NCT01084408|Antimitotic Agents|antimitotic agents|mesh-ancestor
101857176|NCT01084408|Mitosis Modulators|mitosis modulators|mesh-ancestor
101857177|NCT01084408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857178|NCT00098254|Sorafenib|sorafenib|mesh-list
101857179|NCT00098254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101857180|NCT00098254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101857181|NCT00098254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101857182|NCT00098254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857183|NCT00095056|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101857184|NCT00095056|Glipizide|glipizide|mesh-list
101857185|NCT00095056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101857186|NCT00095056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857187|NCT00095056|Incretins|incretins|mesh-ancestor
101857188|NCT00095056|Hormones|hormones|mesh-ancestor
101857189|NCT00095056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101857190|NCT00095056|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101857191|NCT00095056|Protease Inhibitors|protease inhibitors|mesh-ancestor
101857192|NCT00095056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101857193|NCT00095056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857194|NCT00098020|Isotretinoin|isotretinoin|mesh-list
101857195|NCT00098020|Dermatologic Agents|dermatologic agents|mesh-ancestor
101857196|NCT00381680|Leucovorin|leucovorin|mesh-list
101857197|NCT00381680|Cytarabine|cytarabine|mesh-list
101857198|NCT00381680|Dexamethasone|dexamethasone|mesh-list
101857199|NCT00381680|Prednisone|prednisone|mesh-list
101857200|NCT00381680|Cyclophosphamide|cyclophosphamide|mesh-list
101857201|NCT00381680|Doxorubicin|doxorubicin|mesh-list
101857202|NCT00381680|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101857203|NCT00381680|Methotrexate|methotrexate|mesh-list
101857204|NCT00381680|Etoposide|etoposide|mesh-list
101857205|NCT00381680|Vincristine|vincristine|mesh-list
101857206|NCT00381680|Etoposide phosphate|etoposide phosphate|mesh-list
101857207|NCT00381680|Asparaginase|asparaginase|mesh-list
101857208|NCT00381680|Mercaptopurine|mercaptopurine|mesh-list
101857209|NCT00381680|Pegaspargase|pegaspargase|mesh-list
101857210|NCT00381680|Levoleucovorin|levoleucovorin|mesh-list
101857211|NCT00381680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101857212|NCT00381680|Immunologic Factors|immunologic factors|mesh-ancestor
101857213|NCT00381680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857214|NCT00381680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101857215|NCT00381680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101857216|NCT00381680|Alkylating Agents|alkylating agents|mesh-ancestor
101857217|NCT00381680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857218|NCT00381680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101857219|NCT00381680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101857220|NCT00381680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101857221|NCT00381680|Antiemetics|antiemetics|mesh-ancestor
101857222|NCT00381680|Autonomic Agents|autonomic agents|mesh-ancestor
101857223|NCT00381680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101857224|NCT00381680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101857225|NCT00381680|Glucocorticoids|glucocorticoids|mesh-ancestor
101857226|NCT00381680|Hormones|hormones|mesh-ancestor
101857227|NCT00381680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101857228|NCT00381680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101857229|NCT00381680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101857230|NCT00381680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101857231|NCT00381680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101857232|NCT00381680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101857233|NCT00381680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101857234|NCT00381680|Abortifacient Agents|abortifacient agents|mesh-ancestor
101857235|NCT00381680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101857236|NCT00381680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101857237|NCT00381680|Antimetabolites|antimetabolites|mesh-ancestor
101857238|NCT00381680|Dermatologic Agents|dermatologic agents|mesh-ancestor
101857239|NCT00381680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101857240|NCT00381680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101857241|NCT00381680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101857242|NCT00381680|Antiviral Agents|antiviral agents|mesh-ancestor
101857243|NCT00381680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101857244|NCT00381680|Antidotes|antidotes|mesh-ancestor
101857245|NCT00381680|Protective Agents|protective agents|mesh-ancestor
101857246|NCT00381680|Vitamin B Complex|vitamin b complex|mesh-ancestor
101857247|NCT00381680|Vitamins|vitamins|mesh-ancestor
101857249|NCT00381680|Tubulin Modulators|tubulin modulators|mesh-ancestor
101857250|NCT00381680|Antimitotic Agents|antimitotic agents|mesh-ancestor
101857251|NCT00381680|Mitosis Modulators|mitosis modulators|mesh-ancestor
101857252|NCT03292250|Durvalumab|durvalumab|mesh-list
101857253|NCT03292250|Tremelimumab|tremelimumab|mesh-list
101857254|NCT03292250|Nintedanib|nintedanib|mesh-list
101857255|NCT03292250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101857256|NCT03292250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101857257|NCT03292250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101857258|NCT03292250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101687016|NCT03512418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101857259|NCT03292250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857260|NCT01053338|Diphenhydramine|diphenhydramine|mesh-list
101857261|NCT01053338|Promethazine|promethazine|mesh-list
101857262|NCT01053338|Ibuprofen|ibuprofen|mesh-list
101857263|NCT01053338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857264|NCT01053338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101857265|NCT01053338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101857266|NCT01053338|Analgesics|analgesics|mesh-ancestor
101857267|NCT01053338|Sensory System Agents|sensory system agents|mesh-ancestor
101857268|NCT01053338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101857269|NCT01053338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857270|NCT01053338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101857271|NCT01053338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101857272|NCT01053338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101857273|NCT01053338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101857274|NCT01053338|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101857275|NCT01053338|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101857276|NCT01053338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101857277|NCT01053338|Anesthetics, Local|anesthetics, local|mesh-ancestor
101857278|NCT01053338|Anesthetics|anesthetics|mesh-ancestor
101857279|NCT01053338|Antiemetics|antiemetics|mesh-ancestor
101857280|NCT01053338|Autonomic Agents|autonomic agents|mesh-ancestor
101857281|NCT01053338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101857282|NCT01053338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101857283|NCT01053338|Histamine Antagonists|histamine antagonists|mesh-ancestor
101857284|NCT01053338|Histamine Agents|histamine agents|mesh-ancestor
101857285|NCT01053338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101857286|NCT01053338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101857287|NCT01053338|Antipruritics|antipruritics|mesh-ancestor
101857288|NCT01053338|Dermatologic Agents|dermatologic agents|mesh-ancestor
101857289|NCT01050374|Albendazole|albendazole|mesh-list
101857290|NCT01050374|Praziquantel|praziquantel|mesh-list
101857291|NCT01050374|Mebendazole|mebendazole|mesh-list
101857292|NCT01050374|Piperazine|piperazine|mesh-list
101857293|NCT01050374|Piperazine citrate|piperazine citrate|mesh-list
101857294|NCT01050374|DMP 777|dmp 777|mesh-list
101857295|NCT01050374|Anthelmintics|anthelmintics|mesh-ancestor
101857296|NCT01050374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101857297|NCT01050374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101857298|NCT01050374|Anticestodal Agents|anticestodal agents|mesh-ancestor
101857299|NCT01050374|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101857300|NCT01050374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101857301|NCT01050374|Tubulin Modulators|tubulin modulators|mesh-ancestor
101857302|NCT01050374|Antimitotic Agents|antimitotic agents|mesh-ancestor
101857303|NCT01050374|Mitosis Modulators|mitosis modulators|mesh-ancestor
101857304|NCT01050374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857305|NCT01050374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101857306|NCT01050374|Antinematodal Agents|antinematodal agents|mesh-ancestor
101857307|NCT01050374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101857308|NCT00360698|Insulin|insulin|mesh-list
101857309|NCT00360698|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101857310|NCT00360698|Metformin|metformin|mesh-list
101857311|NCT00360698|Insulin Glargine|insulin glargine|mesh-list
101857312|NCT00360698|Glimepiride|glimepiride|mesh-list
101857313|NCT00360698|Insulin glulisine|insulin glulisine|mesh-list
101857314|NCT00360698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101857315|NCT00360698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857316|NCT00360698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101857317|NCT00360698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101857318|NCT00360698|Immunologic Factors|immunologic factors|mesh-ancestor
101857319|NCT03990194|Leuprolide|leuprolide|mesh-list
101857320|NCT03990194|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101857321|NCT03990194|Fertility Agents|fertility agents|mesh-ancestor
101857322|NCT03990194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101857323|NCT03990194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857324|NCT03990194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101857325|NCT03990194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101857326|NCT00380978|Narcotics|narcotics|mesh-list
101857327|NCT00380978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101857328|NCT00380978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857329|NCT00380978|Analgesics|analgesics|mesh-ancestor
101857330|NCT00380978|Sensory System Agents|sensory system agents|mesh-ancestor
101857331|NCT00380978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101857332|NCT00162123|Ipilimumab|ipilimumab|mesh-list
101857333|NCT00162123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101857334|NCT00162123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101857335|NCT00162123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101857336|NCT00162123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857337|NCT00227721|Gemcitabine|gemcitabine|mesh-list
101857338|NCT00227721|Docetaxel|docetaxel|mesh-list
101857339|NCT00227721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101857340|NCT00227721|Antimetabolites|antimetabolites|mesh-ancestor
101857341|NCT00227721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857342|NCT00227721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101857343|NCT00227721|Tubulin Modulators|tubulin modulators|mesh-ancestor
101857344|NCT00227721|Antimitotic Agents|antimitotic agents|mesh-ancestor
101857345|NCT00227721|Mitosis Modulators|mitosis modulators|mesh-ancestor
101857346|NCT01074723|Carotenoids|carotenoids|mesh-list
101857347|NCT01074723|Antioxidants|antioxidants|mesh-ancestor
101857348|NCT01074723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857349|NCT01074723|Protective Agents|protective agents|mesh-ancestor
101857350|NCT01074723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857351|NCT01074801|Insulin|insulin|mesh-list
101857352|NCT01074801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101857353|NCT01074801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101857354|NCT01074801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857355|NCT01074879|Caseins|caseins|mesh-list
101857356|NCT01074879|Chelating Agents|chelating agents|mesh-ancestor
101857357|NCT01074879|Sequestering Agents|sequestering agents|mesh-ancestor
101965393|NCT03955601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101857358|NCT01074879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857359|NCT00226941|Diphenhydramine|diphenhydramine|mesh-list
101857360|NCT00226941|Promethazine|promethazine|mesh-list
101857361|NCT00226941|Capecitabine|capecitabine|mesh-list
101857362|NCT00226941|Oxaliplatin|oxaliplatin|mesh-list
101857363|NCT00226941|Cetuximab|cetuximab|mesh-list
101857364|NCT00226941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101857365|NCT00226941|Antimetabolites|antimetabolites|mesh-ancestor
101857366|NCT00226941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857367|NCT00226941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101857368|NCT00226941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101857369|NCT00226941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101857370|NCT00226941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101857371|NCT00226941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101857372|NCT00226941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857373|NCT00226941|Anesthetics, Local|anesthetics, local|mesh-ancestor
101857374|NCT00226941|Anesthetics|anesthetics|mesh-ancestor
101857375|NCT00226941|Sensory System Agents|sensory system agents|mesh-ancestor
101857376|NCT00226941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101857377|NCT00226941|Antiemetics|antiemetics|mesh-ancestor
101857378|NCT00226941|Autonomic Agents|autonomic agents|mesh-ancestor
101857379|NCT00226941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101857380|NCT00226941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101857381|NCT00226941|Histamine Antagonists|histamine antagonists|mesh-ancestor
101857382|NCT00226941|Histamine Agents|histamine agents|mesh-ancestor
101857383|NCT00226941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101857384|NCT00226941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101857385|NCT00226941|Antipruritics|antipruritics|mesh-ancestor
101857386|NCT00226941|Dermatologic Agents|dermatologic agents|mesh-ancestor
101857387|NCT01075503|Ropivacaine|ropivacaine|mesh-list
101857388|NCT01075503|Anesthetics, Local|anesthetics, local|mesh-ancestor
101857389|NCT01075503|Anesthetics|anesthetics|mesh-ancestor
101857390|NCT01075503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101857391|NCT01075503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857392|NCT01075503|Sensory System Agents|sensory system agents|mesh-ancestor
101857393|NCT01075503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101857394|NCT01075581|Epinephrine|epinephrine|mesh-list
101857395|NCT01075581|Racepinephrine|racepinephrine|mesh-list
101857396|NCT01075581|Epinephryl borate|epinephryl borate|mesh-list
101857397|NCT01075581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101857398|NCT01075581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101857399|NCT01075581|Adrenergic Agents|adrenergic agents|mesh-ancestor
101857400|NCT01075581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101857401|NCT01075581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857402|NCT01075581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857403|NCT01075581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101857404|NCT01075581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101857405|NCT01075581|Autonomic Agents|autonomic agents|mesh-ancestor
101857406|NCT01075581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101857407|NCT01075581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101857408|NCT01075581|Respiratory System Agents|respiratory system agents|mesh-ancestor
101857409|NCT01075581|Mydriatics|mydriatics|mesh-ancestor
101857410|NCT01075581|Sympathomimetics|sympathomimetics|mesh-ancestor
101857411|NCT01075581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101857412|NCT00356408|Certolizumab Pegol|certolizumab pegol|mesh-list
101857413|NCT00356408|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101857414|NCT00356408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101857415|NCT00356408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101857416|NCT00356408|Immunologic Factors|immunologic factors|mesh-ancestor
101857417|NCT00356408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857418|NCT00356408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101857419|NCT00509795|Ranibizumab|ranibizumab|mesh-list
101857420|NCT00509795|Aflibercept|aflibercept|mesh-list
101857421|NCT00509795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101857422|NCT00509795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101857423|NCT00509795|Growth Substances|growth substances|mesh-ancestor
101857424|NCT00509795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857425|NCT00509795|Growth Inhibitors|growth inhibitors|mesh-ancestor
101857426|NCT00509795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101857427|NCT00504257|Bevacizumab|bevacizumab|mesh-list
101857429|NCT00504257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101857430|NCT00504257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101857431|NCT00504257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101857432|NCT00504257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101857433|NCT00504257|Growth Substances|growth substances|mesh-ancestor
101857434|NCT00504257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857435|NCT00504257|Growth Inhibitors|growth inhibitors|mesh-ancestor
101857436|NCT00504257|Tubulin Modulators|tubulin modulators|mesh-ancestor
101857437|NCT00504257|Antimitotic Agents|antimitotic agents|mesh-ancestor
101857438|NCT00504257|Mitosis Modulators|mitosis modulators|mesh-ancestor
101857439|NCT00504257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857440|NCT00509093|Imatinib Mesylate|imatinib mesylate|mesh-list
101857441|NCT00509093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101857442|NCT00509093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101857443|NCT00509093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101857444|NCT00509093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857445|NCT05358509|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
101857446|NCT05358509|Ferric Compounds|ferric compounds|mesh-list
101857447|NCT05358509|Hematinics|hematinics|mesh-ancestor
101857448|NCT00160641|Certolizumab Pegol|certolizumab pegol|mesh-list
101857449|NCT00160641|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101857450|NCT00160641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101857451|NCT00160641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101857452|NCT00160641|Immunologic Factors|immunologic factors|mesh-ancestor
101857453|NCT00160641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857454|NCT00160641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101857455|NCT00493025|Paclitaxel|paclitaxel|mesh-list
101857456|NCT00493025|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101857457|NCT00493025|Cisplatin|cisplatin|mesh-list
101857458|NCT00493025|Gefitinib|gefitinib|mesh-list
101857459|NCT00493025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101857460|NCT00493025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101857461|NCT00493025|Tubulin Modulators|tubulin modulators|mesh-ancestor
101857462|NCT00493025|Antimitotic Agents|antimitotic agents|mesh-ancestor
101857463|NCT00493025|Mitosis Modulators|mitosis modulators|mesh-ancestor
101857464|NCT00493025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857465|NCT00493025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101857466|NCT00493025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101857467|NCT01075113|Sorafenib|sorafenib|mesh-list
101857468|NCT01075113|Vorinostat|vorinostat|mesh-list
101857469|NCT01075113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101857470|NCT01075113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101687136|NCT02686008|Olaparib|olaparib|mesh-list
101857471|NCT01075113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101857472|NCT01075113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857473|NCT01075113|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101857474|NCT01073319|Rivastigmine|rivastigmine|mesh-list
101857475|NCT01073319|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101857476|NCT01073319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101577303|NCT02873091|Narcotics|narcotics|mesh-ancestor
101857477|NCT01073319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857478|NCT01073319|Cholinergic Agents|cholinergic agents|mesh-ancestor
101857479|NCT01073319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101857480|NCT01073319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857481|NCT01073319|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101857482|NCT01073319|Protective Agents|protective agents|mesh-ancestor
101857484|NCT00160563|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101857485|NCT00160563|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101857486|NCT00160563|Histamine Antagonists|histamine antagonists|mesh-ancestor
101857487|NCT00160563|Histamine Agents|histamine agents|mesh-ancestor
101857488|NCT00160563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101857489|NCT00160563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857490|NCT00160563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857491|NCT01050452|Ivermectin|ivermectin|mesh-list
101857492|NCT01050452|Albendazole|albendazole|mesh-list
101857493|NCT01050452|Mebendazole|mebendazole|mesh-list
101857494|NCT01050452|Piperazine|piperazine|mesh-list
101857495|NCT01050452|Piperazine citrate|piperazine citrate|mesh-list
101857496|NCT01050452|DMP 777|dmp 777|mesh-list
101857497|NCT01050452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101857498|NCT01050452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101857499|NCT01050452|Anthelmintics|anthelmintics|mesh-ancestor
101857500|NCT01050452|Anticestodal Agents|anticestodal agents|mesh-ancestor
101857501|NCT01050452|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101857502|NCT01050452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101857503|NCT01050452|Tubulin Modulators|tubulin modulators|mesh-ancestor
101857504|NCT01050452|Antimitotic Agents|antimitotic agents|mesh-ancestor
101857505|NCT01050452|Mitosis Modulators|mitosis modulators|mesh-ancestor
101857506|NCT01050452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857507|NCT01050452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101857508|NCT01050452|Antinematodal Agents|antinematodal agents|mesh-ancestor
101857509|NCT01050452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101857510|NCT00380588|Gemcitabine|gemcitabine|mesh-list
101857511|NCT00380588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101857512|NCT00380588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101857513|NCT00380588|Antimetabolites|antimetabolites|mesh-ancestor
101857514|NCT00380588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857515|NCT00379808|Montelukast|montelukast|mesh-list
101857516|NCT00379808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101857517|NCT00379808|Respiratory System Agents|respiratory system agents|mesh-ancestor
101857518|NCT00379808|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101857519|NCT00379808|Hormone Antagonists|hormone antagonists|mesh-ancestor
101857520|NCT00379808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101857521|NCT00379808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857522|NCT00379808|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101857523|NCT00379808|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101857524|NCT00379808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857525|NCT03990038|Ropivacaine|ropivacaine|mesh-list
101857526|NCT03990038|Anesthetics, Local|anesthetics, local|mesh-ancestor
101857527|NCT03990038|Anesthetics|anesthetics|mesh-ancestor
101857528|NCT03990038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101857529|NCT03990038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857530|NCT03990038|Sensory System Agents|sensory system agents|mesh-ancestor
101857531|NCT03990038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101857532|NCT00355784|Hormones|hormones|mesh-list
101857533|NCT00355784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101857534|NCT00355784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857535|NCT02534636|Interferons|interferons|mesh-list
101857536|NCT02534636|Interferon-alpha|interferon-alpha|mesh-list
101857537|NCT02534636|Interferon alpha-2|interferon alpha-2|mesh-list
101857538|NCT02534636|Deucravacitinib|deucravacitinib|mesh-list
101857539|NCT02534636|Famotidine|famotidine|mesh-list
101857540|NCT02534636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101857541|NCT02534636|Antiviral Agents|antiviral agents|mesh-ancestor
101857542|NCT02534636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101857543|NCT02534636|Immunologic Factors|immunologic factors|mesh-ancestor
101857544|NCT02534636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857545|NCT02534636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101857546|NCT02534636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101857547|NCT02534636|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101857548|NCT02534636|Histamine Antagonists|histamine antagonists|mesh-ancestor
101857549|NCT02534636|Histamine Agents|histamine agents|mesh-ancestor
101857550|NCT02534636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101857551|NCT02534636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577393|NCT04205565|Oxiracetam|oxiracetam|mesh-list
101857552|NCT02534636|Dermatologic Agents|dermatologic agents|mesh-ancestor
101857553|NCT02534636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101857554|NCT02534636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101857555|NCT01053650|Acetaminophen|acetaminophen|mesh-list
101857556|NCT01053650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101857557|NCT01053650|Analgesics|analgesics|mesh-ancestor
101857558|NCT01053650|Sensory System Agents|sensory system agents|mesh-ancestor
101857559|NCT01053650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101857560|NCT01053650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857561|NCT01053650|Antipyretics|antipyretics|mesh-ancestor
101857562|NCT01053728|Insulin Glargine|insulin glargine|mesh-list
101857563|NCT01053728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101857564|NCT01053728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857566|NCT01050608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101857567|NCT01050608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101857568|NCT01050608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101857569|NCT01050608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857570|NCT01053806|Lenalidomide|lenalidomide|mesh-list
101857571|NCT01053806|Azacitidine|azacitidine|mesh-list
101857572|NCT01053806|Immunologic Factors|immunologic factors|mesh-ancestor
101857573|NCT01053806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857574|NCT01053806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101857575|NCT01053806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101857576|NCT01053806|Growth Substances|growth substances|mesh-ancestor
101857577|NCT01053806|Growth Inhibitors|growth inhibitors|mesh-ancestor
101857578|NCT01053806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101857579|NCT01053806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101857580|NCT01053806|Antimetabolites|antimetabolites|mesh-ancestor
101857581|NCT01053806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857582|NCT01053806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101857583|NCT00355472|Mogamulizumab|mogamulizumab|mesh-list
101857584|NCT00355472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101857585|NCT01053884|Anidulafungin|anidulafungin|mesh-list
101857586|NCT01053884|Antifungal Agents|antifungal agents|mesh-ancestor
101857587|NCT01053884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101857588|NCT00492557|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101857589|NCT00492557|Immunologic Factors|immunologic factors|mesh-ancestor
101687158|NCT03384654|Methotrexate|methotrexate|mesh-list
101857590|NCT00492557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857591|NCT01010789|Modafinil|modafinil|mesh-list
101857592|NCT01010789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101857593|NCT01010789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857594|NCT01010789|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101857595|NCT01010789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101857596|NCT01010789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101857597|NCT01010789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857598|NCT01015235|Ketorolac|ketorolac|mesh-list
101857599|NCT01015235|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101857600|NCT01015235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101857601|NCT01015235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101857602|NCT01015235|Analgesics|analgesics|mesh-ancestor
101857603|NCT01015235|Sensory System Agents|sensory system agents|mesh-ancestor
101857604|NCT01015235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101857605|NCT01015235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857606|NCT01015235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101857607|NCT01015235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101857608|NCT01015235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101857609|NCT01015235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101857610|NCT01015235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857611|NCT00508157|Olanzapine|olanzapine|mesh-list
101857612|NCT00508157|Risperidone|risperidone|mesh-list
101857613|NCT00508157|Aripiprazole|aripiprazole|mesh-list
101857614|NCT00508157|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101857615|NCT00508157|Antipsychotic Agents|antipsychotic agents|mesh-list
101857616|NCT00508157|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101857617|NCT00508157|Serotonin Agents|serotonin agents|mesh-ancestor
101857618|NCT00508157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101857619|NCT00508157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857620|NCT00508157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857621|NCT00508157|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101857622|NCT00508157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101857623|NCT00508157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101857624|NCT00508157|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101857625|NCT00508157|Dopamine Agents|dopamine agents|mesh-ancestor
101857626|NCT00508157|Antiemetics|antiemetics|mesh-ancestor
101857627|NCT00508157|Autonomic Agents|autonomic agents|mesh-ancestor
101857628|NCT00508157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101857629|NCT00508157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101857630|NCT00508157|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101857631|NCT00508157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101857632|NCT00508157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101857633|NCT00508157|Antidepressive Agents|antidepressive agents|mesh-ancestor
101857634|NCT00508157|Dopamine Agonists|dopamine agonists|mesh-ancestor
101857635|NCT00508157|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101857636|NCT00508157|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101857637|NCT00508157|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101857638|NCT00508157|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101857639|NCT04331717|Leuprolide|leuprolide|mesh-list
101857640|NCT04331717|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101857641|NCT04331717|Fertility Agents|fertility agents|mesh-ancestor
101857642|NCT04331717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101857643|NCT04331717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857644|NCT04331717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101857645|NCT04331717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101857646|NCT01015391|Azathioprine|azathioprine|mesh-list
101857647|NCT01015391|Antimetabolites|antimetabolites|mesh-ancestor
101857648|NCT01015391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857649|NCT01015391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101857650|NCT01015391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101857651|NCT01015391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101857652|NCT01015391|Immunologic Factors|immunologic factors|mesh-ancestor
101857653|NCT01015391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857654|NCT01015391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101857655|NCT01010945|Paclitaxel|paclitaxel|mesh-list
101857656|NCT01010945|Gemcitabine|gemcitabine|mesh-list
101857657|NCT01010945|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101857658|NCT01010945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101857659|NCT01010945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101857660|NCT01010945|Tubulin Modulators|tubulin modulators|mesh-ancestor
101857661|NCT01010945|Antimitotic Agents|antimitotic agents|mesh-ancestor
101857662|NCT01010945|Mitosis Modulators|mitosis modulators|mesh-ancestor
101857663|NCT01010945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857664|NCT01010945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101857665|NCT01010945|Antimetabolites|antimetabolites|mesh-ancestor
101857666|NCT01010945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101857667|NCT01010945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101857668|NCT00507689|Immunoglobulins|immunoglobulins|mesh-list
101857669|NCT00507689|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101857670|NCT00507689|Antibodies|antibodies|mesh-list
101857671|NCT00507689|Immunologic Factors|immunologic factors|mesh-ancestor
101857672|NCT00507689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857673|NCT00491387|Metoprolol|metoprolol|mesh-list
101857674|NCT00491387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101857675|NCT00491387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101857676|NCT00491387|Sympatholytics|sympatholytics|mesh-ancestor
101857677|NCT00491387|Autonomic Agents|autonomic agents|mesh-ancestor
101857678|NCT00491387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101857679|NCT00491387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857680|NCT00491387|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101857681|NCT00491387|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101857682|NCT00491387|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101857683|NCT00491387|Adrenergic Agents|adrenergic agents|mesh-ancestor
101857684|NCT00491387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101857685|NCT00491387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857686|NCT01011257|Clopidogrel|clopidogrel|mesh-list
101857687|NCT01011257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101857688|NCT01011257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101857689|NCT01011257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101857690|NCT01011257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101857691|NCT01011257|Purinergic Agents|purinergic agents|mesh-ancestor
101857692|NCT01011257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101857693|NCT01011257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857694|NCT01011257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857695|NCT01015547|Sulfasalazine|sulfasalazine|mesh-list
101857696|NCT01015547|Infliximab|infliximab|mesh-list
101857697|NCT01015547|Methotrexate|methotrexate|mesh-list
101857698|NCT01015547|Naltrexone|naltrexone|mesh-list
101857699|NCT01015547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101857700|NCT01015547|Abortifacient Agents|abortifacient agents|mesh-ancestor
101240714|NCT01623505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101857702|NCT01015547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857703|NCT01015547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101857704|NCT01015547|Antimetabolites|antimetabolites|mesh-ancestor
101857705|NCT01015547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965419|NCT00051311|Hormones|hormones|mesh-ancestor
101857706|NCT01015547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101857707|NCT01015547|Dermatologic Agents|dermatologic agents|mesh-ancestor
101857708|NCT01015547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101857709|NCT01015547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101857710|NCT01015547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101857711|NCT01015547|Immunologic Factors|immunologic factors|mesh-ancestor
101857712|NCT01015547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101857713|NCT01015547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101857714|NCT01015547|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101857715|NCT01015547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101857716|NCT01015547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101857717|NCT01015547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101857718|NCT01015547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101857719|NCT01015547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101857720|NCT01015547|Analgesics|analgesics|mesh-ancestor
101857721|NCT01015547|Sensory System Agents|sensory system agents|mesh-ancestor
101857722|NCT01015547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101857723|NCT01015547|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101857724|NCT01015547|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101857725|NCT00491075|Gemcitabine|gemcitabine|mesh-list
101857726|NCT00491075|Pemetrexed|pemetrexed|mesh-list
101857727|NCT00491075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101857728|NCT00491075|Antimetabolites|antimetabolites|mesh-ancestor
101857729|NCT00491075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857730|NCT00491075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101857731|NCT00491075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101857732|NCT00491075|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101857733|NCT00491075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101857734|NCT00507455|Tamsulosin|tamsulosin|mesh-list
101857735|NCT00507455|Solifenacin Succinate|solifenacin succinate|mesh-list
101857736|NCT00507455|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101857737|NCT00507455|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101857738|NCT00507455|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101857739|NCT00507455|Adrenergic Agents|adrenergic agents|mesh-ancestor
101857740|NCT00507455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101857741|NCT00507455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857742|NCT00507455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857743|NCT00507455|Urological Agents|urological agents|mesh-ancestor
101857744|NCT00507455|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101857745|NCT00507455|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101857746|NCT00507455|Cholinergic Agents|cholinergic agents|mesh-ancestor
101857747|NCT04275713|Metformin|metformin|mesh-list
101857748|NCT04275713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101857749|NCT04275713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857750|NCT00506831|Imatinib Mesylate|imatinib mesylate|mesh-list
101857751|NCT00506831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101857752|NCT00506831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101857753|NCT00506831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101857754|NCT00506831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857755|NCT00490919|Buprenorphine|buprenorphine|mesh-list
101857756|NCT00490919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101857757|NCT00490919|Narcotics|narcotics|mesh-ancestor
101857758|NCT00490919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101857759|NCT00490919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857760|NCT00490919|Analgesics|analgesics|mesh-ancestor
101857761|NCT00490919|Sensory System Agents|sensory system agents|mesh-ancestor
101857762|NCT00490919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101240722|NCT01623609|Naloxegol|naloxegol|mesh-list
101857763|NCT00490919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101857764|NCT01015937|Losartan|losartan|mesh-list
101857765|NCT01015937|Enalapril|enalapril|mesh-list
101857766|NCT01015937|Angiotensin II|angiotensin ii|mesh-list
101857767|NCT01015937|Giapreza|giapreza|mesh-list
101857768|NCT01015937|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101857769|NCT01015937|Angiotensinogen|angiotensinogen|mesh-list
101857770|NCT01015937|Turmeric extract|turmeric extract|mesh-list
101857771|NCT01015937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101857772|NCT01015937|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101857773|NCT01015937|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101857774|NCT01015937|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101857775|NCT01015937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857776|NCT01015937|Protease Inhibitors|protease inhibitors|mesh-ancestor
101857777|NCT01015937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101857778|NCT01015937|Antioxidants|antioxidants|mesh-ancestor
101857779|NCT01015937|Protective Agents|protective agents|mesh-ancestor
101857780|NCT01015937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857781|NCT01015937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101857782|NCT01015937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101857783|NCT01012193|Cilostazol|cilostazol|mesh-list
101857784|NCT01012193|Clopidogrel|clopidogrel|mesh-list
101857785|NCT01012193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101857786|NCT01012193|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101857787|NCT01012193|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101857788|NCT01012193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101857789|NCT01012193|Purinergic Agents|purinergic agents|mesh-ancestor
101857790|NCT01012193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101857791|NCT01012193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857792|NCT01012193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857793|NCT01012193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101857794|NCT01012193|Autonomic Agents|autonomic agents|mesh-ancestor
101857795|NCT01012193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101857796|NCT01012193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101857797|NCT01012193|Respiratory System Agents|respiratory system agents|mesh-ancestor
101857798|NCT01012193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101857799|NCT01012193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101857800|NCT01012193|Vasodilator Agents|vasodilator agents|mesh-ancestor
101857801|NCT01012193|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101857802|NCT01012193|Protective Agents|protective agents|mesh-ancestor
101857803|NCT01012193|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101857804|NCT01012193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101857805|NCT01012193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101857807|NCT00503399|Risedronic Acid|risedronic acid|mesh-list
101857808|NCT00503399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101857809|NCT00503399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857810|NCT00503399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101857811|NCT00503399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101857812|NCT00503399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101857813|NCT00503399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857814|NCT00506519|Antithrombins|antithrombins|mesh-list
101857815|NCT00506519|Antithrombin III|antithrombin iii|mesh-list
101857816|NCT00506519|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101857817|NCT00506519|Protease Inhibitors|protease inhibitors|mesh-ancestor
101857818|NCT00506519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101857819|NCT00506519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857820|NCT00506519|Anticoagulants|anticoagulants|mesh-ancestor
101857821|NCT00503009|Fluticasone|fluticasone|mesh-list
101857822|NCT00503009|Xhance|xhance|mesh-list
101857823|NCT00503009|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101857824|NCT00503009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101857825|NCT00503009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101857826|NCT00503009|Autonomic Agents|autonomic agents|mesh-ancestor
101857827|NCT00503009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101857828|NCT00503009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857829|NCT00503009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101857830|NCT00503009|Respiratory System Agents|respiratory system agents|mesh-ancestor
101857831|NCT00503009|Dermatologic Agents|dermatologic agents|mesh-ancestor
101857832|NCT00503009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101857833|NCT00503009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101857834|NCT00503009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101857835|NCT00503009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101857836|NCT00503009|Adrenergic Agents|adrenergic agents|mesh-ancestor
101857837|NCT00503009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101857838|NCT00503009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857839|NCT01016093|Zoledronic Acid|zoledronic acid|mesh-list
101857840|NCT01016093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101857841|NCT01016093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857842|NCT00160251|Ribavirin|ribavirin|mesh-list
101857843|NCT00160251|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101857844|NCT00160251|Antimetabolites|antimetabolites|mesh-ancestor
101857845|NCT00160251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857846|NCT00160251|Antiviral Agents|antiviral agents|mesh-ancestor
101857847|NCT00160251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101577690|NCT01127659|Hormones|hormones|mesh-ancestor
101857848|NCT01075425|Bortezomib|bortezomib|mesh-list
101857849|NCT01075425|Belinostat|belinostat|mesh-list
101857850|NCT01075425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101857851|NCT01075425|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101857852|NCT01075425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101857853|NCT01075425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857855|NCT00378014|Basiliximab|basiliximab|mesh-list
101857856|NCT00378014|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101857857|NCT00378014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101857858|NCT00378014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101857859|NCT00378014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857860|NCT00378014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101857861|NCT00378014|Immunologic Factors|immunologic factors|mesh-ancestor
101857862|NCT00378014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857863|NCT00378014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101857864|NCT00485303|Prednisone|prednisone|mesh-list
101857865|NCT00485303|Abiraterone Acetate|abiraterone acetate|mesh-list
101857866|NCT00485303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101857867|NCT00485303|Glucocorticoids|glucocorticoids|mesh-ancestor
101857868|NCT00485303|Hormones|hormones|mesh-ancestor
101857869|NCT00485303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101857870|NCT00485303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857871|NCT00485303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101857872|NCT00485303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101857873|NCT00485303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101857874|NCT00485303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101857875|NCT00485303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857876|NCT00485303|Hormone Antagonists|hormone antagonists|mesh-ancestor
101857877|NCT00485303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101857878|NCT01018823|Ertugliflozin|ertugliflozin|mesh-list
101857879|NCT01018823|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101857880|NCT01018823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857881|NCT01018823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101857882|NCT01018823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857883|NCT01016249|Epinephrine|epinephrine|mesh-list
101857884|NCT01016249|Racepinephrine|racepinephrine|mesh-list
101857885|NCT01016249|Epinephryl borate|epinephryl borate|mesh-list
101857886|NCT01016249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101857887|NCT01016249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101857888|NCT01016249|Adrenergic Agents|adrenergic agents|mesh-ancestor
101857889|NCT01016249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101857890|NCT01016249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857891|NCT01016249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857892|NCT01016249|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101857893|NCT01016249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101857894|NCT01016249|Autonomic Agents|autonomic agents|mesh-ancestor
101857895|NCT01016249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101857896|NCT01016249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101857897|NCT01016249|Respiratory System Agents|respiratory system agents|mesh-ancestor
101857898|NCT01016249|Mydriatics|mydriatics|mesh-ancestor
101857899|NCT01016249|Sympathomimetics|sympathomimetics|mesh-ancestor
101857900|NCT01016249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101857901|NCT00377858|Insulin|insulin|mesh-list
101857902|NCT00377858|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101857903|NCT00377858|Insulin Glargine|insulin glargine|mesh-list
101857904|NCT00377858|Insulin Lispro|insulin lispro|mesh-list
101857905|NCT00377858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101857906|NCT00377858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857907|NCT00502775|Fluticasone|fluticasone|mesh-list
101857908|NCT00502775|Xhance|xhance|mesh-list
101857909|NCT00502775|Fexofenadine|fexofenadine|mesh-list
101857910|NCT00502775|Terfenadine|terfenadine|mesh-list
101857911|NCT00502775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101857912|NCT00502775|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101857913|NCT00502775|Autonomic Agents|autonomic agents|mesh-ancestor
101857914|NCT00502775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101857915|NCT00502775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857916|NCT00502775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101857917|NCT00502775|Respiratory System Agents|respiratory system agents|mesh-ancestor
101857918|NCT00502775|Dermatologic Agents|dermatologic agents|mesh-ancestor
101857919|NCT00502775|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101857920|NCT00502775|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101857921|NCT00502775|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101857922|NCT00502775|Histamine Antagonists|histamine antagonists|mesh-ancestor
101857923|NCT00502775|Histamine Agents|histamine agents|mesh-ancestor
101857924|NCT00502775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101857925|NCT00502775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857926|NCT01013675|Vaccines|vaccines|mesh-list
101857927|NCT01013675|Immunologic Factors|immunologic factors|mesh-ancestor
101857928|NCT01013675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857929|NCT01054118|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101857930|NCT01054118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101857931|NCT01054118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857932|NCT01054118|Incretins|incretins|mesh-ancestor
101857933|NCT01054118|Hormones|hormones|mesh-ancestor
101857934|NCT01054118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101857935|NCT01054118|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101857936|NCT01054118|Protease Inhibitors|protease inhibitors|mesh-ancestor
101857937|NCT01054118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101857938|NCT01054118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857939|NCT01050842|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101857940|NCT01050842|Bicalutamide|bicalutamide|mesh-list
101857941|NCT01050842|Androgen Antagonists|androgen antagonists|mesh-ancestor
101857942|NCT01050842|Hormone Antagonists|hormone antagonists|mesh-ancestor
101857943|NCT01050842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101857944|NCT01050842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857945|NCT01050842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101857946|NCT01050842|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101857947|NCT01050842|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101857948|NCT01050842|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101857949|NCT01050842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101857950|NCT00485069|Levodopa|levodopa|mesh-list
101857951|NCT00485069|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101857952|NCT00485069|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101857953|NCT00485069|Dopamine Agents|dopamine agents|mesh-ancestor
101857954|NCT00485069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101857955|NCT00485069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857956|NCT00485069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857957|NCT03989336|Manganese|manganese|mesh-list
101857958|NCT03989336|Paclitaxel|paclitaxel|mesh-list
101857959|NCT03989336|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101857960|NCT03989336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101857961|NCT03989336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101857962|NCT03989336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101857963|NCT03989336|Tubulin Modulators|tubulin modulators|mesh-ancestor
101857964|NCT03989336|Antimitotic Agents|antimitotic agents|mesh-ancestor
101857965|NCT03989336|Mitosis Modulators|mitosis modulators|mesh-ancestor
101857966|NCT03989336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857967|NCT03989336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101857968|NCT03989336|Trace Elements|trace elements|mesh-ancestor
101857969|NCT03989336|Micronutrients|micronutrients|mesh-ancestor
101857970|NCT03989336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857971|NCT00355082|Lamotrigine|lamotrigine|mesh-list
101857972|NCT00355082|Anticonvulsants|anticonvulsants|mesh-list
101857973|NCT00355082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101857974|NCT00355082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101857975|NCT00355082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857976|NCT00355082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101857977|NCT00355082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857978|NCT00355082|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101857979|NCT00355082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101857980|NCT00355082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101857981|NCT00355082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101857982|NCT00355082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101857983|NCT00502307|Tivozanib|tivozanib|mesh-list
101857984|NCT00502307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101857985|NCT00502307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101857986|NCT00502307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101857987|NCT00484679|Triamcinolone|triamcinolone|mesh-list
101857988|NCT00484679|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101857989|NCT00484679|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101857990|NCT00484679|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101857991|NCT00484679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101857992|NCT00484679|Glucocorticoids|glucocorticoids|mesh-ancestor
101857993|NCT00484679|Hormones|hormones|mesh-ancestor
101857994|NCT00484679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101857995|NCT00484679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101857996|NCT00484679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101857997|NCT00484679|Immunologic Factors|immunologic factors|mesh-ancestor
101857998|NCT00484679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101857999|NCT00484679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858000|NCT00377312|Hormones|hormones|mesh-list
101858001|NCT00377312|Parathyroid Hormone|parathyroid hormone|mesh-list
101858002|NCT00377312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101858003|NCT00377312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858004|NCT00377312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101858005|NCT00377234|Risedronic Acid|risedronic acid|mesh-list
101858006|NCT00377234|Ibandronic Acid|ibandronic acid|mesh-list
101858007|NCT00377234|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101858008|NCT00377234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101858009|NCT00377234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858010|NCT00377234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101858011|NCT00377234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858012|NCT00377234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101858013|NCT00376688|Sirolimus|sirolimus|mesh-list
101858014|NCT00376688|Temsirolimus|temsirolimus|mesh-list
101858015|NCT00376688|MTOR Inhibitors|mtor inhibitors|mesh-list
101858016|NCT00376688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101858017|NCT00376688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101858018|NCT00376688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101858019|NCT00376688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101858020|NCT00376688|Antifungal Agents|antifungal agents|mesh-ancestor
101240755|NCT01623817|Vancomycin|vancomycin|mesh-list
101858021|NCT00376688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101858022|NCT00376688|Immunologic Factors|immunologic factors|mesh-ancestor
101858023|NCT00376688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858024|NCT00376688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101858025|NCT00376688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101858026|NCT00376688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858027|NCT00376220|Riluzole|riluzole|mesh-list
101858028|NCT00376220|Anticonvulsants|anticonvulsants|mesh-ancestor
101858029|NCT00376220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101858030|NCT00376220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101858031|NCT00376220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101858032|NCT00376220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858033|NCT00376220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858034|NCT00376220|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101858035|NCT00376220|Protective Agents|protective agents|mesh-ancestor
101858036|NCT00375752|Letrozole|letrozole|mesh-list
101858037|NCT00375752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101858038|NCT00375752|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101858039|NCT00375752|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101858040|NCT00375752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101858041|NCT00375752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858042|NCT00375752|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101858043|NCT00375752|Hormone Antagonists|hormone antagonists|mesh-ancestor
101858044|NCT00375752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101858045|NCT00375752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858046|NCT00484289|Abatacept|abatacept|mesh-list
101858047|NCT00484289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101858048|NCT00484289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858049|NCT00484289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101858050|NCT00484289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101858051|NCT00484289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101965437|NCT01091753|Amlodipine|amlodipine|mesh-list
101858052|NCT00484289|Immunologic Factors|immunologic factors|mesh-ancestor
101858053|NCT00484289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858054|NCT00484289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101858055|NCT01013831|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101858056|NCT01013831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101858057|NCT01013831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101858058|NCT01013831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101858059|NCT01013831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858060|NCT01013909|Terbinafine|terbinafine|mesh-list
101858061|NCT01013909|Bifonazole|bifonazole|mesh-list
101858062|NCT01013909|Antifungal Agents|antifungal agents|mesh-ancestor
101858063|NCT01013909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101858064|NCT01013909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101858065|NCT01013909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858066|NCT01013987|Ritonavir|ritonavir|mesh-list
101858067|NCT01013987|Darunavir|darunavir|mesh-list
101858068|NCT01013987|Raltegravir Potassium|raltegravir potassium|mesh-list
101858069|NCT01013987|Maraviroc|maraviroc|mesh-list
101858070|NCT01013987|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101858071|NCT01013987|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101858072|NCT01013987|Protease Inhibitors|protease inhibitors|mesh-ancestor
101858073|NCT01013987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101858074|NCT01013987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858075|NCT01013987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101858076|NCT01013987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101858077|NCT01013987|Antiviral Agents|antiviral agents|mesh-ancestor
101858078|NCT01013987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101858079|NCT01013987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101858080|NCT01013987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101858081|NCT01013987|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101858082|NCT01013987|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101858083|NCT01013987|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101858084|NCT01013987|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101240772|NCT01623921|Analgesics|analgesics|mesh-ancestor
101858085|NCT01013987|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101858086|NCT01019291|Formaldehyde|formaldehyde|mesh-list
101858087|NCT01019291|Disinfectants|disinfectants|mesh-ancestor
101858088|NCT01019291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101858089|NCT01019447|Anti-Infective Agents|anti-infective agents|mesh-list
101858090|NCT01019447|Triclosan|triclosan|mesh-list
101858091|NCT01019447|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101858092|NCT01019447|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101858093|NCT01019447|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101858094|NCT01019447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101858095|NCT01019447|Antimetabolites|antimetabolites|mesh-ancestor
101858096|NCT01019447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858097|NCT01019447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101858098|NCT00490529|Cyclophosphamide|cyclophosphamide|mesh-list
101858099|NCT00490529|Rituximab|rituximab|mesh-list
101858100|NCT00490529|Vaccines|vaccines|mesh-list
101858101|NCT00490529|Immunologic Factors|immunologic factors|mesh-ancestor
101858102|NCT00490529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858103|NCT00490529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101858104|NCT00490529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101858105|NCT00490529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101858106|NCT00490529|Alkylating Agents|alkylating agents|mesh-ancestor
101858107|NCT00490529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858108|NCT00490529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101858109|NCT00490529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101858110|NCT00490529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101858111|NCT00333840|Interferons|interferons|mesh-list
101858112|NCT00333840|Cytarabine|cytarabine|mesh-list
101858113|NCT00333840|Interferon-alpha|interferon-alpha|mesh-list
101858114|NCT00333840|Interferon alpha-2|interferon alpha-2|mesh-list
101858115|NCT00333840|Imatinib Mesylate|imatinib mesylate|mesh-list
101858116|NCT00333840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101858117|NCT00333840|Antiviral Agents|antiviral agents|mesh-ancestor
101858118|NCT00333840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101858119|NCT00333840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101858120|NCT00333840|Antimetabolites|antimetabolites|mesh-ancestor
101858121|NCT00333840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858122|NCT00333840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101858123|NCT00333840|Immunologic Factors|immunologic factors|mesh-ancestor
101858124|NCT00333840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858125|NCT00333840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101858126|NCT00333840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101858127|NCT01019603|Nicotinic Acids|nicotinic acids|mesh-list
101858128|NCT01019603|Tazarotene|tazarotene|mesh-list
101858129|NCT01019603|Dermatologic Agents|dermatologic agents|mesh-ancestor
101858130|NCT01019603|Keratolytic Agents|keratolytic agents|mesh-ancestor
101858131|NCT01019603|Vitamin B Complex|vitamin b complex|mesh-ancestor
101858132|NCT01019603|Vitamins|vitamins|mesh-ancestor
101858133|NCT01019603|Micronutrients|micronutrients|mesh-ancestor
101858134|NCT01019603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858135|NCT00321906|Sirolimus|sirolimus|mesh-list
101858136|NCT00321906|Azathioprine|azathioprine|mesh-list
101858137|NCT00321906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101858138|NCT00321906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101858139|NCT00321906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101858140|NCT00321906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101858141|NCT00321906|Antifungal Agents|antifungal agents|mesh-ancestor
101577988|NCT01011465|Oxytocin|oxytocin|mesh-list
101858142|NCT00321906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101858143|NCT00321906|Immunologic Factors|immunologic factors|mesh-ancestor
101858144|NCT00321906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858145|NCT00321906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858147|NCT00321906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101858148|NCT00321906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101858149|NCT00339144|Dasatinib|dasatinib|mesh-list
101858150|NCT00339144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101858151|NCT00339144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101858152|NCT00339144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101858153|NCT00339144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858154|NCT00321828|Leucovorin|leucovorin|mesh-list
101858155|NCT00321828|Bevacizumab|bevacizumab|mesh-list
101858156|NCT00321828|Fluorouracil|fluorouracil|mesh-list
101858157|NCT00321828|Oxaliplatin|oxaliplatin|mesh-list
101858158|NCT00321828|Levoleucovorin|levoleucovorin|mesh-list
101240781|NCT01624025|Epirubicin|epirubicin|mesh-list
101858159|NCT00321828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101858160|NCT00321828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101858161|NCT00321828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101858162|NCT00321828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101858163|NCT00321828|Growth Substances|growth substances|mesh-ancestor
101858164|NCT00321828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858165|NCT00321828|Growth Inhibitors|growth inhibitors|mesh-ancestor
101858166|NCT00321828|Antimetabolites|antimetabolites|mesh-ancestor
101858167|NCT00321828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858168|NCT00321828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101858169|NCT00321828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101858170|NCT00321828|Immunologic Factors|immunologic factors|mesh-ancestor
101858171|NCT00321828|Antidotes|antidotes|mesh-ancestor
101858172|NCT00321828|Protective Agents|protective agents|mesh-ancestor
101858173|NCT00321828|Vitamin B Complex|vitamin b complex|mesh-ancestor
101858174|NCT00321828|Vitamins|vitamins|mesh-ancestor
101858175|NCT00321828|Micronutrients|micronutrients|mesh-ancestor
101858176|NCT00333138|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101858177|NCT00333138|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101858178|NCT00333138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858179|NCT00333138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101858180|NCT00333138|Immunologic Factors|immunologic factors|mesh-ancestor
101858181|NCT00333138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858182|NCT01061658|Vaccines|vaccines|mesh-list
101858183|NCT01061658|Immunologic Factors|immunologic factors|mesh-ancestor
101858184|NCT01061658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858185|NCT01058382|Progesterone|progesterone|mesh-list
101858186|NCT01058382|Progestins|progestins|mesh-ancestor
101858187|NCT01058382|Hormones|hormones|mesh-ancestor
101858188|NCT01058382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101858189|NCT01058382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858190|NCT01061814|Mipomersen|mipomersen|mesh-list
101858191|NCT01061814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101858192|NCT01061814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101858193|NCT01061814|Antimetabolites|antimetabolites|mesh-ancestor
101858194|NCT01061814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858195|NCT01061814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101858196|NCT00331422|Paclitaxel|paclitaxel|mesh-list
101858198|NCT00331422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101687313|NCT00619268|Interferons|interferons|mesh-list
101858199|NCT00331422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101858200|NCT00331422|Tubulin Modulators|tubulin modulators|mesh-ancestor
101858201|NCT00331422|Antimitotic Agents|antimitotic agents|mesh-ancestor
101858202|NCT00331422|Mitosis Modulators|mitosis modulators|mesh-ancestor
101858203|NCT00331422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858204|NCT00331344|Prednisone|prednisone|mesh-list
101858205|NCT00331344|Mitoxantrone|mitoxantrone|mesh-list
101858206|NCT00331344|Epothilone B|epothilone b|mesh-list
101858207|NCT00331344|Epothilones|epothilones|mesh-list
101858208|NCT00331344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101858209|NCT00331344|Glucocorticoids|glucocorticoids|mesh-ancestor
101858210|NCT00331344|Hormones|hormones|mesh-ancestor
101858211|NCT00331344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101858212|NCT00331344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858213|NCT00331344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101858214|NCT00331344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101858215|NCT00331344|Analgesics|analgesics|mesh-ancestor
101858216|NCT00331344|Sensory System Agents|sensory system agents|mesh-ancestor
101858217|NCT00331344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101858218|NCT00331344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101858219|NCT00331344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101858220|NCT00331344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101858221|NCT00331344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858222|NCT00331344|Tubulin Modulators|tubulin modulators|mesh-ancestor
101858223|NCT00331344|Antimitotic Agents|antimitotic agents|mesh-ancestor
101858224|NCT00331344|Mitosis Modulators|mitosis modulators|mesh-ancestor
101858225|NCT00321672|Capsaicin|capsaicin|mesh-list
101858226|NCT00321672|Antipruritics|antipruritics|mesh-ancestor
101858227|NCT00321672|Dermatologic Agents|dermatologic agents|mesh-ancestor
101858228|NCT00321672|Sensory System Agents|sensory system agents|mesh-ancestor
101858229|NCT00321672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101858230|NCT00321672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858231|NCT00330174|Acamprosate|acamprosate|mesh-list
101858232|NCT00330174|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101858233|NCT00320424|PENTA|penta|mesh-list
101858234|NCT00320424|Fondaparinux|fondaparinux|mesh-list
101858235|NCT00320424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101858236|NCT00320424|Antithrombins|antithrombins|mesh-ancestor
101858237|NCT00320424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101858238|NCT00320424|Protease Inhibitors|protease inhibitors|mesh-ancestor
101858239|NCT00320424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101858240|NCT00320424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858241|NCT00320424|Anticoagulants|anticoagulants|mesh-ancestor
101858242|NCT00320424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101858243|NCT00320424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101858244|NCT00338286|Epoetin Alfa|epoetin alfa|mesh-list
101858245|NCT00338286|Hematinics|hematinics|mesh-ancestor
101858246|NCT00329550|Certolizumab Pegol|certolizumab pegol|mesh-list
101858247|NCT00329550|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101858248|NCT00329550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101858249|NCT00329550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101858250|NCT00329550|Immunologic Factors|immunologic factors|mesh-ancestor
101858251|NCT00329550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858252|NCT00329550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101858253|NCT00375674|Sunitinib|sunitinib|mesh-list
101858254|NCT00375674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101858255|NCT00375674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101858256|NCT00375674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101858257|NCT00375674|Growth Substances|growth substances|mesh-ancestor
101858258|NCT00375674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858259|NCT00375674|Growth Inhibitors|growth inhibitors|mesh-ancestor
101858260|NCT00375674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101858261|NCT00375674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101858262|NCT00375674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858263|NCT03991910|Ramipril|ramipril|mesh-list
101858264|NCT03991910|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101858265|NCT03991910|Protease Inhibitors|protease inhibitors|mesh-ancestor
101858266|NCT03991910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101858267|NCT03991910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858268|NCT03991910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101858269|NCT00320190|Imatinib Mesylate|imatinib mesylate|mesh-list
101858270|NCT00320190|Dasatinib|dasatinib|mesh-list
101858271|NCT00320190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101858272|NCT00320190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101858273|NCT00320190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101858274|NCT00320190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858275|NCT02534402|Prednisone|prednisone|mesh-list
101858276|NCT02534402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101858277|NCT02534402|Glucocorticoids|glucocorticoids|mesh-ancestor
101858278|NCT02534402|Hormones|hormones|mesh-ancestor
101858279|NCT02534402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101858280|NCT02534402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858281|NCT02534402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101858282|NCT02534402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101858283|NCT00319956|Azithromycin|azithromycin|mesh-list
101858284|NCT00319956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101858285|NCT00319956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101858286|NCT01062048|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101526157|NCT00542711|Curcumin|curcumin|mesh-list
101858287|NCT01062048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101858288|NCT01062048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858289|NCT01062048|Incretins|incretins|mesh-ancestor
101858290|NCT01062048|Hormones|hormones|mesh-ancestor
101858291|NCT01062048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101858292|NCT01062048|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101858293|NCT01062048|Protease Inhibitors|protease inhibitors|mesh-ancestor
101858294|NCT01062048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101858295|NCT01062048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858296|NCT00349622|Ceftriaxone|ceftriaxone|mesh-list
101858297|NCT00349622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101858298|NCT00349622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101858299|NCT03987698|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101858300|NCT03987698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858301|NCT03987698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101858302|NCT03987698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101858303|NCT01054508|Nicotinic Acids|nicotinic acids|mesh-list
101858304|NCT01054508|Niacin|niacin|mesh-list
101858305|NCT01054508|Niacinamide|niacinamide|mesh-list
101858306|NCT01054508|Vitamin B Complex|vitamin b complex|mesh-ancestor
101858307|NCT01054508|Vitamins|vitamins|mesh-ancestor
101858308|NCT01054508|Micronutrients|micronutrients|mesh-ancestor
101858309|NCT01054508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858310|NCT01054508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101858311|NCT01054508|Antimetabolites|antimetabolites|mesh-ancestor
101858312|NCT01054508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858313|NCT01054508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101858314|NCT01054508|Vasodilator Agents|vasodilator agents|mesh-ancestor
101858315|NCT00348686|Felodipine|felodipine|mesh-list
101858316|NCT00348686|Candesartan|candesartan|mesh-list
101858317|NCT00348686|Candesartan cilexetil|candesartan cilexetil|mesh-list
101858318|NCT00348686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101858319|NCT00348686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101687380|NCT02680080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101858320|NCT00348686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101858321|NCT00348686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858322|NCT00348686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101858323|NCT00348686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101858324|NCT00348686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101858325|NCT00348686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101858326|NCT00348686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858327|NCT00348686|Vasodilator Agents|vasodilator agents|mesh-ancestor
101858328|NCT00360230|Vaccines|vaccines|mesh-list
101858329|NCT00360230|Immunologic Factors|immunologic factors|mesh-ancestor
101858330|NCT00360230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858331|NCT03989024|Clomiphene|clomiphene|mesh-list
101858332|NCT03989024|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101858333|NCT03989024|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101858334|NCT03989024|Hormone Antagonists|hormone antagonists|mesh-ancestor
101858335|NCT03989024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101858336|NCT03989024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858337|NCT03989024|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101858338|NCT03989024|Fertility Agents|fertility agents|mesh-ancestor
101858339|NCT03989024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101858340|NCT03989024|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101858341|NCT03989024|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101858342|NCT03989024|Hormones|hormones|mesh-ancestor
101858343|NCT03987308|Insulin Aspart|insulin aspart|mesh-list
101858344|NCT03987308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101858345|NCT03987308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858346|NCT00348374|Insulin Lispro|insulin lispro|mesh-list
101858347|NCT00348374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101858348|NCT00348374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858349|NCT03742232|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101858350|NCT03742232|Laxatives|laxatives|mesh-ancestor
101858351|NCT03742232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101858352|NCT03988478|Psychotropic Drugs|psychotropic drugs|mesh-list
101858353|NCT00352664|Donepezil|donepezil|mesh-list
101858354|NCT00352664|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101858355|NCT00352664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101858356|NCT00352664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858357|NCT00352664|Cholinergic Agents|cholinergic agents|mesh-ancestor
101858358|NCT00352664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101858359|NCT00352664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858360|NCT00352664|Nootropic Agents|nootropic agents|mesh-ancestor
101858361|NCT03991442|Amlodipine|amlodipine|mesh-list
101858362|NCT03991442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101858363|NCT03991442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101858364|NCT03991442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101858365|NCT03991442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858366|NCT03991442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101858367|NCT03991442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858368|NCT03991442|Vasodilator Agents|vasodilator agents|mesh-ancestor
101858369|NCT03742310|Vitamin D|vitamin d|mesh-list
101858370|NCT03742310|Calcitriol|calcitriol|mesh-list
101574892|NCT02753803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858371|NCT03742310|Vitamins|vitamins|mesh-ancestor
101858372|NCT03742310|Micronutrients|micronutrients|mesh-ancestor
101858373|NCT03742310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858374|NCT03742310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101858375|NCT03742310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101858376|NCT03742310|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101858377|NCT03742310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101858378|NCT03742310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858379|NCT03742310|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101858380|NCT00490139|Trastuzumab|trastuzumab|mesh-list
101858381|NCT00490139|Lapatinib|lapatinib|mesh-list
101687424|NCT00618176|Antiviral Agents|antiviral agents|mesh-ancestor
101858382|NCT00490139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101858383|NCT00490139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101858384|NCT00490139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101858385|NCT00490139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101858386|NCT00490139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858387|NCT00348140|Rosiglitazone|rosiglitazone|mesh-list
101858388|NCT00348140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101240825|NCT01624116|Acarbose|acarbose|mesh-list
101858389|NCT00348140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858390|NCT01051388|Rabeprazole|rabeprazole|mesh-list
101858391|NCT01051388|Gefarnate|gefarnate|mesh-list
101858392|NCT01051388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101858393|NCT01051388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101858394|NCT01051388|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101858395|NCT01051388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101858396|NCT01051388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858397|NCT00490061|Lapatinib|lapatinib|mesh-list
101858398|NCT00490061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101858399|NCT00490061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101858400|NCT00490061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101965461|NCT00049673|Growth Substances|growth substances|mesh-ancestor
101858401|NCT00490061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858402|NCT00483119|Cyclophosphamide|cyclophosphamide|mesh-list
101858403|NCT00483119|Immunoglobulins|immunoglobulins|mesh-list
101858404|NCT00483119|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101858405|NCT00483119|Antibodies|antibodies|mesh-list
101858406|NCT00483119|gamma-Globulins|gamma-globulins|mesh-list
101858407|NCT00483119|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101858408|NCT00483119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101858409|NCT00483119|Immunologic Factors|immunologic factors|mesh-ancestor
101858410|NCT00483119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858411|NCT00483119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101858412|NCT00483119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101858413|NCT00483119|Alkylating Agents|alkylating agents|mesh-ancestor
101858414|NCT00483119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858415|NCT00483119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101858416|NCT00483119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101858417|NCT01016639|Capecitabine|capecitabine|mesh-list
101858418|NCT01016639|Oxaliplatin|oxaliplatin|mesh-list
101858419|NCT01016639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101858420|NCT01016639|Antimetabolites|antimetabolites|mesh-ancestor
101858421|NCT01016639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858422|NCT01016639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101858423|NCT00501293|Methylphenidate|methylphenidate|mesh-list
101858424|NCT00501293|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101858425|NCT00501293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858426|NCT00501293|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101858427|NCT00501293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101858428|NCT00501293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101858429|NCT00501293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858430|NCT00501293|Dopamine Agents|dopamine agents|mesh-ancestor
101858431|NCT00501293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101858432|NCT01014221|Prednisolone|prednisolone|mesh-list
101858433|NCT01014221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101858434|NCT01014221|Glucocorticoids|glucocorticoids|mesh-ancestor
101858435|NCT01014221|Hormones|hormones|mesh-ancestor
101858436|NCT01014221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101858437|NCT01014221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858438|NCT01014221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101858439|NCT01014221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101858440|NCT00482729|Metformin|metformin|mesh-list
101858441|NCT00482729|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101858442|NCT00482729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101858443|NCT00482729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858444|NCT00482729|Incretins|incretins|mesh-ancestor
101858445|NCT00482729|Hormones|hormones|mesh-ancestor
101687434|NCT04211558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101858446|NCT00482729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101858447|NCT00482729|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101858448|NCT00482729|Protease Inhibitors|protease inhibitors|mesh-ancestor
101858449|NCT00482729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101858450|NCT00482729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858451|NCT00359762|Exenatide|exenatide|mesh-list
101858452|NCT00359762|Glimepiride|glimepiride|mesh-list
101858453|NCT00359762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101858454|NCT00359762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858455|NCT00359762|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101858456|NCT00359762|Incretins|incretins|mesh-ancestor
101858457|NCT00359762|Hormones|hormones|mesh-ancestor
101858458|NCT00359762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101858459|NCT00359762|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101858460|NCT00359762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101858461|NCT00359762|Immunologic Factors|immunologic factors|mesh-ancestor
101858462|NCT03988010|Amantadine|amantadine|mesh-list
101858463|NCT03988010|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101858464|NCT03988010|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101858465|NCT03988010|Antiviral Agents|antiviral agents|mesh-ancestor
101858466|NCT03988010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101858467|NCT03988010|Dopamine Agents|dopamine agents|mesh-ancestor
101965468|NCT00066365|Molgramostim|molgramostim|mesh-list
101858468|NCT03988010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101858469|NCT03988010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858470|NCT03988010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858471|NCT03988010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101858472|NCT03988010|Analgesics|analgesics|mesh-ancestor
101858473|NCT03988010|Sensory System Agents|sensory system agents|mesh-ancestor
101858474|NCT03988010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101858475|NCT01055522|Interleukin-2|interleukin-2|mesh-list
101858476|NCT01055522|Dacarbazine|dacarbazine|mesh-list
101858477|NCT01055522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101858478|NCT01055522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101858479|NCT01055522|Analgesics|analgesics|mesh-ancestor
101858480|NCT01055522|Sensory System Agents|sensory system agents|mesh-ancestor
101858481|NCT01055522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101858482|NCT01055522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858483|NCT01055522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101858484|NCT01055522|Alkylating Agents|alkylating agents|mesh-ancestor
101858485|NCT01055522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858486|NCT03987152|Sirolimus|sirolimus|mesh-list
101858487|NCT03987152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101858488|NCT03987152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101858489|NCT03987152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101858490|NCT03987152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101858491|NCT03987152|Antifungal Agents|antifungal agents|mesh-ancestor
101858492|NCT03987152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101858493|NCT03987152|Immunologic Factors|immunologic factors|mesh-ancestor
101858494|NCT03987152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858495|NCT00347438|Capecitabine|capecitabine|mesh-list
101858496|NCT00347438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101858497|NCT00347438|Antimetabolites|antimetabolites|mesh-ancestor
101858498|NCT00347438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858499|NCT00347438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101858500|NCT00329238|Warfarin|warfarin|mesh-list
101858501|NCT00329238|Dabigatran|dabigatran|mesh-list
101858502|NCT00329238|Anticoagulants|anticoagulants|mesh-ancestor
101858503|NCT00329238|Antithrombins|antithrombins|mesh-ancestor
101858504|NCT00329238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101858505|NCT00329238|Protease Inhibitors|protease inhibitors|mesh-ancestor
101858506|NCT00329238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101858507|NCT00329238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858508|NCT00329160|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101858509|NCT00329160|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101858510|NCT00329160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101858511|NCT00329160|Antimetabolites|antimetabolites|mesh-ancestor
101858512|NCT00329160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858513|NCT00329160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101858514|NCT00329160|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101858515|NCT00329160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101858516|NCT00328926|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101858517|NCT00328926|Hormones|hormones|mesh-list
101858518|NCT00328926|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101858519|NCT00328926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101858520|NCT00328926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858521|NCT00328926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101858522|NCT00347360|Carvedilol|carvedilol|mesh-list
101858523|NCT00347360|Lisinopril|lisinopril|mesh-list
101858524|NCT00347360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101858525|NCT00347360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101858526|NCT00347360|Adrenergic Agents|adrenergic agents|mesh-ancestor
101858527|NCT00347360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101858528|NCT00347360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858529|NCT00347360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858530|NCT00347360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101858531|NCT00347360|Antioxidants|antioxidants|mesh-ancestor
101858532|NCT00347360|Protective Agents|protective agents|mesh-ancestor
101858533|NCT00347360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101858534|NCT00347360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101858535|NCT00347360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101858536|NCT00347360|Vasodilator Agents|vasodilator agents|mesh-ancestor
101858537|NCT00347360|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101858538|NCT00347360|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101858539|NCT00347360|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101858540|NCT00347360|Protease Inhibitors|protease inhibitors|mesh-ancestor
101858541|NCT00347360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101858542|NCT00347360|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101858544|NCT00319020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101858545|NCT00319020|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101858546|NCT00319020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858547|NCT01056224|Remifentanil|remifentanil|mesh-list
101858548|NCT01056224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101858549|NCT01056224|Narcotics|narcotics|mesh-ancestor
101858550|NCT01056224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101858551|NCT01056224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858552|NCT01056224|Analgesics|analgesics|mesh-ancestor
101858553|NCT01056224|Sensory System Agents|sensory system agents|mesh-ancestor
101858554|NCT01056224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101858555|NCT03982680|Gemcitabine|gemcitabine|mesh-list
101858556|NCT03982680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101858557|NCT03982680|Antimetabolites|antimetabolites|mesh-ancestor
101858558|NCT03982680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858559|NCT03982680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101858561|NCT00352118|Fluorouracil|fluorouracil|mesh-list
101858562|NCT00352118|Lenograstim|lenograstim|mesh-list
101858563|NCT00352118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101858564|NCT00352118|Tubulin Modulators|tubulin modulators|mesh-ancestor
101858565|NCT00352118|Antimitotic Agents|antimitotic agents|mesh-ancestor
101858566|NCT00352118|Mitosis Modulators|mitosis modulators|mesh-ancestor
101858567|NCT00352118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858568|NCT00352118|Antimetabolites|antimetabolites|mesh-ancestor
101858569|NCT00352118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101858570|NCT00352118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101858571|NCT00352118|Immunologic Factors|immunologic factors|mesh-ancestor
101858572|NCT00352118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858573|NCT00352118|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101858574|NCT00318474|Mycophenolic Acid|mycophenolic acid|mesh-list
101858575|NCT00318474|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101858576|NCT00318474|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101858577|NCT00318474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101858578|NCT00318474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101858579|NCT00318474|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101858580|NCT00318474|Antitubercular Agents|antitubercular agents|mesh-ancestor
101858581|NCT00318474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101858582|NCT00318474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101858583|NCT00318474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858584|NCT00318474|Protease Inhibitors|protease inhibitors|mesh-ancestor
101858585|NCT00350870|Disulfiram|disulfiram|mesh-list
101858586|NCT00350870|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101858587|NCT00350870|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
101858588|NCT00350870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101858589|NCT00350870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858590|NCT00350792|Carboplatin|carboplatin|mesh-list
101858591|NCT00350792|Pemetrexed|pemetrexed|mesh-list
101858592|NCT00350792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101858594|NCT00350792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858595|NCT00350792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101858596|NCT00350792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101858597|NCT00317772|Topotecan|topotecan|mesh-list
101858598|NCT00317772|Gefitinib|gefitinib|mesh-list
101858599|NCT00317772|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101858600|NCT00317772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101858601|NCT00317772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101858602|NCT00317772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858603|NCT00317772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101858604|NCT00317772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101858605|NCT01325298|Riboflavin|riboflavin|mesh-list
101858606|NCT01325298|Vitamin B Complex|vitamin b complex|mesh-ancestor
101858607|NCT01325298|Vitamins|vitamins|mesh-ancestor
101858608|NCT01325298|Micronutrients|micronutrients|mesh-ancestor
101858609|NCT01325298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858610|NCT01325298|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101858611|NCT01325298|Dermatologic Agents|dermatologic agents|mesh-ancestor
101858612|NCT00350636|Mandelic Acids|mandelic acids|mesh-list
101858613|NCT00350636|Oxybutynin|oxybutynin|mesh-list
101858614|NCT00350636|Parasympatholytics|parasympatholytics|mesh-ancestor
101858615|NCT00350636|Autonomic Agents|autonomic agents|mesh-ancestor
101858616|NCT00350636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101858617|NCT00350636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858618|NCT00350636|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101858619|NCT00350636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101858620|NCT00350636|Cholinergic Agents|cholinergic agents|mesh-ancestor
101858621|NCT00350636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101858622|NCT00350636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858623|NCT00350636|Urological Agents|urological agents|mesh-ancestor
101858624|NCT00350636|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101858625|NCT00350636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101858626|NCT01051544|Factor VIII|factor viii|mesh-list
101858627|NCT01051544|Coagulants|coagulants|mesh-ancestor
101858628|NCT01058720|Vitamin D|vitamin d|mesh-list
101858629|NCT01058720|Cholecalciferol|cholecalciferol|mesh-list
101858630|NCT01058720|Vitamins|vitamins|mesh-ancestor
101858631|NCT01058720|Micronutrients|micronutrients|mesh-ancestor
101858632|NCT01058720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858633|NCT01058720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101858634|NCT01058720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101858635|NCT00346268|Parecoxib|parecoxib|mesh-list
101858636|NCT00346268|Morphine|morphine|mesh-list
101858637|NCT00346268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101858638|NCT00346268|Narcotics|narcotics|mesh-ancestor
101858639|NCT00346268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101858640|NCT00346268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858641|NCT00346268|Analgesics|analgesics|mesh-ancestor
101858642|NCT00346268|Sensory System Agents|sensory system agents|mesh-ancestor
101687515|NCT02777580|Purinergic Agents|purinergic agents|mesh-ancestor
101858643|NCT00346268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101858645|NCT00346268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101858646|NCT00346268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101858647|NCT00346268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858648|NCT00346268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101858649|NCT00346268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101858650|NCT00346268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101858651|NCT00346268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101858652|NCT00327444|Aflibercept|aflibercept|mesh-list
101858653|NCT00327444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101858654|NCT00327444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101858655|NCT00327444|Growth Substances|growth substances|mesh-ancestor
101858656|NCT00327444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858657|NCT00327444|Growth Inhibitors|growth inhibitors|mesh-ancestor
101858658|NCT00327444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101858659|NCT01051622|Technetium Tc 99m Exametazime|technetium tc 99m exametazime|mesh-list
101858660|NCT01051622|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101858661|NCT01051622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858662|NCT03982134|Panobinostat|panobinostat|mesh-list
101858663|NCT03982134|Spartalizumab|spartalizumab|mesh-list
101858664|NCT03982134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101858665|NCT03982134|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101858666|NCT03982134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101858667|NCT03982134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858669|NCT03982134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101858670|NCT00337610|Metformin|metformin|mesh-list
101858671|NCT00337610|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101858672|NCT00337610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101858673|NCT00337610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858674|NCT00337610|Incretins|incretins|mesh-ancestor
101858675|NCT00337610|Hormones|hormones|mesh-ancestor
101858676|NCT00337610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101858677|NCT00337610|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101858678|NCT00337610|Protease Inhibitors|protease inhibitors|mesh-ancestor
101858679|NCT00337610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101858680|NCT00337610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858681|NCT01062204|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101858682|NCT01062204|Laxatives|laxatives|mesh-ancestor
101858683|NCT01062204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101858684|NCT01062282|Iloprost|iloprost|mesh-list
101858685|NCT01062282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101858686|NCT01062282|Vasodilator Agents|vasodilator agents|mesh-ancestor
101858687|NCT03985280|Anesthetics|anesthetics|mesh-list
101858688|NCT03985280|Anesthetics, Local|anesthetics, local|mesh-list
101858689|NCT03985280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101858690|NCT03985280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858691|NCT03985280|Sensory System Agents|sensory system agents|mesh-ancestor
101858692|NCT03985280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101858693|NCT01058876|Nicotine|nicotine|mesh-list
101858694|NCT01058876|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101858695|NCT01058876|Autonomic Agents|autonomic agents|mesh-ancestor
101858696|NCT01058876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101858697|NCT01058876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858698|NCT01058876|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101858699|NCT01058876|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101858700|NCT01058876|Cholinergic Agents|cholinergic agents|mesh-ancestor
101858701|NCT01058876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101858702|NCT01058876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858703|NCT03986762|Clavulanic Acids|clavulanic acids|mesh-list
101858704|NCT03986762|Clavulanic Acid|clavulanic acid|mesh-list
101858705|NCT03986762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101858706|NCT03986762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101858707|NCT03986762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101858708|NCT03986762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858709|NCT03986762|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101858710|NCT01051934|Paclitaxel|paclitaxel|mesh-list
101858711|NCT01051934|Bevacizumab|bevacizumab|mesh-list
101858712|NCT01051934|Carboplatin|carboplatin|mesh-list
101858713|NCT01051934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101858714|NCT01051934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101858715|NCT01051934|Tubulin Modulators|tubulin modulators|mesh-ancestor
101858716|NCT01051934|Antimitotic Agents|antimitotic agents|mesh-ancestor
101858717|NCT01051934|Mitosis Modulators|mitosis modulators|mesh-ancestor
101858718|NCT01051934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858719|NCT01051934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101858720|NCT01051934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101858721|NCT01051934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101858722|NCT01051934|Growth Substances|growth substances|mesh-ancestor
101858723|NCT01051934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858724|NCT01051934|Growth Inhibitors|growth inhibitors|mesh-ancestor
101858725|NCT01325168|Oxytocin|oxytocin|mesh-list
101858726|NCT01325168|Oxytocics|oxytocics|mesh-ancestor
101858727|NCT01325168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101858728|NCT01325168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858729|NCT00316914|Magnesium Sulfate|magnesium sulfate|mesh-list
101858730|NCT00316914|Calcium|calcium|mesh-list
101858731|NCT00316914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101858732|NCT00316914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858733|NCT00316914|Analgesics|analgesics|mesh-ancestor
101858734|NCT00316914|Sensory System Agents|sensory system agents|mesh-ancestor
101858735|NCT00316914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101858736|NCT00316914|Anesthetics|anesthetics|mesh-ancestor
101858737|NCT00316914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101858738|NCT00316914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101858739|NCT00316914|Anticonvulsants|anticonvulsants|mesh-ancestor
101858740|NCT00316914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101858741|NCT00316914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101858742|NCT00316914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858743|NCT00316914|Tocolytic Agents|tocolytic agents|mesh-ancestor
101858744|NCT00316914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101858745|NCT00316602|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
101858746|NCT00316602|Antiviral Agents|antiviral agents|mesh-ancestor
101858747|NCT00316602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101858748|NCT00335972|Dexmedetomidine|dexmedetomidine|mesh-list
101858750|NCT00335972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101858751|NCT00335972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101858752|NCT00335972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858753|NCT00335972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101858754|NCT00335972|Analgesics|analgesics|mesh-ancestor
101858755|NCT00335972|Sensory System Agents|sensory system agents|mesh-ancestor
101858756|NCT00335972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101858757|NCT00335972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101858758|NCT00335972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101858759|NCT00335972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101858760|NCT00335972|Adrenergic Agents|adrenergic agents|mesh-ancestor
101858761|NCT00335972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101858762|NCT00335972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858763|NCT00335972|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101858764|NCT00335972|Narcotics|narcotics|mesh-ancestor
101858765|NCT03983460|Betamethasone|betamethasone|mesh-list
101858766|NCT03983460|Betamethasone Valerate|betamethasone valerate|mesh-list
101858767|NCT03983460|Clobetasol|clobetasol|mesh-list
101240894|NCT01624649|Dopamine Agents|dopamine agents|mesh-ancestor
101858768|NCT03983460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101858769|NCT03983460|Glucocorticoids|glucocorticoids|mesh-ancestor
101858770|NCT03983460|Hormones|hormones|mesh-ancestor
101858771|NCT03983460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101858772|NCT03983460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858773|NCT03983460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101858774|NCT03983460|Respiratory System Agents|respiratory system agents|mesh-ancestor
101858775|NCT01056614|Methotrexate|methotrexate|mesh-list
101858776|NCT01056614|Fludarabine phosphate|fludarabine phosphate|mesh-list
101858777|NCT01056614|Fludarabine|fludarabine|mesh-list
101858778|NCT01056614|Busulfan|busulfan|mesh-list
101858779|NCT01056614|Tacrolimus|tacrolimus|mesh-list
101858780|NCT01056614|Thymoglobulin|thymoglobulin|mesh-list
101858781|NCT01056614|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101858782|NCT01056614|Immunoglobulins|immunoglobulins|mesh-list
101858783|NCT01056614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101858784|NCT01056614|Abortifacient Agents|abortifacient agents|mesh-ancestor
101858785|NCT01056614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101858786|NCT01056614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858787|NCT01056614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101858788|NCT01056614|Antimetabolites|antimetabolites|mesh-ancestor
101858789|NCT01056614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858790|NCT01056614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101858791|NCT01056614|Dermatologic Agents|dermatologic agents|mesh-ancestor
101858792|NCT01056614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101858793|NCT01056614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101858794|NCT01056614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101858795|NCT01056614|Immunologic Factors|immunologic factors|mesh-ancestor
101858796|NCT01056614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101858797|NCT01056614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101858798|NCT01056614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101858799|NCT01056614|Alkylating Agents|alkylating agents|mesh-ancestor
101858800|NCT01056614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101858801|NCT01056614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101858802|NCT00346034|Pregabalin|pregabalin|mesh-list
101858803|NCT00346034|Analgesics|analgesics|mesh-ancestor
101858804|NCT00346034|Sensory System Agents|sensory system agents|mesh-ancestor
101858805|NCT00346034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101858806|NCT00346034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858807|NCT00346034|Anticonvulsants|anticonvulsants|mesh-ancestor
101858808|NCT00346034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101858809|NCT00346034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101858810|NCT00346034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858811|NCT00346034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101858812|NCT00346034|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101578647|NCT04211545|Rabeprazole|rabeprazole|mesh-list
101858813|NCT00346034|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101858814|NCT00346034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101858815|NCT00346034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101858817|NCT00345878|Immunologic Factors|immunologic factors|mesh-ancestor
101858818|NCT00345878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858819|NCT01059110|Salicylates|salicylates|mesh-list
101858820|NCT01059110|Imiquimod|imiquimod|mesh-list
101858821|NCT01059110|Fluorouracil|fluorouracil|mesh-list
101965490|NCT03957629|Tenofovir|tenofovir|mesh-list
101858822|NCT01059110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101858823|NCT01059110|Immunologic Factors|immunologic factors|mesh-ancestor
101858824|NCT01059110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858825|NCT01059110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101858826|NCT01059110|Interferon Inducers|interferon inducers|mesh-ancestor
101858827|NCT01059110|Antimetabolites|antimetabolites|mesh-ancestor
101858828|NCT01059110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858829|NCT01059110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101858830|NCT01059110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101858831|NCT01059110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101858832|NCT01059110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101858833|NCT01059110|Analgesics|analgesics|mesh-ancestor
101858834|NCT01059110|Sensory System Agents|sensory system agents|mesh-ancestor
101858835|NCT01059110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101858836|NCT01059110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101858837|NCT01059110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101858838|NCT01059110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101858839|NCT01059110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101858840|NCT03991364|Methamphetamine|methamphetamine|mesh-list
101858841|NCT03991364|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101858842|NCT03991364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858843|NCT03991364|Sympathomimetics|sympathomimetics|mesh-ancestor
101858844|NCT03991364|Autonomic Agents|autonomic agents|mesh-ancestor
101858845|NCT03991364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101858846|NCT03991364|Dopamine Agents|dopamine agents|mesh-ancestor
101858847|NCT03991364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101858848|NCT03991364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858849|NCT03991364|Adrenergic Agents|adrenergic agents|mesh-ancestor
101858850|NCT03991364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101858851|NCT03991364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101858852|NCT03991364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101858853|NCT03991364|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101858854|NCT00335738|Carboplatin|carboplatin|mesh-list
101858855|NCT00335738|Etoposide|etoposide|mesh-list
101858856|NCT00335738|Vincristine|vincristine|mesh-list
101858857|NCT00335738|Etoposide phosphate|etoposide phosphate|mesh-list
101858858|NCT00335738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101858859|NCT00335738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101858860|NCT00335738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101858861|NCT00335738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101858862|NCT00335738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101858863|NCT00335738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858864|NCT00335738|Tubulin Modulators|tubulin modulators|mesh-ancestor
101858865|NCT00335738|Antimitotic Agents|antimitotic agents|mesh-ancestor
101858866|NCT00335738|Mitosis Modulators|mitosis modulators|mesh-ancestor
101858867|NCT02533076|Capsaicin|capsaicin|mesh-list
101858868|NCT02533076|Antipruritics|antipruritics|mesh-ancestor
101858869|NCT02533076|Dermatologic Agents|dermatologic agents|mesh-ancestor
101858870|NCT02533076|Sensory System Agents|sensory system agents|mesh-ancestor
101858871|NCT02533076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101858872|NCT02533076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858873|NCT03991520|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101858874|NCT03991520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101858875|NCT01056926|Nicotine|nicotine|mesh-list
101858876|NCT01056926|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101858877|NCT01056926|Autonomic Agents|autonomic agents|mesh-ancestor
101858878|NCT01056926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101858879|NCT01056926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858880|NCT01056926|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101858881|NCT01056926|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101858882|NCT01056926|Cholinergic Agents|cholinergic agents|mesh-ancestor
101858883|NCT01056926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101858884|NCT01056926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858885|NCT01059422|Lamivudine|lamivudine|mesh-list
101858886|NCT01059422|Abacavir|abacavir|mesh-list
101858887|NCT01059422|Raltegravir Potassium|raltegravir potassium|mesh-list
101858888|NCT01059422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101858889|NCT01059422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101858890|NCT01059422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405459|NCT00100139|Paclitaxel|paclitaxel|mesh-list
101858891|NCT01059422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858893|NCT01059422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101858894|NCT01059422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101858895|NCT01059422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101858896|NCT01059422|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101858897|NCT01059422|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101858898|NCT01052246|Clindamycin|clindamycin|mesh-list
101858899|NCT01052246|Clindamycin palmitate|clindamycin palmitate|mesh-list
101858900|NCT01052246|Clindamycin phosphate|clindamycin phosphate|mesh-list
101858901|NCT01052246|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101858902|NCT01052246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101858903|NCT01052246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101858904|NCT01052246|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101858905|NCT01052246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101858906|NCT01052246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858907|NCT01052246|Dermatologic Agents|dermatologic agents|mesh-ancestor
101858908|NCT00334958|Rufinamide|rufinamide|mesh-list
101858909|NCT00334958|Anticonvulsants|anticonvulsants|mesh-ancestor
101858910|NCT00334958|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101858911|NCT00334958|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101858912|NCT00334958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101858913|NCT00334958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858914|NCT00326898|Sorafenib|sorafenib|mesh-list
101858915|NCT00326898|Sunitinib|sunitinib|mesh-list
101858916|NCT00326898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101858917|NCT00326898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101858918|NCT00326898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101858919|NCT00326898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858920|NCT00326898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101858921|NCT00326898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101858922|NCT00326898|Growth Substances|growth substances|mesh-ancestor
101858923|NCT00326898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858924|NCT00326898|Growth Inhibitors|growth inhibitors|mesh-ancestor
101858925|NCT01062360|Aspirin|aspirin|mesh-list
101858926|NCT01062360|Pseudoephedrine|pseudoephedrine|mesh-list
101858927|NCT01062360|Ephedrine|ephedrine|mesh-list
101858928|NCT01062360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101858929|NCT01062360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101858930|NCT01062360|Analgesics|analgesics|mesh-ancestor
101858931|NCT01062360|Sensory System Agents|sensory system agents|mesh-ancestor
101858932|NCT01062360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101858933|NCT01062360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858934|NCT01062360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101858935|NCT01062360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101858936|NCT01062360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101858937|NCT01062360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101858938|NCT01062360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858939|NCT01062360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101858940|NCT01062360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101858941|NCT01062360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101858942|NCT01062360|Antipyretics|antipyretics|mesh-ancestor
101858943|NCT01062360|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101858944|NCT01062360|Autonomic Agents|autonomic agents|mesh-ancestor
101858945|NCT01062360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101858946|NCT01062360|Respiratory System Agents|respiratory system agents|mesh-ancestor
101858947|NCT01062360|Nasal Decongestants|nasal decongestants|mesh-ancestor
101858948|NCT01062360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101858949|NCT01062360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101858950|NCT01062360|Sympathomimetics|sympathomimetics|mesh-ancestor
101858951|NCT01062360|Adrenergic Agents|adrenergic agents|mesh-ancestor
101858952|NCT01062360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101858953|NCT01063842|Acetaminophen|acetaminophen|mesh-list
101858954|NCT01063842|Tramadol|tramadol|mesh-list
101858955|NCT01063842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101858956|NCT01063842|Analgesics|analgesics|mesh-ancestor
101858957|NCT01063842|Sensory System Agents|sensory system agents|mesh-ancestor
101526814|NCT04968899|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101858958|NCT01063842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101965505|NCT00065507|Entecavir|entecavir|mesh-list
101858959|NCT01063842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858960|NCT01063842|Antipyretics|antipyretics|mesh-ancestor
101858961|NCT01063842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101858962|NCT01063842|Narcotics|narcotics|mesh-ancestor
101858963|NCT01063842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101578788|NCT01349101|Busulfan|busulfan|mesh-list
101858965|NCT01063920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101858966|NCT01063920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101858967|NCT01063920|Analgesics|analgesics|mesh-ancestor
101858968|NCT01063920|Sensory System Agents|sensory system agents|mesh-ancestor
101858969|NCT01063920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101858970|NCT01063920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858971|NCT01063920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101858972|NCT01063920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101858973|NCT01063920|Gout Suppressants|gout suppressants|mesh-ancestor
101858974|NCT01063920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101858975|NCT01063920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101858976|NCT01063920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858977|NCT01062516|Esomeprazole|esomeprazole|mesh-list
101858978|NCT01062516|Famotidine|famotidine|mesh-list
101858979|NCT01062516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101858980|NCT01062516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101858981|NCT01062516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101858982|NCT01062516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101858983|NCT01062516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858984|NCT01062516|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101858985|NCT01062516|Histamine Antagonists|histamine antagonists|mesh-ancestor
101858986|NCT01062516|Histamine Agents|histamine agents|mesh-ancestor
101858987|NCT01062516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101858988|NCT01062516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101858989|NCT00334802|Paclitaxel|paclitaxel|mesh-list
101858990|NCT00334802|Gemcitabine|gemcitabine|mesh-list
101858991|NCT00334802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101858992|NCT00334802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101858993|NCT00334802|Tubulin Modulators|tubulin modulators|mesh-ancestor
101858994|NCT00334802|Antimitotic Agents|antimitotic agents|mesh-ancestor
101858995|NCT00334802|Mitosis Modulators|mitosis modulators|mesh-ancestor
101858996|NCT00334802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101858997|NCT00334802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101858998|NCT00334802|Antimetabolites|antimetabolites|mesh-ancestor
101858999|NCT03985358|Analgesics, Opioid|analgesics, opioid|mesh-list
101859000|NCT03985358|Narcotics|narcotics|mesh-ancestor
101859001|NCT03985358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101859002|NCT03985358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859003|NCT03985358|Analgesics|analgesics|mesh-ancestor
101859004|NCT03985358|Sensory System Agents|sensory system agents|mesh-ancestor
101859005|NCT03985358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101859006|NCT01052324|Remifentanil|remifentanil|mesh-list
101859007|NCT01052324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101859008|NCT01052324|Narcotics|narcotics|mesh-ancestor
101859009|NCT01052324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101859010|NCT01052324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859011|NCT01052324|Analgesics|analgesics|mesh-ancestor
101859012|NCT01052324|Sensory System Agents|sensory system agents|mesh-ancestor
101859013|NCT01052324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101859014|NCT01059890|Metronidazole|metronidazole|mesh-list
101859015|NCT01059890|Ciprofloxacin|ciprofloxacin|mesh-list
101859016|NCT01059890|Cefotaxime|cefotaxime|mesh-list
101859017|NCT01059890|Cefoxitin|cefoxitin|mesh-list
101859018|NCT01059890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101859019|NCT01059890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101859020|NCT01059890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101859021|NCT01059890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101859022|NCT01059890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101859023|NCT01059890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101859024|NCT01059890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101859025|NCT01059890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859026|NCT01059890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101859027|NCT01059890|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101240927|NCT01624857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101859028|NCT01059890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101859029|NCT01057160|Rizatriptan|rizatriptan|mesh-list
101859030|NCT01057160|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101859031|NCT01057160|Serotonin Agents|serotonin agents|mesh-ancestor
101859032|NCT01057160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101859033|NCT01057160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859034|NCT01057160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859035|NCT03990974|Anti-Infective Agents|anti-infective agents|mesh-list
101859036|NCT03990974|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101859037|NCT00307086|Bortezomib|bortezomib|mesh-list
101859038|NCT00307086|Melphalan|melphalan|mesh-list
101859039|NCT00307086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101859040|NCT00307086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101859041|NCT00307086|Alkylating Agents|alkylating agents|mesh-ancestor
101859042|NCT00307086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859043|NCT00307086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101859044|NCT00307086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101859045|NCT00307086|Immunologic Factors|immunologic factors|mesh-ancestor
101859046|NCT00307086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859047|NCT02533544|Tenofovir|tenofovir|mesh-list
101859048|NCT02533544|Antiviral Agents|antiviral agents|mesh-ancestor
101859049|NCT02533544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101859050|NCT02533544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101859051|NCT02533544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101859052|NCT02533544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101859053|NCT02533544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859054|NCT02533544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101859055|NCT02533544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101859056|NCT03991208|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
101859057|NCT03991208|Antimalarials|antimalarials|mesh-ancestor
101859058|NCT03991208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101859059|NCT03991208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101859060|NCT03991208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101859061|NCT00325416|Melphalan|melphalan|mesh-list
101859062|NCT00325416|Topotecan|topotecan|mesh-list
101859063|NCT00325416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101859064|NCT00325416|Alkylating Agents|alkylating agents|mesh-ancestor
101859065|NCT00325416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859066|NCT00325416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101859067|NCT00325416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101859068|NCT00325416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101859069|NCT00325416|Immunologic Factors|immunologic factors|mesh-ancestor
101859070|NCT00325416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859071|NCT00325416|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101859072|NCT00325416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101859073|NCT00325416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101859074|NCT00314808|Dronabinol|dronabinol|mesh-list
101859075|NCT00314808|Hallucinogens|hallucinogens|mesh-ancestor
101859076|NCT00314808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859077|NCT00314808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101859078|NCT00314808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101859079|NCT00314808|Analgesics|analgesics|mesh-ancestor
101859080|NCT00314808|Sensory System Agents|sensory system agents|mesh-ancestor
101859081|NCT00314808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101859082|NCT00314808|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101859083|NCT00314808|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101859084|NCT00314808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101859085|NCT00314808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859086|NCT00314808|Hormones|hormones|mesh-ancestor
101687605|NCT02511132|Gemcitabine|gemcitabine|mesh-list
101687606|NCT02511132|Docetaxel|docetaxel|mesh-list
101859087|NCT00314808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101859088|NCT01060514|Vinorelbine|vinorelbine|mesh-list
101859089|NCT01060514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101859090|NCT01060514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101859091|NCT01060514|Tubulin Modulators|tubulin modulators|mesh-ancestor
101859092|NCT01060514|Antimitotic Agents|antimitotic agents|mesh-ancestor
101859093|NCT01060514|Mitosis Modulators|mitosis modulators|mesh-ancestor
101859094|NCT01060514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859095|NCT01061216|Insulin|insulin|mesh-list
101859096|NCT01061216|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101859097|NCT01061216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101859098|NCT01061216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859099|NCT00314574|Omalizumab|omalizumab|mesh-list
101859100|NCT00314574|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101859101|NCT00314574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101859102|NCT00314574|Respiratory System Agents|respiratory system agents|mesh-ancestor
101859104|NCT01064154|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101859105|NCT01064154|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101859106|NCT01064154|Adrenergic Agents|adrenergic agents|mesh-ancestor
101859107|NCT01064154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101859108|NCT01064154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578940|NCT05368675|Sensory System Agents|sensory system agents|mesh-ancestor
101578941|NCT05368675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101578942|NCT05368675|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101578943|NCT05368675|Antitussive Agents|antitussive agents|mesh-ancestor
101578944|NCT05368675|Respiratory System Agents|respiratory system agents|mesh-ancestor
101578950|NCT05368051|Capecitabine|capecitabine|mesh-list
101859109|NCT01064154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859110|NCT01064154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101859111|NCT01064154|Antioxidants|antioxidants|mesh-ancestor
101859112|NCT01064154|Protective Agents|protective agents|mesh-ancestor
101859113|NCT01064154|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101859114|NCT01064154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101859115|NCT01064154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101859116|NCT01064154|Vasodilator Agents|vasodilator agents|mesh-ancestor
101859117|NCT01064154|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101859118|NCT01064154|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101859119|NCT00314340|Acetaminophen|acetaminophen|mesh-list
101859120|NCT00314340|Morphine|morphine|mesh-list
101859121|NCT00314340|Hydrocodone|hydrocodone|mesh-list
101859122|NCT00314340|Phenobarbital|phenobarbital|mesh-list
101859123|NCT00314340|Amphetamine|amphetamine|mesh-list
101859124|NCT00314340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101859125|NCT00314340|Narcotics|narcotics|mesh-ancestor
101859126|NCT00314340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101859127|NCT00314340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859128|NCT00314340|Analgesics|analgesics|mesh-ancestor
101859129|NCT00314340|Sensory System Agents|sensory system agents|mesh-ancestor
101859130|NCT00314340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101859131|NCT00314340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101859132|NCT00314340|Antipyretics|antipyretics|mesh-ancestor
101859133|NCT00314340|Antitussive Agents|antitussive agents|mesh-ancestor
101859134|NCT00314340|Respiratory System Agents|respiratory system agents|mesh-ancestor
101859135|NCT00314340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101859136|NCT00314340|Sympathomimetics|sympathomimetics|mesh-ancestor
101859137|NCT00314340|Autonomic Agents|autonomic agents|mesh-ancestor
101859138|NCT00314340|Dopamine Agents|dopamine agents|mesh-ancestor
101859139|NCT00314340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101859140|NCT00314340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859141|NCT00314340|Adrenergic Agents|adrenergic agents|mesh-ancestor
101859142|NCT00314340|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101859143|NCT00314340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101859144|NCT00314340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101859145|NCT00314340|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101859146|NCT00314340|Anticonvulsants|anticonvulsants|mesh-ancestor
101859147|NCT00314340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101859148|NCT00314340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101859149|NCT00314340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101859150|NCT00314340|GABA Modulators|gaba modulators|mesh-ancestor
101859151|NCT00314340|GABA Agents|gaba agents|mesh-ancestor
101859152|NCT00314340|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101859153|NCT00314340|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101859154|NCT00314340|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101859155|NCT00306852|Mitomycins|mitomycins|mesh-list
101859156|NCT00306852|Mitomycin|mitomycin|mesh-list
101859157|NCT00306852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101859158|NCT00306852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101859159|NCT00306852|Alkylating Agents|alkylating agents|mesh-ancestor
101859160|NCT00306852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859161|NCT00306852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101859162|NCT00306852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101859163|NCT00314262|Celecoxib|celecoxib|mesh-list
101859164|NCT00314262|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101859165|NCT00314262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101859166|NCT00314262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101859167|NCT00314262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101859168|NCT00314262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859169|NCT00314262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101859170|NCT00314262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101859171|NCT00314262|Analgesics|analgesics|mesh-ancestor
101859172|NCT00314262|Sensory System Agents|sensory system agents|mesh-ancestor
101859173|NCT00314262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101859174|NCT00314262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859175|NCT00314262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101859176|NCT00314262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101859177|NCT00314262|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101859178|NCT00314262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101859179|NCT00333866|Pregabalin|pregabalin|mesh-list
101859180|NCT00333866|Analgesics|analgesics|mesh-ancestor
101859181|NCT00333866|Sensory System Agents|sensory system agents|mesh-ancestor
101859182|NCT00333866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101859183|NCT00333866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859184|NCT00333866|Anticonvulsants|anticonvulsants|mesh-ancestor
101859185|NCT00333866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101859186|NCT00333866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101859187|NCT00333866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859188|NCT00333866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101859189|NCT00333866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101859190|NCT00333866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101859191|NCT00333866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101859192|NCT00333866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101859193|NCT00324740|Vorinostat|vorinostat|mesh-list
101859194|NCT00324740|Isotretinoin|isotretinoin|mesh-list
101859195|NCT00324740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101859196|NCT00324740|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101859197|NCT00324740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101859198|NCT00324740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859199|NCT00324740|Dermatologic Agents|dermatologic agents|mesh-ancestor
101859200|NCT00333788|Certolizumab Pegol|certolizumab pegol|mesh-list
101859201|NCT00333788|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101859202|NCT00333788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101859203|NCT00333788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101859204|NCT00333788|Immunologic Factors|immunologic factors|mesh-ancestor
101859205|NCT00333788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859206|NCT00333788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101859207|NCT00332696|Methylprednisolone|methylprednisolone|mesh-list
101859208|NCT00332696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101859209|NCT00332696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101859210|NCT00332696|Prednisolone|prednisolone|mesh-list
101859211|NCT00332696|Prednisolone acetate|prednisolone acetate|mesh-list
101859212|NCT00332696|Octreotide|octreotide|mesh-list
101859213|NCT00332696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101859214|NCT00332696|Prednisolone phosphate|prednisolone phosphate|mesh-list
101859215|NCT00332696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101859216|NCT00332696|Antiemetics|antiemetics|mesh-ancestor
101859217|NCT00332696|Autonomic Agents|autonomic agents|mesh-ancestor
101859218|NCT00332696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101859219|NCT00332696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859220|NCT00332696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101859221|NCT00332696|Glucocorticoids|glucocorticoids|mesh-ancestor
101859222|NCT00332696|Hormones|hormones|mesh-ancestor
101859223|NCT00332696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101859224|NCT00332696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101687621|NCT02678520|Goserelin|goserelin|mesh-list
101859225|NCT00332696|Protective Agents|protective agents|mesh-ancestor
101859226|NCT00332696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101859227|NCT00332696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101859228|NCT00313716|Epoetin Alfa|epoetin alfa|mesh-list
101859229|NCT00313716|Hematinics|hematinics|mesh-ancestor
101859230|NCT00313170|Fulvestrant|fulvestrant|mesh-list
101859231|NCT00313170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101859232|NCT00313170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101859233|NCT00313170|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101859234|NCT00313170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101859235|NCT00313170|Hormone Antagonists|hormone antagonists|mesh-ancestor
101859236|NCT00313170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101859237|NCT00313170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859239|NCT00332462|Cyclosporins|cyclosporins|mesh-list
101859240|NCT00332462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101859241|NCT00332462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859242|NCT00332462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101859243|NCT00332462|Immunologic Factors|immunologic factors|mesh-ancestor
101859244|NCT00332462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859245|NCT00332462|Antifungal Agents|antifungal agents|mesh-ancestor
101859246|NCT00332462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101859247|NCT00332462|Dermatologic Agents|dermatologic agents|mesh-ancestor
101859248|NCT00332462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101859249|NCT00332462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101859250|NCT00324038|Acetaminophen|acetaminophen|mesh-list
101859251|NCT00324038|Buprenorphine|buprenorphine|mesh-list
101859253|NCT00324038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101859254|NCT00324038|Analgesics|analgesics|mesh-ancestor
101859255|NCT00324038|Sensory System Agents|sensory system agents|mesh-ancestor
101859256|NCT00324038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101859257|NCT00324038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859258|NCT00324038|Antipyretics|antipyretics|mesh-ancestor
101859259|NCT00324038|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101859260|NCT00324038|Narcotics|narcotics|mesh-ancestor
101859261|NCT00324038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101859262|NCT00324038|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101859263|NCT00324038|Antitussive Agents|antitussive agents|mesh-ancestor
101859264|NCT00324038|Respiratory System Agents|respiratory system agents|mesh-ancestor
101859265|NCT03984110|Dexamethasone|dexamethasone|mesh-list
101859266|NCT03984110|Aflibercept|aflibercept|mesh-list
101859267|NCT03984110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101859268|NCT03984110|Antiemetics|antiemetics|mesh-ancestor
101859269|NCT03984110|Autonomic Agents|autonomic agents|mesh-ancestor
101859270|NCT03984110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101859271|NCT03984110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859272|NCT03984110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101859273|NCT03984110|Glucocorticoids|glucocorticoids|mesh-ancestor
101859274|NCT03984110|Hormones|hormones|mesh-ancestor
101859275|NCT03984110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101859276|NCT03984110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101859277|NCT03984110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101859278|NCT03984110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101859279|NCT03984110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101859280|NCT03984110|Growth Substances|growth substances|mesh-ancestor
101859281|NCT03984110|Growth Inhibitors|growth inhibitors|mesh-ancestor
101859282|NCT00159861|Sildenafil Citrate|sildenafil citrate|mesh-list
101859283|NCT00159861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859284|NCT00159861|Vasodilator Agents|vasodilator agents|mesh-ancestor
101859285|NCT00159861|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101859286|NCT00159861|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101859287|NCT00159861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101859288|NCT00159861|Urological Agents|urological agents|mesh-ancestor
101859289|NCT01057628|Ipragliflozin|ipragliflozin|mesh-list
101859290|NCT01057628|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101859291|NCT01057628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859292|NCT01057628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101859293|NCT01057628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859294|NCT00331760|Cisplatin|cisplatin|mesh-list
101859295|NCT00331760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101859296|NCT00225147|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
101859297|NCT00225147|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101859298|NCT00225147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101859299|NCT00225147|Immunologic Factors|immunologic factors|mesh-ancestor
101859300|NCT00225147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859302|NCT00313014|Buprenorphine|buprenorphine|mesh-list
101859303|NCT00313014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101859304|NCT00313014|Narcotics|narcotics|mesh-ancestor
101859305|NCT00313014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101859306|NCT00313014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859307|NCT00313014|Analgesics|analgesics|mesh-ancestor
101859308|NCT00313014|Sensory System Agents|sensory system agents|mesh-ancestor
101859309|NCT00313014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101859310|NCT00313014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101859311|NCT01075659|Nicotine|nicotine|mesh-list
101859312|NCT01075659|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101859313|NCT01075659|Autonomic Agents|autonomic agents|mesh-ancestor
101859314|NCT01075659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101859315|NCT01075659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859316|NCT01075659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101859317|NCT01075659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101859318|NCT01075659|Cholinergic Agents|cholinergic agents|mesh-ancestor
101859319|NCT01075659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101859320|NCT01075659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859321|NCT01077453|Letrozole|letrozole|mesh-list
101859322|NCT01077453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101859323|NCT01077453|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101859324|NCT01077453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101859325|NCT01077453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101859326|NCT01077453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859327|NCT01077453|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101859328|NCT01077453|Hormone Antagonists|hormone antagonists|mesh-ancestor
101859329|NCT01077453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101859330|NCT01077453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859331|NCT00157209|Cyclophosphamide|cyclophosphamide|mesh-list
101579167|NCT02691403|Bupivacaine|bupivacaine|mesh-list
101859332|NCT00157209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101859333|NCT00157209|Immunologic Factors|immunologic factors|mesh-ancestor
101859334|NCT00157209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859335|NCT00157209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101859336|NCT00157209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101859337|NCT00157209|Alkylating Agents|alkylating agents|mesh-ancestor
101859338|NCT00157209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859339|NCT00157209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101859340|NCT00157209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101859341|NCT00312858|Vaccines|vaccines|mesh-list
101859342|NCT00312858|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101859343|NCT00312858|Immunologic Factors|immunologic factors|mesh-ancestor
101859344|NCT00312858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859345|NCT00156819|Fluticasone|fluticasone|mesh-list
101859347|NCT00156819|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101859348|NCT00156819|Montelukast|montelukast|mesh-list
101859349|NCT00156819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101859350|NCT00156819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101859351|NCT00156819|Autonomic Agents|autonomic agents|mesh-ancestor
101859352|NCT00156819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101859353|NCT00156819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859354|NCT00156819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101859355|NCT00156819|Respiratory System Agents|respiratory system agents|mesh-ancestor
101859356|NCT00156819|Dermatologic Agents|dermatologic agents|mesh-ancestor
101859357|NCT00156819|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101859358|NCT00156819|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101859359|NCT00156819|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101241015|NCT01625793|Interferons|interferons|mesh-list
101859360|NCT00156819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101859361|NCT00156819|Adrenergic Agents|adrenergic agents|mesh-ancestor
101859362|NCT00156819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101859363|NCT00156819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859364|NCT00156819|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101859365|NCT00156819|Hormone Antagonists|hormone antagonists|mesh-ancestor
101859366|NCT00156819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101859367|NCT00156819|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101859368|NCT00156819|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101859370|NCT00224133|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101859371|NCT00224133|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101859372|NCT00224133|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101859373|NCT00224133|Adrenergic Agents|adrenergic agents|mesh-ancestor
101859374|NCT00224133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101859375|NCT00224133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859376|NCT00224133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859377|NCT00224133|Urological Agents|urological agents|mesh-ancestor
101859378|NCT00224055|Ferric gluconate|ferric gluconate|mesh-list
101859379|NCT00224055|Hematinics|hematinics|mesh-ancestor
101859380|NCT00150969|Vitamin K|vitamin k|mesh-list
101859381|NCT00150969|Vitamin K 1|vitamin k 1|mesh-list
101859382|NCT00150969|Vitamins|vitamins|mesh-ancestor
101859383|NCT00150969|Micronutrients|micronutrients|mesh-ancestor
101859384|NCT00150969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859385|NCT00150969|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101859386|NCT00150969|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101859387|NCT00150969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859388|NCT00150969|Hemostatics|hemostatics|mesh-ancestor
101859389|NCT00150969|Coagulants|coagulants|mesh-ancestor
101859390|NCT00150345|Voriconazole|voriconazole|mesh-list
101859391|NCT00150345|Antifungal Agents|antifungal agents|mesh-ancestor
101859392|NCT00150345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101859393|NCT00150345|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101859394|NCT00150345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101859395|NCT00150345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101859396|NCT00150345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859397|NCT00150345|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101859398|NCT00150345|Hormone Antagonists|hormone antagonists|mesh-ancestor
101859399|NCT00150345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101859400|NCT00150345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859401|NCT00150345|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101859402|NCT01077609|Fluticasone|fluticasone|mesh-list
101859404|NCT01077609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101859405|NCT01077609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101859406|NCT01077609|Autonomic Agents|autonomic agents|mesh-ancestor
101859407|NCT01077609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101859408|NCT01077609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859409|NCT01077609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101859410|NCT01077609|Respiratory System Agents|respiratory system agents|mesh-ancestor
101859411|NCT01077609|Dermatologic Agents|dermatologic agents|mesh-ancestor
101859412|NCT01077609|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101859413|NCT00223977|Ferric gluconate|ferric gluconate|mesh-list
101859414|NCT00223977|Ferric Compounds|ferric compounds|mesh-list
101859415|NCT00223977|Hematinics|hematinics|mesh-ancestor
101859416|NCT00148941|Vaccines|vaccines|mesh-list
101859417|NCT00148941|Immunologic Factors|immunologic factors|mesh-ancestor
101859418|NCT00148941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859419|NCT01073553|Cephalexin|cephalexin|mesh-list
101859420|NCT01073553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101859421|NCT01073553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101859422|NCT00148317|Dexamethasone|dexamethasone|mesh-list
101859423|NCT00148317|Doxorubicin|doxorubicin|mesh-list
101859424|NCT00148317|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101859425|NCT00148317|Bortezomib|bortezomib|mesh-list
101859426|NCT00148317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101859427|NCT00148317|Antiemetics|antiemetics|mesh-ancestor
101859428|NCT00148317|Autonomic Agents|autonomic agents|mesh-ancestor
101859429|NCT00148317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101859430|NCT00148317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859431|NCT00148317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101859432|NCT00148317|Glucocorticoids|glucocorticoids|mesh-ancestor
101859433|NCT00148317|Hormones|hormones|mesh-ancestor
101859434|NCT00148317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101859435|NCT00148317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101859436|NCT00148317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101859437|NCT00148317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101859438|NCT00148317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101859439|NCT00148317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101859440|NCT00148317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101687628|NCT02678520|Hormone Antagonists|hormone antagonists|mesh-ancestor
101859441|NCT00148317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859442|NCT00323882|Ipilimumab|ipilimumab|mesh-list
101859443|NCT00323882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101859444|NCT00323882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101859445|NCT00323882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101859446|NCT00323882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859447|NCT00331682|Docetaxel|docetaxel|mesh-list
101859448|NCT00331682|Alvocidib|alvocidib|mesh-list
101859449|NCT00331682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101859450|NCT00331682|Tubulin Modulators|tubulin modulators|mesh-ancestor
101965529|NCT01095731|Acetic Acid|acetic acid|mesh-list
101859451|NCT00331682|Antimitotic Agents|antimitotic agents|mesh-ancestor
101859452|NCT00331682|Mitosis Modulators|mitosis modulators|mesh-ancestor
101859453|NCT00331682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859454|NCT00331682|Growth Inhibitors|growth inhibitors|mesh-ancestor
101859455|NCT00331682|Growth Substances|growth substances|mesh-ancestor
101859456|NCT00331682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859457|NCT00331682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101859458|NCT00331682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101859459|NCT00323492|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101859460|NCT00323492|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101859461|NCT00323492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101859462|NCT00323492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101859463|NCT00323492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859465|NCT00323492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101859466|NCT00323492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101859467|NCT00323492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101859468|NCT00331136|Artesunate|artesunate|mesh-list
101859469|NCT00331136|Pyronaridine|pyronaridine|mesh-list
101859470|NCT00331136|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
101859471|NCT00331136|Antimalarials|antimalarials|mesh-ancestor
101859472|NCT00331136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101859473|NCT00331136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101859474|NCT00331136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101859475|NCT00331136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101859476|NCT00331136|Antiviral Agents|antiviral agents|mesh-ancestor
101859477|NCT00331136|Schistosomicides|schistosomicides|mesh-ancestor
101859478|NCT00331136|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101859479|NCT00331136|Anthelmintics|anthelmintics|mesh-ancestor
101859480|NCT00330668|Mecasermin|mecasermin|mesh-list
101859481|NCT00330668|Growth Substances|growth substances|mesh-ancestor
101579315|NCT05392127|Anesthetics|anesthetics|mesh-ancestor
101859482|NCT00330668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859483|NCT00306384|Alogliptin|alogliptin|mesh-list
101859484|NCT00306384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101859485|NCT00306384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859486|NCT00306384|Incretins|incretins|mesh-ancestor
101859487|NCT00306384|Hormones|hormones|mesh-ancestor
101859488|NCT00306384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101859489|NCT00306384|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101859490|NCT00306384|Protease Inhibitors|protease inhibitors|mesh-ancestor
101859491|NCT00306384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101859492|NCT00306384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859493|NCT01062906|Lidocaine|lidocaine|mesh-list
101859494|NCT01062906|Fentanyl|fentanyl|mesh-list
101859495|NCT01062906|Anesthetics, Local|anesthetics, local|mesh-ancestor
101859496|NCT01062906|Anesthetics|anesthetics|mesh-ancestor
101859497|NCT01062906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101859498|NCT01062906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859499|NCT01062906|Sensory System Agents|sensory system agents|mesh-ancestor
101859500|NCT01062906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101859501|NCT01062906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101859502|NCT01062906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101859503|NCT01062906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101859504|NCT01062906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101859505|NCT01062906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859506|NCT01062906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101859507|NCT01062906|Narcotics|narcotics|mesh-ancestor
101859508|NCT01062906|Analgesics|analgesics|mesh-ancestor
101859509|NCT01062906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101859510|NCT01062906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101859511|NCT01062906|Anesthetics, General|anesthetics, general|mesh-ancestor
101859512|NCT00305604|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101859513|NCT00305604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101859514|NCT00305604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859515|NCT00305604|Incretins|incretins|mesh-ancestor
101859516|NCT00305604|Hormones|hormones|mesh-ancestor
101859517|NCT00305604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101859518|NCT00305604|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101859519|NCT00305604|Protease Inhibitors|protease inhibitors|mesh-ancestor
101859520|NCT00305604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101859521|NCT00305604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859522|NCT01064232|Risperidone|risperidone|mesh-list
101859523|NCT01064232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101859524|NCT01064232|Serotonin Agents|serotonin agents|mesh-ancestor
101859525|NCT01064232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101859526|NCT01064232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859527|NCT01064232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859528|NCT01064232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101859529|NCT01064232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101859530|NCT01064232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101859531|NCT01064232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101859532|NCT01064232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101859533|NCT01064232|Dopamine Agents|dopamine agents|mesh-ancestor
101859534|NCT00501059|Aspirin|aspirin|mesh-list
101859535|NCT00501059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101859536|NCT00501059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101859537|NCT00501059|Analgesics|analgesics|mesh-ancestor
101859538|NCT00501059|Sensory System Agents|sensory system agents|mesh-ancestor
101859539|NCT00501059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101859540|NCT00501059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859541|NCT00501059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101859542|NCT00501059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101859543|NCT00501059|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101859544|NCT00501059|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101859545|NCT00501059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859546|NCT00501059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101859547|NCT00501059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101859548|NCT00501059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101859549|NCT00501059|Antipyretics|antipyretics|mesh-ancestor
101859550|NCT00344318|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101859551|NCT00344318|Immunologic Factors|immunologic factors|mesh-ancestor
101859552|NCT00344318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859553|NCT00322868|Pioglitazone|pioglitazone|mesh-list
101859554|NCT00322868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101859555|NCT00322868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859556|NCT01016717|Omeprazole|omeprazole|mesh-list
101859557|NCT01016717|Pantoprazole|pantoprazole|mesh-list
101859558|NCT01016717|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101859559|NCT01016717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101859560|NCT01016717|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101859561|NCT01016717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101859562|NCT01016717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859563|NCT01016795|Lenograstim|lenograstim|mesh-list
101859564|NCT01016795|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101859565|NCT01016795|Immunologic Factors|immunologic factors|mesh-ancestor
101859566|NCT01016795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859567|NCT00343382|Pilocarpine|pilocarpine|mesh-list
101859568|NCT00343382|Miotics|miotics|mesh-ancestor
101859569|NCT00343382|Autonomic Agents|autonomic agents|mesh-ancestor
101859570|NCT00343382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101859571|NCT00343382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859572|NCT00343382|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101859573|NCT00343382|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101859574|NCT00343382|Cholinergic Agents|cholinergic agents|mesh-ancestor
101859575|NCT00343382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101859576|NCT00343382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859577|NCT00481871|Vitamins|vitamins|mesh-list
101859578|NCT00481871|Folic Acid|folic acid|mesh-list
101859579|NCT00481871|Vitamin B 12|vitamin b 12|mesh-list
101859580|NCT00481871|Vitamin B Complex|vitamin b complex|mesh-list
101859581|NCT00481871|Gemcitabine|gemcitabine|mesh-list
101859582|NCT00481871|10-deazaaminopterin|10-deazaaminopterin|mesh-list
101859583|NCT00481871|Aminopterin|aminopterin|mesh-list
101859584|NCT00481871|Micronutrients|micronutrients|mesh-ancestor
101859585|NCT00481871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859586|NCT00481871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101859587|NCT00481871|Antimetabolites|antimetabolites|mesh-ancestor
101859588|NCT00481871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859589|NCT00481871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101859590|NCT00481871|Hematinics|hematinics|mesh-ancestor
101859591|NCT00481871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101859592|NCT00481871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101859593|NCT00329420|Certolizumab Pegol|certolizumab pegol|mesh-list
101859594|NCT00329420|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101859595|NCT00329420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101859596|NCT00329420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101859597|NCT00329420|Immunologic Factors|immunologic factors|mesh-ancestor
101859598|NCT00329420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859599|NCT00329420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101859600|NCT00329108|Olanzapine|olanzapine|mesh-list
101859601|NCT00329108|Ziprasidone|ziprasidone|mesh-list
101859602|NCT00329108|Antiemetics|antiemetics|mesh-ancestor
101859603|NCT00329108|Autonomic Agents|autonomic agents|mesh-ancestor
101859604|NCT00329108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101859605|NCT00329108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859606|NCT00329108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101859607|NCT00329108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101859608|NCT00329108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101859609|NCT00329108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101859610|NCT00329108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101859611|NCT00329108|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101859612|NCT00329108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101859613|NCT00329108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101859614|NCT00329108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859615|NCT00329108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101859616|NCT00329108|Serotonin Agents|serotonin agents|mesh-ancestor
101859617|NCT00329108|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101859618|NCT00329108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101859619|NCT00329108|Dopamine Agents|dopamine agents|mesh-ancestor
101859620|NCT00329030|Rituximab|rituximab|mesh-list
101859621|NCT00329030|Tositumomab I-131|tositumomab i-131|mesh-list
101859622|NCT00329030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101859623|NCT00329030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101859624|NCT00329030|Immunologic Factors|immunologic factors|mesh-ancestor
101859625|NCT00329030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859626|NCT00329030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101859627|NCT00328562|Gefitinib|gefitinib|mesh-list
101859628|NCT00328562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101859629|NCT00328562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101859630|NCT00328562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101859631|NCT00328562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574893|NCT04219579|Antithrombins|antithrombins|mesh-list
101859632|NCT00328172|Metformin|metformin|mesh-list
101859633|NCT00328172|Linagliptin|linagliptin|mesh-list
101859634|NCT00328172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101859635|NCT00328172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859636|NCT00328172|Incretins|incretins|mesh-ancestor
101859637|NCT00328172|Hormones|hormones|mesh-ancestor
101859638|NCT00328172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101859639|NCT00328172|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101859640|NCT00328172|Protease Inhibitors|protease inhibitors|mesh-ancestor
101859641|NCT00328172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101859642|NCT00328172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859643|NCT01061372|Pregabalin|pregabalin|mesh-list
101859644|NCT01061372|Analgesics|analgesics|mesh-ancestor
101859645|NCT01061372|Sensory System Agents|sensory system agents|mesh-ancestor
101859646|NCT01061372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101859647|NCT01061372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859648|NCT01061372|Anticonvulsants|anticonvulsants|mesh-ancestor
101859649|NCT01061372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101859650|NCT01061372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101859651|NCT01061372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859652|NCT01061372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101859653|NCT01061372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101859654|NCT01061372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101859655|NCT01061372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101859656|NCT01061372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101859657|NCT00328094|Insulin|insulin|mesh-list
101859658|NCT00328094|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101859659|NCT00328094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101859660|NCT00328094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859661|NCT00295932|Prednisone|prednisone|mesh-list
101859662|NCT00295932|Cyclophosphamide|cyclophosphamide|mesh-list
101859663|NCT00295932|Rituximab|rituximab|mesh-list
101859664|NCT00295932|Bortezomib|bortezomib|mesh-list
101859665|NCT00295932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101859666|NCT00295932|Immunologic Factors|immunologic factors|mesh-ancestor
101859667|NCT00295932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859668|NCT00295932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101859669|NCT00295932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101859670|NCT00295932|Alkylating Agents|alkylating agents|mesh-ancestor
101859671|NCT00295932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859672|NCT00295932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101859673|NCT00295932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101859674|NCT00295932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101859675|NCT00295932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101859676|NCT00295932|Glucocorticoids|glucocorticoids|mesh-ancestor
101859677|NCT00295932|Hormones|hormones|mesh-ancestor
101859678|NCT00295932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101859679|NCT00295932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101859680|NCT01063140|Vaccines|vaccines|mesh-list
101859681|NCT01063140|Immunologic Factors|immunologic factors|mesh-ancestor
101859682|NCT01063140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859683|NCT00305448|Fulvestrant|fulvestrant|mesh-list
101859684|NCT00305448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101859685|NCT00305448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101859686|NCT00305448|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101859687|NCT00305448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101859688|NCT00305448|Hormone Antagonists|hormone antagonists|mesh-ancestor
101241146|NCT01627041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859689|NCT00305448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101859690|NCT00305448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859691|NCT01063218|Emollients|emollients|mesh-list
101859692|NCT01063218|Dermatologic Agents|dermatologic agents|mesh-ancestor
101859693|NCT00305058|Morphine|morphine|mesh-list
101859694|NCT00305058|Hydromorphone|hydromorphone|mesh-list
101859695|NCT00305058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101859696|NCT00305058|Narcotics|narcotics|mesh-ancestor
101859697|NCT00305058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101859698|NCT00305058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859699|NCT00305058|Analgesics|analgesics|mesh-ancestor
101859700|NCT00305058|Sensory System Agents|sensory system agents|mesh-ancestor
101859701|NCT00305058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101859702|NCT01061450|Simvastatin|simvastatin|mesh-list
101859703|NCT01061450|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101859704|NCT01061450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101859705|NCT01061450|Antimetabolites|antimetabolites|mesh-ancestor
101859706|NCT01061450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859707|NCT01061450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101859708|NCT01061450|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101859709|NCT01061450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101859710|NCT03986294|Leucovorin|leucovorin|mesh-list
101859711|NCT03986294|Antidotes|antidotes|mesh-ancestor
101859712|NCT03986294|Protective Agents|protective agents|mesh-ancestor
101859713|NCT03986294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859714|NCT03986294|Vitamin B Complex|vitamin b complex|mesh-ancestor
101859715|NCT03986294|Vitamins|vitamins|mesh-ancestor
101859717|NCT00322556|Immunoglobulins|immunoglobulins|mesh-list
101859718|NCT00322556|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101859719|NCT00322556|Antibodies|antibodies|mesh-list
101859720|NCT00322556|Immunologic Factors|immunologic factors|mesh-ancestor
101859721|NCT00322556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859722|NCT00321932|Calcium, Dietary|calcium, dietary|mesh-list
101859723|NCT00321932|Cholecalciferol|cholecalciferol|mesh-list
101859724|NCT00321932|Zoledronic Acid|zoledronic acid|mesh-list
101859725|NCT00321932|Calcium Carbonate|calcium carbonate|mesh-list
101859726|NCT00321932|Calcium|calcium|mesh-list
101965553|NCT01095809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859727|NCT00321932|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101859728|NCT00321932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859729|NCT00321932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101859730|NCT00321932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859732|NCT00321932|Micronutrients|micronutrients|mesh-ancestor
101859733|NCT00321932|Antacids|antacids|mesh-ancestor
101859734|NCT00321932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101859735|NCT00326612|Midazolam|midazolam|mesh-list
101859736|NCT00326612|Diazepam|diazepam|mesh-list
101859737|NCT00326612|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101859738|NCT00326612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101859739|NCT00326612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101859740|NCT00326612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859741|NCT00326612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101859742|NCT00326612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101859743|NCT00326612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101859744|NCT00326612|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101859745|NCT00326612|Anesthetics, General|anesthetics, general|mesh-ancestor
101859746|NCT00326612|Anesthetics|anesthetics|mesh-ancestor
101859747|NCT00326612|GABA Modulators|gaba modulators|mesh-ancestor
101859748|NCT00326612|GABA Agents|gaba agents|mesh-ancestor
101859749|NCT00326612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101859750|NCT00326612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859751|NCT00326612|Anticonvulsants|anticonvulsants|mesh-ancestor
101859752|NCT00326612|Antiemetics|antiemetics|mesh-ancestor
101859753|NCT00326612|Autonomic Agents|autonomic agents|mesh-ancestor
101859754|NCT00326612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101859755|NCT00326612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101859756|NCT00326612|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101859757|NCT00326612|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101859758|NCT01060826|Somatostatin|somatostatin|mesh-list
101859759|NCT01060826|Hormones|hormones|mesh-ancestor
101859760|NCT01060826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101859761|NCT01060826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859762|NCT00321854|Pramipexole|pramipexole|mesh-list
101859763|NCT00321854|Antioxidants|antioxidants|mesh-ancestor
101859764|NCT00321854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859765|NCT00321854|Protective Agents|protective agents|mesh-ancestor
101859766|NCT00321854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859767|NCT00321854|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101859768|NCT00321854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101859769|NCT00321854|Dopamine Agonists|dopamine agonists|mesh-ancestor
101859770|NCT00321854|Dopamine Agents|dopamine agents|mesh-ancestor
101859771|NCT00321854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101859772|NCT03982862|Triamcinolone|triamcinolone|mesh-list
101859773|NCT03982862|Lidocaine|lidocaine|mesh-list
101859774|NCT03982862|Botulinum Toxins|botulinum toxins|mesh-list
101859775|NCT03982862|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101859776|NCT03982862|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101859777|NCT03982862|Anesthetics, Local|anesthetics, local|mesh-ancestor
101859778|NCT03982862|Anesthetics|anesthetics|mesh-ancestor
101859779|NCT03982862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101859780|NCT03982862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859781|NCT03982862|Sensory System Agents|sensory system agents|mesh-ancestor
101859782|NCT03982862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101859783|NCT03982862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101859784|NCT03982862|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101859785|NCT03982862|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101859786|NCT03982862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101859787|NCT03982862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859788|NCT03982862|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101859789|NCT03982862|Cholinergic Agents|cholinergic agents|mesh-ancestor
101859790|NCT03982862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101859791|NCT03982862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101859793|NCT03982862|Hormones|hormones|mesh-ancestor
101859794|NCT03982862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101859795|NCT03982862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101859796|NCT01060904|Doxorubicin|doxorubicin|mesh-list
101859797|NCT01060904|Bleomycin|bleomycin|mesh-list
101859798|NCT01060904|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101859799|NCT01060904|Dacarbazine|dacarbazine|mesh-list
101859800|NCT01060904|Vinblastine|vinblastine|mesh-list
101859801|NCT01060904|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101859802|NCT01060904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101859803|NCT01060904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101859804|NCT01060904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101859805|NCT01060904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101859806|NCT01060904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101859807|NCT01060904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241182|NCT01627158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101859808|NCT01060904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101859809|NCT01060904|Immunotoxins|immunotoxins|mesh-ancestor
101859810|NCT01060904|Immunoconjugates|immunoconjugates|mesh-ancestor
101859811|NCT01060904|Immunologic Factors|immunologic factors|mesh-ancestor
101859812|NCT01060904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859813|NCT01060904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101859814|NCT01060904|Alkylating Agents|alkylating agents|mesh-ancestor
101859815|NCT01060904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101859816|NCT01060904|Tubulin Modulators|tubulin modulators|mesh-ancestor
101859817|NCT01060904|Antimitotic Agents|antimitotic agents|mesh-ancestor
101859818|NCT01060904|Mitosis Modulators|mitosis modulators|mesh-ancestor
101859819|NCT01058174|Fluconazole|fluconazole|mesh-list
101859820|NCT01058174|Amphotericin B|amphotericin b|mesh-list
101859821|NCT01058174|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101859822|NCT01058174|Caspofungin|caspofungin|mesh-list
101859823|NCT01058174|Micafungin|micafungin|mesh-list
101859824|NCT01058174|Antifungal Agents|antifungal agents|mesh-ancestor
101859825|NCT01058174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101859826|NCT01058174|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101859827|NCT01058174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101859828|NCT01058174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101859829|NCT01058174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859830|NCT01058174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101859831|NCT01058174|Hormone Antagonists|hormone antagonists|mesh-ancestor
101859832|NCT01058174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101859833|NCT01058174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859834|NCT01058174|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101859835|NCT01058174|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101859836|NCT01058174|Amebicides|amebicides|mesh-ancestor
101859837|NCT01058174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101859838|NCT01058174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101859839|NCT01058174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101859840|NCT01058252|Indomethacin|indomethacin|mesh-list
101859841|NCT01058252|Letrozole|letrozole|mesh-list
101859842|NCT01058252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101859843|NCT01058252|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101859844|NCT01058252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101859845|NCT01058252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101859846|NCT01058252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859847|NCT01058252|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101859848|NCT01058252|Hormone Antagonists|hormone antagonists|mesh-ancestor
101859849|NCT01058252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101859850|NCT01058252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859851|NCT01058252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101859852|NCT01058252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101859853|NCT01058252|Analgesics|analgesics|mesh-ancestor
101859854|NCT01058252|Sensory System Agents|sensory system agents|mesh-ancestor
101859855|NCT01058252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101859856|NCT01058252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101859857|NCT01058252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101859858|NCT01058252|Gout Suppressants|gout suppressants|mesh-ancestor
101859859|NCT01058252|Tocolytic Agents|tocolytic agents|mesh-ancestor
101859860|NCT01058252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101859861|NCT01058252|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101859862|NCT01058408|Cisplatin|cisplatin|mesh-list
101859863|NCT01058408|Everolimus|everolimus|mesh-list
101859864|NCT01058408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101859865|NCT01058408|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101859866|NCT01058408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101859867|NCT01058408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101965564|NCT00048035|Hematinics|hematinics|mesh-ancestor
101859868|NCT01058408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859869|NCT01058408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101859870|NCT01058408|Immunologic Factors|immunologic factors|mesh-ancestor
101859871|NCT01058408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859872|NCT01061060|Epoprostenol|epoprostenol|mesh-list
101859873|NCT01061060|Beraprost|beraprost|mesh-list
101859874|NCT01061060|Tezosentan|tezosentan|mesh-list
101859875|NCT01061060|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101859876|NCT01061060|Vasodilator Agents|vasodilator agents|mesh-ancestor
101859877|NCT01061060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101859878|NCT00310388|Ezogabine|ezogabine|mesh-list
101859879|NCT00310388|Anticonvulsants|anticonvulsants|mesh-ancestor
101859880|NCT00310388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101859881|NCT00310388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859882|NCT03981770|Anesthetics|anesthetics|mesh-list
101859883|NCT03981770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101859884|NCT03981770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859885|NCT00500357|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101859886|NCT00500357|Immunologic Factors|immunologic factors|mesh-ancestor
101859887|NCT00500357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859888|NCT01063556|Donepezil|donepezil|mesh-list
101859889|NCT01063556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101859890|NCT01063556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101859891|NCT01063556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859892|NCT01063556|Cholinergic Agents|cholinergic agents|mesh-ancestor
101859893|NCT01063556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101859894|NCT01063556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859895|NCT01063556|Nootropic Agents|nootropic agents|mesh-ancestor
101859896|NCT03981458|Hyaluronic Acid|hyaluronic acid|mesh-list
101859897|NCT03981458|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101859898|NCT03981458|Immunologic Factors|immunologic factors|mesh-ancestor
101859899|NCT03981458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859900|NCT03981458|Viscosupplements|viscosupplements|mesh-ancestor
101859901|NCT03981458|Protective Agents|protective agents|mesh-ancestor
101859902|NCT00309842|Cyclosporine|cyclosporine|mesh-list
101859903|NCT00309842|Mycophenolic Acid|mycophenolic acid|mesh-list
101859904|NCT00309842|Cyclophosphamide|cyclophosphamide|mesh-list
101859905|NCT00309842|Fludarabine|fludarabine|mesh-list
101859906|NCT00309842|Fludarabine phosphate|fludarabine phosphate|mesh-list
101859907|NCT00309842|Cyclosporins|cyclosporins|mesh-list
101859908|NCT00309842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101859909|NCT00309842|Immunologic Factors|immunologic factors|mesh-ancestor
101859910|NCT00309842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859911|NCT00309842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101859912|NCT00309842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101859913|NCT00309842|Alkylating Agents|alkylating agents|mesh-ancestor
101859914|NCT00309842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859915|NCT00309842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101859916|NCT00309842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101859917|NCT00309842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101859918|NCT00309842|Antimetabolites|antimetabolites|mesh-ancestor
101859919|NCT00309842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101859920|NCT00309842|Antifungal Agents|antifungal agents|mesh-ancestor
101859921|NCT00309842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101859922|NCT00309842|Dermatologic Agents|dermatologic agents|mesh-ancestor
101859923|NCT00309842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101859924|NCT00309842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101859925|NCT00309842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101859926|NCT00309842|Antitubercular Agents|antitubercular agents|mesh-ancestor
101859927|NCT00309842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101241199|NCT01627171|Bisacodyl|bisacodyl|mesh-list
101859928|NCT03985982|Botulinum Toxins|botulinum toxins|mesh-list
101859929|NCT03985982|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101859930|NCT03985982|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101859931|NCT03985982|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101859932|NCT03985982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101687660|NCT02842931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101859933|NCT03985982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859934|NCT03985982|Cholinergic Agents|cholinergic agents|mesh-ancestor
101859935|NCT03985982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101859936|NCT03985982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859937|NCT03985982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101859938|NCT03985982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101859940|NCT00499889|Methotrexate|methotrexate|mesh-list
101859941|NCT00499889|Fludarabine phosphate|fludarabine phosphate|mesh-list
101859942|NCT00499889|Fludarabine|fludarabine|mesh-list
101859943|NCT00499889|Busulfan|busulfan|mesh-list
101859944|NCT00499889|Imatinib Mesylate|imatinib mesylate|mesh-list
101859945|NCT00499889|Tacrolimus|tacrolimus|mesh-list
101859946|NCT00499889|Thymoglobulin|thymoglobulin|mesh-list
101859947|NCT00499889|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101859948|NCT00499889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101859949|NCT00499889|Abortifacient Agents|abortifacient agents|mesh-ancestor
101859950|NCT00499889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101859951|NCT00499889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859952|NCT00499889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101859953|NCT00499889|Antimetabolites|antimetabolites|mesh-ancestor
101859954|NCT00499889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859955|NCT00499889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101859956|NCT00499889|Dermatologic Agents|dermatologic agents|mesh-ancestor
101859957|NCT00499889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101859958|NCT00499889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101859959|NCT00499889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101859960|NCT00499889|Immunologic Factors|immunologic factors|mesh-ancestor
101859961|NCT00499889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101859962|NCT00499889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101859963|NCT00499889|Antiviral Agents|antiviral agents|mesh-ancestor
101859964|NCT00499889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101859965|NCT00499889|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101859966|NCT00499889|Alkylating Agents|alkylating agents|mesh-ancestor
101859967|NCT00499889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101859968|NCT00499889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101859969|NCT00499889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101859970|NCT00309608|Glimepiride|glimepiride|mesh-list
101859971|NCT00309608|Linagliptin|linagliptin|mesh-list
101859972|NCT00309608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101859973|NCT00309608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101859974|NCT00309608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101859975|NCT00309608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101859976|NCT00309608|Immunologic Factors|immunologic factors|mesh-ancestor
101859977|NCT00309608|Incretins|incretins|mesh-ancestor
101859978|NCT00309608|Hormones|hormones|mesh-ancestor
101859979|NCT00309608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101859980|NCT00309608|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101859981|NCT00309608|Protease Inhibitors|protease inhibitors|mesh-ancestor
101859982|NCT00309608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101859983|NCT00309608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859984|NCT00308750|Carboplatin|carboplatin|mesh-list
101859985|NCT00308750|Docetaxel|docetaxel|mesh-list
101859986|NCT00308750|Pemetrexed|pemetrexed|mesh-list
101859987|NCT00308750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101859988|NCT00308750|Tubulin Modulators|tubulin modulators|mesh-ancestor
101859989|NCT00308750|Antimitotic Agents|antimitotic agents|mesh-ancestor
101859990|NCT00308750|Mitosis Modulators|mitosis modulators|mesh-ancestor
101859991|NCT00308750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101859992|NCT00308750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101859993|NCT00308750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101859994|NCT00308750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101859995|NCT00489359|Carboplatin|carboplatin|mesh-list
101859996|NCT00489359|Pemetrexed|pemetrexed|mesh-list
101859997|NCT00489359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101859998|NCT00489359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101859999|NCT00489359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860000|NCT00489359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101860001|NCT00489359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101860002|NCT00481247|Imatinib Mesylate|imatinib mesylate|mesh-list
101860003|NCT00481247|Dasatinib|dasatinib|mesh-list
101860004|NCT00481247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101860005|NCT00481247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101860006|NCT00481247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101860007|NCT00481247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860008|NCT04101461|Iron|iron|mesh-list
101860009|NCT04101461|Hepcidins|hepcidins|mesh-list
101860010|NCT04101461|Trace Elements|trace elements|mesh-ancestor
101965572|NCT01092221|Antioxidants|antioxidants|mesh-ancestor
101860011|NCT04101461|Micronutrients|micronutrients|mesh-ancestor
101860012|NCT04101461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860013|NCT04101461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101860014|NCT01017107|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
101860015|NCT01017107|Protein C|protein c|mesh-list
101860016|NCT01017107|Anticoagulants|anticoagulants|mesh-ancestor
101860017|NCT01017107|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101860018|NCT01017107|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101860019|NCT01017107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860020|NCT01017107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101860021|NCT03997019|Analgesics, Opioid|analgesics, opioid|mesh-list
101860022|NCT03997019|Narcotics|narcotics|mesh-ancestor
101860023|NCT03997019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101860024|NCT03997019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860025|NCT03997019|Analgesics|analgesics|mesh-ancestor
101860026|NCT03997019|Sensory System Agents|sensory system agents|mesh-ancestor
101860027|NCT03997019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101860028|NCT00480857|Docetaxel|docetaxel|mesh-list
101860029|NCT00480857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101860030|NCT00480857|Tubulin Modulators|tubulin modulators|mesh-ancestor
101860031|NCT00480857|Antimitotic Agents|antimitotic agents|mesh-ancestor
101860032|NCT00480857|Mitosis Modulators|mitosis modulators|mesh-ancestor
101860033|NCT00480857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860034|NCT00499031|Cetuximab|cetuximab|mesh-list
101860035|NCT00499031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101860036|NCT00499031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101860037|NCT00498797|Prednisolone|prednisolone|mesh-list
101860038|NCT00498797|Docetaxel|docetaxel|mesh-list
101860039|NCT00498797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101860040|NCT00498797|Tubulin Modulators|tubulin modulators|mesh-ancestor
101860041|NCT00498797|Antimitotic Agents|antimitotic agents|mesh-ancestor
101860042|NCT00498797|Mitosis Modulators|mitosis modulators|mesh-ancestor
101860043|NCT00498797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860044|NCT00498797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101860045|NCT00498797|Glucocorticoids|glucocorticoids|mesh-ancestor
101860046|NCT00498797|Hormones|hormones|mesh-ancestor
101860047|NCT00498797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101860048|NCT00498797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860049|NCT00498797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101860050|NCT00498485|Sodium Oxybate|sodium oxybate|mesh-list
101860051|NCT00498485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101860052|NCT00498485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101860053|NCT00498485|Anesthetics, General|anesthetics, general|mesh-ancestor
101860054|NCT00498485|Anesthetics|anesthetics|mesh-ancestor
101860055|NCT00498485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101860056|NCT00498485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860057|NCT04242329|Immunomodulating Agents|immunomodulating agents|mesh-list
101241234|NCT01627262|Mesalamine|mesalamine|mesh-list
101860058|NCT04242329|Immunologic Factors|immunologic factors|mesh-ancestor
101860059|NCT04242329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860060|NCT00498173|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101860061|NCT00498173|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101860062|NCT00498173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101860063|NCT00498173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101860064|NCT00498173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860065|NCT00498173|Adrenergic Agents|adrenergic agents|mesh-ancestor
101860066|NCT00498173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101860067|NCT00498173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860068|NCT00295620|Anastrozole|anastrozole|mesh-list
101860069|NCT00295620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101860070|NCT00295620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101860071|NCT00295620|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101860072|NCT00295620|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101860073|NCT00295620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101860074|NCT00295620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860075|NCT00295620|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101860076|NCT00295620|Hormone Antagonists|hormone antagonists|mesh-ancestor
101860077|NCT00295620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101860078|NCT00295620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860080|NCT03980496|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101965575|NCT00047879|Interferons|interferons|mesh-list
101860081|NCT03980496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101860082|NCT03980496|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101860083|NCT03980496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101860084|NCT03980496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860085|NCT01063530|Fluorides|fluorides|mesh-list
101579926|NCT00642577|Antidotes|antidotes|mesh-ancestor
101860086|NCT01063530|Cariostatic Agents|cariostatic agents|mesh-ancestor
101860087|NCT01063530|Protective Agents|protective agents|mesh-ancestor
101860088|NCT01063530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860090|NCT00304356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101860091|NCT00304356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101860092|NCT01069302|Clopidogrel|clopidogrel|mesh-list
101860093|NCT01069302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101860094|NCT01069302|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101860095|NCT01069302|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101860096|NCT01069302|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101860097|NCT01069302|Purinergic Agents|purinergic agents|mesh-ancestor
101860098|NCT01069302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101860099|NCT01069302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860100|NCT01069302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860101|NCT00321620|Zoledronic Acid|zoledronic acid|mesh-list
101860102|NCT00321620|Denosumab|denosumab|mesh-list
101860103|NCT00321620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101860104|NCT00321620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860105|NCT00304278|Cisplatin|cisplatin|mesh-list
101860106|NCT00304278|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101860107|NCT00304278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101860108|NCT00304278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101860109|NCT00304278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101860110|NCT00304278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860111|NCT03981068|Nimorazole|nimorazole|mesh-list
101860112|NCT03981068|Cisplatin|cisplatin|mesh-list
101860113|NCT03981068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101860114|NCT03981068|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
101860115|NCT03981068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101860116|NCT03981068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101860117|NCT03981068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101860118|NCT01064102|Cetirizine|cetirizine|mesh-list
101860119|NCT01064102|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101860120|NCT01064102|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101241242|NCT01627262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101860121|NCT01064102|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101860122|NCT01064102|Histamine Antagonists|histamine antagonists|mesh-ancestor
101860123|NCT01064102|Histamine Agents|histamine agents|mesh-ancestor
101860124|NCT01064102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101860125|NCT01064102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860126|NCT01064102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860127|NCT02532114|Niclosamide|niclosamide|mesh-list
101860128|NCT02532114|Anticestodal Agents|anticestodal agents|mesh-ancestor
101860129|NCT02532114|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101860130|NCT02532114|Anthelmintics|anthelmintics|mesh-ancestor
101860131|NCT02532114|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101860132|NCT02532114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101860133|NCT02532114|Antinematodal Agents|antinematodal agents|mesh-ancestor
101860134|NCT00307736|Bevacizumab|bevacizumab|mesh-list
101860135|NCT00307736|Fluorouracil|fluorouracil|mesh-list
101860136|NCT00307736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101860137|NCT00307736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101860138|NCT00307736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101860139|NCT00307736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101860140|NCT00307736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101860141|NCT00307736|Growth Substances|growth substances|mesh-ancestor
101860142|NCT00307736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860143|NCT00307736|Growth Inhibitors|growth inhibitors|mesh-ancestor
101860144|NCT00307736|Antimetabolites|antimetabolites|mesh-ancestor
101860145|NCT00307736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860146|NCT00307736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101860147|NCT00307736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101860148|NCT00307736|Immunologic Factors|immunologic factors|mesh-ancestor
101860149|NCT00307736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101860150|NCT00307736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101860151|NCT00320528|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101860152|NCT00320528|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101860153|NCT00320528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101860154|NCT00320528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101860155|NCT00320528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860156|NCT00320528|Adrenergic Agents|adrenergic agents|mesh-ancestor
101860157|NCT00320528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101860158|NCT00320528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860159|NCT03979586|Hyaluronic Acid|hyaluronic acid|mesh-list
101860160|NCT03979586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101860161|NCT03979586|Immunologic Factors|immunologic factors|mesh-ancestor
101860162|NCT03979586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860164|NCT03979586|Protective Agents|protective agents|mesh-ancestor
101860165|NCT00294762|Paclitaxel|paclitaxel|mesh-list
101860166|NCT00294762|Carboplatin|carboplatin|mesh-list
101860167|NCT00294762|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101860168|NCT00294762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101860169|NCT00294762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101860170|NCT00294762|Tubulin Modulators|tubulin modulators|mesh-ancestor
101860171|NCT00294762|Antimitotic Agents|antimitotic agents|mesh-ancestor
101860172|NCT00294762|Mitosis Modulators|mitosis modulators|mesh-ancestor
101860173|NCT00294762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860174|NCT00294762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101860175|NCT00294762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101860176|NCT00294684|Methylprednisolone|methylprednisolone|mesh-list
101860177|NCT00294684|Prednisolone|prednisolone|mesh-list
101860178|NCT00294684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101860179|NCT00294684|Antiemetics|antiemetics|mesh-ancestor
101860180|NCT00294684|Autonomic Agents|autonomic agents|mesh-ancestor
101860181|NCT00294684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101860182|NCT00294684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860183|NCT00294684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101860184|NCT00294684|Glucocorticoids|glucocorticoids|mesh-ancestor
101860185|NCT00294684|Hormones|hormones|mesh-ancestor
101860186|NCT00294684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101860187|NCT00294684|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101860188|NCT00294684|Protective Agents|protective agents|mesh-ancestor
101860189|NCT00294684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101860190|NCT00294684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101860191|NCT00307034|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101860192|NCT00307034|Immunologic Factors|immunologic factors|mesh-ancestor
101860193|NCT00307034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860194|NCT01061996|Basiliximab|basiliximab|mesh-list
101860195|NCT01061996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101860196|NCT01061996|Immunologic Factors|immunologic factors|mesh-ancestor
101860197|NCT01061996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860198|NCT01064180|Carvedilol|carvedilol|mesh-list
101860199|NCT01064180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101860200|NCT01064180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101860201|NCT01064180|Adrenergic Agents|adrenergic agents|mesh-ancestor
101860202|NCT01064180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101860203|NCT01064180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860204|NCT01064180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860205|NCT01064180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101860206|NCT01064180|Antioxidants|antioxidants|mesh-ancestor
101860207|NCT01064180|Protective Agents|protective agents|mesh-ancestor
101860208|NCT01064180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101860209|NCT01064180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101860210|NCT01064180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101860211|NCT01064180|Vasodilator Agents|vasodilator agents|mesh-ancestor
101860212|NCT01064180|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101860213|NCT01064180|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101860214|NCT01069536|Metoclopramide|metoclopramide|mesh-list
101860215|NCT01069536|Antiemetics|antiemetics|mesh-ancestor
101860216|NCT01069536|Autonomic Agents|autonomic agents|mesh-ancestor
101860217|NCT01069536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101860218|NCT01069536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860219|NCT01069536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101860220|NCT01069536|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101860221|NCT01069536|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101860222|NCT01069536|Dopamine Agents|dopamine agents|mesh-ancestor
101860223|NCT01069536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101860224|NCT01069536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860225|NCT00320216|Ustekinumab|ustekinumab|mesh-list
101860226|NCT00320216|Dermatologic Agents|dermatologic agents|mesh-ancestor
101860227|NCT00290706|Gemcitabine|gemcitabine|mesh-list
101860229|NCT00290706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101860230|NCT00290706|Antimetabolites|antimetabolites|mesh-ancestor
101860231|NCT00290706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860232|NCT00290706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101860233|NCT03978156|Dronabinol|dronabinol|mesh-list
101860234|NCT03978156|Hallucinogens|hallucinogens|mesh-ancestor
101860235|NCT03978156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860236|NCT03978156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101860237|NCT03978156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101860239|NCT03978156|Sensory System Agents|sensory system agents|mesh-ancestor
101860240|NCT03978156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101860241|NCT03978156|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101860242|NCT03978156|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101860243|NCT03978156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101860244|NCT03978156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860245|NCT03978156|Hormones|hormones|mesh-ancestor
101860246|NCT03978156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101860247|NCT03978234|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101860248|NCT03978234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101406068|NCT00102869|Levodopa|levodopa|mesh-list
101860249|NCT03978234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101860250|NCT03978234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101860251|NCT03978234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860252|NCT03978234|Cholinergic Agents|cholinergic agents|mesh-ancestor
101860253|NCT03978234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101860254|NCT03978234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860255|NCT03978234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101860256|NCT03978234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101860257|NCT01066494|Cytarabine|cytarabine|mesh-list
101860258|NCT01066494|Amonafide|amonafide|mesh-list
101860259|NCT01066494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101860260|NCT01066494|Antimetabolites|antimetabolites|mesh-ancestor
101860261|NCT01066494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860262|NCT01066494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101860263|NCT01066494|Antiviral Agents|antiviral agents|mesh-ancestor
101860264|NCT01066494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101860265|NCT01066494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101860266|NCT01066494|Immunologic Factors|immunologic factors|mesh-ancestor
101860267|NCT01066494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860268|NCT01066494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101860269|NCT01069770|Sunitinib|sunitinib|mesh-list
101860270|NCT01069770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101860271|NCT01069770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101860272|NCT01069770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101860273|NCT01069770|Growth Substances|growth substances|mesh-ancestor
101860274|NCT01069770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860275|NCT01069770|Growth Inhibitors|growth inhibitors|mesh-ancestor
101860276|NCT01069770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101860277|NCT01069770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101860278|NCT01069770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860279|NCT00303108|Carboplatin|carboplatin|mesh-list
101860280|NCT00303108|Doxorubicin|doxorubicin|mesh-list
101860281|NCT00303108|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101860282|NCT00303108|Trastuzumab|trastuzumab|mesh-list
101860283|NCT00303108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101860284|NCT00303108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101860285|NCT00303108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101860286|NCT00303108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101860287|NCT00303108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101860288|NCT00303108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860289|NCT00303108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101860290|NCT00302952|Lovastatin|lovastatin|mesh-list
101860291|NCT00302952|L 647318|l 647318|mesh-list
101860292|NCT00302952|Dihydromevinolin|dihydromevinolin|mesh-list
101860293|NCT00302952|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101860294|NCT00302952|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101860295|NCT00302952|Antimetabolites|antimetabolites|mesh-ancestor
101860296|NCT00302952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860297|NCT00302952|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101860298|NCT00302952|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101860299|NCT00302952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101860301|NCT01066572|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101860302|NCT01066572|Protease Inhibitors|protease inhibitors|mesh-ancestor
101860303|NCT01066572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101860304|NCT01066572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860305|NCT01066572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101860306|NCT01066572|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101860307|NCT01066572|Protective Agents|protective agents|mesh-ancestor
101860308|NCT01066572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860309|NCT01066650|Everolimus|everolimus|mesh-list
101860310|NCT01066650|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101860311|NCT01066650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101860312|NCT01066650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101860313|NCT01066650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860314|NCT01066650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101860315|NCT01066650|Immunologic Factors|immunologic factors|mesh-ancestor
101860316|NCT01066650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860317|NCT01066650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101860318|NCT01066728|Theophylline|theophylline|mesh-list
101860319|NCT01066728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101860320|NCT01066728|Autonomic Agents|autonomic agents|mesh-ancestor
101860321|NCT01066728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101860322|NCT01066728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860323|NCT01066728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101860324|NCT01066728|Respiratory System Agents|respiratory system agents|mesh-ancestor
101860325|NCT01066728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101860326|NCT01066728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101860327|NCT01066728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860328|NCT01066728|Vasodilator Agents|vasodilator agents|mesh-ancestor
101860329|NCT01066728|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101860330|NCT01066728|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101860331|NCT01066728|Purinergic Agents|purinergic agents|mesh-ancestor
101860332|NCT01066728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101860333|NCT01325610|Cholecalciferol|cholecalciferol|mesh-list
101860334|NCT01325610|Vitamin D|vitamin d|mesh-list
101860335|NCT01325610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101860336|NCT01325610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860337|NCT01325610|Vitamins|vitamins|mesh-ancestor
101860338|NCT01325610|Micronutrients|micronutrients|mesh-ancestor
101860339|NCT01325610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101860340|NCT00301080|Cycloserine|cycloserine|mesh-list
101860341|NCT00301080|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101860342|NCT00301080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101860343|NCT00301080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101860344|NCT00301080|Antitubercular Agents|antitubercular agents|mesh-ancestor
101860345|NCT00301080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101860346|NCT00301080|Antimetabolites|antimetabolites|mesh-ancestor
101860347|NCT00301080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860348|NCT01066806|Calcium|calcium|mesh-list
101860349|NCT01066806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101860350|NCT01066806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860351|NCT03977610|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101860352|NCT03977610|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101860353|NCT03977610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860354|NCT01066884|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101860355|NCT01066884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101860356|NCT01066884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101860357|NCT01066884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101860358|NCT01066884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860359|NCT02532270|Phenylephrine|phenylephrine|mesh-list
101860360|NCT02532270|Oxymetazoline|oxymetazoline|mesh-list
101860361|NCT02532270|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101860362|NCT02532270|Mydriatics|mydriatics|mesh-ancestor
101860363|NCT02532270|Autonomic Agents|autonomic agents|mesh-ancestor
101860364|NCT02532270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101860365|NCT02532270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860366|NCT02532270|Sympathomimetics|sympathomimetics|mesh-ancestor
101860367|NCT02532270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101860368|NCT02532270|Nasal Decongestants|nasal decongestants|mesh-ancestor
101860369|NCT02532270|Respiratory System Agents|respiratory system agents|mesh-ancestor
101860370|NCT02532270|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101860371|NCT02532270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101860372|NCT02532270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101860373|NCT02532270|Adrenergic Agents|adrenergic agents|mesh-ancestor
101860374|NCT02532270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101860375|NCT02532270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860376|NCT02532270|Protective Agents|protective agents|mesh-ancestor
101860377|NCT01581450|Nitrous Oxide|nitrous oxide|mesh-list
101860378|NCT01581450|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101860379|NCT01581450|Anesthetics, General|anesthetics, general|mesh-ancestor
101860380|NCT01581450|Anesthetics|anesthetics|mesh-ancestor
101860381|NCT01581450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101860382|NCT01581450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860383|NCT01581450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101860384|NCT01581450|Analgesics|analgesics|mesh-ancestor
101860385|NCT01581450|Sensory System Agents|sensory system agents|mesh-ancestor
101860386|NCT01581450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101860387|NCT00289848|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101860388|NCT00289848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101860389|NCT00289848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860390|NCT00289848|Incretins|incretins|mesh-ancestor
101860391|NCT00289848|Hormones|hormones|mesh-ancestor
101860392|NCT00289848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101860393|NCT00289848|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101860394|NCT00289848|Protease Inhibitors|protease inhibitors|mesh-ancestor
101860395|NCT00289848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101860396|NCT00289848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860397|NCT00289536|Factor VIII|factor viii|mesh-list
101860398|NCT00289536|Coagulants|coagulants|mesh-ancestor
101860399|NCT01066962|Ritonavir|ritonavir|mesh-list
101860400|NCT01066962|Darunavir|darunavir|mesh-list
101860401|NCT01066962|Tenofovir|tenofovir|mesh-list
101860402|NCT01066962|Emtricitabine|emtricitabine|mesh-list
101860403|NCT01066962|Raltegravir Potassium|raltegravir potassium|mesh-list
101860404|NCT01066962|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101860405|NCT01066962|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101860406|NCT01066962|Protease Inhibitors|protease inhibitors|mesh-ancestor
101860407|NCT01066962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101860408|NCT01066962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860409|NCT01066962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101860410|NCT01066962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101860411|NCT01066962|Antiviral Agents|antiviral agents|mesh-ancestor
101860412|NCT01066962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101860413|NCT01066962|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101860414|NCT01066962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101860415|NCT01066962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101860416|NCT01066962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101860417|NCT01066962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101860418|NCT01066962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101860419|NCT01067118|Insulin|insulin|mesh-list
101860420|NCT01067118|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101860421|NCT01067118|Insulin Lispro|insulin lispro|mesh-list
101860422|NCT01067118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101860423|NCT01067118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860424|NCT01067274|Cytarabine|cytarabine|mesh-list
101860425|NCT01067274|Azacitidine|azacitidine|mesh-list
101860426|NCT01067274|Tretinoin|tretinoin|mesh-list
101860427|NCT01067274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101860428|NCT01067274|Antimetabolites|antimetabolites|mesh-ancestor
101860429|NCT01067274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860430|NCT01067274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101860431|NCT01067274|Antiviral Agents|antiviral agents|mesh-ancestor
101860432|NCT01067274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101860433|NCT01067274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101860434|NCT01067274|Immunologic Factors|immunologic factors|mesh-ancestor
101860435|NCT01067274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860436|NCT01067274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101860437|NCT01067274|Keratolytic Agents|keratolytic agents|mesh-ancestor
101860438|NCT01067274|Dermatologic Agents|dermatologic agents|mesh-ancestor
101860439|NCT01065246|Catumaxomab|catumaxomab|mesh-list
101860440|NCT01065246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101860441|NCT01325844|Anesthetics|anesthetics|mesh-list
101860442|NCT01325844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101860443|NCT01325844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860444|NCT01067430|Diclofenac|diclofenac|mesh-list
101860445|NCT01067430|Etoricoxib|etoricoxib|mesh-list
101860446|NCT01067430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101860447|NCT01067430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101860448|NCT01067430|Analgesics|analgesics|mesh-ancestor
101860449|NCT01067430|Sensory System Agents|sensory system agents|mesh-ancestor
101860450|NCT01067430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101860451|NCT01067430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860452|NCT01067430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101860453|NCT01067430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101860454|NCT01067430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101860455|NCT01067430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101860456|NCT01067430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860457|NCT01067430|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101580300|NCT00932698|Ixazomib|ixazomib|mesh-list
101860458|NCT00305864|Temozolomide|temozolomide|mesh-list
101860459|NCT00305864|Motexafin gadolinium|motexafin gadolinium|mesh-list
101860460|NCT00305864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101860461|NCT00305864|Alkylating Agents|alkylating agents|mesh-ancestor
101860462|NCT00305864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860463|NCT00305864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101860464|NCT00305864|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101860465|NCT00305864|Dermatologic Agents|dermatologic agents|mesh-ancestor
101860466|NCT03982784|Morphine|morphine|mesh-list
101860467|NCT03982784|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101860468|NCT03982784|Narcotics|narcotics|mesh-ancestor
101860469|NCT03982784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101860470|NCT03982784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860471|NCT03982784|Analgesics|analgesics|mesh-ancestor
101860472|NCT03982784|Sensory System Agents|sensory system agents|mesh-ancestor
101860473|NCT03982784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101860474|NCT03978884|Losartan|losartan|mesh-list
101860475|NCT03978884|Amlodipine|amlodipine|mesh-list
101860476|NCT03978884|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101860477|NCT03978884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101860478|NCT03978884|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101860479|NCT03978884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101860480|NCT03978884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860481|NCT03978884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101860482|NCT03978884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860483|NCT03978884|Vasodilator Agents|vasodilator agents|mesh-ancestor
101860484|NCT03978884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101241309|NCT01627626|Pilocarpine|pilocarpine|mesh-list
101860485|NCT03978884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101860486|NCT03978884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101860487|NCT03978884|Diuretics|diuretics|mesh-ancestor
101860488|NCT03978884|Natriuretic Agents|natriuretic agents|mesh-ancestor
101860489|NCT03978884|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101860490|NCT00319982|Diltiazem|diltiazem|mesh-list
101860491|NCT00319982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101860492|NCT00319982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101860493|NCT00319982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101860494|NCT00319982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860495|NCT00319982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101860496|NCT00319982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860497|NCT00319982|Vasodilator Agents|vasodilator agents|mesh-ancestor
101860498|NCT00319592|Vaccines|vaccines|mesh-list
101860499|NCT00319592|Immunologic Factors|immunologic factors|mesh-ancestor
101860500|NCT00319592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860501|NCT03980990|Metformin|metformin|mesh-list
101860502|NCT03980990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101860503|NCT03980990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860504|NCT03980756|Esomeprazole|esomeprazole|mesh-list
101860505|NCT03980756|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101860506|NCT03980756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101860507|NCT03980756|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101860508|NCT03980756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101687680|NCT04183296|Sevoflurane|sevoflurane|mesh-list
101860509|NCT03980756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860511|NCT03978494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101860512|NCT03978494|Immunologic Factors|immunologic factors|mesh-ancestor
101860513|NCT03978494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860514|NCT03978494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101860515|NCT03978494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101860516|NCT03978494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860517|NCT01064570|Tretinoin|tretinoin|mesh-list
101860518|NCT01064570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101860519|NCT01064570|Keratolytic Agents|keratolytic agents|mesh-ancestor
101860520|NCT01064570|Dermatologic Agents|dermatologic agents|mesh-ancestor
101860521|NCT01581164|Vaccines|vaccines|mesh-list
101860522|NCT01581164|Immunologic Factors|immunologic factors|mesh-ancestor
101860523|NCT01581164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860524|NCT00319046|Miglustat|miglustat|mesh-list
101860525|NCT00319046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101860526|NCT00319046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860527|NCT00319046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101860528|NCT00319046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101860529|NCT00319046|Antiviral Agents|antiviral agents|mesh-ancestor
101860530|NCT00319046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101860531|NCT00319046|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101574894|NCT04219579|Antithrombin III|antithrombin iii|mesh-list
101860532|NCT00319046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101860533|NCT00319046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860534|NCT00303602|Olanzapine|olanzapine|mesh-list
101860535|NCT00303602|Antiemetics|antiemetics|mesh-ancestor
101860536|NCT00303602|Autonomic Agents|autonomic agents|mesh-ancestor
101860537|NCT00303602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101860538|NCT00303602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860539|NCT00303602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101860540|NCT00303602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101860541|NCT00303602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101860542|NCT00303602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101860543|NCT00303602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101860544|NCT00303602|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101860545|NCT00303602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101860546|NCT00303602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101860547|NCT00303602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860548|NCT00303602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101860549|NCT00303602|Serotonin Agents|serotonin agents|mesh-ancestor
101860550|NCT03979976|Ramipril|ramipril|mesh-list
101860551|NCT03979976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101860552|NCT03979976|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101860553|NCT03979976|Protease Inhibitors|protease inhibitors|mesh-ancestor
101860554|NCT03979976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860555|NCT03979976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101860556|NCT00299130|Methylprednisolone|methylprednisolone|mesh-list
101860557|NCT00299130|Rituximab|rituximab|mesh-list
101860558|NCT00299130|Methotrexate|methotrexate|mesh-list
101860559|NCT00299130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101860560|NCT00299130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101860561|NCT00299130|Immunologic Factors|immunologic factors|mesh-ancestor
101860562|NCT00299130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860563|NCT00299130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101860564|NCT00299130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101860565|NCT00299130|Abortifacient Agents|abortifacient agents|mesh-ancestor
101860566|NCT00299130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101860567|NCT00299130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101860568|NCT00299130|Antimetabolites|antimetabolites|mesh-ancestor
101860569|NCT00299130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860570|NCT00299130|Dermatologic Agents|dermatologic agents|mesh-ancestor
101860571|NCT00299130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101860572|NCT00299130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101860573|NCT00299130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101860574|NCT00299130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101860576|NCT00299130|Antiemetics|antiemetics|mesh-ancestor
101860577|NCT00299130|Autonomic Agents|autonomic agents|mesh-ancestor
101860578|NCT00299130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101860579|NCT00299130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101860581|NCT00299130|Hormones|hormones|mesh-ancestor
101860582|NCT00299130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101860583|NCT00299130|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101860584|NCT00299130|Protective Agents|protective agents|mesh-ancestor
101860585|NCT00288054|Docetaxel|docetaxel|mesh-list
101860586|NCT00288054|Cetuximab|cetuximab|mesh-list
101860587|NCT00288054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101860588|NCT00288054|Tubulin Modulators|tubulin modulators|mesh-ancestor
101860589|NCT00288054|Antimitotic Agents|antimitotic agents|mesh-ancestor
101860590|NCT00288054|Mitosis Modulators|mitosis modulators|mesh-ancestor
101860591|NCT00288054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860592|NCT00288054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101860593|NCT00287586|Testosterone|testosterone|mesh-list
101860594|NCT00287586|Androgens|androgens|mesh-ancestor
101860595|NCT00287586|Hormones|hormones|mesh-ancestor
101860596|NCT00287586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101860597|NCT00287586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860598|NCT01070160|Metformin|metformin|mesh-list
101860599|NCT01070160|Progesterone|progesterone|mesh-list
101860600|NCT01070160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101860601|NCT01070160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860602|NCT01070160|Progestins|progestins|mesh-ancestor
101860603|NCT01070160|Hormones|hormones|mesh-ancestor
101860604|NCT01070160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101860605|NCT03977298|Chlorhexidine|chlorhexidine|mesh-list
101860606|NCT03977298|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101860607|NCT03977298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101860608|NCT03977298|Disinfectants|disinfectants|mesh-ancestor
101860609|NCT03977220|Paclitaxel|paclitaxel|mesh-list
101860610|NCT03977220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101860611|NCT03977220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101860612|NCT03977220|Tubulin Modulators|tubulin modulators|mesh-ancestor
101860613|NCT03977220|Antimitotic Agents|antimitotic agents|mesh-ancestor
101860614|NCT03977220|Mitosis Modulators|mitosis modulators|mesh-ancestor
101860615|NCT03977220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860616|NCT00293202|Etanercept|etanercept|mesh-list
101860617|NCT00293202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101860618|NCT00293202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101860619|NCT00293202|Analgesics|analgesics|mesh-ancestor
101860620|NCT00293202|Sensory System Agents|sensory system agents|mesh-ancestor
101860621|NCT00293202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101860622|NCT00293202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860623|NCT00293202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101860624|NCT00293202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101860625|NCT00293202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101860626|NCT00293202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101860627|NCT00293202|Immunologic Factors|immunologic factors|mesh-ancestor
101860628|NCT00286494|Pioglitazone|pioglitazone|mesh-list
101860629|NCT00286494|Alogliptin|alogliptin|mesh-list
101860630|NCT00286494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101860631|NCT00286494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860632|NCT00286494|Incretins|incretins|mesh-ancestor
101860633|NCT00286494|Hormones|hormones|mesh-ancestor
101860634|NCT00286494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101860635|NCT00286494|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101860636|NCT00286494|Protease Inhibitors|protease inhibitors|mesh-ancestor
101860637|NCT00286494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101860638|NCT00286494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860639|NCT00298740|Insulin|insulin|mesh-list
101860640|NCT00298740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101860641|NCT00298740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860642|NCT01067898|Vitamin D|vitamin d|mesh-list
101860643|NCT01067898|Ergocalciferols|ergocalciferols|mesh-list
101860644|NCT01067898|Cholecalciferol|cholecalciferol|mesh-list
101860645|NCT01067898|Vitamins|vitamins|mesh-list
101965611|NCT00064337|Hormones|hormones|mesh-ancestor
101860646|NCT01067898|Calcium Carbonate|calcium carbonate|mesh-list
101860647|NCT01067898|Micronutrients|micronutrients|mesh-ancestor
101860648|NCT01067898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860649|NCT01067898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101860650|NCT01067898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101860651|NCT01067898|Antacids|antacids|mesh-ancestor
101860652|NCT01067898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860653|NCT01067898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101860654|NCT03979248|Deucravacitinib|deucravacitinib|mesh-list
101860656|NCT03979248|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101860657|NCT03979248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101860658|NCT03979248|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101860659|NCT03979248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101860660|NCT03979248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860661|NCT03979248|Dermatologic Agents|dermatologic agents|mesh-ancestor
101860662|NCT03979248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101860663|NCT00285012|Varenicline|varenicline|mesh-list
101860664|NCT00285012|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101860665|NCT00285012|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101860666|NCT00285012|Cholinergic Agents|cholinergic agents|mesh-ancestor
101860667|NCT00285012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101860668|NCT00285012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860669|NCT00285012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860670|NCT00284934|Mycophenolic Acid|mycophenolic acid|mesh-list
101860671|NCT00284934|Prednisone|prednisone|mesh-list
101860672|NCT00284934|Tacrolimus|tacrolimus|mesh-list
101860673|NCT00284934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101860674|NCT00284934|Glucocorticoids|glucocorticoids|mesh-ancestor
101860675|NCT00284934|Hormones|hormones|mesh-ancestor
101860676|NCT00284934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101860677|NCT00284934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860678|NCT00284934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101860679|NCT00284934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101860680|NCT00284934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101860681|NCT00284934|Immunologic Factors|immunologic factors|mesh-ancestor
101860682|NCT00284934|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101860683|NCT00284934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101860684|NCT00284934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860685|NCT00284934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101860686|NCT00284934|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101860687|NCT00284934|Antitubercular Agents|antitubercular agents|mesh-ancestor
101860688|NCT00284934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101860689|NCT00284934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101860690|NCT00284856|Fluticasone|fluticasone|mesh-list
101860691|NCT00284856|Montelukast|montelukast|mesh-list
101860692|NCT00284856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101860693|NCT00284856|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101860694|NCT00284856|Autonomic Agents|autonomic agents|mesh-ancestor
101860695|NCT00284856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101860696|NCT00284856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860697|NCT00284856|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101860698|NCT00284856|Respiratory System Agents|respiratory system agents|mesh-ancestor
101860699|NCT00284856|Dermatologic Agents|dermatologic agents|mesh-ancestor
101860700|NCT00284856|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101860701|NCT00284856|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101860702|NCT00284856|Hormone Antagonists|hormone antagonists|mesh-ancestor
101860703|NCT00284856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101860704|NCT00284856|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101860705|NCT00284856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101241385|NCT01627938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101860706|NCT00284856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860707|NCT00298272|Methylprednisolone|methylprednisolone|mesh-list
101860708|NCT00298272|Adalimumab|adalimumab|mesh-list
101860709|NCT00298272|Etanercept|etanercept|mesh-list
101860710|NCT00298272|Rituximab|rituximab|mesh-list
101860711|NCT00298272|Methotrexate|methotrexate|mesh-list
101860712|NCT00298272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101860713|NCT00298272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101860714|NCT00298272|Immunologic Factors|immunologic factors|mesh-ancestor
101860715|NCT00298272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860716|NCT00298272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101860717|NCT00298272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101860718|NCT00298272|Abortifacient Agents|abortifacient agents|mesh-ancestor
101860719|NCT00298272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101860720|NCT00298272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101860721|NCT00298272|Antimetabolites|antimetabolites|mesh-ancestor
101860722|NCT00298272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860723|NCT00298272|Dermatologic Agents|dermatologic agents|mesh-ancestor
101860724|NCT00298272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101860725|NCT00298272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101860726|NCT00298272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101860727|NCT00298272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101860728|NCT00298272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101860730|NCT00298272|Autonomic Agents|autonomic agents|mesh-ancestor
101860731|NCT00298272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101860732|NCT00298272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101860733|NCT00298272|Glucocorticoids|glucocorticoids|mesh-ancestor
101860734|NCT00298272|Hormones|hormones|mesh-ancestor
101860735|NCT00298272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101860736|NCT00298272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101860737|NCT00298272|Protective Agents|protective agents|mesh-ancestor
101860738|NCT00298272|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101860739|NCT00298272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101860740|NCT00298272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101860741|NCT00298272|Analgesics|analgesics|mesh-ancestor
101860742|NCT00298272|Sensory System Agents|sensory system agents|mesh-ancestor
101860743|NCT01068054|Cyclosporine|cyclosporine|mesh-list
101860744|NCT01068054|Tacrolimus|tacrolimus|mesh-list
101860745|NCT01068054|Cyclosporins|cyclosporins|mesh-list
101860746|NCT01068054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101860747|NCT01068054|Immunologic Factors|immunologic factors|mesh-ancestor
101860748|NCT01068054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860749|NCT01068054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101860750|NCT01068054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101860751|NCT01068054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860752|NCT01068054|Antifungal Agents|antifungal agents|mesh-ancestor
101860753|NCT01068054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101860754|NCT01068054|Dermatologic Agents|dermatologic agents|mesh-ancestor
101860755|NCT01068054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101860756|NCT00298038|Rifaximin|rifaximin|mesh-list
101860757|NCT00298038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101860758|NCT00298038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101860759|NCT00298038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101860760|NCT00283686|Telmisartan|telmisartan|mesh-list
101860761|NCT00283686|Lisinopril|lisinopril|mesh-list
101860762|NCT00283686|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101860763|NCT00283686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101860764|NCT00283686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101860765|NCT00283686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101860766|NCT00283686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860767|NCT00283686|Protease Inhibitors|protease inhibitors|mesh-ancestor
101860768|NCT00283686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101860769|NCT00283686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101860770|NCT00283686|Protective Agents|protective agents|mesh-ancestor
101860771|NCT00283686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860772|NCT00297882|Artesunate|artesunate|mesh-list
101860773|NCT00297882|Lumefantrine|lumefantrine|mesh-list
101860774|NCT00297882|Artemether|artemether|mesh-list
101860775|NCT00297882|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101860776|NCT00297882|Amodiaquine|amodiaquine|mesh-list
101860777|NCT00297882|Antimalarials|antimalarials|mesh-ancestor
101860778|NCT00297882|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101860779|NCT00297882|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101860780|NCT00297882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101860781|NCT00297882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101860782|NCT00297882|Antiviral Agents|antiviral agents|mesh-ancestor
101860783|NCT00297882|Schistosomicides|schistosomicides|mesh-ancestor
101860784|NCT00297882|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101860785|NCT00297882|Anthelmintics|anthelmintics|mesh-ancestor
101860786|NCT01065870|Gemcitabine|gemcitabine|mesh-list
101860787|NCT01065870|Capecitabine|capecitabine|mesh-list
101860788|NCT01065870|Docetaxel|docetaxel|mesh-list
101860789|NCT01065870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101860790|NCT01065870|Antimetabolites|antimetabolites|mesh-ancestor
101860791|NCT01065870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860792|NCT01065870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101860793|NCT01065870|Tubulin Modulators|tubulin modulators|mesh-ancestor
101860795|NCT01065870|Mitosis Modulators|mitosis modulators|mesh-ancestor
101860796|NCT00297648|Certolizumab Pegol|certolizumab pegol|mesh-list
101860797|NCT00297648|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101860798|NCT00297648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101860799|NCT00297648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101860800|NCT00297648|Immunologic Factors|immunologic factors|mesh-ancestor
101860801|NCT00297648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860802|NCT00297648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101860804|NCT01068132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101860805|NCT01068132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101860806|NCT00297492|Nicotine|nicotine|mesh-list
101860807|NCT00297492|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101860808|NCT00297492|Autonomic Agents|autonomic agents|mesh-ancestor
101860809|NCT00297492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101860810|NCT00297492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860811|NCT00297492|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101860812|NCT00297492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101860813|NCT00297492|Cholinergic Agents|cholinergic agents|mesh-ancestor
101860814|NCT00297492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101860815|NCT00297492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860816|NCT00496769|Aspirin|aspirin|mesh-list
101860817|NCT00496769|Apixaban|apixaban|mesh-list
101860818|NCT00496769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101860819|NCT00496769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101860820|NCT00496769|Analgesics|analgesics|mesh-ancestor
101860821|NCT00496769|Sensory System Agents|sensory system agents|mesh-ancestor
101860822|NCT00496769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101860823|NCT00496769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860824|NCT00496769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101860825|NCT00496769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101860826|NCT00496769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101860827|NCT00496769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101860828|NCT00496769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860829|NCT00496769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101860830|NCT00496769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101860831|NCT00496769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101860832|NCT00496769|Antipyretics|antipyretics|mesh-ancestor
101860833|NCT00496769|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101860834|NCT00496769|Antithrombins|antithrombins|mesh-ancestor
101860835|NCT00496769|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101860836|NCT00496769|Protease Inhibitors|protease inhibitors|mesh-ancestor
101860837|NCT00496769|Anticoagulants|anticoagulants|mesh-ancestor
101860838|NCT01014845|Vaccines|vaccines|mesh-list
101860839|NCT01014845|Immunologic Factors|immunologic factors|mesh-ancestor
101860840|NCT01014845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860841|NCT00488345|Tigecycline|tigecycline|mesh-list
101860842|NCT00488345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101860843|NCT00488345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101860844|NCT00488345|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101860845|NCT00488345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101860846|NCT00488345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860847|NCT00283062|Docetaxel|docetaxel|mesh-list
101860848|NCT00283062|Leuprolide|leuprolide|mesh-list
101860849|NCT00283062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101860850|NCT00283062|Tubulin Modulators|tubulin modulators|mesh-ancestor
101860851|NCT00283062|Antimitotic Agents|antimitotic agents|mesh-ancestor
101860852|NCT00283062|Mitosis Modulators|mitosis modulators|mesh-ancestor
101860853|NCT00283062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860854|NCT00283062|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101860855|NCT00283062|Fertility Agents|fertility agents|mesh-ancestor
101860856|NCT00283062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101860857|NCT00283062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860858|NCT00283062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101860859|NCT00282984|Varenicline|varenicline|mesh-list
101860860|NCT00282984|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101860861|NCT00282984|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101860862|NCT00282984|Cholinergic Agents|cholinergic agents|mesh-ancestor
101860863|NCT00282984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101860864|NCT00282984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860865|NCT00282984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860866|NCT00296400|Atorvastatin|atorvastatin|mesh-list
101860867|NCT00296400|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101860868|NCT00296400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101860869|NCT00296400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101860870|NCT00296400|Antimetabolites|antimetabolites|mesh-ancestor
101860871|NCT00296400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860872|NCT00296400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101860873|NCT00296400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101860874|NCT00296400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101860875|NCT00296244|Mycophenolic Acid|mycophenolic acid|mesh-list
101860876|NCT00296244|Prednisone|prednisone|mesh-list
101860877|NCT00296244|Methylprednisolone|methylprednisolone|mesh-list
101860878|NCT00296244|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101860879|NCT00296244|Tacrolimus|tacrolimus|mesh-list
101860880|NCT00296244|Basiliximab|basiliximab|mesh-list
101860881|NCT00296244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101860882|NCT00296244|Glucocorticoids|glucocorticoids|mesh-ancestor
101860883|NCT00296244|Hormones|hormones|mesh-ancestor
101860884|NCT00296244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101860885|NCT00296244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860886|NCT00296244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101860887|NCT00296244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101860888|NCT00296244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101860889|NCT00296244|Immunologic Factors|immunologic factors|mesh-ancestor
101860890|NCT00296244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101860891|NCT00296244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101860892|NCT00296244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860893|NCT00296244|Antiemetics|antiemetics|mesh-ancestor
101860894|NCT00296244|Autonomic Agents|autonomic agents|mesh-ancestor
101860895|NCT00296244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101860896|NCT00296244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101860897|NCT00296244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101860898|NCT00296244|Protective Agents|protective agents|mesh-ancestor
101860899|NCT00296244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101860900|NCT00296244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101860901|NCT00296244|Antitubercular Agents|antitubercular agents|mesh-ancestor
101860902|NCT00296244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101860903|NCT00296244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101860904|NCT01068444|Pioglitazone|pioglitazone|mesh-list
101860905|NCT01068444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101860906|NCT01068444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860907|NCT00282048|Axitinib|axitinib|mesh-list
101860908|NCT00282048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101860909|NCT00282048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101860910|NCT00282048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101860911|NCT00282048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860913|NCT00474539|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101860914|NCT00474539|Immunologic Factors|immunologic factors|mesh-ancestor
101860915|NCT00474539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860916|NCT01017809|Aprepitant|aprepitant|mesh-list
101860917|NCT01017809|Antiemetics|antiemetics|mesh-ancestor
101860918|NCT01017809|Autonomic Agents|autonomic agents|mesh-ancestor
101860919|NCT01017809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101860920|NCT01017809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860921|NCT01017809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101860922|NCT01017809|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101860923|NCT01017809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101860924|NCT01017809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860925|NCT01020539|Fludarabine|fludarabine|mesh-list
101860926|NCT01020539|Busulfan|busulfan|mesh-list
101860927|NCT01020539|Gemtuzumab|gemtuzumab|mesh-list
101860928|NCT01020539|Isotretinoin|isotretinoin|mesh-list
101860929|NCT01020539|Thymoglobulin|thymoglobulin|mesh-list
101860930|NCT01020539|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101860931|NCT01020539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101860932|NCT01020539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860933|NCT01020539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101860934|NCT01020539|Immunologic Factors|immunologic factors|mesh-ancestor
101860935|NCT01020539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860936|NCT01020539|Alkylating Agents|alkylating agents|mesh-ancestor
101860937|NCT01020539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101860938|NCT01020539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101860939|NCT01020539|Dermatologic Agents|dermatologic agents|mesh-ancestor
101860940|NCT01020539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101860941|NCT01020539|Immunotoxins|immunotoxins|mesh-ancestor
101860942|NCT01020539|Immunoconjugates|immunoconjugates|mesh-ancestor
101860943|NCT00281580|Amlodipine|amlodipine|mesh-list
101860944|NCT00281580|Telmisartan|telmisartan|mesh-list
101860945|NCT00281580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101860946|NCT00281580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101860947|NCT00281580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101860948|NCT00281580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860949|NCT00281580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101860950|NCT00281580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860951|NCT00281580|Vasodilator Agents|vasodilator agents|mesh-ancestor
101860952|NCT00281580|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101860953|NCT00281580|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101860955|NCT00495755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101860956|NCT00495755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101860957|NCT01070862|Thalidomide|thalidomide|mesh-list
101860958|NCT01070862|Dexamethasone|dexamethasone|mesh-list
101860959|NCT01070862|Dexamethasone acetate|dexamethasone acetate|mesh-list
101860960|NCT01070862|Doxorubicin|doxorubicin|mesh-list
101860961|NCT01070862|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101860962|NCT01070862|Melphalan|melphalan|mesh-list
101860963|NCT01070862|Cyclophosphamide|cyclophosphamide|mesh-list
101860964|NCT01070862|Vincristine|vincristine|mesh-list
101860965|NCT01070862|BB 1101|bb 1101|mesh-list
101860966|NCT01070862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101860967|NCT01070862|Antiemetics|antiemetics|mesh-ancestor
101860968|NCT01070862|Autonomic Agents|autonomic agents|mesh-ancestor
101860969|NCT01070862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101860970|NCT01070862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101860971|NCT01070862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101860972|NCT01070862|Glucocorticoids|glucocorticoids|mesh-ancestor
101860973|NCT01070862|Hormones|hormones|mesh-ancestor
101860974|NCT01070862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101860975|NCT01070862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101860976|NCT01070862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101860977|NCT01070862|Protease Inhibitors|protease inhibitors|mesh-ancestor
101860978|NCT01070862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101860979|NCT01070862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101860980|NCT01070862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101860981|NCT01070862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101860982|NCT01070862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101860983|NCT01070862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101860984|NCT01070862|Alkylating Agents|alkylating agents|mesh-ancestor
101860985|NCT01070862|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101860986|NCT01070862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101860987|NCT01070862|Immunologic Factors|immunologic factors|mesh-ancestor
101860988|NCT01070862|Leprostatic Agents|leprostatic agents|mesh-ancestor
101860989|NCT01070862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101860990|NCT01070862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101860991|NCT01070862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101860992|NCT01070862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101860993|NCT01070862|Growth Substances|growth substances|mesh-ancestor
101860994|NCT01070862|Growth Inhibitors|growth inhibitors|mesh-ancestor
101860995|NCT01070862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101860996|NCT01070862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101860997|NCT01070862|Tubulin Modulators|tubulin modulators|mesh-ancestor
101860998|NCT01070862|Antimitotic Agents|antimitotic agents|mesh-ancestor
101860999|NCT01070862|Mitosis Modulators|mitosis modulators|mesh-ancestor
101861001|NCT00495677|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101861002|NCT00495677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861003|NCT00495677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101861004|NCT00495677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101861005|NCT00495677|Antiviral Agents|antiviral agents|mesh-ancestor
101861006|NCT00495677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101861007|NCT00495521|Aminosalicylic Acid|aminosalicylic acid|mesh-list
101861008|NCT00495521|Antitubercular Agents|antitubercular agents|mesh-ancestor
101861009|NCT00495521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101861010|NCT00495521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101861011|NCT00494507|Dichlorphenamide|dichlorphenamide|mesh-list
101861012|NCT00494507|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101861013|NCT00494507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101861014|NCT00494507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861016|NCT00292188|Analgesics|analgesics|mesh-ancestor
101861017|NCT00292188|Sensory System Agents|sensory system agents|mesh-ancestor
101861018|NCT00292188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101861019|NCT00292188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861020|NCT00292188|Anticonvulsants|anticonvulsants|mesh-ancestor
101861021|NCT00292188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101861022|NCT00292188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101861023|NCT00292188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861024|NCT00292188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101861025|NCT00292188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101861026|NCT00292188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101861027|NCT00292188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101861028|NCT00292188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101861029|NCT00271596|Citalopram|citalopram|mesh-list
101861030|NCT00271596|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101861031|NCT00271596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101861032|NCT00271596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101861033|NCT00271596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861034|NCT00271596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101861035|NCT00271596|Serotonin Agents|serotonin agents|mesh-ancestor
101861036|NCT00271596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861037|NCT00271596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101861038|NCT00271596|Antidepressive Agents|antidepressive agents|mesh-ancestor
101861039|NCT00271596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101861040|NCT01068756|Dapagliflozin|dapagliflozin|mesh-list
101861041|NCT01068756|Rifampin|rifampin|mesh-list
101861042|NCT01068756|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101861043|NCT01068756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861044|NCT01068756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101861045|NCT01068756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861046|NCT01068756|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101861047|NCT01068756|Antitubercular Agents|antitubercular agents|mesh-ancestor
101861048|NCT01068756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101861049|NCT01068756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101861050|NCT01068756|Leprostatic Agents|leprostatic agents|mesh-ancestor
101861051|NCT01068756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101861052|NCT01068756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101861053|NCT01068756|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101861054|NCT01068756|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101861055|NCT01068756|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101861056|NCT01068756|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101861057|NCT01068756|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101861058|NCT01068756|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101861060|NCT00291642|Levocetirizine|levocetirizine|mesh-list
101861061|NCT00291642|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101861062|NCT00291642|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101861063|NCT00291642|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101861064|NCT00291642|Histamine Antagonists|histamine antagonists|mesh-ancestor
101861065|NCT00291642|Histamine Agents|histamine agents|mesh-ancestor
101861066|NCT00291642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101861067|NCT00291642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861068|NCT00291642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861069|NCT01070472|Misoprostol|misoprostol|mesh-list
101861070|NCT01070472|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101861071|NCT01070472|Abortifacient Agents|abortifacient agents|mesh-ancestor
101861072|NCT01070472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101861073|NCT01070472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861074|NCT01070472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101861075|NCT01070472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101861076|NCT01070472|Oxytocics|oxytocics|mesh-ancestor
101861077|NCT00280566|Ziprasidone|ziprasidone|mesh-list
101861078|NCT00280566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101861079|NCT00280566|Serotonin Agents|serotonin agents|mesh-ancestor
101861080|NCT00280566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101861081|NCT00280566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861082|NCT00280566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861083|NCT00280566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101861084|NCT00280566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101861085|NCT00280566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101861086|NCT00280566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101861087|NCT00280566|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101861088|NCT00280566|Dopamine Agents|dopamine agents|mesh-ancestor
101861089|NCT00270894|Cyclophosphamide|cyclophosphamide|mesh-list
101861091|NCT00270894|Trastuzumab|trastuzumab|mesh-list
101861092|NCT00270894|Epirubicin|epirubicin|mesh-list
101861093|NCT00270894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101861094|NCT00270894|Immunologic Factors|immunologic factors|mesh-ancestor
101861095|NCT00270894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861096|NCT00270894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101861097|NCT00270894|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101861098|NCT00270894|Alkylating Agents|alkylating agents|mesh-ancestor
101861099|NCT00270894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861100|NCT00270894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101861101|NCT00270894|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101861102|NCT00270894|Tubulin Modulators|tubulin modulators|mesh-ancestor
101861103|NCT00270894|Antimitotic Agents|antimitotic agents|mesh-ancestor
101861104|NCT00270894|Mitosis Modulators|mitosis modulators|mesh-ancestor
101861105|NCT00270894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101861106|NCT00270894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101861107|NCT00270894|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101861108|NCT00270894|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101861109|NCT00270894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101861110|NCT01070628|Levodopa|levodopa|mesh-list
101861111|NCT01070628|Carbidopa|carbidopa|mesh-list
101861112|NCT01070628|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101861113|NCT01070628|Entacapone|entacapone|mesh-list
101861114|NCT01070628|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101861115|NCT01070628|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101861116|NCT01070628|Dopamine Agents|dopamine agents|mesh-ancestor
101861117|NCT01070628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101861118|NCT01070628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861119|NCT01070628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861120|NCT01070628|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101861121|NCT01070628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101861122|NCT01070628|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101861123|NCT01070628|Immunologic Factors|immunologic factors|mesh-ancestor
101861124|NCT01070628|Dopamine Agonists|dopamine agonists|mesh-ancestor
101861125|NCT01070628|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101861126|NCT01070940|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
101861127|NCT01070940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101861128|NCT01070940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861129|NCT00317642|Cytarabine|cytarabine|mesh-list
101861130|NCT00317642|Clofarabine|clofarabine|mesh-list
101241575|NCT01629511|Busulfan|busulfan|mesh-list
101861131|NCT00317642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101861132|NCT00317642|Antimetabolites|antimetabolites|mesh-ancestor
101861133|NCT00317642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861134|NCT00317642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101861135|NCT00317642|Antiviral Agents|antiviral agents|mesh-ancestor
101861136|NCT00317642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101861137|NCT00317642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101861138|NCT00317642|Immunologic Factors|immunologic factors|mesh-ancestor
101861139|NCT00317642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861140|NCT01064726|Fluticasone|fluticasone|mesh-list
101861141|NCT01064726|Xhance|xhance|mesh-list
101861142|NCT01064726|Ibuprofen|ibuprofen|mesh-list
101861143|NCT01064726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101861144|NCT01064726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101861145|NCT01064726|Analgesics|analgesics|mesh-ancestor
101861146|NCT01064726|Sensory System Agents|sensory system agents|mesh-ancestor
101861147|NCT01064726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101861148|NCT01064726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861149|NCT01064726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101861150|NCT01064726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101861151|NCT01064726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101861152|NCT01064726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101861153|NCT01064726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861154|NCT01064726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101861155|NCT01064726|Autonomic Agents|autonomic agents|mesh-ancestor
101861156|NCT01064726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101861157|NCT01064726|Respiratory System Agents|respiratory system agents|mesh-ancestor
101861158|NCT01064726|Dermatologic Agents|dermatologic agents|mesh-ancestor
101861159|NCT01064726|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101861160|NCT00295022|Montelukast|montelukast|mesh-list
101861161|NCT00295022|Levocetirizine|levocetirizine|mesh-list
101861162|NCT00295022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101861163|NCT00295022|Respiratory System Agents|respiratory system agents|mesh-ancestor
101861164|NCT00295022|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101861165|NCT00295022|Hormone Antagonists|hormone antagonists|mesh-ancestor
101861166|NCT00295022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101861167|NCT00295022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861168|NCT00295022|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101861169|NCT00295022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101861170|NCT00295022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861171|NCT00295022|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101861172|NCT00295022|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101861173|NCT00295022|Histamine Antagonists|histamine antagonists|mesh-ancestor
101861175|NCT00295022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101861176|NCT01062152|Lenalidomide|lenalidomide|mesh-list
101861177|NCT01062152|Immunologic Factors|immunologic factors|mesh-ancestor
101861178|NCT01062152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861179|NCT01062152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101861180|NCT01062152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101861181|NCT01062152|Growth Substances|growth substances|mesh-ancestor
101861182|NCT01062152|Growth Inhibitors|growth inhibitors|mesh-ancestor
101861183|NCT01062152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101861184|NCT00303446|Dutasteride|dutasteride|mesh-list
101861185|NCT00303446|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101861186|NCT00303446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101861187|NCT00303446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101861188|NCT00303446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861189|NCT00303446|Hormone Antagonists|hormone antagonists|mesh-ancestor
101861190|NCT00303446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101861191|NCT00303446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861192|NCT01065038|Hydroxyurea|hydroxyurea|mesh-list
101861193|NCT01065038|Anagrelide|anagrelide|mesh-list
101861194|NCT01065038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101861195|NCT01065038|Antisickling Agents|antisickling agents|mesh-ancestor
101861196|NCT01065038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101861197|NCT01065038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861198|NCT01065038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101861199|NCT01065038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101861200|NCT01065038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101861201|NCT01065038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101861202|NCT00291486|Capecitabine|capecitabine|mesh-list
101861203|NCT00291486|Antibodies|antibodies|mesh-list
101861204|NCT00291486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101861205|NCT00291486|Immunologic Factors|immunologic factors|mesh-ancestor
101581050|NCT01145508|Hormones|hormones|mesh-ancestor
101861206|NCT00291486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861207|NCT00291486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101861208|NCT00291486|Antimetabolites|antimetabolites|mesh-ancestor
101861209|NCT00291486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861210|NCT00291486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101861211|NCT00301964|Bevacizumab|bevacizumab|mesh-list
101861212|NCT00301964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101861213|NCT00301964|Antibodies|antibodies|mesh-list
101861214|NCT00301964|Immunoglobulins|immunoglobulins|mesh-list
101861215|NCT00301964|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101861216|NCT00301964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101861217|NCT00301964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101861218|NCT00301964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101861219|NCT00301964|Growth Substances|growth substances|mesh-ancestor
101861220|NCT00301964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861221|NCT00301964|Growth Inhibitors|growth inhibitors|mesh-ancestor
101861222|NCT00301964|Immunologic Factors|immunologic factors|mesh-ancestor
101861223|NCT01070706|Paclitaxel|paclitaxel|mesh-list
101861224|NCT01070706|Gemcitabine|gemcitabine|mesh-list
101861225|NCT01070706|Sunitinib|sunitinib|mesh-list
101861226|NCT01070706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101861227|NCT01070706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101861228|NCT01070706|Tubulin Modulators|tubulin modulators|mesh-ancestor
101861229|NCT01070706|Antimitotic Agents|antimitotic agents|mesh-ancestor
101861230|NCT01070706|Mitosis Modulators|mitosis modulators|mesh-ancestor
101861231|NCT01070706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861232|NCT01070706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101861233|NCT01070706|Antimetabolites|antimetabolites|mesh-ancestor
101861234|NCT01070706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101861235|NCT01070706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101861236|NCT01070706|Growth Substances|growth substances|mesh-ancestor
101861237|NCT01070706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861238|NCT01070706|Growth Inhibitors|growth inhibitors|mesh-ancestor
101861239|NCT01070706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101861240|NCT01070706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101861241|NCT00268242|Gemcitabine|gemcitabine|mesh-list
101861242|NCT00268242|Mitoxantrone|mitoxantrone|mesh-list
101861243|NCT00268242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101861244|NCT00268242|Antimetabolites|antimetabolites|mesh-ancestor
101861245|NCT00268242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861246|NCT00268242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101861247|NCT00268242|Analgesics|analgesics|mesh-ancestor
101861248|NCT00268242|Sensory System Agents|sensory system agents|mesh-ancestor
101861249|NCT00268242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101861250|NCT00268242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861251|NCT00268242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101861252|NCT00268242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101861253|NCT00268242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101861254|NCT00294554|Memantine|memantine|mesh-list
101861255|NCT00294554|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101861256|NCT00294554|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101861257|NCT00294554|Dopamine Agents|dopamine agents|mesh-ancestor
101861258|NCT00294554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101861259|NCT00294554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861260|NCT00294554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861261|NCT00294554|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101861262|NCT00294554|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101861263|NCT00294398|Fluticasone|fluticasone|mesh-list
101861264|NCT00294398|Xhance|xhance|mesh-list
101861265|NCT00294398|Budesonide|budesonide|mesh-list
101861266|NCT00294398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101861267|NCT00294398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101861268|NCT00294398|Autonomic Agents|autonomic agents|mesh-ancestor
101861269|NCT00294398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101861270|NCT00294398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861271|NCT00294398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101861272|NCT00294398|Respiratory System Agents|respiratory system agents|mesh-ancestor
101861273|NCT00294398|Dermatologic Agents|dermatologic agents|mesh-ancestor
101861274|NCT00294398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101861275|NCT00294398|Glucocorticoids|glucocorticoids|mesh-ancestor
101861276|NCT00294398|Hormones|hormones|mesh-ancestor
101861277|NCT00294398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101861278|NCT00279708|Atorvastatin|atorvastatin|mesh-list
101861279|NCT00279708|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101861280|NCT00279708|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101861281|NCT00279708|Antimetabolites|antimetabolites|mesh-ancestor
101861282|NCT00279708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861283|NCT00279708|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101861284|NCT00279708|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101861286|NCT00299702|Aripiprazole|aripiprazole|mesh-list
101861287|NCT00299702|Risperidone|risperidone|mesh-list
101861288|NCT00299702|Antidepressive Agents|antidepressive agents|mesh-ancestor
101861289|NCT00299702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101861290|NCT00299702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101861291|NCT00299702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101861292|NCT00299702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101861293|NCT00299702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861294|NCT00299702|Dopamine Agonists|dopamine agonists|mesh-ancestor
101861295|NCT00299702|Dopamine Agents|dopamine agents|mesh-ancestor
101861296|NCT00299702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101861297|NCT00299702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101965639|NCT00044213|Vitamins|vitamins|mesh-list
101861298|NCT00299702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101861299|NCT00299702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101861300|NCT00299702|Serotonin Agents|serotonin agents|mesh-ancestor
101861301|NCT00299702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101861302|NCT00299702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101861303|NCT00299702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101861304|NCT00299702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101861305|NCT00291330|Warfarin|warfarin|mesh-list
101861306|NCT00291330|Dabigatran|dabigatran|mesh-list
101861307|NCT00291330|Anticoagulants|anticoagulants|mesh-ancestor
101861308|NCT00291330|Antithrombins|antithrombins|mesh-ancestor
101861309|NCT00291330|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101861310|NCT00291330|Protease Inhibitors|protease inhibitors|mesh-ancestor
101861311|NCT00291330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101861312|NCT00291330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861314|NCT03975036|Immunologic Factors|immunologic factors|mesh-ancestor
101861315|NCT03975036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861316|NCT00267150|Mycophenolic Acid|mycophenolic acid|mesh-list
101861317|NCT00267150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101861318|NCT00267150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101861319|NCT00267150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101861320|NCT00267150|Antitubercular Agents|antitubercular agents|mesh-ancestor
101861321|NCT00267150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101861322|NCT00267150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101861323|NCT00267150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101861324|NCT00267150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861325|NCT01582230|Vildagliptin|vildagliptin|mesh-list
101861326|NCT01582230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101861327|NCT01582230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861328|NCT01582230|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101861329|NCT01582230|Protease Inhibitors|protease inhibitors|mesh-ancestor
101861330|NCT01582230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101861331|NCT01582230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861332|NCT00278148|Paclitaxel|paclitaxel|mesh-list
101861333|NCT00278148|Carboplatin|carboplatin|mesh-list
101861334|NCT00278148|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101861335|NCT00278148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101861336|NCT00278148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101861337|NCT00278148|Tubulin Modulators|tubulin modulators|mesh-ancestor
101861338|NCT00278148|Antimitotic Agents|antimitotic agents|mesh-ancestor
101861339|NCT00278148|Mitosis Modulators|mitosis modulators|mesh-ancestor
101861340|NCT00278148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861341|NCT00278148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101861342|NCT00278148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101861343|NCT00299546|Golimumab|golimumab|mesh-list
101241639|NCT01630018|Topotecan|topotecan|mesh-list
101861344|NCT00299546|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101861345|NCT00299546|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101861346|NCT00299546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101861347|NCT00299546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101861348|NCT00299546|Immunologic Factors|immunologic factors|mesh-ancestor
101861349|NCT00299546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861350|NCT03975270|Paclitaxel|paclitaxel|mesh-list
101861351|NCT03975270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101861352|NCT03975270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101861353|NCT03975270|Tubulin Modulators|tubulin modulators|mesh-ancestor
101861354|NCT03975270|Antimitotic Agents|antimitotic agents|mesh-ancestor
101861355|NCT03975270|Mitosis Modulators|mitosis modulators|mesh-ancestor
101861356|NCT03975270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861357|NCT01065116|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101861358|NCT01065116|Antimalarials|antimalarials|mesh-ancestor
101861359|NCT01065116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101861360|NCT01065116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101861361|NCT01065116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101861362|NCT03977792|Docosanol|docosanol|mesh-list
101861363|NCT03977792|Antiviral Agents|antiviral agents|mesh-ancestor
101861364|NCT03977792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101861365|NCT01066598|Rituximab|rituximab|mesh-list
101861366|NCT01066598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101861367|NCT01066598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101861368|NCT01066598|Immunologic Factors|immunologic factors|mesh-ancestor
101861369|NCT01066598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861370|NCT01066598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101861371|NCT01066676|Ibuprofen|ibuprofen|mesh-list
101861372|NCT01066676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101861373|NCT01066676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101861374|NCT01066676|Analgesics|analgesics|mesh-ancestor
101861375|NCT01066676|Sensory System Agents|sensory system agents|mesh-ancestor
101861376|NCT01066676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101861377|NCT01066676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687714|NCT02678208|Coagulants|coagulants|mesh-ancestor
101861378|NCT01066676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101861379|NCT01066676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101861380|NCT01066676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101861381|NCT01066676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101861382|NCT01066676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861383|NCT01065194|Simendan|simendan|mesh-list
101861384|NCT01065194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101861385|NCT01065194|Vasodilator Agents|vasodilator agents|mesh-ancestor
101861386|NCT01065194|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101861387|NCT01065194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101861388|NCT01065194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101861389|NCT01065194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861390|NCT01065194|Protective Agents|protective agents|mesh-ancestor
101861391|NCT01065194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861392|NCT01065272|Dexamethasone|dexamethasone|mesh-list
101861393|NCT01065272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101861394|NCT01065272|Antiemetics|antiemetics|mesh-ancestor
101861395|NCT01065272|Autonomic Agents|autonomic agents|mesh-ancestor
101861396|NCT01065272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101861397|NCT01065272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861398|NCT01065272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101861399|NCT01065272|Glucocorticoids|glucocorticoids|mesh-ancestor
101861400|NCT01065272|Hormones|hormones|mesh-ancestor
101861401|NCT01065272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101861402|NCT01065272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101861403|NCT01065272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101861404|NCT00299156|Clofarabine|clofarabine|mesh-list
101861405|NCT00299156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101861406|NCT00299156|Antimetabolites|antimetabolites|mesh-ancestor
101861407|NCT00299156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861408|NCT00299156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101861409|NCT00277212|Lamotrigine|lamotrigine|mesh-list
101861410|NCT00277212|Anticonvulsants|anticonvulsants|mesh-list
101861411|NCT00277212|Aripiprazole|aripiprazole|mesh-list
101861412|NCT00277212|Antidepressive Agents|antidepressive agents|mesh-ancestor
101861413|NCT00277212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101861414|NCT00277212|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101861415|NCT00277212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101861416|NCT00277212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101861417|NCT00277212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861418|NCT00277212|Dopamine Agonists|dopamine agonists|mesh-ancestor
101861419|NCT00277212|Dopamine Agents|dopamine agents|mesh-ancestor
101861420|NCT00277212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101861421|NCT00277212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861422|NCT00277212|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101861423|NCT00277212|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101861424|NCT00277212|Serotonin Agents|serotonin agents|mesh-ancestor
101861425|NCT00277212|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101861426|NCT00277212|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101861427|NCT00277212|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101861428|NCT00277212|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101861429|NCT00277212|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101861430|NCT00277212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101861431|NCT00277212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101861432|NCT00277212|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101861433|NCT01066754|Fexofenadine|fexofenadine|mesh-list
101861434|NCT01066754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101861435|NCT01066754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101861436|NCT01066754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101861437|NCT01066754|Histamine Antagonists|histamine antagonists|mesh-ancestor
101861438|NCT01066754|Histamine Agents|histamine agents|mesh-ancestor
101861439|NCT01066754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101861440|NCT01066754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861441|NCT01066754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861442|NCT00276744|Sirolimus|sirolimus|mesh-list
101861443|NCT00276744|Gemcitabine|gemcitabine|mesh-list
101861444|NCT00276744|Capecitabine|capecitabine|mesh-list
101861445|NCT00276744|Docetaxel|docetaxel|mesh-list
101861446|NCT00276744|Irinotecan|irinotecan|mesh-list
101861447|NCT00276744|Cetuximab|cetuximab|mesh-list
101861448|NCT00276744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101861449|NCT00276744|Mitomycins|mitomycins|mesh-list
101861451|NCT00276744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101861452|NCT00276744|Antimetabolites|antimetabolites|mesh-ancestor
101861453|NCT00276744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861454|NCT00276744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101861455|NCT00276744|Tubulin Modulators|tubulin modulators|mesh-ancestor
101861456|NCT00276744|Antimitotic Agents|antimitotic agents|mesh-ancestor
101861457|NCT00276744|Mitosis Modulators|mitosis modulators|mesh-ancestor
101861458|NCT00276744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101861459|NCT00276744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101861460|NCT00276744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101861461|NCT00276744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101861462|NCT00276744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101861463|NCT00276744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101861464|NCT00276744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101861465|NCT00276744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101861466|NCT00276744|Antifungal Agents|antifungal agents|mesh-ancestor
101861467|NCT00276744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101861468|NCT00276744|Immunologic Factors|immunologic factors|mesh-ancestor
101861469|NCT00276744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861470|NCT00276744|Alkylating Agents|alkylating agents|mesh-ancestor
101861471|NCT00276744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101861472|NCT00251316|Lithium Carbonate|lithium carbonate|mesh-list
101861473|NCT00251316|Antidepressive Agents|antidepressive agents|mesh-ancestor
101861474|NCT00251316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101861475|NCT00251316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101861476|NCT00251316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861477|NCT00251316|Antimanic Agents|antimanic agents|mesh-ancestor
101861478|NCT00251316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101861479|NCT00251316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101861480|NCT00251316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861481|NCT02532192|Cytarabine|cytarabine|mesh-list
101861482|NCT02532192|Ciprofloxacin|ciprofloxacin|mesh-list
101861483|NCT02532192|Fluconazole|fluconazole|mesh-list
101861484|NCT02532192|Dexamethasone|dexamethasone|mesh-list
101861485|NCT02532192|Rituximab|rituximab|mesh-list
101861486|NCT02532192|Cisplatin|cisplatin|mesh-list
101861487|NCT02532192|Belinostat|belinostat|mesh-list
101861488|NCT02532192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101861489|NCT02532192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101861490|NCT02532192|Immunologic Factors|immunologic factors|mesh-ancestor
101861491|NCT02532192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861492|NCT02532192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101861493|NCT02532192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101861494|NCT02532192|Antiemetics|antiemetics|mesh-ancestor
101861495|NCT02532192|Autonomic Agents|autonomic agents|mesh-ancestor
101861496|NCT02532192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101861497|NCT02532192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101861498|NCT02532192|Glucocorticoids|glucocorticoids|mesh-ancestor
101861499|NCT02532192|Hormones|hormones|mesh-ancestor
101861500|NCT02532192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101861501|NCT02532192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101861502|NCT02532192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101861503|NCT02532192|Antimetabolites|antimetabolites|mesh-ancestor
101241706|NCT01630369|Insulin|insulin|mesh-list
101861504|NCT02532192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861505|NCT02532192|Antiviral Agents|antiviral agents|mesh-ancestor
101861506|NCT02532192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101861507|NCT02532192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101861508|NCT02532192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101861509|NCT02532192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101861510|NCT02532192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101861511|NCT02532192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101861512|NCT02532192|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101861513|NCT02532192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101861514|NCT02532192|Antifungal Agents|antifungal agents|mesh-ancestor
101861515|NCT02532192|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101861516|NCT02532192|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101861517|NCT02532192|Hormone Antagonists|hormone antagonists|mesh-ancestor
101861518|NCT02532192|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101861519|NCT02532192|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101861520|NCT02532192|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101861522|NCT00293462|Immunologic Factors|immunologic factors|mesh-ancestor
101861523|NCT00293462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861525|NCT00316082|Saxagliptin|saxagliptin|mesh-list
101861526|NCT00316082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101861527|NCT00316082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861528|NCT00316082|Incretins|incretins|mesh-ancestor
101861529|NCT00316082|Hormones|hormones|mesh-ancestor
101861530|NCT00316082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101861531|NCT00316082|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101861532|NCT00316082|Protease Inhibitors|protease inhibitors|mesh-ancestor
101861533|NCT00316082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101861534|NCT00316082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861535|NCT00316004|Dextrans|dextrans|mesh-list
101861536|NCT00316004|Anticoagulants|anticoagulants|mesh-ancestor
101861537|NCT00316004|Plasma Substitutes|plasma substitutes|mesh-ancestor
101861538|NCT00316004|Blood Substitutes|blood substitutes|mesh-ancestor
101861539|NCT01066832|Paclitaxel|paclitaxel|mesh-list
101861540|NCT01066832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101861541|NCT01066832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101861542|NCT01066832|Tubulin Modulators|tubulin modulators|mesh-ancestor
101861543|NCT01066832|Antimitotic Agents|antimitotic agents|mesh-ancestor
101861544|NCT01066832|Mitosis Modulators|mitosis modulators|mesh-ancestor
101861545|NCT01066832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861546|NCT00298766|Bortezomib|bortezomib|mesh-list
101861547|NCT00298766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101861548|NCT03979664|Dexamethasone|dexamethasone|mesh-list
101861549|NCT03979664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101861550|NCT03979664|Antiemetics|antiemetics|mesh-ancestor
101861551|NCT03979664|Autonomic Agents|autonomic agents|mesh-ancestor
101861552|NCT03979664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101861553|NCT03979664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861554|NCT03979664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101861555|NCT03979664|Glucocorticoids|glucocorticoids|mesh-ancestor
101861556|NCT03979664|Hormones|hormones|mesh-ancestor
101861557|NCT03979664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101861558|NCT03979664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101861559|NCT03979664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101861560|NCT01325558|Gemcitabine|gemcitabine|mesh-list
101861561|NCT01325558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101861562|NCT01325558|Antimetabolites|antimetabolites|mesh-ancestor
101861563|NCT01325558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861564|NCT01325558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101861565|NCT00315458|Buprenorphine|buprenorphine|mesh-list
101861566|NCT00315458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101861567|NCT00315458|Narcotics|narcotics|mesh-ancestor
101861568|NCT00315458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101861569|NCT00315458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861570|NCT00315458|Analgesics|analgesics|mesh-ancestor
101861571|NCT00315458|Sensory System Agents|sensory system agents|mesh-ancestor
101861572|NCT00315458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101861573|NCT00315458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101861574|NCT01065662|Sirolimus|sirolimus|mesh-list
101861575|NCT01065662|Temsirolimus|temsirolimus|mesh-list
101861576|NCT01065662|MTOR Inhibitors|mtor inhibitors|mesh-list
101861577|NCT01065662|Cediranib|cediranib|mesh-list
101861578|NCT01065662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101861579|NCT01065662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101861580|NCT01065662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861581|NCT01065662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101861582|NCT01065662|Immunologic Factors|immunologic factors|mesh-ancestor
101861583|NCT01065662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861584|NCT01065662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101861585|NCT01065662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101861586|NCT01065662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101861587|NCT01065662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101861588|NCT01065662|Antifungal Agents|antifungal agents|mesh-ancestor
101861590|NCT01581242|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101861591|NCT01581242|Clevudine|clevudine|mesh-list
101861592|NCT01581242|Antiviral Agents|antiviral agents|mesh-ancestor
101861593|NCT01581242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101861594|NCT01581242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101861595|NCT01581242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101861596|NCT01581242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101861597|NCT01581242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861598|NCT03982238|Metformin|metformin|mesh-list
101861599|NCT03982238|Dapagliflozin|dapagliflozin|mesh-list
101861600|NCT03982238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101861601|NCT03982238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861602|NCT03982238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101861603|NCT03982238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861604|NCT00293384|Dexamethasone|dexamethasone|mesh-list
101861605|NCT00293384|Dexamethasone acetate|dexamethasone acetate|mesh-list
101861606|NCT00293384|Cyclophosphamide|cyclophosphamide|mesh-list
101861607|NCT00293384|Aprepitant|aprepitant|mesh-list
101861608|NCT00293384|Granisetron|granisetron|mesh-list
101861609|NCT00293384|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101861610|NCT00293384|BB 1101|bb 1101|mesh-list
101861611|NCT00293384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101861612|NCT00293384|Immunologic Factors|immunologic factors|mesh-ancestor
101861613|NCT00293384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861614|NCT00293384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101861615|NCT00293384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101861616|NCT00293384|Alkylating Agents|alkylating agents|mesh-ancestor
101861617|NCT00293384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861618|NCT00293384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101861619|NCT00293384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101861620|NCT00293384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101861621|NCT00293384|Antiemetics|antiemetics|mesh-ancestor
101861622|NCT00293384|Autonomic Agents|autonomic agents|mesh-ancestor
101861623|NCT00293384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101861624|NCT00293384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101861625|NCT00293384|Glucocorticoids|glucocorticoids|mesh-ancestor
101861626|NCT00293384|Hormones|hormones|mesh-ancestor
101861627|NCT00293384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101861628|NCT00293384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101861629|NCT00293384|Protease Inhibitors|protease inhibitors|mesh-ancestor
101861630|NCT00293384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101861631|NCT00293384|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101861632|NCT00293384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101861633|NCT00293384|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101861634|NCT00293384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101861635|NCT00293384|Serotonin Agents|serotonin agents|mesh-ancestor
101861636|NCT00297830|Zoledronic Acid|zoledronic acid|mesh-list
101861637|NCT00297830|Alendronate|alendronate|mesh-list
101861638|NCT00297830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101861639|NCT00297830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861640|NCT00296816|Bevacizumab|bevacizumab|mesh-list
101861641|NCT00296816|Docetaxel|docetaxel|mesh-list
101861642|NCT00296816|Oxaliplatin|oxaliplatin|mesh-list
101861643|NCT00296816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101861644|NCT00296816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101861645|NCT00296816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101861646|NCT00296816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101861647|NCT00296816|Growth Substances|growth substances|mesh-ancestor
101861648|NCT00296816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861649|NCT00296816|Growth Inhibitors|growth inhibitors|mesh-ancestor
101861650|NCT00296816|Tubulin Modulators|tubulin modulators|mesh-ancestor
101861651|NCT00296816|Antimitotic Agents|antimitotic agents|mesh-ancestor
101861652|NCT00296816|Mitosis Modulators|mitosis modulators|mesh-ancestor
101861653|NCT00296816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861654|NCT01066988|Emollients|emollients|mesh-list
101861655|NCT01066988|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101861657|NCT01066988|Dermatologic Agents|dermatologic agents|mesh-ancestor
101861658|NCT00097786|Nateglinide|nateglinide|mesh-list
101861659|NCT00097786|Valsartan|valsartan|mesh-list
101861660|NCT00097786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101861661|NCT00097786|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101861662|NCT00097786|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101861663|NCT00097786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861664|NCT00097786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101861665|NCT00097786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861666|NCT01081756|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101861667|NCT01081756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101861668|NCT01081756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861669|NCT01081990|Cyclobenzaprine|cyclobenzaprine|mesh-list
101861670|NCT01081990|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101861671|NCT01081990|Antidepressive Agents|antidepressive agents|mesh-ancestor
101861672|NCT01081990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101861673|NCT01081990|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101861674|NCT01081990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861675|NCT01081990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101861676|NCT01081990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101861677|NCT01081990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101861678|NCT01081990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101861680|NCT01084486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101861681|NCT01084486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861682|NCT01082146|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
101861683|NCT01082146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101861684|NCT01082146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101861685|NCT01082146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101861686|NCT01082146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861687|NCT01082146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101861688|NCT01082146|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101861689|NCT01082146|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101861690|NCT01082146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101861691|NCT01082146|Adrenergic Agents|adrenergic agents|mesh-ancestor
101861692|NCT01082146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101861693|NCT01082146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861694|NCT01082146|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101861695|NCT01082146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101861696|NCT01082146|Serotonin Agents|serotonin agents|mesh-ancestor
101861697|NCT01082146|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101861698|NCT01082146|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101861699|NCT01082146|Dopamine Agents|dopamine agents|mesh-ancestor
101861700|NCT01084720|V0034CR|v0034cr|mesh-list
101861701|NCT01084720|Emollients|emollients|mesh-ancestor
101861702|NCT01084720|Dermatologic Agents|dermatologic agents|mesh-ancestor
101861703|NCT03963466|Tranexamic Acid|tranexamic acid|mesh-list
101861704|NCT03963466|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101861705|NCT03963466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101861706|NCT03963466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861707|NCT03963466|Hemostatics|hemostatics|mesh-ancestor
101861708|NCT03963466|Coagulants|coagulants|mesh-ancestor
101861709|NCT01084876|Paclitaxel|paclitaxel|mesh-list
101861710|NCT01084876|Trastuzumab|trastuzumab|mesh-list
101861711|NCT01084876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101861712|NCT01084876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101861713|NCT01084876|Tubulin Modulators|tubulin modulators|mesh-ancestor
101861714|NCT01084876|Antimitotic Agents|antimitotic agents|mesh-ancestor
101861715|NCT01084876|Mitosis Modulators|mitosis modulators|mesh-ancestor
101861716|NCT01084876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861717|NCT01084876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101861718|NCT00117676|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101861719|NCT00117676|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101861720|NCT00117676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101861721|NCT00117676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101861722|NCT00117676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101861723|NCT00117676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861724|NCT00117676|Antiviral Agents|antiviral agents|mesh-ancestor
101861725|NCT00117676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101861726|NCT00117676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101861727|NCT00117676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101861728|NCT00251004|Cyclosporine|cyclosporine|mesh-list
101861729|NCT00251004|Mycophenolic Acid|mycophenolic acid|mesh-list
101861730|NCT00251004|Everolimus|everolimus|mesh-list
101861731|NCT00251004|Cyclosporins|cyclosporins|mesh-list
101861732|NCT00251004|Basiliximab|basiliximab|mesh-list
101861733|NCT00251004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101861734|NCT00251004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861735|NCT00251004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101861736|NCT00251004|Immunologic Factors|immunologic factors|mesh-ancestor
101861737|NCT00251004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861738|NCT00251004|Antifungal Agents|antifungal agents|mesh-ancestor
101861739|NCT00251004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101861740|NCT00251004|Dermatologic Agents|dermatologic agents|mesh-ancestor
101861741|NCT00251004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101861742|NCT00251004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101861743|NCT00251004|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101861744|NCT00251004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101861745|NCT00251004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101861746|NCT00251004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101861747|NCT00251004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101861748|NCT00251004|Antitubercular Agents|antitubercular agents|mesh-ancestor
101861749|NCT00251004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101861750|NCT00275262|Leuprolide|leuprolide|mesh-list
101861751|NCT00275262|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101861752|NCT00275262|Fertility Agents|fertility agents|mesh-ancestor
101861753|NCT00275262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101861754|NCT00275262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861755|NCT00275262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101861756|NCT00275262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101861757|NCT00275028|Cediranib|cediranib|mesh-list
101861758|NCT00275028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101861759|NCT00275028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861760|NCT00275028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101861761|NCT00275028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101861762|NCT00471497|Imatinib Mesylate|imatinib mesylate|mesh-list
101861763|NCT00471497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101861764|NCT00471497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101861765|NCT00471497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101861766|NCT00471497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861767|NCT04357457|Almitrine|almitrine|mesh-list
101861768|NCT04357457|Respiratory System Agents|respiratory system agents|mesh-ancestor
101861769|NCT00493649|Cyclophosphamide|cyclophosphamide|mesh-list
101861770|NCT00493649|Docetaxel|docetaxel|mesh-list
101861771|NCT00493649|Trastuzumab|trastuzumab|mesh-list
101861772|NCT00493649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101861773|NCT00493649|Immunologic Factors|immunologic factors|mesh-ancestor
101861774|NCT00493649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861775|NCT00493649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101861776|NCT00493649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101861777|NCT00493649|Alkylating Agents|alkylating agents|mesh-ancestor
101861778|NCT00493649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861779|NCT00493649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101861780|NCT00493649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101861781|NCT00493649|Tubulin Modulators|tubulin modulators|mesh-ancestor
101861782|NCT00493649|Antimitotic Agents|antimitotic agents|mesh-ancestor
101861783|NCT00493649|Mitosis Modulators|mitosis modulators|mesh-ancestor
101861784|NCT00493649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101861785|NCT01021163|Acetylcysteine|acetylcysteine|mesh-list
101861786|NCT01021163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101861787|NCT01021163|Antiviral Agents|antiviral agents|mesh-ancestor
101861788|NCT01021163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101861789|NCT01021163|Expectorants|expectorants|mesh-ancestor
101861790|NCT01021163|Respiratory System Agents|respiratory system agents|mesh-ancestor
101861791|NCT01021163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101861792|NCT01021163|Antioxidants|antioxidants|mesh-ancestor
101861793|NCT01021163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861794|NCT01021163|Protective Agents|protective agents|mesh-ancestor
101861795|NCT01021163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861796|NCT01021163|Antidotes|antidotes|mesh-ancestor
101861797|NCT01022333|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
101861798|NCT01022333|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101861799|NCT01022333|Protective Agents|protective agents|mesh-ancestor
101861800|NCT01022333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861801|NCT01022333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101861802|NCT00117598|Sirolimus|sirolimus|mesh-list
101861803|NCT00117598|Temsirolimus|temsirolimus|mesh-list
101861804|NCT00117598|MTOR Inhibitors|mtor inhibitors|mesh-list
101861805|NCT00117598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101861806|NCT00117598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101861807|NCT00117598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861808|NCT00117598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101861809|NCT00117598|Immunologic Factors|immunologic factors|mesh-ancestor
101861810|NCT00117598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861811|NCT00117598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101861812|NCT00117598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101861813|NCT00117598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101861814|NCT00117598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101861815|NCT00117598|Antifungal Agents|antifungal agents|mesh-ancestor
101861818|NCT01082458|Anesthetics, Local|anesthetics, local|mesh-ancestor
101861819|NCT01082458|Anesthetics|anesthetics|mesh-ancestor
101861820|NCT01082458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101861821|NCT01082458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861822|NCT01082458|Sensory System Agents|sensory system agents|mesh-ancestor
101861823|NCT01082458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101861824|NCT01082458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101861825|NCT01082458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101861826|NCT01082458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101861827|NCT01082458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101861828|NCT01082458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861829|NCT01082458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101861830|NCT01082458|Narcotics|narcotics|mesh-ancestor
101861831|NCT01082458|Analgesics|analgesics|mesh-ancestor
101861832|NCT00469859|Cytarabine|cytarabine|mesh-list
101861833|NCT00469859|Idarubicin|idarubicin|mesh-list
101861834|NCT00469859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101861835|NCT00469859|Antimetabolites|antimetabolites|mesh-ancestor
101861836|NCT00469859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861837|NCT00469859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101861838|NCT00469859|Antiviral Agents|antiviral agents|mesh-ancestor
101861839|NCT00469859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101861840|NCT00469859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101861841|NCT00469859|Immunologic Factors|immunologic factors|mesh-ancestor
101861842|NCT00469859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861843|NCT00469859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101861844|NCT00469859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101861845|NCT00469859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101861846|NCT00469859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101861847|NCT01021475|Domperidone|domperidone|mesh-list
101861848|NCT01021475|Antiemetics|antiemetics|mesh-ancestor
101861849|NCT01021475|Autonomic Agents|autonomic agents|mesh-ancestor
101861850|NCT01021475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101861851|NCT01021475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861852|NCT01021475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101861853|NCT01021475|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101861854|NCT01021475|Dopamine Agents|dopamine agents|mesh-ancestor
101861855|NCT01021475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101241924|NCT01631526|Vitamin D|vitamin d|mesh-list
101861856|NCT01021475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861857|NCT01085032|Nicotine|nicotine|mesh-list
101861858|NCT01085032|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101861859|NCT01085032|Autonomic Agents|autonomic agents|mesh-ancestor
101861860|NCT01085032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101861861|NCT01085032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861862|NCT01085032|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101861863|NCT01085032|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101861864|NCT01085032|Cholinergic Agents|cholinergic agents|mesh-ancestor
101861865|NCT01085032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101861866|NCT01085032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861867|NCT01021787|Titanium dioxide|titanium dioxide|mesh-list
101861868|NCT01021787|Sunscreening Agents|sunscreening agents|mesh-ancestor
101965670|NCT01096199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101861869|NCT01021787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101861870|NCT01021787|Protective Agents|protective agents|mesh-ancestor
101861871|NCT01021787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861872|NCT01021787|Dermatologic Agents|dermatologic agents|mesh-ancestor
101861873|NCT01021787|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101861874|NCT00093808|Capecitabine|capecitabine|mesh-list
101861875|NCT00093808|Trastuzumab|trastuzumab|mesh-list
101861876|NCT00093808|Vinorelbine|vinorelbine|mesh-list
101861877|NCT00093808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101861878|NCT00093808|Antimetabolites|antimetabolites|mesh-ancestor
101861879|NCT00093808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861880|NCT00093808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101861881|NCT00093808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101581732|NCT05736874|Dermatologic Agents|dermatologic agents|mesh-ancestor
101861882|NCT00093808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101861883|NCT00093808|Tubulin Modulators|tubulin modulators|mesh-ancestor
101861884|NCT00093808|Antimitotic Agents|antimitotic agents|mesh-ancestor
101861885|NCT00093808|Mitosis Modulators|mitosis modulators|mesh-ancestor
101861886|NCT00469079|Nicotine|nicotine|mesh-list
101861887|NCT00469079|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101861888|NCT00469079|Autonomic Agents|autonomic agents|mesh-ancestor
101861889|NCT00469079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101861890|NCT00469079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861891|NCT00469079|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101861892|NCT00469079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101861893|NCT00469079|Cholinergic Agents|cholinergic agents|mesh-ancestor
101861894|NCT00469079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101861895|NCT00469079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861896|NCT01326754|Artesunate|artesunate|mesh-list
101861897|NCT01326754|Lumefantrine|lumefantrine|mesh-list
101861898|NCT01326754|Artemether|artemether|mesh-list
101861899|NCT01326754|Piperaquine|piperaquine|mesh-list
101861900|NCT01326754|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101861901|NCT01326754|Amodiaquine|amodiaquine|mesh-list
101861902|NCT01326754|Artenimol|artenimol|mesh-list
101861903|NCT01326754|Amodiaquine, artesunate drug combination|amodiaquine, artesunate drug combination|mesh-list
101861904|NCT01326754|Antimalarials|antimalarials|mesh-ancestor
101861905|NCT01326754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101861906|NCT01326754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101861907|NCT01326754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101861908|NCT01326754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101861909|NCT01326754|Antiviral Agents|antiviral agents|mesh-ancestor
101861910|NCT01326754|Schistosomicides|schistosomicides|mesh-ancestor
101861911|NCT01326754|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101861912|NCT01326754|Anthelmintics|anthelmintics|mesh-ancestor
101861913|NCT00093496|Gemcitabine|gemcitabine|mesh-list
101861914|NCT00093496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101861915|NCT00093496|Antimetabolites|antimetabolites|mesh-ancestor
101861916|NCT00093496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861917|NCT00093496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101861918|NCT00265122|Ustekinumab|ustekinumab|mesh-list
101861919|NCT00265122|Dermatologic Agents|dermatologic agents|mesh-ancestor
101861920|NCT00096538|Valganciclovir|valganciclovir|mesh-list
101861921|NCT00096538|Antiviral Agents|antiviral agents|mesh-ancestor
101861922|NCT00096538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101861923|NCT00116428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
101861924|NCT03971214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101861925|NCT03971214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861926|NCT03971214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101861927|NCT03971214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101861928|NCT01073748|Acetaminophen|acetaminophen|mesh-list
101861929|NCT01073748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101861930|NCT01073748|Analgesics|analgesics|mesh-ancestor
101861931|NCT01073748|Sensory System Agents|sensory system agents|mesh-ancestor
101861932|NCT01073748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101861933|NCT01073748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861934|NCT01073748|Antipyretics|antipyretics|mesh-ancestor
101861935|NCT00468845|Pregabalin|pregabalin|mesh-list
101861936|NCT00468845|Analgesics|analgesics|mesh-ancestor
101861937|NCT00468845|Sensory System Agents|sensory system agents|mesh-ancestor
101861938|NCT00468845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101861939|NCT00468845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861940|NCT00468845|Anticonvulsants|anticonvulsants|mesh-ancestor
101861941|NCT00468845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101861942|NCT00468845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101861943|NCT00468845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861944|NCT00468845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101861945|NCT00468845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101861946|NCT00468845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101861947|NCT00468845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101861948|NCT00468845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101861949|NCT00468299|Misoprostol|misoprostol|mesh-list
101861950|NCT00468299|Mifepristone|mifepristone|mesh-list
101861951|NCT00468299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101861952|NCT00468299|Abortifacient Agents|abortifacient agents|mesh-ancestor
101861953|NCT00468299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101861954|NCT00468299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861955|NCT00468299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101581807|NCT05559164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101861956|NCT00468299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101861957|NCT00468299|Oxytocics|oxytocics|mesh-ancestor
101861958|NCT00468299|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101861959|NCT00468299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101861960|NCT00468299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101861961|NCT00468299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101861962|NCT00468299|Contraceptive Agents|contraceptive agents|mesh-ancestor
101861963|NCT00468299|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101861964|NCT00468299|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101861965|NCT00468299|Hormone Antagonists|hormone antagonists|mesh-ancestor
101861966|NCT00468299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101861967|NCT00468299|Luteolytic Agents|luteolytic agents|mesh-ancestor
101861968|NCT00468299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101861969|NCT00468299|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101861970|NCT01021865|Glucagon|glucagon|mesh-list
101861971|NCT01021865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101861972|NCT01021865|Regadenoson|regadenoson|mesh-list
101861973|NCT01021865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101861974|NCT01021865|Hormones|hormones|mesh-ancestor
101861975|NCT01021865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101861976|NCT01021865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861977|NCT01021865|Incretins|incretins|mesh-ancestor
101861978|NCT01021865|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
101861979|NCT01021865|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101861980|NCT01021865|Purinergic Agonists|purinergic agonists|mesh-ancestor
101861981|NCT01021865|Purinergic Agents|purinergic agents|mesh-ancestor
101861982|NCT01021865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101861983|NCT01021865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101861984|NCT00468143|Adderall|adderall|mesh-list
101861985|NCT00468143|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101861986|NCT00468143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101861987|NCT00467831|Acetylcysteine|acetylcysteine|mesh-list
101861988|NCT00467831|Erythromycin|erythromycin|mesh-list
101861989|NCT00467831|Erythromycin Estolate|erythromycin estolate|mesh-list
101861990|NCT00467831|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101861991|NCT00467831|Erythromycin stearate|erythromycin stearate|mesh-list
101861992|NCT00467831|Zileuton|zileuton|mesh-list
101861993|NCT00467831|Losartan|losartan|mesh-list
101861994|NCT00467831|Pravastatin|pravastatin|mesh-list
101241999|NCT01632163|Lixisenatide|lixisenatide|mesh-list
101861995|NCT00467831|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101861996|NCT00467831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101861997|NCT00467831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101861998|NCT00467831|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101861999|NCT00467831|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101862000|NCT00467831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862001|NCT00467831|Antiviral Agents|antiviral agents|mesh-ancestor
101862002|NCT00467831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101862003|NCT00467831|Expectorants|expectorants|mesh-ancestor
101965682|NCT01096277|Protease Inhibitors|protease inhibitors|mesh-ancestor
101862004|NCT00467831|Respiratory System Agents|respiratory system agents|mesh-ancestor
101862005|NCT00467831|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101862007|NCT00467831|Protective Agents|protective agents|mesh-ancestor
101862008|NCT00467831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862009|NCT00467831|Antidotes|antidotes|mesh-ancestor
101862010|NCT00467831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101862011|NCT00467831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101862012|NCT00467831|Antimetabolites|antimetabolites|mesh-ancestor
101862013|NCT00467831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101862014|NCT00467831|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101862015|NCT00467831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101862016|NCT00467831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101862017|NCT00467831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101687748|NCT02838173|Ropivacaine|ropivacaine|mesh-list
101862018|NCT00467831|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101862019|NCT00467831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101862020|NCT00467831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101862021|NCT00467831|Analgesics|analgesics|mesh-ancestor
101862022|NCT00467831|Sensory System Agents|sensory system agents|mesh-ancestor
101862023|NCT00467831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101862024|NCT00467831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101862025|NCT00467831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101862026|NCT00467831|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101862027|NCT00467831|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101862028|NCT00467831|Hormone Antagonists|hormone antagonists|mesh-ancestor
101862029|NCT00467831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101862030|NCT00467753|Oxcarbazepine|oxcarbazepine|mesh-list
101862031|NCT00467753|Anticonvulsants|anticonvulsants|mesh-ancestor
101862032|NCT00467753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101862033|NCT00467753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101862034|NCT00467753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101862035|NCT00467753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862036|NCT00467753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101862037|NCT00467753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101862039|NCT01021943|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101862040|NCT01021943|Hormone Antagonists|hormone antagonists|mesh-ancestor
101862041|NCT01021943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101862042|NCT01021943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862043|NCT01021943|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101862044|NCT01021943|Diuretics|diuretics|mesh-ancestor
101862045|NCT01021943|Natriuretic Agents|natriuretic agents|mesh-ancestor
101862046|NCT00116272|Etanercept|etanercept|mesh-list
101862047|NCT00116272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101862048|NCT00116272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101862049|NCT00116272|Analgesics|analgesics|mesh-ancestor
101862050|NCT00116272|Sensory System Agents|sensory system agents|mesh-ancestor
101862051|NCT00116272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101862052|NCT00116272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862053|NCT00116272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101862054|NCT00116272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101862055|NCT00116272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101862056|NCT00116272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101862057|NCT00116272|Immunologic Factors|immunologic factors|mesh-ancestor
101862058|NCT01022021|Rituximab|rituximab|mesh-list
101862059|NCT01022021|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101862060|NCT01022021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101862061|NCT01022021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101862062|NCT01022021|Immunologic Factors|immunologic factors|mesh-ancestor
101862063|NCT01022021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862064|NCT01022021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101862065|NCT01022021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101862066|NCT01022021|Alkylating Agents|alkylating agents|mesh-ancestor
101862067|NCT01022021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862068|NCT00467597|Levodopa|levodopa|mesh-list
101862069|NCT00467597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101862070|NCT00467597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101862071|NCT00467597|Dopamine Agents|dopamine agents|mesh-ancestor
101862072|NCT00467597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101965687|NCT01096355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101862073|NCT00467597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862074|NCT00467597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862076|NCT00115804|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101862077|NCT00115804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101862078|NCT00115804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101862079|NCT00115804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862080|NCT00115804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101862081|NCT00115804|Serotonin Agents|serotonin agents|mesh-ancestor
101862082|NCT00115804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862083|NCT00115804|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101862084|NCT00115804|Antidepressive Agents|antidepressive agents|mesh-ancestor
101862085|NCT00115804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101862086|NCT00115804|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101862087|NCT00115804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101862088|NCT00115804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101862089|NCT00467363|Aspirin|aspirin|mesh-list
101862090|NCT00467363|Folic Acid|folic acid|mesh-list
101862091|NCT00467363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101862092|NCT00467363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101862093|NCT00467363|Analgesics|analgesics|mesh-ancestor
101862094|NCT00467363|Sensory System Agents|sensory system agents|mesh-ancestor
101862095|NCT00467363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101862096|NCT00467363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862097|NCT00467363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101862098|NCT00467363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101862099|NCT00467363|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101862100|NCT00467363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101862101|NCT00467363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862102|NCT00467363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101862103|NCT00467363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101862104|NCT00467363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101862105|NCT00467363|Antipyretics|antipyretics|mesh-ancestor
101862106|NCT00467363|Hematinics|hematinics|mesh-ancestor
101862107|NCT00467363|Vitamin B Complex|vitamin b complex|mesh-ancestor
101862108|NCT00467363|Vitamins|vitamins|mesh-ancestor
101862109|NCT00467363|Micronutrients|micronutrients|mesh-ancestor
101862110|NCT01071174|Dapivirine|dapivirine|mesh-list
101862111|NCT01071174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101862112|NCT01071174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101862113|NCT01071174|Antiviral Agents|antiviral agents|mesh-ancestor
101862114|NCT01071174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101862115|NCT00466505|Celecoxib|celecoxib|mesh-list
101862116|NCT00466505|Cetuximab|cetuximab|mesh-list
101862117|NCT00466505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101862118|NCT00466505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101862119|NCT00466505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101862120|NCT00466505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101862121|NCT00466505|Analgesics|analgesics|mesh-ancestor
101862122|NCT00466505|Sensory System Agents|sensory system agents|mesh-ancestor
101862123|NCT00466505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101862124|NCT00466505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862125|NCT00466505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101862126|NCT00466505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101862127|NCT00466505|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101862128|NCT00466505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101862129|NCT00466505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101862130|NCT00466505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862131|NCT02531568|Warfarin|warfarin|mesh-list
101862132|NCT02531568|Anticoagulants|anticoagulants|mesh-ancestor
101862133|NCT00467051|Paclitaxel|paclitaxel|mesh-list
101862134|NCT00467051|Carboplatin|carboplatin|mesh-list
101862135|NCT00467051|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101862136|NCT00467051|Ifosfamide|ifosfamide|mesh-list
101862137|NCT00467051|Isophosphamide mustard|isophosphamide mustard|mesh-list
101862138|NCT00467051|Lenograstim|lenograstim|mesh-list
101862139|NCT00467051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101862140|NCT00467051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101862141|NCT00467051|Tubulin Modulators|tubulin modulators|mesh-ancestor
101862142|NCT00467051|Antimitotic Agents|antimitotic agents|mesh-ancestor
101862143|NCT00467051|Mitosis Modulators|mitosis modulators|mesh-ancestor
101965689|NCT01096511|Moxifloxacin|moxifloxacin|mesh-list
101862144|NCT00467051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862145|NCT00467051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101862146|NCT00467051|Immunologic Factors|immunologic factors|mesh-ancestor
101862147|NCT00467051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862148|NCT00467051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101862149|NCT00467051|Alkylating Agents|alkylating agents|mesh-ancestor
101862150|NCT00264498|Carboplatin|carboplatin|mesh-list
101862151|NCT00264498|Gemcitabine|gemcitabine|mesh-list
101862152|NCT00264498|Gefitinib|gefitinib|mesh-list
101862153|NCT00264498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101862154|NCT00264498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101862155|NCT00264498|Antimetabolites|antimetabolites|mesh-ancestor
101862156|NCT00264498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862157|NCT00264498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101862158|NCT00264498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101862159|NCT00466193|Zolpidem|zolpidem|mesh-list
101862160|NCT00466193|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101862161|NCT00466193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101862162|NCT00466193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101862163|NCT00466193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862164|NCT00466193|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101862165|NCT00466193|GABA Agonists|gaba agonists|mesh-ancestor
101862166|NCT00466193|GABA Agents|gaba agents|mesh-ancestor
101862167|NCT00466193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101862168|NCT00466193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862169|NCT01072578|Dapagliflozin|dapagliflozin|mesh-list
101862170|NCT01072578|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101862171|NCT01072578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862172|NCT01072578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101862173|NCT01072578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862174|NCT01072734|Vaccines|vaccines|mesh-list
101862175|NCT01072734|Immunologic Factors|immunologic factors|mesh-ancestor
101862176|NCT01072734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862177|NCT03970668|Insulin|insulin|mesh-list
101862178|NCT03970668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101862179|NCT03970668|Linagliptin|linagliptin|mesh-list
101862180|NCT03970668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101862181|NCT03970668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862182|NCT03970668|Incretins|incretins|mesh-ancestor
101862183|NCT03970668|Hormones|hormones|mesh-ancestor
101862184|NCT03970668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101862185|NCT03970668|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101862186|NCT03970668|Protease Inhibitors|protease inhibitors|mesh-ancestor
101862187|NCT03970668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101862188|NCT03970668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862189|NCT00454181|Interferons|interferons|mesh-list
101862190|NCT00454181|Interferon-alpha|interferon-alpha|mesh-list
101862191|NCT00454181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101862192|NCT00454181|Antiviral Agents|antiviral agents|mesh-ancestor
101862193|NCT00454181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101862194|NCT00454181|Immunologic Factors|immunologic factors|mesh-ancestor
101862195|NCT00454181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862196|NCT01073826|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101862197|NCT01073826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101862198|NCT01073826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862199|NCT01073826|Incretins|incretins|mesh-ancestor
101862200|NCT01073826|Hormones|hormones|mesh-ancestor
101242139|NCT01633645|Antimetabolites|antimetabolites|mesh-ancestor
101862201|NCT01073826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101862202|NCT01073826|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101862203|NCT01073826|Protease Inhibitors|protease inhibitors|mesh-ancestor
101862204|NCT01073826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101862205|NCT01073826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862206|NCT01072812|Phenserine|phenserine|mesh-list
101862207|NCT01072812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101862208|NCT01072812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101862209|NCT01072812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862210|NCT01072812|Cholinergic Agents|cholinergic agents|mesh-ancestor
101862211|NCT01072812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101862212|NCT01072812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862213|NCT00237042|Levonorgestrel|levonorgestrel|mesh-list
101862214|NCT00237042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101862215|NCT00237042|Estradiol|estradiol|mesh-list
101862216|NCT00237042|Estrogens|estrogens|mesh-ancestor
101862217|NCT00237042|Hormones|hormones|mesh-ancestor
101862218|NCT00237042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101862219|NCT00237042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862220|NCT00237042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101862221|NCT00237042|Contraceptive Agents|contraceptive agents|mesh-ancestor
101862222|NCT00237042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101862223|NCT00237042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101862224|NCT00237042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101862225|NCT00237042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101862226|NCT00237042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101862227|NCT00465647|Hydromorphone|hydromorphone|mesh-list
101862228|NCT00465647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101862229|NCT00465647|Narcotics|narcotics|mesh-ancestor
101862230|NCT00465647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101862231|NCT00465647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862232|NCT00465647|Analgesics|analgesics|mesh-ancestor
101862233|NCT00465647|Sensory System Agents|sensory system agents|mesh-ancestor
101687757|NCT00641472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101862234|NCT00465647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101862235|NCT00090766|Valganciclovir|valganciclovir|mesh-list
101862236|NCT00090766|Antiviral Agents|antiviral agents|mesh-ancestor
101862237|NCT00090766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101862239|NCT03961828|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
101862240|NCT03961828|Ledipasvir|ledipasvir|mesh-list
101862241|NCT03961828|Antiviral Agents|antiviral agents|mesh-ancestor
101862242|NCT03961828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101862243|NCT00465179|Sunitinib|sunitinib|mesh-list
101862244|NCT00465179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101862245|NCT00465179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101862246|NCT00465179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101862247|NCT00465179|Growth Substances|growth substances|mesh-ancestor
101862248|NCT00465179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862249|NCT00465179|Growth Inhibitors|growth inhibitors|mesh-ancestor
101862250|NCT00465179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101862251|NCT00465179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101862252|NCT00465179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582110|NCT04630808|Latanoprost|latanoprost|mesh-list
101862253|NCT00084136|Tenofovir|tenofovir|mesh-list
101862254|NCT00084136|Lamivudine|lamivudine|mesh-list
101862255|NCT00084136|Emtricitabine|emtricitabine|mesh-list
101862256|NCT00084136|Zidovudine|zidovudine|mesh-list
101862257|NCT00084136|Efavirenz|efavirenz|mesh-list
101862258|NCT00084136|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101862259|NCT00084136|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101862260|NCT00084136|Didanosine|didanosine|mesh-list
101862261|NCT00084136|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101862262|NCT00084136|Antiviral Agents|antiviral agents|mesh-ancestor
101862263|NCT00084136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101862264|NCT00084136|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101862265|NCT00084136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101862266|NCT00084136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101242208|NCT01634230|Phenylacetic acid|phenylacetic acid|mesh-list
101862267|NCT00084136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862268|NCT00084136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101862269|NCT00084136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101862270|NCT00084136|Antimetabolites|antimetabolites|mesh-ancestor
101862271|NCT00084136|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101862272|NCT00084136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101862273|NCT00084136|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101862274|NCT00084136|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101862275|NCT00084136|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101862276|NCT00084136|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101862277|NCT00084136|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101862278|NCT00084136|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101862279|NCT00084136|Protease Inhibitors|protease inhibitors|mesh-ancestor
101862280|NCT03812380|Magnesium citrate|magnesium citrate|mesh-list
101862281|NCT03812380|Cathartics|cathartics|mesh-ancestor
101862282|NCT03812380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101862283|NCT01085422|Temozolomide|temozolomide|mesh-list
101862284|NCT01085422|Veliparib|veliparib|mesh-list
101862285|NCT01085422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101862286|NCT01085422|Alkylating Agents|alkylating agents|mesh-ancestor
101862287|NCT01085422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862288|NCT01085422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101862289|NCT01085422|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101862290|NCT01085422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101862291|NCT01085656|Combretastatin|combretastatin|mesh-list
101862292|NCT01085656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101242252|NCT01634386|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101862293|NCT01085656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101862294|NCT01085656|Tubulin Modulators|tubulin modulators|mesh-ancestor
101862295|NCT01085656|Antimitotic Agents|antimitotic agents|mesh-ancestor
101862296|NCT01085656|Mitosis Modulators|mitosis modulators|mesh-ancestor
101862297|NCT01085656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862298|NCT01087138|Calcium|calcium|mesh-list
101862299|NCT01087138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101862300|NCT01087138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862301|NCT00464945|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101862302|NCT00464945|Immunologic Factors|immunologic factors|mesh-ancestor
101862303|NCT00464945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862304|NCT00464087|Heparin|heparin|mesh-list
101862305|NCT00464087|Calcium heparin|calcium heparin|mesh-list
101862306|NCT00464087|PENTA|penta|mesh-list
101862307|NCT00464087|Bivalirudin|bivalirudin|mesh-list
101862308|NCT00464087|Fondaparinux|fondaparinux|mesh-list
101862309|NCT00464087|Anticoagulants|anticoagulants|mesh-ancestor
101862310|NCT00464087|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101862311|NCT00464087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101862312|NCT00464087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862313|NCT00464087|Antithrombins|antithrombins|mesh-ancestor
101862314|NCT00464087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101862315|NCT00464087|Protease Inhibitors|protease inhibitors|mesh-ancestor
101862316|NCT00464087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101862317|NCT00464087|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101862318|NCT00452699|Fluticasone|fluticasone|mesh-list
101862319|NCT00452699|Xhance|xhance|mesh-list
101862320|NCT00452699|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101862321|NCT00452699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101242300|NCT01634594|Analgesics|analgesics|mesh-ancestor
101862322|NCT00452699|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101862323|NCT00452699|Autonomic Agents|autonomic agents|mesh-ancestor
101862324|NCT00452699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101862325|NCT00452699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862326|NCT00452699|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101862327|NCT00452699|Respiratory System Agents|respiratory system agents|mesh-ancestor
101862328|NCT00452699|Dermatologic Agents|dermatologic agents|mesh-ancestor
101862329|NCT00452699|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101862330|NCT00452699|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101862331|NCT00452699|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101862333|NCT00452699|Adrenergic Agents|adrenergic agents|mesh-ancestor
101862334|NCT00452699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101862335|NCT00452699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862336|NCT00069784|Insulin|insulin|mesh-list
101862337|NCT00069784|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101862338|NCT00069784|Insulin Glargine|insulin glargine|mesh-list
101862339|NCT00069784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101862340|NCT00069784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862341|NCT00090610|Carboplatin|carboplatin|mesh-list
101862342|NCT00090610|Docetaxel|docetaxel|mesh-list
101862343|NCT00090610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101862344|NCT00090610|Tubulin Modulators|tubulin modulators|mesh-ancestor
101862345|NCT00090610|Antimitotic Agents|antimitotic agents|mesh-ancestor
101862346|NCT00090610|Mitosis Modulators|mitosis modulators|mesh-ancestor
101862347|NCT00090610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862348|NCT01326988|Anesthetics|anesthetics|mesh-list
101862349|NCT01326988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101862350|NCT01326988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862351|NCT03962296|Calcium Dobesilate|calcium dobesilate|mesh-list
101862352|NCT03962296|Calcium|calcium|mesh-list
101862353|NCT03962296|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101862354|NCT03962296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862355|NCT03962296|Hemostatics|hemostatics|mesh-ancestor
101862356|NCT03962296|Coagulants|coagulants|mesh-ancestor
101862357|NCT01086046|Heparin|heparin|mesh-list
101862358|NCT01086046|Enoxaparin|enoxaparin|mesh-list
101862359|NCT01086046|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101862360|NCT01086046|Tinzaparin|tinzaparin|mesh-list
101862361|NCT01086046|Dalteparin|dalteparin|mesh-list
101862362|NCT01086046|Anticoagulants|anticoagulants|mesh-ancestor
101862363|NCT01086046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101862364|NCT01086046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101862365|NCT01086046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862366|NCT01090648|Etravirine|etravirine|mesh-list
101862367|NCT01090648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101862368|NCT01090648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101862369|NCT01090648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101862370|NCT01090648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862371|NCT01090648|Antiviral Agents|antiviral agents|mesh-ancestor
101862372|NCT01090648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101862373|NCT03741244|Temozolomide|temozolomide|mesh-list
101862374|NCT03741244|Apatinib|apatinib|mesh-list
101862375|NCT03741244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101862376|NCT03741244|Alkylating Agents|alkylating agents|mesh-ancestor
101862377|NCT03741244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862378|NCT03741244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101862379|NCT03741244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101862380|NCT03741244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101862381|NCT00463385|Thalidomide|thalidomide|mesh-list
101862382|NCT00463385|Prednisone|prednisone|mesh-list
101862383|NCT00463385|Pomalidomide|pomalidomide|mesh-list
101862384|NCT00463385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101862385|NCT00463385|Glucocorticoids|glucocorticoids|mesh-ancestor
101862386|NCT00463385|Hormones|hormones|mesh-ancestor
101862387|NCT00463385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101862388|NCT00463385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862389|NCT00463385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101862390|NCT00463385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101862391|NCT00463385|Immunologic Factors|immunologic factors|mesh-ancestor
101862392|NCT00463385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101862393|NCT00463385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101862394|NCT00463385|Growth Substances|growth substances|mesh-ancestor
101862395|NCT00463385|Growth Inhibitors|growth inhibitors|mesh-ancestor
101862396|NCT00463385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101862397|NCT00463385|Leprostatic Agents|leprostatic agents|mesh-ancestor
101862398|NCT00463385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101862399|NCT00463385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101242405|NCT01635296|Cytarabine|cytarabine|mesh-list
101862400|NCT03839693|Botulinum Toxins|botulinum toxins|mesh-list
101862401|NCT03839693|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101862402|NCT03839693|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101862403|NCT03839693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101862404|NCT03839693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101862405|NCT03839693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862406|NCT03839693|Cholinergic Agents|cholinergic agents|mesh-ancestor
101862407|NCT03839693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101862408|NCT03839693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862409|NCT03839693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101862410|NCT03839693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101862411|NCT00068692|Leucovorin|leucovorin|mesh-list
101862412|NCT00068692|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
101862413|NCT00068692|Tetrahydrofolates|tetrahydrofolates|mesh-list
101862414|NCT00068692|Fluorouracil|fluorouracil|mesh-list
101862415|NCT00068692|Oxaliplatin|oxaliplatin|mesh-list
101862416|NCT00068692|Irinotecan|irinotecan|mesh-list
101862417|NCT00068692|Camptothecin|camptothecin|mesh-list
101862418|NCT00068692|Levoleucovorin|levoleucovorin|mesh-list
101862419|NCT00068692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862420|NCT00068692|Antimetabolites|antimetabolites|mesh-ancestor
101862421|NCT00068692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862422|NCT00068692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101862423|NCT00068692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101862424|NCT00068692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101862425|NCT00068692|Immunologic Factors|immunologic factors|mesh-ancestor
101862426|NCT00068692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101862427|NCT00068692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101862428|NCT00068692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101862429|NCT00068692|Antidotes|antidotes|mesh-ancestor
101862430|NCT00068692|Protective Agents|protective agents|mesh-ancestor
101862431|NCT00068692|Vitamin B Complex|vitamin b complex|mesh-ancestor
101862432|NCT00068692|Vitamins|vitamins|mesh-ancestor
101862433|NCT00068692|Micronutrients|micronutrients|mesh-ancestor
101862434|NCT00068692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101862435|NCT00463151|Rebamipide|rebamipide|mesh-list
101862436|NCT00463151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101862437|NCT00463151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101862438|NCT00463151|Antioxidants|antioxidants|mesh-ancestor
101862439|NCT00463151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862440|NCT00463151|Protective Agents|protective agents|mesh-ancestor
101862441|NCT00463151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862442|NCT00463151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101862443|NCT00068380|Imatinib Mesylate|imatinib mesylate|mesh-list
101862444|NCT00068380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101862445|NCT00068380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101862446|NCT00068380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101862447|NCT00068380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862448|NCT00067990|Losartan|losartan|mesh-list
101862449|NCT00067990|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101862450|NCT00067990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101862451|NCT00067990|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101862452|NCT00067990|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101687767|NCT00641472|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101862453|NCT00067990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862455|NCT00263328|Tofacitinib|tofacitinib|mesh-list
101862456|NCT00263328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101862457|NCT00263328|Immunologic Factors|immunologic factors|mesh-ancestor
101862458|NCT00263328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862459|NCT00263328|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101862460|NCT00263328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101862461|NCT00263328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862462|NCT00263328|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101862463|NCT00263328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101862464|NCT03741660|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
101862465|NCT03741660|Cathartics|cathartics|mesh-ancestor
101862466|NCT03741660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101862467|NCT00262860|Gemcitabine|gemcitabine|mesh-list
101862468|NCT00262860|Bortezomib|bortezomib|mesh-list
101862469|NCT00262860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101862470|NCT00262860|Antimetabolites|antimetabolites|mesh-ancestor
101862471|NCT00262860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862472|NCT00262860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101862473|NCT00236184|Rabeprazole|rabeprazole|mesh-list
101862474|NCT00236184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101862475|NCT00236184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101862476|NCT00236184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101862477|NCT00236184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101862478|NCT00236184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862479|NCT00296504|Ritonavir|ritonavir|mesh-list
101862480|NCT00296504|Fosamprenavir|fosamprenavir|mesh-list
101862481|NCT00296504|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101862482|NCT00296504|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101862483|NCT00296504|Protease Inhibitors|protease inhibitors|mesh-ancestor
101862484|NCT00296504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101862485|NCT00296504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862486|NCT00296504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101862487|NCT00296504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101862488|NCT00296504|Antiviral Agents|antiviral agents|mesh-ancestor
101862489|NCT00296504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101862490|NCT00296504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101862491|NCT00296504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101862492|NCT00313820|Pregabalin|pregabalin|mesh-list
101862493|NCT00313820|Analgesics|analgesics|mesh-ancestor
101862494|NCT00313820|Sensory System Agents|sensory system agents|mesh-ancestor
101862495|NCT00313820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101862496|NCT00313820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862497|NCT00313820|Anticonvulsants|anticonvulsants|mesh-ancestor
101862498|NCT00313820|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101862499|NCT00313820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101862500|NCT00313820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323397|NCT04310709|Nivolumab|nivolumab|mesh-list
101862501|NCT00313820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101862502|NCT00313820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101862503|NCT00313820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101862504|NCT00313820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101862505|NCT00313820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101862507|NCT00235872|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101862508|NCT00235872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101862509|NCT00235872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101862510|NCT00461981|Vaccines|vaccines|mesh-list
101862511|NCT00461981|Immunologic Factors|immunologic factors|mesh-ancestor
101862512|NCT00461981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862513|NCT00296036|Pyridoxine|pyridoxine|mesh-list
101862514|NCT00296036|Vitamin B 6|vitamin b 6|mesh-list
101862515|NCT00296036|Vitamin B Complex|vitamin b complex|mesh-ancestor
101862516|NCT00296036|Vitamins|vitamins|mesh-ancestor
101862517|NCT00296036|Micronutrients|micronutrients|mesh-ancestor
101862518|NCT00296036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862519|NCT01072890|Sirolimus|sirolimus|mesh-list
101862520|NCT01072890|Temsirolimus|temsirolimus|mesh-list
101862521|NCT01072890|MTOR Inhibitors|mtor inhibitors|mesh-list
101862523|NCT01072890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101862524|NCT01072890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862525|NCT01072890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101862526|NCT01072890|Immunologic Factors|immunologic factors|mesh-ancestor
101862527|NCT01072890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862528|NCT01072890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101862529|NCT01072890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101862530|NCT01072890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101862531|NCT01072890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101862532|NCT01072890|Antifungal Agents|antifungal agents|mesh-ancestor
101862533|NCT00089674|Denosumab|denosumab|mesh-list
101862534|NCT00089674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101862535|NCT00089674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862536|NCT01090882|Bupivacaine|bupivacaine|mesh-list
101862537|NCT01090882|Anesthetics, Local|anesthetics, local|mesh-ancestor
101862538|NCT01090882|Anesthetics|anesthetics|mesh-ancestor
101862539|NCT01090882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101862540|NCT01090882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862541|NCT01090882|Sensory System Agents|sensory system agents|mesh-ancestor
101862542|NCT01090882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101862543|NCT01090960|Ipatasertib|ipatasertib|mesh-list
101862544|NCT01090960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101862545|NCT01090960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101862546|NCT01090960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101862547|NCT01090960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862548|NCT01067066|Temozolomide|temozolomide|mesh-list
101862549|NCT01067066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101862550|NCT01067066|Alkylating Agents|alkylating agents|mesh-ancestor
101862551|NCT01067066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862552|NCT01067066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101862553|NCT00313586|Azacitidine|azacitidine|mesh-list
101862554|NCT00313586|Entinostat|entinostat|mesh-list
101862555|NCT00313586|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
101862556|NCT00313586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101862557|NCT00313586|Antimetabolites|antimetabolites|mesh-ancestor
101862558|NCT00313586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862559|NCT00313586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101862560|NCT00313586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101862561|NCT01069328|Paclitaxel|paclitaxel|mesh-list
101862562|NCT01069328|Bevacizumab|bevacizumab|mesh-list
101862563|NCT01069328|Carboplatin|carboplatin|mesh-list
101862564|NCT01069328|Sorafenib|sorafenib|mesh-list
101862565|NCT01069328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101862566|NCT01069328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101862567|NCT01069328|Tubulin Modulators|tubulin modulators|mesh-ancestor
101862568|NCT01069328|Antimitotic Agents|antimitotic agents|mesh-ancestor
101862569|NCT01069328|Mitosis Modulators|mitosis modulators|mesh-ancestor
101862570|NCT01069328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862571|NCT01069328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101862572|NCT01069328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101862573|NCT01069328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101862574|NCT01069328|Growth Substances|growth substances|mesh-ancestor
101862575|NCT01069328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862576|NCT01069328|Growth Inhibitors|growth inhibitors|mesh-ancestor
101862577|NCT01069328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101862578|NCT01069328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101862579|NCT01067222|Modafinil|modafinil|mesh-list
101862580|NCT01067222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101862581|NCT01067222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862582|NCT01067222|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101862583|NCT01067222|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101862584|NCT01067222|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101862585|NCT01067222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862586|NCT00312572|Buprenorphine|buprenorphine|mesh-list
101862587|NCT00312572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101862588|NCT00312572|Narcotics|narcotics|mesh-ancestor
101862589|NCT00312572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101862590|NCT00312572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862591|NCT00312572|Analgesics|analgesics|mesh-ancestor
101862592|NCT00312572|Sensory System Agents|sensory system agents|mesh-ancestor
101862593|NCT00312572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101862594|NCT00312572|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101862595|NCT00290732|Doxorubicin|doxorubicin|mesh-list
101862596|NCT00290732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101862597|NCT00290732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101862598|NCT00290732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101862599|NCT00290732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101862600|NCT00290732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101862601|NCT00290732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101862602|NCT00290732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862603|NCT00312494|Ziprasidone|ziprasidone|mesh-list
101862604|NCT00312494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101862605|NCT00312494|Serotonin Agents|serotonin agents|mesh-ancestor
101862606|NCT00312494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101862607|NCT00312494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862608|NCT00312494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862609|NCT00312494|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101862610|NCT00312494|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101862611|NCT00312494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101862612|NCT00312494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101862613|NCT00312494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101862614|NCT00312494|Dopamine Agents|dopamine agents|mesh-ancestor
101862615|NCT00312338|Moxifloxacin|moxifloxacin|mesh-list
101242514|NCT01635829|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101862616|NCT00312338|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101862617|NCT00312338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101862618|NCT00312338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101862619|NCT00312338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101862620|NCT00312338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101862621|NCT00312338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101862622|NCT00312338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862623|NCT00312338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101862624|NCT00312338|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101862625|NCT00312338|Contraceptive Agents|contraceptive agents|mesh-ancestor
101862626|NCT00312338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101862627|NCT00312338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862628|NCT00312338|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101862629|NCT00312338|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101862630|NCT00312338|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101862631|NCT00290498|Cytarabine|cytarabine|mesh-list
101862632|NCT00290498|Dexamethasone|dexamethasone|mesh-list
101862634|NCT00290498|Cyclophosphamide|cyclophosphamide|mesh-list
101862635|NCT00290498|Rituximab|rituximab|mesh-list
101862636|NCT00290498|Doxorubicin|doxorubicin|mesh-list
101862637|NCT00290498|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101862638|NCT00290498|Methotrexate|methotrexate|mesh-list
101862639|NCT00290498|Vincristine|vincristine|mesh-list
101862640|NCT00290498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101862641|NCT00290498|Immunologic Factors|immunologic factors|mesh-ancestor
101862642|NCT00290498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862643|NCT00290498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101862644|NCT00290498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101862645|NCT00290498|Alkylating Agents|alkylating agents|mesh-ancestor
101862646|NCT00290498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862647|NCT00290498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101862648|NCT00290498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101862649|NCT00290498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101862650|NCT00290498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101862651|NCT00290498|Antiemetics|antiemetics|mesh-ancestor
101862652|NCT00290498|Autonomic Agents|autonomic agents|mesh-ancestor
101862653|NCT00290498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101862654|NCT00290498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101862655|NCT00290498|Glucocorticoids|glucocorticoids|mesh-ancestor
101862656|NCT00290498|Hormones|hormones|mesh-ancestor
101862657|NCT00290498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101862658|NCT00290498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101862659|NCT00290498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101862660|NCT00290498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101862661|NCT00290498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101862662|NCT00290498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101862663|NCT00290498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101862664|NCT00290498|Abortifacient Agents|abortifacient agents|mesh-ancestor
101862665|NCT00290498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101862666|NCT00290498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101862667|NCT00290498|Antimetabolites|antimetabolites|mesh-ancestor
101862668|NCT00290498|Dermatologic Agents|dermatologic agents|mesh-ancestor
101862669|NCT00290498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101862670|NCT00290498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101862671|NCT00290498|Antiviral Agents|antiviral agents|mesh-ancestor
101862672|NCT00290498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101862673|NCT00290498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101862674|NCT00290498|Tubulin Modulators|tubulin modulators|mesh-ancestor
101862675|NCT00290498|Antimitotic Agents|antimitotic agents|mesh-ancestor
101862676|NCT00290498|Mitosis Modulators|mitosis modulators|mesh-ancestor
101862677|NCT01069796|Paclitaxel|paclitaxel|mesh-list
101862678|NCT01069796|Bevacizumab|bevacizumab|mesh-list
101862679|NCT01069796|Capecitabine|capecitabine|mesh-list
101242687|NCT01636596|Insulin Lispro|insulin lispro|mesh-list
101862680|NCT01069796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101862681|NCT01069796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101862682|NCT01069796|Tubulin Modulators|tubulin modulators|mesh-ancestor
101862683|NCT01069796|Antimitotic Agents|antimitotic agents|mesh-ancestor
101862684|NCT01069796|Mitosis Modulators|mitosis modulators|mesh-ancestor
101862685|NCT01069796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862686|NCT01069796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101862687|NCT01069796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101862688|NCT01069796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101862689|NCT01069796|Growth Substances|growth substances|mesh-ancestor
101862690|NCT01069796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862691|NCT01069796|Growth Inhibitors|growth inhibitors|mesh-ancestor
101862692|NCT01069796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101862693|NCT01069796|Antimetabolites|antimetabolites|mesh-ancestor
101862694|NCT01067534|Albuterol|albuterol|mesh-list
101862695|NCT01067534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101862696|NCT01067534|Autonomic Agents|autonomic agents|mesh-ancestor
101862697|NCT01067534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101862698|NCT01067534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862699|NCT01067534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101862700|NCT01067534|Respiratory System Agents|respiratory system agents|mesh-ancestor
101862701|NCT01067534|Tocolytic Agents|tocolytic agents|mesh-ancestor
101862702|NCT01067534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101862703|NCT01067534|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101862704|NCT01067534|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101862705|NCT01067534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101862706|NCT01067534|Adrenergic Agents|adrenergic agents|mesh-ancestor
101862707|NCT01067534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101965725|NCT04235140|Ivacaftor|ivacaftor|mesh-list
101862708|NCT01067534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862709|NCT00451451|Glatiramer Acetate|glatiramer acetate|mesh-list
101862710|NCT00451451|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101862711|NCT00451451|(T,G)-A-L|(t,g)-a-l|mesh-list
101862712|NCT00451451|Dermatologic Agents|dermatologic agents|mesh-ancestor
101862713|NCT00451451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101862714|NCT00451451|Immunologic Factors|immunologic factors|mesh-ancestor
101862715|NCT00451451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862716|NCT00451451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101862717|NCT00451451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101862718|NCT01062698|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101862719|NCT01062698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101862720|NCT01062698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101862721|NCT01062698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862722|NCT03977324|Chlorhexidine|chlorhexidine|mesh-list
101862723|NCT03977324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101862724|NCT03977324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101862725|NCT03977324|Disinfectants|disinfectants|mesh-ancestor
101862726|NCT01069874|Vitamin D|vitamin d|mesh-list
101862727|NCT01069874|Cholecalciferol|cholecalciferol|mesh-list
101862728|NCT01069874|Vitamins|vitamins|mesh-ancestor
101862729|NCT01069874|Micronutrients|micronutrients|mesh-ancestor
101862730|NCT01069874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862731|NCT01069874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101862732|NCT01069874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101862733|NCT01022645|Copper|copper|mesh-list
101862734|NCT01022645|Levonorgestrel|levonorgestrel|mesh-list
101862735|NCT01022645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101862736|NCT01022645|Contraceptive Agents|contraceptive agents|mesh-ancestor
101862737|NCT01022645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101862738|NCT01022645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862739|NCT01022645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101862740|NCT01022645|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101862741|NCT01022645|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101862742|NCT01022645|Trace Elements|trace elements|mesh-ancestor
101862743|NCT01022645|Micronutrients|micronutrients|mesh-ancestor
101862744|NCT01025765|Metformin|metformin|mesh-list
101862745|NCT01025765|Pioglitazone|pioglitazone|mesh-list
101862746|NCT01025765|Acarbose|acarbose|mesh-list
101862747|NCT01025765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101862748|NCT01025765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862749|NCT01025765|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101862750|NCT01025765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101862751|NCT01025765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862752|NCT03824912|Ketoconazole|ketoconazole|mesh-list
101862753|NCT03824912|Antifungal Agents|antifungal agents|mesh-ancestor
101862754|NCT03824912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101862755|NCT03824912|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101862756|NCT03824912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101862757|NCT03824912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101862758|NCT03824912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862759|NCT03824912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101862760|NCT03824912|Hormone Antagonists|hormone antagonists|mesh-ancestor
101862761|NCT03824912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101862762|NCT03824912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862763|NCT03824912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101862764|NCT01062776|Furosemide|furosemide|mesh-list
101862765|NCT01062776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101862766|NCT01062776|Diuretics|diuretics|mesh-ancestor
101862767|NCT01062776|Natriuretic Agents|natriuretic agents|mesh-ancestor
101862768|NCT01062776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862769|NCT01062776|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101862770|NCT01062776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101965730|NCT00043979|Sirolimus|sirolimus|mesh-list
101862771|NCT01062776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862772|NCT01025921|Colistin|colistin|mesh-list
101862773|NCT01025921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101862774|NCT01025921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101862775|NCT01070030|Amlodipine|amlodipine|mesh-list
101862776|NCT01070030|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101862777|NCT01070030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101862778|NCT01070030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101862779|NCT01070030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101862780|NCT01070030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862781|NCT01070030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101862782|NCT01070030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862783|NCT01070030|Vasodilator Agents|vasodilator agents|mesh-ancestor
101862784|NCT01070030|Diuretics|diuretics|mesh-ancestor
101862785|NCT01070030|Natriuretic Agents|natriuretic agents|mesh-ancestor
101862786|NCT01070030|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101862787|NCT00461123|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101862788|NCT00461123|Vasodilator Agents|vasodilator agents|mesh-ancestor
101862789|NCT00461123|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101862790|NCT00461123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101862791|NCT00461123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101862792|NCT00461123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242799|NCT01637155|Vitamins|vitamins|mesh-ancestor
101862793|NCT00461123|Urological Agents|urological agents|mesh-ancestor
101862794|NCT00290342|Edetic Acid|edetic acid|mesh-list
101862795|NCT00290342|Pentetic Acid|pentetic acid|mesh-list
101862796|NCT00290342|Antidotes|antidotes|mesh-ancestor
101862797|NCT00290342|Protective Agents|protective agents|mesh-ancestor
101862798|NCT00290342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862799|NCT00290342|Chelating Agents|chelating agents|mesh-ancestor
101862800|NCT00290342|Sequestering Agents|sequestering agents|mesh-ancestor
101862801|NCT00290342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862802|NCT00290342|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101862803|NCT00290342|Anticoagulants|anticoagulants|mesh-ancestor
101862804|NCT00290342|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101862805|NCT00460811|Linaclotide|linaclotide|mesh-list
101862806|NCT00460811|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
101862807|NCT00460811|Enzyme Activators|enzyme activators|mesh-ancestor
101862808|NCT00460811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862809|NCT00460811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101862810|NCT01070108|Ketamine|ketamine|mesh-list
101862811|NCT01070108|Analgesics|analgesics|mesh-ancestor
101862812|NCT01070108|Sensory System Agents|sensory system agents|mesh-ancestor
101862813|NCT01070108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101862814|NCT01070108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862815|NCT01070108|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101862816|NCT01070108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101862817|NCT01070108|Anesthetics, General|anesthetics, general|mesh-ancestor
101862818|NCT01070108|Anesthetics|anesthetics|mesh-ancestor
101862819|NCT01070108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101862820|NCT01070108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101862821|NCT01070108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101862822|NCT01070108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101862823|NCT01070108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862824|NCT01067690|Indinavir|indinavir|mesh-list
101862825|NCT01067690|Bleomycin|bleomycin|mesh-list
101862826|NCT01067690|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101862827|NCT01067690|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101862828|NCT01067690|Protease Inhibitors|protease inhibitors|mesh-ancestor
101862829|NCT01067690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101862830|NCT01067690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862831|NCT01067690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101862832|NCT01067690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101862833|NCT01067690|Antiviral Agents|antiviral agents|mesh-ancestor
101862834|NCT01067690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101862835|NCT01067690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101862836|NCT01067690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101862837|NCT03982004|Pembrolizumab|pembrolizumab|mesh-list
101862838|NCT03982004|Imiquimod|imiquimod|mesh-list
101862839|NCT03982004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101862840|NCT03982004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101862841|NCT03982004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101862842|NCT03982004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862843|NCT03982004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101862844|NCT03982004|Immunologic Factors|immunologic factors|mesh-ancestor
101862845|NCT03982004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862846|NCT03982004|Interferon Inducers|interferon inducers|mesh-ancestor
101862847|NCT01026233|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101862848|NCT01026233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101862849|NCT01026233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101862850|NCT01026233|Immunotoxins|immunotoxins|mesh-ancestor
101862851|NCT01026233|Immunoconjugates|immunoconjugates|mesh-ancestor
101862852|NCT01026233|Immunologic Factors|immunologic factors|mesh-ancestor
101862853|NCT01026233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862854|NCT01062932|Cycloserine|cycloserine|mesh-list
101862855|NCT01062932|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101862856|NCT01062932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101862857|NCT01062932|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101862858|NCT01062932|Antitubercular Agents|antitubercular agents|mesh-ancestor
101862859|NCT01062932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101862860|NCT01062932|Antimetabolites|antimetabolites|mesh-ancestor
101862861|NCT01062932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862863|NCT01026311|Coenzyme Q10|coenzyme q10|mesh-list
101862864|NCT01026311|Micronutrients|micronutrients|mesh-ancestor
101862865|NCT01026311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862866|NCT01026311|Vitamins|vitamins|mesh-ancestor
101862867|NCT01063010|Bevacizumab|bevacizumab|mesh-list
101862868|NCT01063010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101862869|NCT01063010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101862870|NCT01063010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101862871|NCT01063010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101862872|NCT01063010|Growth Substances|growth substances|mesh-ancestor
101862873|NCT01063010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862874|NCT01063010|Growth Inhibitors|growth inhibitors|mesh-ancestor
101862875|NCT00460577|Bromides|bromides|mesh-list
101862876|NCT00460577|Fenoterol|fenoterol|mesh-list
101862877|NCT00460577|Formoterol Fumarate|formoterol fumarate|mesh-list
101862878|NCT00460577|Ipratropium|ipratropium|mesh-list
101862879|NCT00460577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101862880|NCT00460577|Autonomic Agents|autonomic agents|mesh-ancestor
101862881|NCT00460577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101862882|NCT00460577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862883|NCT00460577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101862884|NCT00460577|Respiratory System Agents|respiratory system agents|mesh-ancestor
101862885|NCT00460577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101862886|NCT00460577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101862887|NCT00460577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101862888|NCT00460577|Adrenergic Agents|adrenergic agents|mesh-ancestor
101862889|NCT00460577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101862890|NCT00460577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862891|NCT00460577|Anticonvulsants|anticonvulsants|mesh-ancestor
101862892|NCT00460577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101862893|NCT00460577|Cholinergic Agents|cholinergic agents|mesh-ancestor
101862894|NCT00460577|Sympathomimetics|sympathomimetics|mesh-ancestor
101862895|NCT00460577|Tocolytic Agents|tocolytic agents|mesh-ancestor
101862896|NCT00460577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101862897|NCT01581320|Vitamin D|vitamin d|mesh-list
101862898|NCT01581320|Cholecalciferol|cholecalciferol|mesh-list
101862899|NCT01581320|Ibandronic Acid|ibandronic acid|mesh-list
101862900|NCT01581320|Vitamins|vitamins|mesh-ancestor
101862901|NCT01581320|Micronutrients|micronutrients|mesh-ancestor
101862902|NCT01581320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862903|NCT01581320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101862904|NCT01581320|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101862905|NCT00289016|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
101862906|NCT00289016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101862907|NCT00289016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101862908|NCT00288704|Rilonacept|rilonacept|mesh-list
101862909|NCT00288704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101862910|NCT00288626|Cytarabine|cytarabine|mesh-list
101862912|NCT00288626|Etoposide|etoposide|mesh-list
101862913|NCT00288626|Melphalan|melphalan|mesh-list
101862914|NCT00288626|Carmustine|carmustine|mesh-list
101862915|NCT00288626|Lenograstim|lenograstim|mesh-list
101862916|NCT00288626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101862917|NCT00288626|Glucocorticoids|glucocorticoids|mesh-ancestor
101862918|NCT00288626|Hormones|hormones|mesh-ancestor
101862919|NCT00288626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101862920|NCT00288626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862921|NCT00288626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101862922|NCT00288626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101862923|NCT00288626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101862924|NCT00288626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101862925|NCT00288626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101862926|NCT00288626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101862927|NCT00288626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862928|NCT00288626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101862929|NCT00288626|Antimetabolites|antimetabolites|mesh-ancestor
101862930|NCT00288626|Antiviral Agents|antiviral agents|mesh-ancestor
101862931|NCT00288626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101862932|NCT00288626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101862933|NCT00288626|Immunologic Factors|immunologic factors|mesh-ancestor
101862934|NCT00288626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101862935|NCT00288626|Alkylating Agents|alkylating agents|mesh-ancestor
101862936|NCT00288626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101862937|NCT00288626|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101862938|NCT00087490|Vancomycin|vancomycin|mesh-list
101862939|NCT00087490|Linezolid|linezolid|mesh-list
101862940|NCT00087490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101862941|NCT00087490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101862942|NCT00087490|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101862943|NCT00087490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101862944|NCT00087490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862945|NCT00087178|Cyclophosphamide|cyclophosphamide|mesh-list
101862946|NCT00087178|Doxorubicin|doxorubicin|mesh-list
101862947|NCT00087178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101862948|NCT00087178|Fluorouracil|fluorouracil|mesh-list
101862949|NCT00087178|Epirubicin|epirubicin|mesh-list
101862950|NCT00087178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101862951|NCT00087178|Immunologic Factors|immunologic factors|mesh-ancestor
101862952|NCT00087178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862953|NCT00087178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101862954|NCT00087178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101862955|NCT00087178|Alkylating Agents|alkylating agents|mesh-ancestor
101862956|NCT00087178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862957|NCT00087178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101862958|NCT00087178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101862959|NCT00087178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101862960|NCT00087178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101862961|NCT00087178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101862962|NCT00087178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101862963|NCT00087178|Antimetabolites|antimetabolites|mesh-ancestor
101862964|NCT00087178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101862965|NCT00288080|Dexamethasone|dexamethasone|mesh-list
101862966|NCT00288080|Prednisone|prednisone|mesh-list
101862967|NCT00288080|Docetaxel|docetaxel|mesh-list
101862968|NCT00288080|Androgen Antagonists|androgen antagonists|mesh-list
101862969|NCT00288080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101862970|NCT00288080|Antiemetics|antiemetics|mesh-ancestor
101862971|NCT00288080|Autonomic Agents|autonomic agents|mesh-ancestor
101862972|NCT00288080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101862973|NCT00288080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862974|NCT00288080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101862975|NCT00288080|Glucocorticoids|glucocorticoids|mesh-ancestor
101862976|NCT00288080|Hormones|hormones|mesh-ancestor
101862977|NCT00288080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101862978|NCT00288080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101862979|NCT00288080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101862980|NCT00288080|Tubulin Modulators|tubulin modulators|mesh-ancestor
101862981|NCT00288080|Antimitotic Agents|antimitotic agents|mesh-ancestor
101862982|NCT00288080|Mitosis Modulators|mitosis modulators|mesh-ancestor
101862983|NCT00288080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101862985|NCT01068392|Prednisolone|prednisolone|mesh-list
101862986|NCT01068392|Oxaliplatin|oxaliplatin|mesh-list
101862987|NCT01068392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101862988|NCT01068392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101862989|NCT01068392|Glucocorticoids|glucocorticoids|mesh-ancestor
101862990|NCT01068392|Hormones|hormones|mesh-ancestor
101862991|NCT01068392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101862992|NCT01068392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101862993|NCT01068392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101862994|NCT01086826|Cisplatin|cisplatin|mesh-list
101862995|NCT01086826|Docetaxel|docetaxel|mesh-list
101862996|NCT01086826|Fluorouracil|fluorouracil|mesh-list
101862997|NCT01086826|Cetuximab|cetuximab|mesh-list
101862998|NCT01086826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101862999|NCT01086826|Tubulin Modulators|tubulin modulators|mesh-ancestor
101863000|NCT01086826|Antimitotic Agents|antimitotic agents|mesh-ancestor
101863001|NCT01086826|Mitosis Modulators|mitosis modulators|mesh-ancestor
101863002|NCT01086826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863003|NCT01086826|Antimetabolites|antimetabolites|mesh-ancestor
101863004|NCT01086826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101863005|NCT01086826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101863006|NCT01086826|Immunologic Factors|immunologic factors|mesh-ancestor
101863007|NCT01086826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242913|NCT01637545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101863008|NCT01086826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101863009|NCT00287690|Genistein|genistein|mesh-list
101863010|NCT00287690|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101863011|NCT00287690|Protective Agents|protective agents|mesh-ancestor
101863012|NCT00287690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863013|NCT00287690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863014|NCT00287690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101863015|NCT00287690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101863016|NCT00287690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863017|NCT00287690|Phytoestrogens|phytoestrogens|mesh-ancestor
101863018|NCT00287690|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101863019|NCT00287690|Estrogens|estrogens|mesh-ancestor
101863020|NCT00287690|Hormones|hormones|mesh-ancestor
101863021|NCT00287690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101863022|NCT01070186|Sunitinib|sunitinib|mesh-list
101863023|NCT01070186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863024|NCT01070186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101863025|NCT01070186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101863026|NCT01070186|Growth Substances|growth substances|mesh-ancestor
101863027|NCT01070186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863028|NCT01070186|Growth Inhibitors|growth inhibitors|mesh-ancestor
101863029|NCT01070186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101863030|NCT01070186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101863031|NCT01070186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863032|NCT00066742|Etoposide|etoposide|mesh-list
101863033|NCT00066742|Etoposide phosphate|etoposide phosphate|mesh-list
101863034|NCT00066742|Tirapazamine|tirapazamine|mesh-list
101863035|NCT00066742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863036|NCT00066742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101863037|NCT00066742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101863038|NCT00066742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101863039|NCT00066742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101863040|NCT00066742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863041|NCT01026467|Carboplatin|carboplatin|mesh-list
101242936|NCT01637571|Dexlansoprazole|dexlansoprazole|mesh-list
101863042|NCT01026467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863043|NCT01094158|Cholic Acids|cholic acids|mesh-list
101863044|NCT01094158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101863045|NCT00460109|Rituximab|rituximab|mesh-list
101863046|NCT00460109|Denileukin diftitox|denileukin diftitox|mesh-list
101863047|NCT00460109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101863048|NCT00460109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863049|NCT00460109|Immunologic Factors|immunologic factors|mesh-ancestor
101863050|NCT00460109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863051|NCT00460109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101863052|NCT03956212|Doxycycline|doxycycline|mesh-list
101863053|NCT03956212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101863054|NCT03956212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101863055|NCT03956212|Antimalarials|antimalarials|mesh-ancestor
101863056|NCT03956212|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101863057|NCT03956212|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101863058|NCT01091818|Midazolam|midazolam|mesh-list
101863059|NCT01091818|Dexmedetomidine|dexmedetomidine|mesh-list
101863060|NCT01091818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101863061|NCT01091818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101863062|NCT01091818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863063|NCT01091818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101863064|NCT01091818|Analgesics|analgesics|mesh-ancestor
101863065|NCT01091818|Sensory System Agents|sensory system agents|mesh-ancestor
101863066|NCT01091818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101863067|NCT01091818|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101863068|NCT01091818|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101863069|NCT01091818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101863070|NCT01091818|Adrenergic Agents|adrenergic agents|mesh-ancestor
101863071|NCT01091818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101863072|NCT01091818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863073|NCT01091818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101863074|NCT01091818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101863075|NCT01091818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101863076|NCT01091818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101863077|NCT01091818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101863078|NCT01091818|Anesthetics, General|anesthetics, general|mesh-ancestor
101863079|NCT01091818|Anesthetics|anesthetics|mesh-ancestor
101863080|NCT01091818|GABA Modulators|gaba modulators|mesh-ancestor
101863081|NCT01091818|GABA Agents|gaba agents|mesh-ancestor
101863082|NCT01091896|Bevacizumab|bevacizumab|mesh-list
101863083|NCT01091896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101863084|NCT01091896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863085|NCT01091896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101863087|NCT01091896|Growth Substances|growth substances|mesh-ancestor
101863088|NCT01091896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863089|NCT01091896|Growth Inhibitors|growth inhibitors|mesh-ancestor
101863090|NCT00065260|Cyclosporine|cyclosporine|mesh-list
101863091|NCT00065260|Alemtuzumab|alemtuzumab|mesh-list
101863092|NCT00065260|Cyclosporins|cyclosporins|mesh-list
101863093|NCT00065260|Thymoglobulin|thymoglobulin|mesh-list
101863094|NCT00065260|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101863095|NCT00065260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101863096|NCT00065260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863097|NCT00065260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101242984|NCT01637675|Analgesics|analgesics|mesh-ancestor
101863098|NCT00065260|Immunologic Factors|immunologic factors|mesh-ancestor
101863099|NCT00065260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863100|NCT00065260|Antifungal Agents|antifungal agents|mesh-ancestor
101863101|NCT00065260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101863102|NCT00065260|Dermatologic Agents|dermatologic agents|mesh-ancestor
101863103|NCT00065260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101863104|NCT00065260|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101863105|NCT00065260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101863106|NCT00065260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863107|NCT01327066|Moxifloxacin|moxifloxacin|mesh-list
101863108|NCT01327066|Droxidopa|droxidopa|mesh-list
101863109|NCT01327066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101863110|NCT01327066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101225916|NCT01531452|Oxaliplatin|oxaliplatin|mesh-list
101863111|NCT01327066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101863112|NCT01327066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101863114|NCT01327066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863115|NCT01327066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863116|NCT01327066|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101863117|NCT01327066|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101863118|NCT01094626|Secretin|secretin|mesh-list
101863119|NCT01094626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101863120|NCT01094626|Hormones|hormones|mesh-ancestor
101863121|NCT01094626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101863122|NCT01094626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863123|NCT03956134|Tapentadol|tapentadol|mesh-list
101863124|NCT03956134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101863125|NCT03956134|Narcotics|narcotics|mesh-ancestor
101863126|NCT03956134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101863127|NCT03956134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863129|NCT03956134|Sensory System Agents|sensory system agents|mesh-ancestor
101863130|NCT03956134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101863131|NCT03956134|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101863132|NCT03956134|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101863133|NCT03956134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101863134|NCT03956134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863135|NCT03956134|Adrenergic Agents|adrenergic agents|mesh-ancestor
101863136|NCT03956134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101863137|NCT00460031|Ketoconazole|ketoconazole|mesh-list
101863138|NCT00460031|Hydrocortisone|hydrocortisone|mesh-list
101863139|NCT00460031|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101863140|NCT00460031|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101863141|NCT00460031|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101863142|NCT00460031|Lenalidomide|lenalidomide|mesh-list
101863143|NCT00460031|Immunologic Factors|immunologic factors|mesh-ancestor
101863144|NCT00460031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863145|NCT00460031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101863146|NCT00460031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101242994|NCT01637753|Carmustine|carmustine|mesh-list
101863147|NCT00460031|Growth Substances|growth substances|mesh-ancestor
101863148|NCT00460031|Growth Inhibitors|growth inhibitors|mesh-ancestor
101863149|NCT00460031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863150|NCT00460031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101863151|NCT00460031|Antifungal Agents|antifungal agents|mesh-ancestor
101863152|NCT00460031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101863153|NCT00460031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101863154|NCT00460031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101863155|NCT00460031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101863156|NCT00460031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863157|NCT00460031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101863158|NCT00460031|Hormone Antagonists|hormone antagonists|mesh-ancestor
101583007|NCT05336968|Anesthetics, Local|anesthetics, local|mesh-ancestor
101863159|NCT00460031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101863160|NCT00460031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101863162|NCT00451217|Neostigmine|neostigmine|mesh-list
101863163|NCT00451217|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101863164|NCT00451217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101863165|NCT00451217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863166|NCT00451217|Cholinergic Agents|cholinergic agents|mesh-ancestor
101863167|NCT00451217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101863168|NCT00451217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863169|NCT00451217|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101863170|NCT00451217|Autonomic Agents|autonomic agents|mesh-ancestor
101863171|NCT00451217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101863172|NCT00451217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101863173|NCT00451217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101863174|NCT00451217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101863175|NCT00459953|Nicotine|nicotine|mesh-list
101863176|NCT00459953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101863177|NCT00459953|Autonomic Agents|autonomic agents|mesh-ancestor
101863178|NCT00459953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101863179|NCT00459953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863180|NCT00459953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101863181|NCT00459953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101863182|NCT00459953|Cholinergic Agents|cholinergic agents|mesh-ancestor
101863183|NCT00459953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101863184|NCT00459953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863185|NCT00459875|Sunitinib|sunitinib|mesh-list
101863186|NCT00459875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863187|NCT00459875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101863188|NCT00459875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101863189|NCT00459875|Growth Substances|growth substances|mesh-ancestor
101863190|NCT00459875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863191|NCT00459875|Growth Inhibitors|growth inhibitors|mesh-ancestor
101863192|NCT00459875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101863193|NCT00459875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324081|NCT00101842|Pemetrexed|pemetrexed|mesh-list
101863194|NCT00459875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863195|NCT00311402|Aspirin|aspirin|mesh-list
101863196|NCT00311402|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
101863197|NCT00311402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101863198|NCT00311402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101863199|NCT00311402|Analgesics|analgesics|mesh-ancestor
101863200|NCT00311402|Sensory System Agents|sensory system agents|mesh-ancestor
101863201|NCT00311402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101863202|NCT00311402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863203|NCT00311402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101863204|NCT00311402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101863205|NCT00311402|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101863206|NCT00311402|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101863207|NCT00311402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863208|NCT00311402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101863209|NCT00311402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101863210|NCT00311402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101863211|NCT00311402|Antipyretics|antipyretics|mesh-ancestor
101863212|NCT03724175|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101863213|NCT03724175|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101863214|NCT03724175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101863215|NCT00450749|Lycopene|lycopene|mesh-list
101863216|NCT00450749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101863217|NCT00450749|Antioxidants|antioxidants|mesh-ancestor
101863218|NCT00450749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863219|NCT00450749|Protective Agents|protective agents|mesh-ancestor
101863220|NCT00450749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863221|NCT00450749|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101863222|NCT00450749|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101863223|NCT00450749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863224|NCT00292370|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101863225|NCT00292370|Paroxetine|paroxetine|mesh-list
101863226|NCT00292370|Antidepressive Agents|antidepressive agents|mesh-ancestor
101863227|NCT00292370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101863228|NCT00292370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101863229|NCT00292370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101863230|NCT00292370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101863231|NCT00292370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863232|NCT00292370|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101863233|NCT00292370|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101863234|NCT00292370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101863235|NCT00292370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863236|NCT00292370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101863238|NCT00292370|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101863239|NCT00292370|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101863240|NCT00292370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101863241|NCT00292370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101863242|NCT00065182|Docetaxel|docetaxel|mesh-list
101863243|NCT00065182|Topotecan|topotecan|mesh-list
101863244|NCT00065182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863245|NCT00065182|Tubulin Modulators|tubulin modulators|mesh-ancestor
101863246|NCT00065182|Antimitotic Agents|antimitotic agents|mesh-ancestor
101863247|NCT00065182|Mitosis Modulators|mitosis modulators|mesh-ancestor
101863248|NCT00065182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863249|NCT00065182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101863250|NCT00065182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101863251|NCT00065182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101863252|NCT01026701|Bortezomib|bortezomib|mesh-list
101863253|NCT01026701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863254|NCT01092130|Vitamin D|vitamin d|mesh-list
101863255|NCT01092130|Vitamins|vitamins|mesh-ancestor
101863256|NCT01092130|Micronutrients|micronutrients|mesh-ancestor
101863257|NCT01092130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863258|NCT01092130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101863259|NCT00064792|Simvastatin|simvastatin|mesh-list
101863260|NCT00064792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101863261|NCT00064792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101863262|NCT00064792|Antimetabolites|antimetabolites|mesh-ancestor
101863263|NCT00064792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863264|NCT00064792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101863265|NCT00064792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101863266|NCT00064792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101863267|NCT01095016|Fenoterol|fenoterol|mesh-list
101863268|NCT01095016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101863269|NCT01095016|Autonomic Agents|autonomic agents|mesh-ancestor
101863270|NCT01095016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101863271|NCT01095016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863272|NCT01095016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101863273|NCT01095016|Respiratory System Agents|respiratory system agents|mesh-ancestor
101863274|NCT01095016|Sympathomimetics|sympathomimetics|mesh-ancestor
101863275|NCT01095016|Tocolytic Agents|tocolytic agents|mesh-ancestor
101863276|NCT01095016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101863277|NCT01095016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101863278|NCT01095016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101863279|NCT01095016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101863280|NCT01095016|Adrenergic Agents|adrenergic agents|mesh-ancestor
101863281|NCT01095016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101863282|NCT01095016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863283|NCT01095172|Prednisolone|prednisolone|mesh-list
101243067|NCT01638247|Tamoxifen|tamoxifen|mesh-list
101863284|NCT01095172|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101863285|NCT01095172|Methylprednisolone|methylprednisolone|mesh-list
101863286|NCT01095172|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101863287|NCT01095172|Prednisolone acetate|prednisolone acetate|mesh-list
101863288|NCT01095172|Hydrocortisone|hydrocortisone|mesh-list
101863289|NCT01095172|Rituximab|rituximab|mesh-list
101863290|NCT01095172|Tacrolimus|tacrolimus|mesh-list
101863291|NCT01095172|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101863292|NCT01095172|Prednisolone phosphate|prednisolone phosphate|mesh-list
101863293|NCT01095172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101863294|NCT01095172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863295|NCT01095172|Immunologic Factors|immunologic factors|mesh-ancestor
101863296|NCT01095172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863297|NCT01095172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101863298|NCT01095172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101863299|NCT01095172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101863300|NCT01095172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101863301|NCT01095172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863302|NCT01095172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101863303|NCT01095172|Glucocorticoids|glucocorticoids|mesh-ancestor
101863304|NCT01095172|Hormones|hormones|mesh-ancestor
101863305|NCT01095172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101863306|NCT01095172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101863308|NCT01095172|Autonomic Agents|autonomic agents|mesh-ancestor
101863309|NCT01095172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101863310|NCT01095172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101863311|NCT01095172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101863312|NCT01095172|Protective Agents|protective agents|mesh-ancestor
101863313|NCT00286442|Metformin|metformin|mesh-list
101863314|NCT00286442|Alogliptin|alogliptin|mesh-list
101863315|NCT00286442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101863316|NCT00286442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863317|NCT00286442|Incretins|incretins|mesh-ancestor
101863318|NCT00286442|Hormones|hormones|mesh-ancestor
101863319|NCT00286442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101863320|NCT00286442|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101863321|NCT00286442|Protease Inhibitors|protease inhibitors|mesh-ancestor
101863322|NCT00286442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101863323|NCT00286442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863324|NCT00063934|Docetaxel|docetaxel|mesh-list
101863325|NCT00063934|Doxorubicin|doxorubicin|mesh-list
101863326|NCT00063934|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101863327|NCT00063934|Oblimersen|oblimersen|mesh-list
101863328|NCT00063934|Lenograstim|lenograstim|mesh-list
101863329|NCT00063934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863330|NCT00063934|Tubulin Modulators|tubulin modulators|mesh-ancestor
101863331|NCT00063934|Antimitotic Agents|antimitotic agents|mesh-ancestor
101863332|NCT00063934|Mitosis Modulators|mitosis modulators|mesh-ancestor
101863333|NCT00063934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863334|NCT00063934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101863335|NCT00063934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101863336|NCT00063934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101863337|NCT00063934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101863338|NCT00063934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101863339|NCT00063934|Immunologic Factors|immunologic factors|mesh-ancestor
101863340|NCT00063934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863341|NCT00063154|Pertuzumab|pertuzumab|mesh-list
101863342|NCT00063154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101863343|NCT00063154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863344|NCT01092520|Gabapentin|gabapentin|mesh-list
101863345|NCT01092520|Analgesics|analgesics|mesh-ancestor
101863346|NCT01092520|Sensory System Agents|sensory system agents|mesh-ancestor
101863347|NCT01092520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101863348|NCT01092520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863349|NCT01092520|Anticonvulsants|anticonvulsants|mesh-ancestor
101863350|NCT01092520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101863351|NCT01092520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101863352|NCT01092520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101863353|NCT01092520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101863354|NCT01092520|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101863355|NCT01092520|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101863356|NCT01092520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101863357|NCT01092520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863358|NCT01092520|Antimanic Agents|antimanic agents|mesh-ancestor
101863359|NCT00458705|Thalidomide|thalidomide|mesh-list
101863360|NCT00458705|Dexamethasone|dexamethasone|mesh-list
101863361|NCT00458705|Doxorubicin|doxorubicin|mesh-list
101863362|NCT00458705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101863363|NCT00458705|Bortezomib|bortezomib|mesh-list
101863364|NCT00458705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101863365|NCT00458705|Antiemetics|antiemetics|mesh-ancestor
101863366|NCT00458705|Autonomic Agents|autonomic agents|mesh-ancestor
101863367|NCT00458705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101863368|NCT00458705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863369|NCT00458705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101863370|NCT00458705|Glucocorticoids|glucocorticoids|mesh-ancestor
101863371|NCT00458705|Hormones|hormones|mesh-ancestor
101863372|NCT00458705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101863373|NCT00458705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101863374|NCT00458705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863375|NCT00458705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101863376|NCT00458705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101863377|NCT00458705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101863378|NCT00458705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101863379|NCT00458705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583230|NCT00970281|Olanzapine|olanzapine|mesh-list
101863380|NCT00458705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101863381|NCT00458705|Immunologic Factors|immunologic factors|mesh-ancestor
101863382|NCT00458705|Leprostatic Agents|leprostatic agents|mesh-ancestor
101863383|NCT00458705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101863384|NCT00458705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101863385|NCT00458705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101863386|NCT00458705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101863387|NCT00458705|Growth Substances|growth substances|mesh-ancestor
101863388|NCT00458705|Growth Inhibitors|growth inhibitors|mesh-ancestor
101863390|NCT00062374|Alovudine|alovudine|mesh-list
101863392|NCT00062374|Irinotecan|irinotecan|mesh-list
101863393|NCT00062374|Camptothecin|camptothecin|mesh-list
101863394|NCT00062374|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101863395|NCT00062374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863396|NCT00062374|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101863397|NCT00062374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101863398|NCT00062374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101863399|NCT00062374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863400|NCT00062374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101863401|NCT00062374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101863402|NCT00062374|Antimetabolites|antimetabolites|mesh-ancestor
101863403|NCT00062374|Antiviral Agents|antiviral agents|mesh-ancestor
101863404|NCT00062374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101863405|NCT00285818|Mifepristone|mifepristone|mesh-list
101863406|NCT00285818|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101863407|NCT00285818|Abortifacient Agents|abortifacient agents|mesh-ancestor
101863408|NCT00285818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101863409|NCT00285818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863410|NCT00285818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101863411|NCT00285818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101863412|NCT00285818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101863413|NCT00285818|Contraceptive Agents|contraceptive agents|mesh-ancestor
101863414|NCT00285818|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101863415|NCT00285818|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101863416|NCT00285818|Hormone Antagonists|hormone antagonists|mesh-ancestor
101863417|NCT00285818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101863418|NCT00285818|Luteolytic Agents|luteolytic agents|mesh-ancestor
101863419|NCT00285818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101863420|NCT00285818|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101863421|NCT01023347|Paclitaxel|paclitaxel|mesh-list
101863422|NCT01023347|genexol-PM|genexol-pm|mesh-list
101863423|NCT01023347|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101863424|NCT01023347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101863425|NCT01023347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863426|NCT01023347|Tubulin Modulators|tubulin modulators|mesh-ancestor
101863427|NCT01023347|Antimitotic Agents|antimitotic agents|mesh-ancestor
101863428|NCT01023347|Mitosis Modulators|mitosis modulators|mesh-ancestor
101863429|NCT01023347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863430|NCT01023425|Donepezil|donepezil|mesh-list
101863431|NCT01023425|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101863432|NCT01023425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101863433|NCT01023425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863434|NCT01023425|Cholinergic Agents|cholinergic agents|mesh-ancestor
101863435|NCT01023425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101863436|NCT01023425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863437|NCT01023425|Nootropic Agents|nootropic agents|mesh-ancestor
101863438|NCT00285584|Bupropion|bupropion|mesh-list
101863439|NCT00285584|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101863440|NCT00285584|Antidepressive Agents|antidepressive agents|mesh-ancestor
101863441|NCT00285584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101863442|NCT00285584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101863443|NCT00285584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101863444|NCT00285584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101863445|NCT00285584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863446|NCT00285584|Dopamine Agents|dopamine agents|mesh-ancestor
101863447|NCT00285584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101863448|NCT00285584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863449|NCT00285584|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101863450|NCT00285584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101863451|NCT00285584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101863452|NCT01583842|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
101863453|NCT01583842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101583303|NCT01131078|Bevacizumab|bevacizumab|mesh-list
101863454|NCT01583842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101863455|NCT01583842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863456|NCT01583842|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101863457|NCT00291668|Certolizumab Pegol|certolizumab pegol|mesh-list
101863458|NCT00291668|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101863459|NCT00291668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101863461|NCT00291668|Immunologic Factors|immunologic factors|mesh-ancestor
101863462|NCT00291668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863463|NCT00291668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101863464|NCT00458393|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101863465|NCT00458393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101863466|NCT00458393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101863467|NCT00458393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101863468|NCT00458393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863469|NCT00458393|Antiviral Agents|antiviral agents|mesh-ancestor
101863470|NCT00458393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101863471|NCT00458393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101863472|NCT00458393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101863473|NCT03955354|Apatinib|apatinib|mesh-list
101863474|NCT03955354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863475|NCT03955354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101863476|NCT03955354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101965787|NCT01092533|Prednisolone|prednisolone|mesh-list
101863477|NCT03955354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863479|NCT01095484|Dopamine Agonists|dopamine agonists|mesh-ancestor
101863480|NCT01095484|Dopamine Agents|dopamine agents|mesh-ancestor
101863481|NCT01095484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101863482|NCT01095484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863483|NCT01095484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863484|NCT01063478|Everolimus|everolimus|mesh-list
101863485|NCT01063478|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101863486|NCT01063478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101863487|NCT01063478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101863488|NCT01063478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863489|NCT01063478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101863490|NCT01063478|Immunologic Factors|immunologic factors|mesh-ancestor
101863491|NCT01063478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863492|NCT01063478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863493|NCT01327144|Acyclovir|acyclovir|mesh-list
101863494|NCT01327144|Famciclovir|famciclovir|mesh-list
101863495|NCT01327144|Antiviral Agents|antiviral agents|mesh-ancestor
101863496|NCT01327144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101863497|NCT01327144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101863498|NCT01327144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101863499|NCT01327144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863500|NCT01323101|Doxycycline|doxycycline|mesh-list
101863501|NCT01323101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101863502|NCT01323101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101863503|NCT01323101|Antimalarials|antimalarials|mesh-ancestor
101863504|NCT01323101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101863505|NCT01323101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101863506|NCT00310856|Vaccines|vaccines|mesh-list
101863507|NCT00310856|Immunologic Factors|immunologic factors|mesh-ancestor
101863508|NCT00310856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863509|NCT03670355|Tenofovir|tenofovir|mesh-list
101863510|NCT03670355|Antiviral Agents|antiviral agents|mesh-ancestor
101863511|NCT03670355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101863512|NCT03670355|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101863513|NCT03670355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101863514|NCT03670355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101863515|NCT03670355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863516|NCT03670355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101863517|NCT03670355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101863518|NCT02532062|Vitamin D|vitamin d|mesh-list
101863519|NCT02532062|Cholecalciferol|cholecalciferol|mesh-list
101863520|NCT02532062|Vitamins|vitamins|mesh-ancestor
101863521|NCT02532062|Micronutrients|micronutrients|mesh-ancestor
101863522|NCT02532062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863523|NCT02532062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101863524|NCT02532062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101863525|NCT00283712|Infliximab|infliximab|mesh-list
101863526|NCT00283712|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101863527|NCT00283712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101240355|NCT01621256|Ancrod|ancrod|mesh-list
101863528|NCT00283712|Dermatologic Agents|dermatologic agents|mesh-ancestor
101863529|NCT00283712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101863530|NCT00283712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101863531|NCT00048724|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101863532|NCT00048724|Antiviral Agents|antiviral agents|mesh-ancestor
101863533|NCT00048724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101863534|NCT00449033|Gemcitabine|gemcitabine|mesh-list
101863535|NCT00449033|Sorafenib|sorafenib|mesh-list
101863536|NCT00449033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863537|NCT00449033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101863538|NCT00449033|Antimetabolites|antimetabolites|mesh-ancestor
101863539|NCT00449033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863540|NCT00449033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101863541|NCT00449033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101863542|NCT01024205|Sunitinib|sunitinib|mesh-list
101863543|NCT01024205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863544|NCT01024205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101863545|NCT01024205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101863546|NCT01024205|Growth Substances|growth substances|mesh-ancestor
101863547|NCT01024205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863548|NCT01024205|Growth Inhibitors|growth inhibitors|mesh-ancestor
101863549|NCT01024205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101863550|NCT01024205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101863551|NCT01024205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863552|NCT00448019|Cyclophosphamide|cyclophosphamide|mesh-list
101863553|NCT00448019|Bevacizumab|bevacizumab|mesh-list
101863554|NCT00448019|Rituximab|rituximab|mesh-list
101863555|NCT00448019|Fludarabine|fludarabine|mesh-list
101863556|NCT00448019|Fludarabine phosphate|fludarabine phosphate|mesh-list
101863557|NCT00448019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101863558|NCT00448019|Immunologic Factors|immunologic factors|mesh-ancestor
101863559|NCT00448019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863560|NCT00448019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101863561|NCT00448019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101863562|NCT00448019|Alkylating Agents|alkylating agents|mesh-ancestor
101863563|NCT00448019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863564|NCT00448019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863565|NCT00448019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101243186|NCT01638715|Immunologic Factors|immunologic factors|mesh-ancestor
101863566|NCT00448019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101863567|NCT00448019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101863568|NCT00448019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101863569|NCT00448019|Growth Substances|growth substances|mesh-ancestor
101863570|NCT00448019|Growth Inhibitors|growth inhibitors|mesh-ancestor
101863571|NCT00448019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101863572|NCT00448019|Antimetabolites|antimetabolites|mesh-ancestor
101863573|NCT00457691|Leucovorin|leucovorin|mesh-list
101863574|NCT00457691|Fluorouracil|fluorouracil|mesh-list
101863575|NCT00457691|Irinotecan|irinotecan|mesh-list
101863576|NCT00457691|Sunitinib|sunitinib|mesh-list
101863577|NCT00457691|Levoleucovorin|levoleucovorin|mesh-list
101863578|NCT00457691|Antimetabolites|antimetabolites|mesh-ancestor
101863579|NCT00457691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863580|NCT00457691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101863581|NCT00457691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863582|NCT00457691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101863583|NCT00457691|Immunologic Factors|immunologic factors|mesh-ancestor
101863584|NCT00457691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863585|NCT00457691|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101863586|NCT00457691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101863587|NCT00457691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101863588|NCT00457691|Antidotes|antidotes|mesh-ancestor
101863589|NCT00457691|Protective Agents|protective agents|mesh-ancestor
101863590|NCT00457691|Vitamin B Complex|vitamin b complex|mesh-ancestor
101863591|NCT00457691|Vitamins|vitamins|mesh-ancestor
101863592|NCT00457691|Micronutrients|micronutrients|mesh-ancestor
101863593|NCT00457691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101863594|NCT00457691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101863595|NCT00457691|Growth Substances|growth substances|mesh-ancestor
101863596|NCT00457691|Growth Inhibitors|growth inhibitors|mesh-ancestor
101863597|NCT00457691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101863598|NCT00447005|Axitinib|axitinib|mesh-list
101863599|NCT00447005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863600|NCT00447005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101863601|NCT00447005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101863602|NCT00447005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863603|NCT01565759|Lithium Carbonate|lithium carbonate|mesh-list
101863604|NCT01565759|Antidepressive Agents|antidepressive agents|mesh-ancestor
101863605|NCT01565759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101863606|NCT01565759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101863607|NCT01565759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863608|NCT01565759|Antimanic Agents|antimanic agents|mesh-ancestor
101863609|NCT01565759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101863610|NCT01565759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101863611|NCT01565759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863612|NCT00446849|Mesalamine|mesalamine|mesh-list
101863613|NCT00446849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101863614|NCT00446849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101863615|NCT00446849|Analgesics|analgesics|mesh-ancestor
101863616|NCT00446849|Sensory System Agents|sensory system agents|mesh-ancestor
101863617|NCT00446849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101863618|NCT00446849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863619|NCT00446849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101863620|NCT00446849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101863621|NCT01565837|Ipilimumab|ipilimumab|mesh-list
101863622|NCT01565837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101863623|NCT01565837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863624|NCT01565837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101863625|NCT01565837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863626|NCT00446459|Mycophenolic Acid|mycophenolic acid|mesh-list
101863627|NCT00446459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101863628|NCT00446459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863629|NCT00446459|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101863630|NCT00446459|Antitubercular Agents|antitubercular agents|mesh-ancestor
101863631|NCT00446459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101863632|NCT00446459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101863633|NCT00446459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101863634|NCT00446459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863635|NCT00456599|Gemcitabine|gemcitabine|mesh-list
101863636|NCT00456599|Oxaliplatin|oxaliplatin|mesh-list
101863637|NCT00456599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101863638|NCT00456599|Antimetabolites|antimetabolites|mesh-ancestor
101863639|NCT00456599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863640|NCT00456599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863641|NCT00456521|Naltrexone|naltrexone|mesh-list
101863642|NCT00456521|Bupropion|bupropion|mesh-list
101863643|NCT00456521|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101863644|NCT00456521|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101863645|NCT00456521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863646|NCT00456521|Sensory System Agents|sensory system agents|mesh-ancestor
101863647|NCT00456521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101863648|NCT00456521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101863649|NCT00456521|Antidepressive Agents|antidepressive agents|mesh-ancestor
101863650|NCT00456521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101863651|NCT00456521|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101863652|NCT00456521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101863653|NCT00456521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101863654|NCT00456521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863655|NCT00456521|Dopamine Agents|dopamine agents|mesh-ancestor
101863656|NCT00456521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101863657|NCT00456521|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101863658|NCT00456521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101863659|NCT00456521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101863660|NCT00456365|Pravastatin|pravastatin|mesh-list
101863661|NCT00456365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101863662|NCT00456365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101863663|NCT00456365|Antimetabolites|antimetabolites|mesh-ancestor
101863664|NCT00456365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863665|NCT00456365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101863666|NCT00456365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101863667|NCT00456365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101863668|NCT03843047|Nicotine|nicotine|mesh-list
101863669|NCT03843047|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101863670|NCT03843047|Autonomic Agents|autonomic agents|mesh-ancestor
101863671|NCT03843047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101863672|NCT03843047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863673|NCT03843047|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101687817|NCT02839421|Moxifloxacin|moxifloxacin|mesh-list
101863674|NCT03843047|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101863675|NCT03843047|Cholinergic Agents|cholinergic agents|mesh-ancestor
101863676|NCT03843047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101863677|NCT03843047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863678|NCT00455741|Estradiol|estradiol|mesh-list
101863679|NCT00455741|Progesterone|progesterone|mesh-list
101863680|NCT00455741|Estrogens|estrogens|mesh-ancestor
101863681|NCT00455741|Hormones|hormones|mesh-ancestor
101863682|NCT00455741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101863683|NCT00455741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863684|NCT00455741|Progestins|progestins|mesh-ancestor
101863685|NCT00445679|Paroxetine|paroxetine|mesh-list
101863686|NCT00445679|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101863687|NCT00445679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101863688|NCT00445679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101863689|NCT00445679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863690|NCT00445679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101863691|NCT00445679|Serotonin Agents|serotonin agents|mesh-ancestor
101863692|NCT00445679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863693|NCT00445679|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101863694|NCT00445679|Antidepressive Agents|antidepressive agents|mesh-ancestor
101863695|NCT00445679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101863696|NCT00445679|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101863697|NCT00445679|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101863698|NCT00445679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101863699|NCT00445601|Gemcitabine|gemcitabine|mesh-list
101863700|NCT00445601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101863701|NCT00445601|Antimetabolites|antimetabolites|mesh-ancestor
101863702|NCT00445601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863703|NCT00445601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863704|NCT00444587|Trastuzumab|trastuzumab|mesh-list
101863705|NCT00444587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101863706|NCT00444587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863707|NCT00235716|Vitamins|vitamins|mesh-list
101863708|NCT00235716|Vitamin E|vitamin e|mesh-list
101243256|NCT01638988|Clomiphene|clomiphene|mesh-list
101863709|NCT00235716|Tocopherols|tocopherols|mesh-list
101863710|NCT00235716|Tocotrienols|tocotrienols|mesh-list
101863711|NCT00235716|alpha-Tocopherol|alpha-tocopherol|mesh-list
101863712|NCT00235716|Memantine|memantine|mesh-list
101863713|NCT00235716|Micronutrients|micronutrients|mesh-ancestor
101863714|NCT00235716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863715|NCT00235716|Antioxidants|antioxidants|mesh-ancestor
101863716|NCT00235716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863717|NCT00235716|Protective Agents|protective agents|mesh-ancestor
101863718|NCT00235716|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101863719|NCT00235716|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101863720|NCT00235716|Dopamine Agents|dopamine agents|mesh-ancestor
101863721|NCT00235716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101863722|NCT00235716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101863723|NCT00235716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101863724|NCT00274742|Blinatumomab|blinatumomab|mesh-list
101863725|NCT00274742|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101863726|NCT00274742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863727|NCT00274742|Immunologic Factors|immunologic factors|mesh-ancestor
101863728|NCT00274742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863729|NCT03970044|Dapagliflozin|dapagliflozin|mesh-list
101863730|NCT03970044|Exenatide|exenatide|mesh-list
101863731|NCT03970044|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101863732|NCT03970044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863733|NCT03970044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101863734|NCT03970044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863735|NCT03970044|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101863736|NCT03970044|Incretins|incretins|mesh-ancestor
101863737|NCT03970044|Hormones|hormones|mesh-ancestor
101863738|NCT03970044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101863739|NCT00444275|Esomeprazole|esomeprazole|mesh-list
101863740|NCT00444275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101863741|NCT00444275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101863742|NCT00444275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101863743|NCT00444275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101863744|NCT00444275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863745|NCT00454805|Fulvestrant|fulvestrant|mesh-list
101863746|NCT00454805|Cediranib|cediranib|mesh-list
101863747|NCT00454805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101863748|NCT00454805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863749|NCT00454805|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101863750|NCT00454805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101863751|NCT00454805|Hormone Antagonists|hormone antagonists|mesh-ancestor
101863752|NCT00454805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101863753|NCT00454805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863754|NCT00454805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101863756|NCT00454805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863758|NCT00283244|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101863759|NCT00283244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101863760|NCT00283244|Antimetabolites|antimetabolites|mesh-ancestor
101863761|NCT00283244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863762|NCT00283244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863763|NCT00283244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101863764|NCT00283244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101863765|NCT00282464|Ziprasidone|ziprasidone|mesh-list
101863766|NCT00282464|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101863767|NCT00282464|Serotonin Agents|serotonin agents|mesh-ancestor
101863768|NCT00282464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101863769|NCT00282464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863770|NCT00282464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863771|NCT00282464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101863772|NCT00282464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101863773|NCT00282464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101863774|NCT00282464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101863775|NCT00282464|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101863776|NCT00282464|Dopamine Agents|dopamine agents|mesh-ancestor
101863777|NCT03841331|Serlopitant|serlopitant|mesh-list
101863778|NCT03841331|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101863779|NCT03841331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101863780|NCT03841331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863781|NCT03841331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863782|NCT00262080|Ecallantide|ecallantide|mesh-list
101863783|NCT00262080|Analgesics|analgesics|mesh-ancestor
101863784|NCT00262080|Sensory System Agents|sensory system agents|mesh-ancestor
101863785|NCT00262080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101863786|NCT00262080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863787|NCT00262080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101863788|NCT00262080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101863789|NCT00262080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101863790|NCT00262080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101863791|NCT01073904|Levonorgestrel|levonorgestrel|mesh-list
101863792|NCT01073904|Norgestrel|norgestrel|mesh-list
101863793|NCT01073904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101863794|NCT01073904|Contraceptive Agents|contraceptive agents|mesh-ancestor
101863795|NCT01073904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101863796|NCT01073904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863797|NCT01073904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101863798|NCT01073904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101863799|NCT01073904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101863800|NCT01073904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101863801|NCT00282308|Rituximab|rituximab|mesh-list
101863802|NCT00282308|Methotrexate|methotrexate|mesh-list
101863803|NCT00282308|Vaccines|vaccines|mesh-list
101863804|NCT00282308|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101863805|NCT00282308|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
101863806|NCT00282308|Immunologic Factors|immunologic factors|mesh-ancestor
101863807|NCT00282308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863808|NCT00282308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101863809|NCT00282308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863810|NCT00282308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101863811|NCT00282308|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101863812|NCT00282308|Abortifacient Agents|abortifacient agents|mesh-ancestor
101863813|NCT00282308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101687825|NCT02841839|Fluorides|fluorides|mesh-list
101863814|NCT00282308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101863815|NCT00282308|Antimetabolites|antimetabolites|mesh-ancestor
101863816|NCT00282308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863817|NCT00282308|Dermatologic Agents|dermatologic agents|mesh-ancestor
101863818|NCT00282308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101863819|NCT00282308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101863820|NCT00282308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101863821|NCT00282308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101863822|NCT00282308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101863824|NCT00281840|Docetaxel|docetaxel|mesh-list
101863825|NCT00281840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101863826|NCT00281840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863827|NCT00281840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101863828|NCT00281840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101863829|NCT00281840|Growth Substances|growth substances|mesh-ancestor
101863830|NCT00281840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863831|NCT00281840|Growth Inhibitors|growth inhibitors|mesh-ancestor
101863832|NCT00281840|Tubulin Modulators|tubulin modulators|mesh-ancestor
101863833|NCT00281840|Antimitotic Agents|antimitotic agents|mesh-ancestor
101863834|NCT00281840|Mitosis Modulators|mitosis modulators|mesh-ancestor
101863835|NCT00281840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863836|NCT00272792|Verapamil|verapamil|mesh-list
101863837|NCT00272792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101863838|NCT00272792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101863839|NCT00272792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101863840|NCT00272792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863841|NCT00272792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101863842|NCT00272792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863843|NCT00272792|Vasodilator Agents|vasodilator agents|mesh-ancestor
101863844|NCT01069094|Leuprolide|leuprolide|mesh-list
101863845|NCT01069094|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101863846|NCT01069094|Fertility Agents|fertility agents|mesh-ancestor
101863847|NCT01069094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101863848|NCT01069094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863849|NCT01069094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101863850|NCT01069094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863851|NCT00048568|Methotrexate|methotrexate|mesh-list
101863852|NCT00048568|Abatacept|abatacept|mesh-list
101863853|NCT00048568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101863854|NCT00048568|Abortifacient Agents|abortifacient agents|mesh-ancestor
101863855|NCT00048568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101863856|NCT00048568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863857|NCT00048568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101863858|NCT00048568|Antimetabolites|antimetabolites|mesh-ancestor
101863859|NCT00048568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863860|NCT00048568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863861|NCT00048568|Dermatologic Agents|dermatologic agents|mesh-ancestor
101863862|NCT00048568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101863863|NCT00048568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101863864|NCT00048568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101863865|NCT00048568|Immunologic Factors|immunologic factors|mesh-ancestor
101863866|NCT00048568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101863867|NCT00048568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101863868|NCT00048568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101863869|NCT00048568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101863870|NCT00262002|Vaccines|vaccines|mesh-list
101863871|NCT00262002|Immunologic Factors|immunologic factors|mesh-ancestor
101243316|NCT01639456|Alkylating Agents|alkylating agents|mesh-ancestor
101863872|NCT00262002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863873|NCT01584076|Donepezil|donepezil|mesh-list
101863874|NCT01584076|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101863875|NCT01584076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101863876|NCT01584076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863877|NCT01584076|Cholinergic Agents|cholinergic agents|mesh-ancestor
101863878|NCT01584076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101863879|NCT01584076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863880|NCT01584076|Nootropic Agents|nootropic agents|mesh-ancestor
101863881|NCT03954964|Analgesics, Opioid|analgesics, opioid|mesh-list
101863882|NCT03954964|Narcotics|narcotics|mesh-ancestor
101863883|NCT03954964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101863884|NCT03954964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863885|NCT03954964|Analgesics|analgesics|mesh-ancestor
101863886|NCT03954964|Sensory System Agents|sensory system agents|mesh-ancestor
101863887|NCT03954964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101863888|NCT00281528|Paclitaxel|paclitaxel|mesh-list
101863889|NCT00281528|Bevacizumab|bevacizumab|mesh-list
101863890|NCT00281528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101863891|NCT00281528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101863892|NCT00281528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863893|NCT00281528|Tubulin Modulators|tubulin modulators|mesh-ancestor
101863894|NCT00281528|Antimitotic Agents|antimitotic agents|mesh-ancestor
101863895|NCT00281528|Mitosis Modulators|mitosis modulators|mesh-ancestor
101863896|NCT00281528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863897|NCT00281528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101863898|NCT00281528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101863899|NCT00281528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101863900|NCT00281528|Growth Substances|growth substances|mesh-ancestor
101863901|NCT00281528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863902|NCT00281528|Growth Inhibitors|growth inhibitors|mesh-ancestor
101863904|NCT01095640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101863905|NCT01095640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101863906|NCT01095640|Analgesics|analgesics|mesh-ancestor
101863907|NCT01095640|Sensory System Agents|sensory system agents|mesh-ancestor
101863908|NCT01095640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101863909|NCT01095640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863910|NCT01095640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101863911|NCT01095640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101863912|NCT01095640|Dermatologic Agents|dermatologic agents|mesh-ancestor
101863913|NCT00280748|Pemetrexed|pemetrexed|mesh-list
101863914|NCT00280748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863915|NCT00280748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101863916|NCT00280748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863917|NCT00280748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101863918|NCT00280748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101863919|NCT03975374|Tobramycin|tobramycin|mesh-list
101863920|NCT03975374|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
101863921|NCT03975374|Dexamethasone|dexamethasone|mesh-list
101863922|NCT03975374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101863923|NCT03975374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101863924|NCT03975374|Antiemetics|antiemetics|mesh-ancestor
101863925|NCT03975374|Autonomic Agents|autonomic agents|mesh-ancestor
101863926|NCT03975374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101863927|NCT03975374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863928|NCT03975374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101863929|NCT03975374|Glucocorticoids|glucocorticoids|mesh-ancestor
101863930|NCT03975374|Hormones|hormones|mesh-ancestor
101863931|NCT03975374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101863932|NCT03975374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101863933|NCT03975374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863934|NCT03975374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101863935|NCT03975374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101863936|NCT03975374|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101863937|NCT00061048|Alemtuzumab|alemtuzumab|mesh-list
101863938|NCT00061048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101863939|NCT00061048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101863940|NCT01581398|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101863941|NCT01581398|Interferon-alpha|interferon-alpha|mesh-list
101863942|NCT01581398|Antiviral Agents|antiviral agents|mesh-ancestor
101863943|NCT01581398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101863944|NCT01581398|Immunologic Factors|immunologic factors|mesh-ancestor
101863945|NCT01581398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863946|NCT03976544|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101863947|NCT03976544|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101863948|NCT03976544|Estradiol|estradiol|mesh-list
101863949|NCT03976544|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101863950|NCT03976544|Progesterone|progesterone|mesh-list
101863951|NCT03976544|Estrogens|estrogens|mesh-ancestor
101863952|NCT03976544|Hormones|hormones|mesh-ancestor
101863953|NCT03976544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101863954|NCT03976544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863955|NCT03976544|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101863956|NCT03976544|Contraceptive Agents|contraceptive agents|mesh-ancestor
101863957|NCT03976544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101863958|NCT03976544|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101863959|NCT03976544|Progestins|progestins|mesh-ancestor
101863960|NCT03741686|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
101863961|NCT03741686|Cathartics|cathartics|mesh-ancestor
101863962|NCT03741686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101863963|NCT00279812|Selenium|selenium|mesh-list
101863964|NCT00279812|Antioxidants|antioxidants|mesh-ancestor
101863965|NCT00279812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101863966|NCT00279812|Protective Agents|protective agents|mesh-ancestor
101863967|NCT00279812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863968|NCT00279812|Trace Elements|trace elements|mesh-ancestor
101863969|NCT00279812|Micronutrients|micronutrients|mesh-ancestor
101863970|NCT01070732|Acetaminophen|acetaminophen|mesh-list
101863971|NCT01070732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101863972|NCT01070732|Analgesics|analgesics|mesh-ancestor
101863973|NCT01070732|Sensory System Agents|sensory system agents|mesh-ancestor
101863974|NCT01070732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101863975|NCT01070732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863977|NCT00207714|Infliximab|infliximab|mesh-list
101863978|NCT00207714|Golimumab|golimumab|mesh-list
101863979|NCT00207714|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101863980|NCT00207714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101863981|NCT00207714|Dermatologic Agents|dermatologic agents|mesh-ancestor
101863982|NCT00207714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101863983|NCT00207714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101863984|NCT00207714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101863985|NCT00207714|Immunologic Factors|immunologic factors|mesh-ancestor
101863986|NCT00207714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101863987|NCT00207090|Rifampin|rifampin|mesh-list
101863988|NCT00207090|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101863989|NCT00207090|Antitubercular Agents|antitubercular agents|mesh-ancestor
101863990|NCT00207090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101863991|NCT00207090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101863992|NCT00207090|Leprostatic Agents|leprostatic agents|mesh-ancestor
101863993|NCT00207090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101863994|NCT00207090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101863995|NCT00207090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243357|NCT01639573|Alemtuzumab|alemtuzumab|mesh-list
101863996|NCT00207090|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101863997|NCT00207090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101863998|NCT00207090|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101863999|NCT00207090|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101864000|NCT00207090|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101864001|NCT00207090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101864002|NCT00059332|Magnesium Sulfate|magnesium sulfate|mesh-list
101864003|NCT00059332|Analgesics|analgesics|mesh-ancestor
101864004|NCT00059332|Sensory System Agents|sensory system agents|mesh-ancestor
101864005|NCT00059332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101864006|NCT00059332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864007|NCT00059332|Anesthetics|anesthetics|mesh-ancestor
101864008|NCT00059332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101864009|NCT00059332|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101864010|NCT00059332|Anticonvulsants|anticonvulsants|mesh-ancestor
101864011|NCT00059332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101864012|NCT00059332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101864013|NCT00059332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864014|NCT00059332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101864015|NCT00059332|Tocolytic Agents|tocolytic agents|mesh-ancestor
101864016|NCT00059332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101864017|NCT00233454|Midostaurin|midostaurin|mesh-list
101864018|NCT00233454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101864019|NCT00233454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101687845|NCT04250831|Chromium|chromium|mesh-list
101864020|NCT00233454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101864021|NCT00233454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864022|NCT00047320|Carboplatin|carboplatin|mesh-list
101864023|NCT00047320|Etoposide|etoposide|mesh-list
101864024|NCT00047320|Ifosfamide|ifosfamide|mesh-list
101864025|NCT00047320|Isophosphamide mustard|isophosphamide mustard|mesh-list
101864026|NCT00047320|Thiotepa|thiotepa|mesh-list
101864027|NCT00047320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101864028|NCT00047320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101864029|NCT00047320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101864030|NCT00047320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101864031|NCT00047320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101864032|NCT00047320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864033|NCT00047320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101864034|NCT00047320|Alkylating Agents|alkylating agents|mesh-ancestor
101864035|NCT00047320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101864036|NCT00047320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101864037|NCT00047320|Immunologic Factors|immunologic factors|mesh-ancestor
101864038|NCT00047320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864039|NCT00233064|Palivizumab|palivizumab|mesh-list
101864040|NCT00233064|Antiviral Agents|antiviral agents|mesh-ancestor
101864041|NCT00233064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101864042|NCT03973086|Cardiac Glycosides|cardiac glycosides|mesh-list
101864043|NCT03973086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101864044|NCT03973086|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101864045|NCT03973086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101864046|NCT03973086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864047|NCT03973086|Protective Agents|protective agents|mesh-ancestor
101864048|NCT03973086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864049|NCT00206076|Mycophenolic Acid|mycophenolic acid|mesh-list
101864050|NCT00206076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101864051|NCT00206076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101864052|NCT00206076|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101864053|NCT00206076|Antitubercular Agents|antitubercular agents|mesh-ancestor
101864054|NCT00206076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101864055|NCT00206076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101864056|NCT00206076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101864057|NCT00206076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864058|NCT00278954|Immunoglobulins|immunoglobulins|mesh-list
101864059|NCT00278954|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101864060|NCT00278954|Antibodies|antibodies|mesh-list
101864061|NCT00278954|gamma-Globulins|gamma-globulins|mesh-list
101864062|NCT00278954|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101864063|NCT00278954|Immunologic Factors|immunologic factors|mesh-ancestor
101864064|NCT00278954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864065|NCT00278564|Methylprednisolone|methylprednisolone|mesh-list
101864066|NCT00278564|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101864067|NCT00278564|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101864068|NCT00278564|Prednisolone|prednisolone|mesh-list
101864069|NCT00278564|Prednisolone acetate|prednisolone acetate|mesh-list
101864070|NCT00278564|Cyclophosphamide|cyclophosphamide|mesh-list
101864071|NCT00278564|Rituximab|rituximab|mesh-list
101864072|NCT00278564|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101864073|NCT00278564|Prednisolone phosphate|prednisolone phosphate|mesh-list
101864074|NCT00278564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101864075|NCT00278564|Immunologic Factors|immunologic factors|mesh-ancestor
101864076|NCT00278564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864077|NCT00278564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101864078|NCT00278564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101864079|NCT00278564|Alkylating Agents|alkylating agents|mesh-ancestor
101864080|NCT00278564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864081|NCT00278564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101864082|NCT00278564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101864083|NCT00278564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101864084|NCT00278564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101864085|NCT00278564|Antiemetics|antiemetics|mesh-ancestor
101864086|NCT00278564|Autonomic Agents|autonomic agents|mesh-ancestor
101864087|NCT00278564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101864088|NCT00278564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101864089|NCT00278564|Glucocorticoids|glucocorticoids|mesh-ancestor
101864090|NCT00278564|Hormones|hormones|mesh-ancestor
101864091|NCT00278564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101864092|NCT00278564|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101864093|NCT00278564|Protective Agents|protective agents|mesh-ancestor
101864094|NCT00278564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101864095|NCT01071564|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
101864096|NCT01071564|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
101864097|NCT01071564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101864098|NCT01071564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864100|NCT00268346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101864101|NCT00268346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101864102|NCT00268346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101864103|NCT00268346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864104|NCT00250718|Levofloxacin|levofloxacin|mesh-list
101864105|NCT00250718|Ofloxacin|ofloxacin|mesh-list
101864106|NCT00250718|Dexamethasone|dexamethasone|mesh-list
101864107|NCT00250718|Rituximab|rituximab|mesh-list
101864108|NCT00250718|Etoposide|etoposide|mesh-list
101864109|NCT00250718|Vincristine|vincristine|mesh-list
101864110|NCT00250718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101864111|NCT00250718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101864112|NCT00250718|Immunologic Factors|immunologic factors|mesh-ancestor
101864113|NCT00250718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864114|NCT00250718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101864115|NCT00250718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101864116|NCT00250718|Antiemetics|antiemetics|mesh-ancestor
101864117|NCT00250718|Autonomic Agents|autonomic agents|mesh-ancestor
101864118|NCT00250718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101864119|NCT00250718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101864120|NCT00250718|Glucocorticoids|glucocorticoids|mesh-ancestor
101864121|NCT00250718|Hormones|hormones|mesh-ancestor
101864122|NCT00250718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101864123|NCT00250718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101864124|NCT00250718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101864125|NCT00250718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101864126|NCT00250718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101864127|NCT00250718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101864128|NCT00250718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864129|NCT00250718|Tubulin Modulators|tubulin modulators|mesh-ancestor
101864130|NCT00250718|Antimitotic Agents|antimitotic agents|mesh-ancestor
101864131|NCT00250718|Mitosis Modulators|mitosis modulators|mesh-ancestor
101864132|NCT00250718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101864133|NCT00250718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101864134|NCT00250718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101864135|NCT00250718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101864136|NCT00250718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101864138|NCT00276614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101864139|NCT00276458|Atorvastatin|atorvastatin|mesh-list
101864140|NCT00276458|Ezetimibe|ezetimibe|mesh-list
101864141|NCT00276458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101864142|NCT00276458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101864143|NCT00276458|Antimetabolites|antimetabolites|mesh-ancestor
101864144|NCT00276458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864145|NCT00276458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101864146|NCT00276458|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101864147|NCT00276458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101864148|NCT00276380|Aspirin|aspirin|mesh-list
101864149|NCT00276380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101864150|NCT00276380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101864151|NCT00276380|Analgesics|analgesics|mesh-ancestor
101864152|NCT00276380|Sensory System Agents|sensory system agents|mesh-ancestor
101864153|NCT00276380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101864154|NCT00276380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864155|NCT00276380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101864156|NCT00276380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101864157|NCT00276380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101864158|NCT00276380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101864159|NCT00276380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864160|NCT00276380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101864161|NCT00276380|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101864162|NCT00276380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101864163|NCT00276380|Antipyretics|antipyretics|mesh-ancestor
101864164|NCT02531984|Azithromycin|azithromycin|mesh-list
101864165|NCT02531984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101864166|NCT02531984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101864167|NCT00267956|Ustekinumab|ustekinumab|mesh-list
101864168|NCT00267956|Dermatologic Agents|dermatologic agents|mesh-ancestor
101864169|NCT00267488|Topotecan|topotecan|mesh-list
101864170|NCT00267488|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101864171|NCT00267488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101864172|NCT00267488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101864173|NCT00267488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864174|NCT00267488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101864175|NCT01073696|Granisetron|granisetron|mesh-list
101864176|NCT01073696|Antiemetics|antiemetics|mesh-ancestor
101864177|NCT01073696|Autonomic Agents|autonomic agents|mesh-ancestor
101864178|NCT01073696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101864179|NCT01073696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864180|NCT01073696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101864181|NCT01073696|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101864182|NCT01073696|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101864183|NCT01073696|Serotonin Agents|serotonin agents|mesh-ancestor
101864184|NCT01073696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101864185|NCT01073696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864187|NCT00058552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101864188|NCT00058552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101864189|NCT01093768|Vasopressins|vasopressins|mesh-list
101864190|NCT01093768|Arginine Vasopressin|arginine vasopressin|mesh-list
101864191|NCT01093768|Oxytocin|oxytocin|mesh-list
101864192|NCT01093768|Oxytocics|oxytocics|mesh-ancestor
101864193|NCT01093768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101864194|NCT01093768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864195|NCT01093768|Hemostatics|hemostatics|mesh-ancestor
101574895|NCT04219579|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101864196|NCT01093768|Coagulants|coagulants|mesh-ancestor
101864197|NCT01093768|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101864198|NCT01093768|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101864199|NCT01093768|Natriuretic Agents|natriuretic agents|mesh-ancestor
101864201|NCT00044512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101864202|NCT00044512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101864203|NCT00044512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101864204|NCT00044512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864205|NCT03805438|Chloroprocaine|chloroprocaine|mesh-list
101864206|NCT03805438|Anesthetics, Local|anesthetics, local|mesh-ancestor
101864207|NCT03805438|Anesthetics|anesthetics|mesh-ancestor
101864208|NCT03805438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101864209|NCT03805438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864210|NCT03805438|Sensory System Agents|sensory system agents|mesh-ancestor
101864211|NCT03805438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101864212|NCT01096420|Topiramate|topiramate|mesh-list
101864213|NCT01096420|Anticonvulsants|anticonvulsants|mesh-ancestor
101864214|NCT01096420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101864215|NCT01096420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864216|NCT03953716|Desogestrel|desogestrel|mesh-list
101864217|NCT03953716|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101864218|NCT03953716|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101864219|NCT03953716|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101864220|NCT03953716|Contraceptive Agents|contraceptive agents|mesh-ancestor
101864221|NCT03953716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101864222|NCT03953716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864223|NCT03953716|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101864224|NCT03953716|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101864225|NCT03953716|Progestins|progestins|mesh-ancestor
101864226|NCT03953716|Hormones|hormones|mesh-ancestor
101864227|NCT03953716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101864228|NCT01096498|Levonorgestrel|levonorgestrel|mesh-list
101864229|NCT01096498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101864230|NCT01096498|Contraceptive Agents|contraceptive agents|mesh-ancestor
101864231|NCT01096498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101864232|NCT01096498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864233|NCT01096498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101864234|NCT01096498|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101864235|NCT01096498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101864236|NCT00147537|Paclitaxel|paclitaxel|mesh-list
101864237|NCT00147537|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101864238|NCT00147537|Carboplatin|carboplatin|mesh-list
101864239|NCT00147537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101864240|NCT00147537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101864241|NCT00147537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101864242|NCT00147537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101864243|NCT00147537|Tubulin Modulators|tubulin modulators|mesh-ancestor
101864244|NCT00147537|Antimitotic Agents|antimitotic agents|mesh-ancestor
101864245|NCT00147537|Mitosis Modulators|mitosis modulators|mesh-ancestor
101864246|NCT00147537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864247|NCT00147537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101864248|NCT00147537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101864249|NCT00147537|Immunologic Factors|immunologic factors|mesh-ancestor
101864250|NCT00147537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864251|NCT00222729|Bevacizumab|bevacizumab|mesh-list
101864252|NCT00222729|Pemetrexed|pemetrexed|mesh-list
101864253|NCT00222729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101864254|NCT00222729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101864255|NCT00222729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101864257|NCT00222729|Growth Substances|growth substances|mesh-ancestor
101864258|NCT00222729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864259|NCT00222729|Growth Inhibitors|growth inhibitors|mesh-ancestor
101864260|NCT00222729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101864261|NCT00222729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864262|NCT00222729|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101864263|NCT00222729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101864264|NCT00147225|Carboplatin|carboplatin|mesh-list
101864265|NCT00147225|Doxorubicin|doxorubicin|mesh-list
101864266|NCT00147225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101864267|NCT00147225|Ifosfamide|ifosfamide|mesh-list
101864268|NCT00147225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101864269|NCT00147225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101864270|NCT00147225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101864271|NCT00147225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101864272|NCT00147225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101864273|NCT00147225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864274|NCT00147225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101864275|NCT00147225|Alkylating Agents|alkylating agents|mesh-ancestor
101864276|NCT00222105|Thalidomide|thalidomide|mesh-list
101864277|NCT00222105|Dexamethasone|dexamethasone|mesh-list
101864278|NCT00222105|Doxorubicin|doxorubicin|mesh-list
101864279|NCT00222105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101864280|NCT00222105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101864281|NCT00222105|Antiemetics|antiemetics|mesh-ancestor
101864282|NCT00222105|Autonomic Agents|autonomic agents|mesh-ancestor
101864283|NCT00222105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101243444|NCT01642771|Docetaxel|docetaxel|mesh-list
101864284|NCT00222105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864285|NCT00222105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101864286|NCT00222105|Glucocorticoids|glucocorticoids|mesh-ancestor
101864287|NCT00222105|Hormones|hormones|mesh-ancestor
101864288|NCT00222105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101864289|NCT00222105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101864290|NCT00222105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101864291|NCT00222105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101864292|NCT00222105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101864293|NCT00222105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101864294|NCT00222105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101864295|NCT00222105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864296|NCT00222105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101864297|NCT00222105|Immunologic Factors|immunologic factors|mesh-ancestor
101864298|NCT00222105|Leprostatic Agents|leprostatic agents|mesh-ancestor
101864299|NCT00222105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101864300|NCT00222105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101864301|NCT00222105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101864302|NCT00222105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101864303|NCT00222105|Growth Substances|growth substances|mesh-ancestor
101864304|NCT00222105|Growth Inhibitors|growth inhibitors|mesh-ancestor
101864305|NCT00247676|Sunitinib|sunitinib|mesh-list
101864306|NCT00247676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101864307|NCT00247676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101864308|NCT00247676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101227128|NCT01538641|Oxaliplatin|oxaliplatin|mesh-list
101864309|NCT00247676|Growth Substances|growth substances|mesh-ancestor
101864310|NCT00247676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864311|NCT00247676|Growth Inhibitors|growth inhibitors|mesh-ancestor
101864312|NCT00247676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101864313|NCT00247676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101864314|NCT00247676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864315|NCT00267020|Gemcitabine|gemcitabine|mesh-list
101864316|NCT00267020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101864317|NCT00267020|Antimetabolites|antimetabolites|mesh-ancestor
101864318|NCT00267020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864319|NCT00267020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101864320|NCT03975062|Dabigatran|dabigatran|mesh-list
101864321|NCT03975062|Antithrombins|antithrombins|mesh-ancestor
101864322|NCT03975062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101864323|NCT03975062|Protease Inhibitors|protease inhibitors|mesh-ancestor
101965832|NCT01616524|Interferon alpha-2|interferon alpha-2|mesh-list
101864324|NCT03975062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101864325|NCT03975062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864326|NCT03975062|Anticoagulants|anticoagulants|mesh-ancestor
101864327|NCT03970772|Glucagon|glucagon|mesh-list
101864328|NCT03970772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101864329|NCT03970772|Hormones|hormones|mesh-ancestor
101864330|NCT03970772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101864331|NCT03970772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864332|NCT00242216|Ritonavir|ritonavir|mesh-list
101864333|NCT00242216|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101864334|NCT00242216|Fosamprenavir|fosamprenavir|mesh-list
101864335|NCT00242216|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101864336|NCT00242216|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101864337|NCT00242216|Protease Inhibitors|protease inhibitors|mesh-ancestor
101864338|NCT00242216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101864339|NCT00242216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243462|NCT01642979|Cyclosporine|cyclosporine|mesh-list
101864340|NCT00242216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101864341|NCT00242216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101864342|NCT00242216|Antiviral Agents|antiviral agents|mesh-ancestor
101864343|NCT00242216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101864344|NCT00242216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101864345|NCT00242216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101864346|NCT00240110|Valproic Acid|valproic acid|mesh-list
101864347|NCT00240110|Lithium Carbonate|lithium carbonate|mesh-list
101864348|NCT00240110|Antidepressive Agents|antidepressive agents|mesh-ancestor
101864349|NCT00240110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101864350|NCT00240110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101864351|NCT00240110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864352|NCT00240110|Antimanic Agents|antimanic agents|mesh-ancestor
101864353|NCT00240110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101864354|NCT00240110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101864355|NCT00240110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864356|NCT00240110|Anticonvulsants|anticonvulsants|mesh-ancestor
101864357|NCT00240110|GABA Agents|gaba agents|mesh-ancestor
101864358|NCT00240110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101864359|NCT00239720|Muromonab-CD3|muromonab-cd3|mesh-list
101864360|NCT00239720|Immunologic Factors|immunologic factors|mesh-ancestor
101864361|NCT00239720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864362|NCT00239720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101864363|NCT02532140|Cefepime|cefepime|mesh-list
101864364|NCT02532140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101864365|NCT02532140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101864366|NCT00266864|Methyltestosterone|methyltestosterone|mesh-list
101864367|NCT00266864|Testosterone|testosterone|mesh-list
101864368|NCT00266864|Testosterone undecanoate|testosterone undecanoate|mesh-list
101864369|NCT00266864|Testosterone enanthate|testosterone enanthate|mesh-list
101864370|NCT00266864|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101864371|NCT00266864|Androgens|androgens|mesh-ancestor
101864372|NCT00266864|Hormones|hormones|mesh-ancestor
101864373|NCT00266864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101864374|NCT00266864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864375|NCT00266864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101864376|NCT00266864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101864377|NCT00266864|Anabolic Agents|anabolic agents|mesh-ancestor
101864378|NCT00266708|Risedronic Acid|risedronic acid|mesh-list
101864379|NCT00266708|Etidronic Acid|etidronic acid|mesh-list
101864380|NCT00266708|Diphosphonates|diphosphonates|mesh-list
101864381|NCT00266708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101687859|NCT02837081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101864382|NCT00266708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101864383|NCT00266708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864384|NCT00266708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101864385|NCT00266708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864386|NCT00266708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101864387|NCT00266630|Carbamazepine|carbamazepine|mesh-list
101864388|NCT00266630|Valproic Acid|valproic acid|mesh-list
101864389|NCT00266630|Olanzapine|olanzapine|mesh-list
101864390|NCT00266630|Antiemetics|antiemetics|mesh-ancestor
101864391|NCT00266630|Autonomic Agents|autonomic agents|mesh-ancestor
101864392|NCT00266630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101864393|NCT00266630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864394|NCT00266630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101864395|NCT00266630|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101864396|NCT00266630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101864397|NCT00266630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101864398|NCT00266630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101864399|NCT00266630|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101864400|NCT00266630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101864401|NCT00266630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101864402|NCT00266630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864403|NCT00266630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101864404|NCT00266630|Serotonin Agents|serotonin agents|mesh-ancestor
101864405|NCT00266630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101864406|NCT00266630|Antimanic Agents|antimanic agents|mesh-ancestor
101864407|NCT00266630|Anticonvulsants|anticonvulsants|mesh-ancestor
101864408|NCT00266630|GABA Agents|gaba agents|mesh-ancestor
101864409|NCT00266630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101864410|NCT00266630|Analgesics|analgesics|mesh-ancestor
101864411|NCT00266630|Sensory System Agents|sensory system agents|mesh-ancestor
101864412|NCT00266630|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101864413|NCT00266630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101864414|NCT00266630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101864415|NCT02531672|Choline|choline|mesh-list
101864416|NCT02531672|Lipotropic Agents|lipotropic agents|mesh-ancestor
101864417|NCT02531672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101864418|NCT02531672|Antimetabolites|antimetabolites|mesh-ancestor
101864419|NCT02531672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584274|NCT01128894|Liraglutide|liraglutide|mesh-list
101864420|NCT02531672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101864421|NCT02531672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101864422|NCT02531672|Nootropic Agents|nootropic agents|mesh-ancestor
101864423|NCT00129129|Vaccines|vaccines|mesh-list
101864424|NCT00129129|Immunologic Factors|immunologic factors|mesh-ancestor
101864425|NCT00129129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864426|NCT00221403|Valproic Acid|valproic acid|mesh-list
101864427|NCT00221403|Risperidone|risperidone|mesh-list
101864428|NCT00221403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101864429|NCT00221403|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101864430|NCT00221403|Serotonin Agents|serotonin agents|mesh-ancestor
101864431|NCT00221403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101864432|NCT00221403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864433|NCT00221403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864434|NCT00221403|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101864435|NCT00221403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101864436|NCT00221403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101864437|NCT00221403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101864438|NCT00221403|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101864439|NCT00221403|Dopamine Agents|dopamine agents|mesh-ancestor
101864440|NCT00221403|Anticonvulsants|anticonvulsants|mesh-ancestor
101864441|NCT00221403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101864442|NCT00221403|GABA Agents|gaba agents|mesh-ancestor
101864443|NCT00221403|Antimanic Agents|antimanic agents|mesh-ancestor
101864444|NCT00145977|Vitamin D|vitamin d|mesh-list
101864445|NCT00145977|Alendronate|alendronate|mesh-list
101864446|NCT00145977|Calcium|calcium|mesh-list
101864447|NCT00145977|Vitamins|vitamins|mesh-ancestor
101864448|NCT00145977|Micronutrients|micronutrients|mesh-ancestor
101864449|NCT00145977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864450|NCT00145977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101864451|NCT00145977|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101864452|NCT00238238|Rituximab|rituximab|mesh-list
101864453|NCT00238238|Lenalidomide|lenalidomide|mesh-list
101687862|NCT00633269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101864455|NCT00238238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101864456|NCT00238238|Immunologic Factors|immunologic factors|mesh-ancestor
101864457|NCT00238238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864458|NCT00238238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101864459|NCT00238238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101864460|NCT00238238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101864461|NCT00238238|Growth Substances|growth substances|mesh-ancestor
101864462|NCT00238238|Growth Inhibitors|growth inhibitors|mesh-ancestor
101864463|NCT01073852|Hydroxychloroquine|hydroxychloroquine|mesh-list
101864464|NCT01073852|Antimalarials|antimalarials|mesh-ancestor
101864465|NCT01073852|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101864466|NCT01073852|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101864467|NCT01073852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101864468|NCT01073852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101864469|NCT01073852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864470|NCT01073852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101864471|NCT01071122|Valsartan|valsartan|mesh-list
101864472|NCT01071122|Nifedipine|nifedipine|mesh-list
101864473|NCT01071122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101864474|NCT01071122|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101864475|NCT01071122|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101864476|NCT01071122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864477|NCT01071122|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101864478|NCT01071122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101864479|NCT01071122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101864480|NCT01071122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864481|NCT01071122|Vasodilator Agents|vasodilator agents|mesh-ancestor
101864482|NCT01071122|Tocolytic Agents|tocolytic agents|mesh-ancestor
101864483|NCT01071122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101864484|NCT01072604|Aspirin|aspirin|mesh-list
101864485|NCT01072604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101864486|NCT01072604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101864487|NCT01072604|Analgesics|analgesics|mesh-ancestor
101864488|NCT01072604|Sensory System Agents|sensory system agents|mesh-ancestor
101864489|NCT01072604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101864490|NCT01072604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864491|NCT01072604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101864492|NCT01072604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101864493|NCT01072604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101864494|NCT01072604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101864495|NCT01072604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864496|NCT01072604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101864497|NCT01072604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101864498|NCT01072604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101864500|NCT00128661|Vaccines|vaccines|mesh-list
101864501|NCT00128661|Immunologic Factors|immunologic factors|mesh-ancestor
101864502|NCT00128661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864503|NCT00145509|Asenapine|asenapine|mesh-list
101864504|NCT00145509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101864505|NCT00145509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101864506|NCT00145509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101864507|NCT00145509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864508|NCT00145509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101864509|NCT03965871|Esketamine|esketamine|mesh-list
101864510|NCT03965871|Antidepressive Agents|antidepressive agents|mesh-ancestor
101864511|NCT03965871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101864512|NCT03965949|Hormones|hormones|mesh-list
101864513|NCT03965949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101864514|NCT03965949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864515|NCT00220779|Immunoglobulins|immunoglobulins|mesh-list
101864516|NCT00220779|Antibodies|antibodies|mesh-list
101864517|NCT00220779|gamma-Globulins|gamma-globulins|mesh-list
101864518|NCT00220779|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101864519|NCT00220779|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101864520|NCT00220779|Immunoglobulin G|immunoglobulin g|mesh-list
101864521|NCT00220779|Immunologic Factors|immunologic factors|mesh-ancestor
101864522|NCT00220779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864523|NCT00207740|Golimumab|golimumab|mesh-list
101864524|NCT00207740|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101864525|NCT00207740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101864526|NCT00207740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101864527|NCT00207740|Immunologic Factors|immunologic factors|mesh-ancestor
101864528|NCT00207740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864530|NCT00265382|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101864531|NCT00265382|Serotonin Agents|serotonin agents|mesh-ancestor
101864532|NCT00265382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101864533|NCT00265382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864534|NCT00265382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864535|NCT00265382|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101864536|NCT00265382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101864537|NCT00265382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101864538|NCT00265382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101864539|NCT00265382|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101864540|NCT00265382|Dopamine Agents|dopamine agents|mesh-ancestor
101864542|NCT03974984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101864543|NCT03974984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864544|NCT00206726|Fludarabine|fludarabine|mesh-list
101864545|NCT00206726|Alemtuzumab|alemtuzumab|mesh-list
101864546|NCT00206726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101864547|NCT00206726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101864548|NCT00237458|Lacosamide|lacosamide|mesh-list
101864549|NCT00237458|Anticonvulsants|anticonvulsants|mesh-ancestor
101864550|NCT00237458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101864551|NCT00237458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101864552|NCT00237458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101864553|NCT00237458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864554|NCT01581788|Valproic Acid|valproic acid|mesh-list
101864555|NCT01581788|Anticonvulsants|anticonvulsants|mesh-ancestor
101864556|NCT01581788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101864557|NCT01581788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864558|NCT01581788|GABA Agents|gaba agents|mesh-ancestor
101864559|NCT01581788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101864560|NCT01581788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864561|NCT01581788|Antimanic Agents|antimanic agents|mesh-ancestor
101864562|NCT01581788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101864563|NCT01581788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101864564|NCT01581788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101864565|NCT00265148|Rosiglitazone|rosiglitazone|mesh-list
101864566|NCT00265148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101864567|NCT00265148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864568|NCT00043186|Denosumab|denosumab|mesh-list
101864569|NCT00043186|Alendronate|alendronate|mesh-list
101864570|NCT00043186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101864571|NCT00043186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864572|NCT00041470|Paclitaxel|paclitaxel|mesh-list
101864573|NCT00041470|Vinorelbine|vinorelbine|mesh-list
101864574|NCT00041470|Trastuzumab|trastuzumab|mesh-list
101584425|NCT00966693|Thalidomide|thalidomide|mesh-list
101864575|NCT00041470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101864576|NCT00041470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101864577|NCT00041470|Tubulin Modulators|tubulin modulators|mesh-ancestor
101864578|NCT00041470|Antimitotic Agents|antimitotic agents|mesh-ancestor
101864579|NCT00041470|Mitosis Modulators|mitosis modulators|mesh-ancestor
101864580|NCT00041470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864581|NCT00041470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101864582|NCT03953950|Losartan|losartan|mesh-list
101864583|NCT03953950|Spironolactone|spironolactone|mesh-list
101864584|NCT03953950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101864585|NCT03953950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101864586|NCT03953950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101864587|NCT03953950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101864588|NCT03953950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864589|NCT03953950|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101864590|NCT03953950|Hormone Antagonists|hormone antagonists|mesh-ancestor
101864591|NCT03953950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101864592|NCT03953950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864593|NCT03953950|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101864594|NCT03953950|Diuretics|diuretics|mesh-ancestor
101864595|NCT03953950|Natriuretic Agents|natriuretic agents|mesh-ancestor
101864596|NCT00206102|Risperidone|risperidone|mesh-list
101864597|NCT00206102|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101864598|NCT00206102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101864599|NCT00206102|Serotonin Agents|serotonin agents|mesh-ancestor
101864600|NCT00206102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101864601|NCT00206102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864602|NCT00206102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864603|NCT00206102|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101864604|NCT00206102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101864605|NCT00206102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101864606|NCT00206102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101864607|NCT00206102|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101864608|NCT00206102|Dopamine Agents|dopamine agents|mesh-ancestor
101864609|NCT00206102|Antidepressive Agents|antidepressive agents|mesh-ancestor
101864610|NCT03954262|Propofol|propofol|mesh-list
101864611|NCT03954262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101864612|NCT03954262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101864613|NCT03954262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864614|NCT03954262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101864615|NCT03954262|Anesthetics, General|anesthetics, general|mesh-ancestor
101864616|NCT03954262|Anesthetics|anesthetics|mesh-ancestor
101864617|NCT00041080|Tamoxifen|tamoxifen|mesh-list
101864618|NCT00041080|Thalidomide|thalidomide|mesh-list
101864619|NCT00041080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101864620|NCT00041080|Hormone Antagonists|hormone antagonists|mesh-ancestor
101864621|NCT00041080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101864622|NCT00041080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864623|NCT00041080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101864624|NCT00041080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101864625|NCT00041080|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101864626|NCT00041080|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101864627|NCT00041080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101864628|NCT00041080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101864629|NCT00041080|Immunologic Factors|immunologic factors|mesh-ancestor
101864630|NCT00041080|Leprostatic Agents|leprostatic agents|mesh-ancestor
101864631|NCT00041080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101864632|NCT00041080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101864633|NCT00041080|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101864634|NCT00041080|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101864635|NCT00041080|Growth Substances|growth substances|mesh-ancestor
101864636|NCT00041080|Growth Inhibitors|growth inhibitors|mesh-ancestor
101864637|NCT00205712|Dexmedetomidine|dexmedetomidine|mesh-list
101864638|NCT00205712|Ketamine|ketamine|mesh-list
101864639|NCT00205712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101864640|NCT00205712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101864641|NCT00205712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864642|NCT00205712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101864643|NCT00205712|Analgesics|analgesics|mesh-ancestor
101864644|NCT00205712|Sensory System Agents|sensory system agents|mesh-ancestor
101864645|NCT00205712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101864646|NCT00205712|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101864647|NCT00205712|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101864648|NCT00205712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101864649|NCT00205712|Adrenergic Agents|adrenergic agents|mesh-ancestor
101864650|NCT00205712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101864651|NCT00205712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864652|NCT00205712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101864653|NCT00205712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101864654|NCT00205712|Anesthetics, General|anesthetics, general|mesh-ancestor
101864655|NCT00205712|Anesthetics|anesthetics|mesh-ancestor
101864656|NCT00205712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101864657|NCT00205712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101864658|NCT03969758|Metronidazole|metronidazole|mesh-list
101864659|NCT03969758|Ciprofloxacin|ciprofloxacin|mesh-list
101864660|NCT03969758|Cefixime|cefixime|mesh-list
101864661|NCT03969758|Liver Extracts|liver extracts|mesh-list
101864662|NCT03969758|Hematinics|hematinics|mesh-ancestor
101864663|NCT03969758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101864664|NCT03969758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101864665|NCT03969758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101864666|NCT03969758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101864667|NCT03969758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101864668|NCT03969758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101864669|NCT03969758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101864670|NCT03969758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864671|NCT03969758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101864672|NCT03969758|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101864673|NCT03969758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101864674|NCT00203294|Triamcinolone|triamcinolone|mesh-list
101864675|NCT00203294|Lidocaine|lidocaine|mesh-list
101864676|NCT00203294|Bupivacaine|bupivacaine|mesh-list
101864677|NCT00203294|Anesthetics, Local|anesthetics, local|mesh-ancestor
101864678|NCT00203294|Anesthetics|anesthetics|mesh-ancestor
101864679|NCT00203294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101864680|NCT00203294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864681|NCT00203294|Sensory System Agents|sensory system agents|mesh-ancestor
101864682|NCT00203294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101864683|NCT00203294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101864684|NCT00203294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101864685|NCT00203294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101864686|NCT00203294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101864687|NCT00203294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864688|NCT00203294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101864689|NCT00203294|Glucocorticoids|glucocorticoids|mesh-ancestor
101864690|NCT00203294|Hormones|hormones|mesh-ancestor
101864691|NCT00203294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101864692|NCT01074086|Everolimus|everolimus|mesh-list
101864693|NCT01074086|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101864694|NCT01074086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101864695|NCT01074086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101864696|NCT01074086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864697|NCT01074086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101864698|NCT01074086|Immunologic Factors|immunologic factors|mesh-ancestor
101864699|NCT01074086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864700|NCT01074086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101864701|NCT00264290|Valganciclovir|valganciclovir|mesh-list
101864702|NCT00264290|Antiviral Agents|antiviral agents|mesh-ancestor
101864703|NCT00264290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101864704|NCT00234494|Bevacizumab|bevacizumab|mesh-list
101864705|NCT00234494|Gemcitabine|gemcitabine|mesh-list
101864706|NCT00234494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101864707|NCT00234494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101864708|NCT00234494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101864709|NCT00234494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101864710|NCT00234494|Growth Substances|growth substances|mesh-ancestor
101864711|NCT00234494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864712|NCT00234494|Growth Inhibitors|growth inhibitors|mesh-ancestor
101864713|NCT00234494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101864714|NCT00234494|Antimetabolites|antimetabolites|mesh-ancestor
101864715|NCT00234494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864716|NCT00234104|Tolvaptan|tolvaptan|mesh-list
101864717|NCT00234104|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101864718|NCT00234104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864719|NCT00234104|Natriuretic Agents|natriuretic agents|mesh-ancestor
101864720|NCT00234104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864721|NCT01582568|Certolizumab Pegol|certolizumab pegol|mesh-list
101864722|NCT01582568|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101864723|NCT01582568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101864724|NCT01582568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101864725|NCT01582568|Immunologic Factors|immunologic factors|mesh-ancestor
101864726|NCT01582568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864727|NCT01582568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101864728|NCT00195338|Etanercept|etanercept|mesh-list
101864729|NCT00195338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101864730|NCT00195338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101864731|NCT00195338|Analgesics|analgesics|mesh-ancestor
101864732|NCT00195338|Sensory System Agents|sensory system agents|mesh-ancestor
101864733|NCT00195338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101864734|NCT00195338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864735|NCT00195338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101864736|NCT00195338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101864737|NCT00195338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101864738|NCT00195338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101864739|NCT00195338|Immunologic Factors|immunologic factors|mesh-ancestor
101864740|NCT01096654|Epinephrine|epinephrine|mesh-list
101864741|NCT01096654|Racepinephrine|racepinephrine|mesh-list
101864742|NCT01096654|Epinephryl borate|epinephryl borate|mesh-list
101864743|NCT01096654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101864744|NCT01096654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101864745|NCT01096654|Adrenergic Agents|adrenergic agents|mesh-ancestor
101864746|NCT01096654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101864747|NCT01096654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864748|NCT01096654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864749|NCT01096654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101243561|NCT01646619|Anesthetics|anesthetics|mesh-ancestor
101864750|NCT01096654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101864751|NCT01096654|Autonomic Agents|autonomic agents|mesh-ancestor
101864752|NCT01096654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101864753|NCT01096654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101864754|NCT01096654|Respiratory System Agents|respiratory system agents|mesh-ancestor
101864756|NCT01096654|Sympathomimetics|sympathomimetics|mesh-ancestor
101864757|NCT01096654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101864758|NCT00035932|Ritonavir|ritonavir|mesh-list
101864759|NCT00035932|Lopinavir|lopinavir|mesh-list
101864760|NCT00035932|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101864761|NCT00035932|Saquinavir|saquinavir|mesh-list
101864762|NCT00035932|Tenofovir|tenofovir|mesh-list
101864763|NCT00035932|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101864764|NCT00035932|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101864765|NCT00035932|Protease Inhibitors|protease inhibitors|mesh-ancestor
101864766|NCT00035932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101864767|NCT00035932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864768|NCT00035932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101864769|NCT00035932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101864770|NCT00035932|Antiviral Agents|antiviral agents|mesh-ancestor
101864771|NCT00035932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101864772|NCT00035932|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101864773|NCT00035932|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101864774|NCT00035932|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101864775|NCT00035932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101864776|NCT03953326|Nitroprusside|nitroprusside|mesh-list
101864777|NCT03953326|Acetylcholine|acetylcholine|mesh-list
101864778|NCT03953326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101864779|NCT03953326|Vasodilator Agents|vasodilator agents|mesh-ancestor
101864780|NCT03953326|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101864781|NCT03953326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864782|NCT03953326|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101864783|NCT03953326|Cholinergic Agents|cholinergic agents|mesh-ancestor
101864784|NCT03953326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101864785|NCT03953326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864786|NCT01097278|Cholecalciferol|cholecalciferol|mesh-list
101864787|NCT01097278|Vitamin D|vitamin d|mesh-list
101864788|NCT01097278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101584650|NCT00648661|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101864789|NCT01097278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584651|NCT00648661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101584652|NCT00648661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101584653|NCT00648661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584654|NCT00648661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101864790|NCT01097278|Vitamins|vitamins|mesh-ancestor
101864791|NCT01097278|Micronutrients|micronutrients|mesh-ancestor
101864792|NCT01097278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101864793|NCT00022516|Cyclophosphamide|cyclophosphamide|mesh-list
101864794|NCT00022516|Methotrexate|methotrexate|mesh-list
101864795|NCT00022516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101864796|NCT00022516|Immunologic Factors|immunologic factors|mesh-ancestor
101864797|NCT00022516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864798|NCT00022516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101864799|NCT00022516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101864800|NCT00022516|Alkylating Agents|alkylating agents|mesh-ancestor
101864801|NCT00022516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864802|NCT00022516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101864803|NCT00022516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101864804|NCT00022516|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101864805|NCT00022516|Abortifacient Agents|abortifacient agents|mesh-ancestor
101864806|NCT00022516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101864807|NCT00022516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101864808|NCT00022516|Antimetabolites|antimetabolites|mesh-ancestor
101864809|NCT00022516|Dermatologic Agents|dermatologic agents|mesh-ancestor
101864810|NCT00022516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101864811|NCT00022516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101864812|NCT00022516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101864814|NCT01097512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101864815|NCT01097512|Antimetabolites|antimetabolites|mesh-ancestor
101864816|NCT01097512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864817|NCT01097512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101864818|NCT00033514|Trastuzumab|trastuzumab|mesh-list
101864819|NCT00033514|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101864820|NCT00033514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101864821|NCT00033514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101864822|NCT00033514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101864823|NCT00033514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101864824|NCT00033514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864825|NCT00006916|Bleomycin|bleomycin|mesh-list
101864826|NCT00006916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101864827|NCT00006916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101864828|NCT02529982|Curcumin|curcumin|mesh-list
101864829|NCT02529982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101864830|NCT02529982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101864831|NCT02529982|Analgesics|analgesics|mesh-ancestor
101864832|NCT02529982|Sensory System Agents|sensory system agents|mesh-ancestor
101864833|NCT02529982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101864834|NCT02529982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864835|NCT02529982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101864836|NCT02529982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101864837|NCT02529982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101864838|NCT02529982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101864839|NCT02529982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864840|NCT00454649|Paclitaxel|paclitaxel|mesh-list
101864841|NCT00454649|Docetaxel|docetaxel|mesh-list
101864842|NCT00454649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101864843|NCT00454649|Cisplatin|cisplatin|mesh-list
101864844|NCT00454649|Carboplatin|carboplatin|mesh-list
101864845|NCT00454649|Gemcitabine|gemcitabine|mesh-list
101864846|NCT00454649|Capecitabine|capecitabine|mesh-list
101864847|NCT00454649|Pemetrexed|pemetrexed|mesh-list
101864848|NCT00454649|Axitinib|axitinib|mesh-list
101864849|NCT00454649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101864850|NCT00454649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101864851|NCT00454649|Tubulin Modulators|tubulin modulators|mesh-ancestor
101864852|NCT00454649|Antimitotic Agents|antimitotic agents|mesh-ancestor
101864853|NCT00454649|Mitosis Modulators|mitosis modulators|mesh-ancestor
101864854|NCT00454649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864855|NCT00454649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101864856|NCT00454649|Antimetabolites|antimetabolites|mesh-ancestor
101864857|NCT00454649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101864858|NCT00454649|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101864859|NCT00454649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101243598|NCT01648777|Bupivacaine|bupivacaine|mesh-list
101864860|NCT00454649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101864861|NCT00454571|Leuprolide|leuprolide|mesh-list
101864862|NCT00454571|Goserelin|goserelin|mesh-list
101864863|NCT00454571|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101864864|NCT00454571|Fertility Agents|fertility agents|mesh-ancestor
101584735|NCT00648193|Paroxetine|paroxetine|mesh-list
101864865|NCT00454571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101864866|NCT00454571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864867|NCT00454571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101864868|NCT00454571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101864870|NCT01323257|Darunavir|darunavir|mesh-list
101864871|NCT01323257|Erythromycin|erythromycin|mesh-list
101864872|NCT01323257|Erythromycin Estolate|erythromycin estolate|mesh-list
101864873|NCT01323257|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101864874|NCT01323257|Erythromycin stearate|erythromycin stearate|mesh-list
101864875|NCT01323257|Simeprevir|simeprevir|mesh-list
101864876|NCT01323257|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101864877|NCT01323257|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101864878|NCT01323257|Protease Inhibitors|protease inhibitors|mesh-ancestor
101864879|NCT01323257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101864880|NCT01323257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864881|NCT01323257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101864882|NCT01323257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101864883|NCT01323257|Antiviral Agents|antiviral agents|mesh-ancestor
101864885|NCT01323257|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101965870|NCT02263690|Lidocaine|lidocaine|mesh-list
101864886|NCT01323257|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101864887|NCT01323257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101864888|NCT01323257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101864889|NCT01323257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101864890|NCT03837743|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101864892|NCT01323335|Uric Acid|uric acid|mesh-list
101864893|NCT01323335|Gout Suppressants|gout suppressants|mesh-ancestor
101864894|NCT01323335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101864895|NCT01323335|Antioxidants|antioxidants|mesh-ancestor
101864896|NCT01323335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864897|NCT01323335|Protective Agents|protective agents|mesh-ancestor
101864898|NCT01323335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864899|NCT03836729|Tenofovir|tenofovir|mesh-list
101864900|NCT03836729|Emtricitabine|emtricitabine|mesh-list
101864901|NCT03836729|Antiviral Agents|antiviral agents|mesh-ancestor
101864902|NCT03836729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101864903|NCT03836729|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101864904|NCT03836729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101864905|NCT03836729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101864906|NCT03836729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864907|NCT03836729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101864908|NCT03836729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101864909|NCT01027481|Ranibizumab|ranibizumab|mesh-list
101864910|NCT01027481|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101864911|NCT01027481|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101864912|NCT01027481|Growth Substances|growth substances|mesh-ancestor
101864913|NCT01027481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864914|NCT01027481|Growth Inhibitors|growth inhibitors|mesh-ancestor
101864915|NCT01027481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101864916|NCT00443729|Ritonavir|ritonavir|mesh-list
101864917|NCT00443729|Lopinavir|lopinavir|mesh-list
101864918|NCT00443729|Raltegravir Potassium|raltegravir potassium|mesh-list
101864919|NCT00443729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101864920|NCT00443729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101864921|NCT00443729|Protease Inhibitors|protease inhibitors|mesh-ancestor
101864922|NCT00443729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101864923|NCT00443729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864924|NCT00443729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101864925|NCT00443729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101864926|NCT00443729|Antiviral Agents|antiviral agents|mesh-ancestor
101864927|NCT00443729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101864928|NCT00443729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101864929|NCT00443729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101864930|NCT00443729|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101864931|NCT00443729|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101864932|NCT00443651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101864933|NCT00443651|Rituximab|rituximab|mesh-list
101864934|NCT00443651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101864935|NCT00443651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101864936|NCT00443651|Immunologic Factors|immunologic factors|mesh-ancestor
101864937|NCT00443651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864938|NCT00443651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101864939|NCT01027715|Anticonvulsants|anticonvulsants|mesh-list
101864940|NCT03567473|Dexamethasone|dexamethasone|mesh-list
101864941|NCT03567473|Dexamethasone acetate|dexamethasone acetate|mesh-list
101864942|NCT03567473|Epinephrine|epinephrine|mesh-list
101864943|NCT03567473|Racepinephrine|racepinephrine|mesh-list
101864944|NCT03567473|Epinephryl borate|epinephryl borate|mesh-list
101864945|NCT03567473|BB 1101|bb 1101|mesh-list
101864946|NCT03567473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101864947|NCT03567473|Antiemetics|antiemetics|mesh-ancestor
101864948|NCT03567473|Autonomic Agents|autonomic agents|mesh-ancestor
101864949|NCT03567473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101864950|NCT03567473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864951|NCT03567473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101864952|NCT03567473|Glucocorticoids|glucocorticoids|mesh-ancestor
101864953|NCT03567473|Hormones|hormones|mesh-ancestor
101864954|NCT03567473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101864955|NCT03567473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101864956|NCT03567473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101864957|NCT03567473|Protease Inhibitors|protease inhibitors|mesh-ancestor
101864958|NCT03567473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101864959|NCT03567473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243629|NCT01650129|Insulin|insulin|mesh-list
101864960|NCT03567473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101864961|NCT03567473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101864962|NCT03567473|Adrenergic Agents|adrenergic agents|mesh-ancestor
101864963|NCT03567473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101864964|NCT03567473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101864965|NCT03567473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101864966|NCT03567473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101864967|NCT03567473|Respiratory System Agents|respiratory system agents|mesh-ancestor
101864969|NCT03567473|Sympathomimetics|sympathomimetics|mesh-ancestor
101864970|NCT03567473|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101864971|NCT00443261|Azacitidine|azacitidine|mesh-list
101864972|NCT00443261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101864973|NCT00443261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101864974|NCT00443261|Antimetabolites|antimetabolites|mesh-ancestor
101864975|NCT00443261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101864976|NCT00443261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101864977|NCT00439517|Cetuximab|cetuximab|mesh-list
101864978|NCT00439517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101864979|NCT00439517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101864980|NCT01028261|CKD732|ckd732|mesh-list
101864981|NCT01028261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101864982|NCT01028261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101864983|NCT01028261|Growth Substances|growth substances|mesh-ancestor
101864984|NCT01028261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864985|NCT01028261|Growth Inhibitors|growth inhibitors|mesh-ancestor
101864986|NCT01028261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101864987|NCT01028339|Mannitol|mannitol|mesh-list
101864988|NCT01028339|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101864989|NCT01028339|Diuretics|diuretics|mesh-ancestor
101864990|NCT01028339|Natriuretic Agents|natriuretic agents|mesh-ancestor
101864991|NCT01028339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101864992|NCT01031459|Interferons|interferons|mesh-list
101864993|NCT01031459|Interferon-beta|interferon-beta|mesh-list
101864994|NCT01031459|Interferon beta-1b|interferon beta-1b|mesh-list
101864995|NCT01031459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101864996|NCT01031459|Antiviral Agents|antiviral agents|mesh-ancestor
101864997|NCT01031459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101864998|NCT01031459|Immunologic Factors|immunologic factors|mesh-ancestor
101864999|NCT01031459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865000|NCT01031459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101865001|NCT00438815|Complement C1s|complement c1s|mesh-list
101865002|NCT00438815|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
101865003|NCT00438815|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
101865004|NCT00438815|Immunologic Factors|immunologic factors|mesh-ancestor
101865005|NCT00438815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865006|NCT00438815|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101865007|NCT00438815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101865008|NCT00438659|Mometasone Furoate|mometasone furoate|mesh-list
101865009|NCT00438659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101865010|NCT00438659|Dermatologic Agents|dermatologic agents|mesh-ancestor
101865011|NCT00438659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101865012|NCT01028495|Gemcitabine|gemcitabine|mesh-list
101865013|NCT01028495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101865014|NCT01028495|Antimetabolites|antimetabolites|mesh-ancestor
101865015|NCT01028495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865016|NCT01028495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101865017|NCT00437645|Amlodipine|amlodipine|mesh-list
101865018|NCT00437645|Valsartan|valsartan|mesh-list
101865019|NCT00437645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101865020|NCT00437645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101865021|NCT00437645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101865022|NCT00437645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865023|NCT00437645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101865024|NCT00437645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865026|NCT00437645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101865027|NCT00437645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101865028|NCT03995147|Prednisone|prednisone|mesh-list
101865029|NCT03995147|Cyclophosphamide|cyclophosphamide|mesh-list
101865030|NCT03995147|Doxorubicin|doxorubicin|mesh-list
101865032|NCT03995147|Vincristine|vincristine|mesh-list
101865033|NCT03995147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101865034|NCT03995147|Immunologic Factors|immunologic factors|mesh-ancestor
101865035|NCT03995147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865037|NCT03995147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101865038|NCT03995147|Alkylating Agents|alkylating agents|mesh-ancestor
101865039|NCT03995147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865040|NCT03995147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101865041|NCT03995147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101865042|NCT03995147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101865043|NCT03995147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101865044|NCT03995147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101865045|NCT03995147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101865046|NCT03995147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101865047|NCT03995147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101865048|NCT03995147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101865049|NCT03995147|Glucocorticoids|glucocorticoids|mesh-ancestor
101865050|NCT03995147|Hormones|hormones|mesh-ancestor
101865051|NCT03995147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101865052|NCT03995147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101865053|NCT03995147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101865054|NCT03995147|Tubulin Modulators|tubulin modulators|mesh-ancestor
101865055|NCT03995147|Antimitotic Agents|antimitotic agents|mesh-ancestor
101865056|NCT03995147|Mitosis Modulators|mitosis modulators|mesh-ancestor
101865057|NCT00437489|Insulin|insulin|mesh-list
101865058|NCT00437489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101865059|NCT00437489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101865060|NCT00437489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865061|NCT01028573|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101865062|NCT01028573|Laxatives|laxatives|mesh-ancestor
101865063|NCT01028573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101865064|NCT04683575|Selenium|selenium|mesh-list
101865065|NCT04683575|Antioxidants|antioxidants|mesh-ancestor
101865066|NCT04683575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865067|NCT04683575|Protective Agents|protective agents|mesh-ancestor
101865068|NCT04683575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865069|NCT04683575|Trace Elements|trace elements|mesh-ancestor
101865070|NCT04683575|Micronutrients|micronutrients|mesh-ancestor
101865071|NCT00442559|Montelukast|montelukast|mesh-list
101865072|NCT00442559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101865073|NCT00442559|Respiratory System Agents|respiratory system agents|mesh-ancestor
101865074|NCT00442559|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101865075|NCT00442559|Hormone Antagonists|hormone antagonists|mesh-ancestor
101865076|NCT00442559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101865077|NCT00442559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865078|NCT00442559|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101865079|NCT00442559|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101865080|NCT00442559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865081|NCT01323491|Nicotine|nicotine|mesh-list
101865082|NCT01323491|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101865083|NCT01323491|Autonomic Agents|autonomic agents|mesh-ancestor
101865084|NCT01323491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101865085|NCT01323491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865086|NCT01323491|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101865087|NCT01323491|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101865088|NCT01323491|Cholinergic Agents|cholinergic agents|mesh-ancestor
101865089|NCT01323491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101865090|NCT01323491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865091|NCT00441545|Sevelamer|sevelamer|mesh-list
101865092|NCT00441545|Chelating Agents|chelating agents|mesh-ancestor
101865093|NCT00441545|Sequestering Agents|sequestering agents|mesh-ancestor
101865094|NCT00441545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865096|NCT00436553|Verteporfin|verteporfin|mesh-list
101865097|NCT00436553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101865098|NCT00436553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101865099|NCT00436553|Growth Substances|growth substances|mesh-ancestor
101865100|NCT00436553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865101|NCT00436553|Growth Inhibitors|growth inhibitors|mesh-ancestor
101865102|NCT00436553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101865103|NCT00436553|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101775325|NCT00680186|Dabigatran|dabigatran|mesh-list
101865104|NCT00436553|Dermatologic Agents|dermatologic agents|mesh-ancestor
101865105|NCT01028729|Gemcitabine|gemcitabine|mesh-list
101865106|NCT01028729|Endostar protein|endostar protein|mesh-list
101865107|NCT01028729|Endostatins|endostatins|mesh-list
101865108|NCT01028729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101865109|NCT01028729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101865110|NCT01028729|Antimetabolites|antimetabolites|mesh-ancestor
101865111|NCT01028729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865112|NCT01028729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101865113|NCT01028729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101865114|NCT01028729|Growth Substances|growth substances|mesh-ancestor
101865115|NCT01028729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865116|NCT01028729|Growth Inhibitors|growth inhibitors|mesh-ancestor
101865117|NCT03357419|Clindamycin|clindamycin|mesh-list
101865118|NCT03357419|Clindamycin palmitate|clindamycin palmitate|mesh-list
101865119|NCT03357419|Clindamycin phosphate|clindamycin phosphate|mesh-list
101865121|NCT03357419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101865122|NCT03357419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101865123|NCT03357419|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101865124|NCT03357419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101865125|NCT03357419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865126|NCT01031927|Glycine|glycine|mesh-list
101865127|NCT01031927|Glycine Agents|glycine agents|mesh-ancestor
101865128|NCT01031927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101865129|NCT01031927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865130|NCT01031927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865131|NCT01032083|Citalopram|citalopram|mesh-list
101865132|NCT01032083|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101865133|NCT01032083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101865134|NCT01032083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101865135|NCT01032083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865136|NCT01032083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101865137|NCT01032083|Serotonin Agents|serotonin agents|mesh-ancestor
101865138|NCT01032083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865139|NCT01032083|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101865140|NCT01032083|Antidepressive Agents|antidepressive agents|mesh-ancestor
101865141|NCT01032083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101865142|NCT00436163|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101865143|NCT00436163|Antiviral Agents|antiviral agents|mesh-ancestor
101865144|NCT00436163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101865145|NCT00006604|Ritonavir|ritonavir|mesh-list
101865146|NCT00006604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101865147|NCT00006604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101865148|NCT00006604|Protease Inhibitors|protease inhibitors|mesh-ancestor
101865149|NCT00006604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101865150|NCT00006604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865151|NCT00006604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101865152|NCT00006604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101865153|NCT00006604|Antiviral Agents|antiviral agents|mesh-ancestor
101865154|NCT00006604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101865155|NCT00006604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101865156|NCT00006604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101865157|NCT00006478|Sargramostim|sargramostim|mesh-list
101865158|NCT00006478|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
101865159|NCT00006478|Immunologic Factors|immunologic factors|mesh-ancestor
101865160|NCT00006478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865161|NCT00006478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101865162|NCT01097902|Ibuprofen|ibuprofen|mesh-list
101243746|NCT01650662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865163|NCT01097902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101865164|NCT01097902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101865165|NCT01097902|Analgesics|analgesics|mesh-ancestor
101865166|NCT01097902|Sensory System Agents|sensory system agents|mesh-ancestor
101865167|NCT01097902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101865168|NCT01097902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865169|NCT01097902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101865170|NCT01097902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101865171|NCT01097902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101865172|NCT01097902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101865173|NCT01097902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865175|NCT00436007|Immunologic Factors|immunologic factors|mesh-ancestor
101865176|NCT00436007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865178|NCT00435461|Xhance|xhance|mesh-list
101865179|NCT00435461|Fexofenadine|fexofenadine|mesh-list
101865180|NCT00435461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101865181|NCT00435461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101865182|NCT00435461|Autonomic Agents|autonomic agents|mesh-ancestor
101865183|NCT00435461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101865184|NCT00435461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865185|NCT00435461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101865186|NCT00435461|Respiratory System Agents|respiratory system agents|mesh-ancestor
101865187|NCT00435461|Dermatologic Agents|dermatologic agents|mesh-ancestor
101865188|NCT00435461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101865189|NCT00435461|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101865190|NCT00435461|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101865191|NCT00435461|Histamine Antagonists|histamine antagonists|mesh-ancestor
101865192|NCT00435461|Histamine Agents|histamine agents|mesh-ancestor
101865193|NCT00435461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101865194|NCT00435461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865195|NCT01097980|Trazodone|trazodone|mesh-list
101865196|NCT01097980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101865197|NCT01097980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101865198|NCT01097980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101865199|NCT01097980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865200|NCT01097980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101865201|NCT01097980|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101865202|NCT01097980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101865203|NCT01097980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101865204|NCT01097980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865205|NCT01097980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101865206|NCT01097980|Serotonin Agents|serotonin agents|mesh-ancestor
101865207|NCT01097980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101865208|NCT01097980|Antidepressive Agents|antidepressive agents|mesh-ancestor
101865209|NCT01029275|Octreotide|octreotide|mesh-list
101865210|NCT01029275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101865211|NCT01029275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101865212|NCT01029275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101865213|NCT04829903|Liraglutide|liraglutide|mesh-list
101865214|NCT04829903|Dulaglutide|dulaglutide|mesh-list
101865215|NCT04829903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101865216|NCT04829903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865217|NCT04829903|Incretins|incretins|mesh-ancestor
101865218|NCT04829903|Hormones|hormones|mesh-ancestor
101865219|NCT04829903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101865220|NCT00440999|Artesunate|artesunate|mesh-list
101865221|NCT00440999|Chloroquine|chloroquine|mesh-list
101865222|NCT00440999|Pyronaridine|pyronaridine|mesh-list
101865223|NCT00440999|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
101865224|NCT00440999|Antimalarials|antimalarials|mesh-ancestor
101865225|NCT00440999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101865226|NCT00440999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101865227|NCT00440999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101865228|NCT00440999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101865229|NCT00440999|Antiviral Agents|antiviral agents|mesh-ancestor
101865230|NCT00440999|Schistosomicides|schistosomicides|mesh-ancestor
101865231|NCT00440999|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101865232|NCT00440999|Anthelmintics|anthelmintics|mesh-ancestor
101865233|NCT00440999|Amebicides|amebicides|mesh-ancestor
101865234|NCT00440999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101865235|NCT00434213|Methylphenidate|methylphenidate|mesh-list
101865236|NCT00434213|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101865237|NCT00434213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865238|NCT00434213|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101865239|NCT00434213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101865240|NCT00434213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101865241|NCT00434213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865242|NCT00434213|Dopamine Agents|dopamine agents|mesh-ancestor
101865243|NCT00434213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101865245|NCT01029743|PENTA|penta|mesh-list
101865246|NCT01029743|Rivaroxaban|rivaroxaban|mesh-list
101865247|NCT01029743|Fondaparinux|fondaparinux|mesh-list
101865248|NCT01029743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101865249|NCT01029743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101865251|NCT01029743|Sensory System Agents|sensory system agents|mesh-ancestor
101865252|NCT01029743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101865253|NCT01029743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865254|NCT01029743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101865255|NCT01029743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101865256|NCT01029743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101865257|NCT01029743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101865258|NCT01029743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865259|NCT01029743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101865260|NCT01029743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101865261|NCT01029743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101865262|NCT01029743|Antipyretics|antipyretics|mesh-ancestor
101865263|NCT01029743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101865264|NCT01029743|Antithrombins|antithrombins|mesh-ancestor
101865265|NCT01029743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101865266|NCT01029743|Protease Inhibitors|protease inhibitors|mesh-ancestor
101865267|NCT01029743|Anticoagulants|anticoagulants|mesh-ancestor
101865268|NCT01029821|Heparin|heparin|mesh-list
101865269|NCT01029821|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101865270|NCT01029821|Tinzaparin|tinzaparin|mesh-list
101865271|NCT01029821|Dalteparin|dalteparin|mesh-list
101865272|NCT01029821|Anticoagulants|anticoagulants|mesh-ancestor
101865273|NCT01029821|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101865274|NCT01029821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101865275|NCT01029821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865276|NCT00006184|Cyclosporine|cyclosporine|mesh-list
101865277|NCT00006184|Prednisone|prednisone|mesh-list
101865278|NCT00006184|Cyclophosphamide|cyclophosphamide|mesh-list
101865279|NCT00006184|Doxorubicin|doxorubicin|mesh-list
101865280|NCT00006184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101865281|NCT00006184|Methotrexate|methotrexate|mesh-list
101865282|NCT00006184|Fludarabine|fludarabine|mesh-list
101865283|NCT00006184|Fludarabine phosphate|fludarabine phosphate|mesh-list
101865284|NCT00006184|Etoposide|etoposide|mesh-list
101865285|NCT00006184|Vincristine|vincristine|mesh-list
101865286|NCT00006184|Bortezomib|bortezomib|mesh-list
101865287|NCT00006184|Molgramostim|molgramostim|mesh-list
101865288|NCT00006184|Cyclosporins|cyclosporins|mesh-list
101865289|NCT00006184|Immunoglobulins|immunoglobulins|mesh-list
101865290|NCT00006184|Lenograstim|lenograstim|mesh-list
101865291|NCT00006184|Sargramostim|sargramostim|mesh-list
101865292|NCT00006184|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
101865293|NCT00006184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101865294|NCT00006184|Immunologic Factors|immunologic factors|mesh-ancestor
101865295|NCT00006184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865296|NCT00006184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101865297|NCT00006184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101865298|NCT00006184|Alkylating Agents|alkylating agents|mesh-ancestor
101243772|NCT01650870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101865299|NCT00006184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865300|NCT00006184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101865301|NCT00006184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101865302|NCT00006184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101865303|NCT00006184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101865304|NCT00006184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101865305|NCT00006184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101865306|NCT00006184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101865307|NCT00006184|Glucocorticoids|glucocorticoids|mesh-ancestor
101865308|NCT00006184|Hormones|hormones|mesh-ancestor
101865309|NCT00006184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101865310|NCT00006184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101865311|NCT00006184|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101865312|NCT00006184|Abortifacient Agents|abortifacient agents|mesh-ancestor
101865313|NCT00006184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101865314|NCT00006184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101865315|NCT00006184|Antimetabolites|antimetabolites|mesh-ancestor
101865316|NCT00006184|Dermatologic Agents|dermatologic agents|mesh-ancestor
101865317|NCT00006184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101865318|NCT00006184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101865319|NCT00006184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101865320|NCT00006184|Tubulin Modulators|tubulin modulators|mesh-ancestor
101865321|NCT00006184|Antimitotic Agents|antimitotic agents|mesh-ancestor
101865322|NCT00006184|Mitosis Modulators|mitosis modulators|mesh-ancestor
101865323|NCT00006184|Antifungal Agents|antifungal agents|mesh-ancestor
101865324|NCT00006184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101865325|NCT00006184|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101865326|NCT00006184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101865327|NCT00433199|Testosterone|testosterone|mesh-list
101865328|NCT00433199|Androgens|androgens|mesh-ancestor
101865329|NCT00433199|Hormones|hormones|mesh-ancestor
101865330|NCT00433199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101865331|NCT00433199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865332|NCT00006046|Antibodies|antibodies|mesh-list
101865333|NCT00006046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101865334|NCT00006046|Immunologic Factors|immunologic factors|mesh-ancestor
101865335|NCT00006046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865336|NCT01098448|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101865337|NCT01098448|Amoxicillin|amoxicillin|mesh-list
101865338|NCT01098448|Metronidazole|metronidazole|mesh-list
101865339|NCT01098448|Tetracycline|tetracycline|mesh-list
101865340|NCT01098448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101865341|NCT01098448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101865342|NCT01098448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101865343|NCT01098448|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101865344|NCT01098448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101865345|NCT01098448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865346|NCT01098526|Efavirenz|efavirenz|mesh-list
101865347|NCT01098526|Dolutegravir|dolutegravir|mesh-list
101865348|NCT01098526|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101865349|NCT01098526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101865350|NCT01098526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101865351|NCT01098526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865352|NCT01098526|Antiviral Agents|antiviral agents|mesh-ancestor
101865353|NCT01098526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101865354|NCT01098526|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101865355|NCT01098526|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101865356|NCT01098526|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101865357|NCT01098526|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101865358|NCT01098526|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101865359|NCT01098526|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101865360|NCT01098526|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101865361|NCT01098526|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101865362|NCT01098526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101865363|NCT01098526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101865364|NCT00005908|Tamoxifen|tamoxifen|mesh-list
101865365|NCT00005908|Cyclophosphamide|cyclophosphamide|mesh-list
101865366|NCT00005908|Docetaxel|docetaxel|mesh-list
101865367|NCT00005908|Doxorubicin|doxorubicin|mesh-list
101865368|NCT00005908|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101865369|NCT00005908|Capecitabine|capecitabine|mesh-list
101865370|NCT00005908|Anastrozole|anastrozole|mesh-list
101865371|NCT00005908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101865372|NCT00005908|Immunologic Factors|immunologic factors|mesh-ancestor
101865373|NCT00005908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865374|NCT00005908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101865375|NCT00005908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101865376|NCT00005908|Alkylating Agents|alkylating agents|mesh-ancestor
101865377|NCT00005908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865378|NCT00005908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101865379|NCT00005908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101865380|NCT00005908|Tubulin Modulators|tubulin modulators|mesh-ancestor
101865381|NCT00005908|Antimitotic Agents|antimitotic agents|mesh-ancestor
101865382|NCT00005908|Mitosis Modulators|mitosis modulators|mesh-ancestor
101865383|NCT00005908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101865384|NCT00005908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101865385|NCT00005908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101865386|NCT00005908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101965901|NCT01399684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101865387|NCT00005908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101865388|NCT00005908|Antimetabolites|antimetabolites|mesh-ancestor
101865389|NCT00005908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101865391|NCT00005908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101865392|NCT00005908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101865393|NCT00005908|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101865394|NCT00005908|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101865395|NCT00005908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101865396|NCT00005908|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101865397|NCT00005908|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101865398|NCT00431951|Tecovirimat|tecovirimat|mesh-list
101865399|NCT00431951|Antiviral Agents|antiviral agents|mesh-ancestor
101865400|NCT00431951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101865401|NCT00004978|Aldesleukin|aldesleukin|mesh-list
101865402|NCT00004978|Interleukin-2|interleukin-2|mesh-list
101865403|NCT00004978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101865404|NCT00004978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101865405|NCT00004978|Analgesics|analgesics|mesh-ancestor
101865406|NCT00004978|Sensory System Agents|sensory system agents|mesh-ancestor
101865407|NCT00004978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101865408|NCT00004978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865409|NCT00004978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101865410|NCT00004978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101865411|NCT00004978|Antiviral Agents|antiviral agents|mesh-ancestor
101865412|NCT00004978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101865413|NCT01030601|Dexamethasone|dexamethasone|mesh-list
101865414|NCT01030601|Dexamethasone acetate|dexamethasone acetate|mesh-list
101865415|NCT01030601|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101865416|NCT01030601|BB 1101|bb 1101|mesh-list
101865417|NCT01030601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101865418|NCT01030601|Antiemetics|antiemetics|mesh-ancestor
101865419|NCT01030601|Autonomic Agents|autonomic agents|mesh-ancestor
101865420|NCT01030601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101865421|NCT01030601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865422|NCT01030601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101865423|NCT01030601|Glucocorticoids|glucocorticoids|mesh-ancestor
101865424|NCT01030601|Hormones|hormones|mesh-ancestor
101865425|NCT01030601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101865426|NCT01030601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101865427|NCT01030601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101865428|NCT01030601|Protease Inhibitors|protease inhibitors|mesh-ancestor
101865429|NCT01030601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101865430|NCT01030601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865431|NCT00430937|Vancomycin|vancomycin|mesh-list
101865432|NCT00430937|Daptomycin|daptomycin|mesh-list
101865433|NCT00430937|Teicoplanin|teicoplanin|mesh-list
101865434|NCT00430937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101865435|NCT00430937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101865436|NCT01101412|Calcium, Dietary|calcium, dietary|mesh-list
101865437|NCT01101412|Ethanol|ethanol|mesh-list
101865438|NCT01101412|Trimethoprim|trimethoprim|mesh-list
101865439|NCT01101412|Sulfamethoxazole|sulfamethoxazole|mesh-list
101865440|NCT01101412|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101865441|NCT01101412|Edetic Acid|edetic acid|mesh-list
101865442|NCT01101412|Calcium|calcium|mesh-list
101865443|NCT01101412|Pentetic Acid|pentetic acid|mesh-list
101865444|NCT01101412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101865445|NCT01101412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865446|NCT01101412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101865447|NCT01101412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101865448|NCT01101412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101865449|NCT01101412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101865450|NCT01101412|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101865451|NCT01101412|Antimalarials|antimalarials|mesh-ancestor
101865452|NCT01101412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101865453|NCT01101412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101865454|NCT01101412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101865455|NCT01101412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101865456|NCT01101412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865457|NCT01101412|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101865458|NCT01101412|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101865459|NCT01101412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101865460|NCT01101412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101865462|NCT01101412|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101865463|NCT01101412|Chelating Agents|chelating agents|mesh-ancestor
101865464|NCT01101412|Sequestering Agents|sequestering agents|mesh-ancestor
101865465|NCT01101412|Antidotes|antidotes|mesh-ancestor
101865466|NCT01101412|Protective Agents|protective agents|mesh-ancestor
101865467|NCT01101412|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101865469|NCT00004888|Doxorubicin|doxorubicin|mesh-list
101865470|NCT00004888|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101865471|NCT00004888|Trastuzumab|trastuzumab|mesh-list
101865472|NCT00004888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101865473|NCT00004888|Tubulin Modulators|tubulin modulators|mesh-ancestor
101865474|NCT00004888|Antimitotic Agents|antimitotic agents|mesh-ancestor
101865475|NCT00004888|Mitosis Modulators|mitosis modulators|mesh-ancestor
101865476|NCT00004888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865477|NCT00004888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101865478|NCT00004888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101865479|NCT00004888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101865480|NCT00004888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101865481|NCT00004888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101865482|NCT01098760|Sorafenib|sorafenib|mesh-list
101865483|NCT01098760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101865484|NCT01098760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101865485|NCT01098760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101865486|NCT01098760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865487|NCT03950830|Disulfiram|disulfiram|mesh-list
101865488|NCT03950830|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101865489|NCT03950830|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
101865490|NCT03950830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101865491|NCT03950830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865492|NCT00430781|Lapatinib|lapatinib|mesh-list
101865493|NCT00430781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101865494|NCT00430781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101865495|NCT00430781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101865496|NCT00430781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865497|NCT01033097|Betamethasone|betamethasone|mesh-list
101865498|NCT01033097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101865499|NCT01033097|Glucocorticoids|glucocorticoids|mesh-ancestor
101865500|NCT01033097|Hormones|hormones|mesh-ancestor
101865501|NCT01033097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101865502|NCT01033097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865503|NCT01033097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101865504|NCT01033097|Respiratory System Agents|respiratory system agents|mesh-ancestor
101865505|NCT00429299|Paclitaxel|paclitaxel|mesh-list
101865506|NCT00429299|Cyclophosphamide|cyclophosphamide|mesh-list
101865507|NCT00429299|Fluorouracil|fluorouracil|mesh-list
101865508|NCT00429299|Trastuzumab|trastuzumab|mesh-list
101865509|NCT00429299|Lapatinib|lapatinib|mesh-list
101865510|NCT00429299|Epirubicin|epirubicin|mesh-list
101865511|NCT00429299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101865512|NCT00429299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101865513|NCT00429299|Tubulin Modulators|tubulin modulators|mesh-ancestor
101865514|NCT00429299|Antimitotic Agents|antimitotic agents|mesh-ancestor
101865515|NCT00429299|Mitosis Modulators|mitosis modulators|mesh-ancestor
101865516|NCT00429299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865517|NCT00429299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101865518|NCT00429299|Immunologic Factors|immunologic factors|mesh-ancestor
101865519|NCT00429299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865520|NCT00429299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101865521|NCT00429299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101865522|NCT00429299|Alkylating Agents|alkylating agents|mesh-ancestor
101865523|NCT00429299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101865524|NCT00429299|Antimetabolites|antimetabolites|mesh-ancestor
101865525|NCT00429299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101865526|NCT00429299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101865527|NCT00429299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101865528|NCT00429299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101865529|NCT00429299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101865530|NCT00429299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101865531|NCT00429299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101865532|NCT01033877|Vaccines|vaccines|mesh-list
101865533|NCT01033877|Immunologic Factors|immunologic factors|mesh-ancestor
101865534|NCT01033877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865535|NCT00428597|Sunitinib|sunitinib|mesh-list
101865536|NCT00428597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101865537|NCT00428597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101865538|NCT00428597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101865539|NCT00428597|Growth Substances|growth substances|mesh-ancestor
101865540|NCT00428597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865541|NCT00428597|Growth Inhibitors|growth inhibitors|mesh-ancestor
101865542|NCT00428597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101865543|NCT00428597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101865544|NCT00428597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865545|NCT01033955|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101865546|NCT01033955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101865547|NCT01033955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101865548|NCT01033955|Antimetabolites|antimetabolites|mesh-ancestor
101865549|NCT01033955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865550|NCT01033955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101865551|NCT01033955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101865552|NCT01033955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101865553|NCT00428441|Warfarin|warfarin|mesh-list
101865554|NCT00428441|Anticoagulants|anticoagulants|mesh-ancestor
101865555|NCT00144339|Tiotropium Bromide|tiotropium bromide|mesh-list
101865556|NCT00144339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101865557|NCT00144339|Autonomic Agents|autonomic agents|mesh-ancestor
101865558|NCT00144339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101865559|NCT00144339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865560|NCT00144339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101865561|NCT00144339|Respiratory System Agents|respiratory system agents|mesh-ancestor
101865562|NCT00144339|Parasympatholytics|parasympatholytics|mesh-ancestor
101865563|NCT00144339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101865564|NCT00144339|Cholinergic Agents|cholinergic agents|mesh-ancestor
101865565|NCT00144339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101865566|NCT00144339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865567|NCT03967665|Acetylcysteine|acetylcysteine|mesh-list
101865568|NCT03967665|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101865569|NCT03967665|Antiviral Agents|antiviral agents|mesh-ancestor
101865570|NCT03967665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101865571|NCT03967665|Expectorants|expectorants|mesh-ancestor
101865572|NCT03967665|Respiratory System Agents|respiratory system agents|mesh-ancestor
101865573|NCT03967665|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101865574|NCT03967665|Antioxidants|antioxidants|mesh-ancestor
101865575|NCT03967665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865576|NCT03967665|Protective Agents|protective agents|mesh-ancestor
101865577|NCT03967665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865578|NCT03967665|Antidotes|antidotes|mesh-ancestor
101865579|NCT00144027|Antipsychotic Agents|antipsychotic agents|mesh-list
101865580|NCT00144027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101865581|NCT00144027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101865582|NCT00144027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865583|NCT00144027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101865584|NCT00127803|Vaccines|vaccines|mesh-list
101865585|NCT00127803|Immunologic Factors|immunologic factors|mesh-ancestor
101865586|NCT00127803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865587|NCT01077999|Paclitaxel|paclitaxel|mesh-list
101865588|NCT01077999|Carboplatin|carboplatin|mesh-list
101865589|NCT01077999|Panitumumab|panitumumab|mesh-list
101865590|NCT01077999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101865591|NCT01077999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101865592|NCT01077999|Tubulin Modulators|tubulin modulators|mesh-ancestor
101865593|NCT01077999|Antimitotic Agents|antimitotic agents|mesh-ancestor
101865594|NCT01077999|Mitosis Modulators|mitosis modulators|mesh-ancestor
101687919|NCT04178850|Hematinics|hematinics|mesh-ancestor
101865595|NCT01077999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865597|NCT01033409|Vaccines|vaccines|mesh-list
101865598|NCT01033409|Immunologic Factors|immunologic factors|mesh-ancestor
101865599|NCT01033409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865600|NCT01037465|Acetylcysteine|acetylcysteine|mesh-list
101865601|NCT01037465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101865602|NCT01037465|Antiviral Agents|antiviral agents|mesh-ancestor
101865603|NCT01037465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101865604|NCT01037465|Expectorants|expectorants|mesh-ancestor
101865605|NCT01037465|Respiratory System Agents|respiratory system agents|mesh-ancestor
101865606|NCT01037465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101865607|NCT01037465|Antioxidants|antioxidants|mesh-ancestor
101865608|NCT01037465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865609|NCT01037465|Protective Agents|protective agents|mesh-ancestor
101865610|NCT01037465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865612|NCT01582425|Isavuconazole|isavuconazole|mesh-list
101865613|NCT01582425|Methadone|methadone|mesh-list
101865614|NCT01582425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101865615|NCT01582425|Narcotics|narcotics|mesh-ancestor
101865616|NCT01582425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101865617|NCT01582425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865618|NCT01582425|Analgesics|analgesics|mesh-ancestor
101865619|NCT01582425|Sensory System Agents|sensory system agents|mesh-ancestor
101865620|NCT01582425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101865621|NCT01582425|Antitussive Agents|antitussive agents|mesh-ancestor
101865622|NCT01582425|Respiratory System Agents|respiratory system agents|mesh-ancestor
101585471|NCT02650609|Prednisolone|prednisolone|mesh-list
101865623|NCT01582425|Antifungal Agents|antifungal agents|mesh-ancestor
101865624|NCT01582425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101865625|NCT00143403|Leucovorin|leucovorin|mesh-list
101865626|NCT00143403|Folic Acid|folic acid|mesh-list
101865627|NCT00143403|Irinotecan|irinotecan|mesh-list
101865628|NCT00143403|Fluorouracil|fluorouracil|mesh-list
101865629|NCT00143403|Levoleucovorin|levoleucovorin|mesh-list
101865630|NCT00143403|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101865631|NCT00143403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101865632|NCT00143403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101865633|NCT00143403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865634|NCT00143403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101865635|NCT00143403|Antimetabolites|antimetabolites|mesh-ancestor
101865636|NCT00143403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101865637|NCT00143403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101865638|NCT00143403|Immunologic Factors|immunologic factors|mesh-ancestor
101865639|NCT00143403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865640|NCT00143403|Antidotes|antidotes|mesh-ancestor
101865641|NCT00143403|Protective Agents|protective agents|mesh-ancestor
101865642|NCT00143403|Vitamin B Complex|vitamin b complex|mesh-ancestor
101865643|NCT00143403|Vitamins|vitamins|mesh-ancestor
101865644|NCT00143403|Micronutrients|micronutrients|mesh-ancestor
101865645|NCT00143403|Hematinics|hematinics|mesh-ancestor
101865646|NCT00220701|Dexetimide|dexetimide|mesh-list
101865647|NCT00220701|Citalopram|citalopram|mesh-list
101865648|NCT00220701|Escitalopram|escitalopram|mesh-list
101243870|NCT01651416|Artemether|artemether|mesh-list
101865649|NCT00220701|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101865650|NCT00220701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101865651|NCT00220701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101865652|NCT00220701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865653|NCT00220701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101865654|NCT00220701|Serotonin Agents|serotonin agents|mesh-ancestor
101865655|NCT00220701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865656|NCT00220701|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101865657|NCT00220701|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101865658|NCT00220701|Parasympatholytics|parasympatholytics|mesh-ancestor
101865659|NCT00220701|Autonomic Agents|autonomic agents|mesh-ancestor
101865660|NCT00220701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101865661|NCT00220701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101865662|NCT00220701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101865663|NCT00220701|Cholinergic Agents|cholinergic agents|mesh-ancestor
101865664|NCT00220701|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101865665|NCT00220701|Antidepressive Agents|antidepressive agents|mesh-ancestor
101865666|NCT00220701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101865667|NCT00127101|Vorinostat|vorinostat|mesh-list
101865668|NCT00127101|Bexarotene|bexarotene|mesh-list
101865669|NCT00127101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101865670|NCT00127101|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101865671|NCT00127101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101865672|NCT00127101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865674|NCT00126555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101865675|NCT00126555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101865676|NCT00126555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101865677|NCT00126555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865678|NCT00004228|Leucovorin|leucovorin|mesh-list
101865679|NCT00004228|Cytarabine|cytarabine|mesh-list
101865680|NCT00004228|Dexamethasone|dexamethasone|mesh-list
101865681|NCT00004228|Prednisone|prednisone|mesh-list
101865682|NCT00004228|Cyclophosphamide|cyclophosphamide|mesh-list
101865683|NCT00004228|Doxorubicin|doxorubicin|mesh-list
101865684|NCT00004228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101865685|NCT00004228|Methotrexate|methotrexate|mesh-list
101865686|NCT00004228|Vincristine|vincristine|mesh-list
101865687|NCT00004228|Daunorubicin|daunorubicin|mesh-list
101865688|NCT00004228|Asparaginase|asparaginase|mesh-list
101865689|NCT00004228|Mercaptopurine|mercaptopurine|mesh-list
101865690|NCT00004228|Thioguanine|thioguanine|mesh-list
101865691|NCT00004228|Levoleucovorin|levoleucovorin|mesh-list
101865692|NCT00004228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101865693|NCT00004228|Immunologic Factors|immunologic factors|mesh-ancestor
101865694|NCT00004228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865695|NCT00004228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101865696|NCT00004228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101865697|NCT00004228|Alkylating Agents|alkylating agents|mesh-ancestor
101865698|NCT00004228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865699|NCT00004228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101865700|NCT00004228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101865701|NCT00004228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101865702|NCT00004228|Antiemetics|antiemetics|mesh-ancestor
101865703|NCT00004228|Autonomic Agents|autonomic agents|mesh-ancestor
101865704|NCT00004228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101865705|NCT00004228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101865706|NCT00004228|Glucocorticoids|glucocorticoids|mesh-ancestor
101865707|NCT00004228|Hormones|hormones|mesh-ancestor
101865708|NCT00004228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101865709|NCT00004228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101865710|NCT00004228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101865711|NCT00004228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101865712|NCT00004228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101865713|NCT00004228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101865714|NCT00004228|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101865715|NCT00004228|Abortifacient Agents|abortifacient agents|mesh-ancestor
101865716|NCT00004228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101865717|NCT00004228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101865718|NCT00004228|Antimetabolites|antimetabolites|mesh-ancestor
101865719|NCT00004228|Dermatologic Agents|dermatologic agents|mesh-ancestor
101243939|NCT01651962|Fentanyl|fentanyl|mesh-list
101865720|NCT00004228|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101865721|NCT00004228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101865722|NCT00004228|Antiviral Agents|antiviral agents|mesh-ancestor
101865723|NCT00004228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101865724|NCT00004228|Antidotes|antidotes|mesh-ancestor
101865725|NCT00004228|Protective Agents|protective agents|mesh-ancestor
101865726|NCT00004228|Vitamin B Complex|vitamin b complex|mesh-ancestor
101865727|NCT00004228|Vitamins|vitamins|mesh-ancestor
101865728|NCT00004228|Micronutrients|micronutrients|mesh-ancestor
101865729|NCT00004228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101865730|NCT00004228|Tubulin Modulators|tubulin modulators|mesh-ancestor
101865731|NCT00004228|Antimitotic Agents|antimitotic agents|mesh-ancestor
101865732|NCT00004228|Mitosis Modulators|mitosis modulators|mesh-ancestor
101865733|NCT01101568|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101865734|NCT01101568|Simvastatin|simvastatin|mesh-list
101865735|NCT01101568|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101865736|NCT01101568|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101865737|NCT01101568|Antimetabolites|antimetabolites|mesh-ancestor
101865738|NCT01101568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865739|NCT01101568|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101865740|NCT01101568|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101865741|NCT01101568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101865742|NCT01087840|Tenofovir|tenofovir|mesh-list
101865743|NCT01087840|Emtricitabine|emtricitabine|mesh-list
101865744|NCT01087840|Raltegravir Potassium|raltegravir potassium|mesh-list
101865745|NCT01087840|Antiviral Agents|antiviral agents|mesh-ancestor
101865746|NCT01087840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101865747|NCT01087840|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101865748|NCT01087840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101865749|NCT01087840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101865750|NCT01087840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865751|NCT01087840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101865752|NCT01087840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101865753|NCT01087840|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101865754|NCT01087840|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101865755|NCT01098994|Vitamin E|vitamin e|mesh-list
101865756|NCT01098994|Tocopherols|tocopherols|mesh-list
101865757|NCT01098994|alpha-Tocopherol|alpha-tocopherol|mesh-list
101865758|NCT01098994|Vitamins|vitamins|mesh-ancestor
101865759|NCT01098994|Micronutrients|micronutrients|mesh-ancestor
101865760|NCT01098994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865761|NCT01098994|Antioxidants|antioxidants|mesh-ancestor
101865762|NCT01098994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865763|NCT01098994|Protective Agents|protective agents|mesh-ancestor
101865764|NCT01099072|Methylphenidate|methylphenidate|mesh-list
101865765|NCT01099072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101865766|NCT01099072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865767|NCT01099072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101865768|NCT01099072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101865769|NCT01099072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101865770|NCT01099072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865771|NCT01099072|Dopamine Agents|dopamine agents|mesh-ancestor
101865772|NCT01099072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101865773|NCT00031486|Valacyclovir|valacyclovir|mesh-list
101865774|NCT00031486|Antiviral Agents|antiviral agents|mesh-ancestor
101865775|NCT00031486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101865776|NCT01099150|Proanthocyanidin|proanthocyanidin|mesh-list
101865777|NCT01099150|Procyanidin|procyanidin|mesh-list
101865778|NCT01099150|Antioxidants|antioxidants|mesh-ancestor
101865779|NCT01099150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865780|NCT01099150|Protective Agents|protective agents|mesh-ancestor
101244008|NCT01652183|Analgesics|analgesics|mesh-ancestor
101865781|NCT01099150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865782|NCT01099150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101865783|NCT01099150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101865784|NCT01099150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101865785|NCT02530060|Tenofovir|tenofovir|mesh-list
101865786|NCT02530060|Emtricitabine|emtricitabine|mesh-list
101865787|NCT02530060|Rilpivirine|rilpivirine|mesh-list
101865788|NCT02530060|Antiviral Agents|antiviral agents|mesh-ancestor
101865789|NCT02530060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101865790|NCT02530060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101865791|NCT02530060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101865792|NCT02530060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101865793|NCT02530060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865794|NCT02530060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101865795|NCT02530060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101865796|NCT01101646|Rabeprazole|rabeprazole|mesh-list
101865797|NCT01101646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101865798|NCT01101646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101865799|NCT01101646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101865800|NCT01101646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101865801|NCT01101646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865802|NCT01101802|Mycophenolic Acid|mycophenolic acid|mesh-list
101865803|NCT01101802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101865804|NCT01101802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101865805|NCT01101802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101865806|NCT01101802|Antitubercular Agents|antitubercular agents|mesh-ancestor
101865807|NCT01101802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101865808|NCT01101802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101865809|NCT01101802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101865810|NCT01101802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865811|NCT01099228|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
101865812|NCT01099228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101865813|NCT01099228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101865814|NCT01099228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865815|NCT01099228|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101865816|NCT01088230|Botulinum Toxins|botulinum toxins|mesh-list
101865817|NCT01088230|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101865818|NCT01088230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101865819|NCT01088230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865820|NCT01088230|Cholinergic Agents|cholinergic agents|mesh-ancestor
101865821|NCT01088230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101865822|NCT01088230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101965923|NCT02265718|Methylphenidate|methylphenidate|mesh-list
101865824|NCT01099462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101865825|NCT01099462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101865826|NCT01099462|Analgesics|analgesics|mesh-ancestor
101865827|NCT01099462|Sensory System Agents|sensory system agents|mesh-ancestor
101865828|NCT01099462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101865829|NCT01099462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865830|NCT01099462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101865831|NCT01099462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101865832|NCT01099462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101865833|NCT01099462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101865834|NCT01099462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865835|NCT00003298|Leucovorin|leucovorin|mesh-list
101865836|NCT00003298|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
101865837|NCT00003298|Tetrahydrofolates|tetrahydrofolates|mesh-list
101865838|NCT00003298|Paclitaxel|paclitaxel|mesh-list
101865839|NCT00003298|Cisplatin|cisplatin|mesh-list
101865840|NCT00003298|Fluorouracil|fluorouracil|mesh-list
101865841|NCT00003298|Calcium|calcium|mesh-list
101865842|NCT00003298|Levoleucovorin|levoleucovorin|mesh-list
101865843|NCT00003298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101865844|NCT00003298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101865845|NCT00003298|Tubulin Modulators|tubulin modulators|mesh-ancestor
101865846|NCT00003298|Antimitotic Agents|antimitotic agents|mesh-ancestor
101865847|NCT00003298|Mitosis Modulators|mitosis modulators|mesh-ancestor
101865848|NCT00003298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865849|NCT00003298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101865850|NCT00003298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865851|NCT00003298|Antimetabolites|antimetabolites|mesh-ancestor
101865852|NCT00003298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101865853|NCT00003298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101574896|NCT04219579|Protease Inhibitors|protease inhibitors|mesh-ancestor
101865854|NCT00003298|Immunologic Factors|immunologic factors|mesh-ancestor
101865855|NCT00003298|Antidotes|antidotes|mesh-ancestor
101865856|NCT00003298|Protective Agents|protective agents|mesh-ancestor
101865857|NCT00003298|Vitamin B Complex|vitamin b complex|mesh-ancestor
101865858|NCT00003298|Vitamins|vitamins|mesh-ancestor
101865859|NCT00003298|Micronutrients|micronutrients|mesh-ancestor
101865860|NCT03960970|Azithromycin|azithromycin|mesh-list
101865861|NCT03960970|Cefoxitin|cefoxitin|mesh-list
101865862|NCT03960970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101865863|NCT03960970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101865864|NCT00002842|Leucovorin|leucovorin|mesh-list
101865865|NCT00002842|Fluorouracil|fluorouracil|mesh-list
101865866|NCT00002842|Floxuridine|floxuridine|mesh-list
101865867|NCT00002842|Calcium|calcium|mesh-list
101865868|NCT00002842|Levoleucovorin|levoleucovorin|mesh-list
101865869|NCT00002842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101865870|NCT00002842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865871|NCT00002842|Antimetabolites|antimetabolites|mesh-ancestor
101865872|NCT00002842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865873|NCT00002842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101865874|NCT00002842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101865875|NCT00002842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101865876|NCT00002842|Immunologic Factors|immunologic factors|mesh-ancestor
101865877|NCT00002842|Antidotes|antidotes|mesh-ancestor
101865878|NCT00002842|Protective Agents|protective agents|mesh-ancestor
101865879|NCT00002842|Vitamin B Complex|vitamin b complex|mesh-ancestor
101865880|NCT00002842|Vitamins|vitamins|mesh-ancestor
101865881|NCT00002842|Micronutrients|micronutrients|mesh-ancestor
101865882|NCT00143247|Insulin|insulin|mesh-list
101865883|NCT00143247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101865884|NCT00143247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865885|NCT00125853|Atenolol|atenolol|mesh-list
101865886|NCT00125853|Nebivolol|nebivolol|mesh-list
101865887|NCT00125853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101865888|NCT00125853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101865889|NCT00125853|Sympatholytics|sympatholytics|mesh-ancestor
101865890|NCT00125853|Autonomic Agents|autonomic agents|mesh-ancestor
101865891|NCT00125853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101865892|NCT00125853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687930|NCT02672358|Trametinib|trametinib|mesh-list
101865893|NCT00125853|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101865894|NCT00125853|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101865895|NCT00125853|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101865897|NCT00125853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101865898|NCT00125853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865899|NCT00125853|Vasodilator Agents|vasodilator agents|mesh-ancestor
101865900|NCT00125853|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101865901|NCT00125853|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101865902|NCT00125853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101865903|NCT00219141|Losartan|losartan|mesh-list
101865904|NCT00219141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101865905|NCT00219141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101865906|NCT00219141|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101865907|NCT00219141|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101865908|NCT00219141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865909|NCT03971487|Ocrelizumab|ocrelizumab|mesh-list
101865910|NCT03971487|Immunologic Factors|immunologic factors|mesh-ancestor
101865911|NCT03971487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865912|NCT00233948|Nelfinavir|nelfinavir|mesh-list
101865913|NCT00233948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101865914|NCT00233948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101865915|NCT00233948|Protease Inhibitors|protease inhibitors|mesh-ancestor
101865916|NCT00233948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101865917|NCT00233948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865918|NCT00233948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101865919|NCT00233948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101865920|NCT00233948|Antiviral Agents|antiviral agents|mesh-ancestor
101865921|NCT00233948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101865922|NCT00233480|Atorvastatin|atorvastatin|mesh-list
101865923|NCT00233480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101865924|NCT00233480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101865925|NCT00233480|Antimetabolites|antimetabolites|mesh-ancestor
101865926|NCT00233480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865927|NCT00233480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101865928|NCT00233480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101574897|NCT04219579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101865929|NCT00233480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101865930|NCT03801928|Infliximab|infliximab|mesh-list
101865931|NCT03801928|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101865933|NCT03801928|Dermatologic Agents|dermatologic agents|mesh-ancestor
101865934|NCT03801928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101865935|NCT03801928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101865936|NCT02530918|Ranibizumab|ranibizumab|mesh-list
101865937|NCT02530918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101865938|NCT02530918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101865939|NCT02530918|Growth Substances|growth substances|mesh-ancestor
101865940|NCT02530918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865941|NCT02530918|Growth Inhibitors|growth inhibitors|mesh-ancestor
101865942|NCT02530918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101865943|NCT03950518|Levamisole|levamisole|mesh-list
101865944|NCT03950518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101865945|NCT03950518|Immunologic Factors|immunologic factors|mesh-ancestor
101865946|NCT03950518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865947|NCT03950518|Antinematodal Agents|antinematodal agents|mesh-ancestor
101865948|NCT03950518|Anthelmintics|anthelmintics|mesh-ancestor
101865949|NCT03950518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101865950|NCT03950518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101865951|NCT03950518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101865952|NCT01100164|Eszopiclone|eszopiclone|mesh-list
101865953|NCT01100164|Zopiclone|zopiclone|mesh-list
101865954|NCT01100164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101865955|NCT01100164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101865956|NCT01100164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865957|NCT01102114|Vaccines|vaccines|mesh-list
101865958|NCT01102114|Immunologic Factors|immunologic factors|mesh-ancestor
101865959|NCT01102114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865960|NCT01327222|Bevacizumab|bevacizumab|mesh-list
101865961|NCT01327222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101865962|NCT01327222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101865963|NCT01327222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101865964|NCT01327222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101865965|NCT01327222|Growth Substances|growth substances|mesh-ancestor
101865966|NCT01327222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865967|NCT01327222|Growth Inhibitors|growth inhibitors|mesh-ancestor
101865968|NCT03950362|Avelumab|avelumab|mesh-list
101865969|NCT03950362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101865970|NCT03950362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101865971|NCT00263588|Lapatinib|lapatinib|mesh-list
101865972|NCT00263588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101865973|NCT00263588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101865974|NCT00263588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101865975|NCT00263588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865976|NCT00213135|Cladribine|cladribine|mesh-list
101865977|NCT00213135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101865978|NCT00213135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101865979|NCT00213135|Immunologic Factors|immunologic factors|mesh-ancestor
101865980|NCT00213135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865981|NCT00077974|Sunitinib|sunitinib|mesh-list
101865982|NCT00077974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101865983|NCT00077974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101865984|NCT00077974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101865985|NCT00077974|Growth Substances|growth substances|mesh-ancestor
101865986|NCT00077974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865987|NCT00077974|Growth Inhibitors|growth inhibitors|mesh-ancestor
101865988|NCT00077974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101865989|NCT00077974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101865990|NCT00077974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101865991|NCT00141921|Etanercept|etanercept|mesh-list
101865992|NCT00141921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101865993|NCT00141921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101865994|NCT00141921|Analgesics|analgesics|mesh-ancestor
101865995|NCT00141921|Sensory System Agents|sensory system agents|mesh-ancestor
101865996|NCT00141921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101865997|NCT00141921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101865998|NCT00141921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101865999|NCT00141921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101866000|NCT00141921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101866001|NCT00141921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101866002|NCT00141921|Immunologic Factors|immunologic factors|mesh-ancestor
101866003|NCT01088620|Pemetrexed|pemetrexed|mesh-list
101866004|NCT01088620|Panitumumab|panitumumab|mesh-list
101866005|NCT01088620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866006|NCT01088620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101866007|NCT01088620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866008|NCT01088620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101866009|NCT01088620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101866010|NCT01088620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101866011|NCT00026494|Temozolomide|temozolomide|mesh-list
101866012|NCT00026494|Vinorelbine|vinorelbine|mesh-list
101866013|NCT00026494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101866014|NCT00026494|Alkylating Agents|alkylating agents|mesh-ancestor
101866015|NCT00026494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866016|NCT00026494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866017|NCT00026494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101866019|NCT00026494|Antimitotic Agents|antimitotic agents|mesh-ancestor
101866020|NCT00026494|Mitosis Modulators|mitosis modulators|mesh-ancestor
101866021|NCT03950050|Ambroxol|ambroxol|mesh-list
101866022|NCT03950050|Expectorants|expectorants|mesh-ancestor
101866023|NCT03950050|Respiratory System Agents|respiratory system agents|mesh-ancestor
101866024|NCT00023764|Bortezomib|bortezomib|mesh-list
101866025|NCT00023764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866026|NCT03961126|Clobetasol|clobetasol|mesh-list
101866027|NCT03961126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101866028|NCT03961126|Glucocorticoids|glucocorticoids|mesh-ancestor
101866029|NCT03961126|Hormones|hormones|mesh-ancestor
101866030|NCT03961126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101866031|NCT03961126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866032|NCT01584778|Eosinophil Cationic Protein|eosinophil cationic protein|mesh-list
101866033|NCT01584778|Immunologic Factors|immunologic factors|mesh-ancestor
101866034|NCT01584778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866035|NCT00189488|Methotrexate|methotrexate|mesh-list
101866036|NCT00189488|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101866037|NCT00189488|Abortifacient Agents|abortifacient agents|mesh-ancestor
101866038|NCT00189488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101866039|NCT00189488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866040|NCT00189488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101866041|NCT00189488|Antimetabolites|antimetabolites|mesh-ancestor
101866042|NCT00189488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866043|NCT00189488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866044|NCT00189488|Dermatologic Agents|dermatologic agents|mesh-ancestor
101866045|NCT00189488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101866046|NCT00189488|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101866047|NCT00189488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101866048|NCT00189488|Immunologic Factors|immunologic factors|mesh-ancestor
101866049|NCT00189488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101866050|NCT00189488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101866051|NCT00233324|Pulmonary Surfactants|pulmonary surfactants|mesh-list
101866052|NCT00233324|Respiratory System Agents|respiratory system agents|mesh-ancestor
101866053|NCT00023452|Isoniazid|isoniazid|mesh-list
101866054|NCT00023452|Rifapentine|rifapentine|mesh-list
101866055|NCT00023452|Antitubercular Agents|antitubercular agents|mesh-ancestor
101866056|NCT00023452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101866057|NCT00023452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101866058|NCT00023452|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101866059|NCT00023452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101866060|NCT00023452|Antimetabolites|antimetabolites|mesh-ancestor
101866061|NCT00023452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866062|NCT00023452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101866063|NCT00023452|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101866064|NCT00023452|Leprostatic Agents|leprostatic agents|mesh-ancestor
101866065|NCT01088932|SRX246|srx246|mesh-list
101866066|NCT01088932|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101866067|NCT01088932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866068|NCT01088932|Natriuretic Agents|natriuretic agents|mesh-ancestor
101866069|NCT01088932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866070|NCT03961048|Ropivacaine|ropivacaine|mesh-list
101866071|NCT03961048|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101866072|NCT03961048|Anesthetics, Local|anesthetics, local|mesh-ancestor
101866073|NCT03961048|Anesthetics|anesthetics|mesh-ancestor
101866074|NCT03961048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101866075|NCT03961048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866076|NCT03961048|Sensory System Agents|sensory system agents|mesh-ancestor
101866077|NCT03961048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101866078|NCT00022672|Trastuzumab|trastuzumab|mesh-list
101866079|NCT00022672|Anastrozole|anastrozole|mesh-list
101866080|NCT00022672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101866081|NCT00022672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866082|NCT00022672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101866083|NCT00022672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101866084|NCT00022672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101866085|NCT00022672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101866086|NCT00022672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866087|NCT00022672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101866088|NCT00022672|Hormone Antagonists|hormone antagonists|mesh-ancestor
101866089|NCT00022672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101866090|NCT00022672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866091|NCT00141453|Olmesartan|olmesartan|mesh-list
101866092|NCT00141453|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101866093|NCT00141453|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101866094|NCT00141453|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101866095|NCT00141453|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101866096|NCT00141453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866097|NCT00076570|Sirolimus|sirolimus|mesh-list
101866098|NCT00076570|Tacrolimus|tacrolimus|mesh-list
101866099|NCT00076570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101866100|NCT00076570|Immunologic Factors|immunologic factors|mesh-ancestor
101866101|NCT00076570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244237|NCT01653041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101866102|NCT00076570|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101866103|NCT00076570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101866104|NCT00076570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866105|NCT00076570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101866106|NCT00076570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101866107|NCT00076570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101866108|NCT00076570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866109|NCT00076570|Antifungal Agents|antifungal agents|mesh-ancestor
101866110|NCT00124449|Abatacept|abatacept|mesh-list
101866111|NCT00124449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101866112|NCT00124449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866113|NCT00124449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101866114|NCT00124449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866115|NCT00124449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101866116|NCT00124449|Immunologic Factors|immunologic factors|mesh-ancestor
101866117|NCT00124449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866118|NCT00124449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101866119|NCT00076336|Lamivudine|lamivudine|mesh-list
101866120|NCT00076336|Telbivudine|telbivudine|mesh-list
101866121|NCT00076336|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101866122|NCT00076336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101866123|NCT00076336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101866124|NCT00076336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866125|NCT00076336|Antiviral Agents|antiviral agents|mesh-ancestor
101866126|NCT00076336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101866127|NCT00076336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101866128|NCT00076336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101866129|NCT00185588|Gemcitabine|gemcitabine|mesh-list
101866130|NCT00185588|Vatalanib|vatalanib|mesh-list
101866131|NCT00185588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101866132|NCT00185588|Antimetabolites|antimetabolites|mesh-ancestor
101866133|NCT00185588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866134|NCT00185588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101244276|NCT01653119|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101866135|NCT00185588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101866136|NCT00185588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101866137|NCT00231842|Ifosfamide|ifosfamide|mesh-list
101866138|NCT00231842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866139|NCT00231842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101866140|NCT00231842|Alkylating Agents|alkylating agents|mesh-ancestor
101866141|NCT00231842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866142|NCT01073150|Tea Tree Oil|tea tree oil|mesh-list
101866143|NCT01073150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101866144|NCT01073150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101866145|NCT00076102|Pirfenidone|pirfenidone|mesh-list
101866146|NCT00076102|Analgesics|analgesics|mesh-ancestor
101866147|NCT00076102|Sensory System Agents|sensory system agents|mesh-ancestor
101866148|NCT00076102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101866149|NCT00076102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866150|NCT00076102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101866151|NCT00076102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101866152|NCT00076102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101866153|NCT00076102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101866154|NCT00076102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866155|NCT03968588|Mycophenolic Acid|mycophenolic acid|mesh-list
101866156|NCT03968588|Tacrolimus|tacrolimus|mesh-list
101866157|NCT03968588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101866158|NCT03968588|Immunologic Factors|immunologic factors|mesh-ancestor
101866159|NCT03968588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866160|NCT03968588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101687961|NCT05279742|Valsartan|valsartan|mesh-list
101866161|NCT03968588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101866162|NCT03968588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866163|NCT03968588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101866164|NCT03968588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866165|NCT03968588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101866166|NCT03968588|Antitubercular Agents|antitubercular agents|mesh-ancestor
101866167|NCT03968588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101866168|NCT03968588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101866170|NCT01582646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101866171|NCT01582646|Autonomic Agents|autonomic agents|mesh-ancestor
101866172|NCT01582646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101866173|NCT01582646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866174|NCT01582646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101866175|NCT01582646|Respiratory System Agents|respiratory system agents|mesh-ancestor
101866176|NCT01582646|Sympathomimetics|sympathomimetics|mesh-ancestor
101866177|NCT01582646|Tocolytic Agents|tocolytic agents|mesh-ancestor
101866178|NCT01582646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101866179|NCT01582646|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101866180|NCT01582646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101866181|NCT01582646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101866182|NCT01582646|Adrenergic Agents|adrenergic agents|mesh-ancestor
101866183|NCT01582646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101866184|NCT01582646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866185|NCT03974360|Erenumab|erenumab|mesh-list
101866186|NCT03974360|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
101866187|NCT03974360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866188|NCT03974360|Analgesics|analgesics|mesh-ancestor
101866189|NCT03974360|Sensory System Agents|sensory system agents|mesh-ancestor
101866190|NCT03974360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101866191|NCT03974360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866192|NCT00184028|Oxaliplatin|oxaliplatin|mesh-list
101866193|NCT00184028|Docetaxel|docetaxel|mesh-list
101866194|NCT00184028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866195|NCT00184028|Tubulin Modulators|tubulin modulators|mesh-ancestor
101866196|NCT00184028|Antimitotic Agents|antimitotic agents|mesh-ancestor
101866197|NCT00184028|Mitosis Modulators|mitosis modulators|mesh-ancestor
101866198|NCT00184028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866199|NCT00183872|Docetaxel|docetaxel|mesh-list
101866200|NCT00183872|Irinotecan|irinotecan|mesh-list
101866201|NCT00183872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866202|NCT00183872|Tubulin Modulators|tubulin modulators|mesh-ancestor
101866203|NCT00183872|Antimitotic Agents|antimitotic agents|mesh-ancestor
101866204|NCT00183872|Mitosis Modulators|mitosis modulators|mesh-ancestor
101866205|NCT00183872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866206|NCT00183872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101866207|NCT00183872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101866208|NCT00183872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101866209|NCT03815175|Aspirin|aspirin|mesh-list
101866210|NCT03815175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101866211|NCT03815175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101866212|NCT03815175|Analgesics|analgesics|mesh-ancestor
101866213|NCT03815175|Sensory System Agents|sensory system agents|mesh-ancestor
101866214|NCT03815175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101866215|NCT03815175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866216|NCT03815175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101866217|NCT03815175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101866218|NCT03815175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101866219|NCT03815175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101866220|NCT03815175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866221|NCT03815175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101866222|NCT03815175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101866223|NCT03815175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101866225|NCT01080027|Interferons|interferons|mesh-list
101866226|NCT01080027|Interferon-beta|interferon-beta|mesh-list
101866227|NCT01080027|Interferon beta-1a|interferon beta-1a|mesh-list
101866228|NCT01080027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866230|NCT01080027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101866231|NCT01080027|Immunologic Factors|immunologic factors|mesh-ancestor
101866232|NCT01080027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866233|NCT01080027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101866235|NCT00262028|Immunologic Factors|immunologic factors|mesh-ancestor
101866236|NCT00262028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866237|NCT00183248|Mycophenolic Acid|mycophenolic acid|mesh-list
101866238|NCT00183248|Sirolimus|sirolimus|mesh-list
101866239|NCT00183248|Alemtuzumab|alemtuzumab|mesh-list
101866240|NCT00183248|Tacrolimus|tacrolimus|mesh-list
101866241|NCT00183248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101866242|NCT00183248|Immunologic Factors|immunologic factors|mesh-ancestor
101866243|NCT00183248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866244|NCT00183248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101866245|NCT00183248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101866246|NCT00183248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244398|NCT01654120|Liraglutide|liraglutide|mesh-list
101866247|NCT00183248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101866248|NCT00183248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866249|NCT00183248|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101866250|NCT00183248|Antitubercular Agents|antitubercular agents|mesh-ancestor
101866251|NCT00183248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101866252|NCT00183248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101866253|NCT00183248|Antifungal Agents|antifungal agents|mesh-ancestor
101866254|NCT00183248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101866255|NCT00230282|Cyclophosphamide|cyclophosphamide|mesh-list
101866256|NCT00230282|Fludarabine|fludarabine|mesh-list
101866257|NCT00230282|Alemtuzumab|alemtuzumab|mesh-list
101866258|NCT00230282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101866259|NCT00230282|Immunologic Factors|immunologic factors|mesh-ancestor
101866260|NCT00230282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866261|NCT00230282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101866262|NCT00230282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101866263|NCT00230282|Alkylating Agents|alkylating agents|mesh-ancestor
101866264|NCT00230282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866265|NCT00230282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866266|NCT00230282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101866267|NCT00230282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101866268|NCT00261950|Cinacalcet|cinacalcet|mesh-list
101866269|NCT00261950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101866270|NCT00261950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866271|NCT00261950|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101866272|NCT00261950|Hormone Antagonists|hormone antagonists|mesh-ancestor
101866273|NCT00261950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101866274|NCT00229658|Pramlintide|pramlintide|mesh-list
101866275|NCT00229658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101866276|NCT00229658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866277|NCT00182078|Sertraline|sertraline|mesh-list
101866278|NCT00182078|Antidepressive Agents|antidepressive agents|mesh-ancestor
101866279|NCT00182078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101866280|NCT00182078|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101866281|NCT00182078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101866282|NCT00182078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101866283|NCT00182078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866284|NCT00182078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101866285|NCT00182078|Serotonin Agents|serotonin agents|mesh-ancestor
101866286|NCT00182078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866288|NCT00181844|Anticonvulsants|anticonvulsants|mesh-ancestor
101866289|NCT00181844|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101866290|NCT00181844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101866291|NCT00181844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866292|NCT00181844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101866293|NCT00181844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866294|NCT00181844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101866295|NCT00181844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101866296|NCT00181844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101866297|NCT00181844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101866298|NCT00181844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101866299|NCT00181766|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101866300|NCT00181766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101586142|NCT00957801|Testosterone|testosterone|mesh-list
101866301|NCT00181766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101866302|NCT00181766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101866303|NCT00181766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866304|NCT00181766|Adrenergic Agents|adrenergic agents|mesh-ancestor
101866305|NCT00181766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101866306|NCT00181766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866308|NCT00180674|Anticoagulants|anticoagulants|mesh-ancestor
101866309|NCT01074632|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
101866310|NCT01074632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101866311|NCT01074632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101866312|NCT01074632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101866313|NCT01074632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866314|NCT01074632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101866315|NCT01074632|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101866316|NCT01074632|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101866317|NCT01074632|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101866318|NCT01074632|Adrenergic Agents|adrenergic agents|mesh-ancestor
101866319|NCT01074632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101866320|NCT01074632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866321|NCT01074632|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101866322|NCT01074632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101866323|NCT01074632|Serotonin Agents|serotonin agents|mesh-ancestor
101866324|NCT01074632|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101866325|NCT01074632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101866326|NCT01074632|Dopamine Agents|dopamine agents|mesh-ancestor
101866327|NCT00076024|Docetaxel|docetaxel|mesh-list
101866328|NCT00076024|Axitinib|axitinib|mesh-list
101866329|NCT00076024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866330|NCT00076024|Tubulin Modulators|tubulin modulators|mesh-ancestor
101866331|NCT00076024|Antimitotic Agents|antimitotic agents|mesh-ancestor
101866332|NCT00076024|Mitosis Modulators|mitosis modulators|mesh-ancestor
101866333|NCT00076024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866334|NCT00076024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101866335|NCT00076024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101866336|NCT01103050|Cetirizine|cetirizine|mesh-list
101866337|NCT01103050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101866338|NCT01103050|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101866339|NCT01103050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101866340|NCT01103050|Histamine Antagonists|histamine antagonists|mesh-ancestor
101866341|NCT01103050|Histamine Agents|histamine agents|mesh-ancestor
101866342|NCT01103050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101866343|NCT01103050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866344|NCT01103050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866345|NCT00075478|Cyclosporine|cyclosporine|mesh-list
101866346|NCT00075478|Mycophenolic Acid|mycophenolic acid|mesh-list
101866347|NCT00075478|Fludarabine|fludarabine|mesh-list
101866348|NCT00075478|Fludarabine phosphate|fludarabine phosphate|mesh-list
101866349|NCT00075478|Cyclosporins|cyclosporins|mesh-list
101866350|NCT00075478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866351|NCT00075478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101866352|NCT00075478|Antimetabolites|antimetabolites|mesh-ancestor
101866353|NCT00075478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866354|NCT00075478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101866355|NCT00075478|Immunologic Factors|immunologic factors|mesh-ancestor
101965991|NCT02263924|Vitamins|vitamins|mesh-ancestor
101866356|NCT00075478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866357|NCT00075478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101866358|NCT00075478|Antifungal Agents|antifungal agents|mesh-ancestor
101866359|NCT00075478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101866360|NCT00075478|Dermatologic Agents|dermatologic agents|mesh-ancestor
101866361|NCT00075478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101866362|NCT00075478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101866363|NCT00075478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101866364|NCT00075478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101866365|NCT00075478|Antitubercular Agents|antitubercular agents|mesh-ancestor
101866366|NCT00075478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101866367|NCT00175916|Brivaracetam|brivaracetam|mesh-list
101866368|NCT00175916|Anticonvulsants|anticonvulsants|mesh-ancestor
101866369|NCT01089088|Gemcitabine|gemcitabine|mesh-list
101866370|NCT01089088|Sunitinib|sunitinib|mesh-list
101866371|NCT01089088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866372|NCT01089088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101866373|NCT01089088|Antimetabolites|antimetabolites|mesh-ancestor
101866374|NCT01089088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866375|NCT01089088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101866376|NCT01089088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101866377|NCT01089088|Growth Substances|growth substances|mesh-ancestor
101866378|NCT01089088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866379|NCT01089088|Growth Inhibitors|growth inhibitors|mesh-ancestor
101866380|NCT01089088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101866381|NCT01089088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101866382|NCT00075400|Imatinib Mesylate|imatinib mesylate|mesh-list
101866383|NCT00075400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866384|NCT00075400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101866385|NCT00075400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101866386|NCT00075400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866387|NCT01103206|Cinacalcet|cinacalcet|mesh-list
101866388|NCT01103206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101866389|NCT01103206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866390|NCT01103206|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101866391|NCT01103206|Hormone Antagonists|hormone antagonists|mesh-ancestor
101866392|NCT01103206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101866393|NCT00228566|Modafinil|modafinil|mesh-list
101866394|NCT00228566|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101866395|NCT00228566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866396|NCT00228566|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101866397|NCT00228566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101866398|NCT00228566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101866399|NCT00228566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866400|NCT05625724|Aspirin|aspirin|mesh-list
101866401|NCT05625724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101866402|NCT05625724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101866403|NCT05625724|Analgesics|analgesics|mesh-ancestor
101866404|NCT05625724|Sensory System Agents|sensory system agents|mesh-ancestor
101866405|NCT05625724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101866406|NCT05625724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866407|NCT05625724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101866408|NCT05625724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101866409|NCT05625724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101866410|NCT05625724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101866411|NCT05625724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866412|NCT05625724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101866413|NCT05625724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101866414|NCT05625724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101866415|NCT05625724|Antipyretics|antipyretics|mesh-ancestor
101866416|NCT01089166|Metformin|metformin|mesh-list
101866417|NCT01089166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101866418|NCT01089166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866419|NCT00203502|Cyclophosphamide|cyclophosphamide|mesh-list
101866420|NCT00203502|Bevacizumab|bevacizumab|mesh-list
101866421|NCT00203502|Docetaxel|docetaxel|mesh-list
101866422|NCT00203502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101866423|NCT00203502|Immunologic Factors|immunologic factors|mesh-ancestor
101866424|NCT00203502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866425|NCT00203502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101965996|NCT02264002|Sympatholytics|sympatholytics|mesh-ancestor
101866426|NCT00203502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101866427|NCT00203502|Alkylating Agents|alkylating agents|mesh-ancestor
101866428|NCT00203502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866429|NCT00203502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866431|NCT00203502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101866432|NCT00203502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101866433|NCT00203502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101866434|NCT00203502|Growth Substances|growth substances|mesh-ancestor
101866435|NCT00203502|Growth Inhibitors|growth inhibitors|mesh-ancestor
101866436|NCT00203502|Tubulin Modulators|tubulin modulators|mesh-ancestor
101866437|NCT00203502|Antimitotic Agents|antimitotic agents|mesh-ancestor
101866438|NCT00203502|Mitosis Modulators|mitosis modulators|mesh-ancestor
101866439|NCT01103518|Cyproterone Acetate|cyproterone acetate|mesh-list
101866440|NCT01103518|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101866441|NCT01103518|Estradiol|estradiol|mesh-list
101866442|NCT01103518|Cyproterone|cyproterone|mesh-list
101866443|NCT01103518|Estrogens|estrogens|mesh-ancestor
101866444|NCT01103518|Hormones|hormones|mesh-ancestor
101866445|NCT01103518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101866446|NCT01103518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866447|NCT01103518|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101866448|NCT01103518|Contraceptive Agents|contraceptive agents|mesh-ancestor
101866449|NCT01103518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101866450|NCT01103518|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101866451|NCT01103518|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101866453|NCT01103518|Androgen Antagonists|androgen antagonists|mesh-ancestor
101866454|NCT01103518|Hormone Antagonists|hormone antagonists|mesh-ancestor
101866455|NCT01103518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866456|NCT01103518|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101866457|NCT01327534|Clopidogrel|clopidogrel|mesh-list
101866458|NCT01327534|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101866459|NCT01327534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101866460|NCT01327534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101866461|NCT01327534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101866462|NCT01327534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101866463|NCT01327534|Purinergic Agents|purinergic agents|mesh-ancestor
101866464|NCT01327534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101866465|NCT01327534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866466|NCT01327534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866467|NCT00232596|Ezogabine|ezogabine|mesh-list
101866468|NCT00232596|Anticonvulsants|anticonvulsants|mesh-ancestor
101866469|NCT00232596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101866470|NCT00232596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866471|NCT00073918|Iodine|iodine|mesh-list
101866472|NCT00073918|Cadexomer iodine|cadexomer iodine|mesh-list
101866473|NCT00073918|Cyclophosphamide|cyclophosphamide|mesh-list
101866474|NCT00073918|Etoposide|etoposide|mesh-list
101866475|NCT00073918|Etoposide phosphate|etoposide phosphate|mesh-list
101866476|NCT00073918|Tositumomab I-131|tositumomab i-131|mesh-list
101866477|NCT00073918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101866478|NCT00073918|Antibodies|antibodies|mesh-list
101866479|NCT00073918|Immunoglobulins|immunoglobulins|mesh-list
101866480|NCT00073918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101866481|NCT00073918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101866482|NCT00073918|Immunologic Factors|immunologic factors|mesh-ancestor
101866483|NCT00073918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866484|NCT00073918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101866485|NCT00073918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101866486|NCT00073918|Alkylating Agents|alkylating agents|mesh-ancestor
101866487|NCT00073918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866488|NCT00073918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866489|NCT00073918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101866490|NCT00073918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101866491|NCT00073918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101866492|NCT00073918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101866493|NCT00073918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101866494|NCT00073918|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101866495|NCT00073918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101866496|NCT00073918|Trace Elements|trace elements|mesh-ancestor
101866497|NCT00073918|Micronutrients|micronutrients|mesh-ancestor
101866498|NCT00231894|Pioglitazone|pioglitazone|mesh-list
101866499|NCT00231894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101866500|NCT00231894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866501|NCT00203424|Bevacizumab|bevacizumab|mesh-list
101866502|NCT00203424|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101866503|NCT00203424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101866504|NCT00203424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866505|NCT00203424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101866506|NCT00203424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101866507|NCT00203424|Growth Substances|growth substances|mesh-ancestor
101866508|NCT00203424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866509|NCT00203424|Growth Inhibitors|growth inhibitors|mesh-ancestor
101866510|NCT00203424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101866511|NCT00203424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101866512|NCT00203424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866513|NCT00203268|Dihydroergotamine|dihydroergotamine|mesh-list
101866514|NCT00203268|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101866515|NCT00203268|Dopamine Agonists|dopamine agonists|mesh-ancestor
101866516|NCT00203268|Dopamine Agents|dopamine agents|mesh-ancestor
101866517|NCT00203268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101866518|NCT00203268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866519|NCT00203268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866520|NCT00203268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101586365|NCT01167257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101866521|NCT00203268|Analgesics|analgesics|mesh-ancestor
101866522|NCT00203268|Sensory System Agents|sensory system agents|mesh-ancestor
101866523|NCT00203268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101866524|NCT00168818|Enoxaparin|enoxaparin|mesh-list
101866525|NCT00168818|Dabigatran|dabigatran|mesh-list
101866526|NCT00168818|Anticoagulants|anticoagulants|mesh-ancestor
101866527|NCT00168818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101866528|NCT00168818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101866529|NCT00168818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866530|NCT00168818|Antithrombins|antithrombins|mesh-ancestor
101866531|NCT00168818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101866532|NCT00168818|Protease Inhibitors|protease inhibitors|mesh-ancestor
101866533|NCT00168818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101866534|NCT00260832|Cytarabine|cytarabine|mesh-list
101866535|NCT00260832|Decitabine|decitabine|mesh-list
101866536|NCT00260832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101866537|NCT00260832|Antimetabolites|antimetabolites|mesh-ancestor
101866538|NCT00260832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866539|NCT00260832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866540|NCT00260832|Antiviral Agents|antiviral agents|mesh-ancestor
101866541|NCT00260832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101866542|NCT00260832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101866543|NCT00260832|Immunologic Factors|immunologic factors|mesh-ancestor
101866544|NCT00260832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866545|NCT00260832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101866546|NCT00168038|Immunoglobulins|immunoglobulins|mesh-list
101866547|NCT00168038|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101866548|NCT00168038|Antibodies|antibodies|mesh-list
101866549|NCT00168038|Immunologic Factors|immunologic factors|mesh-ancestor
101866550|NCT00168038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866551|NCT00166712|Mycophenolic Acid|mycophenolic acid|mesh-list
101866552|NCT00166712|Sirolimus|sirolimus|mesh-list
101866553|NCT00166712|Alemtuzumab|alemtuzumab|mesh-list
101866554|NCT00166712|Tacrolimus|tacrolimus|mesh-list
101866555|NCT00166712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101866556|NCT00166712|Immunologic Factors|immunologic factors|mesh-ancestor
101866557|NCT00166712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866558|NCT00166712|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101866559|NCT00166712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101866560|NCT00166712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866561|NCT00166712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101866562|NCT00166712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866563|NCT00166712|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101866564|NCT00166712|Antitubercular Agents|antitubercular agents|mesh-ancestor
101866565|NCT00166712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101866566|NCT00166712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101866567|NCT00166712|Antifungal Agents|antifungal agents|mesh-ancestor
101866568|NCT00166712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101866570|NCT00073528|Lapatinib|lapatinib|mesh-list
101866571|NCT00073528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866572|NCT00073528|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101866573|NCT00073528|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101866574|NCT00073528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101866575|NCT00073528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866576|NCT00073528|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101866577|NCT00073528|Hormone Antagonists|hormone antagonists|mesh-ancestor
101866578|NCT00073528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101866579|NCT00073528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866580|NCT00073528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101866581|NCT03801148|Dexlansoprazole|dexlansoprazole|mesh-list
101866582|NCT03801148|Lansoprazole|lansoprazole|mesh-list
101866583|NCT03801148|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101866584|NCT03801148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101866585|NCT03801148|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101866586|NCT03801148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101866587|NCT03801148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866588|NCT03960814|Insulin Detemir|insulin detemir|mesh-list
101866589|NCT03960814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101866590|NCT03960814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866591|NCT01103830|Moxifloxacin|moxifloxacin|mesh-list
101866592|NCT01103830|Lumefantrine|lumefantrine|mesh-list
101866593|NCT01103830|Artemether|artemether|mesh-list
101866594|NCT01103830|Piperaquine|piperaquine|mesh-list
101866595|NCT01103830|Artenimol|artenimol|mesh-list
101866596|NCT01103830|Artemisinins|artemisinins|mesh-list
101866597|NCT01103830|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101866598|NCT01103830|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101866599|NCT01103830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101866600|NCT01103830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101866601|NCT01103830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101866602|NCT01103830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101866603|NCT01103830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101866604|NCT01103830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866605|NCT01103830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866606|NCT01103830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101866607|NCT01103830|Contraceptive Agents|contraceptive agents|mesh-ancestor
101866608|NCT01103830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101866609|NCT01103830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866610|NCT01103830|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101866611|NCT01103830|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101866612|NCT01103830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101866613|NCT01103830|Antimalarials|antimalarials|mesh-ancestor
101866614|NCT01103830|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101866615|NCT01103830|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101866616|NCT00072280|Dactinomycin|dactinomycin|mesh-list
101866617|NCT00072280|Cyclophosphamide|cyclophosphamide|mesh-list
101866618|NCT00072280|Ifosfamide|ifosfamide|mesh-list
101866619|NCT00072280|Isophosphamide mustard|isophosphamide mustard|mesh-list
101866620|NCT00072280|Etoposide|etoposide|mesh-list
101866621|NCT00072280|Vincristine|vincristine|mesh-list
101866622|NCT00072280|Lenograstim|lenograstim|mesh-list
101866624|NCT00072280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101866625|NCT00072280|Immunologic Factors|immunologic factors|mesh-ancestor
101866626|NCT00072280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866627|NCT00072280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101866628|NCT00072280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101866629|NCT00072280|Alkylating Agents|alkylating agents|mesh-ancestor
101866630|NCT00072280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866631|NCT00072280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866632|NCT00072280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101866633|NCT00072280|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101866634|NCT00072280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101866635|NCT00072280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101866636|NCT00072280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101866637|NCT00072280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101866638|NCT00072280|Tubulin Modulators|tubulin modulators|mesh-ancestor
101966011|NCT02266264|Hydrocortisone|hydrocortisone|mesh-list
101866639|NCT00072280|Antimitotic Agents|antimitotic agents|mesh-ancestor
101866640|NCT00072280|Mitosis Modulators|mitosis modulators|mesh-ancestor
101866641|NCT00072280|Protective Agents|protective agents|mesh-ancestor
101866643|NCT00072280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101866644|NCT00072280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101866645|NCT00072280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101866646|NCT00072280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101866647|NCT01106716|Lidocaine|lidocaine|mesh-list
101866648|NCT01106716|Anesthetics, Local|anesthetics, local|mesh-ancestor
101866649|NCT01106716|Anesthetics|anesthetics|mesh-ancestor
101866650|NCT01106716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101866651|NCT01106716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866652|NCT01106716|Sensory System Agents|sensory system agents|mesh-ancestor
101866653|NCT01106716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101866654|NCT01106716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101866655|NCT01106716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101866656|NCT01106716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101866657|NCT01106716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101866658|NCT01106716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866659|NCT00071812|Belimumab|belimumab|mesh-list
101866660|NCT00071812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101866661|NCT00071812|Immunologic Factors|immunologic factors|mesh-ancestor
101866662|NCT00071812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866663|NCT01104298|Doxorubicin|doxorubicin|mesh-list
101866664|NCT01104298|Trabectedin|trabectedin|mesh-list
101866665|NCT01104298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101866666|NCT01104298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866667|NCT01104298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101866668|NCT01104298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101866669|NCT01104298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101866670|NCT01104298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866671|NCT01104298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101866672|NCT01104298|Alkylating Agents|alkylating agents|mesh-ancestor
101866673|NCT01106872|Bevacizumab|bevacizumab|mesh-list
101866674|NCT01106872|Gemcitabine|gemcitabine|mesh-list
101866675|NCT01106872|Docetaxel|docetaxel|mesh-list
101866676|NCT01106872|Valproic Acid|valproic acid|mesh-list
101866677|NCT01106872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101866678|NCT01106872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866679|NCT01106872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101866680|NCT01106872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101866681|NCT01106872|Growth Substances|growth substances|mesh-ancestor
101866682|NCT01106872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866683|NCT01106872|Growth Inhibitors|growth inhibitors|mesh-ancestor
101866684|NCT01106872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101866685|NCT01106872|Antimetabolites|antimetabolites|mesh-ancestor
101866686|NCT01106872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866687|NCT01106872|Tubulin Modulators|tubulin modulators|mesh-ancestor
101866688|NCT01106872|Antimitotic Agents|antimitotic agents|mesh-ancestor
101866689|NCT01106872|Mitosis Modulators|mitosis modulators|mesh-ancestor
101866690|NCT01106872|Anticonvulsants|anticonvulsants|mesh-ancestor
101866691|NCT01106872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101866692|NCT01106872|GABA Agents|gaba agents|mesh-ancestor
101866693|NCT01106872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101866694|NCT01106872|Antimanic Agents|antimanic agents|mesh-ancestor
101866695|NCT01106872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101866696|NCT01106872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101866697|NCT01106872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101866698|NCT03960268|Brodalumab|brodalumab|mesh-list
101866699|NCT03960268|Dermatologic Agents|dermatologic agents|mesh-ancestor
101866700|NCT05485480|Analgesics, Opioid|analgesics, opioid|mesh-list
101866701|NCT05485480|Narcotics|narcotics|mesh-ancestor
101866702|NCT05485480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101866703|NCT05485480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866704|NCT05485480|Analgesics|analgesics|mesh-ancestor
101866705|NCT05485480|Sensory System Agents|sensory system agents|mesh-ancestor
101866706|NCT05485480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101866707|NCT05470270|Hydroxyurea|hydroxyurea|mesh-list
101866708|NCT05470270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866709|NCT05470270|Antisickling Agents|antisickling agents|mesh-ancestor
101866710|NCT05470270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101688003|NCT02670954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101866711|NCT05470270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866712|NCT05470270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101866714|NCT01107106|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101866715|NCT01107106|Contraceptive Agents|contraceptive agents|mesh-ancestor
101866716|NCT01107106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101866717|NCT01107106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866718|NCT01107106|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101866719|NCT00259610|Hydroxychloroquine|hydroxychloroquine|mesh-list
101866720|NCT00259610|Sulfasalazine|sulfasalazine|mesh-list
101866721|NCT00259610|Etanercept|etanercept|mesh-list
101866722|NCT00259610|Methotrexate|methotrexate|mesh-list
101866723|NCT00259610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101866724|NCT00259610|Abortifacient Agents|abortifacient agents|mesh-ancestor
101866725|NCT00259610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101866726|NCT00259610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866727|NCT00259610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101866728|NCT00259610|Antimetabolites|antimetabolites|mesh-ancestor
101866729|NCT00259610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866730|NCT00259610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866731|NCT00259610|Dermatologic Agents|dermatologic agents|mesh-ancestor
101866732|NCT00259610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101866733|NCT00259610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101866734|NCT00259610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101866735|NCT00259610|Immunologic Factors|immunologic factors|mesh-ancestor
101866736|NCT00259610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101866737|NCT00259610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101866738|NCT00259610|Antimalarials|antimalarials|mesh-ancestor
101866739|NCT00259610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101866740|NCT00259610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101866741|NCT00259610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101866742|NCT00259610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101866743|NCT00259610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101866744|NCT00259610|Analgesics|analgesics|mesh-ancestor
101866745|NCT00259610|Sensory System Agents|sensory system agents|mesh-ancestor
101866746|NCT00259610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101866747|NCT00259610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101866748|NCT00259610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101866749|NCT05371132|Deferoxamine|deferoxamine|mesh-list
101586588|NCT00910858|Lenalidomide|lenalidomide|mesh-list
101866750|NCT05371132|Siderophores|siderophores|mesh-ancestor
101866751|NCT05371132|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101866752|NCT05371132|Chelating Agents|chelating agents|mesh-ancestor
101866753|NCT05371132|Sequestering Agents|sequestering agents|mesh-ancestor
101866754|NCT05371132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866755|NCT00165776|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
101866756|NCT00165776|Botulinum Toxins|botulinum toxins|mesh-list
101866757|NCT00165776|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101866758|NCT00165776|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101866759|NCT00165776|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101866760|NCT00165776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101866761|NCT00165776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866762|NCT00165776|Cholinergic Agents|cholinergic agents|mesh-ancestor
101866763|NCT00165776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101866764|NCT00165776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866765|NCT00165776|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101866766|NCT00165776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101866767|NCT00165776|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101866768|NCT04459468|Ethiodized Oil|ethiodized oil|mesh-list
101866769|NCT04459468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866770|NCT00165698|Alfacalcidol|alfacalcidol|mesh-list
101866771|NCT00165698|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
101866772|NCT00165698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101866773|NCT00165698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866774|NCT00165698|Vitamins|vitamins|mesh-ancestor
101866775|NCT00165698|Micronutrients|micronutrients|mesh-ancestor
101866776|NCT01075022|Vitamin D|vitamin d|mesh-list
101866777|NCT01075022|Cholecalciferol|cholecalciferol|mesh-list
101866778|NCT01075022|Vitamins|vitamins|mesh-ancestor
101866779|NCT01075022|Micronutrients|micronutrients|mesh-ancestor
101866780|NCT01075022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866781|NCT01075022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101966018|NCT01516918|Antiviral Agents|antiviral agents|mesh-ancestor
101866782|NCT01075022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101866783|NCT00225758|Lapatinib|lapatinib|mesh-list
101866784|NCT00225758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866785|NCT00225758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101866786|NCT00225758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101866787|NCT00225758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866788|NCT01104532|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101866789|NCT01104532|Ipragliflozin|ipragliflozin|mesh-list
101866790|NCT01104532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101866791|NCT01104532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866792|NCT01104532|Incretins|incretins|mesh-ancestor
101866793|NCT01104532|Hormones|hormones|mesh-ancestor
101866794|NCT01104532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101866795|NCT01104532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101866796|NCT01104532|Protease Inhibitors|protease inhibitors|mesh-ancestor
101866797|NCT01104532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101866798|NCT01104532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866799|NCT01104532|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101866800|NCT01107574|Gabapentin|gabapentin|mesh-list
101866801|NCT01107574|Analgesics|analgesics|mesh-ancestor
101866802|NCT01107574|Sensory System Agents|sensory system agents|mesh-ancestor
101866803|NCT01107574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101866804|NCT01107574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866805|NCT01107574|Anticonvulsants|anticonvulsants|mesh-ancestor
101866806|NCT01107574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101866807|NCT01107574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101866808|NCT01107574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101866809|NCT01107574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101866810|NCT01107574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101866811|NCT01107574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101866812|NCT01107574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101866813|NCT01107574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866814|NCT01107574|Antimanic Agents|antimanic agents|mesh-ancestor
101866815|NCT03971500|Ticagrelor|ticagrelor|mesh-list
101866816|NCT03971500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866817|NCT03971500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866818|NCT03971500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101866819|NCT03971500|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101866820|NCT03971500|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101866821|NCT03971500|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101866822|NCT03971500|Purinergic Agents|purinergic agents|mesh-ancestor
101866823|NCT03971500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101866824|NCT00259298|Teriparatide|teriparatide|mesh-list
101866825|NCT00259298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101866826|NCT00259298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866827|NCT00259298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101866828|NCT01108744|Mannitol|mannitol|mesh-list
101866829|NCT01108744|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101866830|NCT01108744|Diuretics|diuretics|mesh-ancestor
101866831|NCT01108744|Natriuretic Agents|natriuretic agents|mesh-ancestor
101866832|NCT01108744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866833|NCT01581866|Ziprasidone|ziprasidone|mesh-list
101866834|NCT01581866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101866835|NCT01581866|Serotonin Agents|serotonin agents|mesh-ancestor
101866836|NCT01581866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101866837|NCT01581866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866838|NCT01581866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866839|NCT01581866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101866840|NCT01581866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101866841|NCT01581866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101866842|NCT01581866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101866843|NCT01581866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101866844|NCT01581866|Dopamine Agents|dopamine agents|mesh-ancestor
101866845|NCT03892642|Avelumab|avelumab|mesh-list
101866846|NCT03892642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101866847|NCT03892642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866848|NCT01107808|Calcium, Dietary|calcium, dietary|mesh-list
101866849|NCT01107808|Vitamin D|vitamin d|mesh-list
101866850|NCT01107808|Ergocalciferols|ergocalciferols|mesh-list
101866852|NCT01107808|Calcium|calcium|mesh-list
101866853|NCT01107808|Vitamins|vitamins|mesh-ancestor
101866854|NCT01107808|Micronutrients|micronutrients|mesh-ancestor
101866855|NCT01107808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866856|NCT01107808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101866857|NCT01107808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101866858|NCT01107808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101866860|NCT01104844|Ibuprofen|ibuprofen|mesh-list
101866861|NCT01104844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101866862|NCT01104844|Analgesics|analgesics|mesh-ancestor
101866863|NCT01104844|Sensory System Agents|sensory system agents|mesh-ancestor
101866864|NCT01104844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101866865|NCT01104844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866866|NCT01104844|Antipyretics|antipyretics|mesh-ancestor
101866867|NCT01104844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101866868|NCT01104844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101866869|NCT01104844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101866870|NCT01104844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101866871|NCT01104844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101866872|NCT01104844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866873|NCT03750136|Furosemide|furosemide|mesh-list
101866874|NCT03750136|Diuretics|diuretics|mesh-ancestor
101866875|NCT03750136|Natriuretic Agents|natriuretic agents|mesh-ancestor
101866876|NCT03750136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866877|NCT03750136|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101866878|NCT03750136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101866879|NCT03750136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866880|NCT01108042|Docetaxel|docetaxel|mesh-list
101866881|NCT01108042|Fluorouracil|fluorouracil|mesh-list
101866882|NCT01108042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866883|NCT01108042|Tubulin Modulators|tubulin modulators|mesh-ancestor
101866884|NCT01108042|Antimitotic Agents|antimitotic agents|mesh-ancestor
101866885|NCT01108042|Mitosis Modulators|mitosis modulators|mesh-ancestor
101866886|NCT01108042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866887|NCT01108042|Antimetabolites|antimetabolites|mesh-ancestor
101866888|NCT01108042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101866889|NCT01108042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101866890|NCT01108042|Immunologic Factors|immunologic factors|mesh-ancestor
101866891|NCT01108042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866892|NCT01105234|Vitamin D|vitamin d|mesh-list
101866893|NCT01105234|Calcipotriene|calcipotriene|mesh-list
101866894|NCT01105234|Vitamins|vitamins|mesh-ancestor
101866895|NCT01105234|Micronutrients|micronutrients|mesh-ancestor
101866896|NCT01105234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866897|NCT01105234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101866898|NCT01105234|Dermatologic Agents|dermatologic agents|mesh-ancestor
101866899|NCT01108198|Mometasone Furoate|mometasone furoate|mesh-list
101866900|NCT01108198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101866901|NCT01108198|Dermatologic Agents|dermatologic agents|mesh-ancestor
101866902|NCT01108198|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101866903|NCT01108900|Sildenafil Citrate|sildenafil citrate|mesh-list
101866904|NCT01108900|Vasodilator Agents|vasodilator agents|mesh-ancestor
101866905|NCT01108900|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101866906|NCT01108900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101866907|NCT01108900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101866908|NCT01108900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866909|NCT01108900|Urological Agents|urological agents|mesh-ancestor
101866910|NCT01105390|Pemetrexed|pemetrexed|mesh-list
101866911|NCT01105390|Rilotumumab|rilotumumab|mesh-list
101866912|NCT01105390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101866913|NCT01105390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866914|NCT01105390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101866915|NCT01105390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866916|NCT01105390|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101866917|NCT01105390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101866918|NCT01105390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101866919|NCT01105390|Immunologic Factors|immunologic factors|mesh-ancestor
101866920|NCT01105390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866921|NCT03947242|Trastuzumab|trastuzumab|mesh-list
101866922|NCT03947242|Vinorelbine|vinorelbine|mesh-list
101327820|NCT00020605|Naloxone|naloxone|mesh-list
101866923|NCT03947242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101866924|NCT03947242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866925|NCT03947242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101866926|NCT03947242|Tubulin Modulators|tubulin modulators|mesh-ancestor
101866928|NCT03947242|Mitosis Modulators|mitosis modulators|mesh-ancestor
101866929|NCT03947242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866930|NCT03944980|Docetaxel|docetaxel|mesh-list
101866931|NCT03944980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866932|NCT03944980|Tubulin Modulators|tubulin modulators|mesh-ancestor
101866933|NCT03944980|Antimitotic Agents|antimitotic agents|mesh-ancestor
101866934|NCT03944980|Mitosis Modulators|mitosis modulators|mesh-ancestor
101866935|NCT03944980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866936|NCT03576664|Carvedilol|carvedilol|mesh-list
101866937|NCT03576664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101866938|NCT03576664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101866939|NCT03576664|Adrenergic Agents|adrenergic agents|mesh-ancestor
101866940|NCT03576664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101866941|NCT03576664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866942|NCT03576664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866943|NCT03576664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101866944|NCT03576664|Antioxidants|antioxidants|mesh-ancestor
101866945|NCT03576664|Protective Agents|protective agents|mesh-ancestor
101866946|NCT03576664|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101866947|NCT03576664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101866948|NCT03576664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101866949|NCT03576664|Vasodilator Agents|vasodilator agents|mesh-ancestor
101866950|NCT03576664|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101866951|NCT03576664|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101866952|NCT01109134|Tirofiban|tirofiban|mesh-list
101866953|NCT01109134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101866954|NCT01109134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101866955|NCT01109134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866956|NCT01109134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101866957|NCT01108588|Aspirin|aspirin|mesh-list
101866958|NCT01108588|Clopidogrel|clopidogrel|mesh-list
101866959|NCT01108588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101866960|NCT01108588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101866961|NCT01108588|Analgesics|analgesics|mesh-ancestor
101866962|NCT01108588|Sensory System Agents|sensory system agents|mesh-ancestor
101866963|NCT01108588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101866964|NCT01108588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866965|NCT01108588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101866966|NCT01108588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101866967|NCT01108588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101866968|NCT01108588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101866969|NCT01108588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866970|NCT01108588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101866971|NCT01108588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101866972|NCT01108588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101866973|NCT01108588|Antipyretics|antipyretics|mesh-ancestor
101586814|NCT01123980|Insulin|insulin|mesh-list
101866974|NCT01108588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101866975|NCT01108588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101866976|NCT01108588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101866977|NCT01108588|Purinergic Agents|purinergic agents|mesh-ancestor
101866978|NCT01108588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101866979|NCT01208740|Metformin|metformin|mesh-list
101866980|NCT01208740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101866981|NCT01208740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866982|NCT01208818|Dexamethasone|dexamethasone|mesh-list
101866983|NCT01208818|Dexamethasone acetate|dexamethasone acetate|mesh-list
101866984|NCT01208818|Cyclophosphamide|cyclophosphamide|mesh-list
101866985|NCT01208818|Bortezomib|bortezomib|mesh-list
101866986|NCT01208818|BB 1101|bb 1101|mesh-list
101866987|NCT01208818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101866988|NCT01208818|Immunologic Factors|immunologic factors|mesh-ancestor
101866989|NCT01208818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101866990|NCT01208818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101866991|NCT01208818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101866992|NCT01208818|Alkylating Agents|alkylating agents|mesh-ancestor
101866993|NCT01208818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101866994|NCT01208818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101866996|NCT01208818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101866997|NCT01208818|Antiemetics|antiemetics|mesh-ancestor
101866998|NCT01208818|Autonomic Agents|autonomic agents|mesh-ancestor
101866999|NCT01208818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101867000|NCT01208818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101867001|NCT01208818|Glucocorticoids|glucocorticoids|mesh-ancestor
101867002|NCT01208818|Hormones|hormones|mesh-ancestor
101867003|NCT01208818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101867004|NCT01208818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101867005|NCT01208818|Protease Inhibitors|protease inhibitors|mesh-ancestor
101867006|NCT01208818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101867007|NCT01111630|Epoetin Alfa|epoetin alfa|mesh-list
101867008|NCT01111630|Hematinics|hematinics|mesh-ancestor
101867009|NCT03942796|Pregabalin|pregabalin|mesh-list
101867010|NCT03942796|Analgesics|analgesics|mesh-ancestor
101867011|NCT03942796|Sensory System Agents|sensory system agents|mesh-ancestor
101867012|NCT03942796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101867013|NCT03942796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867014|NCT03942796|Anticonvulsants|anticonvulsants|mesh-ancestor
101867015|NCT03942796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101867016|NCT03942796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101867017|NCT03942796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867018|NCT03942796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101867019|NCT03942796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101867020|NCT03942796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101867021|NCT03942796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101867022|NCT03942796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101867023|NCT01114282|Bortezomib|bortezomib|mesh-list
101867024|NCT01114282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101867025|NCT01109212|Bindarit|bindarit|mesh-list
101867026|NCT01109212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101867027|NCT01109212|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101867028|NCT01109212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101867029|NCT01109212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867030|NCT01111864|Micronutrients|micronutrients|mesh-list
101867031|NCT01111864|Trace Elements|trace elements|mesh-list
101867032|NCT01111864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867033|NCT01111942|Cisplatin|cisplatin|mesh-list
101867034|NCT01111942|Carboplatin|carboplatin|mesh-list
101867035|NCT01111942|Docetaxel|docetaxel|mesh-list
101867036|NCT01111942|Fluorouracil|fluorouracil|mesh-list
101867037|NCT01111942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101867038|NCT01111942|Tubulin Modulators|tubulin modulators|mesh-ancestor
101867039|NCT01111942|Antimitotic Agents|antimitotic agents|mesh-ancestor
101867040|NCT01111942|Mitosis Modulators|mitosis modulators|mesh-ancestor
101867041|NCT01111942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867042|NCT01111942|Antimetabolites|antimetabolites|mesh-ancestor
101867043|NCT01111942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101867044|NCT01111942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101867045|NCT01111942|Immunologic Factors|immunologic factors|mesh-ancestor
101867046|NCT01111942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867047|NCT01211860|Diazoxide|diazoxide|mesh-list
101867048|NCT01211860|Choline|choline|mesh-list
101867049|NCT01211860|Lipotropic Agents|lipotropic agents|mesh-ancestor
101867050|NCT01211860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101867051|NCT01211860|Antimetabolites|antimetabolites|mesh-ancestor
101867052|NCT01211860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867053|NCT01211860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101867054|NCT01211860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101867055|NCT01211860|Nootropic Agents|nootropic agents|mesh-ancestor
101867056|NCT01211860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101867057|NCT01211860|Vasodilator Agents|vasodilator agents|mesh-ancestor
101867058|NCT01211938|Cetuximab|cetuximab|mesh-list
101867059|NCT01211938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101867060|NCT01211938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101867061|NCT02947438|Epoetin Alfa|epoetin alfa|mesh-list
101867062|NCT02947438|Hematinics|hematinics|mesh-ancestor
101867063|NCT01209130|Rituximab|rituximab|mesh-list
101867064|NCT01209130|Pinatuzumab vedotin|pinatuzumab vedotin|mesh-list
101867065|NCT01209130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101867066|NCT01209130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101867067|NCT01209130|Immunologic Factors|immunologic factors|mesh-ancestor
101867068|NCT01209130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867069|NCT01209130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101867070|NCT01209130|Immunoconjugates|immunoconjugates|mesh-ancestor
101867071|NCT01209208|Budesonide|budesonide|mesh-list
101867072|NCT01209208|Mesalamine|mesalamine|mesh-list
101867073|NCT01209208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101867074|NCT01209208|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101867075|NCT01209208|Autonomic Agents|autonomic agents|mesh-ancestor
101867076|NCT01209208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101867077|NCT01209208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867078|NCT01209208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101867079|NCT01209208|Respiratory System Agents|respiratory system agents|mesh-ancestor
101867080|NCT01209208|Glucocorticoids|glucocorticoids|mesh-ancestor
101867081|NCT01209208|Hormones|hormones|mesh-ancestor
101867082|NCT01209208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101867083|NCT01209208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101867084|NCT01209208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101867085|NCT01209208|Analgesics|analgesics|mesh-ancestor
101867086|NCT01209208|Sensory System Agents|sensory system agents|mesh-ancestor
101867087|NCT01209208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101867088|NCT01114750|Dextrans|dextrans|mesh-list
101867089|NCT01114750|Anticoagulants|anticoagulants|mesh-ancestor
101867090|NCT01114750|Plasma Substitutes|plasma substitutes|mesh-ancestor
101867091|NCT01114750|Blood Substitutes|blood substitutes|mesh-ancestor
101867092|NCT01328470|Cilostazol|cilostazol|mesh-list
101867093|NCT01328470|Clopidogrel|clopidogrel|mesh-list
101867094|NCT01328470|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101867095|NCT01328470|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101867096|NCT01328470|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101867097|NCT01328470|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101867098|NCT01328470|Purinergic Agents|purinergic agents|mesh-ancestor
101867099|NCT01328470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101867100|NCT01328470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867101|NCT01328470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867102|NCT01328470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101867103|NCT01328470|Autonomic Agents|autonomic agents|mesh-ancestor
101867104|NCT01328470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101867105|NCT01328470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101867106|NCT01328470|Respiratory System Agents|respiratory system agents|mesh-ancestor
101867107|NCT01328470|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101867108|NCT01328470|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101867109|NCT01328470|Vasodilator Agents|vasodilator agents|mesh-ancestor
101867110|NCT01328470|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101867111|NCT01328470|Protective Agents|protective agents|mesh-ancestor
101867112|NCT01328470|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101867113|NCT01328470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101867114|NCT01328470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101867115|NCT01109446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101867116|NCT03940378|Levamisole|levamisole|mesh-list
101867117|NCT03940378|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101867118|NCT03940378|Immunologic Factors|immunologic factors|mesh-ancestor
101867119|NCT03940378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867120|NCT03940378|Antinematodal Agents|antinematodal agents|mesh-ancestor
101867121|NCT03940378|Anthelmintics|anthelmintics|mesh-ancestor
101867122|NCT03940378|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101867123|NCT03940378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101867124|NCT03940378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101867125|NCT01115062|Lidocaine|lidocaine|mesh-list
101867126|NCT01115062|Anesthetics, Local|anesthetics, local|mesh-ancestor
101867127|NCT01115062|Anesthetics|anesthetics|mesh-ancestor
101867128|NCT01115062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101867129|NCT01115062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867130|NCT01115062|Sensory System Agents|sensory system agents|mesh-ancestor
101867131|NCT01115062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101867132|NCT01115062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101867133|NCT01115062|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101867134|NCT01115062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101867135|NCT01115062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101867136|NCT01115062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867137|NCT01115140|Folic Acid|folic acid|mesh-list
101867138|NCT01115140|Vitamin B Complex|vitamin b complex|mesh-list
101867139|NCT01115140|Metformin|metformin|mesh-list
101867140|NCT01115140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101867141|NCT01115140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867142|NCT01115140|Hematinics|hematinics|mesh-ancestor
101867143|NCT01115140|Vitamins|vitamins|mesh-ancestor
101867144|NCT01115140|Micronutrients|micronutrients|mesh-ancestor
101867145|NCT01112644|Oxycodone|oxycodone|mesh-list
101867146|NCT01112644|Naloxone|naloxone|mesh-list
101867147|NCT01112644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101867148|NCT01112644|Narcotics|narcotics|mesh-ancestor
101867149|NCT01112644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101867150|NCT01112644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867151|NCT01112644|Analgesics|analgesics|mesh-ancestor
101867152|NCT01112644|Sensory System Agents|sensory system agents|mesh-ancestor
101867153|NCT01112644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101867154|NCT01112644|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101867155|NCT01112722|Histamine|histamine|mesh-list
101867156|NCT01112722|Histamine Agonists|histamine agonists|mesh-ancestor
101867157|NCT01112722|Histamine Agents|histamine agents|mesh-ancestor
101867158|NCT01112722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101867159|NCT01112722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867160|NCT01112722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867161|NCT01015222|Paclitaxel|paclitaxel|mesh-list
101867162|NCT01015222|Bevacizumab|bevacizumab|mesh-list
101867163|NCT01015222|Dasatinib|dasatinib|mesh-list
101867164|NCT01015222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101867165|NCT01015222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101867166|NCT01015222|Tubulin Modulators|tubulin modulators|mesh-ancestor
101867167|NCT01015222|Antimitotic Agents|antimitotic agents|mesh-ancestor
101867168|NCT01015222|Mitosis Modulators|mitosis modulators|mesh-ancestor
101867169|NCT01015222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867170|NCT01015222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101867171|NCT01015222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101867172|NCT01015222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101867173|NCT01015222|Growth Substances|growth substances|mesh-ancestor
101867174|NCT01015222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867175|NCT01015222|Growth Inhibitors|growth inhibitors|mesh-ancestor
101867176|NCT01015222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101867177|NCT01015222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101867178|NCT01212250|Carvedilol|carvedilol|mesh-list
101867179|NCT01212250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101867180|NCT01212250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101867181|NCT01212250|Adrenergic Agents|adrenergic agents|mesh-ancestor
101867182|NCT01212250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101867183|NCT01212250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244906|NCT01656642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101867184|NCT01212250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867185|NCT01212250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101867186|NCT01212250|Antioxidants|antioxidants|mesh-ancestor
101867187|NCT01212250|Protective Agents|protective agents|mesh-ancestor
101867188|NCT01212250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101867189|NCT01212250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101867190|NCT01212250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101867191|NCT01212250|Vasodilator Agents|vasodilator agents|mesh-ancestor
101867192|NCT01212250|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101867193|NCT01212250|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101867194|NCT01209988|Tamsulosin|tamsulosin|mesh-list
101867195|NCT01209988|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101867196|NCT01209988|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101867197|NCT01209988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101867198|NCT01209988|Adrenergic Agents|adrenergic agents|mesh-ancestor
101867199|NCT01209988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101867200|NCT01209988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867201|NCT01209988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867202|NCT01209988|Urological Agents|urological agents|mesh-ancestor
101867203|NCT03943186|Hyaluronic Acid|hyaluronic acid|mesh-list
101867204|NCT03943186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101867206|NCT03943186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867207|NCT03943186|Viscosupplements|viscosupplements|mesh-ancestor
101867208|NCT03943186|Protective Agents|protective agents|mesh-ancestor
101867209|NCT01210066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
101867210|NCT01210066|Fentanyl|fentanyl|mesh-list
101867211|NCT01210066|Analgesics, Opioid|analgesics, opioid|mesh-list
101867212|NCT01210066|Narcotics|narcotics|mesh-ancestor
101867213|NCT01210066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101867214|NCT01210066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867215|NCT01210066|Analgesics|analgesics|mesh-ancestor
101867216|NCT01210066|Sensory System Agents|sensory system agents|mesh-ancestor
101867217|NCT01210066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101867218|NCT01210066|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101867220|NCT01210066|Anesthetics, General|anesthetics, general|mesh-ancestor
101867221|NCT01210066|Anesthetics|anesthetics|mesh-ancestor
101867222|NCT01112878|Clonidine|clonidine|mesh-list
101867223|NCT01112878|Gabapentin|gabapentin|mesh-list
101867224|NCT01112878|Analgesics|analgesics|mesh-ancestor
101867225|NCT01112878|Sensory System Agents|sensory system agents|mesh-ancestor
101867226|NCT01112878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101867227|NCT01112878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867228|NCT01112878|Anticonvulsants|anticonvulsants|mesh-ancestor
101867229|NCT01112878|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101867230|NCT01112878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101867231|NCT01112878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101867232|NCT01112878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101867233|NCT01112878|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101867234|NCT01112878|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101867235|NCT01112878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101867236|NCT01112878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867237|NCT01112878|Antimanic Agents|antimanic agents|mesh-ancestor
101867238|NCT01112878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101867239|NCT01112878|Sympatholytics|sympatholytics|mesh-ancestor
101867240|NCT01112878|Autonomic Agents|autonomic agents|mesh-ancestor
101867241|NCT01112878|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101867242|NCT01112878|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101867243|NCT01112878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101867244|NCT01112878|Adrenergic Agents|adrenergic agents|mesh-ancestor
101867245|NCT01212406|Vitamin D|vitamin d|mesh-list
101867246|NCT01212406|Vitamins|vitamins|mesh-ancestor
101867247|NCT01212406|Micronutrients|micronutrients|mesh-ancestor
101867248|NCT01212406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867249|NCT01212406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101867250|NCT01109758|Fenofibrate|fenofibrate|mesh-list
101867251|NCT01109758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101867252|NCT01109758|Antimetabolites|antimetabolites|mesh-ancestor
101867253|NCT01109758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867254|NCT01109758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101867255|NCT01328236|Dexamethasone|dexamethasone|mesh-list
101867256|NCT01328236|Doxorubicin|doxorubicin|mesh-list
101867257|NCT01328236|Bortezomib|bortezomib|mesh-list
101867258|NCT01328236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101867259|NCT01328236|Antiemetics|antiemetics|mesh-ancestor
101867260|NCT01328236|Autonomic Agents|autonomic agents|mesh-ancestor
101867261|NCT01328236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101867262|NCT01328236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867263|NCT01328236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101867264|NCT01328236|Glucocorticoids|glucocorticoids|mesh-ancestor
101867265|NCT01328236|Hormones|hormones|mesh-ancestor
101867266|NCT01328236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101867267|NCT01328236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101867268|NCT01328236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101867269|NCT01328236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101867270|NCT01328236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101867271|NCT01328236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101867272|NCT01328236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101867273|NCT01328236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867274|NCT01328392|Dexlansoprazole|dexlansoprazole|mesh-list
101867275|NCT01328392|Lansoprazole|lansoprazole|mesh-list
101867276|NCT01328392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101867277|NCT01328392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101867278|NCT01328392|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101867279|NCT01328392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101587118|NCT00656695|Cyclosporine|cyclosporine|mesh-list
101966047|NCT01357642|Respiratory System Agents|respiratory system agents|mesh-ancestor
101867280|NCT01328392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867281|NCT01115842|Vitamin D|vitamin d|mesh-list
101867282|NCT01115842|Vitamins|vitamins|mesh-ancestor
101867283|NCT01115842|Micronutrients|micronutrients|mesh-ancestor
101867284|NCT01115842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867285|NCT01115842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101867286|NCT01210378|Nitroglycerin|nitroglycerin|mesh-list
101867287|NCT01210378|Vasodilator Agents|vasodilator agents|mesh-ancestor
101867288|NCT01116154|Lenalidomide|lenalidomide|mesh-list
101867289|NCT01116154|Vorinostat|vorinostat|mesh-list
101867290|NCT01116154|Immunologic Factors|immunologic factors|mesh-ancestor
101867291|NCT01116154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867292|NCT01116154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101867293|NCT01116154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101867294|NCT01116154|Growth Substances|growth substances|mesh-ancestor
101867295|NCT01116154|Growth Inhibitors|growth inhibitors|mesh-ancestor
101867296|NCT01116154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101867297|NCT01116154|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101867298|NCT01116154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101867299|NCT01116154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867300|NCT01210456|Acetylcysteine|acetylcysteine|mesh-list
101867301|NCT01210456|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101867302|NCT01210456|Antiviral Agents|antiviral agents|mesh-ancestor
101867303|NCT01210456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101867304|NCT01210456|Expectorants|expectorants|mesh-ancestor
101867305|NCT01210456|Respiratory System Agents|respiratory system agents|mesh-ancestor
101867306|NCT01210456|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101867307|NCT01210456|Antioxidants|antioxidants|mesh-ancestor
101867308|NCT01210456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867309|NCT01210456|Protective Agents|protective agents|mesh-ancestor
101867310|NCT01210456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867311|NCT01210456|Antidotes|antidotes|mesh-ancestor
101867312|NCT01116310|Glycine|glycine|mesh-list
101867313|NCT01116310|Glycine Agents|glycine agents|mesh-ancestor
101867314|NCT01116310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101867315|NCT01116310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867316|NCT01116310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867317|NCT01210846|Tivozanib|tivozanib|mesh-list
101867318|NCT01210846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101867319|NCT01210846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101867320|NCT01210846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867321|NCT01116388|Caseins|caseins|mesh-list
101867322|NCT01116388|Chelating Agents|chelating agents|mesh-ancestor
101867323|NCT01116388|Sequestering Agents|sequestering agents|mesh-ancestor
101867324|NCT01116388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867325|NCT01116622|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101867326|NCT01116622|Bexarotene|bexarotene|mesh-list
101867327|NCT01116622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101867328|NCT01116622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101867329|NCT01116622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101867330|NCT01116622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867331|NCT03941626|Immunomodulating Agents|immunomodulating agents|mesh-list
101867332|NCT03941626|Immunologic Factors|immunologic factors|mesh-ancestor
101867333|NCT03941626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867334|NCT01211002|Endostatins|endostatins|mesh-list
101867335|NCT01211002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101867336|NCT01211002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101867337|NCT01211002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101867338|NCT01211002|Growth Substances|growth substances|mesh-ancestor
101867339|NCT01211002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867340|NCT01211002|Growth Inhibitors|growth inhibitors|mesh-ancestor
101867341|NCT01211080|Propranolol|propranolol|mesh-list
101867342|NCT01211080|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101867343|NCT01211080|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101867344|NCT01211080|Adrenergic Agents|adrenergic agents|mesh-ancestor
101867345|NCT01211080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101867346|NCT01211080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867347|NCT01211080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867348|NCT01211080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101867349|NCT01211080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101867350|NCT01211080|Vasodilator Agents|vasodilator agents|mesh-ancestor
101867351|NCT01116700|Dexmedetomidine|dexmedetomidine|mesh-list
101867352|NCT01116700|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101867353|NCT01116700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101867354|NCT01116700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867355|NCT01116700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101867356|NCT01116700|Analgesics|analgesics|mesh-ancestor
101867357|NCT01116700|Sensory System Agents|sensory system agents|mesh-ancestor
101867358|NCT01116700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101867359|NCT01116700|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101867360|NCT01116700|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101867361|NCT01116700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101867362|NCT01116700|Adrenergic Agents|adrenergic agents|mesh-ancestor
101867363|NCT01116700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101867364|NCT01116700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867365|NCT01113424|Nicotine|nicotine|mesh-list
101867366|NCT01113424|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101867367|NCT01113424|Autonomic Agents|autonomic agents|mesh-ancestor
101867368|NCT01113424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101867369|NCT01113424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867370|NCT01113424|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101867371|NCT01113424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101867372|NCT01113424|Cholinergic Agents|cholinergic agents|mesh-ancestor
101867373|NCT01113424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101867374|NCT01113424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867375|NCT01211158|Ketamine|ketamine|mesh-list
101867376|NCT01211158|Propofol|propofol|mesh-list
101867377|NCT01211158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101867378|NCT01211158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101867379|NCT01211158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867380|NCT01211158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101867381|NCT01211158|Anesthetics, General|anesthetics, general|mesh-ancestor
101867382|NCT01211158|Anesthetics|anesthetics|mesh-ancestor
101867383|NCT01211158|Analgesics|analgesics|mesh-ancestor
101867384|NCT01211158|Sensory System Agents|sensory system agents|mesh-ancestor
101867385|NCT01211158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101867386|NCT01211158|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101867387|NCT01211158|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101867388|NCT01211158|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101867389|NCT01211158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101867390|NCT01211158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867391|NCT01110226|Cisplatin|cisplatin|mesh-list
101867392|NCT01110226|Sodium arsenite|sodium arsenite|mesh-list
101867393|NCT01110226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101867394|NCT01110226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101867395|NCT01110226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867396|NCT03789292|Adalimumab|adalimumab|mesh-list
101867397|NCT03789292|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101867398|NCT03789292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101867399|NCT03789292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101867400|NCT01211314|Enalapril|enalapril|mesh-list
101867401|NCT01211314|Lercanidipine|lercanidipine|mesh-list
101867402|NCT01211314|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101867403|NCT01211314|Protease Inhibitors|protease inhibitors|mesh-ancestor
101867404|NCT01211314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101867405|NCT01211314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867406|NCT01211314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101867407|NCT01211314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101867408|NCT01211314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101867409|NCT01211314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101867410|NCT01211314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867411|NCT01110304|Analgesics|analgesics|mesh-list
101867412|NCT01110304|Sensory System Agents|sensory system agents|mesh-ancestor
101867413|NCT01110304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101867414|NCT01110304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867415|NCT02529514|Baclofen|baclofen|mesh-list
101867416|NCT02529514|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101867417|NCT02529514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867418|NCT02529514|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101867419|NCT02529514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101867420|NCT02529514|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101867421|NCT02529514|GABA Agonists|gaba agonists|mesh-ancestor
101867422|NCT02529514|GABA Agents|gaba agents|mesh-ancestor
101867423|NCT02529514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101867424|NCT02529514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867425|NCT01211470|Daptomycin|daptomycin|mesh-list
101867426|NCT01211470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101867427|NCT01211470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101867429|NCT01114048|Dexamethasone|dexamethasone|mesh-list
101867430|NCT01114048|Cyclophosphamide|cyclophosphamide|mesh-list
101867431|NCT01114048|Bortezomib|bortezomib|mesh-list
101867432|NCT01114048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101867433|NCT01114048|Immunologic Factors|immunologic factors|mesh-ancestor
101867434|NCT01114048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867435|NCT01114048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101867436|NCT01114048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101867437|NCT01114048|Alkylating Agents|alkylating agents|mesh-ancestor
101867438|NCT01114048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867439|NCT01114048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101867440|NCT01114048|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101867441|NCT01114048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101867442|NCT01114048|Antiemetics|antiemetics|mesh-ancestor
101867443|NCT01114048|Autonomic Agents|autonomic agents|mesh-ancestor
101867444|NCT01114048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101867445|NCT01114048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101867446|NCT01114048|Glucocorticoids|glucocorticoids|mesh-ancestor
101867447|NCT01114048|Hormones|hormones|mesh-ancestor
101867448|NCT01114048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101867449|NCT01114048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101867450|NCT01114048|Leprostatic Agents|leprostatic agents|mesh-ancestor
101867451|NCT01114048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101867452|NCT01114048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101867453|NCT01114048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101867454|NCT01114048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101867455|NCT01114048|Growth Substances|growth substances|mesh-ancestor
101867456|NCT01114048|Growth Inhibitors|growth inhibitors|mesh-ancestor
101867457|NCT01208194|Immunologic Factors|immunologic factors|mesh-list
101867458|NCT01208194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867459|NCT01211704|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101867460|NCT01211704|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101867461|NCT01211704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101867462|NCT01211704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101867463|NCT01211704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867464|NCT01211704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101867465|NCT01211704|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101867466|NCT01211704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101867467|NCT01211704|Serotonin Agents|serotonin agents|mesh-ancestor
101867468|NCT01211704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101867469|NCT01211704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867470|NCT01211704|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101867471|NCT01211704|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101867472|NCT01211704|Dopamine Agents|dopamine agents|mesh-ancestor
101867473|NCT02529670|Lidocaine|lidocaine|mesh-list
101867474|NCT02529670|Anesthetics, Local|anesthetics, local|mesh-ancestor
101867475|NCT02529670|Anesthetics|anesthetics|mesh-ancestor
101867476|NCT02529670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101867477|NCT02529670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867478|NCT02529670|Sensory System Agents|sensory system agents|mesh-ancestor
101867479|NCT02529670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101867480|NCT02529670|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101867481|NCT02529670|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101867482|NCT02529670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101966063|NCT02264158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101867483|NCT02529670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101244980|NCT01657071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101867484|NCT02529670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867485|NCT01117636|Aspirin|aspirin|mesh-list
101867486|NCT01117636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101867487|NCT01117636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101867488|NCT01117636|Analgesics|analgesics|mesh-ancestor
101867489|NCT01117636|Sensory System Agents|sensory system agents|mesh-ancestor
101867490|NCT01117636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101867491|NCT01117636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867492|NCT01117636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101867493|NCT01117636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101867494|NCT01117636|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101867495|NCT01117636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101867496|NCT01117636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867497|NCT01117636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101867498|NCT01117636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101867499|NCT01117636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101867500|NCT01117636|Antipyretics|antipyretics|mesh-ancestor
101867501|NCT03938740|Insulin|insulin|mesh-list
101867502|NCT03938740|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101867503|NCT03938740|Insulin Lispro|insulin lispro|mesh-list
101867504|NCT03938740|Insulin, Long-Acting|insulin, long-acting|mesh-list
101867505|NCT03938740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101867506|NCT03938740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867507|NCT01110616|Lorazepam|lorazepam|mesh-list
101867508|NCT01110616|Anticonvulsants|anticonvulsants|mesh-ancestor
101867509|NCT01110616|Antiemetics|antiemetics|mesh-ancestor
101867510|NCT01110616|Autonomic Agents|autonomic agents|mesh-ancestor
101867511|NCT01110616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101867512|NCT01110616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867513|NCT01110616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101867514|NCT01110616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101867515|NCT01110616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101867516|NCT01110616|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101867517|NCT01110616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101867518|NCT01110616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101867519|NCT01110616|GABA Modulators|gaba modulators|mesh-ancestor
101867520|NCT01110616|GABA Agents|gaba agents|mesh-ancestor
101867521|NCT01110616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101867522|NCT01110616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867523|NCT03938662|Choline|choline|mesh-list
101867524|NCT03938662|Lipotropic Agents|lipotropic agents|mesh-ancestor
101867525|NCT03938662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101867526|NCT03938662|Antimetabolites|antimetabolites|mesh-ancestor
101867527|NCT03938662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867528|NCT03938662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101867529|NCT03938662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101867530|NCT03938662|Nootropic Agents|nootropic agents|mesh-ancestor
101867531|NCT01213498|Atorvastatin|atorvastatin|mesh-list
101867532|NCT01213498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101867533|NCT01213498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101867534|NCT01213498|Antimetabolites|antimetabolites|mesh-ancestor
101867535|NCT01213498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867536|NCT01213498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101867537|NCT01213498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101966074|NCT01476904|Epinephrine|epinephrine|mesh-list
101867538|NCT01213498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101867539|NCT01111084|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101867540|NCT01111084|Hormones|hormones|mesh-ancestor
101867541|NCT01111084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101867542|NCT01111084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867543|NCT01118260|Anesthetics|anesthetics|mesh-list
101867544|NCT01118260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101867545|NCT01118260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867546|NCT01121770|PENTA|penta|mesh-list
101867547|NCT01121770|Fondaparinux|fondaparinux|mesh-list
101867548|NCT01121770|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101867549|NCT01121770|Antithrombins|antithrombins|mesh-ancestor
101867550|NCT01121770|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101867551|NCT01121770|Protease Inhibitors|protease inhibitors|mesh-ancestor
101867552|NCT01121770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101867553|NCT01121770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867554|NCT01121770|Anticoagulants|anticoagulants|mesh-ancestor
101688051|NCT02671578|Analgesics|analgesics|mesh-ancestor
101867555|NCT01121770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101867556|NCT01121770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101867558|NCT01121848|Fluorouracil|fluorouracil|mesh-list
101867559|NCT01121848|Oxaliplatin|oxaliplatin|mesh-list
101867560|NCT01121848|Antimetabolites|antimetabolites|mesh-ancestor
101867561|NCT01121848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867562|NCT01121848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101867563|NCT01121848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101867564|NCT01121848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101867565|NCT01121848|Immunologic Factors|immunologic factors|mesh-ancestor
101867566|NCT01121848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867567|NCT01121848|Antidotes|antidotes|mesh-ancestor
101867568|NCT01121848|Protective Agents|protective agents|mesh-ancestor
101867569|NCT01121848|Vitamin B Complex|vitamin b complex|mesh-ancestor
101867570|NCT01121848|Vitamins|vitamins|mesh-ancestor
101867571|NCT01121848|Micronutrients|micronutrients|mesh-ancestor
101867572|NCT01122004|Pregabalin|pregabalin|mesh-list
101867573|NCT01122004|Analgesics|analgesics|mesh-ancestor
101867574|NCT01122004|Sensory System Agents|sensory system agents|mesh-ancestor
101867575|NCT01122004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101867576|NCT01122004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867577|NCT01122004|Anticonvulsants|anticonvulsants|mesh-ancestor
101867578|NCT01122004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101587415|NCT02883426|Vaccines|vaccines|mesh-list
101867579|NCT01122004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101867580|NCT01122004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867581|NCT01122004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101867582|NCT01122004|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101867583|NCT01122004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101867584|NCT01122004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101867585|NCT01122004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101867586|NCT03933982|Vinorelbine|vinorelbine|mesh-list
101867587|NCT03933982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101867588|NCT03933982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101867589|NCT03933982|Tubulin Modulators|tubulin modulators|mesh-ancestor
101867590|NCT03933982|Antimitotic Agents|antimitotic agents|mesh-ancestor
101867591|NCT03933982|Mitosis Modulators|mitosis modulators|mesh-ancestor
101867592|NCT03933982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867593|NCT01118572|Celecoxib|celecoxib|mesh-list
101867594|NCT01118572|Etodolac|etodolac|mesh-list
101867595|NCT01118572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101867596|NCT01118572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101867597|NCT01118572|Analgesics|analgesics|mesh-ancestor
101867598|NCT01118572|Sensory System Agents|sensory system agents|mesh-ancestor
101867599|NCT01118572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101867600|NCT01118572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966092|NCT01337752|Dexamethasone|dexamethasone|mesh-list
101867601|NCT01118572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101867602|NCT01118572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101867603|NCT01118572|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101867604|NCT01118572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101867605|NCT01118572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101867606|NCT01118572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867607|NCT03937648|Lasmiditan|lasmiditan|mesh-list
101867608|NCT03937648|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101867609|NCT03937648|Serotonin Agents|serotonin agents|mesh-ancestor
101867610|NCT03937648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101867611|NCT03937648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867612|NCT03937648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867613|NCT01219036|Budesonide|budesonide|mesh-list
101867614|NCT01219036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101867615|NCT01219036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101867616|NCT01219036|Autonomic Agents|autonomic agents|mesh-ancestor
101867617|NCT01219036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101867618|NCT01219036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867619|NCT01219036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101867620|NCT01219036|Respiratory System Agents|respiratory system agents|mesh-ancestor
101867621|NCT01219036|Glucocorticoids|glucocorticoids|mesh-ancestor
101867622|NCT01219036|Hormones|hormones|mesh-ancestor
101867623|NCT01219036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101867624|NCT01124500|Methylphenidate|methylphenidate|mesh-list
101867625|NCT01124500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101867626|NCT01124500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867627|NCT01124500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101867628|NCT01124500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101867629|NCT01124500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101867630|NCT01124500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867632|NCT01124500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101867633|NCT01118884|Promethazine|promethazine|mesh-list
101867634|NCT01118884|Diphenhydramine|diphenhydramine|mesh-list
101867635|NCT01118884|Antipruritics|antipruritics|mesh-ancestor
101867636|NCT01118884|Dermatologic Agents|dermatologic agents|mesh-ancestor
101867637|NCT01118884|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101867638|NCT01118884|Histamine Antagonists|histamine antagonists|mesh-ancestor
101867639|NCT01118884|Histamine Agents|histamine agents|mesh-ancestor
101867640|NCT01118884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101867641|NCT01118884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867642|NCT01118884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867643|NCT01118884|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101867644|NCT01118884|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101867645|NCT01118884|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101867646|NCT01118884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101867647|NCT01118884|Anesthetics, Local|anesthetics, local|mesh-ancestor
101867648|NCT01118884|Anesthetics|anesthetics|mesh-ancestor
101867649|NCT01118884|Sensory System Agents|sensory system agents|mesh-ancestor
101867650|NCT01118884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101867651|NCT01118884|Antiemetics|antiemetics|mesh-ancestor
101867652|NCT01118884|Autonomic Agents|autonomic agents|mesh-ancestor
101867654|NCT01119196|Dialysis Solutions|dialysis solutions|mesh-list
101867655|NCT01119196|Icodextrin|icodextrin|mesh-list
101867656|NCT01119196|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101867657|NCT01213888|Trientine|trientine|mesh-list
101867658|NCT01213888|Chelating Agents|chelating agents|mesh-ancestor
101867659|NCT01213888|Sequestering Agents|sequestering agents|mesh-ancestor
101867660|NCT01213888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867661|NCT01119430|Fluoxetine|fluoxetine|mesh-list
101867662|NCT01119430|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101867663|NCT01119430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101867664|NCT01119430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101867665|NCT01119430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867666|NCT01119430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101867668|NCT01119430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867669|NCT01119430|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101867670|NCT01119430|Antidepressive Agents|antidepressive agents|mesh-ancestor
101867671|NCT01119430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101867672|NCT01119430|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101867673|NCT01119430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101867674|NCT01119430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101867675|NCT02529124|Caseins|caseins|mesh-list
101867676|NCT02529124|Chelating Agents|chelating agents|mesh-ancestor
101867677|NCT02529124|Sequestering Agents|sequestering agents|mesh-ancestor
101867678|NCT02529124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867679|NCT03780244|Mannitol|mannitol|mesh-list
101867680|NCT03780244|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101867681|NCT03780244|Diuretics|diuretics|mesh-ancestor
101867682|NCT03780244|Natriuretic Agents|natriuretic agents|mesh-ancestor
101867683|NCT03780244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867684|NCT01119742|Butenafine|butenafine|mesh-list
101867685|NCT01119742|Antifungal Agents|antifungal agents|mesh-ancestor
101245002|NCT01657201|Voriconazole|voriconazole|mesh-list
101867686|NCT01119742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101867687|NCT01216696|Ipilimumab|ipilimumab|mesh-list
101867688|NCT01216696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101867689|NCT01216696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101867690|NCT01216696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101867691|NCT01216696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867692|NCT03937258|Probenecid|probenecid|mesh-list
101867693|NCT03937258|Abrocitinib|abrocitinib|mesh-list
101867694|NCT03937258|Uricosuric Agents|uricosuric agents|mesh-ancestor
101867695|NCT03937258|Gout Suppressants|gout suppressants|mesh-ancestor
101867696|NCT03937258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101867697|NCT03937258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101867698|NCT03937258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101867699|NCT03937258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867700|NCT01124656|Pioglitazone|pioglitazone|mesh-list
101867701|NCT01124656|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
101867702|NCT01124656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101867703|NCT01124656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867704|NCT01124656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101867705|NCT01124656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101867706|NCT01124656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867707|NCT01122472|Lenalidomide|lenalidomide|mesh-list
101867708|NCT01122472|Immunologic Factors|immunologic factors|mesh-ancestor
101867709|NCT01122472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867710|NCT01122472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101867711|NCT01122472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101867712|NCT01122472|Growth Substances|growth substances|mesh-ancestor
101867713|NCT01122472|Growth Inhibitors|growth inhibitors|mesh-ancestor
101867714|NCT01122472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101867715|NCT01214122|Warfarin|warfarin|mesh-list
101867716|NCT01214122|Anticoagulants|anticoagulants|mesh-ancestor
101867717|NCT03935152|Dydrogesterone|dydrogesterone|mesh-list
101867718|NCT03935152|Progestins|progestins|mesh-ancestor
101867719|NCT03935152|Hormones|hormones|mesh-ancestor
101867720|NCT03935152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101867721|NCT03935152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867722|NCT01216852|Losartan|losartan|mesh-list
101867723|NCT01216852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101867724|NCT01216852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101867725|NCT01216852|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101867726|NCT01216852|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101867727|NCT01216852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867729|NCT03933748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101867730|NCT03933748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101867731|NCT01120366|Methotrexate|methotrexate|mesh-list
101867732|NCT01120366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101867733|NCT01120366|Abortifacient Agents|abortifacient agents|mesh-ancestor
101867734|NCT01120366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101867735|NCT01120366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867736|NCT01120366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101867737|NCT01120366|Antimetabolites|antimetabolites|mesh-ancestor
101867738|NCT01120366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867739|NCT01120366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101867740|NCT01120366|Dermatologic Agents|dermatologic agents|mesh-ancestor
101867741|NCT01120366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101867742|NCT01120366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101867743|NCT01120366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101867744|NCT01120366|Immunologic Factors|immunologic factors|mesh-ancestor
101867745|NCT01120366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101867746|NCT01120366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101867748|NCT01217086|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101867749|NCT01217086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101867750|NCT01217086|Dermatologic Agents|dermatologic agents|mesh-ancestor
101867751|NCT01217086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101867752|NCT01217086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101867753|NCT01120444|Insulin|insulin|mesh-list
101867754|NCT01120444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101867755|NCT01120444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867756|NCT01217398|Bevacizumab|bevacizumab|mesh-list
101867757|NCT01217398|Temozolomide|temozolomide|mesh-list
101867758|NCT01217398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101867759|NCT01217398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101867760|NCT01217398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101867761|NCT01217398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101867762|NCT01217398|Growth Substances|growth substances|mesh-ancestor
101867763|NCT01217398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867764|NCT01217398|Growth Inhibitors|growth inhibitors|mesh-ancestor
101867765|NCT01217398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101867766|NCT01217398|Alkylating Agents|alkylating agents|mesh-ancestor
101867767|NCT01217398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867769|NCT01125124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101867770|NCT01125124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101867771|NCT01214746|Atorvastatin|atorvastatin|mesh-list
101867772|NCT01214746|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101867773|NCT01214746|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101867774|NCT01214746|Antimetabolites|antimetabolites|mesh-ancestor
101867775|NCT01214746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867776|NCT01214746|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101867777|NCT01214746|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101867778|NCT01214746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101867779|NCT03935074|Melphalan|melphalan|mesh-list
101867780|NCT03935074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101867781|NCT03935074|Alkylating Agents|alkylating agents|mesh-ancestor
101867782|NCT03935074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867783|NCT03935074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101867784|NCT03935074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101867785|NCT03935074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101867786|NCT03935074|Immunologic Factors|immunologic factors|mesh-ancestor
101867787|NCT03935074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867788|NCT01217632|Entecavir|entecavir|mesh-list
101867789|NCT01217632|Antiviral Agents|antiviral agents|mesh-ancestor
101867790|NCT01217632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101867791|NCT03933280|Dexmedetomidine|dexmedetomidine|mesh-list
101867792|NCT03933280|Nalbuphine|nalbuphine|mesh-list
101867793|NCT03933280|Propofol|propofol|mesh-list
101867794|NCT03933280|Benoxinate|benoxinate|mesh-list
101867795|NCT03933280|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101867796|NCT03933280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101867797|NCT03933280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101966127|NCT02265484|Rifaximin|rifaximin|mesh-list
101867798|NCT03933280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867800|NCT03933280|Analgesics|analgesics|mesh-ancestor
101867801|NCT03933280|Sensory System Agents|sensory system agents|mesh-ancestor
101867802|NCT03933280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101867803|NCT03933280|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101867804|NCT03933280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101867805|NCT03933280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101867806|NCT03933280|Adrenergic Agents|adrenergic agents|mesh-ancestor
101867807|NCT03933280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101867808|NCT03933280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867809|NCT03933280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101867810|NCT03933280|Anesthetics, General|anesthetics, general|mesh-ancestor
101867811|NCT03933280|Anesthetics|anesthetics|mesh-ancestor
101867812|NCT03933280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101867813|NCT03933280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101867814|NCT03933280|Narcotics|narcotics|mesh-ancestor
101867815|NCT03933280|Anesthetics, Local|anesthetics, local|mesh-ancestor
101867816|NCT01120912|Insulin|insulin|mesh-list
101867817|NCT01120912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101867818|NCT01120912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867819|NCT01219582|Metformin|metformin|mesh-list
101867820|NCT01219582|Acarbose|acarbose|mesh-list
101867821|NCT01219582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101867822|NCT01219582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867823|NCT01219582|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101867824|NCT01219582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101867825|NCT01219582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867826|NCT03933358|Hormones|hormones|mesh-list
101867827|NCT03933358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101867828|NCT03933358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867829|NCT01122940|Phenytoin|phenytoin|mesh-list
101867830|NCT01122940|Anticonvulsants|anticonvulsants|mesh-ancestor
101867831|NCT01122940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101688085|NCT00645060|Antibodies|antibodies|mesh-list
101867832|NCT01122940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101867833|NCT01122940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101867834|NCT01122940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867835|NCT01122940|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101867836|NCT01122940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101867837|NCT01219816|Epratuzumab|epratuzumab|mesh-list
101867838|NCT01219816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101867839|NCT01219816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101867840|NCT01215136|Paclitaxel|paclitaxel|mesh-list
101867841|NCT01215136|Everolimus|everolimus|mesh-list
101867842|NCT01215136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101867843|NCT01215136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101867844|NCT01215136|Tubulin Modulators|tubulin modulators|mesh-ancestor
101867845|NCT01215136|Antimitotic Agents|antimitotic agents|mesh-ancestor
101867846|NCT01215136|Mitosis Modulators|mitosis modulators|mesh-ancestor
101867847|NCT01215136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867848|NCT01215136|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101867849|NCT01215136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101867850|NCT01215136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101867851|NCT01215136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101867852|NCT01215136|Immunologic Factors|immunologic factors|mesh-ancestor
101867853|NCT01215136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867854|NCT01218022|Losartan|losartan|mesh-list
101867855|NCT01218022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101867856|NCT01218022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101867857|NCT01218022|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101867858|NCT01218022|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101867859|NCT01218022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867860|NCT01121458|Clevidipine|clevidipine|mesh-list
101867861|NCT01121458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101867862|NCT01121458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101867863|NCT01121458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867864|NCT01121458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101867865|NCT01121458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867866|NCT01215214|Midazolam|midazolam|mesh-list
101867867|NCT01215214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101867868|NCT01215214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101867869|NCT01215214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101867870|NCT01215214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867871|NCT01215214|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101867872|NCT01215214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101867873|NCT01215214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101867874|NCT01215214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101867875|NCT01215214|Anesthetics, General|anesthetics, general|mesh-ancestor
101867876|NCT01215214|Anesthetics|anesthetics|mesh-ancestor
101867877|NCT01215214|GABA Modulators|gaba modulators|mesh-ancestor
101867878|NCT01215214|GABA Agents|gaba agents|mesh-ancestor
101867879|NCT01215214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101867880|NCT01215214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867881|NCT03936166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101867882|NCT01125670|Darexaban|darexaban|mesh-list
101867883|NCT01125670|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101867884|NCT01125670|Antithrombins|antithrombins|mesh-ancestor
101867885|NCT01125670|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101867886|NCT01125670|Protease Inhibitors|protease inhibitors|mesh-ancestor
101867887|NCT01125670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101867888|NCT01125670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867889|NCT01125670|Anticoagulants|anticoagulants|mesh-ancestor
101867890|NCT03934450|Primaquine|primaquine|mesh-list
101867891|NCT03934450|Antimalarials|antimalarials|mesh-ancestor
101867892|NCT03934450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101867893|NCT03934450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101867894|NCT03934450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101867895|NCT01215682|Vitamin D|vitamin d|mesh-list
101867896|NCT01215682|Vitamins|vitamins|mesh-ancestor
101867897|NCT01215682|Micronutrients|micronutrients|mesh-ancestor
101867898|NCT01215682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867899|NCT01215682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101867900|NCT03932344|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101867901|NCT03932344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101867902|NCT01123408|Haloperidol|haloperidol|mesh-list
101867903|NCT01123408|Olanzapine|olanzapine|mesh-list
101867904|NCT01123408|Haloperidol decanoate|haloperidol decanoate|mesh-list
101867905|NCT01123408|Clozapine|clozapine|mesh-list
101867906|NCT01123408|Antiemetics|antiemetics|mesh-ancestor
101867907|NCT01123408|Autonomic Agents|autonomic agents|mesh-ancestor
101867908|NCT01123408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101867909|NCT01123408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867910|NCT01123408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101867911|NCT01123408|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101867912|NCT01123408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101867913|NCT01123408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101867914|NCT01123408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101867915|NCT01123408|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101867916|NCT01123408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101867917|NCT01123408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101867918|NCT01123408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867919|NCT01123408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101867920|NCT01123408|Serotonin Agents|serotonin agents|mesh-ancestor
101867921|NCT01123408|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101867922|NCT01123408|Dopamine Agents|dopamine agents|mesh-ancestor
101867923|NCT01123408|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101867924|NCT01123408|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101867925|NCT01123408|GABA Antagonists|gaba antagonists|mesh-ancestor
101867926|NCT01123408|GABA Agents|gaba agents|mesh-ancestor
101867927|NCT00141297|Palbociclib|palbociclib|mesh-list
101867928|NCT00141297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101867929|NCT00141297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101867930|NCT00141297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101867931|NCT00141297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867932|NCT01123486|Hydromorphone|hydromorphone|mesh-list
101867933|NCT01123486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101867934|NCT01123486|Narcotics|narcotics|mesh-ancestor
101867935|NCT01123486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101867936|NCT01123486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867937|NCT01123486|Analgesics|analgesics|mesh-ancestor
101867938|NCT01123486|Sensory System Agents|sensory system agents|mesh-ancestor
101867939|NCT01123486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101867940|NCT01123564|Ranibizumab|ranibizumab|mesh-list
101867941|NCT01123564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101867942|NCT01123564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101867943|NCT01123564|Growth Substances|growth substances|mesh-ancestor
101867944|NCT01123564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867945|NCT01123564|Growth Inhibitors|growth inhibitors|mesh-ancestor
101867946|NCT01123564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101867947|NCT01222312|Docetaxel|docetaxel|mesh-list
101867948|NCT01222312|Oxaliplatin|oxaliplatin|mesh-list
101867949|NCT01222312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101867950|NCT01222312|Tubulin Modulators|tubulin modulators|mesh-ancestor
101867951|NCT01222312|Antimitotic Agents|antimitotic agents|mesh-ancestor
101867952|NCT01222312|Mitosis Modulators|mitosis modulators|mesh-ancestor
101245034|NCT01657331|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101867953|NCT01222312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867954|NCT03932266|Docetaxel|docetaxel|mesh-list
101867955|NCT03932266|Endostar protein|endostar protein|mesh-list
101867956|NCT03932266|Endostatins|endostatins|mesh-list
101867957|NCT03932266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101867958|NCT03932266|Tubulin Modulators|tubulin modulators|mesh-ancestor
101867959|NCT03932266|Antimitotic Agents|antimitotic agents|mesh-ancestor
101867960|NCT03932266|Mitosis Modulators|mitosis modulators|mesh-ancestor
101867961|NCT03932266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867962|NCT03932266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101867963|NCT03932266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101867964|NCT03932266|Growth Substances|growth substances|mesh-ancestor
101867965|NCT03932266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867966|NCT03932266|Growth Inhibitors|growth inhibitors|mesh-ancestor
101867967|NCT00141219|Pregabalin|pregabalin|mesh-list
101867968|NCT00141219|Analgesics|analgesics|mesh-ancestor
101867969|NCT00141219|Sensory System Agents|sensory system agents|mesh-ancestor
101867970|NCT00141219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101867971|NCT00141219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867972|NCT00141219|Anticonvulsants|anticonvulsants|mesh-ancestor
101867973|NCT00141219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101867974|NCT00141219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101867975|NCT00141219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867976|NCT00141219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101867977|NCT00141219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101867978|NCT00141219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101867979|NCT00141219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101867980|NCT00141219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101867981|NCT01222468|Nabilone|nabilone|mesh-list
101867982|NCT01222468|Antiemetics|antiemetics|mesh-ancestor
101867983|NCT01222468|Autonomic Agents|autonomic agents|mesh-ancestor
101867984|NCT01222468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101867985|NCT01222468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101867986|NCT01222468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101867987|NCT01222468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101867988|NCT01222468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101867989|NCT01222468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101867990|NCT01222468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101867991|NCT01220284|Vinorelbine|vinorelbine|mesh-list
101867992|NCT01220284|Satraplatin|satraplatin|mesh-list
101867993|NCT01220284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101867994|NCT01220284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101867995|NCT01220284|Tubulin Modulators|tubulin modulators|mesh-ancestor
101688114|NCT00895895|Donepezil|donepezil|mesh-list
101867997|NCT01220284|Mitosis Modulators|mitosis modulators|mesh-ancestor
101867998|NCT01220284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101867999|NCT01127464|Poly ICLC|poly iclc|mesh-list
101868000|NCT01127464|Interferon Inducers|interferon inducers|mesh-ancestor
101868001|NCT01127464|Immunologic Factors|immunologic factors|mesh-ancestor
101868002|NCT01127464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868003|NCT01222780|Vincristine|vincristine|mesh-list
101868004|NCT01222780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101868005|NCT01222780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101868006|NCT01222780|Tubulin Modulators|tubulin modulators|mesh-ancestor
101868007|NCT01222780|Antimitotic Agents|antimitotic agents|mesh-ancestor
101868008|NCT01222780|Mitosis Modulators|mitosis modulators|mesh-ancestor
101868009|NCT01222780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868010|NCT01222936|Panobinostat|panobinostat|mesh-list
101868011|NCT01222936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101868012|NCT01222936|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101868013|NCT01222936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101868014|NCT01222936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868015|NCT01125904|Crizotinib|crizotinib|mesh-list
101868016|NCT01125904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101868017|NCT01125904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101868018|NCT01125904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101868019|NCT01125904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868020|NCT01125982|Propofol|propofol|mesh-list
101868021|NCT01125982|Desflurane|desflurane|mesh-list
101868022|NCT01125982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101868023|NCT01125982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101868024|NCT01125982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868025|NCT01125982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101868026|NCT01125982|Anesthetics, General|anesthetics, general|mesh-ancestor
101868027|NCT01125982|Anesthetics|anesthetics|mesh-ancestor
101868028|NCT01125982|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101868029|NCT01220362|Fentanyl|fentanyl|mesh-list
101868030|NCT01220362|Bupivacaine|bupivacaine|mesh-list
101868031|NCT01220362|Anesthetics, Local|anesthetics, local|mesh-ancestor
101868032|NCT01220362|Anesthetics|anesthetics|mesh-ancestor
101868033|NCT01220362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101868034|NCT01220362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868035|NCT01220362|Sensory System Agents|sensory system agents|mesh-ancestor
101868036|NCT01220362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101868037|NCT01220362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101868038|NCT01220362|Narcotics|narcotics|mesh-ancestor
101868039|NCT01220362|Analgesics|analgesics|mesh-ancestor
101868040|NCT01220362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101868041|NCT01220362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101868042|NCT01220362|Anesthetics, General|anesthetics, general|mesh-ancestor
101868043|NCT01220440|Methylphenidate|methylphenidate|mesh-list
101868044|NCT01220440|Dextroamphetamine|dextroamphetamine|mesh-list
101868045|NCT01220440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101868046|NCT01220440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868047|NCT01220440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101868048|NCT01220440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101868049|NCT01220440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101868050|NCT01220440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868051|NCT01220440|Dopamine Agents|dopamine agents|mesh-ancestor
101868052|NCT01220440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101868053|NCT01123876|Veliparib|veliparib|mesh-list
101868054|NCT01123876|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101868055|NCT01123876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101868056|NCT01123876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868057|NCT01123876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101868058|NCT01124032|Methylphenidate|methylphenidate|mesh-list
101868059|NCT01124032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101868060|NCT01124032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868061|NCT01124032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101868062|NCT01124032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101868063|NCT01124032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101868064|NCT01124032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868065|NCT01124032|Dopamine Agents|dopamine agents|mesh-ancestor
101868066|NCT01124032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101868067|NCT03934294|Metoclopramide|metoclopramide|mesh-list
101868068|NCT03934294|Antiemetics|antiemetics|mesh-ancestor
101868069|NCT03934294|Autonomic Agents|autonomic agents|mesh-ancestor
101868070|NCT03934294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101868071|NCT03934294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868072|NCT03934294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101868073|NCT03934294|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101868074|NCT03934294|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101868075|NCT03934294|Dopamine Agents|dopamine agents|mesh-ancestor
101868076|NCT03934294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101868077|NCT03934294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868078|NCT01218568|Rifaximin|rifaximin|mesh-list
101868079|NCT01218568|Lactulose|lactulose|mesh-list
101868080|NCT01218568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101868081|NCT01218568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101868082|NCT01218568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101868083|NCT01127542|Lenalidomide|lenalidomide|mesh-list
101868084|NCT01127542|Immunologic Factors|immunologic factors|mesh-ancestor
101868085|NCT01127542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868086|NCT01127542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101868087|NCT01127542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101868088|NCT01127542|Growth Substances|growth substances|mesh-ancestor
101868089|NCT01127542|Growth Inhibitors|growth inhibitors|mesh-ancestor
101868090|NCT01127542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101868091|NCT01127620|Cetirizine|cetirizine|mesh-list
101868092|NCT01127620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101868093|NCT01127620|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101868094|NCT01127620|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101868095|NCT01127620|Histamine Antagonists|histamine antagonists|mesh-ancestor
101868096|NCT01127620|Histamine Agents|histamine agents|mesh-ancestor
101868097|NCT01127620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101868098|NCT01127620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868099|NCT01127620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868100|NCT01220518|Infliximab|infliximab|mesh-list
101587955|NCT02642419|Aspirin|aspirin|mesh-list
101868101|NCT01220518|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101868102|NCT01220518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101868103|NCT01220518|Dermatologic Agents|dermatologic agents|mesh-ancestor
101868104|NCT01220518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101868105|NCT01220518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101868106|NCT01220596|Interferons|interferons|mesh-list
101868107|NCT01220596|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101868108|NCT01220596|Interferon-alpha|interferon-alpha|mesh-list
101868109|NCT01220596|Entecavir|entecavir|mesh-list
101868110|NCT01220596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101868111|NCT01220596|Antiviral Agents|antiviral agents|mesh-ancestor
101868112|NCT01220596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101868113|NCT01220596|Immunologic Factors|immunologic factors|mesh-ancestor
101868114|NCT01220596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868115|NCT01218724|Losartan|losartan|mesh-list
101868116|NCT01218724|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101868117|NCT01218724|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101868118|NCT01218724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101868119|NCT01218724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101868120|NCT01218724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101868121|NCT01218724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868122|NCT01218724|Diuretics|diuretics|mesh-ancestor
101868123|NCT01218724|Natriuretic Agents|natriuretic agents|mesh-ancestor
101868124|NCT01218724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868125|NCT01218724|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101868126|NCT01218724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101868127|NCT01126216|Paclitaxel|paclitaxel|mesh-list
101868128|NCT01126216|Cisplatin|cisplatin|mesh-list
101868129|NCT01126216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101868130|NCT01126216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101868131|NCT01126216|Tubulin Modulators|tubulin modulators|mesh-ancestor
101868132|NCT01126216|Antimitotic Agents|antimitotic agents|mesh-ancestor
101868133|NCT01126216|Mitosis Modulators|mitosis modulators|mesh-ancestor
101868134|NCT01126216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868135|NCT01329016|Metformin|metformin|mesh-list
101868136|NCT01329016|Glyburide|glyburide|mesh-list
101868137|NCT01329016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101688151|NCT00910416|Analgesics|analgesics|mesh-ancestor
101868138|NCT01329016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868139|NCT01223326|Acetylcysteine|acetylcysteine|mesh-list
101868140|NCT01223326|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101868141|NCT01223326|Antiviral Agents|antiviral agents|mesh-ancestor
101868142|NCT01223326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101868143|NCT01223326|Expectorants|expectorants|mesh-ancestor
101868144|NCT01223326|Respiratory System Agents|respiratory system agents|mesh-ancestor
101868145|NCT01223326|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101868146|NCT01223326|Antioxidants|antioxidants|mesh-ancestor
101868147|NCT01223326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868148|NCT01223326|Protective Agents|protective agents|mesh-ancestor
101868149|NCT01223326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868150|NCT01223326|Antidotes|antidotes|mesh-ancestor
101868151|NCT01223560|Insulin Aspart|insulin aspart|mesh-list
101868152|NCT01223560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101868153|NCT01223560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868154|NCT01126294|Melatonin|melatonin|mesh-list
101868155|NCT01126294|Antioxidants|antioxidants|mesh-ancestor
101868156|NCT01126294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868157|NCT01126294|Protective Agents|protective agents|mesh-ancestor
101868158|NCT01126294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868159|NCT01126294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101868160|NCT00162266|Abatacept|abatacept|mesh-list
101868161|NCT00162266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101868162|NCT00162266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868163|NCT00162266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101868164|NCT00162266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101868165|NCT00162266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101868166|NCT00162266|Immunologic Factors|immunologic factors|mesh-ancestor
101868167|NCT00162266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868168|NCT00162266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101868169|NCT01126450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101868170|NCT01126450|Cetuximab|cetuximab|mesh-list
101868171|NCT01126450|Lenalidomide|lenalidomide|mesh-list
101868172|NCT01126450|Antibodies|antibodies|mesh-list
101868173|NCT01126450|Immunoglobulins|immunoglobulins|mesh-list
101868174|NCT01126450|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101868175|NCT01126450|Immunologic Factors|immunologic factors|mesh-ancestor
101868176|NCT01126450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588019|NCT00655915|Hormones|hormones|mesh-ancestor
101868177|NCT01126450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101868178|NCT01126450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101868179|NCT01126450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101868180|NCT01126450|Growth Substances|growth substances|mesh-ancestor
101868181|NCT01126450|Growth Inhibitors|growth inhibitors|mesh-ancestor
101868182|NCT01073384|Beclomethasone|beclomethasone|mesh-list
101868183|NCT01073384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101868184|NCT01073384|Glucocorticoids|glucocorticoids|mesh-ancestor
101868185|NCT01073384|Hormones|hormones|mesh-ancestor
101868186|NCT01073384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101868187|NCT01073384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868188|NCT01073384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101868189|NCT01073384|Respiratory System Agents|respiratory system agents|mesh-ancestor
101868190|NCT01126528|Vitamin D|vitamin d|mesh-list
101868191|NCT01126528|Cholecalciferol|cholecalciferol|mesh-list
101868192|NCT01126528|Vitamins|vitamins|mesh-ancestor
101868193|NCT01126528|Micronutrients|micronutrients|mesh-ancestor
101868194|NCT01126528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868195|NCT01126528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101868196|NCT01126528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101868197|NCT00225212|Rituximab|rituximab|mesh-list
101868198|NCT00225212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101868199|NCT00225212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101868200|NCT00225212|Immunologic Factors|immunologic factors|mesh-ancestor
101868201|NCT00225212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868202|NCT00225212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101868203|NCT03853330|Bupivacaine|bupivacaine|mesh-list
101868204|NCT03853330|Anesthetics, Local|anesthetics, local|mesh-ancestor
101868205|NCT03853330|Anesthetics|anesthetics|mesh-ancestor
101868206|NCT03853330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101868207|NCT03853330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868208|NCT03853330|Sensory System Agents|sensory system agents|mesh-ancestor
101868209|NCT03853330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101868210|NCT01581944|Goserelin|goserelin|mesh-list
101868211|NCT01581944|Hormones|hormones|mesh-list
101868212|NCT01581944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101868213|NCT01581944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868214|NCT01581944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101245067|NCT01657487|Xhance|xhance|mesh-list
101868215|NCT01581944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101868217|NCT01226056|Sorafenib|sorafenib|mesh-list
101868218|NCT01226056|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101868219|NCT01226056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101868220|NCT01226056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101868221|NCT01226056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868222|NCT01226056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101868223|NCT01226056|Immunologic Factors|immunologic factors|mesh-ancestor
101868224|NCT01226056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868225|NCT01226056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101868226|NCT00162032|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
101868227|NCT00162032|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101868228|NCT00162032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868229|NCT01126606|Glycerol|glycerol|mesh-list
101868230|NCT01126606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101868231|NCT01126606|Protective Agents|protective agents|mesh-ancestor
101868232|NCT01126606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868233|NCT01329406|Milnacipran|milnacipran|mesh-list
101868234|NCT01329406|Levomilnacipran|levomilnacipran|mesh-list
101868235|NCT01329406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101868236|NCT01329406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101868237|NCT01329406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101868238|NCT01329406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868239|NCT01329406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101868240|NCT01329406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868241|NCT01329406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101868242|NCT01329406|Analgesics|analgesics|mesh-ancestor
101868243|NCT01329406|Sensory System Agents|sensory system agents|mesh-ancestor
101868244|NCT01329406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101868245|NCT01329406|Antidepressive Agents|antidepressive agents|mesh-ancestor
101868246|NCT01329406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101868247|NCT01126684|Atorvastatin|atorvastatin|mesh-list
101868248|NCT01126684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101868249|NCT01126684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101868250|NCT01126684|Antimetabolites|antimetabolites|mesh-ancestor
101868251|NCT01126684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868252|NCT01126684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101868253|NCT01126684|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101868254|NCT01126684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101868255|NCT01224028|Tacrolimus|tacrolimus|mesh-list
101868256|NCT01224028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101868257|NCT01224028|Immunologic Factors|immunologic factors|mesh-ancestor
101868258|NCT01224028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868259|NCT01224028|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101868260|NCT01224028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101868261|NCT01224028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868262|NCT01226212|Sulfalene|sulfalene|mesh-list
101868263|NCT01226212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101868264|NCT01226212|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101868265|NCT01226212|Antimalarials|antimalarials|mesh-ancestor
101868266|NCT01226212|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101868267|NCT01226212|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101868268|NCT01075490|Clonidine|clonidine|mesh-list
101868269|NCT01075490|Analgesics|analgesics|mesh-ancestor
101868270|NCT01075490|Sensory System Agents|sensory system agents|mesh-ancestor
101868271|NCT01075490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101868272|NCT01075490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868273|NCT01075490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101868274|NCT01075490|Sympatholytics|sympatholytics|mesh-ancestor
101868275|NCT01075490|Autonomic Agents|autonomic agents|mesh-ancestor
101868276|NCT01075490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101688164|NCT02669238|Contraceptive Agents|contraceptive agents|mesh-ancestor
101868277|NCT01075490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101868278|NCT01075490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101868279|NCT01075490|Adrenergic Agents|adrenergic agents|mesh-ancestor
101868280|NCT01075490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101868281|NCT01075490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868282|NCT01126138|Docetaxel|docetaxel|mesh-list
101868283|NCT01126138|Capecitabine|capecitabine|mesh-list
101868284|NCT01126138|Vinorelbine|vinorelbine|mesh-list
101868285|NCT01126138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101868286|NCT01126138|Tubulin Modulators|tubulin modulators|mesh-ancestor
101868287|NCT01126138|Antimitotic Agents|antimitotic agents|mesh-ancestor
101868288|NCT01126138|Mitosis Modulators|mitosis modulators|mesh-ancestor
101868289|NCT01126138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868290|NCT01126138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101868291|NCT01126138|Antimetabolites|antimetabolites|mesh-ancestor
101868292|NCT01126138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101868293|NCT03930706|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101868294|NCT03930706|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101868295|NCT03930706|Estradiol|estradiol|mesh-list
101868296|NCT03930706|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101868297|NCT03930706|Estrogens|estrogens|mesh-ancestor
101868298|NCT03930706|Hormones|hormones|mesh-ancestor
101868299|NCT03930706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101868300|NCT03930706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868301|NCT03930706|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101868302|NCT03930706|Contraceptive Agents|contraceptive agents|mesh-ancestor
101868303|NCT03930706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101868304|NCT03930706|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101868305|NCT03932578|Atropine|atropine|mesh-list
101868306|NCT03932578|Metoclopramide|metoclopramide|mesh-list
101868307|NCT03932578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101868308|NCT03932578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101868309|NCT03932578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101868310|NCT03932578|Autonomic Agents|autonomic agents|mesh-ancestor
101868311|NCT03932578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101868312|NCT03932578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868313|NCT03932578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101868314|NCT03932578|Respiratory System Agents|respiratory system agents|mesh-ancestor
101868315|NCT03932578|Mydriatics|mydriatics|mesh-ancestor
101868316|NCT03932578|Parasympatholytics|parasympatholytics|mesh-ancestor
101868317|NCT03932578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101868318|NCT03932578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101868319|NCT03932578|Cholinergic Agents|cholinergic agents|mesh-ancestor
101868320|NCT03932578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101868321|NCT03932578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868322|NCT03932578|Antiemetics|antiemetics|mesh-ancestor
101868323|NCT03932578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101868324|NCT03932578|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101868325|NCT03932578|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101868326|NCT03932578|Dopamine Agents|dopamine agents|mesh-ancestor
101868327|NCT00258440|Epoetin Alfa|epoetin alfa|mesh-list
101868329|NCT01329250|Moxifloxacin|moxifloxacin|mesh-list
101868330|NCT01329250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101868331|NCT01329250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101868332|NCT01329250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101868333|NCT01329250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101868334|NCT01329250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101868335|NCT01329250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868336|NCT01329250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101868337|NCT00224120|Silodosin|silodosin|mesh-list
101868338|NCT00224120|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101868339|NCT00224120|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101868340|NCT00224120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101868341|NCT00224120|Adrenergic Agents|adrenergic agents|mesh-ancestor
101868342|NCT00224120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101245088|NCT01657487|Sympathomimetics|sympathomimetics|mesh-ancestor
101868343|NCT00224120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868344|NCT00224120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868345|NCT00224120|Urological Agents|urological agents|mesh-ancestor
101868346|NCT01226446|Vitamin D|vitamin d|mesh-list
101868347|NCT01226446|Vitamins|vitamins|mesh-ancestor
101868348|NCT01226446|Micronutrients|micronutrients|mesh-ancestor
101868349|NCT01226446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868350|NCT01226446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101868351|NCT01224418|Tacrolimus|tacrolimus|mesh-list
101868352|NCT01224418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101868353|NCT01224418|Immunologic Factors|immunologic factors|mesh-ancestor
101868354|NCT01224418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868355|NCT01224418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101868356|NCT01224418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101868357|NCT01224418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868359|NCT00257660|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101868360|NCT00257660|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101868361|NCT00257660|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101868362|NCT00257660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101868363|NCT00257660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868364|NCT00257660|Cholinergic Agents|cholinergic agents|mesh-ancestor
101868365|NCT00257660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101868366|NCT00257660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868367|NCT00257660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101868368|NCT00257660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101868369|NCT01129180|Azacitidine|azacitidine|mesh-list
101868370|NCT01129180|Bortezomib|bortezomib|mesh-list
101868371|NCT01129180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101868372|NCT01129180|Antimetabolites|antimetabolites|mesh-ancestor
101868373|NCT01129180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868374|NCT01129180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101868375|NCT01129180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101868376|NCT00224042|Ferric gluconate|ferric gluconate|mesh-list
101868377|NCT00224042|Hematinics|hematinics|mesh-ancestor
101868378|NCT01129258|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
101868379|NCT01129258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101868380|NCT01129258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868381|NCT01221376|Imatinib Mesylate|imatinib mesylate|mesh-list
101868382|NCT01221376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101868383|NCT01221376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101868384|NCT01221376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101868385|NCT01221376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868386|NCT01224652|Paclitaxel|paclitaxel|mesh-list
101868387|NCT01224652|Irinotecan|irinotecan|mesh-list
101868388|NCT01224652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101868389|NCT01224652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101868390|NCT01224652|Tubulin Modulators|tubulin modulators|mesh-ancestor
101868391|NCT01224652|Antimitotic Agents|antimitotic agents|mesh-ancestor
101868392|NCT01224652|Mitosis Modulators|mitosis modulators|mesh-ancestor
101688172|NCT02669004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868393|NCT01224652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868394|NCT01224652|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101868395|NCT01224652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101868396|NCT01224652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101868397|NCT00160706|Certolizumab Pegol|certolizumab pegol|mesh-list
101868398|NCT00160706|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101868399|NCT00160706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101588239|NCT00726856|Fenofibrate|fenofibrate|mesh-list
101868400|NCT00160706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101868401|NCT00160706|Immunologic Factors|immunologic factors|mesh-ancestor
101868402|NCT00160706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868403|NCT00160706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101868404|NCT01226602|Ticagrelor|ticagrelor|mesh-list
101868405|NCT01226602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101868406|NCT01226602|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101868407|NCT01226602|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101868408|NCT01226602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101868409|NCT01226602|Purinergic Agents|purinergic agents|mesh-ancestor
101868410|NCT01226602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101868411|NCT01226602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868412|NCT01226602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868413|NCT01226680|Tofacitinib|tofacitinib|mesh-list
101868414|NCT01226680|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101868415|NCT01226680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101868416|NCT01226680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101868417|NCT01226680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868418|NCT00257192|Ziprasidone|ziprasidone|mesh-list
101868419|NCT00257192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101868420|NCT00257192|Serotonin Agents|serotonin agents|mesh-ancestor
101868421|NCT00257192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101868422|NCT00257192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868423|NCT00257192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868424|NCT00257192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101868425|NCT00257192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101868426|NCT00257192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101868427|NCT00257192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101868428|NCT00257192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101868429|NCT00257192|Dopamine Agents|dopamine agents|mesh-ancestor
101868430|NCT01224964|Montelukast|montelukast|mesh-list
101868431|NCT01224964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101868432|NCT01224964|Respiratory System Agents|respiratory system agents|mesh-ancestor
101868433|NCT01224964|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101868434|NCT01224964|Hormone Antagonists|hormone antagonists|mesh-ancestor
101868435|NCT01224964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101868436|NCT01224964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868437|NCT01224964|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101868438|NCT01224964|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101868439|NCT01224964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868440|NCT03967964|Methyltestosterone|methyltestosterone|mesh-list
101868441|NCT03967964|Testosterone|testosterone|mesh-list
101868442|NCT03967964|Testosterone undecanoate|testosterone undecanoate|mesh-list
101868443|NCT03967964|Testosterone enanthate|testosterone enanthate|mesh-list
101688198|NCT02837003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101868444|NCT03967964|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101868445|NCT03967964|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101868446|NCT03967964|Androgens|androgens|mesh-ancestor
101868447|NCT03967964|Hormones|hormones|mesh-ancestor
101868448|NCT03967964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101868449|NCT03967964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868450|NCT03967964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101868451|NCT03967964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101868452|NCT03967964|Anabolic Agents|anabolic agents|mesh-ancestor
101868453|NCT03967964|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101868454|NCT03967964|Immunologic Factors|immunologic factors|mesh-ancestor
101868455|NCT01129414|Omeprazole|omeprazole|mesh-list
101868456|NCT01129414|Clopidogrel|clopidogrel|mesh-list
101868457|NCT01129414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101868458|NCT01129414|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101868459|NCT01129414|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101868460|NCT01129414|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101868461|NCT01129414|Purinergic Agents|purinergic agents|mesh-ancestor
101868462|NCT01129414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101868463|NCT01129414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868464|NCT01129414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868465|NCT01129414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101868466|NCT01129414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101868467|NCT01129414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101868468|NCT01129414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101868469|NCT03967886|Esomeprazole|esomeprazole|mesh-list
101245107|NCT01657682|Crenolanib|crenolanib|mesh-list
101868470|NCT03967886|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101868471|NCT03967886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101588315|NCT00142558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868472|NCT03967886|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101868473|NCT03967886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101868474|NCT03967886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868475|NCT03968042|Thiamine|thiamine|mesh-list
101868476|NCT03968042|Edaravone|edaravone|mesh-list
101868477|NCT03968042|Mitogens|mitogens|mesh-list
101868478|NCT03968042|Vitamins|vitamins|mesh-ancestor
101868479|NCT03968042|Micronutrients|micronutrients|mesh-ancestor
101868480|NCT03968042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868481|NCT03968042|Mitosis Modulators|mitosis modulators|mesh-ancestor
101868482|NCT03968042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868483|NCT03968042|Vitamin B Complex|vitamin b complex|mesh-ancestor
101868484|NCT03968042|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101868485|NCT03968042|Antioxidants|antioxidants|mesh-ancestor
101868486|NCT03968042|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101868487|NCT03968042|Protective Agents|protective agents|mesh-ancestor
101868488|NCT01128322|Niacin|niacin|mesh-list
101868489|NCT01128322|Amlodipine|amlodipine|mesh-list
101868490|NCT01128322|Telmisartan|telmisartan|mesh-list
101868491|NCT01128322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101868492|NCT01128322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101868493|NCT01128322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101868494|NCT01128322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868495|NCT01128322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101868496|NCT01128322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868497|NCT01128322|Vasodilator Agents|vasodilator agents|mesh-ancestor
101868498|NCT01128322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101868499|NCT01128322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101868500|NCT01128322|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101868501|NCT01128322|Antimetabolites|antimetabolites|mesh-ancestor
101868502|NCT01128322|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101868503|NCT01128322|Vitamin B Complex|vitamin b complex|mesh-ancestor
101868505|NCT01128322|Micronutrients|micronutrients|mesh-ancestor
101868506|NCT01129570|Silybin|silybin|mesh-list
101868507|NCT01129570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101868508|NCT01129570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101868509|NCT01129570|Protective Agents|protective agents|mesh-ancestor
101868510|NCT01129570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868511|NCT01073540|Cephalexin|cephalexin|mesh-list
101868512|NCT01073540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101868513|NCT01073540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101868514|NCT03740386|Phentolamine|phentolamine|mesh-list
101868515|NCT03740386|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101868516|NCT03740386|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101868517|NCT03740386|Adrenergic Agents|adrenergic agents|mesh-ancestor
101868518|NCT03740386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101868519|NCT03740386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868520|NCT03740386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868521|NCT03740386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101868522|NCT03927352|Adalimumab|adalimumab|mesh-list
101868523|NCT03927352|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101868524|NCT03927352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101868525|NCT03927352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101868526|NCT01225198|Vitamins|vitamins|mesh-list
101868527|NCT01225198|Micronutrients|micronutrients|mesh-ancestor
101868528|NCT01225198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868529|NCT01226992|Vancomycin|vancomycin|mesh-list
101868530|NCT01226992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101868531|NCT01226992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101868532|NCT01128556|Bepotastine besilate|bepotastine besilate|mesh-list
101868533|NCT01128556|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101868534|NCT03740464|Lenograstim|lenograstim|mesh-list
101868535|NCT03740464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101868536|NCT03740464|Immunologic Factors|immunologic factors|mesh-ancestor
101868537|NCT03740464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868538|NCT03927118|Dexamethasone|dexamethasone|mesh-list
101868539|NCT03927118|Dexamethasone acetate|dexamethasone acetate|mesh-list
101868540|NCT03927118|BB 1101|bb 1101|mesh-list
101868541|NCT03927118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101868542|NCT03927118|Antiemetics|antiemetics|mesh-ancestor
101868543|NCT03927118|Autonomic Agents|autonomic agents|mesh-ancestor
101868544|NCT03927118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101868545|NCT03927118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868546|NCT03927118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101868547|NCT03927118|Glucocorticoids|glucocorticoids|mesh-ancestor
101868548|NCT03927118|Hormones|hormones|mesh-ancestor
101868549|NCT03927118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101868550|NCT03927118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101868551|NCT03927118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101868552|NCT03927118|Protease Inhibitors|protease inhibitors|mesh-ancestor
101868553|NCT03927118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101868554|NCT03927118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868555|NCT01227148|Insulin|insulin|mesh-list
101868556|NCT01227148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101868557|NCT01227148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868558|NCT01227226|Lubricant Eye Drops|lubricant eye drops|mesh-list
101868559|NCT01227226|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101868560|NCT01227226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101868561|NCT01127308|Ertugliflozin|ertugliflozin|mesh-list
101868562|NCT01127308|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101868563|NCT01127308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868564|NCT01127308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101868565|NCT01127308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868566|NCT01128712|Pregabalin|pregabalin|mesh-list
101868567|NCT01128712|Analgesics|analgesics|mesh-ancestor
101868568|NCT01128712|Sensory System Agents|sensory system agents|mesh-ancestor
101868569|NCT01128712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101868570|NCT01128712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868571|NCT01128712|Anticonvulsants|anticonvulsants|mesh-ancestor
101868572|NCT01128712|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101868573|NCT01128712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101868574|NCT01128712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868575|NCT01128712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101868576|NCT01128712|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101868577|NCT01128712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101245147|NCT01657838|Hormone Antagonists|hormone antagonists|mesh-ancestor
101868578|NCT01128712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101868579|NCT01128712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101868580|NCT01127386|Lenalidomide|lenalidomide|mesh-list
101868581|NCT01127386|Immunologic Factors|immunologic factors|mesh-ancestor
101868582|NCT01127386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868583|NCT01127386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101868584|NCT01127386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101868585|NCT01127386|Growth Substances|growth substances|mesh-ancestor
101868586|NCT01127386|Growth Inhibitors|growth inhibitors|mesh-ancestor
101868587|NCT01127386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101868588|NCT01130194|Procarbazine|procarbazine|mesh-list
101868589|NCT01130194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101868590|NCT01225744|Oxaliplatin|oxaliplatin|mesh-list
101868591|NCT01225744|Irinotecan|irinotecan|mesh-list
101868592|NCT01225744|Cetuximab|cetuximab|mesh-list
101868593|NCT01225744|Tegafur|tegafur|mesh-list
101868594|NCT01225744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101868595|NCT01225744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101868596|NCT01225744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101868597|NCT01225744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101868598|NCT01225744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868599|NCT01225744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101868600|NCT01225744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101868601|NCT01225744|Antimetabolites|antimetabolites|mesh-ancestor
101868602|NCT03926806|Vitamins|vitamins|mesh-list
101868603|NCT03926806|Vitamin B Complex|vitamin b complex|mesh-list
101868604|NCT03926806|Micronutrients|micronutrients|mesh-ancestor
101868605|NCT03926806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868606|NCT03926962|Nafithromycin|nafithromycin|mesh-list
101868607|NCT03926962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101868608|NCT03926962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101868609|NCT03926962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101868610|NCT03926962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101868611|NCT03926962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868612|NCT03919786|Anesthetics|anesthetics|mesh-list
101868613|NCT03919786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101868614|NCT03919786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868615|NCT03924544|Mitomycins|mitomycins|mesh-list
101868616|NCT03924544|Mitomycin|mitomycin|mesh-list
101868617|NCT03924544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101868618|NCT03924544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101868619|NCT03924544|Alkylating Agents|alkylating agents|mesh-ancestor
101868620|NCT03924544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868621|NCT03924544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101868622|NCT03924544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101588465|NCT04318652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101868623|NCT01131364|Doxorubicin|doxorubicin|mesh-list
101868624|NCT01131364|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101868625|NCT01131364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101868626|NCT01131364|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101868628|NCT01131364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101868629|NCT01131364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868630|NCT02529202|Dexmedetomidine|dexmedetomidine|mesh-list
101868631|NCT02529202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101868632|NCT02529202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101868633|NCT02529202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868634|NCT02529202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101868635|NCT02529202|Analgesics|analgesics|mesh-ancestor
101868636|NCT02529202|Sensory System Agents|sensory system agents|mesh-ancestor
101868637|NCT02529202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101868638|NCT02529202|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101868639|NCT02529202|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101868640|NCT02529202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101868641|NCT02529202|Adrenergic Agents|adrenergic agents|mesh-ancestor
101868642|NCT02529202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101868643|NCT02529202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868644|NCT00154310|Cyclosporine|cyclosporine|mesh-list
101868645|NCT00154310|Mycophenolic Acid|mycophenolic acid|mesh-list
101868646|NCT00154310|Everolimus|everolimus|mesh-list
101868647|NCT00154310|Cyclosporins|cyclosporins|mesh-list
101868648|NCT00154310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101868649|NCT00154310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868650|NCT00154310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101868651|NCT00154310|Immunologic Factors|immunologic factors|mesh-ancestor
101868652|NCT00154310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868653|NCT00154310|Antifungal Agents|antifungal agents|mesh-ancestor
101868654|NCT00154310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101868655|NCT00154310|Dermatologic Agents|dermatologic agents|mesh-ancestor
101868656|NCT00154310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101868657|NCT00154310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101868658|NCT00154310|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101868659|NCT00154310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101868660|NCT00154310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101868661|NCT00154310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101868662|NCT00154310|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101868663|NCT00154310|Antitubercular Agents|antitubercular agents|mesh-ancestor
101868664|NCT00154310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101868665|NCT03770728|Metformin|metformin|mesh-list
101868666|NCT03770728|Efpeglenatide|efpeglenatide|mesh-list
101868667|NCT03770728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101868668|NCT03770728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868669|NCT01132222|Ibuprofen|ibuprofen|mesh-list
101868670|NCT01132222|Pseudoephedrine|pseudoephedrine|mesh-list
101868671|NCT01132222|Ephedrine|ephedrine|mesh-list
101868672|NCT01132222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101868673|NCT01132222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101868674|NCT01132222|Analgesics|analgesics|mesh-ancestor
101868675|NCT01132222|Sensory System Agents|sensory system agents|mesh-ancestor
101868676|NCT01132222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101868677|NCT01132222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868678|NCT01132222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101868679|NCT01132222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101868680|NCT01132222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101868681|NCT01132222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101868682|NCT01132222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868683|NCT01132222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101868684|NCT01132222|Autonomic Agents|autonomic agents|mesh-ancestor
101868685|NCT01132222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101868686|NCT01132222|Respiratory System Agents|respiratory system agents|mesh-ancestor
101868687|NCT01132222|Nasal Decongestants|nasal decongestants|mesh-ancestor
101868688|NCT01132222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101868689|NCT01132222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101868690|NCT01132222|Sympathomimetics|sympathomimetics|mesh-ancestor
101868691|NCT01132222|Adrenergic Agents|adrenergic agents|mesh-ancestor
101868692|NCT01132222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101868693|NCT03926182|Aflutinib|aflutinib|mesh-list
101868694|NCT03926182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101868695|NCT03926182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101688242|NCT00645918|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101868696|NCT03926182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868698|NCT01130506|Decitabine|decitabine|mesh-list
101868699|NCT01130506|Vorinostat|vorinostat|mesh-list
101868700|NCT01130506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101868701|NCT01130506|Antimetabolites|antimetabolites|mesh-ancestor
101868702|NCT01130506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868703|NCT01130506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101868704|NCT01130506|Antiviral Agents|antiviral agents|mesh-ancestor
101868705|NCT01130506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101868706|NCT01130506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101868707|NCT01130506|Immunologic Factors|immunologic factors|mesh-ancestor
101868708|NCT01130506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868709|NCT01130506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101868710|NCT01130506|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101868711|NCT01130662|Decitabine|decitabine|mesh-list
101868712|NCT01130662|Midostaurin|midostaurin|mesh-list
101868713|NCT01130662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101868714|NCT01130662|Antimetabolites|antimetabolites|mesh-ancestor
101868715|NCT01130662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868716|NCT01130662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101868717|NCT01130662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101868718|NCT01130662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101868719|NCT03925714|Metformin|metformin|mesh-list
101868720|NCT03925714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101868721|NCT03925714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868722|NCT01228552|Ketoprofen|ketoprofen|mesh-list
101868723|NCT01228552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101868724|NCT01228552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101868725|NCT01228552|Analgesics|analgesics|mesh-ancestor
101868726|NCT01228552|Sensory System Agents|sensory system agents|mesh-ancestor
101868727|NCT01228552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101868728|NCT01228552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868729|NCT01228552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101868730|NCT01228552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101868731|NCT01228552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101868732|NCT01228552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101868733|NCT01228552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868734|NCT03919084|Nicotine|nicotine|mesh-list
101868735|NCT03919084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101868736|NCT03919084|Autonomic Agents|autonomic agents|mesh-ancestor
101868737|NCT03919084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101868738|NCT03919084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868739|NCT03919084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101868740|NCT03919084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101868741|NCT03919084|Cholinergic Agents|cholinergic agents|mesh-ancestor
101868742|NCT03919084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101868743|NCT03919084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868744|NCT03923842|Denosumab|denosumab|mesh-list
101868745|NCT03923842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101868746|NCT03923842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868747|NCT01132768|Atenolol|atenolol|mesh-list
101868748|NCT01132768|Olmesartan|olmesartan|mesh-list
101868749|NCT01132768|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101868750|NCT01132768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101868751|NCT01132768|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101868752|NCT01132768|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101868753|NCT01132768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868754|NCT01132768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101868755|NCT01132768|Sympatholytics|sympatholytics|mesh-ancestor
101868756|NCT01132768|Autonomic Agents|autonomic agents|mesh-ancestor
101868757|NCT01132768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101868758|NCT01132768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868759|NCT01132768|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101868760|NCT01132768|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101868761|NCT01132768|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101868762|NCT01132768|Adrenergic Agents|adrenergic agents|mesh-ancestor
101868763|NCT01132768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101868765|NCT01230034|Imidapril|imidapril|mesh-list
101868766|NCT01230034|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101868767|NCT01230034|Protease Inhibitors|protease inhibitors|mesh-ancestor
101868768|NCT01230034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101868769|NCT01230034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868770|NCT01230034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101868771|NCT03918616|Dopamine|dopamine|mesh-list
101868772|NCT03918616|Memantine|memantine|mesh-list
101868773|NCT03918616|Dopamine Agonists|dopamine agonists|mesh-list
101868774|NCT03918616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101868775|NCT03918616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101868776|NCT03918616|Dopamine Agents|dopamine agents|mesh-ancestor
101868777|NCT03918616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101868778|NCT03918616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868779|NCT03918616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868780|NCT03918616|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101868781|NCT03918616|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101868782|NCT03918616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101868783|NCT03918616|Sympathomimetics|sympathomimetics|mesh-ancestor
101868784|NCT03918616|Autonomic Agents|autonomic agents|mesh-ancestor
101868785|NCT03918616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101868786|NCT03918616|Protective Agents|protective agents|mesh-ancestor
101868787|NCT01228630|Loratadine|loratadine|mesh-list
101868788|NCT01228630|Fexofenadine|fexofenadine|mesh-list
101868789|NCT01228630|Pseudoephedrine|pseudoephedrine|mesh-list
101868790|NCT01228630|Ephedrine|ephedrine|mesh-list
101868791|NCT01228630|Antipruritics|antipruritics|mesh-ancestor
101868792|NCT01228630|Dermatologic Agents|dermatologic agents|mesh-ancestor
101868793|NCT01228630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101868794|NCT01228630|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101868795|NCT01228630|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101868796|NCT01228630|Histamine Antagonists|histamine antagonists|mesh-ancestor
101868797|NCT01228630|Histamine Agents|histamine agents|mesh-ancestor
101868798|NCT01228630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101868799|NCT01228630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868800|NCT01228630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868801|NCT01228630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101868802|NCT01228630|Autonomic Agents|autonomic agents|mesh-ancestor
101868803|NCT01228630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101868804|NCT01228630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101868805|NCT01228630|Respiratory System Agents|respiratory system agents|mesh-ancestor
101868806|NCT01228630|Nasal Decongestants|nasal decongestants|mesh-ancestor
101868807|NCT01228630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101868808|NCT01228630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101868809|NCT01228630|Sympathomimetics|sympathomimetics|mesh-ancestor
101868810|NCT01228630|Adrenergic Agents|adrenergic agents|mesh-ancestor
101868811|NCT01134406|Hylan|hylan|mesh-list
101868812|NCT01134406|Viscosupplements|viscosupplements|mesh-ancestor
101868813|NCT01134406|Protective Agents|protective agents|mesh-ancestor
101868814|NCT01134406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868815|NCT01231828|Lactulose|lactulose|mesh-list
101868816|NCT01231828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101868817|NCT03923218|Vitamin D|vitamin d|mesh-list
101868818|NCT03923218|Cholecalciferol|cholecalciferol|mesh-list
101868819|NCT03923218|Vitamins|vitamins|mesh-ancestor
101868820|NCT03923218|Micronutrients|micronutrients|mesh-ancestor
101868821|NCT03923218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868822|NCT03923218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101868823|NCT03923218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101868824|NCT03923140|Tranilast|tranilast|mesh-list
101868825|NCT03923140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101868826|NCT03923140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101868827|NCT03923140|Analgesics|analgesics|mesh-ancestor
101868828|NCT03923140|Sensory System Agents|sensory system agents|mesh-ancestor
101868829|NCT03923140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101688274|NCT04173858|Naloxegol|naloxegol|mesh-list
101245198|NCT01657513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101868830|NCT03923140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868831|NCT03923140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101868832|NCT03923140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101868833|NCT03923140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101868834|NCT03923140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101868835|NCT03923140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868836|NCT03923140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101868837|NCT03923140|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101868838|NCT03923140|Histamine Antagonists|histamine antagonists|mesh-ancestor
101868839|NCT03923140|Histamine Agents|histamine agents|mesh-ancestor
101868840|NCT03923140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101868841|NCT03923140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101868842|NCT03923140|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101868843|NCT01133080|Minocycline|minocycline|mesh-list
101868844|NCT01133080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101868845|NCT01133080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101868846|NCT01230580|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101868847|NCT01230580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
101868848|NCT01230580|Protease Inhibitors|protease inhibitors|mesh-list
101868849|NCT01230580|Antiviral Agents|antiviral agents|mesh-ancestor
101868850|NCT01230580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101868851|NCT01230580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101868852|NCT01230580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868853|NCT01230580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101868854|NCT01230580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101868855|NCT01585792|Glimepiride|glimepiride|mesh-list
101868856|NCT01585792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101868857|NCT01585792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101868858|NCT01585792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868859|NCT01585792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101868860|NCT01585792|Immunologic Factors|immunologic factors|mesh-ancestor
101868861|NCT01134484|Thalidomide|thalidomide|mesh-list
101868862|NCT01134484|Dexamethasone|dexamethasone|mesh-list
101868863|NCT01134484|Bortezomib|bortezomib|mesh-list
101868864|NCT01134484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101868865|NCT01134484|Antiemetics|antiemetics|mesh-ancestor
101868866|NCT01134484|Autonomic Agents|autonomic agents|mesh-ancestor
101868867|NCT01134484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101868868|NCT01134484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868869|NCT01134484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101868870|NCT01134484|Glucocorticoids|glucocorticoids|mesh-ancestor
101868871|NCT01134484|Hormones|hormones|mesh-ancestor
101868872|NCT01134484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101868873|NCT01134484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101868874|NCT01134484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101868875|NCT01134484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101868876|NCT01134484|Immunologic Factors|immunologic factors|mesh-ancestor
101868877|NCT01134484|Leprostatic Agents|leprostatic agents|mesh-ancestor
101868878|NCT01134484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101868879|NCT01134484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101868880|NCT01134484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101868881|NCT01134484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101868882|NCT01134484|Growth Substances|growth substances|mesh-ancestor
101868883|NCT01134484|Growth Inhibitors|growth inhibitors|mesh-ancestor
101868884|NCT01133470|Fexofenadine|fexofenadine|mesh-list
101868885|NCT01133470|Pseudoephedrine|pseudoephedrine|mesh-list
101868886|NCT01133470|Ephedrine|ephedrine|mesh-list
101868887|NCT01133470|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101868888|NCT01133470|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101868889|NCT01133470|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101868890|NCT01133470|Histamine Antagonists|histamine antagonists|mesh-ancestor
101868891|NCT01133470|Histamine Agents|histamine agents|mesh-ancestor
101868892|NCT01133470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101868893|NCT01133470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688283|NCT00646932|Micronutrients|micronutrients|mesh-ancestor
101868894|NCT01133470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868895|NCT01133470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101868896|NCT01133470|Autonomic Agents|autonomic agents|mesh-ancestor
101868897|NCT01133470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101868898|NCT01133470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101868899|NCT01133470|Respiratory System Agents|respiratory system agents|mesh-ancestor
101868900|NCT01133470|Nasal Decongestants|nasal decongestants|mesh-ancestor
101868901|NCT01133470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101868902|NCT01133470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101868903|NCT01133470|Sympathomimetics|sympathomimetics|mesh-ancestor
101868904|NCT01133470|Adrenergic Agents|adrenergic agents|mesh-ancestor
101868905|NCT01134718|Simeprevir|simeprevir|mesh-list
101868906|NCT01134718|Antiviral Agents|antiviral agents|mesh-ancestor
101868907|NCT01134718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101868908|NCT01134718|Protease Inhibitors|protease inhibitors|mesh-ancestor
101868909|NCT01134718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101868910|NCT01134718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868911|NCT03917758|Dapagliflozin|dapagliflozin|mesh-list
101868912|NCT03917758|Empagliflozin|empagliflozin|mesh-list
101868913|NCT03917758|Canagliflozin|canagliflozin|mesh-list
101329830|NCT00028327|Efavirenz|efavirenz|mesh-list
101868914|NCT03917758|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
101868915|NCT03917758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868916|NCT03917758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101868917|NCT03917758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868918|NCT01230736|Timolol|timolol|mesh-list
101868919|NCT01230736|Travoprost|travoprost|mesh-list
101868920|NCT01230736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101868921|NCT01230736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101868922|NCT01230736|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101868923|NCT01230736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101868924|NCT01230736|Adrenergic Agents|adrenergic agents|mesh-ancestor
101868925|NCT01230736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101868926|NCT01230736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868927|NCT01230736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868928|NCT01230736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101868929|NCT01230736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101868930|NCT01133548|Methyltestosterone|methyltestosterone|mesh-list
101868931|NCT01133548|Testosterone|testosterone|mesh-list
101868932|NCT01133548|Testosterone undecanoate|testosterone undecanoate|mesh-list
101868933|NCT01133548|Testosterone enanthate|testosterone enanthate|mesh-list
101868934|NCT01133548|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101868935|NCT01133548|Androgens|androgens|mesh-ancestor
101868936|NCT01133548|Hormones|hormones|mesh-ancestor
101868937|NCT01133548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101868938|NCT01133548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868939|NCT01133548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101868940|NCT01133548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101868941|NCT01133548|Anabolic Agents|anabolic agents|mesh-ancestor
101868942|NCT03917134|Metronidazole|metronidazole|mesh-list
101868943|NCT03917134|Cephalosporins|cephalosporins|mesh-list
101868944|NCT03917134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101868945|NCT03917134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101868946|NCT03917134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101868947|NCT03917134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101868948|NCT01232140|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101868949|NCT01232140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101868950|NCT01231126|Misoprostol|misoprostol|mesh-list
101868951|NCT01231126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101868952|NCT01231126|Abortifacient Agents|abortifacient agents|mesh-ancestor
101868953|NCT01231126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101868954|NCT01231126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868955|NCT01231126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101868956|NCT01231126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101868957|NCT01231126|Oxytocics|oxytocics|mesh-ancestor
101868958|NCT03769090|Budesonide|budesonide|mesh-list
101868960|NCT03769090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101868961|NCT03769090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101868962|NCT03769090|Autonomic Agents|autonomic agents|mesh-ancestor
101868963|NCT03769090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101868964|NCT03769090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868965|NCT03769090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101868966|NCT03769090|Respiratory System Agents|respiratory system agents|mesh-ancestor
101868967|NCT03769090|Glucocorticoids|glucocorticoids|mesh-ancestor
101868968|NCT03769090|Hormones|hormones|mesh-ancestor
101868969|NCT03769090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101868970|NCT03769090|Tocolytic Agents|tocolytic agents|mesh-ancestor
101868971|NCT03769090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101868972|NCT03769090|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101868973|NCT03769090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101868974|NCT03769090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101868975|NCT03769090|Adrenergic Agents|adrenergic agents|mesh-ancestor
101868976|NCT03769090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101868977|NCT03769090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868978|NCT03921736|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101868979|NCT03921736|Perindopril|perindopril|mesh-list
101868980|NCT03921736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101868981|NCT03921736|Diuretics|diuretics|mesh-ancestor
101868982|NCT03921736|Natriuretic Agents|natriuretic agents|mesh-ancestor
101868983|NCT03921736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966214|NCT00039377|Antimetabolites|antimetabolites|mesh-ancestor
101868984|NCT03921736|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101868985|NCT03921736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101868986|NCT03921736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101868987|NCT03921736|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101868988|NCT03921736|Protease Inhibitors|protease inhibitors|mesh-ancestor
101868989|NCT03921736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101868990|NCT05401006|Acitretin|acitretin|mesh-list
101868991|NCT05401006|Keratolytic Agents|keratolytic agents|mesh-ancestor
101868992|NCT05401006|Dermatologic Agents|dermatologic agents|mesh-ancestor
101868993|NCT01232374|Nimotuzumab|nimotuzumab|mesh-list
101868994|NCT01232374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101868995|NCT01232374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101868996|NCT01231438|Alfacalcidol|alfacalcidol|mesh-list
101868997|NCT01231438|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101868998|NCT01231438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101868999|NCT01131754|Heparin|heparin|mesh-list
101869000|NCT01131754|Anticoagulants|anticoagulants|mesh-ancestor
101869001|NCT01131754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101869002|NCT01131754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101869003|NCT01131754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869005|NCT01231594|Dabrafenib|dabrafenib|mesh-list
101869006|NCT01231594|Antineoplastic Agents|antineoplastic agents|mesh-list
101869007|NCT01231594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101869008|NCT01231594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101869009|NCT01231594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869010|NCT01136278|Clonidine|clonidine|mesh-list
101869011|NCT01136278|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
101869012|NCT01136278|Analgesics|analgesics|mesh-ancestor
101869013|NCT01136278|Sensory System Agents|sensory system agents|mesh-ancestor
101869014|NCT01136278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101869015|NCT01136278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869016|NCT01136278|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101869017|NCT01136278|Sympatholytics|sympatholytics|mesh-ancestor
101869018|NCT01136278|Autonomic Agents|autonomic agents|mesh-ancestor
101869019|NCT01136278|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101869020|NCT01136278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101869021|NCT01136278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101869022|NCT01136278|Adrenergic Agents|adrenergic agents|mesh-ancestor
101869023|NCT01136278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101869024|NCT01136278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869025|NCT01136278|Hallucinogens|hallucinogens|mesh-ancestor
101869026|NCT01136278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101869027|NCT01136278|Serotonin Agents|serotonin agents|mesh-ancestor
101869028|NCT01136278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101869029|NCT01136278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101869030|NCT01136278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101869031|NCT05402722|Antibodies|antibodies|mesh-list
101869032|NCT05402722|Immunologic Factors|immunologic factors|mesh-ancestor
101869033|NCT05402722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869034|NCT05480488|Midazolam|midazolam|mesh-list
101869035|NCT05480488|Warfarin|warfarin|mesh-list
101869036|NCT05480488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101869037|NCT05480488|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101869038|NCT05480488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101869039|NCT05480488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869040|NCT05480488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101869041|NCT05480488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101869042|NCT05480488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101869043|NCT05480488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101869044|NCT05480488|Anesthetics, General|anesthetics, general|mesh-ancestor
101869045|NCT05480488|Anesthetics|anesthetics|mesh-ancestor
101869046|NCT05480488|GABA Modulators|gaba modulators|mesh-ancestor
101869047|NCT05480488|GABA Agents|gaba agents|mesh-ancestor
101869048|NCT05480488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101869049|NCT05480488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869050|NCT05480488|Anticoagulants|anticoagulants|mesh-ancestor
101869051|NCT01229332|Carbidopa|carbidopa|mesh-list
101869052|NCT01229332|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101869053|NCT01229332|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101869054|NCT01229332|Dopamine Agents|dopamine agents|mesh-ancestor
101869055|NCT01229332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101869056|NCT01229332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869057|NCT01229332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869058|NCT01229332|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101869059|NCT01229332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101869061|NCT03921034|Anesthetics, Local|anesthetics, local|mesh-ancestor
101869062|NCT03921034|Anesthetics|anesthetics|mesh-ancestor
101869063|NCT03921034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101869064|NCT03921034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869065|NCT03921034|Sensory System Agents|sensory system agents|mesh-ancestor
101869066|NCT03921034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101869067|NCT01136590|Tranexamic Acid|tranexamic acid|mesh-list
101869068|NCT01136590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101869069|NCT01136590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101869070|NCT01136590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869071|NCT01136590|Hemostatics|hemostatics|mesh-ancestor
101869072|NCT01136590|Coagulants|coagulants|mesh-ancestor
101869073|NCT03920878|Aflibercept|aflibercept|mesh-list
101869074|NCT03920878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101869075|NCT03920878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101869076|NCT03920878|Growth Substances|growth substances|mesh-ancestor
101869077|NCT03920878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869078|NCT03920878|Growth Inhibitors|growth inhibitors|mesh-ancestor
101869079|NCT03920878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101869080|NCT03920644|Scopolamine|scopolamine|mesh-list
101869081|NCT03920644|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101869082|NCT03920644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101869083|NCT03920644|Antiemetics|antiemetics|mesh-ancestor
101869084|NCT03920644|Autonomic Agents|autonomic agents|mesh-ancestor
101869085|NCT03920644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101869086|NCT03920644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869087|NCT03920644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101869088|NCT03920644|Mydriatics|mydriatics|mesh-ancestor
101869089|NCT03920644|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101869090|NCT03920644|Cholinergic Agents|cholinergic agents|mesh-ancestor
101869091|NCT03920644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101869092|NCT03920644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869093|NCT03920644|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101869094|NCT03920644|Parasympatholytics|parasympatholytics|mesh-ancestor
101869095|NCT01137916|Imatinib Mesylate|imatinib mesylate|mesh-list
101869096|NCT01137916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101869097|NCT01137916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101869098|NCT01137916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101869099|NCT01137916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869100|NCT01137994|Paclitaxel|paclitaxel|mesh-list
101869101|NCT01137994|Vinorelbine|vinorelbine|mesh-list
101869102|NCT01137994|Docetaxel|docetaxel|mesh-list
101869103|NCT01137994|Trastuzumab|trastuzumab|mesh-list
101869104|NCT01137994|Lapatinib|lapatinib|mesh-list
101869105|NCT01137994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101869106|NCT01137994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101869107|NCT01137994|Tubulin Modulators|tubulin modulators|mesh-ancestor
101869108|NCT01137994|Antimitotic Agents|antimitotic agents|mesh-ancestor
101869109|NCT01137994|Mitosis Modulators|mitosis modulators|mesh-ancestor
101869110|NCT01137994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869111|NCT01137994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101869112|NCT01137994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101869113|NCT01137994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101869114|NCT01138072|Atorvastatin|atorvastatin|mesh-list
101869115|NCT01138072|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101869116|NCT01138072|Simvastatin|simvastatin|mesh-list
101869117|NCT01138072|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101869118|NCT01138072|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101869119|NCT01138072|Antimetabolites|antimetabolites|mesh-ancestor
101869120|NCT01138072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869121|NCT01138072|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101869122|NCT01138072|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101966224|NCT00039377|Antidotes|antidotes|mesh-ancestor
101869123|NCT01138072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101869124|NCT01131910|Vaccines|vaccines|mesh-list
101869125|NCT01131910|Immunologic Factors|immunologic factors|mesh-ancestor
101869126|NCT01131910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869127|NCT03739606|Antibodies|antibodies|mesh-list
101869128|NCT03739606|Immunoglobulins|immunoglobulins|mesh-list
101869129|NCT03739606|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101869130|NCT03739606|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101869131|NCT03739606|Immunologic Factors|immunologic factors|mesh-ancestor
101869132|NCT03739606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869133|NCT05533372|Methotrexate|methotrexate|mesh-list
101869134|NCT05533372|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101869135|NCT05533372|Abortifacient Agents|abortifacient agents|mesh-ancestor
101869136|NCT05533372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101869137|NCT05533372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869138|NCT05533372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101869139|NCT05533372|Antimetabolites|antimetabolites|mesh-ancestor
101869140|NCT05533372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869141|NCT05533372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101869142|NCT05533372|Dermatologic Agents|dermatologic agents|mesh-ancestor
101869143|NCT05533372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101869144|NCT05533372|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101869145|NCT05533372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101869146|NCT05533372|Immunologic Factors|immunologic factors|mesh-ancestor
101869147|NCT05533372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101869148|NCT05533372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101869149|NCT01233622|Vildagliptin|vildagliptin|mesh-list
101869150|NCT01233622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101869151|NCT01233622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869152|NCT01233622|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101869153|NCT01233622|Protease Inhibitors|protease inhibitors|mesh-ancestor
101869154|NCT01233622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101869155|NCT01233622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869156|NCT01138774|Thioctic Acid|thioctic acid|mesh-list
101869157|NCT01138774|Antioxidants|antioxidants|mesh-ancestor
101869158|NCT01138774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869159|NCT01138774|Protective Agents|protective agents|mesh-ancestor
101869160|NCT01138774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869161|NCT01138774|Vitamin B Complex|vitamin b complex|mesh-ancestor
101869162|NCT01138774|Vitamins|vitamins|mesh-ancestor
101869163|NCT01138774|Micronutrients|micronutrients|mesh-ancestor
101869164|NCT01131988|Tacrolimus|tacrolimus|mesh-list
101869165|NCT01131988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101869166|NCT01131988|Immunologic Factors|immunologic factors|mesh-ancestor
101869167|NCT01131988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869168|NCT01131988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101869169|NCT01131988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101869170|NCT01131988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869171|NCT01138852|Ampicillin|ampicillin|mesh-list
101869172|NCT01138852|Cefuroxime|cefuroxime|mesh-list
101869173|NCT01138852|Cefuroxime axetil|cefuroxime axetil|mesh-list
101869174|NCT01138852|Sulbactam|sulbactam|mesh-list
101869175|NCT01138852|Sultamicillin|sultamicillin|mesh-list
101869176|NCT01138852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101869177|NCT01138852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101869178|NCT01138852|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101869179|NCT01138852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101869180|NCT01138852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869181|NCT05487196|Clonidine|clonidine|mesh-list
101869182|NCT05487196|Fentanyl|fentanyl|mesh-list
101869183|NCT05487196|Dexmedetomidine|dexmedetomidine|mesh-list
101869184|NCT05487196|Ropivacaine|ropivacaine|mesh-list
101869185|NCT05487196|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101966231|NCT00039377|Antimitotic Agents|antimitotic agents|mesh-ancestor
101869186|NCT05487196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101869187|NCT05487196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869188|NCT05487196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101869189|NCT05487196|Analgesics|analgesics|mesh-ancestor
101869190|NCT05487196|Sensory System Agents|sensory system agents|mesh-ancestor
101688347|NCT02841137|Progestins|progestins|mesh-ancestor
101869191|NCT05487196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101869192|NCT05487196|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101869193|NCT05487196|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101869194|NCT05487196|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101869195|NCT05487196|Adrenergic Agents|adrenergic agents|mesh-ancestor
101869196|NCT05487196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101869197|NCT05487196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869198|NCT05487196|Anesthetics, Local|anesthetics, local|mesh-ancestor
101869199|NCT05487196|Anesthetics|anesthetics|mesh-ancestor
101869200|NCT05487196|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101869201|NCT05487196|Narcotics|narcotics|mesh-ancestor
101869202|NCT05487196|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101869203|NCT05487196|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101869204|NCT05487196|Anesthetics, General|anesthetics, general|mesh-ancestor
101869205|NCT05487196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101869206|NCT05487196|Sympatholytics|sympatholytics|mesh-ancestor
101869207|NCT05487196|Autonomic Agents|autonomic agents|mesh-ancestor
101869208|NCT01585870|Sorafenib|sorafenib|mesh-list
101869209|NCT01585870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101869210|NCT01585870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101869211|NCT01585870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101869212|NCT01585870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869213|NCT05210140|Escitalopram|escitalopram|mesh-list
101869214|NCT05210140|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101869215|NCT05210140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101245263|NCT01658202|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101869216|NCT05210140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101869217|NCT05210140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869218|NCT05210140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101869219|NCT05210140|Serotonin Agents|serotonin agents|mesh-ancestor
101869220|NCT05210140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869221|NCT01233934|Chlorpheniramine|chlorpheniramine|mesh-list
101869222|NCT01233934|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
101869223|NCT01233934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101869224|NCT01233934|Histamine Antagonists|histamine antagonists|mesh-ancestor
101869225|NCT01233934|Histamine Agents|histamine agents|mesh-ancestor
101869226|NCT01233934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101869227|NCT01233934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869228|NCT01233934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869229|NCT01233934|Antipruritics|antipruritics|mesh-ancestor
101869230|NCT01233934|Dermatologic Agents|dermatologic agents|mesh-ancestor
101869231|NCT01233934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101869232|NCT01236508|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101869233|NCT01236508|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101869234|NCT01236508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869235|NCT05195944|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101869236|NCT05195944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101869237|NCT05195944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869239|NCT05195944|Hormones|hormones|mesh-ancestor
101869240|NCT05195944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101869241|NCT05195944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101869242|NCT05195944|Protease Inhibitors|protease inhibitors|mesh-ancestor
101869243|NCT05195944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101869244|NCT05195944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869245|NCT01236586|Dexamethasone|dexamethasone|mesh-list
101686026|NCT00903617|Niacin|niacin|mesh-list
101869246|NCT01236586|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
101869247|NCT01236586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101869248|NCT01236586|Antiemetics|antiemetics|mesh-ancestor
101869249|NCT01236586|Autonomic Agents|autonomic agents|mesh-ancestor
101869250|NCT01236586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101869251|NCT01236586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869252|NCT01236586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101869253|NCT01236586|Glucocorticoids|glucocorticoids|mesh-ancestor
101869255|NCT01236586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101869256|NCT01236586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101869257|NCT01236586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101869258|NCT01236586|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101869259|NCT01236586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101869260|NCT01236586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869261|NCT01234792|Nicotine|nicotine|mesh-list
101869262|NCT01234792|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101869263|NCT01234792|Autonomic Agents|autonomic agents|mesh-ancestor
101869264|NCT01234792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101869265|NCT01234792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869266|NCT01234792|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101869267|NCT01234792|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101869268|NCT01234792|Cholinergic Agents|cholinergic agents|mesh-ancestor
101869269|NCT01234792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101869270|NCT01234792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869271|NCT03513328|Thiotepa|thiotepa|mesh-list
101869272|NCT03513328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101869273|NCT03513328|Alkylating Agents|alkylating agents|mesh-ancestor
101869274|NCT03513328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869275|NCT03513328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101869276|NCT03513328|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101869277|NCT03513328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101869278|NCT03513328|Immunologic Factors|immunologic factors|mesh-ancestor
101245270|NCT01658215|Autonomic Agents|autonomic agents|mesh-ancestor
101869279|NCT03513328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869280|NCT03467932|Insulin|insulin|mesh-list
101869281|NCT03467932|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101869282|NCT03467932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101869283|NCT03467932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869284|NCT03199612|Sildenafil Citrate|sildenafil citrate|mesh-list
101869285|NCT03199612|Vasodilator Agents|vasodilator agents|mesh-ancestor
101869286|NCT03199612|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101869287|NCT03199612|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101869288|NCT03199612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101869289|NCT03199612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869290|NCT03199612|Urological Agents|urological agents|mesh-ancestor
101869291|NCT01140100|Thiopental|thiopental|mesh-list
101869292|NCT01140100|Propofol|propofol|mesh-list
101869293|NCT01140100|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101869294|NCT01140100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101869295|NCT01140100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869296|NCT01140100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101869297|NCT01140100|Anesthetics, General|anesthetics, general|mesh-ancestor
101869298|NCT01140100|Anesthetics|anesthetics|mesh-ancestor
101869299|NCT01140100|Anticonvulsants|anticonvulsants|mesh-ancestor
101589135|NCT00667771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101869300|NCT01140100|GABA Modulators|gaba modulators|mesh-ancestor
101869301|NCT01140100|GABA Agents|gaba agents|mesh-ancestor
101869302|NCT01140100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101869303|NCT01140100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869304|NCT01141036|Midazolam|midazolam|mesh-list
101869305|NCT01141036|Propofol|propofol|mesh-list
101966257|NCT00154102|Leucovorin|leucovorin|mesh-list
101869307|NCT01141036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101869308|NCT01141036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869309|NCT01141036|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101869310|NCT01141036|Anesthetics, General|anesthetics, general|mesh-ancestor
101869311|NCT01141036|Anesthetics|anesthetics|mesh-ancestor
101869312|NCT01141036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101869313|NCT01141036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101869314|NCT01141036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101869315|NCT01141036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101869316|NCT01141036|GABA Modulators|gaba modulators|mesh-ancestor
101869317|NCT01141036|GABA Agents|gaba agents|mesh-ancestor
101869318|NCT01141036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101869319|NCT01141036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869320|NCT02685826|Dexamethasone|dexamethasone|mesh-list
101869321|NCT02685826|Lenalidomide|lenalidomide|mesh-list
101869322|NCT02685826|Durvalumab|durvalumab|mesh-list
101869323|NCT02685826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101869324|NCT02685826|Antiemetics|antiemetics|mesh-ancestor
101869325|NCT02685826|Autonomic Agents|autonomic agents|mesh-ancestor
101869326|NCT02685826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101869327|NCT02685826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869328|NCT02685826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101869330|NCT02685826|Hormones|hormones|mesh-ancestor
101869331|NCT02685826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101869332|NCT02685826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101869333|NCT02685826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101869334|NCT02685826|Immunologic Factors|immunologic factors|mesh-ancestor
101869335|NCT02685826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101869336|NCT02685826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101869337|NCT02685826|Growth Substances|growth substances|mesh-ancestor
101869338|NCT02685826|Growth Inhibitors|growth inhibitors|mesh-ancestor
101869339|NCT02685826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101869340|NCT04906720|Colchicine|colchicine|mesh-list
101869341|NCT04906720|Gout Suppressants|gout suppressants|mesh-ancestor
101869342|NCT04906720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101869343|NCT04906720|Tubulin Modulators|tubulin modulators|mesh-ancestor
101869344|NCT04906720|Antimitotic Agents|antimitotic agents|mesh-ancestor
101869345|NCT04906720|Mitosis Modulators|mitosis modulators|mesh-ancestor
101869346|NCT04906720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869347|NCT04906720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101869348|NCT01141192|Vitamin D|vitamin d|mesh-list
101869349|NCT01141192|Cholecalciferol|cholecalciferol|mesh-list
101869350|NCT01141192|Vitamins|vitamins|mesh-ancestor
101869351|NCT01141192|Micronutrients|micronutrients|mesh-ancestor
101869352|NCT01141192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869353|NCT01141192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101869354|NCT01141192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101869355|NCT01144000|Daptomycin|daptomycin|mesh-list
101869356|NCT01144000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101869357|NCT01144000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101869358|NCT01140412|Ritonavir|ritonavir|mesh-list
101869359|NCT01140412|Fosamprenavir|fosamprenavir|mesh-list
101869360|NCT01140412|Maraviroc|maraviroc|mesh-list
101869361|NCT01140412|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101869362|NCT01140412|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101869363|NCT01140412|Protease Inhibitors|protease inhibitors|mesh-ancestor
101869364|NCT01140412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101869365|NCT01140412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869366|NCT01140412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101869367|NCT01140412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101869368|NCT01140412|Antiviral Agents|antiviral agents|mesh-ancestor
101869369|NCT01140412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101869370|NCT01140412|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101869371|NCT01140412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101869372|NCT01140412|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101869373|NCT01140412|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101869374|NCT01140412|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101869375|NCT01234324|Cisplatin|cisplatin|mesh-list
101869376|NCT01234324|Capecitabine|capecitabine|mesh-list
101869377|NCT01234324|Epirubicin|epirubicin|mesh-list
101869379|NCT01234324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101869380|NCT01234324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101869381|NCT01234324|Antimetabolites|antimetabolites|mesh-ancestor
101869382|NCT01234324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869383|NCT01234324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101869384|NCT01234324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101869385|NCT01234324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101869386|NCT01234324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101869387|NCT01234324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101869388|NCT02334124|Ceftriaxone|ceftriaxone|mesh-list
101869389|NCT02334124|Floxacillin|floxacillin|mesh-list
101869390|NCT02334124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101869391|NCT02334124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101869392|NCT01144156|Adalimumab|adalimumab|mesh-list
101869393|NCT01144156|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101869394|NCT01144156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101869395|NCT01144156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101869396|NCT01235260|Becaplermin|becaplermin|mesh-list
101869397|NCT01235260|Anticoagulants|anticoagulants|mesh-ancestor
101869398|NCT01235260|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
101869399|NCT01235260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101869400|NCT01235260|Growth Substances|growth substances|mesh-ancestor
101869401|NCT01235260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869402|NCT01144312|Fentanyl|fentanyl|mesh-list
101869403|NCT01144312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101869404|NCT01144312|Narcotics|narcotics|mesh-ancestor
101869405|NCT01144312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101869406|NCT01144312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869407|NCT01144312|Analgesics|analgesics|mesh-ancestor
101869408|NCT01144312|Sensory System Agents|sensory system agents|mesh-ancestor
101869409|NCT01144312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101869410|NCT01144312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101869411|NCT01144312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101869412|NCT01144312|Anesthetics, General|anesthetics, general|mesh-ancestor
101869413|NCT01144312|Anesthetics|anesthetics|mesh-ancestor
101869414|NCT01144390|Methadone|methadone|mesh-list
101869415|NCT01144390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101869416|NCT01144390|Narcotics|narcotics|mesh-ancestor
101869417|NCT01144390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101869418|NCT01144390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869419|NCT01144390|Analgesics|analgesics|mesh-ancestor
101869420|NCT01144390|Sensory System Agents|sensory system agents|mesh-ancestor
101869421|NCT01144390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101869422|NCT01144390|Antitussive Agents|antitussive agents|mesh-ancestor
101869423|NCT01144390|Respiratory System Agents|respiratory system agents|mesh-ancestor
101869424|NCT01329640|Paclitaxel|paclitaxel|mesh-list
101869425|NCT01329640|Cyclophosphamide|cyclophosphamide|mesh-list
101869426|NCT01329640|Trastuzumab|trastuzumab|mesh-list
101869427|NCT01329640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101869428|NCT01329640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101869429|NCT01329640|Tubulin Modulators|tubulin modulators|mesh-ancestor
101869430|NCT01329640|Antimitotic Agents|antimitotic agents|mesh-ancestor
101869431|NCT01329640|Mitosis Modulators|mitosis modulators|mesh-ancestor
101869432|NCT01329640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869433|NCT01329640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101869434|NCT01329640|Immunologic Factors|immunologic factors|mesh-ancestor
101869435|NCT01329640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869436|NCT01329640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101869437|NCT01329640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101869438|NCT01329640|Alkylating Agents|alkylating agents|mesh-ancestor
101869439|NCT01329640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101869440|NCT01329640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101869441|NCT05335018|Lenalidomide|lenalidomide|mesh-list
101869442|NCT05335018|Immunologic Factors|immunologic factors|mesh-ancestor
101869443|NCT05335018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869444|NCT05335018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101869445|NCT05335018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101869446|NCT05335018|Growth Substances|growth substances|mesh-ancestor
101869447|NCT05335018|Growth Inhibitors|growth inhibitors|mesh-ancestor
101869448|NCT05335018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101869449|NCT00114777|Cyclosporine|cyclosporine|mesh-list
101869450|NCT00114777|Abatacept|abatacept|mesh-list
101589285|NCT00662779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869451|NCT00114777|Cyclosporins|cyclosporins|mesh-list
101869452|NCT00114777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101869453|NCT00114777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869454|NCT00114777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101869455|NCT00114777|Immunologic Factors|immunologic factors|mesh-ancestor
101869456|NCT00114777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869457|NCT00114777|Antifungal Agents|antifungal agents|mesh-ancestor
101869458|NCT00114777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101869459|NCT00114777|Dermatologic Agents|dermatologic agents|mesh-ancestor
101869460|NCT00114777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101869461|NCT00114777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101869462|NCT00114777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101869463|NCT00114777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101869464|NCT00114777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101869465|NCT00139737|Ziprasidone|ziprasidone|mesh-list
101869466|NCT00139737|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101869467|NCT00139737|Serotonin Agents|serotonin agents|mesh-ancestor
101869468|NCT00139737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101869469|NCT00139737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869470|NCT00139737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869471|NCT00139737|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101869472|NCT00139737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101869473|NCT00139737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101869474|NCT00139737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101869475|NCT00139737|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101869476|NCT00139737|Dopamine Agents|dopamine agents|mesh-ancestor
101869477|NCT00139659|Insulin|insulin|mesh-list
101869478|NCT00139659|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101869479|NCT00139659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101869480|NCT00139659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869481|NCT01076439|Fluticasone|fluticasone|mesh-list
101869482|NCT01076439|Xhance|xhance|mesh-list
101869483|NCT01076439|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
101869484|NCT01076439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101869485|NCT01076439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101869486|NCT01076439|Autonomic Agents|autonomic agents|mesh-ancestor
101869487|NCT01076439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101869488|NCT01076439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869489|NCT01076439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101869490|NCT01076439|Respiratory System Agents|respiratory system agents|mesh-ancestor
101869491|NCT01076439|Dermatologic Agents|dermatologic agents|mesh-ancestor
101869492|NCT01076439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101869493|NCT01076439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101869494|NCT01076439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101869495|NCT01076439|Analgesics|analgesics|mesh-ancestor
101869496|NCT01076439|Sensory System Agents|sensory system agents|mesh-ancestor
101869497|NCT01076439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101869498|NCT01076439|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101869499|NCT01076439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101869500|NCT01076439|Histamine Antagonists|histamine antagonists|mesh-ancestor
101869501|NCT01076439|Histamine Agents|histamine agents|mesh-ancestor
101869502|NCT01076439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101869503|NCT01076439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869504|NCT03965637|Ascorbic Acid|ascorbic acid|mesh-list
101869506|NCT03965637|Micronutrients|micronutrients|mesh-ancestor
101869507|NCT03965637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869508|NCT03965637|Antioxidants|antioxidants|mesh-ancestor
101869509|NCT03965637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869510|NCT03965637|Protective Agents|protective agents|mesh-ancestor
101869511|NCT01078779|Chloroquine|chloroquine|mesh-list
101869512|NCT01078779|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
101869513|NCT01078779|Amebicides|amebicides|mesh-ancestor
101869514|NCT01078779|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101869515|NCT01078779|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101869516|NCT01078779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101869517|NCT01078779|Antimalarials|antimalarials|mesh-ancestor
101869518|NCT01078779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101869519|NCT01078779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101869520|NCT01078779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101869521|NCT01078779|Analgesics|analgesics|mesh-ancestor
101869522|NCT01078779|Sensory System Agents|sensory system agents|mesh-ancestor
101869523|NCT01078779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101869524|NCT01078779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869525|NCT01078779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101869526|NCT01078779|Filaricides|filaricides|mesh-ancestor
101869527|NCT01078779|Antinematodal Agents|antinematodal agents|mesh-ancestor
101589365|NCT00894166|Dopamine Agents|dopamine agents|mesh-ancestor
101869528|NCT01078779|Anthelmintics|anthelmintics|mesh-ancestor
101869529|NCT00114231|Capecitabine|capecitabine|mesh-list
101869530|NCT00114231|Oxaliplatin|oxaliplatin|mesh-list
101869531|NCT00114231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101869532|NCT00114231|Antimetabolites|antimetabolites|mesh-ancestor
101869533|NCT00114231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869534|NCT00114231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101869535|NCT00113919|Busulfan|busulfan|mesh-list
101869536|NCT00113919|Alkylating Agents|alkylating agents|mesh-ancestor
101869537|NCT00113919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869538|NCT00113919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101869539|NCT00113919|Immunologic Factors|immunologic factors|mesh-ancestor
101869540|NCT00113919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869541|NCT00113919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101869542|NCT00113919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101869543|NCT00113919|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101869545|NCT00113841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101869546|NCT00113841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101869547|NCT00113841|Analgesics|analgesics|mesh-ancestor
101869548|NCT00113841|Sensory System Agents|sensory system agents|mesh-ancestor
101869549|NCT00113841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101869550|NCT00113841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869551|NCT00113841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101869552|NCT00113841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101869553|NCT00113841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101869554|NCT00113841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101869555|NCT00113841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869556|NCT00113607|Dexamethasone|dexamethasone|mesh-list
101869557|NCT00113607|Trabectedin|trabectedin|mesh-list
101869558|NCT00113607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101869559|NCT00113607|Antiemetics|antiemetics|mesh-ancestor
101869560|NCT00113607|Autonomic Agents|autonomic agents|mesh-ancestor
101869561|NCT00113607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101869562|NCT00113607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869563|NCT00113607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101869564|NCT00113607|Glucocorticoids|glucocorticoids|mesh-ancestor
101869565|NCT00113607|Hormones|hormones|mesh-ancestor
101869566|NCT00113607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101869567|NCT00113607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101869568|NCT00113607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101869569|NCT00113607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101869570|NCT00113607|Alkylating Agents|alkylating agents|mesh-ancestor
101869571|NCT00113607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869572|NCT00113529|Sunitinib|sunitinib|mesh-list
101869573|NCT00113529|Gefitinib|gefitinib|mesh-list
101869574|NCT00113529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101245348|NCT01658878|Nivolumab|nivolumab|mesh-list
101869575|NCT00113529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101869576|NCT00113529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101869577|NCT00113529|Growth Substances|growth substances|mesh-ancestor
101869578|NCT00113529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869579|NCT00113529|Growth Inhibitors|growth inhibitors|mesh-ancestor
101869580|NCT00113529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101869581|NCT00113529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101869582|NCT00113529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869583|NCT01079013|Treosulfan|treosulfan|mesh-list
101869584|NCT01079013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101869585|NCT01079013|Alkylating Agents|alkylating agents|mesh-ancestor
101869586|NCT01079013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869587|NCT01079013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101869588|NCT00134901|Memantine|memantine|mesh-list
101869589|NCT00134901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101869590|NCT00134901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101869591|NCT00134901|Dopamine Agents|dopamine agents|mesh-ancestor
101869592|NCT00134901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101869593|NCT00134901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869594|NCT00134901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869595|NCT00134901|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101869596|NCT00134901|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101869597|NCT01076595|Interferons|interferons|mesh-list
101869598|NCT01076595|Interferon-beta|interferon-beta|mesh-list
101869599|NCT01076595|Interferon beta-1b|interferon beta-1b|mesh-list
101869600|NCT01076595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101589434|NCT01163747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101869601|NCT01076595|Antiviral Agents|antiviral agents|mesh-ancestor
101869602|NCT01076595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101869603|NCT01076595|Immunologic Factors|immunologic factors|mesh-ancestor
101869604|NCT01076595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869605|NCT01076595|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101869606|NCT00113373|Lapatinib|lapatinib|mesh-list
101869607|NCT00113373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101869608|NCT00113373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101869609|NCT00113373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101869610|NCT00113373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869611|NCT00113295|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101869613|NCT00113295|Antidepressive Agents|antidepressive agents|mesh-ancestor
101869614|NCT00113295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101869615|NCT00113295|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101869616|NCT00113295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101869617|NCT00113295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101869618|NCT00113295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869619|NCT00113295|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101869620|NCT00113295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101869621|NCT00113295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101869622|NCT00113295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869623|NCT00113295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101869625|NCT00113295|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101869626|NCT00113295|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101869627|NCT00113295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101869628|NCT00113295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101869629|NCT00112905|Sorafenib|sorafenib|mesh-list
101869630|NCT00112905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101869631|NCT00112905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101869632|NCT00112905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101869633|NCT00112905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869634|NCT00427895|Vaccines|vaccines|mesh-list
101869635|NCT00427895|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101869636|NCT00427895|Immunologic Factors|immunologic factors|mesh-ancestor
101869637|NCT00427895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869638|NCT01034189|Paclitaxel|paclitaxel|mesh-list
101869639|NCT01034189|Cetuximab|cetuximab|mesh-list
101869640|NCT01034189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101869641|NCT01034189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101869642|NCT01034189|Tubulin Modulators|tubulin modulators|mesh-ancestor
101869643|NCT01034189|Antimitotic Agents|antimitotic agents|mesh-ancestor
101869644|NCT01034189|Mitosis Modulators|mitosis modulators|mesh-ancestor
101869645|NCT01034189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869646|NCT01034189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101869647|NCT00425945|Pycnogenols|pycnogenols|mesh-list
101869648|NCT00425945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101869649|NCT00425945|Immunologic Factors|immunologic factors|mesh-ancestor
101869650|NCT00425945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869651|NCT00425945|Antioxidants|antioxidants|mesh-ancestor
101869652|NCT00425945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869653|NCT00425945|Protective Agents|protective agents|mesh-ancestor
101869654|NCT00425945|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101869655|NCT00121641|Metformin|metformin|mesh-list
101869656|NCT00121641|Saxagliptin|saxagliptin|mesh-list
101869657|NCT00121641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101869658|NCT00121641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869659|NCT00121641|Incretins|incretins|mesh-ancestor
101869660|NCT00121641|Hormones|hormones|mesh-ancestor
101869661|NCT00121641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101869662|NCT00121641|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101869663|NCT00121641|Protease Inhibitors|protease inhibitors|mesh-ancestor
101869664|NCT00121641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101869665|NCT00121641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869666|NCT00425555|Panobinostat|panobinostat|mesh-list
101869667|NCT00425555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101869668|NCT00425555|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101869669|NCT00425555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101869670|NCT00425555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869671|NCT00424775|Vorinostat|vorinostat|mesh-list
101869672|NCT00424775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101869673|NCT00424775|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101869675|NCT00424775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869676|NCT01034345|Sirolimus|sirolimus|mesh-list
101869677|NCT01034345|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
101869678|NCT01034345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101869679|NCT01034345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101869680|NCT01034345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101869681|NCT01034345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101869682|NCT01034345|Antifungal Agents|antifungal agents|mesh-ancestor
101869683|NCT01034345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101869684|NCT01034345|Immunologic Factors|immunologic factors|mesh-ancestor
101869685|NCT01034345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869686|NCT01034345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101869687|NCT01034345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869688|NCT01763866|Atorvastatin|atorvastatin|mesh-list
101869689|NCT01763866|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101869690|NCT01763866|Simvastatin|simvastatin|mesh-list
101869691|NCT01763866|Ezetimibe|ezetimibe|mesh-list
101869692|NCT01763866|Evolocumab|evolocumab|mesh-list
101869693|NCT01763866|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101869694|NCT01763866|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101869695|NCT01763866|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101869696|NCT01763866|Antimetabolites|antimetabolites|mesh-ancestor
101869697|NCT01763866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869698|NCT01763866|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101869699|NCT01763866|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101869700|NCT01763866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101869701|NCT01763866|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101869702|NCT01763866|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101869703|NCT01763866|Protease Inhibitors|protease inhibitors|mesh-ancestor
101869704|NCT01763866|Immunologic Factors|immunologic factors|mesh-ancestor
101869705|NCT01763866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869706|NCT00132873|Sodium Oxybate|sodium oxybate|mesh-list
101869707|NCT00132873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101869708|NCT00132873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101869709|NCT00132873|Anesthetics, General|anesthetics, general|mesh-ancestor
101869710|NCT00132873|Anesthetics|anesthetics|mesh-ancestor
101869711|NCT00132873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101869712|NCT00132873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869713|NCT01588925|Dexamethasone|dexamethasone|mesh-list
101869714|NCT01588925|Dexamethasone acetate|dexamethasone acetate|mesh-list
101869715|NCT01588925|BB 1101|bb 1101|mesh-list
101869716|NCT01588925|Hyaluronic Acid|hyaluronic acid|mesh-list
101869717|NCT01588925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101869718|NCT01588925|Antiemetics|antiemetics|mesh-ancestor
101869719|NCT01588925|Autonomic Agents|autonomic agents|mesh-ancestor
101869720|NCT01588925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101869721|NCT01588925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869722|NCT01588925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101869723|NCT01588925|Glucocorticoids|glucocorticoids|mesh-ancestor
101869724|NCT01588925|Hormones|hormones|mesh-ancestor
101869725|NCT01588925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101869727|NCT01588925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101869728|NCT01588925|Protease Inhibitors|protease inhibitors|mesh-ancestor
101869729|NCT01588925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101869730|NCT01588925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869731|NCT01588925|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101869732|NCT01588925|Immunologic Factors|immunologic factors|mesh-ancestor
101869733|NCT01588925|Viscosupplements|viscosupplements|mesh-ancestor
101869734|NCT01588925|Protective Agents|protective agents|mesh-ancestor
101869735|NCT01238146|Rituximab|rituximab|mesh-list
101869736|NCT01238146|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101869737|NCT01238146|Obatoclax|obatoclax|mesh-list
101869738|NCT01238146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101869739|NCT01238146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101869740|NCT01238146|Immunologic Factors|immunologic factors|mesh-ancestor
101869741|NCT01238146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869742|NCT01238146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101869743|NCT01238146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101869744|NCT01238146|Alkylating Agents|alkylating agents|mesh-ancestor
101869745|NCT01238146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869746|NCT01238146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101869747|NCT01141894|Phenylephrine|phenylephrine|mesh-list
101869748|NCT01141894|Dobutamine|dobutamine|mesh-list
101869749|NCT01141894|Oxymetazoline|oxymetazoline|mesh-list
101869750|NCT01141894|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
101869751|NCT01141894|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101869752|NCT01141894|Mydriatics|mydriatics|mesh-ancestor
101869753|NCT01141894|Autonomic Agents|autonomic agents|mesh-ancestor
101869754|NCT01141894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101869755|NCT01141894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869757|NCT01141894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101869758|NCT01141894|Nasal Decongestants|nasal decongestants|mesh-ancestor
101869759|NCT01141894|Respiratory System Agents|respiratory system agents|mesh-ancestor
101869760|NCT01141894|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101869761|NCT01141894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101869762|NCT01141894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101869763|NCT01141894|Adrenergic Agents|adrenergic agents|mesh-ancestor
101869764|NCT01141894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101869765|NCT01141894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869766|NCT01141894|Protective Agents|protective agents|mesh-ancestor
101869767|NCT01141894|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101869768|NCT01141894|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101869769|NCT01141894|Plasma Substitutes|plasma substitutes|mesh-ancestor
101869770|NCT01141894|Blood Substitutes|blood substitutes|mesh-ancestor
101869771|NCT01238224|Tadalafil|tadalafil|mesh-list
101869772|NCT01238224|Vasodilator Agents|vasodilator agents|mesh-ancestor
101869773|NCT01238224|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101869774|NCT01238224|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101869775|NCT01238224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101869776|NCT01238224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869777|NCT01238224|Urological Agents|urological agents|mesh-ancestor
101869778|NCT01237444|Ritonavir|ritonavir|mesh-list
101869779|NCT01237444|Lopinavir|lopinavir|mesh-list
101869780|NCT01237444|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101869781|NCT01237444|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101869782|NCT01237444|Protease Inhibitors|protease inhibitors|mesh-ancestor
101869783|NCT01237444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101869784|NCT01237444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869785|NCT01237444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101869786|NCT01237444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101869787|NCT01237444|Antiviral Agents|antiviral agents|mesh-ancestor
101869788|NCT01237444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101869789|NCT01237444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101869790|NCT01237444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101869791|NCT01145170|Nimotuzumab|nimotuzumab|mesh-list
101869792|NCT01145170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101869793|NCT01145170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101869795|NCT01141972|Vitamins|vitamins|mesh-ancestor
101869796|NCT01141972|Micronutrients|micronutrients|mesh-ancestor
101869797|NCT01141972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869798|NCT01141972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101869799|NCT04316806|Rifaximin|rifaximin|mesh-list
101869800|NCT04316806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101869801|NCT04316806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101869802|NCT04316806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101869803|NCT01145326|Lidocaine|lidocaine|mesh-list
101869804|NCT01145326|Anesthetics, Local|anesthetics, local|mesh-ancestor
101869805|NCT01145326|Anesthetics|anesthetics|mesh-ancestor
101869806|NCT01145326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101869807|NCT01145326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869808|NCT01145326|Sensory System Agents|sensory system agents|mesh-ancestor
101869809|NCT01145326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101869810|NCT01145326|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101869811|NCT01145326|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101869812|NCT01145326|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101869813|NCT01145326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101869814|NCT01145326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869815|NCT01144702|Artesunate|artesunate|mesh-list
101869816|NCT01144702|Mefloquine|mefloquine|mesh-list
101869817|NCT01144702|Antimalarials|antimalarials|mesh-ancestor
101869818|NCT01144702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101869819|NCT01144702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101869820|NCT01144702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101869821|NCT01144702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101869822|NCT01144702|Antiviral Agents|antiviral agents|mesh-ancestor
101869823|NCT01144702|Schistosomicides|schistosomicides|mesh-ancestor
101869824|NCT01144702|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101869825|NCT01144702|Anthelmintics|anthelmintics|mesh-ancestor
101869826|NCT01145404|Capecitabine|capecitabine|mesh-list
101869827|NCT01145404|Lapatinib|lapatinib|mesh-list
101688413|NCT02665806|Glucocorticoids|glucocorticoids|mesh-ancestor
101869828|NCT01145404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101869829|NCT01145404|Antimetabolites|antimetabolites|mesh-ancestor
101245409|NCT01659099|Glucocorticoids|glucocorticoids|mesh-ancestor
101869830|NCT01145404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869831|NCT01145404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101869832|NCT01145404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101869833|NCT01145404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101869834|NCT01237522|Metformin|metformin|mesh-list
101869835|NCT01237522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101869836|NCT01237522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869837|NCT01235416|Motesanib diphosphate|motesanib diphosphate|mesh-list
101869838|NCT01235416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101869839|NCT01235416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101869840|NCT01235416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869841|NCT04246996|Gentamicins|gentamicins|mesh-list
101869842|NCT04246996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101869843|NCT04246996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101869844|NCT04246996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101869845|NCT04246996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101869846|NCT04246996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869847|NCT00424463|Edaravone|edaravone|mesh-list
101869848|NCT00424463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101869849|NCT00424463|Antioxidants|antioxidants|mesh-ancestor
101869850|NCT00424463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869851|NCT00424463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101869852|NCT00424463|Protective Agents|protective agents|mesh-ancestor
101869853|NCT00424463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869854|NCT01324115|Nitroarginine|nitroarginine|mesh-list
101869855|NCT01324115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101869856|NCT01324115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869857|NCT01037621|Valacyclovir|valacyclovir|mesh-list
101869858|NCT01037621|Antiviral Agents|antiviral agents|mesh-ancestor
101869859|NCT01037621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101869860|NCT00424385|Sorafenib|sorafenib|mesh-list
101869861|NCT00424385|Imatinib Mesylate|imatinib mesylate|mesh-list
101869862|NCT00424385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101869863|NCT00424385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101869864|NCT00424385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101869865|NCT00424385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869866|NCT03994055|Antioxidants|antioxidants|mesh-list
101869867|NCT03994055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869868|NCT03994055|Protective Agents|protective agents|mesh-ancestor
101869869|NCT03994055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869870|NCT01037699|Hormones|hormones|mesh-list
101869871|NCT01037699|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101869872|NCT01037699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101869873|NCT01037699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869874|NCT00423917|Bevacizumab|bevacizumab|mesh-list
101869875|NCT00423917|Fulvestrant|fulvestrant|mesh-list
101869876|NCT00423917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101869877|NCT00423917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101869878|NCT00423917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101869879|NCT00423917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101869880|NCT00423917|Growth Substances|growth substances|mesh-ancestor
101869881|NCT00423917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869882|NCT00423917|Growth Inhibitors|growth inhibitors|mesh-ancestor
101869883|NCT00423917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101245414|NCT01659099|Tubulin Modulators|tubulin modulators|mesh-ancestor
101869884|NCT00423917|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101869885|NCT00423917|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101869886|NCT00423917|Hormone Antagonists|hormone antagonists|mesh-ancestor
101869887|NCT00423917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101869888|NCT00845026|Olanzapine|olanzapine|mesh-list
101869889|NCT00845026|Risperidone|risperidone|mesh-list
101869890|NCT00845026|Aripiprazole|aripiprazole|mesh-list
101869891|NCT00845026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101869892|NCT00845026|Serotonin Agents|serotonin agents|mesh-ancestor
101869893|NCT00845026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101869894|NCT00845026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869895|NCT00845026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869896|NCT00845026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101869897|NCT00845026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101869898|NCT00845026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101589742|NCT02832778|Tenofovir|tenofovir|mesh-list
101869899|NCT00845026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101869900|NCT00845026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101869901|NCT00845026|Dopamine Agents|dopamine agents|mesh-ancestor
101869902|NCT00845026|Antiemetics|antiemetics|mesh-ancestor
101869903|NCT00845026|Autonomic Agents|autonomic agents|mesh-ancestor
101869904|NCT00845026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101869905|NCT00845026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101869906|NCT00845026|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101869907|NCT00845026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101869908|NCT00845026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101869909|NCT00845026|Antidepressive Agents|antidepressive agents|mesh-ancestor
101869910|NCT00845026|Dopamine Agonists|dopamine agonists|mesh-ancestor
101869911|NCT00845026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101869912|NCT00845026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101869913|NCT00845026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101869914|NCT00845026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101869915|NCT02445131|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101869916|NCT02445131|Obinutuzumab|obinutuzumab|mesh-list
101869918|NCT02445131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101869919|NCT02445131|Alkylating Agents|alkylating agents|mesh-ancestor
101869920|NCT02445131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869921|NCT02445131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101869922|NCT02445131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101869923|NCT02445131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101869924|NCT00003838|Cyclosporine|cyclosporine|mesh-list
101869925|NCT00003838|Methotrexate|methotrexate|mesh-list
101869926|NCT00003838|Cyclosporins|cyclosporins|mesh-list
101869927|NCT00003838|Lenograstim|lenograstim|mesh-list
101869928|NCT00003838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101869929|NCT00003838|Abortifacient Agents|abortifacient agents|mesh-ancestor
101869930|NCT00003838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101869931|NCT00003838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869932|NCT00003838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101869933|NCT00003838|Antimetabolites|antimetabolites|mesh-ancestor
101869934|NCT00003838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869935|NCT00003838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101869936|NCT00003838|Dermatologic Agents|dermatologic agents|mesh-ancestor
101869937|NCT00003838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101869938|NCT00003838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101869939|NCT00003838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101869940|NCT00003838|Immunologic Factors|immunologic factors|mesh-ancestor
101869941|NCT00003838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101869942|NCT00003838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101869943|NCT00003838|Antifungal Agents|antifungal agents|mesh-ancestor
101869944|NCT00003838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101869945|NCT00003838|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101869946|NCT00003838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101869947|NCT01238770|Cyclophosphamide|cyclophosphamide|mesh-list
101869948|NCT01238770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101869949|NCT01238770|Immunologic Factors|immunologic factors|mesh-ancestor
101869950|NCT01238770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869951|NCT01238770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101869952|NCT01238770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101869953|NCT01238770|Alkylating Agents|alkylating agents|mesh-ancestor
101869954|NCT01238770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869955|NCT01238770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101869956|NCT01238770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101869957|NCT01145950|Etanercept|etanercept|mesh-list
101869958|NCT01145950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101869959|NCT01145950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101869960|NCT01145950|Analgesics|analgesics|mesh-ancestor
101869961|NCT01145950|Sensory System Agents|sensory system agents|mesh-ancestor
101869962|NCT01145950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101869963|NCT01145950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869964|NCT01145950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101869965|NCT01145950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101869966|NCT01145950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101869967|NCT01145950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101869968|NCT01145950|Immunologic Factors|immunologic factors|mesh-ancestor
101869970|NCT01238926|Folic Acid|folic acid|mesh-list
101869971|NCT01238926|Hydroxocobalamin|hydroxocobalamin|mesh-list
101869972|NCT01238926|Vitamin B 12|vitamin b 12|mesh-list
101589811|NCT02828566|Anesthetics|anesthetics|mesh-ancestor
101869973|NCT01238926|Vitamin B 6|vitamin b 6|mesh-list
101869974|NCT01238926|Pyridoxal|pyridoxal|mesh-list
101869975|NCT01238926|Pyridoxine|pyridoxine|mesh-list
101869976|NCT01238926|Vitamin B Complex|vitamin b complex|mesh-list
101869977|NCT01238926|Micronutrients|micronutrients|mesh-ancestor
101869978|NCT01238926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869979|NCT01238926|Hematinics|hematinics|mesh-ancestor
101869980|NCT01239004|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
101869981|NCT01239004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101869982|NCT01239004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101869983|NCT01239004|Antimetabolites|antimetabolites|mesh-ancestor
101869984|NCT01239004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101869985|NCT01239004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101869986|NCT01142518|Interferons|interferons|mesh-list
101869987|NCT01142518|Interferon-beta|interferon-beta|mesh-list
101869988|NCT01142518|Interferon beta-1a|interferon beta-1a|mesh-list
101869989|NCT01142518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101869990|NCT01142518|Antiviral Agents|antiviral agents|mesh-ancestor
101869991|NCT01142518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101869992|NCT01142518|Immunologic Factors|immunologic factors|mesh-ancestor
101869993|NCT01142518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101869994|NCT01142518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101869995|NCT00423449|Gemcitabine|gemcitabine|mesh-list
101869996|NCT00423449|Vorinostat|vorinostat|mesh-list
101869997|NCT00423449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101869998|NCT00423449|Antimetabolites|antimetabolites|mesh-ancestor
101869999|NCT00423449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870000|NCT00423449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101870001|NCT00423449|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101870002|NCT00423449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101870003|NCT00423293|Fluorouracil|fluorouracil|mesh-list
101870004|NCT00423293|Mitomycins|mitomycins|mesh-list
101870005|NCT00423293|Mitomycin|mitomycin|mesh-list
101870006|NCT00423293|Antimetabolites|antimetabolites|mesh-ancestor
101870007|NCT00423293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870008|NCT00423293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101870009|NCT00423293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101870010|NCT00423293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101870011|NCT00423293|Immunologic Factors|immunologic factors|mesh-ancestor
101870012|NCT00423293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870013|NCT00423293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101870014|NCT00423293|Alkylating Agents|alkylating agents|mesh-ancestor
101870015|NCT00423293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101870016|NCT00423293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101870017|NCT00422903|Letrozole|letrozole|mesh-list
101870018|NCT00422903|Lapatinib|lapatinib|mesh-list
101870019|NCT00422903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101870020|NCT00422903|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101870021|NCT00422903|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101870022|NCT00422903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101870023|NCT00422903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870024|NCT00422903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101870025|NCT00422903|Hormone Antagonists|hormone antagonists|mesh-ancestor
101870026|NCT00422903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101870027|NCT00422903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870028|NCT00422903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101870029|NCT00422591|Cytarabine|cytarabine|mesh-list
101870030|NCT00422591|Idarubicin|idarubicin|mesh-list
101870031|NCT00422591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101870032|NCT00422591|Antimetabolites|antimetabolites|mesh-ancestor
101870033|NCT00422591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870034|NCT00422591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101870035|NCT00422591|Antiviral Agents|antiviral agents|mesh-ancestor
101870036|NCT00422591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101870037|NCT00422591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101870038|NCT00422591|Immunologic Factors|immunologic factors|mesh-ancestor
101870039|NCT00422591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870040|NCT00422591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101870041|NCT00422591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101870042|NCT00422591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101870043|NCT00422591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101870044|NCT00422513|Epoetin Alfa|epoetin alfa|mesh-list
101870045|NCT00422513|Hematinics|hematinics|mesh-ancestor
101870046|NCT00202878|Simvastatin|simvastatin|mesh-list
101589880|NCT00889720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870047|NCT00202878|Ezetimibe|ezetimibe|mesh-list
101870048|NCT00202878|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
101870049|NCT00202878|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101870050|NCT00202878|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101870051|NCT00202878|Antimetabolites|antimetabolites|mesh-ancestor
101870052|NCT00202878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870053|NCT00202878|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101870054|NCT00202878|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101870055|NCT00202878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101870056|NCT00414011|Moxifloxacin|moxifloxacin|mesh-list
101870057|NCT00414011|Gatifloxacin|gatifloxacin|mesh-list
101870058|NCT00414011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101870059|NCT00414011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101870060|NCT00414011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101870061|NCT00414011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101870062|NCT00414011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101870063|NCT00414011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870064|NCT00414011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101870065|NCT00414011|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101870066|NCT00414011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101870067|NCT00260208|Cyclosporine|cyclosporine|mesh-list
101870068|NCT00260208|Tacrolimus|tacrolimus|mesh-list
101870069|NCT00260208|Cyclosporins|cyclosporins|mesh-list
101870070|NCT00260208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101870071|NCT00260208|Immunologic Factors|immunologic factors|mesh-ancestor
101870072|NCT00260208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870073|NCT00260208|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101870074|NCT00260208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101870075|NCT00260208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870076|NCT00260208|Antifungal Agents|antifungal agents|mesh-ancestor
101870077|NCT00260208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101870078|NCT00260208|Dermatologic Agents|dermatologic agents|mesh-ancestor
101870079|NCT00260208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101870080|NCT00202644|Hydroxyurea|hydroxyurea|mesh-list
101870081|NCT00202644|Anagrelide|anagrelide|mesh-list
101870082|NCT00202644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101870083|NCT00202644|Antisickling Agents|antisickling agents|mesh-ancestor
101870084|NCT00202644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101870085|NCT00202644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870086|NCT00202644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101870087|NCT00202644|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101870088|NCT00202644|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101870089|NCT00202644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101870090|NCT00259740|Denosumab|denosumab|mesh-list
101870091|NCT00259740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101870092|NCT00259740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870093|NCT01073202|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101870094|NCT01073202|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101870095|NCT01073202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101870096|NCT01236040|Vaccines|vaccines|mesh-list
101870097|NCT01236040|Immunologic Factors|immunologic factors|mesh-ancestor
101870098|NCT01236040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870099|NCT03812224|Erenumab|erenumab|mesh-list
101870100|NCT03812224|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
101870101|NCT03812224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870102|NCT03812224|Analgesics|analgesics|mesh-ancestor
101870103|NCT03812224|Sensory System Agents|sensory system agents|mesh-ancestor
101870104|NCT03812224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101870105|NCT03812224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870106|NCT01146028|Tizanidine|tizanidine|mesh-list
101870107|NCT01146028|Analgesics|analgesics|mesh-ancestor
101870108|NCT01146028|Sensory System Agents|sensory system agents|mesh-ancestor
101870109|NCT01146028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101870110|NCT01146028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870111|NCT01146028|Anticonvulsants|anticonvulsants|mesh-ancestor
101870112|NCT01146028|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101870113|NCT01146028|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101870114|NCT01146028|Parasympatholytics|parasympatholytics|mesh-ancestor
101870115|NCT01146028|Autonomic Agents|autonomic agents|mesh-ancestor
101870116|NCT01146028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101870117|NCT01146028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101245486|NCT01659372|Naproxen|naproxen|mesh-list
101870119|NCT01146028|Adrenergic Agents|adrenergic agents|mesh-ancestor
101870120|NCT01146028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101870121|NCT01146028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870122|NCT03530800|Dronabinol|dronabinol|mesh-list
101589955|NCT00596947|Prednisone|prednisone|mesh-list
101870124|NCT03530800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966423|NCT01071850|Metformin|metformin|mesh-list
101870126|NCT03530800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101870127|NCT03530800|Analgesics|analgesics|mesh-ancestor
101870128|NCT03530800|Sensory System Agents|sensory system agents|mesh-ancestor
101870129|NCT03530800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101870130|NCT03530800|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101870131|NCT03530800|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101870132|NCT03530800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101870133|NCT03530800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870134|NCT03530800|Hormones|hormones|mesh-ancestor
101870135|NCT03530800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101870136|NCT04982146|Acetylcysteine|acetylcysteine|mesh-list
101870137|NCT04982146|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101870138|NCT04982146|Antiviral Agents|antiviral agents|mesh-ancestor
101870139|NCT04982146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101870140|NCT04982146|Expectorants|expectorants|mesh-ancestor
101870141|NCT04982146|Respiratory System Agents|respiratory system agents|mesh-ancestor
101870142|NCT04982146|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101870143|NCT04982146|Antioxidants|antioxidants|mesh-ancestor
101870144|NCT04982146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870145|NCT04982146|Protective Agents|protective agents|mesh-ancestor
101870146|NCT04982146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870147|NCT04982146|Antidotes|antidotes|mesh-ancestor
101870148|NCT04958746|Propofol|propofol|mesh-list
101870149|NCT04958746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101870150|NCT04958746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101870151|NCT04958746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870152|NCT04958746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101870153|NCT04958746|Anesthetics, General|anesthetics, general|mesh-ancestor
101870154|NCT04958746|Anesthetics|anesthetics|mesh-ancestor
101870155|NCT01146106|Pravastatin|pravastatin|mesh-list
101870156|NCT01146106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101870157|NCT01146106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101870158|NCT01146106|Antimetabolites|antimetabolites|mesh-ancestor
101870159|NCT01146106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870160|NCT01146106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101870161|NCT01146106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101870162|NCT01146106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101870163|NCT03431584|Hyaluronic Acid|hyaluronic acid|mesh-list
101870164|NCT03431584|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101870165|NCT03431584|Immunologic Factors|immunologic factors|mesh-ancestor
101870166|NCT03431584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870167|NCT03431584|Viscosupplements|viscosupplements|mesh-ancestor
101870168|NCT03431584|Protective Agents|protective agents|mesh-ancestor
101870169|NCT00259272|Olanzapine|olanzapine|mesh-list
101870170|NCT00259272|Antiemetics|antiemetics|mesh-ancestor
101870171|NCT00259272|Autonomic Agents|autonomic agents|mesh-ancestor
101870172|NCT00259272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101870173|NCT00259272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870174|NCT00259272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101870175|NCT00259272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101870176|NCT00259272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101870177|NCT00259272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101870178|NCT00259272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101870179|NCT00259272|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101870180|NCT00259272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101870181|NCT00259272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101870182|NCT00259272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870183|NCT00259272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101870184|NCT00259272|Serotonin Agents|serotonin agents|mesh-ancestor
101870185|NCT03106324|Lenalidomide|lenalidomide|mesh-list
101870186|NCT03106324|Immunologic Factors|immunologic factors|mesh-ancestor
101870187|NCT03106324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870189|NCT03106324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101870190|NCT03106324|Growth Substances|growth substances|mesh-ancestor
101870191|NCT03106324|Growth Inhibitors|growth inhibitors|mesh-ancestor
101870192|NCT03106324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101870193|NCT01147276|Vildagliptin|vildagliptin|mesh-list
101870194|NCT01147276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101870195|NCT01147276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590030|NCT02826070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101870196|NCT01147276|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101870197|NCT01147276|Protease Inhibitors|protease inhibitors|mesh-ancestor
101870198|NCT01147276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101870199|NCT01147276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870200|NCT01239940|Paclitaxel|paclitaxel|mesh-list
101870201|NCT01239940|Everolimus|everolimus|mesh-list
101870202|NCT01239940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101870203|NCT01239940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101870204|NCT01239940|Tubulin Modulators|tubulin modulators|mesh-ancestor
101870205|NCT01239940|Antimitotic Agents|antimitotic agents|mesh-ancestor
101870206|NCT01239940|Mitosis Modulators|mitosis modulators|mesh-ancestor
101870207|NCT01239940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870208|NCT01239940|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101870209|NCT01239940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101870210|NCT01239940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101870211|NCT01239940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101870212|NCT01239940|Immunologic Factors|immunologic factors|mesh-ancestor
101870213|NCT01239940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870214|NCT02526004|Tobramycin|tobramycin|mesh-list
101870215|NCT02526004|Ceftazidime|ceftazidime|mesh-list
101870216|NCT02526004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101870217|NCT02526004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101870218|NCT00421889|Paclitaxel|paclitaxel|mesh-list
101870219|NCT00421889|Carboplatin|carboplatin|mesh-list
101870220|NCT00421889|Belinostat|belinostat|mesh-list
101870221|NCT00421889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101870222|NCT00421889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101870223|NCT00421889|Tubulin Modulators|tubulin modulators|mesh-ancestor
101870224|NCT00421889|Antimitotic Agents|antimitotic agents|mesh-ancestor
101870225|NCT00421889|Mitosis Modulators|mitosis modulators|mesh-ancestor
101870226|NCT00421889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870227|NCT00421889|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101870228|NCT00421889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101870229|NCT03913468|Ascorbic Acid|ascorbic acid|mesh-list
101870230|NCT03913468|Antioxidants|antioxidants|mesh-ancestor
101870231|NCT03913468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870232|NCT03913468|Protective Agents|protective agents|mesh-ancestor
101870233|NCT03913468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870234|NCT03913468|Vitamins|vitamins|mesh-ancestor
101870235|NCT03913468|Micronutrients|micronutrients|mesh-ancestor
101870236|NCT01147354|Selenium|selenium|mesh-list
101870237|NCT01147354|Antioxidants|antioxidants|mesh-ancestor
101870238|NCT01147354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870239|NCT01147354|Protective Agents|protective agents|mesh-ancestor
101870240|NCT01147354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870241|NCT01147354|Trace Elements|trace elements|mesh-ancestor
101870242|NCT01147354|Micronutrients|micronutrients|mesh-ancestor
101870243|NCT04744480|Anesthetics|anesthetics|mesh-list
101870244|NCT04744480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101870245|NCT04744480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870246|NCT01147432|Capsaicin|capsaicin|mesh-list
101870247|NCT01147432|Antipruritics|antipruritics|mesh-ancestor
101870248|NCT01147432|Dermatologic Agents|dermatologic agents|mesh-ancestor
101870249|NCT01147432|Sensory System Agents|sensory system agents|mesh-ancestor
101870250|NCT01147432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101870251|NCT01147432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870252|NCT01147510|Montelukast|montelukast|mesh-list
101870253|NCT01147510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101870254|NCT01147510|Respiratory System Agents|respiratory system agents|mesh-ancestor
101870255|NCT01147510|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101870256|NCT01147510|Hormone Antagonists|hormone antagonists|mesh-ancestor
101870257|NCT01147510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101870258|NCT01147510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870259|NCT01147510|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101870260|NCT01147510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101870261|NCT01147510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870262|NCT03916432|Sirolimus|sirolimus|mesh-list
101870263|NCT03916432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101870264|NCT03916432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101870265|NCT03916432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101870266|NCT03916432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101870267|NCT03916432|Antifungal Agents|antifungal agents|mesh-ancestor
101870268|NCT03916432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101870269|NCT03916432|Immunologic Factors|immunologic factors|mesh-ancestor
101870270|NCT03916432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870271|NCT00421733|Ergocalciferols|ergocalciferols|mesh-list
101870272|NCT00421733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101870273|NCT00421733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870274|NCT00421733|Vitamins|vitamins|mesh-ancestor
101870275|NCT00421733|Micronutrients|micronutrients|mesh-ancestor
101870276|NCT00421733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101870277|NCT00421343|Cholecalciferol|cholecalciferol|mesh-list
101870278|NCT00421343|Vitamin D|vitamin d|mesh-list
101870279|NCT00421343|Alendronate|alendronate|mesh-list
101870280|NCT00421343|Calcium Carbonate|calcium carbonate|mesh-list
101870281|NCT00421343|Calcium|calcium|mesh-list
101870282|NCT00421343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101870283|NCT00421343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870284|NCT00421343|Vitamins|vitamins|mesh-ancestor
101870285|NCT00421343|Micronutrients|micronutrients|mesh-ancestor
101870286|NCT00421343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101870287|NCT00421343|Antacids|antacids|mesh-ancestor
101870288|NCT00421343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870289|NCT00421343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101870290|NCT01147588|Esomeprazole|esomeprazole|mesh-list
101870291|NCT01147588|Omeprazole|omeprazole|mesh-list
101870292|NCT01147588|Lansoprazole|lansoprazole|mesh-list
101870293|NCT01147588|Dexlansoprazole|dexlansoprazole|mesh-list
101870294|NCT01147588|Clopidogrel|clopidogrel|mesh-list
101870295|NCT01147588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101870296|NCT01147588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101870297|NCT01147588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101870298|NCT01147588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101870299|NCT01147588|Purinergic Agents|purinergic agents|mesh-ancestor
101870300|NCT01147588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101870301|NCT01147588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870302|NCT01147588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870303|NCT01147588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101870304|NCT01147588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101870305|NCT01147588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101870306|NCT01147588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101870307|NCT03908242|Salvianolic acid A|salvianolic acid a|mesh-list
101870308|NCT03908242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101870309|NCT03908242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101870310|NCT03908242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870311|NCT03908242|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101870312|NCT00230178|Allopurinol|allopurinol|mesh-list
101870313|NCT00230178|Rasburicase|rasburicase|mesh-list
101870314|NCT00230178|Antimetabolites|antimetabolites|mesh-ancestor
101870315|NCT00230178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870316|NCT00230178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101870317|NCT00230178|Gout Suppressants|gout suppressants|mesh-ancestor
101870318|NCT00230178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101870319|NCT00230178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101870320|NCT00230178|Antioxidants|antioxidants|mesh-ancestor
101870321|NCT00230178|Protective Agents|protective agents|mesh-ancestor
101870322|NCT00230178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870323|NCT03908008|Botulinum Toxins|botulinum toxins|mesh-list
101870324|NCT03908008|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101870325|NCT03908008|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101870326|NCT03908008|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101870327|NCT03908008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101870328|NCT03908008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870329|NCT03908008|Cholinergic Agents|cholinergic agents|mesh-ancestor
101870330|NCT03908008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101870331|NCT03908008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870332|NCT03908008|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101870333|NCT03908008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101870335|NCT01251172|Mechlorethamine|mechlorethamine|mesh-list
101870336|NCT01251172|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
101870337|NCT01251172|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
101870338|NCT01251172|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
101870339|NCT01251172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101870340|NCT01251172|Alkylating Agents|alkylating agents|mesh-ancestor
101870341|NCT01251172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870342|NCT01251172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101870343|NCT01251172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101870344|NCT01251172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101870345|NCT01251172|Immunologic Factors|immunologic factors|mesh-ancestor
101870346|NCT01251172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870347|NCT01251172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101870348|NCT00413777|Tolvaptan|tolvaptan|mesh-list
101870349|NCT00413777|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101870350|NCT00413777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870351|NCT00413777|Natriuretic Agents|natriuretic agents|mesh-ancestor
101870352|NCT00413777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870353|NCT01250236|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101870354|NCT01250236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101870355|NCT01250236|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101870356|NCT01250236|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101870357|NCT01250236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101870358|NCT01250236|Adrenergic Agents|adrenergic agents|mesh-ancestor
101870359|NCT01250236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101870360|NCT01250236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870361|NCT01250236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870362|NCT01074060|Plerixafor|plerixafor|mesh-list
101870363|NCT01074060|Cyclophosphamide|cyclophosphamide|mesh-list
101870364|NCT01074060|Lenograstim|lenograstim|mesh-list
101870365|NCT01074060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101870366|NCT01074060|Immunologic Factors|immunologic factors|mesh-ancestor
101870367|NCT01074060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870368|NCT01074060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101870369|NCT01074060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101870370|NCT01074060|Alkylating Agents|alkylating agents|mesh-ancestor
101870371|NCT01074060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870372|NCT01074060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101870373|NCT01074060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101870374|NCT01074060|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101870375|NCT01074060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101870376|NCT01074060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101870377|NCT01074060|Antiviral Agents|antiviral agents|mesh-ancestor
101870378|NCT01074060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101870379|NCT03915340|Propafenone|propafenone|mesh-list
101870380|NCT03915340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101870381|NCT03915340|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101870382|NCT03915340|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101870383|NCT03915340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101870384|NCT03915340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870385|NCT01581918|Carbamazepine|carbamazepine|mesh-list
101870386|NCT01581918|Anticonvulsants|anticonvulsants|mesh-ancestor
101870387|NCT01581918|Antimanic Agents|antimanic agents|mesh-ancestor
101870388|NCT01581918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101870389|NCT01581918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101870390|NCT01581918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870391|NCT01581918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101870392|NCT01581918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101870393|NCT01581918|Analgesics|analgesics|mesh-ancestor
101870394|NCT01581918|Sensory System Agents|sensory system agents|mesh-ancestor
101870395|NCT01581918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101870396|NCT01581918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101870397|NCT01581918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101870398|NCT01581918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870399|NCT01581918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101870400|NCT01581918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101870401|NCT01582542|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101870402|NCT01582542|Hemostatics|hemostatics|mesh-ancestor
101870404|NCT01582542|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101870405|NCT01582542|Natriuretic Agents|natriuretic agents|mesh-ancestor
101870406|NCT01582542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870407|NCT03912766|Arginine Vasopressin|arginine vasopressin|mesh-list
101870408|NCT03912766|Hemostatics|hemostatics|mesh-ancestor
101870409|NCT03912766|Coagulants|coagulants|mesh-ancestor
101870410|NCT03912766|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101870411|NCT03912766|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101870412|NCT03912766|Natriuretic Agents|natriuretic agents|mesh-ancestor
101870413|NCT03912766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870414|NCT01251328|Anesthetics|anesthetics|mesh-list
101870415|NCT01251328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101870416|NCT01251328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870417|NCT00420641|Paroxetine|paroxetine|mesh-list
101870418|NCT00420641|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101870419|NCT00420641|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101870420|NCT00420641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101870421|NCT00420641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870422|NCT00420641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101870423|NCT00420641|Serotonin Agents|serotonin agents|mesh-ancestor
101870424|NCT00420641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870425|NCT00420641|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101870426|NCT00420641|Antidepressive Agents|antidepressive agents|mesh-ancestor
101870427|NCT00420641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101870428|NCT00420641|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101870429|NCT00420641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101870430|NCT00420641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101870431|NCT00257556|Menotropins|menotropins|mesh-list
101870432|NCT00257556|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101870433|NCT00257556|Hormones|hormones|mesh-ancestor
101870434|NCT00257556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101870435|NCT00257556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870436|NCT00257556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101870437|NCT00257556|Fertility Agents|fertility agents|mesh-ancestor
101870438|NCT00257556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101870439|NCT03906916|Micafungin|micafungin|mesh-list
101870440|NCT03906916|Antifungal Agents|antifungal agents|mesh-ancestor
101870441|NCT03906916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101870442|NCT01250470|Sargramostim|sargramostim|mesh-list
101870443|NCT01250470|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101870444|NCT01250470|Immunologic Factors|immunologic factors|mesh-ancestor
101870445|NCT01250470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870446|NCT01250470|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101870447|NCT01250548|Apremilast|apremilast|mesh-list
101870448|NCT01250548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101870449|NCT01250548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101870450|NCT01250548|Analgesics|analgesics|mesh-ancestor
101870451|NCT01250548|Sensory System Agents|sensory system agents|mesh-ancestor
101870452|NCT01250548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101870453|NCT01250548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870454|NCT01250548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101870455|NCT01250548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101870456|NCT01250548|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101870457|NCT01250548|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101245664|NCT01660399|Docetaxel|docetaxel|mesh-list
101870458|NCT01250548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101870459|NCT01250548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870460|NCT03906838|Ropivacaine|ropivacaine|mesh-list
101870461|NCT03906838|Anesthetics, Local|anesthetics, local|mesh-ancestor
101870462|NCT03906838|Anesthetics|anesthetics|mesh-ancestor
101870463|NCT03906838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101870464|NCT03906838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966458|NCT02269462|Efavirenz|efavirenz|mesh-list
101870465|NCT03906838|Sensory System Agents|sensory system agents|mesh-ancestor
101870466|NCT03906838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101870468|NCT01251484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101870469|NCT01251484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101870470|NCT01251484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101870471|NCT01251484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870472|NCT03914638|Albuterol|albuterol|mesh-list
101870473|NCT03914638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101870474|NCT03914638|Autonomic Agents|autonomic agents|mesh-ancestor
101688433|NCT04172064|Sympathomimetics|sympathomimetics|mesh-ancestor
101870475|NCT03914638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101870476|NCT03914638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870477|NCT03914638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101870478|NCT03914638|Respiratory System Agents|respiratory system agents|mesh-ancestor
101870479|NCT03914638|Tocolytic Agents|tocolytic agents|mesh-ancestor
101870480|NCT03914638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101870481|NCT03914638|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101870482|NCT03914638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101870483|NCT03914638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101870484|NCT03914638|Adrenergic Agents|adrenergic agents|mesh-ancestor
101870485|NCT03914638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101870486|NCT03914638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870487|NCT01148446|Prednisone|prednisone|mesh-list
101870488|NCT01148446|Cyclophosphamide|cyclophosphamide|mesh-list
101870489|NCT01148446|Rituximab|rituximab|mesh-list
101870490|NCT01148446|Doxorubicin|doxorubicin|mesh-list
101870491|NCT01148446|Vincristine|vincristine|mesh-list
101870492|NCT01148446|Epirubicin|epirubicin|mesh-list
101870493|NCT01148446|Vinblastine|vinblastine|mesh-list
101870494|NCT01148446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101870495|NCT01148446|Immunologic Factors|immunologic factors|mesh-ancestor
101870496|NCT01148446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870497|NCT01148446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101870498|NCT01148446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101870499|NCT01148446|Alkylating Agents|alkylating agents|mesh-ancestor
101870500|NCT01148446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870501|NCT01148446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101870502|NCT01148446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101870503|NCT01148446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101870504|NCT01148446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101870505|NCT01148446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101870506|NCT01148446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101870507|NCT01148446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101870508|NCT01148446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101870510|NCT01148446|Hormones|hormones|mesh-ancestor
101870511|NCT01148446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101870512|NCT01148446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101245678|NCT01660477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101870513|NCT01148446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101870514|NCT01148446|Tubulin Modulators|tubulin modulators|mesh-ancestor
101870515|NCT01148446|Antimitotic Agents|antimitotic agents|mesh-ancestor
101870516|NCT01148446|Mitosis Modulators|mitosis modulators|mesh-ancestor
101870517|NCT03914404|Thioctic Acid|thioctic acid|mesh-list
101870518|NCT03914404|Antioxidants|antioxidants|mesh-ancestor
101870519|NCT03914404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870520|NCT03914404|Protective Agents|protective agents|mesh-ancestor
101870521|NCT03914404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870522|NCT03914404|Vitamin B Complex|vitamin b complex|mesh-ancestor
101870523|NCT03914404|Vitamins|vitamins|mesh-ancestor
101870524|NCT03914404|Micronutrients|micronutrients|mesh-ancestor
101870525|NCT01251640|Gemcitabine|gemcitabine|mesh-list
101870526|NCT01251640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101870527|NCT01251640|Antimetabolites|antimetabolites|mesh-ancestor
101870528|NCT01251640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870529|NCT01251640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101870530|NCT00257166|Ziprasidone|ziprasidone|mesh-list
101870531|NCT00257166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101870532|NCT00257166|Serotonin Agents|serotonin agents|mesh-ancestor
101870533|NCT00257166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101870534|NCT00257166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870535|NCT00257166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870536|NCT00257166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101870537|NCT00257166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101870538|NCT00257166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101870539|NCT00257166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101870540|NCT00257166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101870541|NCT00257166|Dopamine Agents|dopamine agents|mesh-ancestor
101870542|NCT03914092|Triamcinolone|triamcinolone|mesh-list
101870543|NCT03914092|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101870544|NCT03914092|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101870545|NCT03914092|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101870546|NCT03914092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101870547|NCT03914092|Glucocorticoids|glucocorticoids|mesh-ancestor
101870548|NCT03914092|Hormones|hormones|mesh-ancestor
101870549|NCT03914092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101870550|NCT03914092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870551|NCT03914092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101870552|NCT03914092|Immunologic Factors|immunologic factors|mesh-ancestor
101870553|NCT03914092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101870554|NCT03914092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870555|NCT03913858|Anesthetics|anesthetics|mesh-list
101870556|NCT03913858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101870557|NCT03913858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870558|NCT00227370|Valganciclovir|valganciclovir|mesh-list
101870559|NCT00227370|Antiviral Agents|antiviral agents|mesh-ancestor
101870560|NCT00227370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101870561|NCT01251796|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101870562|NCT01251796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101870563|NCT01251796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101870564|NCT01251796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101870565|NCT01251796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870566|NCT01251874|Alovudine|alovudine|mesh-list
101870567|NCT01251874|Carboplatin|carboplatin|mesh-list
101870568|NCT01251874|Veliparib|veliparib|mesh-list
101870569|NCT01251874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101870570|NCT01251874|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101870571|NCT01251874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101870572|NCT01251874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870573|NCT01251874|Antiviral Agents|antiviral agents|mesh-ancestor
101870574|NCT01251874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101870575|NCT03911440|Azithromycin|azithromycin|mesh-list
101870576|NCT03911440|Doxycycline|doxycycline|mesh-list
101870577|NCT03911440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101870578|NCT03911440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101870579|NCT03911440|Antimalarials|antimalarials|mesh-ancestor
101870580|NCT03911440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101870581|NCT03911440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101870582|NCT00191100|Gemcitabine|gemcitabine|mesh-list
101870583|NCT00191100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101870584|NCT00191100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101870585|NCT00191100|Antimetabolites|antimetabolites|mesh-ancestor
101870586|NCT00191100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870587|NCT01149226|Chloral Hydrate|chloral hydrate|mesh-list
101870588|NCT01149226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101870589|NCT01149226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101870590|NCT01149226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870591|NCT01252342|Oxytocin|oxytocin|mesh-list
101870592|NCT01252342|Oxytocics|oxytocics|mesh-ancestor
101870593|NCT01252342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101870594|NCT01252342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870595|NCT01254994|Entecavir|entecavir|mesh-list
101870596|NCT01254994|Antiviral Agents|antiviral agents|mesh-ancestor
101870597|NCT01254994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101870598|NCT03904732|Aspirin|aspirin|mesh-list
101870599|NCT03904732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101870600|NCT03904732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101870601|NCT03904732|Analgesics|analgesics|mesh-ancestor
101870602|NCT03904732|Sensory System Agents|sensory system agents|mesh-ancestor
101870603|NCT03904732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101870604|NCT03904732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870605|NCT03904732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101870606|NCT03904732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101870607|NCT03904732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101870608|NCT03904732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101870609|NCT03904732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870610|NCT03904732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101870611|NCT03904732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101870612|NCT03904732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101870613|NCT03904732|Antipyretics|antipyretics|mesh-ancestor
101870614|NCT01252420|Enoxaparin|enoxaparin|mesh-list
101870615|NCT01252420|Anticoagulants|anticoagulants|mesh-ancestor
101870616|NCT01252420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101870617|NCT01252420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101870618|NCT01252420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870619|NCT01149304|Enoxaparin|enoxaparin|mesh-list
101870620|NCT01149304|Pentoxifylline|pentoxifylline|mesh-list
101870621|NCT01149304|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101870622|NCT01149304|Anticoagulants|anticoagulants|mesh-ancestor
101870623|NCT01149304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101870624|NCT01149304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101870625|NCT01149304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870626|NCT01149304|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101870627|NCT01149304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101870628|NCT01149304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101870629|NCT01149304|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101870630|NCT01149304|Protective Agents|protective agents|mesh-ancestor
101245718|NCT01660750|Antiemetics|antiemetics|mesh-ancestor
101870631|NCT01149304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870632|NCT01149304|Vasodilator Agents|vasodilator agents|mesh-ancestor
101870633|NCT01149304|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101870634|NCT01149304|Antioxidants|antioxidants|mesh-ancestor
101870635|NCT01149304|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101870636|NCT01149304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101870637|NCT01254526|Paclitaxel|paclitaxel|mesh-list
101870638|NCT01254526|Bevacizumab|bevacizumab|mesh-list
101870639|NCT01254526|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101870640|NCT01254526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101870641|NCT01254526|Tubulin Modulators|tubulin modulators|mesh-ancestor
101870642|NCT01254526|Antimitotic Agents|antimitotic agents|mesh-ancestor
101870643|NCT01254526|Mitosis Modulators|mitosis modulators|mesh-ancestor
101870644|NCT01254526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870645|NCT01254526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101870646|NCT01254526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101870647|NCT01254526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101870648|NCT01254526|Growth Substances|growth substances|mesh-ancestor
101870649|NCT01254526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870650|NCT01254526|Growth Inhibitors|growth inhibitors|mesh-ancestor
101870652|NCT01148992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101870653|NCT01148992|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101870654|NCT01148992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870655|NCT01148992|Sensory System Agents|sensory system agents|mesh-ancestor
101870656|NCT01148992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101870657|NCT01148992|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101870658|NCT01148992|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101870659|NCT01148992|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101870660|NCT01148992|Adrenergic Agents|adrenergic agents|mesh-ancestor
101870661|NCT01148992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101870662|NCT01148992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870663|NCT03903952|Vitamin B 12|vitamin b 12|mesh-list
101870664|NCT03903952|Hydroxocobalamin|hydroxocobalamin|mesh-list
101870665|NCT03903952|Vitamins|vitamins|mesh-ancestor
101870666|NCT03903952|Micronutrients|micronutrients|mesh-ancestor
101870667|NCT03903952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870668|NCT03903952|Vitamin B Complex|vitamin b complex|mesh-ancestor
101870669|NCT03903952|Hematinics|hematinics|mesh-ancestor
101870670|NCT00257010|Almotriptan|almotriptan|mesh-list
101870671|NCT00257010|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101870672|NCT00257010|Serotonin Agents|serotonin agents|mesh-ancestor
101870673|NCT00257010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101870674|NCT00257010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870675|NCT00257010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870676|NCT03901768|Dexamethasone|dexamethasone|mesh-list
101870677|NCT03901768|Triamcinolone|triamcinolone|mesh-list
101870678|NCT03901768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101870679|NCT03901768|Antiemetics|antiemetics|mesh-ancestor
101870680|NCT03901768|Autonomic Agents|autonomic agents|mesh-ancestor
101688440|NCT04172064|Adrenergic Agents|adrenergic agents|mesh-ancestor
101870681|NCT03901768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101870682|NCT03901768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870683|NCT03901768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101870684|NCT03901768|Glucocorticoids|glucocorticoids|mesh-ancestor
101870685|NCT03901768|Hormones|hormones|mesh-ancestor
101870686|NCT03901768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101870687|NCT03901768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101870688|NCT03901768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101870689|NCT03903718|Oseltamivir|oseltamivir|mesh-list
101870690|NCT03903718|MEDI8852|medi8852|mesh-list
101870691|NCT03903718|Antiviral Agents|antiviral agents|mesh-ancestor
101870692|NCT03903718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101870693|NCT03903718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101870694|NCT03903718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870695|NCT03910504|Rocuronium|rocuronium|mesh-list
101870696|NCT03910504|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101870697|NCT03910504|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101870698|NCT03910504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101870699|NCT03910504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101870700|NCT03910504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870701|NCT03901690|Imiquimod|imiquimod|mesh-list
101870702|NCT03901690|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101870703|NCT03901690|Immunologic Factors|immunologic factors|mesh-ancestor
101870704|NCT03901690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870705|NCT03901690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101870706|NCT03901690|Interferon Inducers|interferon inducers|mesh-ancestor
101870707|NCT03901378|Pembrolizumab|pembrolizumab|mesh-list
101870708|NCT03901378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101870709|NCT03901378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101870710|NCT03901378|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101870711|NCT03901378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870712|NCT00256854|Ropinirole|ropinirole|mesh-list
101870713|NCT00256854|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101870714|NCT00256854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101870715|NCT00256854|Dopamine Agonists|dopamine agonists|mesh-ancestor
101870716|NCT00256854|Dopamine Agents|dopamine agents|mesh-ancestor
101870717|NCT00256854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101870718|NCT00256854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590555|NCT01112982|Colchicine|colchicine|mesh-list
101870719|NCT00256854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870720|NCT00189462|Montelukast|montelukast|mesh-list
101870721|NCT00189462|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101870722|NCT00189462|Respiratory System Agents|respiratory system agents|mesh-ancestor
101870723|NCT00189462|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101870724|NCT00189462|Hormone Antagonists|hormone antagonists|mesh-ancestor
101870725|NCT00189462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101870726|NCT00189462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870727|NCT00189462|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101870728|NCT00189462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101870729|NCT00189462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870730|NCT01150318|Iodine|iodine|mesh-list
101870731|NCT01150318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101870732|NCT01150318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101870733|NCT01150318|Trace Elements|trace elements|mesh-ancestor
101870734|NCT01150318|Micronutrients|micronutrients|mesh-ancestor
101870735|NCT01150318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870736|NCT05667298|Immunomodulating Agents|immunomodulating agents|mesh-list
101870737|NCT05667298|Immunologic Factors|immunologic factors|mesh-ancestor
101870738|NCT05667298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870739|NCT01256632|Ranibizumab|ranibizumab|mesh-list
101688457|NCT04173390|Sensory System Agents|sensory system agents|mesh-ancestor
101966479|NCT02269540|Sertraline|sertraline|mesh-list
101870740|NCT01256632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101870741|NCT01256632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101870742|NCT01256632|Growth Substances|growth substances|mesh-ancestor
101870743|NCT01256632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870744|NCT01256632|Growth Inhibitors|growth inhibitors|mesh-ancestor
101870745|NCT01256632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101870746|NCT00256698|Fulvestrant|fulvestrant|mesh-list
101870747|NCT00256698|Anastrozole|anastrozole|mesh-list
101870748|NCT00256698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101870749|NCT00256698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101870750|NCT00256698|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101870751|NCT00256698|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101870752|NCT00256698|Hormone Antagonists|hormone antagonists|mesh-ancestor
101870753|NCT00256698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101870754|NCT00256698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870755|NCT00256698|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101870756|NCT00256698|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101870757|NCT00256698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101870758|NCT00256698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870759|NCT01150630|Gemcitabine|gemcitabine|mesh-list
101870760|NCT01150630|Capecitabine|capecitabine|mesh-list
101870761|NCT01150630|Epirubicin|epirubicin|mesh-list
101870762|NCT01150630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101870763|NCT01150630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101870764|NCT01150630|Antimetabolites|antimetabolites|mesh-ancestor
101870765|NCT01150630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870766|NCT01150630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101870767|NCT01150630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101870768|NCT01150630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101870769|NCT01150630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101870770|NCT00189306|Imiquimod|imiquimod|mesh-list
101870771|NCT00189306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101870772|NCT00189306|Immunologic Factors|immunologic factors|mesh-ancestor
101870773|NCT00189306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870774|NCT00189306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101870775|NCT00189306|Interferon Inducers|interferon inducers|mesh-ancestor
101870776|NCT03898336|Micronutrients|micronutrients|mesh-list
101870777|NCT03898336|Trace Elements|trace elements|mesh-list
101870778|NCT03898336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870779|NCT03972462|Sirolimus|sirolimus|mesh-list
101870780|NCT03972462|Temsirolimus|temsirolimus|mesh-list
101870781|NCT03972462|MTOR Inhibitors|mtor inhibitors|mesh-list
101870782|NCT03972462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101870783|NCT03972462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101870784|NCT03972462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101870785|NCT03972462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101870786|NCT03972462|Antifungal Agents|antifungal agents|mesh-ancestor
101870787|NCT03972462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101870788|NCT03972462|Immunologic Factors|immunologic factors|mesh-ancestor
101870789|NCT03972462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870790|NCT03972462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101870791|NCT03972462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101870792|NCT03972462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870793|NCT01150786|Selenium|selenium|mesh-list
101870795|NCT01150786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870796|NCT01150786|Protective Agents|protective agents|mesh-ancestor
101870797|NCT01150786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870798|NCT01150786|Trace Elements|trace elements|mesh-ancestor
101870799|NCT01150786|Micronutrients|micronutrients|mesh-ancestor
101870800|NCT03909724|Sunitinib|sunitinib|mesh-list
101870801|NCT03909724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101870802|NCT03909724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101870803|NCT03909724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101870804|NCT03909724|Growth Substances|growth substances|mesh-ancestor
101870805|NCT03909724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870806|NCT03909724|Growth Inhibitors|growth inhibitors|mesh-ancestor
101870807|NCT03909724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101870808|NCT03909724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101870809|NCT03909724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870811|NCT03909646|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101870812|NCT03909646|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
101870813|NCT03909646|Antimetabolites|antimetabolites|mesh-ancestor
101870814|NCT03909646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870815|NCT03909646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101870816|NCT03909646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101870817|NCT03909646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101870818|NCT03909646|Immunologic Factors|immunologic factors|mesh-ancestor
101870819|NCT03909646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870820|NCT03909646|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101870821|NCT03909646|Dermatologic Agents|dermatologic agents|mesh-ancestor
101870822|NCT01256866|Midazolam|midazolam|mesh-list
101870823|NCT01256866|Dexmedetomidine|dexmedetomidine|mesh-list
101870824|NCT01256866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101870825|NCT01256866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101870826|NCT01256866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870827|NCT01256866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101870828|NCT01256866|Analgesics|analgesics|mesh-ancestor
101870829|NCT01256866|Sensory System Agents|sensory system agents|mesh-ancestor
101870830|NCT01256866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101870831|NCT01256866|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101870832|NCT01256866|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101870833|NCT01256866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101870834|NCT01256866|Adrenergic Agents|adrenergic agents|mesh-ancestor
101870835|NCT01256866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101870836|NCT01256866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870837|NCT01256866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101870838|NCT01256866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101870839|NCT01256866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101870840|NCT01256866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101870841|NCT01256866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101870842|NCT01256866|Anesthetics, General|anesthetics, general|mesh-ancestor
101870843|NCT01256866|Anesthetics|anesthetics|mesh-ancestor
101870844|NCT01256866|GABA Modulators|gaba modulators|mesh-ancestor
101870845|NCT01256866|GABA Agents|gaba agents|mesh-ancestor
101870846|NCT03902782|Dexamethasone|dexamethasone|mesh-list
101870847|NCT03902782|Dexamethasone acetate|dexamethasone acetate|mesh-list
101870848|NCT03902782|Epinephrine|epinephrine|mesh-list
101870849|NCT03902782|Bupivacaine|bupivacaine|mesh-list
101870850|NCT03902782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101870851|NCT03902782|Antiemetics|antiemetics|mesh-ancestor
101870852|NCT03902782|Autonomic Agents|autonomic agents|mesh-ancestor
101870853|NCT03902782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101870854|NCT03902782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870855|NCT03902782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101870856|NCT03902782|Glucocorticoids|glucocorticoids|mesh-ancestor
101870857|NCT03902782|Hormones|hormones|mesh-ancestor
101870858|NCT03902782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101870859|NCT03902782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101870860|NCT03902782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101870861|NCT03902782|Anesthetics, Local|anesthetics, local|mesh-ancestor
101870862|NCT03902782|Anesthetics|anesthetics|mesh-ancestor
101870863|NCT03902782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101870864|NCT03902782|Sensory System Agents|sensory system agents|mesh-ancestor
101870865|NCT03902782|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101870866|NCT03902782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101870867|NCT03902782|Adrenergic Agents|adrenergic agents|mesh-ancestor
101870868|NCT03902782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101870869|NCT03902782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870870|NCT03902782|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101870871|NCT03902782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101870872|NCT03902782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101870873|NCT03902782|Respiratory System Agents|respiratory system agents|mesh-ancestor
101870874|NCT03902782|Mydriatics|mydriatics|mesh-ancestor
101870875|NCT03902782|Sympathomimetics|sympathomimetics|mesh-ancestor
101870876|NCT03902782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101870877|NCT03908944|Methadone|methadone|mesh-list
101870878|NCT03908944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101870880|NCT03908944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101870881|NCT03908944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870882|NCT03908944|Analgesics|analgesics|mesh-ancestor
101870883|NCT03908944|Sensory System Agents|sensory system agents|mesh-ancestor
101870884|NCT03908944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101870885|NCT03908944|Antitussive Agents|antitussive agents|mesh-ancestor
101870886|NCT03908944|Respiratory System Agents|respiratory system agents|mesh-ancestor
101870887|NCT03899506|Midazolam|midazolam|mesh-list
101870888|NCT03899506|Olanzapine|olanzapine|mesh-list
101870889|NCT03899506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101870890|NCT03899506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101870891|NCT03899506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101870892|NCT03899506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870893|NCT03899506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101870894|NCT03899506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101870895|NCT03899506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101870896|NCT03899506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101870897|NCT03899506|Anesthetics, General|anesthetics, general|mesh-ancestor
101870898|NCT03899506|Anesthetics|anesthetics|mesh-ancestor
101870899|NCT03899506|GABA Modulators|gaba modulators|mesh-ancestor
101870900|NCT03899506|GABA Agents|gaba agents|mesh-ancestor
101870901|NCT03899506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101870902|NCT03899506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870903|NCT03899506|Antiemetics|antiemetics|mesh-ancestor
101870904|NCT03899506|Autonomic Agents|autonomic agents|mesh-ancestor
101870905|NCT03899506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101870906|NCT03899506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101870907|NCT03899506|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101870908|NCT03899506|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101870909|NCT03899506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101870910|NCT03899506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101870911|NCT03899506|Serotonin Agents|serotonin agents|mesh-ancestor
101870912|NCT03896932|Immunoglobulins|immunoglobulins|mesh-list
101870913|NCT03896932|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101870914|NCT03896932|Antibodies|antibodies|mesh-list
101870915|NCT03896932|gamma-Globulins|gamma-globulins|mesh-list
101870916|NCT03896932|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101870917|NCT03896932|Immunologic Factors|immunologic factors|mesh-ancestor
101870918|NCT03896932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870919|NCT01257334|Empagliflozin|empagliflozin|mesh-list
101870920|NCT01257334|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101870921|NCT01257334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870922|NCT01257334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101870923|NCT01257334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870924|NCT01151176|Insulin|insulin|mesh-list
101870925|NCT01151176|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101870926|NCT01151176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101870927|NCT01151176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870928|NCT01257412|Dapagliflozin|dapagliflozin|mesh-list
101870929|NCT01257412|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101870930|NCT01257412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870931|NCT01257412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101870932|NCT01257412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870933|NCT01257490|Bupropion|bupropion|mesh-list
101870934|NCT01257490|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101870935|NCT01257490|Antidepressive Agents|antidepressive agents|mesh-ancestor
101870936|NCT01257490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101870937|NCT01257490|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101870938|NCT01257490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101870939|NCT01257490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101870940|NCT01257490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590780|NCT00674713|Antipruritics|antipruritics|mesh-ancestor
101870941|NCT01257490|Dopamine Agents|dopamine agents|mesh-ancestor
101870942|NCT01257490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101870943|NCT01257490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870944|NCT01257490|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101870945|NCT01257490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101870947|NCT03894280|Fluticasone|fluticasone|mesh-list
101870948|NCT03894280|Xhance|xhance|mesh-list
101870949|NCT03894280|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101870950|NCT03894280|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101870951|NCT03894280|Charcoal|charcoal|mesh-list
101870952|NCT03894280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101870953|NCT03894280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101870954|NCT03894280|Autonomic Agents|autonomic agents|mesh-ancestor
101870955|NCT03894280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101870956|NCT03894280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870957|NCT03894280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101870958|NCT03894280|Respiratory System Agents|respiratory system agents|mesh-ancestor
101870959|NCT03894280|Dermatologic Agents|dermatologic agents|mesh-ancestor
101870960|NCT03894280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101870961|NCT03894280|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101870962|NCT03894280|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101870963|NCT03894280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101870964|NCT03894280|Adrenergic Agents|adrenergic agents|mesh-ancestor
101870965|NCT03894280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101870966|NCT03894280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870967|NCT03894280|Glucocorticoids|glucocorticoids|mesh-ancestor
101870968|NCT03894280|Hormones|hormones|mesh-ancestor
101870969|NCT03894280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101870970|NCT03894280|Sympathomimetics|sympathomimetics|mesh-ancestor
101870971|NCT03894280|Antidotes|antidotes|mesh-ancestor
101870972|NCT03894280|Protective Agents|protective agents|mesh-ancestor
101870973|NCT03899584|4-Aminopyridine|4-aminopyridine|mesh-list
101870974|NCT03899584|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101870975|NCT03899584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101870976|NCT03899584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870977|NCT01150162|Omeprazole|omeprazole|mesh-list
101870978|NCT01150162|Rebamipide|rebamipide|mesh-list
101870979|NCT01150162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101870980|NCT01150162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101870981|NCT01150162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101870982|NCT01150162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101870983|NCT01150162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101870984|NCT01150162|Antioxidants|antioxidants|mesh-ancestor
101870985|NCT01150162|Protective Agents|protective agents|mesh-ancestor
101870986|NCT01150162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870987|NCT03893734|Methadone|methadone|mesh-list
101870988|NCT03893734|Hydromorphone|hydromorphone|mesh-list
101870989|NCT03893734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101870990|NCT03893734|Narcotics|narcotics|mesh-ancestor
101870991|NCT03893734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101870992|NCT03893734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101870993|NCT03893734|Analgesics|analgesics|mesh-ancestor
101870994|NCT03893734|Sensory System Agents|sensory system agents|mesh-ancestor
101870995|NCT03893734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101870996|NCT03893734|Antitussive Agents|antitussive agents|mesh-ancestor
101870997|NCT03893734|Respiratory System Agents|respiratory system agents|mesh-ancestor
101870998|NCT03899194|Escitalopram|escitalopram|mesh-list
101870999|NCT03899194|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101871000|NCT03899194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101871001|NCT03899194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101871002|NCT03899194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871003|NCT03899194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101871004|NCT03899194|Serotonin Agents|serotonin agents|mesh-ancestor
101871005|NCT03899194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871006|NCT01151800|Benzocaine|benzocaine|mesh-list
101871007|NCT01151800|Anesthetics, Local|anesthetics, local|mesh-ancestor
101871008|NCT01151800|Anesthetics|anesthetics|mesh-ancestor
101871009|NCT01151800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101871010|NCT01151800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871011|NCT01151800|Sensory System Agents|sensory system agents|mesh-ancestor
101871012|NCT01151800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101871014|NCT03896074|Atezolizumab|atezolizumab|mesh-list
101871015|NCT03896074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101871016|NCT03896074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101871017|NCT03896074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101871018|NCT03896074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101871019|NCT03896074|Growth Substances|growth substances|mesh-ancestor
101871020|NCT03896074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871021|NCT03896074|Growth Inhibitors|growth inhibitors|mesh-ancestor
101871022|NCT03896074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101871023|NCT03896074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871024|NCT03899038|Anesthetics|anesthetics|mesh-list
101871025|NCT03899038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101871026|NCT03899038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871027|NCT01151878|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
101871028|NCT01151878|Cathartics|cathartics|mesh-ancestor
101871029|NCT01151878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101871030|NCT03898882|Oxytocin|oxytocin|mesh-list
101871031|NCT03898882|Oxytocics|oxytocics|mesh-ancestor
101871032|NCT03898882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101871033|NCT03898882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871034|NCT01151254|Propofol|propofol|mesh-list
101871035|NCT01151254|Sevoflurane|sevoflurane|mesh-list
101871036|NCT01151254|Isoflurane|isoflurane|mesh-list
101871037|NCT01151254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101871038|NCT01151254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101871039|NCT01151254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871040|NCT01151254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101871041|NCT01151254|Anesthetics, General|anesthetics, general|mesh-ancestor
101871042|NCT01151254|Anesthetics|anesthetics|mesh-ancestor
101871043|NCT01151254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101871044|NCT01151254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101871045|NCT01255774|Ranibizumab|ranibizumab|mesh-list
101871046|NCT01255774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101871047|NCT01255774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101871048|NCT01255774|Growth Substances|growth substances|mesh-ancestor
101871049|NCT01255774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871050|NCT01255774|Growth Inhibitors|growth inhibitors|mesh-ancestor
101871051|NCT01255774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101871052|NCT01255852|Atorvastatin|atorvastatin|mesh-list
101871053|NCT01255852|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101871054|NCT01255852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101871055|NCT01255852|Antimetabolites|antimetabolites|mesh-ancestor
101871056|NCT01255852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871057|NCT01255852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101871058|NCT01255852|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101871059|NCT01255852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101871060|NCT03895528|Lonafarnib|lonafarnib|mesh-list
101871061|NCT03895528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101871062|NCT03895528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871063|NCT01257958|Vitamin D|vitamin d|mesh-list
101871064|NCT01257958|Vitamins|vitamins|mesh-ancestor
101871065|NCT01257958|Micronutrients|micronutrients|mesh-ancestor
101871066|NCT01257958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871067|NCT01257958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101871068|NCT03893032|Modafinil|modafinil|mesh-list
101871069|NCT03893032|Amphetamine|amphetamine|mesh-list
101871070|NCT03893032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101871071|NCT03893032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871072|NCT03893032|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101871073|NCT03893032|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101871074|NCT03893032|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101871075|NCT03893032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871076|NCT03893032|Sympathomimetics|sympathomimetics|mesh-ancestor
101871077|NCT03893032|Autonomic Agents|autonomic agents|mesh-ancestor
101871078|NCT03893032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101871079|NCT03893032|Dopamine Agents|dopamine agents|mesh-ancestor
101871080|NCT03893032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101871081|NCT03893032|Adrenergic Agents|adrenergic agents|mesh-ancestor
101871082|NCT03893032|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101871083|NCT03893032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101871084|NCT03893032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101871085|NCT03893032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101871086|NCT01258036|Hormones|hormones|mesh-list
101871087|NCT01258036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101871088|NCT01258036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871089|NCT03889366|Aprepitant|aprepitant|mesh-list
101871090|NCT03889366|Antiemetics|antiemetics|mesh-ancestor
101871091|NCT03889366|Autonomic Agents|autonomic agents|mesh-ancestor
101245851|NCT01661335|Protease Inhibitors|protease inhibitors|mesh-ancestor
101871092|NCT03889366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101871093|NCT03889366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871094|NCT03889366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101871095|NCT03889366|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101871096|NCT03889366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101688485|NCT00647946|Tenofovir|tenofovir|mesh-list
101871097|NCT03889366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871098|NCT03894826|Vorinostat|vorinostat|mesh-list
101871099|NCT03894826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101871100|NCT03894826|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101871101|NCT03894826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101871102|NCT03894826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871103|NCT03894748|Botulinum Toxins|botulinum toxins|mesh-list
101871104|NCT03894748|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101871105|NCT03894748|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101871106|NCT03894748|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101871107|NCT03894748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101871108|NCT03894748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871109|NCT03894748|Cholinergic Agents|cholinergic agents|mesh-ancestor
101871110|NCT03894748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101871111|NCT03894748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871112|NCT03894748|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101871113|NCT03894748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101871114|NCT01153750|Imatinib Mesylate|imatinib mesylate|mesh-list
101871115|NCT01153750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101871116|NCT01153750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101871117|NCT01153750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101871118|NCT01153750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871119|NCT03888664|Interferons|interferons|mesh-list
101871120|NCT03888664|Interferon-gamma|interferon-gamma|mesh-list
101871121|NCT03888664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101871122|NCT03888664|Antiviral Agents|antiviral agents|mesh-ancestor
101871123|NCT03888664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101871124|NCT00256308|Oxaliplatin|oxaliplatin|mesh-list
101871125|NCT00256308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101871126|NCT01153828|Mupirocin|mupirocin|mesh-list
101871127|NCT01153828|Retapamulin|retapamulin|mesh-list
101871128|NCT01153828|Fusidic Acid|fusidic acid|mesh-list
101871129|NCT01153828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101871130|NCT01153828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101871131|NCT01153828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101871132|NCT01153828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101871133|NCT01153828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871134|NCT01151722|Bevacizumab|bevacizumab|mesh-list
101871135|NCT01151722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101871136|NCT01151722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101871137|NCT01151722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101871138|NCT01151722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101245869|NCT01661530|Vitamin E|vitamin e|mesh-list
101871139|NCT01151722|Growth Substances|growth substances|mesh-ancestor
101871140|NCT01151722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871141|NCT01151722|Growth Inhibitors|growth inhibitors|mesh-ancestor
101871142|NCT01258192|Paclitaxel|paclitaxel|mesh-list
101871143|NCT01258192|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101871144|NCT01258192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101871145|NCT01258192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101871146|NCT01258192|Tubulin Modulators|tubulin modulators|mesh-ancestor
101871147|NCT01258192|Antimitotic Agents|antimitotic agents|mesh-ancestor
101871148|NCT01258192|Mitosis Modulators|mitosis modulators|mesh-ancestor
101871149|NCT01258192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871150|NCT01326078|Propofol|propofol|mesh-list
101871151|NCT01326078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101871152|NCT01326078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101871153|NCT01326078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871154|NCT01326078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101871155|NCT01326078|Anesthetics, General|anesthetics, general|mesh-ancestor
101871156|NCT01326078|Anesthetics|anesthetics|mesh-ancestor
101871157|NCT01260376|Acipimox|acipimox|mesh-list
101871158|NCT01260376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101871159|NCT01260376|Antimetabolites|antimetabolites|mesh-ancestor
101871160|NCT01260376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871161|NCT01260376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101871162|NCT01259050|Copper|copper|mesh-list
101871163|NCT01259050|Trace Elements|trace elements|mesh-ancestor
101871165|NCT01259050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871166|NCT00255840|Ritonavir|ritonavir|mesh-list
101871167|NCT00255840|Lopinavir|lopinavir|mesh-list
101871168|NCT00255840|Lamivudine|lamivudine|mesh-list
101871170|NCT00255840|Stavudine|stavudine|mesh-list
101871171|NCT00255840|Efavirenz|efavirenz|mesh-list
101871172|NCT00255840|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101871173|NCT00255840|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101871174|NCT00255840|Protease Inhibitors|protease inhibitors|mesh-ancestor
101871175|NCT00255840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101871176|NCT00255840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871177|NCT00255840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101871178|NCT00255840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101871179|NCT00255840|Antiviral Agents|antiviral agents|mesh-ancestor
101871180|NCT00255840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101871181|NCT00255840|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101871182|NCT00255840|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101871183|NCT00255840|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101871184|NCT00255840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101871185|NCT00255840|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101871186|NCT00255840|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101871187|NCT00255840|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101871188|NCT00255840|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101871189|NCT00255840|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101871190|NCT00255840|Antimetabolites|antimetabolites|mesh-ancestor
101871191|NCT03972228|Antineoplastic Agents|antineoplastic agents|mesh-list
101871192|NCT00224874|Mycophenolic Acid|mycophenolic acid|mesh-list
101871193|NCT00224874|Etanercept|etanercept|mesh-list
101871194|NCT00224874|Pentostatin|pentostatin|mesh-list
101871195|NCT00224874|Denileukin diftitox|denileukin diftitox|mesh-list
101245893|NCT01661751|Vaccines|vaccines|mesh-list
101871196|NCT00224874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101871197|NCT00224874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101871198|NCT00224874|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101871199|NCT00224874|Antitubercular Agents|antitubercular agents|mesh-ancestor
101871200|NCT00224874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101871201|NCT00224874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101871202|NCT00224874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101871203|NCT00224874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871204|NCT00224874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101871205|NCT00224874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101871206|NCT00224874|Analgesics|analgesics|mesh-ancestor
101871207|NCT00224874|Sensory System Agents|sensory system agents|mesh-ancestor
101871208|NCT00224874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101871209|NCT00224874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871210|NCT00224874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101871211|NCT00224874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101871212|NCT00224874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101871213|NCT00224874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101871214|NCT00224874|Immunologic Factors|immunologic factors|mesh-ancestor
101871215|NCT00224874|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
101871216|NCT03892330|Oxytetracycline|oxytetracycline|mesh-list
101871217|NCT03892330|Cyclophosphamide|cyclophosphamide|mesh-list
101871218|NCT03892330|Doxorubicin|doxorubicin|mesh-list
101871219|NCT03892330|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101871220|NCT03892330|Vincristine|vincristine|mesh-list
101871221|NCT03892330|Pirarubicin|pirarubicin|mesh-list
101871222|NCT03892330|Epirubicin|epirubicin|mesh-list
101871223|NCT03892330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101871224|NCT03892330|Immunologic Factors|immunologic factors|mesh-ancestor
101871225|NCT03892330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871226|NCT03892330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101234099|NCT01576627|Zinc|zinc|mesh-list
101871227|NCT03892330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101871229|NCT03892330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871230|NCT03892330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101871231|NCT03892330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101871232|NCT03892330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101871233|NCT03892330|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101871234|NCT03892330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101871235|NCT03892330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101871236|NCT03892330|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101871237|NCT03892330|Tubulin Modulators|tubulin modulators|mesh-ancestor
101871238|NCT03892330|Antimitotic Agents|antimitotic agents|mesh-ancestor
101871239|NCT03892330|Mitosis Modulators|mitosis modulators|mesh-ancestor
101871240|NCT03892330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101871241|NCT03892330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101871242|NCT00186186|Valproic Acid|valproic acid|mesh-list
101871243|NCT00186186|Anticonvulsants|anticonvulsants|mesh-ancestor
101871244|NCT00186186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101871245|NCT00186186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871247|NCT00186186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101871248|NCT00186186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871249|NCT00186186|Antimanic Agents|antimanic agents|mesh-ancestor
101871250|NCT00186186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101871251|NCT00186186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101871252|NCT00186186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101871253|NCT00185640|Cyclosporine|cyclosporine|mesh-list
101871254|NCT00185640|Mycophenolic Acid|mycophenolic acid|mesh-list
101871255|NCT00185640|Lenograstim|lenograstim|mesh-list
101871256|NCT00185640|Cyclosporins|cyclosporins|mesh-list
101871257|NCT00185640|Thymoglobulin|thymoglobulin|mesh-list
101871258|NCT00185640|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101871259|NCT00185640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101871260|NCT00185640|Immunologic Factors|immunologic factors|mesh-ancestor
101871261|NCT00185640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871262|NCT00185640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101871263|NCT00185640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871264|NCT00185640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101871265|NCT00185640|Antifungal Agents|antifungal agents|mesh-ancestor
101871266|NCT00185640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101871267|NCT00185640|Dermatologic Agents|dermatologic agents|mesh-ancestor
101871268|NCT00185640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101871269|NCT00185640|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101871270|NCT00185640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101871271|NCT00185640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101871272|NCT00185640|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101871273|NCT00185640|Antitubercular Agents|antitubercular agents|mesh-ancestor
101871274|NCT00185640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101871275|NCT03885388|Dactinomycin|dactinomycin|mesh-list
101871276|NCT03885388|Methotrexate|methotrexate|mesh-list
101871277|NCT03885388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101871278|NCT03885388|Abortifacient Agents|abortifacient agents|mesh-ancestor
101871279|NCT03885388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101871280|NCT03885388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871281|NCT03885388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101871282|NCT03885388|Antimetabolites|antimetabolites|mesh-ancestor
101871283|NCT03885388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871284|NCT03885388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101871285|NCT03885388|Dermatologic Agents|dermatologic agents|mesh-ancestor
101871286|NCT03885388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101871287|NCT03885388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101871288|NCT03885388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101871289|NCT03885388|Immunologic Factors|immunologic factors|mesh-ancestor
101871290|NCT03885388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101871291|NCT03885388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101871292|NCT03885388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101871293|NCT03885388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101871294|NCT03885388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101871295|NCT03885388|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101871296|NCT01152346|Azacitidine|azacitidine|mesh-list
101871297|NCT01152346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101871299|NCT01152346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871301|NCT01152346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101871302|NCT01260610|Tenofovir|tenofovir|mesh-list
101871303|NCT01260610|Telbivudine|telbivudine|mesh-list
101871304|NCT01260610|Antiviral Agents|antiviral agents|mesh-ancestor
101871305|NCT01260610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101871306|NCT01260610|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101871307|NCT01260610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101871308|NCT01260610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101871309|NCT01260610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871310|NCT01260610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101871311|NCT01260610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101871312|NCT01155700|Omalizumab|omalizumab|mesh-list
101871313|NCT01155700|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101871314|NCT01155700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101871315|NCT01155700|Respiratory System Agents|respiratory system agents|mesh-ancestor
101871316|NCT03887884|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101591154|NCT02821156|Autonomic Agents|autonomic agents|mesh-ancestor
101871317|NCT03887884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101871318|NCT03887884|Immunologic Factors|immunologic factors|mesh-ancestor
101871319|NCT03887884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871320|NCT03887884|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101871321|NCT03887884|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101871322|NCT03887884|Dopamine Agonists|dopamine agonists|mesh-ancestor
101871323|NCT03887884|Dopamine Agents|dopamine agents|mesh-ancestor
101245922|NCT01662089|Zinc|zinc|mesh-list
101871324|NCT03887884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101871325|NCT03887884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871326|NCT03887650|Dexamethasone|dexamethasone|mesh-list
101871327|NCT03887650|Epinephrine|epinephrine|mesh-list
101871328|NCT03887650|Bupivacaine|bupivacaine|mesh-list
101871329|NCT03887650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101871330|NCT03887650|Antiemetics|antiemetics|mesh-ancestor
101871331|NCT03887650|Autonomic Agents|autonomic agents|mesh-ancestor
101871332|NCT03887650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101871333|NCT03887650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871334|NCT03887650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101871335|NCT03887650|Glucocorticoids|glucocorticoids|mesh-ancestor
101871336|NCT03887650|Hormones|hormones|mesh-ancestor
101871337|NCT03887650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101871338|NCT03887650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101871339|NCT03887650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101871340|NCT03887650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871341|NCT03887650|Anesthetics, Local|anesthetics, local|mesh-ancestor
101871342|NCT03887650|Anesthetics|anesthetics|mesh-ancestor
101871343|NCT03887650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101871344|NCT03887650|Sensory System Agents|sensory system agents|mesh-ancestor
101871345|NCT03887650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101871346|NCT03887650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101871347|NCT03887650|Adrenergic Agents|adrenergic agents|mesh-ancestor
101871348|NCT03887650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101871349|NCT03887650|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101871350|NCT03887650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101871351|NCT03887650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101871352|NCT03887650|Respiratory System Agents|respiratory system agents|mesh-ancestor
101871353|NCT03887650|Mydriatics|mydriatics|mesh-ancestor
101871354|NCT03887650|Sympathomimetics|sympathomimetics|mesh-ancestor
101871355|NCT03887650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101871356|NCT01154530|Chlorhexidine|chlorhexidine|mesh-list
101871357|NCT01154530|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101871358|NCT01154530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101871359|NCT01154530|Disinfectants|disinfectants|mesh-ancestor
101871360|NCT03887416|Dapagliflozin|dapagliflozin|mesh-list
101871361|NCT03887416|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101871362|NCT03887416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871363|NCT03887416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101871364|NCT03887416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871365|NCT01260844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101871366|NCT01260844|Immunologic Factors|immunologic factors|mesh-ancestor
101871367|NCT01260844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871368|NCT03891472|Fluorouracil|fluorouracil|mesh-list
101871369|NCT03891472|Oxaliplatin|oxaliplatin|mesh-list
101871370|NCT03891472|Irinotecan|irinotecan|mesh-list
101871371|NCT03891472|Antimetabolites|antimetabolites|mesh-ancestor
101871372|NCT03891472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871373|NCT03891472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101245936|NCT01662193|Vitamin D|vitamin d|mesh-list
101871374|NCT03891472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101871375|NCT03891472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101871376|NCT03891472|Immunologic Factors|immunologic factors|mesh-ancestor
101871377|NCT03891472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871378|NCT03891472|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101871379|NCT03891472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101871380|NCT03891472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101871381|NCT01262482|Oxaliplatin|oxaliplatin|mesh-list
101871382|NCT01262482|Sorafenib|sorafenib|mesh-list
101871383|NCT01262482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101871384|NCT01262482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101871385|NCT01262482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101871386|NCT01262482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871387|NCT01261078|Epinephrine|epinephrine|mesh-list
101871388|NCT01261078|Racepinephrine|racepinephrine|mesh-list
101871389|NCT01261078|Epinephryl borate|epinephryl borate|mesh-list
101871390|NCT01261078|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101871391|NCT01261078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101871392|NCT01261078|Adrenergic Agents|adrenergic agents|mesh-ancestor
101871393|NCT01261078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101871394|NCT01261078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871395|NCT01261078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871396|NCT01261078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101871397|NCT01261078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101871398|NCT01261078|Autonomic Agents|autonomic agents|mesh-ancestor
101871399|NCT01261078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101871400|NCT01261078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101871401|NCT01261078|Respiratory System Agents|respiratory system agents|mesh-ancestor
101871402|NCT01261078|Mydriatics|mydriatics|mesh-ancestor
101871403|NCT01261078|Sympathomimetics|sympathomimetics|mesh-ancestor
101871404|NCT01261078|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101871405|NCT01155934|Risperidone|risperidone|mesh-list
101871406|NCT01155934|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101871407|NCT01155934|Serotonin Agents|serotonin agents|mesh-ancestor
101871408|NCT01155934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101871409|NCT01155934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871410|NCT01155934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871411|NCT01155934|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101871412|NCT01155934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101871413|NCT01155934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101871414|NCT01155934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101871415|NCT01155934|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101871416|NCT01155934|Dopamine Agents|dopamine agents|mesh-ancestor
101871417|NCT03891550|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
101871418|NCT03891550|Antiviral Agents|antiviral agents|mesh-ancestor
101871419|NCT03891550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101871421|NCT01261156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101871422|NCT01261156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101871423|NCT01261156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101871424|NCT01261156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871425|NCT01261156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101871426|NCT01261156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871427|NCT01261156|Vasodilator Agents|vasodilator agents|mesh-ancestor
101871428|NCT03884530|Aspirin|aspirin|mesh-list
101871429|NCT03884530|Ticagrelor|ticagrelor|mesh-list
101871430|NCT03884530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101871431|NCT03884530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101871432|NCT03884530|Analgesics|analgesics|mesh-ancestor
101871433|NCT03884530|Sensory System Agents|sensory system agents|mesh-ancestor
101871434|NCT03884530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101871435|NCT03884530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871436|NCT03884530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101871437|NCT03884530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101871438|NCT03884530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101871439|NCT03884530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101871440|NCT03884530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871441|NCT03884530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101871442|NCT03884530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101871443|NCT03884530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101871444|NCT03884530|Antipyretics|antipyretics|mesh-ancestor
101688515|NCT00646620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101871445|NCT03884530|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101871446|NCT03884530|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101871447|NCT03884530|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101871448|NCT03884530|Purinergic Agents|purinergic agents|mesh-ancestor
101871449|NCT03884530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101871450|NCT03891316|Sevoflurane|sevoflurane|mesh-list
101871451|NCT03891316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101871452|NCT03891316|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101871453|NCT03891316|Anesthetics, General|anesthetics, general|mesh-ancestor
101871454|NCT03891316|Anesthetics|anesthetics|mesh-ancestor
101871455|NCT03891316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101871456|NCT03891316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871457|NCT03887260|Fentanyl|fentanyl|mesh-list
101871458|NCT03887260|Morphine|morphine|mesh-list
101871459|NCT03887260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101871460|NCT03887260|Narcotics|narcotics|mesh-ancestor
101871461|NCT03887260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101871462|NCT03887260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871463|NCT03887260|Analgesics|analgesics|mesh-ancestor
101871464|NCT03887260|Sensory System Agents|sensory system agents|mesh-ancestor
101871465|NCT03887260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101871466|NCT03887260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101871467|NCT03887260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101871469|NCT03887260|Anesthetics|anesthetics|mesh-ancestor
101871470|NCT03883984|Cysteamine|cysteamine|mesh-list
101871471|NCT03883984|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
101871472|NCT03883984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871473|NCT01586494|Tramadol|tramadol|mesh-list
101871474|NCT01586494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101871475|NCT01586494|Narcotics|narcotics|mesh-ancestor
101871476|NCT01586494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101871477|NCT01586494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871478|NCT01586494|Analgesics|analgesics|mesh-ancestor
101871479|NCT01586494|Sensory System Agents|sensory system agents|mesh-ancestor
101871480|NCT01586494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101871481|NCT03886948|Mirikizumab|mirikizumab|mesh-list
101871482|NCT03886948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101871483|NCT03886948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101871484|NCT03886948|Analgesics|analgesics|mesh-ancestor
101871485|NCT03886948|Sensory System Agents|sensory system agents|mesh-ancestor
101871486|NCT03886948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101871487|NCT03886948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871488|NCT03886948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101871489|NCT03886948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101871490|NCT03886948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101871491|NCT03886948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101871492|NCT01259362|Cocaine|cocaine|mesh-list
101871493|NCT01259362|Anesthetics, Local|anesthetics, local|mesh-ancestor
101871494|NCT01259362|Anesthetics|anesthetics|mesh-ancestor
101871495|NCT01259362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101871496|NCT01259362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871497|NCT01259362|Sensory System Agents|sensory system agents|mesh-ancestor
101871498|NCT01259362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101871499|NCT01259362|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101871500|NCT01259362|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101871501|NCT01259362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101871502|NCT01259362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101871503|NCT01259362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871504|NCT01259362|Dopamine Agents|dopamine agents|mesh-ancestor
101871505|NCT01259362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101871506|NCT03891238|Avelumab|avelumab|mesh-list
101871507|NCT03891238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101871508|NCT03891238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101871509|NCT01261234|Cilostazol|cilostazol|mesh-list
101871510|NCT01261234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101871511|NCT01261234|Autonomic Agents|autonomic agents|mesh-ancestor
101871512|NCT01261234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101871513|NCT01261234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871514|NCT01261234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101871515|NCT01261234|Respiratory System Agents|respiratory system agents|mesh-ancestor
101871516|NCT01261234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101871517|NCT01261234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101871518|NCT01261234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871519|NCT01261234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101871520|NCT01261234|Vasodilator Agents|vasodilator agents|mesh-ancestor
101871521|NCT01261234|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101871522|NCT01261234|Protective Agents|protective agents|mesh-ancestor
101871523|NCT01261234|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101871524|NCT01261234|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101871525|NCT01261234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101871527|NCT01152736|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101871528|NCT01152736|Autonomic Agents|autonomic agents|mesh-ancestor
101871529|NCT01152736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101871530|NCT01152736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871531|NCT01152736|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101871532|NCT01152736|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101871533|NCT01152736|Cholinergic Agents|cholinergic agents|mesh-ancestor
101871534|NCT01152736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101871535|NCT01152736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871536|NCT01154764|Ketoconazole|ketoconazole|mesh-list
101871537|NCT01154764|Antifungal Agents|antifungal agents|mesh-ancestor
101871538|NCT01154764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101871539|NCT01154764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101871540|NCT01154764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101871541|NCT01154764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101871542|NCT01154764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871543|NCT01154764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101871544|NCT01154764|Hormone Antagonists|hormone antagonists|mesh-ancestor
101871545|NCT01154764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101871546|NCT01154764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871547|NCT01154764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101871549|NCT01261546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101871550|NCT01261546|Antiemetics|antiemetics|mesh-ancestor
101871551|NCT01261546|Autonomic Agents|autonomic agents|mesh-ancestor
101871552|NCT01261546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101871553|NCT01261546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871554|NCT01261546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101871555|NCT01261546|Glucocorticoids|glucocorticoids|mesh-ancestor
101871556|NCT01261546|Hormones|hormones|mesh-ancestor
101871557|NCT01261546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101871558|NCT01261546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101871559|NCT01261546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101871560|NCT03883360|Cannabidiol|cannabidiol|mesh-list
101871561|NCT03883360|Anticonvulsants|anticonvulsants|mesh-ancestor
101871562|NCT01261702|Magnesium Sulfate|magnesium sulfate|mesh-list
101871563|NCT01261702|Analgesics|analgesics|mesh-ancestor
101871564|NCT01261702|Sensory System Agents|sensory system agents|mesh-ancestor
101871565|NCT01261702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101871566|NCT01261702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871567|NCT01261702|Anesthetics|anesthetics|mesh-ancestor
101871568|NCT01261702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101871569|NCT01261702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101871570|NCT01261702|Anticonvulsants|anticonvulsants|mesh-ancestor
101871571|NCT01261702|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101871572|NCT01261702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101871573|NCT01261702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871574|NCT01261702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101871575|NCT01261702|Tocolytic Agents|tocolytic agents|mesh-ancestor
101871576|NCT01261702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101871577|NCT01156246|Metformin|metformin|mesh-list
101871578|NCT01156246|Dapagliflozin|dapagliflozin|mesh-list
101871579|NCT01156246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101871580|NCT01156246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871581|NCT01156246|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101871582|NCT01156246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871583|NCT03890770|Deucravacitinib|deucravacitinib|mesh-list
101871584|NCT03890770|Dermatologic Agents|dermatologic agents|mesh-ancestor
101871585|NCT03890770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101871586|NCT03890770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101871587|NCT03890770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871588|NCT03883204|Risperidone|risperidone|mesh-list
101871589|NCT03883204|Aripiprazole|aripiprazole|mesh-list
101871590|NCT03883204|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101871591|NCT03883204|Serotonin Agents|serotonin agents|mesh-ancestor
101871592|NCT03883204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101871593|NCT03883204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871594|NCT03883204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871595|NCT03883204|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101871596|NCT03883204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101871597|NCT03883204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101871598|NCT03883204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101871599|NCT03883204|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101871600|NCT03883204|Dopamine Agents|dopamine agents|mesh-ancestor
101871601|NCT03883204|Antidepressive Agents|antidepressive agents|mesh-ancestor
101871602|NCT03883204|Dopamine Agonists|dopamine agonists|mesh-ancestor
101871603|NCT03883204|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101871604|NCT03883204|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101871605|NCT03883204|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101871606|NCT03883204|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101871607|NCT01263418|Ofatumumab|ofatumumab|mesh-list
101871608|NCT01263418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101871609|NCT03882814|Meperidine|meperidine|mesh-list
101871610|NCT03882814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101871611|NCT03882814|Narcotics|narcotics|mesh-ancestor
101871612|NCT03882814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101871613|NCT03882814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871614|NCT03882814|Analgesics|analgesics|mesh-ancestor
101871615|NCT03882814|Sensory System Agents|sensory system agents|mesh-ancestor
101871616|NCT03882814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101871617|NCT03882814|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101871618|NCT03647566|Listerine|listerine|mesh-list
101871619|NCT03647566|Fluorides|fluorides|mesh-list
101871620|NCT03647566|Sodium Fluoride|sodium fluoride|mesh-list
101871621|NCT03647566|Cariostatic Agents|cariostatic agents|mesh-ancestor
101871622|NCT03647566|Protective Agents|protective agents|mesh-ancestor
101871623|NCT03647566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871624|NCT03647566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101871625|NCT03647566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101871626|NCT01156636|Sildenafil Citrate|sildenafil citrate|mesh-list
101871627|NCT01156636|Vasodilator Agents|vasodilator agents|mesh-ancestor
101871628|NCT01156636|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101871629|NCT01156636|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101871630|NCT01156636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101871631|NCT01156636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871632|NCT01156636|Urological Agents|urological agents|mesh-ancestor
101871633|NCT03889288|Analgesics|analgesics|mesh-list
101871634|NCT03889288|Sensory System Agents|sensory system agents|mesh-ancestor
101871635|NCT03889288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101871636|NCT03889288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871637|NCT01153204|Sildenafil Citrate|sildenafil citrate|mesh-list
101871638|NCT01153204|Citric Acid|citric acid|mesh-list
101871639|NCT01153204|Sodium Citrate|sodium citrate|mesh-list
101871640|NCT01153204|Anticoagulants|anticoagulants|mesh-ancestor
101871641|NCT01153204|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101688525|NCT00646620|Hormones|hormones|mesh-ancestor
101871642|NCT01153204|Chelating Agents|chelating agents|mesh-ancestor
101871643|NCT01153204|Sequestering Agents|sequestering agents|mesh-ancestor
101871644|NCT01153204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871645|NCT01153204|Vasodilator Agents|vasodilator agents|mesh-ancestor
101871646|NCT01153204|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101871647|NCT01153204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101871648|NCT01153204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101871649|NCT01153204|Urological Agents|urological agents|mesh-ancestor
101871650|NCT03760666|Ribavirin|ribavirin|mesh-list
101871651|NCT03760666|Brequinar|brequinar|mesh-list
101871652|NCT03760666|Antimetabolites|antimetabolites|mesh-ancestor
101871653|NCT03760666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871654|NCT03760666|Antiviral Agents|antiviral agents|mesh-ancestor
101871655|NCT03760666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101871656|NCT03760666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101871657|NCT03760666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101871658|NCT03760666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101871659|NCT03760666|Immunologic Factors|immunologic factors|mesh-ancestor
101871660|NCT03760666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871661|NCT01263574|Ethanol|ethanol|mesh-list
101871662|NCT01263574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101871663|NCT01263574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101871664|NCT01263574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101871665|NCT01263574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871666|NCT03464734|Paclitaxel|paclitaxel|mesh-list
101871667|NCT03464734|Pembrolizumab|pembrolizumab|mesh-list
101871668|NCT03464734|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101871669|NCT03464734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101871670|NCT03464734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101871671|NCT03464734|Tubulin Modulators|tubulin modulators|mesh-ancestor
101871672|NCT03464734|Antimitotic Agents|antimitotic agents|mesh-ancestor
101871673|NCT03464734|Mitosis Modulators|mitosis modulators|mesh-ancestor
101871674|NCT03464734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871675|NCT03464734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101871676|NCT03464734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101871677|NCT01156948|Misoprostol|misoprostol|mesh-list
101871678|NCT01156948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101871679|NCT01156948|Abortifacient Agents|abortifacient agents|mesh-ancestor
101871680|NCT01156948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101871681|NCT01156948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871682|NCT01156948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101871683|NCT01156948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101871684|NCT01156948|Oxytocics|oxytocics|mesh-ancestor
101871685|NCT01157026|Tamoxifen|tamoxifen|mesh-list
101871686|NCT01157026|Tocotrienols|tocotrienols|mesh-list
101871687|NCT01157026|Vitamin E|vitamin e|mesh-list
101871688|NCT01157026|Tocopherols|tocopherols|mesh-list
101871689|NCT01157026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101871690|NCT01157026|Hormone Antagonists|hormone antagonists|mesh-ancestor
101871691|NCT01157026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101871692|NCT01157026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871693|NCT01157026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101871694|NCT01157026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101871695|NCT01157026|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101871696|NCT01157026|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101871697|NCT01157026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101871698|NCT01157026|Antioxidants|antioxidants|mesh-ancestor
101871699|NCT01157026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871700|NCT01157026|Protective Agents|protective agents|mesh-ancestor
101871701|NCT01157026|Vitamins|vitamins|mesh-ancestor
101871702|NCT01157026|Micronutrients|micronutrients|mesh-ancestor
101871703|NCT01263652|Dipyrone|dipyrone|mesh-list
101871704|NCT01263652|Diclofenac|diclofenac|mesh-list
101871705|NCT01263652|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
101871706|NCT01263652|Tramadol|tramadol|mesh-list
101871707|NCT01263652|Orphenadrine|orphenadrine|mesh-list
101871708|NCT01263652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101871709|NCT01263652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101871710|NCT01263652|Analgesics|analgesics|mesh-ancestor
101871711|NCT01263652|Sensory System Agents|sensory system agents|mesh-ancestor
101871712|NCT01263652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101688545|NCT00648492|Metformin|metformin|mesh-list
101871713|NCT01263652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871714|NCT01263652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101871715|NCT01263652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101871716|NCT01263652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101871717|NCT01263652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101871718|NCT01263652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871719|NCT01263652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101871720|NCT01263652|Narcotics|narcotics|mesh-ancestor
101871721|NCT01263652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101871722|NCT01263652|Antipyretics|antipyretics|mesh-ancestor
101871723|NCT01263652|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101871724|NCT01263652|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101871725|NCT01263652|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101871726|NCT01263652|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101871727|NCT01263652|Parasympatholytics|parasympatholytics|mesh-ancestor
101871728|NCT01263652|Autonomic Agents|autonomic agents|mesh-ancestor
101871729|NCT01263652|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101871730|NCT01263652|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101871731|NCT01263652|Cholinergic Agents|cholinergic agents|mesh-ancestor
101871732|NCT01263652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101871733|NCT01263652|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
101871734|NCT01263652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101871735|NCT03881644|Sumatriptan|sumatriptan|mesh-list
101871736|NCT03881644|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
101871737|NCT03881644|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101871738|NCT03881644|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101871739|NCT03881644|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101871740|NCT03881644|Serotonin Agents|serotonin agents|mesh-ancestor
101871741|NCT03881644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101871742|NCT03881644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871743|NCT03881644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871744|NCT03881644|Growth Substances|growth substances|mesh-ancestor
101871745|NCT03881644|Vasodilator Agents|vasodilator agents|mesh-ancestor
101871746|NCT01259830|Etoricoxib|etoricoxib|mesh-list
101871747|NCT01259830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101871748|NCT01259830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101871749|NCT01259830|Analgesics|analgesics|mesh-ancestor
101871750|NCT01259830|Sensory System Agents|sensory system agents|mesh-ancestor
101871751|NCT01259830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101871752|NCT01259830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871753|NCT01259830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101871754|NCT01259830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101871755|NCT01259830|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101871756|NCT01259830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101871757|NCT01259830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101871758|NCT01259830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871759|NCT00224484|Vaccines|vaccines|mesh-list
101871760|NCT00224484|Immunologic Factors|immunologic factors|mesh-ancestor
101871761|NCT00224484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871762|NCT01265680|Epoetin Alfa|epoetin alfa|mesh-list
101871763|NCT01265680|Hematinics|hematinics|mesh-ancestor
101871764|NCT01263808|Moxifloxacin|moxifloxacin|mesh-list
101871765|NCT01263808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101591607|NCT02627521|Purinergic Agents|purinergic agents|mesh-ancestor
101871766|NCT01263808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101871767|NCT01263808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101871768|NCT01263808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101871769|NCT01263808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101871770|NCT01263808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871771|NCT01263808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101871772|NCT01157572|Metoprolol|metoprolol|mesh-list
101871773|NCT01157572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101871774|NCT01157572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101871775|NCT01157572|Sympatholytics|sympatholytics|mesh-ancestor
101871776|NCT01157572|Autonomic Agents|autonomic agents|mesh-ancestor
101871777|NCT01157572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101871778|NCT01157572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871779|NCT01157572|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101338223|NCT00071266|Vitamins|vitamins|mesh-ancestor
101871780|NCT01157572|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101871782|NCT01157572|Adrenergic Agents|adrenergic agents|mesh-ancestor
101871783|NCT01157572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101688549|NCT00648570|Citalopram|citalopram|mesh-list
101871784|NCT01157572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871785|NCT01074372|Alirocumab|alirocumab|mesh-list
101871786|NCT01074372|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101871787|NCT01074372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101871788|NCT01074372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101871789|NCT01074372|Antimetabolites|antimetabolites|mesh-ancestor
101871790|NCT01074372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871791|NCT01074372|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101871792|NCT01074372|Protease Inhibitors|protease inhibitors|mesh-ancestor
101871793|NCT01074372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101871794|NCT01074372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101871795|NCT01267942|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101871796|NCT01267942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101871797|NCT01267942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101871798|NCT01267942|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101871799|NCT01267942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101871800|NCT01267942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871801|NCT00254982|Infliximab|infliximab|mesh-list
101871802|NCT00254982|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101871803|NCT00254982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101871804|NCT00254982|Dermatologic Agents|dermatologic agents|mesh-ancestor
101871805|NCT00254982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101871806|NCT00254982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101871807|NCT01586572|Vaccines|vaccines|mesh-list
101871808|NCT01586572|Immunologic Factors|immunologic factors|mesh-ancestor
101871809|NCT01586572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871810|NCT00224016|Mandelic Acids|mandelic acids|mesh-list
101871811|NCT00224016|Oxybutynin|oxybutynin|mesh-list
101871812|NCT00224016|Parasympatholytics|parasympatholytics|mesh-ancestor
101871813|NCT00224016|Autonomic Agents|autonomic agents|mesh-ancestor
101871814|NCT00224016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101871815|NCT00224016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871816|NCT00224016|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101871817|NCT00224016|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101871818|NCT00224016|Cholinergic Agents|cholinergic agents|mesh-ancestor
101871819|NCT00224016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101871820|NCT00224016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871821|NCT00224016|Urological Agents|urological agents|mesh-ancestor
101871822|NCT00224016|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101871823|NCT00224016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101871824|NCT02527174|Cytarabine|cytarabine|mesh-list
101871825|NCT02527174|Idarubicin|idarubicin|mesh-list
101871826|NCT02527174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101871827|NCT02527174|Antimetabolites|antimetabolites|mesh-ancestor
101871828|NCT02527174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871829|NCT02527174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101871830|NCT02527174|Antiviral Agents|antiviral agents|mesh-ancestor
101871831|NCT02527174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101871832|NCT02527174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101871833|NCT02527174|Immunologic Factors|immunologic factors|mesh-ancestor
101871834|NCT02527174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871835|NCT02527174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101871836|NCT02527174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101246086|NCT01663077|GABA Antagonists|gaba antagonists|mesh-ancestor
101871837|NCT02527174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101871838|NCT02527174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101871839|NCT01161940|Nizatidine|nizatidine|mesh-list
101871840|NCT01161940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101871841|NCT01161940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101871842|NCT01161940|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101871843|NCT01161940|Histamine Antagonists|histamine antagonists|mesh-ancestor
101871844|NCT01161940|Histamine Agents|histamine agents|mesh-ancestor
101871845|NCT01161940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101871846|NCT01161940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871847|NCT01161940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871849|NCT01160068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101871850|NCT01160068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871851|NCT01266694|Colchicine|colchicine|mesh-list
101871852|NCT01266694|Gout Suppressants|gout suppressants|mesh-ancestor
101871853|NCT01266694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101871854|NCT01266694|Tubulin Modulators|tubulin modulators|mesh-ancestor
101871855|NCT01266694|Antimitotic Agents|antimitotic agents|mesh-ancestor
101871856|NCT01266694|Mitosis Modulators|mitosis modulators|mesh-ancestor
101871857|NCT01266694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871858|NCT01266694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101871859|NCT03876886|Paclitaxel|paclitaxel|mesh-list
101871860|NCT03876886|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101871861|NCT03876886|Cyclophosphamide|cyclophosphamide|mesh-list
101871862|NCT03876886|Carboplatin|carboplatin|mesh-list
101871863|NCT03876886|Epirubicin|epirubicin|mesh-list
101871864|NCT03876886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101871865|NCT03876886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101871866|NCT03876886|Tubulin Modulators|tubulin modulators|mesh-ancestor
101871867|NCT03876886|Antimitotic Agents|antimitotic agents|mesh-ancestor
101871868|NCT03876886|Mitosis Modulators|mitosis modulators|mesh-ancestor
101871869|NCT03876886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871870|NCT03876886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101871871|NCT03876886|Immunologic Factors|immunologic factors|mesh-ancestor
101871872|NCT03876886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871873|NCT03876886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101871874|NCT03876886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101871875|NCT03876886|Alkylating Agents|alkylating agents|mesh-ancestor
101871876|NCT03876886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101871877|NCT03876886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101871878|NCT03876886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101871879|NCT03876886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101871880|NCT03876886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101871881|NCT01266772|Budesonide|budesonide|mesh-list
101871882|NCT01266772|Montelukast|montelukast|mesh-list
101871883|NCT01266772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101871884|NCT01266772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101871885|NCT01266772|Autonomic Agents|autonomic agents|mesh-ancestor
101871886|NCT01266772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101871887|NCT01266772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871888|NCT01266772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101871889|NCT01266772|Respiratory System Agents|respiratory system agents|mesh-ancestor
101871890|NCT01266772|Glucocorticoids|glucocorticoids|mesh-ancestor
101871891|NCT01266772|Hormones|hormones|mesh-ancestor
101871892|NCT01266772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101871893|NCT01266772|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101871894|NCT01266772|Hormone Antagonists|hormone antagonists|mesh-ancestor
101871895|NCT01266772|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101871896|NCT01266772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101871897|NCT01266772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871898|NCT01264354|Adefovir|adefovir|mesh-list
101871899|NCT01264354|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101871900|NCT01264354|Clevudine|clevudine|mesh-list
101871901|NCT01264354|Antiviral Agents|antiviral agents|mesh-ancestor
101871902|NCT01264354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101871903|NCT01264354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101871904|NCT01264354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101871905|NCT01264354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101871906|NCT01264354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871907|NCT01264432|Veliparib|veliparib|mesh-list
101871908|NCT01264432|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101871909|NCT01264432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101871910|NCT01264432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871911|NCT01264432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101871912|NCT02527096|Lamivudine|lamivudine|mesh-list
101871913|NCT02527096|Dolutegravir|dolutegravir|mesh-list
101871914|NCT02527096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101591752|NCT00680329|Timolol|timolol|mesh-list
101871915|NCT02527096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101871916|NCT02527096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101871917|NCT02527096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871918|NCT02527096|Antiviral Agents|antiviral agents|mesh-ancestor
101871919|NCT02527096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101871921|NCT02527096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101871922|NCT02527096|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101871923|NCT02527096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101871925|NCT01160302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101871926|NCT01160302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101871927|NCT01160302|Analgesics|analgesics|mesh-ancestor
101871928|NCT01160302|Sensory System Agents|sensory system agents|mesh-ancestor
101871929|NCT01160302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101871930|NCT01160302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871931|NCT01160302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101871932|NCT01160302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101871933|NCT01160302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101871934|NCT01160302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101871935|NCT01160302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871936|NCT01162720|Oxymetazoline|oxymetazoline|mesh-list
101871937|NCT01162720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101871938|NCT01162720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101871939|NCT01162720|Adrenergic Agents|adrenergic agents|mesh-ancestor
101871940|NCT01162720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101871941|NCT01162720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871942|NCT01162720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871943|NCT01162720|Sympathomimetics|sympathomimetics|mesh-ancestor
101871944|NCT01162720|Autonomic Agents|autonomic agents|mesh-ancestor
101871945|NCT01162720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101871946|NCT01162720|Nasal Decongestants|nasal decongestants|mesh-ancestor
101871947|NCT01162720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101871948|NCT01162720|Respiratory System Agents|respiratory system agents|mesh-ancestor
101871949|NCT01268176|Vitamin D|vitamin d|mesh-list
101871950|NCT01268176|Cholecalciferol|cholecalciferol|mesh-list
101871951|NCT01268176|Vitamins|vitamins|mesh-ancestor
101871952|NCT01268176|Micronutrients|micronutrients|mesh-ancestor
101871953|NCT01268176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871954|NCT01268176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101871955|NCT01268176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101871956|NCT01264588|Calcium|calcium|mesh-list
101871957|NCT01264588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101871958|NCT01264588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871959|NCT05075200|Tranexamic Acid|tranexamic acid|mesh-list
101871960|NCT05075200|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101871961|NCT05075200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101871962|NCT05075200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871963|NCT05075200|Hemostatics|hemostatics|mesh-ancestor
101871964|NCT05075200|Coagulants|coagulants|mesh-ancestor
101871965|NCT01158274|Capecitabine|capecitabine|mesh-list
101871966|NCT01158274|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
101871967|NCT01158274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101871968|NCT01158274|Antimetabolites|antimetabolites|mesh-ancestor
101871969|NCT01158274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871970|NCT01158274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101871971|NCT01158274|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101871972|NCT01158274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101871973|NCT01267084|Ketoconazole|ketoconazole|mesh-list
101871974|NCT01267084|Dexamethasone|dexamethasone|mesh-list
101871975|NCT01267084|Trabectedin|trabectedin|mesh-list
101871976|NCT01267084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101871977|NCT01267084|Antiemetics|antiemetics|mesh-ancestor
101871978|NCT01267084|Autonomic Agents|autonomic agents|mesh-ancestor
101871979|NCT01267084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101871980|NCT01267084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101871981|NCT01267084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101871982|NCT01267084|Glucocorticoids|glucocorticoids|mesh-ancestor
101871983|NCT01267084|Hormones|hormones|mesh-ancestor
101871984|NCT01267084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101871985|NCT01267084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101871986|NCT01267084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101871987|NCT01267084|Antifungal Agents|antifungal agents|mesh-ancestor
101871988|NCT01267084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101871989|NCT01267084|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101871990|NCT01267084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101871991|NCT01267084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101871992|NCT01267084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101871993|NCT01267084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101871994|NCT01267084|Hormone Antagonists|hormone antagonists|mesh-ancestor
101871995|NCT01267084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101871996|NCT01267084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101871997|NCT01267084|Alkylating Agents|alkylating agents|mesh-ancestor
101871998|NCT01264822|Rabeprazole|rabeprazole|mesh-list
101871999|NCT01264822|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101872000|NCT01264822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101872001|NCT01264822|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101872002|NCT01264822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101872003|NCT01264822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872004|NCT03876574|Dexamethasone|dexamethasone|mesh-list
101872005|NCT03876574|Gemcitabine|gemcitabine|mesh-list
101872006|NCT03876574|Floxuridine|floxuridine|mesh-list
101872007|NCT03876574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101872008|NCT03876574|Antiemetics|antiemetics|mesh-ancestor
101872009|NCT03876574|Autonomic Agents|autonomic agents|mesh-ancestor
101872010|NCT03876574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101872011|NCT03876574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872012|NCT03876574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101872013|NCT03876574|Glucocorticoids|glucocorticoids|mesh-ancestor
101872014|NCT03876574|Hormones|hormones|mesh-ancestor
101872015|NCT03876574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101872016|NCT03876574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101872017|NCT03876574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101872018|NCT03876574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101872019|NCT03876574|Antimetabolites|antimetabolites|mesh-ancestor
101872020|NCT03876574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872021|NCT01161082|Alirocumab|alirocumab|mesh-list
101872022|NCT01161082|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101872023|NCT01161082|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101872024|NCT01161082|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101872025|NCT01161082|Antimetabolites|antimetabolites|mesh-ancestor
101872026|NCT01161082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872027|NCT01161082|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101872028|NCT01161082|Protease Inhibitors|protease inhibitors|mesh-ancestor
101872029|NCT01161082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101872030|NCT01161082|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101872031|NCT01158586|Levobupivacaine|levobupivacaine|mesh-list
101872032|NCT01158586|Anesthetics, Local|anesthetics, local|mesh-ancestor
101872033|NCT01158586|Anesthetics|anesthetics|mesh-ancestor
101872034|NCT01158586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101872035|NCT01158586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872036|NCT01158586|Sensory System Agents|sensory system agents|mesh-ancestor
101872037|NCT01158586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101872038|NCT01267396|Sertraline|sertraline|mesh-list
101872039|NCT01267396|Antidepressive Agents|antidepressive agents|mesh-ancestor
101872040|NCT01267396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101872041|NCT01267396|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101872042|NCT01267396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101872043|NCT01267396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101872044|NCT01267396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872045|NCT01267396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101872046|NCT01267396|Serotonin Agents|serotonin agents|mesh-ancestor
101872047|NCT01267396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101966583|NCT01093157|Hormones|hormones|mesh-list
101872048|NCT01159132|Raltegravir Potassium|raltegravir potassium|mesh-list
101872049|NCT01159132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101872050|NCT01159132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101872051|NCT01159132|Antiviral Agents|antiviral agents|mesh-ancestor
101872052|NCT01159132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101872053|NCT01159132|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101872054|NCT01159132|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101872055|NCT01159132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101246160|NCT01664195|Hematinics|hematinics|mesh-ancestor
101872056|NCT01159132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872057|NCT01161316|Cetuximab|cetuximab|mesh-list
101872058|NCT01161316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101872059|NCT01161316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101872060|NCT01161550|Cytarabine|cytarabine|mesh-list
101591905|NCT00682825|Anesthetics, General|anesthetics, general|mesh-ancestor
101872061|NCT01161550|Tretinoin|tretinoin|mesh-list
101872062|NCT01161550|Cladribine|cladribine|mesh-list
101872063|NCT01161550|Midostaurin|midostaurin|mesh-list
101872064|NCT01161550|Lenograstim|lenograstim|mesh-list
101872065|NCT01161550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101872066|NCT01161550|Antimetabolites|antimetabolites|mesh-ancestor
101872067|NCT01161550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872068|NCT01161550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101872069|NCT01161550|Antiviral Agents|antiviral agents|mesh-ancestor
101872070|NCT01161550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101872071|NCT01161550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101872072|NCT01161550|Immunologic Factors|immunologic factors|mesh-ancestor
101872073|NCT01161550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872074|NCT01161550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101872075|NCT01161550|Keratolytic Agents|keratolytic agents|mesh-ancestor
101872076|NCT01161550|Dermatologic Agents|dermatologic agents|mesh-ancestor
101872077|NCT01161550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101872078|NCT01161550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101872079|NCT01159210|Thrombin|thrombin|mesh-list
101872080|NCT01159210|Hemostatics|hemostatics|mesh-ancestor
101872081|NCT01159210|Coagulants|coagulants|mesh-ancestor
101872082|NCT03879460|Naltrexone|naltrexone|mesh-list
101872083|NCT03879460|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101872084|NCT03879460|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101872085|NCT03879460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872086|NCT03879460|Sensory System Agents|sensory system agents|mesh-ancestor
101872087|NCT03879460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101872088|NCT03877120|Diazepam|diazepam|mesh-list
101872089|NCT03877120|Dexmedetomidine|dexmedetomidine|mesh-list
101872090|NCT03877120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101872091|NCT03877120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101872092|NCT03877120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872093|NCT03877120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101872094|NCT03877120|Analgesics|analgesics|mesh-ancestor
101872095|NCT03877120|Sensory System Agents|sensory system agents|mesh-ancestor
101872096|NCT03877120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101872097|NCT03877120|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101872098|NCT03877120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101872099|NCT03877120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101872100|NCT03877120|Adrenergic Agents|adrenergic agents|mesh-ancestor
101872101|NCT03877120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101872102|NCT03877120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872103|NCT03877120|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101872104|NCT03877120|Anticonvulsants|anticonvulsants|mesh-ancestor
101872105|NCT03877120|Antiemetics|antiemetics|mesh-ancestor
101872106|NCT03877120|Autonomic Agents|autonomic agents|mesh-ancestor
101872107|NCT03877120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101872108|NCT03877120|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101872109|NCT03877120|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101872110|NCT03877120|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101872111|NCT03877120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101872112|NCT03877120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101872113|NCT03877120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101872114|NCT03877120|Anesthetics, General|anesthetics, general|mesh-ancestor
101872115|NCT03877120|Anesthetics|anesthetics|mesh-ancestor
101872116|NCT03877120|GABA Modulators|gaba modulators|mesh-ancestor
101872117|NCT03877120|GABA Agents|gaba agents|mesh-ancestor
101872118|NCT03879382|Cyclophosphamide|cyclophosphamide|mesh-list
101872119|NCT03879382|Fludarabine|fludarabine|mesh-list
101966589|NCT01093235|Docetaxel|docetaxel|mesh-list
101872120|NCT03879382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101872121|NCT03879382|Immunologic Factors|immunologic factors|mesh-ancestor
101872122|NCT03879382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872123|NCT03879382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101872124|NCT03879382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101872125|NCT03879382|Alkylating Agents|alkylating agents|mesh-ancestor
101872126|NCT03879382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872127|NCT03879382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101872128|NCT03879382|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101872129|NCT01166932|Amoxicillin|amoxicillin|mesh-list
101872130|NCT01166932|Ceftriaxone|ceftriaxone|mesh-list
101872131|NCT01166932|Clavulanic Acids|clavulanic acids|mesh-list
101872132|NCT01166932|Clavulanic Acid|clavulanic acid|mesh-list
101872133|NCT01166932|Oxacillin|oxacillin|mesh-list
101872134|NCT01166932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101872135|NCT01166932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101872136|NCT01166932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101872137|NCT01166932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688570|NCT00648258|Valdecoxib|valdecoxib|mesh-list
101872139|NCT01167010|Budesonide|budesonide|mesh-list
101872140|NCT01167010|Formoterol Fumarate|formoterol fumarate|mesh-list
101872141|NCT01167010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101872142|NCT01167010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101872143|NCT01167010|Autonomic Agents|autonomic agents|mesh-ancestor
101872144|NCT01167010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101872145|NCT01167010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872146|NCT01167010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101872147|NCT01167010|Respiratory System Agents|respiratory system agents|mesh-ancestor
101872148|NCT01167010|Glucocorticoids|glucocorticoids|mesh-ancestor
101872149|NCT01167010|Hormones|hormones|mesh-ancestor
101872150|NCT01167010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101872151|NCT01167010|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101872152|NCT01167010|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101872153|NCT01167010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101872154|NCT01167010|Adrenergic Agents|adrenergic agents|mesh-ancestor
101872155|NCT01167010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101872156|NCT01167010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872157|NCT01280188|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101872158|NCT01280188|Hemostatics|hemostatics|mesh-ancestor
101872159|NCT01280188|Coagulants|coagulants|mesh-ancestor
101872160|NCT01280188|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101872161|NCT01280188|Natriuretic Agents|natriuretic agents|mesh-ancestor
101872162|NCT01280188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872163|NCT03871972|Sirolimus|sirolimus|mesh-list
101872164|NCT03871972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101872165|NCT03871972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101872166|NCT03871972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101872167|NCT03871972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101872168|NCT03871972|Antifungal Agents|antifungal agents|mesh-ancestor
101872169|NCT03871972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101872170|NCT03871972|Immunologic Factors|immunologic factors|mesh-ancestor
101872171|NCT03871972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872172|NCT01165060|Bezafibrate|bezafibrate|mesh-list
101872173|NCT01165060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101872174|NCT01165060|Antimetabolites|antimetabolites|mesh-ancestor
101872175|NCT01165060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872176|NCT01165060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101872177|NCT01165294|Ketamine|ketamine|mesh-list
101872178|NCT01165294|Analgesics|analgesics|mesh-ancestor
101872179|NCT01165294|Sensory System Agents|sensory system agents|mesh-ancestor
101872180|NCT01165294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101872181|NCT01165294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872182|NCT01165294|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101872183|NCT01165294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101872184|NCT01165294|Anesthetics, General|anesthetics, general|mesh-ancestor
101872185|NCT01165294|Anesthetics|anesthetics|mesh-ancestor
101872186|NCT01165294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101872187|NCT01165294|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101872188|NCT01165294|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101872190|NCT01165294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872191|NCT01165372|Artesunate|artesunate|mesh-list
101872192|NCT01165372|Piperaquine|piperaquine|mesh-list
101872193|NCT01165372|Artenimol|artenimol|mesh-list
101872194|NCT01165372|Antimalarials|antimalarials|mesh-ancestor
101872195|NCT01165372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101872196|NCT01165372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101872197|NCT01165372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101872198|NCT01165372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101872199|NCT01165372|Antiviral Agents|antiviral agents|mesh-ancestor
101872200|NCT01165372|Schistosomicides|schistosomicides|mesh-ancestor
101872201|NCT01165372|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101872202|NCT01165372|Anthelmintics|anthelmintics|mesh-ancestor
101872203|NCT01280734|Melatonin|melatonin|mesh-list
101872204|NCT01280734|Antioxidants|antioxidants|mesh-ancestor
101872205|NCT01280734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872206|NCT01280734|Protective Agents|protective agents|mesh-ancestor
101872207|NCT01280734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872208|NCT01280734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101872209|NCT01269970|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101872210|NCT01269970|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101872211|NCT01269970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872212|NCT01587430|Cytarabine|cytarabine|mesh-list
101872213|NCT01587430|Daunorubicin|daunorubicin|mesh-list
101872214|NCT01587430|Mitoxantrone|mitoxantrone|mesh-list
101872215|NCT01587430|Idarubicin|idarubicin|mesh-list
101872216|NCT01587430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101872217|NCT01587430|Antimetabolites|antimetabolites|mesh-ancestor
101872218|NCT01587430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872219|NCT01587430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101872220|NCT01587430|Antiviral Agents|antiviral agents|mesh-ancestor
101872221|NCT01587430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101872222|NCT01587430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101872223|NCT01587430|Immunologic Factors|immunologic factors|mesh-ancestor
101872224|NCT01587430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872225|NCT01587430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101872226|NCT01587430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101872227|NCT01587430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101872228|NCT01587430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101872229|NCT01587430|Analgesics|analgesics|mesh-ancestor
101872230|NCT01587430|Sensory System Agents|sensory system agents|mesh-ancestor
101872231|NCT01587430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101872232|NCT03874000|Metformin|metformin|mesh-list
101872233|NCT03874000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101872234|NCT03874000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872235|NCT03757234|Levofloxacin|levofloxacin|mesh-list
101872236|NCT03757234|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101872237|NCT03757234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101872238|NCT03757234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101872239|NCT03757234|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101872240|NCT03757234|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101872241|NCT03757234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101872242|NCT03757234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872243|NCT03757234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101872244|NCT03757234|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101872245|NCT03757234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101872246|NCT03874156|Atorvastatin|atorvastatin|mesh-list
101872247|NCT03874156|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101872248|NCT03874156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101872249|NCT03874156|Antimetabolites|antimetabolites|mesh-ancestor
101872250|NCT03874156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872251|NCT03874156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101872252|NCT03874156|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101872253|NCT03874156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101872255|NCT01167478|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101872256|NCT01167478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872257|NCT01167478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101872258|NCT01167478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101872259|NCT01167478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872260|NCT01167478|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101872261|NCT01167478|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101872262|NCT01167478|Purinergic Agents|purinergic agents|mesh-ancestor
101872263|NCT01167478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101872264|NCT01587196|Naltrexone|naltrexone|mesh-list
101872265|NCT01587196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101872266|NCT01587196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101872267|NCT01587196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872268|NCT01587196|Sensory System Agents|sensory system agents|mesh-ancestor
101872269|NCT01587196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101872270|NCT01281514|Carboplatin|carboplatin|mesh-list
101872271|NCT01281514|Doxorubicin|doxorubicin|mesh-list
101872272|NCT01281514|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101872273|NCT01281514|Everolimus|everolimus|mesh-list
101872274|NCT01281514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101872275|NCT01281514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101872276|NCT01281514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101872277|NCT01281514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101872278|NCT01281514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101872279|NCT01281514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872280|NCT01281514|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101872281|NCT01281514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101872282|NCT01281514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101872283|NCT01281514|Immunologic Factors|immunologic factors|mesh-ancestor
101872284|NCT01281514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872285|NCT00223080|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101872286|NCT00223080|Immunologic Factors|immunologic factors|mesh-ancestor
101872287|NCT00223080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872288|NCT00223080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101872289|NCT00223080|Antacids|antacids|mesh-ancestor
101872290|NCT00223080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872291|NCT00223080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101872292|NCT03971604|Vitamins|vitamins|mesh-list
101872293|NCT03971604|Vitamin E|vitamin e|mesh-list
101872294|NCT03971604|Vitamin A|vitamin a|mesh-list
101872295|NCT03971604|Micronutrients|micronutrients|mesh-ancestor
101872296|NCT03971604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872297|NCT03971604|Antioxidants|antioxidants|mesh-ancestor
101872298|NCT03971604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872299|NCT03971604|Protective Agents|protective agents|mesh-ancestor
101872300|NCT02531490|Labetalol|labetalol|mesh-list
101872301|NCT02531490|Methyldopa|methyldopa|mesh-list
101872302|NCT02531490|Nifedipine|nifedipine|mesh-list
101872303|NCT02531490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101872304|NCT02531490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101872305|NCT02531490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872306|NCT02531490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101872307|NCT02531490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872308|NCT02531490|Vasodilator Agents|vasodilator agents|mesh-ancestor
101872309|NCT02531490|Tocolytic Agents|tocolytic agents|mesh-ancestor
101872310|NCT02531490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101872311|NCT02531490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101872312|NCT02531490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101872313|NCT02531490|Adrenergic Agents|adrenergic agents|mesh-ancestor
101872314|NCT02531490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101872315|NCT02531490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101872316|NCT02531490|Sympathomimetics|sympathomimetics|mesh-ancestor
101872317|NCT02531490|Autonomic Agents|autonomic agents|mesh-ancestor
101872318|NCT02531490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101872319|NCT02531490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101872320|NCT02531490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101872321|NCT02531490|Sympatholytics|sympatholytics|mesh-ancestor
101872322|NCT02531490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101872323|NCT02531490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101872324|NCT02531490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101872325|NCT03871114|Triamcinolone|triamcinolone|mesh-list
101872326|NCT03871114|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101872327|NCT03871114|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101872328|NCT03871114|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101872329|NCT03871114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101872330|NCT03871114|Glucocorticoids|glucocorticoids|mesh-ancestor
101872331|NCT03871114|Hormones|hormones|mesh-ancestor
101872332|NCT03871114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101872333|NCT03871114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872334|NCT03871114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101872335|NCT03871114|Immunologic Factors|immunologic factors|mesh-ancestor
101872336|NCT03871114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101872337|NCT03871114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872338|NCT01281748|Methylprednisolone|methylprednisolone|mesh-list
101872339|NCT01281748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101872340|NCT01281748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101872341|NCT01281748|Prednisolone|prednisolone|mesh-list
101872342|NCT01281748|Prednisolone acetate|prednisolone acetate|mesh-list
101872343|NCT01281748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101872344|NCT01281748|Prednisolone phosphate|prednisolone phosphate|mesh-list
101872345|NCT01281748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101872346|NCT01281748|Antiemetics|antiemetics|mesh-ancestor
101872347|NCT01281748|Autonomic Agents|autonomic agents|mesh-ancestor
101872348|NCT01281748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101872349|NCT01281748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872350|NCT01281748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101872351|NCT01281748|Glucocorticoids|glucocorticoids|mesh-ancestor
101872352|NCT01281748|Hormones|hormones|mesh-ancestor
101872353|NCT01281748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101688578|NCT00648258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101872354|NCT01281748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101872355|NCT01281748|Protective Agents|protective agents|mesh-ancestor
101872356|NCT01281748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101872357|NCT01281748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101872358|NCT00220740|Immunoglobulins|immunoglobulins|mesh-list
101872359|NCT00220740|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101872360|NCT00220740|Antibodies|antibodies|mesh-list
101872361|NCT00220740|gamma-Globulins|gamma-globulins|mesh-list
101872362|NCT00220740|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101872363|NCT00220740|Immunoglobulin G|immunoglobulin g|mesh-list
101872364|NCT00220740|Immunologic Factors|immunologic factors|mesh-ancestor
101872365|NCT00220740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872367|NCT01273402|Immunoglobulins|immunoglobulins|mesh-list
101872368|NCT01273402|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101872369|NCT01273402|Immunologic Factors|immunologic factors|mesh-ancestor
101872370|NCT01273402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872371|NCT03873298|Nitric Oxide|nitric oxide|mesh-list
101872372|NCT03873298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101872373|NCT03873298|Autonomic Agents|autonomic agents|mesh-ancestor
101872374|NCT03873298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101872375|NCT03873298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872376|NCT03873298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101872377|NCT03873298|Respiratory System Agents|respiratory system agents|mesh-ancestor
101872378|NCT03873298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101872379|NCT03873298|Antioxidants|antioxidants|mesh-ancestor
101872380|NCT03873298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872381|NCT03873298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101872382|NCT03873298|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101872383|NCT03873298|Vasodilator Agents|vasodilator agents|mesh-ancestor
101872384|NCT03873298|Gasotransmitters|gasotransmitters|mesh-ancestor
101872385|NCT03873298|Protective Agents|protective agents|mesh-ancestor
101872386|NCT00184002|Prednisone|prednisone|mesh-list
101872387|NCT00184002|Cyclophosphamide|cyclophosphamide|mesh-list
101872388|NCT00184002|Doxorubicin|doxorubicin|mesh-list
101872389|NCT00184002|Vincristine|vincristine|mesh-list
101872390|NCT00184002|Rituximab|rituximab|mesh-list
101872391|NCT00184002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101872392|NCT00184002|Immunologic Factors|immunologic factors|mesh-ancestor
101872393|NCT00184002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872394|NCT00184002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101872395|NCT00184002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101872396|NCT00184002|Alkylating Agents|alkylating agents|mesh-ancestor
101872397|NCT00184002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246286|NCT01665222|Narcotics|narcotics|mesh-ancestor
101872398|NCT00184002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101872399|NCT00184002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101872400|NCT00184002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101872401|NCT00184002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101872402|NCT00184002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101872403|NCT00184002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101872404|NCT00184002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101872405|NCT00184002|Glucocorticoids|glucocorticoids|mesh-ancestor
101872406|NCT00184002|Hormones|hormones|mesh-ancestor
101872407|NCT00184002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101872408|NCT00184002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101872409|NCT00184002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101872410|NCT00184002|Tubulin Modulators|tubulin modulators|mesh-ancestor
101872411|NCT00184002|Antimitotic Agents|antimitotic agents|mesh-ancestor
101872412|NCT00184002|Mitosis Modulators|mitosis modulators|mesh-ancestor
101872413|NCT00184002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101872414|NCT01167946|Methylprednisolone|methylprednisolone|mesh-list
101872415|NCT01167946|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101872416|NCT01167946|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101872417|NCT01167946|Prednisolone|prednisolone|mesh-list
101872418|NCT01167946|Prednisolone acetate|prednisolone acetate|mesh-list
101872419|NCT01167946|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101872420|NCT01167946|Prednisolone phosphate|prednisolone phosphate|mesh-list
101872421|NCT01167946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101872422|NCT01167946|Antiemetics|antiemetics|mesh-ancestor
101872423|NCT01167946|Autonomic Agents|autonomic agents|mesh-ancestor
101872424|NCT01167946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101872425|NCT01167946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872426|NCT01167946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101872427|NCT01167946|Glucocorticoids|glucocorticoids|mesh-ancestor
101872428|NCT01167946|Hormones|hormones|mesh-ancestor
101688581|NCT00648258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101872429|NCT01167946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101872430|NCT01167946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101872431|NCT01167946|Protective Agents|protective agents|mesh-ancestor
101872432|NCT01167946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101872433|NCT01167946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101872435|NCT01275508|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101872436|NCT01275508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101872437|NCT01275508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101872438|NCT01073670|Acetaminophen|acetaminophen|mesh-list
101872439|NCT01073670|Indomethacin|indomethacin|mesh-list
101872440|NCT01073670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101872441|NCT01073670|Analgesics|analgesics|mesh-ancestor
101872442|NCT01073670|Sensory System Agents|sensory system agents|mesh-ancestor
101872443|NCT01073670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101872444|NCT01073670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872446|NCT01073670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101872447|NCT01073670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101872448|NCT01073670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101872449|NCT01073670|Gout Suppressants|gout suppressants|mesh-ancestor
101872450|NCT01073670|Tocolytic Agents|tocolytic agents|mesh-ancestor
101872451|NCT01073670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101872452|NCT01073670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101872453|NCT01073670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101872454|NCT01073670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872455|NCT03971370|Vaccines|vaccines|mesh-list
101872456|NCT03971370|Immunologic Factors|immunologic factors|mesh-ancestor
101872457|NCT03971370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872458|NCT01168336|Betahistine|betahistine|mesh-list
101872459|NCT01168336|Vasodilator Agents|vasodilator agents|mesh-ancestor
101872460|NCT01168336|Histamine Agonists|histamine agonists|mesh-ancestor
101872461|NCT01168336|Histamine Agents|histamine agents|mesh-ancestor
101872462|NCT01168336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101872463|NCT01168336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872464|NCT01168336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872465|NCT00165672|Rabeprazole|rabeprazole|mesh-list
101872466|NCT00165672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101872467|NCT00165672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101872468|NCT00165672|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101872469|NCT00165672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101872470|NCT00165672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872471|NCT03870646|Hyaluronic Acid|hyaluronic acid|mesh-list
101872472|NCT03870646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101872473|NCT03870646|Immunologic Factors|immunologic factors|mesh-ancestor
101872474|NCT03870646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872475|NCT03870646|Viscosupplements|viscosupplements|mesh-ancestor
101872476|NCT03870646|Protective Agents|protective agents|mesh-ancestor
101872478|NCT01168492|Analgesics|analgesics|mesh-ancestor
101872479|NCT01168492|Sensory System Agents|sensory system agents|mesh-ancestor
101872480|NCT01168492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101872481|NCT01168492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872482|NCT01168492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101872483|NCT01168492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101872484|NCT01168492|Anesthetics, General|anesthetics, general|mesh-ancestor
101872485|NCT01168492|Anesthetics|anesthetics|mesh-ancestor
101872486|NCT01168492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101872487|NCT01168492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101872488|NCT01168492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101872489|NCT01168492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101872490|NCT01168492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872491|NCT03870490|Cefepime|cefepime|mesh-list
101872492|NCT03870490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101872493|NCT03870490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101872494|NCT01278082|Budesonide|budesonide|mesh-list
101872495|NCT01278082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101872496|NCT01278082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101872497|NCT01278082|Autonomic Agents|autonomic agents|mesh-ancestor
101872498|NCT01278082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101872499|NCT01278082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872500|NCT01278082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101688584|NCT00648336|Mercaptopurine|mercaptopurine|mesh-list
101872501|NCT01278082|Respiratory System Agents|respiratory system agents|mesh-ancestor
101872502|NCT01278082|Glucocorticoids|glucocorticoids|mesh-ancestor
101872503|NCT01278082|Hormones|hormones|mesh-ancestor
101872504|NCT01278082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101872505|NCT03870256|Misoprostol|misoprostol|mesh-list
101872506|NCT03870256|Carbetocin|carbetocin|mesh-list
101872507|NCT03870256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101872508|NCT03870256|Abortifacient Agents|abortifacient agents|mesh-ancestor
101872509|NCT03870256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101872510|NCT03870256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872511|NCT03870256|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101872512|NCT03870256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101872513|NCT03870256|Oxytocics|oxytocics|mesh-ancestor
101872514|NCT01166542|Paclitaxel|paclitaxel|mesh-list
101872515|NCT01166542|Carboplatin|carboplatin|mesh-list
101872516|NCT01166542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101872517|NCT01166542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101872518|NCT01166542|Tubulin Modulators|tubulin modulators|mesh-ancestor
101872519|NCT01166542|Antimitotic Agents|antimitotic agents|mesh-ancestor
101872520|NCT01166542|Mitosis Modulators|mitosis modulators|mesh-ancestor
101872521|NCT01166542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872522|NCT00169104|Trastuzumab|trastuzumab|mesh-list
101872523|NCT00169104|Vinorelbine|vinorelbine|mesh-list
101872524|NCT00169104|Lenograstim|lenograstim|mesh-list
101872525|NCT00169104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101872526|NCT00169104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101872527|NCT00169104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101872528|NCT00169104|Immunologic Factors|immunologic factors|mesh-ancestor
101872529|NCT00169104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872530|NCT00169104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101966630|NCT03894046|Imipenem|imipenem|mesh-list
101872531|NCT00169104|Tubulin Modulators|tubulin modulators|mesh-ancestor
101872532|NCT00169104|Antimitotic Agents|antimitotic agents|mesh-ancestor
101872533|NCT00169104|Mitosis Modulators|mitosis modulators|mesh-ancestor
101872534|NCT00169104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872535|NCT03872830|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
101872536|NCT03872830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101872537|NCT03872830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101872538|NCT03872830|Analgesics|analgesics|mesh-ancestor
101872539|NCT03872830|Sensory System Agents|sensory system agents|mesh-ancestor
101872540|NCT03872830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101872541|NCT03872830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872542|NCT03872830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101872543|NCT03872830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101872544|NCT02526316|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101872545|NCT02526316|Freund's Adjuvant|freund's adjuvant|mesh-list
101872546|NCT02526316|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101872547|NCT02526316|Immunologic Factors|immunologic factors|mesh-ancestor
101872548|NCT02526316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872549|NCT03872596|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101872550|NCT03872596|Antidepressive Agents|antidepressive agents|mesh-ancestor
101872551|NCT03872596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101872552|NCT03872596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101872553|NCT03872596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101872554|NCT03872596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101872555|NCT03872596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872556|NCT00163020|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
101872557|NCT00163020|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
101872558|NCT00163020|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101872559|NCT00163020|Hormone Antagonists|hormone antagonists|mesh-ancestor
101872560|NCT00163020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101872561|NCT00163020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872562|NCT00163020|Progestins|progestins|mesh-ancestor
101872563|NCT00163020|Hormones|hormones|mesh-ancestor
101872564|NCT01168804|Dexamethasone|dexamethasone|mesh-list
101872565|NCT01168804|Bortezomib|bortezomib|mesh-list
101872566|NCT01168804|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101872567|NCT01168804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101872568|NCT01168804|Antiemetics|antiemetics|mesh-ancestor
101872569|NCT01168804|Autonomic Agents|autonomic agents|mesh-ancestor
101872570|NCT01168804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101872571|NCT01168804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872572|NCT01168804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101872573|NCT01168804|Glucocorticoids|glucocorticoids|mesh-ancestor
101872574|NCT01168804|Hormones|hormones|mesh-ancestor
101688585|NCT00648336|Antimetabolites|antimetabolites|mesh-ancestor
101872575|NCT01168804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101872577|NCT01168804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101872578|NCT01168804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101872579|NCT01168804|Alkylating Agents|alkylating agents|mesh-ancestor
101872580|NCT01168804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872581|NCT03873532|Capecitabine|capecitabine|mesh-list
101872582|NCT03873532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101872583|NCT03873532|Antimetabolites|antimetabolites|mesh-ancestor
101872584|NCT03873532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872585|NCT03873532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101872586|NCT01282528|Infliximab|infliximab|mesh-list
101872587|NCT01282528|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101872588|NCT01282528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101872589|NCT01282528|Dermatologic Agents|dermatologic agents|mesh-ancestor
101872590|NCT01282528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101872591|NCT01282528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101872592|NCT01169506|Silicon|silicon|mesh-list
101872593|NCT01169506|Trace Elements|trace elements|mesh-ancestor
101872594|NCT01169506|Micronutrients|micronutrients|mesh-ancestor
101872595|NCT01169506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872596|NCT01169740|Bilirubin|bilirubin|mesh-list
101872597|NCT01169740|Antioxidants|antioxidants|mesh-ancestor
101966634|NCT03894046|Cilastatin|cilastatin|mesh-list
101872598|NCT01169740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872599|NCT01169740|Protective Agents|protective agents|mesh-ancestor
101872600|NCT01169740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872602|NCT01169584|Sargramostim|sargramostim|mesh-list
101872603|NCT01169584|Immunologic Factors|immunologic factors|mesh-ancestor
101872604|NCT01169584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872605|NCT01169584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101872606|NCT01169818|Insulin Glargine|insulin glargine|mesh-list
101872607|NCT01169818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101872608|NCT01169818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872609|NCT01282762|Vaccines|vaccines|mesh-list
101872610|NCT01282762|Immunologic Factors|immunologic factors|mesh-ancestor
101872611|NCT01282762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872612|NCT01282840|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101872613|NCT01282840|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101872614|NCT01282840|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101872615|NCT01282840|Cholinergic Agents|cholinergic agents|mesh-ancestor
101872616|NCT01282840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101246348|NCT01665404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101872617|NCT01282840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872618|NCT01282840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872619|NCT01282840|Urological Agents|urological agents|mesh-ancestor
101872620|NCT01172548|Imatinib Mesylate|imatinib mesylate|mesh-list
101872621|NCT01172548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101872622|NCT01172548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101872623|NCT01172548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101872624|NCT01172548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872625|NCT01172626|Valproic Acid|valproic acid|mesh-list
101872626|NCT01172626|Anticonvulsants|anticonvulsants|mesh-ancestor
101872627|NCT01172626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101872628|NCT01172626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872629|NCT01172626|GABA Agents|gaba agents|mesh-ancestor
101872630|NCT01172626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101872631|NCT01172626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872632|NCT01172626|Antimanic Agents|antimanic agents|mesh-ancestor
101872633|NCT01172626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101872634|NCT01172626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101872635|NCT01172626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101872636|NCT01172782|Hydromorphone|hydromorphone|mesh-list
101872637|NCT01172782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101872638|NCT01172782|Narcotics|narcotics|mesh-ancestor
101872639|NCT01172782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101872640|NCT01172782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872641|NCT01172782|Analgesics|analgesics|mesh-ancestor
101872642|NCT01172782|Sensory System Agents|sensory system agents|mesh-ancestor
101872643|NCT01172782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101872644|NCT03866746|Aflibercept|aflibercept|mesh-list
101872645|NCT03866746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101872646|NCT03866746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101872647|NCT03866746|Growth Substances|growth substances|mesh-ancestor
101872648|NCT03866746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872649|NCT03866746|Growth Inhibitors|growth inhibitors|mesh-ancestor
101872650|NCT03866746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101872651|NCT03869398|Calcitriol|calcitriol|mesh-list
101872652|NCT03869398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101872653|NCT03869398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872654|NCT03869398|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101872655|NCT03869398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101872656|NCT03869398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872657|NCT03869398|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101872658|NCT03869398|Vitamins|vitamins|mesh-ancestor
101872659|NCT03869398|Micronutrients|micronutrients|mesh-ancestor
101872660|NCT03869398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101872661|NCT01170052|Sirolimus|sirolimus|mesh-list
101872662|NCT01170052|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101872663|NCT01170052|Temsirolimus|temsirolimus|mesh-list
101872664|NCT01170052|MTOR Inhibitors|mtor inhibitors|mesh-list
101592502|NCT04316351|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101872665|NCT01170052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101872666|NCT01170052|Alkylating Agents|alkylating agents|mesh-ancestor
101872667|NCT01170052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872668|NCT01170052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101872669|NCT01170052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101872670|NCT01170052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101872671|NCT01170052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101872672|NCT01170052|Immunologic Factors|immunologic factors|mesh-ancestor
101872673|NCT01170052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872674|NCT01170052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101872675|NCT01170052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101872676|NCT01170052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101872677|NCT01170052|Antifungal Agents|antifungal agents|mesh-ancestor
101872678|NCT01284478|Dexamethasone|dexamethasone|mesh-list
101872679|NCT01284478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101872680|NCT01284478|Antiemetics|antiemetics|mesh-ancestor
101872681|NCT01284478|Autonomic Agents|autonomic agents|mesh-ancestor
101872682|NCT01284478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101872683|NCT01284478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872684|NCT01284478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101872685|NCT01284478|Glucocorticoids|glucocorticoids|mesh-ancestor
101872686|NCT01284478|Hormones|hormones|mesh-ancestor
101872687|NCT01284478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101872688|NCT01284478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101872689|NCT01284478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101872690|NCT00252720|Candesartan|candesartan|mesh-list
101872691|NCT00252720|Candesartan cilexetil|candesartan cilexetil|mesh-list
101872692|NCT00252720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101872693|NCT00252720|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101872694|NCT00252720|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101872695|NCT00252720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872696|NCT01284556|Phenobarbital|phenobarbital|mesh-list
101872697|NCT01284556|Anticonvulsants|anticonvulsants|mesh-ancestor
101872698|NCT01284556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101872699|NCT01284556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101872700|NCT01284556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872701|NCT01284556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101872702|NCT01284556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101872703|NCT01284556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101872704|NCT01284556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872705|NCT01284556|GABA Modulators|gaba modulators|mesh-ancestor
101872706|NCT01284556|GABA Agents|gaba agents|mesh-ancestor
101872707|NCT01284556|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101872708|NCT01284556|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101872709|NCT01284556|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101872710|NCT01170130|Lidocaine|lidocaine|mesh-list
101872711|NCT01170130|Anesthetics, Local|anesthetics, local|mesh-ancestor
101872712|NCT01170130|Anesthetics|anesthetics|mesh-ancestor
101872713|NCT01170130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101872714|NCT01170130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872715|NCT01170130|Sensory System Agents|sensory system agents|mesh-ancestor
101872716|NCT01170130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101872717|NCT01170130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101872718|NCT01170130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101872719|NCT01170130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101872720|NCT01170130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101872721|NCT01170130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872722|NCT03868852|Apatinib|apatinib|mesh-list
101872723|NCT03868852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101872724|NCT03868852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101872725|NCT03868852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101872726|NCT03868852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872727|NCT01283776|Cyclophosphamide|cyclophosphamide|mesh-list
101872728|NCT01283776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101872729|NCT01283776|Immunologic Factors|immunologic factors|mesh-ancestor
101872730|NCT01283776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872731|NCT01283776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101872732|NCT01283776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101872733|NCT01283776|Alkylating Agents|alkylating agents|mesh-ancestor
101872734|NCT01283776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872735|NCT01283776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101872736|NCT01283776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101872737|NCT01163500|Ubiquinone|ubiquinone|mesh-list
101872739|NCT01163500|Micronutrients|micronutrients|mesh-ancestor
101872740|NCT01163500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872741|NCT01163500|Vitamins|vitamins|mesh-ancestor
101872742|NCT01163734|Ranolazine|ranolazine|mesh-list
101872743|NCT01163734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101872744|NCT01163734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101872745|NCT01163734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872746|NCT01284868|Propranolol|propranolol|mesh-list
101872747|NCT01284868|Bisoprolol|bisoprolol|mesh-list
101872748|NCT01284868|Mirabegron|mirabegron|mesh-list
101872749|NCT01284868|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101872750|NCT01284868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101872751|NCT01284868|Adrenergic Agents|adrenergic agents|mesh-ancestor
101872752|NCT01284868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101872753|NCT01284868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872754|NCT01284868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872755|NCT01284868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101872756|NCT01284868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101872757|NCT01284868|Vasodilator Agents|vasodilator agents|mesh-ancestor
101872758|NCT01284868|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101872759|NCT01284868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101872760|NCT01284868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101872761|NCT01284868|Urological Agents|urological agents|mesh-ancestor
101872762|NCT01284868|Sympatholytics|sympatholytics|mesh-ancestor
101872763|NCT01284868|Autonomic Agents|autonomic agents|mesh-ancestor
101872764|NCT01284868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101872765|NCT01284868|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101872766|NCT01170442|Vitamin D|vitamin d|mesh-list
101872767|NCT01170442|Ergocalciferols|ergocalciferols|mesh-list
101872768|NCT01170442|Cholecalciferol|cholecalciferol|mesh-list
101872769|NCT01170442|Vitamins|vitamins|mesh-list
101872770|NCT01170442|Micronutrients|micronutrients|mesh-ancestor
101872771|NCT01170442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872772|NCT01170442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101872773|NCT01170442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101872774|NCT00252564|Leucovorin|leucovorin|mesh-list
101872775|NCT00252564|Bevacizumab|bevacizumab|mesh-list
101872776|NCT00252564|Cetuximab|cetuximab|mesh-list
101872777|NCT00252564|Fluorouracil|fluorouracil|mesh-list
101872778|NCT00252564|Oxaliplatin|oxaliplatin|mesh-list
101872779|NCT00252564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101872780|NCT00252564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101872781|NCT00252564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101872782|NCT00252564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101872783|NCT00252564|Growth Substances|growth substances|mesh-ancestor
101872784|NCT00252564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872785|NCT00252564|Growth Inhibitors|growth inhibitors|mesh-ancestor
101872786|NCT00252564|Antimetabolites|antimetabolites|mesh-ancestor
101872787|NCT00252564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872788|NCT00252564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101872789|NCT00252564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101872790|NCT00252564|Immunologic Factors|immunologic factors|mesh-ancestor
101872791|NCT00252564|Antidotes|antidotes|mesh-ancestor
101872792|NCT00252564|Protective Agents|protective agents|mesh-ancestor
101872793|NCT00252564|Vitamin B Complex|vitamin b complex|mesh-ancestor
101872794|NCT00252564|Vitamins|vitamins|mesh-ancestor
101872795|NCT00252564|Micronutrients|micronutrients|mesh-ancestor
101872796|NCT01284946|Deferasirox|deferasirox|mesh-list
101872797|NCT01284946|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101872798|NCT01284946|Chelating Agents|chelating agents|mesh-ancestor
101872799|NCT01284946|Sequestering Agents|sequestering agents|mesh-ancestor
101872800|NCT01284946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872801|NCT01173562|Mebendazole|mebendazole|mesh-list
101872803|NCT01173562|Piperazine citrate|piperazine citrate|mesh-list
101872804|NCT01173562|DMP 777|dmp 777|mesh-list
101872805|NCT01173562|Antinematodal Agents|antinematodal agents|mesh-ancestor
101872806|NCT01173562|Anthelmintics|anthelmintics|mesh-ancestor
101872807|NCT01173562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101872808|NCT01173562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101872809|NCT01173562|Tubulin Modulators|tubulin modulators|mesh-ancestor
101872810|NCT01173562|Antimitotic Agents|antimitotic agents|mesh-ancestor
101872811|NCT01173562|Mitosis Modulators|mitosis modulators|mesh-ancestor
101872812|NCT01173562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872813|NCT01173562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101872814|NCT01173562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101872815|NCT00166296|Escitalopram|escitalopram|mesh-list
101872816|NCT00166296|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101872817|NCT00166296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101872818|NCT00166296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101872819|NCT00166296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872820|NCT00166296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101872821|NCT00166296|Serotonin Agents|serotonin agents|mesh-ancestor
101872822|NCT00166296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872823|NCT01173640|Midazolam|midazolam|mesh-list
101872824|NCT01173640|Resveratrol|resveratrol|mesh-list
101872825|NCT01173640|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101872826|NCT01173640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101872827|NCT01173640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101872828|NCT01173640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872829|NCT01173640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101872830|NCT01173640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101872831|NCT01173640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101872832|NCT01173640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101872833|NCT01173640|Anesthetics, General|anesthetics, general|mesh-ancestor
101872834|NCT01173640|Anesthetics|anesthetics|mesh-ancestor
101872835|NCT01173640|GABA Modulators|gaba modulators|mesh-ancestor
101872836|NCT01173640|GABA Agents|gaba agents|mesh-ancestor
101872837|NCT01173640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101872838|NCT01173640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872839|NCT01173640|Antioxidants|antioxidants|mesh-ancestor
101872840|NCT01173640|Protective Agents|protective agents|mesh-ancestor
101872841|NCT01173640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101872842|NCT01173640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101872843|NCT00252174|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
101872844|NCT00252174|Hallucinogens|hallucinogens|mesh-ancestor
101872845|NCT00252174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872846|NCT00252174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101872847|NCT00252174|Serotonin Agents|serotonin agents|mesh-ancestor
101872848|NCT00252174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101872849|NCT00252174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872850|NCT00252174|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101872851|NCT00252174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101872852|NCT00252174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101872853|NCT00252174|Adrenergic Agents|adrenergic agents|mesh-ancestor
101872854|NCT03868306|Chrysarobin|chrysarobin|mesh-list
101872855|NCT03868306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101872856|NCT03868306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101872857|NCT03868306|Analgesics|analgesics|mesh-ancestor
101872858|NCT03868306|Sensory System Agents|sensory system agents|mesh-ancestor
101872859|NCT03868306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101872860|NCT03868306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872861|NCT03868306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101872862|NCT03868306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101872863|NCT01164046|Vitamin K|vitamin k|mesh-list
101872864|NCT01164046|Heparin|heparin|mesh-list
101872865|NCT01164046|Enoxaparin|enoxaparin|mesh-list
101872866|NCT01164046|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101872867|NCT01164046|Tinzaparin|tinzaparin|mesh-list
101872868|NCT01164046|Dalteparin|dalteparin|mesh-list
101872869|NCT01164046|Nadroparin|nadroparin|mesh-list
101872870|NCT01164046|Reviparin|reviparin|mesh-list
101872871|NCT01164046|Warfarin|warfarin|mesh-list
101872872|NCT01164046|Acenocoumarol|acenocoumarol|mesh-list
101872873|NCT01164046|Phenprocoumon|phenprocoumon|mesh-list
101872875|NCT01164046|Certoparin|certoparin|mesh-list
101872876|NCT01164046|Vitamins|vitamins|mesh-ancestor
101872877|NCT01164046|Micronutrients|micronutrients|mesh-ancestor
101872878|NCT01164046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872879|NCT01164046|Anticoagulants|anticoagulants|mesh-ancestor
101872880|NCT01164046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101872881|NCT01164046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101872882|NCT01164046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872883|NCT01164046|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101872884|NCT01164046|Hemostatics|hemostatics|mesh-ancestor
101872885|NCT01164046|Coagulants|coagulants|mesh-ancestor
101872886|NCT01075464|Paclitaxel|paclitaxel|mesh-list
101872887|NCT01075464|Bevacizumab|bevacizumab|mesh-list
101872888|NCT01075464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101872889|NCT01075464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101872890|NCT01075464|Tubulin Modulators|tubulin modulators|mesh-ancestor
101872891|NCT01075464|Antimitotic Agents|antimitotic agents|mesh-ancestor
101872892|NCT01075464|Mitosis Modulators|mitosis modulators|mesh-ancestor
101872893|NCT01075464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872894|NCT01075464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101872895|NCT01075464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101872896|NCT01075464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101872897|NCT01075464|Growth Substances|growth substances|mesh-ancestor
101872898|NCT01075464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872899|NCT01075464|Growth Inhibitors|growth inhibitors|mesh-ancestor
101872900|NCT01074996|Leucovorin|leucovorin|mesh-list
101872901|NCT01074996|Antidotes|antidotes|mesh-ancestor
101872902|NCT01074996|Protective Agents|protective agents|mesh-ancestor
101872903|NCT01074996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872904|NCT01074996|Vitamin B Complex|vitamin b complex|mesh-ancestor
101872905|NCT01074996|Vitamins|vitamins|mesh-ancestor
101872906|NCT01074996|Micronutrients|micronutrients|mesh-ancestor
101872915|NCT00160524|Certolizumab Pegol|certolizumab pegol|mesh-list
101872916|NCT00160524|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101872917|NCT00160524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101872918|NCT00160524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101872919|NCT00160524|Immunologic Factors|immunologic factors|mesh-ancestor
101872920|NCT00160524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872921|NCT00160524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101872922|NCT01077570|Repaglinide|repaglinide|mesh-list
101872923|NCT01077570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101872924|NCT01077570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872925|NCT01075698|Telmisartan|telmisartan|mesh-list
101872926|NCT01075698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101872927|NCT01075698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101872928|NCT01075698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101872929|NCT01075698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872930|NCT00159822|Voriconazole|voriconazole|mesh-list
101872931|NCT00159822|Antifungal Agents|antifungal agents|mesh-ancestor
101872932|NCT00159822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101872933|NCT00159822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101872934|NCT00159822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101872935|NCT00159822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101872936|NCT00159822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872937|NCT00159822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101872938|NCT00159822|Hormone Antagonists|hormone antagonists|mesh-ancestor
101872939|NCT00159822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101872940|NCT00159822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872941|NCT00159822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101235771|NCT01594775|Oxytocin|oxytocin|mesh-list
101872942|NCT00158262|Propranolol|propranolol|mesh-list
101872943|NCT00158262|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101872945|NCT00158262|Adrenergic Agents|adrenergic agents|mesh-ancestor
101872946|NCT00158262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101872947|NCT00158262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872948|NCT00158262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872949|NCT00158262|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101872950|NCT00158262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101872951|NCT00158262|Vasodilator Agents|vasodilator agents|mesh-ancestor
101872952|NCT03868072|Tofacitinib|tofacitinib|mesh-list
101872953|NCT03868072|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101872954|NCT03868072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101872955|NCT03868072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101872956|NCT03868072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872957|NCT02526394|Vaccines|vaccines|mesh-list
101872958|NCT02526394|Immunologic Factors|immunologic factors|mesh-ancestor
101872959|NCT02526394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872960|NCT01283932|Pantoprazole|pantoprazole|mesh-list
101872961|NCT01283932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101872962|NCT01283932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101872963|NCT01283932|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101872964|NCT01283932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101872965|NCT01283932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872966|NCT01171300|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101872967|NCT01171300|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101872968|NCT01171300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872969|NCT01171378|Ofatumumab|ofatumumab|mesh-list
101872970|NCT01171378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101872971|NCT01171456|Metformin|metformin|mesh-list
101872972|NCT01171456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101872973|NCT01171456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872974|NCT03865888|Cyclosporine|cyclosporine|mesh-list
101872975|NCT03865888|Tacrolimus|tacrolimus|mesh-list
101872976|NCT03865888|Cyclosporins|cyclosporins|mesh-list
101872977|NCT03865888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101872978|NCT03865888|Immunologic Factors|immunologic factors|mesh-ancestor
101872979|NCT03865888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872980|NCT03865888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101872981|NCT03865888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101872982|NCT03865888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872983|NCT03865888|Antifungal Agents|antifungal agents|mesh-ancestor
101872984|NCT03865888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101872985|NCT03865888|Dermatologic Agents|dermatologic agents|mesh-ancestor
101872986|NCT03865888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101872987|NCT01284166|Timolol|timolol|mesh-list
101872988|NCT01284166|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101872989|NCT01284166|Dorzolamide|dorzolamide|mesh-list
101872990|NCT01284166|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101872991|NCT01284166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101872992|NCT01284166|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101872993|NCT01284166|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101872994|NCT01284166|Adrenergic Agents|adrenergic agents|mesh-ancestor
101872995|NCT01284166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101872996|NCT01284166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101872997|NCT01284166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101872998|NCT01284166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101872999|NCT01284166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101873000|NCT01284166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101873001|NCT01284166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101873002|NCT01284166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101873003|NCT01284166|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101873004|NCT01284166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101873005|NCT01285414|Temozolomide|temozolomide|mesh-list
101873006|NCT01285414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101873007|NCT01285414|Alkylating Agents|alkylating agents|mesh-ancestor
101873008|NCT01285414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873009|NCT01285414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101873010|NCT01172002|Azathioprine|azathioprine|mesh-list
101873011|NCT01172002|Leflunomide|leflunomide|mesh-list
101873012|NCT01172002|Antimetabolites|antimetabolites|mesh-ancestor
101873013|NCT01172002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873014|NCT01172002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101873015|NCT01172002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101873016|NCT01172002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101873017|NCT01172002|Immunologic Factors|immunologic factors|mesh-ancestor
101873018|NCT01172002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873019|NCT01172002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101873020|NCT01172002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101873021|NCT03867994|Carvedilol|carvedilol|mesh-list
101873022|NCT03867994|Atorvastatin|atorvastatin|mesh-list
101873023|NCT03867994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101873024|NCT03867994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101873025|NCT03867994|Antimetabolites|antimetabolites|mesh-ancestor
101873026|NCT03867994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873027|NCT03867994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101873028|NCT03867994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101873029|NCT03867994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101873030|NCT03867994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101873031|NCT03867994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101873032|NCT03867994|Adrenergic Agents|adrenergic agents|mesh-ancestor
101873033|NCT03867994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101873034|NCT03867994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873035|NCT03867994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101873036|NCT03867994|Antioxidants|antioxidants|mesh-ancestor
101873037|NCT03867994|Protective Agents|protective agents|mesh-ancestor
101873038|NCT03867994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101873039|NCT03867994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101873040|NCT03867994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101873041|NCT03867994|Vasodilator Agents|vasodilator agents|mesh-ancestor
101873042|NCT03867994|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101873043|NCT03867994|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101873044|NCT01172236|Lactoferrin|lactoferrin|mesh-list
101873045|NCT01172236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101873046|NCT02525848|Dexamethasone|dexamethasone|mesh-list
101873047|NCT02525848|Gabapentin|gabapentin|mesh-list
101873048|NCT02525848|Aprepitant|aprepitant|mesh-list
101873049|NCT02525848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101873050|NCT02525848|Antiemetics|antiemetics|mesh-ancestor
101873051|NCT02525848|Autonomic Agents|autonomic agents|mesh-ancestor
101873052|NCT02525848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101873053|NCT02525848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873054|NCT02525848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101873055|NCT02525848|Glucocorticoids|glucocorticoids|mesh-ancestor
101873056|NCT02525848|Hormones|hormones|mesh-ancestor
101873057|NCT02525848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101873058|NCT02525848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101873059|NCT02525848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101873060|NCT02525848|Analgesics|analgesics|mesh-ancestor
101873061|NCT02525848|Sensory System Agents|sensory system agents|mesh-ancestor
101873062|NCT02525848|Anticonvulsants|anticonvulsants|mesh-ancestor
101873063|NCT02525848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101873064|NCT02525848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101873065|NCT02525848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101873066|NCT02525848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101873067|NCT02525848|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101873068|NCT02525848|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101873069|NCT02525848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101873070|NCT02525848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873071|NCT02525848|Antimanic Agents|antimanic agents|mesh-ancestor
101873072|NCT02525848|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101873073|NCT01269112|Citric Acid|citric acid|mesh-list
101873074|NCT01269112|Sodium Citrate|sodium citrate|mesh-list
101873075|NCT01269112|Anticoagulants|anticoagulants|mesh-ancestor
101873076|NCT01269112|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101873077|NCT01269112|Chelating Agents|chelating agents|mesh-ancestor
101873078|NCT01269112|Sequestering Agents|sequestering agents|mesh-ancestor
101873079|NCT01269112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873080|NCT01174420|Mitomycins|mitomycins|mesh-list
101873081|NCT01174420|Mitomycin|mitomycin|mesh-list
101873082|NCT01174420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101873083|NCT01174420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101873084|NCT01174420|Alkylating Agents|alkylating agents|mesh-ancestor
101873085|NCT01174420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873086|NCT01174420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101873087|NCT01174420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101873088|NCT01164826|Nabumetone|nabumetone|mesh-list
101873089|NCT01164826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101873090|NCT01164826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101873092|NCT01164826|Sensory System Agents|sensory system agents|mesh-ancestor
101873093|NCT01164826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101873094|NCT01164826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873095|NCT01164826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101873096|NCT01164826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101873097|NCT01164826|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101451891|NCT00208260|Immunologic Factors|immunologic factors|mesh-ancestor
101873098|NCT01164826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101873099|NCT01164826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101873100|NCT01164826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873101|NCT03867370|Lenvatinib|lenvatinib|mesh-list
101873102|NCT03867370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101873103|NCT03867370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101873104|NCT03867370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101873105|NCT03867370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873106|NCT01172392|Interferons|interferons|mesh-list
101873107|NCT01172392|Interferon-alpha|interferon-alpha|mesh-list
101873108|NCT01172392|Interferon alpha-2|interferon alpha-2|mesh-list
101873109|NCT01172392|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101873110|NCT01172392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101873111|NCT01172392|Antiviral Agents|antiviral agents|mesh-ancestor
101873112|NCT01172392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101873113|NCT01172392|Immunologic Factors|immunologic factors|mesh-ancestor
101873114|NCT01172392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592952|NCT02801188|Adrenergic Agents|adrenergic agents|mesh-ancestor
101873115|NCT01172470|Carboplatin|carboplatin|mesh-list
101873116|NCT01172470|Gemcitabine|gemcitabine|mesh-list
101873117|NCT01172470|Pemetrexed|pemetrexed|mesh-list
101873118|NCT01172470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101873119|NCT01172470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101873120|NCT01172470|Antimetabolites|antimetabolites|mesh-ancestor
101873121|NCT01172470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873122|NCT01172470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101873123|NCT01172470|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101873124|NCT01172470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101873125|NCT01175044|Povidone-Iodine|povidone-iodine|mesh-list
101873126|NCT01175044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101873127|NCT01175044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101873128|NCT03864016|Sufentanil|sufentanil|mesh-list
101873129|NCT03864016|Dsuvia|dsuvia|mesh-list
101873130|NCT03864016|Anesthetics|anesthetics|mesh-ancestor
101873131|NCT03864016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101873132|NCT03864016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873133|NCT03864016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101873134|NCT03864016|Narcotics|narcotics|mesh-ancestor
101873135|NCT03864016|Analgesics|analgesics|mesh-ancestor
101873136|NCT03864016|Sensory System Agents|sensory system agents|mesh-ancestor
101873137|NCT03864016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101873138|NCT03864016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101873139|NCT03864016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101873140|NCT03864016|Anesthetics, General|anesthetics, general|mesh-ancestor
101873141|NCT03860662|Baclofen|baclofen|mesh-list
101873142|NCT03860662|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101873143|NCT03860662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873144|NCT03860662|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101873145|NCT03860662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101873146|NCT03860662|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101873147|NCT03860662|GABA Agonists|gaba agonists|mesh-ancestor
101873148|NCT03860662|GABA Agents|gaba agents|mesh-ancestor
101873149|NCT03860662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101873150|NCT03860662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873151|NCT01177696|Psychotropic Drugs|psychotropic drugs|mesh-list
101873152|NCT01177852|Diphenhydramine|diphenhydramine|mesh-list
101873153|NCT01177852|Promethazine|promethazine|mesh-list
101873154|NCT01177852|Brompheniramine|brompheniramine|mesh-list
101873155|NCT01177852|Pseudoephedrine|pseudoephedrine|mesh-list
101873156|NCT01177852|Brompheniramine, pseudoephedrine drug combination|brompheniramine, pseudoephedrine drug combination|mesh-list
101873157|NCT01177852|Ephedrine|ephedrine|mesh-list
101873158|NCT01177852|Dipropizine|dipropizine|mesh-list
101873159|NCT01177852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873160|NCT01177852|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101873161|NCT01177852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101873162|NCT01177852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101873163|NCT01177852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873164|NCT01177852|Anesthetics, Local|anesthetics, local|mesh-ancestor
101873165|NCT01177852|Anesthetics|anesthetics|mesh-ancestor
101873166|NCT01177852|Sensory System Agents|sensory system agents|mesh-ancestor
101873167|NCT01177852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101873168|NCT01177852|Antiemetics|antiemetics|mesh-ancestor
101873169|NCT01177852|Autonomic Agents|autonomic agents|mesh-ancestor
101873170|NCT01177852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101873171|NCT01177852|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101873172|NCT01177852|Histamine Antagonists|histamine antagonists|mesh-ancestor
101873173|NCT01177852|Histamine Agents|histamine agents|mesh-ancestor
101873174|NCT01177852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101873175|NCT01177852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101873176|NCT01177852|Antipruritics|antipruritics|mesh-ancestor
101873177|NCT01177852|Dermatologic Agents|dermatologic agents|mesh-ancestor
101873178|NCT01177852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101873179|NCT01177852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101873180|NCT01177852|Respiratory System Agents|respiratory system agents|mesh-ancestor
101873181|NCT01177852|Nasal Decongestants|nasal decongestants|mesh-ancestor
101873182|NCT01177852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101873183|NCT01177852|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101873184|NCT01177852|Sympathomimetics|sympathomimetics|mesh-ancestor
101873185|NCT01177852|Adrenergic Agents|adrenergic agents|mesh-ancestor
101873186|NCT01177852|Antitussive Agents|antitussive agents|mesh-ancestor
101873187|NCT03863392|Misoprostol|misoprostol|mesh-list
101873188|NCT03863392|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101873189|NCT03863392|Abortifacient Agents|abortifacient agents|mesh-ancestor
101873190|NCT03863392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101873191|NCT03863392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873192|NCT03863392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101873193|NCT03863392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101873194|NCT03863392|Oxytocics|oxytocics|mesh-ancestor
101873195|NCT01175200|Lansoprazole|lansoprazole|mesh-list
101873196|NCT01175200|Dexlansoprazole|dexlansoprazole|mesh-list
101873197|NCT01175200|Clopidogrel|clopidogrel|mesh-list
101873198|NCT01175200|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101873199|NCT01175200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101873200|NCT01175200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101873201|NCT01175200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101873202|NCT01175200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101873203|NCT01175200|Purinergic Agents|purinergic agents|mesh-ancestor
101873204|NCT01175200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101873205|NCT01175200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873206|NCT01175200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873207|NCT01175200|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101873208|NCT01175200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101873209|NCT01175200|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101873210|NCT01175200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101873211|NCT03863626|Furosemide|furosemide|mesh-list
101873212|NCT03863626|Diuretics|diuretics|mesh-ancestor
101873213|NCT03863626|Natriuretic Agents|natriuretic agents|mesh-ancestor
101873214|NCT03863626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873215|NCT03863626|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101873216|NCT03863626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101873217|NCT03863626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873218|NCT01288378|Caspofungin|caspofungin|mesh-list
101873219|NCT01288378|Antifungal Agents|antifungal agents|mesh-ancestor
101873220|NCT01288378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101873221|NCT01288378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101873222|NCT01288378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873224|NCT01178320|Niacinamide|niacinamide|mesh-list
101873225|NCT01178320|Nicotinic Acids|nicotinic acids|mesh-list
101873226|NCT01178320|Simvastatin|simvastatin|mesh-list
101873227|NCT01178320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101873228|NCT01178320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101873230|NCT01178320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873231|NCT01178320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101873232|NCT01178320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101873233|NCT01178320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101873234|NCT01178320|Vasodilator Agents|vasodilator agents|mesh-ancestor
101873235|NCT01178320|Vitamin B Complex|vitamin b complex|mesh-ancestor
101873237|NCT01178320|Micronutrients|micronutrients|mesh-ancestor
101873238|NCT01178320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873239|NCT01175512|Naltrexone|naltrexone|mesh-list
101873240|NCT01175512|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101873241|NCT01175512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101873242|NCT01175512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873243|NCT01175512|Sensory System Agents|sensory system agents|mesh-ancestor
101873244|NCT01175512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101873245|NCT03859570|Pentoxifylline|pentoxifylline|mesh-list
101873246|NCT03859570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101873247|NCT03859570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101873248|NCT03859570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873249|NCT03859570|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101873250|NCT03859570|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101873251|NCT03859570|Protective Agents|protective agents|mesh-ancestor
101873252|NCT03859570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873253|NCT03859570|Vasodilator Agents|vasodilator agents|mesh-ancestor
101873254|NCT03859570|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101873255|NCT03859570|Antioxidants|antioxidants|mesh-ancestor
101873256|NCT03745222|Tislelizumab|tislelizumab|mesh-list
101873257|NCT03745222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101873258|NCT03745222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101873259|NCT01286584|Varenicline|varenicline|mesh-list
101873260|NCT01286584|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101873261|NCT01286584|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101873262|NCT01286584|Cholinergic Agents|cholinergic agents|mesh-ancestor
101873263|NCT01286584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101873264|NCT01286584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873265|NCT01286584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873266|NCT03743038|Minocycline|minocycline|mesh-list
101873267|NCT03743038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101873268|NCT03743038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101873269|NCT03864250|Prednisone|prednisone|mesh-list
101873270|NCT03864250|Tacrolimus|tacrolimus|mesh-list
101873271|NCT03864250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101873272|NCT03864250|Glucocorticoids|glucocorticoids|mesh-ancestor
101873273|NCT03864250|Hormones|hormones|mesh-ancestor
101873274|NCT03864250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101873275|NCT03864250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873276|NCT03864250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101451922|NCT00196664|Paroxetine|paroxetine|mesh-list
101873277|NCT03864250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101873278|NCT03864250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101873279|NCT03864250|Immunologic Factors|immunologic factors|mesh-ancestor
101873280|NCT03864250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101873281|NCT03864250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101873282|NCT03864250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873283|NCT01175746|Nicardipine|nicardipine|mesh-list
101873284|NCT01175746|Remifentanil|remifentanil|mesh-list
101873285|NCT01175746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101873286|NCT01175746|Narcotics|narcotics|mesh-ancestor
101688613|NCT02663700|Artesunate|artesunate|mesh-list
101873287|NCT01175746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101873288|NCT01175746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873290|NCT01175746|Sensory System Agents|sensory system agents|mesh-ancestor
101873291|NCT01175746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101873292|NCT01175746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101873293|NCT01175746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101873294|NCT01175746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101966694|NCT01137526|Donepezil|donepezil|mesh-list
101873295|NCT01175746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873296|NCT01175746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101873297|NCT01175746|Vasodilator Agents|vasodilator agents|mesh-ancestor
101873298|NCT01174810|Exenatide|exenatide|mesh-list
101873299|NCT01174810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101873300|NCT01174810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873301|NCT01174810|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101873302|NCT01174810|Incretins|incretins|mesh-ancestor
101873303|NCT01174810|Hormones|hormones|mesh-ancestor
101873304|NCT01174810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101873305|NCT01178710|Simvastatin|simvastatin|mesh-list
101873306|NCT01178710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101873307|NCT01178710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101873308|NCT01178710|Antimetabolites|antimetabolites|mesh-ancestor
101873309|NCT01178710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873310|NCT01178710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101873311|NCT01178710|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101873312|NCT01178710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101873313|NCT01174888|Cytarabine|cytarabine|mesh-list
101873314|NCT01174888|Etoposide|etoposide|mesh-list
101873315|NCT01174888|Podophyllotoxin|podophyllotoxin|mesh-list
101873316|NCT01174888|Mitoxantrone|mitoxantrone|mesh-list
101873317|NCT01174888|Etoposide phosphate|etoposide phosphate|mesh-list
101873318|NCT01174888|Bortezomib|bortezomib|mesh-list
101873319|NCT01174888|Midostaurin|midostaurin|mesh-list
101873320|NCT01174888|Staurosporine|staurosporine|mesh-list
101873321|NCT01174888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101873322|NCT01174888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101873323|NCT01174888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101873324|NCT01174888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101873325|NCT01174888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101873326|NCT01174888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873327|NCT01174888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101873328|NCT01174888|Antimetabolites|antimetabolites|mesh-ancestor
101873329|NCT01174888|Antiviral Agents|antiviral agents|mesh-ancestor
101873330|NCT01174888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101873331|NCT01174888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101873332|NCT01174888|Immunologic Factors|immunologic factors|mesh-ancestor
101873333|NCT01174888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873335|NCT01174888|Sensory System Agents|sensory system agents|mesh-ancestor
101873336|NCT01174888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101873337|NCT01174888|Keratolytic Agents|keratolytic agents|mesh-ancestor
101873338|NCT01174888|Dermatologic Agents|dermatologic agents|mesh-ancestor
101873339|NCT01174888|Tubulin Modulators|tubulin modulators|mesh-ancestor
101873340|NCT01174888|Antimitotic Agents|antimitotic agents|mesh-ancestor
101873341|NCT01174888|Mitosis Modulators|mitosis modulators|mesh-ancestor
101873342|NCT01174888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101873343|NCT01178788|Progesterone|progesterone|mesh-list
101873344|NCT01178788|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
101873345|NCT01178788|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
101873346|NCT01178788|Progestins|progestins|mesh-ancestor
101873347|NCT01178788|Hormones|hormones|mesh-ancestor
101873348|NCT01178788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101873349|NCT01178788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873350|NCT01178788|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101873351|NCT01178788|Hormone Antagonists|hormone antagonists|mesh-ancestor
101873352|NCT00153816|Vitamin D|vitamin d|mesh-list
101873353|NCT00153816|Cholecalciferol|cholecalciferol|mesh-list
101873354|NCT00153816|Calcium Carbonate|calcium carbonate|mesh-list
101873355|NCT00153816|Calcium|calcium|mesh-list
101873356|NCT00153816|Vitamins|vitamins|mesh-ancestor
101873357|NCT00153816|Micronutrients|micronutrients|mesh-ancestor
101873358|NCT00153816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873359|NCT00153816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101873360|NCT00153816|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101873361|NCT00153816|Antacids|antacids|mesh-ancestor
101873362|NCT00153816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873363|NCT00153816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101873364|NCT02525146|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101873365|NCT02525146|Antiviral Agents|antiviral agents|mesh-ancestor
101873366|NCT02525146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101873368|NCT01077648|Lapatinib|lapatinib|mesh-list
101873369|NCT01077648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101873370|NCT01077648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101873371|NCT01077648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101873372|NCT01077648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101873373|NCT01077648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873374|NCT00151476|Celecoxib|celecoxib|mesh-list
101873375|NCT00151476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101873376|NCT00151476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101873377|NCT00151476|Analgesics|analgesics|mesh-ancestor
101873378|NCT00151476|Sensory System Agents|sensory system agents|mesh-ancestor
101873379|NCT00151476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101873380|NCT00151476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873381|NCT00151476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101873382|NCT00151476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101873383|NCT00151476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101873384|NCT00151476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101873385|NCT00151476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101873386|NCT00151476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873387|NCT01077726|Capecitabine|capecitabine|mesh-list
101873388|NCT01077726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101873389|NCT01077726|Antimetabolites|antimetabolites|mesh-ancestor
101873390|NCT01077726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873391|NCT01077726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101873392|NCT01179100|Lidocaine|lidocaine|mesh-list
101873393|NCT01179100|Anesthetics, Local|anesthetics, local|mesh-ancestor
101873394|NCT01179100|Anesthetics|anesthetics|mesh-ancestor
101873395|NCT01179100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101873396|NCT01179100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873397|NCT01179100|Sensory System Agents|sensory system agents|mesh-ancestor
101873398|NCT01179100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101873399|NCT01179100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101873400|NCT01179100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101873401|NCT01179100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101873402|NCT01179100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101873403|NCT01179100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873404|NCT03864172|Calcium, Dietary|calcium, dietary|mesh-list
101873405|NCT03864172|Calcium|calcium|mesh-list
101873406|NCT03864172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101873407|NCT03864172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873408|NCT03864172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101873409|NCT02525302|Halofuginone|halofuginone|mesh-list
101873410|NCT02525302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101873411|NCT02525302|Coccidiostats|coccidiostats|mesh-ancestor
101873412|NCT02525302|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101873413|NCT02525302|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101873414|NCT02525302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101873415|NCT02525302|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101873416|NCT02525302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101873417|NCT02525302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873418|NCT02525302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101873419|NCT02525302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101873420|NCT02525302|Growth Substances|growth substances|mesh-ancestor
101873421|NCT02525302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873422|NCT02525302|Growth Inhibitors|growth inhibitors|mesh-ancestor
101873423|NCT01286194|Rabeprazole|rabeprazole|mesh-list
101873424|NCT01286194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101873425|NCT01286194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101873426|NCT01286194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101873427|NCT01286194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101873428|NCT01286194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873429|NCT01179256|Curcumin|curcumin|mesh-list
101873430|NCT01179256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101873431|NCT01179256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101873432|NCT01179256|Analgesics|analgesics|mesh-ancestor
101873433|NCT01179256|Sensory System Agents|sensory system agents|mesh-ancestor
101873434|NCT01179256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101873435|NCT01179256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873436|NCT01179256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101873437|NCT01179256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101873438|NCT01179256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101873439|NCT01179256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101873440|NCT01179256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873442|NCT01179412|Cadexomer iodine|cadexomer iodine|mesh-list
101873443|NCT01179412|Povidone-Iodine|povidone-iodine|mesh-list
101873444|NCT01179412|Povidone|povidone|mesh-list
101873445|NCT01179412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101873446|NCT01179412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101873447|NCT01179412|Trace Elements|trace elements|mesh-ancestor
101873448|NCT01179412|Micronutrients|micronutrients|mesh-ancestor
101873449|NCT01179412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873450|NCT01179412|Plasma Substitutes|plasma substitutes|mesh-ancestor
101873451|NCT01179412|Blood Substitutes|blood substitutes|mesh-ancestor
101873452|NCT03862690|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101873453|NCT03862690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101873454|NCT03862690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873455|NCT03862768|Sunitinib|sunitinib|mesh-list
101873456|NCT03862768|Imatinib Mesylate|imatinib mesylate|mesh-list
101873457|NCT03862768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101873458|NCT03862768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101873459|NCT03862768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101873460|NCT03862768|Growth Substances|growth substances|mesh-ancestor
101873461|NCT03862768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873462|NCT03862768|Growth Inhibitors|growth inhibitors|mesh-ancestor
101873463|NCT03862768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101873464|NCT03862768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101873465|NCT03862768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873466|NCT03862456|Azithromycin|azithromycin|mesh-list
101873467|NCT03862456|Metronidazole|metronidazole|mesh-list
101873468|NCT03862456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101873469|NCT03862456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101873470|NCT03862456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101873471|NCT03862456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101873472|NCT03859102|Acetaminophen|acetaminophen|mesh-list
101873473|NCT03859102|Dexamethasone|dexamethasone|mesh-list
101873474|NCT03859102|Gabapentin|gabapentin|mesh-list
101873475|NCT03859102|Ondansetron|ondansetron|mesh-list
101873476|NCT03859102|Anesthetics|anesthetics|mesh-list
101873477|NCT03859102|Anesthetics, Local|anesthetics, local|mesh-list
101873478|NCT03859102|Lansoprazole|lansoprazole|mesh-list
101873479|NCT03859102|Dexlansoprazole|dexlansoprazole|mesh-list
101873480|NCT03859102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101873481|NCT03859102|Antiemetics|antiemetics|mesh-ancestor
101873482|NCT03859102|Autonomic Agents|autonomic agents|mesh-ancestor
101873483|NCT03859102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101873484|NCT03859102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873485|NCT03859102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101873486|NCT03859102|Glucocorticoids|glucocorticoids|mesh-ancestor
101873487|NCT03859102|Hormones|hormones|mesh-ancestor
101873488|NCT03859102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101873489|NCT03859102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101873490|NCT03859102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101873491|NCT03859102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101873492|NCT03859102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101873493|NCT03859102|Analgesics|analgesics|mesh-ancestor
101873494|NCT03859102|Sensory System Agents|sensory system agents|mesh-ancestor
101593328|NCT02788786|Dermatologic Agents|dermatologic agents|mesh-ancestor
101873495|NCT03859102|Antipyretics|antipyretics|mesh-ancestor
101873496|NCT03859102|Anticonvulsants|anticonvulsants|mesh-ancestor
101873497|NCT03859102|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101873498|NCT03859102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101873499|NCT03859102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101873500|NCT03859102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101873501|NCT03859102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101873502|NCT03859102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101873503|NCT03859102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873504|NCT03859102|Antimanic Agents|antimanic agents|mesh-ancestor
101873505|NCT03859102|Antipruritics|antipruritics|mesh-ancestor
101873506|NCT03859102|Dermatologic Agents|dermatologic agents|mesh-ancestor
101873507|NCT03859102|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101873508|NCT03859102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101873509|NCT03859102|Serotonin Agents|serotonin agents|mesh-ancestor
101873510|NCT03859102|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101873511|NCT03859102|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101873512|NCT03859102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101873513|NCT00149994|Cyclosporine|cyclosporine|mesh-list
101873514|NCT00149994|Prednisone|prednisone|mesh-list
101873515|NCT00149994|Methylprednisolone|methylprednisolone|mesh-list
101873516|NCT00149994|Tacrolimus|tacrolimus|mesh-list
101873517|NCT00149994|Cyclosporins|cyclosporins|mesh-list
101873518|NCT00149994|Basiliximab|basiliximab|mesh-list
101873519|NCT00149994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101873520|NCT00149994|Glucocorticoids|glucocorticoids|mesh-ancestor
101873521|NCT00149994|Hormones|hormones|mesh-ancestor
101873522|NCT00149994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101873523|NCT00149994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873524|NCT00149994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101873525|NCT00149994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101873526|NCT00149994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101873527|NCT00149994|Immunologic Factors|immunologic factors|mesh-ancestor
101873528|NCT00149994|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101873529|NCT00149994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101873530|NCT00149994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873531|NCT00149994|Antifungal Agents|antifungal agents|mesh-ancestor
101873532|NCT00149994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101873533|NCT00149994|Dermatologic Agents|dermatologic agents|mesh-ancestor
101873534|NCT00149994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101873535|NCT00149994|Antiemetics|antiemetics|mesh-ancestor
101873536|NCT00149994|Autonomic Agents|autonomic agents|mesh-ancestor
101873537|NCT00149994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101873538|NCT00149994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101873539|NCT00149994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101873540|NCT00149994|Protective Agents|protective agents|mesh-ancestor
101873541|NCT01179646|Pantoprazole|pantoprazole|mesh-list
101873542|NCT01179646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101873543|NCT01179646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101873544|NCT01179646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101873545|NCT01179646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101873546|NCT01179646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873547|NCT01075776|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
101873548|NCT01075776|Acetylcholine|acetylcholine|mesh-list
101873549|NCT01075776|Vasodilator Agents|vasodilator agents|mesh-ancestor
101873550|NCT01075776|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101873551|NCT01075776|Cholinergic Agents|cholinergic agents|mesh-ancestor
101873552|NCT01075776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101873553|NCT01075776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873554|NCT01075776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873555|NCT01075776|Natriuretic Agents|natriuretic agents|mesh-ancestor
101873556|NCT01079910|Fluorides|fluorides|mesh-list
101873557|NCT01079910|Cariostatic Agents|cariostatic agents|mesh-ancestor
101873558|NCT01079910|Protective Agents|protective agents|mesh-ancestor
101873559|NCT01079910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873560|NCT01286896|Sunitinib|sunitinib|mesh-list
101873561|NCT01286896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101873562|NCT01286896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101873563|NCT01286896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101873564|NCT01286896|Growth Substances|growth substances|mesh-ancestor
101873565|NCT01286896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873566|NCT01286896|Growth Inhibitors|growth inhibitors|mesh-ancestor
101873567|NCT01286896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101873568|NCT01286896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101593405|NCT02787928|Hydromorphone|hydromorphone|mesh-list
101873569|NCT01286896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873570|NCT03857854|Pirfenidone|pirfenidone|mesh-list
101873571|NCT03857854|Analgesics|analgesics|mesh-ancestor
101873572|NCT03857854|Sensory System Agents|sensory system agents|mesh-ancestor
101873573|NCT03857854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101873574|NCT03857854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873575|NCT03857854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101873576|NCT03857854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101873577|NCT03857854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101873578|NCT03857854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101873579|NCT03857854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101873580|NCT01287052|Nitrous Oxide|nitrous oxide|mesh-list
101873581|NCT01287052|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101873582|NCT01287052|Anesthetics, General|anesthetics, general|mesh-ancestor
101873583|NCT01287052|Anesthetics|anesthetics|mesh-ancestor
101873584|NCT01287052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101873585|NCT01287052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873586|NCT01287052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101873587|NCT01287052|Analgesics|analgesics|mesh-ancestor
101873588|NCT01287052|Sensory System Agents|sensory system agents|mesh-ancestor
101873589|NCT01287052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101873590|NCT01288924|Parecoxib|parecoxib|mesh-list
101873591|NCT01288924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101873592|NCT01288924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101873593|NCT01288924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101873594|NCT01288924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873595|NCT01288924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101873596|NCT01288924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101873597|NCT01288924|Analgesics|analgesics|mesh-ancestor
101873598|NCT01288924|Sensory System Agents|sensory system agents|mesh-ancestor
101873599|NCT01288924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101873600|NCT01288924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873601|NCT01288924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101873602|NCT01288924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101873603|NCT01179724|Pantoprazole|pantoprazole|mesh-list
101873604|NCT01179724|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101873605|NCT01179724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101873606|NCT01179724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101873607|NCT01179724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101873608|NCT01179724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873609|NCT03862612|Anesthetics|anesthetics|mesh-list
101873610|NCT03862612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101873611|NCT03862612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873612|NCT01287130|Cetuximab|cetuximab|mesh-list
101873613|NCT01287130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101873614|NCT01287130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101873615|NCT00149214|Cyclophosphamide|cyclophosphamide|mesh-list
101873616|NCT00149214|Docetaxel|docetaxel|mesh-list
101873617|NCT00149214|Doxorubicin|doxorubicin|mesh-list
101873618|NCT00149214|Pemetrexed|pemetrexed|mesh-list
101873619|NCT00149214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101873621|NCT00149214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873622|NCT00149214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101873623|NCT00149214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101873624|NCT00149214|Alkylating Agents|alkylating agents|mesh-ancestor
101873625|NCT00149214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873626|NCT00149214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101873627|NCT00149214|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101873628|NCT00149214|Tubulin Modulators|tubulin modulators|mesh-ancestor
101873629|NCT00149214|Antimitotic Agents|antimitotic agents|mesh-ancestor
101873630|NCT00149214|Mitosis Modulators|mitosis modulators|mesh-ancestor
101873631|NCT00149214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101873632|NCT00149214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101873633|NCT00149214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101873634|NCT00149214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101873635|NCT00149214|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101873636|NCT00149214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101873637|NCT03034018|Suvorexant|suvorexant|mesh-list
101966720|NCT05628610|Paclitaxel|paclitaxel|mesh-list
101873638|NCT03034018|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101873639|NCT03034018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101873640|NCT03034018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101873641|NCT03034018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873642|NCT03034018|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
101873643|NCT03034018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101873644|NCT03034018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873645|NCT02525458|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
101873646|NCT02525458|Vasodilator Agents|vasodilator agents|mesh-ancestor
101873647|NCT02525458|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101873648|NCT02525458|Protective Agents|protective agents|mesh-ancestor
101873649|NCT02525458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873650|NCT02555254|Methamphetamine|methamphetamine|mesh-list
101873651|NCT02555254|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101873652|NCT02555254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873653|NCT02555254|Sympathomimetics|sympathomimetics|mesh-ancestor
101873654|NCT02555254|Autonomic Agents|autonomic agents|mesh-ancestor
101873655|NCT02555254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101873656|NCT02555254|Dopamine Agents|dopamine agents|mesh-ancestor
101873657|NCT02555254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101873658|NCT02555254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873659|NCT02555254|Adrenergic Agents|adrenergic agents|mesh-ancestor
101873660|NCT02555254|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101873661|NCT02555254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101873662|NCT02555254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101873663|NCT02555254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101873665|NCT00114972|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101873666|NCT00114972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101873667|NCT00114972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101873668|NCT00114972|Tubulin Modulators|tubulin modulators|mesh-ancestor
101873669|NCT00114972|Antimitotic Agents|antimitotic agents|mesh-ancestor
101873670|NCT00114972|Mitosis Modulators|mitosis modulators|mesh-ancestor
101452070|NCT00208533|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101873671|NCT00114972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873672|NCT02444728|Hydroxychloroquine|hydroxychloroquine|mesh-list
101873673|NCT02444728|Methylprednisolone|methylprednisolone|mesh-list
101873674|NCT02444728|Cyclophosphamide|cyclophosphamide|mesh-list
101873675|NCT02444728|Azathioprine|azathioprine|mesh-list
101873676|NCT02444728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101873677|NCT02444728|Immunologic Factors|immunologic factors|mesh-ancestor
101873678|NCT02444728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873679|NCT02444728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101873680|NCT02444728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101873681|NCT02444728|Alkylating Agents|alkylating agents|mesh-ancestor
101873682|NCT02444728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873683|NCT02444728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101873684|NCT02444728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101873685|NCT02444728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101873686|NCT02444728|Antiemetics|antiemetics|mesh-ancestor
101873687|NCT02444728|Autonomic Agents|autonomic agents|mesh-ancestor
101873688|NCT02444728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101873689|NCT02444728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101873690|NCT02444728|Glucocorticoids|glucocorticoids|mesh-ancestor
101873691|NCT02444728|Hormones|hormones|mesh-ancestor
101873692|NCT02444728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101873693|NCT02444728|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101873694|NCT02444728|Protective Agents|protective agents|mesh-ancestor
101873696|NCT02444728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101873697|NCT02444728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101873698|NCT02444728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101873699|NCT02444728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101873700|NCT02444728|Antimetabolites|antimetabolites|mesh-ancestor
101873701|NCT02444728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101873702|NCT00129402|Simvastatin|simvastatin|mesh-list
101873703|NCT00129402|Ezetimibe|ezetimibe|mesh-list
101873704|NCT00129402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101873705|NCT00129402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101873706|NCT00129402|Antimetabolites|antimetabolites|mesh-ancestor
101873707|NCT00129402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873708|NCT00129402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101873709|NCT00129402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101873710|NCT00129402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101873711|NCT03739528|Levofloxacin|levofloxacin|mesh-list
101873712|NCT03739528|Ofloxacin|ofloxacin|mesh-list
101873713|NCT03739528|Tobramycin|tobramycin|mesh-list
101873714|NCT03739528|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
101873715|NCT03739528|Dexamethasone|dexamethasone|mesh-list
101873716|NCT03739528|Dexamethasone acetate|dexamethasone acetate|mesh-list
101873717|NCT03739528|BB 1101|bb 1101|mesh-list
101873718|NCT03739528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101873719|NCT03739528|Antiemetics|antiemetics|mesh-ancestor
101873720|NCT03739528|Autonomic Agents|autonomic agents|mesh-ancestor
101873721|NCT03739528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101873722|NCT03739528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873723|NCT03739528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101873725|NCT03739528|Hormones|hormones|mesh-ancestor
101873726|NCT03739528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101873727|NCT03739528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101873728|NCT03739528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101873729|NCT03739528|Protease Inhibitors|protease inhibitors|mesh-ancestor
101873730|NCT03739528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101873731|NCT03739528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873732|NCT03739528|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101873733|NCT03739528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101873734|NCT03739528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101873735|NCT03739528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101873736|NCT03739528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101873737|NCT03739528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101873738|NCT03739528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101873739|NCT03739528|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101873740|NCT03739528|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101873741|NCT03857386|Anesthetics|anesthetics|mesh-list
101873742|NCT03857386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101873743|NCT03857386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873744|NCT01587586|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101873745|NCT01587586|Antiviral Agents|antiviral agents|mesh-ancestor
101873746|NCT01587586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101873747|NCT01289236|Milnacipran|milnacipran|mesh-list
101873748|NCT01289236|Levomilnacipran|levomilnacipran|mesh-list
101873749|NCT01289236|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101873750|NCT01289236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101873751|NCT01289236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101873752|NCT01289236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873753|NCT01289236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101873754|NCT01289236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873755|NCT01289236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101873756|NCT01289236|Analgesics|analgesics|mesh-ancestor
101873757|NCT01289236|Sensory System Agents|sensory system agents|mesh-ancestor
101873758|NCT01289236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101873759|NCT01289236|Antidepressive Agents|antidepressive agents|mesh-ancestor
101873760|NCT01289236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101873761|NCT01289938|Diphenhydramine|diphenhydramine|mesh-list
101873762|NCT01289938|Promethazine|promethazine|mesh-list
101873763|NCT01289938|Metoclopramide|metoclopramide|mesh-list
101873764|NCT01289938|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101873765|NCT01289938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101873766|NCT01289938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101873767|NCT01289938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873768|NCT01289938|Anesthetics, Local|anesthetics, local|mesh-ancestor
101873769|NCT01289938|Anesthetics|anesthetics|mesh-ancestor
101873770|NCT01289938|Sensory System Agents|sensory system agents|mesh-ancestor
101873771|NCT01289938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101873772|NCT01289938|Antiemetics|antiemetics|mesh-ancestor
101873773|NCT01289938|Autonomic Agents|autonomic agents|mesh-ancestor
101873774|NCT01289938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101873775|NCT01289938|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101873776|NCT01289938|Histamine Antagonists|histamine antagonists|mesh-ancestor
101873777|NCT01289938|Histamine Agents|histamine agents|mesh-ancestor
101873778|NCT01289938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101873779|NCT01289938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873780|NCT01289938|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101873781|NCT01289938|Antipruritics|antipruritics|mesh-ancestor
101873782|NCT01289938|Dermatologic Agents|dermatologic agents|mesh-ancestor
101873783|NCT01289938|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101873784|NCT01289938|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101873785|NCT01289938|Dopamine Agents|dopamine agents|mesh-ancestor
101873786|NCT00114738|Rituximab|rituximab|mesh-list
101873787|NCT00114738|Bortezomib|bortezomib|mesh-list
101873788|NCT00114738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101873789|NCT00114738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101873790|NCT00114738|Immunologic Factors|immunologic factors|mesh-ancestor
101873791|NCT00114738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873792|NCT00114738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101873793|NCT01180348|Botulinum Toxins|botulinum toxins|mesh-list
101593628|NCT00870103|Hormones|hormones|mesh-ancestor
101873794|NCT01180348|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101873796|NCT01180348|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101873797|NCT01180348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101873798|NCT01180348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873799|NCT01180348|Cholinergic Agents|cholinergic agents|mesh-ancestor
101873800|NCT01180348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101873801|NCT01180348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873802|NCT01180348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101873803|NCT01180348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101873804|NCT01180426|Tosedostat|tosedostat|mesh-list
101873805|NCT01180426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101873806|NCT01180426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873807|NCT00148122|Docetaxel|docetaxel|mesh-list
101873808|NCT00148122|Capecitabine|capecitabine|mesh-list
101873809|NCT00148122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101873810|NCT00148122|Tubulin Modulators|tubulin modulators|mesh-ancestor
101873811|NCT00148122|Antimitotic Agents|antimitotic agents|mesh-ancestor
101873812|NCT00148122|Mitosis Modulators|mitosis modulators|mesh-ancestor
101873813|NCT00148122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873814|NCT00148122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101873815|NCT00148122|Antimetabolites|antimetabolites|mesh-ancestor
101873816|NCT01182142|Capecitabine|capecitabine|mesh-list
101873817|NCT01182142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101873818|NCT01182142|Antimetabolites|antimetabolites|mesh-ancestor
101873819|NCT01182142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873820|NCT01182142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101873821|NCT01180816|Temozolomide|temozolomide|mesh-list
101873822|NCT01180816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101873823|NCT01180816|Alkylating Agents|alkylating agents|mesh-ancestor
101873824|NCT01180816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873825|NCT01180816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101873826|NCT01287598|Rosiglitazone|rosiglitazone|mesh-list
101873827|NCT01287598|Midazolam|midazolam|mesh-list
101873828|NCT01287598|Omeprazole|omeprazole|mesh-list
101873829|NCT01287598|Warfarin|warfarin|mesh-list
101873830|NCT01287598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101452149|NCT00226746|Paclitaxel|paclitaxel|mesh-list
101873831|NCT01287598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101873832|NCT01287598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101873833|NCT01287598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873834|NCT01287598|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101873835|NCT01287598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101873836|NCT01287598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101873837|NCT01287598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101873838|NCT01287598|Anesthetics, General|anesthetics, general|mesh-ancestor
101873839|NCT01287598|Anesthetics|anesthetics|mesh-ancestor
101873840|NCT01287598|GABA Modulators|gaba modulators|mesh-ancestor
101873841|NCT01287598|GABA Agents|gaba agents|mesh-ancestor
101873842|NCT01287598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101873843|NCT01287598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873844|NCT01287598|Anticoagulants|anticoagulants|mesh-ancestor
101873845|NCT01287598|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101873846|NCT01287598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101873847|NCT01287598|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101873848|NCT01287598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101873849|NCT01287598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101873850|NCT03862144|Palonosetron|palonosetron|mesh-list
101873851|NCT03862144|Antiemetics|antiemetics|mesh-ancestor
101873852|NCT03862144|Autonomic Agents|autonomic agents|mesh-ancestor
101873853|NCT03862144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101873854|NCT03862144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873855|NCT03862144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101873856|NCT03862144|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101873857|NCT03862144|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101873858|NCT03862144|Serotonin Agents|serotonin agents|mesh-ancestor
101873859|NCT03862144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101873860|NCT03862144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873861|NCT01290172|Somatostatin|somatostatin|mesh-list
101873862|NCT01290172|Hormones|hormones|mesh-ancestor
101873863|NCT01290172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101873864|NCT01290172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873865|NCT03861598|Carvedilol|carvedilol|mesh-list
101873866|NCT03861598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101873867|NCT03861598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101873868|NCT03861598|Adrenergic Agents|adrenergic agents|mesh-ancestor
101873869|NCT03861598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101873870|NCT03861598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873871|NCT03861598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873872|NCT03861598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101873873|NCT03861598|Antioxidants|antioxidants|mesh-ancestor
101873874|NCT03861598|Protective Agents|protective agents|mesh-ancestor
101873875|NCT03861598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101873876|NCT03861598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101873877|NCT03861598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101873878|NCT03861598|Vasodilator Agents|vasodilator agents|mesh-ancestor
101873879|NCT03861598|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101873880|NCT03861598|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101873881|NCT01184482|Cetuximab|cetuximab|mesh-list
101873882|NCT01184482|Lapatinib|lapatinib|mesh-list
101873883|NCT01184482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101873884|NCT01184482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101873885|NCT01184482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101873886|NCT01184482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101873887|NCT01184482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873888|NCT01184560|Orlistat|orlistat|mesh-list
101873889|NCT01184560|Sibutramine|sibutramine|mesh-list
101873890|NCT01184560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101873891|NCT01184560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873892|NCT01184560|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101873893|NCT01184560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101873894|NCT01184560|Antidepressive Agents|antidepressive agents|mesh-ancestor
101873895|NCT01184560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101873896|NCT01184560|Appetite Depressants|appetite depressants|mesh-ancestor
101873897|NCT01184638|Propofol|propofol|mesh-list
101873898|NCT01184638|Sevoflurane|sevoflurane|mesh-list
101873899|NCT01184638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101873900|NCT01184638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101873901|NCT01184638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873902|NCT01184638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101873903|NCT01184638|Anesthetics, General|anesthetics, general|mesh-ancestor
101873904|NCT01184638|Anesthetics|anesthetics|mesh-ancestor
101873905|NCT01184638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101873906|NCT01184638|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101873907|NCT01290328|Epoetin Alfa|epoetin alfa|mesh-list
101873908|NCT01290328|Hematinics|hematinics|mesh-ancestor
101873909|NCT01184716|Vitamin D|vitamin d|mesh-list
101873910|NCT01184716|Vitamins|vitamins|mesh-ancestor
101873911|NCT01184716|Micronutrients|micronutrients|mesh-ancestor
101873912|NCT01184716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873913|NCT01184716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101873914|NCT01184794|Levobupivacaine|levobupivacaine|mesh-list
101873915|NCT01184794|Anesthetics, Local|anesthetics, local|mesh-ancestor
101873916|NCT01184794|Anesthetics|anesthetics|mesh-ancestor
101873917|NCT01184794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101873918|NCT01184794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873919|NCT01184794|Sensory System Agents|sensory system agents|mesh-ancestor
101873920|NCT01184794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101873921|NCT01587508|Meloxicam|meloxicam|mesh-list
101873922|NCT01587508|Amitriptyline|amitriptyline|mesh-list
101873923|NCT01587508|Cyclobenzaprine|cyclobenzaprine|mesh-list
101873924|NCT01587508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101873925|NCT01587508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101873926|NCT01587508|Analgesics|analgesics|mesh-ancestor
101452192|NCT00226824|Galantamine|galantamine|mesh-list
101873927|NCT01587508|Sensory System Agents|sensory system agents|mesh-ancestor
101873928|NCT01587508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101873929|NCT01587508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873930|NCT01587508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101873931|NCT01587508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101873932|NCT01587508|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101873933|NCT01587508|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101873934|NCT01587508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101873935|NCT01587508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873936|NCT01587508|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101873937|NCT01587508|Antidepressive Agents|antidepressive agents|mesh-ancestor
101873938|NCT01587508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101873939|NCT01587508|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101873940|NCT01587508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101873941|NCT01587508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101593777|NCT00868231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101873942|NCT01587508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101873943|NCT01587508|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101873944|NCT01587508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101873945|NCT01587508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101873946|NCT01587508|Adrenergic Agents|adrenergic agents|mesh-ancestor
101873947|NCT01587508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101873948|NCT00147498|Tofacitinib|tofacitinib|mesh-list
101873949|NCT00147498|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101873950|NCT00147498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101873951|NCT00147498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101873952|NCT00147498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873953|NCT01176760|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
101873954|NCT01176760|Protease Inhibitors|protease inhibitors|mesh-ancestor
101873955|NCT01176760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101873956|NCT01176760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873957|NCT01176760|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101873958|NCT01176760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873959|NCT01080066|Cetuximab|cetuximab|mesh-list
101873960|NCT01080066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101873961|NCT01080066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101873962|NCT01185184|Tofacitinib|tofacitinib|mesh-list
101873963|NCT01185184|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101873964|NCT01185184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101873965|NCT01185184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101873966|NCT01185184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873967|NCT00113568|Tranexamic Acid|tranexamic acid|mesh-list
101873968|NCT00113568|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101873969|NCT00113568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101873970|NCT00113568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101873971|NCT00113568|Hemostatics|hemostatics|mesh-ancestor
101873972|NCT00113568|Coagulants|coagulants|mesh-ancestor
101873973|NCT01185262|Rituximab|rituximab|mesh-list
101873974|NCT01185262|Lenalidomide|lenalidomide|mesh-list
101873975|NCT01185262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101873976|NCT01185262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101873977|NCT01185262|Immunologic Factors|immunologic factors|mesh-ancestor
101873978|NCT01185262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873979|NCT01185262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101873980|NCT01185262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101966753|NCT00908128|Mycophenolic Acid|mycophenolic acid|mesh-list
101452218|NCT00226902|Chrysarobin|chrysarobin|mesh-list
101873981|NCT01185262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101873983|NCT01185262|Growth Inhibitors|growth inhibitors|mesh-ancestor
101873984|NCT00113490|Palivizumab|palivizumab|mesh-list
101873985|NCT00113490|Antiviral Agents|antiviral agents|mesh-ancestor
101873986|NCT00113490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101873987|NCT00146640|Prednisone|prednisone|mesh-list
101873988|NCT00146640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101873989|NCT00146640|Glucocorticoids|glucocorticoids|mesh-ancestor
101873990|NCT00146640|Hormones|hormones|mesh-ancestor
101873991|NCT00146640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101873992|NCT00146640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101873993|NCT00146640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101873994|NCT00146640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101873995|NCT01185418|Haloperidol|haloperidol|mesh-list
101873996|NCT01185418|Risperidone|risperidone|mesh-list
101873997|NCT01185418|Aripiprazole|aripiprazole|mesh-list
101873998|NCT01185418|Haloperidol decanoate|haloperidol decanoate|mesh-list
101873999|NCT01185418|Amisulpride|amisulpride|mesh-list
101874000|NCT01185418|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101874001|NCT01185418|Serotonin Agents|serotonin agents|mesh-ancestor
101874002|NCT01185418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101874003|NCT01185418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874004|NCT01185418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874005|NCT01185418|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101874006|NCT01185418|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101874007|NCT01185418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101874008|NCT01185418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101874009|NCT01185418|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101874010|NCT01185418|Dopamine Agents|dopamine agents|mesh-ancestor
101874011|NCT01185418|Antidepressive Agents|antidepressive agents|mesh-ancestor
101874012|NCT01185418|Dopamine Agonists|dopamine agonists|mesh-ancestor
101874013|NCT01185418|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101874014|NCT01185418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101874015|NCT01185418|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101874016|NCT01185418|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101874017|NCT01185418|Antiemetics|antiemetics|mesh-ancestor
101874018|NCT01185418|Autonomic Agents|autonomic agents|mesh-ancestor
101874019|NCT01185418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101874020|NCT01185418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101874021|NCT01185418|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101874022|NCT01185418|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101874023|NCT01185574|Vitamin D|vitamin d|mesh-list
101874024|NCT01185574|Vitamins|vitamins|mesh-ancestor
101874025|NCT01185574|Micronutrients|micronutrients|mesh-ancestor
101874026|NCT01185574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874027|NCT01185574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101874028|NCT03861364|Propofol|propofol|mesh-list
101874029|NCT03861364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101874030|NCT03861364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101874031|NCT03861364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874032|NCT03861364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101874033|NCT03861364|Anesthetics, General|anesthetics, general|mesh-ancestor
101874034|NCT03861364|Anesthetics|anesthetics|mesh-ancestor
101874035|NCT01185808|Vitamin D|vitamin d|mesh-list
101874036|NCT01185808|Ergocalciferols|ergocalciferols|mesh-list
101874037|NCT01185808|Cholecalciferol|cholecalciferol|mesh-list
101874038|NCT01185808|Vitamins|vitamins|mesh-list
101874039|NCT01185808|Micronutrients|micronutrients|mesh-ancestor
101874040|NCT01185808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874041|NCT01185808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101874042|NCT01185808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101874043|NCT01183624|Analgesics|analgesics|mesh-list
101874044|NCT01183624|Sensory System Agents|sensory system agents|mesh-ancestor
101874045|NCT01183624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101874046|NCT01183624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874047|NCT01291186|Epinephrine|epinephrine|mesh-list
101874048|NCT01291186|Racepinephrine|racepinephrine|mesh-list
101874049|NCT01291186|Bupivacaine|bupivacaine|mesh-list
101874050|NCT01291186|Epinephryl borate|epinephryl borate|mesh-list
101874051|NCT01291186|Anesthetics, Local|anesthetics, local|mesh-ancestor
101874052|NCT01291186|Anesthetics|anesthetics|mesh-ancestor
101874053|NCT01291186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101874054|NCT01291186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874055|NCT01291186|Sensory System Agents|sensory system agents|mesh-ancestor
101874056|NCT01291186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101874057|NCT01291186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101874058|NCT01291186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101874059|NCT01291186|Adrenergic Agents|adrenergic agents|mesh-ancestor
101874060|NCT01291186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101874061|NCT01291186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874062|NCT01291186|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101874063|NCT01291186|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101874064|NCT01291186|Autonomic Agents|autonomic agents|mesh-ancestor
101874065|NCT01291186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101874066|NCT01291186|Respiratory System Agents|respiratory system agents|mesh-ancestor
101874067|NCT01291186|Mydriatics|mydriatics|mesh-ancestor
101874068|NCT01291186|Sympathomimetics|sympathomimetics|mesh-ancestor
101874069|NCT01291186|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101874070|NCT04979338|Bupivacaine|bupivacaine|mesh-list
101874071|NCT04979338|Anesthetics, Local|anesthetics, local|mesh-list
101874072|NCT04979338|Anesthetics|anesthetics|mesh-list
101874073|NCT04979338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101874074|NCT04979338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874075|NCT04979338|Sensory System Agents|sensory system agents|mesh-ancestor
101874076|NCT04979338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101874077|NCT01177306|Guanfacine|guanfacine|mesh-list
101874078|NCT01177306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101874079|NCT01177306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101874080|NCT01177306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101874081|NCT01177306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101874082|NCT01177306|Adrenergic Agents|adrenergic agents|mesh-ancestor
101874083|NCT01177306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101874084|NCT01177306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874085|NCT01177306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874086|NCT01290406|Dactolisib|dactolisib|mesh-list
101874087|NCT01290406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101874088|NCT03854812|Magnesium Sulfate|magnesium sulfate|mesh-list
101874089|NCT03854812|Fentanyl|fentanyl|mesh-list
101874090|NCT03854812|Propofol|propofol|mesh-list
101874091|NCT03854812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101874092|NCT03854812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101874093|NCT03854812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874094|NCT03854812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101874095|NCT03854812|Anesthetics, General|anesthetics, general|mesh-ancestor
101874096|NCT03854812|Anesthetics|anesthetics|mesh-ancestor
101874097|NCT03854812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101874098|NCT03854812|Narcotics|narcotics|mesh-ancestor
101874099|NCT03854812|Analgesics|analgesics|mesh-ancestor
101874100|NCT03854812|Sensory System Agents|sensory system agents|mesh-ancestor
101874101|NCT03854812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101874102|NCT03854812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101874103|NCT03854812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101874104|NCT03854812|Anticonvulsants|anticonvulsants|mesh-ancestor
101874105|NCT03854812|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101874106|NCT03854812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101874107|NCT03854812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874108|NCT03854812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101874109|NCT03854812|Tocolytic Agents|tocolytic agents|mesh-ancestor
101874110|NCT03854812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101874111|NCT01186120|Umirolimus|umirolimus|mesh-list
101874112|NCT01186120|Everolimus|everolimus|mesh-list
101874113|NCT01186120|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101874114|NCT01186120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101874115|NCT01186120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101874116|NCT01186120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874117|NCT01186120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101874118|NCT01186120|Immunologic Factors|immunologic factors|mesh-ancestor
101874119|NCT01186120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874120|NCT01186120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101874121|NCT01186120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101874122|NCT03855826|Amiodarone|amiodarone|mesh-list
101874123|NCT03855826|Nifekalant|nifekalant|mesh-list
101874124|NCT03855826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101874125|NCT03855826|Vasodilator Agents|vasodilator agents|mesh-ancestor
101874126|NCT03855826|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101874127|NCT03855826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101874128|NCT03855826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874129|NCT03855826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101874130|NCT03855826|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101874131|NCT03855826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101874132|NCT03855826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101874133|NCT03855826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101874134|NCT03855826|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101874135|NCT03855826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101874136|NCT01184404|Bosentan|bosentan|mesh-list
101874137|NCT01184404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101874138|NCT01184404|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101874139|NCT01184404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874140|NCT01186588|Canagliflozin|canagliflozin|mesh-list
101874141|NCT01186588|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101874142|NCT01186588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874143|NCT01186588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101874144|NCT01186588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874145|NCT03854266|Heparin|heparin|mesh-list
101874146|NCT03854266|Calcium heparin|calcium heparin|mesh-list
101874147|NCT03854266|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101874148|NCT03854266|Anticoagulants|anticoagulants|mesh-ancestor
101874149|NCT03854266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101874150|NCT03854266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101874151|NCT03854266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874152|NCT01187992|Atorvastatin|atorvastatin|mesh-list
101874153|NCT01187992|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101874154|NCT01187992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101874155|NCT01187992|Antimetabolites|antimetabolites|mesh-ancestor
101874156|NCT01187992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874157|NCT01187992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101874158|NCT01187992|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101874159|NCT01187992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101874160|NCT01191034|Imiquimod|imiquimod|mesh-list
101874161|NCT01191034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101874162|NCT01191034|Immunologic Factors|immunologic factors|mesh-ancestor
101874163|NCT01191034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874164|NCT01191034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101874165|NCT01191034|Interferon Inducers|interferon inducers|mesh-ancestor
101874166|NCT01188148|Memantine|memantine|mesh-list
101874167|NCT01188148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101594001|NCT01094808|Analgesics|analgesics|mesh-ancestor
101874168|NCT01188148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101874169|NCT01188148|Dopamine Agents|dopamine agents|mesh-ancestor
101874170|NCT01188148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101874171|NCT01188148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874172|NCT01188148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874173|NCT01188148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101874174|NCT01188148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101874175|NCT01187212|Cisplatin|cisplatin|mesh-list
101874176|NCT01187212|Capecitabine|capecitabine|mesh-list
101874177|NCT01187212|Sorafenib|sorafenib|mesh-list
101874178|NCT01187212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101874179|NCT01187212|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101874180|NCT01187212|Antimetabolites|antimetabolites|mesh-ancestor
101874181|NCT01187212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874182|NCT01187212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101874183|NCT01187212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101874184|NCT03849508|Phenylephrine|phenylephrine|mesh-list
101874185|NCT03849508|Oxymetazoline|oxymetazoline|mesh-list
101874186|NCT03849508|Norepinephrine|norepinephrine|mesh-list
101874187|NCT03849508|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101874188|NCT03849508|Mydriatics|mydriatics|mesh-ancestor
101874189|NCT03849508|Autonomic Agents|autonomic agents|mesh-ancestor
101874190|NCT03849508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101874191|NCT03849508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874192|NCT03849508|Sympathomimetics|sympathomimetics|mesh-ancestor
101874193|NCT03849508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101874194|NCT03849508|Nasal Decongestants|nasal decongestants|mesh-ancestor
101874195|NCT03849508|Respiratory System Agents|respiratory system agents|mesh-ancestor
101874196|NCT03849508|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101874197|NCT03849508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101874198|NCT03849508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101874199|NCT03849508|Adrenergic Agents|adrenergic agents|mesh-ancestor
101874200|NCT03849508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101874201|NCT03849508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874202|NCT03849508|Protective Agents|protective agents|mesh-ancestor
101874204|NCT03849664|Niacinamide|niacinamide|mesh-list
101874205|NCT03849664|Niacin|niacin|mesh-list
101874206|NCT03849664|Nicotinic Acids|nicotinic acids|mesh-list
101874207|NCT03849664|Flavin Mononucleotide|flavin mononucleotide|mesh-list
101874208|NCT03849664|Povidone|povidone|mesh-list
101874209|NCT03849664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101874210|NCT03849664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874211|NCT03849664|Plasma Substitutes|plasma substitutes|mesh-ancestor
101874212|NCT03849664|Blood Substitutes|blood substitutes|mesh-ancestor
101874213|NCT03849664|Vitamin B Complex|vitamin b complex|mesh-ancestor
101874214|NCT03849664|Vitamins|vitamins|mesh-ancestor
101874215|NCT03849664|Micronutrients|micronutrients|mesh-ancestor
101874216|NCT03849664|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101874217|NCT03849664|Dermatologic Agents|dermatologic agents|mesh-ancestor
101874218|NCT03849664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101874219|NCT03849664|Antimetabolites|antimetabolites|mesh-ancestor
101452292|NCT00203957|Istradefylline|istradefylline|mesh-list
101874220|NCT03849664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874221|NCT03849664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101874222|NCT03849664|Vasodilator Agents|vasodilator agents|mesh-ancestor
101874223|NCT01293838|Escitalopram|escitalopram|mesh-list
101874224|NCT01293838|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101874225|NCT01293838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101874226|NCT01293838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101874227|NCT01293838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874228|NCT01293838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101874229|NCT01293838|Serotonin Agents|serotonin agents|mesh-ancestor
101874230|NCT01293838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874231|NCT01188304|Aspirin|aspirin|mesh-list
101874232|NCT01188304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101874233|NCT01188304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101874234|NCT01188304|Analgesics|analgesics|mesh-ancestor
101874235|NCT01188304|Sensory System Agents|sensory system agents|mesh-ancestor
101874236|NCT01188304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101874237|NCT01188304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874238|NCT01188304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101874239|NCT01188304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101594074|NCT04230070|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101874240|NCT01188304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101874241|NCT01188304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101874242|NCT01188304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874243|NCT01188304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101874244|NCT01188304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101874245|NCT01188304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101874246|NCT01188304|Antipyretics|antipyretics|mesh-ancestor
101874247|NCT02524444|Pyrimethamine|pyrimethamine|mesh-list
101874248|NCT02524444|Sulfadoxine|sulfadoxine|mesh-list
101874249|NCT02524444|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101874250|NCT02524444|Mefloquine|mefloquine|mesh-list
101874251|NCT02524444|Antimalarials|antimalarials|mesh-ancestor
101874252|NCT02524444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101874253|NCT02524444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101874254|NCT02524444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101874255|NCT02524444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101874256|NCT02524444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101874257|NCT02524444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874258|NCT02524444|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101874259|NCT03853642|Nitric Oxide|nitric oxide|mesh-list
101874260|NCT03853642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101874261|NCT03853642|Autonomic Agents|autonomic agents|mesh-ancestor
101874262|NCT03853642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101874263|NCT03853642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874264|NCT03853642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101874265|NCT03853642|Respiratory System Agents|respiratory system agents|mesh-ancestor
101874266|NCT03853642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101874267|NCT03853642|Antioxidants|antioxidants|mesh-ancestor
101874268|NCT03853642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874269|NCT03853642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101874270|NCT03853642|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101874271|NCT03853642|Vasodilator Agents|vasodilator agents|mesh-ancestor
101874272|NCT03853642|Gasotransmitters|gasotransmitters|mesh-ancestor
101874273|NCT03853642|Protective Agents|protective agents|mesh-ancestor
101874274|NCT02296918|Rituximab|rituximab|mesh-list
101874275|NCT02296918|Obinutuzumab|obinutuzumab|mesh-list
101874276|NCT02296918|Venetoclax|venetoclax|mesh-list
101874277|NCT02296918|Acalabrutinib|acalabrutinib|mesh-list
101874278|NCT02296918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101874279|NCT02296918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101874280|NCT02296918|Immunologic Factors|immunologic factors|mesh-ancestor
101874281|NCT02296918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874282|NCT02296918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101874283|NCT01294072|Curcumin|curcumin|mesh-list
101874284|NCT01294072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101874285|NCT01294072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101874286|NCT01294072|Analgesics|analgesics|mesh-ancestor
101874287|NCT01294072|Sensory System Agents|sensory system agents|mesh-ancestor
101874288|NCT01294072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101874289|NCT01294072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874290|NCT01294072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101874291|NCT01294072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101874292|NCT01294072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101874293|NCT01294072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101874294|NCT01294072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874295|NCT01191424|Formoterol Fumarate|formoterol fumarate|mesh-list
101874296|NCT01191424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101874297|NCT01191424|Autonomic Agents|autonomic agents|mesh-ancestor
101874298|NCT01191424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101874299|NCT01191424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874300|NCT01191424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101874301|NCT01191424|Respiratory System Agents|respiratory system agents|mesh-ancestor
101874302|NCT01191424|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101874303|NCT01191424|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101874304|NCT01191424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101874305|NCT01191424|Adrenergic Agents|adrenergic agents|mesh-ancestor
101874306|NCT01191424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101874307|NCT01191424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874308|NCT01291654|Acetaminophen|acetaminophen|mesh-list
101874309|NCT01291654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101874310|NCT01291654|Analgesics|analgesics|mesh-ancestor
101874311|NCT01291654|Sensory System Agents|sensory system agents|mesh-ancestor
101874312|NCT01291654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101874313|NCT01291654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874314|NCT01291654|Antipyretics|antipyretics|mesh-ancestor
101874315|NCT03853096|Cefazolin|cefazolin|mesh-list
101874316|NCT03853096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101874317|NCT03853096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101874318|NCT05671276|Aspirin|aspirin|mesh-list
101874320|NCT05671276|Clopidogrel|clopidogrel|mesh-list
101874321|NCT05671276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101874322|NCT05671276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101874323|NCT05671276|Analgesics|analgesics|mesh-ancestor
101874324|NCT05671276|Sensory System Agents|sensory system agents|mesh-ancestor
101874325|NCT05671276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101874326|NCT05671276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874327|NCT05671276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101874328|NCT05671276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101874329|NCT05671276|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101874330|NCT05671276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101874331|NCT05671276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874332|NCT05671276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101874333|NCT05671276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101874334|NCT05671276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101874335|NCT05671276|Antipyretics|antipyretics|mesh-ancestor
101874336|NCT05671276|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101874337|NCT05671276|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101237185|NCT04246372|Tofacitinib|tofacitinib|mesh-list
101874338|NCT05671276|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101874339|NCT05671276|Purinergic Agents|purinergic agents|mesh-ancestor
101874340|NCT05671276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101874341|NCT05671276|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101874342|NCT05671276|Antithrombins|antithrombins|mesh-ancestor
101874343|NCT05671276|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101874344|NCT05671276|Protease Inhibitors|protease inhibitors|mesh-ancestor
101874345|NCT05671276|Anticoagulants|anticoagulants|mesh-ancestor
101874346|NCT03852160|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101874347|NCT03852160|Mirtazapine|mirtazapine|mesh-list
101874348|NCT03852160|Trazodone|trazodone|mesh-list
101874349|NCT03852160|Agomelatine|agomelatine|mesh-list
101874350|NCT03852160|Bupropion|bupropion|mesh-list
101874351|NCT03852160|Sertraline|sertraline|mesh-list
101874352|NCT03852160|Esketamine|esketamine|mesh-list
101874353|NCT03852160|Escitalopram|escitalopram|mesh-list
101874354|NCT03852160|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101874355|NCT03852160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101874356|NCT03852160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101874357|NCT03852160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874358|NCT03852160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101874359|NCT03852160|Serotonin Agents|serotonin agents|mesh-ancestor
101874360|NCT03852160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874361|NCT03852160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101874362|NCT03852160|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101874363|NCT03852160|Antidepressive Agents|antidepressive agents|mesh-ancestor
101874364|NCT03852160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101874365|NCT03852160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101874366|NCT03852160|Dopamine Agents|dopamine agents|mesh-ancestor
101874367|NCT03852160|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101874368|NCT03852160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101874369|NCT03852160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101874370|NCT03852160|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101874371|NCT03852160|Analgesics|analgesics|mesh-ancestor
101874372|NCT03852160|Sensory System Agents|sensory system agents|mesh-ancestor
101874373|NCT03852160|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101874374|NCT03852160|Histamine Antagonists|histamine antagonists|mesh-ancestor
101874375|NCT03852160|Histamine Agents|histamine agents|mesh-ancestor
101874376|NCT03852160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101874377|NCT03852160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101874378|NCT03852160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101874379|NCT03852160|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101874380|NCT03852160|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101874381|NCT03852160|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101874382|NCT03852160|Adrenergic Agents|adrenergic agents|mesh-ancestor
101452365|NCT00197639|Ritonavir|ritonavir|mesh-list
101874383|NCT03852160|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101874384|NCT03852160|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101874385|NCT03852160|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101874386|NCT03852160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101874387|NCT02524210|Omeprazole|omeprazole|mesh-list
101874388|NCT02524210|Rabeprazole|rabeprazole|mesh-list
101874389|NCT02524210|Dabigatran|dabigatran|mesh-list
101874390|NCT02524210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101874391|NCT02524210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101594221|NCT01141283|Buprenorphine|buprenorphine|mesh-list
101874392|NCT02524210|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101874393|NCT02524210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101874394|NCT02524210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874395|NCT02524210|Antithrombins|antithrombins|mesh-ancestor
101874396|NCT02524210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101874397|NCT02524210|Protease Inhibitors|protease inhibitors|mesh-ancestor
101874398|NCT02524210|Anticoagulants|anticoagulants|mesh-ancestor
101874399|NCT03847792|Dexamethasone|dexamethasone|mesh-list
101874400|NCT03847792|Fentanyl|fentanyl|mesh-list
101874401|NCT03847792|Bupivacaine|bupivacaine|mesh-list
101874402|NCT03847792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101874403|NCT03847792|Antiemetics|antiemetics|mesh-ancestor
101874404|NCT03847792|Autonomic Agents|autonomic agents|mesh-ancestor
101874405|NCT03847792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101874406|NCT03847792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874407|NCT03847792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101874408|NCT03847792|Glucocorticoids|glucocorticoids|mesh-ancestor
101874409|NCT03847792|Hormones|hormones|mesh-ancestor
101874410|NCT03847792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101874411|NCT03847792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101874412|NCT03847792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101874413|NCT03847792|Anesthetics, Local|anesthetics, local|mesh-ancestor
101874414|NCT03847792|Anesthetics|anesthetics|mesh-ancestor
101874415|NCT03847792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101874416|NCT03847792|Sensory System Agents|sensory system agents|mesh-ancestor
101874417|NCT03847792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101874418|NCT03847792|Narcotics|narcotics|mesh-ancestor
101874419|NCT03847792|Analgesics|analgesics|mesh-ancestor
101874420|NCT03847792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101874421|NCT03847792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101874422|NCT03847792|Anesthetics, General|anesthetics, general|mesh-ancestor
101874423|NCT01294618|Interferons|interferons|mesh-list
101874424|NCT01294618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101874425|NCT01294618|Antiviral Agents|antiviral agents|mesh-ancestor
101874426|NCT01294618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101874427|NCT01194232|Sildenafil Citrate|sildenafil citrate|mesh-list
101874428|NCT01194232|Vasodilator Agents|vasodilator agents|mesh-ancestor
101874429|NCT01194232|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101874430|NCT01194232|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101874431|NCT01194232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101874432|NCT01194232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874433|NCT01194232|Urological Agents|urological agents|mesh-ancestor
101874434|NCT01296334|Morphine|morphine|mesh-list
101874435|NCT01296334|Buprenorphine|buprenorphine|mesh-list
101874436|NCT01296334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101874437|NCT01296334|Narcotics|narcotics|mesh-ancestor
101874438|NCT01296334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101874439|NCT01296334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874440|NCT01296334|Analgesics|analgesics|mesh-ancestor
101874441|NCT01296334|Sensory System Agents|sensory system agents|mesh-ancestor
101874442|NCT01296334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101874443|NCT01296334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101874444|NCT03847558|Hormones|hormones|mesh-list
101874445|NCT03847558|Testosterone|testosterone|mesh-list
101874446|NCT03847558|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101874447|NCT03847558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101874448|NCT03847558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874449|NCT03847558|Androgens|androgens|mesh-ancestor
101874450|NCT01189006|Dextromethorphan|dextromethorphan|mesh-list
101874451|NCT01189006|Antitussive Agents|antitussive agents|mesh-ancestor
101874452|NCT01189006|Respiratory System Agents|respiratory system agents|mesh-ancestor
101874453|NCT01189006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101874454|NCT01189006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101874455|NCT01189006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101874456|NCT01189006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874457|NCT01189006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874458|NCT01292356|Cetuximab|cetuximab|mesh-list
101874459|NCT01292356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101874460|NCT01292356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101874461|NCT01294852|Pulmonary Surfactants|pulmonary surfactants|mesh-list
101874462|NCT01294852|Respiratory System Agents|respiratory system agents|mesh-ancestor
101874463|NCT03847246|Entecavir|entecavir|mesh-list
101874464|NCT03847246|Antiviral Agents|antiviral agents|mesh-ancestor
101874465|NCT03847246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101874466|NCT03849196|Bisacodyl|bisacodyl|mesh-list
101874467|NCT03849196|Cathartics|cathartics|mesh-ancestor
101874468|NCT03849196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101874469|NCT03849196|Laxatives|laxatives|mesh-ancestor
101594297|NCT01140503|Apremilast|apremilast|mesh-list
101874470|NCT01292668|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101874471|NCT01292668|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
101874472|NCT01292668|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101874473|NCT01292668|Dermatologic Agents|dermatologic agents|mesh-ancestor
101874475|NCT01296802|Dexfenfluramine|dexfenfluramine|mesh-list
101874476|NCT01296802|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101874477|NCT01296802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101874478|NCT01296802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101874479|NCT01296802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874480|NCT01296802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101874481|NCT01296802|Serotonin Agents|serotonin agents|mesh-ancestor
101874482|NCT01296802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874483|NCT01296802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101874484|NCT01296958|Niclosamide|niclosamide|mesh-list
101874485|NCT01296958|Anticestodal Agents|anticestodal agents|mesh-ancestor
101874486|NCT01296958|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101874487|NCT01296958|Anthelmintics|anthelmintics|mesh-ancestor
101874488|NCT01296958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101874489|NCT01296958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101874490|NCT01296958|Antinematodal Agents|antinematodal agents|mesh-ancestor
101874491|NCT01295086|Docetaxel|docetaxel|mesh-list
101874492|NCT01295086|Capecitabine|capecitabine|mesh-list
101874493|NCT01295086|Oxaliplatin|oxaliplatin|mesh-list
101874494|NCT01295086|Trastuzumab|trastuzumab|mesh-list
101874495|NCT01295086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101874496|NCT01295086|Tubulin Modulators|tubulin modulators|mesh-ancestor
101874497|NCT01295086|Antimitotic Agents|antimitotic agents|mesh-ancestor
101874498|NCT01295086|Mitosis Modulators|mitosis modulators|mesh-ancestor
101874499|NCT01295086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874500|NCT01295086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101874501|NCT01295086|Antimetabolites|antimetabolites|mesh-ancestor
101874502|NCT01295086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101874503|NCT01194700|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101874504|NCT01194700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101874505|NCT01194700|Autonomic Agents|autonomic agents|mesh-ancestor
101874506|NCT01194700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101874507|NCT01194700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874508|NCT01194700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101874509|NCT01194700|Respiratory System Agents|respiratory system agents|mesh-ancestor
101874510|NCT01194700|Glucocorticoids|glucocorticoids|mesh-ancestor
101874511|NCT01194700|Hormones|hormones|mesh-ancestor
101874512|NCT01194700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101874513|NCT01194700|Sympathomimetics|sympathomimetics|mesh-ancestor
101874514|NCT01189318|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101874515|NCT01189318|Antidepressive Agents|antidepressive agents|mesh-ancestor
101874516|NCT01189318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101874517|NCT01189318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101874518|NCT01189318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101874519|NCT01189318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101874520|NCT01189318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874521|NCT01194778|Vitamins|vitamins|mesh-list
101874522|NCT01194778|Vitamin K|vitamin k|mesh-list
101874523|NCT01194778|Vitamin K 2|vitamin k 2|mesh-list
101874524|NCT01194778|Vitamin K 1|vitamin k 1|mesh-list
101874525|NCT01194778|Micronutrients|micronutrients|mesh-ancestor
101874526|NCT01194778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874527|NCT01194778|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101874528|NCT01194778|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101874529|NCT01194778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874530|NCT01194778|Hemostatics|hemostatics|mesh-ancestor
101874531|NCT01194778|Coagulants|coagulants|mesh-ancestor
101874532|NCT01194934|Lenograstim|lenograstim|mesh-list
101874533|NCT01194934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101874534|NCT01194934|Immunologic Factors|immunologic factors|mesh-ancestor
101874535|NCT01194934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874536|NCT01297036|Donepezil|donepezil|mesh-list
101874537|NCT01297036|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101874538|NCT01297036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101874539|NCT01297036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874540|NCT01297036|Cholinergic Agents|cholinergic agents|mesh-ancestor
101874541|NCT01297036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101874542|NCT01297036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874543|NCT01297036|Nootropic Agents|nootropic agents|mesh-ancestor
101874544|NCT03848806|Calcitriol|calcitriol|mesh-list
101874545|NCT03848806|Calcipotriene|calcipotriene|mesh-list
101874546|NCT03848806|Dermatologic Agents|dermatologic agents|mesh-ancestor
101874547|NCT03848806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101874548|NCT03848806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874549|NCT03848806|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101874550|NCT03848806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101874551|NCT03848806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874552|NCT03848806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101874553|NCT03848806|Vitamins|vitamins|mesh-ancestor
101874554|NCT03848806|Micronutrients|micronutrients|mesh-ancestor
101874555|NCT03848806|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101874556|NCT03737110|Rilonacept|rilonacept|mesh-list
101874557|NCT03737110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101874559|NCT01189864|Prednisolone acetate|prednisolone acetate|mesh-list
101874560|NCT01189864|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101874561|NCT01189864|Methylprednisolone|methylprednisolone|mesh-list
101874562|NCT01189864|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101874563|NCT01189864|Prednisolone|prednisolone|mesh-list
101874564|NCT01189864|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101874565|NCT01189864|Prednisolone phosphate|prednisolone phosphate|mesh-list
101874566|NCT01189864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101874567|NCT01189864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101874568|NCT01189864|Analgesics|analgesics|mesh-ancestor
101874569|NCT01189864|Sensory System Agents|sensory system agents|mesh-ancestor
101874570|NCT01189864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101874571|NCT01189864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874572|NCT01189864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101874573|NCT01189864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101874574|NCT01189864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101874575|NCT01189864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101874576|NCT01189864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874577|NCT01189864|Antiemetics|antiemetics|mesh-ancestor
101874578|NCT01189864|Autonomic Agents|autonomic agents|mesh-ancestor
101874579|NCT01189864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101874580|NCT01189864|Glucocorticoids|glucocorticoids|mesh-ancestor
101874581|NCT01189864|Hormones|hormones|mesh-ancestor
101874582|NCT01189864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101874583|NCT01189864|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101874584|NCT01189864|Protective Agents|protective agents|mesh-ancestor
101874585|NCT01189864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101874586|NCT01189864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101874587|NCT01195246|Vaccines|vaccines|mesh-list
101874588|NCT01195246|Immunologic Factors|immunologic factors|mesh-ancestor
101874589|NCT01195246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874590|NCT01191892|Carboplatin|carboplatin|mesh-list
101874591|NCT01191892|Gemcitabine|gemcitabine|mesh-list
101874592|NCT01191892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101874593|NCT01191892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101874594|NCT01191892|Antimetabolites|antimetabolites|mesh-ancestor
101874595|NCT01191892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874596|NCT01293058|Naloxone|naloxone|mesh-list
101874597|NCT01293058|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101874598|NCT01293058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874599|NCT01293058|Sensory System Agents|sensory system agents|mesh-ancestor
101874600|NCT01293058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101874601|NCT01195324|Canagliflozin|canagliflozin|mesh-list
101874602|NCT01195324|Warfarin|warfarin|mesh-list
101874603|NCT01195324|Anticoagulants|anticoagulants|mesh-ancestor
101874604|NCT01195324|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101874605|NCT01195324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874606|NCT01195324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101874607|NCT01195324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874608|NCT01293136|Analgesics, Opioid|analgesics, opioid|mesh-list
101874609|NCT01293136|Narcotics|narcotics|mesh-ancestor
101874610|NCT01293136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101874611|NCT01293136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874612|NCT01293136|Analgesics|analgesics|mesh-ancestor
101874613|NCT01293136|Sensory System Agents|sensory system agents|mesh-ancestor
101874614|NCT01293136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101874615|NCT01293292|Teriparatide|teriparatide|mesh-list
101874616|NCT01293292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101874617|NCT01293292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874618|NCT01293292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101874619|NCT01195714|Ofatumumab|ofatumumab|mesh-list
101874620|NCT01195714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101874621|NCT01190722|Diclofenac|diclofenac|mesh-list
101874622|NCT01190722|Etoricoxib|etoricoxib|mesh-list
101874623|NCT01190722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101874624|NCT01190722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101874625|NCT01190722|Analgesics|analgesics|mesh-ancestor
101874626|NCT01190722|Sensory System Agents|sensory system agents|mesh-ancestor
101688706|NCT02838719|Dexamethasone|dexamethasone|mesh-list
101874627|NCT01190722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101874628|NCT01190722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874629|NCT01190722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101874630|NCT01190722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101874631|NCT01190722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101874632|NCT01190722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101874633|NCT01190722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874634|NCT01190722|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101874635|NCT01196260|Capecitabine|capecitabine|mesh-list
101874636|NCT01196260|Oxaliplatin|oxaliplatin|mesh-list
101874637|NCT01196260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101874638|NCT01196260|Antimetabolites|antimetabolites|mesh-ancestor
101874639|NCT01196260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874640|NCT01196260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101874641|NCT01192984|Mogamulizumab|mogamulizumab|mesh-list
101874642|NCT01192984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101874643|NCT05412082|Leucovorin|leucovorin|mesh-list
101874644|NCT05412082|Fluorouracil|fluorouracil|mesh-list
101874645|NCT05412082|Capecitabine|capecitabine|mesh-list
101874646|NCT05412082|Oxaliplatin|oxaliplatin|mesh-list
101874647|NCT05412082|Antimetabolites|antimetabolites|mesh-ancestor
101874648|NCT05412082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874649|NCT05412082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101874650|NCT05412082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101874651|NCT05412082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101874652|NCT05412082|Immunologic Factors|immunologic factors|mesh-ancestor
101874653|NCT05412082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874654|NCT05412082|Antidotes|antidotes|mesh-ancestor
101874655|NCT05412082|Protective Agents|protective agents|mesh-ancestor
101874656|NCT05412082|Vitamin B Complex|vitamin b complex|mesh-ancestor
101874657|NCT05412082|Vitamins|vitamins|mesh-ancestor
101874658|NCT05412082|Micronutrients|micronutrients|mesh-ancestor
101874659|NCT01193296|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101874660|NCT01193296|Vildagliptin|vildagliptin|mesh-list
101874661|NCT01193296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101874662|NCT01193296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874663|NCT01193296|Incretins|incretins|mesh-ancestor
101874664|NCT01193296|Hormones|hormones|mesh-ancestor
101874665|NCT01193296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101874666|NCT01193296|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101874667|NCT01193296|Protease Inhibitors|protease inhibitors|mesh-ancestor
101874668|NCT01193296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101874669|NCT01193296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874670|NCT01197040|Mycophenolic Acid|mycophenolic acid|mesh-list
101874671|NCT01197040|Prednisone|prednisone|mesh-list
101874672|NCT01197040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101874673|NCT01197040|Glucocorticoids|glucocorticoids|mesh-ancestor
101874674|NCT01197040|Hormones|hormones|mesh-ancestor
101874675|NCT01197040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101874676|NCT01197040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874677|NCT01197040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101874678|NCT01197040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101874679|NCT01197040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101874680|NCT01197040|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101874681|NCT01197040|Antitubercular Agents|antitubercular agents|mesh-ancestor
101874682|NCT01197040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101874683|NCT01197040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101874684|NCT01197040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101874685|NCT01197040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874686|NCT01193452|Leucovorin|leucovorin|mesh-list
101874687|NCT01193452|Fluorouracil|fluorouracil|mesh-list
101874688|NCT01193452|Levoleucovorin|levoleucovorin|mesh-list
101874689|NCT01193452|Antimetabolites|antimetabolites|mesh-ancestor
101874690|NCT01193452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874691|NCT01193452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101874692|NCT01193452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101874693|NCT01193452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101874694|NCT01193452|Immunologic Factors|immunologic factors|mesh-ancestor
101874695|NCT01193452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874696|NCT01193452|Antidotes|antidotes|mesh-ancestor
101594519|NCT02779582|Progesterone|progesterone|mesh-list
101874697|NCT01193452|Protective Agents|protective agents|mesh-ancestor
101874698|NCT01193452|Vitamin B Complex|vitamin b complex|mesh-ancestor
101874700|NCT01193452|Micronutrients|micronutrients|mesh-ancestor
101874701|NCT05670886|Carbetocin|carbetocin|mesh-list
101874702|NCT05670886|Oxytocics|oxytocics|mesh-ancestor
101874703|NCT05670886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101874704|NCT05670886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874705|NCT01295632|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
101874706|NCT01295632|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101874707|NCT01295632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101874708|NCT01295632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874709|NCT03844594|Eptifibatide|eptifibatide|mesh-list
101874710|NCT03844594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101874711|NCT03848182|Gemcitabine|gemcitabine|mesh-list
101874712|NCT03848182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101874713|NCT03848182|Antimetabolites|antimetabolites|mesh-ancestor
101874714|NCT03848182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874715|NCT03848182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101874716|NCT00146328|Tipranavir|tipranavir|mesh-list
101874717|NCT00146328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101874718|NCT00146328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101874719|NCT00146328|Antiviral Agents|antiviral agents|mesh-ancestor
101874720|NCT00146328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101874721|NCT04916938|Psychotropic Drugs|psychotropic drugs|mesh-list
101874722|NCT01295866|Nitric Oxide|nitric oxide|mesh-list
101874723|NCT01295866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101874724|NCT01295866|Autonomic Agents|autonomic agents|mesh-ancestor
101874725|NCT01295866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101874726|NCT01295866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874727|NCT01295866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101874728|NCT01295866|Respiratory System Agents|respiratory system agents|mesh-ancestor
101874729|NCT01295866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101874730|NCT01295866|Antioxidants|antioxidants|mesh-ancestor
101874731|NCT01295866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874732|NCT01295866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101874733|NCT01295866|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101874734|NCT01295866|Vasodilator Agents|vasodilator agents|mesh-ancestor
101874735|NCT01295866|Gasotransmitters|gasotransmitters|mesh-ancestor
101874736|NCT01295866|Protective Agents|protective agents|mesh-ancestor
101874737|NCT03848104|Cefoxitin|cefoxitin|mesh-list
101874738|NCT03848104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101874739|NCT03848104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101874740|NCT05670808|Epinephrine|epinephrine|mesh-list
101874741|NCT05670808|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101874742|NCT05670808|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101874743|NCT05670808|Adrenergic Agents|adrenergic agents|mesh-ancestor
101874744|NCT05670808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101874745|NCT05670808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874746|NCT05670808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874747|NCT05670808|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101874748|NCT05670808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101874749|NCT05670808|Autonomic Agents|autonomic agents|mesh-ancestor
101874750|NCT05670808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101874751|NCT05670808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101874752|NCT05670808|Respiratory System Agents|respiratory system agents|mesh-ancestor
101874753|NCT05670808|Mydriatics|mydriatics|mesh-ancestor
101874754|NCT05670808|Sympathomimetics|sympathomimetics|mesh-ancestor
101874755|NCT05670808|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101874756|NCT01197664|Fluorouracil|fluorouracil|mesh-list
101874757|NCT01197664|Antimetabolites|antimetabolites|mesh-ancestor
101966805|NCT04438720|Tocolytic Agents|tocolytic agents|mesh-ancestor
101874758|NCT01197664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874759|NCT01197664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101874760|NCT01197664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101874761|NCT01197664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101874762|NCT01197664|Immunologic Factors|immunologic factors|mesh-ancestor
101874763|NCT01197664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874764|NCT01199458|Alfentanil|alfentanil|mesh-list
101874765|NCT01199458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101874766|NCT01199458|Narcotics|narcotics|mesh-ancestor
101874767|NCT01199458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101874768|NCT01199458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874769|NCT01199458|Analgesics|analgesics|mesh-ancestor
101874770|NCT01199458|Sensory System Agents|sensory system agents|mesh-ancestor
101874771|NCT01199458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101594592|NCT02779192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101874772|NCT01199458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101874773|NCT01199458|Anesthetics, General|anesthetics, general|mesh-ancestor
101874774|NCT01199458|Anesthetics|anesthetics|mesh-ancestor
101874775|NCT01199614|Parathyroid Hormone|parathyroid hormone|mesh-list
101874776|NCT01199614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874777|NCT01199614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101874778|NCT01588522|Calcitriol|calcitriol|mesh-list
101874779|NCT01588522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101874780|NCT01588522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874781|NCT01588522|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101874782|NCT01588522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101874783|NCT01588522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874784|NCT01588522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101874785|NCT01588522|Vitamins|vitamins|mesh-ancestor
101874786|NCT01588522|Micronutrients|micronutrients|mesh-ancestor
101874787|NCT01588522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101874788|NCT01296178|Idarubicin|idarubicin|mesh-list
101874789|NCT01296178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101874790|NCT01296178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101874791|NCT01296178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101874792|NCT01296178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101874793|NCT01296178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101874794|NCT01296178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874795|NCT01296256|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101874796|NCT01296256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101874797|NCT01296256|Alkylating Agents|alkylating agents|mesh-ancestor
101874798|NCT01296256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874799|NCT01296256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101874800|NCT03731182|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101874801|NCT03731182|Immunologic Factors|immunologic factors|mesh-ancestor
101874802|NCT03731182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874803|NCT03730012|Atezolizumab|atezolizumab|mesh-list
101874804|NCT03730012|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101874805|NCT03730012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874806|NCT03730012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101874807|NCT03730012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101874808|NCT03844360|Anti-Infective Agents|anti-infective agents|mesh-list
101874809|NCT03844360|Bortezomib|bortezomib|mesh-list
101874811|NCT03844360|Dasatinib|dasatinib|mesh-list
101874812|NCT03844360|Pegaspargase|pegaspargase|mesh-list
101874813|NCT03844360|Lenograstim|lenograstim|mesh-list
101874814|NCT03844360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101874815|NCT03844360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101874816|NCT03844360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101874817|NCT03844360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874818|NCT03844360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101874819|NCT03844360|Immunologic Factors|immunologic factors|mesh-ancestor
101874820|NCT03844360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874821|NCT01198054|Lenalidomide|lenalidomide|mesh-list
101874822|NCT01198054|Immunologic Factors|immunologic factors|mesh-ancestor
101874823|NCT01198054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874824|NCT01198054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101874825|NCT01198054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101874826|NCT01198054|Growth Substances|growth substances|mesh-ancestor
101874827|NCT01198054|Growth Inhibitors|growth inhibitors|mesh-ancestor
101874828|NCT01198054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101874829|NCT01202032|Bevacizumab|bevacizumab|mesh-list
101874830|NCT01202032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101874831|NCT01202032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101874832|NCT01202032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101874833|NCT01202032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101874834|NCT01202032|Growth Substances|growth substances|mesh-ancestor
101874835|NCT01202032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874836|NCT01202032|Growth Inhibitors|growth inhibitors|mesh-ancestor
101874837|NCT03844984|Lidocaine|lidocaine|mesh-list
101874838|NCT03844984|Midazolam|midazolam|mesh-list
101874839|NCT03844984|Ketamine|ketamine|mesh-list
101688715|NCT02838719|Glucocorticoids|glucocorticoids|mesh-ancestor
101874840|NCT03844984|Anesthetics, Local|anesthetics, local|mesh-ancestor
101874841|NCT03844984|Anesthetics|anesthetics|mesh-ancestor
101874842|NCT03844984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101874843|NCT03844984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874844|NCT03844984|Sensory System Agents|sensory system agents|mesh-ancestor
101874845|NCT03844984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101594684|NCT04940572|Valproic Acid|valproic acid|mesh-list
101874846|NCT03844984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101874847|NCT03844984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101874848|NCT03844984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101874849|NCT03844984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101874850|NCT03844984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874851|NCT03844984|Analgesics|analgesics|mesh-ancestor
101874852|NCT03844984|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101874853|NCT03844984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101874854|NCT03844984|Anesthetics, General|anesthetics, general|mesh-ancestor
101874855|NCT03844984|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101874856|NCT03844984|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101874857|NCT03844984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101874858|NCT03844984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101874859|NCT03844984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101874860|NCT03844984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101874861|NCT03844984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101874862|NCT03844984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101874863|NCT03844984|GABA Modulators|gaba modulators|mesh-ancestor
101874864|NCT03844984|GABA Agents|gaba agents|mesh-ancestor
101874865|NCT03842020|Amiodarone|amiodarone|mesh-list
101874866|NCT03842020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101874867|NCT03842020|Vasodilator Agents|vasodilator agents|mesh-ancestor
101874868|NCT03842020|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101874869|NCT03842020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101966836|NCT03209570|Zinc Oxide|zinc oxide|mesh-list
101874870|NCT03842020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874871|NCT03842020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101874872|NCT03842020|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101874873|NCT03842020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101874874|NCT03842020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101874875|NCT03842020|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101874876|NCT03842020|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101874877|NCT03842020|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101874878|NCT01200004|Lenalidomide|lenalidomide|mesh-list
101874879|NCT01200004|Azacitidine|azacitidine|mesh-list
101874880|NCT01200004|Immunologic Factors|immunologic factors|mesh-ancestor
101874881|NCT01200004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874882|NCT01200004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101874883|NCT01200004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101874884|NCT01200004|Growth Substances|growth substances|mesh-ancestor
101874885|NCT01200004|Growth Inhibitors|growth inhibitors|mesh-ancestor
101874886|NCT01200004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101874887|NCT01200004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101874888|NCT01200004|Antimetabolites|antimetabolites|mesh-ancestor
101874889|NCT01200004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874890|NCT01200004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101874891|NCT01198210|Dexamethasone|dexamethasone|mesh-list
101874892|NCT01198210|Dexamethasone acetate|dexamethasone acetate|mesh-list
101874893|NCT01198210|Ketamine|ketamine|mesh-list
101874894|NCT01198210|BB 1101|bb 1101|mesh-list
101874895|NCT01198210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101874896|NCT01198210|Antiemetics|antiemetics|mesh-ancestor
101874897|NCT01198210|Autonomic Agents|autonomic agents|mesh-ancestor
101874898|NCT01198210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101874899|NCT01198210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874900|NCT01198210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101874901|NCT01198210|Glucocorticoids|glucocorticoids|mesh-ancestor
101874902|NCT01198210|Hormones|hormones|mesh-ancestor
101874903|NCT01198210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101874904|NCT01198210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101874905|NCT01198210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101874906|NCT01198210|Protease Inhibitors|protease inhibitors|mesh-ancestor
101874907|NCT01198210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101874908|NCT01198210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874909|NCT01198210|Analgesics|analgesics|mesh-ancestor
101874910|NCT01198210|Sensory System Agents|sensory system agents|mesh-ancestor
101874911|NCT01198210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101874912|NCT01198210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101874913|NCT01198210|Anesthetics, General|anesthetics, general|mesh-ancestor
101874914|NCT01198210|Anesthetics|anesthetics|mesh-ancestor
101874915|NCT01198210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101874916|NCT01198210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101874917|NCT01198210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101874918|NCT01198210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101874919|NCT03843736|Drospirenone|drospirenone|mesh-list
101874920|NCT03843736|Contraceptive Agents|contraceptive agents|mesh-list
101874921|NCT03843736|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101874922|NCT03843736|Contraceptives, Oral|contraceptives, oral|mesh-list
101874923|NCT03843736|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
101874924|NCT03843736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101874925|NCT03843736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874926|NCT03843736|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101874927|NCT03843736|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101452573|NCT00230958|Interferons|interferons|mesh-list
101874928|NCT03843736|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101874929|NCT03843736|Estrogens|estrogens|mesh-ancestor
101874930|NCT03843736|Hormones|hormones|mesh-ancestor
101874931|NCT03843736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101874932|NCT03843736|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101874933|NCT03843736|Hormone Antagonists|hormone antagonists|mesh-ancestor
101874934|NCT03843736|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101874935|NCT03843736|Diuretics|diuretics|mesh-ancestor
101874936|NCT03843736|Natriuretic Agents|natriuretic agents|mesh-ancestor
101874937|NCT01200472|Apremilast|apremilast|mesh-list
101874938|NCT01200472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101874939|NCT01200472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101874940|NCT01200472|Analgesics|analgesics|mesh-ancestor
101874941|NCT01200472|Sensory System Agents|sensory system agents|mesh-ancestor
101874942|NCT01200472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101874943|NCT01200472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874944|NCT01200472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101874945|NCT01200472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101874946|NCT01200472|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101874947|NCT01200472|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101874948|NCT01200472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101874949|NCT01200472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874950|NCT04638790|Dexamethasone|dexamethasone|mesh-list
101874951|NCT04638790|Cyclophosphamide|cyclophosphamide|mesh-list
101874952|NCT04638790|Dacarbazine|dacarbazine|mesh-list
101874953|NCT04638790|Doxorubicin|doxorubicin|mesh-list
101874954|NCT04638790|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101874955|NCT04638790|Etoposide|etoposide|mesh-list
101874956|NCT04638790|Vincristine|vincristine|mesh-list
101874957|NCT04638790|Bleomycin|bleomycin|mesh-list
101874958|NCT04638790|Vinblastine|vinblastine|mesh-list
101874959|NCT04638790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101874960|NCT04638790|Immunologic Factors|immunologic factors|mesh-ancestor
101874961|NCT04638790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874962|NCT04638790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101874963|NCT04638790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101874964|NCT04638790|Alkylating Agents|alkylating agents|mesh-ancestor
101874965|NCT04638790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874966|NCT04638790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101688730|NCT02659488|Dopamine Agents|dopamine agents|mesh-ancestor
101874967|NCT04638790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101874968|NCT04638790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101874969|NCT04638790|Antiemetics|antiemetics|mesh-ancestor
101874970|NCT04638790|Autonomic Agents|autonomic agents|mesh-ancestor
101874971|NCT04638790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101874972|NCT04638790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101874973|NCT04638790|Glucocorticoids|glucocorticoids|mesh-ancestor
101874974|NCT04638790|Hormones|hormones|mesh-ancestor
101874975|NCT04638790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101874976|NCT04638790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101874977|NCT04638790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101874978|NCT04638790|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101874979|NCT04638790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101874980|NCT04638790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101874981|NCT04638790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101874982|NCT04638790|Tubulin Modulators|tubulin modulators|mesh-ancestor
101874983|NCT04638790|Antimitotic Agents|antimitotic agents|mesh-ancestor
101874984|NCT04638790|Mitosis Modulators|mitosis modulators|mesh-ancestor
101874985|NCT01200706|Amoxicillin|amoxicillin|mesh-list
101874986|NCT01200706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101874987|NCT01200706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101874988|NCT01200784|Niacinamide|niacinamide|mesh-list
101874989|NCT01200784|Niacin|niacin|mesh-list
101874990|NCT01200784|Nicotinic Acids|nicotinic acids|mesh-list
101874991|NCT01200784|Vitamin B Complex|vitamin b complex|mesh-ancestor
101874992|NCT01200784|Vitamins|vitamins|mesh-ancestor
101874993|NCT01200784|Micronutrients|micronutrients|mesh-ancestor
101874994|NCT01200784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101874995|NCT01200784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101594838|NCT02777788|Paclitaxel|paclitaxel|mesh-list
101874996|NCT01200784|Antimetabolites|antimetabolites|mesh-ancestor
101874997|NCT01200784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101874998|NCT01200784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101874999|NCT01200784|Vasodilator Agents|vasodilator agents|mesh-ancestor
101875000|NCT03841474|Sertraline|sertraline|mesh-list
101875001|NCT03841474|Escitalopram|escitalopram|mesh-list
101875002|NCT03841474|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101875003|NCT03841474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101875004|NCT03841474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101875005|NCT03841474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875006|NCT03841474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101875007|NCT03841474|Serotonin Agents|serotonin agents|mesh-ancestor
101875008|NCT03841474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875009|NCT03841474|Antidepressive Agents|antidepressive agents|mesh-ancestor
101875010|NCT03841474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101875011|NCT01198444|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
101875012|NCT01198444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101875013|NCT01198444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875014|NCT05670184|Ethanol|ethanol|mesh-list
101875015|NCT05670184|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
101875016|NCT05670184|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101875017|NCT05670184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101875018|NCT05670184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101875019|NCT05670184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875020|NCT05670184|Hallucinogens|hallucinogens|mesh-ancestor
101875021|NCT05670184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101875022|NCT05670184|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101875023|NCT05670184|Serotonin Agents|serotonin agents|mesh-ancestor
101875024|NCT05670184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101875025|NCT05670184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875026|NCT05670184|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101875027|NCT05084248|Vitamin D|vitamin d|mesh-list
101875028|NCT05084248|Ergocalciferols|ergocalciferols|mesh-list
101875029|NCT05084248|Vitamins|vitamins|mesh-ancestor
101875030|NCT05084248|Micronutrients|micronutrients|mesh-ancestor
101875031|NCT05084248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875032|NCT05084248|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101875033|NCT05084248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101875034|NCT03842800|Ketamine|ketamine|mesh-list
101875035|NCT03842800|Analgesics|analgesics|mesh-ancestor
101875036|NCT03842800|Sensory System Agents|sensory system agents|mesh-ancestor
101875037|NCT03842800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101875038|NCT03842800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875039|NCT03842800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101875040|NCT03842800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101875041|NCT03842800|Anesthetics, General|anesthetics, general|mesh-ancestor
101875042|NCT03842800|Anesthetics|anesthetics|mesh-ancestor
101875043|NCT03842800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101875044|NCT03842800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101875045|NCT03842800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101875046|NCT03842800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101875047|NCT03842800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875048|NCT01202422|Pregabalin|pregabalin|mesh-list
101875049|NCT01202422|Analgesics|analgesics|mesh-ancestor
101875050|NCT01202422|Sensory System Agents|sensory system agents|mesh-ancestor
101875051|NCT01202422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101875052|NCT01202422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875053|NCT01202422|Anticonvulsants|anticonvulsants|mesh-ancestor
101875054|NCT01202422|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101875055|NCT01202422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101875056|NCT01202422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875057|NCT01202422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101875058|NCT01202422|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101875059|NCT01202422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101875060|NCT01202422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101875061|NCT01202422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101875062|NCT03892018|Paclitaxel|paclitaxel|mesh-list
101875063|NCT03892018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101875064|NCT03892018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101875065|NCT03892018|Tubulin Modulators|tubulin modulators|mesh-ancestor
101875066|NCT03892018|Antimitotic Agents|antimitotic agents|mesh-ancestor
101875067|NCT03892018|Mitosis Modulators|mitosis modulators|mesh-ancestor
101875068|NCT03892018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875069|NCT01198912|Doxycycline|doxycycline|mesh-list
101875070|NCT01198912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101875071|NCT01198912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101875072|NCT01198912|Antimalarials|antimalarials|mesh-ancestor
101875073|NCT01198912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101875074|NCT01198912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101875075|NCT03842488|Raltegravir Potassium|raltegravir potassium|mesh-list
101875076|NCT03842488|Darunavir|darunavir|mesh-list
101875077|NCT03842488|Cobicistat|cobicistat|mesh-list
101875078|NCT03842488|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
101875079|NCT03842488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101875080|NCT03842488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101875081|NCT03842488|Antiviral Agents|antiviral agents|mesh-ancestor
101875082|NCT03842488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101875083|NCT03842488|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101875084|NCT03842488|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101875085|NCT03842488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101875086|NCT03842488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875087|NCT03842488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101875088|NCT03842488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101875089|NCT03842488|Protease Inhibitors|protease inhibitors|mesh-ancestor
101875090|NCT03842488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101875091|NCT03842488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101875092|NCT04256824|Triclosan|triclosan|mesh-list
101875093|NCT04256824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101875094|NCT04256824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101875095|NCT04256824|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101875096|NCT04256824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101875097|NCT04256824|Antimetabolites|antimetabolites|mesh-ancestor
101875098|NCT04256824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875099|NCT04256824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101875100|NCT03842254|Epoetin Alfa|epoetin alfa|mesh-list
101875101|NCT03842254|Hematinics|hematinics|mesh-ancestor
101875102|NCT01201642|Prednisolone|prednisolone|mesh-list
101875103|NCT01201642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101875104|NCT01201642|Glucocorticoids|glucocorticoids|mesh-ancestor
101875105|NCT01201642|Hormones|hormones|mesh-ancestor
101875106|NCT01201642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101875107|NCT01201642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875108|NCT01201642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101875109|NCT01201642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101875110|NCT05004064|Rituximab|rituximab|mesh-list
101875111|NCT05004064|Acalabrutinib|acalabrutinib|mesh-list
101875112|NCT05004064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101875113|NCT05004064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101875114|NCT05004064|Immunologic Factors|immunologic factors|mesh-ancestor
101875115|NCT05004064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875116|NCT05004064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101875117|NCT04982692|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101875118|NCT04982692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101875119|NCT04982692|Immunologic Factors|immunologic factors|mesh-ancestor
101875120|NCT04982692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875121|NCT01202734|Methylphenidate|methylphenidate|mesh-list
101875122|NCT01202734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101875123|NCT01202734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875124|NCT01202734|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101875125|NCT01202734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101875126|NCT01202734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101875127|NCT01202734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875128|NCT01202734|Dopamine Agents|dopamine agents|mesh-ancestor
101875129|NCT01202734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101875130|NCT03173092|Dexamethasone|dexamethasone|mesh-list
101875131|NCT03173092|Lenalidomide|lenalidomide|mesh-list
101875132|NCT03173092|Ixazomib|ixazomib|mesh-list
101875133|NCT03173092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101875134|NCT03173092|Antiemetics|antiemetics|mesh-ancestor
101875135|NCT03173092|Autonomic Agents|autonomic agents|mesh-ancestor
101875136|NCT03173092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101875137|NCT03173092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875138|NCT03173092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101875139|NCT03173092|Glucocorticoids|glucocorticoids|mesh-ancestor
101875140|NCT03173092|Hormones|hormones|mesh-ancestor
101875141|NCT03173092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101875142|NCT03173092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101875143|NCT03173092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101875144|NCT03173092|Immunologic Factors|immunologic factors|mesh-ancestor
101875145|NCT03173092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101875146|NCT03173092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101875147|NCT03173092|Growth Substances|growth substances|mesh-ancestor
101875148|NCT03173092|Growth Inhibitors|growth inhibitors|mesh-ancestor
101875149|NCT03173092|Protease Inhibitors|protease inhibitors|mesh-ancestor
101875150|NCT03173092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101875151|NCT03173092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875153|NCT02966314|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101875154|NCT02966314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101875155|NCT02966314|Respiratory System Agents|respiratory system agents|mesh-ancestor
101875156|NCT01203982|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101875157|NCT01203982|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101875158|NCT01203982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101875159|NCT01203982|Antimetabolites|antimetabolites|mesh-ancestor
101452643|NCT00204620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101875160|NCT01203982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875161|NCT01203982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101875162|NCT01203982|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101875163|NCT01203982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101875164|NCT01202890|Bevacizumab|bevacizumab|mesh-list
101875165|NCT01202890|Lenalidomide|lenalidomide|mesh-list
101875166|NCT01202890|Doxorubicin|doxorubicin|mesh-list
101875167|NCT01202890|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101875168|NCT01202890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101875169|NCT01202890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101875170|NCT01202890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101875171|NCT01202890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101875172|NCT01202890|Growth Substances|growth substances|mesh-ancestor
101875173|NCT01202890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875174|NCT01202890|Growth Inhibitors|growth inhibitors|mesh-ancestor
101875175|NCT01202890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101875176|NCT01202890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101875177|NCT01202890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101875178|NCT01202890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101875179|NCT01202890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875180|NCT01202890|Immunologic Factors|immunologic factors|mesh-ancestor
101875181|NCT01199224|Veliparib|veliparib|mesh-list
101875182|NCT01199224|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101875183|NCT01199224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101875184|NCT01199224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875185|NCT01199224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101875187|NCT01204138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101875188|NCT01204138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101875189|NCT01204138|Analgesics|analgesics|mesh-ancestor
101875190|NCT01204138|Sensory System Agents|sensory system agents|mesh-ancestor
101875191|NCT01204138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101875192|NCT01204138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875193|NCT01204138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101875194|NCT01204138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101875195|NCT01204138|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101875196|NCT01204138|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101875197|NCT01204138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101875198|NCT01204138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875199|NCT02927392|Leuprolide|leuprolide|mesh-list
101875200|NCT02927392|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101875201|NCT02927392|Fertility Agents|fertility agents|mesh-ancestor
101875202|NCT02927392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101875203|NCT02927392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875204|NCT02927392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101875205|NCT02927392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101875206|NCT01204372|Gemcitabine|gemcitabine|mesh-list
101875207|NCT01204372|Trastuzumab|trastuzumab|mesh-list
101875208|NCT01204372|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101875209|NCT01204372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101875210|NCT01204372|Antimetabolites|antimetabolites|mesh-ancestor
101875211|NCT01204372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875212|NCT01204372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101875213|NCT01204372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101875214|NCT01204372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101875215|NCT01204372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101875216|NCT01204450|Sirolimus|sirolimus|mesh-list
101875217|NCT01204450|Temsirolimus|temsirolimus|mesh-list
101595041|NCT02775292|Vaccines|vaccines|mesh-list
101875219|NCT01204450|Valproic Acid|valproic acid|mesh-list
101875220|NCT01204450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101875221|NCT01204450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101875222|NCT01204450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875223|NCT01204450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101875224|NCT01204450|Immunologic Factors|immunologic factors|mesh-ancestor
101875225|NCT01204450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875226|NCT01204450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101875227|NCT01204450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101875228|NCT01204450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101875229|NCT01204450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101875230|NCT01204450|Antifungal Agents|antifungal agents|mesh-ancestor
101875231|NCT01204450|Anticonvulsants|anticonvulsants|mesh-ancestor
101875232|NCT01204450|GABA Agents|gaba agents|mesh-ancestor
101875233|NCT01204450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101875234|NCT01204450|Antimanic Agents|antimanic agents|mesh-ancestor
101875235|NCT01204450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101875236|NCT01204450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101875237|NCT01204450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101875238|NCT03834454|Bupivacaine|bupivacaine|mesh-list
101875239|NCT03834454|Anesthetics, Local|anesthetics, local|mesh-ancestor
101875240|NCT03834454|Anesthetics|anesthetics|mesh-ancestor
101875241|NCT03834454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101875242|NCT03834454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875243|NCT03834454|Sensory System Agents|sensory system agents|mesh-ancestor
101875244|NCT03834454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101875245|NCT02428270|Trametinib|trametinib|mesh-list
101875246|NCT02428270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101875247|NCT02428270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101875248|NCT02428270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101875249|NCT02428270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875250|NCT03829930|Entinostat|entinostat|mesh-list
101688747|NCT02658864|Lafutidine|lafutidine|mesh-list
101875252|NCT03829930|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101875253|NCT03829930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101875254|NCT03829930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875255|NCT01203202|Clomipramine|clomipramine|mesh-list
101875256|NCT01203202|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101875257|NCT01203202|Antidepressive Agents|antidepressive agents|mesh-ancestor
101875258|NCT01203202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101875259|NCT01203202|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101875260|NCT01203202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101875261|NCT01203202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101875262|NCT01203202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875263|NCT01203202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101875264|NCT01203202|Serotonin Agents|serotonin agents|mesh-ancestor
101875265|NCT01203202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875266|NCT02047474|Leucovorin|leucovorin|mesh-list
101875267|NCT02047474|Fluorouracil|fluorouracil|mesh-list
101875268|NCT02047474|Oxaliplatin|oxaliplatin|mesh-list
101875269|NCT02047474|Irinotecan|irinotecan|mesh-list
101875270|NCT02047474|Calcium|calcium|mesh-list
101875271|NCT02047474|Levoleucovorin|levoleucovorin|mesh-list
101875272|NCT02047474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101875273|NCT02047474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875274|NCT02047474|Antimetabolites|antimetabolites|mesh-ancestor
101875275|NCT02047474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875276|NCT02047474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101875277|NCT02047474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101875278|NCT02047474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101875279|NCT02047474|Immunologic Factors|immunologic factors|mesh-ancestor
101875280|NCT02047474|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101875281|NCT02047474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101875282|NCT02047474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101875283|NCT02047474|Antidotes|antidotes|mesh-ancestor
101875284|NCT02047474|Protective Agents|protective agents|mesh-ancestor
101875285|NCT02047474|Vitamin B Complex|vitamin b complex|mesh-ancestor
101875286|NCT02047474|Vitamins|vitamins|mesh-ancestor
101875287|NCT02047474|Micronutrients|micronutrients|mesh-ancestor
101875288|NCT01298284|Propranolol|propranolol|mesh-list
101875289|NCT01298284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101875290|NCT01298284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101875291|NCT01298284|Adrenergic Agents|adrenergic agents|mesh-ancestor
101875292|NCT01298284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101875293|NCT01298284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875294|NCT01298284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875295|NCT01298284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101875296|NCT01298284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101875297|NCT01298284|Vasodilator Agents|vasodilator agents|mesh-ancestor
101875299|NCT01204840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101875300|NCT01204840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875301|NCT01203358|Beractant|beractant|mesh-list
101875302|NCT01203358|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
101875303|NCT01203358|Respiratory System Agents|respiratory system agents|mesh-ancestor
101875304|NCT05669560|Hydrogen Peroxide|hydrogen peroxide|mesh-list
101875305|NCT05669560|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101875306|NCT05669560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101875307|NCT03832426|Ritonavir|ritonavir|mesh-list
101875308|NCT03832426|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101875309|NCT03832426|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101875310|NCT03832426|Protease Inhibitors|protease inhibitors|mesh-ancestor
101875311|NCT03832426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101875312|NCT03832426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875313|NCT03832426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101875314|NCT03832426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101452758|NCT00231582|Paclitaxel|paclitaxel|mesh-list
101875315|NCT03832426|Antiviral Agents|antiviral agents|mesh-ancestor
101875316|NCT03832426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101875317|NCT03832426|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101875318|NCT03832426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101875319|NCT03840070|Hyaluronic Acid|hyaluronic acid|mesh-list
101875320|NCT03840070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101875321|NCT03840070|Immunologic Factors|immunologic factors|mesh-ancestor
101875322|NCT03840070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875323|NCT03840070|Viscosupplements|viscosupplements|mesh-ancestor
101875324|NCT03840070|Protective Agents|protective agents|mesh-ancestor
101875326|NCT03272698|Analgesics|analgesics|mesh-ancestor
101875327|NCT03272698|Sensory System Agents|sensory system agents|mesh-ancestor
101875328|NCT03272698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101875329|NCT03272698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875330|NCT03272698|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101875331|NCT03272698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101875332|NCT03272698|Anesthetics, General|anesthetics, general|mesh-ancestor
101875333|NCT03272698|Anesthetics|anesthetics|mesh-ancestor
101875334|NCT03272698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101875335|NCT03272698|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101875336|NCT03272698|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101875337|NCT03272698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101875338|NCT03272698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875339|NCT01203514|Epoetin Alfa|epoetin alfa|mesh-list
101875340|NCT01203514|Hematinics|hematinics|mesh-ancestor
101875341|NCT01204996|Paclitaxel|paclitaxel|mesh-list
101875342|NCT01204996|Docetaxel|docetaxel|mesh-list
101875343|NCT01204996|Carboplatin|carboplatin|mesh-list
101875344|NCT01204996|Gemcitabine|gemcitabine|mesh-list
101875345|NCT01204996|Doxorubicin|doxorubicin|mesh-list
101875346|NCT01204996|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101875347|NCT01204996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101875348|NCT01204996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101875349|NCT01204996|Tubulin Modulators|tubulin modulators|mesh-ancestor
101875350|NCT01204996|Antimitotic Agents|antimitotic agents|mesh-ancestor
101875351|NCT01204996|Mitosis Modulators|mitosis modulators|mesh-ancestor
101875352|NCT01204996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875353|NCT01204996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101875354|NCT01204996|Antimetabolites|antimetabolites|mesh-ancestor
101875355|NCT01204996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101875356|NCT01204996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101875357|NCT01204996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101875358|NCT01204996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101875359|NCT01297192|Solifenacin Succinate|solifenacin succinate|mesh-list
101875360|NCT01297192|Mirabegron|mirabegron|mesh-list
101875361|NCT01297192|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101875362|NCT01297192|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101875363|NCT01297192|Cholinergic Agents|cholinergic agents|mesh-ancestor
101875364|NCT01297192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101875365|NCT01297192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875366|NCT01297192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875367|NCT01297192|Urological Agents|urological agents|mesh-ancestor
101875368|NCT01297192|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101875369|NCT01297192|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101875370|NCT01297192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101875371|NCT01297192|Adrenergic Agents|adrenergic agents|mesh-ancestor
101875373|NCT01205074|Propranolol|propranolol|mesh-list
101875374|NCT01205074|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101875375|NCT01205074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101875376|NCT01205074|Adrenergic Agents|adrenergic agents|mesh-ancestor
101875377|NCT01205074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101875378|NCT01205074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875379|NCT01205074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875380|NCT01205074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101875381|NCT01205074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101875382|NCT01205074|Vasodilator Agents|vasodilator agents|mesh-ancestor
101875383|NCT01205074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101875384|NCT01205074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101875385|NCT01205074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101875386|NCT05667376|Curcumin|curcumin|mesh-list
101966910|NCT03175172|Pembrolizumab|pembrolizumab|mesh-list
101875387|NCT05667376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101875388|NCT05667376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101875390|NCT05667376|Sensory System Agents|sensory system agents|mesh-ancestor
101875391|NCT05667376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101875392|NCT05667376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875393|NCT05667376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101875394|NCT05667376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101875395|NCT05667376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101875396|NCT05667376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101875397|NCT05667376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875398|NCT03722524|Amlodipine|amlodipine|mesh-list
101875399|NCT03722524|Perindopril|perindopril|mesh-list
101875400|NCT03722524|Indapamide|indapamide|mesh-list
101875401|NCT03722524|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
101875402|NCT03722524|Diuretics|diuretics|mesh-list
101875403|NCT03722524|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101875404|NCT03722524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101875405|NCT03722524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101875406|NCT03722524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101875407|NCT03722524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875408|NCT03722524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101875409|NCT03722524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875410|NCT03722524|Vasodilator Agents|vasodilator agents|mesh-ancestor
101875411|NCT03722524|Natriuretic Agents|natriuretic agents|mesh-ancestor
101875412|NCT03722524|Protease Inhibitors|protease inhibitors|mesh-ancestor
101875413|NCT03722524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101875414|NCT03722524|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101875415|NCT05667220|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101875416|NCT05667220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101875417|NCT05667220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875418|NCT05667220|Incretins|incretins|mesh-ancestor
101875419|NCT05667220|Hormones|hormones|mesh-ancestor
101875420|NCT05667220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101875421|NCT05667220|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101875422|NCT05667220|Protease Inhibitors|protease inhibitors|mesh-ancestor
101875423|NCT05667220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101875424|NCT05667220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875425|NCT01203592|Albuterol|albuterol|mesh-list
101875426|NCT01203592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101875427|NCT01203592|Autonomic Agents|autonomic agents|mesh-ancestor
101875428|NCT01203592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101875429|NCT01203592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875430|NCT01203592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101452800|NCT00198848|Folic Acid|folic acid|mesh-list
101875431|NCT01203592|Respiratory System Agents|respiratory system agents|mesh-ancestor
101875432|NCT01203592|Tocolytic Agents|tocolytic agents|mesh-ancestor
101875433|NCT01203592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101875434|NCT01203592|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101875435|NCT01203592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101875436|NCT01203592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101875437|NCT01203592|Adrenergic Agents|adrenergic agents|mesh-ancestor
101875438|NCT01203592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101875439|NCT01203592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875440|NCT05281276|Celecoxib|celecoxib|mesh-list
101875441|NCT05281276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101875442|NCT05281276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101875443|NCT05281276|Analgesics|analgesics|mesh-ancestor
101875444|NCT05281276|Sensory System Agents|sensory system agents|mesh-ancestor
101875445|NCT05281276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101875446|NCT05281276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875447|NCT05281276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101875448|NCT05281276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101875449|NCT05281276|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101875450|NCT05281276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101875451|NCT05281276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101966918|NCT01088477|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101875452|NCT05281276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875453|NCT03829150|Amoxicillin|amoxicillin|mesh-list
101875454|NCT03829150|Metronidazole|metronidazole|mesh-list
101875455|NCT03829150|Clarithromycin|clarithromycin|mesh-list
101875456|NCT03829150|Dexlansoprazole|dexlansoprazole|mesh-list
101875457|NCT03829150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101875458|NCT03829150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101875459|NCT03829150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101875460|NCT03829150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101875461|NCT03829150|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101875462|NCT03829150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101875463|NCT03829150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875464|NCT03829150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101875465|NCT03829150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101875466|NCT03829150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101875467|NCT03829150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101875468|NCT03829150|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101875469|NCT01205464|Doxycycline|doxycycline|mesh-list
101875470|NCT01205464|Tetracycline|tetracycline|mesh-list
101875471|NCT01205464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101875472|NCT01205464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101875473|NCT01205464|Antimalarials|antimalarials|mesh-ancestor
101875474|NCT01205464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101875475|NCT01205464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101875476|NCT01205464|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101875477|NCT01205464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101875478|NCT01205464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875479|NCT03828838|177Lu-PSMA-617|177lu-psma-617|mesh-list
101875480|NCT03828838|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101875481|NCT03828838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875483|NCT03819010|Palbociclib|palbociclib|mesh-list
101875484|NCT03819010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101875485|NCT03819010|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101875486|NCT03819010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101875487|NCT03819010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101875488|NCT03819010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875489|NCT03819010|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101452816|NCT00231855|Docetaxel|docetaxel|mesh-list
101875490|NCT03819010|Hormone Antagonists|hormone antagonists|mesh-ancestor
101875491|NCT03819010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101875492|NCT03819010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875493|NCT03819010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101875494|NCT03818932|Acetaminophen|acetaminophen|mesh-list
101875495|NCT03818932|Celecoxib|celecoxib|mesh-list
101875496|NCT03818932|Ketorolac|ketorolac|mesh-list
101875497|NCT03818932|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
101875498|NCT03818932|Diazepam|diazepam|mesh-list
101875499|NCT03818932|Gabapentin|gabapentin|mesh-list
101875500|NCT03818932|Hydrocodone|hydrocodone|mesh-list
101875501|NCT03818932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101875502|NCT03818932|Analgesics|analgesics|mesh-ancestor
101875503|NCT03818932|Sensory System Agents|sensory system agents|mesh-ancestor
101875504|NCT03818932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101875505|NCT03818932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875506|NCT03818932|Antipyretics|antipyretics|mesh-ancestor
101875507|NCT03818932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101875508|NCT03818932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101875509|NCT03818932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101875510|NCT03818932|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101875511|NCT03818932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101875512|NCT03818932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101875513|NCT03818932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875514|NCT03818932|Anticonvulsants|anticonvulsants|mesh-ancestor
101595346|NCT02770222|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101875515|NCT03818932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101875516|NCT03818932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101875517|NCT03818932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101875518|NCT03818932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101875519|NCT03818932|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101875520|NCT03818932|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101875521|NCT03818932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101875522|NCT03818932|Antimanic Agents|antimanic agents|mesh-ancestor
101875523|NCT03818932|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101875524|NCT03818932|Narcotics|narcotics|mesh-ancestor
101875525|NCT03818932|Antitussive Agents|antitussive agents|mesh-ancestor
101875526|NCT03818932|Respiratory System Agents|respiratory system agents|mesh-ancestor
101875527|NCT03818932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101875528|NCT03818932|Antiemetics|antiemetics|mesh-ancestor
101875529|NCT03818932|Autonomic Agents|autonomic agents|mesh-ancestor
101875530|NCT03818932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101875531|NCT03818932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101875532|NCT03818932|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101875533|NCT03818932|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101875534|NCT03818932|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101875535|NCT03818932|Anesthetics, General|anesthetics, general|mesh-ancestor
101875536|NCT03818932|Anesthetics|anesthetics|mesh-ancestor
101875537|NCT03818932|GABA Modulators|gaba modulators|mesh-ancestor
101875538|NCT03818932|GABA Agents|gaba agents|mesh-ancestor
101875539|NCT01205932|Enoxaparin|enoxaparin|mesh-list
101875540|NCT01205932|Rivaroxaban|rivaroxaban|mesh-list
101875541|NCT01205932|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101875542|NCT01205932|Antithrombins|antithrombins|mesh-ancestor
101875543|NCT01205932|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101875544|NCT01205932|Protease Inhibitors|protease inhibitors|mesh-ancestor
101875545|NCT01205932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101875546|NCT01205932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875547|NCT01205932|Anticoagulants|anticoagulants|mesh-ancestor
101875548|NCT01205932|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101875549|NCT01205932|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101875550|NCT01300780|Etoricoxib|etoricoxib|mesh-list
101875551|NCT01300780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101875552|NCT01300780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101875553|NCT01300780|Analgesics|analgesics|mesh-ancestor
101875554|NCT01300780|Sensory System Agents|sensory system agents|mesh-ancestor
101875555|NCT01300780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101875556|NCT01300780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875557|NCT01300780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101875558|NCT01300780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101875559|NCT01300780|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101875560|NCT01300780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101875561|NCT01300780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101875562|NCT01300780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875563|NCT01297816|Minocycline|minocycline|mesh-list
101875564|NCT01297816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101875565|NCT01297816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101875566|NCT01297894|Colistin|colistin|mesh-list
101875567|NCT01297894|Fosfomycin|fosfomycin|mesh-list
101875568|NCT01297894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101875569|NCT01297894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101875570|NCT05666362|Benoxinate|benoxinate|mesh-list
101875571|NCT05666362|Anesthetics, Local|anesthetics, local|mesh-ancestor
101875572|NCT05666362|Anesthetics|anesthetics|mesh-ancestor
101875573|NCT05666362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101875574|NCT05666362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875575|NCT05666362|Sensory System Agents|sensory system agents|mesh-ancestor
101875576|NCT05666362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101875577|NCT01206010|Varenicline|varenicline|mesh-list
101875578|NCT01206010|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101875579|NCT01206010|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101875580|NCT01206010|Cholinergic Agents|cholinergic agents|mesh-ancestor
101875581|NCT01206010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101966934|NCT01088555|Antioxidants|antioxidants|mesh-ancestor
101875582|NCT01206010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875583|NCT01206010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875584|NCT05665114|Cytarabine|cytarabine|mesh-list
101875585|NCT05665114|Cyclophosphamide|cyclophosphamide|mesh-list
101875586|NCT05665114|Fludarabine|fludarabine|mesh-list
101875587|NCT05665114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101595419|NCT02768740|Hydrocortisone|hydrocortisone|mesh-list
101875588|NCT05665114|Immunologic Factors|immunologic factors|mesh-ancestor
101875589|NCT05665114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875590|NCT05665114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101875591|NCT05665114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101875592|NCT05665114|Alkylating Agents|alkylating agents|mesh-ancestor
101875593|NCT05665114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875594|NCT05665114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101875595|NCT05665114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101688768|NCT04171284|Docetaxel|docetaxel|mesh-list
101875596|NCT05665114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101875597|NCT05665114|Antimetabolites|antimetabolites|mesh-ancestor
101875598|NCT05665114|Antiviral Agents|antiviral agents|mesh-ancestor
101875599|NCT05665114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101875601|NCT05345002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101875602|NCT05345002|Keratolytic Agents|keratolytic agents|mesh-ancestor
101875603|NCT05345002|Dermatologic Agents|dermatologic agents|mesh-ancestor
101875604|NCT03814642|Esomeprazole|esomeprazole|mesh-list
101875605|NCT03814642|Clopidogrel|clopidogrel|mesh-list
101875606|NCT03814642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101875607|NCT03814642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101875608|NCT03814642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101875609|NCT03814642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101875610|NCT03814642|Purinergic Agents|purinergic agents|mesh-ancestor
101875611|NCT03814642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101875612|NCT03814642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875613|NCT03814642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875614|NCT03814642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101875615|NCT03814642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101875616|NCT03814642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101875617|NCT03814642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101875618|NCT01299220|Acitretin|acitretin|mesh-list
101875619|NCT01299220|Keratolytic Agents|keratolytic agents|mesh-ancestor
101875620|NCT01299220|Dermatologic Agents|dermatologic agents|mesh-ancestor
101875621|NCT03813784|Capecitabine|capecitabine|mesh-list
101875622|NCT03813784|Oxaliplatin|oxaliplatin|mesh-list
101875623|NCT03813784|Apatinib|apatinib|mesh-list
101875624|NCT03813784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101875625|NCT03813784|Antimetabolites|antimetabolites|mesh-ancestor
101875626|NCT03813784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875627|NCT03813784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101875628|NCT03813784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101875629|NCT03813784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101875630|NCT03818308|Sofosbuvir|sofosbuvir|mesh-list
101875631|NCT03818308|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
101875632|NCT03818308|Velpatasvir|velpatasvir|mesh-list
101875633|NCT03818308|Antiviral Agents|antiviral agents|mesh-ancestor
101875634|NCT03818308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101875635|NCT03827044|Avelumab|avelumab|mesh-list
101875636|NCT03827044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101875637|NCT03827044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101875638|NCT00145626|Cyclophosphamide|cyclophosphamide|mesh-list
101875639|NCT00145626|Melphalan|melphalan|mesh-list
101875640|NCT00145626|Thiotepa|thiotepa|mesh-list
101875641|NCT00145626|Fludarabine|fludarabine|mesh-list
101875642|NCT00145626|Antibodies|antibodies|mesh-list
101875643|NCT00145626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101875644|NCT00145626|Immunologic Factors|immunologic factors|mesh-ancestor
101875645|NCT00145626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875646|NCT00145626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101875647|NCT00145626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101875648|NCT00145626|Alkylating Agents|alkylating agents|mesh-ancestor
101875649|NCT00145626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875650|NCT00145626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101875651|NCT00145626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101875652|NCT01206946|Betamethasone|betamethasone|mesh-list
101875653|NCT01206946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101875654|NCT01206946|Glucocorticoids|glucocorticoids|mesh-ancestor
101875656|NCT01206946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101875657|NCT01206946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875658|NCT01206946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101875659|NCT01206946|Respiratory System Agents|respiratory system agents|mesh-ancestor
101875660|NCT03813940|Vaccines|vaccines|mesh-list
101875661|NCT03813940|Immunologic Factors|immunologic factors|mesh-ancestor
101875662|NCT03813940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875663|NCT03967938|Olaparib|olaparib|mesh-list
101875664|NCT03967938|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101875665|NCT03967938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101452864|NCT00199004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101875666|NCT03967938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875667|NCT03967938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101875668|NCT01299298|Mipomersen|mipomersen|mesh-list
101875669|NCT01299298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101875670|NCT01299298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101875671|NCT01299298|Antimetabolites|antimetabolites|mesh-ancestor
101875672|NCT01299298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875673|NCT01299298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101875674|NCT00153062|Telmisartan|telmisartan|mesh-list
101875675|NCT00153062|Clopidogrel|clopidogrel|mesh-list
101875676|NCT00153062|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
101875677|NCT00153062|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101875678|NCT00153062|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101875679|NCT00153062|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101875680|NCT00153062|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101875681|NCT00153062|Purinergic Agents|purinergic agents|mesh-ancestor
101875682|NCT00153062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101875683|NCT00153062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875684|NCT00153062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875685|NCT00153062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101875686|NCT00153062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101875687|NCT00153062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101875688|NCT00145470|Asenapine|asenapine|mesh-list
101875689|NCT00145470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101875690|NCT00145470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101875691|NCT00145470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101875692|NCT00145470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875693|NCT00145470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101875694|NCT03813394|Bevacizumab|bevacizumab|mesh-list
101875695|NCT03813394|Pembrolizumab|pembrolizumab|mesh-list
101875696|NCT03813394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101875697|NCT03813394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101875698|NCT03813394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101875699|NCT03813394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101875700|NCT03813394|Growth Substances|growth substances|mesh-ancestor
101875701|NCT03813394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875702|NCT03813394|Growth Inhibitors|growth inhibitors|mesh-ancestor
101875703|NCT03813394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101452887|NCT00204776|Oxaliplatin|oxaliplatin|mesh-list
101875704|NCT03813394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875705|NCT03813316|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101875706|NCT03813316|Ertugliflozin|ertugliflozin|mesh-list
101875707|NCT03813316|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
101875708|NCT03813316|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
101875709|NCT03813316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101875710|NCT03813316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875711|NCT03813316|Incretins|incretins|mesh-ancestor
101875712|NCT03813316|Hormones|hormones|mesh-ancestor
101875713|NCT03813316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101875714|NCT03813316|Protease Inhibitors|protease inhibitors|mesh-ancestor
101875715|NCT03813316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101875716|NCT03813316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875717|NCT01301248|Cisplatin|cisplatin|mesh-list
101875718|NCT01301248|Cetuximab|cetuximab|mesh-list
101875719|NCT01301248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101875720|NCT01301248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101875721|NCT03817684|BPN14770|bpn14770|mesh-list
101875722|NCT03817684|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101875723|NCT03817684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101875724|NCT03817684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101875725|NCT03817684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875726|NCT01302028|Ipragliflozin|ipragliflozin|mesh-list
101875727|NCT01302028|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101875728|NCT01302028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875729|NCT01302028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101875730|NCT01302028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875731|NCT01302106|Clofarabine|clofarabine|mesh-list
101875732|NCT01302106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101875733|NCT01302106|Antimetabolites|antimetabolites|mesh-ancestor
101875734|NCT01302106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875735|NCT01302106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101875736|NCT00152516|Levetiracetam|levetiracetam|mesh-list
101875737|NCT00152516|Anticonvulsants|anticonvulsants|mesh-ancestor
101875738|NCT00152516|Nootropic Agents|nootropic agents|mesh-ancestor
101688783|NCT02662530|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101875739|NCT00145158|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101875740|NCT00145158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101595565|NCT02696512|Antioxidants|antioxidants|mesh-ancestor
101875741|NCT00145158|Immunologic Factors|immunologic factors|mesh-ancestor
101875742|NCT00145158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875743|NCT05624008|Methamphetamine|methamphetamine|mesh-list
101875744|NCT05624008|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101875745|NCT05624008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875746|NCT05624008|Sympathomimetics|sympathomimetics|mesh-ancestor
101875747|NCT05624008|Autonomic Agents|autonomic agents|mesh-ancestor
101875748|NCT05624008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101875749|NCT05624008|Dopamine Agents|dopamine agents|mesh-ancestor
101875750|NCT05624008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101875751|NCT05624008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875752|NCT05624008|Adrenergic Agents|adrenergic agents|mesh-ancestor
101875753|NCT05624008|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101875754|NCT05624008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101875755|NCT05624008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101875756|NCT05624008|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101875757|NCT05623852|Fucoidan|fucoidan|mesh-list
101875758|NCT05623852|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101875759|NCT05623852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101875760|NCT05623852|Anticoagulants|anticoagulants|mesh-ancestor
101875761|NCT05623852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101875762|NCT01302340|Dronabinol|dronabinol|mesh-list
101875763|NCT01302340|Hallucinogens|hallucinogens|mesh-ancestor
101875764|NCT01302340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875765|NCT01302340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101875766|NCT01302340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101875767|NCT01302340|Analgesics|analgesics|mesh-ancestor
101875768|NCT01302340|Sensory System Agents|sensory system agents|mesh-ancestor
101875769|NCT01302340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101875770|NCT01302340|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101875771|NCT01302340|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101875772|NCT01302340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101875773|NCT01302340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875774|NCT01302340|Hormones|hormones|mesh-ancestor
101875775|NCT01302340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101875776|NCT00150800|Brivaracetam|brivaracetam|mesh-list
101875777|NCT00150800|Anticonvulsants|anticonvulsants|mesh-ancestor
101875778|NCT03812770|Leucovorin|leucovorin|mesh-list
101875779|NCT03812770|Fluorouracil|fluorouracil|mesh-list
101875780|NCT03812770|Oxaliplatin|oxaliplatin|mesh-list
101875781|NCT03812770|Sorafenib|sorafenib|mesh-list
101875782|NCT03812770|Antimetabolites|antimetabolites|mesh-ancestor
101875783|NCT03812770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875784|NCT03812770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101875785|NCT03812770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101875786|NCT03812770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101875787|NCT03812770|Immunologic Factors|immunologic factors|mesh-ancestor
101875788|NCT03812770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875789|NCT03812770|Antidotes|antidotes|mesh-ancestor
101875790|NCT03812770|Protective Agents|protective agents|mesh-ancestor
101875791|NCT03812770|Vitamin B Complex|vitamin b complex|mesh-ancestor
101875792|NCT03812770|Vitamins|vitamins|mesh-ancestor
101875793|NCT03812770|Micronutrients|micronutrients|mesh-ancestor
101875794|NCT03812770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101875795|NCT03812770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101875796|NCT00144300|Pramipexole|pramipexole|mesh-list
101875797|NCT00144300|Antioxidants|antioxidants|mesh-ancestor
101875798|NCT00144300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875799|NCT00144300|Protective Agents|protective agents|mesh-ancestor
101875800|NCT00144300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875801|NCT00144300|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101875802|NCT00144300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101875803|NCT00144300|Dopamine Agonists|dopamine agonists|mesh-ancestor
101875804|NCT00144300|Dopamine Agents|dopamine agents|mesh-ancestor
101875805|NCT00144300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101875806|NCT00149630|Disulfiram|disulfiram|mesh-list
101875807|NCT00149630|Methadone|methadone|mesh-list
101875808|NCT00149630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101875809|NCT00149630|Narcotics|narcotics|mesh-ancestor
101875810|NCT00149630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101875811|NCT00149630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875812|NCT00149630|Analgesics|analgesics|mesh-ancestor
101238708|NCT01611480|Imiquimod|imiquimod|mesh-list
101875813|NCT00149630|Sensory System Agents|sensory system agents|mesh-ancestor
101595644|NCT02774902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101875814|NCT00149630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101875815|NCT00149630|Antitussive Agents|antitussive agents|mesh-ancestor
101875816|NCT00149630|Respiratory System Agents|respiratory system agents|mesh-ancestor
101875818|NCT00149630|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
101875819|NCT00149630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101875820|NCT00149630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875821|NCT01302496|Ipilimumab|ipilimumab|mesh-list
101875822|NCT01302496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101875823|NCT01302496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101875824|NCT01302496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101966978|NCT00886600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101875825|NCT01302496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875826|NCT00127842|Etanercept|etanercept|mesh-list
101875827|NCT00127842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101875828|NCT00127842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101875829|NCT00127842|Analgesics|analgesics|mesh-ancestor
101875830|NCT00127842|Sensory System Agents|sensory system agents|mesh-ancestor
101875831|NCT00127842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101875832|NCT00127842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875833|NCT00127842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101875834|NCT00127842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101875835|NCT00127842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101875836|NCT00127842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101875837|NCT00127842|Immunologic Factors|immunologic factors|mesh-ancestor
101875838|NCT01075802|Tamoxifen|tamoxifen|mesh-list
101875839|NCT01075802|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101875840|NCT01075802|Hormone Antagonists|hormone antagonists|mesh-ancestor
101875841|NCT01075802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101875842|NCT01075802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875843|NCT01075802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101875844|NCT01075802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101875845|NCT01075802|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101875846|NCT01075802|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101875847|NCT01075802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101875848|NCT03816592|Analgesics, Opioid|analgesics, opioid|mesh-list
101875849|NCT03816592|Anesthetics|anesthetics|mesh-list
101875850|NCT03816592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101875851|NCT03816592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875852|NCT03816592|Narcotics|narcotics|mesh-ancestor
101875853|NCT03816592|Analgesics|analgesics|mesh-ancestor
101875854|NCT03816592|Sensory System Agents|sensory system agents|mesh-ancestor
101875855|NCT03816592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101875856|NCT01078038|Sirolimus|sirolimus|mesh-list
101875857|NCT01078038|Everolimus|everolimus|mesh-list
101875858|NCT01078038|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101875859|NCT01078038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101875860|NCT01078038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101875861|NCT01078038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875862|NCT01078038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101875863|NCT01078038|Immunologic Factors|immunologic factors|mesh-ancestor
101875864|NCT01078038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875865|NCT01078038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101875866|NCT01078038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101875867|NCT01078038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101875868|NCT01078038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101875869|NCT01078038|Antifungal Agents|antifungal agents|mesh-ancestor
101875870|NCT00223496|Aripiprazole|aripiprazole|mesh-list
101875871|NCT00223496|Antidepressive Agents|antidepressive agents|mesh-ancestor
101875872|NCT00223496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101875873|NCT00223496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101875874|NCT00223496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101875875|NCT00223496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101875876|NCT00223496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875877|NCT00223496|Dopamine Agonists|dopamine agonists|mesh-ancestor
101875878|NCT00223496|Dopamine Agents|dopamine agents|mesh-ancestor
101875879|NCT00223496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101875880|NCT00223496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875881|NCT00223496|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101875882|NCT00223496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101875883|NCT00223496|Serotonin Agents|serotonin agents|mesh-ancestor
101875884|NCT00223496|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101875885|NCT00223496|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101875886|NCT00223496|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101875887|NCT00223496|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101875888|NCT02531412|Spironolactone|spironolactone|mesh-list
101595718|NCT02766322|Ethanol|ethanol|mesh-list
101875889|NCT02531412|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101875890|NCT02531412|Hormone Antagonists|hormone antagonists|mesh-ancestor
101875891|NCT02531412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101875892|NCT02531412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875893|NCT02531412|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101875894|NCT02531412|Diuretics|diuretics|mesh-ancestor
101875895|NCT02531412|Natriuretic Agents|natriuretic agents|mesh-ancestor
101875896|NCT00126672|Sirolimus|sirolimus|mesh-list
101875897|NCT00126672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101875898|NCT00126672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101875899|NCT00126672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101875900|NCT00126672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101875901|NCT00126672|Antifungal Agents|antifungal agents|mesh-ancestor
101875902|NCT00126672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101875903|NCT00126672|Immunologic Factors|immunologic factors|mesh-ancestor
101875904|NCT00126672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875905|NCT00145574|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
101875906|NCT00145574|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101875907|NCT00145574|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101875908|NCT00145574|Antimetabolites|antimetabolites|mesh-ancestor
101875909|NCT00145574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875910|NCT00145574|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101875911|NCT05034562|Edetic Acid|edetic acid|mesh-list
101875912|NCT05034562|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101875913|NCT05034562|Chelating Agents|chelating agents|mesh-ancestor
101875914|NCT05034562|Sequestering Agents|sequestering agents|mesh-ancestor
101875915|NCT05034562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875916|NCT05034562|Anticoagulants|anticoagulants|mesh-ancestor
101875917|NCT05034562|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101875918|NCT05034562|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101875919|NCT00145496|Olanzapine|olanzapine|mesh-list
101875920|NCT00145496|Asenapine|asenapine|mesh-list
101875921|NCT00145496|Antiemetics|antiemetics|mesh-ancestor
101875922|NCT00145496|Autonomic Agents|autonomic agents|mesh-ancestor
101875923|NCT00145496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101875924|NCT00145496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875925|NCT00145496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101875926|NCT00145496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101875927|NCT00145496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101875928|NCT00145496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101875929|NCT00145496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101875930|NCT00145496|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101875931|NCT00145496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101875932|NCT00145496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101875933|NCT00145496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875934|NCT00145496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101875935|NCT00145496|Serotonin Agents|serotonin agents|mesh-ancestor
101875936|NCT01299922|Cyclosporine|cyclosporine|mesh-list
101875937|NCT01299922|Mycophenolic Acid|mycophenolic acid|mesh-list
101875938|NCT01299922|Cyclosporins|cyclosporins|mesh-list
101875939|NCT01299922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101875940|NCT01299922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101967021|NCT03952325|Nivolumab|nivolumab|mesh-list
101875941|NCT01299922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101875943|NCT01299922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875944|NCT01299922|Antifungal Agents|antifungal agents|mesh-ancestor
101875945|NCT01299922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101875946|NCT01299922|Dermatologic Agents|dermatologic agents|mesh-ancestor
101875947|NCT01299922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101875948|NCT01299922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101875949|NCT01299922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101875950|NCT01299922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101875951|NCT01299922|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101875952|NCT01299922|Antitubercular Agents|antitubercular agents|mesh-ancestor
101875953|NCT01299922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101875955|NCT05030818|Ramipril|ramipril|mesh-list
101875956|NCT05030818|Atorvastatin|atorvastatin|mesh-list
101875957|NCT05030818|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101875958|NCT05030818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101875959|NCT05030818|Antimetabolites|antimetabolites|mesh-ancestor
101875960|NCT05030818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875961|NCT05030818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101875962|NCT05030818|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101875963|NCT05030818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101875964|NCT05030818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101875965|NCT05030818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101875966|NCT05030818|Analgesics|analgesics|mesh-ancestor
101875967|NCT05030818|Sensory System Agents|sensory system agents|mesh-ancestor
101875968|NCT05030818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101875969|NCT05030818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875970|NCT05030818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101875971|NCT05030818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101875972|NCT05030818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101875973|NCT05030818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101875974|NCT05030818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101875975|NCT05030818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101875976|NCT05030818|Antipyretics|antipyretics|mesh-ancestor
101875977|NCT05030818|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101875978|NCT05030818|Protease Inhibitors|protease inhibitors|mesh-ancestor
101875979|NCT05030818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101875980|NCT01582022|Bupivacaine|bupivacaine|mesh-list
101875981|NCT01582022|Anesthetics, Local|anesthetics, local|mesh-ancestor
101875982|NCT01582022|Anesthetics|anesthetics|mesh-ancestor
101875983|NCT01582022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101875984|NCT01582022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875985|NCT01582022|Sensory System Agents|sensory system agents|mesh-ancestor
101875986|NCT01582022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101875987|NCT01582412|Isavuconazole|isavuconazole|mesh-list
101875988|NCT01582412|Digoxin|digoxin|mesh-list
101875989|NCT01582412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101875990|NCT01582412|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101875991|NCT01582412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101875992|NCT01582412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101875993|NCT01582412|Protective Agents|protective agents|mesh-ancestor
101875994|NCT01582412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101875995|NCT01582412|Antifungal Agents|antifungal agents|mesh-ancestor
101875996|NCT01582412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101875997|NCT00255164|Dexlansoprazole|dexlansoprazole|mesh-list
101875998|NCT00255164|Lansoprazole|lansoprazole|mesh-list
101875999|NCT00255164|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101876000|NCT00255164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101876001|NCT00255164|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101876002|NCT00255164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101876003|NCT00255164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876004|NCT01300156|Oxaliplatin|oxaliplatin|mesh-list
101876005|NCT01300156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101876006|NCT00126594|Interferons|interferons|mesh-list
101876007|NCT00126594|Interferon-alpha|interferon-alpha|mesh-list
101876008|NCT00126594|Interferon alpha-2|interferon alpha-2|mesh-list
101876009|NCT00126594|Sorafenib|sorafenib|mesh-list
101876010|NCT00126594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101876011|NCT00126594|Antiviral Agents|antiviral agents|mesh-ancestor
101876012|NCT00126594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101876013|NCT00126594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101876014|NCT00126594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101876015|NCT00126594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876016|NCT00126594|Immunologic Factors|immunologic factors|mesh-ancestor
101876017|NCT00126594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876018|NCT01080456|Tacrolimus|tacrolimus|mesh-list
101876019|NCT01080456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101876020|NCT01080456|Immunologic Factors|immunologic factors|mesh-ancestor
101876021|NCT01080456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876022|NCT01080456|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101876023|NCT01080456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101876024|NCT01080456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876025|NCT03811054|Apatinib|apatinib|mesh-list
101876026|NCT03811054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101876027|NCT03811054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101876028|NCT03811054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101876029|NCT03811054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876030|NCT00126438|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
101876031|NCT00126438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101876032|NCT00126438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101876033|NCT00126438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876034|NCT00126438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101876035|NCT01075854|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101876036|NCT01075854|Hormones|hormones|mesh-ancestor
101876037|NCT01075854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101876038|NCT01075854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876040|NCT03967392|Anesthetics, Local|anesthetics, local|mesh-ancestor
101876041|NCT03967392|Anesthetics|anesthetics|mesh-ancestor
101453000|NCT00232050|Omalizumab|omalizumab|mesh-list
101876042|NCT03967392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101876043|NCT03967392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876044|NCT03967392|Sensory System Agents|sensory system agents|mesh-ancestor
101876045|NCT03967392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101876046|NCT03967392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101876047|NCT03967392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101876048|NCT03967392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101876049|NCT03967392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101876050|NCT03967392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876051|NCT04898764|Mometasone Furoate|mometasone furoate|mesh-list
101876052|NCT04898764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101876053|NCT04898764|Dermatologic Agents|dermatologic agents|mesh-ancestor
101876054|NCT04898764|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101876055|NCT00142584|Metoprolol|metoprolol|mesh-list
101876056|NCT00142584|Nebivolol|nebivolol|mesh-list
101876057|NCT00142584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101876058|NCT00142584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101876059|NCT00142584|Sympatholytics|sympatholytics|mesh-ancestor
101876060|NCT00142584|Autonomic Agents|autonomic agents|mesh-ancestor
101876061|NCT00142584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101876062|NCT00142584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876063|NCT00142584|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101876064|NCT00142584|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101876065|NCT00142584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101876066|NCT00142584|Adrenergic Agents|adrenergic agents|mesh-ancestor
101876067|NCT00142584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101876068|NCT00142584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876069|NCT00142584|Vasodilator Agents|vasodilator agents|mesh-ancestor
101876070|NCT00142584|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101876071|NCT00142584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101876072|NCT00142584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101876073|NCT04848064|Cyclophosphamide|cyclophosphamide|mesh-list
101876074|NCT04848064|Fludarabine|fludarabine|mesh-list
101876075|NCT04848064|Mogamulizumab|mogamulizumab|mesh-list
101876076|NCT04848064|Immunoglobulins|immunoglobulins|mesh-list
101876077|NCT04848064|Immunoglobulin G|immunoglobulin g|mesh-list
101876078|NCT04848064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101876079|NCT04848064|Immunologic Factors|immunologic factors|mesh-ancestor
101876080|NCT04848064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876081|NCT04848064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101876082|NCT04848064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101876083|NCT04848064|Alkylating Agents|alkylating agents|mesh-ancestor
101688805|NCT00649272|Oxybutynin|oxybutynin|mesh-list
101876084|NCT04848064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876085|NCT04848064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101876086|NCT04848064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101876087|NCT03816046|Botulinum Toxins|botulinum toxins|mesh-list
101876088|NCT03816046|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101876089|NCT03816046|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101876090|NCT03816046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101876091|NCT03816046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101876092|NCT03816046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876093|NCT03816046|Cholinergic Agents|cholinergic agents|mesh-ancestor
101876094|NCT03816046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101453020|NCT00229125|Gabapentin|gabapentin|mesh-list
101876095|NCT03816046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876096|NCT03816046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101876097|NCT03816046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101876098|NCT01080534|Tacrolimus|tacrolimus|mesh-list
101876099|NCT01080534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101876100|NCT01080534|Immunologic Factors|immunologic factors|mesh-ancestor
101876101|NCT01080534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876102|NCT01080534|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101876103|NCT01080534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101876104|NCT01080534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876105|NCT00125190|Mecasermin|mecasermin|mesh-list
101876106|NCT00125190|Growth Substances|growth substances|mesh-ancestor
101876107|NCT00125190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876108|NCT00141726|Etanercept|etanercept|mesh-list
101876109|NCT00141726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101876110|NCT00141726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101876111|NCT00141726|Analgesics|analgesics|mesh-ancestor
101876112|NCT00141726|Sensory System Agents|sensory system agents|mesh-ancestor
101876113|NCT00141726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101876114|NCT00141726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876115|NCT00141726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101876116|NCT00141726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101876117|NCT00141726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101876118|NCT00141726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101876119|NCT00141726|Immunologic Factors|immunologic factors|mesh-ancestor
101876120|NCT03967548|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101876121|NCT03967548|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101876122|NCT01301716|Paclitaxel|paclitaxel|mesh-list
101876123|NCT01301716|Bevacizumab|bevacizumab|mesh-list
101876124|NCT01301716|Carboplatin|carboplatin|mesh-list
101876125|NCT01301716|Pemetrexed|pemetrexed|mesh-list
101876126|NCT01301716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101876127|NCT01301716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101876128|NCT01301716|Tubulin Modulators|tubulin modulators|mesh-ancestor
101876129|NCT01301716|Antimitotic Agents|antimitotic agents|mesh-ancestor
101876130|NCT01301716|Mitosis Modulators|mitosis modulators|mesh-ancestor
101876131|NCT01301716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876132|NCT01301716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101876133|NCT01301716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101876134|NCT01301716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101876135|NCT01301716|Growth Substances|growth substances|mesh-ancestor
101876136|NCT01301716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876137|NCT01301716|Growth Inhibitors|growth inhibitors|mesh-ancestor
101876138|NCT01301716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101876139|NCT01301716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101876140|NCT01301716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101876141|NCT01303042|Insulin Lispro|insulin lispro|mesh-list
101876142|NCT01303042|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
101876143|NCT01303042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101876144|NCT01303042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876145|NCT01300312|Diclofenac|diclofenac|mesh-list
101876146|NCT01300312|Eperisone|eperisone|mesh-list
101876147|NCT01300312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101876148|NCT01300312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101876149|NCT01300312|Analgesics|analgesics|mesh-ancestor
101876150|NCT01300312|Sensory System Agents|sensory system agents|mesh-ancestor
101876151|NCT01300312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101453036|NCT00229125|Antiemetics|antiemetics|mesh-ancestor
101876152|NCT01300312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876153|NCT01300312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101876154|NCT01300312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101876155|NCT01300312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101876156|NCT01300312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101876157|NCT01300312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876158|NCT01300312|Anticonvulsants|anticonvulsants|mesh-ancestor
101876159|NCT01300312|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101876160|NCT01300312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101876161|NCT01300312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101876162|NCT01300312|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101876163|NCT01300312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101876164|NCT01300312|Parasympatholytics|parasympatholytics|mesh-ancestor
101876165|NCT01300312|Autonomic Agents|autonomic agents|mesh-ancestor
101876166|NCT01300312|Vasodilator Agents|vasodilator agents|mesh-ancestor
101876167|NCT01567384|Pemetrexed|pemetrexed|mesh-list
101876168|NCT01567384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101876169|NCT01567384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101876170|NCT01567384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876171|NCT01567384|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101876172|NCT01567384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101876173|NCT01080612|Pregabalin|pregabalin|mesh-list
101876174|NCT01080612|Analgesics|analgesics|mesh-ancestor
101876175|NCT01080612|Sensory System Agents|sensory system agents|mesh-ancestor
101876176|NCT01080612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101876177|NCT01080612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876178|NCT01080612|Anticonvulsants|anticonvulsants|mesh-ancestor
101876179|NCT01080612|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101876180|NCT01080612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101876181|NCT01080612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876182|NCT01080612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101876183|NCT01080612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101876184|NCT01080612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101876185|NCT01080612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101876186|NCT01080612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101876187|NCT03815344|Misoprostol|misoprostol|mesh-list
101876188|NCT03815344|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101876189|NCT03815344|Abortifacient Agents|abortifacient agents|mesh-ancestor
101876190|NCT03815344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101876191|NCT03815344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876192|NCT03815344|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101876193|NCT03815344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101876194|NCT03815344|Oxytocics|oxytocics|mesh-ancestor
101876195|NCT03819790|Insulin|insulin|mesh-list
101876196|NCT03819790|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101876197|NCT03819790|Metformin|metformin|mesh-list
101876198|NCT03819790|Insulin Glargine|insulin glargine|mesh-list
101876200|NCT03819790|Gliclazide|gliclazide|mesh-list
101876201|NCT03819790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101876202|NCT03819790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876203|NCT01560442|Buprenorphine|buprenorphine|mesh-list
101876204|NCT01560442|Methadone|methadone|mesh-list
101876205|NCT01560442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101876206|NCT01560442|Narcotics|narcotics|mesh-ancestor
101876207|NCT01560442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101876208|NCT01560442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876209|NCT01560442|Analgesics|analgesics|mesh-ancestor
101876210|NCT01560442|Sensory System Agents|sensory system agents|mesh-ancestor
101876211|NCT01560442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101876212|NCT01560442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101876213|NCT01560442|Antitussive Agents|antitussive agents|mesh-ancestor
101876214|NCT01560442|Respiratory System Agents|respiratory system agents|mesh-ancestor
101876215|NCT00110994|Sorafenib|sorafenib|mesh-list
101876216|NCT00110994|Dacarbazine|dacarbazine|mesh-list
101876217|NCT00110994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101876218|NCT00110994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101876219|NCT00110994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101876220|NCT00110994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876221|NCT00110994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101876222|NCT00110994|Alkylating Agents|alkylating agents|mesh-ancestor
101876223|NCT01560052|Methylprednisolone|methylprednisolone|mesh-list
101876224|NCT01560052|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101876225|NCT01560052|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101876226|NCT01560052|Prednisolone|prednisolone|mesh-list
101876227|NCT01560052|Prednisolone acetate|prednisolone acetate|mesh-list
101876228|NCT01560052|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101876229|NCT01560052|Prednisolone phosphate|prednisolone phosphate|mesh-list
101876230|NCT01560052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101876231|NCT01560052|Antiemetics|antiemetics|mesh-ancestor
101876232|NCT01560052|Autonomic Agents|autonomic agents|mesh-ancestor
101876233|NCT01560052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101876234|NCT01560052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876235|NCT01560052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101876236|NCT01560052|Glucocorticoids|glucocorticoids|mesh-ancestor
101876237|NCT01560052|Hormones|hormones|mesh-ancestor
101967089|NCT03135106|Hormone Antagonists|hormone antagonists|mesh-ancestor
101876238|NCT01560052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101876239|NCT01560052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101876240|NCT01560052|Protective Agents|protective agents|mesh-ancestor
101876241|NCT01560052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101876242|NCT01560052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101876243|NCT05098132|Pembrolizumab|pembrolizumab|mesh-list
101876244|NCT05098132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101876245|NCT05098132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101876246|NCT05098132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101876247|NCT05098132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876248|NCT04356352|Lidocaine|lidocaine|mesh-list
101876249|NCT04356352|Esmolol|esmolol|mesh-list
101876250|NCT04356352|Anesthetics, Local|anesthetics, local|mesh-ancestor
101876251|NCT04356352|Anesthetics|anesthetics|mesh-ancestor
101876252|NCT04356352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101876253|NCT04356352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876254|NCT04356352|Sensory System Agents|sensory system agents|mesh-ancestor
101876255|NCT04356352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101876256|NCT04356352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101876257|NCT04356352|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101876258|NCT04356352|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101876259|NCT04356352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101876260|NCT04356352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876261|NCT04356352|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101876262|NCT04356352|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101876263|NCT04356352|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101876264|NCT04356352|Adrenergic Agents|adrenergic agents|mesh-ancestor
101876265|NCT04356352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101876266|NCT05622994|Rimonabant|rimonabant|mesh-list
101876267|NCT05622994|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101876268|NCT05622994|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
101876269|NCT05622994|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101876270|NCT05622994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101876271|NCT05622994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876272|NCT05622994|Hormones|hormones|mesh-ancestor
101876273|NCT05622994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101876274|NCT05622994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876275|NCT05622916|Ethanol|ethanol|mesh-list
101876276|NCT05622916|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101876277|NCT05622916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101876278|NCT05622916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101876279|NCT05622916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876280|NCT03819556|Caseins|caseins|mesh-list
101876281|NCT03819556|Chelating Agents|chelating agents|mesh-ancestor
101876282|NCT03819556|Sequestering Agents|sequestering agents|mesh-ancestor
101876283|NCT03819556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876284|NCT03804034|Molybdenum|molybdenum|mesh-list
101876285|NCT03804034|Trace Elements|trace elements|mesh-ancestor
101876286|NCT03804034|Micronutrients|micronutrients|mesh-ancestor
101876287|NCT03804034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876288|NCT04246762|Vitamin K|vitamin k|mesh-list
101876290|NCT04246762|Caffeine|caffeine|mesh-list
101876291|NCT04246762|Omeprazole|omeprazole|mesh-list
101876292|NCT04246762|Warfarin|warfarin|mesh-list
101876293|NCT04246762|Vitamins|vitamins|mesh-ancestor
101876294|NCT04246762|Micronutrients|micronutrients|mesh-ancestor
101876295|NCT04246762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876296|NCT04246762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101876297|NCT04246762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101876298|NCT04246762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101876299|NCT04246762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101876300|NCT04246762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101876301|NCT04246762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101876302|NCT04246762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101876303|NCT04246762|Anesthetics, General|anesthetics, general|mesh-ancestor
101876304|NCT04246762|Anesthetics|anesthetics|mesh-ancestor
101876305|NCT04246762|GABA Modulators|gaba modulators|mesh-ancestor
101876306|NCT04246762|GABA Agents|gaba agents|mesh-ancestor
101876307|NCT04246762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101876308|NCT04246762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876309|NCT04246762|Anticoagulants|anticoagulants|mesh-ancestor
101876310|NCT04246762|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101876311|NCT04246762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101876312|NCT04246762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101876313|NCT04246762|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101876314|NCT04246762|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101876315|NCT04246762|Purinergic Agents|purinergic agents|mesh-ancestor
101876316|NCT04246762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101876317|NCT04246762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101876318|NCT04246762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101876319|NCT04246762|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101876320|NCT04246762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101876321|NCT04246762|Hemostatics|hemostatics|mesh-ancestor
101876322|NCT04246762|Coagulants|coagulants|mesh-ancestor
101876323|NCT03799120|Tamsulosin|tamsulosin|mesh-list
101876324|NCT03799120|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101876325|NCT03799120|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101876326|NCT03799120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101876327|NCT03799120|Adrenergic Agents|adrenergic agents|mesh-ancestor
101876328|NCT03799120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101876329|NCT03799120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876330|NCT03799120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453089|NCT00232284|Sertraline|sertraline|mesh-list
101876331|NCT03799120|Urological Agents|urological agents|mesh-ancestor
101876332|NCT03792724|Nivolumab|nivolumab|mesh-list
101876333|NCT03792724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101876334|NCT03792724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101876335|NCT03792724|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101876336|NCT03792724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876337|NCT00144170|Ritonavir|ritonavir|mesh-list
101876338|NCT00144170|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
101876339|NCT00144170|Tipranavir|tipranavir|mesh-list
101876341|NCT00144170|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101876342|NCT00144170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101876343|NCT00144170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876344|NCT00144170|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101876345|NCT00144170|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101876346|NCT00144170|Antiviral Agents|antiviral agents|mesh-ancestor
101876347|NCT00144170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101876348|NCT00144170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101876349|NCT00144170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101876350|NCT00255086|Memantine|memantine|mesh-list
101876351|NCT00255086|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101876352|NCT00255086|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101876353|NCT00255086|Dopamine Agents|dopamine agents|mesh-ancestor
101876354|NCT00255086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101876355|NCT00255086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876356|NCT00255086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876357|NCT00255086|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101876358|NCT00255086|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101876359|NCT00110214|Prednisone|prednisone|mesh-list
101876360|NCT00110214|Bevacizumab|bevacizumab|mesh-list
101876361|NCT00110214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101876362|NCT00110214|Docetaxel|docetaxel|mesh-list
101876363|NCT00110214|Antibodies|antibodies|mesh-list
101876364|NCT00110214|Immunoglobulins|immunoglobulins|mesh-list
101876365|NCT00110214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101876366|NCT00110214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101876367|NCT00110214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101876368|NCT00110214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101876369|NCT00110214|Growth Substances|growth substances|mesh-ancestor
101876370|NCT00110214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876371|NCT00110214|Growth Inhibitors|growth inhibitors|mesh-ancestor
101876372|NCT00110214|Immunologic Factors|immunologic factors|mesh-ancestor
101876373|NCT00110214|Tubulin Modulators|tubulin modulators|mesh-ancestor
101876374|NCT00110214|Antimitotic Agents|antimitotic agents|mesh-ancestor
101876375|NCT00110214|Mitosis Modulators|mitosis modulators|mesh-ancestor
101876376|NCT00110214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876377|NCT00110214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101876378|NCT00110214|Glucocorticoids|glucocorticoids|mesh-ancestor
101876379|NCT00110214|Hormones|hormones|mesh-ancestor
101876380|NCT00110214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101876381|NCT00110214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101876382|NCT04176172|Nicotine|nicotine|mesh-list
101876383|NCT04176172|Varenicline|varenicline|mesh-list
101876384|NCT04176172|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101876385|NCT04176172|Autonomic Agents|autonomic agents|mesh-ancestor
101876386|NCT04176172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101876387|NCT04176172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453113|NCT00205751|Prednisone|prednisone|mesh-list
101876388|NCT04176172|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101876389|NCT04176172|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101876390|NCT04176172|Cholinergic Agents|cholinergic agents|mesh-ancestor
101876391|NCT04176172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101876392|NCT04176172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876393|NCT03795844|Liver Extracts|liver extracts|mesh-list
101876394|NCT03795844|Hematinics|hematinics|mesh-ancestor
101876395|NCT05669170|Methylphenidate|methylphenidate|mesh-list
101876396|NCT05669170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101876397|NCT05669170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876398|NCT05669170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101876399|NCT05669170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101876400|NCT05669170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101876401|NCT05669170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876402|NCT05669170|Dopamine Agents|dopamine agents|mesh-ancestor
101876403|NCT05669170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101876404|NCT03799822|Vitamin K|vitamin k|mesh-list
101876405|NCT03799822|Rivaroxaban|rivaroxaban|mesh-list
101876406|NCT03799822|Vitamins|vitamins|mesh-ancestor
101876407|NCT03799822|Micronutrients|micronutrients|mesh-ancestor
101876408|NCT03799822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876409|NCT03799822|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101876410|NCT03799822|Antithrombins|antithrombins|mesh-ancestor
101876411|NCT03799822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101876412|NCT03799822|Protease Inhibitors|protease inhibitors|mesh-ancestor
101876413|NCT03799822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101596242|NCT04582942|Lactulose|lactulose|mesh-list
101688851|NCT04437329|Nedaplatin|nedaplatin|mesh-list
101876414|NCT03799822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876416|NCT03799822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101876417|NCT03799822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101876418|NCT03799822|Hemostatics|hemostatics|mesh-ancestor
101876419|NCT03799822|Coagulants|coagulants|mesh-ancestor
101876420|NCT03799900|Ketamine|ketamine|mesh-list
101876421|NCT03799900|Analgesics|analgesics|mesh-ancestor
101876422|NCT03799900|Sensory System Agents|sensory system agents|mesh-ancestor
101876423|NCT03799900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101876424|NCT03799900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876425|NCT03799900|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101876426|NCT03799900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101876427|NCT03799900|Anesthetics, General|anesthetics, general|mesh-ancestor
101876428|NCT03799900|Anesthetics|anesthetics|mesh-ancestor
101876429|NCT03799900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101876430|NCT03799900|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101876431|NCT03799900|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101876432|NCT03799900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101876433|NCT03799900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453139|NCT00229476|Sertraline|sertraline|mesh-list
101876434|NCT05624866|Triamcinolone|triamcinolone|mesh-list
101876435|NCT05624866|Dexmedetomidine|dexmedetomidine|mesh-list
101876436|NCT05624866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101876437|NCT05624866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101876438|NCT05624866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876439|NCT05624866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101876440|NCT05624866|Analgesics|analgesics|mesh-ancestor
101876441|NCT05624866|Sensory System Agents|sensory system agents|mesh-ancestor
101876442|NCT05624866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101876443|NCT05624866|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101876444|NCT05624866|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101876445|NCT05624866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101876446|NCT05624866|Adrenergic Agents|adrenergic agents|mesh-ancestor
101876447|NCT05624866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101876448|NCT05624866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876449|NCT05624866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101876450|NCT05624866|Glucocorticoids|glucocorticoids|mesh-ancestor
101876451|NCT05624866|Hormones|hormones|mesh-ancestor
101876452|NCT05624866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101876453|NCT01304602|Irinotecan|irinotecan|mesh-list
101876454|NCT01304602|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101876455|NCT01304602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101876456|NCT01304602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101876457|NCT01304602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876458|NCT01304602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101876459|NCT01304134|Morphine|morphine|mesh-list
101876460|NCT01304134|Oxycodone|oxycodone|mesh-list
101876461|NCT01304134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101876462|NCT01304134|Narcotics|narcotics|mesh-ancestor
101876463|NCT01304134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101876464|NCT01304134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876465|NCT01304134|Analgesics|analgesics|mesh-ancestor
101876466|NCT01304134|Sensory System Agents|sensory system agents|mesh-ancestor
101876467|NCT01304134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101876468|NCT00124020|Vancomycin|vancomycin|mesh-list
101876469|NCT00124020|Telavancin|telavancin|mesh-list
101876470|NCT00124020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101876471|NCT00124020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101876472|NCT05630794|TIC10 compound|tic10 compound|mesh-list
101453163|NCT00229515|Sirolimus|sirolimus|mesh-list
101876473|NCT05630794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101876474|NCT01080846|Misoprostol|misoprostol|mesh-list
101967151|NCT00945646|Hormones|hormones|mesh-ancestor
101876475|NCT01080846|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101876476|NCT01080846|Abortifacient Agents|abortifacient agents|mesh-ancestor
101876477|NCT01080846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101876478|NCT01080846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876479|NCT01080846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101876480|NCT01080846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101876481|NCT01080846|Oxytocics|oxytocics|mesh-ancestor
101876482|NCT01076322|Albuterol|albuterol|mesh-list
101876483|NCT01076322|Procaterol|procaterol|mesh-list
101876484|NCT01076322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101876485|NCT01076322|Autonomic Agents|autonomic agents|mesh-ancestor
101876486|NCT01076322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101876487|NCT01076322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876488|NCT01076322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101876489|NCT01076322|Respiratory System Agents|respiratory system agents|mesh-ancestor
101876490|NCT01076322|Tocolytic Agents|tocolytic agents|mesh-ancestor
101876491|NCT01076322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101876492|NCT01076322|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101876493|NCT01076322|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101876494|NCT01076322|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101876495|NCT01076322|Adrenergic Agents|adrenergic agents|mesh-ancestor
101876496|NCT01076322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101876497|NCT01076322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876498|NCT01076322|Sympathomimetics|sympathomimetics|mesh-ancestor
101876499|NCT03966066|Erythromycin|erythromycin|mesh-list
101876500|NCT03966066|Erythromycin Estolate|erythromycin estolate|mesh-list
101876501|NCT03966066|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101876502|NCT03966066|Erythromycin stearate|erythromycin stearate|mesh-list
101876503|NCT03966066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101876504|NCT03966066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101876505|NCT03966066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101876506|NCT03966066|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101876507|NCT03966066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101876508|NCT03966066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876509|NCT00215540|Pulmonary Surfactants|pulmonary surfactants|mesh-list
101876510|NCT00215540|Respiratory System Agents|respiratory system agents|mesh-ancestor
101876511|NCT01304212|Ketorolac|ketorolac|mesh-list
101876512|NCT01304212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101876513|NCT01304212|Epinephrine|epinephrine|mesh-list
101876514|NCT01304212|Racepinephrine|racepinephrine|mesh-list
101876515|NCT01304212|Morphine|morphine|mesh-list
101876516|NCT01304212|Ropivacaine|ropivacaine|mesh-list
101876517|NCT01304212|Epinephryl borate|epinephryl borate|mesh-list
101876518|NCT01304212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101876519|NCT01304212|Narcotics|narcotics|mesh-ancestor
101876520|NCT01304212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101876521|NCT01304212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876522|NCT01304212|Analgesics|analgesics|mesh-ancestor
101876523|NCT01304212|Sensory System Agents|sensory system agents|mesh-ancestor
101876524|NCT01304212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101453209|NCT00229593|ST 1435|st 1435|mesh-list
101876525|NCT01304212|Anesthetics, Local|anesthetics, local|mesh-ancestor
101876526|NCT01304212|Anesthetics|anesthetics|mesh-ancestor
101876527|NCT01304212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101876528|NCT01304212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101876529|NCT01304212|Adrenergic Agents|adrenergic agents|mesh-ancestor
101876530|NCT01304212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101876531|NCT01304212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876532|NCT01304212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101876533|NCT01304212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101876534|NCT01304212|Autonomic Agents|autonomic agents|mesh-ancestor
101876535|NCT01304212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101876536|NCT01304212|Respiratory System Agents|respiratory system agents|mesh-ancestor
101876537|NCT01304212|Mydriatics|mydriatics|mesh-ancestor
101876538|NCT01304212|Sympathomimetics|sympathomimetics|mesh-ancestor
101876539|NCT01304212|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101876540|NCT01304212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101876541|NCT01304212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101876542|NCT01304212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101876543|NCT01304212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101876544|NCT01304212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101876545|NCT01304212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101876546|NCT00143390|Anastrozole|anastrozole|mesh-list
101876548|NCT00143390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101876549|NCT00143390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101876550|NCT00143390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101876551|NCT00143390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101876552|NCT00143390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101876553|NCT00143390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876554|NCT00143390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101876555|NCT00143390|Hormone Antagonists|hormone antagonists|mesh-ancestor
101876556|NCT00143390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101876557|NCT00143390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876558|NCT03238534|Omeprazole|omeprazole|mesh-list
101876559|NCT03238534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101876560|NCT03238534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101876561|NCT03238534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101876562|NCT03238534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101596392|NCT02757196|Hormones|hormones|mesh-ancestor
101876563|NCT03238534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876564|NCT00141102|Celecoxib|celecoxib|mesh-list
101876565|NCT00141102|Diclofenac|diclofenac|mesh-list
101876567|NCT00141102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101876568|NCT00141102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101876569|NCT00141102|Analgesics|analgesics|mesh-ancestor
101876570|NCT00141102|Sensory System Agents|sensory system agents|mesh-ancestor
101876571|NCT00141102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101876572|NCT00141102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876573|NCT00141102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101876574|NCT00141102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101876575|NCT00141102|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101876576|NCT00141102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101876577|NCT00141102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101876578|NCT00141102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876579|NCT00141102|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101876580|NCT00141102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101876581|NCT00141102|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101876582|NCT03663712|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
101876583|NCT03663712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101876584|NCT03663712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101876585|NCT01078428|Petrolatum|petrolatum|mesh-list
101876586|NCT01078428|Emollients|emollients|mesh-ancestor
101876587|NCT01078428|Dermatologic Agents|dermatologic agents|mesh-ancestor
101876588|NCT01081002|Lidocaine|lidocaine|mesh-list
101876589|NCT01081002|Anesthetics, Local|anesthetics, local|mesh-ancestor
101876591|NCT01081002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101876592|NCT01081002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876593|NCT01081002|Sensory System Agents|sensory system agents|mesh-ancestor
101876594|NCT01081002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101876595|NCT01081002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101967176|NCT02576444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101876596|NCT01081002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101876597|NCT01081002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101876598|NCT01081002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101876599|NCT01081002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876601|NCT03789058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101876602|NCT03789058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101876603|NCT03789058|Analgesics|analgesics|mesh-ancestor
101876604|NCT03789058|Sensory System Agents|sensory system agents|mesh-ancestor
101876605|NCT03789058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101876606|NCT03789058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876607|NCT03789058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101876608|NCT03789058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101876609|NCT03789058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101876610|NCT03789058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101876611|NCT03789058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876612|NCT03788902|Methylphenidate|methylphenidate|mesh-list
101876613|NCT03788902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101876614|NCT03788902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876615|NCT03788902|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101876616|NCT03788902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101876617|NCT03788902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101876618|NCT03788902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876619|NCT03788902|Dopamine Agents|dopamine agents|mesh-ancestor
101876620|NCT03788902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101876621|NCT05669092|Capecitabine|capecitabine|mesh-list
101876622|NCT05669092|Oxaliplatin|oxaliplatin|mesh-list
101876623|NCT05669092|Irinotecan|irinotecan|mesh-list
101876624|NCT05669092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101876625|NCT05669092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101876626|NCT05669092|Antimetabolites|antimetabolites|mesh-ancestor
101876627|NCT05669092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876628|NCT05669092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101876629|NCT05669092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101876630|NCT05669092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101876631|NCT05669092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101876632|NCT05669092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101876633|NCT00255008|Ribavirin|ribavirin|mesh-list
101876634|NCT00255008|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101876635|NCT00255008|Interferon-alpha|interferon-alpha|mesh-list
101876636|NCT00255008|Antimetabolites|antimetabolites|mesh-ancestor
101876637|NCT00255008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876638|NCT00255008|Antiviral Agents|antiviral agents|mesh-ancestor
101876639|NCT00255008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101876640|NCT00255008|Immunologic Factors|immunologic factors|mesh-ancestor
101876641|NCT00255008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876642|NCT01306240|Pulmonary Surfactants|pulmonary surfactants|mesh-list
101876643|NCT01306240|Respiratory System Agents|respiratory system agents|mesh-ancestor
101876644|NCT03714022|Abatacept|abatacept|mesh-list
101876645|NCT03714022|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101876646|NCT03714022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876647|NCT03714022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101876648|NCT03714022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101876649|NCT03714022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101876650|NCT03714022|Immunologic Factors|immunologic factors|mesh-ancestor
101876651|NCT03714022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876652|NCT03714022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101876653|NCT00143312|Voriconazole|voriconazole|mesh-list
101876654|NCT00143312|Antifungal Agents|antifungal agents|mesh-ancestor
101876655|NCT00143312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101876656|NCT00143312|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101876657|NCT00143312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101876658|NCT00143312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101876659|NCT00143312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876661|NCT00143312|Hormone Antagonists|hormone antagonists|mesh-ancestor
101876662|NCT00143312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101876663|NCT00143312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876664|NCT00143312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101876665|NCT04833946|Andrographolide|andrographolide|mesh-list
101876666|NCT04833946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101876667|NCT04833946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101876668|NCT04833946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101876669|NCT04833946|Analgesics|analgesics|mesh-ancestor
101876670|NCT04833946|Sensory System Agents|sensory system agents|mesh-ancestor
101876671|NCT04833946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101876672|NCT04833946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876673|NCT04833946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101876674|NCT04833946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101876675|NCT04833946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101876676|NCT04833946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101876677|NCT04833946|Antiviral Agents|antiviral agents|mesh-ancestor
101876678|NCT04833946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101876679|NCT01077206|Simvastatin|simvastatin|mesh-list
101876680|NCT01077206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101876681|NCT01077206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101876682|NCT01077206|Antimetabolites|antimetabolites|mesh-ancestor
101876683|NCT01077206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876684|NCT01077206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101876685|NCT01077206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101876686|NCT01077206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101876687|NCT05623540|Diphosphonates|diphosphonates|mesh-list
101876688|NCT05623540|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101876689|NCT05623540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876690|NCT05622838|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
101876691|NCT05622838|Protein C Inhibitor|protein c inhibitor|mesh-list
101876692|NCT05622838|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101876693|NCT05622838|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101876694|NCT05622838|Protease Inhibitors|protease inhibitors|mesh-ancestor
101876695|NCT05622838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101876696|NCT05622838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876697|NCT01306318|Diclofenac|diclofenac|mesh-list
101876698|NCT01306318|Eperisone|eperisone|mesh-list
101876699|NCT01306318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101876700|NCT01306318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101876701|NCT01306318|Analgesics|analgesics|mesh-ancestor
101876702|NCT01306318|Sensory System Agents|sensory system agents|mesh-ancestor
101876703|NCT01306318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101876704|NCT01306318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876705|NCT01306318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101876706|NCT01306318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101876707|NCT01306318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101876708|NCT01306318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101876709|NCT01306318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876710|NCT01306318|Anticonvulsants|anticonvulsants|mesh-ancestor
101876711|NCT01306318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101876712|NCT01306318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101876713|NCT01306318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101876714|NCT01306318|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101876715|NCT01306318|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101876716|NCT01306318|Parasympatholytics|parasympatholytics|mesh-ancestor
101876717|NCT01306318|Autonomic Agents|autonomic agents|mesh-ancestor
101876718|NCT01306318|Vasodilator Agents|vasodilator agents|mesh-ancestor
101876720|NCT00254540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101876721|NCT00254540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101876722|NCT00254540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101876723|NCT00254540|Growth Substances|growth substances|mesh-ancestor
101876724|NCT00254540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876725|NCT00254540|Growth Inhibitors|growth inhibitors|mesh-ancestor
101876726|NCT00254540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101876727|NCT00254540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101967218|NCT04473820|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
101876728|NCT00254540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876729|NCT01326494|Prednisone|prednisone|mesh-list
101688910|NCT00649350|Metformin|metformin|mesh-list
101876730|NCT01326494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101876731|NCT01326494|Glucocorticoids|glucocorticoids|mesh-ancestor
101876732|NCT01326494|Hormones|hormones|mesh-ancestor
101876733|NCT01326494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101876734|NCT01326494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876735|NCT01326494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101876736|NCT01326494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101876737|NCT05316220|Mesalamine|mesalamine|mesh-list
101876738|NCT05316220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101876739|NCT05316220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101876740|NCT05316220|Analgesics|analgesics|mesh-ancestor
101876741|NCT05316220|Sensory System Agents|sensory system agents|mesh-ancestor
101876742|NCT05316220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101876743|NCT05316220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876744|NCT05316220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101876745|NCT05316220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101876746|NCT01305850|Losartan|losartan|mesh-list
101876747|NCT01305850|Enalapril|enalapril|mesh-list
101876748|NCT01305850|Enalaprilat|enalaprilat|mesh-list
101876749|NCT01305850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101876750|NCT01305850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101876751|NCT01305850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101876752|NCT01305850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101876753|NCT01305850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876754|NCT01305850|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101876755|NCT01305850|Protease Inhibitors|protease inhibitors|mesh-ancestor
101876756|NCT01305850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101876757|NCT01306630|Capecitabine|capecitabine|mesh-list
101876758|NCT01306630|Tivozanib|tivozanib|mesh-list
101876759|NCT01306630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101876760|NCT01306630|Antimetabolites|antimetabolites|mesh-ancestor
101876761|NCT01306630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876762|NCT01306630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101876763|NCT01306630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101876764|NCT01306630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101876765|NCT01306708|Amitriptyline|amitriptyline|mesh-list
101876766|NCT01306708|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101876767|NCT01306708|Antidepressive Agents|antidepressive agents|mesh-ancestor
101876768|NCT01306708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101876769|NCT01306708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101876770|NCT01306708|Analgesics|analgesics|mesh-ancestor
101876771|NCT01306708|Sensory System Agents|sensory system agents|mesh-ancestor
101876772|NCT01306708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101876773|NCT01306708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876774|NCT01306708|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101876775|NCT01306708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101876776|NCT01306708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101876777|NCT01306708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876778|NCT01306708|Adrenergic Agents|adrenergic agents|mesh-ancestor
101876779|NCT01306708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101876780|NCT03794518|Pioglitazone|pioglitazone|mesh-list
101876781|NCT03794518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101876782|NCT03794518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876783|NCT05566288|Moxifloxacin|moxifloxacin|mesh-list
101876784|NCT05566288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101596621|NCT00939627|Cetuximab|cetuximab|mesh-list
101876785|NCT05566288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101876786|NCT05566288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101876787|NCT05566288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101876788|NCT05566288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101876789|NCT05566288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876790|NCT05566288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101876791|NCT03790540|Benzocaine|benzocaine|mesh-list
101876792|NCT03790540|Anesthetics, Local|anesthetics, local|mesh-ancestor
101876793|NCT03790540|Anesthetics|anesthetics|mesh-ancestor
101876794|NCT03790540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101876795|NCT03790540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876796|NCT03790540|Sensory System Agents|sensory system agents|mesh-ancestor
101876797|NCT03790540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101876798|NCT03794596|Aspirin|aspirin|mesh-list
101876799|NCT03794596|Avelumab|avelumab|mesh-list
101876800|NCT03794596|Lansoprazole|lansoprazole|mesh-list
101876801|NCT03794596|Dexlansoprazole|dexlansoprazole|mesh-list
101876802|NCT03794596|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101876803|NCT03794596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101876804|NCT03794596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101876805|NCT03794596|Analgesics|analgesics|mesh-ancestor
101876806|NCT03794596|Sensory System Agents|sensory system agents|mesh-ancestor
101876807|NCT03794596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101876808|NCT03794596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876809|NCT03794596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101876810|NCT03794596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101876811|NCT03794596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101876812|NCT03794596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101876813|NCT03794596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876814|NCT03794596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101876815|NCT03794596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101876816|NCT03794596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101876817|NCT03794596|Antipyretics|antipyretics|mesh-ancestor
101876818|NCT03794596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101876819|NCT03794596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101876820|NCT03794596|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101876821|NCT03794596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101876822|NCT05571748|Thioctic Acid|thioctic acid|mesh-list
101876823|NCT05571748|Antioxidants|antioxidants|mesh-ancestor
101876824|NCT05571748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876825|NCT05571748|Protective Agents|protective agents|mesh-ancestor
101876826|NCT05571748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876827|NCT05571748|Vitamin B Complex|vitamin b complex|mesh-ancestor
101876828|NCT05571748|Vitamins|vitamins|mesh-ancestor
101876829|NCT05571748|Micronutrients|micronutrients|mesh-ancestor
101876830|NCT03790618|Methamphetamine|methamphetamine|mesh-list
101876831|NCT03790618|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
101876832|NCT03790618|Hallucinogens|hallucinogens|mesh-ancestor
101876833|NCT03790618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876834|NCT03790618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101876835|NCT03790618|Serotonin Agents|serotonin agents|mesh-ancestor
101876836|NCT03790618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101876837|NCT03790618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876838|NCT03790618|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101876839|NCT03790618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101967294|NCT03169244|Dopamine Agents|dopamine agents|mesh-ancestor
101876840|NCT03790618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101876841|NCT03790618|Adrenergic Agents|adrenergic agents|mesh-ancestor
101876842|NCT03790618|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101876843|NCT03790618|Sympathomimetics|sympathomimetics|mesh-ancestor
101876844|NCT03790618|Autonomic Agents|autonomic agents|mesh-ancestor
101876845|NCT03790618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101876846|NCT03790618|Dopamine Agents|dopamine agents|mesh-ancestor
101876847|NCT03790618|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101876848|NCT03790228|Carboplatin|carboplatin|mesh-list
101876849|NCT03790228|Pemetrexed|pemetrexed|mesh-list
101876850|NCT03790228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101876851|NCT03790228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101876852|NCT03790228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876853|NCT03790228|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101876854|NCT03790228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101876855|NCT01304836|Mycophenolic Acid|mycophenolic acid|mesh-list
101876856|NCT01304836|Methylprednisolone|methylprednisolone|mesh-list
101876857|NCT01304836|Prednisolone|prednisolone|mesh-list
101876858|NCT01304836|Tacrolimus|tacrolimus|mesh-list
101876859|NCT01304836|Basiliximab|basiliximab|mesh-list
101596699|NCT02753140|Docetaxel|docetaxel|mesh-list
101876861|NCT01304836|Immunologic Factors|immunologic factors|mesh-ancestor
101876862|NCT01304836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876863|NCT01304836|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101876864|NCT01304836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101876865|NCT01304836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876866|NCT01304836|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101876867|NCT01304836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101876868|NCT01304836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101876869|NCT01304836|Antitubercular Agents|antitubercular agents|mesh-ancestor
101876870|NCT01304836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101876871|NCT01304836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101876872|NCT01304836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101876874|NCT01304836|Autonomic Agents|autonomic agents|mesh-ancestor
101876875|NCT01304836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101876876|NCT01304836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101876877|NCT01304836|Glucocorticoids|glucocorticoids|mesh-ancestor
101876878|NCT01304836|Hormones|hormones|mesh-ancestor
101876879|NCT01304836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101876880|NCT01304836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101876881|NCT01304836|Protective Agents|protective agents|mesh-ancestor
101876882|NCT01304836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101876883|NCT01306864|Hemostatics|hemostatics|mesh-list
101876884|NCT01306864|Coagulants|coagulants|mesh-ancestor
101876885|NCT01307332|Alemtuzumab|alemtuzumab|mesh-list
101876886|NCT01307332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101876887|NCT01307332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101876888|NCT03790384|Mitomycins|mitomycins|mesh-list
101876889|NCT03790384|Mitomycin|mitomycin|mesh-list
101876890|NCT03790384|BCG Vaccine|bcg vaccine|mesh-list
101876891|NCT03790384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101876892|NCT03790384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101876893|NCT03790384|Alkylating Agents|alkylating agents|mesh-ancestor
101876894|NCT03790384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876895|NCT03790384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101876896|NCT03790384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101876897|NCT03790384|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101876898|NCT03790384|Immunologic Factors|immunologic factors|mesh-ancestor
101876899|NCT03790384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876900|NCT01307488|Ritonavir|ritonavir|mesh-list
101876901|NCT01307488|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101876902|NCT01307488|Lamivudine|lamivudine|mesh-list
101967309|NCT05376046|Thrombin|thrombin|mesh-list
101876904|NCT01307488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101876905|NCT01307488|Protease Inhibitors|protease inhibitors|mesh-ancestor
101876906|NCT01307488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101876907|NCT01307488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876908|NCT01307488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101876909|NCT01307488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101876910|NCT01307488|Antiviral Agents|antiviral agents|mesh-ancestor
101876911|NCT01307488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101876912|NCT01307488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101876913|NCT01307488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101876914|NCT01307488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101876915|NCT01307488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101876916|NCT03790072|Cyclophosphamide|cyclophosphamide|mesh-list
101876917|NCT03790072|Fludarabine|fludarabine|mesh-list
101876918|NCT03790072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101876919|NCT03790072|Immunologic Factors|immunologic factors|mesh-ancestor
101876920|NCT03790072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876921|NCT03790072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101876922|NCT03790072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101876923|NCT03790072|Alkylating Agents|alkylating agents|mesh-ancestor
101876924|NCT03790072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876925|NCT03790072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101876926|NCT03790072|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101876927|NCT01306006|Vaccines|vaccines|mesh-list
101876928|NCT01306006|Immunologic Factors|immunologic factors|mesh-ancestor
101876929|NCT01306006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876930|NCT03794440|Sorafenib|sorafenib|mesh-list
101876931|NCT03794440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101876932|NCT03794440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101596770|NCT05318560|Lidocaine|lidocaine|mesh-list
101876933|NCT03794440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101876934|NCT03794440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876936|NCT00139776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101876937|NCT00139776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101876938|NCT00139776|Analgesics|analgesics|mesh-ancestor
101876939|NCT00139776|Sensory System Agents|sensory system agents|mesh-ancestor
101876940|NCT00139776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101876941|NCT00139776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876942|NCT00139776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101876944|NCT00139776|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101876945|NCT00139776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101876946|NCT00139776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101876947|NCT00139776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876948|NCT00413699|Tofacitinib|tofacitinib|mesh-list
101876949|NCT00413699|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101876950|NCT00413699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101876951|NCT00413699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101876952|NCT00413699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876954|NCT03713320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101876955|NCT03713320|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101876956|NCT03713320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101876957|NCT03713320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876958|NCT03712930|Pamiparib|pamiparib|mesh-list
101876959|NCT03712930|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101876960|NCT03712930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101876961|NCT03712930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876962|NCT03712930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101876963|NCT00420407|Vasopressins|vasopressins|mesh-list
101876964|NCT00420407|Arginine Vasopressin|arginine vasopressin|mesh-list
101876965|NCT00420407|Hemostatics|hemostatics|mesh-ancestor
101876966|NCT00420407|Coagulants|coagulants|mesh-ancestor
101876967|NCT00420407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101876968|NCT00420407|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101876969|NCT00420407|Natriuretic Agents|natriuretic agents|mesh-ancestor
101876970|NCT00420407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876971|NCT03789370|Propofol|propofol|mesh-list
101876972|NCT03789370|Sevoflurane|sevoflurane|mesh-list
101453427|NCT00207116|Cetuximab|cetuximab|mesh-list
101876973|NCT03789370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101876974|NCT03789370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101876975|NCT03789370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876976|NCT03789370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101876977|NCT03789370|Anesthetics, General|anesthetics, general|mesh-ancestor
101876978|NCT03789370|Anesthetics|anesthetics|mesh-ancestor
101876979|NCT03789370|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101876980|NCT03789370|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101876981|NCT00420095|Insulin|insulin|mesh-list
101876982|NCT00420095|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101876983|NCT00420095|Insulin Lispro|insulin lispro|mesh-list
101876984|NCT00420095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101876985|NCT00420095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876986|NCT04904692|Dimercaprol|dimercaprol|mesh-list
101876987|NCT04904692|Chelating Agents|chelating agents|mesh-ancestor
101876988|NCT04904692|Sequestering Agents|sequestering agents|mesh-ancestor
101876989|NCT04904692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876990|NCT01038089|Resveratrol|resveratrol|mesh-list
101876991|NCT01038089|Antioxidants|antioxidants|mesh-ancestor
101876992|NCT01038089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101876993|NCT01038089|Protective Agents|protective agents|mesh-ancestor
101876994|NCT01038089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101876995|NCT01038089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101876996|NCT01038089|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101876997|NCT05495464|Cyclophosphamide|cyclophosphamide|mesh-list
101876998|NCT05495464|Rituximab|rituximab|mesh-list
101876999|NCT05495464|Fludarabine|fludarabine|mesh-list
101877000|NCT05495464|Fludarabine phosphate|fludarabine phosphate|mesh-list
101877001|NCT05495464|Acalabrutinib|acalabrutinib|mesh-list
101877002|NCT05495464|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
101877003|NCT05495464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101877004|NCT05495464|Immunologic Factors|immunologic factors|mesh-ancestor
101877005|NCT05495464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877006|NCT05495464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101877007|NCT05495464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101877008|NCT05495464|Alkylating Agents|alkylating agents|mesh-ancestor
101877009|NCT05495464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877010|NCT05495464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101877011|NCT05495464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101877012|NCT05495464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101877013|NCT05495464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101877014|NCT05495464|Antimetabolites|antimetabolites|mesh-ancestor
101877015|NCT00419393|Levetiracetam|levetiracetam|mesh-list
101877016|NCT00419393|Anticonvulsants|anticonvulsants|mesh-ancestor
101877017|NCT00419393|Nootropic Agents|nootropic agents|mesh-ancestor
101877018|NCT01038167|Cyclosporine|cyclosporine|mesh-list
101877019|NCT01038167|Tacrolimus|tacrolimus|mesh-list
101877020|NCT01038167|Cyclosporins|cyclosporins|mesh-list
101877021|NCT01038167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101877022|NCT01038167|Immunologic Factors|immunologic factors|mesh-ancestor
101877023|NCT01038167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877024|NCT01038167|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101877025|NCT01038167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101877026|NCT01038167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877027|NCT01038167|Antifungal Agents|antifungal agents|mesh-ancestor
101877028|NCT01038167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101877029|NCT01038167|Dermatologic Agents|dermatologic agents|mesh-ancestor
101877030|NCT01038167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101877031|NCT03787030|Vitamin E|vitamin e|mesh-list
101877032|NCT03787030|Tocopherols|tocopherols|mesh-list
101877033|NCT03787030|alpha-Tocopherol|alpha-tocopherol|mesh-list
101877034|NCT03787030|Nitroglycerin|nitroglycerin|mesh-list
101877035|NCT03787030|Vitamins|vitamins|mesh-ancestor
101877036|NCT03787030|Micronutrients|micronutrients|mesh-ancestor
101877037|NCT03787030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877038|NCT03787030|Antioxidants|antioxidants|mesh-ancestor
101877039|NCT03787030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877040|NCT03787030|Protective Agents|protective agents|mesh-ancestor
101877041|NCT03787030|Vasodilator Agents|vasodilator agents|mesh-ancestor
101877042|NCT02174549|Tirapazamine|tirapazamine|mesh-list
101877043|NCT02174549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101877044|NCT03786562|Morphine|morphine|mesh-list
101877045|NCT03786562|Nalbuphine|nalbuphine|mesh-list
101877046|NCT03786562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101877047|NCT03786562|Narcotics|narcotics|mesh-ancestor
101877048|NCT03786562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101877049|NCT03786562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877050|NCT03786562|Analgesics|analgesics|mesh-ancestor
101877051|NCT03786562|Sensory System Agents|sensory system agents|mesh-ancestor
101877052|NCT03786562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101877053|NCT01305148|Warfarin|warfarin|mesh-list
101877054|NCT01305148|Anticoagulants|anticoagulants|mesh-ancestor
101877055|NCT01305226|Streptokinase|streptokinase|mesh-list
101877056|NCT01305226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101877057|NCT01305226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101877058|NCT01305226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877059|NCT01308268|Ivermectin|ivermectin|mesh-list
101877060|NCT01308268|Albendazole|albendazole|mesh-list
101877061|NCT01308268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101877062|NCT01308268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101877063|NCT01308268|Anthelmintics|anthelmintics|mesh-ancestor
101877064|NCT01308268|Anticestodal Agents|anticestodal agents|mesh-ancestor
101877065|NCT01308268|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101877066|NCT01308268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101877067|NCT01308268|Tubulin Modulators|tubulin modulators|mesh-ancestor
101877068|NCT01308268|Antimitotic Agents|antimitotic agents|mesh-ancestor
101877069|NCT01308268|Mitosis Modulators|mitosis modulators|mesh-ancestor
101453482|NCT00233025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101877070|NCT01308268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877071|NCT01308268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101877072|NCT01308346|Everolimus|everolimus|mesh-list
101877073|NCT01308346|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101877074|NCT01308346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101877075|NCT01308346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101877076|NCT01308346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877077|NCT01308346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101877078|NCT01308346|Immunologic Factors|immunologic factors|mesh-ancestor
101877079|NCT01308346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877080|NCT01308346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101877081|NCT05694130|Prednisolone|prednisolone|mesh-list
101877082|NCT05694130|Tacrolimus|tacrolimus|mesh-list
101877083|NCT05694130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101877084|NCT05694130|Immunologic Factors|immunologic factors|mesh-ancestor
101877085|NCT05694130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877086|NCT05694130|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101877087|NCT05694130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101967355|NCT00057941|Anastrozole|anastrozole|mesh-list
101877088|NCT05694130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877090|NCT05694130|Glucocorticoids|glucocorticoids|mesh-ancestor
101877092|NCT05694130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101877093|NCT05694130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101877094|NCT05694130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101877095|NCT00419159|Everolimus|everolimus|mesh-list
101877096|NCT00419159|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101877097|NCT00419159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101877098|NCT00419159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101877099|NCT00419159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877100|NCT00419159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101877101|NCT00419159|Immunologic Factors|immunologic factors|mesh-ancestor
101877102|NCT00419159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877103|NCT00419159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101877105|NCT03717064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101877106|NCT03717064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101877107|NCT03717064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101877108|NCT03717064|Antimetabolites|antimetabolites|mesh-ancestor
101877109|NCT03717064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877110|NCT03717064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101877111|NCT03717064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101877112|NCT03716050|Nitroglycerin|nitroglycerin|mesh-list
101877113|NCT03716050|Vasodilator Agents|vasodilator agents|mesh-ancestor
101877114|NCT02113163|Metformin|metformin|mesh-list
101877115|NCT02113163|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
101877116|NCT02113163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101877117|NCT02113163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877118|NCT02113163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101877119|NCT02113163|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101877120|NCT00413153|Ritonavir|ritonavir|mesh-list
101877121|NCT00413153|Lopinavir|lopinavir|mesh-list
101877122|NCT00413153|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101877123|NCT00413153|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101877124|NCT00413153|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101877125|NCT00413153|Protease Inhibitors|protease inhibitors|mesh-ancestor
101877126|NCT00413153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101453516|NCT00207584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101877127|NCT00413153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877128|NCT00413153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101877129|NCT00413153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101877130|NCT00413153|Antiviral Agents|antiviral agents|mesh-ancestor
101877131|NCT00413153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101877132|NCT00413153|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101877133|NCT00413153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101877134|NCT02107937|Paclitaxel|paclitaxel|mesh-list
101877135|NCT02107937|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101877136|NCT02107937|Carboplatin|carboplatin|mesh-list
101877137|NCT02107937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101877138|NCT02107937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101877139|NCT02107937|Tubulin Modulators|tubulin modulators|mesh-ancestor
101877140|NCT02107937|Antimitotic Agents|antimitotic agents|mesh-ancestor
101877141|NCT02107937|Mitosis Modulators|mitosis modulators|mesh-ancestor
101877142|NCT02107937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877143|NCT01312402|Brinzolamide|brinzolamide|mesh-list
101877144|NCT01312402|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101877145|NCT01312402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101877146|NCT01312402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877147|NCT05693428|Propofol|propofol|mesh-list
101877148|NCT05693428|Sevoflurane|sevoflurane|mesh-list
101877149|NCT05693428|Isoflurane|isoflurane|mesh-list
101877150|NCT05693428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101877151|NCT05693428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101877152|NCT05693428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877153|NCT05693428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101877154|NCT05693428|Anesthetics, General|anesthetics, general|mesh-ancestor
101877155|NCT05693428|Anesthetics|anesthetics|mesh-ancestor
101877156|NCT05693428|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101877157|NCT05693428|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101877158|NCT01035281|Nabilone|nabilone|mesh-list
101877159|NCT01035281|Antiemetics|antiemetics|mesh-ancestor
101877160|NCT01035281|Autonomic Agents|autonomic agents|mesh-ancestor
101596999|NCT04267653|Lactoferrin|lactoferrin|mesh-list
101877161|NCT01035281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101877162|NCT01035281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688927|NCT00649038|Protease Inhibitors|protease inhibitors|mesh-ancestor
101877163|NCT01035281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101877164|NCT01035281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101877165|NCT01035281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101877166|NCT01035281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101877167|NCT01035281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101877168|NCT01561066|Octreotide|octreotide|mesh-list
101877169|NCT01561066|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101877170|NCT01561066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101877171|NCT01561066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101877172|NCT01561066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101877173|NCT01561066|Hemostatics|hemostatics|mesh-ancestor
101877174|NCT01561066|Coagulants|coagulants|mesh-ancestor
101877175|NCT00419003|Lamotrigine|lamotrigine|mesh-list
101877176|NCT00419003|Ketamine|ketamine|mesh-list
101877177|NCT00419003|Riluzole|riluzole|mesh-list
101877178|NCT00419003|Analgesics|analgesics|mesh-ancestor
101877179|NCT00419003|Sensory System Agents|sensory system agents|mesh-ancestor
101877180|NCT00419003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101877181|NCT00419003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877182|NCT00419003|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101877183|NCT00419003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101877184|NCT00419003|Anesthetics, General|anesthetics, general|mesh-ancestor
101877185|NCT00419003|Anesthetics|anesthetics|mesh-ancestor
101877186|NCT00419003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101877187|NCT00419003|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101877188|NCT00419003|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101877189|NCT00419003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101877190|NCT00419003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877191|NCT00419003|Anticonvulsants|anticonvulsants|mesh-ancestor
101877192|NCT00419003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101877193|NCT00419003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101877194|NCT00419003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101877195|NCT00419003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101877196|NCT00419003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101877197|NCT00419003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101877198|NCT00419003|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101877199|NCT00419003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101877200|NCT00419003|Protective Agents|protective agents|mesh-ancestor
101877201|NCT00418691|Methylphenidate|methylphenidate|mesh-list
101877202|NCT00418691|Modafinil|modafinil|mesh-list
101877203|NCT00418691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101877204|NCT00418691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877205|NCT00418691|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101877206|NCT00418691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101877207|NCT00418691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101877208|NCT00418691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877209|NCT00418691|Dopamine Agents|dopamine agents|mesh-ancestor
101877210|NCT00418691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101877211|NCT00418691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101877212|NCT00418691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101877213|NCT00418691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101877214|NCT03781258|Warfarin|warfarin|mesh-list
101877215|NCT03781258|Anticoagulants|anticoagulants|mesh-ancestor
101877216|NCT00412373|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101877217|NCT00412373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101877218|NCT00412373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101877219|NCT00412373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101877220|NCT00412373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877221|NCT00412373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101877222|NCT00412373|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101877223|NCT00412373|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101877224|NCT00412373|Serotonin Agents|serotonin agents|mesh-ancestor
101877225|NCT00412373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101877226|NCT00412373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877227|NCT00412373|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101877228|NCT00412373|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101877229|NCT00412373|Dopamine Agents|dopamine agents|mesh-ancestor
101877230|NCT01308658|Ritonavir|ritonavir|mesh-list
101877231|NCT01308658|Darunavir|darunavir|mesh-list
101877232|NCT01308658|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101877233|NCT01308658|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101877234|NCT01308658|Protease Inhibitors|protease inhibitors|mesh-ancestor
101877235|NCT01308658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101877236|NCT01308658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877237|NCT01308658|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101877238|NCT01308658|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101877239|NCT01308658|Antiviral Agents|antiviral agents|mesh-ancestor
101877240|NCT01308658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101877241|NCT01308658|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101877242|NCT01308658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101877243|NCT03777514|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
101877244|NCT03777514|Hematinics|hematinics|mesh-ancestor
101877245|NCT03777514|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101877246|NCT03777514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101877247|NCT03777124|Carboplatin|carboplatin|mesh-list
101877249|NCT03777124|Apatinib|apatinib|mesh-list
101877250|NCT03777124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101877251|NCT03777124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101877252|NCT03777124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877253|NCT03777124|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101877254|NCT03777124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101877255|NCT03777124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101877256|NCT00418379|Immunomodulating Agents|immunomodulating agents|mesh-list
101877257|NCT00418379|Immunologic Factors|immunologic factors|mesh-list
101877258|NCT00418379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877259|NCT03780556|Lornoxicam|lornoxicam|mesh-list
101877260|NCT03780556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101877261|NCT03780556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101877262|NCT03780556|Analgesics|analgesics|mesh-ancestor
101877263|NCT03780556|Sensory System Agents|sensory system agents|mesh-ancestor
101877264|NCT03780556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101877265|NCT03780556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877266|NCT03780556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101877267|NCT03780556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101877268|NCT00418145|Methylprednisolone|methylprednisolone|mesh-list
101877269|NCT00418145|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101877270|NCT00418145|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101877271|NCT00418145|Prednisolone|prednisolone|mesh-list
101877272|NCT00418145|Prednisolone acetate|prednisolone acetate|mesh-list
101877273|NCT00418145|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101877274|NCT00418145|Prednisolone phosphate|prednisolone phosphate|mesh-list
101877275|NCT00418145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101877276|NCT00418145|Antiemetics|antiemetics|mesh-ancestor
101877277|NCT00418145|Autonomic Agents|autonomic agents|mesh-ancestor
101877278|NCT00418145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101877279|NCT00418145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877280|NCT00418145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101877281|NCT00418145|Glucocorticoids|glucocorticoids|mesh-ancestor
101877282|NCT00418145|Hormones|hormones|mesh-ancestor
101877283|NCT00418145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101877284|NCT00418145|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101877285|NCT00418145|Protective Agents|protective agents|mesh-ancestor
101877286|NCT00418145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101877287|NCT00418145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101877288|NCT03780634|Sorafenib|sorafenib|mesh-list
101877289|NCT03780634|Antibodies|antibodies|mesh-list
101877290|NCT03780634|Immunoglobulins|immunoglobulins|mesh-list
101877291|NCT03780634|Immunologic Factors|immunologic factors|mesh-ancestor
101877292|NCT03780634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877293|NCT03780634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101877294|NCT03780634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101877295|NCT03780634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101877296|NCT03780634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877298|NCT03777280|Chromium|chromium|mesh-list
101877299|NCT03777280|Trace Elements|trace elements|mesh-ancestor
101877300|NCT03777280|Micronutrients|micronutrients|mesh-ancestor
101877301|NCT03777280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877302|NCT02043587|Leucovorin|leucovorin|mesh-list
101877303|NCT02043587|Cytarabine|cytarabine|mesh-list
101877304|NCT02043587|Prednisone|prednisone|mesh-list
101877305|NCT02043587|Hydrocortisone|hydrocortisone|mesh-list
101877306|NCT02043587|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101688931|NCT04169256|Anesthetics|anesthetics|mesh-ancestor
101877308|NCT02043587|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101877309|NCT02043587|Cyclophosphamide|cyclophosphamide|mesh-list
101877310|NCT02043587|Rituximab|rituximab|mesh-list
101877311|NCT02043587|Methotrexate|methotrexate|mesh-list
101877312|NCT02043587|Etoposide|etoposide|mesh-list
101877313|NCT02043587|Vincristine|vincristine|mesh-list
101877314|NCT02043587|Daunorubicin|daunorubicin|mesh-list
101877315|NCT02043587|Asparaginase|asparaginase|mesh-list
101877316|NCT02043587|Dasatinib|dasatinib|mesh-list
101877317|NCT02043587|Pegaspargase|pegaspargase|mesh-list
101877318|NCT02043587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101877319|NCT02043587|Immunologic Factors|immunologic factors|mesh-ancestor
101877320|NCT02043587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877321|NCT02043587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101877322|NCT02043587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101877323|NCT02043587|Alkylating Agents|alkylating agents|mesh-ancestor
101877324|NCT02043587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877325|NCT02043587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101877326|NCT02043587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101877327|NCT02043587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101877328|NCT02043587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101877329|NCT02043587|Glucocorticoids|glucocorticoids|mesh-ancestor
101877330|NCT02043587|Hormones|hormones|mesh-ancestor
101877331|NCT02043587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101877332|NCT02043587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101877333|NCT02043587|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101877334|NCT02043587|Abortifacient Agents|abortifacient agents|mesh-ancestor
101877335|NCT02043587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101877336|NCT02043587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101877337|NCT02043587|Antimetabolites|antimetabolites|mesh-ancestor
101877338|NCT02043587|Dermatologic Agents|dermatologic agents|mesh-ancestor
101877339|NCT02043587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101877340|NCT02043587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101877341|NCT02043587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101877342|NCT02043587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101877343|NCT02043587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101877344|NCT02043587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101877345|NCT02043587|Antiviral Agents|antiviral agents|mesh-ancestor
101877346|NCT02043587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101877347|NCT02043587|Antidotes|antidotes|mesh-ancestor
101877348|NCT02043587|Protective Agents|protective agents|mesh-ancestor
101877349|NCT02043587|Vitamin B Complex|vitamin b complex|mesh-ancestor
101877350|NCT02043587|Vitamins|vitamins|mesh-ancestor
101877351|NCT02043587|Micronutrients|micronutrients|mesh-ancestor
101877352|NCT02043587|Tubulin Modulators|tubulin modulators|mesh-ancestor
101877353|NCT02043587|Antimitotic Agents|antimitotic agents|mesh-ancestor
101877354|NCT02043587|Mitosis Modulators|mitosis modulators|mesh-ancestor
101877355|NCT02043587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101877356|NCT02043587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101877357|NCT01561222|Calcitriol|calcitriol|mesh-list
101877358|NCT01561222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101877359|NCT01561222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877360|NCT01561222|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101877361|NCT01561222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101877362|NCT01561222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877363|NCT01561222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101877364|NCT01561222|Vitamins|vitamins|mesh-ancestor
101877365|NCT01561222|Micronutrients|micronutrients|mesh-ancestor
101877366|NCT01561222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101877367|NCT01035515|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
101877368|NCT01035515|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
101877369|NCT01035515|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101877370|NCT01035515|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101877371|NCT01035515|Purinergic Agents|purinergic agents|mesh-ancestor
101877372|NCT01035515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101877373|NCT01035515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877374|NCT01035515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877375|NCT01039025|Cyclophosphamide|cyclophosphamide|mesh-list
101877376|NCT01039025|Melphalan|melphalan|mesh-list
101877377|NCT01039025|Topotecan|topotecan|mesh-list
101877378|NCT01039025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101877379|NCT01039025|Immunologic Factors|immunologic factors|mesh-ancestor
101877380|NCT01039025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877381|NCT01039025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101877382|NCT01039025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101877383|NCT01039025|Alkylating Agents|alkylating agents|mesh-ancestor
101453638|NCT00233532|Verapamil|verapamil|mesh-list
101877384|NCT01039025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877385|NCT01039025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101877386|NCT01039025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101877387|NCT01039025|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101597215|NCT04216888|Analgesics|analgesics|mesh-ancestor
101877388|NCT01039025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101877390|NCT03779776|Vitamins|vitamins|mesh-list
101877391|NCT03779776|Micronutrients|micronutrients|mesh-ancestor
101877392|NCT03779776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877393|NCT00412217|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101877394|NCT00412217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101877395|NCT00412217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101877396|NCT00412217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101877397|NCT00412217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877398|NCT01035593|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
101877399|NCT01035593|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101877400|NCT01035593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101877401|NCT01035593|Immunologic Factors|immunologic factors|mesh-ancestor
101877402|NCT01035593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877403|NCT01317784|Antibodies|antibodies|mesh-list
101877404|NCT01317784|Immunoglobulins|immunoglobulins|mesh-list
101877405|NCT01317784|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
101877406|NCT01317784|Immunologic Factors|immunologic factors|mesh-ancestor
101877407|NCT01317784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877408|NCT03779464|Gemcitabine|gemcitabine|mesh-list
101877409|NCT03779464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101877410|NCT03779464|Antimetabolites|antimetabolites|mesh-ancestor
101877411|NCT03779464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877412|NCT03779464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101877413|NCT01309126|Cetuximab|cetuximab|mesh-list
101877414|NCT01309126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101877415|NCT01309126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101877416|NCT03784378|Agerafenib|agerafenib|mesh-list
101877417|NCT03784378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101877418|NCT03784378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101967459|NCT03204812|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101877419|NCT03784378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877420|NCT01314898|Spironolactone|spironolactone|mesh-list
101877421|NCT01314898|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101877422|NCT01314898|Hormone Antagonists|hormone antagonists|mesh-ancestor
101877423|NCT01314898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101877424|NCT01314898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877425|NCT01314898|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101877426|NCT01314898|Diuretics|diuretics|mesh-ancestor
101877427|NCT01314898|Natriuretic Agents|natriuretic agents|mesh-ancestor
101877428|NCT01315912|Letrozole|letrozole|mesh-list
101877429|NCT01315912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101877430|NCT01315912|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101877431|NCT01315912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101877432|NCT01315912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101877433|NCT01315912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877434|NCT01315912|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101877435|NCT01315912|Hormone Antagonists|hormone antagonists|mesh-ancestor
101877436|NCT01315912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101877437|NCT01315912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877438|NCT03778450|Analgesics, Opioid|analgesics, opioid|mesh-list
101877439|NCT03778450|Analgesics|analgesics|mesh-list
101877440|NCT03778450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
101877441|NCT03778450|Narcotics|narcotics|mesh-ancestor
101877442|NCT03778450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101877443|NCT03778450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877444|NCT03778450|Sensory System Agents|sensory system agents|mesh-ancestor
101877445|NCT03778450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101877446|NCT03776500|Macozinone|macozinone|mesh-list
101877447|NCT03776500|Antitubercular Agents|antitubercular agents|mesh-ancestor
101877448|NCT03776500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101877449|NCT03776500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101877450|NCT03778138|Pemetrexed|pemetrexed|mesh-list
101877451|NCT03778138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101877452|NCT03778138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101877453|NCT03778138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877454|NCT03778138|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101877455|NCT03778138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101877456|NCT03783754|Amlodipine|amlodipine|mesh-list
101877457|NCT03783754|Telmisartan|telmisartan|mesh-list
101877458|NCT03783754|Indapamide|indapamide|mesh-list
101877459|NCT03783754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101877460|NCT03783754|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101877461|NCT03783754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101877462|NCT03783754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877463|NCT03783754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101877464|NCT03783754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877465|NCT03783754|Vasodilator Agents|vasodilator agents|mesh-ancestor
101877466|NCT03783754|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101877467|NCT03783754|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101877468|NCT03783754|Diuretics|diuretics|mesh-ancestor
101877469|NCT03783754|Natriuretic Agents|natriuretic agents|mesh-ancestor
101877470|NCT03783754|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101877471|NCT01309438|Erythromycin|erythromycin|mesh-list
101877472|NCT01309438|Erythromycin Estolate|erythromycin estolate|mesh-list
101877473|NCT01309438|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101877474|NCT01309438|Erythromycin stearate|erythromycin stearate|mesh-list
101877475|NCT01309438|Rivaroxaban|rivaroxaban|mesh-list
101877476|NCT01309438|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101877477|NCT01309438|Antithrombins|antithrombins|mesh-ancestor
101877478|NCT01309438|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101877479|NCT01309438|Protease Inhibitors|protease inhibitors|mesh-ancestor
101877480|NCT01309438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101877481|NCT01309438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877482|NCT01309438|Anticoagulants|anticoagulants|mesh-ancestor
101453688|NCT00208169|Aripiprazole|aripiprazole|mesh-list
101877483|NCT01309438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101877484|NCT01309438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101877485|NCT01309438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101877486|NCT01309438|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101877487|NCT03776032|Darbepoetin alfa|darbepoetin alfa|mesh-list
101877489|NCT03775798|Antiviral Agents|antiviral agents|mesh-list
101877490|NCT03775798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101877491|NCT03775876|Dexmedetomidine|dexmedetomidine|mesh-list
101877492|NCT03775876|Propofol|propofol|mesh-list
101877493|NCT03775876|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101877494|NCT03775876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101877495|NCT03775876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877496|NCT03775876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101877497|NCT03775876|Analgesics|analgesics|mesh-ancestor
101877498|NCT03775876|Sensory System Agents|sensory system agents|mesh-ancestor
101877499|NCT03775876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101877500|NCT03775876|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101877501|NCT03775876|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101877502|NCT03775876|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101877503|NCT03775876|Adrenergic Agents|adrenergic agents|mesh-ancestor
101877504|NCT03775876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101877505|NCT03775876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877506|NCT03775876|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101877507|NCT03775876|Anesthetics, General|anesthetics, general|mesh-ancestor
101877508|NCT03775876|Anesthetics|anesthetics|mesh-ancestor
101877509|NCT01320514|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101877510|NCT01320514|Hemostatics|hemostatics|mesh-ancestor
101877511|NCT01320514|Coagulants|coagulants|mesh-ancestor
101877512|NCT03773536|Artesunate|artesunate|mesh-list
101877513|NCT03773536|Primaquine|primaquine|mesh-list
101877514|NCT03773536|Amodiaquine|amodiaquine|mesh-list
101877515|NCT03773536|Antimalarials|antimalarials|mesh-ancestor
101877516|NCT03773536|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101877517|NCT03773536|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101877518|NCT03773536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101877519|NCT03773536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101877520|NCT03773536|Antiviral Agents|antiviral agents|mesh-ancestor
101877521|NCT03773536|Schistosomicides|schistosomicides|mesh-ancestor
101877522|NCT03773536|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101877523|NCT03773536|Anthelmintics|anthelmintics|mesh-ancestor
101877524|NCT01320592|Paclitaxel|paclitaxel|mesh-list
101877525|NCT01320592|Palbociclib|palbociclib|mesh-list
101877526|NCT01320592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101877527|NCT01320592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101877528|NCT01320592|Tubulin Modulators|tubulin modulators|mesh-ancestor
101877529|NCT01320592|Antimitotic Agents|antimitotic agents|mesh-ancestor
101877530|NCT01320592|Mitosis Modulators|mitosis modulators|mesh-ancestor
101877531|NCT01320592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877532|NCT01320592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101877533|NCT01320592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101877534|NCT03783676|Remifentanil|remifentanil|mesh-list
101877535|NCT03783676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101877536|NCT03783676|Narcotics|narcotics|mesh-ancestor
101877537|NCT03783676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101877538|NCT03783676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877539|NCT03783676|Analgesics|analgesics|mesh-ancestor
101877540|NCT03783676|Sensory System Agents|sensory system agents|mesh-ancestor
101877541|NCT03783676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101877542|NCT03783520|Sodium Hypochlorite|sodium hypochlorite|mesh-list
101877543|NCT03783520|Eusol|eusol|mesh-list
101877544|NCT03783520|Disinfectants|disinfectants|mesh-ancestor
101877545|NCT03783520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101877546|NCT01320982|Aspirin|aspirin|mesh-list
101877547|NCT01320982|Minocycline|minocycline|mesh-list
101877548|NCT01320982|Pramipexole|pramipexole|mesh-list
101877549|NCT01320982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101877550|NCT01320982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101877551|NCT01320982|Analgesics|analgesics|mesh-ancestor
101877552|NCT01320982|Sensory System Agents|sensory system agents|mesh-ancestor
101877553|NCT01320982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101877554|NCT01320982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877555|NCT01320982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101877556|NCT01320982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101877557|NCT01320982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101877558|NCT01320982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101877559|NCT01320982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877560|NCT01320982|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101877561|NCT01320982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101877562|NCT01320982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101877563|NCT01320982|Antipyretics|antipyretics|mesh-ancestor
101877564|NCT01320982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101877565|NCT01320982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101877566|NCT01320982|Antioxidants|antioxidants|mesh-ancestor
101877567|NCT01320982|Protective Agents|protective agents|mesh-ancestor
101877568|NCT01320982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101877569|NCT01320982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101877570|NCT01320982|Dopamine Agonists|dopamine agonists|mesh-ancestor
101877571|NCT01320982|Dopamine Agents|dopamine agents|mesh-ancestor
101877572|NCT01320982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101877573|NCT04893382|Plasma-lyte 148|plasma-lyte 148|mesh-list
101877574|NCT04893382|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101877575|NCT04893382|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101877576|NCT01321138|Morphine|morphine|mesh-list
101877577|NCT01321138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101877578|NCT01321138|Narcotics|narcotics|mesh-ancestor
101877579|NCT01321138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101877580|NCT01321138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877581|NCT01321138|Analgesics|analgesics|mesh-ancestor
101688961|NCT00601458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101877582|NCT01321138|Sensory System Agents|sensory system agents|mesh-ancestor
101877583|NCT01321138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101877584|NCT04628572|Ceftazidime|ceftazidime|mesh-list
101877585|NCT04628572|Avibactam|avibactam|mesh-list
101877586|NCT04628572|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
101877587|NCT04628572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101877588|NCT04628572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101877589|NCT04628572|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101877590|NCT04628572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101877591|NCT04628572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877592|NCT03772990|Calcium|calcium|mesh-list
101877593|NCT03772990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101877594|NCT03772990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877595|NCT03782662|Itraconazole|itraconazole|mesh-list
101877596|NCT03782662|Rifampin|rifampin|mesh-list
101877597|NCT03782662|Verapamil|verapamil|mesh-list
101877598|NCT03782662|Midazolam|midazolam|mesh-list
101877599|NCT03782662|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101877600|NCT03782662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101877601|NCT03782662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101877602|NCT03782662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877603|NCT03782662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101877604|NCT03782662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101877605|NCT03782662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101877606|NCT03782662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101877607|NCT03782662|Anesthetics, General|anesthetics, general|mesh-ancestor
101877608|NCT03782662|Anesthetics|anesthetics|mesh-ancestor
101877609|NCT03782662|GABA Modulators|gaba modulators|mesh-ancestor
101877610|NCT03782662|GABA Agents|gaba agents|mesh-ancestor
101877611|NCT03782662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101877612|NCT03782662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877613|NCT03782662|Antifungal Agents|antifungal agents|mesh-ancestor
101877614|NCT03782662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101877615|NCT03782662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101877616|NCT03782662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101877617|NCT03782662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101877618|NCT03782662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101877620|NCT03782662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101877621|NCT03782662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101877622|NCT03782662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101877623|NCT03782662|Antitubercular Agents|antitubercular agents|mesh-ancestor
101877624|NCT03782662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101877625|NCT03782662|Leprostatic Agents|leprostatic agents|mesh-ancestor
101877626|NCT03782662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101877627|NCT03782662|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101877628|NCT03782662|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101877629|NCT03782662|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101877630|NCT03782662|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101877631|NCT03782662|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101877632|NCT03782662|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101877633|NCT03782662|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101877634|NCT03782662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101877635|NCT03782662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101877636|NCT03782662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101877637|NCT03782662|Vasodilator Agents|vasodilator agents|mesh-ancestor
101877638|NCT01309984|Propofol|propofol|mesh-list
101877639|NCT01309984|Fospropofol|fospropofol|mesh-list
101877640|NCT01309984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101877641|NCT01309984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101877642|NCT01309984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877643|NCT01309984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101877644|NCT01309984|Anesthetics, General|anesthetics, general|mesh-ancestor
101877645|NCT01309984|Anesthetics|anesthetics|mesh-ancestor
101877646|NCT03772054|Propofol|propofol|mesh-list
101877647|NCT03772054|Sevoflurane|sevoflurane|mesh-list
101877648|NCT03772054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101877649|NCT03772054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101877650|NCT03772054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877651|NCT03772054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101877652|NCT03772054|Anesthetics, General|anesthetics, general|mesh-ancestor
101877653|NCT03772054|Anesthetics|anesthetics|mesh-ancestor
101877654|NCT03772054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101877655|NCT03772054|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101877656|NCT03771820|Pembrolizumab|pembrolizumab|mesh-list
101877657|NCT03771820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101877658|NCT03771820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101877659|NCT03771820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101877660|NCT03771820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877661|NCT05531890|Betamethasone|betamethasone|mesh-list
101877662|NCT05531890|Betamethasone Valerate|betamethasone valerate|mesh-list
101877663|NCT05531890|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101877664|NCT05531890|Betamethasone benzoate|betamethasone benzoate|mesh-list
101877665|NCT05531890|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101877666|NCT05531890|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101877667|NCT05531890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101877668|NCT05531890|Glucocorticoids|glucocorticoids|mesh-ancestor
101877670|NCT05531890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101877671|NCT05531890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877672|NCT05531890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101877673|NCT05531890|Respiratory System Agents|respiratory system agents|mesh-ancestor
101877674|NCT00123474|Dasatinib|dasatinib|mesh-list
101877675|NCT00123474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101877676|NCT00123474|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101877677|NCT00123474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101877678|NCT00123474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877679|NCT00142298|Telbivudine|telbivudine|mesh-list
101877680|NCT00142298|Antiviral Agents|antiviral agents|mesh-ancestor
101877681|NCT00142298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101877682|NCT00142298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101877683|NCT00142298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101877684|NCT00142298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877685|NCT03774706|Misoprostol|misoprostol|mesh-list
101877686|NCT03774706|Tranexamic Acid|tranexamic acid|mesh-list
101877687|NCT03774706|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101877688|NCT03774706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101597517|NCT02736604|Nitrous Oxide|nitrous oxide|mesh-list
101453772|NCT00233766|Sirolimus|sirolimus|mesh-list
101877689|NCT03774706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877691|NCT03774706|Coagulants|coagulants|mesh-ancestor
101877692|NCT03774706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101877693|NCT03774706|Abortifacient Agents|abortifacient agents|mesh-ancestor
101877694|NCT03774706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101877695|NCT03774706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877696|NCT03774706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101877697|NCT03774706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101877698|NCT03774706|Oxytocics|oxytocics|mesh-ancestor
101877700|NCT03967496|Amlodipine|amlodipine|mesh-list
101877701|NCT03967496|Lisinopril|lisinopril|mesh-list
101877702|NCT03967496|Bisoprolol|bisoprolol|mesh-list
101877703|NCT03967496|Hydralazine|hydralazine|mesh-list
101877704|NCT03967496|Anesthetics|anesthetics|mesh-list
101877705|NCT03967496|Atorvastatin|atorvastatin|mesh-list
101877706|NCT03967496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101877707|NCT03967496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877708|NCT03967496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101877709|NCT03967496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101877710|NCT03967496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101877711|NCT03967496|Antimetabolites|antimetabolites|mesh-ancestor
101877712|NCT03967496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877713|NCT03967496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101877714|NCT03967496|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101877715|NCT03967496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101877716|NCT03967496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101877717|NCT03967496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101877718|NCT03967496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101877719|NCT03967496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101877720|NCT03967496|Vasodilator Agents|vasodilator agents|mesh-ancestor
101877721|NCT03967496|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101877722|NCT03967496|Protease Inhibitors|protease inhibitors|mesh-ancestor
101877723|NCT03967496|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101877724|NCT03967496|Protective Agents|protective agents|mesh-ancestor
101877725|NCT03967496|Sympatholytics|sympatholytics|mesh-ancestor
101877726|NCT03967496|Autonomic Agents|autonomic agents|mesh-ancestor
101877727|NCT03967496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101877728|NCT03967496|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101877729|NCT03967496|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101877730|NCT03967496|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101877731|NCT03967496|Adrenergic Agents|adrenergic agents|mesh-ancestor
101877732|NCT03967496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101877733|NCT00412061|Everolimus|everolimus|mesh-list
101877734|NCT00412061|Octreotide|octreotide|mesh-list
101877735|NCT00412061|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101877736|NCT00412061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101877737|NCT00412061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101877738|NCT00412061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877739|NCT00412061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101877740|NCT00412061|Immunologic Factors|immunologic factors|mesh-ancestor
101877741|NCT00412061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877742|NCT00412061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101877743|NCT00412061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101877744|NCT00412061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101877745|NCT03964350|Ethanol|ethanol|mesh-list
101877746|NCT03964350|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101877747|NCT03964350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101877748|NCT03964350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101877749|NCT03964350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877750|NCT01310452|Insulin|insulin|mesh-list
101877751|NCT01310452|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101877752|NCT01310452|Insulin Detemir|insulin detemir|mesh-list
101877753|NCT01310452|Protamines|protamines|mesh-list
101877754|NCT01310452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101877755|NCT01310452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877756|NCT01310452|Heparin Antagonists|heparin antagonists|mesh-ancestor
101877757|NCT01310452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877758|NCT01310452|Coagulants|coagulants|mesh-ancestor
101877759|NCT01035671|Vitamin E|vitamin e|mesh-list
101877760|NCT01035671|Tocopherylquinone|tocopherylquinone|mesh-list
101877761|NCT01035671|Anticoagulants|anticoagulants|mesh-ancestor
101877762|NCT01035671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101877763|NCT01035671|Antioxidants|antioxidants|mesh-ancestor
101877764|NCT01035671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877765|NCT01035671|Protective Agents|protective agents|mesh-ancestor
101877766|NCT01035671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877767|NCT01035671|Vitamins|vitamins|mesh-ancestor
101877768|NCT01035671|Micronutrients|micronutrients|mesh-ancestor
101877769|NCT04560868|Nicotine|nicotine|mesh-list
101877770|NCT04560868|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101877771|NCT04560868|Autonomic Agents|autonomic agents|mesh-ancestor
101877772|NCT04560868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101877773|NCT04560868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877774|NCT04560868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101877775|NCT04560868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101877776|NCT04560868|Cholinergic Agents|cholinergic agents|mesh-ancestor
101877777|NCT04560868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101877778|NCT04560868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877779|NCT03769714|Bupivacaine|bupivacaine|mesh-list
101877780|NCT03769714|Anesthetics, Local|anesthetics, local|mesh-ancestor
101877781|NCT03769714|Anesthetics|anesthetics|mesh-ancestor
101877782|NCT03769714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101877783|NCT03769714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877784|NCT03769714|Sensory System Agents|sensory system agents|mesh-ancestor
101877785|NCT03769714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101877786|NCT03769402|Citric Acid|citric acid|mesh-list
101877787|NCT03769402|Sodium Citrate|sodium citrate|mesh-list
101877788|NCT03769402|Anticoagulants|anticoagulants|mesh-ancestor
101877789|NCT03769402|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101877790|NCT03769402|Chelating Agents|chelating agents|mesh-ancestor
101877791|NCT03769402|Sequestering Agents|sequestering agents|mesh-ancestor
101877792|NCT03769402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877793|NCT00411671|Sorafenib|sorafenib|mesh-list
101877794|NCT00411671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101877795|NCT00411671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101877796|NCT00411671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101877797|NCT00411671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877798|NCT01035983|Frovatriptan|frovatriptan|mesh-list
101877799|NCT01035983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101877801|NCT01035983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101877802|NCT01035983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877803|NCT01035983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877804|NCT03770806|Acetaminophen|acetaminophen|mesh-list
101877805|NCT03770806|Celecoxib|celecoxib|mesh-list
101877806|NCT03770806|Oxycodone|oxycodone|mesh-list
101877807|NCT03770806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101877808|NCT03770806|Analgesics|analgesics|mesh-ancestor
101877809|NCT03770806|Sensory System Agents|sensory system agents|mesh-ancestor
101877810|NCT03770806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101877811|NCT03770806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877812|NCT03770806|Antipyretics|antipyretics|mesh-ancestor
101877813|NCT03770806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101877814|NCT03770806|Narcotics|narcotics|mesh-ancestor
101877815|NCT03770806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101877816|NCT03770806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101877817|NCT03770806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101877818|NCT03770806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101877819|NCT03770806|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101877820|NCT03770806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101877821|NCT03770806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101877822|NCT03770806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877823|NCT01039103|Methylprednisolone|methylprednisolone|mesh-list
101877824|NCT01039103|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101877825|NCT01039103|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101877826|NCT01039103|Prednisolone|prednisolone|mesh-list
101877827|NCT01039103|Prednisolone acetate|prednisolone acetate|mesh-list
101877828|NCT01039103|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101877829|NCT01039103|Prednisolone phosphate|prednisolone phosphate|mesh-list
101877830|NCT01039103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101877831|NCT01039103|Antiemetics|antiemetics|mesh-ancestor
101877832|NCT01039103|Autonomic Agents|autonomic agents|mesh-ancestor
101877833|NCT01039103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101877834|NCT01039103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877835|NCT01039103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101877836|NCT01039103|Glucocorticoids|glucocorticoids|mesh-ancestor
101877837|NCT01039103|Hormones|hormones|mesh-ancestor
101597661|NCT03633058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877838|NCT01039103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101877839|NCT01039103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101877840|NCT01039103|Protective Agents|protective agents|mesh-ancestor
101877841|NCT01039103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101877842|NCT01039103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101877844|NCT01039181|Calcitriol|calcitriol|mesh-list
101877845|NCT01039181|Vitamins|vitamins|mesh-ancestor
101877846|NCT01039181|Micronutrients|micronutrients|mesh-ancestor
101877848|NCT01039181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101877849|NCT01039181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101877850|NCT01039181|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101877851|NCT01039181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101877852|NCT01039181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877853|NCT01039181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101877854|NCT03770026|Clomiphene|clomiphene|mesh-list
101877855|NCT03770026|Enclomiphene|enclomiphene|mesh-list
101877856|NCT03770026|Zuclomiphene|zuclomiphene|mesh-list
101877857|NCT03770026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101877858|NCT03770026|Hormone Antagonists|hormone antagonists|mesh-ancestor
101453829|NCT00233805|Immunologic Factors|immunologic factors|mesh-ancestor
101877859|NCT03770026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101877860|NCT03770026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877861|NCT03770026|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101877862|NCT03770026|Fertility Agents|fertility agents|mesh-ancestor
101877863|NCT03770026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101877864|NCT03770026|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101877865|NCT03770026|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101877866|NCT03769870|Atorvastatin|atorvastatin|mesh-list
101877867|NCT03769870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101877868|NCT03769870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101877869|NCT03769870|Antimetabolites|antimetabolites|mesh-ancestor
101877870|NCT03769870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877871|NCT03769870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101877872|NCT03769870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101877873|NCT03769870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101877874|NCT01589081|Nicotine|nicotine|mesh-list
101877875|NCT01589081|Progesterone|progesterone|mesh-list
101877876|NCT01589081|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101877877|NCT01589081|Autonomic Agents|autonomic agents|mesh-ancestor
101877878|NCT01589081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101877879|NCT01589081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877880|NCT01589081|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101877881|NCT01589081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101877882|NCT01589081|Cholinergic Agents|cholinergic agents|mesh-ancestor
101877883|NCT01589081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101877884|NCT01589081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877885|NCT01589081|Progestins|progestins|mesh-ancestor
101877886|NCT01589081|Hormones|hormones|mesh-ancestor
101877887|NCT01589081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101877888|NCT01567540|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101877889|NCT01567540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101877890|NCT01567540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877891|NCT01567540|Incretins|incretins|mesh-ancestor
101877892|NCT01567540|Hormones|hormones|mesh-ancestor
101877893|NCT01567540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101877894|NCT01567540|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101877895|NCT01567540|Protease Inhibitors|protease inhibitors|mesh-ancestor
101877896|NCT01567540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101877897|NCT01567540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877898|NCT01036841|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101877899|NCT01036841|Hemostatics|hemostatics|mesh-ancestor
101877900|NCT01036841|Coagulants|coagulants|mesh-ancestor
101877901|NCT01036841|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101877902|NCT01036841|Natriuretic Agents|natriuretic agents|mesh-ancestor
101877903|NCT01036841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877904|NCT03709576|Azacitidine|azacitidine|mesh-list
101877905|NCT03709576|Pevonedistat|pevonedistat|mesh-list
101877906|NCT03709576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101877907|NCT03709576|Antimetabolites|antimetabolites|mesh-ancestor
101877908|NCT03709576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877909|NCT03709576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101877910|NCT03709576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101877911|NCT00122460|Cisplatin|cisplatin|mesh-list
101877912|NCT00122460|Carboplatin|carboplatin|mesh-list
101877913|NCT00122460|Fluorouracil|fluorouracil|mesh-list
101877914|NCT00122460|Cetuximab|cetuximab|mesh-list
101877915|NCT00122460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101877916|NCT00122460|Antimetabolites|antimetabolites|mesh-ancestor
101877917|NCT00122460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877918|NCT00122460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101877919|NCT00122460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101877920|NCT00122460|Immunologic Factors|immunologic factors|mesh-ancestor
101877921|NCT00122460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877922|NCT00122460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101877923|NCT03763396|Ketoconazole|ketoconazole|mesh-list
101877924|NCT03763396|Posaconazole|posaconazole|mesh-list
101877925|NCT03763396|Antifungal Agents|antifungal agents|mesh-ancestor
101877926|NCT03763396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101877927|NCT03763396|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101877928|NCT03763396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101877929|NCT03763396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101877930|NCT03763396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877931|NCT03763396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101877932|NCT03763396|Hormone Antagonists|hormone antagonists|mesh-ancestor
101877933|NCT03763396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101877934|NCT03763396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877935|NCT03763396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101877936|NCT03763396|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101877937|NCT03763396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101877938|NCT03763396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101877939|NCT01320436|Aminosalicylic Acid|aminosalicylic acid|mesh-list
101877940|NCT01320436|Curcumin|curcumin|mesh-list
101877941|NCT01320436|Mesalamine|mesalamine|mesh-list
101877942|NCT01320436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101877943|NCT01320436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101877944|NCT01320436|Analgesics|analgesics|mesh-ancestor
101877945|NCT01320436|Sensory System Agents|sensory system agents|mesh-ancestor
101877946|NCT01320436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101877947|NCT01320436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877948|NCT01320436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101877949|NCT01320436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101877950|NCT01320436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101877951|NCT01320436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101877952|NCT01320436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877953|NCT01320436|Antitubercular Agents|antitubercular agents|mesh-ancestor
101877954|NCT01320436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101877955|NCT01320436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101877956|NCT04794088|Imatinib Mesylate|imatinib mesylate|mesh-list
101877957|NCT04794088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101877958|NCT04794088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101877959|NCT04794088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101877960|NCT04794088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877961|NCT03763084|Acetaminophen|acetaminophen|mesh-list
101877962|NCT03763084|Sufentanil|sufentanil|mesh-list
101877963|NCT03763084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101877964|NCT03763084|Analgesics|analgesics|mesh-ancestor
101877965|NCT03763084|Sensory System Agents|sensory system agents|mesh-ancestor
101877966|NCT03763084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101877967|NCT03763084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877968|NCT03763084|Antipyretics|antipyretics|mesh-ancestor
101877969|NCT03763084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101877970|NCT03763084|Narcotics|narcotics|mesh-ancestor
101877971|NCT03763084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101877972|NCT03763084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101877973|NCT03763084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101877974|NCT03763084|Anesthetics, General|anesthetics, general|mesh-ancestor
101877975|NCT03763084|Anesthetics|anesthetics|mesh-ancestor
101877976|NCT01567618|Docetaxel|docetaxel|mesh-list
101877977|NCT01567618|Fluorouracil|fluorouracil|mesh-list
101877978|NCT01567618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101877979|NCT01567618|Tubulin Modulators|tubulin modulators|mesh-ancestor
101877980|NCT01567618|Antimitotic Agents|antimitotic agents|mesh-ancestor
101877981|NCT01567618|Mitosis Modulators|mitosis modulators|mesh-ancestor
101877982|NCT01567618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101877983|NCT01567618|Antimetabolites|antimetabolites|mesh-ancestor
101877984|NCT01567618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101877985|NCT01567618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101877986|NCT01567618|Immunologic Factors|immunologic factors|mesh-ancestor
101877987|NCT01567618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597812|NCT01121549|Exemestane|exemestane|mesh-list
101877988|NCT04771078|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
101877989|NCT04771078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101877990|NCT04771078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101877991|NCT03762928|Efavirenz|efavirenz|mesh-list
101877992|NCT03762928|Midazolam|midazolam|mesh-list
101877993|NCT03762928|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101877994|NCT03762928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101877995|NCT03762928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101877996|NCT03762928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101877997|NCT03762928|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101877998|NCT03762928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101877999|NCT03762928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101878000|NCT03762928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101878001|NCT03762928|Anesthetics, General|anesthetics, general|mesh-ancestor
101878002|NCT03762928|Anesthetics|anesthetics|mesh-ancestor
101878003|NCT03762928|GABA Modulators|gaba modulators|mesh-ancestor
101878004|NCT03762928|GABA Agents|gaba agents|mesh-ancestor
101878005|NCT03762928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101878006|NCT03762928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878007|NCT03762928|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101878008|NCT03762928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101878009|NCT03762928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878010|NCT03762928|Antiviral Agents|antiviral agents|mesh-ancestor
101878011|NCT03762928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101878012|NCT03762928|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101878013|NCT03762928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101878014|NCT03762928|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101878015|NCT03762928|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101878016|NCT03762928|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101878017|NCT03762928|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101878018|NCT01561456|Docetaxel|docetaxel|mesh-list
101878019|NCT01561456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101878020|NCT01561456|Tubulin Modulators|tubulin modulators|mesh-ancestor
101878021|NCT01561456|Antimitotic Agents|antimitotic agents|mesh-ancestor
101878022|NCT01561456|Mitosis Modulators|mitosis modulators|mesh-ancestor
101878023|NCT01561456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878025|NCT00137436|Docetaxel|docetaxel|mesh-list
101878026|NCT00137436|Sunitinib|sunitinib|mesh-list
101878027|NCT00137436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101878028|NCT00137436|Tubulin Modulators|tubulin modulators|mesh-ancestor
101878029|NCT00137436|Antimitotic Agents|antimitotic agents|mesh-ancestor
101878030|NCT00137436|Mitosis Modulators|mitosis modulators|mesh-ancestor
101878031|NCT00137436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878032|NCT00137436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101878033|NCT00137436|Glucocorticoids|glucocorticoids|mesh-ancestor
101878034|NCT00137436|Hormones|hormones|mesh-ancestor
101878035|NCT00137436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101878036|NCT00137436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878037|NCT00137436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101878038|NCT00137436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101878039|NCT00137436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101878040|NCT00137436|Growth Substances|growth substances|mesh-ancestor
101878041|NCT00137436|Growth Inhibitors|growth inhibitors|mesh-ancestor
101878042|NCT00137436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101878043|NCT00137436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878044|NCT03762538|Propofol|propofol|mesh-list
101878045|NCT03762538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101878046|NCT03762538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101878047|NCT03762538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878048|NCT03762538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101878049|NCT03762538|Anesthetics, General|anesthetics, general|mesh-ancestor
101878050|NCT03762538|Anesthetics|anesthetics|mesh-ancestor
101878051|NCT03762382|Tenofovir|tenofovir|mesh-list
101878052|NCT03762382|Levonorgestrel|levonorgestrel|mesh-list
101878053|NCT03762382|Antiviral Agents|antiviral agents|mesh-ancestor
101878054|NCT03762382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101878055|NCT03762382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101878056|NCT03762382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101878057|NCT03762382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878058|NCT03762382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878059|NCT03762382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101878060|NCT03762382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101878061|NCT03762382|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101878062|NCT03762382|Contraceptive Agents|contraceptive agents|mesh-ancestor
101878063|NCT03762382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101878064|NCT03762382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878065|NCT03762382|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101878066|NCT03762382|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101878067|NCT03762382|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101878068|NCT03767920|Dexamethasone|dexamethasone|mesh-list
101878069|NCT03767920|Dexamethasone acetate|dexamethasone acetate|mesh-list
101878070|NCT03767920|Bupivacaine|bupivacaine|mesh-list
101878071|NCT03767920|BB 1101|bb 1101|mesh-list
101878072|NCT03767920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101878073|NCT03767920|Antiemetics|antiemetics|mesh-ancestor
101878074|NCT03767920|Autonomic Agents|autonomic agents|mesh-ancestor
101878075|NCT03767920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101878076|NCT03767920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878077|NCT03767920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101878078|NCT03767920|Glucocorticoids|glucocorticoids|mesh-ancestor
101878079|NCT03767920|Hormones|hormones|mesh-ancestor
101878080|NCT03767920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101878081|NCT03767920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101878082|NCT03767920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101878083|NCT03767920|Protease Inhibitors|protease inhibitors|mesh-ancestor
101878084|NCT03767920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878085|NCT03767920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878087|NCT03767920|Anesthetics|anesthetics|mesh-ancestor
101878088|NCT03767920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101878089|NCT03767920|Sensory System Agents|sensory system agents|mesh-ancestor
101878090|NCT03834623|Nivolumab|nivolumab|mesh-list
101878091|NCT03834623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101878092|NCT03834623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101878093|NCT03834623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101878094|NCT03834623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878095|NCT03762148|Vitamins|vitamins|mesh-list
101878096|NCT03762148|Ascorbic Acid|ascorbic acid|mesh-list
101878097|NCT03762148|Ferrous fumarate|ferrous fumarate|mesh-list
101878099|NCT03762148|Micronutrients|micronutrients|mesh-ancestor
101878100|NCT03762148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878101|NCT03762148|Antioxidants|antioxidants|mesh-ancestor
101878102|NCT03762148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878103|NCT03762148|Protective Agents|protective agents|mesh-ancestor
101878104|NCT03762148|Trace Elements|trace elements|mesh-ancestor
101878105|NCT01589159|Capecitabine|capecitabine|mesh-list
101878106|NCT01589159|Etoposide|etoposide|mesh-list
101878107|NCT01589159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101878108|NCT01589159|Antimetabolites|antimetabolites|mesh-ancestor
101878109|NCT01589159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878110|NCT01589159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101878111|NCT01589159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101878112|NCT01589159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101878113|NCT01589159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101878114|NCT01589159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878115|NCT03711292|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101878116|NCT03711292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101878117|NCT03937895|Pembrolizumab|pembrolizumab|mesh-list
101878118|NCT03937895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101878119|NCT03937895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101878120|NCT03937895|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101878121|NCT03937895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878122|NCT03625648|Pentoxifylline|pentoxifylline|mesh-list
101878123|NCT03625648|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101878124|NCT03625648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878125|NCT03625648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878126|NCT03625648|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101878127|NCT03625648|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101878128|NCT03625648|Protective Agents|protective agents|mesh-ancestor
101878129|NCT03625648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878130|NCT03625648|Vasodilator Agents|vasodilator agents|mesh-ancestor
101878131|NCT03625648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101878132|NCT03625648|Antioxidants|antioxidants|mesh-ancestor
101878133|NCT03767296|Phenylephrine|phenylephrine|mesh-list
101878134|NCT03767296|Oxymetazoline|oxymetazoline|mesh-list
101878135|NCT03767296|Ephedrine|ephedrine|mesh-list
101878136|NCT03767296|Pseudoephedrine|pseudoephedrine|mesh-list
101878137|NCT03767296|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101878138|NCT03767296|Mydriatics|mydriatics|mesh-ancestor
101597957|NCT02734186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101878140|NCT03767296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101878141|NCT03767296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878142|NCT03767296|Sympathomimetics|sympathomimetics|mesh-ancestor
101878143|NCT03767296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101878144|NCT03767296|Nasal Decongestants|nasal decongestants|mesh-ancestor
101967561|NCT00713518|Growth Substances|growth substances|mesh-ancestor
101878145|NCT03767296|Respiratory System Agents|respiratory system agents|mesh-ancestor
101878146|NCT03767296|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101878147|NCT03767296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101878148|NCT03767296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101878149|NCT03767296|Adrenergic Agents|adrenergic agents|mesh-ancestor
101878150|NCT03767296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101878151|NCT03767296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878152|NCT03767296|Protective Agents|protective agents|mesh-ancestor
101878153|NCT03767296|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101878154|NCT03767296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101878155|NCT03767296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101878156|NCT00410813|Dasatinib|dasatinib|mesh-list
101878157|NCT00410813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101878158|NCT00410813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101878159|NCT00410813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878160|NCT00410813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878161|NCT03760978|Dexmedetomidine|dexmedetomidine|mesh-list
101878162|NCT03760978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101878163|NCT03760978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101878164|NCT03760978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878165|NCT03760978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101878166|NCT03760978|Analgesics|analgesics|mesh-ancestor
101878167|NCT03760978|Sensory System Agents|sensory system agents|mesh-ancestor
101878168|NCT03760978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101878169|NCT03760978|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101878170|NCT03760978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101878171|NCT03760978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101878172|NCT03760978|Adrenergic Agents|adrenergic agents|mesh-ancestor
101878173|NCT03760978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101878174|NCT03760978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878175|NCT03766984|Diclofenac|diclofenac|mesh-list
101878176|NCT03766984|Tramadol|tramadol|mesh-list
101878177|NCT03766984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101878178|NCT03766984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101878179|NCT03766984|Analgesics|analgesics|mesh-ancestor
101878180|NCT03766984|Sensory System Agents|sensory system agents|mesh-ancestor
101878181|NCT03766984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101878182|NCT03766984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878183|NCT03766984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101878184|NCT03766984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101878185|NCT03766984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101878186|NCT03766984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878187|NCT03766984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878188|NCT03766984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101878189|NCT03766984|Narcotics|narcotics|mesh-ancestor
101878190|NCT03766984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101878191|NCT00405821|Acyclovir|acyclovir|mesh-list
101878192|NCT00405821|Antiviral Agents|antiviral agents|mesh-ancestor
101878193|NCT00405821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101878194|NCT03928600|Misoprostol|misoprostol|mesh-list
101878195|NCT03928600|Dinoprostone|dinoprostone|mesh-list
101878196|NCT03928600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101878197|NCT03928600|Abortifacient Agents|abortifacient agents|mesh-ancestor
101878198|NCT03928600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101878199|NCT03928600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878200|NCT03928600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101878201|NCT03928600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101878202|NCT03928600|Oxytocics|oxytocics|mesh-ancestor
101878211|NCT01322152|Capecitabine|capecitabine|mesh-list
101878212|NCT01322152|Irinotecan|irinotecan|mesh-list
101878213|NCT01322152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101878214|NCT01322152|Antimetabolites|antimetabolites|mesh-ancestor
101878215|NCT01322152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878216|NCT01322152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101878217|NCT01322152|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101878218|NCT01322152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101967578|NCT00708292|Hormones|hormones|mesh-ancestor
101878219|NCT01322152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878220|NCT01446016|Paclitaxel|paclitaxel|mesh-list
101878221|NCT01446016|Docetaxel|docetaxel|mesh-list
101878222|NCT01446016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101878224|NCT01446016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101878225|NCT01446016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101878226|NCT01446016|Tubulin Modulators|tubulin modulators|mesh-ancestor
101878227|NCT01446016|Antimitotic Agents|antimitotic agents|mesh-ancestor
101878228|NCT01446016|Mitosis Modulators|mitosis modulators|mesh-ancestor
101878229|NCT01446016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878230|NCT00137046|Insulin|insulin|mesh-list
101878231|NCT00137046|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101878232|NCT00137046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101878233|NCT00137046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878234|NCT03760354|Methylprednisolone|methylprednisolone|mesh-list
101878235|NCT03760354|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101878236|NCT03760354|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101878237|NCT03760354|Prednisolone|prednisolone|mesh-list
101878238|NCT03760354|Prednisolone acetate|prednisolone acetate|mesh-list
101878239|NCT03760354|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101878240|NCT03760354|Prednisolone phosphate|prednisolone phosphate|mesh-list
101878241|NCT03760354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101878242|NCT03760354|Antiemetics|antiemetics|mesh-ancestor
101878243|NCT03760354|Autonomic Agents|autonomic agents|mesh-ancestor
101878244|NCT03760354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101878245|NCT03760354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878246|NCT03760354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101878247|NCT03760354|Glucocorticoids|glucocorticoids|mesh-ancestor
101878248|NCT03760354|Hormones|hormones|mesh-ancestor
101878249|NCT03760354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101878250|NCT03760354|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101878251|NCT03760354|Protective Agents|protective agents|mesh-ancestor
101878252|NCT03760354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101878253|NCT03760354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101878254|NCT03760276|Voriconazole|voriconazole|mesh-list
101878255|NCT03760276|Antifungal Agents|antifungal agents|mesh-ancestor
101878256|NCT03760276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101878257|NCT03760276|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101878258|NCT03760276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101878259|NCT03760276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878260|NCT03760276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878261|NCT03760276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101878262|NCT03760276|Hormone Antagonists|hormone antagonists|mesh-ancestor
102074174|NCT03554304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878263|NCT03760276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101878264|NCT03760276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878265|NCT03760276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101878266|NCT03766594|Folic Acid|folic acid|mesh-list
101878267|NCT03766594|Sildenafil Citrate|sildenafil citrate|mesh-list
101878268|NCT03766594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878269|NCT03766594|Vasodilator Agents|vasodilator agents|mesh-ancestor
101878270|NCT03766594|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101878271|NCT03766594|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101878272|NCT03766594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878273|NCT03766594|Urological Agents|urological agents|mesh-ancestor
101878274|NCT03766594|Hematinics|hematinics|mesh-ancestor
101878275|NCT03766594|Vitamin B Complex|vitamin b complex|mesh-ancestor
101878276|NCT03766594|Vitamins|vitamins|mesh-ancestor
101878277|NCT03766594|Micronutrients|micronutrients|mesh-ancestor
101878278|NCT03766594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878279|NCT00122382|Methotrexate|methotrexate|mesh-list
101878280|NCT00122382|Abatacept|abatacept|mesh-list
101878281|NCT00122382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101878282|NCT00122382|Abortifacient Agents|abortifacient agents|mesh-ancestor
101878283|NCT00122382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101878284|NCT00122382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878285|NCT00122382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101878286|NCT00122382|Antimetabolites|antimetabolites|mesh-ancestor
101598110|NCT02729662|Natriuretic Agents|natriuretic agents|mesh-ancestor
101878287|NCT00122382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878288|NCT00122382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101878289|NCT00122382|Dermatologic Agents|dermatologic agents|mesh-ancestor
101878290|NCT00122382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878291|NCT00122382|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101878292|NCT00122382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101878293|NCT00122382|Immunologic Factors|immunologic factors|mesh-ancestor
101878294|NCT00122382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101878295|NCT00122382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101878296|NCT00122382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101878297|NCT00122382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101878298|NCT01028716|Mycophenolic Acid|mycophenolic acid|mesh-list
101878299|NCT01028716|Cyclophosphamide|cyclophosphamide|mesh-list
101878300|NCT01028716|Fludarabine|fludarabine|mesh-list
101878301|NCT01028716|Fludarabine phosphate|fludarabine phosphate|mesh-list
101878302|NCT01028716|Tacrolimus|tacrolimus|mesh-list
101878303|NCT01028716|Lenograstim|lenograstim|mesh-list
101878304|NCT01028716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101878305|NCT01028716|Immunologic Factors|immunologic factors|mesh-ancestor
101878306|NCT01028716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878307|NCT01028716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101878308|NCT01028716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101878309|NCT01028716|Alkylating Agents|alkylating agents|mesh-ancestor
101878310|NCT01028716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878311|NCT01028716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101878312|NCT01028716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101878313|NCT01028716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101878314|NCT01028716|Antimetabolites|antimetabolites|mesh-ancestor
101878315|NCT01028716|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101878316|NCT01028716|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101878317|NCT01028716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878318|NCT01028716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101878319|NCT01028716|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101967626|NCT01759238|Bevacizumab|bevacizumab|mesh-list
101878320|NCT01028716|Antitubercular Agents|antitubercular agents|mesh-ancestor
101878321|NCT01028716|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101878322|NCT01028716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101878324|NCT02531724|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101878325|NCT02531724|Vasodilator Agents|vasodilator agents|mesh-ancestor
101878326|NCT02531724|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101878327|NCT02531724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101878328|NCT02531724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878329|NCT02531724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878330|NCT02531724|Protective Agents|protective agents|mesh-ancestor
101878331|NCT02531724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878332|NCT03760198|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101878333|NCT03760198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101878334|NCT03760198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101878335|NCT03760198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878336|NCT03760198|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101878337|NCT03760198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101878338|NCT03760198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878339|NCT03760198|Cholinergic Agents|cholinergic agents|mesh-ancestor
101878340|NCT03760198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101878341|NCT00106704|Pioglitazone|pioglitazone|mesh-list
101878342|NCT00106704|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101878343|NCT00106704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101878344|NCT00106704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878345|NCT00106704|Incretins|incretins|mesh-ancestor
101878346|NCT00106704|Hormones|hormones|mesh-ancestor
101878347|NCT00106704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101878348|NCT00106704|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101878349|NCT00106704|Protease Inhibitors|protease inhibitors|mesh-ancestor
101878350|NCT00106704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878351|NCT00106704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878352|NCT03759886|Metronidazole|metronidazole|mesh-list
101878353|NCT03759886|Paromomycin|paromomycin|mesh-list
101878354|NCT03759886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101878355|NCT03759886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101878356|NCT03759886|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101878357|NCT03759886|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101878358|NCT01081158|Ritonavir|ritonavir|mesh-list
101878359|NCT01081158|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101878360|NCT01081158|Interferon-alpha|interferon-alpha|mesh-list
101878361|NCT01081158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101878362|NCT01081158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101878363|NCT01081158|Protease Inhibitors|protease inhibitors|mesh-ancestor
101878364|NCT01081158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878365|NCT01081158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878366|NCT01081158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101878367|NCT01081158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101878368|NCT01081158|Antiviral Agents|antiviral agents|mesh-ancestor
101878369|NCT01081158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101878370|NCT01081158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101878371|NCT01081158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101878372|NCT01081158|Immunologic Factors|immunologic factors|mesh-ancestor
101878373|NCT01081158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878375|NCT00105066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101878376|NCT00105066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878377|NCT01322308|Pioglitazone|pioglitazone|mesh-list
101878378|NCT01322308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101453991|NCT00209300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101878379|NCT01322308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878380|NCT05208268|Rabeprazole|rabeprazole|mesh-list
101878381|NCT05208268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101878382|NCT05208268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101878383|NCT05208268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101878384|NCT05208268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878385|NCT05208268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878386|NCT03165292|Topotecan|topotecan|mesh-list
101878387|NCT03165292|Thiotepa|thiotepa|mesh-list
101878388|NCT03165292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101967632|NCT01759238|Growth Substances|growth substances|mesh-ancestor
101878389|NCT03165292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101878390|NCT03165292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878391|NCT03165292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878392|NCT03165292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101878393|NCT03165292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101878394|NCT03165292|Alkylating Agents|alkylating agents|mesh-ancestor
101878395|NCT03165292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101878396|NCT03165292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101878397|NCT03165292|Immunologic Factors|immunologic factors|mesh-ancestor
101878398|NCT03165292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878399|NCT03759262|Vitamin D|vitamin d|mesh-list
101878400|NCT03759262|Cholecalciferol|cholecalciferol|mesh-list
101878401|NCT03759262|Vitamins|vitamins|mesh-ancestor
101878402|NCT03759262|Micronutrients|micronutrients|mesh-ancestor
101878403|NCT03759262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878404|NCT03759262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101878405|NCT03759262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101878406|NCT00135330|Exenatide|exenatide|mesh-list
101878407|NCT00135330|Rosiglitazone|rosiglitazone|mesh-list
101878408|NCT00135330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101878409|NCT00135330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878410|NCT00135330|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101878411|NCT00135330|Incretins|incretins|mesh-ancestor
101878412|NCT00135330|Hormones|hormones|mesh-ancestor
101878413|NCT00135330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101878414|NCT01076478|Cilostazol|cilostazol|mesh-list
101878415|NCT01076478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101878416|NCT01076478|Autonomic Agents|autonomic agents|mesh-ancestor
101878417|NCT01076478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101878418|NCT01076478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878419|NCT01076478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101878420|NCT01076478|Respiratory System Agents|respiratory system agents|mesh-ancestor
101689014|NCT00649662|Ciprofloxacin|ciprofloxacin|mesh-list
101878421|NCT01076478|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101878422|NCT01076478|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101878423|NCT01076478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878424|NCT01076478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101878425|NCT01076478|Vasodilator Agents|vasodilator agents|mesh-ancestor
101878426|NCT01076478|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101878427|NCT01076478|Protective Agents|protective agents|mesh-ancestor
101878428|NCT01076478|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101878429|NCT01076478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101878430|NCT01076478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878431|NCT01076556|Cyclophosphamide|cyclophosphamide|mesh-list
101878432|NCT01076556|Rituximab|rituximab|mesh-list
101878433|NCT01076556|Alvocidib|alvocidib|mesh-list
101878434|NCT01076556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101598262|NCT00833911|Tramadol|tramadol|mesh-list
101878435|NCT01076556|Antibodies|antibodies|mesh-list
101878436|NCT01076556|Immunoglobulins|immunoglobulins|mesh-list
101878437|NCT01076556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101878438|NCT01076556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101878439|NCT01076556|Immunologic Factors|immunologic factors|mesh-ancestor
101878440|NCT01076556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878441|NCT01076556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101878442|NCT01076556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101878443|NCT01076556|Alkylating Agents|alkylating agents|mesh-ancestor
101878444|NCT01076556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878445|NCT01076556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101878446|NCT01076556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101878447|NCT01076556|Growth Inhibitors|growth inhibitors|mesh-ancestor
101878448|NCT01076556|Growth Substances|growth substances|mesh-ancestor
101878449|NCT01076556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101878450|NCT01076556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878452|NCT03965442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101878453|NCT03965442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101878454|NCT03965442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101878455|NCT03965442|Adrenergic Agents|adrenergic agents|mesh-ancestor
101878456|NCT03965442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101878457|NCT03965442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878458|NCT03965442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878459|NCT00134082|Cyclophosphamide|cyclophosphamide|mesh-list
101878460|NCT00134082|Rituximab|rituximab|mesh-list
101878461|NCT00134082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101878462|NCT00134082|Immunologic Factors|immunologic factors|mesh-ancestor
101878463|NCT00134082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878464|NCT00134082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101878465|NCT00134082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101878466|NCT00134082|Alkylating Agents|alkylating agents|mesh-ancestor
101878467|NCT00134082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878468|NCT00134082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101878469|NCT00134082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101878470|NCT00134082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101878471|NCT03765346|Oxycodone|oxycodone|mesh-list
101878472|NCT03765346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101878473|NCT03765346|Narcotics|narcotics|mesh-ancestor
101878474|NCT03765346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101878475|NCT03765346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878476|NCT03765346|Analgesics|analgesics|mesh-ancestor
101878477|NCT03765346|Sensory System Agents|sensory system agents|mesh-ancestor
101878478|NCT03765346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101878479|NCT01078818|Ferrous fumarate|ferrous fumarate|mesh-list
101878480|NCT01078818|Trace Elements|trace elements|mesh-ancestor
101878481|NCT01078818|Micronutrients|micronutrients|mesh-ancestor
101878482|NCT01078818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878483|NCT01079052|Famotidine|famotidine|mesh-list
101878484|NCT01079052|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101878485|NCT01079052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101878486|NCT01079052|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101878487|NCT01079052|Histamine Antagonists|histamine antagonists|mesh-ancestor
101878488|NCT01079052|Histamine Agents|histamine agents|mesh-ancestor
101878489|NCT01079052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101878490|NCT01079052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878491|NCT01079052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878492|NCT01326468|Sirolimus|sirolimus|mesh-list
101878493|NCT01326468|Cisplatin|cisplatin|mesh-list
101878494|NCT01326468|Cetuximab|cetuximab|mesh-list
101878495|NCT01326468|Temsirolimus|temsirolimus|mesh-list
101878496|NCT01326468|MTOR Inhibitors|mtor inhibitors|mesh-list
101878497|NCT01326468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101878498|NCT01326468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101878499|NCT01326468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101878500|NCT01326468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878501|NCT01326468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878502|NCT01326468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101878503|NCT01326468|Immunologic Factors|immunologic factors|mesh-ancestor
101878504|NCT01326468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878505|NCT01326468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101878506|NCT01326468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101878507|NCT01326468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101878508|NCT01326468|Antifungal Agents|antifungal agents|mesh-ancestor
101878509|NCT01076634|Insulin|insulin|mesh-list
101878510|NCT01076634|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101878511|NCT01076634|Insulin, Long-Acting|insulin, long-acting|mesh-list
101878512|NCT01076634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101878513|NCT01076634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878514|NCT00132678|Risperidone|risperidone|mesh-list
101878515|NCT00132678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101878516|NCT00132678|Serotonin Agents|serotonin agents|mesh-ancestor
101878517|NCT00132678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101878518|NCT00132678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878519|NCT00132678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878520|NCT00132678|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101878521|NCT00132678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101878522|NCT00132678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101878523|NCT00132678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101967639|NCT00835042|Moexipril|moexipril|mesh-list
101878524|NCT00132678|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101878525|NCT00132678|Dopamine Agents|dopamine agents|mesh-ancestor
101878526|NCT01081548|Atorvastatin|atorvastatin|mesh-list
101878527|NCT01081548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101878528|NCT01081548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101878529|NCT01081548|Antimetabolites|antimetabolites|mesh-ancestor
101878530|NCT01081548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878531|NCT01081548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101878532|NCT01081548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101878533|NCT01081548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878534|NCT00101400|Sorafenib|sorafenib|mesh-list
101878535|NCT00101400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101878536|NCT00101400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101878537|NCT00101400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878538|NCT00101400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878539|NCT01076790|Dexmedetomidine|dexmedetomidine|mesh-list
101878540|NCT01076790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101878541|NCT01076790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101878542|NCT01076790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878543|NCT01076790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101878544|NCT01076790|Analgesics|analgesics|mesh-ancestor
101878545|NCT01076790|Sensory System Agents|sensory system agents|mesh-ancestor
101878546|NCT01076790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101878547|NCT01076790|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101878548|NCT01076790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101878549|NCT01076790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101878550|NCT01076790|Adrenergic Agents|adrenergic agents|mesh-ancestor
101878551|NCT01076790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101878552|NCT01076790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878553|NCT01582932|Calcipotriene|calcipotriene|mesh-list
101878554|NCT01582932|Dermatologic Agents|dermatologic agents|mesh-ancestor
101878555|NCT03965286|Sofosbuvir|sofosbuvir|mesh-list
101878556|NCT03965286|Ledipasvir|ledipasvir|mesh-list
101878557|NCT03965286|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
101878558|NCT03965286|Antiviral Agents|antiviral agents|mesh-ancestor
101878559|NCT03965286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101878560|NCT01079286|Sirolimus|sirolimus|mesh-list
101878561|NCT01079286|Nelfinavir|nelfinavir|mesh-list
101878562|NCT01079286|Temsirolimus|temsirolimus|mesh-list
101878563|NCT01079286|MTOR Inhibitors|mtor inhibitors|mesh-list
101878564|NCT01079286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101878565|NCT01079286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878566|NCT01079286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878568|NCT01079286|Immunologic Factors|immunologic factors|mesh-ancestor
101878569|NCT01079286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878570|NCT01079286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101878571|NCT01079286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101878572|NCT01079286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101878573|NCT01079286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101878574|NCT01079286|Antifungal Agents|antifungal agents|mesh-ancestor
101878575|NCT01079286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101878576|NCT01079286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101878577|NCT01079286|Protease Inhibitors|protease inhibitors|mesh-ancestor
101878578|NCT01079286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101878579|NCT01079286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101878580|NCT01079286|Antiviral Agents|antiviral agents|mesh-ancestor
101878581|NCT01081704|Ustekinumab|ustekinumab|mesh-list
101878582|NCT01081704|Dermatologic Agents|dermatologic agents|mesh-ancestor
101878583|NCT00141518|Levodopa|levodopa|mesh-list
101878584|NCT00141518|Carbidopa|carbidopa|mesh-list
101878585|NCT00141518|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101878586|NCT00141518|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101878587|NCT00141518|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101878588|NCT00141518|Dopamine Agents|dopamine agents|mesh-ancestor
101878589|NCT00141518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101878590|NCT00141518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878591|NCT00141518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878592|NCT00141518|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101878593|NCT00141518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878594|NCT00141518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101878595|NCT00141518|Immunologic Factors|immunologic factors|mesh-ancestor
101878596|NCT00141518|Dopamine Agonists|dopamine agonists|mesh-ancestor
101878597|NCT01075880|Interferons|interferons|mesh-list
101878598|NCT01075880|Interferon-beta|interferon-beta|mesh-list
101878599|NCT01075880|Interferon beta-1a|interferon beta-1a|mesh-list
101878600|NCT01075880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101878601|NCT01075880|Antiviral Agents|antiviral agents|mesh-ancestor
101878602|NCT01075880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101878603|NCT01075880|Immunologic Factors|immunologic factors|mesh-ancestor
101878604|NCT01075880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878605|NCT01075880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101878606|NCT00098748|Maraviroc|maraviroc|mesh-list
101878607|NCT00098748|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101878608|NCT00098748|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101878609|NCT00098748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878610|NCT00098748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101878611|NCT00098748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101878612|NCT00098748|Antiviral Agents|antiviral agents|mesh-ancestor
101878613|NCT00098748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101878614|NCT00098748|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101878615|NCT00130520|Bevacizumab|bevacizumab|mesh-list
101878616|NCT00130520|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101878617|NCT00130520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101878618|NCT00130520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101878619|NCT00130520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101878620|NCT00130520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101878621|NCT00130520|Growth Substances|growth substances|mesh-ancestor
101878622|NCT00130520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878623|NCT00130520|Growth Inhibitors|growth inhibitors|mesh-ancestor
101878624|NCT00130520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101878625|NCT00130520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878626|NCT00130520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878627|NCT00130442|Dacarbazine|dacarbazine|mesh-list
101878628|NCT00130442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101878629|NCT00130442|Alkylating Agents|alkylating agents|mesh-ancestor
101878630|NCT00130442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878631|NCT00130442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101878632|NCT00130208|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
101878633|NCT00130208|Anticoagulants|anticoagulants|mesh-ancestor
101878634|NCT00130208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101878635|NCT00130208|Antimetabolites|antimetabolites|mesh-ancestor
101878636|NCT00130208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878637|NCT00130208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101878638|NCT00130208|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101878639|NCT00130208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101878640|NCT00130208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101878641|NCT00130208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878642|NCT00253370|Cisplatin|cisplatin|mesh-list
101878643|NCT00253370|Docetaxel|docetaxel|mesh-list
101878644|NCT00253370|Sorafenib|sorafenib|mesh-list
101878645|NCT00253370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101878646|NCT00253370|Tubulin Modulators|tubulin modulators|mesh-ancestor
101878647|NCT00253370|Antimitotic Agents|antimitotic agents|mesh-ancestor
101878648|NCT00253370|Mitosis Modulators|mitosis modulators|mesh-ancestor
101878649|NCT00253370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878650|NCT00253370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101878651|NCT00253370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878652|NCT03966170|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
101878653|NCT03966170|Nootropic Agents|nootropic agents|mesh-ancestor
101878654|NCT00140426|Risperidone|risperidone|mesh-list
101878655|NCT00140426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101878656|NCT00140426|Serotonin Agents|serotonin agents|mesh-ancestor
101878657|NCT00140426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101878658|NCT00140426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878659|NCT00140426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878660|NCT00140426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101598482|NCT02715232|Cyproterone|cyproterone|mesh-list
101878661|NCT00140426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101878662|NCT00140426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101878663|NCT00140426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101878664|NCT00140426|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101878665|NCT00140426|Dopamine Agents|dopamine agents|mesh-ancestor
101878666|NCT03966560|Timolol|timolol|mesh-list
101878667|NCT03966560|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101878668|NCT03966560|Bimatoprost|bimatoprost|mesh-list
101878669|NCT03966560|Travoprost|travoprost|mesh-list
101878670|NCT03966560|Dorzolamide|dorzolamide|mesh-list
101878671|NCT03966560|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101878672|NCT03966560|Latanoprost|latanoprost|mesh-list
101878673|NCT03966560|Brinzolamide|brinzolamide|mesh-list
101878674|NCT03966560|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101878675|NCT03966560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878676|NCT03966560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878677|NCT03966560|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101878678|NCT03966560|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101878679|NCT03966560|Adrenergic Agents|adrenergic agents|mesh-ancestor
101878680|NCT03966560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101878681|NCT03966560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878682|NCT03966560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101878683|NCT03966560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101878684|NCT03966560|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101878685|NCT03966560|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101878686|NCT03966560|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101878687|NCT03966560|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101878688|NCT01072058|Adalimumab|adalimumab|mesh-list
101878689|NCT01072058|Infliximab|infliximab|mesh-list
101878690|NCT01072058|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
101878691|NCT01072058|Etanercept|etanercept|mesh-list
101878692|NCT01072058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101878693|NCT01072058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101878694|NCT01072058|Dermatologic Agents|dermatologic agents|mesh-ancestor
101878695|NCT01072058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101878696|NCT01072058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101878697|NCT01072058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101878698|NCT01072058|Analgesics|analgesics|mesh-ancestor
101878699|NCT01072058|Sensory System Agents|sensory system agents|mesh-ancestor
101878700|NCT01072058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101878701|NCT01072058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878702|NCT01072058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101878703|NCT01072058|Immunologic Factors|immunologic factors|mesh-ancestor
101878704|NCT00121134|Cyclophosphamide|cyclophosphamide|mesh-list
101878705|NCT00121134|Bevacizumab|bevacizumab|mesh-list
101878706|NCT00121134|Capecitabine|capecitabine|mesh-list
101878707|NCT00121134|Methotrexate|methotrexate|mesh-list
101878708|NCT00121134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101878709|NCT00121134|Immunologic Factors|immunologic factors|mesh-ancestor
101878710|NCT00121134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878711|NCT00121134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101878712|NCT00121134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101878713|NCT00121134|Alkylating Agents|alkylating agents|mesh-ancestor
101878714|NCT00121134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878715|NCT00121134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101878716|NCT00121134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101878717|NCT00121134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101878718|NCT00121134|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101878719|NCT00121134|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101878720|NCT00121134|Growth Substances|growth substances|mesh-ancestor
101878721|NCT00121134|Growth Inhibitors|growth inhibitors|mesh-ancestor
101878722|NCT00121134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101878723|NCT00121134|Antimetabolites|antimetabolites|mesh-ancestor
101878724|NCT00121134|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101878725|NCT00121134|Abortifacient Agents|abortifacient agents|mesh-ancestor
101878726|NCT00121134|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101878727|NCT00121134|Dermatologic Agents|dermatologic agents|mesh-ancestor
101878728|NCT00121134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878729|NCT00121134|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101967660|NCT03070522|Prednisone|prednisone|mesh-list
101878730|NCT00121134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101878731|NCT03966378|Grape Seed Extract|grape seed extract|mesh-list
101878732|NCT03966378|Calcium|calcium|mesh-list
101878733|NCT03966378|Caseins|caseins|mesh-list
101878734|NCT03966378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101598580|NCT00611416|Caffeine|caffeine|mesh-list
101878735|NCT03966378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878736|NCT03966378|Chelating Agents|chelating agents|mesh-ancestor
101878737|NCT03966378|Sequestering Agents|sequestering agents|mesh-ancestor
101878738|NCT03966378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878739|NCT03966378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101878740|NCT03966378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101878742|NCT03966378|Protective Agents|protective agents|mesh-ancestor
101878743|NCT02657434|Carboplatin|carboplatin|mesh-list
101878744|NCT02657434|Pemetrexed|pemetrexed|mesh-list
101878745|NCT02657434|Atezolizumab|atezolizumab|mesh-list
101878746|NCT02657434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101878747|NCT02657434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878748|NCT02657434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878749|NCT02657434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101878750|NCT02657434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101878751|NCT02657434|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101878752|NCT02657434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101878753|NCT02652052|Dasatinib|dasatinib|mesh-list
101878754|NCT02652052|Quercetin|quercetin|mesh-list
101878755|NCT02652052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101878756|NCT02652052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101878758|NCT02652052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878759|NCT02652052|Antioxidants|antioxidants|mesh-ancestor
101878760|NCT02652052|Protective Agents|protective agents|mesh-ancestor
101878761|NCT02652052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878762|NCT00119262|Tamoxifen|tamoxifen|mesh-list
101878763|NCT00119262|Cyclophosphamide|cyclophosphamide|mesh-list
101878764|NCT00119262|Bevacizumab|bevacizumab|mesh-list
101878765|NCT00119262|Doxorubicin|doxorubicin|mesh-list
101878766|NCT00119262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101878767|NCT00119262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101878768|NCT00119262|Antibodies|antibodies|mesh-list
101878769|NCT00119262|Immunoglobulins|immunoglobulins|mesh-list
101878770|NCT00119262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101878771|NCT00119262|Lenograstim|lenograstim|mesh-list
101878772|NCT00119262|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101878773|NCT00119262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101878774|NCT00119262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878775|NCT00119262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101878776|NCT00119262|Immunologic Factors|immunologic factors|mesh-ancestor
101878777|NCT00119262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878778|NCT00119262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101878779|NCT00119262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101878780|NCT00119262|Alkylating Agents|alkylating agents|mesh-ancestor
101878781|NCT00119262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101878782|NCT00119262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101878783|NCT00119262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101878784|NCT00119262|Growth Substances|growth substances|mesh-ancestor
101878785|NCT00119262|Growth Inhibitors|growth inhibitors|mesh-ancestor
101878786|NCT00119262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101878787|NCT00119262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101878788|NCT00119262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101878789|NCT00119262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878790|NCT00119262|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101878791|NCT00119262|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101878792|NCT00119262|Hormone Antagonists|hormone antagonists|mesh-ancestor
101878793|NCT00119262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101878794|NCT00119262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101878795|NCT00119262|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101878796|NCT00119262|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101878797|NCT00119262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101878798|NCT00119262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101878799|NCT00131664|Metformin|metformin|mesh-list
101878800|NCT00131664|Glimepiride|glimepiride|mesh-list
101878801|NCT00131664|Rosiglitazone|rosiglitazone|mesh-list
101878802|NCT00131664|Maleic acid|maleic acid|mesh-list
101878803|NCT00131664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101878804|NCT00131664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878805|NCT00131664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878806|NCT00131664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878807|NCT00131664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101878808|NCT00131664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101878809|NCT00131664|Immunologic Factors|immunologic factors|mesh-ancestor
101878810|NCT05050318|Vaccines|vaccines|mesh-list
101598629|NCT02712502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101878811|NCT05050318|Immunologic Factors|immunologic factors|mesh-ancestor
101878812|NCT05050318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878813|NCT03778996|Sirolimus|sirolimus|mesh-list
101878814|NCT03778996|Phenytoin|phenytoin|mesh-list
101878815|NCT03778996|Methoxsalen|methoxsalen|mesh-list
101878816|NCT03778996|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
101878817|NCT03778996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101878818|NCT03778996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101878819|NCT03778996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101878820|NCT03778996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101878821|NCT03778996|Antifungal Agents|antifungal agents|mesh-ancestor
101878822|NCT03778996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101878823|NCT03778996|Immunologic Factors|immunologic factors|mesh-ancestor
101878824|NCT03778996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878825|NCT03778996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878826|NCT03778996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878827|NCT03778996|Anticonvulsants|anticonvulsants|mesh-ancestor
101878828|NCT03778996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101878829|NCT03778996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101241669|NCT01630083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101878831|NCT03778996|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101878832|NCT03778996|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101878833|NCT03778996|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101878834|NCT03778996|Dermatologic Agents|dermatologic agents|mesh-ancestor
101878835|NCT03764722|Simendan|simendan|mesh-list
101878836|NCT03764722|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101878837|NCT03764722|Vasodilator Agents|vasodilator agents|mesh-ancestor
101878838|NCT03764722|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101878839|NCT03764722|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101878840|NCT03764722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878841|NCT03764722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878842|NCT03764722|Protective Agents|protective agents|mesh-ancestor
101878843|NCT03764722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878844|NCT05024734|Gemcitabine|gemcitabine|mesh-list
101878845|NCT05024734|Docetaxel|docetaxel|mesh-list
101878846|NCT05024734|Epirubicin|epirubicin|mesh-list
101878847|NCT05024734|Mitomycins|mitomycins|mesh-list
101878848|NCT05024734|Mitomycin|mitomycin|mesh-list
101878849|NCT05024734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101878850|NCT05024734|Antimetabolites|antimetabolites|mesh-ancestor
101878851|NCT05024734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878852|NCT05024734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101878853|NCT05024734|Tubulin Modulators|tubulin modulators|mesh-ancestor
101878854|NCT05024734|Antimitotic Agents|antimitotic agents|mesh-ancestor
101878855|NCT05024734|Mitosis Modulators|mitosis modulators|mesh-ancestor
101878856|NCT05024734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101878857|NCT05024734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101878858|NCT05024734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101878859|NCT05024734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878860|NCT05024734|Alkylating Agents|alkylating agents|mesh-ancestor
101878861|NCT05024734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101878862|NCT03699124|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
101878863|NCT03699124|Antiviral Agents|antiviral agents|mesh-ancestor
101878864|NCT03699124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101878865|NCT03756298|Capecitabine|capecitabine|mesh-list
101878866|NCT03756298|Atezolizumab|atezolizumab|mesh-list
101878867|NCT03756298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101878868|NCT03756298|Antimetabolites|antimetabolites|mesh-ancestor
101878869|NCT03756298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878870|NCT03756298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101878871|NCT03756298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101878872|NCT03756298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101878873|NCT03756220|Ascorbic Acid|ascorbic acid|mesh-list
101878874|NCT03756220|Thiamine|thiamine|mesh-list
101878875|NCT03756220|Vitamins|vitamins|mesh-ancestor
101878876|NCT03756220|Micronutrients|micronutrients|mesh-ancestor
101878877|NCT03756220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878878|NCT03756220|Antioxidants|antioxidants|mesh-ancestor
101878879|NCT03756220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878880|NCT03756220|Protective Agents|protective agents|mesh-ancestor
101878881|NCT03756220|Vitamin B Complex|vitamin b complex|mesh-ancestor
101878882|NCT04980040|Alogliptin|alogliptin|mesh-list
101878883|NCT04980040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101878884|NCT04980040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878885|NCT04980040|Incretins|incretins|mesh-ancestor
101878886|NCT04980040|Hormones|hormones|mesh-ancestor
101878887|NCT04980040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101878888|NCT04980040|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101878889|NCT04980040|Protease Inhibitors|protease inhibitors|mesh-ancestor
101878890|NCT04980040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878891|NCT04980040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878893|NCT00131352|Viscosupplements|viscosupplements|mesh-ancestor
101878894|NCT00131352|Protective Agents|protective agents|mesh-ancestor
101878895|NCT00131352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878896|NCT00136916|Insulin|insulin|mesh-list
101878897|NCT00136916|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101878898|NCT00136916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101878899|NCT00136916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878900|NCT04633564|Bevacizumab|bevacizumab|mesh-list
101878901|NCT04633564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101878902|NCT04633564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101878903|NCT04633564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101878904|NCT04633564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101878905|NCT04633564|Growth Substances|growth substances|mesh-ancestor
101878906|NCT04633564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878907|NCT04633564|Growth Inhibitors|growth inhibitors|mesh-ancestor
101878908|NCT03756064|Carboplatin|carboplatin|mesh-list
101878909|NCT03756064|Docetaxel|docetaxel|mesh-list
101878910|NCT03756064|Trastuzumab|trastuzumab|mesh-list
101878911|NCT03756064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101878912|NCT03756064|Tubulin Modulators|tubulin modulators|mesh-ancestor
101878913|NCT03756064|Antimitotic Agents|antimitotic agents|mesh-ancestor
101878914|NCT03756064|Mitosis Modulators|mitosis modulators|mesh-ancestor
101878915|NCT03756064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878916|NCT03756064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101878917|NCT04607980|Ustekinumab|ustekinumab|mesh-list
101878918|NCT04607980|Dermatologic Agents|dermatologic agents|mesh-ancestor
101878919|NCT03764020|Melatonin|melatonin|mesh-list
101878920|NCT03764020|Antioxidants|antioxidants|mesh-ancestor
101878921|NCT03764020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878922|NCT03764020|Protective Agents|protective agents|mesh-ancestor
101878923|NCT03764020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878924|NCT03764020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101878925|NCT00135512|Bupropion|bupropion|mesh-list
101878926|NCT00135512|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101878927|NCT00135512|Antidepressive Agents|antidepressive agents|mesh-ancestor
101878928|NCT00135512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101878929|NCT00135512|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101878930|NCT00135512|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101878931|NCT00135512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101878932|NCT00135512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878933|NCT00135512|Dopamine Agents|dopamine agents|mesh-ancestor
101878934|NCT00135512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101878935|NCT00135512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878936|NCT00135512|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101878937|NCT00135512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101878938|NCT00135512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878939|NCT00130728|Bevacizumab|bevacizumab|mesh-list
101878940|NCT00130728|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101878941|NCT00130728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101878942|NCT00130728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101878943|NCT00130728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101878944|NCT00130728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101878945|NCT00130728|Growth Substances|growth substances|mesh-ancestor
101878946|NCT00130728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878947|NCT00130728|Growth Inhibitors|growth inhibitors|mesh-ancestor
101878948|NCT00130728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101878949|NCT00130728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878950|NCT00130728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878951|NCT00129974|Gemcitabine|gemcitabine|mesh-list
101878952|NCT00129974|Pemetrexed|pemetrexed|mesh-list
101878953|NCT00129974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101878954|NCT00129974|Antimetabolites|antimetabolites|mesh-ancestor
101878955|NCT00129974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878956|NCT00129974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101878957|NCT00129974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878958|NCT00129974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101878959|NCT00129974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101878960|NCT03966326|Fentanyl|fentanyl|mesh-list
101598776|NCT02708992|Cefixime|cefixime|mesh-list
101878961|NCT03966326|Anesthetics|anesthetics|mesh-list
101878962|NCT03966326|Sevoflurane|sevoflurane|mesh-list
101878963|NCT03966326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101878964|NCT03966326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101878965|NCT03966326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101878966|NCT03966326|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101878967|NCT03966326|Anesthetics, General|anesthetics, general|mesh-ancestor
101878968|NCT03966326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101878969|NCT03966326|Narcotics|narcotics|mesh-ancestor
101878970|NCT03966326|Analgesics|analgesics|mesh-ancestor
101878971|NCT03966326|Sensory System Agents|sensory system agents|mesh-ancestor
101878972|NCT03966326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101878973|NCT03966326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101878974|NCT03966326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101878975|NCT00119106|Tenofovir|tenofovir|mesh-list
101878976|NCT00119106|Antiviral Agents|antiviral agents|mesh-ancestor
101878977|NCT00119106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101878978|NCT00119106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101878979|NCT00119106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101878980|NCT00119106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878981|NCT00119106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878982|NCT00119106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101878983|NCT00119106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101878984|NCT03758014|Lomustine|lomustine|mesh-list
101878985|NCT03758014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101878986|NCT03758014|Alkylating Agents|alkylating agents|mesh-ancestor
101878987|NCT03758014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878988|NCT03758014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101878989|NCT00135356|Ritonavir|ritonavir|mesh-list
101878990|NCT00135356|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101878991|NCT00135356|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
101878992|NCT00135356|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
101878993|NCT00135356|Protease Inhibitors|protease inhibitors|mesh-list
101878994|NCT00135356|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101878995|NCT00135356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101878996|NCT00135356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101878997|NCT00135356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101878998|NCT00135356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101878999|NCT00135356|Antiviral Agents|antiviral agents|mesh-ancestor
101879000|NCT00135356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101879001|NCT00135356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101879002|NCT00135356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101879003|NCT00135356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101879005|NCT00118716|Xhance|xhance|mesh-list
101879006|NCT00118716|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101879007|NCT00118716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101879008|NCT00118716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101879009|NCT00118716|Autonomic Agents|autonomic agents|mesh-ancestor
101879010|NCT00118716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101879011|NCT00118716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879012|NCT00118716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101879013|NCT00118716|Respiratory System Agents|respiratory system agents|mesh-ancestor
101879014|NCT00118716|Dermatologic Agents|dermatologic agents|mesh-ancestor
101879015|NCT00118716|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101879016|NCT00118716|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101879017|NCT00118716|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101879018|NCT00118716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101879019|NCT00118716|Adrenergic Agents|adrenergic agents|mesh-ancestor
101879020|NCT00118716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101879021|NCT00118716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879022|NCT00118482|Fludrocortisone|fludrocortisone|mesh-list
101879023|NCT00118482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101879024|NCT03966950|Melatonin|melatonin|mesh-list
101879025|NCT03966950|Antioxidants|antioxidants|mesh-ancestor
101879026|NCT03966950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879027|NCT03966950|Protective Agents|protective agents|mesh-ancestor
101879028|NCT03966950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879029|NCT03966950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101879030|NCT03755752|Diminazene aceturate|diminazene aceturate|mesh-list
101879031|NCT03755752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101879032|NCT03755752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101879033|NCT03755752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101879034|NCT03755752|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101879035|NCT01076582|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101879036|NCT01076582|Desogestrel|desogestrel|mesh-list
101879037|NCT01076582|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101879038|NCT01076582|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101879039|NCT01076582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101879040|NCT01076582|Contraceptive Agents|contraceptive agents|mesh-ancestor
101879041|NCT01076582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101879042|NCT01076582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879043|NCT01076582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101879044|NCT01076582|Estrogens|estrogens|mesh-ancestor
101879045|NCT01076582|Hormones|hormones|mesh-ancestor
101879046|NCT01076582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101879047|NCT01076582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101879048|NCT01076582|Progestins|progestins|mesh-ancestor
101879049|NCT01081938|Insulin|insulin|mesh-list
101879050|NCT01081938|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101879051|NCT01081938|Insulin Glargine|insulin glargine|mesh-list
101879052|NCT01081938|Insulin glulisine|insulin glulisine|mesh-list
101879053|NCT01081938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101879054|NCT01081938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879055|NCT01082796|Glipizide|glipizide|mesh-list
101879056|NCT01082796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101879057|NCT01082796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879058|NCT03763786|Cetrorelix|cetrorelix|mesh-list
101879059|NCT03763786|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101879060|NCT03763786|Fertility Agents|fertility agents|mesh-ancestor
101879061|NCT03763786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101879062|NCT03763786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879063|NCT03763786|Hormone Antagonists|hormone antagonists|mesh-ancestor
101879064|NCT03763786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101879065|NCT01079364|Insulin|insulin|mesh-list
101879066|NCT01079364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101879067|NCT01079364|Insulin Glargine|insulin glargine|mesh-list
101879068|NCT01079364|Insulin Aspart|insulin aspart|mesh-list
101879069|NCT01079364|Insulin glulisine|insulin glulisine|mesh-list
101879070|NCT01079364|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101879071|NCT01079364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101879072|NCT01079364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879073|NCT01077752|Acetaminophen|acetaminophen|mesh-list
101879074|NCT01077752|Lidocaine|lidocaine|mesh-list
101879075|NCT01077752|Morphine|morphine|mesh-list
101879076|NCT01077752|Ropivacaine|ropivacaine|mesh-list
101879077|NCT01077752|Anesthetics, Local|anesthetics, local|mesh-ancestor
101879078|NCT01077752|Anesthetics|anesthetics|mesh-ancestor
101879079|NCT01077752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101879080|NCT01077752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879081|NCT01077752|Sensory System Agents|sensory system agents|mesh-ancestor
101879082|NCT01077752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101879083|NCT01077752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101879084|NCT01077752|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101879085|NCT01077752|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101879086|NCT01077752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101879087|NCT01077752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879088|NCT01077752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101879089|NCT01077752|Narcotics|narcotics|mesh-ancestor
101879090|NCT01077752|Analgesics|analgesics|mesh-ancestor
101879091|NCT01077752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101879092|NCT01077752|Antipyretics|antipyretics|mesh-ancestor
101879093|NCT00129272|Bupropion|bupropion|mesh-list
101879094|NCT00129272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101879095|NCT00129272|Antidepressive Agents|antidepressive agents|mesh-ancestor
101879096|NCT00129272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101879097|NCT00129272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101879098|NCT00129272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101879099|NCT00129272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101879100|NCT00129272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879101|NCT00129272|Dopamine Agents|dopamine agents|mesh-ancestor
101879102|NCT00129272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101879103|NCT00129272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879104|NCT00129272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101879105|NCT00129272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101879106|NCT00129272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101879107|NCT01326338|Nitazoxanide|nitazoxanide|mesh-list
101879108|NCT01326338|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101879109|NCT01326338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101879110|NCT03963648|Nitric Oxide|nitric oxide|mesh-list
101879111|NCT03963648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101879112|NCT03963648|Autonomic Agents|autonomic agents|mesh-ancestor
101879113|NCT03963648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101879114|NCT03963648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879115|NCT03963648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101879116|NCT03963648|Respiratory System Agents|respiratory system agents|mesh-ancestor
101879117|NCT03963648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101879119|NCT03963648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879120|NCT03963648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101879121|NCT03963648|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101879122|NCT03963648|Vasodilator Agents|vasodilator agents|mesh-ancestor
101879124|NCT03963648|Protective Agents|protective agents|mesh-ancestor
101879125|NCT04899232|Antithrombins|antithrombins|mesh-list
101879126|NCT04899232|Antithrombin III|antithrombin iii|mesh-list
101879127|NCT04899232|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101879128|NCT04899232|Protease Inhibitors|protease inhibitors|mesh-ancestor
101879129|NCT04899232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101879130|NCT04899232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879131|NCT04899232|Anticoagulants|anticoagulants|mesh-ancestor
101879132|NCT03757858|Antibodies|antibodies|mesh-list
101879133|NCT03757858|Immunologic Factors|immunologic factors|mesh-ancestor
101879134|NCT03757858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879135|NCT01079676|Lenograstim|lenograstim|mesh-list
101879136|NCT01079676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101879137|NCT01079676|Immunologic Factors|immunologic factors|mesh-ancestor
101879138|NCT01079676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101967699|NCT00679588|Enoxaparin|enoxaparin|mesh-list
101879139|NCT01082250|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
101879140|NCT01082250|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101879141|NCT01082250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101879142|NCT01082250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101879143|NCT01082250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879144|NCT01082250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101879145|NCT01082250|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101879146|NCT01082250|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101879147|NCT01082250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101879148|NCT01082250|Adrenergic Agents|adrenergic agents|mesh-ancestor
101879149|NCT01082250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101879150|NCT01082250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879151|NCT01082250|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101879152|NCT01082250|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101879153|NCT01082250|Serotonin Agents|serotonin agents|mesh-ancestor
101879154|NCT01082250|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101879155|NCT01082250|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101879156|NCT01082250|Dopamine Agents|dopamine agents|mesh-ancestor
101879157|NCT00133952|Ruboxistaurin|ruboxistaurin|mesh-list
101879158|NCT00133952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101879159|NCT00133952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879160|NCT04555096|Avasopasem manganese|avasopasem manganese|mesh-list
101879161|NCT04555096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101879162|NCT04555096|Antioxidants|antioxidants|mesh-ancestor
101879163|NCT04555096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879164|NCT04555096|Protective Agents|protective agents|mesh-ancestor
101879165|NCT04555096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879166|NCT00097500|Metformin|metformin|mesh-list
101879167|NCT00097500|Insulin Glargine|insulin glargine|mesh-list
101879168|NCT00097500|Exenatide|exenatide|mesh-list
101879169|NCT00097500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101879170|NCT00097500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879171|NCT00097500|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101879172|NCT00097500|Incretins|incretins|mesh-ancestor
101879173|NCT00097500|Hormones|hormones|mesh-ancestor
101879174|NCT00097500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101879175|NCT01082484|Treprostinil|treprostinil|mesh-list
101879176|NCT01082484|Iloprost|iloprost|mesh-list
101879177|NCT01082484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101879178|NCT01082484|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101879179|NCT01082484|Vasodilator Agents|vasodilator agents|mesh-ancestor
101879180|NCT05459974|Colchicine|colchicine|mesh-list
101879181|NCT05459974|Gout Suppressants|gout suppressants|mesh-ancestor
101879182|NCT05459974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101879183|NCT05459974|Tubulin Modulators|tubulin modulators|mesh-ancestor
101879184|NCT05459974|Antimitotic Agents|antimitotic agents|mesh-ancestor
101879185|NCT05459974|Mitosis Modulators|mitosis modulators|mesh-ancestor
101879186|NCT05459974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879187|NCT05459974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101879188|NCT03754816|Anesthetics|anesthetics|mesh-list
101879189|NCT03754816|Levobupivacaine|levobupivacaine|mesh-list
101879190|NCT03754816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101879191|NCT03754816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879192|NCT03754816|Anesthetics, Local|anesthetics, local|mesh-ancestor
101879193|NCT03754816|Sensory System Agents|sensory system agents|mesh-ancestor
101879194|NCT03754816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101879195|NCT04542694|Favipiravir|favipiravir|mesh-list
101879196|NCT04542694|Antiviral Agents|antiviral agents|mesh-ancestor
101879197|NCT04542694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101879198|NCT03965208|Heparin|heparin|mesh-list
101879199|NCT03965208|Calcium heparin|calcium heparin|mesh-list
101879200|NCT03965208|Bivalirudin|bivalirudin|mesh-list
101879201|NCT03965208|Anticoagulants|anticoagulants|mesh-ancestor
101879202|NCT03965208|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101879203|NCT03965208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101879204|NCT03965208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879205|NCT03965208|Antithrombins|antithrombins|mesh-ancestor
101879206|NCT03965208|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101879207|NCT03965208|Protease Inhibitors|protease inhibitors|mesh-ancestor
101879208|NCT03965208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101879209|NCT01083264|Gestodene|gestodene|mesh-list
101454220|NCT01089790|Incretins|incretins|mesh-ancestor
101879210|NCT01083264|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101879211|NCT01083264|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101879212|NCT01083264|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101879213|NCT01083264|Contraceptive Agents|contraceptive agents|mesh-ancestor
101879214|NCT01083264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101879215|NCT01083264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879216|NCT01083264|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101879217|NCT01083264|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101879218|NCT01083264|Progestins|progestins|mesh-ancestor
101879219|NCT01083264|Hormones|hormones|mesh-ancestor
101879220|NCT01083264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101879221|NCT00129116|Vaccines|vaccines|mesh-list
101879222|NCT00129116|Immunologic Factors|immunologic factors|mesh-ancestor
101879223|NCT00129116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879224|NCT00117156|Rituximab|rituximab|mesh-list
101879225|NCT00117156|Fludarabine|fludarabine|mesh-list
101879226|NCT00117156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101879227|NCT00117156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101879228|NCT00117156|Immunologic Factors|immunologic factors|mesh-ancestor
101879229|NCT00117156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879230|NCT00117156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101879231|NCT01083420|Minocycline|minocycline|mesh-list
101879232|NCT01083420|Dexamethasone|dexamethasone|mesh-list
101879233|NCT01083420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101879234|NCT01083420|Antiemetics|antiemetics|mesh-ancestor
101879235|NCT01083420|Autonomic Agents|autonomic agents|mesh-ancestor
101879236|NCT01083420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101879237|NCT01083420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879238|NCT01083420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101879239|NCT01083420|Glucocorticoids|glucocorticoids|mesh-ancestor
101879240|NCT01083420|Hormones|hormones|mesh-ancestor
101879241|NCT01083420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101879242|NCT01083420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101879243|NCT01083420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101879244|NCT01083420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101879245|NCT01083420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101879246|NCT00096954|Omalizumab|omalizumab|mesh-list
101879247|NCT00096954|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101879248|NCT00096954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101879249|NCT00096954|Respiratory System Agents|respiratory system agents|mesh-ancestor
101879250|NCT00096486|Everolimus|everolimus|mesh-list
101879251|NCT00096486|Gefitinib|gefitinib|mesh-list
101879252|NCT00096486|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101879253|NCT00096486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101879254|NCT00096486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101879255|NCT00096486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879256|NCT00096486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101879257|NCT00096486|Immunologic Factors|immunologic factors|mesh-ancestor
101879258|NCT00096486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879259|NCT00096486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101879261|NCT00116844|Antiviral Agents|antiviral agents|mesh-ancestor
101879262|NCT00116844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101879263|NCT03963336|Acetazolamide|acetazolamide|mesh-list
101879264|NCT03963336|Anticonvulsants|anticonvulsants|mesh-ancestor
101879265|NCT03963336|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101879266|NCT03963336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101879267|NCT03963336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879268|NCT03963336|Diuretics|diuretics|mesh-ancestor
101879269|NCT03963336|Natriuretic Agents|natriuretic agents|mesh-ancestor
101879270|NCT03963336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879271|NCT00132314|Risperidone|risperidone|mesh-list
101454238|NCT01084330|Docetaxel|docetaxel|mesh-list
101879272|NCT00132314|Antipsychotic Agents|antipsychotic agents|mesh-list
101879273|NCT00132314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101879274|NCT00132314|Serotonin Agents|serotonin agents|mesh-ancestor
101879275|NCT00132314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101967716|NCT00151996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101879276|NCT00132314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879277|NCT00132314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879278|NCT00132314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101879279|NCT00132314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101879280|NCT00132314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101879281|NCT00132314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101879282|NCT00132314|Dopamine Agents|dopamine agents|mesh-ancestor
101879283|NCT04539262|Remdesivir|remdesivir|mesh-list
101879284|NCT04539262|Antimetabolites|antimetabolites|mesh-ancestor
101879285|NCT04539262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879286|NCT04539262|Antiviral Agents|antiviral agents|mesh-ancestor
101879287|NCT04539262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101879288|NCT04537234|Vaccines|vaccines|mesh-list
101879289|NCT04537234|Immunologic Factors|immunologic factors|mesh-ancestor
101879290|NCT04537234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879291|NCT04537078|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101879292|NCT04537078|Contraceptive Agents|contraceptive agents|mesh-list
101879293|NCT04537078|Contraceptives, Oral|contraceptives, oral|mesh-list
101879294|NCT04537078|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101879295|NCT04537078|Cetrorelix|cetrorelix|mesh-list
101879296|NCT04537078|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
101879297|NCT04537078|Progesterone|progesterone|mesh-list
101879298|NCT04537078|Dydrogesterone|dydrogesterone|mesh-list
101879299|NCT04537078|Estradiol|estradiol|mesh-list
101879300|NCT04537078|Progestins|progestins|mesh-ancestor
101879301|NCT04537078|Hormones|hormones|mesh-ancestor
101879302|NCT04537078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101879303|NCT04537078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879304|NCT04537078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101879305|NCT04537078|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101879306|NCT04537078|Luteolytic Agents|luteolytic agents|mesh-ancestor
101879307|NCT04537078|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101879308|NCT04537078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101879309|NCT04537078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101879310|NCT04537078|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101879311|NCT04537078|Fertility Agents|fertility agents|mesh-ancestor
101879312|NCT04537078|Hormone Antagonists|hormone antagonists|mesh-ancestor
101879313|NCT04537078|Estrogens|estrogens|mesh-ancestor
101879314|NCT04532164|Antifungal Agents|antifungal agents|mesh-list
101879315|NCT04532164|Clotrimazole|clotrimazole|mesh-list
101879316|NCT04532164|Miconazole|miconazole|mesh-list
101879317|NCT04532164|Butenafine|butenafine|mesh-list
101879318|NCT04532164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101879319|NCT04532164|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101879320|NCT04532164|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101879321|NCT04532164|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101879322|NCT04532164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101879323|NCT04532164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879324|NCT04532164|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101879325|NCT04532164|Hormone Antagonists|hormone antagonists|mesh-ancestor
101879326|NCT04532164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101879327|NCT04532164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879328|NCT04532164|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101879329|NCT04532164|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101879330|NCT04531540|Butenafine|butenafine|mesh-list
101879331|NCT04531540|Antifungal Agents|antifungal agents|mesh-ancestor
101879332|NCT04531540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101879333|NCT04799782|Mirtazapine|mirtazapine|mesh-list
101879334|NCT04799782|Antidepressive Agents|antidepressive agents|mesh-ancestor
101879335|NCT04799782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101879336|NCT04799782|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101879337|NCT04799782|Histamine Antagonists|histamine antagonists|mesh-ancestor
101879338|NCT04799782|Histamine Agents|histamine agents|mesh-ancestor
101879339|NCT04799782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101879340|NCT04799782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879341|NCT04799782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879342|NCT04799782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101879343|NCT04799782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101879344|NCT04799782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101879345|NCT04799782|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101879346|NCT04799782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101879347|NCT04799782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101879349|NCT04799782|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101879350|NCT04799782|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101879351|NCT04799782|Serotonin Agents|serotonin agents|mesh-ancestor
101879352|NCT04799782|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101879353|NCT04790812|Acetaminophen|acetaminophen|mesh-list
101879355|NCT04790812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101879356|NCT04790812|Analgesics|analgesics|mesh-ancestor
101879357|NCT04790812|Sensory System Agents|sensory system agents|mesh-ancestor
101879358|NCT04790812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101879359|NCT04790812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879360|NCT04790812|Antipyretics|antipyretics|mesh-ancestor
101879361|NCT04790812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101879362|NCT04790812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101879363|NCT04790812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101879364|NCT04790812|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101879365|NCT04790812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101879366|NCT04790812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101879367|NCT04790812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879368|NCT03697252|Xanomeline|xanomeline|mesh-list
101879369|NCT03697252|Trospium chloride|trospium chloride|mesh-list
101879370|NCT03697252|Parasympatholytics|parasympatholytics|mesh-ancestor
101879371|NCT03697252|Autonomic Agents|autonomic agents|mesh-ancestor
101879372|NCT03697252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101879373|NCT03697252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879374|NCT03697252|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101879375|NCT03697252|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101879376|NCT03697252|Cholinergic Agents|cholinergic agents|mesh-ancestor
101879377|NCT03697252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101879378|NCT03697252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879379|NCT03697252|Urological Agents|urological agents|mesh-ancestor
101879380|NCT03697252|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101879381|NCT03697252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101879382|NCT03697252|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101879383|NCT03697252|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101879384|NCT03701074|Acetaminophen|acetaminophen|mesh-list
101879385|NCT03701074|Ibuprofen|ibuprofen|mesh-list
101879386|NCT03701074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101879387|NCT03701074|Analgesics|analgesics|mesh-ancestor
101879388|NCT03701074|Sensory System Agents|sensory system agents|mesh-ancestor
101879389|NCT03701074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101879390|NCT03701074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879391|NCT03701074|Antipyretics|antipyretics|mesh-ancestor
101879392|NCT03701074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101879393|NCT03701074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101879394|NCT03701074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101879395|NCT03701074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101879396|NCT03701074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101879397|NCT03701074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879398|NCT03757390|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
101879399|NCT03757390|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101879400|NCT03757390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101879401|NCT03757390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101879402|NCT03757390|Antimetabolites|antimetabolites|mesh-ancestor
101879403|NCT03757390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879404|NCT03757390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101879405|NCT03757390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101879406|NCT03757390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101879407|NCT03757390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101879408|NCT03757156|Aspirin|aspirin|mesh-list
101879409|NCT03757156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101879410|NCT03757156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101879411|NCT03757156|Analgesics|analgesics|mesh-ancestor
101879412|NCT03757156|Sensory System Agents|sensory system agents|mesh-ancestor
101599231|NCT00607035|Olmesartan|olmesartan|mesh-list
101879413|NCT03757156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101879414|NCT03757156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879415|NCT03757156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101879416|NCT03757156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101967729|NCT00829504|Ropinirole|ropinirole|mesh-list
101879417|NCT03757156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101879418|NCT03757156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101879419|NCT03757156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879420|NCT03757156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101879421|NCT03757156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101879422|NCT03757156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101879424|NCT03750916|Docetaxel|docetaxel|mesh-list
101879425|NCT03750916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101879426|NCT03750916|Tubulin Modulators|tubulin modulators|mesh-ancestor
101879427|NCT03750916|Antimitotic Agents|antimitotic agents|mesh-ancestor
101879428|NCT03750916|Mitosis Modulators|mitosis modulators|mesh-ancestor
101879429|NCT03750916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879430|NCT05322148|Loteprednol Etabonate|loteprednol etabonate|mesh-list
101879431|NCT05322148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101879432|NCT03750760|Atorvastatin|atorvastatin|mesh-list
101879433|NCT03750760|Ezetimibe|ezetimibe|mesh-list
101879434|NCT03750760|Alirocumab|alirocumab|mesh-list
101879435|NCT03750760|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101879436|NCT03750760|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101879437|NCT03750760|Antimetabolites|antimetabolites|mesh-ancestor
101879438|NCT03750760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879439|NCT03750760|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101879440|NCT03750760|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101879441|NCT03750760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101879442|NCT03750760|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101879443|NCT03750760|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101879444|NCT03750760|Protease Inhibitors|protease inhibitors|mesh-ancestor
101879445|NCT01076894|Anesthetics|anesthetics|mesh-list
101879446|NCT01076894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101879447|NCT01076894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879448|NCT00130832|Vaccines|vaccines|mesh-list
101879449|NCT00130832|Immunologic Factors|immunologic factors|mesh-ancestor
101879450|NCT00130832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879451|NCT00096018|Thalidomide|thalidomide|mesh-list
101879452|NCT00096018|Fludarabine|fludarabine|mesh-list
101879453|NCT00096018|Fludarabine phosphate|fludarabine phosphate|mesh-list
101879454|NCT00096018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101879455|NCT00096018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101879456|NCT00096018|Antimetabolites|antimetabolites|mesh-ancestor
101879457|NCT00096018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879458|NCT00096018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101879459|NCT00096018|Immunologic Factors|immunologic factors|mesh-ancestor
101879460|NCT00096018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879461|NCT00096018|Leprostatic Agents|leprostatic agents|mesh-ancestor
101879462|NCT00096018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101879463|NCT00096018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101879464|NCT00096018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101879465|NCT00096018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101879466|NCT00096018|Growth Substances|growth substances|mesh-ancestor
101879467|NCT00096018|Growth Inhibitors|growth inhibitors|mesh-ancestor
101879468|NCT01079754|Morphine|morphine|mesh-list
101879469|NCT01079754|Analgesics, Opioid|analgesics, opioid|mesh-list
101879470|NCT01079754|Narcotics|narcotics|mesh-ancestor
101879471|NCT01079754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101879472|NCT01079754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879473|NCT01079754|Analgesics|analgesics|mesh-ancestor
101879474|NCT01079754|Sensory System Agents|sensory system agents|mesh-ancestor
101879475|NCT01079754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101879476|NCT04701658|Bamlanivimab|bamlanivimab|mesh-list
101879477|NCT04701658|Antiviral Agents|antiviral agents|mesh-ancestor
101879478|NCT04701658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101879479|NCT01322776|Cyclophosphamide|cyclophosphamide|mesh-list
101879480|NCT01322776|Fludarabine|fludarabine|mesh-list
101879481|NCT01322776|Bortezomib|bortezomib|mesh-list
101879482|NCT01322776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101879483|NCT01322776|Immunologic Factors|immunologic factors|mesh-ancestor
101879484|NCT01322776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879485|NCT01322776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101879486|NCT01322776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101879487|NCT01322776|Alkylating Agents|alkylating agents|mesh-ancestor
101879488|NCT01322776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879489|NCT01322776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101879490|NCT01322776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101879492|NCT00128102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101879493|NCT00128102|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101879495|NCT00128102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879496|NCT03965858|Esketamine|esketamine|mesh-list
101879497|NCT03965858|Antidepressive Agents|antidepressive agents|mesh-ancestor
101879498|NCT03965858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101879499|NCT04668274|Resveratrol|resveratrol|mesh-list
101879500|NCT04668274|Antioxidants|antioxidants|mesh-ancestor
101879501|NCT04668274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879502|NCT04668274|Protective Agents|protective agents|mesh-ancestor
101879503|NCT04668274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879504|NCT04668274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101879505|NCT04668274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101879506|NCT01077908|Antiviral Agents|antiviral agents|mesh-list
101879507|NCT01077908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101879508|NCT04406194|Favipiravir|favipiravir|mesh-list
101879509|NCT04406194|Antiviral Agents|antiviral agents|mesh-ancestor
101879510|NCT04406194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101879511|NCT03822884|Epoetin Alfa|epoetin alfa|mesh-list
101879512|NCT03822884|Hematinics|hematinics|mesh-ancestor
101879513|NCT03822416|Nicotine|nicotine|mesh-list
101879514|NCT03822416|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101879515|NCT03822416|Autonomic Agents|autonomic agents|mesh-ancestor
101879516|NCT03822416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101879517|NCT03822416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879518|NCT03822416|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101879519|NCT03822416|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101879520|NCT03822416|Cholinergic Agents|cholinergic agents|mesh-ancestor
101879521|NCT03822416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101879522|NCT03822416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879523|NCT04405570|Molnupiravir|molnupiravir|mesh-list
101879524|NCT04405570|Antiviral Agents|antiviral agents|mesh-ancestor
101879525|NCT04405570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101879526|NCT00127712|Amiodarone|amiodarone|mesh-list
101879527|NCT00127712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101879528|NCT00127712|Vasodilator Agents|vasodilator agents|mesh-ancestor
101879529|NCT00127712|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101879530|NCT00127712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101879531|NCT00127712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879532|NCT00127712|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101879533|NCT00127712|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101879534|NCT00127712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101879535|NCT00127712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101879536|NCT00127712|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101879537|NCT00127712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101879538|NCT00127712|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101879539|NCT01082744|Sufentanil|sufentanil|mesh-list
101879540|NCT01082744|Ropivacaine|ropivacaine|mesh-list
101879541|NCT01082744|Anesthetics, Local|anesthetics, local|mesh-ancestor
101879542|NCT01082744|Anesthetics|anesthetics|mesh-ancestor
101879543|NCT01082744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101879544|NCT01082744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879545|NCT01082744|Sensory System Agents|sensory system agents|mesh-ancestor
101879546|NCT01082744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101879547|NCT01082744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101879548|NCT01082744|Narcotics|narcotics|mesh-ancestor
101879549|NCT01082744|Analgesics|analgesics|mesh-ancestor
101879550|NCT01082744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101879551|NCT01082744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101879552|NCT01082744|Anesthetics, General|anesthetics, general|mesh-ancestor
101879553|NCT00096356|Vitamins|vitamins|mesh-list
101879554|NCT00096356|Vitamin E|vitamin e|mesh-list
101879555|NCT00096356|Tocopherols|tocopherols|mesh-list
101879556|NCT00096356|Tocotrienols|tocotrienols|mesh-list
101879557|NCT00096356|alpha-Tocopherol|alpha-tocopherol|mesh-list
101879558|NCT00096356|Micronutrients|micronutrients|mesh-ancestor
101879559|NCT00096356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879560|NCT00096356|Antioxidants|antioxidants|mesh-ancestor
101967737|NCT00829426|Alprazolam|alprazolam|mesh-list
101879561|NCT00096356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879562|NCT00096356|Protective Agents|protective agents|mesh-ancestor
101879563|NCT03749590|Magnesium Sulfate|magnesium sulfate|mesh-list
101879564|NCT03749590|Analgesics|analgesics|mesh-ancestor
101599373|NCT04862962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101879565|NCT03749590|Sensory System Agents|sensory system agents|mesh-ancestor
101879566|NCT03749590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101879567|NCT03749590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879568|NCT03749590|Anesthetics|anesthetics|mesh-ancestor
101879569|NCT03749590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101879570|NCT03749590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101879571|NCT03749590|Anticonvulsants|anticonvulsants|mesh-ancestor
101879572|NCT03749590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101879573|NCT03749590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101879574|NCT03749590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879575|NCT03749590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101879576|NCT03749590|Tocolytic Agents|tocolytic agents|mesh-ancestor
101879577|NCT03749590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101879578|NCT01076816|Dexmedetomidine|dexmedetomidine|mesh-list
101879579|NCT01076816|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101879580|NCT01076816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101879581|NCT01076816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879582|NCT01076816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101879583|NCT01076816|Analgesics|analgesics|mesh-ancestor
101879584|NCT01076816|Sensory System Agents|sensory system agents|mesh-ancestor
101879585|NCT01076816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101879586|NCT01076816|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101879587|NCT01076816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101879588|NCT01076816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101879589|NCT01076816|Adrenergic Agents|adrenergic agents|mesh-ancestor
101879590|NCT01076816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101879591|NCT01076816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879592|NCT03749356|Tacrolimus|tacrolimus|mesh-list
101879593|NCT03749356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101879594|NCT03749356|Immunologic Factors|immunologic factors|mesh-ancestor
101879595|NCT03749356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879596|NCT03749356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101879597|NCT03749356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101689117|NCT00620438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101879598|NCT03749356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879599|NCT04358068|Azithromycin|azithromycin|mesh-list
101879600|NCT04358068|Hydroxychloroquine|hydroxychloroquine|mesh-list
101879601|NCT04358068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101879602|NCT04358068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101879603|NCT04358068|Antimalarials|antimalarials|mesh-ancestor
101879604|NCT04358068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101879605|NCT04358068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101879606|NCT04358068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101879607|NCT04358068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879608|NCT04358068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101879609|NCT00096278|Calcium, Dietary|calcium, dietary|mesh-list
101879610|NCT00096278|Leucovorin|leucovorin|mesh-list
101879611|NCT00096278|Folic Acid|folic acid|mesh-list
101879612|NCT00096278|Bevacizumab|bevacizumab|mesh-list
101879613|NCT00096278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101879614|NCT00096278|Fluorouracil|fluorouracil|mesh-list
101879615|NCT00096278|Oxaliplatin|oxaliplatin|mesh-list
101879616|NCT00096278|Endothelial Growth Factors|endothelial growth factors|mesh-list
101879617|NCT00096278|Antibodies|antibodies|mesh-list
101879618|NCT00096278|Immunoglobulins|immunoglobulins|mesh-list
101879619|NCT00096278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101879620|NCT00096278|Immunoglobulin G|immunoglobulin g|mesh-list
101879621|NCT00096278|Calcium|calcium|mesh-list
101879622|NCT00096278|Levoleucovorin|levoleucovorin|mesh-list
101879623|NCT00096278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101879624|NCT00096278|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101879625|NCT00096278|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101879626|NCT00096278|Growth Substances|growth substances|mesh-ancestor
101879627|NCT00096278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879628|NCT00096278|Growth Inhibitors|growth inhibitors|mesh-ancestor
101879629|NCT00096278|Immunologic Factors|immunologic factors|mesh-ancestor
101879630|NCT00096278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101879631|NCT00096278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101879632|NCT00096278|Antimetabolites|antimetabolites|mesh-ancestor
101879633|NCT00096278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879634|NCT00096278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101879635|NCT00096278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101879636|NCT00096278|Antidotes|antidotes|mesh-ancestor
101879637|NCT00096278|Protective Agents|protective agents|mesh-ancestor
101879638|NCT00096278|Vitamin B Complex|vitamin b complex|mesh-ancestor
101879639|NCT00096278|Vitamins|vitamins|mesh-ancestor
101879640|NCT00096278|Micronutrients|micronutrients|mesh-ancestor
101879641|NCT00096278|Hematinics|hematinics|mesh-ancestor
101879643|NCT00095940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101879644|NCT00095940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101879645|NCT00095940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101879646|NCT00095940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879647|NCT00114218|Gemcitabine|gemcitabine|mesh-list
101879648|NCT00114218|Docetaxel|docetaxel|mesh-list
101879649|NCT00114218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101879650|NCT00114218|Antimetabolites|antimetabolites|mesh-ancestor
101879651|NCT00114218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879652|NCT00114218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101879653|NCT00114218|Tubulin Modulators|tubulin modulators|mesh-ancestor
101879654|NCT00114218|Antimitotic Agents|antimitotic agents|mesh-ancestor
101879655|NCT00114218|Mitosis Modulators|mitosis modulators|mesh-ancestor
101879656|NCT01077986|Capecitabine|capecitabine|mesh-list
101879657|NCT01077986|Cetuximab|cetuximab|mesh-list
101879658|NCT01077986|Everolimus|everolimus|mesh-list
101879659|NCT01077986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101879660|NCT01077986|Antimetabolites|antimetabolites|mesh-ancestor
101879661|NCT01077986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879662|NCT01077986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101879663|NCT01077986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101879664|NCT01077986|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101879665|NCT01077986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101879666|NCT01077986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101879667|NCT01077986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101879668|NCT01077986|Immunologic Factors|immunologic factors|mesh-ancestor
101879669|NCT01077986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879670|NCT03963024|Treosulfan|treosulfan|mesh-list
101879671|NCT03963024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101879672|NCT03963024|Alkylating Agents|alkylating agents|mesh-ancestor
101879673|NCT03963024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879674|NCT03963024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101879675|NCT01082718|Artesunate|artesunate|mesh-list
101879676|NCT01082718|Mefloquine|mefloquine|mesh-list
101879677|NCT01082718|Antimalarials|antimalarials|mesh-ancestor
101879678|NCT01082718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101879679|NCT01082718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101879680|NCT01082718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101879681|NCT01082718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101879682|NCT01082718|Antiviral Agents|antiviral agents|mesh-ancestor
101879683|NCT01082718|Schistosomicides|schistosomicides|mesh-ancestor
101879684|NCT01082718|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101879685|NCT01082718|Anthelmintics|anthelmintics|mesh-ancestor
101879686|NCT04380142|Levodopa|levodopa|mesh-list
101879687|NCT04380142|Carbidopa|carbidopa|mesh-list
101879688|NCT04380142|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101879689|NCT04380142|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101879690|NCT04380142|Dopamine Agents|dopamine agents|mesh-ancestor
101879691|NCT04380142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101879692|NCT04380142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879693|NCT04380142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879694|NCT04380142|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101879695|NCT04380142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101879696|NCT04336228|Dexetimide|dexetimide|mesh-list
101879697|NCT04336228|Citalopram|citalopram|mesh-list
101879698|NCT04336228|Escitalopram|escitalopram|mesh-list
101879699|NCT04336228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879700|NCT04336228|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101879701|NCT04336228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101879702|NCT04336228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101879703|NCT04336228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879704|NCT04336228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101879705|NCT04336228|Serotonin Agents|serotonin agents|mesh-ancestor
101879706|NCT04336228|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101879707|NCT04336228|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101879708|NCT04336228|Parasympatholytics|parasympatholytics|mesh-ancestor
101879709|NCT04336228|Autonomic Agents|autonomic agents|mesh-ancestor
101879710|NCT04336228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101879711|NCT04336228|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101879712|NCT04336228|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101879713|NCT04336228|Cholinergic Agents|cholinergic agents|mesh-ancestor
101879714|NCT04336228|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101879715|NCT04336228|Antidepressive Agents|antidepressive agents|mesh-ancestor
101879716|NCT04336228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101879717|NCT03917446|Propofol|propofol|mesh-list
101879718|NCT03917446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101879719|NCT03917446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101879720|NCT03917446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879721|NCT03917446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101879722|NCT03917446|Anesthetics, General|anesthetics, general|mesh-ancestor
101879723|NCT03917446|Anesthetics|anesthetics|mesh-ancestor
101879724|NCT04332874|Dactinomycin|dactinomycin|mesh-list
101879725|NCT04332874|Pembrolizumab|pembrolizumab|mesh-list
101879726|NCT04332874|Melphalan|melphalan|mesh-list
101879727|NCT04332874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101879728|NCT04332874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101879729|NCT04332874|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101879730|NCT04332874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879731|NCT04332874|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101879732|NCT04332874|Alkylating Agents|alkylating agents|mesh-ancestor
101879733|NCT04332874|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101879734|NCT04332874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101879735|NCT04332874|Immunologic Factors|immunologic factors|mesh-ancestor
101879736|NCT04332874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879737|NCT04332874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101879738|NCT04332874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101879739|NCT04332874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101879740|NCT04332874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101879741|NCT04332874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101879742|NCT04332874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101879743|NCT03748108|Lidocaine|lidocaine|mesh-list
101879744|NCT03748108|Anesthetics, Local|anesthetics, local|mesh-ancestor
101879745|NCT03748108|Anesthetics|anesthetics|mesh-ancestor
101879746|NCT03748108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101879747|NCT03748108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879748|NCT03748108|Sensory System Agents|sensory system agents|mesh-ancestor
101879749|NCT03748108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101879750|NCT03748108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101879751|NCT03748108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101879752|NCT03748108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101879753|NCT03748108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101879754|NCT03748108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879756|NCT04171414|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101879757|NCT04171414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101879758|NCT04171414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101879759|NCT04167670|Amoxicillin|amoxicillin|mesh-list
101879760|NCT04167670|Clarithromycin|clarithromycin|mesh-list
101879761|NCT04167670|Lansoprazole|lansoprazole|mesh-list
101879762|NCT04167670|Dexlansoprazole|dexlansoprazole|mesh-list
101879763|NCT04167670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101879764|NCT04167670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101879765|NCT04167670|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101879766|NCT04167670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101879767|NCT04167670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879768|NCT04167670|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101879769|NCT04167670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101879770|NCT04167670|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101879771|NCT04167670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101879772|NCT04167670|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101879773|NCT00113516|Paclitaxel|paclitaxel|mesh-list
101879774|NCT00113516|Carboplatin|carboplatin|mesh-list
101879775|NCT00113516|Sunitinib|sunitinib|mesh-list
101879776|NCT00113516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101879777|NCT00113516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101879778|NCT00113516|Tubulin Modulators|tubulin modulators|mesh-ancestor
101879779|NCT00113516|Antimitotic Agents|antimitotic agents|mesh-ancestor
101879780|NCT00113516|Mitosis Modulators|mitosis modulators|mesh-ancestor
101879781|NCT00113516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879782|NCT00113516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101879783|NCT00113516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101879784|NCT00113516|Growth Substances|growth substances|mesh-ancestor
101879785|NCT00113516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879786|NCT00113516|Growth Inhibitors|growth inhibitors|mesh-ancestor
101879787|NCT00113516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101879788|NCT00113516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101879789|NCT04142242|Vaccines|vaccines|mesh-list
101599590|NCT02882087|Antimetabolites|antimetabolites|mesh-ancestor
101879790|NCT04142242|Immunologic Factors|immunologic factors|mesh-ancestor
101879791|NCT04142242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879792|NCT03251326|Propranolol|propranolol|mesh-list
101879793|NCT03251326|Nabilone|nabilone|mesh-list
101879794|NCT03251326|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101879795|NCT03251326|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101879796|NCT03251326|Adrenergic Agents|adrenergic agents|mesh-ancestor
101879797|NCT03251326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101879798|NCT03251326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879799|NCT03251326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879800|NCT03251326|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101879801|NCT03251326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101879802|NCT03251326|Vasodilator Agents|vasodilator agents|mesh-ancestor
101879803|NCT03251326|Antiemetics|antiemetics|mesh-ancestor
101879804|NCT03251326|Autonomic Agents|autonomic agents|mesh-ancestor
101879805|NCT03251326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101879806|NCT03251326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101879807|NCT03251326|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101879808|NCT03251326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101879809|NCT03251326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101879810|NCT03251326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101879811|NCT04140292|Vitamin D|vitamin d|mesh-list
101879812|NCT04140292|Cholecalciferol|cholecalciferol|mesh-list
101879813|NCT04140292|Vitamins|vitamins|mesh-ancestor
101879814|NCT04140292|Micronutrients|micronutrients|mesh-ancestor
101879815|NCT04140292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879816|NCT04140292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101967777|NCT00770848|Rilotumumab|rilotumumab|mesh-list
101879817|NCT04140292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101879818|NCT00127166|Fluticasone|fluticasone|mesh-list
101879819|NCT00127166|Xhance|xhance|mesh-list
101205926|NCT01428544|PENTA|penta|mesh-list
101879821|NCT00127166|Montelukast|montelukast|mesh-list
101879822|NCT00127166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101879823|NCT00127166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101879824|NCT00127166|Autonomic Agents|autonomic agents|mesh-ancestor
101879825|NCT00127166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101879826|NCT00127166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879827|NCT00127166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101879828|NCT00127166|Respiratory System Agents|respiratory system agents|mesh-ancestor
101879829|NCT00127166|Dermatologic Agents|dermatologic agents|mesh-ancestor
101879830|NCT00127166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101879831|NCT00127166|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101879832|NCT00127166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101879833|NCT00127166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101879834|NCT00127166|Adrenergic Agents|adrenergic agents|mesh-ancestor
101879835|NCT00127166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101879836|NCT00127166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879837|NCT00127166|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101879838|NCT00127166|Hormone Antagonists|hormone antagonists|mesh-ancestor
101879839|NCT00127166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101879840|NCT00127166|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101879841|NCT00127166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101879842|NCT00125138|Metylperon|metylperon|mesh-list
101879843|NCT00125138|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101879844|NCT00125138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101879845|NCT00125138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101879846|NCT00125138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879847|NCT00125138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101879848|NCT04132336|Naproxen|naproxen|mesh-list
101879849|NCT04132336|Caffeine|caffeine|mesh-list
101879850|NCT04132336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101879851|NCT04132336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879852|NCT04132336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101879853|NCT04132336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101879854|NCT04132336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879855|NCT04132336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101879856|NCT04132336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101879857|NCT04132336|Purinergic Agents|purinergic agents|mesh-ancestor
101879858|NCT04132336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101879859|NCT04132336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101879860|NCT04132336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101879861|NCT04132336|Analgesics|analgesics|mesh-ancestor
101879862|NCT04132336|Sensory System Agents|sensory system agents|mesh-ancestor
101879863|NCT04132336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101599663|NCT01059864|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101879864|NCT04132336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101879865|NCT04132336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101879866|NCT04132336|Gout Suppressants|gout suppressants|mesh-ancestor
101879867|NCT04132336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101879868|NCT04131556|Maribavir|maribavir|mesh-list
101879869|NCT04131556|Antiviral Agents|antiviral agents|mesh-ancestor
101879870|NCT04131556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101879871|NCT04315636|Pulmonary Surfactants|pulmonary surfactants|mesh-list
101879872|NCT04315636|Respiratory System Agents|respiratory system agents|mesh-ancestor
101879873|NCT03691948|Analgesics, Opioid|analgesics, opioid|mesh-list
101879874|NCT03691948|Narcotics|narcotics|mesh-ancestor
101879875|NCT03691948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101879876|NCT03691948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879877|NCT03691948|Analgesics|analgesics|mesh-ancestor
101879878|NCT03691948|Sensory System Agents|sensory system agents|mesh-ancestor
101879879|NCT03691948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101879880|NCT04124926|Lansoprazole|lansoprazole|mesh-list
101879881|NCT04124926|Dexlansoprazole|dexlansoprazole|mesh-list
101879882|NCT04124926|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101879883|NCT04124926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101879884|NCT04124926|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101879885|NCT04124926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101879886|NCT04124926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879887|NCT03746158|Curcumin|curcumin|mesh-list
101879888|NCT03746158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101879889|NCT03746158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101879891|NCT03746158|Sensory System Agents|sensory system agents|mesh-ancestor
101879892|NCT03746158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101879893|NCT03746158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879894|NCT03746158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101879895|NCT03746158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101879896|NCT03746158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101879897|NCT03746158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101879898|NCT03746158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879899|NCT03747094|Fentanyl|fentanyl|mesh-list
101879900|NCT03747094|Ketamine|ketamine|mesh-list
101879901|NCT03747094|Analgesics|analgesics|mesh-ancestor
101879902|NCT03747094|Sensory System Agents|sensory system agents|mesh-ancestor
101879903|NCT03747094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101879904|NCT03747094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879905|NCT03747094|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101879906|NCT03747094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101879907|NCT03747094|Anesthetics, General|anesthetics, general|mesh-ancestor
101879908|NCT03747094|Anesthetics|anesthetics|mesh-ancestor
101879909|NCT03747094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101879910|NCT03747094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101879911|NCT03747094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101879912|NCT03747094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101879913|NCT03747094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879914|NCT03747094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101879915|NCT03747094|Narcotics|narcotics|mesh-ancestor
101879916|NCT03747094|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101879917|NCT04105972|Ivacaftor|ivacaftor|mesh-list
101879918|NCT04105972|Elexacaftor|elexacaftor|mesh-list
101879919|NCT04105972|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101879920|NCT04105972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101879921|NCT04105972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879922|NCT00124982|Abatacept|abatacept|mesh-list
101879923|NCT00124982|Antirheumatic Agents|antirheumatic agents|mesh-list
101879924|NCT00124982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101879925|NCT00124982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879926|NCT00124982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101879927|NCT00124982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101879928|NCT00124982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101879929|NCT00124982|Immunologic Factors|immunologic factors|mesh-ancestor
101879930|NCT00124982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879931|NCT04090528|Pembrolizumab|pembrolizumab|mesh-list
101967806|NCT00672412|Antimetabolites|antimetabolites|mesh-ancestor
101879932|NCT04090528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101879933|NCT04090528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101879934|NCT04090528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101879935|NCT04090528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879936|NCT04249336|Listerine|listerine|mesh-list
101879937|NCT04249336|Calcium|calcium|mesh-list
101879938|NCT04249336|Fluorides|fluorides|mesh-list
101879939|NCT04249336|Sodium Fluoride|sodium fluoride|mesh-list
101879940|NCT04249336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101879941|NCT04249336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879942|NCT04249336|Cariostatic Agents|cariostatic agents|mesh-ancestor
101879943|NCT04249336|Protective Agents|protective agents|mesh-ancestor
101879944|NCT04249336|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101454439|NCT00210158|Anesthetics|anesthetics|mesh-ancestor
101879945|NCT04249336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101879946|NCT03752476|Lactams|lactams|mesh-list
101879947|NCT03752476|beta-Lactams|beta-lactams|mesh-list
101879948|NCT03752476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101879949|NCT03752476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101879950|NCT04078126|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101879951|NCT04078126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101879952|NCT04078126|Respiratory System Agents|respiratory system agents|mesh-ancestor
101879953|NCT04380688|Acalabrutinib|acalabrutinib|mesh-list
101879954|NCT04380688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101879955|NCT00124748|Imatinib Mesylate|imatinib mesylate|mesh-list
101879956|NCT00124748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101879957|NCT00124748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101879958|NCT00124748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101879959|NCT00124748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879961|NCT01078142|Rituximab|rituximab|mesh-list
101879962|NCT01078142|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101879963|NCT01078142|Temsirolimus|temsirolimus|mesh-list
101879964|NCT01078142|MTOR Inhibitors|mtor inhibitors|mesh-list
101879965|NCT01078142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101879966|NCT01078142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101879967|NCT01078142|Immunologic Factors|immunologic factors|mesh-ancestor
101879968|NCT01078142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879969|NCT01078142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101879970|NCT01078142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101879971|NCT01078142|Alkylating Agents|alkylating agents|mesh-ancestor
101879972|NCT01078142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879973|NCT01078142|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101879974|NCT01078142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101879975|NCT01078142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101879976|NCT01078142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101879977|NCT01078142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101879978|NCT01078142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101879979|NCT01078142|Antifungal Agents|antifungal agents|mesh-ancestor
101879980|NCT04060654|Buprenorphine|buprenorphine|mesh-list
101879981|NCT04060654|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101879982|NCT04060654|Narcotics|narcotics|mesh-ancestor
101879983|NCT04060654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101879984|NCT04060654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101879985|NCT04060654|Analgesics|analgesics|mesh-ancestor
101879986|NCT04060654|Sensory System Agents|sensory system agents|mesh-ancestor
101879987|NCT04060654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101879988|NCT04060654|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101879989|NCT00096200|Paclitaxel|paclitaxel|mesh-list
101879990|NCT00096200|Carboplatin|carboplatin|mesh-list
101879991|NCT00096200|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101879992|NCT00096200|Sorafenib|sorafenib|mesh-list
101879993|NCT00096200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101879994|NCT00096200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101879995|NCT00096200|Tubulin Modulators|tubulin modulators|mesh-ancestor
101879996|NCT00096200|Antimitotic Agents|antimitotic agents|mesh-ancestor
101879997|NCT00096200|Mitosis Modulators|mitosis modulators|mesh-ancestor
101879998|NCT00096200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101879999|NCT00096200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101880000|NCT00096200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101880001|NCT00096044|Rituximab|rituximab|mesh-list
101880002|NCT00096044|Lenalidomide|lenalidomide|mesh-list
101880003|NCT00096044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101880004|NCT00096044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101880005|NCT00096044|Immunologic Factors|immunologic factors|mesh-ancestor
101880006|NCT00096044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880007|NCT00096044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101880008|NCT00096044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101880009|NCT00096044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101880010|NCT00096044|Growth Substances|growth substances|mesh-ancestor
101454461|NCT04996771|Cisplatin|cisplatin|mesh-list
101880011|NCT00096044|Growth Inhibitors|growth inhibitors|mesh-ancestor
101880012|NCT03963128|Vitamin D|vitamin d|mesh-list
101880013|NCT03963128|Cholecalciferol|cholecalciferol|mesh-list
101880014|NCT03963128|Vitamins|vitamins|mesh-ancestor
101880015|NCT03963128|Micronutrients|micronutrients|mesh-ancestor
101880016|NCT03963128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599812|NCT03522064|Androgens|androgens|mesh-ancestor
101880017|NCT03963128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101880018|NCT03963128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101880019|NCT01083212|Gemfibrozil|gemfibrozil|mesh-list
101880020|NCT01083212|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101880021|NCT01083212|Antimetabolites|antimetabolites|mesh-ancestor
101880022|NCT01083212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880023|NCT01083212|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101880024|NCT01083212|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101880025|NCT01083212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101880026|NCT01083212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101880027|NCT01083290|Spironolactone|spironolactone|mesh-list
101880028|NCT01083290|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101880029|NCT01083290|Hormone Antagonists|hormone antagonists|mesh-ancestor
101880030|NCT01083290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101880031|NCT01083290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880032|NCT01083290|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101880033|NCT01083290|Diuretics|diuretics|mesh-ancestor
101880034|NCT01083290|Natriuretic Agents|natriuretic agents|mesh-ancestor
101880035|NCT01326650|Vitamin D|vitamin d|mesh-list
101880036|NCT01326650|Ergocalciferols|ergocalciferols|mesh-list
101880037|NCT01326650|Cholecalciferol|cholecalciferol|mesh-list
101880038|NCT01326650|Vitamins|vitamins|mesh-list
101880039|NCT01326650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101880040|NCT01326650|Micronutrients|micronutrients|mesh-ancestor
101880041|NCT01326650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880042|NCT01326650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101880043|NCT01326650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101880044|NCT03689374|Insulin|insulin|mesh-list
101880045|NCT03689374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101880046|NCT03689374|Insulin Glargine|insulin glargine|mesh-list
101880047|NCT03689374|Insulin Aspart|insulin aspart|mesh-list
101880048|NCT03689374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101880049|NCT03689374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880050|NCT00113360|Everolimus|everolimus|mesh-list
101880051|NCT00113360|Octreotide|octreotide|mesh-list
101880052|NCT00113360|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101880053|NCT00113360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101880054|NCT00113360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101880055|NCT00113360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880056|NCT00113360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101880057|NCT00113360|Immunologic Factors|immunologic factors|mesh-ancestor
101880058|NCT00113360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880059|NCT00113360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101880060|NCT00113360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101880061|NCT00113360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101880062|NCT03745300|Atorvastatin|atorvastatin|mesh-list
101880063|NCT03745300|Simvastatin|simvastatin|mesh-list
101880064|NCT03745300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101880065|NCT03745300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101880066|NCT03745300|Antimetabolites|antimetabolites|mesh-ancestor
101880067|NCT03745300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880068|NCT03745300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101880069|NCT03745300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101880070|NCT03745300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101880071|NCT00112736|Sirolimus|sirolimus|mesh-list
101880072|NCT00112736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101880073|NCT00112736|Temsirolimus|temsirolimus|mesh-list
101880074|NCT00112736|MTOR Inhibitors|mtor inhibitors|mesh-list
101880075|NCT00112736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101880076|NCT00112736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101880077|NCT00112736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101880078|NCT00112736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880079|NCT00112736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101880080|NCT00112736|Immunologic Factors|immunologic factors|mesh-ancestor
101880081|NCT00112736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880082|NCT00112736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101880083|NCT00112736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101880084|NCT00112736|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101880085|NCT00112736|Antifungal Agents|antifungal agents|mesh-ancestor
101880086|NCT04052620|Diclofenac|diclofenac|mesh-list
101880087|NCT04052620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101880088|NCT04052620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101880089|NCT04052620|Analgesics|analgesics|mesh-ancestor
101880090|NCT04052620|Sensory System Agents|sensory system agents|mesh-ancestor
101880091|NCT04052620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101880092|NCT04052620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880093|NCT04052620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101880094|NCT04052620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101880095|NCT04052620|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101880096|NCT04052620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101880097|NCT04052620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880099|NCT00112580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101880100|NCT00112580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101880101|NCT00112580|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101880102|NCT00112580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880103|NCT04238650|Bevacizumab|bevacizumab|mesh-list
101880104|NCT04238650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101880105|NCT04238650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101880107|NCT04238650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101880108|NCT04238650|Growth Substances|growth substances|mesh-ancestor
101880109|NCT04238650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880110|NCT04238650|Growth Inhibitors|growth inhibitors|mesh-ancestor
101880111|NCT04049578|Balovaptan|balovaptan|mesh-list
101880112|NCT04049578|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101967853|NCT03907826|Antibodies|antibodies|mesh-list
101880113|NCT04049578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880114|NCT04049578|Natriuretic Agents|natriuretic agents|mesh-ancestor
101880115|NCT04049578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880116|NCT00095498|Denosumab|denosumab|mesh-list
101880117|NCT00095498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101880118|NCT00095498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880119|NCT04237792|Dexmedetomidine|dexmedetomidine|mesh-list
101880120|NCT04237792|Propofol|propofol|mesh-list
101880121|NCT04237792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101880122|NCT04237792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101880123|NCT04237792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880124|NCT04237792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101880125|NCT04237792|Analgesics|analgesics|mesh-ancestor
101880126|NCT04237792|Sensory System Agents|sensory system agents|mesh-ancestor
101880127|NCT04237792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101880128|NCT04237792|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101880129|NCT04237792|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101880130|NCT04237792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101880131|NCT04237792|Adrenergic Agents|adrenergic agents|mesh-ancestor
101880132|NCT04237792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101880133|NCT04237792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880134|NCT04237792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101880135|NCT04237792|Anesthetics, General|anesthetics, general|mesh-ancestor
101880136|NCT04237792|Anesthetics|anesthetics|mesh-ancestor
101880137|NCT03744988|Androgens|androgens|mesh-list
101880138|NCT03744988|Hormones|hormones|mesh-ancestor
101880139|NCT03744988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101880140|NCT03744988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880141|NCT03746782|Thrombin|thrombin|mesh-list
101880142|NCT03746782|Hemostatics|hemostatics|mesh-ancestor
101880143|NCT03746782|Coagulants|coagulants|mesh-ancestor
101880144|NCT04026568|4-Aminopyridine|4-aminopyridine|mesh-list
101880145|NCT04026568|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101880146|NCT04026568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101880147|NCT04026568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880148|NCT04024228|Hemagglutinins|hemagglutinins|mesh-list
101880149|NCT04024228|Vaccines|vaccines|mesh-list
101880150|NCT04024228|Immunologic Factors|immunologic factors|mesh-ancestor
101880151|NCT04024228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880152|NCT04024228|Agglutinins|agglutinins|mesh-ancestor
101880153|NCT04024228|Coagulants|coagulants|mesh-ancestor
101880154|NCT04023682|Hand Sanitizers|hand sanitizers|mesh-list
101880155|NCT04023682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101880156|NCT04023682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101880157|NCT04023682|Disinfectants|disinfectants|mesh-ancestor
101880158|NCT04018612|Acetaminophen|acetaminophen|mesh-list
101880159|NCT04018612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101880160|NCT04018612|Analgesics|analgesics|mesh-ancestor
101880161|NCT04018612|Sensory System Agents|sensory system agents|mesh-ancestor
101880162|NCT04018612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101880163|NCT04018612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599960|NCT01976182|Methotrexate|methotrexate|mesh-list
101880164|NCT04018612|Antipyretics|antipyretics|mesh-ancestor
101880165|NCT04207840|Epinephrine|epinephrine|mesh-list
101880166|NCT04207840|Racepinephrine|racepinephrine|mesh-list
101880167|NCT04207840|Albuterol|albuterol|mesh-list
101880168|NCT04207840|Epinephryl borate|epinephryl borate|mesh-list
101880169|NCT04207840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101880170|NCT04207840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101880171|NCT04207840|Adrenergic Agents|adrenergic agents|mesh-ancestor
101880172|NCT04207840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101880173|NCT04207840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880174|NCT04207840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880175|NCT04207840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101880176|NCT04207840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101880177|NCT04207840|Autonomic Agents|autonomic agents|mesh-ancestor
101689138|NCT00600756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101880178|NCT04207840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101967860|NCT00042289|Darunavir|darunavir|mesh-list
101880180|NCT04207840|Respiratory System Agents|respiratory system agents|mesh-ancestor
101880181|NCT04207840|Mydriatics|mydriatics|mesh-ancestor
101880182|NCT04207840|Sympathomimetics|sympathomimetics|mesh-ancestor
101880183|NCT04207840|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101880184|NCT04207840|Tocolytic Agents|tocolytic agents|mesh-ancestor
101880185|NCT04207840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101880186|NCT04207840|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101880187|NCT04195828|Paclitaxel|paclitaxel|mesh-list
101880188|NCT04195828|Apatinib|apatinib|mesh-list
101880189|NCT04195828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101880190|NCT04195828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101880191|NCT04195828|Tubulin Modulators|tubulin modulators|mesh-ancestor
101880192|NCT04195828|Antimitotic Agents|antimitotic agents|mesh-ancestor
101880193|NCT04195828|Mitosis Modulators|mitosis modulators|mesh-ancestor
101880194|NCT04195828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880195|NCT04195828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101880196|NCT04195828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101880197|NCT03744364|Misoprostol|misoprostol|mesh-list
101880198|NCT03744364|Dinoprostone|dinoprostone|mesh-list
101880199|NCT03744364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101880200|NCT03744364|Abortifacient Agents|abortifacient agents|mesh-ancestor
101880201|NCT03744364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101880202|NCT03744364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880203|NCT03744364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101880204|NCT03744364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101880205|NCT03744364|Oxytocics|oxytocics|mesh-ancestor
101880206|NCT03744208|Antibodies|antibodies|mesh-list
101880207|NCT03744208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101880208|NCT03744208|Immunologic Factors|immunologic factors|mesh-ancestor
101880209|NCT03744208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880210|NCT05069896|Mirikizumab|mirikizumab|mesh-list
101880211|NCT05069896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101880212|NCT05069896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101880213|NCT05069896|Analgesics|analgesics|mesh-ancestor
101880214|NCT05069896|Sensory System Agents|sensory system agents|mesh-ancestor
101880215|NCT05069896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101880216|NCT05069896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880217|NCT05069896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101880218|NCT05069896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101880219|NCT05069896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101880220|NCT05069896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101880221|NCT01562626|Flucytosine|flucytosine|mesh-list
101880222|NCT01562626|Antifungal Agents|antifungal agents|mesh-ancestor
101880223|NCT01562626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101880224|NCT01562626|Antimetabolites|antimetabolites|mesh-ancestor
101880225|NCT01562626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880226|NCT04470622|Aprepitant|aprepitant|mesh-list
101880227|NCT04470622|Antiemetics|antiemetics|mesh-ancestor
101880228|NCT04470622|Autonomic Agents|autonomic agents|mesh-ancestor
101880229|NCT04470622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101880230|NCT04470622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880231|NCT04470622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101880232|NCT04470622|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101880233|NCT04470622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101880234|NCT04470622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880235|NCT04465396|Teduglutide|teduglutide|mesh-list
101880236|NCT04465396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101880237|NCT04465396|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101880238|NCT04465396|Protective Agents|protective agents|mesh-ancestor
101880239|NCT04465396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880240|NCT03996694|Oxycodone|oxycodone|mesh-list
101880241|NCT03996694|Buprenorphine|buprenorphine|mesh-list
101880242|NCT03996694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101880243|NCT03996694|Narcotics|narcotics|mesh-ancestor
101880244|NCT03996694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101880245|NCT03996694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880246|NCT03996694|Analgesics|analgesics|mesh-ancestor
101880247|NCT03996694|Sensory System Agents|sensory system agents|mesh-ancestor
101880248|NCT03996694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101880249|NCT03996694|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101880251|NCT03743896|Antipruritics|antipruritics|mesh-ancestor
101880252|NCT03743896|Dermatologic Agents|dermatologic agents|mesh-ancestor
101880253|NCT03743896|Sensory System Agents|sensory system agents|mesh-ancestor
101880254|NCT03743896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101880255|NCT03743896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880256|NCT03737344|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101880257|NCT03737344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101880258|NCT03751228|Deucravacitinib|deucravacitinib|mesh-list
101880259|NCT03751228|Dermatologic Agents|dermatologic agents|mesh-ancestor
101880260|NCT03751228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101880261|NCT03751228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101880262|NCT03751228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880263|NCT03656692|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101454556|NCT04570345|Ticagrelor|ticagrelor|mesh-list
101880265|NCT03656692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101880266|NCT03656692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880267|NCT04439266|Crizotinib|crizotinib|mesh-list
101880268|NCT04439266|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101880269|NCT04439266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101880270|NCT04439266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101880271|NCT04439266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101880272|NCT04439266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880273|NCT01329796|Lidocaine|lidocaine|mesh-list
101880274|NCT01329796|Anesthetics, Local|anesthetics, local|mesh-ancestor
101880275|NCT01329796|Anesthetics|anesthetics|mesh-ancestor
101880276|NCT01329796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101880277|NCT01329796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880278|NCT01329796|Sensory System Agents|sensory system agents|mesh-ancestor
101880279|NCT01329796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101880280|NCT01329796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101880281|NCT01329796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101880282|NCT01329796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101880283|NCT01329796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101880284|NCT01329796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880285|NCT04428502|Etanercept|etanercept|mesh-list
101880286|NCT04428502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101880287|NCT04428502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101880288|NCT04428502|Analgesics|analgesics|mesh-ancestor
101880289|NCT04428502|Sensory System Agents|sensory system agents|mesh-ancestor
101880290|NCT04428502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101880291|NCT04428502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880292|NCT04428502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101880293|NCT04428502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101880294|NCT04428502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101880295|NCT04428502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101880296|NCT04428502|Immunologic Factors|immunologic factors|mesh-ancestor
101880297|NCT03736330|Pembrolizumab|pembrolizumab|mesh-list
101880298|NCT03736330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101880299|NCT03736330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101880300|NCT03736330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101880301|NCT03736330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880302|NCT04428424|Etanercept|etanercept|mesh-list
101880303|NCT04428424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101880304|NCT04428424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101880305|NCT04428424|Analgesics|analgesics|mesh-ancestor
101880306|NCT04428424|Sensory System Agents|sensory system agents|mesh-ancestor
101880307|NCT04428424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101880308|NCT04428424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880309|NCT04428424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101880310|NCT04428424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101880311|NCT04428424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101880312|NCT04428424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101880313|NCT04428424|Immunologic Factors|immunologic factors|mesh-ancestor
101880314|NCT00095238|Irbesartan|irbesartan|mesh-list
101880315|NCT00095238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101967881|NCT00042289|Isoniazid|isoniazid|mesh-list
101880316|NCT00095238|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101880317|NCT00095238|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101880318|NCT00095238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880319|NCT01087008|Zoledronic Acid|zoledronic acid|mesh-list
101880320|NCT01087008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101880321|NCT01087008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880323|NCT01084044|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101880324|NCT01084044|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101880325|NCT01084044|Protease Inhibitors|protease inhibitors|mesh-ancestor
101880326|NCT01084044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101880327|NCT01084044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880328|NCT01090518|Hydrocortisone|hydrocortisone|mesh-list
101880329|NCT01090518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101880330|NCT01090596|Naproxen|naproxen|mesh-list
101880331|NCT01090596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101880332|NCT01090596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101880333|NCT01090596|Analgesics|analgesics|mesh-ancestor
101880334|NCT01090596|Sensory System Agents|sensory system agents|mesh-ancestor
101880335|NCT01090596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101880336|NCT01090596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880337|NCT01090596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101880338|NCT01090596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101880339|NCT01090596|Gout Suppressants|gout suppressants|mesh-ancestor
101880340|NCT01090596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101880341|NCT01090596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101880342|NCT01090596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880343|NCT01084122|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101880344|NCT01084122|Hematinics|hematinics|mesh-ancestor
101880345|NCT01084200|Propofol|propofol|mesh-list
101880346|NCT01084200|Sevoflurane|sevoflurane|mesh-list
101880347|NCT01084200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101880348|NCT01084200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101880349|NCT01084200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880350|NCT01084200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101880351|NCT01084200|Anesthetics, General|anesthetics, general|mesh-ancestor
101880352|NCT01084200|Anesthetics|anesthetics|mesh-ancestor
101880353|NCT01084200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101880354|NCT01084200|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101880355|NCT00094770|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101880356|NCT00094770|Glipizide|glipizide|mesh-list
101880357|NCT00094770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101880358|NCT00094770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880359|NCT00094770|Incretins|incretins|mesh-ancestor
101880360|NCT00094770|Hormones|hormones|mesh-ancestor
101880361|NCT00094770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101880362|NCT00094770|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101880363|NCT00094770|Protease Inhibitors|protease inhibitors|mesh-ancestor
101880364|NCT00094770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101880365|NCT00094770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880366|NCT01087398|Cyclosporine|cyclosporine|mesh-list
101880367|NCT01087398|Cyclophosphamide|cyclophosphamide|mesh-list
101880368|NCT01087398|Busulfan|busulfan|mesh-list
101880369|NCT01087398|Methotrexate|methotrexate|mesh-list
101880370|NCT01087398|Fludarabine|fludarabine|mesh-list
101880371|NCT01087398|Cyclosporins|cyclosporins|mesh-list
101880372|NCT01087398|Thymoglobulin|thymoglobulin|mesh-list
101880373|NCT01087398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101880374|NCT01087398|Immunologic Factors|immunologic factors|mesh-ancestor
101880375|NCT01087398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880376|NCT01087398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101880377|NCT01087398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101880378|NCT01087398|Alkylating Agents|alkylating agents|mesh-ancestor
101880379|NCT01087398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880380|NCT01087398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101600182|NCT04263519|Tacrolimus|tacrolimus|mesh-list
101600183|NCT04263519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101600184|NCT04263519|Immunologic Factors|immunologic factors|mesh-ancestor
101600185|NCT04263519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600186|NCT04263519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101600187|NCT04263519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101600188|NCT04263519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600189|NCT00637767|Melphalan|melphalan|mesh-list
101600190|NCT00637767|Antibodies|antibodies|mesh-list
101880381|NCT01087398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101880382|NCT01087398|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101880383|NCT01087398|Abortifacient Agents|abortifacient agents|mesh-ancestor
101880384|NCT01087398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101880385|NCT01087398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101880386|NCT01087398|Antimetabolites|antimetabolites|mesh-ancestor
101880387|NCT01087398|Dermatologic Agents|dermatologic agents|mesh-ancestor
101880388|NCT01087398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101880389|NCT01087398|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101880390|NCT01087398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101880391|NCT01087398|Antifungal Agents|antifungal agents|mesh-ancestor
101880392|NCT01087398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101880393|NCT01087398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101880394|NCT01087476|Doxycycline|doxycycline|mesh-list
101880395|NCT01087476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101880396|NCT01087476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101880397|NCT01087476|Antimalarials|antimalarials|mesh-ancestor
101880398|NCT01087476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101880399|NCT01087476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101880401|NCT00069108|Capecitabine|capecitabine|mesh-list
101880402|NCT00069108|Oxaliplatin|oxaliplatin|mesh-list
101880403|NCT00069108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101880404|NCT00069108|Antimetabolites|antimetabolites|mesh-ancestor
101880405|NCT00069108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880406|NCT00069108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101880407|NCT00069108|Antidotes|antidotes|mesh-ancestor
101880408|NCT00069108|Protective Agents|protective agents|mesh-ancestor
101880409|NCT00069108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880410|NCT00069108|Vitamin B Complex|vitamin b complex|mesh-ancestor
101880411|NCT00069108|Vitamins|vitamins|mesh-ancestor
101880412|NCT00069108|Micronutrients|micronutrients|mesh-ancestor
101880413|NCT00405587|Vemurafenib|vemurafenib|mesh-list
101880414|NCT00405587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101880415|NCT00405587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101880416|NCT00405587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101880417|NCT00405587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880418|NCT01040429|Clonidine|clonidine|mesh-list
101880419|NCT01040429|Analgesics|analgesics|mesh-ancestor
101880420|NCT01040429|Sensory System Agents|sensory system agents|mesh-ancestor
101880421|NCT01040429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101880422|NCT01040429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880423|NCT01040429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101880424|NCT01040429|Sympatholytics|sympatholytics|mesh-ancestor
101880425|NCT01040429|Autonomic Agents|autonomic agents|mesh-ancestor
101880426|NCT01040429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101880427|NCT01040429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101880428|NCT01040429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101880429|NCT01040429|Adrenergic Agents|adrenergic agents|mesh-ancestor
101880430|NCT01040429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101880431|NCT01040429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880432|NCT01039883|Albaconazole|albaconazole|mesh-list
101880433|NCT01039883|Antifungal Agents|antifungal agents|mesh-ancestor
101880434|NCT01039883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101880435|NCT00405275|Hydroxychloroquine|hydroxychloroquine|mesh-list
101880436|NCT00405275|Sulfasalazine|sulfasalazine|mesh-list
101880437|NCT00405275|Etanercept|etanercept|mesh-list
101880438|NCT00405275|Methotrexate|methotrexate|mesh-list
101880439|NCT00405275|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101880440|NCT00405275|Abortifacient Agents|abortifacient agents|mesh-ancestor
101880441|NCT00405275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101880442|NCT00405275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880443|NCT00405275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101880444|NCT00405275|Antimetabolites|antimetabolites|mesh-ancestor
101880445|NCT00405275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880446|NCT00405275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101880447|NCT00405275|Dermatologic Agents|dermatologic agents|mesh-ancestor
101880448|NCT00405275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101880449|NCT00405275|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101880450|NCT00405275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101880451|NCT00405275|Immunologic Factors|immunologic factors|mesh-ancestor
101880452|NCT00405275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101880453|NCT00405275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101880454|NCT00405275|Antimalarials|antimalarials|mesh-ancestor
101880455|NCT00405275|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101880456|NCT00405275|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101880457|NCT00405275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101880458|NCT00405275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101880459|NCT00405275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101880460|NCT00405275|Analgesics|analgesics|mesh-ancestor
101880461|NCT00405275|Sensory System Agents|sensory system agents|mesh-ancestor
101880462|NCT00405275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101880463|NCT00405275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101880464|NCT00405275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101880465|NCT00404651|Vaccines|vaccines|mesh-list
101880466|NCT00404651|Immunologic Factors|immunologic factors|mesh-ancestor
101880467|NCT00404651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880468|NCT00404495|Irinotecan|irinotecan|mesh-list
101880469|NCT00404495|Temozolomide|temozolomide|mesh-list
101880470|NCT00404495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101880471|NCT00404495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101880472|NCT00404495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101880473|NCT00404495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880474|NCT00404495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101880475|NCT00404495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101880476|NCT00404495|Alkylating Agents|alkylating agents|mesh-ancestor
101880477|NCT00409409|Immunomodulating Agents|immunomodulating agents|mesh-list
101880478|NCT00409409|Immunologic Factors|immunologic factors|mesh-ancestor
101880479|NCT00409409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880480|NCT00409331|Amifostine|amifostine|mesh-list
101880481|NCT00409331|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101880482|NCT00409331|Protective Agents|protective agents|mesh-ancestor
101880483|NCT00409331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880484|NCT00362219|Morphine|morphine|mesh-list
101880485|NCT00362219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101880486|NCT00362219|Narcotics|narcotics|mesh-ancestor
101880487|NCT00362219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101880488|NCT00362219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880489|NCT00362219|Analgesics|analgesics|mesh-ancestor
101880490|NCT00362219|Sensory System Agents|sensory system agents|mesh-ancestor
101880491|NCT00362219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101880492|NCT01040585|Linezolid|linezolid|mesh-list
101880493|NCT01040585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101880494|NCT01040585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101880495|NCT01040585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101880496|NCT01040585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101880497|NCT01040585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880498|NCT01040195|Hydroxychloroquine|hydroxychloroquine|mesh-list
101880499|NCT01040195|Methotrexate|methotrexate|mesh-list
101880500|NCT01040195|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101880501|NCT01040195|Abortifacient Agents|abortifacient agents|mesh-ancestor
101880502|NCT01040195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101880503|NCT01040195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880504|NCT01040195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101880505|NCT01040195|Antimetabolites|antimetabolites|mesh-ancestor
101880506|NCT01040195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880507|NCT01040195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101880508|NCT01040195|Dermatologic Agents|dermatologic agents|mesh-ancestor
101880509|NCT01040195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101880510|NCT01040195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101880511|NCT01040195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101880512|NCT01040195|Immunologic Factors|immunologic factors|mesh-ancestor
101880513|NCT01040195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101880514|NCT01040195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101880515|NCT01040195|Antimalarials|antimalarials|mesh-ancestor
101880516|NCT01040195|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101880517|NCT01040195|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101880518|NCT01040195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101880519|NCT01040273|Bupivacaine|bupivacaine|mesh-list
101880520|NCT01040273|Anesthetics, Local|anesthetics, local|mesh-ancestor
101880521|NCT01040273|Anesthetics|anesthetics|mesh-ancestor
101880522|NCT01040273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101880523|NCT01040273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880524|NCT01040273|Sensory System Agents|sensory system agents|mesh-ancestor
101880525|NCT01040273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101880526|NCT00408629|Adalimumab|adalimumab|mesh-list
101880527|NCT00408629|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101880528|NCT00408629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101880529|NCT00408629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101880530|NCT00408317|Pancrelipase|pancrelipase|mesh-list
101880531|NCT00408317|Pancreatin|pancreatin|mesh-list
101880532|NCT00408317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101880533|NCT00112502|Thalidomide|thalidomide|mesh-list
101880534|NCT00112502|Celecoxib|celecoxib|mesh-list
101880535|NCT00112502|Temozolomide|temozolomide|mesh-list
101880536|NCT00112502|Isotretinoin|isotretinoin|mesh-list
101880537|NCT00112502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101880538|NCT00112502|Alkylating Agents|alkylating agents|mesh-ancestor
101880539|NCT00112502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880540|NCT00112502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101880541|NCT00112502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101880542|NCT00112502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101880544|NCT00112502|Sensory System Agents|sensory system agents|mesh-ancestor
101880545|NCT00112502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101880546|NCT00112502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880547|NCT00112502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101880548|NCT00112502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101880549|NCT00112502|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101880550|NCT00112502|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101880551|NCT00112502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101880552|NCT00112502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101880553|NCT00112502|Immunologic Factors|immunologic factors|mesh-ancestor
101880554|NCT00112502|Leprostatic Agents|leprostatic agents|mesh-ancestor
101880555|NCT00112502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101880556|NCT00112502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101880557|NCT00112502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101880558|NCT00112502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101880559|NCT00112502|Growth Substances|growth substances|mesh-ancestor
101880560|NCT00112502|Growth Inhibitors|growth inhibitors|mesh-ancestor
101880561|NCT00112502|Dermatologic Agents|dermatologic agents|mesh-ancestor
101880562|NCT03965546|Sorafenib|sorafenib|mesh-list
101880563|NCT03965546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101880564|NCT03965546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101880565|NCT03965546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101880566|NCT03965546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880567|NCT01083992|Vitamin D|vitamin d|mesh-list
101880568|NCT01083992|Vildagliptin|vildagliptin|mesh-list
101880569|NCT01083992|Vitamins|vitamins|mesh-ancestor
101880570|NCT01083992|Micronutrients|micronutrients|mesh-ancestor
101880571|NCT01083992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880572|NCT01083992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101880573|NCT01083992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101880574|NCT01083992|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101880575|NCT01083992|Protease Inhibitors|protease inhibitors|mesh-ancestor
101880576|NCT01083992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101880577|NCT01083992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880578|NCT03822182|Dexamethasone|dexamethasone|mesh-list
101880579|NCT03822182|Bupivacaine|bupivacaine|mesh-list
101880580|NCT03822182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101880581|NCT03822182|Antiemetics|antiemetics|mesh-ancestor
101880582|NCT03822182|Autonomic Agents|autonomic agents|mesh-ancestor
101880583|NCT03822182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101880584|NCT03822182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880585|NCT03822182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101880586|NCT03822182|Glucocorticoids|glucocorticoids|mesh-ancestor
101880587|NCT03822182|Hormones|hormones|mesh-ancestor
101880588|NCT03822182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101880589|NCT03822182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101880590|NCT03822182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101880591|NCT03822182|Anesthetics, Local|anesthetics, local|mesh-ancestor
101880592|NCT03822182|Anesthetics|anesthetics|mesh-ancestor
101880593|NCT03822182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101880594|NCT03822182|Sensory System Agents|sensory system agents|mesh-ancestor
101880595|NCT01078610|Adalimumab|adalimumab|mesh-list
101880596|NCT01078610|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101880597|NCT01078610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101880598|NCT01078610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101880599|NCT01080482|Tacrolimus|tacrolimus|mesh-list
101880600|NCT01080482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101880601|NCT01080482|Immunologic Factors|immunologic factors|mesh-ancestor
101880602|NCT01080482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880603|NCT01080482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101880604|NCT01080482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101880605|NCT01080482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880606|NCT03965624|Ixazomib|ixazomib|mesh-list
101880607|NCT03965624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101880608|NCT03965624|Protease Inhibitors|protease inhibitors|mesh-ancestor
101880609|NCT03965624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101880610|NCT03965624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880611|NCT01080560|Cyclosporine|cyclosporine|mesh-list
101880612|NCT01080560|Cyclosporins|cyclosporins|mesh-list
101880613|NCT01080560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101880614|NCT01080560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880615|NCT01080560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101880616|NCT01080560|Immunologic Factors|immunologic factors|mesh-ancestor
101880617|NCT01080560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880618|NCT01080560|Antifungal Agents|antifungal agents|mesh-ancestor
101880619|NCT01080560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101880620|NCT01080560|Dermatologic Agents|dermatologic agents|mesh-ancestor
101880621|NCT01080560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101880622|NCT01080560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101880623|NCT00094328|Anastrozole|anastrozole|mesh-list
101880624|NCT00094328|Bicalutamide|bicalutamide|mesh-list
101880625|NCT00094328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101880626|NCT00094328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101880627|NCT00094328|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101880628|NCT00094328|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101880629|NCT00094328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101880630|NCT00094328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880631|NCT00094328|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101880632|NCT00094328|Hormone Antagonists|hormone antagonists|mesh-ancestor
101880633|NCT00094328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101880634|NCT00094328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880635|NCT00094328|Androgen Antagonists|androgen antagonists|mesh-ancestor
101880636|NCT00094172|Atorvastatin|atorvastatin|mesh-list
101880637|NCT00094172|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101880638|NCT00094172|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101880639|NCT00094172|Antimetabolites|antimetabolites|mesh-ancestor
101880640|NCT00094172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880641|NCT00094172|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101880642|NCT00094172|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101880643|NCT00094172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101880644|NCT00094094|Axitinib|axitinib|mesh-list
101880645|NCT00094094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101880646|NCT00094094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101880647|NCT00094094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101880648|NCT00094094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880649|NCT03962816|Vaccines|vaccines|mesh-list
101880650|NCT03962816|Immunologic Factors|immunologic factors|mesh-ancestor
101880651|NCT03962816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880652|NCT01080638|polysaccharide-K|polysaccharide-k|mesh-list
101880653|NCT01080638|Abciximab|abciximab|mesh-list
101880654|NCT01080638|Anticoagulants|anticoagulants|mesh-ancestor
101880655|NCT01080638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101880656|NCT01080638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101880657|NCT01080638|Immunologic Factors|immunologic factors|mesh-ancestor
101880658|NCT01080638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880659|NCT01080638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101880660|NCT01080638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101880661|NCT01080638|Antiviral Agents|antiviral agents|mesh-ancestor
101880662|NCT01080638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101880663|NCT01080638|Interferon Inducers|interferon inducers|mesh-ancestor
101880664|NCT01080638|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101880665|NCT01080638|Protective Agents|protective agents|mesh-ancestor
101880666|NCT00110396|Interferons|interferons|mesh-list
101880667|NCT00110396|Interferon-beta|interferon-beta|mesh-list
101880668|NCT00110396|Interferon beta-1a|interferon beta-1a|mesh-list
101880669|NCT00110396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101880670|NCT00110396|Antiviral Agents|antiviral agents|mesh-ancestor
101880671|NCT00110396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101880672|NCT00110396|Immunologic Factors|immunologic factors|mesh-ancestor
101880673|NCT00110396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880674|NCT00110396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101880675|NCT00093470|Tipifarnib|tipifarnib|mesh-list
101880676|NCT00093470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101880677|NCT00407537|Amlodipine|amlodipine|mesh-list
101880678|NCT00407537|Atorvastatin|atorvastatin|mesh-list
101880679|NCT00407537|Calcium|calcium|mesh-list
101880680|NCT00407537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101880681|NCT00407537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880682|NCT00407537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101880683|NCT00407537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101880684|NCT00407537|Antimetabolites|antimetabolites|mesh-ancestor
101880685|NCT00407537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880686|NCT00407537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101880687|NCT00407537|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101880688|NCT00407537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101880689|NCT00407537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101880690|NCT00407537|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101880691|NCT00407537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101880692|NCT00407537|Vasodilator Agents|vasodilator agents|mesh-ancestor
101880694|NCT00094458|Azathioprine|azathioprine|mesh-list
101880695|NCT00094458|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101880696|NCT00094458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101880697|NCT00094458|Dermatologic Agents|dermatologic agents|mesh-ancestor
101880698|NCT00094458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101880699|NCT00094458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101880700|NCT00094458|Antimetabolites|antimetabolites|mesh-ancestor
101880701|NCT00094458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880702|NCT00094458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101880703|NCT00094458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101880704|NCT00094458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101880705|NCT00094458|Immunologic Factors|immunologic factors|mesh-ancestor
101880706|NCT00094458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880707|NCT00406367|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
101880708|NCT00406367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101880709|NCT00406367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101880710|NCT00406367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880711|NCT00406367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101880712|NCT00406367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101880713|NCT00406367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880714|NCT00406367|Cholinergic Agents|cholinergic agents|mesh-ancestor
101880715|NCT00406367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101880716|NCT01041443|Tetrahydrouridine|tetrahydrouridine|mesh-list
101880717|NCT01041443|Antimetabolites|antimetabolites|mesh-ancestor
101880718|NCT01041443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880719|NCT03961464|Cycloserine|cycloserine|mesh-list
101880720|NCT03961464|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101880721|NCT03961464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101880722|NCT03961464|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101880723|NCT03961464|Antitubercular Agents|antitubercular agents|mesh-ancestor
101880724|NCT03961464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101880725|NCT03961464|Antimetabolites|antimetabolites|mesh-ancestor
101880726|NCT03961464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880727|NCT01087554|Sirolimus|sirolimus|mesh-list
101880728|NCT01087554|Everolimus|everolimus|mesh-list
101880729|NCT01087554|MTOR Inhibitors|mtor inhibitors|mesh-list
101880730|NCT01087554|Temsirolimus|temsirolimus|mesh-list
101880731|NCT01087554|Vorinostat|vorinostat|mesh-list
101880732|NCT01087554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101880733|NCT01087554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101880734|NCT01087554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880735|NCT01087554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101880736|NCT01087554|Immunologic Factors|immunologic factors|mesh-ancestor
101880737|NCT01087554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880738|NCT01087554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101880739|NCT01087554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101880740|NCT01087554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101880741|NCT01087554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101880742|NCT01087554|Antifungal Agents|antifungal agents|mesh-ancestor
101880743|NCT01087554|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101880744|NCT01087632|Folic Acid|folic acid|mesh-list
101880745|NCT01087632|Coenzyme Q10|coenzyme q10|mesh-list
101880746|NCT01087632|Policosanol|policosanol|mesh-list
101880747|NCT01087632|Red yeast rice|red yeast rice|mesh-list
101880748|NCT01087632|Hematinics|hematinics|mesh-ancestor
101880749|NCT01087632|Vitamin B Complex|vitamin b complex|mesh-ancestor
101880750|NCT01087632|Vitamins|vitamins|mesh-ancestor
101880751|NCT01087632|Micronutrients|micronutrients|mesh-ancestor
101880752|NCT01087632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880753|NCT01087632|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101880754|NCT01087632|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101880755|NCT01087632|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101880756|NCT01087632|Antimetabolites|antimetabolites|mesh-ancestor
101880757|NCT01087632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880758|NCT01087632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101880759|NCT01087632|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101880760|NCT01087632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101880762|NCT00394589|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101880763|NCT00394589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101880764|NCT00394589|Dermatologic Agents|dermatologic agents|mesh-ancestor
101880765|NCT00394589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101880766|NCT00394589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101880767|NCT00068406|Cisplatin|cisplatin|mesh-list
101880768|NCT00068406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101880769|NCT00403559|Ketoconazole|ketoconazole|mesh-list
101880770|NCT00403559|Pimecrolimus|pimecrolimus|mesh-list
101880771|NCT00403559|Antifungal Agents|antifungal agents|mesh-ancestor
101880772|NCT00403559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101880773|NCT00403559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101880774|NCT00403559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101880775|NCT00403559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101880776|NCT00403559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880777|NCT00403559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101880778|NCT00403559|Hormone Antagonists|hormone antagonists|mesh-ancestor
101880779|NCT00403559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101880780|NCT00403559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880781|NCT00403559|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101880782|NCT00403559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101880783|NCT00403559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101880784|NCT00403559|Analgesics|analgesics|mesh-ancestor
101880785|NCT00403559|Sensory System Agents|sensory system agents|mesh-ancestor
101880786|NCT00403559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101880787|NCT00403559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101880788|NCT00403559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101880789|NCT00403559|Dermatologic Agents|dermatologic agents|mesh-ancestor
101880790|NCT00403559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101880791|NCT00403559|Immunologic Factors|immunologic factors|mesh-ancestor
101880792|NCT00403559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101880793|NCT01087710|Vitamins|vitamins|mesh-list
101880794|NCT01087710|Antioxidants|antioxidants|mesh-list
101880795|NCT01087710|Micronutrients|micronutrients|mesh-ancestor
101880796|NCT01087710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880797|NCT01087710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880798|NCT01087710|Protective Agents|protective agents|mesh-ancestor
101880799|NCT00403481|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101880801|NCT00403481|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101880802|NCT00403481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101880803|NCT00403481|Diuretics|diuretics|mesh-ancestor
101880804|NCT00403481|Natriuretic Agents|natriuretic agents|mesh-ancestor
101880805|NCT00403481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880806|NCT00403481|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101880807|NCT00403481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101880808|NCT00403481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880809|NCT00403481|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101880810|NCT00403481|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101880811|NCT00402779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101880812|NCT00402779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101880813|NCT00402779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101880814|NCT00402779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101880815|NCT00402779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880816|NCT00394433|Bevacizumab|bevacizumab|mesh-list
101880817|NCT00394433|Cisplatin|cisplatin|mesh-list
101880818|NCT00394433|Docetaxel|docetaxel|mesh-list
101880819|NCT00394433|Irinotecan|irinotecan|mesh-list
101880820|NCT00394433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101880821|NCT00394433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101880822|NCT00394433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101880823|NCT00394433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101880824|NCT00394433|Growth Substances|growth substances|mesh-ancestor
101880825|NCT00394433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880826|NCT00394433|Growth Inhibitors|growth inhibitors|mesh-ancestor
101880827|NCT00394433|Tubulin Modulators|tubulin modulators|mesh-ancestor
101880828|NCT00394433|Antimitotic Agents|antimitotic agents|mesh-ancestor
101880829|NCT00394433|Mitosis Modulators|mitosis modulators|mesh-ancestor
101880830|NCT00394433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880831|NCT00394433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101880832|NCT00394433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101880833|NCT00394433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101880834|NCT00092534|Vaccines|vaccines|mesh-list
101880835|NCT00092534|Immunologic Factors|immunologic factors|mesh-ancestor
101880836|NCT00092534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880837|NCT00068250|Rituximab|rituximab|mesh-list
101880838|NCT00068250|Methotrexate|methotrexate|mesh-list
101880839|NCT00068250|Temozolomide|temozolomide|mesh-list
101880840|NCT00068250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101880841|NCT00068250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101880842|NCT00068250|Immunologic Factors|immunologic factors|mesh-ancestor
101880843|NCT00068250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880844|NCT00068250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101880845|NCT00068250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101880846|NCT00068250|Abortifacient Agents|abortifacient agents|mesh-ancestor
101880847|NCT00068250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101880848|NCT00068250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101880849|NCT00068250|Antimetabolites|antimetabolites|mesh-ancestor
101880850|NCT00068250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880851|NCT00068250|Dermatologic Agents|dermatologic agents|mesh-ancestor
101880852|NCT00068250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101880853|NCT00068250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101880854|NCT00068250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101880855|NCT00068250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101880856|NCT00068250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101880857|NCT00068250|Alkylating Agents|alkylating agents|mesh-ancestor
101880858|NCT03957720|Penicillamine|penicillamine|mesh-list
101880859|NCT03957720|Succimer|succimer|mesh-list
101880860|NCT03957720|Antidotes|antidotes|mesh-ancestor
101880861|NCT03957720|Protective Agents|protective agents|mesh-ancestor
101880862|NCT03957720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880863|NCT03957720|Chelating Agents|chelating agents|mesh-ancestor
101880864|NCT03957720|Sequestering Agents|sequestering agents|mesh-ancestor
101880865|NCT03957720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880866|NCT03957720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101880867|NCT00393029|Aldesleukin|aldesleukin|mesh-list
101880868|NCT00393029|Cyclophosphamide|cyclophosphamide|mesh-list
101880869|NCT00393029|Fludarabine|fludarabine|mesh-list
101349133|NCT03957057|Iron|iron|mesh-list
101880870|NCT00393029|Fludarabine phosphate|fludarabine phosphate|mesh-list
101880871|NCT00393029|Interleukin-2|interleukin-2|mesh-list
101880872|NCT00393029|Lenograstim|lenograstim|mesh-list
101880873|NCT00393029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101880874|NCT00393029|Immunologic Factors|immunologic factors|mesh-ancestor
101880875|NCT00393029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880876|NCT00393029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101880877|NCT00393029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101880878|NCT00393029|Alkylating Agents|alkylating agents|mesh-ancestor
101880879|NCT00393029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454817|NCT00238212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101880880|NCT00393029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101880881|NCT00393029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101880882|NCT00393029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101880883|NCT00393029|Antimetabolites|antimetabolites|mesh-ancestor
101880884|NCT00393029|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101880885|NCT00393029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101880886|NCT00393029|Analgesics|analgesics|mesh-ancestor
101880887|NCT00393029|Sensory System Agents|sensory system agents|mesh-ancestor
101880888|NCT00393029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101880889|NCT00393029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101880890|NCT00393029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101880891|NCT00393029|Antiviral Agents|antiviral agents|mesh-ancestor
101880892|NCT00393029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101880893|NCT00402233|Pramipexole|pramipexole|mesh-list
101880894|NCT00402233|Antioxidants|antioxidants|mesh-ancestor
101880895|NCT00402233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880896|NCT00402233|Protective Agents|protective agents|mesh-ancestor
101880897|NCT00402233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880898|NCT00402233|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101880899|NCT00402233|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101880900|NCT00402233|Dopamine Agonists|dopamine agonists|mesh-ancestor
101880901|NCT00402233|Dopamine Agents|dopamine agents|mesh-ancestor
101880902|NCT00402233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101880903|NCT03993431|Methamphetamine|methamphetamine|mesh-list
101880904|NCT03993431|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101880905|NCT03993431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880906|NCT03993431|Sympathomimetics|sympathomimetics|mesh-ancestor
101880907|NCT03993431|Autonomic Agents|autonomic agents|mesh-ancestor
101880908|NCT03993431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101880909|NCT03993431|Dopamine Agents|dopamine agents|mesh-ancestor
101600734|NCT02705872|Dsuvia|dsuvia|mesh-list
101880910|NCT03993431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101880911|NCT03993431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880912|NCT03993431|Adrenergic Agents|adrenergic agents|mesh-ancestor
101880913|NCT03993431|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101880914|NCT03993431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101880915|NCT03993431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101880916|NCT03993431|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101880917|NCT00401843|Dexamethasone|dexamethasone|mesh-list
101880919|NCT00401843|Siltuximab|siltuximab|mesh-list
101880920|NCT00401843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101880921|NCT00401843|Antiemetics|antiemetics|mesh-ancestor
101880922|NCT00401843|Autonomic Agents|autonomic agents|mesh-ancestor
101880923|NCT00401843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101880924|NCT00401843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880925|NCT00401843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101880926|NCT00401843|Glucocorticoids|glucocorticoids|mesh-ancestor
101880927|NCT00401843|Hormones|hormones|mesh-ancestor
101880928|NCT00401843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101880929|NCT00401843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101880930|NCT00401843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101880931|NCT00401531|Vaccines|vaccines|mesh-list
101880932|NCT00401531|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101880933|NCT00401531|Immunologic Factors|immunologic factors|mesh-ancestor
101880934|NCT00401531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880935|NCT00401375|Methylnaltrexone|methylnaltrexone|mesh-list
101880936|NCT00401375|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101880937|NCT00401375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880938|NCT00401375|Sensory System Agents|sensory system agents|mesh-ancestor
101880939|NCT00401375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101880940|NCT00400517|Thalidomide|thalidomide|mesh-list
101880941|NCT00400517|Sargramostim|sargramostim|mesh-list
101880942|NCT00400517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101880943|NCT00400517|Immunologic Factors|immunologic factors|mesh-ancestor
101880944|NCT00400517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880945|NCT00400517|Leprostatic Agents|leprostatic agents|mesh-ancestor
101880946|NCT00400517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101880947|NCT00400517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101880948|NCT00400517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101880949|NCT00400517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101880950|NCT00400517|Growth Substances|growth substances|mesh-ancestor
101880951|NCT00400517|Growth Inhibitors|growth inhibitors|mesh-ancestor
101880952|NCT00400517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101880953|NCT01044095|Vaccines|vaccines|mesh-list
101880954|NCT01044095|Immunologic Factors|immunologic factors|mesh-ancestor
101880955|NCT01044095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880956|NCT00392171|Temozolomide|temozolomide|mesh-list
101880957|NCT00392171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101880958|NCT00392171|Alkylating Agents|alkylating agents|mesh-ancestor
101880959|NCT00392171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880960|NCT00392171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101880961|NCT00091832|Denosumab|denosumab|mesh-list
101880962|NCT00091832|Diphosphonates|diphosphonates|mesh-list
101880963|NCT00091832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101880964|NCT00091832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880965|NCT00391391|Vaccines|vaccines|mesh-list
101880966|NCT00391391|Immunologic Factors|immunologic factors|mesh-ancestor
101880967|NCT00391391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880968|NCT01044251|Frovatriptan|frovatriptan|mesh-list
101880969|NCT01044251|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101880970|NCT01044251|Serotonin Agents|serotonin agents|mesh-ancestor
101880971|NCT01044251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101880972|NCT01044251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880973|NCT01044251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880974|NCT01044329|Triamcinolone|triamcinolone|mesh-list
101880975|NCT01044329|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101880976|NCT01044329|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101880977|NCT01044329|Bevacizumab|bevacizumab|mesh-list
101880978|NCT01044329|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101880979|NCT01044329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101880980|NCT01044329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101880981|NCT01044329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101880982|NCT01044329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101880983|NCT01044329|Growth Substances|growth substances|mesh-ancestor
101880984|NCT01044329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101880985|NCT01044329|Growth Inhibitors|growth inhibitors|mesh-ancestor
101880986|NCT01044329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101880987|NCT01044329|Glucocorticoids|glucocorticoids|mesh-ancestor
101880988|NCT01044329|Hormones|hormones|mesh-ancestor
101880989|NCT01044329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101880990|NCT01044329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101880991|NCT01044329|Immunologic Factors|immunologic factors|mesh-ancestor
101880992|NCT01044329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101880993|NCT01044329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101880994|NCT00091442|Docetaxel|docetaxel|mesh-list
101880995|NCT00091442|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101880996|NCT00091442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101880997|NCT00091442|Tubulin Modulators|tubulin modulators|mesh-ancestor
101880998|NCT00091442|Antimitotic Agents|antimitotic agents|mesh-ancestor
101880999|NCT00091442|Mitosis Modulators|mitosis modulators|mesh-ancestor
101881000|NCT00091442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881001|NCT00091442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101881002|NCT00390689|Pramipexole|pramipexole|mesh-list
101881003|NCT00390689|Antioxidants|antioxidants|mesh-ancestor
101881004|NCT00390689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881005|NCT00390689|Protective Agents|protective agents|mesh-ancestor
101881006|NCT00390689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881007|NCT00390689|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101881008|NCT00390689|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101881009|NCT00390689|Dopamine Agonists|dopamine agonists|mesh-ancestor
101881010|NCT00390689|Dopamine Agents|dopamine agents|mesh-ancestor
101881011|NCT00390689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101881013|NCT01079078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101881014|NCT01079078|Analgesics|analgesics|mesh-ancestor
101881015|NCT01079078|Sensory System Agents|sensory system agents|mesh-ancestor
101881016|NCT01079078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101881017|NCT01079078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881018|NCT01079078|Antipyretics|antipyretics|mesh-ancestor
101881019|NCT00390455|Fulvestrant|fulvestrant|mesh-list
101881020|NCT00390455|Lapatinib|lapatinib|mesh-list
101881021|NCT00390455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101881022|NCT00390455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101881023|NCT00390455|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101881024|NCT00390455|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101881025|NCT00390455|Hormone Antagonists|hormone antagonists|mesh-ancestor
101881026|NCT00390455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101881027|NCT00390455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881028|NCT00390455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101881029|NCT00390455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881030|NCT00390455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881031|NCT03812510|Hydrogen Peroxide|hydrogen peroxide|mesh-list
101881032|NCT03812510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101881033|NCT03812510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101881034|NCT01583114|Perindopril|perindopril|mesh-list
101881035|NCT01583114|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101881036|NCT01583114|Protease Inhibitors|protease inhibitors|mesh-ancestor
101881037|NCT01583114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881038|NCT01583114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881039|NCT01583114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101881040|NCT01079312|Fentanyl|fentanyl|mesh-list
101881041|NCT01079312|Remifentanil|remifentanil|mesh-list
101881042|NCT01079312|Propofol|propofol|mesh-list
101881043|NCT01079312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
101881044|NCT01079312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101881045|NCT01079312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881046|NCT01079312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101881047|NCT01079312|Anesthetics, General|anesthetics, general|mesh-ancestor
101881048|NCT01079312|Anesthetics|anesthetics|mesh-ancestor
101881049|NCT01079312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101881050|NCT01079312|Narcotics|narcotics|mesh-ancestor
101881051|NCT01079312|Analgesics|analgesics|mesh-ancestor
101881052|NCT01079312|Sensory System Agents|sensory system agents|mesh-ancestor
101881053|NCT01079312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101881054|NCT01079312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101881055|NCT01044485|Docetaxel|docetaxel|mesh-list
101881056|NCT01044485|Lapatinib|lapatinib|mesh-list
101881057|NCT01044485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101881058|NCT01044485|Tubulin Modulators|tubulin modulators|mesh-ancestor
101881059|NCT01044485|Antimitotic Agents|antimitotic agents|mesh-ancestor
101881060|NCT01044485|Mitosis Modulators|mitosis modulators|mesh-ancestor
101881061|NCT01044485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881062|NCT01044485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101881063|NCT01044485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881065|NCT00119678|Abatacept|abatacept|mesh-list
101881066|NCT00119678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101881067|NCT00119678|Glucocorticoids|glucocorticoids|mesh-ancestor
101881068|NCT00119678|Hormones|hormones|mesh-ancestor
101454867|NCT00211328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101881069|NCT00119678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101881070|NCT00119678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881071|NCT00119678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101881072|NCT00119678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101881073|NCT00119678|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101881074|NCT00119678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881075|NCT00119678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101881076|NCT00119678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101881077|NCT00119678|Immunologic Factors|immunologic factors|mesh-ancestor
101881078|NCT00119678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101881079|NCT00110084|Paclitaxel|paclitaxel|mesh-list
101881080|NCT00110084|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101881081|NCT00110084|Gemcitabine|gemcitabine|mesh-list
101881082|NCT00110084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101881083|NCT00110084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101881084|NCT00110084|Tubulin Modulators|tubulin modulators|mesh-ancestor
101881085|NCT00110084|Antimitotic Agents|antimitotic agents|mesh-ancestor
101881086|NCT00110084|Mitosis Modulators|mitosis modulators|mesh-ancestor
101881087|NCT00110084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881088|NCT00110084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101881089|NCT00110084|Antimetabolites|antimetabolites|mesh-ancestor
101881090|NCT00390221|Daclizumab|daclizumab|mesh-list
101881091|NCT00390221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101881092|NCT00390221|Immunologic Factors|immunologic factors|mesh-ancestor
101881093|NCT00390221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881094|NCT00389831|Rotigotine|rotigotine|mesh-list
101881095|NCT00389831|Dopamine Agonists|dopamine agonists|mesh-ancestor
101881096|NCT00389831|Dopamine Agents|dopamine agents|mesh-ancestor
101881097|NCT00389831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101881098|NCT00389831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881099|NCT00389831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881100|NCT00389519|Ramipril|ramipril|mesh-list
101881101|NCT00389519|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101881102|NCT00389519|Protease Inhibitors|protease inhibitors|mesh-ancestor
101881103|NCT00389519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881104|NCT00389519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881105|NCT00389519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101881106|NCT00389441|Axitinib|axitinib|mesh-list
101881107|NCT00389441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101881108|NCT00389441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101881109|NCT00389441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881110|NCT00389441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881111|NCT00118898|Ritonavir|ritonavir|mesh-list
101881112|NCT00118898|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101881113|NCT00118898|Tenofovir|tenofovir|mesh-list
101881114|NCT00118898|Lamivudine|lamivudine|mesh-list
101881115|NCT00118898|Emtricitabine|emtricitabine|mesh-list
101881116|NCT00118898|Abacavir|abacavir|mesh-list
101881117|NCT00118898|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101881118|NCT00118898|Efavirenz|efavirenz|mesh-list
101881119|NCT00118898|Dideoxynucleosides|dideoxynucleosides|mesh-list
101881120|NCT00118898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101881121|NCT00118898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101881122|NCT00118898|Protease Inhibitors|protease inhibitors|mesh-ancestor
101881123|NCT00118898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102074175|NCT03554304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101881124|NCT00118898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881125|NCT00118898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101881126|NCT00118898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101881127|NCT00118898|Antiviral Agents|antiviral agents|mesh-ancestor
101881128|NCT00118898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101881129|NCT00118898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101881130|NCT00118898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101881131|NCT00118898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101881132|NCT00118898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101881133|NCT00118898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101881134|NCT00118898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101881135|NCT00118898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101881136|NCT00118898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101881137|NCT00118898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101881138|NCT00118898|Antimetabolites|antimetabolites|mesh-ancestor
101881139|NCT00118430|Antidepressive Agents|antidepressive agents|mesh-list
101881140|NCT00118430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101881141|NCT01085552|Epoetin Alfa|epoetin alfa|mesh-list
101881142|NCT01085552|Hematinics|hematinics|mesh-ancestor
101881143|NCT01085708|Rabeprazole|rabeprazole|mesh-list
101881144|NCT01085708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101881145|NCT01085708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101881146|NCT01085708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101967950|NCT00039871|Ribavirin|ribavirin|mesh-list
101881147|NCT01085708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881148|NCT01085708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881149|NCT00090584|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101881150|NCT00090584|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101881151|NCT00090584|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101881152|NCT00090584|Cholinergic Agents|cholinergic agents|mesh-ancestor
101881153|NCT00090584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101881154|NCT00090584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881155|NCT00090584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881156|NCT00090584|Urological Agents|urological agents|mesh-ancestor
101881158|NCT01079624|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101881159|NCT01079624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101881161|NCT01079624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101881162|NCT01079624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881163|NCT01079624|Incretins|incretins|mesh-ancestor
101881164|NCT01086020|Atorvastatin|atorvastatin|mesh-list
101881165|NCT01086020|Ezetimibe|ezetimibe|mesh-list
101881166|NCT01086020|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101881167|NCT01086020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101881168|NCT01086020|Antimetabolites|antimetabolites|mesh-ancestor
101881169|NCT01086020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881170|NCT01086020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101881171|NCT01086020|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101881172|NCT01086020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881173|NCT03670810|Lasmiditan|lasmiditan|mesh-list
101881174|NCT03670810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101881175|NCT03670810|Serotonin Agents|serotonin agents|mesh-ancestor
101881176|NCT03670810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101881177|NCT03670810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881178|NCT03670810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881179|NCT01086254|Gemcitabine|gemcitabine|mesh-list
101881180|NCT01086254|Iniparib|iniparib|mesh-list
101881181|NCT01086254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101881182|NCT01086254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101881183|NCT01086254|Antimetabolites|antimetabolites|mesh-ancestor
101881184|NCT01086254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881185|NCT01086254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101881186|NCT01086254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881187|NCT01086332|Nelfinavir|nelfinavir|mesh-list
101881188|NCT01086332|Gemcitabine|gemcitabine|mesh-list
101881189|NCT01086332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101881190|NCT01086332|Antimetabolites|antimetabolites|mesh-ancestor
101881191|NCT01086332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881192|NCT01086332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101881193|NCT01086332|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101881194|NCT01086332|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101881196|NCT01086332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881197|NCT01086332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101881198|NCT01086332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101881199|NCT01086332|Antiviral Agents|antiviral agents|mesh-ancestor
101881200|NCT01086332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101881201|NCT01811368|Cyclosporine|cyclosporine|mesh-list
101881202|NCT01811368|Mycophenolic Acid|mycophenolic acid|mesh-list
101881203|NCT01811368|Rituximab|rituximab|mesh-list
101881204|NCT01811368|Cyclosporins|cyclosporins|mesh-list
101881205|NCT01811368|Thymoglobulin|thymoglobulin|mesh-list
101881206|NCT01811368|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101881207|NCT01811368|Immunoglobulins|immunoglobulins|mesh-list
101881208|NCT01811368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101881209|NCT01811368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101881210|NCT01811368|Immunologic Factors|immunologic factors|mesh-ancestor
101881211|NCT01811368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881212|NCT01811368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101881213|NCT01811368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881214|NCT01811368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881215|NCT01811368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101881216|NCT01811368|Antifungal Agents|antifungal agents|mesh-ancestor
101881217|NCT01811368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101881218|NCT01811368|Dermatologic Agents|dermatologic agents|mesh-ancestor
101881219|NCT01811368|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101967953|NCT00039871|Antimetabolites|antimetabolites|mesh-ancestor
101881220|NCT01811368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101881221|NCT01811368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101881222|NCT01811368|Antitubercular Agents|antitubercular agents|mesh-ancestor
101881223|NCT01811368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101881224|NCT00089648|Sunitinib|sunitinib|mesh-list
101881225|NCT00089648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101881226|NCT00089648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101881227|NCT00089648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101881228|NCT00089648|Growth Substances|growth substances|mesh-ancestor
101881229|NCT00089648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881230|NCT00089648|Growth Inhibitors|growth inhibitors|mesh-ancestor
101881231|NCT00089648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101881232|NCT00089648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881233|NCT00089648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881234|NCT01079702|Capecitabine|capecitabine|mesh-list
101881235|NCT01079702|Everolimus|everolimus|mesh-list
101881236|NCT01079702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101881237|NCT01079702|Antimetabolites|antimetabolites|mesh-ancestor
101881238|NCT01079702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881239|NCT01079702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101881240|NCT01079702|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101881241|NCT01079702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101881242|NCT01079702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881243|NCT01079702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101881244|NCT01079702|Immunologic Factors|immunologic factors|mesh-ancestor
101881245|NCT01079702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881246|NCT00118040|Genistein|genistein|mesh-list
101881247|NCT00118040|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101881248|NCT00118040|Protective Agents|protective agents|mesh-ancestor
101881249|NCT00118040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881250|NCT00118040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101881251|NCT00118040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101881252|NCT00118040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881253|NCT00118040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881254|NCT00118040|Phytoestrogens|phytoestrogens|mesh-ancestor
101881255|NCT00118040|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101881256|NCT00118040|Estrogens|estrogens|mesh-ancestor
101881257|NCT00118040|Hormones|hormones|mesh-ancestor
101881258|NCT00118040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101881259|NCT03961958|Propofol|propofol|mesh-list
101881260|NCT03961958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101881261|NCT03961958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101881262|NCT03961958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881263|NCT03961958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101881264|NCT03961958|Anesthetics, General|anesthetics, general|mesh-ancestor
101881265|NCT03961958|Anesthetics|anesthetics|mesh-ancestor
101881266|NCT00389207|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101881267|NCT00389207|Nevirapine|nevirapine|mesh-list
101881268|NCT00389207|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101881269|NCT00389207|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101881270|NCT00389207|Protease Inhibitors|protease inhibitors|mesh-ancestor
101881271|NCT00389207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881272|NCT00389207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881273|NCT00389207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101881274|NCT00389207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101881275|NCT00389207|Antiviral Agents|antiviral agents|mesh-ancestor
101881276|NCT00389207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101881277|NCT00389207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101881278|NCT00389207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101881279|NCT00389207|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101881280|NCT00389207|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101881281|NCT00388973|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101881282|NCT00388973|Antidepressive Agents|antidepressive agents|mesh-ancestor
101881283|NCT00388973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101881284|NCT00388973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101881285|NCT00388973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101601082|NCT00918957|Tobramycin|tobramycin|mesh-list
101881286|NCT00388973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101881287|NCT00388973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881288|NCT00388583|Vaccines|vaccines|mesh-list
101881289|NCT00388583|Immunologic Factors|immunologic factors|mesh-ancestor
101881290|NCT00388583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881291|NCT00117572|Docetaxel|docetaxel|mesh-list
101881292|NCT00117572|Fluorouracil|fluorouracil|mesh-list
101881293|NCT00117572|Hydroxyurea|hydroxyurea|mesh-list
101881294|NCT00117572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101881295|NCT00117572|Tubulin Modulators|tubulin modulators|mesh-ancestor
101881296|NCT00117572|Antimitotic Agents|antimitotic agents|mesh-ancestor
101881297|NCT00117572|Mitosis Modulators|mitosis modulators|mesh-ancestor
101881298|NCT00117572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881299|NCT00117572|Antimetabolites|antimetabolites|mesh-ancestor
101881300|NCT00117572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101881301|NCT00117572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101881302|NCT00117572|Immunologic Factors|immunologic factors|mesh-ancestor
101881303|NCT00117572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881304|NCT00117572|Antisickling Agents|antisickling agents|mesh-ancestor
101881305|NCT00117572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881306|NCT00117572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101881307|NCT00388505|Tobramycin|tobramycin|mesh-list
101881308|NCT00388505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101881309|NCT00388505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101881310|NCT00388349|Cyclophosphamide|cyclophosphamide|mesh-list
101881311|NCT00388349|Carmustine|carmustine|mesh-list
101881312|NCT00388349|Gemcitabine|gemcitabine|mesh-list
101881313|NCT00388349|Etoposide|etoposide|mesh-list
101881314|NCT00388349|Vinorelbine|vinorelbine|mesh-list
101881315|NCT00388349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101881316|NCT00388349|Immunologic Factors|immunologic factors|mesh-ancestor
101881317|NCT00388349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881318|NCT00388349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101881319|NCT00388349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101881320|NCT00388349|Alkylating Agents|alkylating agents|mesh-ancestor
101881321|NCT00388349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881322|NCT00388349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101881323|NCT00388349|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101881324|NCT00388349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101881325|NCT00388349|Antimetabolites|antimetabolites|mesh-ancestor
101881326|NCT00388349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101881327|NCT00388349|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101881328|NCT00388349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101881329|NCT00388349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881330|NCT00388349|Tubulin Modulators|tubulin modulators|mesh-ancestor
101881331|NCT00388349|Antimitotic Agents|antimitotic agents|mesh-ancestor
101881332|NCT00388349|Mitosis Modulators|mitosis modulators|mesh-ancestor
101454970|NCT00238407|Docetaxel|docetaxel|mesh-list
101881333|NCT00117338|Montelukast|montelukast|mesh-list
101881334|NCT00117338|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101881335|NCT00117338|Respiratory System Agents|respiratory system agents|mesh-ancestor
101881336|NCT00117338|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101881337|NCT00117338|Hormone Antagonists|hormone antagonists|mesh-ancestor
101881338|NCT00117338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101881339|NCT00117338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881340|NCT00117338|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101881341|NCT00117338|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101881342|NCT00117338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881343|NCT00388037|Sunitinib|sunitinib|mesh-list
101881344|NCT00388037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101881345|NCT00388037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101881346|NCT00388037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101881347|NCT00388037|Growth Substances|growth substances|mesh-ancestor
101881348|NCT00388037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881349|NCT00388037|Growth Inhibitors|growth inhibitors|mesh-ancestor
101881350|NCT00388037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101881351|NCT00388037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881352|NCT00388037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881353|NCT00387881|Naproxen|naproxen|mesh-list
101881354|NCT00387881|Sumatriptan|sumatriptan|mesh-list
101881355|NCT00387881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101881356|NCT00387881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101881357|NCT00387881|Analgesics|analgesics|mesh-ancestor
101881358|NCT00387881|Sensory System Agents|sensory system agents|mesh-ancestor
101881359|NCT00387881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101881360|NCT00387881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881361|NCT00387881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101881362|NCT00387881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101881363|NCT00387881|Gout Suppressants|gout suppressants|mesh-ancestor
101881364|NCT00387881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101881365|NCT00387881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881366|NCT00387881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881367|NCT00387881|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101881368|NCT00387881|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101881369|NCT00387881|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101881370|NCT00387881|Serotonin Agents|serotonin agents|mesh-ancestor
101881371|NCT00387881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101881373|NCT00084656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101881374|NCT00084656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101881375|NCT00084656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101881376|NCT00084656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881377|NCT00387647|Azacitidine|azacitidine|mesh-list
101881378|NCT00387647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101454997|NCT00211484|Anecortave|anecortave|mesh-list
101881379|NCT00387647|Antimetabolites|antimetabolites|mesh-ancestor
101881380|NCT00387647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881381|NCT00387647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101881382|NCT00387647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881383|NCT00386009|Tadalafil|tadalafil|mesh-list
101881384|NCT00386009|Vasodilator Agents|vasodilator agents|mesh-ancestor
101881385|NCT00386009|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101881386|NCT00386009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101881387|NCT00386009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881388|NCT00386009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881389|NCT00386009|Urological Agents|urological agents|mesh-ancestor
101881390|NCT01045889|Prednisone|prednisone|mesh-list
101881391|NCT01045889|Cyclophosphamide|cyclophosphamide|mesh-list
101881392|NCT01045889|Melphalan|melphalan|mesh-list
101881393|NCT01045889|Rituximab|rituximab|mesh-list
101881394|NCT01045889|Etoposide|etoposide|mesh-list
101881395|NCT01045889|Vincristine|vincristine|mesh-list
101881396|NCT01045889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101881397|NCT01045889|Immunologic Factors|immunologic factors|mesh-ancestor
101881398|NCT01045889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881399|NCT01045889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101881400|NCT01045889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101881401|NCT01045889|Alkylating Agents|alkylating agents|mesh-ancestor
101689185|NCT02652234|Growth Substances|growth substances|mesh-ancestor
101881402|NCT01045889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881403|NCT01045889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101881404|NCT01045889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101881405|NCT01045889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101881406|NCT01045889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101881407|NCT01045889|Glucocorticoids|glucocorticoids|mesh-ancestor
101881409|NCT01045889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101881410|NCT01045889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101881411|NCT01045889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101881412|NCT01045889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101881413|NCT01045889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101881414|NCT01045889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881415|NCT01045889|Tubulin Modulators|tubulin modulators|mesh-ancestor
101881416|NCT01045889|Antimitotic Agents|antimitotic agents|mesh-ancestor
101881417|NCT01045889|Mitosis Modulators|mitosis modulators|mesh-ancestor
101881418|NCT00373685|Celecoxib|celecoxib|mesh-list
101881419|NCT00373685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101881420|NCT00373685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101881421|NCT00373685|Analgesics|analgesics|mesh-ancestor
101881422|NCT00373685|Sensory System Agents|sensory system agents|mesh-ancestor
101881423|NCT00373685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101881424|NCT00373685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881425|NCT00373685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101881426|NCT00373685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101881427|NCT00373685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101881428|NCT00373685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101881429|NCT00373685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881430|NCT00373685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881431|NCT00373529|Clofarabine|clofarabine|mesh-list
101881432|NCT00373529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101881433|NCT00373529|Antimetabolites|antimetabolites|mesh-ancestor
101601231|NCT00704743|Calpastatin|calpastatin|mesh-list
101881434|NCT00373529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881436|NCT00373295|Baclofen|baclofen|mesh-list
101881437|NCT00373295|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101881438|NCT00373295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881439|NCT00373295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101881440|NCT00373295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101881441|NCT00373295|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101881442|NCT00373295|GABA Agonists|gaba agonists|mesh-ancestor
101881443|NCT00373295|GABA Agents|gaba agents|mesh-ancestor
101881444|NCT00373295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101881445|NCT00373295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881446|NCT00385541|Morphine|morphine|mesh-list
101881447|NCT00385541|Hydromorphone|hydromorphone|mesh-list
101881448|NCT00385541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101881449|NCT00385541|Narcotics|narcotics|mesh-ancestor
101881450|NCT00385541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101881451|NCT00385541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881452|NCT00385541|Analgesics|analgesics|mesh-ancestor
101881453|NCT00385541|Sensory System Agents|sensory system agents|mesh-ancestor
101881454|NCT00385541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101881455|NCT01046045|Everolimus|everolimus|mesh-list
101881456|NCT01046045|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101881457|NCT01046045|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101881458|NCT01046045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881459|NCT01046045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881460|NCT01046045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101881461|NCT01046045|Immunologic Factors|immunologic factors|mesh-ancestor
101881462|NCT01046045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881463|NCT01046045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101881464|NCT01044719|Meropenem|meropenem|mesh-list
101881465|NCT01044719|Tobramycin|tobramycin|mesh-list
101881466|NCT01044719|Ceftazidime|ceftazidime|mesh-list
101881467|NCT01044719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101881468|NCT01044719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101881469|NCT01045109|Vitamin D|vitamin d|mesh-list
101881470|NCT01045109|Ergocalciferols|ergocalciferols|mesh-list
101881471|NCT01045109|Cholecalciferol|cholecalciferol|mesh-list
101881472|NCT01045109|Vitamins|vitamins|mesh-list
101881473|NCT01045109|Micronutrients|micronutrients|mesh-ancestor
101881474|NCT01045109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689189|NCT04211012|Paclitaxel|paclitaxel|mesh-list
101881475|NCT01045109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101881476|NCT01045109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101881478|NCT00094302|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
101881479|NCT00094302|Hormone Antagonists|hormone antagonists|mesh-ancestor
101881480|NCT00094302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101881481|NCT00094302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881482|NCT00094302|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101881483|NCT00094302|Diuretics|diuretics|mesh-ancestor
101881484|NCT00094302|Natriuretic Agents|natriuretic agents|mesh-ancestor
101881485|NCT00372905|Rituximab|rituximab|mesh-list
101881486|NCT00372905|Bortezomib|bortezomib|mesh-list
101881487|NCT00372905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101881488|NCT00372905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101881489|NCT00372905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101881490|NCT00372905|Immunologic Factors|immunologic factors|mesh-ancestor
101881491|NCT00372905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881492|NCT00372905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101881493|NCT00384839|Azacitidine|azacitidine|mesh-list
101881494|NCT00384839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101881495|NCT00384839|Antimetabolites|antimetabolites|mesh-ancestor
101881496|NCT00384839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881497|NCT00384839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101881498|NCT00384839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881499|NCT01046279|Bevacizumab|bevacizumab|mesh-list
101881500|NCT01046279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101881501|NCT01046279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101881502|NCT01046279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101881503|NCT01046279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101881504|NCT01046279|Growth Substances|growth substances|mesh-ancestor
101881505|NCT01046279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881506|NCT01046279|Growth Inhibitors|growth inhibitors|mesh-ancestor
101881508|NCT00384293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101881509|NCT00384293|Antimetabolites|antimetabolites|mesh-ancestor
101881510|NCT00384293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881511|NCT00384293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101881512|NCT00384293|Vasodilator Agents|vasodilator agents|mesh-ancestor
101881513|NCT00384293|Vitamin B Complex|vitamin b complex|mesh-ancestor
101881515|NCT00384293|Micronutrients|micronutrients|mesh-ancestor
101881516|NCT00384293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881517|NCT01087866|Metformin|metformin|mesh-list
101881518|NCT01087866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101881519|NCT01087866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881520|NCT01090830|Paclitaxel|paclitaxel|mesh-list
101881521|NCT01090830|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101881522|NCT01090830|Bevacizumab|bevacizumab|mesh-list
101881523|NCT01090830|Carboplatin|carboplatin|mesh-list
101881524|NCT01090830|Belinostat|belinostat|mesh-list
101881525|NCT01090830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101881526|NCT01090830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101881527|NCT01090830|Tubulin Modulators|tubulin modulators|mesh-ancestor
101881528|NCT01090830|Antimitotic Agents|antimitotic agents|mesh-ancestor
101881529|NCT01090830|Mitosis Modulators|mitosis modulators|mesh-ancestor
101881530|NCT01090830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881531|NCT01090830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101881532|NCT01090830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101881533|NCT01090830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101881535|NCT01090830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881536|NCT01090830|Growth Inhibitors|growth inhibitors|mesh-ancestor
101881537|NCT01090830|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101881538|NCT01090830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881539|NCT01084824|Cantharidin|cantharidin|mesh-list
101881540|NCT01084824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881541|NCT01084824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881542|NCT01088022|Dexamethasone|dexamethasone|mesh-list
101881543|NCT01088022|Dexamethasone acetate|dexamethasone acetate|mesh-list
101881544|NCT01088022|Aprepitant|aprepitant|mesh-list
101881545|NCT01088022|Palonosetron|palonosetron|mesh-list
101881546|NCT01088022|BB 1101|bb 1101|mesh-list
101881547|NCT01088022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101881548|NCT01088022|Antiemetics|antiemetics|mesh-ancestor
101881549|NCT01088022|Autonomic Agents|autonomic agents|mesh-ancestor
101881550|NCT01088022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101881551|NCT01088022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881552|NCT01088022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101881553|NCT01088022|Glucocorticoids|glucocorticoids|mesh-ancestor
101881554|NCT01088022|Hormones|hormones|mesh-ancestor
101881555|NCT01088022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101881556|NCT01088022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101881557|NCT01088022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101881558|NCT01088022|Protease Inhibitors|protease inhibitors|mesh-ancestor
101881559|NCT01088022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881560|NCT01088022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881561|NCT01088022|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101881562|NCT01088022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101881563|NCT01088022|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101881564|NCT01088022|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101881565|NCT01088022|Serotonin Agents|serotonin agents|mesh-ancestor
101881566|NCT00067002|Cyclophosphamide|cyclophosphamide|mesh-list
101881567|NCT00067002|Melphalan|melphalan|mesh-list
101881568|NCT00067002|Thiotepa|thiotepa|mesh-list
101881569|NCT00067002|Rituximab|rituximab|mesh-list
101881570|NCT00067002|Fludarabine|fludarabine|mesh-list
101881571|NCT00067002|Fludarabine phosphate|fludarabine phosphate|mesh-list
101881572|NCT00067002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101881573|NCT00067002|Immunologic Factors|immunologic factors|mesh-ancestor
101881574|NCT00067002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881575|NCT00067002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101881576|NCT00067002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101881577|NCT00067002|Alkylating Agents|alkylating agents|mesh-ancestor
101881578|NCT00067002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881579|NCT00067002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101881580|NCT00067002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101881581|NCT00067002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101881582|NCT00067002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101881583|NCT00067002|Antimetabolites|antimetabolites|mesh-ancestor
101881584|NCT01090908|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101881585|NCT01090908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101881586|NCT01084902|Latanoprost|latanoprost|mesh-list
101881587|NCT01084902|Brinzolamide|brinzolamide|mesh-list
101881588|NCT01084902|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101881589|NCT01084902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101881590|NCT01084902|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101881591|NCT01084902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881592|NCT01084902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881593|NCT01084980|Tacrolimus|tacrolimus|mesh-list
101881594|NCT01084980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101881595|NCT01084980|Immunologic Factors|immunologic factors|mesh-ancestor
101881596|NCT01084980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881597|NCT01084980|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101881598|NCT01084980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881599|NCT01084980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881600|NCT01085058|Lenograstim|lenograstim|mesh-list
101881601|NCT01085058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101881602|NCT01085058|Immunologic Factors|immunologic factors|mesh-ancestor
101881603|NCT01085058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881604|NCT01088178|Levonorgestrel|levonorgestrel|mesh-list
101881605|NCT01088178|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101881606|NCT01088178|Contraceptive Agents|contraceptive agents|mesh-ancestor
101881607|NCT01088178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101881608|NCT01088178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881609|NCT01088178|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101881610|NCT01088178|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101881611|NCT01088178|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101881612|NCT01088256|Etoricoxib|etoricoxib|mesh-list
101881613|NCT01088256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101881614|NCT01088256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101881615|NCT01088256|Analgesics|analgesics|mesh-ancestor
101881616|NCT01088256|Sensory System Agents|sensory system agents|mesh-ancestor
101881617|NCT01088256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101881618|NCT01088256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881619|NCT01088256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101881620|NCT01088256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101881621|NCT01088256|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101881622|NCT01088256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101881623|NCT01088256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881624|NCT01088256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881625|NCT01326858|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
101881627|NCT01326858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101881628|NCT01326858|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101881629|NCT01326858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101881630|NCT01326858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101881631|NCT01326858|Analgesics|analgesics|mesh-ancestor
101881632|NCT01326858|Sensory System Agents|sensory system agents|mesh-ancestor
101881633|NCT01326858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101881634|NCT01326858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881635|NCT01326858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101881636|NCT01326858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101881637|NCT01326858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101881638|NCT01326858|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101881639|NCT01326858|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101881640|NCT01326858|Histamine Antagonists|histamine antagonists|mesh-ancestor
101881641|NCT01326858|Histamine Agents|histamine agents|mesh-ancestor
101881642|NCT01326858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101881643|NCT01326858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881644|NCT01326858|Antipruritics|antipruritics|mesh-ancestor
101881645|NCT01326858|Dermatologic Agents|dermatologic agents|mesh-ancestor
101881646|NCT00091572|Temozolomide|temozolomide|mesh-list
101881647|NCT00091572|Dacarbazine|dacarbazine|mesh-list
101881648|NCT00091572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101881649|NCT00091572|Alkylating Agents|alkylating agents|mesh-ancestor
101881650|NCT00091572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881651|NCT00091572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101881652|NCT01091220|Certolizumab Pegol|certolizumab pegol|mesh-list
101881653|NCT01091220|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101881654|NCT01091220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101881655|NCT01091220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101881656|NCT01091220|Immunologic Factors|immunologic factors|mesh-ancestor
101881657|NCT01091220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881658|NCT01091220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101881659|NCT00084266|Vancomycin|vancomycin|mesh-list
101881660|NCT00084266|Linezolid|linezolid|mesh-list
101881661|NCT00084266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101881662|NCT00084266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101881663|NCT00084266|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101881664|NCT00084266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881665|NCT00084266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881666|NCT01086878|Trimethoprim|trimethoprim|mesh-list
101881667|NCT01086878|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101881668|NCT01086878|Sulfamethoxazole|sulfamethoxazole|mesh-list
101881669|NCT01086878|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101881670|NCT01086878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101881671|NCT01086878|Antimalarials|antimalarials|mesh-ancestor
101881672|NCT01086878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101881673|NCT01086878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101881674|NCT01086878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101881675|NCT01086878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881676|NCT01086878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881677|NCT01086878|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101689211|NCT00650442|Estradiol|estradiol|mesh-list
101881678|NCT01086878|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101881679|NCT01086878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101881680|NCT01086878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101881682|NCT01086956|Ropivacaine|ropivacaine|mesh-list
101881683|NCT01086956|Anesthetics, Local|anesthetics, local|mesh-ancestor
101881684|NCT01086956|Anesthetics|anesthetics|mesh-ancestor
101881685|NCT01086956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101968008|NCT00006721|Rituximab|rituximab|mesh-list
101881686|NCT01086956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881687|NCT01086956|Sensory System Agents|sensory system agents|mesh-ancestor
101881688|NCT01086956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101881689|NCT01086956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101881690|NCT01086956|Narcotics|narcotics|mesh-ancestor
101881691|NCT01086956|Analgesics|analgesics|mesh-ancestor
101881692|NCT01086956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101881693|NCT01086956|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101881694|NCT01086956|Anesthetics, General|anesthetics, general|mesh-ancestor
101881695|NCT00091026|Bevacizumab|bevacizumab|mesh-list
101881696|NCT00091026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101881697|NCT00091026|Cetuximab|cetuximab|mesh-list
101881698|NCT00091026|Gemcitabine|gemcitabine|mesh-list
101881699|NCT00091026|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101881700|NCT00091026|Antibodies|antibodies|mesh-list
101881701|NCT00091026|Immunoglobulins|immunoglobulins|mesh-list
101881702|NCT00091026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101881703|NCT00091026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101881704|NCT00091026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101881705|NCT00091026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101881706|NCT00091026|Growth Substances|growth substances|mesh-ancestor
101881707|NCT00091026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881708|NCT00091026|Growth Inhibitors|growth inhibitors|mesh-ancestor
101881709|NCT00091026|Immunologic Factors|immunologic factors|mesh-ancestor
101881710|NCT00091026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101881711|NCT00091026|Antimetabolites|antimetabolites|mesh-ancestor
101881712|NCT00091026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881713|NCT00091026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101881714|NCT00091026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881715|NCT01091376|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101881716|NCT01091376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101881717|NCT01091376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101881718|NCT01091376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881719|NCT01091376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881720|NCT00115778|Immunoglobulins|immunoglobulins|mesh-list
101881721|NCT00115778|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101881722|NCT00115778|gamma-Globulins|gamma-globulins|mesh-list
101881723|NCT00115778|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101881724|NCT00115778|Immunologic Factors|immunologic factors|mesh-ancestor
101881725|NCT00115778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881726|NCT00100178|Mycophenolic Acid|mycophenolic acid|mesh-list
101881727|NCT00100178|Daclizumab|daclizumab|mesh-list
101881728|NCT00100178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101881729|NCT00100178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101881730|NCT00100178|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101881731|NCT00100178|Antitubercular Agents|antitubercular agents|mesh-ancestor
101881732|NCT00100178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101881733|NCT00100178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101881734|NCT00100178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881735|NCT00100178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881736|NCT00100178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101881737|NCT00100178|Immunologic Factors|immunologic factors|mesh-ancestor
101881738|NCT00100178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881740|NCT00099632|Lopinavir|lopinavir|mesh-list
101881741|NCT00099632|Tenofovir|tenofovir|mesh-list
101881742|NCT00099632|Lamivudine|lamivudine|mesh-list
101881743|NCT00099632|Emtricitabine|emtricitabine|mesh-list
101881744|NCT00099632|Zidovudine|zidovudine|mesh-list
101881745|NCT00099632|Nevirapine|nevirapine|mesh-list
101881746|NCT00099632|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101881747|NCT00099632|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101881748|NCT00099632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101881749|NCT00099632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101881750|NCT00099632|Protease Inhibitors|protease inhibitors|mesh-ancestor
101881751|NCT00099632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881752|NCT00099632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881753|NCT00099632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101881754|NCT00099632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101332521|NCT00000959|Pyridoxine|pyridoxine|mesh-list
101881756|NCT00099632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101881757|NCT00099632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101881758|NCT00099632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101881759|NCT00099632|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101881760|NCT00099632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101881761|NCT00099632|Antimetabolites|antimetabolites|mesh-ancestor
101881762|NCT00099632|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101881763|NCT00099632|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101881764|NCT01087190|Isoniazid|isoniazid|mesh-list
101881765|NCT01087190|Antitubercular Agents|antitubercular agents|mesh-ancestor
101881766|NCT01087190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101881767|NCT01087190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101881768|NCT01087190|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101881769|NCT01087190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101881770|NCT01087190|Antimetabolites|antimetabolites|mesh-ancestor
101881771|NCT01087190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881772|NCT01087190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101881773|NCT01090466|Sirolimus|sirolimus|mesh-list
101881774|NCT01090466|Gemcitabine|gemcitabine|mesh-list
101881775|NCT01090466|Temsirolimus|temsirolimus|mesh-list
101881776|NCT01090466|MTOR Inhibitors|mtor inhibitors|mesh-list
101881777|NCT01090466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101881778|NCT01090466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101881779|NCT01090466|Antimetabolites|antimetabolites|mesh-ancestor
101881780|NCT01090466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881781|NCT01090466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101881782|NCT01090466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881783|NCT01090466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101881784|NCT01090466|Immunologic Factors|immunologic factors|mesh-ancestor
101881785|NCT01090466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881786|NCT01090466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101881787|NCT01090466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101881788|NCT01090466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101881789|NCT01090466|Antifungal Agents|antifungal agents|mesh-ancestor
101881790|NCT04116398|Dexamethasone|dexamethasone|mesh-list
101881791|NCT04116398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101881792|NCT04116398|Antiemetics|antiemetics|mesh-ancestor
101881793|NCT04116398|Autonomic Agents|autonomic agents|mesh-ancestor
101881794|NCT04116398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101881795|NCT04116398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881796|NCT04116398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101881797|NCT04116398|Glucocorticoids|glucocorticoids|mesh-ancestor
101881798|NCT04116398|Hormones|hormones|mesh-ancestor
101881799|NCT04116398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101881800|NCT04116398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101881801|NCT04116398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101881802|NCT00098774|Leucovorin|leucovorin|mesh-list
101881803|NCT00098774|Cytarabine|cytarabine|mesh-list
101881804|NCT00098774|Rituximab|rituximab|mesh-list
101881805|NCT00098774|Methotrexate|methotrexate|mesh-list
101881806|NCT00098774|Etoposide|etoposide|mesh-list
101881807|NCT00098774|Temozolomide|temozolomide|mesh-list
101881808|NCT00098774|Calcium|calcium|mesh-list
101881809|NCT00098774|Levoleucovorin|levoleucovorin|mesh-list
101881810|NCT00098774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101881811|NCT00098774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101881812|NCT00098774|Immunologic Factors|immunologic factors|mesh-ancestor
101881813|NCT00098774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881814|NCT00098774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101881815|NCT00098774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101881816|NCT00098774|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101881817|NCT00098774|Abortifacient Agents|abortifacient agents|mesh-ancestor
101881818|NCT00098774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101881819|NCT00098774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101881820|NCT00098774|Antimetabolites|antimetabolites|mesh-ancestor
101881821|NCT00098774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881822|NCT00098774|Dermatologic Agents|dermatologic agents|mesh-ancestor
101881823|NCT00098774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881824|NCT00098774|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101881825|NCT00098774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101881826|NCT00098774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101881827|NCT00098774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101881828|NCT00098774|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101881829|NCT00098774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101881831|NCT00098774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101881832|NCT00098774|Antidotes|antidotes|mesh-ancestor
101881833|NCT00098774|Protective Agents|protective agents|mesh-ancestor
101881834|NCT00098774|Vitamin B Complex|vitamin b complex|mesh-ancestor
101881835|NCT00098774|Vitamins|vitamins|mesh-ancestor
101881836|NCT00098774|Micronutrients|micronutrients|mesh-ancestor
101881837|NCT00098774|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101881838|NCT00098774|Alkylating Agents|alkylating agents|mesh-ancestor
101881839|NCT01081652|Progesterone|progesterone|mesh-list
101881840|NCT01081652|Progestins|progestins|mesh-ancestor
101881841|NCT01081652|Hormones|hormones|mesh-ancestor
101881842|NCT01081652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101881843|NCT01081652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881844|NCT01087580|Prednisone|prednisone|mesh-list
101881845|NCT01087580|Docetaxel|docetaxel|mesh-list
101881846|NCT01087580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101881847|NCT01087580|Tubulin Modulators|tubulin modulators|mesh-ancestor
101881848|NCT01087580|Antimitotic Agents|antimitotic agents|mesh-ancestor
101881849|NCT01087580|Mitosis Modulators|mitosis modulators|mesh-ancestor
101881850|NCT01087580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881851|NCT01087580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101881852|NCT01087580|Glucocorticoids|glucocorticoids|mesh-ancestor
101881853|NCT01087580|Hormones|hormones|mesh-ancestor
101881854|NCT01087580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101881855|NCT01087580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881856|NCT01087580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101881857|NCT01087658|Calcium|calcium|mesh-list
101881858|NCT01087658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101881859|NCT01087658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881860|NCT03958058|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101881861|NCT03958058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101881862|NCT03958058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101881863|NCT03958058|Antitubercular Agents|antitubercular agents|mesh-ancestor
101881864|NCT01081730|Ustekinumab|ustekinumab|mesh-list
101881865|NCT01081730|Dermatologic Agents|dermatologic agents|mesh-ancestor
101881866|NCT01090700|Simeprevir|simeprevir|mesh-list
101881867|NCT01090700|Dexetimide|dexetimide|mesh-list
101881868|NCT01090700|Citalopram|citalopram|mesh-list
101881869|NCT01090700|Escitalopram|escitalopram|mesh-list
101881870|NCT01090700|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101881871|NCT01090700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101881872|NCT01090700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101881873|NCT01090700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881874|NCT01090700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101881875|NCT01090700|Serotonin Agents|serotonin agents|mesh-ancestor
101881876|NCT01090700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881877|NCT01090700|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101881878|NCT01090700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101881879|NCT01090700|Parasympatholytics|parasympatholytics|mesh-ancestor
101881880|NCT01090700|Autonomic Agents|autonomic agents|mesh-ancestor
101881881|NCT01090700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101881882|NCT01090700|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101881883|NCT01090700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101881884|NCT01090700|Cholinergic Agents|cholinergic agents|mesh-ancestor
101881885|NCT01090700|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101881886|NCT01090700|Antidepressive Agents|antidepressive agents|mesh-ancestor
101881887|NCT01090700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101881888|NCT01090700|Antiviral Agents|antiviral agents|mesh-ancestor
101881889|NCT01090700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101881890|NCT01090700|Protease Inhibitors|protease inhibitors|mesh-ancestor
101881891|NCT01090700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881892|NCT03957902|Aspirin|aspirin|mesh-list
101881893|NCT03957902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101881894|NCT03957902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101881895|NCT03957902|Analgesics|analgesics|mesh-ancestor
101881896|NCT03957902|Sensory System Agents|sensory system agents|mesh-ancestor
101881897|NCT03957902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101881898|NCT03957902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881899|NCT03957902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101881900|NCT03957902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101881901|NCT03957902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101881902|NCT03957902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101881903|NCT03957902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881904|NCT03957902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101881905|NCT03957902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101881906|NCT03957902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881907|NCT03957902|Antipyretics|antipyretics|mesh-ancestor
101881908|NCT00384059|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101881909|NCT00384059|Immunologic Factors|immunologic factors|mesh-ancestor
101881910|NCT00384059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881911|NCT01046435|Amoxicillin|amoxicillin|mesh-list
101881912|NCT01046435|Metronidazole|metronidazole|mesh-list
101881913|NCT01046435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101881914|NCT01046435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101881915|NCT01046435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101881916|NCT01046435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101881917|NCT00858364|Darbepoetin alfa|darbepoetin alfa|mesh-list
101881918|NCT00858364|Hematinics|hematinics|mesh-ancestor
101881919|NCT00382733|Topotecan|topotecan|mesh-list
101881920|NCT00382733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101881921|NCT00382733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101881922|NCT00382733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881923|NCT00382733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881924|NCT00382733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101881925|NCT03992885|Pemetrexed|pemetrexed|mesh-list
101881926|NCT03992885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101881927|NCT03992885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881928|NCT03992885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881929|NCT03992885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101881930|NCT03992885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101881931|NCT03739294|Fluticasone|fluticasone|mesh-list
101881932|NCT03739294|Xhance|xhance|mesh-list
101881933|NCT03739294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101881934|NCT03739294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101881935|NCT03739294|Autonomic Agents|autonomic agents|mesh-ancestor
101881936|NCT03739294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101881937|NCT03739294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881938|NCT03739294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101455162|NCT05425654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101881939|NCT03739294|Respiratory System Agents|respiratory system agents|mesh-ancestor
101881940|NCT03739294|Dermatologic Agents|dermatologic agents|mesh-ancestor
101881941|NCT03739294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101881942|NCT03732508|Fluorouracil|fluorouracil|mesh-list
101881943|NCT03732508|Irinotecan|irinotecan|mesh-list
101881944|NCT03732508|Antimetabolites|antimetabolites|mesh-ancestor
101881945|NCT03732508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881946|NCT03732508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101881947|NCT03732508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101881948|NCT03732508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101881949|NCT03732508|Immunologic Factors|immunologic factors|mesh-ancestor
101881950|NCT03732508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881951|NCT03732508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101881952|NCT03732508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101881953|NCT03732508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881954|NCT03628924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101881955|NCT03628924|Immunologic Factors|immunologic factors|mesh-ancestor
101881956|NCT03628924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881957|NCT00112437|Vitamin D|vitamin d|mesh-list
101881958|NCT00112437|Cholecalciferol|cholecalciferol|mesh-list
101881959|NCT00112437|Calcium Carbonate|calcium carbonate|mesh-list
101881960|NCT00112437|Calcium|calcium|mesh-list
101881961|NCT00112437|Vitamins|vitamins|mesh-ancestor
101881962|NCT00112437|Micronutrients|micronutrients|mesh-ancestor
101881963|NCT00112437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101968034|NCT00006289|Neurotropin|neurotropin|mesh-list
101881964|NCT00112437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101881965|NCT00112437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101881966|NCT00112437|Antacids|antacids|mesh-ancestor
101881967|NCT00112437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881968|NCT00112437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101881969|NCT03653416|Bupivacaine|bupivacaine|mesh-list
101881970|NCT03653416|Anesthetics, Local|anesthetics, local|mesh-ancestor
101881971|NCT03653416|Anesthetics|anesthetics|mesh-ancestor
101881972|NCT03653416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101881973|NCT03653416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881974|NCT03653416|Sensory System Agents|sensory system agents|mesh-ancestor
101881975|NCT03653416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101881976|NCT01076673|Hyaluronic Acid|hyaluronic acid|mesh-list
101881977|NCT01076673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101881978|NCT01076673|Immunologic Factors|immunologic factors|mesh-ancestor
101881979|NCT01076673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101881980|NCT01076673|Viscosupplements|viscosupplements|mesh-ancestor
101881981|NCT01076673|Protective Agents|protective agents|mesh-ancestor
101881982|NCT00119379|Tenofovir|tenofovir|mesh-list
101881983|NCT00119379|Antiviral Agents|antiviral agents|mesh-ancestor
101881984|NCT00119379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101881985|NCT00119379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101881986|NCT00119379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101881987|NCT00119379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881988|NCT00119379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101881989|NCT00119379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101881990|NCT00119379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101881991|NCT01080417|Mycophenolic Acid|mycophenolic acid|mesh-list
101881992|NCT01080417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101881993|NCT01080417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101881994|NCT01080417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101881995|NCT01080417|Antitubercular Agents|antitubercular agents|mesh-ancestor
101881996|NCT01080417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101455186|NCT00238914|Naltrexone|naltrexone|mesh-list
101881997|NCT01080417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101881998|NCT01080417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101881999|NCT01080417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882000|NCT01079481|Everolimus|everolimus|mesh-list
101882001|NCT01079481|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101882002|NCT01079481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101882003|NCT01079481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101882004|NCT01079481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882005|NCT01079481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101882006|NCT01079481|Immunologic Factors|immunologic factors|mesh-ancestor
101882007|NCT01079481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882008|NCT01079481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101882009|NCT03964779|Antibodies|antibodies|mesh-list
101882010|NCT03964779|Immunoglobulins|immunoglobulins|mesh-list
101882011|NCT03964779|Immunologic Factors|immunologic factors|mesh-ancestor
101882012|NCT03964779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882013|NCT00131937|Sorafenib|sorafenib|mesh-list
101882014|NCT00131937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101882015|NCT00131937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101882016|NCT00131937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101882017|NCT00131937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882018|NCT01079559|Tobramycin|tobramycin|mesh-list
101882019|NCT01079559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101882020|NCT01079559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101882021|NCT00131469|Teriparatide|teriparatide|mesh-list
101882022|NCT00131469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101882023|NCT00131469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882024|NCT00131469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101882025|NCT00372593|Cytarabine|cytarabine|mesh-list
101882026|NCT00372593|Etoposide|etoposide|mesh-list
101882027|NCT00372593|Daunorubicin|daunorubicin|mesh-list
101882028|NCT00372593|Mitoxantrone|mitoxantrone|mesh-list
101882029|NCT00372593|Asparaginase|asparaginase|mesh-list
101882030|NCT00372593|Gemtuzumab|gemtuzumab|mesh-list
101882031|NCT00372593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101882032|NCT00372593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101882033|NCT00372593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101882034|NCT00372593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101882035|NCT00372593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101882036|NCT00372593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882037|NCT00372593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101882038|NCT00372593|Antimetabolites|antimetabolites|mesh-ancestor
101882039|NCT00372593|Antiviral Agents|antiviral agents|mesh-ancestor
101882040|NCT00372593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101882041|NCT00372593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101882042|NCT00372593|Immunologic Factors|immunologic factors|mesh-ancestor
101882043|NCT00372593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882044|NCT00372593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101882045|NCT00372593|Analgesics|analgesics|mesh-ancestor
101882046|NCT00372593|Sensory System Agents|sensory system agents|mesh-ancestor
101882047|NCT00372593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101882048|NCT00372593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101882049|NCT00372593|Immunotoxins|immunotoxins|mesh-ancestor
101882050|NCT00372593|Immunoconjugates|immunoconjugates|mesh-ancestor
101882051|NCT01324583|Prednisolone|prednisolone|mesh-list
101882052|NCT01324583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101882053|NCT01324583|Glucocorticoids|glucocorticoids|mesh-ancestor
101882054|NCT01324583|Hormones|hormones|mesh-ancestor
101882055|NCT01324583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101882056|NCT01324583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882057|NCT01324583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101882058|NCT01324583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101882059|NCT00382109|Sirolimus|sirolimus|mesh-list
101882060|NCT00382109|Cyclophosphamide|cyclophosphamide|mesh-list
101882061|NCT00382109|Thiotepa|thiotepa|mesh-list
101882062|NCT00382109|Methotrexate|methotrexate|mesh-list
101882063|NCT00382109|Tacrolimus|tacrolimus|mesh-list
101882064|NCT00382109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101882065|NCT00382109|Immunologic Factors|immunologic factors|mesh-ancestor
101882066|NCT00382109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882067|NCT00382109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101882068|NCT00382109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101882069|NCT00382109|Alkylating Agents|alkylating agents|mesh-ancestor
101882070|NCT00382109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882071|NCT00382109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101882072|NCT00382109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101882073|NCT00382109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101882074|NCT00382109|Abortifacient Agents|abortifacient agents|mesh-ancestor
101882075|NCT00382109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101882076|NCT00382109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101882077|NCT00382109|Antimetabolites|antimetabolites|mesh-ancestor
101882078|NCT00382109|Dermatologic Agents|dermatologic agents|mesh-ancestor
101882079|NCT00382109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101882080|NCT00382109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101882081|NCT00382109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101882082|NCT00382109|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101882083|NCT00382109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101882084|NCT00382109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101882085|NCT00382109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101882086|NCT00382109|Antifungal Agents|antifungal agents|mesh-ancestor
101882087|NCT00381797|Deoxyglucose|deoxyglucose|mesh-list
101882088|NCT00381797|Bevacizumab|bevacizumab|mesh-list
101882089|NCT00381797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101882090|NCT00381797|Irinotecan|irinotecan|mesh-list
101882091|NCT00381797|Camptothecin|camptothecin|mesh-list
101882092|NCT00381797|Endothelial Growth Factors|endothelial growth factors|mesh-list
101882093|NCT00381797|Antibodies|antibodies|mesh-list
101882094|NCT00381797|Immunoglobulins|immunoglobulins|mesh-list
101882095|NCT00381797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101882096|NCT00381797|Immunoglobulin G|immunoglobulin g|mesh-list
101882097|NCT00381797|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101882098|NCT00381797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101882099|NCT00381797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101882100|NCT00381797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101882101|NCT00381797|Growth Substances|growth substances|mesh-ancestor
101882102|NCT00381797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882103|NCT00381797|Growth Inhibitors|growth inhibitors|mesh-ancestor
101882104|NCT00381797|Immunologic Factors|immunologic factors|mesh-ancestor
101882105|NCT00381797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101882106|NCT00381797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101882107|NCT00381797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101882108|NCT00381797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882109|NCT00381797|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101882110|NCT00381797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101882111|NCT00381797|Antimetabolites|antimetabolites|mesh-ancestor
101882112|NCT00381797|Antiviral Agents|antiviral agents|mesh-ancestor
101882113|NCT00381797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101601908|NCT00831181|Antidotes|antidotes|mesh-ancestor
101882114|NCT03665038|Brexanolone|brexanolone|mesh-list
101882115|NCT03665038|Neurosteroids|neurosteroids|mesh-ancestor
101882116|NCT03665038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101882117|NCT03665038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882118|NCT03665038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882119|NCT03665038|GABA Modulators|gaba modulators|mesh-ancestor
101882120|NCT03665038|GABA Agents|gaba agents|mesh-ancestor
101882121|NCT03664024|Carboplatin|carboplatin|mesh-list
101882122|NCT03664024|Pembrolizumab|pembrolizumab|mesh-list
101882124|NCT03664024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101882125|NCT03664024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101882126|NCT03664024|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101882127|NCT03664024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882128|NCT03664024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101882129|NCT03664024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101882130|NCT03664024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101882131|NCT03624946|Immunoglobulins|immunoglobulins|mesh-list
101882133|NCT03624946|gamma-Globulins|gamma-globulins|mesh-list
101882134|NCT03624946|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101882135|NCT03624946|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101882136|NCT03624946|Immunoglobulin G|immunoglobulin g|mesh-list
101882137|NCT03624946|Immunologic Factors|immunologic factors|mesh-ancestor
101882138|NCT03624946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882139|NCT03735082|Paclitaxel|paclitaxel|mesh-list
101882140|NCT03735082|Carboplatin|carboplatin|mesh-list
101882141|NCT03735082|Apatinib|apatinib|mesh-list
101882142|NCT03735082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101882143|NCT03735082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101882144|NCT03735082|Tubulin Modulators|tubulin modulators|mesh-ancestor
101882145|NCT03735082|Antimitotic Agents|antimitotic agents|mesh-ancestor
101882146|NCT03735082|Mitosis Modulators|mitosis modulators|mesh-ancestor
101882147|NCT03735082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882148|NCT03735082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101882149|NCT03735082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101882150|NCT00381095|Pregabalin|pregabalin|mesh-list
101882151|NCT00381095|Analgesics|analgesics|mesh-ancestor
101882152|NCT00381095|Sensory System Agents|sensory system agents|mesh-ancestor
101882153|NCT00381095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101882154|NCT00381095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882155|NCT00381095|Anticonvulsants|anticonvulsants|mesh-ancestor
101882156|NCT00381095|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101882157|NCT00381095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101455268|NCT04668469|Zinc|zinc|mesh-list
101882158|NCT00381095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882159|NCT00381095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101882160|NCT00381095|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101882161|NCT00381095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101882162|NCT00381095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101882163|NCT00381095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101882164|NCT03737656|Progesterone|progesterone|mesh-list
101882165|NCT03737656|Progestins|progestins|mesh-ancestor
101882166|NCT03737656|Hormones|hormones|mesh-ancestor
101882167|NCT03737656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101882168|NCT03737656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882169|NCT00112047|Tenofovir|tenofovir|mesh-list
101882170|NCT00112047|Lamivudine|lamivudine|mesh-list
101882171|NCT00112047|Emtricitabine|emtricitabine|mesh-list
101882172|NCT00112047|Zidovudine|zidovudine|mesh-list
101882173|NCT00112047|Efavirenz|efavirenz|mesh-list
101882174|NCT00112047|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101882175|NCT00112047|Antiviral Agents|antiviral agents|mesh-ancestor
101882176|NCT00112047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101882177|NCT00112047|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101882178|NCT00112047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101882179|NCT00112047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101882180|NCT00112047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882181|NCT00112047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101882182|NCT00112047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101882183|NCT00112047|Antimetabolites|antimetabolites|mesh-ancestor
101882184|NCT00112047|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101882185|NCT00112047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101882186|NCT00112047|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101882187|NCT00112047|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101882188|NCT00112047|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101882189|NCT00112047|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101882190|NCT03658876|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101882191|NCT03658876|Hematinics|hematinics|mesh-ancestor
101882192|NCT03618628|Carbon Fiber|carbon fiber|mesh-list
101882193|NCT03618628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101882194|NCT03618628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101882195|NCT03639922|Imatinib Mesylate|imatinib mesylate|mesh-list
101882196|NCT03639922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101882197|NCT03639922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101882198|NCT03639922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101882199|NCT03639922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882201|NCT03734614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101882202|NCT03734614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101882203|NCT03734614|Analgesics|analgesics|mesh-ancestor
101882204|NCT03734614|Sensory System Agents|sensory system agents|mesh-ancestor
101882205|NCT03734614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101882206|NCT03734614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882207|NCT03734614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101882208|NCT03734614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101882209|NCT03734614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101882210|NCT03734614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101882211|NCT03734614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882212|NCT03734614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101882213|NCT03734614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101882214|NCT03734614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101882215|NCT03734614|Antipyretics|antipyretics|mesh-ancestor
101882217|NCT00380393|Immunologic Factors|immunologic factors|mesh-ancestor
101882218|NCT00380393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882219|NCT00380081|Zolpidem|zolpidem|mesh-list
101882220|NCT00380081|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101882221|NCT00380081|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101882222|NCT00380081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101882223|NCT00380081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882224|NCT00380081|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101882225|NCT00380081|GABA Agonists|gaba agonists|mesh-ancestor
101882226|NCT00380081|GABA Agents|gaba agents|mesh-ancestor
101882227|NCT00380081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101882228|NCT00380081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882229|NCT03579940|Lasmiditan|lasmiditan|mesh-list
101882230|NCT03579940|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101882231|NCT03579940|Serotonin Agents|serotonin agents|mesh-ancestor
101882232|NCT03579940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101882233|NCT03579940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882234|NCT03579940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882235|NCT03732040|Fluorides|fluorides|mesh-list
101882236|NCT03732040|Cariostatic Agents|cariostatic agents|mesh-ancestor
101882237|NCT03732040|Protective Agents|protective agents|mesh-ancestor
101882238|NCT03732040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882239|NCT00098306|Maraviroc|maraviroc|mesh-list
101882240|NCT00098306|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101882241|NCT00098306|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101882242|NCT00098306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882243|NCT00098306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101882244|NCT00098306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101882245|NCT00098306|Antiviral Agents|antiviral agents|mesh-ancestor
101882246|NCT00098306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101882247|NCT00098306|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101882249|NCT03615040|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101882250|NCT03615040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101882251|NCT03615040|Antiviral Agents|antiviral agents|mesh-ancestor
101882252|NCT03615040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101882253|NCT01090778|Hormones|hormones|mesh-list
101882254|NCT01090778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101882255|NCT01090778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882256|NCT00068588|Capecitabine|capecitabine|mesh-list
101882257|NCT00068588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101882258|NCT00068588|Antimetabolites|antimetabolites|mesh-ancestor
101882259|NCT00068588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882260|NCT00068588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101882261|NCT01088282|Dipivefrin|dipivefrin|mesh-list
101882262|NCT01088282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101882263|NCT01088282|Adrenergic Agents|adrenergic agents|mesh-ancestor
101882264|NCT01088282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101882265|NCT01088282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882266|NCT01088282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882267|NCT03963752|Megestrol|megestrol|mesh-list
101882268|NCT03963752|Megestrol Acetate|megestrol acetate|mesh-list
101882269|NCT03963752|Leuprolide|leuprolide|mesh-list
101882270|NCT03963752|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101882271|NCT03963752|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101882272|NCT03963752|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101882273|NCT03963752|Contraceptive Agents|contraceptive agents|mesh-ancestor
101882274|NCT03963752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101882275|NCT03963752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882276|NCT03963752|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101882277|NCT03963752|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101882278|NCT03963752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101882279|NCT03963752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101882280|NCT03963752|Appetite Stimulants|appetite stimulants|mesh-ancestor
101882281|NCT03963752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101882282|NCT03963752|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101882283|NCT03963752|Fertility Agents|fertility agents|mesh-ancestor
101882284|NCT03734302|Brexpiprazole|brexpiprazole|mesh-list
101882285|NCT03734302|Serotonin Agents|serotonin agents|mesh-ancestor
101882286|NCT03734302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101882287|NCT03734302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882288|NCT03734302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882289|NCT03734302|Dopamine Agonists|dopamine agonists|mesh-ancestor
101882290|NCT03734302|Dopamine Agents|dopamine agents|mesh-ancestor
101882291|NCT01310296|Lofexidine|lofexidine|mesh-list
101882292|NCT01310296|Clonidine|clonidine|mesh-list
101882293|NCT01310296|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101882294|NCT01310296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101882295|NCT01310296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882296|NCT01310296|Sensory System Agents|sensory system agents|mesh-ancestor
101882297|NCT01310296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101882298|NCT01310296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101882299|NCT01310296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101882300|NCT01310296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101882301|NCT01310296|Adrenergic Agents|adrenergic agents|mesh-ancestor
101882302|NCT01310296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101882303|NCT01310296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882304|NCT01310296|Analgesics|analgesics|mesh-ancestor
101882305|NCT01310296|Sympatholytics|sympatholytics|mesh-ancestor
101882306|NCT01310296|Autonomic Agents|autonomic agents|mesh-ancestor
101882307|NCT03734068|Doxorubicin|doxorubicin|mesh-list
101882308|NCT03734068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101882309|NCT03734068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101882310|NCT03734068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101882311|NCT03734068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101882312|NCT03734068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101882313|NCT03734068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882314|NCT03575806|Chlorotrianisene|chlorotrianisene|mesh-list
101882315|NCT03575806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882316|NCT03575806|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101882317|NCT03575806|Estrogens|estrogens|mesh-ancestor
101882318|NCT03575806|Hormones|hormones|mesh-ancestor
101882319|NCT03575806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101882320|NCT03575806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101882321|NCT03575806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101882322|NCT03606460|Ocrelizumab|ocrelizumab|mesh-list
101882323|NCT03606460|Immunologic Factors|immunologic factors|mesh-ancestor
101882324|NCT03606460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882325|NCT03729310|Triamcinolone|triamcinolone|mesh-list
101882326|NCT03729310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101882327|NCT03729310|Glucocorticoids|glucocorticoids|mesh-ancestor
101882328|NCT03729310|Hormones|hormones|mesh-ancestor
101455314|NCT00211952|Celecoxib|celecoxib|mesh-list
101882329|NCT03729310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101882330|NCT03729310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882331|NCT03731494|Nickel|nickel|mesh-list
101689233|NCT00649818|Lorazepam|lorazepam|mesh-list
101882332|NCT03731494|Trace Elements|trace elements|mesh-ancestor
101882333|NCT03731494|Micronutrients|micronutrients|mesh-ancestor
101882334|NCT03731494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882335|NCT00111813|Bortezomib|bortezomib|mesh-list
101882336|NCT00111813|Vorinostat|vorinostat|mesh-list
101882337|NCT00111813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101882338|NCT00111813|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101882339|NCT00111813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101602134|NCT04213612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101882340|NCT00111813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882341|NCT00118287|Etanercept|etanercept|mesh-list
101882342|NCT00118287|Azacitidine|azacitidine|mesh-list
101882343|NCT00118287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101882344|NCT00118287|Antimetabolites|antimetabolites|mesh-ancestor
101882345|NCT00118287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882346|NCT00118287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101882347|NCT00118287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101882348|NCT00118287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101882349|NCT00118287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101882350|NCT00118287|Analgesics|analgesics|mesh-ancestor
101882351|NCT00118287|Sensory System Agents|sensory system agents|mesh-ancestor
101882352|NCT00118287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101882353|NCT00118287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882354|NCT00118287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101882355|NCT00118287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101882356|NCT00118287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101882357|NCT00118287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101882358|NCT00118287|Immunologic Factors|immunologic factors|mesh-ancestor
101882359|NCT03965247|Lithium Carbonate|lithium carbonate|mesh-list
101882360|NCT03965247|Antidepressive Agents|antidepressive agents|mesh-ancestor
101882361|NCT03965247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101882362|NCT03965247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101882363|NCT03965247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882364|NCT03965247|Antimanic Agents|antimanic agents|mesh-ancestor
101882365|NCT03965247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101882366|NCT03965247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101882367|NCT03965247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882368|NCT01079715|Propranolol|propranolol|mesh-list
101882369|NCT01079715|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101882370|NCT01079715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101882371|NCT01079715|Adrenergic Agents|adrenergic agents|mesh-ancestor
101882372|NCT01079715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101882373|NCT01079715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882374|NCT01079715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882375|NCT01079715|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101882376|NCT01079715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101882377|NCT01079715|Vasodilator Agents|vasodilator agents|mesh-ancestor
101882379|NCT00130689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101882380|NCT00130689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101882381|NCT01326585|Dexamethasone|dexamethasone|mesh-list
101882382|NCT01326585|Dexamethasone acetate|dexamethasone acetate|mesh-list
101882383|NCT01326585|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101882384|NCT01326585|BB 1101|bb 1101|mesh-list
101882385|NCT01326585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101882386|NCT01326585|Antiemetics|antiemetics|mesh-ancestor
101882387|NCT01326585|Autonomic Agents|autonomic agents|mesh-ancestor
101882388|NCT01326585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101882389|NCT01326585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882390|NCT01326585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101882391|NCT01326585|Glucocorticoids|glucocorticoids|mesh-ancestor
101882392|NCT01326585|Hormones|hormones|mesh-ancestor
101882393|NCT01326585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101882394|NCT01326585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101882395|NCT01326585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101882396|NCT01326585|Protease Inhibitors|protease inhibitors|mesh-ancestor
101882397|NCT01326585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101882398|NCT01326585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882399|NCT03964935|Minocycline|minocycline|mesh-list
101882400|NCT03964935|Lycopene|lycopene|mesh-list
101882401|NCT03964935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101882402|NCT03964935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101882403|NCT03964935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101882405|NCT03964935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882406|NCT03964935|Protective Agents|protective agents|mesh-ancestor
101882407|NCT03964935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882408|NCT03964935|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101882409|NCT03964935|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101882410|NCT03964935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101882411|NCT03605212|Febuxostat|febuxostat|mesh-list
101882412|NCT03605212|Gout Suppressants|gout suppressants|mesh-ancestor
101882413|NCT03605212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101882414|NCT00117507|Deferasirox|deferasirox|mesh-list
101882415|NCT00117507|Chelating Agents|chelating agents|mesh-list
101882416|NCT00117507|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101882417|NCT00117507|Sequestering Agents|sequestering agents|mesh-ancestor
101882418|NCT00117507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882419|NCT03621046|Zolpidem|zolpidem|mesh-list
101882420|NCT03621046|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101882421|NCT03621046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101882422|NCT03621046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101882423|NCT03621046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882424|NCT03621046|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101882425|NCT03621046|GABA Agonists|gaba agonists|mesh-ancestor
101882426|NCT03621046|GABA Agents|gaba agents|mesh-ancestor
101882427|NCT03621046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101882428|NCT03621046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882429|NCT03965013|Insulin Glargine|insulin glargine|mesh-list
101882430|NCT03965013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101882431|NCT03965013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882432|NCT03603496|Nicotine|nicotine|mesh-list
101882433|NCT03603496|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101882434|NCT03603496|Autonomic Agents|autonomic agents|mesh-ancestor
101882435|NCT03603496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101882436|NCT03603496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882437|NCT03603496|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101882438|NCT03603496|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101882439|NCT03603496|Cholinergic Agents|cholinergic agents|mesh-ancestor
101882440|NCT03603496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101882441|NCT03603496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882442|NCT00096135|Leucovorin|leucovorin|mesh-list
101882443|NCT00096135|Cytarabine|cytarabine|mesh-list
101882444|NCT00096135|Dexamethasone|dexamethasone|mesh-list
101882445|NCT00096135|Hydrocortisone|hydrocortisone|mesh-list
101882446|NCT00096135|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101882447|NCT00096135|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101882448|NCT00096135|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101882449|NCT00096135|Cyclophosphamide|cyclophosphamide|mesh-list
101882450|NCT00096135|Methotrexate|methotrexate|mesh-list
101882452|NCT00096135|Vincristine|vincristine|mesh-list
101882453|NCT00096135|Daunorubicin|daunorubicin|mesh-list
101882454|NCT00096135|Asparaginase|asparaginase|mesh-list
101882455|NCT00096135|Mercaptopurine|mercaptopurine|mesh-list
101882456|NCT00096135|Pegaspargase|pegaspargase|mesh-list
101882457|NCT00096135|Lenograstim|lenograstim|mesh-list
101882458|NCT00096135|Levoleucovorin|levoleucovorin|mesh-list
101882459|NCT00096135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101882460|NCT00096135|Immunologic Factors|immunologic factors|mesh-ancestor
101882461|NCT00096135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882462|NCT00096135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101882463|NCT00096135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101882464|NCT00096135|Alkylating Agents|alkylating agents|mesh-ancestor
101882465|NCT00096135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882466|NCT00096135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101882467|NCT00096135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101882468|NCT00096135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101882469|NCT00096135|Antiemetics|antiemetics|mesh-ancestor
101882470|NCT00096135|Autonomic Agents|autonomic agents|mesh-ancestor
101882471|NCT00096135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101882472|NCT00096135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101882473|NCT00096135|Glucocorticoids|glucocorticoids|mesh-ancestor
101882474|NCT00096135|Hormones|hormones|mesh-ancestor
101882475|NCT00096135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101882476|NCT00096135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101882477|NCT00096135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101882478|NCT00096135|Abortifacient Agents|abortifacient agents|mesh-ancestor
101689245|NCT00649818|GABA Modulators|gaba modulators|mesh-ancestor
101882479|NCT00096135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101882480|NCT00096135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101882481|NCT00096135|Antimetabolites|antimetabolites|mesh-ancestor
101882482|NCT00096135|Dermatologic Agents|dermatologic agents|mesh-ancestor
101882483|NCT00096135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101882484|NCT00096135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101882485|NCT00096135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101882486|NCT00096135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101882487|NCT00096135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101882488|NCT00096135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101882489|NCT00096135|Antiviral Agents|antiviral agents|mesh-ancestor
101882490|NCT00096135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101882491|NCT00096135|Antidotes|antidotes|mesh-ancestor
101882492|NCT00096135|Protective Agents|protective agents|mesh-ancestor
101882493|NCT00096135|Vitamin B Complex|vitamin b complex|mesh-ancestor
101882494|NCT00096135|Vitamins|vitamins|mesh-ancestor
101882495|NCT00096135|Micronutrients|micronutrients|mesh-ancestor
101882496|NCT00096135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101882497|NCT00096135|Tubulin Modulators|tubulin modulators|mesh-ancestor
101882498|NCT00096135|Antimitotic Agents|antimitotic agents|mesh-ancestor
101882499|NCT00096135|Mitosis Modulators|mitosis modulators|mesh-ancestor
101882500|NCT00096135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101882501|NCT00116805|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101882502|NCT00116805|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101882503|NCT00116805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101882504|NCT00116805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101882505|NCT00116805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101882506|NCT00116805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882507|NCT00116805|Antiviral Agents|antiviral agents|mesh-ancestor
101882508|NCT00116805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101882509|NCT00116805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101882510|NCT00116805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101882511|NCT00116649|Imiquimod|imiquimod|mesh-list
101882512|NCT00116649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101882513|NCT00116649|Immunologic Factors|immunologic factors|mesh-ancestor
101882514|NCT00116649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882515|NCT00116649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101882516|NCT00116649|Interferon Inducers|interferon inducers|mesh-ancestor
101882517|NCT01080651|Voriconazole|voriconazole|mesh-list
101882518|NCT01080651|Antifungal Agents|antifungal agents|mesh-ancestor
101882519|NCT01080651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101882520|NCT01080651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101882521|NCT01080651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101882522|NCT01080651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101882523|NCT01080651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882524|NCT01080651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101882525|NCT01080651|Hormone Antagonists|hormone antagonists|mesh-ancestor
101882526|NCT01080651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101882527|NCT01080651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882528|NCT01080651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101882529|NCT01080729|Hormones|hormones|mesh-list
101882530|NCT01080729|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101882531|NCT01080729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101882532|NCT01080729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882533|NCT03962907|Chlorhexidine|chlorhexidine|mesh-list
101882534|NCT03962907|Mupirocin|mupirocin|mesh-list
101882535|NCT03962907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101882536|NCT03962907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101882537|NCT03962907|Disinfectants|disinfectants|mesh-ancestor
101882538|NCT03962907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101882539|NCT03962907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101882540|NCT03962907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101882541|NCT03962907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882542|NCT00083889|Interferons|interferons|mesh-list
101882543|NCT00083889|Interferon-alpha|interferon-alpha|mesh-list
101882544|NCT00083889|Sunitinib|sunitinib|mesh-list
101882545|NCT00083889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101882546|NCT00083889|Antiviral Agents|antiviral agents|mesh-ancestor
101882547|NCT00083889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101882548|NCT00083889|Immunologic Factors|immunologic factors|mesh-ancestor
101882549|NCT00083889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882550|NCT00083889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101882551|NCT00083889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101882552|NCT00083889|Growth Substances|growth substances|mesh-ancestor
101882553|NCT00083889|Growth Inhibitors|growth inhibitors|mesh-ancestor
101882554|NCT00083889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101882555|NCT00083889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101882556|NCT00083889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882557|NCT03639532|Tacrine|tacrine|mesh-list
101882558|NCT03639532|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101882559|NCT03639532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101882560|NCT03639532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882561|NCT03639532|Cholinergic Agents|cholinergic agents|mesh-ancestor
101882562|NCT03639532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101882563|NCT03639532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882564|NCT03639532|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101882565|NCT03639532|Autonomic Agents|autonomic agents|mesh-ancestor
101882566|NCT03639532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101882567|NCT03639532|Nootropic Agents|nootropic agents|mesh-ancestor
101882568|NCT03571516|Teduglutide|teduglutide|mesh-list
101882569|NCT03571516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101882570|NCT03571516|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101882571|NCT03571516|Protective Agents|protective agents|mesh-ancestor
101882572|NCT03571516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882573|NCT03600376|Dantrolene|dantrolene|mesh-list
101882574|NCT03600376|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101882575|NCT03600376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882576|NCT03600376|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101882577|NCT03600376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101882578|NCT03961659|Metformin|metformin|mesh-list
101882579|NCT03961659|Dapagliflozin|dapagliflozin|mesh-list
101882580|NCT03961659|Acarbose|acarbose|mesh-list
101882581|NCT03961659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101882582|NCT03961659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882583|NCT03961659|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101882584|NCT03961659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882585|NCT03961659|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101882586|NCT03961659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101882588|NCT03599362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101882589|NCT03599362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101882590|NCT03599362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101882591|NCT03599362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882592|NCT03741309|Calcium|calcium|mesh-list
101882593|NCT03741309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101882594|NCT03741309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882595|NCT00082407|Insulin Aspart|insulin aspart|mesh-list
101882596|NCT00082407|Exenatide|exenatide|mesh-list
101882597|NCT00082407|Biphasic Insulins|biphasic insulins|mesh-list
101882598|NCT00082407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101882599|NCT00082407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882600|NCT00082407|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101882601|NCT00082407|Incretins|incretins|mesh-ancestor
101882602|NCT00082407|Hormones|hormones|mesh-ancestor
101882603|NCT00082407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101882604|NCT01080963|Daptomycin|daptomycin|mesh-list
101882605|NCT01080963|Cefuroxime|cefuroxime|mesh-list
101882606|NCT01080963|Cefuroxime axetil|cefuroxime axetil|mesh-list
101882607|NCT01080963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101882608|NCT01080963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101882609|NCT01083381|Risperidone|risperidone|mesh-list
101882610|NCT01083381|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101882611|NCT01083381|Serotonin Agents|serotonin agents|mesh-ancestor
101882612|NCT01083381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101882613|NCT01083381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882614|NCT01083381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882615|NCT01083381|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101882616|NCT01083381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101882617|NCT01083381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101882618|NCT01083381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101882619|NCT01083381|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101882620|NCT01083381|Dopamine Agents|dopamine agents|mesh-ancestor
101882621|NCT01087359|Melatonin|melatonin|mesh-list
101882622|NCT01087359|Antioxidants|antioxidants|mesh-ancestor
101689250|NCT02830139|Oxaliplatin|oxaliplatin|mesh-list
101882623|NCT01087359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882624|NCT01087359|Protective Agents|protective agents|mesh-ancestor
101882625|NCT01087359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882626|NCT01087359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101882628|NCT01087437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101882629|NCT01087437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882630|NCT01083537|Paclitaxel|paclitaxel|mesh-list
101882631|NCT01083537|Cisplatin|cisplatin|mesh-list
101882632|NCT01083537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101882633|NCT01083537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101882634|NCT01083537|Tubulin Modulators|tubulin modulators|mesh-ancestor
101882635|NCT01083537|Antimitotic Agents|antimitotic agents|mesh-ancestor
101882636|NCT01083537|Mitosis Modulators|mitosis modulators|mesh-ancestor
101882637|NCT01083537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882638|NCT03597022|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
101882639|NCT03597022|Immunoglobulins|immunoglobulins|mesh-list
101882640|NCT03597022|Immunoglobulin G|immunoglobulin g|mesh-list
101882641|NCT03597022|Immunologic Factors|immunologic factors|mesh-ancestor
101882642|NCT03597022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882644|NCT03597022|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101882645|NCT03597022|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101882646|NCT03597022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882647|NCT03597022|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101882648|NCT03597022|Protease Inhibitors|protease inhibitors|mesh-ancestor
101882649|NCT03597022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101882650|NCT03597022|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101882651|NCT03597022|Antithrombins|antithrombins|mesh-ancestor
101882652|NCT03569098|Hemagglutinins|hemagglutinins|mesh-list
101882653|NCT03569098|Botulinum Toxins|botulinum toxins|mesh-list
101882654|NCT03569098|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101882655|NCT03569098|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101882656|NCT03569098|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101882657|NCT03569098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101882658|NCT03569098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882659|NCT03569098|Cholinergic Agents|cholinergic agents|mesh-ancestor
101882660|NCT03569098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101882661|NCT03569098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882662|NCT03569098|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101882663|NCT03569098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101882664|NCT03569098|Agglutinins|agglutinins|mesh-ancestor
101882665|NCT03569098|Immunologic Factors|immunologic factors|mesh-ancestor
101882666|NCT03569098|Coagulants|coagulants|mesh-ancestor
101882667|NCT03727282|Dobutamine|dobutamine|mesh-list
101882668|NCT03727282|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101882669|NCT03727282|Sympathomimetics|sympathomimetics|mesh-ancestor
101882670|NCT03727282|Autonomic Agents|autonomic agents|mesh-ancestor
101882671|NCT03727282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101882672|NCT03727282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882673|NCT03727282|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101882674|NCT03727282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101882675|NCT03727282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101882676|NCT03727282|Adrenergic Agents|adrenergic agents|mesh-ancestor
101882677|NCT03727282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101882678|NCT03727282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882679|NCT03727282|Protective Agents|protective agents|mesh-ancestor
101882680|NCT03568942|Gepotidacin|gepotidacin|mesh-list
101882681|NCT03568942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101882682|NCT03568942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101882683|NCT03568942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882684|NCT03568942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101882685|NCT00110019|Paclitaxel|paclitaxel|mesh-list
101882686|NCT00110019|Carboplatin|carboplatin|mesh-list
101882687|NCT00110019|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101882688|NCT00110019|Sorafenib|sorafenib|mesh-list
101882689|NCT00110019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101882690|NCT00110019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101882691|NCT00110019|Tubulin Modulators|tubulin modulators|mesh-ancestor
101882692|NCT00110019|Antimitotic Agents|antimitotic agents|mesh-ancestor
101882693|NCT00110019|Mitosis Modulators|mitosis modulators|mesh-ancestor
101882694|NCT00110019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689253|NCT02830139|Antimetabolites|antimetabolites|mesh-ancestor
101882695|NCT00110019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101882696|NCT00110019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101882697|NCT03642262|Guaifenesin|guaifenesin|mesh-list
101882698|NCT03642262|Expectorants|expectorants|mesh-ancestor
101882699|NCT03642262|Respiratory System Agents|respiratory system agents|mesh-ancestor
101882700|NCT03727048|Ketorolac|ketorolac|mesh-list
101882701|NCT03727048|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101882702|NCT03727048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101882703|NCT03727048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101882704|NCT03727048|Analgesics|analgesics|mesh-ancestor
101882705|NCT03727048|Sensory System Agents|sensory system agents|mesh-ancestor
101882706|NCT03727048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101882707|NCT03727048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882708|NCT03727048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101882709|NCT03727048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101882710|NCT03727048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101882711|NCT03727048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101882712|NCT03727048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882713|NCT00095979|Epothilones|epothilones|mesh-list
101882714|NCT00095979|Epothilone B|epothilone b|mesh-list
101882715|NCT00095979|Tubulin Modulators|tubulin modulators|mesh-ancestor
101882716|NCT00095979|Antimitotic Agents|antimitotic agents|mesh-ancestor
101602510|NCT00621478|Diazepam|diazepam|mesh-list
101882717|NCT00095979|Mitosis Modulators|mitosis modulators|mesh-ancestor
101882718|NCT00095979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882719|NCT00095979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101882720|NCT01087593|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101882721|NCT01087593|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101882722|NCT01087593|Estradiol|estradiol|mesh-list
101882723|NCT01087593|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101882724|NCT01087593|Estrogens|estrogens|mesh-ancestor
101882725|NCT01087593|Hormones|hormones|mesh-ancestor
101882726|NCT01087593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101882727|NCT01087593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882728|NCT01087593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101882729|NCT01087593|Contraceptive Agents|contraceptive agents|mesh-ancestor
101882730|NCT01087593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101882731|NCT01087593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101882732|NCT00082173|Moxifloxacin|moxifloxacin|mesh-list
101882733|NCT00082173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101882734|NCT00082173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101882735|NCT00082173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101882736|NCT00082173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101882737|NCT00082173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101882738|NCT00082173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882739|NCT00082173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101882740|NCT01087749|Losartan|losartan|mesh-list
101882741|NCT01087749|Propranolol|propranolol|mesh-list
101882742|NCT01087749|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101882743|NCT01087749|Eprosartan|eprosartan|mesh-list
101882744|NCT01087749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101882745|NCT01087749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101882746|NCT01087749|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101882747|NCT01087749|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101882748|NCT01087749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882749|NCT01087749|Diuretics|diuretics|mesh-ancestor
101882750|NCT01087749|Natriuretic Agents|natriuretic agents|mesh-ancestor
101882751|NCT01087749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882752|NCT01087749|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101882753|NCT01087749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101882754|NCT01087749|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101882755|NCT01087749|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101968127|NCT01100125|Insulin|insulin|mesh-list
101882756|NCT01087749|Adrenergic Agents|adrenergic agents|mesh-ancestor
101455413|NCT00239304|Gefitinib|gefitinib|mesh-list
101882757|NCT01087749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101882758|NCT01087749|Vasodilator Agents|vasodilator agents|mesh-ancestor
101882759|NCT01087749|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
101882760|NCT00108069|Tamoxifen|tamoxifen|mesh-list
101882761|NCT00108069|Bortezomib|bortezomib|mesh-list
101882762|NCT00108069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101882763|NCT00108069|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101882764|NCT00108069|Hormone Antagonists|hormone antagonists|mesh-ancestor
101882765|NCT00108069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101882766|NCT00108069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882767|NCT00108069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101882768|NCT00108069|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101882769|NCT00108069|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101882770|NCT00108069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101882771|NCT00079274|Leucovorin|leucovorin|mesh-list
101882772|NCT00079274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101882773|NCT00079274|Cetuximab|cetuximab|mesh-list
101882774|NCT00079274|Fluorouracil|fluorouracil|mesh-list
101882775|NCT00079274|Oxaliplatin|oxaliplatin|mesh-list
101882776|NCT00079274|Irinotecan|irinotecan|mesh-list
101882777|NCT00079274|Antibodies|antibodies|mesh-list
101882778|NCT00079274|Immunoglobulins|immunoglobulins|mesh-list
101882779|NCT00079274|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101882780|NCT00079274|Levoleucovorin|levoleucovorin|mesh-list
101882781|NCT00079274|Immunologic Factors|immunologic factors|mesh-ancestor
101882782|NCT00079274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882783|NCT00079274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101882784|NCT00079274|Antimetabolites|antimetabolites|mesh-ancestor
101882785|NCT00079274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882786|NCT00079274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101882787|NCT00079274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101882788|NCT00079274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101882789|NCT00079274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101882790|NCT00079274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101882791|NCT00079274|Antidotes|antidotes|mesh-ancestor
101882792|NCT00079274|Protective Agents|protective agents|mesh-ancestor
101882793|NCT00079274|Vitamin B Complex|vitamin b complex|mesh-ancestor
101882794|NCT00079274|Vitamins|vitamins|mesh-ancestor
101882795|NCT00079274|Micronutrients|micronutrients|mesh-ancestor
101882796|NCT01081964|Levofloxacin|levofloxacin|mesh-list
101882797|NCT01081964|Fluoroquinolones|fluoroquinolones|mesh-list
101882798|NCT01081964|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101882799|NCT01081964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101882800|NCT01081964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101882801|NCT01081964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101882802|NCT01081964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101882803|NCT01081964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101882804|NCT01081964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882805|NCT01081964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101882806|NCT01081964|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101882807|NCT01081964|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101882808|NCT01081964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101882809|NCT00079040|Bevacizumab|bevacizumab|mesh-list
101882810|NCT00079040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101882811|NCT00079040|Etoposide|etoposide|mesh-list
101882812|NCT00079040|Etoposide phosphate|etoposide phosphate|mesh-list
101882813|NCT00079040|Antibodies|antibodies|mesh-list
101882814|NCT00079040|Immunoglobulins|immunoglobulins|mesh-list
101882815|NCT00079040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101882816|NCT00079040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101882817|NCT00079040|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101882818|NCT00079040|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101882819|NCT00079040|Growth Substances|growth substances|mesh-ancestor
101882820|NCT00079040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882821|NCT00079040|Growth Inhibitors|growth inhibitors|mesh-ancestor
101882822|NCT00079040|Immunologic Factors|immunologic factors|mesh-ancestor
101882823|NCT00079040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101455418|NCT00239343|Gefitinib|gefitinib|mesh-list
101882824|NCT00079040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101882826|NCT00079040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101882827|NCT00079040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882828|NCT01088516|Ritonavir|ritonavir|mesh-list
101882829|NCT01088516|Lopinavir|lopinavir|mesh-list
101882830|NCT01088516|Zidovudine|zidovudine|mesh-list
101882831|NCT01088516|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101882832|NCT01088516|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101882833|NCT01088516|Protease Inhibitors|protease inhibitors|mesh-ancestor
101882834|NCT01088516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101882835|NCT01088516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882836|NCT01088516|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101882837|NCT01088516|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101882838|NCT01088516|Antiviral Agents|antiviral agents|mesh-ancestor
101882839|NCT01088516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101882840|NCT01088516|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101882841|NCT01088516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101882842|NCT01088516|Antimetabolites|antimetabolites|mesh-ancestor
101882843|NCT01088516|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101882844|NCT01088516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101882845|NCT00078806|Etanercept|etanercept|mesh-list
101882846|NCT00078806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101882847|NCT00078806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101882848|NCT00078806|Analgesics|analgesics|mesh-ancestor
101882849|NCT00078806|Sensory System Agents|sensory system agents|mesh-ancestor
101882850|NCT00078806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101882851|NCT00078806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882852|NCT00078806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101882853|NCT00078806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101882854|NCT00078806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101882855|NCT00078806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101882856|NCT00078806|Immunologic Factors|immunologic factors|mesh-ancestor
101882857|NCT00078338|Interferons|interferons|mesh-list
101882858|NCT00078338|Interferon-beta|interferon-beta|mesh-list
101882859|NCT00078338|Interferon beta-1a|interferon beta-1a|mesh-list
101882860|NCT00078338|Glatiramer Acetate|glatiramer acetate|mesh-list
101882861|NCT00078338|(T,G)-A-L|(t,g)-a-l|mesh-list
101882862|NCT00078338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101882863|NCT00078338|Antiviral Agents|antiviral agents|mesh-ancestor
101882864|NCT00078338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101882865|NCT00078338|Immunologic Factors|immunologic factors|mesh-ancestor
101882866|NCT00078338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882867|NCT00078338|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101882868|NCT00078338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101882869|NCT00078338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101882870|NCT01088594|Pioglitazone|pioglitazone|mesh-list
101882871|NCT01088594|Rosiglitazone|rosiglitazone|mesh-list
101882872|NCT01088594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101882873|NCT01088594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882874|NCT01082120|Pioglitazone|pioglitazone|mesh-list
101882875|NCT01082120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101882876|NCT01082120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882877|NCT03808688|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101882878|NCT03808688|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101882879|NCT03808298|Moxifloxacin|moxifloxacin|mesh-list
101882880|NCT03808298|Balovaptan|balovaptan|mesh-list
101882881|NCT03808298|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101882882|NCT03808298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101882883|NCT03808298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101882884|NCT03808298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101882885|NCT03808298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101882886|NCT03808298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101882887|NCT03808298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882888|NCT03808298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101882889|NCT03808298|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101882890|NCT03808298|Contraceptive Agents|contraceptive agents|mesh-ancestor
101882891|NCT03808298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101968151|NCT03948685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101882892|NCT03808298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882893|NCT03808298|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101882894|NCT03808298|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101882895|NCT03808298|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101882896|NCT03808298|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101882897|NCT03808298|Natriuretic Agents|natriuretic agents|mesh-ancestor
101882898|NCT00077636|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101882899|NCT00077636|Interferon-alpha|interferon-alpha|mesh-list
101882900|NCT00077636|Ribavirin|ribavirin|mesh-list
101882901|NCT00077636|Antiviral Agents|antiviral agents|mesh-ancestor
101882902|NCT00077636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101882903|NCT00077636|Immunologic Factors|immunologic factors|mesh-ancestor
101882904|NCT00077636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882905|NCT00077636|Antimetabolites|antimetabolites|mesh-ancestor
101882906|NCT00077636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882907|NCT01082198|Vaccines|vaccines|mesh-list
101882908|NCT01082198|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
101882909|NCT01082198|Immunologic Factors|immunologic factors|mesh-ancestor
101882910|NCT01082198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882911|NCT01082198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101882912|NCT01088750|Prednisolone|prednisolone|mesh-list
101882913|NCT01088750|Cyclophosphamide|cyclophosphamide|mesh-list
101882914|NCT01088750|Vinblastine|vinblastine|mesh-list
101689259|NCT02651610|Docetaxel|docetaxel|mesh-list
101882915|NCT01088750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101882916|NCT01088750|Immunologic Factors|immunologic factors|mesh-ancestor
101882917|NCT01088750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882918|NCT01088750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101882919|NCT01088750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101882920|NCT01088750|Alkylating Agents|alkylating agents|mesh-ancestor
101882921|NCT01088750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882922|NCT01088750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101882923|NCT01088750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101882924|NCT01088750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101882925|NCT01088750|Glucocorticoids|glucocorticoids|mesh-ancestor
101882926|NCT01088750|Hormones|hormones|mesh-ancestor
101882927|NCT01088750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101882928|NCT01088750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101882929|NCT01088750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101882930|NCT01088750|Tubulin Modulators|tubulin modulators|mesh-ancestor
101882931|NCT01088750|Antimitotic Agents|antimitotic agents|mesh-ancestor
101882932|NCT01088750|Mitosis Modulators|mitosis modulators|mesh-ancestor
101882933|NCT01091012|Sildenafil Citrate|sildenafil citrate|mesh-list
101882934|NCT01091012|Vasodilator Agents|vasodilator agents|mesh-ancestor
101882935|NCT01091012|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101882936|NCT01091012|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101882937|NCT01091012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101882938|NCT01091012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882939|NCT01091012|Urological Agents|urological agents|mesh-ancestor
101882940|NCT01082276|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
101882941|NCT01082276|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101882942|NCT01082276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101882943|NCT01082276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101882944|NCT01082276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882945|NCT01082276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101882946|NCT01082276|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101882947|NCT01082276|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101882948|NCT01082276|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101882949|NCT01082276|Adrenergic Agents|adrenergic agents|mesh-ancestor
101882950|NCT01082276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101882951|NCT01082276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882952|NCT01082276|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101882953|NCT01082276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101882954|NCT01082276|Serotonin Agents|serotonin agents|mesh-ancestor
101968165|NCT01585051|Vitamin D|vitamin d|mesh-list
101882955|NCT01082276|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101882956|NCT01082276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101882957|NCT01082276|Dopamine Agents|dopamine agents|mesh-ancestor
101882958|NCT01088906|Pemetrexed|pemetrexed|mesh-list
101882959|NCT01088906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101882960|NCT01088906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101882961|NCT01088906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882962|NCT01088906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101882963|NCT01088906|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101882964|NCT00095199|Docetaxel|docetaxel|mesh-list
101882965|NCT00095199|Pemetrexed|pemetrexed|mesh-list
101882966|NCT00095199|Cetuximab|cetuximab|mesh-list
101882967|NCT00095199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101882968|NCT00095199|Tubulin Modulators|tubulin modulators|mesh-ancestor
101882969|NCT00095199|Antimitotic Agents|antimitotic agents|mesh-ancestor
101882970|NCT00095199|Mitosis Modulators|mitosis modulators|mesh-ancestor
101882971|NCT00095199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882972|NCT00095199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101882973|NCT00095199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101882974|NCT00095199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101882975|NCT00095199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101882976|NCT00075764|Fulvestrant|fulvestrant|mesh-list
101882977|NCT00075764|Anastrozole|anastrozole|mesh-list
101882978|NCT00075764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101882979|NCT00075764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101882980|NCT00075764|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101882981|NCT00075764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101882982|NCT00075764|Hormone Antagonists|hormone antagonists|mesh-ancestor
101882983|NCT00075764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101882984|NCT00075764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882985|NCT00075764|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101882986|NCT00075764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101882987|NCT00075764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101882988|NCT00075764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101882989|NCT03567616|Dexamethasone|dexamethasone|mesh-list
101882990|NCT03567616|Venetoclax|venetoclax|mesh-list
101882991|NCT03567616|Pomalidomide|pomalidomide|mesh-list
101882992|NCT03567616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101882993|NCT03567616|Antiemetics|antiemetics|mesh-ancestor
101882994|NCT03567616|Autonomic Agents|autonomic agents|mesh-ancestor
101882995|NCT03567616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101882996|NCT03567616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101882997|NCT03567616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101882998|NCT03567616|Glucocorticoids|glucocorticoids|mesh-ancestor
101882999|NCT03567616|Hormones|hormones|mesh-ancestor
101883000|NCT03567616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101883001|NCT03567616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101883002|NCT03567616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101883003|NCT03567616|Immunologic Factors|immunologic factors|mesh-ancestor
101883004|NCT03567616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101883005|NCT03567616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101883006|NCT03567616|Growth Substances|growth substances|mesh-ancestor
101883007|NCT03567616|Growth Inhibitors|growth inhibitors|mesh-ancestor
101883008|NCT03567382|Tenofovir|tenofovir|mesh-list
101883009|NCT03567382|Antiviral Agents|antiviral agents|mesh-ancestor
101883010|NCT03567382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101883011|NCT03567382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101883012|NCT03567382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101883013|NCT03567382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101883014|NCT03567382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883015|NCT03567382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101883016|NCT03567382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101883017|NCT03591874|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101883019|NCT03591874|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101883020|NCT03591874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101883021|NCT03591874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101883022|NCT03591874|Adrenergic Agents|adrenergic agents|mesh-ancestor
101883023|NCT03591874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101883024|NCT03591874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883025|NCT03591874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883026|NCT03730714|Epinephrine|epinephrine|mesh-list
101883027|NCT03730714|Racepinephrine|racepinephrine|mesh-list
101883029|NCT03730714|Anesthetics|anesthetics|mesh-list
101883030|NCT03730714|Anesthetics, Local|anesthetics, local|mesh-list
101883031|NCT03730714|Epinephryl borate|epinephryl borate|mesh-list
101883032|NCT03730714|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101883033|NCT03730714|Narcotics|narcotics|mesh-ancestor
101883034|NCT03730714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101883035|NCT03730714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883036|NCT03730714|Analgesics|analgesics|mesh-ancestor
101883037|NCT03730714|Sensory System Agents|sensory system agents|mesh-ancestor
101883038|NCT03730714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101883039|NCT03730714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101883040|NCT03730714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101883041|NCT03730714|Adrenergic Agents|adrenergic agents|mesh-ancestor
101883042|NCT03730714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101883043|NCT03730714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883044|NCT03730714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101883045|NCT03730714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101883046|NCT03730714|Autonomic Agents|autonomic agents|mesh-ancestor
101883047|NCT03730714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101883048|NCT03730714|Respiratory System Agents|respiratory system agents|mesh-ancestor
101883049|NCT03730714|Mydriatics|mydriatics|mesh-ancestor
101883050|NCT03730714|Sympathomimetics|sympathomimetics|mesh-ancestor
101883051|NCT03730714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101883052|NCT00106353|Temsirolimus|temsirolimus|mesh-list
101883053|NCT00106353|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101883054|NCT00106353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101883055|NCT00106353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101883056|NCT00106353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883057|NCT00106353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101883058|NCT00106353|Immunologic Factors|immunologic factors|mesh-ancestor
101883059|NCT00106353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883060|NCT00106353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101883062|NCT01087983|Sirolimus|sirolimus|mesh-list
101883063|NCT01087983|Lapatinib|lapatinib|mesh-list
101883064|NCT01087983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101883065|NCT01087983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883066|NCT01087983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101883067|NCT01087983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101883068|NCT01087983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101883069|NCT01087983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101883070|NCT01087983|Antifungal Agents|antifungal agents|mesh-ancestor
101883071|NCT01087983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101883072|NCT01087983|Immunologic Factors|immunologic factors|mesh-ancestor
101883073|NCT01087983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101883074|NCT01087983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101883075|NCT01087983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883076|NCT00080301|Capecitabine|capecitabine|mesh-list
101883077|NCT00080301|Epothilones|epothilones|mesh-list
101883078|NCT00080301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101883079|NCT00080301|Antimetabolites|antimetabolites|mesh-ancestor
101883080|NCT00080301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883081|NCT00080301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101883082|NCT00080301|Tubulin Modulators|tubulin modulators|mesh-ancestor
101883083|NCT00080301|Antimitotic Agents|antimitotic agents|mesh-ancestor
101883084|NCT00080301|Mitosis Modulators|mitosis modulators|mesh-ancestor
101883085|NCT03961503|Vancomycin|vancomycin|mesh-list
101883086|NCT03961503|Daptomycin|daptomycin|mesh-list
101883087|NCT03961503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101883088|NCT03961503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101883089|NCT00079677|Modafinil|modafinil|mesh-list
101883090|NCT00079677|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101883091|NCT00079677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883092|NCT00079677|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101883093|NCT00079677|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101883094|NCT00079677|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101883095|NCT00079677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883097|NCT01081353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101883098|NCT01081353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101883099|NCT01081353|Analgesics|analgesics|mesh-ancestor
101883100|NCT01081353|Sensory System Agents|sensory system agents|mesh-ancestor
101883101|NCT01081353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101883102|NCT01081353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883103|NCT01081353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101883104|NCT01081353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101883105|NCT01081353|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101883106|NCT01081353|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101883107|NCT01081353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883108|NCT01081353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101883109|NCT01081353|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101883110|NCT01081353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101883111|NCT01081353|Antipyretics|antipyretics|mesh-ancestor
101883112|NCT00095121|Lamivudine|lamivudine|mesh-list
101883113|NCT00095121|Adefovir|adefovir|mesh-list
101883114|NCT00095121|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101883115|NCT00095121|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101883116|NCT00095121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101883117|NCT00095121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101883118|NCT00095121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883119|NCT00095121|Antiviral Agents|antiviral agents|mesh-ancestor
101883120|NCT00095121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101883121|NCT00095121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101883122|NCT00095121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101883123|NCT01081431|Lenalidomide|lenalidomide|mesh-list
101883124|NCT01081431|Immunologic Factors|immunologic factors|mesh-ancestor
101883125|NCT01081431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883126|NCT01081431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101883127|NCT01081431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101883128|NCT01081431|Growth Substances|growth substances|mesh-ancestor
101883129|NCT01081431|Growth Inhibitors|growth inhibitors|mesh-ancestor
101883130|NCT01081431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101455494|NCT00239499|Cholinergic Agents|cholinergic agents|mesh-ancestor
101883131|NCT03962829|1-(3-chlorophenyl)piperazine|1-(3-chlorophenyl)piperazine|mesh-list
101883132|NCT03962829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101883133|NCT03962829|Serotonin Agents|serotonin agents|mesh-ancestor
101883134|NCT03962829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101883135|NCT03962829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883136|NCT03962829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883137|NCT01084473|Dexmedetomidine|dexmedetomidine|mesh-list
101883138|NCT01084473|Morphine|morphine|mesh-list
101883139|NCT01084473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101883140|NCT01084473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101883141|NCT01084473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883142|NCT01084473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101883143|NCT01084473|Analgesics|analgesics|mesh-ancestor
101883144|NCT01084473|Sensory System Agents|sensory system agents|mesh-ancestor
101883145|NCT01084473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101883146|NCT01084473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101883147|NCT01084473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101883148|NCT01084473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101883149|NCT01084473|Adrenergic Agents|adrenergic agents|mesh-ancestor
101883150|NCT01084473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101883151|NCT01084473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883152|NCT01084473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101883153|NCT01084473|Narcotics|narcotics|mesh-ancestor
101883154|NCT01088373|Lenalidomide|lenalidomide|mesh-list
101883155|NCT01088373|Azacitidine|azacitidine|mesh-list
101883156|NCT01088373|Immunologic Factors|immunologic factors|mesh-ancestor
101883157|NCT01088373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883158|NCT01088373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101883159|NCT01088373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101883160|NCT01088373|Growth Substances|growth substances|mesh-ancestor
101883161|NCT01088373|Growth Inhibitors|growth inhibitors|mesh-ancestor
101968181|NCT00003631|Melphalan|melphalan|mesh-list
101883162|NCT01088373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101883163|NCT01088373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101883164|NCT01088373|Antimetabolites|antimetabolites|mesh-ancestor
101883165|NCT01088373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883166|NCT01088373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101883167|NCT01088451|Insulin|insulin|mesh-list
101883168|NCT01088451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101883169|NCT01088451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883171|NCT00075218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101883172|NCT00075218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101883173|NCT00075218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101883174|NCT00075218|Growth Substances|growth substances|mesh-ancestor
101883175|NCT00075218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883176|NCT00075218|Growth Inhibitors|growth inhibitors|mesh-ancestor
101883177|NCT00075218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101883178|NCT00075218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101883179|NCT00075218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883180|NCT01089140|Tranexamic Acid|tranexamic acid|mesh-list
101883181|NCT01089140|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101883182|NCT01089140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101883183|NCT01089140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883184|NCT01089140|Hemostatics|hemostatics|mesh-ancestor
101883185|NCT01089140|Coagulants|coagulants|mesh-ancestor
101883186|NCT00094653|Ipilimumab|ipilimumab|mesh-list
101883187|NCT00094653|Vaccines|vaccines|mesh-list
101883188|NCT00094653|Antibodies|antibodies|mesh-list
101883189|NCT00094653|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101883190|NCT00094653|Immunologic Factors|immunologic factors|mesh-ancestor
101883191|NCT00094653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883192|NCT00094653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101883193|NCT00094653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101883194|NCT00094653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101883195|NCT00094653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883196|NCT00104247|Verapamil|verapamil|mesh-list
101883197|NCT00104247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101455499|NCT00239499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101883198|NCT00104247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101883199|NCT00104247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101883200|NCT00104247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883201|NCT00104247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101883202|NCT00104247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883203|NCT00104247|Vasodilator Agents|vasodilator agents|mesh-ancestor
101883204|NCT05665348|Bevacizumab|bevacizumab|mesh-list
101883205|NCT05665348|Ipilimumab|ipilimumab|mesh-list
101883206|NCT05665348|Atezolizumab|atezolizumab|mesh-list
101883207|NCT05665348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101883208|NCT05665348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101883209|NCT05665348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101883210|NCT05665348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101883211|NCT05665348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101883213|NCT05665348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883214|NCT05665348|Growth Inhibitors|growth inhibitors|mesh-ancestor
101883215|NCT05665348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101883216|NCT05665348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883217|NCT05665348|Immunologic Factors|immunologic factors|mesh-ancestor
101883218|NCT03726736|Docetaxel|docetaxel|mesh-list
101883219|NCT03726736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101883220|NCT03726736|Tubulin Modulators|tubulin modulators|mesh-ancestor
101883221|NCT03726736|Antimitotic Agents|antimitotic agents|mesh-ancestor
101883222|NCT03726736|Mitosis Modulators|mitosis modulators|mesh-ancestor
101883223|NCT03726736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883224|NCT03591406|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101883225|NCT03591406|Hematinics|hematinics|mesh-ancestor
101883226|NCT03726580|Propofol|propofol|mesh-list
101883227|NCT03726580|Sevoflurane|sevoflurane|mesh-list
101883228|NCT03726580|Isoflurane|isoflurane|mesh-list
101883229|NCT03726580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101883230|NCT03726580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101883231|NCT03726580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883232|NCT03726580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101883233|NCT03726580|Anesthetics, General|anesthetics, general|mesh-ancestor
101883234|NCT03726580|Anesthetics|anesthetics|mesh-ancestor
101883235|NCT03726580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101883236|NCT03726580|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101883237|NCT03730558|Aflibercept|aflibercept|mesh-list
101883238|NCT03730558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101883239|NCT03730558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101883240|NCT03730558|Growth Substances|growth substances|mesh-ancestor
101883241|NCT03730558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883242|NCT03730558|Growth Inhibitors|growth inhibitors|mesh-ancestor
101883243|NCT03730558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101883244|NCT03588910|Acetaminophen|acetaminophen|mesh-list
101883245|NCT03588910|Ibuprofen|ibuprofen|mesh-list
101883246|NCT03588910|Oxycodone|oxycodone|mesh-list
101883247|NCT03588910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101883248|NCT03588910|Analgesics|analgesics|mesh-ancestor
101883249|NCT03588910|Sensory System Agents|sensory system agents|mesh-ancestor
101883250|NCT03588910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101883251|NCT03588910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883252|NCT03588910|Antipyretics|antipyretics|mesh-ancestor
101883253|NCT03588910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101883254|NCT03588910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101883255|NCT03588910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101883256|NCT03588910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101883257|NCT03588910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101883258|NCT03588910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883259|NCT03588910|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101883260|NCT03588910|Narcotics|narcotics|mesh-ancestor
101883261|NCT03588910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101883262|NCT03730402|Bupivacaine|bupivacaine|mesh-list
101883263|NCT03730402|Anesthetics, Local|anesthetics, local|mesh-ancestor
101883264|NCT03730402|Anesthetics|anesthetics|mesh-ancestor
101883265|NCT03730402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101883266|NCT03730402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883267|NCT03730402|Sensory System Agents|sensory system agents|mesh-ancestor
101883268|NCT03730402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101883269|NCT00103857|Metformin|metformin|mesh-list
101883270|NCT00103857|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101883271|NCT00103857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101883272|NCT00103857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883273|NCT00103857|Incretins|incretins|mesh-ancestor
101883274|NCT00103857|Hormones|hormones|mesh-ancestor
101883275|NCT00103857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101883276|NCT00103857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101883277|NCT00103857|Protease Inhibitors|protease inhibitors|mesh-ancestor
101883278|NCT00103857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101883279|NCT00103857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883280|NCT03587584|Bupivacaine|bupivacaine|mesh-list
101883281|NCT03587584|Anesthetics, Local|anesthetics, local|mesh-ancestor
101883282|NCT03587584|Anesthetics|anesthetics|mesh-ancestor
101883283|NCT03587584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101883284|NCT03587584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883285|NCT03587584|Sensory System Agents|sensory system agents|mesh-ancestor
101883286|NCT03587584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101883287|NCT03586726|Rifampin|rifampin|mesh-list
101883288|NCT03586726|Balovaptan|balovaptan|mesh-list
101883289|NCT03586726|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101883290|NCT03586726|Antitubercular Agents|antitubercular agents|mesh-ancestor
101883291|NCT03586726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101883292|NCT03586726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101883293|NCT03586726|Leprostatic Agents|leprostatic agents|mesh-ancestor
101883294|NCT03586726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101883295|NCT03586726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101883296|NCT03586726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883297|NCT03586726|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101883298|NCT03586726|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101883299|NCT03586726|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101968198|NCT00003631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101883300|NCT03586726|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101883301|NCT03586726|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101883302|NCT03586726|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101883303|NCT03586726|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101883305|NCT03586726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883312|NCT03721900|Ketamine|ketamine|mesh-list
101883313|NCT03721900|Analgesics|analgesics|mesh-ancestor
101883314|NCT03721900|Sensory System Agents|sensory system agents|mesh-ancestor
101883315|NCT03721900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101883316|NCT03721900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883317|NCT03721900|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101883318|NCT03721900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101883319|NCT03721900|Anesthetics, General|anesthetics, general|mesh-ancestor
101883320|NCT03721900|Anesthetics|anesthetics|mesh-ancestor
101883321|NCT03721900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101883322|NCT03721900|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101883323|NCT03721900|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101883324|NCT03721900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101883325|NCT03721900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883326|NCT03585712|Norgestrel|norgestrel|mesh-list
101883327|NCT03585712|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101883328|NCT03585712|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101883329|NCT03585712|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101883330|NCT03585712|Contraceptive Agents|contraceptive agents|mesh-ancestor
101883331|NCT03585712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101308738|NCT00005940|Busulfan|busulfan|mesh-list
101883332|NCT03585712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883333|NCT03585712|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101883334|NCT03585712|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101883335|NCT01082510|Tegafur|tegafur|mesh-list
101883336|NCT01082510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101883337|NCT01082510|Antimetabolites|antimetabolites|mesh-ancestor
101689270|NCT04208594|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101883338|NCT01082510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883339|NCT01082510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101883340|NCT03583372|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101883341|NCT03583372|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101883342|NCT03583372|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101883343|NCT03583372|Cholinergic Agents|cholinergic agents|mesh-ancestor
101883344|NCT03583372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101883345|NCT03583372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883346|NCT03583372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883347|NCT03583372|Urological Agents|urological agents|mesh-ancestor
101883348|NCT01091324|Dextromethorphan|dextromethorphan|mesh-list
101883349|NCT01091324|Silymarin|silymarin|mesh-list
101883350|NCT01091324|Antitussive Agents|antitussive agents|mesh-ancestor
101883351|NCT01091324|Respiratory System Agents|respiratory system agents|mesh-ancestor
101883352|NCT01091324|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101883353|NCT01091324|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101883354|NCT01091324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101883355|NCT01091324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883356|NCT01091324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883357|NCT01091324|Antioxidants|antioxidants|mesh-ancestor
101883358|NCT01091324|Protective Agents|protective agents|mesh-ancestor
101883359|NCT05782608|Ibuprofen|ibuprofen|mesh-list
101883360|NCT05782608|Ketorolac|ketorolac|mesh-list
101883361|NCT05782608|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101883362|NCT05782608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101883363|NCT05782608|Analgesics|analgesics|mesh-ancestor
101883364|NCT05782608|Sensory System Agents|sensory system agents|mesh-ancestor
101883365|NCT05782608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101883366|NCT05782608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883367|NCT05782608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101883368|NCT05782608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101883369|NCT05782608|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101883370|NCT05782608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101883371|NCT05782608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883372|NCT05782426|Paclitaxel|paclitaxel|mesh-list
101883373|NCT05782426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101883374|NCT05782426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101883375|NCT05782426|Tubulin Modulators|tubulin modulators|mesh-ancestor
101883376|NCT05782426|Antimitotic Agents|antimitotic agents|mesh-ancestor
101883377|NCT05782426|Mitosis Modulators|mitosis modulators|mesh-ancestor
101883378|NCT05782426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883379|NCT05782348|Listerine|listerine|mesh-list
101883380|NCT05782348|Sodium Fluoride|sodium fluoride|mesh-list
101883381|NCT05782348|Cariostatic Agents|cariostatic agents|mesh-ancestor
101883382|NCT05782348|Protective Agents|protective agents|mesh-ancestor
101883383|NCT05782348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883384|NCT05782348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101883385|NCT05782348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101883386|NCT05782192|Alogliptin|alogliptin|mesh-list
101883387|NCT05782192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101883388|NCT05782192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883389|NCT05782192|Incretins|incretins|mesh-ancestor
101883390|NCT05782192|Hormones|hormones|mesh-ancestor
101883391|NCT05782192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101883392|NCT05782192|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101883393|NCT05782192|Protease Inhibitors|protease inhibitors|mesh-ancestor
101883394|NCT05782192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101883395|NCT05782192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883397|NCT05781997|Autonomic Agents|autonomic agents|mesh-ancestor
101883398|NCT05781997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101883399|NCT05781997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883400|NCT05781854|Dexmedetomidine|dexmedetomidine|mesh-list
101883401|NCT05781854|Bupivacaine|bupivacaine|mesh-list
101883402|NCT05781854|Anesthetics, Local|anesthetics, local|mesh-ancestor
101883403|NCT05781854|Anesthetics|anesthetics|mesh-ancestor
101883404|NCT05781854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101883405|NCT05781854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883406|NCT05781854|Sensory System Agents|sensory system agents|mesh-ancestor
101883407|NCT05781854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101883408|NCT05781854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101883409|NCT05781854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101883410|NCT05781854|Analgesics|analgesics|mesh-ancestor
101883411|NCT05781854|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101883412|NCT05781854|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101883413|NCT05781854|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101883414|NCT05781854|Adrenergic Agents|adrenergic agents|mesh-ancestor
101883415|NCT05781854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101883416|NCT05781854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883417|NCT05781685|Testosterone|testosterone|mesh-list
101883418|NCT05781685|Androgens|androgens|mesh-ancestor
101883419|NCT05781685|Hormones|hormones|mesh-ancestor
101883420|NCT05781685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101883421|NCT05781685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883422|NCT05781633|Bevacizumab|bevacizumab|mesh-list
101883423|NCT05781633|Etoposide|etoposide|mesh-list
101883424|NCT05781633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101883425|NCT05781633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101883426|NCT05781633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101883427|NCT05781633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101883428|NCT05781633|Growth Substances|growth substances|mesh-ancestor
101883429|NCT05781633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883430|NCT05781633|Growth Inhibitors|growth inhibitors|mesh-ancestor
101883431|NCT05781633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101883432|NCT05781633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101883433|NCT05781633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101883434|NCT05781633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101883435|NCT05781633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883436|NCT05781620|Vitamin D|vitamin d|mesh-list
101883437|NCT05781620|Vitamins|vitamins|mesh-ancestor
101883438|NCT05781620|Micronutrients|micronutrients|mesh-ancestor
101883439|NCT05781620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883440|NCT05781620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101883441|NCT05781529|Hyaluronic Acid|hyaluronic acid|mesh-list
101883442|NCT05781529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101883443|NCT05781529|Immunologic Factors|immunologic factors|mesh-ancestor
101883444|NCT05781529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883445|NCT05781529|Viscosupplements|viscosupplements|mesh-ancestor
101883446|NCT05781529|Protective Agents|protective agents|mesh-ancestor
101883447|NCT05780554|Cyclophosphamide|cyclophosphamide|mesh-list
101883448|NCT05780554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101883449|NCT05780554|Immunologic Factors|immunologic factors|mesh-ancestor
101883450|NCT05780554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883451|NCT05780554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101883452|NCT05780554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101883453|NCT05780554|Alkylating Agents|alkylating agents|mesh-ancestor
101883454|NCT05780554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883455|NCT05780554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101883456|NCT05780554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101883457|NCT05869812|Calcium, Dietary|calcium, dietary|mesh-list
101883458|NCT05869812|Calcium|calcium|mesh-list
101883459|NCT05869812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101883460|NCT05869812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883461|NCT05869812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101883462|NCT05869760|Carotenoids|carotenoids|mesh-list
101883463|NCT05869760|Antioxidants|antioxidants|mesh-ancestor
101883464|NCT05869760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883465|NCT05869760|Protective Agents|protective agents|mesh-ancestor
101883466|NCT05869760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883467|NCT05869591|Apixaban|apixaban|mesh-list
101883468|NCT05869591|Edoxaban|edoxaban|mesh-list
101883469|NCT05869591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101883470|NCT05869591|Antithrombins|antithrombins|mesh-ancestor
101883471|NCT05869591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101883472|NCT05869591|Protease Inhibitors|protease inhibitors|mesh-ancestor
101883473|NCT05869591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101689297|NCT04724720|Histamine Agents|histamine agents|mesh-ancestor
101883474|NCT05869591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883475|NCT05869591|Anticoagulants|anticoagulants|mesh-ancestor
101883476|NCT05869578|Anesthetics|anesthetics|mesh-list
101883477|NCT05869578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101883478|NCT05869578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883479|NCT05869227|Capecitabine|capecitabine|mesh-list
101883480|NCT05869227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101883481|NCT05869227|Antimetabolites|antimetabolites|mesh-ancestor
101883482|NCT05869227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883483|NCT05869227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101883484|NCT05869201|Vaccines|vaccines|mesh-list
101883485|NCT05869201|Immunologic Factors|immunologic factors|mesh-ancestor
101883486|NCT05869201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883487|NCT05869097|Trifluridine|trifluridine|mesh-list
101883488|NCT05869097|Bevacizumab|bevacizumab|mesh-list
101883489|NCT05869097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101883490|NCT05869097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101883491|NCT05869097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101883492|NCT05869097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101883493|NCT05869097|Growth Substances|growth substances|mesh-ancestor
101883494|NCT05869097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883495|NCT05869097|Growth Inhibitors|growth inhibitors|mesh-ancestor
101883496|NCT05869097|Antimetabolites|antimetabolites|mesh-ancestor
101883497|NCT05869097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883498|NCT05869097|Antiviral Agents|antiviral agents|mesh-ancestor
101883499|NCT05869097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101883500|NCT05868993|Ropivacaine|ropivacaine|mesh-list
101883501|NCT05868993|Anesthetics, Local|anesthetics, local|mesh-ancestor
101883502|NCT05868993|Anesthetics|anesthetics|mesh-ancestor
101883503|NCT05868993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101883504|NCT05868993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883505|NCT05868993|Sensory System Agents|sensory system agents|mesh-ancestor
101883506|NCT05868993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101883507|NCT05868967|Fexuprazan|fexuprazan|mesh-list
101883508|NCT05868967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101883509|NCT05868720|Risperidone|risperidone|mesh-list
101883510|NCT05868720|Aripiprazole|aripiprazole|mesh-list
101883511|NCT05868720|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101883512|NCT05868720|Serotonin Agents|serotonin agents|mesh-ancestor
101883513|NCT05868720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101883514|NCT05868720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883515|NCT05868720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883516|NCT05868720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101883517|NCT05868720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101883518|NCT05868720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101883519|NCT05868720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101883520|NCT05868720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101883521|NCT05868720|Dopamine Agents|dopamine agents|mesh-ancestor
101883522|NCT05868720|Antidepressive Agents|antidepressive agents|mesh-ancestor
101883523|NCT05868720|Dopamine Agonists|dopamine agonists|mesh-ancestor
101883524|NCT05868720|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101883525|NCT05868720|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101883526|NCT05868720|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101883527|NCT05868720|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101883528|NCT05868395|Rituximab|rituximab|mesh-list
101883529|NCT05868395|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101883530|NCT05868395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101883531|NCT05868395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101883532|NCT05868395|Immunologic Factors|immunologic factors|mesh-ancestor
101883533|NCT05868395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883534|NCT05868395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101883535|NCT05868395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101883536|NCT05868395|Alkylating Agents|alkylating agents|mesh-ancestor
101883537|NCT05868395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883538|NCT05868317|Fluorouracil|fluorouracil|mesh-list
101883539|NCT05868317|Irinotecan|irinotecan|mesh-list
101883540|NCT05868317|Folfirinox|folfirinox|mesh-list
101883541|NCT05868317|Oxaliplatin|oxaliplatin|mesh-list
101883542|NCT05868317|Antimetabolites|antimetabolites|mesh-ancestor
101883543|NCT05868317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883544|NCT05868317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101689301|NCT02833103|Pinaverium|pinaverium|mesh-list
101883546|NCT05868317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101883547|NCT05868317|Immunologic Factors|immunologic factors|mesh-ancestor
101883548|NCT05868317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883549|NCT05868317|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101883550|NCT05868317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101883551|NCT05868317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101883552|NCT05868200|Listerine|listerine|mesh-list
101883553|NCT05868200|Sodium Fluoride|sodium fluoride|mesh-list
101883554|NCT05868200|Cariostatic Agents|cariostatic agents|mesh-ancestor
101883555|NCT05868200|Protective Agents|protective agents|mesh-ancestor
101883556|NCT05868200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883557|NCT05868200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101883558|NCT05868200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101883559|NCT05868109|Nitric Oxide|nitric oxide|mesh-list
101883560|NCT05868109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101883561|NCT05868109|Autonomic Agents|autonomic agents|mesh-ancestor
101883562|NCT05868109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101883563|NCT05868109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883564|NCT05868109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101883565|NCT05868109|Respiratory System Agents|respiratory system agents|mesh-ancestor
101883566|NCT05868109|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101883567|NCT05868109|Antioxidants|antioxidants|mesh-ancestor
101883568|NCT05868109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883569|NCT05868109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101883570|NCT05868109|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101883571|NCT05868109|Vasodilator Agents|vasodilator agents|mesh-ancestor
101883572|NCT05868109|Gasotransmitters|gasotransmitters|mesh-ancestor
101883573|NCT05868109|Protective Agents|protective agents|mesh-ancestor
101455562|NCT00213200|Morphine|morphine|mesh-list
101883574|NCT05867472|Sevoflurane|sevoflurane|mesh-list
101883575|NCT05867472|Isoflurane|isoflurane|mesh-list
101883576|NCT05867472|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101883577|NCT05867472|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101883578|NCT05867472|Anesthetics, General|anesthetics, general|mesh-ancestor
101883579|NCT05867472|Anesthetics|anesthetics|mesh-ancestor
101883580|NCT05867472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101883581|NCT05867472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883582|NCT05865080|Ketamine|ketamine|mesh-list
101883583|NCT05865080|Analgesics|analgesics|mesh-ancestor
101883584|NCT05865080|Sensory System Agents|sensory system agents|mesh-ancestor
101883585|NCT05865080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101883586|NCT05865080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883587|NCT05865080|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101883588|NCT05865080|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101883589|NCT05865080|Anesthetics, General|anesthetics, general|mesh-ancestor
101883590|NCT05865080|Anesthetics|anesthetics|mesh-ancestor
101883591|NCT05865080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101883592|NCT05865080|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101883593|NCT05865080|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101883594|NCT05865080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101883595|NCT05865080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883596|NCT05863286|Botulinum Toxins|botulinum toxins|mesh-list
101883597|NCT05863286|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101883598|NCT05863286|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101883599|NCT05863286|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101883600|NCT05863286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101883601|NCT05863286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883602|NCT05863286|Cholinergic Agents|cholinergic agents|mesh-ancestor
101883603|NCT05863286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101883604|NCT05863286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883605|NCT05863286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101883606|NCT05863286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101883607|NCT05851768|Dexmedetomidine|dexmedetomidine|mesh-list
101883608|NCT05851768|Bupivacaine|bupivacaine|mesh-list
101883609|NCT05851768|Anesthetics, Local|anesthetics, local|mesh-ancestor
101883610|NCT05851768|Anesthetics|anesthetics|mesh-ancestor
101883611|NCT05851768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101883612|NCT05851768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883613|NCT05851768|Sensory System Agents|sensory system agents|mesh-ancestor
101883614|NCT05851768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101346607|NCT00028782|Imidazole|imidazole|mesh-list
101883615|NCT05851768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101883616|NCT05851768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101883617|NCT05851768|Analgesics|analgesics|mesh-ancestor
101883618|NCT05851768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101883619|NCT05851768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101883620|NCT05851768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101883621|NCT05851768|Adrenergic Agents|adrenergic agents|mesh-ancestor
101883622|NCT05851768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101883623|NCT05851768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883624|NCT05768373|Fluorides|fluorides|mesh-list
101883625|NCT05768373|Cariostatic Agents|cariostatic agents|mesh-ancestor
101308758|NCT00005940|Antimetabolites|antimetabolites|mesh-ancestor
101883626|NCT05768373|Protective Agents|protective agents|mesh-ancestor
101883627|NCT05768373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883628|NCT05734690|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101883629|NCT05734690|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101883630|NCT05734690|Adrenergic Agents|adrenergic agents|mesh-ancestor
101883631|NCT05734690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101883632|NCT05734690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883633|NCT05734690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883634|NCT05733624|Cyclosporine|cyclosporine|mesh-list
101883635|NCT05733624|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101883636|NCT05733624|Cyclosporins|cyclosporins|mesh-list
101883637|NCT05733624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101883638|NCT05733624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883639|NCT05733624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101883640|NCT05733624|Immunologic Factors|immunologic factors|mesh-ancestor
101883641|NCT05733624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883642|NCT05733624|Antifungal Agents|antifungal agents|mesh-ancestor
101883643|NCT05733624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101883644|NCT05733624|Dermatologic Agents|dermatologic agents|mesh-ancestor
101883645|NCT05733624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101883646|NCT05733624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101883647|NCT05733624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101883648|NCT05717049|Theophylline|theophylline|mesh-list
101883649|NCT05717049|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101883650|NCT05717049|Autonomic Agents|autonomic agents|mesh-ancestor
101883651|NCT05717049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101883652|NCT05717049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883653|NCT05717049|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101883654|NCT05717049|Respiratory System Agents|respiratory system agents|mesh-ancestor
101883655|NCT05717049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101883656|NCT05717049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101883657|NCT05717049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883658|NCT05717049|Vasodilator Agents|vasodilator agents|mesh-ancestor
101883659|NCT05717049|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101883660|NCT05717049|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101883661|NCT05717049|Purinergic Agents|purinergic agents|mesh-ancestor
101883662|NCT05717049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101883664|NCT05645900|Immunologic Factors|immunologic factors|mesh-ancestor
101883665|NCT05645900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883666|NCT05642572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101883667|NCT05642572|Osimertinib|osimertinib|mesh-list
101883668|NCT05642572|Ramucirumab|ramucirumab|mesh-list
101883669|NCT05642572|Antibodies|antibodies|mesh-list
101883670|NCT05642572|Immunoglobulins|immunoglobulins|mesh-list
101883671|NCT05642572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101883672|NCT05642572|Lexatumumab|lexatumumab|mesh-list
101883673|NCT05642572|Immunologic Factors|immunologic factors|mesh-ancestor
101883674|NCT05642572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883675|NCT05642572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101883676|NCT05642572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101883677|NCT05642572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101883678|NCT05642572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883679|NCT05518799|Midazolam|midazolam|mesh-list
101883680|NCT05518799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101883681|NCT05518799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101883682|NCT05518799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101883683|NCT05518799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308771|NCT00005943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101883684|NCT05518799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101883685|NCT05518799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101883686|NCT05518799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101883688|NCT05518799|Anesthetics, General|anesthetics, general|mesh-ancestor
101883689|NCT05518799|Anesthetics|anesthetics|mesh-ancestor
101883690|NCT05518799|GABA Modulators|gaba modulators|mesh-ancestor
101883691|NCT05518799|GABA Agents|gaba agents|mesh-ancestor
101883692|NCT05518799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101883693|NCT05518799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883695|NCT05447702|Cyclophosphamide|cyclophosphamide|mesh-list
101883696|NCT05447702|Apatinib|apatinib|mesh-list
101883697|NCT05447702|Epirubicin|epirubicin|mesh-list
101883698|NCT05447702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101883699|NCT05447702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101883700|NCT05447702|Tubulin Modulators|tubulin modulators|mesh-ancestor
101883701|NCT05447702|Antimitotic Agents|antimitotic agents|mesh-ancestor
101883702|NCT05447702|Mitosis Modulators|mitosis modulators|mesh-ancestor
101883703|NCT05447702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883704|NCT05447702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101883705|NCT05447702|Immunologic Factors|immunologic factors|mesh-ancestor
101883706|NCT05447702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883707|NCT05447702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101883708|NCT05447702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101883709|NCT05447702|Alkylating Agents|alkylating agents|mesh-ancestor
101883710|NCT05447702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101883711|NCT05447702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101883712|NCT05447702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101883713|NCT05447702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101883714|NCT05447702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101883715|NCT05447702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101883716|NCT05418010|Natalizumab|natalizumab|mesh-list
101883717|NCT05418010|Immunologic Factors|immunologic factors|mesh-ancestor
101883718|NCT05418010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883719|NCT05413369|Metformin|metformin|mesh-list
101883720|NCT05413369|Insulin Glargine|insulin glargine|mesh-list
101883721|NCT05413369|Lixisenatide|lixisenatide|mesh-list
101883722|NCT05413369|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
101883723|NCT05413369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101883724|NCT05413369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883725|NCT05413369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883726|NCT05391971|Bupivacaine|bupivacaine|mesh-list
101883727|NCT05391971|Anesthetics, Local|anesthetics, local|mesh-ancestor
101883728|NCT05391971|Anesthetics|anesthetics|mesh-ancestor
101883729|NCT05391971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101883730|NCT05391971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883731|NCT05391971|Sensory System Agents|sensory system agents|mesh-ancestor
101883732|NCT05391971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101883733|NCT05361720|Nivolumab|nivolumab|mesh-list
101883734|NCT05361720|Ipilimumab|ipilimumab|mesh-list
101883735|NCT05361720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101883736|NCT05361720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101883737|NCT05361720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101883738|NCT05361720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883739|NCT05323396|Metronidazole|metronidazole|mesh-list
101883740|NCT05323396|Albendazole|albendazole|mesh-list
101883741|NCT05323396|Praziquantel|praziquantel|mesh-list
101883742|NCT05323396|Antiparasitic Agents|antiparasitic agents|mesh-list
101883743|NCT05323396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101883744|NCT05323396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101883745|NCT05323396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101883746|NCT05323396|Anthelmintics|anthelmintics|mesh-ancestor
101883747|NCT05323396|Anticestodal Agents|anticestodal agents|mesh-ancestor
101883748|NCT05323396|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101883749|NCT05323396|Tubulin Modulators|tubulin modulators|mesh-ancestor
101883750|NCT05323396|Antimitotic Agents|antimitotic agents|mesh-ancestor
101883751|NCT05323396|Mitosis Modulators|mitosis modulators|mesh-ancestor
101883752|NCT05323396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883753|NCT05323396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101883754|NCT05266469|Ofatumumab|ofatumumab|mesh-list
101883755|NCT05266469|Ocrelizumab|ocrelizumab|mesh-list
101883756|NCT05266469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101883757|NCT05266469|Immunologic Factors|immunologic factors|mesh-ancestor
101883758|NCT05266469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883759|NCT05222529|Glycopyrrolate|glycopyrrolate|mesh-list
101883760|NCT05222529|Bromides|bromides|mesh-list
101883761|NCT05222529|Anticonvulsants|anticonvulsants|mesh-ancestor
101883762|NCT05222529|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101883763|NCT05222529|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101883764|NCT05222529|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101883765|NCT05222529|Cholinergic Agents|cholinergic agents|mesh-ancestor
101883766|NCT05222529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101883767|NCT05222529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883768|NCT05222529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883769|NCT05178550|Heparin|heparin|mesh-list
101883770|NCT05178550|Anticoagulants|anticoagulants|mesh-ancestor
101883771|NCT05178550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101883772|NCT05178550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101883773|NCT05178550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883774|NCT05168566|Maleic acid|maleic acid|mesh-list
101883775|NCT05168566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101883776|NCT05168566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883777|NCT05085782|Propranolol|propranolol|mesh-list
101883778|NCT05085782|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101883779|NCT05085782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101883780|NCT05085782|Adrenergic Agents|adrenergic agents|mesh-ancestor
101883781|NCT05085782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101883782|NCT05085782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883783|NCT05085782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883784|NCT05085782|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101883785|NCT05085782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101883786|NCT05085782|Vasodilator Agents|vasodilator agents|mesh-ancestor
101883787|NCT05011123|Vaccines|vaccines|mesh-list
101883788|NCT05011123|Immunologic Factors|immunologic factors|mesh-ancestor
101883789|NCT05011123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883790|NCT04829383|Bevacizumab|bevacizumab|mesh-list
101883791|NCT04829383|Atezolizumab|atezolizumab|mesh-list
101883792|NCT04829383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101883793|NCT04829383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101883794|NCT04829383|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101883795|NCT04829383|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101883796|NCT04829383|Growth Substances|growth substances|mesh-ancestor
101883797|NCT04829383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883798|NCT04829383|Growth Inhibitors|growth inhibitors|mesh-ancestor
101883799|NCT04829383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101883800|NCT04829383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883801|NCT04821375|Bazedoxifene|bazedoxifene|mesh-list
101883802|NCT04821375|Estrogens|estrogens|mesh-list
101883803|NCT04821375|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101883804|NCT04821375|Hormones|hormones|mesh-ancestor
101883805|NCT04821375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101883806|NCT04821375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455589|NCT00239889|Katacalcin|katacalcin|mesh-list
101883807|NCT04821375|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101883808|NCT04821375|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101883809|NCT04821375|Hormone Antagonists|hormone antagonists|mesh-ancestor
101883810|NCT04821375|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101883811|NCT04781387|REP 3123|rep 3123|mesh-list
101883812|NCT04781387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101883813|NCT04781387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101883814|NCT04732195|Pilocarpine|pilocarpine|mesh-list
101883815|NCT04732195|Miotics|miotics|mesh-ancestor
101883816|NCT04732195|Autonomic Agents|autonomic agents|mesh-ancestor
101883817|NCT04732195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101883818|NCT04732195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883819|NCT04732195|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101883820|NCT04732195|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101883821|NCT04732195|Cholinergic Agents|cholinergic agents|mesh-ancestor
101883822|NCT04732195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101883823|NCT04732195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883824|NCT04704921|Ranibizumab|ranibizumab|mesh-list
101883825|NCT04704921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101883826|NCT04704921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101883827|NCT04704921|Growth Substances|growth substances|mesh-ancestor
101883828|NCT04704921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883829|NCT04704921|Growth Inhibitors|growth inhibitors|mesh-ancestor
101883830|NCT04704921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101883831|NCT04703426|Pembrolizumab|pembrolizumab|mesh-list
101883832|NCT04703426|Sargramostim|sargramostim|mesh-list
101883833|NCT04703426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101883834|NCT04703426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101883835|NCT04703426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101883836|NCT04703426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883837|NCT04703426|Immunologic Factors|immunologic factors|mesh-ancestor
101883838|NCT04703426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883839|NCT04681482|Apixaban|apixaban|mesh-list
101883840|NCT04681482|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101883841|NCT04681482|Antithrombins|antithrombins|mesh-ancestor
101883842|NCT04681482|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101883843|NCT04681482|Protease Inhibitors|protease inhibitors|mesh-ancestor
101883844|NCT04681482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101883845|NCT04681482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883846|NCT04681482|Anticoagulants|anticoagulants|mesh-ancestor
101883847|NCT04635644|Morphine|morphine|mesh-list
101883848|NCT04635644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101883849|NCT04635644|Narcotics|narcotics|mesh-ancestor
101883850|NCT04635644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101883851|NCT04635644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883852|NCT04635644|Analgesics|analgesics|mesh-ancestor
101883853|NCT04635644|Sensory System Agents|sensory system agents|mesh-ancestor
101883854|NCT04635644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101883855|NCT04631601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101883857|NCT04631601|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
101883858|NCT04631601|Hormones|hormones|mesh-ancestor
101883859|NCT04631601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101883860|NCT04631601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883861|NCT04631601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883862|NCT04631601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101883863|NCT04631601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101883864|NCT04631601|Androgen Antagonists|androgen antagonists|mesh-ancestor
101883865|NCT04631601|Hormone Antagonists|hormone antagonists|mesh-ancestor
101883866|NCT04580277|Tofacitinib|tofacitinib|mesh-list
101883867|NCT04580277|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101883868|NCT04580277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101883869|NCT04580277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101883870|NCT04580277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883871|NCT04571229|Mifamurtide|mifamurtide|mesh-list
101883872|NCT04571229|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101883873|NCT04571229|Immunologic Factors|immunologic factors|mesh-ancestor
101883874|NCT04571229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883875|NCT04535713|Gemcitabine|gemcitabine|mesh-list
101883876|NCT04535713|Docetaxel|docetaxel|mesh-list
101883877|NCT04535713|Doxorubicin|doxorubicin|mesh-list
101883878|NCT04535713|Nivolumab|nivolumab|mesh-list
101883879|NCT04535713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101883880|NCT04535713|Antimetabolites|antimetabolites|mesh-ancestor
101883881|NCT04535713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883882|NCT04535713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101883883|NCT04535713|Tubulin Modulators|tubulin modulators|mesh-ancestor
101883884|NCT04535713|Antimitotic Agents|antimitotic agents|mesh-ancestor
101883885|NCT04535713|Mitosis Modulators|mitosis modulators|mesh-ancestor
101883886|NCT04535713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101883887|NCT04535713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101883888|NCT04535713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101883889|NCT04535713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101883890|NCT04535713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101883891|NCT04535713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101883892|NCT04526132|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
101883893|NCT04526132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101883894|NCT04526132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101883895|NCT04526132|Analgesics|analgesics|mesh-ancestor
101883896|NCT04526132|Sensory System Agents|sensory system agents|mesh-ancestor
101883897|NCT04526132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101883898|NCT04526132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883899|NCT04526132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101883900|NCT04526132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101883901|NCT04514653|Ranibizumab|ranibizumab|mesh-list
101883902|NCT04514653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101883903|NCT04514653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101883904|NCT04514653|Growth Substances|growth substances|mesh-ancestor
101883905|NCT04514653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883906|NCT04514653|Growth Inhibitors|growth inhibitors|mesh-ancestor
101883907|NCT04514653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101883909|NCT04507438|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101883910|NCT04507438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101883911|NCT04507438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883912|NCT04507438|Cholinergic Agents|cholinergic agents|mesh-ancestor
101883913|NCT04507438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101883914|NCT04507438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883915|NCT04507438|Nootropic Agents|nootropic agents|mesh-ancestor
101883916|NCT04505670|Donepezil|donepezil|mesh-list
101603721|NCT01161446|Antibodies|antibodies|mesh-list
101883918|NCT04505670|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101883919|NCT04505670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101455635|NCT00240045|Sympathomimetics|sympathomimetics|mesh-ancestor
101883920|NCT04505670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883921|NCT04505670|Cholinergic Agents|cholinergic agents|mesh-ancestor
101883922|NCT04505670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101883923|NCT04505670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883924|NCT04505670|Nootropic Agents|nootropic agents|mesh-ancestor
101883925|NCT04505670|Dermatologic Agents|dermatologic agents|mesh-ancestor
101883926|NCT04505670|Sunscreening Agents|sunscreening agents|mesh-ancestor
101883927|NCT04505670|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101883928|NCT04505670|Protective Agents|protective agents|mesh-ancestor
101883929|NCT04493320|Levodopa|levodopa|mesh-list
101883930|NCT04493320|Carbidopa|carbidopa|mesh-list
101883931|NCT04493320|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101883932|NCT04493320|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101883933|NCT04493320|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101883934|NCT04493320|Dopamine Agents|dopamine agents|mesh-ancestor
101883935|NCT04493320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101883936|NCT04493320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883937|NCT04493320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883938|NCT04493320|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101883939|NCT04493320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101883940|NCT04493320|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101883941|NCT04493320|Immunologic Factors|immunologic factors|mesh-ancestor
101883942|NCT04493320|Dopamine Agonists|dopamine agonists|mesh-ancestor
101883943|NCT04417166|Pembrolizumab|pembrolizumab|mesh-list
101883944|NCT04417166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101883945|NCT04417166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101883946|NCT04417166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101883947|NCT04417166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883948|NCT04270747|Aflibercept|aflibercept|mesh-list
101883949|NCT04270747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101883950|NCT04270747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101883951|NCT04270747|Growth Substances|growth substances|mesh-ancestor
101883952|NCT04270747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883953|NCT04270747|Growth Inhibitors|growth inhibitors|mesh-ancestor
101883954|NCT04270747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101883955|NCT04218123|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101883956|NCT04218123|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101883957|NCT04218123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101883958|NCT04218123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101883959|NCT04218123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883960|NCT04218123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101883961|NCT04218123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101883962|NCT04218123|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101883963|NCT04218123|Antidepressive Agents|antidepressive agents|mesh-ancestor
101883964|NCT04218123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101883965|NCT04189744|Metronidazole|metronidazole|mesh-list
101883966|NCT04189744|Pyrimethamine|pyrimethamine|mesh-list
101883967|NCT04189744|Piperaquine|piperaquine|mesh-list
101883968|NCT04189744|Sulfadoxine|sulfadoxine|mesh-list
101883969|NCT04189744|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101883970|NCT04189744|Artenimol|artenimol|mesh-list
101883971|NCT04189744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101883972|NCT04189744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101883973|NCT04189744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101883974|NCT04189744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101883975|NCT04189744|Antimalarials|antimalarials|mesh-ancestor
101883976|NCT04189744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101883977|NCT04189744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101883978|NCT04189744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883979|NCT04189744|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101883982|NCT04175470|Tocopherols|tocopherols|mesh-list
101883983|NCT04175470|Bevacizumab|bevacizumab|mesh-list
101883984|NCT04175470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101883985|NCT04175470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101883986|NCT04175470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101883987|NCT04175470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101883988|NCT04175470|Growth Substances|growth substances|mesh-ancestor
101883989|NCT04175470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603799|NCT01160822|Analgesics|analgesics|mesh-ancestor
101883990|NCT04175470|Growth Inhibitors|growth inhibitors|mesh-ancestor
101883991|NCT04175470|Antioxidants|antioxidants|mesh-ancestor
101883992|NCT04175470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101883993|NCT04175470|Protective Agents|protective agents|mesh-ancestor
101883994|NCT04175470|Vitamins|vitamins|mesh-ancestor
101883995|NCT04175470|Micronutrients|micronutrients|mesh-ancestor
101883996|NCT04165330|Nivolumab|nivolumab|mesh-list
101883997|NCT04165330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101883998|NCT04165330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101883999|NCT04165330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101884000|NCT04165330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884001|NCT04149574|Nivolumab|nivolumab|mesh-list
101884002|NCT04149574|BCG Vaccine|bcg vaccine|mesh-list
101884003|NCT04149574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101884004|NCT04149574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101884005|NCT04149574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101884006|NCT04149574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884007|NCT04149574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101884008|NCT04149574|Immunologic Factors|immunologic factors|mesh-ancestor
101884009|NCT04149574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884010|NCT04115878|Oxybutynin|oxybutynin|mesh-list
101884011|NCT04115878|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101884012|NCT04115878|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101884013|NCT04115878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101884014|NCT04115878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101884015|NCT04115878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884016|NCT04115878|Adrenergic Agents|adrenergic agents|mesh-ancestor
101884017|NCT04115878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101884018|NCT04115878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884019|NCT04115878|Parasympatholytics|parasympatholytics|mesh-ancestor
101884020|NCT04115878|Autonomic Agents|autonomic agents|mesh-ancestor
101884021|NCT04115878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101884022|NCT04115878|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101884023|NCT04115878|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101884024|NCT04115878|Cholinergic Agents|cholinergic agents|mesh-ancestor
101884025|NCT04115878|Urological Agents|urological agents|mesh-ancestor
101884026|NCT03965130|Glucagon|glucagon|mesh-list
101884027|NCT03965130|Hormones|hormones|mesh-ancestor
101884028|NCT03965130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101884029|NCT03965130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884030|NCT03965130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101884031|NCT03900884|Letrozole|letrozole|mesh-list
101884032|NCT03900884|Venetoclax|venetoclax|mesh-list
101884033|NCT03900884|Palbociclib|palbociclib|mesh-list
101884034|NCT03900884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101884035|NCT03900884|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101884036|NCT03900884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101884037|NCT03900884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101884038|NCT03900884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884039|NCT03900884|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101884040|NCT03900884|Hormone Antagonists|hormone antagonists|mesh-ancestor
101884041|NCT03900884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101968270|NCT00003199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101884042|NCT03900884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884043|NCT03900884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101884045|NCT03878524|Leucovorin|leucovorin|mesh-list
101884046|NCT03878524|Vitamin A|vitamin a|mesh-list
101884047|NCT03878524|Sirolimus|sirolimus|mesh-list
101884048|NCT03878524|Celecoxib|celecoxib|mesh-list
101884049|NCT03878524|Paclitaxel|paclitaxel|mesh-list
101884050|NCT03878524|Maytansine|maytansine|mesh-list
101884051|NCT03878524|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101884052|NCT03878524|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101884053|NCT03878524|Bevacizumab|bevacizumab|mesh-list
101884054|NCT03878524|Carboplatin|carboplatin|mesh-list
101884055|NCT03878524|Doxorubicin|doxorubicin|mesh-list
101884056|NCT03878524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101884057|NCT03878524|Pembrolizumab|pembrolizumab|mesh-list
101884058|NCT03878524|Fluorouracil|fluorouracil|mesh-list
101884059|NCT03878524|Capecitabine|capecitabine|mesh-list
101884060|NCT03878524|Oxaliplatin|oxaliplatin|mesh-list
101884061|NCT03878524|Nivolumab|nivolumab|mesh-list
101884062|NCT03878524|Trastuzumab|trastuzumab|mesh-list
101884063|NCT03878524|Everolimus|everolimus|mesh-list
101884064|NCT03878524|Bortezomib|bortezomib|mesh-list
101603884|NCT00641212|Budesonide|budesonide|mesh-list
101884065|NCT03878524|Ipilimumab|ipilimumab|mesh-list
101884066|NCT03878524|Sorafenib|sorafenib|mesh-list
101884067|NCT03878524|Temsirolimus|temsirolimus|mesh-list
101884068|NCT03878524|Durvalumab|durvalumab|mesh-list
101884070|NCT03878524|Daunorubicin|daunorubicin|mesh-list
101884071|NCT03878524|Venetoclax|venetoclax|mesh-list
101884072|NCT03878524|Dasatinib|dasatinib|mesh-list
101884073|NCT03878524|Lenvatinib|lenvatinib|mesh-list
101884074|NCT03878524|Olaparib|olaparib|mesh-list
101884075|NCT03878524|Palbociclib|palbociclib|mesh-list
101884076|NCT03878524|Pertuzumab|pertuzumab|mesh-list
101884077|NCT03878524|Vorinostat|vorinostat|mesh-list
101884078|NCT03878524|Trametinib|trametinib|mesh-list
101884079|NCT03878524|Tretinoin|tretinoin|mesh-list
101884080|NCT03878524|Retinol palmitate|retinol palmitate|mesh-list
101884081|NCT03878524|Bicalutamide|bicalutamide|mesh-list
101884082|NCT03878524|Afatinib|afatinib|mesh-list
101884083|NCT03878524|Vemurafenib|vemurafenib|mesh-list
101884084|NCT03878524|Dabrafenib|dabrafenib|mesh-list
101884085|NCT03878524|Panobinostat|panobinostat|mesh-list
101884086|NCT03878524|Ponatinib|ponatinib|mesh-list
101884087|NCT03878524|Idelalisib|idelalisib|mesh-list
101884088|NCT03878524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101884089|NCT03878524|MTOR Inhibitors|mtor inhibitors|mesh-list
101884090|NCT03878524|Losartan|losartan|mesh-list
101884091|NCT03878524|Endothelial Growth Factors|endothelial growth factors|mesh-list
101884092|NCT03878524|Antibodies|antibodies|mesh-list
101884093|NCT03878524|Immunoglobulins|immunoglobulins|mesh-list
101884094|NCT03878524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101884095|NCT03878524|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101884096|NCT03878524|Immunoglobulin G|immunoglobulin g|mesh-list
101884097|NCT03878524|Entrectinib|entrectinib|mesh-list
101884098|NCT03878524|Immunoconjugates|immunoconjugates|mesh-list
101884099|NCT03878524|Benzenesulfonamide|benzenesulfonamide|mesh-list
101884100|NCT03878524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101455699|NCT00243750|Antimetabolites|antimetabolites|mesh-ancestor
101884101|NCT03878524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101884102|NCT03878524|Tubulin Modulators|tubulin modulators|mesh-ancestor
101884103|NCT03878524|Antimitotic Agents|antimitotic agents|mesh-ancestor
101884104|NCT03878524|Mitosis Modulators|mitosis modulators|mesh-ancestor
101884105|NCT03878524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884106|NCT03878524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101884107|NCT03878524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101884108|NCT03878524|Growth Substances|growth substances|mesh-ancestor
101884109|NCT03878524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884110|NCT03878524|Growth Inhibitors|growth inhibitors|mesh-ancestor
101884111|NCT03878524|Micronutrients|micronutrients|mesh-ancestor
101884112|NCT03878524|Immunologic Factors|immunologic factors|mesh-ancestor
101884113|NCT03878524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101884114|NCT03878524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101884115|NCT03878524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101884116|NCT03878524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101884117|NCT03878524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101884118|NCT03878524|Antimetabolites|antimetabolites|mesh-ancestor
101884119|NCT03878524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101884120|NCT03878524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101884121|NCT03878524|Antidotes|antidotes|mesh-ancestor
101884122|NCT03878524|Protective Agents|protective agents|mesh-ancestor
101884123|NCT03878524|Vitamin B Complex|vitamin b complex|mesh-ancestor
101884124|NCT03878524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101884125|NCT03878524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101884126|NCT03878524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101884127|NCT03878524|Antifungal Agents|antifungal agents|mesh-ancestor
101884128|NCT03878524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101884129|NCT03878524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101884130|NCT03878524|Analgesics|analgesics|mesh-ancestor
101884131|NCT03878524|Sensory System Agents|sensory system agents|mesh-ancestor
101884132|NCT03878524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101884133|NCT03878524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101884134|NCT03878524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101884135|NCT03878524|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101884136|NCT03878524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101884137|NCT03878524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101884138|NCT03878524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101884139|NCT03878524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101884140|NCT03878524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101884141|NCT03878524|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101884142|NCT03878524|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101884143|NCT03878524|Keratolytic Agents|keratolytic agents|mesh-ancestor
101884144|NCT03878524|Dermatologic Agents|dermatologic agents|mesh-ancestor
101884145|NCT03878524|Antioxidants|antioxidants|mesh-ancestor
101884146|NCT03878524|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101884147|NCT03878524|Androgen Antagonists|androgen antagonists|mesh-ancestor
101884148|NCT03878524|Hormone Antagonists|hormone antagonists|mesh-ancestor
101884149|NCT03878524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101884150|NCT03878524|Immunotoxins|immunotoxins|mesh-ancestor
101884151|NCT03878524|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101884152|NCT03761030|Levodopa|levodopa|mesh-list
101884153|NCT03761030|Carbidopa|carbidopa|mesh-list
101884154|NCT03761030|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101884155|NCT03761030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101884156|NCT03761030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101884157|NCT03761030|Dopamine Agents|dopamine agents|mesh-ancestor
101884158|NCT03761030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101884159|NCT03761030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884160|NCT03761030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884161|NCT03761030|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101884162|NCT03761030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101884163|NCT03761030|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101884164|NCT03761030|Immunologic Factors|immunologic factors|mesh-ancestor
101884165|NCT03761030|Dopamine Agonists|dopamine agonists|mesh-ancestor
101884166|NCT03742505|Cholecalciferol|cholecalciferol|mesh-list
101884167|NCT03742505|Vitamin D|vitamin d|mesh-list
101884168|NCT03742505|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101884169|NCT03742505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884170|NCT03742505|Vitamins|vitamins|mesh-ancestor
101884171|NCT03742505|Micronutrients|micronutrients|mesh-ancestor
101884172|NCT03742505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101884173|NCT03663205|Cisplatin|cisplatin|mesh-list
101884174|NCT03663205|Carboplatin|carboplatin|mesh-list
101884175|NCT03663205|Pemetrexed|pemetrexed|mesh-list
101884176|NCT03663205|Tislelizumab|tislelizumab|mesh-list
101884177|NCT03663205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101884178|NCT03663205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101884179|NCT03663205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884180|NCT03663205|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101884181|NCT03663205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101884182|NCT03663205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101884183|NCT03638999|Ketorolac|ketorolac|mesh-list
101884184|NCT03638999|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101884185|NCT03638999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101884186|NCT03638999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101884187|NCT03638999|Analgesics|analgesics|mesh-ancestor
101884188|NCT03638999|Sensory System Agents|sensory system agents|mesh-ancestor
101884189|NCT03638999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101884190|NCT03638999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884191|NCT03638999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101884193|NCT03638999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101884194|NCT03638999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101884195|NCT03638999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884196|NCT03600883|Sotorasib|sotorasib|mesh-list
101884197|NCT03600883|Midazolam|midazolam|mesh-list
101884198|NCT03600883|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101884199|NCT03600883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101884200|NCT03600883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101884201|NCT03600883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884202|NCT03600883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101884203|NCT03600883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101884204|NCT03600883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101884205|NCT03600883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101884206|NCT03600883|Anesthetics, General|anesthetics, general|mesh-ancestor
101884208|NCT03600883|GABA Modulators|gaba modulators|mesh-ancestor
101884209|NCT03600883|GABA Agents|gaba agents|mesh-ancestor
101884210|NCT03600883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101884211|NCT03600883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884212|NCT03600883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101884213|NCT03600883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101884214|NCT03600883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101884215|NCT03575793|Nivolumab|nivolumab|mesh-list
101884216|NCT03575793|Ipilimumab|ipilimumab|mesh-list
101884217|NCT03575793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101884218|NCT03575793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101884219|NCT03575793|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101884220|NCT03575793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884221|NCT03572088|Terlipressin|terlipressin|mesh-list
101884222|NCT03572088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101884223|NCT03572088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101884225|NCT03560934|Hallucinogens|hallucinogens|mesh-ancestor
101884226|NCT03560934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884227|NCT03560934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101884228|NCT03560934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101884229|NCT03560934|Analgesics|analgesics|mesh-ancestor
101884230|NCT03560934|Sensory System Agents|sensory system agents|mesh-ancestor
101884231|NCT03560934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101884232|NCT03560934|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101884233|NCT03560934|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101884234|NCT03560934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101884235|NCT03560934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884236|NCT03560934|Hormones|hormones|mesh-ancestor
101884237|NCT03560934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101884238|NCT03527472|Memantine|memantine|mesh-list
101884239|NCT03527472|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101884240|NCT03527472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101884241|NCT03527472|Dopamine Agents|dopamine agents|mesh-ancestor
101884242|NCT03527472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101884243|NCT03527472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884244|NCT03527472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884245|NCT03527472|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101884246|NCT03527472|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101884247|NCT03483012|Atezolizumab|atezolizumab|mesh-list
101884248|NCT03483012|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101884249|NCT03483012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884250|NCT03483012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101884251|NCT03483012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101884252|NCT03477396|Estrogens|estrogens|mesh-list
101884253|NCT03477396|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101884254|NCT03477396|Hormones|hormones|mesh-ancestor
101884255|NCT03477396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101884256|NCT03477396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884257|NCT03477396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101884258|NCT03477396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101884259|NCT03477396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884260|NCT03477396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101884261|NCT03477396|Hormone Antagonists|hormone antagonists|mesh-ancestor
101884262|NCT03388788|CGP 12177|cgp 12177|mesh-list
101884263|NCT03388788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101884264|NCT03388788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101884265|NCT03388788|Adrenergic Agents|adrenergic agents|mesh-ancestor
101884266|NCT03388788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101884267|NCT03388788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884268|NCT03388788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884269|NCT03388788|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101884270|NCT03388788|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101884271|NCT03283761|Leucovorin|leucovorin|mesh-list
101884272|NCT03283761|Paclitaxel|paclitaxel|mesh-list
101884273|NCT03283761|Fluorouracil|fluorouracil|mesh-list
101884274|NCT03283761|Oxaliplatin|oxaliplatin|mesh-list
101689331|NCT02648490|Antipyretics|antipyretics|mesh-ancestor
101884275|NCT03283761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101884276|NCT03283761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101884277|NCT03283761|Tubulin Modulators|tubulin modulators|mesh-ancestor
101884278|NCT03283761|Antimitotic Agents|antimitotic agents|mesh-ancestor
101884279|NCT03283761|Mitosis Modulators|mitosis modulators|mesh-ancestor
101455714|NCT00243789|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101884280|NCT03283761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884281|NCT03283761|Antimetabolites|antimetabolites|mesh-ancestor
101884282|NCT03283761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101884283|NCT03283761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101884284|NCT03283761|Immunologic Factors|immunologic factors|mesh-ancestor
101884285|NCT03283761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884286|NCT03283761|Antidotes|antidotes|mesh-ancestor
101884287|NCT03283761|Protective Agents|protective agents|mesh-ancestor
101884288|NCT03283761|Vitamin B Complex|vitamin b complex|mesh-ancestor
101884289|NCT03283761|Vitamins|vitamins|mesh-ancestor
101884290|NCT03283761|Micronutrients|micronutrients|mesh-ancestor
101884291|NCT03240081|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101884292|NCT03240081|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101884293|NCT03240081|Estradiol|estradiol|mesh-list
101884294|NCT03240081|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101884295|NCT03240081|Estrogens|estrogens|mesh-ancestor
101884296|NCT03240081|Hormones|hormones|mesh-ancestor
101884297|NCT03240081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101884298|NCT03240081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884299|NCT03240081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101884300|NCT03240081|Contraceptive Agents|contraceptive agents|mesh-ancestor
101884301|NCT03240081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101884302|NCT03240081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101884303|NCT03236857|Venetoclax|venetoclax|mesh-list
101884304|NCT03236857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101884305|NCT03097120|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101884306|NCT03097120|Medroxyprogesterone|medroxyprogesterone|mesh-list
101884307|NCT03097120|Estrogens|estrogens|mesh-list
101884308|NCT03097120|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101884309|NCT03097120|Hormones|hormones|mesh-ancestor
101884310|NCT03097120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101884311|NCT03097120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884312|NCT03097120|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101884313|NCT03097120|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101884314|NCT03097120|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101884315|NCT03097120|Contraceptive Agents|contraceptive agents|mesh-ancestor
101884316|NCT03097120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101884317|NCT03097120|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101884318|NCT03097120|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101884319|NCT03097120|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101884320|NCT03097120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101884321|NCT03097120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101884322|NCT03056755|Letrozole|letrozole|mesh-list
101884323|NCT03056755|Fulvestrant|fulvestrant|mesh-list
101884324|NCT03056755|Leuprolide|leuprolide|mesh-list
101884325|NCT03056755|Goserelin|goserelin|mesh-list
101884326|NCT03056755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101884327|NCT03056755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101884328|NCT03056755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101884329|NCT03056755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101884330|NCT03056755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884331|NCT03056755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101884332|NCT03056755|Hormone Antagonists|hormone antagonists|mesh-ancestor
101884333|NCT03056755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101884334|NCT03056755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884335|NCT03056755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101884336|NCT03056755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101884337|NCT03056755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101884338|NCT03056755|Fertility Agents|fertility agents|mesh-ancestor
101884339|NCT03056755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101884340|NCT03003520|Prednisone|prednisone|mesh-list
101884341|NCT03003520|Prednisolone|prednisolone|mesh-list
101884342|NCT03003520|Cyclophosphamide|cyclophosphamide|mesh-list
101884343|NCT03003520|Rituximab|rituximab|mesh-list
101884344|NCT03003520|Doxorubicin|doxorubicin|mesh-list
101884345|NCT03003520|Vincristine|vincristine|mesh-list
101884346|NCT03003520|Lenalidomide|lenalidomide|mesh-list
101884347|NCT03003520|Durvalumab|durvalumab|mesh-list
101884348|NCT03003520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101884349|NCT03003520|Immunologic Factors|immunologic factors|mesh-ancestor
101884350|NCT03003520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884351|NCT03003520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101884352|NCT03003520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101884353|NCT03003520|Alkylating Agents|alkylating agents|mesh-ancestor
101884354|NCT03003520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884355|NCT03003520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101884356|NCT03003520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101884357|NCT03003520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101884358|NCT03003520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101884359|NCT03003520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101884360|NCT03003520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101884361|NCT03003520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101884362|NCT03003520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101884363|NCT03003520|Glucocorticoids|glucocorticoids|mesh-ancestor
101884364|NCT03003520|Hormones|hormones|mesh-ancestor
101884365|NCT03003520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101884366|NCT03003520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101884367|NCT03003520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101884368|NCT03003520|Tubulin Modulators|tubulin modulators|mesh-ancestor
101884369|NCT03003520|Antimitotic Agents|antimitotic agents|mesh-ancestor
101884370|NCT03003520|Mitosis Modulators|mitosis modulators|mesh-ancestor
101884371|NCT03003520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101884372|NCT03003520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101884373|NCT03003520|Growth Substances|growth substances|mesh-ancestor
101884374|NCT03003520|Growth Inhibitors|growth inhibitors|mesh-ancestor
101884375|NCT02989597|Dexamethasone|dexamethasone|mesh-list
101884376|NCT02989597|Sufentanil|sufentanil|mesh-list
101884377|NCT02989597|Ketamine|ketamine|mesh-list
101884378|NCT02989597|Remifentanil|remifentanil|mesh-list
101884379|NCT02989597|Methadone|methadone|mesh-list
101884380|NCT02989597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101884381|NCT02989597|Antiemetics|antiemetics|mesh-ancestor
101884382|NCT02989597|Autonomic Agents|autonomic agents|mesh-ancestor
101884383|NCT02989597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101884384|NCT02989597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884385|NCT02989597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101884386|NCT02989597|Glucocorticoids|glucocorticoids|mesh-ancestor
101884387|NCT02989597|Hormones|hormones|mesh-ancestor
101884388|NCT02989597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101884389|NCT02989597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101884390|NCT02989597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101884391|NCT02989597|Analgesics|analgesics|mesh-ancestor
101884392|NCT02989597|Sensory System Agents|sensory system agents|mesh-ancestor
101884393|NCT02989597|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101884394|NCT02989597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101884395|NCT02989597|Anesthetics, General|anesthetics, general|mesh-ancestor
101884397|NCT02989597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101884398|NCT02989597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101884399|NCT02989597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101884400|NCT02989597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101884401|NCT02989597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884402|NCT02989597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101884403|NCT02989597|Narcotics|narcotics|mesh-ancestor
101884404|NCT02989597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101884405|NCT02989597|Antitussive Agents|antitussive agents|mesh-ancestor
101884406|NCT02989597|Respiratory System Agents|respiratory system agents|mesh-ancestor
101884407|NCT02958527|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101884408|NCT02958527|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101884409|NCT02958527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101884410|NCT02958527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101884411|NCT02958527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884412|NCT02958527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101884413|NCT02958527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884414|NCT02958527|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101884415|NCT02958527|Antidepressive Agents|antidepressive agents|mesh-ancestor
101884416|NCT02958527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101884417|NCT02768701|Cyclophosphamide|cyclophosphamide|mesh-list
101884418|NCT02768701|Pembrolizumab|pembrolizumab|mesh-list
101884419|NCT02768701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101884420|NCT02768701|Immunologic Factors|immunologic factors|mesh-ancestor
101884421|NCT02768701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884422|NCT02768701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101884423|NCT02768701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101884424|NCT02768701|Alkylating Agents|alkylating agents|mesh-ancestor
101884425|NCT02768701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884426|NCT02768701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101884427|NCT02768701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101884428|NCT02768701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101884429|NCT02768701|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101884430|NCT02621944|Melatonin|melatonin|mesh-list
101884431|NCT02621944|Antioxidants|antioxidants|mesh-ancestor
101884432|NCT02621944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884433|NCT02621944|Protective Agents|protective agents|mesh-ancestor
101884434|NCT02621944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884435|NCT02621944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101884436|NCT02620046|Vedolizumab|vedolizumab|mesh-list
101884437|NCT02620046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101884438|NCT02586025|Docetaxel|docetaxel|mesh-list
101884439|NCT02586025|Trastuzumab|trastuzumab|mesh-list
101884440|NCT02586025|Pertuzumab|pertuzumab|mesh-list
101884441|NCT02586025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101884442|NCT02586025|Tubulin Modulators|tubulin modulators|mesh-ancestor
101884443|NCT02586025|Antimitotic Agents|antimitotic agents|mesh-ancestor
101884444|NCT02586025|Mitosis Modulators|mitosis modulators|mesh-ancestor
101884445|NCT02586025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884446|NCT02586025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101884447|NCT02465164|Oxytocin|oxytocin|mesh-list
101884448|NCT02465164|Oxytocics|oxytocics|mesh-ancestor
101884449|NCT02465164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101884450|NCT02465164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884451|NCT02446600|Paclitaxel|paclitaxel|mesh-list
101884452|NCT02446600|Carboplatin|carboplatin|mesh-list
101884453|NCT02446600|Gemcitabine|gemcitabine|mesh-list
101884454|NCT02446600|Doxorubicin|doxorubicin|mesh-list
101884455|NCT02446600|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101884456|NCT02446600|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101884457|NCT02446600|Olaparib|olaparib|mesh-list
101884458|NCT02446600|Cediranib|cediranib|mesh-list
101884459|NCT02446600|Maleic acid|maleic acid|mesh-list
101884460|NCT02446600|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101884461|NCT02446600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101884462|NCT02446600|Tubulin Modulators|tubulin modulators|mesh-ancestor
101884463|NCT02446600|Antimitotic Agents|antimitotic agents|mesh-ancestor
101968313|NCT01104649|Riluzole|riluzole|mesh-list
101884464|NCT02446600|Mitosis Modulators|mitosis modulators|mesh-ancestor
101884465|NCT02446600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884466|NCT02446600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101884467|NCT02446600|Antimetabolites|antimetabolites|mesh-ancestor
101884468|NCT02446600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101884469|NCT02446600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101884470|NCT02446600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101884471|NCT02446600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101884472|NCT02446600|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101884473|NCT02446600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101884474|NCT02094261|Osimertinib|osimertinib|mesh-list
101884475|NCT02094261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101884476|NCT02094261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101884477|NCT02094261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101884478|NCT02094261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884479|NCT01955512|Clopidogrel|clopidogrel|mesh-list
101884480|NCT01955512|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101884481|NCT01955512|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101884482|NCT01955512|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101884483|NCT01955512|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101884484|NCT01955512|Purinergic Agents|purinergic agents|mesh-ancestor
101884485|NCT01955512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101884486|NCT01955512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884487|NCT01955512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884488|NCT01194570|Ocrelizumab|ocrelizumab|mesh-list
101884489|NCT01194570|Immunologic Factors|immunologic factors|mesh-ancestor
101884490|NCT01194570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884491|NCT00227617|Leucovorin|leucovorin|mesh-list
101884492|NCT00227617|Bevacizumab|bevacizumab|mesh-list
101884493|NCT00227617|Fluorouracil|fluorouracil|mesh-list
101884494|NCT00227617|Oxaliplatin|oxaliplatin|mesh-list
101884495|NCT00227617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101884496|NCT00227617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101884497|NCT00227617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101884498|NCT00227617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101884499|NCT00227617|Growth Substances|growth substances|mesh-ancestor
101884500|NCT00227617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884501|NCT00227617|Growth Inhibitors|growth inhibitors|mesh-ancestor
101884502|NCT00227617|Antimetabolites|antimetabolites|mesh-ancestor
101884503|NCT00227617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884504|NCT00227617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101884505|NCT00227617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101884506|NCT00227617|Immunologic Factors|immunologic factors|mesh-ancestor
101884507|NCT00227617|Antidotes|antidotes|mesh-ancestor
101884508|NCT00227617|Protective Agents|protective agents|mesh-ancestor
101884509|NCT00227617|Vitamin B Complex|vitamin b complex|mesh-ancestor
101884510|NCT00227617|Vitamins|vitamins|mesh-ancestor
101884511|NCT00227617|Micronutrients|micronutrients|mesh-ancestor
101884512|NCT05710081|Broncho-Vaxom|broncho-vaxom|mesh-list
101884513|NCT05710081|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101884514|NCT05710081|Immunologic Factors|immunologic factors|mesh-ancestor
101884515|NCT05710081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884516|NCT05703191|Nitric Oxide|nitric oxide|mesh-list
101884517|NCT05703191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101884518|NCT05703191|Autonomic Agents|autonomic agents|mesh-ancestor
101884519|NCT05703191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101884520|NCT05703191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884521|NCT05703191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101884522|NCT05703191|Respiratory System Agents|respiratory system agents|mesh-ancestor
101884523|NCT05703191|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101884524|NCT05703191|Antioxidants|antioxidants|mesh-ancestor
101884525|NCT05703191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884527|NCT05703191|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101884528|NCT05703191|Vasodilator Agents|vasodilator agents|mesh-ancestor
101884529|NCT05703191|Gasotransmitters|gasotransmitters|mesh-ancestor
101884530|NCT05703191|Protective Agents|protective agents|mesh-ancestor
101884531|NCT05687071|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
101884532|NCT05687071|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101884533|NCT05687071|Antimetabolites|antimetabolites|mesh-ancestor
101884534|NCT05687071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884535|NCT05687071|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101884536|NCT05687071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101884537|NCT05687071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101884538|NCT05687071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884539|NCT05657470|Tenecteplase|tenecteplase|mesh-list
101884540|NCT05657470|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101884541|NCT05657470|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101308818|NCT00005958|Tubulin Modulators|tubulin modulators|mesh-ancestor
101884542|NCT05657470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884543|NCT05649059|Cannabidiol|cannabidiol|mesh-list
101884544|NCT05649059|Anticonvulsants|anticonvulsants|mesh-ancestor
101884545|NCT05639686|Remifentanil|remifentanil|mesh-list
101884546|NCT05639686|Anesthetics|anesthetics|mesh-list
101884547|NCT05639686|Propofol|propofol|mesh-list
101884548|NCT05639686|Isoflurane|isoflurane|mesh-list
101884549|NCT05639686|Tranexamic Acid|tranexamic acid|mesh-list
101884550|NCT05639686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101884551|NCT05639686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884552|NCT05639686|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101884553|NCT05639686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101884554|NCT05639686|Anesthetics, General|anesthetics, general|mesh-ancestor
101884555|NCT05639686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101884556|NCT05639686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101884557|NCT05639686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884558|NCT05639686|Hemostatics|hemostatics|mesh-ancestor
101884559|NCT05639686|Coagulants|coagulants|mesh-ancestor
101884560|NCT05639686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101884561|NCT05639686|Narcotics|narcotics|mesh-ancestor
101884562|NCT05639686|Analgesics|analgesics|mesh-ancestor
101884563|NCT05639686|Sensory System Agents|sensory system agents|mesh-ancestor
101884564|NCT05639686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101884565|NCT05639686|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101884566|NCT05633576|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101884567|NCT05633576|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101884568|NCT05586074|Cytarabine|cytarabine|mesh-list
101884569|NCT05586074|Fludarabine|fludarabine|mesh-list
101884570|NCT05586074|Azacitidine|azacitidine|mesh-list
101884572|NCT05586074|Idarubicin|idarubicin|mesh-list
101884573|NCT05586074|Lenograstim|lenograstim|mesh-list
101884574|NCT05586074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101884575|NCT05586074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101884576|NCT05586074|Antimetabolites|antimetabolites|mesh-ancestor
101884577|NCT05586074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884578|NCT05586074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101884579|NCT05586074|Immunologic Factors|immunologic factors|mesh-ancestor
101884580|NCT05586074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884581|NCT05586074|Antiviral Agents|antiviral agents|mesh-ancestor
101884582|NCT05586074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101884583|NCT05586074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101884584|NCT05586074|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101884585|NCT05586074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101884586|NCT05586074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101884587|NCT05586074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101884588|NCT05568615|Edaravone|edaravone|mesh-list
101884589|NCT05568615|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101884590|NCT05568615|Antioxidants|antioxidants|mesh-ancestor
101884591|NCT05568615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884592|NCT05568615|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101884593|NCT05568615|Protective Agents|protective agents|mesh-ancestor
101884594|NCT05568615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884595|NCT05541146|Paclitaxel|paclitaxel|mesh-list
101884596|NCT05541146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101884597|NCT05541146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101884598|NCT05541146|Tubulin Modulators|tubulin modulators|mesh-ancestor
101884599|NCT05541146|Antimitotic Agents|antimitotic agents|mesh-ancestor
101884600|NCT05541146|Mitosis Modulators|mitosis modulators|mesh-ancestor
101884601|NCT05541146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884602|NCT05532358|Midazolam|midazolam|mesh-list
101884603|NCT05532358|Fluvoxamine|fluvoxamine|mesh-list
101884604|NCT05532358|Caffeine|caffeine|mesh-list
101884605|NCT05532358|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101968322|NCT01327729|Interferons|interferons|mesh-list
101884607|NCT05532358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101884608|NCT05532358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884609|NCT05532358|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101884610|NCT05532358|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101884611|NCT05532358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101884612|NCT05532358|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101884613|NCT05532358|Anesthetics, General|anesthetics, general|mesh-ancestor
101884614|NCT05532358|Anesthetics|anesthetics|mesh-ancestor
101884615|NCT05532358|GABA Modulators|gaba modulators|mesh-ancestor
101884616|NCT05532358|GABA Agents|gaba agents|mesh-ancestor
101884617|NCT05532358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101884618|NCT05532358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884619|NCT05532358|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101884620|NCT05532358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101884621|NCT05532358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101884622|NCT05532358|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101884623|NCT05532358|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101884624|NCT05532358|Purinergic Agents|purinergic agents|mesh-ancestor
101884625|NCT05532358|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101884626|NCT05532358|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101884627|NCT05532358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101884628|NCT05532358|Serotonin Agents|serotonin agents|mesh-ancestor
101884629|NCT05532358|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101884630|NCT05532358|Antidepressive Agents|antidepressive agents|mesh-ancestor
101884631|NCT05532358|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101884632|NCT05532358|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101884633|NCT05532358|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101884634|NCT05525416|Propranolol|propranolol|mesh-list
101884635|NCT05525416|Nitroprusside|nitroprusside|mesh-list
101884636|NCT05525416|Phentolamine|phentolamine|mesh-list
101884637|NCT05525416|Phenylephrine|phenylephrine|mesh-list
101884638|NCT05525416|Oxymetazoline|oxymetazoline|mesh-list
101884639|NCT05525416|Norepinephrine|norepinephrine|mesh-list
101884640|NCT05525416|Synephrine|synephrine|mesh-list
101884641|NCT05525416|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101884642|NCT05525416|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101247501|NCT05479370|Vaccines|vaccines|mesh-list
101884643|NCT05525416|Adrenergic Agents|adrenergic agents|mesh-ancestor
101884644|NCT05525416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101884645|NCT05525416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884646|NCT05525416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884647|NCT05525416|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101884648|NCT05525416|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101884649|NCT05525416|Vasodilator Agents|vasodilator agents|mesh-ancestor
101884650|NCT05525416|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101884651|NCT05525416|Mydriatics|mydriatics|mesh-ancestor
101884652|NCT05525416|Autonomic Agents|autonomic agents|mesh-ancestor
101884653|NCT05525416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101884654|NCT05525416|Sympathomimetics|sympathomimetics|mesh-ancestor
101884655|NCT05525416|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101884656|NCT05525416|Nasal Decongestants|nasal decongestants|mesh-ancestor
101884657|NCT05525416|Respiratory System Agents|respiratory system agents|mesh-ancestor
101884658|NCT05525416|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101884659|NCT05525416|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101884660|NCT05525416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101884661|NCT05525416|Protective Agents|protective agents|mesh-ancestor
101884662|NCT05525416|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101884663|NCT05525416|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101884664|NCT05491512|Carboplatin|carboplatin|mesh-list
101884665|NCT05491512|Fluorouracil|fluorouracil|mesh-list
101884666|NCT05491512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101884667|NCT05491512|Antimetabolites|antimetabolites|mesh-ancestor
101884668|NCT05491512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884669|NCT05491512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101884670|NCT05491512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101884671|NCT05491512|Immunologic Factors|immunologic factors|mesh-ancestor
101884672|NCT05491512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884673|NCT05449405|Chlorpheniramine|chlorpheniramine|mesh-list
101884674|NCT05449405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884675|NCT05449405|Antipruritics|antipruritics|mesh-ancestor
101884676|NCT05449405|Dermatologic Agents|dermatologic agents|mesh-ancestor
101884677|NCT05449405|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101884678|NCT05449405|Histamine Antagonists|histamine antagonists|mesh-ancestor
101884679|NCT05449405|Histamine Agents|histamine agents|mesh-ancestor
101884680|NCT05449405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101884681|NCT05449405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884682|NCT05449405|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101884683|NCT05412706|Niraparib|niraparib|mesh-list
101884684|NCT05412706|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101884685|NCT05412706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101884686|NCT05412706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884687|NCT05412706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101884688|NCT05394740|Leucovorin|leucovorin|mesh-list
101884689|NCT05394740|Fluorouracil|fluorouracil|mesh-list
101884690|NCT05394740|Capecitabine|capecitabine|mesh-list
101884691|NCT05394740|Oxaliplatin|oxaliplatin|mesh-list
101884692|NCT05394740|Nivolumab|nivolumab|mesh-list
101884693|NCT05394740|Antimetabolites|antimetabolites|mesh-ancestor
101884694|NCT05394740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884695|NCT05394740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101884696|NCT05394740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101884697|NCT05394740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101884698|NCT05394740|Immunologic Factors|immunologic factors|mesh-ancestor
101884699|NCT05394740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884700|NCT05394740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101884701|NCT05394740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101884702|NCT05394740|Antidotes|antidotes|mesh-ancestor
101884703|NCT05394740|Protective Agents|protective agents|mesh-ancestor
101884704|NCT05394740|Vitamin B Complex|vitamin b complex|mesh-ancestor
101884705|NCT05394740|Vitamins|vitamins|mesh-ancestor
101884706|NCT05394740|Micronutrients|micronutrients|mesh-ancestor
101884707|NCT05390021|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101884708|NCT05390021|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101884709|NCT05390021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884710|NCT05273996|Bupropion|bupropion|mesh-list
101884711|NCT05273996|Sertraline|sertraline|mesh-list
101884712|NCT05273996|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101884713|NCT05273996|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101884714|NCT05273996|Antidepressive Agents|antidepressive agents|mesh-ancestor
101884715|NCT05273996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101884716|NCT05273996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101884717|NCT05273996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101884718|NCT05273996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101884719|NCT05273996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884720|NCT05273996|Dopamine Agents|dopamine agents|mesh-ancestor
101884721|NCT05273996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101884722|NCT05273996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884723|NCT05273996|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101884724|NCT05273996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101884725|NCT05273996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101884726|NCT05273996|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101884727|NCT05273996|Serotonin Agents|serotonin agents|mesh-ancestor
101884728|NCT05273996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101884729|NCT05264025|Fexofenadine|fexofenadine|mesh-list
101884730|NCT05264025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101884731|NCT05264025|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101884732|NCT05264025|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101884733|NCT05264025|Histamine Antagonists|histamine antagonists|mesh-ancestor
101884734|NCT05264025|Histamine Agents|histamine agents|mesh-ancestor
101884735|NCT05264025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101884736|NCT05264025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884737|NCT05264025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884738|NCT05262244|Bevacizumab|bevacizumab|mesh-list
101884739|NCT05262244|Vedolizumab|vedolizumab|mesh-list
101884740|NCT05262244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101884741|NCT05262244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101884742|NCT05262244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101884743|NCT05262244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101968331|NCT01342952|Ambrisentan|ambrisentan|mesh-list
101884744|NCT05262244|Growth Substances|growth substances|mesh-ancestor
101884745|NCT05262244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884746|NCT05262244|Growth Inhibitors|growth inhibitors|mesh-ancestor
101884747|NCT05262244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101884749|NCT05244213|Carboplatin|carboplatin|mesh-list
101604556|NCT04175002|Hormones|hormones|mesh-ancestor
101884750|NCT05244213|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101884751|NCT05244213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101884752|NCT05244213|Tubulin Modulators|tubulin modulators|mesh-ancestor
101884753|NCT05244213|Antimitotic Agents|antimitotic agents|mesh-ancestor
101884754|NCT05244213|Mitosis Modulators|mitosis modulators|mesh-ancestor
101884755|NCT05244213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884756|NCT05233956|Chrysarobin|chrysarobin|mesh-list
101884757|NCT05233956|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101884758|NCT05233956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101884759|NCT05233956|Analgesics|analgesics|mesh-ancestor
101884760|NCT05233956|Sensory System Agents|sensory system agents|mesh-ancestor
101884761|NCT05233956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101884762|NCT05233956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884763|NCT05233956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101884764|NCT05233956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101884765|NCT05231148|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101884766|NCT05231148|Calcium|calcium|mesh-list
101884767|NCT05231148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101884768|NCT05231148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884769|NCT05231148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101884770|NCT05219487|Risdiplam|risdiplam|mesh-list
101884771|NCT05219487|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101884772|NCT05219487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101884773|NCT05219487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884774|NCT05169112|Leuprolide|leuprolide|mesh-list
101884775|NCT05169112|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101884776|NCT05169112|Fertility Agents|fertility agents|mesh-ancestor
101884777|NCT05169112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101884778|NCT05169112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884779|NCT05169112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101884780|NCT05169112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101884781|NCT05137184|Fentanyl|fentanyl|mesh-list
101884782|NCT05137184|Morphine|morphine|mesh-list
101884783|NCT05137184|Methoxyflurane|methoxyflurane|mesh-list
101455805|NCT00244023|Androgens|androgens|mesh-ancestor
101884784|NCT05137184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101884785|NCT05137184|Narcotics|narcotics|mesh-ancestor
101884786|NCT05137184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101884787|NCT05137184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884788|NCT05137184|Analgesics|analgesics|mesh-ancestor
101884789|NCT05137184|Sensory System Agents|sensory system agents|mesh-ancestor
101884790|NCT05137184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101884791|NCT05137184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101884792|NCT05137184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101884793|NCT05137184|Anesthetics, General|anesthetics, general|mesh-ancestor
101884794|NCT05137184|Anesthetics|anesthetics|mesh-ancestor
101884795|NCT05137184|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101884796|NCT05097209|Cisplatin|cisplatin|mesh-list
101884797|NCT05097209|Gemcitabine|gemcitabine|mesh-list
101884798|NCT05097209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101884799|NCT05097209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101884800|NCT05097209|Antimetabolites|antimetabolites|mesh-ancestor
101884801|NCT05097209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884802|NCT05067998|Vitamins|vitamins|mesh-list
101884803|NCT05067998|Micronutrients|micronutrients|mesh-ancestor
101884804|NCT05067998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884805|NCT05065411|Everolimus|everolimus|mesh-list
101884806|NCT05065411|Fulvestrant|fulvestrant|mesh-list
101884807|NCT05065411|Exemestane|exemestane|mesh-list
101884808|NCT05065411|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101884809|NCT05065411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101884810|NCT05065411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101884811|NCT05065411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884812|NCT05065411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101884813|NCT05065411|Immunologic Factors|immunologic factors|mesh-ancestor
101884814|NCT05065411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884815|NCT05065411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101884816|NCT05065411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101884817|NCT05065411|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101884818|NCT05065411|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101884819|NCT05065411|Hormone Antagonists|hormone antagonists|mesh-ancestor
101884820|NCT05065411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101884821|NCT05065411|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101884822|NCT05065411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101884823|NCT05025293|Zoledronic Acid|zoledronic acid|mesh-list
101884824|NCT05025293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101884825|NCT05025293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884826|NCT05021991|Pramoxine|pramoxine|mesh-list
101884827|NCT05021991|Anesthetics, Local|anesthetics, local|mesh-ancestor
101884828|NCT05021991|Anesthetics|anesthetics|mesh-ancestor
101884829|NCT05021991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101884830|NCT05021991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884831|NCT05021991|Sensory System Agents|sensory system agents|mesh-ancestor
101884832|NCT05021991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101884833|NCT05001776|PENTA|penta|mesh-list
101884834|NCT05001776|Fondaparinux|fondaparinux|mesh-list
101884835|NCT05001776|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101884836|NCT05001776|Antithrombins|antithrombins|mesh-ancestor
101884837|NCT05001776|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101884838|NCT05001776|Protease Inhibitors|protease inhibitors|mesh-ancestor
101884839|NCT05001776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101884840|NCT05001776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884841|NCT05001776|Anticoagulants|anticoagulants|mesh-ancestor
101884842|NCT05001776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101884843|NCT05001776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101884844|NCT04991974|Buprenorphine|buprenorphine|mesh-list
101884845|NCT04991974|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101884846|NCT04991974|Naloxone|naloxone|mesh-list
101884847|NCT04991974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101884848|NCT04991974|Narcotics|narcotics|mesh-ancestor
101455827|NCT00214604|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101884849|NCT04991974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101884850|NCT04991974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884851|NCT04991974|Analgesics|analgesics|mesh-ancestor
101884852|NCT04991974|Sensory System Agents|sensory system agents|mesh-ancestor
101884853|NCT04991974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101884854|NCT04991974|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101884855|NCT04977479|Vaccines|vaccines|mesh-list
101884856|NCT04977479|Immunologic Factors|immunologic factors|mesh-ancestor
101884857|NCT04977479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884858|NCT04971473|Hormones|hormones|mesh-list
101884859|NCT04971473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101884860|NCT04971473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884861|NCT04943588|Antibodies|antibodies|mesh-list
101884862|NCT04943588|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
101884863|NCT04943588|Immunologic Factors|immunologic factors|mesh-ancestor
101884864|NCT04943588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884865|NCT04917692|Empagliflozin|empagliflozin|mesh-list
101884866|NCT04917692|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101884867|NCT04917692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884868|NCT04917692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101884869|NCT04917692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884870|NCT04915248|Dexamethasone|dexamethasone|mesh-list
101884871|NCT04915248|Dexamethasone acetate|dexamethasone acetate|mesh-list
101884872|NCT04915248|Bortezomib|bortezomib|mesh-list
101884873|NCT04915248|Daratumumab|daratumumab|mesh-list
101884874|NCT04915248|BB 1101|bb 1101|mesh-list
101884875|NCT04915248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101884876|NCT04915248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101884877|NCT04915248|Antiemetics|antiemetics|mesh-ancestor
101884878|NCT04915248|Autonomic Agents|autonomic agents|mesh-ancestor
101884879|NCT04915248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101884880|NCT04915248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884881|NCT04915248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101884882|NCT04915248|Glucocorticoids|glucocorticoids|mesh-ancestor
101884883|NCT04915248|Hormones|hormones|mesh-ancestor
101884884|NCT04915248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101884885|NCT04915248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101884886|NCT04915248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101884887|NCT04915248|Protease Inhibitors|protease inhibitors|mesh-ancestor
101884888|NCT04915248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101884889|NCT04915248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884890|NCT04915248|Immunologic Factors|immunologic factors|mesh-ancestor
101884891|NCT04893785|Temozolomide|temozolomide|mesh-list
101884892|NCT04893785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101884893|NCT04893785|Alkylating Agents|alkylating agents|mesh-ancestor
101884894|NCT04893785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884895|NCT04893785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101884896|NCT04881747|Lasmiditan|lasmiditan|mesh-list
101884897|NCT04881747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101884898|NCT04881747|Serotonin Agents|serotonin agents|mesh-ancestor
101884899|NCT04881747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101884900|NCT04881747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604703|NCT04173832|Antiviral Agents|antiviral agents|mesh-ancestor
101884901|NCT04881747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884902|NCT04862949|Bevacizumab|bevacizumab|mesh-list
101884903|NCT04862949|Atezolizumab|atezolizumab|mesh-list
101884904|NCT04862949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101884905|NCT04862949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101884906|NCT04862949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101455839|NCT00214643|Fosmidomycin|fosmidomycin|mesh-list
101884907|NCT04862949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101884908|NCT04862949|Growth Substances|growth substances|mesh-ancestor
101884909|NCT04862949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884910|NCT04862949|Growth Inhibitors|growth inhibitors|mesh-ancestor
101884911|NCT04862949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101884912|NCT04862949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884913|NCT04848974|Cytarabine|cytarabine|mesh-list
101884914|NCT04848974|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
101884915|NCT04848974|Cladribine|cladribine|mesh-list
101884916|NCT04848974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101884917|NCT04848974|Antimetabolites|antimetabolites|mesh-ancestor
101884918|NCT04848974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884919|NCT04848974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101884920|NCT04848974|Antiviral Agents|antiviral agents|mesh-ancestor
101884921|NCT04848974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101884922|NCT04848974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101884923|NCT04848974|Immunologic Factors|immunologic factors|mesh-ancestor
101884924|NCT04848974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884925|NCT04840823|Enoxacin|enoxacin|mesh-list
101884926|NCT04840823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101884927|NCT04840823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101884928|NCT04840823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101884929|NCT04840823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101884930|NCT04840823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101689354|NCT02648412|Ketamine|ketamine|mesh-list
101884931|NCT04840823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884932|NCT04840823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101884933|NCT04840823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101884934|NCT04840823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101884936|NCT04781959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101884937|NCT04781959|Immunologic Factors|immunologic factors|mesh-ancestor
101884938|NCT04781959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884939|NCT04729608|Paclitaxel|paclitaxel|mesh-list
101884940|NCT04729608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101884941|NCT04729608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101884942|NCT04729608|Tubulin Modulators|tubulin modulators|mesh-ancestor
101884943|NCT04729608|Antimitotic Agents|antimitotic agents|mesh-ancestor
101884944|NCT04729608|Mitosis Modulators|mitosis modulators|mesh-ancestor
101884945|NCT04729608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884946|NCT04652245|Fluticasone|fluticasone|mesh-list
101884948|NCT04652245|Azelastine|azelastine|mesh-list
101884949|NCT04652245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101884950|NCT04652245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101884951|NCT04652245|Autonomic Agents|autonomic agents|mesh-ancestor
101884952|NCT04652245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101884953|NCT04652245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884955|NCT04652245|Respiratory System Agents|respiratory system agents|mesh-ancestor
101884956|NCT04652245|Dermatologic Agents|dermatologic agents|mesh-ancestor
101884957|NCT04652245|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101884958|NCT04652245|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101884959|NCT04652245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101884960|NCT04652245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884961|NCT04652245|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101884962|NCT04652245|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101884963|NCT04652245|Histamine Antagonists|histamine antagonists|mesh-ancestor
101884964|NCT04652245|Histamine Agents|histamine agents|mesh-ancestor
101884965|NCT04652245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101884966|NCT04642287|Fluorouracil|fluorouracil|mesh-list
101884967|NCT04642287|Calcipotriene|calcipotriene|mesh-list
101884968|NCT04642287|Petrolatum|petrolatum|mesh-list
101884969|NCT04642287|Antimetabolites|antimetabolites|mesh-ancestor
101884970|NCT04642287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884971|NCT04642287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101884972|NCT04642287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101884973|NCT04642287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101884974|NCT04642287|Immunologic Factors|immunologic factors|mesh-ancestor
101884975|NCT04642287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455853|NCT00214682|Vitamin B 12|vitamin b 12|mesh-list
101884976|NCT04642287|Dermatologic Agents|dermatologic agents|mesh-ancestor
101884977|NCT04642287|Emollients|emollients|mesh-ancestor
101884978|NCT04635735|Ipilimumab|ipilimumab|mesh-list
101884979|NCT04635735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101884980|NCT04635735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101884981|NCT04635735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101884982|NCT04635735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101884983|NCT04595513|Sirolimus|sirolimus|mesh-list
101884984|NCT04595513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101884985|NCT04595513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101884986|NCT04595513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101884987|NCT04595513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101884988|NCT04595513|Antifungal Agents|antifungal agents|mesh-ancestor
101884989|NCT04595513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101884990|NCT04595513|Immunologic Factors|immunologic factors|mesh-ancestor
101884991|NCT04595513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884992|NCT04564339|Ravulizumab|ravulizumab|mesh-list
101884993|NCT04564339|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101884994|NCT04564339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101884995|NCT04564339|Immunologic Factors|immunologic factors|mesh-ancestor
101884996|NCT04564339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101884997|NCT04543110|Durvalumab|durvalumab|mesh-list
101884998|NCT04543110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101884999|NCT04543110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101885000|NCT04487652|Coenzyme Q10|coenzyme q10|mesh-list
101885001|NCT04487652|Vitamins|vitamins|mesh-ancestor
101885002|NCT04487652|Micronutrients|micronutrients|mesh-ancestor
101885003|NCT04487652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885004|NCT04454489|Pembrolizumab|pembrolizumab|mesh-list
101885005|NCT04454489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101885006|NCT04454489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101885007|NCT04454489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101885008|NCT04454489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885009|NCT04447183|Iodine|iodine|mesh-list
101885010|NCT04447183|Hormones|hormones|mesh-list
101885011|NCT04447183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101885012|NCT04447183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885013|NCT04447183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101885014|NCT04447183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101885015|NCT04447183|Trace Elements|trace elements|mesh-ancestor
101885016|NCT04447183|Micronutrients|micronutrients|mesh-ancestor
101885017|NCT04429334|Nangibotide|nangibotide|mesh-list
101885018|NCT04429334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101885019|NCT04421820|Leucovorin|leucovorin|mesh-list
101885020|NCT04421820|Fluorouracil|fluorouracil|mesh-list
101885021|NCT04421820|Oxaliplatin|oxaliplatin|mesh-list
101885022|NCT04421820|Antimetabolites|antimetabolites|mesh-ancestor
101968354|NCT01341080|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101885027|NCT04421820|Immunologic Factors|immunologic factors|mesh-ancestor
101885028|NCT04421820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885029|NCT04421820|Antidotes|antidotes|mesh-ancestor
101885030|NCT04421820|Protective Agents|protective agents|mesh-ancestor
101885031|NCT04421820|Vitamin B Complex|vitamin b complex|mesh-ancestor
101885032|NCT04421820|Vitamins|vitamins|mesh-ancestor
101885033|NCT04421820|Micronutrients|micronutrients|mesh-ancestor
101885034|NCT04408443|Vitamin D|vitamin d|mesh-list
101885035|NCT04408443|Cholecalciferol|cholecalciferol|mesh-list
101885036|NCT04408443|Vitamins|vitamins|mesh-ancestor
101885037|NCT04408443|Micronutrients|micronutrients|mesh-ancestor
101885038|NCT04408443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885039|NCT04408443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101885040|NCT04408443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101885041|NCT04405739|Molnupiravir|molnupiravir|mesh-list
101885042|NCT04405739|Antiviral Agents|antiviral agents|mesh-ancestor
101885043|NCT04405739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101885044|NCT04396457|Pembrolizumab|pembrolizumab|mesh-list
101885045|NCT04396457|Pemetrexed|pemetrexed|mesh-list
101885046|NCT04396457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101885047|NCT04396457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101885048|NCT04396457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101885049|NCT04396457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885050|NCT04396457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101885051|NCT04396457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101885052|NCT04396457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101885054|NCT04377204|Bupivacaine|bupivacaine|mesh-list
101885055|NCT04377204|Anesthetics, Local|anesthetics, local|mesh-ancestor
101885056|NCT04377204|Anesthetics|anesthetics|mesh-ancestor
101885057|NCT04377204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101885058|NCT04377204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885059|NCT04377204|Sensory System Agents|sensory system agents|mesh-ancestor
101885060|NCT04377204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101885061|NCT04377204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101885062|NCT04377204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101885063|NCT04377204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101885064|NCT04377204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101885065|NCT04377204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885066|NCT04349267|Nivolumab|nivolumab|mesh-list
101885067|NCT04349267|Cetuximab|cetuximab|mesh-list
101885068|NCT04349267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101885069|NCT04349267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101885070|NCT04349267|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101885071|NCT04349267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885072|NCT04346589|Antibodies|antibodies|mesh-list
101885073|NCT04346589|Immunoglobulins|immunoglobulins|mesh-list
101885074|NCT04346589|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101885075|NCT04346589|Immunologic Factors|immunologic factors|mesh-ancestor
101885076|NCT04346589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885077|NCT05934253|Chloroprocaine|chloroprocaine|mesh-list
101885078|NCT05934253|Anesthetics, Local|anesthetics, local|mesh-ancestor
101885079|NCT05934253|Anesthetics|anesthetics|mesh-ancestor
101885080|NCT05934253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101885081|NCT05934253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885082|NCT05934253|Sensory System Agents|sensory system agents|mesh-ancestor
101885083|NCT05934253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101968366|NCT01334060|Vaccines|vaccines|mesh-list
101885090|NCT05934110|Orlistat|orlistat|mesh-list
101885091|NCT05934110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101885092|NCT05934110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885093|NCT05934110|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101885094|NCT05934110|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101885095|NCT05934097|Prednisone|prednisone|mesh-list
101885096|NCT05934097|Cyclophosphamide|cyclophosphamide|mesh-list
101885097|NCT05934097|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101885098|NCT05934097|Rituximab|rituximab|mesh-list
101885099|NCT05934097|Doxorubicin|doxorubicin|mesh-list
101885100|NCT05934097|Vincristine|vincristine|mesh-list
101885101|NCT05934097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101885102|NCT05934097|Immunologic Factors|immunologic factors|mesh-ancestor
101885103|NCT05934097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885104|NCT05934097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101885105|NCT05934097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101885106|NCT05934097|Alkylating Agents|alkylating agents|mesh-ancestor
101885107|NCT05934097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885108|NCT05934097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101885109|NCT05934097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101885110|NCT05934097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101885111|NCT05934097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101885112|NCT05934097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101885113|NCT05934097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101885114|NCT05934097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101885115|NCT05934097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101885116|NCT05934097|Glucocorticoids|glucocorticoids|mesh-ancestor
101885117|NCT05934097|Hormones|hormones|mesh-ancestor
101885118|NCT05934097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101885119|NCT05934097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101885120|NCT05934097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101885121|NCT05934097|Tubulin Modulators|tubulin modulators|mesh-ancestor
101885122|NCT05934097|Antimitotic Agents|antimitotic agents|mesh-ancestor
101885123|NCT05934097|Mitosis Modulators|mitosis modulators|mesh-ancestor
101885124|NCT05934071|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
101885125|NCT05934071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885126|NCT05934071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101885142|NCT05933486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885143|NCT05933486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101885144|NCT05933486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101885145|NCT05933486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101885146|NCT05933486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101885147|NCT05933486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101885148|NCT05933447|Moxifloxacin|moxifloxacin|mesh-list
101885149|NCT05933447|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101885150|NCT05933447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101885151|NCT05933447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101885152|NCT05933447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101885153|NCT05933447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101885154|NCT05933447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101885155|NCT05933447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885156|NCT05933447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101885157|NCT05933447|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101885158|NCT05933447|Contraceptive Agents|contraceptive agents|mesh-ancestor
101885159|NCT05933447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101885160|NCT05933447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885161|NCT05933447|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101885162|NCT05933447|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101885163|NCT05933447|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101885179|NCT05933213|Mescaline|mescaline|mesh-list
101885180|NCT05933213|Glucocorticoids|glucocorticoids|mesh-list
101885181|NCT05933213|Hormones|hormones|mesh-ancestor
101885182|NCT05933213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101885183|NCT05933213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885184|NCT05933213|Hallucinogens|hallucinogens|mesh-ancestor
101885185|NCT05933213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101455905|NCT00214994|Tiagabine|tiagabine|mesh-list
101885186|NCT05933213|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101885187|NCT05933213|Serotonin Agents|serotonin agents|mesh-ancestor
101885188|NCT05933213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101885189|NCT05933213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885191|NCT05933044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101885192|NCT05933044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101885193|NCT05933031|Lansoprazole|lansoprazole|mesh-list
101885194|NCT05933031|Dexlansoprazole|dexlansoprazole|mesh-list
101885195|NCT05933031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101885196|NCT05933031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101885197|NCT05933031|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101885198|NCT05933031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101885199|NCT05933031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885200|NCT05932966|Insulin|insulin|mesh-list
101885202|NCT05932966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885203|NCT05932849|Benralizumab|benralizumab|mesh-list
101885204|NCT05932849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101885205|NCT05932849|Respiratory System Agents|respiratory system agents|mesh-ancestor
101885206|NCT05932693|Menthol|menthol|mesh-list
101885207|NCT05932693|Antipruritics|antipruritics|mesh-ancestor
101885208|NCT05932693|Dermatologic Agents|dermatologic agents|mesh-ancestor
101885209|NCT05932667|Fulvestrant|fulvestrant|mesh-list
101885210|NCT05932667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101885211|NCT05932667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101885212|NCT05932667|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101885213|NCT05932667|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101885214|NCT05932667|Hormone Antagonists|hormone antagonists|mesh-ancestor
101885215|NCT05932667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101885216|NCT05932667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885217|NCT05932550|Maraviroc|maraviroc|mesh-list
101885218|NCT05932550|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101885219|NCT05932550|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101885220|NCT05932550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885221|NCT05932550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101885222|NCT05932550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101885223|NCT05932550|Antiviral Agents|antiviral agents|mesh-ancestor
101885224|NCT05932550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101885225|NCT05932550|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101885226|NCT05932524|Dexamethasone|dexamethasone|mesh-list
101885227|NCT05932524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101885228|NCT05932524|Antiemetics|antiemetics|mesh-ancestor
101885229|NCT05932524|Autonomic Agents|autonomic agents|mesh-ancestor
101885230|NCT05932524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101885231|NCT05932524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885232|NCT05932524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101885233|NCT05932524|Glucocorticoids|glucocorticoids|mesh-ancestor
101885234|NCT05932524|Hormones|hormones|mesh-ancestor
101885235|NCT05932524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101885236|NCT05932524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101885237|NCT05932524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101885245|NCT05932472|Aspirin|aspirin|mesh-list
101885246|NCT05932472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101885247|NCT05932472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101885248|NCT05932472|Analgesics|analgesics|mesh-ancestor
101885249|NCT05932472|Sensory System Agents|sensory system agents|mesh-ancestor
101885250|NCT05932472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101885251|NCT05932472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885252|NCT05932472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101885253|NCT05932472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101455914|NCT00240630|Naproxen|naproxen|mesh-list
101885254|NCT05932472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101885255|NCT05932472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101885256|NCT05932472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248087|NCT02931890|Paclitaxel|paclitaxel|mesh-list
101968378|NCT01332344|Autonomic Agents|autonomic agents|mesh-ancestor
101885257|NCT05932472|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101885258|NCT05932472|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101885260|NCT05932472|Antipyretics|antipyretics|mesh-ancestor
101885261|NCT05932407|Vortioxetine|vortioxetine|mesh-list
101885262|NCT05932407|Antidepressive Agents|antidepressive agents|mesh-ancestor
101885263|NCT05932407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101885264|NCT05932407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101885265|NCT05932407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101885266|NCT05932407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101885267|NCT05932407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885268|NCT05932407|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101885269|NCT05932407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101885270|NCT05932407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101885271|NCT05932407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885272|NCT05932407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101885273|NCT05932407|Serotonin Agents|serotonin agents|mesh-ancestor
101605084|NCT04172740|Calcium|calcium|mesh-list
101885274|NCT05932407|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101885275|NCT05932407|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101885276|NCT05932407|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101885277|NCT05932407|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101885279|NCT05932316|Bronchodilator Agents|bronchodilator agents|mesh-list
101885280|NCT05932316|Autonomic Agents|autonomic agents|mesh-ancestor
101885281|NCT05932316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101885282|NCT05932316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885283|NCT05932316|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101885284|NCT05932316|Respiratory System Agents|respiratory system agents|mesh-ancestor
101885285|NCT05932316|Tocolytic Agents|tocolytic agents|mesh-ancestor
101885286|NCT05932316|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101885287|NCT05932316|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101885288|NCT05932316|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101885289|NCT05932316|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101885290|NCT05932316|Adrenergic Agents|adrenergic agents|mesh-ancestor
101885291|NCT05932316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101885292|NCT05932316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885293|NCT05932303|Itraconazole|itraconazole|mesh-list
101885294|NCT05932303|Carbamazepine|carbamazepine|mesh-list
101885295|NCT05932303|Gemfibrozil|gemfibrozil|mesh-list
101885296|NCT05932303|Antifungal Agents|antifungal agents|mesh-ancestor
101885297|NCT05932303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101885298|NCT05932303|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101885299|NCT05932303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101885300|NCT05932303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101885301|NCT05932303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885302|NCT05932303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101885303|NCT05932303|Hormone Antagonists|hormone antagonists|mesh-ancestor
101885304|NCT05932303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101885305|NCT05932303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885306|NCT05932303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101885307|NCT05932303|Anticonvulsants|anticonvulsants|mesh-ancestor
101885308|NCT05932303|Antimanic Agents|antimanic agents|mesh-ancestor
101885309|NCT05932303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101885310|NCT05932303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101885311|NCT05932303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101885312|NCT05932303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101885313|NCT05932303|Analgesics|analgesics|mesh-ancestor
101885314|NCT05932303|Sensory System Agents|sensory system agents|mesh-ancestor
101885315|NCT05932303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101885316|NCT05932303|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101885317|NCT05932303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101885318|NCT05932303|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101885319|NCT05932303|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101885320|NCT05932303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101885321|NCT05932303|Antimetabolites|antimetabolites|mesh-ancestor
101885322|NCT05932303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101885323|NCT05932303|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101885324|NCT05932277|Fexofenadine|fexofenadine|mesh-list
101885325|NCT05932277|Flurbiprofen|flurbiprofen|mesh-list
101885326|NCT05932277|Midazolam|midazolam|mesh-list
101885327|NCT05932277|Caffeine|caffeine|mesh-list
101885328|NCT05932277|Bupropion|bupropion|mesh-list
101885330|NCT05932277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101885331|NCT05932277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101885332|NCT05932277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101885333|NCT05932277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885334|NCT05932277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101885335|NCT05932277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101885336|NCT05932277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101885337|NCT05932277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101885338|NCT05932277|Anesthetics, General|anesthetics, general|mesh-ancestor
101885339|NCT05932277|Anesthetics|anesthetics|mesh-ancestor
101885340|NCT05932277|GABA Modulators|gaba modulators|mesh-ancestor
101885341|NCT05932277|GABA Agents|gaba agents|mesh-ancestor
101885342|NCT05932277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101885343|NCT05932277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885344|NCT05932277|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101885345|NCT05932277|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101885346|NCT05932277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101885347|NCT05932277|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101885348|NCT05932277|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101885349|NCT05932277|Purinergic Agents|purinergic agents|mesh-ancestor
101885350|NCT05932277|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101885351|NCT05932277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101885352|NCT05932277|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101885353|NCT05932277|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101885354|NCT05932277|Antidepressive Agents|antidepressive agents|mesh-ancestor
101885355|NCT05932277|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101885356|NCT05932277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101885357|NCT05932277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101885358|NCT05932277|Dopamine Agents|dopamine agents|mesh-ancestor
101885359|NCT05932277|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101885360|NCT05932277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101885361|NCT05932277|Analgesics|analgesics|mesh-ancestor
101885362|NCT05932277|Sensory System Agents|sensory system agents|mesh-ancestor
101885363|NCT05932277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101885364|NCT05932277|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101885365|NCT05932277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101885366|NCT05932277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101885367|NCT05932277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101885368|NCT05932277|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101885369|NCT05932277|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101885370|NCT05932277|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101885371|NCT05932277|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101885372|NCT05932277|Histamine Antagonists|histamine antagonists|mesh-ancestor
101885373|NCT05932277|Histamine Agents|histamine agents|mesh-ancestor
101885374|NCT05932264|Apatinib|apatinib|mesh-list
101885375|NCT05932264|Fluzoparib|fluzoparib|mesh-list
101885376|NCT05932264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101885377|NCT05932264|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101885378|NCT05932264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101885379|NCT05932264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885380|NCT05932264|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101885381|NCT05932186|Anesthetics|anesthetics|mesh-list
101885382|NCT05932186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101885383|NCT05932186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885384|NCT05931965|Vitamin B 12|vitamin b 12|mesh-list
101885385|NCT05931965|Hydroxocobalamin|hydroxocobalamin|mesh-list
101885386|NCT05931965|Vitamins|vitamins|mesh-ancestor
101885387|NCT05931965|Micronutrients|micronutrients|mesh-ancestor
101885388|NCT05931965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885389|NCT05931965|Vitamin B Complex|vitamin b complex|mesh-ancestor
101885390|NCT05931965|Hematinics|hematinics|mesh-ancestor
101885391|NCT05931822|Fluorides|fluorides|mesh-list
101885392|NCT05931822|Fluorides, Topical|fluorides, topical|mesh-list
101968389|NCT01332344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101968390|NCT01332344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885394|NCT05931822|Protective Agents|protective agents|mesh-ancestor
101885395|NCT05931822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885396|NCT05931757|Blinatumomab|blinatumomab|mesh-list
101885397|NCT05931757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101885398|NCT05931744|Prednisone|prednisone|mesh-list
101885399|NCT05931744|Budesonide|budesonide|mesh-list
101885400|NCT05931744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101885401|NCT05931744|Glucocorticoids|glucocorticoids|mesh-ancestor
101885402|NCT05931744|Hormones|hormones|mesh-ancestor
101689361|NCT02648412|Anesthetics, General|anesthetics, general|mesh-ancestor
101885403|NCT05931744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101885404|NCT05931744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885405|NCT05931744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101885406|NCT05931744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101885407|NCT05931744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101885408|NCT05931744|Autonomic Agents|autonomic agents|mesh-ancestor
101885409|NCT05931744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101885410|NCT05931744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101885411|NCT05931744|Respiratory System Agents|respiratory system agents|mesh-ancestor
101885412|NCT05931718|Epoetin Alfa|epoetin alfa|mesh-list
101885413|NCT05931718|Luspatercept|luspatercept|mesh-list
101885414|NCT05931718|Hematinics|hematinics|mesh-ancestor
101885415|NCT05931601|Norepinephrine|norepinephrine|mesh-list
101885416|NCT05931601|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101885417|NCT05931601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101885418|NCT05931601|Adrenergic Agents|adrenergic agents|mesh-ancestor
101885419|NCT05931601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101885420|NCT05931601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885421|NCT05931601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885422|NCT05931601|Sympathomimetics|sympathomimetics|mesh-ancestor
101885423|NCT05931601|Autonomic Agents|autonomic agents|mesh-ancestor
101885424|NCT05931601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101885425|NCT05931601|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101885426|NCT05931575|Quinine|quinine|mesh-list
101885427|NCT05931575|Fasudil|fasudil|mesh-list
101885428|NCT05931575|1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine|1-(5-isoquinolinesulfonyl)-2-methylpiperazine|mesh-list
101885429|NCT05931575|Antimalarials|antimalarials|mesh-ancestor
101885430|NCT05931575|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101885431|NCT05931575|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101885432|NCT05931575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101885433|NCT05931575|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101885434|NCT05931575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885435|NCT05931575|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101885436|NCT05931575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101885437|NCT05931575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101885438|NCT05931575|Analgesics|analgesics|mesh-ancestor
101885439|NCT05931575|Sensory System Agents|sensory system agents|mesh-ancestor
101885440|NCT05931575|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101885441|NCT05931575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101885442|NCT05931575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885443|NCT05931575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101885444|NCT05931575|Vasodilator Agents|vasodilator agents|mesh-ancestor
101885445|NCT05931575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101885446|NCT05931575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101885447|NCT05931484|Gemfibrozil|gemfibrozil|mesh-list
101885448|NCT05931484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101885449|NCT05931484|Antimetabolites|antimetabolites|mesh-ancestor
101885450|NCT05931484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885451|NCT05931484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101885452|NCT05931484|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101885453|NCT05931484|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101885454|NCT05931484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101885455|NCT05931458|Infliximab|infliximab|mesh-list
101885456|NCT05931458|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101885457|NCT05931458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101885458|NCT05931458|Dermatologic Agents|dermatologic agents|mesh-ancestor
101885459|NCT05931458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101885460|NCT05931458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101885461|NCT05931393|Nivolumab|nivolumab|mesh-list
101885462|NCT05931393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101885463|NCT05931393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101885464|NCT05931393|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101885465|NCT05931393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885466|NCT05931328|Pomalidomide|pomalidomide|mesh-list
101885467|NCT05931328|Thiotepa|thiotepa|mesh-list
101885468|NCT05931328|Immunologic Factors|immunologic factors|mesh-ancestor
101885469|NCT05931328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885470|NCT05931328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101885471|NCT05931328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101885472|NCT05931328|Growth Substances|growth substances|mesh-ancestor
101885473|NCT05931328|Growth Inhibitors|growth inhibitors|mesh-ancestor
101885474|NCT05931328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101885475|NCT05931328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101885476|NCT05931328|Alkylating Agents|alkylating agents|mesh-ancestor
101885477|NCT05931328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885478|NCT05931328|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101885479|NCT05931328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101885480|NCT05931302|FAPI-46|fapi-46|mesh-list
101885481|NCT05931302|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101885482|NCT05931302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885483|NCT05931276|Metoprolol|metoprolol|mesh-list
101885484|NCT05931276|Carvedilol|carvedilol|mesh-list
101885485|NCT05931276|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101885486|NCT05931276|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101885487|NCT05931276|Sympatholytics|sympatholytics|mesh-ancestor
101885488|NCT05931276|Autonomic Agents|autonomic agents|mesh-ancestor
101885489|NCT05931276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101885490|NCT05931276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885491|NCT05931276|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101885492|NCT05931276|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101885493|NCT05931276|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101885494|NCT05931276|Adrenergic Agents|adrenergic agents|mesh-ancestor
101885495|NCT05931276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101885496|NCT05931276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605296|NCT00648934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101885497|NCT05931276|Antioxidants|antioxidants|mesh-ancestor
101885498|NCT05931276|Protective Agents|protective agents|mesh-ancestor
101885499|NCT05931276|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101885500|NCT05931276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101885501|NCT05931276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101885502|NCT05931276|Vasodilator Agents|vasodilator agents|mesh-ancestor
101885503|NCT05931276|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101885504|NCT05931276|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101885506|NCT05931263|Carmustine|carmustine|mesh-list
101885507|NCT05931263|Melphalan|melphalan|mesh-list
101885508|NCT05931263|Etoposide|etoposide|mesh-list
101885509|NCT05931263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101885510|NCT05931263|Alkylating Agents|alkylating agents|mesh-ancestor
101885511|NCT05931263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885512|NCT05931263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101885513|NCT05931263|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101885514|NCT05931263|Antimetabolites|antimetabolites|mesh-ancestor
101885515|NCT05931263|Antiviral Agents|antiviral agents|mesh-ancestor
101885516|NCT05931263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101885517|NCT05931263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101885518|NCT05931263|Immunologic Factors|immunologic factors|mesh-ancestor
101885519|NCT05931263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885520|NCT05931263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101885521|NCT05931263|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101885522|NCT05931263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101885523|NCT05931263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101885524|NCT05931263|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101885525|NCT05931224|Antihypertensive Agents|antihypertensive agents|mesh-list
101885526|NCT05931042|Trastuzumab|trastuzumab|mesh-list
101885538|NCT05930938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101885539|NCT05930912|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101885541|NCT05930912|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101885542|NCT05930912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101885543|NCT05930912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101885544|NCT05930912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885545|NCT05930912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101885546|NCT05930912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885548|NCT05930912|Sensory System Agents|sensory system agents|mesh-ancestor
101885549|NCT05930912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101885550|NCT05930912|Antidepressive Agents|antidepressive agents|mesh-ancestor
101885551|NCT05930912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101885552|NCT05930912|Dopamine Agents|dopamine agents|mesh-ancestor
101885553|NCT05930912|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101885554|NCT05930912|Serotonin Agents|serotonin agents|mesh-ancestor
101885560|NCT05930665|Bevacizumab|bevacizumab|mesh-list
101885561|NCT05930665|Carboplatin|carboplatin|mesh-list
101885562|NCT05930665|Pemetrexed|pemetrexed|mesh-list
101885563|NCT05930665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101885564|NCT05930665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101885565|NCT05930665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101885566|NCT05930665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101885567|NCT05930665|Growth Substances|growth substances|mesh-ancestor
101885568|NCT05930665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885569|NCT05930665|Growth Inhibitors|growth inhibitors|mesh-ancestor
101885570|NCT05930665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101885571|NCT05930665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885573|NCT05930665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101885574|NCT05930613|Certolizumab Pegol|certolizumab pegol|mesh-list
101885575|NCT05930613|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101885576|NCT05930613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101885577|NCT05930613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101885578|NCT05930613|Immunologic Factors|immunologic factors|mesh-ancestor
101885579|NCT05930613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885580|NCT05930613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101885588|NCT05930405|Sufentanil|sufentanil|mesh-list
101885589|NCT05930405|Ropivacaine|ropivacaine|mesh-list
101885590|NCT05930405|Anesthetics, Local|anesthetics, local|mesh-ancestor
101885591|NCT05930405|Anesthetics|anesthetics|mesh-ancestor
101885592|NCT05930405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101885593|NCT05930405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885594|NCT05930405|Sensory System Agents|sensory system agents|mesh-ancestor
101885595|NCT05930405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101885596|NCT05930405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101885598|NCT05930405|Analgesics|analgesics|mesh-ancestor
101885599|NCT05930405|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101885600|NCT05930405|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101885601|NCT05930405|Anesthetics, General|anesthetics, general|mesh-ancestor
101885602|NCT05930236|Methylprednisolone|methylprednisolone|mesh-list
101885603|NCT05930236|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101885604|NCT05930236|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101885605|NCT05930236|Prednisolone|prednisolone|mesh-list
101885606|NCT05930236|Prednisolone acetate|prednisolone acetate|mesh-list
101885607|NCT05930236|Lidocaine|lidocaine|mesh-list
101885608|NCT05930236|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101885609|NCT05930236|Prednisolone phosphate|prednisolone phosphate|mesh-list
101885610|NCT05930236|Anesthetics, Local|anesthetics, local|mesh-ancestor
101885611|NCT05930236|Anesthetics|anesthetics|mesh-ancestor
101885612|NCT05930236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101885613|NCT05930236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885614|NCT05930236|Sensory System Agents|sensory system agents|mesh-ancestor
101885615|NCT05930236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101885616|NCT05930236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101885617|NCT05930236|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101885618|NCT05930236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101885619|NCT05930236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101885620|NCT05930236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885621|NCT05930236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101885622|NCT05930236|Antiemetics|antiemetics|mesh-ancestor
101885623|NCT05930236|Autonomic Agents|autonomic agents|mesh-ancestor
101885624|NCT05930236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101885625|NCT05930236|Glucocorticoids|glucocorticoids|mesh-ancestor
101885626|NCT05930236|Hormones|hormones|mesh-ancestor
101885627|NCT05930236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101885628|NCT05930236|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101885629|NCT05930236|Protective Agents|protective agents|mesh-ancestor
101885630|NCT05930236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101885631|NCT05930236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101885632|NCT05930171|Acetaminophen|acetaminophen|mesh-list
101885633|NCT05930171|Bupivacaine|bupivacaine|mesh-list
101885634|NCT05930171|Anesthetics, Local|anesthetics, local|mesh-ancestor
101885635|NCT05930171|Anesthetics|anesthetics|mesh-ancestor
101885636|NCT05930171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101885637|NCT05930171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885638|NCT05930171|Sensory System Agents|sensory system agents|mesh-ancestor
101885639|NCT05930171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101885640|NCT05930171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101885641|NCT05930171|Analgesics|analgesics|mesh-ancestor
101885642|NCT05930171|Antipyretics|antipyretics|mesh-ancestor
101885643|NCT05930119|Rabeprazole|rabeprazole|mesh-list
101885644|NCT05930119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101885645|NCT05930119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101885646|NCT05930119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101885647|NCT05930119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101885648|NCT05930119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885649|NCT05930080|Celecoxib|celecoxib|mesh-list
101885650|NCT05930080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101885651|NCT05930080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101885652|NCT05930080|Analgesics|analgesics|mesh-ancestor
101885653|NCT05930080|Sensory System Agents|sensory system agents|mesh-ancestor
101885654|NCT05930080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101885655|NCT05930080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885656|NCT05930080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101885657|NCT05930080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101885658|NCT05930080|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101885659|NCT05930080|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101885660|NCT05930080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101885662|NCT05930002|Ivermectin|ivermectin|mesh-list
101885663|NCT05930002|Colchicine|colchicine|mesh-list
101885664|NCT05930002|Gout Suppressants|gout suppressants|mesh-ancestor
101885665|NCT05930002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101885666|NCT05930002|Tubulin Modulators|tubulin modulators|mesh-ancestor
101885667|NCT05930002|Antimitotic Agents|antimitotic agents|mesh-ancestor
101885668|NCT05930002|Mitosis Modulators|mitosis modulators|mesh-ancestor
101885669|NCT05930002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885670|NCT05930002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101885671|NCT05930002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101885672|NCT05930002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101885673|NCT05929092|Cyclophosphamide|cyclophosphamide|mesh-list
101885674|NCT05929092|Busulfan|busulfan|mesh-list
101885675|NCT05929092|Fludarabine|fludarabine|mesh-list
101885676|NCT05929092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101885677|NCT05929092|Immunologic Factors|immunologic factors|mesh-ancestor
101885678|NCT05929092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885679|NCT05929092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101885680|NCT05929092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101885681|NCT05929092|Alkylating Agents|alkylating agents|mesh-ancestor
101885682|NCT05929092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885683|NCT05929092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101885684|NCT05929092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101885685|NCT05928897|Disitamab vedotin|disitamab vedotin|mesh-list
101885686|NCT05928897|Immunoconjugates|immunoconjugates|mesh-ancestor
101885687|NCT05928897|Immunologic Factors|immunologic factors|mesh-ancestor
101885688|NCT05928897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885689|NCT05926505|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101885690|NCT05926505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101885691|NCT05926336|Anesthetics|anesthetics|mesh-list
101885692|NCT05926336|Propofol|propofol|mesh-list
101885693|NCT05926336|Sevoflurane|sevoflurane|mesh-list
101885694|NCT05926336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101689369|NCT00650520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101885695|NCT05926336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885696|NCT05926336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101885697|NCT05926336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101885698|NCT05926336|Anesthetics, General|anesthetics, general|mesh-ancestor
101885699|NCT05926336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101885700|NCT05926336|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101885701|NCT05925894|Anesthetics|anesthetics|mesh-list
101885703|NCT05925894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101885704|NCT05925894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885705|NCT05925894|Autonomic Agents|autonomic agents|mesh-ancestor
101885706|NCT05925894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101885707|NCT05923086|Lidocaine|lidocaine|mesh-list
101885708|NCT05923086|Anesthetics, Local|anesthetics, local|mesh-ancestor
101885709|NCT05923086|Anesthetics|anesthetics|mesh-ancestor
101885710|NCT05923086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101885711|NCT05923086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885712|NCT05923086|Sensory System Agents|sensory system agents|mesh-ancestor
101885713|NCT05923086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101885714|NCT05923086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101885715|NCT05923086|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101885716|NCT05923086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101885717|NCT05923086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101885718|NCT05923086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885719|NCT05909618|Nivolumab|nivolumab|mesh-list
101885720|NCT05909618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101885721|NCT05909618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101605561|NCT00843193|Xhance|xhance|mesh-list
101885722|NCT05909618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101885723|NCT05909618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101885724|NCT05909618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885725|NCT05902117|Arginine Vasopressin|arginine vasopressin|mesh-list
101885726|NCT05902117|Hemostatics|hemostatics|mesh-ancestor
101885727|NCT05902117|Coagulants|coagulants|mesh-ancestor
101885728|NCT05902117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101885729|NCT05902117|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101885730|NCT05902117|Natriuretic Agents|natriuretic agents|mesh-ancestor
101885731|NCT05902117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885732|NCT05900284|Metformin|metformin|mesh-list
101885733|NCT05900284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101885734|NCT05900284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885735|NCT05899010|Progesterone|progesterone|mesh-list
101885736|NCT05899010|Progestins|progestins|mesh-ancestor
101885737|NCT05899010|Hormones|hormones|mesh-ancestor
101885738|NCT05899010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101885739|NCT05899010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885743|NCT05894577|Montelukast|montelukast|mesh-list
101885744|NCT05894577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101885745|NCT05894577|Respiratory System Agents|respiratory system agents|mesh-ancestor
101885746|NCT05894577|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101885747|NCT05894577|Hormone Antagonists|hormone antagonists|mesh-ancestor
101885748|NCT05894577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101885749|NCT05894577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885750|NCT05894577|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101885751|NCT05894577|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101885752|NCT05894577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885753|NCT05894564|Fluvoxamine|fluvoxamine|mesh-list
101885754|NCT05894564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101885755|NCT05894564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885756|NCT05894564|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101885757|NCT05894564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101885758|NCT05894564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101885759|NCT05894564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885760|NCT05894564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101885761|NCT05894564|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101689371|NCT00650520|Hormone Antagonists|hormone antagonists|mesh-ancestor
101885762|NCT05894564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101885763|NCT05894564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101885765|NCT05894564|Serotonin Agents|serotonin agents|mesh-ancestor
101885766|NCT05894564|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101885767|NCT05894564|Antidepressive Agents|antidepressive agents|mesh-ancestor
101885768|NCT05894564|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101885769|NCT05894564|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101885770|NCT05894564|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101885771|NCT05894538|Ivermectin|ivermectin|mesh-list
101885772|NCT05894538|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101885773|NCT05894538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101885774|NCT05886036|Deoxyglucose|deoxyglucose|mesh-list
101885775|NCT05886036|Rituximab|rituximab|mesh-list
101885776|NCT05886036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101885777|NCT05886036|Antibodies|antibodies|mesh-list
101885778|NCT05886036|Immunoglobulins|immunoglobulins|mesh-list
101885779|NCT05886036|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101885780|NCT05886036|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101885781|NCT05886036|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101885782|NCT05886036|Immunologic Factors|immunologic factors|mesh-ancestor
101885783|NCT05886036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885784|NCT05886036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101885785|NCT05886036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101885786|NCT05886036|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101456074|NCT00244452|Cetrorelix|cetrorelix|mesh-list
101885787|NCT05886036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885788|NCT05886036|Antimetabolites|antimetabolites|mesh-ancestor
101885789|NCT05886036|Antiviral Agents|antiviral agents|mesh-ancestor
101885790|NCT05886036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101885791|NCT05877573|Capecitabine|capecitabine|mesh-list
101885792|NCT05877573|Oxaliplatin|oxaliplatin|mesh-list
101885793|NCT05877573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101885794|NCT05877573|Antimetabolites|antimetabolites|mesh-ancestor
101885795|NCT05877573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885796|NCT05877573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101885798|NCT05872542|Fluorides|fluorides|mesh-list
101968437|NCT03326492|Antivenins|antivenins|mesh-list
101885799|NCT05872542|Sodium Fluoride|sodium fluoride|mesh-list
101885800|NCT05872542|Fluorides, Topical|fluorides, topical|mesh-list
101885801|NCT05872542|Cariostatic Agents|cariostatic agents|mesh-ancestor
101885802|NCT05872542|Protective Agents|protective agents|mesh-ancestor
101885803|NCT05872542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885804|NCT05872542|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101885805|NCT05872542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101885806|NCT05872425|Drospirenone|drospirenone|mesh-list
101885807|NCT05872425|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101885808|NCT05872425|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
101885809|NCT05872425|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101885810|NCT05872425|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101885811|NCT05872425|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101885812|NCT05872425|Contraceptive Agents|contraceptive agents|mesh-ancestor
101885813|NCT05872425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101885814|NCT05872425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885815|NCT05872425|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101885816|NCT05872425|Estrogens|estrogens|mesh-ancestor
101885817|NCT05872425|Hormones|hormones|mesh-ancestor
101885818|NCT05872425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101885819|NCT05872425|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101885820|NCT05872425|Hormone Antagonists|hormone antagonists|mesh-ancestor
101885821|NCT05872425|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101885822|NCT05872425|Diuretics|diuretics|mesh-ancestor
101885823|NCT05872425|Natriuretic Agents|natriuretic agents|mesh-ancestor
101885824|NCT05870709|Valsartan|valsartan|mesh-list
101885825|NCT05870709|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101885826|NCT05870709|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101885827|NCT05870709|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101885828|NCT05870709|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101885829|NCT05870709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885830|NCT05870514|Propofol|propofol|mesh-list
101885831|NCT05870514|Fospropofol|fospropofol|mesh-list
101885832|NCT05870514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101885833|NCT05870514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101689375|NCT00650520|Dopamine Agents|dopamine agents|mesh-ancestor
101885834|NCT05870514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885835|NCT05870514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101885836|NCT05870514|Anesthetics, General|anesthetics, general|mesh-ancestor
101885837|NCT05870514|Anesthetics|anesthetics|mesh-ancestor
101885838|NCT05851560|Hyaluronic Acid|hyaluronic acid|mesh-list
101885839|NCT05851560|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101885840|NCT05851560|Immunologic Factors|immunologic factors|mesh-ancestor
101885841|NCT05851560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885842|NCT05851560|Viscosupplements|viscosupplements|mesh-ancestor
101885843|NCT05851560|Protective Agents|protective agents|mesh-ancestor
101885844|NCT05817240|Nintedanib|nintedanib|mesh-list
101885845|NCT05817240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101885846|NCT05817240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101885847|NCT05817240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101885848|NCT05817240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885849|NCT05810363|Propofol|propofol|mesh-list
101885850|NCT05810363|Etomidate|etomidate|mesh-list
101885851|NCT05810363|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101885852|NCT05810363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101885853|NCT05810363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885854|NCT05810363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101885855|NCT05810363|Anesthetics, General|anesthetics, general|mesh-ancestor
101885856|NCT05810363|Anesthetics|anesthetics|mesh-ancestor
101885857|NCT05804123|Acetylcysteine|acetylcysteine|mesh-list
101885858|NCT05804123|Ciprofloxacin|ciprofloxacin|mesh-list
101885859|NCT05804123|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101885860|NCT05804123|Cefotaxime|cefotaxime|mesh-list
101885861|NCT05804123|Cefoxitin|cefoxitin|mesh-list
101885862|NCT05804123|Xylometazoline|xylometazoline|mesh-list
101885863|NCT05804123|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101885864|NCT05804123|Antiviral Agents|antiviral agents|mesh-ancestor
101885865|NCT05804123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101885866|NCT05804123|Expectorants|expectorants|mesh-ancestor
101885867|NCT05804123|Respiratory System Agents|respiratory system agents|mesh-ancestor
101885868|NCT05804123|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101885869|NCT05804123|Antioxidants|antioxidants|mesh-ancestor
101885870|NCT05804123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885871|NCT05804123|Protective Agents|protective agents|mesh-ancestor
101885872|NCT05804123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885874|NCT05804123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101885875|NCT05804123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101885876|NCT05804123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101885877|NCT05804123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101885878|NCT05804123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101885879|NCT05804123|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101885880|NCT05804123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101885881|NCT05804123|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101885882|NCT05804123|Nasal Decongestants|nasal decongestants|mesh-ancestor
101885883|NCT05804123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101885884|NCT05803148|Midodrine|midodrine|mesh-list
101885885|NCT05803148|Sympathomimetics|sympathomimetics|mesh-ancestor
101885886|NCT05803148|Autonomic Agents|autonomic agents|mesh-ancestor
101885887|NCT05803148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101885888|NCT05803148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885889|NCT05803148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101885890|NCT05803148|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101885891|NCT05803148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101885892|NCT05803148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101885893|NCT05803148|Adrenergic Agents|adrenergic agents|mesh-ancestor
101885894|NCT05803148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101885895|NCT05803148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885896|NCT05802849|Acetazolamide|acetazolamide|mesh-list
101885897|NCT05802849|Anticonvulsants|anticonvulsants|mesh-ancestor
101885898|NCT05802849|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101885899|NCT05802849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101885900|NCT05802849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885901|NCT05802849|Diuretics|diuretics|mesh-ancestor
101885902|NCT05802849|Natriuretic Agents|natriuretic agents|mesh-ancestor
101885903|NCT05802849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885904|NCT05785832|Insulin|insulin|mesh-list
101885905|NCT05785832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101885906|NCT05785832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885907|NCT05773664|Dexamethasone|dexamethasone|mesh-list
101885908|NCT05773664|Dexamethasone acetate|dexamethasone acetate|mesh-list
101885909|NCT05773664|Ichthammol|ichthammol|mesh-list
101885910|NCT05773664|BB 1101|bb 1101|mesh-list
101885911|NCT05773664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101885912|NCT05773664|Antiemetics|antiemetics|mesh-ancestor
101885913|NCT05773664|Autonomic Agents|autonomic agents|mesh-ancestor
101885914|NCT05773664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101885915|NCT05773664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885916|NCT05773664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101885917|NCT05773664|Glucocorticoids|glucocorticoids|mesh-ancestor
101885918|NCT05773664|Hormones|hormones|mesh-ancestor
101885919|NCT05773664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101885920|NCT05773664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101885921|NCT05773664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101885922|NCT05773664|Protease Inhibitors|protease inhibitors|mesh-ancestor
101885923|NCT05773664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101885924|NCT05773664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885925|NCT05773664|Dermatologic Agents|dermatologic agents|mesh-ancestor
101885926|NCT05769309|Fentanyl|fentanyl|mesh-list
101885927|NCT05769309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101885928|NCT05769309|Narcotics|narcotics|mesh-ancestor
101885929|NCT05769309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101885930|NCT05769309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885931|NCT05769309|Analgesics|analgesics|mesh-ancestor
101885932|NCT05769309|Sensory System Agents|sensory system agents|mesh-ancestor
101885933|NCT05769309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101885934|NCT05769309|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101885935|NCT05769309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101885936|NCT05769309|Anesthetics, General|anesthetics, general|mesh-ancestor
101885938|NCT05748366|Analgesics|analgesics|mesh-list
101885939|NCT05748366|Sensory System Agents|sensory system agents|mesh-ancestor
101885940|NCT05748366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101885941|NCT05748366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885942|NCT05738161|Cisplatin|cisplatin|mesh-list
101885943|NCT05738161|Gemcitabine|gemcitabine|mesh-list
101885944|NCT05738161|Magrolimab|magrolimab|mesh-list
101885945|NCT05738161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101885946|NCT05738161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101885947|NCT05738161|Antimetabolites|antimetabolites|mesh-ancestor
101885948|NCT05738161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885949|NCT05738161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101885950|NCT05732701|Oxymetazoline|oxymetazoline|mesh-list
101885951|NCT05732701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101885952|NCT05732701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101885953|NCT05732701|Adrenergic Agents|adrenergic agents|mesh-ancestor
101885954|NCT05732701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101885955|NCT05732701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456113|NCT04667299|Antacids|antacids|mesh-ancestor
101885956|NCT05732701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885957|NCT05732701|Sympathomimetics|sympathomimetics|mesh-ancestor
101885958|NCT05732701|Autonomic Agents|autonomic agents|mesh-ancestor
101885959|NCT05732701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101885960|NCT05732701|Nasal Decongestants|nasal decongestants|mesh-ancestor
101885961|NCT05732701|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101885962|NCT05732701|Respiratory System Agents|respiratory system agents|mesh-ancestor
101885963|NCT05723055|Nivolumab|nivolumab|mesh-list
101885964|NCT05723055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101885965|NCT05723055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101885966|NCT05723055|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101885967|NCT05723055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885968|NCT05709977|Histamine Antagonists|histamine antagonists|mesh-list
101885969|NCT05709977|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
101885971|NCT05709977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101885972|NCT05709977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885973|NCT05709977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101885974|NCT05709821|Pembrolizumab|pembrolizumab|mesh-list
101885975|NCT05709821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101885976|NCT05709821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101885977|NCT05709821|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101885978|NCT05709821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885979|NCT05705804|Atorvastatin|atorvastatin|mesh-list
101885980|NCT05705804|Pitavastatin|pitavastatin|mesh-list
101885981|NCT05705804|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101885982|NCT05705804|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101885983|NCT05705804|Antimetabolites|antimetabolites|mesh-ancestor
101885984|NCT05705804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101885985|NCT05705804|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101885986|NCT05705804|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101885987|NCT05705804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101885988|NCT05703659|Sulfalene|sulfalene|mesh-list
101885989|NCT05703659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101885990|NCT05703659|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101885991|NCT05703659|Antimalarials|antimalarials|mesh-ancestor
101885992|NCT05703659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101885993|NCT05703659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101885994|NCT05701189|Immunoglobulins|immunoglobulins|mesh-list
101885995|NCT05701189|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101885996|NCT05701189|Antibodies|antibodies|mesh-list
101885997|NCT05701189|gamma-Globulins|gamma-globulins|mesh-list
101885998|NCT05701189|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101885999|NCT05701189|Immunologic Factors|immunologic factors|mesh-ancestor
101886000|NCT05701189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886001|NCT05691491|Temozolomide|temozolomide|mesh-list
101886002|NCT05691491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101886027|NCT05636787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101886029|NCT05636787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886030|NCT05636787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101886031|NCT05636787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101886032|NCT05636787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101886033|NCT05636787|Immunologic Factors|immunologic factors|mesh-ancestor
101886034|NCT05636787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886035|NCT05635162|Rituximab|rituximab|mesh-list
101886036|NCT05635162|Zanubrutinib|zanubrutinib|mesh-list
101886037|NCT05635162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101886038|NCT05635162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101886039|NCT05635162|Immunologic Factors|immunologic factors|mesh-ancestor
101886040|NCT05635162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886041|NCT05635162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101886042|NCT05635162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101886043|NCT05635162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101886044|NCT05635162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886045|NCT05631912|Cyclophosphamide|cyclophosphamide|mesh-list
101886046|NCT05631912|Fludarabine|fludarabine|mesh-list
101886047|NCT05631912|Fludarabine phosphate|fludarabine phosphate|mesh-list
101886048|NCT05631912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101886049|NCT05631912|Immunologic Factors|immunologic factors|mesh-ancestor
101886050|NCT05631912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886051|NCT05631912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101886052|NCT05631912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101886053|NCT05631912|Alkylating Agents|alkylating agents|mesh-ancestor
101886054|NCT05631912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886055|NCT05631912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101886056|NCT05631912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101886057|NCT05631912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101886058|NCT05631912|Antimetabolites|antimetabolites|mesh-ancestor
101886059|NCT05627557|Acetaminophen|acetaminophen|mesh-list
101886060|NCT05627557|Diphenhydramine|diphenhydramine|mesh-list
101886061|NCT05627557|Promethazine|promethazine|mesh-list
101886062|NCT05627557|Prednisone|prednisone|mesh-list
101886063|NCT05627557|Methylprednisolone|methylprednisolone|mesh-list
101886064|NCT05627557|Obinutuzumab|obinutuzumab|mesh-list
101886065|NCT05627557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101886066|NCT05627557|Glucocorticoids|glucocorticoids|mesh-ancestor
101886068|NCT05627557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101886069|NCT05627557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886070|NCT05627557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101886071|NCT05627557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101886072|NCT05627557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101886073|NCT05627557|Analgesics|analgesics|mesh-ancestor
101886074|NCT05627557|Sensory System Agents|sensory system agents|mesh-ancestor
101886075|NCT05627557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101886076|NCT05627557|Antipyretics|antipyretics|mesh-ancestor
101886077|NCT05627557|Antiemetics|antiemetics|mesh-ancestor
101886078|NCT05627557|Autonomic Agents|autonomic agents|mesh-ancestor
101886079|NCT05627557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101886080|NCT05627557|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101886081|NCT05627557|Protective Agents|protective agents|mesh-ancestor
101886082|NCT05627557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101886083|NCT05627557|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101886084|NCT05627557|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101886085|NCT05627557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101886086|NCT05627557|Anesthetics, Local|anesthetics, local|mesh-ancestor
101886087|NCT05627557|Anesthetics|anesthetics|mesh-ancestor
101886088|NCT05627557|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101886089|NCT05627557|Histamine Antagonists|histamine antagonists|mesh-ancestor
101886090|NCT05627557|Histamine Agents|histamine agents|mesh-ancestor
101886091|NCT05627557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101886092|NCT05627557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886093|NCT05627557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101886094|NCT05627557|Antipruritics|antipruritics|mesh-ancestor
101605895|NCT02658760|Analgesics|analgesics|mesh-ancestor
101886095|NCT05627557|Dermatologic Agents|dermatologic agents|mesh-ancestor
101886096|NCT05623059|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101886097|NCT05623059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101886098|NCT05623059|Immunologic Factors|immunologic factors|mesh-ancestor
101886099|NCT05623059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886100|NCT05615948|Ketamine|ketamine|mesh-list
101886101|NCT05615948|Analgesics|analgesics|mesh-ancestor
101886102|NCT05615948|Sensory System Agents|sensory system agents|mesh-ancestor
101886103|NCT05615948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101886104|NCT05615948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886105|NCT05615948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886106|NCT05615948|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101886107|NCT05615948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101886108|NCT05615948|Anesthetics, General|anesthetics, general|mesh-ancestor
101886109|NCT05615948|Anesthetics|anesthetics|mesh-ancestor
101886110|NCT05615948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101886111|NCT05615948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101886112|NCT05615948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101886113|NCT05615948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101886114|NCT05614349|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
101886115|NCT05614349|Antiviral Agents|antiviral agents|mesh-ancestor
101886116|NCT05614349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101886117|NCT05609630|Upadacitinib|upadacitinib|mesh-list
101886118|NCT05609630|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101886119|NCT05609630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101886120|NCT05609630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101886121|NCT05609630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886122|NCT05609630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101886123|NCT05595460|Carboplatin|carboplatin|mesh-list
101886124|NCT05595460|Etoposide|etoposide|mesh-list
101886125|NCT05595460|Atezolizumab|atezolizumab|mesh-list
101886126|NCT05595460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101886127|NCT05595460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101886128|NCT05595460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101886129|NCT05595460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101886130|NCT05595460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101886131|NCT05595460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886132|NCT05595460|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101886133|NCT05595460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101886134|NCT05594667|Psilocybin|psilocybin|mesh-list
101886135|NCT05594667|Hallucinogens|hallucinogens|mesh-ancestor
101886136|NCT05594667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886138|NCT05590377|Daratumumab|daratumumab|mesh-list
101886139|NCT05590377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101886140|NCT05589818|Pembrolizumab|pembrolizumab|mesh-list
101886141|NCT05589818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101886142|NCT05589818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101886143|NCT05589818|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101886144|NCT05589818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886145|NCT05586360|Simvastatin|simvastatin|mesh-list
101886146|NCT05586360|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101886147|NCT05586360|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101886148|NCT05586360|Antimetabolites|antimetabolites|mesh-ancestor
101886149|NCT05586360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886150|NCT05586360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101886151|NCT05586360|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101886152|NCT05586360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101886153|NCT05583474|Carteolol|carteolol|mesh-list
101886154|NCT05583474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101886155|NCT05583474|Latanoprost|latanoprost|mesh-list
101886156|NCT05583474|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101886157|NCT05583474|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101886158|NCT05583474|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101886159|NCT05583474|Adrenergic Agents|adrenergic agents|mesh-ancestor
101886160|NCT05583474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101886161|NCT05583474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886162|NCT05583474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886163|NCT05583474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101886164|NCT05583474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101886165|NCT05583474|Sympatholytics|sympatholytics|mesh-ancestor
101886166|NCT05583474|Autonomic Agents|autonomic agents|mesh-ancestor
101886167|NCT05583474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101886168|NCT05573360|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101886169|NCT05573360|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101605971|NCT04477486|Venetoclax|venetoclax|mesh-list
101886173|NCT05545072|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101886174|NCT05545072|Immunologic Factors|immunologic factors|mesh-ancestor
101886175|NCT05545072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886179|NCT05542615|Pirfenidone|pirfenidone|mesh-list
101886180|NCT05542615|Analgesics|analgesics|mesh-ancestor
101886181|NCT05542615|Sensory System Agents|sensory system agents|mesh-ancestor
101886182|NCT05542615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101886183|NCT05542615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689406|NCT00651300|Analgesics|analgesics|mesh-ancestor
101886185|NCT05542615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101886186|NCT05542615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101886187|NCT05542615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101886188|NCT05542615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101886189|NCT05532163|Natalizumab|natalizumab|mesh-list
101886190|NCT05532163|Immunologic Factors|immunologic factors|mesh-ancestor
101886191|NCT05532163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886192|NCT05510141|Nitrous Oxide|nitrous oxide|mesh-list
101886193|NCT05510141|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101886194|NCT05510141|Anesthetics, General|anesthetics, general|mesh-ancestor
101886195|NCT05510141|Anesthetics|anesthetics|mesh-ancestor
101968477|NCT00004124|Prednisone|prednisone|mesh-list
101886196|NCT05510141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101886197|NCT05510141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886198|NCT05510141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101886199|NCT05510141|Analgesics|analgesics|mesh-ancestor
101886200|NCT05510141|Sensory System Agents|sensory system agents|mesh-ancestor
101886201|NCT05510141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101886202|NCT05509634|Dexamethasone|dexamethasone|mesh-list
101886203|NCT05509634|Dexamethasone acetate|dexamethasone acetate|mesh-list
101886204|NCT05509634|Palonosetron|palonosetron|mesh-list
101886205|NCT05509634|Fosaprepitant|fosaprepitant|mesh-list
101886206|NCT05509634|Aprepitant|aprepitant|mesh-list
101886207|NCT05509634|BB 1101|bb 1101|mesh-list
101886208|NCT05509634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101886209|NCT05509634|Antiemetics|antiemetics|mesh-ancestor
101886210|NCT05509634|Autonomic Agents|autonomic agents|mesh-ancestor
101886211|NCT05509634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101886212|NCT05509634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886213|NCT05509634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101886214|NCT05509634|Glucocorticoids|glucocorticoids|mesh-ancestor
101886215|NCT05509634|Hormones|hormones|mesh-ancestor
101886216|NCT05509634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101886217|NCT05509634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101886218|NCT05509634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101886219|NCT05509634|Protease Inhibitors|protease inhibitors|mesh-ancestor
101886220|NCT05509634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101886221|NCT05509634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886222|NCT05509634|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101886223|NCT05509634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101886224|NCT05509634|Serotonin Agents|serotonin agents|mesh-ancestor
101886225|NCT05509634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101886226|NCT05509634|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101886227|NCT05502315|Nivolumab|nivolumab|mesh-list
101886228|NCT05502315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101886229|NCT05502315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101886230|NCT05502315|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101456188|NCT04720833|Vitamin D|vitamin d|mesh-list
101886231|NCT05502315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886232|NCT05501600|Lidocaine|lidocaine|mesh-list
101886233|NCT05501600|Anesthetics, Local|anesthetics, local|mesh-ancestor
101886234|NCT05501600|Anesthetics|anesthetics|mesh-ancestor
101886235|NCT05501600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101886236|NCT05501600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886237|NCT05501600|Sensory System Agents|sensory system agents|mesh-ancestor
101886238|NCT05501600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101886239|NCT05501600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101886240|NCT05501600|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101886241|NCT05501600|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101886242|NCT05501600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101886243|NCT05501600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606046|NCT02658214|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101886245|NCT05501548|Olaparib|olaparib|mesh-list
101886246|NCT05501548|Vitamins|vitamins|mesh-ancestor
101886247|NCT05501548|Micronutrients|micronutrients|mesh-ancestor
101886248|NCT05501548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886249|NCT05501548|Antioxidants|antioxidants|mesh-ancestor
101886250|NCT05501548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886251|NCT05501548|Protective Agents|protective agents|mesh-ancestor
101886252|NCT05501548|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101886253|NCT05501548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101886254|NCT05501548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101886255|NCT05498155|Durvalumab|durvalumab|mesh-list
101886257|NCT05498155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101886258|NCT05498155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101886259|NCT05498155|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101886260|NCT05498155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101886261|NCT05498155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886263|NCT05488405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101886264|NCT05488405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101886265|NCT05488405|Analgesics|analgesics|mesh-ancestor
101886266|NCT05488405|Sensory System Agents|sensory system agents|mesh-ancestor
101886267|NCT05488405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101886268|NCT05488405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886269|NCT05488405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101886270|NCT05488405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101886271|NCT05457933|Dapagliflozin|dapagliflozin|mesh-list
101886272|NCT05457933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101886273|NCT05457933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886274|NCT05457933|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101886275|NCT05457933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886276|NCT05455424|Niraparib|niraparib|mesh-list
101886277|NCT05455424|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101886278|NCT05455424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101886279|NCT05455424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886280|NCT05455424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101886281|NCT05444543|Fluticasone|fluticasone|mesh-list
101886282|NCT05444543|Xhance|xhance|mesh-list
101886283|NCT05444543|Budesonide|budesonide|mesh-list
101886284|NCT05444543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101886285|NCT05444543|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101886286|NCT05444543|Autonomic Agents|autonomic agents|mesh-ancestor
101886287|NCT05444543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101886288|NCT05444543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886289|NCT05444543|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101886290|NCT05444543|Respiratory System Agents|respiratory system agents|mesh-ancestor
101886291|NCT05444543|Dermatologic Agents|dermatologic agents|mesh-ancestor
101886292|NCT05444543|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101886293|NCT05444543|Glucocorticoids|glucocorticoids|mesh-ancestor
101886294|NCT05444543|Hormones|hormones|mesh-ancestor
101886295|NCT05444543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101886296|NCT05443971|Durvalumab|durvalumab|mesh-list
101886297|NCT05443971|Immunoglobulins|immunoglobulins|mesh-list
101886298|NCT05443971|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101886299|NCT05443971|Immunoglobulin G|immunoglobulin g|mesh-list
101968530|NCT01335074|Sirolimus|sirolimus|mesh-list
101886300|NCT05443971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101886301|NCT05443971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101886302|NCT05443971|Immunologic Factors|immunologic factors|mesh-ancestor
101886303|NCT05443971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886304|NCT05437575|Fentanyl|fentanyl|mesh-list
101886305|NCT05437575|Ketamine|ketamine|mesh-list
101886306|NCT05437575|Analgesics|analgesics|mesh-ancestor
101886307|NCT05437575|Sensory System Agents|sensory system agents|mesh-ancestor
101886308|NCT05437575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101886309|NCT05437575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886310|NCT05437575|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101886311|NCT05437575|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101886312|NCT05437575|Anesthetics, General|anesthetics, general|mesh-ancestor
101886313|NCT05437575|Anesthetics|anesthetics|mesh-ancestor
101886314|NCT05437575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101886315|NCT05437575|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101886316|NCT05437575|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101606126|NCT00649636|Fluoxetine|fluoxetine|mesh-list
101886317|NCT05437575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101886318|NCT05437575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886319|NCT05437575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101886321|NCT05437575|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101886322|NCT05431270|Antibodies|antibodies|mesh-list
101886323|NCT05431270|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101886324|NCT05431270|Immunologic Factors|immunologic factors|mesh-ancestor
101886325|NCT05431270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886326|NCT05421741|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101886327|NCT05421741|Vancomycin|vancomycin|mesh-list
101886328|NCT05421741|Gentamicins|gentamicins|mesh-list
101886329|NCT05421741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101886330|NCT05421741|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101886331|NCT05421741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101886332|NCT05421741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886333|NCT05416658|Antipsychotic Agents|antipsychotic agents|mesh-list
101886334|NCT05416658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101886335|NCT05416658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101886336|NCT05416658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886337|NCT05416658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101886339|NCT05416021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101886340|NCT05416021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101886341|NCT05416021|Antiviral Agents|antiviral agents|mesh-ancestor
101886342|NCT05416021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101886343|NCT05393271|Midazolam|midazolam|mesh-list
101886344|NCT05393271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101886345|NCT05393271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101886346|NCT05393271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101886347|NCT05393271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886348|NCT05393271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101886349|NCT05393271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101886350|NCT05393271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101886351|NCT05393271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101886352|NCT05393271|Anesthetics, General|anesthetics, general|mesh-ancestor
101886353|NCT05393271|Anesthetics|anesthetics|mesh-ancestor
101886354|NCT05393271|GABA Modulators|gaba modulators|mesh-ancestor
101886355|NCT05393271|GABA Agents|gaba agents|mesh-ancestor
101886356|NCT05393271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101886357|NCT05393271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886358|NCT05388487|Complement Factor H|complement factor h|mesh-list
101886359|NCT05388487|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101886360|NCT05388487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101886361|NCT05388487|Immunologic Factors|immunologic factors|mesh-ancestor
101886362|NCT05388487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886363|NCT05388058|Cannabidiol|cannabidiol|mesh-list
101886364|NCT05388058|Anticonvulsants|anticonvulsants|mesh-ancestor
101886365|NCT05374525|Cabotegravir|cabotegravir|mesh-list
101886366|NCT05374525|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101886367|NCT05374525|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101886368|NCT05374525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101886369|NCT05374525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886370|NCT05374525|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101886371|NCT05374525|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101886372|NCT05374525|Antiviral Agents|antiviral agents|mesh-ancestor
101333061|NCT00001118|Enfuvirtide|enfuvirtide|mesh-list
101886468|NCT05296837|Antimalarials|antimalarials|mesh-ancestor
101886469|NCT05296837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101886470|NCT05296837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101886471|NCT05291130|Vitamin E|vitamin e|mesh-list
101886472|NCT05291130|Vitamins|vitamins|mesh-ancestor
101886473|NCT05291130|Micronutrients|micronutrients|mesh-ancestor
101886474|NCT05291130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886475|NCT05291130|Antioxidants|antioxidants|mesh-ancestor
101886476|NCT05291130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886477|NCT05291130|Protective Agents|protective agents|mesh-ancestor
101886479|NCT05280769|Nicotine|nicotine|mesh-list
101886480|NCT05280769|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101886481|NCT05280769|Autonomic Agents|autonomic agents|mesh-ancestor
101886482|NCT05280769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101886483|NCT05280769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886484|NCT05280769|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101886485|NCT05280769|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101886487|NCT05280769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101886488|NCT05280769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886489|NCT05280769|Respiratory System Agents|respiratory system agents|mesh-ancestor
101886490|NCT05259722|Alitretinoin|alitretinoin|mesh-list
101886491|NCT05259722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101886492|NCT05259722|Dermatologic Agents|dermatologic agents|mesh-ancestor
101886493|NCT05256745|Paclitaxel|paclitaxel|mesh-list
101886494|NCT05256745|Docetaxel|docetaxel|mesh-list
101886495|NCT05256745|Cyclophosphamide|cyclophosphamide|mesh-list
101886496|NCT05256745|Carboplatin|carboplatin|mesh-list
101886497|NCT05256745|Doxorubicin|doxorubicin|mesh-list
101886498|NCT05256745|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101886499|NCT05256745|Trastuzumab|trastuzumab|mesh-list
101886500|NCT05256745|Pertuzumab|pertuzumab|mesh-list
101886501|NCT05256745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101886502|NCT05256745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101886503|NCT05256745|Tubulin Modulators|tubulin modulators|mesh-ancestor
101886504|NCT05256745|Antimitotic Agents|antimitotic agents|mesh-ancestor
101886505|NCT05256745|Mitosis Modulators|mitosis modulators|mesh-ancestor
101886506|NCT05256745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886507|NCT05256745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101886508|NCT05256745|Immunologic Factors|immunologic factors|mesh-ancestor
101886509|NCT05256745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886510|NCT05256745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101886511|NCT05256745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101886512|NCT05256745|Alkylating Agents|alkylating agents|mesh-ancestor
101886513|NCT05256745|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101886514|NCT05256745|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101886515|NCT05256745|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101886516|NCT05256745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101886517|NCT05256745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101886518|NCT05256745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101886519|NCT05252390|Olaparib|olaparib|mesh-list
101886520|NCT05252390|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101886521|NCT05252390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101886522|NCT05252390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886523|NCT05252390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101886524|NCT05243797|Lenalidomide|lenalidomide|mesh-list
101886525|NCT05243797|Immunologic Factors|immunologic factors|mesh-ancestor
101886526|NCT05243797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886527|NCT05243797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101886528|NCT05243797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101886529|NCT05243797|Growth Substances|growth substances|mesh-ancestor
101886530|NCT05243797|Growth Inhibitors|growth inhibitors|mesh-ancestor
101886531|NCT05243797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101886532|NCT05243342|Daratumumab|daratumumab|mesh-list
101886533|NCT05243342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101886534|NCT05219513|Obinutuzumab|obinutuzumab|mesh-list
101886535|NCT05219513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101886536|NCT05219513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101886537|NCT05206266|Turmeric extract|turmeric extract|mesh-list
101886538|NCT05206266|Antioxidants|antioxidants|mesh-ancestor
101886539|NCT05206266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886540|NCT05206266|Protective Agents|protective agents|mesh-ancestor
101606380|NCT03542266|Cc-486|cc-486|mesh-list
101886541|NCT05206266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886542|NCT05188898|Hyaluronic Acid|hyaluronic acid|mesh-list
101886543|NCT05188898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101886544|NCT05188898|Immunologic Factors|immunologic factors|mesh-ancestor
101886545|NCT05188898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886546|NCT05188898|Viscosupplements|viscosupplements|mesh-ancestor
101886547|NCT05188898|Protective Agents|protective agents|mesh-ancestor
101886548|NCT05169268|Aripiprazole|aripiprazole|mesh-list
101886549|NCT05169268|Brexpiprazole|brexpiprazole|mesh-list
101886550|NCT05169268|Antidepressive Agents|antidepressive agents|mesh-ancestor
101886551|NCT05169268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101886552|NCT05169268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101886553|NCT05169268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101886554|NCT05169268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101886555|NCT05169268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886556|NCT05169268|Dopamine Agonists|dopamine agonists|mesh-ancestor
101886557|NCT05169268|Dopamine Agents|dopamine agents|mesh-ancestor
101886558|NCT05169268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101886559|NCT05169268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886560|NCT05169268|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101886561|NCT05169268|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101886562|NCT05169268|Serotonin Agents|serotonin agents|mesh-ancestor
101886563|NCT05169268|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101886564|NCT05169268|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101886565|NCT05169268|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101886566|NCT05169268|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101886568|NCT05166746|Clindamycin palmitate|clindamycin palmitate|mesh-list
101886569|NCT05166746|Clindamycin phosphate|clindamycin phosphate|mesh-list
101886570|NCT05166746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101886571|NCT05166746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101886572|NCT05166746|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101886573|NCT05166746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101886574|NCT05166746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886575|NCT05160298|Ropivacaine|ropivacaine|mesh-list
101886576|NCT05160298|Anesthetics, Local|anesthetics, local|mesh-ancestor
101886577|NCT05160298|Anesthetics|anesthetics|mesh-ancestor
101886578|NCT05160298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101886579|NCT05160298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886580|NCT05160298|Sensory System Agents|sensory system agents|mesh-ancestor
101886581|NCT05160298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101886582|NCT05155579|Vaccines|vaccines|mesh-list
101886583|NCT05155579|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101886584|NCT05155579|Immunologic Factors|immunologic factors|mesh-ancestor
101886585|NCT05155579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886586|NCT05145400|Dexamethasone|dexamethasone|mesh-list
101886587|NCT05145400|Lenalidomide|lenalidomide|mesh-list
101886588|NCT05145400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101886589|NCT05145400|Antiemetics|antiemetics|mesh-ancestor
101886590|NCT05145400|Autonomic Agents|autonomic agents|mesh-ancestor
101886591|NCT05145400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101886592|NCT05145400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886593|NCT05145400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101886594|NCT05145400|Glucocorticoids|glucocorticoids|mesh-ancestor
101886595|NCT05145400|Hormones|hormones|mesh-ancestor
101886596|NCT05145400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101886597|NCT05145400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101886598|NCT05145400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101886599|NCT05145400|Immunologic Factors|immunologic factors|mesh-ancestor
101886600|NCT05145400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101886601|NCT05145400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101886602|NCT05145400|Growth Substances|growth substances|mesh-ancestor
101886603|NCT05145400|Growth Inhibitors|growth inhibitors|mesh-ancestor
101886604|NCT05143281|Dexamethasone|dexamethasone|mesh-list
101886605|NCT05143281|Dexamethasone acetate|dexamethasone acetate|mesh-list
101886606|NCT05143281|BB 1101|bb 1101|mesh-list
101886607|NCT05143281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101886608|NCT05143281|Antiemetics|antiemetics|mesh-ancestor
101886609|NCT05143281|Autonomic Agents|autonomic agents|mesh-ancestor
101886610|NCT05143281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101886611|NCT05143281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886612|NCT05143281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101886613|NCT05143281|Glucocorticoids|glucocorticoids|mesh-ancestor
101886614|NCT05143281|Hormones|hormones|mesh-ancestor
101886615|NCT05143281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101886616|NCT05143281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101886617|NCT05143281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101886618|NCT05143281|Protease Inhibitors|protease inhibitors|mesh-ancestor
101886619|NCT05143281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101968560|NCT01337804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101886620|NCT05143281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886622|NCT05133297|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101886623|NCT05133297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101886624|NCT05133297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101886625|NCT05133297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886627|NCT05117710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101886628|NCT05117710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101886629|NCT05117710|Analgesics|analgesics|mesh-ancestor
101886630|NCT05117710|Sensory System Agents|sensory system agents|mesh-ancestor
101886631|NCT05117710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101886632|NCT05117710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886633|NCT05117710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101886634|NCT05117710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101886635|NCT05117710|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101886636|NCT05117710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101886637|NCT05117710|Antioxidants|antioxidants|mesh-ancestor
101886638|NCT05117710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886639|NCT05117710|Protective Agents|protective agents|mesh-ancestor
101886640|NCT05117710|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101886641|NCT05117710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101886642|NCT05117710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101886643|NCT05117242|Pembrolizumab|pembrolizumab|mesh-list
101886644|NCT05117242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101886645|NCT05117242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101886646|NCT05117242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101886647|NCT05117242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886652|NCT05114746|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101886653|NCT05114746|177Lu-PSMA-617|177lu-psma-617|mesh-list
101886654|NCT05114746|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101886655|NCT05114746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886656|NCT05106192|Triamcinolone|triamcinolone|mesh-list
101886657|NCT05106192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101886658|NCT05106192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101886659|NCT05106192|Mechlorethamine|mechlorethamine|mesh-list
101886660|NCT05106192|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
101886661|NCT05106192|Bexarotene|bexarotene|mesh-list
101886662|NCT05106192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101886663|NCT05106192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101886664|NCT05106192|Glucocorticoids|glucocorticoids|mesh-ancestor
101886665|NCT05106192|Hormones|hormones|mesh-ancestor
101886666|NCT05106192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101886667|NCT05106192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886668|NCT05106192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101886669|NCT05106192|Immunologic Factors|immunologic factors|mesh-ancestor
101886670|NCT05106192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101886671|NCT05106192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886672|NCT05106192|Alkylating Agents|alkylating agents|mesh-ancestor
101886673|NCT05106192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101886674|NCT05106192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101886675|NCT05105022|Propofol|propofol|mesh-list
101886676|NCT05105022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101886677|NCT05105022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101886678|NCT05105022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886679|NCT05105022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101886680|NCT05105022|Anesthetics, General|anesthetics, general|mesh-ancestor
101886681|NCT05105022|Anesthetics|anesthetics|mesh-ancestor
101886682|NCT05103605|Osimertinib|osimertinib|mesh-list
101886683|NCT05103605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101886684|NCT05103605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101886685|NCT05103605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101886686|NCT05103605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886687|NCT05099718|Hyaluronic Acid|hyaluronic acid|mesh-list
101886688|NCT05099718|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101886689|NCT05099718|Immunologic Factors|immunologic factors|mesh-ancestor
101886690|NCT05099718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886691|NCT05099718|Viscosupplements|viscosupplements|mesh-ancestor
101886692|NCT05099718|Protective Agents|protective agents|mesh-ancestor
101886694|NCT05096468|Ketamine|ketamine|mesh-list
101886695|NCT05096468|Esketamine|esketamine|mesh-list
101886696|NCT05096468|Analgesics|analgesics|mesh-ancestor
101886697|NCT05096468|Sensory System Agents|sensory system agents|mesh-ancestor
101886698|NCT05096468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101886699|NCT05096468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886700|NCT05096468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101886701|NCT05096468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101886702|NCT05096468|Anesthetics, General|anesthetics, general|mesh-ancestor
101886703|NCT05096468|Anesthetics|anesthetics|mesh-ancestor
101886704|NCT05096468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101886705|NCT05096468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101886706|NCT05096468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101886707|NCT05096468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101886708|NCT05096468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886709|NCT05096468|Anticonvulsants|anticonvulsants|mesh-ancestor
101886710|NCT05096468|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101886711|NCT05096468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101886712|NCT05096468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101886713|NCT05096468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101886714|NCT05096468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101886715|NCT05096468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101886716|NCT05096468|Antidepressive Agents|antidepressive agents|mesh-ancestor
101886717|NCT05085028|Pembrolizumab|pembrolizumab|mesh-list
101886718|NCT05085028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101886719|NCT05085028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101886720|NCT05085028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101886721|NCT05085028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886722|NCT05084365|Sulforaphane|sulforaphane|mesh-list
101886723|NCT05084365|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101886724|NCT05084365|Protective Agents|protective agents|mesh-ancestor
101886725|NCT05084365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886726|NCT05084365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101886727|NCT05081180|Lenvatinib|lenvatinib|mesh-list
101886728|NCT05081180|Avelumab|avelumab|mesh-list
101886729|NCT05081180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101886730|NCT05081180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101886731|NCT05081180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101886732|NCT05081180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886733|NCT05081180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101886734|NCT05079789|Amiloride|amiloride|mesh-list
101886735|NCT05079789|Furosemide|furosemide|mesh-list
101886736|NCT05079789|Diuretics|diuretics|mesh-ancestor
101886737|NCT05079789|Natriuretic Agents|natriuretic agents|mesh-ancestor
101886738|NCT05079789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886739|NCT05079789|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101886740|NCT05079789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101886741|NCT05079789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886742|NCT05079789|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
101886743|NCT05079789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101886744|NCT05079789|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101886745|NCT05079789|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101886746|NCT05056727|Valsartan|valsartan|mesh-list
101886747|NCT05056727|Lisinopril|lisinopril|mesh-list
101886748|NCT05056727|Irbesartan|irbesartan|mesh-list
101886749|NCT05056727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101886750|NCT05056727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101886751|NCT05056727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101886752|NCT05056727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886753|NCT05056727|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101886754|NCT05056727|Protease Inhibitors|protease inhibitors|mesh-ancestor
101886755|NCT05056727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101886756|NCT05056727|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101886757|NCT05056727|Protective Agents|protective agents|mesh-ancestor
101886758|NCT05056727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886759|NCT05028569|Botulinum Toxins|botulinum toxins|mesh-list
101886760|NCT05028569|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101886761|NCT05028569|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101886762|NCT05028569|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101886763|NCT05028569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101689427|NCT00621998|Antiemetics|antiemetics|mesh-ancestor
101968568|NCT01776424|Sensory System Agents|sensory system agents|mesh-ancestor
101886764|NCT05028569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886765|NCT05028569|Cholinergic Agents|cholinergic agents|mesh-ancestor
101886766|NCT05028569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101886767|NCT05028569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886768|NCT05028569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101886769|NCT05028569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101886771|NCT05025423|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101886772|NCT05025423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101886773|NCT05025423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101886774|NCT05025423|Alkylating Agents|alkylating agents|mesh-ancestor
101886775|NCT05025423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886776|NCT05023993|Niacinamide|niacinamide|mesh-list
101886777|NCT05023993|Niacin|niacin|mesh-list
101886778|NCT05023993|Nicotinic Acids|nicotinic acids|mesh-list
101886779|NCT05023993|Vitamin B Complex|vitamin b complex|mesh-ancestor
101886780|NCT05023993|Vitamins|vitamins|mesh-ancestor
101886781|NCT05023993|Micronutrients|micronutrients|mesh-ancestor
101886782|NCT05023993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886783|NCT05023993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101886784|NCT05023993|Antimetabolites|antimetabolites|mesh-ancestor
101886785|NCT05023993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886786|NCT05023993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101886787|NCT05023993|Vasodilator Agents|vasodilator agents|mesh-ancestor
101886788|NCT05021926|Lidocaine|lidocaine|mesh-list
101886789|NCT05021926|Hyaluronic Acid|hyaluronic acid|mesh-list
101886790|NCT05021926|Anesthetics, Local|anesthetics, local|mesh-ancestor
101886791|NCT05021926|Anesthetics|anesthetics|mesh-ancestor
101886792|NCT05021926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101886793|NCT05021926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886794|NCT05021926|Sensory System Agents|sensory system agents|mesh-ancestor
101886795|NCT05021926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101886796|NCT05021926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101886797|NCT05021926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101886798|NCT05021926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101886799|NCT05021926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101886800|NCT05021926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886801|NCT05021926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101886802|NCT05021926|Immunologic Factors|immunologic factors|mesh-ancestor
101886803|NCT05021926|Viscosupplements|viscosupplements|mesh-ancestor
101886804|NCT05021926|Protective Agents|protective agents|mesh-ancestor
101886805|NCT05021913|Lidocaine|lidocaine|mesh-list
101886806|NCT05021913|Hyaluronic Acid|hyaluronic acid|mesh-list
101886807|NCT05021913|Anesthetics, Local|anesthetics, local|mesh-ancestor
101886808|NCT05021913|Anesthetics|anesthetics|mesh-ancestor
101886809|NCT05021913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101886810|NCT05021913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886811|NCT05021913|Sensory System Agents|sensory system agents|mesh-ancestor
101886812|NCT05021913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101886813|NCT05021913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101886814|NCT05021913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101886815|NCT05021913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101886816|NCT05021913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101886817|NCT05021913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886818|NCT05021913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101886819|NCT05021913|Immunologic Factors|immunologic factors|mesh-ancestor
101886820|NCT05021913|Viscosupplements|viscosupplements|mesh-ancestor
101886821|NCT05021913|Protective Agents|protective agents|mesh-ancestor
101886822|NCT04999241|Infliximab|infliximab|mesh-list
101886823|NCT04999241|Mesalamine|mesalamine|mesh-list
101886824|NCT04999241|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101886825|NCT04999241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101886826|NCT04999241|Dermatologic Agents|dermatologic agents|mesh-ancestor
101886827|NCT04999241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101886828|NCT04999241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101968579|NCT01776424|Antipyretics|antipyretics|mesh-ancestor
101886829|NCT04999241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101886830|NCT04999241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101886832|NCT04999241|Sensory System Agents|sensory system agents|mesh-ancestor
101886833|NCT04999241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101886834|NCT04999241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886835|NCT04997993|Leflunomide|leflunomide|mesh-list
101886836|NCT04997993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101886837|NCT04997993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886838|NCT04997993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101886839|NCT04997993|Immunologic Factors|immunologic factors|mesh-ancestor
101886840|NCT04997993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886841|NCT04992065|Evolocumab|evolocumab|mesh-list
101886842|NCT04992065|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101886843|NCT04992065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101886844|NCT04992065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101886845|NCT04992065|Antimetabolites|antimetabolites|mesh-ancestor
101886846|NCT04992065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886847|NCT04992065|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101886848|NCT04992065|Protease Inhibitors|protease inhibitors|mesh-ancestor
101886849|NCT04992065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101886850|NCT04992065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101886851|NCT04965090|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
101886852|NCT04965090|Lazertinib|lazertinib|mesh-list
101886853|NCT04965090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101886854|NCT04965090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101886855|NCT04965090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886856|NCT04965090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101886857|NCT04965090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101886858|NCT04941287|Atezolizumab|atezolizumab|mesh-list
101886859|NCT04941287|Immunoglobulins|immunoglobulins|mesh-list
101886860|NCT04941287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101886861|NCT04941287|Immunoglobulin G|immunoglobulin g|mesh-list
101886862|NCT04941287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101886863|NCT04941287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886864|NCT04941287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101886865|NCT04941287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101886866|NCT04941287|Immunologic Factors|immunologic factors|mesh-ancestor
101886867|NCT04941287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886868|NCT04916548|Ketamine|ketamine|mesh-list
101886869|NCT04916548|Analgesics|analgesics|mesh-ancestor
101886870|NCT04916548|Sensory System Agents|sensory system agents|mesh-ancestor
101886871|NCT04916548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101886872|NCT04916548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886873|NCT04916548|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101886874|NCT04916548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101886875|NCT04916548|Anesthetics, General|anesthetics, general|mesh-ancestor
101886876|NCT04916548|Anesthetics|anesthetics|mesh-ancestor
101886877|NCT04916548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101886878|NCT04916548|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101886879|NCT04916548|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101886880|NCT04916548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101886881|NCT04916548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886882|NCT04906902|Acalabrutinib|acalabrutinib|mesh-list
101886883|NCT04906902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101886884|NCT04906096|GDC-0084|gdc-0084|mesh-list
101886885|NCT04906096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101886886|NCT04906096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886887|NCT04901494|Serotonin|serotonin|mesh-list
101886888|NCT04901494|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
101886889|NCT04901494|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101886890|NCT04901494|Serotonin Agents|serotonin agents|mesh-ancestor
101886891|NCT04901494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101886892|NCT04901494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886893|NCT04901494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886894|NCT04901494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101886895|NCT04901494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101886896|NCT04898114|Magnesium Sulfate|magnesium sulfate|mesh-list
101886897|NCT04898114|Sildenafil Citrate|sildenafil citrate|mesh-list
101886898|NCT04898114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886899|NCT04898114|Vasodilator Agents|vasodilator agents|mesh-ancestor
101886900|NCT04898114|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101886901|NCT04898114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101886902|NCT04898114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101886903|NCT04898114|Urological Agents|urological agents|mesh-ancestor
101886904|NCT04898114|Analgesics|analgesics|mesh-ancestor
101886905|NCT04898114|Sensory System Agents|sensory system agents|mesh-ancestor
101886906|NCT04898114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101886907|NCT04898114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886909|NCT04898114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101886910|NCT04898114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101886911|NCT04898114|Anticonvulsants|anticonvulsants|mesh-ancestor
101886912|NCT04898114|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101606717|NCT00826267|Trastuzumab|trastuzumab|mesh-list
101886913|NCT04898114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101886914|NCT04898114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101886915|NCT04898114|Tocolytic Agents|tocolytic agents|mesh-ancestor
101886916|NCT04898114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101886917|NCT04897217|Megestrol|megestrol|mesh-list
101886918|NCT04897217|Megestrol Acetate|megestrol acetate|mesh-list
101886919|NCT04897217|Levonorgestrel|levonorgestrel|mesh-list
101886920|NCT04897217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101886921|NCT04897217|Contraceptive Agents|contraceptive agents|mesh-ancestor
101886922|NCT04897217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101886923|NCT04897217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886924|NCT04897217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101886925|NCT04897217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101886926|NCT04897217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101886927|NCT04897217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101886928|NCT04897217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101886929|NCT04897217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101886930|NCT04897217|Appetite Stimulants|appetite stimulants|mesh-ancestor
101886931|NCT04897217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101886932|NCT04897022|Pembrolizumab|pembrolizumab|mesh-list
101886933|NCT04897022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101886934|NCT04897022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101886935|NCT04897022|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101886936|NCT04897022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886937|NCT04873583|Methylprednisolone|methylprednisolone|mesh-list
101886938|NCT04873583|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101886939|NCT04873583|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101886940|NCT04873583|Prednisolone|prednisolone|mesh-list
101886941|NCT04873583|Prednisolone acetate|prednisolone acetate|mesh-list
101886942|NCT04873583|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101886943|NCT04873583|Prednisolone phosphate|prednisolone phosphate|mesh-list
101886944|NCT04873583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101886945|NCT04873583|Antiemetics|antiemetics|mesh-ancestor
101886946|NCT04873583|Autonomic Agents|autonomic agents|mesh-ancestor
101886947|NCT04873583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101886948|NCT04873583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886949|NCT04873583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101886950|NCT04873583|Glucocorticoids|glucocorticoids|mesh-ancestor
101886951|NCT04873583|Hormones|hormones|mesh-ancestor
101886952|NCT04873583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101886953|NCT04873583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101886954|NCT04873583|Protective Agents|protective agents|mesh-ancestor
101886955|NCT04873583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101886956|NCT04873583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101886957|NCT04870203|Adalimumab|adalimumab|mesh-list
101886958|NCT04870203|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101886959|NCT04870203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101886960|NCT04870203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101886961|NCT04867707|Zanamivir|zanamivir|mesh-list
101886962|NCT04867707|Antiviral Agents|antiviral agents|mesh-ancestor
101886963|NCT04867707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101886964|NCT04867707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101886965|NCT04867707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886966|NCT04860661|Esketamine|esketamine|mesh-list
101886967|NCT04860661|Antidepressive Agents|antidepressive agents|mesh-ancestor
101886968|NCT04860661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101886969|NCT04853199|Quercetin|quercetin|mesh-list
101886970|NCT04853199|Antioxidants|antioxidants|mesh-ancestor
101886971|NCT04853199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886972|NCT04853199|Protective Agents|protective agents|mesh-ancestor
101886973|NCT04853199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886974|NCT04804722|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101886975|NCT04804722|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101886976|NCT04804722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101886977|NCT04801485|Inositol|inositol|mesh-list
101886978|NCT04801485|Vitamin B Complex|vitamin b complex|mesh-ancestor
101886979|NCT04801485|Vitamins|vitamins|mesh-ancestor
101886980|NCT04801485|Micronutrients|micronutrients|mesh-ancestor
101886981|NCT04801485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886982|NCT04753970|Cilostazol|cilostazol|mesh-list
101886983|NCT04753970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101886984|NCT04753970|Autonomic Agents|autonomic agents|mesh-ancestor
101886985|NCT04753970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101886986|NCT04753970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101886987|NCT04753970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101606821|NCT00848965|Xhance|xhance|mesh-list
101886998|NCT04753970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101887010|NCT04741204|Metformin|metformin|mesh-list
101887011|NCT04741204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101887012|NCT04741204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887013|NCT04727723|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
101887014|NCT04727723|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101887015|NCT04727723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887016|NCT04725188|Docetaxel|docetaxel|mesh-list
101887017|NCT04725188|Pembrolizumab|pembrolizumab|mesh-list
101887018|NCT04725188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887019|NCT04725188|Tubulin Modulators|tubulin modulators|mesh-ancestor
101887020|NCT04725188|Antimitotic Agents|antimitotic agents|mesh-ancestor
101887021|NCT04725188|Mitosis Modulators|mitosis modulators|mesh-ancestor
101308880|NCT00005970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101887022|NCT04725188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887023|NCT04725188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101887024|NCT04725188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101887025|NCT04723394|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
101887026|NCT04723394|Antiviral Agents|antiviral agents|mesh-ancestor
101887027|NCT04723394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101887028|NCT04722523|Carboplatin|carboplatin|mesh-list
101887029|NCT04722523|Docetaxel|docetaxel|mesh-list
101887030|NCT04722523|Cetuximab|cetuximab|mesh-list
101887031|NCT04722523|Cemiplimab|cemiplimab|mesh-list
101887032|NCT04722523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887033|NCT04722523|Tubulin Modulators|tubulin modulators|mesh-ancestor
101887034|NCT04722523|Antimitotic Agents|antimitotic agents|mesh-ancestor
101887035|NCT04722523|Mitosis Modulators|mitosis modulators|mesh-ancestor
101887036|NCT04722523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887037|NCT04722523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101887038|NCT04718792|Psilocybin|psilocybin|mesh-list
101887039|NCT04718792|Hallucinogens|hallucinogens|mesh-ancestor
101887040|NCT04718792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887041|NCT04718792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101887042|NCT04707196|Fulvestrant|fulvestrant|mesh-list
101887043|NCT04707196|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101887044|NCT04707196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101887045|NCT04707196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887046|NCT04707196|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101887047|NCT04707196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101887048|NCT04707196|Hormone Antagonists|hormone antagonists|mesh-ancestor
101887049|NCT04707196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101887050|NCT04707196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887051|NCT04707196|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101887052|NCT04707196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101887053|NCT04707196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887054|NCT04700527|Butyric Acid|butyric acid|mesh-list
101887055|NCT04700527|Histamine Antagonists|histamine antagonists|mesh-ancestor
101887056|NCT04700527|Histamine Agents|histamine agents|mesh-ancestor
101968595|NCT00642148|Glucocorticoids|glucocorticoids|mesh-ancestor
101887057|NCT04700527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101887058|NCT04700527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887059|NCT04700527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887060|NCT04681144|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
101887061|NCT04681144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887062|NCT04667585|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101887063|NCT04667585|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101887064|NCT04667585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887065|NCT04663750|Aflibercept|aflibercept|mesh-list
101887066|NCT04663750|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101887067|NCT04663750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101887068|NCT04663750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101887069|NCT04663750|Growth Substances|growth substances|mesh-ancestor
101887070|NCT04663750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887071|NCT04663750|Growth Inhibitors|growth inhibitors|mesh-ancestor
101887072|NCT04663750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887073|NCT04663750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101887074|NCT04663750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101887075|NCT04663750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887076|NCT04656145|Chlorhexidine|chlorhexidine|mesh-list
101887077|NCT04656145|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101887078|NCT04656145|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101887079|NCT04656145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101887080|NCT04656145|Disinfectants|disinfectants|mesh-ancestor
101887081|NCT04656145|Dermatologic Agents|dermatologic agents|mesh-ancestor
101887083|NCT04641975|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101887084|NCT04641975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101887085|NCT04641975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101887086|NCT04641975|Adrenergic Agents|adrenergic agents|mesh-ancestor
101887087|NCT04641975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101887088|NCT04641975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887089|NCT04641975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887090|NCT04641975|Urological Agents|urological agents|mesh-ancestor
101887091|NCT04613206|Vaccines|vaccines|mesh-list
101887092|NCT04613206|Immunologic Factors|immunologic factors|mesh-ancestor
101887093|NCT04613206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887094|NCT04590508|Xanthohumol|xanthohumol|mesh-list
101887095|NCT04590508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887096|NCT04590508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101887097|NCT04590508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101887098|NCT04590508|Growth Substances|growth substances|mesh-ancestor
101887099|NCT04590508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887100|NCT04590508|Growth Inhibitors|growth inhibitors|mesh-ancestor
101887101|NCT04572295|Fulvestrant|fulvestrant|mesh-list
101887102|NCT04572295|Exemestane|exemestane|mesh-list
101887103|NCT04572295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101887104|NCT04572295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887105|NCT04572295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101887106|NCT04572295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101887107|NCT04572295|Hormone Antagonists|hormone antagonists|mesh-ancestor
101887108|NCT04572295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101887109|NCT04572295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887110|NCT04572295|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101887111|NCT04572295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101887112|NCT04572295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101887113|NCT04572295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887114|NCT04557527|Hyaluronic Acid|hyaluronic acid|mesh-list
101887115|NCT04557527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101887116|NCT04557527|Immunologic Factors|immunologic factors|mesh-ancestor
101887117|NCT04557527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887118|NCT04557527|Viscosupplements|viscosupplements|mesh-ancestor
101887119|NCT04557527|Protective Agents|protective agents|mesh-ancestor
101887120|NCT04543383|Thrombin|thrombin|mesh-list
101887121|NCT04543383|Hemostatics|hemostatics|mesh-ancestor
101887122|NCT04543383|Coagulants|coagulants|mesh-ancestor
101887123|NCT04539366|Cyclophosphamide|cyclophosphamide|mesh-list
101887124|NCT04539366|Fludarabine|fludarabine|mesh-list
101887125|NCT04539366|Fludarabine phosphate|fludarabine phosphate|mesh-list
101887126|NCT04539366|Immunologic Factors|immunologic factors|mesh-ancestor
101887127|NCT04539366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887128|NCT04539366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101887129|NCT04539366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101887130|NCT04539366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101887131|NCT04539366|Alkylating Agents|alkylating agents|mesh-ancestor
101887132|NCT04539366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887133|NCT04539366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887134|NCT04539366|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101887135|NCT04539366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101606960|NCT02642146|Calcium|calcium|mesh-list
101887136|NCT04539366|Antimetabolites|antimetabolites|mesh-ancestor
101887138|NCT04533880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101887139|NCT04533880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887140|NCT04532606|Anesthetics|anesthetics|mesh-list
101887141|NCT04532606|Propofol|propofol|mesh-list
101887142|NCT04532606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101887143|NCT04532606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887144|NCT04532606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101887145|NCT04532606|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101887146|NCT04532606|Anesthetics, General|anesthetics, general|mesh-ancestor
101887147|NCT04513145|Ropivacaine|ropivacaine|mesh-list
101887148|NCT04513145|Anesthetics, Local|anesthetics, local|mesh-ancestor
101887149|NCT04513145|Anesthetics|anesthetics|mesh-ancestor
101887150|NCT04513145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101887151|NCT04513145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887152|NCT04513145|Sensory System Agents|sensory system agents|mesh-ancestor
101887153|NCT04513145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101887154|NCT04478266|Letrozole|letrozole|mesh-list
101887155|NCT04478266|Palbociclib|palbociclib|mesh-list
101887156|NCT04478266|Goserelin|goserelin|mesh-list
101887157|NCT04478266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887158|NCT04478266|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101887159|NCT04478266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101887160|NCT04478266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101887161|NCT04478266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887162|NCT04478266|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101887163|NCT04478266|Hormone Antagonists|hormone antagonists|mesh-ancestor
101887164|NCT04478266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101887165|NCT04478266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887166|NCT04478266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101887167|NCT04478266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101887168|NCT04466475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101887169|NCT04466475|Melphalan|melphalan|mesh-list
101887170|NCT04466475|Mechlorethamine|mechlorethamine|mesh-list
101887171|NCT04466475|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
101887172|NCT04466475|Daratumumab|daratumumab|mesh-list
101887173|NCT04466475|Antibodies|antibodies|mesh-list
101887174|NCT04466475|Immunoglobulins|immunoglobulins|mesh-list
101887175|NCT04466475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101887176|NCT04466475|Immunologic Factors|immunologic factors|mesh-ancestor
101887177|NCT04466475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887178|NCT04466475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887179|NCT04466475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101887180|NCT04466475|Alkylating Agents|alkylating agents|mesh-ancestor
101887181|NCT04466475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887182|NCT04466475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101887183|NCT04466475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101887184|NCT04460885|Insulin|insulin|mesh-list
101887185|NCT04460885|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101887186|NCT04460885|Insulin Glargine|insulin glargine|mesh-list
101887187|NCT04460885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101887188|NCT04460885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887189|NCT04459715|Cisplatin|cisplatin|mesh-list
101887190|NCT04459715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887191|NCT04418154|Paclitaxel|paclitaxel|mesh-list
101968605|NCT00626704|Doxorubicin|doxorubicin|mesh-list
101887192|NCT04418154|Cyclophosphamide|cyclophosphamide|mesh-list
101887194|NCT04418154|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101887195|NCT04418154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101887196|NCT04418154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887197|NCT04418154|Tubulin Modulators|tubulin modulators|mesh-ancestor
101887198|NCT04418154|Antimitotic Agents|antimitotic agents|mesh-ancestor
101887199|NCT04418154|Mitosis Modulators|mitosis modulators|mesh-ancestor
101887200|NCT04418154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887201|NCT04418154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101887202|NCT04418154|Immunologic Factors|immunologic factors|mesh-ancestor
101887203|NCT04418154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887204|NCT04418154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101887205|NCT04418154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101887206|NCT04418154|Alkylating Agents|alkylating agents|mesh-ancestor
101887207|NCT04418154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101607019|NCT02646592|Narcotics|narcotics|mesh-ancestor
101887208|NCT04418154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101887209|NCT04418154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101887210|NCT04418154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101887211|NCT04418154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101887212|NCT04417192|Pembrolizumab|pembrolizumab|mesh-list
101887213|NCT04417192|Olaparib|olaparib|mesh-list
101887214|NCT04417192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101887215|NCT04417192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887216|NCT04417192|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101887217|NCT04417192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887218|NCT04417192|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101887219|NCT04417192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101887220|NCT04409002|Niraparib|niraparib|mesh-list
101887221|NCT04409002|Dostarlimab|dostarlimab|mesh-list
101887222|NCT04409002|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101887223|NCT04409002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101887224|NCT04409002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887225|NCT04409002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887226|NCT04404361|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
101887227|NCT04404361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101887228|NCT04404361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101887229|NCT04404361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887230|NCT04343885|Docetaxel|docetaxel|mesh-list
101887231|NCT04343885|177Lu-PSMA-617|177lu-psma-617|mesh-list
101887232|NCT04343885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887233|NCT04343885|Tubulin Modulators|tubulin modulators|mesh-ancestor
101887234|NCT04343885|Antimitotic Agents|antimitotic agents|mesh-ancestor
101887235|NCT04343885|Mitosis Modulators|mitosis modulators|mesh-ancestor
101887236|NCT04343885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887237|NCT04343885|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101887238|NCT04338061|Teriflunomide|teriflunomide|mesh-list
101887239|NCT04338061|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101887240|NCT04338061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101887241|NCT04338061|Analgesics|analgesics|mesh-ancestor
101887242|NCT04338061|Sensory System Agents|sensory system agents|mesh-ancestor
101887243|NCT04338061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101887244|NCT04338061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887245|NCT04338061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101887246|NCT04338061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101887247|NCT04338061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101887248|NCT04338061|Immunologic Factors|immunologic factors|mesh-ancestor
101887249|NCT04338022|Teriflunomide|teriflunomide|mesh-list
101887250|NCT04338022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101887251|NCT04338022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101887252|NCT04338022|Analgesics|analgesics|mesh-ancestor
101887253|NCT04338022|Sensory System Agents|sensory system agents|mesh-ancestor
101887254|NCT04338022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101887255|NCT04338022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887256|NCT04338022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101887257|NCT04338022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101887258|NCT04338022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101887259|NCT04338022|Immunologic Factors|immunologic factors|mesh-ancestor
101607093|NCT02884310|Analgesics|analgesics|mesh-ancestor
101887290|NCT04311502|Pyridoxal|pyridoxal|mesh-list
101887291|NCT04311502|Vitamin B 6|vitamin b 6|mesh-list
101887293|NCT04311502|Rifapentine|rifapentine|mesh-list
101887294|NCT04311502|Clofazimine|clofazimine|mesh-list
101887295|NCT04311502|Isoniazid|isoniazid|mesh-list
101887296|NCT04311502|Pyrazinamide|pyrazinamide|mesh-list
101887297|NCT04311502|Ethambutol|ethambutol|mesh-list
101887298|NCT04311502|Vitamins|vitamins|mesh-ancestor
101887299|NCT04311502|Micronutrients|micronutrients|mesh-ancestor
101887300|NCT04311502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887301|NCT04311502|Vitamin B Complex|vitamin b complex|mesh-ancestor
101887302|NCT04311502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101887303|NCT04311502|Antitubercular Agents|antitubercular agents|mesh-ancestor
101887304|NCT04311502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101887305|NCT04311502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101887306|NCT04311502|Leprostatic Agents|leprostatic agents|mesh-ancestor
101887307|NCT04311502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101887308|NCT04311502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101887309|NCT04311502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887310|NCT04311502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101887311|NCT04311502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101887312|NCT04311502|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101887313|NCT04311502|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101887314|NCT04311502|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101887315|NCT04311502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101887316|NCT04311502|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101887317|NCT04311502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101887318|NCT04311502|Antimetabolites|antimetabolites|mesh-ancestor
101887319|NCT04311502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101887320|NCT04311502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101887321|NCT04310995|Nicorandil|nicorandil|mesh-list
101887322|NCT04310995|Diltiazem|diltiazem|mesh-list
101887323|NCT04310995|Isosorbide|isosorbide|mesh-list
101887324|NCT04310995|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
101887325|NCT04310995|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
101887326|NCT04310995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101887327|NCT04310995|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101887328|NCT04310995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101887329|NCT04310995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887330|NCT04310995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101887331|NCT04310995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887332|NCT04310995|Vasodilator Agents|vasodilator agents|mesh-ancestor
101887333|NCT04310995|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101887334|NCT04310995|Diuretics|diuretics|mesh-ancestor
101887335|NCT04310995|Natriuretic Agents|natriuretic agents|mesh-ancestor
101887336|NCT04310995|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101887337|NCT04310995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101887338|NCT04310995|Vitamin B Complex|vitamin b complex|mesh-ancestor
101887339|NCT04310995|Vitamins|vitamins|mesh-ancestor
101887340|NCT04310995|Micronutrients|micronutrients|mesh-ancestor
101887341|NCT04302324|Clarithromycin|clarithromycin|mesh-list
101887342|NCT04302324|Dexamethasone|dexamethasone|mesh-list
101887343|NCT04302324|Daratumumab|daratumumab|mesh-list
101887344|NCT04302324|Pomalidomide|pomalidomide|mesh-list
101887345|NCT04302324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101887346|NCT04302324|Antiemetics|antiemetics|mesh-ancestor
101887347|NCT04302324|Autonomic Agents|autonomic agents|mesh-ancestor
101887348|NCT04302324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101887349|NCT04302324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887350|NCT04302324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101887351|NCT04302324|Glucocorticoids|glucocorticoids|mesh-ancestor
101887352|NCT04302324|Hormones|hormones|mesh-ancestor
101887353|NCT04302324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101887354|NCT04302324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101887355|NCT04302324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887356|NCT04302324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101887357|NCT04302324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101887358|NCT04302324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101887359|NCT04302324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101887360|NCT04302324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887361|NCT04302324|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101887362|NCT04302324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101887363|NCT04302324|Immunologic Factors|immunologic factors|mesh-ancestor
101887364|NCT04302324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101887365|NCT04302324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101887366|NCT04302324|Growth Substances|growth substances|mesh-ancestor
101887367|NCT04302324|Growth Inhibitors|growth inhibitors|mesh-ancestor
101887368|NCT04292743|Leucovorin|leucovorin|mesh-list
101887369|NCT04292743|Fluorouracil|fluorouracil|mesh-list
101887370|NCT04292743|Oxaliplatin|oxaliplatin|mesh-list
101887371|NCT04292743|Irinotecan|irinotecan|mesh-list
101887372|NCT04292743|Folfirinox|folfirinox|mesh-list
101887373|NCT04292743|Eryaspase|eryaspase|mesh-list
101887374|NCT04292743|Antimetabolites|antimetabolites|mesh-ancestor
101887375|NCT04292743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887376|NCT04292743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101887377|NCT04292743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887378|NCT04292743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101887379|NCT04292743|Immunologic Factors|immunologic factors|mesh-ancestor
101887380|NCT04292743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887381|NCT04292743|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101887382|NCT04292743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101887383|NCT04292743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101887384|NCT04292743|Antidotes|antidotes|mesh-ancestor
101887385|NCT04292743|Protective Agents|protective agents|mesh-ancestor
101887386|NCT04292743|Vitamin B Complex|vitamin b complex|mesh-ancestor
101887387|NCT04292743|Vitamins|vitamins|mesh-ancestor
101887388|NCT04292743|Micronutrients|micronutrients|mesh-ancestor
101887389|NCT04270175|Dexamethasone|dexamethasone|mesh-list
101887390|NCT04270175|Daratumumab|daratumumab|mesh-list
101887391|NCT04270175|Pomalidomide|pomalidomide|mesh-list
101887392|NCT04270175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101887393|NCT04270175|Antiemetics|antiemetics|mesh-ancestor
101887394|NCT04270175|Autonomic Agents|autonomic agents|mesh-ancestor
101887395|NCT04270175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101887396|NCT04270175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887397|NCT04270175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101887398|NCT04270175|Glucocorticoids|glucocorticoids|mesh-ancestor
101887399|NCT04270175|Hormones|hormones|mesh-ancestor
101887400|NCT04270175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101887401|NCT04270175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101887402|NCT04270175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887403|NCT04270175|Immunologic Factors|immunologic factors|mesh-ancestor
101887404|NCT04270175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101887405|NCT04270175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101887406|NCT04270175|Growth Substances|growth substances|mesh-ancestor
101887407|NCT04270175|Growth Inhibitors|growth inhibitors|mesh-ancestor
101887408|NCT04267549|Paclitaxel|paclitaxel|mesh-list
101887409|NCT04267549|Apatinib|apatinib|mesh-list
101887410|NCT04267549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101887411|NCT04267549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887412|NCT04267549|Tubulin Modulators|tubulin modulators|mesh-ancestor
101887413|NCT04267549|Antimitotic Agents|antimitotic agents|mesh-ancestor
101887414|NCT04267549|Mitosis Modulators|mitosis modulators|mesh-ancestor
101887415|NCT04267549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887416|NCT04267549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101887417|NCT04267549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101887418|NCT04262336|Sodium thiosulfate|sodium thiosulfate|mesh-list
101887419|NCT04262336|Hyaluronic Acid|hyaluronic acid|mesh-list
101887420|NCT04262336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101887421|NCT04262336|Immunologic Factors|immunologic factors|mesh-ancestor
101887422|NCT04262336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887423|NCT04262336|Viscosupplements|viscosupplements|mesh-ancestor
101887424|NCT04262336|Protective Agents|protective agents|mesh-ancestor
101887425|NCT04262336|Antidotes|antidotes|mesh-ancestor
101887426|NCT04262336|Antioxidants|antioxidants|mesh-ancestor
101887427|NCT04262336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887428|NCT04262336|Antitubercular Agents|antitubercular agents|mesh-ancestor
101887429|NCT04262336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101887430|NCT04262336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101887431|NCT04262336|Chelating Agents|chelating agents|mesh-ancestor
101887432|NCT04262336|Sequestering Agents|sequestering agents|mesh-ancestor
101887433|NCT04250155|Atezolizumab|atezolizumab|mesh-list
101887434|NCT04250155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101887435|NCT04250155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887436|NCT04250155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101887437|NCT04250155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887438|NCT04242238|Avelumab|avelumab|mesh-list
101887439|NCT04242238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101887440|NCT04242238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887441|NCT04235959|Tirzepatide|tirzepatide|mesh-list
101887442|NCT04235959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101887443|NCT04235959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887444|NCT04235959|Incretins|incretins|mesh-ancestor
101887446|NCT04235959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101887447|NCT04235101|Trastuzumab|trastuzumab|mesh-list
101887448|NCT04235101|Niraparib|niraparib|mesh-list
101887449|NCT04235101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101887450|NCT04235101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887451|NCT04235101|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101887452|NCT04235101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101887453|NCT04235101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887454|NCT04200534|Nicotine|nicotine|mesh-list
101887455|NCT04200534|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101887456|NCT04200534|Autonomic Agents|autonomic agents|mesh-ancestor
101887457|NCT04200534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101887458|NCT04200534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887459|NCT04200534|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101887460|NCT04200534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101887461|NCT04200534|Cholinergic Agents|cholinergic agents|mesh-ancestor
101887462|NCT04200534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101887463|NCT04200534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887464|NCT04182360|Carbetocin|carbetocin|mesh-list
101887465|NCT04182360|Oxytocics|oxytocics|mesh-ancestor
101887466|NCT04182360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101887467|NCT04182360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887468|NCT04147533|Imatinib Mesylate|imatinib mesylate|mesh-list
101887469|NCT04147533|Dasatinib|dasatinib|mesh-list
101887470|NCT04147533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887471|NCT04147533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101887472|NCT04147533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101887473|NCT04147533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887474|NCT04115384|Insulin|insulin|mesh-list
101887475|NCT04115384|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101887476|NCT04115384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101887477|NCT04115384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887478|NCT04112368|Estradiol|estradiol|mesh-list
101887479|NCT04112368|Progesterone|progesterone|mesh-list
101887480|NCT04112368|Estrogens|estrogens|mesh-ancestor
101887481|NCT04112368|Hormones|hormones|mesh-ancestor
101887482|NCT04112368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101887483|NCT04112368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887484|NCT04112368|Progestins|progestins|mesh-ancestor
101887485|NCT04088188|Cisplatin|cisplatin|mesh-list
101887486|NCT04088188|Gemcitabine|gemcitabine|mesh-list
101887487|NCT04088188|Ivosidenib|ivosidenib|mesh-list
101887488|NCT04088188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887489|NCT04088188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101887490|NCT04088188|Antimetabolites|antimetabolites|mesh-ancestor
101887491|NCT04088188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887492|NCT04088188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101887493|NCT04083599|Paclitaxel|paclitaxel|mesh-list
101887494|NCT04083599|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101887495|NCT04083599|Carboplatin|carboplatin|mesh-list
101887496|NCT04083599|Gemcitabine|gemcitabine|mesh-list
101887497|NCT04083599|Pembrolizumab|pembrolizumab|mesh-list
101887498|NCT04083599|Pemetrexed|pemetrexed|mesh-list
101887499|NCT04083599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101887500|NCT04083599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887501|NCT04083599|Tubulin Modulators|tubulin modulators|mesh-ancestor
101887502|NCT04083599|Antimitotic Agents|antimitotic agents|mesh-ancestor
101887503|NCT04083599|Mitosis Modulators|mitosis modulators|mesh-ancestor
101887504|NCT04083599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887505|NCT04083599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101887506|NCT04083599|Antimetabolites|antimetabolites|mesh-ancestor
101775342|NCT00656292|Antimetabolites|antimetabolites|mesh-ancestor
101887507|NCT04083599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101887508|NCT04083599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101887509|NCT04083599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101887510|NCT04083599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101887511|NCT04083599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101887512|NCT04080804|Nivolumab|nivolumab|mesh-list
101887513|NCT04080804|Ipilimumab|ipilimumab|mesh-list
101887514|NCT04080804|Relatlimab|relatlimab|mesh-list
101887515|NCT04080804|Antibodies|antibodies|mesh-list
101607317|NCT04290858|Antioxidants|antioxidants|mesh-ancestor
101887516|NCT04080804|Immunoglobulins|immunoglobulins|mesh-list
101887517|NCT04080804|Immunologic Factors|immunologic factors|mesh-ancestor
101887518|NCT04080804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887519|NCT04080804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101887520|NCT04080804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887521|NCT04080804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101887522|NCT04080804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887523|NCT04069273|Paclitaxel|paclitaxel|mesh-list
101887524|NCT04069273|Pembrolizumab|pembrolizumab|mesh-list
101887525|NCT04069273|Ramucirumab|ramucirumab|mesh-list
101887526|NCT04069273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101887527|NCT04069273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887528|NCT04069273|Tubulin Modulators|tubulin modulators|mesh-ancestor
101887529|NCT04069273|Antimitotic Agents|antimitotic agents|mesh-ancestor
101887530|NCT04069273|Mitosis Modulators|mitosis modulators|mesh-ancestor
101887531|NCT04069273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887532|NCT04069273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101887533|NCT04069273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101887534|NCT04067115|Alovudine|alovudine|mesh-list
101887535|NCT04067115|Irinotecan|irinotecan|mesh-list
101887536|NCT04067115|Trabectedin|trabectedin|mesh-list
101887537|NCT04067115|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101887538|NCT04067115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101887539|NCT04067115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101887540|NCT04067115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887541|NCT04067115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887542|NCT04067115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101887543|NCT04067115|Alkylating Agents|alkylating agents|mesh-ancestor
101887544|NCT04067115|Antiviral Agents|antiviral agents|mesh-ancestor
101887545|NCT04067115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101887546|NCT04066192|Brexpiprazole|brexpiprazole|mesh-list
101887547|NCT04066192|Serotonin Agents|serotonin agents|mesh-ancestor
101887548|NCT04066192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101968633|NCT02280694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101887549|NCT04066192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887550|NCT04066192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887551|NCT04066192|Dopamine Agonists|dopamine agonists|mesh-ancestor
101887552|NCT04066192|Dopamine Agents|dopamine agents|mesh-ancestor
101887553|NCT04062123|Fentanyl|fentanyl|mesh-list
101887554|NCT04062123|Dexmedetomidine|dexmedetomidine|mesh-list
101887555|NCT04062123|Propofol|propofol|mesh-list
101887556|NCT04062123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101887557|NCT04062123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101887558|NCT04062123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887559|NCT04062123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101887560|NCT04062123|Analgesics|analgesics|mesh-ancestor
101887561|NCT04062123|Sensory System Agents|sensory system agents|mesh-ancestor
101887562|NCT04062123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101887563|NCT04062123|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101887564|NCT04062123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101887565|NCT04062123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101887566|NCT04062123|Adrenergic Agents|adrenergic agents|mesh-ancestor
101887567|NCT04062123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101887568|NCT04062123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887569|NCT04062123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101887570|NCT04062123|Anesthetics, General|anesthetics, general|mesh-ancestor
101887571|NCT04062123|Anesthetics|anesthetics|mesh-ancestor
101887572|NCT04062123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101887573|NCT04062123|Narcotics|narcotics|mesh-ancestor
101887574|NCT04062123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101887575|NCT04059562|Irinotecan|irinotecan|mesh-list
101887576|NCT04059562|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101887577|NCT04059562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101887578|NCT04059562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101887579|NCT04059562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887580|NCT04059562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887581|NCT04040088|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
101887582|NCT04040088|Chelating Agents|chelating agents|mesh-ancestor
101887583|NCT04040088|Sequestering Agents|sequestering agents|mesh-ancestor
101887584|NCT04040088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887585|NCT04009681|Antibodies|antibodies|mesh-list
101887586|NCT04009681|Immunologic Factors|immunologic factors|mesh-ancestor
101689449|NCT00891527|Bevacizumab|bevacizumab|mesh-list
101887587|NCT04009681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887588|NCT03992261|Halobetasol|halobetasol|mesh-list
101887589|NCT03992261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101607395|NCT00599326|Deferasirox|deferasirox|mesh-list
101887592|NCT03991884|Cyclophosphamide|cyclophosphamide|mesh-list
101887593|NCT03991884|Doxorubicin|doxorubicin|mesh-list
101887594|NCT03991884|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101887595|NCT03991884|Etoposide|etoposide|mesh-list
101887596|NCT03991884|Vincristine|vincristine|mesh-list
101887597|NCT03991884|Etoposide phosphate|etoposide phosphate|mesh-list
101887598|NCT03991884|Daunorubicin|daunorubicin|mesh-list
101887599|NCT03991884|Podophyllotoxin|podophyllotoxin|mesh-list
101887600|NCT03991884|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
101887601|NCT03991884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101887602|NCT03991884|Immunologic Factors|immunologic factors|mesh-ancestor
101887603|NCT03991884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887604|NCT03991884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101887605|NCT03991884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101887606|NCT03991884|Alkylating Agents|alkylating agents|mesh-ancestor
101887607|NCT03991884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887608|NCT03991884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887609|NCT03991884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101887610|NCT03991884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101887611|NCT03991884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101887612|NCT03991884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101887614|NCT03991884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101887615|NCT03991884|Glucocorticoids|glucocorticoids|mesh-ancestor
101887616|NCT03991884|Hormones|hormones|mesh-ancestor
101887617|NCT03991884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101887618|NCT03991884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101887619|NCT03991884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101887620|NCT03991884|Tubulin Modulators|tubulin modulators|mesh-ancestor
101887621|NCT03991884|Antimitotic Agents|antimitotic agents|mesh-ancestor
101887622|NCT03991884|Mitosis Modulators|mitosis modulators|mesh-ancestor
101887623|NCT03991884|Keratolytic Agents|keratolytic agents|mesh-ancestor
101887624|NCT03991884|Dermatologic Agents|dermatologic agents|mesh-ancestor
101887625|NCT03991884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101887626|NCT03991884|Immunotoxins|immunotoxins|mesh-ancestor
101887627|NCT03991884|Immunoconjugates|immunoconjugates|mesh-ancestor
101887628|NCT03984565|Cannabidiol|cannabidiol|mesh-list
101887629|NCT03984565|Anticonvulsants|anticonvulsants|mesh-ancestor
101887630|NCT03980509|Curcumin|curcumin|mesh-list
101887631|NCT03980509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101887632|NCT03980509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101887633|NCT03980509|Analgesics|analgesics|mesh-ancestor
101887634|NCT03980509|Sensory System Agents|sensory system agents|mesh-ancestor
101887635|NCT03980509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101887636|NCT03980509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887637|NCT03980509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101887638|NCT03980509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101887639|NCT03980509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887640|NCT03980509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101887641|NCT03980509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887642|NCT03978039|Immunomodulating Agents|immunomodulating agents|mesh-list
101887643|NCT03978039|Immunologic Factors|immunologic factors|mesh-ancestor
101887644|NCT03978039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887645|NCT03961971|Spartalizumab|spartalizumab|mesh-list
101887646|NCT03961971|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101887647|NCT03961971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887648|NCT03961971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101887649|NCT03961971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887650|NCT03947385|Crizotinib|crizotinib|mesh-list
101887651|NCT03947385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887652|NCT03947385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101887653|NCT03947385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101887654|NCT03947385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887655|NCT03918798|Chloroprocaine|chloroprocaine|mesh-list
101887656|NCT03918798|Procaine|procaine|mesh-list
101887657|NCT03918798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101887658|NCT03918798|Anesthetics, Local|anesthetics, local|mesh-ancestor
101887659|NCT03918798|Anesthetics|anesthetics|mesh-ancestor
101887660|NCT03918798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101887661|NCT03918798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887662|NCT03918798|Sensory System Agents|sensory system agents|mesh-ancestor
101887663|NCT03918798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101887664|NCT03917381|Docetaxel|docetaxel|mesh-list
101887665|NCT03917381|Pembrolizumab|pembrolizumab|mesh-list
101887666|NCT03917381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887667|NCT03917381|Tubulin Modulators|tubulin modulators|mesh-ancestor
101887668|NCT03917381|Antimitotic Agents|antimitotic agents|mesh-ancestor
101887669|NCT03917381|Mitosis Modulators|mitosis modulators|mesh-ancestor
101887670|NCT03917381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887671|NCT03917381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101887672|NCT03917381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101887673|NCT03890289|Obinutuzumab|obinutuzumab|mesh-list
101887675|NCT03890289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101887676|NCT03890289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887677|NCT03890289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101887678|NCT03890289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887679|NCT03858322|Paclitaxel|paclitaxel|mesh-list
101887680|NCT03858322|Cyclophosphamide|cyclophosphamide|mesh-list
101887681|NCT03858322|Carboplatin|carboplatin|mesh-list
101887682|NCT03858322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101887683|NCT03858322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887684|NCT03858322|Tubulin Modulators|tubulin modulators|mesh-ancestor
101887685|NCT03858322|Antimitotic Agents|antimitotic agents|mesh-ancestor
101887686|NCT03858322|Mitosis Modulators|mitosis modulators|mesh-ancestor
101887687|NCT03858322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887688|NCT03858322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101887689|NCT03858322|Immunologic Factors|immunologic factors|mesh-ancestor
101887690|NCT03858322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887691|NCT03858322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101887692|NCT03858322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101887693|NCT03858322|Alkylating Agents|alkylating agents|mesh-ancestor
101887694|NCT03858322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101887695|NCT03828799|Folfirinox|folfirinox|mesh-list
101887696|NCT03828799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887697|NCT03825289|Hydroxychloroquine|hydroxychloroquine|mesh-list
101887698|NCT03825289|Trametinib|trametinib|mesh-list
101887699|NCT03825289|Antimalarials|antimalarials|mesh-ancestor
101887700|NCT03825289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101887701|NCT03825289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101887702|NCT03825289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101887703|NCT03825289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101887704|NCT03825289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887705|NCT03825289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101887706|NCT03825289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887707|NCT03825289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101887708|NCT03802591|Capecitabine|capecitabine|mesh-list
101887709|NCT03802591|Oxaliplatin|oxaliplatin|mesh-list
101887710|NCT03802591|Antibodies|antibodies|mesh-list
101887711|NCT03802591|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101887712|NCT03802591|Immunologic Factors|immunologic factors|mesh-ancestor
101887713|NCT03802591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887714|NCT03802591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101887715|NCT03802591|Antimetabolites|antimetabolites|mesh-ancestor
101887716|NCT03802591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887717|NCT03802591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887718|NCT03800602|Metformin|metformin|mesh-list
101887719|NCT03800602|Nivolumab|nivolumab|mesh-list
101887720|NCT03800602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101887721|NCT03800602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887722|NCT03800602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101887723|NCT03800602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887724|NCT03800602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101887725|NCT03800602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887726|NCT03779191|Bevacizumab|bevacizumab|mesh-list
101887727|NCT03779191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101887728|NCT03779191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887729|NCT03779191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101887730|NCT03779191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101887731|NCT03779191|Growth Substances|growth substances|mesh-ancestor
101887732|NCT03779191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887734|NCT03775902|Nicorandil|nicorandil|mesh-list
101887735|NCT03775902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101887736|NCT03775902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101887737|NCT03775902|Vasodilator Agents|vasodilator agents|mesh-ancestor
101887738|NCT03775902|Vitamin B Complex|vitamin b complex|mesh-ancestor
101887739|NCT03775902|Vitamins|vitamins|mesh-ancestor
101887740|NCT03775902|Micronutrients|micronutrients|mesh-ancestor
101887741|NCT03775902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887742|NCT03772925|Belinostat|belinostat|mesh-list
101887743|NCT03772925|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101887744|NCT03772925|Pevonedistat|pevonedistat|mesh-list
101887745|NCT03772925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887746|NCT03772925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887747|NCT03772925|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101887748|NCT03753074|Tenofovir|tenofovir|mesh-list
101887749|NCT03753074|Antiviral Agents|antiviral agents|mesh-ancestor
101887750|NCT03753074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101968657|NCT02280772|Cathartics|cathartics|mesh-ancestor
101887751|NCT03753074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101887752|NCT03753074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101887753|NCT03753074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101887754|NCT03753074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887755|NCT03753074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101887756|NCT03753074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101887757|NCT03743662|Bevacizumab|bevacizumab|mesh-list
101887758|NCT03743662|Nivolumab|nivolumab|mesh-list
101887759|NCT03743662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101887760|NCT03743662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887761|NCT03743662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101887762|NCT03743662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101887763|NCT03743662|Growth Substances|growth substances|mesh-ancestor
101887764|NCT03743662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887765|NCT03743662|Growth Inhibitors|growth inhibitors|mesh-ancestor
101887766|NCT03743662|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101887767|NCT03743662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887768|NCT03735121|Atezolizumab|atezolizumab|mesh-list
101887769|NCT03735121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101887770|NCT03735121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887771|NCT03735121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101887772|NCT03735121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887773|NCT03715946|Nivolumab|nivolumab|mesh-list
101887774|NCT03715946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101887775|NCT03715946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887776|NCT03715946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101887777|NCT03715946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887778|NCT03712878|Mycophenolic Acid|mycophenolic acid|mesh-list
101887779|NCT03712878|Cyclophosphamide|cyclophosphamide|mesh-list
101887780|NCT03712878|Tacrolimus|tacrolimus|mesh-list
101887781|NCT03712878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101887782|NCT03712878|Immunologic Factors|immunologic factors|mesh-ancestor
101887783|NCT03712878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887784|NCT03712878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101887785|NCT03712878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101887786|NCT03712878|Alkylating Agents|alkylating agents|mesh-ancestor
101887787|NCT03712878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887788|NCT03712878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887789|NCT03712878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101887790|NCT03712878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101887791|NCT03712878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101887792|NCT03712878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101887793|NCT03712878|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101887794|NCT03712878|Antitubercular Agents|antitubercular agents|mesh-ancestor
101887795|NCT03712878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101887796|NCT03712878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101887797|NCT03703167|Rituximab|rituximab|mesh-list
101887798|NCT03703167|Lenalidomide|lenalidomide|mesh-list
101887799|NCT03703167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101887800|NCT03703167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887801|NCT03703167|Immunologic Factors|immunologic factors|mesh-ancestor
101887802|NCT03703167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887803|NCT03703167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101887804|NCT03703167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101887805|NCT03703167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101887806|NCT03703167|Growth Substances|growth substances|mesh-ancestor
101887807|NCT03703167|Growth Inhibitors|growth inhibitors|mesh-ancestor
101887822|NCT03651206|Dostarlimab|dostarlimab|mesh-list
101887823|NCT03651206|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101887824|NCT03651206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101887825|NCT03651206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887826|NCT03651206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887827|NCT03643510|Fulvestrant|fulvestrant|mesh-list
101887828|NCT03643510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101887829|NCT03643510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887830|NCT03643510|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101887831|NCT03643510|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101887832|NCT03643510|Hormone Antagonists|hormone antagonists|mesh-ancestor
101887833|NCT03643510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101887834|NCT03643510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887836|NCT03641313|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101887837|NCT03641313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101887838|NCT03641313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101887839|NCT03641313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887840|NCT03641313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887841|NCT03618537|Dexamethasone|dexamethasone|mesh-list
101887842|NCT03618537|Ixazomib|ixazomib|mesh-list
101887843|NCT03618537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101887844|NCT03618537|Antiemetics|antiemetics|mesh-ancestor
101887845|NCT03618537|Autonomic Agents|autonomic agents|mesh-ancestor
101887846|NCT03618537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101887847|NCT03618537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887848|NCT03618537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101887849|NCT03618537|Glucocorticoids|glucocorticoids|mesh-ancestor
101887850|NCT03618537|Hormones|hormones|mesh-ancestor
101887851|NCT03618537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101887852|NCT03618537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101887853|NCT03618537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887854|NCT03618537|Protease Inhibitors|protease inhibitors|mesh-ancestor
101887855|NCT03618537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101887856|NCT03618537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887857|NCT03587844|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101887858|NCT03587844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101887859|NCT03587844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101887860|NCT03587844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887861|NCT03587844|Immunotoxins|immunotoxins|mesh-ancestor
101887862|NCT03587844|Immunoconjugates|immunoconjugates|mesh-ancestor
101887863|NCT03587844|Immunologic Factors|immunologic factors|mesh-ancestor
101887864|NCT03587844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887865|NCT03552692|Venetoclax|venetoclax|mesh-list
101887866|NCT03552692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887867|NCT03502733|Nivolumab|nivolumab|mesh-list
101887868|NCT03502733|Ipilimumab|ipilimumab|mesh-list
101887869|NCT03502733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101887870|NCT03502733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887871|NCT03502733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101887872|NCT03502733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887873|NCT03485417|Aripiprazole|aripiprazole|mesh-list
101887874|NCT03485417|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101887875|NCT03485417|Antidepressive Agents|antidepressive agents|mesh-ancestor
101887876|NCT03485417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101887877|NCT03485417|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101887878|NCT03485417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101887879|NCT03485417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101887880|NCT03485417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887881|NCT03485417|Dopamine Agonists|dopamine agonists|mesh-ancestor
101887882|NCT03485417|Dopamine Agents|dopamine agents|mesh-ancestor
101887883|NCT03485417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101887884|NCT03485417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887885|NCT03485417|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101887886|NCT03485417|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101887887|NCT03485417|Serotonin Agents|serotonin agents|mesh-ancestor
101887888|NCT03485417|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101887889|NCT03485417|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101607711|NCT02637700|Antibodies|antibodies|mesh-list
101887890|NCT03485417|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101887891|NCT03485417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101887892|NCT03485274|Vortioxetine|vortioxetine|mesh-list
101887893|NCT03485274|Antidepressive Agents|antidepressive agents|mesh-ancestor
101887894|NCT03485274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101887895|NCT03485274|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101887896|NCT03485274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101887897|NCT03485274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101887898|NCT03485274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887899|NCT03485274|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101887900|NCT03485274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101887901|NCT03485274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101887902|NCT03485274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887903|NCT03485274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101887904|NCT03485274|Serotonin Agents|serotonin agents|mesh-ancestor
101887905|NCT03485274|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101887906|NCT03485274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101887907|NCT03485274|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101887908|NCT03485274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101887909|NCT03484819|Nivolumab|nivolumab|mesh-list
101887910|NCT03484819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101887911|NCT03484819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887912|NCT03484819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101887913|NCT03484819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887914|NCT03434028|Norepinephrine|norepinephrine|mesh-list
101887915|NCT03434028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
101887916|NCT03434028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101887917|NCT03434028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101887918|NCT03434028|Adrenergic Agents|adrenergic agents|mesh-ancestor
101887919|NCT03434028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101887920|NCT03434028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887921|NCT03434028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887922|NCT03434028|Sympathomimetics|sympathomimetics|mesh-ancestor
101887923|NCT03434028|Autonomic Agents|autonomic agents|mesh-ancestor
101887924|NCT03434028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101887925|NCT03412773|Sorafenib|sorafenib|mesh-list
101887926|NCT03412773|Tislelizumab|tislelizumab|mesh-list
101887927|NCT03412773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887928|NCT03412773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101887929|NCT03412773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101887930|NCT03412773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887931|NCT03412773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101887932|NCT03404960|Nivolumab|nivolumab|mesh-list
101887933|NCT03404960|Ipilimumab|ipilimumab|mesh-list
101887934|NCT03404960|Niraparib|niraparib|mesh-list
101887935|NCT03404960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101887936|NCT03404960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887937|NCT03404960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101887938|NCT03404960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887939|NCT03404960|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101887940|NCT03404960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101887941|NCT03393845|Pembrolizumab|pembrolizumab|mesh-list
101887942|NCT03393845|Fulvestrant|fulvestrant|mesh-list
101887943|NCT03393845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101887944|NCT03393845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887945|NCT03393845|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101887946|NCT03393845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887947|NCT03393845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101887948|NCT03393845|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101887949|NCT03393845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101887950|NCT03393845|Hormone Antagonists|hormone antagonists|mesh-ancestor
101887951|NCT03393845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101887952|NCT03393845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887953|NCT03391466|Cyclophosphamide|cyclophosphamide|mesh-list
101887954|NCT03391466|Fludarabine|fludarabine|mesh-list
101887955|NCT03391466|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
101887956|NCT03391466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101887957|NCT03391466|Immunologic Factors|immunologic factors|mesh-ancestor
101887958|NCT03391466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887959|NCT03391466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101887960|NCT03391466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101887961|NCT03391466|Alkylating Agents|alkylating agents|mesh-ancestor
101887962|NCT03391466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887963|NCT03391466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887964|NCT03391466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101887965|NCT03391466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101887966|NCT03391427|Lidocaine|lidocaine|mesh-list
101887967|NCT03391427|Ketamine|ketamine|mesh-list
101887968|NCT03391427|Anesthetics, Local|anesthetics, local|mesh-ancestor
101887969|NCT03391427|Anesthetics|anesthetics|mesh-ancestor
101887970|NCT03391427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101887971|NCT03391427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101887972|NCT03391427|Sensory System Agents|sensory system agents|mesh-ancestor
101887973|NCT03391427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101887974|NCT03391427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101887975|NCT03391427|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101887976|NCT03391427|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101887977|NCT03391427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101887978|NCT03391427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887979|NCT03391427|Analgesics|analgesics|mesh-ancestor
101887980|NCT03391427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101887981|NCT03391427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101887982|NCT03391427|Anesthetics, General|anesthetics, general|mesh-ancestor
101887983|NCT03391427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101887984|NCT03391427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101887985|NCT03391427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101887986|NCT03381274|Osimertinib|osimertinib|mesh-list
101887987|NCT03381274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101887988|NCT03381274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101887989|NCT03381274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101887990|NCT03381274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101887991|NCT03290950|Dexamethasone|dexamethasone|mesh-list
101887992|NCT03290950|Dexamethasone acetate|dexamethasone acetate|mesh-list
101887993|NCT03290950|Lenalidomide|lenalidomide|mesh-list
101887994|NCT03290950|Daratumumab|daratumumab|mesh-list
101887995|NCT03290950|BB 1101|bb 1101|mesh-list
101887996|NCT03290950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101887997|NCT03290950|Antiemetics|antiemetics|mesh-ancestor
101887998|NCT03290950|Autonomic Agents|autonomic agents|mesh-ancestor
101887999|NCT03290950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101888000|NCT03290950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888001|NCT03290950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101888002|NCT03290950|Glucocorticoids|glucocorticoids|mesh-ancestor
101888003|NCT03290950|Hormones|hormones|mesh-ancestor
101888004|NCT03290950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101888005|NCT03290950|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101888006|NCT03290950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888007|NCT03290950|Protease Inhibitors|protease inhibitors|mesh-ancestor
101888008|NCT03290950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101888009|NCT03290950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888010|NCT03290950|Immunologic Factors|immunologic factors|mesh-ancestor
101888011|NCT03290950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101888012|NCT03290950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101775450|NCT00656136|Afatinib|afatinib|mesh-list
101888013|NCT03290950|Growth Substances|growth substances|mesh-ancestor
101888014|NCT03290950|Growth Inhibitors|growth inhibitors|mesh-ancestor
101888015|NCT03264404|Pembrolizumab|pembrolizumab|mesh-list
101888016|NCT03264404|Azacitidine|azacitidine|mesh-list
101888017|NCT03264404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101888018|NCT03264404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888019|NCT03264404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101888020|NCT03264404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888021|NCT03264404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101888022|NCT03264404|Antimetabolites|antimetabolites|mesh-ancestor
101888023|NCT03264404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101888024|NCT03241745|Nivolumab|nivolumab|mesh-list
101968677|NCT00758290|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101888025|NCT03241745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101888026|NCT03241745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888027|NCT03241745|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101888028|NCT03241745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888029|NCT03188432|Carboplatin|carboplatin|mesh-list
101888030|NCT03188432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888031|NCT03132532|Paclitaxel|paclitaxel|mesh-list
101888032|NCT03132532|Etoposide|etoposide|mesh-list
101888033|NCT03132532|Podophyllotoxin|podophyllotoxin|mesh-list
101888034|NCT03132532|Cisplatin|cisplatin|mesh-list
101888035|NCT03132532|Carboplatin|carboplatin|mesh-list
101607848|NCT00657514|Ranolazine|ranolazine|mesh-list
101888036|NCT03132532|Pemetrexed|pemetrexed|mesh-list
101888038|NCT03132532|Etoposide phosphate|etoposide phosphate|mesh-list
101888039|NCT03132532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101888040|NCT03132532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888041|NCT03132532|Tubulin Modulators|tubulin modulators|mesh-ancestor
101888042|NCT03132532|Antimitotic Agents|antimitotic agents|mesh-ancestor
101888043|NCT03132532|Mitosis Modulators|mitosis modulators|mesh-ancestor
101888044|NCT03132532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888045|NCT03132532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101888046|NCT03132532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101888047|NCT03132532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101888048|NCT03132532|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101888049|NCT03132532|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101888050|NCT03132532|Keratolytic Agents|keratolytic agents|mesh-ancestor
101888051|NCT03132532|Dermatologic Agents|dermatologic agents|mesh-ancestor
101888052|NCT03129555|Rivaroxaban|rivaroxaban|mesh-list
101888053|NCT03129555|Apixaban|apixaban|mesh-list
101888054|NCT03129555|Edoxaban|edoxaban|mesh-list
101888055|NCT03129555|Dabigatran|dabigatran|mesh-list
101888056|NCT03129555|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101888057|NCT03129555|Antithrombins|antithrombins|mesh-ancestor
101888058|NCT03129555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101888059|NCT03129555|Protease Inhibitors|protease inhibitors|mesh-ancestor
101888060|NCT03129555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101888061|NCT03129555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888062|NCT03129555|Anticoagulants|anticoagulants|mesh-ancestor
101888063|NCT03129490|Rivaroxaban|rivaroxaban|mesh-list
101888064|NCT03129490|Apixaban|apixaban|mesh-list
101888065|NCT03129490|Edoxaban|edoxaban|mesh-list
101888066|NCT03129490|Dabigatran|dabigatran|mesh-list
101888067|NCT03129490|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101888068|NCT03129490|Antithrombins|antithrombins|mesh-ancestor
101888069|NCT03129490|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101888070|NCT03129490|Protease Inhibitors|protease inhibitors|mesh-ancestor
101888071|NCT03129490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101888072|NCT03129490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888073|NCT03129490|Anticoagulants|anticoagulants|mesh-ancestor
101888074|NCT03121014|Methotrexate|methotrexate|mesh-list
101888075|NCT03121014|Fludarabine|fludarabine|mesh-list
101888076|NCT03121014|Busulfan|busulfan|mesh-list
101888077|NCT03121014|Tacrolimus|tacrolimus|mesh-list
101888078|NCT03121014|Thymoglobulin|thymoglobulin|mesh-list
101888079|NCT03121014|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101888080|NCT03121014|Abortifacient Agents|abortifacient agents|mesh-ancestor
101888081|NCT03121014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101888082|NCT03121014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888083|NCT03121014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101888084|NCT03121014|Antimetabolites|antimetabolites|mesh-ancestor
101888085|NCT03121014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888086|NCT03121014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888087|NCT03121014|Dermatologic Agents|dermatologic agents|mesh-ancestor
101888088|NCT03121014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101888089|NCT03121014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101888090|NCT03121014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101888091|NCT03121014|Immunologic Factors|immunologic factors|mesh-ancestor
101888092|NCT03121014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101888093|NCT03121014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101888094|NCT03121014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101888095|NCT03121014|Alkylating Agents|alkylating agents|mesh-ancestor
101888096|NCT03121014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101888097|NCT03121014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101888098|NCT03118570|Vitamin D|vitamin d|mesh-list
101888099|NCT03118570|Zoledronic Acid|zoledronic acid|mesh-list
101888100|NCT03118570|Calcium|calcium|mesh-list
101888101|NCT03118570|Vitamins|vitamins|mesh-ancestor
101888102|NCT03118570|Micronutrients|micronutrients|mesh-ancestor
101888103|NCT03118570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888104|NCT03118570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101888105|NCT03118570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101888106|NCT03114319|Nazartinib|nazartinib|mesh-list
101888107|NCT03114319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888108|NCT03076320|Adapalene|adapalene|mesh-list
101888109|NCT03076320|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101888110|NCT03076320|Dermatologic Agents|dermatologic agents|mesh-ancestor
101888111|NCT03076320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101888112|NCT03076320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101888113|NCT03076320|Analgesics|analgesics|mesh-ancestor
101888114|NCT03076320|Sensory System Agents|sensory system agents|mesh-ancestor
101888115|NCT03076320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101888116|NCT03076320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888117|NCT03076320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101888118|NCT03076320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101888119|NCT03069937|Docetaxel|docetaxel|mesh-list
101888120|NCT03069937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888121|NCT03069937|Tubulin Modulators|tubulin modulators|mesh-ancestor
101888122|NCT03069937|Antimitotic Agents|antimitotic agents|mesh-ancestor
101888123|NCT03069937|Mitosis Modulators|mitosis modulators|mesh-ancestor
101888124|NCT03069937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888125|NCT03066739|Remifentanil|remifentanil|mesh-list
101888126|NCT03066739|Naloxone|naloxone|mesh-list
101888127|NCT03066739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101888128|NCT03066739|Narcotics|narcotics|mesh-ancestor
101888129|NCT03066739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101888130|NCT03066739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888131|NCT03066739|Analgesics|analgesics|mesh-ancestor
101888132|NCT03066739|Sensory System Agents|sensory system agents|mesh-ancestor
101888133|NCT03066739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101888134|NCT03066739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101888135|NCT03054896|Venetoclax|venetoclax|mesh-list
101888136|NCT03054896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888137|NCT03038672|Nivolumab|nivolumab|mesh-list
101888138|NCT03038672|Immunoglobulins|immunoglobulins|mesh-list
101888139|NCT03038672|Immunoglobulin G|immunoglobulin g|mesh-list
101888140|NCT03038672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101888141|NCT03038672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101888142|NCT03038672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888143|NCT03038672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101888144|NCT03038672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888145|NCT03038672|Immunologic Factors|immunologic factors|mesh-ancestor
101775465|NCT02559908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101888146|NCT03038672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888147|NCT03033303|Isotretinoin|isotretinoin|mesh-list
101888148|NCT03033303|Dermatologic Agents|dermatologic agents|mesh-ancestor
101888149|NCT03009981|Prednisone|prednisone|mesh-list
101888150|NCT03009981|Leuprolide|leuprolide|mesh-list
101888151|NCT03009981|Abiraterone Acetate|abiraterone acetate|mesh-list
101888152|NCT03009981|Bicalutamide|bicalutamide|mesh-list
101888153|NCT03009981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101888154|NCT03009981|Glucocorticoids|glucocorticoids|mesh-ancestor
101888155|NCT03009981|Hormones|hormones|mesh-ancestor
101888156|NCT03009981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101888157|NCT03009981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888158|NCT03009981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101888159|NCT03009981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888160|NCT03009981|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101888161|NCT03009981|Fertility Agents|fertility agents|mesh-ancestor
101888162|NCT03009981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101888163|NCT03009981|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101888164|NCT03009981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101888165|NCT03009981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888166|NCT03009981|Hormone Antagonists|hormone antagonists|mesh-ancestor
101888167|NCT03009981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101251016|NCT04012177|Niacin|niacin|mesh-list
101888168|NCT03009981|Androgen Antagonists|androgen antagonists|mesh-ancestor
101888169|NCT03009240|Decitabine|decitabine|mesh-list
101888170|NCT03009240|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101888171|NCT03009240|Pevonedistat|pevonedistat|mesh-list
101888172|NCT03009240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101888173|NCT03009240|Antimetabolites|antimetabolites|mesh-ancestor
101888174|NCT03009240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888175|NCT03009240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888176|NCT03006705|Capecitabine|capecitabine|mesh-list
101888177|NCT03006705|Tegafur|tegafur|mesh-list
101888178|NCT03006705|Oxaliplatin|oxaliplatin|mesh-list
101888179|NCT03006705|Nivolumab|nivolumab|mesh-list
101888180|NCT03006705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101888181|NCT03006705|Antimetabolites|antimetabolites|mesh-ancestor
101888182|NCT03006705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888183|NCT03006705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888184|NCT03006705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101888185|NCT03006705|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101888186|NCT02971683|Abatacept|abatacept|mesh-list
101888187|NCT02971683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101888188|NCT02971683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888189|NCT02971683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101888190|NCT02971683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888191|NCT02971683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101888192|NCT02971683|Immunologic Factors|immunologic factors|mesh-ancestor
101888193|NCT02971683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888194|NCT02971683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101888195|NCT02950051|Cyclophosphamide|cyclophosphamide|mesh-list
101888196|NCT02950051|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101888197|NCT02950051|Rituximab|rituximab|mesh-list
101888198|NCT02950051|Fludarabine|fludarabine|mesh-list
101888199|NCT02950051|Venetoclax|venetoclax|mesh-list
101888200|NCT02950051|Obinutuzumab|obinutuzumab|mesh-list
101888201|NCT02950051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101888202|NCT02950051|Immunologic Factors|immunologic factors|mesh-ancestor
101888203|NCT02950051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888204|NCT02950051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101888205|NCT02950051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101888206|NCT02950051|Alkylating Agents|alkylating agents|mesh-ancestor
101888207|NCT02950051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888208|NCT02950051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888209|NCT02950051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101888210|NCT02950051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101888211|NCT02949219|Pembrolizumab|pembrolizumab|mesh-list
101888212|NCT02949219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101888213|NCT02949219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888214|NCT02949219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101888215|NCT02949219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888216|NCT02921022|Paclitaxel|paclitaxel|mesh-list
101888217|NCT02921022|Gemcitabine|gemcitabine|mesh-list
101888218|NCT02921022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101888219|NCT02921022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888220|NCT02921022|Tubulin Modulators|tubulin modulators|mesh-ancestor
101888221|NCT02921022|Antimitotic Agents|antimitotic agents|mesh-ancestor
101888222|NCT02921022|Mitosis Modulators|mitosis modulators|mesh-ancestor
101888223|NCT02921022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888224|NCT02921022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101888225|NCT02921022|Antimetabolites|antimetabolites|mesh-ancestor
101888226|NCT02918162|Pembrolizumab|pembrolizumab|mesh-list
101888227|NCT02918162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101888228|NCT02918162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888229|NCT02918162|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101888230|NCT02918162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888231|NCT02899299|Carboplatin|carboplatin|mesh-list
101888232|NCT02899299|Nivolumab|nivolumab|mesh-list
101888233|NCT02899299|Pemetrexed|pemetrexed|mesh-list
101888234|NCT02899299|Ipilimumab|ipilimumab|mesh-list
101888235|NCT02899299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888236|NCT02899299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101888237|NCT02899299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101888238|NCT02899299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888239|NCT02899299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101888240|NCT02899299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101888241|NCT02899299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101888242|NCT02899195|Durvalumab|durvalumab|mesh-list
101888243|NCT02899195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101888244|NCT02899195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888245|NCT02833233|Nivolumab|nivolumab|mesh-list
101888246|NCT02833233|Ipilimumab|ipilimumab|mesh-list
101888247|NCT02833233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101888248|NCT02833233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888249|NCT02833233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101888250|NCT02833233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888251|NCT02814916|Dalbavancin|dalbavancin|mesh-list
101888252|NCT02814916|Teicoplanin|teicoplanin|mesh-list
101888253|NCT02814916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101888254|NCT02814916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101888255|NCT02804594|Acetylcysteine|acetylcysteine|mesh-list
101888256|NCT02804594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101888257|NCT02804594|Antiviral Agents|antiviral agents|mesh-ancestor
101888258|NCT02804594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101888259|NCT02804594|Expectorants|expectorants|mesh-ancestor
101888260|NCT02804594|Respiratory System Agents|respiratory system agents|mesh-ancestor
101888261|NCT02804594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101888262|NCT02804594|Antioxidants|antioxidants|mesh-ancestor
101888263|NCT02804594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888264|NCT02804594|Protective Agents|protective agents|mesh-ancestor
101888265|NCT02804594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608074|NCT02865174|Heparin|heparin|mesh-list
101888266|NCT02804594|Antidotes|antidotes|mesh-ancestor
101888267|NCT02728050|Cytarabine|cytarabine|mesh-list
101888268|NCT02728050|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
101888269|NCT02728050|Sorafenib|sorafenib|mesh-list
101888270|NCT02728050|Mitoxantrone|mitoxantrone|mesh-list
101888271|NCT02728050|Cladribine|cladribine|mesh-list
101888272|NCT02728050|Lenograstim|lenograstim|mesh-list
101888273|NCT02728050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101888274|NCT02728050|Antimetabolites|antimetabolites|mesh-ancestor
101888275|NCT02728050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888276|NCT02728050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888277|NCT02728050|Antiviral Agents|antiviral agents|mesh-ancestor
101888278|NCT02728050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101888279|NCT02728050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101888280|NCT02728050|Immunologic Factors|immunologic factors|mesh-ancestor
101888281|NCT02728050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888282|NCT02728050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101888283|NCT02728050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101888284|NCT02728050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101888285|NCT02728050|Analgesics|analgesics|mesh-ancestor
101888286|NCT02728050|Sensory System Agents|sensory system agents|mesh-ancestor
101888287|NCT02728050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101888288|NCT02728050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101888289|NCT02728050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101888290|NCT02698254|Bevacizumab|bevacizumab|mesh-list
101888291|NCT02698254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101888292|NCT02698254|Endothelial Growth Factors|endothelial growth factors|mesh-list
101888293|NCT02698254|Antibodies|antibodies|mesh-list
101888294|NCT02698254|Immunoglobulins|immunoglobulins|mesh-list
101888295|NCT02698254|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101888296|NCT02698254|Immunoglobulin G|immunoglobulin g|mesh-list
101888297|NCT02698254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888298|NCT02698254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101888299|NCT02698254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101888300|NCT02698254|Growth Substances|growth substances|mesh-ancestor
101888301|NCT02698254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888302|NCT02698254|Growth Inhibitors|growth inhibitors|mesh-ancestor
101888303|NCT02698254|Immunologic Factors|immunologic factors|mesh-ancestor
101888304|NCT02659930|Doxorubicin|doxorubicin|mesh-list
101888305|NCT02659930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101888306|NCT02659930|Pomalidomide|pomalidomide|mesh-list
101888307|NCT02659930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101888308|NCT02659930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888309|NCT02659930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101888310|NCT02659930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101888311|NCT02659930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101888312|NCT02659930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888313|NCT02659930|Immunologic Factors|immunologic factors|mesh-ancestor
101888314|NCT02659930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888315|NCT02659930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101968700|NCT02274142|Adrenergic Agents|adrenergic agents|mesh-ancestor
101888316|NCT02659930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101888317|NCT02659930|Growth Substances|growth substances|mesh-ancestor
101888318|NCT02659930|Growth Inhibitors|growth inhibitors|mesh-ancestor
101888320|NCT02633059|Dexamethasone acetate|dexamethasone acetate|mesh-list
101888322|NCT02633059|Ichthammol|ichthammol|mesh-list
101888323|NCT02633059|BB 1101|bb 1101|mesh-list
101888324|NCT02633059|Glycine|glycine|mesh-list
101888325|NCT02633059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101888326|NCT02633059|Antiemetics|antiemetics|mesh-ancestor
101888327|NCT02633059|Autonomic Agents|autonomic agents|mesh-ancestor
101888328|NCT02633059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101888329|NCT02633059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888330|NCT02633059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101888331|NCT02633059|Glucocorticoids|glucocorticoids|mesh-ancestor
101888332|NCT02633059|Hormones|hormones|mesh-ancestor
101888333|NCT02633059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101888334|NCT02633059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101888335|NCT02633059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888336|NCT02633059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888337|NCT02633059|Protease Inhibitors|protease inhibitors|mesh-ancestor
101888338|NCT02633059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101888339|NCT02633059|Dermatologic Agents|dermatologic agents|mesh-ancestor
101888340|NCT02633059|Glycine Agents|glycine agents|mesh-ancestor
101888341|NCT02633059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101888342|NCT02598349|Capecitabine|capecitabine|mesh-list
101888343|NCT02598349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101888344|NCT02598349|Antimetabolites|antimetabolites|mesh-ancestor
101888345|NCT02598349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888346|NCT02598349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888347|NCT02581943|Paclitaxel|paclitaxel|mesh-list
101888348|NCT02581943|Carboplatin|carboplatin|mesh-list
101888349|NCT02581943|Pembrolizumab|pembrolizumab|mesh-list
101888350|NCT02581943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101888351|NCT02581943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101888352|NCT02581943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888353|NCT02581943|Tubulin Modulators|tubulin modulators|mesh-ancestor
101888354|NCT02581943|Antimitotic Agents|antimitotic agents|mesh-ancestor
101888355|NCT02581943|Mitosis Modulators|mitosis modulators|mesh-ancestor
101888356|NCT02581943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888357|NCT02581943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101888358|NCT02581943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101888359|NCT02568553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101888360|NCT02568553|Lenalidomide|lenalidomide|mesh-list
101888361|NCT02568553|Blinatumomab|blinatumomab|mesh-list
101888362|NCT02568553|Antibodies|antibodies|mesh-list
101888363|NCT02568553|Immunoglobulins|immunoglobulins|mesh-list
101888364|NCT02568553|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101888365|NCT02568553|Muromonab-CD3|muromonab-cd3|mesh-list
101888366|NCT02568553|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101888367|NCT02568553|Immunologic Factors|immunologic factors|mesh-ancestor
101888368|NCT02568553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888369|NCT02568553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888370|NCT02568553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101888371|NCT02568553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101888372|NCT02568553|Growth Substances|growth substances|mesh-ancestor
101888373|NCT02568553|Growth Inhibitors|growth inhibitors|mesh-ancestor
101888374|NCT02568553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101888375|NCT02562235|Riociguat|riociguat|mesh-list
101888376|NCT02562235|Enzyme Activators|enzyme activators|mesh-ancestor
101888377|NCT02562235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888378|NCT02527200|Liraglutide|liraglutide|mesh-list
101888379|NCT02527200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101888380|NCT02527200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888381|NCT02527200|Incretins|incretins|mesh-ancestor
101888382|NCT02527200|Hormones|hormones|mesh-ancestor
101888383|NCT02527200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101888384|NCT02520791|Antibodies|antibodies|mesh-list
101888385|NCT02520791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101888386|NCT02520791|Immunologic Factors|immunologic factors|mesh-ancestor
101888387|NCT02520791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888388|NCT02510040|Botulinum Toxins|botulinum toxins|mesh-list
101333227|NCT00001190|Deslorelin|deslorelin|mesh-list
101888389|NCT02510040|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101888390|NCT02510040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101888391|NCT02510040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888392|NCT02510040|Cholinergic Agents|cholinergic agents|mesh-ancestor
101888393|NCT02510040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101888394|NCT02510040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888395|NCT02414269|Cyclophosphamide|cyclophosphamide|mesh-list
101888396|NCT02414269|Pembrolizumab|pembrolizumab|mesh-list
101888397|NCT02414269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101888398|NCT02414269|Immunologic Factors|immunologic factors|mesh-ancestor
101888399|NCT02414269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888400|NCT02414269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101888401|NCT02414269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101888402|NCT02414269|Alkylating Agents|alkylating agents|mesh-ancestor
101888403|NCT02414269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888404|NCT02414269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888405|NCT02414269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101888406|NCT02414269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101888407|NCT02414269|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101888408|NCT02413736|Imatinib Mesylate|imatinib mesylate|mesh-list
101888409|NCT02413736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888410|NCT02413736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101888411|NCT02413736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101888412|NCT02413736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888413|NCT02341989|Carboplatin|carboplatin|mesh-list
101888415|NCT02341989|Bleomycin|bleomycin|mesh-list
101888416|NCT02341989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888417|NCT02341989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101888418|NCT02341989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101888419|NCT02341989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101888420|NCT02341989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101888421|NCT02341989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888422|NCT02341989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101888423|NCT02296125|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101888424|NCT02296125|Gefitinib|gefitinib|mesh-list
101888425|NCT02296125|Osimertinib|osimertinib|mesh-list
101888426|NCT02296125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888427|NCT02296125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101888428|NCT02296125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101888429|NCT02296125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888430|NCT02285192|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101888431|NCT02285192|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101888432|NCT02285192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888433|NCT02267603|Pembrolizumab|pembrolizumab|mesh-list
101888434|NCT02267603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101888435|NCT02267603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888436|NCT02267603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101888437|NCT02267603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888438|NCT02244125|Dexamethasone|dexamethasone|mesh-list
101888439|NCT02244125|Cyclophosphamide|cyclophosphamide|mesh-list
101888440|NCT02244125|Pomalidomide|pomalidomide|mesh-list
101888441|NCT02244125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101888442|NCT02244125|Immunologic Factors|immunologic factors|mesh-ancestor
101888443|NCT02244125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888444|NCT02244125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101888445|NCT02244125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101888446|NCT02244125|Alkylating Agents|alkylating agents|mesh-ancestor
101888447|NCT02244125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888448|NCT02244125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888449|NCT02244125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101888450|NCT02244125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101888451|NCT02244125|Antiemetics|antiemetics|mesh-ancestor
101888452|NCT02244125|Autonomic Agents|autonomic agents|mesh-ancestor
101888453|NCT02244125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101888454|NCT02244125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101888455|NCT02244125|Glucocorticoids|glucocorticoids|mesh-ancestor
101888456|NCT02244125|Hormones|hormones|mesh-ancestor
101888457|NCT02244125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101888458|NCT02244125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101888467|NCT02243878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888468|NCT02243878|Growth Inhibitors|growth inhibitors|mesh-ancestor
101888469|NCT02243878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888471|NCT02199236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101888473|NCT02199236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888474|NCT02199236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888482|NCT02157051|Vaccines|vaccines|mesh-list
101888483|NCT02157051|Immunologic Factors|immunologic factors|mesh-ancestor
101888484|NCT02157051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888485|NCT02111941|Vaccines|vaccines|mesh-list
101888486|NCT02111941|Immunologic Factors|immunologic factors|mesh-ancestor
101888487|NCT02111941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888488|NCT02037048|Leucovorin|leucovorin|mesh-list
101888489|NCT02037048|Paclitaxel|paclitaxel|mesh-list
101888490|NCT02037048|Carboplatin|carboplatin|mesh-list
101888491|NCT02037048|Fluorouracil|fluorouracil|mesh-list
101888492|NCT02037048|Oxaliplatin|oxaliplatin|mesh-list
101888493|NCT02037048|Calcium|calcium|mesh-list
101888494|NCT02037048|Levoleucovorin|levoleucovorin|mesh-list
101888495|NCT02037048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101888497|NCT02037048|Tubulin Modulators|tubulin modulators|mesh-ancestor
101888498|NCT02037048|Antimitotic Agents|antimitotic agents|mesh-ancestor
101888499|NCT02037048|Mitosis Modulators|mitosis modulators|mesh-ancestor
101888500|NCT02037048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888501|NCT02037048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101888502|NCT02037048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888503|NCT02037048|Antimetabolites|antimetabolites|mesh-ancestor
101888504|NCT02037048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101888505|NCT02037048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101888506|NCT02037048|Immunologic Factors|immunologic factors|mesh-ancestor
101888507|NCT02037048|Antidotes|antidotes|mesh-ancestor
101888508|NCT02037048|Protective Agents|protective agents|mesh-ancestor
101888509|NCT02037048|Vitamin B Complex|vitamin b complex|mesh-ancestor
101888510|NCT02037048|Vitamins|vitamins|mesh-ancestor
101888511|NCT02037048|Micronutrients|micronutrients|mesh-ancestor
101888512|NCT01935089|Interferons|interferons|mesh-list
101888513|NCT01935089|Interferon-alpha|interferon-alpha|mesh-list
101888514|NCT01935089|Interferon alpha-2|interferon alpha-2|mesh-list
101888515|NCT01935089|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101888516|NCT01935089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888517|NCT01935089|Antiviral Agents|antiviral agents|mesh-ancestor
101888518|NCT01935089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101888519|NCT01935089|Immunologic Factors|immunologic factors|mesh-ancestor
101888520|NCT01935089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888530|NCT01803152|Gemcitabine|gemcitabine|mesh-list
101888531|NCT01803152|Imiquimod|imiquimod|mesh-list
101888532|NCT01803152|Vaccines|vaccines|mesh-list
101888533|NCT01803152|Immunologic Factors|immunologic factors|mesh-ancestor
101775552|NCT00655980|Vitamin B 12|vitamin b 12|mesh-list
101888534|NCT01803152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888535|NCT01803152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101888536|NCT01803152|Antimetabolites|antimetabolites|mesh-ancestor
101888537|NCT01803152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888538|NCT01803152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888539|NCT01803152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101888540|NCT01803152|Interferon Inducers|interferon inducers|mesh-ancestor
101888541|NCT01787409|Vitamin D|vitamin d|mesh-list
101888542|NCT01787409|Cholecalciferol|cholecalciferol|mesh-list
101888543|NCT01787409|Vitamins|vitamins|mesh-ancestor
101888544|NCT01787409|Micronutrients|micronutrients|mesh-ancestor
101888545|NCT01787409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888546|NCT01787409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101888547|NCT01787409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101888548|NCT01773707|Abatacept|abatacept|mesh-list
101888549|NCT01773707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101888550|NCT01773707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888551|NCT01773707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101888552|NCT01773707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888553|NCT01773707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101888554|NCT01773707|Immunologic Factors|immunologic factors|mesh-ancestor
101968714|NCT00752050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101888555|NCT01773707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888556|NCT01773707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101888557|NCT01628640|Interferons|interferons|mesh-list
101888558|NCT01628640|Interferon-beta|interferon-beta|mesh-list
101888559|NCT01628640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888560|NCT01628640|Antiviral Agents|antiviral agents|mesh-ancestor
101888561|NCT01628640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101888562|NCT01628640|Immunologic Factors|immunologic factors|mesh-ancestor
101888563|NCT01628640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888564|NCT01628029|Melatonin|melatonin|mesh-list
101888565|NCT01628029|Methylphenidate|methylphenidate|mesh-list
101888566|NCT01628029|Antioxidants|antioxidants|mesh-ancestor
101888567|NCT01628029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888568|NCT01628029|Protective Agents|protective agents|mesh-ancestor
101888569|NCT01628029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888570|NCT01628029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101888571|NCT01628029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101888572|NCT01628029|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101888573|NCT01628029|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101888574|NCT01628029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101888575|NCT01628029|Dopamine Agents|dopamine agents|mesh-ancestor
101888576|NCT01628029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101888577|NCT01504815|Cisplatin|cisplatin|mesh-list
101888578|NCT01504815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888579|NCT01494662|Capecitabine|capecitabine|mesh-list
101888580|NCT01494662|Trastuzumab|trastuzumab|mesh-list
101888581|NCT01494662|Maytansine|maytansine|mesh-list
101888582|NCT01494662|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101888583|NCT01494662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101888584|NCT01494662|Antimetabolites|antimetabolites|mesh-ancestor
101888585|NCT01494662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888586|NCT01494662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888587|NCT01494662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101888588|NCT01494662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101888589|NCT01494662|Tubulin Modulators|tubulin modulators|mesh-ancestor
101888590|NCT01494662|Antimitotic Agents|antimitotic agents|mesh-ancestor
101888591|NCT01494662|Mitosis Modulators|mitosis modulators|mesh-ancestor
101888592|NCT01494662|Immunotoxins|immunotoxins|mesh-ancestor
101888593|NCT01494662|Immunoconjugates|immunoconjugates|mesh-ancestor
101888594|NCT01494662|Immunologic Factors|immunologic factors|mesh-ancestor
101888595|NCT01494662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888596|NCT01413100|Mycophenolic Acid|mycophenolic acid|mesh-list
101888597|NCT01413100|Plerixafor|plerixafor|mesh-list
101888598|NCT01413100|Cyclophosphamide|cyclophosphamide|mesh-list
101888599|NCT01413100|Thymoglobulin|thymoglobulin|mesh-list
101888600|NCT01413100|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101888601|NCT01413100|Lenograstim|lenograstim|mesh-list
101888602|NCT01413100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101888603|NCT01413100|Immunologic Factors|immunologic factors|mesh-ancestor
101888604|NCT01413100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888605|NCT01413100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101888606|NCT01413100|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101888607|NCT01413100|Alkylating Agents|alkylating agents|mesh-ancestor
101888608|NCT01413100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888609|NCT01413100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888610|NCT01413100|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101888611|NCT01413100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101888612|NCT01413100|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101888613|NCT01413100|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101888614|NCT01413100|Antitubercular Agents|antitubercular agents|mesh-ancestor
101888615|NCT01413100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101888616|NCT01413100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101888617|NCT01413100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101888618|NCT01413100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101888619|NCT01413100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101888620|NCT01413100|Antiviral Agents|antiviral agents|mesh-ancestor
101888622|NCT01334944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101888623|NCT01334944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101888624|NCT01334944|Analgesics|analgesics|mesh-ancestor
101888625|NCT01334944|Sensory System Agents|sensory system agents|mesh-ancestor
101888626|NCT01334944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101968718|NCT02276014|Antioxidants|antioxidants|mesh-ancestor
101888627|NCT01334944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888628|NCT01334944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101888629|NCT01334944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101888630|NCT01334944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101888631|NCT01334944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101888632|NCT01334944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888633|NCT01140373|Cyclophosphamide|cyclophosphamide|mesh-list
101888634|NCT01140373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101888635|NCT01140373|Immunologic Factors|immunologic factors|mesh-ancestor
101888636|NCT01140373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888637|NCT01140373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101888638|NCT01140373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101888639|NCT01140373|Alkylating Agents|alkylating agents|mesh-ancestor
101888640|NCT01140373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888641|NCT01140373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888642|NCT01140373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101888643|NCT00810732|Nifedipine|nifedipine|mesh-list
101888644|NCT00810732|Sitaxsentan|sitaxsentan|mesh-list
101608459|NCT00629382|Polymyxins|polymyxins|mesh-list
101888645|NCT00810732|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101888646|NCT00810732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101888647|NCT00810732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888648|NCT00810732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101888649|NCT00810732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888650|NCT00810732|Vasodilator Agents|vasodilator agents|mesh-ancestor
101888651|NCT00810732|Tocolytic Agents|tocolytic agents|mesh-ancestor
101888652|NCT00810732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101888653|NCT00810732|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101888654|NCT00770809|Paclitaxel|paclitaxel|mesh-list
101888655|NCT00770809|Trastuzumab|trastuzumab|mesh-list
101888656|NCT00770809|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101888657|NCT00770809|Lapatinib|lapatinib|mesh-list
101888658|NCT00770809|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
101888659|NCT00770809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101888660|NCT00770809|Antibodies|antibodies|mesh-list
101888661|NCT00770809|Immunoglobulins|immunoglobulins|mesh-list
101888662|NCT00770809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101888663|NCT00770809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101888664|NCT00770809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888665|NCT00770809|Tubulin Modulators|tubulin modulators|mesh-ancestor
101888666|NCT00770809|Antimitotic Agents|antimitotic agents|mesh-ancestor
101888667|NCT00770809|Mitosis Modulators|mitosis modulators|mesh-ancestor
101888668|NCT00770809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888669|NCT00770809|Immunologic Factors|immunologic factors|mesh-ancestor
101888670|NCT00770809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888671|NCT00770809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101888672|NCT00770809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101888673|NCT00719888|Cyclosporine|cyclosporine|mesh-list
101888674|NCT00719888|Mycophenolic Acid|mycophenolic acid|mesh-list
101888675|NCT00719888|Cyclophosphamide|cyclophosphamide|mesh-list
101888676|NCT00719888|Thiotepa|thiotepa|mesh-list
101888677|NCT00719888|Fludarabine|fludarabine|mesh-list
101888678|NCT00719888|Cyclosporins|cyclosporins|mesh-list
101888679|NCT00719888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101888680|NCT00719888|Immunologic Factors|immunologic factors|mesh-ancestor
101888681|NCT00719888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888682|NCT00719888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101888683|NCT00719888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101888684|NCT00719888|Alkylating Agents|alkylating agents|mesh-ancestor
101888685|NCT00719888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888686|NCT00719888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888687|NCT00719888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101888688|NCT00719888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101888689|NCT00719888|Antifungal Agents|antifungal agents|mesh-ancestor
101888690|NCT00719888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101888691|NCT00719888|Dermatologic Agents|dermatologic agents|mesh-ancestor
101968722|NCT02276014|Provitamins|provitamins|mesh-ancestor
101888692|NCT00719888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101888693|NCT00719888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101888694|NCT00719888|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101888695|NCT00719888|Antitubercular Agents|antitubercular agents|mesh-ancestor
101888696|NCT00719888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101888697|NCT00571727|Mecasermin|mecasermin|mesh-list
101888698|NCT00571727|Growth Substances|growth substances|mesh-ancestor
101888699|NCT00571727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888700|NCT00489307|Dexamethasone|dexamethasone|mesh-list
101888701|NCT00489307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101888702|NCT00489307|Antiemetics|antiemetics|mesh-ancestor
101888703|NCT00489307|Autonomic Agents|autonomic agents|mesh-ancestor
101888704|NCT00489307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101888705|NCT00489307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888706|NCT00489307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101888707|NCT00489307|Glucocorticoids|glucocorticoids|mesh-ancestor
101888708|NCT00489307|Hormones|hormones|mesh-ancestor
101888709|NCT00489307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101888710|NCT00489307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101888711|NCT00489307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888712|NCT00427349|Octreotide|octreotide|mesh-list
101888713|NCT00427349|Motesanib diphosphate|motesanib diphosphate|mesh-list
101888714|NCT00427349|Imetelstat|imetelstat|mesh-list
101888715|NCT00427349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101888716|NCT00427349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101888717|NCT00427349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888718|NCT00427349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101608524|NCT03762564|Mitosis Modulators|mitosis modulators|mesh-ancestor
101888719|NCT00427349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101888720|NCT00427349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888721|NCT00309985|Docetaxel|docetaxel|mesh-list
101888722|NCT00309985|Androgens|androgens|mesh-list
101888723|NCT00309985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888724|NCT00309985|Tubulin Modulators|tubulin modulators|mesh-ancestor
101888725|NCT00309985|Antimitotic Agents|antimitotic agents|mesh-ancestor
101888726|NCT00309985|Mitosis Modulators|mitosis modulators|mesh-ancestor
101888727|NCT00309985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888728|NCT00309985|Hormones|hormones|mesh-ancestor
101888729|NCT00309985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101888730|NCT00309985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888731|NCT00295893|Paclitaxel|paclitaxel|mesh-list
101888732|NCT00295893|Docetaxel|docetaxel|mesh-list
101888733|NCT00295893|Cyclophosphamide|cyclophosphamide|mesh-list
101888734|NCT00295893|Carboplatin|carboplatin|mesh-list
101888735|NCT00295893|Doxorubicin|doxorubicin|mesh-list
101888736|NCT00295893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101888737|NCT00295893|Trastuzumab|trastuzumab|mesh-list
101888738|NCT00295893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101888739|NCT00295893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888740|NCT00295893|Tubulin Modulators|tubulin modulators|mesh-ancestor
101888741|NCT00295893|Antimitotic Agents|antimitotic agents|mesh-ancestor
101888742|NCT00295893|Mitosis Modulators|mitosis modulators|mesh-ancestor
101888743|NCT00295893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888744|NCT00295893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101888745|NCT00295893|Immunologic Factors|immunologic factors|mesh-ancestor
101888746|NCT00295893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888747|NCT00295893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101888748|NCT00295893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101888749|NCT00295893|Alkylating Agents|alkylating agents|mesh-ancestor
101251572|NCT05215951|Osimertinib|osimertinib|mesh-list
101888750|NCT00295893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101888751|NCT00295893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101888752|NCT00295893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101888753|NCT00295893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101888754|NCT00295893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775633|NCT00809874|Caseins|caseins|mesh-list
101888755|NCT00295893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101888756|NCT00200174|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101888757|NCT00200174|Exemestane|exemestane|mesh-list
101888758|NCT00200174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888759|NCT00200174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101888760|NCT00200174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101968732|NCT02281240|Heparin|heparin|mesh-list
101888761|NCT00200174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101888762|NCT00200174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888763|NCT00200174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101888764|NCT00200174|Hormone Antagonists|hormone antagonists|mesh-ancestor
101888765|NCT00200174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101888766|NCT00200174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888767|NCT00200174|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101888768|NCT00200174|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101888769|NCT00200174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101888770|NCT00195091|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
101888771|NCT00195091|Chelating Agents|chelating agents|mesh-ancestor
101888772|NCT00195091|Sequestering Agents|sequestering agents|mesh-ancestor
101888773|NCT00195091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888774|NCT00195091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101888775|NCT00195091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101888776|NCT00195091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101888777|NCT00195091|Growth Substances|growth substances|mesh-ancestor
101888778|NCT00195091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888779|NCT00195091|Growth Inhibitors|growth inhibitors|mesh-ancestor
101888780|NCT00195091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888781|NCT00098787|Leucovorin|leucovorin|mesh-list
101888782|NCT00098787|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
101888783|NCT00098787|Tetrahydrofolates|tetrahydrofolates|mesh-list
101888784|NCT00098787|Bevacizumab|bevacizumab|mesh-list
101888785|NCT00098787|Fluorouracil|fluorouracil|mesh-list
101888786|NCT00098787|Oxaliplatin|oxaliplatin|mesh-list
101888787|NCT00098787|Irinotecan|irinotecan|mesh-list
101888788|NCT00098787|Camptothecin|camptothecin|mesh-list
101888789|NCT00098787|Levoleucovorin|levoleucovorin|mesh-list
101888790|NCT00098787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101888791|NCT00098787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888792|NCT00098787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101888793|NCT00098787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101888794|NCT00098787|Growth Substances|growth substances|mesh-ancestor
101888795|NCT00098787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888796|NCT00098787|Growth Inhibitors|growth inhibitors|mesh-ancestor
101888797|NCT00098787|Antimetabolites|antimetabolites|mesh-ancestor
101888798|NCT00098787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888799|NCT00098787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101888800|NCT00098787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101888801|NCT00098787|Immunologic Factors|immunologic factors|mesh-ancestor
101888802|NCT00098787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101888803|NCT00098787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101888804|NCT00098787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101888805|NCT00098787|Antidotes|antidotes|mesh-ancestor
101888806|NCT00098787|Protective Agents|protective agents|mesh-ancestor
101888807|NCT00098787|Vitamin B Complex|vitamin b complex|mesh-ancestor
101888808|NCT00098787|Vitamins|vitamins|mesh-ancestor
101888809|NCT00098787|Micronutrients|micronutrients|mesh-ancestor
101775653|NCT00535288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101888810|NCT00098787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101888811|NCT00075946|Rituximab|rituximab|mesh-list
101888812|NCT00075946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101888813|NCT00075946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888814|NCT00075946|Immunologic Factors|immunologic factors|mesh-ancestor
101888815|NCT00075946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888816|NCT00075946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101888817|NCT00074165|Cytarabine|cytarabine|mesh-list
101888818|NCT00074165|Sodium thiosulfate|sodium thiosulfate|mesh-list
101888819|NCT00074165|Cyclophosphamide|cyclophosphamide|mesh-list
101888820|NCT00074165|Rituximab|rituximab|mesh-list
101888821|NCT00074165|Carboplatin|carboplatin|mesh-list
101888822|NCT00074165|Etoposide|etoposide|mesh-list
101888823|NCT00074165|Etoposide phosphate|etoposide phosphate|mesh-list
101888824|NCT00074165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101888825|NCT00074165|Immunologic Factors|immunologic factors|mesh-ancestor
101888826|NCT00074165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888827|NCT00074165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101888828|NCT00074165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101888829|NCT00074165|Alkylating Agents|alkylating agents|mesh-ancestor
101888830|NCT00074165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888831|NCT00074165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888832|NCT00074165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101888833|NCT00074165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101888834|NCT00074165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101888835|NCT00074165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101888836|NCT00074165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101888837|NCT00074165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101888838|NCT00074165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101888839|NCT00074165|Antimetabolites|antimetabolites|mesh-ancestor
101888840|NCT00074165|Antiviral Agents|antiviral agents|mesh-ancestor
101888841|NCT00074165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101888842|NCT00074165|Antidotes|antidotes|mesh-ancestor
101888843|NCT00074165|Protective Agents|protective agents|mesh-ancestor
101888844|NCT00074165|Antioxidants|antioxidants|mesh-ancestor
101888845|NCT00074165|Antitubercular Agents|antitubercular agents|mesh-ancestor
101888846|NCT00074165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101888847|NCT00074165|Chelating Agents|chelating agents|mesh-ancestor
101888848|NCT00074165|Sequestering Agents|sequestering agents|mesh-ancestor
101888849|NCT00059930|Leucovorin|leucovorin|mesh-list
101888850|NCT00059930|Dexamethasone|dexamethasone|mesh-list
101888851|NCT00059930|Fluorouracil|fluorouracil|mesh-list
101888852|NCT00059930|Oxaliplatin|oxaliplatin|mesh-list
101888853|NCT00059930|Floxuridine|floxuridine|mesh-list
101888854|NCT00059930|Calcium|calcium|mesh-list
101888855|NCT00059930|Levoleucovorin|levoleucovorin|mesh-list
101888856|NCT00059930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101888857|NCT00059930|Antiemetics|antiemetics|mesh-ancestor
101888858|NCT00059930|Autonomic Agents|autonomic agents|mesh-ancestor
101888859|NCT00059930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101888860|NCT00059930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888861|NCT00059930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101888862|NCT00059930|Glucocorticoids|glucocorticoids|mesh-ancestor
101888863|NCT00059930|Hormones|hormones|mesh-ancestor
101888864|NCT00059930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101888865|NCT00059930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101888866|NCT00059930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888867|NCT00059930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101888868|NCT00059930|Antimetabolites|antimetabolites|mesh-ancestor
101888869|NCT00059930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775670|NCT00921830|Ibuprofen|ibuprofen|mesh-list
101888870|NCT00059930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101888871|NCT00059930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101888872|NCT00059930|Immunologic Factors|immunologic factors|mesh-ancestor
101888873|NCT00059930|Antidotes|antidotes|mesh-ancestor
101888874|NCT00059930|Protective Agents|protective agents|mesh-ancestor
101888875|NCT00059930|Vitamin B Complex|vitamin b complex|mesh-ancestor
101888877|NCT00059930|Micronutrients|micronutrients|mesh-ancestor
101888878|NCT00057876|Gemcitabine|gemcitabine|mesh-list
101888879|NCT00057876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101888880|NCT00057876|Antimetabolites|antimetabolites|mesh-ancestor
101888881|NCT00057876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888882|NCT00057876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888883|NCT00057837|Cisplatin|cisplatin|mesh-list
101888884|NCT00057837|Irinotecan|irinotecan|mesh-list
101888885|NCT00057837|Etoposide|etoposide|mesh-list
101888886|NCT00057837|Etoposide phosphate|etoposide phosphate|mesh-list
101888887|NCT00057837|Topotecan|topotecan|mesh-list
101888888|NCT00057837|Podophyllotoxin|podophyllotoxin|mesh-list
101888889|NCT00057837|Camptothecin|camptothecin|mesh-list
101888890|NCT00057837|Lenograstim|lenograstim|mesh-list
101888891|NCT00057837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888892|NCT00057837|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101888893|NCT00057837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101888894|NCT00057837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101888895|NCT00057837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888896|NCT00057837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101888897|NCT00057837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101888898|NCT00057837|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101888899|NCT00057837|Immunologic Factors|immunologic factors|mesh-ancestor
101251715|NCT04824092|Hormones|hormones|mesh-ancestor
101888900|NCT00057837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888901|NCT00057837|Keratolytic Agents|keratolytic agents|mesh-ancestor
101888902|NCT00057837|Dermatologic Agents|dermatologic agents|mesh-ancestor
101888903|NCT00057837|Tubulin Modulators|tubulin modulators|mesh-ancestor
101888904|NCT00057837|Antimitotic Agents|antimitotic agents|mesh-ancestor
101888905|NCT00057837|Mitosis Modulators|mitosis modulators|mesh-ancestor
101888907|NCT00046930|Daunorubicin|daunorubicin|mesh-list
101888908|NCT00046930|Molgramostim|molgramostim|mesh-list
101888909|NCT00046930|Lenograstim|lenograstim|mesh-list
101888910|NCT00046930|Sargramostim|sargramostim|mesh-list
101888911|NCT00046930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101888912|NCT00046930|Antimetabolites|antimetabolites|mesh-ancestor
101888913|NCT00046930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888914|NCT00046930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888915|NCT00046930|Antiviral Agents|antiviral agents|mesh-ancestor
101888916|NCT00046930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101888917|NCT00046930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101888918|NCT00046930|Immunologic Factors|immunologic factors|mesh-ancestor
101888919|NCT00046930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888920|NCT00046930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101888921|NCT00046930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101888922|NCT00046930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101888923|NCT00046930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101888924|NCT00046930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101888925|NCT00042939|Docetaxel|docetaxel|mesh-list
101888926|NCT00042939|Irinotecan|irinotecan|mesh-list
101888927|NCT00042939|Cetuximab|cetuximab|mesh-list
101888928|NCT00042939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888929|NCT00042939|Tubulin Modulators|tubulin modulators|mesh-ancestor
101888930|NCT00042939|Antimitotic Agents|antimitotic agents|mesh-ancestor
101888931|NCT00042939|Mitosis Modulators|mitosis modulators|mesh-ancestor
101888932|NCT00042939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888933|NCT00042939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101888934|NCT00042939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101888935|NCT00042939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101888936|NCT00042939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101888937|NCT00008385|Selenium|selenium|mesh-list
101888938|NCT00008385|Antioxidants|antioxidants|mesh-ancestor
101888939|NCT00008385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888940|NCT00008385|Protective Agents|protective agents|mesh-ancestor
101888941|NCT00008385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888942|NCT00008385|Trace Elements|trace elements|mesh-ancestor
101888943|NCT00008385|Micronutrients|micronutrients|mesh-ancestor
101888944|NCT00003927|Paclitaxel|paclitaxel|mesh-list
101888945|NCT00003927|Cyclophosphamide|cyclophosphamide|mesh-list
101888946|NCT00003927|Doxorubicin|doxorubicin|mesh-list
101888947|NCT00003927|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101888948|NCT00003927|Amifostine|amifostine|mesh-list
101888949|NCT00003927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101888950|NCT00003927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888951|NCT00003927|Tubulin Modulators|tubulin modulators|mesh-ancestor
101888952|NCT00003927|Antimitotic Agents|antimitotic agents|mesh-ancestor
101888953|NCT00003927|Mitosis Modulators|mitosis modulators|mesh-ancestor
101888954|NCT00003927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888955|NCT00003927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101888956|NCT00003927|Immunologic Factors|immunologic factors|mesh-ancestor
101888957|NCT00003927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888958|NCT00003927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101888959|NCT00003927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101888960|NCT00003927|Alkylating Agents|alkylating agents|mesh-ancestor
101888961|NCT00003927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101888962|NCT00003927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101888963|NCT00003927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101888964|NCT00003927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101888965|NCT00003927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101888966|NCT00003927|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101888967|NCT00003927|Protective Agents|protective agents|mesh-ancestor
101888969|NCT00003910|Cyclophosphamide|cyclophosphamide|mesh-list
101888971|NCT00003910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101888972|NCT00003910|Immunologic Factors|immunologic factors|mesh-ancestor
101888973|NCT00003910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101888974|NCT00003910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101888975|NCT00003910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101888976|NCT00003910|Alkylating Agents|alkylating agents|mesh-ancestor
101888977|NCT00003910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101888978|NCT00003910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101888979|NCT00003910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101888980|NCT00003910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101888981|NCT00003910|Glucocorticoids|glucocorticoids|mesh-ancestor
101888982|NCT00003910|Hormones|hormones|mesh-ancestor
101888983|NCT00003910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101888984|NCT00003910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101888985|NCT00003910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101888986|NCT00003910|Abortifacient Agents|abortifacient agents|mesh-ancestor
101888987|NCT00003910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101888988|NCT00003910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101888989|NCT00003910|Antimetabolites|antimetabolites|mesh-ancestor
101888990|NCT00003910|Dermatologic Agents|dermatologic agents|mesh-ancestor
101888991|NCT00003910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775696|NCT04836832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101888992|NCT00003910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101888993|NCT00003910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101888994|NCT00003907|Cisplatin|cisplatin|mesh-list
101888995|NCT00003907|Doxorubicin|doxorubicin|mesh-list
101888996|NCT00003907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101888997|NCT00003907|Mitomycins|mitomycins|mesh-list
101888998|NCT00003907|Mitomycin|mitomycin|mesh-list
101888999|NCT00003907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889000|NCT00003907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101889001|NCT00003907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101889002|NCT00003907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101889003|NCT00003907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101889004|NCT00003907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889005|NCT00003907|Alkylating Agents|alkylating agents|mesh-ancestor
101889006|NCT00003907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101889007|NCT04331067|Paclitaxel|paclitaxel|mesh-list
101889008|NCT04331067|Carboplatin|carboplatin|mesh-list
101889009|NCT04331067|Nivolumab|nivolumab|mesh-list
101889010|NCT04331067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101889011|NCT04331067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889012|NCT04331067|Tubulin Modulators|tubulin modulators|mesh-ancestor
101889013|NCT04331067|Antimitotic Agents|antimitotic agents|mesh-ancestor
101889014|NCT04331067|Mitosis Modulators|mitosis modulators|mesh-ancestor
101889015|NCT04331067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889016|NCT04331067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101889017|NCT04331067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101889018|NCT04329221|Calcitriol|calcitriol|mesh-list
101889019|NCT04329221|Fluorouracil|fluorouracil|mesh-list
101889020|NCT04329221|Calcipotriene|calcipotriene|mesh-list
101889021|NCT04329221|Petrolatum|petrolatum|mesh-list
101889022|NCT04329221|Antimetabolites|antimetabolites|mesh-ancestor
101889023|NCT04329221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889024|NCT04329221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101889025|NCT04329221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889026|NCT04329221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101889027|NCT04329221|Immunologic Factors|immunologic factors|mesh-ancestor
101608822|NCT05779410|Ergocalciferols|ergocalciferols|mesh-list
101889028|NCT04329221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889029|NCT04329221|Dermatologic Agents|dermatologic agents|mesh-ancestor
102074176|NCT03554304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101889030|NCT04329221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101889031|NCT04329221|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101889032|NCT04329221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101889033|NCT04329221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101889034|NCT04329221|Vitamins|vitamins|mesh-ancestor
101889035|NCT04329221|Micronutrients|micronutrients|mesh-ancestor
101889036|NCT04329221|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101889037|NCT04329221|Emollients|emollients|mesh-ancestor
101889038|NCT04324840|Temozolomide|temozolomide|mesh-list
101889039|NCT04324840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101889040|NCT04324840|Alkylating Agents|alkylating agents|mesh-ancestor
101889041|NCT04324840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889042|NCT04324840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889044|NCT04316013|Propofol|propofol|mesh-list
101889045|NCT04316013|Sevoflurane|sevoflurane|mesh-list
101889046|NCT04316013|Anesthetics, Local|anesthetics, local|mesh-ancestor
101889047|NCT04316013|Anesthetics|anesthetics|mesh-ancestor
101889048|NCT04316013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101889049|NCT04316013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889050|NCT04316013|Sensory System Agents|sensory system agents|mesh-ancestor
101889051|NCT04316013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101889052|NCT04316013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101889053|NCT04316013|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101889054|NCT04316013|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101889055|NCT04316013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101889056|NCT04316013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889057|NCT04316013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101889058|NCT04316013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101889059|NCT04316013|Anesthetics, General|anesthetics, general|mesh-ancestor
101889060|NCT04316013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101889061|NCT04316013|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101889062|NCT04312594|Acetylcysteine|acetylcysteine|mesh-list
101889063|NCT04312594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101889064|NCT04312594|Antiviral Agents|antiviral agents|mesh-ancestor
101889065|NCT04312594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101889066|NCT04312594|Expectorants|expectorants|mesh-ancestor
101889067|NCT04312594|Respiratory System Agents|respiratory system agents|mesh-ancestor
101889068|NCT04312594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101889069|NCT04312594|Antioxidants|antioxidants|mesh-ancestor
101889070|NCT04312594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889071|NCT04312594|Protective Agents|protective agents|mesh-ancestor
101889072|NCT04312594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889073|NCT04312594|Antidotes|antidotes|mesh-ancestor
101889074|NCT04270474|Cholinergic Antagonists|cholinergic antagonists|mesh-list
101889075|NCT04270474|Cholinergic Agents|cholinergic agents|mesh-ancestor
101889076|NCT04270474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101889077|NCT04270474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889078|NCT04270474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889079|NCT04264897|Metformin|metformin|mesh-list
101889080|NCT04264897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101889081|NCT04264897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889082|NCT04225026|Manganese|manganese|mesh-list
101889083|NCT04225026|Avasopasem manganese|avasopasem manganese|mesh-list
101889084|NCT04225026|Trace Elements|trace elements|mesh-ancestor
101889085|NCT04225026|Micronutrients|micronutrients|mesh-ancestor
101889086|NCT04225026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074177|NCT03554304|Contraceptive Agents|contraceptive agents|mesh-ancestor
101889087|NCT04225026|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101889088|NCT04225026|Antioxidants|antioxidants|mesh-ancestor
101889089|NCT04225026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889090|NCT04225026|Protective Agents|protective agents|mesh-ancestor
101889091|NCT04177108|Paclitaxel|paclitaxel|mesh-list
101889092|NCT04177108|Atezolizumab|atezolizumab|mesh-list
101889093|NCT04177108|Ipatasertib|ipatasertib|mesh-list
101889094|NCT04177108|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101889095|NCT04177108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101889096|NCT04177108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889097|NCT04177108|Tubulin Modulators|tubulin modulators|mesh-ancestor
101889098|NCT04177108|Antimitotic Agents|antimitotic agents|mesh-ancestor
101889099|NCT04177108|Mitosis Modulators|mitosis modulators|mesh-ancestor
101889100|NCT04177108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889101|NCT04177108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101889102|NCT04177108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101889103|NCT04177108|Immunologic Factors|immunologic factors|mesh-ancestor
101889104|NCT04177108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889105|NCT04177108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101889106|NCT04177108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101889108|NCT04140513|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101889109|NCT04140513|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101889110|NCT04140513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889111|NCT04140513|Antimetabolites|antimetabolites|mesh-ancestor
101889112|NCT04140513|Antiviral Agents|antiviral agents|mesh-ancestor
101889113|NCT04140513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101889114|NCT04111627|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101889115|NCT04111627|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101889116|NCT04111627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101889117|NCT04111627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101889118|NCT04111627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889119|NCT04111627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101889120|NCT04111627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889121|NCT04111627|Analgesics|analgesics|mesh-ancestor
101889122|NCT04111627|Sensory System Agents|sensory system agents|mesh-ancestor
101889123|NCT04111627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101889124|NCT04111627|Antidepressive Agents|antidepressive agents|mesh-ancestor
101889125|NCT04111627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101889126|NCT04111627|Dopamine Agents|dopamine agents|mesh-ancestor
101889127|NCT04090710|Nivolumab|nivolumab|mesh-list
101889128|NCT04090710|Ipilimumab|ipilimumab|mesh-list
101889129|NCT04090710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101889130|NCT04090710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889131|NCT04090710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101889132|NCT04090710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889133|NCT04069312|Azithromycin|azithromycin|mesh-list
101889134|NCT04069312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101889135|NCT04069312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101889136|NCT04032080|Prexasertib|prexasertib|mesh-list
101889137|NCT04032080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101889138|NCT04032080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101889139|NCT04032080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889140|NCT03983954|Durvalumab|durvalumab|mesh-list
101889141|NCT03983954|Obinutuzumab|obinutuzumab|mesh-list
101889142|NCT03983954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101889143|NCT03983954|Naptumomab estafenatox|naptumomab estafenatox|mesh-list
101889144|NCT03983954|Immunoconjugates|immunoconjugates|mesh-list
101889145|NCT03983954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101889146|NCT03983954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889147|NCT03983954|Immunologic Factors|immunologic factors|mesh-ancestor
101889148|NCT03983954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889149|NCT03982277|Rifampin|rifampin|mesh-list
101889150|NCT03982277|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101889151|NCT03982277|Antitubercular Agents|antitubercular agents|mesh-ancestor
101889152|NCT03982277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101889153|NCT03982277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101889154|NCT03982277|Leprostatic Agents|leprostatic agents|mesh-ancestor
101889155|NCT03982277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101889156|NCT03982277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101889157|NCT03982277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889158|NCT03982277|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101889159|NCT03982277|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101889160|NCT03982277|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101889161|NCT03982277|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101889162|NCT03982277|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101889163|NCT03982277|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101889164|NCT03955978|Dostarlimab|dostarlimab|mesh-list
101889165|NCT03955978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889166|NCT03940352|Venetoclax|venetoclax|mesh-list
101889167|NCT03940352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889168|NCT03918499|Cyclophosphamide|cyclophosphamide|mesh-list
101889169|NCT03918499|Pembrolizumab|pembrolizumab|mesh-list
101889170|NCT03918499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101889171|NCT03918499|Immunologic Factors|immunologic factors|mesh-ancestor
101889172|NCT03918499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889173|NCT03918499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101889174|NCT03918499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101889175|NCT03918499|Alkylating Agents|alkylating agents|mesh-ancestor
101608983|NCT05565001|Cromakalim|cromakalim|mesh-list
101889176|NCT03918499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889177|NCT03918499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889178|NCT03918499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101689512|NCT00650598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101889179|NCT03918499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101889180|NCT03918499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101889182|NCT03914443|Docetaxel|docetaxel|mesh-list
101889183|NCT03914443|Fluorouracil|fluorouracil|mesh-list
101889184|NCT03914443|Nivolumab|nivolumab|mesh-list
101889185|NCT03914443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889186|NCT03914443|Tubulin Modulators|tubulin modulators|mesh-ancestor
101889187|NCT03914443|Antimitotic Agents|antimitotic agents|mesh-ancestor
101889188|NCT03914443|Mitosis Modulators|mitosis modulators|mesh-ancestor
101889189|NCT03914443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889190|NCT03914443|Antimetabolites|antimetabolites|mesh-ancestor
101889191|NCT03914443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101889192|NCT03914443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101889193|NCT03914443|Immunologic Factors|immunologic factors|mesh-ancestor
101889194|NCT03914443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889195|NCT03914443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101889196|NCT03914443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101889197|NCT03815890|Nivolumab|nivolumab|mesh-list
101889198|NCT03815890|Ipilimumab|ipilimumab|mesh-list
101889199|NCT03815890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101889200|NCT03815890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889201|NCT03815890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101889202|NCT03815890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889203|NCT03794583|Treprostinil|treprostinil|mesh-list
101889204|NCT03794583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101889205|NCT03777657|Capecitabine|capecitabine|mesh-list
101889206|NCT03777657|Oxaliplatin|oxaliplatin|mesh-list
101889207|NCT03777657|Tislelizumab|tislelizumab|mesh-list
101889208|NCT03777657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889209|NCT03777657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101889210|NCT03777657|Antimetabolites|antimetabolites|mesh-ancestor
101889211|NCT03777657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889212|NCT03777657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101889213|NCT03711474|Dexamethasone|dexamethasone|mesh-list
101889214|NCT03711474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101889215|NCT03711474|Antiemetics|antiemetics|mesh-ancestor
101889216|NCT03711474|Autonomic Agents|autonomic agents|mesh-ancestor
101889217|NCT03711474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101889218|NCT03711474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889219|NCT03711474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101889220|NCT03711474|Glucocorticoids|glucocorticoids|mesh-ancestor
101889221|NCT03711474|Hormones|hormones|mesh-ancestor
101889222|NCT03711474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101889223|NCT03711474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101889224|NCT03711474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889225|NCT03482024|Tirzepatide|tirzepatide|mesh-list
101889226|NCT03482024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101889227|NCT03482024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889228|NCT03482024|Incretins|incretins|mesh-ancestor
101889229|NCT03482024|Hormones|hormones|mesh-ancestor
101889230|NCT03482024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101889231|NCT03423199|Tamoxifen|tamoxifen|mesh-list
101889232|NCT03423199|Goserelin|goserelin|mesh-list
101889233|NCT03423199|Palbociclib|palbociclib|mesh-list
101889234|NCT03423199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101889235|NCT03423199|Hormone Antagonists|hormone antagonists|mesh-ancestor
101889236|NCT03423199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101889237|NCT03423199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889238|NCT03423199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101889239|NCT03423199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889240|NCT03423199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101889241|NCT03423199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101889242|NCT03423199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101889243|NCT03423199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101889244|NCT03423199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101889245|NCT03423199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889246|NCT03423147|Chlorhexidine|chlorhexidine|mesh-list
101889247|NCT03423147|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101889248|NCT03423147|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101889249|NCT03423147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101889250|NCT03423147|Disinfectants|disinfectants|mesh-ancestor
101889251|NCT03423147|Dermatologic Agents|dermatologic agents|mesh-ancestor
101889252|NCT03418532|Osimertinib|osimertinib|mesh-list
101889253|NCT03418532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889254|NCT03418532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101889255|NCT03418532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101889256|NCT03418532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889257|NCT03417401|Plasminogen|plasminogen|mesh-list
101889258|NCT03417401|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101889259|NCT03417401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101889260|NCT03417401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101889261|NCT03417401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889262|NCT03322631|Tirzepatide|tirzepatide|mesh-list
101889263|NCT03322631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101889264|NCT03322631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889265|NCT03322631|Incretins|incretins|mesh-ancestor
101889267|NCT03322631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101889268|NCT03290612|Ascorbic Acid|ascorbic acid|mesh-list
101889269|NCT03290612|Vitamins|vitamins|mesh-ancestor
101889270|NCT03290612|Micronutrients|micronutrients|mesh-ancestor
101889271|NCT03290612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889272|NCT03290612|Antioxidants|antioxidants|mesh-ancestor
101889273|NCT03290612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889274|NCT03290612|Protective Agents|protective agents|mesh-ancestor
101889275|NCT03086642|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
101889276|NCT03086642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101889277|NCT03086642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889278|NCT03057795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101889279|NCT03057795|Nivolumab|nivolumab|mesh-list
101889280|NCT03057795|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101889281|NCT03057795|Antibodies|antibodies|mesh-list
101889282|NCT03057795|Immunoglobulins|immunoglobulins|mesh-list
101889283|NCT03057795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101889284|NCT03057795|Immunoconjugates|immunoconjugates|mesh-list
101889285|NCT03057795|Immunologic Factors|immunologic factors|mesh-ancestor
101889286|NCT03057795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889287|NCT03057795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889288|NCT03057795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101889289|NCT03057795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889290|NCT03057795|Immunotoxins|immunotoxins|mesh-ancestor
101889291|NCT03018704|Topiramate|topiramate|mesh-list
101889292|NCT03018704|Anticonvulsants|anticonvulsants|mesh-ancestor
101889293|NCT03018704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101889294|NCT03018704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889295|NCT02978612|Capecitabine|capecitabine|mesh-list
101889296|NCT02978612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101889297|NCT02978612|Antimetabolites|antimetabolites|mesh-ancestor
101889298|NCT02978612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889299|NCT02978612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889300|NCT02970500|Methylphenidate|methylphenidate|mesh-list
101889301|NCT02970500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101889302|NCT02970500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889303|NCT02970500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101889304|NCT02970500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101889305|NCT02970500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101889306|NCT02970500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889307|NCT02970500|Dopamine Agents|dopamine agents|mesh-ancestor
101889308|NCT02970500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101889309|NCT02951130|Milrinone|milrinone|mesh-list
101889310|NCT02951130|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101889311|NCT02951130|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101889312|NCT02951130|Vasodilator Agents|vasodilator agents|mesh-ancestor
101889313|NCT02951130|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101889314|NCT02951130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101889315|NCT02951130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101889316|NCT02951130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889317|NCT02951130|Protective Agents|protective agents|mesh-ancestor
101889318|NCT02951130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889319|NCT02810743|Olaparib|olaparib|mesh-list
101889320|NCT02810743|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101889321|NCT02810743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101889322|NCT02810743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609119|NCT05108649|Nicotine|nicotine|mesh-list
101889323|NCT02810743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889324|NCT02617407|Listerine|listerine|mesh-list
101689517|NCT00620204|Atorvastatin|atorvastatin|mesh-list
101889325|NCT02617407|Sodium Fluoride|sodium fluoride|mesh-list
101889326|NCT02617407|Cariostatic Agents|cariostatic agents|mesh-ancestor
101889327|NCT02617407|Protective Agents|protective agents|mesh-ancestor
101889328|NCT02617407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889329|NCT02617407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101889330|NCT02617407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101889331|NCT02537509|Cholecalciferol|cholecalciferol|mesh-list
101889332|NCT02537509|Vitamin D|vitamin d|mesh-list
101889333|NCT02537509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101889334|NCT02537509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889335|NCT02537509|Vitamins|vitamins|mesh-ancestor
101889336|NCT02537509|Micronutrients|micronutrients|mesh-ancestor
101889337|NCT02537509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101889338|NCT02490878|Bevacizumab|bevacizumab|mesh-list
101889339|NCT02490878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101889340|NCT02490878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889341|NCT02490878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101889342|NCT02490878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101889343|NCT02490878|Growth Substances|growth substances|mesh-ancestor
101889344|NCT02490878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889345|NCT02490878|Growth Inhibitors|growth inhibitors|mesh-ancestor
101889346|NCT02332850|Dexamethasone|dexamethasone|mesh-list
101889347|NCT02332850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101889348|NCT02332850|Antiemetics|antiemetics|mesh-ancestor
101889349|NCT02332850|Autonomic Agents|autonomic agents|mesh-ancestor
101889350|NCT02332850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101889351|NCT02332850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889352|NCT02332850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101889353|NCT02332850|Glucocorticoids|glucocorticoids|mesh-ancestor
101889354|NCT02332850|Hormones|hormones|mesh-ancestor
101889355|NCT02332850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101889356|NCT02332850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101889357|NCT02332850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889358|NCT02262325|Etoposide|etoposide|mesh-list
101889359|NCT02262325|Etoposide phosphate|etoposide phosphate|mesh-list
101889360|NCT02262325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101775853|NCT02559674|Tubulin Modulators|tubulin modulators|mesh-ancestor
101889361|NCT02262325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101889362|NCT02262325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101889363|NCT02262325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101889364|NCT02262325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101889365|NCT02262325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889366|NCT02205762|Cytarabine|cytarabine|mesh-list
101889367|NCT02205762|Prednisone|prednisone|mesh-list
101889368|NCT02205762|Indomethacin|indomethacin|mesh-list
101889369|NCT02205762|Methotrexate|methotrexate|mesh-list
101889370|NCT02205762|Mercaptopurine|mercaptopurine|mesh-list
101889371|NCT02205762|Vinblastine|vinblastine|mesh-list
101889372|NCT02205762|Cladribine|cladribine|mesh-list
101889373|NCT02205762|Immunoglobulins|immunoglobulins|mesh-list
101889374|NCT02205762|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101889375|NCT02205762|gamma-Globulins|gamma-globulins|mesh-list
101889376|NCT02205762|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101889377|NCT02205762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101889378|NCT02205762|Glucocorticoids|glucocorticoids|mesh-ancestor
101889379|NCT02205762|Hormones|hormones|mesh-ancestor
101889380|NCT02205762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101889381|NCT02205762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889382|NCT02205762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101889383|NCT02205762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889384|NCT02205762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101889385|NCT02205762|Abortifacient Agents|abortifacient agents|mesh-ancestor
101889386|NCT02205762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101889387|NCT02205762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101889388|NCT02205762|Antimetabolites|antimetabolites|mesh-ancestor
101889389|NCT02205762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889390|NCT02205762|Dermatologic Agents|dermatologic agents|mesh-ancestor
101889391|NCT02205762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101889392|NCT02205762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101889393|NCT02205762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101889394|NCT02205762|Immunologic Factors|immunologic factors|mesh-ancestor
101889395|NCT02205762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101889396|NCT02205762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101609196|NCT04879225|Menthol|menthol|mesh-list
101889397|NCT02205762|Antiviral Agents|antiviral agents|mesh-ancestor
101889398|NCT02205762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101889399|NCT02205762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101889400|NCT02205762|Tubulin Modulators|tubulin modulators|mesh-ancestor
101889401|NCT02205762|Antimitotic Agents|antimitotic agents|mesh-ancestor
101889402|NCT02205762|Mitosis Modulators|mitosis modulators|mesh-ancestor
101775870|NCT00759122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101889403|NCT02205762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101889404|NCT02205762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101889405|NCT02205762|Analgesics|analgesics|mesh-ancestor
101889406|NCT02205762|Sensory System Agents|sensory system agents|mesh-ancestor
101889407|NCT02205762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101889408|NCT02205762|Gout Suppressants|gout suppressants|mesh-ancestor
101889409|NCT02205762|Tocolytic Agents|tocolytic agents|mesh-ancestor
101889410|NCT02205762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101889411|NCT01996267|Paclitaxel|paclitaxel|mesh-list
101889412|NCT01996267|Cyclophosphamide|cyclophosphamide|mesh-list
101889413|NCT01996267|Carboplatin|carboplatin|mesh-list
101889414|NCT01996267|Fluorouracil|fluorouracil|mesh-list
101889415|NCT01996267|Trastuzumab|trastuzumab|mesh-list
101889416|NCT01996267|Pertuzumab|pertuzumab|mesh-list
101889417|NCT01996267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101889418|NCT01996267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889419|NCT01996267|Tubulin Modulators|tubulin modulators|mesh-ancestor
101889420|NCT01996267|Antimitotic Agents|antimitotic agents|mesh-ancestor
101889421|NCT01996267|Mitosis Modulators|mitosis modulators|mesh-ancestor
101889422|NCT01996267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889423|NCT01996267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101889424|NCT01996267|Immunologic Factors|immunologic factors|mesh-ancestor
101889425|NCT01996267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889426|NCT01996267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101889427|NCT01996267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101889428|NCT01996267|Alkylating Agents|alkylating agents|mesh-ancestor
101889429|NCT01996267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101889430|NCT01996267|Antimetabolites|antimetabolites|mesh-ancestor
101889431|NCT01996267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101889432|NCT01996267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101889433|NCT01934218|Hyaluronic Acid|hyaluronic acid|mesh-list
101889434|NCT01934218|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101889435|NCT01934218|Immunologic Factors|immunologic factors|mesh-ancestor
101889436|NCT01934218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889437|NCT01934218|Viscosupplements|viscosupplements|mesh-ancestor
101889438|NCT01934218|Protective Agents|protective agents|mesh-ancestor
101889439|NCT01898117|Paclitaxel|paclitaxel|mesh-list
101889440|NCT01898117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101889441|NCT01898117|Cyclophosphamide|cyclophosphamide|mesh-list
101889442|NCT01898117|Carboplatin|carboplatin|mesh-list
101889443|NCT01898117|Atezolizumab|atezolizumab|mesh-list
101889444|NCT01898117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101889445|NCT01898117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101889446|NCT01898117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889447|NCT01898117|Tubulin Modulators|tubulin modulators|mesh-ancestor
101889448|NCT01898117|Antimitotic Agents|antimitotic agents|mesh-ancestor
101889449|NCT01898117|Mitosis Modulators|mitosis modulators|mesh-ancestor
101889450|NCT01898117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889451|NCT01898117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101889452|NCT01898117|Immunologic Factors|immunologic factors|mesh-ancestor
101889453|NCT01898117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889454|NCT01898117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101889455|NCT01898117|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101889456|NCT01898117|Alkylating Agents|alkylating agents|mesh-ancestor
101889457|NCT01898117|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101889458|NCT01898117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101889459|NCT01898117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101889460|NCT01623167|Cyclosporine|cyclosporine|mesh-list
101889461|NCT01623167|Cyclosporins|cyclosporins|mesh-list
101889462|NCT01623167|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101889463|NCT01623167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101889464|NCT01623167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889465|NCT01623167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101889466|NCT01623167|Immunologic Factors|immunologic factors|mesh-ancestor
101889467|NCT01623167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889468|NCT01623167|Antifungal Agents|antifungal agents|mesh-ancestor
101889469|NCT01623167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101889470|NCT01623167|Dermatologic Agents|dermatologic agents|mesh-ancestor
101889471|NCT01623167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101889472|NCT01623167|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101889474|NCT01233635|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101609270|NCT04425473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101889475|NCT01233635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101889476|NCT01233635|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101889477|NCT01233635|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101889478|NCT01233635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889479|NCT00385606|Rofecoxib|rofecoxib|mesh-list
101889480|NCT00385606|Gemcitabine|gemcitabine|mesh-list
101889481|NCT00385606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889482|NCT00385606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101889483|NCT00385606|Antimetabolites|antimetabolites|mesh-ancestor
101889484|NCT00385606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889485|NCT00385606|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101889486|NCT00385606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101889487|NCT00385606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101889488|NCT00385606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101889489|NCT00385606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101889490|NCT00385606|Analgesics|analgesics|mesh-ancestor
101889491|NCT00385606|Sensory System Agents|sensory system agents|mesh-ancestor
101889492|NCT00385606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101889493|NCT00385606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889494|NCT00385606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101889495|NCT00385606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101889496|NCT03721744|Paclitaxel|paclitaxel|mesh-list
101889497|NCT03721744|Gemcitabine|gemcitabine|mesh-list
101889498|NCT03721744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101889499|NCT03721744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889500|NCT03721744|Tubulin Modulators|tubulin modulators|mesh-ancestor
101889501|NCT03721744|Antimitotic Agents|antimitotic agents|mesh-ancestor
101889502|NCT03721744|Mitosis Modulators|mitosis modulators|mesh-ancestor
101889503|NCT03721744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889504|NCT03721744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101889505|NCT03721744|Antimetabolites|antimetabolites|mesh-ancestor
101889506|NCT01589354|Ropivacaine|ropivacaine|mesh-list
101775916|NCT02559440|Mydriatics|mydriatics|mesh-ancestor
101889507|NCT01589354|Anesthetics, Local|anesthetics, local|mesh-ancestor
101889508|NCT01589354|Anesthetics|anesthetics|mesh-ancestor
101889509|NCT01589354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101889510|NCT01589354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889511|NCT01589354|Sensory System Agents|sensory system agents|mesh-ancestor
101889512|NCT01589354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101889513|NCT01583660|Acetaminophen|acetaminophen|mesh-list
101889514|NCT01583660|Celecoxib|celecoxib|mesh-list
101889515|NCT01583660|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
101889516|NCT01583660|Oxycodone|oxycodone|mesh-list
101889517|NCT01583660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101889518|NCT01583660|Analgesics|analgesics|mesh-ancestor
101889519|NCT01583660|Sensory System Agents|sensory system agents|mesh-ancestor
101889520|NCT01583660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101889521|NCT01583660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889522|NCT01583660|Antipyretics|antipyretics|mesh-ancestor
101889523|NCT01583660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101889524|NCT01583660|Narcotics|narcotics|mesh-ancestor
101889525|NCT01583660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101889526|NCT01583660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101889527|NCT01583660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101889528|NCT01583660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101889529|NCT01583660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101889530|NCT01583660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101889531|NCT01583660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101889532|NCT01583660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889533|NCT03960866|Phentolamine|phentolamine|mesh-list
101889534|NCT03960866|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101889535|NCT03960866|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101889536|NCT03960866|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101889537|NCT03960866|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101889538|NCT03960866|Adrenergic Agents|adrenergic agents|mesh-ancestor
101889539|NCT03960866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101889540|NCT03960866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889541|NCT03960866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889542|NCT03960866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101889543|NCT01089218|Amoxicillin|amoxicillin|mesh-list
101889544|NCT01089218|Clavulanic Acid|clavulanic acid|mesh-list
101889545|NCT01089218|Clavulanic Acids|clavulanic acids|mesh-list
101889546|NCT01089218|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101889547|NCT01089218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101889548|NCT01089218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101889549|NCT01089218|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101889550|NCT01089218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101889551|NCT01089218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889553|NCT03957668|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101889554|NCT03957668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101889555|NCT03957668|Laxatives|laxatives|mesh-ancestor
101889556|NCT01089452|Amlodipine|amlodipine|mesh-list
101889557|NCT01089452|Olmesartan|olmesartan|mesh-list
101889558|NCT01089452|Perindopril|perindopril|mesh-list
101889559|NCT01089452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101889560|NCT01089452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101889561|NCT01089452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101889562|NCT01089452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889563|NCT01089452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101889564|NCT01089452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889565|NCT01089452|Vasodilator Agents|vasodilator agents|mesh-ancestor
101889566|NCT01089452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101775945|NCT00940953|Budesonide|budesonide|mesh-list
101889567|NCT01089452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101889568|NCT01089452|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101889569|NCT01089452|Protease Inhibitors|protease inhibitors|mesh-ancestor
101889570|NCT01089452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101889571|NCT04880980|Itraconazole|itraconazole|mesh-list
101889572|NCT04880980|Terbinafine|terbinafine|mesh-list
101889573|NCT04880980|Antifungal Agents|antifungal agents|mesh-ancestor
101889574|NCT04880980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101889575|NCT04880980|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101889576|NCT04880980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101889577|NCT04880980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101889578|NCT04880980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889579|NCT04880980|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101889580|NCT04880980|Hormone Antagonists|hormone antagonists|mesh-ancestor
101889581|NCT04880980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101889582|NCT04880980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889583|NCT04880980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101889584|NCT01583504|Anesthetics|anesthetics|mesh-list
101889585|NCT01583504|Anesthetics, Local|anesthetics, local|mesh-list
101889586|NCT01583504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101889587|NCT01583504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889588|NCT01583504|Sensory System Agents|sensory system agents|mesh-ancestor
101889589|NCT01583504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101889590|NCT01583036|Digoxin|digoxin|mesh-list
101889591|NCT01583036|Ezogabine|ezogabine|mesh-list
101889592|NCT01583036|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101889593|NCT01583036|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101889594|NCT01583036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101889595|NCT01583036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889596|NCT01583036|Protective Agents|protective agents|mesh-ancestor
101889597|NCT01583036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889598|NCT01583036|Anticonvulsants|anticonvulsants|mesh-ancestor
101889599|NCT01583036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101889600|NCT01091792|Bevacizumab|bevacizumab|mesh-list
101889601|NCT01091792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101889602|NCT01091792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889603|NCT01091792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101889604|NCT01091792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101889605|NCT01091792|Growth Substances|growth substances|mesh-ancestor
101889606|NCT01091792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889607|NCT01091792|Growth Inhibitors|growth inhibitors|mesh-ancestor
101889608|NCT03510910|Acetaminophen|acetaminophen|mesh-list
101889609|NCT03510910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101889610|NCT03510910|Analgesics|analgesics|mesh-ancestor
101889611|NCT03510910|Sensory System Agents|sensory system agents|mesh-ancestor
101889612|NCT03510910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101889613|NCT03510910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889614|NCT03510910|Antipyretics|antipyretics|mesh-ancestor
101889615|NCT01091870|Sildenafil Citrate|sildenafil citrate|mesh-list
101889616|NCT01091870|Citric Acid|citric acid|mesh-list
101889617|NCT01091870|Sodium Citrate|sodium citrate|mesh-list
101889618|NCT01091870|Anticoagulants|anticoagulants|mesh-ancestor
101889619|NCT01091870|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101889620|NCT01091870|Chelating Agents|chelating agents|mesh-ancestor
101889621|NCT01091870|Sequestering Agents|sequestering agents|mesh-ancestor
101889622|NCT01091870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889623|NCT01091870|Vasodilator Agents|vasodilator agents|mesh-ancestor
101889624|NCT01091870|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101889625|NCT01091870|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101889626|NCT01091870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101889627|NCT01091870|Urological Agents|urological agents|mesh-ancestor
101889628|NCT03509350|Vitamins|vitamins|mesh-list
101889629|NCT03509350|Ascorbic Acid|ascorbic acid|mesh-list
101889630|NCT03509350|Thiamine|thiamine|mesh-list
101889631|NCT03509350|Hydrocortisone|hydrocortisone|mesh-list
101889632|NCT03509350|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101889633|NCT03509350|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101775959|NCT00940953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101889634|NCT03509350|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101889635|NCT03509350|Micronutrients|micronutrients|mesh-ancestor
101889636|NCT03509350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889637|NCT03509350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101889638|NCT03509350|Antioxidants|antioxidants|mesh-ancestor
101889639|NCT03509350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889640|NCT03509350|Protective Agents|protective agents|mesh-ancestor
101889641|NCT03509350|Vitamin B Complex|vitamin b complex|mesh-ancestor
101889642|NCT00072410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101889643|NCT00072410|Antibodies|antibodies|mesh-list
101889644|NCT00072410|Immunoglobulins|immunoglobulins|mesh-list
101889645|NCT00072410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101889646|NCT00072410|Immunologic Factors|immunologic factors|mesh-ancestor
101889647|NCT00072410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889648|NCT00072410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889649|NCT03478696|Budesonide|budesonide|mesh-list
101889650|NCT03478696|Albuterol|albuterol|mesh-list
101889651|NCT03478696|Formoterol Fumarate|formoterol fumarate|mesh-list
101889652|NCT03478696|Tiotropium Bromide|tiotropium bromide|mesh-list
101889653|NCT03478696|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101889654|NCT03478696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101889655|NCT03478696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101889656|NCT03478696|Autonomic Agents|autonomic agents|mesh-ancestor
101889657|NCT03478696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101889658|NCT03478696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889659|NCT03478696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101889660|NCT03478696|Respiratory System Agents|respiratory system agents|mesh-ancestor
101889661|NCT03478696|Glucocorticoids|glucocorticoids|mesh-ancestor
101889662|NCT03478696|Hormones|hormones|mesh-ancestor
101889663|NCT03478696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101889664|NCT03478696|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101889665|NCT03478696|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101889666|NCT03478696|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101889667|NCT03478696|Adrenergic Agents|adrenergic agents|mesh-ancestor
101889668|NCT03478696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101889669|NCT03478696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889670|NCT03478696|Parasympatholytics|parasympatholytics|mesh-ancestor
101889671|NCT03478696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101889672|NCT03478696|Cholinergic Agents|cholinergic agents|mesh-ancestor
101968796|NCT00662506|Cediranib|cediranib|mesh-list
101889673|NCT03478696|Tocolytic Agents|tocolytic agents|mesh-ancestor
101889674|NCT03478696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101889676|NCT00072176|Temsirolimus|temsirolimus|mesh-list
101889677|NCT00072176|MTOR Inhibitors|mtor inhibitors|mesh-list
101889678|NCT00072176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101889679|NCT00072176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101889680|NCT00072176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889681|NCT00072176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101889682|NCT00072176|Immunologic Factors|immunologic factors|mesh-ancestor
101889683|NCT00072176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889684|NCT00072176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889685|NCT00072176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101889686|NCT00072176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101889687|NCT00072176|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101889688|NCT00072176|Antifungal Agents|antifungal agents|mesh-ancestor
101889689|NCT00071396|Rituximab|rituximab|mesh-list
101889690|NCT00071396|Alemtuzumab|alemtuzumab|mesh-list
101889691|NCT00071396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101889692|NCT00071396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889693|NCT00071396|Immunologic Factors|immunologic factors|mesh-ancestor
101889694|NCT00071396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889695|NCT00071396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101609504|NCT03321656|Tacrolimus|tacrolimus|mesh-list
101889696|NCT03472534|Diacerein|diacerein|mesh-list
101889697|NCT03472534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101889698|NCT03725020|Fluorides|fluorides|mesh-list
101889700|NCT03725020|Cariostatic Agents|cariostatic agents|mesh-ancestor
101889701|NCT03725020|Protective Agents|protective agents|mesh-ancestor
101889702|NCT03725020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889703|NCT03721432|Pregabalin|pregabalin|mesh-list
101889704|NCT03721432|Analgesics|analgesics|mesh-ancestor
101889705|NCT03721432|Sensory System Agents|sensory system agents|mesh-ancestor
101889706|NCT03721432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101889707|NCT03721432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889708|NCT03721432|Anticonvulsants|anticonvulsants|mesh-ancestor
101889709|NCT03721432|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101889710|NCT03721432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101889711|NCT03721432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889712|NCT03721432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101889713|NCT03721432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101889714|NCT03721432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101889715|NCT03721432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101889716|NCT03721432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101889717|NCT03469336|Betamethasone|betamethasone|mesh-list
101889718|NCT03469336|Calcipotriene|calcipotriene|mesh-list
101889719|NCT03469336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101889720|NCT03469336|Glucocorticoids|glucocorticoids|mesh-ancestor
101889721|NCT03469336|Hormones|hormones|mesh-ancestor
101889722|NCT03469336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101889723|NCT03469336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889724|NCT03469336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101889725|NCT03469336|Respiratory System Agents|respiratory system agents|mesh-ancestor
101889726|NCT03469336|Dermatologic Agents|dermatologic agents|mesh-ancestor
101889727|NCT03719560|Cytarabine|cytarabine|mesh-list
101889728|NCT03719560|Methotrexate|methotrexate|mesh-list
101889729|NCT03719560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101889730|NCT03719560|Abortifacient Agents|abortifacient agents|mesh-ancestor
101889731|NCT03719560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101889732|NCT03719560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889733|NCT03719560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101889734|NCT03719560|Antimetabolites|antimetabolites|mesh-ancestor
101889735|NCT03719560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889736|NCT03719560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101776002|NCT00762398|Chrysarobin|chrysarobin|mesh-list
101889737|NCT03719560|Dermatologic Agents|dermatologic agents|mesh-ancestor
101889738|NCT03719560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101889739|NCT03719560|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101889740|NCT03719560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101889741|NCT03719560|Immunologic Factors|immunologic factors|mesh-ancestor
101889742|NCT03719560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101889743|NCT03719560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101889744|NCT03719560|Antiviral Agents|antiviral agents|mesh-ancestor
101889745|NCT03719560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101889746|NCT03469258|Pancrelipase|pancrelipase|mesh-list
101889747|NCT03469258|Pancreatin|pancreatin|mesh-list
101889748|NCT03469258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101889749|NCT00066170|Sodium Oxybate|sodium oxybate|mesh-list
101889750|NCT00066170|Modafinil|modafinil|mesh-list
101889751|NCT00066170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101889752|NCT00066170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889753|NCT00066170|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101889754|NCT00066170|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101889755|NCT00066170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101889756|NCT00066170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889757|NCT00066170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101889758|NCT00066170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101889759|NCT00066170|Anesthetics, General|anesthetics, general|mesh-ancestor
101889760|NCT00066170|Anesthetics|anesthetics|mesh-ancestor
101889761|NCT00066170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101889762|NCT00065468|Interferons|interferons|mesh-list
101889763|NCT00065468|Interferon-alpha|interferon-alpha|mesh-list
101889764|NCT00065468|Sirolimus|sirolimus|mesh-list
101889765|NCT00065468|Temsirolimus|temsirolimus|mesh-list
101889766|NCT00065468|MTOR Inhibitors|mtor inhibitors|mesh-list
101889767|NCT00065468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889768|NCT00065468|Antiviral Agents|antiviral agents|mesh-ancestor
101889769|NCT00065468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101889770|NCT00065468|Immunologic Factors|immunologic factors|mesh-ancestor
101889771|NCT00065468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889772|NCT00065468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101889773|NCT00065468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101889774|NCT00065468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889775|NCT00065468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101889776|NCT00065468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101889777|NCT00065468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101889778|NCT00065468|Antifungal Agents|antifungal agents|mesh-ancestor
101889780|NCT00071006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889781|NCT00071006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101889782|NCT00071006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101889783|NCT00071006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889784|NCT01089998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101889785|NCT01089998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101889786|NCT01089998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889787|NCT00094107|Axitinib|axitinib|mesh-list
101889788|NCT00094107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889789|NCT00094107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101889790|NCT00094107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101889791|NCT00094107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889792|NCT00102063|Aripiprazole|aripiprazole|mesh-list
101889793|NCT00102063|Antidepressive Agents|antidepressive agents|mesh-ancestor
101889794|NCT00102063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101889795|NCT00102063|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101889796|NCT00102063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101889797|NCT00102063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101889798|NCT00102063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889799|NCT00102063|Dopamine Agonists|dopamine agonists|mesh-ancestor
101889800|NCT00102063|Dopamine Agents|dopamine agents|mesh-ancestor
101889801|NCT00102063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101889802|NCT00102063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889803|NCT00102063|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101889804|NCT00102063|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101889805|NCT00102063|Serotonin Agents|serotonin agents|mesh-ancestor
101889806|NCT00102063|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101889807|NCT00102063|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101889808|NCT00102063|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101889809|NCT00102063|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101889810|NCT00065156|Lenalidomide|lenalidomide|mesh-list
101889811|NCT00065156|Immunologic Factors|immunologic factors|mesh-ancestor
101889812|NCT00065156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889813|NCT00065156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101889814|NCT00065156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101889815|NCT00065156|Growth Substances|growth substances|mesh-ancestor
101889816|NCT00065156|Growth Inhibitors|growth inhibitors|mesh-ancestor
101889817|NCT00065156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889818|NCT01094210|Fluorides|fluorides|mesh-list
101889819|NCT01094210|Fluorides, Topical|fluorides, topical|mesh-list
101889820|NCT01094210|Cariostatic Agents|cariostatic agents|mesh-ancestor
101889821|NCT01094210|Protective Agents|protective agents|mesh-ancestor
101889822|NCT01094210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889823|NCT01094444|Vitamin K|vitamin k|mesh-list
101889824|NCT01094444|Vitamin K 3|vitamin k 3|mesh-list
101889825|NCT01094444|Vitamins|vitamins|mesh-ancestor
101889826|NCT01094444|Micronutrients|micronutrients|mesh-ancestor
101889827|NCT01094444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889828|NCT01094444|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101889829|NCT01094444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101889830|NCT01094444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889831|NCT01094444|Hemostatics|hemostatics|mesh-ancestor
101889832|NCT01094444|Coagulants|coagulants|mesh-ancestor
101889833|NCT00078819|Etanercept|etanercept|mesh-list
101889834|NCT00078819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101889835|NCT00078819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101889836|NCT00078819|Analgesics|analgesics|mesh-ancestor
101889837|NCT00078819|Sensory System Agents|sensory system agents|mesh-ancestor
101889838|NCT00078819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101889839|NCT00078819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889840|NCT00078819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101889841|NCT00078819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101889842|NCT00078819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101889843|NCT00078819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101889844|NCT00078819|Immunologic Factors|immunologic factors|mesh-ancestor
101889845|NCT01088607|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101889846|NCT01088607|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101889847|NCT01088607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101889848|NCT00098865|Thalidomide|thalidomide|mesh-list
101889849|NCT00098865|Temozolomide|temozolomide|mesh-list
101889850|NCT00098865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101889851|NCT00098865|Alkylating Agents|alkylating agents|mesh-ancestor
101889852|NCT00098865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889853|NCT00098865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889854|NCT00098865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101889855|NCT00098865|Immunologic Factors|immunologic factors|mesh-ancestor
101889856|NCT00098865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889857|NCT00098865|Leprostatic Agents|leprostatic agents|mesh-ancestor
101889858|NCT00098865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101889859|NCT00098865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101889860|NCT00098865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101889861|NCT00098865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101889862|NCT00098865|Growth Substances|growth substances|mesh-ancestor
101889863|NCT00098865|Growth Inhibitors|growth inhibitors|mesh-ancestor
101889864|NCT01084863|Paclitaxel|paclitaxel|mesh-list
101889865|NCT01084863|Trastuzumab|trastuzumab|mesh-list
101889866|NCT01084863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101889867|NCT01084863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889868|NCT01084863|Tubulin Modulators|tubulin modulators|mesh-ancestor
101889869|NCT01084863|Antimitotic Agents|antimitotic agents|mesh-ancestor
101889870|NCT01084863|Mitosis Modulators|mitosis modulators|mesh-ancestor
101889871|NCT01084863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889872|NCT01084863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101889873|NCT03719404|Chlorhexidine|chlorhexidine|mesh-list
101889874|NCT03719404|Sodium Hypochlorite|sodium hypochlorite|mesh-list
101889875|NCT03719404|Eusol|eusol|mesh-list
101889876|NCT03719404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101889877|NCT03719404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101889878|NCT03719404|Disinfectants|disinfectants|mesh-ancestor
101889879|NCT03720886|Teriparatide|teriparatide|mesh-list
101889880|NCT03720886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101889881|NCT03720886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889882|NCT03720886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101889883|NCT00077649|Ribavirin|ribavirin|mesh-list
101889884|NCT00077649|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101889885|NCT00077649|Interferon-alpha|interferon-alpha|mesh-list
101889886|NCT00077649|Interferon alpha-2|interferon alpha-2|mesh-list
101889887|NCT00077649|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
101889888|NCT00077649|Antimetabolites|antimetabolites|mesh-ancestor
101889889|NCT00077649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889890|NCT00077649|Antiviral Agents|antiviral agents|mesh-ancestor
101889891|NCT00077649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101889892|NCT00077649|Immunologic Factors|immunologic factors|mesh-ancestor
101889893|NCT00077649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889894|NCT00077649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889895|NCT00038948|Cyclosporine|cyclosporine|mesh-list
101889896|NCT00038948|Sirolimus|sirolimus|mesh-list
101889897|NCT00038948|Tacrolimus|tacrolimus|mesh-list
101889898|NCT00038948|Cyclosporins|cyclosporins|mesh-list
101889899|NCT00038948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101889900|NCT00038948|Immunologic Factors|immunologic factors|mesh-ancestor
101889901|NCT00038948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889902|NCT00038948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101889903|NCT00038948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101889904|NCT00038948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889905|NCT00038948|Antifungal Agents|antifungal agents|mesh-ancestor
101889906|NCT00038948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101889907|NCT00038948|Dermatologic Agents|dermatologic agents|mesh-ancestor
101889908|NCT00038948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101689536|NCT02832089|Adrenergic Agents|adrenergic agents|mesh-ancestor
101889909|NCT00038948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101889910|NCT00038948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101889911|NCT00038948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889912|NCT01096940|Simvastatin|simvastatin|mesh-list
101889913|NCT01096940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101889914|NCT01096940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101889915|NCT01096940|Antimetabolites|antimetabolites|mesh-ancestor
101889916|NCT01096940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889917|NCT01096940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101889918|NCT01096940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101889919|NCT01096940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101889920|NCT02530424|Trastuzumab|trastuzumab|mesh-list
101889921|NCT02530424|Pertuzumab|pertuzumab|mesh-list
101889922|NCT02530424|Fulvestrant|fulvestrant|mesh-list
101889923|NCT02530424|Palbociclib|palbociclib|mesh-list
101889924|NCT02530424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101889925|NCT02530424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889926|NCT02530424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101889927|NCT02530424|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101889928|NCT02530424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101889929|NCT02530424|Hormone Antagonists|hormone antagonists|mesh-ancestor
101889930|NCT02530424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101889931|NCT02530424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889932|NCT02530424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101889933|NCT02530424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101889934|NCT02530424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889935|NCT01088763|Dexamethasone|dexamethasone|mesh-list
101889936|NCT01088763|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
101889937|NCT01088763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101889938|NCT01088763|Antiemetics|antiemetics|mesh-ancestor
101889939|NCT01088763|Autonomic Agents|autonomic agents|mesh-ancestor
101889940|NCT01088763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101889941|NCT01088763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889942|NCT01088763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101889943|NCT01088763|Glucocorticoids|glucocorticoids|mesh-ancestor
101889944|NCT01088763|Hormones|hormones|mesh-ancestor
101889945|NCT01088763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101889946|NCT01088763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101889947|NCT01088763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889948|NCT01088763|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101889949|NCT01088763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101968819|NCT00658762|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101889950|NCT01088763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889951|NCT01094600|Secretin|secretin|mesh-list
101889952|NCT01094600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101889953|NCT01094600|Hormones|hormones|mesh-ancestor
101889954|NCT01094600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101889955|NCT01094600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889956|NCT01097252|Cisplatin|cisplatin|mesh-list
101889957|NCT01097252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889958|NCT02530502|Pembrolizumab|pembrolizumab|mesh-list
101889959|NCT02530502|Temozolomide|temozolomide|mesh-list
101889960|NCT02530502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101889961|NCT02530502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889962|NCT02530502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101889963|NCT02530502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889964|NCT02530502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101889965|NCT02530502|Alkylating Agents|alkylating agents|mesh-ancestor
101889966|NCT00054704|Riluzole|riluzole|mesh-list
101889967|NCT00054704|Anticonvulsants|anticonvulsants|mesh-ancestor
101889968|NCT00054704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101889969|NCT00054704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101889970|NCT00054704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101889971|NCT00054704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889972|NCT00054704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889973|NCT00054704|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101889974|NCT00054704|Protective Agents|protective agents|mesh-ancestor
101889975|NCT01092572|Simvastatin|simvastatin|mesh-list
101889976|NCT01092572|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101889977|NCT01092572|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101889978|NCT01092572|Antimetabolites|antimetabolites|mesh-ancestor
101889979|NCT01092572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889980|NCT01092572|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101889981|NCT01092572|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101889982|NCT01092572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101889983|NCT00031694|Paclitaxel|paclitaxel|mesh-list
101889984|NCT00031694|Bryostatin 1|bryostatin 1|mesh-list
101889985|NCT00031694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101889986|NCT00031694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101889987|NCT00031694|Tubulin Modulators|tubulin modulators|mesh-ancestor
101889988|NCT00031694|Antimitotic Agents|antimitotic agents|mesh-ancestor
101889989|NCT00031694|Mitosis Modulators|mitosis modulators|mesh-ancestor
101889990|NCT00031694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889991|NCT00031694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101889992|NCT00031694|Immunologic Factors|immunologic factors|mesh-ancestor
101889993|NCT00031694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889994|NCT03953066|Melatonin|melatonin|mesh-list
101889995|NCT03953066|Antioxidants|antioxidants|mesh-ancestor
101609794|NCT01131104|Sildenafil Citrate|sildenafil citrate|mesh-list
101889996|NCT03953066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101889997|NCT03953066|Protective Agents|protective agents|mesh-ancestor
101889998|NCT03953066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101889999|NCT03953066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101890000|NCT00093795|Paclitaxel|paclitaxel|mesh-list
101890001|NCT00093795|Docetaxel|docetaxel|mesh-list
101890002|NCT00093795|Cyclophosphamide|cyclophosphamide|mesh-list
101890003|NCT00093795|Gemcitabine|gemcitabine|mesh-list
101890004|NCT00093795|Doxorubicin|doxorubicin|mesh-list
101890005|NCT00093795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101890006|NCT00093795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101890007|NCT00093795|Tubulin Modulators|tubulin modulators|mesh-ancestor
101890008|NCT00093795|Antimitotic Agents|antimitotic agents|mesh-ancestor
101890009|NCT00093795|Mitosis Modulators|mitosis modulators|mesh-ancestor
101890010|NCT00093795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890011|NCT00093795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101890012|NCT00093795|Immunologic Factors|immunologic factors|mesh-ancestor
101890013|NCT00093795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890014|NCT00093795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101890015|NCT00093795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101890016|NCT00093795|Alkylating Agents|alkylating agents|mesh-ancestor
101890017|NCT00093795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101890018|NCT00093795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101890019|NCT00093795|Antimetabolites|antimetabolites|mesh-ancestor
101890020|NCT00093795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101890021|NCT00093795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101890022|NCT00093795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101890023|NCT00093795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101890024|NCT01092806|Tacrolimus|tacrolimus|mesh-list
101890025|NCT01092806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101890026|NCT01092806|Immunologic Factors|immunologic factors|mesh-ancestor
101890027|NCT01092806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890028|NCT01092806|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101890029|NCT01092806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101890030|NCT01092806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890031|NCT01094912|Analgesics, Opioid|analgesics, opioid|mesh-list
101890032|NCT01094912|Narcotics|narcotics|mesh-ancestor
101890033|NCT01094912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101890034|NCT01094912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890035|NCT01094912|Analgesics|analgesics|mesh-ancestor
101890036|NCT01094912|Sensory System Agents|sensory system agents|mesh-ancestor
101890037|NCT01094912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101890038|NCT01092962|Mycophenolic Acid|mycophenolic acid|mesh-list
101890039|NCT01092962|Cyclophosphamide|cyclophosphamide|mesh-list
101890040|NCT01092962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101890041|NCT01092962|Immunologic Factors|immunologic factors|mesh-ancestor
101890042|NCT01092962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890043|NCT01092962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101776072|NCT00652626|Azacitidine|azacitidine|mesh-list
101890044|NCT01092962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101890045|NCT01092962|Alkylating Agents|alkylating agents|mesh-ancestor
101689541|NCT02832089|Antioxidants|antioxidants|mesh-ancestor
101890046|NCT01092962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890047|NCT01092962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101890048|NCT01092962|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101890049|NCT01092962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101890050|NCT01092962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101890051|NCT01092962|Antitubercular Agents|antitubercular agents|mesh-ancestor
101890052|NCT01092962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101890053|NCT01092962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101890054|NCT01092962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101890055|NCT03802994|Vaccines|vaccines|mesh-list
101890056|NCT03802994|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101890057|NCT03802994|Immunologic Factors|immunologic factors|mesh-ancestor
101890058|NCT03802994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890059|NCT01088919|Pioglitazone|pioglitazone|mesh-list
101890060|NCT01088919|Ipragliflozin|ipragliflozin|mesh-list
101890061|NCT01088919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101890062|NCT01088919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890063|NCT01088919|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101890064|NCT01088919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890065|NCT03802916|Deferiprone|deferiprone|mesh-list
101890066|NCT03802916|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101890067|NCT03802916|Chelating Agents|chelating agents|mesh-ancestor
101890068|NCT03802916|Sequestering Agents|sequestering agents|mesh-ancestor
101890069|NCT03802916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890070|NCT03720340|Oprelvekin|oprelvekin|mesh-list
101890071|NCT03720340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101890072|NCT01094990|Dexamethasone|dexamethasone|mesh-list
101890073|NCT01094990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101890074|NCT01094990|Antiemetics|antiemetics|mesh-ancestor
101890075|NCT01094990|Autonomic Agents|autonomic agents|mesh-ancestor
101890076|NCT01094990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101890077|NCT01094990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890078|NCT01094990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101890079|NCT01094990|Glucocorticoids|glucocorticoids|mesh-ancestor
101890080|NCT01094990|Hormones|hormones|mesh-ancestor
101890081|NCT01094990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101890082|NCT01094990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101890083|NCT01094990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101890084|NCT01584050|Folic Acid|folic acid|mesh-list
101890085|NCT01584050|Hematinics|hematinics|mesh-ancestor
101890086|NCT01584050|Vitamin B Complex|vitamin b complex|mesh-ancestor
101890087|NCT01584050|Vitamins|vitamins|mesh-ancestor
101890088|NCT01584050|Micronutrients|micronutrients|mesh-ancestor
101890089|NCT01584050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890090|NCT03952832|Leflunomide|leflunomide|mesh-list
101890091|NCT03952832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101890092|NCT03952832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890093|NCT03952832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101890094|NCT03952832|Immunologic Factors|immunologic factors|mesh-ancestor
101890095|NCT03952832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890096|NCT01311076|Insulin|insulin|mesh-list
101890097|NCT01311076|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101890098|NCT01311076|Insulin Lispro|insulin lispro|mesh-list
101890099|NCT01311076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101890100|NCT01311076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890101|NCT01098344|Gemcitabine|gemcitabine|mesh-list
101890102|NCT01098344|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
101890103|NCT01098344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101890104|NCT01098344|Antimetabolites|antimetabolites|mesh-ancestor
101890105|NCT01098344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890106|NCT01098344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101890107|NCT01098344|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101890108|NCT01098344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101890109|NCT01098656|Lenalidomide|lenalidomide|mesh-list
101890110|NCT01098656|Immunologic Factors|immunologic factors|mesh-ancestor
101890111|NCT01098656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890112|NCT01098656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101890113|NCT01098656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101890114|NCT01098656|Growth Substances|growth substances|mesh-ancestor
101890115|NCT01098656|Growth Inhibitors|growth inhibitors|mesh-ancestor
101890116|NCT01098656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101890117|NCT00076011|Mitogens|mitogens|mesh-list
101890118|NCT00076011|Endothelial Growth Factors|endothelial growth factors|mesh-list
101890119|NCT00076011|Mitosis Modulators|mitosis modulators|mesh-ancestor
101890120|NCT00076011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890121|NCT00076011|Growth Substances|growth substances|mesh-ancestor
101890122|NCT00076011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890123|NCT03465436|Moxifloxacin|moxifloxacin|mesh-list
101890124|NCT03465436|Lasmiditan|lasmiditan|mesh-list
101890125|NCT03465436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101890126|NCT03465436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101890127|NCT03465436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101890128|NCT03465436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101890129|NCT03465436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101890130|NCT03465436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890131|NCT03465436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101890132|NCT03465436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890133|NCT03465436|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101890134|NCT03465436|Serotonin Agents|serotonin agents|mesh-ancestor
101890135|NCT03465436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101890136|NCT01098890|Plasminogen|plasminogen|mesh-list
101890137|NCT01098890|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101890138|NCT01098890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101890139|NCT01098890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101890140|NCT01098890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890141|NCT00053846|Buspirone|buspirone|mesh-list
101890142|NCT00053846|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101890143|NCT00053846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101890144|NCT00053846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101890145|NCT00053846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890146|NCT00053846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101890147|NCT00053846|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101890148|NCT00053846|Serotonin Agents|serotonin agents|mesh-ancestor
101890149|NCT00053846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101890150|NCT00053846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890151|NCT01089075|Hydrocortisone|hydrocortisone|mesh-list
101890152|NCT01089075|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101890153|NCT01089075|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101890154|NCT01089075|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101890155|NCT01089075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101890156|NCT00090987|Imatinib Mesylate|imatinib mesylate|mesh-list
101890157|NCT00090987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101890158|NCT00090987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101890159|NCT00090987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101890160|NCT00090987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890161|NCT03489304|Zaleplon|zaleplon|mesh-list
101890162|NCT03489304|Anticonvulsants|anticonvulsants|mesh-ancestor
101890163|NCT03489304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101890164|NCT03489304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101890165|NCT03489304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890166|NCT03489304|GABA Modulators|gaba modulators|mesh-ancestor
101890167|NCT03489304|GABA Agents|gaba agents|mesh-ancestor
101890168|NCT03489304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101890169|NCT03489304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890170|NCT03718624|Paclitaxel|paclitaxel|mesh-list
101890171|NCT03718624|Apatinib|apatinib|mesh-list
101890172|NCT03718624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101890173|NCT03718624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101890174|NCT03718624|Tubulin Modulators|tubulin modulators|mesh-ancestor
101890175|NCT03718624|Antimitotic Agents|antimitotic agents|mesh-ancestor
101890176|NCT03718624|Mitosis Modulators|mitosis modulators|mesh-ancestor
101890177|NCT03718624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890178|NCT03718624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101890179|NCT03718624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101890180|NCT03543358|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
101890181|NCT03543358|Immunoconjugates|immunoconjugates|mesh-list
101890182|NCT03543358|Immunologic Factors|immunologic factors|mesh-ancestor
101890183|NCT03543358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890184|NCT03485950|Meropenem|meropenem|mesh-list
101890185|NCT03485950|Tazobactam|tazobactam|mesh-list
101890186|NCT03485950|Piperacillin|piperacillin|mesh-list
101890187|NCT03485950|Cefepime|cefepime|mesh-list
101890188|NCT03485950|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101890189|NCT03485950|Ceftolozane|ceftolozane|mesh-list
101890190|NCT03485950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101890191|NCT03485950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101890192|NCT03485950|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101890194|NCT03485950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890195|NCT00060944|Dexamethasone|dexamethasone|mesh-list
101890196|NCT00060944|Dexamethasone acetate|dexamethasone acetate|mesh-list
101890197|NCT00060944|Trabectedin|trabectedin|mesh-list
101890198|NCT00060944|BB 1101|bb 1101|mesh-list
101890199|NCT00060944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101890200|NCT00060944|Antiemetics|antiemetics|mesh-ancestor
101890201|NCT00060944|Autonomic Agents|autonomic agents|mesh-ancestor
101890202|NCT00060944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101890203|NCT00060944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890204|NCT00060944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101890205|NCT00060944|Glucocorticoids|glucocorticoids|mesh-ancestor
101890206|NCT00060944|Hormones|hormones|mesh-ancestor
101890207|NCT00060944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101890208|NCT00060944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101890209|NCT00060944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101890210|NCT00060944|Protease Inhibitors|protease inhibitors|mesh-ancestor
101890211|NCT00060944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101890212|NCT00060944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890213|NCT00060944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101890214|NCT00060944|Alkylating Agents|alkylating agents|mesh-ancestor
101890215|NCT03956732|Vitamin D|vitamin d|mesh-list
101890216|NCT03956732|Caseins|caseins|mesh-list
101890217|NCT03956732|Vitamins|vitamins|mesh-ancestor
101890218|NCT03956732|Micronutrients|micronutrients|mesh-ancestor
101890219|NCT03956732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890220|NCT03956732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101890222|NCT03956732|Sequestering Agents|sequestering agents|mesh-ancestor
101890223|NCT03956732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890224|NCT01093274|Picosulfate sodium|picosulfate sodium|mesh-list
101890225|NCT01093274|Cathartics|cathartics|mesh-ancestor
101890226|NCT01093274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101890227|NCT01584206|Ezetimibe|ezetimibe|mesh-list
101890228|NCT01584206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101890229|NCT01584206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101890230|NCT01584206|Antimetabolites|antimetabolites|mesh-ancestor
101890231|NCT01584206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890232|NCT01584206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101890233|NCT03541252|Cisplatin|cisplatin|mesh-list
101890234|NCT03541252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101890235|NCT00031460|Acyclovir|acyclovir|mesh-list
101890236|NCT00031460|Antiviral Agents|antiviral agents|mesh-ancestor
101890237|NCT00031460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101890238|NCT03540160|Serlopitant|serlopitant|mesh-list
101890239|NCT03540160|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101890240|NCT03540160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101890241|NCT03540160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890242|NCT03540160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890243|NCT01095302|Docetaxel|docetaxel|mesh-list
101890244|NCT01095302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101890245|NCT01095302|Tubulin Modulators|tubulin modulators|mesh-ancestor
101890246|NCT01095302|Antimitotic Agents|antimitotic agents|mesh-ancestor
101890247|NCT01095302|Mitosis Modulators|mitosis modulators|mesh-ancestor
101890248|NCT01095302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890249|NCT03459040|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
101890250|NCT03459040|Protein C Inhibitor|protein c inhibitor|mesh-list
101890251|NCT03459040|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101890252|NCT03459040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101890253|NCT03459040|Protease Inhibitors|protease inhibitors|mesh-ancestor
101890254|NCT03459040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101890255|NCT03459040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890256|NCT03457636|Doxycycline|doxycycline|mesh-list
101890257|NCT03457636|Adapalene|adapalene|mesh-list
101890258|NCT03457636|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
101890259|NCT03457636|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101890260|NCT03457636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101890261|NCT03457636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101890262|NCT03457636|Antimalarials|antimalarials|mesh-ancestor
101890263|NCT03457636|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101890264|NCT03457636|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101689549|NCT04247633|Palbociclib|palbociclib|mesh-list
101890265|NCT03457636|Dermatologic Agents|dermatologic agents|mesh-ancestor
101890266|NCT03457636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101890267|NCT03457636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101890269|NCT03457636|Sensory System Agents|sensory system agents|mesh-ancestor
101890270|NCT03457636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101890271|NCT03457636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890272|NCT03457636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101890273|NCT03457636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101890274|NCT01099436|Zoledronic Acid|zoledronic acid|mesh-list
101890275|NCT01099436|Cyclophosphamide|cyclophosphamide|mesh-list
101890276|NCT01099436|Docetaxel|docetaxel|mesh-list
101890277|NCT01099436|Doxorubicin|doxorubicin|mesh-list
101890278|NCT01099436|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101890279|NCT01099436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101890280|NCT01099436|Immunologic Factors|immunologic factors|mesh-ancestor
101890281|NCT01099436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890282|NCT01099436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101890283|NCT01099436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101890284|NCT01099436|Alkylating Agents|alkylating agents|mesh-ancestor
101890285|NCT01099436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890286|NCT01099436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101890287|NCT01099436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101890288|NCT01099436|Tubulin Modulators|tubulin modulators|mesh-ancestor
101890289|NCT01099436|Antimitotic Agents|antimitotic agents|mesh-ancestor
101890290|NCT01099436|Mitosis Modulators|mitosis modulators|mesh-ancestor
101890291|NCT01099436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101890292|NCT01099436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101890293|NCT01099436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101890294|NCT01099436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101890295|NCT01099436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101890296|NCT01099592|Citalopram|citalopram|mesh-list
101890297|NCT01099592|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101890298|NCT01099592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101890299|NCT01099592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101890300|NCT01099592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890301|NCT01099592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101890302|NCT01099592|Serotonin Agents|serotonin agents|mesh-ancestor
101890303|NCT01099592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890304|NCT01099592|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101890305|NCT01099592|Antidepressive Agents|antidepressive agents|mesh-ancestor
101890306|NCT01099592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101890307|NCT01099748|Methadone|methadone|mesh-list
101890308|NCT01099748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101890309|NCT01099748|Narcotics|narcotics|mesh-ancestor
101890310|NCT01099748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101890311|NCT01099748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890312|NCT01099748|Analgesics|analgesics|mesh-ancestor
101890313|NCT01099748|Sensory System Agents|sensory system agents|mesh-ancestor
101890314|NCT01099748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101890315|NCT01099748|Antitussive Agents|antitussive agents|mesh-ancestor
101890316|NCT01099748|Respiratory System Agents|respiratory system agents|mesh-ancestor
101890317|NCT03481816|Vaccines|vaccines|mesh-list
101890318|NCT03481816|Immunologic Factors|immunologic factors|mesh-ancestor
101890319|NCT03481816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890320|NCT03956888|Acetylcysteine|acetylcysteine|mesh-list
101890321|NCT03956888|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101890322|NCT03956888|Antiviral Agents|antiviral agents|mesh-ancestor
101890323|NCT03956888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101890324|NCT03956888|Expectorants|expectorants|mesh-ancestor
101890325|NCT03956888|Respiratory System Agents|respiratory system agents|mesh-ancestor
101890326|NCT03956888|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101890327|NCT03956888|Antioxidants|antioxidants|mesh-ancestor
101890328|NCT03956888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890329|NCT03956888|Protective Agents|protective agents|mesh-ancestor
101890330|NCT03956888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890331|NCT03956888|Antidotes|antidotes|mesh-ancestor
101890332|NCT03955406|Anesthetics|anesthetics|mesh-list
101890333|NCT03955406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101890334|NCT03955406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890335|NCT03538054|Dextromethorphan|dextromethorphan|mesh-list
101890336|NCT03538054|Antitussive Agents|antitussive agents|mesh-ancestor
101689552|NCT04247633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101890337|NCT03538054|Respiratory System Agents|respiratory system agents|mesh-ancestor
101890338|NCT03538054|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101890339|NCT03538054|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101890340|NCT03538054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101890341|NCT03538054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890342|NCT03538054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776138|NCT00945789|Vasodilator Agents|vasodilator agents|mesh-ancestor
101890343|NCT03480802|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101890344|NCT03480802|Immunologic Factors|immunologic factors|mesh-ancestor
101890345|NCT03480802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890346|NCT00050960|Paclitaxel|paclitaxel|mesh-list
101890347|NCT00050960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101890348|NCT00050960|Carboplatin|carboplatin|mesh-list
101890349|NCT00050960|Bexarotene|bexarotene|mesh-list
101890350|NCT00050960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101890351|NCT00050960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101968856|NCT01106053|Pramipexole|pramipexole|mesh-list
101890352|NCT00050960|Tubulin Modulators|tubulin modulators|mesh-ancestor
101890353|NCT00050960|Antimitotic Agents|antimitotic agents|mesh-ancestor
101890354|NCT00050960|Mitosis Modulators|mitosis modulators|mesh-ancestor
101890355|NCT00050960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890356|NCT00097773|Ciprofloxacin|ciprofloxacin|mesh-list
101890357|NCT00097773|Tobramycin|tobramycin|mesh-list
101890358|NCT00097773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101890359|NCT00097773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101890360|NCT00097773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101890361|NCT00097773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101890362|NCT00097773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101890363|NCT00097773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890364|NCT00097773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101890365|NCT00097773|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101890366|NCT00097773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101890367|NCT03480022|Liraglutide|liraglutide|mesh-list
101890368|NCT03480022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101890369|NCT03480022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890370|NCT03480022|Incretins|incretins|mesh-ancestor
101890371|NCT03480022|Hormones|hormones|mesh-ancestor
101890372|NCT03480022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101890373|NCT01093820|Epoetin Alfa|epoetin alfa|mesh-list
101890374|NCT01093820|Hematinics|hematinics|mesh-ancestor
101890375|NCT00049322|Bevacizumab|bevacizumab|mesh-list
101890376|NCT00049322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101890377|NCT00049322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101890378|NCT00049322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101890379|NCT00049322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101890380|NCT00049322|Growth Substances|growth substances|mesh-ancestor
101890381|NCT00049322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890382|NCT00049322|Growth Inhibitors|growth inhibitors|mesh-ancestor
101890383|NCT00008138|Paclitaxel|paclitaxel|mesh-list
101890384|NCT00008138|Carboplatin|carboplatin|mesh-list
101890385|NCT00008138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101890386|NCT00008138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101890387|NCT00008138|Tubulin Modulators|tubulin modulators|mesh-ancestor
101890388|NCT00008138|Antimitotic Agents|antimitotic agents|mesh-ancestor
101890389|NCT00008138|Mitosis Modulators|mitosis modulators|mesh-ancestor
101890390|NCT00008138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890391|NCT03436732|LMB-100|lmb-100|mesh-list
101890392|NCT03436732|Immunoconjugates|immunoconjugates|mesh-ancestor
101890393|NCT03436732|Immunologic Factors|immunologic factors|mesh-ancestor
101890394|NCT03436732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890395|NCT01100060|Azithromycin|azithromycin|mesh-list
101890396|NCT01100060|Chloroquine|chloroquine|mesh-list
101890397|NCT01100060|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
101890398|NCT01100060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101890399|NCT01100060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101890400|NCT01100060|Amebicides|amebicides|mesh-ancestor
101890401|NCT01100060|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101890402|NCT01100060|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101890403|NCT01100060|Antimalarials|antimalarials|mesh-ancestor
101890404|NCT01100060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101890405|NCT01100060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101890406|NCT01100060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101890407|NCT01100060|Analgesics|analgesics|mesh-ancestor
101890409|NCT01100060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101890410|NCT01100060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890411|NCT01100060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101890412|NCT01100060|Filaricides|filaricides|mesh-ancestor
101890413|NCT01100060|Antinematodal Agents|antinematodal agents|mesh-ancestor
101890414|NCT01100060|Anthelmintics|anthelmintics|mesh-ancestor
101890415|NCT01100216|Nicotine|nicotine|mesh-list
101890416|NCT01100216|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101890417|NCT01100216|Autonomic Agents|autonomic agents|mesh-ancestor
101890418|NCT01100216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101890419|NCT01100216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890420|NCT01100216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101890421|NCT01100216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101890422|NCT01100216|Cholinergic Agents|cholinergic agents|mesh-ancestor
101890423|NCT01100216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101890424|NCT01100216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890425|NCT01100294|Vaccines|vaccines|mesh-list
101890426|NCT01100294|Immunologic Factors|immunologic factors|mesh-ancestor
101890427|NCT01100294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890428|NCT03436420|Calcium|calcium|mesh-list
101890429|NCT03436420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101890430|NCT03436420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890431|NCT01100372|Gemcitabine|gemcitabine|mesh-list
101890432|NCT01100372|Doxorubicin|doxorubicin|mesh-list
101890433|NCT01100372|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101890434|NCT01100372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101890435|NCT01100372|Antimetabolites|antimetabolites|mesh-ancestor
101890436|NCT01100372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890437|NCT01100372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101890438|NCT01100372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101890439|NCT01100372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101890440|NCT01100372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101890441|NCT01100372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101890442|NCT00027560|Cyclosporine|cyclosporine|mesh-list
101890443|NCT00027560|Fludarabine|fludarabine|mesh-list
101890444|NCT00027560|Fludarabine phosphate|fludarabine phosphate|mesh-list
101890445|NCT00027560|Melphalan|melphalan|mesh-list
101890446|NCT00027560|Alemtuzumab|alemtuzumab|mesh-list
101890447|NCT00027560|Cyclosporins|cyclosporins|mesh-list
101890448|NCT00027560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101890449|NCT00027560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101890450|NCT00027560|Antimetabolites|antimetabolites|mesh-ancestor
101890451|NCT00027560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890452|NCT00027560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101890453|NCT00027560|Immunologic Factors|immunologic factors|mesh-ancestor
101890454|NCT00027560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890455|NCT00027560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101890456|NCT00027560|Antifungal Agents|antifungal agents|mesh-ancestor
101890457|NCT00027560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101890458|NCT00027560|Dermatologic Agents|dermatologic agents|mesh-ancestor
101890459|NCT00027560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101890460|NCT00027560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101890461|NCT00027560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101890462|NCT00027560|Alkylating Agents|alkylating agents|mesh-ancestor
101890463|NCT00027560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101890464|NCT00027560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101890465|NCT02529878|Paclitaxel|paclitaxel|mesh-list
101890466|NCT02529878|Apatinib|apatinib|mesh-list
101890467|NCT02529878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101890468|NCT02529878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101890469|NCT02529878|Tubulin Modulators|tubulin modulators|mesh-ancestor
101890470|NCT02529878|Antimitotic Agents|antimitotic agents|mesh-ancestor
101890471|NCT02529878|Mitosis Modulators|mitosis modulators|mesh-ancestor
101890472|NCT02529878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890473|NCT02529878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101890474|NCT02529878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101890475|NCT03451006|Metformin|metformin|mesh-list
101890476|NCT03451006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101890477|NCT03451006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890478|NCT05625854|Cocaine|cocaine|mesh-list
101890479|NCT05625854|Anesthetics, Local|anesthetics, local|mesh-ancestor
101890480|NCT05625854|Anesthetics|anesthetics|mesh-ancestor
101890481|NCT05625854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101689557|NCT04324229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101890482|NCT05625854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890483|NCT05625854|Sensory System Agents|sensory system agents|mesh-ancestor
101890484|NCT05625854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101890485|NCT05625854|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101890486|NCT05625854|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101890487|NCT05625854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101890488|NCT05625854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101890489|NCT05625854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890490|NCT05625854|Dopamine Agents|dopamine agents|mesh-ancestor
101890491|NCT05625854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101890492|NCT01327118|Dinoprost|dinoprost|mesh-list
101890493|NCT01327118|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
101890494|NCT01327118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101890495|NCT01327118|Abortifacient Agents|abortifacient agents|mesh-ancestor
101890496|NCT01327118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101890497|NCT01327118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890498|NCT01327118|Oxytocics|oxytocics|mesh-ancestor
101890499|NCT03449758|Hydroxychloroquine|hydroxychloroquine|mesh-list
101890500|NCT03449758|Chloroquine|chloroquine|mesh-list
101890501|NCT03449758|Sulfasalazine|sulfasalazine|mesh-list
101890502|NCT03449758|Methotrexate|methotrexate|mesh-list
101890503|NCT03449758|Azathioprine|azathioprine|mesh-list
101890504|NCT03449758|Leflunomide|leflunomide|mesh-list
101890505|NCT03449758|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101890506|NCT03449758|Abortifacient Agents|abortifacient agents|mesh-ancestor
101890507|NCT03449758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101890508|NCT03449758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890509|NCT03449758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101890510|NCT03449758|Antimetabolites|antimetabolites|mesh-ancestor
101890511|NCT03449758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890512|NCT03449758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101890513|NCT03449758|Dermatologic Agents|dermatologic agents|mesh-ancestor
101890514|NCT03449758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101890515|NCT03449758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101890516|NCT03449758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101890517|NCT03449758|Immunologic Factors|immunologic factors|mesh-ancestor
101890518|NCT03449758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101890519|NCT03449758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101890520|NCT03449758|Antimalarials|antimalarials|mesh-ancestor
101890521|NCT03449758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101890522|NCT03449758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101890523|NCT03449758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101890524|NCT03449758|Amebicides|amebicides|mesh-ancestor
101890525|NCT03449758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101890527|NCT03449758|Analgesics|analgesics|mesh-ancestor
101890528|NCT03449758|Sensory System Agents|sensory system agents|mesh-ancestor
101890529|NCT03449758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101890530|NCT03449758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101890531|NCT03449758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101890532|NCT03449446|Firsocostat|firsocostat|mesh-list
101890533|NCT03449446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101890534|NCT03449446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890535|NCT03716596|Antibodies|antibodies|mesh-list
101890536|NCT03716596|Immunologic Factors|immunologic factors|mesh-ancestor
101890537|NCT03716596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890538|NCT05650840|Calcium Carbonate|calcium carbonate|mesh-list
101890539|NCT05650840|Calcium|calcium|mesh-list
101890540|NCT05650840|Charcoal|charcoal|mesh-list
101890541|NCT05650840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101890542|NCT05650840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890543|NCT05650840|Antacids|antacids|mesh-ancestor
101890544|NCT05650840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890545|NCT05650840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101890546|NCT05650840|Antidotes|antidotes|mesh-ancestor
101890547|NCT05650840|Protective Agents|protective agents|mesh-ancestor
101890548|NCT03722914|Benzonatate|benzonatate|mesh-list
101890549|NCT03722914|Antitussive Agents|antitussive agents|mesh-ancestor
101890550|NCT03722914|Respiratory System Agents|respiratory system agents|mesh-ancestor
101890551|NCT03429556|Botulinum Toxins|botulinum toxins|mesh-list
101890552|NCT03429556|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101890553|NCT03429556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101890554|NCT03429556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890555|NCT03429556|Cholinergic Agents|cholinergic agents|mesh-ancestor
101890556|NCT03429556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101890557|NCT03429556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890558|NCT03444766|Nivolumab|nivolumab|mesh-list
101890559|NCT03444766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101890560|NCT03444766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101890561|NCT03444766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101890562|NCT03444766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890563|NCT03526432|Bevacizumab|bevacizumab|mesh-list
101890564|NCT03526432|Atezolizumab|atezolizumab|mesh-list
101890565|NCT03526432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101890566|NCT03526432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101890567|NCT03526432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101890568|NCT03526432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101890569|NCT03526432|Growth Substances|growth substances|mesh-ancestor
101890570|NCT03526432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890571|NCT03526432|Growth Inhibitors|growth inhibitors|mesh-ancestor
101890572|NCT03526432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101890573|NCT03526432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890574|NCT01310842|Nicotine|nicotine|mesh-list
101890575|NCT01310842|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101890576|NCT01310842|Autonomic Agents|autonomic agents|mesh-ancestor
101890577|NCT01310842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101890578|NCT01310842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890579|NCT01310842|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101890580|NCT01310842|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101890581|NCT01310842|Cholinergic Agents|cholinergic agents|mesh-ancestor
101890582|NCT01310842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101890583|NCT01310842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890584|NCT03722290|Metformin|metformin|mesh-list
101890585|NCT03722290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101890586|NCT03722290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890587|NCT03717688|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101890588|NCT03717688|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
101890589|NCT03717688|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101890590|NCT03717688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101890591|NCT03717688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890592|NCT03717688|Incretins|incretins|mesh-ancestor
101890593|NCT03717688|Hormones|hormones|mesh-ancestor
101890594|NCT03717688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101890595|NCT03717688|Protease Inhibitors|protease inhibitors|mesh-ancestor
101890596|NCT03717688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610397|NCT00659776|Hematinics|hematinics|mesh-ancestor
101890597|NCT03717688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890598|NCT03717688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101890599|NCT02953678|Prednisone|prednisone|mesh-list
101890600|NCT02953678|Methylprednisolone|methylprednisolone|mesh-list
101890601|NCT02953678|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101890602|NCT02953678|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101890603|NCT02953678|Prednisolone|prednisolone|mesh-list
101890604|NCT02953678|Prednisolone acetate|prednisolone acetate|mesh-list
101890605|NCT02953678|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101890606|NCT02953678|Prednisolone phosphate|prednisolone phosphate|mesh-list
101890607|NCT02953678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101890608|NCT02953678|Glucocorticoids|glucocorticoids|mesh-ancestor
101890609|NCT02953678|Hormones|hormones|mesh-ancestor
101890610|NCT02953678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101890611|NCT02953678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890612|NCT02953678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101890613|NCT02953678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101890614|NCT02953678|Antiemetics|antiemetics|mesh-ancestor
101890615|NCT02953678|Autonomic Agents|autonomic agents|mesh-ancestor
101890616|NCT02953678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101890617|NCT02953678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101890618|NCT02953678|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101890619|NCT02953678|Protective Agents|protective agents|mesh-ancestor
101890620|NCT00090753|Epoetin Alfa|epoetin alfa|mesh-list
101890621|NCT00090753|Darbepoetin alfa|darbepoetin alfa|mesh-list
101890622|NCT00090753|Hematinics|hematinics|mesh-ancestor
101890623|NCT00048932|Abatacept|abatacept|mesh-list
101890624|NCT00048932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101689562|NCT04430894|Dexamethasone|dexamethasone|mesh-list
101890625|NCT00048932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890626|NCT00048932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101890628|NCT00048932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101890629|NCT00048932|Immunologic Factors|immunologic factors|mesh-ancestor
101890630|NCT00048932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890631|NCT00048932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101890632|NCT00073983|Gemcitabine|gemcitabine|mesh-list
101890633|NCT00073983|Docetaxel|docetaxel|mesh-list
101890634|NCT00073983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101890635|NCT00073983|Antimetabolites|antimetabolites|mesh-ancestor
101890636|NCT00073983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890637|NCT00073983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101890638|NCT00073983|Tubulin Modulators|tubulin modulators|mesh-ancestor
101890639|NCT00073983|Antimitotic Agents|antimitotic agents|mesh-ancestor
101890640|NCT00073983|Mitosis Modulators|mitosis modulators|mesh-ancestor
101890641|NCT02952820|Lemborexant|lemborexant|mesh-list
101890642|NCT02952820|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
101890643|NCT02952820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101890644|NCT02952820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890645|NCT02952820|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101890646|NCT02952820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101890647|NCT02952820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101890648|NCT02952820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890649|NCT01583361|Oxaliplatin|oxaliplatin|mesh-list
101890650|NCT01583361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101890651|NCT01085487|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
101890652|NCT01085487|Levonorgestrel|levonorgestrel|mesh-list
101890653|NCT01085487|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101890654|NCT01085487|Contraceptive Agents|contraceptive agents|mesh-ancestor
101890655|NCT01085487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101890656|NCT01085487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890657|NCT01085487|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101890658|NCT01085487|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101890659|NCT01085487|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101890660|NCT01085487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101890661|NCT01085487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890662|NCT01085487|Hemostatics|hemostatics|mesh-ancestor
101890663|NCT01085487|Coagulants|coagulants|mesh-ancestor
101890664|NCT01089309|Spironolactone|spironolactone|mesh-list
101890665|NCT01089309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101890666|NCT01089309|Hormone Antagonists|hormone antagonists|mesh-ancestor
101890667|NCT01089309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101890668|NCT01089309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890669|NCT01089309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101610463|NCT00667108|Antimanic Agents|antimanic agents|mesh-ancestor
101890670|NCT01089309|Diuretics|diuretics|mesh-ancestor
101890671|NCT01089309|Natriuretic Agents|natriuretic agents|mesh-ancestor
101890672|NCT01085721|Chlorpheniramine|chlorpheniramine|mesh-list
101890673|NCT01085721|Phenylpropanolamine|phenylpropanolamine|mesh-list
101890674|NCT01085721|Pseudoephedrine|pseudoephedrine|mesh-list
101890675|NCT01085721|Ephedrine|ephedrine|mesh-list
101890676|NCT01085721|Guaifenesin|guaifenesin|mesh-list
101890677|NCT01085721|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
101890678|NCT01085721|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
101890679|NCT01085721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101890680|NCT01085721|Autonomic Agents|autonomic agents|mesh-ancestor
101890681|NCT01085721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101890682|NCT01085721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890683|NCT01085721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101890684|NCT01085721|Respiratory System Agents|respiratory system agents|mesh-ancestor
101890685|NCT01085721|Nasal Decongestants|nasal decongestants|mesh-ancestor
101890686|NCT01085721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101890687|NCT01085721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101890688|NCT01085721|Sympathomimetics|sympathomimetics|mesh-ancestor
101890689|NCT01085721|Adrenergic Agents|adrenergic agents|mesh-ancestor
101890690|NCT01085721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101968892|NCT00612742|Testosterone|testosterone|mesh-list
101890691|NCT01085721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890693|NCT01085721|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101890694|NCT01085721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101890695|NCT01085721|Appetite Depressants|appetite depressants|mesh-ancestor
101890696|NCT01085721|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101890697|NCT01085721|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101890698|NCT01085721|Histamine Antagonists|histamine antagonists|mesh-ancestor
101890699|NCT01085721|Histamine Agents|histamine agents|mesh-ancestor
101890700|NCT01085721|Antipruritics|antipruritics|mesh-ancestor
101890701|NCT01085721|Dermatologic Agents|dermatologic agents|mesh-ancestor
101890702|NCT01085721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101890703|NCT01089465|Dermatologic Agents|dermatologic agents|mesh-list
101890704|NCT00006392|Vitamins|vitamins|mesh-list
101890705|NCT00006392|Vitamin E|vitamin e|mesh-list
101890706|NCT00006392|Tocopherols|tocopherols|mesh-list
101890707|NCT00006392|Tocotrienols|tocotrienols|mesh-list
101890708|NCT00006392|alpha-Tocopherol|alpha-tocopherol|mesh-list
101890709|NCT00006392|Selenium|selenium|mesh-list
101890710|NCT00006392|Micronutrients|micronutrients|mesh-ancestor
101890711|NCT00006392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890712|NCT00006392|Antioxidants|antioxidants|mesh-ancestor
101890713|NCT00006392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890714|NCT00006392|Protective Agents|protective agents|mesh-ancestor
101890715|NCT00006392|Trace Elements|trace elements|mesh-ancestor
101890716|NCT01089621|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101890717|NCT01089621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101890718|NCT01089621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101890719|NCT01089621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101890720|NCT01089621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890721|NCT01089621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101890722|NCT01089621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890723|NCT01089621|Analgesics|analgesics|mesh-ancestor
101890724|NCT01089621|Sensory System Agents|sensory system agents|mesh-ancestor
101890725|NCT01089621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101890726|NCT01089621|Antidepressive Agents|antidepressive agents|mesh-ancestor
101890727|NCT01089621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101890728|NCT01089621|Dopamine Agents|dopamine agents|mesh-ancestor
101890729|NCT01101152|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101890730|NCT01101152|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101890731|NCT01101152|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101890732|NCT01101152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101890733|NCT01101152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890734|NCT01101152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101890735|NCT01101152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890736|NCT01101152|Antidepressive Agents|antidepressive agents|mesh-ancestor
101890737|NCT01101152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101890738|NCT00379769|Metformin|metformin|mesh-list
101890739|NCT00379769|Rosiglitazone|rosiglitazone|mesh-list
101890740|NCT00379769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101890741|NCT00379769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890742|NCT00006164|Ribavirin|ribavirin|mesh-list
101610566|NCT04282746|Ketamine|ketamine|mesh-list
101890743|NCT00006164|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101890744|NCT00006164|Interferon-alpha|interferon-alpha|mesh-list
101890745|NCT00006164|Antimetabolites|antimetabolites|mesh-ancestor
101890746|NCT00006164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890748|NCT00006164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101890749|NCT00006164|Immunologic Factors|immunologic factors|mesh-ancestor
101890750|NCT00006164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890751|NCT00378599|Interferons|interferons|mesh-list
101890752|NCT00378599|Interferon-alpha|interferon-alpha|mesh-list
101890753|NCT00378599|Interferon alpha-2|interferon alpha-2|mesh-list
101890754|NCT00378599|Ribavirin|ribavirin|mesh-list
101890755|NCT00378599|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101890756|NCT00378599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101890757|NCT00378599|Antiviral Agents|antiviral agents|mesh-ancestor
101776256|NCT00950625|Lidocaine|lidocaine|mesh-list
101890758|NCT00378599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101890759|NCT00378599|Immunologic Factors|immunologic factors|mesh-ancestor
101890760|NCT00378599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890761|NCT00378599|Antimetabolites|antimetabolites|mesh-ancestor
101968898|NCT05016895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101890762|NCT00378599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890764|NCT01046981|Metronidazole|metronidazole|mesh-list
101890765|NCT01046981|Cefazolin|cefazolin|mesh-list
101890766|NCT01046981|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101890767|NCT01046981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101890768|NCT01046981|Antitubercular Agents|antitubercular agents|mesh-ancestor
101890769|NCT01046981|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101890770|NCT01046981|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101890771|NCT00378209|Dexamethasone|dexamethasone|mesh-list
101890772|NCT00378209|Lenalidomide|lenalidomide|mesh-list
101890773|NCT00378209|Bortezomib|bortezomib|mesh-list
101890774|NCT00378209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101890775|NCT00378209|Antiemetics|antiemetics|mesh-ancestor
101890776|NCT00378209|Autonomic Agents|autonomic agents|mesh-ancestor
101890777|NCT00378209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101890778|NCT00378209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890779|NCT00378209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101890780|NCT00378209|Glucocorticoids|glucocorticoids|mesh-ancestor
101890781|NCT00378209|Hormones|hormones|mesh-ancestor
101890782|NCT00378209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101890783|NCT00378209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101890784|NCT00378209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101890785|NCT00378209|Immunologic Factors|immunologic factors|mesh-ancestor
101890786|NCT00378209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101890787|NCT00378209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101890788|NCT00378209|Growth Substances|growth substances|mesh-ancestor
101890789|NCT00378209|Growth Inhibitors|growth inhibitors|mesh-ancestor
101890790|NCT01047059|Bevacizumab|bevacizumab|mesh-list
101890791|NCT01047059|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101890792|NCT01047059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101890793|NCT01047059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101890794|NCT01047059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101890795|NCT01047059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101890796|NCT01047059|Growth Substances|growth substances|mesh-ancestor
101890797|NCT01047059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890798|NCT01047059|Growth Inhibitors|growth inhibitors|mesh-ancestor
101890799|NCT01047059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101890800|NCT01047059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101890801|NCT01047059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890802|NCT00377819|Denosumab|denosumab|mesh-list
101890803|NCT00377819|Alendronate|alendronate|mesh-list
101890804|NCT00377819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101890805|NCT00377819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890806|NCT00377429|Catumaxomab|catumaxomab|mesh-list
101890807|NCT00377429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101890808|NCT01047215|Aripiprazole|aripiprazole|mesh-list
101890809|NCT01047215|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101890810|NCT01047215|Antidepressive Agents|antidepressive agents|mesh-ancestor
101890811|NCT01047215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101890812|NCT01047215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101890813|NCT01047215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101890814|NCT01047215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101890815|NCT01047215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890816|NCT01047215|Dopamine Agonists|dopamine agonists|mesh-ancestor
101890817|NCT01047215|Dopamine Agents|dopamine agents|mesh-ancestor
101890818|NCT01047215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101890819|NCT01047215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610612|NCT04204902|Tepotinib|tepotinib|mesh-list
101890820|NCT01047215|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101890821|NCT01047215|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101890822|NCT01047215|Serotonin Agents|serotonin agents|mesh-ancestor
101890823|NCT01047215|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101890824|NCT01047215|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101890825|NCT01047215|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101890826|NCT01047215|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101890827|NCT03715582|Trimetazidine|trimetazidine|mesh-list
101890828|NCT03715582|Vasodilator Agents|vasodilator agents|mesh-ancestor
101890829|NCT00376961|Prednisone|prednisone|mesh-list
101890830|NCT00376961|Cyclophosphamide|cyclophosphamide|mesh-list
101890831|NCT00376961|Rituximab|rituximab|mesh-list
101890832|NCT00376961|Doxorubicin|doxorubicin|mesh-list
101890833|NCT00376961|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101890834|NCT00376961|Vincristine|vincristine|mesh-list
101890836|NCT00376961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101890837|NCT00376961|Immunologic Factors|immunologic factors|mesh-ancestor
101890838|NCT00376961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890839|NCT00376961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101689571|NCT04430894|Hormones|hormones|mesh-ancestor
101890840|NCT00376961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101890841|NCT00376961|Alkylating Agents|alkylating agents|mesh-ancestor
101890842|NCT00376961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890843|NCT00376961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101890844|NCT00376961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101890845|NCT00376961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101890846|NCT00376961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101890847|NCT00376961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101890848|NCT00376961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101890849|NCT00376961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101890850|NCT00376961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101890851|NCT00376961|Glucocorticoids|glucocorticoids|mesh-ancestor
101890852|NCT00376961|Hormones|hormones|mesh-ancestor
101890853|NCT00376961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101890854|NCT00376961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101890855|NCT00376961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101890856|NCT00376961|Tubulin Modulators|tubulin modulators|mesh-ancestor
101890857|NCT00376961|Antimitotic Agents|antimitotic agents|mesh-ancestor
101890858|NCT00376961|Mitosis Modulators|mitosis modulators|mesh-ancestor
101890859|NCT00376259|Adefovir|adefovir|mesh-list
101890860|NCT00376259|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101890861|NCT00376259|Telbivudine|telbivudine|mesh-list
101890862|NCT00376259|Antiviral Agents|antiviral agents|mesh-ancestor
101890863|NCT00376259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101890864|NCT00376259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101890865|NCT00376259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101890866|NCT00376259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101890867|NCT00376259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890868|NCT03715348|Thrombin|thrombin|mesh-list
101890869|NCT03715348|Hemostatics|hemostatics|mesh-ancestor
101890870|NCT03715348|Coagulants|coagulants|mesh-ancestor
101890871|NCT01041755|N-Methylaspartate|n-methylaspartate|mesh-list
101890872|NCT01041755|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
101890873|NCT01041755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101890874|NCT01041755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101890875|NCT01041755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890876|NCT01041755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890877|NCT00365105|Vitamin D|vitamin d|mesh-list
101890878|NCT00365105|Zoledronic Acid|zoledronic acid|mesh-list
101890879|NCT00365105|Calcium|calcium|mesh-list
101890880|NCT00365105|Vitamins|vitamins|mesh-ancestor
101890881|NCT00365105|Micronutrients|micronutrients|mesh-ancestor
101890882|NCT00365105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890883|NCT00365105|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101890884|NCT00365105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101890885|NCT01049633|Aspirin|aspirin|mesh-list
101890886|NCT01049633|Sirolimus|sirolimus|mesh-list
101890887|NCT01049633|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101890888|NCT01049633|Antifungal Agents|antifungal agents|mesh-list
101890889|NCT01049633|Clotrimazole|clotrimazole|mesh-list
101890890|NCT01049633|Miconazole|miconazole|mesh-list
101890891|NCT01049633|Trimethoprim|trimethoprim|mesh-list
101890892|NCT01049633|Sulfamethoxazole|sulfamethoxazole|mesh-list
101610684|NCT04282200|Analgesics|analgesics|mesh-ancestor
101890893|NCT01049633|Valganciclovir|valganciclovir|mesh-list
101890894|NCT01049633|Antiviral Agents|antiviral agents|mesh-list
101890895|NCT01049633|Heparin|heparin|mesh-list
101890896|NCT01049633|Enoxaparin|enoxaparin|mesh-list
101890897|NCT01049633|Pentoxifylline|pentoxifylline|mesh-list
101890898|NCT01049633|Tacrolimus|tacrolimus|mesh-list
101890899|NCT01049633|Basiliximab|basiliximab|mesh-list
101890900|NCT01049633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101890901|NCT01049633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101890902|NCT01049633|Analgesics|analgesics|mesh-ancestor
101890903|NCT01049633|Sensory System Agents|sensory system agents|mesh-ancestor
101890904|NCT01049633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101890905|NCT01049633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890906|NCT01049633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101890907|NCT01049633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101890908|NCT01049633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101890909|NCT01049633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101890910|NCT01049633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890911|NCT01049633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101890912|NCT01049633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101890913|NCT01049633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101890914|NCT01049633|Antipyretics|antipyretics|mesh-ancestor
101890915|NCT01049633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101890916|NCT01049633|Immunologic Factors|immunologic factors|mesh-ancestor
101890917|NCT01049633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101890918|NCT01049633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101890919|NCT01049633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101890920|NCT01049633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101890921|NCT01049633|Anticoagulants|anticoagulants|mesh-ancestor
101890922|NCT01049633|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101890923|NCT01049633|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101890924|NCT01049633|Protective Agents|protective agents|mesh-ancestor
101890925|NCT01049633|Vasodilator Agents|vasodilator agents|mesh-ancestor
101890926|NCT01049633|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101890927|NCT01049633|Antioxidants|antioxidants|mesh-ancestor
101890928|NCT01049633|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101890929|NCT01049633|Antimalarials|antimalarials|mesh-ancestor
101890930|NCT01049633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101890931|NCT01049633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101890932|NCT01049633|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101890933|NCT01049633|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101890934|NCT01049633|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101890935|NCT01049633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101890936|NCT01049633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101890937|NCT01049633|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101890938|NCT01049633|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101776308|NCT00760448|Insulin|insulin|mesh-list
101890939|NCT01049633|Hormone Antagonists|hormone antagonists|mesh-ancestor
101890940|NCT01049633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101890941|NCT01049633|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101890942|NCT01049633|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101890943|NCT00399893|Octreotide|octreotide|mesh-list
101890944|NCT00399893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101890945|NCT00399893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101890946|NCT00399893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101890947|NCT01049711|Epoetin Alfa|epoetin alfa|mesh-list
101890948|NCT01049711|Hematinics|hematinics|mesh-ancestor
101890949|NCT00048542|Adalimumab|adalimumab|mesh-list
101890950|NCT00048542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101890951|NCT00048542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101890952|NCT00048542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101890953|NCT03814590|Vaccines|vaccines|mesh-list
101890954|NCT03814590|Immunologic Factors|immunologic factors|mesh-ancestor
101890955|NCT03814590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890956|NCT01583244|Abatacept|abatacept|mesh-list
101890957|NCT01583244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101890958|NCT01583244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890959|NCT01583244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101890960|NCT01583244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101890961|NCT01583244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101890962|NCT01583244|Immunologic Factors|immunologic factors|mesh-ancestor
101890963|NCT01583244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890964|NCT01583244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101890965|NCT01085526|Immunomodulating Agents|immunomodulating agents|mesh-list
101890966|NCT01085526|Immunologic Factors|immunologic factors|mesh-list
101890967|NCT01085526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890968|NCT00048074|Ibandronic Acid|ibandronic acid|mesh-list
101890969|NCT00048074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101890970|NCT00048074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890971|NCT01102946|Ranibizumab|ranibizumab|mesh-list
101890972|NCT01102946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101890973|NCT01102946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101890974|NCT01102946|Growth Substances|growth substances|mesh-ancestor
101890975|NCT01102946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890976|NCT01102946|Growth Inhibitors|growth inhibitors|mesh-ancestor
101890977|NCT01102946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101890978|NCT01103024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101890979|NCT01103024|Immunologic Factors|immunologic factors|mesh-ancestor
101890980|NCT01103024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890981|NCT01101386|Voriconazole|voriconazole|mesh-list
101890982|NCT01101386|Antifungal Agents|antifungal agents|mesh-ancestor
101890983|NCT01101386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101890984|NCT01101386|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101890985|NCT01101386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101890986|NCT01101386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101890987|NCT01101386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101890988|NCT01101386|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101890989|NCT01101386|Hormone Antagonists|hormone antagonists|mesh-ancestor
101890990|NCT01101386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101890991|NCT01101386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101890992|NCT01101386|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101890994|NCT00005906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101890995|NCT00005906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101890996|NCT00005906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101890997|NCT01103336|Nicorandil|nicorandil|mesh-list
101890998|NCT01103336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101890999|NCT01103336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101891000|NCT01103336|Vasodilator Agents|vasodilator agents|mesh-ancestor
101891001|NCT01103336|Vitamin B Complex|vitamin b complex|mesh-ancestor
101891002|NCT01103336|Vitamins|vitamins|mesh-ancestor
101891003|NCT01103336|Micronutrients|micronutrients|mesh-ancestor
101891004|NCT01103336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891005|NCT03950960|Itraconazole|itraconazole|mesh-list
101891006|NCT03950960|Antifungal Agents|antifungal agents|mesh-ancestor
101891007|NCT03950960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101891008|NCT03950960|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101891009|NCT03950960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101891010|NCT03950960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101891011|NCT03950960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891012|NCT03950960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101891013|NCT03950960|Hormone Antagonists|hormone antagonists|mesh-ancestor
101891014|NCT03950960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101891015|NCT03950960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891016|NCT03950960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101891017|NCT03954860|Tranexamic Acid|tranexamic acid|mesh-list
101891018|NCT03954860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101891019|NCT03954860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101891020|NCT03954860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891021|NCT03954860|Hemostatics|hemostatics|mesh-ancestor
101891022|NCT03954860|Coagulants|coagulants|mesh-ancestor
101891023|NCT00066690|Tamoxifen|tamoxifen|mesh-list
101891024|NCT00066690|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101891025|NCT00066690|Exemestane|exemestane|mesh-list
101891026|NCT00066690|Tryptophan|tryptophan|mesh-list
101891027|NCT00066690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891028|NCT00066690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101891029|NCT00066690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891030|NCT00066690|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101891031|NCT00066690|Hormone Antagonists|hormone antagonists|mesh-ancestor
101891032|NCT00066690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101891033|NCT00066690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101968918|NCT00612118|Histamine Agents|histamine agents|mesh-ancestor
101891034|NCT00066690|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101891035|NCT00066690|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101891036|NCT00066690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101891037|NCT00066690|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101891038|NCT00066690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101891039|NCT00066690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101891040|NCT00066690|Luteolytic Agents|luteolytic agents|mesh-ancestor
101891041|NCT00066690|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101891042|NCT00066690|Contraceptive Agents|contraceptive agents|mesh-ancestor
101891043|NCT00066690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101776332|NCT00308581|Certolizumab Pegol|certolizumab pegol|mesh-list
101891044|NCT00066690|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101891045|NCT00066690|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101891046|NCT00066690|Antidepressive Agents|antidepressive agents|mesh-ancestor
101891047|NCT00066690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101891048|NCT03409276|Vaccines|vaccines|mesh-list
101891049|NCT03409276|Immunologic Factors|immunologic factors|mesh-ancestor
101891050|NCT03409276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891051|NCT00004562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
101891052|NCT00004562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101891053|NCT00004562|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101891054|NCT00004562|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101891055|NCT00004562|Adrenergic Agents|adrenergic agents|mesh-list
101689580|NCT02829281|Triamcinolone|triamcinolone|mesh-list
101891056|NCT00004562|Adrenergic Antagonists|adrenergic antagonists|mesh-list
101891057|NCT00004562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101891058|NCT00004562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891059|NCT00004562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891060|NCT00004562|Protease Inhibitors|protease inhibitors|mesh-ancestor
101891061|NCT00004412|Arginine butyrate|arginine butyrate|mesh-list
101891062|NCT00004412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101891063|NCT00004088|Pamidronate|pamidronate|mesh-list
101891064|NCT00004088|Interferons|interferons|mesh-list
101891065|NCT00004088|Interferon-alpha|interferon-alpha|mesh-list
101891066|NCT00004088|Thalidomide|thalidomide|mesh-list
101891067|NCT00004088|Cyclophosphamide|cyclophosphamide|mesh-list
101891068|NCT00004088|Melphalan|melphalan|mesh-list
101891069|NCT00004088|Busulfan|busulfan|mesh-list
101891070|NCT00004088|Lenograstim|lenograstim|mesh-list
101891071|NCT00004088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101891072|NCT00004088|Immunologic Factors|immunologic factors|mesh-ancestor
101891073|NCT00004088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891074|NCT00004088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101891075|NCT00004088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101891076|NCT00004088|Alkylating Agents|alkylating agents|mesh-ancestor
101891077|NCT00004088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891078|NCT00004088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101891079|NCT00004088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101891080|NCT00004088|Antiviral Agents|antiviral agents|mesh-ancestor
101891081|NCT00004088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101891082|NCT00004088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101891083|NCT00004088|Leprostatic Agents|leprostatic agents|mesh-ancestor
101891084|NCT00004088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101891085|NCT00004088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101891086|NCT00004088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101891087|NCT00004088|Growth Substances|growth substances|mesh-ancestor
101891088|NCT00004088|Growth Inhibitors|growth inhibitors|mesh-ancestor
101891089|NCT00004088|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101891090|NCT03439072|Glucagon|glucagon|mesh-list
101891091|NCT03439072|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101891092|NCT03439072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101891093|NCT03439072|Hormones|hormones|mesh-ancestor
101891094|NCT03439072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101891095|NCT03439072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891096|NCT03439072|Incretins|incretins|mesh-ancestor
101891097|NCT00078312|Modafinil|modafinil|mesh-list
101891098|NCT00078312|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101891099|NCT00078312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891100|NCT00078312|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101891101|NCT00078312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101891103|NCT00078312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891104|NCT01085838|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101891105|NCT01085838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101891106|NCT01085838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101891107|NCT01085838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101891108|NCT01085838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891109|NCT00003896|Paclitaxel|paclitaxel|mesh-list
101891110|NCT00003896|Doxorubicin|doxorubicin|mesh-list
101891111|NCT00003896|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101891112|NCT00003896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101891113|NCT00003896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101891114|NCT00003896|Tubulin Modulators|tubulin modulators|mesh-ancestor
101891115|NCT00003896|Antimitotic Agents|antimitotic agents|mesh-ancestor
101891116|NCT00003896|Mitosis Modulators|mitosis modulators|mesh-ancestor
101891117|NCT00003896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891118|NCT00003896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101891119|NCT00003896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101891120|NCT00003896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101891121|NCT00003896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101891122|NCT01091766|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101891123|NCT03712540|Rifampin|rifampin|mesh-list
101891124|NCT03712540|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101891125|NCT03712540|Antitubercular Agents|antitubercular agents|mesh-ancestor
101891126|NCT03712540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101891127|NCT03712540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101891128|NCT03712540|Leprostatic Agents|leprostatic agents|mesh-ancestor
101689583|NCT02829281|Botulinum Toxins|botulinum toxins|mesh-list
101891129|NCT03712540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101891130|NCT03712540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101891131|NCT03712540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891132|NCT03712540|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101891133|NCT03712540|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101891134|NCT03712540|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101891135|NCT03712540|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101891136|NCT03712540|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101891137|NCT03712540|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101891138|NCT05472220|Carboplatin|carboplatin|mesh-list
101891139|NCT05472220|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
101891140|NCT05472220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101891141|NCT05472220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101891142|NCT05472220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891143|NCT00003782|Cyclophosphamide|cyclophosphamide|mesh-list
101891144|NCT00003782|Docetaxel|docetaxel|mesh-list
101891145|NCT00003782|Doxorubicin|doxorubicin|mesh-list
101891146|NCT00003782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101891147|NCT00003782|Immunologic Factors|immunologic factors|mesh-ancestor
101891148|NCT00003782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891149|NCT00003782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101891150|NCT00003782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101891151|NCT00003782|Alkylating Agents|alkylating agents|mesh-ancestor
101891152|NCT00003782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891153|NCT00003782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101891154|NCT00003782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101891155|NCT00003782|Tubulin Modulators|tubulin modulators|mesh-ancestor
101891156|NCT00003782|Antimitotic Agents|antimitotic agents|mesh-ancestor
101891157|NCT00003782|Mitosis Modulators|mitosis modulators|mesh-ancestor
101891158|NCT00003782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101891159|NCT00003782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101891160|NCT00003782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101891161|NCT00003782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101891162|NCT03389308|Diacerein|diacerein|mesh-list
101891163|NCT03389308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101891164|NCT03714490|Capecitabine|capecitabine|mesh-list
101891165|NCT03714490|Oxaliplatin|oxaliplatin|mesh-list
101891166|NCT03714490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101891167|NCT03714490|Antimetabolites|antimetabolites|mesh-ancestor
101891168|NCT03714490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891169|NCT03714490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101891170|NCT03407170|Pembrolizumab|pembrolizumab|mesh-list
101968936|NCT02280070|Fluorouracil|fluorouracil|mesh-list
101891171|NCT03407170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101891172|NCT03407170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101891173|NCT03407170|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101891174|NCT03407170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891175|NCT01103648|Simvastatin|simvastatin|mesh-list
101891176|NCT01103648|Ezetimibe|ezetimibe|mesh-list
101891177|NCT01103648|Hypolipidemic Agents|hypolipidemic agents|mesh-list
101891178|NCT01103648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
101891179|NCT01103648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101891180|NCT01103648|Antimetabolites|antimetabolites|mesh-ancestor
101891181|NCT01103648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891182|NCT01103648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101891183|NCT01103648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101891184|NCT03406858|Pembrolizumab|pembrolizumab|mesh-list
101891185|NCT03406858|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101891186|NCT03406858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101891187|NCT03406858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101891188|NCT03406858|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101891189|NCT03406858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891190|NCT03406858|Immunologic Factors|immunologic factors|mesh-ancestor
101891191|NCT03406858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891192|NCT01095848|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101610980|NCT00911859|Alkylating Agents|alkylating agents|mesh-ancestor
101891193|NCT01095848|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101891194|NCT01095848|Immunologic Factors|immunologic factors|mesh-ancestor
101891195|NCT01095848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891196|NCT01095926|Doxorubicin|doxorubicin|mesh-list
101891197|NCT01095926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101891198|NCT01095926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101891199|NCT01095926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101891200|NCT01095926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101891201|NCT01095926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101891202|NCT01095926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891203|NCT00003656|Interferons|interferons|mesh-list
101891204|NCT00003656|Interferon-alpha|interferon-alpha|mesh-list
101891205|NCT00003656|Tretinoin|tretinoin|mesh-list
101891206|NCT00003656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101891207|NCT00003656|Antiviral Agents|antiviral agents|mesh-ancestor
101891208|NCT00003656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101891209|NCT00003656|Immunologic Factors|immunologic factors|mesh-ancestor
101891210|NCT00003656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891211|NCT00003656|Keratolytic Agents|keratolytic agents|mesh-ancestor
101891212|NCT00003656|Dermatologic Agents|dermatologic agents|mesh-ancestor
101891213|NCT00003590|Hydroxyurea|hydroxyurea|mesh-list
101891214|NCT00003590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101891215|NCT00003590|Antisickling Agents|antisickling agents|mesh-ancestor
101891216|NCT00003590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101891217|NCT00003590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891218|NCT00003590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101891219|NCT03948620|Penicillins|penicillins|mesh-list
101891220|NCT03948620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101891221|NCT03948620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101891222|NCT03416374|Dexamethasone|dexamethasone|mesh-list
101891223|NCT03416374|Lenalidomide|lenalidomide|mesh-list
101891224|NCT03416374|Bortezomib|bortezomib|mesh-list
101891225|NCT03416374|Ixazomib|ixazomib|mesh-list
101891226|NCT03416374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101891227|NCT03416374|Antiemetics|antiemetics|mesh-ancestor
101891228|NCT03416374|Autonomic Agents|autonomic agents|mesh-ancestor
101891229|NCT03416374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101891230|NCT03416374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891231|NCT03416374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101891232|NCT03416374|Glucocorticoids|glucocorticoids|mesh-ancestor
101891233|NCT03416374|Hormones|hormones|mesh-ancestor
101891234|NCT03416374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101891235|NCT03416374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101891236|NCT03416374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101891237|NCT03416374|Immunologic Factors|immunologic factors|mesh-ancestor
101968937|NCT02280070|Tegafur|tegafur|mesh-list
101891238|NCT03416374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101891239|NCT03416374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101891240|NCT03416374|Growth Substances|growth substances|mesh-ancestor
101891241|NCT03416374|Growth Inhibitors|growth inhibitors|mesh-ancestor
101891242|NCT03416374|Protease Inhibitors|protease inhibitors|mesh-ancestor
101891243|NCT03416374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101891244|NCT03416374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891245|NCT00077766|Darbepoetin alfa|darbepoetin alfa|mesh-list
101891246|NCT00077766|Hematinics|hematinics|mesh-ancestor
101891247|NCT01096082|Lithium Carbonate|lithium carbonate|mesh-list
101891248|NCT01096082|Antidepressive Agents|antidepressive agents|mesh-ancestor
101891249|NCT01096082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101891250|NCT01096082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101891251|NCT01096082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891252|NCT01096082|Antimanic Agents|antimanic agents|mesh-ancestor
101891253|NCT01096082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101891254|NCT01096082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101891255|NCT01096082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891256|NCT03388138|Ketotifen|ketotifen|mesh-list
101891257|NCT03388138|Antipruritics|antipruritics|mesh-ancestor
101891258|NCT03388138|Dermatologic Agents|dermatologic agents|mesh-ancestor
101891259|NCT03388138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101891260|NCT03388138|Histamine Antagonists|histamine antagonists|mesh-ancestor
101891261|NCT03388138|Histamine Agents|histamine agents|mesh-ancestor
101891262|NCT03388138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101891263|NCT03388138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891264|NCT03388138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891265|NCT03388138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101891266|NCT01101620|Simendan|simendan|mesh-list
101891267|NCT01101620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101891268|NCT01101620|Vasodilator Agents|vasodilator agents|mesh-ancestor
101891269|NCT01101620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101891270|NCT01101620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101891272|NCT01101620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891273|NCT01101620|Protective Agents|protective agents|mesh-ancestor
101891274|NCT01101620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891275|NCT02952898|Diclofenac|diclofenac|mesh-list
101891276|NCT02952898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101891277|NCT02952898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101891278|NCT02952898|Analgesics|analgesics|mesh-ancestor
101891279|NCT02952898|Sensory System Agents|sensory system agents|mesh-ancestor
101891280|NCT02952898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101891281|NCT02952898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891282|NCT02952898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101891283|NCT02952898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101891284|NCT02952898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101891285|NCT02952898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101891286|NCT02952898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891287|NCT01101698|Vitamin D|vitamin d|mesh-list
101891288|NCT01101698|Cholecalciferol|cholecalciferol|mesh-list
101891289|NCT01101698|Vitamins|vitamins|mesh-list
101891290|NCT01101698|Vitamin K|vitamin k|mesh-list
101891291|NCT01101698|Vitamin K 2|vitamin k 2|mesh-list
101891292|NCT01101698|Micronutrients|micronutrients|mesh-ancestor
101891293|NCT01101698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891294|NCT01101698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101891295|NCT01101698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101891296|NCT01101698|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101891297|NCT01101698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101891298|NCT01101698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891299|NCT01101698|Hemostatics|hemostatics|mesh-ancestor
101891300|NCT01101698|Coagulants|coagulants|mesh-ancestor
101891301|NCT00045734|Imatinib Mesylate|imatinib mesylate|mesh-list
101891302|NCT00045734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101891303|NCT00045734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101891304|NCT00045734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101968946|NCT02280070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101891305|NCT00045734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891306|NCT05513768|Protein C|protein c|mesh-list
101891307|NCT05513768|Anticoagulants|anticoagulants|mesh-ancestor
101891308|NCT05513768|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101891309|NCT05513768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101891310|NCT05513768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891311|NCT03387046|Methylprednisolone|methylprednisolone|mesh-list
101891312|NCT03387046|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101891313|NCT03387046|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101891314|NCT03387046|Prednisolone|prednisolone|mesh-list
101891315|NCT03387046|Prednisolone acetate|prednisolone acetate|mesh-list
101891316|NCT03387046|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101891317|NCT03387046|Prednisolone phosphate|prednisolone phosphate|mesh-list
101891318|NCT03387046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101891319|NCT03387046|Antiemetics|antiemetics|mesh-ancestor
101891320|NCT03387046|Autonomic Agents|autonomic agents|mesh-ancestor
101891321|NCT03387046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101891322|NCT03387046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891323|NCT03387046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101891324|NCT03387046|Glucocorticoids|glucocorticoids|mesh-ancestor
101891325|NCT03387046|Hormones|hormones|mesh-ancestor
101689597|NCT02829281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101891326|NCT03387046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101891327|NCT03387046|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101891328|NCT03387046|Protective Agents|protective agents|mesh-ancestor
101891329|NCT03387046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101891330|NCT03387046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101891331|NCT01101776|Interferons|interferons|mesh-list
101891332|NCT01101776|Interferon-beta|interferon-beta|mesh-list
101891333|NCT01101776|Interferon beta-1a|interferon beta-1a|mesh-list
101891334|NCT01101776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101891335|NCT01101776|Antiviral Agents|antiviral agents|mesh-ancestor
101891336|NCT01101776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101891337|NCT01101776|Immunologic Factors|immunologic factors|mesh-ancestor
101891338|NCT01101776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891339|NCT01101776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101891340|NCT00045110|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101891341|NCT00045110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101891342|NCT00045110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101891343|NCT00045110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101611128|NCT00910689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101891344|NCT00045110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891345|NCT03353740|Edetic Acid|edetic acid|mesh-list
101891346|NCT03353740|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101891347|NCT03353740|Chelating Agents|chelating agents|mesh-ancestor
101891348|NCT03353740|Sequestering Agents|sequestering agents|mesh-ancestor
101891349|NCT03353740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891350|NCT03353740|Anticoagulants|anticoagulants|mesh-ancestor
101891351|NCT03353740|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101891352|NCT03353740|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101891353|NCT04814602|Proglumide|proglumide|mesh-list
101891354|NCT04814602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101891355|NCT04814602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101891356|NCT01104038|Chlorhexidine|chlorhexidine|mesh-list
101891357|NCT01104038|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101891358|NCT01104038|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101891359|NCT01104038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101891360|NCT01104038|Disinfectants|disinfectants|mesh-ancestor
101891361|NCT01104038|Dermatologic Agents|dermatologic agents|mesh-ancestor
101891362|NCT03386344|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
101891363|NCT03386344|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101891364|NCT03386344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891365|NCT03386344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101891366|NCT03386344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891367|NCT00399035|Leucovorin|leucovorin|mesh-list
101891368|NCT00399035|Fluorouracil|fluorouracil|mesh-list
101891369|NCT00399035|Capecitabine|capecitabine|mesh-list
101891370|NCT00399035|Oxaliplatin|oxaliplatin|mesh-list
101891371|NCT00399035|Cediranib|cediranib|mesh-list
101891372|NCT00399035|Levoleucovorin|levoleucovorin|mesh-list
101891373|NCT00399035|Antimetabolites|antimetabolites|mesh-ancestor
101891374|NCT00399035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891375|NCT00399035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101891376|NCT00399035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101891377|NCT00399035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101891378|NCT00399035|Immunologic Factors|immunologic factors|mesh-ancestor
101891379|NCT00399035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891380|NCT00399035|Antidotes|antidotes|mesh-ancestor
101891381|NCT00399035|Protective Agents|protective agents|mesh-ancestor
101891382|NCT00399035|Vitamin B Complex|vitamin b complex|mesh-ancestor
101891383|NCT00399035|Vitamins|vitamins|mesh-ancestor
101891384|NCT00399035|Micronutrients|micronutrients|mesh-ancestor
101891385|NCT00399035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101891386|NCT00399035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101891387|NCT00073749|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
101891388|NCT00073749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101891389|NCT00073749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101891390|NCT00073749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101891391|NCT00073749|Immunotoxins|immunotoxins|mesh-ancestor
101891392|NCT00073749|Immunoconjugates|immunoconjugates|mesh-ancestor
101891393|NCT00073749|Immunologic Factors|immunologic factors|mesh-ancestor
101891394|NCT00073749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891395|NCT03960801|Remifentanil|remifentanil|mesh-list
101891396|NCT03960801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101891397|NCT03960801|Narcotics|narcotics|mesh-ancestor
101689610|NCT04168944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101891398|NCT03960801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101891399|NCT03960801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891400|NCT03960801|Analgesics|analgesics|mesh-ancestor
101891401|NCT03960801|Sensory System Agents|sensory system agents|mesh-ancestor
101776427|NCT00805116|Cod Liver Oil|cod liver oil|mesh-list
101891402|NCT03960801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101891403|NCT01583439|Ritonavir|ritonavir|mesh-list
101891404|NCT01583439|Lopinavir|lopinavir|mesh-list
101891405|NCT01583439|Tenofovir|tenofovir|mesh-list
101891406|NCT01583439|Lamivudine|lamivudine|mesh-list
101891407|NCT01583439|Emtricitabine|emtricitabine|mesh-list
101891408|NCT01583439|Zidovudine|zidovudine|mesh-list
101891409|NCT01583439|Efavirenz|efavirenz|mesh-list
101891410|NCT01583439|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101891411|NCT01583439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101891412|NCT01583439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101891413|NCT01583439|Protease Inhibitors|protease inhibitors|mesh-ancestor
101891414|NCT01583439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101891415|NCT01583439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891416|NCT01583439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101891417|NCT01583439|Antiviral Agents|antiviral agents|mesh-ancestor
101891418|NCT01583439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101611216|NCT00879970|Vitamin D|vitamin d|mesh-list
101891419|NCT01583439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101891420|NCT01583439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101891421|NCT01583439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101891422|NCT01583439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101891424|NCT01583439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101891425|NCT01583439|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101891426|NCT01583439|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101891427|NCT01583439|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101891428|NCT01583439|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101891429|NCT02530827|Hypolipidemic Agents|hypolipidemic agents|mesh-list
101891430|NCT02530827|Antimetabolites|antimetabolites|mesh-ancestor
101891431|NCT02530827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891432|NCT02530827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101891433|NCT00398567|Trastuzumab|trastuzumab|mesh-list
101891434|NCT00398567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101891435|NCT00398567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101891436|NCT01082289|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
101891437|NCT01082289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101891438|NCT01082289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101891439|NCT01082289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101891440|NCT01082289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891441|NCT01082289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101891442|NCT01082289|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101891443|NCT01082289|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101891444|NCT01082289|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101891445|NCT01082289|Adrenergic Agents|adrenergic agents|mesh-ancestor
101891446|NCT01082289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101891447|NCT01082289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891448|NCT01082289|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101891449|NCT01082289|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101891450|NCT01082289|Serotonin Agents|serotonin agents|mesh-ancestor
101891451|NCT01082289|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101891452|NCT01082289|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101891453|NCT01082289|Dopamine Agents|dopamine agents|mesh-ancestor
101891455|NCT05842213|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101891456|NCT05842213|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101891457|NCT05842213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101891458|NCT05842213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101891459|NCT05842213|Immunologic Factors|immunologic factors|mesh-ancestor
101891460|NCT05842213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891461|NCT05842174|Hydroxychloroquine|hydroxychloroquine|mesh-list
101891462|NCT05842174|Ethiodized Oil|ethiodized oil|mesh-list
101891463|NCT05842174|Antimalarials|antimalarials|mesh-ancestor
101891464|NCT05842174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101891465|NCT05842174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101891466|NCT05842174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101891467|NCT05842174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101891468|NCT05842174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891469|NCT05842174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101891470|NCT05842174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101891472|NCT05842096|Immunologic Factors|immunologic factors|mesh-ancestor
101891473|NCT05842096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891474|NCT05841992|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101891475|NCT05841992|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101891476|NCT05841992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891477|NCT05841849|Aprepitant|aprepitant|mesh-list
101891478|NCT05841849|Fosaprepitant|fosaprepitant|mesh-list
101891479|NCT05841849|Palonosetron|palonosetron|mesh-list
101891480|NCT05841849|Antiemetics|antiemetics|mesh-ancestor
101891481|NCT05841849|Autonomic Agents|autonomic agents|mesh-ancestor
101891482|NCT05841849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101891483|NCT05841849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891484|NCT05841849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101891485|NCT05841849|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101891486|NCT05841849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101891487|NCT05841849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891488|NCT05841849|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101891489|NCT05841849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101891490|NCT05841849|Serotonin Agents|serotonin agents|mesh-ancestor
101891491|NCT05841771|Azacitidine|azacitidine|mesh-list
101611279|NCT02628574|Antimetabolites|antimetabolites|mesh-ancestor
101891492|NCT05841771|Decitabine|decitabine|mesh-list
101891493|NCT05841771|Venetoclax|venetoclax|mesh-list
101891494|NCT05841771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101891495|NCT05841771|Antimetabolites|antimetabolites|mesh-ancestor
101891496|NCT05841771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891497|NCT05841771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101891498|NCT05841771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101891499|NCT05841758|Hydroxychloroquine|hydroxychloroquine|mesh-list
101891500|NCT05841758|Antimalarials|antimalarials|mesh-ancestor
101891501|NCT05841758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101891502|NCT05841758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101891503|NCT05841758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101891504|NCT05841758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101891505|NCT05841758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891506|NCT05841758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101891507|NCT05841654|Antihypertensive Agents|antihypertensive agents|mesh-list
101891508|NCT05841654|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
101891509|NCT05841654|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101891510|NCT05841654|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101891511|NCT05841654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891512|NCT05841641|Hemostatics|hemostatics|mesh-list
101891513|NCT05841641|Coagulants|coagulants|mesh-ancestor
101891514|NCT05841589|Chlorhexidine|chlorhexidine|mesh-list
101891515|NCT05841589|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101891516|NCT05841589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101891517|NCT05841589|Disinfectants|disinfectants|mesh-ancestor
101891526|NCT05841446|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101891527|NCT05841446|Antithrombins|antithrombins|mesh-ancestor
101891528|NCT05841446|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101891529|NCT05841446|Protease Inhibitors|protease inhibitors|mesh-ancestor
101891530|NCT05841446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101891531|NCT05841446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891532|NCT05841446|Anticoagulants|anticoagulants|mesh-ancestor
101891533|NCT05841394|Esomeprazole|esomeprazole|mesh-list
101891534|NCT05841394|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101891535|NCT05841394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101891536|NCT05841394|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101891537|NCT05841394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101891538|NCT05841394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891539|NCT05841381|Paclitaxel|paclitaxel|mesh-list
101891540|NCT05841381|Trastuzumab|trastuzumab|mesh-list
101891541|NCT05841381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101891542|NCT05841381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101891543|NCT05841381|Tubulin Modulators|tubulin modulators|mesh-ancestor
101891544|NCT05841381|Antimitotic Agents|antimitotic agents|mesh-ancestor
101891545|NCT05841381|Mitosis Modulators|mitosis modulators|mesh-ancestor
101891546|NCT05841381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891547|NCT05841381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101891549|NCT05841303|Antioxidants|antioxidants|mesh-ancestor
101891550|NCT05841303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891551|NCT05841303|Protective Agents|protective agents|mesh-ancestor
101891552|NCT05841303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891553|NCT05841303|Vitamins|vitamins|mesh-ancestor
101891554|NCT05841303|Micronutrients|micronutrients|mesh-ancestor
101891555|NCT05841290|Anesthetics|anesthetics|mesh-list
101891556|NCT05841290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101891557|NCT05841290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891558|NCT05841251|Phenylephrine|phenylephrine|mesh-list
101891559|NCT05841251|Oxymetazoline|oxymetazoline|mesh-list
101891560|NCT05841251|Tranexamic Acid|tranexamic acid|mesh-list
101891561|NCT05841251|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101891562|NCT05841251|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101891563|NCT05841251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891564|NCT05841251|Hemostatics|hemostatics|mesh-ancestor
101891565|NCT05841251|Coagulants|coagulants|mesh-ancestor
101891566|NCT05841251|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101891567|NCT05841251|Mydriatics|mydriatics|mesh-ancestor
101891568|NCT05841251|Autonomic Agents|autonomic agents|mesh-ancestor
101891569|NCT05841251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101891570|NCT05841251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891571|NCT05841251|Sympathomimetics|sympathomimetics|mesh-ancestor
101891572|NCT05841251|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101891573|NCT05841251|Nasal Decongestants|nasal decongestants|mesh-ancestor
101891574|NCT05841251|Respiratory System Agents|respiratory system agents|mesh-ancestor
101891575|NCT05841251|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101891576|NCT05841251|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101891577|NCT05841251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101891578|NCT05841251|Adrenergic Agents|adrenergic agents|mesh-ancestor
101891579|NCT05841251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101891580|NCT05841251|Protective Agents|protective agents|mesh-ancestor
101891581|NCT05841147|Tirofiban|tirofiban|mesh-list
101891582|NCT05841147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101891583|NCT05841147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101891584|NCT05841147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891585|NCT05841147|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101891586|NCT05841121|Dexamethasone|dexamethasone|mesh-list
101891587|NCT05841121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101891588|NCT05841121|Antiemetics|antiemetics|mesh-ancestor
101891589|NCT05841121|Autonomic Agents|autonomic agents|mesh-ancestor
101891590|NCT05841121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101891591|NCT05841121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891592|NCT05841121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101891593|NCT05841121|Glucocorticoids|glucocorticoids|mesh-ancestor
101891594|NCT05841121|Hormones|hormones|mesh-ancestor
101891595|NCT05841121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101891596|NCT05841121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101891597|NCT05841121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101891598|NCT05841056|Amiodarone|amiodarone|mesh-list
101891599|NCT05841056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101891600|NCT05841056|Vasodilator Agents|vasodilator agents|mesh-ancestor
101891601|NCT05841056|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101891602|NCT05841056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101891603|NCT05841056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891604|NCT05841056|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101891605|NCT05841056|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101891606|NCT05841056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101891607|NCT05841056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101891608|NCT05841056|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101891609|NCT05841056|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101891610|NCT05841056|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101891611|NCT05841043|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101891612|NCT05841043|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101891613|NCT05840952|Itraconazole|itraconazole|mesh-list
101891614|NCT05840952|Carbamazepine|carbamazepine|mesh-list
101891615|NCT05840952|Midazolam|midazolam|mesh-list
101891616|NCT05840952|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101891617|NCT05840952|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101891618|NCT05840952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101891619|NCT05840952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891620|NCT05840952|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101891621|NCT05840952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101891622|NCT05840952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101891623|NCT05840952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101891624|NCT05840952|Anesthetics, General|anesthetics, general|mesh-ancestor
101891625|NCT05840952|Anesthetics|anesthetics|mesh-ancestor
101891626|NCT05840952|GABA Modulators|gaba modulators|mesh-ancestor
101891627|NCT05840952|GABA Agents|gaba agents|mesh-ancestor
101891628|NCT05840952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101891629|NCT05840952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891630|NCT05840952|Antifungal Agents|antifungal agents|mesh-ancestor
101891631|NCT05840952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101891632|NCT05840952|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101891633|NCT05840952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101891634|NCT05840952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101891635|NCT05840952|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101891636|NCT05840952|Hormone Antagonists|hormone antagonists|mesh-ancestor
101891637|NCT05840952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101891638|NCT05840952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101891639|NCT05840952|Anticonvulsants|anticonvulsants|mesh-ancestor
101891640|NCT05840952|Antimanic Agents|antimanic agents|mesh-ancestor
101891641|NCT05840952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101891642|NCT05840952|Analgesics|analgesics|mesh-ancestor
101611438|NCT00676936|Hormones|hormones|mesh-ancestor
101891643|NCT05840952|Sensory System Agents|sensory system agents|mesh-ancestor
101891644|NCT05840952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101891645|NCT05840952|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101891646|NCT05840952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101891647|NCT05840952|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101891648|NCT05840952|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101891649|NCT05840913|Epinephrine|epinephrine|mesh-list
101891650|NCT05840913|Carticaine|carticaine|mesh-list
101891651|NCT05840913|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101891652|NCT05840913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101891653|NCT05840913|Adrenergic Agents|adrenergic agents|mesh-ancestor
101891654|NCT05840913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101891655|NCT05840913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891656|NCT05840913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891657|NCT05840913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101891658|NCT05840913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101891659|NCT05840913|Autonomic Agents|autonomic agents|mesh-ancestor
101891660|NCT05840913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101891661|NCT05840913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101891662|NCT05840913|Respiratory System Agents|respiratory system agents|mesh-ancestor
101891663|NCT05840913|Mydriatics|mydriatics|mesh-ancestor
101891664|NCT05840913|Sympathomimetics|sympathomimetics|mesh-ancestor
101891665|NCT05840913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101891666|NCT05840913|Anesthetics, Local|anesthetics, local|mesh-ancestor
101891667|NCT05840913|Anesthetics|anesthetics|mesh-ancestor
101891668|NCT05840913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101891669|NCT05840913|Sensory System Agents|sensory system agents|mesh-ancestor
101891670|NCT05840822|Cannabidiol|cannabidiol|mesh-list
101891671|NCT05840822|Anticonvulsants|anticonvulsants|mesh-ancestor
101891672|NCT05840796|Caseins|caseins|mesh-list
101891673|NCT05840796|Chelating Agents|chelating agents|mesh-ancestor
101891674|NCT05840796|Sequestering Agents|sequestering agents|mesh-ancestor
101891675|NCT05840796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891676|NCT05840770|Cemiplimab|cemiplimab|mesh-list
101891677|NCT05840770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101891678|NCT05840770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101891679|NCT05840068|Metformin|metformin|mesh-list
101891680|NCT05840068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101891681|NCT05840068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891682|NCT05834569|Acetaminophen|acetaminophen|mesh-list
101891683|NCT05834569|Ibuprofen|ibuprofen|mesh-list
101891684|NCT05834569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101891685|NCT05834569|Analgesics|analgesics|mesh-ancestor
101891686|NCT05834569|Sensory System Agents|sensory system agents|mesh-ancestor
101891687|NCT05834569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101891688|NCT05834569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891689|NCT05834569|Antipyretics|antipyretics|mesh-ancestor
101891690|NCT05834569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101891691|NCT05834569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101891692|NCT05834569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101891693|NCT05834569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101891694|NCT05834569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101891695|NCT05834569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891696|NCT05834023|Lidocaine|lidocaine|mesh-list
101891697|NCT05834023|Bupivacaine|bupivacaine|mesh-list
101891698|NCT05834023|Anesthetics, Local|anesthetics, local|mesh-ancestor
101891699|NCT05834023|Anesthetics|anesthetics|mesh-ancestor
101891700|NCT05834023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101891701|NCT05834023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891702|NCT05834023|Sensory System Agents|sensory system agents|mesh-ancestor
101891703|NCT05834023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101891704|NCT05834023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101891705|NCT05834023|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101891706|NCT05834023|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101891707|NCT05834023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101891708|NCT05834023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891709|NCT05804708|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
101891710|NCT05804708|Hallucinogens|hallucinogens|mesh-ancestor
101891711|NCT05804708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891712|NCT05804708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101891713|NCT05804708|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101891714|NCT05804708|Serotonin Agents|serotonin agents|mesh-ancestor
101891715|NCT05804708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101891716|NCT05804708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891717|NCT05804708|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101891718|NCT05787600|Chlorhexidine|chlorhexidine|mesh-list
101891719|NCT05787600|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101891720|NCT05787600|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101891721|NCT05787600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101891722|NCT05787600|Disinfectants|disinfectants|mesh-ancestor
101891723|NCT05787600|Dermatologic Agents|dermatologic agents|mesh-ancestor
101891724|NCT05782816|Oxytocin|oxytocin|mesh-list
101891725|NCT05782816|Oxytocics|oxytocics|mesh-ancestor
101891726|NCT05782816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101891727|NCT05782816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891728|NCT05768932|Paclitaxel|paclitaxel|mesh-list
101891729|NCT05768932|Carboplatin|carboplatin|mesh-list
101891730|NCT05768932|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101891731|NCT05768932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101891732|NCT05768932|Tubulin Modulators|tubulin modulators|mesh-ancestor
101891733|NCT05768932|Antimitotic Agents|antimitotic agents|mesh-ancestor
101891734|NCT05768932|Mitosis Modulators|mitosis modulators|mesh-ancestor
101891735|NCT05768932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891736|NCT05726318|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101891737|NCT05726318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101891738|NCT05653882|Pembrolizumab|pembrolizumab|mesh-list
101891739|NCT05653882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101891740|NCT05653882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101891741|NCT05653882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101891742|NCT05653882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891743|NCT05637398|Colchicine|colchicine|mesh-list
101891744|NCT05637398|Gout Suppressants|gout suppressants|mesh-ancestor
101891745|NCT05637398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101891746|NCT05637398|Tubulin Modulators|tubulin modulators|mesh-ancestor
101891747|NCT05637398|Antimitotic Agents|antimitotic agents|mesh-ancestor
101891748|NCT05637398|Mitosis Modulators|mitosis modulators|mesh-ancestor
101891749|NCT05637398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891750|NCT05637398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101891751|NCT05633602|Pembrolizumab|pembrolizumab|mesh-list
101891752|NCT05633602|Ramucirumab|ramucirumab|mesh-list
101891753|NCT05633602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101891754|NCT05633602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101891755|NCT05633602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101891756|NCT05633602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891757|NCT05604729|Botulinum Toxins|botulinum toxins|mesh-list
101891758|NCT05604729|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101891759|NCT05604729|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101891760|NCT05604729|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101891761|NCT05604729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101891762|NCT05604729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891763|NCT05604729|Cholinergic Agents|cholinergic agents|mesh-ancestor
101891764|NCT05604729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101891765|NCT05604729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891766|NCT05604729|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101891767|NCT05604729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101891768|NCT05583071|Rituximab|rituximab|mesh-list
101891769|NCT05583071|Methotrexate|methotrexate|mesh-list
101891770|NCT05583071|Lenalidomide|lenalidomide|mesh-list
101891771|NCT05583071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101891772|NCT05583071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101891773|NCT05583071|Immunologic Factors|immunologic factors|mesh-ancestor
101891774|NCT05583071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891775|NCT05583071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101891776|NCT05583071|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101891777|NCT05583071|Abortifacient Agents|abortifacient agents|mesh-ancestor
101891778|NCT05583071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101891779|NCT05583071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101891780|NCT05583071|Antimetabolites|antimetabolites|mesh-ancestor
101891781|NCT05583071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891782|NCT05583071|Dermatologic Agents|dermatologic agents|mesh-ancestor
101891783|NCT05583071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101891784|NCT05583071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101891785|NCT05583071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101891786|NCT05583071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101891787|NCT05583071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101891788|NCT05583071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101891789|NCT05583071|Growth Substances|growth substances|mesh-ancestor
101891790|NCT05583071|Growth Inhibitors|growth inhibitors|mesh-ancestor
101891791|NCT05417113|Bupivacaine|bupivacaine|mesh-list
101891792|NCT05417113|Anesthetics, Local|anesthetics, local|mesh-ancestor
101891793|NCT05417113|Anesthetics|anesthetics|mesh-ancestor
101891794|NCT05417113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101891795|NCT05417113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891796|NCT05417113|Sensory System Agents|sensory system agents|mesh-ancestor
101891797|NCT05417113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101891798|NCT05394298|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101891799|NCT05394298|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101891800|NCT05394298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101891801|NCT05394298|Antitubercular Agents|antitubercular agents|mesh-ancestor
101891802|NCT05390359|Oxymetazoline|oxymetazoline|mesh-list
101891803|NCT05390359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101891804|NCT05390359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101891805|NCT05390359|Adrenergic Agents|adrenergic agents|mesh-ancestor
101891806|NCT05390359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101891807|NCT05390359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891808|NCT05390359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891809|NCT05390359|Sympathomimetics|sympathomimetics|mesh-ancestor
101891810|NCT05390359|Autonomic Agents|autonomic agents|mesh-ancestor
101891811|NCT05390359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101891812|NCT05390359|Nasal Decongestants|nasal decongestants|mesh-ancestor
101891813|NCT05390359|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101891814|NCT05390359|Respiratory System Agents|respiratory system agents|mesh-ancestor
101891815|NCT05330078|Botulinum Toxins|botulinum toxins|mesh-list
101891816|NCT05330078|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101891817|NCT05330078|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101891818|NCT05330078|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101891819|NCT05330078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101891820|NCT05330078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891821|NCT05330078|Cholinergic Agents|cholinergic agents|mesh-ancestor
101891822|NCT05330078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101891823|NCT05330078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891824|NCT05330078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101891825|NCT05330078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101891826|NCT05309564|Botulinum Toxins|botulinum toxins|mesh-list
101891827|NCT05309564|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101891828|NCT05309564|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101891829|NCT05309564|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101891830|NCT05309564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101891831|NCT05309564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891832|NCT05309564|Cholinergic Agents|cholinergic agents|mesh-ancestor
101891833|NCT05309564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101891834|NCT05309564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891835|NCT05309564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101891836|NCT05309564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101891837|NCT05249569|Avelumab|avelumab|mesh-list
101891838|NCT05249569|Bavituximab|bavituximab|mesh-list
101891839|NCT05249569|Axitinib|axitinib|mesh-list
101891840|NCT05249569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101891841|NCT05249569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101891842|NCT05249569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101891843|NCT05249569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101891844|NCT05249569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891845|NCT05245071|Maytansine|maytansine|mesh-list
101891846|NCT05245071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101891847|NCT05245071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101891848|NCT05245071|Tubulin Modulators|tubulin modulators|mesh-ancestor
101891849|NCT05245071|Antimitotic Agents|antimitotic agents|mesh-ancestor
101891850|NCT05245071|Mitosis Modulators|mitosis modulators|mesh-ancestor
101891851|NCT05245071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891852|NCT05212662|Cysteamine|cysteamine|mesh-list
101891853|NCT05212662|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
101891854|NCT05212662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891855|NCT05182073|Cyclophosphamide|cyclophosphamide|mesh-list
101891856|NCT05182073|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101891857|NCT05182073|Fludarabine|fludarabine|mesh-list
101891858|NCT05182073|Daratumumab|daratumumab|mesh-list
101891859|NCT05182073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101891860|NCT05182073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101891861|NCT05182073|Immunologic Factors|immunologic factors|mesh-ancestor
101891862|NCT05182073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891863|NCT05182073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101891864|NCT05182073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101891865|NCT05182073|Alkylating Agents|alkylating agents|mesh-ancestor
101611651|NCT00876928|Vitamins|vitamins|mesh-ancestor
101891866|NCT05182073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891867|NCT05182073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101891868|NCT05182073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101891869|NCT05180318|Ketamine|ketamine|mesh-list
101891870|NCT05180318|Esketamine|esketamine|mesh-list
101891871|NCT05180318|Analgesics|analgesics|mesh-ancestor
101891872|NCT05180318|Sensory System Agents|sensory system agents|mesh-ancestor
101891873|NCT05180318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101891874|NCT05180318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891875|NCT05180318|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101891876|NCT05180318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101891877|NCT05180318|Anesthetics, General|anesthetics, general|mesh-ancestor
101891878|NCT05180318|Anesthetics|anesthetics|mesh-ancestor
101891879|NCT05180318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101891880|NCT05180318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101891881|NCT05180318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101891882|NCT05180318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101891883|NCT05180318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891884|NCT05180318|Antidepressive Agents|antidepressive agents|mesh-ancestor
101891885|NCT05180318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101891886|NCT05177822|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101891887|NCT05177822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101891888|NCT05096663|Vitamins|vitamins|mesh-list
101891889|NCT05096663|Folic Acid|folic acid|mesh-list
101891890|NCT05096663|Hydroxocobalamin|hydroxocobalamin|mesh-list
101891891|NCT05096663|Vitamin B 12|vitamin b 12|mesh-list
101891892|NCT05096663|Vitamin B Complex|vitamin b complex|mesh-list
101891893|NCT05096663|Dexamethasone|dexamethasone|mesh-list
101891894|NCT05096663|Dexamethasone acetate|dexamethasone acetate|mesh-list
101891895|NCT05096663|Gemcitabine|gemcitabine|mesh-list
101891896|NCT05096663|Docetaxel|docetaxel|mesh-list
101891897|NCT05096663|Pembrolizumab|pembrolizumab|mesh-list
101891898|NCT05096663|Pemetrexed|pemetrexed|mesh-list
101891899|NCT05096663|Ramucirumab|ramucirumab|mesh-list
101891900|NCT05096663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101891901|NCT05096663|Antibodies|antibodies|mesh-list
101891902|NCT05096663|Immunoglobulins|immunoglobulins|mesh-list
101891903|NCT05096663|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101891904|NCT05096663|Lexatumumab|lexatumumab|mesh-list
101891905|NCT05096663|BB 1101|bb 1101|mesh-list
101891906|NCT05096663|Micronutrients|micronutrients|mesh-ancestor
101891907|NCT05096663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891908|NCT05096663|Immunologic Factors|immunologic factors|mesh-ancestor
101891909|NCT05096663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101891910|NCT05096663|Antiemetics|antiemetics|mesh-ancestor
101891911|NCT05096663|Autonomic Agents|autonomic agents|mesh-ancestor
101891912|NCT05096663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101891913|NCT05096663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101891914|NCT05096663|Glucocorticoids|glucocorticoids|mesh-ancestor
101891915|NCT05096663|Hormones|hormones|mesh-ancestor
101891916|NCT05096663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101891917|NCT05096663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101891918|NCT05096663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101891919|NCT05096663|Protease Inhibitors|protease inhibitors|mesh-ancestor
101891920|NCT05096663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101891921|NCT05096663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891922|NCT05096663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101891923|NCT05096663|Antimetabolites|antimetabolites|mesh-ancestor
101891924|NCT05096663|Tubulin Modulators|tubulin modulators|mesh-ancestor
101891925|NCT05096663|Antimitotic Agents|antimitotic agents|mesh-ancestor
101891926|NCT05096663|Mitosis Modulators|mitosis modulators|mesh-ancestor
101891927|NCT05096663|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101891928|NCT05096663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101891929|NCT05096663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101891930|NCT05096663|Hematinics|hematinics|mesh-ancestor
101891931|NCT05009082|Paclitaxel|paclitaxel|mesh-list
101891932|NCT05009082|Bevacizumab|bevacizumab|mesh-list
101891933|NCT05009082|Carboplatin|carboplatin|mesh-list
101891934|NCT05009082|Niraparib|niraparib|mesh-list
101891935|NCT05009082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101891936|NCT05009082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101891937|NCT05009082|Tubulin Modulators|tubulin modulators|mesh-ancestor
101891938|NCT05009082|Antimitotic Agents|antimitotic agents|mesh-ancestor
101891939|NCT05009082|Mitosis Modulators|mitosis modulators|mesh-ancestor
101611725|NCT02627248|Immunologic Factors|immunologic factors|mesh-ancestor
101891940|NCT05009082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891941|NCT05009082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101891942|NCT05009082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101891943|NCT05009082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101891945|NCT05009082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891946|NCT05009082|Growth Inhibitors|growth inhibitors|mesh-ancestor
101891947|NCT05009082|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101891948|NCT05009082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101891949|NCT05002413|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101891950|NCT05002413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101891951|NCT04982796|Psilocybin|psilocybin|mesh-list
101891952|NCT04982796|Hallucinogens|hallucinogens|mesh-ancestor
101891953|NCT04982796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891954|NCT04982796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101891955|NCT04970576|Warfarin|warfarin|mesh-list
101891956|NCT04970576|Rivaroxaban|rivaroxaban|mesh-list
101891957|NCT04970576|Anticoagulants|anticoagulants|mesh-ancestor
101891958|NCT04970576|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101891959|NCT04970576|Antithrombins|antithrombins|mesh-ancestor
101891960|NCT04970576|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101891961|NCT04970576|Protease Inhibitors|protease inhibitors|mesh-ancestor
101891962|NCT04970576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101891963|NCT04970576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891964|NCT04941911|Octreotide|octreotide|mesh-list
101891965|NCT04941911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101891966|NCT04941911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101891967|NCT04941911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101891968|NCT04858490|Diazepam|diazepam|mesh-list
101891969|NCT04858490|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101891970|NCT04858490|Anticonvulsants|anticonvulsants|mesh-ancestor
101891971|NCT04858490|Antiemetics|antiemetics|mesh-ancestor
101891972|NCT04858490|Autonomic Agents|autonomic agents|mesh-ancestor
101891973|NCT04858490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101891974|NCT04858490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891975|NCT04858490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101891976|NCT04858490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101891977|NCT04858490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101891978|NCT04858490|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101891979|NCT04858490|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101891980|NCT04858490|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101891981|NCT04858490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101891982|NCT04858490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101891983|NCT04858490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101891984|NCT04858490|Anesthetics, General|anesthetics, general|mesh-ancestor
101891985|NCT04858490|Anesthetics|anesthetics|mesh-ancestor
101891986|NCT04858490|GABA Modulators|gaba modulators|mesh-ancestor
101891987|NCT04858490|GABA Agents|gaba agents|mesh-ancestor
101891988|NCT04858490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101891989|NCT04858490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891990|NCT04790032|Cangrelor|cangrelor|mesh-list
101891991|NCT04790032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101891992|NCT04790032|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101891993|NCT04790032|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101891994|NCT04790032|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101891995|NCT04790032|Purinergic Agents|purinergic agents|mesh-ancestor
101891996|NCT04790032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101891997|NCT04790032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101891998|NCT04790032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101891999|NCT04779879|Sotrovimab|sotrovimab|mesh-list
101892000|NCT04779879|Antiviral Agents|antiviral agents|mesh-ancestor
101892001|NCT04779879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101892002|NCT04768101|Corticosterone|corticosterone|mesh-list
101892003|NCT04768101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101892004|NCT04681729|Histamine Antagonists|histamine antagonists|mesh-list
101892005|NCT04681729|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
101892006|NCT04681729|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
101892007|NCT04681729|Histamine Agents|histamine agents|mesh-ancestor
101892008|NCT04681729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101892009|NCT04681729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892010|NCT04681729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892011|NCT04629729|Cyclophosphamide|cyclophosphamide|mesh-list
101892012|NCT04629729|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101892013|NCT04629729|Fludarabine|fludarabine|mesh-list
101892014|NCT04629729|Interleukin-2|interleukin-2|mesh-list
101892015|NCT04629729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101892016|NCT04629729|Immunologic Factors|immunologic factors|mesh-ancestor
101892017|NCT04629729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892018|NCT04629729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101892019|NCT04629729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101892020|NCT04629729|Alkylating Agents|alkylating agents|mesh-ancestor
101892021|NCT04629729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892022|NCT04629729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892023|NCT04629729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101892024|NCT04629729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101892025|NCT04629729|Analgesics|analgesics|mesh-ancestor
101892026|NCT04629729|Sensory System Agents|sensory system agents|mesh-ancestor
101892027|NCT04629729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101892028|NCT04599075|Insulin|insulin|mesh-list
101892029|NCT04599075|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101892030|NCT04599075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101892031|NCT04599075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892032|NCT04574583|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
101892033|NCT04574583|Antiviral Agents|antiviral agents|mesh-ancestor
101892034|NCT04574583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101892035|NCT04544202|Trametinib|trametinib|mesh-list
101892036|NCT04544202|Dabrafenib|dabrafenib|mesh-list
101892037|NCT04544202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892038|NCT04544202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101892039|NCT04544202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101892040|NCT04544202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892041|NCT04523363|Metformin|metformin|mesh-list
101892042|NCT04523363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101892043|NCT04523363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892044|NCT04516447|Paclitaxel|paclitaxel|mesh-list
101892045|NCT04516447|Carboplatin|carboplatin|mesh-list
101892046|NCT04516447|Gemcitabine|gemcitabine|mesh-list
101892047|NCT04516447|Doxorubicin|doxorubicin|mesh-list
101892048|NCT04516447|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101892049|NCT04516447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101892050|NCT04516447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892051|NCT04516447|Tubulin Modulators|tubulin modulators|mesh-ancestor
101892052|NCT04516447|Antimitotic Agents|antimitotic agents|mesh-ancestor
101892053|NCT04516447|Mitosis Modulators|mitosis modulators|mesh-ancestor
101892054|NCT04516447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892055|NCT04516447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101892056|NCT04516447|Antimetabolites|antimetabolites|mesh-ancestor
101892057|NCT04516447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101892058|NCT04516447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101892059|NCT04516447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101892060|NCT04516447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101892061|NCT04495894|Ketorolac|ketorolac|mesh-list
101892062|NCT04495894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101892063|NCT04495894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101892064|NCT04495894|Analgesics|analgesics|mesh-ancestor
101892065|NCT04495894|Sensory System Agents|sensory system agents|mesh-ancestor
101892066|NCT04495894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101892067|NCT04495894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892068|NCT04495894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101892069|NCT04495894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101892070|NCT04495894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101892071|NCT04495894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101892072|NCT04495894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892073|NCT04489433|Trametinib|trametinib|mesh-list
101892074|NCT04489433|Dabrafenib|dabrafenib|mesh-list
101892075|NCT04489433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892076|NCT04489433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101892077|NCT04489433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101892078|NCT04489433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892079|NCT04478721|Meropenem|meropenem|mesh-list
101892080|NCT04478721|Temocillin|temocillin|mesh-list
101892081|NCT04478721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101892082|NCT04478721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101892083|NCT04370054|Factor VIII|factor viii|mesh-list
101892084|NCT04370054|Coagulants|coagulants|mesh-ancestor
101892085|NCT04283500|Buprenorphine|buprenorphine|mesh-list
101892086|NCT04283500|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101892087|NCT04283500|Naloxone|naloxone|mesh-list
101892088|NCT04283500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101892089|NCT04283500|Narcotics|narcotics|mesh-ancestor
101892090|NCT04283500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101892091|NCT04283500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892092|NCT04283500|Analgesics|analgesics|mesh-ancestor
101892093|NCT04283500|Sensory System Agents|sensory system agents|mesh-ancestor
101892094|NCT04283500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101892095|NCT04283500|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101892096|NCT04223791|Islatravir|islatravir|mesh-list
101892097|NCT04223791|Antiviral Agents|antiviral agents|mesh-ancestor
101892098|NCT04223791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101892099|NCT04223791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101892100|NCT04223791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892101|NCT04223791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101892102|NCT04223791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101892103|NCT04223791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101892104|NCT04205812|Paclitaxel|paclitaxel|mesh-list
101892105|NCT04205812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101892106|NCT04205812|Carboplatin|carboplatin|mesh-list
101892107|NCT04205812|Pemetrexed|pemetrexed|mesh-list
101892108|NCT04205812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101892109|NCT04205812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892110|NCT04205812|Tubulin Modulators|tubulin modulators|mesh-ancestor
101892111|NCT04205812|Antimitotic Agents|antimitotic agents|mesh-ancestor
101892112|NCT04205812|Mitosis Modulators|mitosis modulators|mesh-ancestor
101892113|NCT04205812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892114|NCT04205812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101892115|NCT04205812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101892116|NCT04205812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101892117|NCT04191421|Spartalizumab|spartalizumab|mesh-list
101892118|NCT04191421|Siltuximab|siltuximab|mesh-list
101892119|NCT04191421|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101892120|NCT04191421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892121|NCT04191421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101892122|NCT04191421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892123|NCT03982030|Dalbavancin|dalbavancin|mesh-list
101892124|NCT03982030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101892125|NCT03982030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101892126|NCT03918850|Buprenorphine|buprenorphine|mesh-list
101892127|NCT03918850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101892128|NCT03918850|Narcotics|narcotics|mesh-ancestor
101892129|NCT03918850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101892130|NCT03918850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892131|NCT03918850|Analgesics|analgesics|mesh-ancestor
101892132|NCT03918850|Sensory System Agents|sensory system agents|mesh-ancestor
101892133|NCT03918850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101892134|NCT03918850|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101969162|NCT00595426|Warfarin|warfarin|mesh-list
101892136|NCT03917914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101892137|NCT03917914|Sympatholytics|sympatholytics|mesh-ancestor
101892138|NCT03917914|Autonomic Agents|autonomic agents|mesh-ancestor
101892139|NCT03917914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101892140|NCT03917914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892141|NCT03917914|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101892142|NCT03917914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101892143|NCT03917914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101892144|NCT03917914|Adrenergic Agents|adrenergic agents|mesh-ancestor
101892145|NCT03917914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101892146|NCT03917914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892147|NCT03915067|Botulinum Toxins|botulinum toxins|mesh-list
101892148|NCT03915067|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101892149|NCT03915067|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101892150|NCT03915067|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101892151|NCT03915067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101892152|NCT03915067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892153|NCT03915067|Cholinergic Agents|cholinergic agents|mesh-ancestor
101892154|NCT03915067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101892155|NCT03915067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892156|NCT03915067|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101892157|NCT03915067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101892158|NCT03911466|Buprenorphine|buprenorphine|mesh-list
101892159|NCT03911466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101892160|NCT03911466|Narcotics|narcotics|mesh-ancestor
101892161|NCT03911466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101892162|NCT03911466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892163|NCT03911466|Analgesics|analgesics|mesh-ancestor
101892164|NCT03911466|Sensory System Agents|sensory system agents|mesh-ancestor
101892165|NCT03911466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101892166|NCT03911466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101892167|NCT03903133|Vitamin E|vitamin e|mesh-list
101892168|NCT03903133|Antioxidants|antioxidants|mesh-list
101892169|NCT03903133|Vitamins|vitamins|mesh-ancestor
101892170|NCT03903133|Micronutrients|micronutrients|mesh-ancestor
101892171|NCT03903133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892172|NCT03903133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892173|NCT03903133|Protective Agents|protective agents|mesh-ancestor
101892174|NCT03841305|Liver Extracts|liver extracts|mesh-list
101892175|NCT03841305|Hematinics|hematinics|mesh-ancestor
101892176|NCT03798626|Leucovorin|leucovorin|mesh-list
101892177|NCT03798626|Paclitaxel|paclitaxel|mesh-list
101892178|NCT03798626|Bevacizumab|bevacizumab|mesh-list
101892179|NCT03798626|Fluorouracil|fluorouracil|mesh-list
101892180|NCT03798626|Oxaliplatin|oxaliplatin|mesh-list
101892181|NCT03798626|Irinotecan|irinotecan|mesh-list
101892182|NCT03798626|Ramucirumab|ramucirumab|mesh-list
101892183|NCT03798626|Levoleucovorin|levoleucovorin|mesh-list
101892184|NCT03798626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101892185|NCT03798626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892186|NCT03798626|Tubulin Modulators|tubulin modulators|mesh-ancestor
101892187|NCT03798626|Antimitotic Agents|antimitotic agents|mesh-ancestor
101892188|NCT03798626|Mitosis Modulators|mitosis modulators|mesh-ancestor
101892189|NCT03798626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689644|NCT00621452|Aldesleukin|aldesleukin|mesh-list
101892190|NCT03798626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101892191|NCT03798626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101892192|NCT03798626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101892193|NCT03798626|Growth Substances|growth substances|mesh-ancestor
101892194|NCT03798626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892195|NCT03798626|Growth Inhibitors|growth inhibitors|mesh-ancestor
101892197|NCT03798626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101892198|NCT03798626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101892199|NCT03798626|Immunologic Factors|immunologic factors|mesh-ancestor
101892200|NCT03798626|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101892201|NCT03798626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101892202|NCT03798626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101892203|NCT03798626|Antidotes|antidotes|mesh-ancestor
101892204|NCT03798626|Protective Agents|protective agents|mesh-ancestor
101892205|NCT03798626|Vitamin B Complex|vitamin b complex|mesh-ancestor
101892206|NCT03798626|Vitamins|vitamins|mesh-ancestor
101892207|NCT03798626|Micronutrients|micronutrients|mesh-ancestor
101892208|NCT03768414|Paclitaxel|paclitaxel|mesh-list
101892209|NCT03768414|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101892210|NCT03768414|Cisplatin|cisplatin|mesh-list
101892211|NCT03768414|Gemcitabine|gemcitabine|mesh-list
101892212|NCT03768414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101892213|NCT03768414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892214|NCT03768414|Tubulin Modulators|tubulin modulators|mesh-ancestor
101892215|NCT03768414|Antimitotic Agents|antimitotic agents|mesh-ancestor
101892216|NCT03768414|Mitosis Modulators|mitosis modulators|mesh-ancestor
101892217|NCT03768414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892218|NCT03768414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101892219|NCT03768414|Antimetabolites|antimetabolites|mesh-ancestor
101892220|NCT03743766|Nivolumab|nivolumab|mesh-list
101892221|NCT03743766|Relatlimab|relatlimab|mesh-list
101776599|NCT00770666|Dopamine Agents|dopamine agents|mesh-ancestor
101892222|NCT03743766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101892223|NCT03743766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892224|NCT03743766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101892225|NCT03743766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892226|NCT03727633|Idarubicin|idarubicin|mesh-list
101892227|NCT03727633|Ethiodized Oil|ethiodized oil|mesh-list
101892228|NCT03727633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101892229|NCT03727633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892230|NCT03727633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101892231|NCT03727633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101892232|NCT03727633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101892233|NCT03727633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892234|NCT03698019|Pembrolizumab|pembrolizumab|mesh-list
101892235|NCT03698019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101892236|NCT03698019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892237|NCT03698019|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101892238|NCT03698019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892239|NCT03694002|Paclitaxel|paclitaxel|mesh-list
101892240|NCT03694002|Carboplatin|carboplatin|mesh-list
101892241|NCT03694002|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101892242|NCT03694002|Ramucirumab|ramucirumab|mesh-list
101892243|NCT03694002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101892244|NCT03694002|Antibodies|antibodies|mesh-list
101892245|NCT03694002|Immunoglobulins|immunoglobulins|mesh-list
101892246|NCT03694002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101892247|NCT03694002|Lexatumumab|lexatumumab|mesh-list
101892248|NCT03694002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101892254|NCT03694002|Immunologic Factors|immunologic factors|mesh-ancestor
101892255|NCT03694002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892257|NCT03623321|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101892258|NCT03623321|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101892259|NCT03623321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101892260|NCT03623321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101892261|NCT03623321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101892262|NCT03623321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892263|NCT03623321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101892264|NCT03623321|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101892266|NCT03623321|Serotonin Agents|serotonin agents|mesh-ancestor
101892267|NCT03623321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101892268|NCT03623321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892274|NCT03447314|Pembrolizumab|pembrolizumab|mesh-list
101892275|NCT03447314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101892276|NCT03447314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892277|NCT03447314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101892278|NCT03447314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892279|NCT03423121|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
101892280|NCT03423121|Antiviral Agents|antiviral agents|mesh-ancestor
101892281|NCT03423121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101892282|NCT03423121|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101892283|NCT03423121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101892284|NCT03365882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101892285|NCT03365882|Trastuzumab|trastuzumab|mesh-list
101892286|NCT03365882|Cetuximab|cetuximab|mesh-list
101892287|NCT03365882|Pertuzumab|pertuzumab|mesh-list
101892288|NCT03365882|Irinotecan|irinotecan|mesh-list
101776628|NCT00811200|Hormones|hormones|mesh-ancestor
101892289|NCT03365882|Camptothecin|camptothecin|mesh-list
101892290|NCT03365882|Antibodies|antibodies|mesh-list
101892291|NCT03365882|Immunoglobulins|immunoglobulins|mesh-list
101892292|NCT03365882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101892293|NCT03365882|Immunologic Factors|immunologic factors|mesh-ancestor
101892294|NCT03365882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892295|NCT03365882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892296|NCT03365882|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101892297|NCT03365882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101892298|NCT03365882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101892299|NCT03365882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892300|NCT03365882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101892301|NCT03364530|Gemcitabine|gemcitabine|mesh-list
101892302|NCT03364530|Oxaliplatin|oxaliplatin|mesh-list
101892303|NCT03364530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101892304|NCT03364530|Antimetabolites|antimetabolites|mesh-ancestor
101892305|NCT03364530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892306|NCT03364530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892307|NCT03289910|Carboplatin|carboplatin|mesh-list
101892308|NCT03289910|Topotecan|topotecan|mesh-list
101892309|NCT03289910|Veliparib|veliparib|mesh-list
101892310|NCT03289910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892311|NCT03289910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101892312|NCT03289910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101892313|NCT03289910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101892314|NCT03289910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892315|NCT03289910|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101892316|NCT03253133|Oxaliplatin|oxaliplatin|mesh-list
101892317|NCT03253133|Oxycodone|oxycodone|mesh-list
101892318|NCT03253133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892319|NCT03253133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101892320|NCT03253133|Narcotics|narcotics|mesh-ancestor
101892321|NCT03253133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101892322|NCT03253133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892323|NCT03253133|Analgesics|analgesics|mesh-ancestor
101892324|NCT03253133|Sensory System Agents|sensory system agents|mesh-ancestor
101892325|NCT03253133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101892326|NCT03252756|Cannabidiol|cannabidiol|mesh-list
101892327|NCT03252756|Anticonvulsants|anticonvulsants|mesh-ancestor
101892328|NCT03225417|Sirolimus|sirolimus|mesh-list
101892329|NCT03225417|Cyclophosphamide|cyclophosphamide|mesh-list
101892330|NCT03225417|Ixazomib|ixazomib|mesh-list
101892331|NCT03225417|Tacrolimus|tacrolimus|mesh-list
101892332|NCT03225417|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101892333|NCT03225417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101892334|NCT03225417|Immunologic Factors|immunologic factors|mesh-ancestor
101892335|NCT03225417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892336|NCT03225417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101892337|NCT03225417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101892338|NCT03225417|Alkylating Agents|alkylating agents|mesh-ancestor
101892339|NCT03225417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892340|NCT03225417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892341|NCT03225417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101892342|NCT03225417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101892343|NCT03225417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101892344|NCT03225417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101892345|NCT03225417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101892346|NCT03225417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101892347|NCT03225417|Antifungal Agents|antifungal agents|mesh-ancestor
101892348|NCT03225417|Protease Inhibitors|protease inhibitors|mesh-ancestor
101892349|NCT03218826|Docetaxel|docetaxel|mesh-list
101892350|NCT03218826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892351|NCT03218826|Tubulin Modulators|tubulin modulators|mesh-ancestor
101892352|NCT03218826|Antimitotic Agents|antimitotic agents|mesh-ancestor
101892353|NCT03218826|Mitosis Modulators|mitosis modulators|mesh-ancestor
101892354|NCT03218826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892355|NCT03091660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101892356|NCT03091660|Vaccines|vaccines|mesh-list
101892357|NCT03091660|BCG Vaccine|bcg vaccine|mesh-list
101892358|NCT03091660|Immunologic Factors|immunologic factors|mesh-ancestor
101892359|NCT03091660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892360|NCT03091660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101892361|NCT03091595|Drospirenone|drospirenone|mesh-list
101892362|NCT03091595|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101892363|NCT03091595|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101892364|NCT03091595|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101892365|NCT03091595|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101892366|NCT03091595|Contraceptive Agents|contraceptive agents|mesh-ancestor
101892367|NCT03091595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101892368|NCT03091595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892369|NCT03091595|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101892370|NCT03091595|Estrogens|estrogens|mesh-ancestor
101892371|NCT03091595|Hormones|hormones|mesh-ancestor
101892372|NCT03091595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101892373|NCT03091595|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101892374|NCT03091595|Hormone Antagonists|hormone antagonists|mesh-ancestor
101892375|NCT03091595|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101892376|NCT03091595|Diuretics|diuretics|mesh-ancestor
101892377|NCT03091595|Natriuretic Agents|natriuretic agents|mesh-ancestor
101892378|NCT02822378|Vitamin D|vitamin d|mesh-list
101892379|NCT02822378|Calcium|calcium|mesh-list
101892380|NCT02822378|Vitamins|vitamins|mesh-ancestor
101892381|NCT02822378|Micronutrients|micronutrients|mesh-ancestor
101892382|NCT02822378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892383|NCT02822378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101892384|NCT02822378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101892385|NCT02595931|Irinotecan|irinotecan|mesh-list
101892386|NCT02595931|Camptothecin|camptothecin|mesh-list
101892387|NCT02595931|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101892388|NCT02595931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101892389|NCT02595931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101892390|NCT02595931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892391|NCT02595931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892392|NCT02595931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101892393|NCT02577406|Cytarabine|cytarabine|mesh-list
101892394|NCT02577406|Azacitidine|azacitidine|mesh-list
101892395|NCT02577406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101892396|NCT02577406|Antimetabolites|antimetabolites|mesh-ancestor
101892397|NCT02577406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892398|NCT02577406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892399|NCT02577406|Antiviral Agents|antiviral agents|mesh-ancestor
101892400|NCT02577406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101892401|NCT02577406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101892402|NCT02577406|Immunologic Factors|immunologic factors|mesh-ancestor
101892403|NCT02577406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892404|NCT02577406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101892405|NCT02498600|Nivolumab|nivolumab|mesh-list
101892406|NCT02498600|Ipilimumab|ipilimumab|mesh-list
101892407|NCT02498600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101892408|NCT02498600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892409|NCT02498600|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101892410|NCT02498600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892411|NCT01925131|Prednisone|prednisone|mesh-list
101892412|NCT01925131|Cyclophosphamide|cyclophosphamide|mesh-list
101892413|NCT01925131|Vincristine|vincristine|mesh-list
101892414|NCT01925131|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
101892415|NCT01925131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101892416|NCT01925131|Immunologic Factors|immunologic factors|mesh-ancestor
101892417|NCT01925131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892418|NCT01925131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101892419|NCT01925131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101892420|NCT01925131|Alkylating Agents|alkylating agents|mesh-ancestor
101892421|NCT01925131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892422|NCT01925131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892423|NCT01925131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101892424|NCT01925131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101892425|NCT01925131|Glucocorticoids|glucocorticoids|mesh-ancestor
101892426|NCT01925131|Hormones|hormones|mesh-ancestor
101969189|NCT01208935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101892427|NCT01925131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101892428|NCT01925131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101892429|NCT01925131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101892431|NCT01925131|Antimitotic Agents|antimitotic agents|mesh-ancestor
101892432|NCT01925131|Mitosis Modulators|mitosis modulators|mesh-ancestor
101892433|NCT01925131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101892434|NCT01925131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101892435|NCT01925131|Immunotoxins|immunotoxins|mesh-ancestor
101892436|NCT01925131|Immunoconjugates|immunoconjugates|mesh-ancestor
101892437|NCT01809691|Bicalutamide|bicalutamide|mesh-list
101892438|NCT01809691|Androgen Antagonists|androgen antagonists|mesh-ancestor
101892439|NCT01809691|Hormone Antagonists|hormone antagonists|mesh-ancestor
101892440|NCT01809691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101892441|NCT01809691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892442|NCT01809691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892443|NCT01698918|Dexamethasone|dexamethasone|mesh-list
101892444|NCT01698918|Everolimus|everolimus|mesh-list
101892445|NCT01698918|Letrozole|letrozole|mesh-list
101892446|NCT01698918|Exemestane|exemestane|mesh-list
101892447|NCT01698918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101892448|NCT01698918|Antiemetics|antiemetics|mesh-ancestor
101892449|NCT01698918|Autonomic Agents|autonomic agents|mesh-ancestor
101892450|NCT01698918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101892451|NCT01698918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892452|NCT01698918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101892453|NCT01698918|Glucocorticoids|glucocorticoids|mesh-ancestor
101892454|NCT01698918|Hormones|hormones|mesh-ancestor
101892455|NCT01698918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101892456|NCT01698918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101892457|NCT01698918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892458|NCT01698918|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101892459|NCT01698918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101892460|NCT01698918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101892461|NCT01698918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892462|NCT01698918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101892463|NCT01698918|Immunologic Factors|immunologic factors|mesh-ancestor
101892464|NCT01698918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101892465|NCT01698918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101892466|NCT01698918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101892467|NCT01698918|Hormone Antagonists|hormone antagonists|mesh-ancestor
101892468|NCT01674140|Tamoxifen|tamoxifen|mesh-list
101892469|NCT01674140|Everolimus|everolimus|mesh-list
101892470|NCT01674140|Letrozole|letrozole|mesh-list
101892471|NCT01674140|Anastrozole|anastrozole|mesh-list
101892472|NCT01674140|Leuprolide|leuprolide|mesh-list
101892473|NCT01674140|Exemestane|exemestane|mesh-list
101892474|NCT01674140|Goserelin|goserelin|mesh-list
101892475|NCT01674140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892476|NCT01674140|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101892477|NCT01674140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101892478|NCT01674140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101892479|NCT01674140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101892480|NCT01674140|Immunologic Factors|immunologic factors|mesh-ancestor
101892481|NCT01674140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892482|NCT01674140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892483|NCT01674140|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101892484|NCT01674140|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101892485|NCT01674140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101892486|NCT01674140|Hormone Antagonists|hormone antagonists|mesh-ancestor
101892487|NCT01674140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101892488|NCT01674140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101892489|NCT01674140|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101892490|NCT01674140|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101892491|NCT01674140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101892492|NCT01674140|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101892494|NCT01674140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101892495|NCT01574274|Pegaspargase|pegaspargase|mesh-list
101892496|NCT01574274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892497|NCT01495403|Hydroxychloroquine|hydroxychloroquine|mesh-list
101892498|NCT01495403|Antimalarials|antimalarials|mesh-ancestor
101892499|NCT01495403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101892500|NCT01495403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101892501|NCT01495403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101892502|NCT01495403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101892503|NCT01495403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892504|NCT01495403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101892506|NCT00840177|Idarubicin|idarubicin|mesh-list
101892507|NCT00840177|Pravastatin|pravastatin|mesh-list
101892508|NCT00840177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101892509|NCT00840177|Antimetabolites|antimetabolites|mesh-ancestor
101892510|NCT00840177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892511|NCT00840177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892512|NCT00840177|Antiviral Agents|antiviral agents|mesh-ancestor
101892513|NCT00840177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101892514|NCT00840177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101892515|NCT00840177|Immunologic Factors|immunologic factors|mesh-ancestor
101892516|NCT00840177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892517|NCT00840177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101892518|NCT00840177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101892519|NCT00840177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101892520|NCT00840177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101892521|NCT00840177|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101892522|NCT00840177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101892523|NCT00840177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101892524|NCT00840177|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101892525|NCT01347580|Ticagrelor|ticagrelor|mesh-list
101892526|NCT01347580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101892527|NCT01347580|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101892528|NCT01347580|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101892529|NCT01347580|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101892530|NCT01347580|Purinergic Agents|purinergic agents|mesh-ancestor
101892531|NCT01347580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101892532|NCT01347580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892533|NCT01347580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892534|NCT00398411|Moxifloxacin|moxifloxacin|mesh-list
101892535|NCT00398411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101892536|NCT00398411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101892537|NCT00398411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101892538|NCT00398411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101892539|NCT00398411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101892540|NCT00398411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892541|NCT00398411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892542|NCT03352414|Alvimopan|alvimopan|mesh-list
101892543|NCT03352414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101892544|NCT00364793|Emtricitabine|emtricitabine|mesh-list
101892545|NCT00364793|Efavirenz|efavirenz|mesh-list
101892546|NCT00364793|Didanosine|didanosine|mesh-list
101892547|NCT00364793|Antiviral Agents|antiviral agents|mesh-ancestor
101892548|NCT00364793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101892549|NCT00364793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101892550|NCT00364793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101892551|NCT00364793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101612330|NCT00952068|Tramadol|tramadol|mesh-list
101892552|NCT00364793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892553|NCT00364793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101892554|NCT00364793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101892555|NCT00364793|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101892556|NCT00364793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101892557|NCT00364793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101892558|NCT00364793|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101892559|NCT00364793|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101892560|NCT00364793|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101892561|NCT00364793|Antimetabolites|antimetabolites|mesh-ancestor
101892562|NCT03351478|Empagliflozin|empagliflozin|mesh-list
101892563|NCT03351478|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
101892564|NCT03351478|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101892565|NCT03351478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892566|NCT03351478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101892567|NCT03351478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892569|NCT00363545|Immunologic Factors|immunologic factors|mesh-ancestor
101892570|NCT00363545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892571|NCT03351244|BI 409306|bi 409306|mesh-list
101892572|NCT03351244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101892573|NCT03351244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101892574|NCT03351244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892575|NCT03386032|Desonide|desonide|mesh-list
101892576|NCT03386032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101892577|NCT00077610|Epoetin Alfa|epoetin alfa|mesh-list
101892578|NCT00077610|Hematinics|hematinics|mesh-ancestor
101892579|NCT00066222|Etoposide|etoposide|mesh-list
101892580|NCT00066222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892581|NCT00066222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101892582|NCT00066222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101892583|NCT00066222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101892584|NCT00066222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101892585|NCT00066222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892586|NCT00397943|Vaccines|vaccines|mesh-list
101892587|NCT00397943|Immunologic Factors|immunologic factors|mesh-ancestor
101892588|NCT00397943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892589|NCT00066066|Amoxicillin|amoxicillin|mesh-list
101892590|NCT00066066|Metronidazole|metronidazole|mesh-list
101892591|NCT00066066|Doxycycline|doxycycline|mesh-list
101892592|NCT00066066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101892593|NCT00066066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101892594|NCT00066066|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101892595|NCT00066066|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101892596|NCT00066066|Antimalarials|antimalarials|mesh-ancestor
101892597|NCT00363467|Busulfan|busulfan|mesh-list
101892598|NCT00363467|Alkylating Agents|alkylating agents|mesh-ancestor
101892599|NCT00363467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892600|NCT00363467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101892601|NCT00363467|Immunologic Factors|immunologic factors|mesh-ancestor
101892602|NCT00363467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892603|NCT00363467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101892604|NCT00363467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892605|NCT00363467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101892606|NCT00397631|Pioglitazone|pioglitazone|mesh-list
101892607|NCT00397631|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101892608|NCT00397631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101892609|NCT00397631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892610|NCT00397631|Incretins|incretins|mesh-ancestor
101892611|NCT00397631|Hormones|hormones|mesh-ancestor
101892612|NCT00397631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101892613|NCT00397631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101892614|NCT00397631|Protease Inhibitors|protease inhibitors|mesh-ancestor
101892615|NCT00397631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101892616|NCT00397631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892617|NCT00077376|Carboplatin|carboplatin|mesh-list
101892618|NCT00077376|Trastuzumab|trastuzumab|mesh-list
101892619|NCT00077376|Epothilone B|epothilone b|mesh-list
101892620|NCT00077376|Epothilones|epothilones|mesh-list
101892621|NCT00077376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892622|NCT00077376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101892623|NCT00077376|Tubulin Modulators|tubulin modulators|mesh-ancestor
101892624|NCT00077376|Antimitotic Agents|antimitotic agents|mesh-ancestor
101892625|NCT00077376|Mitosis Modulators|mitosis modulators|mesh-ancestor
101892626|NCT00077376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892628|NCT01088724|Rituximab|rituximab|mesh-list
101892629|NCT01088724|Doxorubicin|doxorubicin|mesh-list
101892630|NCT01088724|Fludarabine|fludarabine|mesh-list
101892631|NCT01088724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101892632|NCT01088724|Immunologic Factors|immunologic factors|mesh-ancestor
101892633|NCT01088724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892634|NCT01088724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101892635|NCT01088724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101892636|NCT01088724|Alkylating Agents|alkylating agents|mesh-ancestor
101892637|NCT01088724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892638|NCT01088724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892639|NCT01088724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101892640|NCT01088724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101892641|NCT01088724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101892642|NCT01088724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101892643|NCT01088724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101892644|NCT01088724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101892646|NCT03957174|Reboxetine|reboxetine|mesh-list
101892647|NCT03957174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101892648|NCT03957174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101892649|NCT03957174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892650|NCT03957174|Cholinergic Agents|cholinergic agents|mesh-ancestor
101892651|NCT03957174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101892652|NCT03957174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892653|NCT03957174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101892654|NCT03957174|Protective Agents|protective agents|mesh-ancestor
101892655|NCT03957174|Antidepressive Agents|antidepressive agents|mesh-ancestor
101892656|NCT03957174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101892657|NCT03957174|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101892658|NCT03957174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101892659|NCT03957174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101892660|NCT03957174|Adrenergic Agents|adrenergic agents|mesh-ancestor
101892661|NCT00363311|Dutasteride|dutasteride|mesh-list
101892662|NCT00363311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101892663|NCT00363311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101892664|NCT00363311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101892665|NCT00363311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892666|NCT00363311|Hormone Antagonists|hormone antagonists|mesh-ancestor
101892667|NCT00363311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101892668|NCT00363311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892669|NCT00362609|Pantoprazole|pantoprazole|mesh-list
101892670|NCT00362609|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101892671|NCT00362609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101892672|NCT00362609|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101892673|NCT00362609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101892674|NCT00362609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892675|NCT02534753|Ascorbic Acid|ascorbic acid|mesh-list
101892676|NCT02534753|Antioxidants|antioxidants|mesh-ancestor
101892677|NCT02534753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892678|NCT02534753|Protective Agents|protective agents|mesh-ancestor
101892679|NCT02534753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892680|NCT02534753|Vitamins|vitamins|mesh-ancestor
101892681|NCT02534753|Micronutrients|micronutrients|mesh-ancestor
101892682|NCT01042457|Mycophenolic Acid|mycophenolic acid|mesh-list
101892683|NCT01042457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101892684|NCT01042457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892685|NCT01042457|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101892686|NCT01042457|Antitubercular Agents|antitubercular agents|mesh-ancestor
101892687|NCT01042457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101892688|NCT01042457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101892689|NCT01042457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101892690|NCT01042457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892691|NCT00362297|Valacyclovir|valacyclovir|mesh-list
101892692|NCT00362297|Acyclovir|acyclovir|mesh-list
101892693|NCT00362297|Antiviral Agents|antiviral agents|mesh-ancestor
101892694|NCT00362297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101892695|NCT01042691|Oxaliplatin|oxaliplatin|mesh-list
101892696|NCT01042691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892697|NCT00090402|Thioctic Acid|thioctic acid|mesh-list
101892698|NCT00090402|Antioxidants|antioxidants|mesh-ancestor
101612470|NCT03504501|Lamotrigine|lamotrigine|mesh-list
101892699|NCT00090402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892700|NCT00090402|Protective Agents|protective agents|mesh-ancestor
101892701|NCT00090402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892702|NCT00090402|Vitamin B Complex|vitamin b complex|mesh-ancestor
101892703|NCT00090402|Vitamins|vitamins|mesh-ancestor
101969210|NCT00580216|Warfarin|warfarin|mesh-list
101892704|NCT00090402|Micronutrients|micronutrients|mesh-ancestor
101892705|NCT00361283|Atorvastatin|atorvastatin|mesh-list
101892706|NCT00361283|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101892707|NCT00361283|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101892708|NCT00361283|Antimetabolites|antimetabolites|mesh-ancestor
101892709|NCT00361283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892710|NCT00361283|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102074178|NCT03554304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101892711|NCT00361283|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101892712|NCT00361283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101892713|NCT00077064|Captopril|captopril|mesh-list
101892714|NCT00077064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101892715|NCT00077064|Protease Inhibitors|protease inhibitors|mesh-ancestor
101892716|NCT00077064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101892717|NCT00077064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892718|NCT00077064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101892719|NCT00396383|Plerixafor|plerixafor|mesh-list
101892720|NCT00396383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101892721|NCT00396383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101892722|NCT00396383|Antiviral Agents|antiviral agents|mesh-ancestor
101892723|NCT00396383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101892724|NCT02534363|Aripiprazole|aripiprazole|mesh-list
101892725|NCT02534363|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101892726|NCT02534363|Ziprasidone|ziprasidone|mesh-list
101892727|NCT02534363|Antidepressive Agents|antidepressive agents|mesh-ancestor
101892728|NCT02534363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101892729|NCT02534363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101892730|NCT02534363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101892731|NCT02534363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101892732|NCT02534363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892733|NCT02534363|Dopamine Agonists|dopamine agonists|mesh-ancestor
101892734|NCT02534363|Dopamine Agents|dopamine agents|mesh-ancestor
101892735|NCT02534363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101892736|NCT02534363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892737|NCT02534363|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101892738|NCT02534363|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101892739|NCT02534363|Serotonin Agents|serotonin agents|mesh-ancestor
101892740|NCT02534363|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101892741|NCT02534363|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101892742|NCT02534363|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101892743|NCT02534363|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101892744|NCT01050491|Sitaxsentan|sitaxsentan|mesh-list
101892745|NCT01050491|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101892746|NCT01050491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892747|NCT01088958|Micronutrients|micronutrients|mesh-list
101892748|NCT01088958|Trace Elements|trace elements|mesh-list
101892749|NCT01088958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892750|NCT03404518|Acetaminophen|acetaminophen|mesh-list
101892751|NCT03404518|Ibuprofen|ibuprofen|mesh-list
101892752|NCT03404518|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
101892753|NCT03404518|Hydrocodone|hydrocodone|mesh-list
101892754|NCT03404518|Narcotics|narcotics|mesh-list
101892755|NCT03404518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101892756|NCT03404518|Analgesics|analgesics|mesh-ancestor
101892757|NCT03404518|Sensory System Agents|sensory system agents|mesh-ancestor
101892758|NCT03404518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101892759|NCT03404518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892760|NCT03404518|Antipyretics|antipyretics|mesh-ancestor
101892761|NCT03404518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101892762|NCT03404518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101892763|NCT03404518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101892764|NCT03404518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101892765|NCT03404518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101892766|NCT03404518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892768|NCT03404518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101892769|NCT03404518|Antitussive Agents|antitussive agents|mesh-ancestor
101892770|NCT03404518|Respiratory System Agents|respiratory system agents|mesh-ancestor
101892771|NCT03404206|Ibuprofen|ibuprofen|mesh-list
101892772|NCT03404206|Naproxen|naproxen|mesh-list
101892773|NCT03404206|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101892774|NCT03404206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101892776|NCT03404206|Sensory System Agents|sensory system agents|mesh-ancestor
101892777|NCT03404206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101892778|NCT03404206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892779|NCT03404206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101892780|NCT03404206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101892781|NCT03404206|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101892782|NCT03404206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101892783|NCT03404206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892784|NCT03404206|Gout Suppressants|gout suppressants|mesh-ancestor
101892785|NCT00394901|Pregabalin|pregabalin|mesh-list
101892786|NCT00394901|Analgesics|analgesics|mesh-ancestor
101892787|NCT00394901|Sensory System Agents|sensory system agents|mesh-ancestor
101892788|NCT00394901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101892789|NCT00394901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892790|NCT00394901|Anticonvulsants|anticonvulsants|mesh-ancestor
101892791|NCT00394901|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101892792|NCT00394901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101892793|NCT00394901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892794|NCT00394901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101892795|NCT00394901|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101892796|NCT00394901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101892797|NCT00394901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101892798|NCT00394901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101892799|NCT03349060|Abrocitinib|abrocitinib|mesh-list
101892800|NCT03349060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101892801|NCT03349060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101892802|NCT03349060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892803|NCT03348904|Paclitaxel|paclitaxel|mesh-list
101892804|NCT03348904|Carboplatin|carboplatin|mesh-list
101892805|NCT03348904|Gemcitabine|gemcitabine|mesh-list
101892806|NCT03348904|Nivolumab|nivolumab|mesh-list
101892807|NCT03348904|Pemetrexed|pemetrexed|mesh-list
101892808|NCT03348904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101892809|NCT03348904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892810|NCT03348904|Tubulin Modulators|tubulin modulators|mesh-ancestor
101892811|NCT03348904|Antimitotic Agents|antimitotic agents|mesh-ancestor
101892812|NCT03348904|Mitosis Modulators|mitosis modulators|mesh-ancestor
101892813|NCT03348904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892814|NCT03348904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101892815|NCT03348904|Antimetabolites|antimetabolites|mesh-ancestor
101892816|NCT03348904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101892817|NCT03348904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101892818|NCT03348904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101892819|NCT03348904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101892820|NCT03348904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101892821|NCT00359021|Etravirine|etravirine|mesh-list
101969244|NCT01107145|Analgesics|analgesics|mesh-ancestor
101892822|NCT00359021|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101892823|NCT00359021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101892824|NCT00359021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101892825|NCT00359021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892826|NCT00359021|Antiviral Agents|antiviral agents|mesh-ancestor
101892827|NCT00359021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101892828|NCT00360269|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101892829|NCT00360269|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101892830|NCT00360269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101892831|NCT00360269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101892832|NCT00360269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892833|NCT00360269|Adrenergic Agents|adrenergic agents|mesh-ancestor
101892834|NCT00360269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101892835|NCT00360269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892836|NCT01052597|Curcumin|curcumin|mesh-list
101892837|NCT01052597|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101892838|NCT01052597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101892839|NCT01052597|Analgesics|analgesics|mesh-ancestor
101892840|NCT01052597|Sensory System Agents|sensory system agents|mesh-ancestor
101892841|NCT01052597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101892842|NCT01052597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892843|NCT01052597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101892844|NCT01052597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101892845|NCT01052597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892846|NCT01052597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101892847|NCT01052597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892849|NCT01051115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892850|NCT01051115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101892851|NCT01051115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101892852|NCT01051115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892853|NCT00076752|Diphenhydramine|diphenhydramine|mesh-list
101892854|NCT00076752|Promethazine|promethazine|mesh-list
101892855|NCT00076752|Methylprednisolone|methylprednisolone|mesh-list
101892856|NCT00076752|Cyclophosphamide|cyclophosphamide|mesh-list
101892857|NCT00076752|Rituximab|rituximab|mesh-list
101892858|NCT00076752|Fludarabine|fludarabine|mesh-list
101892859|NCT00076752|Fludarabine phosphate|fludarabine phosphate|mesh-list
101892860|NCT00076752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101892861|NCT00076752|Immunologic Factors|immunologic factors|mesh-ancestor
101892862|NCT00076752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892863|NCT00076752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101892864|NCT00076752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101892865|NCT00076752|Alkylating Agents|alkylating agents|mesh-ancestor
101892866|NCT00076752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892867|NCT00076752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892868|NCT00076752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101892869|NCT00076752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101892870|NCT00076752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101892871|NCT00076752|Antimetabolites|antimetabolites|mesh-ancestor
101892872|NCT00076752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101892873|NCT00076752|Antiemetics|antiemetics|mesh-ancestor
101892874|NCT00076752|Autonomic Agents|autonomic agents|mesh-ancestor
101892875|NCT00076752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101892876|NCT00076752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101892877|NCT00076752|Glucocorticoids|glucocorticoids|mesh-ancestor
101892878|NCT00076752|Hormones|hormones|mesh-ancestor
101892879|NCT00076752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101892880|NCT00076752|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101892881|NCT00076752|Protective Agents|protective agents|mesh-ancestor
101375858|NCT00236353|Risperidone|risperidone|mesh-list
101892882|NCT00076752|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101892883|NCT00076752|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101892884|NCT00076752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101892885|NCT00076752|Anesthetics, Local|anesthetics, local|mesh-ancestor
101892886|NCT00076752|Anesthetics|anesthetics|mesh-ancestor
101892887|NCT00076752|Sensory System Agents|sensory system agents|mesh-ancestor
101892888|NCT00076752|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101892889|NCT00076752|Histamine Antagonists|histamine antagonists|mesh-ancestor
101892890|NCT00076752|Histamine Agents|histamine agents|mesh-ancestor
101892891|NCT00076752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101892892|NCT00076752|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101892893|NCT00076752|Antipruritics|antipruritics|mesh-ancestor
101892894|NCT00076752|Dermatologic Agents|dermatologic agents|mesh-ancestor
101892895|NCT03384940|Trastuzumab|trastuzumab|mesh-list
101892896|NCT03384940|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
101892897|NCT03384940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101892898|NCT03384940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892899|NCT03384940|Immunoconjugates|immunoconjugates|mesh-ancestor
101892900|NCT03384940|Immunologic Factors|immunologic factors|mesh-ancestor
101892901|NCT03384940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892902|NCT00075582|Dactinomycin|dactinomycin|mesh-list
101892903|NCT00075582|Cactinomycin|cactinomycin|mesh-list
101892904|NCT00075582|Cyclophosphamide|cyclophosphamide|mesh-list
101892905|NCT00075582|Vincristine|vincristine|mesh-list
101892906|NCT00075582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101892907|NCT00075582|Immunologic Factors|immunologic factors|mesh-ancestor
101892908|NCT00075582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892909|NCT00075582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101689687|NCT00650754|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101892910|NCT00075582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101892911|NCT00075582|Alkylating Agents|alkylating agents|mesh-ancestor
101892912|NCT00075582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892913|NCT00075582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892914|NCT00075582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101892915|NCT00075582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101892916|NCT00075582|Tubulin Modulators|tubulin modulators|mesh-ancestor
101892917|NCT00075582|Antimitotic Agents|antimitotic agents|mesh-ancestor
101892918|NCT00075582|Mitosis Modulators|mitosis modulators|mesh-ancestor
101892919|NCT00075582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101892920|NCT00075582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101892921|NCT00075582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101612694|NCT04310228|Favipiravir|favipiravir|mesh-list
101892922|NCT00075582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101892923|NCT00075582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101892924|NCT00075582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101892925|NCT00063258|Paclitaxel|paclitaxel|mesh-list
101892926|NCT00063258|Carboplatin|carboplatin|mesh-list
101892927|NCT00063258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101892928|NCT00063258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101892929|NCT00063258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892930|NCT00063258|Tubulin Modulators|tubulin modulators|mesh-ancestor
101892931|NCT00063258|Antimitotic Agents|antimitotic agents|mesh-ancestor
101892932|NCT00063258|Mitosis Modulators|mitosis modulators|mesh-ancestor
101892933|NCT00063258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892934|NCT00063258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101892935|NCT00063258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101892936|NCT00088530|Prednisone|prednisone|mesh-list
101892937|NCT00088530|Cyclophosphamide|cyclophosphamide|mesh-list
101892938|NCT00088530|Rituximab|rituximab|mesh-list
101892939|NCT00088530|Gemcitabine|gemcitabine|mesh-list
101892940|NCT00088530|Etoposide|etoposide|mesh-list
101892941|NCT00088530|Vincristine|vincristine|mesh-list
101892942|NCT00088530|Vinorelbine|vinorelbine|mesh-list
101892943|NCT00088530|Pixantrone|pixantrone|mesh-list
101892944|NCT00088530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101892945|NCT00088530|Immunologic Factors|immunologic factors|mesh-ancestor
101892946|NCT00088530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892947|NCT00088530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101892948|NCT00088530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101892949|NCT00088530|Alkylating Agents|alkylating agents|mesh-ancestor
101892950|NCT00088530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892951|NCT00088530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101892952|NCT00088530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101892953|NCT00088530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101892954|NCT00088530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101892955|NCT00088530|Antimetabolites|antimetabolites|mesh-ancestor
101892956|NCT00088530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101892957|NCT00088530|Glucocorticoids|glucocorticoids|mesh-ancestor
101892958|NCT00088530|Hormones|hormones|mesh-ancestor
101892959|NCT00088530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101892960|NCT00088530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101892961|NCT00088530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101892962|NCT00088530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101892963|NCT00088530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101892964|NCT00088530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101892965|NCT00088530|Tubulin Modulators|tubulin modulators|mesh-ancestor
101892966|NCT00088530|Antimitotic Agents|antimitotic agents|mesh-ancestor
101892967|NCT00088530|Mitosis Modulators|mitosis modulators|mesh-ancestor
101892968|NCT00359801|Insulin|insulin|mesh-list
101892969|NCT00359801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101892970|NCT00359801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101892971|NCT00359801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892972|NCT03990701|Metomidate|metomidate|mesh-list
101892973|NCT03990701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101892974|NCT03990701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101892975|NCT03990701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892976|NCT01051193|Oxcarbazepine|oxcarbazepine|mesh-list
101892977|NCT01051193|Anticonvulsants|anticonvulsants|mesh-ancestor
101892978|NCT01051193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101892979|NCT01051193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101892980|NCT01051193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101689689|NCT00650754|Immunologic Factors|immunologic factors|mesh-ancestor
101892981|NCT01051193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892982|NCT01051193|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101892983|NCT01051193|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101892984|NCT01051271|Midazolam|midazolam|mesh-list
101892985|NCT01051271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101892986|NCT01051271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101892987|NCT01051271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101776828|NCT00807534|Bromides|bromides|mesh-list
101892988|NCT01051271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101892989|NCT01051271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101892990|NCT01051271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101892991|NCT01051271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101892992|NCT01051271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101892993|NCT01051271|Anesthetics, General|anesthetics, general|mesh-ancestor
101892994|NCT01051271|Anesthetics|anesthetics|mesh-ancestor
101892995|NCT01051271|GABA Modulators|gaba modulators|mesh-ancestor
101892996|NCT01051271|GABA Agents|gaba agents|mesh-ancestor
101892997|NCT01051271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101892998|NCT01051271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101892999|NCT01051427|Hemostatics|hemostatics|mesh-list
101893000|NCT01051427|Surgiflo|surgiflo|mesh-list
101893001|NCT01051427|Coagulants|coagulants|mesh-ancestor
101893002|NCT01052909|Glimepiride|glimepiride|mesh-list
101893003|NCT01052909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101893004|NCT01052909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101969281|NCT02286544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101893005|NCT01052909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893006|NCT01052909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101893007|NCT01052909|Immunologic Factors|immunologic factors|mesh-ancestor
101893008|NCT00045032|Trastuzumab|trastuzumab|mesh-list
101893009|NCT00045032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101893010|NCT00045032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101893011|NCT01052987|Tranilast|tranilast|mesh-list
101893012|NCT01052987|Allopurinol|allopurinol|mesh-list
101893013|NCT01052987|Antimetabolites|antimetabolites|mesh-ancestor
101893014|NCT01052987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893015|NCT01052987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101893016|NCT01052987|Gout Suppressants|gout suppressants|mesh-ancestor
101893017|NCT01052987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101893018|NCT01052987|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101893019|NCT01052987|Antioxidants|antioxidants|mesh-ancestor
101893020|NCT01052987|Protective Agents|protective agents|mesh-ancestor
101893021|NCT01052987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893022|NCT01052987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101893023|NCT01052987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101893024|NCT01052987|Analgesics|analgesics|mesh-ancestor
101893025|NCT01052987|Sensory System Agents|sensory system agents|mesh-ancestor
101893026|NCT01052987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101893027|NCT01052987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101893028|NCT01052987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101893029|NCT01052987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101893030|NCT01052987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101893031|NCT01052987|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101893032|NCT01052987|Histamine Antagonists|histamine antagonists|mesh-ancestor
101893033|NCT01052987|Histamine Agents|histamine agents|mesh-ancestor
101893034|NCT01052987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101893035|NCT01052987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101893036|NCT01052987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101893037|NCT02533973|Calcipotriene|calcipotriene|mesh-list
101893038|NCT02533973|Dermatologic Agents|dermatologic agents|mesh-ancestor
101893039|NCT01053065|Atorvastatin|atorvastatin|mesh-list
101893040|NCT01053065|Cholestyramine Resin|cholestyramine resin|mesh-list
101893041|NCT01053065|Gamma-sitosterol|gamma-sitosterol|mesh-list
101893042|NCT01053065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101893043|NCT01053065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101893044|NCT01053065|Antimetabolites|antimetabolites|mesh-ancestor
101893045|NCT01053065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893046|NCT01053065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101893047|NCT01053065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101893048|NCT01053065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101893049|NCT01051583|Bevacizumab|bevacizumab|mesh-list
101893050|NCT01051583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101893051|NCT01051583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101893052|NCT01051583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101893053|NCT01051583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101893054|NCT01051583|Growth Substances|growth substances|mesh-ancestor
101893055|NCT01051583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893056|NCT01051583|Growth Inhibitors|growth inhibitors|mesh-ancestor
101893057|NCT05386706|Metformin|metformin|mesh-list
101893058|NCT05386706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101893059|NCT05386706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893060|NCT03950804|Eculizumab|eculizumab|mesh-list
101893061|NCT03950804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101893062|NCT03950804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101893063|NCT03950804|Immunologic Factors|immunologic factors|mesh-ancestor
101893064|NCT03950804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893065|NCT00356915|Itraconazole|itraconazole|mesh-list
101893066|NCT00356915|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
101893067|NCT00356915|Antifungal Agents|antifungal agents|mesh-ancestor
101893068|NCT00356915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101893069|NCT00356915|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101893070|NCT00356915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101893071|NCT00356915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101612838|NCT00954174|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101893072|NCT00356915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893074|NCT00356915|Hormone Antagonists|hormone antagonists|mesh-ancestor
101893075|NCT00356915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101893076|NCT00356915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893077|NCT00356915|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101893078|NCT00356759|Warfarin|warfarin|mesh-list
101893079|NCT00356759|Anticoagulants|anticoagulants|mesh-ancestor
101893080|NCT00356603|Sumatriptan|sumatriptan|mesh-list
101893081|NCT00356603|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101893082|NCT00356603|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101893083|NCT00356603|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101893084|NCT00356603|Serotonin Agents|serotonin agents|mesh-ancestor
101893085|NCT00356603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101893086|NCT00356603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893087|NCT00356603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893088|NCT01052051|Vitamin D|vitamin d|mesh-list
101893089|NCT01052051|Cholecalciferol|cholecalciferol|mesh-list
101893090|NCT01052051|Calcium Carbonate|calcium carbonate|mesh-list
101893091|NCT01052051|Calcium|calcium|mesh-list
101893092|NCT01052051|Vitamins|vitamins|mesh-ancestor
101893093|NCT01052051|Micronutrients|micronutrients|mesh-ancestor
101893094|NCT01052051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893095|NCT01052051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101893096|NCT01052051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101893097|NCT01052051|Antacids|antacids|mesh-ancestor
101893098|NCT01052051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893099|NCT01052051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101893100|NCT00002558|Paclitaxel|paclitaxel|mesh-list
101893101|NCT00002558|Etoposide|etoposide|mesh-list
101893102|NCT00002558|Carboplatin|carboplatin|mesh-list
101893103|NCT00002558|Ifosfamide|ifosfamide|mesh-list
101893104|NCT00002558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101893105|NCT00002558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101893106|NCT00002558|Tubulin Modulators|tubulin modulators|mesh-ancestor
101893107|NCT00002558|Antimitotic Agents|antimitotic agents|mesh-ancestor
101893108|NCT00002558|Mitosis Modulators|mitosis modulators|mesh-ancestor
101893109|NCT00002558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893110|NCT00002558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101893111|NCT00002558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101893112|NCT00002558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101893113|NCT00002558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101893114|NCT00002558|Alkylating Agents|alkylating agents|mesh-ancestor
101893115|NCT00001880|Cyclosporine|cyclosporine|mesh-list
101893116|NCT00001880|Methotrexate|methotrexate|mesh-list
101893117|NCT00001880|Cyclosporins|cyclosporins|mesh-list
101893118|NCT00001880|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101893119|NCT00001880|Abortifacient Agents|abortifacient agents|mesh-ancestor
101893120|NCT00001880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101893121|NCT00001880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893122|NCT00001880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101893123|NCT00001880|Antimetabolites|antimetabolites|mesh-ancestor
101969296|NCT00384904|Protease Inhibitors|protease inhibitors|mesh-ancestor
101893124|NCT00001880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893125|NCT00001880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101893126|NCT00001880|Dermatologic Agents|dermatologic agents|mesh-ancestor
101893127|NCT00001880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101893128|NCT00001880|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101893129|NCT00001880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101893130|NCT00001880|Immunologic Factors|immunologic factors|mesh-ancestor
101893131|NCT00001880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101893132|NCT00001880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101893133|NCT00001880|Antifungal Agents|antifungal agents|mesh-ancestor
101893134|NCT00001880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101893135|NCT00001880|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101893137|NCT01096472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101893138|NCT01096472|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101893139|NCT05627648|Mitogens|mitogens|mesh-list
101893140|NCT05627648|Mitosis Modulators|mitosis modulators|mesh-ancestor
101893141|NCT05627648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893142|NCT05296772|Pembrolizumab|pembrolizumab|mesh-list
101893143|NCT05296772|Antibodies|antibodies|mesh-list
101893144|NCT05296772|Immunoglobulins|immunoglobulins|mesh-list
101893145|NCT05296772|Immunologic Factors|immunologic factors|mesh-ancestor
101893146|NCT05296772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893147|NCT05296772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101893148|NCT05296772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101893149|NCT05296772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101893150|NCT05296772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893151|NCT03947528|Sarpogrelate|sarpogrelate|mesh-list
101893152|NCT03947528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101893153|NCT03947528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101893154|NCT03947528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893155|NCT03947528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101893156|NCT03947528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101776877|NCT00654732|Rituximab|rituximab|mesh-list
101893157|NCT03947528|Serotonin Agents|serotonin agents|mesh-ancestor
101893158|NCT03947528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101893159|NCT03947528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893160|NCT01104896|Nicotine|nicotine|mesh-list
101893161|NCT01104896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101893162|NCT01104896|Autonomic Agents|autonomic agents|mesh-ancestor
101893163|NCT01104896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101893164|NCT01104896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893165|NCT01104896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101893166|NCT01104896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101893167|NCT01104896|Cholinergic Agents|cholinergic agents|mesh-ancestor
101893168|NCT01104896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101893169|NCT01104896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893170|NCT00043550|Sertraline|sertraline|mesh-list
101893171|NCT00043550|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101893172|NCT00043550|Antidepressive Agents|antidepressive agents|mesh-ancestor
101893173|NCT00043550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101893174|NCT00043550|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101893175|NCT00043550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101893176|NCT00043550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101893177|NCT00043550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101893178|NCT00043550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101893179|NCT00043550|Serotonin Agents|serotonin agents|mesh-ancestor
101893180|NCT00043550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893181|NCT00043550|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101893182|NCT00043550|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101893183|NCT01102244|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
101893184|NCT01102244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101893185|NCT01102244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101893186|NCT01102244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101893187|NCT01102244|Glucocorticoids|glucocorticoids|mesh-ancestor
101893188|NCT01102244|Hormones|hormones|mesh-ancestor
101893189|NCT01102244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101893190|NCT01102244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101893191|NCT01102244|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101893192|NCT01102244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102032348|NCT01372839|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102032349|NCT01372839|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102032350|NCT01372839|Antimetabolites|antimetabolites|mesh-ancestor
102032351|NCT01372839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032352|NCT01372839|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102032353|NCT01372839|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102032354|NCT01372839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102032355|NCT01065350|Ketamine|ketamine|mesh-list
102032356|NCT01065350|Propofol|propofol|mesh-list
102032357|NCT01065350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102032358|NCT01065350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102032359|NCT01065350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032360|NCT01065350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102032361|NCT01065350|Anesthetics, General|anesthetics, general|mesh-ancestor
102032362|NCT01065350|Anesthetics|anesthetics|mesh-ancestor
102032363|NCT01065350|Analgesics|analgesics|mesh-ancestor
101776887|NCT00654732|Imidazole|imidazole|mesh-list
102032364|NCT01065350|Sensory System Agents|sensory system agents|mesh-ancestor
102032365|NCT01065350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102032366|NCT01065350|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102032367|NCT01065350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102032368|NCT01065350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102032369|NCT01065350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102032370|NCT01065350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032371|NCT02914977|Daunorubicin|daunorubicin|mesh-list
102032372|NCT02914977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102032373|NCT02914977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102032374|NCT02914977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102032375|NCT02914977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102032376|NCT02914977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102032377|NCT02914977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333878|NCT00041431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601154|NCT04300686|Immunologic Factors|immunologic factors|mesh-ancestor
101601155|NCT04300686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601156|NCT04300686|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101601157|NCT04300686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101601158|NCT04300686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101601159|NCT01098539|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101601160|NCT01098539|rGLP-1 protein|rglp-1 protein|mesh-list
101601161|NCT01098539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101601162|NCT01098539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601163|NCT01098539|Incretins|incretins|mesh-ancestor
102032378|NCT03718715|Metformin|metformin|mesh-list
102032379|NCT03718715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102032380|NCT03718715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032381|NCT05079022|Aflutinib|aflutinib|mesh-list
102032382|NCT05079022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102032383|NCT05079022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102032384|NCT05079022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032385|NCT05078788|Triamcinolone|triamcinolone|mesh-list
102032386|NCT05078788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102032387|NCT05078788|Glucocorticoids|glucocorticoids|mesh-ancestor
102032388|NCT05078788|Hormones|hormones|mesh-ancestor
102032389|NCT05078788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102032390|NCT05078788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032391|NCT02032654|Floxacillin|floxacillin|mesh-list
102032392|NCT02032654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102032393|NCT02032654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102032394|NCT04734886|Vitamin D|vitamin d|mesh-list
102032395|NCT04734886|Ergocalciferols|ergocalciferols|mesh-list
102032396|NCT04734886|Cholecalciferol|cholecalciferol|mesh-list
102032397|NCT04734886|Vitamins|vitamins|mesh-list
102032398|NCT04734886|Micronutrients|micronutrients|mesh-ancestor
101601164|NCT01098539|Hormones|hormones|mesh-ancestor
101601165|NCT01098539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101601166|NCT01098539|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101601167|NCT01098539|Protease Inhibitors|protease inhibitors|mesh-ancestor
101601168|NCT01098539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101601169|NCT01098539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601170|NCT04922723|Daratumumab|daratumumab|mesh-list
101601171|NCT04922723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101601172|NCT01098461|rGLP-1 protein|rglp-1 protein|mesh-list
101601173|NCT01098461|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101601174|NCT01098461|Incretins|incretins|mesh-ancestor
101601175|NCT01098461|Hormones|hormones|mesh-ancestor
101601176|NCT01098461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101601177|NCT01098461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601178|NCT01098305|Varenicline|varenicline|mesh-list
101601179|NCT01098305|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101601180|NCT01098305|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101601181|NCT01098305|Cholinergic Agents|cholinergic agents|mesh-ancestor
101601182|NCT01098305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101601183|NCT01098305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601184|NCT01098305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601185|NCT00833833|Aspirin|aspirin|mesh-list
101601186|NCT00833833|Dexamethasone|dexamethasone|mesh-list
101601187|NCT00833833|Dexamethasone acetate|dexamethasone acetate|mesh-list
101601188|NCT00833833|Pomalidomide|pomalidomide|mesh-list
101601189|NCT00833833|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101601190|NCT00833833|BB 1101|bb 1101|mesh-list
101601191|NCT00833833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101601193|NCT00833833|Autonomic Agents|autonomic agents|mesh-ancestor
101601194|NCT00833833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101601195|NCT00833833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601196|NCT00833833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101601197|NCT00833833|Glucocorticoids|glucocorticoids|mesh-ancestor
101601198|NCT00833833|Hormones|hormones|mesh-ancestor
101601199|NCT00833833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102032399|NCT04734886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032400|NCT04734886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102032401|NCT04734886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102032402|NCT03114969|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
102032404|NCT03114969|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102032405|NCT03114969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102032406|NCT03114969|Respiratory System Agents|respiratory system agents|mesh-ancestor
102032407|NCT03114969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102032408|NCT03114969|Autonomic Agents|autonomic agents|mesh-ancestor
102032409|NCT03114969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102032410|NCT03114969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032412|NCT03114969|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102032413|NCT03114969|Cholinergic Agents|cholinergic agents|mesh-ancestor
102032414|NCT03114969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102032415|NCT03114969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032416|NCT03114969|Glucocorticoids|glucocorticoids|mesh-ancestor
102032417|NCT03114969|Hormones|hormones|mesh-ancestor
101628299|NCT02590705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333928|NCT00017511|Cevimeline|cevimeline|mesh-list
101601200|NCT00833833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101601201|NCT00833833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101601202|NCT00833833|Protease Inhibitors|protease inhibitors|mesh-ancestor
101601203|NCT00833833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101601204|NCT00833833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601205|NCT00833833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101601206|NCT00833833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101601207|NCT00833833|Analgesics|analgesics|mesh-ancestor
101601208|NCT00833833|Sensory System Agents|sensory system agents|mesh-ancestor
101601209|NCT00833833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101601210|NCT00833833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101601211|NCT00833833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101601212|NCT00833833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101601213|NCT00833833|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101601214|NCT00833833|Antipyretics|antipyretics|mesh-ancestor
101601215|NCT00833833|Immunologic Factors|immunologic factors|mesh-ancestor
101601216|NCT00833833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101601217|NCT00833833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101601218|NCT00833833|Growth Substances|growth substances|mesh-ancestor
101601219|NCT00833833|Growth Inhibitors|growth inhibitors|mesh-ancestor
101601220|NCT01098071|Mometasone Furoate|mometasone furoate|mesh-list
101601221|NCT01098071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101601222|NCT01098071|Dermatologic Agents|dermatologic agents|mesh-ancestor
101601223|NCT01098071|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101601236|NCT01097057|Plerixafor|plerixafor|mesh-list
101601237|NCT01097057|Rituximab|rituximab|mesh-list
101601238|NCT01097057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101601239|NCT01097057|Carboplatin|carboplatin|mesh-list
101601240|NCT01097057|Etoposide|etoposide|mesh-list
101601241|NCT01097057|Etoposide phosphate|etoposide phosphate|mesh-list
101601242|NCT01097057|Ifosfamide|ifosfamide|mesh-list
101601243|NCT01097057|Isophosphamide mustard|isophosphamide mustard|mesh-list
101601244|NCT01097057|Podophyllotoxin|podophyllotoxin|mesh-list
101601245|NCT01097057|Antibodies|antibodies|mesh-list
101601246|NCT01097057|Immunoglobulins|immunoglobulins|mesh-list
102032418|NCT03114969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102032419|NCT03114969|Sympathomimetics|sympathomimetics|mesh-ancestor
102032420|NCT05078710|Immunosuppressive Agents|immunosuppressive agents|mesh-list
102032421|NCT05078710|Immunologic Factors|immunologic factors|mesh-ancestor
102032422|NCT05078710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032423|NCT03144778|Durvalumab|durvalumab|mesh-list
102032424|NCT03144778|Ipilimumab|ipilimumab|mesh-list
101601247|NCT01097057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101601248|NCT01097057|Lenograstim|lenograstim|mesh-list
101601249|NCT01097057|Immunologic Factors|immunologic factors|mesh-ancestor
101601250|NCT01097057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601251|NCT01097057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101601252|NCT01097057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101601253|NCT01097057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101601254|NCT01097057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101601255|NCT01097057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101601256|NCT01097057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101601257|NCT01097057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601258|NCT01097057|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101601259|NCT01097057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101601260|NCT01097057|Alkylating Agents|alkylating agents|mesh-ancestor
101601261|NCT01097057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101601262|NCT01097057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101601263|NCT01097057|Antiviral Agents|antiviral agents|mesh-ancestor
101601264|NCT01097057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101601265|NCT01097057|Keratolytic Agents|keratolytic agents|mesh-ancestor
101601266|NCT01097057|Dermatologic Agents|dermatologic agents|mesh-ancestor
101601267|NCT01097057|Tubulin Modulators|tubulin modulators|mesh-ancestor
101601268|NCT01097057|Antimitotic Agents|antimitotic agents|mesh-ancestor
101601269|NCT01097057|Mitosis Modulators|mitosis modulators|mesh-ancestor
101601271|NCT02612701|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101601272|NCT02612701|Autonomic Agents|autonomic agents|mesh-ancestor
101601273|NCT02612701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101601274|NCT02612701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601275|NCT02612701|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101601276|NCT02612701|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101601277|NCT02612701|Cholinergic Agents|cholinergic agents|mesh-ancestor
101601278|NCT02612701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101601279|NCT02612701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601280|NCT01096667|Ertugliflozin|ertugliflozin|mesh-list
101601281|NCT01096667|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101601282|NCT01096667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101601283|NCT01096667|Diuretics|diuretics|mesh-ancestor
101601284|NCT01096667|Natriuretic Agents|natriuretic agents|mesh-ancestor
101601285|NCT01096667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601286|NCT01096667|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101601287|NCT01096667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101601288|NCT01096667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601289|NCT01096667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101601290|NCT01096667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101601291|NCT01014624|Clopidogrel|clopidogrel|mesh-list
101451780|NCT00208143|Serotonin Agents|serotonin agents|mesh-ancestor
101776932|NCT00767468|Sorafenib|sorafenib|mesh-list
101601295|NCT01014624|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101601296|NCT01014624|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101601297|NCT01014624|Purinergic Agents|purinergic agents|mesh-ancestor
101601298|NCT01014624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101601299|NCT01014624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601300|NCT01014624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601302|NCT01021878|Dialysis Solutions|dialysis solutions|mesh-ancestor
101601303|NCT01021878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101601304|NCT02872428|Valproic Acid|valproic acid|mesh-list
101601305|NCT02872428|Anticonvulsants|anticonvulsants|mesh-ancestor
101258294|NCT01730326|Antipyretics|antipyretics|mesh-ancestor
101601306|NCT02872428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101601307|NCT02872428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601308|NCT02872428|GABA Agents|gaba agents|mesh-ancestor
101601309|NCT02872428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102032426|NCT03144778|Immunoglobulins|immunoglobulins|mesh-list
102032427|NCT03144778|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102032428|NCT03144778|Immunoglobulin G|immunoglobulin g|mesh-list
102032429|NCT03144778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102032430|NCT03144778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102032431|NCT03144778|Immunologic Factors|immunologic factors|mesh-ancestor
102032432|NCT03144778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032433|NCT03144778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102032434|NCT03144778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032435|NCT03142360|Beraprost|beraprost|mesh-list
102032436|NCT03142360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102032437|NCT03142360|Vasodilator Agents|vasodilator agents|mesh-ancestor
102032438|NCT05124678|Isoniazid|isoniazid|mesh-list
102032439|NCT05124678|Antitubercular Agents|antitubercular agents|mesh-ancestor
102032440|NCT05124678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101333955|NCT00042016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101601310|NCT02872428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601311|NCT02872428|Antimanic Agents|antimanic agents|mesh-ancestor
101601312|NCT02872428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101601313|NCT02872428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101601314|NCT02872428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101601315|NCT02873364|Vitamin D|vitamin d|mesh-list
101601316|NCT02873364|Ergocalciferols|ergocalciferols|mesh-list
101601317|NCT02873364|Cholecalciferol|cholecalciferol|mesh-list
101601318|NCT02873364|Vitamins|vitamins|mesh-list
101601319|NCT02873364|Micronutrients|micronutrients|mesh-ancestor
101601320|NCT02873364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601321|NCT02873364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101601322|NCT02873364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101601323|NCT00628290|Cannabidiol|cannabidiol|mesh-list
101601324|NCT00628290|Amisulpride|amisulpride|mesh-list
101601325|NCT00628290|Anticonvulsants|anticonvulsants|mesh-ancestor
101601326|NCT00628290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101601327|NCT00628290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101601328|NCT00628290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101601329|NCT00628290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601330|NCT00628290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101601331|NCT00628290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101601332|NCT00628290|Dopamine Agents|dopamine agents|mesh-ancestor
101601333|NCT00628290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101601334|NCT00628290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601335|NCT00628290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101601336|NCT00628290|Antidepressive Agents|antidepressive agents|mesh-ancestor
101601337|NCT04559412|Etanercept|etanercept|mesh-list
101601338|NCT04559412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101601339|NCT04559412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101601340|NCT04559412|Analgesics|analgesics|mesh-ancestor
101601341|NCT04559412|Sensory System Agents|sensory system agents|mesh-ancestor
101601342|NCT04559412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101601344|NCT04559412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101601345|NCT04559412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101601346|NCT04559412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101601347|NCT04559412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101601348|NCT04559412|Immunologic Factors|immunologic factors|mesh-ancestor
101601349|NCT00854113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
101776940|NCT00669032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601350|NCT00854113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601351|NCT00854113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102032442|NCT05124678|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102032443|NCT05124678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102032444|NCT05124678|Antimetabolites|antimetabolites|mesh-ancestor
101601352|NCT00854113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601353|NCT02872584|Prednisone|prednisone|mesh-list
101601354|NCT02872584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101601355|NCT02872584|Glucocorticoids|glucocorticoids|mesh-ancestor
101601356|NCT02872584|Hormones|hormones|mesh-ancestor
101601357|NCT02872584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101601358|NCT02872584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601359|NCT02872584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101601360|NCT02872584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101601361|NCT00704821|Docetaxel|docetaxel|mesh-list
101537498|NCT04574141|Melatonin|melatonin|mesh-list
101601368|NCT00704899|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101601369|NCT00704899|Antidepressive Agents|antidepressive agents|mesh-ancestor
101601370|NCT00704899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101601371|NCT00704899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101601372|NCT00704899|Analgesics|analgesics|mesh-ancestor
101601373|NCT00704899|Sensory System Agents|sensory system agents|mesh-ancestor
101601374|NCT00704899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101601375|NCT00704899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601376|NCT00704899|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101601377|NCT00704899|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101601378|NCT00704899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101601379|NCT00704899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601380|NCT00704899|Adrenergic Agents|adrenergic agents|mesh-ancestor
101601381|NCT00704899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101601382|NCT01104701|Exenatide|exenatide|mesh-list
101601383|NCT01104701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101601384|NCT01104701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601385|NCT01104701|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101601386|NCT01104701|Incretins|incretins|mesh-ancestor
101601387|NCT01104701|Hormones|hormones|mesh-ancestor
101601388|NCT01104701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101601389|NCT00833755|Ketamine|ketamine|mesh-list
101601390|NCT00833755|Analgesics|analgesics|mesh-ancestor
101601391|NCT00833755|Sensory System Agents|sensory system agents|mesh-ancestor
101601392|NCT00833755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101601393|NCT00833755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601394|NCT00833755|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101601395|NCT00833755|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101601396|NCT00833755|Anesthetics, General|anesthetics, general|mesh-ancestor
101601397|NCT00833755|Anesthetics|anesthetics|mesh-ancestor
101601398|NCT00833755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101601399|NCT00833755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101601400|NCT00833755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101601401|NCT00833755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101601402|NCT00833755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601403|NCT01021332|Tamsulosin|tamsulosin|mesh-list
101601404|NCT01021332|Solifenacin Succinate|solifenacin succinate|mesh-list
101601405|NCT01021332|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101601406|NCT01021332|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101601407|NCT01021332|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101601408|NCT01021332|Adrenergic Agents|adrenergic agents|mesh-ancestor
101601409|NCT01021332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101601410|NCT01021332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601411|NCT01021332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601412|NCT01021332|Urological Agents|urological agents|mesh-ancestor
101601413|NCT01021332|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101601414|NCT01021332|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101601416|NCT00923091|Amlodipine|amlodipine|mesh-list
101601417|NCT00923091|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101601418|NCT00923091|Olmesartan|olmesartan|mesh-list
101601419|NCT00923091|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101601420|NCT00923091|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
101601421|NCT00923091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101601422|NCT00923091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101601423|NCT00923091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102032445|NCT05124678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032446|NCT05124678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102032447|NCT05761860|Oxycodone|oxycodone|mesh-list
102032448|NCT05761860|Oxytocin|oxytocin|mesh-list
101601424|NCT00923091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601425|NCT00923091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101601426|NCT00923091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601427|NCT00923091|Vasodilator Agents|vasodilator agents|mesh-ancestor
101601428|NCT00923091|Diuretics|diuretics|mesh-ancestor
101601429|NCT00923091|Natriuretic Agents|natriuretic agents|mesh-ancestor
101601436|NCT00853957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101601437|NCT00853957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601438|NCT00853957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101601439|NCT00853957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601440|NCT00853957|Vasodilator Agents|vasodilator agents|mesh-ancestor
101601441|NCT01021020|Colchicine|colchicine|mesh-list
101601442|NCT01021020|Probenecid|probenecid|mesh-list
101601443|NCT01021020|Gout Suppressants|gout suppressants|mesh-ancestor
101601444|NCT01021020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101601445|NCT01021020|Tubulin Modulators|tubulin modulators|mesh-ancestor
101601446|NCT01021020|Antimitotic Agents|antimitotic agents|mesh-ancestor
101601447|NCT01021020|Mitosis Modulators|mitosis modulators|mesh-ancestor
101601448|NCT01021020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601449|NCT01021020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101601450|NCT01021020|Uricosuric Agents|uricosuric agents|mesh-ancestor
101601451|NCT00833053|Infliximab|infliximab|mesh-list
101601452|NCT00833053|Methotrexate|methotrexate|mesh-list
101601453|NCT00833053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101601454|NCT00833053|Abortifacient Agents|abortifacient agents|mesh-ancestor
101601455|NCT00833053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101601456|NCT00833053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601457|NCT00833053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101601458|NCT00833053|Antimetabolites|antimetabolites|mesh-ancestor
101601459|NCT00833053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601460|NCT00833053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101601461|NCT00833053|Dermatologic Agents|dermatologic agents|mesh-ancestor
101601462|NCT00833053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101601463|NCT00833053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101601464|NCT00833053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101601465|NCT00833053|Immunologic Factors|immunologic factors|mesh-ancestor
101601466|NCT00833053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101601467|NCT00833053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101601468|NCT00833053|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101601469|NCT00833053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101601470|NCT00833053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101601471|NCT01020786|Carboplatin|carboplatin|mesh-list
101601472|NCT01020786|Pemetrexed|pemetrexed|mesh-list
101601473|NCT01020786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101601474|NCT01020786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101601475|NCT01020786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601476|NCT01020786|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101601477|NCT01020786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101601478|NCT00918645|Calcium|calcium|mesh-list
101601479|NCT00918645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101601480|NCT00918645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601481|NCT01020474|Pregabalin|pregabalin|mesh-list
101601482|NCT01020474|Analgesics|analgesics|mesh-ancestor
101601483|NCT01020474|Sensory System Agents|sensory system agents|mesh-ancestor
101601484|NCT01020474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101601485|NCT01020474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601486|NCT01020474|Anticonvulsants|anticonvulsants|mesh-ancestor
101601487|NCT01020474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101601488|NCT01020474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101601489|NCT01020474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601490|NCT01020474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101601491|NCT01020474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101601492|NCT01020474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101601493|NCT01020474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101601494|NCT01020474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102032449|NCT05761860|Oxytocics|oxytocics|mesh-ancestor
102032450|NCT05761860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102032451|NCT05761860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032452|NCT05761860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102032453|NCT05761860|Narcotics|narcotics|mesh-ancestor
102032454|NCT05761860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102032455|NCT05761860|Analgesics|analgesics|mesh-ancestor
102032456|NCT05761860|Sensory System Agents|sensory system agents|mesh-ancestor
102032457|NCT05761860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102032458|NCT03122145|Capsaicin|capsaicin|mesh-list
102032459|NCT03122145|Antipruritics|antipruritics|mesh-ancestor
101601495|NCT02872818|Metformin|metformin|mesh-list
101601496|NCT02872818|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101601506|NCT02872818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101601508|NCT02872818|Contraceptive Agents|contraceptive agents|mesh-ancestor
101601509|NCT02872818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101601510|NCT02872818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101601511|NCT02872818|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101601512|NCT02872818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101601513|NCT02872818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101601514|NCT02872818|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101601515|NCT02872818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101601516|NCT02872818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101601517|NCT00922779|Ribavirin|ribavirin|mesh-list
101601518|NCT00922779|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101601519|NCT00922779|Antimetabolites|antimetabolites|mesh-ancestor
101601520|NCT00922779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601521|NCT00922779|Antiviral Agents|antiviral agents|mesh-ancestor
101601522|NCT00922779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101601523|NCT04528680|Paclitaxel|paclitaxel|mesh-list
101601524|NCT04528680|Carboplatin|carboplatin|mesh-list
101601525|NCT04528680|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101601526|NCT04528680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101601527|NCT04528680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101601528|NCT04528680|Tubulin Modulators|tubulin modulators|mesh-ancestor
101601529|NCT04528680|Antimitotic Agents|antimitotic agents|mesh-ancestor
101601530|NCT04528680|Mitosis Modulators|mitosis modulators|mesh-ancestor
101601531|NCT04528680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601532|NCT04570410|Gemcitabine|gemcitabine|mesh-list
101601533|NCT04570410|Tislelizumab|tislelizumab|mesh-list
101601534|NCT04570410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101601535|NCT04570410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101601536|NCT04570410|Antimetabolites|antimetabolites|mesh-ancestor
101601537|NCT04570410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601538|NCT04570410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101601539|NCT04203771|Ibuprofen|ibuprofen|mesh-list
101601540|NCT04203771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101601541|NCT04203771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101601542|NCT04203771|Analgesics|analgesics|mesh-ancestor
101601543|NCT04203771|Sensory System Agents|sensory system agents|mesh-ancestor
101601544|NCT04203771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101601545|NCT04203771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601546|NCT04203771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101601547|NCT04203771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101601548|NCT04203771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101601549|NCT04203771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101601550|NCT04203771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601551|NCT04256733|Capsaicin|capsaicin|mesh-list
101601552|NCT04256733|Antipruritics|antipruritics|mesh-ancestor
101601553|NCT04256733|Dermatologic Agents|dermatologic agents|mesh-ancestor
101601554|NCT04256733|Sensory System Agents|sensory system agents|mesh-ancestor
101601555|NCT04256733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101601556|NCT04256733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601557|NCT01025232|Ranibizumab|ranibizumab|mesh-list
102032460|NCT03122145|Dermatologic Agents|dermatologic agents|mesh-ancestor
102032461|NCT03122145|Sensory System Agents|sensory system agents|mesh-ancestor
102032462|NCT03122145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102032463|NCT03122145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032464|NCT05081674|Pembrolizumab|pembrolizumab|mesh-list
102032465|NCT05081674|Nivolumab|nivolumab|mesh-list
102032466|NCT05081674|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102032467|NCT05081674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101601558|NCT01025232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101601559|NCT01025232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101601560|NCT01025232|Growth Substances|growth substances|mesh-ancestor
101601561|NCT01025232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601567|NCT05321199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601568|NCT05321199|Hemostatics|hemostatics|mesh-ancestor
101601569|NCT05321199|Coagulants|coagulants|mesh-ancestor
101601570|NCT04300452|Carbetocin|carbetocin|mesh-list
101601571|NCT04300452|Ergonovine|ergonovine|mesh-list
101601572|NCT04300452|Oxytocics|oxytocics|mesh-ancestor
101601573|NCT04300452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101601574|NCT04300452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601575|NCT01025154|Cytarabine|cytarabine|mesh-list
101601576|NCT01025154|Clofarabine|clofarabine|mesh-list
101601577|NCT01025154|Idarubicin|idarubicin|mesh-list
101601578|NCT01025154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101601579|NCT01025154|Antimetabolites|antimetabolites|mesh-ancestor
101601580|NCT01025154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601581|NCT01025154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101601582|NCT01025154|Antiviral Agents|antiviral agents|mesh-ancestor
101601583|NCT01025154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101601584|NCT01025154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101601585|NCT01025154|Immunologic Factors|immunologic factors|mesh-ancestor
101601586|NCT01025154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601587|NCT01025154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101601588|NCT01025154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101601589|NCT01025154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101601590|NCT01025154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101601591|NCT04252365|Pembrolizumab|pembrolizumab|mesh-list
101601592|NCT04252365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101601593|NCT04252365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101601594|NCT04252365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101601595|NCT04252365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601596|NCT04252443|Analgesics, Opioid|analgesics, opioid|mesh-list
101601597|NCT04252443|Analgesics|analgesics|mesh-list
101601598|NCT04252443|Narcotics|narcotics|mesh-ancestor
101601599|NCT04252443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101601600|NCT04252443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601601|NCT04252443|Sensory System Agents|sensory system agents|mesh-ancestor
101601602|NCT04252443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101601603|NCT00832819|Paclitaxel|paclitaxel|mesh-list
101601604|NCT00832819|Carboplatin|carboplatin|mesh-list
101601605|NCT00832819|Lenvatinib|lenvatinib|mesh-list
101601606|NCT00832819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101601607|NCT00832819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101601608|NCT00832819|Tubulin Modulators|tubulin modulators|mesh-ancestor
101601609|NCT00832819|Antimitotic Agents|antimitotic agents|mesh-ancestor
101601610|NCT00832819|Mitosis Modulators|mitosis modulators|mesh-ancestor
101601611|NCT00832819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601612|NCT00832819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101601613|NCT00832819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101601614|NCT04820361|Parasympatholytics|parasympatholytics|mesh-list
101601615|NCT04820361|Autonomic Agents|autonomic agents|mesh-ancestor
101601616|NCT04820361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101601617|NCT04820361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601618|NCT00853723|Teriparatide|teriparatide|mesh-list
101601619|NCT00853723|Hormones|hormones|mesh-list
101601620|NCT00853723|Parathyroid Hormone|parathyroid hormone|mesh-list
102032468|NCT05081674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102032469|NCT05081674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102032470|NCT05081674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032471|NCT05081674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102032472|NCT05081674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102032474|NCT05003076|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102032475|NCT05003076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601621|NCT00853723|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
101601622|NCT00853723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101601623|NCT00853723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601624|NCT00853723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101601625|NCT00853723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101601626|NCT00918255|Adalimumab|adalimumab|mesh-list
101601627|NCT00918255|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101601628|NCT00918255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101601629|NCT00918255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101601630|NCT01096589|Monensin|monensin|mesh-list
101601631|NCT01096589|Antifungal Agents|antifungal agents|mesh-ancestor
101601632|NCT01096589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101601640|NCT01096589|Ionophores|ionophores|mesh-ancestor
101601641|NCT01096589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101601642|NCT01096589|Sodium Ionophores|sodium ionophores|mesh-ancestor
101601643|NCT04252521|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
101601644|NCT04252521|Ketoprofen|ketoprofen|mesh-list
101601645|NCT04252521|Metoclopramide|metoclopramide|mesh-list
101601646|NCT04252521|Antiemetics|antiemetics|mesh-ancestor
101601647|NCT04252521|Autonomic Agents|autonomic agents|mesh-ancestor
101601648|NCT04252521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101601649|NCT04252521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601650|NCT04252521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101601651|NCT04252521|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101601652|NCT04252521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101601653|NCT04252521|Dopamine Agents|dopamine agents|mesh-ancestor
101601654|NCT04252521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101601655|NCT04252521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601656|NCT04252521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101601657|NCT04252521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101601658|NCT04252521|Analgesics|analgesics|mesh-ancestor
101601659|NCT04252521|Sensory System Agents|sensory system agents|mesh-ancestor
101601660|NCT04252521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101601661|NCT04252521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101601662|NCT04252521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101601663|NCT04252521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101601664|NCT00845065|Ribavirin|ribavirin|mesh-list
101601665|NCT00845065|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101601666|NCT00845065|Antimetabolites|antimetabolites|mesh-ancestor
101601667|NCT00845065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601668|NCT00845065|Antiviral Agents|antiviral agents|mesh-ancestor
101601669|NCT00845065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101601670|NCT04772001|Carboplatin|carboplatin|mesh-list
101601671|NCT04772001|Cisplatin|cisplatin|mesh-list
101601672|NCT04772001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101601673|NCT00702091|Ramipril|ramipril|mesh-list
101601674|NCT00702091|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101601675|NCT00702091|Protease Inhibitors|protease inhibitors|mesh-ancestor
101601676|NCT00702091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101601677|NCT00702091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601678|NCT00702091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101601679|NCT00832585|Alefacept|alefacept|mesh-list
101601680|NCT00832585|Dermatologic Agents|dermatologic agents|mesh-ancestor
101601681|NCT00832585|Immunologic Factors|immunologic factors|mesh-ancestor
101601682|NCT00832585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601683|NCT00918567|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102032476|NCT05003076|Sympathomimetics|sympathomimetics|mesh-ancestor
102032477|NCT05003076|Autonomic Agents|autonomic agents|mesh-ancestor
102032478|NCT05003076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102032479|NCT05003076|Dopamine Agents|dopamine agents|mesh-ancestor
102032480|NCT05003076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102032481|NCT05003076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032482|NCT05003076|Adrenergic Agents|adrenergic agents|mesh-ancestor
101752254|NCT00848302|Gasotransmitters|gasotransmitters|mesh-ancestor
101601684|NCT00918567|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101601685|NCT00918567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101601686|NCT00918567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101601687|NCT00918567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601688|NCT00918567|Adrenergic Agents|adrenergic agents|mesh-ancestor
101601689|NCT00918567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101601690|NCT00918567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601691|NCT05252325|Lidocaine|lidocaine|mesh-list
101601692|NCT05252325|Hyaluronic Acid|hyaluronic acid|mesh-list
101601693|NCT05252325|Anesthetics, Local|anesthetics, local|mesh-ancestor
101601694|NCT05252325|Anesthetics|anesthetics|mesh-ancestor
101601695|NCT05252325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101601696|NCT05252325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601697|NCT05252325|Sensory System Agents|sensory system agents|mesh-ancestor
101601698|NCT05252325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101601699|NCT05252325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101601700|NCT05252325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101601711|NCT01024920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101601712|NCT01024920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101601713|NCT01024920|Growth Substances|growth substances|mesh-ancestor
101601714|NCT01024920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601715|NCT01024920|Growth Inhibitors|growth inhibitors|mesh-ancestor
101601716|NCT01024920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101601717|NCT01024920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101601718|NCT01024920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601719|NCT00832117|Cisplatin|cisplatin|mesh-list
101601720|NCT00832117|Epothilones|epothilones|mesh-list
101601721|NCT00832117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101601722|NCT00832117|Tubulin Modulators|tubulin modulators|mesh-ancestor
101601723|NCT00832117|Antimitotic Agents|antimitotic agents|mesh-ancestor
101601724|NCT00832117|Mitosis Modulators|mitosis modulators|mesh-ancestor
101601725|NCT00832117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601726|NCT02872272|Amikacin|amikacin|mesh-list
101601727|NCT02872272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101601728|NCT02872272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101601729|NCT00831493|Vorinostat|vorinostat|mesh-list
101601730|NCT00831493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101601731|NCT00831493|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101601732|NCT00831493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101601733|NCT00831493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601734|NCT00705445|Zinc|zinc|mesh-list
101601735|NCT00705445|Trace Elements|trace elements|mesh-list
101601736|NCT00705445|Micronutrients|micronutrients|mesh-list
101601737|NCT00705445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601738|NCT02879981|Trimethoprim|trimethoprim|mesh-list
101601739|NCT02879981|Sulfamethoxazole|sulfamethoxazole|mesh-list
101601740|NCT02879981|Phenylpropanolamine|phenylpropanolamine|mesh-list
101601741|NCT02879981|Guaifenesin|guaifenesin|mesh-list
101601742|NCT02879981|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
101601743|NCT02879981|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101601744|NCT02879981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101601745|NCT02879981|Antimalarials|antimalarials|mesh-ancestor
101601746|NCT02879981|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101601747|NCT02879981|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101601748|NCT02879981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101601749|NCT02879981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101601750|NCT02879981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601751|NCT02879981|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102032483|NCT05003076|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102032484|NCT05003076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102032485|NCT05003076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102032486|NCT05003076|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102032488|NCT03144856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102032489|NCT03144856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102032490|NCT03144856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101334016|NCT02970643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101601752|NCT02879981|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101601753|NCT02879981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101601754|NCT02879981|Expectorants|expectorants|mesh-ancestor
101601755|NCT02879981|Respiratory System Agents|respiratory system agents|mesh-ancestor
101601756|NCT02879981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101601757|NCT02879981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101601758|NCT02879981|Adrenergic Agents|adrenergic agents|mesh-ancestor
101601759|NCT02879981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101601760|NCT02879981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601761|NCT02879981|Appetite Depressants|appetite depressants|mesh-ancestor
101601762|NCT02879981|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101601763|NCT02879981|Sympathomimetics|sympathomimetics|mesh-ancestor
101601764|NCT02879981|Autonomic Agents|autonomic agents|mesh-ancestor
101601765|NCT02879981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101601766|NCT02879981|Nasal Decongestants|nasal decongestants|mesh-ancestor
101601780|NCT04307693|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101601781|NCT04307693|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101601783|NCT04307693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101601784|NCT04307693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101601785|NCT04307693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101601786|NCT02878421|Nicotine|nicotine|mesh-list
101601787|NCT02878421|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101601788|NCT02878421|Autonomic Agents|autonomic agents|mesh-ancestor
101601789|NCT02878421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101601790|NCT02878421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601791|NCT02878421|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101601792|NCT02878421|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101601793|NCT02878421|Cholinergic Agents|cholinergic agents|mesh-ancestor
101601794|NCT02878421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101601795|NCT02878421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601796|NCT01019694|Albuterol|albuterol|mesh-list
101601797|NCT01019694|Ipratropium|ipratropium|mesh-list
101601798|NCT01019694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101601799|NCT01019694|Autonomic Agents|autonomic agents|mesh-ancestor
101601800|NCT01019694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101601801|NCT01019694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601802|NCT01019694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101601803|NCT01019694|Respiratory System Agents|respiratory system agents|mesh-ancestor
101601804|NCT01019694|Tocolytic Agents|tocolytic agents|mesh-ancestor
101601805|NCT01019694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101601806|NCT01019694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101601807|NCT01019694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101601808|NCT01019694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101601809|NCT01019694|Adrenergic Agents|adrenergic agents|mesh-ancestor
101601810|NCT01019694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101601811|NCT01019694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601812|NCT01019694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101601813|NCT01019694|Cholinergic Agents|cholinergic agents|mesh-ancestor
101601814|NCT00831415|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101601815|NCT00831415|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101601816|NCT00831415|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101601817|NCT00831415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101601818|NCT00831415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601819|NCT00831415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101601820|NCT00831415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601821|NCT00831415|Antidepressive Agents|antidepressive agents|mesh-ancestor
102032491|NCT03144856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032492|NCT03141970|Prednisone|prednisone|mesh-list
102032493|NCT03141970|Prednisolone|prednisolone|mesh-list
102032494|NCT03141970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102032495|NCT03141970|Glucocorticoids|glucocorticoids|mesh-ancestor
102032496|NCT03141970|Hormones|hormones|mesh-ancestor
102032497|NCT03141970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102032498|NCT03141970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032499|NCT03141970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102032500|NCT03141970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102032501|NCT04949022|Insulin|insulin|mesh-list
102032502|NCT04949022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102032503|NCT04949022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032504|NCT02327338|Ibuprofen|ibuprofen|mesh-list
102032505|NCT02327338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102032506|NCT02327338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102032507|NCT02327338|Analgesics|analgesics|mesh-ancestor
102032508|NCT02327338|Sensory System Agents|sensory system agents|mesh-ancestor
102032509|NCT02327338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102032510|NCT02327338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032511|NCT02327338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102032512|NCT02327338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102032513|NCT02327338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102032514|NCT02327338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101334023|NCT02970643|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101334024|NCT02970643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101334025|NCT02970643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101334026|NCT02970643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334027|NCT02970643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101334028|NCT02970643|Serotonin Agents|serotonin agents|mesh-ancestor
101334029|NCT02970643|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101601822|NCT00831415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101601823|NCT01095653|Metformin|metformin|mesh-list
101601824|NCT01095653|Dapagliflozin|dapagliflozin|mesh-list
101601825|NCT01095653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101601826|NCT01095653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601827|NCT01095653|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101601829|NCT00920907|Ipilimumab|ipilimumab|mesh-list
101601830|NCT00920907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101601831|NCT00920907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101601832|NCT00920907|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102032515|NCT02327338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032517|NCT02327416|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102032518|NCT02327416|Interferon-alpha|interferon-alpha|mesh-list
102032519|NCT02327416|Adefovir|adefovir|mesh-list
102032520|NCT02327416|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
102032521|NCT02327416|Molgramostim|molgramostim|mesh-list
101601833|NCT00920907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601834|NCT00700297|Colchicine|colchicine|mesh-list
101601835|NCT00700297|Gout Suppressants|gout suppressants|mesh-ancestor
101601836|NCT00700297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101601837|NCT00700297|Tubulin Modulators|tubulin modulators|mesh-ancestor
101601838|NCT00700297|Antimitotic Agents|antimitotic agents|mesh-ancestor
101601839|NCT00700297|Mitosis Modulators|mitosis modulators|mesh-ancestor
101601840|NCT00700297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601841|NCT00700297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101601842|NCT04307147|Capecitabine|capecitabine|mesh-list
101601843|NCT04307147|Vinorelbine|vinorelbine|mesh-list
101601844|NCT04307147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101601845|NCT04307147|Antimetabolites|antimetabolites|mesh-ancestor
101264831|NCT01769768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101601846|NCT04307147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601847|NCT04307147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101601848|NCT04307147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101601849|NCT04307147|Tubulin Modulators|tubulin modulators|mesh-ancestor
101601850|NCT04307147|Antimitotic Agents|antimitotic agents|mesh-ancestor
101601851|NCT04307147|Mitosis Modulators|mitosis modulators|mesh-ancestor
101601852|NCT00844831|Lubiprostone|lubiprostone|mesh-list
101601853|NCT00844831|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101601854|NCT00844831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101601855|NCT00844831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601856|NCT00920829|Naltrexone|naltrexone|mesh-list
101601857|NCT00920829|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101601858|NCT00920829|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101601859|NCT00920829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601860|NCT00920829|Sensory System Agents|sensory system agents|mesh-ancestor
101601861|NCT00920829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101601862|NCT05010876|Icatibant|icatibant|mesh-list
101601863|NCT05010876|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
101601864|NCT05010876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101601865|NCT05010876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101601866|NCT05010876|Analgesics|analgesics|mesh-ancestor
101601867|NCT05010876|Sensory System Agents|sensory system agents|mesh-ancestor
101601868|NCT05010876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101601869|NCT05010876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601870|NCT05010876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101601871|NCT05010876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101601872|NCT05010876|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
101601873|NCT05010876|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
101601874|NCT05010876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601875|NCT05010876|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101601876|NCT05010876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101601877|NCT05010876|Immunologic Factors|immunologic factors|mesh-ancestor
101601878|NCT04307069|Oxytocin|oxytocin|mesh-list
101601879|NCT04307069|Oxytocics|oxytocics|mesh-ancestor
101601880|NCT04307069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101601881|NCT04307069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601882|NCT04251741|Adalimumab|adalimumab|mesh-list
101601883|NCT04251741|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101601884|NCT04251741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101601885|NCT04251741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101601886|NCT02878265|Vitamins|vitamins|mesh-list
101601887|NCT02878265|Vitamin A|vitamin a|mesh-list
101601888|NCT02878265|Zinc|zinc|mesh-list
101601889|NCT02878265|Retinol palmitate|retinol palmitate|mesh-list
101601890|NCT02878265|Micronutrients|micronutrients|mesh-ancestor
101601891|NCT02878265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601892|NCT02878265|Trace Elements|trace elements|mesh-ancestor
101601893|NCT02878265|Antioxidants|antioxidants|mesh-ancestor
101601894|NCT02878265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032522|NCT02327416|Sargramostim|sargramostim|mesh-list
102032523|NCT02327416|Antiviral Agents|antiviral agents|mesh-ancestor
102032524|NCT02327416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102032525|NCT02327416|Immunologic Factors|immunologic factors|mesh-ancestor
102032526|NCT02327416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032527|NCT02327416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102032528|NCT02327416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101334054|NCT00017628|Hormones|hormones|mesh-ancestor
101601895|NCT02878265|Protective Agents|protective agents|mesh-ancestor
101601896|NCT02878265|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101601897|NCT02878265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101601898|NCT00831181|Leucovorin|leucovorin|mesh-list
101601899|NCT00831181|Fluorouracil|fluorouracil|mesh-list
101601900|NCT00831181|Oxaliplatin|oxaliplatin|mesh-list
101601910|NCT00831181|Vitamin B Complex|vitamin b complex|mesh-ancestor
101601911|NCT00831181|Vitamins|vitamins|mesh-ancestor
101601912|NCT00831181|Micronutrients|micronutrients|mesh-ancestor
101601913|NCT01023672|Modafinil|modafinil|mesh-list
101601914|NCT01023672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101601915|NCT01023672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601916|NCT01023672|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101601917|NCT01023672|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101601918|NCT01023672|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101601919|NCT01023672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601920|NCT00705835|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101601921|NCT00705835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101601922|NCT00705835|Immunologic Factors|immunologic factors|mesh-ancestor
101601923|NCT00705835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601924|NCT00705835|Antacids|antacids|mesh-ancestor
101601925|NCT00705835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601926|NCT00705835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101601927|NCT00702637|Modafinil|modafinil|mesh-list
101601928|NCT00702637|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101601929|NCT00702637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601930|NCT00702637|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101601931|NCT00702637|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101601932|NCT00702637|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101601933|NCT00702637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601934|NCT04786275|Fentanyl|fentanyl|mesh-list
101601935|NCT04786275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101601936|NCT04786275|Narcotics|narcotics|mesh-ancestor
101601937|NCT04786275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101601938|NCT04786275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601939|NCT04786275|Analgesics|analgesics|mesh-ancestor
101601940|NCT04786275|Sensory System Agents|sensory system agents|mesh-ancestor
101601941|NCT04786275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101601942|NCT04786275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101601943|NCT04786275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101601944|NCT04786275|Anesthetics, General|anesthetics, general|mesh-ancestor
101601945|NCT04786275|Anesthetics|anesthetics|mesh-ancestor
101601946|NCT00844753|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101601947|NCT00844753|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101601948|NCT00844753|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101601949|NCT00844753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101601950|NCT00844753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601951|NCT00844753|Adrenergic Agents|adrenergic agents|mesh-ancestor
101601952|NCT00844753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101601953|NCT00844753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601954|NCT05525611|Cabergoline|cabergoline|mesh-list
101601955|NCT05525611|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101601956|NCT05525611|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101601957|NCT05525611|Dopamine Agonists|dopamine agonists|mesh-ancestor
101601958|NCT05525611|Dopamine Agents|dopamine agents|mesh-ancestor
101601959|NCT05525611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101601960|NCT05525611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601961|NCT05525611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601962|NCT00917553|Doxycycline|doxycycline|mesh-list
102032529|NCT02327416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102032530|NCT02327416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032531|NCT02327416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102032532|NCT02926950|Metformin|metformin|mesh-list
101628300|NCT02590705|Sensory System Agents|sensory system agents|mesh-ancestor
101601963|NCT00917553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101601964|NCT00917553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101601965|NCT00917553|Antimalarials|antimalarials|mesh-ancestor
101601966|NCT00917553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101601978|NCT01018680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101601979|NCT01018680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601980|NCT01018680|Analgesics|analgesics|mesh-ancestor
101601981|NCT01018680|Sensory System Agents|sensory system agents|mesh-ancestor
101601982|NCT01018680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101601983|NCT01018680|Antidepressive Agents|antidepressive agents|mesh-ancestor
101601984|NCT01018680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101601985|NCT01018680|Dopamine Agents|dopamine agents|mesh-ancestor
101601986|NCT04255017|Ritonavir|ritonavir|mesh-list
101601987|NCT04255017|Lopinavir|lopinavir|mesh-list
101601988|NCT04255017|Oseltamivir|oseltamivir|mesh-list
101601989|NCT04255017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101601990|NCT04255017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101601991|NCT04255017|Protease Inhibitors|protease inhibitors|mesh-ancestor
101601992|NCT04255017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101601993|NCT04255017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601994|NCT04255017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101601995|NCT04255017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101601996|NCT04255017|Antiviral Agents|antiviral agents|mesh-ancestor
101601997|NCT04255017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101777018|NCT00537238|Pregabalin|pregabalin|mesh-list
101601998|NCT04255017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101601999|NCT04255017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101602000|NCT04592991|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
101602001|NCT04592991|Chelating Agents|chelating agents|mesh-ancestor
101602002|NCT04592991|Sequestering Agents|sequestering agents|mesh-ancestor
101602003|NCT04592991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602004|NCT01017120|Tazarotene|tazarotene|mesh-list
101602005|NCT01017120|Dermatologic Agents|dermatologic agents|mesh-ancestor
101602006|NCT01017120|Keratolytic Agents|keratolytic agents|mesh-ancestor
101602007|NCT02872038|Cefazolin|cefazolin|mesh-list
101602008|NCT02872038|Ceftazidime|ceftazidime|mesh-list
101602009|NCT02872038|Cefepime|cefepime|mesh-list
101602010|NCT02872038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101602011|NCT02872038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101602012|NCT00627900|Sirolimus|sirolimus|mesh-list
101602013|NCT00627900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101602014|NCT00627900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101602015|NCT00627900|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101602016|NCT00627900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101602017|NCT00627900|Antifungal Agents|antifungal agents|mesh-ancestor
101602018|NCT00627900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101602019|NCT00627900|Immunologic Factors|immunologic factors|mesh-ancestor
101602020|NCT00627900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602021|NCT02996110|Nivolumab|nivolumab|mesh-list
101602022|NCT02996110|Ipilimumab|ipilimumab|mesh-list
101602023|NCT02996110|Relatlimab|relatlimab|mesh-list
101602024|NCT02996110|Linrodostat|linrodostat|mesh-list
101602025|NCT02996110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101602026|NCT02996110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101602027|NCT02996110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101602028|NCT02996110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602029|NCT02996110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101602030|NCT01103063|Azithromycin|azithromycin|mesh-list
101602034|NCT01103063|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101602035|NCT01103063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101602036|NCT01103063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101602037|NCT01103063|Amebicides|amebicides|mesh-ancestor
101602038|NCT01103063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101602039|NCT01103063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101602040|NCT01103063|Antimalarials|antimalarials|mesh-ancestor
101602041|NCT01103063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101602042|NCT01103063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102032533|NCT02926950|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
102032534|NCT02926950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102032535|NCT02926950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334064|NCT00042562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101602043|NCT01103063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101602044|NCT01103063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602045|NCT01103063|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101602046|NCT02987998|Pembrolizumab|pembrolizumab|mesh-list
101602047|NCT02987998|Etoposide|etoposide|mesh-list
101602048|NCT02987998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101602049|NCT02987998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101602050|NCT02987998|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101602051|NCT02987998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259048|NCT01735383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101602052|NCT02987998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101602053|NCT02987998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101602054|NCT02987998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101602055|NCT02987998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101602056|NCT04213378|Paclitaxel|paclitaxel|mesh-list
101602057|NCT04213378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101602058|NCT04213378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101602059|NCT04213378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101602060|NCT04213378|Tubulin Modulators|tubulin modulators|mesh-ancestor
101602061|NCT04213378|Antimitotic Agents|antimitotic agents|mesh-ancestor
101602062|NCT04213378|Mitosis Modulators|mitosis modulators|mesh-ancestor
101602063|NCT04213378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602064|NCT04213924|Ibuprofen|ibuprofen|mesh-list
101602065|NCT04213924|Lidocaine|lidocaine|mesh-list
101602066|NCT04213924|Bupivacaine|bupivacaine|mesh-list
101602067|NCT04213924|Anesthetics, Local|anesthetics, local|mesh-ancestor
101602068|NCT04213924|Anesthetics|anesthetics|mesh-ancestor
101602069|NCT04213924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101602070|NCT04213924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602071|NCT04213924|Sensory System Agents|sensory system agents|mesh-ancestor
101602072|NCT04213924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101602073|NCT04213924|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101602074|NCT04213924|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101602075|NCT04213924|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101602076|NCT04213924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101602077|NCT04213924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602078|NCT04213924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101602079|NCT04213924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101602080|NCT04213924|Analgesics|analgesics|mesh-ancestor
101602081|NCT04213924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101602082|NCT04213924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101602083|NCT04213924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101602084|NCT04213924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101602085|NCT00616720|Interferons|interferons|mesh-list
101602086|NCT00616720|Aldesleukin|aldesleukin|mesh-list
101602087|NCT00616720|Interferon-gamma|interferon-gamma|mesh-list
101602088|NCT00616720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101602089|NCT00616720|Antiviral Agents|antiviral agents|mesh-ancestor
101602090|NCT00616720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101602091|NCT00616720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101602092|NCT00616720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101602093|NCT01091675|Etoricoxib|etoricoxib|mesh-list
101602094|NCT01091675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101602095|NCT01091675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101602096|NCT01091675|Analgesics|analgesics|mesh-ancestor
101602097|NCT01091675|Sensory System Agents|sensory system agents|mesh-ancestor
101602098|NCT01091675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101602099|NCT01091675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602100|NCT01091675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101602101|NCT01091675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101602102|NCT01091675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101602110|NCT02739412|Analgesics|analgesics|mesh-ancestor
101602111|NCT02739412|Sensory System Agents|sensory system agents|mesh-ancestor
101602112|NCT02739412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102032536|NCT02926950|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102032537|NCT02926950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032539|NCT01064414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101602113|NCT02739412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602114|NCT02739412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101602115|NCT02739412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101602116|NCT02739412|Antiviral Agents|antiviral agents|mesh-ancestor
101602117|NCT02739412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101602118|NCT04213612|Cyclophosphamide|cyclophosphamide|mesh-list
101602119|NCT04213612|Doxorubicin|doxorubicin|mesh-list
101602120|NCT04213612|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101602121|NCT04213612|Vincristine|vincristine|mesh-list
101602122|NCT04213612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101602123|NCT04213612|Immunologic Factors|immunologic factors|mesh-ancestor
101602124|NCT04213612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602125|NCT04213612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101602126|NCT04213612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101602127|NCT04213612|Alkylating Agents|alkylating agents|mesh-ancestor
101777032|NCT00537238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101602128|NCT04213612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602129|NCT04213612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101602130|NCT04213612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101602131|NCT04213612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101602132|NCT04213612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101602133|NCT04213612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101602135|NCT04213612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101602136|NCT04213612|Tubulin Modulators|tubulin modulators|mesh-ancestor
101602137|NCT04213612|Antimitotic Agents|antimitotic agents|mesh-ancestor
101602138|NCT04213612|Mitosis Modulators|mitosis modulators|mesh-ancestor
101602139|NCT01091519|Fesoterodine|fesoterodine|mesh-list
101602140|NCT01091519|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101602141|NCT01091519|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101602142|NCT01091519|Cholinergic Agents|cholinergic agents|mesh-ancestor
101602143|NCT01091519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101602144|NCT01091519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602145|NCT01091519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602146|NCT01091519|Urological Agents|urological agents|mesh-ancestor
101602147|NCT02878031|Amoxicillin|amoxicillin|mesh-list
101602148|NCT02878031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101602149|NCT02878031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101602150|NCT02879669|Cyclophosphamide|cyclophosphamide|mesh-list
101602151|NCT02879669|Carboplatin|carboplatin|mesh-list
101602152|NCT02879669|Pemetrexed|pemetrexed|mesh-list
101602153|NCT02879669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101602154|NCT02879669|Immunologic Factors|immunologic factors|mesh-ancestor
101602155|NCT02879669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602156|NCT02879669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101602157|NCT02879669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101602158|NCT02879669|Alkylating Agents|alkylating agents|mesh-ancestor
101602159|NCT02879669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602160|NCT02879669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101602161|NCT02879669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101602162|NCT02879669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101602163|NCT02879669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101602164|NCT02879669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101602165|NCT04875533|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101602166|NCT04875533|Immunologic Factors|immunologic factors|mesh-ancestor
101602167|NCT04875533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602168|NCT00918333|Everolimus|everolimus|mesh-list
101602169|NCT00918333|Panobinostat|panobinostat|mesh-list
101602170|NCT00918333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
101602171|NCT00918333|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101602182|NCT01090973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101602183|NCT01090973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602184|NCT02607904|Cannabidiol|cannabidiol|mesh-list
101602185|NCT02607904|Anticonvulsants|anticonvulsants|mesh-ancestor
101602186|NCT05295394|Lamivudine|lamivudine|mesh-list
101602187|NCT05295394|Dolutegravir|dolutegravir|mesh-list
102032540|NCT01064414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032541|NCT01064414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102032542|NCT01064414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032543|NCT03433703|Lenvatinib|lenvatinib|mesh-list
102032544|NCT03433703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334074|NCT00001487|Immunologic Factors|immunologic factors|mesh-ancestor
101602188|NCT05295394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101602189|NCT05295394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101602190|NCT05295394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101602191|NCT05295394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602192|NCT05295394|Antiviral Agents|antiviral agents|mesh-ancestor
101602193|NCT05295394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101602194|NCT05295394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101602195|NCT05295394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101602196|NCT05295394|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101602197|NCT05295394|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101602198|NCT02871648|Fludrocortisone|fludrocortisone|mesh-list
101602199|NCT02871648|Eplerenone|eplerenone|mesh-list
101602200|NCT02871648|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101602201|NCT02871648|Hormone Antagonists|hormone antagonists|mesh-ancestor
101602202|NCT02871648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101602203|NCT02871648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602204|NCT02871648|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101602205|NCT02871648|Diuretics|diuretics|mesh-ancestor
101602206|NCT02871648|Natriuretic Agents|natriuretic agents|mesh-ancestor
101602207|NCT02871648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101602208|NCT02871648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101602209|NCT00637845|Esomeprazole|esomeprazole|mesh-list
101602210|NCT00637845|Lansoprazole|lansoprazole|mesh-list
101602211|NCT00637845|Dexlansoprazole|dexlansoprazole|mesh-list
101602212|NCT00637845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101602213|NCT00637845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101602214|NCT00637845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101264864|NCT01769898|Budesonide|budesonide|mesh-list
101602215|NCT00637845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101602216|NCT00637845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602217|NCT04738695|Antibodies|antibodies|mesh-list
101602218|NCT04738695|Immunologic Factors|immunologic factors|mesh-ancestor
101602219|NCT04738695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602220|NCT02497300|Amiloride|amiloride|mesh-list
101602221|NCT02497300|Spironolactone|spironolactone|mesh-list
101602222|NCT02497300|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101602223|NCT02497300|Hormone Antagonists|hormone antagonists|mesh-ancestor
101602224|NCT02497300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101602225|NCT02497300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602226|NCT02497300|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101602227|NCT02497300|Diuretics|diuretics|mesh-ancestor
101602228|NCT02497300|Natriuretic Agents|natriuretic agents|mesh-ancestor
101602229|NCT02497300|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
101602230|NCT02497300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101602231|NCT02497300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101602232|NCT02497300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602233|NCT02497300|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101602234|NCT04254471|Carboplatin|carboplatin|mesh-list
101602245|NCT04254471|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101602246|NCT00631527|Sunitinib|sunitinib|mesh-list
101602247|NCT00631527|Leuprolide|leuprolide|mesh-list
101602248|NCT00631527|Goserelin|goserelin|mesh-list
101602249|NCT00631527|Bicalutamide|bicalutamide|mesh-list
101602250|NCT00631527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101602251|NCT00631527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101602252|NCT00631527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101602253|NCT00631527|Growth Substances|growth substances|mesh-ancestor
101602254|NCT00631527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602255|NCT00631527|Growth Inhibitors|growth inhibitors|mesh-ancestor
101602256|NCT00631527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101602257|NCT00631527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101602258|NCT00631527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032545|NCT03433703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102032547|NCT03433703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032548|NCT01374633|Sevoflurane|sevoflurane|mesh-list
102032549|NCT01374633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102032550|NCT01374633|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102032551|NCT01374633|Anesthetics, General|anesthetics, general|mesh-ancestor
101602259|NCT00631527|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101602260|NCT00631527|Fertility Agents|fertility agents|mesh-ancestor
101602261|NCT00631527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101602262|NCT00631527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101602263|NCT00631527|Androgen Antagonists|androgen antagonists|mesh-ancestor
101602264|NCT00631527|Hormone Antagonists|hormone antagonists|mesh-ancestor
101602265|NCT00631527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101602266|NCT00620620|Zaleplon|zaleplon|mesh-list
101602267|NCT00620620|Anticonvulsants|anticonvulsants|mesh-ancestor
101602268|NCT00620620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101602269|NCT00620620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101602270|NCT00620620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602271|NCT00620620|GABA Modulators|gaba modulators|mesh-ancestor
101602272|NCT00620620|GABA Agents|gaba agents|mesh-ancestor
101602273|NCT00620620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101602274|NCT00620620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602275|NCT00916383|Donepezil|donepezil|mesh-list
101602276|NCT00916383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101602277|NCT00916383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101602278|NCT00916383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602279|NCT00916383|Cholinergic Agents|cholinergic agents|mesh-ancestor
101602280|NCT00916383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101602281|NCT00916383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602282|NCT00916383|Nootropic Agents|nootropic agents|mesh-ancestor
101602283|NCT00617500|Hormones|hormones|mesh-list
101602284|NCT00617500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101602285|NCT00617500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602286|NCT04209478|Morphine|morphine|mesh-list
101602287|NCT04209478|Tramadol|tramadol|mesh-list
101602288|NCT04209478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101602289|NCT04209478|Narcotics|narcotics|mesh-ancestor
101602290|NCT04209478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101602291|NCT04209478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602292|NCT04209478|Analgesics|analgesics|mesh-ancestor
101602293|NCT04209478|Sensory System Agents|sensory system agents|mesh-ancestor
101602294|NCT04209478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101602295|NCT05252715|Vaccines|vaccines|mesh-list
101602296|NCT05252715|Immunologic Factors|immunologic factors|mesh-ancestor
101602297|NCT05252715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602298|NCT04209166|Norepinephrine|norepinephrine|mesh-list
101602299|NCT04209166|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101602307|NCT04209166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101602308|NCT04209166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602309|NCT04209166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101602310|NCT04209166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101602311|NCT04209166|Adrenergic Agents|adrenergic agents|mesh-ancestor
101602312|NCT04209166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101602313|NCT04209166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602314|NCT04209166|Sympathomimetics|sympathomimetics|mesh-ancestor
101602315|NCT04209166|Autonomic Agents|autonomic agents|mesh-ancestor
101602316|NCT04209166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101602317|NCT04209166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101602318|NCT04209166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101602319|NCT04209166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101602320|NCT04209166|Serotonin Agents|serotonin agents|mesh-ancestor
101602321|NCT04209166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101602322|NCT04766008|Metformin|metformin|mesh-list
101602323|NCT04766008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101602324|NCT04766008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602325|NCT00916149|Lamotrigine|lamotrigine|mesh-list
102032552|NCT01374633|Anesthetics|anesthetics|mesh-ancestor
102032553|NCT01374633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101752327|NCT02544880|Vasodilator Agents|vasodilator agents|mesh-ancestor
102032554|NCT01374633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032555|NCT01178814|Lenalidomide|lenalidomide|mesh-list
102032556|NCT01178814|Immunologic Factors|immunologic factors|mesh-ancestor
102032557|NCT01178814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032558|NCT01178814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102032559|NCT01178814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101334086|NCT00042718|Azithromycin|azithromycin|mesh-list
101334087|NCT00042718|Levofloxacin|levofloxacin|mesh-list
101602326|NCT00916149|Levetiracetam|levetiracetam|mesh-list
101602327|NCT00916149|Anticonvulsants|anticonvulsants|mesh-ancestor
101602328|NCT00916149|Nootropic Agents|nootropic agents|mesh-ancestor
101602329|NCT00916149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101602330|NCT00916149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101602331|NCT00916149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602332|NCT00916149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101602333|NCT00916149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602334|NCT00916149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101602335|NCT00916149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101602336|NCT00916149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101602337|NCT00916149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101602338|NCT00916149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101602339|NCT00617656|Cisplatin|cisplatin|mesh-list
101602340|NCT00617656|Gemcitabine|gemcitabine|mesh-list
101602341|NCT00617656|Docetaxel|docetaxel|mesh-list
101602342|NCT00617656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101602343|NCT00617656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101602344|NCT00617656|Antimetabolites|antimetabolites|mesh-ancestor
101602345|NCT00617656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602346|NCT00617656|Tubulin Modulators|tubulin modulators|mesh-ancestor
101602347|NCT00617656|Antimitotic Agents|antimitotic agents|mesh-ancestor
101602348|NCT00617656|Mitosis Modulators|mitosis modulators|mesh-ancestor
101602349|NCT00175162|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
101602350|NCT00175162|Vasodilator Agents|vasodilator agents|mesh-ancestor
101602351|NCT00175162|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101602352|NCT00175162|Protective Agents|protective agents|mesh-ancestor
101602353|NCT00175162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264865|NCT01769898|Theophylline|theophylline|mesh-list
101602417|NCT00621166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101602418|NCT00621166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101602419|NCT00621166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101602420|NCT04555798|Meropenem|meropenem|mesh-list
101602421|NCT04555798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101602422|NCT04555798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101602423|NCT00617968|Docetaxel|docetaxel|mesh-list
101602424|NCT00617968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101602431|NCT00621400|Melphalan|melphalan|mesh-list
101602432|NCT00621400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101602433|NCT00621400|Antiemetics|antiemetics|mesh-ancestor
101602434|NCT00621400|Autonomic Agents|autonomic agents|mesh-ancestor
101602435|NCT00621400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101602436|NCT00621400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602437|NCT00621400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101602438|NCT00621400|Glucocorticoids|glucocorticoids|mesh-ancestor
101602440|NCT00621400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101602441|NCT00621400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101602442|NCT00621400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101602443|NCT00621400|Immunologic Factors|immunologic factors|mesh-ancestor
101602444|NCT00621400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101602445|NCT00621400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101602446|NCT00621400|Growth Substances|growth substances|mesh-ancestor
101602447|NCT00621400|Growth Inhibitors|growth inhibitors|mesh-ancestor
102032560|NCT01178814|Growth Substances|growth substances|mesh-ancestor
102032561|NCT01178814|Growth Inhibitors|growth inhibitors|mesh-ancestor
102032562|NCT01178814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102032563|NCT05202288|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
102032564|NCT05202288|Antiviral Agents|antiviral agents|mesh-ancestor
102032565|NCT05202288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101602448|NCT00621400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101602449|NCT00621400|Alkylating Agents|alkylating agents|mesh-ancestor
101602450|NCT00621400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602451|NCT00621400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101602452|NCT00621400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101602453|NCT04208854|Vinorelbine|vinorelbine|mesh-list
101602454|NCT04208854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101602455|NCT04208854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101602456|NCT04208854|Tubulin Modulators|tubulin modulators|mesh-ancestor
101602457|NCT04208854|Antimitotic Agents|antimitotic agents|mesh-ancestor
101602458|NCT04208854|Mitosis Modulators|mitosis modulators|mesh-ancestor
101602459|NCT04208854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602460|NCT01090427|Ustekinumab|ustekinumab|mesh-list
101602461|NCT01090427|Dermatologic Agents|dermatologic agents|mesh-ancestor
101602462|NCT04208776|Propranolol|propranolol|mesh-list
101602463|NCT04208776|Midodrine|midodrine|mesh-list
101602464|NCT04208776|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101602465|NCT04208776|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101602466|NCT04208776|Adrenergic Agents|adrenergic agents|mesh-ancestor
101602467|NCT04208776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101602468|NCT04208776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602469|NCT04208776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602470|NCT04208776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101602471|NCT04208776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101602472|NCT04208776|Vasodilator Agents|vasodilator agents|mesh-ancestor
101602473|NCT04208776|Sympathomimetics|sympathomimetics|mesh-ancestor
101602474|NCT04208776|Autonomic Agents|autonomic agents|mesh-ancestor
101602475|NCT04208776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101602476|NCT04208776|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101602477|NCT04208776|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101602478|NCT04208776|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101602479|NCT04208776|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101602480|NCT02879435|Bupivacaine|bupivacaine|mesh-list
101602481|NCT02879435|Anesthetics, Local|anesthetics, local|mesh-ancestor
101602482|NCT02879435|Anesthetics|anesthetics|mesh-ancestor
101602483|NCT02879435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101602484|NCT02879435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602485|NCT02879435|Sensory System Agents|sensory system agents|mesh-ancestor
101602486|NCT02879435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101602487|NCT02879513|Paclitaxel|paclitaxel|mesh-list
101602488|NCT02879513|Cyclophosphamide|cyclophosphamide|mesh-list
101602489|NCT02879513|Epirubicin|epirubicin|mesh-list
101602490|NCT02879513|Fluorouracil|fluorouracil|mesh-list
101602491|NCT02879513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101602492|NCT02879513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101602493|NCT02879513|Tubulin Modulators|tubulin modulators|mesh-ancestor
101602494|NCT02879513|Antimitotic Agents|antimitotic agents|mesh-ancestor
101602495|NCT02879513|Mitosis Modulators|mitosis modulators|mesh-ancestor
101602499|NCT02879513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602500|NCT02879513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101602501|NCT02879513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101602502|NCT02879513|Alkylating Agents|alkylating agents|mesh-ancestor
101602503|NCT02879513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101602504|NCT02879513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101602505|NCT02879513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101602506|NCT02879513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101602507|NCT02879513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101602508|NCT02879513|Antimetabolites|antimetabolites|mesh-ancestor
101602509|NCT02879513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101602511|NCT00621478|Lorazepam|lorazepam|mesh-list
101602512|NCT00621478|Anticonvulsants|anticonvulsants|mesh-ancestor
101602513|NCT00621478|Antiemetics|antiemetics|mesh-ancestor
101602514|NCT00621478|Autonomic Agents|autonomic agents|mesh-ancestor
102032566|NCT05762484|Clindamycin|clindamycin|mesh-list
102032567|NCT05762484|Clindamycin palmitate|clindamycin palmitate|mesh-list
102032568|NCT05762484|Clindamycin phosphate|clindamycin phosphate|mesh-list
102032569|NCT05762484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102032570|NCT05762484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102032571|NCT05762484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102032572|NCT05762484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101334102|NCT00042796|Decitabine|decitabine|mesh-list
101602515|NCT00621478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101602516|NCT00621478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602517|NCT00621478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101602518|NCT00621478|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101602519|NCT00621478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101602520|NCT00621478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101602521|NCT00621478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101602522|NCT00621478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101602523|NCT00621478|GABA Modulators|gaba modulators|mesh-ancestor
101602524|NCT00621478|GABA Agents|gaba agents|mesh-ancestor
101602525|NCT00621478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101602526|NCT00621478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602527|NCT00621478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101602528|NCT00621478|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101602529|NCT00621478|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101602530|NCT00621478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101602531|NCT00621478|Anesthetics, General|anesthetics, general|mesh-ancestor
101602532|NCT00621478|Anesthetics|anesthetics|mesh-ancestor
101602533|NCT00621556|Secretin|secretin|mesh-list
101602534|NCT00621556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101602535|NCT00621556|Hormones|hormones|mesh-ancestor
101602536|NCT00621556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101602537|NCT00621556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602538|NCT00618046|Oxcarbazepine|oxcarbazepine|mesh-list
101602539|NCT00618046|Anticonvulsants|anticonvulsants|mesh-ancestor
101602540|NCT00618046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101602541|NCT00618046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101602542|NCT00618046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101602543|NCT00618046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602544|NCT00618046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101602545|NCT00618046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101602546|NCT04308551|Aspirin|aspirin|mesh-list
101602547|NCT04308551|Indobufen|indobufen|mesh-list
101602548|NCT04308551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101602549|NCT04308551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101602550|NCT04308551|Analgesics|analgesics|mesh-ancestor
101602551|NCT04308551|Sensory System Agents|sensory system agents|mesh-ancestor
101602552|NCT04308551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101602553|NCT04308551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602554|NCT04308551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101602555|NCT04308551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101602556|NCT04308551|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101602557|NCT04308551|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101602558|NCT04308551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602559|NCT04308551|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101602560|NCT04308551|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101602561|NCT04308551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101602562|NCT04308551|Antipyretics|antipyretics|mesh-ancestor
101602563|NCT04306913|Cardioplegic Solutions|cardioplegic solutions|mesh-list
101602564|NCT04306913|Esmolol|esmolol|mesh-list
101602565|NCT04306913|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101602566|NCT04306913|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101602567|NCT04306913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101602579|NCT02299414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602580|NCT02299414|Vasodilator Agents|vasodilator agents|mesh-ancestor
101602581|NCT02299414|Tocolytic Agents|tocolytic agents|mesh-ancestor
101602582|NCT02299414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101602583|NCT01016262|Mesalamine|mesalamine|mesh-list
101602584|NCT01016262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102032573|NCT05762484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032574|NCT03462641|Flumazenil|flumazenil|mesh-list
102032575|NCT03462641|Antidotes|antidotes|mesh-ancestor
102032576|NCT03462641|Protective Agents|protective agents|mesh-ancestor
102032577|NCT03462641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032578|NCT03462641|GABA Modulators|gaba modulators|mesh-ancestor
102032579|NCT03462641|GABA Agents|gaba agents|mesh-ancestor
102032580|NCT03462641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102032581|NCT03462641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032582|NCT05201352|Trifluridine|trifluridine|mesh-list
101602585|NCT01016262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101602587|NCT01016262|Sensory System Agents|sensory system agents|mesh-ancestor
101602588|NCT01016262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101602589|NCT01016262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602590|NCT01016262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101602591|NCT01016262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101602592|NCT00625937|Docetaxel|docetaxel|mesh-list
101602593|NCT00625937|Tegafur|tegafur|mesh-list
101602594|NCT00625937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101602595|NCT00625937|Tubulin Modulators|tubulin modulators|mesh-ancestor
101602596|NCT00625937|Antimitotic Agents|antimitotic agents|mesh-ancestor
101602597|NCT00625937|Mitosis Modulators|mitosis modulators|mesh-ancestor
101602598|NCT00625937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602599|NCT00625937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101602600|NCT00625937|Antimetabolites|antimetabolites|mesh-ancestor
101602601|NCT01001910|Carboplatin|carboplatin|mesh-list
101602602|NCT01001910|Pemetrexed|pemetrexed|mesh-list
101602603|NCT01001910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101602604|NCT01001910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101602605|NCT01001910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602606|NCT01001910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101602607|NCT01001910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101602608|NCT04308317|Tetrandrine|tetrandrine|mesh-list
101602609|NCT04308317|Antimalarials|antimalarials|mesh-ancestor
101602610|NCT04308317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101602611|NCT04308317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101602612|NCT04308317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101602613|NCT04308317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101602614|NCT04308317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101602615|NCT04308317|Antiviral Agents|antiviral agents|mesh-ancestor
101602616|NCT04308317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101602617|NCT04308317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101602618|NCT04308317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602619|NCT04308317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101602620|NCT04308317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602621|NCT04308317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101602622|NCT04308317|Immunologic Factors|immunologic factors|mesh-ancestor
101602623|NCT01009554|Listerine|listerine|mesh-list
101602624|NCT01009554|Fluorides|fluorides|mesh-list
101602625|NCT01009554|Sodium Fluoride|sodium fluoride|mesh-list
101602626|NCT01009554|Cariostatic Agents|cariostatic agents|mesh-ancestor
101602627|NCT01009554|Protective Agents|protective agents|mesh-ancestor
101602628|NCT01009554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602633|NCT04211896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101602634|NCT04211896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101602635|NCT04211896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602637|NCT04188184|Tranexamic Acid|tranexamic acid|mesh-list
101602638|NCT04188184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101602639|NCT04188184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101602640|NCT04188184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602641|NCT04188184|Hemostatics|hemostatics|mesh-ancestor
101602642|NCT04188184|Coagulants|coagulants|mesh-ancestor
101602643|NCT04188184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101602644|NCT04188184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101602645|NCT04188184|Adrenergic Agents|adrenergic agents|mesh-ancestor
102032583|NCT05201352|Antimetabolites|antimetabolites|mesh-ancestor
102032584|NCT05201352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032585|NCT05201352|Antiviral Agents|antiviral agents|mesh-ancestor
102032586|NCT05201352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102032587|NCT04128956|Aspirin|aspirin|mesh-list
102032588|NCT04128956|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102032589|NCT04128956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102032590|NCT04128956|Analgesics|analgesics|mesh-ancestor
102032591|NCT04128956|Sensory System Agents|sensory system agents|mesh-ancestor
102032592|NCT04128956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102032593|NCT04128956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032594|NCT04128956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102032595|NCT04128956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102032596|NCT04128956|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102032597|NCT04128956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102032598|NCT04128956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032599|NCT04128956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102032600|NCT04128956|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102032601|NCT04128956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102032602|NCT04128956|Antipyretics|antipyretics|mesh-ancestor
102032603|NCT05761704|Anticoagulants|anticoagulants|mesh-list
102032604|NCT03652142|Nivolumab|nivolumab|mesh-list
102032605|NCT03652142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102032606|NCT03652142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102032607|NCT03652142|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101334128|NCT00042874|Leucovorin|leucovorin|mesh-list
101602646|NCT04188184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101602647|NCT04188184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602648|NCT04188184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101602649|NCT04188184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101602650|NCT04188184|Autonomic Agents|autonomic agents|mesh-ancestor
101602651|NCT04188184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101602652|NCT04188184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101602653|NCT04188184|Respiratory System Agents|respiratory system agents|mesh-ancestor
101602654|NCT04188184|Mydriatics|mydriatics|mesh-ancestor
101602655|NCT04188184|Sympathomimetics|sympathomimetics|mesh-ancestor
101602656|NCT04188184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101602657|NCT01006590|Metformin|metformin|mesh-list
101602658|NCT01006590|Saxagliptin|saxagliptin|mesh-list
101602659|NCT01006590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101602660|NCT01006590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602661|NCT01006590|Incretins|incretins|mesh-ancestor
101602662|NCT01006590|Hormones|hormones|mesh-ancestor
101602663|NCT01006590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101602664|NCT01006590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101602665|NCT01006590|Protease Inhibitors|protease inhibitors|mesh-ancestor
101602666|NCT01006590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101602667|NCT01006590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602668|NCT04212832|Bupivacaine|bupivacaine|mesh-list
102032608|NCT03652142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032609|NCT05762328|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102032610|NCT05762328|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102032611|NCT05762328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102032612|NCT05762328|Antitubercular Agents|antitubercular agents|mesh-ancestor
102032614|NCT04629378|Meropenem|meropenem|mesh-list
102032615|NCT04629378|Clavulanic Acid|clavulanic acid|mesh-list
102032616|NCT04629378|Clavulanic Acids|clavulanic acids|mesh-list
102032617|NCT04629378|Pyrazinamide|pyrazinamide|mesh-list
101602669|NCT04212832|Anesthetics, Local|anesthetics, local|mesh-ancestor
101602670|NCT04212832|Anesthetics|anesthetics|mesh-ancestor
101602671|NCT04212832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101602672|NCT04212832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602673|NCT04212832|Sensory System Agents|sensory system agents|mesh-ancestor
101602674|NCT04212832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101602675|NCT00621790|Fenoldopam|fenoldopam|mesh-list
101602676|NCT00621790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101602677|NCT00621790|Vasodilator Agents|vasodilator agents|mesh-ancestor
101602678|NCT00621790|Dopamine Agonists|dopamine agonists|mesh-ancestor
101602679|NCT00621790|Dopamine Agents|dopamine agents|mesh-ancestor
101602680|NCT00621790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101602681|NCT00621790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602682|NCT00621790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602683|NCT00618124|Capecitabine|capecitabine|mesh-list
101602684|NCT00618124|Sunitinib|sunitinib|mesh-list
101602685|NCT00618124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101602686|NCT00618124|Antimetabolites|antimetabolites|mesh-ancestor
101602687|NCT00618124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602688|NCT00618124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101602689|NCT00618124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101602690|NCT00618124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101602691|NCT00618124|Growth Substances|growth substances|mesh-ancestor
101602692|NCT00618124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602693|NCT00618124|Growth Inhibitors|growth inhibitors|mesh-ancestor
101602694|NCT00618124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101602695|NCT00618124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101602696|NCT00621868|Ipragliflozin|ipragliflozin|mesh-list
101602697|NCT00621868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101602698|NCT00621868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602711|NCT01001832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101602712|NCT01001832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101602713|NCT01001832|Immunologic Factors|immunologic factors|mesh-ancestor
101602714|NCT01001832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602715|NCT01001832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101602716|NCT01001598|Danazol|danazol|mesh-list
101602717|NCT01001598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101602718|NCT01001598|Hormone Antagonists|hormone antagonists|mesh-ancestor
101602719|NCT01001598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101602720|NCT01001598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602721|NCT01006356|Hydromorphone|hydromorphone|mesh-list
101602722|NCT01006356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101602723|NCT01006356|Narcotics|narcotics|mesh-ancestor
101602724|NCT01006356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101602725|NCT01006356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602726|NCT01006356|Analgesics|analgesics|mesh-ancestor
101602727|NCT01006356|Sensory System Agents|sensory system agents|mesh-ancestor
101602728|NCT01006356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101602729|NCT01089725|Tanezumab|tanezumab|mesh-list
101602730|NCT01089725|Analgesics|analgesics|mesh-ancestor
101602731|NCT01089725|Sensory System Agents|sensory system agents|mesh-ancestor
101602732|NCT01089725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101602733|NCT01089725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602734|NCT01190930|Calcium, Dietary|calcium, dietary|mesh-list
101602735|NCT01190930|Leucovorin|leucovorin|mesh-list
101602736|NCT01190930|Folic Acid|folic acid|mesh-list
102032618|NCT04629378|Bedaquiline|bedaquiline|mesh-list
102032619|NCT04629378|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102032620|NCT04629378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102032621|NCT04629378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102032622|NCT04629378|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102032623|NCT04629378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101602737|NCT01190930|Cytarabine|cytarabine|mesh-list
101602738|NCT01190930|Dexamethasone|dexamethasone|mesh-list
101602739|NCT01190930|Dexamethasone acetate|dexamethasone acetate|mesh-list
101602740|NCT01190930|Cyclophosphamide|cyclophosphamide|mesh-list
101602741|NCT01190930|Doxorubicin|doxorubicin|mesh-list
101602742|NCT01190930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101602743|NCT01190930|Methotrexate|methotrexate|mesh-list
101602744|NCT01190930|Vincristine|vincristine|mesh-list
101602745|NCT01190930|Asparaginase|asparaginase|mesh-list
101602746|NCT01190930|Mercaptopurine|mercaptopurine|mesh-list
101602747|NCT01190930|Pegaspargase|pegaspargase|mesh-list
101602748|NCT01190930|Thioguanine|thioguanine|mesh-list
101602749|NCT01190930|BB 1101|bb 1101|mesh-list
101602750|NCT01190930|Calcium|calcium|mesh-list
101602751|NCT01190930|2-Aminopurine|2-aminopurine|mesh-list
101602752|NCT01190930|Levoleucovorin|levoleucovorin|mesh-list
101602753|NCT01190930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101602754|NCT01190930|Immunologic Factors|immunologic factors|mesh-ancestor
101602755|NCT01190930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602756|NCT01190930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101602757|NCT01190930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101602758|NCT01190930|Alkylating Agents|alkylating agents|mesh-ancestor
101602759|NCT01190930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602760|NCT01190930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101602761|NCT01190930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101602762|NCT01190930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101602763|NCT01190930|Antiemetics|antiemetics|mesh-ancestor
101602764|NCT01190930|Autonomic Agents|autonomic agents|mesh-ancestor
101602773|NCT01190930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101602774|NCT01190930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101602775|NCT01190930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101602776|NCT01190930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101602777|NCT01190930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101602778|NCT01190930|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101602779|NCT01190930|Abortifacient Agents|abortifacient agents|mesh-ancestor
101602780|NCT01190930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101602781|NCT01190930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101602782|NCT01190930|Antimetabolites|antimetabolites|mesh-ancestor
101602783|NCT01190930|Dermatologic Agents|dermatologic agents|mesh-ancestor
101602784|NCT01190930|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101602785|NCT01190930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101602786|NCT01190930|Antiviral Agents|antiviral agents|mesh-ancestor
101602787|NCT01190930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101602789|NCT01190930|Protective Agents|protective agents|mesh-ancestor
101602790|NCT01190930|Vitamin B Complex|vitamin b complex|mesh-ancestor
101602791|NCT01190930|Vitamins|vitamins|mesh-ancestor
101602792|NCT01190930|Micronutrients|micronutrients|mesh-ancestor
101602793|NCT01190930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101602794|NCT01190930|Tubulin Modulators|tubulin modulators|mesh-ancestor
101602795|NCT01190930|Antimitotic Agents|antimitotic agents|mesh-ancestor
101602796|NCT01190930|Mitosis Modulators|mitosis modulators|mesh-ancestor
101602797|NCT01190930|Hematinics|hematinics|mesh-ancestor
101602798|NCT00619216|Mycophenolic Acid|mycophenolic acid|mesh-list
101777097|NCT05355610|Glucocorticoids|glucocorticoids|mesh-ancestor
101602799|NCT00619216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101602800|NCT00619216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101602801|NCT00619216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101602802|NCT00619216|Antitubercular Agents|antitubercular agents|mesh-ancestor
101602803|NCT00619216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101602804|NCT00619216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101602805|NCT00619216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101602806|NCT00619216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602807|NCT00619372|Muromonab-CD3|muromonab-cd3|mesh-list
101602808|NCT00619372|Immunologic Factors|immunologic factors|mesh-ancestor
101602809|NCT00619372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602810|NCT00619372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101602811|NCT00618202|Balsalazide|balsalazide|mesh-list
102032624|NCT04629378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032625|NCT04629378|Antitubercular Agents|antitubercular agents|mesh-ancestor
101752405|NCT00712764|Adenosine|adenosine|mesh-list
102032627|NCT03651674|Clozapine|clozapine|mesh-list
102032628|NCT03651674|Antiemetics|antiemetics|mesh-ancestor
102032630|NCT03651674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102032631|NCT03651674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032632|NCT03651674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102032633|NCT03651674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101602812|NCT00618202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101602813|NCT00618202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101602814|NCT00618202|Analgesics|analgesics|mesh-ancestor
101602815|NCT00618202|Sensory System Agents|sensory system agents|mesh-ancestor
101602816|NCT00618202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101602817|NCT00618202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602818|NCT00618202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101602819|NCT00618202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101602820|NCT00618202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101602821|NCT00626015|Temozolomide|temozolomide|mesh-list
101602822|NCT00626015|Daclizumab|daclizumab|mesh-list
101602823|NCT00626015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101602824|NCT00626015|Alkylating Agents|alkylating agents|mesh-ancestor
101602825|NCT00626015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602826|NCT00626015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101602827|NCT00626015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101602828|NCT00626015|Immunologic Factors|immunologic factors|mesh-ancestor
101602829|NCT00626015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602830|NCT00618280|Nicotine|nicotine|mesh-list
101602852|NCT00622258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602853|NCT00622258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101602854|NCT00622258|Immunologic Factors|immunologic factors|mesh-ancestor
101602855|NCT00622258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602856|NCT00622258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101602858|NCT01812616|Analgesics|analgesics|mesh-ancestor
101602859|NCT01812616|Sensory System Agents|sensory system agents|mesh-ancestor
101602860|NCT01812616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101602861|NCT01812616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602862|NCT00618358|Thrombin|thrombin|mesh-list
101602863|NCT00618358|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
101602864|NCT00618358|Hemostatics|hemostatics|mesh-ancestor
101602865|NCT00618358|Coagulants|coagulants|mesh-ancestor
101602866|NCT01178762|Azithromycin|azithromycin|mesh-list
101602867|NCT01178762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101602868|NCT01178762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101602869|NCT03563560|Cytarabine|cytarabine|mesh-list
101602870|NCT03563560|Mitoxantrone|mitoxantrone|mesh-list
101602871|NCT03563560|Alvocidib|alvocidib|mesh-list
101602872|NCT03563560|Daunorubicin|daunorubicin|mesh-list
101602873|NCT03563560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101602874|NCT03563560|Antimetabolites|antimetabolites|mesh-ancestor
101602875|NCT03563560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602876|NCT03563560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101602877|NCT03563560|Antiviral Agents|antiviral agents|mesh-ancestor
101602878|NCT03563560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101602879|NCT03563560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101602880|NCT03563560|Immunologic Factors|immunologic factors|mesh-ancestor
101602881|NCT03563560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602882|NCT03563560|Analgesics|analgesics|mesh-ancestor
101602883|NCT03563560|Sensory System Agents|sensory system agents|mesh-ancestor
101602884|NCT03563560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101602885|NCT03563560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101602894|NCT01178138|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101602895|NCT01178138|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101602896|NCT01178138|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101602897|NCT01178138|Adrenergic Agents|adrenergic agents|mesh-ancestor
102032634|NCT03651674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102032635|NCT03651674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102032636|NCT03651674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102032637|NCT03651674|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102032638|NCT03651674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102032639|NCT03651674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102032640|NCT03651674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602898|NCT01178138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101602899|NCT01178138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602900|NCT01178138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602901|NCT01190228|Vaccines|vaccines|mesh-list
101602902|NCT01190228|Immunologic Factors|immunologic factors|mesh-ancestor
101602903|NCT01190228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602904|NCT01009086|Ustekinumab|ustekinumab|mesh-list
101602905|NCT01009086|Dermatologic Agents|dermatologic agents|mesh-ancestor
101602906|NCT01190150|Tranexamic Acid|tranexamic acid|mesh-list
101602907|NCT01190150|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101602908|NCT01190150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101602909|NCT01190150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602910|NCT01190150|Hemostatics|hemostatics|mesh-ancestor
101602911|NCT01190150|Coagulants|coagulants|mesh-ancestor
101602912|NCT04315688|Insulin|insulin|mesh-list
101602913|NCT04315688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101602914|NCT04315688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602915|NCT05210062|Succinylcholine|succinylcholine|mesh-list
101602916|NCT05210062|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
101602917|NCT05210062|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101602918|NCT05210062|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101602919|NCT05210062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101602920|NCT05210062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602921|NCT01001520|Tolcapone|tolcapone|mesh-list
101602922|NCT01001520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101602923|NCT01001520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101602924|NCT01001520|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101602925|NCT01001520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101602926|NCT01001520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602927|NCT00619840|Methylphenidate|methylphenidate|mesh-list
101602928|NCT00619840|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101602929|NCT00619840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602930|NCT00619840|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101602931|NCT00619840|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101602932|NCT00619840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101602933|NCT00619840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602934|NCT00619840|Dopamine Agents|dopamine agents|mesh-ancestor
101602935|NCT00619840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101602936|NCT01189604|Propofol|propofol|mesh-list
101602937|NCT01189604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101602938|NCT01189604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101602939|NCT01189604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602940|NCT01189604|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101602941|NCT01189604|Anesthetics, General|anesthetics, general|mesh-ancestor
101602942|NCT01189604|Anesthetics|anesthetics|mesh-ancestor
101602943|NCT02697058|Calcium, Dietary|calcium, dietary|mesh-list
101602944|NCT02697058|Leucovorin|leucovorin|mesh-list
101602945|NCT02697058|Fluorouracil|fluorouracil|mesh-list
101602946|NCT02697058|Calcium|calcium|mesh-list
101602947|NCT02697058|Levoleucovorin|levoleucovorin|mesh-list
101602948|NCT02697058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101602949|NCT02697058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602950|NCT02697058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101602951|NCT02697058|Antimetabolites|antimetabolites|mesh-ancestor
101602952|NCT02697058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032641|NCT03651674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102032642|NCT03651674|Serotonin Agents|serotonin agents|mesh-ancestor
102032643|NCT03651674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102032644|NCT03651674|GABA Antagonists|gaba antagonists|mesh-ancestor
102032645|NCT03651674|GABA Agents|gaba agents|mesh-ancestor
102032646|NCT01061840|Molgramostim|molgramostim|mesh-list
102032647|NCT01061840|Vaccines|vaccines|mesh-list
101602967|NCT00622414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602968|NCT00622414|Growth Inhibitors|growth inhibitors|mesh-ancestor
101602969|NCT00622414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101602970|NCT01008696|Rabeprazole|rabeprazole|mesh-list
101602971|NCT01008696|Lansoprazole|lansoprazole|mesh-list
101602972|NCT01008696|Dexlansoprazole|dexlansoprazole|mesh-list
101602973|NCT01008696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101602974|NCT01008696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101602975|NCT01008696|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101602976|NCT01008696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101602977|NCT01008696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602978|NCT01955980|Budesonide|budesonide|mesh-list
101602979|NCT01955980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101602980|NCT01955980|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101602981|NCT01955980|Autonomic Agents|autonomic agents|mesh-ancestor
101602982|NCT01955980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101602983|NCT01955980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602984|NCT01955980|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101602985|NCT01955980|Respiratory System Agents|respiratory system agents|mesh-ancestor
101602986|NCT01955980|Glucocorticoids|glucocorticoids|mesh-ancestor
101602987|NCT01955980|Hormones|hormones|mesh-ancestor
101602988|NCT01955980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101602989|NCT02870478|Atropine|atropine|mesh-list
101602990|NCT02870478|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101602991|NCT02870478|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101602992|NCT02870478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101602993|NCT02870478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101602994|NCT02870478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101602995|NCT02870478|Autonomic Agents|autonomic agents|mesh-ancestor
101602996|NCT02870478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101602997|NCT02870478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602998|NCT02870478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101602999|NCT02870478|Respiratory System Agents|respiratory system agents|mesh-ancestor
101603000|NCT02870478|Mydriatics|mydriatics|mesh-ancestor
101603001|NCT02870478|Parasympatholytics|parasympatholytics|mesh-ancestor
101603002|NCT02870478|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101603003|NCT02870478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101603004|NCT02870478|Cholinergic Agents|cholinergic agents|mesh-ancestor
101603005|NCT02870478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101603006|NCT02870478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603007|NCT04296162|Capecitabine|capecitabine|mesh-list
101603008|NCT04296162|Trastuzumab|trastuzumab|mesh-list
101603009|NCT04296162|Vinorelbine|vinorelbine|mesh-list
101603010|NCT04296162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101603011|NCT04296162|Antimetabolites|antimetabolites|mesh-ancestor
101603012|NCT04296162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603013|NCT04296162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101603020|NCT00619996|Sorafenib|sorafenib|mesh-list
101603021|NCT00619996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101603022|NCT00619996|Tubulin Modulators|tubulin modulators|mesh-ancestor
101603023|NCT00619996|Antimitotic Agents|antimitotic agents|mesh-ancestor
101603024|NCT00619996|Mitosis Modulators|mitosis modulators|mesh-ancestor
101603025|NCT00619996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603026|NCT00619996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101603027|NCT00619996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775277|NCT00935961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603028|NCT02870790|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101603029|NCT02870790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101603030|NCT02870790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101603031|NCT02870790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101603032|NCT02870790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032648|NCT01061840|Sargramostim|sargramostim|mesh-list
102032649|NCT01061840|Immunologic Factors|immunologic factors|mesh-ancestor
102032650|NCT01061840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032651|NCT01061840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102032652|NCT02926638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102032653|NCT02926638|Rilotumumab|rilotumumab|mesh-list
102032654|NCT02926638|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102032655|NCT02926638|Antibodies|antibodies|mesh-list
102032656|NCT02926638|Immunoglobulins|immunoglobulins|mesh-list
102032657|NCT02926638|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102032658|NCT02926638|Immunologic Factors|immunologic factors|mesh-ancestor
102032659|NCT02926638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032660|NCT02926638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102032661|NCT02926638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102032662|NCT02926638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102032663|NCT02926638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032664|NCT03650582|Glucagon|glucagon|mesh-list
102032665|NCT03650582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102032666|NCT03650582|Hormones|hormones|mesh-ancestor
102032667|NCT03650582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102032668|NCT03650582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032669|NCT02903030|Silicon|silicon|mesh-list
102032670|NCT02903030|Trace Elements|trace elements|mesh-ancestor
102032671|NCT02903030|Micronutrients|micronutrients|mesh-ancestor
102032672|NCT02903030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032673|NCT02969408|Albuterol|albuterol|mesh-list
101260017|NCT01742390|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101603033|NCT02870790|Antiviral Agents|antiviral agents|mesh-ancestor
101603034|NCT02870790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101603035|NCT02870790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101603036|NCT02870790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101603037|NCT00622570|Pentobarbital|pentobarbital|mesh-list
101603038|NCT00622570|Thiopental|thiopental|mesh-list
101603039|NCT00622570|Anticonvulsants|anticonvulsants|mesh-ancestor
101603040|NCT00622570|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101603041|NCT00622570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101603042|NCT00622570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603043|NCT00622570|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101603044|NCT00622570|Anesthetics, General|anesthetics, general|mesh-ancestor
101603045|NCT00622570|Anesthetics|anesthetics|mesh-ancestor
101603046|NCT00622570|GABA Modulators|gaba modulators|mesh-ancestor
101603047|NCT00622570|GABA Agents|gaba agents|mesh-ancestor
101603048|NCT00622570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101603049|NCT00622570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603050|NCT00622570|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101603051|NCT00890266|Riboflavin|riboflavin|mesh-list
101603052|NCT00890266|Vitamin B Complex|vitamin b complex|mesh-ancestor
101603053|NCT00890266|Vitamins|vitamins|mesh-ancestor
101603054|NCT00890266|Micronutrients|micronutrients|mesh-ancestor
101603055|NCT00890266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603056|NCT00890266|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101603057|NCT00890266|Dermatologic Agents|dermatologic agents|mesh-ancestor
102032674|NCT02969408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102032675|NCT02969408|Autonomic Agents|autonomic agents|mesh-ancestor
102032676|NCT02969408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102032677|NCT02969408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032678|NCT02969408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102032679|NCT02969408|Respiratory System Agents|respiratory system agents|mesh-ancestor
102032680|NCT02969408|Tocolytic Agents|tocolytic agents|mesh-ancestor
102032681|NCT02969408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102032682|NCT02969408|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102032683|NCT02969408|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102032684|NCT02969408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102032685|NCT02969408|Adrenergic Agents|adrenergic agents|mesh-ancestor
102032686|NCT02969408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102032687|NCT02969408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032688|NCT05180214|Ketorolac|ketorolac|mesh-list
102032689|NCT05180214|Bupivacaine|bupivacaine|mesh-list
102032690|NCT05180214|Anesthetics, Local|anesthetics, local|mesh-ancestor
102032691|NCT05180214|Anesthetics|anesthetics|mesh-ancestor
102032692|NCT05180214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101334212|NCT00043264|Antitubercular Agents|antitubercular agents|mesh-ancestor
101603058|NCT01176968|Eplerenone|eplerenone|mesh-list
101603059|NCT01176968|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101603060|NCT01176968|Hormone Antagonists|hormone antagonists|mesh-ancestor
101603061|NCT01176968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101603062|NCT01176968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603063|NCT01176968|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101603064|NCT01176968|Diuretics|diuretics|mesh-ancestor
101603065|NCT01176968|Natriuretic Agents|natriuretic agents|mesh-ancestor
101603066|NCT01176968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101603067|NCT02697370|Factor VIII|factor viii|mesh-list
101603068|NCT02697370|Coagulants|coagulants|mesh-ancestor
101603069|NCT02691442|Epinephrine|epinephrine|mesh-list
101603070|NCT02691442|Ropivacaine|ropivacaine|mesh-list
101603071|NCT02691442|Levobupivacaine|levobupivacaine|mesh-list
101603072|NCT02691442|Anesthetics, Local|anesthetics, local|mesh-ancestor
101603073|NCT02691442|Anesthetics|anesthetics|mesh-ancestor
101603074|NCT02691442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101603075|NCT02691442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603076|NCT02691442|Sensory System Agents|sensory system agents|mesh-ancestor
101603077|NCT02691442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101603078|NCT02691442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101603079|NCT02691442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101603080|NCT02691442|Adrenergic Agents|adrenergic agents|mesh-ancestor
101603090|NCT02691442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101603091|NCT00622648|Enoxaparin|enoxaparin|mesh-list
101603092|NCT00622648|Anticoagulants|anticoagulants|mesh-ancestor
101603093|NCT00622648|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101603094|NCT00622648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101603095|NCT00622648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603096|NCT02687854|Vitamin K|vitamin k|mesh-list
101603097|NCT02687854|Apixaban|apixaban|mesh-list
101603098|NCT02687854|Vitamins|vitamins|mesh-ancestor
101603099|NCT02687854|Micronutrients|micronutrients|mesh-ancestor
101603100|NCT02687854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603101|NCT02687854|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101603102|NCT02687854|Antithrombins|antithrombins|mesh-ancestor
102032693|NCT05180214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032694|NCT05180214|Sensory System Agents|sensory system agents|mesh-ancestor
102032695|NCT05180214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102032696|NCT05180214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102032697|NCT05180214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102032698|NCT05180214|Analgesics|analgesics|mesh-ancestor
102032699|NCT05180214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102032700|NCT05180214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102032701|NCT05180214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102032702|NCT05180214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101752474|NCT00857038|Doxycycline|doxycycline|mesh-list
101334231|NCT02970604|Aspirin|aspirin|mesh-list
101603103|NCT02687854|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101603104|NCT02687854|Protease Inhibitors|protease inhibitors|mesh-ancestor
101603105|NCT02687854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101603106|NCT02687854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603107|NCT02687854|Anticoagulants|anticoagulants|mesh-ancestor
101603108|NCT02687854|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101603109|NCT02687854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101603110|NCT02687854|Hemostatics|hemostatics|mesh-ancestor
101603111|NCT02687854|Coagulants|coagulants|mesh-ancestor
101603112|NCT01005966|Listerine|listerine|mesh-list
101603113|NCT01005966|Fluorides|fluorides|mesh-list
101603114|NCT01005966|Sodium Fluoride|sodium fluoride|mesh-list
101603115|NCT01005966|Fluorophosphate|fluorophosphate|mesh-list
101603116|NCT01005966|Cariostatic Agents|cariostatic agents|mesh-ancestor
101603117|NCT01005966|Protective Agents|protective agents|mesh-ancestor
101603118|NCT01005966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603119|NCT01005966|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101603120|NCT01005966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101603121|NCT00628680|Heparin|heparin|mesh-list
101603122|NCT00628680|Anticoagulants|anticoagulants|mesh-ancestor
101603123|NCT00628680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101603124|NCT00628680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101603125|NCT00628680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603126|NCT00603304|Saw palmetto extract|saw palmetto extract|mesh-list
101603127|NCT00603304|Urological Agents|urological agents|mesh-ancestor
101603128|NCT01176032|Losartan|losartan|mesh-list
101603129|NCT01176032|Amlodipine|amlodipine|mesh-list
101603130|NCT01176032|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101603131|NCT01176032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101603132|NCT01176032|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101603133|NCT01176032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101603134|NCT01176032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603135|NCT01176032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101603136|NCT01176032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603137|NCT01176032|Vasodilator Agents|vasodilator agents|mesh-ancestor
101603138|NCT01176032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101603139|NCT01176032|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101603140|NCT01176032|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101603141|NCT01176032|Diuretics|diuretics|mesh-ancestor
101603142|NCT01176032|Natriuretic Agents|natriuretic agents|mesh-ancestor
101603143|NCT01176032|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101603144|NCT01008618|Fentanyl|fentanyl|mesh-list
101603145|NCT01008618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101603146|NCT01008618|Narcotics|narcotics|mesh-ancestor
101603147|NCT01008618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101603148|NCT01008618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603154|NCT01008618|Anesthetics, General|anesthetics, general|mesh-ancestor
101603155|NCT01008618|Anesthetics|anesthetics|mesh-ancestor
101603157|NCT01001208|Methotrexate|methotrexate|mesh-list
101603158|NCT01001208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101603159|NCT01001208|Abortifacient Agents|abortifacient agents|mesh-ancestor
101603160|NCT01001208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102032703|NCT05180214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032704|NCT01060124|Fentanyl|fentanyl|mesh-list
102032705|NCT01060124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102032706|NCT01060124|Narcotics|narcotics|mesh-ancestor
102032707|NCT01060124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102032708|NCT01060124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032709|NCT01060124|Analgesics|analgesics|mesh-ancestor
101603161|NCT01001208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603162|NCT01001208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101603163|NCT01001208|Antimetabolites|antimetabolites|mesh-ancestor
101603164|NCT01001208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603165|NCT01001208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101603166|NCT01001208|Dermatologic Agents|dermatologic agents|mesh-ancestor
101603167|NCT01001208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101603168|NCT01001208|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101603169|NCT01001208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101603170|NCT01001208|Immunologic Factors|immunologic factors|mesh-ancestor
101603171|NCT01001208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101603172|NCT01001208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101603173|NCT01001208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101603174|NCT01001208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101603175|NCT01001208|Analgesics|analgesics|mesh-ancestor
101603176|NCT01001208|Sensory System Agents|sensory system agents|mesh-ancestor
101603177|NCT01001208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101603178|NCT01001208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101603179|NCT01001208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101603180|NCT01000974|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101603181|NCT01000974|Immunologic Factors|immunologic factors|mesh-ancestor
101603182|NCT01000974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603183|NCT01193842|Prednisone|prednisone|mesh-list
101603184|NCT01193842|Cortisone|cortisone|mesh-list
101603185|NCT01193842|Cyclophosphamide|cyclophosphamide|mesh-list
101603186|NCT01193842|Rituximab|rituximab|mesh-list
101603187|NCT01193842|Doxorubicin|doxorubicin|mesh-list
101603188|NCT01193842|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101603189|NCT01193842|Etoposide|etoposide|mesh-list
101603190|NCT01193842|Vincristine|vincristine|mesh-list
101603191|NCT01193842|Etoposide phosphate|etoposide phosphate|mesh-list
101603192|NCT01193842|Vorinostat|vorinostat|mesh-list
101603193|NCT01193842|Podophyllotoxin|podophyllotoxin|mesh-list
101603194|NCT01193842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101603195|NCT01193842|Antibodies|antibodies|mesh-list
101603196|NCT01193842|Immunoglobulins|immunoglobulins|mesh-list
101603197|NCT01193842|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101603198|NCT01193842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101603199|NCT01193842|Immunologic Factors|immunologic factors|mesh-ancestor
101603200|NCT01193842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603201|NCT01193842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101603202|NCT01193842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101603203|NCT01193842|Alkylating Agents|alkylating agents|mesh-ancestor
101603204|NCT01193842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603205|NCT01193842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101603206|NCT01193842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101603207|NCT01193842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101603208|NCT01193842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101603209|NCT01193842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101603210|NCT01193842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101603211|NCT01193842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101603212|NCT01193842|Glucocorticoids|glucocorticoids|mesh-ancestor
101603213|NCT01193842|Hormones|hormones|mesh-ancestor
101603214|NCT01193842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101603215|NCT01193842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101603216|NCT01193842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101603217|NCT01193842|Tubulin Modulators|tubulin modulators|mesh-ancestor
101603218|NCT01193842|Antimitotic Agents|antimitotic agents|mesh-ancestor
101603219|NCT01193842|Mitosis Modulators|mitosis modulators|mesh-ancestor
101603224|NCT01004406|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
102032710|NCT01060124|Sensory System Agents|sensory system agents|mesh-ancestor
102032711|NCT01060124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102032712|NCT01060124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102032713|NCT01060124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102032714|NCT01060124|Anesthetics, General|anesthetics, general|mesh-ancestor
102032715|NCT01060124|Anesthetics|anesthetics|mesh-ancestor
102032716|NCT03461003|Losartan|losartan|mesh-list
102032717|NCT03461003|Amlodipine|amlodipine|mesh-list
102032718|NCT03461003|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102032719|NCT03461003|Lisinopril|lisinopril|mesh-list
102032720|NCT03461003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102032721|NCT03461003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102032722|NCT03461003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101334248|NCT00043342|Interferon-gamma|interferon-gamma|mesh-list
101603225|NCT01004406|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101603226|NCT01004406|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101603227|NCT01004406|Antimetabolites|antimetabolites|mesh-ancestor
101603228|NCT01004406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603229|NCT01004406|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101603230|NCT01004406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101603232|NCT01093612|Trastuzumab|trastuzumab|mesh-list
101603233|NCT01093612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101603234|NCT01093612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101603235|NCT01093612|Trace Elements|trace elements|mesh-ancestor
101603236|NCT01093612|Micronutrients|micronutrients|mesh-ancestor
101603237|NCT01093612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603238|NCT01182350|Bevacizumab|bevacizumab|mesh-list
101603239|NCT01182350|Temozolomide|temozolomide|mesh-list
101603240|NCT01182350|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101603241|NCT01182350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101603242|NCT01182350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101603243|NCT01182350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101603244|NCT01182350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101603245|NCT01182350|Growth Substances|growth substances|mesh-ancestor
101603246|NCT01182350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603247|NCT01182350|Growth Inhibitors|growth inhibitors|mesh-ancestor
101603248|NCT01182350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101603249|NCT01182350|Alkylating Agents|alkylating agents|mesh-ancestor
101603250|NCT01182350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603251|NCT01182350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101603252|NCT01182350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101603253|NCT00603538|Paclitaxel|paclitaxel|mesh-list
101603254|NCT00603538|Carboplatin|carboplatin|mesh-list
101603255|NCT00603538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101603256|NCT00603538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101603257|NCT00603538|Tubulin Modulators|tubulin modulators|mesh-ancestor
101603258|NCT00603538|Antimitotic Agents|antimitotic agents|mesh-ancestor
101603259|NCT00603538|Mitosis Modulators|mitosis modulators|mesh-ancestor
101603260|NCT00603538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603261|NCT04185766|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101603262|NCT02537860|Fentanyl|fentanyl|mesh-list
101603263|NCT02537860|Bupivacaine|bupivacaine|mesh-list
101603264|NCT02537860|Anesthetics, Local|anesthetics, local|mesh-ancestor
101603265|NCT02537860|Anesthetics|anesthetics|mesh-ancestor
101603266|NCT02537860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101603267|NCT02537860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603268|NCT02537860|Sensory System Agents|sensory system agents|mesh-ancestor
101603269|NCT02537860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101603270|NCT02537860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101603271|NCT02537860|Narcotics|narcotics|mesh-ancestor
101603272|NCT02537860|Analgesics|analgesics|mesh-ancestor
101603273|NCT02537860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101603274|NCT02537860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102032723|NCT03461003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032724|NCT03461003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102032725|NCT03461003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032726|NCT03461003|Vasodilator Agents|vasodilator agents|mesh-ancestor
102032727|NCT03461003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102032728|NCT03461003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102032729|NCT03461003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102032730|NCT03461003|Diuretics|diuretics|mesh-ancestor
101603275|NCT02537860|Anesthetics, General|anesthetics, general|mesh-ancestor
101603276|NCT03844750|Pembrolizumab|pembrolizumab|mesh-list
101603277|NCT03844750|Vactosertib|vactosertib|mesh-list
101603278|NCT03844750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101603279|NCT03844750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101603280|NCT03844750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101603281|NCT03844750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603282|NCT03844750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101603283|NCT03844750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101603284|NCT04521946|Mycophenolic Acid|mycophenolic acid|mesh-list
101603285|NCT04521946|Fludarabine|fludarabine|mesh-list
101603286|NCT04521946|Fludarabine phosphate|fludarabine phosphate|mesh-list
101603287|NCT04521946|Etoposide|etoposide|mesh-list
101603288|NCT04521946|Etoposide phosphate|etoposide phosphate|mesh-list
101603289|NCT04521946|Melphalan|melphalan|mesh-list
101603290|NCT04521946|Mechlorethamine|mechlorethamine|mesh-list
101603291|NCT04521946|Thiotepa|thiotepa|mesh-list
101603292|NCT04521946|Podophyllotoxin|podophyllotoxin|mesh-list
101603304|NCT04521946|Antimetabolites|antimetabolites|mesh-ancestor
101603305|NCT04521946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603306|NCT04521946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101603307|NCT04521946|Immunologic Factors|immunologic factors|mesh-ancestor
101603308|NCT04521946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603309|NCT04521946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101603310|NCT04521946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101603311|NCT04521946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101603312|NCT04521946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101603313|NCT04521946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101603314|NCT04521946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101603315|NCT04521946|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101603316|NCT04521946|Antitubercular Agents|antitubercular agents|mesh-ancestor
101603317|NCT04521946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101603318|NCT04521946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101603319|NCT04521946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101603320|NCT04521946|Alkylating Agents|alkylating agents|mesh-ancestor
101603321|NCT04521946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101603322|NCT04521946|Keratolytic Agents|keratolytic agents|mesh-ancestor
101603323|NCT04521946|Dermatologic Agents|dermatologic agents|mesh-ancestor
101603324|NCT04521946|Tubulin Modulators|tubulin modulators|mesh-ancestor
101603325|NCT04521946|Antimitotic Agents|antimitotic agents|mesh-ancestor
101603326|NCT04521946|Mitosis Modulators|mitosis modulators|mesh-ancestor
101603328|NCT01162304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101603329|NCT01162304|Narcotics|narcotics|mesh-ancestor
101603330|NCT01162304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101603331|NCT01162304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603332|NCT01162304|Analgesics|analgesics|mesh-ancestor
101603333|NCT01162304|Sensory System Agents|sensory system agents|mesh-ancestor
101603334|NCT01162304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101603335|NCT04515394|Cetuximab|cetuximab|mesh-list
101603336|NCT04515394|Tepotinib|tepotinib|mesh-list
101603337|NCT04515394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101603338|NCT04515394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101603339|NCT04206176|Ticagrelor|ticagrelor|mesh-list
101603340|NCT04206176|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101603341|NCT04206176|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101603342|NCT04206176|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101603343|NCT04206176|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102032731|NCT03461003|Natriuretic Agents|natriuretic agents|mesh-ancestor
102032732|NCT03461003|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102032733|NCT03461003|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102032734|NCT03461003|Protease Inhibitors|protease inhibitors|mesh-ancestor
102032735|NCT03461003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102032736|NCT03461003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102032737|NCT03461003|Protective Agents|protective agents|mesh-ancestor
102032738|NCT03650348|Atezolizumab|atezolizumab|mesh-list
102032739|NCT03650348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102032740|NCT03650348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334269|NCT00043537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603344|NCT04206176|Purinergic Agents|purinergic agents|mesh-ancestor
101603345|NCT04206176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101603346|NCT04206176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603347|NCT04206176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603348|NCT01175018|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101603349|NCT01175018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101603350|NCT00638326|Clopidogrel|clopidogrel|mesh-list
101603351|NCT00638326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101603352|NCT00638326|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101603353|NCT00638326|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101603354|NCT00638326|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101603355|NCT00638326|Purinergic Agents|purinergic agents|mesh-ancestor
101603356|NCT00638326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101603357|NCT00638326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603372|NCT02885558|Efonidipine|efonidipine|mesh-list
101603374|NCT02885558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101603375|NCT02885558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101603376|NCT02885558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603377|NCT02885558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101603378|NCT02885558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603379|NCT02885558|Vasodilator Agents|vasodilator agents|mesh-ancestor
101603380|NCT02885558|Tocolytic Agents|tocolytic agents|mesh-ancestor
101603381|NCT02885558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101603382|NCT02885558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101603383|NCT02885558|Diuretics|diuretics|mesh-ancestor
101603384|NCT02885558|Natriuretic Agents|natriuretic agents|mesh-ancestor
101603385|NCT01008150|Paclitaxel|paclitaxel|mesh-list
101603386|NCT01008150|Cyclophosphamide|cyclophosphamide|mesh-list
101603387|NCT01008150|Doxorubicin|doxorubicin|mesh-list
101603388|NCT01008150|Trastuzumab|trastuzumab|mesh-list
101603389|NCT01008150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101603390|NCT01008150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101603391|NCT01008150|Tubulin Modulators|tubulin modulators|mesh-ancestor
101603392|NCT01008150|Antimitotic Agents|antimitotic agents|mesh-ancestor
101603393|NCT01008150|Mitosis Modulators|mitosis modulators|mesh-ancestor
101603394|NCT01008150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603395|NCT01008150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101603396|NCT01008150|Immunologic Factors|immunologic factors|mesh-ancestor
101603397|NCT01008150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603398|NCT01008150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101603399|NCT01008150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101603400|NCT01008150|Alkylating Agents|alkylating agents|mesh-ancestor
101603401|NCT01008150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101603402|NCT01008150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101603403|NCT01008150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101603404|NCT01008150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101603405|NCT01008150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101603406|NCT01008150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101603407|NCT04186936|Simethicone|simethicone|mesh-list
101603408|NCT04186936|Loperamide|loperamide|mesh-list
102032741|NCT03650348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102032742|NCT03650348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102032744|NCT05761470|Fluzoparib|fluzoparib|mesh-list
102032745|NCT05761470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102032746|NCT05761470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334279|NCT00043576|Calcitriol|calcitriol|mesh-list
101603409|NCT04186936|Antidiarrheals|antidiarrheals|mesh-list
101603410|NCT04186936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101603411|NCT04186936|Antifoaming Agents|antifoaming agents|mesh-ancestor
101603412|NCT04186936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603413|NCT04186936|Emollients|emollients|mesh-ancestor
101603414|NCT04186936|Dermatologic Agents|dermatologic agents|mesh-ancestor
101603415|NCT02689180|Furosemide|furosemide|mesh-list
101603416|NCT02689180|Diuretics|diuretics|mesh-ancestor
101603417|NCT02689180|Natriuretic Agents|natriuretic agents|mesh-ancestor
101603418|NCT02689180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451781|NCT00208143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101603420|NCT02689180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101603421|NCT02689180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603423|NCT02689336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101603424|NCT02689336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101603425|NCT02689336|Alkylating Agents|alkylating agents|mesh-ancestor
101603426|NCT02689336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603427|NCT02689336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101603428|NCT02689336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101603429|NCT02689336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101603430|NCT03650764|Pembrolizumab|pembrolizumab|mesh-list
101603431|NCT03650764|Ramucirumab|ramucirumab|mesh-list
101603432|NCT03650764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101603433|NCT03650764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101603434|NCT03650764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101777183|NCT00776282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603435|NCT03650764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603436|NCT02685592|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101603437|NCT02685592|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101603438|NCT02685592|Dermatologic Agents|dermatologic agents|mesh-ancestor
101603439|NCT01007448|Bexarotene|bexarotene|mesh-list
101603440|NCT01007448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101603441|NCT02686684|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101603442|NCT02686684|Dermatologic Agents|dermatologic agents|mesh-ancestor
101603443|NCT02686684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101603444|NCT02686684|Immunologic Factors|immunologic factors|mesh-ancestor
101603445|NCT02686684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603446|NCT04294056|Propofol|propofol|mesh-list
101603447|NCT04294056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101603448|NCT04294056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101603449|NCT04294056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603450|NCT04294056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101603451|NCT04294056|Anesthetics, General|anesthetics, general|mesh-ancestor
101603452|NCT04294056|Anesthetics|anesthetics|mesh-ancestor
101603453|NCT04186702|Ranibizumab|ranibizumab|mesh-list
101603454|NCT04186702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101603455|NCT04186702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101603456|NCT04186702|Growth Substances|growth substances|mesh-ancestor
101603457|NCT04186702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603458|NCT04186702|Growth Inhibitors|growth inhibitors|mesh-ancestor
101603459|NCT04186702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101603460|NCT04187014|Tranexamic Acid|tranexamic acid|mesh-list
101603461|NCT04187014|Aminocaproic Acid|aminocaproic acid|mesh-list
101603462|NCT04187014|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101603463|NCT04187014|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101603464|NCT04187014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603465|NCT04187014|Hemostatics|hemostatics|mesh-ancestor
101603466|NCT04187014|Coagulants|coagulants|mesh-ancestor
101603467|NCT02686840|Misoprostol|misoprostol|mesh-list
101603468|NCT02686840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101603469|NCT02686840|Abortifacient Agents|abortifacient agents|mesh-ancestor
101603470|NCT02686840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101603471|NCT02686840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032747|NCT05761470|Tubulin Modulators|tubulin modulators|mesh-ancestor
102032748|NCT05761470|Antimitotic Agents|antimitotic agents|mesh-ancestor
102032749|NCT05761470|Mitosis Modulators|mitosis modulators|mesh-ancestor
102032750|NCT05761470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032751|NCT05761470|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102032752|NCT05761470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102032753|NCT01372293|Contraceptive Agents|contraceptive agents|mesh-list
102032754|NCT01372293|Contraceptives, Oral|contraceptives, oral|mesh-list
102032755|NCT01372293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
102032756|NCT01372293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102032757|NCT01372293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334291|NCT00043576|Vitamins|vitamins|mesh-ancestor
101603472|NCT02686840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101603473|NCT02686840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101603474|NCT02686840|Oxytocics|oxytocics|mesh-ancestor
101603475|NCT00638482|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101603476|NCT00638482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101603477|NCT00638482|Diuretics|diuretics|mesh-ancestor
101603478|NCT00638482|Natriuretic Agents|natriuretic agents|mesh-ancestor
101603479|NCT00638482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603480|NCT00638482|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101603481|NCT00638482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101603482|NCT00638482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603483|NCT00638560|Vitamins|vitamins|mesh-list
101603484|NCT00638560|Vitamin E|vitamin e|mesh-list
101603485|NCT00638560|Antioxidants|antioxidants|mesh-list
101603486|NCT00638560|Micronutrients|micronutrients|mesh-ancestor
101603487|NCT00638560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603488|NCT00638560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603489|NCT00638560|Protective Agents|protective agents|mesh-ancestor
101603490|NCT00638638|Abciximab|abciximab|mesh-list
101603491|NCT00638638|Anticoagulants|anticoagulants|mesh-ancestor
101603504|NCT04203160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603506|NCT01004250|Pemetrexed|pemetrexed|mesh-list
101603507|NCT01004250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101603508|NCT01004250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101603509|NCT01004250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101603510|NCT01004250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101603511|NCT01004250|Growth Substances|growth substances|mesh-ancestor
101603512|NCT01004250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603513|NCT01004250|Growth Inhibitors|growth inhibitors|mesh-ancestor
101603514|NCT01004250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101603515|NCT01004250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603516|NCT01004250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101603517|NCT01004250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101603518|NCT02688634|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101603519|NCT02688634|Amoxicillin|amoxicillin|mesh-list
101603520|NCT02688634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101603521|NCT00639496|Acetylcysteine|acetylcysteine|mesh-list
101603522|NCT00639496|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101603523|NCT00639496|Antiviral Agents|antiviral agents|mesh-ancestor
101603524|NCT00639496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101603525|NCT00639496|Expectorants|expectorants|mesh-ancestor
101603526|NCT00639496|Respiratory System Agents|respiratory system agents|mesh-ancestor
101603527|NCT00639496|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101603528|NCT00639496|Antioxidants|antioxidants|mesh-ancestor
101603529|NCT00639496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603530|NCT00639496|Protective Agents|protective agents|mesh-ancestor
101603531|NCT00639496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603532|NCT00639496|Antidotes|antidotes|mesh-ancestor
101603533|NCT02688400|Celecoxib|celecoxib|mesh-list
101603534|NCT02688400|Diacerein|diacerein|mesh-list
101603535|NCT02688400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102032758|NCT01372293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102032759|NCT02904902|Adalimumab|adalimumab|mesh-list
102032760|NCT02904902|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102032761|NCT02904902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102032762|NCT02904902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102032763|NCT03650270|Phenytoin|phenytoin|mesh-list
101603536|NCT02688400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101603537|NCT02688400|Analgesics|analgesics|mesh-ancestor
101603538|NCT02688400|Sensory System Agents|sensory system agents|mesh-ancestor
101603539|NCT02688400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101603540|NCT02688400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603541|NCT02688400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101603542|NCT02688400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101603543|NCT02688400|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101603544|NCT02688400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101603545|NCT02688400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101603546|NCT02688400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603547|NCT00639574|Nefopam|nefopam|mesh-list
101603548|NCT00639574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101603549|NCT00639574|Analgesics|analgesics|mesh-ancestor
101603550|NCT00639574|Sensory System Agents|sensory system agents|mesh-ancestor
101603551|NCT00639574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101603552|NCT00639574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603553|NCT02685046|Imatinib Mesylate|imatinib mesylate|mesh-list
101603555|NCT02685046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101603556|NCT02685046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101603557|NCT02685046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603558|NCT01004172|Bevacizumab|bevacizumab|mesh-list
101603559|NCT01004172|Trastuzumab|trastuzumab|mesh-list
101603560|NCT01004172|Carboplatin|carboplatin|mesh-list
101603561|NCT01004172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101603562|NCT01004172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101603563|NCT01004172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101603564|NCT01004172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101603565|NCT01004172|Growth Substances|growth substances|mesh-ancestor
101603566|NCT01004172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603567|NCT01004172|Growth Inhibitors|growth inhibitors|mesh-ancestor
101603569|NCT02688322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101603570|NCT02688322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101603571|NCT02688322|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101603572|NCT02688322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101603573|NCT02688322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603574|NCT02685748|Aspirin|aspirin|mesh-list
101603575|NCT02685748|Pantoprazole|pantoprazole|mesh-list
101603576|NCT02685748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101603577|NCT02685748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101603578|NCT02685748|Analgesics|analgesics|mesh-ancestor
101603579|NCT02685748|Sensory System Agents|sensory system agents|mesh-ancestor
101603580|NCT02685748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101603581|NCT02685748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603582|NCT02685748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101603583|NCT02685748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101603584|NCT02685748|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101603585|NCT02685748|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101603586|NCT02685748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603587|NCT02685748|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101603588|NCT02685748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101603589|NCT02685748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101603590|NCT02685748|Antipyretics|antipyretics|mesh-ancestor
101603591|NCT02685748|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101603592|NCT02685748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101603593|NCT02685748|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101603594|NCT02685670|Cyclophosphamide|cyclophosphamide|mesh-list
101603595|NCT02685670|Fludarabine|fludarabine|mesh-list
101603596|NCT02685670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101603597|NCT02685670|Immunologic Factors|immunologic factors|mesh-ancestor
101603598|NCT02685670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603599|NCT02685670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102032764|NCT03650270|Midazolam|midazolam|mesh-list
102032765|NCT03650270|Phenobarbital|phenobarbital|mesh-list
102032766|NCT03650270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102032767|NCT03650270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102032768|NCT03650270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102032769|NCT03650270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032770|NCT03650270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102032771|NCT03650270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102032772|NCT03650270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102032773|NCT03650270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102032774|NCT03650270|Anesthetics, General|anesthetics, general|mesh-ancestor
101603600|NCT02685670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101603601|NCT02685670|Alkylating Agents|alkylating agents|mesh-ancestor
101603602|NCT02685670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603603|NCT02685670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101603604|NCT02685670|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101603605|NCT02687932|Valsartan|valsartan|mesh-list
101603606|NCT02687932|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101603607|NCT02687932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101603608|NCT02687932|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101603609|NCT02687932|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101603610|NCT02687932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603611|NCT00641602|Esomeprazole|esomeprazole|mesh-list
101603612|NCT00641602|Lansoprazole|lansoprazole|mesh-list
101603613|NCT00641602|Dexlansoprazole|dexlansoprazole|mesh-list
101603614|NCT00641602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101603615|NCT00641602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101603616|NCT00641602|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101603617|NCT00641602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101603618|NCT00641602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603619|NCT05663944|Sirolimus|sirolimus|mesh-list
101603620|NCT05663944|Liver Extracts|liver extracts|mesh-list
101603621|NCT05663944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101603622|NCT05663944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101603623|NCT05663944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101603624|NCT05663944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101603625|NCT05663944|Antifungal Agents|antifungal agents|mesh-ancestor
101603626|NCT05663944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101603636|NCT02682862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603637|NCT02682862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101603638|NCT02682862|Respiratory System Agents|respiratory system agents|mesh-ancestor
101603639|NCT02682862|Parasympatholytics|parasympatholytics|mesh-ancestor
101603640|NCT02682862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101603641|NCT02682862|Cholinergic Agents|cholinergic agents|mesh-ancestor
101603642|NCT02682862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101603643|NCT02682862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603644|NCT02682862|Anticonvulsants|anticonvulsants|mesh-ancestor
101603645|NCT02073838|Ribavirin|ribavirin|mesh-list
101603646|NCT02073838|Decitabine|decitabine|mesh-list
101603647|NCT02073838|Antimetabolites|antimetabolites|mesh-ancestor
101603648|NCT02073838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603649|NCT02073838|Antiviral Agents|antiviral agents|mesh-ancestor
101603650|NCT02073838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101603651|NCT02073838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101603652|NCT02073838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101603653|NCT02073838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101603654|NCT00640198|Memantine|memantine|mesh-list
101603655|NCT00640198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101603656|NCT00640198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101603657|NCT00640198|Dopamine Agents|dopamine agents|mesh-ancestor
101603658|NCT00640198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101603659|NCT00640198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603660|NCT00640198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603661|NCT00640198|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102032777|NCT03650270|GABA Agents|gaba agents|mesh-ancestor
102032778|NCT03650270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102032779|NCT03650270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032780|NCT03650270|Anticonvulsants|anticonvulsants|mesh-ancestor
102032781|NCT03650270|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102032782|NCT03650270|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102032783|NCT03650270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102032784|NCT03650270|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102032785|NCT03650270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101603662|NCT00640198|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101603665|NCT04293822|Cetirizine|cetirizine|mesh-list
101603666|NCT04293822|Minoxidil|minoxidil|mesh-list
101603667|NCT04293822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101603668|NCT04293822|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101603669|NCT04293822|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101603670|NCT04293822|Histamine Antagonists|histamine antagonists|mesh-ancestor
101603671|NCT04293822|Histamine Agents|histamine agents|mesh-ancestor
101603672|NCT04293822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101603673|NCT04293822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603674|NCT04293822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603675|NCT04293822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101603676|NCT04293822|Vasodilator Agents|vasodilator agents|mesh-ancestor
101603677|NCT02680600|Cefepime|cefepime|mesh-list
101603678|NCT02680600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101603679|NCT02680600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101603680|NCT02680678|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101603681|NCT04182724|Paclitaxel|paclitaxel|mesh-list
101603682|NCT04182724|Apatinib|apatinib|mesh-list
101603683|NCT04182724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101603684|NCT04182724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101603685|NCT04182724|Tubulin Modulators|tubulin modulators|mesh-ancestor
101603686|NCT04182724|Antimitotic Agents|antimitotic agents|mesh-ancestor
101777225|NCT00943449|Sorafenib|sorafenib|mesh-list
101603687|NCT04182724|Mitosis Modulators|mitosis modulators|mesh-ancestor
101603688|NCT04182724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603689|NCT04182724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101603690|NCT04182724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101603691|NCT04184518|Durvalumab|durvalumab|mesh-list
101603692|NCT04184518|Cediranib|cediranib|mesh-list
101603693|NCT04184518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101603694|NCT04184518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101603695|NCT04184518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101603699|NCT01174238|Carboplatin|carboplatin|mesh-list
101603700|NCT01174238|Axitinib|axitinib|mesh-list
101603701|NCT01174238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101603702|NCT01174238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101603703|NCT01174238|Tubulin Modulators|tubulin modulators|mesh-ancestor
101603704|NCT01174238|Antimitotic Agents|antimitotic agents|mesh-ancestor
101603705|NCT01174238|Mitosis Modulators|mitosis modulators|mesh-ancestor
101603706|NCT01174238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603707|NCT01174238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101603708|NCT01174238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101603709|NCT02928406|Atezolizumab|atezolizumab|mesh-list
101603710|NCT02928406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101603711|NCT02928406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603712|NCT02928406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101603713|NCT02928406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101603714|NCT04315454|Levobupivacaine|levobupivacaine|mesh-list
101603715|NCT04315454|Anesthetics, Local|anesthetics, local|mesh-ancestor
101603716|NCT04315454|Anesthetics|anesthetics|mesh-ancestor
102032786|NCT03650270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102032787|NCT03650270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102032788|NCT03650270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102032789|NCT03650270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102032790|NCT05285228|Fluorides|fluorides|mesh-list
102032791|NCT05285228|Fluorides, Topical|fluorides, topical|mesh-list
102032792|NCT05285228|Cariostatic Agents|cariostatic agents|mesh-ancestor
102032793|NCT05285228|Protective Agents|protective agents|mesh-ancestor
102032794|NCT05285228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032795|NCT04075526|Vancomycin|vancomycin|mesh-list
102032796|NCT04075526|Povidone-Iodine|povidone-iodine|mesh-list
102032797|NCT04075526|Povidone|povidone|mesh-list
102032798|NCT04075526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102032799|NCT04075526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102032800|NCT04075526|Plasma Substitutes|plasma substitutes|mesh-ancestor
101603717|NCT04315454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101603718|NCT04315454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603719|NCT04315454|Sensory System Agents|sensory system agents|mesh-ancestor
101603720|NCT04315454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101603722|NCT01161446|Immunoglobulins|immunoglobulins|mesh-list
101603723|NCT01161446|Immunologic Factors|immunologic factors|mesh-ancestor
101603724|NCT01161446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603725|NCT00641680|Fluticasone|fluticasone|mesh-list
101603726|NCT00641680|Xhance|xhance|mesh-list
101603727|NCT00641680|Budesonide|budesonide|mesh-list
101603728|NCT00641680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101603729|NCT00641680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101603730|NCT00641680|Autonomic Agents|autonomic agents|mesh-ancestor
101603731|NCT00641680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101603732|NCT00641680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603733|NCT00641680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101603734|NCT00641680|Respiratory System Agents|respiratory system agents|mesh-ancestor
101603735|NCT00641680|Dermatologic Agents|dermatologic agents|mesh-ancestor
101603736|NCT00641680|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101603737|NCT00641680|Glucocorticoids|glucocorticoids|mesh-ancestor
101603738|NCT00641680|Hormones|hormones|mesh-ancestor
101603739|NCT00641680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101603740|NCT01174004|Pimavanserin|pimavanserin|mesh-list
101603741|NCT01174004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101603742|NCT01174004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101603743|NCT01174004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101603744|NCT01174004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101603745|NCT01174004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101603746|NCT01174004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603747|NCT01174004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101603748|NCT01174004|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101603749|NCT01174004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101603750|NCT01174004|Serotonin Agents|serotonin agents|mesh-ancestor
101603751|NCT01174004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101603752|NCT01174004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603753|NCT01173692|Minocycline|minocycline|mesh-list
101603754|NCT01173692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101603755|NCT01173692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101603756|NCT00641758|Pycnogenols|pycnogenols|mesh-list
101603757|NCT00641758|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101603758|NCT00641758|Immunologic Factors|immunologic factors|mesh-ancestor
101603759|NCT00641758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603760|NCT00641758|Antioxidants|antioxidants|mesh-ancestor
101603761|NCT00641758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603762|NCT00641758|Protective Agents|protective agents|mesh-ancestor
101603763|NCT00641758|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102032801|NCT04075526|Blood Substitutes|blood substitutes|mesh-ancestor
102032802|NCT04075526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102032804|NCT05204628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102032805|NCT05204628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102032806|NCT05204628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102032807|NCT05204628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032808|NCT03650738|Paclitaxel|paclitaxel|mesh-list
102032809|NCT03650738|Carboplatin|carboplatin|mesh-list
102032810|NCT03650738|Apatinib|apatinib|mesh-list
102032811|NCT03650738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102032812|NCT03650738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102032813|NCT03650738|Tubulin Modulators|tubulin modulators|mesh-ancestor
102032814|NCT03650738|Antimitotic Agents|antimitotic agents|mesh-ancestor
102032815|NCT03650738|Mitosis Modulators|mitosis modulators|mesh-ancestor
102032816|NCT03650738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032817|NCT03650738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102032818|NCT03650738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102032819|NCT02904200|Silicon|silicon|mesh-list
102032820|NCT02904200|Trace Elements|trace elements|mesh-ancestor
102032821|NCT02904200|Micronutrients|micronutrients|mesh-ancestor
102032822|NCT02904200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032823|NCT03432533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102032824|NCT03432533|Immunologic Factors|immunologic factors|mesh-ancestor
102032825|NCT03432533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032826|NCT03621800|Menthol|menthol|mesh-list
102032827|NCT03621800|Antipruritics|antipruritics|mesh-ancestor
102032828|NCT03621800|Dermatologic Agents|dermatologic agents|mesh-ancestor
102032829|NCT03649334|Ketorolac|ketorolac|mesh-list
102032830|NCT03649334|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102032831|NCT03649334|Fentanyl|fentanyl|mesh-list
102032832|NCT03649334|Ketamine|ketamine|mesh-list
102032833|NCT03649334|Analgesics|analgesics|mesh-ancestor
101603764|NCT00640276|Pitavastatin|pitavastatin|mesh-list
101603765|NCT00640276|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101603766|NCT00640276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101603767|NCT00640276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101603768|NCT00640276|Antimetabolites|antimetabolites|mesh-ancestor
101603784|NCT01101035|Allopurinol|allopurinol|mesh-list
101603785|NCT01101035|Febuxostat|febuxostat|mesh-list
101603786|NCT01101035|Antimetabolites|antimetabolites|mesh-ancestor
101603787|NCT01101035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603788|NCT01101035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101603789|NCT01101035|Gout Suppressants|gout suppressants|mesh-ancestor
101603790|NCT01101035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102032837|NCT03649334|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102032838|NCT03649334|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102032839|NCT03649334|Anesthetics, General|anesthetics, general|mesh-ancestor
102032840|NCT03649334|Anesthetics|anesthetics|mesh-ancestor
102032841|NCT03649334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102032842|NCT03649334|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102032843|NCT03649334|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102032844|NCT03649334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102032845|NCT03649334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032846|NCT03649334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102032847|NCT03649334|Narcotics|narcotics|mesh-ancestor
102032848|NCT03649334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102032849|NCT03649334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102032850|NCT03649334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102032851|NCT03649334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102032852|NCT03649334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102032853|NCT03649334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102032854|NCT03649334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102032855|NCT02901548|Durvalumab|durvalumab|mesh-list
102032856|NCT02901548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102032857|NCT02901548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102032858|NCT03457727|Omeprazole|omeprazole|mesh-list
102032859|NCT03457727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102032860|NCT03457727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102032861|NCT03457727|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102032862|NCT03457727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102032863|NCT03457727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032868|NCT03648554|Dulaglutide|dulaglutide|mesh-list
102032871|NCT03648320|Immunomodulating Agents|immunomodulating agents|mesh-list
102032872|NCT03648320|Immunologic Factors|immunologic factors|mesh-ancestor
102032873|NCT03648320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032874|NCT05284994|Osimertinib|osimertinib|mesh-list
102032875|NCT05284994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102032876|NCT05284994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102032877|NCT05284994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102032878|NCT05284994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032879|NCT03068754|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102032881|NCT03068754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102032882|NCT03068754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032883|NCT02965820|Contact Lens Solutions|contact lens solutions|mesh-list
102032884|NCT02965820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102032885|NCT02965820|Disinfectants|disinfectants|mesh-ancestor
102032886|NCT02965820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102032887|NCT03430895|Durvalumab|durvalumab|mesh-list
102032888|NCT03430895|Tremelimumab|tremelimumab|mesh-list
102032889|NCT03430895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102032890|NCT03430895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102032891|NCT05745480|Analgesics, Opioid|analgesics, opioid|mesh-list
102032892|NCT05745480|Narcotics|narcotics|mesh-ancestor
102032893|NCT05745480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102032894|NCT05745480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032895|NCT05745480|Analgesics|analgesics|mesh-ancestor
102032896|NCT05745480|Sensory System Agents|sensory system agents|mesh-ancestor
101603791|NCT01101035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101603792|NCT01101035|Antioxidants|antioxidants|mesh-ancestor
101603793|NCT01101035|Protective Agents|protective agents|mesh-ancestor
101603794|NCT01101035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603795|NCT01160822|Naproxen|naproxen|mesh-list
101603796|NCT01160822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101603797|NCT01160822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101603798|NCT01160822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101603800|NCT01160822|Sensory System Agents|sensory system agents|mesh-ancestor
101603801|NCT01160822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101603802|NCT01160822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603803|NCT01160822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101603804|NCT01160822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101603805|NCT01160822|Gout Suppressants|gout suppressants|mesh-ancestor
101603806|NCT01160822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101603807|NCT01160822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101603808|NCT01160822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603809|NCT01160822|Immunologic Factors|immunologic factors|mesh-ancestor
101603810|NCT01006980|Dacarbazine|dacarbazine|mesh-list
101603811|NCT01006980|Vemurafenib|vemurafenib|mesh-list
101603812|NCT01006980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101603813|NCT01006980|Alkylating Agents|alkylating agents|mesh-ancestor
102032897|NCT05745480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102032899|NCT03452189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102032900|NCT03452189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102032901|NCT00603954|Fludarabine|fludarabine|mesh-list
102032902|NCT00603954|Fludarabine phosphate|fludarabine phosphate|mesh-list
102032903|NCT00603954|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102032904|NCT00603954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102032905|NCT00603954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102032906|NCT00603954|Antimetabolites|antimetabolites|mesh-ancestor
102032907|NCT00603954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032908|NCT00603954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102032909|NCT00603954|Immunologic Factors|immunologic factors|mesh-ancestor
102032910|NCT00603954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032911|NCT03427619|Picibanil|picibanil|mesh-list
102032912|NCT03427619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102032913|NCT03712475|Pregabalin|pregabalin|mesh-list
102032914|NCT03712475|Analgesics|analgesics|mesh-ancestor
102032915|NCT03712475|Sensory System Agents|sensory system agents|mesh-ancestor
102032916|NCT03712475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102032917|NCT03712475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032918|NCT03712475|Anticonvulsants|anticonvulsants|mesh-ancestor
102032919|NCT03712475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102032920|NCT03712475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102032921|NCT03712475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603814|NCT01006980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603815|NCT01006980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101603816|NCT01006980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101603817|NCT01006980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101603818|NCT04296240|Capecitabine|capecitabine|mesh-list
101603819|NCT04296240|Oxaliplatin|oxaliplatin|mesh-list
101603820|NCT04296240|Antiemetics|antiemetics|mesh-list
101603821|NCT04296240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101603822|NCT04296240|Antimetabolites|antimetabolites|mesh-ancestor
101603823|NCT04296240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603824|NCT04296240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101603825|NCT04296240|Autonomic Agents|autonomic agents|mesh-ancestor
101603826|NCT04296240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101603827|NCT04296240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603828|NCT04296240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101603829|NCT04205058|Caffeine|caffeine|mesh-list
101603830|NCT04205058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101603838|NCT04205058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101603839|NCT04183738|Ritonavir|ritonavir|mesh-list
101603840|NCT04183738|Darunavir|darunavir|mesh-list
101603841|NCT04183738|Dolutegravir|dolutegravir|mesh-list
101603842|NCT04183738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101603843|NCT04183738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101603844|NCT04183738|Protease Inhibitors|protease inhibitors|mesh-ancestor
101603845|NCT04183738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102032922|NCT03712475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102032923|NCT03712475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102032924|NCT03712475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102032925|NCT03712475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102032926|NCT03712475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102032927|NCT02435433|Ramucirumab|ramucirumab|mesh-list
101752701|NCT00849160|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102032928|NCT02435433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102032930|NCT01372371|Gentamicins|gentamicins|mesh-list
102032931|NCT01372371|Cefuroxime|cefuroxime|mesh-list
102032932|NCT01372371|Cefuroxime axetil|cefuroxime axetil|mesh-list
102032933|NCT01372371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102032934|NCT01372371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102032935|NCT01372371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102032936|NCT01372371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102032937|NCT01372371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032938|NCT03120351|Lidocaine|lidocaine|mesh-list
102032939|NCT03120351|Anesthetics, Local|anesthetics, local|mesh-ancestor
102032940|NCT03120351|Anesthetics|anesthetics|mesh-ancestor
102032941|NCT03120351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102032942|NCT03120351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032943|NCT03120351|Sensory System Agents|sensory system agents|mesh-ancestor
102032944|NCT03120351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102032945|NCT03120351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102032946|NCT03120351|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102032947|NCT03120351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102032948|NCT03120351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102032949|NCT03120351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032950|NCT05165355|Aflutinib|aflutinib|mesh-list
102032951|NCT05165355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101334455|NCT00044551|Taxane|taxane|mesh-list
101603846|NCT04183738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603847|NCT04183738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101603848|NCT04183738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101603850|NCT04183738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101603851|NCT04183738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101603852|NCT04183738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101603853|NCT04183738|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101603854|NCT04183738|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101603855|NCT02682082|Bupivacaine|bupivacaine|mesh-list
101603856|NCT02682082|Anesthetics, Local|anesthetics, local|mesh-ancestor
102032952|NCT05165355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102032953|NCT05165355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032955|NCT01374789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102032956|NCT01374789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102032957|NCT02354703|Ondansetron|ondansetron|mesh-list
102032958|NCT02354703|Antiemetics|antiemetics|mesh-ancestor
102032959|NCT02354703|Autonomic Agents|autonomic agents|mesh-ancestor
102032960|NCT02354703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102032961|NCT02354703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032962|NCT02354703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102032963|NCT02354703|Antipruritics|antipruritics|mesh-ancestor
102032964|NCT02354703|Dermatologic Agents|dermatologic agents|mesh-ancestor
102032965|NCT02354703|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102032966|NCT02354703|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102032967|NCT02354703|Serotonin Agents|serotonin agents|mesh-ancestor
102032968|NCT02354703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102032969|NCT02354703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032970|NCT05008887|Fluorouracil|fluorouracil|mesh-list
102032971|NCT05008887|Methotrexate|methotrexate|mesh-list
102032972|NCT05008887|Antimetabolites|antimetabolites|mesh-ancestor
102032973|NCT05008887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032974|NCT05008887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102032975|NCT05008887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102032976|NCT05008887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102032977|NCT05008887|Immunologic Factors|immunologic factors|mesh-ancestor
102032978|NCT05008887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032979|NCT05008887|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102032980|NCT05008887|Abortifacient Agents|abortifacient agents|mesh-ancestor
102032981|NCT05008887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102032982|NCT05008887|Dermatologic Agents|dermatologic agents|mesh-ancestor
102032983|NCT05008887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101603857|NCT02682082|Anesthetics|anesthetics|mesh-ancestor
101603858|NCT02682082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101603859|NCT02682082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603860|NCT02682082|Sensory System Agents|sensory system agents|mesh-ancestor
101603861|NCT02682082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101603862|NCT00640432|Celecoxib|celecoxib|mesh-list
101603863|NCT00640432|Diclofenac|diclofenac|mesh-list
101603864|NCT00640432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101603865|NCT00640432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102032984|NCT05008887|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102032985|NCT05008887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102032986|NCT05008887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101603866|NCT00640432|Analgesics|analgesics|mesh-ancestor
101603867|NCT00640432|Sensory System Agents|sensory system agents|mesh-ancestor
101603868|NCT00640432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101603869|NCT00640432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603870|NCT00640432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101603871|NCT00640432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101603872|NCT00640432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101777251|NCT00952029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101603873|NCT00640432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101603874|NCT00640432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101603875|NCT00640432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603876|NCT02679664|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101603877|NCT02679664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101603878|NCT02679664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101603879|NCT02679664|Antimetabolites|antimetabolites|mesh-ancestor
101603880|NCT02679664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603881|NCT02679664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101603882|NCT02679664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101603883|NCT02679664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101603885|NCT00641212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101603886|NCT00641212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101603887|NCT00641212|Autonomic Agents|autonomic agents|mesh-ancestor
101603888|NCT00641212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101603889|NCT00641212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603890|NCT00641212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101603891|NCT00641212|Respiratory System Agents|respiratory system agents|mesh-ancestor
101603892|NCT00641212|Glucocorticoids|glucocorticoids|mesh-ancestor
101603893|NCT00641212|Hormones|hormones|mesh-ancestor
101603894|NCT00641212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101603895|NCT04183192|Reslizumab|reslizumab|mesh-list
101603896|NCT04183192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101603897|NCT04183192|Respiratory System Agents|respiratory system agents|mesh-ancestor
101603898|NCT02681848|Nicotine|nicotine|mesh-list
101603901|NCT02681848|Autonomic Agents|autonomic agents|mesh-ancestor
101603902|NCT02681848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101603903|NCT02681848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603904|NCT02681848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101603905|NCT02681848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101603906|NCT02681848|Cholinergic Agents|cholinergic agents|mesh-ancestor
101603907|NCT02681848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101603908|NCT02681848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603909|NCT00997386|Melphalan|melphalan|mesh-list
101603910|NCT00997386|Busulfan|busulfan|mesh-list
101603911|NCT00997386|Alemtuzumab|alemtuzumab|mesh-list
101603912|NCT00997386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101603913|NCT00997386|Alkylating Agents|alkylating agents|mesh-ancestor
101603914|NCT00997386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603915|NCT00997386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101603916|NCT00997386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101603917|NCT00997386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101603918|NCT00997386|Immunologic Factors|immunologic factors|mesh-ancestor
101603919|NCT00997386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603920|NCT00997386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101264889|NCT01769911|Cytarabine|cytarabine|mesh-list
101603922|NCT02679820|Trace Elements|trace elements|mesh-ancestor
101603923|NCT02679820|Micronutrients|micronutrients|mesh-ancestor
101603924|NCT02679820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603925|NCT00641914|Budesonide|budesonide|mesh-list
101603926|NCT00641914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101603927|NCT00641914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101603928|NCT00641914|Autonomic Agents|autonomic agents|mesh-ancestor
101603929|NCT00641914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101603930|NCT00641914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603931|NCT00641914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101603932|NCT00641914|Respiratory System Agents|respiratory system agents|mesh-ancestor
101603933|NCT00641914|Glucocorticoids|glucocorticoids|mesh-ancestor
101603934|NCT00641914|Hormones|hormones|mesh-ancestor
101603935|NCT00641914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101603936|NCT00640588|Adefovir|adefovir|mesh-list
102032988|NCT01376193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102032989|NCT01376193|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102032990|NCT01376193|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102032991|NCT01376193|Serotonin Agents|serotonin agents|mesh-ancestor
101603937|NCT00640588|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101603938|NCT00640588|Telbivudine|telbivudine|mesh-list
101603939|NCT00640588|Antiviral Agents|antiviral agents|mesh-ancestor
101603940|NCT00640588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101777258|NCT00667862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101603941|NCT00640588|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101603942|NCT00640588|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101603943|NCT00640588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101603944|NCT00640588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603945|NCT05663398|Ibuprofen|ibuprofen|mesh-list
101603946|NCT05663398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101603947|NCT05663398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101603948|NCT05663398|Analgesics|analgesics|mesh-ancestor
101603949|NCT05663398|Sensory System Agents|sensory system agents|mesh-ancestor
101603950|NCT05663398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101603951|NCT05663398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603952|NCT05663398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101603953|NCT05663398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101603954|NCT05663398|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101603955|NCT05663398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101603956|NCT05663398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603957|NCT00640744|Atorvastatin|atorvastatin|mesh-list
101603958|NCT00640744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101603959|NCT00640744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101603960|NCT00640744|Antimetabolites|antimetabolites|mesh-ancestor
101603961|NCT00640744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603962|NCT00640744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101603963|NCT00640744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101603964|NCT00640744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101603965|NCT02678104|Chlorhexidine|chlorhexidine|mesh-list
101603966|NCT02678104|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101603967|NCT02678104|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101603968|NCT02678104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101603969|NCT02678104|Disinfectants|disinfectants|mesh-ancestor
101603970|NCT02678104|Dermatologic Agents|dermatologic agents|mesh-ancestor
101603971|NCT02681536|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101603976|NCT02681536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603977|NCT02681536|Luteolytic Agents|luteolytic agents|mesh-ancestor
101603978|NCT02681536|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101603979|NCT02681536|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101603980|NCT02681536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101603981|NCT02681536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101603983|NCT04183114|Immunologic Factors|immunologic factors|mesh-ancestor
101603984|NCT04183114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603985|NCT00996996|Iodine|iodine|mesh-list
101603986|NCT00996996|Tositumomab I-131|tositumomab i-131|mesh-list
101603987|NCT00996996|Antibodies|antibodies|mesh-list
101603988|NCT00996996|Immunoglobulins|immunoglobulins|mesh-list
101603989|NCT00996996|Immunologic Factors|immunologic factors|mesh-ancestor
101603990|NCT00996996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603991|NCT00996996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101603992|NCT00996996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101603993|NCT00996996|Trace Elements|trace elements|mesh-ancestor
101603994|NCT00996996|Micronutrients|micronutrients|mesh-ancestor
101603995|NCT00996996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101603996|NCT04182568|Paclitaxel|paclitaxel|mesh-list
101603997|NCT04182568|Docetaxel|docetaxel|mesh-list
101603998|NCT04182568|Cyclophosphamide|cyclophosphamide|mesh-list
101603999|NCT04182568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101604000|NCT04182568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101604001|NCT04182568|Tubulin Modulators|tubulin modulators|mesh-ancestor
101604002|NCT04182568|Antimitotic Agents|antimitotic agents|mesh-ancestor
101604003|NCT04182568|Mitosis Modulators|mitosis modulators|mesh-ancestor
101604004|NCT04182568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604005|NCT04182568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101604006|NCT04182568|Immunologic Factors|immunologic factors|mesh-ancestor
102032992|NCT01376193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102032993|NCT01376193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032994|NCT01376193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032995|NCT04944771|Rabeprazole|rabeprazole|mesh-list
102032996|NCT04944771|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101604007|NCT04182568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604008|NCT04182568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101604009|NCT04182568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101604010|NCT04182568|Alkylating Agents|alkylating agents|mesh-ancestor
101604011|NCT04182568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101604012|NCT00641446|Budesonide|budesonide|mesh-list
101604013|NCT00641446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101604014|NCT00641446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101604015|NCT00641446|Autonomic Agents|autonomic agents|mesh-ancestor
101604016|NCT00641446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101604017|NCT00641446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604018|NCT00641446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101604019|NCT00641446|Respiratory System Agents|respiratory system agents|mesh-ancestor
101604020|NCT00641446|Glucocorticoids|glucocorticoids|mesh-ancestor
101604021|NCT00641446|Hormones|hormones|mesh-ancestor
101604022|NCT00641446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101604023|NCT05663164|Thiamine|thiamine|mesh-list
101604024|NCT05663164|Vitamins|vitamins|mesh-ancestor
101604025|NCT05663164|Micronutrients|micronutrients|mesh-ancestor
101604026|NCT05663164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604027|NCT05663164|Vitamin B Complex|vitamin b complex|mesh-ancestor
101604028|NCT02537470|Remogliflozin etabonate|remogliflozin etabonate|mesh-list
101604029|NCT02537470|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101604030|NCT02537470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604031|NCT02537470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101604032|NCT02537470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604033|NCT02678728|Dexmedetomidine|dexmedetomidine|mesh-list
101604034|NCT02678728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101604035|NCT02678728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101604036|NCT02678728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604037|NCT02678728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101604038|NCT02678728|Analgesics|analgesics|mesh-ancestor
101604039|NCT02678728|Sensory System Agents|sensory system agents|mesh-ancestor
101604040|NCT02678728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101604041|NCT02678728|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101604042|NCT02678728|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101604057|NCT04180072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604058|NCT02678650|Anesthetics|anesthetics|mesh-list
101604059|NCT02678650|Propofol|propofol|mesh-list
101604060|NCT02678650|Isoflurane|isoflurane|mesh-list
101604061|NCT02678650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101604062|NCT02678650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604063|NCT02678650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101604064|NCT02678650|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101604065|NCT02678650|Anesthetics, General|anesthetics, general|mesh-ancestor
101604066|NCT02678650|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101604067|NCT04180150|Entecavir|entecavir|mesh-list
101604068|NCT04180150|Antiviral Agents|antiviral agents|mesh-ancestor
101604069|NCT04180150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101604070|NCT02678338|Magrolimab|magrolimab|mesh-list
101604071|NCT02678338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101604072|NCT02678338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101604074|NCT00642226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101604075|NCT00642226|Glucocorticoids|glucocorticoids|mesh-ancestor
101604076|NCT00642226|Hormones|hormones|mesh-ancestor
101604077|NCT00642226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101604078|NCT00642226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604079|NCT05511610|Sevoflurane|sevoflurane|mesh-list
101604080|NCT05511610|Desflurane|desflurane|mesh-list
101604081|NCT05511610|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101604082|NCT05511610|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101604083|NCT05511610|Anesthetics, General|anesthetics, general|mesh-ancestor
101604084|NCT05511610|Anesthetics|anesthetics|mesh-ancestor
101604085|NCT05511610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102032997|NCT04944771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102032998|NCT04944771|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102032999|NCT04944771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102033000|NCT04944771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033001|NCT01375023|Thymoglobulin|thymoglobulin|mesh-list
102033002|NCT01375023|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102033003|NCT01375023|Immunologic Factors|immunologic factors|mesh-ancestor
102033004|NCT01375023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033005|NCT01375023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102033007|NCT05197101|Oxytocics|oxytocics|mesh-ancestor
102033008|NCT05197101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102033009|NCT05197101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604086|NCT05511610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604087|NCT02675530|Ketamine|ketamine|mesh-list
101604088|NCT02675530|Analgesics|analgesics|mesh-ancestor
101604089|NCT02675530|Sensory System Agents|sensory system agents|mesh-ancestor
101604090|NCT02675530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101604091|NCT02675530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604092|NCT02675530|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101604093|NCT02675530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101604094|NCT02675530|Anesthetics, General|anesthetics, general|mesh-ancestor
101604095|NCT02675530|Anesthetics|anesthetics|mesh-ancestor
101604096|NCT02675530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101604097|NCT02675530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101604098|NCT02675530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101604099|NCT02675530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101604100|NCT02675530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604101|NCT02675374|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
101604102|NCT02675374|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101604103|NCT02675374|Histamine Antagonists|histamine antagonists|mesh-ancestor
101604107|NCT02675374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604109|NCT02678260|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101604110|NCT02678260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604111|NCT02678260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101604112|NCT02678260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101604113|NCT04179604|Simendan|simendan|mesh-list
101604114|NCT04179604|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101604115|NCT04179604|Vasodilator Agents|vasodilator agents|mesh-ancestor
101604116|NCT04179604|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101604117|NCT04179604|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101604118|NCT04179604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101604119|NCT04179604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604120|NCT04179604|Protective Agents|protective agents|mesh-ancestor
101604121|NCT04179604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604122|NCT02675140|Vitamins|vitamins|mesh-list
101604123|NCT02675140|Vitamin A|vitamin a|mesh-list
101604124|NCT02675140|Albendazole|albendazole|mesh-list
101604125|NCT02675140|Retinol palmitate|retinol palmitate|mesh-list
101604126|NCT02675140|Micronutrients|micronutrients|mesh-ancestor
101604127|NCT02675140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604128|NCT02675140|Antioxidants|antioxidants|mesh-ancestor
101604129|NCT02675140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604130|NCT02675140|Protective Agents|protective agents|mesh-ancestor
101604131|NCT02675140|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101604132|NCT02675140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101604133|NCT02675140|Anthelmintics|anthelmintics|mesh-ancestor
101604134|NCT02675140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101604135|NCT02675140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101604136|NCT02675140|Anticestodal Agents|anticestodal agents|mesh-ancestor
101604137|NCT02675140|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101604138|NCT02675140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101604139|NCT02675140|Tubulin Modulators|tubulin modulators|mesh-ancestor
102033010|NCT01375101|Quercetin|quercetin|mesh-list
102033011|NCT01375101|Antioxidants|antioxidants|mesh-ancestor
102033012|NCT01375101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033013|NCT01375101|Protective Agents|protective agents|mesh-ancestor
102033014|NCT01375101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033015|NCT04865289|Paclitaxel|paclitaxel|mesh-list
102033016|NCT04865289|Carboplatin|carboplatin|mesh-list
101604140|NCT02675140|Antimitotic Agents|antimitotic agents|mesh-ancestor
101604141|NCT02675140|Mitosis Modulators|mitosis modulators|mesh-ancestor
101604142|NCT02674906|Heparin|heparin|mesh-list
101604143|NCT02674906|Calcium heparin|calcium heparin|mesh-list
101604144|NCT02674906|Anticoagulants|anticoagulants|mesh-list
101604145|NCT02674906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604147|NCT02674906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101604148|NCT01160744|Carboplatin|carboplatin|mesh-list
101604149|NCT01160744|Gemcitabine|gemcitabine|mesh-list
101604150|NCT01160744|Pemetrexed|pemetrexed|mesh-list
101604151|NCT01160744|Ramucirumab|ramucirumab|mesh-list
101604152|NCT01160744|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101604153|NCT01160744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101604154|NCT01160744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101604155|NCT01160744|Antimetabolites|antimetabolites|mesh-ancestor
101604156|NCT01160744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604157|NCT01160744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101604158|NCT01160744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101604159|NCT01160744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101604160|NCT01160744|Immunologic Factors|immunologic factors|mesh-ancestor
101604161|NCT01160744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604162|NCT02677246|Denosumab|denosumab|mesh-list
101604163|NCT02677246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101604164|NCT02677246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604165|NCT01160354|Plerixafor|plerixafor|mesh-list
101604166|NCT01160354|Clofarabine|clofarabine|mesh-list
101604167|NCT01160354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101604168|NCT01160354|Antimetabolites|antimetabolites|mesh-ancestor
101604169|NCT01160354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604170|NCT01160354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101604171|NCT01160354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101604172|NCT01160354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101604173|NCT01160354|Antiviral Agents|antiviral agents|mesh-ancestor
101604174|NCT01160354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101604175|NCT04178512|Dexamethasone|dexamethasone|mesh-list
101604176|NCT04178512|Dexamethasone acetate|dexamethasone acetate|mesh-list
101604177|NCT04178512|Fentanyl|fentanyl|mesh-list
101604188|NCT04178512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101604189|NCT04178512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101604190|NCT04178512|Protease Inhibitors|protease inhibitors|mesh-ancestor
101604191|NCT04178512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101604192|NCT04178512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604193|NCT04178512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101604194|NCT04178512|Narcotics|narcotics|mesh-ancestor
101604195|NCT04178512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101604196|NCT04178512|Analgesics|analgesics|mesh-ancestor
101604197|NCT04178512|Sensory System Agents|sensory system agents|mesh-ancestor
101604198|NCT04178512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101604199|NCT04178512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101604200|NCT04178512|Anesthetics, General|anesthetics, general|mesh-ancestor
101604201|NCT04178512|Anesthetics|anesthetics|mesh-ancestor
101604202|NCT01160198|Ascorbic Acid|ascorbic acid|mesh-list
101604203|NCT01160198|Chelating Agents|chelating agents|mesh-list
101604205|NCT01160198|Sequestering Agents|sequestering agents|mesh-ancestor
101604206|NCT01160198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604207|NCT01160198|Glycine Agents|glycine agents|mesh-ancestor
101604208|NCT01160198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101604209|NCT01160198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604210|NCT01160198|Antioxidants|antioxidants|mesh-ancestor
101604211|NCT01160198|Protective Agents|protective agents|mesh-ancestor
101604212|NCT01160198|Vitamins|vitamins|mesh-ancestor
101604213|NCT01160198|Micronutrients|micronutrients|mesh-ancestor
101604214|NCT02676934|Anesthetics|anesthetics|mesh-list
101604215|NCT02676934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102033017|NCT04865289|Pembrolizumab|pembrolizumab|mesh-list
102033018|NCT04865289|Lenvatinib|lenvatinib|mesh-list
102033019|NCT04865289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102033020|NCT04865289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033021|NCT04865289|Tubulin Modulators|tubulin modulators|mesh-ancestor
102033022|NCT04865289|Antimitotic Agents|antimitotic agents|mesh-ancestor
101604216|NCT02676934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604217|NCT05351086|Dihydroergotamine|dihydroergotamine|mesh-list
101604218|NCT05351086|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101604219|NCT05351086|Dopamine Agonists|dopamine agonists|mesh-ancestor
101604220|NCT05351086|Dopamine Agents|dopamine agents|mesh-ancestor
101604221|NCT05351086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101604222|NCT05351086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604223|NCT05351086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604224|NCT05351086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101411836|NCT00463762|Sulbactam|sulbactam|mesh-list
101604225|NCT05351086|Analgesics|analgesics|mesh-ancestor
101604226|NCT05351086|Sensory System Agents|sensory system agents|mesh-ancestor
101604227|NCT05351086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101604228|NCT02885168|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
101604229|NCT02885168|Phenylephrine|phenylephrine|mesh-list
101604230|NCT02885168|Protein C|protein c|mesh-list
101604231|NCT02885168|Oxymetazoline|oxymetazoline|mesh-list
101604232|NCT02885168|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101604233|NCT02885168|Mydriatics|mydriatics|mesh-ancestor
101604234|NCT02885168|Autonomic Agents|autonomic agents|mesh-ancestor
101604235|NCT02885168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101604236|NCT02885168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604237|NCT02885168|Sympathomimetics|sympathomimetics|mesh-ancestor
101604238|NCT02885168|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101604239|NCT02885168|Nasal Decongestants|nasal decongestants|mesh-ancestor
101604240|NCT02885168|Respiratory System Agents|respiratory system agents|mesh-ancestor
101604241|NCT02885168|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101604242|NCT02885168|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101604243|NCT02885168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101604250|NCT02885168|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101604251|NCT02885168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101604252|NCT01159574|Clarithromycin|clarithromycin|mesh-list
101604253|NCT01159574|Dexamethasone|dexamethasone|mesh-list
101604254|NCT01159574|Pomalidomide|pomalidomide|mesh-list
101604255|NCT01159574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101604256|NCT01159574|Antiemetics|antiemetics|mesh-ancestor
101604257|NCT01159574|Autonomic Agents|autonomic agents|mesh-ancestor
101604258|NCT01159574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101604259|NCT01159574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604260|NCT01159574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101604261|NCT01159574|Glucocorticoids|glucocorticoids|mesh-ancestor
101604262|NCT01159574|Hormones|hormones|mesh-ancestor
101604263|NCT01159574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101604264|NCT01159574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101604265|NCT01159574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101604266|NCT01159574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101604267|NCT01159574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101604268|NCT01159574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101604269|NCT01159574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101604270|NCT01159574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604271|NCT01159574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101604272|NCT01159574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101604273|NCT01159574|Immunologic Factors|immunologic factors|mesh-ancestor
101604274|NCT01159574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101604275|NCT01159574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101604276|NCT01159574|Growth Substances|growth substances|mesh-ancestor
101604277|NCT01159574|Growth Inhibitors|growth inhibitors|mesh-ancestor
101604278|NCT01158950|Tolcapone|tolcapone|mesh-list
101604279|NCT01158950|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101604280|NCT01158950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101604281|NCT01158950|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101604282|NCT01158950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101604283|NCT01158950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604284|NCT00910234|Epoetin Alfa|epoetin alfa|mesh-list
101604285|NCT00910234|Hematinics|hematinics|mesh-ancestor
102033023|NCT04865289|Mitosis Modulators|mitosis modulators|mesh-ancestor
102033024|NCT04865289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033025|NCT04865289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102033026|NCT04865289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102033027|NCT04865289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102033028|NCT04865289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102033029|NCT03633591|Tolcapone|tolcapone|mesh-list
102033030|NCT03633591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102033031|NCT03633591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102033032|NCT03633591|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101604286|NCT05652322|Furosemide|furosemide|mesh-list
101604287|NCT05652322|Diuretics|diuretics|mesh-ancestor
101604288|NCT05652322|Natriuretic Agents|natriuretic agents|mesh-ancestor
101604289|NCT05652322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604290|NCT05652322|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101604291|NCT05652322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101604292|NCT05652322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604293|NCT01172288|Acetylcysteine|acetylcysteine|mesh-list
101604294|NCT01172288|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101604295|NCT01172288|Antiviral Agents|antiviral agents|mesh-ancestor
101604297|NCT01172288|Expectorants|expectorants|mesh-ancestor
101604298|NCT01172288|Respiratory System Agents|respiratory system agents|mesh-ancestor
101604299|NCT01172288|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101604300|NCT01172288|Antioxidants|antioxidants|mesh-ancestor
101604301|NCT01172288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604302|NCT01172288|Protective Agents|protective agents|mesh-ancestor
101604303|NCT01172288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604304|NCT01172288|Antidotes|antidotes|mesh-ancestor
101604305|NCT02676622|Aldesleukin|aldesleukin|mesh-list
101604306|NCT02676622|Cyclophosphamide|cyclophosphamide|mesh-list
101604307|NCT02676622|Thymoglobulin|thymoglobulin|mesh-list
101604308|NCT02676622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101604309|NCT02676622|Immunologic Factors|immunologic factors|mesh-ancestor
101604310|NCT02676622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604311|NCT02676622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101604312|NCT02676622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101604330|NCT00644020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604331|NCT00644020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101604332|NCT00644020|Alkylating Agents|alkylating agents|mesh-ancestor
101604333|NCT00644020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101604334|NCT00644020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101604335|NCT04178980|Simvastatin|simvastatin|mesh-list
101604336|NCT04178980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101604337|NCT04178980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101604338|NCT04178980|Antimetabolites|antimetabolites|mesh-ancestor
101604339|NCT04178980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604340|NCT04178980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101604341|NCT04178980|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101604342|NCT04178980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101604343|NCT02674048|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
101604344|NCT02674048|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101604345|NCT02674048|Dermatologic Agents|dermatologic agents|mesh-ancestor
101604346|NCT02672566|Enoxaparin|enoxaparin|mesh-list
101604347|NCT02672566|Anticoagulants|anticoagulants|mesh-ancestor
101604348|NCT02672566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101604349|NCT02672566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101604350|NCT02672566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604351|NCT02672488|Metformin|metformin|mesh-list
101604352|NCT02672488|Sorafenib|sorafenib|mesh-list
101604353|NCT02672488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101604354|NCT02672488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604355|NCT02672488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101604356|NCT02672488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101604357|NCT02672488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102033033|NCT03633591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102033034|NCT03633591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033036|NCT01376271|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102033037|NCT01376271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102033038|NCT01376271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102033039|NCT01376271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033040|NCT01376271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102033041|NCT01376271|Serotonin Agents|serotonin agents|mesh-ancestor
102033042|NCT01376271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033043|NCT01376271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102033044|NCT01376271|Antidepressive Agents|antidepressive agents|mesh-ancestor
102033045|NCT01376271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102033046|NCT01376271|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102033047|NCT01376271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102033048|NCT01376271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102033049|NCT04885881|Lidocaine|lidocaine|mesh-list
102033050|NCT04885881|Anesthetics, Local|anesthetics, local|mesh-ancestor
102033051|NCT04885881|Anesthetics|anesthetics|mesh-ancestor
102033052|NCT04885881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102033053|NCT04885881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033054|NCT04885881|Sensory System Agents|sensory system agents|mesh-ancestor
102033055|NCT04885881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102033056|NCT04885881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101334565|NCT00044785|Immunologic Factors|immunologic factors|mesh-ancestor
101604358|NCT02672488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604359|NCT02537392|Folic Acid|folic acid|mesh-list
101604360|NCT02537392|Vitamin B Complex|vitamin b complex|mesh-list
101604361|NCT02537392|Vitamins|vitamins|mesh-ancestor
101604362|NCT02537392|Micronutrients|micronutrients|mesh-ancestor
101604363|NCT02537392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604364|NCT02537392|Hematinics|hematinics|mesh-ancestor
101604365|NCT02673814|Durvalumab|durvalumab|mesh-list
101604366|NCT02673814|Bavituximab|bavituximab|mesh-list
101604367|NCT02673814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101604368|NCT02673814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101604369|NCT00644176|Azithromycin|azithromycin|mesh-list
101604370|NCT00644176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101604371|NCT00644176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101604372|NCT04178200|Lidocaine|lidocaine|mesh-list
101604377|NCT04178200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101604378|NCT04178200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604379|NCT04178200|Sensory System Agents|sensory system agents|mesh-ancestor
101604380|NCT04178200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101604381|NCT04178200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101604382|NCT04178200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102033057|NCT04885881|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102033058|NCT04885881|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102033059|NCT04885881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102033060|NCT04885881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033061|NCT04820205|Dexmedetomidine|dexmedetomidine|mesh-list
102033062|NCT04820205|Ketamine|ketamine|mesh-list
102033063|NCT04820205|Chloral Hydrate|chloral hydrate|mesh-list
102033064|NCT04820205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102033065|NCT04820205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102033066|NCT04820205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033067|NCT04820205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102033068|NCT04820205|Analgesics|analgesics|mesh-ancestor
102033069|NCT04820205|Sensory System Agents|sensory system agents|mesh-ancestor
102033070|NCT04820205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102033071|NCT04820205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102033072|NCT04820205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102033073|NCT04820205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102033074|NCT04820205|Adrenergic Agents|adrenergic agents|mesh-ancestor
101752850|NCT00723164|GABA Modulators|gaba modulators|mesh-ancestor
102033075|NCT04820205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102033076|NCT04820205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033077|NCT04820205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102033078|NCT04820205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101334588|NCT00018213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101604383|NCT04178200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101604384|NCT04178200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101604385|NCT04178200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604387|NCT02537158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101604388|NCT02537158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101604389|NCT02537158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101604390|NCT02537158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604391|NCT02676154|Fesoterodine|fesoterodine|mesh-list
101604392|NCT02676154|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101604393|NCT02676154|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101604394|NCT02676154|Cholinergic Agents|cholinergic agents|mesh-ancestor
101604395|NCT02676154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101604396|NCT02676154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777298|NCT02557958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101604397|NCT02676154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604398|NCT02676154|Urological Agents|urological agents|mesh-ancestor
101604399|NCT02676310|Bimatoprost|bimatoprost|mesh-list
101604400|NCT02676310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101604401|NCT04177186|Botulinum Toxins|botulinum toxins|mesh-list
101604402|NCT04177186|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101604403|NCT04177186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101604404|NCT04177186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604405|NCT04177186|Cholinergic Agents|cholinergic agents|mesh-ancestor
101604406|NCT04177186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102033079|NCT04820205|Anesthetics, General|anesthetics, general|mesh-ancestor
102033080|NCT04820205|Anesthetics|anesthetics|mesh-ancestor
102033081|NCT04820205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102033082|NCT04820205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102033083|NCT01375257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102033084|NCT01375257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102033085|NCT01375257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102033086|NCT01375257|Antitubercular Agents|antitubercular agents|mesh-ancestor
102033087|NCT01375335|Dobutamine|dobutamine|mesh-list
102033088|NCT01375335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102033089|NCT01375335|Sympathomimetics|sympathomimetics|mesh-ancestor
102033090|NCT01375335|Autonomic Agents|autonomic agents|mesh-ancestor
102033091|NCT01375335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102033092|NCT01375335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033093|NCT01375335|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102033094|NCT01375335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102033095|NCT01375335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102033096|NCT01375335|Adrenergic Agents|adrenergic agents|mesh-ancestor
102033097|NCT01375335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102033098|NCT01375335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033099|NCT01375335|Protective Agents|protective agents|mesh-ancestor
102033100|NCT01373463|Carboplatin|carboplatin|mesh-list
102033101|NCT01373463|Pemetrexed|pemetrexed|mesh-list
102033102|NCT01373463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033103|NCT01373463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102033109|NCT03113409|Naltrexone|naltrexone|mesh-list
102033129|NCT03634293|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102033130|NCT03634293|Protease Inhibitors|protease inhibitors|mesh-ancestor
102033131|NCT03634293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102033132|NCT03634293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102033133|NCT01373541|Palmitic Acid|palmitic acid|mesh-list
102033134|NCT01373541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102033135|NCT01373541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033136|NCT03633747|Propranolol|propranolol|mesh-list
102033137|NCT03633747|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102033138|NCT03633747|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102033139|NCT03633747|Adrenergic Agents|adrenergic agents|mesh-ancestor
102033140|NCT03633747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102033141|NCT03633747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033142|NCT03633747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033143|NCT03633747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102033144|NCT03633747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102033145|NCT03633747|Vasodilator Agents|vasodilator agents|mesh-ancestor
102033146|NCT01376817|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102033147|NCT01376817|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102033148|NCT01376817|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102033149|NCT01376817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101752923|NCT00618748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102033151|NCT01373697|Ketoprofen|ketoprofen|mesh-list
101334666|NCT02970682|Tamoxifen|tamoxifen|mesh-list
101604407|NCT04177186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604408|NCT04180384|Paclitaxel|paclitaxel|mesh-list
101604409|NCT04180384|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101604410|NCT04180384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101604411|NCT04180384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101604412|NCT04180384|Tubulin Modulators|tubulin modulators|mesh-ancestor
101604413|NCT04180384|Antimitotic Agents|antimitotic agents|mesh-ancestor
101604414|NCT04180384|Mitosis Modulators|mitosis modulators|mesh-ancestor
101604415|NCT04180384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604416|NCT00643240|Antibodies|antibodies|mesh-list
101604417|NCT00643240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101604418|NCT00643240|Immunologic Factors|immunologic factors|mesh-ancestor
101604419|NCT00643240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604420|NCT02671708|Cyclophosphamide|cyclophosphamide|mesh-list
101604421|NCT02671708|Busulfan|busulfan|mesh-list
101604422|NCT02671708|Idarubicin|idarubicin|mesh-list
101604423|NCT02671708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101604424|NCT02671708|Immunologic Factors|immunologic factors|mesh-ancestor
101604425|NCT02671708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604426|NCT02671708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101604427|NCT02671708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101604428|NCT02671708|Alkylating Agents|alkylating agents|mesh-ancestor
101604429|NCT02671708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604430|NCT02671708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101604431|NCT02671708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102033152|NCT01373697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102033153|NCT01373697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102033154|NCT01373697|Analgesics|analgesics|mesh-ancestor
102033155|NCT01373697|Sensory System Agents|sensory system agents|mesh-ancestor
102033156|NCT01373697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102033157|NCT01373697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033158|NCT01373697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102033159|NCT01373697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102033160|NCT01373697|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102033161|NCT01373697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102033162|NCT01373697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033163|NCT01375881|Ritonavir|ritonavir|mesh-list
102033164|NCT01375881|Darunavir|darunavir|mesh-list
102033165|NCT01375881|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102033166|NCT01375881|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102033167|NCT01375881|Protease Inhibitors|protease inhibitors|mesh-ancestor
102033168|NCT01375881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102033169|NCT01375881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033170|NCT01375881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102033171|NCT01375881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102033172|NCT01375881|Antiviral Agents|antiviral agents|mesh-ancestor
102033173|NCT01375881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102033174|NCT01375881|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102033175|NCT01375881|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102033176|NCT04690023|Ropivacaine|ropivacaine|mesh-list
102033177|NCT04690023|Anesthetics, Local|anesthetics, local|mesh-ancestor
102033178|NCT04690023|Anesthetics|anesthetics|mesh-ancestor
102033179|NCT04690023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102033180|NCT04690023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604432|NCT02671708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101604433|NCT02671708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101604434|NCT02671708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101604435|NCT02671708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101604436|NCT04176328|Teicoplanin|teicoplanin|mesh-list
101604437|NCT04176328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101777333|NCT00773084|Lisinopril|lisinopril|mesh-list
101604438|NCT04176328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101604439|NCT04177342|Fentanyl|fentanyl|mesh-list
101604440|NCT04177342|Oxycodone|oxycodone|mesh-list
101604441|NCT04177342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101604442|NCT04177342|Narcotics|narcotics|mesh-ancestor
101604460|NCT05243524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101604461|NCT05243524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101604462|NCT04175158|Bevacizumab|bevacizumab|mesh-list
101604463|NCT04175158|Endothelial Growth Factors|endothelial growth factors|mesh-list
101604464|NCT04175158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102033181|NCT04690023|Sensory System Agents|sensory system agents|mesh-ancestor
102033182|NCT04690023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102033183|NCT03066804|Valsartan|valsartan|mesh-list
102033184|NCT03066804|Enalapril|enalapril|mesh-list
102033185|NCT03066804|Enalaprilat|enalaprilat|mesh-list
102033186|NCT03066804|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102033187|NCT03066804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102033188|NCT03066804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102033189|NCT03066804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102033190|NCT03066804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033191|NCT03066804|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102033192|NCT03066804|Protease Inhibitors|protease inhibitors|mesh-ancestor
102033193|NCT03066804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102033194|NCT03629262|Sufentanil|sufentanil|mesh-list
102033195|NCT03629262|Dexmedetomidine|dexmedetomidine|mesh-list
102033197|NCT03629262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101604465|NCT04175158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101604466|NCT04175158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101604467|NCT04175158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101604468|NCT04175158|Growth Substances|growth substances|mesh-ancestor
101604469|NCT04175158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604470|NCT04175158|Growth Inhibitors|growth inhibitors|mesh-ancestor
101604471|NCT02671318|Sirolimus|sirolimus|mesh-list
101604472|NCT02671318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101604473|NCT02671318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101604474|NCT02671318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101604475|NCT02671318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101604476|NCT02671318|Antifungal Agents|antifungal agents|mesh-ancestor
101604477|NCT02671318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101604478|NCT02671318|Immunologic Factors|immunologic factors|mesh-ancestor
101604479|NCT02671318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604480|NCT00644722|Pyrithione zinc|pyrithione zinc|mesh-list
101604481|NCT00644722|Keratolytic Agents|keratolytic agents|mesh-ancestor
101604482|NCT00644722|Dermatologic Agents|dermatologic agents|mesh-ancestor
101604483|NCT02668588|Octreotide|octreotide|mesh-list
101604484|NCT02668588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101604485|NCT02668588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101604486|NCT02668588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101604487|NCT02671084|Sevoflurane|sevoflurane|mesh-list
101604488|NCT02671084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101604489|NCT02671084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101604490|NCT02671084|Anesthetics, General|anesthetics, general|mesh-ancestor
101604491|NCT02671084|Anesthetics|anesthetics|mesh-ancestor
101604492|NCT02671084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101604493|NCT02671084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604494|NCT00644800|Ziprasidone|ziprasidone|mesh-list
101604495|NCT00644800|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101604496|NCT00644800|Serotonin Agents|serotonin agents|mesh-ancestor
101604497|NCT00644800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101604498|NCT00644800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604499|NCT00644800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604512|NCT02670616|Immunologic Factors|immunologic factors|mesh-ancestor
101604513|NCT02670616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604514|NCT02670616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101604515|NCT02670616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101604516|NCT02670616|Alkylating Agents|alkylating agents|mesh-ancestor
101604517|NCT02670616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604518|NCT02670616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033198|NCT03629262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102033199|NCT03629262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033200|NCT03629262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102033202|NCT03629262|Sensory System Agents|sensory system agents|mesh-ancestor
102033203|NCT03629262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102033204|NCT03629262|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102033205|NCT03629262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102033206|NCT03629262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102033207|NCT03629262|Adrenergic Agents|adrenergic agents|mesh-ancestor
102033208|NCT03629262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102033209|NCT03629262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033210|NCT03629262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102033211|NCT03629262|Narcotics|narcotics|mesh-ancestor
102033212|NCT03629262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102033213|NCT03629262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102033214|NCT03629262|Anesthetics, General|anesthetics, general|mesh-ancestor
102033215|NCT03629262|Anesthetics|anesthetics|mesh-ancestor
102033216|NCT05208294|Sulpiride|sulpiride|mesh-list
102033217|NCT05208294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102033218|NCT05208294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102033219|NCT05208294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102033220|NCT05208294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033221|NCT05208294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102033222|NCT05208294|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102033223|NCT05208294|Dopamine Agents|dopamine agents|mesh-ancestor
102033224|NCT05208294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102033225|NCT05208294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033226|NCT05208294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102033227|NCT05208294|Antidepressive Agents|antidepressive agents|mesh-ancestor
102033228|NCT05213988|Clofibric Acid|clofibric acid|mesh-list
102033229|NCT05213988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102033230|NCT05213988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102033231|NCT05213988|Antimetabolites|antimetabolites|mesh-ancestor
101604519|NCT02670616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101604520|NCT02670616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101604522|NCT02670616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101604523|NCT02670616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101604524|NCT02670616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101604525|NCT02670616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102033232|NCT05213988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033233|NCT05213988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102033234|NCT05207904|Paclitaxel|paclitaxel|mesh-list
102033235|NCT05207904|Carboplatin|carboplatin|mesh-list
102033236|NCT05207904|Tislelizumab|tislelizumab|mesh-list
102033237|NCT05207904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102033238|NCT05207904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033239|NCT05207904|Tubulin Modulators|tubulin modulators|mesh-ancestor
102033240|NCT05207904|Antimitotic Agents|antimitotic agents|mesh-ancestor
102033241|NCT05207904|Mitosis Modulators|mitosis modulators|mesh-ancestor
102033242|NCT05207904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033243|NCT05207904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102033244|NCT05207514|Ethanol|ethanol|mesh-list
102033245|NCT05207514|Cyclophosphamide|cyclophosphamide|mesh-list
102033246|NCT05207514|Docetaxel|docetaxel|mesh-list
102033247|NCT05207514|Doxorubicin|doxorubicin|mesh-list
102033248|NCT05207514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102033249|NCT05207514|Immunologic Factors|immunologic factors|mesh-ancestor
102033250|NCT05207514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033251|NCT05207514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102033252|NCT05207514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101604526|NCT02670616|Tubulin Modulators|tubulin modulators|mesh-ancestor
101604527|NCT02670616|Antimitotic Agents|antimitotic agents|mesh-ancestor
101604528|NCT02670616|Mitosis Modulators|mitosis modulators|mesh-ancestor
101604529|NCT02670616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101604530|NCT02670616|Glucocorticoids|glucocorticoids|mesh-ancestor
101604531|NCT02670616|Hormones|hormones|mesh-ancestor
101604532|NCT02670616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101604533|NCT02670616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101604534|NCT00645502|Risperidone|risperidone|mesh-list
101604535|NCT00645502|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101604536|NCT00645502|Serotonin Agents|serotonin agents|mesh-ancestor
101604537|NCT00645502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101604538|NCT00645502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604539|NCT00645502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604540|NCT00645502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101604541|NCT00645502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101604542|NCT00645502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101604543|NCT00645502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101604544|NCT00645502|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101604545|NCT00645502|Dopamine Agents|dopamine agents|mesh-ancestor
101604546|NCT00644956|Sildenafil Citrate|sildenafil citrate|mesh-list
101604547|NCT00644956|Tadalafil|tadalafil|mesh-list
101604548|NCT00644956|Vasodilator Agents|vasodilator agents|mesh-ancestor
101604549|NCT00644956|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101604550|NCT00644956|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101604551|NCT00644956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101604552|NCT00644956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604553|NCT00644956|Urological Agents|urological agents|mesh-ancestor
101261526|NCT01750541|Haloperidol|haloperidol|mesh-list
101604554|NCT04175002|Progesterone|progesterone|mesh-list
101604555|NCT04175002|Progestins|progestins|mesh-ancestor
101604557|NCT04175002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101604558|NCT04175002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033253|NCT05207514|Alkylating Agents|alkylating agents|mesh-ancestor
102033254|NCT05207514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033255|NCT05207514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033256|NCT05207514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102033257|NCT05207514|Tubulin Modulators|tubulin modulators|mesh-ancestor
102033258|NCT05207514|Antimitotic Agents|antimitotic agents|mesh-ancestor
102033259|NCT05207514|Mitosis Modulators|mitosis modulators|mesh-ancestor
102033260|NCT05207514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102033261|NCT05207514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102033262|NCT05207514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102033263|NCT05207514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102033264|NCT05207514|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102033265|NCT05207514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102033266|NCT05207514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102033267|NCT03118947|Pimavanserin|pimavanserin|mesh-list
102033268|NCT03118947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102033269|NCT03118947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102033270|NCT03118947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102033271|NCT03118947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102033272|NCT03118947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102033273|NCT03118947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033274|NCT03118947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102033275|NCT03118947|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102033276|NCT03118947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102033277|NCT03118947|Serotonin Agents|serotonin agents|mesh-ancestor
102033278|NCT03118947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102033279|NCT03118947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033280|NCT03998319|Tenecteplase|tenecteplase|mesh-list
102033281|NCT03998319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102033282|NCT03998319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101334791|NCT04394130|Ropivacaine|ropivacaine|mesh-list
101604559|NCT02670772|Tenofovir|tenofovir|mesh-list
101604560|NCT02670772|Stavudine|stavudine|mesh-list
101604561|NCT02670772|Antiviral Agents|antiviral agents|mesh-ancestor
101604562|NCT02670772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101604563|NCT02670772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101604564|NCT02670772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101604565|NCT02670772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101604574|NCT02667730|Analgesics|analgesics|mesh-ancestor
101604575|NCT02667730|Sensory System Agents|sensory system agents|mesh-ancestor
101604576|NCT02667730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101604577|NCT02667730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604578|NCT02667730|Antipyretics|antipyretics|mesh-ancestor
101604579|NCT02667730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102033283|NCT03998319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033285|NCT03953079|Aflibercept|aflibercept|mesh-list
102033286|NCT03953079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033287|NCT03953079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102033288|NCT03953079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102033289|NCT03953079|Growth Substances|growth substances|mesh-ancestor
102033290|NCT03953079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033291|NCT03953079|Growth Inhibitors|growth inhibitors|mesh-ancestor
102033292|NCT03953079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102033293|NCT03953079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102033294|NCT03953079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033295|NCT03794427|Anesthetics|anesthetics|mesh-list
102033296|NCT03794427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101604580|NCT02667730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101604581|NCT02667730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101604582|NCT02667730|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101604583|NCT02667730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101604584|NCT02667730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101604585|NCT02667730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604586|NCT02667730|Gout Suppressants|gout suppressants|mesh-ancestor
101604587|NCT04294992|Ondansetron|ondansetron|mesh-list
101604588|NCT04294992|Antiemetics|antiemetics|mesh-ancestor
101604589|NCT04294992|Autonomic Agents|autonomic agents|mesh-ancestor
101604590|NCT04294992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101604591|NCT04294992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604592|NCT04294992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101604593|NCT04294992|Antipruritics|antipruritics|mesh-ancestor
101604594|NCT04294992|Dermatologic Agents|dermatologic agents|mesh-ancestor
101604595|NCT04294992|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101604596|NCT04294992|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101604597|NCT04294992|Serotonin Agents|serotonin agents|mesh-ancestor
101604598|NCT04294992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101604599|NCT04294992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604601|NCT00628914|Eszopiclone|eszopiclone|mesh-list
101604602|NCT00628914|Citalopram|citalopram|mesh-list
101604603|NCT00628914|Escitalopram|escitalopram|mesh-list
101604604|NCT00628914|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101604605|NCT00628914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101604606|NCT00628914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101604607|NCT00628914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604608|NCT00628914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101604609|NCT00628914|Serotonin Agents|serotonin agents|mesh-ancestor
101604610|NCT00628914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604611|NCT00628914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101777377|NCT00776828|Cilostazol|cilostazol|mesh-list
101604612|NCT00628914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101604613|NCT00628914|Parasympatholytics|parasympatholytics|mesh-ancestor
101604614|NCT00628914|Autonomic Agents|autonomic agents|mesh-ancestor
101604615|NCT00628914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101604616|NCT00628914|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101604617|NCT00628914|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101604618|NCT00628914|Cholinergic Agents|cholinergic agents|mesh-ancestor
101604619|NCT00628914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101604620|NCT00628914|Antidepressive Agents|antidepressive agents|mesh-ancestor
101604621|NCT00628914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101604622|NCT00628914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101604623|NCT00628914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101604624|NCT02870634|Copper|copper|mesh-list
101604625|NCT02870634|Trace Elements|trace elements|mesh-ancestor
101604626|NCT02870634|Micronutrients|micronutrients|mesh-ancestor
102033297|NCT03794427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753069|NCT00853294|Histamine Agents|histamine agents|mesh-ancestor
102033299|NCT03410901|Immunologic Factors|immunologic factors|mesh-ancestor
102033300|NCT03410901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033302|NCT03357939|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102033303|NCT03357939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102033304|NCT03357939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102033305|NCT03567057|Amantadine|amantadine|mesh-list
102033306|NCT03567057|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102033307|NCT03567057|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102033308|NCT03567057|Antiviral Agents|antiviral agents|mesh-ancestor
102033309|NCT03567057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102033310|NCT03567057|Dopamine Agents|dopamine agents|mesh-ancestor
102033311|NCT03567057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102033312|NCT03567057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033313|NCT03567057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033314|NCT03567057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102033315|NCT03567057|Analgesics|analgesics|mesh-ancestor
102033316|NCT03567057|Sensory System Agents|sensory system agents|mesh-ancestor
102033317|NCT03567057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102033318|NCT03057600|Paclitaxel|paclitaxel|mesh-list
102033319|NCT03057600|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102033320|NCT03057600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033321|NCT03057600|Tubulin Modulators|tubulin modulators|mesh-ancestor
102033322|NCT03057600|Antimitotic Agents|antimitotic agents|mesh-ancestor
102033323|NCT03057600|Mitosis Modulators|mitosis modulators|mesh-ancestor
102033324|NCT03057600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033325|NCT04382937|Ribavirin|ribavirin|mesh-list
102033326|NCT04382937|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102033327|NCT04382937|Antimetabolites|antimetabolites|mesh-ancestor
101604627|NCT02870634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604628|NCT00645580|Fluvoxamine|fluvoxamine|mesh-list
101604629|NCT00645580|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101604630|NCT00645580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101604631|NCT00645580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101604632|NCT00645580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604633|NCT00645580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101604637|NCT00645580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604638|NCT00645580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101604639|NCT00645580|Serotonin Agents|serotonin agents|mesh-ancestor
101604640|NCT00645580|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101604641|NCT00645580|Antidepressive Agents|antidepressive agents|mesh-ancestor
102033328|NCT04382937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033329|NCT04382937|Antiviral Agents|antiviral agents|mesh-ancestor
102033330|NCT04382937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102033331|NCT05206890|Fluzoparib|fluzoparib|mesh-list
102033332|NCT05206890|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102033333|NCT05206890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101604642|NCT00645580|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101604643|NCT00645580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101604644|NCT00645580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101604645|NCT00645580|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101604646|NCT02670304|Aspirin|aspirin|mesh-list
101604647|NCT02670304|Letrozole|letrozole|mesh-list
101604648|NCT02670304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101604649|NCT02670304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101604650|NCT02670304|Analgesics|analgesics|mesh-ancestor
101604651|NCT02670304|Sensory System Agents|sensory system agents|mesh-ancestor
101604652|NCT02670304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101604653|NCT02670304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604654|NCT02670304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101604655|NCT02670304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101604656|NCT02670304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101604657|NCT02670304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101604658|NCT02670304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604659|NCT02670304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101604660|NCT02670304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101604661|NCT02670304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101604662|NCT02670304|Antipyretics|antipyretics|mesh-ancestor
101604663|NCT02670304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101604664|NCT02670304|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101604665|NCT02670304|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101604666|NCT02670304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101604667|NCT02670304|Hormone Antagonists|hormone antagonists|mesh-ancestor
101604668|NCT02670304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101604669|NCT00998946|Vitamins|vitamins|mesh-list
101604670|NCT00998946|Folic Acid|folic acid|mesh-list
101604671|NCT00998946|Vitamin B 12|vitamin b 12|mesh-list
101604672|NCT00998946|Vitamin B Complex|vitamin b complex|mesh-list
101604673|NCT00998946|10-deazaaminopterin|10-deazaaminopterin|mesh-list
101604674|NCT00998946|Micronutrients|micronutrients|mesh-ancestor
101604675|NCT00998946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604676|NCT00998946|Hematinics|hematinics|mesh-ancestor
101604677|NCT00998946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101604678|NCT00998946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101604679|NCT00998946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101604680|NCT00998946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604681|NCT01158404|LY900009|ly900009|mesh-list
101604682|NCT01158404|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101604683|NCT01158404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101604684|NCT01158404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604685|NCT02670070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101604686|NCT02670070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101604687|NCT02670070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101604688|NCT02670070|Antimetabolites|antimetabolites|mesh-ancestor
101604689|NCT02670070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604690|NCT02670070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101604691|NCT02670070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101604692|NCT02670070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101604693|NCT00645034|Sildenafil Citrate|sildenafil citrate|mesh-list
101604694|NCT00645034|Vasodilator Agents|vasodilator agents|mesh-ancestor
101604695|NCT00645034|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101604696|NCT00645034|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101604697|NCT00645034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101604698|NCT00645034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604699|NCT00645034|Urological Agents|urological agents|mesh-ancestor
101604700|NCT04173832|Amantadine|amantadine|mesh-list
101604701|NCT04173832|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101604702|NCT04173832|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102033334|NCT05206890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033335|NCT05206890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033336|NCT02966301|Arsenic Trioxide|arsenic trioxide|mesh-list
102033337|NCT02966301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033338|NCT03107091|Terlipressin|terlipressin|mesh-list
102033339|NCT03107091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102033340|NCT03107091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102033341|NCT03849768|Gefitinib|gefitinib|mesh-list
102033342|NCT03849768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033343|NCT03849768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102033344|NCT03849768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102033345|NCT03849768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033346|NCT03189693|Anesthetics|anesthetics|mesh-list
102033347|NCT03189693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102033348|NCT03189693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604712|NCT04173832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101604713|NCT00645658|Testosterone|testosterone|mesh-list
101604714|NCT00645658|Androgens|androgens|mesh-ancestor
101604715|NCT00645658|Hormones|hormones|mesh-ancestor
101604716|NCT00645658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101604717|NCT00645658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604718|NCT02666170|Thioctic Acid|thioctic acid|mesh-list
101604719|NCT02666170|Antioxidants|antioxidants|mesh-ancestor
101604720|NCT02666170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604721|NCT02666170|Protective Agents|protective agents|mesh-ancestor
101604722|NCT02666170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604723|NCT02666170|Vitamin B Complex|vitamin b complex|mesh-ancestor
101604724|NCT02666170|Vitamins|vitamins|mesh-ancestor
101604725|NCT02666170|Micronutrients|micronutrients|mesh-ancestor
101604726|NCT02667262|Analgesics, Opioid|analgesics, opioid|mesh-list
101604727|NCT02667262|Narcotics|narcotics|mesh-ancestor
101604728|NCT02667262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101604729|NCT02667262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604730|NCT02667262|Analgesics|analgesics|mesh-ancestor
101604731|NCT02667262|Sensory System Agents|sensory system agents|mesh-ancestor
101604732|NCT02667262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101604733|NCT00646126|Artesunate|artesunate|mesh-list
101604734|NCT00646126|Pyrimethamine|pyrimethamine|mesh-list
101604735|NCT00646126|Sulfadoxine|sulfadoxine|mesh-list
101604736|NCT00646126|Antimalarials|antimalarials|mesh-ancestor
101604737|NCT00646126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101604738|NCT00646126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101604739|NCT00646126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101604740|NCT00646126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101604741|NCT00646126|Antiviral Agents|antiviral agents|mesh-ancestor
101604742|NCT00646126|Schistosomicides|schistosomicides|mesh-ancestor
101604743|NCT00646126|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101604744|NCT00646126|Anthelmintics|anthelmintics|mesh-ancestor
101604745|NCT00646126|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101604746|NCT00646126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101604747|NCT00646126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604748|NCT00646126|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101604749|NCT02537080|Nimodipine|nimodipine|mesh-list
101604750|NCT02537080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101604751|NCT02537080|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101604752|NCT02537080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101604753|NCT02537080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604754|NCT02537080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101604755|NCT02537080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033349|NCT03065400|Pembrolizumab|pembrolizumab|mesh-list
102033350|NCT03065400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102033351|NCT03065400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033352|NCT03065400|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102033353|NCT03065400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033354|NCT05734716|Epoetin Alfa|epoetin alfa|mesh-list
102033355|NCT05734716|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
102033356|NCT05734716|Hematinics|hematinics|mesh-ancestor
102033357|NCT05733000|Thioctic Acid|thioctic acid|mesh-list
102033358|NCT05733000|Hydroxychloroquine|hydroxychloroquine|mesh-list
102033359|NCT05733000|Gemcitabine|gemcitabine|mesh-list
102033360|NCT05733000|Fluorouracil|fluorouracil|mesh-list
102033361|NCT05733000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101604756|NCT02537080|Vasodilator Agents|vasodilator agents|mesh-ancestor
101604757|NCT02667496|Sargramostim|sargramostim|mesh-list
101604758|NCT02667496|Immunologic Factors|immunologic factors|mesh-ancestor
101604759|NCT02667496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604760|NCT00645112|Azithromycin|azithromycin|mesh-list
101604761|NCT00645112|Cefdinir|cefdinir|mesh-list
101604762|NCT00645112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101604763|NCT00645112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101604764|NCT02666092|Antibodies|antibodies|mesh-list
101604765|NCT02666092|Immunologic Factors|immunologic factors|mesh-ancestor
101604766|NCT02666092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604767|NCT00645814|Adalimumab|adalimumab|mesh-list
101604768|NCT00645814|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101604769|NCT00645814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101604770|NCT00645814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101604771|NCT04174378|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101604776|NCT04174378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604777|NCT04174378|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101604778|NCT04174378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101604779|NCT04174378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101604781|NCT00645892|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101604782|NCT00645892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101604783|NCT00645892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101604784|NCT00645190|Galantamine|galantamine|mesh-list
101604785|NCT00645190|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101604786|NCT00645190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101604787|NCT00645190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604788|NCT00645190|Cholinergic Agents|cholinergic agents|mesh-ancestor
101604789|NCT00645190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101604790|NCT00645190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604791|NCT00645190|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101604792|NCT00645190|Autonomic Agents|autonomic agents|mesh-ancestor
101604793|NCT00645190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101604794|NCT00645190|Nootropic Agents|nootropic agents|mesh-ancestor
101604795|NCT00910390|Ethylene|ethylene|mesh-list
101604796|NCT00910390|Plant Growth Regulators|plant growth regulators|mesh-ancestor
101604797|NCT00910390|Growth Substances|growth substances|mesh-ancestor
101604798|NCT00910390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604799|NCT02665936|Dexamethasone|dexamethasone|mesh-list
101604800|NCT02665936|Dexamethasone acetate|dexamethasone acetate|mesh-list
101604801|NCT02665936|Levobupivacaine|levobupivacaine|mesh-list
101604802|NCT02665936|BB 1101|bb 1101|mesh-list
101604803|NCT02665936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101604804|NCT02665936|Antiemetics|antiemetics|mesh-ancestor
101604805|NCT02665936|Autonomic Agents|autonomic agents|mesh-ancestor
101604806|NCT02665936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101604807|NCT02665936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604808|NCT02665936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101604809|NCT02665936|Glucocorticoids|glucocorticoids|mesh-ancestor
101604810|NCT02665936|Hormones|hormones|mesh-ancestor
101604811|NCT02665936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101604812|NCT02665936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102033362|NCT05733000|Antimetabolites|antimetabolites|mesh-ancestor
102033363|NCT05733000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033364|NCT05733000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033365|NCT05733000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102033366|NCT05733000|Immunologic Factors|immunologic factors|mesh-ancestor
102033367|NCT05733000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033368|NCT05733000|Antimalarials|antimalarials|mesh-ancestor
102033369|NCT05733000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102033370|NCT05733000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101753150|NCT00724022|Hormones|hormones|mesh-ancestor
101604813|NCT02665936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101604814|NCT02665936|Protease Inhibitors|protease inhibitors|mesh-ancestor
101604815|NCT02665936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101604816|NCT02665936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604817|NCT02665936|Anesthetics, Local|anesthetics, local|mesh-ancestor
101604818|NCT02665936|Anesthetics|anesthetics|mesh-ancestor
101604819|NCT02665936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101604820|NCT02665936|Sensory System Agents|sensory system agents|mesh-ancestor
101604821|NCT02665780|Cetylpyridinium|cetylpyridinium|mesh-list
101604822|NCT02665780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101604823|NCT02665780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101604824|NCT04292886|Tamoxifen|tamoxifen|mesh-list
101604825|NCT04292886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604826|NCT04292886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101604827|NCT04292886|Hormone Antagonists|hormone antagonists|mesh-ancestor
101777408|NCT02556866|Hormones|hormones|mesh-ancestor
101604828|NCT04292886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101604829|NCT04292886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101604830|NCT04292886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101604831|NCT04292886|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101604832|NCT04292886|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101604833|NCT04292886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101604834|NCT04292418|Mycophenolic Acid|mycophenolic acid|mesh-list
101604835|NCT04292418|Tacrolimus|tacrolimus|mesh-list
101604836|NCT04292418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101604837|NCT04292418|Immunologic Factors|immunologic factors|mesh-ancestor
101604838|NCT04292418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604839|NCT04292418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101604840|NCT04292418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101604841|NCT04292418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604855|NCT02666716|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101604856|NCT02666716|Hormone Antagonists|hormone antagonists|mesh-ancestor
101604857|NCT02666716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101604858|NCT02666716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604859|NCT02666716|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101604860|NCT02666716|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101604861|NCT04064476|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101604862|NCT04064476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101604863|NCT04064476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101604864|NCT04064476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101604865|NCT04064476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604866|NCT04064476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101604867|NCT04064476|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101604868|NCT04064476|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101604869|NCT04064476|Serotonin Agents|serotonin agents|mesh-ancestor
101604870|NCT04064476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101604871|NCT04064476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604872|NCT04064476|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101604873|NCT04064476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101604874|NCT04064476|Dopamine Agents|dopamine agents|mesh-ancestor
101604875|NCT02669368|Magnesium Sulfate|magnesium sulfate|mesh-list
101604877|NCT02669368|Analgesics|analgesics|mesh-ancestor
101604878|NCT02669368|Sensory System Agents|sensory system agents|mesh-ancestor
101604879|NCT02669368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102033371|NCT05733000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102033372|NCT05733000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102033373|NCT05733000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102033374|NCT05733000|Antioxidants|antioxidants|mesh-ancestor
102033375|NCT05733000|Protective Agents|protective agents|mesh-ancestor
102033376|NCT05733000|Vitamin B Complex|vitamin b complex|mesh-ancestor
102033377|NCT05733000|Vitamins|vitamins|mesh-ancestor
101604880|NCT02669368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604881|NCT02669368|Anesthetics|anesthetics|mesh-ancestor
101604882|NCT02669368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101604883|NCT02669368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101604884|NCT02669368|Anticonvulsants|anticonvulsants|mesh-ancestor
101604885|NCT02669368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101604886|NCT02669368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101604887|NCT02669368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604888|NCT02669368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101604889|NCT02669368|Tocolytic Agents|tocolytic agents|mesh-ancestor
101604890|NCT02669368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101604891|NCT02669368|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101604892|NCT02669368|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101604893|NCT02669368|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101604894|NCT00645268|Sildenafil Citrate|sildenafil citrate|mesh-list
101604895|NCT00645268|Vasodilator Agents|vasodilator agents|mesh-ancestor
101604896|NCT00645268|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101604897|NCT00645268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101604902|NCT02666014|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101604903|NCT02666014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101604904|NCT02666014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604905|NCT02666014|Cholinergic Agents|cholinergic agents|mesh-ancestor
101604906|NCT02666014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101604907|NCT02666014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604908|NCT02666014|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101604909|NCT02666014|Autonomic Agents|autonomic agents|mesh-ancestor
101604910|NCT02666014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101604911|NCT02665702|Cisplatin|cisplatin|mesh-list
101604912|NCT02665702|Vinorelbine|vinorelbine|mesh-list
101604913|NCT02665702|Endostar protein|endostar protein|mesh-list
101604914|NCT02665702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101604915|NCT02665702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101604916|NCT02665702|Tubulin Modulators|tubulin modulators|mesh-ancestor
101604917|NCT02665702|Antimitotic Agents|antimitotic agents|mesh-ancestor
101604918|NCT02665702|Mitosis Modulators|mitosis modulators|mesh-ancestor
101604919|NCT02665702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604920|NCT02665702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101604921|NCT02665702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101604922|NCT02665702|Growth Substances|growth substances|mesh-ancestor
101604923|NCT02665702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261912|NCT01754116|Midazolam|midazolam|mesh-list
101604924|NCT02665702|Growth Inhibitors|growth inhibitors|mesh-ancestor
101604925|NCT00646750|Rituximab|rituximab|mesh-list
101604926|NCT00646750|Melphalan|melphalan|mesh-list
101604927|NCT00646750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101604928|NCT00646750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101604929|NCT00646750|Immunologic Factors|immunologic factors|mesh-ancestor
101604930|NCT00646750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604931|NCT00646750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101604932|NCT00646750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101604933|NCT00646750|Alkylating Agents|alkylating agents|mesh-ancestor
101604934|NCT00646750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604935|NCT00646750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101604936|NCT00646750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101604937|NCT00646516|Budesonide|budesonide|mesh-list
101604938|NCT00646516|Formoterol Fumarate|formoterol fumarate|mesh-list
101604939|NCT00646516|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101604940|NCT00646516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101604941|NCT00646516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101604942|NCT00646516|Autonomic Agents|autonomic agents|mesh-ancestor
101604943|NCT00646516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102033378|NCT05733000|Micronutrients|micronutrients|mesh-ancestor
102033379|NCT03417180|Remifentanil|remifentanil|mesh-list
102033380|NCT03417180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102033381|NCT03417180|Narcotics|narcotics|mesh-ancestor
102033382|NCT03417180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102033383|NCT03417180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033384|NCT03417180|Analgesics|analgesics|mesh-ancestor
102033385|NCT03417180|Sensory System Agents|sensory system agents|mesh-ancestor
102033386|NCT03417180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102033387|NCT03085095|Leuprolide|leuprolide|mesh-list
102033388|NCT03085095|Relugolix|relugolix|mesh-list
102033389|NCT03085095|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102033390|NCT03085095|Fertility Agents|fertility agents|mesh-ancestor
102033391|NCT03085095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102033392|NCT03085095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033393|NCT03085095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102033394|NCT03085095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033395|NCT03085095|Androgen Antagonists|androgen antagonists|mesh-ancestor
102033396|NCT03085095|Hormone Antagonists|hormone antagonists|mesh-ancestor
102033397|NCT03085095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102033398|NCT02891811|Thalidomide|thalidomide|mesh-list
102033399|NCT02891811|Dexamethasone|dexamethasone|mesh-list
102033400|NCT02891811|Lenalidomide|lenalidomide|mesh-list
101604944|NCT00646516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604945|NCT00646516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101604946|NCT00646516|Respiratory System Agents|respiratory system agents|mesh-ancestor
101604947|NCT00646516|Glucocorticoids|glucocorticoids|mesh-ancestor
101604948|NCT00646516|Hormones|hormones|mesh-ancestor
101604949|NCT00646516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101604950|NCT00646516|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101604951|NCT00646516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101604952|NCT00646516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101604953|NCT00646516|Adrenergic Agents|adrenergic agents|mesh-ancestor
101604954|NCT00646516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101604955|NCT00646516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604956|NCT02665624|Calcium, Dietary|calcium, dietary|mesh-list
101604957|NCT02665624|Sennosides|sennosides|mesh-list
101604958|NCT02665624|Senna Extract|senna extract|mesh-list
101604959|NCT02665624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101604960|NCT02665624|Calcium|calcium|mesh-list
101604961|NCT02665624|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101604962|NCT02665624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604963|NCT02665624|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101604964|NCT02665624|Laxatives|laxatives|mesh-ancestor
101604965|NCT02665624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101604966|NCT02665624|Cathartics|cathartics|mesh-ancestor
101604967|NCT00646594|Fluticasone|fluticasone|mesh-list
101604972|NCT00646594|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101604973|NCT00646594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101604974|NCT00646594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101604975|NCT00646594|Autonomic Agents|autonomic agents|mesh-ancestor
101604976|NCT00646594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101604977|NCT00646594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033401|NCT02891811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102033402|NCT02891811|Antiemetics|antiemetics|mesh-ancestor
102033403|NCT02891811|Autonomic Agents|autonomic agents|mesh-ancestor
102033404|NCT02891811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102033405|NCT02891811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033406|NCT02891811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102033407|NCT02891811|Glucocorticoids|glucocorticoids|mesh-ancestor
102033408|NCT02891811|Hormones|hormones|mesh-ancestor
102033409|NCT02891811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102033410|NCT02891811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102033411|NCT02891811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033412|NCT02891811|Immunologic Factors|immunologic factors|mesh-ancestor
102033413|NCT02891811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102033414|NCT02891811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102033415|NCT02891811|Growth Substances|growth substances|mesh-ancestor
102033416|NCT02891811|Growth Inhibitors|growth inhibitors|mesh-ancestor
102033417|NCT02891811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102033418|NCT02891811|Leprostatic Agents|leprostatic agents|mesh-ancestor
102033419|NCT02891811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102033420|NCT02891811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101604978|NCT00646594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101604979|NCT00646594|Respiratory System Agents|respiratory system agents|mesh-ancestor
101604980|NCT00646594|Dermatologic Agents|dermatologic agents|mesh-ancestor
101604981|NCT00646594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101604982|NCT00646594|Glucocorticoids|glucocorticoids|mesh-ancestor
101604983|NCT00646594|Hormones|hormones|mesh-ancestor
101604984|NCT00646594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101604985|NCT00646594|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101604986|NCT00646594|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101604987|NCT00646594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101604988|NCT00646594|Adrenergic Agents|adrenergic agents|mesh-ancestor
101604989|NCT00646594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101604990|NCT00646594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604991|NCT00646594|Sympathomimetics|sympathomimetics|mesh-ancestor
101604992|NCT00646984|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101604993|NCT00646984|Antiviral Agents|antiviral agents|mesh-ancestor
101604994|NCT00646984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101604995|NCT04773184|Capsaicin|capsaicin|mesh-list
101604996|NCT04773184|Antipruritics|antipruritics|mesh-ancestor
101604997|NCT04773184|Dermatologic Agents|dermatologic agents|mesh-ancestor
101604998|NCT04773184|Sensory System Agents|sensory system agents|mesh-ancestor
101604999|NCT04773184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101605000|NCT04773184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605001|NCT00647140|Levodopa|levodopa|mesh-list
101605002|NCT00647140|Dopamine Agents|dopamine agents|mesh-ancestor
101605003|NCT00647140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101605004|NCT00647140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605005|NCT00647140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605006|NCT00647140|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101605007|NCT00647140|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101605008|NCT00647218|Paclitaxel|paclitaxel|mesh-list
101605009|NCT00647218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101605010|NCT00647218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101605011|NCT00647218|Tubulin Modulators|tubulin modulators|mesh-ancestor
101605012|NCT00647218|Antimitotic Agents|antimitotic agents|mesh-ancestor
102033421|NCT02811783|Naloxone|naloxone|mesh-list
102033422|NCT02811783|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102033423|NCT02811783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033424|NCT02811783|Sensory System Agents|sensory system agents|mesh-ancestor
102033425|NCT02811783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102033426|NCT02649855|Docetaxel|docetaxel|mesh-list
102033427|NCT02649855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033428|NCT02649855|Tubulin Modulators|tubulin modulators|mesh-ancestor
102033429|NCT02649855|Antimitotic Agents|antimitotic agents|mesh-ancestor
102033430|NCT02649855|Mitosis Modulators|mitosis modulators|mesh-ancestor
102033431|NCT02649855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033432|NCT05720715|Cyclosporine|cyclosporine|mesh-list
102033433|NCT05720715|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102033434|NCT05720715|Cyclosporins|cyclosporins|mesh-list
102033435|NCT05720715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102033436|NCT05720715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033437|NCT05720715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102033438|NCT05720715|Immunologic Factors|immunologic factors|mesh-ancestor
101605013|NCT00647218|Mitosis Modulators|mitosis modulators|mesh-ancestor
101605014|NCT00647218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605015|NCT00994890|Tanezumab|tanezumab|mesh-list
101605016|NCT00994890|Analgesics|analgesics|mesh-ancestor
101605017|NCT00994890|Sensory System Agents|sensory system agents|mesh-ancestor
101605018|NCT00994890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101605019|NCT00994890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605020|NCT02663830|Sildenafil Citrate|sildenafil citrate|mesh-list
101605021|NCT02663830|Clomiphene|clomiphene|mesh-list
101605022|NCT02663830|Enclomiphene|enclomiphene|mesh-list
101605023|NCT02663830|Zuclomiphene|zuclomiphene|mesh-list
101605024|NCT02663830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605025|NCT02663830|Vasodilator Agents|vasodilator agents|mesh-ancestor
101605026|NCT02663830|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101605027|NCT02663830|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101605028|NCT02663830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101605029|NCT02663830|Urological Agents|urological agents|mesh-ancestor
101605030|NCT02663830|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101605031|NCT02663830|Hormone Antagonists|hormone antagonists|mesh-ancestor
101605032|NCT02663830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101605033|NCT02663830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605034|NCT02663830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101605036|NCT02663830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101605037|NCT02663830|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101605038|NCT02663830|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101605043|NCT00648544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605044|NCT00648544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101605045|NCT00648544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101605046|NCT00648544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101605047|NCT00648622|Carvedilol|carvedilol|mesh-list
101605048|NCT00648622|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101605049|NCT00648622|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101605050|NCT00648622|Adrenergic Agents|adrenergic agents|mesh-ancestor
101605051|NCT00648622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101605052|NCT00648622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605053|NCT00648622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605054|NCT00648622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101605055|NCT00648622|Antioxidants|antioxidants|mesh-ancestor
102033439|NCT05720715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033440|NCT05720715|Antifungal Agents|antifungal agents|mesh-ancestor
102033441|NCT05720715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102033442|NCT05720715|Dermatologic Agents|dermatologic agents|mesh-ancestor
102033443|NCT05720715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102033444|NCT05720715|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102033445|NCT05720715|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102033446|NCT02310867|Abatacept|abatacept|mesh-list
102033447|NCT02310867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102033448|NCT02310867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033449|NCT02310867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102033450|NCT02310867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033451|NCT02310867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101605056|NCT00648622|Protective Agents|protective agents|mesh-ancestor
101605057|NCT00648622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101605058|NCT00648622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101605059|NCT00648622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101605060|NCT00648622|Vasodilator Agents|vasodilator agents|mesh-ancestor
101605061|NCT00648622|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101605062|NCT00648622|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101605063|NCT00994422|Ivermectin|ivermectin|mesh-list
101605064|NCT00994422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101605065|NCT00994422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101605066|NCT00648778|Loxapine|loxapine|mesh-list
101605067|NCT00648778|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101605068|NCT00648778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101605069|NCT00648778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101605070|NCT00648778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605071|NCT00648778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101605072|NCT00648778|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101605073|NCT00648778|Dopamine Agents|dopamine agents|mesh-ancestor
101605074|NCT00648778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101605075|NCT00648778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605076|NCT00645424|Atorvastatin|atorvastatin|mesh-list
101605077|NCT00645424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101605078|NCT00645424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101605079|NCT00645424|Antimetabolites|antimetabolites|mesh-ancestor
101605080|NCT00645424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605081|NCT00645424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101605082|NCT00645424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101605083|NCT00645424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101605085|NCT04172740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101605086|NCT04172740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605087|NCT02663596|Vancomycin|vancomycin|mesh-list
101605088|NCT02663596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101605089|NCT02663596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101605090|NCT00647530|Fluorouracil|fluorouracil|mesh-list
101605091|NCT00647530|Capecitabine|capecitabine|mesh-list
101605092|NCT00647530|Oxaliplatin|oxaliplatin|mesh-list
101605093|NCT00647530|Panitumumab|panitumumab|mesh-list
101605094|NCT00647530|Antimetabolites|antimetabolites|mesh-ancestor
101605095|NCT00647530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605096|NCT00647530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101605097|NCT00647530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101605098|NCT00647530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101605099|NCT00647530|Immunologic Factors|immunologic factors|mesh-ancestor
101605100|NCT00647530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605101|NCT00647530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101605102|NCT00647608|Propranolol|propranolol|mesh-list
101605103|NCT00647608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101605104|NCT00647608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102033452|NCT02310867|Immunologic Factors|immunologic factors|mesh-ancestor
102033453|NCT02310867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033454|NCT02310867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102033455|NCT05757219|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
102033456|NCT05757219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102033457|NCT05757219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033459|NCT03106077|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
102033460|NCT03106077|Immunoconjugates|immunoconjugates|mesh-ancestor
102033461|NCT03106077|Immunologic Factors|immunologic factors|mesh-ancestor
102033462|NCT03106077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033463|NCT03106077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102033464|NCT03106077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033465|NCT03106077|Tubulin Modulators|tubulin modulators|mesh-ancestor
102033466|NCT03106077|Antimitotic Agents|antimitotic agents|mesh-ancestor
102033467|NCT03106077|Mitosis Modulators|mitosis modulators|mesh-ancestor
102033468|NCT03106077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033469|NCT03648008|Morphine|morphine|mesh-list
102033470|NCT03648008|Hydromorphone|hydromorphone|mesh-list
102033471|NCT03648008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102033472|NCT03648008|Narcotics|narcotics|mesh-ancestor
102033473|NCT03648008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102033474|NCT03648008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033475|NCT03648008|Analgesics|analgesics|mesh-ancestor
102033476|NCT03648008|Sensory System Agents|sensory system agents|mesh-ancestor
102033477|NCT03648008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102033478|NCT05702541|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102033479|NCT05702541|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102033480|NCT05702541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102033481|NCT05253495|Cytarabine|cytarabine|mesh-list
102033482|NCT05253495|Etoposide|etoposide|mesh-list
101334982|NCT00046462|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
101605105|NCT00647608|Adrenergic Agents|adrenergic agents|mesh-ancestor
101605106|NCT00647608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101605107|NCT00647608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605109|NCT00647608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101605110|NCT00647608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101605115|NCT02663440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101605117|NCT02663440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605118|NCT02663440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101605119|NCT02663440|Immunologic Factors|immunologic factors|mesh-ancestor
101605120|NCT02663440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605121|NCT04171180|Budesonide|budesonide|mesh-list
101605122|NCT04171180|Formoterol Fumarate|formoterol fumarate|mesh-list
101605123|NCT04171180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102033483|NCT05253495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102033484|NCT05253495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033485|NCT05253495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102033486|NCT05253495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102033487|NCT05253495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102033488|NCT05253495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033489|NCT05253495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102033490|NCT05253495|Antimetabolites|antimetabolites|mesh-ancestor
102033491|NCT05253495|Antiviral Agents|antiviral agents|mesh-ancestor
102033492|NCT05253495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102033493|NCT05253495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102033494|NCT05253495|Immunologic Factors|immunologic factors|mesh-ancestor
102033495|NCT05253495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033496|NCT05054751|Fulvestrant|fulvestrant|mesh-list
102033497|NCT05054751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102033498|NCT05054751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033499|NCT05054751|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102033500|NCT05054751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102033501|NCT05054751|Hormone Antagonists|hormone antagonists|mesh-ancestor
102033502|NCT05054751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102033503|NCT05054751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033504|NCT00604617|Interferons|interferons|mesh-list
102033505|NCT00604617|Interferon-gamma|interferon-gamma|mesh-list
102033506|NCT00604617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033507|NCT00604617|Antiviral Agents|antiviral agents|mesh-ancestor
102033508|NCT00604617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102033509|NCT03426995|Cantharidin|cantharidin|mesh-list
102033510|NCT03426995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102033511|NCT03426995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033512|NCT05200299|Leucovorin|leucovorin|mesh-list
102033513|NCT05200299|Fluorouracil|fluorouracil|mesh-list
102033514|NCT05200299|Capecitabine|capecitabine|mesh-list
102033515|NCT05200299|Oxaliplatin|oxaliplatin|mesh-list
102033516|NCT05200299|Irinotecan|irinotecan|mesh-list
101777439|NCT00777218|Topiramate|topiramate|mesh-list
102033517|NCT05200299|Levoleucovorin|levoleucovorin|mesh-list
102033518|NCT05200299|Antimetabolites|antimetabolites|mesh-ancestor
102033522|NCT05200299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102033523|NCT05200299|Immunologic Factors|immunologic factors|mesh-ancestor
102033524|NCT05200299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033525|NCT05200299|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102033526|NCT05200299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102033527|NCT05200299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102033528|NCT05200299|Antidotes|antidotes|mesh-ancestor
102033529|NCT05200299|Protective Agents|protective agents|mesh-ancestor
102033530|NCT05200299|Vitamin B Complex|vitamin b complex|mesh-ancestor
102033531|NCT05200299|Vitamins|vitamins|mesh-ancestor
102033532|NCT05200299|Micronutrients|micronutrients|mesh-ancestor
102033533|NCT03322566|Pembrolizumab|pembrolizumab|mesh-list
102033534|NCT03322566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102033535|NCT03322566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033536|NCT03322566|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102033537|NCT03322566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033538|NCT03822975|Heparin|heparin|mesh-list
102033539|NCT03822975|Calcium heparin|calcium heparin|mesh-list
102033540|NCT03822975|Bivalirudin|bivalirudin|mesh-list
102033541|NCT03822975|Anticoagulants|anticoagulants|mesh-ancestor
101605124|NCT04171180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101605125|NCT04171180|Autonomic Agents|autonomic agents|mesh-ancestor
101605126|NCT04171180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101605127|NCT04171180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605128|NCT04171180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101605129|NCT04171180|Respiratory System Agents|respiratory system agents|mesh-ancestor
101605130|NCT04171180|Glucocorticoids|glucocorticoids|mesh-ancestor
101605131|NCT04171180|Hormones|hormones|mesh-ancestor
101605132|NCT04171180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101605133|NCT04171180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101605134|NCT04171180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101605135|NCT04171180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101605136|NCT04171180|Adrenergic Agents|adrenergic agents|mesh-ancestor
101605137|NCT04171180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101605138|NCT04171180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605139|NCT02660008|Glucagon|glucagon|mesh-list
101605140|NCT02660008|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101605141|NCT02660008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101605142|NCT02660008|Hormones|hormones|mesh-ancestor
101605143|NCT02660008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101605144|NCT02660008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605145|NCT02660008|Incretins|incretins|mesh-ancestor
101605146|NCT00649168|Bromocriptine|bromocriptine|mesh-list
101605147|NCT00649168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101605148|NCT00649168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101605149|NCT00649168|Hormone Antagonists|hormone antagonists|mesh-ancestor
101605150|NCT00649168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101605151|NCT00649168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605152|NCT00649168|Dopamine Agonists|dopamine agonists|mesh-ancestor
101605153|NCT00649168|Dopamine Agents|dopamine agents|mesh-ancestor
101605154|NCT00649168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101605155|NCT00649168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605156|NCT02663206|Botulinum Toxins|botulinum toxins|mesh-list
101605157|NCT02663206|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102033542|NCT03822975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102033543|NCT03822975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102033544|NCT03822975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033545|NCT03822975|Antithrombins|antithrombins|mesh-ancestor
102033546|NCT03822975|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102033547|NCT03822975|Protease Inhibitors|protease inhibitors|mesh-ancestor
102033548|NCT03822975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102033549|NCT05732532|Dexamethasone|dexamethasone|mesh-list
102033550|NCT05732532|Lidocaine|lidocaine|mesh-list
102033551|NCT05732532|Bupivacaine|bupivacaine|mesh-list
102033552|NCT05732532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102033553|NCT05732532|Antiemetics|antiemetics|mesh-ancestor
102033554|NCT05732532|Autonomic Agents|autonomic agents|mesh-ancestor
102033555|NCT05732532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102033556|NCT05732532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033557|NCT05732532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102033558|NCT05732532|Glucocorticoids|glucocorticoids|mesh-ancestor
101605158|NCT02663206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101605159|NCT02663206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605160|NCT02663206|Cholinergic Agents|cholinergic agents|mesh-ancestor
101605161|NCT02663206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101605162|NCT02663206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605163|NCT02663284|Ropivacaine|ropivacaine|mesh-list
101605164|NCT02663284|Anesthetics, Local|anesthetics, local|mesh-ancestor
101605165|NCT02663284|Anesthetics|anesthetics|mesh-ancestor
101605166|NCT02663284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101605167|NCT02663284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605168|NCT02663284|Sensory System Agents|sensory system agents|mesh-ancestor
101605169|NCT02663284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101605170|NCT00647686|Fentanyl|fentanyl|mesh-list
101605171|NCT00647686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101605172|NCT00647686|Narcotics|narcotics|mesh-ancestor
101605173|NCT00647686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101605174|NCT00647686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605175|NCT00647686|Analgesics|analgesics|mesh-ancestor
101605176|NCT00647686|Sensory System Agents|sensory system agents|mesh-ancestor
101605177|NCT00647686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101605178|NCT00647686|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101605179|NCT00647686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101605180|NCT00647686|Anesthetics, General|anesthetics, general|mesh-ancestor
101605188|NCT02663050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605189|NCT02663050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101605190|NCT02663050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101605191|NCT02663050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101605192|NCT02663050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101605193|NCT02663050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605194|NCT00648856|Sertraline|sertraline|mesh-list
101605195|NCT00648856|Antidepressive Agents|antidepressive agents|mesh-ancestor
101605196|NCT00648856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101605197|NCT00648856|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101605198|NCT00648856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101605199|NCT00648856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101605200|NCT00648856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605201|NCT00648856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101605202|NCT00648856|Serotonin Agents|serotonin agents|mesh-ancestor
101605203|NCT00648856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605204|NCT01171976|Ranibizumab|ranibizumab|mesh-list
101605205|NCT01171976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102033559|NCT05732532|Hormones|hormones|mesh-ancestor
102033560|NCT05732532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102033561|NCT05732532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102033562|NCT05732532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033563|NCT05732532|Anesthetics, Local|anesthetics, local|mesh-ancestor
102033564|NCT05732532|Anesthetics|anesthetics|mesh-ancestor
102033565|NCT05732532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102033566|NCT05732532|Sensory System Agents|sensory system agents|mesh-ancestor
102033567|NCT05732532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102033568|NCT05732532|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102033569|NCT05732532|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102033570|NCT05732532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102033571|NCT05732532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033572|NCT05178225|Ubiquinone|ubiquinone|mesh-list
101777457|NCT04047758|Palbociclib|palbociclib|mesh-list
101605206|NCT01171976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101605207|NCT01171976|Growth Substances|growth substances|mesh-ancestor
101605208|NCT01171976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605209|NCT01171976|Growth Inhibitors|growth inhibitors|mesh-ancestor
101605210|NCT01171976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101605211|NCT00996216|Antiviral Agents|antiviral agents|mesh-list
101605212|NCT00996216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101605213|NCT00647842|Fentanyl|fentanyl|mesh-list
101605214|NCT00647842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101605215|NCT00647842|Narcotics|narcotics|mesh-ancestor
101605216|NCT00647842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101605217|NCT00647842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605218|NCT00647842|Analgesics|analgesics|mesh-ancestor
101605219|NCT00647842|Sensory System Agents|sensory system agents|mesh-ancestor
101262200|NCT01755676|Orlistat|orlistat|mesh-list
101605220|NCT00647842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101605221|NCT00647842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101605222|NCT00647842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101605223|NCT00647842|Anesthetics, General|anesthetics, general|mesh-ancestor
101605224|NCT00647842|Anesthetics|anesthetics|mesh-ancestor
101605225|NCT02662972|Botulinum Toxins|botulinum toxins|mesh-list
101605226|NCT02662972|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101605227|NCT02662972|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101605228|NCT02662972|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101605229|NCT02662972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101605230|NCT02662972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605231|NCT02662972|Cholinergic Agents|cholinergic agents|mesh-ancestor
101605232|NCT02662972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101605233|NCT02662972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605234|NCT02662972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101605235|NCT02662972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101605236|NCT02662894|Valsartan|valsartan|mesh-list
101605237|NCT02662894|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101605238|NCT02662894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101605239|NCT02662894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101605240|NCT02662894|Antimetabolites|antimetabolites|mesh-ancestor
101605241|NCT02662894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605242|NCT02662894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101605243|NCT02662894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101605244|NCT02662894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101605245|NCT02662894|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101605246|NCT02662894|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101605247|NCT02662894|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101605248|NCT04291794|Propofol|propofol|mesh-list
101605257|NCT02662660|Bupivacaine|bupivacaine|mesh-list
102033573|NCT05178225|Coenzyme Q10|coenzyme q10|mesh-list
102033574|NCT05178225|Anticoagulants|anticoagulants|mesh-list
102033575|NCT05178225|Micronutrients|micronutrients|mesh-ancestor
102033576|NCT05178225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033577|NCT05178225|Vitamins|vitamins|mesh-ancestor
102033578|NCT02969018|PF-06700841|pf-06700841|mesh-list
102033579|NCT02969018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102033580|NCT02969018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102033581|NCT02969018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033582|NCT03255096|Rituximab|rituximab|mesh-list
102033583|NCT03255096|Venetoclax|venetoclax|mesh-list
102033584|NCT03255096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102033585|NCT03255096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033586|NCT03255096|Immunologic Factors|immunologic factors|mesh-ancestor
102033587|NCT03255096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033588|NCT03255096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102033589|NCT01319721|Mitomycins|mitomycins|mesh-list
102033590|NCT01319721|Mitomycin|mitomycin|mesh-list
102033591|NCT01319721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102033592|NCT01319721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033593|NCT01319721|Alkylating Agents|alkylating agents|mesh-ancestor
102033594|NCT01319721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335102|NCT00047203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335106|NCT04163874|Pramlintide|pramlintide|mesh-list
101605258|NCT02662660|Levobupivacaine|levobupivacaine|mesh-list
101605259|NCT02662660|Anesthetics, Local|anesthetics, local|mesh-ancestor
101605260|NCT02662660|Anesthetics|anesthetics|mesh-ancestor
101605261|NCT02662660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101605262|NCT02662660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605263|NCT02662660|Sensory System Agents|sensory system agents|mesh-ancestor
101605264|NCT02662660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101605265|NCT02662660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101605266|NCT02662660|Analgesics|analgesics|mesh-ancestor
101605267|NCT02662660|Antipyretics|antipyretics|mesh-ancestor
101605268|NCT02662660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101605269|NCT02662660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101605270|NCT02662660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101605271|NCT02868606|Insulin|insulin|mesh-list
101605272|NCT02868606|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101605273|NCT02868606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101605274|NCT02868606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605275|NCT00647920|Adalimumab|adalimumab|mesh-list
101605276|NCT00647920|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101605277|NCT00647920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101605278|NCT00647920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101605279|NCT00830869|Ixazomib|ixazomib|mesh-list
101605280|NCT00830869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101605281|NCT00830869|Protease Inhibitors|protease inhibitors|mesh-ancestor
101605282|NCT00830869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101605283|NCT00830869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605284|NCT02662504|Cisplatin|cisplatin|mesh-list
101605285|NCT02662504|Pemetrexed|pemetrexed|mesh-list
101605286|NCT02662504|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
101605287|NCT02662504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033595|NCT01319721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102033596|NCT01319721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102033597|NCT03792867|Doxorubicin|doxorubicin|mesh-list
102033598|NCT03792867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102033599|NCT03792867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033600|NCT03792867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102033601|NCT03792867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102033602|NCT03792867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102033603|NCT03792867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033604|NCT03015324|Hydroxychloroquine|hydroxychloroquine|mesh-list
102033605|NCT03015324|Antimalarials|antimalarials|mesh-ancestor
102033606|NCT03015324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102033607|NCT03015324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102033608|NCT03015324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102033609|NCT03015324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102033610|NCT03015324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033611|NCT03015324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102033612|NCT05139849|Methylprednisolone|methylprednisolone|mesh-list
102033613|NCT05139849|Hydrocortisone|hydrocortisone|mesh-list
102033614|NCT05139849|Vasopressins|vasopressins|mesh-list
102033615|NCT05139849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102033616|NCT05139849|Antiemetics|antiemetics|mesh-ancestor
102033617|NCT05139849|Autonomic Agents|autonomic agents|mesh-ancestor
102033618|NCT05139849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102033619|NCT05139849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033620|NCT05139849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102033621|NCT05139849|Glucocorticoids|glucocorticoids|mesh-ancestor
102033622|NCT05139849|Hormones|hormones|mesh-ancestor
102033623|NCT05139849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102033624|NCT05139849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102033625|NCT05139849|Protective Agents|protective agents|mesh-ancestor
102033626|NCT05139849|Hemostatics|hemostatics|mesh-ancestor
102033627|NCT05139849|Coagulants|coagulants|mesh-ancestor
102033628|NCT05139849|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101605288|NCT02662504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101605289|NCT02662504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605290|NCT02662504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101605291|NCT02662504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101605292|NCT02662504|Dermatologic Agents|dermatologic agents|mesh-ancestor
101605293|NCT02662504|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101605294|NCT00648934|Topiramate|topiramate|mesh-list
101605295|NCT00648934|Anticonvulsants|anticonvulsants|mesh-ancestor
102033629|NCT05139849|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102033630|NCT05139849|Natriuretic Agents|natriuretic agents|mesh-ancestor
102033631|NCT03315741|Pirfenidone|pirfenidone|mesh-list
102033632|NCT03315741|Analgesics|analgesics|mesh-ancestor
102033633|NCT03315741|Sensory System Agents|sensory system agents|mesh-ancestor
102033634|NCT03315741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102033635|NCT03315741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033636|NCT03315741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102033637|NCT03315741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102033638|NCT03315741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102033639|NCT03315741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102033640|NCT03315741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033641|NCT05077449|Fulvestrant|fulvestrant|mesh-list
102033642|NCT05077449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102033643|NCT05077449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033644|NCT05077449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102033645|NCT05077449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102033646|NCT05077449|Hormone Antagonists|hormone antagonists|mesh-ancestor
102033647|NCT05077449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102033648|NCT05077449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033649|NCT03632733|Tetracycline|tetracycline|mesh-list
102033650|NCT03632733|Clotrimazole|clotrimazole|mesh-list
102033651|NCT03632733|Miconazole|miconazole|mesh-list
102033652|NCT03632733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102033653|NCT03632733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102033654|NCT03632733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102033655|NCT03632733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102033656|NCT03632733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033657|NCT03632733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102033658|NCT03632733|Antifungal Agents|antifungal agents|mesh-ancestor
102033671|NCT03259425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033672|NCT03259425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102033673|NCT03259425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033674|NCT03061188|Nivolumab|nivolumab|mesh-list
102033675|NCT03061188|Veliparib|veliparib|mesh-list
102033676|NCT03061188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102033677|NCT03061188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033678|NCT03061188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102033679|NCT03061188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033680|NCT03061188|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102033681|NCT03061188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102033683|NCT05588453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102033684|NCT05588453|Alkylating Agents|alkylating agents|mesh-ancestor
102033685|NCT05588453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033686|NCT05588453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033687|NCT05186454|Dexamethasone|dexamethasone|mesh-list
102033688|NCT05186454|Midazolam|midazolam|mesh-list
102033689|NCT05186454|Morphine|morphine|mesh-list
102033690|NCT05186454|Bupivacaine|bupivacaine|mesh-list
102033691|NCT05186454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102033692|NCT05186454|Antiemetics|antiemetics|mesh-ancestor
102033693|NCT05186454|Autonomic Agents|autonomic agents|mesh-ancestor
102033694|NCT05186454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102033695|NCT05186454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033696|NCT05186454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102033697|NCT05186454|Glucocorticoids|glucocorticoids|mesh-ancestor
102033698|NCT05186454|Hormones|hormones|mesh-ancestor
102033699|NCT05186454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102033700|NCT05186454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102033701|NCT05186454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101605297|NCT00648934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605298|NCT02659228|Anesthetics|anesthetics|mesh-list
101605299|NCT02659228|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
101605300|NCT02659228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101605301|NCT02659228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605302|NCT02659228|Anesthetics, General|anesthetics, general|mesh-ancestor
101605303|NCT00844519|Maraviroc|maraviroc|mesh-list
101605304|NCT00844519|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101605305|NCT00844519|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101605306|NCT00844519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605307|NCT00844519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101605308|NCT00844519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102033702|NCT05186454|Anesthetics, Local|anesthetics, local|mesh-ancestor
102033703|NCT05186454|Anesthetics|anesthetics|mesh-ancestor
102033704|NCT05186454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102033705|NCT05186454|Sensory System Agents|sensory system agents|mesh-ancestor
102033706|NCT05186454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102033707|NCT05186454|Narcotics|narcotics|mesh-ancestor
102033708|NCT05186454|Analgesics|analgesics|mesh-ancestor
102033709|NCT05186454|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102033710|NCT05186454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102033711|NCT05186454|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102033712|NCT05186454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102033713|NCT05186454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102033714|NCT05186454|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102033715|NCT05186454|Anesthetics, General|anesthetics, general|mesh-ancestor
102033716|NCT05186454|GABA Modulators|gaba modulators|mesh-ancestor
102033717|NCT05186454|GABA Agents|gaba agents|mesh-ancestor
102033718|NCT05186454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102033719|NCT05186454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033720|NCT02113878|Cisplatin|cisplatin|mesh-list
102033721|NCT02113878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033722|NCT05162898|Lenvatinib|lenvatinib|mesh-list
102033723|NCT05162898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033724|NCT05162898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102033725|NCT05162898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102033726|NCT05162898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033727|NCT05113290|Sorafenib|sorafenib|mesh-list
102033728|NCT05113290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033729|NCT05113290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102033730|NCT05113290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102033731|NCT05113290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033732|NCT03477162|Metformin|metformin|mesh-list
102033733|NCT03477162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102033735|NCT03461952|Nivolumab|nivolumab|mesh-list
102033745|NCT03619824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033746|NCT01759836|Atorvastatin|atorvastatin|mesh-list
102033747|NCT01759836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102033748|NCT01759836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102033749|NCT01759836|Antimetabolites|antimetabolites|mesh-ancestor
102033750|NCT01759836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033751|NCT01759836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102033752|NCT01759836|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102033753|NCT01759836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102033754|NCT03447821|Rifamycins|rifamycins|mesh-list
102033755|NCT03447821|Rifamycin SV|rifamycin sv|mesh-list
102033756|NCT03447821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102033757|NCT03447821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102033758|NCT03447821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102033759|NCT05630339|Vitamin D|vitamin d|mesh-list
102033760|NCT05630339|Cholecalciferol|cholecalciferol|mesh-list
102033761|NCT05630339|Vitamins|vitamins|mesh-ancestor
102033762|NCT05630339|Micronutrients|micronutrients|mesh-ancestor
102033763|NCT05630339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033764|NCT05630339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101335275|NCT00048607|Antiemetics|antiemetics|mesh-ancestor
101605309|NCT00844519|Antiviral Agents|antiviral agents|mesh-ancestor
101605310|NCT00844519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101605311|NCT00844519|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101605312|NCT00702793|Varenicline|varenicline|mesh-list
101605313|NCT00702793|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101605314|NCT00702793|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101605315|NCT00702793|Cholinergic Agents|cholinergic agents|mesh-ancestor
101605316|NCT00702793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101605318|NCT00702793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605319|NCT02662426|Oseltamivir|oseltamivir|mesh-list
101605320|NCT02662426|Antiviral Agents|antiviral agents|mesh-ancestor
101605321|NCT02662426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101605322|NCT02662426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101605323|NCT02662426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605324|NCT00994110|Pasireotide|pasireotide|mesh-list
101605325|NCT00994110|Hormones|hormones|mesh-ancestor
101605326|NCT00994110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101775278|NCT00935961|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101605327|NCT00994110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605328|NCT02662348|Aldesleukin|aldesleukin|mesh-list
101605329|NCT02662348|Interleukin-2|interleukin-2|mesh-list
101605330|NCT02662348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101605331|NCT02662348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101605332|NCT02662348|Analgesics|analgesics|mesh-ancestor
101605333|NCT02662348|Sensory System Agents|sensory system agents|mesh-ancestor
101605334|NCT02662348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101605335|NCT02662348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605336|NCT02662348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101605337|NCT02662348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101605338|NCT02662348|Antiviral Agents|antiviral agents|mesh-ancestor
101605339|NCT02662348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101605340|NCT02868372|Povidone-Iodine|povidone-iodine|mesh-list
101605341|NCT02868372|Povidone|povidone|mesh-list
101605342|NCT02868372|Plasma Substitutes|plasma substitutes|mesh-ancestor
102033765|NCT05630339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102033766|NCT03447353|Acetaminophen|acetaminophen|mesh-list
102033767|NCT03447353|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
102033768|NCT03447353|Hydrocodone|hydrocodone|mesh-list
102033769|NCT03447353|Alprazolam|alprazolam|mesh-list
102033770|NCT03447353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102033771|NCT03447353|Analgesics|analgesics|mesh-ancestor
102033772|NCT03447353|Sensory System Agents|sensory system agents|mesh-ancestor
102033773|NCT03447353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102033774|NCT03447353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033775|NCT03447353|Antipyretics|antipyretics|mesh-ancestor
102033776|NCT03447353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102033777|NCT03447353|Narcotics|narcotics|mesh-ancestor
102033778|NCT03447353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102033779|NCT03447353|Antitussive Agents|antitussive agents|mesh-ancestor
102033780|NCT03447353|Respiratory System Agents|respiratory system agents|mesh-ancestor
102033781|NCT03447353|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102033782|NCT03447353|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102033783|NCT03447353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102033784|NCT03447353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102033785|NCT03447353|GABA Modulators|gaba modulators|mesh-ancestor
102033786|NCT03447353|GABA Agents|gaba agents|mesh-ancestor
102033787|NCT03447353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101335287|NCT00048763|Autonomic Agents|autonomic agents|mesh-ancestor
101605343|NCT02868372|Blood Substitutes|blood substitutes|mesh-ancestor
101605344|NCT02868372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101605345|NCT02868372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101605346|NCT00629148|Capecitabine|capecitabine|mesh-list
101605347|NCT00629148|Vinorelbine|vinorelbine|mesh-list
101605348|NCT00629148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101605349|NCT00629148|Antimetabolites|antimetabolites|mesh-ancestor
101605350|NCT00629148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605351|NCT00629148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101605352|NCT00629148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101605353|NCT00629148|Tubulin Modulators|tubulin modulators|mesh-ancestor
101605354|NCT00629148|Antimitotic Agents|antimitotic agents|mesh-ancestor
101605355|NCT00629148|Mitosis Modulators|mitosis modulators|mesh-ancestor
101605356|NCT01157234|Metoprolol|metoprolol|mesh-list
101605357|NCT01157234|Nebivolol|nebivolol|mesh-list
101605358|NCT01157234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101605359|NCT01157234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101605360|NCT01157234|Sympatholytics|sympatholytics|mesh-ancestor
101605361|NCT01157234|Autonomic Agents|autonomic agents|mesh-ancestor
101605362|NCT01157234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101605363|NCT01157234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605364|NCT01157234|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101605365|NCT01157234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101605366|NCT01157234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101605367|NCT01157234|Adrenergic Agents|adrenergic agents|mesh-ancestor
101605368|NCT01157234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101777492|NCT00671060|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101605369|NCT01157234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605370|NCT01157234|Vasodilator Agents|vasodilator agents|mesh-ancestor
102033788|NCT03447353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033789|NCT03447353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102033790|NCT03447353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102033791|NCT03447353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102033792|NCT03446885|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102033793|NCT03446885|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102033794|NCT03446885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033795|NCT03446885|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102033796|NCT03446885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102033797|NCT03446885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102033798|NCT03446885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033799|NCT03446885|Dopamine Agents|dopamine agents|mesh-ancestor
102033800|NCT03446885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102033801|NCT00710970|Tamoxifen|tamoxifen|mesh-list
102033802|NCT00710970|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
102033803|NCT00710970|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102033804|NCT00710970|Hormone Antagonists|hormone antagonists|mesh-ancestor
102033805|NCT00710970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102033806|NCT00710970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033807|NCT00710970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102033808|NCT00710970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033809|NCT00710970|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102033810|NCT00710970|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102033811|NCT00710970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102033812|NCT03421379|Glucagon|glucagon|mesh-list
102033813|NCT03421379|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102033814|NCT03421379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102033815|NCT03421379|Hormones|hormones|mesh-ancestor
101335310|NCT00048802|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101605371|NCT01157234|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101605372|NCT01157234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101605373|NCT01157234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101605374|NCT04170790|Saxagliptin|saxagliptin|mesh-list
101605375|NCT04170790|Sildenafil Citrate|sildenafil citrate|mesh-list
101605376|NCT04170790|Vasodilator Agents|vasodilator agents|mesh-ancestor
101605377|NCT04170790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101605378|NCT04170790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101605379|NCT04170790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101605380|NCT04170790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605381|NCT04170790|Urological Agents|urological agents|mesh-ancestor
101605382|NCT04170790|Incretins|incretins|mesh-ancestor
102033816|NCT03421379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102033817|NCT03421379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033818|NCT03421379|Incretins|incretins|mesh-ancestor
102033819|NCT03712241|Indomethacin|indomethacin|mesh-list
102033820|NCT03712241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102033821|NCT03712241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102033822|NCT03712241|Analgesics|analgesics|mesh-ancestor
102033823|NCT03712241|Sensory System Agents|sensory system agents|mesh-ancestor
102033824|NCT03712241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102033825|NCT03712241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033826|NCT03712241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102033827|NCT03712241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102033828|NCT03712241|Gout Suppressants|gout suppressants|mesh-ancestor
102033829|NCT03712241|Tocolytic Agents|tocolytic agents|mesh-ancestor
102033830|NCT03712241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102033831|NCT03712241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102033832|NCT03712241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102033833|NCT03712241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033836|NCT02675946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102033837|NCT02675946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033838|NCT02675946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102033839|NCT02675946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033840|NCT02900378|Valsartan|valsartan|mesh-list
102033841|NCT02900378|Enalapril|enalapril|mesh-list
102033842|NCT02900378|Enalaprilat|enalaprilat|mesh-list
102033843|NCT02900378|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102033844|NCT02900378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102033845|NCT02900378|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102033846|NCT02900378|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101605383|NCT04170790|Hormones|hormones|mesh-ancestor
101605384|NCT04170790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101605385|NCT04170790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605386|NCT04170790|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101605387|NCT04170790|Protease Inhibitors|protease inhibitors|mesh-ancestor
101605395|NCT00995670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605396|NCT00995670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101605397|NCT00995670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101605398|NCT00995670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102033847|NCT02900378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033848|NCT02900378|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102033849|NCT02900378|Protease Inhibitors|protease inhibitors|mesh-ancestor
102033850|NCT02900378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102033851|NCT03058692|Vaccines|vaccines|mesh-list
102033852|NCT03058692|Immunologic Factors|immunologic factors|mesh-ancestor
102033853|NCT03058692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033854|NCT03647150|Amoxicillin|amoxicillin|mesh-list
102033855|NCT03647150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102033856|NCT03647150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102033857|NCT03056352|Diphenhydramine|diphenhydramine|mesh-list
102033858|NCT03056352|Promethazine|promethazine|mesh-list
102033859|NCT03056352|Metoclopramide|metoclopramide|mesh-list
102033860|NCT03056352|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102033861|NCT03056352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102033862|NCT03056352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102033863|NCT03056352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033864|NCT03056352|Anesthetics, Local|anesthetics, local|mesh-ancestor
102033865|NCT03056352|Anesthetics|anesthetics|mesh-ancestor
102033866|NCT03056352|Sensory System Agents|sensory system agents|mesh-ancestor
102033867|NCT03056352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102033868|NCT03056352|Antiemetics|antiemetics|mesh-ancestor
102033869|NCT03056352|Autonomic Agents|autonomic agents|mesh-ancestor
102033870|NCT03056352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102033871|NCT03056352|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102033872|NCT03056352|Histamine Antagonists|histamine antagonists|mesh-ancestor
102033873|NCT03056352|Histamine Agents|histamine agents|mesh-ancestor
102033874|NCT03056352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102033875|NCT03056352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033876|NCT03056352|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102033877|NCT03056352|Antipruritics|antipruritics|mesh-ancestor
102033878|NCT03056352|Dermatologic Agents|dermatologic agents|mesh-ancestor
101335376|NCT05576181|Etoposide|etoposide|mesh-list
101605399|NCT00995670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101605400|NCT00995670|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101605401|NCT00995670|Anesthetics, General|anesthetics, general|mesh-ancestor
101605402|NCT00995670|Anesthetics|anesthetics|mesh-ancestor
101605403|NCT00995670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101605404|NCT02658838|Heparin|heparin|mesh-list
101605405|NCT02658838|Calcium heparin|calcium heparin|mesh-list
101605406|NCT02658838|Enoxaparin|enoxaparin|mesh-list
101605407|NCT02658838|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101605408|NCT02658838|Tinzaparin|tinzaparin|mesh-list
101605409|NCT02658838|Dalteparin|dalteparin|mesh-list
101605410|NCT02658838|Enoxaparin sodium|enoxaparin sodium|mesh-list
102033879|NCT03056352|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102033880|NCT03056352|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102033881|NCT03056352|Dopamine Agents|dopamine agents|mesh-ancestor
102033882|NCT04360980|Colchicine|colchicine|mesh-list
102033883|NCT04360980|Gout Suppressants|gout suppressants|mesh-ancestor
102033884|NCT04360980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102033885|NCT04360980|Tubulin Modulators|tubulin modulators|mesh-ancestor
102033886|NCT04360980|Antimitotic Agents|antimitotic agents|mesh-ancestor
102033887|NCT04360980|Mitosis Modulators|mitosis modulators|mesh-ancestor
102033888|NCT04360980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033889|NCT04360980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033890|NCT03647072|Famotidine|famotidine|mesh-list
102033891|NCT03647072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102033892|NCT03647072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102033893|NCT03647072|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102033894|NCT03647072|Histamine Antagonists|histamine antagonists|mesh-ancestor
102033895|NCT03647072|Histamine Agents|histamine agents|mesh-ancestor
102033896|NCT03647072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102033897|NCT03647072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033898|NCT03647072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033899|NCT05284136|Prednisolone|prednisolone|mesh-list
102033900|NCT05284136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102033901|NCT05284136|Glucocorticoids|glucocorticoids|mesh-ancestor
102033903|NCT05284136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102033904|NCT05284136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033905|NCT05284136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102033906|NCT05284136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033907|NCT03646916|Dexamethasone|dexamethasone|mesh-list
102033908|NCT03646916|Dexamethasone acetate|dexamethasone acetate|mesh-list
101605411|NCT02658838|Ticagrelor|ticagrelor|mesh-list
101605412|NCT02658838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
101605413|NCT02658838|Anticoagulants|anticoagulants|mesh-ancestor
101605414|NCT02658838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101605415|NCT02658838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101605416|NCT02658838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605417|NCT02658838|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101605418|NCT02658838|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101605419|NCT02658838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101605420|NCT02658838|Purinergic Agents|purinergic agents|mesh-ancestor
101605421|NCT02658838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101605422|NCT02658838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605423|NCT00648076|Valproic Acid|valproic acid|mesh-list
101605424|NCT00648076|Anticonvulsants|anticonvulsants|mesh-ancestor
101605425|NCT00648076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101605426|NCT00648076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033909|NCT03646916|BB 1101|bb 1101|mesh-list
102033910|NCT03646916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102033911|NCT03646916|Antiemetics|antiemetics|mesh-ancestor
102033912|NCT03646916|Autonomic Agents|autonomic agents|mesh-ancestor
102033913|NCT03646916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102033914|NCT03646916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033915|NCT03646916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102033916|NCT03646916|Glucocorticoids|glucocorticoids|mesh-ancestor
102033917|NCT03646916|Hormones|hormones|mesh-ancestor
102033918|NCT03646916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102033919|NCT03646916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102033920|NCT03646916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033921|NCT03646916|Protease Inhibitors|protease inhibitors|mesh-ancestor
102033922|NCT03646916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102033923|NCT03646916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605427|NCT00648076|GABA Agents|gaba agents|mesh-ancestor
101605428|NCT00648076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101605429|NCT00648076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605430|NCT00648076|Antimanic Agents|antimanic agents|mesh-ancestor
101605431|NCT00648076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101605432|NCT00648076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101605433|NCT00648076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101605434|NCT00649012|Pioglitazone|pioglitazone|mesh-list
101605435|NCT00649012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101605436|NCT00649012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605437|NCT04685590|Dasatinib|dasatinib|mesh-list
101605438|NCT04685590|Quercetin|quercetin|mesh-list
101605439|NCT04685590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101605440|NCT04685590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101605441|NCT04685590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101605442|NCT04685590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605443|NCT04685590|Antioxidants|antioxidants|mesh-ancestor
101605444|NCT04685590|Protective Agents|protective agents|mesh-ancestor
101605445|NCT04685590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605446|NCT04170088|Tranexamic Acid|tranexamic acid|mesh-list
101605447|NCT04170088|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101605448|NCT04170088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101605449|NCT04170088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605450|NCT04170088|Hemostatics|hemostatics|mesh-ancestor
101605451|NCT04170088|Coagulants|coagulants|mesh-ancestor
101605452|NCT00648154|Letrozole|letrozole|mesh-list
101605453|NCT00648154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101605454|NCT00648154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101605455|NCT00648154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101605456|NCT00648154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101537597|NCT04565496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101605477|NCT02661100|Pembrolizumab|pembrolizumab|mesh-list
101605478|NCT02661100|Poly ICLC|poly iclc|mesh-list
101605479|NCT02661100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101605480|NCT02661100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101605481|NCT02661100|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101605482|NCT02661100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605483|NCT02661100|Interferon Inducers|interferon inducers|mesh-ancestor
101605484|NCT02661100|Immunologic Factors|immunologic factors|mesh-ancestor
101605485|NCT02661100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605486|NCT00601354|Orlistat|orlistat|mesh-list
101605487|NCT00601354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101605488|NCT00601354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605489|NCT00601354|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101605490|NCT00601354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102033924|NCT04305756|Enoxaparin|enoxaparin|mesh-list
102033925|NCT04305756|Anticoagulants|anticoagulants|mesh-ancestor
102033926|NCT04305756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102033927|NCT04305756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102033928|NCT04305756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033929|NCT05283980|Bupivacaine|bupivacaine|mesh-list
102033930|NCT05283980|Anesthetics, Local|anesthetics, local|mesh-ancestor
102033931|NCT05283980|Anesthetics|anesthetics|mesh-ancestor
102033932|NCT05283980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102033933|NCT05283980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033934|NCT05283980|Sensory System Agents|sensory system agents|mesh-ancestor
102033935|NCT05283980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102033936|NCT03645980|Sorafenib|sorafenib|mesh-list
102033937|NCT03645980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101605491|NCT02660866|Vorapaxar|vorapaxar|mesh-list
101605492|NCT02660866|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101605493|NCT00853099|Adalimumab|adalimumab|mesh-list
101605494|NCT00853099|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101605495|NCT00853099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101605496|NCT00853099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101605497|NCT00648310|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101605498|NCT00648310|Estrogens|estrogens|mesh-list
101605499|NCT00648310|Hormones|hormones|mesh-ancestor
101605500|NCT00648310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101605501|NCT00648310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605502|NCT00648310|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101605503|NCT00648310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101605504|NCT00648310|Cholinergic Agents|cholinergic agents|mesh-ancestor
101605505|NCT00648310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101605506|NCT00648310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605526|NCT00830167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101605527|NCT00830167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605528|NCT00830167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101605529|NCT00830167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101605530|NCT00830167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101605531|NCT00830167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101605532|NCT00830167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101605533|NCT00992394|Etanercept|etanercept|mesh-list
101605534|NCT00992394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101605535|NCT00992394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101605536|NCT00992394|Analgesics|analgesics|mesh-ancestor
101605537|NCT00992394|Sensory System Agents|sensory system agents|mesh-ancestor
101605538|NCT00992394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101605539|NCT00992394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605540|NCT00992394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101605541|NCT00992394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101605542|NCT00992394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101605543|NCT00992394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101605544|NCT00992394|Immunologic Factors|immunologic factors|mesh-ancestor
101605545|NCT00829933|Warfarin|warfarin|mesh-list
101605546|NCT00829933|Edoxaban|edoxaban|mesh-list
101605547|NCT00829933|Anticoagulants|anticoagulants|mesh-ancestor
101605548|NCT00829933|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101605549|NCT00829933|Antithrombins|antithrombins|mesh-ancestor
101605550|NCT00829933|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101605551|NCT00829933|Protease Inhibitors|protease inhibitors|mesh-ancestor
101605552|NCT00829933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101605553|NCT00829933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605554|NCT01170962|Ribavirin|ribavirin|mesh-list
101605555|NCT01170962|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101605556|NCT01170962|Antimetabolites|antimetabolites|mesh-ancestor
102033938|NCT03645980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102033939|NCT03645980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102033940|NCT03645980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033941|NCT04315038|Anesthetics|anesthetics|mesh-list
102033942|NCT04315038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102033943|NCT04315038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033944|NCT03645200|Apatinib|apatinib|mesh-list
102033945|NCT03645200|Fluzoparib|fluzoparib|mesh-list
102033946|NCT03645200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033947|NCT03645200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102033948|NCT03645200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102033949|NCT03645200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033950|NCT03645200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102033951|NCT03055338|Risperidone|risperidone|mesh-list
102033952|NCT03055338|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102033953|NCT03055338|Serotonin Agents|serotonin agents|mesh-ancestor
102033954|NCT03055338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102033955|NCT03055338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033956|NCT03055338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033957|NCT03055338|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102033958|NCT03055338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101335462|NCT00049777|Anticoagulants|anticoagulants|mesh-ancestor
101605557|NCT01170962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605558|NCT01170962|Antiviral Agents|antiviral agents|mesh-ancestor
101605559|NCT01170962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101605560|NCT00843193|Fluticasone|fluticasone|mesh-list
101605562|NCT00843193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101605563|NCT00843193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101605564|NCT00843193|Autonomic Agents|autonomic agents|mesh-ancestor
101605567|NCT00843193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101605568|NCT00843193|Respiratory System Agents|respiratory system agents|mesh-ancestor
101605569|NCT00843193|Dermatologic Agents|dermatologic agents|mesh-ancestor
101605570|NCT00843193|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101605571|NCT00853021|Aldesleukin|aldesleukin|mesh-list
101605572|NCT00853021|Bevacizumab|bevacizumab|mesh-list
101605573|NCT00853021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101605574|NCT00853021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101605575|NCT00853021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101605576|NCT00853021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101605577|NCT00853021|Growth Substances|growth substances|mesh-ancestor
101605578|NCT00853021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605579|NCT00853021|Growth Inhibitors|growth inhibitors|mesh-ancestor
101605580|NCT00853021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101605581|NCT00853021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101605582|NCT00853021|Antiviral Agents|antiviral agents|mesh-ancestor
101605583|NCT00853021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101605584|NCT00913237|Desipramine|desipramine|mesh-list
101605585|NCT00913237|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101605586|NCT00913237|Antidepressive Agents|antidepressive agents|mesh-ancestor
101605587|NCT00913237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101605588|NCT00913237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101605589|NCT00913237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033959|NCT03055338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102033960|NCT03055338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102033961|NCT03055338|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102033962|NCT03055338|Dopamine Agents|dopamine agents|mesh-ancestor
102033963|NCT03645668|Meropenem|meropenem|mesh-list
102033964|NCT03645668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102033965|NCT03645668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102033966|NCT04186494|Liraglutide|liraglutide|mesh-list
102033967|NCT04186494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102033968|NCT04186494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033969|NCT04186494|Incretins|incretins|mesh-ancestor
102033970|NCT04186494|Hormones|hormones|mesh-ancestor
102033971|NCT04186494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102033972|NCT03712163|Ketotifen|ketotifen|mesh-list
102033973|NCT03712163|Antipruritics|antipruritics|mesh-ancestor
102033974|NCT03712163|Dermatologic Agents|dermatologic agents|mesh-ancestor
102033975|NCT03712163|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102033976|NCT03712163|Histamine Antagonists|histamine antagonists|mesh-ancestor
102033977|NCT03712163|Histamine Agents|histamine agents|mesh-ancestor
102033978|NCT03712163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102033979|NCT03712163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033980|NCT03712163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033981|NCT03712163|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102033982|NCT01311167|Dexamethasone|dexamethasone|mesh-list
102033983|NCT01311167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102033984|NCT01311167|Antiemetics|antiemetics|mesh-ancestor
102033985|NCT01311167|Autonomic Agents|autonomic agents|mesh-ancestor
102033986|NCT01311167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102033987|NCT01311167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102033988|NCT01311167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102033989|NCT01311167|Glucocorticoids|glucocorticoids|mesh-ancestor
102033991|NCT01311167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101605590|NCT00913237|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101605591|NCT00913237|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101605592|NCT00913237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101605593|NCT00913237|Adrenergic Agents|adrenergic agents|mesh-ancestor
101605594|NCT00913237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101605595|NCT00913237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605596|NCT05367284|Testosterone|testosterone|mesh-list
101605597|NCT05367284|Androgens|androgens|mesh-ancestor
101605598|NCT05367284|Hormones|hormones|mesh-ancestor
101605599|NCT05367284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102033992|NCT01311167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102033993|NCT01311167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033994|NCT04233840|Nivolumab|nivolumab|mesh-list
102033995|NCT04233840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102033996|NCT04233840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102033997|NCT04233840|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102033998|NCT04233840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102033999|NCT02896400|Nicotine|nicotine|mesh-list
102034000|NCT02896400|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101605600|NCT05367284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605601|NCT00843115|Donepezil|donepezil|mesh-list
101605602|NCT00843115|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101605603|NCT00843115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101605604|NCT00843115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605605|NCT00843115|Cholinergic Agents|cholinergic agents|mesh-ancestor
101605606|NCT00843115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101605607|NCT00843115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605608|NCT00843115|Nootropic Agents|nootropic agents|mesh-ancestor
101605609|NCT01156376|Listerine|listerine|mesh-list
101605610|NCT01156376|Fluorides|fluorides|mesh-list
101605611|NCT01156376|Cariostatic Agents|cariostatic agents|mesh-ancestor
101605612|NCT01156376|Protective Agents|protective agents|mesh-ancestor
101605613|NCT01156376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605614|NCT01156376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101605615|NCT01156376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101605616|NCT01156142|Doxepin|doxepin|mesh-list
101605617|NCT01156142|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101605618|NCT01156142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101605619|NCT01156142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101605620|NCT01156142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605621|NCT01156142|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101605622|NCT01156142|Antidepressive Agents|antidepressive agents|mesh-ancestor
101605623|NCT01156142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101605624|NCT01156142|Histamine Antagonists|histamine antagonists|mesh-ancestor
101605625|NCT01156142|Histamine Agents|histamine agents|mesh-ancestor
101605626|NCT01156142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101605627|NCT01156142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605629|NCT00842257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101605630|NCT00842257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101605631|NCT00706069|Capecitabine|capecitabine|mesh-list
101605632|NCT00706069|Vinorelbine|vinorelbine|mesh-list
101605633|NCT00706069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101605634|NCT00706069|Antimetabolites|antimetabolites|mesh-ancestor
101605635|NCT00706069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605636|NCT00706069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101605637|NCT00706069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101605648|NCT01155284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101605649|NCT01155284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101605650|NCT01155284|Protease Inhibitors|protease inhibitors|mesh-ancestor
101605651|NCT01155284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101605652|NCT01155284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605653|NCT01155284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101605654|NCT01155284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101605655|NCT01155284|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101605656|NCT00852397|Apixaban|apixaban|mesh-list
101605657|NCT00852397|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101605658|NCT00852397|Antithrombins|antithrombins|mesh-ancestor
101605659|NCT00852397|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101605660|NCT00852397|Protease Inhibitors|protease inhibitors|mesh-ancestor
101605661|NCT00852397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101605662|NCT00852397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605663|NCT00852397|Anticoagulants|anticoagulants|mesh-ancestor
101605664|NCT00852241|Hyaluronic Acid|hyaluronic acid|mesh-list
101605665|NCT00852241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102034002|NCT02896400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102034003|NCT02896400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034004|NCT02896400|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102034005|NCT02896400|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102034006|NCT02896400|Cholinergic Agents|cholinergic agents|mesh-ancestor
102034007|NCT02896400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101456947|NCT04644094|Hormones|hormones|mesh-ancestor
101605666|NCT00852241|Immunologic Factors|immunologic factors|mesh-ancestor
101605667|NCT00852241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605668|NCT00852241|Viscosupplements|viscosupplements|mesh-ancestor
101605669|NCT00852241|Protective Agents|protective agents|mesh-ancestor
101605670|NCT02612233|Pregabalin|pregabalin|mesh-list
101605671|NCT02612233|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101605672|NCT02612233|Analgesics|analgesics|mesh-ancestor
101605673|NCT02612233|Sensory System Agents|sensory system agents|mesh-ancestor
101605674|NCT02612233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101605675|NCT02612233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605676|NCT02612233|Anticonvulsants|anticonvulsants|mesh-ancestor
101605677|NCT02612233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101605678|NCT02612233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101605679|NCT02612233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605680|NCT02612233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101605681|NCT02612233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101605682|NCT02612233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101605683|NCT02612233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101605684|NCT02612233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101605685|NCT02612233|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101605686|NCT02612233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101605687|NCT02612233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101605688|NCT02612233|Antidepressive Agents|antidepressive agents|mesh-ancestor
101605689|NCT02612233|Dopamine Agents|dopamine agents|mesh-ancestor
101605690|NCT01169636|Carboplatin|carboplatin|mesh-list
101605691|NCT01169636|Etoposide|etoposide|mesh-list
101605692|NCT01169636|Ifosfamide|ifosfamide|mesh-list
101605693|NCT01169636|Panobinostat|panobinostat|mesh-list
101605694|NCT01169636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101605695|NCT01169636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101605696|NCT01169636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101605697|NCT01169636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101605698|NCT01169636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101605699|NCT01169636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605700|NCT01169636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101605701|NCT01169636|Alkylating Agents|alkylating agents|mesh-ancestor
101605702|NCT01169636|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101605704|NCT00706225|Estrogens|estrogens|mesh-list
101605709|NCT00706225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101605710|NCT00706225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101605712|NCT00706225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101605713|NCT04117009|Remifentanil|remifentanil|mesh-list
101605714|NCT04117009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101605715|NCT04117009|Narcotics|narcotics|mesh-ancestor
101605716|NCT04117009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101605717|NCT04117009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605718|NCT04117009|Analgesics|analgesics|mesh-ancestor
101605719|NCT04117009|Sensory System Agents|sensory system agents|mesh-ancestor
101605720|NCT04117009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101605721|NCT04117243|Misoprostol|misoprostol|mesh-list
101605722|NCT04117243|Tranexamic Acid|tranexamic acid|mesh-list
101605723|NCT04117243|Oxytocin|oxytocin|mesh-list
101605724|NCT04117243|Oxytocics|oxytocics|mesh-ancestor
101605725|NCT04117243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101605726|NCT04117243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605727|NCT04117243|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101605728|NCT04117243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101605729|NCT04117243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605730|NCT04117243|Hemostatics|hemostatics|mesh-ancestor
101605731|NCT04117243|Coagulants|coagulants|mesh-ancestor
102034008|NCT02896400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034009|NCT03404843|Fasudil|fasudil|mesh-list
102034010|NCT03404843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102034011|NCT03404843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102034012|NCT03404843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034013|NCT03404843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102034014|NCT03404843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034015|NCT03404843|Vasodilator Agents|vasodilator agents|mesh-ancestor
102034016|NCT03404843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101335530|NCT00050362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101605732|NCT04117243|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101605733|NCT04117243|Abortifacient Agents|abortifacient agents|mesh-ancestor
101605734|NCT04117243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101605735|NCT04117243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101605736|NCT01169558|Bevacizumab|bevacizumab|mesh-list
101605737|NCT01169558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101605738|NCT01169558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101605739|NCT01169558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101605740|NCT01169558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101605741|NCT01169558|Growth Substances|growth substances|mesh-ancestor
101605742|NCT01169558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605743|NCT01169558|Growth Inhibitors|growth inhibitors|mesh-ancestor
101605744|NCT00700687|Aspirin|aspirin|mesh-list
101605745|NCT00700687|Celecoxib|celecoxib|mesh-list
101262724|NCT01758380|Metformin|metformin|mesh-list
101605746|NCT00700687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101605747|NCT00700687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101605748|NCT00700687|Analgesics|analgesics|mesh-ancestor
101605749|NCT00700687|Sensory System Agents|sensory system agents|mesh-ancestor
101605750|NCT00700687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101605751|NCT00700687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605752|NCT00700687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101605753|NCT00700687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101605754|NCT00700687|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101605755|NCT00700687|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101605756|NCT00700687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605757|NCT00700687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101605758|NCT00700687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101605759|NCT00700687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101605760|NCT00700687|Antipyretics|antipyretics|mesh-ancestor
101605761|NCT00700687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101605762|NCT00840463|Ambrisentan|ambrisentan|mesh-list
101605763|NCT00840463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101605764|NCT00700765|Insulin Detemir|insulin detemir|mesh-list
101605765|NCT00700765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101605766|NCT00700765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605767|NCT00839527|Metformin|metformin|mesh-list
101605768|NCT00839527|Pioglitazone|pioglitazone|mesh-list
101605769|NCT00839527|Glimepiride|glimepiride|mesh-list
101605770|NCT00839527|rGLP-1 protein|rglp-1 protein|mesh-list
101605771|NCT00839527|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101605772|NCT00839527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101605773|NCT00839527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605774|NCT00839527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101605789|NCT00706927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101605790|NCT00706927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101605791|NCT00706927|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101605792|NCT00706927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101605793|NCT00706927|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101605794|NCT00706927|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101605795|NCT00706927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101605796|NCT00707083|Dexamethasone|dexamethasone|mesh-list
101605797|NCT00707083|Methotrexate|methotrexate|mesh-list
101605798|NCT00707083|Vincristine|vincristine|mesh-list
102034017|NCT03404843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102034018|NCT05284448|Pentoxifylline|pentoxifylline|mesh-list
102034019|NCT05284448|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102034020|NCT05284448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102034021|NCT05284448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034022|NCT05284448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102034023|NCT05284448|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102034024|NCT05284448|Protective Agents|protective agents|mesh-ancestor
102034025|NCT05284448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034026|NCT05284448|Vasodilator Agents|vasodilator agents|mesh-ancestor
102034027|NCT05284448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102034028|NCT05284448|Antioxidants|antioxidants|mesh-ancestor
102034029|NCT03032250|Hydrocortisone|hydrocortisone|mesh-list
102034030|NCT03032250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102034031|NCT03444155|Folic Acid|folic acid|mesh-list
102034032|NCT03444155|Vitamin B Complex|vitamin b complex|mesh-list
102034033|NCT03444155|Vitamins|vitamins|mesh-ancestor
102034034|NCT03444155|Micronutrients|micronutrients|mesh-ancestor
101605799|NCT00707083|Mercaptopurine|mercaptopurine|mesh-list
101605800|NCT00707083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101605801|NCT00707083|Antiemetics|antiemetics|mesh-ancestor
101605802|NCT00707083|Autonomic Agents|autonomic agents|mesh-ancestor
101605803|NCT00707083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101605804|NCT00707083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605805|NCT00707083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101605806|NCT00707083|Glucocorticoids|glucocorticoids|mesh-ancestor
101605807|NCT00707083|Hormones|hormones|mesh-ancestor
101605808|NCT00707083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101605809|NCT00707083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101605810|NCT00707083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101605811|NCT00707083|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101605812|NCT00707083|Abortifacient Agents|abortifacient agents|mesh-ancestor
101605813|NCT00707083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101605814|NCT00707083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101605815|NCT00707083|Antimetabolites|antimetabolites|mesh-ancestor
101605816|NCT00707083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605817|NCT00707083|Dermatologic Agents|dermatologic agents|mesh-ancestor
101605818|NCT00707083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101605819|NCT00707083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101605820|NCT00707083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101605821|NCT00707083|Immunologic Factors|immunologic factors|mesh-ancestor
101605822|NCT00707083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101605823|NCT00707083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101605824|NCT00707083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101605825|NCT00707083|Tubulin Modulators|tubulin modulators|mesh-ancestor
101605826|NCT00707083|Antimitotic Agents|antimitotic agents|mesh-ancestor
101605827|NCT00707083|Mitosis Modulators|mitosis modulators|mesh-ancestor
101605828|NCT05500261|Dexmedetomidine|dexmedetomidine|mesh-list
101605829|NCT05500261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101605830|NCT05500261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101605831|NCT05500261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605832|NCT05500261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101605833|NCT05500261|Analgesics|analgesics|mesh-ancestor
101605834|NCT05500261|Sensory System Agents|sensory system agents|mesh-ancestor
101605845|NCT04116931|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101605846|NCT04116931|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101605847|NCT04116931|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102034035|NCT03444155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034036|NCT03444155|Hematinics|hematinics|mesh-ancestor
102034037|NCT02898116|Durvalumab|durvalumab|mesh-list
102034038|NCT02898116|Ensartinib|ensartinib|mesh-list
102034039|NCT02898116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102034040|NCT02898116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102034041|NCT02898116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102034042|NCT02898116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102034043|NCT02898116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034044|NCT03717701|Metformin|metformin|mesh-list
102034045|NCT03717701|Esomeprazole|esomeprazole|mesh-list
102034046|NCT03717701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102034047|NCT03717701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034048|NCT03717701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101753826|NCT00804531|Hormones|hormones|mesh-ancestor
102034049|NCT03717701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102034050|NCT03717701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102034051|NCT03717701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102034052|NCT03717701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034053|NCT03658304|Mitomycins|mitomycins|mesh-list
102034054|NCT03658304|Mitomycin|mitomycin|mesh-list
102034055|NCT03658304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102034056|NCT03658304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102034057|NCT03658304|Alkylating Agents|alkylating agents|mesh-ancestor
102034058|NCT03658304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034059|NCT03658304|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101605848|NCT04116931|Purinergic Agents|purinergic agents|mesh-ancestor
101605849|NCT04116931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101605850|NCT04116931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605851|NCT04116931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605852|NCT00600886|Octreotide|octreotide|mesh-list
101605853|NCT00600886|Pasireotide|pasireotide|mesh-list
101605854|NCT00600886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101605855|NCT00600886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101605856|NCT00600886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101605857|NCT00600886|Hormones|hormones|mesh-ancestor
101605858|NCT00600886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101605859|NCT00600886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605860|NCT00649324|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101605861|NCT00649324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101605862|NCT00649324|Diuretics|diuretics|mesh-ancestor
101605863|NCT00649324|Natriuretic Agents|natriuretic agents|mesh-ancestor
101777558|NCT00773630|Vasodilator Agents|vasodilator agents|mesh-ancestor
101605864|NCT00649324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605865|NCT00649324|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101605866|NCT00649324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101605867|NCT00649324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605868|NCT00648388|Cilostazol|cilostazol|mesh-list
101605869|NCT00648388|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101605870|NCT00648388|Autonomic Agents|autonomic agents|mesh-ancestor
102034060|NCT03658304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102034061|NCT03422159|Ascorbic Acid|ascorbic acid|mesh-list
102034062|NCT03422159|Thiamine|thiamine|mesh-list
102034063|NCT03422159|Hydrocortisone|hydrocortisone|mesh-list
102034064|NCT03422159|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
102034065|NCT03422159|Vitamins|vitamins|mesh-ancestor
102034066|NCT03422159|Micronutrients|micronutrients|mesh-ancestor
101605871|NCT00648388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101605872|NCT00648388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605873|NCT00648388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101605874|NCT00648388|Respiratory System Agents|respiratory system agents|mesh-ancestor
101605875|NCT00648388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101605876|NCT00648388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101605877|NCT00648388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605878|NCT00648388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101605879|NCT00648388|Vasodilator Agents|vasodilator agents|mesh-ancestor
101605880|NCT00648388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101605881|NCT00648388|Protective Agents|protective agents|mesh-ancestor
101605882|NCT00648388|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101605883|NCT00648388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101605884|NCT00648388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101605885|NCT02658760|Dexmedetomidine|dexmedetomidine|mesh-list
101605886|NCT02658760|Bupivacaine|bupivacaine|mesh-list
101605887|NCT02658760|Anesthetics, Local|anesthetics, local|mesh-ancestor
101605888|NCT02658760|Anesthetics|anesthetics|mesh-ancestor
101605889|NCT02658760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101605890|NCT02658760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605891|NCT02658760|Sensory System Agents|sensory system agents|mesh-ancestor
101605892|NCT02658760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101605893|NCT02658760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101605894|NCT02658760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101605896|NCT02658760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101605897|NCT02658760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101605931|NCT00649090|Hormone Antagonists|hormone antagonists|mesh-ancestor
101605932|NCT00649090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101605933|NCT00649090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605935|NCT00838903|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101605936|NCT00838903|Glimepiride|glimepiride|mesh-list
101605937|NCT00838903|rGLP-1 protein|rglp-1 protein|mesh-list
101605938|NCT00838903|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101605939|NCT00838903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101605940|NCT00838903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605941|NCT00838903|Incretins|incretins|mesh-ancestor
101605942|NCT00838903|Hormones|hormones|mesh-ancestor
101605945|NCT00838903|Protease Inhibitors|protease inhibitors|mesh-ancestor
101605946|NCT00838903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101605947|NCT00838903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605948|NCT00838903|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101605949|NCT00838903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101605950|NCT00838903|Immunologic Factors|immunologic factors|mesh-ancestor
101605951|NCT00648466|Sumatriptan|sumatriptan|mesh-list
101605952|NCT00648466|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101605953|NCT00648466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101605954|NCT00648466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101605955|NCT00648466|Serotonin Agents|serotonin agents|mesh-ancestor
101605956|NCT00648466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101605957|NCT00648466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605958|NCT00648466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605959|NCT00649402|Amlodipine|amlodipine|mesh-list
101605960|NCT00649402|Benazepril|benazepril|mesh-list
101605961|NCT00649402|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101605962|NCT00649402|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101777565|NCT04016922|Hematinics|hematinics|mesh-ancestor
101605963|NCT00649402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101605964|NCT00649402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605965|NCT00649402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101605966|NCT00649402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605967|NCT00649402|Vasodilator Agents|vasodilator agents|mesh-ancestor
101605968|NCT00649402|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102034067|NCT03422159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034068|NCT03422159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102034070|NCT03422159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605969|NCT00649402|Protease Inhibitors|protease inhibitors|mesh-ancestor
101605970|NCT00649402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101605972|NCT04477486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101605973|NCT00649480|Balsalazide|balsalazide|mesh-list
101605974|NCT00649480|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101605975|NCT00649480|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101605976|NCT00649480|Analgesics|analgesics|mesh-ancestor
101605977|NCT00649480|Sensory System Agents|sensory system agents|mesh-ancestor
101605978|NCT00649480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101605979|NCT00649480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605980|NCT00649480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101605981|NCT00649480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101605982|NCT00649480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101605983|NCT02656342|Cycloserine|cycloserine|mesh-list
101605984|NCT02656342|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101605985|NCT02656342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101605986|NCT02656342|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101605987|NCT02656342|Antitubercular Agents|antitubercular agents|mesh-ancestor
101605988|NCT02656342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101605989|NCT02656342|Antimetabolites|antimetabolites|mesh-ancestor
101605990|NCT02656342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605991|NCT04169464|Sofosbuvir|sofosbuvir|mesh-list
101605992|NCT04169464|Antiviral Agents|antiviral agents|mesh-ancestor
101605993|NCT04169464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101605994|NCT00650416|Carvedilol|carvedilol|mesh-list
101605995|NCT00650416|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101605996|NCT00650416|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101605997|NCT00650416|Adrenergic Agents|adrenergic agents|mesh-ancestor
101605998|NCT00650416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101605999|NCT00650416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606000|NCT00650416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606001|NCT00650416|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101606002|NCT00650416|Antioxidants|antioxidants|mesh-ancestor
101606003|NCT00650416|Protective Agents|protective agents|mesh-ancestor
101606004|NCT00650416|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101606005|NCT00650416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101606006|NCT00650416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101606007|NCT00650416|Vasodilator Agents|vasodilator agents|mesh-ancestor
101606008|NCT00650416|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101606009|NCT00650416|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101606010|NCT00649948|Metformin|metformin|mesh-list
101606011|NCT00649948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101606012|NCT00649948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606013|NCT04167982|Isotretinoin|isotretinoin|mesh-list
101606043|NCT02658214|Folic Acid|folic acid|mesh-list
101606044|NCT02658214|Paclitaxel|paclitaxel|mesh-list
101606045|NCT02658214|Etoposide|etoposide|mesh-list
101606047|NCT02658214|Carboplatin|carboplatin|mesh-list
101606048|NCT02658214|Gemcitabine|gemcitabine|mesh-list
101606049|NCT02658214|Fluorouracil|fluorouracil|mesh-list
101606050|NCT02658214|Oxaliplatin|oxaliplatin|mesh-list
101606051|NCT02658214|Durvalumab|durvalumab|mesh-list
101606052|NCT02658214|Tremelimumab|tremelimumab|mesh-list
101606053|NCT02658214|Levoleucovorin|levoleucovorin|mesh-list
101606054|NCT02658214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101606055|NCT02658214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101606056|NCT02658214|Tubulin Modulators|tubulin modulators|mesh-ancestor
101606057|NCT02658214|Antimitotic Agents|antimitotic agents|mesh-ancestor
101606058|NCT02658214|Mitosis Modulators|mitosis modulators|mesh-ancestor
101606059|NCT02658214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606060|NCT02658214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101606061|NCT02658214|Antimetabolites|antimetabolites|mesh-ancestor
101606062|NCT02658214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606063|NCT02658214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101606079|NCT04169230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606080|NCT04169230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101606081|NCT04169230|Serotonin Agents|serotonin agents|mesh-ancestor
101606082|NCT04169230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034071|NCT03422159|Protective Agents|protective agents|mesh-ancestor
102034072|NCT03422159|Vitamin B Complex|vitamin b complex|mesh-ancestor
102034073|NCT04538040|Tenofovir|tenofovir|mesh-list
102034074|NCT04538040|Emtricitabine|emtricitabine|mesh-list
102034075|NCT04538040|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
102034076|NCT04538040|Antiviral Agents|antiviral agents|mesh-ancestor
102034077|NCT04538040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102034078|NCT04538040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102034079|NCT04538040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102034080|NCT04538040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101606083|NCT04169230|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101606084|NCT04169230|Antidepressive Agents|antidepressive agents|mesh-ancestor
101606085|NCT04169230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101606086|NCT04201756|Afatinib|afatinib|mesh-list
101606087|NCT04201756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101606088|NCT04201756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101606089|NCT04201756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101606090|NCT04201756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606091|NCT02651350|Methylprednisolone|methylprednisolone|mesh-list
101606092|NCT02651350|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101606093|NCT02651350|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101606094|NCT02651350|Prednisolone|prednisolone|mesh-list
101606095|NCT02651350|Prednisolone acetate|prednisolone acetate|mesh-list
101606096|NCT02651350|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101606097|NCT02651350|Prednisolone phosphate|prednisolone phosphate|mesh-list
101606098|NCT02651350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101606099|NCT02651350|Antiemetics|antiemetics|mesh-ancestor
101606100|NCT02651350|Autonomic Agents|autonomic agents|mesh-ancestor
101606101|NCT02651350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101606102|NCT02651350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606103|NCT02651350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101606104|NCT02651350|Glucocorticoids|glucocorticoids|mesh-ancestor
101606105|NCT02651350|Hormones|hormones|mesh-ancestor
101606106|NCT02651350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101606107|NCT02651350|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101606108|NCT02651350|Protective Agents|protective agents|mesh-ancestor
101606109|NCT02651350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101606110|NCT02651350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101606111|NCT02658292|Naftifine|naftifine|mesh-list
101606112|NCT02658292|Antifungal Agents|antifungal agents|mesh-ancestor
101606113|NCT02658292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101606114|NCT02651038|Micafungin|micafungin|mesh-list
101606115|NCT02651038|Antifungal Agents|antifungal agents|mesh-ancestor
101606116|NCT02651038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101606117|NCT00650026|Adalimumab|adalimumab|mesh-list
101606118|NCT00650026|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101606119|NCT00650026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101263107|NCT01760330|Antipyretics|antipyretics|mesh-ancestor
101606120|NCT00650026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101606121|NCT00838513|Eculizumab|eculizumab|mesh-list
101606122|NCT00838513|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101606123|NCT00838513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101606124|NCT00838513|Immunologic Factors|immunologic factors|mesh-ancestor
101606155|NCT00700921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101606157|NCT00850993|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
101606158|NCT00850993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101606159|NCT00850993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606160|NCT02657512|Rivaroxaban|rivaroxaban|mesh-list
101606161|NCT02657512|Charcoal|charcoal|mesh-list
101606162|NCT02657512|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101606163|NCT02657512|Antithrombins|antithrombins|mesh-ancestor
101606164|NCT02657512|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101606165|NCT02657512|Protease Inhibitors|protease inhibitors|mesh-ancestor
101606166|NCT02657512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101606186|NCT00649714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606188|NCT00600028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102034081|NCT04538040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034082|NCT04538040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102034083|NCT04538040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102034084|NCT02297412|Minocycline|minocycline|mesh-list
102034085|NCT02297412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102034086|NCT02297412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101606189|NCT00600028|Immunologic Factors|immunologic factors|mesh-ancestor
101606190|NCT00600028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606191|NCT00600028|Leprostatic Agents|leprostatic agents|mesh-ancestor
101606192|NCT00600028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101606193|NCT00600028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101606194|NCT00600028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101606195|NCT00600028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101606197|NCT00600028|Growth Inhibitors|growth inhibitors|mesh-ancestor
101606198|NCT00600028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101606200|NCT02650102|Risperidone|risperidone|mesh-list
101606201|NCT02650102|Aripiprazole|aripiprazole|mesh-list
101606202|NCT02650102|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101606203|NCT02650102|Ziprasidone|ziprasidone|mesh-list
101606204|NCT02650102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101606205|NCT02650102|Serotonin Agents|serotonin agents|mesh-ancestor
101606206|NCT02650102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101606207|NCT02650102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606208|NCT02650102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606209|NCT02650102|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101606210|NCT02650102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101606211|NCT02650102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101606212|NCT02650102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101606213|NCT02650102|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101606214|NCT02650102|Dopamine Agents|dopamine agents|mesh-ancestor
101606215|NCT02650102|Antiemetics|antiemetics|mesh-ancestor
101606216|NCT02650102|Autonomic Agents|autonomic agents|mesh-ancestor
101606217|NCT02650102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101606218|NCT02650102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101606219|NCT02650102|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101606220|NCT02650102|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101606223|NCT02650102|Dopamine Agonists|dopamine agonists|mesh-ancestor
101606224|NCT02650102|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101606225|NCT02650102|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101606226|NCT02650102|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101606227|NCT02650102|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101606229|NCT00650182|Naltrexone|naltrexone|mesh-list
101606230|NCT00650182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101606231|NCT00650182|Narcotics|narcotics|mesh-ancestor
101606232|NCT00650182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101606233|NCT00650182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606234|NCT00650182|Analgesics|analgesics|mesh-ancestor
101606235|NCT00650182|Sensory System Agents|sensory system agents|mesh-ancestor
101606236|NCT00650182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101606237|NCT00650182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101606238|NCT00650182|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101606239|NCT00650182|Anesthetics, General|anesthetics, general|mesh-ancestor
101606240|NCT00650182|Anesthetics|anesthetics|mesh-ancestor
101606241|NCT00650182|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101606242|NCT00650182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101606243|NCT00910780|Olanzapine|olanzapine|mesh-list
101606244|NCT00910780|Aripiprazole|aripiprazole|mesh-list
101606245|NCT00910780|Antidepressive Agents|antidepressive agents|mesh-ancestor
101606246|NCT00910780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101606247|NCT00910780|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101606248|NCT00910780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101606249|NCT00910780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101606250|NCT00910780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606251|NCT00910780|Dopamine Agonists|dopamine agonists|mesh-ancestor
101606252|NCT00910780|Dopamine Agents|dopamine agents|mesh-ancestor
101606253|NCT00910780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101606254|NCT00910780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606255|NCT00910780|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102034087|NCT03644576|Pseudoephedrine|pseudoephedrine|mesh-list
102034088|NCT03644576|Ephedrine|ephedrine|mesh-list
102034089|NCT03644576|Ozanimod|ozanimod|mesh-list
102034090|NCT03644576|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102034091|NCT03644576|Autonomic Agents|autonomic agents|mesh-ancestor
102034092|NCT03644576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102034093|NCT03644576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034094|NCT03644576|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102034095|NCT03644576|Respiratory System Agents|respiratory system agents|mesh-ancestor
102034096|NCT03644576|Nasal Decongestants|nasal decongestants|mesh-ancestor
101606256|NCT00910780|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101606257|NCT00910780|Serotonin Agents|serotonin agents|mesh-ancestor
101606258|NCT00910780|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101606259|NCT00910780|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101606260|NCT00910780|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101606261|NCT00910780|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101606262|NCT00910780|Antiemetics|antiemetics|mesh-ancestor
101606263|NCT00910780|Autonomic Agents|autonomic agents|mesh-ancestor
101606264|NCT00910780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101606265|NCT00910780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101606266|NCT00910780|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101606267|NCT00910780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101606268|NCT00910780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101606269|NCT02656810|Teriparatide|teriparatide|mesh-list
101606270|NCT02656810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101606272|NCT02656810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101606273|NCT02649478|Fluticasone|fluticasone|mesh-list
101606274|NCT02649478|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101606275|NCT02649478|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101606276|NCT02649478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101606277|NCT02649478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101606278|NCT02649478|Autonomic Agents|autonomic agents|mesh-ancestor
101606279|NCT02649478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101606280|NCT02649478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606281|NCT02649478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101606282|NCT02649478|Respiratory System Agents|respiratory system agents|mesh-ancestor
101606283|NCT02649478|Dermatologic Agents|dermatologic agents|mesh-ancestor
101606284|NCT02649478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101606285|NCT02649478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101606286|NCT02649478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101606287|NCT02649478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101606288|NCT02649478|Adrenergic Agents|adrenergic agents|mesh-ancestor
101606289|NCT02649478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101606290|NCT02649478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606292|NCT02649478|Hormones|hormones|mesh-ancestor
101606293|NCT02649478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101606304|NCT04168138|Cytarabine|cytarabine|mesh-list
101606305|NCT04168138|Decitabine|decitabine|mesh-list
101606306|NCT04168138|Aclarubicin|aclarubicin|mesh-list
101606307|NCT04168138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101606308|NCT04168138|Antimetabolites|antimetabolites|mesh-ancestor
101606309|NCT04168138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606310|NCT04168138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101606311|NCT04168138|Antiviral Agents|antiviral agents|mesh-ancestor
101606312|NCT04168138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101606313|NCT04168138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101606314|NCT04168138|Immunologic Factors|immunologic factors|mesh-ancestor
101606315|NCT04168138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606316|NCT04168138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101606317|NCT04168138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101606318|NCT04168138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101606319|NCT04168138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101606320|NCT00649870|Valacyclovir|valacyclovir|mesh-list
101606321|NCT00649870|Antiviral Agents|antiviral agents|mesh-ancestor
101606322|NCT00649870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102034098|NCT03644576|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102034099|NCT03644576|Sympathomimetics|sympathomimetics|mesh-ancestor
102034100|NCT03644576|Adrenergic Agents|adrenergic agents|mesh-ancestor
102034101|NCT03644576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101606323|NCT04167280|Ipratropium|ipratropium|mesh-list
101606324|NCT04167280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101606325|NCT04167280|Autonomic Agents|autonomic agents|mesh-ancestor
101606326|NCT04167280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101606327|NCT04167280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606328|NCT04167280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101606329|NCT04167280|Respiratory System Agents|respiratory system agents|mesh-ancestor
101606330|NCT04167280|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101606331|NCT04167280|Cholinergic Agents|cholinergic agents|mesh-ancestor
101606332|NCT04167280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101606333|NCT04167280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606334|NCT02648854|Metformin|metformin|mesh-list
101606335|NCT02648854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101606336|NCT02648854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606337|NCT02652598|Tolcapone|tolcapone|mesh-list
101606338|NCT02652598|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101606339|NCT02652598|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101606340|NCT02652598|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101606341|NCT02652598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101606342|NCT02652598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606343|NCT02648776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
101606344|NCT02648776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101606345|NCT02648776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606346|NCT02648464|Hydroxychloroquine|hydroxychloroquine|mesh-list
101606347|NCT02648464|Antimalarials|antimalarials|mesh-ancestor
101606348|NCT02648464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101606349|NCT02648464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101606350|NCT02648464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101606351|NCT02648464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101606352|NCT02648464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606353|NCT02648464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101606354|NCT02645032|Vaccines|vaccines|mesh-list
101606355|NCT02645032|Immunologic Factors|immunologic factors|mesh-ancestor
101606356|NCT02645032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606357|NCT02644954|Metformin|metformin|mesh-list
101606358|NCT02644954|Calcipotriene|calcipotriene|mesh-list
101606359|NCT02644954|Coal Tar|coal tar|mesh-list
101606360|NCT02644954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101606386|NCT00652600|Propranolol|propranolol|mesh-list
101606387|NCT00652600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101606388|NCT00652600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101606389|NCT00652600|Adrenergic Agents|adrenergic agents|mesh-ancestor
101606390|NCT00652600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101606391|NCT00652600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606392|NCT00652600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606393|NCT00652600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101606394|NCT00652600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101606395|NCT00652600|Vasodilator Agents|vasodilator agents|mesh-ancestor
101606396|NCT03201250|Dexamethasone|dexamethasone|mesh-list
101606397|NCT03201250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101606398|NCT03201250|Antiemetics|antiemetics|mesh-ancestor
101606399|NCT03201250|Autonomic Agents|autonomic agents|mesh-ancestor
101606400|NCT03201250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101606401|NCT03201250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606402|NCT03201250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101606403|NCT03201250|Glucocorticoids|glucocorticoids|mesh-ancestor
101606404|NCT03201250|Hormones|hormones|mesh-ancestor
101606405|NCT03201250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101606406|NCT03201250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101606407|NCT03201250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101606408|NCT04166578|Lidocaine|lidocaine|mesh-list
101606409|NCT04166578|Anesthetics, Local|anesthetics, local|mesh-ancestor
101606410|NCT04166578|Anesthetics|anesthetics|mesh-ancestor
101606411|NCT04166578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101606412|NCT04166578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034102|NCT03644576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034103|NCT03644576|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102034104|NCT03644576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102034105|NCT03644576|Immunologic Factors|immunologic factors|mesh-ancestor
102034106|NCT03418727|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101335625|NCT00051259|Bupropion|bupropion|mesh-list
101606434|NCT00651352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606435|NCT02641210|Albendazole|albendazole|mesh-list
101777589|NCT00307489|Tenofovir|tenofovir|mesh-list
101606436|NCT02641210|Anthelmintics|anthelmintics|mesh-ancestor
101606437|NCT02641210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101606438|NCT02641210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101606439|NCT02641210|Anticestodal Agents|anticestodal agents|mesh-ancestor
101606440|NCT02641210|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101606441|NCT02641210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101606442|NCT02641210|Tubulin Modulators|tubulin modulators|mesh-ancestor
101606443|NCT02641210|Antimitotic Agents|antimitotic agents|mesh-ancestor
101606444|NCT02641210|Mitosis Modulators|mitosis modulators|mesh-ancestor
101606445|NCT02641210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606446|NCT02641210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101606447|NCT02644408|Megestrol|megestrol|mesh-list
101606448|NCT02644408|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101606449|NCT02644408|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101606450|NCT02644408|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101606451|NCT02644408|Contraceptive Agents|contraceptive agents|mesh-ancestor
101606452|NCT02644408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101606453|NCT02644408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606454|NCT02644408|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101606455|NCT02644408|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101606456|NCT02644408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101606457|NCT02644408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101606458|NCT05758597|Midazolam|midazolam|mesh-list
101606459|NCT05758597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101606460|NCT05758597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101606461|NCT05758597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101606463|NCT05758597|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101606464|NCT05758597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101606465|NCT05758597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101606466|NCT05758597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101606467|NCT05758597|Anesthetics, General|anesthetics, general|mesh-ancestor
101606469|NCT05758597|GABA Modulators|gaba modulators|mesh-ancestor
101606470|NCT05758597|GABA Agents|gaba agents|mesh-ancestor
101606471|NCT05758597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101606472|NCT05758597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606473|NCT02644486|Irbesartan|irbesartan|mesh-list
101606474|NCT02644486|Sevelamer|sevelamer|mesh-list
101606475|NCT02644486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101606476|NCT02644486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101606477|NCT02644486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101606478|NCT02644486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606479|NCT02644486|Chelating Agents|chelating agents|mesh-ancestor
101606480|NCT02644486|Sequestering Agents|sequestering agents|mesh-ancestor
101606481|NCT00827359|Everolimus|everolimus|mesh-list
101606482|NCT00827359|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101606483|NCT00827359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101606484|NCT00827359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101606485|NCT00827359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606486|NCT00827359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101606487|NCT00827359|Immunologic Factors|immunologic factors|mesh-ancestor
101606488|NCT00827359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606489|NCT00827359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101606490|NCT02641288|Ropivacaine|ropivacaine|mesh-list
101606491|NCT02641288|Anesthetics, Local|anesthetics, local|mesh-ancestor
101606492|NCT02641288|Anesthetics|anesthetics|mesh-ancestor
101263482|NCT01762306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101606493|NCT02641288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101606494|NCT02641288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606495|NCT02641288|Sensory System Agents|sensory system agents|mesh-ancestor
101606496|NCT02641288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102034107|NCT03418727|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102034108|NCT03418727|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102034109|NCT03418727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102034110|NCT03418727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102034111|NCT03418727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102034112|NCT03418727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102034113|NCT03418727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102034114|NCT03418727|Adrenergic Agents|adrenergic agents|mesh-ancestor
102034115|NCT03418727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101606497|NCT04165174|Apatinib|apatinib|mesh-list
101606498|NCT04165174|Antibodies|antibodies|mesh-list
101606499|NCT04165174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101606500|NCT04165174|Immunologic Factors|immunologic factors|mesh-ancestor
101606501|NCT04165174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606502|NCT04165174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101606503|NCT04165174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101606504|NCT04165174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101606505|NCT04165174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606506|NCT02613247|Hylan|hylan|mesh-list
101606507|NCT02613247|Viscosupplements|viscosupplements|mesh-ancestor
101606508|NCT02613247|Protective Agents|protective agents|mesh-ancestor
101606509|NCT02613247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606510|NCT02641132|Mitomycins|mitomycins|mesh-list
101606511|NCT02641132|Mitomycin|mitomycin|mesh-list
101606512|NCT02641132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101606513|NCT02641132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101606514|NCT02641132|Alkylating Agents|alkylating agents|mesh-ancestor
101606515|NCT02641132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606516|NCT02641132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101606517|NCT02641132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101606518|NCT00653614|Drospirenone|drospirenone|mesh-list
101606519|NCT00653614|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101606520|NCT00653614|Hormone Antagonists|hormone antagonists|mesh-ancestor
101606521|NCT00653614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101606522|NCT00653614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606523|NCT00653614|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101606524|NCT00653614|Diuretics|diuretics|mesh-ancestor
101606525|NCT00653614|Natriuretic Agents|natriuretic agents|mesh-ancestor
101606526|NCT02644252|Tocotrienols|tocotrienols|mesh-list
101606527|NCT02644252|Vitamin E|vitamin e|mesh-list
101606528|NCT02644252|Tocopherols|tocopherols|mesh-list
101606529|NCT02644252|Carboplatin|carboplatin|mesh-list
101606530|NCT02644252|Vinorelbine|vinorelbine|mesh-list
101606531|NCT02644252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101606532|NCT02644252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101606533|NCT02644252|Tubulin Modulators|tubulin modulators|mesh-ancestor
101606534|NCT02644252|Antimitotic Agents|antimitotic agents|mesh-ancestor
101606535|NCT02644252|Mitosis Modulators|mitosis modulators|mesh-ancestor
101606561|NCT02640976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101606562|NCT02640976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606563|NCT02640976|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101606564|NCT02640976|Fertility Agents|fertility agents|mesh-ancestor
101606565|NCT02640976|Hormone Antagonists|hormone antagonists|mesh-ancestor
101606566|NCT02640976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101606567|NCT02644018|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
101606568|NCT02644018|Antiviral Agents|antiviral agents|mesh-ancestor
101606569|NCT02644018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101606570|NCT02647918|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
101606571|NCT02647918|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101606572|NCT02647918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606573|NCT02647918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101606574|NCT02647918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606575|NCT03130036|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101606576|NCT03130036|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102034116|NCT03418727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034117|NCT03418727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034118|NCT03418727|Laxatives|laxatives|mesh-ancestor
102034119|NCT03418727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102034121|NCT01180374|Cannabidiol|cannabidiol|mesh-list
102034122|NCT01180374|Anticonvulsants|anticonvulsants|mesh-ancestor
102034123|NCT01180374|Hallucinogens|hallucinogens|mesh-ancestor
102034124|NCT01180374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034125|NCT01180374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101335644|NCT05639777|Analgesics|analgesics|mesh-ancestor
101606577|NCT03130036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606578|NCT02535988|Thymalfasin|thymalfasin|mesh-list
101606579|NCT02535988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101606580|NCT02535988|Immunologic Factors|immunologic factors|mesh-ancestor
101606581|NCT02535988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606582|NCT02640898|Docetaxel|docetaxel|mesh-list
101606593|NCT02535910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606594|NCT02535910|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101606595|NCT02535910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101606596|NCT00849901|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101606597|NCT00849901|Fluoxetine|fluoxetine|mesh-list
101606598|NCT00849901|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101606599|NCT00849901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101606600|NCT00849901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101606601|NCT00849901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606602|NCT00849901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101606603|NCT00849901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606604|NCT00849901|Analgesics|analgesics|mesh-ancestor
101606605|NCT00849901|Sensory System Agents|sensory system agents|mesh-ancestor
101606606|NCT00849901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101606607|NCT00849901|Antidepressive Agents|antidepressive agents|mesh-ancestor
101606608|NCT00849901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101606609|NCT00849901|Dopamine Agents|dopamine agents|mesh-ancestor
101606610|NCT00849901|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101606611|NCT00849901|Serotonin Agents|serotonin agents|mesh-ancestor
101606612|NCT00849901|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101606613|NCT00849901|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101606614|NCT00849901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101606615|NCT00849901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101606616|NCT02641054|Levodopa|levodopa|mesh-list
101606617|NCT02641054|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101606618|NCT02641054|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101606619|NCT02641054|Dopamine Agents|dopamine agents|mesh-ancestor
101606620|NCT02641054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101606621|NCT02641054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606622|NCT02641054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606623|NCT02643784|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101606624|NCT02643784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101606625|NCT02643784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101606626|NCT02643784|Antimetabolites|antimetabolites|mesh-ancestor
101606627|NCT02643784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606628|NCT02643784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101606629|NCT02643784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101606630|NCT02643784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101606632|NCT04166890|Carticaine|carticaine|mesh-list
101606633|NCT04166890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101606634|NCT04166890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101606635|NCT04166890|Adrenergic Agents|adrenergic agents|mesh-ancestor
101606636|NCT04166890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101606637|NCT04166890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034126|NCT01180374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102034127|NCT01180374|Analgesics|analgesics|mesh-ancestor
102034128|NCT01180374|Sensory System Agents|sensory system agents|mesh-ancestor
102034129|NCT01180374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102034130|NCT01180374|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102034131|NCT01180374|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102034132|NCT01180374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102034133|NCT01180374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335649|NCT05639777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101606638|NCT04166890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606639|NCT04166890|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101606640|NCT04166890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101606641|NCT04166890|Autonomic Agents|autonomic agents|mesh-ancestor
101606642|NCT04166890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101606643|NCT04166890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101606644|NCT04166890|Respiratory System Agents|respiratory system agents|mesh-ancestor
101606645|NCT04166890|Mydriatics|mydriatics|mesh-ancestor
101606646|NCT04166890|Sympathomimetics|sympathomimetics|mesh-ancestor
101606647|NCT04166890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101606676|NCT00651586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101606677|NCT00651586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101606678|NCT00651586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101606679|NCT00651586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101606680|NCT00651586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606681|NCT00651586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101606682|NCT00651586|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101606683|NCT00651586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101606685|NCT02640508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101606686|NCT02640508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101606687|NCT02640508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101606688|NCT02640508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606689|NCT05312606|Chlorhexidine|chlorhexidine|mesh-list
101606690|NCT05312606|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101606691|NCT05312606|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101606692|NCT05312606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101606693|NCT05312606|Disinfectants|disinfectants|mesh-ancestor
101606694|NCT05312606|Dermatologic Agents|dermatologic agents|mesh-ancestor
101606710|NCT04313270|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101606711|NCT04313270|Protease Inhibitors|protease inhibitors|mesh-ancestor
101606712|NCT04313270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101606713|NCT04313270|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101606714|NCT02640118|Lixisenatide|lixisenatide|mesh-list
101606715|NCT02640118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101606716|NCT02640118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606718|NCT00826267|Lapatinib|lapatinib|mesh-list
101606719|NCT00826267|Afatinib|afatinib|mesh-list
101606720|NCT00826267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101606721|NCT00826267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101606722|NCT00826267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101606723|NCT00826267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101606724|NCT00826267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606725|NCT00653848|Docetaxel|docetaxel|mesh-list
101606726|NCT00653848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101606727|NCT00653848|Tubulin Modulators|tubulin modulators|mesh-ancestor
101606728|NCT00653848|Antimitotic Agents|antimitotic agents|mesh-ancestor
101606729|NCT00653848|Mitosis Modulators|mitosis modulators|mesh-ancestor
101606730|NCT00653848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606731|NCT00707551|Ketoconazole|ketoconazole|mesh-list
101606732|NCT00707551|Verapamil|verapamil|mesh-list
101606733|NCT00707551|Antifungal Agents|antifungal agents|mesh-ancestor
101606734|NCT00707551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101606735|NCT00707551|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101606736|NCT00707551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101606737|NCT00707551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102034134|NCT01180374|Hormones|hormones|mesh-ancestor
102034135|NCT01180374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102034136|NCT03418571|Gontivimab|gontivimab|mesh-list
102034137|NCT03418571|Antiviral Agents|antiviral agents|mesh-ancestor
102034138|NCT03418571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102034139|NCT03715517|Morphine|morphine|mesh-list
102034140|NCT03715517|Hydromorphone|hydromorphone|mesh-list
102034141|NCT03715517|Bupivacaine|bupivacaine|mesh-list
102034142|NCT03715517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102034143|NCT03715517|Anesthetics, Local|anesthetics, local|mesh-ancestor
102034144|NCT03715517|Anesthetics|anesthetics|mesh-ancestor
101335655|NCT00051298|Autonomic Agents|autonomic agents|mesh-ancestor
101606738|NCT00707551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606739|NCT00707551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101606740|NCT00707551|Hormone Antagonists|hormone antagonists|mesh-ancestor
101606741|NCT00707551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101606742|NCT00707551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606743|NCT00707551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101606744|NCT00707551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101606745|NCT00707551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101606746|NCT00707551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101606747|NCT00707551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101606748|NCT00707551|Vasodilator Agents|vasodilator agents|mesh-ancestor
101606749|NCT00986154|Heparin|heparin|mesh-list
101606750|NCT00986154|Calcium heparin|calcium heparin|mesh-list
101606751|NCT00986154|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101606752|NCT00986154|Tinzaparin|tinzaparin|mesh-list
101606753|NCT00986154|Dalteparin|dalteparin|mesh-list
101606754|NCT00986154|Warfarin|warfarin|mesh-list
101606755|NCT00986154|Edoxaban|edoxaban|mesh-list
101606756|NCT00986154|Anticoagulants|anticoagulants|mesh-ancestor
101606757|NCT00986154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101606758|NCT00986154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101606764|NCT00986154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101606765|NCT00653926|Epinephrine|epinephrine|mesh-list
101606766|NCT00653926|Ropivacaine|ropivacaine|mesh-list
101606767|NCT00653926|Anesthetics, Local|anesthetics, local|mesh-ancestor
101606768|NCT00653926|Anesthetics|anesthetics|mesh-ancestor
101606769|NCT00653926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101606770|NCT00653926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606771|NCT00653926|Sensory System Agents|sensory system agents|mesh-ancestor
101606772|NCT00653926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101606773|NCT00653926|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101606774|NCT00653926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101606775|NCT00653926|Adrenergic Agents|adrenergic agents|mesh-ancestor
101606776|NCT00653926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101606777|NCT00653926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606778|NCT00653926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101606779|NCT00653926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101606781|NCT00653926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101606782|NCT00653926|Respiratory System Agents|respiratory system agents|mesh-ancestor
101606783|NCT00653926|Mydriatics|mydriatics|mesh-ancestor
101606784|NCT00653926|Sympathomimetics|sympathomimetics|mesh-ancestor
101606785|NCT00653926|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101606786|NCT02613091|Clemastine|clemastine|mesh-list
101606787|NCT02613091|Antipruritics|antipruritics|mesh-ancestor
101606788|NCT02613091|Dermatologic Agents|dermatologic agents|mesh-ancestor
101606789|NCT02613091|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101606790|NCT02613091|Histamine Antagonists|histamine antagonists|mesh-ancestor
101606791|NCT02613091|Histamine Agents|histamine agents|mesh-ancestor
101606792|NCT02613091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101606793|NCT02613091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606794|NCT02613091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606795|NCT02613091|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101606796|NCT02639806|Lidocaine|lidocaine|mesh-list
102034145|NCT03715517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102034146|NCT03715517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034147|NCT03715517|Sensory System Agents|sensory system agents|mesh-ancestor
102034148|NCT03715517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102034149|NCT03715517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102034150|NCT03715517|Narcotics|narcotics|mesh-ancestor
102034151|NCT03715517|Analgesics|analgesics|mesh-ancestor
102034152|NCT03717467|Magnesium Sulfate|magnesium sulfate|mesh-list
102034153|NCT03717467|Analgesics|analgesics|mesh-ancestor
102034154|NCT03717467|Sensory System Agents|sensory system agents|mesh-ancestor
101777635|NCT04003090|Nootropic Agents|nootropic agents|mesh-ancestor
102034155|NCT03717467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102034156|NCT03717467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034157|NCT03717467|Anesthetics|anesthetics|mesh-ancestor
102034158|NCT03717467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102034159|NCT03717467|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102034160|NCT03717467|Anticonvulsants|anticonvulsants|mesh-ancestor
101335669|NCT00398008|Naltrexone|naltrexone|mesh-list
101606797|NCT02639806|Sevoflurane|sevoflurane|mesh-list
101606798|NCT02639806|Anesthetics, Local|anesthetics, local|mesh-ancestor
101606799|NCT02639806|Anesthetics|anesthetics|mesh-ancestor
101606800|NCT02639806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101606801|NCT02639806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606802|NCT02639806|Sensory System Agents|sensory system agents|mesh-ancestor
101606803|NCT02639806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101606804|NCT02639806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101606805|NCT02639806|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101606806|NCT02639806|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101606807|NCT02639806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101606808|NCT02639806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606809|NCT02639806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101606810|NCT02639806|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101606811|NCT02639806|Anesthetics, General|anesthetics, general|mesh-ancestor
101606812|NCT02646904|Beclomethasone|beclomethasone|mesh-list
101606813|NCT02646904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101606814|NCT02646904|Glucocorticoids|glucocorticoids|mesh-ancestor
101606815|NCT02646904|Hormones|hormones|mesh-ancestor
101606816|NCT02646904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101606817|NCT02646904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606818|NCT02646904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101606819|NCT02646904|Respiratory System Agents|respiratory system agents|mesh-ancestor
101606820|NCT00848965|Fluticasone|fluticasone|mesh-list
101606822|NCT00848965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101606823|NCT00848965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101606824|NCT00848965|Autonomic Agents|autonomic agents|mesh-ancestor
101606825|NCT00848965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101606826|NCT00848965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606827|NCT00848965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101606828|NCT00848965|Respiratory System Agents|respiratory system agents|mesh-ancestor
101606829|NCT00848965|Dermatologic Agents|dermatologic agents|mesh-ancestor
101606833|NCT00654082|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101606834|NCT00654082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101606835|NCT00654082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101606836|NCT00654082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606837|NCT00654082|Urological Agents|urological agents|mesh-ancestor
101606838|NCT00654160|Leucovorin|leucovorin|mesh-list
101606839|NCT00654160|Fluorouracil|fluorouracil|mesh-list
101606840|NCT00654160|Irinotecan|irinotecan|mesh-list
101606841|NCT00654160|Calcium|calcium|mesh-list
102034161|NCT03717467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102034162|NCT03717467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102034163|NCT03717467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034164|NCT03717467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102034166|NCT03717467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102034167|NCT01318122|Pioglitazone|pioglitazone|mesh-list
102034168|NCT01318122|Alogliptin|alogliptin|mesh-list
102034169|NCT01318122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102034170|NCT01318122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034171|NCT01318122|Incretins|incretins|mesh-ancestor
102034172|NCT01318122|Hormones|hormones|mesh-ancestor
101628301|NCT02590705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101606842|NCT00654160|Levoleucovorin|levoleucovorin|mesh-list
101606843|NCT00654160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101606844|NCT00654160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606845|NCT00654160|Antimetabolites|antimetabolites|mesh-ancestor
101606846|NCT00654160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606847|NCT00654160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101606848|NCT00654160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101606849|NCT00654160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101606850|NCT00654160|Immunologic Factors|immunologic factors|mesh-ancestor
101606851|NCT00654160|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101606852|NCT00654160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101606853|NCT00654160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101606854|NCT00654160|Antidotes|antidotes|mesh-ancestor
101606855|NCT00654160|Protective Agents|protective agents|mesh-ancestor
101606856|NCT00654160|Vitamin B Complex|vitamin b complex|mesh-ancestor
101606857|NCT00654160|Vitamins|vitamins|mesh-ancestor
101606858|NCT00654160|Micronutrients|micronutrients|mesh-ancestor
101606859|NCT02642380|Dexamethasone|dexamethasone|mesh-list
101606860|NCT02642380|Dexamethasone acetate|dexamethasone acetate|mesh-list
101606861|NCT02642380|BB 1101|bb 1101|mesh-list
101606862|NCT02642380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101606863|NCT02642380|Antiemetics|antiemetics|mesh-ancestor
101606864|NCT02642380|Autonomic Agents|autonomic agents|mesh-ancestor
101606865|NCT02642380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101606866|NCT02642380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606867|NCT02642380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101606868|NCT02642380|Glucocorticoids|glucocorticoids|mesh-ancestor
101606869|NCT02642380|Hormones|hormones|mesh-ancestor
101606870|NCT02642380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101606871|NCT02642380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101606872|NCT02642380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101606873|NCT02642380|Protease Inhibitors|protease inhibitors|mesh-ancestor
101606874|NCT02642380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101606875|NCT02642380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606876|NCT01154036|Atorvastatin|atorvastatin|mesh-list
101606877|NCT01154036|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101606878|NCT01154036|Ezetimibe|ezetimibe|mesh-list
101606879|NCT01154036|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101606880|NCT01154036|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101606881|NCT01154036|Antimetabolites|antimetabolites|mesh-ancestor
101606882|NCT01154036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606883|NCT01154036|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101606884|NCT01154036|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101606885|NCT01154036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101606886|NCT00816595|Cyclophosphamide|cyclophosphamide|mesh-list
101606887|NCT00816595|Bevacizumab|bevacizumab|mesh-list
101606888|NCT00816595|Rituximab|rituximab|mesh-list
101606889|NCT00816595|Pentostatin|pentostatin|mesh-list
101606890|NCT00816595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101606891|NCT00816595|Immunologic Factors|immunologic factors|mesh-ancestor
102034173|NCT01318122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102034174|NCT01318122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102034175|NCT01318122|Protease Inhibitors|protease inhibitors|mesh-ancestor
102034176|NCT01318122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102034177|NCT01318122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034178|NCT02954159|Vedolizumab|vedolizumab|mesh-list
102034179|NCT02954159|Tacrolimus|tacrolimus|mesh-list
102034180|NCT02954159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102034181|NCT02954159|Immunologic Factors|immunologic factors|mesh-ancestor
102034182|NCT02954159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034183|NCT02954159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102034184|NCT02954159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102034185|NCT02954159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034186|NCT02954159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102034187|NCT03763422|Temozolomide|temozolomide|mesh-list
101606892|NCT00816595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606893|NCT00816595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101606894|NCT00816595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101606895|NCT00816595|Alkylating Agents|alkylating agents|mesh-ancestor
101606896|NCT00816595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606897|NCT00816595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101606898|NCT00816595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101606899|NCT00816595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101606900|NCT00816595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101606901|NCT00816595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101606902|NCT00816595|Growth Substances|growth substances|mesh-ancestor
101606903|NCT00816595|Growth Inhibitors|growth inhibitors|mesh-ancestor
101606912|NCT01166438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101606913|NCT01166438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606914|NCT01166438|Cholinergic Agents|cholinergic agents|mesh-ancestor
101606915|NCT01166438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101606916|NCT01166438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606917|NCT01166438|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101606918|NCT01166438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101606919|NCT01166438|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101606920|NCT01166438|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101606921|NCT01166438|Urological Agents|urological agents|mesh-ancestor
101606922|NCT01166438|Parasympatholytics|parasympatholytics|mesh-ancestor
101606923|NCT01166438|Autonomic Agents|autonomic agents|mesh-ancestor
101606924|NCT00707707|Paclitaxel|paclitaxel|mesh-list
101606925|NCT00707707|Olaparib|olaparib|mesh-list
101606926|NCT00707707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101606927|NCT00707707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101606928|NCT00707707|Tubulin Modulators|tubulin modulators|mesh-ancestor
101606929|NCT00707707|Antimitotic Agents|antimitotic agents|mesh-ancestor
101606930|NCT00707707|Mitosis Modulators|mitosis modulators|mesh-ancestor
101606931|NCT00707707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606932|NCT00707707|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101606933|NCT00707707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101606934|NCT01153958|Metronidazole|metronidazole|mesh-list
101606935|NCT01153958|Chlorquinaldol|chlorquinaldol|mesh-list
101606936|NCT01153958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101606937|NCT01153958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101606938|NCT01153958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101606939|NCT01153958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101606940|NCT00707785|Vitamin A|vitamin a|mesh-list
101606941|NCT00707785|Vitamins|vitamins|mesh-ancestor
101606942|NCT00707785|Micronutrients|micronutrients|mesh-ancestor
102034188|NCT03763422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102034189|NCT03763422|Alkylating Agents|alkylating agents|mesh-ancestor
102034190|NCT03763422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034191|NCT03763422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102034192|NCT03667716|Nivolumab|nivolumab|mesh-list
102034193|NCT03667716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102034194|NCT03667716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102034195|NCT03667716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102034196|NCT03667716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034197|NCT03740334|Dexamethasone|dexamethasone|mesh-list
102034198|NCT03740334|Everolimus|everolimus|mesh-list
102034199|NCT03740334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102034200|NCT03740334|Antiemetics|antiemetics|mesh-ancestor
102034201|NCT03740334|Autonomic Agents|autonomic agents|mesh-ancestor
102034202|NCT03740334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102034203|NCT03740334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034204|NCT03740334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101458077|NCT00221390|Ropinirole|ropinirole|mesh-list
101606943|NCT00707785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606944|NCT00599638|Pregabalin|pregabalin|mesh-list
101606945|NCT00599638|Analgesics|analgesics|mesh-ancestor
101606946|NCT00599638|Sensory System Agents|sensory system agents|mesh-ancestor
101606947|NCT00599638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101606948|NCT00599638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606949|NCT00599638|Anticonvulsants|anticonvulsants|mesh-ancestor
101606950|NCT00599638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101606951|NCT00599638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101606952|NCT00599638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606953|NCT00599638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101606954|NCT00599638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101606955|NCT00599638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101606956|NCT00599638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101606957|NCT00599638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101606958|NCT02642146|Calcium Channel Blockers|calcium channel blockers|mesh-list
101606959|NCT02642146|Vasodilator Agents|vasodilator agents|mesh-list
101606961|NCT02642146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
101606962|NCT02642146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101606963|NCT02642146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606964|NCT02642146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101606965|NCT02642146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606966|NCT02642146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101606967|NCT00654394|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101606968|NCT00654394|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101606969|NCT00654394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101606970|NCT00654394|Antimetabolites|antimetabolites|mesh-ancestor
101606971|NCT00654394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606976|NCT00653302|Insulin Glargine|insulin glargine|mesh-list
101606977|NCT00653302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101606978|NCT00653302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606979|NCT02638870|Amitriptyline|amitriptyline|mesh-list
101606980|NCT02638870|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101606981|NCT02638870|Antidepressive Agents|antidepressive agents|mesh-ancestor
101606982|NCT02638870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101606983|NCT02638870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101606984|NCT02638870|Analgesics|analgesics|mesh-ancestor
102034205|NCT03740334|Glucocorticoids|glucocorticoids|mesh-ancestor
102034206|NCT03740334|Hormones|hormones|mesh-ancestor
102034207|NCT03740334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102034208|NCT03740334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102034209|NCT03740334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102034210|NCT03740334|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102034211|NCT03740334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102034212|NCT03740334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102034213|NCT03740334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034214|NCT03740334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102034215|NCT03740334|Immunologic Factors|immunologic factors|mesh-ancestor
102034216|NCT03440411|Dexamethasone|dexamethasone|mesh-list
102034217|NCT03440411|Cyclophosphamide|cyclophosphamide|mesh-list
101606985|NCT02638870|Sensory System Agents|sensory system agents|mesh-ancestor
101606986|NCT02638870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101606987|NCT02638870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606988|NCT02638870|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101606989|NCT02638870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101606990|NCT02638870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101606991|NCT02638870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606992|NCT02638870|Adrenergic Agents|adrenergic agents|mesh-ancestor
101606993|NCT02638870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101606995|NCT02641990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101606996|NCT02641990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606997|NCT02641990|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101606998|NCT02641990|Incretins|incretins|mesh-ancestor
101606999|NCT02641990|Hormones|hormones|mesh-ancestor
101607000|NCT02641990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101607001|NCT00653380|Doxycycline|doxycycline|mesh-list
101607002|NCT00653380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101607003|NCT00653380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101607004|NCT00653380|Antimalarials|antimalarials|mesh-ancestor
101607005|NCT00653380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101607006|NCT00653380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101607007|NCT02646592|Alfentanil|alfentanil|mesh-list
101607008|NCT02646592|Propofol|propofol|mesh-list
101607009|NCT02646592|Sevoflurane|sevoflurane|mesh-list
101607010|NCT02646592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101607011|NCT02646592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101607012|NCT02646592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607013|NCT02646592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101607014|NCT02646592|Anesthetics, General|anesthetics, general|mesh-ancestor
101607015|NCT02646592|Anesthetics|anesthetics|mesh-ancestor
101607016|NCT02646592|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101607017|NCT02646592|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101607018|NCT02646592|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101607020|NCT02646592|Analgesics|analgesics|mesh-ancestor
101607021|NCT02646592|Sensory System Agents|sensory system agents|mesh-ancestor
101607022|NCT02646592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101607023|NCT02646670|Ranibizumab|ranibizumab|mesh-list
101607024|NCT02646670|Aflibercept|aflibercept|mesh-list
101607025|NCT02646670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101607026|NCT02646670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101607027|NCT02646670|Growth Substances|growth substances|mesh-ancestor
101607028|NCT02646670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607029|NCT02646670|Growth Inhibitors|growth inhibitors|mesh-ancestor
101607030|NCT02646670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101607031|NCT00651976|Letrozole|letrozole|mesh-list
101607032|NCT00651976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101607033|NCT00651976|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101607034|NCT00651976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101607035|NCT00651976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102034218|NCT03440411|Pomalidomide|pomalidomide|mesh-list
102034219|NCT03440411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102034220|NCT03440411|Immunologic Factors|immunologic factors|mesh-ancestor
102034221|NCT03440411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034222|NCT03440411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102034223|NCT03440411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102034224|NCT03440411|Alkylating Agents|alkylating agents|mesh-ancestor
102034225|NCT03440411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034226|NCT03440411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102034227|NCT03440411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102034228|NCT03440411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102034229|NCT03440411|Antiemetics|antiemetics|mesh-ancestor
101607036|NCT00651976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607037|NCT00651976|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101607038|NCT00651976|Hormone Antagonists|hormone antagonists|mesh-ancestor
101607039|NCT00651976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101607040|NCT00651976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607041|NCT01166282|Adalimumab|adalimumab|mesh-list
101607042|NCT01166282|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101607043|NCT01166282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101607044|NCT01166282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101607049|NCT01153724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101607050|NCT01153724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101607051|NCT01153724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607052|NCT01153724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101607053|NCT01153724|Hormone Antagonists|hormone antagonists|mesh-ancestor
101607054|NCT01153724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101607055|NCT01153724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607056|NCT01153724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101607057|NCT01153724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101607058|NCT02884388|Anesthetics|anesthetics|mesh-list
101607059|NCT02884388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101607060|NCT02884388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607062|NCT02885948|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101607063|NCT02885948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607064|NCT02885948|Sensory System Agents|sensory system agents|mesh-ancestor
101607065|NCT02885948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101607066|NCT01152788|Dacarbazine|dacarbazine|mesh-list
101607067|NCT01152788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101607068|NCT01152788|Alkylating Agents|alkylating agents|mesh-ancestor
101607069|NCT01152788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607070|NCT01152788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101607071|NCT01165424|Mometasone Furoate|mometasone furoate|mesh-list
101607072|NCT01165424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101607073|NCT01165424|Dermatologic Agents|dermatologic agents|mesh-ancestor
101607074|NCT01165424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101607075|NCT00598702|Acetaminophen|acetaminophen|mesh-list
101607076|NCT00598702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101607077|NCT00598702|Analgesics|analgesics|mesh-ancestor
101607078|NCT00598702|Sensory System Agents|sensory system agents|mesh-ancestor
101607079|NCT00598702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101607080|NCT00598702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607081|NCT00598702|Antipyretics|antipyretics|mesh-ancestor
101607082|NCT01148810|Siponimod|siponimod|mesh-list
101607083|NCT01148810|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101607084|NCT01148810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607085|NCT01148810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101607086|NCT01148810|Immunologic Factors|immunologic factors|mesh-ancestor
101607087|NCT01148810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034231|NCT03440411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102034232|NCT03440411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102034233|NCT03440411|Glucocorticoids|glucocorticoids|mesh-ancestor
102034234|NCT03440411|Hormones|hormones|mesh-ancestor
102034235|NCT03440411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102034236|NCT03440411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102034237|NCT03440411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102034238|NCT03440411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102034239|NCT03440411|Growth Substances|growth substances|mesh-ancestor
101607088|NCT02884310|Remifentanil|remifentanil|mesh-list
101607089|NCT02884310|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101607090|NCT02884310|Narcotics|narcotics|mesh-ancestor
101607091|NCT02884310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101607092|NCT02884310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607094|NCT02884310|Sensory System Agents|sensory system agents|mesh-ancestor
101607095|NCT02884310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101607096|NCT01164956|Methylphenidate|methylphenidate|mesh-list
101607097|NCT01164956|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101607098|NCT01164956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607099|NCT01164956|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101607100|NCT01164956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101607101|NCT01164956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101607102|NCT01164956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607103|NCT01164956|Dopamine Agents|dopamine agents|mesh-ancestor
101607104|NCT01164956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101607105|NCT01151540|Rufinamide|rufinamide|mesh-list
101607106|NCT01151540|Anticonvulsants|anticonvulsants|mesh-ancestor
101607107|NCT01151540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101607108|NCT01151540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101607109|NCT01151540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101607110|NCT01151540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607111|NCT01163786|Bortezomib|bortezomib|mesh-list
101607112|NCT01163786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101607113|NCT05367362|Minocycline|minocycline|mesh-list
101607135|NCT04292184|Antitubercular Agents|antitubercular agents|mesh-ancestor
101607136|NCT04292184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101607137|NCT04292184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101607138|NCT04292184|Chelating Agents|chelating agents|mesh-ancestor
101607139|NCT04292184|Sequestering Agents|sequestering agents|mesh-ancestor
101607140|NCT01147640|Metronidazole|metronidazole|mesh-list
101607142|NCT01147640|Tazobactam|tazobactam|mesh-list
101607143|NCT01147640|Ceftolozane|ceftolozane|mesh-list
101607144|NCT01147640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101607145|NCT01147640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101607146|NCT01147640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101607147|NCT01147640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101607148|NCT01147640|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101607149|NCT01147640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101607150|NCT01147640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607151|NCT02867982|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101607152|NCT02867982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101607153|NCT01121900|Trazodone|trazodone|mesh-list
101607154|NCT01121900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101607155|NCT01121900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101607156|NCT01121900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101607157|NCT01121900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607158|NCT01121900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101607159|NCT01121900|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101607160|NCT01121900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101607161|NCT01121900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101607162|NCT01121900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607163|NCT01121900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102034240|NCT03440411|Growth Inhibitors|growth inhibitors|mesh-ancestor
102034241|NCT03714737|Vaccines|vaccines|mesh-list
102034242|NCT03714737|Immunologic Factors|immunologic factors|mesh-ancestor
102034243|NCT03714737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034244|NCT03389555|Vitamins|vitamins|mesh-list
102034245|NCT03389555|Ascorbic Acid|ascorbic acid|mesh-list
102034246|NCT03389555|Thiamine|thiamine|mesh-list
102034247|NCT03389555|Hydrocortisone|hydrocortisone|mesh-list
102034248|NCT03389555|Micronutrients|micronutrients|mesh-ancestor
102034249|NCT03389555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034250|NCT03389555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102034251|NCT03389555|Antioxidants|antioxidants|mesh-ancestor
102034252|NCT03389555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034253|NCT03389555|Protective Agents|protective agents|mesh-ancestor
102034254|NCT03389555|Vitamin B Complex|vitamin b complex|mesh-ancestor
102034255|NCT03395639|Heparin|heparin|mesh-list
102034256|NCT03395639|Enoxaparin|enoxaparin|mesh-list
102034257|NCT03395639|Warfarin|warfarin|mesh-list
102034258|NCT03395639|Edoxaban|edoxaban|mesh-list
102034259|NCT03395639|Anticoagulants|anticoagulants|mesh-ancestor
101607164|NCT01121900|Serotonin Agents|serotonin agents|mesh-ancestor
101607165|NCT01121900|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101607166|NCT01121900|Antidepressive Agents|antidepressive agents|mesh-ancestor
101607169|NCT01121666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101607171|NCT00984126|Factor VIII|factor viii|mesh-list
101607172|NCT00984126|Coagulants|coagulants|mesh-ancestor
101607173|NCT02868996|Kallikreins|kallikreins|mesh-list
101607174|NCT02868996|Coagulants|coagulants|mesh-ancestor
101607175|NCT02868996|Fertility Agents, Male|fertility agents, male|mesh-ancestor
101607176|NCT02868996|Fertility Agents|fertility agents|mesh-ancestor
101607177|NCT02868996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101607178|NCT02868996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607179|NCT00629226|Cetuximab|cetuximab|mesh-list
101607180|NCT00629226|Bortezomib|bortezomib|mesh-list
101607181|NCT00629226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101607182|NCT00629226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101607183|NCT00629304|Antithrombin III|antithrombin iii|mesh-list
101607184|NCT00629304|Antithrombins|antithrombins|mesh-list
101607185|NCT00629304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101607186|NCT00629304|Protease Inhibitors|protease inhibitors|mesh-ancestor
101607187|NCT00629304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101607188|NCT00629304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607189|NCT00629304|Anticoagulants|anticoagulants|mesh-ancestor
101607190|NCT05297929|Irbesartan|irbesartan|mesh-list
101607191|NCT05297929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101607192|NCT05297929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101607193|NCT05297929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101607194|NCT05297929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607195|NCT00826111|Eszopiclone|eszopiclone|mesh-list
101607196|NCT00826111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101607197|NCT00826111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101607198|NCT00826111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607199|NCT00982644|Insulin|insulin|mesh-list
101607200|NCT00982644|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101607201|NCT00982644|Insulin Glargine|insulin glargine|mesh-list
101607202|NCT00982644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101607203|NCT00982644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607204|NCT00815659|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101777694|NCT04100447|Hemostatics|hemostatics|mesh-ancestor
101607205|NCT00815659|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102034260|NCT03395639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102034261|NCT03395639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102034262|NCT03395639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034263|NCT03395639|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102034264|NCT03395639|Antithrombins|antithrombins|mesh-ancestor
102034265|NCT03395639|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102034266|NCT03395639|Protease Inhibitors|protease inhibitors|mesh-ancestor
102034267|NCT03395639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102034268|NCT03353922|Cyclobenzaprine|cyclobenzaprine|mesh-list
102034269|NCT03353922|Tolperisone|tolperisone|mesh-list
102034270|NCT03353922|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102034271|NCT03353922|Antidepressive Agents|antidepressive agents|mesh-ancestor
102034272|NCT03353922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102034273|NCT03353922|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102034274|NCT03353922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034275|NCT03353922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102034276|NCT03353922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101607206|NCT00815659|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101607207|NCT00815659|Antimetabolites|antimetabolites|mesh-ancestor
101607208|NCT00815659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607209|NCT00815659|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101607210|NCT00815659|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101607211|NCT00815659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101607212|NCT02867904|Methylprednisolone|methylprednisolone|mesh-list
101607213|NCT02867904|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101607214|NCT02867904|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101607216|NCT02867904|Prednisolone acetate|prednisolone acetate|mesh-list
101607217|NCT02867904|Bupivacaine|bupivacaine|mesh-list
101607218|NCT02867904|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101607219|NCT02867904|Prednisolone phosphate|prednisolone phosphate|mesh-list
101607220|NCT02867904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101607221|NCT02867904|Antiemetics|antiemetics|mesh-ancestor
101607222|NCT02867904|Autonomic Agents|autonomic agents|mesh-ancestor
101607223|NCT02867904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101607224|NCT02867904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607225|NCT02867904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101607226|NCT02867904|Glucocorticoids|glucocorticoids|mesh-ancestor
101607227|NCT02867904|Hormones|hormones|mesh-ancestor
101607228|NCT02867904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101607229|NCT02867904|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101607230|NCT02867904|Protective Agents|protective agents|mesh-ancestor
101607231|NCT02867904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101607232|NCT02867904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101607233|NCT02867904|Anesthetics, Local|anesthetics, local|mesh-ancestor
101607234|NCT02867904|Anesthetics|anesthetics|mesh-ancestor
101607235|NCT02867904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101607236|NCT02867904|Sensory System Agents|sensory system agents|mesh-ancestor
101607237|NCT04290936|Tenofovir|tenofovir|mesh-list
101607238|NCT04290936|Antiviral Agents|antiviral agents|mesh-ancestor
101607239|NCT04290936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101607240|NCT04290936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101607269|NCT04291092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607270|NCT02867280|Sorafenib|sorafenib|mesh-list
101607271|NCT02867280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101607272|NCT02867280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101607273|NCT02867280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101607274|NCT02867280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607275|NCT04290390|Itraconazole|itraconazole|mesh-list
102034277|NCT03353922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102034278|NCT03353922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102034280|NCT03395405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102034281|NCT03395405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102034282|NCT03387683|Dapagliflozin|dapagliflozin|mesh-list
102034283|NCT03387683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102034284|NCT03387683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034285|NCT03387683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102034286|NCT03387683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034287|NCT05467553|Tenofovir|tenofovir|mesh-list
102034288|NCT05467553|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
102034289|NCT05467553|Antiviral Agents|antiviral agents|mesh-ancestor
102034290|NCT05467553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102034291|NCT05467553|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101335793|NCT00052351|Tubulin Modulators|tubulin modulators|mesh-ancestor
101607276|NCT04290390|Rifampin|rifampin|mesh-list
101607277|NCT04290390|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101607278|NCT04290390|Estradiol|estradiol|mesh-list
101607279|NCT04290390|Estrogens|estrogens|mesh-ancestor
101607280|NCT04290390|Hormones|hormones|mesh-ancestor
101607281|NCT04290390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101607282|NCT04290390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607283|NCT04290390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101607284|NCT04290390|Contraceptive Agents|contraceptive agents|mesh-ancestor
101607285|NCT04290390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101607296|NCT04290390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101607297|NCT04290390|Antitubercular Agents|antitubercular agents|mesh-ancestor
101607298|NCT04290390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101607299|NCT04290390|Leprostatic Agents|leprostatic agents|mesh-ancestor
101607300|NCT04290390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101607301|NCT04290390|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101607302|NCT04290390|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101607303|NCT04290390|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101607304|NCT04290390|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101607305|NCT04290390|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101607306|NCT04290390|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101607307|NCT04290390|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101607308|NCT04290390|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101607310|NCT04290858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101607311|NCT04290858|Autonomic Agents|autonomic agents|mesh-ancestor
101607312|NCT04290858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101607313|NCT04290858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607314|NCT04290858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101607315|NCT04290858|Respiratory System Agents|respiratory system agents|mesh-ancestor
101607316|NCT04290858|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101607318|NCT04290858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607319|NCT04290858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101607320|NCT04290858|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101607321|NCT04290858|Vasodilator Agents|vasodilator agents|mesh-ancestor
101607322|NCT04290858|Gasotransmitters|gasotransmitters|mesh-ancestor
101607323|NCT04290858|Protective Agents|protective agents|mesh-ancestor
101607324|NCT05326555|Imidacloprid|imidacloprid|mesh-list
101607325|NCT05326555|Cholinergic Agents|cholinergic agents|mesh-ancestor
101607326|NCT05326555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101607327|NCT05326555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607328|NCT05326555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034292|NCT05467553|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102034293|NCT05467553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102034294|NCT05467553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034295|NCT05467553|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102034296|NCT05467553|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102034297|NCT05467553|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102034298|NCT05467553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102034299|NCT02942004|Pregnanolone|pregnanolone|mesh-list
102034300|NCT02942004|Brexanolone|brexanolone|mesh-list
102034301|NCT02942004|Neurosteroids|neurosteroids|mesh-ancestor
102034302|NCT02942004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102034303|NCT02942004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034304|NCT02942004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034305|NCT02942004|GABA Modulators|gaba modulators|mesh-ancestor
102034306|NCT02942004|GABA Agents|gaba agents|mesh-ancestor
102034307|NCT02942004|Anesthetics|anesthetics|mesh-ancestor
102034308|NCT02942004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102034309|NCT03414983|Leucovorin|leucovorin|mesh-list
101607329|NCT02610829|Vitamin E|vitamin e|mesh-list
101607330|NCT02610829|Tocopherols|tocopherols|mesh-list
101607331|NCT02610829|Tocotrienols|tocotrienols|mesh-list
101607332|NCT02610829|alpha-Tocopherol|alpha-tocopherol|mesh-list
101607333|NCT02610829|gamma-Tocopherol|gamma-tocopherol|mesh-list
101607334|NCT02610829|Vitamins|vitamins|mesh-ancestor
101607335|NCT02610829|Micronutrients|micronutrients|mesh-ancestor
101607336|NCT02610829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607337|NCT02610829|Antioxidants|antioxidants|mesh-ancestor
101607338|NCT02610829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607339|NCT02610829|Protective Agents|protective agents|mesh-ancestor
101607340|NCT02865564|Gentamicins|gentamicins|mesh-list
101607341|NCT02865564|Ampicillin|ampicillin|mesh-list
101607342|NCT02865564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101607343|NCT02865564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101607344|NCT02865564|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101607345|NCT02865564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101607346|NCT02865564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607347|NCT00814879|Raltegravir Potassium|raltegravir potassium|mesh-list
101607368|NCT00814801|Autonomic Agents|autonomic agents|mesh-ancestor
101607369|NCT00814801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101607370|NCT00814801|Nootropic Agents|nootropic agents|mesh-ancestor
101607371|NCT00653458|Ondansetron|ondansetron|mesh-list
101607372|NCT00653458|Antiemetics|antiemetics|mesh-ancestor
101607373|NCT00653458|Autonomic Agents|autonomic agents|mesh-ancestor
101607374|NCT00653458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101607375|NCT00653458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607376|NCT00653458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101607377|NCT00653458|Antipruritics|antipruritics|mesh-ancestor
101607378|NCT00653458|Dermatologic Agents|dermatologic agents|mesh-ancestor
101607379|NCT00653458|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101607380|NCT00653458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101607381|NCT00653458|Serotonin Agents|serotonin agents|mesh-ancestor
101607382|NCT00653458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101607383|NCT00653458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607384|NCT02708836|Anesthetics|anesthetics|mesh-list
101607385|NCT02708836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101607386|NCT02708836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607387|NCT00708565|Iloprost|iloprost|mesh-list
101607388|NCT00708565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102034310|NCT03414983|Bevacizumab|bevacizumab|mesh-list
102034312|NCT03414983|Fluorouracil|fluorouracil|mesh-list
102034313|NCT03414983|Oxaliplatin|oxaliplatin|mesh-list
102034314|NCT03414983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102034315|NCT03414983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102034316|NCT03414983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102034317|NCT03414983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102034318|NCT03414983|Growth Substances|growth substances|mesh-ancestor
102034319|NCT03414983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034320|NCT03414983|Growth Inhibitors|growth inhibitors|mesh-ancestor
102034321|NCT03414983|Antimetabolites|antimetabolites|mesh-ancestor
102034322|NCT03414983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335826|NCT00052468|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101607389|NCT00708565|Vasodilator Agents|vasodilator agents|mesh-ancestor
101607390|NCT00812461|Nalmefene|nalmefene|mesh-list
101607391|NCT00812461|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101607392|NCT00812461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607393|NCT00812461|Sensory System Agents|sensory system agents|mesh-ancestor
101607394|NCT00812461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101607396|NCT00599326|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101607397|NCT00599326|Chelating Agents|chelating agents|mesh-ancestor
101607398|NCT00599326|Sequestering Agents|sequestering agents|mesh-ancestor
101607399|NCT00599326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607400|NCT00978432|Everolimus|everolimus|mesh-list
101607401|NCT00978432|Panobinostat|panobinostat|mesh-list
101607402|NCT00978432|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101607403|NCT00978432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101607410|NCT00978432|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101607411|NCT04166812|Nitric Oxide|nitric oxide|mesh-list
101607412|NCT04166812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101607413|NCT04166812|Autonomic Agents|autonomic agents|mesh-ancestor
101607414|NCT04166812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101607415|NCT04166812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607416|NCT04166812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101607417|NCT04166812|Respiratory System Agents|respiratory system agents|mesh-ancestor
101607418|NCT04166812|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101607419|NCT04166812|Antioxidants|antioxidants|mesh-ancestor
101607420|NCT04166812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607421|NCT04166812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101607422|NCT04166812|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101607423|NCT04166812|Vasodilator Agents|vasodilator agents|mesh-ancestor
101607424|NCT04166812|Gasotransmitters|gasotransmitters|mesh-ancestor
101607425|NCT04166812|Protective Agents|protective agents|mesh-ancestor
101607426|NCT00708799|Azithromycin|azithromycin|mesh-list
101777704|NCT03274804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101607427|NCT00708799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101607428|NCT00708799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101607429|NCT02610127|Factor VIII|factor viii|mesh-list
101607430|NCT02610127|Coagulants|coagulants|mesh-ancestor
101607431|NCT00814333|Thrombin|thrombin|mesh-list
101607432|NCT00814333|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
101607433|NCT00814333|Hemostatics|hemostatics|mesh-ancestor
101607434|NCT00814333|Coagulants|coagulants|mesh-ancestor
101607436|NCT01147250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101607437|NCT01147250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607438|NCT00813943|Temozolomide|temozolomide|mesh-list
101607439|NCT00813943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101607440|NCT00813943|Alkylating Agents|alkylating agents|mesh-ancestor
101607441|NCT00813943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607442|NCT00813943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101607443|NCT00821509|Disinfectants|disinfectants|mesh-list
101607444|NCT00821509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101607445|NCT00913861|Fentanyl|fentanyl|mesh-list
102034323|NCT03414983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102034324|NCT03414983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102034325|NCT03414983|Immunologic Factors|immunologic factors|mesh-ancestor
102034326|NCT03414983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102034327|NCT03414983|Antidotes|antidotes|mesh-ancestor
102034328|NCT03414983|Protective Agents|protective agents|mesh-ancestor
102034329|NCT03414983|Vitamin B Complex|vitamin b complex|mesh-ancestor
102034330|NCT03414983|Vitamins|vitamins|mesh-ancestor
102034331|NCT03414983|Micronutrients|micronutrients|mesh-ancestor
102034332|NCT03414359|Lidocaine|lidocaine|mesh-list
102034333|NCT03414359|Chloroprocaine|chloroprocaine|mesh-list
102034334|NCT03414359|Anesthetics, Local|anesthetics, local|mesh-ancestor
102034335|NCT03414359|Anesthetics|anesthetics|mesh-ancestor
102034336|NCT03414359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102034337|NCT03414359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034338|NCT03414359|Sensory System Agents|sensory system agents|mesh-ancestor
102034339|NCT03414359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102034340|NCT03414359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102034341|NCT03414359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102034342|NCT03414359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102034343|NCT03414359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102034344|NCT03414359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034345|NCT03285295|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
102034346|NCT03285295|Immunologic Factors|immunologic factors|mesh-ancestor
102034347|NCT03285295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034348|NCT02583048|Dolutegravir|dolutegravir|mesh-list
102034349|NCT02583048|Bedaquiline|bedaquiline|mesh-list
102034350|NCT02583048|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102034351|NCT02583048|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101607446|NCT00913861|Propofol|propofol|mesh-list
101607447|NCT00913861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101607448|NCT00913861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101607449|NCT00913861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607450|NCT00913861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101607451|NCT00913861|Anesthetics, General|anesthetics, general|mesh-ancestor
101607452|NCT00913861|Anesthetics|anesthetics|mesh-ancestor
101607453|NCT00913861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101607454|NCT00913861|Narcotics|narcotics|mesh-ancestor
101607455|NCT00913861|Analgesics|analgesics|mesh-ancestor
101607456|NCT00913861|Sensory System Agents|sensory system agents|mesh-ancestor
101607457|NCT00913861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101607458|NCT00913861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101607459|NCT00709189|Folic Acid|folic acid|mesh-list
101607460|NCT00709189|Norgestimate|norgestimate|mesh-list
101607461|NCT00709189|Estradiol|estradiol|mesh-list
101607462|NCT00709189|Estrogens|estrogens|mesh-ancestor
101607463|NCT00709189|Hormones|hormones|mesh-ancestor
101607464|NCT00709189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102034353|NCT02583048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034355|NCT02583048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102034356|NCT02583048|Antiviral Agents|antiviral agents|mesh-ancestor
102034357|NCT02583048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102034358|NCT02583048|Antitubercular Agents|antitubercular agents|mesh-ancestor
102034359|NCT02583048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102034360|NCT04661137|Dexamethasone|dexamethasone|mesh-list
102034361|NCT04661137|Daratumumab|daratumumab|mesh-list
102034362|NCT04661137|Pomalidomide|pomalidomide|mesh-list
102034363|NCT04661137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102034364|NCT04661137|Antiemetics|antiemetics|mesh-ancestor
102034365|NCT04661137|Autonomic Agents|autonomic agents|mesh-ancestor
102034366|NCT04661137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102034367|NCT04661137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034368|NCT04661137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102034369|NCT04661137|Glucocorticoids|glucocorticoids|mesh-ancestor
102034370|NCT04661137|Hormones|hormones|mesh-ancestor
102034371|NCT04661137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102034372|NCT04661137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102034408|NCT02313870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102034409|NCT02313870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034410|NCT02313870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102034411|NCT02313870|Antimetabolites|antimetabolites|mesh-ancestor
102034412|NCT02313870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034413|NCT02313870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102034414|NCT02313870|Dermatologic Agents|dermatologic agents|mesh-ancestor
102034415|NCT02313870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102034416|NCT02313870|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102034417|NCT02313870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102034418|NCT02313870|Immunologic Factors|immunologic factors|mesh-ancestor
102034470|NCT00659646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102034471|NCT00659646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102034472|NCT00659646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102034473|NCT00659646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034474|NCT00659646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102034475|NCT00659646|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102034476|NCT00659646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102034477|NCT00659646|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102034479|NCT02236572|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102034480|NCT02236572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102034481|NCT02236572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102034482|NCT02236572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034483|NCT02236572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102034484|NCT02236572|Immunologic Factors|immunologic factors|mesh-ancestor
102034485|NCT02236572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034486|NCT02236572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102034487|NCT03054870|Xenon|xenon|mesh-list
102034490|NCT03054870|Anesthetics|anesthetics|mesh-ancestor
102034524|NCT05222334|Sensory System Agents|sensory system agents|mesh-ancestor
102034525|NCT05222334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102034527|NCT04465266|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102034528|NCT04465266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034529|NCT04465266|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102034530|NCT04465266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102034594|NCT03822780|Antimalarials|antimalarials|mesh-ancestor
102034595|NCT03822780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102034596|NCT03822780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102034597|NCT03822780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102034598|NCT03822780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102034599|NCT03822780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034600|NCT03822780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102034601|NCT04765644|Celecoxib|celecoxib|mesh-list
102034602|NCT04765644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102034603|NCT04765644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102034604|NCT04765644|Analgesics|analgesics|mesh-ancestor
102034605|NCT04765644|Sensory System Agents|sensory system agents|mesh-ancestor
102034606|NCT04765644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102034607|NCT04765644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034608|NCT04765644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102034609|NCT04765644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102034610|NCT04765644|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102034611|NCT04765644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102034612|NCT04765644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102034613|NCT04765644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034614|NCT03052764|Botulinum Toxins|botulinum toxins|mesh-list
102034615|NCT03052764|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102034616|NCT03052764|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102034617|NCT03052764|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102034618|NCT03052764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102034641|NCT02951819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102034642|NCT02951819|Immunologic Factors|immunologic factors|mesh-ancestor
102034643|NCT02951819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034644|NCT02951819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102034645|NCT02951819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102034646|NCT02951819|Alkylating Agents|alkylating agents|mesh-ancestor
102034647|NCT02951819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034648|NCT02951819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102034649|NCT02951819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102034650|NCT02951819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102034651|NCT02951819|Antiemetics|antiemetics|mesh-ancestor
102034652|NCT02951819|Autonomic Agents|autonomic agents|mesh-ancestor
102034653|NCT02951819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102034654|NCT02951819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102034655|NCT02951819|Glucocorticoids|glucocorticoids|mesh-ancestor
102034656|NCT02951819|Hormones|hormones|mesh-ancestor
102034659|NCT05191290|Heparin|heparin|mesh-list
102034700|NCT05570526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034701|NCT05570526|Protective Agents|protective agents|mesh-ancestor
102034702|NCT05570526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034703|NCT05570526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102034704|NCT03707639|Apatinib|apatinib|mesh-list
102034705|NCT03707639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102034706|NCT03707639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102034707|NCT03707639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102034708|NCT03707639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034709|NCT03334721|Gabapentin|gabapentin|mesh-list
102034710|NCT03334721|Analgesics|analgesics|mesh-ancestor
102034711|NCT03334721|Sensory System Agents|sensory system agents|mesh-ancestor
102034712|NCT03334721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102034713|NCT03334721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034714|NCT03334721|Anticonvulsants|anticonvulsants|mesh-ancestor
102034715|NCT03334721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102034716|NCT03334721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102034757|NCT03380429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102034758|NCT03380429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102034759|NCT03380429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102034760|NCT03380429|Adrenergic Agents|adrenergic agents|mesh-ancestor
102034761|NCT03380429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102034762|NCT03380429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034763|NCT05096442|Paclitaxel|paclitaxel|mesh-list
102034764|NCT05096442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102034765|NCT05096442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102034766|NCT05096442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102034767|NCT05096442|Tubulin Modulators|tubulin modulators|mesh-ancestor
102034768|NCT05096442|Antimitotic Agents|antimitotic agents|mesh-ancestor
102034769|NCT05096442|Mitosis Modulators|mitosis modulators|mesh-ancestor
102034771|NCT01313143|Esmolol|esmolol|mesh-list
102034817|NCT04690231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102034818|NCT04690231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102034819|NCT04690231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102034820|NCT04690231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102034821|NCT04690231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034822|NCT04690231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102034823|NCT04690231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102034824|NCT04690231|Alkylating Agents|alkylating agents|mesh-ancestor
102034825|NCT03270085|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
102034826|NCT03270085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102034827|NCT03270085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102034828|NCT03270085|Antimetabolites|antimetabolites|mesh-ancestor
102034829|NCT03270085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034830|NCT03270085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102034831|NCT04998006|Ethanol|ethanol|mesh-list
102034832|NCT04998006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102034833|NCT04998006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102034834|NCT04998006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102034835|NCT04998006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034836|NCT04234945|Doxycycline|doxycycline|mesh-list
102034837|NCT04234945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102034870|NCT03334409|Ascorbic Acid|ascorbic acid|mesh-list
102034871|NCT03334409|Micronutrients|micronutrients|mesh-ancestor
102034872|NCT03334409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034873|NCT03334409|Antioxidants|antioxidants|mesh-ancestor
102034874|NCT03334409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034875|NCT03334409|Protective Agents|protective agents|mesh-ancestor
102034876|NCT02891915|Amoxicillin|amoxicillin|mesh-list
102034877|NCT02891915|Clavulanic Acid|clavulanic acid|mesh-list
102034878|NCT02891915|Clavulanic Acids|clavulanic acids|mesh-list
102034879|NCT02891915|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102034881|NCT02891915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102034882|NCT02891915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102034883|NCT02891915|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102034884|NCT02891915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102034885|NCT02891915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034887|NCT05230368|Romidepsin|romidepsin|mesh-list
102034888|NCT05230368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102034889|NCT05230368|Antimetabolites|antimetabolites|mesh-ancestor
102034890|NCT05230368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034891|NCT05230368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102034892|NCT05230368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102034893|NCT05230368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102034895|NCT03046446|FX006|fx006|mesh-list
102034921|NCT05035303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102034922|NCT05035303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102034923|NCT05035303|Respiratory System Agents|respiratory system agents|mesh-ancestor
102034924|NCT05035303|Mydriatics|mydriatics|mesh-ancestor
102034925|NCT05035303|Sympathomimetics|sympathomimetics|mesh-ancestor
102034926|NCT05035303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102034927|NCT03347279|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102034928|NCT03347279|Immunologic Factors|immunologic factors|mesh-ancestor
102034929|NCT03347279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102034930|NCT03262441|Mycophenolic Acid|mycophenolic acid|mesh-list
102034931|NCT03262441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102034932|NCT03262441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102034933|NCT03262441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102034934|NCT03262441|Antitubercular Agents|antitubercular agents|mesh-ancestor
102034983|NCT04625088|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102034984|NCT04625088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102034985|NCT04625088|Cholinergic Agents|cholinergic agents|mesh-ancestor
102034986|NCT04625088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102034987|NCT04625088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034988|NCT03568422|Paclitaxel|paclitaxel|mesh-list
102034989|NCT03568422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102034990|NCT03568422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102034991|NCT03568422|Tubulin Modulators|tubulin modulators|mesh-ancestor
102034992|NCT03568422|Antimitotic Agents|antimitotic agents|mesh-ancestor
102034993|NCT03568422|Mitosis Modulators|mitosis modulators|mesh-ancestor
102034994|NCT03568422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102034995|NCT02547493|Abatacept|abatacept|mesh-list
102034996|NCT02547493|Vaccines|vaccines|mesh-list
102034997|NCT02547493|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102034998|NCT02547493|Immunologic Factors|immunologic factors|mesh-ancestor
102034999|NCT02547493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035000|NCT02547493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102035001|NCT02547493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035002|NCT02547493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102035003|NCT02547493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102035004|NCT02547493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102035005|NCT02547493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102035006|NCT03259789|Bexagliflozin|bexagliflozin|mesh-list
102035007|NCT03259789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102035008|NCT03259789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035009|NCT03259555|Brexpiprazole|brexpiprazole|mesh-list
102035010|NCT03259555|Serotonin Agents|serotonin agents|mesh-ancestor
102035011|NCT03259555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102035012|NCT03259555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035024|NCT03049488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035025|NCT03049488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102035026|NCT04484922|Dexmedetomidine|dexmedetomidine|mesh-list
102035027|NCT04484922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101754822|NCT00808743|Celecoxib|celecoxib|mesh-list
102035028|NCT04484922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102035029|NCT04484922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035030|NCT04484922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102035031|NCT04484922|Analgesics|analgesics|mesh-ancestor
102035032|NCT04484922|Sensory System Agents|sensory system agents|mesh-ancestor
102035033|NCT04484922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102035034|NCT04484922|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102035035|NCT04484922|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102035036|NCT04484922|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102035037|NCT04484922|Adrenergic Agents|adrenergic agents|mesh-ancestor
102035038|NCT04484922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102035039|NCT04484922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035040|NCT04446390|Listerine|listerine|mesh-list
102035041|NCT04446390|Sodium Fluoride|sodium fluoride|mesh-list
102035042|NCT04446390|Cariostatic Agents|cariostatic agents|mesh-ancestor
102035043|NCT04446390|Protective Agents|protective agents|mesh-ancestor
102035047|NCT02338921|Metformin|metformin|mesh-list
102035075|NCT04400058|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102035076|NCT04400058|Immunologic Factors|immunologic factors|mesh-ancestor
102035077|NCT04400058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035078|NCT04745845|Norepinephrine|norepinephrine|mesh-list
102035079|NCT04745845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102035080|NCT04745845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102035081|NCT04745845|Adrenergic Agents|adrenergic agents|mesh-ancestor
102035082|NCT04745845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102035083|NCT04745845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035084|NCT04745845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035085|NCT04745845|Sympathomimetics|sympathomimetics|mesh-ancestor
102035086|NCT04745845|Autonomic Agents|autonomic agents|mesh-ancestor
102035087|NCT04745845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102035088|NCT04745845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102035089|NCT04173247|Mineral Oil|mineral oil|mesh-list
102035090|NCT04173247|Emollients|emollients|mesh-ancestor
102035134|NCT03646526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102035135|NCT03646526|Analgesics|analgesics|mesh-ancestor
102035136|NCT03646526|Sensory System Agents|sensory system agents|mesh-ancestor
102035137|NCT03646526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102035138|NCT03646526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035139|NCT03646526|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102035140|NCT03646526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102035141|NCT03646526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102035142|NCT03646526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035143|NCT03646526|Adrenergic Agents|adrenergic agents|mesh-ancestor
102035144|NCT03646526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102035146|NCT03646370|Antiviral Agents|antiviral agents|mesh-ancestor
102035194|NCT03626298|Vasodilator Agents|vasodilator agents|mesh-ancestor
102035195|NCT03626298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102035196|NCT03626298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102035197|NCT03626298|Analgesics|analgesics|mesh-ancestor
102035198|NCT03626298|Sensory System Agents|sensory system agents|mesh-ancestor
102035199|NCT03626298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102035200|NCT03626298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102035201|NCT03626298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102035202|NCT03626298|Dermatologic Agents|dermatologic agents|mesh-ancestor
102035203|NCT03644264|Sevelamer|sevelamer|mesh-list
102035204|NCT03644264|Chelating Agents|chelating agents|mesh-ancestor
102035205|NCT03644264|Sequestering Agents|sequestering agents|mesh-ancestor
102035206|NCT03644264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035207|NCT02298348|Cyclophosphamide|cyclophosphamide|mesh-list
102035208|NCT02298348|Sorafenib|sorafenib|mesh-list
102035209|NCT02298348|Topotecan|topotecan|mesh-list
102035210|NCT02298348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102035211|NCT02298348|Immunologic Factors|immunologic factors|mesh-ancestor
102035212|NCT02298348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035213|NCT02298348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102035214|NCT02298348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102035215|NCT02298348|Alkylating Agents|alkylating agents|mesh-ancestor
102035216|NCT02298348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035223|NCT03240133|Berotralstat|berotralstat|mesh-list
102035245|NCT02030964|Cyclophosphamide|cyclophosphamide|mesh-list
102035246|NCT02030964|Topotecan|topotecan|mesh-list
102035247|NCT02030964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102035248|NCT02030964|Immunologic Factors|immunologic factors|mesh-ancestor
102035249|NCT02030964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035250|NCT02030964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102035251|NCT02030964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101755053|NCT00734448|Inositol|inositol|mesh-list
102035252|NCT02030964|Alkylating Agents|alkylating agents|mesh-ancestor
102035253|NCT02030964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035254|NCT02030964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102035255|NCT02030964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102035256|NCT02030964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102035257|NCT02030964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102035258|NCT02030964|Analgesics|analgesics|mesh-ancestor
102035259|NCT02030964|Sensory System Agents|sensory system agents|mesh-ancestor
102035260|NCT02030964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102035261|NCT02030964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102035262|NCT02030964|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102035263|NCT02030964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102035373|NCT05214807|Sequestering Agents|sequestering agents|mesh-ancestor
102035374|NCT05214807|Hemostatics|hemostatics|mesh-ancestor
102035375|NCT05214807|Coagulants|coagulants|mesh-ancestor
102035376|NCT05214807|Viscosupplements|viscosupplements|mesh-ancestor
102035377|NCT05214807|Protective Agents|protective agents|mesh-ancestor
102035378|NCT05214807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035379|NCT02454855|Melatonin|melatonin|mesh-list
102035380|NCT02454855|Antioxidants|antioxidants|mesh-ancestor
102035381|NCT02454855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035382|NCT02454855|Protective Agents|protective agents|mesh-ancestor
102035383|NCT02454855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035384|NCT02454855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102035385|NCT03343067|Norethindrone|norethindrone|mesh-list
102035386|NCT03343067|Norethindrone Acetate|norethindrone acetate|mesh-list
102035387|NCT03343067|Estradiol|estradiol|mesh-list
102035388|NCT03343067|Estrogens|estrogens|mesh-ancestor
102035389|NCT03343067|Hormones|hormones|mesh-ancestor
102035390|NCT03343067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102035391|NCT03343067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035392|NCT03343067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102035393|NCT03343067|Contraceptive Agents|contraceptive agents|mesh-ancestor
102035394|NCT03343067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102035395|NCT03343067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102035427|NCT03706703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102035428|NCT03706703|Tubulin Modulators|tubulin modulators|mesh-ancestor
102035429|NCT03706703|Antimitotic Agents|antimitotic agents|mesh-ancestor
102035430|NCT03706703|Mitosis Modulators|mitosis modulators|mesh-ancestor
102035431|NCT03706703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035432|NCT03706703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102035433|NCT03706703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102035434|NCT03706703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102035435|NCT03706703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102035436|NCT03706703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102035437|NCT03706703|Growth Substances|growth substances|mesh-ancestor
102035438|NCT03706703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035439|NCT03706703|Growth Inhibitors|growth inhibitors|mesh-ancestor
102035440|NCT05642403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102035441|NCT03706547|Cyclophosphamide|cyclophosphamide|mesh-list
102035442|NCT03706547|Fludarabine|fludarabine|mesh-list
102035443|NCT03706547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102035444|NCT03706547|Immunologic Factors|immunologic factors|mesh-ancestor
102035445|NCT03706547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035446|NCT03706547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102035447|NCT03706547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102035448|NCT03706547|Alkylating Agents|alkylating agents|mesh-ancestor
102035449|NCT03706547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035450|NCT03706547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102035451|NCT03706547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102035452|NCT05682209|Octreotide|octreotide|mesh-list
102035453|NCT05682209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102035454|NCT05682209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102035455|NCT05682209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102035456|NCT03708497|Misoprostol|misoprostol|mesh-list
102035457|NCT03708497|Tranexamic Acid|tranexamic acid|mesh-list
102035458|NCT03708497|Carbetocin|carbetocin|mesh-list
102035459|NCT03708497|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102035460|NCT03708497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101628302|NCT02590705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101607465|NCT00709189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607466|NCT00709189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101607467|NCT00709189|Contraceptive Agents|contraceptive agents|mesh-ancestor
101607468|NCT00709189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101607469|NCT00709189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102035461|NCT03708497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035463|NCT03708497|Coagulants|coagulants|mesh-ancestor
102035464|NCT03708497|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102035465|NCT03708497|Abortifacient Agents|abortifacient agents|mesh-ancestor
102035466|NCT03708497|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102035467|NCT03708497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035468|NCT03708497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102035469|NCT03708497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102035470|NCT03708497|Oxytocics|oxytocics|mesh-ancestor
102035471|NCT04608903|Sulforaphane|sulforaphane|mesh-list
102035472|NCT04608903|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102035473|NCT04608903|Protective Agents|protective agents|mesh-ancestor
102035526|NCT03643874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102035527|NCT03643874|Respiratory System Agents|respiratory system agents|mesh-ancestor
102035528|NCT03643874|Tocolytic Agents|tocolytic agents|mesh-ancestor
102035529|NCT03643874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102035530|NCT03643874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102035531|NCT03643874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102035532|NCT03643874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102035533|NCT03643874|Adrenergic Agents|adrenergic agents|mesh-ancestor
102035534|NCT03643874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102035535|NCT03643874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035536|NCT03254485|Praliciguat|praliciguat|mesh-list
102035537|NCT03254485|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102035538|NCT03254485|Enzyme Activators|enzyme activators|mesh-ancestor
102035539|NCT03254485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035540|NCT03254485|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102035541|NCT00769327|Imatinib Mesylate|imatinib mesylate|mesh-list
102035542|NCT00769327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102035543|NCT00769327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102035544|NCT00769327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102035545|NCT00769327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035546|NCT01068704|Letrozole|letrozole|mesh-list
102035547|NCT01068704|Lapatinib|lapatinib|mesh-list
102035548|NCT01068704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102035549|NCT01068704|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102035550|NCT01068704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102035551|NCT01068704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102035552|NCT01068704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035553|NCT01068704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102035554|NCT01068704|Hormone Antagonists|hormone antagonists|mesh-ancestor
102035555|NCT01068704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102035558|NCT03339401|Brincidofovir|brincidofovir|mesh-list
102035567|NCT05179525|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102035568|NCT05179525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102035569|NCT05179525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102035570|NCT05179525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102035571|NCT05179525|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102035572|NCT05179525|Dopamine Agents|dopamine agents|mesh-ancestor
102035573|NCT03370289|Vaccines|vaccines|mesh-list
102035574|NCT03370289|Immunologic Factors|immunologic factors|mesh-ancestor
102035575|NCT03370289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035576|NCT01344824|Bevacizumab|bevacizumab|mesh-list
102035577|NCT01344824|Carboplatin|carboplatin|mesh-list
102035578|NCT01344824|Pemetrexed|pemetrexed|mesh-list
102035579|NCT01344824|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102035580|NCT01344824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102035581|NCT01344824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102035609|NCT05137496|Hormones|hormones|mesh-ancestor
102035628|NCT02959892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102035629|NCT02959892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102035630|NCT02959892|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102035632|NCT01661400|Thalidomide|thalidomide|mesh-list
102035633|NCT01661400|Cyclophosphamide|cyclophosphamide|mesh-list
102035634|NCT01661400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102035635|NCT01661400|Immunologic Factors|immunologic factors|mesh-ancestor
102035636|NCT01661400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035637|NCT01661400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102035638|NCT01661400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102035639|NCT01661400|Alkylating Agents|alkylating agents|mesh-ancestor
102035640|NCT01661400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035641|NCT01661400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102035642|NCT01661400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102035686|NCT03367793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102035687|NCT03367793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102035688|NCT03367793|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102035689|NCT03367793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102035690|NCT03367793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102035691|NCT03367793|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102035692|NCT03367793|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102035693|NCT05178745|Fluorouracil|fluorouracil|mesh-list
102035694|NCT05178745|Irinotecan|irinotecan|mesh-list
102035695|NCT05178745|Aflibercept|aflibercept|mesh-list
102035696|NCT05178745|Antimetabolites|antimetabolites|mesh-ancestor
102035697|NCT05178745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035698|NCT05178745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102035699|NCT05178745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102035700|NCT05178745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102035701|NCT05178745|Immunologic Factors|immunologic factors|mesh-ancestor
102035702|NCT05178745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035703|NCT05178745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101607470|NCT00709189|Hematinics|hematinics|mesh-ancestor
101607471|NCT00709189|Vitamin B Complex|vitamin b complex|mesh-ancestor
101607472|NCT00709189|Vitamins|vitamins|mesh-ancestor
101607473|NCT00709189|Micronutrients|micronutrients|mesh-ancestor
101607474|NCT00709189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101607475|NCT00709189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101264981|NCT01770236|Acetaminophen|acetaminophen|mesh-list
101607513|NCT00652132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101607514|NCT00652132|Chelating Agents|chelating agents|mesh-ancestor
101607515|NCT00652132|Sequestering Agents|sequestering agents|mesh-ancestor
101607516|NCT00655174|Fluvoxamine|fluvoxamine|mesh-list
101607518|NCT00655174|Antidepressive Agents|antidepressive agents|mesh-ancestor
101607540|NCT00655018|Micronutrients|micronutrients|mesh-ancestor
101607541|NCT00655018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607542|NCT00655018|Antioxidants|antioxidants|mesh-ancestor
101607543|NCT00655018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607544|NCT00655018|Protective Agents|protective agents|mesh-ancestor
101607545|NCT02635750|Donepezil|donepezil|mesh-list
101607546|NCT02635750|BI 409306|bi 409306|mesh-list
101607547|NCT02635750|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101607548|NCT02635750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101607549|NCT02635750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607550|NCT02635750|Cholinergic Agents|cholinergic agents|mesh-ancestor
101607551|NCT02635750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101607552|NCT02635750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607553|NCT02635750|Nootropic Agents|nootropic agents|mesh-ancestor
101607554|NCT02635750|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101607555|NCT04164238|Paclitaxel|paclitaxel|mesh-list
101607556|NCT04164238|Carboplatin|carboplatin|mesh-list
101607557|NCT04164238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101607558|NCT04164238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101607559|NCT04164238|Tubulin Modulators|tubulin modulators|mesh-ancestor
101607560|NCT04164238|Antimitotic Agents|antimitotic agents|mesh-ancestor
101607561|NCT04164238|Mitosis Modulators|mitosis modulators|mesh-ancestor
101607562|NCT04164238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607563|NCT02645734|Bevacizumab|bevacizumab|mesh-list
101607564|NCT02645734|Aflibercept|aflibercept|mesh-list
101607565|NCT02645734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101607566|NCT02645734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101607567|NCT02645734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102035704|NCT05178745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102035705|NCT05178745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102035706|NCT05178745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102035707|NCT05178745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102035708|NCT05178745|Growth Substances|growth substances|mesh-ancestor
102035709|NCT05178745|Growth Inhibitors|growth inhibitors|mesh-ancestor
102035710|NCT05178511|Ensartinib|ensartinib|mesh-list
102035711|NCT05178511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102035712|NCT05178511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102035713|NCT05178511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102035714|NCT05178511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035715|NCT05571163|Sotorasib|sotorasib|mesh-list
102035716|NCT05571163|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102035717|NCT05571163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035718|NCT05571163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102035719|NCT05571163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102035720|NCT03995641|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102035721|NCT03995641|Bupivacaine|bupivacaine|mesh-list
102035730|NCT03995641|Hormones|hormones|mesh-ancestor
102035758|NCT04677439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035759|NCT05689710|Inositol|inositol|mesh-list
102035760|NCT05689710|Vitamin B Complex|vitamin b complex|mesh-ancestor
102035761|NCT05689710|Vitamins|vitamins|mesh-ancestor
102035762|NCT05689710|Micronutrients|micronutrients|mesh-ancestor
102035763|NCT05689710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035764|NCT02777424|Thrombin|thrombin|mesh-list
102035765|NCT02777424|Hemostatics|hemostatics|mesh-ancestor
102035766|NCT02777424|Coagulants|coagulants|mesh-ancestor
102035767|NCT01347073|Glycerol|glycerol|mesh-list
102035768|NCT01347073|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102035769|NCT01347073|Protective Agents|protective agents|mesh-ancestor
102035770|NCT01347073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035771|NCT01315236|Amikacin|amikacin|mesh-list
102035772|NCT01315236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102035773|NCT01315236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102035774|NCT03730051|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
102035775|NCT03730051|Chelating Agents|chelating agents|mesh-ancestor
102035776|NCT03730051|Sequestering Agents|sequestering agents|mesh-ancestor
102035777|NCT03730051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035779|NCT05627466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102035780|NCT05627466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102035781|NCT03364049|Pembrolizumab|pembrolizumab|mesh-list
102035782|NCT03364049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102035783|NCT03364049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102035784|NCT03364049|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102035785|NCT03364049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035786|NCT05343078|Dapagliflozin|dapagliflozin|mesh-list
102035787|NCT05343078|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102035788|NCT05343078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035789|NCT05343078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102035790|NCT05343078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035791|NCT03710369|Sildenafil Citrate|sildenafil citrate|mesh-list
101607568|NCT02645734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101607569|NCT02645734|Growth Substances|growth substances|mesh-ancestor
101607570|NCT02645734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607591|NCT00655252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101607593|NCT00655252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607594|NCT00655252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102035792|NCT03710369|Vasodilator Agents|vasodilator agents|mesh-ancestor
102035793|NCT03710369|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102035794|NCT03710369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102035795|NCT03710369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102035796|NCT03710369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035797|NCT03710369|Urological Agents|urological agents|mesh-ancestor
102035798|NCT03706157|Doxorubicin|doxorubicin|mesh-list
102035799|NCT03706157|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102035800|NCT03706157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102035801|NCT03706157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102035802|NCT03706157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102035803|NCT03706157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102035804|NCT03706157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102035805|NCT03706157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035806|NCT03707795|Betamethasone|betamethasone|mesh-list
102035807|NCT03707795|Betamethasone Valerate|betamethasone valerate|mesh-list
102035808|NCT03707795|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
102035809|NCT03707795|Betamethasone benzoate|betamethasone benzoate|mesh-list
102035810|NCT03707795|Betamethasone acetate|betamethasone acetate|mesh-list
102035811|NCT03707795|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
102035846|NCT05058924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102035847|NCT05058924|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102035848|NCT05058924|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102035849|NCT05058924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755625|NCT00864760|Gabapentin|gabapentin|mesh-list
102035850|NCT05058924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102035851|NCT05058924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102035852|NCT05058924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102035853|NCT05058924|Antipyretics|antipyretics|mesh-ancestor
102035854|NCT05058924|Anticoagulants|anticoagulants|mesh-ancestor
102035855|NCT05681429|Acetaminophen|acetaminophen|mesh-list
102035856|NCT05681429|Parecoxib|parecoxib|mesh-list
102035857|NCT05681429|Lidocaine|lidocaine|mesh-list
102035858|NCT05681429|Dexmedetomidine|dexmedetomidine|mesh-list
102035859|NCT05681429|Sevoflurane|sevoflurane|mesh-list
102035860|NCT05681429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102035861|NCT05681429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102035862|NCT05681429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035864|NCT05681429|Analgesics|analgesics|mesh-ancestor
102035903|NCT03705533|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102035904|NCT03705533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035905|NCT03357731|Nitroglycerin|nitroglycerin|mesh-list
102035906|NCT03357731|Vasodilator Agents|vasodilator agents|mesh-ancestor
102035907|NCT03357341|Albuterol|albuterol|mesh-list
102035908|NCT03357341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102035909|NCT03357341|Autonomic Agents|autonomic agents|mesh-ancestor
102035910|NCT03357341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102035911|NCT03357341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035912|NCT03357341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102035913|NCT03357341|Respiratory System Agents|respiratory system agents|mesh-ancestor
102035914|NCT03357341|Tocolytic Agents|tocolytic agents|mesh-ancestor
102035966|NCT05229653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102035967|NCT05229653|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102035968|NCT05229653|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102035969|NCT05229653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102035970|NCT05229653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035972|NCT05551949|Estrogens|estrogens|mesh-ancestor
102035973|NCT05551949|Hormones|hormones|mesh-ancestor
102035974|NCT05551949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102035975|NCT05551949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035976|NCT05541497|Varenicline|varenicline|mesh-list
102035977|NCT05541497|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102035978|NCT05541497|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102035979|NCT05541497|Cholinergic Agents|cholinergic agents|mesh-ancestor
102035980|NCT05541497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102035981|NCT05541497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102035982|NCT05541497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035983|NCT05283954|Ivermectin|ivermectin|mesh-list
102035984|NCT05283954|Albendazole|albendazole|mesh-list
102035985|NCT05283954|Prednisolone|prednisolone|mesh-list
102035986|NCT05283954|Fluoxetine|fluoxetine|mesh-list
101777753|NCT00321685|Antidotes|antidotes|mesh-ancestor
102035987|NCT05283954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102035988|NCT05283954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102035989|NCT05283954|Glucocorticoids|glucocorticoids|mesh-ancestor
102035990|NCT05283954|Hormones|hormones|mesh-ancestor
102035991|NCT05283954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102035992|NCT05283954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102035993|NCT05283954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102035994|NCT05283954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036008|NCT05283954|Anthelmintics|anthelmintics|mesh-ancestor
102036009|NCT05283954|Anticestodal Agents|anticestodal agents|mesh-ancestor
102036010|NCT05283954|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102036011|NCT05283954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102036012|NCT05283954|Tubulin Modulators|tubulin modulators|mesh-ancestor
102036013|NCT05283954|Antimitotic Agents|antimitotic agents|mesh-ancestor
102036014|NCT05283954|Mitosis Modulators|mitosis modulators|mesh-ancestor
102036015|NCT01312415|Morphine|morphine|mesh-list
102036016|NCT01312415|Levobupivacaine|levobupivacaine|mesh-list
102036017|NCT01312415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102036018|NCT01312415|Narcotics|narcotics|mesh-ancestor
102036019|NCT01312415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102036021|NCT01312415|Analgesics|analgesics|mesh-ancestor
102036074|NCT05438303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102036075|NCT05438303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101755848|NCT00873340|Interferons|interferons|mesh-list
102036076|NCT05438303|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102036077|NCT05438303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102036078|NCT05438303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102036079|NCT05438303|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102036080|NCT05438303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102036081|NCT05438303|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102036082|NCT05438303|Antithrombins|antithrombins|mesh-ancestor
102036083|NCT05438303|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102036084|NCT05438303|Protease Inhibitors|protease inhibitors|mesh-ancestor
102036085|NCT05438303|Anticoagulants|anticoagulants|mesh-ancestor
102036086|NCT05432141|Vaccines|vaccines|mesh-list
102036087|NCT05432141|Immunologic Factors|immunologic factors|mesh-ancestor
102036088|NCT05432141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036089|NCT04956809|Dapagliflozin|dapagliflozin|mesh-list
102036090|NCT04956809|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102036091|NCT04956809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036092|NCT04956809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102036094|NCT04735913|Abiraterone Acetate|abiraterone acetate|mesh-list
102036126|NCT04906889|Narcotics|narcotics|mesh-ancestor
102036127|NCT02948777|Evolocumab|evolocumab|mesh-list
102036128|NCT02948777|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102036129|NCT02948777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102036130|NCT02948777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102036131|NCT02948777|Antimetabolites|antimetabolites|mesh-ancestor
102036132|NCT02948777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036133|NCT02948777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102036134|NCT02948777|Protease Inhibitors|protease inhibitors|mesh-ancestor
102036191|NCT04751669|Micronutrients|micronutrients|mesh-list
102036192|NCT04751669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036193|NCT04731233|Triamcinolone|triamcinolone|mesh-list
102036194|NCT04731233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102036195|NCT04731233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102036196|NCT04731233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102036197|NCT04731233|Mitogens|mitogens|mesh-list
102036198|NCT04731233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102036199|NCT04731233|Glucocorticoids|glucocorticoids|mesh-ancestor
102036200|NCT04731233|Hormones|hormones|mesh-ancestor
102036201|NCT04731233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102036202|NCT04731233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036203|NCT04731233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102036204|NCT04731233|Immunologic Factors|immunologic factors|mesh-ancestor
102036205|NCT04731233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102036206|NCT04731233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036208|NCT04695977|Nivolumab|nivolumab|mesh-list
102036247|NCT03629873|Antimetabolites|antimetabolites|mesh-ancestor
102036248|NCT03629873|Antiviral Agents|antiviral agents|mesh-ancestor
102036249|NCT03629873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102036250|NCT04294043|Gallium nitrate|gallium nitrate|mesh-list
102036251|NCT04294043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102036252|NCT04294043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036253|NCT04294043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102036254|NCT02899793|Pembrolizumab|pembrolizumab|mesh-list
102036255|NCT02899793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102036256|NCT02899793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102036257|NCT02899793|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102036258|NCT02899793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036259|NCT04981145|Hydroxychloroquine|hydroxychloroquine|mesh-list
102036260|NCT04981145|Antimalarials|antimalarials|mesh-ancestor
102036261|NCT04981145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102036262|NCT04981145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102036263|NCT04981145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102036264|NCT04981145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102036265|NCT04981145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036266|NCT04981145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102036267|NCT02864147|Imiquimod|imiquimod|mesh-list
102036268|NCT02864147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102036269|NCT02864147|Immunologic Factors|immunologic factors|mesh-ancestor
102036270|NCT02864147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036298|NCT03638063|Purinergic Agonists|purinergic agonists|mesh-ancestor
102036299|NCT03638063|Purinergic Agents|purinergic agents|mesh-ancestor
102036300|NCT03638063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102036301|NCT03638063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036303|NCT04869371|Docetaxel|docetaxel|mesh-list
102036304|NCT04869371|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102036305|NCT04869371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102036306|NCT04869371|Tubulin Modulators|tubulin modulators|mesh-ancestor
102036307|NCT04869371|Antimitotic Agents|antimitotic agents|mesh-ancestor
102036308|NCT04869371|Mitosis Modulators|mitosis modulators|mesh-ancestor
102036309|NCT04869371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036310|NCT04869371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102036311|NCT04869371|Glucocorticoids|glucocorticoids|mesh-ancestor
102036312|NCT04869371|Hormones|hormones|mesh-ancestor
102036313|NCT04869371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102036314|NCT04869371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036354|NCT03320057|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102036355|NCT04741139|Acetaminophen|acetaminophen|mesh-list
102036356|NCT04741139|Diphenhydramine|diphenhydramine|mesh-list
102036357|NCT04741139|Promethazine|promethazine|mesh-list
102036358|NCT04741139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102036359|NCT04741139|Analgesics|analgesics|mesh-ancestor
102036360|NCT04741139|Sensory System Agents|sensory system agents|mesh-ancestor
102036361|NCT04741139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102036362|NCT04741139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036363|NCT04741139|Antipyretics|antipyretics|mesh-ancestor
102036364|NCT04741139|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102036365|NCT04741139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102036366|NCT04741139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102036367|NCT04741139|Anesthetics, Local|anesthetics, local|mesh-ancestor
102036368|NCT04741139|Anesthetics|anesthetics|mesh-ancestor
102036369|NCT04741139|Antiemetics|antiemetics|mesh-ancestor
102036370|NCT04741139|Autonomic Agents|autonomic agents|mesh-ancestor
101756158|NCT01608451|Vitamin D|vitamin d|mesh-list
102036415|NCT04853147|Antiemetics|antiemetics|mesh-ancestor
102036416|NCT04853147|Autonomic Agents|autonomic agents|mesh-ancestor
102036417|NCT04853147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102036418|NCT04853147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036419|NCT04853147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102036420|NCT04853147|Glucocorticoids|glucocorticoids|mesh-ancestor
102036421|NCT04853147|Hormones|hormones|mesh-ancestor
102036422|NCT04853147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102036423|NCT04853147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102036424|NCT04853147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102036425|NCT04853147|Protease Inhibitors|protease inhibitors|mesh-ancestor
102036479|NCT02384759|Growth Substances|growth substances|mesh-ancestor
102036480|NCT02384759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777767|NCT00777998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101777768|NCT00777998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101777769|NCT00777998|Growth Substances|growth substances|mesh-ancestor
102036481|NCT02384759|Growth Inhibitors|growth inhibitors|mesh-ancestor
102036482|NCT02384759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102036483|NCT05276687|Vancomycin|vancomycin|mesh-list
102036484|NCT05276687|Povidone-Iodine|povidone-iodine|mesh-list
102036485|NCT05276687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102036486|NCT05276687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102036487|NCT05276687|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102036488|NCT03036150|Dapagliflozin|dapagliflozin|mesh-list
102036489|NCT03036150|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102036490|NCT03036150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036491|NCT03036150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102036492|NCT03036150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036493|NCT03332771|Metformin|metformin|mesh-list
102036494|NCT03332771|Glimepiride|glimepiride|mesh-list
102036496|NCT03332771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102036535|NCT04731480|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102036536|NCT04731480|Anesthetics, General|anesthetics, general|mesh-ancestor
102036537|NCT04731480|Anesthetics|anesthetics|mesh-ancestor
102036538|NCT03039192|Esketamine|esketamine|mesh-list
102036539|NCT03039192|Antidepressive Agents|antidepressive agents|mesh-ancestor
102036540|NCT03039192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102036541|NCT03698279|Vaccines|vaccines|mesh-list
102036542|NCT03698279|Immunologic Factors|immunologic factors|mesh-ancestor
102036543|NCT03698279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036544|NCT03038880|Ranibizumab|ranibizumab|mesh-list
102036545|NCT03038880|Faricimab|faricimab|mesh-list
102036546|NCT03038880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102036547|NCT03038880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102036548|NCT03038880|Growth Substances|growth substances|mesh-ancestor
102036549|NCT03038880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036550|NCT03038880|Growth Inhibitors|growth inhibitors|mesh-ancestor
102036551|NCT03038880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102036595|NCT01220531|Thymoglobulin|thymoglobulin|mesh-list
102036596|NCT01220531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102036597|NCT01220531|Immunologic Factors|immunologic factors|mesh-ancestor
102036598|NCT01220531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036599|NCT01220531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102036600|NCT01220531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102036601|NCT01220531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036602|NCT01220531|Antifungal Agents|antifungal agents|mesh-ancestor
102036603|NCT01220531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102036604|NCT01220531|Dermatologic Agents|dermatologic agents|mesh-ancestor
102036605|NCT01220531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102036606|NCT01220531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102036607|NCT01220531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102036612|NCT01220531|Antiemetics|antiemetics|mesh-ancestor
102036656|NCT04282811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102036658|NCT03229759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102036659|NCT03229759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102036660|NCT03476681|Pembrolizumab|pembrolizumab|mesh-list
102036661|NCT03476681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102036662|NCT03476681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102036663|NCT03476681|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102036664|NCT03476681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036665|NCT03620825|Indomethacin|indomethacin|mesh-list
102036666|NCT03620825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102036667|NCT03620825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102036668|NCT03620825|Analgesics|analgesics|mesh-ancestor
102036669|NCT03620825|Sensory System Agents|sensory system agents|mesh-ancestor
102036715|NCT00492349|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102036716|NCT00492349|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102036717|NCT00492349|Cholinergic Agents|cholinergic agents|mesh-ancestor
102036718|NCT00492349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102036719|NCT00492349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036720|NCT00492349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036721|NCT03924193|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101309049|NCT00006006|Growth Substances|growth substances|mesh-ancestor
102036722|NCT03924193|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102036723|NCT03924193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036724|NCT03924193|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102036725|NCT03924193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102036726|NCT03924193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102036727|NCT03924193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036728|NCT03924193|Dopamine Agents|dopamine agents|mesh-ancestor
102036729|NCT03924193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102036730|NCT03308825|Vaccines|vaccines|mesh-list
102036731|NCT03308825|Immunologic Factors|immunologic factors|mesh-ancestor
102036732|NCT03308825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036733|NCT04235855|Liver Extracts|liver extracts|mesh-list
102036767|NCT03665545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102036768|NCT03665545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102036769|NCT03665545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036770|NCT03665545|Interferon Inducers|interferon inducers|mesh-ancestor
102036771|NCT03665545|Immunologic Factors|immunologic factors|mesh-ancestor
102036772|NCT03665545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036774|NCT03665545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102036775|NCT03665545|Antiviral Agents|antiviral agents|mesh-ancestor
102036776|NCT03665545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102036777|NCT03305081|Copper|copper|mesh-list
102036778|NCT03305081|Levonorgestrel|levonorgestrel|mesh-list
102036779|NCT03305081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102036788|NCT04079881|Insulin|insulin|mesh-list
102036831|NCT03273257|Riociguat|riociguat|mesh-list
102036832|NCT03273257|Enzyme Activators|enzyme activators|mesh-ancestor
102036833|NCT03273257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036834|NCT02553473|Doxycycline|doxycycline|mesh-list
102036835|NCT02553473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102036836|NCT02553473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102036837|NCT02553473|Antimalarials|antimalarials|mesh-ancestor
102036838|NCT02553473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102036839|NCT02553473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102036840|NCT04270877|Naltrexone|naltrexone|mesh-list
102036841|NCT04270877|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102036842|NCT04270877|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102036843|NCT04270877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036844|NCT04270877|Sensory System Agents|sensory system agents|mesh-ancestor
102036845|NCT04270877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102036846|NCT03271151|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102036847|NCT03271151|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102036848|NCT03271151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102036849|NCT03271151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102036850|NCT03271151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036885|NCT02889809|Autonomic Agents|autonomic agents|mesh-ancestor
102036886|NCT02889809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102036887|NCT02889809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036888|NCT02889809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102036889|NCT02889809|Respiratory System Agents|respiratory system agents|mesh-ancestor
102036890|NCT02889809|Dermatologic Agents|dermatologic agents|mesh-ancestor
102036891|NCT02889809|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102036892|NCT02889809|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102036893|NCT02889809|Hormone Antagonists|hormone antagonists|mesh-ancestor
102036894|NCT02889809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101756668|NCT00885586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102036895|NCT02889809|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102036896|NCT02889809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102036897|NCT02889809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036898|NCT03625518|Oxytocin|oxytocin|mesh-list
102036899|NCT03625518|Dinoprostone|dinoprostone|mesh-list
102036900|NCT03625518|Oxytocics|oxytocics|mesh-ancestor
102036940|NCT04180397|Furosemide|furosemide|mesh-list
102036941|NCT04180397|Diuretics|diuretics|mesh-ancestor
102036942|NCT04180397|Natriuretic Agents|natriuretic agents|mesh-ancestor
102036943|NCT04180397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036944|NCT04180397|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102036945|NCT04180397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102036946|NCT04180397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036947|NCT04174859|Rivaroxaban|rivaroxaban|mesh-list
102036948|NCT04174859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102036949|NCT04174859|Antithrombins|antithrombins|mesh-ancestor
102036950|NCT04174859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102036951|NCT04174859|Protease Inhibitors|protease inhibitors|mesh-ancestor
102036952|NCT04174859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102036953|NCT04174859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036954|NCT04174859|Anticoagulants|anticoagulants|mesh-ancestor
102036955|NCT03295721|Bupivacaine|bupivacaine|mesh-list
102036956|NCT03295721|Anesthetics, Local|anesthetics, local|mesh-ancestor
102036957|NCT03295721|Anesthetics|anesthetics|mesh-ancestor
102036958|NCT03295721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102036959|NCT03295721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036960|NCT03295721|Sensory System Agents|sensory system agents|mesh-ancestor
102036961|NCT03295721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102036962|NCT00803790|Vitamin D|vitamin d|mesh-list
102036963|NCT00803790|Ergocalciferols|ergocalciferols|mesh-list
102036964|NCT00803790|Cholecalciferol|cholecalciferol|mesh-list
102036965|NCT00803790|Alendronate|alendronate|mesh-list
102036966|NCT00803790|Vitamins|vitamins|mesh-list
102036967|NCT00803790|Micronutrients|micronutrients|mesh-ancestor
102036968|NCT00803790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036969|NCT00803790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102036970|NCT00803790|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102036972|NCT00442338|Theophylline|theophylline|mesh-list
102036973|NCT00442338|Montelukast|montelukast|mesh-list
101607595|NCT00655252|Immunologic Factors|immunologic factors|mesh-ancestor
101607596|NCT00655252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607597|NCT00655252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101607598|NCT00883090|Fibrinolysin|fibrinolysin|mesh-list
101607599|NCT00883090|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101607600|NCT00883090|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101607601|NCT00883090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607602|NCT02645656|Curcumin|curcumin|mesh-list
101607603|NCT02645656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102036974|NCT00442338|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102036975|NCT00442338|Respiratory System Agents|respiratory system agents|mesh-ancestor
102036976|NCT00442338|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102036977|NCT00442338|Hormone Antagonists|hormone antagonists|mesh-ancestor
102036978|NCT00442338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102036979|NCT00442338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102036980|NCT00442338|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102036981|NCT00442338|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102036982|NCT00442338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102036983|NCT00442338|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102036984|NCT00442338|Autonomic Agents|autonomic agents|mesh-ancestor
102036985|NCT00442338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102036986|NCT00442338|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102036987|NCT00442338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102036988|NCT00442338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102036989|NCT00442338|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102036990|NCT00442338|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102036991|NCT00442338|Purinergic Agents|purinergic agents|mesh-ancestor
102036992|NCT00442338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102036993|NCT00442338|Protective Agents|protective agents|mesh-ancestor
102036994|NCT00442338|Vasodilator Agents|vasodilator agents|mesh-ancestor
102036995|NCT03506412|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
102036996|NCT03506412|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102036997|NCT03506412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037093|NCT01498770|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102037094|NCT01498770|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102037095|NCT01498770|Adrenergic Agents|adrenergic agents|mesh-ancestor
102037096|NCT01498770|GABA Antagonists|gaba antagonists|mesh-ancestor
102037098|NCT01498770|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102037099|NCT00140946|Montelukast|montelukast|mesh-list
102037100|NCT00140946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037101|NCT00140946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037102|NCT00140946|Respiratory System Agents|respiratory system agents|mesh-ancestor
102037153|NCT05224128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102037154|NCT05224128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037155|NCT05416827|Dexamethasone|dexamethasone|mesh-list
102037156|NCT05416827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102037157|NCT05416827|Antiemetics|antiemetics|mesh-ancestor
102037158|NCT05416827|Autonomic Agents|autonomic agents|mesh-ancestor
102037159|NCT05416827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102037219|NCT05137548|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102037220|NCT05044611|Amiloride|amiloride|mesh-list
102037221|NCT05044611|Diuretics|diuretics|mesh-ancestor
102037222|NCT05044611|Natriuretic Agents|natriuretic agents|mesh-ancestor
102037223|NCT05044611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037224|NCT05044611|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
102037225|NCT05044611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102037226|NCT05044611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102037285|NCT05417997|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102037286|NCT05417997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102037287|NCT05417997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037290|NCT05417997|Anticoagulants|anticoagulants|mesh-ancestor
102037355|NCT04319757|Fludarabine|fludarabine|mesh-list
102037356|NCT04319757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102037357|NCT04319757|Immunologic Factors|immunologic factors|mesh-ancestor
102037358|NCT04319757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037359|NCT04319757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102037360|NCT04319757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102037361|NCT04319757|Alkylating Agents|alkylating agents|mesh-ancestor
102037362|NCT04319757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037363|NCT04319757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037364|NCT04319757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102037365|NCT05180461|Ivermectin|ivermectin|mesh-list
102037366|NCT05180461|Emodepside|emodepside|mesh-list
102037367|NCT05180461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102037368|NCT05180461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102037369|NCT02496611|Exenatide|exenatide|mesh-list
102037370|NCT02496611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102037371|NCT02496611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037372|NCT02496611|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102037373|NCT02496611|Incretins|incretins|mesh-ancestor
102037414|NCT03208933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102037415|NCT03208933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037416|NCT03208933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102037417|NCT03208933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102037418|NCT03208933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102037419|NCT03208933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102037420|NCT03208933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037422|NCT02499120|Palbociclib|palbociclib|mesh-list
102037423|NCT02499120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102037424|NCT02499120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037425|NCT02499120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102037426|NCT02499120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102037475|NCT02932579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102037476|NCT02932579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037477|NCT02932579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102037478|NCT02932579|Narcotics|narcotics|mesh-ancestor
102037479|NCT02932579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102037480|NCT02932579|Antipyretics|antipyretics|mesh-ancestor
102037481|NCT04748757|Annexin A5|annexin a5|mesh-list
102037482|NCT04748757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102037483|NCT04748757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037484|NCT03207451|Aspirin|aspirin|mesh-list
102037485|NCT03207451|Clopidogrel|clopidogrel|mesh-list
102037486|NCT03207451|Vorapaxar|vorapaxar|mesh-list
102037487|NCT03207451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102037489|NCT03207451|Analgesics|analgesics|mesh-ancestor
102037490|NCT03207451|Sensory System Agents|sensory system agents|mesh-ancestor
102037491|NCT03207451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102037492|NCT03207451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037493|NCT03207451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102037494|NCT03207451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102037495|NCT03207451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102037496|NCT03207451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102037497|NCT03207451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037498|NCT03207451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102037526|NCT03701256|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102037527|NCT03701256|Cholinergic Agents|cholinergic agents|mesh-ancestor
102037528|NCT03701256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101387676|NCT00322699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102037529|NCT03701256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037530|NCT04780581|Dexamethasone|dexamethasone|mesh-list
102037531|NCT04780581|Methylprednisolone|methylprednisolone|mesh-list
102037532|NCT04780581|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102037533|NCT04780581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102037534|NCT04780581|Prednisolone|prednisolone|mesh-list
102037535|NCT04780581|Prednisolone acetate|prednisolone acetate|mesh-list
102037536|NCT04780581|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102037537|NCT04780581|Prednisolone phosphate|prednisolone phosphate|mesh-list
102037538|NCT04780581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102037539|NCT04780581|Antiemetics|antiemetics|mesh-ancestor
102037540|NCT04780581|Autonomic Agents|autonomic agents|mesh-ancestor
102037587|NCT03703596|Antimitotic Agents|antimitotic agents|mesh-ancestor
102037588|NCT03703596|Mitosis Modulators|mitosis modulators|mesh-ancestor
102037589|NCT03703596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037590|NCT01137773|Insulin|insulin|mesh-list
102037591|NCT01137773|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102037592|NCT01137773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102037593|NCT01137773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037594|NCT03698292|Metoclopramide|metoclopramide|mesh-list
102037595|NCT03698292|Antiemetics|antiemetics|mesh-ancestor
102037596|NCT03698292|Autonomic Agents|autonomic agents|mesh-ancestor
102037597|NCT03698292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102037598|NCT03698292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037599|NCT03698292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102037600|NCT03698292|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102037601|NCT03698292|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102037602|NCT03698292|Dopamine Agents|dopamine agents|mesh-ancestor
102037603|NCT03698292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102037604|NCT03698292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037605|NCT04614909|Temozolomide|temozolomide|mesh-list
102037606|NCT04614909|Olaparib|olaparib|mesh-list
102037643|NCT04066023|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102037644|NCT04066023|Serotonin Agents|serotonin agents|mesh-ancestor
102037645|NCT04066023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102037646|NCT04066023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037647|NCT04066023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037648|NCT03106987|Olaparib|olaparib|mesh-list
102037649|NCT03106987|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102037650|NCT03106987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102037651|NCT03106987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037652|NCT03106987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037705|NCT03697668|Imatinib Mesylate|imatinib mesylate|mesh-list
102037706|NCT03697668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037707|NCT03697668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102037708|NCT03697668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102037709|NCT03697668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037710|NCT03697668|Antimalarials|antimalarials|mesh-ancestor
102037711|NCT03697668|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102037712|NCT03697668|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102037713|NCT03697668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102037714|NCT03702738|Acetylcysteine|acetylcysteine|mesh-list
102037715|NCT03702738|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102037769|NCT00265941|Cetuximab|cetuximab|mesh-list
102037770|NCT00265941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037771|NCT00265941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102037772|NCT03699384|Azacitidine|azacitidine|mesh-list
102037773|NCT03699384|Avelumab|avelumab|mesh-list
102037774|NCT03699384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102037775|NCT03699384|Antimetabolites|antimetabolites|mesh-ancestor
102037776|NCT03699384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037777|NCT03699384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037778|NCT03699384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102037779|NCT03699384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102037780|NCT05378763|Docetaxel|docetaxel|mesh-list
102037781|NCT05378763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037782|NCT05378763|Tubulin Modulators|tubulin modulators|mesh-ancestor
102037783|NCT05378763|Antimitotic Agents|antimitotic agents|mesh-ancestor
102037784|NCT05378763|Mitosis Modulators|mitosis modulators|mesh-ancestor
102037786|NCT02937571|Dexamethasone|dexamethasone|mesh-list
102037827|NCT03696186|GABA Agents|gaba agents|mesh-ancestor
102037828|NCT03696186|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102037829|NCT03696186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102037830|NCT03696186|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102037831|NCT03698916|Celecoxib|celecoxib|mesh-list
102037832|NCT03698916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102037833|NCT03698916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102037834|NCT03698916|Analgesics|analgesics|mesh-ancestor
102037835|NCT03698916|Sensory System Agents|sensory system agents|mesh-ancestor
102037836|NCT03698916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102037837|NCT03698916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037889|NCT03698682|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102037890|NCT03698682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102037891|NCT03029832|Atezolizumab|atezolizumab|mesh-list
102037892|NCT03029832|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102037893|NCT03029832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037894|NCT03029832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102037895|NCT03029832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037896|NCT05598567|Anesthetics|anesthetics|mesh-list
102037897|NCT05598567|Sevoflurane|sevoflurane|mesh-list
102037898|NCT05598567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102037899|NCT05598567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037952|NCT04224558|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102037953|NCT04224558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102037954|NCT04224558|Immunologic Factors|immunologic factors|mesh-ancestor
102037955|NCT04224558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102037956|NCT04224558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102037957|NCT04224558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102037958|NCT04224558|Alkylating Agents|alkylating agents|mesh-ancestor
102037959|NCT04224558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102037960|NCT04224558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102037961|NCT04224558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102037962|NCT04224558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102037963|NCT04224558|Analgesics|analgesics|mesh-ancestor
102038015|NCT04203498|Nabiximols|nabiximols|mesh-list
102038016|NCT04203498|Analgesics|analgesics|mesh-ancestor
102038017|NCT04203498|Sensory System Agents|sensory system agents|mesh-ancestor
102038018|NCT04203498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102038019|NCT04203498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038020|NCT03691896|Cholecalciferol|cholecalciferol|mesh-list
102038021|NCT03691896|Vitamin D|vitamin d|mesh-list
102038022|NCT03691896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102038023|NCT03691896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038024|NCT03691896|Vitamins|vitamins|mesh-ancestor
102038025|NCT03691896|Micronutrients|micronutrients|mesh-ancestor
102038026|NCT03691896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102038027|NCT03691818|Ibuprofen|ibuprofen|mesh-list
102038028|NCT03691818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102038029|NCT03691818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102038030|NCT03691818|Analgesics|analgesics|mesh-ancestor
102038031|NCT03691818|Sensory System Agents|sensory system agents|mesh-ancestor
102038074|NCT03636685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102038075|NCT03636685|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102038076|NCT03636685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102038077|NCT03257631|Thalidomide|thalidomide|mesh-list
102038078|NCT03257631|Pomalidomide|pomalidomide|mesh-list
102038079|NCT03257631|Immunologic Factors|immunologic factors|mesh-ancestor
102038080|NCT03257631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038081|NCT03257631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102038082|NCT03257631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102038084|NCT03257631|Growth Inhibitors|growth inhibitors|mesh-ancestor
102038085|NCT03257631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102038086|NCT03257631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102038087|NCT03257631|Leprostatic Agents|leprostatic agents|mesh-ancestor
102038088|NCT03257631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102038089|NCT03257631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102038090|NCT03883581|Quinidine|quinidine|mesh-list
102038091|NCT03883581|Quinidine gluconate|quinidine gluconate|mesh-list
102038133|NCT03113643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102038134|NCT03113643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102038135|NCT03091491|Nivolumab|nivolumab|mesh-list
102038136|NCT03091491|Ipilimumab|ipilimumab|mesh-list
102038137|NCT03091491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102038138|NCT03091491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102038139|NCT03091491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101387677|NCT00322972|Azithromycin|azithromycin|mesh-list
102038140|NCT03091491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038141|NCT05598255|Dexamethasone|dexamethasone|mesh-list
102038142|NCT05598255|Levobupivacaine|levobupivacaine|mesh-list
102038143|NCT05598255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102038144|NCT05598255|Antiemetics|antiemetics|mesh-ancestor
102038150|NCT05598255|Hormones|hormones|mesh-ancestor
102038196|NCT03693222|Narcotics|narcotics|mesh-ancestor
102038197|NCT03693222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102038198|NCT03693222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038199|NCT03693222|Analgesics|analgesics|mesh-ancestor
102038200|NCT03693222|Sensory System Agents|sensory system agents|mesh-ancestor
102038201|NCT03693222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102038202|NCT03693066|Chlorhexidine|chlorhexidine|mesh-list
102038203|NCT03693066|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102038204|NCT03693066|Disinfectants|disinfectants|mesh-list
102038205|NCT03693066|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102038206|NCT03693066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102038207|NCT03693066|Dermatologic Agents|dermatologic agents|mesh-ancestor
102038260|NCT03197935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102038261|NCT03197935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102038262|NCT04941261|Vaccines|vaccines|mesh-list
102038263|NCT04941261|Immunologic Factors|immunologic factors|mesh-ancestor
102038264|NCT04941261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038328|NCT03926052|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102038329|NCT03926052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102038330|NCT03926052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038331|NCT03926052|Dopamine Agents|dopamine agents|mesh-ancestor
102038332|NCT03926052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102038333|NCT05411991|Chlorthalidone|chlorthalidone|mesh-list
102038334|NCT05411991|Acetazolamide|acetazolamide|mesh-list
102038335|NCT05411991|Bumetanide|bumetanide|mesh-list
102038336|NCT05411991|Diuretics|diuretics|mesh-list
102038337|NCT05411991|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
102038338|NCT05411991|Natriuretic Agents|natriuretic agents|mesh-ancestor
102038339|NCT05411991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038392|NCT02740335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038394|NCT05351151|Anesthetics, Local|anesthetics, local|mesh-ancestor
102038395|NCT05351151|Anesthetics|anesthetics|mesh-ancestor
102038396|NCT05351151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102038397|NCT05351151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038398|NCT05351151|Sensory System Agents|sensory system agents|mesh-ancestor
102038399|NCT05351151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102038400|NCT05351151|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102038401|NCT05351151|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102038402|NCT05351151|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102038403|NCT05351151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102038404|NCT05351151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038405|NCT01568931|Coal Tar|coal tar|mesh-list
102038451|NCT03685032|Dermatologic Agents|dermatologic agents|mesh-ancestor
102038452|NCT03685032|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102038453|NCT03685032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102038454|NCT03685032|Serotonin Agents|serotonin agents|mesh-ancestor
102038455|NCT03685032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102038456|NCT03685032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038458|NCT02451111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102038459|NCT02451111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102038460|NCT02451111|Immunologic Factors|immunologic factors|mesh-ancestor
102038461|NCT02451111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038462|NCT02451111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102038463|NCT03689010|Azelaic acid|azelaic acid|mesh-list
102038464|NCT03689010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102038465|NCT03689010|Dermatologic Agents|dermatologic agents|mesh-ancestor
102038466|NCT05451771|Dexamethasone|dexamethasone|mesh-list
102038467|NCT05451771|Dexamethasone acetate|dexamethasone acetate|mesh-list
102038468|NCT05451771|Venetoclax|venetoclax|mesh-list
102038469|NCT05451771|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102038470|NCT05451771|Daratumumab|daratumumab|mesh-list
102038471|NCT05451771|Pomalidomide|pomalidomide|mesh-list
102038472|NCT05451771|Ixazomib|ixazomib|mesh-list
102038473|NCT05451771|BB 1101|bb 1101|mesh-list
101777799|NCT00306787|Valacyclovir|valacyclovir|mesh-list
102038474|NCT05451771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102038475|NCT05451771|Antiemetics|antiemetics|mesh-ancestor
102038476|NCT05451771|Autonomic Agents|autonomic agents|mesh-ancestor
102038504|NCT04220775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102038505|NCT01381887|Canagliflozin|canagliflozin|mesh-list
102038506|NCT01381887|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102038507|NCT01381887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038576|NCT03679182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102038577|NCT03679182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102038578|NCT03679182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102038579|NCT03679182|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102038580|NCT03679182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102038581|NCT03679182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102038582|NCT03679182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038583|NCT03679182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102038584|NCT03679182|Serotonin Agents|serotonin agents|mesh-ancestor
102038585|NCT03184987|Albuterol|albuterol|mesh-list
102038586|NCT03184987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102038587|NCT03184987|Autonomic Agents|autonomic agents|mesh-ancestor
102038588|NCT03184987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102038589|NCT03184987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038590|NCT03184987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102038591|NCT03184987|Respiratory System Agents|respiratory system agents|mesh-ancestor
102038592|NCT03184987|Tocolytic Agents|tocolytic agents|mesh-ancestor
102038593|NCT03184987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102038594|NCT03184987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102038595|NCT03184987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102038596|NCT03184987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102038597|NCT03184987|Adrenergic Agents|adrenergic agents|mesh-ancestor
102038598|NCT03184987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102038599|NCT03184987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038600|NCT03193333|Timolol|timolol|mesh-list
102038601|NCT03193333|Brimonidine Tartrate|brimonidine tartrate|mesh-list
102038602|NCT03193333|Dorzolamide|dorzolamide|mesh-list
102038603|NCT03193333|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102038604|NCT03193333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102038605|NCT03193333|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102038617|NCT03193333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102038618|NCT03026166|Nivolumab|nivolumab|mesh-list
102038619|NCT03026166|Ipilimumab|ipilimumab|mesh-list
102038620|NCT03026166|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
102038621|NCT03026166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102038622|NCT03026166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102038623|NCT03026166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102038624|NCT03026166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038625|NCT03026166|Immunoconjugates|immunoconjugates|mesh-ancestor
102038626|NCT03026166|Immunologic Factors|immunologic factors|mesh-ancestor
102038627|NCT03026166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038628|NCT03573648|Palbociclib|palbociclib|mesh-list
102038629|NCT03573648|Avelumab|avelumab|mesh-list
102038630|NCT03573648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102038631|NCT03573648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102038632|NCT03573648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102038633|NCT03573648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038676|NCT03678090|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102038677|NCT03678090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038678|NCT03678012|Hydrogen Peroxide|hydrogen peroxide|mesh-list
102038679|NCT03678012|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102038680|NCT03678012|Hematinics|hematinics|mesh-ancestor
102038681|NCT03678012|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102038682|NCT03678012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101758465|NCT04062890|Vigabatrin|vigabatrin|mesh-list
102038683|NCT03678012|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102038684|NCT03678012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102038685|NCT03676296|Puerarin|puerarin|mesh-list
102038686|NCT03676296|Vasodilator Agents|vasodilator agents|mesh-ancestor
102038687|NCT03676140|Azithromycin|azithromycin|mesh-list
102038738|NCT03246906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102038739|NCT03246906|Antifungal Agents|antifungal agents|mesh-ancestor
102038740|NCT03246906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102038741|NCT03246906|Dermatologic Agents|dermatologic agents|mesh-ancestor
102038742|NCT03246906|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102038743|NCT03246906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102038744|NCT03246906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102038745|NCT03246906|Antitubercular Agents|antitubercular agents|mesh-ancestor
102038746|NCT03246906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102038747|NCT03675594|Cobalt|cobalt|mesh-list
102038748|NCT03675594|Chromium|chromium|mesh-list
102038749|NCT03675594|Trace Elements|trace elements|mesh-ancestor
102038750|NCT03675594|Micronutrients|micronutrients|mesh-ancestor
102038751|NCT03675594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038752|NCT03671538|Pemetrexed|pemetrexed|mesh-list
102038753|NCT03671538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102038754|NCT03671538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102038755|NCT03671538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038758|NCT05420467|Paclitaxel|paclitaxel|mesh-list
102038795|NCT03671070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038796|NCT03671070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102038797|NCT03671070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102038799|NCT03671070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102038800|NCT03671070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102038801|NCT03671070|Respiratory System Agents|respiratory system agents|mesh-ancestor
102038802|NCT03671070|Mydriatics|mydriatics|mesh-ancestor
102038803|NCT03671070|Sympathomimetics|sympathomimetics|mesh-ancestor
102038804|NCT03671070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102038805|NCT03670758|Protein S|protein s|mesh-list
102038860|NCT03670212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038861|NCT03670212|Urological Agents|urological agents|mesh-ancestor
102038862|NCT03165955|Paclitaxel|paclitaxel|mesh-list
102038863|NCT03165955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102038864|NCT03165955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102038865|NCT03165955|Tubulin Modulators|tubulin modulators|mesh-ancestor
102038866|NCT03165955|Antimitotic Agents|antimitotic agents|mesh-ancestor
102038867|NCT03165955|Mitosis Modulators|mitosis modulators|mesh-ancestor
102038868|NCT03165955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038869|NCT05263921|Ritonavir|ritonavir|mesh-list
102038870|NCT05263921|Nirmatrelvir|nirmatrelvir|mesh-list
102038871|NCT05263921|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102038872|NCT05263921|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102038873|NCT05263921|Protease Inhibitors|protease inhibitors|mesh-ancestor
102038874|NCT05263921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102038875|NCT05263921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038917|NCT03165721|Guadecitabine|guadecitabine|mesh-list
102038918|NCT03165721|Azacitidine|azacitidine|mesh-list
102038919|NCT03165721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102038920|NCT03165721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102038921|NCT03165721|Antimetabolites|antimetabolites|mesh-ancestor
102038922|NCT03165721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102038923|NCT03165721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102038924|NCT02224872|Mycophenolic Acid|mycophenolic acid|mesh-list
102038925|NCT02224872|Cyclophosphamide|cyclophosphamide|mesh-list
102038926|NCT02224872|Fludarabine|fludarabine|mesh-list
102038927|NCT02224872|Tacrolimus|tacrolimus|mesh-list
102038928|NCT02224872|Thymoglobulin|thymoglobulin|mesh-list
102038929|NCT02224872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102038930|NCT02224872|Immunologic Factors|immunologic factors|mesh-ancestor
102038931|NCT02224872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038932|NCT02224872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102038977|NCT03676374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038978|NCT01829958|Prednisone|prednisone|mesh-list
102038979|NCT01829958|Rituximab|rituximab|mesh-list
102038980|NCT01829958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102038981|NCT01829958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102038982|NCT01829958|Immunologic Factors|immunologic factors|mesh-ancestor
102038983|NCT01829958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102038984|NCT01829958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101758759|NCT00921128|Muscimol|muscimol|mesh-list
102038985|NCT01829958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102039045|NCT03668262|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102039046|NCT03668262|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102039048|NCT03668262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102039049|NCT03668262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039050|NCT03668262|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
102039051|NCT03668262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102039052|NCT03668262|Cholinergic Agents|cholinergic agents|mesh-ancestor
102039053|NCT03668262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102039054|NCT03668262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039055|NCT03668964|Vitamin D|vitamin d|mesh-list
102039056|NCT03668964|Cholecalciferol|cholecalciferol|mesh-list
102039057|NCT03668964|Vitamins|vitamins|mesh-list
102039058|NCT03668964|Vitamin E|vitamin e|mesh-list
102039059|NCT03668964|Tocopherols|tocopherols|mesh-list
102039060|NCT03668964|alpha-Tocopherol|alpha-tocopherol|mesh-list
101758837|NCT00572572|Aprepitant|aprepitant|mesh-list
102039061|NCT03668964|Vitamin A|vitamin a|mesh-list
102039062|NCT03668964|Riboflavin|riboflavin|mesh-list
102039063|NCT03668964|Vitamin B Complex|vitamin b complex|mesh-list
102039064|NCT03668964|Micronutrients|micronutrients|mesh-ancestor
102039065|NCT03668964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039066|NCT03668964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102039073|NCT03668730|Paclitaxel|paclitaxel|mesh-list
102039098|NCT03021018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102039099|NCT03021018|GABA Modulators|gaba modulators|mesh-ancestor
102039100|NCT03021018|GABA Agents|gaba agents|mesh-ancestor
102039101|NCT03021018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102039102|NCT03021018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039103|NCT02509507|Pembrolizumab|pembrolizumab|mesh-list
102039104|NCT02509507|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
102039105|NCT02509507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102039106|NCT02509507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102039107|NCT02509507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102039163|NCT02924688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102039164|NCT02924688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039165|NCT02924688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102039166|NCT02924688|Respiratory System Agents|respiratory system agents|mesh-ancestor
102039167|NCT02924688|Dermatologic Agents|dermatologic agents|mesh-ancestor
102039168|NCT02924688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102039169|NCT02924688|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102039170|NCT02924688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102039171|NCT02924688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102039172|NCT02924688|Adrenergic Agents|adrenergic agents|mesh-ancestor
102039173|NCT02924688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102039174|NCT02924688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039176|NCT02924688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102039177|NCT02924688|Glucocorticoids|glucocorticoids|mesh-ancestor
102039178|NCT02924688|Hormones|hormones|mesh-ancestor
102039179|NCT02924688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102039180|NCT02924688|Sympathomimetics|sympathomimetics|mesh-ancestor
102039181|NCT03668418|Camptothecin|camptothecin|mesh-list
102039182|NCT03668418|Docetaxel|docetaxel|mesh-list
102039183|NCT03668418|Gemcitabine|gemcitabine|mesh-list
102039184|NCT03668418|Fluorouracil|fluorouracil|mesh-list
102039185|NCT03668418|Oxaliplatin|oxaliplatin|mesh-list
102039186|NCT03668418|Irinotecan|irinotecan|mesh-list
102039215|NCT02125513|Tubulin Modulators|tubulin modulators|mesh-ancestor
102039216|NCT02125513|Antimitotic Agents|antimitotic agents|mesh-ancestor
102039217|NCT02125513|Mitosis Modulators|mitosis modulators|mesh-ancestor
102039218|NCT02125513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039219|NCT04575948|Chlorhexidine|chlorhexidine|mesh-list
102039220|NCT04575948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102039221|NCT04575948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102039222|NCT04575948|Disinfectants|disinfectants|mesh-ancestor
102039223|NCT03666546|Methamphetamine|methamphetamine|mesh-list
102039224|NCT03666546|Lactulose|lactulose|mesh-list
102039225|NCT03666546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102039226|NCT03666546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102039280|NCT03003000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102039281|NCT03003000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102039282|NCT03003000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387678|NCT00322972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102039283|NCT03003000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039284|NCT03003000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102039285|NCT03003000|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102039286|NCT03003000|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102039287|NCT03003000|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102039344|NCT03620591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102039345|NCT03620591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102039346|NCT03620591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102039347|NCT03620591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102039348|NCT03620591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039350|NCT05178953|Pentoxifylline|pentoxifylline|mesh-list
102039351|NCT05178953|Zinc Sulfate|zinc sulfate|mesh-list
102039352|NCT05178953|Trace Elements|trace elements|mesh-ancestor
102039353|NCT05178953|Micronutrients|micronutrients|mesh-ancestor
102039354|NCT05178953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039355|NCT05178953|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102039356|NCT05178953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102039357|NCT05178953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039358|NCT05178953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102039359|NCT05178953|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102039369|NCT03251963|Enoxaparin|enoxaparin|mesh-list
102039403|NCT03000348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039404|NCT03664986|Bupivacaine|bupivacaine|mesh-list
102039405|NCT03664986|Anesthetics, Local|anesthetics, local|mesh-ancestor
102039406|NCT03664986|Anesthetics|anesthetics|mesh-ancestor
102039407|NCT03664986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102039408|NCT03664986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039409|NCT03664986|Sensory System Agents|sensory system agents|mesh-ancestor
102039410|NCT03664986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102039411|NCT03492918|Pembrolizumab|pembrolizumab|mesh-list
102039412|NCT03492918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102039413|NCT03492918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102039416|NCT03247673|Bevacizumab|bevacizumab|mesh-list
102039463|NCT03282227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102039464|NCT03282227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039465|NCT03282227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039466|NCT03282227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102039467|NCT03282227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102039468|NCT03282227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102039469|NCT03240575|Fluticasone|fluticasone|mesh-list
102039470|NCT03240575|Xhance|xhance|mesh-list
102039471|NCT03240575|Tiotropium Bromide|tiotropium bromide|mesh-list
102039472|NCT03240575|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102039473|NCT03240575|Olodaterol|olodaterol|mesh-list
102039474|NCT03240575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102039476|NCT03240575|Autonomic Agents|autonomic agents|mesh-ancestor
102039526|NCT03618758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102039527|NCT03618758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102039528|NCT03618758|Tubulin Modulators|tubulin modulators|mesh-ancestor
102039529|NCT03618758|Antimitotic Agents|antimitotic agents|mesh-ancestor
102039530|NCT03618758|Mitosis Modulators|mitosis modulators|mesh-ancestor
102039531|NCT03618758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039532|NCT03617900|Acetaminophen|acetaminophen|mesh-list
102039534|NCT03617900|Analgesics|analgesics|mesh-ancestor
102039594|NCT02873702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102039595|NCT02873702|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102039596|NCT02873702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102039597|NCT02873702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039599|NCT03616262|Anesthetics, Local|anesthetics, local|mesh-ancestor
102039600|NCT03616262|Anesthetics|anesthetics|mesh-ancestor
102039601|NCT03616262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102039602|NCT03616262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039603|NCT03616262|Sensory System Agents|sensory system agents|mesh-ancestor
102039610|NCT03615950|Vitamin D|vitamin d|mesh-list
102039659|NCT02870972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102039660|NCT02870972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039661|NCT03214367|Insulin|insulin|mesh-list
102039662|NCT03214367|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102039663|NCT03214367|Insulin Glargine|insulin glargine|mesh-list
102039664|NCT03214367|Insulin Lispro|insulin lispro|mesh-list
102039665|NCT03214367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102039666|NCT03214367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039667|NCT03662958|Leuprolide|leuprolide|mesh-list
102039725|NCT05384210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102039726|NCT05384210|Antidepressive Agents|antidepressive agents|mesh-ancestor
102039727|NCT02032394|Chlorhexidine|chlorhexidine|mesh-list
102039728|NCT02032394|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
102039729|NCT02032394|Povidone-Iodine|povidone-iodine|mesh-list
102039730|NCT02032394|Povidone|povidone|mesh-list
102039731|NCT02032394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102039732|NCT02032394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102039733|NCT02032394|Disinfectants|disinfectants|mesh-ancestor
102039734|NCT02032394|Dermatologic Agents|dermatologic agents|mesh-ancestor
102039735|NCT02032394|Plasma Substitutes|plasma substitutes|mesh-ancestor
102039736|NCT02032394|Blood Substitutes|blood substitutes|mesh-ancestor
102039737|NCT03239483|Dapivirine|dapivirine|mesh-list
102039738|NCT03239483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102039739|NCT03239483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102039740|NCT03239483|Antiviral Agents|antiviral agents|mesh-ancestor
102039741|NCT03239483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102039787|NCT03662568|Antiviral Agents|antiviral agents|mesh-ancestor
102039788|NCT03662568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102039789|NCT03662568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102039790|NCT03662568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102039791|NCT03662568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102039792|NCT03662568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102039793|NCT02993250|Simeprevir|simeprevir|mesh-list
102039794|NCT02993250|Odalasvir|odalasvir|mesh-list
102039795|NCT02993250|Antiviral Agents|antiviral agents|mesh-ancestor
102039796|NCT02993250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102039797|NCT02993250|Protease Inhibitors|protease inhibitors|mesh-ancestor
102039798|NCT02993250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102039799|NCT02993250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039800|NCT03661788|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102039801|NCT03661788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102039802|NCT03661788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102039803|NCT03661788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102039804|NCT03661788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039805|NCT03661788|Adrenergic Agents|adrenergic agents|mesh-ancestor
102039806|NCT03661788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102039807|NCT03661788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039808|NCT05383820|Ketorolac|ketorolac|mesh-list
102039809|NCT05383820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102039810|NCT05383820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102039811|NCT05383820|Analgesics|analgesics|mesh-ancestor
102039812|NCT05383820|Sensory System Agents|sensory system agents|mesh-ancestor
102039813|NCT05383820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102039814|NCT05383820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039815|NCT05383820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102039816|NCT05383820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101759585|NCT02538718|Ritodrine|ritodrine|mesh-list
102039817|NCT05383820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102039818|NCT05383820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101341300|NCT00143143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101607604|NCT02645656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101607605|NCT02645656|Analgesics|analgesics|mesh-ancestor
101607606|NCT02645656|Sensory System Agents|sensory system agents|mesh-ancestor
101607607|NCT02645656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102039819|NCT05383820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039821|NCT03611504|Coagulants|coagulants|mesh-ancestor
102039822|NCT02954510|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102039823|NCT02954510|Hematinics|hematinics|mesh-ancestor
102039824|NCT02954510|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102039825|NCT02954510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102039826|NCT02032784|Octreotide|octreotide|mesh-list
102039827|NCT02032784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101777827|NCT01066195|Pemetrexed|pemetrexed|mesh-list
102039828|NCT02032784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102039829|NCT02032784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102039830|NCT03611426|Thrombin|thrombin|mesh-list
102039831|NCT03611426|Hemostatics|hemostatics|mesh-ancestor
102039884|NCT03611348|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102039885|NCT02033018|Aflibercept|aflibercept|mesh-list
102039886|NCT02033018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102039887|NCT02033018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102039888|NCT02033018|Growth Substances|growth substances|mesh-ancestor
102039889|NCT02033018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039890|NCT02033018|Growth Inhibitors|growth inhibitors|mesh-ancestor
102039891|NCT02033018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101759650|NCT00838071|Antibodies|antibodies|mesh-list
102039892|NCT03155100|Dexamethasone|dexamethasone|mesh-list
102039893|NCT03155100|Elotuzumab|elotuzumab|mesh-list
102039894|NCT03155100|Proteasome Inhibitors|proteasome inhibitors|mesh-list
102039895|NCT03155100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102039896|NCT03155100|Antiemetics|antiemetics|mesh-ancestor
102039897|NCT03155100|Autonomic Agents|autonomic agents|mesh-ancestor
102039898|NCT03155100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102039899|NCT03155100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039900|NCT03155100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102039901|NCT03155100|Glucocorticoids|glucocorticoids|mesh-ancestor
102039902|NCT03155100|Hormones|hormones|mesh-ancestor
102039903|NCT03155100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102039904|NCT03155100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102039905|NCT03155100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102039906|NCT03155100|Protease Inhibitors|protease inhibitors|mesh-ancestor
102039907|NCT03155100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102039908|NCT03155100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039909|NCT02033096|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
102039910|NCT02033096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102039930|NCT03428945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102039931|NCT03428945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102039932|NCT03208127|Antiviral Agents|antiviral agents|mesh-list
102039933|NCT03208127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102039934|NCT03941093|Leucovorin|leucovorin|mesh-list
102039935|NCT03941093|Paclitaxel|paclitaxel|mesh-list
102039936|NCT03941093|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102039937|NCT03941093|Gemcitabine|gemcitabine|mesh-list
102039938|NCT03941093|Irinotecan|irinotecan|mesh-list
102039939|NCT03941093|Fluorouracil|fluorouracil|mesh-list
102039940|NCT03941093|Folfirinox|folfirinox|mesh-list
102039941|NCT03941093|Levoleucovorin|levoleucovorin|mesh-list
102039942|NCT03941093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102039943|NCT03941093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102039944|NCT03941093|Tubulin Modulators|tubulin modulators|mesh-ancestor
102039945|NCT03941093|Antimitotic Agents|antimitotic agents|mesh-ancestor
102039946|NCT03941093|Mitosis Modulators|mitosis modulators|mesh-ancestor
102039949|NCT03941093|Antimetabolites|antimetabolites|mesh-ancestor
102039991|NCT02097121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102039992|NCT02097121|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102039993|NCT02097121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102039994|NCT02075671|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102039995|NCT02075671|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102039996|NCT02075671|Dermatologic Agents|dermatologic agents|mesh-ancestor
102039997|NCT02560298|Paclitaxel|paclitaxel|mesh-list
102039998|NCT02560298|Cisplatin|cisplatin|mesh-list
102039999|NCT02560298|Carboplatin|carboplatin|mesh-list
102040000|NCT02560298|Fluorouracil|fluorouracil|mesh-list
102040001|NCT02560298|Capecitabine|capecitabine|mesh-list
102040002|NCT02560298|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102040003|NCT02560298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102040004|NCT02560298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102040005|NCT02560298|Tubulin Modulators|tubulin modulators|mesh-ancestor
102040006|NCT02560298|Antimitotic Agents|antimitotic agents|mesh-ancestor
102040052|NCT01330693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040053|NCT01330693|Adrenergic Agents|adrenergic agents|mesh-ancestor
102040054|NCT01330693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102040055|NCT01330693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040059|NCT02863328|Empagliflozin|empagliflozin|mesh-list
102040060|NCT02863328|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101387679|NCT00322972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102040061|NCT02863328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040062|NCT02863328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102040063|NCT02863328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040064|NCT03040141|Oseltamivir|oseltamivir|mesh-list
102040065|NCT03040141|Antiviral Agents|antiviral agents|mesh-ancestor
102040066|NCT03040141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102040067|NCT03040141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102040068|NCT03040141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040069|NCT02937701|Infliximab|infliximab|mesh-list
102040070|NCT02937701|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102040071|NCT02937701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102040072|NCT02937701|Dermatologic Agents|dermatologic agents|mesh-ancestor
102040073|NCT02937701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102040074|NCT02937701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102040075|NCT05186623|Ustekinumab|ustekinumab|mesh-list
102040076|NCT05186623|Vedolizumab|vedolizumab|mesh-list
102040095|NCT04602845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102040096|NCT04602845|Anesthetics, General|anesthetics, general|mesh-ancestor
102040097|NCT04602845|Anesthetics|anesthetics|mesh-ancestor
102040098|NCT04602845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102040099|NCT04602845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102040100|NCT04602845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102040101|NCT04602845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102040102|NCT04602845|GABA Modulators|gaba modulators|mesh-ancestor
102040103|NCT04602845|GABA Agents|gaba agents|mesh-ancestor
102040104|NCT04602845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102040105|NCT04602845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040106|NCT04602845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102040107|NCT04602845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102040108|NCT04602845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102040109|NCT04602845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102040110|NCT04602845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102040111|NCT04602845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102040153|NCT03636373|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102040154|NCT03636373|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102040155|NCT03636373|Etanercept|etanercept|mesh-list
102040156|NCT03636373|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102040157|NCT03636373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102040158|NCT03636373|Glucocorticoids|glucocorticoids|mesh-ancestor
102040159|NCT03636373|Hormones|hormones|mesh-ancestor
102040160|NCT03636373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102040161|NCT03636373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040162|NCT03636373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102040163|NCT03636373|Immunologic Factors|immunologic factors|mesh-ancestor
102040164|NCT03636373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102040165|NCT03636373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040166|NCT03636373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102040167|NCT03636373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102040168|NCT03636373|Analgesics|analgesics|mesh-ancestor
102040169|NCT03636373|Sensory System Agents|sensory system agents|mesh-ancestor
102040170|NCT03636373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102040171|NCT03636373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102040172|NCT03636373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102040173|NCT04485325|Etanercept|etanercept|mesh-list
102040174|NCT04485325|Tofacitinib|tofacitinib|mesh-list
102040175|NCT04485325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102040176|NCT04485325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102040177|NCT04485325|Analgesics|analgesics|mesh-ancestor
102040178|NCT04485325|Sensory System Agents|sensory system agents|mesh-ancestor
102040179|NCT04485325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102040180|NCT04485325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040181|NCT04485325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102040182|NCT04485325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102040183|NCT04485325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102040184|NCT04485325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102040185|NCT04485325|Immunologic Factors|immunologic factors|mesh-ancestor
102040186|NCT04485325|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102040187|NCT04485325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101341672|NCT03090737|Nivolumab|nivolumab|mesh-list
101607608|NCT02645656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607609|NCT02645656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102040188|NCT04485325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102040189|NCT04485325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040190|NCT03610178|Insulin|insulin|mesh-list
102040191|NCT03610178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102040192|NCT03610178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102040193|NCT03610178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040194|NCT02033798|Tamsulosin|tamsulosin|mesh-list
101759954|NCT00394771|Estradiol|estradiol|mesh-list
102040195|NCT02033798|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102040196|NCT02033798|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102040197|NCT02033798|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102040198|NCT02033798|Adrenergic Agents|adrenergic agents|mesh-ancestor
102040199|NCT02033798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102040200|NCT02033798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040201|NCT02033798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040202|NCT02033798|Urological Agents|urological agents|mesh-ancestor
102040243|NCT03203447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102040244|NCT03203447|Growth Substances|growth substances|mesh-ancestor
102040245|NCT03203447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040246|NCT03203447|Growth Inhibitors|growth inhibitors|mesh-ancestor
102040247|NCT03203447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102040248|NCT03203447|Glucocorticoids|glucocorticoids|mesh-ancestor
102040250|NCT03203447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102040251|NCT03203447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102040252|NCT03203447|Immunologic Factors|immunologic factors|mesh-ancestor
102040253|NCT03203447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102040254|NCT03203447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040255|NCT01068678|Insulin|insulin|mesh-list
102040256|NCT01068678|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102040257|NCT01068678|Insulin Glargine|insulin glargine|mesh-list
102040258|NCT01068678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102040259|NCT01068678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040260|NCT03202511|Tenofovir|tenofovir|mesh-list
102040261|NCT03202511|Emtricitabine|emtricitabine|mesh-list
102040262|NCT03202511|Probenecid|probenecid|mesh-list
102040263|NCT03202511|Antiviral Agents|antiviral agents|mesh-ancestor
102040264|NCT03202511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102040265|NCT03202511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101760026|NCT00907036|Melphalan|melphalan|mesh-list
102040295|NCT03636971|Viscosupplements|viscosupplements|mesh-ancestor
102040296|NCT03636971|Protective Agents|protective agents|mesh-ancestor
102040297|NCT03636971|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102040298|NCT03636971|Diuretics|diuretics|mesh-ancestor
102040299|NCT03636971|Natriuretic Agents|natriuretic agents|mesh-ancestor
102040300|NCT03636971|Cathartics|cathartics|mesh-ancestor
102040301|NCT03636971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102040302|NCT03610100|Gemcitabine|gemcitabine|mesh-list
102040303|NCT03610100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102040304|NCT03610100|Antimetabolites|antimetabolites|mesh-ancestor
102040305|NCT03610100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040306|NCT03610100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102040307|NCT03657966|Paclitaxel|paclitaxel|mesh-list
102040308|NCT03657966|Carboplatin|carboplatin|mesh-list
102040357|NCT02960113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040359|NCT02960113|Mydriatics|mydriatics|mesh-ancestor
102040360|NCT02960113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102040361|NCT02960113|Cholinergic Agents|cholinergic agents|mesh-ancestor
102040362|NCT02960113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102040363|NCT02960113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040364|NCT02960113|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102040365|NCT02960113|Parasympatholytics|parasympatholytics|mesh-ancestor
102040366|NCT04458324|Buspirone|buspirone|mesh-list
102040367|NCT04458324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102040368|NCT04458324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102040369|NCT04458324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102040370|NCT04458324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040371|NCT04458324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102040372|NCT04458324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102040373|NCT04458324|Serotonin Agents|serotonin agents|mesh-ancestor
102040374|NCT04458324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102040375|NCT04458324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040376|NCT03657420|Dexamethasone|dexamethasone|mesh-list
102040377|NCT03657420|Pomalidomide|pomalidomide|mesh-list
102040378|NCT03657420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102040379|NCT03657420|Antiemetics|antiemetics|mesh-ancestor
102040380|NCT03657420|Autonomic Agents|autonomic agents|mesh-ancestor
102040381|NCT03657420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102040382|NCT03657420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040383|NCT03657420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102040384|NCT03657420|Glucocorticoids|glucocorticoids|mesh-ancestor
102040385|NCT03657420|Hormones|hormones|mesh-ancestor
102040386|NCT03657420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102040387|NCT03657420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102040388|NCT03657420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102040389|NCT03657420|Immunologic Factors|immunologic factors|mesh-ancestor
102040399|NCT02984982|Fenofibrate|fenofibrate|mesh-list
102040400|NCT02984982|Bezafibrate|bezafibrate|mesh-list
102040401|NCT02984982|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102040402|NCT02984982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102040403|NCT02984982|Antimetabolites|antimetabolites|mesh-ancestor
102040404|NCT02984982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040405|NCT02984982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102040406|NCT02984982|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102040407|NCT02984982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102040408|NCT02984982|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102040409|NCT02984982|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102040410|NCT02984982|Protease Inhibitors|protease inhibitors|mesh-ancestor
102040464|NCT02981472|Protease Inhibitors|protease inhibitors|mesh-ancestor
102040465|NCT02981472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102040466|NCT02981472|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102040468|NCT02981472|Coagulants|coagulants|mesh-ancestor
102040469|NCT03656172|Chrysarobin|chrysarobin|mesh-list
102040470|NCT03656172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102040471|NCT03656172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102040472|NCT03656172|Analgesics|analgesics|mesh-ancestor
102040473|NCT03656172|Sensory System Agents|sensory system agents|mesh-ancestor
102040474|NCT03656172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102040475|NCT03656172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040476|NCT03656172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102040477|NCT03656172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102040478|NCT03656094|Docetaxel|docetaxel|mesh-list
102040479|NCT03656094|Pembrolizumab|pembrolizumab|mesh-list
102040480|NCT03656094|Pemetrexed|pemetrexed|mesh-list
102040481|NCT03656094|Vinorelbine|vinorelbine|mesh-list
102040493|NCT04298034|Labetalol|labetalol|mesh-list
102040522|NCT00849667|Taxane|taxane|mesh-list
102040523|NCT00849667|Farletuzumab|farletuzumab|mesh-list
102040524|NCT00849667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102040525|NCT03201419|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
102040526|NCT03201419|Hemostatics|hemostatics|mesh-ancestor
102040527|NCT03201419|Coagulants|coagulants|mesh-ancestor
102040528|NCT03201419|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102040529|NCT03201419|Natriuretic Agents|natriuretic agents|mesh-ancestor
102040530|NCT03201419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040531|NCT01764633|Evolocumab|evolocumab|mesh-list
102040532|NCT01764633|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102040533|NCT01764633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102040534|NCT01764633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102040535|NCT01764633|Antimetabolites|antimetabolites|mesh-ancestor
102040536|NCT01764633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040537|NCT01764633|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102040538|NCT01764633|Protease Inhibitors|protease inhibitors|mesh-ancestor
102040539|NCT01764633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102040540|NCT01764633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102040541|NCT02924389|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102040542|NCT02924389|Dolutegravir|dolutegravir|mesh-list
102040543|NCT02924389|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
102040544|NCT02924389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102040545|NCT02924389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102040546|NCT02924389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102040548|NCT02924389|Antiviral Agents|antiviral agents|mesh-ancestor
102040571|NCT01331707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102040572|NCT03953807|Dexamethasone|dexamethasone|mesh-list
102040573|NCT03953807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102040574|NCT03953807|Antiemetics|antiemetics|mesh-ancestor
102040575|NCT03953807|Autonomic Agents|autonomic agents|mesh-ancestor
102040576|NCT03953807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102040577|NCT03953807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040578|NCT03953807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102040579|NCT03953807|Glucocorticoids|glucocorticoids|mesh-ancestor
102040580|NCT03953807|Hormones|hormones|mesh-ancestor
102040581|NCT03953807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102040582|NCT03953807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102040583|NCT03953807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102040632|NCT05431075|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102040633|NCT05431075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102040634|NCT05431075|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102040635|NCT05431075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102040636|NCT05431075|Antacids|antacids|mesh-ancestor
102040637|NCT05431075|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102040638|NCT05431075|Diuretics|diuretics|mesh-ancestor
102040639|NCT05431075|Natriuretic Agents|natriuretic agents|mesh-ancestor
102040640|NCT05431075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040641|NCT05431075|Expectorants|expectorants|mesh-ancestor
102040642|NCT05431075|Respiratory System Agents|respiratory system agents|mesh-ancestor
102040643|NCT03636659|Amphotericin B|amphotericin b|mesh-list
102040644|NCT03636659|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102040696|NCT01382589|Afamelanotide|afamelanotide|mesh-list
102040697|NCT01382589|Dermatologic Agents|dermatologic agents|mesh-ancestor
102040698|NCT03671759|Caffeine|caffeine|mesh-list
102040699|NCT03671759|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102040700|NCT03671759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040701|NCT03671759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102040702|NCT03671759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102040703|NCT03671759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040704|NCT03671759|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102040705|NCT03671759|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102040706|NCT03671759|Purinergic Agents|purinergic agents|mesh-ancestor
102040707|NCT03671759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102040708|NCT01384227|Proflavine|proflavine|mesh-list
102040709|NCT01384227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102040711|NCT01382511|Simvastatin|simvastatin|mesh-list
102040756|NCT01333891|Adrenergic Agents|adrenergic agents|mesh-ancestor
102040757|NCT01333891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102040758|NCT01333891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040759|NCT01333891|Protective Agents|protective agents|mesh-ancestor
102040760|NCT01333891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102040761|NCT01333891|Vasodilator Agents|vasodilator agents|mesh-ancestor
102040762|NCT01333891|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102040763|NCT04853875|Amoxicillin|amoxicillin|mesh-list
102040764|NCT04853875|Metronidazole|metronidazole|mesh-list
102040765|NCT04853875|Clarithromycin|clarithromycin|mesh-list
102040766|NCT04853875|Tetracycline|tetracycline|mesh-list
102040767|NCT04853875|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
102040768|NCT04853875|Bismuth|bismuth|mesh-list
102040769|NCT04853875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102040770|NCT04853875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102040771|NCT04853875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102040772|NCT04853875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102040773|NCT04853875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102040815|NCT01331941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102040816|NCT01331941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102040817|NCT01331941|Growth Substances|growth substances|mesh-ancestor
102040818|NCT01331941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040819|NCT01331941|Growth Inhibitors|growth inhibitors|mesh-ancestor
102040820|NCT02886715|Nicotinic Acids|nicotinic acids|mesh-list
102040821|NCT02886715|Tazarotene|tazarotene|mesh-list
102040822|NCT02886715|Dermatologic Agents|dermatologic agents|mesh-ancestor
102040823|NCT02886715|Keratolytic Agents|keratolytic agents|mesh-ancestor
102040824|NCT02886715|Vitamin B Complex|vitamin b complex|mesh-ancestor
102040825|NCT02886715|Vitamins|vitamins|mesh-ancestor
102040826|NCT02886715|Micronutrients|micronutrients|mesh-ancestor
102040827|NCT02886715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040828|NCT01337791|Telbivudine|telbivudine|mesh-list
102040834|NCT01334203|Ranolazine|ranolazine|mesh-list
102040878|NCT01381497|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102040879|NCT01381497|Serotonin Agents|serotonin agents|mesh-ancestor
102040880|NCT01381497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102040881|NCT04221997|Sertraline|sertraline|mesh-list
101777857|NCT04001608|Sofosbuvir|sofosbuvir|mesh-list
102040882|NCT04221997|Antidepressive Agents|antidepressive agents|mesh-ancestor
102040883|NCT04221997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102040884|NCT04221997|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102040885|NCT04221997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102040886|NCT04221997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102040887|NCT04221997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040888|NCT04221997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102040889|NCT04221997|Serotonin Agents|serotonin agents|mesh-ancestor
102040890|NCT04221997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040891|NCT03635827|Xenon|xenon|mesh-list
102040892|NCT03635827|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102040893|NCT03635827|Anesthetics, General|anesthetics, general|mesh-ancestor
102040894|NCT03635827|Anesthetics|anesthetics|mesh-ancestor
102040895|NCT03635827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102040934|NCT03084315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102040935|NCT03084315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040936|NCT03187301|Moxifloxacin|moxifloxacin|mesh-list
102040937|NCT03187301|Apomorphine|apomorphine|mesh-list
102040938|NCT03187301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102040939|NCT03187301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102040940|NCT03187301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102040941|NCT03187301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102040942|NCT03187301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102040943|NCT03187301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040944|NCT03187301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102040945|NCT03187301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102040946|NCT03187301|Emetics|emetics|mesh-ancestor
102040947|NCT03187301|Autonomic Agents|autonomic agents|mesh-ancestor
102040948|NCT03187301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102040995|NCT05421897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102040996|NCT05421897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102040997|NCT05421897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102040998|NCT05421897|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102040999|NCT05421897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102041000|NCT05421897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102041001|NCT03077919|Ropivacaine|ropivacaine|mesh-list
102041002|NCT03077919|Anesthetics, Local|anesthetics, local|mesh-ancestor
102041003|NCT03077919|Anesthetics|anesthetics|mesh-ancestor
102041004|NCT03077919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102041060|NCT03083847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102041061|NCT03083847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102041062|NCT03083847|Analgesics|analgesics|mesh-ancestor
102041063|NCT03083847|Sensory System Agents|sensory system agents|mesh-ancestor
102041064|NCT03083847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102041065|NCT03083847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041066|NCT03083847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102041067|NCT03083847|Filaricides|filaricides|mesh-ancestor
102041068|NCT03083847|Antinematodal Agents|antinematodal agents|mesh-ancestor
102041069|NCT03083847|Anthelmintics|anthelmintics|mesh-ancestor
102041070|NCT03083847|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102041071|NCT03083847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102041072|NCT03083847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041073|NCT03082677|Ixazomib|ixazomib|mesh-list
102041074|NCT03082677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102041075|NCT03082677|Protease Inhibitors|protease inhibitors|mesh-ancestor
102041076|NCT03082677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102041077|NCT03082677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041078|NCT03136055|Paclitaxel|paclitaxel|mesh-list
102041079|NCT03136055|Pembrolizumab|pembrolizumab|mesh-list
102041080|NCT03136055|Irinotecan|irinotecan|mesh-list
102041081|NCT03136055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102041082|NCT03136055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102041083|NCT03136055|Tubulin Modulators|tubulin modulators|mesh-ancestor
102041084|NCT03136055|Antimitotic Agents|antimitotic agents|mesh-ancestor
102041085|NCT03136055|Mitosis Modulators|mitosis modulators|mesh-ancestor
102041086|NCT03136055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342573|NCT00010049|Imatinib Mesylate|imatinib mesylate|mesh-list
101607610|NCT02645656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101607611|NCT02645656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101607612|NCT02645656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101607613|NCT02645656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607614|NCT01132820|Cediranib|cediranib|mesh-list
101607615|NCT01132820|Maleic acid|maleic acid|mesh-list
101607616|NCT01132820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101607617|NCT01132820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607618|NCT01132820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101607619|NCT01132820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101607620|NCT00655330|Valsartan|valsartan|mesh-list
101607621|NCT00655330|Probucol|probucol|mesh-list
101607622|NCT00655330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101607623|NCT00655330|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101607626|NCT00655330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101607627|NCT00655330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101607628|NCT00655330|Antimetabolites|antimetabolites|mesh-ancestor
101607629|NCT00655330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101607630|NCT00655330|Antioxidants|antioxidants|mesh-ancestor
102041087|NCT03136055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102041089|NCT03136055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102041090|NCT03136055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102041091|NCT03136055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102041092|NCT03221309|Analgesics, Opioid|analgesics, opioid|mesh-list
102041093|NCT03221309|Narcotics|narcotics|mesh-ancestor
102041094|NCT03221309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102041095|NCT03221309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041096|NCT03221309|Analgesics|analgesics|mesh-ancestor
102041097|NCT03221309|Sensory System Agents|sensory system agents|mesh-ancestor
102041098|NCT03221309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102041099|NCT03426657|Durvalumab|durvalumab|mesh-list
102041100|NCT03426657|Tremelimumab|tremelimumab|mesh-list
102041101|NCT03426657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102041102|NCT03426657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102041103|NCT02858180|Sofosbuvir|sofosbuvir|mesh-list
102041104|NCT02858180|Ledipasvir|ledipasvir|mesh-list
102041105|NCT02858180|Antiviral Agents|antiviral agents|mesh-ancestor
102041106|NCT02858180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102041143|NCT00480805|Losartan|losartan|mesh-list
102041144|NCT00480805|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102041145|NCT00480805|Ramipril|ramipril|mesh-list
102041146|NCT00480805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102041147|NCT00480805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102041148|NCT00480805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102041149|NCT00480805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102041150|NCT00480805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041151|NCT00480805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041152|NCT00480805|Diuretics|diuretics|mesh-ancestor
102041153|NCT00480805|Natriuretic Agents|natriuretic agents|mesh-ancestor
102041154|NCT00480805|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102041155|NCT00480805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102041203|NCT01332565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041204|NCT01332565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102041205|NCT01332565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102041206|NCT01332565|Antiviral Agents|antiviral agents|mesh-ancestor
102041207|NCT01332565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102041208|NCT01314677|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102041209|NCT01314677|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102041210|NCT01314677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041211|NCT02736227|Everolimus|everolimus|mesh-list
102041212|NCT02736227|Tacrolimus|tacrolimus|mesh-list
102041213|NCT02736227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102041214|NCT02736227|Immunologic Factors|immunologic factors|mesh-ancestor
102041215|NCT02736227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041216|NCT02736227|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102041217|NCT02736227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102041218|NCT02736227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041219|NCT02736227|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102041220|NCT02736227|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102041261|NCT01339039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102041262|NCT01339039|Growth Substances|growth substances|mesh-ancestor
102041263|NCT01339039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041264|NCT01339039|Growth Inhibitors|growth inhibitors|mesh-ancestor
102041265|NCT01339039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102041266|NCT01339039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102041267|NCT01339039|Antiviral Agents|antiviral agents|mesh-ancestor
102041268|NCT01339039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102041269|NCT03176459|Bupivacaine|bupivacaine|mesh-list
102041270|NCT03176459|Anesthetics, Local|anesthetics, local|mesh-ancestor
102041271|NCT03176459|Anesthetics|anesthetics|mesh-ancestor
102041272|NCT03176459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102041273|NCT03176459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041274|NCT03176459|Sensory System Agents|sensory system agents|mesh-ancestor
102041276|NCT01332955|Ribavirin|ribavirin|mesh-list
102041321|NCT01335529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761067|NCT00833079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102041323|NCT01335529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041324|NCT00308347|Losartan|losartan|mesh-list
102041325|NCT00308347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102041326|NCT00308347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102041327|NCT00308347|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102041328|NCT00308347|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102041384|NCT01380717|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102041385|NCT01380717|Adrenergic Agents|adrenergic agents|mesh-ancestor
102041386|NCT01380717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102041387|NCT01380717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041388|NCT01380717|Protease Inhibitors|protease inhibitors|mesh-ancestor
102041389|NCT01380717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102041390|NCT01380717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102041391|NCT03080493|Acetaminophen|acetaminophen|mesh-list
102041392|NCT03080493|Ibuprofen|ibuprofen|mesh-list
102041393|NCT03080493|Gabapentin|gabapentin|mesh-list
102041394|NCT03080493|Codeine|codeine|mesh-list
102041395|NCT03080493|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102041396|NCT03080493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102041397|NCT03080493|Analgesics|analgesics|mesh-ancestor
102041398|NCT03080493|Sensory System Agents|sensory system agents|mesh-ancestor
102041399|NCT03080493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102041400|NCT03080493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041401|NCT03080493|Antipyretics|antipyretics|mesh-ancestor
102041402|NCT03080493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102041441|NCT01339910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102041442|NCT01339910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102041443|NCT01339910|Antimetabolites|antimetabolites|mesh-ancestor
102041444|NCT01339910|Antiviral Agents|antiviral agents|mesh-ancestor
102041445|NCT01339910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102041446|NCT02647827|Metformin|metformin|mesh-list
102041447|NCT02647827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102041448|NCT02647827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041449|NCT03655392|Nitric Oxide|nitric oxide|mesh-list
102041450|NCT03655392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102041451|NCT03655392|Autonomic Agents|autonomic agents|mesh-ancestor
102041452|NCT03655392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102041453|NCT03655392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041454|NCT03655392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102041455|NCT03655392|Respiratory System Agents|respiratory system agents|mesh-ancestor
102041456|NCT03655392|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102041499|NCT01066104|Respiratory System Agents|respiratory system agents|mesh-ancestor
102041500|NCT01066104|Immunologic Factors|immunologic factors|mesh-ancestor
102041501|NCT01066104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041502|NCT02736968|Auranofin|auranofin|mesh-list
102041503|NCT02736968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102041504|NCT03608306|Methamphetamine|methamphetamine|mesh-list
102041505|NCT03608306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102041506|NCT03608306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041507|NCT03608306|Sympathomimetics|sympathomimetics|mesh-ancestor
102041508|NCT03608306|Autonomic Agents|autonomic agents|mesh-ancestor
102041509|NCT03608306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102041559|NCT03077607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041560|NCT03077607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102041561|NCT03077607|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102041562|NCT03077607|Antitubercular Agents|antitubercular agents|mesh-ancestor
102041563|NCT03077607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102041564|NCT03077607|Leprostatic Agents|leprostatic agents|mesh-ancestor
102041565|NCT03077607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102041566|NCT03077607|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102041567|NCT03077607|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102041568|NCT03077607|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102041569|NCT03077607|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102041570|NCT03077607|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102041618|NCT01379001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102041619|NCT01379001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041621|NCT01379001|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102041622|NCT01379001|Antiemetics|antiemetics|mesh-ancestor
102041623|NCT01379001|Autonomic Agents|autonomic agents|mesh-ancestor
102041624|NCT01379001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102041625|NCT01379001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102041626|NCT01379001|Mydriatics|mydriatics|mesh-ancestor
102041627|NCT01379001|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102041628|NCT01379001|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102041629|NCT01379001|Parasympatholytics|parasympatholytics|mesh-ancestor
102041630|NCT03172325|Folic Acid|folic acid|mesh-list
102041631|NCT03172325|Prednisolone|prednisolone|mesh-list
102041682|NCT03653520|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102041683|NCT03653520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102041684|NCT03653520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102041685|NCT03653520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102041686|NCT03653520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102041687|NCT03653520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102041688|NCT03653520|Anesthetics, General|anesthetics, general|mesh-ancestor
102041689|NCT03653520|Anesthetics|anesthetics|mesh-ancestor
102041690|NCT03653520|GABA Modulators|gaba modulators|mesh-ancestor
102041691|NCT03653520|GABA Agents|gaba agents|mesh-ancestor
102041692|NCT01208090|Ponesimod|ponesimod|mesh-list
102041693|NCT01208090|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102041694|NCT01208090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041695|NCT01208090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102041696|NCT01208090|Immunologic Factors|immunologic factors|mesh-ancestor
102041744|NCT01141712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102041745|NCT01141712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102041746|NCT01141712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102041747|NCT01141712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102041748|NCT01141712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102041749|NCT01141712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041750|NCT01141712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102041751|NCT01141712|Antimetabolites|antimetabolites|mesh-ancestor
102041752|NCT01141712|Antiviral Agents|antiviral agents|mesh-ancestor
102041753|NCT01141712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102041754|NCT01141712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102041807|NCT03606824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102041808|NCT03606824|Antimetabolites|antimetabolites|mesh-ancestor
102041809|NCT03606824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041810|NCT03606824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102041811|NCT03606824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102041812|NCT03604016|Tenofovir|tenofovir|mesh-list
102041813|NCT03604016|Antiviral Agents|antiviral agents|mesh-ancestor
102041814|NCT03604016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102041815|NCT03604016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102041816|NCT03604016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102041817|NCT03604016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102041819|NCT03604016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102041871|NCT01378533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102041872|NCT01378533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102041873|NCT01378533|Tubulin Modulators|tubulin modulators|mesh-ancestor
102041874|NCT01378533|Antimitotic Agents|antimitotic agents|mesh-ancestor
102041875|NCT01378533|Mitosis Modulators|mitosis modulators|mesh-ancestor
102041876|NCT01378533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041877|NCT01378533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102041878|NCT01378533|Immunologic Factors|immunologic factors|mesh-ancestor
102041879|NCT01378533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041880|NCT01378533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102041881|NCT01378533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102041933|NCT04483115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102041934|NCT04483115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102041935|NCT04483115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041936|NCT04483115|Urological Agents|urological agents|mesh-ancestor
102041937|NCT04054362|Paclitaxel|paclitaxel|mesh-list
102041938|NCT04054362|Gemcitabine|gemcitabine|mesh-list
102041939|NCT04054362|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102041940|NCT04054362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102041941|NCT04054362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102041942|NCT04054362|Tubulin Modulators|tubulin modulators|mesh-ancestor
102041943|NCT04054362|Antimitotic Agents|antimitotic agents|mesh-ancestor
102041944|NCT04054362|Mitosis Modulators|mitosis modulators|mesh-ancestor
102041945|NCT04054362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102041946|NCT04054362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102041947|NCT04054362|Antimetabolites|antimetabolites|mesh-ancestor
102041948|NCT04467281|Daratumumab|daratumumab|mesh-list
102041949|NCT04467281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102041950|NCT01378143|Pentamidine|pentamidine|mesh-list
102041951|NCT01378143|Antifungal Agents|antifungal agents|mesh-ancestor
102041952|NCT01378143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102041953|NCT01378143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102041954|NCT01378143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102041955|NCT01378143|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
102041956|NCT02973048|Bupivacaine|bupivacaine|mesh-list
102041957|NCT02973048|Prilocaine|prilocaine|mesh-list
102041983|NCT03652116|Bupivacaine|bupivacaine|mesh-list
102041984|NCT03652116|Anesthetics, Local|anesthetics, local|mesh-ancestor
102041985|NCT03652116|Anesthetics|anesthetics|mesh-ancestor
102041986|NCT03652116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102041987|NCT03652116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102041988|NCT03652116|Sensory System Agents|sensory system agents|mesh-ancestor
102041989|NCT03652116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102041990|NCT03652116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102041991|NCT03652116|Narcotics|narcotics|mesh-ancestor
102041992|NCT03652116|Analgesics|analgesics|mesh-ancestor
102041993|NCT03652116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102041994|NCT02232087|Fluticasone|fluticasone|mesh-list
102041995|NCT02232087|Xhance|xhance|mesh-list
102041996|NCT02232087|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102041997|NCT02232087|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
102041998|NCT02232087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102041999|NCT02232087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102042000|NCT02232087|Autonomic Agents|autonomic agents|mesh-ancestor
102042001|NCT02232087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101761739|NCT00842595|Hormones|hormones|mesh-ancestor
102042002|NCT02232087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042003|NCT02232087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102042004|NCT02232087|Respiratory System Agents|respiratory system agents|mesh-ancestor
102042005|NCT02232087|Dermatologic Agents|dermatologic agents|mesh-ancestor
102042006|NCT02232087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102042007|NCT02232087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102042008|NCT02232087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102042009|NCT02232087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102042010|NCT02232087|Adrenergic Agents|adrenergic agents|mesh-ancestor
102042011|NCT02232087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101387680|NCT00090558|Nitroglycerin|nitroglycerin|mesh-list
102042012|NCT02232087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042014|NCT02232087|Hormones|hormones|mesh-ancestor
102042015|NCT02232087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102042016|NCT02232087|Sympathomimetics|sympathomimetics|mesh-ancestor
102042017|NCT01380015|Rosmarinic acid|rosmarinic acid|mesh-list
102042018|NCT01380015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102042022|NCT01380015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102042023|NCT01380015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042024|NCT01380015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102042025|NCT01380015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102042026|NCT01380015|Antioxidants|antioxidants|mesh-ancestor
102042027|NCT01380015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042028|NCT01380015|Protective Agents|protective agents|mesh-ancestor
102042029|NCT01380015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102042030|NCT01380015|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102042031|NCT01380015|Protease Inhibitors|protease inhibitors|mesh-ancestor
102042032|NCT01380015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102042033|NCT03603626|Pregabalin|pregabalin|mesh-list
102042086|NCT03606590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042088|NCT03163667|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102042089|NCT03163667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102042090|NCT03163667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102042091|NCT03163667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042092|NCT03163667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102042093|NCT03163667|Immunologic Factors|immunologic factors|mesh-ancestor
102042094|NCT03163667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042095|NCT03163667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102042096|NCT03603548|Tacrolimus|tacrolimus|mesh-list
102042097|NCT03603548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102042149|NCT03167411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102042151|NCT02237768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102042152|NCT02237768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102042153|NCT05461833|Octylonium|octylonium|mesh-list
102042154|NCT05461833|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102042155|NCT05461833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102042156|NCT05461833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042158|NCT05461833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042213|NCT05462535|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102042214|NCT05462535|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102042215|NCT05462535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102042216|NCT05462535|Diuretics|diuretics|mesh-ancestor
102042217|NCT05462535|Natriuretic Agents|natriuretic agents|mesh-ancestor
102042218|NCT05462535|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102042219|NCT05764317|Amlodipine|amlodipine|mesh-list
102042220|NCT05764317|Perindopril|perindopril|mesh-list
102042221|NCT05764317|Atorvastatin|atorvastatin|mesh-list
102042222|NCT05764317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102042223|NCT05764317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102042224|NCT05764317|Antimetabolites|antimetabolites|mesh-ancestor
102042225|NCT05764317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042226|NCT05764317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102042228|NCT05764317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102042273|NCT02978495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102042274|NCT02978495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102042275|NCT02978495|Tubulin Modulators|tubulin modulators|mesh-ancestor
102042276|NCT02978495|Antimitotic Agents|antimitotic agents|mesh-ancestor
102042277|NCT02978495|Mitosis Modulators|mitosis modulators|mesh-ancestor
102042278|NCT02978495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042279|NCT02978495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102042280|NCT02978495|Immunologic Factors|immunologic factors|mesh-ancestor
102042281|NCT02978495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042282|NCT02978495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102042283|NCT02978495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102042284|NCT02978495|Alkylating Agents|alkylating agents|mesh-ancestor
102042285|NCT02978495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102042286|NCT02978495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102042287|NCT02978495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102042288|NCT02978495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102042331|NCT03075267|Formoterol Fumarate|formoterol fumarate|mesh-list
102042332|NCT03075267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102042333|NCT03075267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102042334|NCT03075267|Autonomic Agents|autonomic agents|mesh-ancestor
102042335|NCT03075267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102042336|NCT03075267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042337|NCT03075267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102042338|NCT03075267|Respiratory System Agents|respiratory system agents|mesh-ancestor
102042339|NCT03075267|Glucocorticoids|glucocorticoids|mesh-ancestor
102042340|NCT03075267|Hormones|hormones|mesh-ancestor
102042341|NCT03075267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102042342|NCT03075267|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102042343|NCT03075267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102042344|NCT03075267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102042345|NCT03075267|Adrenergic Agents|adrenergic agents|mesh-ancestor
102042346|NCT03075267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102042347|NCT03075267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042348|NCT03075267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102042349|NCT03075267|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102042350|NCT03075267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102042368|NCT03074331|Sofosbuvir|sofosbuvir|mesh-list
102042385|NCT03825302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042386|NCT03825302|Miotics|miotics|mesh-ancestor
102042387|NCT03825302|Autonomic Agents|autonomic agents|mesh-ancestor
102042388|NCT03825302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102042389|NCT03825302|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102042390|NCT03825302|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
102042391|NCT03825302|Respiratory System Agents|respiratory system agents|mesh-ancestor
102042392|NCT03825302|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102042393|NCT03825302|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102042394|NCT03825302|Cholinergic Agents|cholinergic agents|mesh-ancestor
102042395|NCT03825302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102042397|NCT02238392|Adenosine|adenosine|mesh-list
102042447|NCT02238314|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102042448|NCT02238314|Protease Inhibitors|protease inhibitors|mesh-ancestor
102042449|NCT02238314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102042450|NCT02238314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042451|NCT02238314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102042452|NCT02238314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102042453|NCT02238314|Antiviral Agents|antiviral agents|mesh-ancestor
102042454|NCT02238314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102042455|NCT02238314|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102042456|NCT02238314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102042457|NCT02238314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102042458|NCT02238470|Warfarin|warfarin|mesh-list
102042459|NCT02238470|Rivaroxaban|rivaroxaban|mesh-list
102042460|NCT02238470|Dabigatran|dabigatran|mesh-list
102042461|NCT02238470|Apixaban|apixaban|mesh-list
102042462|NCT02238470|Anticoagulants|anticoagulants|mesh-list
102042463|NCT02238470|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102042464|NCT02238470|Antithrombins|antithrombins|mesh-ancestor
102042466|NCT02238470|Protease Inhibitors|protease inhibitors|mesh-ancestor
102042507|NCT03586154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102042508|NCT03586154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102042509|NCT03586154|Anesthetics, General|anesthetics, general|mesh-ancestor
102042510|NCT03586154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102042511|NCT03586154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102042512|NCT03586154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102042513|NCT03586154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042514|NCT03629847|Everolimus|everolimus|mesh-list
102042515|NCT03629847|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102042516|NCT03629847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102042517|NCT03629847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102042518|NCT03629847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042519|NCT03629847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102042520|NCT03629847|Immunologic Factors|immunologic factors|mesh-ancestor
102042521|NCT03629847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042522|NCT03629847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102042523|NCT01314833|Paclitaxel|paclitaxel|mesh-list
102042524|NCT01314833|Docetaxel|docetaxel|mesh-list
102042525|NCT01314833|Cyclophosphamide|cyclophosphamide|mesh-list
102042526|NCT01314833|Fluorouracil|fluorouracil|mesh-list
102042564|NCT02737826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102042565|NCT02737826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102042566|NCT02737826|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102042567|NCT02737826|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102042568|NCT02737826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102042569|NCT02737826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042570|NCT02737826|Antimanic Agents|antimanic agents|mesh-ancestor
102042571|NCT03367715|Nivolumab|nivolumab|mesh-list
102042572|NCT03367715|Ipilimumab|ipilimumab|mesh-list
102042573|NCT03367715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102042574|NCT03367715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102042575|NCT03367715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102042576|NCT03367715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042577|NCT04064931|Niacin|niacin|mesh-list
102042578|NCT04064931|Vitamins|vitamins|mesh-ancestor
102042579|NCT04064931|Micronutrients|micronutrients|mesh-ancestor
102042580|NCT04064931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042581|NCT04064931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102042582|NCT04064931|Antimetabolites|antimetabolites|mesh-ancestor
102042583|NCT04064931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042584|NCT04064931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102042585|NCT04064931|Vasodilator Agents|vasodilator agents|mesh-ancestor
102042586|NCT04064931|Vitamin B Complex|vitamin b complex|mesh-ancestor
102042587|NCT03577652|Ticagrelor|ticagrelor|mesh-list
102042588|NCT03577652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102042589|NCT03577652|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102042590|NCT03577652|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102042591|NCT03577652|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102042592|NCT03577652|Purinergic Agents|purinergic agents|mesh-ancestor
102042596|NCT03620513|Lidocaine|lidocaine|mesh-list
102042607|NCT03620513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102042608|NCT03620513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102042609|NCT03620513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102042610|NCT03620513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102042611|NCT03620513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102042612|NCT03620513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042613|NCT03620513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102042614|NCT03620513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102042615|NCT03620513|Adrenergic Agents|adrenergic agents|mesh-ancestor
102042616|NCT03620513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102042617|NCT03620513|Sympathomimetics|sympathomimetics|mesh-ancestor
102042618|NCT03620513|Autonomic Agents|autonomic agents|mesh-ancestor
102042619|NCT03620513|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102042620|NCT03620513|Respiratory System Agents|respiratory system agents|mesh-ancestor
102042621|NCT03620513|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102042622|NCT03620513|Mydriatics|mydriatics|mesh-ancestor
102042623|NCT03620513|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102042628|NCT03585062|Paclitaxel|paclitaxel|mesh-list
102042661|NCT05763771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102042662|NCT05763771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042663|NCT05763771|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102042664|NCT05763771|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102042665|NCT05763771|Cholinergic Agents|cholinergic agents|mesh-ancestor
102042666|NCT05763771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102042667|NCT05763771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042669|NCT03579758|Capecitabine|capecitabine|mesh-list
102042670|NCT03579758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102042671|NCT03579758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102042672|NCT03579758|Antimetabolites|antimetabolites|mesh-ancestor
102042673|NCT03579758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042674|NCT03577574|Anesthetics|anesthetics|mesh-list
102042675|NCT03577574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102042676|NCT03577574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042721|NCT03582878|Mycophenolic Acid|mycophenolic acid|mesh-list
102042722|NCT03582878|Sirolimus|sirolimus|mesh-list
102042723|NCT03582878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102042724|NCT03582878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102042725|NCT03582878|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102042726|NCT03582878|Antitubercular Agents|antitubercular agents|mesh-ancestor
102042727|NCT03582878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102042728|NCT03582878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102042729|NCT03582878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102042730|NCT03582878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042731|NCT03582878|Antifungal Agents|antifungal agents|mesh-ancestor
102042732|NCT03582878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102042733|NCT03582878|Immunologic Factors|immunologic factors|mesh-ancestor
102042734|NCT03582878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042735|NCT05763693|Azithromycin|azithromycin|mesh-list
102042736|NCT05763693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102042737|NCT05763693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102042738|NCT02238704|Calcium, Dietary|calcium, dietary|mesh-list
102042740|NCT02238704|Folic Acid|folic acid|mesh-list
102042741|NCT02238704|Vitamin B Complex|vitamin b complex|mesh-list
102042742|NCT02238704|Calcium|calcium|mesh-list
102042743|NCT02238704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102042744|NCT02238704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042746|NCT02238704|Trace Elements|trace elements|mesh-ancestor
102042775|NCT02238860|Tenofovir|tenofovir|mesh-list
102042776|NCT02238860|Antiviral Agents|antiviral agents|mesh-ancestor
102042777|NCT02238860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102042778|NCT02238860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102042779|NCT02238860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102042780|NCT02238860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102042781|NCT02238860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042782|NCT02238860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102042783|NCT02238860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102042784|NCT01333709|Folfirinox|folfirinox|mesh-list
102042839|NCT02968563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042840|NCT01329887|Ketanserin|ketanserin|mesh-list
102042841|NCT01329887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102042842|NCT01329887|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102042843|NCT01329887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102042844|NCT01329887|Serotonin Agents|serotonin agents|mesh-ancestor
102042845|NCT01329887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102042846|NCT01329887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042847|NCT01329887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042848|NCT01334099|Tremelimumab|tremelimumab|mesh-list
102042849|NCT01334099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102042850|NCT01331525|Ipilimumab|ipilimumab|mesh-list
102042851|NCT01331525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102042852|NCT01331525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102042853|NCT01331525|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102042854|NCT01331525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042855|NCT01334177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102042856|NCT01334177|Cetuximab|cetuximab|mesh-list
102042895|NCT02904096|Sensory System Agents|sensory system agents|mesh-ancestor
102042896|NCT02904096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102042897|NCT02904096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102042898|NCT02904096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102042899|NCT02904096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102042900|NCT02904096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102042901|NCT02904096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042902|NCT04079712|Nivolumab|nivolumab|mesh-list
102042903|NCT04079712|Ipilimumab|ipilimumab|mesh-list
102042904|NCT04079712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102042905|NCT04079712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102042906|NCT04079712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102042907|NCT04079712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042953|NCT01502085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102042954|NCT01502085|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102042955|NCT01502085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102042956|NCT01502085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042957|NCT03648684|Caffeine|caffeine|mesh-list
101387681|NCT00090558|Vasodilator Agents|vasodilator agents|mesh-ancestor
102042958|NCT03648684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102042959|NCT03648684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042960|NCT03648684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102042961|NCT03648684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102042962|NCT03648684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042963|NCT03648684|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102042964|NCT03648684|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102042965|NCT03648684|Purinergic Agents|purinergic agents|mesh-ancestor
102042966|NCT03648684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102042967|NCT03647982|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102042968|NCT03647982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102042969|NCT03647982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102042970|NCT03647982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042971|NCT03647982|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102042972|NCT03647982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102042973|NCT03647982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102042974|NCT03647982|Cholinergic Agents|cholinergic agents|mesh-ancestor
102042975|NCT03647982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102042976|NCT02901054|Ondansetron|ondansetron|mesh-list
102042977|NCT02901054|Antiemetics|antiemetics|mesh-ancestor
102042978|NCT02901054|Autonomic Agents|autonomic agents|mesh-ancestor
102042979|NCT02901054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102042980|NCT02901054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102042996|NCT03647670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102042997|NCT03647670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102042998|NCT03647670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102042999|NCT03647670|Anesthetics, General|anesthetics, general|mesh-ancestor
102043000|NCT03647670|Anesthetics|anesthetics|mesh-ancestor
102043001|NCT03647670|GABA Modulators|gaba modulators|mesh-ancestor
102043002|NCT03647670|GABA Agents|gaba agents|mesh-ancestor
102043003|NCT03647670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102043004|NCT03647670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043005|NCT03647670|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102043006|NCT03647670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102043007|NCT02966340|Prazosin|prazosin|mesh-list
102043008|NCT02966340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102043009|NCT02966340|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102043010|NCT02966340|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102043011|NCT02966340|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102043012|NCT02966340|Adrenergic Agents|adrenergic agents|mesh-ancestor
102043013|NCT02966340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102043014|NCT02966340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043016|NCT05284734|Anesthetics|anesthetics|mesh-list
102043050|NCT05205603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102043051|NCT05205603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043052|NCT03578900|Citric Acid|citric acid|mesh-list
102043053|NCT03578900|Sodium Citrate|sodium citrate|mesh-list
102043054|NCT03578900|Anticoagulants|anticoagulants|mesh-ancestor
102043055|NCT03578900|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102043056|NCT03578900|Chelating Agents|chelating agents|mesh-ancestor
102043057|NCT03578900|Sequestering Agents|sequestering agents|mesh-ancestor
102043058|NCT03578900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043059|NCT02550002|Aflibercept|aflibercept|mesh-list
102043060|NCT02550002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102043061|NCT02550002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102043062|NCT02550002|Growth Substances|growth substances|mesh-ancestor
102043063|NCT02550002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043064|NCT02550002|Growth Inhibitors|growth inhibitors|mesh-ancestor
102043066|NCT03574376|Bupivacaine|bupivacaine|mesh-list
102043108|NCT03576638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102043109|NCT03576638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043110|NCT03576638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043111|NCT03576638|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
102043112|NCT03576638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102043113|NCT03576638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102043114|NCT03576638|Immunologic Factors|immunologic factors|mesh-ancestor
102043115|NCT03576638|Dopamine Agonists|dopamine agonists|mesh-ancestor
102043116|NCT04284657|Citric Acid|citric acid|mesh-list
102043117|NCT04284657|Sodium Citrate|sodium citrate|mesh-list
102043118|NCT04284657|Pravastatin|pravastatin|mesh-list
102043119|NCT04284657|Anticoagulants|anticoagulants|mesh-ancestor
102043120|NCT04284657|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102043121|NCT04284657|Chelating Agents|chelating agents|mesh-ancestor
102043168|NCT03578354|4-Aminopyridine|4-aminopyridine|mesh-list
102043169|NCT03578354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102043170|NCT03578354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102043171|NCT03578354|Sympatholytics|sympatholytics|mesh-ancestor
102043172|NCT03578354|Autonomic Agents|autonomic agents|mesh-ancestor
102043173|NCT03578354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102043174|NCT03578354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043175|NCT03578354|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102043176|NCT03578354|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102043177|NCT03578354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102043178|NCT03578354|Adrenergic Agents|adrenergic agents|mesh-ancestor
102043179|NCT03578354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102043180|NCT03578354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043181|NCT03578354|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102043182|NCT03578354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102043194|NCT02239952|Sunitinib|sunitinib|mesh-list
102043222|NCT03578042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102043223|NCT03578042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102043224|NCT03578042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102043225|NCT03578042|Diuretics|diuretics|mesh-ancestor
102043226|NCT03578042|Natriuretic Agents|natriuretic agents|mesh-ancestor
102043227|NCT03578042|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102043228|NCT03646500|Remifentanil|remifentanil|mesh-list
102043229|NCT03646500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102043230|NCT03646500|Narcotics|narcotics|mesh-ancestor
102043231|NCT03646500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102043232|NCT03646500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043233|NCT03646500|Analgesics|analgesics|mesh-ancestor
102043234|NCT03646500|Sensory System Agents|sensory system agents|mesh-ancestor
102043235|NCT03646500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102043236|NCT03574064|Glucagon|glucagon|mesh-list
102043237|NCT03574064|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
102043238|NCT03574064|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102043239|NCT03574064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102043240|NCT03574064|Hormones|hormones|mesh-ancestor
102043276|NCT03621618|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102043278|NCT03621618|Adrenergic Agents|adrenergic agents|mesh-ancestor
102043279|NCT03621618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102043280|NCT03621618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043281|NCT03621618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043283|NCT03621618|Autonomic Agents|autonomic agents|mesh-ancestor
102043284|NCT03621618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102043285|NCT03621618|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102043286|NCT03621618|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102043287|NCT03621618|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102043288|NCT03621618|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102043289|NCT03621618|Protective Agents|protective agents|mesh-ancestor
102043290|NCT03944304|Paclitaxel|paclitaxel|mesh-list
102043291|NCT03944304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102043292|NCT03944304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102043293|NCT03944304|Tubulin Modulators|tubulin modulators|mesh-ancestor
102043294|NCT03944304|Antimitotic Agents|antimitotic agents|mesh-ancestor
102043295|NCT03944304|Mitosis Modulators|mitosis modulators|mesh-ancestor
102043297|NCT05204121|Elsulfavirine|elsulfavirine|mesh-list
102043333|NCT02899728|Podophyllotoxin|podophyllotoxin|mesh-list
102043334|NCT02899728|Cediranib|cediranib|mesh-list
102043335|NCT02899728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
102043336|NCT02899728|Maleic acid|maleic acid|mesh-list
102043337|NCT02899728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102043338|NCT02899728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101387682|NCT00323011|Leucovorin|leucovorin|mesh-list
102043339|NCT02899728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102043340|NCT02899728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102043341|NCT02899728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102043342|NCT02899728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043343|NCT02899728|Keratolytic Agents|keratolytic agents|mesh-ancestor
102043344|NCT02899728|Dermatologic Agents|dermatologic agents|mesh-ancestor
102043345|NCT02899728|Tubulin Modulators|tubulin modulators|mesh-ancestor
102043346|NCT02899728|Antimitotic Agents|antimitotic agents|mesh-ancestor
102043347|NCT02899728|Mitosis Modulators|mitosis modulators|mesh-ancestor
102043348|NCT02899728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102043349|NCT03646266|Bromides|bromides|mesh-list
102043350|NCT03646266|Rocuronium|rocuronium|mesh-list
101763084|NCT00363649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102043351|NCT03646266|Anticonvulsants|anticonvulsants|mesh-ancestor
102043352|NCT03646266|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102043353|NCT03646266|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102043354|NCT03646266|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102043357|NCT04052178|Capsaicin|capsaicin|mesh-list
102043383|NCT03768492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102043384|NCT03768492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102043385|NCT03768492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043386|NCT03768492|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102043387|NCT03768492|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102043388|NCT03768492|Purinergic Agents|purinergic agents|mesh-ancestor
102043389|NCT03768492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102043390|NCT01345188|Ranolazine|ranolazine|mesh-list
102043450|NCT01335685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043452|NCT01335685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102043453|NCT01335685|Immunologic Factors|immunologic factors|mesh-ancestor
102043454|NCT01335685|Protease Inhibitors|protease inhibitors|mesh-ancestor
102043455|NCT01335685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102043456|NCT01335763|Insulin Glargine|insulin glargine|mesh-list
102043457|NCT01335763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102043458|NCT01335763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043459|NCT04462965|Temozolomide|temozolomide|mesh-list
102043460|NCT04462965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102043464|NCT01339663|Aldesleukin|aldesleukin|mesh-list
102043515|NCT01333423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102043516|NCT01333423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102043517|NCT00092209|Losartan|losartan|mesh-list
102043518|NCT00092209|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102043519|NCT00092209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102043520|NCT00092209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102043521|NCT00092209|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102043522|NCT00092209|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102043523|NCT00092209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043524|NCT00092209|Diuretics|diuretics|mesh-ancestor
102043525|NCT00092209|Natriuretic Agents|natriuretic agents|mesh-ancestor
102043526|NCT00092209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043578|NCT03619785|Fentanyl|fentanyl|mesh-list
101763321|NCT02566928|Bacitracin|bacitracin|mesh-list
102043579|NCT03619785|Ketamine|ketamine|mesh-list
102043580|NCT03619785|Morphine|morphine|mesh-list
102043581|NCT03619785|Gabapentin|gabapentin|mesh-list
102043582|NCT03619785|Hydromorphone|hydromorphone|mesh-list
102043583|NCT03619785|Hydrocodone|hydrocodone|mesh-list
102043584|NCT03619785|Bupivacaine|bupivacaine|mesh-list
102043585|NCT03619785|Anesthetics, Local|anesthetics, local|mesh-ancestor
102043586|NCT03619785|Anesthetics|anesthetics|mesh-ancestor
102043587|NCT03619785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102043588|NCT03619785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043589|NCT03619785|Sensory System Agents|sensory system agents|mesh-ancestor
102043590|NCT03619785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102043591|NCT03619785|Analgesics|analgesics|mesh-ancestor
102043592|NCT03619785|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102043593|NCT03619785|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102043594|NCT03619785|Anesthetics, General|anesthetics, general|mesh-ancestor
102043595|NCT03619785|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102043596|NCT03619785|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102043597|NCT03619785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102043598|NCT03619785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043599|NCT03619785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102043600|NCT03619785|Narcotics|narcotics|mesh-ancestor
102043601|NCT03619785|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102043602|NCT03619785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102043603|NCT03619785|Antipyretics|antipyretics|mesh-ancestor
102043604|NCT03619785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102043605|NCT03619785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102043606|NCT03619785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102043607|NCT03619785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102043608|NCT03619785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102043609|NCT03619785|Anticonvulsants|anticonvulsants|mesh-ancestor
102043610|NCT03619785|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102043622|NCT05184517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102043623|NCT05184517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043624|NCT05184517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102043625|NCT05184517|Immunologic Factors|immunologic factors|mesh-ancestor
102043626|NCT05184517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043627|NCT05184517|Antifungal Agents|antifungal agents|mesh-ancestor
102043628|NCT05184517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102043629|NCT05184517|Dermatologic Agents|dermatologic agents|mesh-ancestor
102043630|NCT05184517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102043631|NCT05184517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102043632|NCT02962284|Methylprednisolone|methylprednisolone|mesh-list
102043633|NCT02962284|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102043634|NCT02962284|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102043635|NCT02962284|Prednisolone|prednisolone|mesh-list
102043641|NCT02962284|Antiemetics|antiemetics|mesh-ancestor
102043684|NCT03161093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102043685|NCT03161093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102043686|NCT03161093|Analgesics|analgesics|mesh-ancestor
102043687|NCT03161093|Sensory System Agents|sensory system agents|mesh-ancestor
102043688|NCT03161093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102043689|NCT03161093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043690|NCT03161093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102043691|NCT03161093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102043692|NCT03161093|Gout Suppressants|gout suppressants|mesh-ancestor
102043693|NCT03161093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102043694|NCT03161093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102043695|NCT03161093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043696|NCT03573284|Nitric Oxide|nitric oxide|mesh-list
102043697|NCT03573284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102043698|NCT03573284|Autonomic Agents|autonomic agents|mesh-ancestor
102043699|NCT03573284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102043700|NCT03573284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043701|NCT03573284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102043714|NCT01334333|Tacrolimus|tacrolimus|mesh-list
102043739|NCT02847494|Metoclopramide|metoclopramide|mesh-list
102043740|NCT02847494|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102043741|NCT02847494|Prednisolone phosphate|prednisolone phosphate|mesh-list
102043742|NCT02847494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102043743|NCT02847494|Antiemetics|antiemetics|mesh-ancestor
102043744|NCT02847494|Autonomic Agents|autonomic agents|mesh-ancestor
102043745|NCT02847494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102043746|NCT02847494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043747|NCT02847494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102043748|NCT02847494|Glucocorticoids|glucocorticoids|mesh-ancestor
102043749|NCT02847494|Hormones|hormones|mesh-ancestor
102043750|NCT02847494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102043751|NCT02847494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102043752|NCT02847494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102043753|NCT02847494|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102043754|NCT02847494|Protective Agents|protective agents|mesh-ancestor
102043755|NCT02847494|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102043756|NCT02847494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102043795|NCT03575234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102043796|NCT03575234|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102043797|NCT03575234|Alkylating Agents|alkylating agents|mesh-ancestor
101387683|NCT00323011|Folic Acid|folic acid|mesh-list
101777944|NCT00814866|Adalimumab|adalimumab|mesh-list
102043798|NCT03575234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043799|NCT03575234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102043800|NCT03575234|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102043801|NCT03575234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102043802|NCT03575234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102043803|NCT04508855|Heparin|heparin|mesh-list
102043804|NCT04508855|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102043805|NCT04508855|Tinzaparin|tinzaparin|mesh-list
101763537|NCT00752934|Baclofen|baclofen|mesh-list
102043806|NCT04508855|Dalteparin|dalteparin|mesh-list
102043807|NCT04508855|Anticoagulants|anticoagulants|mesh-ancestor
102043808|NCT04508855|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102043809|NCT04508855|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102043854|NCT03158311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043855|NCT03158311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102043856|NCT03158311|Respiratory System Agents|respiratory system agents|mesh-ancestor
102043857|NCT03158311|Dermatologic Agents|dermatologic agents|mesh-ancestor
102043858|NCT03158311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102043859|NCT03158311|Parasympatholytics|parasympatholytics|mesh-ancestor
102043860|NCT03158311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102043861|NCT03158311|Cholinergic Agents|cholinergic agents|mesh-ancestor
102043862|NCT03158311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102043863|NCT03158311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102043864|NCT03158311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102043865|NCT03158311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102043866|NCT03158311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102043867|NCT03158311|Adrenergic Agents|adrenergic agents|mesh-ancestor
102043914|NCT03571490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102043915|NCT03571490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043916|NCT03571490|Sensory System Agents|sensory system agents|mesh-ancestor
102043917|NCT03571490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102043918|NCT01331993|Naproxen|naproxen|mesh-list
102043919|NCT01331993|Esomeprazole|esomeprazole|mesh-list
102043920|NCT01331993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102043921|NCT01331993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102043922|NCT01331993|Analgesics|analgesics|mesh-ancestor
102043923|NCT01331993|Sensory System Agents|sensory system agents|mesh-ancestor
102043924|NCT01331993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102043925|NCT01331993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043926|NCT01331993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102043927|NCT01331993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102043928|NCT01331993|Gout Suppressants|gout suppressants|mesh-ancestor
102043929|NCT01331993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102043930|NCT01331993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102043969|NCT01338311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102043970|NCT01338311|Autonomic Agents|autonomic agents|mesh-ancestor
102043971|NCT01338311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102043972|NCT01338311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102043973|NCT01338311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102043974|NCT01338311|Respiratory System Agents|respiratory system agents|mesh-ancestor
102043975|NCT01338311|Tocolytic Agents|tocolytic agents|mesh-ancestor
102043976|NCT01338311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102043977|NCT01338311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102043978|NCT01338311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102043979|NCT01338311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102043980|NCT01338311|Adrenergic Agents|adrenergic agents|mesh-ancestor
102044032|NCT00383435|Mometasone Furoate|mometasone furoate|mesh-list
102044033|NCT00383435|Formoterol Fumarate|formoterol fumarate|mesh-list
102044034|NCT00383435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102044035|NCT00383435|Autonomic Agents|autonomic agents|mesh-ancestor
102044036|NCT00383435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102044037|NCT00383435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044038|NCT00383435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102044039|NCT00383435|Respiratory System Agents|respiratory system agents|mesh-ancestor
102044098|NCT01332383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044099|NCT01332383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044100|NCT01342237|Carboplatin|carboplatin|mesh-list
102044101|NCT01342237|Etoposide|etoposide|mesh-list
102044102|NCT01342237|Melphalan|melphalan|mesh-list
102044103|NCT01342237|Topotecan|topotecan|mesh-list
102044104|NCT01342237|Thiotepa|thiotepa|mesh-list
102044105|NCT01342237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102044106|NCT01342237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102044107|NCT01342237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102044108|NCT01342237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102044109|NCT01342237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102044110|NCT01342237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044111|NCT01342237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102044112|NCT01342237|Alkylating Agents|alkylating agents|mesh-ancestor
102044113|NCT01342237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102044114|NCT01342237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102044115|NCT01342237|Immunologic Factors|immunologic factors|mesh-ancestor
102044116|NCT01342237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044117|NCT01342237|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102044118|NCT01337323|Fluticasone|fluticasone|mesh-list
102044120|NCT01337323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102044121|NCT01337323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102044122|NCT01337323|Autonomic Agents|autonomic agents|mesh-ancestor
102044123|NCT01337323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102044124|NCT01337323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044148|NCT03067610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102044149|NCT03067610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102044150|NCT03067610|Tubulin Modulators|tubulin modulators|mesh-ancestor
102044151|NCT03067610|Antimitotic Agents|antimitotic agents|mesh-ancestor
102044152|NCT03067610|Mitosis Modulators|mitosis modulators|mesh-ancestor
102044153|NCT03067610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044154|NCT03067610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102044155|NCT00381485|Mometasone Furoate|mometasone furoate|mesh-list
102044156|NCT00381485|Formoterol Fumarate|formoterol fumarate|mesh-list
102044157|NCT00381485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102044158|NCT00381485|Autonomic Agents|autonomic agents|mesh-ancestor
102044159|NCT00381485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102044160|NCT00381485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044208|NCT01342627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044209|NCT03160703|Fluorides|fluorides|mesh-list
102044210|NCT03160703|Tin Fluorides|tin fluorides|mesh-list
102044211|NCT03160703|Fluorophosphate|fluorophosphate|mesh-list
102044212|NCT03160703|Cariostatic Agents|cariostatic agents|mesh-ancestor
102044213|NCT03160703|Protective Agents|protective agents|mesh-ancestor
102044214|NCT03160703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044215|NCT01332617|Zoledronic Acid|zoledronic acid|mesh-list
102044216|NCT01332617|Methylprednisolone|methylprednisolone|mesh-list
102044217|NCT01332617|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102044218|NCT01332617|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102044219|NCT01332617|Prednisolone|prednisolone|mesh-list
102044220|NCT01332617|Prednisolone acetate|prednisolone acetate|mesh-list
102044221|NCT01332617|Diclofenac|diclofenac|mesh-list
102044222|NCT01332617|Bortezomib|bortezomib|mesh-list
102044224|NCT01332617|Simvastatin|simvastatin|mesh-list
102044269|NCT01342939|Incretins|incretins|mesh-list
102044270|NCT01342939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102044271|NCT01342939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044272|NCT01342939|Hormones|hormones|mesh-ancestor
102044273|NCT01342939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102044274|NCT01342939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102044275|NCT01342939|Protease Inhibitors|protease inhibitors|mesh-ancestor
102044276|NCT01342939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102044277|NCT01342939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044278|NCT03569540|Glyburide|glyburide|mesh-list
102044279|NCT03569540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102044280|NCT03569540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044281|NCT05708690|Tranexamic Acid|tranexamic acid|mesh-list
102044282|NCT05708690|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102044283|NCT05708690|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102044284|NCT05708690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044285|NCT05708690|Hemostatics|hemostatics|mesh-ancestor
102044286|NCT05708690|Coagulants|coagulants|mesh-ancestor
102044287|NCT04851821|Quercetin|quercetin|mesh-list
102044288|NCT04851821|Antioxidants|antioxidants|mesh-ancestor
102044289|NCT04851821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044290|NCT04851821|Protective Agents|protective agents|mesh-ancestor
102044291|NCT04851821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044292|NCT03379727|Midostaurin|midostaurin|mesh-list
102044293|NCT03379727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102044294|NCT03379727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102044295|NCT03379727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102044315|NCT02247128|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102044316|NCT02247128|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102044317|NCT02247128|Purinergic Agents|purinergic agents|mesh-ancestor
102044318|NCT02247128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102044319|NCT01339481|Abatacept|abatacept|mesh-list
102044320|NCT01339481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102044321|NCT01339481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044322|NCT01339481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102044323|NCT01339481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102044324|NCT01339481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102044325|NCT01339481|Immunologic Factors|immunologic factors|mesh-ancestor
102044326|NCT01339481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044327|NCT01339481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102044328|NCT01344031|Fulvestrant|fulvestrant|mesh-list
102044329|NCT01344031|Anastrozole|anastrozole|mesh-list
101764069|NCT04005339|Antidotes|antidotes|mesh-ancestor
102044331|NCT01344031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102044370|NCT05708534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102044371|NCT05708534|Immunologic Factors|immunologic factors|mesh-ancestor
102044372|NCT05708534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044373|NCT05708534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102044374|NCT03000374|Leucovorin|leucovorin|mesh-list
102044375|NCT03000374|Fluorouracil|fluorouracil|mesh-list
102044376|NCT03000374|Oxaliplatin|oxaliplatin|mesh-list
102044377|NCT03000374|Panitumumab|panitumumab|mesh-list
102044378|NCT03000374|Antimetabolites|antimetabolites|mesh-ancestor
102044379|NCT03000374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044438|NCT01333085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102044439|NCT01333085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102044440|NCT01333085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102044441|NCT01333085|Immunologic Factors|immunologic factors|mesh-ancestor
102044442|NCT01333085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044443|NCT01344655|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102044444|NCT01344655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102044445|NCT01344655|Autonomic Agents|autonomic agents|mesh-ancestor
102044446|NCT01344655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102044447|NCT01344655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044448|NCT01344655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102044449|NCT01344655|Respiratory System Agents|respiratory system agents|mesh-ancestor
102044450|NCT01344655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102044451|NCT01344655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102044452|NCT01344655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102044453|NCT01344655|Adrenergic Agents|adrenergic agents|mesh-ancestor
102044454|NCT01344655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102044455|NCT01344655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044456|NCT04734535|Thrombin|thrombin|mesh-list
102044457|NCT04734535|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
102044494|NCT03564704|Pegaspargase|pegaspargase|mesh-list
102044495|NCT03564704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102044496|NCT03564704|Immunologic Factors|immunologic factors|mesh-ancestor
102044497|NCT03564704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044498|NCT03564704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102044499|NCT03564704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102044500|NCT03564704|Alkylating Agents|alkylating agents|mesh-ancestor
102044501|NCT03564704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044502|NCT03564704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102044503|NCT03564704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102044559|NCT05352854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044561|NCT01841177|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102044562|NCT01841177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102044563|NCT01841177|Vasodilator Agents|vasodilator agents|mesh-ancestor
102044564|NCT01841177|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102044565|NCT01841177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102044566|NCT01841177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387684|NCT00323011|Bevacizumab|bevacizumab|mesh-list
102044567|NCT01841177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044568|NCT01841177|Protective Agents|protective agents|mesh-ancestor
102044620|NCT02836652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102044621|NCT02836652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102044622|NCT02836652|Antipyretics|antipyretics|mesh-ancestor
102044623|NCT02836652|Anticoagulants|anticoagulants|mesh-ancestor
102044624|NCT02836496|Prednisone|prednisone|mesh-list
102044625|NCT02836496|Prednisolone|prednisolone|mesh-list
102044626|NCT02836496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102044627|NCT02836496|Glucocorticoids|glucocorticoids|mesh-ancestor
102044628|NCT02836496|Hormones|hormones|mesh-ancestor
101764357|NCT04444804|Phenprocoumon|phenprocoumon|mesh-list
102044629|NCT02836496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102044630|NCT02836496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044631|NCT02836496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102044632|NCT02836496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102044633|NCT01344967|Zoledronic Acid|zoledronic acid|mesh-list
102044634|NCT01344967|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102044635|NCT01344967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044636|NCT05250661|Propolis|propolis|mesh-list
102044637|NCT05250661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102044638|NCT04044781|BPN14770|bpn14770|mesh-list
102044639|NCT04044781|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102044643|NCT01345279|Paclitaxel|paclitaxel|mesh-list
102044674|NCT01333631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102044675|NCT01333631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044676|NCT01333631|Antimanic Agents|antimanic agents|mesh-ancestor
102044677|NCT01333631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102044678|NCT01333631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102044679|NCT01333631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102044680|NCT04611763|Flurbiprofen|flurbiprofen|mesh-list
102044681|NCT04611763|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
102044682|NCT04611763|Analgesics|analgesics|mesh-ancestor
102044683|NCT04611763|Sensory System Agents|sensory system agents|mesh-ancestor
102044684|NCT04611763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102044685|NCT04611763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044686|NCT04611763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102044687|NCT04611763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102044688|NCT04611763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102044689|NCT04611763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102044690|NCT04611763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102044691|NCT04611763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102044692|NCT04611763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044693|NCT01341782|Ergocalciferols|ergocalciferols|mesh-list
102044694|NCT01341782|Calcitriol|calcitriol|mesh-list
102044695|NCT01341782|Maxacalcitol|maxacalcitol|mesh-list
102044696|NCT01341782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102044697|NCT01341782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044698|NCT01341782|Vitamins|vitamins|mesh-ancestor
102044699|NCT01341782|Micronutrients|micronutrients|mesh-ancestor
102044700|NCT01341782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102044701|NCT01341782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102044721|NCT03564158|Vaborbactam|vaborbactam|mesh-list
102044722|NCT03564158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102044723|NCT03564158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102044724|NCT03564158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102044725|NCT03564158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102044726|NCT03564158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102044727|NCT03564158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044728|NCT03564158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102044729|NCT03564158|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102044730|NCT02677298|Botulinum Toxins|botulinum toxins|mesh-list
102044731|NCT02677298|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102044732|NCT02677298|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102044733|NCT02677298|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102044734|NCT02677298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102044736|NCT02677298|Cholinergic Agents|cholinergic agents|mesh-ancestor
102044778|NCT01346137|Sensory System Agents|sensory system agents|mesh-ancestor
102044779|NCT01346137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102044780|NCT01346137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102044781|NCT01346137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102044782|NCT01346137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102044783|NCT01346137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102044784|NCT01346137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102044785|NCT01346137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102044786|NCT01346137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044787|NCT00521599|Mometasone Furoate|mometasone furoate|mesh-list
102044788|NCT00521599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102044789|NCT00521599|Dermatologic Agents|dermatologic agents|mesh-ancestor
102044790|NCT00521599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102044791|NCT00442897|Atorvastatin|atorvastatin|mesh-list
102044792|NCT00442897|Simvastatin|simvastatin|mesh-list
102044793|NCT00442897|Ezetimibe|ezetimibe|mesh-list
102044794|NCT00442897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102044795|NCT00442897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102044796|NCT00442897|Antimetabolites|antimetabolites|mesh-ancestor
102044797|NCT00442897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044798|NCT00442897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102044799|NCT00442897|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102044800|NCT00442897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102044801|NCT01346215|Heparin|heparin|mesh-list
102044802|NCT01346215|Calcium heparin|calcium heparin|mesh-list
102044803|NCT01346215|Anticoagulants|anticoagulants|mesh-ancestor
102044804|NCT01346215|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102044805|NCT01346215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102044806|NCT01346215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044807|NCT02834390|Cytarabine|cytarabine|mesh-list
102044821|NCT02834390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102044822|NCT02834390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102044823|NCT01317433|Doxycycline|doxycycline|mesh-list
102044824|NCT01317433|Cetuximab|cetuximab|mesh-list
102044825|NCT01317433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102044826|NCT01317433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102044827|NCT01317433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102044828|NCT01317433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102044829|NCT01317433|Antimalarials|antimalarials|mesh-ancestor
102044830|NCT01317433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102044831|NCT01317433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102044832|NCT01317511|Caseins|caseins|mesh-list
102044833|NCT01317511|Chelating Agents|chelating agents|mesh-ancestor
102044834|NCT01317511|Sequestering Agents|sequestering agents|mesh-ancestor
102044835|NCT01317511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044836|NCT01356602|Triamcinolone|triamcinolone|mesh-list
102044837|NCT01356602|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102044838|NCT01356602|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102044879|NCT01348009|Antimetabolites|antimetabolites|mesh-ancestor
102044880|NCT01348009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044881|NCT01343173|Imatinib Mesylate|imatinib mesylate|mesh-list
102044882|NCT01343173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102044883|NCT01343173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102044884|NCT01343173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102044885|NCT01343173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044886|NCT01348243|Clodronic Acid|clodronic acid|mesh-list
102044888|NCT01348243|Anesthetics, Local|anesthetics, local|mesh-ancestor
102044889|NCT01348243|Anesthetics|anesthetics|mesh-ancestor
102044890|NCT01348243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102044892|NCT01348243|Sensory System Agents|sensory system agents|mesh-ancestor
102044942|NCT01317589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102044943|NCT01317589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102044944|NCT01317589|Anesthetics, General|anesthetics, general|mesh-ancestor
102044945|NCT01317589|Anesthetics|anesthetics|mesh-ancestor
102044946|NCT01317589|Antitussive Agents|antitussive agents|mesh-ancestor
102044947|NCT01317589|Respiratory System Agents|respiratory system agents|mesh-ancestor
102044948|NCT02825420|Trabectedin|trabectedin|mesh-list
102044949|NCT02825420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102044950|NCT02825420|Alkylating Agents|alkylating agents|mesh-ancestor
102044951|NCT02825420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102044952|NCT02825420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102044953|NCT02829944|Ketorolac|ketorolac|mesh-list
102044954|NCT02829944|Ropivacaine|ropivacaine|mesh-list
102044955|NCT02829944|Anesthetics, Local|anesthetics, local|mesh-ancestor
102044956|NCT02829944|Anesthetics|anesthetics|mesh-ancestor
102044957|NCT02829944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102045000|NCT03563144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102045001|NCT03563144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102045002|NCT03563144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102045003|NCT03563144|Growth Substances|growth substances|mesh-ancestor
102045004|NCT03563144|Growth Inhibitors|growth inhibitors|mesh-ancestor
102045005|NCT03563144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102045006|NCT03563144|Antimetabolites|antimetabolites|mesh-ancestor
102045007|NCT03563144|Antidotes|antidotes|mesh-ancestor
102045008|NCT03563144|Protective Agents|protective agents|mesh-ancestor
102045009|NCT03563144|Vitamin B Complex|vitamin b complex|mesh-ancestor
102045010|NCT03563144|Vitamins|vitamins|mesh-ancestor
102045011|NCT03563144|Micronutrients|micronutrients|mesh-ancestor
102045012|NCT01338818|Methylphenidate|methylphenidate|mesh-list
102045013|NCT01338818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102045014|NCT01338818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045015|NCT01338818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102045016|NCT01338818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102045017|NCT01338818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102045019|NCT01338818|Dopamine Agents|dopamine agents|mesh-ancestor
102045055|NCT02259920|p-Hydroxyamphetamine|p-hydroxyamphetamine|mesh-list
102045056|NCT02259920|Mydriatics|mydriatics|mesh-ancestor
102045057|NCT02259920|Autonomic Agents|autonomic agents|mesh-ancestor
102045058|NCT02259920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102045059|NCT02259920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045060|NCT02259920|Sympathomimetics|sympathomimetics|mesh-ancestor
102045061|NCT01371656|Levofloxacin|levofloxacin|mesh-list
102045062|NCT01371656|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102045063|NCT01371656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102045064|NCT01371656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102045065|NCT01371656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102045066|NCT01371656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102045067|NCT01371656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102045068|NCT01371656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045069|NCT01371656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102045070|NCT01371656|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102045072|NCT04541888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102045112|NCT02035982|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102045113|NCT02035982|Autonomic Agents|autonomic agents|mesh-ancestor
102045114|NCT02035982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102045115|NCT02035982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102045116|NCT02035982|Protective Agents|protective agents|mesh-ancestor
102045117|NCT05707832|Amphotericin B|amphotericin b|mesh-list
102045118|NCT05707832|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102045119|NCT05707832|Cholesteryl sulfate|cholesteryl sulfate|mesh-list
102045120|NCT05707832|Amebicides|amebicides|mesh-ancestor
102045121|NCT05707832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102045122|NCT05707832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102045123|NCT05707832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102045124|NCT05707832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102045176|NCT04412785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102045177|NCT04412785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102045179|NCT01352611|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102045180|NCT01352611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045181|NCT01352611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102045182|NCT01352611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102045183|NCT01352611|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102045184|NCT01352611|GABA Agonists|gaba agonists|mesh-ancestor
102045185|NCT01352611|GABA Agents|gaba agents|mesh-ancestor
102045186|NCT01352611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102045187|NCT01352611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045188|NCT02819804|Nivolumab|nivolumab|mesh-list
102045189|NCT02819804|Dasatinib|dasatinib|mesh-list
102045190|NCT02819804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102045236|NCT02036528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045237|NCT02036528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102045238|NCT02036528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102045239|NCT02036528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102045240|NCT02036528|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102045241|NCT02880865|Vaccines|vaccines|mesh-list
102045242|NCT02880865|Immunologic Factors|immunologic factors|mesh-ancestor
102045243|NCT02880865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045244|NCT03635125|Metoprolol|metoprolol|mesh-list
102045245|NCT03635125|Nebivolol|nebivolol|mesh-list
102045246|NCT03635125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102045247|NCT03635125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102045248|NCT03635125|Sympatholytics|sympatholytics|mesh-ancestor
102045249|NCT03635125|Autonomic Agents|autonomic agents|mesh-ancestor
102045250|NCT03635125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102045251|NCT03635125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045252|NCT03635125|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102045254|NCT03635125|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102045291|NCT01318681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045292|NCT03604159|Buprenorphine|buprenorphine|mesh-list
102045293|NCT03604159|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102045294|NCT03604159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102045295|NCT03604159|Narcotics|narcotics|mesh-ancestor
102045296|NCT03604159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102045297|NCT03604159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045298|NCT03604159|Analgesics|analgesics|mesh-ancestor
102045299|NCT03604159|Sensory System Agents|sensory system agents|mesh-ancestor
102045300|NCT03604159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102045353|NCT02048384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102045354|NCT02048384|Immunologic Factors|immunologic factors|mesh-ancestor
102045355|NCT01353391|Metformin|metformin|mesh-list
102045356|NCT01353391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102045357|NCT01353391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045358|NCT01349335|Tolvaptan|tolvaptan|mesh-list
102045359|NCT01349335|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
102045360|NCT01349335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045361|NCT01349335|Natriuretic Agents|natriuretic agents|mesh-ancestor
102045362|NCT01349335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045363|NCT03009487|Amlodipine|amlodipine|mesh-list
102045364|NCT03009487|Olmesartan|olmesartan|mesh-list
102045365|NCT03009487|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
102045367|NCT03009487|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102045413|NCT02050178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045414|NCT02050178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102045415|NCT02050178|Antimetabolites|antimetabolites|mesh-ancestor
102045416|NCT02048852|Menthol|menthol|mesh-list
102045417|NCT02048852|Nicotine|nicotine|mesh-list
102045418|NCT02048852|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102045419|NCT02048852|Autonomic Agents|autonomic agents|mesh-ancestor
102045420|NCT02048852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102045421|NCT02048852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045422|NCT02048852|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102045423|NCT02048852|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102045424|NCT02048852|Cholinergic Agents|cholinergic agents|mesh-ancestor
102045425|NCT02048852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102045426|NCT02048852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045427|NCT02048852|Antipruritics|antipruritics|mesh-ancestor
102045428|NCT02048852|Dermatologic Agents|dermatologic agents|mesh-ancestor
102045429|NCT02048930|Budesonide|budesonide|mesh-list
102045430|NCT02048930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102045431|NCT02048930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102045432|NCT02048930|Autonomic Agents|autonomic agents|mesh-ancestor
102045433|NCT02048930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102045434|NCT02048930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045435|NCT02048930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102045436|NCT02048930|Respiratory System Agents|respiratory system agents|mesh-ancestor
102045462|NCT02050802|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
102045463|NCT02051738|Mebendazole|mebendazole|mesh-list
102045464|NCT02051738|Piperazine|piperazine|mesh-list
102045465|NCT02051738|Piperazine citrate|piperazine citrate|mesh-list
102045466|NCT02051738|DMP 777|dmp 777|mesh-list
102045467|NCT02051738|Antinematodal Agents|antinematodal agents|mesh-ancestor
102045468|NCT02051738|Anthelmintics|anthelmintics|mesh-ancestor
102045469|NCT02051738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102045470|NCT02051738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102045471|NCT02051738|Tubulin Modulators|tubulin modulators|mesh-ancestor
102045472|NCT02051738|Antimitotic Agents|antimitotic agents|mesh-ancestor
102045473|NCT02051738|Mitosis Modulators|mitosis modulators|mesh-ancestor
102045474|NCT02051738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045475|NCT02051738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102045476|NCT02051738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102045477|NCT02050958|Ibuprofen|ibuprofen|mesh-list
102045478|NCT02050958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102045479|NCT02050958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102045480|NCT02050958|Analgesics|analgesics|mesh-ancestor
102045481|NCT02050958|Sensory System Agents|sensory system agents|mesh-ancestor
102045482|NCT02050958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102045483|NCT02050958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045484|NCT02050958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102045515|NCT01357681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045516|NCT01357681|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
102045517|NCT01357681|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102045518|NCT01357681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102045519|NCT01357681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102045520|NCT01543633|Propofol|propofol|mesh-list
102045521|NCT01543633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102045522|NCT01543633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102045523|NCT01543633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765256|NCT01050985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102045525|NCT01543633|Anesthetics, General|anesthetics, general|mesh-ancestor
102045526|NCT01543633|Anesthetics|anesthetics|mesh-ancestor
102045527|NCT03561740|Capecitabine|capecitabine|mesh-list
102045528|NCT03561740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102045529|NCT03561740|Antimetabolites|antimetabolites|mesh-ancestor
102045530|NCT03561740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045532|NCT01357759|Gimsilumab|gimsilumab|mesh-list
102045574|NCT02053766|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102045575|NCT02053766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102045576|NCT02053766|Adrenergic Agents|adrenergic agents|mesh-ancestor
102045577|NCT02053766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102045578|NCT02053766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045579|NCT02053766|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102045580|NCT02053766|Anesthetics, General|anesthetics, general|mesh-ancestor
102045581|NCT02053766|Anesthetics|anesthetics|mesh-ancestor
102045582|NCT02053766|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102045583|NCT02053766|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102045584|NCT02053922|Misoprostol|misoprostol|mesh-list
102045586|NCT02053922|Carbetocin|carbetocin|mesh-list
102045587|NCT02053922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102045588|NCT02053922|Abortifacient Agents|abortifacient agents|mesh-ancestor
102045589|NCT02053922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102045590|NCT02053922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045591|NCT02053922|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102045633|NCT01336439|Botulinum Toxins|botulinum toxins|mesh-list
102045634|NCT01336439|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102045635|NCT01336439|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102045636|NCT01336439|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102045637|NCT01336439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102045638|NCT01336439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045639|NCT01336439|Cholinergic Agents|cholinergic agents|mesh-ancestor
102045640|NCT01336439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102045641|NCT01336439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045642|NCT01336439|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102045643|NCT01336439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102045644|NCT01336595|Cobalt|cobalt|mesh-list
102045696|NCT01315691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102045697|NCT01315691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102045698|NCT05654090|Sulbactam|sulbactam|mesh-list
102045699|NCT05654090|Cefoperazone|cefoperazone|mesh-list
102045700|NCT05654090|Sulperazone|sulperazone|mesh-list
102045701|NCT05654090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102045702|NCT05654090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102045703|NCT05654090|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102045704|NCT05654090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102045705|NCT05654090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045706|NCT05654090|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102045707|NCT02054468|Remifentanil|remifentanil|mesh-list
102045759|NCT01336985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045760|NCT01336985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102045761|NCT01337375|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102045762|NCT01337375|Interferon-alpha|interferon-alpha|mesh-list
102045763|NCT01337375|Antiviral Agents|antiviral agents|mesh-ancestor
102045764|NCT01337375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102045765|NCT01337375|Immunologic Factors|immunologic factors|mesh-ancestor
102045766|NCT01337375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045767|NCT03635411|Niacinamide|niacinamide|mesh-list
102045769|NCT03635411|Nicotinic Acids|nicotinic acids|mesh-list
102045770|NCT03635411|Vitamin B Complex|vitamin b complex|mesh-ancestor
102045771|NCT03635411|Vitamins|vitamins|mesh-ancestor
102045772|NCT03635411|Micronutrients|micronutrients|mesh-ancestor
102045773|NCT03635411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045774|NCT03635411|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102045775|NCT03635411|Antimetabolites|antimetabolites|mesh-ancestor
102045782|NCT02748512|Hormones|hormones|mesh-ancestor
102045819|NCT01353937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045820|NCT04705883|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
102045821|NCT04705883|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102045822|NCT04705883|Immunologic Factors|immunologic factors|mesh-ancestor
102045823|NCT04705883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045824|NCT02053298|Timolol|timolol|mesh-list
102045825|NCT02053298|Dorzolamide|dorzolamide|mesh-list
102045826|NCT02053298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102045827|NCT02053298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102045828|NCT02053298|Adrenergic Agents|adrenergic agents|mesh-ancestor
102045829|NCT02053298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102045830|NCT02053298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102045831|NCT02053298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045832|NCT02053298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102045833|NCT02053298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102045834|NCT02053298|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102045835|NCT02053298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102045836|NCT02054936|Warfarin|warfarin|mesh-list
102045837|NCT02054936|Rivaroxaban|rivaroxaban|mesh-list
102045838|NCT02054936|Anticoagulants|anticoagulants|mesh-ancestor
102045845|NCT04782791|Nivolumab|nivolumab|mesh-list
102045872|NCT02056184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102045874|NCT02800928|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102045875|NCT02800928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045876|NCT02800928|Sensory System Agents|sensory system agents|mesh-ancestor
102045877|NCT02800928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102045878|NCT02056418|Prednisone|prednisone|mesh-list
102045879|NCT02056418|Hydrocortisone|hydrocortisone|mesh-list
102045880|NCT02056418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102045881|NCT02056418|Glucocorticoids|glucocorticoids|mesh-ancestor
102045882|NCT02056418|Hormones|hormones|mesh-ancestor
102045883|NCT02056418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102045884|NCT02056418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045885|NCT02056418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102045886|NCT02056418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102045887|NCT02055014|Liraglutide|liraglutide|mesh-list
102045888|NCT02055014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102045889|NCT02055014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045929|NCT02059616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102045930|NCT02059616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045931|NCT02059616|Vasodilator Agents|vasodilator agents|mesh-ancestor
102045932|NCT02059616|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102045933|NCT02059616|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102045935|NCT02059694|Epinephrine|epinephrine|mesh-list
102045936|NCT02059694|Racepinephrine|racepinephrine|mesh-list
102045937|NCT02059694|Epinephryl borate|epinephryl borate|mesh-list
102045938|NCT02059694|Anesthetics, Local|anesthetics, local|mesh-ancestor
102045939|NCT02059694|Anesthetics|anesthetics|mesh-ancestor
102045992|NCT02059772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102045993|NCT02059772|Growth Inhibitors|growth inhibitors|mesh-ancestor
102045994|NCT02059772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102045995|NCT01344083|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
102045996|NCT01344083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102045997|NCT01344083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102045998|NCT01344083|Analgesics|analgesics|mesh-ancestor
102045999|NCT01344083|Sensory System Agents|sensory system agents|mesh-ancestor
102046000|NCT01344083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102046001|NCT01344083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046002|NCT01344083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102046003|NCT01344083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102046004|NCT01344083|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102046005|NCT01344083|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102046006|NCT01344083|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102046021|NCT00982111|Pemetrexed|pemetrexed|mesh-list
102046047|NCT02060318|Dermatologic Agents|dermatologic agents|mesh-ancestor
102046048|NCT02060318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102046049|NCT02060318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102046050|NCT01318837|Solifenacin Succinate|solifenacin succinate|mesh-list
102046051|NCT01318837|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102046052|NCT01318837|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102046053|NCT01318837|Cholinergic Agents|cholinergic agents|mesh-ancestor
102046054|NCT01318837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102046055|NCT01318837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046056|NCT01318837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046057|NCT01318837|Urological Agents|urological agents|mesh-ancestor
102046058|NCT01350037|Remifentanil|remifentanil|mesh-list
102046059|NCT01350037|Alfentanil|alfentanil|mesh-list
102046060|NCT01350037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102046061|NCT01350037|Narcotics|narcotics|mesh-ancestor
102046107|NCT02060396|Analgesics|analgesics|mesh-ancestor
102046108|NCT02060396|Sensory System Agents|sensory system agents|mesh-ancestor
102046109|NCT02060396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102046110|NCT02060396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046111|NCT02060396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102046112|NCT02060396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102046113|NCT02060396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102046114|NCT02060396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102046115|NCT02060396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046116|NCT02060396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102046128|NCT02058212|Vitamin E|vitamin e|mesh-list
102046172|NCT02060552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102046173|NCT05384574|Cholecalciferol|cholecalciferol|mesh-list
102046174|NCT05384574|Vitamin D|vitamin d|mesh-list
102046175|NCT05384574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102046176|NCT05384574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046177|NCT05384574|Vitamins|vitamins|mesh-ancestor
102046178|NCT05384574|Micronutrients|micronutrients|mesh-ancestor
102046179|NCT05384574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102046180|NCT04355585|Colchicine|colchicine|mesh-list
102046181|NCT04355585|Gout Suppressants|gout suppressants|mesh-ancestor
102046182|NCT04355585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102046183|NCT04355585|Tubulin Modulators|tubulin modulators|mesh-ancestor
102046184|NCT04355585|Antimitotic Agents|antimitotic agents|mesh-ancestor
102046185|NCT04355585|Mitosis Modulators|mitosis modulators|mesh-ancestor
102046186|NCT04355585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046187|NCT04355585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102046188|NCT02031744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102046189|NCT02031744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102046190|NCT02031744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102046191|NCT02031744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102046228|NCT01342289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046229|NCT01342289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102046230|NCT01342289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102046231|NCT01342289|Alkylating Agents|alkylating agents|mesh-ancestor
102046232|NCT01342289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046233|NCT01342289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102046234|NCT01342289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102046235|NCT01342289|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102046236|NCT01342289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102046237|NCT01342289|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102046292|NCT03618264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102046294|NCT03617016|Domperidone|domperidone|mesh-list
102046295|NCT03617016|Antiemetics|antiemetics|mesh-ancestor
102046296|NCT03617016|Autonomic Agents|autonomic agents|mesh-ancestor
102046297|NCT03617016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102046298|NCT03617016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046299|NCT03617016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102046300|NCT03617016|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102046301|NCT03617016|Dopamine Agents|dopamine agents|mesh-ancestor
102046302|NCT03617016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102046303|NCT03617016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046304|NCT02060786|Clopidogrel|clopidogrel|mesh-list
102046353|NCT01342679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046355|NCT01342835|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102046356|NCT01342835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102046357|NCT01342835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046358|NCT01342835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102046359|NCT01342835|Anesthetics, General|anesthetics, general|mesh-ancestor
102046360|NCT01342835|Anesthetics|anesthetics|mesh-ancestor
102046361|NCT01344863|Trastuzumab|trastuzumab|mesh-list
102046362|NCT01344863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102046363|NCT01344863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102046364|NCT03139279|Dexmedetomidine|dexmedetomidine|mesh-list
102046365|NCT03139279|Propofol|propofol|mesh-list
102046416|NCT03138967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102046417|NCT03138967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102046418|NCT03138967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102046419|NCT01547117|Carbon Monoxide|carbon monoxide|mesh-list
102046420|NCT01547117|Antimetabolites|antimetabolites|mesh-ancestor
102046421|NCT01547117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046422|NCT01547117|Gasotransmitters|gasotransmitters|mesh-ancestor
102046423|NCT01547117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102046424|NCT01547117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046425|NCT01358383|Naproxen|naproxen|mesh-list
102046426|NCT01358383|Esomeprazole|esomeprazole|mesh-list
102046427|NCT01358383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102046428|NCT01358383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102046430|NCT01358383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102046478|NCT03793400|Growth Inhibitors|growth inhibitors|mesh-ancestor
102046479|NCT01318369|Diazepam|diazepam|mesh-list
102046480|NCT01318369|Dronabinol|dronabinol|mesh-list
102046481|NCT01318369|Hallucinogens|hallucinogens|mesh-ancestor
102046482|NCT01318369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046483|NCT01318369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102046484|NCT01318369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102046485|NCT01318369|Analgesics|analgesics|mesh-ancestor
102046486|NCT01318369|Sensory System Agents|sensory system agents|mesh-ancestor
102046487|NCT01318369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102046488|NCT01318369|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102046489|NCT01318369|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102046490|NCT01318369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102046491|NCT01318369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046492|NCT01318369|Hormones|hormones|mesh-ancestor
102046540|NCT02063360|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102046541|NCT02063360|Protease Inhibitors|protease inhibitors|mesh-ancestor
102046542|NCT02063360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102046543|NCT02063360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046544|NCT02063360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102046545|NCT02063360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102046546|NCT02063360|Antiviral Agents|antiviral agents|mesh-ancestor
102046547|NCT02063360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102046548|NCT02063360|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102046549|NCT02063360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102046550|NCT02063360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102046551|NCT02063360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102046552|NCT02063360|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102046553|NCT02063360|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102046554|NCT03614832|Clopidogrel|clopidogrel|mesh-list
102046597|NCT02061800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102046598|NCT02061800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102046599|NCT02061800|Glucocorticoids|glucocorticoids|mesh-ancestor
102046600|NCT02061800|Hormones|hormones|mesh-ancestor
102046601|NCT02061800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102046602|NCT02061800|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102046603|NCT02061800|Protective Agents|protective agents|mesh-ancestor
102046604|NCT02061800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102046605|NCT02061800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102046606|NCT01350817|Docetaxel|docetaxel|mesh-list
102046607|NCT01350817|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102046608|NCT01350817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102046609|NCT01350817|Tubulin Modulators|tubulin modulators|mesh-ancestor
102046610|NCT01350817|Antimitotic Agents|antimitotic agents|mesh-ancestor
102046611|NCT01350817|Mitosis Modulators|mitosis modulators|mesh-ancestor
102046612|NCT01350817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046613|NCT01350817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102046614|NCT01350817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102046616|NCT01986075|Adderall|adderall|mesh-list
102046652|NCT02797808|Antidepressive Agents|antidepressive agents|mesh-ancestor
102046653|NCT02797808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102046654|NCT02797808|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102046655|NCT02797808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102046656|NCT02797808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102046657|NCT02797808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046658|NCT02797808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102046659|NCT02797808|Serotonin Agents|serotonin agents|mesh-ancestor
102046660|NCT02797808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046661|NCT02796560|Travoprost|travoprost|mesh-list
102046719|NCT03789968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102046720|NCT03789968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102046721|NCT03789968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102046722|NCT03789968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102046723|NCT03789968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046724|NCT03789968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102046725|NCT03789968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102046726|NCT05089643|Capecitabine|capecitabine|mesh-list
102046727|NCT05089643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101766467|NCT05750966|Ciprofloxacin|ciprofloxacin|mesh-list
102046728|NCT05089643|Antimetabolites|antimetabolites|mesh-ancestor
102046729|NCT05089643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046731|NCT02871492|Acyclovir|acyclovir|mesh-list
102046778|NCT01370408|Ondansetron|ondansetron|mesh-list
102046779|NCT01370408|Palonosetron|palonosetron|mesh-list
102046780|NCT01370408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102046781|NCT01370408|Antiemetics|antiemetics|mesh-ancestor
102046782|NCT01370408|Autonomic Agents|autonomic agents|mesh-ancestor
102046783|NCT01370408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102046784|NCT01370408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046785|NCT01370408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102046786|NCT01370408|Glucocorticoids|glucocorticoids|mesh-ancestor
102046787|NCT01370408|Hormones|hormones|mesh-ancestor
102046788|NCT01370408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102046789|NCT01370408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102046790|NCT01370408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102046839|NCT02065466|Alkylating Agents|alkylating agents|mesh-ancestor
102046840|NCT03446040|Nivolumab|nivolumab|mesh-list
102046841|NCT03446040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102046842|NCT03446040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102046843|NCT03446040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102046844|NCT03446040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046845|NCT05208801|Morphine|morphine|mesh-list
102046846|NCT05208801|Bupivacaine|bupivacaine|mesh-list
102046847|NCT05208801|Anesthetics, Local|anesthetics, local|mesh-ancestor
102046848|NCT05208801|Anesthetics|anesthetics|mesh-ancestor
102046849|NCT05208801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102046850|NCT05208801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046851|NCT05208801|Sensory System Agents|sensory system agents|mesh-ancestor
102046852|NCT05208801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102046853|NCT05208801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102046854|NCT05208801|Narcotics|narcotics|mesh-ancestor
102046855|NCT05208801|Analgesics|analgesics|mesh-ancestor
102046856|NCT02064140|Rocuronium|rocuronium|mesh-list
102046857|NCT02064140|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102046895|NCT01343381|Heparin|heparin|mesh-list
102046896|NCT01343381|Calcium heparin|calcium heparin|mesh-list
102046897|NCT01343381|Anticoagulants|anticoagulants|mesh-ancestor
102046898|NCT01343381|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102046899|NCT01343381|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102046900|NCT01343381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046901|NCT03620149|Denosumab|denosumab|mesh-list
102046902|NCT03620149|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102046903|NCT03620149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046904|NCT02064374|Metformin|metformin|mesh-list
102046905|NCT02064374|Dolutegravir|dolutegravir|mesh-list
102046906|NCT02064374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102046907|NCT02064374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046908|NCT02064374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102046909|NCT02064374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102046910|NCT02064374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102046911|NCT02064374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046912|NCT02064374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102046913|NCT02064374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102046914|NCT02064374|Antiviral Agents|antiviral agents|mesh-ancestor
102046951|NCT04519437|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
102046952|NCT04519437|Antiviral Agents|antiviral agents|mesh-ancestor
101766684|NCT05288283|Cannabidiol|cannabidiol|mesh-list
102046953|NCT04519437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102046954|NCT01359085|Pregabalin|pregabalin|mesh-list
102046955|NCT01359085|Analgesics|analgesics|mesh-ancestor
102046956|NCT01359085|Sensory System Agents|sensory system agents|mesh-ancestor
102046957|NCT01359085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102046958|NCT01359085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102046959|NCT01359085|Anticonvulsants|anticonvulsants|mesh-ancestor
102046960|NCT01359085|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102046961|NCT01359085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102046962|NCT01359085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102046963|NCT01359085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102046964|NCT01359085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102047008|NCT03560024|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
102047009|NCT03560024|Growth Substances|growth substances|mesh-ancestor
102047010|NCT03560024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047011|NCT03560024|Vasodilator Agents|vasodilator agents|mesh-ancestor
102047012|NCT03560024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102047013|NCT03560024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047015|NCT05095857|Esketamine|esketamine|mesh-list
102047016|NCT05095857|Analgesics|analgesics|mesh-ancestor
102047017|NCT05095857|Sensory System Agents|sensory system agents|mesh-ancestor
102047018|NCT05095857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102047019|NCT05095857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047020|NCT05095857|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102047021|NCT05095857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102047022|NCT05095857|Anesthetics, General|anesthetics, general|mesh-ancestor
102047023|NCT05095857|Anesthetics|anesthetics|mesh-ancestor
102047024|NCT05095857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102047025|NCT05095857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102047063|NCT03730337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102047064|NCT03730337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102047065|NCT03730337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047066|NCT01351597|Docetaxel|docetaxel|mesh-list
102047067|NCT01351597|Oxaliplatin|oxaliplatin|mesh-list
102047068|NCT01351597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102047069|NCT01351597|Tubulin Modulators|tubulin modulators|mesh-ancestor
102047070|NCT01351597|Antimitotic Agents|antimitotic agents|mesh-ancestor
102047071|NCT01351597|Mitosis Modulators|mitosis modulators|mesh-ancestor
102047072|NCT01351597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047073|NCT02793128|Mitomycins|mitomycins|mesh-list
102047074|NCT02793128|Mitomycin|mitomycin|mesh-list
102047075|NCT02793128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102047076|NCT02793128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102047077|NCT02793128|Alkylating Agents|alkylating agents|mesh-ancestor
102047078|NCT02793128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047079|NCT02793128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102047080|NCT02793128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102047081|NCT03612180|Metoprolol|metoprolol|mesh-list
102047082|NCT03612180|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102047083|NCT03612180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102047084|NCT03612180|Sympatholytics|sympatholytics|mesh-ancestor
102047085|NCT03612180|Autonomic Agents|autonomic agents|mesh-ancestor
102047086|NCT03612180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102047114|NCT04065789|Antiemetics|antiemetics|mesh-ancestor
102047115|NCT04065789|Autonomic Agents|autonomic agents|mesh-ancestor
102047116|NCT04065789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102047117|NCT04065789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047118|NCT04065789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102047119|NCT04065789|Glucocorticoids|glucocorticoids|mesh-ancestor
102047120|NCT04065789|Hormones|hormones|mesh-ancestor
102047121|NCT04065789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102047122|NCT04065789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102047123|NCT04065789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102047124|NCT04065789|Immunologic Factors|immunologic factors|mesh-ancestor
102047125|NCT04065789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102047126|NCT04065789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102047127|NCT04065789|Growth Substances|growth substances|mesh-ancestor
102047128|NCT04065789|Growth Inhibitors|growth inhibitors|mesh-ancestor
102047129|NCT02066558|Carbon Monoxide|carbon monoxide|mesh-list
102047130|NCT02066558|Antimetabolites|antimetabolites|mesh-ancestor
102047131|NCT02066558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047132|NCT02066558|Gasotransmitters|gasotransmitters|mesh-ancestor
102047133|NCT02066558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102047134|NCT02066558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047135|NCT02064842|Ritonavir|ritonavir|mesh-list
102047136|NCT02064842|Simeprevir|simeprevir|mesh-list
102047137|NCT02064842|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102047165|NCT01359397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102047166|NCT01359397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102047167|NCT01359397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102047168|NCT01359397|Growth Substances|growth substances|mesh-ancestor
102047169|NCT01359397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047170|NCT01359397|Growth Inhibitors|growth inhibitors|mesh-ancestor
102047171|NCT01359397|Tubulin Modulators|tubulin modulators|mesh-ancestor
102047172|NCT01359397|Antimitotic Agents|antimitotic agents|mesh-ancestor
102047173|NCT01359397|Mitosis Modulators|mitosis modulators|mesh-ancestor
102047174|NCT01359397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047175|NCT01359397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102047176|NCT01359397|Antimetabolites|antimetabolites|mesh-ancestor
102047178|NCT05250245|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102047179|NCT05250245|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102047224|NCT02424019|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
102047225|NCT02424019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102047226|NCT02424019|Glucocorticoids|glucocorticoids|mesh-ancestor
102047227|NCT02424019|Hormones|hormones|mesh-ancestor
102047228|NCT02424019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102047229|NCT02424019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047230|NCT02066870|Arsenic Trioxide|arsenic trioxide|mesh-list
102047231|NCT02066870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102047232|NCT03611244|Benzocaine|benzocaine|mesh-list
102047233|NCT03611244|Anesthetics, Local|anesthetics, local|mesh-ancestor
102047234|NCT03611244|Anesthetics|anesthetics|mesh-ancestor
102047235|NCT03611244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102047236|NCT03611244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047237|NCT03611244|Sensory System Agents|sensory system agents|mesh-ancestor
102047238|NCT03611244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102047239|NCT01359709|Nicotine|nicotine|mesh-list
102047240|NCT01359709|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102047241|NCT01359709|Autonomic Agents|autonomic agents|mesh-ancestor
102047242|NCT01359709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102047243|NCT01359709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047244|NCT01359709|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102047245|NCT01359709|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102047246|NCT01359709|Cholinergic Agents|cholinergic agents|mesh-ancestor
102047247|NCT01359709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102047248|NCT01359709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047249|NCT02826486|Leucovorin|leucovorin|mesh-list
102047250|NCT02826486|Pembrolizumab|pembrolizumab|mesh-list
102047251|NCT02826486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102047252|NCT02826486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102047253|NCT02826486|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102047255|NCT02826486|Antidotes|antidotes|mesh-ancestor
102047267|NCT02825940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102047268|NCT02825940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102047270|NCT02304991|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102047271|NCT02304991|Protective Agents|protective agents|mesh-ancestor
102047272|NCT02304991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047273|NCT02069132|Warfarin|warfarin|mesh-list
102047274|NCT02069132|Anticoagulants|anticoagulants|mesh-ancestor
102047275|NCT01352065|Bosentan|bosentan|mesh-list
102047276|NCT01352065|Ambrisentan|ambrisentan|mesh-list
102047277|NCT01352065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102047278|NCT01352065|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102047279|NCT01352065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047280|NCT01356043|Niacin|niacin|mesh-list
102047281|NCT01356043|Amlodipine|amlodipine|mesh-list
102047282|NCT01356043|Telmisartan|telmisartan|mesh-list
102047283|NCT01356043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102047284|NCT01356043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102047285|NCT01356043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102047286|NCT01356043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047287|NCT01356043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102047288|NCT01356043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047289|NCT01356043|Vasodilator Agents|vasodilator agents|mesh-ancestor
102047290|NCT01356043|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102047291|NCT01356043|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102047292|NCT01356043|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102047293|NCT01356043|Antimetabolites|antimetabolites|mesh-ancestor
102047294|NCT01356043|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102047295|NCT01356043|Vitamin B Complex|vitamin b complex|mesh-ancestor
102047296|NCT01356043|Vitamins|vitamins|mesh-ancestor
102047297|NCT01356043|Micronutrients|micronutrients|mesh-ancestor
102047298|NCT02065388|Warfarin|warfarin|mesh-list
102047299|NCT02065388|Anticoagulants|anticoagulants|mesh-ancestor
102047300|NCT01317563|Vitamin A|vitamin a|mesh-list
102047301|NCT01317563|Selenium|selenium|mesh-list
102047302|NCT01317563|Vitamins|vitamins|mesh-ancestor
102047303|NCT01317563|Micronutrients|micronutrients|mesh-ancestor
101607631|NCT00655330|Protective Agents|protective agents|mesh-ancestor
101607632|NCT00655330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607634|NCT00655408|Trace Elements|trace elements|mesh-ancestor
101607635|NCT00655408|Micronutrients|micronutrients|mesh-ancestor
102047304|NCT01317563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047305|NCT01317563|Antioxidants|antioxidants|mesh-ancestor
102047306|NCT01317563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047307|NCT01317563|Protective Agents|protective agents|mesh-ancestor
102047308|NCT01317563|Trace Elements|trace elements|mesh-ancestor
102047309|NCT02067338|Morphine|morphine|mesh-list
102047310|NCT02067338|Cellulose, Oxidized|cellulose, oxidized|mesh-list
102047311|NCT02067338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102047312|NCT02067338|Narcotics|narcotics|mesh-ancestor
102047313|NCT02067338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102047314|NCT02067338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047315|NCT02067338|Analgesics|analgesics|mesh-ancestor
102047316|NCT02067338|Sensory System Agents|sensory system agents|mesh-ancestor
102047317|NCT02067338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102047318|NCT02067338|Hemostatics|hemostatics|mesh-ancestor
102047319|NCT02067338|Coagulants|coagulants|mesh-ancestor
102047320|NCT01352143|Thrombin|thrombin|mesh-list
102047321|NCT01352143|Hemostatics|hemostatics|mesh-ancestor
102047322|NCT01352143|Coagulants|coagulants|mesh-ancestor
102047323|NCT01352299|Pyrithione zinc|pyrithione zinc|mesh-list
102047324|NCT01352299|Keratolytic Agents|keratolytic agents|mesh-ancestor
102047325|NCT01352299|Dermatologic Agents|dermatologic agents|mesh-ancestor
102047326|NCT05188495|Trastuzumab|trastuzumab|mesh-list
102047327|NCT05188495|Pertuzumab|pertuzumab|mesh-list
102047328|NCT05188495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102047329|NCT05188495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102047330|NCT02069288|Fludrocortisone|fludrocortisone|mesh-list
102047331|NCT02069288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102047333|NCT01356121|Propofol|propofol|mesh-list
102047334|NCT01356121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102047335|NCT01356121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102047336|NCT01356121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047337|NCT01356121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102047338|NCT01356121|Anesthetics, General|anesthetics, general|mesh-ancestor
102047339|NCT01356121|Anesthetics|anesthetics|mesh-ancestor
102047349|NCT01336608|Xhance|xhance|mesh-list
102047350|NCT01336608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102047351|NCT01336608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102047352|NCT01336608|Autonomic Agents|autonomic agents|mesh-ancestor
102047353|NCT01336608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102047354|NCT01336608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047355|NCT01336608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102047356|NCT01336608|Respiratory System Agents|respiratory system agents|mesh-ancestor
102047416|NCT01356355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047417|NCT01356355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047419|NCT01356433|Vitamins|vitamins|mesh-list
102047420|NCT01356433|Ascorbic Acid|ascorbic acid|mesh-list
102047421|NCT01356433|Micronutrients|micronutrients|mesh-ancestor
102047422|NCT01356433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047423|NCT01356433|Antioxidants|antioxidants|mesh-ancestor
102047424|NCT01356433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047425|NCT01356433|Protective Agents|protective agents|mesh-ancestor
102047426|NCT03691727|Tirofiban|tirofiban|mesh-list
102047427|NCT03691727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102047428|NCT03691727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102047429|NCT03691727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047430|NCT03691727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102047431|NCT01346371|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102047432|NCT01346371|Lubricant Eye Drops|lubricant eye drops|mesh-list
102047433|NCT01346371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102047434|NCT01356511|Dexamethasone|dexamethasone|mesh-list
102047435|NCT01356511|Prednisone|prednisone|mesh-list
102047436|NCT01356511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102047437|NCT01356511|Antiemetics|antiemetics|mesh-ancestor
102047438|NCT01356511|Autonomic Agents|autonomic agents|mesh-ancestor
102047439|NCT01356511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102047440|NCT01356511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047441|NCT01356511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102047442|NCT01356511|Glucocorticoids|glucocorticoids|mesh-ancestor
102047443|NCT01356511|Hormones|hormones|mesh-ancestor
101387685|NCT00323011|Fluorouracil|fluorouracil|mesh-list
102047444|NCT01356511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102047462|NCT05076409|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102047463|NCT05076409|Hormone Antagonists|hormone antagonists|mesh-ancestor
102047464|NCT05076409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102047465|NCT05076409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047466|NCT05076409|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102047467|NCT05076409|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102047468|NCT05076409|Nootropic Agents|nootropic agents|mesh-ancestor
102047469|NCT02076386|Dolutegravir|dolutegravir|mesh-list
102047470|NCT02076386|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102047471|NCT02076386|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102047472|NCT02076386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102047473|NCT02076386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047474|NCT02076386|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102047475|NCT02076386|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102047476|NCT02076386|Antiviral Agents|antiviral agents|mesh-ancestor
102047477|NCT02076386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102047478|NCT01347593|Ceftizoxime|ceftizoxime|mesh-list
102047479|NCT01347593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101767209|NCT03948074|Analgesics|analgesics|mesh-ancestor
102047481|NCT02072330|Amlodipine|amlodipine|mesh-list
102047515|NCT02070458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047516|NCT02070458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102047517|NCT02070458|Antimetabolites|antimetabolites|mesh-ancestor
102047518|NCT02070458|Antiviral Agents|antiviral agents|mesh-ancestor
102047519|NCT02070458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102047520|NCT02070458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102047521|NCT02070458|Immunologic Factors|immunologic factors|mesh-ancestor
102047522|NCT02070458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047523|NCT02070458|Analgesics|analgesics|mesh-ancestor
102047524|NCT02070458|Sensory System Agents|sensory system agents|mesh-ancestor
102047525|NCT02070458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102047526|NCT02070458|Protease Inhibitors|protease inhibitors|mesh-ancestor
102047527|NCT02070458|Glycine Agents|glycine agents|mesh-ancestor
102047528|NCT02070458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102047529|NCT03131479|Licogliflozin|licogliflozin|mesh-list
102047530|NCT03131479|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102047531|NCT03131479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047532|NCT03131479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102047571|NCT02072798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102047572|NCT04943549|Bupivacaine|bupivacaine|mesh-list
102047573|NCT04943549|Anesthetics, Local|anesthetics, local|mesh-ancestor
102047574|NCT04943549|Anesthetics|anesthetics|mesh-ancestor
102047575|NCT04943549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102047576|NCT04943549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047577|NCT04943549|Sensory System Agents|sensory system agents|mesh-ancestor
102047578|NCT04943549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102047579|NCT04252105|Antioxidants|antioxidants|mesh-list
102047580|NCT04252105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047581|NCT04252105|Protective Agents|protective agents|mesh-ancestor
102047586|NCT02077400|Cefazolin|cefazolin|mesh-list
102047636|NCT02930941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047637|NCT02930941|Hemostatics|hemostatics|mesh-ancestor
102047638|NCT02930941|Coagulants|coagulants|mesh-ancestor
102047639|NCT02077634|Prednisone|prednisone|mesh-list
102047640|NCT02077634|Abiraterone Acetate|abiraterone acetate|mesh-list
102047641|NCT02077634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102047642|NCT02077634|Glucocorticoids|glucocorticoids|mesh-ancestor
102047703|NCT02073734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102047704|NCT02071004|Aspirin|aspirin|mesh-list
101767440|NCT03382938|Anesthetics|anesthetics|mesh-ancestor
102047705|NCT02071004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102047706|NCT02071004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102047707|NCT02071004|Analgesics|analgesics|mesh-ancestor
102047708|NCT02071004|Sensory System Agents|sensory system agents|mesh-ancestor
102047709|NCT02071004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102047710|NCT02071004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047711|NCT02071004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101387686|NCT00323011|Irinotecan|irinotecan|mesh-list
102047767|NCT01353209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102047768|NCT01353209|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102047769|NCT01353209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102047770|NCT01353209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102047776|NCT03637491|Avelumab|avelumab|mesh-list
102047835|NCT03446157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047837|NCT04700007|Promethazine|promethazine|mesh-list
102047838|NCT04700007|Morphine|morphine|mesh-list
102047839|NCT04700007|Capsaicin|capsaicin|mesh-list
102047840|NCT04700007|Histamine|histamine|mesh-list
102047841|NCT04700007|Histamine Antagonists|histamine antagonists|mesh-list
102047842|NCT04700007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102047843|NCT04700007|Narcotics|narcotics|mesh-ancestor
102047844|NCT04700007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102047845|NCT04700007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047846|NCT04700007|Analgesics|analgesics|mesh-ancestor
102047900|NCT03137303|Respiratory System Agents|respiratory system agents|mesh-ancestor
102047902|NCT03137303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102047903|NCT03137303|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102047904|NCT03137303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102047905|NCT03137303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102047906|NCT03137303|Adrenergic Agents|adrenergic agents|mesh-ancestor
102047969|NCT03074318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102047970|NCT02071316|Esomeprazole|esomeprazole|mesh-list
102047971|NCT02071316|Tranexamic Acid|tranexamic acid|mesh-list
102047972|NCT02071316|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102047973|NCT02071316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102047974|NCT02071316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047975|NCT02071316|Hemostatics|hemostatics|mesh-ancestor
102047976|NCT02071316|Coagulants|coagulants|mesh-ancestor
102047977|NCT02071316|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102047978|NCT02071316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102047979|NCT02071316|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102047980|NCT02071316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102047981|NCT02074202|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102047982|NCT02074202|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102047983|NCT02074202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102047984|NCT02074280|Rifaximin|rifaximin|mesh-list
102047985|NCT02074280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102048026|NCT01317953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102048027|NCT01317953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102048028|NCT02078336|Atropine|atropine|mesh-list
102048029|NCT02078336|Midazolam|midazolam|mesh-list
102048030|NCT02078336|Droperidol|droperidol|mesh-list
102048101|NCT02075528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102048102|NCT02075528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102048103|NCT02075528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102048104|NCT02075528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048105|NCT02075528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102048106|NCT02075528|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102048107|NCT02075528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102048108|NCT02075528|Serotonin Agents|serotonin agents|mesh-ancestor
102048109|NCT02075528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102048111|NCT02075528|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102048163|NCT01357811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048164|NCT04300985|Magnesium Sulfate|magnesium sulfate|mesh-list
102048165|NCT04300985|Dexmedetomidine|dexmedetomidine|mesh-list
102048187|NCT02079194|Aspirin|aspirin|mesh-list
102048235|NCT01358435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048236|NCT01318265|Ketoconazole|ketoconazole|mesh-list
102048308|NCT02083328|Natriuretic Agents|natriuretic agents|mesh-ancestor
102048322|NCT02940548|Amlodipine|amlodipine|mesh-list
102048381|NCT02083640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102048382|NCT02083640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048383|NCT01352039|Heparin|heparin|mesh-list
102048454|NCT01361399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048455|NCT01361399|Sensory System Agents|sensory system agents|mesh-ancestor
102048456|NCT01361399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102048457|NCT01361399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101778151|NCT00808392|Vaccines|vaccines|mesh-list
102048458|NCT01361399|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102048459|NCT01361399|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102048460|NCT01361399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102048461|NCT01361399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048463|NCT01361399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102048517|NCT03609996|Ranibizumab|ranibizumab|mesh-list
102048518|NCT03609996|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102048519|NCT03609996|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102048520|NCT03609996|Growth Substances|growth substances|mesh-ancestor
102048521|NCT03609996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048522|NCT03609996|Growth Inhibitors|growth inhibitors|mesh-ancestor
102048523|NCT03609996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102048524|NCT02088008|Valsartan|valsartan|mesh-list
102048525|NCT02088008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102048526|NCT02088008|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101768266|NCT00966004|Mirabegron|mirabegron|mesh-list
102048527|NCT02088008|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102048528|NCT02088008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048529|NCT01361789|Dexamethasone|dexamethasone|mesh-list
102048577|NCT02084342|Tranexamic Acid|tranexamic acid|mesh-list
102048578|NCT02084342|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102048579|NCT02084342|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102048580|NCT02084342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048581|NCT02084342|Hemostatics|hemostatics|mesh-ancestor
102048582|NCT02084342|Coagulants|coagulants|mesh-ancestor
102048583|NCT02084342|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102048584|NCT02084342|Natriuretic Agents|natriuretic agents|mesh-ancestor
102048585|NCT02084342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048586|NCT01371487|Trametinib|trametinib|mesh-list
102048587|NCT01371487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102048588|NCT01371487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101768335|NCT00966316|Aspirin|aspirin|mesh-list
102048639|NCT02088398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102048640|NCT02088398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048641|NCT02084576|Ketorolac|ketorolac|mesh-list
102048642|NCT02084576|Nepafenac|nepafenac|mesh-list
102048643|NCT02084576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102048644|NCT02084576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102048645|NCT02084576|Analgesics|analgesics|mesh-ancestor
102048646|NCT02084576|Sensory System Agents|sensory system agents|mesh-ancestor
102048647|NCT02084576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102048648|NCT02084576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048649|NCT02084576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102048650|NCT02084576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102048652|NCT02084576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102048701|NCT02942277|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102048703|NCT02942277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102048704|NCT02942277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102048705|NCT02942277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102048706|NCT05042947|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102048707|NCT05042947|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
102048708|NCT05042947|beta-Endorphin|beta-endorphin|mesh-list
102048709|NCT05042947|Hormones|hormones|mesh-ancestor
102048710|NCT05042947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102048714|NCT02082236|Sufentanil|sufentanil|mesh-list
102048764|NCT02143063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102048765|NCT02143063|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102048766|NCT02143063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102048767|NCT02143063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102048835|NCT02791490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102048836|NCT02791490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102048837|NCT02791490|Protease Inhibitors|protease inhibitors|mesh-ancestor
102048838|NCT02791490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102048839|NCT02791490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048840|NCT04635631|Talazoparib|talazoparib|mesh-list
101778158|NCT00780104|Cytarabine|cytarabine|mesh-list
102048841|NCT04635631|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102048842|NCT04635631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102048843|NCT04635631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048844|NCT04635631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102048896|NCT02086292|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102048897|NCT02086292|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102048898|NCT02086292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102048899|NCT02086292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102048900|NCT02425644|Teriflunomide|teriflunomide|mesh-list
102048901|NCT02425644|Ponesimod|ponesimod|mesh-list
102048902|NCT02425644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102048903|NCT02425644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102048904|NCT02425644|Analgesics|analgesics|mesh-ancestor
102048905|NCT02425644|Sensory System Agents|sensory system agents|mesh-ancestor
102048906|NCT02425644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102048907|NCT02425644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048908|NCT02425644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102048958|NCT02086838|Hematinics|hematinics|mesh-list
102048959|NCT02086838|Anticoagulants|anticoagulants|mesh-ancestor
102048960|NCT02086838|Plasma Substitutes|plasma substitutes|mesh-ancestor
102048961|NCT02086838|Blood Substitutes|blood substitutes|mesh-ancestor
102048962|NCT02236962|Pioglitazone|pioglitazone|mesh-list
102048963|NCT02236962|Ephedrine|ephedrine|mesh-list
102048964|NCT02236962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102048965|NCT02236962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102048967|NCT02236962|Sympathomimetics|sympathomimetics|mesh-ancestor
102049026|NCT02087462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049028|NCT02087540|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102049029|NCT02087540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102049030|NCT02087540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102049096|NCT01111305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102049097|NCT01111305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049098|NCT03752307|Prednisone|prednisone|mesh-list
102049099|NCT03752307|Methylprednisolone|methylprednisolone|mesh-list
102049100|NCT03752307|Isoxsuprine|isoxsuprine|mesh-list
102049101|NCT03752307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102049102|NCT03752307|Glucocorticoids|glucocorticoids|mesh-ancestor
102049103|NCT03752307|Hormones|hormones|mesh-ancestor
102049165|NCT02095886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102049166|NCT01372579|Carboplatin|carboplatin|mesh-list
102049167|NCT01372579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102049168|NCT02090036|Lumefantrine|lumefantrine|mesh-list
102049170|NCT02090036|Primaquine|primaquine|mesh-list
102049171|NCT02090036|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102049172|NCT02090036|Antimalarials|antimalarials|mesh-ancestor
102049173|NCT02090036|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102049174|NCT02090036|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102049175|NCT02090036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102049176|NCT03125629|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102049177|NCT03125629|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102049178|NCT03125629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049179|NCT02092376|Cholecalciferol|cholecalciferol|mesh-list
102049180|NCT02092376|Vitamin D|vitamin d|mesh-list
102049181|NCT02092376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102049182|NCT02092376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049183|NCT02092376|Vitamins|vitamins|mesh-ancestor
102049184|NCT02092376|Micronutrients|micronutrients|mesh-ancestor
102049185|NCT02092376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102049186|NCT05452928|Valacyclovir|valacyclovir|mesh-list
102049187|NCT05452928|Acyclovir|acyclovir|mesh-list
102049188|NCT05452928|Antiviral Agents|antiviral agents|mesh-ancestor
102049189|NCT05452928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102049190|NCT03125395|Ivacaftor|ivacaftor|mesh-list
102049191|NCT03125395|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102049217|NCT02092766|Antiviral Agents|antiviral agents|mesh-ancestor
102049218|NCT02092766|Schistosomicides|schistosomicides|mesh-ancestor
102049226|NCT02092766|Analgesics|analgesics|mesh-ancestor
102049293|NCT01567059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102049297|NCT01567059|Glycine Agents|glycine agents|mesh-ancestor
102049369|NCT02099240|Rifampin|rifampin|mesh-list
102049370|NCT02099240|Clindamycin|clindamycin|mesh-list
102049371|NCT02099240|Clindamycin palmitate|clindamycin palmitate|mesh-list
102049372|NCT02099240|Clindamycin phosphate|clindamycin phosphate|mesh-list
102049373|NCT02099240|Gentamicins|gentamicins|mesh-list
102049374|NCT02099240|Isoniazid|isoniazid|mesh-list
102049375|NCT02099240|Meropenem|meropenem|mesh-list
102049454|NCT02099240|Netilmicin|netilmicin|mesh-list
102049455|NCT02099240|Sulfacetamide|sulfacetamide|mesh-list
102049456|NCT02099240|Novobiocin|novobiocin|mesh-list
102049457|NCT02099240|Quinupristin-dalfopristin|quinupristin-dalfopristin|mesh-list
102049458|NCT02099240|Virginiamycin|virginiamycin|mesh-list
102049459|NCT02099240|Enoxacin|enoxacin|mesh-list
102049472|NCT02099240|Loracarbef|loracarbef|mesh-list
102049528|NCT02099240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102049529|NCT02099240|Antimetabolites|antimetabolites|mesh-ancestor
102049530|NCT02099240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102049531|NCT02099240|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102049532|NCT02099240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102049533|NCT02099240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102049534|NCT02099240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102049536|NCT02099240|Sensory System Agents|sensory system agents|mesh-ancestor
102049537|NCT02099240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102049538|NCT02099240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102049539|NCT02099240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102049540|NCT02099240|Protease Inhibitors|protease inhibitors|mesh-ancestor
102049541|NCT02099240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102049542|NCT02099240|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102049591|NCT05215743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049593|NCT05215743|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102049594|NCT05215743|Chelating Agents|chelating agents|mesh-ancestor
102049667|NCT02100176|Autonomic Agents|autonomic agents|mesh-ancestor
102049668|NCT02100176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102049669|NCT02100176|Protective Agents|protective agents|mesh-ancestor
102049670|NCT02250482|Factor VIII|factor viii|mesh-list
102049671|NCT02250482|Coagulants|coagulants|mesh-ancestor
102049740|NCT04964193|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102049741|NCT04964193|Estrogens|estrogens|mesh-ancestor
102049742|NCT04964193|Hormones|hormones|mesh-ancestor
102049743|NCT04964193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102049744|NCT04964193|Androgen Antagonists|androgen antagonists|mesh-ancestor
102049745|NCT04964193|Hormone Antagonists|hormone antagonists|mesh-ancestor
102049746|NCT04964193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102049747|NCT04964193|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
102049748|NCT02100488|Insulin|insulin|mesh-list
102049749|NCT02100488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102049750|NCT02100488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102049751|NCT02100488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049752|NCT02095418|Mycophenolic Acid|mycophenolic acid|mesh-list
102049753|NCT02095418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102049754|NCT02095418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102049761|NCT04865497|Vaccines|vaccines|mesh-list
102049798|NCT02098460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049800|NCT02098460|Respiratory System Agents|respiratory system agents|mesh-ancestor
102049801|NCT02098460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102049872|NCT02102672|Vasodilator Agents|vasodilator agents|mesh-ancestor
102049873|NCT02106338|REP 3123|rep 3123|mesh-list
102049874|NCT02106338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102049875|NCT02106338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102049876|NCT03121261|Clonidine|clonidine|mesh-list
102049877|NCT03121261|Levobupivacaine|levobupivacaine|mesh-list
102049878|NCT03121261|Analgesics|analgesics|mesh-ancestor
102049879|NCT03121261|Sensory System Agents|sensory system agents|mesh-ancestor
102049880|NCT03121261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102049881|NCT03121261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102049882|NCT03121261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102049883|NCT03121261|Sympatholytics|sympatholytics|mesh-ancestor
102049884|NCT03121261|Autonomic Agents|autonomic agents|mesh-ancestor
102049885|NCT03121261|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101387687|NCT00323011|Dalteparin|dalteparin|mesh-list
102049886|NCT03121261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102049887|NCT03121261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102049888|NCT03121261|Adrenergic Agents|adrenergic agents|mesh-ancestor
102049889|NCT03121261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102049890|NCT03121261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049928|NCT01372423|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102049929|NCT01372423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102049930|NCT01372423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102049931|NCT02106650|Leucovorin|leucovorin|mesh-list
102049932|NCT02106650|Folic Acid|folic acid|mesh-list
102049933|NCT02106650|Vitamin B 12|vitamin b 12|mesh-list
102049935|NCT02106650|Vitamins|vitamins|mesh-ancestor
102049999|NCT02101892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050000|NCT02101892|Adrenergic Agents|adrenergic agents|mesh-ancestor
102050001|NCT02101892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102050072|NCT03117361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102050073|NCT03117361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050074|NCT03117361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102050075|NCT03117361|Glucocorticoids|glucocorticoids|mesh-ancestor
102050077|NCT03117361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102050078|NCT03117361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102050079|NCT03117361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102050080|NCT03053427|Gabapentin|gabapentin|mesh-list
102050081|NCT03053427|Analgesics|analgesics|mesh-ancestor
102050082|NCT03053427|Sensory System Agents|sensory system agents|mesh-ancestor
102050083|NCT03053427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102050084|NCT03053427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050134|NCT02103686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102050135|NCT02103686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050136|NCT02103686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102050137|NCT02103686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102050138|NCT02103686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102050139|NCT02103686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102050140|NCT02103686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102050141|NCT02110082|Cetuximab|cetuximab|mesh-list
102050142|NCT02110082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102050143|NCT02110082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102050144|NCT02103764|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102050145|NCT02103764|Medroxyprogesterone|medroxyprogesterone|mesh-list
102050146|NCT02103764|Desogestrel|desogestrel|mesh-list
102050147|NCT02103764|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102050148|NCT02103764|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102050190|NCT02110394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050192|NCT02373241|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102050193|NCT02373241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102050194|NCT02373241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102050195|NCT02373241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102050196|NCT02373241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050197|NCT05656131|Fluzoparib|fluzoparib|mesh-list
102050198|NCT05656131|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102050199|NCT05656131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102050200|NCT05656131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050201|NCT05656131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102050203|NCT02103998|Hormones|hormones|mesh-list
102050204|NCT02103998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102050205|NCT02103998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050246|NCT01345929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050247|NCT01345929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102050248|NCT01345929|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102050249|NCT01345929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102050251|NCT02107742|Anesthetics, Local|anesthetics, local|mesh-ancestor
102050252|NCT02107742|Anesthetics|anesthetics|mesh-ancestor
101778184|NCT04047680|Ritonavir|ritonavir|mesh-list
102050253|NCT02107742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102050254|NCT02107742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050255|NCT02107742|Sensory System Agents|sensory system agents|mesh-ancestor
102050256|NCT02107742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102050257|NCT02107742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102050258|NCT02107742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102050259|NCT02107742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102050260|NCT02107742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102050261|NCT02107742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050303|NCT05617521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050304|NCT05617521|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102050305|NCT05617521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102050306|NCT05617521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050307|NCT05617521|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102050308|NCT05617521|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102050309|NCT05617521|Purinergic Agents|purinergic agents|mesh-ancestor
102050310|NCT05617521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102050311|NCT02108210|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102050312|NCT02108210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102050313|NCT02104700|Tenofovir|tenofovir|mesh-list
102050314|NCT02104700|Emtricitabine|emtricitabine|mesh-list
102050315|NCT02104700|Rilpivirine|rilpivirine|mesh-list
102050316|NCT02104700|Antiviral Agents|antiviral agents|mesh-ancestor
102050317|NCT02104700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102050318|NCT02104700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102050319|NCT02104700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102050320|NCT02104700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102050321|NCT02104700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050322|NCT02104700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102050356|NCT02108366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050357|NCT02108366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102050358|NCT02108366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102050359|NCT02108366|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102050360|NCT02108366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102050361|NCT02108366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102050362|NCT02108366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050363|NCT02108366|Antiviral Agents|antiviral agents|mesh-ancestor
102050364|NCT02108366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102050421|NCT02251184|Antipyretics|antipyretics|mesh-ancestor
102050422|NCT02251184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102050427|NCT02108756|Pantoprazole|pantoprazole|mesh-list
102050495|NCT02112422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102050496|NCT02112422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102050497|NCT02112422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102050498|NCT02112422|Protease Inhibitors|protease inhibitors|mesh-ancestor
102050499|NCT02112422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102050500|NCT02112422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050501|NCT02109614|Niacin|niacin|mesh-list
102050502|NCT02109614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102050503|NCT02109614|Antimetabolites|antimetabolites|mesh-ancestor
102050504|NCT02109614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050505|NCT02109614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102050506|NCT02109614|Vasodilator Agents|vasodilator agents|mesh-ancestor
102050507|NCT02109614|Vitamin B Complex|vitamin b complex|mesh-ancestor
102050554|NCT02114528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
102050555|NCT02114528|Mexiletine|mexiletine|mesh-list
102050556|NCT02114528|Procainamide|procainamide|mesh-list
102050557|NCT02114528|Vasodilator Agents|vasodilator agents|mesh-ancestor
102050558|NCT02114528|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102050559|NCT02114528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102050621|NCT04854343|Antiviral Agents|antiviral agents|mesh-ancestor
102050622|NCT04854343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102050623|NCT04854343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102050624|NCT01376713|Dacarbazine|dacarbazine|mesh-list
102050626|NCT01376713|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102050627|NCT01376713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102050628|NCT01376713|Alkylating Agents|alkylating agents|mesh-ancestor
102050629|NCT01376713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050630|NCT01376713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102050631|NCT01376713|Immunologic Factors|immunologic factors|mesh-ancestor
102050632|NCT01376713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050633|NCT03728179|Aspirin|aspirin|mesh-list
102050634|NCT03728179|Celecoxib|celecoxib|mesh-list
102050635|NCT03728179|Cyclophosphamide|cyclophosphamide|mesh-list
102050636|NCT03728179|Nivolumab|nivolumab|mesh-list
102050637|NCT03728179|Ipilimumab|ipilimumab|mesh-list
102050638|NCT03728179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102050639|NCT03728179|Immunologic Factors|immunologic factors|mesh-ancestor
102050640|NCT03728179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050641|NCT03728179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102050642|NCT03728179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102050662|NCT01368536|Amlodipine|amlodipine|mesh-list
102050677|NCT05103735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102050678|NCT05103735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102050679|NCT05103735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050680|NCT05103735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102050681|NCT05103735|Analgesics|analgesics|mesh-ancestor
102050682|NCT05103735|Sensory System Agents|sensory system agents|mesh-ancestor
102050683|NCT05103735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102050684|NCT05103735|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102050685|NCT05103735|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102050686|NCT05103735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102050687|NCT05103735|Adrenergic Agents|adrenergic agents|mesh-ancestor
102050738|NCT01373359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101770435|NCT03987529|Propofol|propofol|mesh-list
102050739|NCT01373359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050740|NCT01373359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102050741|NCT01373359|Abortifacient Agents|abortifacient agents|mesh-ancestor
102050742|NCT01373359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102050743|NCT01373359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102050744|NCT02123264|Zoledronic Acid|zoledronic acid|mesh-list
102050745|NCT02123264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102050746|NCT02123264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050747|NCT02251964|Rituximab|rituximab|mesh-list
102050748|NCT02251964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102050749|NCT02251964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102050750|NCT02251964|Immunologic Factors|immunologic factors|mesh-ancestor
102050751|NCT02251964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050752|NCT02251964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102050753|NCT04739995|Naltrexone|naltrexone|mesh-list
102050754|NCT04739995|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102050755|NCT04739995|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102050757|NCT04739995|Sensory System Agents|sensory system agents|mesh-ancestor
102050792|NCT02858076|Growth Inhibitors|growth inhibitors|mesh-ancestor
102050793|NCT02858076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102050794|NCT01319695|Hormones|hormones|mesh-list
102050795|NCT01319695|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102050796|NCT01319695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102050797|NCT01319695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050798|NCT04594759|Isotretinoin|isotretinoin|mesh-list
102050799|NCT04594759|Dermatologic Agents|dermatologic agents|mesh-ancestor
102050800|NCT02123498|Omeprazole|omeprazole|mesh-list
102050801|NCT02123498|Pantoprazole|pantoprazole|mesh-list
102050802|NCT02123498|Ranitidine|ranitidine|mesh-list
102050803|NCT02123498|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
102050804|NCT02123498|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102050805|NCT02123498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102050806|NCT02123498|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102050807|NCT02123498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102050808|NCT02123498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050809|NCT02123498|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102050810|NCT02123498|Histamine Antagonists|histamine antagonists|mesh-ancestor
102050811|NCT02123498|Histamine Agents|histamine agents|mesh-ancestor
102050812|NCT02123498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102050813|NCT02123498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050814|NCT02115776|Amoxicillin|amoxicillin|mesh-list
102050815|NCT02115776|Clavulanic Acid|clavulanic acid|mesh-list
102050816|NCT02115776|Clavulanic Acids|clavulanic acids|mesh-list
102050817|NCT02115776|Chlorhexidine|chlorhexidine|mesh-list
102050818|NCT02115776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102050819|NCT02115776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102050820|NCT02115776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102050821|NCT02115776|Disinfectants|disinfectants|mesh-ancestor
102050822|NCT02115776|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102050823|NCT02115776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102050824|NCT02115776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607636|NCT00655408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607637|NCT04163536|Methylprednisolone|methylprednisolone|mesh-list
101607638|NCT04163536|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101607639|NCT04163536|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101607640|NCT04163536|Prednisolone|prednisolone|mesh-list
101607641|NCT04163536|Prednisolone acetate|prednisolone acetate|mesh-list
101607642|NCT04163536|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101607643|NCT04163536|Prednisolone phosphate|prednisolone phosphate|mesh-list
101607644|NCT04163536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101607645|NCT04163536|Antiemetics|antiemetics|mesh-ancestor
101607646|NCT04163536|Autonomic Agents|autonomic agents|mesh-ancestor
102050825|NCT02123654|Asunaprevir|asunaprevir|mesh-list
102050826|NCT02123654|Protease Inhibitors|protease inhibitors|mesh-ancestor
102050827|NCT02123654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102050897|NCT03627039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102050898|NCT03627039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102050899|NCT03627039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102050900|NCT03627039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102050966|NCT03553238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102050968|NCT03553238|Hormones|hormones|mesh-ancestor
102050969|NCT03553238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102051036|NCT02859961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051037|NCT02859961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102051043|NCT02124200|Nicotine|nicotine|mesh-list
102051108|NCT02624869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102051109|NCT02624869|Antimetabolites|antimetabolites|mesh-ancestor
102051110|NCT02624869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387688|NCT00323011|Levoleucovorin|levoleucovorin|mesh-list
102051111|NCT02624869|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102051112|NCT02624869|Protease Inhibitors|protease inhibitors|mesh-ancestor
102051113|NCT02624869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102051114|NCT02624869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102051115|NCT02121782|Vaccines|vaccines|mesh-list
102051116|NCT02121782|Immunologic Factors|immunologic factors|mesh-ancestor
102051117|NCT02121782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051118|NCT03553082|Propofol|propofol|mesh-list
102051119|NCT03553082|Sevoflurane|sevoflurane|mesh-list
102051174|NCT02747004|Hormone Antagonists|hormone antagonists|mesh-ancestor
102051175|NCT02747004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102051176|NCT02747004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051183|NCT04454515|Dexmedetomidine|dexmedetomidine|mesh-list
102051219|NCT02117726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102051220|NCT02117726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102051221|NCT02117726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102051222|NCT02117726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102051223|NCT02117726|GABA Modulators|gaba modulators|mesh-ancestor
102051224|NCT02117726|GABA Agents|gaba agents|mesh-ancestor
102051225|NCT02733432|Fluconazole|fluconazole|mesh-list
102051290|NCT03605940|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102051291|NCT03605940|Dermatologic Agents|dermatologic agents|mesh-ancestor
102051292|NCT03607734|Amoxicillin|amoxicillin|mesh-list
102051293|NCT03607734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102051363|NCT02931539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102051364|NCT03602118|Phenobarbital|phenobarbital|mesh-list
102051365|NCT03602118|Anticonvulsants|anticonvulsants|mesh-ancestor
102051433|NCT03522415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051434|NCT03522415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102051435|NCT03522415|Antimetabolites|antimetabolites|mesh-ancestor
102051503|NCT03604224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051504|NCT03604224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102051576|NCT02127866|Adrenergic Agents|adrenergic agents|mesh-ancestor
102051577|NCT02127866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102051578|NCT02127866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575040|NCT05215873|Oxytocics|oxytocics|mesh-ancestor
102051650|NCT03603756|Antimitotic Agents|antimitotic agents|mesh-ancestor
102051651|NCT03603756|Mitosis Modulators|mitosis modulators|mesh-ancestor
102051652|NCT03603756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051653|NCT03603756|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102051720|NCT03118765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102051721|NCT03118765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051794|NCT01375699|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102051795|NCT01375699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102051796|NCT01375699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102051797|NCT01375699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102051798|NCT01375699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102051862|NCT05811793|Growth Inhibitors|growth inhibitors|mesh-ancestor
102051937|NCT05801224|Protective Agents|protective agents|mesh-ancestor
102051938|NCT05793489|Silybin|silybin|mesh-list
102051939|NCT05793489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102051940|NCT05793489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102051941|NCT05793489|Protective Agents|protective agents|mesh-ancestor
102051942|NCT05793489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102051943|NCT05754853|Paclitaxel|paclitaxel|mesh-list
102051944|NCT05754853|Docetaxel|docetaxel|mesh-list
102051945|NCT05754853|Gemcitabine|gemcitabine|mesh-list
102051946|NCT05754853|Pemetrexed|pemetrexed|mesh-list
102051947|NCT05754853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102051948|NCT05754853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102051949|NCT05754853|Tubulin Modulators|tubulin modulators|mesh-ancestor
102051950|NCT05754853|Antimitotic Agents|antimitotic agents|mesh-ancestor
102051951|NCT05754853|Mitosis Modulators|mitosis modulators|mesh-ancestor
102051952|NCT05754853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102051953|NCT05754853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102051954|NCT05754853|Antimetabolites|antimetabolites|mesh-ancestor
102051955|NCT05754853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102051956|NCT05754853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102051958|NCT05747625|Panitumumab|panitumumab|mesh-list
102051993|NCT05705427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102051994|NCT05705427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102051995|NCT05705427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102051997|NCT05705427|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102052063|NCT05511766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102052064|NCT05511766|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102052065|NCT05511766|Antioxidants|antioxidants|mesh-ancestor
102052133|NCT05416957|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102052134|NCT05416957|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102052135|NCT05416957|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102052204|NCT05327595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102052205|NCT05327595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052206|NCT05327595|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102052207|NCT05327595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102052208|NCT05327595|Antimetabolites|antimetabolites|mesh-ancestor
102052271|NCT05191862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102052272|NCT05191862|Autonomic Agents|autonomic agents|mesh-ancestor
102052273|NCT05191862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102052274|NCT05191862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052340|NCT05048212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102052341|NCT05048212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052342|NCT05037500|Decitabine|decitabine|mesh-list
102052343|NCT05037500|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
102052344|NCT05037500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102052408|NCT04928391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102052409|NCT04928391|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102052410|NCT04928391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102052411|NCT04928391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102052476|NCT04899687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102052477|NCT04899687|Antitussive Agents|antitussive agents|mesh-ancestor
102052478|NCT04899687|Respiratory System Agents|respiratory system agents|mesh-ancestor
102052513|NCT04722601|Cc-486|cc-486|mesh-list
102052550|NCT04624906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052552|NCT04610320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102052553|NCT04546399|Calcium, Dietary|calcium, dietary|mesh-list
102052554|NCT04546399|Leucovorin|leucovorin|mesh-list
102052555|NCT04546399|Folic Acid|folic acid|mesh-list
102052556|NCT04546399|Cytarabine|cytarabine|mesh-list
102052557|NCT04546399|Dexamethasone|dexamethasone|mesh-list
102052622|NCT04546399|Protective Agents|protective agents|mesh-ancestor
102052623|NCT04546399|Vitamin B Complex|vitamin b complex|mesh-ancestor
102052625|NCT04546399|Micronutrients|micronutrients|mesh-ancestor
102052626|NCT04546399|Tubulin Modulators|tubulin modulators|mesh-ancestor
102052693|NCT04417998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052694|NCT04408508|Amoxicillin|amoxicillin|mesh-list
102052695|NCT04408508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102052696|NCT04408508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102052697|NCT04262206|Atorvastatin|atorvastatin|mesh-list
102052698|NCT04262206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102052699|NCT04262206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102052700|NCT04262206|Antimetabolites|antimetabolites|mesh-ancestor
102052701|NCT04262206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052702|NCT04262206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102052703|NCT04262206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102052752|NCT04083495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052753|NCT04083495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102052754|NCT04083495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102052755|NCT04082442|Evolocumab|evolocumab|mesh-list
102052756|NCT04082442|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102052757|NCT04082442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102052758|NCT04082442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102052759|NCT04082442|Antimetabolites|antimetabolites|mesh-ancestor
102052760|NCT04082442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052761|NCT04082442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102052762|NCT04082442|Protease Inhibitors|protease inhibitors|mesh-ancestor
102052763|NCT04082442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102052764|NCT04082442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102052765|NCT04080518|Dapagliflozin|dapagliflozin|mesh-list
102052768|NCT04080518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102052810|NCT04014803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102052811|NCT03980184|Guanfacine|guanfacine|mesh-list
102052812|NCT03980184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102052813|NCT03980184|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102052814|NCT03980184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102052815|NCT03980184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102052816|NCT03980184|Adrenergic Agents|adrenergic agents|mesh-ancestor
102052817|NCT03980184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102052818|NCT03980184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102052819|NCT03980184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102052820|NCT03945903|Golimumab|golimumab|mesh-list
102052821|NCT03945903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102052822|NCT03945903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102052823|NCT03945903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102052824|NCT03945903|Immunologic Factors|immunologic factors|mesh-ancestor
102052868|NCT03934684|Growth Substances|growth substances|mesh-ancestor
102052869|NCT03934684|Growth Inhibitors|growth inhibitors|mesh-ancestor
102052870|NCT03875235|Durvalumab|durvalumab|mesh-list
102052871|NCT03875235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102052872|NCT03875235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102052873|NCT03873805|Vidarabine|vidarabine|mesh-list
102052874|NCT03873805|Cyclophosphamide|cyclophosphamide|mesh-list
102052875|NCT03873805|Fludarabine|fludarabine|mesh-list
102052936|NCT03660930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102052937|NCT03660930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102052947|NCT03643796|Dexmedetomidine|dexmedetomidine|mesh-list
102053007|NCT03436433|Levetiracetam|levetiracetam|mesh-list
102053008|NCT03436433|Anticonvulsants|anticonvulsants|mesh-ancestor
102053009|NCT03436433|Nootropic Agents|nootropic agents|mesh-ancestor
101778274|NCT00647556|Dermatologic Agents|dermatologic agents|mesh-ancestor
102053010|NCT03436433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102053011|NCT03436433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102053080|NCT03279289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102053081|NCT03279289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102053082|NCT03279289|Immunologic Factors|immunologic factors|mesh-ancestor
102053083|NCT03279289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053084|NCT03279289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102053085|NCT03279289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102053086|NCT03279289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102053087|NCT03279289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102053088|NCT03279289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102053089|NCT03279289|Growth Substances|growth substances|mesh-ancestor
102053090|NCT03279289|Growth Inhibitors|growth inhibitors|mesh-ancestor
102053091|NCT03279289|Antidotes|antidotes|mesh-ancestor
102053092|NCT03279289|Protective Agents|protective agents|mesh-ancestor
102053093|NCT03279289|Vitamin B Complex|vitamin b complex|mesh-ancestor
102053094|NCT03279289|Vitamins|vitamins|mesh-ancestor
102053095|NCT03279289|Micronutrients|micronutrients|mesh-ancestor
102053096|NCT03279289|Hematinics|hematinics|mesh-ancestor
102053097|NCT03207867|Spartalizumab|spartalizumab|mesh-list
102053098|NCT03207867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102053137|NCT03176498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102053138|NCT03176498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053139|NCT03176498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102053140|NCT03176498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102053141|NCT03176498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102053143|NCT03176498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102053144|NCT03176498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102053145|NCT03176498|Antimetabolites|antimetabolites|mesh-ancestor
102053146|NCT03176498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102053200|NCT02949284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102053201|NCT02949284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102053202|NCT02949284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102053203|NCT02949284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053204|NCT02949284|Hormone Antagonists|hormone antagonists|mesh-ancestor
102053205|NCT02949284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102053206|NCT02949284|Androgen Antagonists|androgen antagonists|mesh-ancestor
102053207|NCT02916862|Calcium, Dietary|calcium, dietary|mesh-list
102053266|NCT02473042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102053267|NCT02473042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102053268|NCT02473042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102053269|NCT02473042|Antipruritics|antipruritics|mesh-ancestor
102053270|NCT02473042|Dermatologic Agents|dermatologic agents|mesh-ancestor
102053271|NCT02473042|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102053272|NCT02473042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102053273|NCT02473042|Serotonin Agents|serotonin agents|mesh-ancestor
102053274|NCT02473042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102053275|NCT02473042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053276|NCT02473042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102053277|NCT02473042|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102053278|NCT02473042|Histamine Antagonists|histamine antagonists|mesh-ancestor
102053279|NCT02473042|Histamine Agents|histamine agents|mesh-ancestor
102053280|NCT02473042|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102053281|NCT02473042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102053282|NCT02359331|Amoxicillin|amoxicillin|mesh-list
102053283|NCT02359331|Moxifloxacin|moxifloxacin|mesh-list
102053284|NCT02359331|Metronidazole|metronidazole|mesh-list
102053285|NCT02359331|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102053286|NCT02359331|Tetracycline|tetracycline|mesh-list
102053287|NCT02359331|Anti-Infective Agents|anti-infective agents|mesh-list
102053322|NCT02057133|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102053323|NCT02057133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102053324|NCT02057133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102053326|NCT02057133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102053394|NCT01529593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102053395|NCT01529593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053396|NCT01529593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102053397|NCT01529593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102053398|NCT01529593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053399|NCT01529593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102053400|NCT01529593|Immunologic Factors|immunologic factors|mesh-ancestor
102053401|NCT01529593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102053402|NCT01529593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102053403|NCT01529593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102053404|NCT01529593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102053405|NCT01529593|Antifungal Agents|antifungal agents|mesh-ancestor
102053407|NCT01446133|Lenalidomide|lenalidomide|mesh-list
102053408|NCT01446133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102053409|NCT01446133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102053410|NCT01446133|Immunologic Factors|immunologic factors|mesh-ancestor
102053411|NCT01446133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053412|NCT01446133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102053413|NCT01446133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102053414|NCT01446133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102053415|NCT01446133|Growth Substances|growth substances|mesh-ancestor
102053416|NCT01446133|Growth Inhibitors|growth inhibitors|mesh-ancestor
102053417|NCT01424982|Cytarabine|cytarabine|mesh-list
102053418|NCT01424982|Dexamethasone|dexamethasone|mesh-list
102053419|NCT01424982|Prednisone|prednisone|mesh-list
102053446|NCT01424982|Autonomic Agents|autonomic agents|mesh-ancestor
102053447|NCT01424982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102053448|NCT01424982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102053449|NCT01424982|Glucocorticoids|glucocorticoids|mesh-ancestor
102053450|NCT01424982|Hormones|hormones|mesh-ancestor
102053452|NCT01424982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102053516|NCT01187199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102053518|NCT01187199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102053519|NCT01187199|Immunologic Factors|immunologic factors|mesh-ancestor
102053520|NCT01187199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102053521|NCT01187199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102053522|NCT01187199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102053523|NCT01187199|Antifungal Agents|antifungal agents|mesh-ancestor
102053524|NCT00778063|Dexmedetomidine|dexmedetomidine|mesh-list
102053525|NCT00778063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102053526|NCT00778063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102053527|NCT00778063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053528|NCT00778063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102053577|NCT00330941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053579|NCT03149107|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102053580|NCT03149107|Antiviral Agents|antiviral agents|mesh-ancestor
102053581|NCT03149107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102053582|NCT03149107|Expectorants|expectorants|mesh-ancestor
102053648|NCT05759845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102053649|NCT05759845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102053650|NCT05759845|Analgesics|analgesics|mesh-ancestor
102053651|NCT05759845|Sensory System Agents|sensory system agents|mesh-ancestor
102053652|NCT05759845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102053653|NCT05759845|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102053657|NCT05759845|Adrenergic Agents|adrenergic agents|mesh-ancestor
102053716|NCT02128646|Analgesics|analgesics|mesh-ancestor
102053717|NCT02128646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102053718|NCT02128646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102053719|NCT02128646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102053720|NCT02128646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102053721|NCT02128646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053722|NCT05199103|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102053731|NCT05198947|Ivermectin|ivermectin|mesh-list
102053784|NCT02129114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102053785|NCT02129114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102053786|NCT02136992|Pirfenidone|pirfenidone|mesh-list
102053787|NCT02136992|Analgesics|analgesics|mesh-ancestor
102053788|NCT02136992|Sensory System Agents|sensory system agents|mesh-ancestor
102053792|NCT02136992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102053853|NCT02137616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102053854|NCT02137616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102053857|NCT02137616|Dopamine Agents|dopamine agents|mesh-ancestor
102053922|NCT02138084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
102053923|NCT02129582|Methotrexate|methotrexate|mesh-list
102053924|NCT02129582|Fludarabine phosphate|fludarabine phosphate|mesh-list
102053925|NCT02129582|Fludarabine|fludarabine|mesh-list
102053926|NCT02129582|Busulfan|busulfan|mesh-list
102053927|NCT02129582|Tacrolimus|tacrolimus|mesh-list
102053928|NCT02129582|Thymoglobulin|thymoglobulin|mesh-list
102053929|NCT02129582|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102053930|NCT02129582|Immunoglobulins|immunoglobulins|mesh-list
102053931|NCT02129582|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102053932|NCT02129582|Abortifacient Agents|abortifacient agents|mesh-ancestor
102053933|NCT02129582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102053934|NCT02129582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053935|NCT02129582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102053936|NCT02129582|Antimetabolites|antimetabolites|mesh-ancestor
102053937|NCT02129582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102053938|NCT02129582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102053939|NCT02129582|Dermatologic Agents|dermatologic agents|mesh-ancestor
102053940|NCT02129582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102053941|NCT02129582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102053942|NCT02129582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102053943|NCT02129582|Immunologic Factors|immunologic factors|mesh-ancestor
102053944|NCT02129582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102053945|NCT02129582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102053946|NCT02129582|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102053947|NCT02129582|Alkylating Agents|alkylating agents|mesh-ancestor
102053948|NCT02129582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102053949|NCT02129582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102053950|NCT02138396|Fentanyl|fentanyl|mesh-list
102053951|NCT02138396|Naltrexone|naltrexone|mesh-list
102053952|NCT02138396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102053953|NCT02138396|Narcotics|narcotics|mesh-ancestor
102053967|NCT04560881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102053969|NCT02828761|Calcium|calcium|mesh-list
102053970|NCT02828761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102054037|NCT05062135|Hormones|hormones|mesh-ancestor
102054038|NCT05062135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102054039|NCT05062135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054040|NCT02130518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102054041|NCT02134106|Polymyxins|polymyxins|mesh-list
102054042|NCT02134106|Doripenem|doripenem|mesh-list
102054043|NCT02134106|Polymyxin B|polymyxin b|mesh-list
102054044|NCT02134106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102054045|NCT02134106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102054046|NCT01354301|Mycophenolic Acid|mycophenolic acid|mesh-list
102054047|NCT01354301|Everolimus|everolimus|mesh-list
102054048|NCT01354301|Tacrolimus|tacrolimus|mesh-list
102054049|NCT01354301|Thymoglobulin|thymoglobulin|mesh-list
102054050|NCT01354301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102054051|NCT01354301|Immunologic Factors|immunologic factors|mesh-ancestor
102054052|NCT01354301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054053|NCT01354301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102054054|NCT01354301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102054055|NCT01354301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054056|NCT01354301|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102054057|NCT01354301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102054058|NCT01354301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102054059|NCT01354301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102054060|NCT01354301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102054061|NCT01354301|Antitubercular Agents|antitubercular agents|mesh-ancestor
102054064|NCT02134262|Cyclophosphamide|cyclophosphamide|mesh-list
102054087|NCT02253212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102054088|NCT01355939|Zinc Oxide|zinc oxide|mesh-list
102054089|NCT01355939|Dermatologic Agents|dermatologic agents|mesh-ancestor
102054090|NCT01355939|Sunscreening Agents|sunscreening agents|mesh-ancestor
102054092|NCT01355939|Protective Agents|protective agents|mesh-ancestor
102054156|NCT01360151|Ranibizumab|ranibizumab|mesh-list
102054157|NCT01360151|Verteporfin|verteporfin|mesh-list
102054158|NCT01360151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102054159|NCT01360151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102054160|NCT01360151|Growth Substances|growth substances|mesh-ancestor
102054161|NCT01360151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054162|NCT01360151|Growth Inhibitors|growth inhibitors|mesh-ancestor
102054163|NCT01360151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102054164|NCT01360151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102054165|NCT01360151|Dermatologic Agents|dermatologic agents|mesh-ancestor
102054166|NCT01363037|Maraviroc|maraviroc|mesh-list
102054167|NCT01363037|Dapivirine|dapivirine|mesh-list
102054176|NCT01363115|Vitamin D|vitamin d|mesh-list
102054221|NCT02134886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102054222|NCT02134886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102054224|NCT01360463|Methadone|methadone|mesh-list
102054294|NCT01319357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054295|NCT01319357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102054296|NCT02135354|Azithromycin|azithromycin|mesh-list
102054297|NCT02135354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102054298|NCT02135354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102054299|NCT02055053|Bupivacaine|bupivacaine|mesh-list
102054300|NCT02055053|Anesthetics, Local|anesthetics, local|mesh-ancestor
102054301|NCT02055053|Anesthetics|anesthetics|mesh-ancestor
102054302|NCT02055053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102054360|NCT02135588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054366|NCT01491763|Imatinib Mesylate|imatinib mesylate|mesh-list
102054367|NCT01491763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102054368|NCT01491763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102054369|NCT01491763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102054370|NCT01491763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054371|NCT01363817|Dexamethasone|dexamethasone|mesh-list
102054372|NCT01363817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102054433|NCT01356797|Sensory System Agents|sensory system agents|mesh-ancestor
102054434|NCT01356797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102054435|NCT01356797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102054436|NCT01356797|Narcotics|narcotics|mesh-ancestor
102054437|NCT01356797|Analgesics|analgesics|mesh-ancestor
102054441|NCT02238132|Ipratropium|ipratropium|mesh-list
102054504|NCT03598452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102054505|NCT03598452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054506|NCT03549026|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102054575|NCT03862170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102054576|NCT03862170|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102054577|NCT03862170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102054578|NCT02140580|Pulmonary Surfactants|pulmonary surfactants|mesh-list
102054648|NCT03585894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102054649|NCT03585894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054650|NCT03585894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102054651|NCT03585894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102054718|NCT02238288|Sympathomimetics|sympathomimetics|mesh-ancestor
102054719|NCT02238288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102054720|NCT02238288|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102054790|NCT02253446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054792|NCT05417893|Everolimus|everolimus|mesh-list
102054793|NCT05417893|MTOR Inhibitors|mtor inhibitors|mesh-list
102054794|NCT05417893|Temsirolimus|temsirolimus|mesh-list
102054795|NCT05417893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102054796|NCT05417893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102054797|NCT05417893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054798|NCT05417893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102054799|NCT05417893|Immunologic Factors|immunologic factors|mesh-ancestor
102054800|NCT05417893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054801|NCT05417893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102054802|NCT05417893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102054803|NCT05417893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102054804|NCT05417893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102054805|NCT05417893|Antifungal Agents|antifungal agents|mesh-ancestor
102054806|NCT03585348|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
102054807|NCT03585348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102054819|NCT01563224|Baclofen|baclofen|mesh-list
102054845|NCT03432065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102054846|NCT03432065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102054847|NCT03432065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054848|NCT03432065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102054849|NCT03432065|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102054850|NCT03432065|Serotonin Agents|serotonin agents|mesh-ancestor
102054851|NCT03432065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102054852|NCT03432065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102054853|NCT03577626|Hemay005|hemay005|mesh-list
102054854|NCT03577626|Dermatologic Agents|dermatologic agents|mesh-ancestor
102054855|NCT03577626|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102054856|NCT03577626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102054857|NCT03577626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102054859|NCT03412799|Paclitaxel|paclitaxel|mesh-list
102054905|NCT04631471|Autonomic Agents|autonomic agents|mesh-ancestor
102054906|NCT04631471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102054907|NCT04631471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054976|NCT02253758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102054977|NCT02253758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102054978|NCT02253758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102054979|NCT02253758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102054980|NCT02253758|Anesthetics, General|anesthetics, general|mesh-ancestor
102055046|NCT05179772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102055047|NCT05179772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102055048|NCT05179772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102055049|NCT05179772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102055050|NCT05179772|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102055051|NCT05179772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102055052|NCT05179772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102055053|NCT05179772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055056|NCT01364987|Mycophenolic Acid|mycophenolic acid|mesh-list
102055112|NCT05574998|Mitosis Modulators|mitosis modulators|mesh-ancestor
102055113|NCT05574998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055114|NCT05574998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102055115|NCT05574998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102055116|NCT05574998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102055117|NCT05574998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102055118|NCT05574998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102055119|NCT05574998|Growth Substances|growth substances|mesh-ancestor
102055120|NCT05574998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778341|NCT00815568|Busulfan|busulfan|mesh-list
102055121|NCT05574998|Growth Inhibitors|growth inhibitors|mesh-ancestor
102055176|NCT03576456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102055177|NCT03576456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102055178|NCT03576456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102055179|NCT03576456|GABA Modulators|gaba modulators|mesh-ancestor
102055180|NCT03576456|GABA Agents|gaba agents|mesh-ancestor
102055181|NCT03576456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102055182|NCT03576456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055183|NCT03576378|Prednisone|prednisone|mesh-list
102055184|NCT03576378|Cyclophosphamide|cyclophosphamide|mesh-list
102055185|NCT03576378|Etoposide|etoposide|mesh-list
102055186|NCT03576378|Mitoxantrone|mitoxantrone|mesh-list
102055187|NCT03576378|Procarbazine|procarbazine|mesh-list
102055188|NCT03576378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102055189|NCT03576378|Immunologic Factors|immunologic factors|mesh-ancestor
102055191|NCT03576378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102055238|NCT04465916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102055239|NCT04465916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102055240|NCT04465916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055241|NCT04465916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102055242|NCT04465916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102055243|NCT01366235|Chloroquine|chloroquine|mesh-list
102055244|NCT01366235|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
102055245|NCT01366235|Amebicides|amebicides|mesh-ancestor
102055246|NCT01366235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102055247|NCT01366235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102055248|NCT01366235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102055249|NCT01366235|Antimalarials|antimalarials|mesh-ancestor
102055250|NCT01366235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102055251|NCT01366235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102055301|NCT02253524|Autonomic Agents|autonomic agents|mesh-ancestor
102055302|NCT02253524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102055303|NCT02253524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055304|NCT02253524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102055305|NCT02253524|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102055306|NCT02253524|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102055307|NCT02253524|Dopamine Agents|dopamine agents|mesh-ancestor
102055308|NCT02253524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102055309|NCT02253524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055310|NCT02253524|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102055311|NCT02253524|Histamine Antagonists|histamine antagonists|mesh-ancestor
102055312|NCT02253524|Histamine Agents|histamine agents|mesh-ancestor
102055313|NCT02253602|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102055314|NCT02253602|Hematinics|hematinics|mesh-ancestor
102055315|NCT02253602|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102055316|NCT02253602|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102055317|NCT03575520|Cyclophosphamide|cyclophosphamide|mesh-list
102055318|NCT03575520|Doxorubicin|doxorubicin|mesh-list
102055319|NCT03575520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102055320|NCT03575520|Immunologic Factors|immunologic factors|mesh-ancestor
102055321|NCT03575520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055355|NCT02239614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055356|NCT02239614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102055357|NCT03572400|Gemcitabine|gemcitabine|mesh-list
102055358|NCT03572400|Durvalumab|durvalumab|mesh-list
102055359|NCT03572400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102055360|NCT03572400|Antimetabolites|antimetabolites|mesh-ancestor
102055361|NCT03572400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055362|NCT03572400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102055363|NCT03572400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102055364|NCT02253836|Ritonavir|ritonavir|mesh-list
102055365|NCT02253836|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102055366|NCT02253836|Tipranavir|tipranavir|mesh-list
102055367|NCT02253836|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102055368|NCT02253836|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102055369|NCT02253836|Protease Inhibitors|protease inhibitors|mesh-ancestor
102055370|NCT02253836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102055371|NCT02253836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055372|NCT02253836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102055373|NCT02253836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102055374|NCT02253836|Antiviral Agents|antiviral agents|mesh-ancestor
102055375|NCT02253836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102055376|NCT02253836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102055377|NCT02253836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102055378|NCT03575130|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102055379|NCT03575130|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102055380|NCT02241018|Antibodies|antibodies|mesh-list
102055402|NCT04039022|Antitussive Agents|antitussive agents|mesh-ancestor
102055403|NCT04039022|Respiratory System Agents|respiratory system agents|mesh-ancestor
102055475|NCT03546530|Antiviral Agents|antiviral agents|mesh-ancestor
102055476|NCT03546530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102055477|NCT03546530|Antioxidants|antioxidants|mesh-ancestor
102055478|NCT03546530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055546|NCT01366547|Antimetabolites|antimetabolites|mesh-ancestor
102055547|NCT05190341|Ibuprofen|ibuprofen|mesh-list
102055548|NCT05190341|Ketorolac|ketorolac|mesh-list
102055549|NCT05190341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102055550|NCT05190341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102055551|NCT05190341|Analgesics|analgesics|mesh-ancestor
102055552|NCT05190341|Sensory System Agents|sensory system agents|mesh-ancestor
102055553|NCT05190341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102055554|NCT05190341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055555|NCT05190341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102055556|NCT05190341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102055557|NCT05190341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102055558|NCT05190341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102055559|NCT05190341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055560|NCT04347239|Leronlimab|leronlimab|mesh-list
102055561|NCT04347239|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102055605|NCT00109850|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102055681|NCT02254148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102055682|NCT02254148|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102055683|NCT02254148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102055684|NCT02254148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102055685|NCT02254148|Sympatholytics|sympatholytics|mesh-ancestor
102055686|NCT02254148|Autonomic Agents|autonomic agents|mesh-ancestor
102055687|NCT02254148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102055688|NCT02254148|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102055750|NCT03571230|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102055751|NCT03571230|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102055752|NCT03571230|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102055753|NCT03571230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102055754|NCT03571230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055755|NCT03571230|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102055756|NCT03571230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102055757|NCT03571230|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102055758|NCT03571230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102055759|NCT03571230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102055760|NCT03571230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102055761|NCT03571230|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102055762|NCT03571230|Antacids|antacids|mesh-ancestor
102055813|NCT05489211|Micronutrients|micronutrients|mesh-ancestor
102055814|NCT05489211|Antiemetics|antiemetics|mesh-ancestor
102055815|NCT05489211|Autonomic Agents|autonomic agents|mesh-ancestor
102055816|NCT05489211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102055817|NCT05489211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102055818|NCT05489211|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102055819|NCT02254226|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102055820|NCT02254226|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102055821|NCT02254226|Autonomic Agents|autonomic agents|mesh-ancestor
101778377|NCT01062139|Cetirizine|cetirizine|mesh-list
102055822|NCT02254226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102055823|NCT02254226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102055824|NCT02254226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102055825|NCT02254226|Respiratory System Agents|respiratory system agents|mesh-ancestor
102055826|NCT02254226|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102055827|NCT02254226|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102055828|NCT02254226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102055871|NCT03545516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055873|NCT04753879|Gemcitabine|gemcitabine|mesh-list
102055942|NCT04704219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102055943|NCT04704219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102055945|NCT00842348|Lanreotide|lanreotide|mesh-list
102055946|NCT00842348|Somatostatin|somatostatin|mesh-list
102055947|NCT00842348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102055948|NCT00842348|Hormones|hormones|mesh-ancestor
102056009|NCT02649673|Topotecan|topotecan|mesh-list
102056010|NCT02649673|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102056015|NCT03568968|Niacinamide|niacinamide|mesh-list
102056083|NCT01367483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056084|NCT01367483|Sensory System Agents|sensory system agents|mesh-ancestor
102056085|NCT01367483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102056086|NCT02140736|Epoetin Alfa|epoetin alfa|mesh-list
102056087|NCT02140736|Hematinics|hematinics|mesh-ancestor
102056088|NCT05417035|Testosterone undecanoate|testosterone undecanoate|mesh-list
102056153|NCT02144792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102056154|NCT02144792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056155|NCT02144792|Vasodilator Agents|vasodilator agents|mesh-ancestor
102056156|NCT03566394|Gabapentin|gabapentin|mesh-list
102056157|NCT03566394|Analgesics|analgesics|mesh-ancestor
102056158|NCT03566394|Sensory System Agents|sensory system agents|mesh-ancestor
102056159|NCT03566394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102056219|NCT02145104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102056220|NCT02145104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102056290|NCT03567408|Bivalirudin|bivalirudin|mesh-list
102056291|NCT03567408|Antithrombins|antithrombins|mesh-ancestor
102056292|NCT03567408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102056293|NCT03567408|Protease Inhibitors|protease inhibitors|mesh-ancestor
102056294|NCT03567408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102056295|NCT03567408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056296|NCT03567408|Anticoagulants|anticoagulants|mesh-ancestor
102056297|NCT05354076|Doxorubicin|doxorubicin|mesh-list
102056298|NCT05354076|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102056299|NCT05354076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102056300|NCT05354076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102056301|NCT05354076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102056355|NCT04162756|Cyclophosphamide|cyclophosphamide|mesh-list
102056356|NCT04162756|Fludarabine|fludarabine|mesh-list
102056357|NCT04162756|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
102056358|NCT04162756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102056359|NCT04162756|Immunologic Factors|immunologic factors|mesh-ancestor
102056360|NCT04162756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056361|NCT04162756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102056362|NCT04162756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102056363|NCT04162756|Alkylating Agents|alkylating agents|mesh-ancestor
102056364|NCT04162756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056365|NCT04162756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102056366|NCT04162756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102056367|NCT04162756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102056368|NCT04544267|Vaccines|vaccines|mesh-list
102056369|NCT04544267|Immunologic Factors|immunologic factors|mesh-ancestor
102056414|NCT01368419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102056415|NCT01368419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102056416|NCT01368419|Growth Substances|growth substances|mesh-ancestor
102056417|NCT01368419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056418|NCT01368419|Growth Inhibitors|growth inhibitors|mesh-ancestor
102056419|NCT01368419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102056420|NCT04639219|Trastuzumab|trastuzumab|mesh-list
102056421|NCT04639219|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
102056422|NCT04639219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102056423|NCT04639219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102056477|NCT03110848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102056479|NCT03110848|Protective Agents|protective agents|mesh-ancestor
102056480|NCT03110848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102056481|NCT03110848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102056482|NCT03139474|Hormones|hormones|mesh-list
102056483|NCT03139474|Hormone Antagonists|hormone antagonists|mesh-list
102056484|NCT03139474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102056485|NCT03139474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056486|NCT01368887|Niacinamide|niacinamide|mesh-list
102056487|NCT01368887|Niacin|niacin|mesh-list
102056488|NCT01368887|Nicotinic Acids|nicotinic acids|mesh-list
102056538|NCT03521687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102056539|NCT03521687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056540|NCT03521687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102056541|NCT03521687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102056542|NCT03521687|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102056543|NCT03521687|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102056544|NCT03521687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102056545|NCT03521687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056546|NCT03141658|Ketamine|ketamine|mesh-list
102056547|NCT03141658|Analgesics|analgesics|mesh-ancestor
102056548|NCT03141658|Sensory System Agents|sensory system agents|mesh-ancestor
102056549|NCT03141658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102056550|NCT03141658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056551|NCT03141658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102056552|NCT03141658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102056553|NCT03141658|Anesthetics, General|anesthetics, general|mesh-ancestor
102056554|NCT03141658|Anesthetics|anesthetics|mesh-ancestor
102056555|NCT03141658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102056556|NCT03141658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102056557|NCT03141658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102056558|NCT03141658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102056559|NCT03141658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056560|NCT03498131|Melatonin|melatonin|mesh-list
102056561|NCT03498131|Antioxidants|antioxidants|mesh-ancestor
102056562|NCT03498131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056563|NCT03498131|Protective Agents|protective agents|mesh-ancestor
102056564|NCT03498131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056565|NCT03498131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102056566|NCT01319825|Milnacipran|milnacipran|mesh-list
102056567|NCT01319825|Levomilnacipran|levomilnacipran|mesh-list
102056578|NCT01319825|Antidepressive Agents|antidepressive agents|mesh-ancestor
102056579|NCT01319825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102056580|NCT01369277|Nicotinic Acids|nicotinic acids|mesh-list
102056581|NCT01369277|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
102056582|NCT01369277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102056583|NCT01369277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056584|NCT01369277|Vitamin B Complex|vitamin b complex|mesh-ancestor
102056585|NCT01369277|Vitamins|vitamins|mesh-ancestor
102056586|NCT01369277|Micronutrients|micronutrients|mesh-ancestor
102056587|NCT01369277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056588|NCT02983006|Nivolumab|nivolumab|mesh-list
102056589|NCT02983006|DS-8273a|ds-8273a|mesh-list
102056590|NCT02983006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102056591|NCT02983006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102056592|NCT02983006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102056594|NCT03811756|Coenzyme Q10|coenzyme q10|mesh-list
102056638|NCT05760053|Carboplatin|carboplatin|mesh-list
102056639|NCT05760053|Etoposide|etoposide|mesh-list
102056640|NCT05760053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102056641|NCT05760053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102056644|NCT05760053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102056711|NCT05375305|Sensory System Agents|sensory system agents|mesh-ancestor
102056712|NCT05375305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102056784|NCT02681237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056785|NCT02681237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102056786|NCT02681237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102056788|NCT00089245|Cadexomer iodine|cadexomer iodine|mesh-list
102056789|NCT00089245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102056790|NCT00089245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102056791|NCT00089245|Trace Elements|trace elements|mesh-ancestor
102056792|NCT00089245|Micronutrients|micronutrients|mesh-ancestor
102056793|NCT00089245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056794|NCT02674529|Escitalopram|escitalopram|mesh-list
102056795|NCT02674529|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102056796|NCT02674529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102056797|NCT02674529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102056798|NCT02674529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056799|NCT02674529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102056800|NCT02674529|Serotonin Agents|serotonin agents|mesh-ancestor
102056801|NCT02674529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056802|NCT05081986|Cycloserine|cycloserine|mesh-list
102056803|NCT05081986|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102056804|NCT05081986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102056805|NCT05081986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102056806|NCT05081986|Antitubercular Agents|antitubercular agents|mesh-ancestor
102056807|NCT05081986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102056808|NCT05081986|Antimetabolites|antimetabolites|mesh-ancestor
102056809|NCT05081986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056810|NCT05418907|Exenatide|exenatide|mesh-list
102056811|NCT05418907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102056812|NCT05418907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056813|NCT05418907|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102056814|NCT05418907|Incretins|incretins|mesh-ancestor
102056815|NCT05418907|Hormones|hormones|mesh-ancestor
101358383|NCT00203359|Analgesics|analgesics|mesh-ancestor
101607647|NCT04163536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101607648|NCT04163536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607649|NCT04163536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101607650|NCT04163536|Glucocorticoids|glucocorticoids|mesh-ancestor
101607651|NCT04163536|Hormones|hormones|mesh-ancestor
101607652|NCT04163536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101607653|NCT04163536|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102056816|NCT05418907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102056817|NCT02666599|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102056818|NCT02666599|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102056819|NCT02666599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056821|NCT03632317|Panobinostat|panobinostat|mesh-list
102056822|NCT03632317|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102056823|NCT03632317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102056824|NCT03632317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102056825|NCT03632317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056826|NCT03632317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102056827|NCT03632317|Immunologic Factors|immunologic factors|mesh-ancestor
102056828|NCT03632317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102056829|NCT03632317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102056830|NCT03632317|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102056831|NCT02591784|Nimotuzumab|nimotuzumab|mesh-list
102056832|NCT02591784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102056833|NCT02591784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102056834|NCT02653963|Triamcinolone|triamcinolone|mesh-list
102056835|NCT02653963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102056836|NCT02653963|Glucocorticoids|glucocorticoids|mesh-ancestor
102056837|NCT02653963|Hormones|hormones|mesh-ancestor
102056868|NCT04052776|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
102056869|NCT04052776|Buspirone|buspirone|mesh-list
102056870|NCT04052776|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102056871|NCT04052776|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102056938|NCT04005209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102056939|NCT03904108|Ramucirumab|ramucirumab|mesh-list
102056940|NCT03904108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102056941|NCT02833350|Folic Acid|folic acid|mesh-list
102056942|NCT02833350|Adalimumab|adalimumab|mesh-list
102057007|NCT03355534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102057008|NCT03355534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102057009|NCT03355534|Adrenergic Agents|adrenergic agents|mesh-ancestor
102057010|NCT03355534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102057011|NCT03355534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057012|NCT05385562|Triamcinolone|triamcinolone|mesh-list
102057013|NCT05385562|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102057014|NCT05385562|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102057015|NCT05385562|Hyaluronic Acid|hyaluronic acid|mesh-list
102057016|NCT05385562|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102057017|NCT05385562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102057018|NCT05385562|Glucocorticoids|glucocorticoids|mesh-ancestor
102057019|NCT05385562|Hormones|hormones|mesh-ancestor
102057020|NCT05385562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102057021|NCT05385562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057022|NCT05385562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102057023|NCT05385562|Immunologic Factors|immunologic factors|mesh-ancestor
102057024|NCT05385562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102057063|NCT03139708|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102057064|NCT03139708|Cholinergic Agents|cholinergic agents|mesh-ancestor
102057065|NCT01358760|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
102057066|NCT01358760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102057067|NCT01358760|Immunologic Factors|immunologic factors|mesh-ancestor
102057068|NCT01358760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057069|NCT05330364|Cladribine|cladribine|mesh-list
102057070|NCT05330364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102057071|NCT05330364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102057072|NCT05330364|Immunologic Factors|immunologic factors|mesh-ancestor
102057073|NCT05330364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057074|NCT05087368|Vaccines|vaccines|mesh-list
102057075|NCT05087368|Immunologic Factors|immunologic factors|mesh-ancestor
102057076|NCT05087368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057077|NCT01341990|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102057078|NCT05087134|Choline|choline|mesh-list
102057079|NCT05087134|Lipotropic Agents|lipotropic agents|mesh-ancestor
102057080|NCT05087134|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102057081|NCT05087134|Antimetabolites|antimetabolites|mesh-ancestor
102057082|NCT05087134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057083|NCT05087134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102057084|NCT05087134|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102057085|NCT05087134|Nootropic Agents|nootropic agents|mesh-ancestor
102057086|NCT03048747|Tolvaptan|tolvaptan|mesh-list
101607661|NCT00652288|Insulin, Long-Acting|insulin, long-acting|mesh-list
101607662|NCT00652288|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101607663|NCT00652288|Insulin Lispro|insulin lispro|mesh-list
101607664|NCT00652288|Insulin Detemir|insulin detemir|mesh-list
101607665|NCT00652288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101607666|NCT00652288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607667|NCT00911092|Fluorouracil|fluorouracil|mesh-list
101607668|NCT00911092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101607669|NCT00911092|Antimetabolites|antimetabolites|mesh-ancestor
101607670|NCT00911092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778426|NCT00780728|Sildenafil Citrate|sildenafil citrate|mesh-list
101607671|NCT00911092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101607672|NCT00911092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101607673|NCT00911092|Immunologic Factors|immunologic factors|mesh-ancestor
101607674|NCT00911092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607675|NCT02635360|Pembrolizumab|pembrolizumab|mesh-list
101607676|NCT02635360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101607677|NCT02635360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101607678|NCT02635360|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101607679|NCT02635360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607680|NCT02635282|Fentanyl|fentanyl|mesh-list
101607681|NCT02635282|Midazolam|midazolam|mesh-list
101607682|NCT02635282|Ketamine|ketamine|mesh-list
101607683|NCT02635282|Analgesics|analgesics|mesh-ancestor
101607684|NCT02635282|Sensory System Agents|sensory system agents|mesh-ancestor
101607685|NCT02635282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101607686|NCT02635282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607687|NCT02635282|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101607688|NCT02635282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101607689|NCT02635282|Anesthetics, General|anesthetics, general|mesh-ancestor
101607690|NCT02635282|Anesthetics|anesthetics|mesh-ancestor
101607691|NCT02635282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101607692|NCT02635282|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101607693|NCT02635282|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101607694|NCT02635282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101607695|NCT02635282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607696|NCT02635282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101264691|NCT01768897|Vitamins|vitamins|mesh-ancestor
101607701|NCT02635282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101607702|NCT02635282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101607703|NCT02635282|GABA Modulators|gaba modulators|mesh-ancestor
101607704|NCT02635282|GABA Agents|gaba agents|mesh-ancestor
101607705|NCT00655798|Antioxidants|antioxidants|mesh-list
101607706|NCT00655798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607707|NCT00655798|Protective Agents|protective agents|mesh-ancestor
101607708|NCT00655798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607709|NCT02637700|Immunoglobulins|immunoglobulins|mesh-list
101607710|NCT02637700|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101607712|NCT02637700|gamma-Globulins|gamma-globulins|mesh-list
101607714|NCT02637700|Immunologic Factors|immunologic factors|mesh-ancestor
101607715|NCT02637700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607716|NCT02637466|Vortioxetine|vortioxetine|mesh-list
101607717|NCT02637466|Antidepressive Agents|antidepressive agents|mesh-ancestor
101607718|NCT02637466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101607719|NCT02637466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101607720|NCT02637466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101607721|NCT02637466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101607722|NCT02637466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607723|NCT02637466|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101607724|NCT02637466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101607725|NCT02637466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101607726|NCT02637466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607727|NCT02637466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101607728|NCT02637466|Serotonin Agents|serotonin agents|mesh-ancestor
101607729|NCT02637466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101607730|NCT02637466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101607731|NCT02637466|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101607732|NCT02637466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101607733|NCT02634970|Ranibizumab|ranibizumab|mesh-list
101607735|NCT02634970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101607736|NCT02634970|Growth Substances|growth substances|mesh-ancestor
101607737|NCT02634970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607738|NCT02634970|Growth Inhibitors|growth inhibitors|mesh-ancestor
101607739|NCT02634970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101607740|NCT00885352|Metformin|metformin|mesh-list
101607741|NCT00885352|Pioglitazone|pioglitazone|mesh-list
101607742|NCT00885352|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101607743|NCT00885352|Glipizide|glipizide|mesh-list
101607744|NCT00885352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101607745|NCT00885352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607746|NCT00885352|Incretins|incretins|mesh-ancestor
101607747|NCT00885352|Hormones|hormones|mesh-ancestor
101607748|NCT00885352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101607749|NCT00885352|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101607750|NCT00885352|Protease Inhibitors|protease inhibitors|mesh-ancestor
101607751|NCT00885352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101607752|NCT00885352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607753|NCT00656032|Cinacalcet|cinacalcet|mesh-list
101607754|NCT00656032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101607755|NCT00656032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607756|NCT00656032|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101607757|NCT00656032|Hormone Antagonists|hormone antagonists|mesh-ancestor
101607758|NCT00656032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101607759|NCT00885118|Empagliflozin|empagliflozin|mesh-list
101607760|NCT00885118|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101607761|NCT00885118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607762|NCT00885118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101607763|NCT00885118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607764|NCT00656812|Rituximab|rituximab|mesh-list
102057136|NCT02123823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057137|NCT02123823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102057138|NCT02123823|Immunologic Factors|immunologic factors|mesh-ancestor
102057139|NCT02123823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057140|NCT02123823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101607765|NCT00656812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101607766|NCT00656812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101607767|NCT00656812|Immunologic Factors|immunologic factors|mesh-ancestor
101607771|NCT00656110|Methylprednisolone|methylprednisolone|mesh-list
101607772|NCT00656110|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101607773|NCT00656110|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101607774|NCT00656110|Prednisolone|prednisolone|mesh-list
101607775|NCT00656110|Prednisolone acetate|prednisolone acetate|mesh-list
101607776|NCT00656110|Lidocaine|lidocaine|mesh-list
101607777|NCT00656110|Bupivacaine|bupivacaine|mesh-list
101607778|NCT00656110|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101607779|NCT00656110|Prednisolone phosphate|prednisolone phosphate|mesh-list
101607780|NCT00656110|Anesthetics, Local|anesthetics, local|mesh-ancestor
101607781|NCT00656110|Anesthetics|anesthetics|mesh-ancestor
101607782|NCT00656110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101607783|NCT00656110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607784|NCT00656110|Sensory System Agents|sensory system agents|mesh-ancestor
101607785|NCT00656110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101607786|NCT00656110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101607787|NCT00656110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101607788|NCT00656110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101607789|NCT00656110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101607790|NCT00656110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607791|NCT00656110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101607792|NCT00656110|Antiemetics|antiemetics|mesh-ancestor
101607793|NCT00656110|Autonomic Agents|autonomic agents|mesh-ancestor
101607794|NCT00656110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101607795|NCT00656110|Glucocorticoids|glucocorticoids|mesh-ancestor
101607796|NCT00656110|Hormones|hormones|mesh-ancestor
101607797|NCT00656110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101607798|NCT00656110|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101607799|NCT00656110|Protective Agents|protective agents|mesh-ancestor
101607800|NCT00656110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101607801|NCT00656110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101607802|NCT00656110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101607803|NCT00656110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101607804|NCT00656188|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101607805|NCT00656188|Vasodilator Agents|vasodilator agents|mesh-ancestor
101264984|NCT01770236|Sensory System Agents|sensory system agents|mesh-ancestor
101607806|NCT00656188|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101607807|NCT00656188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101607808|NCT00656188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101607809|NCT00656188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607810|NCT00656188|Urological Agents|urological agents|mesh-ancestor
101607812|NCT00880906|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101607813|NCT00880906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101607814|NCT00880906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101607815|NCT00880906|Autonomic Agents|autonomic agents|mesh-ancestor
101607816|NCT00880906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101607817|NCT00880906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607818|NCT00880906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101607819|NCT00880906|Respiratory System Agents|respiratory system agents|mesh-ancestor
101607820|NCT00880906|Dermatologic Agents|dermatologic agents|mesh-ancestor
101607821|NCT00880906|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101607822|NCT00880906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101607823|NCT00880906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607824|NCT04160026|Pyrimethamine|pyrimethamine|mesh-list
101607825|NCT04160026|Piperaquine|piperaquine|mesh-list
101607826|NCT04160026|Sulfadoxine|sulfadoxine|mesh-list
101607827|NCT04160026|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101607828|NCT04160026|Antimalarials|antimalarials|mesh-ancestor
101607829|NCT04160026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102057141|NCT02123823|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102057142|NCT02123823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102057143|NCT02123823|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102057144|NCT02123823|Hormone Antagonists|hormone antagonists|mesh-ancestor
102057145|NCT02123823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102057147|NCT05085652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102057148|NCT05085652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057149|NCT03136510|Apixaban|apixaban|mesh-list
102057150|NCT03136510|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101358744|NCT00072540|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101607830|NCT04160026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101607831|NCT04160026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101607832|NCT04160026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101607833|NCT04160026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101607834|NCT04160026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607835|NCT04160026|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101607836|NCT04159870|Rifaximin|rifaximin|mesh-list
101607837|NCT04159870|Norfloxacin|norfloxacin|mesh-list
101607838|NCT04159870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101607839|NCT04159870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101607842|NCT04159870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101607843|NCT04159870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101607844|NCT04159870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607845|NCT04159870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101607846|NCT04159870|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101607847|NCT04159870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101607849|NCT00657514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101607850|NCT00657514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101607851|NCT00657514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607852|NCT00656266|Mycophenolic Acid|mycophenolic acid|mesh-list
101607853|NCT00656266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101607854|NCT00656266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101607855|NCT00656266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101607856|NCT00656266|Antitubercular Agents|antitubercular agents|mesh-ancestor
101607857|NCT00656266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101607858|NCT00656266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101607859|NCT00656266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101607860|NCT00656266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607861|NCT00882310|Gemcitabine|gemcitabine|mesh-list
101607862|NCT00882310|Capecitabine|capecitabine|mesh-list
101607863|NCT00882310|Docetaxel|docetaxel|mesh-list
101607864|NCT00882310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101607865|NCT00882310|Antimetabolites|antimetabolites|mesh-ancestor
101607866|NCT00882310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607867|NCT00882310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101607868|NCT00882310|Tubulin Modulators|tubulin modulators|mesh-ancestor
101607869|NCT00882310|Antimitotic Agents|antimitotic agents|mesh-ancestor
101607870|NCT00882310|Mitosis Modulators|mitosis modulators|mesh-ancestor
101607871|NCT00884650|Analgesics|analgesics|mesh-list
101607872|NCT00884650|Sensory System Agents|sensory system agents|mesh-ancestor
101607873|NCT00884650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101607874|NCT00884650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607875|NCT02636842|Aripiprazole|aripiprazole|mesh-list
101607876|NCT02636842|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
101607877|NCT02636842|Antidepressive Agents|antidepressive agents|mesh-ancestor
101607878|NCT02636842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101607879|NCT02636842|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101607880|NCT02636842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101607881|NCT02636842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101607882|NCT02636842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607883|NCT02636842|Dopamine Agonists|dopamine agonists|mesh-ancestor
101607884|NCT02636842|Dopamine Agents|dopamine agents|mesh-ancestor
101607885|NCT02636842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102057152|NCT03136510|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102057153|NCT03136510|Protease Inhibitors|protease inhibitors|mesh-ancestor
102057154|NCT03136510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102057155|NCT03136510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057156|NCT03136510|Anticoagulants|anticoagulants|mesh-ancestor
102057157|NCT05692245|Dexamethasone|dexamethasone|mesh-list
102057158|NCT05692245|Ondansetron|ondansetron|mesh-list
102057159|NCT05692245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102057160|NCT05692245|Antiemetics|antiemetics|mesh-ancestor
102057161|NCT05692245|Autonomic Agents|autonomic agents|mesh-ancestor
102057162|NCT05692245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102057163|NCT05692245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057164|NCT05692245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102057165|NCT05692245|Glucocorticoids|glucocorticoids|mesh-ancestor
102057166|NCT05692245|Hormones|hormones|mesh-ancestor
102057167|NCT05692245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102057168|NCT05692245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102057169|NCT05692245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102057170|NCT05692245|Antipruritics|antipruritics|mesh-ancestor
102057171|NCT05692245|Dermatologic Agents|dermatologic agents|mesh-ancestor
102057172|NCT05692245|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102057173|NCT05692245|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102057174|NCT05692245|Serotonin Agents|serotonin agents|mesh-ancestor
102057175|NCT05692245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102057176|NCT05692245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057177|NCT05085106|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
102057178|NCT05085106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102057179|NCT05085106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102057180|NCT05085106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102057181|NCT05085106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102057182|NCT05085106|Analgesics|analgesics|mesh-ancestor
102057183|NCT05085106|Sensory System Agents|sensory system agents|mesh-ancestor
102057184|NCT05085106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101607886|NCT02636842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607887|NCT02636842|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101607888|NCT02636842|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101607889|NCT02636842|Serotonin Agents|serotonin agents|mesh-ancestor
102057185|NCT05085106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057186|NCT05085106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102057187|NCT05085106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102057188|NCT05692167|Dexmedetomidine|dexmedetomidine|mesh-list
102057189|NCT05692167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102057190|NCT05692167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102057191|NCT05692167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607890|NCT02636842|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101607891|NCT02636842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101607892|NCT02636842|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101607893|NCT02636842|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101607894|NCT04161976|Insulin Lispro|insulin lispro|mesh-list
101607895|NCT04161976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101607896|NCT04161976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607897|NCT00656422|Insulin|insulin|mesh-list
101607898|NCT00656422|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101607899|NCT00656422|Insulin Detemir|insulin detemir|mesh-list
101607900|NCT00656422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101607901|NCT00656422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607902|NCT02634034|Pitavastatin|pitavastatin|mesh-list
101607903|NCT02634034|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101607904|NCT02634034|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101607905|NCT02634034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101607906|NCT02634034|Antimetabolites|antimetabolites|mesh-ancestor
101607907|NCT02634034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607908|NCT02634034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101607909|NCT02634034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101607910|NCT00657748|Triacetin|triacetin|mesh-list
101607911|NCT00657748|Lithium Carbonate|lithium carbonate|mesh-list
101607912|NCT00657748|Antidepressive Agents|antidepressive agents|mesh-ancestor
101607928|NCT04161586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101607929|NCT02636218|Ketamine|ketamine|mesh-list
101607930|NCT02636218|Analgesics|analgesics|mesh-ancestor
101607931|NCT02636218|Sensory System Agents|sensory system agents|mesh-ancestor
101607932|NCT02636218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101607933|NCT02636218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607934|NCT02636218|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101607935|NCT02636218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101607936|NCT02636218|Anesthetics, General|anesthetics, general|mesh-ancestor
101607937|NCT02636218|Anesthetics|anesthetics|mesh-ancestor
101607938|NCT02636218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101607939|NCT02636218|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101607940|NCT02636218|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101607941|NCT02636218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101607942|NCT02636218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607943|NCT04161508|Glycopyrrolate|glycopyrrolate|mesh-list
101607944|NCT04161508|Neostigmine|neostigmine|mesh-list
101607945|NCT04161508|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101607946|NCT04161508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101607947|NCT04161508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607948|NCT04161508|Cholinergic Agents|cholinergic agents|mesh-ancestor
101607949|NCT04161508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101607950|NCT04161508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607951|NCT04161508|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101607952|NCT04161508|Autonomic Agents|autonomic agents|mesh-ancestor
101607953|NCT04161508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101607954|NCT04161508|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101607955|NCT04161508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101607956|NCT04161508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101607957|NCT00598078|Sodium Oxybate|sodium oxybate|mesh-list
101607958|NCT00598078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101607959|NCT00598078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101607960|NCT00598078|Anesthetics, General|anesthetics, general|mesh-ancestor
101607961|NCT00598078|Anesthetics|anesthetics|mesh-ancestor
101607962|NCT00598078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101607963|NCT00598078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607964|NCT00883558|Insulin|insulin|mesh-list
102057192|NCT05692167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102057193|NCT05692167|Analgesics|analgesics|mesh-ancestor
102057194|NCT05692167|Sensory System Agents|sensory system agents|mesh-ancestor
102057195|NCT05692167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102057196|NCT05692167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102057197|NCT05692167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102057198|NCT05692167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101607965|NCT00883558|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101607966|NCT00883558|Insulin Glargine|insulin glargine|mesh-list
101607967|NCT00883558|Insulin Lispro|insulin lispro|mesh-list
101607968|NCT00883558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101607969|NCT00883558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607970|NCT04162834|Papaverine|papaverine|mesh-list
101607971|NCT04162834|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101607972|NCT04162834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101778525|NCT00642174|Purinergic Agents|purinergic agents|mesh-ancestor
101607989|NCT00597766|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101607990|NCT00597766|Lidocaine|lidocaine|mesh-list
101607991|NCT00597766|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101607992|NCT00597766|Anesthetics, Local|anesthetics, local|mesh-ancestor
101607993|NCT00597766|Anesthetics|anesthetics|mesh-ancestor
101607994|NCT00597766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101607995|NCT00597766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607996|NCT00597766|Sensory System Agents|sensory system agents|mesh-ancestor
101607997|NCT00597766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101607998|NCT00597766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101607999|NCT00597766|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101608000|NCT00597766|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101608001|NCT00597766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101608002|NCT00597766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608003|NCT00597766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101608004|NCT00597766|Glucocorticoids|glucocorticoids|mesh-ancestor
101608005|NCT00597766|Hormones|hormones|mesh-ancestor
101608006|NCT00597766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101608007|NCT00597766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101608008|NCT00597766|Immunologic Factors|immunologic factors|mesh-ancestor
101608009|NCT00597766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101608010|NCT04161274|Silver Nitrate|silver nitrate|mesh-list
101608011|NCT04161274|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101608012|NCT04161274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101608013|NCT00657982|Everolimus|everolimus|mesh-list
101608014|NCT00657982|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101608015|NCT00657982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101608016|NCT00657982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101608017|NCT00657982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608018|NCT00657982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101608019|NCT00657982|Immunologic Factors|immunologic factors|mesh-ancestor
101608020|NCT00657982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608021|NCT00657982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101608022|NCT04159246|Sofosbuvir|sofosbuvir|mesh-list
101608023|NCT04159246|Antiviral Agents|antiviral agents|mesh-ancestor
101608024|NCT04159246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101608025|NCT00979992|Sunitinib|sunitinib|mesh-list
101608026|NCT00979992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101608027|NCT00979992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101608028|NCT00979992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101608029|NCT00979992|Growth Substances|growth substances|mesh-ancestor
101608034|NCT00979992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608036|NCT01079741|Mineral Oil|mineral oil|mesh-list
101608037|NCT01079741|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101608038|NCT01079741|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101608039|NCT01079741|Freund's Adjuvant|freund's adjuvant|mesh-list
101608040|NCT01079741|Poly ICLC|poly iclc|mesh-list
101608041|NCT01079741|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101608042|NCT01079741|Immunologic Factors|immunologic factors|mesh-ancestor
101608043|NCT01079741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608044|NCT01079741|Interferon Inducers|interferon inducers|mesh-ancestor
101608045|NCT01079741|Laxatives|laxatives|mesh-ancestor
101608046|NCT01079741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102057199|NCT05692167|Adrenergic Agents|adrenergic agents|mesh-ancestor
102057200|NCT05692167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102057201|NCT05692167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057202|NCT05084872|Hydroxychloroquine|hydroxychloroquine|mesh-list
102057203|NCT05084872|Antimalarials|antimalarials|mesh-ancestor
102057204|NCT05084872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102057205|NCT05084872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102057206|NCT05084872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102057207|NCT05084872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101608047|NCT01079741|Antiviral Agents|antiviral agents|mesh-ancestor
101608048|NCT01079741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101608049|NCT01079741|Emollients|emollients|mesh-ancestor
101608050|NCT01079741|Dermatologic Agents|dermatologic agents|mesh-ancestor
101608051|NCT02877641|Vitamin D|vitamin d|mesh-list
101608052|NCT02877641|Cholecalciferol|cholecalciferol|mesh-list
101608053|NCT02877641|Vitamins|vitamins|mesh-list
101608054|NCT02877641|Micronutrients|micronutrients|mesh-ancestor
101608055|NCT02877641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608056|NCT02877641|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101608057|NCT02877641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101608058|NCT01079663|Chlorhexidine|chlorhexidine|mesh-list
101608059|NCT01079663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101608060|NCT01079663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101608061|NCT01079663|Disinfectants|disinfectants|mesh-ancestor
101608062|NCT02867046|Dexamethasone|dexamethasone|mesh-list
101608063|NCT02867046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101608064|NCT02867046|Antiemetics|antiemetics|mesh-ancestor
101608065|NCT02867046|Autonomic Agents|autonomic agents|mesh-ancestor
101608066|NCT02867046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101608067|NCT02867046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608068|NCT02867046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101608069|NCT02867046|Glucocorticoids|glucocorticoids|mesh-ancestor
101608070|NCT02867046|Hormones|hormones|mesh-ancestor
101608071|NCT02867046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101608072|NCT02867046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101608073|NCT02867046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101608075|NCT02865174|Enoxaparin|enoxaparin|mesh-list
101608076|NCT02865174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101608077|NCT02865174|Tinzaparin|tinzaparin|mesh-list
101608078|NCT02865174|Dalteparin|dalteparin|mesh-list
101608079|NCT02865174|Tranylcypromine|tranylcypromine|mesh-list
101608080|NCT02865174|Tranexamic Acid|tranexamic acid|mesh-list
101608081|NCT02865174|Thrombin|thrombin|mesh-list
101608082|NCT02865174|Anticoagulants|anticoagulants|mesh-ancestor
101608083|NCT02865174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101608084|NCT02865174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101608085|NCT02865174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608086|NCT02865174|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101608087|NCT02865174|Hemostatics|hemostatics|mesh-ancestor
101608088|NCT02865174|Coagulants|coagulants|mesh-ancestor
101608089|NCT02865174|Antidepressive Agents|antidepressive agents|mesh-ancestor
101608090|NCT02865174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101608091|NCT02865174|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101608092|NCT02865174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101608093|NCT02865174|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101608094|NCT02865174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101608095|NCT02865174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101608096|NCT02865174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608097|NCT00879814|Vaccines|vaccines|mesh-list
101608098|NCT00879814|Immunologic Factors|immunologic factors|mesh-ancestor
101608099|NCT00879814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608100|NCT02633176|Docetaxel|docetaxel|mesh-list
101608101|NCT02633176|Capecitabine|capecitabine|mesh-list
101608102|NCT02633176|Cetuximab|cetuximab|mesh-list
101608103|NCT02633176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101608104|NCT02633176|Tubulin Modulators|tubulin modulators|mesh-ancestor
101608105|NCT02633176|Antimitotic Agents|antimitotic agents|mesh-ancestor
101608108|NCT02633176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102057208|NCT05084872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057209|NCT05084872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102057210|NCT00159796|Olanzapine|olanzapine|mesh-list
102057211|NCT00159796|Asenapine|asenapine|mesh-list
102057212|NCT00159796|Antiemetics|antiemetics|mesh-ancestor
102057213|NCT00159796|Autonomic Agents|autonomic agents|mesh-ancestor
102057214|NCT00159796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102057215|NCT00159796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057216|NCT00159796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102057217|NCT00159796|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102057218|NCT00159796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102057219|NCT00159796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102057220|NCT00159796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102057221|NCT00159796|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102057222|NCT00159796|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101608110|NCT02633176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101608111|NCT04156984|Golimumab|golimumab|mesh-list
101608112|NCT04156984|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101608113|NCT04156984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101608114|NCT04156984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101608115|NCT04156984|Immunologic Factors|immunologic factors|mesh-ancestor
101608116|NCT04156984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608117|NCT04158778|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
101608118|NCT04158778|Hallucinogens|hallucinogens|mesh-ancestor
101608119|NCT04158778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608120|NCT04158778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101608121|NCT04158778|Serotonin Agents|serotonin agents|mesh-ancestor
101608122|NCT04158778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101608123|NCT04158778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608124|NCT04158778|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101608125|NCT04158778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101608126|NCT04158778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101608127|NCT04158778|Adrenergic Agents|adrenergic agents|mesh-ancestor
101608128|NCT01132664|Capecitabine|capecitabine|mesh-list
101608129|NCT01132664|Trastuzumab|trastuzumab|mesh-list
101608130|NCT01132664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101608131|NCT01132664|Antimetabolites|antimetabolites|mesh-ancestor
101608132|NCT01132664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608133|NCT01132664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101608134|NCT01132664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101608135|NCT01078805|Teriparatide|teriparatide|mesh-list
101608136|NCT01078805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101608137|NCT01078805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608138|NCT01078805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101608139|NCT00820027|Ibuprofen|ibuprofen|mesh-list
101608140|NCT00820027|Etoricoxib|etoricoxib|mesh-list
101608141|NCT00820027|Morphine|morphine|mesh-list
101608142|NCT00820027|Oxycodone|oxycodone|mesh-list
101608143|NCT00820027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101608144|NCT00820027|Narcotics|narcotics|mesh-ancestor
101608145|NCT00820027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101608146|NCT00820027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608147|NCT00820027|Analgesics|analgesics|mesh-ancestor
101608148|NCT00820027|Sensory System Agents|sensory system agents|mesh-ancestor
101608149|NCT00820027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101608150|NCT00820027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101608151|NCT00820027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101608152|NCT00820027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102057223|NCT00159796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102057224|NCT00159796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057225|NCT00159796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102057226|NCT00159796|Serotonin Agents|serotonin agents|mesh-ancestor
102057227|NCT03626571|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102057228|NCT03626571|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102057229|NCT03626571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057230|NCT03327844|Calcium, Dietary|calcium, dietary|mesh-list
102057231|NCT03327844|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102057232|NCT03327844|Metronidazole|metronidazole|mesh-list
102057233|NCT03327844|Ciprofloxacin|ciprofloxacin|mesh-list
102057234|NCT03327844|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102057235|NCT03327844|Calcium|calcium|mesh-list
101459120|NCT04601701|Hormones|hormones|mesh-ancestor
101608153|NCT00820027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101608154|NCT00820027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101608155|NCT00820027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101608156|NCT00820027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608157|NCT00820027|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101608158|NCT02876549|Chloroquine|chloroquine|mesh-list
101608159|NCT02876549|Primaquine|primaquine|mesh-list
101608160|NCT02876549|Amebicides|amebicides|mesh-ancestor
101608161|NCT02876549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101608162|NCT02876549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101608163|NCT02876549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101608164|NCT02876549|Antimalarials|antimalarials|mesh-ancestor
101608165|NCT02876549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101608166|NCT00913549|Clemastine|clemastine|mesh-list
101608167|NCT00913549|Antipruritics|antipruritics|mesh-ancestor
101608168|NCT00913549|Dermatologic Agents|dermatologic agents|mesh-ancestor
101608169|NCT00913549|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101608170|NCT00913549|Histamine Antagonists|histamine antagonists|mesh-ancestor
101608171|NCT00913549|Histamine Agents|histamine agents|mesh-ancestor
101608172|NCT00913549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101608173|NCT00913549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608174|NCT00913549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608175|NCT00913549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101608176|NCT01076153|Clarithromycin|clarithromycin|mesh-list
101608177|NCT01076153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101608195|NCT01076075|Protease Inhibitors|protease inhibitors|mesh-ancestor
101608196|NCT01076075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101608197|NCT01076075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608198|NCT01076075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101608199|NCT01076075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101608200|NCT01076075|Immunologic Factors|immunologic factors|mesh-ancestor
101608201|NCT01075763|Interferons|interferons|mesh-list
101608202|NCT01075763|Interferon-beta|interferon-beta|mesh-list
101608203|NCT01075763|Interferon beta-1a|interferon beta-1a|mesh-list
101608204|NCT01075763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101608205|NCT01075763|Antiviral Agents|antiviral agents|mesh-ancestor
101608206|NCT01075763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101608207|NCT01075763|Immunologic Factors|immunologic factors|mesh-ancestor
101608208|NCT01075763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608209|NCT01075763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101608210|NCT00881530|Metformin|metformin|mesh-list
101608211|NCT00881530|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101608212|NCT00881530|Empagliflozin|empagliflozin|mesh-list
101608213|NCT00881530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101608214|NCT00881530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608215|NCT00881530|Incretins|incretins|mesh-ancestor
101608216|NCT00881530|Hormones|hormones|mesh-ancestor
101608217|NCT00881530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101608218|NCT00881530|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102057236|NCT03327844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102057237|NCT03327844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057238|NCT03327844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102057239|NCT03327844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102057240|NCT03327844|Antitubercular Agents|antitubercular agents|mesh-ancestor
101608219|NCT00881530|Protease Inhibitors|protease inhibitors|mesh-ancestor
101608220|NCT00881530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101608221|NCT00881530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608222|NCT00881530|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101608224|NCT02632474|Lamivudine|lamivudine|mesh-list
101608225|NCT02632474|Efavirenz|efavirenz|mesh-list
101608226|NCT02632474|Antiviral Agents|antiviral agents|mesh-ancestor
101608227|NCT02632474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101608228|NCT02632474|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101608229|NCT02632474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101608230|NCT02632474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101608231|NCT02632474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608232|NCT02632474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101608233|NCT02632474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101608234|NCT02632474|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101608235|NCT02632474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101537864|NCT00194675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101608241|NCT04156750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101608242|NCT04156750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608243|NCT02877173|Alprostadil|alprostadil|mesh-list
101608244|NCT02877173|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101608245|NCT02877173|Vasodilator Agents|vasodilator agents|mesh-ancestor
101608246|NCT02877173|Urological Agents|urological agents|mesh-ancestor
101608247|NCT04305743|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101608248|NCT04305743|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101608249|NCT04305743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101608250|NCT04305743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101608251|NCT04305743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608252|NCT04305743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101608253|NCT04305743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101608254|NCT04305743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608255|NCT04305743|Cholinergic Agents|cholinergic agents|mesh-ancestor
101608256|NCT04305743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101608257|NCT00661180|Sorafenib|sorafenib|mesh-list
101608258|NCT00661180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101608259|NCT00661180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101608260|NCT00661180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101608261|NCT00661180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608262|NCT01078571|Adalimumab|adalimumab|mesh-list
101608263|NCT01078571|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101608264|NCT01078571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101608265|NCT01078571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101608266|NCT04160416|Capecitabine|capecitabine|mesh-list
101608267|NCT04160416|Oxaliplatin|oxaliplatin|mesh-list
101608268|NCT04160416|Irinotecan|irinotecan|mesh-list
101608269|NCT04160416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101608270|NCT04160416|Antimetabolites|antimetabolites|mesh-ancestor
101608271|NCT04160416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608272|NCT04160416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101608273|NCT04160416|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101608274|NCT04160416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101608275|NCT04160416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101608276|NCT00661336|Melphalan|melphalan|mesh-list
101608277|NCT00661336|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
101608278|NCT00661336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101608279|NCT00661336|Alkylating Agents|alkylating agents|mesh-ancestor
101608280|NCT00661336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608281|NCT00661336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101608282|NCT00661336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101608283|NCT00661336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101608284|NCT00661336|Immunologic Factors|immunologic factors|mesh-ancestor
101608285|NCT00661336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057241|NCT03327844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102057242|NCT03327844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102057243|NCT03327844|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102057244|NCT03327844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102057245|NCT03327844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101608286|NCT00661336|Antimetabolites|antimetabolites|mesh-ancestor
101608287|NCT00661336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101608288|NCT00661336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101608289|NCT00661336|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101608290|NCT00661336|Protective Agents|protective agents|mesh-ancestor
101608291|NCT04158700|Pembrolizumab|pembrolizumab|mesh-list
101608292|NCT04158700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101608293|NCT04158700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101608294|NCT04158700|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101608295|NCT04158700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608296|NCT00657202|Ranibizumab|ranibizumab|mesh-list
101608297|NCT00657202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101608298|NCT00657202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101608299|NCT00657202|Growth Substances|growth substances|mesh-ancestor
101608300|NCT00657202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608301|NCT00657202|Growth Inhibitors|growth inhibitors|mesh-ancestor
101608302|NCT00657202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101608303|NCT00626483|Basiliximab|basiliximab|mesh-list
101608304|NCT00626483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101608308|NCT00626717|Vitamin B Complex|vitamin b complex|mesh-ancestor
101608309|NCT00626717|Vitamins|vitamins|mesh-ancestor
101608310|NCT00626717|Micronutrients|micronutrients|mesh-ancestor
101608311|NCT00626717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608312|NCT00626717|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101608313|NCT00626717|Dermatologic Agents|dermatologic agents|mesh-ancestor
101608314|NCT04156204|Tacrolimus|tacrolimus|mesh-list
101608315|NCT04156204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101608316|NCT04156204|Immunologic Factors|immunologic factors|mesh-ancestor
101608317|NCT04156204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608318|NCT04156204|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101608319|NCT04156204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101608320|NCT04156204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608321|NCT02631694|Propranolol|propranolol|mesh-list
101608322|NCT02631694|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101608323|NCT02631694|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101608324|NCT02631694|Adrenergic Agents|adrenergic agents|mesh-ancestor
101608325|NCT02631694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101608326|NCT02631694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608327|NCT02631694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608328|NCT02631694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101608329|NCT02631694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101608330|NCT02631694|Vasodilator Agents|vasodilator agents|mesh-ancestor
101608331|NCT04305587|Clopidogrel|clopidogrel|mesh-list
101608332|NCT04305587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101608333|NCT04305587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101608334|NCT04305587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101608335|NCT04305587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101608336|NCT04305587|Purinergic Agents|purinergic agents|mesh-ancestor
101608337|NCT04305587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101608338|NCT04305587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608339|NCT04305587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608340|NCT00658840|Capecitabine|capecitabine|mesh-list
101608341|NCT00658840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101608342|NCT00658840|Antimetabolites|antimetabolites|mesh-ancestor
101608343|NCT00658840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608344|NCT00658840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101608345|NCT00658918|Ciclesonide|ciclesonide|mesh-list
101608346|NCT00658918|Glucocorticoids|glucocorticoids|mesh-ancestor
101608347|NCT00658918|Hormones|hormones|mesh-ancestor
101608348|NCT00658918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101608349|NCT00658918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608350|NCT00658918|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101608351|NCT02876081|Afatinib|afatinib|mesh-list
101608352|NCT02876081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102057246|NCT03327844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057248|NCT03327844|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102057249|NCT03327844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102057250|NCT05008510|Camptothecin|camptothecin|mesh-list
102057251|NCT05008510|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
102057252|NCT05008510|Immunoconjugates|immunoconjugates|mesh-list
102057253|NCT05008510|Immunologic Factors|immunologic factors|mesh-ancestor
102057254|NCT05008510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057255|NCT05008510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102057256|NCT05008510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102057257|NCT05008510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102057258|NCT05008510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102057259|NCT05008510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102057260|NCT05008510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057261|NCT05194995|Cetuximab|cetuximab|mesh-list
101358855|NCT00399204|Pioglitazone|pioglitazone|mesh-list
101608353|NCT02876081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101608354|NCT02876081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101608355|NCT02876081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608356|NCT02631616|Somatostatin|somatostatin|mesh-list
101608357|NCT02631616|Hormones|hormones|mesh-ancestor
101608358|NCT02631616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101608359|NCT02631616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608360|NCT00661648|Pancrelipase|pancrelipase|mesh-list
101608361|NCT00661648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101608362|NCT00659074|Ondansetron|ondansetron|mesh-list
101608363|NCT00659074|Antiemetics|antiemetics|mesh-ancestor
101608364|NCT00659074|Autonomic Agents|autonomic agents|mesh-ancestor
101608365|NCT00659074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101608366|NCT00659074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608367|NCT00659074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101608368|NCT00659074|Antipruritics|antipruritics|mesh-ancestor
101608369|NCT00659074|Dermatologic Agents|dermatologic agents|mesh-ancestor
101608370|NCT00659074|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101608371|NCT00659074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101608372|NCT00659074|Serotonin Agents|serotonin agents|mesh-ancestor
101608373|NCT00659074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101265355|NCT01773044|Lidocaine|lidocaine|mesh-list
101608374|NCT00659074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608381|NCT01077713|Growth Substances|growth substances|mesh-ancestor
101608382|NCT01077713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608383|NCT01077713|Growth Inhibitors|growth inhibitors|mesh-ancestor
101608384|NCT01077713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101608385|NCT01077713|Antimetabolites|antimetabolites|mesh-ancestor
101608386|NCT01077713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608387|NCT00813709|Interferon beta-1a|interferon beta-1a|mesh-list
101608388|NCT00813709|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101608389|NCT00813709|Immunologic Factors|immunologic factors|mesh-ancestor
101608390|NCT00813709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608391|NCT00813709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101608392|NCT00813709|Antiviral Agents|antiviral agents|mesh-ancestor
101608393|NCT00813709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101608395|NCT01077323|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101608396|NCT01077323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608397|NCT01077323|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102057262|NCT05194995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102057263|NCT05194995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102057264|NCT05187039|Anesthetics|anesthetics|mesh-list
102057265|NCT05187039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102057266|NCT05187039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057267|NCT03136666|Candesartan|candesartan|mesh-list
102057268|NCT03136666|Candesartan cilexetil|candesartan cilexetil|mesh-list
102057269|NCT03136666|Nifedipine|nifedipine|mesh-list
102057270|NCT03136666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101358881|NCT00411190|Analgesics|analgesics|mesh-ancestor
101608398|NCT01077323|Incretins|incretins|mesh-ancestor
101608399|NCT01077323|Hormones|hormones|mesh-ancestor
101608400|NCT01077323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101608401|NCT03870438|Lamivudine|lamivudine|mesh-list
101608402|NCT03870438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101608403|NCT03870438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101608404|NCT03870438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101608405|NCT03870438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608406|NCT03870438|Antiviral Agents|antiviral agents|mesh-ancestor
101608407|NCT03870438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101608408|NCT03870438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101608409|NCT03870438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101608410|NCT04287894|Pemetrexed|pemetrexed|mesh-list
101608411|NCT04287894|Durvalumab|durvalumab|mesh-list
101608412|NCT04287894|Tremelimumab|tremelimumab|mesh-list
101608413|NCT04287894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101608414|NCT04287894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101608415|NCT04287894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608416|NCT04287894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101608417|NCT04287894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101608418|NCT04287894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101608419|NCT04287426|Remifentanil|remifentanil|mesh-list
101608420|NCT04287426|Rocuronium|rocuronium|mesh-list
101608421|NCT04287426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101608422|NCT04287426|Narcotics|narcotics|mesh-ancestor
101608423|NCT04287426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101608424|NCT04287426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608425|NCT04287426|Analgesics|analgesics|mesh-ancestor
101608426|NCT04287426|Sensory System Agents|sensory system agents|mesh-ancestor
101608427|NCT04287426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101608428|NCT04287426|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101608429|NCT04287426|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101608430|NCT04287426|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101608431|NCT04047576|Sirolimus|sirolimus|mesh-list
101608432|NCT04047576|Prednisone|prednisone|mesh-list
101608433|NCT04047576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101608434|NCT04047576|Glucocorticoids|glucocorticoids|mesh-ancestor
101608435|NCT04047576|Hormones|hormones|mesh-ancestor
101608436|NCT04047576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101608437|NCT04047576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608438|NCT04047576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101608439|NCT04047576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101608440|NCT04047576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101608441|NCT04047576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101608442|NCT04047576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101608443|NCT04047576|Antifungal Agents|antifungal agents|mesh-ancestor
101608446|NCT00976950|Ritonavir|ritonavir|mesh-list
101608447|NCT00976950|Tipranavir|tipranavir|mesh-list
101608448|NCT00976950|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101608449|NCT00976950|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101608450|NCT00976950|Protease Inhibitors|protease inhibitors|mesh-ancestor
101608451|NCT00976950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101608452|NCT00976950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608453|NCT00976950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101608454|NCT00976950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101608455|NCT00976950|Antiviral Agents|antiviral agents|mesh-ancestor
102057271|NCT03136666|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102057272|NCT03136666|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102057273|NCT03136666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057274|NCT03136666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102057275|NCT03136666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102057276|NCT03136666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102057277|NCT03136666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057278|NCT03136666|Vasodilator Agents|vasodilator agents|mesh-ancestor
102057279|NCT03136666|Tocolytic Agents|tocolytic agents|mesh-ancestor
102057280|NCT03136666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102057281|NCT03255083|Osimertinib|osimertinib|mesh-list
102057282|NCT03255083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102057283|NCT03255083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101608456|NCT00976950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101608457|NCT00976950|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101608458|NCT00976950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101608460|NCT00629382|Polymyxin B|polymyxin b|mesh-list
101608461|NCT00629382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101608462|NCT00629382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101608463|NCT02866032|Ciclopirox|ciclopirox|mesh-list
101608464|NCT02866032|Antifungal Agents|antifungal agents|mesh-ancestor
101608465|NCT02866032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101608466|NCT00976716|Celecoxib|celecoxib|mesh-list
101608467|NCT00976716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101608468|NCT00976716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101608469|NCT00976716|Analgesics|analgesics|mesh-ancestor
101608470|NCT00976716|Sensory System Agents|sensory system agents|mesh-ancestor
101608471|NCT00976716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101608472|NCT00976716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608473|NCT00976716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101608474|NCT00976716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101608475|NCT00976716|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101608476|NCT00976716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101608477|NCT00976716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101608478|NCT00976716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608480|NCT00973674|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101608481|NCT00973674|Hormones|hormones|mesh-ancestor
101608482|NCT00973674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101608483|NCT00973674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608484|NCT00819091|Linagliptin|linagliptin|mesh-list
101608485|NCT00819091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101608486|NCT00819091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608487|NCT00819091|Incretins|incretins|mesh-ancestor
101608488|NCT00819091|Hormones|hormones|mesh-ancestor
101608489|NCT00819091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101778589|NCT00992524|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101608490|NCT00819091|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101608491|NCT00819091|Protease Inhibitors|protease inhibitors|mesh-ancestor
101608492|NCT00819091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101608493|NCT00819091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608494|NCT02864784|Calcium Carbonate|calcium carbonate|mesh-list
101608495|NCT02864784|Calcium|calcium|mesh-list
101608496|NCT02864784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101608497|NCT02864784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608498|NCT02864784|Antacids|antacids|mesh-ancestor
101608499|NCT02864784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608500|NCT02864784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101608501|NCT00819013|Vaccines|vaccines|mesh-list
101608502|NCT00819013|Immunologic Factors|immunologic factors|mesh-ancestor
102057284|NCT03255083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102057285|NCT03255083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057286|NCT04861558|Fluorouracil|fluorouracil|mesh-list
102057287|NCT04861558|Oxaliplatin|oxaliplatin|mesh-list
102057288|NCT04861558|Irinotecan|irinotecan|mesh-list
102057289|NCT04861558|Antimetabolites|antimetabolites|mesh-ancestor
102057290|NCT04861558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776996|NCT00560391|Hormones|hormones|mesh-ancestor
102057291|NCT04861558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102057292|NCT04861558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102057293|NCT04861558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101608503|NCT00819013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608504|NCT04868461|Caseins|caseins|mesh-list
101608505|NCT04868461|Chelating Agents|chelating agents|mesh-ancestor
101608506|NCT04868461|Sequestering Agents|sequestering agents|mesh-ancestor
101608507|NCT04868461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608508|NCT02865642|Escitalopram|escitalopram|mesh-list
101608509|NCT02865642|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
101608510|NCT02865642|Serotonin|serotonin|mesh-list
101608511|NCT02865642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101608512|NCT02865642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101608513|NCT02865642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608514|NCT02865642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101608515|NCT02865642|Serotonin Agents|serotonin agents|mesh-ancestor
101608516|NCT02865642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608517|NCT02865642|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101608527|NCT00629616|Anastrozole|anastrozole|mesh-list
101608528|NCT00629616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101608529|NCT00629616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101608530|NCT00629616|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101608531|NCT00629616|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101608532|NCT00629616|Hormone Antagonists|hormone antagonists|mesh-ancestor
101608533|NCT00629616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101608534|NCT00629616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608535|NCT00629616|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101608536|NCT00629616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101608537|NCT00629616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101608538|NCT00629616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608539|NCT02864628|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
101608540|NCT02864628|Antiviral Agents|antiviral agents|mesh-ancestor
101608541|NCT02864628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101608542|NCT01120184|Paclitaxel|paclitaxel|mesh-list
101608543|NCT01120184|Maytansine|maytansine|mesh-list
101608544|NCT01120184|Docetaxel|docetaxel|mesh-list
101608545|NCT01120184|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101608546|NCT01120184|Trastuzumab|trastuzumab|mesh-list
101608547|NCT01120184|Pertuzumab|pertuzumab|mesh-list
101608548|NCT01120184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101264992|NCT01770301|Tubulin Modulators|tubulin modulators|mesh-ancestor
101608549|NCT01120184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101608550|NCT01120184|Tubulin Modulators|tubulin modulators|mesh-ancestor
101608551|NCT01120184|Antimitotic Agents|antimitotic agents|mesh-ancestor
101608552|NCT01120184|Mitosis Modulators|mitosis modulators|mesh-ancestor
101608553|NCT01120184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608554|NCT01120184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101608555|NCT01120184|Immunotoxins|immunotoxins|mesh-ancestor
101608556|NCT01120184|Immunoconjugates|immunoconjugates|mesh-ancestor
101608557|NCT01120184|Immunologic Factors|immunologic factors|mesh-ancestor
101608558|NCT01120184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608559|NCT01120028|Sirolimus|sirolimus|mesh-list
101608560|NCT01120028|Alemtuzumab|alemtuzumab|mesh-list
101608561|NCT01120028|Tacrolimus|tacrolimus|mesh-list
101608562|NCT01120028|Basiliximab|basiliximab|mesh-list
101608563|NCT01120028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102057294|NCT04861558|Immunologic Factors|immunologic factors|mesh-ancestor
102057295|NCT04861558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057296|NCT04861558|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102057297|NCT04861558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102057298|NCT04861558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102057299|NCT03735537|Zoledronic Acid|zoledronic acid|mesh-list
102057300|NCT03735537|Teriparatide|teriparatide|mesh-list
102057301|NCT03735537|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102057302|NCT03735537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102057303|NCT03735537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057304|NCT03735537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102057305|NCT04531059|Metronidazole|metronidazole|mesh-list
102057306|NCT04531059|Minocycline|minocycline|mesh-list
102057307|NCT04531059|Tetracycline|tetracycline|mesh-list
102057308|NCT04531059|Potassium Citrate|potassium citrate|mesh-list
101608564|NCT01120028|Immunologic Factors|immunologic factors|mesh-ancestor
101608565|NCT01120028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608566|NCT01120028|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101608567|NCT01120028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101608568|NCT01120028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608569|NCT01120028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101608570|NCT01120028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101608571|NCT01120028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101608572|NCT01120028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101608573|NCT01120028|Antifungal Agents|antifungal agents|mesh-ancestor
101608574|NCT01120028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101608575|NCT00878800|Doxorubicin|doxorubicin|mesh-list
101608576|NCT00878800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101608578|NCT00878800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101608579|NCT00878800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101608580|NCT00878800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101608581|NCT00878800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101608582|NCT00878800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101608583|NCT00878800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608584|NCT00878800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101608589|NCT04158856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101608590|NCT04158856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101608591|NCT01119950|Glycopyrrolate|glycopyrrolate|mesh-list
101608592|NCT01119950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101608593|NCT01119950|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101608594|NCT01119950|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101608595|NCT01119950|Cholinergic Agents|cholinergic agents|mesh-ancestor
101608596|NCT01119950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101608597|NCT01119950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608598|NCT01119950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608599|NCT02882828|Tacrolimus|tacrolimus|mesh-list
101608600|NCT02882828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101608601|NCT02882828|Immunologic Factors|immunologic factors|mesh-ancestor
101608602|NCT02882828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608603|NCT02882828|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101608604|NCT02882828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101608605|NCT02882828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608606|NCT02882126|Treprostinil|treprostinil|mesh-list
101608607|NCT02882126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101608608|NCT01145222|Midazolam|midazolam|mesh-list
101608609|NCT01145222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101608610|NCT01145222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101608611|NCT01145222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102057310|NCT04531059|Bismuth|bismuth|mesh-list
102057311|NCT04531059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057312|NCT04531059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102057313|NCT04531059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102057314|NCT04531059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101608612|NCT01145222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608613|NCT01145222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101608614|NCT01145222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101608615|NCT01145222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101608616|NCT01145222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101608617|NCT01145222|Anesthetics, General|anesthetics, general|mesh-ancestor
101608618|NCT01145222|Anesthetics|anesthetics|mesh-ancestor
101608619|NCT01145222|GABA Modulators|gaba modulators|mesh-ancestor
101608620|NCT01145222|GABA Agents|gaba agents|mesh-ancestor
101608621|NCT01145222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101608622|NCT01145222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608623|NCT01145066|Borage oil|borage oil|mesh-list
101608624|NCT01145066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101608625|NCT01132118|Hydroxychloroquine|hydroxychloroquine|mesh-list
101608626|NCT01132118|Antimalarials|antimalarials|mesh-ancestor
101608627|NCT01132118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101608628|NCT01132118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101608629|NCT01132118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101608630|NCT01132118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101608631|NCT01132118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608632|NCT01132118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101608633|NCT00637442|Galantamine|galantamine|mesh-list
101608634|NCT00637442|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101608635|NCT00637442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101608636|NCT00637442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608637|NCT00637442|Cholinergic Agents|cholinergic agents|mesh-ancestor
101608638|NCT00637442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101608639|NCT00637442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608640|NCT00637442|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101608641|NCT00637442|Autonomic Agents|autonomic agents|mesh-ancestor
101608642|NCT00637442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101608643|NCT00637442|Nootropic Agents|nootropic agents|mesh-ancestor
101608644|NCT00969618|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101608645|NCT00969618|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101608646|NCT00969618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101608647|NCT00969618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101608648|NCT00969618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608649|NCT00969618|Adrenergic Agents|adrenergic agents|mesh-ancestor
101608650|NCT00969618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101608651|NCT00969618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608652|NCT02864472|Ranibizumab|ranibizumab|mesh-list
101608653|NCT02864472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101608654|NCT02864472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101608655|NCT02864472|Growth Substances|growth substances|mesh-ancestor
101608658|NCT02864472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101608660|NCT00975000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101608661|NCT00975000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608662|NCT00975000|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101608663|NCT00975000|Hormone Antagonists|hormone antagonists|mesh-ancestor
101608664|NCT00975000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101608665|NCT02863614|Ibuprofen|ibuprofen|mesh-list
101608666|NCT02863614|Lorazepam|lorazepam|mesh-list
101608667|NCT02863614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101608668|NCT02863614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101608669|NCT02863614|Analgesics|analgesics|mesh-ancestor
101608670|NCT02863614|Sensory System Agents|sensory system agents|mesh-ancestor
101608671|NCT02863614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101265658|NCT01775839|Antipyretics|antipyretics|mesh-ancestor
101608672|NCT02863614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608673|NCT02863614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101608674|NCT02863614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101608675|NCT02863614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102057315|NCT04531059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102057316|NCT04531059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102057317|NCT04531059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101358931|NCT00068484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101778607|NCT00532948|Antimetabolites|antimetabolites|mesh-ancestor
101608676|NCT02863614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101608677|NCT02863614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608678|NCT02863614|Anticonvulsants|anticonvulsants|mesh-ancestor
101608679|NCT02863614|Antiemetics|antiemetics|mesh-ancestor
101608680|NCT02863614|Autonomic Agents|autonomic agents|mesh-ancestor
101608681|NCT02863614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101608682|NCT02863614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101608683|NCT02863614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101608684|NCT02863614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101608685|NCT02863614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101608686|NCT02863614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101608687|NCT02863614|GABA Modulators|gaba modulators|mesh-ancestor
101608688|NCT02863614|GABA Agents|gaba agents|mesh-ancestor
101608689|NCT02863614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101608690|NCT00974922|Vitamin D|vitamin d|mesh-list
101608691|NCT00974922|Cholecalciferol|cholecalciferol|mesh-list
101608692|NCT00974922|Vitamins|vitamins|mesh-ancestor
101608693|NCT00974922|Micronutrients|micronutrients|mesh-ancestor
101608694|NCT00974922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608695|NCT00974922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101608696|NCT00974922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101608698|NCT00972504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101608699|NCT00972504|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101608700|NCT00972504|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101608701|NCT00972504|Histamine Antagonists|histamine antagonists|mesh-ancestor
101608702|NCT00972504|Histamine Agents|histamine agents|mesh-ancestor
101608703|NCT00972504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101608704|NCT00972504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608705|NCT00972504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608706|NCT00969150|Milnacipran|milnacipran|mesh-list
101608707|NCT00969150|Levomilnacipran|levomilnacipran|mesh-list
101608708|NCT00969150|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101608709|NCT00969150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101608710|NCT00969150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101608711|NCT00969150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608712|NCT00969150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101608713|NCT00969150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608714|NCT00969150|Antidepressive Agents|antidepressive agents|mesh-ancestor
101608715|NCT00969150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101608716|NCT00969150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101608717|NCT00969150|Analgesics|analgesics|mesh-ancestor
101608718|NCT00969150|Sensory System Agents|sensory system agents|mesh-ancestor
101608719|NCT00969150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101608720|NCT03925194|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101608721|NCT03925194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101608722|NCT00974220|Fentanyl|fentanyl|mesh-list
101608723|NCT00974220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101608724|NCT00974220|Narcotics|narcotics|mesh-ancestor
101608725|NCT00974220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101608726|NCT00974220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608727|NCT00974220|Analgesics|analgesics|mesh-ancestor
101608731|NCT00974220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101608732|NCT00974220|Anesthetics, General|anesthetics, general|mesh-ancestor
101608733|NCT00974220|Anesthetics|anesthetics|mesh-ancestor
101608734|NCT00971178|Dexmedetomidine|dexmedetomidine|mesh-list
101608735|NCT00971178|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101608736|NCT00971178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101608737|NCT00971178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608738|NCT00971178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101608739|NCT00971178|Analgesics|analgesics|mesh-ancestor
101608740|NCT00971178|Sensory System Agents|sensory system agents|mesh-ancestor
101608741|NCT00971178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101608742|NCT00971178|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101608743|NCT00971178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101608744|NCT00971178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101608745|NCT00971178|Adrenergic Agents|adrenergic agents|mesh-ancestor
101608746|NCT00971178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102057318|NCT04531059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102057319|NCT04531059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102057320|NCT04531059|Antacids|antacids|mesh-ancestor
102057321|NCT04531059|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102057322|NCT04531059|Diuretics|diuretics|mesh-ancestor
102057323|NCT04531059|Natriuretic Agents|natriuretic agents|mesh-ancestor
102057324|NCT04531059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057325|NCT04531059|Expectorants|expectorants|mesh-ancestor
101358933|NCT00206596|Sargramostim|sargramostim|mesh-list
101608747|NCT00971178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608749|NCT00970944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101608750|NCT00970944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101608751|NCT00970944|Antiviral Agents|antiviral agents|mesh-ancestor
101608752|NCT00970944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101608753|NCT00970944|Dopamine Agents|dopamine agents|mesh-ancestor
101608754|NCT00970944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101608755|NCT00970944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608756|NCT00970944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608757|NCT00970944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101608758|NCT00970944|Analgesics|analgesics|mesh-ancestor
101608759|NCT00970944|Sensory System Agents|sensory system agents|mesh-ancestor
101608760|NCT00970944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101608761|NCT05780723|Mesalamine|mesalamine|mesh-list
101608762|NCT05780723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101608763|NCT05780723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101608764|NCT05780723|Analgesics|analgesics|mesh-ancestor
101608765|NCT05780723|Sensory System Agents|sensory system agents|mesh-ancestor
101608766|NCT05780723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101608767|NCT05780723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608768|NCT05780723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101608769|NCT05780723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101608770|NCT05780515|Immunoglobulins|immunoglobulins|mesh-list
101608771|NCT05780515|Immunoglobulin G|immunoglobulin g|mesh-list
101608772|NCT05780515|Immunologic Factors|immunologic factors|mesh-ancestor
101608773|NCT05780515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608774|NCT05780489|Estradiol|estradiol|mesh-list
101608775|NCT05780489|Progesterone|progesterone|mesh-list
101608776|NCT05780489|Estrogens|estrogens|mesh-ancestor
101608777|NCT05780489|Hormones|hormones|mesh-ancestor
101608778|NCT05780489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101608779|NCT05780489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608780|NCT05780489|Progestins|progestins|mesh-ancestor
101608781|NCT05780320|Amiodarone|amiodarone|mesh-list
101608782|NCT05780320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101608783|NCT05780320|Vasodilator Agents|vasodilator agents|mesh-ancestor
101608784|NCT05780320|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101608785|NCT05780320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101608786|NCT05780320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608787|NCT05780320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101608788|NCT05780320|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101608789|NCT05780320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101608790|NCT05780320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101608791|NCT05780320|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101608792|NCT05780320|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101608793|NCT05780320|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101608794|NCT05780294|Asparaginase|asparaginase|mesh-list
101608795|NCT05780294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101608796|NCT05780229|Analgesics|analgesics|mesh-list
101608797|NCT05780229|Sensory System Agents|sensory system agents|mesh-ancestor
101608798|NCT05780229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101608801|NCT05780151|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101608802|NCT05780151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608803|NCT05780086|Icodextrin|icodextrin|mesh-list
101608804|NCT05780086|Dialysis Solutions|dialysis solutions|mesh-ancestor
101608805|NCT05780086|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101608806|NCT05779514|Mirabegron|mirabegron|mesh-list
101608807|NCT05779514|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102057326|NCT04531059|Respiratory System Agents|respiratory system agents|mesh-ancestor
102057327|NCT05090176|Povidone|povidone|mesh-list
102057328|NCT05090176|Plasma Substitutes|plasma substitutes|mesh-ancestor
102057329|NCT05090176|Blood Substitutes|blood substitutes|mesh-ancestor
102057330|NCT01316055|4-Aminopyridine|4-aminopyridine|mesh-list
102057331|NCT01316055|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102057332|NCT01316055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102057333|NCT01316055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057334|NCT05659563|Tamoxifen|tamoxifen|mesh-list
102057335|NCT05659563|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102057336|NCT05659563|Hormone Antagonists|hormone antagonists|mesh-ancestor
102057337|NCT05659563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102057338|NCT05659563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057339|NCT05659563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102057340|NCT05659563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102057341|NCT05659563|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102057342|NCT05659563|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102057343|NCT05659563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101608808|NCT05779514|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101608809|NCT05779514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101608810|NCT05779514|Adrenergic Agents|adrenergic agents|mesh-ancestor
101608811|NCT05779514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101608812|NCT05779514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608813|NCT05779514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608814|NCT05779514|Urological Agents|urological agents|mesh-ancestor
101608815|NCT05779423|Nivolumab|nivolumab|mesh-list
101608816|NCT05779423|Ipilimumab|ipilimumab|mesh-list
101608817|NCT05779423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101608818|NCT05779423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101608819|NCT05779423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101608820|NCT05779423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608821|NCT05779410|Vitamin D|vitamin d|mesh-list
101608823|NCT05779410|Cholecalciferol|cholecalciferol|mesh-list
101608824|NCT05779410|Vitamins|vitamins|mesh-list
101608825|NCT05779410|Micronutrients|micronutrients|mesh-ancestor
101608826|NCT05779410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608827|NCT05779410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101608828|NCT05779410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101608829|NCT05779254|Metronidazole|metronidazole|mesh-list
101608830|NCT05779254|Neomycin|neomycin|mesh-list
101608831|NCT05779254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101608832|NCT05779254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101608833|NCT05779254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101608834|NCT05779254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101608835|NCT05779254|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101608836|NCT05779254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101608837|NCT05779254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608838|NCT05779059|Ticagrelor|ticagrelor|mesh-list
101608839|NCT05779059|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101608840|NCT05779059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101608841|NCT05779059|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101608842|NCT05779059|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101608843|NCT05779059|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101608844|NCT05779059|Purinergic Agents|purinergic agents|mesh-ancestor
102057344|NCT04558294|Ketanserin|ketanserin|mesh-list
102057345|NCT04558294|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
102057346|NCT04558294|Hallucinogens|hallucinogens|mesh-ancestor
102057347|NCT04558294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057348|NCT04558294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102057349|NCT04558294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102057350|NCT04558294|Serotonin Agents|serotonin agents|mesh-ancestor
102057351|NCT04558294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102057352|NCT04558294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057353|NCT04558294|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102057354|NCT04558294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102057355|NCT04558294|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102057356|NCT05626257|Omalizumab|omalizumab|mesh-list
102057357|NCT05626257|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102057358|NCT05626257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101459807|NCT00253305|Naftifine|naftifine|mesh-list
101608845|NCT05779059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101608846|NCT05779059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608847|NCT05779059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608848|NCT05778422|Anesthetics|anesthetics|mesh-list
101608849|NCT05778422|Anesthetics, Local|anesthetics, local|mesh-list
101608850|NCT05778422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101608851|NCT05778422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608852|NCT05778422|Sensory System Agents|sensory system agents|mesh-ancestor
101608853|NCT05778422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101608854|NCT05774366|Desflurane|desflurane|mesh-list
101608855|NCT05774366|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101608856|NCT05774366|Anesthetics, General|anesthetics, general|mesh-ancestor
101608857|NCT05774366|Anesthetics|anesthetics|mesh-ancestor
101608858|NCT05774366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101608859|NCT05774366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608860|NCT05774067|Terlipressin|terlipressin|mesh-list
101608861|NCT05774067|Vasopressins|vasopressins|mesh-list
101608862|NCT05774067|Norepinephrine|norepinephrine|mesh-list
101608863|NCT05774067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101608864|NCT05774067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101608865|NCT05774067|Adrenergic Agents|adrenergic agents|mesh-ancestor
101608866|NCT05774067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101608867|NCT05774067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608868|NCT05774067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608869|NCT05774067|Sympathomimetics|sympathomimetics|mesh-ancestor
101608870|NCT05774067|Autonomic Agents|autonomic agents|mesh-ancestor
101608871|NCT05774067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101608872|NCT05774067|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101608879|NCT05769842|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101608880|NCT05769842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101608881|NCT05769842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608882|NCT05769842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101608883|NCT05769842|Anesthetics, General|anesthetics, general|mesh-ancestor
101608884|NCT05769842|Anesthetics|anesthetics|mesh-ancestor
101608885|NCT05755997|Cerebrolysin|cerebrolysin|mesh-list
101608886|NCT05755997|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101608887|NCT05755997|Protective Agents|protective agents|mesh-ancestor
101608888|NCT05755997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608889|NCT05755997|Nootropic Agents|nootropic agents|mesh-ancestor
101608890|NCT05739929|Colchicine|colchicine|mesh-list
101608891|NCT05739929|Gout Suppressants|gout suppressants|mesh-ancestor
101608892|NCT05739929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101608893|NCT05739929|Tubulin Modulators|tubulin modulators|mesh-ancestor
101608894|NCT05739929|Antimitotic Agents|antimitotic agents|mesh-ancestor
102057359|NCT05626257|Respiratory System Agents|respiratory system agents|mesh-ancestor
102057360|NCT04396821|Paclitaxel|paclitaxel|mesh-list
102057361|NCT04396821|Gemcitabine|gemcitabine|mesh-list
102057362|NCT04396821|Nivolumab|nivolumab|mesh-list
102057363|NCT04396821|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102057364|NCT04396821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102057365|NCT04396821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102057366|NCT04396821|Tubulin Modulators|tubulin modulators|mesh-ancestor
102057367|NCT04396821|Antimitotic Agents|antimitotic agents|mesh-ancestor
102057368|NCT04396821|Mitosis Modulators|mitosis modulators|mesh-ancestor
102057369|NCT04396821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608895|NCT05739929|Mitosis Modulators|mitosis modulators|mesh-ancestor
101608896|NCT05739929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608897|NCT05739929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101608898|NCT05734508|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
101608899|NCT05734508|Antiviral Agents|antiviral agents|mesh-ancestor
101608900|NCT05734508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101608901|NCT05712265|Fluvoxamine|fluvoxamine|mesh-list
101608902|NCT05712265|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101608903|NCT05712265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101608904|NCT05712265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101778644|NCT00995332|GABA Agents|gaba agents|mesh-ancestor
101608905|NCT05712265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608906|NCT05712265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101608907|NCT05712265|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101608908|NCT05712265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101608909|NCT05712265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101608910|NCT05712265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608911|NCT05712265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101608912|NCT05712265|Serotonin Agents|serotonin agents|mesh-ancestor
101608913|NCT05712265|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101608914|NCT05712265|Antidepressive Agents|antidepressive agents|mesh-ancestor
101608915|NCT05712265|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101608916|NCT05712265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101608917|NCT05712265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101608918|NCT05712265|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101608919|NCT05659654|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101608920|NCT05659654|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101608921|NCT05659654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101608922|NCT05637060|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101608923|NCT05637060|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101608924|NCT05637060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101608925|NCT05637060|Antimetabolites|antimetabolites|mesh-ancestor
101608926|NCT05637060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608927|NCT05637060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101608928|NCT05637060|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101608929|NCT05637060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101608930|NCT05635604|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
101608931|NCT05635604|Growth Substances|growth substances|mesh-ancestor
101608932|NCT05635604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608933|NCT05635604|Vasodilator Agents|vasodilator agents|mesh-ancestor
101608934|NCT05635604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101608935|NCT05635604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608936|NCT05620784|Furosemide|furosemide|mesh-list
101608937|NCT05620784|Diuretics|diuretics|mesh-list
101608938|NCT05620784|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
101608939|NCT05620784|Natriuretic Agents|natriuretic agents|mesh-ancestor
101538508|NCT00474188|Hormones|hormones|mesh-ancestor
101608947|NCT05616494|Mitosis Modulators|mitosis modulators|mesh-ancestor
101608948|NCT05616494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608949|NCT05614609|Lidocaine|lidocaine|mesh-list
102057370|NCT04396821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102057371|NCT04396821|Antimetabolites|antimetabolites|mesh-ancestor
102057372|NCT04396821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102057373|NCT04396821|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102057375|NCT03378466|Calcium heparin|calcium heparin|mesh-list
102057376|NCT03378466|Anticoagulants|anticoagulants|mesh-ancestor
102057377|NCT03378466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101358986|NCT00068523|Dermatologic Agents|dermatologic agents|mesh-ancestor
101608950|NCT05614609|Anesthetics, Local|anesthetics, local|mesh-ancestor
101608951|NCT05614609|Anesthetics|anesthetics|mesh-ancestor
101608952|NCT05614609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101608953|NCT05614609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608954|NCT05614609|Sensory System Agents|sensory system agents|mesh-ancestor
101608955|NCT05614609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101608956|NCT05614609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101608957|NCT05614609|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101608958|NCT05614609|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101608959|NCT05614609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101608960|NCT05614609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608961|NCT05598957|Vitamin D|vitamin d|mesh-list
101608962|NCT05598957|Vitamins|vitamins|mesh-ancestor
101608963|NCT05598957|Micronutrients|micronutrients|mesh-ancestor
101778650|NCT00992914|Lidocaine|lidocaine|mesh-list
101608964|NCT05598957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608965|NCT05598957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101608966|NCT05567068|Mesalamine|mesalamine|mesh-list
101608967|NCT05567068|Atorvastatin|atorvastatin|mesh-list
101608968|NCT05567068|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101608969|NCT05567068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101608970|NCT05567068|Antimetabolites|antimetabolites|mesh-ancestor
101608971|NCT05567068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608972|NCT05567068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101608973|NCT05567068|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101608974|NCT05567068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101608975|NCT05567068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101608976|NCT05567068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101608977|NCT05567068|Analgesics|analgesics|mesh-ancestor
101608978|NCT05567068|Sensory System Agents|sensory system agents|mesh-ancestor
101608979|NCT05567068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101608980|NCT05567068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608981|NCT05567068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101608982|NCT05567068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101608984|NCT05565001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101608985|NCT05565001|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101608986|NCT05565001|Autonomic Agents|autonomic agents|mesh-ancestor
101608987|NCT05565001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101608988|NCT05565001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608989|NCT05565001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101608990|NCT05565001|Respiratory System Agents|respiratory system agents|mesh-ancestor
101608991|NCT05565001|Parasympatholytics|parasympatholytics|mesh-ancestor
101608992|NCT05565001|Vasodilator Agents|vasodilator agents|mesh-ancestor
101608993|NCT05561062|Atorvastatin|atorvastatin|mesh-list
101608994|NCT05561062|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101608995|NCT05561062|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101608996|NCT05561062|Antimetabolites|antimetabolites|mesh-ancestor
101608997|NCT05561062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608998|NCT05561062|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101608999|NCT05561062|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101609000|NCT05561062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101609001|NCT05550402|Bromides|bromides|mesh-list
101609002|NCT05550402|Albuterol|albuterol|mesh-list
101609003|NCT05550402|Ipratropium|ipratropium|mesh-list
101609004|NCT05550402|Anticonvulsants|anticonvulsants|mesh-ancestor
101609005|NCT05550402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101609006|NCT05550402|Autonomic Agents|autonomic agents|mesh-ancestor
101609007|NCT05550402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101609014|NCT05550402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101609015|NCT05550402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102057378|NCT03378466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102057379|NCT03378466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057380|NCT05077540|Misoprostol|misoprostol|mesh-list
102057381|NCT05077540|Oxytocin|oxytocin|mesh-list
102057382|NCT05077540|Oxytocics|oxytocics|mesh-ancestor
102057383|NCT05077540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102057384|NCT05077540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057385|NCT05077540|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102057386|NCT05077540|Abortifacient Agents|abortifacient agents|mesh-ancestor
102057387|NCT05077540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101609016|NCT05550402|Adrenergic Agents|adrenergic agents|mesh-ancestor
101609017|NCT05550402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101609018|NCT05550402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609019|NCT05550402|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101609020|NCT05550402|Cholinergic Agents|cholinergic agents|mesh-ancestor
101609021|NCT05444946|Itraconazole|itraconazole|mesh-list
101609022|NCT05444946|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
101609023|NCT05444946|Prednisone|prednisone|mesh-list
101609024|NCT05444946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101609025|NCT05444946|Glucocorticoids|glucocorticoids|mesh-ancestor
101609026|NCT05444946|Hormones|hormones|mesh-ancestor
101609027|NCT05444946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101609028|NCT05444946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609029|NCT05444946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101609030|NCT05444946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101609031|NCT05444946|Antifungal Agents|antifungal agents|mesh-ancestor
101609032|NCT05444946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101609033|NCT05444946|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101609034|NCT05444946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101609035|NCT05444946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101609036|NCT05444946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609037|NCT05444946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101609038|NCT05444946|Hormone Antagonists|hormone antagonists|mesh-ancestor
101609039|NCT05444946|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101609040|NCT05409157|Bisacodyl|bisacodyl|mesh-list
101609041|NCT05409157|Cathartics|cathartics|mesh-ancestor
101609042|NCT05409157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101609043|NCT05409157|Laxatives|laxatives|mesh-ancestor
101609044|NCT05407519|Tislelizumab|tislelizumab|mesh-list
101609045|NCT05407519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101609046|NCT05407519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101609047|NCT05380856|Neurotransmitter Agents|neurotransmitter agents|mesh-list
101609048|NCT05380856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609049|NCT05380856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609050|NCT05355311|Acetylcarnitine|acetylcarnitine|mesh-list
101609051|NCT05355311|Vitamin B Complex|vitamin b complex|mesh-ancestor
101609052|NCT05355311|Vitamins|vitamins|mesh-ancestor
101609053|NCT05355311|Micronutrients|micronutrients|mesh-ancestor
101609054|NCT05355311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609055|NCT05355311|Nootropic Agents|nootropic agents|mesh-ancestor
101609056|NCT05311033|Tranexamic Acid|tranexamic acid|mesh-list
101609057|NCT05311033|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101609058|NCT05311033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101609059|NCT05311033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609060|NCT05311033|Hemostatics|hemostatics|mesh-ancestor
101609061|NCT05311033|Coagulants|coagulants|mesh-ancestor
101609062|NCT05281562|Ascorbic Acid|ascorbic acid|mesh-list
101609063|NCT05281562|Vitamins|vitamins|mesh-ancestor
101609064|NCT05281562|Micronutrients|micronutrients|mesh-ancestor
101609065|NCT05281562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609066|NCT05281562|Antioxidants|antioxidants|mesh-ancestor
101609067|NCT05281562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609068|NCT05281562|Protective Agents|protective agents|mesh-ancestor
101609069|NCT05276596|Norepinephrine|norepinephrine|mesh-list
101609070|NCT05276596|Ephedrine|ephedrine|mesh-list
102057388|NCT05077540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102057389|NCT04977375|Pembrolizumab|pembrolizumab|mesh-list
102057390|NCT04977375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102057391|NCT04977375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102057392|NCT04977375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102057393|NCT04977375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057394|NCT02744898|Paclitaxel|paclitaxel|mesh-list
102057395|NCT02744898|Carboplatin|carboplatin|mesh-list
102057396|NCT02744898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102057397|NCT02744898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102057398|NCT02744898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102057399|NCT02744898|Tubulin Modulators|tubulin modulators|mesh-ancestor
101359003|NCT00040157|Antiviral Agents|antiviral agents|mesh-ancestor
101609071|NCT05276596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101609072|NCT05276596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101609073|NCT05276596|Adrenergic Agents|adrenergic agents|mesh-ancestor
101609074|NCT05276596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101609075|NCT05276596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538642|NCT01087970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101609079|NCT05276596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101609080|NCT05276596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101609081|NCT05276596|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101609082|NCT05241262|Acetylcysteine|acetylcysteine|mesh-list
101609083|NCT05241262|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101609084|NCT05241262|Antiviral Agents|antiviral agents|mesh-ancestor
101609085|NCT05241262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101609086|NCT05241262|Expectorants|expectorants|mesh-ancestor
101609087|NCT05241262|Respiratory System Agents|respiratory system agents|mesh-ancestor
101609088|NCT05241262|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101609089|NCT05241262|Antioxidants|antioxidants|mesh-ancestor
101609090|NCT05241262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609091|NCT05241262|Protective Agents|protective agents|mesh-ancestor
101609092|NCT05241262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609093|NCT05241262|Antidotes|antidotes|mesh-ancestor
101609094|NCT05178849|Anesthetics|anesthetics|mesh-list
101609095|NCT05178849|Anesthetics, Local|anesthetics, local|mesh-list
101609096|NCT05178849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101609097|NCT05178849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609098|NCT05178849|Sensory System Agents|sensory system agents|mesh-ancestor
101609099|NCT05178849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101609100|NCT05161936|Lumasiran|lumasiran|mesh-list
101609101|NCT05161936|Renal Agents|renal agents|mesh-ancestor
101609102|NCT05143424|Morphine|morphine|mesh-list
101609103|NCT05143424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101609104|NCT05143424|Narcotics|narcotics|mesh-ancestor
101609105|NCT05143424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101609106|NCT05143424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609107|NCT05143424|Analgesics|analgesics|mesh-ancestor
101609108|NCT05143424|Sensory System Agents|sensory system agents|mesh-ancestor
101609109|NCT05143424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101609110|NCT05126238|Lithium Carbonate|lithium carbonate|mesh-list
101609111|NCT05126238|Antidepressive Agents|antidepressive agents|mesh-ancestor
101609112|NCT05126238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101609113|NCT05126238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101609114|NCT05126238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609115|NCT05126238|Antimanic Agents|antimanic agents|mesh-ancestor
101609116|NCT05126238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101609117|NCT05126238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101609118|NCT05126238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266108|NCT01779830|Zolpidem|zolpidem|mesh-list
101609120|NCT05108649|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101609121|NCT05108649|Autonomic Agents|autonomic agents|mesh-ancestor
102057400|NCT02744898|Antimitotic Agents|antimitotic agents|mesh-ancestor
102057401|NCT02744898|Mitosis Modulators|mitosis modulators|mesh-ancestor
102057402|NCT02744898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057403|NCT03587311|Paclitaxel|paclitaxel|mesh-list
102057404|NCT03587311|Maytansine|maytansine|mesh-list
102057405|NCT03587311|Bevacizumab|bevacizumab|mesh-list
102057406|NCT03587311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101460093|NCT00253851|Heparin|heparin|mesh-list
101609122|NCT05108649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101609123|NCT05108649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609124|NCT05108649|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101609125|NCT05108649|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101609126|NCT05108649|Cholinergic Agents|cholinergic agents|mesh-ancestor
101778684|NCT05189002|Dalteparin|dalteparin|mesh-list
101609127|NCT05108649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101265007|NCT01770444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101609128|NCT05108649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609130|NCT05023070|Anticonvulsants|anticonvulsants|mesh-ancestor
101609131|NCT05003713|Prednisone|prednisone|mesh-list
101609132|NCT05003713|Cortisone|cortisone|mesh-list
101609133|NCT05003713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101609134|NCT05003713|Glucocorticoids|glucocorticoids|mesh-ancestor
101609135|NCT05003713|Hormones|hormones|mesh-ancestor
101609136|NCT05003713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101609137|NCT05003713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609138|NCT05003713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101609139|NCT05003713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101609140|NCT04990128|Triamcinolone|triamcinolone|mesh-list
101609141|NCT04990128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101609142|NCT04990128|Glucocorticoids|glucocorticoids|mesh-ancestor
101609143|NCT04990128|Hormones|hormones|mesh-ancestor
101609144|NCT04990128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101609145|NCT04990128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609146|NCT04907370|Cisplatin|cisplatin|mesh-list
101609147|NCT04907370|Gemcitabine|gemcitabine|mesh-list
101609148|NCT04907370|Antibodies|antibodies|mesh-list
101609149|NCT04907370|Antibodies, Blocking|antibodies, blocking|mesh-list
101609155|NCT04907370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609157|NCT04903054|Prednisone|prednisone|mesh-list
101609158|NCT04903054|Methylprednisolone|methylprednisolone|mesh-list
101609159|NCT04903054|Tacrolimus|tacrolimus|mesh-list
101609160|NCT04903054|Thymoglobulin|thymoglobulin|mesh-list
101609161|NCT04903054|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101609162|NCT04903054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101609163|NCT04903054|Glucocorticoids|glucocorticoids|mesh-ancestor
101609164|NCT04903054|Hormones|hormones|mesh-ancestor
101609165|NCT04903054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101609166|NCT04903054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609167|NCT04903054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101609168|NCT04903054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101609169|NCT04903054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101609170|NCT04903054|Immunologic Factors|immunologic factors|mesh-ancestor
101609171|NCT04903054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101609172|NCT04903054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101609173|NCT04903054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609174|NCT04903054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101609175|NCT04903054|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101609176|NCT04903054|Antitubercular Agents|antitubercular agents|mesh-ancestor
101609177|NCT04903054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101609178|NCT04903054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101609179|NCT04903054|Antiemetics|antiemetics|mesh-ancestor
101609180|NCT04903054|Autonomic Agents|autonomic agents|mesh-ancestor
101609181|NCT04903054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101609182|NCT04903054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101609183|NCT04903054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101609184|NCT04903054|Protective Agents|protective agents|mesh-ancestor
101609185|NCT04901702|Irinotecan|irinotecan|mesh-list
101609186|NCT04901702|Temozolomide|temozolomide|mesh-list
101609187|NCT04901702|Talazoparib|talazoparib|mesh-list
101609188|NCT04901702|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101609189|NCT04901702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102057407|NCT03587311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102057408|NCT03587311|Endothelial Growth Factors|endothelial growth factors|mesh-list
102057409|NCT03587311|Antibodies|antibodies|mesh-list
102057410|NCT03587311|Immunoglobulins|immunoglobulins|mesh-list
102057411|NCT03587311|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101609190|NCT04901702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101609191|NCT04901702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609192|NCT04901702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101609193|NCT04901702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101609194|NCT04901702|Alkylating Agents|alkylating agents|mesh-ancestor
101609195|NCT04901702|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101609197|NCT04879225|Antipruritics|antipruritics|mesh-ancestor
101609198|NCT04879225|Dermatologic Agents|dermatologic agents|mesh-ancestor
101609199|NCT04834557|Digoxin|digoxin|mesh-list
101609200|NCT04834557|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101609201|NCT04834557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101609202|NCT04834557|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101609203|NCT04834557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775279|NCT00935961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101609204|NCT04834557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609205|NCT04834557|Protective Agents|protective agents|mesh-ancestor
101609206|NCT04834557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609207|NCT04834557|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101609208|NCT04834557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101609209|NCT04825093|Vitamin D|vitamin d|mesh-list
101609210|NCT04825093|Vitamins|vitamins|mesh-ancestor
101609211|NCT04825093|Micronutrients|micronutrients|mesh-ancestor
101609212|NCT04825093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609213|NCT04825093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101609214|NCT04793152|Vancomycin|vancomycin|mesh-list
101609215|NCT04793152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101609216|NCT04793152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101609217|NCT04770493|Lamotrigine|lamotrigine|mesh-list
101609218|NCT04770493|Anticonvulsants|anticonvulsants|mesh-ancestor
101609219|NCT04770493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101609224|NCT04770493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101609225|NCT04770493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101609226|NCT04770493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101609227|NCT04770493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101609228|NCT04770493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101609230|NCT04741464|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101609231|NCT04741464|Dalteparin|dalteparin|mesh-list
101609232|NCT04741464|Anticoagulants|anticoagulants|mesh-ancestor
101609233|NCT04741464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101609234|NCT04741464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101609235|NCT04741464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609236|NCT04663555|Dexamethasone|dexamethasone|mesh-list
101609237|NCT04663555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101609238|NCT04663555|Antiemetics|antiemetics|mesh-ancestor
101609239|NCT04663555|Autonomic Agents|autonomic agents|mesh-ancestor
101609240|NCT04663555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101609241|NCT04663555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609242|NCT04663555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101609243|NCT04663555|Glucocorticoids|glucocorticoids|mesh-ancestor
101609244|NCT04663555|Hormones|hormones|mesh-ancestor
101609245|NCT04663555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101609246|NCT04663555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101609247|NCT04663555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101609248|NCT04565288|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101609249|NCT04565288|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101609250|NCT04565288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101609251|NCT04565288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101609252|NCT04565288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609253|NCT04565288|Adrenergic Agents|adrenergic agents|mesh-ancestor
101609254|NCT04565288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101609255|NCT04565288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609256|NCT04496024|Ofloxacin|ofloxacin|mesh-list
101609257|NCT04496024|Levofloxacin|levofloxacin|mesh-list
101609258|NCT04496024|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101609259|NCT04496024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102057412|NCT03587311|Immunoglobulin G|immunoglobulin g|mesh-list
102057413|NCT03587311|Anetumab ravtansine|anetumab ravtansine|mesh-list
102057414|NCT03587311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102057415|NCT03587311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102057416|NCT03587311|Tubulin Modulators|tubulin modulators|mesh-ancestor
102057417|NCT03587311|Antimitotic Agents|antimitotic agents|mesh-ancestor
101609260|NCT04496024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101609261|NCT04496024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101609262|NCT04496024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101609263|NCT04496024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101609264|NCT04496024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609265|NCT04496024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101609266|NCT04496024|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101609267|NCT04496024|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101609268|NCT04425473|Esketamine|esketamine|mesh-list
101609269|NCT04425473|Antidepressive Agents|antidepressive agents|mesh-ancestor
101609271|NCT04387071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101609272|NCT04387071|Antibodies|antibodies|mesh-list
101609273|NCT04387071|Immunoglobulins|immunoglobulins|mesh-list
101609274|NCT04387071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101609275|NCT04387071|Immunologic Factors|immunologic factors|mesh-ancestor
101609276|NCT04387071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609277|NCT04387071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101609278|NCT04350502|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101609279|NCT04350502|Amoxicillin|amoxicillin|mesh-list
101609280|NCT04350502|Clavulanic Acids|clavulanic acids|mesh-list
101609281|NCT04350502|Clavulanic Acid|clavulanic acid|mesh-list
101609282|NCT04350502|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101609283|NCT04350502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101609284|NCT04350502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101609285|NCT04350502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609286|NCT04350502|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101609287|NCT04300920|Acetylcysteine|acetylcysteine|mesh-list
101609288|NCT04300920|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101609291|NCT04300920|Expectorants|expectorants|mesh-ancestor
101609292|NCT04300920|Respiratory System Agents|respiratory system agents|mesh-ancestor
101609293|NCT04300920|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101609294|NCT04300920|Antioxidants|antioxidants|mesh-ancestor
101609295|NCT04300920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609296|NCT04300920|Protective Agents|protective agents|mesh-ancestor
101609297|NCT04300920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609298|NCT04300920|Antidotes|antidotes|mesh-ancestor
101609299|NCT04252768|Paclitaxel|paclitaxel|mesh-list
101609300|NCT04252768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101609301|NCT04252768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101609302|NCT04252768|Tubulin Modulators|tubulin modulators|mesh-ancestor
101609303|NCT04252768|Antimitotic Agents|antimitotic agents|mesh-ancestor
101609304|NCT04252768|Mitosis Modulators|mitosis modulators|mesh-ancestor
101609305|NCT04252768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609306|NCT04222010|Anesthetics|anesthetics|mesh-list
101609307|NCT04222010|Ropivacaine|ropivacaine|mesh-list
101609308|NCT04222010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101609309|NCT04222010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609310|NCT04222010|Anesthetics, Local|anesthetics, local|mesh-ancestor
101609311|NCT04222010|Sensory System Agents|sensory system agents|mesh-ancestor
101609312|NCT04222010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101609313|NCT04150900|Pembrolizumab|pembrolizumab|mesh-list
101609314|NCT04150900|Bavituximab|bavituximab|mesh-list
101609315|NCT04150900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101609316|NCT04150900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101609317|NCT04150900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101609318|NCT04150900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609319|NCT04084171|Insulin|insulin|mesh-list
101609320|NCT04084171|Pancrelipase|pancrelipase|mesh-list
101609321|NCT04084171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101609322|NCT04084171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609323|NCT04084171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101609324|NCT04047706|Nivolumab|nivolumab|mesh-list
101609325|NCT04047706|Temozolomide|temozolomide|mesh-list
101609326|NCT04047706|Linrodostat|linrodostat|mesh-list
102057418|NCT03587311|Mitosis Modulators|mitosis modulators|mesh-ancestor
102057419|NCT03587311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778718|NCT00821496|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102057420|NCT03587311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102057421|NCT03587311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102057422|NCT03587311|Growth Substances|growth substances|mesh-ancestor
101609327|NCT04047706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101609328|NCT04047706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101609329|NCT04047706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101609330|NCT04047706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609331|NCT04047706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101609332|NCT04047706|Alkylating Agents|alkylating agents|mesh-ancestor
101609333|NCT04047706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101609334|NCT03967249|Octreotide|octreotide|mesh-list
101609335|NCT03967249|Lanreotide|lanreotide|mesh-list
101609336|NCT03967249|Somatostatin|somatostatin|mesh-list
101609337|NCT03967249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101609338|NCT03967249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101609339|NCT03967249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101609340|NCT03967249|Hormones|hormones|mesh-ancestor
101609341|NCT03967249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101609342|NCT03967249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266335|NCT01781377|Propofol|propofol|mesh-list
101609343|NCT03935139|Glycerol|glycerol|mesh-list
101609344|NCT03935139|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101609345|NCT03935139|Protective Agents|protective agents|mesh-ancestor
101609346|NCT03935139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609347|NCT03927079|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101609348|NCT03927079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101609349|NCT03927079|Dimercaprol|dimercaprol|mesh-list
101609350|NCT03927079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101609351|NCT03927079|Antitubercular Agents|antitubercular agents|mesh-ancestor
101609352|NCT03927079|Chelating Agents|chelating agents|mesh-ancestor
101609353|NCT03927079|Sequestering Agents|sequestering agents|mesh-ancestor
101609354|NCT03927079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609355|NCT03926403|Anesthetics|anesthetics|mesh-list
101609356|NCT03926403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101609357|NCT03926403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609358|NCT03884101|Paclitaxel|paclitaxel|mesh-list
101609359|NCT03884101|Carboplatin|carboplatin|mesh-list
101609360|NCT03884101|Pembrolizumab|pembrolizumab|mesh-list
101609361|NCT03884101|Lenvatinib|lenvatinib|mesh-list
101538901|NCT04671836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101609364|NCT03884101|Tubulin Modulators|tubulin modulators|mesh-ancestor
101609365|NCT03884101|Antimitotic Agents|antimitotic agents|mesh-ancestor
101609366|NCT03884101|Mitosis Modulators|mitosis modulators|mesh-ancestor
101609367|NCT03884101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609368|NCT03884101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101609369|NCT03884101|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101609370|NCT03884101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101609371|NCT03884101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101609372|NCT03871621|Metformin|metformin|mesh-list
101609373|NCT03871621|Dapagliflozin|dapagliflozin|mesh-list
101609374|NCT03871621|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
101609375|NCT03871621|Meglitinide|meglitinide|mesh-list
101609376|NCT03871621|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101609377|NCT03871621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609378|NCT03871621|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101609379|NCT03871621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609380|NCT03867188|Bupivacaine|bupivacaine|mesh-list
101609381|NCT03867188|Anesthetics, Local|anesthetics, local|mesh-ancestor
101609382|NCT03867188|Anesthetics|anesthetics|mesh-ancestor
101609383|NCT03867188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101609384|NCT03867188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609385|NCT03867188|Sensory System Agents|sensory system agents|mesh-ancestor
101609386|NCT03867188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101609387|NCT03796884|Linaclotide|linaclotide|mesh-list
101609388|NCT03796884|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
101609389|NCT03796884|Enzyme Activators|enzyme activators|mesh-ancestor
101609390|NCT03796884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057423|NCT03587311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057424|NCT03587311|Growth Inhibitors|growth inhibitors|mesh-ancestor
102057425|NCT03587311|Immunologic Factors|immunologic factors|mesh-ancestor
102057426|NCT03587311|Immunoconjugates|immunoconjugates|mesh-ancestor
102057427|NCT03097315|Triamcinolone|triamcinolone|mesh-list
102057428|NCT03097315|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102057429|NCT03097315|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102057430|NCT03097315|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101359035|NCT00206986|Clonidine|clonidine|mesh-list
101609391|NCT03796884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101609392|NCT03745040|Bupivacaine|bupivacaine|mesh-list
101609393|NCT03745040|Anesthetics, Local|anesthetics, local|mesh-ancestor
101609394|NCT03745040|Anesthetics|anesthetics|mesh-ancestor
101609395|NCT03745040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101609396|NCT03745040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609397|NCT03745040|Sensory System Agents|sensory system agents|mesh-ancestor
101609398|NCT03745040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101609399|NCT03740737|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101609400|NCT03740737|Hormones|hormones|mesh-ancestor
101609401|NCT03740737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101609402|NCT03740737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609403|NCT03686345|Midostaurin|midostaurin|mesh-list
101609404|NCT03686345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101609405|NCT03686345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101609406|NCT03686345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101609407|NCT03686345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609408|NCT03671967|Meropenem|meropenem|mesh-list
101609409|NCT03671967|Tazobactam|tazobactam|mesh-list
101609410|NCT03671967|Piperacillin|piperacillin|mesh-list
101609411|NCT03671967|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101609412|NCT03671967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101609413|NCT03671967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101609414|NCT03671967|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101609415|NCT03671967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101609416|NCT03671967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609417|NCT03657810|Acetaminophen|acetaminophen|mesh-list
101609418|NCT03657810|Promethazine|promethazine|mesh-list
101609419|NCT03657810|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
101609420|NCT03657810|Hydrocodone|hydrocodone|mesh-list
101609421|NCT03657810|Oxycodone|oxycodone|mesh-list
101609422|NCT03657810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101609423|NCT03657810|Analgesics|analgesics|mesh-ancestor
101609424|NCT03657810|Sensory System Agents|sensory system agents|mesh-ancestor
101609425|NCT03657810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101609426|NCT03657810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609427|NCT03657810|Antipyretics|antipyretics|mesh-ancestor
101609428|NCT03657810|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101609429|NCT03657810|Narcotics|narcotics|mesh-ancestor
101609430|NCT03657810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101609431|NCT03657810|Antitussive Agents|antitussive agents|mesh-ancestor
101609432|NCT03657810|Respiratory System Agents|respiratory system agents|mesh-ancestor
101609433|NCT03657810|Antipruritics|antipruritics|mesh-ancestor
101609439|NCT03657810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609440|NCT03657810|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101609441|NCT03657810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101609442|NCT03657810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101609443|NCT03657810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101609444|NCT03640026|Tacrolimus|tacrolimus|mesh-list
101609445|NCT03640026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101609446|NCT03640026|Immunologic Factors|immunologic factors|mesh-ancestor
101609447|NCT03640026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609448|NCT03640026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101609449|NCT03640026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101609450|NCT03640026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609451|NCT03638297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
101609452|NCT03638297|Antibodies|antibodies|mesh-list
101609453|NCT03638297|Immunologic Factors|immunologic factors|mesh-ancestor
102057431|NCT03097315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102057432|NCT03097315|Glucocorticoids|glucocorticoids|mesh-ancestor
102057433|NCT03097315|Hormones|hormones|mesh-ancestor
102057434|NCT03097315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102057435|NCT03097315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057436|NCT03097315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102057437|NCT03097315|Immunologic Factors|immunologic factors|mesh-ancestor
102057438|NCT03097315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102057439|NCT03097315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609454|NCT03638297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609455|NCT03638297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101609456|NCT03638297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609457|NCT03638297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101609458|NCT03638297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101609459|NCT03638297|Analgesics|analgesics|mesh-ancestor
101609460|NCT03638297|Sensory System Agents|sensory system agents|mesh-ancestor
101609461|NCT03638297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101609462|NCT03638297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101609463|NCT03638297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101609464|NCT03544736|Paclitaxel|paclitaxel|mesh-list
101609465|NCT03544736|Carboplatin|carboplatin|mesh-list
101609466|NCT03544736|Nivolumab|nivolumab|mesh-list
101609467|NCT03544736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101609468|NCT03544736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101609469|NCT03544736|Tubulin Modulators|tubulin modulators|mesh-ancestor
101609470|NCT03544736|Antimitotic Agents|antimitotic agents|mesh-ancestor
101609471|NCT03544736|Mitosis Modulators|mitosis modulators|mesh-ancestor
101609472|NCT03544736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609473|NCT03544736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101609474|NCT03544736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101609475|NCT03533010|Vitamin D|vitamin d|mesh-list
101609476|NCT03533010|Vitamins|vitamins|mesh-ancestor
101609477|NCT03533010|Micronutrients|micronutrients|mesh-ancestor
101609478|NCT03533010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609479|NCT03533010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101609480|NCT03409198|Cyclophosphamide|cyclophosphamide|mesh-list
101609481|NCT03409198|Doxorubicin|doxorubicin|mesh-list
101609482|NCT03409198|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101609483|NCT03409198|Nivolumab|nivolumab|mesh-list
101609484|NCT03409198|Ipilimumab|ipilimumab|mesh-list
101609485|NCT03409198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101609486|NCT03409198|Immunologic Factors|immunologic factors|mesh-ancestor
101609487|NCT03409198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609488|NCT03409198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101609489|NCT03409198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101609490|NCT03409198|Alkylating Agents|alkylating agents|mesh-ancestor
101609491|NCT03409198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609492|NCT03409198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101609493|NCT03409198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101609494|NCT03409198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101609495|NCT03409198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101609496|NCT03409198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101609497|NCT03409198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101609498|NCT03409198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101609499|NCT03409198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101609500|NCT03382548|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101609501|NCT03382548|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101609502|NCT03382548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101609503|NCT03382548|Antitubercular Agents|antitubercular agents|mesh-ancestor
101609509|NCT03321656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101778746|NCT00999700|Cetuximab|cetuximab|mesh-list
101609510|NCT03321656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609512|NCT03236987|Clarithromycin|clarithromycin|mesh-list
101609513|NCT03236987|Rifampin|rifampin|mesh-list
101609514|NCT03236987|Ethambutol|ethambutol|mesh-list
101609515|NCT03236987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102057440|NCT05530707|Niacinamide|niacinamide|mesh-list
102057441|NCT05530707|Niacin|niacin|mesh-list
102057442|NCT05530707|Nicotinic Acids|nicotinic acids|mesh-list
102057443|NCT05530707|Vitamin B Complex|vitamin b complex|mesh-ancestor
102057444|NCT05530707|Vitamins|vitamins|mesh-ancestor
102057445|NCT05530707|Micronutrients|micronutrients|mesh-ancestor
102057446|NCT05530707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359056|NCT00040274|Dexelvucitabine|dexelvucitabine|mesh-list
101609516|NCT03236987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101609517|NCT03236987|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101609518|NCT03236987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101609519|NCT03236987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609520|NCT03236987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101609521|NCT03236987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101609522|NCT03236987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101609523|NCT03236987|Antitubercular Agents|antitubercular agents|mesh-ancestor
101609524|NCT03236987|Leprostatic Agents|leprostatic agents|mesh-ancestor
101609525|NCT03236987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101609526|NCT03236987|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101609527|NCT03236987|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101609528|NCT03236987|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101609529|NCT03236987|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101609530|NCT03236987|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101609531|NCT03236987|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101609532|NCT03094637|Pembrolizumab|pembrolizumab|mesh-list
101609533|NCT03094637|Azacitidine|azacitidine|mesh-list
101609534|NCT03094637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101609535|NCT03094637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101609536|NCT03094637|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101609537|NCT03094637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609538|NCT03094637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101609539|NCT03094637|Antimetabolites|antimetabolites|mesh-ancestor
101609540|NCT03094637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101609541|NCT03055507|Acetaminophen|acetaminophen|mesh-list
101609542|NCT03055507|Ibuprofen|ibuprofen|mesh-list
101609543|NCT03055507|Oxycodone|oxycodone|mesh-list
101609544|NCT03055507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101609545|NCT03055507|Analgesics|analgesics|mesh-ancestor
101609546|NCT03055507|Sensory System Agents|sensory system agents|mesh-ancestor
101609547|NCT03055507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101609548|NCT03055507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609549|NCT03055507|Antipyretics|antipyretics|mesh-ancestor
101609550|NCT03055507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101609551|NCT03055507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101609552|NCT03055507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101609553|NCT03055507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101609554|NCT03055507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101609555|NCT03055507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609556|NCT03055507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101609557|NCT03055507|Narcotics|narcotics|mesh-ancestor
101609558|NCT03055507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101609559|NCT03038256|Capecitabine|capecitabine|mesh-list
101609560|NCT03038256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101609561|NCT03038256|Antimetabolites|antimetabolites|mesh-ancestor
101609562|NCT03038256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609563|NCT03038256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101609564|NCT02870738|Triamcinolone|triamcinolone|mesh-list
101609565|NCT02870738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101609566|NCT02870738|Glucocorticoids|glucocorticoids|mesh-ancestor
101609567|NCT02870738|Hormones|hormones|mesh-ancestor
101266571|NCT01783106|Budesonide|budesonide|mesh-list
101609568|NCT02870738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101609569|NCT02870738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609570|NCT02789982|Propranolol|propranolol|mesh-list
101609571|NCT02789982|Adrenergic Agents|adrenergic agents|mesh-list
101609572|NCT02789982|Adrenergic Antagonists|adrenergic antagonists|mesh-list
101609573|NCT02789982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102057447|NCT05530707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102057448|NCT05530707|Antimetabolites|antimetabolites|mesh-ancestor
102057449|NCT05530707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057450|NCT05530707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101609574|NCT02789982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101609579|NCT02789982|Vasodilator Agents|vasodilator agents|mesh-ancestor
101609581|NCT02667886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101609582|NCT02667886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101609583|NCT02667886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101609584|NCT02667886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609585|NCT02614066|Cyclophosphamide|cyclophosphamide|mesh-list
101609586|NCT02614066|Fludarabine|fludarabine|mesh-list
101609587|NCT02614066|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
101609588|NCT02614066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101609589|NCT02614066|Immunologic Factors|immunologic factors|mesh-ancestor
101609590|NCT02614066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609591|NCT02614066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101609592|NCT02614066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101609593|NCT02614066|Alkylating Agents|alkylating agents|mesh-ancestor
101609594|NCT02614066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609595|NCT02614066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101609596|NCT02614066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101609597|NCT02614066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101609598|NCT02587195|Teriflunomide|teriflunomide|mesh-list
101609599|NCT02587195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101609600|NCT02587195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101609601|NCT02587195|Analgesics|analgesics|mesh-ancestor
101609602|NCT02587195|Sensory System Agents|sensory system agents|mesh-ancestor
101609603|NCT02587195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101609604|NCT02587195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609605|NCT02587195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101609606|NCT02587195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101609607|NCT02587195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101609608|NCT02587195|Immunologic Factors|immunologic factors|mesh-ancestor
101609610|NCT02582008|Nicotine|nicotine|mesh-list
101609611|NCT02582008|Varenicline|varenicline|mesh-list
101609612|NCT02582008|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101609613|NCT02582008|Autonomic Agents|autonomic agents|mesh-ancestor
101609614|NCT02582008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101609615|NCT02582008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609616|NCT02582008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101609617|NCT02582008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101609618|NCT02582008|Cholinergic Agents|cholinergic agents|mesh-ancestor
101609619|NCT02582008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101609620|NCT02582008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609621|NCT02582008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101609622|NCT02582008|Antidepressive Agents|antidepressive agents|mesh-ancestor
101609623|NCT02582008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101609624|NCT02582008|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101609625|NCT02582008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101609626|NCT02582008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101609627|NCT02582008|Dopamine Agents|dopamine agents|mesh-ancestor
101609628|NCT02582008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101609629|NCT02582008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101609630|NCT02582008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101609631|NCT02502799|Methylphenidate|methylphenidate|mesh-list
101609632|NCT02502799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101609633|NCT02502799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609634|NCT02502799|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101609635|NCT02502799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101609636|NCT02502799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101609637|NCT02502799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609638|NCT02502799|Dopamine Agents|dopamine agents|mesh-ancestor
101609639|NCT02502799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101609640|NCT02135133|Ofatumumab|ofatumumab|mesh-list
101609641|NCT02135133|Idelalisib|idelalisib|mesh-list
101609642|NCT02135133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101609643|NCT02135133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101609657|NCT01717586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102057451|NCT05530707|Vasodilator Agents|vasodilator agents|mesh-ancestor
102057452|NCT02833974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102057453|NCT03093415|Grazoprevir|grazoprevir|mesh-list
102057454|NCT03093415|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
102057455|NCT03093415|Antiviral Agents|antiviral agents|mesh-ancestor
102057456|NCT03093415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101609658|NCT01717586|Antimetabolites|antimetabolites|mesh-ancestor
101609659|NCT01717586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609660|NCT01717586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101609661|NCT01717586|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101609662|NCT01717586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101609663|NCT01523977|Prednisone|prednisone|mesh-list
101609664|NCT01523977|Doxorubicin|doxorubicin|mesh-list
101609665|NCT01523977|Dexrazoxane|dexrazoxane|mesh-list
101609666|NCT01523977|Vincristine|vincristine|mesh-list
101609667|NCT01523977|Everolimus|everolimus|mesh-list
101609668|NCT01523977|Asparaginase|asparaginase|mesh-list
101609669|NCT01523977|Pegaspargase|pegaspargase|mesh-list
101609670|NCT01523977|Razoxane|razoxane|mesh-list
101609671|NCT01523977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101609672|NCT01523977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101609673|NCT01523977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101609674|NCT01523977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101609675|NCT01523977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101609676|NCT01523977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609677|NCT01523977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101609678|NCT01523977|Glucocorticoids|glucocorticoids|mesh-ancestor
101609679|NCT01523977|Hormones|hormones|mesh-ancestor
101609680|NCT01523977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101609681|NCT01523977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609682|NCT01523977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101609683|NCT01523977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101609684|NCT01523977|Tubulin Modulators|tubulin modulators|mesh-ancestor
101609685|NCT01523977|Antimitotic Agents|antimitotic agents|mesh-ancestor
101609686|NCT01523977|Mitosis Modulators|mitosis modulators|mesh-ancestor
101609687|NCT01523977|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101609688|NCT01523977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101609689|NCT01523977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101609690|NCT01523977|Immunologic Factors|immunologic factors|mesh-ancestor
101609691|NCT01523977|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101609692|NCT01523977|Protective Agents|protective agents|mesh-ancestor
101609693|NCT01107717|Metformin|metformin|mesh-list
101609694|NCT01107717|Pioglitazone|pioglitazone|mesh-list
101609695|NCT01107717|Exenatide|exenatide|mesh-list
101609696|NCT01107717|Glyburide|glyburide|mesh-list
101609697|NCT01107717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101609698|NCT01107717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609699|NCT01107717|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101609700|NCT01107717|Incretins|incretins|mesh-ancestor
101609701|NCT01107717|Hormones|hormones|mesh-ancestor
101609702|NCT01107717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101609703|NCT00782574|Olaparib|olaparib|mesh-list
101609704|NCT00782574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101609705|NCT00782574|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101609706|NCT00782574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101539241|NCT00556127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101609710|NCT00753545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101609711|NCT00753545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609712|NCT00753545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101609713|NCT00635362|Levonorgestrel|levonorgestrel|mesh-list
101609714|NCT00635362|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101609715|NCT00635362|Contraceptive Agents|contraceptive agents|mesh-ancestor
101609716|NCT00635362|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101609717|NCT00635362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609718|NCT00635362|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101609719|NCT00635362|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101609720|NCT00635362|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101609721|NCT00408447|Fludarabine|fludarabine|mesh-list
101609722|NCT00408447|Busulfan|busulfan|mesh-list
101609723|NCT00408447|Alemtuzumab|alemtuzumab|mesh-list
101609724|NCT00408447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102057457|NCT01358526|Oxycodone|oxycodone|mesh-list
102057458|NCT01358526|Naloxone|naloxone|mesh-list
102057459|NCT01358526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102057460|NCT01358526|Narcotics|narcotics|mesh-ancestor
102057461|NCT01358526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102057462|NCT01358526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057463|NCT01358526|Analgesics|analgesics|mesh-ancestor
102057464|NCT01358526|Sensory System Agents|sensory system agents|mesh-ancestor
102057465|NCT01358526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102057466|NCT01358526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102057467|NCT05434689|Dexamethasone|dexamethasone|mesh-list
102057468|NCT05434689|Daratumumab|daratumumab|mesh-list
102057469|NCT05434689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102057470|NCT05434689|Antiemetics|antiemetics|mesh-ancestor
102057471|NCT05434689|Autonomic Agents|autonomic agents|mesh-ancestor
102057472|NCT05434689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102057473|NCT05434689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057474|NCT05434689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102057475|NCT05434689|Glucocorticoids|glucocorticoids|mesh-ancestor
102057476|NCT05434689|Hormones|hormones|mesh-ancestor
102057477|NCT05434689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102057478|NCT05434689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102057479|NCT05434689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102057480|NCT01310010|Dasatinib|dasatinib|mesh-list
101609725|NCT00408447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609726|NCT00408447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101609727|NCT00408447|Immunologic Factors|immunologic factors|mesh-ancestor
101609728|NCT00408447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609729|NCT00408447|Alkylating Agents|alkylating agents|mesh-ancestor
101609730|NCT00408447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101609731|NCT00408447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101609732|NCT00408447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101609733|NCT00278915|Fulvestrant|fulvestrant|mesh-list
101609734|NCT00278915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101609735|NCT00278915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101609736|NCT00278915|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101609737|NCT00278915|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101609738|NCT00278915|Hormone Antagonists|hormone antagonists|mesh-ancestor
101609739|NCT00278915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101609740|NCT00278915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609741|NCT04285320|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101609742|NCT04285320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101609743|NCT04285320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101609744|NCT04285320|Antitubercular Agents|antitubercular agents|mesh-ancestor
101609745|NCT00970632|Tadalafil|tadalafil|mesh-list
101609746|NCT00970632|Tamsulosin|tamsulosin|mesh-list
101609747|NCT00970632|Vasodilator Agents|vasodilator agents|mesh-ancestor
101609748|NCT00970632|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101609749|NCT00970632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101609750|NCT00970632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101609751|NCT00970632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057481|NCT01310010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102057482|NCT01310010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102057483|NCT01310010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102057484|NCT01310010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057485|NCT02830776|Bimatoprost|bimatoprost|mesh-list
102057486|NCT02830776|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101609752|NCT00970632|Urological Agents|urological agents|mesh-ancestor
101609753|NCT00970632|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101609754|NCT00970632|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101609755|NCT00970632|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101609756|NCT00970632|Adrenergic Agents|adrenergic agents|mesh-ancestor
101609757|NCT00970632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101609758|NCT00970632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609759|NCT01144364|Rituximab|rituximab|mesh-list
101609760|NCT01144364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101609761|NCT01144364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101609762|NCT01144364|Immunologic Factors|immunologic factors|mesh-ancestor
101609763|NCT01144364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609764|NCT01144364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101609765|NCT00965094|Mycophenolic Acid|mycophenolic acid|mesh-list
101609766|NCT00965094|Everolimus|everolimus|mesh-list
101609767|NCT00965094|Tacrolimus|tacrolimus|mesh-list
101609768|NCT00965094|Basiliximab|basiliximab|mesh-list
101609769|NCT00965094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101609770|NCT00965094|Immunologic Factors|immunologic factors|mesh-ancestor
101609771|NCT00965094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609772|NCT00965094|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101609773|NCT00965094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101609774|NCT00965094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609775|NCT00965094|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101609780|NCT00965094|Antitubercular Agents|antitubercular agents|mesh-ancestor
101609781|NCT00965094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101609782|NCT00965094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101609784|NCT01131182|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101609785|NCT01131182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101609786|NCT01131182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609787|NCT01131182|Incretins|incretins|mesh-ancestor
101609788|NCT01131182|Hormones|hormones|mesh-ancestor
101609789|NCT01131182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101609790|NCT01131182|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101609791|NCT01131182|Protease Inhibitors|protease inhibitors|mesh-ancestor
101266789|NCT01784913|Sargramostim|sargramostim|mesh-list
101609792|NCT01131182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101609793|NCT01131182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609795|NCT01131104|Tadalafil|tadalafil|mesh-list
101609796|NCT01131104|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101609797|NCT01131104|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
101609798|NCT01131104|Vasodilator Agents|vasodilator agents|mesh-ancestor
101609799|NCT01131104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101609800|NCT01131104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101609801|NCT01131104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609802|NCT01131104|Urological Agents|urological agents|mesh-ancestor
101609803|NCT04264884|Daratumumab|daratumumab|mesh-list
101609804|NCT04264884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101609805|NCT01118780|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101609806|NCT01118780|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101609807|NCT01118780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101609808|NCT01118780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101609809|NCT01118780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609810|NCT01118780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101609811|NCT01118780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609812|NCT01118780|Analgesics|analgesics|mesh-ancestor
101609813|NCT01118780|Sensory System Agents|sensory system agents|mesh-ancestor
101778800|NCT00821652|Freund's Adjuvant|freund's adjuvant|mesh-list
101609814|NCT01118780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101609815|NCT01118780|Antidepressive Agents|antidepressive agents|mesh-ancestor
101609816|NCT01118780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101609817|NCT01118780|Dopamine Agents|dopamine agents|mesh-ancestor
101609818|NCT00629928|Esomeprazole|esomeprazole|mesh-list
102057487|NCT02830776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102057488|NCT02830776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102057490|NCT03563664|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102057491|NCT03563664|Hormone Antagonists|hormone antagonists|mesh-ancestor
102057492|NCT03563664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102057493|NCT03563664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057494|NCT01904136|Mycophenolic Acid|mycophenolic acid|mesh-list
102057495|NCT01904136|Cyclophosphamide|cyclophosphamide|mesh-list
102057496|NCT01904136|Melphalan|melphalan|mesh-list
102057497|NCT01904136|Mechlorethamine|mechlorethamine|mesh-list
102057498|NCT01904136|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
102057499|NCT01904136|Fludarabine|fludarabine|mesh-list
102057500|NCT01904136|Tacrolimus|tacrolimus|mesh-list
102057501|NCT01904136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101609819|NCT00629928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101609820|NCT00629928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101609821|NCT00629928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101609822|NCT00629928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101609823|NCT00629928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609824|NCT00964782|Sildenafil Citrate|sildenafil citrate|mesh-list
101609825|NCT00964782|Vasodilator Agents|vasodilator agents|mesh-ancestor
101609826|NCT00964782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101609827|NCT00964782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101609828|NCT00964782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101609829|NCT00964782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609830|NCT00964782|Urological Agents|urological agents|mesh-ancestor
101609831|NCT02882984|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101609832|NCT02882984|Gefitinib|gefitinib|mesh-list
101609833|NCT02882984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101609834|NCT02882984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101609835|NCT02882984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101609836|NCT02882984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609837|NCT00966654|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101609838|NCT00966654|Incretins|incretins|mesh-ancestor
101609839|NCT00966654|Hormones|hormones|mesh-ancestor
101609840|NCT00966654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101609841|NCT00966654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609842|NCT00625196|Fluticasone|fluticasone|mesh-list
101609843|NCT00625196|Xhance|xhance|mesh-list
101609844|NCT00625196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101609854|NCT03262116|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101609855|NCT03262116|Insulin Lispro|insulin lispro|mesh-list
101609856|NCT03262116|Insulin Aspart|insulin aspart|mesh-list
101609857|NCT03262116|Pancrelipase|pancrelipase|mesh-list
101609858|NCT03262116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101609859|NCT03262116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609860|NCT03262116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101609861|NCT01130168|Amlodipine|amlodipine|mesh-list
101609862|NCT01130168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101609863|NCT01130168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101609864|NCT01130168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101609865|NCT01130168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609866|NCT01130168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101609867|NCT01130168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609868|NCT01130168|Vasodilator Agents|vasodilator agents|mesh-ancestor
101609869|NCT04284852|Niraparib|niraparib|mesh-list
101609870|NCT04284852|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101609871|NCT04284852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387689|NCT00323011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101609872|NCT04284852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609873|NCT04284852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102057502|NCT01904136|Immunologic Factors|immunologic factors|mesh-ancestor
102057503|NCT01904136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057504|NCT01904136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102057505|NCT01904136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102057506|NCT01904136|Alkylating Agents|alkylating agents|mesh-ancestor
102057507|NCT01904136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057508|NCT01904136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102057509|NCT01904136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102057510|NCT01904136|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102057511|NCT01904136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102057512|NCT01904136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101609874|NCT04283292|Capsaicin|capsaicin|mesh-list
101609875|NCT04283292|Antipruritics|antipruritics|mesh-ancestor
101609876|NCT04283292|Dermatologic Agents|dermatologic agents|mesh-ancestor
101609877|NCT04283292|Sensory System Agents|sensory system agents|mesh-ancestor
101609878|NCT04283292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101609879|NCT04283292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609880|NCT01144052|Interferons|interferons|mesh-list
101609881|NCT01144052|Interferon-beta|interferon-beta|mesh-list
101609882|NCT01144052|Natalizumab|natalizumab|mesh-list
101609883|NCT01144052|Interferon beta-1b|interferon beta-1b|mesh-list
101609884|NCT01144052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101609885|NCT01144052|Antiviral Agents|antiviral agents|mesh-ancestor
101609886|NCT01144052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101609887|NCT01144052|Immunologic Factors|immunologic factors|mesh-ancestor
101609888|NCT01144052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609889|NCT01144052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101609890|NCT04283526|Decitabine|decitabine|mesh-list
101609891|NCT04283526|Spartalizumab|spartalizumab|mesh-list
101609892|NCT04283526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101609893|NCT04283526|Antimetabolites|antimetabolites|mesh-ancestor
101609894|NCT04283526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609895|NCT04283526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101609896|NCT04283526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101609897|NCT04283526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101609898|NCT04283526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101609899|NCT01118312|Mometasone Furoate|mometasone furoate|mesh-list
101609900|NCT01118312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101609901|NCT01118312|Dermatologic Agents|dermatologic agents|mesh-ancestor
101609902|NCT01118312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101609903|NCT01117766|Pregabalin|pregabalin|mesh-list
101609904|NCT01117766|Analgesics|analgesics|mesh-ancestor
101609905|NCT01117766|Sensory System Agents|sensory system agents|mesh-ancestor
101609906|NCT01117766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101609907|NCT01117766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609908|NCT01117766|Anticonvulsants|anticonvulsants|mesh-ancestor
101609909|NCT01117766|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101609910|NCT01117766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101609911|NCT01117766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609912|NCT01117766|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101609913|NCT01117766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101609914|NCT01117766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101609915|NCT01117766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101609916|NCT01117766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101609918|NCT04312880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101609919|NCT04312880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101609920|NCT04312880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609921|NCT04312880|Hemostatics|hemostatics|mesh-ancestor
101609922|NCT04312880|Coagulants|coagulants|mesh-ancestor
101609923|NCT01117454|Flecainide|flecainide|mesh-list
101609924|NCT01117454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101609925|NCT01117454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101609926|NCT01117454|Adrenergic Agents|adrenergic agents|mesh-ancestor
101609927|NCT01117454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102057514|NCT01904136|Antitubercular Agents|antitubercular agents|mesh-ancestor
102057515|NCT01904136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102057516|NCT01904136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102057517|NCT03041181|Gemcitabine|gemcitabine|mesh-list
102057518|NCT03041181|Docetaxel|docetaxel|mesh-list
102057519|NCT03041181|Nivolumab|nivolumab|mesh-list
102057520|NCT03041181|Pemetrexed|pemetrexed|mesh-list
101359127|NCT00207844|Selenium|selenium|mesh-list
101609928|NCT01117454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609929|NCT01117454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609930|NCT01117454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101609931|NCT01117454|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101609932|NCT01117454|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101609933|NCT01117454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101609935|NCT01129622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101609936|NCT01129622|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101609937|NCT01129622|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101609938|NCT01129622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101609939|NCT01129622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266940|NCT01785693|Clonidine|clonidine|mesh-list
101609940|NCT01129622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101609941|NCT01129622|Hormone Antagonists|hormone antagonists|mesh-ancestor
101609942|NCT01129622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101609943|NCT01129622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609944|NCT01128842|Capecitabine|capecitabine|mesh-list
101609945|NCT01128842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101609946|NCT01128842|Antimetabolites|antimetabolites|mesh-ancestor
101609947|NCT01128842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609948|NCT01128842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101609949|NCT00625274|Esomeprazole|esomeprazole|mesh-list
101609950|NCT00625274|Pantoprazole|pantoprazole|mesh-list
101609951|NCT00625274|Lansoprazole|lansoprazole|mesh-list
101609952|NCT00625274|Dexlansoprazole|dexlansoprazole|mesh-list
101609953|NCT00625274|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101609954|NCT00625274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101609955|NCT00625274|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101609956|NCT00625274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101609957|NCT00625274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609958|NCT03624036|Cyclophosphamide|cyclophosphamide|mesh-list
101609959|NCT03624036|Fludarabine|fludarabine|mesh-list
101609960|NCT03624036|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
101609961|NCT03624036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101609962|NCT03624036|Immunologic Factors|immunologic factors|mesh-ancestor
101609963|NCT03624036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609964|NCT03624036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101609965|NCT03624036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101609966|NCT03624036|Alkylating Agents|alkylating agents|mesh-ancestor
101609967|NCT03624036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609968|NCT03624036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101609969|NCT03624036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101609970|NCT03624036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101609971|NCT00915525|Botulinum Toxins|botulinum toxins|mesh-list
101609972|NCT00915525|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101609973|NCT00915525|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101609974|NCT00915525|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101609975|NCT00915525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101609976|NCT00915525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609977|NCT00915525|Cholinergic Agents|cholinergic agents|mesh-ancestor
101609978|NCT00915525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101778826|NCT00994006|Magnesium citrate|magnesium citrate|mesh-list
101609979|NCT00915525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609980|NCT00915525|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101609981|NCT00915525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101609982|NCT04669041|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101609983|NCT04669041|Ezetimibe|ezetimibe|mesh-list
101539513|NCT02211911|Bisacodyl|bisacodyl|mesh-list
102057521|NCT03041181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102057522|NCT03041181|Antimetabolites|antimetabolites|mesh-ancestor
102057523|NCT03041181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057524|NCT03041181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102057525|NCT03041181|Tubulin Modulators|tubulin modulators|mesh-ancestor
102057526|NCT03041181|Antimitotic Agents|antimitotic agents|mesh-ancestor
102057527|NCT03041181|Mitosis Modulators|mitosis modulators|mesh-ancestor
101359137|NCT00072930|Prednisone|prednisone|mesh-list
101609989|NCT04669041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101609991|NCT05132595|Ketorolac|ketorolac|mesh-list
101609992|NCT05132595|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101609993|NCT05132595|Esketamine|esketamine|mesh-list
101609994|NCT05132595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101609995|NCT05132595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101609996|NCT05132595|Analgesics|analgesics|mesh-ancestor
101609997|NCT05132595|Sensory System Agents|sensory system agents|mesh-ancestor
101609998|NCT05132595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101609999|NCT05132595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610000|NCT05132595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101610002|NCT05132595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101610003|NCT05132595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610004|NCT05132595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610005|NCT05132595|Antidepressive Agents|antidepressive agents|mesh-ancestor
101610006|NCT05132595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101610007|NCT01074047|Azacitidine|azacitidine|mesh-list
101610008|NCT01074047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101610009|NCT01074047|Antimetabolites|antimetabolites|mesh-ancestor
101610010|NCT01074047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610011|NCT01074047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101610012|NCT01074047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610013|NCT05226117|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
101610014|NCT05226117|Immunoconjugates|immunoconjugates|mesh-ancestor
101610015|NCT05226117|Immunologic Factors|immunologic factors|mesh-ancestor
101610016|NCT05226117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610017|NCT01142726|Methotrexate|methotrexate|mesh-list
101610018|NCT01142726|Abatacept|abatacept|mesh-list
101610019|NCT01142726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101610020|NCT01142726|Abortifacient Agents|abortifacient agents|mesh-ancestor
101610021|NCT01142726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101610022|NCT01142726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610023|NCT01142726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101610024|NCT01142726|Antimetabolites|antimetabolites|mesh-ancestor
101610025|NCT01142726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610026|NCT01142726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101610027|NCT01142726|Dermatologic Agents|dermatologic agents|mesh-ancestor
101610028|NCT01142726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610029|NCT01142726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101610030|NCT01142726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101610031|NCT01142726|Immunologic Factors|immunologic factors|mesh-ancestor
101610032|NCT01142726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101610033|NCT01142726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101610034|NCT01142726|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101610035|NCT01142726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101610036|NCT04472637|Atorvastatin|atorvastatin|mesh-list
101610037|NCT04472637|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101610038|NCT04472637|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101610039|NCT04472637|Antimetabolites|antimetabolites|mesh-ancestor
101610040|NCT04472637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610041|NCT04472637|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101610042|NCT04472637|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101610043|NCT04472637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610044|NCT01142336|Simvastatin|simvastatin|mesh-list
101610045|NCT01142336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101610046|NCT01142336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101610047|NCT01142336|Antimetabolites|antimetabolites|mesh-ancestor
102057528|NCT03041181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102057529|NCT03041181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102057530|NCT03041181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102057531|NCT03041181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102057532|NCT03041181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102057533|NCT05351229|Morphine|morphine|mesh-list
102057534|NCT05351229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102057535|NCT05351229|Narcotics|narcotics|mesh-ancestor
101610048|NCT01142336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610049|NCT01142336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101610050|NCT01142336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101610051|NCT01142336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610066|NCT01128296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101610067|NCT01128296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610068|NCT01128296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101610069|NCT05082909|Probenecid|probenecid|mesh-list
101610070|NCT05082909|Uricosuric Agents|uricosuric agents|mesh-ancestor
101610071|NCT05082909|Gout Suppressants|gout suppressants|mesh-ancestor
101610072|NCT05082909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101610073|NCT04253145|Atezolizumab|atezolizumab|mesh-list
101610074|NCT04253145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101610075|NCT04253145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610076|NCT04253145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101610077|NCT04253145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101610078|NCT04240509|Tenofovir|tenofovir|mesh-list
101610079|NCT04240509|Emtricitabine|emtricitabine|mesh-list
101610080|NCT04240509|Antiviral Agents|antiviral agents|mesh-ancestor
101610081|NCT04240509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101610082|NCT04240509|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101610083|NCT04240509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101610084|NCT04240509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610085|NCT04240509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610086|NCT04240509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101610087|NCT04240509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101610088|NCT04450329|Aflibercept|aflibercept|mesh-list
101610089|NCT04450329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101610090|NCT04450329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101610091|NCT04450329|Growth Substances|growth substances|mesh-ancestor
101610092|NCT04450329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610093|NCT04450329|Growth Inhibitors|growth inhibitors|mesh-ancestor
101610094|NCT04450329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101610095|NCT01115738|Clopidogrel|clopidogrel|mesh-list
101610096|NCT01115738|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101610097|NCT01115738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101610098|NCT01115738|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101610099|NCT01115738|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101610100|NCT01115738|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101610101|NCT01115738|Purinergic Agents|purinergic agents|mesh-ancestor
101610102|NCT01115738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101610103|NCT01115738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610104|NCT01115738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610105|NCT00632073|Maleic acid|maleic acid|mesh-list
101610106|NCT00632073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610107|NCT00632073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610108|NCT01141478|Sorafenib|sorafenib|mesh-list
101610109|NCT01141478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101610110|NCT01141478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101610111|NCT01141478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101539639|NCT01129882|Dopamine Agents|dopamine agents|mesh-ancestor
101610137|NCT04646187|Adalimumab|adalimumab|mesh-list
101610138|NCT04646187|Infliximab|infliximab|mesh-list
101610139|NCT04646187|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101610140|NCT04646187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101610141|NCT04646187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101610142|NCT04646187|Dermatologic Agents|dermatologic agents|mesh-ancestor
101610143|NCT04646187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101610144|NCT04282902|Pirfenidone|pirfenidone|mesh-list
102057536|NCT05351229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102057537|NCT05351229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057538|NCT05351229|Analgesics|analgesics|mesh-ancestor
102057539|NCT05351229|Sensory System Agents|sensory system agents|mesh-ancestor
102057540|NCT05351229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102057541|NCT05121909|Listerine|listerine|mesh-list
102057542|NCT05121909|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
102057543|NCT05121909|Sodium Fluoride|sodium fluoride|mesh-list
102057544|NCT05121909|Cariostatic Agents|cariostatic agents|mesh-ancestor
102057545|NCT05121909|Protective Agents|protective agents|mesh-ancestor
102057546|NCT05121909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057547|NCT05121909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102057548|NCT02828124|Nivolumab|nivolumab|mesh-list
102057549|NCT02828124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102057550|NCT02828124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102057551|NCT02828124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102057552|NCT02828124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057554|NCT04761393|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102057555|NCT04761393|Anesthetics, General|anesthetics, general|mesh-ancestor
102057556|NCT04761393|Anesthetics|anesthetics|mesh-ancestor
102057557|NCT04761393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102057558|NCT04761393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057559|NCT02829996|Latanoprost|latanoprost|mesh-list
102057560|NCT02829996|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102057561|NCT02829996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102057562|NCT05385549|Imatinib Mesylate|imatinib mesylate|mesh-list
102057563|NCT05385549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102057564|NCT05385549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102057565|NCT05385549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102057566|NCT05385549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057569|NCT05197062|Aticaprant|aticaprant|mesh-list
102057579|NCT05000736|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102057581|NCT05000736|Hormone Antagonists|hormone antagonists|mesh-ancestor
102057582|NCT05000736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102057583|NCT05000736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057584|NCT05000736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102057585|NCT05000736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102057586|NCT05000736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057587|NCT05000736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102057588|NCT03828162|Anticoagulants|anticoagulants|mesh-list
102057589|NCT03563040|Methoxsalen|methoxsalen|mesh-list
102057590|NCT03563040|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102057591|NCT03563040|Dermatologic Agents|dermatologic agents|mesh-ancestor
102057592|NCT03094416|Esomeprazole|esomeprazole|mesh-list
102057593|NCT03094416|Omeprazole|omeprazole|mesh-list
102057594|NCT03094416|Rabeprazole|rabeprazole|mesh-list
102057595|NCT03094416|Pantoprazole|pantoprazole|mesh-list
101610145|NCT04282902|Analgesics|analgesics|mesh-ancestor
101610146|NCT04282902|Sensory System Agents|sensory system agents|mesh-ancestor
101610147|NCT04282902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101610148|NCT04282902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610149|NCT04282902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101610151|NCT04282902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101610152|NCT04282902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101610153|NCT04282902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101610154|NCT02860962|Dextromethorphan|dextromethorphan|mesh-list
101610155|NCT02860962|Antitussive Agents|antitussive agents|mesh-ancestor
101610156|NCT02860962|Respiratory System Agents|respiratory system agents|mesh-ancestor
101610157|NCT02860962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101610158|NCT02860962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101610159|NCT02860962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101610160|NCT02860962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610163|NCT04432623|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101610164|NCT04432623|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101610165|NCT04432623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610166|NCT04432623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610168|NCT04432623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101610169|NCT04432623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610170|NCT00878722|Idarubicin|idarubicin|mesh-list
101610171|NCT00878722|Belinostat|belinostat|mesh-list
101610172|NCT00878722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101610173|NCT00878722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101610174|NCT00878722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101610175|NCT00878722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101610176|NCT00878722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610177|NCT00878722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610178|NCT00878722|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101610179|NCT03432897|Olaparib|olaparib|mesh-list
101610180|NCT03432897|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101610181|NCT03432897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610182|NCT03432897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610183|NCT03432897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101610184|NCT00659386|Immunoglobulins|immunoglobulins|mesh-list
101610185|NCT00659386|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101610186|NCT00659386|Antibodies|antibodies|mesh-list
101610187|NCT00659386|gamma-Globulins|gamma-globulins|mesh-list
101610188|NCT00659386|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102057596|NCT03094416|Lansoprazole|lansoprazole|mesh-list
102057597|NCT03094416|Dexlansoprazole|dexlansoprazole|mesh-list
102057598|NCT03094416|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
102057599|NCT03094416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102057600|NCT03094416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102057601|NCT03094416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102057602|NCT03094416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057603|NCT05109429|Analgesics, Opioid|analgesics, opioid|mesh-list
102057604|NCT05109429|Narcotics|narcotics|mesh-ancestor
102057605|NCT05109429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102057606|NCT05109429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057607|NCT05109429|Analgesics|analgesics|mesh-ancestor
102057608|NCT05109429|Sensory System Agents|sensory system agents|mesh-ancestor
102057609|NCT05109429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102057610|NCT01338870|Nicotinic Acids|nicotinic acids|mesh-list
102057611|NCT01338870|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101628303|NCT02590705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101610189|NCT00659386|Immunologic Factors|immunologic factors|mesh-ancestor
101610190|NCT00659386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610191|NCT04160325|Azathioprine|azathioprine|mesh-list
101610192|NCT04160325|Antimetabolites|antimetabolites|mesh-ancestor
101610193|NCT04160325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610194|NCT04160325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101610195|NCT04160325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101610196|NCT04160325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101610197|NCT04160325|Immunologic Factors|immunologic factors|mesh-ancestor
101610198|NCT04160325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610199|NCT04160325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101610200|NCT04155814|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101610201|NCT04155814|Hematinics|hematinics|mesh-ancestor
101610202|NCT04547439|Melatonin|melatonin|mesh-list
101610203|NCT04547439|Antioxidants|antioxidants|mesh-ancestor
101610204|NCT04547439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610205|NCT04547439|Protective Agents|protective agents|mesh-ancestor
101610206|NCT04547439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610207|NCT04547439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101610208|NCT04158076|Amlodipine|amlodipine|mesh-list
101610209|NCT04158076|Telmisartan|telmisartan|mesh-list
101610210|NCT04158076|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
101610211|NCT04158076|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101610212|NCT04158076|Ezetimibe|ezetimibe|mesh-list
101610213|NCT04158076|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101610214|NCT04158076|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101610215|NCT04158076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101610216|NCT04158076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610217|NCT04158076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101610218|NCT04158076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610220|NCT04158076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101610221|NCT04158076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101610222|NCT04158076|Antimetabolites|antimetabolites|mesh-ancestor
101610223|NCT04158076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101610224|NCT04158076|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101610225|NCT04158076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610226|NCT04158076|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101610227|NCT04158076|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101610228|NCT00961350|Aspirin|aspirin|mesh-list
101610229|NCT00961350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102057612|NCT01338870|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
102057613|NCT01338870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102057614|NCT01338870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057615|NCT01338870|Incretins|incretins|mesh-ancestor
102057616|NCT01338870|Hormones|hormones|mesh-ancestor
102057617|NCT01338870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101610230|NCT00961350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101610231|NCT00961350|Analgesics|analgesics|mesh-ancestor
101610248|NCT03537690|Tubulin Modulators|tubulin modulators|mesh-ancestor
101610249|NCT03537690|Antimitotic Agents|antimitotic agents|mesh-ancestor
101610250|NCT03537690|Mitosis Modulators|mitosis modulators|mesh-ancestor
101610251|NCT03537690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610252|NCT04032184|Chlorhexidine|chlorhexidine|mesh-list
101610253|NCT04032184|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101610254|NCT04032184|Fluorides|fluorides|mesh-list
101610255|NCT04032184|Cariostatic Agents|cariostatic agents|mesh-ancestor
101610256|NCT04032184|Protective Agents|protective agents|mesh-ancestor
101610257|NCT04032184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610258|NCT04032184|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101610259|NCT04032184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101610260|NCT04032184|Disinfectants|disinfectants|mesh-ancestor
101610261|NCT04032184|Dermatologic Agents|dermatologic agents|mesh-ancestor
101610262|NCT04246437|Carbidopa|carbidopa|mesh-list
101610263|NCT04246437|Entacapone|entacapone|mesh-list
101610264|NCT04246437|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101610265|NCT04246437|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101610266|NCT04246437|Dopamine Agents|dopamine agents|mesh-ancestor
101610267|NCT04246437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101610268|NCT04246437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610269|NCT04246437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610270|NCT04246437|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101610271|NCT04246437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610272|NCT04246437|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101610273|NCT00662896|Ibuprofen|ibuprofen|mesh-list
101610274|NCT00662896|Naproxen|naproxen|mesh-list
101610275|NCT00662896|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
101610276|NCT00662896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101610277|NCT00662896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101610278|NCT00662896|Analgesics|analgesics|mesh-ancestor
101610279|NCT00662896|Sensory System Agents|sensory system agents|mesh-ancestor
101610280|NCT00662896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101610281|NCT00662896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610282|NCT00662896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101610283|NCT00662896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101610284|NCT00662896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101610285|NCT00662896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610286|NCT00662896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610287|NCT00662896|Gout Suppressants|gout suppressants|mesh-ancestor
101610288|NCT00662896|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101610289|NCT00963924|Cycloserine|cycloserine|mesh-list
101610295|NCT00963924|Antimetabolites|antimetabolites|mesh-ancestor
101610296|NCT00963924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610297|NCT04155658|Fluorides|fluorides|mesh-list
101610298|NCT04155658|Cariostatic Agents|cariostatic agents|mesh-ancestor
101610299|NCT04155658|Protective Agents|protective agents|mesh-ancestor
101610300|NCT04155658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610301|NCT02861976|Analgesics, Opioid|analgesics, opioid|mesh-list
101610302|NCT02861976|Narcotics|narcotics|mesh-ancestor
101610303|NCT02861976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101610304|NCT02861976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610305|NCT02861976|Analgesics|analgesics|mesh-ancestor
101610306|NCT02861976|Sensory System Agents|sensory system agents|mesh-ancestor
101610307|NCT02861976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101610308|NCT00666484|Prednisolone|prednisolone|mesh-list
101267316|NCT01788371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101610309|NCT00666484|Cyclophosphamide|cyclophosphamide|mesh-list
101610310|NCT00666484|Doxorubicin|doxorubicin|mesh-list
101610311|NCT00666484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102057619|NCT01338870|Protease Inhibitors|protease inhibitors|mesh-ancestor
102057620|NCT01338870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102057621|NCT01338870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057622|NCT01338870|Vitamin B Complex|vitamin b complex|mesh-ancestor
101610312|NCT00666484|Etoposide|etoposide|mesh-list
101610313|NCT00666484|Vincristine|vincristine|mesh-list
101610314|NCT00666484|Procarbazine|procarbazine|mesh-list
101610315|NCT00666484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101610316|NCT00666484|Immunologic Factors|immunologic factors|mesh-ancestor
101610317|NCT00666484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610318|NCT00666484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101610319|NCT00666484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101610320|NCT00666484|Alkylating Agents|alkylating agents|mesh-ancestor
101610321|NCT00666484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610322|NCT00666484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101610323|NCT00666484|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101610324|NCT00666484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101610325|NCT00666484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101610326|NCT00666484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101610327|NCT00666484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610328|NCT00666484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101610329|NCT00666484|Tubulin Modulators|tubulin modulators|mesh-ancestor
101610330|NCT00666484|Antimitotic Agents|antimitotic agents|mesh-ancestor
101610331|NCT00666484|Mitosis Modulators|mitosis modulators|mesh-ancestor
101610332|NCT00666484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101610333|NCT00666484|Glucocorticoids|glucocorticoids|mesh-ancestor
101610334|NCT00666484|Hormones|hormones|mesh-ancestor
101610335|NCT00666484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101610336|NCT00666484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101610337|NCT00663130|Tadalafil|tadalafil|mesh-list
101610338|NCT00663130|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101610339|NCT00663130|Vasodilator Agents|vasodilator agents|mesh-ancestor
101610340|NCT00663130|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101610341|NCT00663130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101610342|NCT00663130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610343|NCT00663130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610344|NCT00663130|Urological Agents|urological agents|mesh-ancestor
101610345|NCT00965562|Fluoxetine|fluoxetine|mesh-list
101610346|NCT00965562|Calcium|calcium|mesh-list
101610347|NCT00965562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101610348|NCT00965562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610349|NCT00965562|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101610350|NCT00965562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101610351|NCT00965562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101610352|NCT00965562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610353|NCT00965562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101610354|NCT00965562|Serotonin Agents|serotonin agents|mesh-ancestor
101610355|NCT00965562|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101610356|NCT00965562|Antidepressive Agents|antidepressive agents|mesh-ancestor
101610357|NCT00965562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101610367|NCT00666796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101610368|NCT00666796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610369|NCT00666796|Anticonvulsants|anticonvulsants|mesh-ancestor
101610370|NCT00666796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101610371|NCT00666796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101610372|NCT00666796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101610373|NCT00666796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101610374|NCT00666796|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101610375|NCT00666796|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101610376|NCT00666796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101610377|NCT00666796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610378|NCT00666796|Antimanic Agents|antimanic agents|mesh-ancestor
101610379|NCT00666796|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101610380|NCT00666796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101610382|NCT00912093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102057624|NCT01338870|Micronutrients|micronutrients|mesh-ancestor
102057625|NCT02824224|Tamoxifen|tamoxifen|mesh-list
102057626|NCT02824224|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102057627|NCT02824224|Hormone Antagonists|hormone antagonists|mesh-ancestor
102057628|NCT02824224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102057629|NCT02824224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057630|NCT02824224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102057631|NCT02824224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101610383|NCT00912093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101610384|NCT00912093|Analgesics|analgesics|mesh-ancestor
101610385|NCT00912093|Sensory System Agents|sensory system agents|mesh-ancestor
101610386|NCT00912093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101610387|NCT00912093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610388|NCT00912093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101610389|NCT00912093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101610390|NCT00912093|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
101610391|NCT00912093|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
101610392|NCT00912093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610393|NCT00912093|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101610394|NCT00912093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101610395|NCT00912093|Immunologic Factors|immunologic factors|mesh-ancestor
101610396|NCT00659776|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
101610398|NCT00659776|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101610399|NCT00659776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101610400|NCT03500484|Liraglutide|liraglutide|mesh-list
101610401|NCT03500484|Glucagon|glucagon|mesh-list
101610402|NCT03500484|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101610403|NCT03500484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101610404|NCT03500484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610405|NCT03500484|Incretins|incretins|mesh-ancestor
101610406|NCT03500484|Hormones|hormones|mesh-ancestor
101610407|NCT03500484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101610408|NCT03500484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101610409|NCT03929601|Rituximab|rituximab|mesh-list
101610410|NCT03929601|Abatacept|abatacept|mesh-list
101610411|NCT03929601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101610412|NCT03929601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101610413|NCT03929601|Immunologic Factors|immunologic factors|mesh-ancestor
101610414|NCT03929601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610415|NCT03929601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101610416|NCT03929601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101610417|NCT03929601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610418|NCT03929601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101610419|NCT02631460|Carboplatin|carboplatin|mesh-list
101610420|NCT02631460|Pemetrexed|pemetrexed|mesh-list
101610421|NCT02631460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101610422|NCT02631460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610423|NCT02631460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610424|NCT02631460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101539944|NCT04545801|Ketamine|ketamine|mesh-list
101610430|NCT04282824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610431|NCT04282824|Anticoagulants|anticoagulants|mesh-ancestor
101610432|NCT04282824|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101610433|NCT04282824|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101610434|NCT00663286|Clindamycin|clindamycin|mesh-list
101610435|NCT00663286|Clindamycin palmitate|clindamycin palmitate|mesh-list
101610436|NCT00663286|Clindamycin phosphate|clindamycin phosphate|mesh-list
101610437|NCT00663286|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101610438|NCT00663286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101610439|NCT00663286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101610440|NCT00663286|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101610441|NCT00663286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610442|NCT00663286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610443|NCT00663286|Dermatologic Agents|dermatologic agents|mesh-ancestor
101610444|NCT03237702|Carotenoids|carotenoids|mesh-list
102057632|NCT02824224|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102057633|NCT02824224|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102057634|NCT02824224|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102057635|NCT01338792|Oxaliplatin|oxaliplatin|mesh-list
102057636|NCT01338792|Pemetrexed|pemetrexed|mesh-list
102057637|NCT01338792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102057638|NCT01338792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628304|NCT02590705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101610445|NCT03237702|Antioxidants|antioxidants|mesh-ancestor
101610446|NCT03237702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610447|NCT03237702|Protective Agents|protective agents|mesh-ancestor
101610448|NCT03237702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610450|NCT00667108|Analgesics|analgesics|mesh-ancestor
101610451|NCT00667108|Sensory System Agents|sensory system agents|mesh-ancestor
101610452|NCT00667108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101610453|NCT00667108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610454|NCT00667108|Anticonvulsants|anticonvulsants|mesh-ancestor
101610455|NCT00667108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101610456|NCT00667108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101610457|NCT00667108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101610458|NCT00667108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101267464|NCT01789294|Mesalamine|mesalamine|mesh-list
101610459|NCT00667108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101610460|NCT00667108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101610461|NCT00667108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101610462|NCT00667108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610464|NCT00961116|Fenofibrate|fenofibrate|mesh-list
101610465|NCT00961116|Fenofibric acid|fenofibric acid|mesh-list
101610466|NCT00961116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101610467|NCT00961116|Antimetabolites|antimetabolites|mesh-ancestor
101610468|NCT00961116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610469|NCT00961116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101610470|NCT00961116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101610471|NCT04158388|Tryptophan|tryptophan|mesh-list
101610472|NCT04158388|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101610473|NCT04158388|Antidepressive Agents|antidepressive agents|mesh-ancestor
101610474|NCT04158388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101610475|NCT04283136|Padsevonil|padsevonil|mesh-list
101610476|NCT04283136|Anticonvulsants|anticonvulsants|mesh-ancestor
101610477|NCT04283058|Ketamine|ketamine|mesh-list
101610478|NCT04283058|Anesthetics|anesthetics|mesh-list
101610479|NCT04283058|Analgesics|analgesics|mesh-ancestor
101610480|NCT04283058|Sensory System Agents|sensory system agents|mesh-ancestor
101610481|NCT04283058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101610482|NCT04283058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610483|NCT04283058|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101610484|NCT04283058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101610485|NCT04283058|Anesthetics, General|anesthetics, general|mesh-ancestor
101610486|NCT04283058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101610487|NCT04283058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101610488|NCT04283058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101610489|NCT04283058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101610490|NCT04283058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610491|NCT00631995|Vaccines|vaccines|mesh-list
101610492|NCT00631995|Immunologic Factors|immunologic factors|mesh-ancestor
101610493|NCT00631995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610494|NCT00663442|Methylphenidate|methylphenidate|mesh-list
101540005|NCT01124734|Temozolomide|temozolomide|mesh-list
101610528|NCT00911157|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101610529|NCT00911157|Antithrombins|antithrombins|mesh-ancestor
101610530|NCT00911157|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101610531|NCT00911157|Protease Inhibitors|protease inhibitors|mesh-ancestor
101610532|NCT00911157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610533|NCT00960570|Efavirenz|efavirenz|mesh-list
101610534|NCT00960570|Fenofibric acid|fenofibric acid|mesh-list
101610535|NCT00960570|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101610536|NCT00960570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101540075|NCT01124617|Analgesics|analgesics|mesh-ancestor
102057639|NCT01338792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057640|NCT01338792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102057641|NCT01338792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102057642|NCT01314105|Carboplatin|carboplatin|mesh-list
102057643|NCT01314105|Nintedanib|nintedanib|mesh-list
102057644|NCT01314105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102057645|NCT01314105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102057646|NCT01314105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610565|NCT00625430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610567|NCT04282746|Analgesics|analgesics|mesh-ancestor
101610568|NCT04282746|Sensory System Agents|sensory system agents|mesh-ancestor
101610569|NCT04282746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101610570|NCT04282746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610571|NCT04282746|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101610572|NCT04282746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101610573|NCT04282746|Anesthetics, General|anesthetics, general|mesh-ancestor
101610574|NCT04282746|Anesthetics|anesthetics|mesh-ancestor
101610575|NCT04282746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101610576|NCT04282746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101610577|NCT04282746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101610578|NCT04282746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101610579|NCT04282746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610580|NCT03773445|Golimumab|golimumab|mesh-list
101610581|NCT03773445|Antibodies|antibodies|mesh-list
101610582|NCT03773445|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101610583|NCT03773445|Immunologic Factors|immunologic factors|mesh-ancestor
101610584|NCT03773445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610585|NCT03773445|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101610586|NCT03773445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101610587|NCT03773445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101610588|NCT00630084|Interferons|interferons|mesh-list
101610589|NCT00630084|Ribavirin|ribavirin|mesh-list
101610590|NCT00630084|Interferon-alpha|interferon-alpha|mesh-list
101610591|NCT00630084|Interferon alpha-2|interferon alpha-2|mesh-list
101610592|NCT00630084|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101610593|NCT00630084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101610594|NCT00630084|Antiviral Agents|antiviral agents|mesh-ancestor
101610595|NCT00630084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101610596|NCT00630084|Antimetabolites|antimetabolites|mesh-ancestor
101610597|NCT00630084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610598|NCT00630084|Immunologic Factors|immunologic factors|mesh-ancestor
101610599|NCT00630084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610600|NCT01126424|Solifenacin Succinate|solifenacin succinate|mesh-list
101610601|NCT01126424|Oxybutynin|oxybutynin|mesh-list
101610602|NCT01126424|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101610603|NCT01126424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101610604|NCT01126424|Cholinergic Agents|cholinergic agents|mesh-ancestor
101610605|NCT01126424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101610606|NCT01126424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610607|NCT01126424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267614|NCT01792570|Antiviral Agents|antiviral agents|mesh-ancestor
101610608|NCT01126424|Urological Agents|urological agents|mesh-ancestor
101610609|NCT01126424|Parasympatholytics|parasympatholytics|mesh-ancestor
101610610|NCT01126424|Autonomic Agents|autonomic agents|mesh-ancestor
101610611|NCT01126424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101265079|NCT01771081|Ranibizumab|ranibizumab|mesh-list
101610613|NCT04204902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101610615|NCT01126268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101610616|NCT01126268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101610617|NCT04284150|Midazolam|midazolam|mesh-list
101610618|NCT04284150|Dexmedetomidine|dexmedetomidine|mesh-list
101610619|NCT04284150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101610620|NCT04284150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101610621|NCT04284150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610622|NCT04284150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101610623|NCT04284150|Analgesics|analgesics|mesh-ancestor
101610624|NCT04284150|Sensory System Agents|sensory system agents|mesh-ancestor
102057647|NCT01314105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057649|NCT01966471|Docetaxel|docetaxel|mesh-list
102057650|NCT01966471|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102057651|NCT01966471|Cyclophosphamide|cyclophosphamide|mesh-list
102057652|NCT01966471|Doxorubicin|doxorubicin|mesh-list
102057653|NCT01966471|Fluorouracil|fluorouracil|mesh-list
101610625|NCT04284150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101610626|NCT04284150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101610627|NCT04284150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101610628|NCT04284150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101610629|NCT04284150|Adrenergic Agents|adrenergic agents|mesh-ancestor
101610630|NCT04284150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101610631|NCT04284150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610632|NCT04284150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101610633|NCT04284150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101610634|NCT04284150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101610635|NCT04284150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101610636|NCT04284150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101610637|NCT04284150|Anesthetics, General|anesthetics, general|mesh-ancestor
101610653|NCT00879658|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101610654|NCT00879658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610655|NCT00879658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101610656|NCT00879658|Immunologic Factors|immunologic factors|mesh-ancestor
101610657|NCT00879658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610658|NCT00959946|Capecitabine|capecitabine|mesh-list
101610659|NCT00959946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101610660|NCT00959946|Antimetabolites|antimetabolites|mesh-ancestor
101610661|NCT00959946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610662|NCT00959946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101610663|NCT00667264|Ropivacaine|ropivacaine|mesh-list
101610664|NCT00667264|Anesthetics, Local|anesthetics, local|mesh-ancestor
101610665|NCT00667264|Anesthetics|anesthetics|mesh-ancestor
101610666|NCT00667264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101610667|NCT00667264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610668|NCT00667264|Sensory System Agents|sensory system agents|mesh-ancestor
101610669|NCT00667264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101778928|NCT00640224|Estradiol|estradiol|mesh-list
101610670|NCT00660244|Anastrozole|anastrozole|mesh-list
101610671|NCT00660244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101610672|NCT00660244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101610673|NCT00660244|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101610674|NCT00660244|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101610675|NCT00660244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610676|NCT00660244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610677|NCT00660244|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101610678|NCT00660244|Hormone Antagonists|hormone antagonists|mesh-ancestor
101610679|NCT00660244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101610680|NCT00660244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610681|NCT04282200|Ketorolac|ketorolac|mesh-list
101610682|NCT04282200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101610683|NCT04282200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101610685|NCT04282200|Sensory System Agents|sensory system agents|mesh-ancestor
101610686|NCT04282200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101610687|NCT04282200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610688|NCT04282200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101610689|NCT04282200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101610690|NCT04282200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101610691|NCT04282200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610692|NCT04282200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610693|NCT00667498|Metformin|metformin|mesh-list
101610694|NCT00667498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101610695|NCT00667498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540208|NCT00577421|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101610697|NCT02860650|Antiviral Agents|antiviral agents|mesh-ancestor
101610698|NCT02860650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101610699|NCT00667966|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
102057654|NCT01966471|Trastuzumab|trastuzumab|mesh-list
102057655|NCT01966471|Epirubicin|epirubicin|mesh-list
102057656|NCT01966471|Pertuzumab|pertuzumab|mesh-list
101359266|NCT00208273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610700|NCT00667966|Vasodilator Agents|vasodilator agents|mesh-ancestor
101610701|NCT00667966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101610702|NCT00667966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101610703|NCT00667966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610704|NCT00667966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610705|NCT00667966|Urological Agents|urological agents|mesh-ancestor
101610706|NCT04283916|Botulinum Toxins|botulinum toxins|mesh-list
101610707|NCT04283916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101610708|NCT04283916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101610709|NCT04283916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610710|NCT04283916|Cholinergic Agents|cholinergic agents|mesh-ancestor
101610711|NCT04283916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101610712|NCT04283916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610713|NCT00911937|Fesoterodine|fesoterodine|mesh-list
101610714|NCT00911937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101610715|NCT00911937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101610716|NCT00911937|Cholinergic Agents|cholinergic agents|mesh-ancestor
101610717|NCT00911937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101610718|NCT00911937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610719|NCT00911937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610720|NCT00911937|Urological Agents|urological agents|mesh-ancestor
101610721|NCT00663598|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101610722|NCT00663598|Vasodilator Agents|vasodilator agents|mesh-ancestor
101610723|NCT00663598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101610724|NCT00663598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101610725|NCT00663598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610726|NCT00663598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610727|NCT00663598|Urological Agents|urological agents|mesh-ancestor
101610728|NCT02859480|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101610729|NCT02859480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101610730|NCT02859480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101610731|NCT02859480|Antimetabolites|antimetabolites|mesh-ancestor
101775280|NCT00935961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610732|NCT02859480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610733|NCT02859480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101610734|NCT02859480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101610735|NCT02859480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610736|NCT01076543|Sirolimus|sirolimus|mesh-list
101610737|NCT01076543|Lenalidomide|lenalidomide|mesh-list
101610738|NCT01076543|Temsirolimus|temsirolimus|mesh-list
101610739|NCT01076543|MTOR Inhibitors|mtor inhibitors|mesh-list
101610740|NCT01076543|Immunologic Factors|immunologic factors|mesh-ancestor
101610741|NCT01076543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610742|NCT01076543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101610743|NCT01076543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101610744|NCT01076543|Growth Substances|growth substances|mesh-ancestor
101610745|NCT01076543|Growth Inhibitors|growth inhibitors|mesh-ancestor
101610746|NCT01076543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101610747|NCT01076543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101610748|NCT01076543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101610749|NCT01076543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101610750|NCT01076543|Antifungal Agents|antifungal agents|mesh-ancestor
101610751|NCT01076543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101610752|NCT01076543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101610753|NCT01076543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610754|NCT01076543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610755|NCT00668044|Ciprofloxacin|ciprofloxacin|mesh-list
101610756|NCT00668044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101610757|NCT00668044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101610758|NCT00668044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101610759|NCT00668044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101610760|NCT00668044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610761|NCT00668044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610762|NCT00668044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101610763|NCT00668044|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101610764|NCT00668044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102057657|NCT01966471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102057658|NCT01966471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102057659|NCT01966471|Tubulin Modulators|tubulin modulators|mesh-ancestor
102057660|NCT01966471|Antimitotic Agents|antimitotic agents|mesh-ancestor
102057661|NCT01966471|Mitosis Modulators|mitosis modulators|mesh-ancestor
102057662|NCT01966471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057663|NCT01966471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102057664|NCT01966471|Immunologic Factors|immunologic factors|mesh-ancestor
102057665|NCT01966471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610771|NCT02860494|Immunologic Factors|immunologic factors|mesh-ancestor
101610772|NCT02860494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610773|NCT02860494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101610775|NCT00663832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101610776|NCT00663832|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101610777|NCT00663832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610778|NCT00663832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610779|NCT04281576|Capecitabine|capecitabine|mesh-list
101610780|NCT04281576|Oxaliplatin|oxaliplatin|mesh-list
101610781|NCT04281576|Trastuzumab|trastuzumab|mesh-list
101610782|NCT04281576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101610783|NCT04281576|Antimetabolites|antimetabolites|mesh-ancestor
101610784|NCT04281576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610785|NCT04281576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101610786|NCT04281576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101610787|NCT00668122|Ciprofloxacin|ciprofloxacin|mesh-list
101610788|NCT00668122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101610789|NCT00668122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101610790|NCT00668122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101610791|NCT00668122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101610792|NCT00668122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610793|NCT00668122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610794|NCT00668122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101610795|NCT00668122|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101610796|NCT00668122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101610797|NCT04304807|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101610798|NCT04304807|Melatonin|melatonin|mesh-list
101610799|NCT04304807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101610800|NCT04304807|Antioxidants|antioxidants|mesh-ancestor
101610801|NCT04304807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610802|NCT04304807|Protective Agents|protective agents|mesh-ancestor
101610803|NCT04304807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610804|NCT04304807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101610805|NCT04280874|Dinoprostone|dinoprostone|mesh-list
101610806|NCT04280874|Oxytocics|oxytocics|mesh-ancestor
101610807|NCT04280874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101610808|NCT04280874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610809|NCT00663910|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101610810|NCT00663910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101610811|NCT00663910|Dermatologic Agents|dermatologic agents|mesh-ancestor
101610812|NCT04157998|Metoclopramide|metoclopramide|mesh-list
101610813|NCT04157998|Antiemetics|antiemetics|mesh-ancestor
101610814|NCT04157998|Autonomic Agents|autonomic agents|mesh-ancestor
101610815|NCT04157998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101610816|NCT04157998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610817|NCT04157998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101610818|NCT04157998|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101610819|NCT04157998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101610820|NCT04157998|Dopamine Agents|dopamine agents|mesh-ancestor
101610821|NCT04157998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101610822|NCT04157998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610823|NCT01072877|Polidocanol|polidocanol|mesh-list
101610824|NCT01072877|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
101610825|NCT01072877|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102057666|NCT01966471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102057667|NCT01966471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102057668|NCT01966471|Alkylating Agents|alkylating agents|mesh-ancestor
101359279|NCT00208312|Vasodilator Agents|vasodilator agents|mesh-ancestor
101610826|NCT00630474|Xylometazoline|xylometazoline|mesh-list
101610827|NCT00630474|Nasal Decongestants|nasal decongestants|mesh-ancestor
101610828|NCT00630474|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101610829|NCT00630474|Respiratory System Agents|respiratory system agents|mesh-ancestor
101610830|NCT00957528|Methyltestosterone|methyltestosterone|mesh-list
101610831|NCT00957528|Testosterone|testosterone|mesh-list
101610832|NCT00957528|Testosterone undecanoate|testosterone undecanoate|mesh-list
101610833|NCT00957528|Testosterone enanthate|testosterone enanthate|mesh-list
101610861|NCT02858622|Sensory System Agents|sensory system agents|mesh-ancestor
101610862|NCT02858622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101610863|NCT02858622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101610864|NCT02858622|Narcotics|narcotics|mesh-ancestor
101610865|NCT02858622|Analgesics|analgesics|mesh-ancestor
101610866|NCT02858622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101610867|NCT02858622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101610868|NCT02858622|Anesthetics, General|anesthetics, general|mesh-ancestor
101610869|NCT02191566|Oxaliplatin|oxaliplatin|mesh-list
101610870|NCT02191566|Tegafur|tegafur|mesh-list
101610871|NCT02191566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101610872|NCT02191566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101610873|NCT02191566|Antimetabolites|antimetabolites|mesh-ancestor
101610874|NCT02191566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610875|NCT00596830|Paclitaxel|paclitaxel|mesh-list
101610876|NCT00596830|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101610877|NCT00596830|Carboplatin|carboplatin|mesh-list
101778961|NCT01001260|Aspirin|aspirin|mesh-list
101610878|NCT00596830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101265119|NCT01771406|Nebivolol|nebivolol|mesh-list
101610879|NCT00596830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101610880|NCT00596830|Tubulin Modulators|tubulin modulators|mesh-ancestor
101610881|NCT00596830|Antimitotic Agents|antimitotic agents|mesh-ancestor
101610882|NCT00596830|Mitosis Modulators|mitosis modulators|mesh-ancestor
101540389|NCT00578825|Antimetabolites|antimetabolites|mesh-ancestor
101610894|NCT05143164|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101610896|NCT05143164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610897|NCT00664144|Rasburicase|rasburicase|mesh-list
101610898|NCT00664144|Gout Suppressants|gout suppressants|mesh-ancestor
101610899|NCT00664144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101610900|NCT02819856|Ebselen|ebselen|mesh-list
101610901|NCT02819856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101610902|NCT02819856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101610903|NCT02819856|Analgesics|analgesics|mesh-ancestor
101610904|NCT02819856|Sensory System Agents|sensory system agents|mesh-ancestor
101610905|NCT02819856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101610906|NCT02819856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610907|NCT02819856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101610908|NCT02819856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101610909|NCT02819856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101610910|NCT02819856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101610911|NCT02819856|Antioxidants|antioxidants|mesh-ancestor
101610912|NCT02819856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610913|NCT02819856|Protective Agents|protective agents|mesh-ancestor
101610914|NCT02819856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101610915|NCT02819856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610916|NCT02819856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101610917|NCT02630290|Dexmedetomidine|dexmedetomidine|mesh-list
101610918|NCT02630290|Ropivacaine|ropivacaine|mesh-list
101610919|NCT02630290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101610920|NCT02630290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101610921|NCT02630290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610922|NCT02630290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101610923|NCT02630290|Analgesics|analgesics|mesh-ancestor
101610924|NCT02630290|Sensory System Agents|sensory system agents|mesh-ancestor
101610925|NCT02630290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101610926|NCT02630290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101610927|NCT02630290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101610928|NCT02630290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101610929|NCT02630290|Adrenergic Agents|adrenergic agents|mesh-ancestor
101610930|NCT02630290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101610931|NCT02630290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057669|NCT01966471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102057670|NCT01966471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102057671|NCT01966471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102057672|NCT01966471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102057673|NCT01966471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102057675|NCT01966471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102057676|NCT01966471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102057677|NCT01966471|Immunotoxins|immunotoxins|mesh-ancestor
102057678|NCT01966471|Immunoconjugates|immunoconjugates|mesh-ancestor
102057679|NCT04188847|Apatinib|apatinib|mesh-list
102057680|NCT04188847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101610932|NCT02630290|Anesthetics, Local|anesthetics, local|mesh-ancestor
101610933|NCT02630290|Anesthetics|anesthetics|mesh-ancestor
101610934|NCT02856906|Salicylic Acid|salicylic acid|mesh-list
101610935|NCT02856906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101610936|NCT02856906|Antifungal Agents|antifungal agents|mesh-ancestor
101610937|NCT02856906|Keratolytic Agents|keratolytic agents|mesh-ancestor
101610938|NCT02856906|Dermatologic Agents|dermatologic agents|mesh-ancestor
101610939|NCT00668356|Didanosine|didanosine|mesh-list
101610940|NCT00668356|Antimetabolites|antimetabolites|mesh-ancestor
101778969|NCT01001260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101610941|NCT00668356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610942|NCT00668356|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101610943|NCT00668356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101610944|NCT00668356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101540444|NCT04535817|Omalizumab|omalizumab|mesh-list
101610969|NCT00911859|Melphalan|melphalan|mesh-list
101610970|NCT00911859|Siltuximab|siltuximab|mesh-list
101610971|NCT00911859|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101610972|NCT00911859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101610973|NCT00911859|Glucocorticoids|glucocorticoids|mesh-ancestor
101610974|NCT00911859|Hormones|hormones|mesh-ancestor
101610975|NCT00911859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101610976|NCT00911859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610977|NCT00911859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101610978|NCT00911859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101267995|NCT01800799|Celecoxib|celecoxib|mesh-list
101610979|NCT00911859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101610981|NCT00911859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610982|NCT00911859|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101610983|NCT00911859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101610984|NCT00911859|Immunologic Factors|immunologic factors|mesh-ancestor
101610985|NCT02725593|Dapagliflozin|dapagliflozin|mesh-list
101610986|NCT02725593|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101610987|NCT02725593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610988|NCT02725593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101610989|NCT02725593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610990|NCT00911625|Insulin|insulin|mesh-list
101610991|NCT00911625|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101610992|NCT00911625|Insulin Glargine|insulin glargine|mesh-list
101610993|NCT00911625|Insulin glulisine|insulin glulisine|mesh-list
101610994|NCT00911625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101610995|NCT00911625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611003|NCT00958074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101611004|NCT00958074|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101611005|NCT00958074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101611006|NCT00958074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611007|NCT00660868|Pentoxifylline|pentoxifylline|mesh-list
101611008|NCT00660868|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101611009|NCT00660868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101611010|NCT00660868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611011|NCT00660868|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101611012|NCT00660868|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102057681|NCT04188847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102057682|NCT04188847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102057683|NCT04188847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057684|NCT05255107|Riboflavin|riboflavin|mesh-list
101611013|NCT00660868|Protective Agents|protective agents|mesh-ancestor
101611014|NCT00660868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611015|NCT00660868|Vasodilator Agents|vasodilator agents|mesh-ancestor
101611016|NCT00660868|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101611017|NCT00660868|Antioxidants|antioxidants|mesh-ancestor
101611018|NCT00664690|Celecoxib|celecoxib|mesh-list
101611019|NCT00664690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101611020|NCT00664690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101611021|NCT00664690|Analgesics|analgesics|mesh-ancestor
101611022|NCT00664690|Sensory System Agents|sensory system agents|mesh-ancestor
101265124|NCT01771406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101611023|NCT00664690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101611024|NCT00664690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611025|NCT00664690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101611026|NCT00664690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101611027|NCT00664690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101611028|NCT00664690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101611029|NCT00664690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101611030|NCT00664690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611031|NCT00809965|Rivaroxaban|rivaroxaban|mesh-list
101611032|NCT00809965|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101611033|NCT00809965|Antithrombins|antithrombins|mesh-ancestor
101611034|NCT00809965|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101611035|NCT00809965|Protease Inhibitors|protease inhibitors|mesh-ancestor
101611036|NCT00809965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101611037|NCT00809965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611038|NCT00809965|Anticoagulants|anticoagulants|mesh-ancestor
101611039|NCT04338165|Evolocumab|evolocumab|mesh-list
101611040|NCT04338165|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101611041|NCT04338165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101611042|NCT04338165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101611043|NCT04338165|Antimetabolites|antimetabolites|mesh-ancestor
101611044|NCT04338165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611045|NCT04338165|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101611046|NCT04338165|Protease Inhibitors|protease inhibitors|mesh-ancestor
101611047|NCT04338165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101611048|NCT04338165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101611049|NCT00664846|Aspirin|aspirin|mesh-list
101611050|NCT00664846|Clopidogrel|clopidogrel|mesh-list
101611051|NCT00664846|Atorvastatin|atorvastatin|mesh-list
101611052|NCT00664846|Simvastatin|simvastatin|mesh-list
101268073|NCT01801644|Cisplatin|cisplatin|mesh-list
101611053|NCT00664846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101611054|NCT00664846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101611055|NCT00664846|Analgesics|analgesics|mesh-ancestor
101611056|NCT00664846|Sensory System Agents|sensory system agents|mesh-ancestor
101611057|NCT00664846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101611058|NCT00664846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611059|NCT00664846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101611060|NCT00664846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101611061|NCT00664846|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101611062|NCT00664846|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101540544|NCT04532775|Analgesics|analgesics|mesh-ancestor
101611065|NCT00664846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101611066|NCT00664846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101611067|NCT00664846|Antipyretics|antipyretics|mesh-ancestor
101611068|NCT00664846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101611069|NCT00664846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101611070|NCT00664846|Antimetabolites|antimetabolites|mesh-ancestor
101611071|NCT00664846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101611072|NCT00664846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101611073|NCT00664846|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101611074|NCT00664846|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101611075|NCT00664846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101611076|NCT00664846|Purinergic Agents|purinergic agents|mesh-ancestor
101611077|NCT00664846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101611078|NCT00913783|Clomipramine|clomipramine|mesh-list
101611079|NCT00913783|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102057685|NCT05255107|Lubricant Eye Drops|lubricant eye drops|mesh-list
102057686|NCT05255107|Vitamin B Complex|vitamin b complex|mesh-ancestor
102057687|NCT05255107|Vitamins|vitamins|mesh-ancestor
102057688|NCT05255107|Micronutrients|micronutrients|mesh-ancestor
102057689|NCT05255107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057690|NCT05255107|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102057691|NCT05255107|Dermatologic Agents|dermatologic agents|mesh-ancestor
102057692|NCT05255107|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102057693|NCT05255107|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102057694|NCT03227471|Ivacaftor|ivacaftor|mesh-list
102057695|NCT03227471|Elexacaftor|elexacaftor|mesh-list
102057696|NCT03227471|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102057697|NCT03227471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102057698|NCT03227471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057699|NCT01354314|Fluconazole|fluconazole|mesh-list
102057700|NCT01354314|Paroxetine|paroxetine|mesh-list
102057701|NCT01354314|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102057702|NCT01354314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102057703|NCT01354314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102057704|NCT01354314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057705|NCT01354314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102057706|NCT01354314|Serotonin Agents|serotonin agents|mesh-ancestor
101359297|NCT00068952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359301|NCT00208546|Cetuximab|cetuximab|mesh-list
101611080|NCT00913783|Antidepressive Agents|antidepressive agents|mesh-ancestor
101611081|NCT00913783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101611082|NCT00913783|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101611083|NCT00913783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101611084|NCT00913783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101611085|NCT00913783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611086|NCT00913783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101611087|NCT00913783|Serotonin Agents|serotonin agents|mesh-ancestor
101611088|NCT00913783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611089|NCT00661102|Capecitabine|capecitabine|mesh-list
101611090|NCT00661102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101611091|NCT00661102|Antimetabolites|antimetabolites|mesh-ancestor
101611092|NCT00661102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611093|NCT00661102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101611095|NCT00669370|Capecitabine|capecitabine|mesh-list
101611096|NCT00669370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101611097|NCT00669370|Tubulin Modulators|tubulin modulators|mesh-ancestor
101611098|NCT00669370|Antimitotic Agents|antimitotic agents|mesh-ancestor
101611099|NCT00669370|Mitosis Modulators|mitosis modulators|mesh-ancestor
101611100|NCT00669370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611101|NCT00669370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101611102|NCT00669370|Antimetabolites|antimetabolites|mesh-ancestor
101611103|NCT00665314|Plerixafor|plerixafor|mesh-list
101611104|NCT00665314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101611105|NCT00665314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101611106|NCT00665314|Antiviral Agents|antiviral agents|mesh-ancestor
102057707|NCT01354314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057708|NCT01354314|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102057709|NCT01354314|Antidepressive Agents|antidepressive agents|mesh-ancestor
102057710|NCT01354314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102057711|NCT01354314|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102057712|NCT01354314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102057713|NCT01354314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102057714|NCT01354314|Antifungal Agents|antifungal agents|mesh-ancestor
102057715|NCT01354314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102057716|NCT01354314|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102057717|NCT01354314|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102057718|NCT01354314|Hormone Antagonists|hormone antagonists|mesh-ancestor
102057719|NCT01354314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102057720|NCT01354314|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102057721|NCT01354314|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102057722|NCT04509336|Orphenadrine|orphenadrine|mesh-list
102057723|NCT04509336|Baclofen|baclofen|mesh-list
102057724|NCT04509336|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102057725|NCT04509336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057726|NCT04509336|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102057727|NCT04509336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102057728|NCT04509336|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102057729|NCT04509336|GABA Agonists|gaba agonists|mesh-ancestor
102057730|NCT04509336|GABA Agents|gaba agents|mesh-ancestor
101359322|NCT00208585|Serotonin Agents|serotonin agents|mesh-ancestor
101611107|NCT00665314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101611108|NCT04154722|Azithromycin|azithromycin|mesh-list
101611109|NCT04154722|Meropenem|meropenem|mesh-list
101611110|NCT04154722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101611111|NCT04154722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101611112|NCT02631928|Insulin|insulin|mesh-list
101611113|NCT02631928|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101611114|NCT02631928|Biphasic Insulins|biphasic insulins|mesh-list
101611115|NCT02631928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101611116|NCT02631928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611117|NCT00632385|Eletriptan|eletriptan|mesh-list
101611118|NCT00632385|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101611119|NCT00632385|Serotonin Agents|serotonin agents|mesh-ancestor
101611120|NCT00632385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101611121|NCT00632385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611122|NCT00632385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611123|NCT00910689|Propranolol|propranolol|mesh-list
101611124|NCT00910689|Nadolol|nadolol|mesh-list
101611125|NCT00910689|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101611126|NCT00910689|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101611127|NCT00910689|Adrenergic Agents|adrenergic agents|mesh-ancestor
101611129|NCT00910689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611130|NCT00910689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057731|NCT04509336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102057732|NCT04509336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057733|NCT04509336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102057734|NCT04509336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102057735|NCT04509336|Parasympatholytics|parasympatholytics|mesh-ancestor
102057736|NCT04509336|Autonomic Agents|autonomic agents|mesh-ancestor
102057737|NCT04509336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102057738|NCT04509336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102057739|NCT04509336|Cholinergic Agents|cholinergic agents|mesh-ancestor
102057740|NCT04509336|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
102057741|NCT04509336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102057742|NCT04509336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102057743|NCT03194321|Tacrolimus|tacrolimus|mesh-list
102057744|NCT03194321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102057745|NCT03194321|Immunologic Factors|immunologic factors|mesh-ancestor
102057746|NCT03194321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057747|NCT03194321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102057748|NCT03194321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101359344|NCT00208741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101359346|NCT00208741|GABA Agents|gaba agents|mesh-ancestor
101611131|NCT00910689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101611132|NCT00910689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101611133|NCT00910689|Vasodilator Agents|vasodilator agents|mesh-ancestor
101611134|NCT00910689|Sympatholytics|sympatholytics|mesh-ancestor
101611135|NCT00910689|Autonomic Agents|autonomic agents|mesh-ancestor
101611140|NCT04669717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101611141|NCT04669717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101611142|NCT04669717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101611143|NCT04669717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101611144|NCT00809341|Prednisone|prednisone|mesh-list
101611145|NCT00809341|Cyclophosphamide|cyclophosphamide|mesh-list
101611146|NCT00809341|Ifosfamide|ifosfamide|mesh-list
101611147|NCT00809341|Rituximab|rituximab|mesh-list
101611148|NCT00809341|Carboplatin|carboplatin|mesh-list
101611149|NCT00809341|Doxorubicin|doxorubicin|mesh-list
101611150|NCT00809341|Etoposide|etoposide|mesh-list
101611151|NCT00809341|Vincristine|vincristine|mesh-list
101611152|NCT00809341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101611153|NCT00809341|Immunologic Factors|immunologic factors|mesh-ancestor
101611154|NCT00809341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611155|NCT00809341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101611156|NCT00809341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101611157|NCT00809341|Alkylating Agents|alkylating agents|mesh-ancestor
101611158|NCT00809341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611159|NCT00809341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101611160|NCT00809341|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101611161|NCT00809341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101611162|NCT00809341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101611163|NCT00809341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101611164|NCT00809341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101611165|NCT00809341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101611166|NCT00809341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101611167|NCT00809341|Glucocorticoids|glucocorticoids|mesh-ancestor
101611168|NCT00809341|Hormones|hormones|mesh-ancestor
101611169|NCT00809341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102057749|NCT03194321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057750|NCT05231460|Narcotics|narcotics|mesh-list
102057751|NCT05231460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102057752|NCT05231460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057753|NCT05231460|Analgesics|analgesics|mesh-ancestor
102057754|NCT05231460|Sensory System Agents|sensory system agents|mesh-ancestor
102057755|NCT05231460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102057756|NCT01374581|Artesunate|artesunate|mesh-list
102057757|NCT01374581|Lumefantrine|lumefantrine|mesh-list
102057758|NCT01374581|Artemether|artemether|mesh-list
102057759|NCT01374581|Amodiaquine|amodiaquine|mesh-list
101611170|NCT00809341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101611171|NCT00809341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101611172|NCT00809341|Tubulin Modulators|tubulin modulators|mesh-ancestor
101611173|NCT00809341|Antimitotic Agents|antimitotic agents|mesh-ancestor
101611175|NCT02609581|Immunomodulating Agents|immunomodulating agents|mesh-list
101611176|NCT02609581|Immunologic Factors|immunologic factors|mesh-list
101611177|NCT02609581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611178|NCT00811135|Bevacizumab|bevacizumab|mesh-list
101611179|NCT00811135|Trastuzumab|trastuzumab|mesh-list
101611180|NCT00811135|Capecitabine|capecitabine|mesh-list
101611181|NCT00811135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101611182|NCT00811135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101611183|NCT00811135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101611184|NCT00811135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101611185|NCT00811135|Growth Substances|growth substances|mesh-ancestor
101611186|NCT00811135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611187|NCT00811135|Growth Inhibitors|growth inhibitors|mesh-ancestor
101611188|NCT00811135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101611189|NCT00811135|Antimetabolites|antimetabolites|mesh-ancestor
101611190|NCT00811135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611191|NCT00811057|Indomethacin|indomethacin|mesh-list
101611192|NCT00811057|Magnesium Sulfate|magnesium sulfate|mesh-list
101611193|NCT00811057|Nifedipine|nifedipine|mesh-list
101611194|NCT00811057|Analgesics|analgesics|mesh-ancestor
101611195|NCT00811057|Sensory System Agents|sensory system agents|mesh-ancestor
101611196|NCT00811057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101611197|NCT00811057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611198|NCT00811057|Anesthetics|anesthetics|mesh-ancestor
101611199|NCT00811057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101611200|NCT00811057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101611201|NCT00811057|Anticonvulsants|anticonvulsants|mesh-ancestor
101611202|NCT00811057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101611203|NCT00811057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101611204|NCT00811057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611205|NCT00811057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101611206|NCT00811057|Tocolytic Agents|tocolytic agents|mesh-ancestor
101611207|NCT00811057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101611208|NCT00811057|Vasodilator Agents|vasodilator agents|mesh-ancestor
101611209|NCT00811057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101611253|NCT00910299|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101611254|NCT00910299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101611256|NCT00910299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101611257|NCT00910299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611258|NCT00910299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611259|NCT03007329|Dapagliflozin|dapagliflozin|mesh-list
101611260|NCT03007329|Exenatide|exenatide|mesh-list
101611261|NCT03007329|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101611262|NCT03007329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611263|NCT03007329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101611264|NCT03007329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611265|NCT03007329|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101611266|NCT03007329|Incretins|incretins|mesh-ancestor
101611267|NCT03007329|Hormones|hormones|mesh-ancestor
102057760|NCT01374581|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102057761|NCT01374581|Quinine|quinine|mesh-list
102057762|NCT01374581|Clindamycin|clindamycin|mesh-list
102057763|NCT01374581|Clindamycin palmitate|clindamycin palmitate|mesh-list
102057764|NCT01374581|Clindamycin phosphate|clindamycin phosphate|mesh-list
102057765|NCT01374581|Antimalarials|antimalarials|mesh-ancestor
102057766|NCT01374581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102057767|NCT01374581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102057768|NCT01374581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102057769|NCT01374581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102057770|NCT01374581|Antiviral Agents|antiviral agents|mesh-ancestor
102057771|NCT01374581|Schistosomicides|schistosomicides|mesh-ancestor
101611268|NCT03007329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101611269|NCT04072341|Propolis|propolis|mesh-list
101611270|NCT04072341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101611271|NCT04030039|Interferons|interferons|mesh-list
101611272|NCT04030039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101611273|NCT04030039|Antiviral Agents|antiviral agents|mesh-ancestor
101611274|NCT04030039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101611275|NCT02628574|Gemcitabine|gemcitabine|mesh-list
101611276|NCT02628574|Pembrolizumab|pembrolizumab|mesh-list
101611277|NCT02628574|Nivolumab|nivolumab|mesh-list
101611278|NCT02628574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101611280|NCT02628574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611281|NCT02628574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101611282|NCT02628574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101611283|NCT02628574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101611284|NCT00596362|Bevacizumab|bevacizumab|mesh-list
101611285|NCT00596362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101611286|NCT00596362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101611287|NCT00596362|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101611288|NCT00596362|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101611289|NCT00596362|Growth Substances|growth substances|mesh-ancestor
101611290|NCT00596362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611291|NCT00596362|Growth Inhibitors|growth inhibitors|mesh-ancestor
101611292|NCT00907803|Tecovirimat|tecovirimat|mesh-list
101611293|NCT00907803|Antiviral Agents|antiviral agents|mesh-ancestor
101611294|NCT00907803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101611295|NCT00669994|Ciprofloxacin|ciprofloxacin|mesh-list
101611296|NCT00669994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101611297|NCT00669994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101611298|NCT00669994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101611299|NCT00669994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101611300|NCT00669994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101611301|NCT00669994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611302|NCT00669994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101611303|NCT00669994|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101611304|NCT00669994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101611305|NCT02790723|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101611306|NCT02790723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101611307|NCT00676156|Thioctic Acid|thioctic acid|mesh-list
101611308|NCT00676156|Antioxidants|antioxidants|mesh-ancestor
101611309|NCT00676156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611310|NCT00676156|Protective Agents|protective agents|mesh-ancestor
101611311|NCT00676156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611312|NCT00676156|Vitamin B Complex|vitamin b complex|mesh-ancestor
101611313|NCT00676156|Vitamins|vitamins|mesh-ancestor
101611314|NCT00676156|Micronutrients|micronutrients|mesh-ancestor
101611315|NCT00670150|Arsenic Trioxide|arsenic trioxide|mesh-list
101611316|NCT00670150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101611317|NCT00914017|Atorvastatin|atorvastatin|mesh-list
101611318|NCT00914017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101611319|NCT00914017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101611350|NCT00591253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102057773|NCT01374581|Anthelmintics|anthelmintics|mesh-ancestor
102057774|NCT01374581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102057775|NCT01374581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102057776|NCT01374581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102057777|NCT01374581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057778|NCT01374581|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102057779|NCT01374581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057780|NCT01374581|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101359386|NCT00208858|Anticonvulsants|anticonvulsants|mesh-ancestor
101611351|NCT00591253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101611352|NCT00591253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611353|NCT00676702|Vitamin K|vitamin k|mesh-list
101611354|NCT00676702|Pancrelipase|pancrelipase|mesh-list
101611355|NCT00676702|Pancreatin|pancreatin|mesh-list
101611356|NCT00676702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101611357|NCT00676702|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101611358|NCT00676702|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101611359|NCT00676702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611360|NCT00676702|Hemostatics|hemostatics|mesh-ancestor
101611365|NCT05753371|Metformin|metformin|mesh-list
101611366|NCT05753371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101611367|NCT05753371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611368|NCT00671476|Doxorubicin|doxorubicin|mesh-list
101611369|NCT00671476|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101611370|NCT00671476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101611371|NCT00671476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101611372|NCT00671476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101611373|NCT00671476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101611374|NCT00671476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101611375|NCT00671476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611376|NCT00908583|Methylprednisolone|methylprednisolone|mesh-list
101611377|NCT00908583|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101611378|NCT00908583|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101611379|NCT00908583|Prednisolone|prednisolone|mesh-list
101611380|NCT00908583|Prednisolone acetate|prednisolone acetate|mesh-list
101611381|NCT00908583|Rituximab|rituximab|mesh-list
101611382|NCT00908583|Bortezomib|bortezomib|mesh-list
101611383|NCT00908583|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101611384|NCT00908583|Prednisolone phosphate|prednisolone phosphate|mesh-list
101611385|NCT00908583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101611386|NCT00908583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101611387|NCT00908583|Immunologic Factors|immunologic factors|mesh-ancestor
101611388|NCT00908583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611389|NCT00908583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101611390|NCT00908583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101611391|NCT00908583|Antiemetics|antiemetics|mesh-ancestor
101611392|NCT00908583|Autonomic Agents|autonomic agents|mesh-ancestor
101611393|NCT00908583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101611394|NCT00908583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101611395|NCT00908583|Glucocorticoids|glucocorticoids|mesh-ancestor
101611396|NCT00908583|Hormones|hormones|mesh-ancestor
101611397|NCT00908583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101611398|NCT00908583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101611399|NCT00908583|Protective Agents|protective agents|mesh-ancestor
101611400|NCT00908583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101611401|NCT05519241|Paclitaxel|paclitaxel|mesh-list
101611402|NCT05519241|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101611403|NCT05519241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101611404|NCT05519241|Tubulin Modulators|tubulin modulators|mesh-ancestor
101611405|NCT05519241|Antimitotic Agents|antimitotic agents|mesh-ancestor
101611406|NCT05519241|Mitosis Modulators|mitosis modulators|mesh-ancestor
101611407|NCT05519241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611408|NCT00671632|Triazolam|triazolam|mesh-list
101611409|NCT00671632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102057781|NCT01374581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102057782|NCT01374581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102057783|NCT01374581|Analgesics|analgesics|mesh-ancestor
102057784|NCT01374581|Sensory System Agents|sensory system agents|mesh-ancestor
102057785|NCT01354938|Clarithromycin|clarithromycin|mesh-list
102057786|NCT01354938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102057787|NCT01354938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102057788|NCT01354938|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102057789|NCT01354938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102057790|NCT01354938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057791|NCT01354938|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102057792|NCT01354938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101779034|NCT01066429|Glucocorticoids|glucocorticoids|mesh-ancestor
102057793|NCT03065556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102057794|NCT01374737|Dexmedetomidine|dexmedetomidine|mesh-list
102057795|NCT01374737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102057796|NCT01374737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102057797|NCT01374737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057798|NCT01374737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102057799|NCT01374737|Analgesics|analgesics|mesh-ancestor
102057800|NCT01374737|Sensory System Agents|sensory system agents|mesh-ancestor
102057801|NCT01374737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101611410|NCT00671632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101611411|NCT00671632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101611412|NCT00671632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101611413|NCT00671632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611414|NCT00671632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101611415|NCT00671632|GABA Modulators|gaba modulators|mesh-ancestor
101611416|NCT00671632|GABA Agents|gaba agents|mesh-ancestor
101611417|NCT00671632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101611418|NCT00671632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611419|NCT04153708|Antibodies|antibodies|mesh-list
101611420|NCT04153708|Immunoglobulins|immunoglobulins|mesh-list
101611421|NCT04153708|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
101611422|NCT04153708|Immunologic Factors|immunologic factors|mesh-ancestor
101611423|NCT04153708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611424|NCT00676936|Methylprednisolone|methylprednisolone|mesh-list
101611425|NCT00676936|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101611426|NCT00676936|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101611427|NCT00676936|Prednisolone|prednisolone|mesh-list
101611428|NCT00676936|Prednisolone acetate|prednisolone acetate|mesh-list
101611429|NCT00676936|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101611430|NCT00676936|Prednisolone phosphate|prednisolone phosphate|mesh-list
101611431|NCT00676936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101611432|NCT00676936|Antiemetics|antiemetics|mesh-ancestor
101611433|NCT00676936|Autonomic Agents|autonomic agents|mesh-ancestor
101611434|NCT00676936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101611441|NCT00676936|Protective Agents|protective agents|mesh-ancestor
101611442|NCT00676936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101611443|NCT00676936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101611444|NCT02629744|Etrolizumab|etrolizumab|mesh-list
101611445|NCT02629744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101611446|NCT02629744|Immunologic Factors|immunologic factors|mesh-ancestor
101611447|NCT02629744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057802|NCT01374737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102057803|NCT01374737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102057804|NCT01374737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102057805|NCT01374737|Adrenergic Agents|adrenergic agents|mesh-ancestor
102057806|NCT01374737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102057807|NCT01374737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057808|NCT03631615|Antibodies|antibodies|mesh-list
102057809|NCT03631615|Immunologic Factors|immunologic factors|mesh-ancestor
102057810|NCT03631615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057811|NCT01376453|Fluorouracil|fluorouracil|mesh-list
102057812|NCT01376453|Sorafenib|sorafenib|mesh-list
102057813|NCT01376453|Antimetabolites|antimetabolites|mesh-ancestor
101611448|NCT00677170|Pevonedistat|pevonedistat|mesh-list
101611449|NCT00677170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101611450|NCT00677170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611451|NCT00908349|Oxcarbazepine|oxcarbazepine|mesh-list
101611452|NCT00908349|Anticonvulsants|anticonvulsants|mesh-ancestor
101611453|NCT00908349|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101611454|NCT00908349|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101611455|NCT00908349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101611456|NCT00908349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611457|NCT00908349|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101611458|NCT00908349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101611459|NCT01125566|Trastuzumab|trastuzumab|mesh-list
101611460|NCT01125566|Vinorelbine|vinorelbine|mesh-list
101611461|NCT01125566|Afatinib|afatinib|mesh-list
101611462|NCT01125566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101611463|NCT01125566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101611464|NCT01125566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101611465|NCT01125566|Tubulin Modulators|tubulin modulators|mesh-ancestor
101611466|NCT01125566|Antimitotic Agents|antimitotic agents|mesh-ancestor
101611467|NCT01125566|Mitosis Modulators|mitosis modulators|mesh-ancestor
101611468|NCT01125566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611469|NCT01125566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101611470|NCT01125566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101611471|NCT04031872|Capecitabine|capecitabine|mesh-list
101611472|NCT04031872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101611473|NCT04031872|Antimetabolites|antimetabolites|mesh-ancestor
101611474|NCT04031872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611475|NCT04031872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101611476|NCT00670696|Tetracaine|tetracaine|mesh-list
101611477|NCT00670696|Anesthetics, Local|anesthetics, local|mesh-ancestor
101611478|NCT00670696|Anesthetics|anesthetics|mesh-ancestor
101611479|NCT00670696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101611480|NCT00670696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611481|NCT00670696|Sensory System Agents|sensory system agents|mesh-ancestor
101611482|NCT00670696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101611483|NCT00677248|Ezetimibe|ezetimibe|mesh-list
101611484|NCT00677248|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101611485|NCT00677248|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101611486|NCT00677248|Antimetabolites|antimetabolites|mesh-ancestor
101611487|NCT00677248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611488|NCT00677248|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101611489|NCT00671710|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101611490|NCT00671710|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101611491|NCT00671710|Dermatologic Agents|dermatologic agents|mesh-ancestor
101611492|NCT00671008|Insulin|insulin|mesh-list
101611493|NCT00671008|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101611494|NCT00671008|Insulin Aspart|insulin aspart|mesh-list
101611495|NCT00671008|Insulin Detemir|insulin detemir|mesh-list
101611496|NCT00671008|Biphasic Insulins|biphasic insulins|mesh-list
101611497|NCT00671008|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101611498|NCT00671008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102057814|NCT01376453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057815|NCT01376453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102057816|NCT01376453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102057817|NCT01376453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102057818|NCT01376453|Immunologic Factors|immunologic factors|mesh-ancestor
101611499|NCT00671008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611500|NCT00911716|Cyclophosphamide|cyclophosphamide|mesh-list
101611501|NCT00911716|Bevacizumab|bevacizumab|mesh-list
101611502|NCT00911716|Docetaxel|docetaxel|mesh-list
101611503|NCT00911716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101611504|NCT00911716|Immunologic Factors|immunologic factors|mesh-ancestor
101611538|NCT00672022|Miglustat|miglustat|mesh-list
101611539|NCT00672022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101611540|NCT00672022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611541|NCT00672022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101611542|NCT00672022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101611543|NCT00672022|Antiviral Agents|antiviral agents|mesh-ancestor
101611544|NCT00672022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101611545|NCT00672022|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101541038|NCT02881762|Maraviroc|maraviroc|mesh-list
101611554|NCT00680602|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101611555|NCT00680602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101611556|NCT00680602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101611557|NCT00680602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611558|NCT00680602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101611560|NCT00680602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611561|NCT00680602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101611562|NCT00680602|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101611563|NCT00680602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101611564|NCT00680602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101611565|NCT00680680|Dutasteride|dutasteride|mesh-list
101611566|NCT00680680|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101611567|NCT00680680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101611568|NCT00680680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101611569|NCT00680680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611570|NCT00680680|Hormone Antagonists|hormone antagonists|mesh-ancestor
101611571|NCT00680680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101611572|NCT00680680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611573|NCT00808015|Varenicline|varenicline|mesh-list
101265171|NCT01771822|Analgesics|analgesics|mesh-ancestor
101611574|NCT00808015|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101611575|NCT00808015|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101611576|NCT00808015|Cholinergic Agents|cholinergic agents|mesh-ancestor
101611577|NCT00808015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101611578|NCT00808015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611579|NCT00808015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611581|NCT00680758|Everolimus|everolimus|mesh-list
101611582|NCT00680758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101611583|NCT00680758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101611584|NCT00680758|Tubulin Modulators|tubulin modulators|mesh-ancestor
101611585|NCT00680758|Antimitotic Agents|antimitotic agents|mesh-ancestor
101611586|NCT00680758|Mitosis Modulators|mitosis modulators|mesh-ancestor
101611587|NCT00680758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611588|NCT00680758|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101611589|NCT00680758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101611590|NCT00680758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101611591|NCT00680758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101611592|NCT00680758|Immunologic Factors|immunologic factors|mesh-ancestor
101611593|NCT00680758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611594|NCT00678106|Dalbavancin|dalbavancin|mesh-list
101611595|NCT00678106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101611596|NCT00678106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101611597|NCT00810199|Methotrexate|methotrexate|mesh-list
101611598|NCT00810199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101611599|NCT00810199|Abortifacient Agents|abortifacient agents|mesh-ancestor
101611600|NCT00810199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102057819|NCT01376453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057820|NCT01376453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102057821|NCT01376453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102057823|NCT05107219|Plecanatide|plecanatide|mesh-list
102057824|NCT05107219|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
102057825|NCT05107219|Enzyme Activators|enzyme activators|mesh-ancestor
102057826|NCT05107219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057827|NCT05107219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102057828|NCT01568125|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102057829|NCT01568125|Incretins|incretins|mesh-list
102057830|NCT01568125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057831|NCT01568125|Hormones|hormones|mesh-ancestor
102057832|NCT01568125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102057833|NCT02288897|Temozolomide|temozolomide|mesh-list
102057834|NCT02288897|Dacarbazine|dacarbazine|mesh-list
102057835|NCT02288897|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
102057836|NCT02288897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102057837|NCT02288897|Alkylating Agents|alkylating agents|mesh-ancestor
102057838|NCT02288897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057839|NCT02288897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102057840|NCT02288897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102057841|NCT05707572|Methylprednisolone|methylprednisolone|mesh-list
102057842|NCT05707572|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102057843|NCT05707572|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102057844|NCT05707572|Prednisolone|prednisolone|mesh-list
102057845|NCT05707572|Prednisolone acetate|prednisolone acetate|mesh-list
102057846|NCT05707572|Lidocaine|lidocaine|mesh-list
102057847|NCT05707572|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102057866|NCT05707572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102057867|NCT05707572|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102057868|NCT05707572|Protective Agents|protective agents|mesh-ancestor
101779054|NCT00994786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102057869|NCT05707572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102057870|NCT05707572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102057871|NCT02035800|Adalimumab|adalimumab|mesh-list
102057872|NCT02035800|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102057873|NCT02035800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102057874|NCT02035800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102057875|NCT03993912|Dexamethasone|dexamethasone|mesh-list
102057876|NCT03993912|Lenalidomide|lenalidomide|mesh-list
102057877|NCT03993912|Daratumumab|daratumumab|mesh-list
102057878|NCT03993912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102057879|NCT03993912|Antiemetics|antiemetics|mesh-ancestor
102057880|NCT03993912|Autonomic Agents|autonomic agents|mesh-ancestor
102057881|NCT03993912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101359480|NCT00209209|Glucocorticoids|glucocorticoids|mesh-ancestor
101611601|NCT00810199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611602|NCT00810199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101611603|NCT00810199|Antimetabolites|antimetabolites|mesh-ancestor
101611604|NCT00810199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611605|NCT00810199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101611606|NCT00810199|Dermatologic Agents|dermatologic agents|mesh-ancestor
101611607|NCT00810199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101611608|NCT00810199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101611609|NCT00810199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101611610|NCT00810199|Immunologic Factors|immunologic factors|mesh-ancestor
101611611|NCT00810199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101611616|NCT00877006|Rituximab|rituximab|mesh-list
101611617|NCT00877006|Doxorubicin|doxorubicin|mesh-list
101611618|NCT00877006|Vincristine|vincristine|mesh-list
101611619|NCT00877006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101611620|NCT00877006|Immunologic Factors|immunologic factors|mesh-ancestor
101611621|NCT00877006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611622|NCT00877006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101611623|NCT00877006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101611624|NCT00877006|Alkylating Agents|alkylating agents|mesh-ancestor
101611625|NCT00877006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611626|NCT00877006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101611627|NCT00877006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101611628|NCT00877006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101611629|NCT00877006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101611630|NCT00877006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101611631|NCT00877006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101611632|NCT00877006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101611633|NCT00877006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101611634|NCT00877006|Glucocorticoids|glucocorticoids|mesh-ancestor
101611635|NCT00877006|Hormones|hormones|mesh-ancestor
101611636|NCT00877006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101611637|NCT00877006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101611638|NCT00877006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101611639|NCT00877006|Tubulin Modulators|tubulin modulators|mesh-ancestor
101611640|NCT00877006|Antimitotic Agents|antimitotic agents|mesh-ancestor
101611641|NCT00877006|Mitosis Modulators|mitosis modulators|mesh-ancestor
101611642|NCT00678184|Atorvastatin|atorvastatin|mesh-list
101611643|NCT00678184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101611644|NCT00678184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102057882|NCT03993912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057883|NCT03993912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102057884|NCT03993912|Glucocorticoids|glucocorticoids|mesh-ancestor
102057885|NCT03993912|Hormones|hormones|mesh-ancestor
102057886|NCT03993912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102057887|NCT03993912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102057888|NCT03993912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102057889|NCT03993912|Immunologic Factors|immunologic factors|mesh-ancestor
102057890|NCT03993912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102057891|NCT03993912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102057892|NCT03993912|Growth Substances|growth substances|mesh-ancestor
102057893|NCT03993912|Growth Inhibitors|growth inhibitors|mesh-ancestor
102057894|NCT01568749|Acetaminophen|acetaminophen|mesh-list
102057895|NCT01568749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102057897|NCT01568749|Sensory System Agents|sensory system agents|mesh-ancestor
102057898|NCT01568749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102057899|NCT01568749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057900|NCT01568749|Antipyretics|antipyretics|mesh-ancestor
102057901|NCT02819310|Laxatives|laxatives|mesh-list
102057902|NCT02819310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102057903|NCT03633773|Immunomodulating Agents|immunomodulating agents|mesh-list
102057904|NCT03633773|Immunologic Factors|immunologic factors|mesh-ancestor
102057905|NCT03633773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057906|NCT01375361|Albuterol|albuterol|mesh-list
102057907|NCT01375361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102057908|NCT01375361|Autonomic Agents|autonomic agents|mesh-ancestor
102057909|NCT01375361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102057910|NCT01375361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057911|NCT01375361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102057912|NCT01375361|Respiratory System Agents|respiratory system agents|mesh-ancestor
101611645|NCT00678184|Antimetabolites|antimetabolites|mesh-ancestor
101611646|NCT00678184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611647|NCT00678184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101611648|NCT00678184|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101611649|NCT00678184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101611650|NCT00876928|Vitamin D|vitamin d|mesh-list
101268675|NCT01808911|Rituximab|rituximab|mesh-list
101611652|NCT00876928|Micronutrients|micronutrients|mesh-ancestor
101611653|NCT00876928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611654|NCT00876928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101611655|NCT02627950|Metoclopramide|metoclopramide|mesh-list
101611656|NCT02627950|Ticagrelor|ticagrelor|mesh-list
101611657|NCT02627950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101611658|NCT02627950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102057913|NCT01375361|Tocolytic Agents|tocolytic agents|mesh-ancestor
102057914|NCT01375361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102057915|NCT01375361|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102057916|NCT01375361|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102057917|NCT01375361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102057918|NCT01375361|Adrenergic Agents|adrenergic agents|mesh-ancestor
101359532|NCT00399126|Paclitaxel|paclitaxel|mesh-list
101611659|NCT02627950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101611660|NCT02627950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101611661|NCT02627950|Purinergic Agents|purinergic agents|mesh-ancestor
101611662|NCT02627950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101611663|NCT02627950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611664|NCT02627950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611665|NCT02627950|Antiemetics|antiemetics|mesh-ancestor
101611666|NCT02627950|Autonomic Agents|autonomic agents|mesh-ancestor
101611667|NCT02627950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101611668|NCT02627950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101611669|NCT02627950|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101611670|NCT02627950|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101611671|NCT02627950|Dopamine Agents|dopamine agents|mesh-ancestor
101611672|NCT00807937|Lorazepam|lorazepam|mesh-list
101611673|NCT00807937|Anticonvulsants|anticonvulsants|mesh-ancestor
101611674|NCT00807937|Antiemetics|antiemetics|mesh-ancestor
101611675|NCT00807937|Autonomic Agents|autonomic agents|mesh-ancestor
101611676|NCT00807937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101611677|NCT00807937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611678|NCT00807937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101611679|NCT00807937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101611680|NCT00807937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101611681|NCT00807937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101611682|NCT00807937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101611689|NCT00681148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101611690|NCT00681148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101611691|NCT00681148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611692|NCT00681148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101611693|NCT00681148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101611694|NCT00681148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611695|NCT00681148|Cholinergic Agents|cholinergic agents|mesh-ancestor
101611696|NCT00681148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101611697|NCT04935229|Nivolumab|nivolumab|mesh-list
101611698|NCT04935229|Ipilimumab|ipilimumab|mesh-list
101611699|NCT04935229|Relatlimab|relatlimab|mesh-list
101611700|NCT04935229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101611701|NCT04935229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101611702|NCT04935229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101611703|NCT04935229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611704|NCT00681226|Ramipril|ramipril|mesh-list
101611705|NCT00681226|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101611706|NCT00681226|Protease Inhibitors|protease inhibitors|mesh-ancestor
101611707|NCT00681226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101611708|NCT00681226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611709|NCT00681226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101611710|NCT00678964|Carboplatin|carboplatin|mesh-list
101611711|NCT00678964|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101611712|NCT00678964|Vinorelbine|vinorelbine|mesh-list
101611713|NCT00678964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101611714|NCT00678964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101611715|NCT00678964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101611716|NCT00678964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611717|NCT00678964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101611718|NCT00678964|Tubulin Modulators|tubulin modulators|mesh-ancestor
101611719|NCT00678964|Antimitotic Agents|antimitotic agents|mesh-ancestor
101611720|NCT00678964|Mitosis Modulators|mitosis modulators|mesh-ancestor
101611721|NCT02627248|Cyclophosphamide|cyclophosphamide|mesh-list
101611722|NCT02627248|Docetaxel|docetaxel|mesh-list
101611723|NCT02627248|Epirubicin|epirubicin|mesh-list
101611724|NCT02627248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101268736|NCT01809444|Prednisone|prednisone|mesh-list
102057919|NCT01375361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102057920|NCT01375361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057921|NCT01376765|Aluminum Hydroxide|aluminum hydroxide|mesh-list
102057922|NCT01376765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102057923|NCT01376765|Immunologic Factors|immunologic factors|mesh-ancestor
102057924|NCT01376765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359535|NCT00399126|Tubulin Modulators|tubulin modulators|mesh-ancestor
101611726|NCT02627248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611727|NCT02627248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101611728|NCT02627248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101611729|NCT02627248|Alkylating Agents|alkylating agents|mesh-ancestor
101611730|NCT02627248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611731|NCT02627248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101611732|NCT02627248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101611733|NCT02627248|Tubulin Modulators|tubulin modulators|mesh-ancestor
101611734|NCT02627248|Antimitotic Agents|antimitotic agents|mesh-ancestor
101611735|NCT02627248|Mitosis Modulators|mitosis modulators|mesh-ancestor
101611736|NCT02627248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101611737|NCT02627248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101611738|NCT02627248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101611739|NCT02627248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101611740|NCT03993535|Serotonin|serotonin|mesh-list
101611741|NCT03993535|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
101611742|NCT03993535|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101611743|NCT03993535|Serotonin Agents|serotonin agents|mesh-ancestor
101611744|NCT03993535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101611745|NCT03993535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611746|NCT03993535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611747|NCT03993535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101611748|NCT03993535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101611749|NCT02626936|Insulin|insulin|mesh-list
101611750|NCT02626936|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101611755|NCT02626936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101611756|NCT02626936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101611758|NCT00912262|Antipruritics|antipruritics|mesh-ancestor
101611759|NCT00912262|Dermatologic Agents|dermatologic agents|mesh-ancestor
101611760|NCT00912262|Sensory System Agents|sensory system agents|mesh-ancestor
101611761|NCT00912262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101611762|NCT00912262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611763|NCT00906945|Cytarabine|cytarabine|mesh-list
101611764|NCT00906945|Plerixafor|plerixafor|mesh-list
101611765|NCT00906945|Etoposide|etoposide|mesh-list
101611766|NCT00906945|Mitoxantrone|mitoxantrone|mesh-list
101611767|NCT00906945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101611768|NCT00906945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101611769|NCT00906945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101611770|NCT00906945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101611771|NCT00906945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101611772|NCT00906945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611773|NCT00906945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101611774|NCT00906945|Antimetabolites|antimetabolites|mesh-ancestor
101611775|NCT00906945|Antiviral Agents|antiviral agents|mesh-ancestor
101611776|NCT00906945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101611777|NCT00906945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101611778|NCT00906945|Immunologic Factors|immunologic factors|mesh-ancestor
101611779|NCT00906945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611780|NCT00906945|Analgesics|analgesics|mesh-ancestor
101611781|NCT00906945|Sensory System Agents|sensory system agents|mesh-ancestor
101611782|NCT00906945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101611783|NCT00906945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101611784|NCT00906945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101611785|NCT00807235|Pulmonary Surfactants|pulmonary surfactants|mesh-list
101611786|NCT00807235|Respiratory System Agents|respiratory system agents|mesh-ancestor
101611787|NCT02627560|Tranexamic Acid|tranexamic acid|mesh-list
101611788|NCT02627560|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102057926|NCT01376765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057927|NCT01376765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102057928|NCT03278509|Metoprolol|metoprolol|mesh-list
102057929|NCT03278509|Bisoprolol|bisoprolol|mesh-list
102057930|NCT03278509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102057931|NCT03278509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102057932|NCT03278509|Sympatholytics|sympatholytics|mesh-ancestor
102057933|NCT03278509|Autonomic Agents|autonomic agents|mesh-ancestor
102057934|NCT03278509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102057935|NCT03278509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057936|NCT03278509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102057937|NCT03278509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102057938|NCT03278509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102057939|NCT03278509|Adrenergic Agents|adrenergic agents|mesh-ancestor
102057940|NCT03278509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102057941|NCT03278509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057942|NCT05754593|Hormones|hormones|mesh-list
102057943|NCT05754593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102057944|NCT05754593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359544|NCT00209716|Cisplatin|cisplatin|mesh-list
101611789|NCT02627560|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101611790|NCT02627560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611791|NCT02627560|Hemostatics|hemostatics|mesh-ancestor
101611792|NCT02627560|Coagulants|coagulants|mesh-ancestor
101611793|NCT00681460|Metformin|metformin|mesh-list
101611794|NCT00681460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101611795|NCT00681460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611796|NCT00876694|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101611797|NCT00876694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101611798|NCT00876694|Autonomic Agents|autonomic agents|mesh-ancestor
101611799|NCT00876694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101611800|NCT00876694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611801|NCT00876694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101611802|NCT00876694|Respiratory System Agents|respiratory system agents|mesh-ancestor
101611803|NCT00876694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101611804|NCT00876694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101611805|NCT00876694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101611806|NCT00876694|Adrenergic Agents|adrenergic agents|mesh-ancestor
101611807|NCT00876694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101611808|NCT00876694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611809|NCT05752903|Dexmedetomidine|dexmedetomidine|mesh-list
101611810|NCT05752903|Ketamine|ketamine|mesh-list
101611811|NCT05752903|Propofol|propofol|mesh-list
101611812|NCT05752903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101611813|NCT05752903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101611814|NCT05752903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611815|NCT05752903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101611816|NCT05752903|Analgesics|analgesics|mesh-ancestor
101611817|NCT05752903|Sensory System Agents|sensory system agents|mesh-ancestor
101611818|NCT05752903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101611819|NCT05752903|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101611820|NCT05752903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102057946|NCT05196347|Dapagliflozin|dapagliflozin|mesh-list
102057947|NCT05196347|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102057948|NCT05196347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057949|NCT05196347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102057950|NCT05196347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057951|NCT01358201|Cytarabine|cytarabine|mesh-list
102057952|NCT01358201|Dexamethasone|dexamethasone|mesh-list
102057953|NCT01358201|Methotrexate|methotrexate|mesh-list
102057954|NCT01358201|Vincristine|vincristine|mesh-list
102057955|NCT01358201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102057956|NCT01358201|Antiemetics|antiemetics|mesh-ancestor
102057957|NCT01358201|Autonomic Agents|autonomic agents|mesh-ancestor
102057958|NCT01358201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102057959|NCT01358201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102057960|NCT01358201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102057961|NCT01358201|Glucocorticoids|glucocorticoids|mesh-ancestor
102057962|NCT01358201|Hormones|hormones|mesh-ancestor
102057963|NCT01358201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102057964|NCT01358201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102057965|NCT01358201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102057966|NCT01358201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102057967|NCT01358201|Abortifacient Agents|abortifacient agents|mesh-ancestor
102057968|NCT01358201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102057969|NCT01358201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102057970|NCT01358201|Antimetabolites|antimetabolites|mesh-ancestor
101359563|NCT00209794|Sulfadoxine|sulfadoxine|mesh-list
101611821|NCT05752903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101611822|NCT05752903|Adrenergic Agents|adrenergic agents|mesh-ancestor
101611827|NCT05752903|Anesthetics|anesthetics|mesh-ancestor
101611828|NCT05752903|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101611829|NCT05752903|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101611830|NCT05752903|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101611831|NCT00590317|Ondansetron|ondansetron|mesh-list
101611832|NCT00590317|Prochlorperazine|prochlorperazine|mesh-list
101611833|NCT00590317|Antiemetics|antiemetics|mesh-ancestor
101611834|NCT00590317|Autonomic Agents|autonomic agents|mesh-ancestor
101611835|NCT00590317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101611836|NCT00590317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611837|NCT00590317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101611838|NCT00590317|Antipruritics|antipruritics|mesh-ancestor
101611839|NCT00590317|Dermatologic Agents|dermatologic agents|mesh-ancestor
101611840|NCT00590317|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101611841|NCT00590317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101611842|NCT00590317|Serotonin Agents|serotonin agents|mesh-ancestor
101611843|NCT00590317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101611844|NCT00590317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611845|NCT00590317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102057971|NCT01358201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057972|NCT01358201|Dermatologic Agents|dermatologic agents|mesh-ancestor
102057973|NCT01358201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102057974|NCT01358201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102057975|NCT01358201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102057976|NCT01358201|Immunologic Factors|immunologic factors|mesh-ancestor
102057977|NCT01358201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102057978|NCT01358201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102057979|NCT01358201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102057980|NCT01358201|Tubulin Modulators|tubulin modulators|mesh-ancestor
101611846|NCT00590317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101611847|NCT00590317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101611848|NCT00590317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101611849|NCT00590317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101611850|NCT00590317|Dopamine Agents|dopamine agents|mesh-ancestor
101611852|NCT01139762|Finasteride|finasteride|mesh-list
101611853|NCT01139762|Vasodilator Agents|vasodilator agents|mesh-ancestor
101611854|NCT01139762|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101611855|NCT01139762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101611856|NCT01139762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101611857|NCT01139762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611858|NCT01139762|Urological Agents|urological agents|mesh-ancestor
101611859|NCT01139762|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101611860|NCT01139762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101611861|NCT01139762|Hormone Antagonists|hormone antagonists|mesh-ancestor
101611862|NCT01139762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101611863|NCT01139762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611864|NCT00805285|Budesonide|budesonide|mesh-list
101611865|NCT00805285|Hydrocortisone|hydrocortisone|mesh-list
101611866|NCT00805285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101611867|NCT00805285|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101611868|NCT00805285|Autonomic Agents|autonomic agents|mesh-ancestor
101611869|NCT00805285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101611870|NCT00805285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611871|NCT00805285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101611872|NCT00805285|Respiratory System Agents|respiratory system agents|mesh-ancestor
101268889|NCT01810731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611873|NCT00805285|Glucocorticoids|glucocorticoids|mesh-ancestor
101611874|NCT00805285|Hormones|hormones|mesh-ancestor
101611875|NCT00805285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101611876|NCT02606773|Ascorbic Acid|ascorbic acid|mesh-list
101611877|NCT02606773|Antioxidants|antioxidants|mesh-ancestor
101611878|NCT02606773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611879|NCT02606773|Protective Agents|protective agents|mesh-ancestor
101611880|NCT02606773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611881|NCT02606773|Vitamins|vitamins|mesh-ancestor
101611882|NCT02606773|Micronutrients|micronutrients|mesh-ancestor
101611883|NCT04310774|Tegafur|tegafur|mesh-list
101611884|NCT04310774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101611885|NCT04310774|Antimetabolites|antimetabolites|mesh-ancestor
101611886|NCT04310774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611887|NCT04310774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101611888|NCT01139450|Tacrolimus|tacrolimus|mesh-list
101611889|NCT01139450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101611890|NCT01139450|Immunologic Factors|immunologic factors|mesh-ancestor
101611891|NCT01139450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611893|NCT01139450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101611894|NCT01139450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611895|NCT00805207|Estradiol|estradiol|mesh-list
101611896|NCT00805207|Estrogens|estrogens|mesh-list
101611897|NCT00805207|Testosterone|testosterone|mesh-list
101611898|NCT00805207|Progesterone|progesterone|mesh-list
101611899|NCT00805207|Glucocorticoids|glucocorticoids|mesh-list
101611900|NCT00805207|Hormones|hormones|mesh-ancestor
102057981|NCT01358201|Antimitotic Agents|antimitotic agents|mesh-ancestor
102057982|NCT01358201|Mitosis Modulators|mitosis modulators|mesh-ancestor
102057983|NCT01358201|Antiviral Agents|antiviral agents|mesh-ancestor
102057984|NCT01358201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102057985|NCT02969083|Cisplatin|cisplatin|mesh-list
102057986|NCT02969083|Gemcitabine|gemcitabine|mesh-list
102057987|NCT02969083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102057988|NCT02969083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102057989|NCT02969083|Antimetabolites|antimetabolites|mesh-ancestor
102057990|NCT02969083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057991|NCT04726475|Cannabidiol|cannabidiol|mesh-list
102057992|NCT04726475|Anticonvulsants|anticonvulsants|mesh-ancestor
102057993|NCT02951767|Atezolizumab|atezolizumab|mesh-list
102057994|NCT02951767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102057995|NCT02951767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102057996|NCT02951767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102057997|NCT02951767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102057998|NCT05170763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102057999|NCT03091777|Metronidazole|metronidazole|mesh-list
102058000|NCT03091777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102058001|NCT03091777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102058002|NCT03091777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102058003|NCT03091777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102058004|NCT05603741|Lidocaine|lidocaine|mesh-list
102058005|NCT05603741|Anesthetics, Local|anesthetics, local|mesh-ancestor
102058006|NCT05603741|Anesthetics|anesthetics|mesh-ancestor
102058007|NCT05603741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102058008|NCT05603741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058009|NCT05603741|Sensory System Agents|sensory system agents|mesh-ancestor
101611901|NCT00805207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101611902|NCT00805207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611903|NCT00805207|Androgens|androgens|mesh-ancestor
101611904|NCT00805207|Progestins|progestins|mesh-ancestor
101611905|NCT00805675|Tenofovir|tenofovir|mesh-list
101611906|NCT00805675|Telbivudine|telbivudine|mesh-list
101611907|NCT00805675|Antiviral Agents|antiviral agents|mesh-ancestor
101611908|NCT00805675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101611909|NCT00805675|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101611910|NCT00805675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101611911|NCT00805675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775281|NCT00935961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101611912|NCT00805675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611914|NCT00805675|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101611915|NCT03958201|Rocuronium|rocuronium|mesh-list
101611916|NCT03958201|Neostigmine|neostigmine|mesh-list
101611917|NCT03958201|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102058010|NCT05603741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102058011|NCT05603741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101611918|NCT03958201|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101611919|NCT03958201|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101611920|NCT03958201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101611921|NCT03958201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611922|NCT03958201|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101611923|NCT03958201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101611924|NCT03958201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611925|NCT03958201|Cholinergic Agents|cholinergic agents|mesh-ancestor
101611926|NCT03958201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101611927|NCT03958201|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101611928|NCT03958201|Autonomic Agents|autonomic agents|mesh-ancestor
101611929|NCT00589303|Metoprolol|metoprolol|mesh-list
101611930|NCT00589303|Amiodarone|amiodarone|mesh-list
101611931|NCT00589303|Verapamil|verapamil|mesh-list
101611932|NCT00589303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101611933|NCT00589303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101611934|NCT00589303|Sympatholytics|sympatholytics|mesh-ancestor
101611935|NCT00589303|Autonomic Agents|autonomic agents|mesh-ancestor
101611936|NCT00589303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101611937|NCT00589303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611938|NCT00589303|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101611939|NCT00589303|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101611940|NCT00589303|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101611941|NCT00589303|Adrenergic Agents|adrenergic agents|mesh-ancestor
101611942|NCT00589303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101611943|NCT00589303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611944|NCT00589303|Vasodilator Agents|vasodilator agents|mesh-ancestor
101611945|NCT00589303|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101611946|NCT00589303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101611947|NCT00589303|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101611948|NCT00589303|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101611949|NCT00589303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101611950|NCT00589303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101611951|NCT00589303|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101611952|NCT00589303|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101779098|NCT01004068|Fertility Agents|fertility agents|mesh-ancestor
101611953|NCT00589303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101611954|NCT00589303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101611955|NCT00589303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101611956|NCT02607943|Insulin|insulin|mesh-list
101611957|NCT02607943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101611958|NCT02607943|Insulin Glargine|insulin glargine|mesh-list
101611959|NCT02607943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101611960|NCT02607943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611961|NCT02606617|Mosapride|mosapride|mesh-list
101611962|NCT02606617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101611963|NCT02606617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101611964|NCT02606617|Serotonin Agents|serotonin agents|mesh-ancestor
101611965|NCT02606617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101611969|NCT00914095|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101611970|NCT00914095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611971|NCT00914095|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101611972|NCT00914095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101611973|NCT00914095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101611974|NCT00914095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611975|NCT00914095|Dopamine Agents|dopamine agents|mesh-ancestor
101611976|NCT00914095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101611977|NCT03903835|Prednisone|prednisone|mesh-list
101611978|NCT03903835|Carboplatin|carboplatin|mesh-list
101611979|NCT03903835|Docetaxel|docetaxel|mesh-list
101611980|NCT03903835|Abiraterone Acetate|abiraterone acetate|mesh-list
101611981|NCT03903835|Niraparib|niraparib|mesh-list
101611982|NCT03903835|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
101611983|NCT03903835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101611984|NCT03903835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101611985|NCT03903835|Tubulin Modulators|tubulin modulators|mesh-ancestor
101611986|NCT03903835|Antimitotic Agents|antimitotic agents|mesh-ancestor
101611987|NCT03903835|Mitosis Modulators|mitosis modulators|mesh-ancestor
101611988|NCT03903835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611989|NCT03903835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101611990|NCT03903835|Glucocorticoids|glucocorticoids|mesh-ancestor
102058012|NCT05603741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102058013|NCT05603741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102058014|NCT05603741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102058015|NCT05603741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058017|NCT05392361|Baclofen|baclofen|mesh-list
102058018|NCT05392361|Analgesics|analgesics|mesh-ancestor
102058019|NCT05392361|Sensory System Agents|sensory system agents|mesh-ancestor
102058020|NCT05392361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101611991|NCT03903835|Hormones|hormones|mesh-ancestor
101611992|NCT03903835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101611993|NCT03903835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611994|NCT03903835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101611995|NCT03903835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101611996|NCT03903835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101611997|NCT03903835|Hormone Antagonists|hormone antagonists|mesh-ancestor
101611998|NCT03903835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101611999|NCT03903835|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101612000|NCT05745337|Metoprolol|metoprolol|mesh-list
101612001|NCT05745337|Verapamil|verapamil|mesh-list
101612002|NCT05745337|Diltiazem|diltiazem|mesh-list
101612003|NCT05745337|Calcium Channel Blockers|calcium channel blockers|mesh-list
101612004|NCT05745337|Calcium|calcium|mesh-list
101612005|NCT05745337|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101612006|NCT05745337|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101612007|NCT05745337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612008|NCT05745337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101612009|NCT05745337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101612010|NCT05745337|Sympatholytics|sympatholytics|mesh-ancestor
101612011|NCT05745337|Autonomic Agents|autonomic agents|mesh-ancestor
101612012|NCT05745337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101612013|NCT05745337|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101612014|NCT05745337|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101612015|NCT05745337|Adrenergic Agents|adrenergic agents|mesh-ancestor
101612016|NCT05745337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101612017|NCT05745337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612018|NCT05745337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101612019|NCT05745337|Vasodilator Agents|vasodilator agents|mesh-ancestor
101612020|NCT00952380|Dalteparin|dalteparin|mesh-list
101612021|NCT00952380|Tinzaparin|tinzaparin|mesh-list
101612022|NCT00952380|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101612023|NCT00952380|Anticoagulants|anticoagulants|mesh-ancestor
101612024|NCT00952380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101612025|NCT00952380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101612026|NCT00952380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612027|NCT03859921|Dydrogesterone|dydrogesterone|mesh-list
101612028|NCT03859921|Progestins|progestins|mesh-ancestor
101612029|NCT03859921|Hormones|hormones|mesh-ancestor
101612030|NCT03859921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101612031|NCT03859921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612032|NCT02856750|Gabapentin|gabapentin|mesh-list
101612033|NCT02856750|Analgesics|analgesics|mesh-ancestor
101612034|NCT02856750|Sensory System Agents|sensory system agents|mesh-ancestor
101612035|NCT02856750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101612036|NCT02856750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612045|NCT02856750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612047|NCT05751967|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101612048|NCT05751967|Fenofibrate|fenofibrate|mesh-list
101612049|NCT05751967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101612050|NCT05751967|Antimetabolites|antimetabolites|mesh-ancestor
101612051|NCT05751967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612052|NCT05751967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101612053|NCT05751967|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101612054|NCT05751967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101612055|NCT02857920|Bevacizumab|bevacizumab|mesh-list
102058021|NCT05392361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058022|NCT05392361|Anticonvulsants|anticonvulsants|mesh-ancestor
102058023|NCT05392361|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102058024|NCT05392361|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102058025|NCT05392361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101612056|NCT02857920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101612057|NCT02857920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101612058|NCT02857920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101612059|NCT02857920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101612060|NCT02857920|Growth Substances|growth substances|mesh-ancestor
101612061|NCT02857920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612062|NCT02857920|Growth Inhibitors|growth inhibitors|mesh-ancestor
101612063|NCT02607631|Pembrolizumab|pembrolizumab|mesh-list
101612064|NCT02607631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101612065|NCT02607631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101612066|NCT02607631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101612067|NCT02607631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612068|NCT02857842|Prednisolone|prednisolone|mesh-list
101612069|NCT02857842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101612070|NCT02857842|Glucocorticoids|glucocorticoids|mesh-ancestor
101612072|NCT02857842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101612073|NCT02857842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612074|NCT02857842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101612075|NCT02857842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101612076|NCT03635437|Alprazolam|alprazolam|mesh-list
101612077|NCT03635437|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
101612078|NCT03635437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101612079|NCT03635437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101612080|NCT03635437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612081|NCT03635437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101612082|NCT03635437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101612083|NCT03635437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101612084|NCT03635437|GABA Modulators|gaba modulators|mesh-ancestor
101612085|NCT03635437|GABA Agents|gaba agents|mesh-ancestor
101612086|NCT03635437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101612087|NCT03635437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612088|NCT00803179|Hormones|hormones|mesh-list
101612089|NCT00803179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101612090|NCT00803179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612091|NCT00804193|Ciclopirox|ciclopirox|mesh-list
101612092|NCT00804193|Antifungal Agents|antifungal agents|mesh-ancestor
101612093|NCT00804193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101269118|NCT01812330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101612095|NCT05697211|Hematinics|hematinics|mesh-ancestor
101612096|NCT00957996|Peramivir|peramivir|mesh-list
101612097|NCT00957996|Antiviral Agents|antiviral agents|mesh-ancestor
101612098|NCT00957996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101612099|NCT00957996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101612100|NCT00957996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612101|NCT02606539|Leucovorin|leucovorin|mesh-list
101612102|NCT02606539|Folic Acid|folic acid|mesh-list
101612111|NCT02606539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612113|NCT02606539|Dermatologic Agents|dermatologic agents|mesh-ancestor
101612114|NCT02606539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101612115|NCT02606539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101612116|NCT02606539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101612117|NCT02606539|Immunologic Factors|immunologic factors|mesh-ancestor
101612118|NCT02606539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101612119|NCT02606539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101612120|NCT02606539|Antidotes|antidotes|mesh-ancestor
101612121|NCT02606539|Protective Agents|protective agents|mesh-ancestor
101612122|NCT02606539|Vitamin B Complex|vitamin b complex|mesh-ancestor
101612123|NCT02606539|Vitamins|vitamins|mesh-ancestor
101612124|NCT02606539|Micronutrients|micronutrients|mesh-ancestor
101612125|NCT02606539|Hematinics|hematinics|mesh-ancestor
101612126|NCT00589693|Imipenem|imipenem|mesh-list
101612127|NCT00589693|Doripenem|doripenem|mesh-list
101612128|NCT00589693|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
101612129|NCT00589693|Cilastatin|cilastatin|mesh-list
101612130|NCT00589693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101612131|NCT00589693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102058026|NCT05392361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102058027|NCT05392361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102058028|NCT05392361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102058029|NCT05392361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102058030|NCT05392361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058031|NCT05392361|Antimanic Agents|antimanic agents|mesh-ancestor
102058032|NCT05392361|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102058033|NCT05392361|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102058034|NCT05392361|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
102058035|NCT05392361|GABA Agonists|gaba agonists|mesh-ancestor
102058036|NCT05392361|GABA Agents|gaba agents|mesh-ancestor
102058037|NCT05338541|Etoposide|etoposide|mesh-list
102058038|NCT05338541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102058039|NCT05338541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058040|NCT05338541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101359652|NCT00209950|Anticonvulsants|anticonvulsants|mesh-ancestor
101612132|NCT00589693|Protease Inhibitors|protease inhibitors|mesh-ancestor
101612133|NCT00589693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101612134|NCT00589693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612135|NCT02606383|Ketoconazole|ketoconazole|mesh-list
101612136|NCT02606383|Antifungal Agents|antifungal agents|mesh-ancestor
101612137|NCT02606383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101612138|NCT02606383|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101612139|NCT02606383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101612140|NCT02606383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101612141|NCT02606383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779129|NCT01004692|Salicylic Acid|salicylic acid|mesh-list
101612142|NCT02606383|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101612143|NCT02606383|Hormone Antagonists|hormone antagonists|mesh-ancestor
101612144|NCT02606383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101612145|NCT02606383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612146|NCT02606383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101612147|NCT05660473|Cytarabine|cytarabine|mesh-list
101612148|NCT05660473|Dexamethasone|dexamethasone|mesh-list
101612149|NCT05660473|Prednisone|prednisone|mesh-list
101612150|NCT05660473|Cyclophosphamide|cyclophosphamide|mesh-list
101612151|NCT05660473|Methotrexate|methotrexate|mesh-list
101612152|NCT05660473|Vincristine|vincristine|mesh-list
101612153|NCT05660473|Daunorubicin|daunorubicin|mesh-list
101612154|NCT05660473|Venetoclax|venetoclax|mesh-list
101612155|NCT05660473|Mercaptopurine|mercaptopurine|mesh-list
101612156|NCT05660473|Pegaspargase|pegaspargase|mesh-list
101612157|NCT05660473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101612158|NCT05660473|Immunologic Factors|immunologic factors|mesh-ancestor
101612159|NCT05660473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612160|NCT05660473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101612161|NCT05660473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101612162|NCT05660473|Alkylating Agents|alkylating agents|mesh-ancestor
101612163|NCT05660473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612164|NCT05660473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101612165|NCT05660473|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101612166|NCT05660473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101612167|NCT05660473|Antiemetics|antiemetics|mesh-ancestor
101612168|NCT05660473|Autonomic Agents|autonomic agents|mesh-ancestor
101612169|NCT05660473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101612170|NCT05660473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101612176|NCT05660473|Abortifacient Agents|abortifacient agents|mesh-ancestor
101612177|NCT05660473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101612178|NCT05660473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101612179|NCT05660473|Antimetabolites|antimetabolites|mesh-ancestor
102058041|NCT05338541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102058043|NCT05338541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058044|NCT05335655|Dexmedetomidine|dexmedetomidine|mesh-list
102058045|NCT05335655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102058046|NCT05335655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102058047|NCT05335655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058048|NCT05335655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102058049|NCT05335655|Analgesics|analgesics|mesh-ancestor
102058050|NCT05335655|Sensory System Agents|sensory system agents|mesh-ancestor
101612180|NCT05660473|Dermatologic Agents|dermatologic agents|mesh-ancestor
101612181|NCT05660473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101612182|NCT05660473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101612183|NCT05660473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101612184|NCT05660473|Antiviral Agents|antiviral agents|mesh-ancestor
101612185|NCT05660473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101612186|NCT05660473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101612187|NCT05660473|Tubulin Modulators|tubulin modulators|mesh-ancestor
101612188|NCT05660473|Antimitotic Agents|antimitotic agents|mesh-ancestor
101612189|NCT05660473|Mitosis Modulators|mitosis modulators|mesh-ancestor
101612190|NCT05660473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101612191|NCT05660473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101612192|NCT05660473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101612193|NCT00803101|Protein C|protein c|mesh-list
101612194|NCT00803101|Protein S|protein s|mesh-list
101612195|NCT00803101|Anticoagulants|anticoagulants|mesh-ancestor
101612196|NCT00803101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101612197|NCT00803101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101612198|NCT00803101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612199|NCT00801229|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101612200|NCT00801229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101612201|NCT00801229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612202|NCT00801229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101612203|NCT00801229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101612204|NCT00801229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101612205|NCT00801229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612206|NCT00801229|Dopamine Agents|dopamine agents|mesh-ancestor
101612207|NCT00801229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101612208|NCT04269954|Heparin|heparin|mesh-list
101612209|NCT04269954|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101612210|NCT04269954|Tinzaparin|tinzaparin|mesh-list
101612211|NCT04269954|Dalteparin|dalteparin|mesh-list
101612212|NCT04269954|Batroxobin|batroxobin|mesh-list
101612213|NCT04269954|Anticoagulants|anticoagulants|mesh-ancestor
101612214|NCT04269954|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101612215|NCT04269954|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101612216|NCT04269954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612217|NCT04269954|Hemostatics|hemostatics|mesh-ancestor
101612218|NCT04269954|Coagulants|coagulants|mesh-ancestor
101612219|NCT00630630|Levetiracetam|levetiracetam|mesh-list
101612220|NCT00630630|Anticonvulsants|anticonvulsants|mesh-ancestor
101612221|NCT00630630|Nootropic Agents|nootropic agents|mesh-ancestor
101612222|NCT01254864|Prednisone|prednisone|mesh-list
101612223|NCT01254864|Sunitinib|sunitinib|mesh-list
101612224|NCT01254864|Dasatinib|dasatinib|mesh-list
101612225|NCT01254864|Abiraterone Acetate|abiraterone acetate|mesh-list
101612226|NCT01254864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101612227|NCT01254864|Glucocorticoids|glucocorticoids|mesh-ancestor
101612228|NCT01254864|Hormones|hormones|mesh-ancestor
101612229|NCT01254864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101612230|NCT01254864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612231|NCT01254864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101612232|NCT01254864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101612233|NCT01254864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101612234|NCT01254864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102058051|NCT05335655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102058052|NCT05335655|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102058053|NCT05335655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102058054|NCT05335655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102058055|NCT05335655|Adrenergic Agents|adrenergic agents|mesh-ancestor
102058056|NCT05335655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102058057|NCT05335655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058059|NCT04589351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101612235|NCT01254864|Growth Substances|growth substances|mesh-ancestor
101612236|NCT01254864|Growth Inhibitors|growth inhibitors|mesh-ancestor
101612237|NCT01254864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101612238|NCT01254864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101612239|NCT01254864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541633|NCT04529187|Analgesics|analgesics|mesh-ancestor
101612247|NCT02854722|Vitamins|vitamins|mesh-list
101612248|NCT02854722|Calcium|calcium|mesh-list
101612249|NCT02854722|Deferasirox|deferasirox|mesh-list
101612250|NCT02854722|Micronutrients|micronutrients|mesh-ancestor
101269269|NCT01813201|Hormones|hormones|mesh-ancestor
101612251|NCT02854722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612252|NCT02854722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101612253|NCT02854722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101612254|NCT02854722|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101612255|NCT02854722|Chelating Agents|chelating agents|mesh-ancestor
101612256|NCT02854722|Sequestering Agents|sequestering agents|mesh-ancestor
101612257|NCT02854722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612258|NCT00800683|Linagliptin|linagliptin|mesh-list
101612259|NCT00800683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101612260|NCT00800683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612261|NCT00800683|Incretins|incretins|mesh-ancestor
101612262|NCT00800683|Hormones|hormones|mesh-ancestor
101612263|NCT00800683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101612264|NCT00800683|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101612265|NCT00800683|Protease Inhibitors|protease inhibitors|mesh-ancestor
101612266|NCT00800683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101612267|NCT00800683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612268|NCT01113710|Rotigotine|rotigotine|mesh-list
101612269|NCT01113710|Dopamine Agonists|dopamine agonists|mesh-ancestor
101612270|NCT01113710|Dopamine Agents|dopamine agents|mesh-ancestor
101612271|NCT01113710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101612272|NCT01113710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612273|NCT01113710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612274|NCT01124162|Losartan|losartan|mesh-list
101612275|NCT01124162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101612276|NCT01124162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101612277|NCT01124162|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101612278|NCT01124162|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101612279|NCT01124162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612280|NCT00923533|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101612281|NCT00923533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101612282|NCT00923533|Diuretics|diuretics|mesh-ancestor
101612283|NCT00923533|Natriuretic Agents|natriuretic agents|mesh-ancestor
101612284|NCT00923533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612285|NCT00923533|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101612286|NCT00923533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101612287|NCT00923533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612288|NCT00906399|Interferons|interferons|mesh-list
101612289|NCT00906399|Interferon-beta|interferon-beta|mesh-list
101612290|NCT00906399|Interferon beta-1a|interferon beta-1a|mesh-list
101612291|NCT00906399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101612292|NCT00906399|Antiviral Agents|antiviral agents|mesh-ancestor
101612293|NCT00906399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101612294|NCT00906399|Immunologic Factors|immunologic factors|mesh-ancestor
101612295|NCT00906399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612296|NCT00906399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102058060|NCT04589351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102058061|NCT04589351|Antimetabolites|antimetabolites|mesh-ancestor
102058062|NCT04589351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058063|NCT04589351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102058064|NCT02818998|Aflibercept|aflibercept|mesh-list
102058065|NCT02818998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101612297|NCT00947856|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101612298|NCT00947856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101612299|NCT00947856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101612300|NCT00947856|Immunotoxins|immunotoxins|mesh-ancestor
101612301|NCT00947856|Immunoconjugates|immunoconjugates|mesh-ancestor
101612302|NCT00947856|Immunologic Factors|immunologic factors|mesh-ancestor
101612303|NCT00947856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612304|NCT00947544|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
101612305|NCT00947544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101612307|NCT00907335|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101612308|NCT00907335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101612309|NCT00907335|Keratolytic Agents|keratolytic agents|mesh-ancestor
101612314|NCT00947154|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101612315|NCT00947154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101612316|NCT00947154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101612317|NCT00947154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612318|NCT00947154|Dopamine Agonists|dopamine agonists|mesh-ancestor
101612319|NCT00947154|Dopamine Agents|dopamine agents|mesh-ancestor
101612320|NCT00947154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101612321|NCT00947154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612322|NCT00947154|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101612323|NCT00947154|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101269399|NCT01813812|Rebamipide|rebamipide|mesh-list
101612324|NCT00947154|Serotonin Agents|serotonin agents|mesh-ancestor
101612325|NCT00947154|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101612326|NCT00947154|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101612327|NCT00947154|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101612328|NCT00947154|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101612329|NCT01862952|Anticonvulsants|anticonvulsants|mesh-list
101612331|NCT00952068|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101612332|NCT00952068|Narcotics|narcotics|mesh-ancestor
101612333|NCT00952068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101612334|NCT00952068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612335|NCT00952068|Analgesics|analgesics|mesh-ancestor
101612336|NCT00952068|Sensory System Agents|sensory system agents|mesh-ancestor
101612337|NCT00952068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101612338|NCT00951912|Genistein|genistein|mesh-list
101612339|NCT00951912|Daidzein|daidzein|mesh-list
101612340|NCT00951912|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101612341|NCT00951912|Protective Agents|protective agents|mesh-ancestor
101612342|NCT00951912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779150|NCT01005160|Metformin|metformin|mesh-list
101612343|NCT00951912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101612344|NCT00951912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101612345|NCT00951912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101612346|NCT00951912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612347|NCT00951912|Phytoestrogens|phytoestrogens|mesh-ancestor
101612348|NCT00951912|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101612349|NCT00951912|Estrogens|estrogens|mesh-ancestor
101612350|NCT00951912|Hormones|hormones|mesh-ancestor
101612351|NCT00951912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101612352|NCT02882594|Anesthetics|anesthetics|mesh-list
101612353|NCT02882594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101612354|NCT02882594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612355|NCT02856048|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101612356|NCT02856048|Luteolytic Agents|luteolytic agents|mesh-ancestor
101612357|NCT02856048|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101612358|NCT02856048|Contraceptive Agents|contraceptive agents|mesh-ancestor
101612359|NCT02856048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101612360|NCT02856048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612361|NCT02856048|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101612362|NCT02856048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101612363|NCT02856048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101612371|NCT01123070|Rituximab|rituximab|mesh-list
102058066|NCT02818998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102058067|NCT02818998|Growth Substances|growth substances|mesh-ancestor
102058068|NCT02818998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058069|NCT02818998|Growth Inhibitors|growth inhibitors|mesh-ancestor
102058070|NCT02818998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058072|NCT02821416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101612372|NCT01123070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101612373|NCT01123070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101612374|NCT01123070|Immunologic Factors|immunologic factors|mesh-ancestor
101612375|NCT01123070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612376|NCT01123070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101612377|NCT02857686|Anesthetics|anesthetics|mesh-list
101612378|NCT02857686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101612379|NCT02857686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612381|NCT03198741|Clopidogrel|clopidogrel|mesh-list
101612382|NCT03198741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101612383|NCT03198741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101612384|NCT03198741|Analgesics|analgesics|mesh-ancestor
101612385|NCT03198741|Sensory System Agents|sensory system agents|mesh-ancestor
101612386|NCT03198741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101612387|NCT03198741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612388|NCT03198741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101612402|NCT01122680|Bromides|bromides|mesh-list
101612403|NCT01122680|Tiotropium Bromide|tiotropium bromide|mesh-list
101612404|NCT01122680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101612405|NCT01122680|Autonomic Agents|autonomic agents|mesh-ancestor
101612406|NCT01122680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101612407|NCT01122680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612408|NCT01122680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101612409|NCT01122680|Respiratory System Agents|respiratory system agents|mesh-ancestor
101612410|NCT01122680|Parasympatholytics|parasympatholytics|mesh-ancestor
101612411|NCT01122680|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101612412|NCT01122680|Cholinergic Agents|cholinergic agents|mesh-ancestor
101612413|NCT01122680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101612414|NCT01122680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612415|NCT01122680|Anticonvulsants|anticonvulsants|mesh-ancestor
101612416|NCT00946998|Sertraline|sertraline|mesh-list
101612417|NCT00946998|Antidepressive Agents|antidepressive agents|mesh-ancestor
101612418|NCT00946998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101612419|NCT00946998|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101612420|NCT00946998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101612421|NCT00946998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101612422|NCT00946998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612423|NCT00946998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101612424|NCT00946998|Serotonin Agents|serotonin agents|mesh-ancestor
101612425|NCT00946998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612426|NCT01138826|Amlodipine|amlodipine|mesh-list
101612427|NCT01138826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101612428|NCT01138826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101537708|NCT00198029|Hylan|hylan|mesh-list
101612429|NCT01138826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101612430|NCT01138826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612431|NCT01138826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101612432|NCT01138826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612433|NCT01138826|Vasodilator Agents|vasodilator agents|mesh-ancestor
101612434|NCT00906087|Timolol|timolol|mesh-list
101612435|NCT00906087|Dorzolamide|dorzolamide|mesh-list
101612436|NCT00906087|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101612437|NCT00906087|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101612438|NCT00906087|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101612439|NCT00906087|Adrenergic Agents|adrenergic agents|mesh-ancestor
101612440|NCT00906087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101612441|NCT00906087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612442|NCT00906087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612443|NCT00906087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101612444|NCT00906087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102058073|NCT02821416|Respiratory System Agents|respiratory system agents|mesh-ancestor
102058074|NCT03108521|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
102058075|NCT03108521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102058076|NCT03108521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058077|NCT03108521|Incretins|incretins|mesh-ancestor
102058078|NCT03108521|Hormones|hormones|mesh-ancestor
102058079|NCT03108521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102058080|NCT03108521|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102058081|NCT03108521|Protease Inhibitors|protease inhibitors|mesh-ancestor
102058082|NCT03108521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101359696|NCT00041288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101612445|NCT00906087|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101612446|NCT00906087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101612449|NCT03525795|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
101612450|NCT03525795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101612451|NCT03525795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101612452|NCT03525795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101612453|NCT03525795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612454|NCT03525795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101612455|NCT03522831|Albuterol|albuterol|mesh-list
101612456|NCT03522831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101612457|NCT03522831|Autonomic Agents|autonomic agents|mesh-ancestor
101612458|NCT03522831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101612459|NCT03522831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612460|NCT03522831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101612461|NCT03522831|Respiratory System Agents|respiratory system agents|mesh-ancestor
101612462|NCT03522831|Tocolytic Agents|tocolytic agents|mesh-ancestor
101612463|NCT03522831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101612464|NCT03522831|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101612465|NCT03522831|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101612466|NCT03522831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101612467|NCT03522831|Adrenergic Agents|adrenergic agents|mesh-ancestor
101612468|NCT03522831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101612469|NCT03522831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612471|NCT03504501|Lovastatin|lovastatin|mesh-list
101612472|NCT03504501|L 647318|l 647318|mesh-list
101612473|NCT03504501|Dihydromevinolin|dihydromevinolin|mesh-list
101612474|NCT03504501|Anticonvulsants|anticonvulsants|mesh-ancestor
101612475|NCT03504501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101612476|NCT03504501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101612477|NCT03504501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612478|NCT03504501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101612479|NCT03504501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612480|NCT03504501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101612481|NCT03504501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101612482|NCT03504501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101612483|NCT03504501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101612484|NCT03504501|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101612485|NCT03504501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101612486|NCT03504501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101612487|NCT03504501|Antimetabolites|antimetabolites|mesh-ancestor
101612488|NCT03504501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101612489|NCT03504501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101612490|NCT03504501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101612491|NCT02420574|Albendazole|albendazole|mesh-list
101612492|NCT02420574|Anthelmintics|anthelmintics|mesh-ancestor
101612493|NCT02420574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101612494|NCT02420574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101612495|NCT02420574|Anticestodal Agents|anticestodal agents|mesh-ancestor
101612496|NCT02420574|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102058083|NCT03108521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058085|NCT04500509|Dinoprostone|dinoprostone|mesh-list
102058086|NCT04500509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102058087|NCT04500509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102058088|NCT04500509|Analgesics|analgesics|mesh-ancestor
102058089|NCT04500509|Sensory System Agents|sensory system agents|mesh-ancestor
102058090|NCT04500509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102058091|NCT04500509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058092|NCT04500509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102058093|NCT04500509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102058094|NCT04500509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101612497|NCT02420574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101612498|NCT02420574|Tubulin Modulators|tubulin modulators|mesh-ancestor
101612499|NCT02420574|Antimitotic Agents|antimitotic agents|mesh-ancestor
101612500|NCT02420574|Mitosis Modulators|mitosis modulators|mesh-ancestor
101612501|NCT02420574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612502|NCT02420574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101612503|NCT02855502|Prednisolone|prednisolone|mesh-list
101612504|NCT02855502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101612505|NCT02855502|Glucocorticoids|glucocorticoids|mesh-ancestor
101612506|NCT02855502|Hormones|hormones|mesh-ancestor
101612507|NCT02855502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101612508|NCT02855502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612509|NCT02855502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101612510|NCT02855502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101612511|NCT02853864|Dexmedetomidine|dexmedetomidine|mesh-list
101612512|NCT02853864|Propofol|propofol|mesh-list
101612513|NCT02853864|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101612514|NCT02853864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101612515|NCT02853864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612516|NCT02853864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101612518|NCT02853864|Sensory System Agents|sensory system agents|mesh-ancestor
101612523|NCT02853864|Adrenergic Agents|adrenergic agents|mesh-ancestor
101612524|NCT02853864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101612525|NCT02853864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612526|NCT02853864|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101612527|NCT02853864|Anesthetics, General|anesthetics, general|mesh-ancestor
101612528|NCT02853864|Anesthetics|anesthetics|mesh-ancestor
101612530|NCT00907257|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101612531|NCT00907257|Dermatologic Agents|dermatologic agents|mesh-ancestor
101612532|NCT00907257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101612533|NCT00907257|Keratolytic Agents|keratolytic agents|mesh-ancestor
101612534|NCT01138046|Paclitaxel|paclitaxel|mesh-list
101612535|NCT01138046|Lapatinib|lapatinib|mesh-list
101612536|NCT01138046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101612537|NCT01138046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101612538|NCT01138046|Tubulin Modulators|tubulin modulators|mesh-ancestor
101612539|NCT01138046|Antimitotic Agents|antimitotic agents|mesh-ancestor
101269564|NCT01814501|Levoleucovorin|levoleucovorin|mesh-list
101612540|NCT01138046|Mitosis Modulators|mitosis modulators|mesh-ancestor
101612541|NCT01138046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612542|NCT01138046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101612543|NCT01138046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101612544|NCT02350764|Nivolumab|nivolumab|mesh-list
101612545|NCT02350764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101612546|NCT02350764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101612547|NCT02350764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101612548|NCT02350764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612549|NCT00876460|Docetaxel|docetaxel|mesh-list
101612550|NCT00876460|Nintedanib|nintedanib|mesh-list
101612551|NCT00876460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101612552|NCT00876460|Tubulin Modulators|tubulin modulators|mesh-ancestor
102058095|NCT04500509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102058096|NCT04500509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058097|NCT04500509|Oxytocics|oxytocics|mesh-ancestor
102058098|NCT04500509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102058099|NCT05760599|Bevacizumab|bevacizumab|mesh-list
102058100|NCT05760599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102058101|NCT05760599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058102|NCT05760599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102058103|NCT05760599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102058104|NCT05760599|Growth Substances|growth substances|mesh-ancestor
102058105|NCT05760599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359728|NCT00210301|Modafinil|modafinil|mesh-list
101612553|NCT00876460|Antimitotic Agents|antimitotic agents|mesh-ancestor
101612554|NCT00876460|Mitosis Modulators|mitosis modulators|mesh-ancestor
101612555|NCT00876460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612556|NCT00876460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101612557|NCT00876460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101612558|NCT01137812|Metformin|metformin|mesh-list
101612559|NCT01137812|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101612560|NCT01137812|Canagliflozin|canagliflozin|mesh-list
101612561|NCT01137812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101612562|NCT01137812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612563|NCT01137812|Incretins|incretins|mesh-ancestor
101612564|NCT01137812|Hormones|hormones|mesh-ancestor
101612565|NCT01137812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101612566|NCT01137812|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101612567|NCT01137812|Protease Inhibitors|protease inhibitors|mesh-ancestor
101612568|NCT01137812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101612569|NCT01137812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612570|NCT01137812|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101612571|NCT00679510|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101612572|NCT00679510|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101612573|NCT00679510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101612574|NCT00679510|Antimetabolites|antimetabolites|mesh-ancestor
101612575|NCT00679510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612576|NCT00679510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101612577|NCT00679510|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101612578|NCT00679510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101612579|NCT04146220|Prednisolone|prednisolone|mesh-list
101612580|NCT04146220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101612581|NCT04146220|Glucocorticoids|glucocorticoids|mesh-ancestor
101612582|NCT04146220|Hormones|hormones|mesh-ancestor
101612583|NCT04146220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101612584|NCT04146220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612585|NCT04146220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101612586|NCT04146220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101612587|NCT00679666|Riboflavin|riboflavin|mesh-list
101612594|NCT00679744|Pyrimethamine|pyrimethamine|mesh-list
101612595|NCT00679744|Antimalarials|antimalarials|mesh-ancestor
101612596|NCT00679744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101612597|NCT00679744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101612598|NCT00679744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101612599|NCT00679744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101612600|NCT00679744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101612601|NCT00679744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612602|NCT00681772|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101612603|NCT00681772|Vasodilator Agents|vasodilator agents|mesh-ancestor
101612604|NCT00681772|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101612605|NCT00681772|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101612606|NCT00681772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101612607|NCT00681772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058107|NCT04441073|Lidocaine|lidocaine|mesh-list
102058108|NCT04441073|Anesthetics, Local|anesthetics, local|mesh-ancestor
102058109|NCT04441073|Anesthetics|anesthetics|mesh-ancestor
102058110|NCT04441073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102058111|NCT04441073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058112|NCT04441073|Sensory System Agents|sensory system agents|mesh-ancestor
102058113|NCT04441073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102058114|NCT04441073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102058115|NCT04441073|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101612608|NCT00681772|Urological Agents|urological agents|mesh-ancestor
101612609|NCT00946920|Goserelin|goserelin|mesh-list
101612610|NCT00946920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101612611|NCT00946920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101612612|NCT00679900|SR 46349B|sr 46349b|mesh-list
101612613|NCT00679900|Lormetazepam|lormetazepam|mesh-list
101612614|NCT00679900|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101612615|NCT00679900|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101612616|NCT00679900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269638|NCT01814865|Prednisone|prednisone|mesh-list
101612617|NCT00679900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101612618|NCT00679900|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101612619|NCT00679900|Serotonin Agents|serotonin agents|mesh-ancestor
101612620|NCT00679900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101612621|NCT00679900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612622|NCT00679900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101612623|NCT00679900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101612624|NCT00945906|Fibrinolysin|fibrinolysin|mesh-list
101612625|NCT00945906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101612626|NCT00945906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101612627|NCT00945906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612628|NCT00681928|Letrozole|letrozole|mesh-list
101612629|NCT00681928|Anastrozole|anastrozole|mesh-list
101612630|NCT00681928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101612631|NCT00681928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101612632|NCT00681928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101612633|NCT00681928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101612634|NCT00681928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612635|NCT00681928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101612636|NCT00681928|Hormone Antagonists|hormone antagonists|mesh-ancestor
101612637|NCT00681928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101612638|NCT00681928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612639|NCT00681928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101612640|NCT00594646|Tenofovir|tenofovir|mesh-list
101612641|NCT00594646|Emtricitabine|emtricitabine|mesh-list
101612642|NCT00594646|Raltegravir Potassium|raltegravir potassium|mesh-list
101612643|NCT00594646|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101612644|NCT00594646|Antiviral Agents|antiviral agents|mesh-ancestor
101612645|NCT00594646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101612646|NCT00594646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101612647|NCT00594646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101612648|NCT00594646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101612649|NCT00594646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612650|NCT00594646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101612651|NCT00594646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101612652|NCT00594646|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101612653|NCT00594646|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101612654|NCT00680134|Tavaborole|tavaborole|mesh-list
101612655|NCT00680134|Antifungal Agents|antifungal agents|mesh-ancestor
101612666|NCT00682006|Chlorhexidine|chlorhexidine|mesh-list
101612667|NCT00682006|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101612668|NCT00682006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101612669|NCT00682006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101612670|NCT00682006|Disinfectants|disinfectants|mesh-ancestor
102058116|NCT04441073|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102058117|NCT04441073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101612671|NCT00682006|Dermatologic Agents|dermatologic agents|mesh-ancestor
101612672|NCT02855346|Dapivirine|dapivirine|mesh-list
101612673|NCT02855346|Levonorgestrel|levonorgestrel|mesh-list
101612674|NCT02855346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101612675|NCT02855346|Contraceptive Agents|contraceptive agents|mesh-ancestor
101612676|NCT02855346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101612677|NCT02855346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612678|NCT02855346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101612679|NCT02855346|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101612680|NCT02855346|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101612681|NCT02855346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101612682|NCT02855346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101612683|NCT02855346|Antiviral Agents|antiviral agents|mesh-ancestor
101612684|NCT02855346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101612685|NCT01111604|Ramucirumab|ramucirumab|mesh-list
101612686|NCT01111604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101612687|NCT00950742|Trastuzumab|trastuzumab|mesh-list
101612688|NCT00950742|Afatinib|afatinib|mesh-list
101612689|NCT00950742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101612690|NCT00950742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101612691|NCT00950742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101612692|NCT00950742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101612693|NCT00950742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612695|NCT04310228|Antiviral Agents|antiviral agents|mesh-ancestor
101612696|NCT04310228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101612697|NCT00955110|Oxymorphone|oxymorphone|mesh-list
101612698|NCT00955110|Oxycodone|oxycodone|mesh-list
101612699|NCT00955110|Hydromorphone|hydromorphone|mesh-list
101612700|NCT00955110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101612701|NCT00955110|Narcotics|narcotics|mesh-ancestor
101612702|NCT00955110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101612703|NCT00955110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612704|NCT00955110|Analgesics|analgesics|mesh-ancestor
101612705|NCT00955110|Sensory System Agents|sensory system agents|mesh-ancestor
101612706|NCT00955110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101612707|NCT00955110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101612708|NCT05056142|Anesthetics|anesthetics|mesh-list
101612709|NCT05056142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101612710|NCT05056142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612711|NCT00950664|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101612712|NCT00950664|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101612713|NCT00950664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101612714|NCT00950664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101612715|NCT00950664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612716|NCT00950664|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101612717|NCT00950664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101612718|NCT00950664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612719|NCT00950664|Cholinergic Agents|cholinergic agents|mesh-ancestor
101612720|NCT00950664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101612721|NCT01111526|Panobinostat|panobinostat|mesh-list
101612722|NCT01111526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101612723|NCT01111526|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101612724|NCT01111526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101542053|NCT01646736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101612730|NCT02881346|Calcipotriene|calcipotriene|mesh-list
101612731|NCT02881346|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101612732|NCT02881346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101612733|NCT02881346|Glucocorticoids|glucocorticoids|mesh-ancestor
101612734|NCT02881346|Hormones|hormones|mesh-ancestor
101612735|NCT02881346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101612736|NCT02881346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612737|NCT02881346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101612738|NCT02881346|Respiratory System Agents|respiratory system agents|mesh-ancestor
101612739|NCT02881346|Dermatologic Agents|dermatologic agents|mesh-ancestor
101612740|NCT00630708|Losartan|losartan|mesh-list
101612741|NCT00630708|Benazepril|benazepril|mesh-list
101612742|NCT00630708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101612743|NCT00630708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101612744|NCT00630708|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101612745|NCT00630708|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101612746|NCT00630708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058118|NCT04441073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058119|NCT02817828|Drospirenone|drospirenone|mesh-list
102058120|NCT02817828|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102058121|NCT02817828|Hormone Antagonists|hormone antagonists|mesh-ancestor
101779174|NCT01005472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102058122|NCT02817828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102058123|NCT02817828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058124|NCT02817828|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101612747|NCT00630708|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101612748|NCT00630708|Protease Inhibitors|protease inhibitors|mesh-ancestor
101612749|NCT00630708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101612750|NCT01111292|Inositol|inositol|mesh-list
101612751|NCT01111292|Vitamin B Complex|vitamin b complex|mesh-ancestor
101612752|NCT01111292|Vitamins|vitamins|mesh-ancestor
101612753|NCT01111292|Micronutrients|micronutrients|mesh-ancestor
101612754|NCT01111292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612755|NCT02853630|Metformin|metformin|mesh-list
101612756|NCT02853630|Vildagliptin|vildagliptin|mesh-list
101612757|NCT02853630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101612758|NCT02853630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612759|NCT02853630|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101612760|NCT02853630|Protease Inhibitors|protease inhibitors|mesh-ancestor
101612761|NCT02853630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101612762|NCT02853630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612763|NCT04309838|Treprostinil|treprostinil|mesh-list
101612764|NCT04309838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101612765|NCT05367206|Paclitaxel|paclitaxel|mesh-list
101612766|NCT05367206|Carboplatin|carboplatin|mesh-list
101612767|NCT05367206|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101612768|NCT05367206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101612769|NCT05367206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101612770|NCT05367206|Tubulin Modulators|tubulin modulators|mesh-ancestor
101612771|NCT05367206|Antimitotic Agents|antimitotic agents|mesh-ancestor
101612772|NCT05367206|Mitosis Modulators|mitosis modulators|mesh-ancestor
101612773|NCT05367206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612774|NCT00637286|Zolmitriptan|zolmitriptan|mesh-list
101612775|NCT00637286|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101612776|NCT00637286|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101612777|NCT00637286|Serotonin Agents|serotonin agents|mesh-ancestor
101612778|NCT00637286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101612779|NCT00637286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612780|NCT00637286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612781|NCT00944658|Apremilast|apremilast|mesh-list
101612782|NCT00944658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101612783|NCT00944658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101612784|NCT00944658|Analgesics|analgesics|mesh-ancestor
101612785|NCT00944658|Sensory System Agents|sensory system agents|mesh-ancestor
101612786|NCT00944658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101612787|NCT00944658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612788|NCT00944658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101612789|NCT00944658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101612790|NCT00944658|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101612791|NCT00944658|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101612792|NCT00944658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101612793|NCT00944658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612796|NCT01110200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101612798|NCT01110200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101612799|NCT01110200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612800|NCT01110200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101612801|NCT01110200|Respiratory System Agents|respiratory system agents|mesh-ancestor
101612802|NCT01110200|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101612803|NCT01110200|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101612804|NCT01110200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101612805|NCT01110200|Adrenergic Agents|adrenergic agents|mesh-ancestor
101612806|NCT01110200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102058126|NCT02817828|Natriuretic Agents|natriuretic agents|mesh-ancestor
102058127|NCT03632681|Insulin|insulin|mesh-list
102058128|NCT03632681|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102058129|NCT03632681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102058130|NCT03632681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058131|NCT05597995|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
102058132|NCT05597995|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
101612807|NCT01110200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612808|NCT01110200|Glucocorticoids|glucocorticoids|mesh-ancestor
101612809|NCT01110200|Hormones|hormones|mesh-ancestor
101612810|NCT01110200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101612811|NCT01110200|Sympathomimetics|sympathomimetics|mesh-ancestor
101612812|NCT05182112|Gemcitabine|gemcitabine|mesh-list
101612813|NCT05182112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101612814|NCT05182112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101612815|NCT05182112|Antimetabolites|antimetabolites|mesh-ancestor
101612816|NCT05182112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612817|NCT01136954|Zonisamide|zonisamide|mesh-list
101612818|NCT01136954|Anticonvulsants|anticonvulsants|mesh-ancestor
101612819|NCT01136954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101612820|NCT01136954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101612821|NCT01136954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612822|NCT01136954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101612823|NCT01136954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612824|NCT01108094|Itraconazole|itraconazole|mesh-list
101612825|NCT01108094|Antifungal Agents|antifungal agents|mesh-ancestor
101612826|NCT01108094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101612827|NCT01108094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101612828|NCT01108094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101612829|NCT01108094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101612830|NCT01108094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612831|NCT01108094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101612832|NCT01108094|Hormone Antagonists|hormone antagonists|mesh-ancestor
101612833|NCT01108094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101612834|NCT01108094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612835|NCT01108094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101612836|NCT00954174|Paclitaxel|paclitaxel|mesh-list
101612837|NCT00954174|Carboplatin|carboplatin|mesh-list
101269861|NCT01816620|Antiemetics|antiemetics|mesh-ancestor
101612839|NCT00954174|Ifosfamide|ifosfamide|mesh-list
101612840|NCT00954174|Isophosphamide mustard|isophosphamide mustard|mesh-list
101612841|NCT00954174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101612842|NCT00954174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101612843|NCT00954174|Tubulin Modulators|tubulin modulators|mesh-ancestor
101612844|NCT00954174|Antimitotic Agents|antimitotic agents|mesh-ancestor
101612845|NCT00954174|Mitosis Modulators|mitosis modulators|mesh-ancestor
101612846|NCT00954174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612847|NCT00954174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101612848|NCT00954174|Alkylating Agents|alkylating agents|mesh-ancestor
101612849|NCT04309058|Vitamin D|vitamin d|mesh-list
101612850|NCT04309058|Vitamins|vitamins|mesh-ancestor
101612851|NCT04309058|Micronutrients|micronutrients|mesh-ancestor
101612852|NCT04309058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612853|NCT04309058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101612854|NCT01136408|Warfarin|warfarin|mesh-list
101612855|NCT01136408|Dabigatran|dabigatran|mesh-list
101612856|NCT01136408|Anticoagulants|anticoagulants|mesh-ancestor
101612857|NCT01136408|Antithrombins|antithrombins|mesh-ancestor
101612858|NCT01136408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101612859|NCT01136408|Protease Inhibitors|protease inhibitors|mesh-ancestor
101612860|NCT01136408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101612861|NCT01136408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612862|NCT01136174|Nintedanib|nintedanib|mesh-list
101612863|NCT01136174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101542177|NCT04528056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101612867|NCT01135394|Pioglitazone|pioglitazone|mesh-list
101612868|NCT01135394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102058133|NCT05597995|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102058134|NCT05597917|Trabectedin|trabectedin|mesh-list
102058135|NCT05597917|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102058136|NCT05597917|Alkylating Agents|alkylating agents|mesh-ancestor
102058137|NCT05597917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058138|NCT05597917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101612869|NCT01135394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612871|NCT00949884|Olmesartan|olmesartan|mesh-list
101612872|NCT00949884|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101612873|NCT00949884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101612874|NCT00949884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101779183|NCT03999580|Vitamin D|vitamin d|mesh-list
101612875|NCT00949884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101612876|NCT00949884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101612877|NCT00949884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612878|NCT00949650|Pemetrexed|pemetrexed|mesh-list
101612879|NCT00949650|Afatinib|afatinib|mesh-list
101612880|NCT00949650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101612881|NCT00949650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101612882|NCT00949650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612883|NCT00949650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101612884|NCT00949650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101612885|NCT00949650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101612886|NCT03082755|Gabapentin|gabapentin|mesh-list
101612887|NCT03082755|Analgesics|analgesics|mesh-ancestor
101612888|NCT03082755|Sensory System Agents|sensory system agents|mesh-ancestor
101612889|NCT03082755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101612890|NCT03082755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612891|NCT03082755|Anticonvulsants|anticonvulsants|mesh-ancestor
101612892|NCT03082755|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101612893|NCT03082755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101612894|NCT03082755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101612895|NCT03082755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101612896|NCT03082755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101612897|NCT03082755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101612898|NCT03082755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101612899|NCT03082755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612900|NCT03082755|Antimanic Agents|antimanic agents|mesh-ancestor
101612901|NCT05332353|BCG Vaccine|bcg vaccine|mesh-list
101612902|NCT05332353|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101612903|NCT05332353|Immunologic Factors|immunologic factors|mesh-ancestor
101612904|NCT05332353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612905|NCT00904215|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101612906|NCT00904215|Telmisartan|telmisartan|mesh-list
101612907|NCT00904215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101612908|NCT00904215|Diuretics|diuretics|mesh-ancestor
101612909|NCT00904215|Natriuretic Agents|natriuretic agents|mesh-ancestor
101612910|NCT00904215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612911|NCT00904215|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101612912|NCT00904215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101612913|NCT00904215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612914|NCT00904215|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101612915|NCT00904215|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101612916|NCT05317689|Psilocybin|psilocybin|mesh-list
101612917|NCT05317689|Psilocin|psilocin|mesh-list
101612918|NCT05317689|Hallucinogens|hallucinogens|mesh-ancestor
101612919|NCT05317689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612920|NCT05317689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101612921|NCT05293665|Vaccines|vaccines|mesh-list
101612922|NCT05293665|Immunologic Factors|immunologic factors|mesh-ancestor
101612923|NCT05293665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612924|NCT00905307|Aripiprazole|aripiprazole|mesh-list
101612925|NCT00905307|Antidepressive Agents|antidepressive agents|mesh-ancestor
101612926|NCT00905307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101612927|NCT00905307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101612928|NCT00905307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101612929|NCT00905307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101612930|NCT00905307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058139|NCT03796650|Vancomycin|vancomycin|mesh-list
102058140|NCT03796650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102058141|NCT03796650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102058142|NCT05597527|Apatinib|apatinib|mesh-list
102058143|NCT05597527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058144|NCT05597527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102058145|NCT05597527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102058146|NCT05597527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058147|NCT05198141|Letrozole|letrozole|mesh-list
101463672|NCT02212210|Prednisolone|prednisolone|mesh-list
101612931|NCT00905307|Dopamine Agonists|dopamine agonists|mesh-ancestor
101612932|NCT00905307|Dopamine Agents|dopamine agents|mesh-ancestor
101612933|NCT00905307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101612934|NCT00905307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612948|NCT00904839|Growth Substances|growth substances|mesh-ancestor
101612949|NCT00904839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612950|NCT00904839|Growth Inhibitors|growth inhibitors|mesh-ancestor
101612951|NCT00904839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101612952|NCT00904839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101612953|NCT00904839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612954|NCT04985955|Tofacitinib|tofacitinib|mesh-list
101612955|NCT04985955|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101612956|NCT04985955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101612957|NCT04985955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101612958|NCT04985955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612960|NCT02821923|Vasodilator Agents|vasodilator agents|mesh-ancestor
101612961|NCT00903357|Ascorbic Acid|ascorbic acid|mesh-list
101612962|NCT00903357|Montelukast|montelukast|mesh-list
101612963|NCT00903357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101612964|NCT00903357|Respiratory System Agents|respiratory system agents|mesh-ancestor
101612965|NCT00903357|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101612966|NCT00903357|Hormone Antagonists|hormone antagonists|mesh-ancestor
101612967|NCT00903357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101612968|NCT00903357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612969|NCT00903357|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101612970|NCT00903357|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101612971|NCT00903357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612972|NCT00903357|Antioxidants|antioxidants|mesh-ancestor
101612973|NCT00903357|Protective Agents|protective agents|mesh-ancestor
101612974|NCT00903357|Vitamins|vitamins|mesh-ancestor
101612975|NCT00903357|Micronutrients|micronutrients|mesh-ancestor
101612976|NCT02754063|3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol|3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol|mesh-list
101612977|NCT02754063|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101612978|NCT02754063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101612979|NCT02754063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101612980|NCT02754063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612981|NCT02754063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101612982|NCT02754063|Dopamine Agonists|dopamine agonists|mesh-ancestor
101612983|NCT02754063|Dopamine Agents|dopamine agents|mesh-ancestor
101612984|NCT02754063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101612985|NCT02754063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612990|NCT04202289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101612991|NCT04202289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101612992|NCT04202289|Coccidiostats|coccidiostats|mesh-ancestor
101612993|NCT04202289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101613005|NCT01730313|Pyridoxine|pyridoxine|mesh-list
101613006|NCT01730313|Vitamin B 6|vitamin b 6|mesh-list
101613007|NCT01730313|Phenytoin|phenytoin|mesh-list
101613008|NCT01730313|Valproic Acid|valproic acid|mesh-list
101613009|NCT01730313|Vitamins|vitamins|mesh-ancestor
101613010|NCT01730313|Micronutrients|micronutrients|mesh-ancestor
101779202|NCT00530842|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101613011|NCT01730313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613026|NCT01730313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101613027|NCT02849379|Immunomodulating Agents|immunomodulating agents|mesh-list
101613028|NCT02849379|Immunologic Factors|immunologic factors|mesh-ancestor
102058148|NCT05198141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058149|NCT05198141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102058150|NCT05198141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102058151|NCT05198141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102058152|NCT05198141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058153|NCT05198141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101613029|NCT02849379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613031|NCT01104662|Daptomycin|daptomycin|mesh-list
101613032|NCT01104662|Penicillins|penicillins|mesh-list
101613033|NCT01104662|Cloxacillin|cloxacillin|mesh-list
101613034|NCT01104662|Oxacillin|oxacillin|mesh-list
101613035|NCT01104662|Nafcillin|nafcillin|mesh-list
101613036|NCT01104662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101613037|NCT01104662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101613038|NCT05062785|Insulin|insulin|mesh-list
101613039|NCT05062785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101613040|NCT05062785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613041|NCT01103960|Amlodipine|amlodipine|mesh-list
101613042|NCT01103960|Telmisartan|telmisartan|mesh-list
101613043|NCT01103960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101613044|NCT01103960|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101613045|NCT01103960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101613046|NCT01103960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613047|NCT01103960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101613048|NCT01103960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613049|NCT01103960|Vasodilator Agents|vasodilator agents|mesh-ancestor
101613050|NCT01103960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101613051|NCT01103960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101613052|NCT04413279|Dexamethasone|dexamethasone|mesh-list
101613053|NCT04413279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101613054|NCT04413279|Antiemetics|antiemetics|mesh-ancestor
101613055|NCT04413279|Autonomic Agents|autonomic agents|mesh-ancestor
101613056|NCT04413279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101613057|NCT04413279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270082|NCT01817972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101613058|NCT04413279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101613059|NCT04413279|Glucocorticoids|glucocorticoids|mesh-ancestor
101613060|NCT04413279|Hormones|hormones|mesh-ancestor
101613061|NCT04413279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101613062|NCT04413279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101613063|NCT04413279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101613064|NCT04975256|Adagrasib|adagrasib|mesh-list
101613065|NCT04975256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101613066|NCT02880800|Morphine|morphine|mesh-list
101613067|NCT02880800|Hydromorphone|hydromorphone|mesh-list
101613068|NCT02880800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101613069|NCT02880800|Narcotics|narcotics|mesh-ancestor
101613070|NCT02880800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101613071|NCT02880800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613084|NCT01107392|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101613085|NCT01107392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101613086|NCT05037279|BCG Vaccine|bcg vaccine|mesh-list
101613087|NCT05037279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101613088|NCT05037279|Immunologic Factors|immunologic factors|mesh-ancestor
101613089|NCT05037279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613090|NCT01106846|Ketamine|ketamine|mesh-list
101613091|NCT01106846|Analgesics|analgesics|mesh-ancestor
101613092|NCT01106846|Sensory System Agents|sensory system agents|mesh-ancestor
101613093|NCT01106846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101613094|NCT01106846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613095|NCT01106846|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101613096|NCT01106846|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101613097|NCT01106846|Anesthetics, General|anesthetics, general|mesh-ancestor
101613098|NCT01106846|Anesthetics|anesthetics|mesh-ancestor
101613099|NCT01106846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101613100|NCT01106846|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101613101|NCT01106846|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101613102|NCT01106846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101613103|NCT01106846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613104|NCT05034783|Exenatide|exenatide|mesh-list
102058154|NCT05198141|Hormone Antagonists|hormone antagonists|mesh-ancestor
102058155|NCT05198141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102058156|NCT05198141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058157|NCT02813694|Moxifloxacin|moxifloxacin|mesh-list
102058158|NCT02813694|Lefamulin|lefamulin|mesh-list
102058159|NCT02813694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102058160|NCT02813694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101613105|NCT05034783|Edetic Acid|edetic acid|mesh-list
101613106|NCT05034783|Chelating Agents|chelating agents|mesh-ancestor
101613107|NCT05034783|Sequestering Agents|sequestering agents|mesh-ancestor
101613108|NCT05034783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613109|NCT05034783|Anticoagulants|anticoagulants|mesh-ancestor
101613110|NCT05034783|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101613111|NCT05034783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101613112|NCT05034783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613113|NCT05034783|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101613115|NCT05034783|Hormones|hormones|mesh-ancestor
101613116|NCT05034783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101613117|NCT00902577|Misonidazole|misonidazole|mesh-list
101613118|NCT00902577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101613119|NCT00902577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101613120|NCT00902577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101613121|NCT00902577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101613122|NCT04202367|Bupivacaine|bupivacaine|mesh-list
101613123|NCT04202367|Anesthetics, Local|anesthetics, local|mesh-ancestor
101613124|NCT04202367|Anesthetics|anesthetics|mesh-ancestor
101613125|NCT04202367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101613126|NCT04202367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613127|NCT04202367|Sensory System Agents|sensory system agents|mesh-ancestor
101613128|NCT04202367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101613129|NCT02846493|Dexamethasone|dexamethasone|mesh-list
101613130|NCT02846493|Bromocriptine|bromocriptine|mesh-list
101613131|NCT02846493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101613132|NCT02846493|Antiemetics|antiemetics|mesh-ancestor
101613133|NCT02846493|Autonomic Agents|autonomic agents|mesh-ancestor
101542438|NCT02279511|Vasodilator Agents|vasodilator agents|mesh-ancestor
101613145|NCT02846493|Dopamine Agonists|dopamine agonists|mesh-ancestor
101613146|NCT02846493|Dopamine Agents|dopamine agents|mesh-ancestor
101613147|NCT02846493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101613148|NCT02846493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613150|NCT01106690|Pioglitazone|pioglitazone|mesh-list
101613151|NCT01106690|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101613152|NCT01106690|Canagliflozin|canagliflozin|mesh-list
101613153|NCT01106690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101613154|NCT01106690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613155|NCT01106690|Incretins|incretins|mesh-ancestor
101613156|NCT01106690|Hormones|hormones|mesh-ancestor
101613157|NCT01106690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101613158|NCT01106690|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101613159|NCT01106690|Protease Inhibitors|protease inhibitors|mesh-ancestor
101613160|NCT01106690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101613161|NCT01106690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613162|NCT01106690|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101613163|NCT04286529|Calcitriol|calcitriol|mesh-list
101613164|NCT04286529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101613165|NCT04286529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613166|NCT04286529|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101613167|NCT04286529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101613168|NCT04286529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613169|NCT04286529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101613170|NCT04286529|Vitamins|vitamins|mesh-ancestor
101613171|NCT04286529|Micronutrients|micronutrients|mesh-ancestor
101613172|NCT04286529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101613173|NCT01103180|Escitalopram|escitalopram|mesh-list
101613174|NCT01103180|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101613175|NCT01103180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102058161|NCT02813694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102058162|NCT02813694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102058163|NCT02813694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101359787|NCT00041327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101613176|NCT01103180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101613177|NCT01103180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613178|NCT01103180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101613179|NCT01103180|Serotonin Agents|serotonin agents|mesh-ancestor
101613180|NCT01103180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613181|NCT00625898|Cyclophosphamide|cyclophosphamide|mesh-list
101613182|NCT00625898|Bevacizumab|bevacizumab|mesh-list
101613183|NCT00625898|Carboplatin|carboplatin|mesh-list
101613184|NCT00625898|Docetaxel|docetaxel|mesh-list
101613185|NCT00625898|Fluorouracil|fluorouracil|mesh-list
101613186|NCT00625898|Trastuzumab|trastuzumab|mesh-list
101613187|NCT00625898|Epirubicin|epirubicin|mesh-list
101613188|NCT00625898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101613189|NCT00625898|Immunologic Factors|immunologic factors|mesh-ancestor
101613190|NCT00625898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613191|NCT00625898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101613192|NCT00625898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101613193|NCT00625898|Alkylating Agents|alkylating agents|mesh-ancestor
101613194|NCT00625898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613195|NCT00625898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101613196|NCT00625898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101613203|NCT00625898|Antimitotic Agents|antimitotic agents|mesh-ancestor
101613204|NCT00625898|Mitosis Modulators|mitosis modulators|mesh-ancestor
101613205|NCT00625898|Antimetabolites|antimetabolites|mesh-ancestor
101613206|NCT00625898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101613207|NCT00625898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101613208|NCT00625898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101613209|NCT00625898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101613210|NCT00625898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101613211|NCT02853552|Misoprostol|misoprostol|mesh-list
101270230|NCT01819402|Pioglitazone|pioglitazone|mesh-list
101613212|NCT02853552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101613213|NCT02853552|Abortifacient Agents|abortifacient agents|mesh-ancestor
101613214|NCT02853552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101613215|NCT02853552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613216|NCT02853552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101613217|NCT02853552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101613218|NCT02853552|Oxytocics|oxytocics|mesh-ancestor
101613219|NCT04268472|Darunavir|darunavir|mesh-list
101613220|NCT04268472|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101613221|NCT04268472|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101613222|NCT04268472|Protease Inhibitors|protease inhibitors|mesh-ancestor
101613223|NCT04268472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101613224|NCT04268472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613225|NCT04268472|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101613226|NCT04268472|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101613227|NCT04268472|Antiviral Agents|antiviral agents|mesh-ancestor
101613228|NCT04268472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101613229|NCT02844621|Omeprazole|omeprazole|mesh-list
101613230|NCT02844621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101613231|NCT02844621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101613232|NCT02844621|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101613233|NCT02844621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101613234|NCT02844621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613235|NCT01106534|Aspirin|aspirin|mesh-list
101613236|NCT01106534|Everolimus|everolimus|mesh-list
101613237|NCT01106534|Clopidogrel|clopidogrel|mesh-list
101613238|NCT01106534|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101613239|NCT01106534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101613240|NCT01106534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101613241|NCT01106534|Analgesics|analgesics|mesh-ancestor
101613242|NCT01106534|Sensory System Agents|sensory system agents|mesh-ancestor
101613243|NCT01106534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101613244|NCT01106534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613245|NCT01106534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101613246|NCT01106534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101613247|NCT01106534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101613248|NCT01106534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102058164|NCT02813694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058165|NCT02813694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058166|NCT03632161|Dexmedetomidine|dexmedetomidine|mesh-list
102058167|NCT03632161|Bupivacaine|bupivacaine|mesh-list
102058168|NCT03632161|Anesthetics, Local|anesthetics, local|mesh-ancestor
102058169|NCT03632161|Anesthetics|anesthetics|mesh-ancestor
102058170|NCT03632161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101463947|NCT04564456|Glucocorticoids|glucocorticoids|mesh-ancestor
101613249|NCT01106534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613250|NCT01106534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101613251|NCT01106534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101613252|NCT01106534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101613253|NCT01106534|Antipyretics|antipyretics|mesh-ancestor
101613254|NCT01106534|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101613255|NCT01106534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101613256|NCT01106534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101613257|NCT01106534|Immunologic Factors|immunologic factors|mesh-ancestor
101613258|NCT01106534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101613259|NCT01106534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101613260|NCT01106534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101613261|NCT01106534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101613262|NCT01106534|Purinergic Agents|purinergic agents|mesh-ancestor
101613263|NCT01106534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101613264|NCT00941304|Oxycodone|oxycodone|mesh-list
101613265|NCT00941304|Buprenorphine|buprenorphine|mesh-list
101613268|NCT00941304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101613269|NCT00941304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613271|NCT00941304|Sensory System Agents|sensory system agents|mesh-ancestor
101613272|NCT00941304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101613273|NCT00941304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101613274|NCT02846025|Folic Acid|folic acid|mesh-list
101613275|NCT02846025|Vitamin B Complex|vitamin b complex|mesh-list
101613276|NCT02846025|Antioxidants|antioxidants|mesh-list
101613277|NCT02846025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613278|NCT02846025|Protective Agents|protective agents|mesh-ancestor
101613279|NCT02846025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613280|NCT02846025|Hematinics|hematinics|mesh-ancestor
101613281|NCT02846025|Vitamins|vitamins|mesh-ancestor
101613282|NCT02846025|Micronutrients|micronutrients|mesh-ancestor
101613283|NCT02880410|Temozolomide|temozolomide|mesh-list
101613284|NCT02880410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101613285|NCT02880410|Alkylating Agents|alkylating agents|mesh-ancestor
101613286|NCT02880410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613287|NCT02880410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101613288|NCT02879006|Omalizumab|omalizumab|mesh-list
101613290|NCT02879006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101613291|NCT02879006|Respiratory System Agents|respiratory system agents|mesh-ancestor
101613292|NCT00941070|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101613293|NCT00941070|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101613294|NCT00941070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613295|NCT02857218|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
101613296|NCT02857218|Hematinics|hematinics|mesh-ancestor
101613297|NCT02857218|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101613298|NCT02857218|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101613299|NCT00602316|Chelating Agents|chelating agents|mesh-list
101613300|NCT00602316|Sequestering Agents|sequestering agents|mesh-ancestor
101613301|NCT00602316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613302|NCT00602394|Lithium Carbonate|lithium carbonate|mesh-list
101613303|NCT00602394|Antidepressive Agents|antidepressive agents|mesh-ancestor
101613304|NCT00602394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101613305|NCT00602394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101613306|NCT00602394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613307|NCT00602394|Antimanic Agents|antimanic agents|mesh-ancestor
101613308|NCT00602394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101613309|NCT00602394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101613310|NCT00602394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613311|NCT04956302|Dexamethasone|dexamethasone|mesh-list
102058171|NCT03632161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058172|NCT03632161|Sensory System Agents|sensory system agents|mesh-ancestor
102058173|NCT03632161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102058174|NCT03632161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102058175|NCT03632161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102058177|NCT03632161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102058178|NCT03632161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101613312|NCT04956302|Dexamethasone acetate|dexamethasone acetate|mesh-list
101613313|NCT04956302|Bortezomib|bortezomib|mesh-list
101613314|NCT04956302|Daratumumab|daratumumab|mesh-list
101613315|NCT04956302|Panobinostat|panobinostat|mesh-list
101613316|NCT04956302|Ichthammol|ichthammol|mesh-list
101613317|NCT04956302|BB 1101|bb 1101|mesh-list
101613318|NCT04956302|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101613319|NCT04956302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101613320|NCT04956302|Antiemetics|antiemetics|mesh-ancestor
101613321|NCT04956302|Autonomic Agents|autonomic agents|mesh-ancestor
101613322|NCT04956302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101613323|NCT04956302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613324|NCT04956302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101613325|NCT04956302|Glucocorticoids|glucocorticoids|mesh-ancestor
101613326|NCT04956302|Hormones|hormones|mesh-ancestor
101613327|NCT04956302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101613328|NCT04956302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101613329|NCT04956302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101613330|NCT04956302|Protease Inhibitors|protease inhibitors|mesh-ancestor
101613331|NCT04956302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775282|NCT00935961|Immunologic Factors|immunologic factors|mesh-ancestor
101613332|NCT04956302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613333|NCT04956302|Immunologic Factors|immunologic factors|mesh-ancestor
101613334|NCT04956302|Dermatologic Agents|dermatologic agents|mesh-ancestor
101613335|NCT04956302|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101613336|NCT02848443|Trifluridine|trifluridine|mesh-list
101613337|NCT02848443|Bevacizumab|bevacizumab|mesh-list
101613338|NCT02848443|Nivolumab|nivolumab|mesh-list
101613339|NCT02848443|Oxaliplatin|oxaliplatin|mesh-list
101613340|NCT02848443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101613345|NCT02848443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613346|NCT02848443|Growth Inhibitors|growth inhibitors|mesh-ancestor
101613347|NCT02848443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101613348|NCT02848443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613349|NCT02848443|Antimetabolites|antimetabolites|mesh-ancestor
101613350|NCT02848443|Antiviral Agents|antiviral agents|mesh-ancestor
101613351|NCT02848443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101613352|NCT00632697|Pentoxifylline|pentoxifylline|mesh-list
101613353|NCT00632697|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101613354|NCT00632697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101613355|NCT00632697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613356|NCT00632697|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101613357|NCT00632697|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101613358|NCT00632697|Protective Agents|protective agents|mesh-ancestor
101613359|NCT00632697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613360|NCT00632697|Vasodilator Agents|vasodilator agents|mesh-ancestor
101613361|NCT00632697|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101613362|NCT00632697|Antioxidants|antioxidants|mesh-ancestor
101613363|NCT02848209|Phenol|phenol|mesh-list
101613364|NCT02848209|Croton Oil|croton oil|mesh-list
101613365|NCT02848209|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101613366|NCT02848209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101613367|NCT02848209|Disinfectants|disinfectants|mesh-ancestor
101613368|NCT02848209|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
101613369|NCT02848209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101613370|NCT02848209|Dermatologic Agents|dermatologic agents|mesh-ancestor
101613371|NCT05337969|Metformin|metformin|mesh-list
101613372|NCT05337969|Vildagliptin|vildagliptin|mesh-list
101613373|NCT05337969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101613374|NCT05337969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058179|NCT03632161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102058180|NCT03632161|Adrenergic Agents|adrenergic agents|mesh-ancestor
102058181|NCT03632161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102058182|NCT03632161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058183|NCT03103919|Rotigotine|rotigotine|mesh-list
102058184|NCT03103919|Dopamine Agonists|dopamine agonists|mesh-ancestor
102058185|NCT03103919|Dopamine Agents|dopamine agents|mesh-ancestor
102058186|NCT03103919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101613375|NCT05337969|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101613376|NCT05337969|Protease Inhibitors|protease inhibitors|mesh-ancestor
101613377|NCT05337969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101613378|NCT05337969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613379|NCT02844153|Metformin|metformin|mesh-list
101613380|NCT02844153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101613381|NCT02844153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613382|NCT02844387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101613383|NCT02844075|Pembrolizumab|pembrolizumab|mesh-list
101613384|NCT02844075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101613385|NCT02844075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101613386|NCT02844075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101613387|NCT02844075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613388|NCT02844309|Thalidomide|thalidomide|mesh-list
101613389|NCT02844309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101613390|NCT02844309|Immunologic Factors|immunologic factors|mesh-ancestor
101613391|NCT02844309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613392|NCT02844309|Leprostatic Agents|leprostatic agents|mesh-ancestor
101613393|NCT02844309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101613394|NCT02844309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101613395|NCT02844309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101613396|NCT02844309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101613397|NCT02844309|Growth Substances|growth substances|mesh-ancestor
101613398|NCT02844309|Growth Inhibitors|growth inhibitors|mesh-ancestor
101613399|NCT02844309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101613400|NCT02845713|Ivermectin|ivermectin|mesh-list
101613401|NCT02845713|Albendazole|albendazole|mesh-list
101613402|NCT02845713|Diethylcarbamazine|diethylcarbamazine|mesh-list
101613403|NCT02845713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101613404|NCT02845713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101613405|NCT02845713|Anthelmintics|anthelmintics|mesh-ancestor
101613406|NCT02845713|Anticestodal Agents|anticestodal agents|mesh-ancestor
101613407|NCT02845713|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101613408|NCT02845713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101613409|NCT02845713|Tubulin Modulators|tubulin modulators|mesh-ancestor
101613410|NCT02845713|Antimitotic Agents|antimitotic agents|mesh-ancestor
101613411|NCT02845713|Mitosis Modulators|mitosis modulators|mesh-ancestor
101613412|NCT02845713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613427|NCT02848287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101613428|NCT02848287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613429|NCT02848287|Sensory System Agents|sensory system agents|mesh-ancestor
101613430|NCT02848287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101613431|NCT05337657|Letrozole|letrozole|mesh-list
101613432|NCT05337657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101613433|NCT05337657|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101613434|NCT05337657|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101613435|NCT05337657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101613436|NCT05337657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613437|NCT05337657|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101613438|NCT05337657|Hormone Antagonists|hormone antagonists|mesh-ancestor
101613439|NCT05337657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101613440|NCT05337657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613463|NCT04385589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613464|NCT02847429|Crenolanib|crenolanib|mesh-list
101613465|NCT02847429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101613466|NCT04750005|Listerine|listerine|mesh-list
101613467|NCT04750005|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101613468|NCT04750005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101613469|NCT05336721|Capecitabine|capecitabine|mesh-list
102058187|NCT03103919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058188|NCT03103919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777895|NCT00569946|Axitinib|axitinib|mesh-list
102058189|NCT04173325|Nivolumab|nivolumab|mesh-list
102058190|NCT04173325|Irinotecan|irinotecan|mesh-list
102058191|NCT04173325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101613470|NCT05336721|Chiauranib|chiauranib|mesh-list
101613471|NCT05336721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101613472|NCT05336721|Antimetabolites|antimetabolites|mesh-ancestor
101613473|NCT05336721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613474|NCT05336721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101613475|NCT05336721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101613476|NCT05336721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101613477|NCT00653913|Ezetimibe|ezetimibe|mesh-list
101613478|NCT00653913|Pitavastatin|pitavastatin|mesh-list
101613479|NCT00653913|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101613480|NCT00653913|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101613481|NCT00653913|Antimetabolites|antimetabolites|mesh-ancestor
101613482|NCT00653913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613483|NCT00653913|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101613484|NCT00653913|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101613485|NCT00653913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101613486|NCT00652431|Niacin|niacin|mesh-list
101613487|NCT00652431|Niacinamide|niacinamide|mesh-list
101613488|NCT00652431|Nicotinic Acids|nicotinic acids|mesh-list
101613489|NCT00652431|Simvastatin|simvastatin|mesh-list
101613490|NCT00652431|Ezetimibe|ezetimibe|mesh-list
101613491|NCT00652431|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
101613492|NCT00652431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101613493|NCT00652431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101613494|NCT00652431|Antimetabolites|antimetabolites|mesh-ancestor
101613495|NCT00652431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613496|NCT00652431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101542759|NCT02216045|Antimetabolites|antimetabolites|mesh-ancestor
101613500|NCT00652431|Vitamin B Complex|vitamin b complex|mesh-ancestor
101613502|NCT00652431|Micronutrients|micronutrients|mesh-ancestor
101613503|NCT00652431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613505|NCT00380523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101613506|NCT00380523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101613507|NCT00380523|Analgesics|analgesics|mesh-ancestor
101613508|NCT00380523|Sensory System Agents|sensory system agents|mesh-ancestor
101613509|NCT00380523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101613510|NCT00380523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613511|NCT00380523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101613512|NCT00380523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101613513|NCT00380523|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101613514|NCT00380523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101270529|NCT01821235|Antimanic Agents|antimanic agents|mesh-ancestor
101613515|NCT00380523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101613516|NCT00380523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613518|NCT00319995|Montelukast|montelukast|mesh-list
101613519|NCT00319995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101613520|NCT00319995|Respiratory System Agents|respiratory system agents|mesh-ancestor
101613521|NCT00319995|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101613522|NCT00319995|Hormone Antagonists|hormone antagonists|mesh-ancestor
101613523|NCT00319995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101613524|NCT00319995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613525|NCT00319995|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101613526|NCT00319995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101613527|NCT00319995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613528|NCT00319995|Antipruritics|antipruritics|mesh-ancestor
101613529|NCT00319995|Dermatologic Agents|dermatologic agents|mesh-ancestor
101613530|NCT00319995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101613531|NCT00319995|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101613532|NCT00319995|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101613533|NCT00319995|Histamine Antagonists|histamine antagonists|mesh-ancestor
101613534|NCT00319995|Histamine Agents|histamine agents|mesh-ancestor
101613535|NCT00319995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102058192|NCT04173325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058193|NCT04173325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102058194|NCT04173325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058195|NCT04173325|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101464208|NCT00233714|Sirolimus|sirolimus|mesh-list
101613536|NCT03304821|Sargramostim|sargramostim|mesh-list
101613537|NCT03304821|Immunologic Factors|immunologic factors|mesh-ancestor
101613538|NCT03304821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613539|NCT02842281|Levan|levan|mesh-list
101613540|NCT02842281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101613541|NCT03721341|Hormones|hormones|mesh-list
101613542|NCT03721341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101613543|NCT03721341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613544|NCT02842437|Dexmedetomidine|dexmedetomidine|mesh-list
101613545|NCT02842437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101613546|NCT02842437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101613547|NCT02842437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613548|NCT02842437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101613549|NCT02842437|Analgesics|analgesics|mesh-ancestor
101613550|NCT02842437|Sensory System Agents|sensory system agents|mesh-ancestor
101613551|NCT02842437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101613552|NCT02842437|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101613553|NCT02842437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101613554|NCT02842437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101613555|NCT02842437|Adrenergic Agents|adrenergic agents|mesh-ancestor
101613556|NCT02842437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101613557|NCT02842437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613558|NCT00157911|Simvastatin|simvastatin|mesh-list
101613559|NCT00157911|Ezetimibe|ezetimibe|mesh-list
101613560|NCT00157911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101613561|NCT00157911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101613562|NCT00157911|Antimetabolites|antimetabolites|mesh-ancestor
101613563|NCT00157911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613564|NCT00157911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101613565|NCT00157911|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101613566|NCT00157911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101613580|NCT03708549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101613581|NCT03708549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613583|NCT00156117|Asenapine|asenapine|mesh-list
101613584|NCT00156117|Antiemetics|antiemetics|mesh-ancestor
101613585|NCT00156117|Autonomic Agents|autonomic agents|mesh-ancestor
101613586|NCT00156117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101613587|NCT00156117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613588|NCT00156117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101613589|NCT00156117|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101613590|NCT00156117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101613591|NCT00156117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101613592|NCT00156117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101613593|NCT00156117|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101613594|NCT00156117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101613595|NCT00156117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101613596|NCT00156117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613597|NCT00156117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101613598|NCT00156117|Serotonin Agents|serotonin agents|mesh-ancestor
101613599|NCT00140985|Losartan|losartan|mesh-list
101613600|NCT00140985|Amlodipine|amlodipine|mesh-list
101613601|NCT00140985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101613602|NCT00140985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101613603|NCT00140985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101613604|NCT00140985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613605|NCT00140985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101613606|NCT00140985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613607|NCT00140985|Vasodilator Agents|vasodilator agents|mesh-ancestor
101613608|NCT00140985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101613609|NCT00140985|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101613610|NCT00140985|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101613611|NCT00140907|Losartan|losartan|mesh-list
102058196|NCT04173325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102058197|NCT04173325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102058199|NCT02810964|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102058200|NCT02810964|Protective Agents|protective agents|mesh-ancestor
102058201|NCT02810964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058202|NCT02810964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058203|NCT04073147|Venetoclax|venetoclax|mesh-list
102058204|NCT04073147|Obinutuzumab|obinutuzumab|mesh-list
102058205|NCT04073147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101613612|NCT00140907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101613613|NCT00140907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101613614|NCT00140907|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101613615|NCT00140907|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101613616|NCT00140907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613617|NCT00132717|Atorvastatin|atorvastatin|mesh-list
101613618|NCT00132717|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101613619|NCT00132717|Simvastatin|simvastatin|mesh-list
101613620|NCT00132717|Ezetimibe|ezetimibe|mesh-list
101613621|NCT00132717|Pravastatin|pravastatin|mesh-list
101613622|NCT00132717|Lovastatin|lovastatin|mesh-list
101613623|NCT00132717|L 647318|l 647318|mesh-list
101613624|NCT00132717|Dihydromevinolin|dihydromevinolin|mesh-list
101613625|NCT00132717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101613626|NCT00132717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101613627|NCT00132717|Antimetabolites|antimetabolites|mesh-ancestor
101613628|NCT00132717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613634|NCT00127179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613636|NCT00127179|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101613637|NCT00127179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101613638|NCT00127179|Hormone Antagonists|hormone antagonists|mesh-ancestor
101613639|NCT00127179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101613640|NCT00127179|Urological Agents|urological agents|mesh-ancestor
101613641|NCT00953706|Ivacaftor|ivacaftor|mesh-list
101613642|NCT00953706|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101613643|NCT00953706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101613644|NCT00953706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613645|NCT02852382|Morphine|morphine|mesh-list
101613646|NCT02852382|Bupivacaine|bupivacaine|mesh-list
101613647|NCT02852382|Anesthetics, Local|anesthetics, local|mesh-ancestor
101613648|NCT02852382|Anesthetics|anesthetics|mesh-ancestor
101613649|NCT02852382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101613650|NCT02852382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613651|NCT02852382|Sensory System Agents|sensory system agents|mesh-ancestor
101613652|NCT02852382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101613653|NCT02852382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101613654|NCT02852382|Narcotics|narcotics|mesh-ancestor
101613655|NCT02852382|Analgesics|analgesics|mesh-ancestor
101613656|NCT00630942|Minocycline|minocycline|mesh-list
101613657|NCT00630942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101613658|NCT00630942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101613659|NCT00602550|Zidovudine|zidovudine|mesh-list
101613660|NCT00602550|Antimetabolites|antimetabolites|mesh-ancestor
101613661|NCT00602550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613662|NCT00602550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101270682|NCT01822405|Vitamins|vitamins|mesh-ancestor
101613663|NCT00602550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101613664|NCT00602550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101613665|NCT00602550|Antiviral Agents|antiviral agents|mesh-ancestor
101613666|NCT00602550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101613667|NCT00602550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101613668|NCT00602550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101613669|NCT00602706|Melphalan|melphalan|mesh-list
101613670|NCT00602706|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
101613671|NCT00602706|Sargramostim|sargramostim|mesh-list
101613672|NCT00602706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101613673|NCT00602706|Alkylating Agents|alkylating agents|mesh-ancestor
102058206|NCT04073147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102058207|NCT02707159|Paclitaxel|paclitaxel|mesh-list
102058208|NCT02707159|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102058209|NCT02707159|Gemcitabine|gemcitabine|mesh-list
102058210|NCT02707159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102058211|NCT02707159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101613674|NCT00602706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613675|NCT00602706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101613676|NCT00602706|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101613677|NCT00602706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101613678|NCT00602706|Immunologic Factors|immunologic factors|mesh-ancestor
101613679|NCT00602706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613680|NCT00602706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101613681|NCT00602706|Analgesics|analgesics|mesh-ancestor
101613682|NCT00602706|Sensory System Agents|sensory system agents|mesh-ancestor
101613683|NCT00602706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101613684|NCT00604344|Insulin|insulin|mesh-list
101613685|NCT00604344|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101613686|NCT00604344|Insulin Detemir|insulin detemir|mesh-list
101613687|NCT00604344|Isophane Insulin, Human|isophane insulin, human|mesh-list
101613688|NCT00604344|Insulin, Isophane|insulin, isophane|mesh-list
101613689|NCT00604344|Isophane insulin, beef|isophane insulin, beef|mesh-list
101613690|NCT00604344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101613691|NCT00604344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613692|NCT02851914|Antidepressive Agents|antidepressive agents|mesh-list
101613693|NCT02851914|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
101613694|NCT02851914|Serotonin|serotonin|mesh-list
101613695|NCT02851914|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
101613696|NCT02851914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101613700|NCT02851914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613701|NCT02851914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613702|NCT02851914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101613703|NCT02851914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101613705|NCT00938964|Anesthetics, Local|anesthetics, local|mesh-ancestor
101613706|NCT00938964|Anesthetics|anesthetics|mesh-ancestor
101613707|NCT00938964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101613708|NCT00938964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613709|NCT00938964|Sensory System Agents|sensory system agents|mesh-ancestor
101613710|NCT00938964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101613711|NCT00938964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101613712|NCT00938964|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101613713|NCT00938964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101613714|NCT00938964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101613715|NCT00938964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613716|NCT00938886|Naltrexone|naltrexone|mesh-list
101613717|NCT00938886|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101613718|NCT00938886|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101613719|NCT00938886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613721|NCT00938886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101613722|NCT02852070|Dimercaprol|dimercaprol|mesh-list
101613723|NCT02852070|Chelating Agents|chelating agents|mesh-ancestor
101613724|NCT02852070|Sequestering Agents|sequestering agents|mesh-ancestor
101613725|NCT02852070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613726|NCT00602862|Bevacizumab|bevacizumab|mesh-list
101613727|NCT00602862|Sorafenib|sorafenib|mesh-list
101613728|NCT00602862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101613729|NCT00602862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101613730|NCT00602862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101613731|NCT00602862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101613732|NCT00602862|Growth Substances|growth substances|mesh-ancestor
101613733|NCT00602862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613734|NCT00602862|Growth Inhibitors|growth inhibitors|mesh-ancestor
101613735|NCT00602862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101613736|NCT00602862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101270770|NCT01822951|Donepezil|donepezil|mesh-list
101613737|NCT00602862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613738|NCT00942708|Fluoxetine|fluoxetine|mesh-list
102058212|NCT02707159|Tubulin Modulators|tubulin modulators|mesh-ancestor
102058213|NCT02707159|Antimitotic Agents|antimitotic agents|mesh-ancestor
102058214|NCT02707159|Mitosis Modulators|mitosis modulators|mesh-ancestor
102058215|NCT02707159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058216|NCT02707159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101613739|NCT00942708|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101613740|NCT00942708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101613741|NCT00942708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101613742|NCT00942708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613743|NCT00942708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101613744|NCT00942708|Serotonin Agents|serotonin agents|mesh-ancestor
101613745|NCT00942708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613746|NCT00942708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101613747|NCT00942708|Antidepressive Agents|antidepressive agents|mesh-ancestor
101613748|NCT00942708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101613749|NCT00942708|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101613750|NCT00942708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101613751|NCT00942708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101613752|NCT00942084|Acyclovir|acyclovir|mesh-list
101613753|NCT00942084|Antiviral Agents|antiviral agents|mesh-ancestor
101613754|NCT00942084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101613755|NCT00941928|Cyclophosphamide|cyclophosphamide|mesh-list
101613756|NCT00941928|Fludarabine|fludarabine|mesh-list
101613757|NCT00941928|Fludarabine phosphate|fludarabine phosphate|mesh-list
101613758|NCT00941928|Interleukin-2|interleukin-2|mesh-list
101613759|NCT00941928|Epratuzumab|epratuzumab|mesh-list
101613760|NCT00941928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101613761|NCT00941928|Immunologic Factors|immunologic factors|mesh-ancestor
101613762|NCT00941928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613763|NCT00941928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101613764|NCT00941928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101613765|NCT00941928|Alkylating Agents|alkylating agents|mesh-ancestor
101543016|NCT01686789|Interferons|interferons|mesh-list
101613770|NCT00941928|Antimetabolites|antimetabolites|mesh-ancestor
101613771|NCT00941928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101613772|NCT00941928|Analgesics|analgesics|mesh-ancestor
101613773|NCT00941928|Sensory System Agents|sensory system agents|mesh-ancestor
101613774|NCT00941928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101613775|NCT00941928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101613776|NCT02852694|Adalimumab|adalimumab|mesh-list
101613777|NCT02852694|Methotrexate|methotrexate|mesh-list
101613778|NCT02852694|Mercaptopurine|mercaptopurine|mesh-list
101613779|NCT02852694|Azathioprine|azathioprine|mesh-list
101613780|NCT02852694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101613781|NCT02852694|Abortifacient Agents|abortifacient agents|mesh-ancestor
101613782|NCT02852694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101613783|NCT02852694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613784|NCT02852694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101613785|NCT02852694|Antimetabolites|antimetabolites|mesh-ancestor
101613786|NCT02852694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613787|NCT02852694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101613788|NCT02852694|Dermatologic Agents|dermatologic agents|mesh-ancestor
101613789|NCT02852694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101613790|NCT02852694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101613791|NCT02852694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101613792|NCT02852694|Immunologic Factors|immunologic factors|mesh-ancestor
101613793|NCT02852694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101613794|NCT02852694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101613795|NCT02852694|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101613796|NCT02852694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101613797|NCT00604578|Pioglitazone|pioglitazone|mesh-list
101613798|NCT00604578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101613799|NCT00604578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613801|NCT00937560|Bevacizumab|bevacizumab|mesh-list
101613802|NCT00937560|Carboplatin|carboplatin|mesh-list
101613803|NCT00937560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101613804|NCT00937560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101613805|NCT00937560|Tubulin Modulators|tubulin modulators|mesh-ancestor
101613806|NCT00937560|Antimitotic Agents|antimitotic agents|mesh-ancestor
101613807|NCT00937560|Mitosis Modulators|mitosis modulators|mesh-ancestor
102058217|NCT02707159|Antimetabolites|antimetabolites|mesh-ancestor
102058218|NCT04113187|Propranolol|propranolol|mesh-list
102058219|NCT04113187|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102058220|NCT04113187|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102058221|NCT04113187|Adrenergic Agents|adrenergic agents|mesh-ancestor
102058222|NCT04113187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102058223|NCT04113187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058224|NCT04113187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058225|NCT04113187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102058226|NCT04113187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101613808|NCT00937560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613809|NCT00937560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101613810|NCT00937560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101613811|NCT00937560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101613812|NCT00937560|Growth Substances|growth substances|mesh-ancestor
101613813|NCT00937560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613814|NCT00937560|Growth Inhibitors|growth inhibitors|mesh-ancestor
101613815|NCT04268394|Metformin|metformin|mesh-list
101613816|NCT04268394|Itraconazole|itraconazole|mesh-list
101613817|NCT04268394|Rifampin|rifampin|mesh-list
101613818|NCT04268394|Sulfasalazine|sulfasalazine|mesh-list
101613819|NCT04268394|Methotrexate|methotrexate|mesh-list
101613820|NCT04268394|Digoxin|digoxin|mesh-list
101613821|NCT04268394|Midazolam|midazolam|mesh-list
101613822|NCT04268394|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101613823|NCT04268394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101613824|NCT04268394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613825|NCT04268394|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101613826|NCT04268394|Abortifacient Agents|abortifacient agents|mesh-ancestor
101613827|NCT04268394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101613828|NCT04268394|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101613829|NCT04268394|Antimetabolites|antimetabolites|mesh-ancestor
101613830|NCT04268394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613831|NCT04268394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101613832|NCT04268394|Dermatologic Agents|dermatologic agents|mesh-ancestor
101613833|NCT04268394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101613834|NCT04268394|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101613835|NCT04268394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101613836|NCT04268394|Immunologic Factors|immunologic factors|mesh-ancestor
101613837|NCT04268394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101613869|NCT04268394|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101613870|NCT04268394|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101613871|NCT04268394|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101613872|NCT04268394|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101613874|NCT04268394|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101613875|NCT04268394|Protective Agents|protective agents|mesh-ancestor
101613876|NCT04268394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101613877|NCT04268394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101613878|NCT04268394|Analgesics|analgesics|mesh-ancestor
101613879|NCT04268394|Sensory System Agents|sensory system agents|mesh-ancestor
101613880|NCT04268394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101613881|NCT04268394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101613882|NCT04268394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101270899|NCT01824199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101613883|NCT02851212|Metformin|metformin|mesh-list
101613884|NCT02851212|Canagliflozin|canagliflozin|mesh-list
101613885|NCT02851212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101613886|NCT02851212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613887|NCT02851212|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101613888|NCT02851212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613889|NCT00594568|N2-((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-L-alaninamide|n2-((2s)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-n1-((7s)-5-methyl-6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-l-alaninamide|mesh-list
102058227|NCT04113187|Vasodilator Agents|vasodilator agents|mesh-ancestor
102058228|NCT03103763|Warfarin|warfarin|mesh-list
102058229|NCT03103763|Anticoagulants|anticoagulants|mesh-ancestor
102058230|NCT05197517|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102058231|NCT05197517|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102058232|NCT05197517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102058233|NCT05197517|Antimetabolites|antimetabolites|mesh-ancestor
102058234|NCT05197517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058235|NCT05197517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101613890|NCT00594568|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101613891|NCT00594568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101613892|NCT00594568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613893|NCT04143802|Dulaglutide|dulaglutide|mesh-list
101613894|NCT04143802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101613895|NCT04143802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613896|NCT00682630|Artesunate|artesunate|mesh-list
101613897|NCT00682630|Pyronaridine|pyronaridine|mesh-list
101613898|NCT00682630|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
101613899|NCT00682630|Antimalarials|antimalarials|mesh-ancestor
101613900|NCT00682630|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101613901|NCT00682630|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101613902|NCT00682630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101613903|NCT00682630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101613904|NCT00682630|Antiviral Agents|antiviral agents|mesh-ancestor
101613905|NCT00682630|Schistosomicides|schistosomicides|mesh-ancestor
101613906|NCT00682630|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101613907|NCT00682630|Anthelmintics|anthelmintics|mesh-ancestor
101613908|NCT00875056|Vorinostat|vorinostat|mesh-list
101613909|NCT00875056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101613910|NCT00875056|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101613911|NCT00875056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101613912|NCT00875056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613913|NCT00685594|Vitamin D|vitamin d|mesh-list
101613914|NCT00685594|Cholecalciferol|cholecalciferol|mesh-list
101613915|NCT00685594|Vitamins|vitamins|mesh-ancestor
101613916|NCT00685594|Micronutrients|micronutrients|mesh-ancestor
101613917|NCT00685594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613918|NCT00685594|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101613919|NCT00685594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101613920|NCT00685672|Epinephrine|epinephrine|mesh-list
101613921|NCT00685672|Racepinephrine|racepinephrine|mesh-list
101613922|NCT00685672|Epinephryl borate|epinephryl borate|mesh-list
101613923|NCT00685672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101613924|NCT00685672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101613925|NCT00685672|Adrenergic Agents|adrenergic agents|mesh-ancestor
101613926|NCT00685672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101613927|NCT00685672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613928|NCT00685672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613929|NCT00685672|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101613930|NCT00685672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101613931|NCT00685672|Autonomic Agents|autonomic agents|mesh-ancestor
101613932|NCT00685672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101613933|NCT00685672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101613934|NCT00685672|Respiratory System Agents|respiratory system agents|mesh-ancestor
101613941|NCT00683176|Antimetabolites|antimetabolites|mesh-ancestor
101613942|NCT00683176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613943|NCT00683176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101613944|NCT00683176|Lipotropic Agents|lipotropic agents|mesh-ancestor
101613945|NCT00683176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101613946|NCT00683176|Nootropic Agents|nootropic agents|mesh-ancestor
101613947|NCT02626234|Digoxin|digoxin|mesh-list
101613948|NCT02626234|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101613949|NCT02626234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101613950|NCT02626234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101613951|NCT02626234|Antimetabolites|antimetabolites|mesh-ancestor
101613952|NCT02626234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613953|NCT02626234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102058236|NCT05197517|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102058237|NCT05197517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102058239|NCT04011475|Olodaterol|olodaterol|mesh-list
102058240|NCT04011475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101613954|NCT02626234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101613955|NCT02626234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101613956|NCT02626234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101613957|NCT02626234|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101613958|NCT02626234|Protective Agents|protective agents|mesh-ancestor
101613959|NCT02626234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613960|NCT00685828|Imatinib Mesylate|imatinib mesylate|mesh-list
101613961|NCT00685828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101613962|NCT00685828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101613963|NCT00685828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101613964|NCT00685828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613965|NCT00685906|Ticagrelor|ticagrelor|mesh-list
101613966|NCT00685906|Levonorgestrel|levonorgestrel|mesh-list
101613967|NCT00685906|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101613968|NCT00685906|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
101613969|NCT00685906|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
101613970|NCT00685906|Estradiol|estradiol|mesh-list
101613971|NCT00685906|Estrogens|estrogens|mesh-ancestor
101613972|NCT00685906|Hormones|hormones|mesh-ancestor
101613973|NCT00685906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101613974|NCT00685906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613975|NCT00685906|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101613976|NCT00685906|Contraceptive Agents|contraceptive agents|mesh-ancestor
101613977|NCT00685906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101613978|NCT00685906|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101613979|NCT00685906|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101613980|NCT00685906|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101613981|NCT00685906|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101613982|NCT00685906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101613983|NCT00685906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101613984|NCT00685906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101613985|NCT00685906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101613986|NCT00685906|Purinergic Agents|purinergic agents|mesh-ancestor
101613987|NCT00685906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101613988|NCT00685906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613989|NCT00685906|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101613990|NCT00685906|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
101613991|NCT00685906|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101613992|NCT00685906|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101613993|NCT04139824|Naproxen|naproxen|mesh-list
101613994|NCT04139824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101613995|NCT04139824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101613996|NCT04139824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101613997|NCT04139824|Analgesics|analgesics|mesh-ancestor
101613998|NCT04139824|Sensory System Agents|sensory system agents|mesh-ancestor
101613999|NCT04139824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101265297|NCT01772797|Ceritinib|ceritinib|mesh-list
101614000|NCT04139824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614002|NCT04139824|Gout Suppressants|gout suppressants|mesh-ancestor
101543260|NCT02216565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101614006|NCT00940602|Deferasirox|deferasirox|mesh-list
101614007|NCT00940602|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101614008|NCT00940602|Chelating Agents|chelating agents|mesh-ancestor
101614009|NCT00940602|Sequestering Agents|sequestering agents|mesh-ancestor
101614010|NCT00940602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614011|NCT00686140|Celecoxib|celecoxib|mesh-list
101614012|NCT00686140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101614013|NCT00686140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101614014|NCT00686140|Analgesics|analgesics|mesh-ancestor
101614015|NCT00686140|Sensory System Agents|sensory system agents|mesh-ancestor
101614016|NCT00686140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101614017|NCT00686140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058241|NCT04011475|Autonomic Agents|autonomic agents|mesh-ancestor
102058242|NCT04011475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102058243|NCT04011475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058244|NCT04011475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102058245|NCT04011475|Respiratory System Agents|respiratory system agents|mesh-ancestor
102058246|NCT04011475|Parasympatholytics|parasympatholytics|mesh-ancestor
102058247|NCT04011475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102058248|NCT04011475|Cholinergic Agents|cholinergic agents|mesh-ancestor
101614018|NCT00686140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101614019|NCT00686140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101614020|NCT00686140|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101614021|NCT00686140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101614022|NCT00686140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614023|NCT00686140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614024|NCT00686218|Imatinib Mesylate|imatinib mesylate|mesh-list
101614025|NCT00686218|Panobinostat|panobinostat|mesh-list
101614026|NCT00686218|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
101614027|NCT00686218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101614028|NCT00686218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101271054|NCT01825044|Cyclosporine|cyclosporine|mesh-list
101614029|NCT00686218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614030|NCT00686218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614031|NCT00683956|Propofol|propofol|mesh-list
101614032|NCT00683956|Anesthetics|anesthetics|mesh-ancestor
101614033|NCT00683956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101614034|NCT00683956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614035|NCT00683956|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101614036|NCT00683956|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101614037|NCT00683956|Anesthetics, General|anesthetics, general|mesh-ancestor
101614038|NCT02850744|Temozolomide|temozolomide|mesh-list
101614039|NCT02850744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101614040|NCT02850744|Alkylating Agents|alkylating agents|mesh-ancestor
101614041|NCT02850744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614042|NCT02850744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101614043|NCT04139668|Naltrexone|naltrexone|mesh-list
101614044|NCT04139668|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101614045|NCT04139668|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101614046|NCT04139668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614047|NCT04139668|Sensory System Agents|sensory system agents|mesh-ancestor
101614048|NCT04139668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101614049|NCT04266756|Selexipag|selexipag|mesh-list
101614050|NCT04266756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101614051|NCT00606060|Factor VIII|factor viii|mesh-list
101614052|NCT00606060|Coagulants|coagulants|mesh-ancestor
101614053|NCT00875524|Vaccines|vaccines|mesh-list
101614054|NCT00875524|Immunologic Factors|immunologic factors|mesh-ancestor
101614055|NCT00875524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614056|NCT01094288|Docetaxel|docetaxel|mesh-list
101614057|NCT01094288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101614058|NCT01094288|Tubulin Modulators|tubulin modulators|mesh-ancestor
101614059|NCT01094288|Antimitotic Agents|antimitotic agents|mesh-ancestor
101614060|NCT01094288|Mitosis Modulators|mitosis modulators|mesh-ancestor
101614061|NCT01094288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614062|NCT05380986|Apatinib|apatinib|mesh-list
101614063|NCT05380986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101614064|NCT05380986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101614065|NCT05380986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614066|NCT05380986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614067|NCT00684112|Gabapentin|gabapentin|mesh-list
101614068|NCT00684112|Analgesics|analgesics|mesh-ancestor
101614069|NCT00684112|Sensory System Agents|sensory system agents|mesh-ancestor
101614070|NCT00684112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101614071|NCT00684112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614072|NCT00684112|Anticonvulsants|anticonvulsants|mesh-ancestor
101543329|NCT04534322|Melphalan|melphalan|mesh-list
101614077|NCT00684112|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101614078|NCT00684112|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101614079|NCT00684112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102058249|NCT04011475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102058250|NCT04011475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058251|NCT05110781|Atezolizumab|atezolizumab|mesh-list
102058252|NCT05110781|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102058253|NCT05110781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102058254|NCT05110781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058255|NCT05110781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101614080|NCT00684112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614082|NCT00684190|Esomeprazole|esomeprazole|mesh-list
101614083|NCT00684190|Lesogaberan|lesogaberan|mesh-list
101614084|NCT00684190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101614085|NCT00684190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101614086|NCT00684190|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101614087|NCT00684190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614088|NCT00684190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614089|NCT00684190|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101614090|NCT00684190|GABA Agonists|gaba agonists|mesh-ancestor
101614091|NCT00684190|GABA Agents|gaba agents|mesh-ancestor
101614092|NCT00684190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101614093|NCT00684190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614094|NCT00684268|Silybin|silybin|mesh-list
101614095|NCT00684268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101614096|NCT00684268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101614097|NCT00684268|Protective Agents|protective agents|mesh-ancestor
101614098|NCT00684268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614099|NCT00604656|Insulin Aspart|insulin aspart|mesh-list
101614100|NCT00604656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101614101|NCT00604656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614102|NCT00684346|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101614103|NCT00684346|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101614104|NCT00684346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614105|NCT00874120|Phenylephrine|phenylephrine|mesh-list
101614106|NCT00874120|Oxymetazoline|oxymetazoline|mesh-list
101614107|NCT00874120|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101614108|NCT00874120|Mydriatics|mydriatics|mesh-ancestor
101614109|NCT00874120|Autonomic Agents|autonomic agents|mesh-ancestor
101614110|NCT00874120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101614111|NCT00874120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614112|NCT00874120|Sympathomimetics|sympathomimetics|mesh-ancestor
101614113|NCT00874120|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101614114|NCT00874120|Nasal Decongestants|nasal decongestants|mesh-ancestor
101614115|NCT00874120|Respiratory System Agents|respiratory system agents|mesh-ancestor
101614116|NCT00874120|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101614117|NCT00874120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101614118|NCT00874120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101614119|NCT00874120|Adrenergic Agents|adrenergic agents|mesh-ancestor
101614120|NCT00874120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101614121|NCT00874120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614122|NCT00874120|Protective Agents|protective agents|mesh-ancestor
101614123|NCT00939822|Simvastatin|simvastatin|mesh-list
101614124|NCT00939822|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101614125|NCT00939822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101614126|NCT00939822|Antimetabolites|antimetabolites|mesh-ancestor
101614127|NCT00939822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614128|NCT00939822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101614129|NCT00939822|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101614130|NCT00939822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614131|NCT00685126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101614132|NCT00685126|Albuterol|albuterol|mesh-list
101614133|NCT00685126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101614134|NCT00685126|Autonomic Agents|autonomic agents|mesh-ancestor
101614135|NCT00685126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101614136|NCT00685126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614137|NCT00685126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101614138|NCT00685126|Respiratory System Agents|respiratory system agents|mesh-ancestor
101614139|NCT00685126|Tocolytic Agents|tocolytic agents|mesh-ancestor
102058256|NCT05110781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058257|NCT05110781|Immunologic Factors|immunologic factors|mesh-ancestor
102058258|NCT05110781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058259|NCT03663335|Tacrolimus|tacrolimus|mesh-list
102058260|NCT03663335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102058261|NCT03663335|Immunologic Factors|immunologic factors|mesh-ancestor
102058262|NCT03663335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058263|NCT03663335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101614140|NCT00685126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101614141|NCT00685126|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101614142|NCT00685126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101614147|NCT00687388|Celecoxib|celecoxib|mesh-list
101614148|NCT00687388|Doxazosin|doxazosin|mesh-list
101614149|NCT00687388|Prazosin|prazosin|mesh-list
101614150|NCT00687388|Tamsulosin|tamsulosin|mesh-list
101614151|NCT00687388|Alfuzosin|alfuzosin|mesh-list
101614152|NCT00687388|Terazosin|terazosin|mesh-list
101614153|NCT00687388|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
101614154|NCT00687388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101614155|NCT00687388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101614156|NCT00687388|Analgesics|analgesics|mesh-ancestor
101614157|NCT00687388|Sensory System Agents|sensory system agents|mesh-ancestor
101614158|NCT00687388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101614159|NCT00687388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614160|NCT00687388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101614161|NCT00687388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101614162|NCT00687388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101614163|NCT00687388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101614164|NCT00687388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614165|NCT00687388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614166|NCT00687388|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101614167|NCT00687388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101614168|NCT00687388|Adrenergic Agents|adrenergic agents|mesh-ancestor
101614169|NCT00687388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101614170|NCT00687388|Urological Agents|urological agents|mesh-ancestor
101614171|NCT00687388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101614172|NCT00939510|Lenalidomide|lenalidomide|mesh-list
101614173|NCT00939510|Sargramostim|sargramostim|mesh-list
101614174|NCT00939510|Immunologic Factors|immunologic factors|mesh-ancestor
101614175|NCT00939510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614176|NCT00939510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101614177|NCT00939510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101614178|NCT00939510|Growth Substances|growth substances|mesh-ancestor
101614179|NCT00939510|Growth Inhibitors|growth inhibitors|mesh-ancestor
101614180|NCT00939510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101614181|NCT00687466|Insulin|insulin|mesh-list
101614182|NCT00687466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101614183|NCT00687466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614184|NCT04266288|Ketamine|ketamine|mesh-list
101614185|NCT04266288|Analgesics|analgesics|mesh-ancestor
101614186|NCT04266288|Sensory System Agents|sensory system agents|mesh-ancestor
101614187|NCT04266288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101614188|NCT04266288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614189|NCT04266288|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101614190|NCT04266288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101614191|NCT04266288|Anesthetics, General|anesthetics, general|mesh-ancestor
101614192|NCT04266288|Anesthetics|anesthetics|mesh-ancestor
101614193|NCT04266288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101614194|NCT04266288|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101614195|NCT04266288|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101614196|NCT04266288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101614197|NCT04266288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614198|NCT00687622|Trametinib|trametinib|mesh-list
101614199|NCT00687622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101614200|NCT00687622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101614201|NCT00687622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614202|NCT00687622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614203|NCT00687700|Propranolol|propranolol|mesh-list
102058265|NCT03663335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058266|NCT03632915|Lacosamide|lacosamide|mesh-list
102058267|NCT03632915|Phenytoin|phenytoin|mesh-list
102058268|NCT03632915|Ketamine|ketamine|mesh-list
102058269|NCT03632915|Levetiracetam|levetiracetam|mesh-list
102058270|NCT03632915|Valproic Acid|valproic acid|mesh-list
102058271|NCT03632915|Phenobarbital|phenobarbital|mesh-list
102058272|NCT03632915|Analgesics|analgesics|mesh-ancestor
102058273|NCT03632915|Sensory System Agents|sensory system agents|mesh-ancestor
102058274|NCT03632915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102058275|NCT03632915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058276|NCT03632915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101614204|NCT00687700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101614205|NCT00687700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101614206|NCT00687700|Adrenergic Agents|adrenergic agents|mesh-ancestor
101614207|NCT00687700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101614208|NCT00687700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614209|NCT00687700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614210|NCT00687700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101614211|NCT00687700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101614212|NCT00687700|Vasodilator Agents|vasodilator agents|mesh-ancestor
101614213|NCT00935532|Insulin|insulin|mesh-list
101614242|NCT01093586|Prednisolone acetate|prednisolone acetate|mesh-list
101614243|NCT01093586|Cyclophosphamide|cyclophosphamide|mesh-list
101614244|NCT01093586|Busulfan|busulfan|mesh-list
101614245|NCT01093586|Cyclosporins|cyclosporins|mesh-list
101614246|NCT01093586|Thymoglobulin|thymoglobulin|mesh-list
101614247|NCT01093586|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101614248|NCT01093586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101614249|NCT01093586|Prednisolone phosphate|prednisolone phosphate|mesh-list
101614250|NCT01093586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101614251|NCT01093586|Immunologic Factors|immunologic factors|mesh-ancestor
101614252|NCT01093586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614253|NCT01093586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101614254|NCT01093586|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101614255|NCT01093586|Alkylating Agents|alkylating agents|mesh-ancestor
101614256|NCT01093586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614257|NCT01093586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101614258|NCT01093586|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101614259|NCT01093586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614260|NCT01093586|Antifungal Agents|antifungal agents|mesh-ancestor
101614261|NCT01093586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101614266|NCT01093586|Antitubercular Agents|antitubercular agents|mesh-ancestor
101614267|NCT01093586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101614268|NCT01093586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101614269|NCT01093586|Antiemetics|antiemetics|mesh-ancestor
101614270|NCT01093586|Autonomic Agents|autonomic agents|mesh-ancestor
101614271|NCT01093586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101614272|NCT01093586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101614273|NCT01093586|Glucocorticoids|glucocorticoids|mesh-ancestor
101614274|NCT01093586|Hormones|hormones|mesh-ancestor
101614275|NCT01093586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101614276|NCT01093586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101614277|NCT01093586|Protective Agents|protective agents|mesh-ancestor
101614278|NCT01093586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101614279|NCT04266132|Bupivacaine|bupivacaine|mesh-list
101614280|NCT04266132|Anesthetics, Local|anesthetics, local|mesh-ancestor
101614281|NCT04266132|Anesthetics|anesthetics|mesh-ancestor
101614282|NCT04266132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101614283|NCT04266132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614284|NCT04266132|Sensory System Agents|sensory system agents|mesh-ancestor
101614285|NCT04266132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101614286|NCT02625454|Acetaminophen|acetaminophen|mesh-list
101614287|NCT02625454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101614288|NCT02625454|Analgesics|analgesics|mesh-ancestor
101614289|NCT02625454|Sensory System Agents|sensory system agents|mesh-ancestor
102058277|NCT03632915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102058278|NCT03632915|Anesthetics, General|anesthetics, general|mesh-ancestor
102058279|NCT03632915|Anesthetics|anesthetics|mesh-ancestor
102058280|NCT03632915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101614290|NCT02625454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101614291|NCT02625454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614292|NCT02625454|Antipyretics|antipyretics|mesh-ancestor
101614293|NCT00606450|Thalidomide|thalidomide|mesh-list
101614294|NCT00606450|Apremilast|apremilast|mesh-list
101614295|NCT00606450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101614296|NCT00606450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101614297|NCT00606450|Analgesics|analgesics|mesh-ancestor
101614298|NCT00606450|Sensory System Agents|sensory system agents|mesh-ancestor
101614299|NCT00606450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101614300|NCT00606450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614301|NCT00606450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101614302|NCT00606450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101614303|NCT00606450|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101614304|NCT00606450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101614305|NCT00606450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614306|NCT00606450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614307|NCT00606450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101614308|NCT00606450|Immunologic Factors|immunologic factors|mesh-ancestor
101614309|NCT00606450|Leprostatic Agents|leprostatic agents|mesh-ancestor
101614310|NCT00606450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101614311|NCT00606450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101614312|NCT00606450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101614313|NCT00606450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101614314|NCT00606450|Growth Substances|growth substances|mesh-ancestor
101614315|NCT00606450|Growth Inhibitors|growth inhibitors|mesh-ancestor
101614316|NCT00606450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101614317|NCT04138888|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101614318|NCT04138888|Olmesartan|olmesartan|mesh-list
101614319|NCT04138888|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101614320|NCT04138888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101614321|NCT04138888|Diuretics|diuretics|mesh-ancestor
101614322|NCT04138888|Natriuretic Agents|natriuretic agents|mesh-ancestor
101614323|NCT04138888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614324|NCT04138888|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101614325|NCT04138888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101614326|NCT04138888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614327|NCT04138888|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101614328|NCT04138888|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101614329|NCT01098110|Asenapine|asenapine|mesh-list
101614330|NCT01098110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101614331|NCT01098110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101543585|NCT02216786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101614334|NCT01098110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101614335|NCT00688402|Lesogaberan|lesogaberan|mesh-list
101614336|NCT00688402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101614337|NCT00688402|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101614338|NCT00688402|GABA Agonists|gaba agonists|mesh-ancestor
101614339|NCT00688402|GABA Agents|gaba agents|mesh-ancestor
101614340|NCT00688402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101614341|NCT00688402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614342|NCT00688402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614343|NCT04138264|Analgesics, Opioid|analgesics, opioid|mesh-list
101614344|NCT04138264|Narcotics|narcotics|mesh-ancestor
101614345|NCT04138264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101614346|NCT04138264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614347|NCT04138264|Analgesics|analgesics|mesh-ancestor
101614348|NCT04138264|Sensory System Agents|sensory system agents|mesh-ancestor
101779353|NCT00640146|Methylnaltrexone|methylnaltrexone|mesh-list
101614349|NCT04138264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101614351|NCT00688480|Antimetabolites|antimetabolites|mesh-ancestor
101614352|NCT00688480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614353|NCT00688480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614354|NCT00688480|Gout Suppressants|gout suppressants|mesh-ancestor
101614355|NCT00688480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101614356|NCT00688480|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102058281|NCT03632915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102058282|NCT03632915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102058283|NCT03632915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102058284|NCT03632915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058285|NCT03632915|Anticonvulsants|anticonvulsants|mesh-ancestor
102058286|NCT03632915|Nootropic Agents|nootropic agents|mesh-ancestor
102058287|NCT03632915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102058288|NCT03632915|GABA Agents|gaba agents|mesh-ancestor
102058289|NCT03632915|Antimanic Agents|antimanic agents|mesh-ancestor
102058290|NCT03632915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102058291|NCT03632915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102058292|NCT03632915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102058293|NCT03632915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102058294|NCT03632915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102058295|NCT03632915|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102058296|NCT03632915|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102058297|NCT03632915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102058298|NCT03632915|GABA Modulators|gaba modulators|mesh-ancestor
102058299|NCT03632915|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102058300|NCT03632915|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102058301|NCT05649605|Methyltestosterone|methyltestosterone|mesh-list
102058302|NCT05649605|Testosterone|testosterone|mesh-list
102058303|NCT05649605|Testosterone undecanoate|testosterone undecanoate|mesh-list
102058304|NCT05649605|Testosterone enanthate|testosterone enanthate|mesh-list
102058305|NCT05649605|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
102058306|NCT05649605|Androgens|androgens|mesh-ancestor
101614357|NCT00688480|Antioxidants|antioxidants|mesh-ancestor
101614358|NCT00688480|Protective Agents|protective agents|mesh-ancestor
101614359|NCT00688480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614360|NCT01092728|Dasatinib|dasatinib|mesh-list
101614361|NCT01092728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101614362|NCT01092728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101614363|NCT01092728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614364|NCT01092728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614365|NCT00688558|Simvastatin|simvastatin|mesh-list
101614366|NCT00688558|Dalcetrapib|dalcetrapib|mesh-list
101614367|NCT00688558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101614368|NCT00688558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101614369|NCT00688558|Antimetabolites|antimetabolites|mesh-ancestor
101614370|NCT00688558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614371|NCT00688558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101614372|NCT00688558|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101614373|NCT00688558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614374|NCT02625376|Resveratrol|resveratrol|mesh-list
101614375|NCT02625376|Antioxidants|antioxidants|mesh-ancestor
101614376|NCT02625376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614377|NCT02625376|Protective Agents|protective agents|mesh-ancestor
101614378|NCT02625376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058307|NCT05649605|Hormones|hormones|mesh-ancestor
102058308|NCT05649605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102058309|NCT05649605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058310|NCT05649605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102058311|NCT05649605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058312|NCT05649605|Anabolic Agents|anabolic agents|mesh-ancestor
102058313|NCT05640479|Pregabalin|pregabalin|mesh-list
102058314|NCT05640479|Dexmedetomidine|dexmedetomidine|mesh-list
102058315|NCT05640479|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102058316|NCT05640479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101359935|NCT00211471|Anecortave|anecortave|mesh-list
101614379|NCT02625376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614380|NCT02625376|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101614381|NCT04153084|Picosulfate sodium|picosulfate sodium|mesh-list
101614382|NCT04153084|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101614383|NCT04153084|Cathartics|cathartics|mesh-ancestor
101614384|NCT04153084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101614385|NCT04153084|Laxatives|laxatives|mesh-ancestor
101614386|NCT00688948|Alfuzosin|alfuzosin|mesh-list
101614387|NCT00688948|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101614388|NCT00688948|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101614389|NCT00688948|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101614390|NCT00688948|Adrenergic Agents|adrenergic agents|mesh-ancestor
101614391|NCT00688948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101614392|NCT00688948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614393|NCT00688948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614394|NCT00688948|Urological Agents|urological agents|mesh-ancestor
101614395|NCT04152694|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
101614396|NCT04152694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101614397|NCT04152694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101614398|NCT00873730|Etanercept|etanercept|mesh-list
101614399|NCT00873730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101614400|NCT00873730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101614401|NCT00873730|Analgesics|analgesics|mesh-ancestor
101614402|NCT00873730|Sensory System Agents|sensory system agents|mesh-ancestor
101614403|NCT00873730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101614404|NCT00873730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614417|NCT00689416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614419|NCT00689494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101614420|NCT00689494|Contraceptive Agents|contraceptive agents|mesh-ancestor
101614421|NCT00689494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101614422|NCT00689494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614423|NCT00689494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101614424|NCT00689494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101614425|NCT00689494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101614426|NCT00672568|Capsaicin|capsaicin|mesh-list
101614427|NCT00672568|Antipruritics|antipruritics|mesh-ancestor
101614428|NCT00672568|Dermatologic Agents|dermatologic agents|mesh-ancestor
101614429|NCT00672568|Sensory System Agents|sensory system agents|mesh-ancestor
101614430|NCT00672568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101614431|NCT00672568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614432|NCT00604032|Tretinoin|tretinoin|mesh-list
101614433|NCT00604032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101614434|NCT00604032|Keratolytic Agents|keratolytic agents|mesh-ancestor
101614435|NCT00604032|Dermatologic Agents|dermatologic agents|mesh-ancestor
101614436|NCT00874432|Lisinopril|lisinopril|mesh-list
101614437|NCT00874432|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101614438|NCT00874432|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101614439|NCT00874432|Protease Inhibitors|protease inhibitors|mesh-ancestor
101614440|NCT00874432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614441|NCT00874432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101614442|NCT00874432|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101614443|NCT00874432|Protective Agents|protective agents|mesh-ancestor
101614444|NCT00874432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058317|NCT05640479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058318|NCT05640479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102058319|NCT05640479|Analgesics|analgesics|mesh-ancestor
102058320|NCT05640479|Sensory System Agents|sensory system agents|mesh-ancestor
102058321|NCT05640479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102058322|NCT05640479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101359946|NCT00211588|Cholinergic Agents|cholinergic agents|mesh-ancestor
101614445|NCT00935220|Linagliptin|linagliptin|mesh-list
101614446|NCT00935220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101614447|NCT00935220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614448|NCT00935220|Incretins|incretins|mesh-ancestor
101614449|NCT00935220|Hormones|hormones|mesh-ancestor
101614450|NCT00935220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101614451|NCT00935220|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101614452|NCT00935220|Protease Inhibitors|protease inhibitors|mesh-ancestor
101614453|NCT00935220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614454|NCT00935220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614455|NCT00691912|Paclitaxel|paclitaxel|mesh-list
101614456|NCT00691912|Doxorubicin|doxorubicin|mesh-list
101614457|NCT00691912|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101614458|NCT00691912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101614459|NCT00691912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101614460|NCT00691912|Tubulin Modulators|tubulin modulators|mesh-ancestor
101614461|NCT00691912|Antimitotic Agents|antimitotic agents|mesh-ancestor
101614462|NCT00691912|Mitosis Modulators|mitosis modulators|mesh-ancestor
101614463|NCT00691912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614464|NCT00691912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101614465|NCT00691912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101614466|NCT00691912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101614467|NCT00691912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614479|NCT05382390|Immunologic Factors|immunologic factors|mesh-ancestor
101614480|NCT05382390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614481|NCT05382390|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101614482|NCT05382390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614483|NCT05382390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101614484|NCT05382390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101614485|NCT05382390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101614486|NCT00689806|Lovastatin|lovastatin|mesh-list
101614487|NCT00689806|L 647318|l 647318|mesh-list
101614488|NCT00689806|Dihydromevinolin|dihydromevinolin|mesh-list
101614489|NCT00689806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101614490|NCT00689806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101614491|NCT00689806|Antimetabolites|antimetabolites|mesh-ancestor
101614492|NCT00689806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614493|NCT00689806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101614494|NCT00689806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101614495|NCT00689806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614496|NCT00594958|Vaccines|vaccines|mesh-list
101614497|NCT00594958|Immunologic Factors|immunologic factors|mesh-ancestor
101614498|NCT00594958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614500|NCT04204044|Vitamin B Complex|vitamin b complex|mesh-list
101614501|NCT04204044|Inositol|inositol|mesh-list
101614502|NCT04204044|Metformin|metformin|mesh-list
101614503|NCT04204044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101614504|NCT04204044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614505|NCT04204044|Hematinics|hematinics|mesh-ancestor
101614506|NCT04204044|Vitamins|vitamins|mesh-ancestor
101614507|NCT04204044|Micronutrients|micronutrients|mesh-ancestor
101614508|NCT00594880|Interferons|interferons|mesh-list
101614509|NCT00594880|Interferon-alpha|interferon-alpha|mesh-list
101614510|NCT00594880|Interferon alpha-2|interferon alpha-2|mesh-list
101614511|NCT00594880|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101614512|NCT00594880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101614513|NCT00594880|Antiviral Agents|antiviral agents|mesh-ancestor
101614514|NCT00594880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101614515|NCT00594880|Immunologic Factors|immunologic factors|mesh-ancestor
101614516|NCT00594880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614517|NCT00690118|Pioglitazone|pioglitazone|mesh-list
101614518|NCT00690118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102058323|NCT05640479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102058324|NCT05640479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102058325|NCT05640479|Adrenergic Agents|adrenergic agents|mesh-ancestor
102058326|NCT05640479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102058327|NCT05640479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614519|NCT00690118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614520|NCT00694252|Lapatinib|lapatinib|mesh-list
101614521|NCT00694252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101614522|NCT00694252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101614523|NCT00694252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614524|NCT00694252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614525|NCT00871858|Fulvestrant|fulvestrant|mesh-list
101614526|NCT00871858|Anastrozole|anastrozole|mesh-list
101614527|NCT00871858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101614528|NCT00871858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101614529|NCT00871858|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101614530|NCT00871858|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101614531|NCT00871858|Hormone Antagonists|hormone antagonists|mesh-ancestor
101614532|NCT00871858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101614533|NCT00871858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614534|NCT00871858|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101614535|NCT00871858|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101614551|NCT00694408|Prednisolone acetate|prednisolone acetate|mesh-list
101614552|NCT00694408|Hydrocortisone|hydrocortisone|mesh-list
101614553|NCT00694408|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101614554|NCT00694408|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101614555|NCT00694408|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101614556|NCT00694408|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101614557|NCT00694408|Prednisolone phosphate|prednisolone phosphate|mesh-list
101614558|NCT00694408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101614559|NCT00694408|Antiemetics|antiemetics|mesh-ancestor
101614560|NCT00694408|Autonomic Agents|autonomic agents|mesh-ancestor
101614561|NCT00694408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101614562|NCT00694408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614563|NCT00694408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101614564|NCT00694408|Glucocorticoids|glucocorticoids|mesh-ancestor
101614565|NCT00694408|Hormones|hormones|mesh-ancestor
101614566|NCT00694408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101614567|NCT00694408|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101614568|NCT00694408|Protective Agents|protective agents|mesh-ancestor
101614569|NCT00694408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101614570|NCT00694408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101614572|NCT04136782|Docetaxel|docetaxel|mesh-list
101614573|NCT04136782|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101614574|NCT04136782|Carboplatin|carboplatin|mesh-list
101614575|NCT04136782|Epirubicin|epirubicin|mesh-list
101614576|NCT04136782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101614577|NCT04136782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101614578|NCT04136782|Tubulin Modulators|tubulin modulators|mesh-ancestor
101614579|NCT04136782|Antimitotic Agents|antimitotic agents|mesh-ancestor
101614580|NCT04136782|Mitosis Modulators|mitosis modulators|mesh-ancestor
101614581|NCT04136782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614582|NCT04136782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101614583|NCT04136782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101614584|NCT04136782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101614585|NCT04136782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614586|NCT04137640|Cyclophosphamide|cyclophosphamide|mesh-list
101614587|NCT04137640|Docetaxel|docetaxel|mesh-list
101614588|NCT04137640|Letrozole|letrozole|mesh-list
101614589|NCT04137640|Epirubicin|epirubicin|mesh-list
101614590|NCT04137640|Palbociclib|palbociclib|mesh-list
101614591|NCT04137640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101614592|NCT04137640|Immunologic Factors|immunologic factors|mesh-ancestor
101614593|NCT04137640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614594|NCT04137640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101614595|NCT04137640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101614596|NCT04137640|Alkylating Agents|alkylating agents|mesh-ancestor
101614597|NCT04137640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614604|NCT04137640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102058328|NCT05640479|Anticonvulsants|anticonvulsants|mesh-ancestor
102058329|NCT05640479|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102058330|NCT05640479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102058331|NCT05640479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102058332|NCT05640479|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101614605|NCT04137640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614606|NCT04137640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101614607|NCT04137640|Hormone Antagonists|hormone antagonists|mesh-ancestor
101614608|NCT04137640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101614609|NCT04137640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101614610|NCT04137640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101614611|NCT04137640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101614612|NCT04137640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101614613|NCT02624830|Glyburide|glyburide|mesh-list
101614614|NCT02624830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101614615|NCT02624830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614616|NCT02629042|Prednisolone|prednisolone|mesh-list
101614617|NCT02629042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614618|NCT02629042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101614619|NCT02629042|Glucocorticoids|glucocorticoids|mesh-ancestor
101614620|NCT02629042|Hormones|hormones|mesh-ancestor
101614621|NCT02629042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101614622|NCT02629042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101614623|NCT02629042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101614624|NCT00692614|Triamcinolone|triamcinolone|mesh-list
101614625|NCT00692614|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101614626|NCT00692614|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101614627|NCT00692614|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101614628|NCT00692614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101614629|NCT00692614|Glucocorticoids|glucocorticoids|mesh-ancestor
101614630|NCT00692614|Hormones|hormones|mesh-ancestor
101614631|NCT00692614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101614632|NCT00692614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271653|NCT01829802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101614633|NCT00692614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101614634|NCT00692614|Immunologic Factors|immunologic factors|mesh-ancestor
101614635|NCT00692614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614636|NCT00692614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614637|NCT04136470|Nivolumab|nivolumab|mesh-list
101614638|NCT04136470|Ipilimumab|ipilimumab|mesh-list
101614639|NCT04136470|Atezolizumab|atezolizumab|mesh-list
101614640|NCT04136470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101614641|NCT04136470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101614642|NCT04136470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101614643|NCT04136470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614644|NCT00673426|Enoxaparin|enoxaparin|mesh-list
101614645|NCT00673426|Anticoagulants|anticoagulants|mesh-ancestor
101614646|NCT00673426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101614647|NCT00673426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101614648|NCT00673426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614649|NCT00673504|Gemcitabine|gemcitabine|mesh-list
101614650|NCT00673504|Sunitinib|sunitinib|mesh-list
101614651|NCT00673504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101614652|NCT00673504|Antimetabolites|antimetabolites|mesh-ancestor
101614653|NCT00673504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614654|NCT00673504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101614655|NCT00673504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101614656|NCT00673504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101614657|NCT00673504|Growth Substances|growth substances|mesh-ancestor
101614658|NCT00673504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614659|NCT00673504|Growth Inhibitors|growth inhibitors|mesh-ancestor
101614660|NCT00673504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101614661|NCT00673504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614662|NCT00673582|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101614663|NCT00673582|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101614664|NCT00673582|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101614665|NCT00673582|Antimetabolites|antimetabolites|mesh-ancestor
101614675|NCT00912574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614676|NCT00912574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058333|NCT05640479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102058334|NCT05640479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102058335|NCT05309525|Tranexamic Acid|tranexamic acid|mesh-list
102058336|NCT05309525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102058337|NCT05309525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101778054|NCT00812760|Levodopa|levodopa|mesh-list
102058338|NCT05309525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614677|NCT00912574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101614678|NCT00695032|Ifosfamide|ifosfamide|mesh-list
101614679|NCT00695032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101614680|NCT00695032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101614681|NCT00695032|Alkylating Agents|alkylating agents|mesh-ancestor
101614682|NCT00695032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614683|NCT04137328|Liraglutide|liraglutide|mesh-list
101614684|NCT04137328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101614685|NCT04137328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614686|NCT04137328|Incretins|incretins|mesh-ancestor
101614687|NCT04137328|Hormones|hormones|mesh-ancestor
101614688|NCT04137328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101614689|NCT00693004|Donepezil|donepezil|mesh-list
101614690|NCT00693004|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101614691|NCT00693004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614692|NCT00693004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614693|NCT00693004|Cholinergic Agents|cholinergic agents|mesh-ancestor
101614694|NCT00693004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101614695|NCT00693004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614696|NCT00693004|Nootropic Agents|nootropic agents|mesh-ancestor
101614697|NCT00695344|Mycophenolic Acid|mycophenolic acid|mesh-list
101614698|NCT00695344|Everolimus|everolimus|mesh-list
101614699|NCT00695344|Azathioprine|azathioprine|mesh-list
101614700|NCT00695344|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101614701|NCT00695344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101614702|NCT00695344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614703|NCT00695344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614704|NCT00695344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101614705|NCT00695344|Immunologic Factors|immunologic factors|mesh-ancestor
101614706|NCT00695344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614707|NCT00695344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101614708|NCT00695344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101614709|NCT00695344|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101614710|NCT00695344|Antitubercular Agents|antitubercular agents|mesh-ancestor
101614711|NCT00695344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101614712|NCT00695344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101614713|NCT00695344|Antimetabolites|antimetabolites|mesh-ancestor
101614714|NCT00695344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101614715|NCT00695344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101614716|NCT02624362|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
101614717|NCT02624362|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101614718|NCT02624362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101614719|NCT02624362|Disinfectants|disinfectants|mesh-ancestor
101614720|NCT00607542|Baclofen|baclofen|mesh-list
101614721|NCT00607542|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101614722|NCT00607542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614723|NCT00607542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101614724|NCT00607542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101614725|NCT00607542|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101614726|NCT00607542|GABA Agonists|gaba agonists|mesh-ancestor
101614727|NCT00607542|GABA Agents|gaba agents|mesh-ancestor
101614728|NCT00607542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101614729|NCT00607542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614730|NCT00936858|Everolimus|everolimus|mesh-list
101614731|NCT00936858|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101614757|NCT04136080|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
101614758|NCT00693862|Levodopa|levodopa|mesh-list
101614759|NCT00693862|Carbidopa|carbidopa|mesh-list
101614760|NCT00693862|Entacapone|entacapone|mesh-list
101614761|NCT00693862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101614762|NCT00693862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101614763|NCT00693862|Dopamine Agents|dopamine agents|mesh-ancestor
101614764|NCT00693862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102058339|NCT05309525|Hemostatics|hemostatics|mesh-ancestor
102058340|NCT05309525|Coagulants|coagulants|mesh-ancestor
102058341|NCT04905563|Acetaminophen|acetaminophen|mesh-list
102058342|NCT04905563|Ibuprofen|ibuprofen|mesh-list
102058343|NCT04905563|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
102058344|NCT04905563|Hydrocodone|hydrocodone|mesh-list
102058345|NCT04905563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102058346|NCT04905563|Analgesics|analgesics|mesh-ancestor
101614765|NCT00693862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614766|NCT00693862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614767|NCT00693862|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101614768|NCT00693862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614769|NCT00693862|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101614770|NCT05377788|Lazertinib|lazertinib|mesh-list
101614771|NCT05377788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101614772|NCT05377788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614773|NCT05377788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614774|NCT00674050|Fluticasone|fluticasone|mesh-list
101614775|NCT00674050|Albuterol|albuterol|mesh-list
101614776|NCT00674050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614777|NCT00674050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101544036|NCT01602861|Diuretics|diuretics|mesh-ancestor
101614783|NCT00674050|Dermatologic Agents|dermatologic agents|mesh-ancestor
101271807|NCT01834820|Mydriatics|mydriatics|mesh-ancestor
101614784|NCT00674050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101614785|NCT00674050|Tocolytic Agents|tocolytic agents|mesh-ancestor
101614786|NCT00674050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101614787|NCT00674050|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101614788|NCT00674050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101614789|NCT00674050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101614790|NCT00674050|Adrenergic Agents|adrenergic agents|mesh-ancestor
101614791|NCT00674050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101775283|NCT00935961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614792|NCT00674050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614794|NCT00872170|Vasodilator Agents|vasodilator agents|mesh-ancestor
101614795|NCT00872170|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101614796|NCT00872170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101614797|NCT00872170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614798|NCT00872170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614799|NCT00872170|Urological Agents|urological agents|mesh-ancestor
101614800|NCT00936702|Paclitaxel|paclitaxel|mesh-list
101614801|NCT00936702|Carboplatin|carboplatin|mesh-list
101614802|NCT00936702|Everolimus|everolimus|mesh-list
101614803|NCT00936702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101614804|NCT00936702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101614805|NCT00936702|Tubulin Modulators|tubulin modulators|mesh-ancestor
101614806|NCT00936702|Antimitotic Agents|antimitotic agents|mesh-ancestor
101614807|NCT00936702|Mitosis Modulators|mitosis modulators|mesh-ancestor
101614808|NCT00936702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614809|NCT00936702|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101614810|NCT00936702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101614811|NCT00936702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614812|NCT00936702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101614813|NCT00936702|Immunologic Factors|immunologic factors|mesh-ancestor
101614814|NCT00936702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614815|NCT00694174|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101614816|NCT00607932|Indole-3-carbinol|indole-3-carbinol|mesh-list
101614817|NCT00607932|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101614818|NCT00607932|Protective Agents|protective agents|mesh-ancestor
101614819|NCT00607932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614820|NCT00607932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101614821|NCT00674596|Ramipril|ramipril|mesh-list
101614822|NCT00674596|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101614823|NCT00674596|Protease Inhibitors|protease inhibitors|mesh-ancestor
101614824|NCT00674596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614825|NCT00674596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614826|NCT00674596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101614827|NCT00674674|Topotecan|topotecan|mesh-list
102058347|NCT04905563|Sensory System Agents|sensory system agents|mesh-ancestor
102058348|NCT04905563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102058349|NCT04905563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058350|NCT04905563|Antipyretics|antipyretics|mesh-ancestor
102058351|NCT04905563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102058352|NCT04905563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102058353|NCT04905563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101614828|NCT00674674|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101614829|NCT00674674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101614830|NCT00674674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614831|NCT00674674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614832|NCT00674674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101614833|NCT02628886|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101614834|NCT02628886|Immunologic Factors|immunologic factors|mesh-ancestor
101614835|NCT02628886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614836|NCT04265508|Hemostatics|hemostatics|mesh-list
101614837|NCT04265508|Coagulants|coagulants|mesh-ancestor
101614838|NCT02623738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101614839|NCT02623738|Latanoprost|latanoprost|mesh-list
101614840|NCT02623738|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101614841|NCT00607074|Albendazole|albendazole|mesh-list
101614842|NCT00607074|Anthelmintics|anthelmintics|mesh-list
101614843|NCT00607074|Secnidazole|secnidazole|mesh-list
101614844|NCT00607074|Metronidazole|metronidazole|mesh-list
101614845|NCT00607074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101614846|NCT00607074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101614847|NCT00607074|Anticestodal Agents|anticestodal agents|mesh-ancestor
101614856|NCT02623582|Cyclophosphamide|cyclophosphamide|mesh-list
101614857|NCT02623582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101614858|NCT02623582|Immunologic Factors|immunologic factors|mesh-ancestor
101614859|NCT02623582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614860|NCT02623582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101614861|NCT02623582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101614862|NCT02623582|Alkylating Agents|alkylating agents|mesh-ancestor
101614863|NCT02623582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614864|NCT02623582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101614865|NCT02623582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101775284|NCT01055431|Iron|iron|mesh-list
101614866|NCT00696202|Levonorgestrel|levonorgestrel|mesh-list
101614867|NCT00696202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101614868|NCT00696202|Contraceptive Agents|contraceptive agents|mesh-ancestor
101614869|NCT00696202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101614870|NCT00696202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614871|NCT00696202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101614872|NCT00696202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101614873|NCT00696202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101614874|NCT00674752|Gabapentin|gabapentin|mesh-list
101614875|NCT00674752|Analgesics|analgesics|mesh-ancestor
101614876|NCT00674752|Sensory System Agents|sensory system agents|mesh-ancestor
101614877|NCT00674752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101614878|NCT00674752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614879|NCT00674752|Anticonvulsants|anticonvulsants|mesh-ancestor
101614880|NCT00674752|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101614881|NCT00674752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101614882|NCT00674752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101614883|NCT00674752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101614884|NCT00674752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101614885|NCT00674752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101614886|NCT00674752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101614887|NCT00674752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614888|NCT00674752|Antimanic Agents|antimanic agents|mesh-ancestor
101614889|NCT04265274|Copper|copper|mesh-list
101614890|NCT04265274|Disulfiram|disulfiram|mesh-list
101614891|NCT04265274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614892|NCT04265274|Trace Elements|trace elements|mesh-ancestor
101614893|NCT04265274|Micronutrients|micronutrients|mesh-ancestor
101614894|NCT04265274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614895|NCT04265274|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
102058354|NCT04905563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102058355|NCT04905563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102058356|NCT04905563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058357|NCT04905563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102058358|NCT04905563|Narcotics|narcotics|mesh-ancestor
102058359|NCT04905563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102058360|NCT04905563|Antitussive Agents|antitussive agents|mesh-ancestor
102058361|NCT04905563|Respiratory System Agents|respiratory system agents|mesh-ancestor
102058362|NCT02810418|Paclitaxel|paclitaxel|mesh-list
102058363|NCT02810418|LMB-100|lmb-100|mesh-list
101614896|NCT04265274|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
101614897|NCT04265274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614898|NCT00607152|Allopurinol|allopurinol|mesh-list
101614899|NCT00607152|Rasburicase|rasburicase|mesh-list
101614900|NCT00607152|Antimetabolites|antimetabolites|mesh-ancestor
101614901|NCT00607152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614902|NCT00607152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614903|NCT00607152|Gout Suppressants|gout suppressants|mesh-ancestor
101614904|NCT00607152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101614905|NCT00607152|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101614906|NCT00607152|Antioxidants|antioxidants|mesh-ancestor
101614907|NCT00607152|Protective Agents|protective agents|mesh-ancestor
101614908|NCT00607152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614909|NCT00696748|Methyltestosterone|methyltestosterone|mesh-list
101614910|NCT00696748|Testosterone|testosterone|mesh-list
101614911|NCT00696748|Testosterone undecanoate|testosterone undecanoate|mesh-list
101614912|NCT00696748|Testosterone enanthate|testosterone enanthate|mesh-list
101614913|NCT00696748|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101614920|NCT00696748|Anabolic Agents|anabolic agents|mesh-ancestor
101614922|NCT02621554|Antioxidants|antioxidants|mesh-ancestor
101614923|NCT02621554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614924|NCT02621554|Protective Agents|protective agents|mesh-ancestor
101614925|NCT02621554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614926|NCT02621554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614927|NCT02621554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101614928|NCT02623036|Enalapril|enalapril|mesh-list
101614929|NCT02623036|Lisinopril|lisinopril|mesh-list
101614930|NCT02623036|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101614931|NCT02623036|Protease Inhibitors|protease inhibitors|mesh-ancestor
101614932|NCT02623036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614933|NCT02623036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614934|NCT02623036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101614935|NCT02623036|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101614936|NCT02623036|Protective Agents|protective agents|mesh-ancestor
101614937|NCT02623036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614938|NCT00696826|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101614939|NCT00696826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101614940|NCT00696826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614942|NCT00696826|Hormones|hormones|mesh-ancestor
101614943|NCT00696826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101614944|NCT00696826|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101614945|NCT00696826|Protease Inhibitors|protease inhibitors|mesh-ancestor
101614946|NCT00696826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614947|NCT00696826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614948|NCT01092182|Prednisone|prednisone|mesh-list
101614949|NCT01092182|Cyclophosphamide|cyclophosphamide|mesh-list
101614950|NCT01092182|Rituximab|rituximab|mesh-list
101614951|NCT01092182|Doxorubicin|doxorubicin|mesh-list
101614952|NCT01092182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101614953|NCT01092182|Etoposide|etoposide|mesh-list
101614954|NCT01092182|Etoposide phosphate|etoposide phosphate|mesh-list
101614955|NCT01092182|Vincristine|vincristine|mesh-list
101614956|NCT01092182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101614957|NCT01092182|Immunologic Factors|immunologic factors|mesh-ancestor
101614958|NCT01092182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614959|NCT01092182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102058364|NCT02810418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102058365|NCT02810418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058366|NCT02810418|Tubulin Modulators|tubulin modulators|mesh-ancestor
102058367|NCT02810418|Antimitotic Agents|antimitotic agents|mesh-ancestor
101614960|NCT01092182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101614961|NCT01092182|Alkylating Agents|alkylating agents|mesh-ancestor
101614962|NCT01092182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614963|NCT01092182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101614964|NCT01092182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101614965|NCT01092182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101614966|NCT01092182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101614967|NCT01092182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101614968|NCT01092182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101614969|NCT01092182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614970|NCT01092182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101614971|NCT01092182|Glucocorticoids|glucocorticoids|mesh-ancestor
101614972|NCT01092182|Hormones|hormones|mesh-ancestor
101614973|NCT01092182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101614974|NCT01092182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101614975|NCT01092182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101614976|NCT01092182|Tubulin Modulators|tubulin modulators|mesh-ancestor
101614977|NCT01092182|Antimitotic Agents|antimitotic agents|mesh-ancestor
101614978|NCT01092182|Mitosis Modulators|mitosis modulators|mesh-ancestor
101614979|NCT04135378|Ascorbic Acid|ascorbic acid|mesh-list
101614980|NCT04135378|Vitamins|vitamins|mesh-ancestor
101614981|NCT04135378|Micronutrients|micronutrients|mesh-ancestor
101614982|NCT04135378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614990|NCT02878772|Analgesics|analgesics|mesh-ancestor
101614991|NCT02878772|Sensory System Agents|sensory system agents|mesh-ancestor
101614992|NCT02878772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101614993|NCT02878772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614994|NCT02878772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101614995|NCT02878772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101614996|NCT02878772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101614997|NCT02878772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101614998|NCT02878772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614999|NCT02878772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101615000|NCT02878772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101615001|NCT02878772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101615002|NCT02878772|Antipyretics|antipyretics|mesh-ancestor
101615003|NCT02878772|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101615004|NCT02878772|Vasodilator Agents|vasodilator agents|mesh-ancestor
101615005|NCT02878772|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101615006|NCT02878772|Protective Agents|protective agents|mesh-ancestor
101615007|NCT02878772|Nootropic Agents|nootropic agents|mesh-ancestor
101615008|NCT02623114|Methylphenidate|methylphenidate|mesh-list
101272023|NCT01840813|Oxytocics|oxytocics|mesh-ancestor
101615009|NCT02623114|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101615010|NCT02623114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101615011|NCT02623114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615012|NCT02623114|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101615013|NCT02623114|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101615014|NCT02623114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101615015|NCT02623114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615017|NCT02623114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101615018|NCT02623114|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101615019|NCT02623114|Adrenergic Agents|adrenergic agents|mesh-ancestor
101615020|NCT00932646|Olodaterol|olodaterol|mesh-list
101615021|NCT00932646|Formoterol Fumarate|formoterol fumarate|mesh-list
101615022|NCT00932646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101615023|NCT00932646|Autonomic Agents|autonomic agents|mesh-ancestor
101615024|NCT00932646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101615025|NCT00932646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615026|NCT00932646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101615027|NCT00932646|Respiratory System Agents|respiratory system agents|mesh-ancestor
101615028|NCT00932646|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101615029|NCT00932646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101615030|NCT00932646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101615031|NCT00932646|Adrenergic Agents|adrenergic agents|mesh-ancestor
102058368|NCT02810418|Mitosis Modulators|mitosis modulators|mesh-ancestor
102058369|NCT02810418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058370|NCT02810418|Immunoconjugates|immunoconjugates|mesh-ancestor
102058371|NCT02810418|Immunologic Factors|immunologic factors|mesh-ancestor
102058372|NCT02810418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058373|NCT02959541|Leucovorin|leucovorin|mesh-list
101615032|NCT00932646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101615033|NCT00932646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615034|NCT00871234|Etravirine|etravirine|mesh-list
101615035|NCT00871234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101615036|NCT00871234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101615037|NCT00871234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101615038|NCT00871234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615039|NCT00871234|Antiviral Agents|antiviral agents|mesh-ancestor
101615040|NCT00871234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101615041|NCT04267224|Ticagrelor|ticagrelor|mesh-list
101615042|NCT04267224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101615043|NCT04267224|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101615044|NCT04267224|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101615045|NCT04267224|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101615046|NCT04267224|Purinergic Agents|purinergic agents|mesh-ancestor
101615047|NCT04267224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101615048|NCT04267224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615052|NCT00675220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615053|NCT04264260|Colchicine|colchicine|mesh-list
101615054|NCT04264260|Gout Suppressants|gout suppressants|mesh-ancestor
101615055|NCT04264260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101615056|NCT04264260|Tubulin Modulators|tubulin modulators|mesh-ancestor
101615057|NCT04264260|Antimitotic Agents|antimitotic agents|mesh-ancestor
101615058|NCT04264260|Mitosis Modulators|mitosis modulators|mesh-ancestor
101615059|NCT04264260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615060|NCT04264260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101615061|NCT04267146|Nivolumab|nivolumab|mesh-list
101615062|NCT04267146|Temozolomide|temozolomide|mesh-list
101615063|NCT04267146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101615064|NCT04267146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101615065|NCT04267146|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101615066|NCT04267146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615067|NCT04267146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101615068|NCT04267146|Alkylating Agents|alkylating agents|mesh-ancestor
101615069|NCT02691078|Octreotide|octreotide|mesh-list
101615070|NCT02691078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101615071|NCT02691078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101615072|NCT02691078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101615073|NCT02621320|Vitamin D|vitamin d|mesh-list
101615074|NCT02621320|Vitamins|vitamins|mesh-ancestor
101615075|NCT02621320|Micronutrients|micronutrients|mesh-ancestor
101615076|NCT02621320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615077|NCT02621320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101615078|NCT01097330|Amiodarone|amiodarone|mesh-list
101615079|NCT01097330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101615080|NCT01097330|Vasodilator Agents|vasodilator agents|mesh-ancestor
101615081|NCT01097330|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101615082|NCT01097330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101615083|NCT01097330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615084|NCT01097330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101615085|NCT01097330|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101615086|NCT01097330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101615088|NCT01097330|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101615089|NCT01097330|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101615090|NCT01097330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101615091|NCT00934440|Bevacizumab|bevacizumab|mesh-list
101615092|NCT00934440|Azacitidine|azacitidine|mesh-list
101615093|NCT00934440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101615094|NCT00934440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101615095|NCT00934440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102058374|NCT02959541|Levoleucovorin|levoleucovorin|mesh-list
102058375|NCT02959541|Antidotes|antidotes|mesh-ancestor
102058376|NCT02959541|Protective Agents|protective agents|mesh-ancestor
102058377|NCT02959541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058378|NCT02959541|Vitamin B Complex|vitamin b complex|mesh-ancestor
102058379|NCT02959541|Vitamins|vitamins|mesh-ancestor
102058380|NCT02959541|Micronutrients|micronutrients|mesh-ancestor
102058381|NCT05705700|Dutasteride|dutasteride|mesh-list
102058382|NCT05705700|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101615096|NCT00934440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101615097|NCT00934440|Growth Substances|growth substances|mesh-ancestor
101615098|NCT00934440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615099|NCT00934440|Growth Inhibitors|growth inhibitors|mesh-ancestor
101615100|NCT00934440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101615101|NCT00934440|Antimetabolites|antimetabolites|mesh-ancestor
101615102|NCT00934440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615103|NCT00934440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101615104|NCT02622802|Acetaminophen|acetaminophen|mesh-list
101615105|NCT02622802|Azithromycin|azithromycin|mesh-list
101615106|NCT02622802|Erythromycin|erythromycin|mesh-list
101615107|NCT02622802|Erythromycin Estolate|erythromycin estolate|mesh-list
101615108|NCT02622802|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101615109|NCT02622802|Erythromycin stearate|erythromycin stearate|mesh-list
101615110|NCT02622802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101615111|NCT02622802|Analgesics|analgesics|mesh-ancestor
101615112|NCT02622802|Sensory System Agents|sensory system agents|mesh-ancestor
101615113|NCT02622802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101615114|NCT02622802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615115|NCT02622802|Antipyretics|antipyretics|mesh-ancestor
101615116|NCT02622802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101615117|NCT02622802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101615118|NCT02622802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101615119|NCT02622802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101615120|NCT02622802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101544353|NCT01604928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101615125|NCT05158374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615126|NCT05158374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101615127|NCT05158374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101615128|NCT05158374|Analgesics|analgesics|mesh-ancestor
101615129|NCT05158374|Sensory System Agents|sensory system agents|mesh-ancestor
101615130|NCT05158374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101615131|NCT05158374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101615132|NCT05158374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101615133|NCT05158374|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101615134|NCT05158374|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101615135|NCT05158374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615136|NCT05158374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101615137|NCT05158374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101615138|NCT05158374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101615139|NCT05158374|Antipyretics|antipyretics|mesh-ancestor
101615140|NCT00934362|Pulmonary Surfactants|pulmonary surfactants|mesh-list
101615141|NCT00934362|Respiratory System Agents|respiratory system agents|mesh-ancestor
101615142|NCT00675688|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101615143|NCT00675688|Bazedoxifene|bazedoxifene|mesh-list
101615145|NCT00675688|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101615146|NCT00675688|Hormones|hormones|mesh-ancestor
101615147|NCT00675688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101615148|NCT00675688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615149|NCT00675688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101615150|NCT00675688|Hormone Antagonists|hormone antagonists|mesh-ancestor
101615151|NCT00675688|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101615152|NCT00675688|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101615153|NCT00675688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101615154|NCT02622334|Latanoprost|latanoprost|mesh-list
101615155|NCT02622334|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101615156|NCT02622334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101615157|NCT00696514|Vitamin D|vitamin d|mesh-list
101615158|NCT00696514|Ergocalciferols|ergocalciferols|mesh-list
102058383|NCT05705700|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102058384|NCT05705700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102058385|NCT05705700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058386|NCT05705700|Hormone Antagonists|hormone antagonists|mesh-ancestor
102058387|NCT05705700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102058388|NCT05705700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058389|NCT02498951|Obinutuzumab|obinutuzumab|mesh-list
102058390|NCT02498951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102058391|NCT02498951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058392|NCT02260050|Epinastine|epinastine|mesh-list
102058393|NCT02260050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102058394|NCT02260050|Histamine Antagonists|histamine antagonists|mesh-ancestor
101615159|NCT00696514|Cholecalciferol|cholecalciferol|mesh-list
101615160|NCT00696514|Vitamins|vitamins|mesh-list
101615161|NCT00696514|Folic Acid|folic acid|mesh-list
101615162|NCT00696514|Vitamin B 12|vitamin b 12|mesh-list
101615163|NCT00696514|Micronutrients|micronutrients|mesh-ancestor
101615164|NCT00696514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615165|NCT00696514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101779435|NCT00303667|Dermatologic Agents|dermatologic agents|mesh-ancestor
101615166|NCT00696514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101615167|NCT00696514|Hematinics|hematinics|mesh-ancestor
101615168|NCT00696514|Vitamin B Complex|vitamin b complex|mesh-ancestor
101615169|NCT04263870|Capecitabine|capecitabine|mesh-list
101615170|NCT04263870|Oxaliplatin|oxaliplatin|mesh-list
101615171|NCT04263870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101615172|NCT04263870|Antimetabolites|antimetabolites|mesh-ancestor
101615173|NCT04263870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615174|NCT04263870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101615175|NCT05317182|Salicylic Acid|salicylic acid|mesh-list
101615176|NCT05317182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101615177|NCT05317182|Antifungal Agents|antifungal agents|mesh-ancestor
101615178|NCT05317182|Keratolytic Agents|keratolytic agents|mesh-ancestor
101615179|NCT05317182|Dermatologic Agents|dermatologic agents|mesh-ancestor
101615180|NCT00871000|Pentetic Acid|pentetic acid|mesh-list
101615181|NCT00871000|Antidotes|antidotes|mesh-ancestor
101615182|NCT00871000|Protective Agents|protective agents|mesh-ancestor
101615183|NCT00871000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615184|NCT00871000|Chelating Agents|chelating agents|mesh-ancestor
101615185|NCT00871000|Sequestering Agents|sequestering agents|mesh-ancestor
101615186|NCT00871000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615187|NCT00871000|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101615188|NCT01096784|Mecasermin|mecasermin|mesh-list
101615189|NCT01096784|Growth Substances|growth substances|mesh-ancestor
101615190|NCT01096784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615191|NCT00696592|Bevacizumab|bevacizumab|mesh-list
101615192|NCT00696592|Verteporfin|verteporfin|mesh-list
101544424|NCT01648127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101615195|NCT00696592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101615196|NCT00696592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101615197|NCT00696592|Growth Substances|growth substances|mesh-ancestor
101615198|NCT00696592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615199|NCT00696592|Growth Inhibitors|growth inhibitors|mesh-ancestor
101615200|NCT00696592|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101615201|NCT00696592|Dermatologic Agents|dermatologic agents|mesh-ancestor
101615202|NCT02622022|Morphine|morphine|mesh-list
101615203|NCT02622022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101615204|NCT02622022|Narcotics|narcotics|mesh-ancestor
101615205|NCT02622022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101615206|NCT02622022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615207|NCT02622022|Analgesics|analgesics|mesh-ancestor
101615208|NCT02622022|Sensory System Agents|sensory system agents|mesh-ancestor
101615209|NCT02622022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101615210|NCT00934050|Inositol|inositol|mesh-list
101615211|NCT00934050|Vitamin B Complex|vitamin b complex|mesh-ancestor
102058395|NCT02260050|Histamine Agents|histamine agents|mesh-ancestor
102058396|NCT02260050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102058397|NCT02260050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058398|NCT02260050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058399|NCT02036736|Propofol|propofol|mesh-list
102058400|NCT02036736|Anesthetics|anesthetics|mesh-list
102058401|NCT02036736|Desflurane|desflurane|mesh-list
102058402|NCT02036736|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102058403|NCT02036736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101360021|NCT00212212|Micronutrients|micronutrients|mesh-ancestor
101615212|NCT00934050|Vitamins|vitamins|mesh-ancestor
101615213|NCT00934050|Micronutrients|micronutrients|mesh-ancestor
101615214|NCT00934050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615215|NCT02620618|Infliximab|infliximab|mesh-list
101615216|NCT02620618|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101615217|NCT02620618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101615218|NCT02620618|Dermatologic Agents|dermatologic agents|mesh-ancestor
101615219|NCT02620618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101615220|NCT02620618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101615221|NCT04135456|Mannitol|mannitol|mesh-list
101615222|NCT04135456|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101615223|NCT04135456|Diuretics|diuretics|mesh-ancestor
101615224|NCT04135456|Natriuretic Agents|natriuretic agents|mesh-ancestor
101615225|NCT04135456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615226|NCT01091168|Alkylating Agents|alkylating agents|mesh-list
101615227|NCT01091168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615228|NCT05321576|Analgesics, Opioid|analgesics, opioid|mesh-list
101615229|NCT05321576|Narcotics|narcotics|mesh-ancestor
101615230|NCT05321576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101615231|NCT05321576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615232|NCT05321576|Analgesics|analgesics|mesh-ancestor
101615233|NCT05321576|Sensory System Agents|sensory system agents|mesh-ancestor
101615234|NCT05321576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101615235|NCT00864916|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101615236|NCT00864916|Pentoxifylline|pentoxifylline|mesh-list
101615237|NCT00864916|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101615238|NCT00864916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101615239|NCT00864916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615240|NCT00864916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101615241|NCT00864916|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101615242|NCT00864916|Protective Agents|protective agents|mesh-ancestor
101615243|NCT00864916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615244|NCT00864916|Vasodilator Agents|vasodilator agents|mesh-ancestor
101615245|NCT00864916|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101615246|NCT00864916|Antioxidants|antioxidants|mesh-ancestor
101615247|NCT00864916|Antiviral Agents|antiviral agents|mesh-ancestor
101615248|NCT00864916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101615249|NCT00864682|Lidocaine|lidocaine|mesh-list
101615250|NCT00864682|Propofol|propofol|mesh-list
101615251|NCT00864682|Anesthetics, Local|anesthetics, local|mesh-ancestor
101615252|NCT00864682|Anesthetics|anesthetics|mesh-ancestor
101615253|NCT00864682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101615254|NCT00864682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615255|NCT00864682|Sensory System Agents|sensory system agents|mesh-ancestor
101615256|NCT00864682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101615257|NCT00864682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101615258|NCT00864682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101615259|NCT00864682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101615260|NCT00864682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101615261|NCT00864682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615262|NCT00864682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101615263|NCT00864682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101615264|NCT00864682|Anesthetics, General|anesthetics, general|mesh-ancestor
101615265|NCT00931944|Pramipexole|pramipexole|mesh-list
101615266|NCT00931944|Antioxidants|antioxidants|mesh-ancestor
101615272|NCT00931944|Dopamine Agonists|dopamine agonists|mesh-ancestor
102058404|NCT02036736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058406|NCT02036736|Anesthetics, General|anesthetics, general|mesh-ancestor
102058407|NCT02036736|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102058408|NCT05693688|Atosiban|atosiban|mesh-list
102058409|NCT05693688|Hormone Antagonists|hormone antagonists|mesh-ancestor
102058410|NCT05693688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102058411|NCT05693688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615273|NCT00931944|Dopamine Agents|dopamine agents|mesh-ancestor
101615274|NCT00931944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101615275|NCT02614456|Interferons|interferons|mesh-list
101615276|NCT02614456|Interferon-gamma|interferon-gamma|mesh-list
101615277|NCT02614456|Nivolumab|nivolumab|mesh-list
101615278|NCT02614456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101615279|NCT02614456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101615280|NCT02614456|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101615281|NCT02614456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615282|NCT02614456|Antiviral Agents|antiviral agents|mesh-ancestor
101615283|NCT02614456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101615284|NCT04130230|Choline|choline|mesh-list
101615285|NCT04130230|Neostigmine|neostigmine|mesh-list
101615286|NCT04130230|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101615287|NCT04130230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101615288|NCT04130230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615289|NCT04130230|Cholinergic Agents|cholinergic agents|mesh-ancestor
101615290|NCT04130230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101615291|NCT04130230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615292|NCT04130230|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101615293|NCT04130230|Autonomic Agents|autonomic agents|mesh-ancestor
101779451|NCT00761189|Serotonin Agents|serotonin agents|mesh-ancestor
101615294|NCT04130230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101615295|NCT04130230|Lipotropic Agents|lipotropic agents|mesh-ancestor
101615296|NCT04130230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101615297|NCT04130230|Antimetabolites|antimetabolites|mesh-ancestor
101615298|NCT04130230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101615299|NCT04130230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101615300|NCT04130230|Nootropic Agents|nootropic agents|mesh-ancestor
101615301|NCT05148702|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101615302|NCT05148702|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101615303|NCT05148702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101615304|NCT05148702|Antitubercular Agents|antitubercular agents|mesh-ancestor
101615305|NCT02616874|Romidepsin|romidepsin|mesh-list
101615306|NCT02616874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101615307|NCT02616874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101615308|NCT02616874|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101615309|NCT02616874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101615310|NCT02616874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615312|NCT04133428|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101615314|NCT04133428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101615315|NCT04133428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101615316|NCT04133428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615317|NCT00869050|Capecitabine|capecitabine|mesh-list
101615318|NCT00869050|Temozolomide|temozolomide|mesh-list
101615319|NCT00869050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101615320|NCT00869050|Antimetabolites|antimetabolites|mesh-ancestor
101615321|NCT00869050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615322|NCT00869050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101615323|NCT00869050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101615324|NCT00869050|Alkylating Agents|alkylating agents|mesh-ancestor
101615325|NCT04133506|Aspirin|aspirin|mesh-list
101615326|NCT04133506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101615327|NCT04133506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101615328|NCT04133506|Analgesics|analgesics|mesh-ancestor
101615329|NCT04133506|Sensory System Agents|sensory system agents|mesh-ancestor
101615330|NCT04133506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101615331|NCT04133506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058412|NCT05693688|Tocolytic Agents|tocolytic agents|mesh-ancestor
102058413|NCT05693688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102058414|NCT02047422|Metolazone|metolazone|mesh-list
102058415|NCT02047422|Furosemide|furosemide|mesh-list
102058416|NCT02047422|Spironolactone|spironolactone|mesh-list
101615332|NCT04133506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101615333|NCT04133506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101615334|NCT04133506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101615335|NCT04133506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101544566|NCT01648829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101615338|NCT04133506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101615339|NCT04133506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101615340|NCT04133506|Antipyretics|antipyretics|mesh-ancestor
101615341|NCT04872218|Abatacept|abatacept|mesh-list
101615342|NCT04872218|Immunologic Factors|immunologic factors|mesh-ancestor
101615343|NCT04872218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615344|NCT04872218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101615345|NCT04872218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615346|NCT04872218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101615347|NCT04872218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101615348|NCT04872218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101615349|NCT04872218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101615350|NCT04133194|Mesalamine|mesalamine|mesh-list
101615351|NCT04133194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101615352|NCT04133194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101615353|NCT04133194|Analgesics|analgesics|mesh-ancestor
101615354|NCT04133194|Sensory System Agents|sensory system agents|mesh-ancestor
101615355|NCT04133194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101615356|NCT04133194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615357|NCT04133194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101615358|NCT04133194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101615359|NCT00698464|Pasireotide|pasireotide|mesh-list
101615360|NCT00698464|Hormones|hormones|mesh-ancestor
101615361|NCT00698464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101615362|NCT00698464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615363|NCT04933682|Rifampin|rifampin|mesh-list
101615364|NCT04933682|Fluconazole|fluconazole|mesh-list
101615365|NCT04933682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101615366|NCT04933682|Antitubercular Agents|antitubercular agents|mesh-ancestor
101615367|NCT04933682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101615368|NCT04933682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101615369|NCT04933682|Leprostatic Agents|leprostatic agents|mesh-ancestor
101615370|NCT04933682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101615371|NCT04933682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101615372|NCT04933682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615373|NCT04933682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101615374|NCT04933682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101615375|NCT04933682|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101615376|NCT04933682|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101615377|NCT04933682|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101615378|NCT04933682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101615379|NCT04933682|Antifungal Agents|antifungal agents|mesh-ancestor
101615380|NCT04933682|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101775285|NCT01055431|Trace Elements|trace elements|mesh-ancestor
101615381|NCT04933682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101615382|NCT04933682|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101615383|NCT04933682|Hormone Antagonists|hormone antagonists|mesh-ancestor
101615384|NCT04933682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101615385|NCT04933682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615386|NCT04933682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101615387|NCT04933682|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101615388|NCT00927186|Zoledronic Acid|zoledronic acid|mesh-list
101615389|NCT00927186|Teriparatide|teriparatide|mesh-list
101615390|NCT00927186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101615391|NCT00927186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615392|NCT00927186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101615393|NCT00593554|Fludarabine|fludarabine|mesh-list
101615394|NCT00593554|Thiotepa|thiotepa|mesh-list
101615395|NCT00593554|Thymoglobulin|thymoglobulin|mesh-list
101615396|NCT00593554|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102058417|NCT02047422|Diuretics|diuretics|mesh-ancestor
102058418|NCT02047422|Natriuretic Agents|natriuretic agents|mesh-ancestor
102058419|NCT02047422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058420|NCT02047422|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102058421|NCT02047422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102058422|NCT02047422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360040|NCT00411736|Azithromycin|azithromycin|mesh-list
101360041|NCT00411736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101615397|NCT00593554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101615398|NCT00593554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615399|NCT00593554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101615400|NCT00593554|Immunologic Factors|immunologic factors|mesh-ancestor
101615401|NCT00593554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615402|NCT00593554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101615403|NCT00593554|Alkylating Agents|alkylating agents|mesh-ancestor
101615409|NCT01101308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615410|NCT01101308|Analgesics|analgesics|mesh-ancestor
101615411|NCT01101308|Sensory System Agents|sensory system agents|mesh-ancestor
101615412|NCT01101308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101615413|NCT00626054|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101615414|NCT00926796|Azithromycin|azithromycin|mesh-list
101615415|NCT00926796|Gentamicins|gentamicins|mesh-list
101615416|NCT00926796|Gemifloxacin|gemifloxacin|mesh-list
101615417|NCT00926796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101615418|NCT00926796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101615419|NCT00926796|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101615420|NCT00926796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101615421|NCT00926796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615422|NCT00926796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101615423|NCT00926796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101615424|NCT00926796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101615425|NCT00696982|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101615426|NCT00696982|Glyburide|glyburide|mesh-list
101615427|NCT00696982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101615428|NCT00696982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615429|NCT00696982|Incretins|incretins|mesh-ancestor
101615430|NCT00696982|Hormones|hormones|mesh-ancestor
101615431|NCT00696982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101615432|NCT00696982|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101615433|NCT00696982|Protease Inhibitors|protease inhibitors|mesh-ancestor
101615434|NCT00696982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101615435|NCT00696982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615436|NCT01087736|Topiramate|topiramate|mesh-list
101615437|NCT01087736|Anticonvulsants|anticonvulsants|mesh-ancestor
101615438|NCT01087736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101615439|NCT01087736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615440|NCT04262388|Durvalumab|durvalumab|mesh-list
101615441|NCT04262388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101615442|NCT04262388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101615443|NCT00608712|Esomeprazole|esomeprazole|mesh-list
101615444|NCT00608712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101615445|NCT00608712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101615446|NCT00608712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101615447|NCT00608712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101615448|NCT00608712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615449|NCT01079936|Lenalidomide|lenalidomide|mesh-list
101615450|NCT01079936|Melphalan|melphalan|mesh-list
101615451|NCT01079936|Immunologic Factors|immunologic factors|mesh-ancestor
101615452|NCT01079936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615453|NCT01079936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101615454|NCT01079936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101615455|NCT01079936|Growth Substances|growth substances|mesh-ancestor
101615456|NCT01079936|Growth Inhibitors|growth inhibitors|mesh-ancestor
101615457|NCT01079936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101615458|NCT01079936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102058423|NCT02047422|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102058424|NCT02047422|Hormone Antagonists|hormone antagonists|mesh-ancestor
102058425|NCT02047422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102058426|NCT02047422|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102058427|NCT02047422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102058428|NCT02047422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102058429|NCT02048358|Methylprednisolone|methylprednisolone|mesh-list
101615459|NCT01079936|Alkylating Agents|alkylating agents|mesh-ancestor
101615460|NCT01079936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615461|NCT01079936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101615462|NCT01079936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101615464|NCT00931710|Amlodipine|amlodipine|mesh-list
101615465|NCT00931710|Valsartan|valsartan|mesh-list
101615466|NCT00931710|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101615467|NCT00931710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101615468|NCT00931710|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101615469|NCT00931710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101615470|NCT00931710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615471|NCT00931710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101615472|NCT00931710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615473|NCT00931710|Vasodilator Agents|vasodilator agents|mesh-ancestor
101615474|NCT00931710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101615481|NCT01100528|Interferon-alpha|interferon-alpha|mesh-list
101615482|NCT01100528|Interferon alpha-2|interferon alpha-2|mesh-list
101615483|NCT01100528|Dacarbazine|dacarbazine|mesh-list
101615484|NCT01100528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101615485|NCT01100528|Antiviral Agents|antiviral agents|mesh-ancestor
101615486|NCT01100528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101615487|NCT01100528|Immunologic Factors|immunologic factors|mesh-ancestor
101615488|NCT01100528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615489|NCT01100528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101615490|NCT01100528|Alkylating Agents|alkylating agents|mesh-ancestor
101615491|NCT01100528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615492|NCT01079234|Insulin|insulin|mesh-list
101615493|NCT01079234|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101615494|NCT01079234|Insulin Glargine|insulin glargine|mesh-list
101615495|NCT01079234|Insulin Aspart|insulin aspart|mesh-list
101615496|NCT01079234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101615497|NCT01079234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615498|NCT00931632|Nitric Oxide|nitric oxide|mesh-list
101615499|NCT00931632|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101615500|NCT00931632|Autonomic Agents|autonomic agents|mesh-ancestor
101615501|NCT00931632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101615502|NCT00931632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615503|NCT00931632|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101615504|NCT00931632|Respiratory System Agents|respiratory system agents|mesh-ancestor
101615505|NCT00931632|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101615506|NCT00931632|Antioxidants|antioxidants|mesh-ancestor
101615507|NCT00931632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615508|NCT00931632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101615509|NCT00931632|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101615510|NCT00931632|Vasodilator Agents|vasodilator agents|mesh-ancestor
101615511|NCT00931632|Gasotransmitters|gasotransmitters|mesh-ancestor
101615512|NCT00931632|Protective Agents|protective agents|mesh-ancestor
101615513|NCT00608790|Albuterol|albuterol|mesh-list
101615514|NCT00608790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101615515|NCT00608790|Autonomic Agents|autonomic agents|mesh-ancestor
101615516|NCT00608790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101615517|NCT00608790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615518|NCT00608790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101615519|NCT00608790|Respiratory System Agents|respiratory system agents|mesh-ancestor
101615520|NCT00608790|Tocolytic Agents|tocolytic agents|mesh-ancestor
101615521|NCT00608790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101615522|NCT00608790|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101615523|NCT00608790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102058430|NCT02048358|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102058431|NCT02048358|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102058432|NCT02048358|Prednisolone|prednisolone|mesh-list
101615524|NCT00608790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101615525|NCT00608790|Adrenergic Agents|adrenergic agents|mesh-ancestor
101615526|NCT00608790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101615527|NCT00608790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615528|NCT01078922|Ofatumumab|ofatumumab|mesh-list
101615530|NCT00609570|Calcium|calcium|mesh-list
101615531|NCT00609570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101615532|NCT00609570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615533|NCT00863746|Sorafenib|sorafenib|mesh-list
101615534|NCT00863746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101615535|NCT00863746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101615536|NCT00863746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101615537|NCT00863746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615538|NCT04992156|Palbociclib|palbociclib|mesh-list
101615539|NCT04992156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101615540|NCT04992156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101615541|NCT04992156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101615542|NCT04992156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615543|NCT00608946|Copper|copper|mesh-list
101615544|NCT00608946|Trace Elements|trace elements|mesh-ancestor
101615545|NCT00608946|Micronutrients|micronutrients|mesh-ancestor
101615550|NCT02615938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101615551|NCT02615938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101615552|NCT02615938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101779478|NCT00302731|Hormones|hormones|mesh-list
101615553|NCT02615938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615554|NCT02615938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101615556|NCT00926328|Fluorides|fluorides|mesh-list
101615557|NCT00926328|Cariostatic Agents|cariostatic agents|mesh-ancestor
101615558|NCT00926328|Protective Agents|protective agents|mesh-ancestor
101615559|NCT00926328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615560|NCT00926328|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101615561|NCT00926328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101615562|NCT00926328|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101615563|NCT00926328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101615564|NCT00926328|Antimetabolites|antimetabolites|mesh-ancestor
101615565|NCT00926328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615566|NCT00926328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101615567|NCT04203732|Anesthetics|anesthetics|mesh-list
101615568|NCT04203732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101615569|NCT04203732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615570|NCT00863512|Gemcitabine|gemcitabine|mesh-list
101615571|NCT00863512|Docetaxel|docetaxel|mesh-list
101615572|NCT00863512|Pemetrexed|pemetrexed|mesh-list
101615573|NCT00863512|Vinorelbine|vinorelbine|mesh-list
101615574|NCT00863512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101615575|NCT00863512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101615576|NCT00863512|Antimetabolites|antimetabolites|mesh-ancestor
101615577|NCT00863512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615578|NCT00863512|Tubulin Modulators|tubulin modulators|mesh-ancestor
101615579|NCT00863512|Antimitotic Agents|antimitotic agents|mesh-ancestor
101615580|NCT00863512|Mitosis Modulators|mitosis modulators|mesh-ancestor
101615581|NCT00863512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101615582|NCT00863512|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101615583|NCT00863512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101615584|NCT00863512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101615585|NCT02619994|Levofloxacin|levofloxacin|mesh-list
101615586|NCT02619994|Linezolid|linezolid|mesh-list
101615587|NCT02619994|Pyrazinamide|pyrazinamide|mesh-list
101615588|NCT02619994|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101615589|NCT02619994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101615590|NCT02619994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101615591|NCT02619994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101615592|NCT02619994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101615593|NCT02619994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101615594|NCT02619994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615595|NCT02619994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101615596|NCT02619994|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101615597|NCT02619994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101615598|NCT02619994|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102058433|NCT02048358|Prednisolone acetate|prednisolone acetate|mesh-list
102058434|NCT02048358|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102058435|NCT02048358|Prednisolone phosphate|prednisolone phosphate|mesh-list
102058436|NCT02048358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102058437|NCT02048358|Antiemetics|antiemetics|mesh-ancestor
102058438|NCT02048358|Autonomic Agents|autonomic agents|mesh-ancestor
102058439|NCT02048358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102058440|NCT02048358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058441|NCT02048358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102058442|NCT02048358|Glucocorticoids|glucocorticoids|mesh-ancestor
102058443|NCT02048358|Hormones|hormones|mesh-ancestor
101615599|NCT02619994|Antitubercular Agents|antitubercular agents|mesh-ancestor
101615600|NCT04263402|Methylprednisolone|methylprednisolone|mesh-list
101615601|NCT04263402|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101615602|NCT04263402|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101615603|NCT04263402|Prednisolone|prednisolone|mesh-list
101615604|NCT04263402|Prednisolone acetate|prednisolone acetate|mesh-list
101615605|NCT04263402|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101615606|NCT04263402|Prednisolone phosphate|prednisolone phosphate|mesh-list
101615607|NCT04263402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101615608|NCT04263402|Antiemetics|antiemetics|mesh-ancestor
101615609|NCT04263402|Autonomic Agents|autonomic agents|mesh-ancestor
101615610|NCT04263402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101615611|NCT04263402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615612|NCT04263402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101615613|NCT04263402|Glucocorticoids|glucocorticoids|mesh-ancestor
101615615|NCT04263402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101615616|NCT04263402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101615617|NCT04263402|Protective Agents|protective agents|mesh-ancestor
101615622|NCT00868192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101615623|NCT00868192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101615624|NCT00868192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101615625|NCT00868192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101615626|NCT00868192|Growth Substances|growth substances|mesh-ancestor
101615627|NCT00868192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615628|NCT00868192|Growth Inhibitors|growth inhibitors|mesh-ancestor
101615629|NCT00868192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101615630|NCT00868192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615631|NCT00868192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101615632|NCT00868192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101615634|NCT02615782|Tamsulosin|tamsulosin|mesh-list
101615635|NCT02615782|Vasodilator Agents|vasodilator agents|mesh-ancestor
101615636|NCT02615782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101615637|NCT02615782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101615638|NCT02615782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101615639|NCT02615782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615640|NCT02615782|Urological Agents|urological agents|mesh-ancestor
101615641|NCT02615782|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101615642|NCT02615782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101615643|NCT02615782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101615644|NCT02615782|Adrenergic Agents|adrenergic agents|mesh-ancestor
101615645|NCT02615782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101615646|NCT02615782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615647|NCT00930930|Paclitaxel|paclitaxel|mesh-list
101615648|NCT00930930|Everolimus|everolimus|mesh-list
101615649|NCT00930930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101615650|NCT00930930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101615651|NCT00930930|Tubulin Modulators|tubulin modulators|mesh-ancestor
101615652|NCT00930930|Antimitotic Agents|antimitotic agents|mesh-ancestor
101615653|NCT00930930|Mitosis Modulators|mitosis modulators|mesh-ancestor
101615654|NCT00930930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615655|NCT00930930|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101615656|NCT00930930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101615657|NCT00930930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102058444|NCT02048358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102058445|NCT02048358|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102058446|NCT02048358|Protective Agents|protective agents|mesh-ancestor
102058447|NCT02048358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102058448|NCT02048358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058449|NCT02928029|Dexamethasone|dexamethasone|mesh-list
101615658|NCT00930930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101615659|NCT00930930|Immunologic Factors|immunologic factors|mesh-ancestor
101615660|NCT00930930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615661|NCT00698776|Lenalidomide|lenalidomide|mesh-list
101615662|NCT00698776|KRN 7000|krn 7000|mesh-list
101615663|NCT00698776|Immunologic Factors|immunologic factors|mesh-ancestor
101615664|NCT00698776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615665|NCT00698776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101615666|NCT00698776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101615667|NCT00698776|Growth Substances|growth substances|mesh-ancestor
101615668|NCT00698776|Growth Inhibitors|growth inhibitors|mesh-ancestor
101615669|NCT00698776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101615670|NCT00698776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101615671|NCT04122040|Roxithromycin|roxithromycin|mesh-list
101615672|NCT04122040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101615673|NCT04122040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101615674|NCT04258956|Avelumab|avelumab|mesh-list
101615675|NCT04258956|Axitinib|axitinib|mesh-list
101615676|NCT04258956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101615677|NCT04258956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101615678|NCT04258956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101615679|NCT04258956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101615680|NCT04258956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615681|NCT00862654|Ketoconazole|ketoconazole|mesh-list
101615682|NCT00862654|Clobetasol|clobetasol|mesh-list
101615683|NCT00862654|Antifungal Agents|antifungal agents|mesh-ancestor
101615684|NCT00862654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101615685|NCT00862654|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101615686|NCT00862654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101615687|NCT00862654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101615688|NCT00862654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615692|NCT00862654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615693|NCT00862654|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101615694|NCT00862654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101615695|NCT00862654|Glucocorticoids|glucocorticoids|mesh-ancestor
101615697|NCT00609180|Antioxidants|antioxidants|mesh-list
101615698|NCT00609180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615699|NCT00609180|Protective Agents|protective agents|mesh-ancestor
101615700|NCT00609180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615701|NCT00867490|Amlodipine|amlodipine|mesh-list
101615702|NCT00867490|Candesartan|candesartan|mesh-list
101615703|NCT00867490|Candesartan cilexetil|candesartan cilexetil|mesh-list
101615704|NCT00867490|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101615705|NCT00867490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101615706|NCT00867490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101615707|NCT00867490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101615708|NCT00867490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615709|NCT00867490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101615710|NCT00867490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615711|NCT00867490|Vasodilator Agents|vasodilator agents|mesh-ancestor
101615712|NCT00867490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101615713|NCT00867490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101615714|NCT00867490|Diuretics|diuretics|mesh-ancestor
101615715|NCT00867490|Natriuretic Agents|natriuretic agents|mesh-ancestor
101615716|NCT00867490|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101615717|NCT00697060|Docetaxel|docetaxel|mesh-list
101615718|NCT00697060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101615719|NCT00697060|Tubulin Modulators|tubulin modulators|mesh-ancestor
101615720|NCT00697060|Antimitotic Agents|antimitotic agents|mesh-ancestor
101615721|NCT00697060|Mitosis Modulators|mitosis modulators|mesh-ancestor
101615722|NCT00697060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058450|NCT02928029|Bortezomib|bortezomib|mesh-list
102058451|NCT02928029|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
102058452|NCT02928029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102058453|NCT02928029|Antiemetics|antiemetics|mesh-ancestor
102058454|NCT02928029|Autonomic Agents|autonomic agents|mesh-ancestor
102058455|NCT02928029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101615723|NCT00867334|Imatinib Mesylate|imatinib mesylate|mesh-list
101615724|NCT00867334|Panitumumab|panitumumab|mesh-list
101615725|NCT00867334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101615726|NCT00867334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101615727|NCT00867334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101615728|NCT00867334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615729|NCT00867334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101615730|NCT00925704|Calcitriol|calcitriol|mesh-list
101615731|NCT00925704|Sevelamer|sevelamer|mesh-list
101615732|NCT00925704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101615733|NCT00925704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615734|NCT00925704|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101615735|NCT00925704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101615736|NCT00925704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615737|NCT00925704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101615738|NCT00925704|Vitamins|vitamins|mesh-ancestor
101615739|NCT00925704|Micronutrients|micronutrients|mesh-ancestor
101615740|NCT00925704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101615741|NCT00925704|Chelating Agents|chelating agents|mesh-ancestor
101615742|NCT00925704|Sequestering Agents|sequestering agents|mesh-ancestor
101615743|NCT00697138|Amphetamine|amphetamine|mesh-list
101615744|NCT00697138|Dextroamphetamine|dextroamphetamine|mesh-list
101615745|NCT00697138|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101615746|NCT00697138|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101615747|NCT00697138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101615748|NCT00697138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101615749|NCT00697138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615750|NCT00697138|Adrenergic Agents|adrenergic agents|mesh-ancestor
101615751|NCT00697138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101615752|NCT00697138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615753|NCT00697138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101615754|NCT00697138|Sympathomimetics|sympathomimetics|mesh-ancestor
101615755|NCT00697138|Autonomic Agents|autonomic agents|mesh-ancestor
101272779|NCT01845272|Vasodilator Agents|vasodilator agents|mesh-ancestor
101615756|NCT00697138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101615757|NCT00697138|Dopamine Agents|dopamine agents|mesh-ancestor
101615763|NCT00609960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615764|NCT00609960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101615765|NCT00609960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101615766|NCT00609960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101615767|NCT00609960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101615768|NCT00609960|Anesthetics, General|anesthetics, general|mesh-ancestor
101615769|NCT00609960|Anesthetics|anesthetics|mesh-ancestor
101615770|NCT00609960|GABA Modulators|gaba modulators|mesh-ancestor
101615771|NCT00609960|GABA Agents|gaba agents|mesh-ancestor
101615772|NCT00609960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101615773|NCT00609960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615774|NCT04879134|Apomorphine|apomorphine|mesh-list
101615776|NCT04879134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615777|NCT04879134|Autonomic Agents|autonomic agents|mesh-ancestor
101615778|NCT04879134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101615779|NCT04879134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101615780|NCT04879134|Dopamine Agonists|dopamine agonists|mesh-ancestor
101615781|NCT04879134|Dopamine Agents|dopamine agents|mesh-ancestor
101615782|NCT04879134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101615783|NCT04879134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615784|NCT04134130|Methyltestosterone|methyltestosterone|mesh-list
101615785|NCT04134130|Testosterone|testosterone|mesh-list
101615786|NCT04134130|Testosterone undecanoate|testosterone undecanoate|mesh-list
101615787|NCT04134130|Testosterone enanthate|testosterone enanthate|mesh-list
101615788|NCT04134130|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101615789|NCT04134130|Androgens|androgens|mesh-ancestor
101615790|NCT04134130|Hormones|hormones|mesh-ancestor
101615791|NCT04134130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102058456|NCT02928029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058457|NCT02928029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102058458|NCT02928029|Glucocorticoids|glucocorticoids|mesh-ancestor
102058459|NCT02928029|Hormones|hormones|mesh-ancestor
102058460|NCT02928029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102058461|NCT02928029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102058462|NCT02928029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058463|NCT02050074|Metformin|metformin|mesh-list
102058464|NCT02050074|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
102058465|NCT02050074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101615792|NCT04134130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615793|NCT04134130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101615794|NCT04134130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101615795|NCT04134130|Anabolic Agents|anabolic agents|mesh-ancestor
101615796|NCT04258644|Paclitaxel|paclitaxel|mesh-list
101615797|NCT04258644|Apatinib|apatinib|mesh-list
101615798|NCT04258644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101615799|NCT04258644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101615800|NCT04258644|Tubulin Modulators|tubulin modulators|mesh-ancestor
101615801|NCT04258644|Antimitotic Agents|antimitotic agents|mesh-ancestor
101615802|NCT04258644|Mitosis Modulators|mitosis modulators|mesh-ancestor
101615803|NCT04258644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615804|NCT04258644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101615805|NCT04258644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101615806|NCT02619448|Paclitaxel|paclitaxel|mesh-list
101615807|NCT02619448|Carboplatin|carboplatin|mesh-list
101615808|NCT02619448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101615809|NCT02619448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101615810|NCT02619448|Tubulin Modulators|tubulin modulators|mesh-ancestor
101615811|NCT02619448|Antimitotic Agents|antimitotic agents|mesh-ancestor
101615812|NCT02619448|Mitosis Modulators|mitosis modulators|mesh-ancestor
101615813|NCT02619448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615814|NCT00610038|Glyburide|glyburide|mesh-list
101615815|NCT00610038|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101615816|NCT00610038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615817|NCT02619526|Carvedilol|carvedilol|mesh-list
101615818|NCT02619526|Nebivolol|nebivolol|mesh-list
101615819|NCT02619526|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101615820|NCT02619526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101615821|NCT02619526|Adrenergic Agents|adrenergic agents|mesh-ancestor
101615822|NCT02619526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101615823|NCT02619526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615824|NCT02619526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615825|NCT02619526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101615826|NCT02619526|Antioxidants|antioxidants|mesh-ancestor
101615827|NCT02619526|Protective Agents|protective agents|mesh-ancestor
101615828|NCT02619526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101615850|NCT00925548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615851|NCT00925548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101615852|NCT00925548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101615854|NCT00866788|Diphenhydramine|diphenhydramine|mesh-list
101615855|NCT00866788|Promethazine|promethazine|mesh-list
101615856|NCT00866788|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
101615857|NCT00866788|Histamine Antagonists|histamine antagonists|mesh-list
101615858|NCT00866788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101615859|NCT00866788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101615860|NCT00866788|Respiratory System Agents|respiratory system agents|mesh-ancestor
101615861|NCT00866788|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101615862|NCT00866788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101615863|NCT00866788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101615864|NCT00866788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615865|NCT00866788|Anesthetics, Local|anesthetics, local|mesh-ancestor
101615866|NCT00866788|Anesthetics|anesthetics|mesh-ancestor
101615867|NCT00866788|Sensory System Agents|sensory system agents|mesh-ancestor
101615868|NCT00866788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102058466|NCT02050074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058467|NCT02050074|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102058468|NCT02050074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102058469|NCT02050074|Antimetabolites|antimetabolites|mesh-ancestor
102058470|NCT02050074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058471|NCT02050074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101615869|NCT00866788|Antiemetics|antiemetics|mesh-ancestor
101615870|NCT00866788|Autonomic Agents|autonomic agents|mesh-ancestor
101615871|NCT00866788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101615872|NCT00866788|Histamine Agents|histamine agents|mesh-ancestor
101615873|NCT00866788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101615874|NCT00866788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615875|NCT00866788|Antipruritics|antipruritics|mesh-ancestor
101615876|NCT00866788|Dermatologic Agents|dermatologic agents|mesh-ancestor
101615877|NCT04132570|Budesonide|budesonide|mesh-list
101615878|NCT04132570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101615879|NCT04132570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101615880|NCT04132570|Autonomic Agents|autonomic agents|mesh-ancestor
101615881|NCT04132570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101615888|NCT00699244|Anesthetics|anesthetics|mesh-list
101615889|NCT00699244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101615890|NCT00699244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615891|NCT00699322|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101615892|NCT00699322|Glimepiride|glimepiride|mesh-list
101615893|NCT00699322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101615894|NCT00699322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615895|NCT00699322|Incretins|incretins|mesh-ancestor
101615896|NCT00699322|Hormones|hormones|mesh-ancestor
101615897|NCT00699322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101615898|NCT00699322|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101615899|NCT00699322|Protease Inhibitors|protease inhibitors|mesh-ancestor
101615900|NCT00699322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101615901|NCT00699322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615902|NCT00699322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101615903|NCT00699322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101615904|NCT00699322|Immunologic Factors|immunologic factors|mesh-ancestor
101615905|NCT00860470|Iron|iron|mesh-list
101615906|NCT00860470|Trace Elements|trace elements|mesh-list
101615908|NCT00860470|Micronutrients|micronutrients|mesh-list
101615909|NCT00860470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615910|NCT00860470|Hematinics|hematinics|mesh-ancestor
101615911|NCT00860470|Vitamin B Complex|vitamin b complex|mesh-ancestor
101615912|NCT00860470|Vitamins|vitamins|mesh-ancestor
101615913|NCT00923364|Cyclophosphamide|cyclophosphamide|mesh-list
101615914|NCT00923364|Fludarabine|fludarabine|mesh-list
101615915|NCT00923364|Fludarabine phosphate|fludarabine phosphate|mesh-list
101615916|NCT00923364|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101615917|NCT00923364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101615918|NCT00923364|Immunologic Factors|immunologic factors|mesh-ancestor
101615919|NCT00923364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615920|NCT00923364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101615921|NCT00923364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101615922|NCT00923364|Alkylating Agents|alkylating agents|mesh-ancestor
101615923|NCT00923364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615924|NCT00923364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101615925|NCT00923364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101615926|NCT00923364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101615927|NCT00923364|Antimetabolites|antimetabolites|mesh-ancestor
101615928|NCT02613676|Bilirubin|bilirubin|mesh-list
101615929|NCT02613676|Antioxidants|antioxidants|mesh-ancestor
101615930|NCT02613676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615931|NCT02613676|Protective Agents|protective agents|mesh-ancestor
101615932|NCT02613676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615933|NCT00860158|Dasatinib|dasatinib|mesh-list
101615934|NCT00860158|Leuprolide|leuprolide|mesh-list
101615935|NCT00860158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101615936|NCT00860158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101615937|NCT00860158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101615938|NCT00860158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615939|NCT00860158|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102058473|NCT02050152|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102058474|NCT02050152|Anesthetics, General|anesthetics, general|mesh-ancestor
101615940|NCT00860158|Fertility Agents|fertility agents|mesh-ancestor
101615941|NCT00860158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101615942|NCT00860158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615943|NCT00860158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101615944|NCT02878538|Deferiprone|deferiprone|mesh-list
101615945|NCT02878538|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101615946|NCT02878538|Chelating Agents|chelating agents|mesh-ancestor
101615947|NCT02878538|Sequestering Agents|sequestering agents|mesh-ancestor
101615948|NCT02878538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615949|NCT04134598|Tamoxifen|tamoxifen|mesh-list
101615950|NCT04134598|Letrozole|letrozole|mesh-list
101615951|NCT04134598|Anastrozole|anastrozole|mesh-list
101615952|NCT04134598|Exemestane|exemestane|mesh-list
101615958|NCT04134598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101615959|NCT04134598|Hormone Antagonists|hormone antagonists|mesh-ancestor
101615960|NCT04134598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101615961|NCT04134598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615962|NCT04134598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101615963|NCT04134598|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101615964|NCT04134598|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101615965|NCT04134598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101615966|NCT04134052|Midazolam|midazolam|mesh-list
101615967|NCT04134052|Ketamine|ketamine|mesh-list
101615968|NCT04134052|Analgesics|analgesics|mesh-ancestor
101615969|NCT04134052|Sensory System Agents|sensory system agents|mesh-ancestor
101615970|NCT04134052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101615971|NCT04134052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615972|NCT04134052|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101615973|NCT04134052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101615974|NCT04134052|Anesthetics, General|anesthetics, general|mesh-ancestor
101615975|NCT04134052|Anesthetics|anesthetics|mesh-ancestor
101615976|NCT04134052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101615977|NCT04134052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101615978|NCT04134052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101615979|NCT04134052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101615980|NCT04134052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615981|NCT04134052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101615982|NCT04134052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101615983|NCT04134052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101615984|NCT04134052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101615985|NCT04134052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101615986|NCT04134052|GABA Modulators|gaba modulators|mesh-ancestor
101615987|NCT04134052|GABA Agents|gaba agents|mesh-ancestor
101615988|NCT02615080|Pemirolast|pemirolast|mesh-list
101615989|NCT02615080|Histamine Antagonists|histamine antagonists|mesh-ancestor
101615990|NCT02615080|Histamine Agents|histamine agents|mesh-ancestor
101615991|NCT02615080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101615992|NCT02615080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615993|NCT02615080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615994|NCT00859456|Sunitinib|sunitinib|mesh-list
101615995|NCT00859456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101615996|NCT00859456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101615997|NCT00859456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101615998|NCT00859456|Growth Substances|growth substances|mesh-ancestor
101615999|NCT00859456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616000|NCT00859456|Growth Inhibitors|growth inhibitors|mesh-ancestor
101616001|NCT00859456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101616002|NCT00859456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101616003|NCT00859456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616004|NCT01075646|Ropivacaine|ropivacaine|mesh-list
101616005|NCT01075646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101616006|NCT01075646|Anesthetics, Local|anesthetics, local|mesh-ancestor
101616007|NCT01075646|Anesthetics|anesthetics|mesh-ancestor
101616008|NCT01075646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101616009|NCT01075646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616010|NCT01075646|Sensory System Agents|sensory system agents|mesh-ancestor
101616011|NCT01075646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101616012|NCT00799903|Darapladib|darapladib|mesh-list
101616013|NCT00799903|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
102058475|NCT02050152|Anesthetics|anesthetics|mesh-ancestor
102058476|NCT02050152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102058477|NCT02050152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058478|NCT02050152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102058479|NCT02050152|Analgesics|analgesics|mesh-ancestor
102058480|NCT02050152|Sensory System Agents|sensory system agents|mesh-ancestor
102058481|NCT02050152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102058482|NCT02806986|Immunoglobulins|immunoglobulins|mesh-list
102058483|NCT02806986|gamma-Globulins|gamma-globulins|mesh-list
102058484|NCT02806986|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102058485|NCT02806986|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101616014|NCT00799903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101616015|NCT00799903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616016|NCT01075256|Calcium, Dietary|calcium, dietary|mesh-list
101616017|NCT01075256|Calcium|calcium|mesh-list
101616018|NCT01075256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101616019|NCT01075256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616020|NCT01075256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101616025|NCT02876432|Sensory System Agents|sensory system agents|mesh-ancestor
101616026|NCT02876432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101616027|NCT02876432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616028|NCT02876432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101616029|NCT02876432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101616030|NCT02876432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101616031|NCT02876432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101616032|NCT02876432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616033|NCT02876276|Hyaluronic Acid|hyaluronic acid|mesh-list
101616034|NCT02876276|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101616035|NCT02876276|Immunologic Factors|immunologic factors|mesh-ancestor
101616036|NCT02876276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616037|NCT02876276|Viscosupplements|viscosupplements|mesh-ancestor
101616038|NCT02876276|Protective Agents|protective agents|mesh-ancestor
101616039|NCT00923130|Bevacizumab|bevacizumab|mesh-list
101616040|NCT00923130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101616041|NCT00923130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101616042|NCT00923130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101616043|NCT00923130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101616044|NCT00923130|Growth Substances|growth substances|mesh-ancestor
101616045|NCT00923130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616046|NCT00923130|Growth Inhibitors|growth inhibitors|mesh-ancestor
101616047|NCT04258098|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101616049|NCT04258098|Streptomycin|streptomycin|mesh-list
101616050|NCT04258098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101616051|NCT04258098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101616052|NCT04258098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101616053|NCT04258098|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101616054|NCT04258098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101616055|NCT04258098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616056|NCT02605915|Cyclophosphamide|cyclophosphamide|mesh-list
101616057|NCT02605915|Carboplatin|carboplatin|mesh-list
101616058|NCT02605915|Docetaxel|docetaxel|mesh-list
101616059|NCT02605915|Doxorubicin|doxorubicin|mesh-list
101616060|NCT02605915|Trastuzumab|trastuzumab|mesh-list
101616061|NCT02605915|Atezolizumab|atezolizumab|mesh-list
101616062|NCT02605915|Pertuzumab|pertuzumab|mesh-list
101616063|NCT02605915|Maytansine|maytansine|mesh-list
101616064|NCT02605915|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101616065|NCT02605915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101616066|NCT02605915|Immunologic Factors|immunologic factors|mesh-ancestor
101616067|NCT02605915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616068|NCT02605915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101616069|NCT02605915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101616070|NCT02605915|Alkylating Agents|alkylating agents|mesh-ancestor
101616071|NCT02605915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058486|NCT02806986|Immunologic Factors|immunologic factors|mesh-ancestor
102058487|NCT02806986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058488|NCT03095651|Insulin Glargine|insulin glargine|mesh-list
102058489|NCT03095651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102058490|NCT03095651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058491|NCT04717193|Epinephrine|epinephrine|mesh-list
102058492|NCT04717193|Racepinephrine|racepinephrine|mesh-list
102058493|NCT04717193|Bupivacaine|bupivacaine|mesh-list
101616072|NCT02605915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101616073|NCT02605915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101779535|NCT00302107|Serotonin Agents|serotonin agents|mesh-ancestor
101616074|NCT02605915|Tubulin Modulators|tubulin modulators|mesh-ancestor
101616075|NCT02605915|Antimitotic Agents|antimitotic agents|mesh-ancestor
101616076|NCT02605915|Mitosis Modulators|mitosis modulators|mesh-ancestor
101616077|NCT02605915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101616078|NCT02605915|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101616079|NCT02605915|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101616080|NCT02605915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101616081|NCT02605915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101616082|NCT02605915|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101616083|NCT02605915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101616084|NCT02605915|Immunotoxins|immunotoxins|mesh-ancestor
101616085|NCT02605915|Immunoconjugates|immunoconjugates|mesh-ancestor
101616086|NCT04028323|Octreotide|octreotide|mesh-list
101616087|NCT04028323|Terlipressin|terlipressin|mesh-list
101616088|NCT04028323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101616089|NCT04028323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101616090|NCT04028323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101616091|NCT04028323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101616092|NCT04028323|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101616093|NCT02607163|Dexmedetomidine|dexmedetomidine|mesh-list
101616094|NCT02607163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101616101|NCT02607163|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101616103|NCT02607163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101616104|NCT02607163|Adrenergic Agents|adrenergic agents|mesh-ancestor
101616105|NCT02607163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101616106|NCT02607163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616107|NCT01075100|Carboplatin|carboplatin|mesh-list
101616108|NCT01075100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101616109|NCT02876354|Vitamin K|vitamin k|mesh-list
101616110|NCT02876354|Vitamin K 2|vitamin k 2|mesh-list
101616111|NCT02876354|Vitamins|vitamins|mesh-ancestor
101616112|NCT02876354|Micronutrients|micronutrients|mesh-ancestor
101616113|NCT02876354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616114|NCT02876354|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101616115|NCT02876354|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101616116|NCT02876354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616117|NCT02876354|Hemostatics|hemostatics|mesh-ancestor
101616118|NCT02876354|Coagulants|coagulants|mesh-ancestor
101616119|NCT00626678|Prednisone|prednisone|mesh-list
101616120|NCT00626678|Azathioprine|azathioprine|mesh-list
101616121|NCT00626678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101616122|NCT00626678|Glucocorticoids|glucocorticoids|mesh-ancestor
101616123|NCT00626678|Hormones|hormones|mesh-ancestor
101616124|NCT00626678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101616125|NCT00626678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616126|NCT00626678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101616127|NCT00626678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101616128|NCT00626678|Antimetabolites|antimetabolites|mesh-ancestor
101616129|NCT00626678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616130|NCT00626678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101273159|NCT01848236|Vitamin D|vitamin d|mesh-list
101616131|NCT00626678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101616132|NCT00626678|Immunologic Factors|immunologic factors|mesh-ancestor
101616133|NCT00626678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101616134|NCT00803023|Sodium Oxybate|sodium oxybate|mesh-list
101616135|NCT00803023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101616136|NCT00803023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101616137|NCT00803023|Anesthetics, General|anesthetics, general|mesh-ancestor
101616138|NCT00803023|Anesthetics|anesthetics|mesh-ancestor
101616139|NCT00803023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102058494|NCT04717193|Anesthetics, Local|anesthetics, local|mesh-list
102058495|NCT04717193|Anesthetics|anesthetics|mesh-list
102058496|NCT04717193|Epinephryl borate|epinephryl borate|mesh-list
102058497|NCT04717193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102058498|NCT04717193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058499|NCT04717193|Sensory System Agents|sensory system agents|mesh-ancestor
101616140|NCT00803023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616141|NCT03076021|Dextromethorphan|dextromethorphan|mesh-list
101616142|NCT03076021|Isotretinoin|isotretinoin|mesh-list
101616143|NCT03076021|Antitussive Agents|antitussive agents|mesh-ancestor
101616144|NCT03076021|Respiratory System Agents|respiratory system agents|mesh-ancestor
101616145|NCT03076021|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101616146|NCT03076021|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101616147|NCT03076021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101616148|NCT03076021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616149|NCT03076021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616150|NCT03076021|Dermatologic Agents|dermatologic agents|mesh-ancestor
101616151|NCT00859222|Bevacizumab|bevacizumab|mesh-list
101616152|NCT00859222|Panobinostat|panobinostat|mesh-list
101616153|NCT00859222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101616154|NCT00859222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101616155|NCT00859222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101616156|NCT00859222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101616157|NCT00859222|Growth Substances|growth substances|mesh-ancestor
101616158|NCT00859222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616159|NCT00859222|Growth Inhibitors|growth inhibitors|mesh-ancestor
101616160|NCT00859222|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101616161|NCT00859222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101616166|NCT00858988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101616167|NCT00858832|Methylergonovine|methylergonovine|mesh-list
101616168|NCT00858832|Oxytocics|oxytocics|mesh-ancestor
101616169|NCT00858832|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101616170|NCT00858832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616171|NCT01071512|Natalizumab|natalizumab|mesh-list
101616172|NCT01071512|Immunologic Factors|immunologic factors|mesh-ancestor
101616173|NCT01071512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616174|NCT00626834|Vigabatrin|vigabatrin|mesh-list
101616175|NCT00626834|Anticonvulsants|anticonvulsants|mesh-ancestor
101616176|NCT00626834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101616177|NCT00626834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616178|NCT00626834|GABA Agents|gaba agents|mesh-ancestor
101616179|NCT00626834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101616180|NCT00626834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616181|NCT04255992|Calcium, Dietary|calcium, dietary|mesh-list
101616182|NCT04255992|Vitamin D|vitamin d|mesh-list
101616183|NCT04255992|Calcium|calcium|mesh-list
101616184|NCT04255992|Vitamins|vitamins|mesh-ancestor
101616185|NCT04255992|Micronutrients|micronutrients|mesh-ancestor
101616186|NCT04255992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616187|NCT04255992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101616188|NCT04255992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101616189|NCT02618824|Tryptophan|tryptophan|mesh-list
101616190|NCT02618824|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101616191|NCT02618824|Antidepressive Agents|antidepressive agents|mesh-ancestor
101616192|NCT02618824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101616193|NCT00610350|Simendan|simendan|mesh-list
101616194|NCT00610350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101616195|NCT00610350|Vasodilator Agents|vasodilator agents|mesh-ancestor
101616196|NCT00610350|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101616197|NCT00610350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101616198|NCT00610350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101616199|NCT00610350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616201|NCT00610350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616202|NCT01071200|Hormones|hormones|mesh-list
101616203|NCT01071200|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101616204|NCT01071200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101616205|NCT01071200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616206|NCT04255836|Durvalumab|durvalumab|mesh-list
101616207|NCT04255836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102058500|NCT04717193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102058501|NCT04717193|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102058502|NCT04717193|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102058503|NCT04717193|Adrenergic Agents|adrenergic agents|mesh-ancestor
102058504|NCT04717193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102058505|NCT04717193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058506|NCT04717193|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102058507|NCT04717193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102058508|NCT04717193|Autonomic Agents|autonomic agents|mesh-ancestor
101616208|NCT04255836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101616210|NCT00699478|Vitamin B Complex|vitamin b complex|mesh-ancestor
101616211|NCT00699478|Vitamins|vitamins|mesh-ancestor
101616212|NCT00699478|Micronutrients|micronutrients|mesh-ancestor
101616213|NCT00699478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616214|NCT01070888|Budesonide|budesonide|mesh-list
101616215|NCT01070888|Formoterol Fumarate|formoterol fumarate|mesh-list
101616216|NCT01070888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101616217|NCT01070888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101616218|NCT01070888|Autonomic Agents|autonomic agents|mesh-ancestor
101616219|NCT01070888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101616220|NCT01070888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616221|NCT01070888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101616222|NCT01070888|Respiratory System Agents|respiratory system agents|mesh-ancestor
101616223|NCT01070888|Glucocorticoids|glucocorticoids|mesh-ancestor
101616224|NCT01070888|Hormones|hormones|mesh-ancestor
101616225|NCT01070888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101616226|NCT01070888|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101616227|NCT01070888|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101616228|NCT01070888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101616229|NCT01070888|Adrenergic Agents|adrenergic agents|mesh-ancestor
101616230|NCT01070888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101616231|NCT01070888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616232|NCT00857896|Fesoterodine|fesoterodine|mesh-list
101616233|NCT00857896|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101616234|NCT00857896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101616235|NCT00857896|Cholinergic Agents|cholinergic agents|mesh-ancestor
101616236|NCT00857896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101616240|NCT05652673|Nivolumab|nivolumab|mesh-list
101616241|NCT05652673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101616242|NCT05652673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101616243|NCT05652673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101616244|NCT05652673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616245|NCT00857818|Risperidone|risperidone|mesh-list
101616246|NCT00857818|Aripiprazole|aripiprazole|mesh-list
101616247|NCT00857818|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101616248|NCT00857818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101616249|NCT00857818|Serotonin Agents|serotonin agents|mesh-ancestor
101616250|NCT00857818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101616251|NCT00857818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616252|NCT00857818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616253|NCT00857818|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101616254|NCT00857818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101616255|NCT00857818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101616256|NCT00857818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101616257|NCT00857818|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101616258|NCT00857818|Dopamine Agents|dopamine agents|mesh-ancestor
101616259|NCT00857818|Antidepressive Agents|antidepressive agents|mesh-ancestor
101616260|NCT00857818|Dopamine Agonists|dopamine agonists|mesh-ancestor
101616261|NCT00857818|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101616262|NCT00857818|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101616263|NCT00857818|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101616264|NCT00857818|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101616265|NCT02618668|Ketamine|ketamine|mesh-list
101616266|NCT02618668|Propofol|propofol|mesh-list
101616267|NCT02618668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102058509|NCT04717193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102058510|NCT04717193|Respiratory System Agents|respiratory system agents|mesh-ancestor
102058511|NCT04717193|Mydriatics|mydriatics|mesh-ancestor
102058512|NCT04717193|Sympathomimetics|sympathomimetics|mesh-ancestor
102058513|NCT04717193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102058514|NCT05212025|Gemcitabine|gemcitabine|mesh-list
102058515|NCT05212025|Adavosertib|adavosertib|mesh-list
102058516|NCT05212025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102058517|NCT05212025|Antimetabolites|antimetabolites|mesh-ancestor
102058518|NCT05212025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616268|NCT02618668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101616269|NCT02618668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616270|NCT02618668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101779564|NCT00315445|Acetaminophen|acetaminophen|mesh-list
101616271|NCT02618668|Anesthetics, General|anesthetics, general|mesh-ancestor
101616272|NCT02618668|Anesthetics|anesthetics|mesh-ancestor
101616273|NCT02618668|Analgesics|analgesics|mesh-ancestor
101616274|NCT02618668|Sensory System Agents|sensory system agents|mesh-ancestor
101616275|NCT02618668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101616276|NCT02618668|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101616277|NCT02618668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101616278|NCT02618668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101616279|NCT02618668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101616280|NCT02618668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616281|NCT01074944|Eliglustat|eliglustat|mesh-list
101616282|NCT01074944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101616283|NCT01074944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616284|NCT00802945|Etirinotecan pegol|etirinotecan pegol|mesh-list
101616285|NCT00802945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101616286|NCT00802945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101616287|NCT00802945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101616288|NCT00802945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101616289|NCT00802945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616290|NCT01074554|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101616291|NCT01074554|Azithromycin|azithromycin|mesh-list
101616292|NCT01074554|Levofloxacin|levofloxacin|mesh-list
101616293|NCT01074554|Rifampin|rifampin|mesh-list
101616294|NCT01074554|Ethambutol|ethambutol|mesh-list
101616295|NCT01074554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101616296|NCT01074554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101616297|NCT01074554|Antitubercular Agents|antitubercular agents|mesh-ancestor
101616298|NCT01074554|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101616299|NCT01074554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101616300|NCT01074554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101616301|NCT01074554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101616302|NCT01074554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616303|NCT01074554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101616304|NCT01074554|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101616305|NCT01074554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101616306|NCT01074554|Leprostatic Agents|leprostatic agents|mesh-ancestor
101616325|NCT00857584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616327|NCT00857584|Serotonin Agents|serotonin agents|mesh-ancestor
101616328|NCT00798967|Teduglutide|teduglutide|mesh-list
101616329|NCT00798967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101616330|NCT00798967|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101616331|NCT00798967|Protective Agents|protective agents|mesh-ancestor
101616332|NCT00798967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616333|NCT04132102|Afatinib|afatinib|mesh-list
101616334|NCT04132102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101616335|NCT04132102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101616336|NCT04132102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101616337|NCT04132102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616338|NCT02618356|Raltitrexed|raltitrexed|mesh-list
101616339|NCT02618356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101616340|NCT02618356|Antimetabolites|antimetabolites|mesh-ancestor
102058519|NCT05212025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058521|NCT02051868|Paclitaxel|paclitaxel|mesh-list
102058522|NCT02051868|Carboplatin|carboplatin|mesh-list
102058523|NCT02051868|Fluorouracil|fluorouracil|mesh-list
102058524|NCT02051868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102058525|NCT02051868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058526|NCT02051868|Tubulin Modulators|tubulin modulators|mesh-ancestor
102058527|NCT02051868|Antimitotic Agents|antimitotic agents|mesh-ancestor
102058528|NCT02051868|Mitosis Modulators|mitosis modulators|mesh-ancestor
102058529|NCT02051868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058530|NCT02051868|Antimetabolites|antimetabolites|mesh-ancestor
102058531|NCT02051868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102058532|NCT02051868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102058533|NCT02051868|Immunologic Factors|immunologic factors|mesh-ancestor
102058534|NCT02051868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058535|NCT04696757|Capecitabine|capecitabine|mesh-list
101779570|NCT00315445|Sensory System Agents|sensory system agents|mesh-ancestor
102058536|NCT04696757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102058537|NCT04696757|Antimetabolites|antimetabolites|mesh-ancestor
102058538|NCT04696757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058539|NCT04696757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058540|NCT02049294|Omalizumab|omalizumab|mesh-list
102058541|NCT02049294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101616341|NCT02618356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616342|NCT02618356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101616343|NCT02618356|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101616344|NCT02618356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101616345|NCT00697996|Rituximab|rituximab|mesh-list
101616346|NCT00697996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101616347|NCT00697996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101616348|NCT00697996|Immunologic Factors|immunologic factors|mesh-ancestor
101616349|NCT00697996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616350|NCT00697996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101616351|NCT04118842|Rifampin|rifampin|mesh-list
101616352|NCT04118842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101616353|NCT04118842|Antitubercular Agents|antitubercular agents|mesh-ancestor
101273380|NCT01850121|Infliximab|infliximab|mesh-list
101616354|NCT04118842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101616355|NCT04118842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101616356|NCT04118842|Leprostatic Agents|leprostatic agents|mesh-ancestor
101616357|NCT04118842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101616361|NCT04118842|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101616362|NCT04118842|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101616363|NCT04118842|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101616364|NCT04118842|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101616365|NCT04118842|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101616366|NCT00699634|Nabilone|nabilone|mesh-list
101616367|NCT00699634|Antiemetics|antiemetics|mesh-ancestor
101616368|NCT00699634|Autonomic Agents|autonomic agents|mesh-ancestor
101616369|NCT00699634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101616370|NCT00699634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616371|NCT00699634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102058542|NCT02049294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102058543|NCT02049294|Respiratory System Agents|respiratory system agents|mesh-ancestor
102058544|NCT02051946|Ethacrynic Acid|ethacrynic acid|mesh-list
102058546|NCT02051946|Natriuretic Agents|natriuretic agents|mesh-ancestor
102058547|NCT02051946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058548|NCT02051946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101360160|NCT00214318|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101616372|NCT00699634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101616373|NCT00699634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101616374|NCT00699634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101616375|NCT00699634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101616376|NCT00798889|Sunitinib|sunitinib|mesh-list
101616377|NCT00798889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101616378|NCT00798889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101616379|NCT00798889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101616380|NCT00798889|Growth Substances|growth substances|mesh-ancestor
101616381|NCT00798889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616382|NCT00798889|Growth Inhibitors|growth inhibitors|mesh-ancestor
101616383|NCT00798889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101616384|NCT00798889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101616385|NCT00798889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616386|NCT04113889|Acetylcarnitine|acetylcarnitine|mesh-list
101616387|NCT04113889|Metformin|metformin|mesh-list
101616388|NCT04113889|Pioglitazone|pioglitazone|mesh-list
101616389|NCT04113889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101616390|NCT04113889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616391|NCT04113889|Vitamin B Complex|vitamin b complex|mesh-ancestor
101616392|NCT04113889|Vitamins|vitamins|mesh-ancestor
101616393|NCT04113889|Micronutrients|micronutrients|mesh-ancestor
101616394|NCT04113889|Nootropic Agents|nootropic agents|mesh-ancestor
101616395|NCT00796861|Sunitinib|sunitinib|mesh-list
101616396|NCT00796861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101616397|NCT00796861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101616398|NCT00796861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101616399|NCT00796861|Growth Substances|growth substances|mesh-ancestor
101616400|NCT00796861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616401|NCT00796861|Growth Inhibitors|growth inhibitors|mesh-ancestor
101616402|NCT00796861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101616403|NCT00796861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101616404|NCT00796861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616405|NCT00914563|Lithium Carbonate|lithium carbonate|mesh-list
101616406|NCT00914563|Antidepressive Agents|antidepressive agents|mesh-ancestor
101616407|NCT00914563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101616408|NCT00914563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101616409|NCT00914563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616410|NCT00914563|Antimanic Agents|antimanic agents|mesh-ancestor
101616411|NCT00914563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101616412|NCT00914563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101616413|NCT00914563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616414|NCT00914797|Terbutaline|terbutaline|mesh-list
101616415|NCT00914797|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101616416|NCT00914797|Autonomic Agents|autonomic agents|mesh-ancestor
101616417|NCT00914797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101616418|NCT00914797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616419|NCT00914797|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101616420|NCT00914797|Respiratory System Agents|respiratory system agents|mesh-ancestor
101616421|NCT00914797|Sympathomimetics|sympathomimetics|mesh-ancestor
101616422|NCT00914797|Tocolytic Agents|tocolytic agents|mesh-ancestor
101616423|NCT00914797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101616424|NCT00914797|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101616425|NCT00914797|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101616426|NCT00914797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101616427|NCT00914797|Adrenergic Agents|adrenergic agents|mesh-ancestor
101616428|NCT00914797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101616433|NCT00798655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101616434|NCT00914641|Apixaban|apixaban|mesh-list
101616435|NCT00914641|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102058549|NCT02051946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387690|NCT00323011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058551|NCT02049606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101616436|NCT00914641|Antithrombins|antithrombins|mesh-ancestor
101616437|NCT00914641|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101616438|NCT00914641|Protease Inhibitors|protease inhibitors|mesh-ancestor
101616439|NCT00914641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101616440|NCT00914641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616441|NCT00914641|Anticoagulants|anticoagulants|mesh-ancestor
101616442|NCT00796549|Afatinib|afatinib|mesh-list
101616443|NCT00796549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101616444|NCT00796549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101616445|NCT00796549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101616446|NCT00796549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616447|NCT00856492|Paclitaxel|paclitaxel|mesh-list
101616448|NCT00856492|Cyclophosphamide|cyclophosphamide|mesh-list
101616449|NCT00856492|Bevacizumab|bevacizumab|mesh-list
101616450|NCT00856492|Doxorubicin|doxorubicin|mesh-list
101779701|NCT05732051|Niacin|niacin|mesh-list
101616451|NCT00856492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101616452|NCT00856492|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101616453|NCT00856492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101616454|NCT00856492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101616455|NCT00856492|Tubulin Modulators|tubulin modulators|mesh-ancestor
101616456|NCT00856492|Antimitotic Agents|antimitotic agents|mesh-ancestor
101616457|NCT00856492|Mitosis Modulators|mitosis modulators|mesh-ancestor
101616458|NCT00856492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616459|NCT00856492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101616460|NCT00856492|Immunologic Factors|immunologic factors|mesh-ancestor
101616461|NCT00856492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616462|NCT00856492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101616463|NCT00856492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101616464|NCT00856492|Alkylating Agents|alkylating agents|mesh-ancestor
101616465|NCT00856492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101616466|NCT00856492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101616467|NCT00856492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101616468|NCT00856492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101616469|NCT00856492|Growth Substances|growth substances|mesh-ancestor
101616470|NCT00856492|Growth Inhibitors|growth inhibitors|mesh-ancestor
101616471|NCT00856492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101616472|NCT00856492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101616473|NCT00856492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101616474|NCT00856492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101616475|NCT04111159|Propofol|propofol|mesh-list
101616476|NCT04111159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101616477|NCT04111159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101616478|NCT04111159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616479|NCT04111159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101779914|NCT05255276|Rifampin|rifampin|mesh-list
101616480|NCT04111159|Anesthetics, General|anesthetics, general|mesh-ancestor
101616481|NCT04111159|Anesthetics|anesthetics|mesh-ancestor
101616482|NCT00697372|Sirolimus|sirolimus|mesh-list
101616483|NCT00697372|Everolimus|everolimus|mesh-list
101616484|NCT00697372|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101616485|NCT00697372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101616486|NCT00697372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101616487|NCT00697372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616488|NCT00697372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101616490|NCT00697372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616491|NCT00697372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101616492|NCT00697372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101616493|NCT00697372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101616494|NCT00697372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101616495|NCT00697372|Antifungal Agents|antifungal agents|mesh-ancestor
101616496|NCT04111003|Anesthetics|anesthetics|mesh-list
101616497|NCT04111003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101616498|NCT04111003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616499|NCT00856180|Cyclophosphamide|cyclophosphamide|mesh-list
101616500|NCT00856180|Bevacizumab|bevacizumab|mesh-list
101616501|NCT00856180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101616505|NCT00856180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101616507|NCT00856180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616508|NCT00856180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058552|NCT02049606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102058553|NCT02049606|Analgesics|analgesics|mesh-ancestor
102058554|NCT02049606|Sensory System Agents|sensory system agents|mesh-ancestor
102058555|NCT02049606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102058556|NCT02049606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467096|NCT04589845|Maytansine|maytansine|mesh-list
101616509|NCT00856180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101616510|NCT00856180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101780034|NCT04972552|Ubiquinone|ubiquinone|mesh-list
101616511|NCT00856180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101616512|NCT00856180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101616513|NCT00856180|Growth Substances|growth substances|mesh-ancestor
101616514|NCT00856180|Growth Inhibitors|growth inhibitors|mesh-ancestor
101616516|NCT02605213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101616517|NCT02605213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101616518|NCT00900627|Paclitaxel|paclitaxel|mesh-list
101616519|NCT00900627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101616520|NCT00900627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101616521|NCT00900627|Tubulin Modulators|tubulin modulators|mesh-ancestor
101616522|NCT00900627|Antimitotic Agents|antimitotic agents|mesh-ancestor
101616523|NCT00900627|Mitosis Modulators|mitosis modulators|mesh-ancestor
101616524|NCT00900627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616525|NCT00866320|Sorafenib|sorafenib|mesh-list
101616526|NCT00866320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101616527|NCT00866320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101616528|NCT00866320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101616529|NCT00866320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616530|NCT04115449|Dexmedetomidine|dexmedetomidine|mesh-list
101616531|NCT04115449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101616532|NCT04115449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101616533|NCT04115449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616534|NCT04115449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101616535|NCT04115449|Analgesics|analgesics|mesh-ancestor
101780154|NCT04618913|Protease Inhibitors|protease inhibitors|mesh-ancestor
101780155|NCT04618913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101780156|NCT04618913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780157|NCT04618913|Anticoagulants|anticoagulants|mesh-ancestor
101616536|NCT04115449|Sensory System Agents|sensory system agents|mesh-ancestor
101616537|NCT04115449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101616538|NCT04115449|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101616539|NCT04115449|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101616540|NCT04115449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101616541|NCT04115449|Adrenergic Agents|adrenergic agents|mesh-ancestor
101616542|NCT04115449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101437631|NCT00166244|Mycophenolic Acid|mycophenolic acid|mesh-list
101780221|NCT04266275|Curcumin|curcumin|mesh-list
101780222|NCT04266275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101780223|NCT04266275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101780224|NCT04266275|Analgesics|analgesics|mesh-ancestor
101780225|NCT04266275|Sensory System Agents|sensory system agents|mesh-ancestor
101780226|NCT04266275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101780227|NCT04266275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780228|NCT04266275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101616543|NCT04115449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616544|NCT04133974|Methadone|methadone|mesh-list
101616545|NCT04133974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101616546|NCT04133974|Narcotics|narcotics|mesh-ancestor
101616547|NCT04133974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101616548|NCT04133974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616549|NCT04133974|Analgesics|analgesics|mesh-ancestor
101616550|NCT04133974|Sensory System Agents|sensory system agents|mesh-ancestor
101616551|NCT04133974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101616552|NCT04133974|Antitussive Agents|antitussive agents|mesh-ancestor
101616553|NCT04133974|Respiratory System Agents|respiratory system agents|mesh-ancestor
101616554|NCT03679611|Neostigmine|neostigmine|mesh-list
101616555|NCT03679611|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101780280|NCT04041232|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101780281|NCT04041232|Protective Agents|protective agents|mesh-ancestor
101780282|NCT04041232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616556|NCT03679611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101616557|NCT03679611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616558|NCT03679611|Cholinergic Agents|cholinergic agents|mesh-ancestor
101616559|NCT03679611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101616560|NCT03679611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616561|NCT03679611|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101616562|NCT03679611|Autonomic Agents|autonomic agents|mesh-ancestor
101616563|NCT03679611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101616564|NCT00914953|Oxytocin|oxytocin|mesh-list
101616565|NCT00914953|Oxytocics|oxytocics|mesh-ancestor
101616566|NCT00914953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101616567|NCT00914953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616568|NCT00869518|Trimethoprim|trimethoprim|mesh-list
101616569|NCT00869518|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101616570|NCT00869518|Sulfamethoxazole|sulfamethoxazole|mesh-list
101780345|NCT03729778|Immunologic Factors|immunologic factors|mesh-ancestor
101780346|NCT03729778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780347|NCT03681561|Nivolumab|nivolumab|mesh-list
101780348|NCT03681561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101616571|NCT00869518|Rifabutin|rifabutin|mesh-list
101616572|NCT00869518|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102058557|NCT02049606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102058558|NCT02049606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102058559|NCT02049606|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102058560|NCT02049606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102058561|NCT02049606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101360176|NCT00214318|Sympathomimetics|sympathomimetics|mesh-ancestor
101616579|NCT00869518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616580|NCT00869518|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101780403|NCT03608163|Diazoxide|diazoxide|mesh-list
101780404|NCT03608163|Naloxone|naloxone|mesh-list
101616581|NCT00869518|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101616582|NCT00869518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101616583|NCT00869518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101616584|NCT00869518|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101616585|NCT00869518|Antitubercular Agents|antitubercular agents|mesh-ancestor
101616587|NCT00869440|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101616588|NCT00869440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101616589|NCT00869440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101780476|NCT03448783|Apixaban|apixaban|mesh-list
101616590|NCT00869440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616591|NCT00869440|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101616592|NCT00869440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101616593|NCT00869440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101616594|NCT00869440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101616595|NCT00869440|Anesthetics, General|anesthetics, general|mesh-ancestor
101616597|NCT00869440|GABA Modulators|gaba modulators|mesh-ancestor
101616598|NCT00869440|GABA Agents|gaba agents|mesh-ancestor
101616599|NCT00869440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101616600|NCT00869440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616601|NCT00895947|Interferons|interferons|mesh-list
101616602|NCT00895947|Interferon-alpha|interferon-alpha|mesh-list
101616603|NCT00895947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101616604|NCT00895947|Antiviral Agents|antiviral agents|mesh-ancestor
101616605|NCT00895947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101616606|NCT00895947|Immunologic Factors|immunologic factors|mesh-ancestor
101616607|NCT00895947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616608|NCT02604823|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101616609|NCT02604823|Antiviral Agents|antiviral agents|mesh-ancestor
101616610|NCT02604823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101616611|NCT02841579|Osimertinib|osimertinib|mesh-list
101616612|NCT02841579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101616613|NCT02841579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101616614|NCT02841579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101780547|NCT03011268|Adalimumab|adalimumab|mesh-list
101616615|NCT02841579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616616|NCT00588445|Gefitinib|gefitinib|mesh-list
101616617|NCT00588445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101616618|NCT00588445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101616619|NCT00588445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101616620|NCT00588445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616621|NCT00092781|Celecoxib|celecoxib|mesh-list
101616622|NCT00092781|Etoricoxib|etoricoxib|mesh-list
101616623|NCT00092781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101616624|NCT00092781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101616625|NCT00092781|Analgesics|analgesics|mesh-ancestor
101616626|NCT00092781|Sensory System Agents|sensory system agents|mesh-ancestor
101780585|NCT02889523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101780586|NCT02889523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101780587|NCT02889523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101780588|NCT02889523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101780589|NCT02889523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101780590|NCT02889523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101780591|NCT02889523|Tubulin Modulators|tubulin modulators|mesh-ancestor
101780592|NCT02889523|Antimitotic Agents|antimitotic agents|mesh-ancestor
101780593|NCT02889523|Mitosis Modulators|mitosis modulators|mesh-ancestor
101616627|NCT00092781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101616628|NCT00092781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616629|NCT00092781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101616630|NCT00092781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101616631|NCT00092781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101616632|NCT00092781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101616633|NCT00092781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101616634|NCT00092781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616635|NCT00092703|Diclofenac|diclofenac|mesh-list
101616636|NCT00092703|Etoricoxib|etoricoxib|mesh-list
101780671|NCT02272790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101616637|NCT00092703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101616639|NCT00092703|Analgesics|analgesics|mesh-ancestor
101616640|NCT00092703|Sensory System Agents|sensory system agents|mesh-ancestor
101616641|NCT00092703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101616642|NCT00092703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616648|NCT00092703|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102058562|NCT02049606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058564|NCT05071703|Etoposide|etoposide|mesh-list
102058566|NCT05071703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058567|NCT05071703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101616649|NCT00699946|Olanzapine|olanzapine|mesh-list
101616650|NCT00699946|Antiemetics|antiemetics|mesh-ancestor
101616651|NCT00699946|Autonomic Agents|autonomic agents|mesh-ancestor
101616652|NCT00699946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101616653|NCT00699946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616654|NCT00699946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101616655|NCT00699946|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101616656|NCT00699946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101616657|NCT00699946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101616658|NCT00699946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101616659|NCT00699946|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101616660|NCT00699946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101780800|NCT00199069|Abortifacient Agents|abortifacient agents|mesh-ancestor
101616661|NCT00699946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101616662|NCT00699946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616663|NCT00699946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101616664|NCT00699946|Serotonin Agents|serotonin agents|mesh-ancestor
101616665|NCT00796315|Doxylamine|doxylamine|mesh-list
101616666|NCT00796315|Doxylamine succinate|doxylamine succinate|mesh-list
101616667|NCT00796315|Antiemetics|antiemetics|mesh-ancestor
101616668|NCT00796315|Autonomic Agents|autonomic agents|mesh-ancestor
101616669|NCT00796315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101616670|NCT00796315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616671|NCT00796315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101616672|NCT00796315|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101616673|NCT00796315|Histamine Antagonists|histamine antagonists|mesh-ancestor
101616674|NCT00796315|Histamine Agents|histamine agents|mesh-ancestor
101616675|NCT00796315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101616676|NCT00796315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616677|NCT00855166|Metformin|metformin|mesh-list
101616678|NCT00855166|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101616679|NCT00855166|Dapagliflozin|dapagliflozin|mesh-list
101616680|NCT00855166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101780861|NCT01067365|Citric Acid|citric acid|mesh-list
101616681|NCT00855166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616682|NCT00855166|Incretins|incretins|mesh-ancestor
101616683|NCT00855166|Hormones|hormones|mesh-ancestor
101616684|NCT00855166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101616685|NCT00855166|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101616686|NCT00855166|Protease Inhibitors|protease inhibitors|mesh-ancestor
101616687|NCT00855166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101616688|NCT00855166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616689|NCT00855166|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101616690|NCT00854620|Sorafenib|sorafenib|mesh-list
101616691|NCT00854620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101616692|NCT00854620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101616693|NCT00854620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101780916|NCT00816816|Docetaxel|docetaxel|mesh-list
101616694|NCT00854620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616695|NCT00793585|Allopurinol|allopurinol|mesh-list
101616696|NCT00793585|Antimetabolites|antimetabolites|mesh-ancestor
101616697|NCT00793585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616698|NCT00793585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101780976|NCT01067599|Nicotine|nicotine|mesh-list
101616699|NCT00793585|Gout Suppressants|gout suppressants|mesh-ancestor
101616700|NCT00793585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101616701|NCT00793585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101616702|NCT00793585|Antioxidants|antioxidants|mesh-ancestor
101616703|NCT00793585|Protective Agents|protective agents|mesh-ancestor
101616704|NCT00793585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616705|NCT02013141|Telavancin|telavancin|mesh-list
101616706|NCT02013141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101616707|NCT02013141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101616708|NCT04107103|Nivolumab|nivolumab|mesh-list
101616709|NCT04107103|Pemetrexed|pemetrexed|mesh-list
101775286|NCT01055431|Micronutrients|micronutrients|mesh-ancestor
101304297|NCT02012088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101365162|NCT00049361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058568|NCT05071703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102058569|NCT05071703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102058570|NCT05071703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102058571|NCT05071703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058572|NCT05071703|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102058573|NCT02037516|Neostigmine|neostigmine|mesh-list
102058574|NCT02037516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102058575|NCT02037516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102058576|NCT02037516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058577|NCT02037516|Cholinergic Agents|cholinergic agents|mesh-ancestor
102058578|NCT02037516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102058579|NCT02037516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058580|NCT02037516|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102058581|NCT02037516|Autonomic Agents|autonomic agents|mesh-ancestor
102058582|NCT02037516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102058583|NCT02052024|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
102058584|NCT02052024|Botulinum Toxins|botulinum toxins|mesh-list
102058585|NCT02052024|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101360185|NCT00214552|Rabeprazole|rabeprazole|mesh-list
101365164|NCT00049361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101365165|NCT00049361|Immunologic Factors|immunologic factors|mesh-ancestor
101365166|NCT00049361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365167|NCT00049361|Leprostatic Agents|leprostatic agents|mesh-ancestor
101365168|NCT00049361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101365169|NCT00049361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101365170|NCT00049361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101365171|NCT00049361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101365172|NCT00049361|Growth Substances|growth substances|mesh-ancestor
101365173|NCT00049361|Growth Inhibitors|growth inhibitors|mesh-ancestor
101365174|NCT00150436|Pregabalin|pregabalin|mesh-list
101365175|NCT00150436|Analgesics|analgesics|mesh-ancestor
101365176|NCT00150436|Sensory System Agents|sensory system agents|mesh-ancestor
101365177|NCT00150436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101365178|NCT00150436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365179|NCT00150436|Anticonvulsants|anticonvulsants|mesh-ancestor
101365180|NCT00150436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101365181|NCT00150436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101365182|NCT00150436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365183|NCT00150436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101365184|NCT00150436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101365185|NCT00150436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101365186|NCT00150436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101365187|NCT00150436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101365188|NCT00150553|Carbamazepine|carbamazepine|mesh-list
101365189|NCT00150553|Anticonvulsants|anticonvulsants|mesh-ancestor
101365190|NCT00150553|Antimanic Agents|antimanic agents|mesh-ancestor
101365191|NCT00150553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101365192|NCT00150553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101365193|NCT00150553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365194|NCT00150553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101365195|NCT00150553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101365196|NCT00150553|Analgesics|analgesics|mesh-ancestor
101365197|NCT00150553|Sensory System Agents|sensory system agents|mesh-ancestor
101365198|NCT00150553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101365199|NCT00150553|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102058586|NCT02052024|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102058587|NCT02052024|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102058588|NCT02052024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102058589|NCT02052024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058590|NCT02052024|Cholinergic Agents|cholinergic agents|mesh-ancestor
102058591|NCT02052024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102058592|NCT02052024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058593|NCT02052024|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102058594|NCT02052024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101365200|NCT00150553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101365209|NCT00150631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365211|NCT00082446|Immunologic Factors|immunologic factors|mesh-ancestor
101365212|NCT00082446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365213|NCT00049439|Cyclophosphamide|cyclophosphamide|mesh-list
101365214|NCT00049439|Lomustine|lomustine|mesh-list
101365215|NCT00049439|Etoposide|etoposide|mesh-list
101365216|NCT00049439|Procarbazine|procarbazine|mesh-list
101365217|NCT00049439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101365218|NCT00049439|Immunologic Factors|immunologic factors|mesh-ancestor
101365219|NCT00049439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365220|NCT00049439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101365221|NCT00049439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101365222|NCT00049439|Alkylating Agents|alkylating agents|mesh-ancestor
101365223|NCT00049439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365224|NCT00049439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101365225|NCT00049439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101365226|NCT00049439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101365227|NCT00049439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101365228|NCT00049439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101365229|NCT00049439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101365230|NCT00150670|Cisplatin|cisplatin|mesh-list
101365231|NCT00150670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101365232|NCT00150709|Levetiracetam|levetiracetam|mesh-list
101365233|NCT00150709|Anticonvulsants|anticonvulsants|mesh-ancestor
101365234|NCT00150709|Nootropic Agents|nootropic agents|mesh-ancestor
101365235|NCT00150748|Levetiracetam|levetiracetam|mesh-list
101365236|NCT00150748|Anticonvulsants|anticonvulsants|mesh-ancestor
101365237|NCT00150748|Nootropic Agents|nootropic agents|mesh-ancestor
101365238|NCT00150787|Levetiracetam|levetiracetam|mesh-list
101304299|NCT02012088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101304300|NCT02012088|Tubulin Modulators|tubulin modulators|mesh-ancestor
101365242|NCT00150826|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101365243|NCT00150826|Protease Inhibitors|protease inhibitors|mesh-ancestor
101365244|NCT00150826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101365245|NCT00150826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365246|NCT00150826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101365247|NCT00150865|Ropivacaine|ropivacaine|mesh-list
101365248|NCT00150865|Anesthetics, Local|anesthetics, local|mesh-ancestor
101365249|NCT00150865|Anesthetics|anesthetics|mesh-ancestor
101365250|NCT00150865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101365251|NCT00150865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365252|NCT00150865|Sensory System Agents|sensory system agents|mesh-ancestor
101365253|NCT00150865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101365255|NCT00049556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101365256|NCT00049556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101365257|NCT00049556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101365258|NCT00049556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365259|NCT00150982|Alefacept|alefacept|mesh-list
101365260|NCT00150982|Dermatologic Agents|dermatologic agents|mesh-ancestor
101365261|NCT00150982|Immunologic Factors|immunologic factors|mesh-ancestor
101365262|NCT00150982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365263|NCT00049634|Cyclosporine|cyclosporine|mesh-list
101365264|NCT00049634|Cyclophosphamide|cyclophosphamide|mesh-list
101365265|NCT00049634|Busulfan|busulfan|mesh-list
101365266|NCT00049634|Methotrexate|methotrexate|mesh-list
102058595|NCT02052024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102058596|NCT02037672|Metformin|metformin|mesh-list
102058597|NCT02037672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102058598|NCT02037672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058599|NCT02049762|Aspirin|aspirin|mesh-list
102058600|NCT02049762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102058601|NCT02049762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102058602|NCT02049762|Analgesics|analgesics|mesh-ancestor
101365267|NCT00049634|Cyclosporins|cyclosporins|mesh-list
101365268|NCT00049634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101365269|NCT00049634|Immunologic Factors|immunologic factors|mesh-ancestor
101365273|NCT00049634|Alkylating Agents|alkylating agents|mesh-ancestor
101365274|NCT00049634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365275|NCT00049634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101365276|NCT00049634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101365277|NCT00049634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101365278|NCT00049634|Abortifacient Agents|abortifacient agents|mesh-ancestor
101365279|NCT00049634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101365280|NCT00049634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101365282|NCT00049634|Dermatologic Agents|dermatologic agents|mesh-ancestor
101365283|NCT00049634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101781506|NCT05244694|Insulin|insulin|mesh-list
101365284|NCT00049634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101365285|NCT00049634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101365286|NCT00049634|Antifungal Agents|antifungal agents|mesh-ancestor
101365287|NCT00049634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101365288|NCT00049634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101365289|NCT00151060|Paclitaxel|paclitaxel|mesh-list
101365290|NCT00151060|Etoposide|etoposide|mesh-list
101365291|NCT00151060|Estramustine|estramustine|mesh-list
101365292|NCT00151060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101365293|NCT00151060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101365294|NCT00151060|Tubulin Modulators|tubulin modulators|mesh-ancestor
101365295|NCT00151060|Antimitotic Agents|antimitotic agents|mesh-ancestor
101365296|NCT00151060|Mitosis Modulators|mitosis modulators|mesh-ancestor
101365297|NCT00151060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365298|NCT00151060|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101365299|NCT00151060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101365300|NCT00151060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101365301|NCT00151060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101365302|NCT00151060|Alkylating Agents|alkylating agents|mesh-ancestor
101365303|NCT00151060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101365304|NCT00151138|Atenolol|atenolol|mesh-list
101365305|NCT00151138|Lisinopril|lisinopril|mesh-list
101365306|NCT00151138|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101365307|NCT00151138|Protease Inhibitors|protease inhibitors|mesh-ancestor
101365308|NCT00151138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101365309|NCT00151138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365310|NCT00151138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101304304|NCT02012140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101545993|NCT02894268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101365315|NCT00151138|Sympatholytics|sympatholytics|mesh-ancestor
101365316|NCT00151138|Autonomic Agents|autonomic agents|mesh-ancestor
101365317|NCT00151138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101781770|NCT00296725|Fluoxetine|fluoxetine|mesh-list
101365318|NCT00151138|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101365319|NCT00151138|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101365320|NCT00151138|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101365321|NCT00151138|Adrenergic Agents|adrenergic agents|mesh-ancestor
101365322|NCT00151138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101365323|NCT00082485|Baclofen|baclofen|mesh-list
101365324|NCT00082485|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101365325|NCT00082485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365326|NCT00082485|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101365327|NCT00082485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101365328|NCT00082485|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101365329|NCT00082485|GABA Agonists|gaba agonists|mesh-ancestor
101365330|NCT00082485|GABA Agents|gaba agents|mesh-ancestor
101365331|NCT00082485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102058603|NCT02049762|Sensory System Agents|sensory system agents|mesh-ancestor
102058604|NCT02049762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102058605|NCT02049762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058606|NCT02049762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102058607|NCT02049762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102058608|NCT02049762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102058609|NCT02049762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102058610|NCT02049762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365332|NCT00082485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365333|NCT00151255|Cytarabine|cytarabine|mesh-list
101365334|NCT00151255|Mitoxantrone|mitoxantrone|mesh-list
101365335|NCT00151255|Idarubicin|idarubicin|mesh-list
101365336|NCT00151255|Tretinoin|tretinoin|mesh-list
101781889|NCT00997750|Lornoxicam|lornoxicam|mesh-list
101365337|NCT00151255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101365338|NCT00151255|Antimetabolites|antimetabolites|mesh-ancestor
101365339|NCT00151255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365340|NCT00151255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101365353|NCT00151255|Keratolytic Agents|keratolytic agents|mesh-ancestor
101365354|NCT00151255|Dermatologic Agents|dermatologic agents|mesh-ancestor
101365355|NCT00049751|Adalimumab|adalimumab|mesh-list
101365356|NCT00049751|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101365357|NCT00049751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101365358|NCT00049751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101365359|NCT00151294|Dexetimide|dexetimide|mesh-list
101365360|NCT00151294|Citalopram|citalopram|mesh-list
101365361|NCT00151294|Antidepressive Agents|antidepressive agents|mesh-list
101365362|NCT00151294|Escitalopram|escitalopram|mesh-list
101365363|NCT00151294|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101365364|NCT00151294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101365365|NCT00151294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101365366|NCT00151294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365367|NCT00151294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101365368|NCT00151294|Serotonin Agents|serotonin agents|mesh-ancestor
101365369|NCT00151294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365370|NCT00151294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101365371|NCT00151294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101365372|NCT00151294|Parasympatholytics|parasympatholytics|mesh-ancestor
101365373|NCT00151294|Autonomic Agents|autonomic agents|mesh-ancestor
101365374|NCT00151294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101365375|NCT00151294|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101782090|NCT04187872|Pembrolizumab|pembrolizumab|mesh-list
101365376|NCT00151294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101365377|NCT00151294|Cholinergic Agents|cholinergic agents|mesh-ancestor
101365378|NCT00151294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101365379|NCT00151294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101365380|NCT00151450|Pregabalin|pregabalin|mesh-list
101365381|NCT00151450|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101365382|NCT00151450|Analgesics|analgesics|mesh-ancestor
101365383|NCT00151450|Sensory System Agents|sensory system agents|mesh-ancestor
101365384|NCT00151450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101365385|NCT00151450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365386|NCT00151450|Anticonvulsants|anticonvulsants|mesh-ancestor
101365387|NCT00151450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101365388|NCT00151450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101365389|NCT00151450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365391|NCT00151450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101365392|NCT00151450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101365393|NCT00151450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101365394|NCT00151450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101365395|NCT00151450|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101365396|NCT00151450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101365397|NCT00151450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101365398|NCT00151450|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101365399|NCT00151450|Antidepressive Agents|antidepressive agents|mesh-ancestor
101365400|NCT00151489|Pregabalin|pregabalin|mesh-list
101365401|NCT00151489|Analgesics|analgesics|mesh-ancestor
101782280|NCT00311155|Amlodipine|amlodipine|mesh-list
102058611|NCT02049762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102058612|NCT02049762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102058613|NCT02049762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102058614|NCT02049762|Antipyretics|antipyretics|mesh-ancestor
102058615|NCT03561558|Ibuprofen|ibuprofen|mesh-list
102058616|NCT03561558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102058617|NCT03561558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102058618|NCT03561558|Analgesics|analgesics|mesh-ancestor
102058619|NCT03561558|Sensory System Agents|sensory system agents|mesh-ancestor
102058620|NCT03561558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102058621|NCT03561558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058622|NCT03561558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102058623|NCT03561558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102058624|NCT03561558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102058625|NCT03561558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102058626|NCT03561558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058627|NCT03099161|Pembrolizumab|pembrolizumab|mesh-list
102058628|NCT03099161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101365402|NCT00151489|Sensory System Agents|sensory system agents|mesh-ancestor
101365407|NCT00151489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101365408|NCT00151489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365409|NCT00151489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101365410|NCT00151489|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101365411|NCT00151489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101365412|NCT00151489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101365413|NCT00151489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101365414|NCT00049790|Paclitaxel|paclitaxel|mesh-list
101365415|NCT00049790|Carboplatin|carboplatin|mesh-list
101365416|NCT00049790|Angiostatins|angiostatins|mesh-list
101365417|NCT00049790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101365418|NCT00049790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101365419|NCT00049790|Tubulin Modulators|tubulin modulators|mesh-ancestor
101365420|NCT00049790|Antimitotic Agents|antimitotic agents|mesh-ancestor
101365421|NCT00049790|Mitosis Modulators|mitosis modulators|mesh-ancestor
101365422|NCT00049790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365423|NCT00049790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101365424|NCT00049790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101365425|NCT00049790|Growth Substances|growth substances|mesh-ancestor
101782464|NCT00943839|Growth Substances|growth substances|mesh-ancestor
101365426|NCT00049790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365427|NCT00049790|Growth Inhibitors|growth inhibitors|mesh-ancestor
101365428|NCT00082524|Caspofungin|caspofungin|mesh-list
101365429|NCT00082524|Antifungal Agents|antifungal agents|mesh-ancestor
101365430|NCT00082524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101365431|NCT00082524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101365432|NCT00082524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365433|NCT00406003|Paroxetine|paroxetine|mesh-list
101365434|NCT00406003|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101365435|NCT00406003|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101365436|NCT00406003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101365437|NCT00406003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365438|NCT00406003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101365439|NCT00406003|Serotonin Agents|serotonin agents|mesh-ancestor
101365440|NCT00406003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365441|NCT00406003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102058629|NCT03099161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058630|NCT03099161|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102058631|NCT03099161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058632|NCT04639115|Ozanimod|ozanimod|mesh-list
102058633|NCT04639115|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102058634|NCT04639115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058635|NCT04639115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102058636|NCT04639115|Immunologic Factors|immunologic factors|mesh-ancestor
102058637|NCT04639115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058638|NCT04260659|Lidocaine|lidocaine|mesh-list
102058639|NCT04260659|Magnesium Sulfate|magnesium sulfate|mesh-list
101365442|NCT00406003|Antidepressive Agents|antidepressive agents|mesh-ancestor
101365443|NCT00406003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101365444|NCT00406003|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101365445|NCT00406003|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101365446|NCT00406003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101365447|NCT00049829|Zoledronic Acid|zoledronic acid|mesh-list
101365448|NCT00049829|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101365449|NCT00049829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365450|NCT00406042|Prednisolone|prednisolone|mesh-list
101365451|NCT00406042|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101365452|NCT00406042|Methylprednisolone|methylprednisolone|mesh-list
101365453|NCT00406042|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101365454|NCT00406042|Prednisolone acetate|prednisolone acetate|mesh-list
101365455|NCT00406042|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101365456|NCT00406042|Prednisolone phosphate|prednisolone phosphate|mesh-list
101365457|NCT00406042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101365458|NCT00406042|Glucocorticoids|glucocorticoids|mesh-ancestor
101365459|NCT00406042|Hormones|hormones|mesh-ancestor
101546130|NCT04477382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101387691|NCT00323011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101365460|NCT00406042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101304308|NCT02012140|Purinergic Agents|purinergic agents|mesh-ancestor
101304309|NCT02012140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101365462|NCT00406042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101365463|NCT00406042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101365464|NCT00406042|Antiemetics|antiemetics|mesh-ancestor
101365465|NCT00406042|Autonomic Agents|autonomic agents|mesh-ancestor
101365466|NCT00406042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101365467|NCT00406042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101365468|NCT00406042|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101365469|NCT00406042|Protective Agents|protective agents|mesh-ancestor
101365470|NCT00082563|Azithromycin|azithromycin|mesh-list
101365488|NCT00082563|Antinematodal Agents|antinematodal agents|mesh-ancestor
101365489|NCT00082563|Anthelmintics|anthelmintics|mesh-ancestor
101365491|NCT00151528|Analgesics|analgesics|mesh-ancestor
101365492|NCT00151528|Sensory System Agents|sensory system agents|mesh-ancestor
101365493|NCT00151528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101365494|NCT00151528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365495|NCT00151528|Anticonvulsants|anticonvulsants|mesh-ancestor
101365496|NCT00151528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101365497|NCT00151528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101365498|NCT00151528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365499|NCT00151528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101365500|NCT00151528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101365501|NCT00151528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101365502|NCT00151528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101365503|NCT00151528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101365504|NCT00397787|Sunitinib|sunitinib|mesh-list
101365505|NCT00397787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101365506|NCT00397787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101365507|NCT00397787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101365508|NCT00397787|Growth Substances|growth substances|mesh-ancestor
102058640|NCT04260659|Fentanyl|fentanyl|mesh-list
102058641|NCT04260659|Dexmedetomidine|dexmedetomidine|mesh-list
102058642|NCT04260659|Ketamine|ketamine|mesh-list
102058643|NCT04260659|Remifentanil|remifentanil|mesh-list
102058644|NCT04260659|Anesthetics, Local|anesthetics, local|mesh-ancestor
102058645|NCT04260659|Anesthetics|anesthetics|mesh-ancestor
102058646|NCT04260659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102058647|NCT04260659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058648|NCT04260659|Sensory System Agents|sensory system agents|mesh-ancestor
101360259|NCT00069498|Sensory System Agents|sensory system agents|mesh-ancestor
101365509|NCT00397787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365510|NCT00397787|Growth Inhibitors|growth inhibitors|mesh-ancestor
101365511|NCT00397787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101365512|NCT00397787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101365513|NCT00397787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365514|NCT00082602|Galantamine|galantamine|mesh-list
101365515|NCT00082602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101365516|NCT00082602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101365517|NCT00082602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365518|NCT00082602|Cholinergic Agents|cholinergic agents|mesh-ancestor
101365519|NCT00082602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101365520|NCT00082602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365521|NCT00082602|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101365522|NCT00082602|Autonomic Agents|autonomic agents|mesh-ancestor
101365523|NCT00082602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101365524|NCT00082602|Nootropic Agents|nootropic agents|mesh-ancestor
101365525|NCT00151567|Tamsulosin|tamsulosin|mesh-list
101365526|NCT00151567|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101783040|NCT00949299|Analgesics|analgesics|mesh-ancestor
101365527|NCT00151567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101365528|NCT00151567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101365529|NCT00151567|Adrenergic Agents|adrenergic agents|mesh-ancestor
101365530|NCT00151567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101365535|NCT00397826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101365536|NCT00397826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101365537|NCT00397826|Antimetabolites|antimetabolites|mesh-ancestor
101365538|NCT00397826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365539|NCT00397826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101365540|NCT00397826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101365541|NCT00397826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101365542|NCT00151684|Diazoxide|diazoxide|mesh-list
101365543|NCT00151684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101365544|NCT00151684|Vasodilator Agents|vasodilator agents|mesh-ancestor
101365545|NCT00151762|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
101365546|NCT00151762|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101365547|NCT00151762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101365548|NCT00151762|Antimetabolites|antimetabolites|mesh-ancestor
101365549|NCT00151762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365550|NCT00151762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101365551|NCT00151801|Interferons|interferons|mesh-list
101365552|NCT00151801|Interferon-beta|interferon-beta|mesh-list
101365554|NCT00151801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101365555|NCT00151801|Antiviral Agents|antiviral agents|mesh-ancestor
101365556|NCT00151801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101365557|NCT00151801|Immunologic Factors|immunologic factors|mesh-ancestor
101365558|NCT00151801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365559|NCT00151801|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101365560|NCT04725253|Niacinamide|niacinamide|mesh-list
101365561|NCT04725253|Niacin|niacin|mesh-list
101365562|NCT04725253|Nicotinic Acids|nicotinic acids|mesh-list
101365563|NCT04725253|Vitamin B Complex|vitamin b complex|mesh-ancestor
101365564|NCT04725253|Vitamins|vitamins|mesh-ancestor
101365565|NCT04725253|Micronutrients|micronutrients|mesh-ancestor
101365566|NCT04725253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365567|NCT04725253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101365568|NCT04725253|Antimetabolites|antimetabolites|mesh-ancestor
101365569|NCT04725253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783292|NCT00836316|Levobupivacaine|levobupivacaine|mesh-list
101365570|NCT04725253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102058649|NCT04260659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102058650|NCT04260659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102058651|NCT04260659|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102058652|NCT04260659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102058653|NCT04260659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102058654|NCT04260659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058655|NCT04260659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101783359|NCT00962637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102058656|NCT04260659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102058657|NCT04260659|Analgesics|analgesics|mesh-ancestor
102058658|NCT04260659|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101360271|NCT00397241|Timolol|timolol|mesh-list
101365571|NCT04725253|Vasodilator Agents|vasodilator agents|mesh-ancestor
101365572|NCT00082719|Interferons|interferons|mesh-list
101365573|NCT00082719|Interferon-alpha|interferon-alpha|mesh-list
101365574|NCT00082719|Interferon alpha-2|interferon alpha-2|mesh-list
101365575|NCT00082719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101365576|NCT00082719|Antiviral Agents|antiviral agents|mesh-ancestor
101365577|NCT00082719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101365578|NCT00082719|Immunologic Factors|immunologic factors|mesh-ancestor
101365579|NCT00082719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365580|NCT00151957|Methylphenidate|methylphenidate|mesh-list
101365581|NCT00151957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101365582|NCT00151957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365583|NCT00151957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101365584|NCT00151957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101365585|NCT00151957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101387692|NCT00323011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101365586|NCT00151957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365587|NCT00151957|Dopamine Agents|dopamine agents|mesh-ancestor
101365588|NCT00151957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101365589|NCT00049946|Risperidone|risperidone|mesh-list
101365590|NCT00049946|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101365591|NCT00049946|Serotonin Agents|serotonin agents|mesh-ancestor
101365592|NCT00049946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101365593|NCT00049946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365594|NCT00049946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365595|NCT00049946|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101365596|NCT00049946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101365597|NCT00049946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101365598|NCT00049946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101365599|NCT00049946|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101365600|NCT00049946|Dopamine Agents|dopamine agents|mesh-ancestor
101365601|NCT00152035|Amphetamine|amphetamine|mesh-list
101365610|NCT00152035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101365611|NCT00152035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365612|NCT00152035|Adrenergic Agents|adrenergic agents|mesh-ancestor
101365613|NCT00152035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101365614|NCT00152035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101365615|NCT00152035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101365616|NCT00152035|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101365617|NCT00049985|Darbepoetin alfa|darbepoetin alfa|mesh-list
101365618|NCT00049985|Hematinics|hematinics|mesh-ancestor
101365619|NCT00152191|Cyclophosphamide|cyclophosphamide|mesh-list
101365620|NCT00152191|Fluorouracil|fluorouracil|mesh-list
101365621|NCT00152191|Methotrexate|methotrexate|mesh-list
101365622|NCT00152191|Tegafur|tegafur|mesh-list
101365623|NCT00152191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101365624|NCT00152191|Immunologic Factors|immunologic factors|mesh-ancestor
101365625|NCT00152191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546271|NCT01175824|Insulin|insulin|mesh-list
101304322|NCT02012166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101365629|NCT00152191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365630|NCT00152191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058659|NCT04260659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102058660|NCT04260659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102058661|NCT04260659|Adrenergic Agents|adrenergic agents|mesh-ancestor
102058662|NCT04260659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102058663|NCT04260659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102058664|NCT04260659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102058665|NCT04260659|Anesthetics, General|anesthetics, general|mesh-ancestor
102058666|NCT04260659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102058667|NCT04260659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102058668|NCT04260659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101365631|NCT00152191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101365632|NCT00152191|Antimetabolites|antimetabolites|mesh-ancestor
101365633|NCT00152191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101365634|NCT00152191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101365635|NCT00152191|Abortifacient Agents|abortifacient agents|mesh-ancestor
101365636|NCT00152191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101365637|NCT00152191|Dermatologic Agents|dermatologic agents|mesh-ancestor
101365638|NCT00152191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101365639|NCT00152191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101365640|NCT00152191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101365641|NCT00152230|Tegafur|tegafur|mesh-list
101365642|NCT00152230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101365643|NCT00152230|Antimetabolites|antimetabolites|mesh-ancestor
101365644|NCT00152230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365645|NCT00152230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101365646|NCT00152308|Sirolimus|sirolimus|mesh-list
101365647|NCT00152308|Ethanol|ethanol|mesh-list
101365648|NCT00152308|Temsirolimus|temsirolimus|mesh-list
101365649|NCT00152308|MTOR Inhibitors|mtor inhibitors|mesh-list
101365650|NCT00152308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101365651|NCT00152308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101365652|NCT00152308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101365653|NCT00152308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101365654|NCT00152308|Antifungal Agents|antifungal agents|mesh-ancestor
101365655|NCT00152308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101365656|NCT00152308|Immunologic Factors|immunologic factors|mesh-ancestor
101365657|NCT00152308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365658|NCT00152308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101365659|NCT00152308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101365660|NCT00152308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365661|NCT00152308|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101365662|NCT00152308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101365663|NCT00152386|Certolizumab Pegol|certolizumab pegol|mesh-list
101365664|NCT00152386|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101783783|NCT03952143|Insulin|insulin|mesh-list
101365665|NCT00152386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101365666|NCT00152386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101365667|NCT00152386|Immunologic Factors|immunologic factors|mesh-ancestor
101365668|NCT00152386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365669|NCT00152386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101365670|NCT00082836|Rituximab|rituximab|mesh-list
101365679|NCT00152425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101365680|NCT00152425|Immunologic Factors|immunologic factors|mesh-ancestor
101365681|NCT00152425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365682|NCT00152425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101365683|NCT00152542|Nitric Oxide|nitric oxide|mesh-list
101365684|NCT00152542|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101365685|NCT00152542|Autonomic Agents|autonomic agents|mesh-ancestor
101365686|NCT00152542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101365687|NCT00152542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365688|NCT00152542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101365689|NCT00152542|Respiratory System Agents|respiratory system agents|mesh-ancestor
101365690|NCT00152542|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101365691|NCT00152542|Antioxidants|antioxidants|mesh-ancestor
101783854|NCT03943095|Fluorides|fluorides|mesh-list
101365692|NCT00152542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058669|NCT04260659|Narcotics|narcotics|mesh-ancestor
102058670|NCT04260659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102058671|NCT04260659|Anticonvulsants|anticonvulsants|mesh-ancestor
102058672|NCT04260659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102058673|NCT04260659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102058674|NCT04260659|Tocolytic Agents|tocolytic agents|mesh-ancestor
102058675|NCT04260659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102058676|NCT05068661|Fentanyl|fentanyl|mesh-list
102058677|NCT05068661|Bupivacaine|bupivacaine|mesh-list
102058678|NCT05068661|Ropivacaine|ropivacaine|mesh-list
102058679|NCT05068661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102058680|NCT05068661|Anesthetics, Local|anesthetics, local|mesh-ancestor
102058681|NCT05068661|Anesthetics|anesthetics|mesh-ancestor
102058682|NCT05068661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102058683|NCT05068661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360288|NCT00073320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101304325|NCT02012244|Anesthetics, Local|anesthetics, local|mesh-list
101365695|NCT00152542|Vasodilator Agents|vasodilator agents|mesh-ancestor
101365696|NCT00152542|Gasotransmitters|gasotransmitters|mesh-ancestor
101365697|NCT00152542|Protective Agents|protective agents|mesh-ancestor
101365698|NCT00043680|Celecoxib|celecoxib|mesh-list
101365699|NCT00043680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101365700|NCT00043680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101365701|NCT00043680|Analgesics|analgesics|mesh-ancestor
101365702|NCT00043680|Sensory System Agents|sensory system agents|mesh-ancestor
101365703|NCT00043680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101365704|NCT00043680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365705|NCT00043680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101365706|NCT00043680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101365707|NCT00043680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101365708|NCT00043680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101365709|NCT00043680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101365710|NCT00043680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365711|NCT00152581|Interferons|interferons|mesh-list
101365712|NCT00152581|Ribavirin|ribavirin|mesh-list
101365713|NCT00152581|Interferon-alpha|interferon-alpha|mesh-list
101365714|NCT00152581|Interferon alpha-2|interferon alpha-2|mesh-list
101365715|NCT00152581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101365716|NCT00152581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101365717|NCT00152581|Antiviral Agents|antiviral agents|mesh-ancestor
101365718|NCT00152581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101365719|NCT00152581|Antimetabolites|antimetabolites|mesh-ancestor
101365720|NCT00152581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365721|NCT00152581|Immunologic Factors|immunologic factors|mesh-ancestor
101365722|NCT00152581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365723|NCT00152620|Dexamethasone|dexamethasone|mesh-list
101365724|NCT00152620|Methylprednisolone|methylprednisolone|mesh-list
101365725|NCT00152620|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101365726|NCT00152620|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101365727|NCT00152620|Prednisolone|prednisolone|mesh-list
101365728|NCT00152620|Prednisolone acetate|prednisolone acetate|mesh-list
101365729|NCT00152620|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101365730|NCT00152620|Prednisolone phosphate|prednisolone phosphate|mesh-list
101365731|NCT00152620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101365732|NCT00152620|Antiemetics|antiemetics|mesh-ancestor
101365733|NCT00152620|Autonomic Agents|autonomic agents|mesh-ancestor
101365734|NCT00152620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101365735|NCT00152620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365736|NCT00152620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101365739|NCT00152620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102058684|NCT05068661|Sensory System Agents|sensory system agents|mesh-ancestor
102058685|NCT05068661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102058686|NCT05068661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102058687|NCT05068661|Narcotics|narcotics|mesh-ancestor
102058688|NCT05068661|Analgesics|analgesics|mesh-ancestor
102058689|NCT05068661|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102058690|NCT05068661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102058691|NCT05068661|Anesthetics, General|anesthetics, general|mesh-ancestor
102058692|NCT04455815|Gabexate|gabexate|mesh-list
102058693|NCT04455815|Camostat|camostat|mesh-list
101365741|NCT00152620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101365742|NCT00152620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101365743|NCT00152620|Protective Agents|protective agents|mesh-ancestor
101365744|NCT00050141|Tipifarnib|tipifarnib|mesh-list
101365745|NCT00050141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101365746|NCT04725214|Temozolomide|temozolomide|mesh-list
101365747|NCT04725214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101365748|NCT04725214|Alkylating Agents|alkylating agents|mesh-ancestor
101365749|NCT04725214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365750|NCT04725214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101365751|NCT00050180|Indinavir|indinavir|mesh-list
101365752|NCT00050180|Saquinavir|saquinavir|mesh-list
101365753|NCT00050180|Midazolam|midazolam|mesh-list
101365754|NCT00050180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101365755|NCT00050180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101365756|NCT00050180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101365757|NCT00050180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365758|NCT00050180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101365759|NCT00050180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101365760|NCT00050180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101365761|NCT00050180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101365762|NCT00050180|Anesthetics, General|anesthetics, general|mesh-ancestor
101365763|NCT00050180|Anesthetics|anesthetics|mesh-ancestor
101365764|NCT00050180|GABA Modulators|gaba modulators|mesh-ancestor
101365765|NCT00050180|GABA Agents|gaba agents|mesh-ancestor
101304326|NCT02012244|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101304327|NCT02012244|Narcotics|narcotics|mesh-ancestor
101304328|NCT02012244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101304329|NCT02012244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304330|NCT02012244|Analgesics|analgesics|mesh-ancestor
101304331|NCT02012244|Sensory System Agents|sensory system agents|mesh-ancestor
101304332|NCT02012244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101365768|NCT00050180|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101365769|NCT00050180|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101365770|NCT00050180|Protease Inhibitors|protease inhibitors|mesh-ancestor
101784048|NCT02545530|Autonomic Agents|autonomic agents|mesh-ancestor
101365771|NCT00050180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101365772|NCT00050180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101365773|NCT00050180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101365774|NCT00050180|Antiviral Agents|antiviral agents|mesh-ancestor
101365775|NCT00050180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101365776|NCT00050180|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101365777|NCT00050180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101784105|NCT00266227|Antimetabolites|antimetabolites|mesh-ancestor
101365778|NCT00082914|Denileukin diftitox|denileukin diftitox|mesh-list
101365779|NCT00082914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101365781|NCT00152815|Antioxidants|antioxidants|mesh-list
101365782|NCT00152815|Vitamins|vitamins|mesh-ancestor
101365783|NCT00152815|Micronutrients|micronutrients|mesh-ancestor
101365784|NCT00152815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365785|NCT00152815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365786|NCT00152815|Protective Agents|protective agents|mesh-ancestor
101365787|NCT00043719|Vitamin D|vitamin d|mesh-list
101365788|NCT00043719|Nitroglycerin|nitroglycerin|mesh-list
101365789|NCT00043719|Calcium|calcium|mesh-list
101365790|NCT00043719|Vitamins|vitamins|mesh-ancestor
101365791|NCT00043719|Micronutrients|micronutrients|mesh-ancestor
101365792|NCT00043719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784183|NCT00855660|Riociguat|riociguat|mesh-list
101365793|NCT00043719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101365794|NCT00043719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102058694|NCT04455815|Protease Inhibitors|protease inhibitors|mesh-ancestor
102058695|NCT04455815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102058696|NCT04455815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360315|NCT00041483|Anecortave|anecortave|mesh-list
101365795|NCT00043719|Vasodilator Agents|vasodilator agents|mesh-ancestor
101365796|NCT00152854|Acetaminophen|acetaminophen|mesh-list
101365797|NCT00152854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101365798|NCT00152854|Analgesics|analgesics|mesh-ancestor
101365799|NCT00152854|Sensory System Agents|sensory system agents|mesh-ancestor
101365800|NCT00152854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101365801|NCT00152854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365802|NCT00152854|Antipyretics|antipyretics|mesh-ancestor
101365803|NCT00050297|N-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|n-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|mesh-list
101365804|NCT00050297|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101365805|NCT00050297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365806|NCT00152893|Chromium|chromium|mesh-list
101365807|NCT00152893|Niacin|niacin|mesh-list
101365808|NCT00152893|Trace Elements|trace elements|mesh-ancestor
101365809|NCT00152893|Micronutrients|micronutrients|mesh-ancestor
101365810|NCT00152893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365818|NCT00152932|Dorzolamide|dorzolamide|mesh-list
101365819|NCT00152932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101365820|NCT00152932|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101784362|NCT00966615|Dialysis Solutions|dialysis solutions|mesh-list
101365821|NCT00152932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101365822|NCT00152932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365823|NCT00083031|Cyclophosphamide|cyclophosphamide|mesh-list
101365824|NCT00083031|Bevacizumab|bevacizumab|mesh-list
101365825|NCT00083031|Methotrexate|methotrexate|mesh-list
101365826|NCT00083031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101365827|NCT00083031|Immunologic Factors|immunologic factors|mesh-ancestor
101365828|NCT00083031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365829|NCT00083031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101365830|NCT00083031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101365831|NCT00083031|Alkylating Agents|alkylating agents|mesh-ancestor
101365832|NCT00083031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365833|NCT00083031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101365834|NCT00083031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101365835|NCT00083031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101304333|NCT02012244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101304334|NCT02012244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101304335|NCT02012244|Anesthetics, General|anesthetics, general|mesh-ancestor
101365838|NCT00083031|Growth Substances|growth substances|mesh-ancestor
101365839|NCT00083031|Growth Inhibitors|growth inhibitors|mesh-ancestor
101365840|NCT00083031|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101365841|NCT00083031|Abortifacient Agents|abortifacient agents|mesh-ancestor
101365842|NCT00083031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101365843|NCT00083031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101365844|NCT00083031|Antimetabolites|antimetabolites|mesh-ancestor
101365845|NCT00083031|Dermatologic Agents|dermatologic agents|mesh-ancestor
101784569|NCT00971685|Hormones|hormones|mesh-ancestor
101365846|NCT00083031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101365847|NCT00083031|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101365848|NCT00083031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101365849|NCT00050336|Lonafarnib|lonafarnib|mesh-list
101365850|NCT00050336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101365851|NCT00050336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365852|NCT00043758|Tolvaptan|tolvaptan|mesh-list
101365853|NCT00043758|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101365854|NCT00043758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365855|NCT00043758|Natriuretic Agents|natriuretic agents|mesh-ancestor
101365856|NCT00043758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365857|NCT00050375|Oregovomab|oregovomab|mesh-list
101365858|NCT00050375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101365859|NCT00050375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101365860|NCT00153049|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101365861|NCT00153049|Telmisartan|telmisartan|mesh-list
101365862|NCT00153049|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
101365863|NCT00153049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101365864|NCT00153049|Diuretics|diuretics|mesh-ancestor
101365865|NCT00153049|Natriuretic Agents|natriuretic agents|mesh-ancestor
102058697|NCT04455815|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102058698|NCT04455815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102058699|NCT04455815|Anticoagulants|anticoagulants|mesh-ancestor
102058700|NCT04197713|Olaparib|olaparib|mesh-list
102058701|NCT04197713|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
101365866|NCT00153049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365867|NCT00153049|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101365868|NCT00153049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101365869|NCT00153049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365870|NCT00153049|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101365871|NCT00153049|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101365872|NCT00153088|Telmisartan|telmisartan|mesh-list
101365873|NCT00153088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101365874|NCT00153088|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101365875|NCT00153088|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101365880|NCT00083070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365882|NCT00050414|Dexamethasone|dexamethasone|mesh-list
101365883|NCT00050414|Trabectedin|trabectedin|mesh-list
101365884|NCT00050414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101365885|NCT00050414|Antiemetics|antiemetics|mesh-ancestor
101784846|NCT00792350|Sorafenib|sorafenib|mesh-list
101365886|NCT00050414|Autonomic Agents|autonomic agents|mesh-ancestor
101365887|NCT00050414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101365888|NCT00050414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365889|NCT00050414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101365890|NCT00050414|Glucocorticoids|glucocorticoids|mesh-ancestor
101365891|NCT00050414|Hormones|hormones|mesh-ancestor
101365892|NCT00050414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101365893|NCT00050414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101365894|NCT00050414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101365895|NCT00050414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101365896|NCT00050414|Alkylating Agents|alkylating agents|mesh-ancestor
101365897|NCT00050414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365898|NCT00153127|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101365899|NCT00153127|Laxatives|laxatives|mesh-ancestor
101365900|NCT00153127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101365901|NCT00083109|Suramin|suramin|mesh-list
101365902|NCT00083109|Fluorouracil|fluorouracil|mesh-list
101365903|NCT00083109|Antimetabolites|antimetabolites|mesh-ancestor
101365904|NCT00083109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365905|NCT00083109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101333836|NCT00017316|Growth Inhibitors|growth inhibitors|mesh-ancestor
101365906|NCT00083109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101365907|NCT00083109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101365908|NCT00083109|Immunologic Factors|immunologic factors|mesh-ancestor
101546545|NCT01608464|Tubulin Modulators|tubulin modulators|mesh-ancestor
101365912|NCT00083109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101784949|NCT00960453|Incretins|incretins|mesh-ancestor
101365913|NCT00083109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101365914|NCT00083109|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101365915|NCT00083109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101365916|NCT00153244|Lamotrigine|lamotrigine|mesh-list
101365917|NCT00153244|Anticonvulsants|anticonvulsants|mesh-ancestor
101365918|NCT00153244|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101365919|NCT00153244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101365920|NCT00153244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365921|NCT00153244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101365922|NCT00153244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365923|NCT00153244|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101365924|NCT00153244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101365925|NCT00153244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101365926|NCT00153244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101365927|NCT00153244|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101365928|NCT00153283|Gabapentin|gabapentin|mesh-list
101365929|NCT00153283|Analgesics|analgesics|mesh-ancestor
101365930|NCT00153283|Sensory System Agents|sensory system agents|mesh-ancestor
101365931|NCT00153283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101365932|NCT00153283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365933|NCT00153283|Anticonvulsants|anticonvulsants|mesh-ancestor
101365934|NCT00153283|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102058702|NCT04197713|Adavosertib|adavosertib|mesh-list
102058703|NCT04197713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102058704|NCT04197713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058705|NCT04197713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058706|NCT04303403|Trametinib|trametinib|mesh-list
102058707|NCT04303403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058708|NCT04303403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101778454|NCT00784862|Tamoxifen|tamoxifen|mesh-list
101365935|NCT00153283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101365936|NCT00153283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101365937|NCT00153283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101365938|NCT00153283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101365939|NCT00153283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101365940|NCT00153283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101365941|NCT00153283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365942|NCT00153283|Antimanic Agents|antimanic agents|mesh-ancestor
101365943|NCT00050531|Interferons|interferons|mesh-list
101365944|NCT00050531|Interferon-alpha|interferon-alpha|mesh-list
101365958|NCT00050531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365960|NCT00083148|Irinotecan|irinotecan|mesh-list
101365961|NCT00083148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101365962|NCT00083148|Antimetabolites|antimetabolites|mesh-ancestor
101365963|NCT00083148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365964|NCT00083148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101365965|NCT00083148|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101365966|NCT00083148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101365967|NCT00083148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101365968|NCT00153517|Metronidazole|metronidazole|mesh-list
101365969|NCT00153517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101365970|NCT00153517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101365971|NCT00153517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101365972|NCT00153517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101365973|NCT00153556|Vaccines|vaccines|mesh-list
101365974|NCT00153556|Immunologic Factors|immunologic factors|mesh-ancestor
101365975|NCT00153556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365976|NCT00083187|Hydroxyurea|hydroxyurea|mesh-list
101365977|NCT00083187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101365978|NCT00083187|Antisickling Agents|antisickling agents|mesh-ancestor
101365979|NCT00083187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101365980|NCT00083187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365981|NCT00083187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101365982|NCT00153634|Azithromycin|azithromycin|mesh-list
101365983|NCT00153634|Ciprofloxacin|ciprofloxacin|mesh-list
101365984|NCT00153634|Meropenem|meropenem|mesh-list
101365985|NCT00153634|Tazobactam|tazobactam|mesh-list
101365986|NCT00153634|Piperacillin|piperacillin|mesh-list
101365987|NCT00153634|Tobramycin|tobramycin|mesh-list
101365988|NCT00153634|Clavulanic Acid|clavulanic acid|mesh-list
101365989|NCT00153634|Amikacin|amikacin|mesh-list
101365990|NCT00153634|Ceftazidime|ceftazidime|mesh-list
101365991|NCT00153634|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101365992|NCT00153634|Ticarcillin|ticarcillin|mesh-list
101365993|NCT00153634|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
101365994|NCT00153634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101365996|NCT00153634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101365997|NCT00153634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101366003|NCT00153634|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101366004|NCT00050609|Tadalafil|tadalafil|mesh-list
101366005|NCT00050609|Vasodilator Agents|vasodilator agents|mesh-ancestor
101366006|NCT00050609|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101366007|NCT00050609|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101366008|NCT00050609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101366014|NCT00153673|Analgesics|analgesics|mesh-ancestor
101785471|NCT00973245|Warfarin|warfarin|mesh-list
101366015|NCT00153673|Sensory System Agents|sensory system agents|mesh-ancestor
101366016|NCT00153673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101366017|NCT00153673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366018|NCT00153673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101366019|NCT00153673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101366020|NCT00153673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102058709|NCT04303403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102058710|NCT04303403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058711|NCT04148495|Acetaminophen|acetaminophen|mesh-list
102058712|NCT04148495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101785527|NCT04040322|Iloprost|iloprost|mesh-list
102058713|NCT04148495|Analgesics|analgesics|mesh-ancestor
102058714|NCT04148495|Sensory System Agents|sensory system agents|mesh-ancestor
102058715|NCT04148495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102058716|NCT04148495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058717|NCT04148495|Antipyretics|antipyretics|mesh-ancestor
102058718|NCT05060003|Atezolizumab|atezolizumab|mesh-list
102058719|NCT05060003|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101366021|NCT00153673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101366022|NCT00153673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101366023|NCT00153673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366024|NCT00050648|Cyclosporine|cyclosporine|mesh-list
101366025|NCT00050648|Cyclosporins|cyclosporins|mesh-list
101366026|NCT00050648|Daclizumab|daclizumab|mesh-list
101366027|NCT00050648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101366028|NCT00050648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366029|NCT00050648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101366030|NCT00050648|Immunologic Factors|immunologic factors|mesh-ancestor
101366031|NCT00050648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366032|NCT00050648|Antifungal Agents|antifungal agents|mesh-ancestor
101366033|NCT00050648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101366034|NCT00050648|Dermatologic Agents|dermatologic agents|mesh-ancestor
101366035|NCT00050648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101366036|NCT00050648|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101366037|NCT00153868|Darbepoetin alfa|darbepoetin alfa|mesh-list
101366038|NCT00153868|Hematinics|hematinics|mesh-ancestor
101366039|NCT00153907|Capecitabine|capecitabine|mesh-list
101366040|NCT00153907|Vinorelbine|vinorelbine|mesh-list
101366041|NCT00153907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101366042|NCT00153907|Antimetabolites|antimetabolites|mesh-ancestor
101366043|NCT00153907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366044|NCT00153907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366045|NCT00153907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101366046|NCT00153907|Tubulin Modulators|tubulin modulators|mesh-ancestor
101366047|NCT00153907|Antimitotic Agents|antimitotic agents|mesh-ancestor
101366048|NCT00153907|Mitosis Modulators|mitosis modulators|mesh-ancestor
101366049|NCT00050726|Interleukin-2|interleukin-2|mesh-list
101366050|NCT00050726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366051|NCT00050726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101366052|NCT00050726|Analgesics|analgesics|mesh-ancestor
101366053|NCT00050726|Sensory System Agents|sensory system agents|mesh-ancestor
101366054|NCT00050726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101366055|NCT00050726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366056|NCT00153946|Edaravone|edaravone|mesh-list
101366057|NCT00153946|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101366058|NCT00153946|Antioxidants|antioxidants|mesh-ancestor
101366059|NCT00153946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366060|NCT00153946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101366061|NCT00153946|Protective Agents|protective agents|mesh-ancestor
101366062|NCT00153946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366063|NCT00154024|Irbesartan|irbesartan|mesh-list
101366064|NCT00154024|Atorvastatin|atorvastatin|mesh-list
101366065|NCT00154024|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101366066|NCT00154024|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101366067|NCT00154024|Antimetabolites|antimetabolites|mesh-ancestor
101366068|NCT00154024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366069|NCT00154024|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101366070|NCT00154024|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101366071|NCT00154024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101366077|NCT00154141|Coagulants|coagulants|mesh-ancestor
101366078|NCT00154180|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101366082|NCT00154180|Estrogens|estrogens|mesh-list
102058720|NCT05060003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058721|NCT05060003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102058722|NCT05060003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058723|NCT04203641|Doxorubicin|doxorubicin|mesh-list
102058724|NCT04203641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102058725|NCT04203641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366083|NCT00154180|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101366084|NCT00154180|Progesterone|progesterone|mesh-list
101366086|NCT00154180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101366087|NCT00154180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366088|NCT00154180|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101366089|NCT00154180|Contraceptive Agents|contraceptive agents|mesh-ancestor
101366090|NCT00154180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101366091|NCT00154180|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101366092|NCT00154180|Progestins|progestins|mesh-ancestor
101366093|NCT00154219|Lumiracoxib|lumiracoxib|mesh-list
101366094|NCT00154219|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101366095|NCT00154219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101366096|NCT00154219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101366097|NCT00154219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366098|NCT00154219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101366099|NCT00154219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101366100|NCT00154219|Analgesics|analgesics|mesh-ancestor
101366101|NCT00154219|Sensory System Agents|sensory system agents|mesh-ancestor
101366102|NCT00154219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101366103|NCT00154219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366104|NCT00154219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101366105|NCT00154219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101366106|NCT00043875|Lamotrigine|lamotrigine|mesh-list
101366107|NCT00043875|Anticonvulsants|anticonvulsants|mesh-ancestor
101366108|NCT00043875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101366109|NCT00043875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101366110|NCT00043875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366111|NCT00043875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101366112|NCT00043875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366113|NCT00043875|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101366114|NCT00043875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101366115|NCT00043875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101366116|NCT00043875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101366117|NCT00043875|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101366118|NCT00154258|Clozapine|clozapine|mesh-list
101366119|NCT00154258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101366120|NCT00154258|Serotonin Agents|serotonin agents|mesh-ancestor
101366121|NCT00154258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101366122|NCT00154258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366123|NCT00154258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366124|NCT00154258|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101366125|NCT00154258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101366126|NCT00154258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101366127|NCT00154258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101366128|NCT00154258|GABA Antagonists|gaba antagonists|mesh-ancestor
101366129|NCT00154258|GABA Agents|gaba agents|mesh-ancestor
101366130|NCT00154336|Methotrexate|methotrexate|mesh-list
101366131|NCT00154336|Imatinib Mesylate|imatinib mesylate|mesh-list
101366132|NCT00154336|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101366133|NCT00154336|Abortifacient Agents|abortifacient agents|mesh-ancestor
101366134|NCT00154336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101366135|NCT00154336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304341|NCT02012322|Micronutrients|micronutrients|mesh-ancestor
101366141|NCT00154336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101366142|NCT00154336|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101366143|NCT00154336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101366144|NCT00154336|Immunologic Factors|immunologic factors|mesh-ancestor
101366145|NCT00154336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101366146|NCT00154336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101366147|NCT00154336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102058726|NCT04203641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102058727|NCT04203641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102058728|NCT04203641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102058729|NCT04203641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058731|NCT05051189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102058732|NCT05051189|Narcotics|narcotics|mesh-ancestor
102058733|NCT05051189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102058734|NCT05051189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058735|NCT05051189|Analgesics|analgesics|mesh-ancestor
101366148|NCT00050804|Sertraline|sertraline|mesh-list
101366149|NCT00050804|Antidepressive Agents|antidepressive agents|mesh-ancestor
101366161|NCT00043914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101366162|NCT00043914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366163|NCT00043914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101786499|NCT00802958|Glucocorticoids|glucocorticoids|mesh-ancestor
101366164|NCT00043914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366165|NCT00043914|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101366166|NCT00043914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101366167|NCT00043914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101366168|NCT00043914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101366169|NCT00043914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101366170|NCT04705987|Colchicine|colchicine|mesh-list
101366171|NCT04705987|Gout Suppressants|gout suppressants|mesh-ancestor
101366172|NCT04705987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101366173|NCT04705987|Tubulin Modulators|tubulin modulators|mesh-ancestor
101366174|NCT04705987|Antimitotic Agents|antimitotic agents|mesh-ancestor
101366175|NCT04705987|Mitosis Modulators|mitosis modulators|mesh-ancestor
101366176|NCT04705987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366177|NCT04705987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366178|NCT04705909|Pitavastatin|pitavastatin|mesh-list
101366179|NCT04705909|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
101387693|NCT00323011|Growth Substances|growth substances|mesh-ancestor
101366180|NCT04705909|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101366181|NCT04705909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101366182|NCT04705909|Antimetabolites|antimetabolites|mesh-ancestor
101366183|NCT04705909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366184|NCT04705909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101366185|NCT04705909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101366186|NCT00083304|Efaproxiral|efaproxiral|mesh-list
101366187|NCT00083304|Antisickling Agents|antisickling agents|mesh-ancestor
101366188|NCT00050843|Thalidomide|thalidomide|mesh-list
101366189|NCT00050843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101366190|NCT00050843|Immunologic Factors|immunologic factors|mesh-ancestor
101366191|NCT00050843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366192|NCT00050843|Leprostatic Agents|leprostatic agents|mesh-ancestor
101366193|NCT00050843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101366194|NCT00050843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101366195|NCT00050843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101366196|NCT00050843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101366197|NCT00050843|Growth Substances|growth substances|mesh-ancestor
101366198|NCT00050843|Growth Inhibitors|growth inhibitors|mesh-ancestor
101366199|NCT00050843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366200|NCT00406237|Tigecycline|tigecycline|mesh-list
101366201|NCT00406237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101366202|NCT00406237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101366203|NCT00406237|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101366204|NCT00406237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101366205|NCT00406237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366206|NCT00406432|Paroxetine|paroxetine|mesh-list
101366207|NCT00406432|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101546818|NCT00593697|Mitosis Modulators|mitosis modulators|mesh-ancestor
101366231|NCT00406471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366232|NCT00050921|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
101366233|NCT00050921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101366235|NCT00050921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058736|NCT05051189|Sensory System Agents|sensory system agents|mesh-ancestor
102058737|NCT05051189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102058738|NCT05051189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102058739|NCT05051189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102058740|NCT05051189|Anesthetics, General|anesthetics, general|mesh-ancestor
102058742|NCT04521647|Nicotine|nicotine|mesh-list
102058743|NCT04521647|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102058744|NCT04521647|Autonomic Agents|autonomic agents|mesh-ancestor
101366236|NCT00154687|Paclitaxel|paclitaxel|mesh-list
101366237|NCT00154687|Fluorouracil|fluorouracil|mesh-list
101786904|NCT05279391|Dexamethasone|dexamethasone|mesh-list
101366238|NCT00154687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101366239|NCT00154687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366240|NCT00154687|Tubulin Modulators|tubulin modulators|mesh-ancestor
101366241|NCT00154687|Antimitotic Agents|antimitotic agents|mesh-ancestor
101366242|NCT00154687|Mitosis Modulators|mitosis modulators|mesh-ancestor
101366243|NCT00154687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366244|NCT00154687|Antimetabolites|antimetabolites|mesh-ancestor
101366245|NCT00154687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101366246|NCT00154687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101366247|NCT00154687|Immunologic Factors|immunologic factors|mesh-ancestor
101366248|NCT00154687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366249|NCT00083460|Thalidomide|thalidomide|mesh-list
101366250|NCT00083460|Dexamethasone|dexamethasone|mesh-list
101366251|NCT00083460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101366252|NCT00083460|Antiemetics|antiemetics|mesh-ancestor
101366253|NCT00083460|Autonomic Agents|autonomic agents|mesh-ancestor
101366254|NCT00083460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101366255|NCT00083460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366256|NCT00083460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101366257|NCT00083460|Glucocorticoids|glucocorticoids|mesh-ancestor
101366258|NCT00083460|Hormones|hormones|mesh-ancestor
101366259|NCT00083460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101366270|NCT00083460|Growth Inhibitors|growth inhibitors|mesh-ancestor
101366271|NCT00154726|Paclitaxel|paclitaxel|mesh-list
101366272|NCT00154726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101366273|NCT00154726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366274|NCT00154726|Tubulin Modulators|tubulin modulators|mesh-ancestor
101366275|NCT00154726|Antimitotic Agents|antimitotic agents|mesh-ancestor
101366276|NCT00154726|Mitosis Modulators|mitosis modulators|mesh-ancestor
101366277|NCT00154726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366278|NCT00154804|Paclitaxel|paclitaxel|mesh-list
101366279|NCT00154804|Cisplatin|cisplatin|mesh-list
101366280|NCT00154804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101366281|NCT00154804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366286|NCT00154843|Lycopene|lycopene|mesh-list
101366287|NCT00154843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101366288|NCT00154843|Antioxidants|antioxidants|mesh-ancestor
101366289|NCT00154843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366290|NCT00154843|Protective Agents|protective agents|mesh-ancestor
101366291|NCT00154843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366292|NCT00154843|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101366293|NCT00154843|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101366294|NCT00154843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366295|NCT00043953|Ritonavir|ritonavir|mesh-list
101366296|NCT00043953|Lopinavir|lopinavir|mesh-list
101304345|NCT02012335|Analgesics|analgesics|mesh-ancestor
101787077|NCT00657020|Nicotine|nicotine|mesh-list
101304346|NCT02012335|Sensory System Agents|sensory system agents|mesh-ancestor
101366297|NCT00043953|Saquinavir|saquinavir|mesh-list
101366298|NCT00043953|Lamivudine|lamivudine|mesh-list
101366299|NCT00043953|Zidovudine|zidovudine|mesh-list
101366300|NCT00043953|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101366301|NCT00043953|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101366302|NCT00043953|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101366303|NCT00043953|Protease Inhibitors|protease inhibitors|mesh-ancestor
101366304|NCT00043953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101366305|NCT00043953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366306|NCT00043953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101366307|NCT00043953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102058745|NCT04521647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102058746|NCT04521647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058748|NCT04521647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102058749|NCT04521647|Cholinergic Agents|cholinergic agents|mesh-ancestor
102058750|NCT04521647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101366308|NCT00043953|Antiviral Agents|antiviral agents|mesh-ancestor
101366309|NCT00043953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101366310|NCT00043953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101366311|NCT00043953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101787203|NCT00797810|Prednisone|prednisone|mesh-list
101366312|NCT00043953|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101366313|NCT00043953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101366314|NCT00043953|Antimetabolites|antimetabolites|mesh-ancestor
101366315|NCT00154882|Paclitaxel|paclitaxel|mesh-list
101366316|NCT00154882|Cisplatin|cisplatin|mesh-list
101366317|NCT00154882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101366318|NCT00154882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366319|NCT00154882|Tubulin Modulators|tubulin modulators|mesh-ancestor
101366320|NCT00154882|Antimitotic Agents|antimitotic agents|mesh-ancestor
101366321|NCT00154882|Mitosis Modulators|mitosis modulators|mesh-ancestor
101366322|NCT00154882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366323|NCT00051077|Ribavirin|ribavirin|mesh-list
101366324|NCT00051077|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101366325|NCT00051077|Adefovir|adefovir|mesh-list
101366326|NCT00051077|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101366327|NCT00051077|Antimetabolites|antimetabolites|mesh-ancestor
101546935|NCT01605734|Sorafenib|sorafenib|mesh-list
101366333|NCT00051077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101366334|NCT00155233|Morphine|morphine|mesh-list
101366335|NCT00155233|Nalbuphine|nalbuphine|mesh-list
101366336|NCT00155233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101366337|NCT00155233|Narcotics|narcotics|mesh-ancestor
101366338|NCT00155233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101787405|NCT00873834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101366339|NCT00155233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366340|NCT00155233|Analgesics|analgesics|mesh-ancestor
101366341|NCT00155233|Sensory System Agents|sensory system agents|mesh-ancestor
101366342|NCT00155233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101366343|NCT00051116|Lenalidomide|lenalidomide|mesh-list
101366344|NCT00051116|Immunologic Factors|immunologic factors|mesh-ancestor
101366345|NCT00051116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366346|NCT00051116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101366347|NCT00051116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101366348|NCT00051116|Growth Substances|growth substances|mesh-ancestor
101366349|NCT00051116|Growth Inhibitors|growth inhibitors|mesh-ancestor
101366350|NCT00051116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366351|NCT00155272|Thalidomide|thalidomide|mesh-list
101366352|NCT00155272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101366353|NCT00155272|Immunologic Factors|immunologic factors|mesh-ancestor
101366360|NCT00155272|Growth Substances|growth substances|mesh-ancestor
101366361|NCT00155272|Growth Inhibitors|growth inhibitors|mesh-ancestor
101366362|NCT00155272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366364|NCT00155350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101366365|NCT00155350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366366|NCT00051155|Timolol|timolol|mesh-list
101366367|NCT00051155|Travoprost|travoprost|mesh-list
101366368|NCT00051155|Latanoprost|latanoprost|mesh-list
101366369|NCT00051155|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101366370|NCT00051155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101366371|NCT00051155|Adrenergic Agents|adrenergic agents|mesh-ancestor
101366372|NCT00051155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101366373|NCT00051155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304347|NCT02012335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101304348|NCT02012335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304349|NCT02012335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101304350|NCT02012335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101304351|NCT02012335|Anesthetics, General|anesthetics, general|mesh-ancestor
101366374|NCT00051155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366375|NCT00051155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101366376|NCT00051155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101366377|NCT00051155|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102058751|NCT04521647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058752|NCT04172597|Loperamide|loperamide|mesh-list
102058753|NCT04172597|Antidiarrheals|antidiarrheals|mesh-list
102058754|NCT04172597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102058755|NCT00446225|Carboplatin|carboplatin|mesh-list
102058756|NCT00446225|Docetaxel|docetaxel|mesh-list
102058757|NCT00446225|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
102058758|NCT00446225|Gemcitabine|gemcitabine|mesh-list
102058759|NCT00446225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058760|NCT00446225|Tubulin Modulators|tubulin modulators|mesh-ancestor
101360367|NCT00215839|Ribavirin|ribavirin|mesh-list
101366378|NCT00051155|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101366379|NCT00083538|Thalidomide|thalidomide|mesh-list
101366380|NCT00083538|Dexamethasone|dexamethasone|mesh-list
101366381|NCT00083538|Cyclophosphamide|cyclophosphamide|mesh-list
101366382|NCT00083538|Etoposide|etoposide|mesh-list
101366383|NCT00083538|Doxorubicin|doxorubicin|mesh-list
101366384|NCT00083538|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101366385|NCT00083538|Cisplatin|cisplatin|mesh-list
101366386|NCT00083538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101366387|NCT00083538|Immunologic Factors|immunologic factors|mesh-ancestor
101366388|NCT00083538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366389|NCT00083538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101366390|NCT00083538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101366391|NCT00083538|Alkylating Agents|alkylating agents|mesh-ancestor
101366392|NCT00083538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366393|NCT00083538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366394|NCT00083538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101366395|NCT00083538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101366396|NCT00083538|Antiemetics|antiemetics|mesh-ancestor
101366397|NCT00083538|Autonomic Agents|autonomic agents|mesh-ancestor
101366398|NCT00083538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101366399|NCT00083538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101366406|NCT00083538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101366407|NCT00083538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101366408|NCT00083538|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101366409|NCT00083538|Leprostatic Agents|leprostatic agents|mesh-ancestor
101366410|NCT00083538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101366411|NCT00083538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101366412|NCT00083538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101366413|NCT00083538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101366414|NCT00083538|Growth Substances|growth substances|mesh-ancestor
101366415|NCT00083538|Growth Inhibitors|growth inhibitors|mesh-ancestor
101366416|NCT00083577|Thalidomide|thalidomide|mesh-list
101366417|NCT00083577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101366418|NCT00083577|Immunologic Factors|immunologic factors|mesh-ancestor
101366419|NCT00083577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366420|NCT00083577|Leprostatic Agents|leprostatic agents|mesh-ancestor
101366421|NCT00083577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101366422|NCT00083577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101366437|NCT00406744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101366438|NCT00406744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101366439|NCT00406744|Growth Substances|growth substances|mesh-ancestor
101366440|NCT00406744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366441|NCT00406744|Growth Inhibitors|growth inhibitors|mesh-ancestor
101366442|NCT00399750|Bevacizumab|bevacizumab|mesh-list
101366443|NCT00399750|Oxaliplatin|oxaliplatin|mesh-list
101366444|NCT00399750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101366445|NCT00399750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366446|NCT00399750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101366447|NCT00399750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101366448|NCT00399750|Growth Substances|growth substances|mesh-ancestor
101366449|NCT00399750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366450|NCT00399750|Growth Inhibitors|growth inhibitors|mesh-ancestor
101366451|NCT00044148|Ruboxistaurin|ruboxistaurin|mesh-list
101366452|NCT00044148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101788217|NCT00882414|Hematinics|hematinics|mesh-ancestor
101304353|NCT02012335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102058761|NCT00446225|Antimitotic Agents|antimitotic agents|mesh-ancestor
102058762|NCT00446225|Mitosis Modulators|mitosis modulators|mesh-ancestor
102058763|NCT00446225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058764|NCT00446225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102058765|NCT00446225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102058766|NCT00446225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102058767|NCT00446225|Antimetabolites|antimetabolites|mesh-ancestor
102058768|NCT03080935|Evolocumab|evolocumab|mesh-list
101304354|NCT02012335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101304355|NCT02012335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101304356|NCT02012335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101304357|NCT02012335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304359|NCT02012387|Vaccines|vaccines|mesh-list
101304360|NCT02012387|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101304361|NCT02012387|Immunologic Factors|immunologic factors|mesh-ancestor
101304362|NCT02012387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304363|NCT02012387|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101304364|NCT02012387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101304365|NCT02012387|Respiratory System Agents|respiratory system agents|mesh-ancestor
101366453|NCT00044148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366454|NCT00156286|Imatinib Mesylate|imatinib mesylate|mesh-list
101366455|NCT00156286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366456|NCT00156286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101366457|NCT00156286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101366458|NCT00156286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366459|NCT00156325|Escitalopram|escitalopram|mesh-list
101366460|NCT00156325|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101366461|NCT00156325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101366462|NCT00156325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101366463|NCT00156325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366464|NCT00156325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101366465|NCT00156325|Serotonin Agents|serotonin agents|mesh-ancestor
101366466|NCT00156325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366470|NCT00156403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101788548|NCT04037514|Acetaminophen|acetaminophen|mesh-list
101366471|NCT00156403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366472|NCT00156403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101366473|NCT00156403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366474|NCT00156403|Vasodilator Agents|vasodilator agents|mesh-ancestor
101366475|NCT00051272|Bupropion|bupropion|mesh-list
101366476|NCT00051272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101366477|NCT00051272|Antidepressive Agents|antidepressive agents|mesh-ancestor
101788652|NCT02543034|Petrolatum|petrolatum|mesh-list
101366478|NCT00051272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101366479|NCT00051272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101366480|NCT00051272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101366481|NCT00051272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101366497|NCT00156520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366498|NCT00156520|Hemostatics|hemostatics|mesh-ancestor
101366499|NCT00156520|Coagulants|coagulants|mesh-ancestor
101366500|NCT00083694|Thalidomide|thalidomide|mesh-list
101366501|NCT00083694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101366502|NCT00083694|Immunologic Factors|immunologic factors|mesh-ancestor
101366503|NCT00083694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366504|NCT00083694|Leprostatic Agents|leprostatic agents|mesh-ancestor
101366505|NCT00083694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101366506|NCT00083694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101366507|NCT00083694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101366508|NCT00083694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101366509|NCT00083694|Growth Substances|growth substances|mesh-ancestor
101366510|NCT00083694|Growth Inhibitors|growth inhibitors|mesh-ancestor
101366511|NCT00083694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366512|NCT00051389|Fosinopril|fosinopril|mesh-list
101304367|NCT02012465|Insulin Glargine|insulin glargine|mesh-list
101304368|NCT02012465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101304369|NCT02012465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058769|NCT03080935|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102058770|NCT03080935|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102058771|NCT03080935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102058772|NCT03080935|Antimetabolites|antimetabolites|mesh-ancestor
101366513|NCT00051389|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101366514|NCT00051389|Protease Inhibitors|protease inhibitors|mesh-ancestor
101366515|NCT00051389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101366516|NCT00051389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366517|NCT00051389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101366518|NCT00156949|Epoetin Alfa|epoetin alfa|mesh-list
101366519|NCT00156949|Hematinics|hematinics|mesh-ancestor
101366520|NCT00156988|Sulfadiazine|sulfadiazine|mesh-list
101366521|NCT00156988|Silver Sulfadiazine|silver sulfadiazine|mesh-list
101366522|NCT00156988|Cerium nitrate|cerium nitrate|mesh-list
101366523|NCT00156988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101366524|NCT00156988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101788897|NCT00654368|Analgesics|analgesics|mesh-ancestor
101366525|NCT00156988|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101366526|NCT00156988|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101366527|NCT00156988|Coccidiostats|coccidiostats|mesh-ancestor
101366528|NCT00156988|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101366529|NCT00157066|Ergocalciferols|ergocalciferols|mesh-list
101366530|NCT00157066|Vitamin D|vitamin d|mesh-list
101366531|NCT00157066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101366532|NCT00157066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366533|NCT00157066|Vitamins|vitamins|mesh-ancestor
101366534|NCT00157066|Micronutrients|micronutrients|mesh-ancestor
101366535|NCT00157066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101366536|NCT00157105|Factor VIII|factor viii|mesh-list
101366537|NCT00157105|Coagulants|coagulants|mesh-ancestor
101366538|NCT00083772|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101366539|NCT00083772|Natriuretic Agents|natriuretic agents|mesh-ancestor
101366540|NCT00083772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366541|NCT00157261|Tenecteplase|tenecteplase|mesh-list
101366542|NCT00157261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101366543|NCT00157261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101366558|NCT00157378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101366559|NCT00157378|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101366560|NCT00157378|Dopamine Agents|dopamine agents|mesh-ancestor
101366561|NCT00157378|Antiemetics|antiemetics|mesh-ancestor
101366562|NCT00157378|Autonomic Agents|autonomic agents|mesh-ancestor
101366563|NCT00157378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101366564|NCT00157378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101366565|NCT00157378|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101366566|NCT00406861|Montelukast|montelukast|mesh-list
101366578|NCT00044265|Protease Inhibitors|protease inhibitors|mesh-ancestor
101366579|NCT00044265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101366580|NCT00044265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366581|NCT00044265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101366582|NCT00398099|Ertapenem|ertapenem|mesh-list
101366583|NCT00398099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101366584|NCT00398099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101366585|NCT00406978|Thalidomide|thalidomide|mesh-list
101366586|NCT00406978|Prednisone|prednisone|mesh-list
101366587|NCT00406978|Melphalan|melphalan|mesh-list
101366588|NCT00406978|Defibrotide|defibrotide|mesh-list
101366589|NCT00406978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101366590|NCT00406978|Glucocorticoids|glucocorticoids|mesh-ancestor
101366591|NCT00406978|Hormones|hormones|mesh-ancestor
101366592|NCT00406978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101366593|NCT00406978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366594|NCT00406978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101366595|NCT00406978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101304370|NCT02012517|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101304371|NCT02012517|Cefazolin|cefazolin|mesh-list
101304372|NCT02012517|Cephalexin|cephalexin|mesh-list
101366596|NCT00406978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101366597|NCT00406978|Alkylating Agents|alkylating agents|mesh-ancestor
101366598|NCT00406978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366599|NCT00406978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101366600|NCT00406978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101366601|NCT00406978|Immunologic Factors|immunologic factors|mesh-ancestor
101366602|NCT00406978|Leprostatic Agents|leprostatic agents|mesh-ancestor
101366603|NCT00406978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101366604|NCT00406978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102058773|NCT03080935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058774|NCT03080935|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102058775|NCT03080935|Protease Inhibitors|protease inhibitors|mesh-ancestor
102058776|NCT03080935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102058777|NCT03080935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102058778|NCT04479449|Otaplimastat|otaplimastat|mesh-list
102058779|NCT04479449|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101366615|NCT00044343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366616|NCT00044343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101366617|NCT00044343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101366618|NCT00044343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366619|NCT00157690|Alendronate|alendronate|mesh-list
101366620|NCT00157690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101366621|NCT00157690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366622|NCT00051506|Carboplatin|carboplatin|mesh-list
101366623|NCT00051506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366624|NCT00157729|Pyridoxal|pyridoxal|mesh-list
101366625|NCT00157729|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
101366626|NCT00157729|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101366627|NCT00157729|Protease Inhibitors|protease inhibitors|mesh-ancestor
101366628|NCT00157729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101366629|NCT00157729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366630|NCT00157729|Vitamin B Complex|vitamin b complex|mesh-ancestor
101366631|NCT00157729|Vitamins|vitamins|mesh-ancestor
101366632|NCT00157729|Micronutrients|micronutrients|mesh-ancestor
101366633|NCT00157729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366634|NCT00051545|Seocalcitol|seocalcitol|mesh-list
101366638|NCT00051545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366640|NCT00157885|Amodiaquine|amodiaquine|mesh-list
101366641|NCT00157885|Antimalarials|antimalarials|mesh-ancestor
101366642|NCT00157885|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101366643|NCT00157885|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101366644|NCT00157885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101366645|NCT00157885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366646|NCT00157885|Antiviral Agents|antiviral agents|mesh-ancestor
101366647|NCT00157885|Schistosomicides|schistosomicides|mesh-ancestor
101366648|NCT00157885|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101366649|NCT00157885|Anthelmintics|anthelmintics|mesh-ancestor
101366650|NCT00158002|Topiramate|topiramate|mesh-list
101366651|NCT00158002|Anticonvulsants|anticonvulsants|mesh-ancestor
101366652|NCT00158002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101366653|NCT00158002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366654|NCT00158041|Amifostine|amifostine|mesh-list
101366655|NCT00158041|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101366656|NCT00158041|Protective Agents|protective agents|mesh-ancestor
101366657|NCT00158041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366658|NCT00051584|Gemcitabine|gemcitabine|mesh-list
101366659|NCT00051584|Doxorubicin|doxorubicin|mesh-list
101366660|NCT00051584|Immunoconjugates|immunoconjugates|mesh-list
101366661|NCT00051584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101366662|NCT00051584|Antimetabolites|antimetabolites|mesh-ancestor
101366663|NCT00051584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366664|NCT00051584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366665|NCT00051584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101366666|NCT00051584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101366667|NCT00051584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101366668|NCT00051584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101366669|NCT00051584|Immunologic Factors|immunologic factors|mesh-ancestor
101366670|NCT00051584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366671|NCT00044382|Lenalidomide|lenalidomide|mesh-list
101366672|NCT00044382|Immunologic Factors|immunologic factors|mesh-ancestor
101366676|NCT00044382|Growth Substances|growth substances|mesh-ancestor
101366677|NCT00044382|Growth Inhibitors|growth inhibitors|mesh-ancestor
101366678|NCT00044382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101304373|NCT02012517|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101366679|NCT00158158|Nicotine|nicotine|mesh-list
101366680|NCT00158158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101366681|NCT00158158|Autonomic Agents|autonomic agents|mesh-ancestor
101366682|NCT00158158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102058780|NCT04479449|Protective Agents|protective agents|mesh-ancestor
102058781|NCT04479449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058783|NCT03674567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102058784|NCT03674567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058785|NCT03674567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102058786|NCT03674567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058787|NCT04986605|Methoxsalen|methoxsalen|mesh-list
102058788|NCT04986605|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101468769|NCT00241475|Gefitinib|gefitinib|mesh-list
101366683|NCT00158158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366684|NCT00158158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101366685|NCT00158158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101366686|NCT00158158|Cholinergic Agents|cholinergic agents|mesh-ancestor
101789810|NCT00893256|Risperidone|risperidone|mesh-list
101366687|NCT00158158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101366688|NCT00158158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366689|NCT00051623|Infliximab|infliximab|mesh-list
101366690|NCT00051623|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101366691|NCT00051623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101366692|NCT00051623|Dermatologic Agents|dermatologic agents|mesh-ancestor
101366693|NCT00051623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101366694|NCT00051623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101366695|NCT00158236|Buprenorphine|buprenorphine|mesh-list
101366696|NCT00158236|Hydromorphone|hydromorphone|mesh-list
101366697|NCT00158236|Naloxone|naloxone|mesh-list
101366698|NCT00158236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101366699|NCT00158236|Narcotics|narcotics|mesh-ancestor
101789888|NCT00893724|Vitamin E|vitamin e|mesh-list
101366700|NCT00158236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101366701|NCT00158236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366702|NCT00158236|Analgesics|analgesics|mesh-ancestor
101366703|NCT00158236|Sensory System Agents|sensory system agents|mesh-ancestor
101366704|NCT00158236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101366705|NCT00158236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101366706|NCT00158275|Antidepressive Agents|antidepressive agents|mesh-list
101366707|NCT00158275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101366708|NCT00044421|Ruboxistaurin|ruboxistaurin|mesh-list
101366709|NCT00044421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101366710|NCT00044421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366711|NCT00051701|Alemtuzumab|alemtuzumab|mesh-list
101366717|NCT00158470|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101366718|NCT00158470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101366719|NCT00158470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101366720|NCT00158470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366721|NCT00158470|Antiviral Agents|antiviral agents|mesh-ancestor
101366722|NCT00158470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101366723|NCT00158470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101366724|NCT00158470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101366725|NCT00158470|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101366726|NCT00158470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101366727|NCT00158470|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101366728|NCT00158470|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101366729|NCT00158470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101366730|NCT00158470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101366731|NCT00158470|Antimetabolites|antimetabolites|mesh-ancestor
101366732|NCT00158509|Valacyclovir|valacyclovir|mesh-list
101790063|NCT00635492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101366733|NCT00158509|Antiviral Agents|antiviral agents|mesh-ancestor
101366734|NCT00158509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101366735|NCT00158548|Artesunate|artesunate|mesh-list
101366736|NCT00158548|Chloroquine|chloroquine|mesh-list
101366737|NCT00158548|Primaquine|primaquine|mesh-list
101366738|NCT00158548|Amodiaquine|amodiaquine|mesh-list
101366739|NCT00158548|Antimalarials|antimalarials|mesh-ancestor
101366740|NCT00158548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101366741|NCT00158548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101366742|NCT00158548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101366743|NCT00158548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058789|NCT04986605|Dermatologic Agents|dermatologic agents|mesh-ancestor
102058791|NCT04390399|Paclitaxel|paclitaxel|mesh-list
102058792|NCT04390399|Cyclophosphamide|cyclophosphamide|mesh-list
102058793|NCT04390399|Gemcitabine|gemcitabine|mesh-list
102058794|NCT04390399|Fluorouracil|fluorouracil|mesh-list
102058795|NCT04390399|Irinotecan|irinotecan|mesh-list
102058796|NCT04390399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102058797|NCT04390399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101360410|NCT00216112|Docetaxel|docetaxel|mesh-list
101366744|NCT00158548|Antiviral Agents|antiviral agents|mesh-ancestor
101366745|NCT00158548|Schistosomicides|schistosomicides|mesh-ancestor
101366746|NCT00158548|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101366767|NCT00158821|Tenofovir|tenofovir|mesh-list
101366768|NCT00158821|Lamivudine|lamivudine|mesh-list
101366769|NCT00158821|Efavirenz|efavirenz|mesh-list
101366770|NCT00158821|Stavudine|stavudine|mesh-list
101366771|NCT00158821|Antiviral Agents|antiviral agents|mesh-ancestor
101366772|NCT00158821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101366773|NCT00158821|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101366774|NCT00158821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101304374|NCT02012517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101304375|NCT02012517|Antitubercular Agents|antitubercular agents|mesh-ancestor
101304376|NCT02012556|Tesamorelin|tesamorelin|mesh-list
101304377|NCT02012556|Growth Substances|growth substances|mesh-ancestor
101304378|NCT02012556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304379|NCT02012569|Hemostatics|hemostatics|mesh-list
101366775|NCT00158821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101366776|NCT00158821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366777|NCT00158821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101366778|NCT00158821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101366779|NCT00158821|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101366780|NCT00158821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101366781|NCT00158821|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101366782|NCT00158821|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101366783|NCT00158821|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101366784|NCT00158821|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101366785|NCT00158821|Antimetabolites|antimetabolites|mesh-ancestor
101366786|NCT05568147|Aspirin|aspirin|mesh-list
101366787|NCT05568147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101366788|NCT05568147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101366789|NCT05568147|Analgesics|analgesics|mesh-ancestor
101366790|NCT05568147|Sensory System Agents|sensory system agents|mesh-ancestor
101366791|NCT05568147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101366792|NCT05568147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366793|NCT05568147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101366794|NCT05568147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101366795|NCT05568147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101366796|NCT05568147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101366797|NCT05568147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366802|NCT00051896|Vanoxerine|vanoxerine|mesh-list
101366808|NCT00051896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101366809|NCT00051896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366811|NCT04724473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366812|NCT04724473|Keratolytic Agents|keratolytic agents|mesh-ancestor
101366813|NCT04724473|Dermatologic Agents|dermatologic agents|mesh-ancestor
101366814|NCT00159016|Imatinib Mesylate|imatinib mesylate|mesh-list
101366815|NCT00159016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366816|NCT00159016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101366817|NCT00159016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101366818|NCT00159016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366819|NCT00159094|Vinorelbine|vinorelbine|mesh-list
101366820|NCT00159094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101366821|NCT00159094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366822|NCT00159094|Tubulin Modulators|tubulin modulators|mesh-ancestor
101366823|NCT00159094|Antimitotic Agents|antimitotic agents|mesh-ancestor
101366824|NCT00159094|Mitosis Modulators|mitosis modulators|mesh-ancestor
101366825|NCT00159094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058798|NCT04390399|Tubulin Modulators|tubulin modulators|mesh-ancestor
102058799|NCT04390399|Antimitotic Agents|antimitotic agents|mesh-ancestor
102058800|NCT04390399|Mitosis Modulators|mitosis modulators|mesh-ancestor
102058801|NCT04390399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058802|NCT04390399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102058803|NCT04390399|Immunologic Factors|immunologic factors|mesh-ancestor
101366826|NCT02965053|Sevelamer|sevelamer|mesh-list
101366827|NCT02965053|Chelating Agents|chelating agents|mesh-ancestor
101366828|NCT02965053|Sequestering Agents|sequestering agents|mesh-ancestor
101366829|NCT02965053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366831|NCT00159133|Antipsychotic Agents|antipsychotic agents|mesh-list
101366832|NCT00159133|Anticonvulsants|anticonvulsants|mesh-ancestor
101366833|NCT00159133|Antiemetics|antiemetics|mesh-ancestor
101366834|NCT00159133|Autonomic Agents|autonomic agents|mesh-ancestor
101366835|NCT00159133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101790504|NCT00906126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101366836|NCT00159133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366837|NCT00159133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101366838|NCT00159133|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101366839|NCT00159133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101366840|NCT00159133|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101366841|NCT00159133|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101366842|NCT00159133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101366843|NCT00159133|GABA Modulators|gaba modulators|mesh-ancestor
101366844|NCT00159133|GABA Agents|gaba agents|mesh-ancestor
101304380|NCT02012569|Coagulants|coagulants|mesh-ancestor
101304381|NCT02012595|Donepezil|donepezil|mesh-list
101304382|NCT02012595|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101304383|NCT02012595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101790645|NCT00909168|Immunotoxins|immunotoxins|mesh-ancestor
101304384|NCT02012595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304385|NCT02012595|Cholinergic Agents|cholinergic agents|mesh-ancestor
101304386|NCT02012595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101304387|NCT02012595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304388|NCT02012595|Nootropic Agents|nootropic agents|mesh-ancestor
101304389|NCT02012738|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
101366845|NCT00159133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101366846|NCT00159133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366847|NCT00051974|Bortezomib|bortezomib|mesh-list
101366848|NCT00051974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366849|NCT00159211|Pioglitazone|pioglitazone|mesh-list
101366850|NCT00159211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101366851|NCT00159211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366852|NCT05567718|Anesthetics|anesthetics|mesh-list
101366853|NCT05567718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101366854|NCT05567718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366855|NCT00052013|Vatalanib|vatalanib|mesh-list
101366856|NCT00052013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101366857|NCT00052013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101790776|NCT00821600|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101366858|NCT00052013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366859|NCT00159445|Gemcitabine|gemcitabine|mesh-list
101366860|NCT00159445|Capecitabine|capecitabine|mesh-list
101366861|NCT00159445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101366862|NCT00159445|Antimetabolites|antimetabolites|mesh-ancestor
101366863|NCT00159445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366864|NCT00159445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366865|NCT00044460|Rosiglitazone|rosiglitazone|mesh-list
101366866|NCT00044460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101366888|NCT00052052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366889|NCT00052052|Antiviral Agents|antiviral agents|mesh-ancestor
101366890|NCT00052052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101366891|NCT00159679|Pregabalin|pregabalin|mesh-list
101366892|NCT00159679|Analgesics|analgesics|mesh-ancestor
101366893|NCT00159679|Sensory System Agents|sensory system agents|mesh-ancestor
101366894|NCT00159679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101366895|NCT00159679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366896|NCT00159679|Anticonvulsants|anticonvulsants|mesh-ancestor
101366897|NCT00159679|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101366898|NCT00159679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101366899|NCT00159679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366900|NCT00159679|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102058804|NCT04390399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058805|NCT04390399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102058806|NCT04390399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102058807|NCT04390399|Alkylating Agents|alkylating agents|mesh-ancestor
102058808|NCT04390399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102058809|NCT04390399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102058810|NCT04390399|Antimetabolites|antimetabolites|mesh-ancestor
102058811|NCT04390399|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102058812|NCT04390399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102058813|NCT04390399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102058814|NCT04390399|Antidotes|antidotes|mesh-ancestor
102058815|NCT04390399|Protective Agents|protective agents|mesh-ancestor
102058816|NCT04390399|Vitamin B Complex|vitamin b complex|mesh-ancestor
102058817|NCT04390399|Vitamins|vitamins|mesh-ancestor
102058818|NCT04390399|Micronutrients|micronutrients|mesh-ancestor
102058819|NCT01383655|Magnesium Sulfate|magnesium sulfate|mesh-list
102058820|NCT01383655|Analgesics|analgesics|mesh-ancestor
102058821|NCT01383655|Sensory System Agents|sensory system agents|mesh-ancestor
102058822|NCT01383655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101360422|NCT00216190|Midazolam|midazolam|mesh-list
101366901|NCT00159679|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101366902|NCT00159679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101791178|NCT00907452|Growth Substances|growth substances|mesh-ancestor
101366903|NCT00159679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101366904|NCT00159679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101366906|NCT00159718|Atorvastatin|atorvastatin|mesh-list
101366907|NCT00159718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101366908|NCT00159718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101366909|NCT00159718|Antimetabolites|antimetabolites|mesh-ancestor
101366910|NCT00159718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366911|NCT00159718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101366912|NCT00159718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101366913|NCT00159718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101366914|NCT00159718|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101304390|NCT02012738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101304391|NCT02012738|Immunologic Factors|immunologic factors|mesh-ancestor
101333838|NCT00041275|Megestrol|megestrol|mesh-list
101366915|NCT00159718|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101366916|NCT00159718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101366917|NCT00159718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101366918|NCT00159718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366919|NCT00159718|Vasodilator Agents|vasodilator agents|mesh-ancestor
101366920|NCT00159757|Ziprasidone|ziprasidone|mesh-list
101366921|NCT00159757|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101366922|NCT00159757|Serotonin Agents|serotonin agents|mesh-ancestor
101366923|NCT00159757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101791308|NCT00224029|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101366924|NCT00159757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366925|NCT00159757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366926|NCT00159757|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101366927|NCT00159757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101366928|NCT00159757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101366929|NCT00159757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101366930|NCT00159757|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101791385|NCT00822536|Aspirin|aspirin|mesh-list
101366931|NCT00159757|Dopamine Agents|dopamine agents|mesh-ancestor
101366932|NCT00159835|Atorvastatin|atorvastatin|mesh-list
101366948|NCT00052169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101366949|NCT00052169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101366950|NCT00159952|Insulin|insulin|mesh-list
102058823|NCT01383655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058824|NCT01383655|Anesthetics|anesthetics|mesh-ancestor
102058825|NCT01383655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102058826|NCT01383655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102058827|NCT01383655|Anticonvulsants|anticonvulsants|mesh-ancestor
101791439|NCT00822614|Anesthetics|anesthetics|mesh-ancestor
102058828|NCT01383655|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102058829|NCT01383655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101366951|NCT00159952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101366952|NCT00159952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366953|NCT00052208|Gefitinib|gefitinib|mesh-list
101366954|NCT00052208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366955|NCT00052208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101366956|NCT00052208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101366957|NCT00052208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366958|NCT00407017|Moxifloxacin|moxifloxacin|mesh-list
101366959|NCT00407017|Gatifloxacin|gatifloxacin|mesh-list
101366960|NCT00407017|Ketorolac|ketorolac|mesh-list
101366961|NCT00407017|Nepafenac|nepafenac|mesh-list
101366962|NCT00407017|Prednisolone acetate|prednisolone acetate|mesh-list
101366963|NCT00407017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101366964|NCT00407017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101366983|NCT00160069|Sagopilone|sagopilone|mesh-list
101366984|NCT00160069|Epothilones|epothilones|mesh-list
101366985|NCT00160069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366986|NCT00160069|Tubulin Modulators|tubulin modulators|mesh-ancestor
101366987|NCT00160069|Antimitotic Agents|antimitotic agents|mesh-ancestor
101366988|NCT00160069|Mitosis Modulators|mitosis modulators|mesh-ancestor
101366989|NCT00160069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366990|NCT00052286|Modafinil|modafinil|mesh-list
101366991|NCT00052286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101366992|NCT00052286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366993|NCT00052286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101366994|NCT00052286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101367004|NCT05567484|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101367005|NCT05567484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101367006|NCT05567484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367007|NCT05567484|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101367008|NCT05567484|Hormone Antagonists|hormone antagonists|mesh-ancestor
101304392|NCT02012738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304393|NCT02012777|Propranolol|propranolol|mesh-list
101367009|NCT05567484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101367010|NCT05567484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367011|NCT05567484|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101367013|NCT00160264|Lactulose|lactulose|mesh-list
101367014|NCT00160264|Calcium|calcium|mesh-list
101367015|NCT00160264|Vitamins|vitamins|mesh-ancestor
101367016|NCT00160264|Micronutrients|micronutrients|mesh-ancestor
101367017|NCT00160264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367018|NCT00160264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101367019|NCT00160264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101367020|NCT00160264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101367021|NCT00160342|Methyltestosterone|methyltestosterone|mesh-list
101367022|NCT00160342|Estrogens|estrogens|mesh-list
101367023|NCT00160342|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
101367024|NCT00160342|Estrone|estrone|mesh-list
101367025|NCT00160342|Testosterone|testosterone|mesh-list
101367026|NCT00160342|Testosterone undecanoate|testosterone undecanoate|mesh-list
101367027|NCT00160342|Testosterone enanthate|testosterone enanthate|mesh-list
101367028|NCT00160342|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101367029|NCT00160342|Hormones|hormones|mesh-ancestor
101367038|NCT00052403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101367039|NCT00052403|Antibodies|antibodies|mesh-list
101367040|NCT00052403|Immunoglobulins|immunoglobulins|mesh-list
101367041|NCT00052403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101791755|NCT04469556|Antidotes|antidotes|mesh-ancestor
101367042|NCT00052403|Antibodies, Anti-Idiotypic|antibodies, anti-idiotypic|mesh-list
101367043|NCT00052403|Immunologic Factors|immunologic factors|mesh-list
101367044|NCT00052403|Mitogens|mitogens|mesh-list
101367045|NCT00052403|Immunomodulating Agents|immunomodulating agents|mesh-list
101367046|NCT00052403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058830|NCT01383655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058831|NCT01383655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102058832|NCT01383655|Tocolytic Agents|tocolytic agents|mesh-ancestor
102058833|NCT01383655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102058834|NCT01568281|Anastrozole|anastrozole|mesh-list
101360446|NCT00216268|Ribavirin|ribavirin|mesh-list
101367047|NCT00052403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101367048|NCT00052403|Mitosis Modulators|mitosis modulators|mesh-ancestor
101367049|NCT00052403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367050|NCT00160498|Lercanidipine|lercanidipine|mesh-list
101367051|NCT00160498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101367052|NCT00160498|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101367053|NCT00160498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101367054|NCT00160498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367055|NCT00160498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101367056|NCT00160498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367058|NCT00160537|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101367059|NCT00160537|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101367060|NCT00160537|Histamine Antagonists|histamine antagonists|mesh-ancestor
101367078|NCT00160849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101367079|NCT00160849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101367080|NCT00160888|Nitroprusside|nitroprusside|mesh-list
101367081|NCT00160888|Acetylcholine|acetylcholine|mesh-list
101367082|NCT00160888|Bradykinin|bradykinin|mesh-list
101367083|NCT00160888|Kininogens|kininogens|mesh-list
101367084|NCT00160888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101367085|NCT00160888|Vasodilator Agents|vasodilator agents|mesh-ancestor
101367086|NCT00160888|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101367087|NCT00160888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367088|NCT00160888|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101367089|NCT00160888|Cholinergic Agents|cholinergic agents|mesh-ancestor
101367090|NCT00160888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101791929|NCT00933582|Naproxen|naproxen|mesh-list
101367091|NCT00160888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367092|NCT00160888|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
101367093|NCT00160888|Protease Inhibitors|protease inhibitors|mesh-ancestor
101367094|NCT00160888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101367095|NCT00160927|Nitroprusside|nitroprusside|mesh-list
101367096|NCT00160927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101367097|NCT00160927|Vasodilator Agents|vasodilator agents|mesh-ancestor
101367098|NCT00160927|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101304394|NCT02012777|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101367099|NCT00160927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367100|NCT00160966|Cyclosporine|cyclosporine|mesh-list
101367101|NCT00160966|Mycophenolic Acid|mycophenolic acid|mesh-list
101367102|NCT00160966|Everolimus|everolimus|mesh-list
101367103|NCT00160966|Tacrolimus|tacrolimus|mesh-list
101367104|NCT00160966|Cyclosporins|cyclosporins|mesh-list
101367105|NCT00160966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101367106|NCT00160966|Immunologic Factors|immunologic factors|mesh-ancestor
101367107|NCT00160966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367108|NCT00160966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101367109|NCT00160966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101367110|NCT00160966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367111|NCT00160966|Antifungal Agents|antifungal agents|mesh-ancestor
101367115|NCT00160966|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101367116|NCT00160966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101367117|NCT00160966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101367118|NCT00160966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101367119|NCT00160966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101367120|NCT00160966|Antitubercular Agents|antitubercular agents|mesh-ancestor
101367129|NCT00052559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101367130|NCT00052559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101367132|NCT00052559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367133|NCT00052559|Growth Inhibitors|growth inhibitors|mesh-ancestor
101367134|NCT00052559|Immunologic Factors|immunologic factors|mesh-ancestor
101367135|NCT00052559|Antimetabolites|antimetabolites|mesh-ancestor
101792141|NCT05361057|Cytarabine|cytarabine|mesh-list
102058835|NCT01568281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102058836|NCT01568281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058837|NCT01568281|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102058838|NCT01568281|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102058839|NCT01568281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102058840|NCT01568281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367136|NCT00052559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367137|NCT00052559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101367138|NCT00052559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101367139|NCT00161083|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101367140|NCT00161083|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101367141|NCT00161083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101367143|NCT00044577|Lamivudine|lamivudine|mesh-list
101367144|NCT00044577|Abacavir|abacavir|mesh-list
101367145|NCT00044577|Dideoxynucleosides|dideoxynucleosides|mesh-list
101367146|NCT00044577|Antiviral Agents|antiviral agents|mesh-ancestor
101792191|NCT00832442|Sympatholytics|sympatholytics|mesh-ancestor
101367147|NCT00044577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101367148|NCT00044577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101367149|NCT00044577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101367150|NCT00044577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101367151|NCT00044577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367152|NCT00044577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101367153|NCT00044577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101367154|NCT00044577|Antimetabolites|antimetabolites|mesh-ancestor
101367155|NCT00161122|Vaccines|vaccines|mesh-list
101367156|NCT00161122|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101367157|NCT00161122|Immunologic Factors|immunologic factors|mesh-ancestor
101792247|NCT04043702|Topiramate|topiramate|mesh-list
101367158|NCT00161122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367159|NCT00161200|Pantoprazole|pantoprazole|mesh-list
101367160|NCT00161200|Ranitidine|ranitidine|mesh-list
101367161|NCT00161200|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
101367162|NCT00161200|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101367163|NCT00161200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101367164|NCT00161200|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101367165|NCT00161200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101367166|NCT00161200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367167|NCT00161200|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101367168|NCT00161200|Histamine Antagonists|histamine antagonists|mesh-ancestor
101367169|NCT00161200|Histamine Agents|histamine agents|mesh-ancestor
101367170|NCT00161200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101367171|NCT00161200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367172|NCT00161239|Prednisone|prednisone|mesh-list
101367173|NCT00161239|Methotrexate|methotrexate|mesh-list
101367174|NCT00161239|Asparaginase|asparaginase|mesh-list
101367175|NCT00161239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101367176|NCT00161239|Glucocorticoids|glucocorticoids|mesh-ancestor
101367177|NCT00161239|Hormones|hormones|mesh-ancestor
101367178|NCT00161239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101367179|NCT00161239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304395|NCT02012777|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101304396|NCT02012777|Adrenergic Agents|adrenergic agents|mesh-ancestor
101304397|NCT02012777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101792296|NCT00537381|Docetaxel|docetaxel|mesh-list
101333839|NCT00041275|Megestrol Acetate|megestrol acetate|mesh-list
101367180|NCT00161239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101367181|NCT00161239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101367182|NCT00161239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101367183|NCT00161239|Abortifacient Agents|abortifacient agents|mesh-ancestor
101367184|NCT00161239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101367185|NCT00161239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101367186|NCT00161239|Antimetabolites|antimetabolites|mesh-ancestor
101367187|NCT00161239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367188|NCT00161239|Dermatologic Agents|dermatologic agents|mesh-ancestor
101367189|NCT00161239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101367202|NCT00161278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367203|NCT00044616|Fluoxetine|fluoxetine|mesh-list
101367204|NCT00044616|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102058841|NCT01568281|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102058842|NCT01568281|Hormone Antagonists|hormone antagonists|mesh-ancestor
102058843|NCT01568281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102058844|NCT01568281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058845|NCT02921789|Mycophenolic Acid|mycophenolic acid|mesh-list
102058846|NCT02921789|Prednisone|prednisone|mesh-list
102058847|NCT02921789|Tacrolimus|tacrolimus|mesh-list
102058848|NCT02921789|Basiliximab|basiliximab|mesh-list
101360460|NCT00216385|Gatifloxacin|gatifloxacin|mesh-list
101367205|NCT00044616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101367206|NCT00044616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101367207|NCT00044616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367208|NCT00044616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101367209|NCT00044616|Serotonin Agents|serotonin agents|mesh-ancestor
101367210|NCT00044616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367211|NCT00044616|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101367212|NCT00044616|Antidepressive Agents|antidepressive agents|mesh-ancestor
101367213|NCT00044616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101367214|NCT00044616|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101367215|NCT00044616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101367216|NCT00044616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101367217|NCT00161356|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101367218|NCT00161356|Antifungal Agents|antifungal agents|mesh-ancestor
101367219|NCT00161356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101367220|NCT00161356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101367221|NCT00161356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101367222|NCT00052676|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
101367223|NCT00052676|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101367224|NCT00052676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367225|NCT00161434|Valacyclovir|valacyclovir|mesh-list
101367226|NCT00161434|Antiviral Agents|antiviral agents|mesh-ancestor
101367227|NCT00161434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101367228|NCT00044694|Exenatide|exenatide|mesh-list
101367229|NCT00044694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101792538|NCT00625742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101367230|NCT00044694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367231|NCT00044694|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101367232|NCT00044694|Incretins|incretins|mesh-ancestor
101367233|NCT00044694|Hormones|hormones|mesh-ancestor
101367234|NCT00044694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101367235|NCT00052754|Gefitinib|gefitinib|mesh-list
101367236|NCT00052754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101367237|NCT00052754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101367238|NCT00052754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101367239|NCT00052754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367240|NCT00161590|Alemtuzumab|alemtuzumab|mesh-list
101367241|NCT00161590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101367242|NCT00161590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101367243|NCT00161668|Gemtuzumab|gemtuzumab|mesh-list
101367244|NCT00161668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101367245|NCT00161668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101367246|NCT00161668|Immunotoxins|immunotoxins|mesh-ancestor
101367247|NCT00161668|Immunoconjugates|immunoconjugates|mesh-ancestor
101792596|NCT03997864|Prazosin|prazosin|mesh-list
101367248|NCT00161668|Immunologic Factors|immunologic factors|mesh-ancestor
101304398|NCT02012777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304399|NCT02012777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304400|NCT02012777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101367249|NCT00161668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367250|NCT00052832|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
101367252|NCT00052832|Micronutrients|micronutrients|mesh-ancestor
101367253|NCT00052832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367254|NCT00052832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101367255|NCT00161707|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
101367258|NCT00161707|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101367260|NCT00161707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101367270|NCT00044733|Immunologic Factors|immunologic factors|mesh-ancestor
102058849|NCT02921789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101792664|NCT00840398|Buspirone|buspirone|mesh-list
102058850|NCT02921789|Glucocorticoids|glucocorticoids|mesh-ancestor
102058851|NCT02921789|Hormones|hormones|mesh-ancestor
102058852|NCT02921789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102058853|NCT02921789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058854|NCT02921789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101367271|NCT00044733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367272|NCT00052949|Imatinib Mesylate|imatinib mesylate|mesh-list
101367273|NCT00052949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101367274|NCT00052949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101367275|NCT00052949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101792703|NCT00834860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101367276|NCT00052949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367277|NCT00161902|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101367278|NCT00161902|Hemostatics|hemostatics|mesh-ancestor
101367279|NCT00161902|Coagulants|coagulants|mesh-ancestor
101367280|NCT00053027|Rituximab|rituximab|mesh-list
101367281|NCT00053027|Cladribine|cladribine|mesh-list
101367282|NCT00053027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101367283|NCT00053027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101367284|NCT00053027|Immunologic Factors|immunologic factors|mesh-ancestor
101367285|NCT00053027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367286|NCT00053027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101367287|NCT00053027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101367288|NCT00161980|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101367289|NCT00161980|Hemostatics|hemostatics|mesh-ancestor
101367290|NCT00161980|Coagulants|coagulants|mesh-ancestor
101367291|NCT00162019|Factor VIII|factor viii|mesh-list
101367292|NCT00162019|Coagulants|coagulants|mesh-ancestor
101367293|NCT00162214|Ketoconazole|ketoconazole|mesh-list
101367294|NCT00162214|Dasatinib|dasatinib|mesh-list
101367295|NCT00162214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101367296|NCT00162214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101367297|NCT00162214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101367298|NCT00162214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367299|NCT00162214|Antifungal Agents|antifungal agents|mesh-ancestor
101367300|NCT00162214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101367301|NCT00162214|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101792834|NCT00825656|Capsaicin|capsaicin|mesh-list
101367302|NCT00162214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101367303|NCT00162214|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101367304|NCT00162214|Hormone Antagonists|hormone antagonists|mesh-ancestor
101367305|NCT00162214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101367306|NCT00162214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367307|NCT00162214|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101367308|NCT04731116|Cannabidiol|cannabidiol|mesh-list
101367309|NCT04731116|Anticonvulsants|anticonvulsants|mesh-ancestor
101367310|NCT00407056|Difluprednate|difluprednate|mesh-list
101367311|NCT00407056|Glucocorticoids|glucocorticoids|mesh-ancestor
101367312|NCT00407056|Hormones|hormones|mesh-ancestor
101367313|NCT00407056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101367314|NCT00407056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367315|NCT00405457|Cyclosporine|cyclosporine|mesh-list
101367316|NCT00405457|Cyclosporins|cyclosporins|mesh-list
101367317|NCT00405457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101367318|NCT00405457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367319|NCT00405457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101367320|NCT00405457|Immunologic Factors|immunologic factors|mesh-ancestor
101367321|NCT00405457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367322|NCT00405457|Antifungal Agents|antifungal agents|mesh-ancestor
101367323|NCT00405457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101367324|NCT00405457|Dermatologic Agents|dermatologic agents|mesh-ancestor
101367325|NCT00405457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101304401|NCT02012777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101304402|NCT02012777|Vasodilator Agents|vasodilator agents|mesh-ancestor
101304403|NCT02012920|Seviteronel|seviteronel|mesh-list
101367326|NCT00405457|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101367327|NCT00053105|Cytarabine|cytarabine|mesh-list
101367328|NCT00053105|Methylprednisolone|methylprednisolone|mesh-list
101367342|NCT00053105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101367343|NCT00053105|Immunologic Factors|immunologic factors|mesh-ancestor
102058855|NCT02921789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058856|NCT02921789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102058857|NCT02921789|Immunologic Factors|immunologic factors|mesh-ancestor
102058858|NCT02921789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102058859|NCT02921789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102058860|NCT02921789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058861|NCT02921789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101367344|NCT00053105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367345|NCT00053105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101367346|NCT00053105|Antiemetics|antiemetics|mesh-ancestor
101367347|NCT00053105|Autonomic Agents|autonomic agents|mesh-ancestor
101547727|NCT01380080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101367351|NCT00053105|Hormones|hormones|mesh-ancestor
101367352|NCT00053105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101367353|NCT00053105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101367354|NCT00053105|Protective Agents|protective agents|mesh-ancestor
101367355|NCT00053105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101367356|NCT00053105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101367357|NCT00053105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101367358|NCT00053105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101367359|NCT00162331|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
101367360|NCT00162331|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101793056|NCT03902613|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101367361|NCT00162331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367363|NCT00162409|Hematinics|hematinics|mesh-ancestor
101367364|NCT00162409|Vitamin B Complex|vitamin b complex|mesh-ancestor
101367365|NCT00162409|Vitamins|vitamins|mesh-ancestor
101367366|NCT00162409|Micronutrients|micronutrients|mesh-ancestor
101367367|NCT00162409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367368|NCT00053144|Cytarabine|cytarabine|mesh-list
101367369|NCT00053144|Irinotecan|irinotecan|mesh-list
101367370|NCT00053144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101367371|NCT00053144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101367372|NCT00053144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101367373|NCT00053144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367374|NCT00053144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101367375|NCT00053144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101367376|NCT00053144|Antimetabolites|antimetabolites|mesh-ancestor
101367377|NCT00053144|Antiviral Agents|antiviral agents|mesh-ancestor
101367378|NCT00053144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101367379|NCT00053144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101367380|NCT00053144|Immunologic Factors|immunologic factors|mesh-ancestor
101793185|NCT00844142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101367381|NCT00053144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367382|NCT00162487|Albuterol|albuterol|mesh-list
101367383|NCT00162487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101367384|NCT00162487|Autonomic Agents|autonomic agents|mesh-ancestor
101367385|NCT00162487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101367386|NCT00162487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367387|NCT00162487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101367388|NCT00162487|Respiratory System Agents|respiratory system agents|mesh-ancestor
101367389|NCT00162487|Tocolytic Agents|tocolytic agents|mesh-ancestor
101367390|NCT00162487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101367391|NCT00162487|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101367392|NCT00162487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101367407|NCT00162565|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101367408|NCT00162565|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101367409|NCT00162565|Adrenergic Agents|adrenergic agents|mesh-ancestor
101367410|NCT00162565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101367411|NCT00162565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367412|NCT00162565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367413|NCT00162604|Cefuroxime|cefuroxime|mesh-list
101367414|NCT00162604|Cefuroxime axetil|cefuroxime axetil|mesh-list
101367415|NCT00162604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101367416|NCT00162604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101367417|NCT00162643|Ritonavir|ritonavir|mesh-list
101367418|NCT00162643|Lopinavir|lopinavir|mesh-list
101367419|NCT00162643|Lamivudine|lamivudine|mesh-list
101367420|NCT00162643|Zidovudine|zidovudine|mesh-list
101367421|NCT00162643|Efavirenz|efavirenz|mesh-list
101367422|NCT00162643|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102058862|NCT02921789|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102058863|NCT02921789|Antitubercular Agents|antitubercular agents|mesh-ancestor
102058864|NCT02921789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102058865|NCT02921789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102058866|NCT02564900|Camptothecin|camptothecin|mesh-list
102058867|NCT02564900|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
102058868|NCT02564900|Immunoconjugates|immunoconjugates|mesh-list
102058869|NCT02564900|Immunologic Factors|immunologic factors|mesh-ancestor
102058870|NCT02564900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058871|NCT02564900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102058872|NCT02564900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058873|NCT02564900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101367423|NCT00162643|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101367424|NCT00162643|Protease Inhibitors|protease inhibitors|mesh-ancestor
101367425|NCT00162643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101304404|NCT02012920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101304405|NCT02012920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101304406|NCT02012920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101304407|NCT02012920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304408|NCT02012933|Amifampridine|amifampridine|mesh-list
101367426|NCT00162643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367427|NCT00162643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101367428|NCT00162643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101367429|NCT00162643|Antiviral Agents|antiviral agents|mesh-ancestor
101367430|NCT00162643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101367434|NCT00162643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101367436|NCT00162643|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101367437|NCT00162643|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101367438|NCT00162643|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101367439|NCT00162643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101367440|NCT00162643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101367441|NCT00162682|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101367442|NCT00162682|Antiviral Agents|antiviral agents|mesh-ancestor
101367443|NCT00162682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101367444|NCT00044772|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101367445|NCT00044772|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101793420|NCT00855530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367446|NCT00044772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101367447|NCT00044772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101367448|NCT00044772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367449|NCT00044772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101367450|NCT00044772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367451|NCT00044772|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101367452|NCT00044772|Antidepressive Agents|antidepressive agents|mesh-ancestor
101367453|NCT00044772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101367458|NCT00162721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101367459|NCT00162721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101367460|NCT00162721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101367461|NCT00162721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367462|NCT00162721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101367463|NCT00162721|Alkylating Agents|alkylating agents|mesh-ancestor
101367464|NCT00053222|Arsenic Trioxide|arsenic trioxide|mesh-list
101367465|NCT00053222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101367466|NCT00162760|Thalidomide|thalidomide|mesh-list
101793543|NCT02773485|Cisplatin|cisplatin|mesh-list
101367467|NCT00162760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101367468|NCT00162760|Immunologic Factors|immunologic factors|mesh-ancestor
101367469|NCT00162760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367470|NCT00162760|Leprostatic Agents|leprostatic agents|mesh-ancestor
101367471|NCT00162760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101367472|NCT00162760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102058874|NCT02564900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102058875|NCT02564900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101360494|NCT00216580|Risperidone|risperidone|mesh-list
101367473|NCT00162760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101367474|NCT00162760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101367475|NCT00162760|Growth Substances|growth substances|mesh-ancestor
101367476|NCT00162760|Growth Inhibitors|growth inhibitors|mesh-ancestor
101367477|NCT00162760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101367479|NCT00162799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101367480|NCT00044811|Fexofenadine|fexofenadine|mesh-list
101367481|NCT00044811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101367482|NCT00044811|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101367483|NCT00044811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101367484|NCT00044811|Histamine Antagonists|histamine antagonists|mesh-ancestor
101367485|NCT00044811|Histamine Agents|histamine agents|mesh-ancestor
101367486|NCT00044811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101367487|NCT00044811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367488|NCT00044811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367489|NCT00162877|Esomeprazole|esomeprazole|mesh-list
101367490|NCT00162877|Rabeprazole|rabeprazole|mesh-list
101304409|NCT02012933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101304410|NCT02012933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101304411|NCT02012933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304412|NCT02012933|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101304414|NCT02012933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367491|NCT00162877|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101367492|NCT00162877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101367493|NCT00162877|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101367494|NCT00162877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101367495|NCT00162877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367500|NCT00162916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367501|NCT00162916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101367502|NCT00162916|Serotonin Agents|serotonin agents|mesh-ancestor
101793663|NCT02592863|Antioxidants|antioxidants|mesh-ancestor
101367503|NCT00162916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367504|NCT00162916|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101367505|NCT00162916|Antidepressive Agents|antidepressive agents|mesh-ancestor
101367506|NCT00162916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101367507|NCT00163072|Megestrol Acetate|megestrol acetate|mesh-list
101367508|NCT00163072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101367509|NCT00163072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101367510|NCT00163072|Appetite Stimulants|appetite stimulants|mesh-ancestor
101367511|NCT00163072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101367512|NCT00163072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367513|NCT00163111|Amphotericin B|amphotericin b|mesh-list
101367514|NCT00163111|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101367515|NCT00163111|Fluconazole|fluconazole|mesh-list
101367516|NCT00163111|Amebicides|amebicides|mesh-ancestor
101367517|NCT00163111|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101367518|NCT00163111|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101367519|NCT00163111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101367520|NCT00163111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101367521|NCT00163111|Antifungal Agents|antifungal agents|mesh-ancestor
101367522|NCT00163111|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101367523|NCT00163111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101367524|NCT00163111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101367529|NCT00163111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367530|NCT00163111|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101367531|NCT00163111|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101367532|NCT00163150|Atorvastatin|atorvastatin|mesh-list
101367533|NCT00163150|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101367534|NCT00163150|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101367535|NCT00163150|Antimetabolites|antimetabolites|mesh-ancestor
101367536|NCT00163150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367537|NCT00163150|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101367538|NCT00163150|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101367539|NCT00163150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101367540|NCT00163267|Clopidogrel|clopidogrel|mesh-list
101367541|NCT00163267|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102058876|NCT02564900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058877|NCT01568333|Decitabine|decitabine|mesh-list
102058878|NCT01568333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102058879|NCT01568333|Antimetabolites|antimetabolites|mesh-ancestor
102058880|NCT01568333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058881|NCT01568333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058882|NCT01568333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102058883|NCT03437005|Ketoconazole|ketoconazole|mesh-list
102058884|NCT03437005|Desonide|desonide|mesh-list
102058885|NCT03437005|Antifungal Agents|antifungal agents|mesh-ancestor
101367542|NCT00163267|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101367543|NCT00163267|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101793899|NCT00849368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101367544|NCT00163267|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101367545|NCT00163267|Purinergic Agents|purinergic agents|mesh-ancestor
101367546|NCT00163267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101367547|NCT00163267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367548|NCT00163267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367549|NCT00163306|Pantoprazole|pantoprazole|mesh-list
101367550|NCT00163306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101367551|NCT00163306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101367552|NCT00163306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101367553|NCT00163306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101304415|NCT02012946|Simendan|simendan|mesh-list
101304416|NCT02012946|Dobutamine|dobutamine|mesh-list
101304417|NCT02012946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101304418|NCT02012946|Vasodilator Agents|vasodilator agents|mesh-ancestor
101304419|NCT02012946|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101367554|NCT00163306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367555|NCT00044889|Clofarabine|clofarabine|mesh-list
101367556|NCT00044889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101367557|NCT00044889|Antimetabolites|antimetabolites|mesh-ancestor
101367558|NCT00044889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367559|NCT00044889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101367560|NCT00163345|Ciclesonide|ciclesonide|mesh-list
101367561|NCT00163345|Glucocorticoids|glucocorticoids|mesh-ancestor
101367562|NCT00163345|Hormones|hormones|mesh-ancestor
101367567|NCT00163384|Glucocorticoids|glucocorticoids|mesh-ancestor
101367568|NCT00163384|Hormones|hormones|mesh-ancestor
101367569|NCT00163384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101367570|NCT00163384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367571|NCT00163384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101367572|NCT00163423|Ciclesonide|ciclesonide|mesh-list
101367573|NCT00163423|Glucocorticoids|glucocorticoids|mesh-ancestor
101367574|NCT00163423|Hormones|hormones|mesh-ancestor
101367575|NCT00163423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101794096|NCT00507442|Hormones|hormones|mesh-ancestor
101367576|NCT00163423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367577|NCT00163423|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101367578|NCT04731038|Paclitaxel|paclitaxel|mesh-list
101367579|NCT04731038|Carboplatin|carboplatin|mesh-list
101367580|NCT04731038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101367581|NCT04731038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101367582|NCT04731038|Tubulin Modulators|tubulin modulators|mesh-ancestor
101367583|NCT04731038|Antimitotic Agents|antimitotic agents|mesh-ancestor
101367584|NCT04731038|Mitosis Modulators|mitosis modulators|mesh-ancestor
101367585|NCT04731038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367586|NCT00163462|Ciclesonide|ciclesonide|mesh-list
101367587|NCT00163462|Glucocorticoids|glucocorticoids|mesh-ancestor
101367588|NCT00163462|Hormones|hormones|mesh-ancestor
101794168|NCT00865436|Metformin|metformin|mesh-list
101367589|NCT00163462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101367590|NCT00163462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367591|NCT00163462|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101367596|NCT00053300|Leprostatic Agents|leprostatic agents|mesh-ancestor
101367597|NCT00053300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101367598|NCT00053300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101794219|NCT00864734|Metformin|metformin|mesh-list
102058886|NCT03437005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102058887|NCT03437005|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102058888|NCT03437005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102058889|NCT03437005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102058890|NCT03437005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058891|NCT03437005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102058892|NCT03437005|Hormone Antagonists|hormone antagonists|mesh-ancestor
102058893|NCT03437005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102058894|NCT03437005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058895|NCT03437005|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102058896|NCT03437005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102058897|NCT03943823|Estrogens|estrogens|mesh-list
102058898|NCT03943823|Hormones|hormones|mesh-ancestor
102058899|NCT03943823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102058900|NCT03943823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058901|NCT02535338|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101794351|NCT03121534|Dexamethasone|dexamethasone|mesh-list
102058902|NCT02535338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058903|NCT02535338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102058904|NCT02535338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102058905|NCT02535338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058906|NCT02484248|Ketotifen|ketotifen|mesh-list
102058907|NCT02484248|Antipruritics|antipruritics|mesh-ancestor
102058908|NCT02484248|Dermatologic Agents|dermatologic agents|mesh-ancestor
101367599|NCT00053300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101367600|NCT00053300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101367601|NCT00053300|Growth Substances|growth substances|mesh-ancestor
101367602|NCT00053300|Growth Inhibitors|growth inhibitors|mesh-ancestor
101367603|NCT00053300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101367604|NCT00163501|Ciclesonide|ciclesonide|mesh-list
101367605|NCT00163501|Glucocorticoids|glucocorticoids|mesh-ancestor
101367606|NCT00163501|Hormones|hormones|mesh-ancestor
101367607|NCT00163501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101367608|NCT00163501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367609|NCT00163501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101367610|NCT00163540|Formaldehyde|formaldehyde|mesh-list
101367611|NCT00163540|Disinfectants|disinfectants|mesh-ancestor
101367612|NCT00163540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101367613|NCT00053339|Tamoxifen|tamoxifen|mesh-list
101367614|NCT00053339|Trastuzumab|trastuzumab|mesh-list
101367615|NCT00053339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101367616|NCT00053339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101367617|NCT00053339|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101367618|NCT00053339|Hormone Antagonists|hormone antagonists|mesh-ancestor
101367619|NCT00053339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101367620|NCT00053339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367621|NCT00053339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101304420|NCT02012946|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102058909|NCT02484248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102058910|NCT02484248|Histamine Antagonists|histamine antagonists|mesh-ancestor
102058911|NCT02484248|Histamine Agents|histamine agents|mesh-ancestor
102058912|NCT02484248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102058913|NCT02484248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360535|NCT00216658|Anesthetics, General|anesthetics, general|mesh-ancestor
101304421|NCT02012946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101304422|NCT02012946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304423|NCT02012946|Protective Agents|protective agents|mesh-ancestor
101367622|NCT00053339|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101367623|NCT00053339|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101367624|NCT00053339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101367625|NCT00163618|Formaldehyde|formaldehyde|mesh-list
101367626|NCT00163618|Disinfectants|disinfectants|mesh-ancestor
101367627|NCT00163618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101367628|NCT00053378|Calcium|calcium|mesh-list
101367629|NCT00053378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101367630|NCT00053378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367631|NCT02970383|Narcotics|narcotics|mesh-list
101367638|NCT05502900|Antioxidants|antioxidants|mesh-ancestor
101367639|NCT05502900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367640|NCT05502900|Protective Agents|protective agents|mesh-ancestor
101367641|NCT05502900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367642|NCT05502900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101367643|NCT00163969|Ketamine|ketamine|mesh-list
101367644|NCT00163969|Analgesics|analgesics|mesh-ancestor
101367645|NCT00163969|Sensory System Agents|sensory system agents|mesh-ancestor
101367646|NCT00163969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101367647|NCT00163969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367648|NCT00163969|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101367649|NCT00163969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101367650|NCT00163969|Anesthetics, General|anesthetics, general|mesh-ancestor
101367651|NCT00163969|Anesthetics|anesthetics|mesh-ancestor
101367652|NCT00163969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101367653|NCT00163969|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101367654|NCT00163969|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101367655|NCT00163969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101367656|NCT00163969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367657|NCT00164008|Zoledronic Acid|zoledronic acid|mesh-list
101367658|NCT00164008|Pamidronate|pamidronate|mesh-list
101367659|NCT00164008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101367660|NCT00164008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367661|NCT00164047|Nitrous Oxide|nitrous oxide|mesh-list
101367666|NCT00164047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367668|NCT00164047|Analgesics|analgesics|mesh-ancestor
101367669|NCT00164047|Sensory System Agents|sensory system agents|mesh-ancestor
101367670|NCT00164047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101367671|NCT00164086|Atorvastatin|atorvastatin|mesh-list
101367672|NCT00164086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101367673|NCT00164086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101367674|NCT00164086|Antimetabolites|antimetabolites|mesh-ancestor
101794524|NCT00871442|Narcotics|narcotics|mesh-ancestor
101367675|NCT00164086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367676|NCT00164086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101367677|NCT00164086|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101367678|NCT00164086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101367679|NCT00164125|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101367680|NCT00164125|Laxatives|laxatives|mesh-ancestor
101367681|NCT00164125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101367682|NCT00164164|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101367683|NCT00164164|Laxatives|laxatives|mesh-ancestor
101367684|NCT00164164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101367685|NCT00164242|Galantamine|galantamine|mesh-list
101367686|NCT00164242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101367687|NCT00164242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101367688|NCT00164242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367689|NCT00164242|Cholinergic Agents|cholinergic agents|mesh-ancestor
102058914|NCT02484248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058915|NCT02484248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102058916|NCT02419742|Paclitaxel|paclitaxel|mesh-list
102058917|NCT02419742|Docetaxel|docetaxel|mesh-list
102058918|NCT02419742|Cyclophosphamide|cyclophosphamide|mesh-list
102058919|NCT02419742|Carboplatin|carboplatin|mesh-list
101360540|NCT00216775|Ribavirin|ribavirin|mesh-list
101304424|NCT02012946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367690|NCT00164242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101367691|NCT00164242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367692|NCT00164242|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101367693|NCT00164242|Autonomic Agents|autonomic agents|mesh-ancestor
101367694|NCT00164242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101367695|NCT00164242|Nootropic Agents|nootropic agents|mesh-ancestor
101367696|NCT00162955|Valsartan|valsartan|mesh-list
101367697|NCT00162955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101367698|NCT00162955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101367699|NCT00162955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101367700|NCT00162955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367701|NCT00164281|Isoniazid|isoniazid|mesh-list
101367702|NCT00164281|Antitubercular Agents|antitubercular agents|mesh-ancestor
101367703|NCT00164281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101367708|NCT00164281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367710|NCT00044928|Tazobactam|tazobactam|mesh-list
101367711|NCT00044928|Piperacillin|piperacillin|mesh-list
101367712|NCT00044928|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101367713|NCT00044928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101367714|NCT00044928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101367715|NCT00044928|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101367716|NCT00044928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101367717|NCT00044928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367718|NCT00164359|Artesunate|artesunate|mesh-list
101367719|NCT00164359|Amodiaquine|amodiaquine|mesh-list
101367720|NCT00164359|Dapsone|dapsone|mesh-list
101367721|NCT00164359|Chlorproguanil|chlorproguanil|mesh-list
101367722|NCT00164359|Antimalarials|antimalarials|mesh-ancestor
101367723|NCT00164359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101367724|NCT00164359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101367725|NCT00164359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101367726|NCT00164359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101367728|NCT00164359|Schistosomicides|schistosomicides|mesh-ancestor
101367729|NCT00164359|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101367730|NCT00164359|Anthelmintics|anthelmintics|mesh-ancestor
101367731|NCT00164359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101367732|NCT00164359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101367733|NCT00164359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367737|NCT00053612|Vitamins|vitamins|mesh-ancestor
101367738|NCT00053612|Micronutrients|micronutrients|mesh-ancestor
101367739|NCT00053612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367740|NCT00045006|Vorinostat|vorinostat|mesh-list
101367741|NCT00045006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101367742|NCT00045006|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101367743|NCT00045006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101367744|NCT00045006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367745|NCT00164710|Artesunate|artesunate|mesh-list
101367746|NCT00164710|Lumefantrine|lumefantrine|mesh-list
101367747|NCT00164710|Artemether|artemether|mesh-list
101367748|NCT00164710|Pyrimethamine|pyrimethamine|mesh-list
101367749|NCT00164710|Sulfadoxine|sulfadoxine|mesh-list
101367750|NCT00164710|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101367751|NCT00164710|Amodiaquine|amodiaquine|mesh-list
101367752|NCT00164710|Dapsone|dapsone|mesh-list
101367753|NCT00164710|Chlorproguanil|chlorproguanil|mesh-list
101367754|NCT00164710|Antimalarials|antimalarials|mesh-ancestor
101367755|NCT00164710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101367756|NCT00164710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101367757|NCT00164710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101367758|NCT00164710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101367759|NCT00164710|Antiviral Agents|antiviral agents|mesh-ancestor
101367760|NCT00164710|Schistosomicides|schistosomicides|mesh-ancestor
101367761|NCT00164710|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101367762|NCT00164710|Anthelmintics|anthelmintics|mesh-ancestor
101367763|NCT00164710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102058920|NCT02419742|Doxorubicin|doxorubicin|mesh-list
102058921|NCT02419742|Trastuzumab|trastuzumab|mesh-list
102058922|NCT02419742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102058923|NCT02419742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058924|NCT02419742|Tubulin Modulators|tubulin modulators|mesh-ancestor
101367764|NCT00164710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101367765|NCT00164710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367766|NCT00164710|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101367767|NCT00164710|Leprostatic Agents|leprostatic agents|mesh-ancestor
101304426|NCT02012946|Autonomic Agents|autonomic agents|mesh-ancestor
101304427|NCT02012946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101367768|NCT00164710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101367769|NCT00045045|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101367770|NCT00045045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101367771|NCT00045045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367772|NCT00164749|Curcumin|curcumin|mesh-list
101367773|NCT00164749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101367774|NCT00164749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101367775|NCT00164749|Analgesics|analgesics|mesh-ancestor
101367776|NCT00164749|Sensory System Agents|sensory system agents|mesh-ancestor
101367777|NCT00164749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101367787|NCT00164788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101367788|NCT00164788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101367789|NCT00164788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367790|NCT00053768|Prednisone|prednisone|mesh-list
101367791|NCT00053768|Cyclophosphamide|cyclophosphamide|mesh-list
101367792|NCT00053768|Doxorubicin|doxorubicin|mesh-list
101367793|NCT00053768|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101367794|NCT00053768|Etoposide|etoposide|mesh-list
101367795|NCT00053768|Vincristine|vincristine|mesh-list
101367796|NCT00053768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101367797|NCT00053768|Immunologic Factors|immunologic factors|mesh-ancestor
101367798|NCT00053768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367799|NCT00053768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101367800|NCT00053768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101367801|NCT00053768|Alkylating Agents|alkylating agents|mesh-ancestor
101367802|NCT00053768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367803|NCT00053768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101367804|NCT00053768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101367805|NCT00053768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101367806|NCT00053768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101367807|NCT00053768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101367808|NCT00053768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101367821|NCT00045123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367822|NCT00164866|Omeprazole|omeprazole|mesh-list
101367823|NCT00164866|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101367824|NCT00164866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101367825|NCT00164866|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101367826|NCT00164866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101367827|NCT00164866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367828|NCT00407212|Maleic acid|maleic acid|mesh-list
101367829|NCT00407212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101367830|NCT00407212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367831|NCT00165139|Cyclophosphamide|cyclophosphamide|mesh-list
101367832|NCT00165139|Melphalan|melphalan|mesh-list
101367833|NCT00165139|Ifosfamide|ifosfamide|mesh-list
101367834|NCT00165139|Carboplatin|carboplatin|mesh-list
101367835|NCT00165139|Etoposide|etoposide|mesh-list
101367836|NCT00165139|Vincristine|vincristine|mesh-list
101367837|NCT00165139|Doxorubicin|doxorubicin|mesh-list
101367838|NCT00165139|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101367839|NCT00165139|Lenograstim|lenograstim|mesh-list
101367840|NCT00165139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101367841|NCT00165139|Immunologic Factors|immunologic factors|mesh-ancestor
101367842|NCT00165139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367843|NCT00165139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101367844|NCT00165139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101367845|NCT00165139|Alkylating Agents|alkylating agents|mesh-ancestor
101367846|NCT00165139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367847|NCT00165139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058925|NCT02419742|Antimitotic Agents|antimitotic agents|mesh-ancestor
102058926|NCT02419742|Mitosis Modulators|mitosis modulators|mesh-ancestor
102058927|NCT02419742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058928|NCT02419742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102058929|NCT02419742|Immunologic Factors|immunologic factors|mesh-ancestor
101367848|NCT00165139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101367849|NCT00165139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101304428|NCT02012946|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101304429|NCT02012946|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101304430|NCT02012946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101304431|NCT02012946|Adrenergic Agents|adrenergic agents|mesh-ancestor
101304432|NCT02012946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101304433|NCT02012998|Vaccines|vaccines|mesh-list
101304434|NCT02012998|Immunologic Factors|immunologic factors|mesh-ancestor
101367863|NCT00053807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367864|NCT00053807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101367865|NCT00053807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101367866|NCT00053807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101367867|NCT00053807|Immunologic Factors|immunologic factors|mesh-ancestor
101367868|NCT00053807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367869|NCT00053807|Antiviral Agents|antiviral agents|mesh-ancestor
101367870|NCT00053807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101367871|NCT00053807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101367872|NCT00053807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101367879|NCT00165178|Methotrexate|methotrexate|mesh-list
101367880|NCT00165178|Vincristine|vincristine|mesh-list
101367881|NCT00165178|Asparaginase|asparaginase|mesh-list
101367882|NCT00165178|Dexrazoxane|dexrazoxane|mesh-list
101367883|NCT00165178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101367884|NCT00165178|Antiemetics|antiemetics|mesh-ancestor
101367885|NCT00165178|Autonomic Agents|autonomic agents|mesh-ancestor
101367886|NCT00165178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101367887|NCT00165178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367888|NCT00165178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101367889|NCT00165178|Glucocorticoids|glucocorticoids|mesh-ancestor
101367891|NCT00165178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101367892|NCT00165178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101367893|NCT00165178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101367894|NCT00165178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101367895|NCT00165178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101367896|NCT00165178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101367897|NCT00165178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101367898|NCT00165178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367899|NCT00165178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101367900|NCT00165178|Abortifacient Agents|abortifacient agents|mesh-ancestor
101367901|NCT00165178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101367902|NCT00165178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101367903|NCT00165178|Antimetabolites|antimetabolites|mesh-ancestor
101367904|NCT00165178|Dermatologic Agents|dermatologic agents|mesh-ancestor
101367905|NCT00165178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101367906|NCT00165178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101367907|NCT00165178|Immunologic Factors|immunologic factors|mesh-ancestor
101367908|NCT00165178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101367909|NCT00165178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101367910|NCT00165178|Antiviral Agents|antiviral agents|mesh-ancestor
101367911|NCT00165178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101367912|NCT00165178|Antidotes|antidotes|mesh-ancestor
101367913|NCT00165178|Protective Agents|protective agents|mesh-ancestor
101367914|NCT00165178|Vitamin B Complex|vitamin b complex|mesh-ancestor
101367915|NCT00165178|Vitamins|vitamins|mesh-ancestor
101367916|NCT00165178|Micronutrients|micronutrients|mesh-ancestor
101367917|NCT00165178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101304436|NCT02013102|Decitabine|decitabine|mesh-list
101367918|NCT00165178|Tubulin Modulators|tubulin modulators|mesh-ancestor
101367919|NCT00165178|Antimitotic Agents|antimitotic agents|mesh-ancestor
101367920|NCT00165178|Mitosis Modulators|mitosis modulators|mesh-ancestor
101367921|NCT00165178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101367922|NCT00165217|Thalidomide|thalidomide|mesh-list
101367923|NCT00165217|Capecitabine|capecitabine|mesh-list
101367924|NCT00165217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101367925|NCT00165217|Antimetabolites|antimetabolites|mesh-ancestor
102058930|NCT02419742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102058931|NCT02419742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102058932|NCT02419742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102058933|NCT02419742|Alkylating Agents|alkylating agents|mesh-ancestor
102058934|NCT02419742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102058935|NCT02419742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101367926|NCT00165217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367927|NCT00165217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101367928|NCT00165217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101367929|NCT00165217|Immunologic Factors|immunologic factors|mesh-ancestor
101367930|NCT00165217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367931|NCT00165217|Leprostatic Agents|leprostatic agents|mesh-ancestor
101367932|NCT00165217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101367933|NCT00165217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101367934|NCT00165217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101367935|NCT00165217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101367936|NCT00165217|Growth Substances|growth substances|mesh-ancestor
101367937|NCT00165217|Growth Inhibitors|growth inhibitors|mesh-ancestor
101367938|NCT00165295|Sildenafil Citrate|sildenafil citrate|mesh-list
101367939|NCT00165295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367940|NCT00165295|Vasodilator Agents|vasodilator agents|mesh-ancestor
101367941|NCT00165295|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101367942|NCT00165295|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101367943|NCT00165295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101367944|NCT00165295|Urological Agents|urological agents|mesh-ancestor
101367945|NCT00053885|Vatalanib|vatalanib|mesh-list
101367953|NCT00165334|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101367954|NCT00165334|Tubulin Modulators|tubulin modulators|mesh-ancestor
101367955|NCT00165334|Antimitotic Agents|antimitotic agents|mesh-ancestor
101367956|NCT00165334|Mitosis Modulators|mitosis modulators|mesh-ancestor
101367957|NCT00165334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367958|NCT00165373|Endostatins|endostatins|mesh-list
101367959|NCT00165373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101367960|NCT00165373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101367961|NCT00165373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101367962|NCT00165373|Growth Substances|growth substances|mesh-ancestor
101367963|NCT00165373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367964|NCT00165373|Growth Inhibitors|growth inhibitors|mesh-ancestor
101367965|NCT00165451|Thalidomide|thalidomide|mesh-list
101367966|NCT00165451|Celecoxib|celecoxib|mesh-list
101367967|NCT00165451|Cyclophosphamide|cyclophosphamide|mesh-list
101367968|NCT00165451|Etoposide|etoposide|mesh-list
101367969|NCT00165451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101367970|NCT00165451|Immunologic Factors|immunologic factors|mesh-ancestor
101367971|NCT00165451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367972|NCT00165451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101367973|NCT00165451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101367974|NCT00165451|Alkylating Agents|alkylating agents|mesh-ancestor
101367975|NCT00165451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367976|NCT00165451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101367977|NCT00165451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101367978|NCT00165451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101367979|NCT00165451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101367980|NCT00165451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101367981|NCT00165451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101367982|NCT00165451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101367983|NCT00165451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101367984|NCT00165451|Analgesics|analgesics|mesh-ancestor
101367985|NCT00165451|Sensory System Agents|sensory system agents|mesh-ancestor
101367986|NCT00165451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101367987|NCT00165451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101367988|NCT00165451|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101367989|NCT00165451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101367993|NCT00165451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101367994|NCT00165451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101367995|NCT00165451|Growth Substances|growth substances|mesh-ancestor
101367996|NCT00165451|Growth Inhibitors|growth inhibitors|mesh-ancestor
102058937|NCT02419742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102058938|NCT02419742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102058939|NCT02419742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102058941|NCT02409290|Levofloxacin|levofloxacin|mesh-list
102058942|NCT02409290|Isoniazid|isoniazid|mesh-list
101367997|NCT00165490|Irinotecan|irinotecan|mesh-list
101367998|NCT00165490|Cetuximab|cetuximab|mesh-list
101367999|NCT00165490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368000|NCT00165490|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101368001|NCT00165490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101368002|NCT00165490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101368003|NCT00165490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368004|NCT00165490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101368005|NCT00165568|Bevacizumab|bevacizumab|mesh-list
101368006|NCT00165568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101368007|NCT00165568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368008|NCT00165568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101368009|NCT00165568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101368010|NCT00165568|Growth Substances|growth substances|mesh-ancestor
101368011|NCT00165568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368031|NCT00053963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101368032|NCT00053963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368034|NCT00165763|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101368035|NCT00165763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101368036|NCT00165763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368037|NCT00165763|Cholinergic Agents|cholinergic agents|mesh-ancestor
101368038|NCT00165763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101368039|NCT00165763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368040|NCT00165763|Nootropic Agents|nootropic agents|mesh-ancestor
101368041|NCT00165880|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
101368042|NCT00165880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368043|NCT00165880|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101368044|NCT00165880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101368045|NCT00165880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368046|NCT00045318|Exatecan|exatecan|mesh-list
101368047|NCT00045318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101368048|NCT00045318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101368049|NCT00045318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101368050|NCT00045318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368051|NCT00045318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368052|NCT00054002|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
101368053|NCT00054002|Trioxsalen|trioxsalen|mesh-list
101368054|NCT00054002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368055|NCT00054002|Dermatologic Agents|dermatologic agents|mesh-ancestor
101368056|NCT00054002|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101368057|NCT00054041|Vaccines|vaccines|mesh-list
101368058|NCT00054041|Immunologic Factors|immunologic factors|mesh-ancestor
101368059|NCT00054041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368060|NCT00166153|Mycophenolic Acid|mycophenolic acid|mesh-list
101368061|NCT00166153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101368062|NCT00166153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368063|NCT00166153|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101368064|NCT00166153|Antitubercular Agents|antitubercular agents|mesh-ancestor
101368065|NCT00166153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101368066|NCT00166153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101368067|NCT00166153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101368068|NCT00166153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368103|NCT00166465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101368104|NCT00166465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368105|NCT00166465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101368106|NCT00166465|Immunologic Factors|immunologic factors|mesh-ancestor
101368107|NCT00166465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368108|NCT00166465|Antidotes|antidotes|mesh-ancestor
101368109|NCT00166465|Protective Agents|protective agents|mesh-ancestor
101368110|NCT00166465|Vitamin B Complex|vitamin b complex|mesh-ancestor
101548368|NCT04327232|Spironolactone|spironolactone|mesh-list
102058943|NCT02409290|Pyrazinamide|pyrazinamide|mesh-list
102058944|NCT02409290|Ethambutol|ethambutol|mesh-list
102058945|NCT02409290|Bedaquiline|bedaquiline|mesh-list
102058946|NCT02409290|Clofazimine|clofazimine|mesh-list
101368115|NCT00166621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101368116|NCT00166621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101368117|NCT00166621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368118|NCT00166621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101368119|NCT00166621|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101368120|NCT00166621|Serotonin Agents|serotonin agents|mesh-ancestor
101368121|NCT00166621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101368122|NCT00166621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368123|NCT00054236|Methylprednisolone|methylprednisolone|mesh-list
101368124|NCT00054236|Cyclophosphamide|cyclophosphamide|mesh-list
101368125|NCT00054236|Fludarabine|fludarabine|mesh-list
101368126|NCT00054236|Fludarabine phosphate|fludarabine phosphate|mesh-list
101368127|NCT00054236|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101368128|NCT00054236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101368129|NCT00054236|Immunologic Factors|immunologic factors|mesh-ancestor
101368130|NCT00054236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368131|NCT00054236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101368132|NCT00054236|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101368133|NCT00054236|Alkylating Agents|alkylating agents|mesh-ancestor
101368134|NCT00054236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368135|NCT00054236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368136|NCT00054236|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101368137|NCT00054236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101368138|NCT00054236|Antimetabolites|antimetabolites|mesh-ancestor
101368139|NCT00054236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101368140|NCT00054236|Antiemetics|antiemetics|mesh-ancestor
101368141|NCT00054236|Autonomic Agents|autonomic agents|mesh-ancestor
101368142|NCT00054236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101368143|NCT00054236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101368144|NCT00054236|Glucocorticoids|glucocorticoids|mesh-ancestor
101368145|NCT00054236|Hormones|hormones|mesh-ancestor
101368146|NCT00054236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101368147|NCT00054236|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101368148|NCT00054236|Protective Agents|protective agents|mesh-ancestor
101368149|NCT00054392|Paclitaxel|paclitaxel|mesh-list
101368150|NCT00054392|Carboplatin|carboplatin|mesh-list
101368151|NCT00054392|Gemcitabine|gemcitabine|mesh-list
101368152|NCT00054392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101368153|NCT00054392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368154|NCT00054392|Tubulin Modulators|tubulin modulators|mesh-ancestor
101368155|NCT00054392|Antimitotic Agents|antimitotic agents|mesh-ancestor
101368156|NCT00054392|Mitosis Modulators|mitosis modulators|mesh-ancestor
101368157|NCT00054392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368158|NCT00054392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101368159|NCT00054392|Antimetabolites|antimetabolites|mesh-ancestor
101368160|NCT00166816|Cyclosporine|cyclosporine|mesh-list
101368161|NCT00166816|Sirolimus|sirolimus|mesh-list
101368162|NCT00166816|Tacrolimus|tacrolimus|mesh-list
101368163|NCT00166816|Cyclosporins|cyclosporins|mesh-list
101368164|NCT00166816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101368165|NCT00166816|Immunologic Factors|immunologic factors|mesh-ancestor
101368166|NCT00166816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368167|NCT00166816|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101368171|NCT00166816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101368172|NCT00166816|Dermatologic Agents|dermatologic agents|mesh-ancestor
101368173|NCT00166816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101368174|NCT00166816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101368175|NCT00166816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101368176|NCT00166816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368177|NCT04723732|Chlorhexidine|chlorhexidine|mesh-list
101368178|NCT04723732|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101368179|NCT04723732|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101368180|NCT04723732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101368181|NCT04723732|Disinfectants|disinfectants|mesh-ancestor
101368182|NCT04723732|Dermatologic Agents|dermatologic agents|mesh-ancestor
101368186|NCT00054431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101304446|NCT02013115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101304447|NCT02013115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368187|NCT00054431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102058948|NCT02409290|Prothionamide|prothionamide|mesh-list
102058949|NCT02409290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102058950|NCT02409290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101368189|NCT00054431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368190|NCT00054431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101368191|NCT00054431|Antimetabolites|antimetabolites|mesh-ancestor
101368192|NCT00054470|Trastuzumab|trastuzumab|mesh-list
101368193|NCT00054470|Tipifarnib|tipifarnib|mesh-list
101368194|NCT00054470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101368195|NCT00054470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368196|NCT00054548|Paclitaxel|paclitaxel|mesh-list
101368197|NCT00054548|Oblimersen|oblimersen|mesh-list
101368198|NCT00054548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101368199|NCT00054548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368200|NCT00054548|Tubulin Modulators|tubulin modulators|mesh-ancestor
101368201|NCT00054548|Antimitotic Agents|antimitotic agents|mesh-ancestor
101368202|NCT00054548|Mitosis Modulators|mitosis modulators|mesh-ancestor
101368203|NCT00054548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368204|NCT00045513|Fludarabine|fludarabine|mesh-list
101368205|NCT00045513|Fludarabine phosphate|fludarabine phosphate|mesh-list
101368206|NCT00045513|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
101368207|NCT00045513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368208|NCT00045513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101368209|NCT00045513|Antimetabolites|antimetabolites|mesh-ancestor
101368210|NCT00045513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368211|NCT00045513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101368212|NCT00045513|Immunologic Factors|immunologic factors|mesh-ancestor
101368213|NCT00045513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368214|NCT00045513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101368215|NCT00045513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101368216|NCT00167401|Docetaxel|docetaxel|mesh-list
101368217|NCT00167401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368218|NCT00167401|Tubulin Modulators|tubulin modulators|mesh-ancestor
101368219|NCT00167401|Antimitotic Agents|antimitotic agents|mesh-ancestor
101368220|NCT00167401|Mitosis Modulators|mitosis modulators|mesh-ancestor
101368221|NCT00167401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368222|NCT00167479|Risperidone|risperidone|mesh-list
101368223|NCT00167479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101368224|NCT00167479|Serotonin Agents|serotonin agents|mesh-ancestor
101368225|NCT00167479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101368226|NCT00167479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368227|NCT00167479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368228|NCT00167479|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101368229|NCT00167479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101368230|NCT00167479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101368231|NCT00167479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101368232|NCT00167479|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101368233|NCT00167479|Dopamine Agents|dopamine agents|mesh-ancestor
101368234|NCT00054587|Cyclophosphamide|cyclophosphamide|mesh-list
101368235|NCT00054587|Docetaxel|docetaxel|mesh-list
101368236|NCT00054587|Fluorouracil|fluorouracil|mesh-list
101368237|NCT00054587|Trastuzumab|trastuzumab|mesh-list
101368238|NCT00054587|Epirubicin|epirubicin|mesh-list
101368239|NCT00054587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101368240|NCT00054587|Immunologic Factors|immunologic factors|mesh-ancestor
101368241|NCT00054587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368248|NCT00054587|Tubulin Modulators|tubulin modulators|mesh-ancestor
101368249|NCT00054587|Antimitotic Agents|antimitotic agents|mesh-ancestor
101368250|NCT00054587|Mitosis Modulators|mitosis modulators|mesh-ancestor
101368251|NCT00054587|Antimetabolites|antimetabolites|mesh-ancestor
101368252|NCT00054587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101368253|NCT00054587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101368254|NCT00054587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101368255|NCT00054587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101368256|NCT00054587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101544315|NCT01608360|Anesthetics|anesthetics|mesh-ancestor
101368257|NCT00054587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101368258|NCT00167518|Triamcinolone|triamcinolone|mesh-list
101368259|NCT00167518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101368263|NCT00167518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304448|NCT02013115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102058951|NCT02409290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102058952|NCT02409290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102058953|NCT02409290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101470141|NCT00247715|Ranitidine|ranitidine|mesh-list
101304449|NCT02013115|Respiratory System Agents|respiratory system agents|mesh-ancestor
101368265|NCT00167557|Ribavirin|ribavirin|mesh-list
101368266|NCT00167557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368267|NCT00167557|Antiviral Agents|antiviral agents|mesh-ancestor
101368268|NCT00167557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101368269|NCT00167557|Antimetabolites|antimetabolites|mesh-ancestor
101368270|NCT00167557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368271|NCT00167674|Zidovudine|zidovudine|mesh-list
101368272|NCT00167674|Nevirapine|nevirapine|mesh-list
101368273|NCT00167674|Antimetabolites|antimetabolites|mesh-ancestor
101368274|NCT00167674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368275|NCT00167674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101368276|NCT00167674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101368277|NCT00167674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101368278|NCT00167674|Antiviral Agents|antiviral agents|mesh-ancestor
101368279|NCT00167674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101368280|NCT00167674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101368281|NCT00167674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101368282|NCT00167674|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101368283|NCT00167674|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101368284|NCT00054626|Gemcitabine|gemcitabine|mesh-list
101368285|NCT00054626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368286|NCT00054626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101368287|NCT00054626|Antimetabolites|antimetabolites|mesh-ancestor
101368288|NCT00054626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368289|NCT00167713|Ibuprofen|ibuprofen|mesh-list
101368290|NCT00167713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101368291|NCT00167713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101368292|NCT00167713|Analgesics|analgesics|mesh-ancestor
101368293|NCT00167713|Sensory System Agents|sensory system agents|mesh-ancestor
101368294|NCT00167713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101368295|NCT00167713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368296|NCT00167713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101368297|NCT00167713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101368298|NCT00167713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101368299|NCT00167713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101368300|NCT00167713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368301|NCT00167791|Rituximab|rituximab|mesh-list
101368302|NCT00167791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101368303|NCT00167791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368304|NCT00167791|Immunologic Factors|immunologic factors|mesh-ancestor
101368305|NCT00167791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368306|NCT00167791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101368307|NCT00045591|Celecoxib|celecoxib|mesh-list
101368308|NCT00045591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101368317|NCT00045591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101368319|NCT00045591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368320|NCT00167908|Amifostine|amifostine|mesh-list
101368321|NCT00167908|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101368322|NCT00167908|Protective Agents|protective agents|mesh-ancestor
101368323|NCT00167908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368324|NCT00167947|Cyclosporine|cyclosporine|mesh-list
101368325|NCT00167947|Sirolimus|sirolimus|mesh-list
101368326|NCT00167947|Cyclosporins|cyclosporins|mesh-list
101368327|NCT00167947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101368328|NCT00167947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368329|NCT00167947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101368330|NCT00167947|Immunologic Factors|immunologic factors|mesh-ancestor
101368331|NCT00167947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368332|NCT00167947|Antifungal Agents|antifungal agents|mesh-ancestor
101368333|NCT00167947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101368334|NCT00167947|Dermatologic Agents|dermatologic agents|mesh-ancestor
101368335|NCT00167947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101368336|NCT00167947|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101368337|NCT00167947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101368338|NCT00167947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101304452|NCT02013115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102058954|NCT02409290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058955|NCT02409290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058956|NCT02409290|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102058957|NCT02409290|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102058958|NCT02409290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102058959|NCT02409290|Antitubercular Agents|antitubercular agents|mesh-ancestor
102058960|NCT02409290|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101368344|NCT00168025|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101368347|NCT00168025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368348|NCT00168181|Pilocarpine|pilocarpine|mesh-list
101368349|NCT00168181|Miotics|miotics|mesh-ancestor
101368350|NCT00168181|Autonomic Agents|autonomic agents|mesh-ancestor
101368351|NCT00168181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101368352|NCT00168181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368353|NCT00168181|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101368354|NCT00168181|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101368355|NCT00168181|Cholinergic Agents|cholinergic agents|mesh-ancestor
101368356|NCT00168181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101368357|NCT00168181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368358|NCT00407251|Epothilone B|epothilone b|mesh-list
101368359|NCT00407251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368360|NCT00407251|Tubulin Modulators|tubulin modulators|mesh-ancestor
101368361|NCT00407251|Antimitotic Agents|antimitotic agents|mesh-ancestor
101368362|NCT00407251|Mitosis Modulators|mitosis modulators|mesh-ancestor
101368363|NCT00407251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368364|NCT00045669|Imatinib Mesylate|imatinib mesylate|mesh-list
101368365|NCT00045669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368366|NCT00045669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101368367|NCT00045669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101368368|NCT00045669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368369|NCT00407290|Neostigmine|neostigmine|mesh-list
101368370|NCT00407290|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101368371|NCT00407290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101368372|NCT00407290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368373|NCT00407290|Cholinergic Agents|cholinergic agents|mesh-ancestor
101368374|NCT00407290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101368388|NCT00407446|Urological Agents|urological agents|mesh-ancestor
101368389|NCT00168415|Botulinum Toxins|botulinum toxins|mesh-list
101368390|NCT00168415|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101368391|NCT00168415|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101368392|NCT00168415|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101368393|NCT00168415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101368394|NCT00168415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368395|NCT00168415|Cholinergic Agents|cholinergic agents|mesh-ancestor
101368396|NCT00168415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101368397|NCT00168415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368398|NCT00168415|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101368399|NCT00168415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101368400|NCT00168493|Antidepressive Agents|antidepressive agents|mesh-list
101368401|NCT00168493|Serotonin|serotonin|mesh-list
101368402|NCT00168493|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
101368403|NCT00168493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101368404|NCT00168493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101368405|NCT00168493|Serotonin Agents|serotonin agents|mesh-ancestor
101368406|NCT00168493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101368407|NCT00168493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368408|NCT00168493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368409|NCT00168493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101368410|NCT00168493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101368411|NCT00168532|Trimethoprim|trimethoprim|mesh-list
101368412|NCT00168532|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101368413|NCT00168532|Sulfamethoxazole|sulfamethoxazole|mesh-list
102058961|NCT02409290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102058962|NCT02409290|Antimetabolites|antimetabolites|mesh-ancestor
102058963|NCT02409290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102058964|NCT02409290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102058965|NCT02409290|Leprostatic Agents|leprostatic agents|mesh-ancestor
102058966|NCT02409290|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102058967|NCT02898077|Paclitaxel|paclitaxel|mesh-list
102058968|NCT02898077|Ramucirumab|ramucirumab|mesh-list
102058969|NCT02898077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102058970|NCT02898077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058971|NCT02898077|Tubulin Modulators|tubulin modulators|mesh-ancestor
102058972|NCT02898077|Antimitotic Agents|antimitotic agents|mesh-ancestor
101360587|NCT00412204|Bromides|bromides|mesh-list
101368414|NCT00168532|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101368415|NCT00168532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101368416|NCT00168532|Antimalarials|antimalarials|mesh-ancestor
101368417|NCT00168532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101368424|NCT00168532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101368426|NCT00168610|Vitamin A|vitamin a|mesh-list
101368427|NCT00168610|Vitamins|vitamins|mesh-ancestor
101368428|NCT00168610|Micronutrients|micronutrients|mesh-ancestor
101368429|NCT00168610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368430|NCT04731948|Vitamins|vitamins|mesh-list
101368431|NCT04731948|Folic Acid|folic acid|mesh-list
101368432|NCT04731948|Hydroxocobalamin|hydroxocobalamin|mesh-list
101368433|NCT04731948|Vitamin B 12|vitamin b 12|mesh-list
101368434|NCT04731948|Vitamin B Complex|vitamin b complex|mesh-list
101368435|NCT04731948|Micronutrients|micronutrients|mesh-ancestor
101368441|NCT00168649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368443|NCT00168688|Trace Elements|trace elements|mesh-list
101368444|NCT00168688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368445|NCT00168766|Interferons|interferons|mesh-list
101368446|NCT00168766|Interferon-beta|interferon-beta|mesh-list
101368447|NCT00168766|Interferon beta-1a|interferon beta-1a|mesh-list
101368448|NCT00168766|Methylprednisolone|methylprednisolone|mesh-list
101368449|NCT00168766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368450|NCT00168766|Antiviral Agents|antiviral agents|mesh-ancestor
101368451|NCT00168766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101368452|NCT00168766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101368453|NCT00168766|Antiemetics|antiemetics|mesh-ancestor
101368454|NCT00168766|Autonomic Agents|autonomic agents|mesh-ancestor
101368455|NCT00168766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101368456|NCT00168766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368457|NCT00168766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101368458|NCT00168766|Glucocorticoids|glucocorticoids|mesh-ancestor
101368459|NCT00168766|Hormones|hormones|mesh-ancestor
101368460|NCT00168766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101368461|NCT00168766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101368462|NCT00168766|Protective Agents|protective agents|mesh-ancestor
101368463|NCT00168766|Immunologic Factors|immunologic factors|mesh-ancestor
101368464|NCT00168766|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101368465|NCT00168883|Paclitaxel|paclitaxel|mesh-list
101368466|NCT00168883|Vinorelbine|vinorelbine|mesh-list
101368467|NCT00168883|Carboplatin|carboplatin|mesh-list
101368468|NCT00168883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101368469|NCT00168883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368470|NCT00168883|Tubulin Modulators|tubulin modulators|mesh-ancestor
101368471|NCT00168883|Antimitotic Agents|antimitotic agents|mesh-ancestor
101368472|NCT00168883|Mitosis Modulators|mitosis modulators|mesh-ancestor
101368473|NCT00168883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368474|NCT04731909|Cisplatin|cisplatin|mesh-list
101368475|NCT04731909|Carboplatin|carboplatin|mesh-list
101368476|NCT04731909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368477|NCT00168922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101368478|NCT00168922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101368479|NCT00168922|Alkylating Agents|alkylating agents|mesh-ancestor
102058973|NCT02898077|Mitosis Modulators|mitosis modulators|mesh-ancestor
102058974|NCT02898077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058975|NCT02145884|Timolol|timolol|mesh-list
102058976|NCT02145884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058977|NCT02145884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102058978|NCT02145884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102058979|NCT02145884|Adrenergic Agents|adrenergic agents|mesh-ancestor
102058980|NCT02145884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102058981|NCT02145884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794854|NCT04083911|Cytarabine|cytarabine|mesh-list
102058982|NCT02145884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102058983|NCT02145884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101368480|NCT00168922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368481|NCT00168922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368482|NCT00054938|Aspirin|aspirin|mesh-list
101368483|NCT00054938|Ramipril|ramipril|mesh-list
101368484|NCT00054938|Pravastatin|pravastatin|mesh-list
101368485|NCT00054938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368486|NCT00054938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101548691|NCT01095835|Antiviral Agents|antiviral agents|mesh-ancestor
101368500|NCT00054938|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101304456|NCT02013154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101304457|NCT02013154|Tubulin Modulators|tubulin modulators|mesh-ancestor
101304458|NCT02013154|Antimitotic Agents|antimitotic agents|mesh-ancestor
101304459|NCT02013154|Mitosis Modulators|mitosis modulators|mesh-ancestor
101368501|NCT00054938|Protease Inhibitors|protease inhibitors|mesh-ancestor
101368502|NCT00054938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101368503|NCT00054938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101368504|NCT00054938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101368505|NCT00054938|Antimetabolites|antimetabolites|mesh-ancestor
101368506|NCT00054938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101368525|NCT00045747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368526|NCT00045747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101368527|NCT00045747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101368528|NCT00169039|Chlorpromazine|chlorpromazine|mesh-list
101368530|NCT00169039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101368531|NCT00169039|Serotonin Agents|serotonin agents|mesh-ancestor
101368532|NCT00169039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101368533|NCT00169039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368534|NCT00169039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368535|NCT00169039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101368536|NCT00169039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101368537|NCT00169039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101368538|NCT00169039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101368539|NCT00169039|GABA Antagonists|gaba antagonists|mesh-ancestor
101368540|NCT00169039|GABA Agents|gaba agents|mesh-ancestor
101368541|NCT00169039|Antiemetics|antiemetics|mesh-ancestor
101368542|NCT00169039|Autonomic Agents|autonomic agents|mesh-ancestor
101368543|NCT00169039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101368544|NCT00169039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101368545|NCT00169039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101368546|NCT00169039|Dopamine Agents|dopamine agents|mesh-ancestor
101368547|NCT00169078|Chloroquine|chloroquine|mesh-list
101368548|NCT00169078|Amebicides|amebicides|mesh-ancestor
101368549|NCT00169078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101368550|NCT00169078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101368551|NCT00169078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101368552|NCT00169078|Antimalarials|antimalarials|mesh-ancestor
101368553|NCT00169078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101368554|NCT00054977|Fluorouracil|fluorouracil|mesh-list
101368555|NCT00054977|Antimetabolites|antimetabolites|mesh-ancestor
101368556|NCT00054977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368557|NCT00054977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101368558|NCT00054977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058984|NCT03544814|Cisplatin|cisplatin|mesh-list
102058985|NCT03544814|Pemetrexed|pemetrexed|mesh-list
102058986|NCT03544814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058987|NCT03544814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102058988|NCT03544814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102058989|NCT03544814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102058990|NCT03544814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102058991|NCT03097133|Esketamine|esketamine|mesh-list
102058992|NCT03097133|Antidepressive Agents|antidepressive agents|mesh-ancestor
101368559|NCT00054977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101368560|NCT00054977|Immunologic Factors|immunologic factors|mesh-ancestor
101368561|NCT00054977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368562|NCT00169156|Prednisone|prednisone|mesh-list
101368563|NCT00169156|Cyclophosphamide|cyclophosphamide|mesh-list
101368590|NCT00169195|Rituximab|rituximab|mesh-list
101368591|NCT00169195|Gemcitabine|gemcitabine|mesh-list
101368592|NCT00169195|Oxaliplatin|oxaliplatin|mesh-list
101368593|NCT00169195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101368594|NCT00169195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368595|NCT00169195|Immunologic Factors|immunologic factors|mesh-ancestor
101368596|NCT00169195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368597|NCT00169195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101368598|NCT00169195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101368599|NCT00169195|Antimetabolites|antimetabolites|mesh-ancestor
101368600|NCT00169195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368601|NCT00169234|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101368602|NCT00169234|Immunologic Factors|immunologic factors|mesh-ancestor
101368603|NCT00169234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368604|NCT00169468|Rituximab|rituximab|mesh-list
101368605|NCT00169468|Bortezomib|bortezomib|mesh-list
101368606|NCT00169468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101304460|NCT02013154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368607|NCT00169468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368608|NCT00169468|Immunologic Factors|immunologic factors|mesh-ancestor
101368609|NCT00169468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368610|NCT00169468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101368611|NCT00169546|Fluticasone|fluticasone|mesh-list
101368613|NCT00169546|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101368614|NCT00169546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101368615|NCT00169546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101368616|NCT00169546|Autonomic Agents|autonomic agents|mesh-ancestor
101368617|NCT00169546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101368618|NCT00169546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368632|NCT00398372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368633|NCT00398372|Immunologic Factors|immunologic factors|mesh-ancestor
101368634|NCT00398372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368635|NCT00398372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101368636|NCT00169585|Levofloxacin|levofloxacin|mesh-list
101368637|NCT00169585|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101368638|NCT00169585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101368639|NCT00169585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101368640|NCT00169585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101368641|NCT00169585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101368642|NCT00169585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101368643|NCT00169585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368644|NCT00169585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368645|NCT00169585|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101368646|NCT00169585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101368648|NCT00169624|Gliclazide|gliclazide|mesh-list
101368649|NCT00169624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101368650|NCT00169624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368651|NCT00407641|Heparin|heparin|mesh-list
101368652|NCT00407641|Tinzaparin|tinzaparin|mesh-list
101368653|NCT00407641|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101368654|NCT00407641|Dalteparin|dalteparin|mesh-list
101368655|NCT00407641|Anticoagulants|anticoagulants|mesh-ancestor
102058993|NCT03097133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102058994|NCT02148380|Carboplatin|carboplatin|mesh-list
102058995|NCT02148380|Pemetrexed|pemetrexed|mesh-list
102058996|NCT02148380|Gefitinib|gefitinib|mesh-list
102058997|NCT02148380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102058998|NCT02148380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102058999|NCT02148380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059000|NCT02148380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102059001|NCT02148380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102059002|NCT02148380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102059003|NCT02146118|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101368656|NCT00407641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101368657|NCT00407641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101368658|NCT00407641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368659|NCT00407680|Valsartan|valsartan|mesh-list
101368660|NCT00407680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101368661|NCT00407680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101368662|NCT00407680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101368663|NCT00407680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368664|NCT00169819|Abciximab|abciximab|mesh-list
101368686|NCT00055250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368687|NCT00055250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368689|NCT00170209|Isoniazid|isoniazid|mesh-list
101368690|NCT00170209|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101368691|NCT00170209|Antitubercular Agents|antitubercular agents|mesh-ancestor
101368692|NCT00170209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101368693|NCT00170209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101368694|NCT00170209|Leprostatic Agents|leprostatic agents|mesh-ancestor
101368695|NCT00170209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101304461|NCT02013154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101304462|NCT02013154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101304463|NCT02013219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101304464|NCT02013219|Atezolizumab|atezolizumab|mesh-list
101304465|NCT02013219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101304466|NCT02013219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101304467|NCT02013219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101304468|NCT02013219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304469|NCT02013219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101304470|NCT02013219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101304471|NCT02013232|Aripiprazole|aripiprazole|mesh-list
101304472|NCT02013232|Antidepressive Agents|antidepressive agents|mesh-ancestor
101304473|NCT02013232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101304474|NCT02013232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101304475|NCT02013232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101304476|NCT02013232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101304477|NCT02013232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304478|NCT02013232|Dopamine Agonists|dopamine agonists|mesh-ancestor
101368696|NCT00170209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101368697|NCT00170209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368698|NCT00170209|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101368699|NCT00170209|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101368700|NCT00170209|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101368701|NCT00170209|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101368702|NCT00170209|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101368703|NCT00170209|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101368704|NCT00170209|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101368705|NCT00170209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101368706|NCT00170209|Antimetabolites|antimetabolites|mesh-ancestor
101368707|NCT00170209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101368708|NCT02964091|Sofosbuvir|sofosbuvir|mesh-list
101368714|NCT00170404|Vitamin A|vitamin a|mesh-list
101368715|NCT00170404|Thiamine|thiamine|mesh-list
102059004|NCT02146118|Silybin|silybin|mesh-list
102059005|NCT02146118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102059006|NCT02146118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102059007|NCT02146118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102059008|NCT02146118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059009|NCT02146118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102059010|NCT02146118|Protective Agents|protective agents|mesh-ancestor
102059011|NCT02146118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360627|NCT00217243|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101368716|NCT00170404|Selenium|selenium|mesh-list
101368717|NCT00170404|Micronutrients|micronutrients|mesh-list
101368718|NCT00170404|Trace Elements|trace elements|mesh-list
101368719|NCT00170404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368720|NCT00170404|Hematinics|hematinics|mesh-ancestor
101368721|NCT00170404|Vitamin B Complex|vitamin b complex|mesh-ancestor
101368722|NCT00170404|Antioxidants|antioxidants|mesh-ancestor
101368723|NCT00170404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368724|NCT00170404|Protective Agents|protective agents|mesh-ancestor
101368725|NCT00055367|Natalizumab|natalizumab|mesh-list
101368726|NCT00055367|Immunologic Factors|immunologic factors|mesh-ancestor
101368727|NCT00055367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368728|NCT00170677|Topotecan|topotecan|mesh-list
101368729|NCT00170677|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101368730|NCT00170677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101368731|NCT00170677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101368732|NCT00170677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368733|NCT00170677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368734|NCT00170755|Darifenacin|darifenacin|mesh-list
101304479|NCT02013232|Dopamine Agents|dopamine agents|mesh-ancestor
101304480|NCT02013232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101304481|NCT02013232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304482|NCT02013232|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101304483|NCT02013232|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101368735|NCT00170755|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101368736|NCT00170755|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101368737|NCT00170755|Cholinergic Agents|cholinergic agents|mesh-ancestor
101368738|NCT00170755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101368739|NCT00170755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368740|NCT00170755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368741|NCT00170755|Urological Agents|urological agents|mesh-ancestor
101368742|NCT00170794|Everolimus|everolimus|mesh-list
101368743|NCT00170794|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101368744|NCT00170794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101368745|NCT00170794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101368746|NCT00170794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368747|NCT00170794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101368748|NCT00170794|Immunologic Factors|immunologic factors|mesh-ancestor
101368749|NCT00170794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368750|NCT00170794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368751|NCT00170833|Everolimus|everolimus|mesh-list
101368770|NCT00170872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368771|NCT00170872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101368772|NCT00170872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101368773|NCT00170989|Valsartan|valsartan|mesh-list
101368774|NCT00170989|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101368775|NCT00170989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101368776|NCT00170989|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101368777|NCT00170989|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101368778|NCT00170989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368779|NCT00170989|Diuretics|diuretics|mesh-ancestor
101368780|NCT00170989|Natriuretic Agents|natriuretic agents|mesh-ancestor
101368781|NCT00170989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368782|NCT00170989|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102059012|NCT02142140|Methylphenidate|methylphenidate|mesh-list
102059013|NCT02142140|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
102059014|NCT02142140|Adderall|adderall|mesh-list
102059016|NCT02142140|Dextroamphetamine|dextroamphetamine|mesh-list
102059017|NCT02142140|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
102059018|NCT02142140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059019|NCT02142140|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102059020|NCT02142140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102059021|NCT02142140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102059022|NCT02142140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059023|NCT02142140|Dopamine Agents|dopamine agents|mesh-ancestor
102059024|NCT02142140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102059025|NCT02142140|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102059026|NCT02142140|Adrenergic Agents|adrenergic agents|mesh-ancestor
102059027|NCT02142218|Nivolumab|nivolumab|mesh-list
102059028|NCT02142218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102059029|NCT02142218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102059030|NCT02142218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102059031|NCT02142218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059032|NCT02142296|Aflibercept|aflibercept|mesh-list
102059033|NCT02142296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101368783|NCT00170989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101368784|NCT00171028|Valsartan|valsartan|mesh-list
101368785|NCT00171028|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101368786|NCT00171028|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101368787|NCT00171028|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101368788|NCT00171028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368789|NCT00055484|Zonisamide|zonisamide|mesh-list
101368790|NCT00055484|Anticonvulsants|anticonvulsants|mesh-ancestor
101368791|NCT00055484|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101368792|NCT00055484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101368797|NCT00171067|Lisinopril|lisinopril|mesh-list
101368798|NCT00171067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101368799|NCT00171067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101368800|NCT00171067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101368801|NCT00171067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368802|NCT00171067|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101368803|NCT00171067|Protease Inhibitors|protease inhibitors|mesh-ancestor
101368804|NCT00171067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101368816|NCT00171145|Cholinergic Agents|cholinergic agents|mesh-ancestor
101368817|NCT00171145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101368818|NCT00171145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368819|NCT00171145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368820|NCT00171145|Urological Agents|urological agents|mesh-ancestor
101368821|NCT00171184|Darifenacin|darifenacin|mesh-list
101368822|NCT00171184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101368823|NCT00171184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101304484|NCT02013232|Serotonin Agents|serotonin agents|mesh-ancestor
101368824|NCT00171184|Cholinergic Agents|cholinergic agents|mesh-ancestor
102059034|NCT02142296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102059035|NCT02142296|Growth Substances|growth substances|mesh-ancestor
102059036|NCT02142296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059037|NCT02142296|Growth Inhibitors|growth inhibitors|mesh-ancestor
102059038|NCT02142296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102059040|NCT02142530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102059041|NCT02142530|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102059042|NCT02142530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102059043|NCT02142530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368825|NCT00171184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101368826|NCT00171184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368827|NCT00171184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368828|NCT00171184|Urological Agents|urological agents|mesh-ancestor
101368830|NCT00055523|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101368831|NCT00055523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101368832|NCT00055523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101368833|NCT00171379|Mycophenolic Acid|mycophenolic acid|mesh-list
101368834|NCT00171379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101368835|NCT00171379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368836|NCT00171379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101368837|NCT00171379|Antitubercular Agents|antitubercular agents|mesh-ancestor
101368838|NCT00171379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101368839|NCT00171379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101368840|NCT00171379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101368841|NCT00171379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368842|NCT00171418|Tegaserod|tegaserod|mesh-list
101368843|NCT00171418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101368844|NCT00171418|Serotonin Agents|serotonin agents|mesh-ancestor
101368845|NCT00171418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101368846|NCT00171418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368847|NCT00171418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368848|NCT00171457|Tegaserod|tegaserod|mesh-list
101368849|NCT00171457|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101368850|NCT00171457|Serotonin Agents|serotonin agents|mesh-ancestor
101368851|NCT00171457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101368852|NCT00171457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368853|NCT00171457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368854|NCT00055562|Lenalidomide|lenalidomide|mesh-list
101368855|NCT00055562|Immunologic Factors|immunologic factors|mesh-ancestor
101368856|NCT00055562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368857|NCT00055562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101368858|NCT00055562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101368859|NCT00055562|Growth Substances|growth substances|mesh-ancestor
101368860|NCT00055562|Growth Inhibitors|growth inhibitors|mesh-ancestor
101368861|NCT00055562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368862|NCT00171496|Cyclosporine|cyclosporine|mesh-list
101368863|NCT00171496|Tacrolimus|tacrolimus|mesh-list
101368864|NCT00171496|Cyclosporins|cyclosporins|mesh-list
101368865|NCT00171496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101368866|NCT00171496|Immunologic Factors|immunologic factors|mesh-ancestor
101794882|NCT00994383|Morphine|morphine|mesh-list
101368870|NCT00171496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368872|NCT00171496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101368873|NCT00171496|Dermatologic Agents|dermatologic agents|mesh-ancestor
101368879|NCT00171535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101368880|NCT00171535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368881|NCT00171535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101368882|NCT00171535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368883|NCT00171535|Vasodilator Agents|vasodilator agents|mesh-ancestor
101368884|NCT00171535|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101368885|NCT00171535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102059044|NCT01383343|Calcium, Dietary|calcium, dietary|mesh-list
102059045|NCT01383343|Leucovorin|leucovorin|mesh-list
102059046|NCT01383343|Folic Acid|folic acid|mesh-list
102059047|NCT01383343|Bevacizumab|bevacizumab|mesh-list
102059048|NCT01383343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102059049|NCT01383343|Fluorouracil|fluorouracil|mesh-list
102059050|NCT01383343|Irinotecan|irinotecan|mesh-list
102059051|NCT01383343|Sorafenib|sorafenib|mesh-list
102059052|NCT01383343|Camptothecin|camptothecin|mesh-list
102059053|NCT01383343|Endothelial Growth Factors|endothelial growth factors|mesh-list
101368886|NCT00171574|Valsartan|valsartan|mesh-list
101368887|NCT00171574|Lisinopril|lisinopril|mesh-list
101368888|NCT00171574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101368889|NCT00171574|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101368890|NCT00171574|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101368891|NCT00171574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368892|NCT00171574|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101368893|NCT00171574|Protease Inhibitors|protease inhibitors|mesh-ancestor
101368894|NCT00171574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101368895|NCT00171574|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101368896|NCT00171574|Protective Agents|protective agents|mesh-ancestor
101304485|NCT02013232|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101304487|NCT02013232|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101304488|NCT02013232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101368897|NCT00171574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368898|NCT00171613|Octreotide|octreotide|mesh-list
101368899|NCT00171613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101368900|NCT00171613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101368901|NCT00171613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368902|NCT04920981|Atezolizumab|atezolizumab|mesh-list
101368903|NCT04920981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101368904|NCT04920981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368905|NCT04920981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101368906|NCT04920981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368907|NCT00055640|Prednisone|prednisone|mesh-list
101368908|NCT00055640|Cyclophosphamide|cyclophosphamide|mesh-list
101368909|NCT00055640|Rituximab|rituximab|mesh-list
101368910|NCT00055640|Doxorubicin|doxorubicin|mesh-list
101368911|NCT00055640|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101368912|NCT00055640|Vincristine|vincristine|mesh-list
101368913|NCT00055640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101368914|NCT00055640|Immunologic Factors|immunologic factors|mesh-ancestor
101368915|NCT00055640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368916|NCT00055640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101368917|NCT00055640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101368918|NCT00055640|Alkylating Agents|alkylating agents|mesh-ancestor
101368919|NCT00055640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368920|NCT00055640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368921|NCT00055640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101368922|NCT00055640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101368923|NCT00055640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101368924|NCT00055640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101368925|NCT00055640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101368926|NCT00055640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101368927|NCT00055640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101368928|NCT00055640|Glucocorticoids|glucocorticoids|mesh-ancestor
101368929|NCT00055640|Hormones|hormones|mesh-ancestor
101368930|NCT00055640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101368931|NCT00055640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101368932|NCT00055640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101368933|NCT00055640|Tubulin Modulators|tubulin modulators|mesh-ancestor
101368934|NCT00055640|Antimitotic Agents|antimitotic agents|mesh-ancestor
101368935|NCT00055640|Mitosis Modulators|mitosis modulators|mesh-ancestor
101368936|NCT00171652|Diclofenac|diclofenac|mesh-list
101368947|NCT00171652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368954|NCT00171691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368955|NCT00171691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102059054|NCT01383343|Antibodies|antibodies|mesh-list
102059055|NCT01383343|Immunoglobulins|immunoglobulins|mesh-list
102059056|NCT01383343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102059057|NCT01383343|Immunoglobulin G|immunoglobulin g|mesh-list
102059058|NCT01383343|Calcium|calcium|mesh-list
102059059|NCT01383343|Levoleucovorin|levoleucovorin|mesh-list
101368956|NCT00171691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101368957|NCT00171691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101368958|NCT00171691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101368959|NCT00171691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368961|NCT00171769|Anticoagulants|anticoagulants|mesh-ancestor
101368962|NCT00171808|Letrozole|letrozole|mesh-list
101368963|NCT00171808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368964|NCT00171808|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101368965|NCT00171808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101368966|NCT00171808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101368967|NCT00171808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368968|NCT00171808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101368969|NCT00171808|Hormone Antagonists|hormone antagonists|mesh-ancestor
101368970|NCT00171808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101368971|NCT00171808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368972|NCT00171847|Trastuzumab|trastuzumab|mesh-list
101368973|NCT00171847|Letrozole|letrozole|mesh-list
101368974|NCT00171847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101304489|NCT02013258|Oxytocin|oxytocin|mesh-list
101304490|NCT02013258|Oxytocics|oxytocics|mesh-ancestor
101368975|NCT00171847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368976|NCT00171847|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101368977|NCT00171847|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101368978|NCT00171847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101368979|NCT00171847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368980|NCT00171847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101368981|NCT00171847|Hormone Antagonists|hormone antagonists|mesh-ancestor
101368982|NCT00171847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101368983|NCT00171847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368984|NCT00055679|Cyclophosphamide|cyclophosphamide|mesh-list
101368985|NCT00055679|Fluorouracil|fluorouracil|mesh-list
101368986|NCT00055679|Epirubicin|epirubicin|mesh-list
101368987|NCT00055679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101368988|NCT00055679|Immunologic Factors|immunologic factors|mesh-ancestor
101368989|NCT00055679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368990|NCT00055679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101368991|NCT00055679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101368992|NCT00055679|Alkylating Agents|alkylating agents|mesh-ancestor
101368993|NCT00055679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368994|NCT00055679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368995|NCT00055679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101368996|NCT00055679|Antimetabolites|antimetabolites|mesh-ancestor
101368997|NCT00055679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101368998|NCT00055679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101369001|NCT00055679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101369002|NCT00171886|Octreotide|octreotide|mesh-list
101369003|NCT00171886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101369004|NCT00171886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101369005|NCT00171886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101369006|NCT00171964|Zoledronic Acid|zoledronic acid|mesh-list
101369007|NCT00171964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101369008|NCT00171964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369009|NCT00172003|Zoledronic Acid|zoledronic acid|mesh-list
101369010|NCT00172003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101369011|NCT00172003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369013|NCT00055718|Antioxidants|antioxidants|mesh-ancestor
101369014|NCT00055718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369015|NCT00055718|Protective Agents|protective agents|mesh-ancestor
101369016|NCT00055718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369026|NCT00399867|Antimetabolites|antimetabolites|mesh-ancestor
101369027|NCT00399867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369028|NCT00399867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102059060|NCT01383343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102059061|NCT01383343|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102059062|NCT01383343|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102059063|NCT01383343|Growth Substances|growth substances|mesh-ancestor
102059064|NCT01383343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059065|NCT01383343|Growth Inhibitors|growth inhibitors|mesh-ancestor
102059066|NCT01383343|Immunologic Factors|immunologic factors|mesh-ancestor
102059067|NCT01383343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101369029|NCT00399867|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101369030|NCT00399867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101369031|NCT00055835|Paclitaxel|paclitaxel|mesh-list
101369032|NCT00055835|Carboplatin|carboplatin|mesh-list
101369033|NCT00055835|Gemcitabine|gemcitabine|mesh-list
101369034|NCT00055835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101369035|NCT00055835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101369036|NCT00055835|Tubulin Modulators|tubulin modulators|mesh-ancestor
101369037|NCT00055835|Antimitotic Agents|antimitotic agents|mesh-ancestor
101369038|NCT00055835|Mitosis Modulators|mitosis modulators|mesh-ancestor
101369039|NCT00055835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369040|NCT00055835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101369041|NCT00055835|Antimetabolites|antimetabolites|mesh-ancestor
101369042|NCT00172354|Hydrocortisone|hydrocortisone|mesh-list
101369043|NCT00172354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101369044|NCT00055874|Interferons|interferons|mesh-list
101369045|NCT00055874|Cytarabine|cytarabine|mesh-list
101369046|NCT00055874|Interferon-alpha|interferon-alpha|mesh-list
101369047|NCT00055874|Imatinib Mesylate|imatinib mesylate|mesh-list
101304491|NCT02013258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101304492|NCT02013258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304493|NCT02013271|Paclitaxel|paclitaxel|mesh-list
101369048|NCT00055874|Hydroxyurea|hydroxyurea|mesh-list
101369049|NCT00055874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101369050|NCT00055874|Antiviral Agents|antiviral agents|mesh-ancestor
101369051|NCT00055874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101369052|NCT00055874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101369053|NCT00055874|Antimetabolites|antimetabolites|mesh-ancestor
101369054|NCT00055874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369055|NCT00055874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101369056|NCT00055874|Immunologic Factors|immunologic factors|mesh-ancestor
101369057|NCT00055874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369058|NCT00055874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101369059|NCT00055874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101369060|NCT00055874|Antisickling Agents|antisickling agents|mesh-ancestor
101369061|NCT00055874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101369062|NCT00407719|Bevacizumab|bevacizumab|mesh-list
101369063|NCT00407719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101369064|NCT00407719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101369065|NCT00407719|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101369066|NCT00407719|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101794912|NCT00532935|Incretins|incretins|mesh-ancestor
101369067|NCT00407719|Growth Substances|growth substances|mesh-ancestor
101369068|NCT00407719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369069|NCT00407719|Growth Inhibitors|growth inhibitors|mesh-ancestor
101369081|NCT00055913|Bevacizumab|bevacizumab|mesh-list
101369082|NCT00055913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101369083|NCT00055913|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101369084|NCT00055913|Antibodies|antibodies|mesh-list
101369085|NCT00055913|Immunoglobulins|immunoglobulins|mesh-list
101369086|NCT00055913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101369087|NCT00055913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101369088|NCT00055913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101369089|NCT00055913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101369090|NCT00055913|Growth Substances|growth substances|mesh-ancestor
101369091|NCT00055913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369101|NCT00045864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101369102|NCT00045864|Immunologic Factors|immunologic factors|mesh-ancestor
101369103|NCT00045864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369104|NCT00045864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102059070|NCT01383343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059071|NCT01383343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102059072|NCT01383343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102059073|NCT01383343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101369105|NCT00045864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101369107|NCT00045864|Sensory System Agents|sensory system agents|mesh-ancestor
101369108|NCT00045864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101369109|NCT00045864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101369110|NCT00045864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101369111|NCT00045864|Antiviral Agents|antiviral agents|mesh-ancestor
101369112|NCT00045864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101369113|NCT00055952|Exatecan|exatecan|mesh-list
101369114|NCT00055952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101369115|NCT00055952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101369116|NCT00055952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101369117|NCT00055952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369118|NCT00055952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101369119|NCT00055991|Bexarotene|bexarotene|mesh-list
101369120|NCT00055991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101369121|NCT04631484|Riboflavin|riboflavin|mesh-list
101304494|NCT02013271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101304495|NCT02013271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101304496|NCT02013271|Tubulin Modulators|tubulin modulators|mesh-ancestor
101369122|NCT04631484|Niacinamide|niacinamide|mesh-list
101369124|NCT04631484|Nicotinic Acids|nicotinic acids|mesh-list
101369125|NCT04631484|Vitamin B Complex|vitamin b complex|mesh-ancestor
101369126|NCT04631484|Vitamins|vitamins|mesh-ancestor
101369127|NCT04631484|Micronutrients|micronutrients|mesh-ancestor
101369128|NCT04631484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369129|NCT04631484|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101369130|NCT04631484|Dermatologic Agents|dermatologic agents|mesh-ancestor
101369131|NCT04631484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101369132|NCT04631484|Antimetabolites|antimetabolites|mesh-ancestor
101369133|NCT04631484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369134|NCT04631484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101369135|NCT04631484|Vasodilator Agents|vasodilator agents|mesh-ancestor
101369136|NCT00056030|Leucovorin|leucovorin|mesh-list
101369137|NCT00056030|Fluorouracil|fluorouracil|mesh-list
101369138|NCT00056030|Oxaliplatin|oxaliplatin|mesh-list
101369139|NCT00056030|Cetuximab|cetuximab|mesh-list
101369140|NCT00056030|Calcium|calcium|mesh-list
101369141|NCT00056030|Levoleucovorin|levoleucovorin|mesh-list
101369142|NCT00056030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101369143|NCT00056030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369144|NCT00056030|Antimetabolites|antimetabolites|mesh-ancestor
101369145|NCT00056030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369146|NCT00056030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101369152|NCT00056030|Vitamin B Complex|vitamin b complex|mesh-ancestor
101369153|NCT00056030|Vitamins|vitamins|mesh-ancestor
101369154|NCT00056030|Micronutrients|micronutrients|mesh-ancestor
101369155|NCT00056030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101369156|NCT00046020|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101369157|NCT00046020|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101369158|NCT00046020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101369159|NCT00046020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101369160|NCT00046020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549256|NCT01090453|Immunologic Factors|immunologic factors|mesh-ancestor
101369165|NCT00046020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101369167|NCT00173875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101369168|NCT00173875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101369169|NCT00173875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101369170|NCT00173875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304515|NCT02013453|Tubulin Modulators|tubulin modulators|mesh-ancestor
101304516|NCT02013453|Antimitotic Agents|antimitotic agents|mesh-ancestor
101369199|NCT00174226|Buspirone|buspirone|mesh-list
101369200|NCT00174226|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101369201|NCT00174226|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101369202|NCT00174226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101369203|NCT00174226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101369204|NCT00174226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369205|NCT00174226|Adrenergic Agents|adrenergic agents|mesh-ancestor
102059086|NCT03631147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102059087|NCT03631147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102059089|NCT02148848|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102059090|NCT02148848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102059091|NCT02148848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059092|NCT02148848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102059093|NCT02148848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059094|NCT02148848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102059096|NCT03265145|Muscarinic Antagonists|muscarinic antagonists|mesh-list
101360711|NCT00218140|Nicotine|nicotine|mesh-list
101369206|NCT00174226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101369207|NCT00174226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369208|NCT00174226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101369209|NCT00174226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101369210|NCT00174226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101369220|NCT00174304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369222|NCT00174304|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101369224|NCT00174304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101369225|NCT00174304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101369226|NCT00174304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101369227|NCT00174304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101369228|NCT00174304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369229|NCT00174304|Vasodilator Agents|vasodilator agents|mesh-ancestor
101369230|NCT00174343|Exemestane|exemestane|mesh-list
101369231|NCT00174343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101369232|NCT00174343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101369233|NCT00174343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101369234|NCT00174343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101369235|NCT00174343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369236|NCT00174343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101369237|NCT00174343|Hormone Antagonists|hormone antagonists|mesh-ancestor
101304517|NCT02013453|Mitosis Modulators|mitosis modulators|mesh-ancestor
101304518|NCT02013453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304519|NCT02013453|Antimetabolites|antimetabolites|mesh-ancestor
101369238|NCT00174343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101369239|NCT00174343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369240|NCT00174499|Nicotine|nicotine|mesh-list
101369241|NCT00174499|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101369242|NCT00174499|Autonomic Agents|autonomic agents|mesh-ancestor
101369243|NCT00174499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101369244|NCT00174499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369245|NCT00174499|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101369246|NCT00174499|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101369247|NCT00174499|Cholinergic Agents|cholinergic agents|mesh-ancestor
101369248|NCT00174499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101369249|NCT00174499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369250|NCT00174538|Codeine|codeine|mesh-list
101369251|NCT00174538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101369252|NCT00174538|Narcotics|narcotics|mesh-ancestor
101369253|NCT00174538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101369254|NCT00174538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369255|NCT00174538|Analgesics|analgesics|mesh-ancestor
101369256|NCT00174538|Sensory System Agents|sensory system agents|mesh-ancestor
101369257|NCT00174538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101369258|NCT00174538|Antitussive Agents|antitussive agents|mesh-ancestor
101369259|NCT00174538|Respiratory System Agents|respiratory system agents|mesh-ancestor
101369260|NCT00174577|Risperidone|risperidone|mesh-list
101369261|NCT00174577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101369262|NCT00174577|Serotonin Agents|serotonin agents|mesh-ancestor
102059098|NCT03265145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059099|NCT03265145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059100|NCT03265145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102059101|NCT05344495|Midazolam|midazolam|mesh-list
102059102|NCT05344495|Bupivacaine|bupivacaine|mesh-list
102059103|NCT05344495|Anesthetics, Local|anesthetics, local|mesh-ancestor
101360721|NCT00042029|Aprepitant|aprepitant|mesh-list
101369263|NCT00174577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101369264|NCT00174577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369265|NCT00174577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369266|NCT00174577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101369267|NCT00174577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101369268|NCT00174577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101369269|NCT00174577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101369270|NCT00174577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101369271|NCT00174577|Dopamine Agents|dopamine agents|mesh-ancestor
101369272|NCT00046137|Teriparatide|teriparatide|mesh-list
101369273|NCT00046137|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101369274|NCT00046137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101369275|NCT00046137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369276|NCT00046137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101369277|NCT00046137|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101369278|NCT00046137|Hormone Antagonists|hormone antagonists|mesh-ancestor
101369279|NCT00046137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101369280|NCT00046137|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101549378|NCT01075321|Lenalidomide|lenalidomide|mesh-list
101369295|NCT00174616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101369296|NCT00174655|Cyclophosphamide|cyclophosphamide|mesh-list
101369297|NCT00174655|Docetaxel|docetaxel|mesh-list
101369298|NCT00174655|Doxorubicin|doxorubicin|mesh-list
101369299|NCT00174655|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101369300|NCT00174655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101369301|NCT00174655|Immunologic Factors|immunologic factors|mesh-ancestor
101369302|NCT00174655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369303|NCT00174655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101369304|NCT00174655|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101369305|NCT00174655|Alkylating Agents|alkylating agents|mesh-ancestor
101369306|NCT00174655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369307|NCT00174655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101369308|NCT00174655|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101369309|NCT00174655|Tubulin Modulators|tubulin modulators|mesh-ancestor
101369310|NCT00174655|Antimitotic Agents|antimitotic agents|mesh-ancestor
101369311|NCT00174655|Mitosis Modulators|mitosis modulators|mesh-ancestor
101304520|NCT02013453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101369312|NCT00174655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101369313|NCT00174655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101369314|NCT00174655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101369315|NCT00174655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101369316|NCT00174694|Telithromycin|telithromycin|mesh-list
101369317|NCT00174694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101369318|NCT00174694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101369319|NCT00174733|Ciclesonide|ciclesonide|mesh-list
101369320|NCT00174733|Glucocorticoids|glucocorticoids|mesh-ancestor
101369322|NCT00174733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101369323|NCT00174733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369324|NCT00174733|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101369325|NCT00056264|Infliximab|infliximab|mesh-list
101369326|NCT00056264|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101369327|NCT00056264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101369328|NCT00056264|Dermatologic Agents|dermatologic agents|mesh-ancestor
101369329|NCT00056264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101369330|NCT00056264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101369331|NCT00174772|Cisplatin|cisplatin|mesh-list
101369332|NCT00174772|Docetaxel|docetaxel|mesh-list
101369333|NCT00174772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102059104|NCT05344495|Anesthetics|anesthetics|mesh-ancestor
102059105|NCT05344495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102059106|NCT05344495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059107|NCT05344495|Sensory System Agents|sensory system agents|mesh-ancestor
102059108|NCT05344495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102059109|NCT05344495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102059110|NCT05344495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102059111|NCT05344495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102059112|NCT05344495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102059113|NCT05344495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102059114|NCT05344495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102059115|NCT05344495|Anesthetics, General|anesthetics, general|mesh-ancestor
101369334|NCT00174772|Tubulin Modulators|tubulin modulators|mesh-ancestor
101369335|NCT00174772|Antimitotic Agents|antimitotic agents|mesh-ancestor
101369336|NCT00174772|Mitosis Modulators|mitosis modulators|mesh-ancestor
101369337|NCT00174772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369338|NCT00174811|Telithromycin|telithromycin|mesh-list
101369339|NCT00174811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101369340|NCT00174811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101369342|NCT02963779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101369343|NCT02963779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101369344|NCT02963779|Analgesics|analgesics|mesh-ancestor
101369345|NCT02963779|Sensory System Agents|sensory system agents|mesh-ancestor
101369346|NCT02963779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101369347|NCT02963779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369348|NCT02963779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101369349|NCT02963779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101369350|NCT02963779|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101369351|NCT02963779|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101369352|NCT02963779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101369353|NCT02963779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369354|NCT00046176|Lamivudine|lamivudine|mesh-list
101549448|NCT00623402|Antiviral Agents|antiviral agents|mesh-ancestor
101369370|NCT00174928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101369372|NCT00174928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369373|NCT00175045|Lansoprazole|lansoprazole|mesh-list
101369374|NCT00175045|Dexlansoprazole|dexlansoprazole|mesh-list
101369375|NCT00175045|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101369376|NCT00175045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101369377|NCT00175045|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101369378|NCT00175045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101369379|NCT00175045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369380|NCT00056381|Anidulafungin|anidulafungin|mesh-list
101369381|NCT00056381|Antifungal Agents|antifungal agents|mesh-ancestor
101369382|NCT00056381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101369383|NCT00175123|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101369384|NCT00175123|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101369385|NCT00175123|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101369386|NCT00175123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101369387|NCT00175123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369388|NCT00175123|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101369389|NCT00175123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101369390|NCT00175123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304521|NCT02013453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101304522|NCT02013453|Immunologic Factors|immunologic factors|mesh-ancestor
101304523|NCT02013453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304524|NCT02013453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101304525|NCT02013453|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101369391|NCT00175123|Cholinergic Agents|cholinergic agents|mesh-ancestor
101369392|NCT00175123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102059117|NCT05344495|GABA Agents|gaba agents|mesh-ancestor
102059118|NCT05344495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102059119|NCT05344495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059120|NCT01593241|Carboplatin|carboplatin|mesh-list
102059121|NCT01593241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102059122|NCT05960565|Glucagon|glucagon|mesh-list
102059123|NCT05960565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101369393|NCT00175357|Methadone|methadone|mesh-list
101369394|NCT00175357|Heroin|heroin|mesh-list
101369395|NCT00175357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101369396|NCT00175357|Narcotics|narcotics|mesh-ancestor
101369397|NCT00175357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101369398|NCT00175357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369399|NCT00175357|Analgesics|analgesics|mesh-ancestor
101369400|NCT00175357|Sensory System Agents|sensory system agents|mesh-ancestor
101369401|NCT00175357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101369402|NCT00175357|Antitussive Agents|antitussive agents|mesh-ancestor
101369403|NCT00175357|Respiratory System Agents|respiratory system agents|mesh-ancestor
101369404|NCT00046254|Zoledronic Acid|zoledronic acid|mesh-list
101369405|NCT00046254|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101369406|NCT00046254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369407|NCT00175396|Ascorbic Acid|ascorbic acid|mesh-list
101369408|NCT00175396|Leuprolide|leuprolide|mesh-list
101369409|NCT00175396|Methyltestosterone|methyltestosterone|mesh-list
101369410|NCT00175396|Flutamide|flutamide|mesh-list
101369411|NCT00175396|Bicalutamide|bicalutamide|mesh-list
101369412|NCT00175396|Nilutamide|nilutamide|mesh-list
101369413|NCT00175396|Buserelin|buserelin|mesh-list
101369414|NCT00175396|Androgens|androgens|mesh-list
101369415|NCT00175396|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101369416|NCT00175396|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101369417|NCT00175396|Fertility Agents|fertility agents|mesh-ancestor
101369418|NCT00175396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101369419|NCT00175396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369420|NCT00175396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101369421|NCT00175396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101369422|NCT00175396|Hormones|hormones|mesh-ancestor
101369447|NCT00175591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369448|NCT00175591|Sensory System Agents|sensory system agents|mesh-ancestor
101369449|NCT00175591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101369450|NCT00175630|Bupivacaine|bupivacaine|mesh-list
101369451|NCT00175630|Anesthetics, Local|anesthetics, local|mesh-ancestor
101369452|NCT00175630|Anesthetics|anesthetics|mesh-ancestor
101369453|NCT00175630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101369454|NCT00175630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369455|NCT00175630|Sensory System Agents|sensory system agents|mesh-ancestor
101369456|NCT00175630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101369458|NCT00056537|Immunoconjugates|immunoconjugates|mesh-ancestor
101369459|NCT00056537|Immunologic Factors|immunologic factors|mesh-ancestor
101369460|NCT00056537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369461|NCT00408031|Cycloserine|cycloserine|mesh-list
101369462|NCT00408031|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101369463|NCT00408031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101369464|NCT00408031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101369465|NCT00408031|Antitubercular Agents|antitubercular agents|mesh-ancestor
101369466|NCT00408031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101369467|NCT00408031|Antimetabolites|antimetabolites|mesh-ancestor
101369468|NCT00408031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369469|NCT00175747|Budesonide|budesonide|mesh-list
101369470|NCT00175747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101369471|NCT00175747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101369472|NCT00175747|Autonomic Agents|autonomic agents|mesh-ancestor
101794951|NCT00994617|Losartan|losartan|mesh-list
101369473|NCT00175747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101369474|NCT00175747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369475|NCT00175747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101369476|NCT00175747|Respiratory System Agents|respiratory system agents|mesh-ancestor
101369477|NCT00175747|Glucocorticoids|glucocorticoids|mesh-ancestor
101369478|NCT00175747|Hormones|hormones|mesh-ancestor
102059125|NCT05960565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102059126|NCT05960565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059127|NCT05960227|Dextrans|dextrans|mesh-list
102059128|NCT05960227|Iron-Dextran Complex|iron-dextran complex|mesh-list
102059129|NCT05960227|Anticoagulants|anticoagulants|mesh-ancestor
102059130|NCT05960227|Plasma Substitutes|plasma substitutes|mesh-ancestor
102059131|NCT05960227|Blood Substitutes|blood substitutes|mesh-ancestor
102059132|NCT05960227|Hematinics|hematinics|mesh-ancestor
102059133|NCT05960110|Fluorides|fluorides|mesh-list
102059134|NCT05960110|Fluorides, Topical|fluorides, topical|mesh-list
102059135|NCT05960110|Cariostatic Agents|cariostatic agents|mesh-ancestor
102059136|NCT05960110|Protective Agents|protective agents|mesh-ancestor
102059137|NCT05960110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304526|NCT02013453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101304528|NCT02013453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101304529|NCT02013453|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101304530|NCT02013570|Dexmedetomidine|dexmedetomidine|mesh-list
101369479|NCT00175747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101369480|NCT04493619|Carboplatin|carboplatin|mesh-list
101369494|NCT00175903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101369495|NCT00175903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369496|NCT00175903|GABA Agents|gaba agents|mesh-ancestor
101369497|NCT00175903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101369498|NCT00175903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369499|NCT00175903|Antimanic Agents|antimanic agents|mesh-ancestor
101369500|NCT00175903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101369501|NCT00175903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101369502|NCT00175903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101369503|NCT00175903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101369504|NCT00175903|Analgesics|analgesics|mesh-ancestor
101369505|NCT00175903|Sensory System Agents|sensory system agents|mesh-ancestor
101369506|NCT00175903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101369507|NCT00175903|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101369508|NCT00175903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101369509|NCT00175903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101369510|NCT00175903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101369511|NCT00056654|Leuprolide|leuprolide|mesh-list
101369512|NCT00056654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101369513|NCT00056654|Fertility Agents|fertility agents|mesh-ancestor
101369514|NCT00056654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101369515|NCT00056654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369516|NCT00056654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101369517|NCT00056654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101369518|NCT00175981|Sildenafil Citrate|sildenafil citrate|mesh-list
101369519|NCT00175981|Fluvoxamine|fluvoxamine|mesh-list
101369520|NCT00175981|Vasodilator Agents|vasodilator agents|mesh-ancestor
101369521|NCT00175981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101369522|NCT00175981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101369527|NCT00175981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101369528|NCT00175981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101369529|NCT00175981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369530|NCT00175981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101369531|NCT00175981|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101369532|NCT00175981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101369533|NCT00175981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101369534|NCT00175981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101369535|NCT00175981|Serotonin Agents|serotonin agents|mesh-ancestor
101369536|NCT00175981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101369537|NCT00175981|Antidepressive Agents|antidepressive agents|mesh-ancestor
102059139|NCT05959889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102059140|NCT05959889|Respiratory System Agents|respiratory system agents|mesh-ancestor
102059141|NCT05959889|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102059142|NCT05959889|Hormone Antagonists|hormone antagonists|mesh-ancestor
102059143|NCT05959889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102059144|NCT05959889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360759|NCT00042068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101369538|NCT00175981|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101369539|NCT00175981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101369540|NCT00175981|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101369541|NCT04420533|Mirabegron|mirabegron|mesh-list
101369555|NCT00176020|Micronutrients|micronutrients|mesh-ancestor
101369556|NCT00176020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369557|NCT00176020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101369558|NCT00176020|Antimetabolites|antimetabolites|mesh-ancestor
101369559|NCT00176020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369560|NCT00176020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101369561|NCT00176020|Vasodilator Agents|vasodilator agents|mesh-ancestor
101369562|NCT00176059|Immunoglobulins|immunoglobulins|mesh-list
101369563|NCT00176059|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101369564|NCT00176059|Antibodies|antibodies|mesh-list
101369565|NCT00176059|gamma-Globulins|gamma-globulins|mesh-list
101369566|NCT00176059|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101369567|NCT00176059|Immunologic Factors|immunologic factors|mesh-ancestor
101369568|NCT00176059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369569|NCT00176098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
101369570|NCT00176098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101369571|NCT00176098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369572|NCT00176293|Dexamethasone|dexamethasone|mesh-list
101369573|NCT00176293|Doxorubicin|doxorubicin|mesh-list
101369574|NCT00176293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101369575|NCT00176293|Antiemetics|antiemetics|mesh-ancestor
101369576|NCT00176293|Autonomic Agents|autonomic agents|mesh-ancestor
101369577|NCT00176293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101369578|NCT00176293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369579|NCT00176293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101369580|NCT00176293|Glucocorticoids|glucocorticoids|mesh-ancestor
101369581|NCT00176293|Hormones|hormones|mesh-ancestor
101369582|NCT00176293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101369583|NCT00176293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101369584|NCT00176293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101369585|NCT00176293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101369586|NCT00176293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101369587|NCT00176293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101369588|NCT00176293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101369589|NCT00176293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369590|NCT00056693|Sunitinib|sunitinib|mesh-list
101369591|NCT00056693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101369592|NCT00056693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101369593|NCT00056693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101369594|NCT00056693|Growth Substances|growth substances|mesh-ancestor
101369595|NCT00056693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369596|NCT00056693|Growth Inhibitors|growth inhibitors|mesh-ancestor
101369597|NCT00056693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101369598|NCT00056693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101369599|NCT00056693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369600|NCT00176332|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101369601|NCT00176332|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101369602|NCT00176332|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101369603|NCT00176332|Antimetabolites|antimetabolites|mesh-ancestor
101369615|NCT00176449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369617|NCT00176449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102059145|NCT05959889|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102059146|NCT05959889|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102059147|NCT05959889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059148|NCT05959863|Captopril|captopril|mesh-list
102059149|NCT05959863|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102059150|NCT05959863|Protease Inhibitors|protease inhibitors|mesh-ancestor
102059151|NCT05959863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102059152|NCT05959863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059153|NCT05959863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102059154|NCT05959759|Dimethyl Fumarate|dimethyl fumarate|mesh-list
102059155|NCT05959759|Dermatologic Agents|dermatologic agents|mesh-ancestor
101369618|NCT00176449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369619|NCT00176449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101369620|NCT00176449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101369621|NCT00176449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101369622|NCT00398450|Interferons|interferons|mesh-list
101369623|NCT00398450|Interferon-alpha|interferon-alpha|mesh-list
101369624|NCT00398450|Interferon alpha-2|interferon alpha-2|mesh-list
101369625|NCT00398450|Azacitidine|azacitidine|mesh-list
101369626|NCT00398450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101369627|NCT00398450|Antiviral Agents|antiviral agents|mesh-ancestor
101369628|NCT00398450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101369629|NCT00398450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101369630|NCT00398450|Antimetabolites|antimetabolites|mesh-ancestor
101369631|NCT00398450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369632|NCT00398450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101369633|NCT00398450|Immunologic Factors|immunologic factors|mesh-ancestor
101369634|NCT00398450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369635|NCT00046293|Abciximab|abciximab|mesh-list
101369636|NCT00046293|Anticoagulants|anticoagulants|mesh-ancestor
101369637|NCT00046293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101369638|NCT00176527|Interferons|interferons|mesh-list
101369639|NCT00176527|Interferon-alpha|interferon-alpha|mesh-list
101369640|NCT00176527|Interferon alpha-2|interferon alpha-2|mesh-list
101304532|NCT02013570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101304533|NCT02013570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304534|NCT02013570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101369641|NCT00176527|Docetaxel|docetaxel|mesh-list
101369642|NCT00176527|Estramustine|estramustine|mesh-list
101369643|NCT00176527|Isotretinoin|isotretinoin|mesh-list
101369644|NCT00176527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101369645|NCT00176527|Tubulin Modulators|tubulin modulators|mesh-ancestor
101369646|NCT00176527|Antimitotic Agents|antimitotic agents|mesh-ancestor
101369647|NCT00176527|Mitosis Modulators|mitosis modulators|mesh-ancestor
101369648|NCT00176527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369649|NCT00176527|Antiviral Agents|antiviral agents|mesh-ancestor
101369650|NCT00176527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101369651|NCT00176527|Immunologic Factors|immunologic factors|mesh-ancestor
101369652|NCT00176527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369653|NCT00176527|Dermatologic Agents|dermatologic agents|mesh-ancestor
101369654|NCT00176527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101369655|NCT00176527|Alkylating Agents|alkylating agents|mesh-ancestor
101369656|NCT00176527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101528363|NCT04628325|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101528364|NCT04628325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101528365|NCT04628325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528366|NCT04657497|Camostat|camostat|mesh-list
101528367|NCT04657497|Protease Inhibitors|protease inhibitors|mesh-ancestor
101528368|NCT04657497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528369|NCT04657497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528370|NCT04657497|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101528371|NCT04657497|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102059156|NCT05959759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102059158|NCT05959759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059159|NCT05959616|Ciprofloxacin|ciprofloxacin|mesh-list
102059160|NCT05959616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102059161|NCT05959616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102059162|NCT05959616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102059163|NCT05959616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102059164|NCT05959616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101360778|NCT00218530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101528372|NCT01214434|Emollients|emollients|mesh-list
101528373|NCT01214434|Dermatologic Agents|dermatologic agents|mesh-ancestor
101528374|NCT04971356|Aspirin|aspirin|mesh-list
101528375|NCT04971356|Ticagrelor|ticagrelor|mesh-list
101528376|NCT04971356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101549702|NCT01072357|Bevacizumab|bevacizumab|mesh-list
101369670|NCT00398489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369671|NCT00398489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101369672|NCT00398489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101369673|NCT00398489|Tubulin Modulators|tubulin modulators|mesh-ancestor
101369674|NCT00398489|Antimitotic Agents|antimitotic agents|mesh-ancestor
101369675|NCT00398489|Mitosis Modulators|mitosis modulators|mesh-ancestor
101369676|NCT00398489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101369677|NCT00398489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101369678|NCT00398489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101369679|NCT00398489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101369680|NCT00398489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101369681|NCT00398489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101369682|NCT00398489|Hormone Antagonists|hormone antagonists|mesh-ancestor
101369683|NCT00398489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101369684|NCT00398489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101369685|NCT00398489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101369686|NCT00398489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101369687|NCT00398489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101369688|NCT00398489|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101369689|NCT00398489|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101369690|NCT00176761|Interleukin-2|interleukin-2|mesh-list
101369691|NCT00176761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101369692|NCT00176761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101369693|NCT00176761|Analgesics|analgesics|mesh-ancestor
101369694|NCT00176761|Sensory System Agents|sensory system agents|mesh-ancestor
101369695|NCT00176761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101369696|NCT00176761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369697|NCT00176995|Eflornithine|eflornithine|mesh-list
101369698|NCT00176995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101369699|NCT00176995|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101369700|NCT00176995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101369701|NCT00176995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101369702|NCT00176995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101369703|NCT00176995|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
101304535|NCT02013570|Analgesics|analgesics|mesh-ancestor
101304536|NCT02013570|Sensory System Agents|sensory system agents|mesh-ancestor
101304537|NCT02013570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101369704|NCT00176995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101369705|NCT00176995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369706|NCT00423527|Levetiracetam|levetiracetam|mesh-list
101369707|NCT00423527|Anticonvulsants|anticonvulsants|mesh-ancestor
101369708|NCT00423527|Nootropic Agents|nootropic agents|mesh-ancestor
101369709|NCT00408148|Rimonabant|rimonabant|mesh-list
101369716|NCT00408148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101369717|NCT00408148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369718|NCT00397566|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
101369719|NCT00397566|BMS-707035|bms-707035|mesh-list
101369720|NCT00397566|Integrase Inhibitors|integrase inhibitors|mesh-list
101369721|NCT00397566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102059165|NCT05959616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059167|NCT05959616|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102059168|NCT05959616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102059170|NCT05959603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102059171|NCT05959603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102059172|NCT05959447|Dabigatran|dabigatran|mesh-list
102059173|NCT05959447|Gemfibrozil|gemfibrozil|mesh-list
102059174|NCT05959447|Antithrombins|antithrombins|mesh-ancestor
102059175|NCT05959447|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102059176|NCT05959447|Protease Inhibitors|protease inhibitors|mesh-ancestor
102059177|NCT05959447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102059178|NCT05959447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369722|NCT00397566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369723|NCT00397566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101369724|NCT00397566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101369725|NCT00397566|Antiviral Agents|antiviral agents|mesh-ancestor
101369726|NCT00397566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101369727|NCT00177424|Sertraline|sertraline|mesh-list
101369728|NCT00177424|Antidepressive Agents|antidepressive agents|mesh-ancestor
101369729|NCT00177424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101369730|NCT00177424|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101369731|NCT00177424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101369732|NCT00177424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101369733|NCT00177424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369734|NCT00177424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101369735|NCT00177424|Serotonin Agents|serotonin agents|mesh-ancestor
101369736|NCT00177424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369737|NCT00177580|Pravastatin|pravastatin|mesh-list
101369738|NCT00177580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101369739|NCT00177580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101795008|NCT01014052|Retinol acetate|retinol acetate|mesh-list
101369752|NCT00056810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101369753|NCT00056810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369755|NCT00177853|Irinotecan|irinotecan|mesh-list
101369756|NCT00177853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101369757|NCT00177853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101369758|NCT00177853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101369759|NCT00177853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369760|NCT00177853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101369761|NCT00177853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101369762|NCT00177853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101369763|NCT00177853|Analgesics|analgesics|mesh-ancestor
101369764|NCT00177853|Sensory System Agents|sensory system agents|mesh-ancestor
101369765|NCT00177853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101369766|NCT00177853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369767|NCT00177853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101369768|NCT00177853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101369769|NCT00177853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101369770|NCT00177853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101369771|NCT00178048|Paroxetine|paroxetine|mesh-list
101369772|NCT00178048|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101369773|NCT00178048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101369774|NCT00178048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101304538|NCT02013570|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101795100|NCT02586311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101369779|NCT00178048|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101369780|NCT00178048|Antidepressive Agents|antidepressive agents|mesh-ancestor
101369781|NCT00178048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102059179|NCT05959447|Anticoagulants|anticoagulants|mesh-ancestor
102059180|NCT05959447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102059181|NCT05959447|Antimetabolites|antimetabolites|mesh-ancestor
102059182|NCT05959447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102059183|NCT05959447|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102059184|NCT05959447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102059185|NCT05959044|Folic Acid|folic acid|mesh-list
102059186|NCT05959044|Vitamins|vitamins|mesh-ancestor
102059187|NCT05959044|Micronutrients|micronutrients|mesh-ancestor
102059188|NCT05959044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059189|NCT05959044|Hematinics|hematinics|mesh-ancestor
102059190|NCT05959044|Vitamin B Complex|vitamin b complex|mesh-ancestor
102059191|NCT05958914|Calcitonin|calcitonin|mesh-list
102059192|NCT05958914|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
102059193|NCT05958914|Katacalcin|katacalcin|mesh-list
102059194|NCT05958914|Enkephalins|enkephalins|mesh-list
102059195|NCT05958914|Vasodilator Agents|vasodilator agents|mesh-ancestor
102059196|NCT05958914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102059197|NCT05958914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059198|NCT05958914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102059199|NCT05958914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102059200|NCT05958914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059201|NCT05958810|Lumefantrine|lumefantrine|mesh-list
102059202|NCT05958810|Artemether|artemether|mesh-list
102059203|NCT05958810|Primaquine|primaquine|mesh-list
102059204|NCT05958810|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102059205|NCT05958810|Antimalarials|antimalarials|mesh-ancestor
102059206|NCT05958810|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102059207|NCT05958810|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102059208|NCT05958810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102059209|NCT05958797|Chloroquine|chloroquine|mesh-list
102059210|NCT05958797|Primaquine|primaquine|mesh-list
102059211|NCT05958797|Amebicides|amebicides|mesh-ancestor
101369782|NCT00178048|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101369783|NCT00178048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101369784|NCT00178048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101369785|NCT00056966|Fludarabine|fludarabine|mesh-list
101369786|NCT00056966|Alemtuzumab|alemtuzumab|mesh-list
101369787|NCT00056966|Tacrolimus|tacrolimus|mesh-list
101369788|NCT00056966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101369789|NCT00056966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369790|NCT00056966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101795435|NCT04080713|Hormones|hormones|mesh-ancestor
101369791|NCT00056966|Immunologic Factors|immunologic factors|mesh-ancestor
101369792|NCT00056966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369793|NCT00056966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102059213|NCT05958797|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102059214|NCT05958797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102059215|NCT05958797|Antimalarials|antimalarials|mesh-ancestor
102059216|NCT05958797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102059217|NCT05958758|Psilocybin|psilocybin|mesh-list
102059218|NCT05958758|Hallucinogens|hallucinogens|mesh-ancestor
102059219|NCT05958758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059220|NCT05958758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102059221|NCT05958719|Azacitidine|azacitidine|mesh-list
101795502|NCT00920465|Misoprostol|misoprostol|mesh-list
102059222|NCT05958719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102059223|NCT05958719|Antimetabolites|antimetabolites|mesh-ancestor
102059224|NCT05958719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059225|NCT05958719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101360833|NCT00219466|Zinc|zinc|mesh-list
101369794|NCT00056966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101369795|NCT00056966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101369796|NCT00178828|Bupropion|bupropion|mesh-list
101369797|NCT00178828|Sertraline|sertraline|mesh-list
101369798|NCT00178828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101369799|NCT00178828|Antidepressive Agents|antidepressive agents|mesh-ancestor
101369800|NCT00178828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101369801|NCT00178828|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101369811|NCT00178828|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101369813|NCT00408187|Cyclosporine|cyclosporine|mesh-list
101369814|NCT00408187|Cyclosporins|cyclosporins|mesh-list
101369815|NCT00408187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101369816|NCT00408187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369817|NCT00408187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101369818|NCT00408187|Immunologic Factors|immunologic factors|mesh-ancestor
101369819|NCT00408187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369820|NCT00408187|Antifungal Agents|antifungal agents|mesh-ancestor
101369821|NCT00408187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101369822|NCT00408187|Dermatologic Agents|dermatologic agents|mesh-ancestor
101369823|NCT00408187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101369824|NCT00408187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101369825|NCT00408226|Pemetrexed|pemetrexed|mesh-list
101369826|NCT00408226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101369827|NCT00408226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101369828|NCT00408226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369829|NCT00408226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101369830|NCT00408226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101369831|NCT02963896|Gentamicins|gentamicins|mesh-list
101795695|NCT00996567|Cetuximab|cetuximab|mesh-list
101369832|NCT02963896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101369833|NCT02963896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101369834|NCT02963896|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101369835|NCT02963896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101369836|NCT02963896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369837|NCT00178945|Botulinum Toxins|botulinum toxins|mesh-list
101369838|NCT00178945|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101369839|NCT00178945|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101369840|NCT00178945|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101369841|NCT00178945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101369842|NCT00178945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369854|NCT00397722|Serotonin Agents|serotonin agents|mesh-ancestor
101369855|NCT00397722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369856|NCT00397722|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101369857|NCT00397722|Antidepressive Agents|antidepressive agents|mesh-ancestor
101369858|NCT00397722|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101369859|NCT00397722|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102059226|NCT05958719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102059227|NCT05958290|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102059228|NCT05958290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102059229|NCT05955885|Flurbiprofen|flurbiprofen|mesh-list
102059230|NCT05955885|Benzydamine|benzydamine|mesh-list
102059231|NCT05955885|Analgesics|analgesics|mesh-ancestor
102059232|NCT05955885|Sensory System Agents|sensory system agents|mesh-ancestor
102059233|NCT05955885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102059234|NCT05955885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059235|NCT05955885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102059236|NCT05955885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102059237|NCT05955885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101304539|NCT02013570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101304540|NCT02013570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101304541|NCT02013570|Adrenergic Agents|adrenergic agents|mesh-ancestor
101304542|NCT02013570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101369860|NCT00397722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101369861|NCT00397722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101369862|NCT00179023|Trimethaphan|trimethaphan|mesh-list
101369863|NCT00179023|Pseudoephedrine|pseudoephedrine|mesh-list
101369864|NCT00179023|Ephedrine|ephedrine|mesh-list
101369865|NCT00179023|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
101369866|NCT00179023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101369867|NCT00179023|Autonomic Agents|autonomic agents|mesh-ancestor
101369868|NCT00179023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101795884|NCT00997347|Misoprostol|misoprostol|mesh-list
101369869|NCT00179023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369870|NCT00179023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101369881|NCT00179023|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
101369882|NCT00179023|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101369883|NCT00179023|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101369884|NCT00179023|Cholinergic Agents|cholinergic agents|mesh-ancestor
101369885|NCT00179023|Vasodilator Agents|vasodilator agents|mesh-ancestor
101369886|NCT00057005|Cyclophosphamide|cyclophosphamide|mesh-list
101369887|NCT00057005|Alemtuzumab|alemtuzumab|mesh-list
101369888|NCT00057005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101369889|NCT00057005|Immunologic Factors|immunologic factors|mesh-ancestor
101369890|NCT00057005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369891|NCT00057005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101369892|NCT00057005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101369893|NCT00057005|Alkylating Agents|alkylating agents|mesh-ancestor
101369894|NCT00057005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369895|NCT00057005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101369896|NCT00057005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101369897|NCT00057005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101369898|NCT00179062|Olanzapine|olanzapine|mesh-list
101369899|NCT00179062|Risperidone|risperidone|mesh-list
101369900|NCT00179062|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101369901|NCT00179062|Serotonin Agents|serotonin agents|mesh-ancestor
101369902|NCT00179062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101369903|NCT00179062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369904|NCT00179062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369910|NCT00179062|Dopamine Agents|dopamine agents|mesh-ancestor
101369911|NCT00179062|Antiemetics|antiemetics|mesh-ancestor
101369912|NCT00179062|Autonomic Agents|autonomic agents|mesh-ancestor
101369913|NCT00179062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101369914|NCT00179062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101369915|NCT00179062|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101369916|NCT00179062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101369917|NCT00179062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101369918|NCT04723459|Ivermectin|ivermectin|mesh-list
101369919|NCT04723459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101369920|NCT04723459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101369921|NCT00179257|Sertraline|sertraline|mesh-list
101369922|NCT00179257|Antidepressive Agents|antidepressive agents|mesh-ancestor
102059239|NCT05955885|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101575042|NCT05215873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059240|NCT05955885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102059241|NCT05955885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059242|NCT05952752|Dexamethasone|dexamethasone|mesh-list
102059243|NCT05952752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102059244|NCT05952752|Antiemetics|antiemetics|mesh-ancestor
101369923|NCT00179257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101369924|NCT00179257|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101369925|NCT00179257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101369926|NCT00179257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101369927|NCT00179257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369928|NCT00179257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101369929|NCT00179257|Serotonin Agents|serotonin agents|mesh-ancestor
101369930|NCT00179257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369931|NCT00408382|Atorvastatin|atorvastatin|mesh-list
101304543|NCT02013570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304545|NCT02013856|Procyanidin|procyanidin|mesh-list
101304546|NCT02013856|Antioxidants|antioxidants|mesh-ancestor
101369932|NCT00408382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101369933|NCT00408382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101369934|NCT00408382|Antimetabolites|antimetabolites|mesh-ancestor
101549954|NCT01070329|Analgesics|analgesics|mesh-ancestor
101369946|NCT00057122|Leprostatic Agents|leprostatic agents|mesh-ancestor
101369947|NCT00057122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101369948|NCT00057122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101369949|NCT00057122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369950|NCT00057122|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101369951|NCT00057122|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101369952|NCT00057122|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101369953|NCT00057122|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101369954|NCT00057122|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101369955|NCT00057122|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101369956|NCT00057122|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101369957|NCT00057122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101369958|NCT00057122|Antimetabolites|antimetabolites|mesh-ancestor
101369959|NCT00057122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101369960|NCT00179608|Lenalidomide|lenalidomide|mesh-list
101369961|NCT00179608|Immunologic Factors|immunologic factors|mesh-ancestor
101369962|NCT00179608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369963|NCT00179608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101369964|NCT00179608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101369965|NCT00179608|Growth Substances|growth substances|mesh-ancestor
101369966|NCT00179608|Growth Inhibitors|growth inhibitors|mesh-ancestor
101369967|NCT00179608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101369968|NCT00179686|Lenalidomide|lenalidomide|mesh-list
101369969|NCT00179686|Immunologic Factors|immunologic factors|mesh-ancestor
101369970|NCT00179686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369971|NCT00179686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101369972|NCT00179686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101369988|NCT00179725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101369990|NCT00179725|Growth Inhibitors|growth inhibitors|mesh-ancestor
101248852|NCT02638519|Xenon|xenon|mesh-list
101248853|NCT02638519|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101248854|NCT02638519|Anesthetics, General|anesthetics, general|mesh-ancestor
101248855|NCT02638519|Anesthetics|anesthetics|mesh-ancestor
101248856|NCT02638519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101248857|NCT02638519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248858|NCT02408549|Lacosamide|lacosamide|mesh-list
101248859|NCT02408549|Anticonvulsants|anticonvulsants|mesh-ancestor
101248860|NCT02408549|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101248861|NCT02408549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101248862|NCT02408549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101248863|NCT02408549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248864|NCT02376699|Paclitaxel|paclitaxel|mesh-list
101248865|NCT02376699|Gemcitabine|gemcitabine|mesh-list
101248866|NCT02376699|Pembrolizumab|pembrolizumab|mesh-list
101248867|NCT02376699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101248868|NCT02376699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101248869|NCT02376699|Tubulin Modulators|tubulin modulators|mesh-ancestor
101248870|NCT02376699|Antimitotic Agents|antimitotic agents|mesh-ancestor
101248871|NCT02376699|Mitosis Modulators|mitosis modulators|mesh-ancestor
101248872|NCT02376699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248873|NCT02376699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101248874|NCT02376699|Antimetabolites|antimetabolites|mesh-ancestor
101248877|NCT02141542|Tremelimumab|tremelimumab|mesh-list
101369991|NCT00179764|Busulfan|busulfan|mesh-list
101369992|NCT00179764|Alkylating Agents|alkylating agents|mesh-ancestor
101369993|NCT00179764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369994|NCT00179764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101369995|NCT00179764|Immunologic Factors|immunologic factors|mesh-ancestor
101369996|NCT00179764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369997|NCT00179764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101369998|NCT00179764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101369999|NCT00179764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101370000|NCT00179881|Thalidomide|thalidomide|mesh-list
101370001|NCT00179881|Carboplatin|carboplatin|mesh-list
102059245|NCT05952752|Autonomic Agents|autonomic agents|mesh-ancestor
102059246|NCT05952752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102059247|NCT05952752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059248|NCT05952752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102059249|NCT05952752|Glucocorticoids|glucocorticoids|mesh-ancestor
102059250|NCT05952752|Hormones|hormones|mesh-ancestor
102059251|NCT05952752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102059252|NCT05952752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102059253|NCT05952752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102059254|NCT05949125|Cyclophosphamide|cyclophosphamide|mesh-list
102059255|NCT05949125|Fludarabine|fludarabine|mesh-list
102059256|NCT05949125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102059257|NCT05949125|Immunologic Factors|immunologic factors|mesh-ancestor
102059258|NCT05949125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059259|NCT05949125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102059260|NCT05949125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101370002|NCT00179881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101370003|NCT00179881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101370004|NCT00179881|Immunologic Factors|immunologic factors|mesh-ancestor
101370005|NCT00179881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370006|NCT00179881|Leprostatic Agents|leprostatic agents|mesh-ancestor
101370007|NCT00179881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101370008|NCT00179881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101370009|NCT00179881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101370010|NCT00179881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101370011|NCT00179881|Growth Substances|growth substances|mesh-ancestor
101550018|NCT00593255|Insulin|insulin|mesh-list
101370015|NCT00180037|Ubiquinone|ubiquinone|mesh-list
101370016|NCT00180037|Coenzyme Q10|coenzyme q10|mesh-list
101370017|NCT00180037|Micronutrients|micronutrients|mesh-ancestor
101370018|NCT00180037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370019|NCT00180037|Vitamins|vitamins|mesh-ancestor
101370020|NCT00180076|Budesonide|budesonide|mesh-list
101370021|NCT00180076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101370022|NCT00180076|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101370023|NCT00180076|Autonomic Agents|autonomic agents|mesh-ancestor
101370024|NCT00180076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101370025|NCT00180076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370026|NCT00180076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101370027|NCT00180076|Respiratory System Agents|respiratory system agents|mesh-ancestor
101370028|NCT00180076|Glucocorticoids|glucocorticoids|mesh-ancestor
101370029|NCT00180076|Hormones|hormones|mesh-ancestor
101370030|NCT00180076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101370031|NCT00180115|Cytarabine|cytarabine|mesh-list
101370032|NCT00180115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101370035|NCT00180115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101370036|NCT00180115|Antiviral Agents|antiviral agents|mesh-ancestor
101370037|NCT00180115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101370038|NCT00180115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101370039|NCT00180115|Immunologic Factors|immunologic factors|mesh-ancestor
101370040|NCT00180115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370041|NCT00046527|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101370042|NCT00046527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101370043|NCT00180310|Paclitaxel|paclitaxel|mesh-list
101370044|NCT00180310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101370045|NCT00180310|Everolimus|everolimus|mesh-list
101370046|NCT00180310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101370047|NCT00180310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101370048|NCT00180310|Tubulin Modulators|tubulin modulators|mesh-ancestor
102059261|NCT05949125|Alkylating Agents|alkylating agents|mesh-ancestor
102059262|NCT05949125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059263|NCT05949125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101249130|NCT01690325|Epirubicin|epirubicin|mesh-list
102059264|NCT05949125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102059265|NCT05923060|Aminolevulinic Acid|aminolevulinic acid|mesh-list
102059266|NCT05923060|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102059267|NCT05923060|Dermatologic Agents|dermatologic agents|mesh-ancestor
102059268|NCT05914857|Dapagliflozin|dapagliflozin|mesh-list
102059269|NCT05914857|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101370049|NCT00180310|Antimitotic Agents|antimitotic agents|mesh-ancestor
101370050|NCT00180310|Mitosis Modulators|mitosis modulators|mesh-ancestor
101370051|NCT00180310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370052|NCT00180310|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101370053|NCT00180310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101370054|NCT00180310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101370055|NCT00180310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101370056|NCT00180310|Immunologic Factors|immunologic factors|mesh-ancestor
101370057|NCT00180310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370058|NCT00057278|Gabapentin|gabapentin|mesh-list
101370059|NCT00057278|Analgesics|analgesics|mesh-ancestor
101370060|NCT00057278|Sensory System Agents|sensory system agents|mesh-ancestor
101370061|NCT00057278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101370062|NCT00057278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370063|NCT00057278|Anticonvulsants|anticonvulsants|mesh-ancestor
101370064|NCT00057278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101370065|NCT00057278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101370066|NCT00057278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101370067|NCT00057278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101370068|NCT00057278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101370069|NCT00057278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101370070|NCT00057278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101370071|NCT00057278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370072|NCT00057278|Antimanic Agents|antimanic agents|mesh-ancestor
101370073|NCT00180622|Nitric Oxide|nitric oxide|mesh-list
101370074|NCT00180622|Carbon Monoxide|carbon monoxide|mesh-list
101370075|NCT00180622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101370076|NCT00180622|Autonomic Agents|autonomic agents|mesh-ancestor
101370077|NCT00180622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101370078|NCT00180622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370079|NCT00180622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101370083|NCT00180622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370084|NCT00180622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101370085|NCT00180622|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101370086|NCT00180622|Vasodilator Agents|vasodilator agents|mesh-ancestor
101370087|NCT00180622|Gasotransmitters|gasotransmitters|mesh-ancestor
101370088|NCT00180622|Protective Agents|protective agents|mesh-ancestor
101370089|NCT00180622|Antimetabolites|antimetabolites|mesh-ancestor
101249395|NCT01691495|PENTA|penta|mesh-list
101370091|NCT00180895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101370092|NCT00180895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101370093|NCT00180895|Immunologic Factors|immunologic factors|mesh-ancestor
101370094|NCT00180895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370095|NCT00180895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101370096|NCT00180973|Hydroxyurea|hydroxyurea|mesh-list
101370097|NCT00180973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101370098|NCT00180973|Antisickling Agents|antisickling agents|mesh-ancestor
101370099|NCT00180973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101370100|NCT00180973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370101|NCT00180973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101370103|NCT04729491|Nitazoxanide|nitazoxanide|mesh-list
101370104|NCT04729491|Dutasteride|dutasteride|mesh-list
101370105|NCT04729491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101370112|NCT04729491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101370114|NCT04729491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101370115|NCT00057356|Conivaptan|conivaptan|mesh-list
102059270|NCT05914857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059271|NCT05914857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102059272|NCT05914857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059274|NCT05909696|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102059275|NCT05909696|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102059276|NCT05909696|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102059277|NCT05909696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102059278|NCT05909696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059279|NCT05908331|Sirolimus|sirolimus|mesh-list
101370116|NCT00057356|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101370117|NCT00057356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370118|NCT00057356|Natriuretic Agents|natriuretic agents|mesh-ancestor
101370119|NCT00057356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370120|NCT00181012|Lidocaine|lidocaine|mesh-list
101370121|NCT00181012|Anesthetics, Local|anesthetics, local|mesh-ancestor
101370122|NCT00181012|Anesthetics|anesthetics|mesh-ancestor
101370123|NCT00181012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101370124|NCT00181012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370125|NCT00181012|Sensory System Agents|sensory system agents|mesh-ancestor
101370126|NCT00181012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101370127|NCT00181012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101370128|NCT00181012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101370129|NCT00181012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101370130|NCT00181012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101387699|NCT00323011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101370131|NCT00181012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370132|NCT00181246|Fentanyl|fentanyl|mesh-list
101370133|NCT00181246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101370134|NCT00181246|Narcotics|narcotics|mesh-ancestor
101370135|NCT00181246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101370136|NCT00181246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370137|NCT00181246|Analgesics|analgesics|mesh-ancestor
101370138|NCT00181246|Sensory System Agents|sensory system agents|mesh-ancestor
101370139|NCT00181246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101370140|NCT00181246|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101249747|NCT05288192|Triamcinolone|triamcinolone|mesh-list
101370141|NCT00181246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101370142|NCT00181246|Anesthetics, General|anesthetics, general|mesh-ancestor
101370143|NCT00181246|Anesthetics|anesthetics|mesh-ancestor
101370144|NCT00181558|Zoledronic Acid|zoledronic acid|mesh-list
101370145|NCT00181558|Atrasentan|atrasentan|mesh-list
101370146|NCT00181558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101370147|NCT00181558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370148|NCT00181558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101370152|NCT00181597|Hydrocortisone|hydrocortisone|mesh-list
101370153|NCT00181597|Trilostane|trilostane|mesh-list
101249816|NCT05291052|Antimetabolites|antimetabolites|mesh-ancestor
101370154|NCT00181597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101304554|NCT02013895|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101304555|NCT02013895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370155|NCT00181597|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101370156|NCT00181597|Abortifacient Agents|abortifacient agents|mesh-ancestor
101370157|NCT00181597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101370158|NCT00181597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370159|NCT00181597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101370160|NCT00181597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101370161|NCT00181597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370162|NCT00181636|Galantamine|galantamine|mesh-list
101370163|NCT00181636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101370164|NCT00181636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101370165|NCT00181636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370166|NCT00181636|Cholinergic Agents|cholinergic agents|mesh-ancestor
101370167|NCT00181636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102059281|NCT05908331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102059282|NCT05908331|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102059283|NCT05908331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102059284|NCT05908331|Antifungal Agents|antifungal agents|mesh-ancestor
101249888|NCT05292677|Anesthetics|anesthetics|mesh-list
102059285|NCT05908331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102059286|NCT05908331|Immunologic Factors|immunologic factors|mesh-ancestor
102059287|NCT05908331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471924|NCT01685398|Timolol|timolol|mesh-list
101370168|NCT00181636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370169|NCT00181636|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101370170|NCT00181636|Autonomic Agents|autonomic agents|mesh-ancestor
101370188|NCT00181870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101370189|NCT00181870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370190|NCT00181870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101370191|NCT00181870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101370193|NCT00181870|Sensory System Agents|sensory system agents|mesh-ancestor
101370194|NCT00181870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101370195|NCT00181870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101370196|NCT00181870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101370197|NCT00181870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370198|NCT00181870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101370199|NCT00181870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101370200|NCT00181948|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101370201|NCT00181948|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101370202|NCT00181948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101370203|NCT00181948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101370204|NCT00181948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370205|NCT00181948|Adrenergic Agents|adrenergic agents|mesh-ancestor
101370206|NCT00181948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101370207|NCT00181948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370208|NCT00181987|Methylphenidate|methylphenidate|mesh-list
101370209|NCT00181987|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101370210|NCT00181987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370211|NCT00181987|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101370212|NCT00181987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101370213|NCT00181987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101370214|NCT00181987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370215|NCT00181987|Dopamine Agents|dopamine agents|mesh-ancestor
101370216|NCT00181987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101370217|NCT00182104|Warfarin|warfarin|mesh-list
101370218|NCT00182104|Anticoagulants|anticoagulants|mesh-ancestor
101370219|NCT00182143|Heparin|heparin|mesh-list
101370220|NCT00182143|Calcium heparin|calcium heparin|mesh-list
101370221|NCT00182143|Dalteparin|dalteparin|mesh-list
101370222|NCT00182143|Tinzaparin|tinzaparin|mesh-list
101370223|NCT00182143|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101370224|NCT00182143|Anticoagulants|anticoagulants|mesh-ancestor
101370225|NCT00182143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101370226|NCT00182143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101370227|NCT00182143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370246|NCT00408655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101370247|NCT00408655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101370248|NCT00408655|Tubulin Modulators|tubulin modulators|mesh-ancestor
101370249|NCT00408655|Antimitotic Agents|antimitotic agents|mesh-ancestor
101370251|NCT00408655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370253|NCT00408655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101370254|NCT00408655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101304557|NCT02013960|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101304558|NCT02013960|Abortifacient Agents|abortifacient agents|mesh-ancestor
101304559|NCT02013960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101370255|NCT00408655|Immunologic Factors|immunologic factors|mesh-ancestor
101370256|NCT00408655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059288|NCT05907811|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
102059289|NCT05907811|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102059290|NCT05907811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102059291|NCT05907811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059292|NCT05903352|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102059293|NCT05903352|Anti-Infective Agents|anti-infective agents|mesh-list
102059294|NCT05902780|Dexmedetomidine|dexmedetomidine|mesh-list
102059295|NCT05902780|Bupivacaine|bupivacaine|mesh-list
102059296|NCT05902780|Anesthetics, Local|anesthetics, local|mesh-ancestor
102059297|NCT05902780|Anesthetics|anesthetics|mesh-ancestor
102059298|NCT05902780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101370257|NCT00408655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101370258|NCT00408655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101370259|NCT00408655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101370260|NCT00408655|Antifungal Agents|antifungal agents|mesh-ancestor
101370261|NCT00182377|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
101370262|NCT00182377|Plasma Substitutes|plasma substitutes|mesh-ancestor
101370263|NCT00182377|Blood Substitutes|blood substitutes|mesh-ancestor
101370264|NCT00182455|Topiramate|topiramate|mesh-list
101370265|NCT00182455|Anticonvulsants|anticonvulsants|mesh-ancestor
101370266|NCT00182455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101370267|NCT00182455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370268|NCT00182494|Metformin|metformin|mesh-list
101370269|NCT00182494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101370270|NCT00182494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370271|NCT00182533|Sertraline|sertraline|mesh-list
101370272|NCT00182533|Antidepressive Agents|antidepressive agents|mesh-ancestor
101370273|NCT00182533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101370274|NCT00182533|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101370275|NCT00182533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101370276|NCT00182533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101370277|NCT00182533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370278|NCT00182533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101370279|NCT00182533|Serotonin Agents|serotonin agents|mesh-ancestor
101370280|NCT00182533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370281|NCT00182572|Naltrexone|naltrexone|mesh-list
101370282|NCT00182572|Buprenorphine|buprenorphine|mesh-list
101370283|NCT00182572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101370284|NCT00182572|Narcotics|narcotics|mesh-ancestor
101370285|NCT00182572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101370304|NCT00182650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250170|NCT05296005|Antidotes|antidotes|mesh-ancestor
101370305|NCT00182650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101370306|NCT00182650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101370307|NCT00182650|Antimetabolites|antimetabolites|mesh-ancestor
101370308|NCT00182650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370309|NCT00182650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101370310|NCT00182650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101370311|NCT00182650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101370312|NCT00182650|Antiviral Agents|antiviral agents|mesh-ancestor
101370313|NCT00182650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101370314|NCT00182806|Gemcitabine|gemcitabine|mesh-list
101370315|NCT00182806|Irinotecan|irinotecan|mesh-list
101370316|NCT00182806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101370317|NCT00182806|Antimetabolites|antimetabolites|mesh-ancestor
101387700|NCT00323011|Immunologic Factors|immunologic factors|mesh-ancestor
101370318|NCT00182806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370319|NCT00182806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101370320|NCT00182806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101370321|NCT00182806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101370322|NCT00182806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101370323|NCT00182845|Donepezil|donepezil|mesh-list
101370324|NCT00182845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101370325|NCT00182845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101250301|NCT05262686|Belimumab|belimumab|mesh-list
101370326|NCT00182845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370327|NCT00182845|Cholinergic Agents|cholinergic agents|mesh-ancestor
102059299|NCT05902780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059300|NCT05902780|Sensory System Agents|sensory system agents|mesh-ancestor
102059301|NCT05902780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102059302|NCT05902780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102059303|NCT05902780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102059304|NCT05902780|Analgesics|analgesics|mesh-ancestor
102059305|NCT05902780|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102059306|NCT05902780|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102059307|NCT05902780|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102059308|NCT05902780|Adrenergic Agents|adrenergic agents|mesh-ancestor
102059309|NCT05902780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101360924|NCT00077337|Romidepsin|romidepsin|mesh-list
101370328|NCT00182845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101370329|NCT00182845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250387|NCT05192629|Anesthetics|anesthetics|mesh-ancestor
101370330|NCT00182845|Nootropic Agents|nootropic agents|mesh-ancestor
101370331|NCT00182884|Donepezil|donepezil|mesh-list
101370332|NCT00182884|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101370333|NCT00182884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101370334|NCT00182884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370335|NCT00182884|Cholinergic Agents|cholinergic agents|mesh-ancestor
101370336|NCT00182884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101304560|NCT02013960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304562|NCT02013960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101370341|NCT00183001|Micronutrients|micronutrients|mesh-ancestor
101370342|NCT00183001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250454|NCT05096325|Insulin|insulin|mesh-list
101370349|NCT00183040|Testosterone|testosterone|mesh-list
101370350|NCT00183040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101370351|NCT00183040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370352|NCT00183040|Androgens|androgens|mesh-ancestor
101370353|NCT00057395|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
101370354|NCT00057395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101370355|NCT00183235|Aripiprazole|aripiprazole|mesh-list
101370356|NCT00183235|Antidepressive Agents|antidepressive agents|mesh-ancestor
101250507|NCT04989049|Folic Acid|folic acid|mesh-list
101370357|NCT00183235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101370358|NCT00183235|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101370359|NCT00183235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101370360|NCT00183235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101370361|NCT00183235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370362|NCT00183235|Dopamine Agonists|dopamine agonists|mesh-ancestor
101370363|NCT00183235|Dopamine Agents|dopamine agents|mesh-ancestor
101370364|NCT00183235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101370365|NCT00183235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370366|NCT00183235|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101370367|NCT00183235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101370368|NCT00183235|Serotonin Agents|serotonin agents|mesh-ancestor
101370369|NCT00183235|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101370370|NCT00183235|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101370371|NCT00183235|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101370372|NCT00183235|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101370373|NCT00057512|Masoprocol|masoprocol|mesh-list
101370374|NCT00057512|Antioxidants|antioxidants|mesh-ancestor
101370375|NCT00057512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370376|NCT00057512|Protective Agents|protective agents|mesh-ancestor
101370377|NCT00057512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370378|NCT00057512|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101370379|NCT00057512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101370380|NCT00057512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101370381|NCT00057512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101370382|NCT00057512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101370383|NCT00057512|Analgesics|analgesics|mesh-ancestor
101370384|NCT00057512|Sensory System Agents|sensory system agents|mesh-ancestor
102059310|NCT05902780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059311|NCT05901350|Levodopa|levodopa|mesh-list
102059312|NCT05901350|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102059313|NCT05901350|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101779024|NCT01066429|Dexamethasone|dexamethasone|mesh-list
102059315|NCT05901350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102059316|NCT05901350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059317|NCT05901350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370385|NCT00057512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101370386|NCT00057512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101250801|NCT04402658|Albuterol|albuterol|mesh-list
101370387|NCT00057512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101370388|NCT00183742|Docetaxel|docetaxel|mesh-list
101370389|NCT00183742|Doxorubicin|doxorubicin|mesh-list
101370390|NCT00183742|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101370391|NCT00183742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101370392|NCT00183742|Tubulin Modulators|tubulin modulators|mesh-ancestor
101370393|NCT00183742|Antimitotic Agents|antimitotic agents|mesh-ancestor
101370394|NCT00183742|Mitosis Modulators|mitosis modulators|mesh-ancestor
101370395|NCT00183742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370396|NCT00183742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101370397|NCT00183742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101370398|NCT00183742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101370399|NCT00183742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101370400|NCT02965248|Calcium, Dietary|calcium, dietary|mesh-list
101370401|NCT02965248|Leucovorin|leucovorin|mesh-list
101370402|NCT02965248|Capecitabine|capecitabine|mesh-list
101370403|NCT02965248|Raltitrexed|raltitrexed|mesh-list
101370404|NCT02965248|Oxaliplatin|oxaliplatin|mesh-list
101370405|NCT02965248|Calcium|calcium|mesh-list
101370406|NCT02965248|Levoleucovorin|levoleucovorin|mesh-list
101370407|NCT02965248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101370408|NCT02965248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370409|NCT02965248|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101370410|NCT02965248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101370429|NCT00183820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370430|NCT00183820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101370431|NCT00183820|Antimetabolites|antimetabolites|mesh-ancestor
101370432|NCT02969720|Titanium dioxide|titanium dioxide|mesh-list
101370433|NCT02969720|Sunscreening Agents|sunscreening agents|mesh-ancestor
101370434|NCT02969720|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101370435|NCT02969720|Protective Agents|protective agents|mesh-ancestor
101370436|NCT02969720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370437|NCT02969720|Dermatologic Agents|dermatologic agents|mesh-ancestor
101370438|NCT02969720|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101370440|NCT00183859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101370441|NCT00183859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101370442|NCT00183859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101370443|NCT00183859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370444|NCT00183859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101370445|NCT00183898|Capecitabine|capecitabine|mesh-list
101370446|NCT00183898|Oxaliplatin|oxaliplatin|mesh-list
101370447|NCT00183898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101370448|NCT00183898|Antimetabolites|antimetabolites|mesh-ancestor
101370449|NCT00183898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370450|NCT00183898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101370451|NCT04730765|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101370452|NCT04730765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101370453|NCT00183937|Docetaxel|docetaxel|mesh-list
101370454|NCT00183937|Bortezomib|bortezomib|mesh-list
101370455|NCT00183937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101370456|NCT00183937|Tubulin Modulators|tubulin modulators|mesh-ancestor
101370457|NCT00183937|Antimitotic Agents|antimitotic agents|mesh-ancestor
101370458|NCT00183937|Mitosis Modulators|mitosis modulators|mesh-ancestor
101370459|NCT00183937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370460|NCT00408772|Bevacizumab|bevacizumab|mesh-list
101370461|NCT00408772|Capecitabine|capecitabine|mesh-list
101370462|NCT00408772|Oxaliplatin|oxaliplatin|mesh-list
102059318|NCT05894018|Fluzoparib|fluzoparib|mesh-list
102059319|NCT05894018|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102059320|NCT05894018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102059321|NCT05894018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059322|NCT05894018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102059323|NCT05892276|Cannabidiol|cannabidiol|mesh-list
102059324|NCT05892276|Anticonvulsants|anticonvulsants|mesh-ancestor
102059325|NCT05891262|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101360943|NCT00077415|Antimetabolites|antimetabolites|mesh-ancestor
101370463|NCT00408772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101370464|NCT00408772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101370465|NCT00408772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101370466|NCT00408772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101370467|NCT00408772|Growth Substances|growth substances|mesh-ancestor
101370468|NCT00408772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370469|NCT00408772|Growth Inhibitors|growth inhibitors|mesh-ancestor
101370470|NCT00408772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101370471|NCT00408772|Antimetabolites|antimetabolites|mesh-ancestor
101370472|NCT00408772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370473|NCT00408850|Pioglitazone|pioglitazone|mesh-list
101370474|NCT00408850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101370475|NCT00408850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370498|NCT00184015|Growth Substances|growth substances|mesh-ancestor
101370499|NCT00184015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370500|NCT00184015|Growth Inhibitors|growth inhibitors|mesh-ancestor
101370501|NCT00184171|Budesonide|budesonide|mesh-list
101370502|NCT00184171|Bismuth|bismuth|mesh-list
101370503|NCT00184171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101370504|NCT00184171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101370505|NCT00184171|Autonomic Agents|autonomic agents|mesh-ancestor
101370506|NCT00184171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101370507|NCT00184171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370508|NCT00184171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101370509|NCT00184171|Respiratory System Agents|respiratory system agents|mesh-ancestor
101370510|NCT00184171|Glucocorticoids|glucocorticoids|mesh-ancestor
101370511|NCT00184171|Hormones|hormones|mesh-ancestor
101251310|NCT05797597|Aspirin|aspirin|mesh-list
101370512|NCT00184171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101370513|NCT00184171|Antacids|antacids|mesh-ancestor
101370514|NCT00184171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370519|NCT00057707|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101251379|NCT05756504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101304567|NCT02013986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101304568|NCT02013986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101304569|NCT02013986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304570|NCT02013986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101304571|NCT02013986|Anesthetics, General|anesthetics, general|mesh-ancestor
101304572|NCT02013986|Anesthetics|anesthetics|mesh-ancestor
101304573|NCT02013986|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101304574|NCT02013986|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101304575|NCT02013986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101304576|NCT02013986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101304577|NCT02013986|GABA Modulators|gaba modulators|mesh-ancestor
101304578|NCT02013986|GABA Agents|gaba agents|mesh-ancestor
101304579|NCT02013986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101304580|NCT02013986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304581|NCT02014064|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101370520|NCT00057707|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101370521|NCT00057707|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101370522|NCT00057707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370523|NCT00184522|Esomeprazole|esomeprazole|mesh-list
101370524|NCT00184522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101370525|NCT00184522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101370526|NCT00184522|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101370527|NCT00184522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101370554|NCT00184795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101370556|NCT00058253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102059327|NCT05891262|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
102059328|NCT05891262|Estradiol|estradiol|mesh-list
101251597|NCT05161468|Hormones|hormones|mesh-ancestor
101251598|NCT05161468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101251599|NCT05161468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101251600|NCT05161468|Immunologic Factors|immunologic factors|mesh-ancestor
101370557|NCT00058253|Tubulin Modulators|tubulin modulators|mesh-ancestor
101370558|NCT00058253|Antimitotic Agents|antimitotic agents|mesh-ancestor
101370559|NCT00058253|Mitosis Modulators|mitosis modulators|mesh-ancestor
101370560|NCT00058253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370561|NCT00046800|Lurtotecan|lurtotecan|mesh-list
101370562|NCT00046800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101370563|NCT00058292|Cytarabine|cytarabine|mesh-list
101370564|NCT00058292|Rituximab|rituximab|mesh-list
101370565|NCT00058292|Etoposide|etoposide|mesh-list
101370566|NCT00058292|Etoposide phosphate|etoposide phosphate|mesh-list
101370567|NCT00058292|Melphalan|melphalan|mesh-list
101370568|NCT00058292|Carmustine|carmustine|mesh-list
101370569|NCT00058292|Lenograstim|lenograstim|mesh-list
101370570|NCT00058292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101370571|NCT00058292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101370572|NCT00058292|Immunologic Factors|immunologic factors|mesh-ancestor
101370573|NCT00058292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370574|NCT00058292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101370575|NCT00058292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101370576|NCT00058292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101370577|NCT00058292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101370578|NCT00058292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101370588|NCT00058292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101370589|NCT03816774|Simethicone|simethicone|mesh-list
101370590|NCT03816774|Antifoaming Agents|antifoaming agents|mesh-ancestor
101370591|NCT03816774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251688|NCT04835506|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101251689|NCT04835506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101251690|NCT04835506|Dermatologic Agents|dermatologic agents|mesh-ancestor
101251691|NCT04835506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101251692|NCT04835506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101251693|NCT04824092|Prednisone|prednisone|mesh-list
101251694|NCT04824092|Cyclophosphamide|cyclophosphamide|mesh-list
101251695|NCT04824092|Rituximab|rituximab|mesh-list
101251696|NCT04824092|Doxorubicin|doxorubicin|mesh-list
101251697|NCT04824092|Vincristine|vincristine|mesh-list
101251698|NCT04824092|Lenalidomide|lenalidomide|mesh-list
101251699|NCT04824092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101251700|NCT04824092|Immunologic Factors|immunologic factors|mesh-ancestor
101251701|NCT04824092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251702|NCT04824092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101251703|NCT04824092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101251704|NCT04824092|Alkylating Agents|alkylating agents|mesh-ancestor
101251705|NCT04824092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370592|NCT03816774|Emollients|emollients|mesh-ancestor
101370593|NCT03816774|Dermatologic Agents|dermatologic agents|mesh-ancestor
101370594|NCT00184912|Caffeine|caffeine|mesh-list
101370595|NCT00184912|Annexin A5|annexin a5|mesh-list
101370596|NCT00184912|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101370597|NCT00184912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370598|NCT00184912|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101370599|NCT00184912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101370600|NCT00184912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370601|NCT00184912|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101370602|NCT00184912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101370603|NCT00184912|Purinergic Agents|purinergic agents|mesh-ancestor
101370604|NCT00184912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101370605|NCT00184951|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101370606|NCT00184951|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101370607|NCT00184951|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101370615|NCT00184990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370617|NCT00058331|Hematinics|hematinics|mesh-ancestor
101370618|NCT00185068|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101370619|NCT00185068|Olmesartan|olmesartan|mesh-list
101370620|NCT00185068|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101370621|NCT00185068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101370622|NCT00185068|Diuretics|diuretics|mesh-ancestor
101370623|NCT00185068|Natriuretic Agents|natriuretic agents|mesh-ancestor
101370624|NCT00185068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370625|NCT00185068|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101370626|NCT00185068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101370627|NCT00185068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251780|NCT04594187|Immunomodulating Agents|immunomodulating agents|mesh-list
101251789|NCT04545554|Vitamin D|vitamin d|mesh-list
101251790|NCT04545554|Calcium|calcium|mesh-list
101251791|NCT04545554|Vitamins|vitamins|mesh-ancestor
101251792|NCT04545554|Micronutrients|micronutrients|mesh-ancestor
101251793|NCT04545554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370628|NCT00185068|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101370629|NCT00185068|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101370630|NCT00185107|Simvastatin|simvastatin|mesh-list
101370631|NCT00185107|Ezetimibe|ezetimibe|mesh-list
101370632|NCT00185107|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
101370633|NCT00185107|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101370634|NCT00185107|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101370635|NCT00185107|Antimetabolites|antimetabolites|mesh-ancestor
101370636|NCT00185107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370637|NCT00185107|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101370638|NCT00185107|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101370639|NCT00185107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101370640|NCT00058448|Docetaxel|docetaxel|mesh-list
101370641|NCT00058448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102059329|NCT05891262|Estrogens|estrogens|mesh-ancestor
102059330|NCT05891262|Hormones|hormones|mesh-ancestor
102059331|NCT05891262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102059332|NCT05891262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370643|NCT00058448|Antimitotic Agents|antimitotic agents|mesh-ancestor
101370644|NCT00058448|Mitosis Modulators|mitosis modulators|mesh-ancestor
101370645|NCT00058448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370646|NCT00185185|Atenolol|atenolol|mesh-list
101370647|NCT00185185|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101370648|NCT00185185|Olmesartan|olmesartan|mesh-list
101370649|NCT00185185|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101370650|NCT00185185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101370651|NCT00185185|Diuretics|diuretics|mesh-ancestor
101370652|NCT00185185|Natriuretic Agents|natriuretic agents|mesh-ancestor
101370653|NCT00185185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370654|NCT00185185|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101370655|NCT00185185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101387701|NCT00323011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101370656|NCT00185185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370657|NCT00185185|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101370658|NCT00185185|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101370659|NCT00185185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101370660|NCT00185185|Sympatholytics|sympatholytics|mesh-ancestor
101370661|NCT00185185|Autonomic Agents|autonomic agents|mesh-ancestor
101370662|NCT00185185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101370663|NCT00185185|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101370664|NCT00185185|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101370665|NCT00185185|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101370666|NCT00185185|Adrenergic Agents|adrenergic agents|mesh-ancestor
101370667|NCT00185185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101370668|NCT00185224|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
101370669|NCT00185224|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101304582|NCT02014064|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101304583|NCT02014064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101304584|NCT02014064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101387702|NCT00323011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101304585|NCT02014064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370674|NCT00185224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370675|NCT00185224|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101370676|NCT00185224|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101370677|NCT00185224|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101370678|NCT00185224|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
101370679|NCT00185224|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101370680|NCT00185224|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101370681|NCT00185302|Entinostat|entinostat|mesh-list
101370682|NCT00185302|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
101370683|NCT00185302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101370684|NCT00185302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101370685|NCT00185302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370686|NCT03784014|Durvalumab|durvalumab|mesh-list
101370687|NCT03784014|Olaparib|olaparib|mesh-list
101370688|NCT03784014|Palbociclib|palbociclib|mesh-list
101370689|NCT03784014|Lapatinib|lapatinib|mesh-list
101370690|NCT03784014|Trametinib|trametinib|mesh-list
101370691|NCT03784014|Dabrafenib|dabrafenib|mesh-list
101370692|NCT03784014|Ceritinib|ceritinib|mesh-list
101370693|NCT03784014|Futibatinib|futibatinib|mesh-list
101370694|NCT03784014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101370695|NCT03784014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101370696|NCT03784014|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101370697|NCT03784014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101370698|NCT03784014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370699|NCT03784014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101370700|NCT00058487|Thalidomide|thalidomide|mesh-list
101370701|NCT00058487|Epirubicin|epirubicin|mesh-list
101370702|NCT00058487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101370703|NCT00058487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101370704|NCT00058487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101370705|NCT00058487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101370706|NCT00058487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102059333|NCT05891262|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102059334|NCT05891262|Contraceptive Agents|contraceptive agents|mesh-ancestor
102059335|NCT05891262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102059336|NCT05891262|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102059337|NCT05891262|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101370707|NCT00058487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370708|NCT00058487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101370709|NCT00058487|Immunologic Factors|immunologic factors|mesh-ancestor
101370710|NCT00058487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370711|NCT00058487|Leprostatic Agents|leprostatic agents|mesh-ancestor
101370712|NCT00058487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101370713|NCT00058487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101370714|NCT00058487|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101370741|NCT00185575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101370742|NCT00185575|Dopamine Agents|dopamine agents|mesh-ancestor
101370743|NCT03731832|Dexamethasone|dexamethasone|mesh-list
101370744|NCT03731832|Cyclophosphamide|cyclophosphamide|mesh-list
101370745|NCT03731832|Pomalidomide|pomalidomide|mesh-list
101370746|NCT03731832|Ixazomib|ixazomib|mesh-list
101370747|NCT03731832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101370748|NCT03731832|Immunologic Factors|immunologic factors|mesh-ancestor
101370749|NCT03731832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370750|NCT03731832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101370751|NCT03731832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101370752|NCT03731832|Alkylating Agents|alkylating agents|mesh-ancestor
101370753|NCT03731832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370754|NCT03731832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101370755|NCT03731832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101370756|NCT03731832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101370757|NCT03731832|Antiemetics|antiemetics|mesh-ancestor
101370758|NCT03731832|Autonomic Agents|autonomic agents|mesh-ancestor
101370759|NCT03731832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101370760|NCT03731832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101304586|NCT02014064|Adrenergic Agents|adrenergic agents|mesh-ancestor
101304587|NCT02014064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101370767|NCT03731832|Growth Substances|growth substances|mesh-ancestor
101370768|NCT03731832|Growth Inhibitors|growth inhibitors|mesh-ancestor
101370769|NCT03731832|Protease Inhibitors|protease inhibitors|mesh-ancestor
101370770|NCT03731832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101370777|NCT00185887|Respiratory System Agents|respiratory system agents|mesh-ancestor
101370778|NCT00185887|Sympathomimetics|sympathomimetics|mesh-ancestor
101370779|NCT00185887|Tocolytic Agents|tocolytic agents|mesh-ancestor
101370780|NCT00185887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101370781|NCT00185887|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101370782|NCT00185887|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101370783|NCT00185887|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101370784|NCT00185887|Adrenergic Agents|adrenergic agents|mesh-ancestor
101370785|NCT00185887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101370786|NCT00185887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370787|NCT00186082|Cefoxitin|cefoxitin|mesh-list
101370788|NCT00186082|Cefotetan|cefotetan|mesh-list
101370789|NCT00186082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101370790|NCT00186082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101370791|NCT00186277|Docetaxel|docetaxel|mesh-list
101370792|NCT00186277|Oxaliplatin|oxaliplatin|mesh-list
101370793|NCT00186277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101370794|NCT00186277|Tubulin Modulators|tubulin modulators|mesh-ancestor
101370795|NCT00186277|Antimitotic Agents|antimitotic agents|mesh-ancestor
101370796|NCT00186277|Mitosis Modulators|mitosis modulators|mesh-ancestor
101387703|NCT00323011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101370797|NCT00186277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370798|NCT00186316|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
101370799|NCT00186316|Immunologic Factors|immunologic factors|mesh-ancestor
101370800|NCT00186316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370801|NCT00058682|Anidulafungin|anidulafungin|mesh-list
101370802|NCT00058682|Antifungal Agents|antifungal agents|mesh-ancestor
101370803|NCT00058682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101370804|NCT00186589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101370805|NCT00186589|Immunologic Factors|immunologic factors|mesh-ancestor
101370806|NCT00186589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370807|NCT00186706|Selenium|selenium|mesh-list
101370808|NCT00186706|Antioxidants|antioxidants|mesh-ancestor
102059338|NCT05891262|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102059339|NCT05891262|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102059340|NCT05891262|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101387704|NCT00323011|Antidotes|antidotes|mesh-ancestor
102059341|NCT05891262|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
102059342|NCT05852262|Cephalexin|cephalexin|mesh-list
102059343|NCT05852262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102059344|NCT05852262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102059345|NCT05822440|Itraconazole|itraconazole|mesh-list
102059346|NCT05822440|Antifungal Agents|antifungal agents|mesh-ancestor
102059347|NCT05822440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101370809|NCT00186706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370810|NCT00186706|Protective Agents|protective agents|mesh-ancestor
101370811|NCT00186706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370812|NCT00186706|Trace Elements|trace elements|mesh-ancestor
101370813|NCT00186706|Micronutrients|micronutrients|mesh-ancestor
101370814|NCT00409201|Reboxetine|reboxetine|mesh-list
101370815|NCT00409201|Antidepressive Agents|antidepressive agents|mesh-ancestor
101370816|NCT00409201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101370817|NCT00409201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101370818|NCT00409201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101370819|NCT00409201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101370820|NCT00409201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370821|NCT00409201|Adrenergic Agents|adrenergic agents|mesh-ancestor
101387705|NCT00323011|Protective Agents|protective agents|mesh-ancestor
101370822|NCT00409201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101370823|NCT00409201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370824|NCT00046878|Carmustine|carmustine|mesh-list
101370825|NCT00046878|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
101370826|NCT00046878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101370827|NCT00046878|Alkylating Agents|alkylating agents|mesh-ancestor
101370828|NCT00046878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370829|NCT00046878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101370844|NCT00186862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101370845|NCT00186862|Analgesics|analgesics|mesh-ancestor
101370846|NCT00186862|Sensory System Agents|sensory system agents|mesh-ancestor
101370847|NCT00186862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101370848|NCT00186940|Rasburicase|rasburicase|mesh-list
101370849|NCT00186940|Gout Suppressants|gout suppressants|mesh-ancestor
101370850|NCT00186940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101370851|NCT00186979|Cefixime|cefixime|mesh-list
101370852|NCT00186979|Cefpodoxime|cefpodoxime|mesh-list
101304588|NCT02014064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304589|NCT02013089|Everolimus|everolimus|mesh-list
101370858|NCT00186979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101370859|NCT00186979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101370860|NCT00186979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370861|NCT00186979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101370862|NCT00186979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101370863|NCT00186979|Tubulin Modulators|tubulin modulators|mesh-ancestor
101370864|NCT00186979|Antimitotic Agents|antimitotic agents|mesh-ancestor
101370865|NCT00186979|Mitosis Modulators|mitosis modulators|mesh-ancestor
101370866|NCT00186979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101370867|NCT00186979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101370868|NCT00186979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101370869|NCT00187057|Cytarabine|cytarabine|mesh-list
101370870|NCT00187057|Dexamethasone|dexamethasone|mesh-list
101370871|NCT00187057|Prednisone|prednisone|mesh-list
101370872|NCT00187057|Cyclophosphamide|cyclophosphamide|mesh-list
101370873|NCT00187057|Doxorubicin|doxorubicin|mesh-list
101370874|NCT00187057|Methotrexate|methotrexate|mesh-list
101370875|NCT00187057|Etoposide|etoposide|mesh-list
101370876|NCT00187057|Vincristine|vincristine|mesh-list
101370877|NCT00187057|Daunorubicin|daunorubicin|mesh-list
101370878|NCT00187057|Asparaginase|asparaginase|mesh-list
101370879|NCT00187057|Mercaptopurine|mercaptopurine|mesh-list
101370880|NCT00187057|Vinblastine|vinblastine|mesh-list
101370881|NCT00187057|Procarbazine|procarbazine|mesh-list
101370882|NCT00187057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102059348|NCT05822440|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102059349|NCT05822440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102059350|NCT05822440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101370883|NCT00187057|Immunologic Factors|immunologic factors|mesh-ancestor
101370884|NCT00187057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370885|NCT00187057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101370886|NCT00187057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101370887|NCT00187057|Alkylating Agents|alkylating agents|mesh-ancestor
101370888|NCT00187057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370889|NCT00187057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101253300|NCT02367794|Paclitaxel|paclitaxel|mesh-list
101370890|NCT00187057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101370891|NCT00187057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101370892|NCT00187057|Antiemetics|antiemetics|mesh-ancestor
101370893|NCT00187057|Autonomic Agents|autonomic agents|mesh-ancestor
101370894|NCT00187057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101370895|NCT00187057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101370896|NCT00187057|Glucocorticoids|glucocorticoids|mesh-ancestor
101370908|NCT00187057|Antimetabolites|antimetabolites|mesh-ancestor
101370909|NCT00187057|Dermatologic Agents|dermatologic agents|mesh-ancestor
101370910|NCT00187057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101370911|NCT00187057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101370912|NCT00187057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101370913|NCT00187057|Antiviral Agents|antiviral agents|mesh-ancestor
101370914|NCT00187057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101253445|NCT02040857|Tamoxifen|tamoxifen|mesh-list
101370915|NCT00187057|Tubulin Modulators|tubulin modulators|mesh-ancestor
101370916|NCT00187057|Antimitotic Agents|antimitotic agents|mesh-ancestor
101370917|NCT00187057|Mitosis Modulators|mitosis modulators|mesh-ancestor
101370918|NCT00046917|Irinotecan|irinotecan|mesh-list
101370919|NCT00046917|Alvocidib|alvocidib|mesh-list
101370920|NCT00046917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101370921|NCT00046917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101370922|NCT00046917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101253517|NCT01913730|Hormones|hormones|mesh-ancestor
101370923|NCT00046917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101370924|NCT00046917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370925|NCT00046917|Growth Inhibitors|growth inhibitors|mesh-ancestor
101370926|NCT00046917|Growth Substances|growth substances|mesh-ancestor
101370927|NCT00046917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370928|NCT00046917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101370930|NCT00187174|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101370931|NCT00187174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101370932|NCT00187174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101370933|NCT00187174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370934|NCT00187174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101370935|NCT00187174|Immunologic Factors|immunologic factors|mesh-ancestor
101370936|NCT00187174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304590|NCT02013089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101370943|NCT00187330|Respiratory System Agents|respiratory system agents|mesh-ancestor
101370945|NCT00187330|Antioxidants|antioxidants|mesh-ancestor
101370946|NCT00187330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370947|NCT00187330|Protective Agents|protective agents|mesh-ancestor
101370948|NCT00187330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370949|NCT00187330|Antidotes|antidotes|mesh-ancestor
101370950|NCT00187408|Heparin|heparin|mesh-list
101370951|NCT00187408|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101370952|NCT00187408|Tinzaparin|tinzaparin|mesh-list
101370953|NCT00187408|Dalteparin|dalteparin|mesh-list
101370954|NCT00187408|Anticoagulants|anticoagulants|mesh-ancestor
101370955|NCT00187408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101370956|NCT00187408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101370957|NCT00187408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370958|NCT00187447|Indomethacin|indomethacin|mesh-list
101370959|NCT00187447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101370972|NCT00187447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370973|NCT02969564|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
101370974|NCT02969564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101370975|NCT02969564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370976|NCT00187525|Memantine|memantine|mesh-list
101370977|NCT00187525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101370978|NCT00187525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101370979|NCT00187525|Dopamine Agents|dopamine agents|mesh-ancestor
101628305|NCT02590705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101370980|NCT00187525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101370981|NCT00187525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370982|NCT00187525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370983|NCT00187525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101370984|NCT00187525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101370985|NCT00187564|Thioctic Acid|thioctic acid|mesh-list
101370986|NCT00187564|Antioxidants|antioxidants|mesh-ancestor
101370987|NCT00187564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370988|NCT00187564|Protective Agents|protective agents|mesh-ancestor
101370989|NCT00187564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370990|NCT00187564|Vitamin B Complex|vitamin b complex|mesh-ancestor
101370991|NCT00187564|Vitamins|vitamins|mesh-ancestor
101370992|NCT00187564|Micronutrients|micronutrients|mesh-ancestor
101370993|NCT00046995|Leucovorin|leucovorin|mesh-list
101370994|NCT00046995|Carboplatin|carboplatin|mesh-list
101370995|NCT00046995|Fluorouracil|fluorouracil|mesh-list
101370996|NCT00046995|Calcium|calcium|mesh-list
101370997|NCT00046995|Levoleucovorin|levoleucovorin|mesh-list
101370998|NCT00046995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101370999|NCT00046995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101371000|NCT00046995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371001|NCT00046995|Antimetabolites|antimetabolites|mesh-ancestor
101371002|NCT00046995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371003|NCT00046995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101371004|NCT00046995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101371005|NCT00046995|Immunologic Factors|immunologic factors|mesh-ancestor
101371006|NCT00046995|Antidotes|antidotes|mesh-ancestor
101371007|NCT00046995|Protective Agents|protective agents|mesh-ancestor
101371008|NCT00046995|Vitamin B Complex|vitamin b complex|mesh-ancestor
101371009|NCT00046995|Vitamins|vitamins|mesh-ancestor
101371010|NCT00046995|Micronutrients|micronutrients|mesh-ancestor
101371011|NCT00058955|Sodium Oxybate|sodium oxybate|mesh-list
101371012|NCT00058955|Triazolam|triazolam|mesh-list
101371013|NCT00058955|Pentobarbital|pentobarbital|mesh-list
101371014|NCT00058955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101371019|NCT00058955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371020|NCT00058955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101371021|NCT00058955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101371022|NCT00058955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101371023|NCT00058955|GABA Modulators|gaba modulators|mesh-ancestor
101371026|NCT00058955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371027|NCT00058955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101371028|NCT00187759|Cephalexin|cephalexin|mesh-list
101371029|NCT00187759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101371030|NCT00187759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101371031|NCT00187798|Metformin|metformin|mesh-list
101371032|NCT00187798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101371033|NCT00187798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371034|NCT00058994|Anecortave|anecortave|mesh-list
101371035|NCT00058994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101371036|NCT00058994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101371037|NCT00058994|Growth Substances|growth substances|mesh-ancestor
101254055|NCT01696422|Vaccines|vaccines|mesh-list
101371038|NCT00058994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371039|NCT00058994|Growth Inhibitors|growth inhibitors|mesh-ancestor
101371040|NCT00058994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371041|NCT00187915|Cyclosporine|cyclosporine|mesh-list
101371042|NCT00187915|Mycophenolic Acid|mycophenolic acid|mesh-list
101371043|NCT00187915|Tacrolimus|tacrolimus|mesh-list
101371044|NCT00187915|Cyclosporins|cyclosporins|mesh-list
101371045|NCT00187915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101371046|NCT00187915|Immunologic Factors|immunologic factors|mesh-ancestor
101371047|NCT00187915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371048|NCT00187915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101371049|NCT00187915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101254129|NCT01696799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371050|NCT00187915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371051|NCT00187915|Antifungal Agents|antifungal agents|mesh-ancestor
101371052|NCT00187915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101371053|NCT00187915|Dermatologic Agents|dermatologic agents|mesh-ancestor
101371054|NCT00187915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101371055|NCT00187915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101371056|NCT00187915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371057|NCT00187915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101371058|NCT00187915|Antitubercular Agents|antitubercular agents|mesh-ancestor
101371059|NCT00187915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101371060|NCT00187993|Hormones|hormones|mesh-list
102059351|NCT05822440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059352|NCT05822440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102059353|NCT05822440|Hormone Antagonists|hormone antagonists|mesh-ancestor
102059354|NCT05822440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102059355|NCT05822440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059356|NCT05822440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102059358|NCT05805839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102059359|NCT05790252|Buprenorphine|buprenorphine|mesh-list
101371061|NCT00187993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101371062|NCT00187993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371063|NCT00188071|Acetaminophen|acetaminophen|mesh-list
101371064|NCT00188071|Ketoprofen|ketoprofen|mesh-list
101371065|NCT00188071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101371066|NCT00188071|Analgesics|analgesics|mesh-ancestor
101371067|NCT00188071|Sensory System Agents|sensory system agents|mesh-ancestor
101371068|NCT00188071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101371069|NCT00188071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371070|NCT00188071|Antipyretics|antipyretics|mesh-ancestor
101371071|NCT00188071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101371072|NCT00188071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101371073|NCT00188071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101371074|NCT00188071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101371075|NCT00188071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371076|NCT00188071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371077|NCT00188227|Midazolam|midazolam|mesh-list
101371078|NCT00188227|Pirinitramide|pirinitramide|mesh-list
101371083|NCT00188227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101371084|NCT00188227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101371085|NCT00188227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101371086|NCT00188227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101371087|NCT00188227|Anesthetics, General|anesthetics, general|mesh-ancestor
101304598|NCT02013089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304599|NCT02013089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101304600|NCT02013089|Immunologic Factors|immunologic factors|mesh-ancestor
101371089|NCT00188227|GABA Modulators|gaba modulators|mesh-ancestor
101371090|NCT00188227|GABA Agents|gaba agents|mesh-ancestor
101371091|NCT00188227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101371092|NCT00188227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371093|NCT00188227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101371094|NCT00188227|Narcotics|narcotics|mesh-ancestor
101371095|NCT00188227|Analgesics|analgesics|mesh-ancestor
101371096|NCT00188227|Sensory System Agents|sensory system agents|mesh-ancestor
101371097|NCT00188227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101371098|NCT00188266|Fluorouracil|fluorouracil|mesh-list
101371103|NCT00188266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371104|NCT00188266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101371105|NCT00188266|Immunologic Factors|immunologic factors|mesh-ancestor
101371106|NCT00188266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371107|NCT00047073|Sirolimus|sirolimus|mesh-list
101371108|NCT00047073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101371109|NCT00047073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101371110|NCT00047073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101371111|NCT00047073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371112|NCT00047073|Antifungal Agents|antifungal agents|mesh-ancestor
101371113|NCT00047073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101371114|NCT00047073|Immunologic Factors|immunologic factors|mesh-ancestor
101371115|NCT00047073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371116|NCT00188383|Amantadine|amantadine|mesh-list
101371117|NCT00188383|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101371118|NCT00188383|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101371119|NCT00188383|Antiviral Agents|antiviral agents|mesh-ancestor
101371120|NCT00188383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101371121|NCT00188383|Dopamine Agents|dopamine agents|mesh-ancestor
101371122|NCT00188383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101371123|NCT00188383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371124|NCT00188383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371125|NCT00188383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101371126|NCT00188383|Analgesics|analgesics|mesh-ancestor
101371127|NCT00188383|Sensory System Agents|sensory system agents|mesh-ancestor
101371128|NCT00188383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101371129|NCT02969447|Oxytocin|oxytocin|mesh-list
101371130|NCT02969447|Oxytocics|oxytocics|mesh-ancestor
101371131|NCT02969447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101371132|NCT02969447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371133|NCT00188617|Gefitinib|gefitinib|mesh-list
101371134|NCT00188617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371135|NCT00188617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101371136|NCT00188617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371137|NCT00188617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371138|NCT00047112|Fluorouracil|fluorouracil|mesh-list
101371139|NCT00047112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371140|NCT00047112|Antimetabolites|antimetabolites|mesh-ancestor
101371141|NCT00047112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371142|NCT00047112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101371143|NCT00047112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101371144|NCT00047112|Immunologic Factors|immunologic factors|mesh-ancestor
101371145|NCT00047112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371146|NCT00409318|Etanercept|etanercept|mesh-list
101371147|NCT00409318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101371148|NCT00409318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101371149|NCT00409318|Analgesics|analgesics|mesh-ancestor
101371150|NCT00409318|Sensory System Agents|sensory system agents|mesh-ancestor
101254735|NCT01700478|Oxytocics|oxytocics|mesh-ancestor
101371159|NCT00409357|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101371160|NCT00409357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101304602|NCT02013089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101304603|NCT02013089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101304604|NCT02013089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101304605|NCT02013089|Growth Substances|growth substances|mesh-ancestor
101304606|NCT02013089|Growth Inhibitors|growth inhibitors|mesh-ancestor
101304607|NCT02014103|Tacrolimus|tacrolimus|mesh-list
101304608|NCT02014103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101304609|NCT02014103|Immunologic Factors|immunologic factors|mesh-ancestor
101304610|NCT02014103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304611|NCT02014103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101304612|NCT02014103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101304613|NCT02014103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371161|NCT00409357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101371162|NCT00409357|Adrenergic Agents|adrenergic agents|mesh-ancestor
101371163|NCT00409357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101371164|NCT00409357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371165|NCT00409357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371166|NCT00409357|Urological Agents|urological agents|mesh-ancestor
101371167|NCT00059267|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101371168|NCT00059267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101371179|NCT00188773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101371180|NCT00188773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101371181|NCT00188773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371182|NCT00188773|Antiviral Agents|antiviral agents|mesh-ancestor
101371183|NCT00188773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101371184|NCT00188773|Expectorants|expectorants|mesh-ancestor
101371185|NCT00188773|Respiratory System Agents|respiratory system agents|mesh-ancestor
101371186|NCT00188773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101371187|NCT00188773|Antioxidants|antioxidants|mesh-ancestor
101371188|NCT00188773|Protective Agents|protective agents|mesh-ancestor
101371189|NCT00188773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371190|NCT00188773|Antidotes|antidotes|mesh-ancestor
101371191|NCT00188773|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101371192|NCT00188773|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101371193|NCT00188773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101371194|NCT00188812|Donepezil|donepezil|mesh-list
101371195|NCT00188812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101371196|NCT00188812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371197|NCT00188812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371198|NCT00188812|Cholinergic Agents|cholinergic agents|mesh-ancestor
101371199|NCT00188812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101371200|NCT00188812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059360|NCT05790252|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102059361|NCT05790252|Narcotics|narcotics|mesh-ancestor
102059362|NCT05790252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102059363|NCT05790252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059364|NCT05790252|Analgesics|analgesics|mesh-ancestor
102059365|NCT05790252|Sensory System Agents|sensory system agents|mesh-ancestor
102059366|NCT05790252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101371201|NCT00188812|Nootropic Agents|nootropic agents|mesh-ancestor
101371203|NCT02963194|Oxytocics|oxytocics|mesh-ancestor
101371204|NCT02963194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101371205|NCT02963194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371206|NCT00059306|Aspirin|aspirin|mesh-list
101371207|NCT00059306|Clopidogrel|clopidogrel|mesh-list
101371208|NCT00059306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101371209|NCT00059306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101371210|NCT00059306|Analgesics|analgesics|mesh-ancestor
101371211|NCT00059306|Sensory System Agents|sensory system agents|mesh-ancestor
101371212|NCT00059306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101371213|NCT00059306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371214|NCT00059306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101371217|NCT00059306|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101371218|NCT00059306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371219|NCT00059306|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101371220|NCT00059306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101371221|NCT00059306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371222|NCT00059306|Antipyretics|antipyretics|mesh-ancestor
101371223|NCT00059306|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101371224|NCT00059306|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101371225|NCT00059306|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101371226|NCT00059306|Purinergic Agents|purinergic agents|mesh-ancestor
101371227|NCT00059306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101371228|NCT00188929|Deoxyglucose|deoxyglucose|mesh-list
101371229|NCT00188929|Antimetabolites|antimetabolites|mesh-ancestor
101371230|NCT00188929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371231|NCT00188929|Antiviral Agents|antiviral agents|mesh-ancestor
101371232|NCT00188929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101371233|NCT03428373|Rivaroxaban|rivaroxaban|mesh-list
101371271|NCT00189124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371278|NCT00189358|Hormone Antagonists|hormone antagonists|mesh-ancestor
101371279|NCT00189358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101371280|NCT00189358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371281|NCT00189358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101371282|NCT00189358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371283|NCT00189358|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101371284|NCT00189358|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101371285|NCT00189358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101371286|NCT00189358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101371287|NCT00189358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371288|NCT00189358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371289|NCT00189397|Azathioprine|azathioprine|mesh-list
101371290|NCT00189397|Antimetabolites|antimetabolites|mesh-ancestor
101371291|NCT00189397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371292|NCT00189397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101371293|NCT00189397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371294|NCT00189397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101371295|NCT00189397|Immunologic Factors|immunologic factors|mesh-ancestor
101371296|NCT00189397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371297|NCT00189397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101371298|NCT00189514|Pramlintide|pramlintide|mesh-list
101371299|NCT00189514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101371300|NCT00189514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371301|NCT00189553|Paclitaxel|paclitaxel|mesh-list
101371302|NCT00189553|Carboplatin|carboplatin|mesh-list
101371304|NCT00189553|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101371305|NCT00189553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102059367|NCT05790252|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102059368|NCT05789173|Efavirenz|efavirenz|mesh-list
102059369|NCT05789173|Clonidine|clonidine|mesh-list
102059370|NCT05789173|Methadone|methadone|mesh-list
102059371|NCT05789173|Tizanidine|tizanidine|mesh-list
102059372|NCT05789173|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102059373|NCT05789173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102059374|NCT05789173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102059375|NCT05789173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059376|NCT05789173|Antiviral Agents|antiviral agents|mesh-ancestor
101255677|NCT01706510|Clopidogrel|clopidogrel|mesh-list
102059377|NCT05789173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102059378|NCT05789173|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101371306|NCT00189553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371307|NCT00189553|Tubulin Modulators|tubulin modulators|mesh-ancestor
101371308|NCT00189553|Antimitotic Agents|antimitotic agents|mesh-ancestor
101371309|NCT00189553|Mitosis Modulators|mitosis modulators|mesh-ancestor
101371310|NCT00189553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371311|NCT00189553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101371312|NCT00189553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101371313|NCT00189553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101371314|NCT00189553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371315|NCT00189709|Fluconazole|fluconazole|mesh-list
101371316|NCT00189709|Micafungin|micafungin|mesh-list
101371317|NCT00189709|Antifungal Agents|antifungal agents|mesh-ancestor
101371318|NCT00189709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101371319|NCT00189709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101371320|NCT00189709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101371321|NCT00189709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371322|NCT00189709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371323|NCT00189709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101371326|NCT00189709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371327|NCT00189709|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101371328|NCT00189709|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101371329|NCT04722796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101371330|NCT00189748|Tacrolimus|tacrolimus|mesh-list
101371331|NCT00189748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101371332|NCT00189748|Immunologic Factors|immunologic factors|mesh-ancestor
101371333|NCT00189748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371334|NCT00189748|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101371335|NCT00189748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371336|NCT00189748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371337|NCT00189787|Tacrolimus|tacrolimus|mesh-list
101371338|NCT00189787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101371339|NCT00189787|Immunologic Factors|immunologic factors|mesh-ancestor
101371340|NCT00189787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256015|NCT01708707|Narcotics|narcotics|mesh-ancestor
101371341|NCT00189787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101371352|NCT00189826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101371353|NCT00189826|Immunologic Factors|immunologic factors|mesh-ancestor
101371354|NCT00189826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371355|NCT00189826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101371356|NCT00189826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371357|NCT00189826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371358|NCT00047190|Tipifarnib|tipifarnib|mesh-list
101371359|NCT00047190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371360|NCT00189904|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
101371361|NCT00189904|Antiviral Agents|antiviral agents|mesh-ancestor
101371362|NCT00189904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101371363|NCT00189943|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
101371364|NCT00189943|Antiviral Agents|antiviral agents|mesh-ancestor
101371365|NCT00189943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101371366|NCT00189982|Factor VIII|factor viii|mesh-list
102059379|NCT05789173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102059380|NCT05789173|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101256180|NCT01709942|Hormone Antagonists|hormone antagonists|mesh-ancestor
102059381|NCT05789173|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102059382|NCT05789173|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102059383|NCT05789173|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101371367|NCT00189982|Coagulants|coagulants|mesh-ancestor
101371368|NCT00190021|Donepezil|donepezil|mesh-list
101371369|NCT00190021|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101371370|NCT00190021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371371|NCT00190021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371372|NCT00190021|Cholinergic Agents|cholinergic agents|mesh-ancestor
101371373|NCT00190021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101256245|NCT01710228|Prednisolone|prednisolone|mesh-list
101371374|NCT00190021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371375|NCT00190021|Nootropic Agents|nootropic agents|mesh-ancestor
101371376|NCT00190060|Testosterone|testosterone|mesh-list
101371377|NCT00190060|Androgens|androgens|mesh-ancestor
101371378|NCT00190060|Hormones|hormones|mesh-ancestor
101371379|NCT00190060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101371380|NCT00190060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371381|NCT00047229|Doxorubicin|doxorubicin|mesh-list
101371382|NCT00047229|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101371383|NCT00047229|Oblimersen|oblimersen|mesh-list
101371384|NCT00047229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101371385|NCT00047229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371386|NCT00047229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101371387|NCT00047229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101371388|NCT00047229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371389|NCT00047229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371390|NCT00190099|Dexamethasone|dexamethasone|mesh-list
101371391|NCT00190099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101371392|NCT00190099|Antiemetics|antiemetics|mesh-ancestor
101371393|NCT00190099|Autonomic Agents|autonomic agents|mesh-ancestor
101371394|NCT00190099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101371395|NCT00190099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371396|NCT00190099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101304622|NCT02014337|Contraceptive Agents|contraceptive agents|mesh-ancestor
101371401|NCT00190099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371402|NCT02963077|Cholestyramine Resin|cholestyramine resin|mesh-list
101256314|NCT01710592|Epirubicin|epirubicin|mesh-list
101371403|NCT02963077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101371404|NCT02963077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101371405|NCT02963077|Antimetabolites|antimetabolites|mesh-ancestor
101371447|NCT03238365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371449|NCT03238365|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101371450|NCT03238365|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101371451|NCT03238365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371452|NCT03238365|Urological Agents|urological agents|mesh-ancestor
101371453|NCT00059618|Carboplatin|carboplatin|mesh-list
101371454|NCT00059618|Bortezomib|bortezomib|mesh-list
101371455|NCT00059618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371456|NCT00190333|Escitalopram|escitalopram|mesh-list
101371457|NCT00190333|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101371458|NCT00190333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101371459|NCT00190333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101256441|NCT01711320|Omeprazole|omeprazole|mesh-list
101371460|NCT00190333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371461|NCT00190333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101371462|NCT00190333|Serotonin Agents|serotonin agents|mesh-ancestor
101371463|NCT00190333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371464|NCT00190372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
101371465|NCT00190372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101371466|NCT00190372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371467|NCT00190411|Celiprolol|celiprolol|mesh-list
101371468|NCT00190411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101371469|NCT00190411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101371470|NCT00190411|Sympathomimetics|sympathomimetics|mesh-ancestor
101371471|NCT00190411|Autonomic Agents|autonomic agents|mesh-ancestor
101371472|NCT00190411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101371473|NCT00190411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059384|NCT05789173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102059385|NCT05789173|Narcotics|narcotics|mesh-ancestor
102059386|NCT05789173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102059387|NCT05789173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473055|NCT02270749|Vitamins|vitamins|mesh-ancestor
101371474|NCT00190411|Vasodilator Agents|vasodilator agents|mesh-ancestor
101371475|NCT00190411|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101371476|NCT00190411|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101371477|NCT00190411|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101371478|NCT00190411|Adrenergic Agents|adrenergic agents|mesh-ancestor
101371479|NCT00190411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101371480|NCT00190411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371481|NCT00047307|Gemcitabine|gemcitabine|mesh-list
101371482|NCT00047307|Alvocidib|alvocidib|mesh-list
101371483|NCT00047307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101371484|NCT00047307|Antimetabolites|antimetabolites|mesh-ancestor
101371485|NCT00047307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371486|NCT00047307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371487|NCT00047307|Growth Inhibitors|growth inhibitors|mesh-ancestor
101371488|NCT00047307|Growth Substances|growth substances|mesh-ancestor
101371489|NCT00047307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371490|NCT00047307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101371491|NCT00047307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371492|NCT00190489|Docetaxel|docetaxel|mesh-list
101371493|NCT00190489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371494|NCT00190489|Tubulin Modulators|tubulin modulators|mesh-ancestor
101371495|NCT00190489|Antimitotic Agents|antimitotic agents|mesh-ancestor
101371496|NCT00190489|Mitosis Modulators|mitosis modulators|mesh-ancestor
101371497|NCT00190489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371498|NCT00190567|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101371499|NCT00190567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101371500|NCT00190567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101371501|NCT00190567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101371502|NCT00190567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371531|NCT00190645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101371532|NCT00190645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101256883|NCT01713426|Anticonvulsants|anticonvulsants|mesh-ancestor
101371533|NCT00190645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371534|NCT00190645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101371535|NCT00190645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371536|NCT00190645|Analgesics|analgesics|mesh-ancestor
101371537|NCT00190645|Sensory System Agents|sensory system agents|mesh-ancestor
101371538|NCT00190645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101371539|NCT00190645|Antidepressive Agents|antidepressive agents|mesh-ancestor
101371540|NCT00190645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101371541|NCT00190645|Dopamine Agents|dopamine agents|mesh-ancestor
101371542|NCT00190762|Pemetrexed|pemetrexed|mesh-list
101371543|NCT00190762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371544|NCT00190762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101257051|NCT01714193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101371545|NCT00190762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371546|NCT00190762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101371547|NCT00190762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101371548|NCT00190801|Pemetrexed|pemetrexed|mesh-list
101371549|NCT00190801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371550|NCT00190801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371551|NCT00190801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371552|NCT00190801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101371553|NCT00190801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101371554|NCT00047346|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101371555|NCT00047346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371556|NCT00047346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101371557|NCT00047346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371572|NCT00190879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371574|NCT00190918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371575|NCT00190918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101305331|NCT02018965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371576|NCT00190918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371577|NCT00190918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102059389|NCT05789173|Sensory System Agents|sensory system agents|mesh-ancestor
102059390|NCT05789173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102059391|NCT05789173|Antitussive Agents|antitussive agents|mesh-ancestor
102059392|NCT05789173|Respiratory System Agents|respiratory system agents|mesh-ancestor
102059393|NCT05789173|Anticonvulsants|anticonvulsants|mesh-ancestor
101371578|NCT00190918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101371579|NCT00190957|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101371580|NCT00190957|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101371581|NCT00190957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101371582|NCT00190957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101371583|NCT00190957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371584|NCT00190957|Adrenergic Agents|adrenergic agents|mesh-ancestor
101371585|NCT00190957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101371586|NCT00190957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371587|NCT00190996|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101305332|NCT02018965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101371591|NCT00190996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371592|NCT00190996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101371593|NCT00190996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371595|NCT00190996|Sensory System Agents|sensory system agents|mesh-ancestor
101371596|NCT00190996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101371597|NCT00190996|Antidepressive Agents|antidepressive agents|mesh-ancestor
101371598|NCT00190996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101371599|NCT00190996|Dopamine Agents|dopamine agents|mesh-ancestor
101371600|NCT00191035|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101371601|NCT00191035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101304626|NCT02014337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101304627|NCT02014337|Luteolytic Agents|luteolytic agents|mesh-ancestor
101371602|NCT00191035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101371603|NCT00191035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101371604|NCT00191035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371605|NCT00191035|Adrenergic Agents|adrenergic agents|mesh-ancestor
101371606|NCT00191035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101371607|NCT00191035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371609|NCT02922894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101371610|NCT02922894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101371616|NCT02922894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101371617|NCT02922894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371618|NCT02922894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101371620|NCT02922894|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101257479|NCT01716767|Analgesics|analgesics|mesh-list
101371621|NCT02922894|Antidepressive Agents|antidepressive agents|mesh-ancestor
101371622|NCT00191230|Carboplatin|carboplatin|mesh-list
101371623|NCT00191230|Gemcitabine|gemcitabine|mesh-list
101371624|NCT00191230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371625|NCT00191230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101371626|NCT00191230|Antimetabolites|antimetabolites|mesh-ancestor
101371627|NCT00191230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371628|NCT00191347|Gemcitabine|gemcitabine|mesh-list
101371629|NCT00191347|Pemetrexed|pemetrexed|mesh-list
101371630|NCT00191347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101371631|NCT00191347|Antimetabolites|antimetabolites|mesh-ancestor
101371632|NCT00191347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371633|NCT00191347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371634|NCT00191347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371635|NCT00191347|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101371636|NCT00191347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101371637|NCT00191425|Teriparatide|teriparatide|mesh-list
101371638|NCT00191425|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101371639|NCT00191425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101371640|NCT00191425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371641|NCT00191425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101371642|NCT00191425|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101371643|NCT00191425|Hormone Antagonists|hormone antagonists|mesh-ancestor
101371644|NCT00191425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102059394|NCT05789173|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102059395|NCT05789173|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102059396|NCT05789173|Parasympatholytics|parasympatholytics|mesh-ancestor
102059397|NCT05789173|Autonomic Agents|autonomic agents|mesh-ancestor
102059398|NCT05789173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102059399|NCT05789173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101371645|NCT00191425|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101371646|NCT00191425|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101371647|NCT00191464|Insulin|insulin|mesh-list
101371648|NCT00191464|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101371649|NCT00191464|Metformin|metformin|mesh-list
101371650|NCT00191464|Insulin Glargine|insulin glargine|mesh-list
101371651|NCT00191464|Insulin Lispro|insulin lispro|mesh-list
101371652|NCT00191464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101371653|NCT00191464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371654|NCT04723030|Paclitaxel|paclitaxel|mesh-list
101257827|NCT01718678|Melatonin|melatonin|mesh-list
101371655|NCT04723030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101371656|NCT04723030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371662|NCT00191503|Pemetrexed|pemetrexed|mesh-list
101371663|NCT00191503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101371664|NCT00191503|Antimetabolites|antimetabolites|mesh-ancestor
101371665|NCT00191503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371666|NCT00191503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371667|NCT00191503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371668|NCT00191503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101371669|NCT00191503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101371670|NCT00191542|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101371671|NCT00191542|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101371672|NCT00191542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101371673|NCT00191542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101456548|NCT00245115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101304628|NCT02014337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101304629|NCT02014337|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101371674|NCT00191542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371675|NCT00191542|Adrenergic Agents|adrenergic agents|mesh-ancestor
101371676|NCT00191542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101371701|NCT00191659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371702|NCT00191698|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101371703|NCT00191698|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101371704|NCT00191698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101371705|NCT00191698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101371706|NCT00191698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371707|NCT00191698|Adrenergic Agents|adrenergic agents|mesh-ancestor
101371708|NCT00191698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101371709|NCT00191698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371710|NCT02470299|Ketorolac|ketorolac|mesh-list
101371711|NCT02470299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101371712|NCT02470299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101371713|NCT02470299|Analgesics|analgesics|mesh-ancestor
101371714|NCT02470299|Sensory System Agents|sensory system agents|mesh-ancestor
101371715|NCT02470299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101371716|NCT02470299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371717|NCT02470299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101371718|NCT02470299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101371719|NCT02470299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101371720|NCT02470299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371721|NCT02470299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371731|NCT00191893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101371732|NCT00191893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371733|NCT00191893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101371734|NCT00191932|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101371735|NCT00191932|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101371736|NCT00191932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101371737|NCT00191932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101258190|NCT01727427|Aspirin|aspirin|mesh-list
102059400|NCT05789173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102059401|NCT05789173|Adrenergic Agents|adrenergic agents|mesh-ancestor
102059402|NCT05789173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102059403|NCT05789173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102059404|NCT05789173|Sympatholytics|sympatholytics|mesh-ancestor
102059405|NCT05778760|Vitamin A|vitamin a|mesh-list
101371738|NCT00191932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371739|NCT00191932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101371740|NCT00191932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371742|NCT00191932|Sensory System Agents|sensory system agents|mesh-ancestor
101371743|NCT00191932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101371744|NCT00191932|Antidepressive Agents|antidepressive agents|mesh-ancestor
101371745|NCT00191932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101371746|NCT00191932|Dopamine Agents|dopamine agents|mesh-ancestor
101371747|NCT00059813|Interferons|interferons|mesh-list
101371748|NCT00059813|Interferon-alpha|interferon-alpha|mesh-list
101371749|NCT00059813|Interferon alpha-2|interferon alpha-2|mesh-list
101371750|NCT00059813|Oblimersen|oblimersen|mesh-list
101371751|NCT00059813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371752|NCT00059813|Antiviral Agents|antiviral agents|mesh-ancestor
101371753|NCT00059813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101371764|NCT00047502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101371766|NCT00047502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371767|NCT00192049|Gemcitabine|gemcitabine|mesh-list
101371768|NCT00192049|Mitomycins|mitomycins|mesh-list
101371769|NCT00192049|Mitomycin|mitomycin|mesh-list
101371770|NCT00192049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101371771|NCT00192049|Antimetabolites|antimetabolites|mesh-ancestor
101258464|NCT01731301|Ribavirin|ribavirin|mesh-list
101371772|NCT00192049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371773|NCT00192049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371774|NCT00192049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101371775|NCT00192049|Alkylating Agents|alkylating agents|mesh-ancestor
101304630|NCT02014428|Hyaluronic Acid|hyaluronic acid|mesh-list
101304631|NCT02014428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101304632|NCT02014428|Immunologic Factors|immunologic factors|mesh-ancestor
101304633|NCT02014428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371776|NCT00192049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101371777|NCT00192049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371778|NCT00192088|Oxaliplatin|oxaliplatin|mesh-list
101371779|NCT00192088|Pemetrexed|pemetrexed|mesh-list
101371780|NCT00192088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371781|NCT00192088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371782|NCT00192088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371783|NCT00192088|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101371784|NCT00192088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101371785|NCT00059852|Gemcitabine|gemcitabine|mesh-list
101371786|NCT00059852|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101371803|NCT00047580|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101371804|NCT00047580|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101371805|NCT00047580|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101371806|NCT00047580|Adrenergic Agents|adrenergic agents|mesh-ancestor
101371807|NCT00047580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101371808|NCT00047580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371810|NCT02968901|Macitentan|macitentan|mesh-list
101371811|NCT02968901|Vasodilator Agents|vasodilator agents|mesh-ancestor
101371812|NCT02968901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101371813|NCT02968901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101371814|NCT02968901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371815|NCT02968901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371816|NCT02968901|Urological Agents|urological agents|mesh-ancestor
101305333|NCT02018965|Antimetabolites|antimetabolites|mesh-ancestor
101371817|NCT02968901|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101371818|NCT02968901|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101371819|NCT02968901|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
101371820|NCT00192595|Tenofovir|tenofovir|mesh-list
101371821|NCT00192595|Lamivudine|lamivudine|mesh-list
101371822|NCT00192595|Zidovudine|zidovudine|mesh-list
101371823|NCT00192595|Efavirenz|efavirenz|mesh-list
101371824|NCT00192595|Antiviral Agents|antiviral agents|mesh-ancestor
101371825|NCT00192595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101371826|NCT00192595|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102059407|NCT05778760|Micronutrients|micronutrients|mesh-ancestor
102059408|NCT05778760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059409|NCT05773274|Everolimus|everolimus|mesh-list
101258941|NCT01734954|GABA Agents|gaba agents|mesh-ancestor
102059410|NCT05773274|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102059411|NCT05773274|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101361031|NCT00073593|Heparin|heparin|mesh-list
101371827|NCT00192595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101371828|NCT00192595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371829|NCT00192595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371830|NCT00192595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101371834|NCT00192595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101371835|NCT00192595|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101371836|NCT00192595|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101371837|NCT00192595|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101371838|NCT00192595|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101371839|NCT00192634|Tenofovir|tenofovir|mesh-list
101371840|NCT00192634|Lamivudine|lamivudine|mesh-list
101371841|NCT00192634|Emtricitabine|emtricitabine|mesh-list
101371842|NCT00192634|Abacavir|abacavir|mesh-list
101371843|NCT00192634|Antiviral Agents|antiviral agents|mesh-ancestor
101371844|NCT00192634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101371845|NCT00192634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101371869|NCT00193024|Epirubicin|epirubicin|mesh-list
101371870|NCT00193024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371871|NCT00193024|Tubulin Modulators|tubulin modulators|mesh-ancestor
101371872|NCT00193024|Antimitotic Agents|antimitotic agents|mesh-ancestor
101371873|NCT00193024|Mitosis Modulators|mitosis modulators|mesh-ancestor
101371874|NCT00193024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371875|NCT00193024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101371876|NCT00193024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101371877|NCT00193024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101371878|NCT00193024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371879|NCT00193102|Thalidomide|thalidomide|mesh-list
101371880|NCT00193102|Capecitabine|capecitabine|mesh-list
101371881|NCT00193102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101304634|NCT02014428|Viscosupplements|viscosupplements|mesh-ancestor
101304635|NCT02014428|Protective Agents|protective agents|mesh-ancestor
101304636|NCT02014454|Propranolol|propranolol|mesh-list
101371882|NCT00193102|Antimetabolites|antimetabolites|mesh-ancestor
101387706|NCT00323011|Vitamin B Complex|vitamin b complex|mesh-ancestor
101371883|NCT00193102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371884|NCT00193102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371885|NCT00193102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101371886|NCT00193102|Immunologic Factors|immunologic factors|mesh-ancestor
101371887|NCT00193102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371888|NCT00193102|Leprostatic Agents|leprostatic agents|mesh-ancestor
101371889|NCT00193102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101371890|NCT00193102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101371891|NCT00193102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101371892|NCT00193102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101259397|NCT01738087|Xhance|xhance|mesh-list
101371893|NCT00193102|Growth Substances|growth substances|mesh-ancestor
101371894|NCT00193102|Growth Inhibitors|growth inhibitors|mesh-ancestor
101371895|NCT00193141|Paclitaxel|paclitaxel|mesh-list
101371896|NCT00193141|Carboplatin|carboplatin|mesh-list
101371897|NCT00193141|Fluorouracil|fluorouracil|mesh-list
101371898|NCT00193141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101371920|NCT00193297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371922|NCT00193336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371923|NCT00193336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101371924|NCT00193336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371925|NCT00193336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371926|NCT00193531|Paclitaxel|paclitaxel|mesh-list
101371927|NCT00193531|Etoposide|etoposide|mesh-list
101371928|NCT00193531|Carboplatin|carboplatin|mesh-list
101371929|NCT00193531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101371930|NCT00193531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371931|NCT00193531|Tubulin Modulators|tubulin modulators|mesh-ancestor
101371932|NCT00193531|Antimitotic Agents|antimitotic agents|mesh-ancestor
101371933|NCT00193531|Mitosis Modulators|mitosis modulators|mesh-ancestor
101371934|NCT00193531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059412|NCT05773274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102059413|NCT05773274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102059414|NCT05773274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059415|NCT05773274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102059416|NCT05773274|Immunologic Factors|immunologic factors|mesh-ancestor
102059417|NCT05773274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059418|NCT05773274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102059419|NCT05773274|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102059420|NCT05757999|Magnesium Sulfate|magnesium sulfate|mesh-list
102059421|NCT05757999|Analgesics|analgesics|mesh-ancestor
102059422|NCT05757999|Sensory System Agents|sensory system agents|mesh-ancestor
101361033|NCT00073593|Protamines|protamines|mesh-list
101371935|NCT00193531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101371936|NCT00193531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101371937|NCT00193531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371938|NCT00193570|Docetaxel|docetaxel|mesh-list
101371939|NCT00193570|Topotecan|topotecan|mesh-list
101371940|NCT00193570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371941|NCT00193570|Tubulin Modulators|tubulin modulators|mesh-ancestor
101371942|NCT00193570|Antimitotic Agents|antimitotic agents|mesh-ancestor
101371943|NCT00193570|Mitosis Modulators|mitosis modulators|mesh-ancestor
101371944|NCT00193570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371963|NCT00409591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101371964|NCT00409591|Antiviral Agents|antiviral agents|mesh-ancestor
101371965|NCT00409591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101371966|NCT00409591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101371967|NCT00409591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101371968|NCT00409591|Antimetabolites|antimetabolites|mesh-ancestor
101371969|NCT00409591|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101371970|NCT00409591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101371971|NCT00409591|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101259909|NCT01741558|Micronutrients|micronutrients|mesh-ancestor
101371972|NCT00409591|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101371973|NCT00409630|Fluticasone|fluticasone|mesh-list
101371974|NCT00409630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101371975|NCT00409630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101371976|NCT00409630|Autonomic Agents|autonomic agents|mesh-ancestor
101371977|NCT00409630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101371978|NCT00409630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371979|NCT00409630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101304637|NCT02014454|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101304638|NCT02014454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101371980|NCT00409630|Respiratory System Agents|respiratory system agents|mesh-ancestor
101371981|NCT00409630|Dermatologic Agents|dermatologic agents|mesh-ancestor
101371982|NCT00409630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101371984|NCT00060125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371985|NCT00193648|Rosiglitazone|rosiglitazone|mesh-list
101371986|NCT00193648|Adalimumab|adalimumab|mesh-list
101371987|NCT00193648|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101371988|NCT00193648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101371989|NCT00193648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101371990|NCT00193648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101371991|NCT00193648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371992|NCT00193726|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101371993|NCT00193726|Estradiol|estradiol|mesh-list
101371994|NCT00193726|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101371995|NCT00193726|Estrogens|estrogens|mesh-ancestor
101371996|NCT00193726|Hormones|hormones|mesh-ancestor
101371997|NCT00193726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101371998|NCT00193726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371999|NCT00193726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101372000|NCT00193726|Contraceptive Agents|contraceptive agents|mesh-ancestor
101372001|NCT00193726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102059423|NCT05757999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102059424|NCT05757999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059425|NCT05757999|Anesthetics|anesthetics|mesh-ancestor
102059426|NCT05757999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102059427|NCT05757999|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102059428|NCT05757999|Anticonvulsants|anticonvulsants|mesh-ancestor
102059429|NCT05757999|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102059430|NCT05757999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102059431|NCT05757999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059432|NCT05757999|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102059433|NCT05757999|Tocolytic Agents|tocolytic agents|mesh-ancestor
102059434|NCT05757999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102059435|NCT05750264|Ibuprofen|ibuprofen|mesh-list
102059436|NCT05750264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102059437|NCT05750264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101372002|NCT00193726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101372003|NCT00193726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101372004|NCT00193726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101372005|NCT00193882|Cisplatin|cisplatin|mesh-list
101372006|NCT00193882|Fluorouracil|fluorouracil|mesh-list
101372007|NCT00193882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101372008|NCT00193882|Antimetabolites|antimetabolites|mesh-ancestor
101372009|NCT00193882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372010|NCT00193882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101372011|NCT00193882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101372012|NCT00193882|Immunologic Factors|immunologic factors|mesh-ancestor
101372013|NCT00193882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372019|NCT00060242|Antimitotic Agents|antimitotic agents|mesh-ancestor
101372020|NCT00060242|Mitosis Modulators|mitosis modulators|mesh-ancestor
101387707|NCT00323011|Vitamins|vitamins|mesh-ancestor
101372021|NCT00060242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372022|NCT00193921|Cisplatin|cisplatin|mesh-list
101372032|NCT00193921|Mitosis Modulators|mitosis modulators|mesh-ancestor
101372034|NCT00194038|Antidepressive Agents|antidepressive agents|mesh-ancestor
101372035|NCT00194038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101372036|NCT00194038|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101372037|NCT00194038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101372038|NCT00194038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101372039|NCT00194038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372040|NCT00194038|Dopamine Agonists|dopamine agonists|mesh-ancestor
101372041|NCT00194038|Dopamine Agents|dopamine agents|mesh-ancestor
101372042|NCT00194038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101372043|NCT00194038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372044|NCT00194038|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101372045|NCT00194038|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101372046|NCT00194038|Serotonin Agents|serotonin agents|mesh-ancestor
101372047|NCT00194038|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101372048|NCT00194038|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101372049|NCT00194038|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101372050|NCT00194038|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101372051|NCT00060359|Paclitaxel|paclitaxel|mesh-list
101372052|NCT00060359|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101372053|NCT00060359|Carboplatin|carboplatin|mesh-list
101372054|NCT00060359|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
101387708|NCT00323011|Micronutrients|micronutrients|mesh-ancestor
101372055|NCT00060359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101372056|NCT00060359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101372057|NCT00060359|Tubulin Modulators|tubulin modulators|mesh-ancestor
101372058|NCT00060359|Antimitotic Agents|antimitotic agents|mesh-ancestor
102059438|NCT05750264|Analgesics|analgesics|mesh-ancestor
102059439|NCT05750264|Sensory System Agents|sensory system agents|mesh-ancestor
102059440|NCT05750264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102059441|NCT05750264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372059|NCT00060359|Mitosis Modulators|mitosis modulators|mesh-ancestor
101372060|NCT00060359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260876|NCT01747135|Betadex|betadex|mesh-list
101372061|NCT00194272|Methotrexate|methotrexate|mesh-list
101304639|NCT02014454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101304640|NCT02014454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101304641|NCT02014454|Adrenergic Agents|adrenergic agents|mesh-ancestor
101372062|NCT00194272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101372063|NCT00194272|Abortifacient Agents|abortifacient agents|mesh-ancestor
101372064|NCT00194272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101372065|NCT00194272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372066|NCT00194272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101372067|NCT00194272|Antimetabolites|antimetabolites|mesh-ancestor
101372068|NCT00194272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372069|NCT00194272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101372070|NCT00194272|Dermatologic Agents|dermatologic agents|mesh-ancestor
101372071|NCT00194272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101372072|NCT00194272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101372073|NCT00194272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101372074|NCT00194272|Immunologic Factors|immunologic factors|mesh-ancestor
101372075|NCT00194272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101387709|NCT00323011|Hematinics|hematinics|mesh-ancestor
101372076|NCT00194272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101372077|NCT00398528|Glatiramer Acetate|glatiramer acetate|mesh-list
101372079|NCT00398528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101372080|NCT00398528|Immunologic Factors|immunologic factors|mesh-ancestor
101372081|NCT00398528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372082|NCT00398528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101372083|NCT00398528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101372084|NCT00194467|Valganciclovir|valganciclovir|mesh-list
101372085|NCT00194467|Antiviral Agents|antiviral agents|mesh-ancestor
101372086|NCT00194467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101372087|NCT00194623|Botulinum Toxins|botulinum toxins|mesh-list
101372088|NCT00194623|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101372089|NCT00194623|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101372093|NCT00194623|Cholinergic Agents|cholinergic agents|mesh-ancestor
101261089|NCT01748344|Cetirizine|cetirizine|mesh-list
101372094|NCT00194623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101372099|NCT00194740|Vinorelbine|vinorelbine|mesh-list
101372100|NCT00194740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101372101|NCT00194740|Tubulin Modulators|tubulin modulators|mesh-ancestor
101372102|NCT00194740|Antimitotic Agents|antimitotic agents|mesh-ancestor
101372103|NCT00194740|Mitosis Modulators|mitosis modulators|mesh-ancestor
101372104|NCT00194740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372105|NCT00194740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101372106|NCT00194818|Mesalamine|mesalamine|mesh-list
101372107|NCT00194818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101372108|NCT00194818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101372109|NCT00194818|Analgesics|analgesics|mesh-ancestor
101372110|NCT00194818|Sensory System Agents|sensory system agents|mesh-ancestor
101372111|NCT00194818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101372112|NCT00194818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372113|NCT00194818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101372114|NCT00194818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101372115|NCT00194857|Epoetin Alfa|epoetin alfa|mesh-list
101372116|NCT00194857|Hematinics|hematinics|mesh-ancestor
101387710|NCT00323011|Anticoagulants|anticoagulants|mesh-ancestor
101372118|NCT00194935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101372119|NCT00194935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101372120|NCT00194935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101372121|NCT00194935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372122|NCT00194935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101372123|NCT00194974|Clonidine|clonidine|mesh-list
101372124|NCT00194974|Labetalol|labetalol|mesh-list
101372125|NCT00194974|Methyldopa|methyldopa|mesh-list
101372126|NCT00194974|Nifedipine|nifedipine|mesh-list
101372127|NCT00194974|Analgesics|analgesics|mesh-ancestor
101372128|NCT00194974|Sensory System Agents|sensory system agents|mesh-ancestor
101372129|NCT00194974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101372130|NCT00194974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059442|NCT05750264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102059443|NCT05750264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102059444|NCT05750264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102059445|NCT05750264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102059446|NCT05750264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059447|NCT05741164|Pembrolizumab|pembrolizumab|mesh-list
102059448|NCT05741164|Propranolol|propranolol|mesh-list
102059449|NCT05741164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102059450|NCT05741164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102059451|NCT05741164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102059452|NCT05741164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261291|NCT01749150|Ritonavir|ritonavir|mesh-list
102059453|NCT05741164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102059454|NCT05741164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102059455|NCT05741164|Adrenergic Agents|adrenergic agents|mesh-ancestor
102059456|NCT05741164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102059457|NCT05741164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059458|NCT05741164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102059459|NCT05741164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102059460|NCT05741164|Vasodilator Agents|vasodilator agents|mesh-ancestor
102059461|NCT05729646|Oxaliplatin|oxaliplatin|mesh-list
101372131|NCT00194974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101372132|NCT00194974|Sympatholytics|sympatholytics|mesh-ancestor
101372133|NCT00194974|Autonomic Agents|autonomic agents|mesh-ancestor
101372134|NCT00194974|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101372135|NCT00194974|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101372136|NCT00194974|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101304642|NCT02014454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101304643|NCT02014454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372137|NCT00194974|Adrenergic Agents|adrenergic agents|mesh-ancestor
101372138|NCT00194974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101372139|NCT00194974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372140|NCT00194974|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101372141|NCT00194974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101372142|NCT00194974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101372143|NCT00194974|Vasodilator Agents|vasodilator agents|mesh-ancestor
101372144|NCT00194974|Tocolytic Agents|tocolytic agents|mesh-ancestor
101372145|NCT00194974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101372146|NCT00194974|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101372147|NCT00194974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101372148|NCT00194974|Sympathomimetics|sympathomimetics|mesh-ancestor
101372149|NCT00194974|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101372150|NCT00194974|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101372151|NCT00195208|Pantoprazole|pantoprazole|mesh-list
101261373|NCT01749423|Botulinum Toxins|botulinum toxins|mesh-list
101372152|NCT00195208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101372153|NCT00195208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101372154|NCT00195208|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101372155|NCT00195208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101372156|NCT00195208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372157|NCT02963116|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101372158|NCT02963116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101372159|NCT02963116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101372160|NCT02963116|Antimetabolites|antimetabolites|mesh-ancestor
102059462|NCT05729646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102059463|NCT05691465|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102059464|NCT05691465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059465|NCT05691465|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102059466|NCT05689359|Hydroxychloroquine|hydroxychloroquine|mesh-list
102059467|NCT05689359|Antimalarials|antimalarials|mesh-ancestor
101361089|NCT00220987|Insulin|insulin|mesh-list
101372166|NCT00195286|Piperacillin|piperacillin|mesh-list
101372167|NCT00195286|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101372168|NCT00195286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101372169|NCT00195286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101372170|NCT00195286|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101372177|NCT00195364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101372178|NCT00195364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101372180|NCT00195364|Sensory System Agents|sensory system agents|mesh-ancestor
101372181|NCT00195364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101372182|NCT00195364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372183|NCT00195364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101372184|NCT00195364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101372185|NCT00195364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101372186|NCT00195364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101372187|NCT00195364|Immunologic Factors|immunologic factors|mesh-ancestor
101372188|NCT00195481|Sirolimus|sirolimus|mesh-list
101372189|NCT00195481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101372190|NCT00195481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101372191|NCT00195481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101372192|NCT00195481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101372193|NCT00195481|Antifungal Agents|antifungal agents|mesh-ancestor
101372194|NCT00195481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101372195|NCT00195481|Immunologic Factors|immunologic factors|mesh-ancestor
101372196|NCT00195481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372197|NCT00195559|Levonorgestrel|levonorgestrel|mesh-list
101372198|NCT00195559|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101372199|NCT00195559|Estradiol|estradiol|mesh-list
101372200|NCT00195559|Estrogens|estrogens|mesh-ancestor
101372201|NCT00195559|Hormones|hormones|mesh-ancestor
101372202|NCT00195559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101372203|NCT00195559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372204|NCT00195559|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101372205|NCT00195559|Contraceptive Agents|contraceptive agents|mesh-ancestor
101372206|NCT00195559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101372207|NCT00195559|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101372208|NCT00195559|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101372209|NCT00195559|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101304644|NCT02014454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304645|NCT02014454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101304646|NCT02014454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101372210|NCT00195559|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101372211|NCT00084240|Azithromycin|azithromycin|mesh-list
101372212|NCT00084240|Chloroquine|chloroquine|mesh-list
101372213|NCT00084240|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
101372214|NCT00084240|Pyrimethamine|pyrimethamine|mesh-list
101372215|NCT00084240|Sulfadoxine|sulfadoxine|mesh-list
101372216|NCT00084240|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101372217|NCT00084240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101372218|NCT00084240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101372219|NCT00084240|Amebicides|amebicides|mesh-ancestor
101372220|NCT00084240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101372221|NCT00084240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101372222|NCT00084240|Antimalarials|antimalarials|mesh-ancestor
101372223|NCT00084240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101261862|NCT01753375|Vitamin D|vitamin d|mesh-list
101372224|NCT00084240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101372225|NCT00084240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101372226|NCT00084240|Analgesics|analgesics|mesh-ancestor
101372227|NCT00084240|Sensory System Agents|sensory system agents|mesh-ancestor
101372228|NCT00084240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101372229|NCT00084240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372235|NCT00084240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101261911|NCT01754116|Cabotegravir|cabotegravir|mesh-list
102059468|NCT05689359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102059469|NCT05689359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102059470|NCT05689359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102059471|NCT05689359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102059472|NCT05689359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059473|NCT05689359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102059475|NCT05664217|Antithrombins|antithrombins|mesh-list
101361097|NCT00221026|Methoxsalen|methoxsalen|mesh-list
101372236|NCT00084240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372237|NCT00084240|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101372238|NCT00195598|Paroxetine|paroxetine|mesh-list
101372239|NCT00195598|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101372240|NCT00195598|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101372250|NCT00195598|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101372251|NCT00195598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101372253|NCT00195598|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101372254|NCT00195637|Immunoglobulins|immunoglobulins|mesh-list
101372255|NCT00195637|Antibodies|antibodies|mesh-list
101372256|NCT00195637|gamma-Globulins|gamma-globulins|mesh-list
101372257|NCT00195637|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101372258|NCT00195637|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101372259|NCT00195637|Immunologic Factors|immunologic factors|mesh-ancestor
101372260|NCT00195637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372261|NCT00195754|Valproic Acid|valproic acid|mesh-list
101372262|NCT00195754|Anticonvulsants|anticonvulsants|mesh-ancestor
101372263|NCT00195754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387711|NCT00323011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101372264|NCT00195754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372265|NCT00195754|GABA Agents|gaba agents|mesh-ancestor
101372266|NCT00195754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101372267|NCT00195754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372268|NCT00195754|Antimanic Agents|antimanic agents|mesh-ancestor
101372269|NCT00195754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101372270|NCT00195754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101372271|NCT00195754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101372272|NCT00195793|Atorvastatin|atorvastatin|mesh-list
101372273|NCT00195793|Ezetimibe|ezetimibe|mesh-list
101372274|NCT00195793|Fenofibrate|fenofibrate|mesh-list
101372275|NCT00195793|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101372276|NCT00195793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101372277|NCT00195793|Antimetabolites|antimetabolites|mesh-ancestor
101372278|NCT00195793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372279|NCT00195793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101372280|NCT00195793|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101304648|NCT02014506|Cyclophosphamide|cyclophosphamide|mesh-list
101262357|NCT01756508|Eculizumab|eculizumab|mesh-list
101304650|NCT02014506|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101372281|NCT00195793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101372282|NCT00195871|Cytarabine|cytarabine|mesh-list
101372283|NCT00195871|Prednisone|prednisone|mesh-list
101372284|NCT00195871|Cyclophosphamide|cyclophosphamide|mesh-list
101372285|NCT00195871|Methotrexate|methotrexate|mesh-list
101372286|NCT00195871|Etoposide|etoposide|mesh-list
101372287|NCT00195871|Vincristine|vincristine|mesh-list
101372288|NCT00195871|Daunorubicin|daunorubicin|mesh-list
101372289|NCT00195871|Asparaginase|asparaginase|mesh-list
101372290|NCT00195871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101372291|NCT00195871|Immunologic Factors|immunologic factors|mesh-ancestor
101372292|NCT00195871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372293|NCT00195871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101372294|NCT00195871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101372295|NCT00195871|Alkylating Agents|alkylating agents|mesh-ancestor
101372296|NCT00195871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372297|NCT00195871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101372298|NCT00195871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101372299|NCT00195871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101372300|NCT00195871|Glucocorticoids|glucocorticoids|mesh-ancestor
102059476|NCT05664217|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102059477|NCT05664217|Protease Inhibitors|protease inhibitors|mesh-ancestor
102059478|NCT05664217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102059479|NCT05664217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059480|NCT05664217|Anticoagulants|anticoagulants|mesh-ancestor
102059481|NCT05660395|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
102059482|NCT05660395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102059483|NCT05660395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101372307|NCT00195871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101372309|NCT00195871|Dermatologic Agents|dermatologic agents|mesh-ancestor
101372325|NCT00195910|Narcotics|narcotics|mesh-ancestor
101372326|NCT00195910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101372327|NCT00195910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372328|NCT00195910|Analgesics|analgesics|mesh-ancestor
101372329|NCT00195910|Sensory System Agents|sensory system agents|mesh-ancestor
101372330|NCT00195910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101372331|NCT00195988|Mycophenolic Acid|mycophenolic acid|mesh-list
101372332|NCT00195988|Tacrolimus|tacrolimus|mesh-list
101372333|NCT00195988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101372335|NCT00195988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372336|NCT00195988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101372337|NCT00195988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387713|NCT00323206|Interleukin-12|interleukin-12|mesh-list
101372338|NCT00195988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372339|NCT00195988|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101372340|NCT00195988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101372341|NCT00195988|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101372342|NCT00195988|Antitubercular Agents|antitubercular agents|mesh-ancestor
101372343|NCT00195988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101372344|NCT00195988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101372345|NCT00060476|Rofecoxib|rofecoxib|mesh-list
101372346|NCT00060476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101372347|NCT00060476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101372348|NCT00060476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101372349|NCT00060476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372350|NCT00060476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101262582|NCT01757795|Otaplimastat|otaplimastat|mesh-list
101372351|NCT00060476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101372352|NCT00060476|Analgesics|analgesics|mesh-ancestor
101372353|NCT00060476|Sensory System Agents|sensory system agents|mesh-ancestor
101372354|NCT00060476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101372355|NCT00060476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372356|NCT00060476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101372357|NCT00060476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101304651|NCT02014506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101304652|NCT02014506|Immunologic Factors|immunologic factors|mesh-ancestor
101304653|NCT02014506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304654|NCT02014506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101304655|NCT02014506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101304656|NCT02014506|Alkylating Agents|alkylating agents|mesh-ancestor
101372358|NCT00084279|Interferons|interferons|mesh-list
101372359|NCT00084279|Ribavirin|ribavirin|mesh-list
101372360|NCT00084279|Interferon-alpha|interferon-alpha|mesh-list
101372361|NCT00084279|Interferon-gamma|interferon-gamma|mesh-list
101372362|NCT00084279|Interferon alfacon-1|interferon alfacon-1|mesh-list
101372363|NCT00084279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101372364|NCT00084279|Antiviral Agents|antiviral agents|mesh-ancestor
101372375|NCT00196378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101372378|NCT00196417|Certoparin|certoparin|mesh-list
101372379|NCT00196417|Anticoagulants|anticoagulants|mesh-ancestor
101372380|NCT00196417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101372381|NCT00196417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101372382|NCT00196417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372383|NCT00060554|Heparin|heparin|mesh-list
101372384|NCT00060554|PENTA|penta|mesh-list
101372385|NCT00060554|Fondaparinux|fondaparinux|mesh-list
101372386|NCT00060554|Anticoagulants|anticoagulants|mesh-ancestor
101372387|NCT00060554|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102059487|NCT05557136|Anesthetics, General|anesthetics, general|mesh-ancestor
102059488|NCT05557136|Anesthetics|anesthetics|mesh-ancestor
102059489|NCT05557136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102059490|NCT05557136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059494|NCT05534243|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
102059495|NCT05534243|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102059496|NCT05534243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102059497|NCT05534243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059498|NCT05502081|Remdesivir|remdesivir|mesh-list
102059499|NCT05502081|Favipiravir|favipiravir|mesh-list
101372388|NCT00060554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101372389|NCT00060554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372390|NCT00060554|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101372391|NCT00060554|Antithrombins|antithrombins|mesh-ancestor
101372392|NCT00060554|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101372393|NCT00060554|Protease Inhibitors|protease inhibitors|mesh-ancestor
101372394|NCT00060554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101372395|NCT00048087|Docetaxel|docetaxel|mesh-list
101372396|NCT00048087|Gefitinib|gefitinib|mesh-list
101372397|NCT00048087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101372398|NCT00048087|Tubulin Modulators|tubulin modulators|mesh-ancestor
101372399|NCT00048087|Antimitotic Agents|antimitotic agents|mesh-ancestor
101372400|NCT00048087|Mitosis Modulators|mitosis modulators|mesh-ancestor
101372401|NCT00048087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372402|NCT00048087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101372403|NCT00048087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101372404|NCT00196534|Thrombin|thrombin|mesh-list
101372405|NCT00196534|Hemostatics|hemostatics|mesh-ancestor
101372406|NCT00196534|Coagulants|coagulants|mesh-ancestor
101372407|NCT00048126|Capecitabine|capecitabine|mesh-list
101372408|NCT00048126|Irinotecan|irinotecan|mesh-list
101372409|NCT00048126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101372410|NCT00048126|Antimetabolites|antimetabolites|mesh-ancestor
101372411|NCT00048126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372412|NCT00048126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101372413|NCT00048126|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101372414|NCT00048126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101372415|NCT00048126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101372416|NCT00196612|Emtricitabine|emtricitabine|mesh-list
101372418|NCT00196612|Didanosine|didanosine|mesh-list
101372419|NCT00196612|Antiviral Agents|antiviral agents|mesh-ancestor
101372420|NCT00196612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101262839|NCT01759524|Lidocaine|lidocaine|mesh-list
101372421|NCT00196612|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101372422|NCT00196612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101372423|NCT00196612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101372424|NCT00196612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372425|NCT00196612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101372426|NCT00196612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101372427|NCT00196612|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101372428|NCT00196612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101372429|NCT00196612|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101304657|NCT02014506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304658|NCT02014506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101304659|NCT02014506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102059500|NCT05502081|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
102059501|NCT05502081|Antimetabolites|antimetabolites|mesh-ancestor
102059502|NCT05502081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059503|NCT05502081|Antiviral Agents|antiviral agents|mesh-ancestor
102059504|NCT05502081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102059505|NCT05494385|Gabapentin|gabapentin|mesh-list
102059506|NCT05494385|Analgesics|analgesics|mesh-ancestor
102059507|NCT05494385|Sensory System Agents|sensory system agents|mesh-ancestor
102059508|NCT05494385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102059509|NCT05494385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304660|NCT02014532|Montelukast|montelukast|mesh-list
101372430|NCT00196612|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101372431|NCT00196612|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101372432|NCT00196612|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101372433|NCT00196612|Antimetabolites|antimetabolites|mesh-ancestor
101372434|NCT00196690|Donepezil|donepezil|mesh-list
101372435|NCT00196690|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101372436|NCT00196690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101372437|NCT00196690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372449|NCT00084396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372450|NCT00084396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101372451|NCT00084396|Hormone Antagonists|hormone antagonists|mesh-ancestor
101372452|NCT00084396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101372453|NCT00084396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372455|NCT00196846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101372456|NCT00196846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101372457|NCT00060632|Sirolimus|sirolimus|mesh-list
101372458|NCT00060632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101372459|NCT00060632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101372460|NCT00060632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101372461|NCT00060632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101372462|NCT00060632|Antifungal Agents|antifungal agents|mesh-ancestor
101372463|NCT00060632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101372464|NCT00060632|Immunologic Factors|immunologic factors|mesh-ancestor
101372465|NCT00060632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372466|NCT00196885|Acetylcysteine|acetylcysteine|mesh-list
101372467|NCT00196885|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101372468|NCT00196885|Antiviral Agents|antiviral agents|mesh-ancestor
101372469|NCT00196885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101372470|NCT00196885|Expectorants|expectorants|mesh-ancestor
101372471|NCT00196885|Respiratory System Agents|respiratory system agents|mesh-ancestor
101372472|NCT00196885|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101372473|NCT00196885|Antioxidants|antioxidants|mesh-ancestor
101372474|NCT00196885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372475|NCT00196885|Protective Agents|protective agents|mesh-ancestor
101372476|NCT00196885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372477|NCT00196885|Antidotes|antidotes|mesh-ancestor
101372478|NCT00048204|Paroxetine|paroxetine|mesh-list
101372479|NCT00048204|Vestipitant|vestipitant|mesh-list
101372480|NCT00048204|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101372481|NCT00048204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101372482|NCT00048204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101372483|NCT00048204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372484|NCT00048204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101372485|NCT00048204|Serotonin Agents|serotonin agents|mesh-ancestor
101263000|NCT01760096|Hormones|hormones|mesh-ancestor
101372486|NCT00048204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372487|NCT00048204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101372488|NCT00048204|Antidepressive Agents|antidepressive agents|mesh-ancestor
101372489|NCT00048204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101372490|NCT00048204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101372491|NCT00048204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101372492|NCT00048204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102059510|NCT05494385|Anticonvulsants|anticonvulsants|mesh-ancestor
102059511|NCT05494385|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102059512|NCT05494385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102059513|NCT05494385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102059514|NCT05494385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102059515|NCT05494385|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102059516|NCT05494385|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101372493|NCT00048204|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101372494|NCT00197080|Ropinirole|ropinirole|mesh-list
101372495|NCT00197080|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101372496|NCT00197080|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101372497|NCT00197080|Dopamine Agonists|dopamine agonists|mesh-ancestor
101372498|NCT00197080|Dopamine Agents|dopamine agents|mesh-ancestor
101372499|NCT00197080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101304661|NCT02014532|Leukotriene Antagonists|leukotriene antagonists|mesh-list
101387714|NCT00323206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101372500|NCT00197080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372501|NCT00197080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372502|NCT00060671|Rituximab|rituximab|mesh-list
101372503|NCT00060671|Pixantrone|pixantrone|mesh-list
101372504|NCT00060671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101372505|NCT00060671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101372506|NCT00060671|Immunologic Factors|immunologic factors|mesh-ancestor
101372507|NCT00060671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372508|NCT00060671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101372516|NCT00197197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372520|NCT00197197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101372522|NCT00409903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101372523|NCT00409903|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
101372524|NCT00409903|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101372525|NCT00409903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372526|NCT00084435|Docetaxel|docetaxel|mesh-list
101372527|NCT00084435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101372528|NCT00084435|Tubulin Modulators|tubulin modulators|mesh-ancestor
101372529|NCT00084435|Antimitotic Agents|antimitotic agents|mesh-ancestor
101372530|NCT00084435|Mitosis Modulators|mitosis modulators|mesh-ancestor
101263333|NCT01761318|Hormones|hormones|mesh-ancestor
101372531|NCT00084435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372532|NCT00197353|Bupivacaine|bupivacaine|mesh-list
101372533|NCT00197353|Anesthetics, Local|anesthetics, local|mesh-ancestor
101372534|NCT00197353|Anesthetics|anesthetics|mesh-ancestor
101372535|NCT00197353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101372536|NCT00197353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372537|NCT00197353|Sensory System Agents|sensory system agents|mesh-ancestor
101372538|NCT00197353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101372539|NCT02962999|Ketamine|ketamine|mesh-list
101372540|NCT02962999|Analgesics|analgesics|mesh-ancestor
101372541|NCT02962999|Sensory System Agents|sensory system agents|mesh-ancestor
101372542|NCT02962999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101387715|NCT00323206|Immunologic Factors|immunologic factors|mesh-ancestor
101372543|NCT02962999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372544|NCT02962999|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101372545|NCT02962999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101372546|NCT02962999|Anesthetics, General|anesthetics, general|mesh-ancestor
101372547|NCT02962999|Anesthetics|anesthetics|mesh-ancestor
101372548|NCT02962999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101372549|NCT02962999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101372550|NCT02962999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101372551|NCT02962999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101372552|NCT02962999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372553|NCT00084513|Trastuzumab|trastuzumab|mesh-list
101372554|NCT00084513|Imatinib Mesylate|imatinib mesylate|mesh-list
101372555|NCT00084513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101372556|NCT00084513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101372557|NCT00084513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101372558|NCT00084513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101372559|NCT00084513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372560|NCT00084591|Capecitabine|capecitabine|mesh-list
101372561|NCT00084591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102059517|NCT05494385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102059518|NCT05494385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059519|NCT05494385|Antimanic Agents|antimanic agents|mesh-ancestor
102059520|NCT05455294|Decitabine|decitabine|mesh-list
102059521|NCT05455294|Venetoclax|venetoclax|mesh-list
102059522|NCT05455294|Navitoclax|navitoclax|mesh-list
102059523|NCT05455294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102059524|NCT05455294|Antimetabolites|antimetabolites|mesh-ancestor
102059525|NCT05455294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059526|NCT05455294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102059527|NCT05455294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101372562|NCT00084591|Antimetabolites|antimetabolites|mesh-ancestor
101372563|NCT00084591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372564|NCT00084591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101372565|NCT00197548|Folic Acid|folic acid|mesh-list
101372566|NCT00197548|Vitamin B Complex|vitamin b complex|mesh-list
101372567|NCT00197548|Vitamins|vitamins|mesh-ancestor
101372568|NCT00197548|Micronutrients|micronutrients|mesh-ancestor
101372569|NCT00197548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372570|NCT00197548|Hematinics|hematinics|mesh-ancestor
101372571|NCT00197587|Nevirapine|nevirapine|mesh-list
101372572|NCT00197587|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101372573|NCT00197587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101372574|NCT00197587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101372589|NCT00197743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372591|NCT00197743|Provitamins|provitamins|mesh-ancestor
101304662|NCT02014532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101304663|NCT02014532|Respiratory System Agents|respiratory system agents|mesh-ancestor
101372592|NCT00084630|Imatinib Mesylate|imatinib mesylate|mesh-list
101372593|NCT00084630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101372594|NCT00084630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101372595|NCT00084630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101372596|NCT00084630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372597|NCT00197821|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101372598|NCT00197821|Immunologic Factors|immunologic factors|mesh-ancestor
101372599|NCT00197821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372600|NCT00084669|Zolpidem|zolpidem|mesh-list
101372618|NCT00060866|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101372619|NCT00060866|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101372620|NCT00060866|Adrenergic Agents|adrenergic agents|mesh-ancestor
101372621|NCT00060866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101372622|NCT00060866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372623|NCT00060866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372624|NCT00060866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101372625|NCT00060866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101372626|NCT00060866|Vasodilator Agents|vasodilator agents|mesh-ancestor
101372628|NCT00048360|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101372629|NCT00048360|Antidepressive Agents|antidepressive agents|mesh-ancestor
101372630|NCT00048360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101372631|NCT00048360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101372632|NCT00048360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101372637|NCT00048360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372638|NCT00048360|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101372639|NCT00048360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101372640|NCT00048360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101372641|NCT00198055|Aripiprazole|aripiprazole|mesh-list
101372642|NCT00198055|Antidepressive Agents|antidepressive agents|mesh-ancestor
101372643|NCT00198055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101372644|NCT00198055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101372645|NCT00198055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101372646|NCT00198055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101372647|NCT00198055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059528|NCT05437796|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
102059529|NCT05437796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102059530|NCT05437796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059531|NCT05396014|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
102059532|NCT05396014|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102059533|NCT05396014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102059534|NCT05396014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102059535|NCT05396014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059536|NCT05396014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102059537|NCT05396014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372648|NCT00198055|Dopamine Agonists|dopamine agonists|mesh-ancestor
101372649|NCT00198055|Dopamine Agents|dopamine agents|mesh-ancestor
101372650|NCT00198055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101372651|NCT00198055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372652|NCT00198055|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101372653|NCT00198055|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101372654|NCT00198055|Serotonin Agents|serotonin agents|mesh-ancestor
101372655|NCT00198055|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101372656|NCT00198055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101372677|NCT00198172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101372678|NCT00198172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101372679|NCT00198172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101372680|NCT00198172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101372681|NCT00198172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101372682|NCT00198172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372683|NCT00198250|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101372684|NCT00198250|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101372685|NCT00198250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101372686|NCT00198250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101372687|NCT00198250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372688|NCT00198250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101372689|NCT00198250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372690|NCT00198250|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101372691|NCT00198250|Antidepressive Agents|antidepressive agents|mesh-ancestor
101372692|NCT00198250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101372693|NCT00084708|Calcitriol|calcitriol|mesh-list
101372694|NCT00084708|Dexamethasone|dexamethasone|mesh-list
101372695|NCT00084708|Gefitinib|gefitinib|mesh-list
101372696|NCT00084708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101372697|NCT00084708|Antiemetics|antiemetics|mesh-ancestor
101372698|NCT00084708|Autonomic Agents|autonomic agents|mesh-ancestor
101372699|NCT00084708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101372700|NCT00084708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372701|NCT00084708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101372713|NCT00084708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101372714|NCT00084708|Vitamins|vitamins|mesh-ancestor
101372715|NCT00084708|Micronutrients|micronutrients|mesh-ancestor
101372716|NCT00084708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101372717|NCT00198367|Cisplatin|cisplatin|mesh-list
101372718|NCT00198367|Carboplatin|carboplatin|mesh-list
101372719|NCT00198367|Vinorelbine|vinorelbine|mesh-list
101372724|NCT00198367|Antimitotic Agents|antimitotic agents|mesh-ancestor
101372725|NCT00198367|Mitosis Modulators|mitosis modulators|mesh-ancestor
101372726|NCT00198445|Bromfenac|bromfenac|mesh-list
101372727|NCT00198445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101372728|NCT00198445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101372729|NCT00198445|Analgesics|analgesics|mesh-ancestor
101372730|NCT00198445|Sensory System Agents|sensory system agents|mesh-ancestor
101372731|NCT00198445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101372732|NCT00198445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059538|NCT05396014|Analgesics|analgesics|mesh-ancestor
102059539|NCT05396014|Sensory System Agents|sensory system agents|mesh-ancestor
102059540|NCT05396014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101474160|NCT04709081|Anesthetics|anesthetics|mesh-ancestor
101372733|NCT00198445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101372734|NCT00198445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101372735|NCT00048399|Fludarabine|fludarabine|mesh-list
101372736|NCT00048399|Alemtuzumab|alemtuzumab|mesh-list
101372737|NCT00048399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101372738|NCT00048399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101372739|NCT00060905|Valproic Acid|valproic acid|mesh-list
101372740|NCT00060905|Anticonvulsants|anticonvulsants|mesh-ancestor
101372741|NCT00060905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101372742|NCT00060905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372743|NCT00060905|GABA Agents|gaba agents|mesh-ancestor
101304665|NCT02014532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101372744|NCT00060905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101372745|NCT00060905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372746|NCT00060905|Antimanic Agents|antimanic agents|mesh-ancestor
101372747|NCT00060905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101372748|NCT00060905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101372749|NCT00060905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101372750|NCT00198523|Tobramycin|tobramycin|mesh-list
101372751|NCT00198523|Prednisolone|prednisolone|mesh-list
101264064|NCT01765738|Rifampin|rifampin|mesh-list
101372752|NCT00198523|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101372753|NCT00198523|Methylprednisolone|methylprednisolone|mesh-list
101372754|NCT00198523|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101372755|NCT00198523|Prednisolone acetate|prednisolone acetate|mesh-list
101372756|NCT00198523|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101372757|NCT00198523|Prednisolone phosphate|prednisolone phosphate|mesh-list
101372758|NCT00198523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101372759|NCT00198523|Glucocorticoids|glucocorticoids|mesh-ancestor
101372760|NCT00198523|Hormones|hormones|mesh-ancestor
101372761|NCT00198523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101372762|NCT00198523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372763|NCT00198523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101372772|NCT00198523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101372774|NCT00198562|Amlodipine|amlodipine|mesh-list
101372775|NCT00198562|Antihypertensive Agents|antihypertensive agents|mesh-list
101372776|NCT00198562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101372777|NCT00198562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101372778|NCT00198562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372779|NCT00198562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101372780|NCT00198562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372781|NCT00198562|Vasodilator Agents|vasodilator agents|mesh-ancestor
101372782|NCT00198562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101372783|NCT00198562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101372784|NCT00198562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101372786|NCT00409942|Furosemide|furosemide|mesh-list
101372787|NCT00409942|Diuretics|diuretics|mesh-ancestor
101372788|NCT00409942|Natriuretic Agents|natriuretic agents|mesh-ancestor
101372789|NCT00409942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372790|NCT00409942|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101372791|NCT00409942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101372792|NCT00409942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372793|NCT00409942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101372794|NCT00084786|Docetaxel|docetaxel|mesh-list
101372795|NCT00084786|Gefitinib|gefitinib|mesh-list
101372796|NCT00084786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101372802|NCT00084786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101372803|NCT00409981|Paclitaxel|paclitaxel|mesh-list
101372804|NCT00409981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101372805|NCT00409981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101372806|NCT00409981|Tubulin Modulators|tubulin modulators|mesh-ancestor
101372807|NCT00409981|Antimitotic Agents|antimitotic agents|mesh-ancestor
101372808|NCT00409981|Mitosis Modulators|mitosis modulators|mesh-ancestor
101372809|NCT00409981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372810|NCT00198601|Gentamicins|gentamicins|mesh-list
101372811|NCT00198601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101372812|NCT00198601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102059541|NCT05396014|Antidepressive Agents|antidepressive agents|mesh-ancestor
102059542|NCT05396014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102059543|NCT05396014|Dopamine Agents|dopamine agents|mesh-ancestor
102059545|NCT05357989|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102059546|NCT05357989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102059547|NCT05357989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059548|NCT05357989|Cholinergic Agents|cholinergic agents|mesh-ancestor
102059549|NCT05357989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102059550|NCT05357989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372813|NCT00198601|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101372814|NCT00198601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101372815|NCT00198601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372816|NCT00198640|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101372817|NCT00198640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101372818|NCT00198679|Chlorhexidine|chlorhexidine|mesh-list
101372819|NCT00198679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101372820|NCT00198679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101372821|NCT00198679|Disinfectants|disinfectants|mesh-ancestor
101372822|NCT00084825|Docetaxel|docetaxel|mesh-list
101304666|NCT02014532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304667|NCT02014532|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101372823|NCT00084825|Imatinib Mesylate|imatinib mesylate|mesh-list
101372824|NCT00084825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101372825|NCT00084825|Tubulin Modulators|tubulin modulators|mesh-ancestor
101372826|NCT00084825|Antimitotic Agents|antimitotic agents|mesh-ancestor
101372827|NCT00084825|Mitosis Modulators|mitosis modulators|mesh-ancestor
101372828|NCT00084825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372829|NCT00084825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101264324|NCT01767298|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101372833|NCT00048477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372835|NCT00199147|Fludarabine|fludarabine|mesh-list
101372837|NCT00199147|Idarubicin|idarubicin|mesh-list
101372838|NCT00199147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101372839|NCT00199147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101372840|NCT00199147|Antimetabolites|antimetabolites|mesh-ancestor
101372841|NCT00199147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372842|NCT00199147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101372843|NCT00199147|Immunologic Factors|immunologic factors|mesh-ancestor
101372844|NCT00199147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372845|NCT00199147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101372846|NCT00199147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101372847|NCT00199147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101264394|NCT01767584|Cephalexin|cephalexin|mesh-list
101372848|NCT00199147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101372849|NCT00199147|Antiviral Agents|antiviral agents|mesh-ancestor
101372850|NCT00199147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101372851|NCT00199147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101372853|NCT00199186|Dexamethasone|dexamethasone|mesh-list
101372854|NCT00199186|Dexamethasone acetate|dexamethasone acetate|mesh-list
101372855|NCT00199186|Cyclophosphamide|cyclophosphamide|mesh-list
101372856|NCT00199186|Methotrexate|methotrexate|mesh-list
101372857|NCT00199186|Vincristine|vincristine|mesh-list
101372858|NCT00199186|Imatinib Mesylate|imatinib mesylate|mesh-list
101372859|NCT00199186|Idarubicin|idarubicin|mesh-list
101372860|NCT00199186|BB 1101|bb 1101|mesh-list
101372861|NCT00199186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101372862|NCT00199186|Immunologic Factors|immunologic factors|mesh-ancestor
101372863|NCT00199186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372864|NCT00199186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101372865|NCT00199186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101372866|NCT00199186|Alkylating Agents|alkylating agents|mesh-ancestor
101372867|NCT00199186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372868|NCT00199186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101372869|NCT00199186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101372874|NCT00199186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101372875|NCT00199186|Glucocorticoids|glucocorticoids|mesh-ancestor
101372876|NCT00199186|Hormones|hormones|mesh-ancestor
102059552|NCT05348577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102059553|NCT05348577|Tubulin Modulators|tubulin modulators|mesh-ancestor
102059554|NCT05348577|Antimitotic Agents|antimitotic agents|mesh-ancestor
102059555|NCT05348577|Mitosis Modulators|mitosis modulators|mesh-ancestor
102059556|NCT05348577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059557|NCT05304455|Heparin|heparin|mesh-list
102059558|NCT05304455|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101372877|NCT00199186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101264526|NCT01768312|Cyclosporins|cyclosporins|mesh-list
101372878|NCT00199186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101372879|NCT00199186|Protease Inhibitors|protease inhibitors|mesh-ancestor
101372880|NCT00199186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101372881|NCT00199186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101372882|NCT00199186|Abortifacient Agents|abortifacient agents|mesh-ancestor
101372883|NCT00199186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101372884|NCT00199186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101372885|NCT00199186|Antimetabolites|antimetabolites|mesh-ancestor
101372886|NCT00199186|Dermatologic Agents|dermatologic agents|mesh-ancestor
101372887|NCT00199186|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101372888|NCT00199186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101372889|NCT00199186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101372890|NCT00199186|Tubulin Modulators|tubulin modulators|mesh-ancestor
101372891|NCT00199186|Antimitotic Agents|antimitotic agents|mesh-ancestor
101264579|NCT01768377|GABA Modulators|gaba modulators|mesh-ancestor
101372892|NCT00199186|Mitosis Modulators|mitosis modulators|mesh-ancestor
101372893|NCT00199186|Antiviral Agents|antiviral agents|mesh-ancestor
101372894|NCT00199186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101372895|NCT00199186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101372896|NCT00199186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101304668|NCT02014532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101304669|NCT02014532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372897|NCT00199186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101372898|NCT00199186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101372899|NCT00199225|Moxifloxacin|moxifloxacin|mesh-list
101372900|NCT00199225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101372901|NCT00199225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101372902|NCT00199225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101372903|NCT00199225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101372910|NCT00061022|Protective Agents|protective agents|mesh-ancestor
101372911|NCT00061022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372912|NCT00199264|Albaconazole|albaconazole|mesh-list
101372913|NCT00199264|Antifungal Agents|antifungal agents|mesh-ancestor
101372914|NCT00199264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101264693|NCT01768988|Pregabalin|pregabalin|mesh-list
101372915|NCT00199342|Ecromeximab|ecromeximab|mesh-list
101372916|NCT00199342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101372917|NCT00199342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101372918|NCT00199420|Istradefylline|istradefylline|mesh-list
101372919|NCT00199420|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
101372920|NCT00199420|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101372921|NCT00199420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101372922|NCT00199420|Purinergic Agents|purinergic agents|mesh-ancestor
101372923|NCT00199420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101372924|NCT00199420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372925|NCT00199420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372927|NCT00199576|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101372928|NCT00199576|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101372929|NCT00199576|Prednisolone|prednisolone|mesh-list
101372930|NCT00199576|Prednisolone acetate|prednisolone acetate|mesh-list
101372931|NCT00199576|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101372932|NCT00199576|Prednisolone phosphate|prednisolone phosphate|mesh-list
101372933|NCT00199576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101372934|NCT00199576|Antiemetics|antiemetics|mesh-ancestor
101372935|NCT00199576|Autonomic Agents|autonomic agents|mesh-ancestor
101372936|NCT00199576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101372937|NCT00199576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372938|NCT00199576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101372939|NCT00199576|Glucocorticoids|glucocorticoids|mesh-ancestor
102059560|NCT05304455|Dalteparin|dalteparin|mesh-list
102059561|NCT05304455|Dipyridamole|dipyridamole|mesh-list
102059562|NCT05304455|Apixaban|apixaban|mesh-list
102059563|NCT05304455|Anticoagulants|anticoagulants|mesh-ancestor
102059564|NCT05304455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102059565|NCT05304455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102059566|NCT05304455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059567|NCT05304455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102059568|NCT05304455|Antithrombins|antithrombins|mesh-ancestor
102059569|NCT05304455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102059570|NCT05304455|Protease Inhibitors|protease inhibitors|mesh-ancestor
102059571|NCT05304455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102059572|NCT05304455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102059573|NCT05304455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102059574|NCT05304455|Vasodilator Agents|vasodilator agents|mesh-ancestor
102059575|NCT05263557|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
102059576|NCT05263557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102059577|NCT05263557|Immunologic Factors|immunologic factors|mesh-ancestor
101361184|NCT00122785|Antiemetics|antiemetics|mesh-ancestor
101372940|NCT00199576|Hormones|hormones|mesh-ancestor
101372941|NCT00199576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101372942|NCT00199576|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101372943|NCT00199576|Protective Agents|protective agents|mesh-ancestor
101372944|NCT00199576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101372951|NCT00084942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101372952|NCT02968394|Omalizumab|omalizumab|mesh-list
101264772|NCT01769625|Analgesics|analgesics|mesh-ancestor
101372953|NCT02968394|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101372954|NCT02968394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101372955|NCT02968394|Respiratory System Agents|respiratory system agents|mesh-ancestor
101372956|NCT00199771|Dextrans|dextrans|mesh-list
101372957|NCT00199771|Anticoagulants|anticoagulants|mesh-ancestor
101372958|NCT00199771|Plasma Substitutes|plasma substitutes|mesh-ancestor
101372959|NCT00199771|Blood Substitutes|blood substitutes|mesh-ancestor
101372960|NCT00084981|Decitabine|decitabine|mesh-list
101372961|NCT00084981|Azacitidine|azacitidine|mesh-list
101372962|NCT00084981|Valproic Acid|valproic acid|mesh-list
101372963|NCT00084981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101372964|NCT00084981|Antimetabolites|antimetabolites|mesh-ancestor
101372965|NCT00084981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372966|NCT00084981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101372967|NCT00084981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101372968|NCT00084981|Anticonvulsants|anticonvulsants|mesh-ancestor
101372969|NCT00084981|GABA Agents|gaba agents|mesh-ancestor
101372970|NCT00084981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101372971|NCT00084981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372972|NCT00084981|Antimanic Agents|antimanic agents|mesh-ancestor
101372973|NCT00084981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101372988|NCT00085020|Lapatinib|lapatinib|mesh-list
101304671|NCT02014545|Schistosomicides|schistosomicides|mesh-ancestor
101372989|NCT00085020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101372990|NCT00085020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101372991|NCT00085020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101372992|NCT00085020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101372993|NCT00085020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372994|NCT00410215|Bisacodyl|bisacodyl|mesh-list
101372995|NCT00410215|Cathartics|cathartics|mesh-ancestor
101372996|NCT00410215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101372997|NCT00410215|Laxatives|laxatives|mesh-ancestor
101372998|NCT00410254|Midazolam|midazolam|mesh-list
102059578|NCT05263557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059579|NCT05236842|Sulthiame|sulthiame|mesh-list
102059580|NCT05236842|Anticonvulsants|anticonvulsants|mesh-ancestor
102059581|NCT05232825|Diphenhydramine|diphenhydramine|mesh-list
102059582|NCT05232825|Promethazine|promethazine|mesh-list
101372999|NCT00410254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101373000|NCT00410254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101264872|NCT01769898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101373001|NCT00410254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101373002|NCT00410254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373003|NCT00410254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101373004|NCT00410254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101373005|NCT00410254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101373006|NCT00410254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101373007|NCT00410254|Anesthetics, General|anesthetics, general|mesh-ancestor
101373008|NCT00410254|Anesthetics|anesthetics|mesh-ancestor
101373009|NCT00410254|GABA Modulators|gaba modulators|mesh-ancestor
101373010|NCT00410254|GABA Agents|gaba agents|mesh-ancestor
101373011|NCT00410254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101373012|NCT00410254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373013|NCT00061178|Bevacizumab|bevacizumab|mesh-list
101373014|NCT00061178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101373015|NCT00061178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101373016|NCT00061178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101373017|NCT00061178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101373018|NCT00061178|Growth Substances|growth substances|mesh-ancestor
101373019|NCT00061178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373020|NCT00061178|Growth Inhibitors|growth inhibitors|mesh-ancestor
101373021|NCT00200395|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101373022|NCT00200395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101373023|NCT00200395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101373024|NCT00200395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101373025|NCT00200395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373026|NCT00200434|Nebivolol|nebivolol|mesh-list
101373027|NCT00200434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101373028|NCT00200434|Vasodilator Agents|vasodilator agents|mesh-ancestor
101373034|NCT00200434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373041|NCT00200473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101373042|NCT00200473|Adrenergic Agents|adrenergic agents|mesh-ancestor
101373043|NCT00200473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101373044|NCT00200473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373045|NCT00200473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373047|NCT02962804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101373048|NCT02962804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101373049|NCT02962804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101373050|NCT02962804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373051|NCT00048555|Galiximab|galiximab|mesh-list
101373052|NCT00048555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101373053|NCT00048555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101373054|NCT00200512|Apomorphine|apomorphine|mesh-list
101373055|NCT00200512|Emetics|emetics|mesh-ancestor
101373056|NCT00200512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373057|NCT00200512|Autonomic Agents|autonomic agents|mesh-ancestor
101373058|NCT00200512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101373059|NCT00200512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101373060|NCT00200512|Dopamine Agonists|dopamine agonists|mesh-ancestor
101373061|NCT00200512|Dopamine Agents|dopamine agents|mesh-ancestor
101373062|NCT00200512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101373063|NCT00200512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373064|NCT00200551|Cyclosporine|cyclosporine|mesh-list
101373065|NCT00200551|Mycophenolic Acid|mycophenolic acid|mesh-list
101373066|NCT00200551|Cyclosporins|cyclosporins|mesh-list
101304672|NCT02014545|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101304673|NCT02014545|Anthelmintics|anthelmintics|mesh-ancestor
101373067|NCT00200551|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101373068|NCT00200551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101373069|NCT00200551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373070|NCT00200551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101373071|NCT00200551|Immunologic Factors|immunologic factors|mesh-ancestor
102059584|NCT05232825|Methylprednisolone|methylprednisolone|mesh-list
102059585|NCT05232825|Desloratadine|desloratadine|mesh-list
102059586|NCT05232825|Ocrelizumab|ocrelizumab|mesh-list
102059587|NCT05232825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102059588|NCT05232825|Antiemetics|antiemetics|mesh-ancestor
102059589|NCT05232825|Autonomic Agents|autonomic agents|mesh-ancestor
102059590|NCT05232825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102059591|NCT05232825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059592|NCT05232825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102059593|NCT05232825|Glucocorticoids|glucocorticoids|mesh-ancestor
102059594|NCT05232825|Hormones|hormones|mesh-ancestor
101361205|NCT00122824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101373072|NCT00200551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373073|NCT00200551|Antifungal Agents|antifungal agents|mesh-ancestor
101373074|NCT00200551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101373075|NCT00200551|Dermatologic Agents|dermatologic agents|mesh-ancestor
101373076|NCT00200551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101373077|NCT00200551|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101373078|NCT00200551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101373079|NCT00200551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101373080|NCT00200551|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101373081|NCT00200551|Antitubercular Agents|antitubercular agents|mesh-ancestor
101373082|NCT00200551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101373084|NCT00061256|Alendronate|alendronate|mesh-list
101373085|NCT00061256|Calcium Carbonate|calcium carbonate|mesh-list
101373087|NCT00061256|Vitamins|vitamins|mesh-ancestor
101373088|NCT00061256|Micronutrients|micronutrients|mesh-ancestor
101373089|NCT00061256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373090|NCT00061256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101373091|NCT00061256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101373092|NCT00061256|Antacids|antacids|mesh-ancestor
101373093|NCT00061256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373094|NCT00061256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101373095|NCT00200590|Acetaminophen|acetaminophen|mesh-list
101373096|NCT00200590|Morphine|morphine|mesh-list
101373097|NCT00200590|Nalbuphine|nalbuphine|mesh-list
101373098|NCT00200590|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101373099|NCT00200590|Narcotics|narcotics|mesh-ancestor
101373100|NCT00200590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101373101|NCT00200590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373102|NCT00200590|Analgesics|analgesics|mesh-ancestor
101373103|NCT00200590|Sensory System Agents|sensory system agents|mesh-ancestor
101373104|NCT00200590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101373114|NCT00200629|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101373117|NCT00200629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101373118|NCT00200629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373119|NCT00200668|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101373120|NCT00200668|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101373121|NCT00200668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373123|NCT00048594|Antiemetics|antiemetics|mesh-ancestor
101373124|NCT00048594|Autonomic Agents|autonomic agents|mesh-ancestor
101373125|NCT00048594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101373126|NCT00048594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373127|NCT00048594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101373128|NCT00048594|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101373129|NCT00048594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101373130|NCT00048594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373131|NCT00200941|Topiramate|topiramate|mesh-list
101373132|NCT00200941|Anticonvulsants|anticonvulsants|mesh-ancestor
101373133|NCT00200941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101373134|NCT00200941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373135|NCT00201253|Dimercaprol|dimercaprol|mesh-list
101373136|NCT00201253|Chelating Agents|chelating agents|mesh-ancestor
101373137|NCT00201253|Sequestering Agents|sequestering agents|mesh-ancestor
101309064|NCT00006012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102059595|NCT05232825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102059596|NCT05232825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102059597|NCT05232825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102059598|NCT05232825|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102059599|NCT05232825|Protective Agents|protective agents|mesh-ancestor
101373138|NCT00201253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373139|NCT00201331|Leucovorin|leucovorin|mesh-list
101373140|NCT00201331|Antidotes|antidotes|mesh-ancestor
101373141|NCT00201331|Protective Agents|protective agents|mesh-ancestor
101373142|NCT00201331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373143|NCT00201331|Vitamin B Complex|vitamin b complex|mesh-ancestor
101373144|NCT00201331|Vitamins|vitamins|mesh-ancestor
101373145|NCT00201331|Micronutrients|micronutrients|mesh-ancestor
101373146|NCT00048672|Imatinib Mesylate|imatinib mesylate|mesh-list
101373147|NCT00048672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101373148|NCT00048672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101304674|NCT02014545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101304675|NCT02014545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101304676|NCT02014558|Voriconazole|voriconazole|mesh-list
101304677|NCT02014558|Cephalexin|cephalexin|mesh-list
101304678|NCT02014558|Midazolam|midazolam|mesh-list
101373149|NCT00048672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101373150|NCT00048672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373151|NCT00201682|Etanercept|etanercept|mesh-list
101373152|NCT00201682|Rituximab|rituximab|mesh-list
101373153|NCT00201682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101373154|NCT00201682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101373155|NCT00201682|Immunologic Factors|immunologic factors|mesh-ancestor
101373156|NCT00201682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373157|NCT00201682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101373158|NCT00201682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101373159|NCT00201682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101373160|NCT00201682|Analgesics|analgesics|mesh-ancestor
101373161|NCT00201682|Sensory System Agents|sensory system agents|mesh-ancestor
101373162|NCT00201682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101373163|NCT00201682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101373164|NCT00201682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101373165|NCT00201682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101373166|NCT00410371|Lamotrigine|lamotrigine|mesh-list
101373167|NCT00410371|Anticonvulsants|anticonvulsants|mesh-ancestor
101373168|NCT00410371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101373169|NCT00410371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101309418|NCT00423384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373170|NCT00410371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373171|NCT00410371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101373174|NCT00410371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101373175|NCT00410371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101373176|NCT00410371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101373177|NCT00410371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101373178|NCT00410449|Tocopherols|tocopherols|mesh-list
101373179|NCT00410449|Vitamin E|vitamin e|mesh-list
101373180|NCT00410449|Tocotrienols|tocotrienols|mesh-list
101373181|NCT00410449|alpha-Tocopherol|alpha-tocopherol|mesh-list
101373182|NCT00410449|Antioxidants|antioxidants|mesh-ancestor
101373183|NCT00410449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373184|NCT00410449|Protective Agents|protective agents|mesh-ancestor
101373185|NCT00410449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373187|NCT00410449|Micronutrients|micronutrients|mesh-ancestor
101373188|NCT00061451|Gemcitabine|gemcitabine|mesh-list
101373189|NCT00061451|Pemetrexed|pemetrexed|mesh-list
101373190|NCT00061451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101373191|NCT00061451|Antimetabolites|antimetabolites|mesh-ancestor
101373192|NCT00061451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373193|NCT00061451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101373194|NCT00061451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101373195|NCT00061451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101373196|NCT00061451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101373197|NCT00410527|Meropenem|meropenem|mesh-list
101373198|NCT00410527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101373199|NCT00410527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101309632|NCT00006051|Immunologic Factors|immunologic factors|mesh-ancestor
102059600|NCT05232825|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102059601|NCT05232825|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102059602|NCT05232825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102059603|NCT05232825|Anesthetics, Local|anesthetics, local|mesh-ancestor
102059604|NCT05232825|Anesthetics|anesthetics|mesh-ancestor
102059605|NCT05232825|Sensory System Agents|sensory system agents|mesh-ancestor
101361223|NCT00122863|Analgesics|analgesics|mesh-ancestor
101373200|NCT00048750|Micafungin|micafungin|mesh-list
101373201|NCT00048750|Antifungal Agents|antifungal agents|mesh-ancestor
101373202|NCT00048750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101373203|NCT00221416|Aripiprazole|aripiprazole|mesh-list
101373204|NCT00221416|Antidepressive Agents|antidepressive agents|mesh-ancestor
101309709|NCT00006081|Bryostatin 1|bryostatin 1|mesh-list
101373205|NCT00221416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101373206|NCT00221416|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101373207|NCT00221416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101373208|NCT00221416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101373209|NCT00221416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373210|NCT00221416|Dopamine Agonists|dopamine agonists|mesh-ancestor
101373211|NCT00221416|Dopamine Agents|dopamine agents|mesh-ancestor
101373212|NCT00221416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101373213|NCT00221416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373214|NCT00221416|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101373215|NCT00221416|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101373216|NCT00221416|Serotonin Agents|serotonin agents|mesh-ancestor
101373217|NCT00221416|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101304679|NCT02014558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101304680|NCT02014558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101333843|NCT00041275|Contraceptive Agents|contraceptive agents|mesh-ancestor
101373218|NCT00221416|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101373219|NCT00221416|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101373220|NCT00221416|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101373221|NCT00221494|Pindolol|pindolol|mesh-list
101373222|NCT00221494|Citalopram|citalopram|mesh-list
101309857|NCT00006168|Dermatologic Agents|dermatologic agents|mesh-ancestor
101373223|NCT00221494|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101373224|NCT00221494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101309920|NCT00006204|Sensory System Agents|sensory system agents|mesh-ancestor
101373225|NCT00221494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101373226|NCT00221494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373227|NCT00221494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101373229|NCT00221494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373230|NCT00221494|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101373231|NCT00221494|Antidepressive Agents|antidepressive agents|mesh-ancestor
101373232|NCT00221494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101373233|NCT00221494|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101373234|NCT00221494|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101373235|NCT00221494|Adrenergic Agents|adrenergic agents|mesh-ancestor
101373236|NCT00221494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101373237|NCT00221494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101373238|NCT00221494|Vasodilator Agents|vasodilator agents|mesh-ancestor
101373239|NCT00221611|Baclofen|baclofen|mesh-list
101373240|NCT00221611|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101373241|NCT00221611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373242|NCT00221611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101373243|NCT00221611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101373244|NCT00221611|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101373264|NCT00221689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373265|NCT02968121|Brexpiprazole|brexpiprazole|mesh-list
101373266|NCT02968121|Serotonin Agents|serotonin agents|mesh-ancestor
101310147|NCT00006294|Amlodipine|amlodipine|mesh-list
101373267|NCT02968121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101373268|NCT02968121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373269|NCT02968121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373270|NCT02968121|Dopamine Agonists|dopamine agonists|mesh-ancestor
101373271|NCT02968121|Dopamine Agents|dopamine agents|mesh-ancestor
101373272|NCT00412789|Epothilone B|epothilone b|mesh-list
101373273|NCT00412789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101373274|NCT00412789|Tubulin Modulators|tubulin modulators|mesh-ancestor
101373275|NCT00412789|Antimitotic Agents|antimitotic agents|mesh-ancestor
102059606|NCT05232825|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102059607|NCT05232825|Histamine Antagonists|histamine antagonists|mesh-ancestor
102059608|NCT05232825|Histamine Agents|histamine agents|mesh-ancestor
102059609|NCT05232825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101310292|NCT00005854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102059610|NCT05232825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059611|NCT05232825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102059612|NCT05232825|Antipruritics|antipruritics|mesh-ancestor
102059613|NCT05232825|Dermatologic Agents|dermatologic agents|mesh-ancestor
102059614|NCT05232825|Immunologic Factors|immunologic factors|mesh-ancestor
102059615|NCT05232825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102059616|NCT05232825|Cholinergic Agents|cholinergic agents|mesh-ancestor
102059617|NCT05232825|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102059618|NCT05231122|Bevacizumab|bevacizumab|mesh-list
102059619|NCT05231122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102059620|NCT05231122|Pembrolizumab|pembrolizumab|mesh-list
102059621|NCT05231122|Endothelial Growth Factors|endothelial growth factors|mesh-list
102059622|NCT05231122|Antibodies|antibodies|mesh-list
102059623|NCT05231122|Immunoglobulins|immunoglobulins|mesh-list
102059624|NCT05231122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102059625|NCT05231122|Immunoglobulin G|immunoglobulin g|mesh-list
101361228|NCT00122863|Dopamine Agents|dopamine agents|mesh-ancestor
101373282|NCT00048828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101373283|NCT00048828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373284|NCT00048828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101373285|NCT00048828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101373286|NCT00048828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101373287|NCT00048828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101373288|NCT00048828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101373289|NCT00048828|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101373290|NCT00048828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101373291|NCT00048828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101373292|NCT00048828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373293|NCT00048828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101373294|NCT00048828|Serotonin Agents|serotonin agents|mesh-ancestor
101373295|NCT00048828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101373296|NCT00048828|GABA Antagonists|gaba antagonists|mesh-ancestor
101373297|NCT00048828|GABA Agents|gaba agents|mesh-ancestor
101373298|NCT00061529|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101373299|NCT00061529|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101373300|NCT00061529|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101373303|NCT00061529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101373304|NCT00061529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101373305|NCT00061529|Adrenergic Agents|adrenergic agents|mesh-ancestor
101373306|NCT00061529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101373307|NCT00061529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373308|NCT00061529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373310|NCT00221845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101373311|NCT00221845|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101373312|NCT00221845|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101373313|NCT00221845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373314|NCT00085761|Capsaicin|capsaicin|mesh-list
101373315|NCT00085761|Antipruritics|antipruritics|mesh-ancestor
101373316|NCT00085761|Dermatologic Agents|dermatologic agents|mesh-ancestor
101310662|NCT00005974|Alvocidib|alvocidib|mesh-list
102059626|NCT05231122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102059627|NCT05231122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102059628|NCT05231122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102059629|NCT05231122|Growth Substances|growth substances|mesh-ancestor
102059630|NCT05231122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059631|NCT05231122|Growth Inhibitors|growth inhibitors|mesh-ancestor
102059632|NCT05231122|Immunologic Factors|immunologic factors|mesh-ancestor
101373317|NCT00085761|Sensory System Agents|sensory system agents|mesh-ancestor
101373318|NCT00085761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101373319|NCT00085761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373320|NCT00221962|Aripiprazole|aripiprazole|mesh-list
101373321|NCT00221962|Antidepressive Agents|antidepressive agents|mesh-ancestor
101373322|NCT00221962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101373323|NCT00221962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101373324|NCT00221962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101373325|NCT00221962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101373326|NCT00221962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373327|NCT00221962|Dopamine Agonists|dopamine agonists|mesh-ancestor
101373328|NCT00221962|Dopamine Agents|dopamine agents|mesh-ancestor
101373329|NCT00221962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101310790|NCT00006001|Semaxinib|semaxinib|mesh-list
101373330|NCT00221962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373331|NCT00221962|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101373332|NCT00221962|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101373333|NCT00221962|Serotonin Agents|serotonin agents|mesh-ancestor
101373334|NCT00221962|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101373335|NCT00221962|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101373336|NCT00221962|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101373337|NCT00221962|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101373338|NCT02968160|Telmisartan|telmisartan|mesh-list
101373339|NCT02968160|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101373340|NCT02968160|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101373341|NCT02968160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101373342|NCT02968160|Antimetabolites|antimetabolites|mesh-ancestor
101373343|NCT02968160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373344|NCT02968160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101373345|NCT02968160|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101310930|NCT00006037|Irinotecan|irinotecan|mesh-list
101373346|NCT02968160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101373347|NCT02968160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101373354|NCT00222079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101373355|NCT00222079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373356|NCT00222235|Cycloserine|cycloserine|mesh-list
101373358|NCT00222235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101373359|NCT00222235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101373360|NCT00222235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101373361|NCT00222235|Antitubercular Agents|antitubercular agents|mesh-ancestor
101373362|NCT00222235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101373363|NCT00222235|Antimetabolites|antimetabolites|mesh-ancestor
101373364|NCT00222235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373365|NCT00222235|Glycine Agents|glycine agents|mesh-ancestor
101373366|NCT00222235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101373367|NCT00222235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373368|NCT00061646|Carboplatin|carboplatin|mesh-list
101373369|NCT00061646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101373370|NCT00222469|Bevacizumab|bevacizumab|mesh-list
101373383|NCT00222547|Vitamin A|vitamin a|mesh-list
101373384|NCT00222547|Albendazole|albendazole|mesh-list
101373385|NCT00222547|Vitamins|vitamins|mesh-ancestor
101373386|NCT00222547|Micronutrients|micronutrients|mesh-ancestor
101373387|NCT00222547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373388|NCT00222547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373389|NCT00222547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101373390|NCT00222547|Anthelmintics|anthelmintics|mesh-ancestor
101373391|NCT00222547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101304681|NCT02014558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101304682|NCT02014558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304684|NCT02014558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102059633|NCT05231122|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102059634|NCT05231122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059635|NCT05219110|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102059636|NCT05201300|Propofol|propofol|mesh-list
101304685|NCT02014558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101373392|NCT00222547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101373393|NCT00222547|Anticestodal Agents|anticestodal agents|mesh-ancestor
101373394|NCT00222547|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101373395|NCT00222547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101373396|NCT00222547|Tubulin Modulators|tubulin modulators|mesh-ancestor
101373397|NCT00222547|Antimitotic Agents|antimitotic agents|mesh-ancestor
101373398|NCT00222547|Mitosis Modulators|mitosis modulators|mesh-ancestor
101373399|NCT00086034|Motexafin gadolinium|motexafin gadolinium|mesh-list
101373400|NCT00086034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101373401|NCT00086034|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101373402|NCT00086034|Dermatologic Agents|dermatologic agents|mesh-ancestor
101373403|NCT02968082|Scopolamine|scopolamine|mesh-list
101311146|NCT05660200|Iron|iron|mesh-list
101373404|NCT02968082|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101373405|NCT02968082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101373406|NCT02968082|Antiemetics|antiemetics|mesh-ancestor
101373407|NCT02968082|Autonomic Agents|autonomic agents|mesh-ancestor
101373408|NCT02968082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101373409|NCT02968082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373410|NCT02968082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101373411|NCT02968082|Mydriatics|mydriatics|mesh-ancestor
101373412|NCT02968082|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101373413|NCT02968082|Cholinergic Agents|cholinergic agents|mesh-ancestor
101373414|NCT02968082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101311190|NCT05546320|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101373415|NCT02968082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373416|NCT02968082|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101373417|NCT02968082|Parasympatholytics|parasympatholytics|mesh-ancestor
101373418|NCT00222820|Escitalopram|escitalopram|mesh-list
101373419|NCT00222820|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101373420|NCT00222820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101373421|NCT00222820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101373422|NCT00222820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373423|NCT00222820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101373424|NCT00222820|Serotonin Agents|serotonin agents|mesh-ancestor
101373451|NCT00223015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373452|NCT00061763|Deferasirox|deferasirox|mesh-list
101373453|NCT00061763|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101373454|NCT00061763|Chelating Agents|chelating agents|mesh-ancestor
101373455|NCT00061763|Sequestering Agents|sequestering agents|mesh-ancestor
101373456|NCT00061763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373457|NCT00223054|Cyclosporine|cyclosporine|mesh-list
101373458|NCT00223054|Sirolimus|sirolimus|mesh-list
101373459|NCT00223054|Everolimus|everolimus|mesh-list
101373460|NCT00223054|Tacrolimus|tacrolimus|mesh-list
101373461|NCT00223054|Cyclosporins|cyclosporins|mesh-list
101373462|NCT00223054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101373463|NCT00223054|Immunologic Factors|immunologic factors|mesh-ancestor
101373464|NCT00223054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373465|NCT00223054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101373466|NCT00223054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101373467|NCT00223054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373468|NCT00223054|Antifungal Agents|antifungal agents|mesh-ancestor
101373469|NCT00223054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101373470|NCT00223054|Dermatologic Agents|dermatologic agents|mesh-ancestor
101373471|NCT00223054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101373472|NCT00223054|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101373473|NCT00223054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101373474|NCT00223054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101373475|NCT00223054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101304686|NCT02014558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101304687|NCT02014558|Anesthetics, General|anesthetics, general|mesh-ancestor
101304688|NCT02014558|Anesthetics|anesthetics|mesh-ancestor
101373476|NCT00223054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101373477|NCT00223210|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101373478|NCT00223210|Antidepressive Agents|antidepressive agents|mesh-ancestor
101373479|NCT00223210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101373480|NCT00223210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101373481|NCT00223210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102059637|NCT05201300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102059638|NCT05201300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102059639|NCT05201300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059640|NCT05201300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102059641|NCT05201300|Anesthetics, General|anesthetics, general|mesh-ancestor
102059642|NCT05201300|Anesthetics|anesthetics|mesh-ancestor
101361257|NCT00042965|Gemcitabine|gemcitabine|mesh-list
101373482|NCT00223210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101373483|NCT00223210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373484|NCT00061802|Risperidone|risperidone|mesh-list
101373485|NCT00061802|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101373486|NCT00061802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101373492|NCT00061802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101373493|NCT00061802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101373494|NCT00061802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101373495|NCT00061802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101373496|NCT00061802|Dopamine Agents|dopamine agents|mesh-ancestor
101311615|NCT00006708|Rituximab|rituximab|mesh-list
101373497|NCT00061802|Antidepressive Agents|antidepressive agents|mesh-ancestor
101373498|NCT00223249|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101373499|NCT00223249|Antidepressive Agents|antidepressive agents|mesh-ancestor
101373500|NCT00223249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101373501|NCT00223249|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101373502|NCT00223249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101373503|NCT00223249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101373504|NCT00223249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373505|NCT00223288|Escitalopram|escitalopram|mesh-list
101373506|NCT00223288|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101373507|NCT00223288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101373508|NCT00223288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101373509|NCT00223288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373510|NCT00223288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101373511|NCT00223288|Serotonin Agents|serotonin agents|mesh-ancestor
101373512|NCT00223288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373513|NCT00085449|Cyclosporine|cyclosporine|mesh-list
101373514|NCT00085449|Mycophenolic Acid|mycophenolic acid|mesh-list
101373515|NCT00085449|Fludarabine|fludarabine|mesh-list
101373520|NCT00085449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101373521|NCT00085449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101373522|NCT00085449|Antimetabolites|antimetabolites|mesh-ancestor
101373523|NCT00085449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373524|NCT00085449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101373525|NCT00085449|Immunologic Factors|immunologic factors|mesh-ancestor
101373526|NCT00085449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373527|NCT00085449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101373528|NCT00085449|Antifungal Agents|antifungal agents|mesh-ancestor
101373529|NCT00085449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101373530|NCT00085449|Dermatologic Agents|dermatologic agents|mesh-ancestor
101373531|NCT00085449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101373532|NCT00085449|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101373533|NCT00085449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101373534|NCT00085449|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101373535|NCT00085449|Antitubercular Agents|antitubercular agents|mesh-ancestor
101373536|NCT00085449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101373537|NCT00085449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101373538|NCT00085449|Alkylating Agents|alkylating agents|mesh-ancestor
101373539|NCT00085449|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101373540|NCT00085449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101373541|NCT00223561|Methylphenidate|methylphenidate|mesh-list
101373542|NCT00223561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101373543|NCT00223561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373544|NCT00223561|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101373545|NCT00223561|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101373546|NCT00223561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101373547|NCT00223561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373548|NCT00223561|Dopamine Agents|dopamine agents|mesh-ancestor
101373549|NCT00223561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102059643|NCT05200208|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
102059645|NCT05198050|Letrozole|letrozole|mesh-list
102059646|NCT05198050|Alprostadil|alprostadil|mesh-list
102059647|NCT05198050|Misoprostol|misoprostol|mesh-list
102059648|NCT05198050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102059649|NCT05198050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102059650|NCT05198050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102059651|NCT05198050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101304690|NCT02014558|GABA Agents|gaba agents|mesh-ancestor
101304691|NCT02014558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101304692|NCT02014558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373550|NCT00223639|Topiramate|topiramate|mesh-list
101373551|NCT00223639|Anticonvulsants|anticonvulsants|mesh-ancestor
101373552|NCT00223639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101373553|NCT00223639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373554|NCT00223717|Aspirin|aspirin|mesh-list
101373555|NCT00223717|Losartan|losartan|mesh-list
101373570|NCT00223717|Nitroglycerin|nitroglycerin|mesh-list
101373571|NCT00223717|Dipyridamole|dipyridamole|mesh-list
101373572|NCT00223717|Carbidopa|carbidopa|mesh-list
101373573|NCT00223717|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
101373574|NCT00223717|Tamsulosin|tamsulosin|mesh-list
101373575|NCT00223717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101373576|NCT00223717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101373577|NCT00223717|Analgesics|analgesics|mesh-ancestor
101373578|NCT00223717|Sensory System Agents|sensory system agents|mesh-ancestor
101373579|NCT00223717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101373580|NCT00223717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373581|NCT00223717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101373582|NCT00223717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101373583|NCT00223717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101373584|NCT00223717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101373585|NCT00223717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373586|NCT00223717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101373587|NCT00223717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101373588|NCT00223717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101373589|NCT00223717|Antipyretics|antipyretics|mesh-ancestor
101373590|NCT00223717|Vasodilator Agents|vasodilator agents|mesh-ancestor
101373591|NCT00223717|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101373592|NCT00223717|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101373593|NCT00223717|Urological Agents|urological agents|mesh-ancestor
101373594|NCT00223717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101373595|NCT00223717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101373596|NCT00223717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101373597|NCT00223717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101373604|NCT00223717|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101373605|NCT00223717|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101373606|NCT00223717|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101373607|NCT00223717|Adrenergic Agents|adrenergic agents|mesh-ancestor
101373608|NCT00223717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101373609|NCT00223717|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101373610|NCT00223717|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101373611|NCT00223717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101373612|NCT00223717|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101373613|NCT00223717|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101373614|NCT00223717|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101373615|NCT00223717|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101373616|NCT00223717|Dopamine Agents|dopamine agents|mesh-ancestor
101373617|NCT00223717|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101373618|NCT00223717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101373619|NCT00223717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101373620|NCT00223717|Tocolytic Agents|tocolytic agents|mesh-ancestor
101373621|NCT00223717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101312159|NCT00006232|Hormones|hormones|mesh-ancestor
101373639|NCT00061919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101373640|NCT00061919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102059652|NCT05198050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059653|NCT05198050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102059654|NCT05198050|Hormone Antagonists|hormone antagonists|mesh-ancestor
102059655|NCT05198050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102059656|NCT05198050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059657|NCT05198050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102059658|NCT05198050|Abortifacient Agents|abortifacient agents|mesh-ancestor
102059659|NCT05198050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102059660|NCT05198050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102059661|NCT05198050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102059662|NCT05198050|Oxytocics|oxytocics|mesh-ancestor
102059663|NCT05198050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102059664|NCT05198050|Vasodilator Agents|vasodilator agents|mesh-ancestor
102059665|NCT05198050|Urological Agents|urological agents|mesh-ancestor
102059666|NCT05182840|Empagliflozin|empagliflozin|mesh-list
102059667|NCT05182840|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101387716|NCT00323206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059668|NCT05182840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059669|NCT05182840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102059670|NCT05182840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059671|NCT05119439|Misoprostol|misoprostol|mesh-list
102059672|NCT05119439|Mifepristone|mifepristone|mesh-list
102059673|NCT05119439|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102059674|NCT05119439|Abortifacient Agents|abortifacient agents|mesh-ancestor
102059675|NCT05119439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101373641|NCT00061919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101373642|NCT00061919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101373643|NCT00061919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373644|NCT00061919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101373645|NCT00061919|Immunologic Factors|immunologic factors|mesh-ancestor
101304693|NCT02014558|Antifungal Agents|antifungal agents|mesh-ancestor
101304694|NCT02014558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101304695|NCT02014558|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101304696|NCT02014558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101304697|NCT02014558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101373646|NCT00061919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373647|NCT00061919|Leprostatic Agents|leprostatic agents|mesh-ancestor
101373648|NCT00061919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101373649|NCT00061919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101373650|NCT00061919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101373651|NCT00061919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101373652|NCT00061919|Growth Substances|growth substances|mesh-ancestor
101373653|NCT00061919|Growth Inhibitors|growth inhibitors|mesh-ancestor
101373655|NCT00085527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101373656|NCT00085527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101373657|NCT00085527|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101373658|NCT00085527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102059676|NCT05119439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059677|NCT05119439|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102059678|NCT05119439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102059680|NCT05119439|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
102059681|NCT05119439|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102059682|NCT05119439|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101312340|NCT00006337|Levodopa|levodopa|mesh-list
102059683|NCT05119439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102059684|NCT05119439|Contraceptive Agents|contraceptive agents|mesh-ancestor
102059685|NCT05119439|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101373659|NCT00085527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373660|NCT00061958|Arsenic Trioxide|arsenic trioxide|mesh-list
101373661|NCT00061958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101373662|NCT00224068|Ferric gluconate|ferric gluconate|mesh-list
101373663|NCT00224068|Hematinics|hematinics|mesh-ancestor
101373665|NCT00224146|Parasympatholytics|parasympatholytics|mesh-ancestor
101373666|NCT00224146|Autonomic Agents|autonomic agents|mesh-ancestor
101373667|NCT00224146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101373668|NCT00224146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373669|NCT00224146|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101373670|NCT00224146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101373671|NCT00224146|Cholinergic Agents|cholinergic agents|mesh-ancestor
101373672|NCT00224146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101373673|NCT00224146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373674|NCT00224146|Urological Agents|urological agents|mesh-ancestor
101373675|NCT00061997|Inositol|inositol|mesh-list
101373676|NCT00061997|Vitamin B Complex|vitamin b complex|mesh-ancestor
101373686|NCT00062036|Fludarabine|fludarabine|mesh-list
101373687|NCT00062036|Fludarabine phosphate|fludarabine phosphate|mesh-list
101373688|NCT00062036|Interleukin-2|interleukin-2|mesh-list
101373689|NCT00062036|Freund's Adjuvant|freund's adjuvant|mesh-list
101373690|NCT00062036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101373691|NCT00062036|Immunologic Factors|immunologic factors|mesh-ancestor
101373692|NCT00062036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373693|NCT00062036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101373694|NCT00062036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101373695|NCT00062036|Alkylating Agents|alkylating agents|mesh-ancestor
101373696|NCT00062036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373697|NCT00062036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101373698|NCT00062036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101373699|NCT00062036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101373700|NCT00062036|Antimetabolites|antimetabolites|mesh-ancestor
101373701|NCT00062036|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101312401|NCT00006349|Micronutrients|micronutrients|mesh-ancestor
101373702|NCT00062036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101373703|NCT00062036|Analgesics|analgesics|mesh-ancestor
101373704|NCT00062036|Sensory System Agents|sensory system agents|mesh-ancestor
101373705|NCT00062036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101373706|NCT00062036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101373707|NCT00062036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101373708|NCT00062036|Antiviral Agents|antiviral agents|mesh-ancestor
101373709|NCT00062036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101373710|NCT00224302|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101373711|NCT00224302|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101373712|NCT00224302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101373713|NCT00224302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101373714|NCT00224302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373715|NCT00224302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101373716|NCT00224302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373717|NCT00224302|Analgesics|analgesics|mesh-ancestor
101304698|NCT02014558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101304699|NCT02014558|Hormone Antagonists|hormone antagonists|mesh-ancestor
101373718|NCT00224302|Sensory System Agents|sensory system agents|mesh-ancestor
102059686|NCT05119439|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
102059687|NCT05119439|Hormone Antagonists|hormone antagonists|mesh-ancestor
102059688|NCT05119439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102059689|NCT05119439|Luteolytic Agents|luteolytic agents|mesh-ancestor
102059690|NCT05119439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102059691|NCT05119439|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102059693|NCT05065021|Bevacizumab|bevacizumab|mesh-list
102059694|NCT05065021|Niraparib|niraparib|mesh-list
102059695|NCT05065021|Dostarlimab|dostarlimab|mesh-list
102059696|NCT05065021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102059697|NCT05065021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361309|NCT00043004|Antimetabolites|antimetabolites|mesh-ancestor
101373719|NCT00224302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101373720|NCT00224302|Antidepressive Agents|antidepressive agents|mesh-ancestor
101373721|NCT00224302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101373722|NCT00224302|Dopamine Agents|dopamine agents|mesh-ancestor
101373723|NCT00062075|Romidepsin|romidepsin|mesh-list
101373724|NCT00062075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101373725|NCT00062075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101373726|NCT00062075|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101373727|NCT00062075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101373728|NCT00062075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373729|NCT00224419|Nicotine|nicotine|mesh-list
101373730|NCT00224419|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101373731|NCT00224419|Autonomic Agents|autonomic agents|mesh-ancestor
101373732|NCT00224419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101373733|NCT00224419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373734|NCT00224419|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101373735|NCT00224419|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101373736|NCT00224419|Cholinergic Agents|cholinergic agents|mesh-ancestor
101373737|NCT00224419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101373738|NCT00224419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373739|NCT00224458|Efavirenz|efavirenz|mesh-list
101373740|NCT00224458|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101373741|NCT00224458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101373742|NCT00224458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101373743|NCT00224458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101373744|NCT00224458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373745|NCT00224458|Antiviral Agents|antiviral agents|mesh-ancestor
101373772|NCT00095082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101373773|NCT00095082|Insulin Glargine|insulin glargine|mesh-list
101373774|NCT00095082|Insulin Aspart|insulin aspart|mesh-list
101373775|NCT00095082|Insulin Detemir|insulin detemir|mesh-list
101373776|NCT00095082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101373777|NCT00095082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373778|NCT00062231|Amoxicillin|amoxicillin|mesh-list
101373779|NCT00062231|Moxifloxacin|moxifloxacin|mesh-list
101373785|NCT00062231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101373786|NCT00062231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101373787|NCT00062231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101373788|NCT00062231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101373789|NCT00062231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101373790|NCT00062231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373791|NCT00062231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101373792|NCT00062231|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101373793|NCT00062231|Contraceptive Agents|contraceptive agents|mesh-ancestor
101373794|NCT00062231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101373795|NCT00062231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373800|NCT00062231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101373802|NCT00224692|Ketamine|ketamine|mesh-list
101373803|NCT00224692|Analgesics|analgesics|mesh-ancestor
101373804|NCT00224692|Sensory System Agents|sensory system agents|mesh-ancestor
102059698|NCT05065021|Tubulin Modulators|tubulin modulators|mesh-ancestor
102059699|NCT05065021|Antimitotic Agents|antimitotic agents|mesh-ancestor
102059700|NCT05065021|Mitosis Modulators|mitosis modulators|mesh-ancestor
102059701|NCT05065021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059702|NCT05065021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102059703|NCT05065021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102059704|NCT05065021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102059705|NCT05065021|Growth Substances|growth substances|mesh-ancestor
102059706|NCT05065021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059707|NCT05065021|Growth Inhibitors|growth inhibitors|mesh-ancestor
102059708|NCT05065021|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101373805|NCT00224692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101373806|NCT00224692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373807|NCT00224692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101373808|NCT00224692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101373809|NCT00224692|Anesthetics, General|anesthetics, general|mesh-ancestor
101373810|NCT00224692|Anesthetics|anesthetics|mesh-ancestor
101373811|NCT00224692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101373812|NCT00224692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101373813|NCT00224692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101373814|NCT00224692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101373815|NCT00224692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304700|NCT02014558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101373818|NCT00224809|Clopidogrel|clopidogrel|mesh-list
101373819|NCT00224809|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101373820|NCT00224809|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101373821|NCT00224809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
101373822|NCT00224809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101373823|NCT00224809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101373825|NCT00224809|Sensory System Agents|sensory system agents|mesh-ancestor
101373826|NCT00224809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101373827|NCT00224809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373828|NCT00224809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101373829|NCT00224809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101373830|NCT00224809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101373831|NCT00224809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101373832|NCT00224809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373833|NCT00224809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101373834|NCT00224809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101373835|NCT00224809|Antipyretics|antipyretics|mesh-ancestor
101373836|NCT00224809|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101373837|NCT00224809|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101373838|NCT00224809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101373839|NCT00224809|Purinergic Agents|purinergic agents|mesh-ancestor
101373840|NCT00224809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101373841|NCT00224809|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101373842|NCT00224809|Hormone Antagonists|hormone antagonists|mesh-ancestor
101373843|NCT00224809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101373844|NCT00224809|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101373845|NCT00224809|Diuretics|diuretics|mesh-ancestor
101373846|NCT00224809|Natriuretic Agents|natriuretic agents|mesh-ancestor
101373847|NCT00224809|Protease Inhibitors|protease inhibitors|mesh-ancestor
101373848|NCT00062270|Gemcitabine|gemcitabine|mesh-list
101373849|NCT00062270|Docetaxel|docetaxel|mesh-list
101373850|NCT00062270|Gefitinib|gefitinib|mesh-list
101373855|NCT00062270|Tubulin Modulators|tubulin modulators|mesh-ancestor
101373856|NCT00062270|Antimitotic Agents|antimitotic agents|mesh-ancestor
102059709|NCT05065021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102059710|NCT05020392|Vidarabine|vidarabine|mesh-list
102059711|NCT05020392|Fludarabine|fludarabine|mesh-list
102059712|NCT05020392|Fludarabine phosphate|fludarabine phosphate|mesh-list
102059713|NCT05020392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102059714|NCT05020392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101373857|NCT00062270|Mitosis Modulators|mitosis modulators|mesh-ancestor
101373858|NCT00062270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101373859|NCT00062270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101373860|NCT00413023|Casopitant|casopitant|mesh-list
101373861|NCT00413023|Antiemetics|antiemetics|mesh-ancestor
101373862|NCT00413023|Autonomic Agents|autonomic agents|mesh-ancestor
101373863|NCT00413023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101373868|NCT00413023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373869|NCT00095277|Darbepoetin alfa|darbepoetin alfa|mesh-list
101373870|NCT00095277|Hematinics|hematinics|mesh-ancestor
101373871|NCT00413101|Epoetin Alfa|epoetin alfa|mesh-list
101373872|NCT00413101|Hematinics|hematinics|mesh-ancestor
101373874|NCT00413179|Clomiphene|clomiphene|mesh-list
101373875|NCT00413179|Enclomiphene|enclomiphene|mesh-list
101373876|NCT00413179|Zuclomiphene|zuclomiphene|mesh-list
101373877|NCT00413179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101373878|NCT00413179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373879|NCT00413179|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101373880|NCT00413179|Hormone Antagonists|hormone antagonists|mesh-ancestor
101373881|NCT00413179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101373882|NCT00413179|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101373883|NCT00413179|Fertility Agents|fertility agents|mesh-ancestor
101373884|NCT00413179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101373885|NCT00413179|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101373886|NCT00413179|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101373887|NCT00413257|Nefopam|nefopam|mesh-list
101373888|NCT00413257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101373889|NCT00413257|Analgesics|analgesics|mesh-ancestor
101373890|NCT00413257|Sensory System Agents|sensory system agents|mesh-ancestor
101373891|NCT00413257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101304701|NCT02014558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101304702|NCT02014558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101304703|NCT02014623|Immunomodulating Agents|immunomodulating agents|mesh-list
101373892|NCT00413257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373893|NCT00095316|Caspofungin|caspofungin|mesh-list
101373894|NCT00095316|Antifungal Agents|antifungal agents|mesh-ancestor
101373895|NCT00095316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101373896|NCT00095316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101373897|NCT00095316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373898|NCT00225043|Phenylephrine|phenylephrine|mesh-list
101373899|NCT00225043|Epinephrine|epinephrine|mesh-list
101373900|NCT00225043|Oxymetazoline|oxymetazoline|mesh-list
101373901|NCT00225043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101373902|NCT00225043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101373903|NCT00225043|Adrenergic Agents|adrenergic agents|mesh-ancestor
101373904|NCT00225043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101373905|NCT00225043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373906|NCT00225043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373907|NCT00225043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101373908|NCT00225043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101373909|NCT00225043|Autonomic Agents|autonomic agents|mesh-ancestor
101373910|NCT00225043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101373911|NCT00225043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101373912|NCT00225043|Respiratory System Agents|respiratory system agents|mesh-ancestor
101373913|NCT00225043|Mydriatics|mydriatics|mesh-ancestor
101373914|NCT00225043|Sympathomimetics|sympathomimetics|mesh-ancestor
101373915|NCT00225043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101373916|NCT00225043|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101373917|NCT00225043|Nasal Decongestants|nasal decongestants|mesh-ancestor
101373918|NCT00225043|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101373919|NCT00225043|Protective Agents|protective agents|mesh-ancestor
101373920|NCT00095355|Valproic Acid|valproic acid|mesh-list
101373921|NCT00095355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101373922|NCT00095355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101373923|NCT00095355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059715|NCT05020392|Antimetabolites|antimetabolites|mesh-ancestor
102059716|NCT05020392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059717|NCT05020392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102059718|NCT05020392|Immunologic Factors|immunologic factors|mesh-ancestor
102059719|NCT05020392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059720|NCT05020392|Antiviral Agents|antiviral agents|mesh-ancestor
102059721|NCT05020392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102059722|NCT04992468|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101361342|NCT00043043|Celecoxib|celecoxib|mesh-list
101373924|NCT00095355|Antimanic Agents|antimanic agents|mesh-ancestor
101373941|NCT00225238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101373942|NCT00225238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373944|NCT00062426|Bevacizumab|bevacizumab|mesh-list
101373945|NCT00062426|Fluorouracil|fluorouracil|mesh-list
101373946|NCT00062426|Capecitabine|capecitabine|mesh-list
101373947|NCT00062426|Oxaliplatin|oxaliplatin|mesh-list
101373948|NCT00062426|Calcium|calcium|mesh-list
101373949|NCT00062426|Levoleucovorin|levoleucovorin|mesh-list
101373950|NCT00062426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101373951|NCT00062426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101373952|NCT00062426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101373953|NCT00062426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101373954|NCT00062426|Growth Substances|growth substances|mesh-ancestor
101373955|NCT00062426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373956|NCT00062426|Growth Inhibitors|growth inhibitors|mesh-ancestor
101373957|NCT00062426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101373958|NCT00062426|Antimetabolites|antimetabolites|mesh-ancestor
101373959|NCT00062426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373960|NCT00062426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101373961|NCT00062426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101373962|NCT00062426|Immunologic Factors|immunologic factors|mesh-ancestor
101373963|NCT00062426|Antidotes|antidotes|mesh-ancestor
101373964|NCT00062426|Protective Agents|protective agents|mesh-ancestor
101373965|NCT00062426|Vitamin B Complex|vitamin b complex|mesh-ancestor
101373966|NCT00062426|Vitamins|vitamins|mesh-ancestor
101373967|NCT00062426|Micronutrients|micronutrients|mesh-ancestor
101304704|NCT02014623|Histamine Antagonists|histamine antagonists|mesh-list
101304705|NCT02014623|Immunologic Factors|immunologic factors|mesh-ancestor
101304706|NCT02014623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304707|NCT02014623|Histamine Agents|histamine agents|mesh-ancestor
101373968|NCT00095433|Ranibizumab|ranibizumab|mesh-list
101373969|NCT00095433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101373970|NCT00095433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101373971|NCT00095433|Growth Substances|growth substances|mesh-ancestor
101373972|NCT00095433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373973|NCT00095433|Growth Inhibitors|growth inhibitors|mesh-ancestor
101373974|NCT00095433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101373975|NCT00225355|Rosiglitazone|rosiglitazone|mesh-list
101373976|NCT00225355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101373977|NCT00225355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373978|NCT00225433|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101373979|NCT00225433|Ganirelix|ganirelix|mesh-list
101373980|NCT00225433|Hormones|hormones|mesh-ancestor
101373981|NCT00225433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101373982|NCT00225433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373983|NCT00225433|Hormone Antagonists|hormone antagonists|mesh-ancestor
101373984|NCT00095472|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
101373985|NCT00095472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101373986|NCT00095472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373987|NCT02962258|Amlodipine|amlodipine|mesh-list
101373988|NCT02962258|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101373989|NCT02962258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101373990|NCT02962258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101373994|NCT02962258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373996|NCT02962258|Diuretics|diuretics|mesh-ancestor
101312534|NCT00006379|Antimetabolites|antimetabolites|mesh-ancestor
102059724|NCT04992468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102059725|NCT04992468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059726|NCT04975100|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
102059727|NCT04975100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102059728|NCT04975100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101373997|NCT02962258|Natriuretic Agents|natriuretic agents|mesh-ancestor
101373998|NCT02962258|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101374000|NCT00225511|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101374001|NCT00225511|Levomilnacipran|levomilnacipran|mesh-list
101374002|NCT00225511|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101374003|NCT00225511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101374004|NCT00225511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101374005|NCT00225511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374012|NCT00225511|Analgesics|analgesics|mesh-ancestor
101374013|NCT00225511|Sensory System Agents|sensory system agents|mesh-ancestor
101374014|NCT00225511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101374015|NCT00095511|Aripiprazole|aripiprazole|mesh-list
101374016|NCT00095511|Antidepressive Agents|antidepressive agents|mesh-ancestor
101374017|NCT00095511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101374018|NCT00095511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101374019|NCT00095511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101374020|NCT00095511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101374021|NCT00095511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374022|NCT00095511|Dopamine Agonists|dopamine agonists|mesh-ancestor
101374023|NCT00095511|Dopamine Agents|dopamine agents|mesh-ancestor
101374024|NCT00095511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101374025|NCT00095511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374026|NCT00095511|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101374027|NCT00095511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101374028|NCT00095511|Serotonin Agents|serotonin agents|mesh-ancestor
101374029|NCT00095511|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101374030|NCT00095511|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101374031|NCT00095511|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101374032|NCT00095511|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101374033|NCT00225589|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101374034|NCT00225589|Calcium|calcium|mesh-list
101374035|NCT00225589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101374036|NCT00225589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374037|NCT00225589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101304708|NCT02014623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101304709|NCT02014623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304711|NCT02014636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101304712|NCT02014636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101374038|NCT00225589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101374039|NCT00225589|Antimetabolites|antimetabolites|mesh-ancestor
101374040|NCT00225589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374041|NCT00225589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101374042|NCT00225589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101374043|NCT00225589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101374044|NCT02967887|Fluorouracil|fluorouracil|mesh-list
101374045|NCT02967887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101374046|NCT02967887|Antimetabolites|antimetabolites|mesh-ancestor
101374047|NCT02967887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374048|NCT02967887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101374049|NCT02967887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101374050|NCT02967887|Immunologic Factors|immunologic factors|mesh-ancestor
101374051|NCT02967887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374053|NCT00225667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101374054|NCT00225667|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101374055|NCT00225667|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101374056|NCT00225667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059729|NCT04975100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059730|NCT04975100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102059731|NCT04975100|Serotonin Agents|serotonin agents|mesh-ancestor
102059732|NCT04975100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059733|NCT04970342|Alprazolam|alprazolam|mesh-list
101374057|NCT00225706|Ibuprofen|ibuprofen|mesh-list
101374058|NCT00225706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101374075|NCT00225862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101374076|NCT00225862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101374077|NCT00225862|Dopamine Agonists|dopamine agonists|mesh-ancestor
101374078|NCT00225862|Dopamine Agents|dopamine agents|mesh-ancestor
101374079|NCT00225862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101374080|NCT00225862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374081|NCT00225862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374082|NCT00095706|Bevacizumab|bevacizumab|mesh-list
101374083|NCT00095706|Trastuzumab|trastuzumab|mesh-list
101374084|NCT00095706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101374085|NCT00095706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101374086|NCT00095706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101374087|NCT00095706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101374088|NCT00095706|Growth Substances|growth substances|mesh-ancestor
101374089|NCT00095706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374090|NCT00095706|Growth Inhibitors|growth inhibitors|mesh-ancestor
101374091|NCT00225901|Mitogens|mitogens|mesh-list
101374092|NCT00225901|Mitosis Modulators|mitosis modulators|mesh-ancestor
101374093|NCT00225901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374094|NCT00225979|Octreotide|octreotide|mesh-list
101374095|NCT00225979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101374096|NCT00225979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101374097|NCT00225979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101374098|NCT02967731|Mometasone Furoate|mometasone furoate|mesh-list
101374099|NCT02967731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101374100|NCT02967731|Dermatologic Agents|dermatologic agents|mesh-ancestor
101374101|NCT02967731|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101374102|NCT00095745|Aripiprazole|aripiprazole|mesh-list
101374103|NCT00095745|Antidepressive Agents|antidepressive agents|mesh-list
101304713|NCT02014636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101374104|NCT00095745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101374105|NCT00095745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101374106|NCT00095745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101374107|NCT00095745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101374108|NCT00095745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374109|NCT00095745|Dopamine Agonists|dopamine agonists|mesh-ancestor
101374110|NCT00095745|Dopamine Agents|dopamine agents|mesh-ancestor
101374111|NCT00095745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101374112|NCT00095745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374113|NCT00095745|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101374114|NCT00095745|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101374115|NCT00095745|Serotonin Agents|serotonin agents|mesh-ancestor
101374116|NCT00095745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101374117|NCT00095745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101374118|NCT00095745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101374133|NCT00226096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101374134|NCT00226096|Sympatholytics|sympatholytics|mesh-ancestor
101374135|NCT00226096|Autonomic Agents|autonomic agents|mesh-ancestor
101374136|NCT00226096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101374137|NCT00226096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374138|NCT00226096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101374139|NCT00226096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101374140|NCT00226096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101374141|NCT00226096|Adrenergic Agents|adrenergic agents|mesh-ancestor
101374142|NCT00226096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101374143|NCT00226096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374144|NCT00226096|Analgesics|analgesics|mesh-ancestor
101374145|NCT00226096|Sensory System Agents|sensory system agents|mesh-ancestor
101374146|NCT00226096|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101374147|NCT00226096|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102059734|NCT04970342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059736|NCT04970342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102059737|NCT04970342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059738|NCT04970342|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102059739|NCT04970342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102059740|NCT04970342|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102059741|NCT04970342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101361361|NCT00043082|Carboplatin|carboplatin|mesh-list
101374153|NCT00226096|Sympathomimetics|sympathomimetics|mesh-ancestor
101374154|NCT00226096|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101374155|NCT00226096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101374156|NCT00226096|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101374157|NCT00226096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101374158|NCT00226096|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101374159|NCT00226096|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101374160|NCT00226096|Serotonin Agents|serotonin agents|mesh-ancestor
101374161|NCT00226096|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101374162|NCT00226096|Protease Inhibitors|protease inhibitors|mesh-ancestor
101374163|NCT00226096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101374164|NCT00226135|Lamotrigine|lamotrigine|mesh-list
101374165|NCT00226135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101374166|NCT00226135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374167|NCT00226135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101374168|NCT00226135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101374169|NCT00226135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374170|NCT00226135|Anticonvulsants|anticonvulsants|mesh-ancestor
101374171|NCT00226135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101374172|NCT00226135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101374173|NCT00226135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101374174|NCT00226135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101374175|NCT00226135|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101374177|NCT00400374|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101374178|NCT00400374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101374179|NCT00400374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101304714|NCT02014636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304715|NCT02014714|Fentanyl|fentanyl|mesh-list
101304716|NCT02014714|Morphine|morphine|mesh-list
101374180|NCT00400374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101374181|NCT00400374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374182|NCT00400374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101374183|NCT00400374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101374184|NCT00400374|Analgesics|analgesics|mesh-ancestor
101374185|NCT00400374|Sensory System Agents|sensory system agents|mesh-ancestor
101374186|NCT00400374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101374191|NCT00400374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101374192|NCT00226330|Pioglitazone|pioglitazone|mesh-list
101374193|NCT00226330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101374194|NCT00226330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374195|NCT00075426|Arsenic Trioxide|arsenic trioxide|mesh-list
101374196|NCT00075426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101374197|NCT00226408|Interferons|interferons|mesh-list
101374198|NCT00226408|Interferon-alpha|interferon-alpha|mesh-list
101374199|NCT00226408|Interferon alpha-2|interferon alpha-2|mesh-list
101374200|NCT00226408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101374201|NCT00226408|Antiviral Agents|antiviral agents|mesh-ancestor
101374202|NCT00226408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101374203|NCT00226408|Immunologic Factors|immunologic factors|mesh-ancestor
101374204|NCT00226408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374205|NCT00226447|Interferons|interferons|mesh-list
101374206|NCT00226447|Lamivudine|lamivudine|mesh-list
101374207|NCT00226447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101374208|NCT00226447|Antiviral Agents|antiviral agents|mesh-ancestor
101374209|NCT00226447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102059742|NCT04970342|GABA Modulators|gaba modulators|mesh-ancestor
102059743|NCT04970342|GABA Agents|gaba agents|mesh-ancestor
102059744|NCT04959981|Osimertinib|osimertinib|mesh-list
102059745|NCT04959981|Sotorasib|sotorasib|mesh-list
102059746|NCT04959981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102059747|NCT04959981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102059748|NCT04959981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101374210|NCT00226447|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101374211|NCT00226447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101374212|NCT00226447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101374213|NCT00226447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374214|NCT00226447|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101374215|NCT00226447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101374216|NCT00062660|Tipranavir|tipranavir|mesh-list
101374217|NCT00062660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101374243|NCT00095823|Dopamine Agonists|dopamine agonists|mesh-ancestor
101374244|NCT00095823|Dopamine Agents|dopamine agents|mesh-ancestor
101374245|NCT00095823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101374246|NCT00095823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374247|NCT00095823|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101374248|NCT00095823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101374249|NCT00095823|Serotonin Agents|serotonin agents|mesh-ancestor
101374250|NCT00095823|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101374251|NCT00095823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101374252|NCT00095823|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101374253|NCT00095823|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101374254|NCT00226564|Alfentanil|alfentanil|mesh-list
101374255|NCT00226564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101374256|NCT00226564|Narcotics|narcotics|mesh-ancestor
101374257|NCT00226564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101374258|NCT00226564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374259|NCT00226564|Analgesics|analgesics|mesh-ancestor
101374260|NCT00226564|Sensory System Agents|sensory system agents|mesh-ancestor
101374261|NCT00226564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101374262|NCT00226564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101374263|NCT00226564|Anesthetics, General|anesthetics, general|mesh-ancestor
101374264|NCT00226564|Anesthetics|anesthetics|mesh-ancestor
101374265|NCT00062699|Calcitriol|calcitriol|mesh-list
101374266|NCT00062699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101374267|NCT00062699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374268|NCT00062699|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101374285|NCT00399243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101374286|NCT00399243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374287|NCT00399243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374288|NCT00226837|Nitrous Oxide|nitrous oxide|mesh-list
101374289|NCT00226837|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101304717|NCT02014714|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101304718|NCT02014714|Narcotics|narcotics|mesh-ancestor
101304719|NCT02014714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101304720|NCT02014714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374290|NCT00226837|Anesthetics, General|anesthetics, general|mesh-ancestor
101374291|NCT00226837|Anesthetics|anesthetics|mesh-ancestor
101374292|NCT00226837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101374293|NCT00226837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374301|NCT00226915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101374302|NCT00226915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101374303|NCT00226915|Tubulin Modulators|tubulin modulators|mesh-ancestor
101374304|NCT00226915|Antimitotic Agents|antimitotic agents|mesh-ancestor
101374305|NCT00226915|Mitosis Modulators|mitosis modulators|mesh-ancestor
101374306|NCT00226915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374307|NCT00095862|Interferons|interferons|mesh-list
101374308|NCT00095862|Interferon-alpha|interferon-alpha|mesh-list
101374309|NCT00095862|Cyclophosphamide|cyclophosphamide|mesh-list
101374310|NCT00095862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101374311|NCT00095862|Immunologic Factors|immunologic factors|mesh-ancestor
101374312|NCT00095862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374313|NCT00095862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102059749|NCT04959981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059750|NCT04959981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102059751|NCT04959981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102059752|NCT04901377|Dienogest|dienogest|mesh-list
102059753|NCT04901377|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101374314|NCT00095862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101374315|NCT00095862|Alkylating Agents|alkylating agents|mesh-ancestor
101374316|NCT00095862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374317|NCT00095862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101374318|NCT00095862|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101374319|NCT00095862|Antiviral Agents|antiviral agents|mesh-ancestor
101374320|NCT00095862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101374321|NCT00226954|Zoledronic Acid|zoledronic acid|mesh-list
101374322|NCT00226954|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101374323|NCT00226954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374324|NCT00227032|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101374325|NCT00227032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101374326|NCT00227032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101374327|NCT00227032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101374336|NCT00227110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374337|NCT00062894|Tositumomab I-131|tositumomab i-131|mesh-list
101374338|NCT00062894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101374339|NCT00227188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101374340|NCT00227188|Immunologic Factors|immunologic factors|mesh-ancestor
101374341|NCT00227188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374342|NCT00096057|Antibodies|antibodies|mesh-list
101374343|NCT00096057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101374344|NCT00096057|Immunologic Factors|immunologic factors|mesh-ancestor
101374345|NCT00096057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374346|NCT00227461|Levetiracetam|levetiracetam|mesh-list
101374347|NCT00227461|Anticonvulsants|anticonvulsants|mesh-ancestor
101374348|NCT00227461|Nootropic Agents|nootropic agents|mesh-ancestor
101374349|NCT00227500|Pravastatin|pravastatin|mesh-list
101374350|NCT00227500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101374351|NCT00227500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101374352|NCT00227500|Antimetabolites|antimetabolites|mesh-ancestor
101374353|NCT00227500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374354|NCT00227500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101374355|NCT00227500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101374356|NCT00227500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101374357|NCT00096096|Mycophenolic Acid|mycophenolic acid|mesh-list
101374358|NCT00096096|Tacrolimus|tacrolimus|mesh-list
101374359|NCT00096096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101374360|NCT00096096|Immunologic Factors|immunologic factors|mesh-ancestor
101374361|NCT00096096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374362|NCT00096096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101374363|NCT00096096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101304721|NCT02014714|Analgesics|analgesics|mesh-ancestor
101304722|NCT02014714|Sensory System Agents|sensory system agents|mesh-ancestor
101374364|NCT00096096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374365|NCT00096096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101374366|NCT00096096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101374367|NCT00096096|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101374368|NCT00096096|Antitubercular Agents|antitubercular agents|mesh-ancestor
101374389|NCT00227656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101374390|NCT00227656|Antimetabolites|antimetabolites|mesh-ancestor
101374391|NCT00227656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374392|NCT00227656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101374393|NCT00227656|Antiviral Agents|antiviral agents|mesh-ancestor
101374394|NCT00227656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101374413|NCT00063011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374414|NCT00227773|Octreotide|octreotide|mesh-list
101374415|NCT00227773|Hormones|hormones|mesh-list
101374416|NCT00227773|Somatostatin|somatostatin|mesh-list
101374417|NCT00227773|Mitogens|mitogens|mesh-list
101374418|NCT00227773|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101374419|NCT00227773|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101374420|NCT00227773|Vatalanib|vatalanib|mesh-list
101374421|NCT00227773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102059754|NCT04901377|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102059755|NCT04901377|Estradiol|estradiol|mesh-list
102059756|NCT04901377|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102059757|NCT04901377|Estrogens|estrogens|mesh-ancestor
102059758|NCT04901377|Hormones|hormones|mesh-ancestor
102059759|NCT04901377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102059760|NCT04901377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361379|NCT00123916|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101374422|NCT00227773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374424|NCT00227773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374425|NCT00227773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101374426|NCT00227773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101374427|NCT00227773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101374428|NCT00227773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101374429|NCT00227812|Bupropion|bupropion|mesh-list
101374430|NCT00227812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101374431|NCT00227812|Antidepressive Agents|antidepressive agents|mesh-ancestor
101374432|NCT00227812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101374433|NCT00227812|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101374434|NCT00227812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101374435|NCT00227812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101374436|NCT00227812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374437|NCT00227812|Dopamine Agents|dopamine agents|mesh-ancestor
101374438|NCT00227812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101374439|NCT00227812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374440|NCT00227812|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101374441|NCT00227812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101374442|NCT00227812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101374443|NCT00096291|Paclitaxel|paclitaxel|mesh-list
101374479|NCT02962492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374480|NCT02962492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101374481|NCT02962492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374482|NCT02962492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101374484|NCT02962492|Hormones|hormones|mesh-ancestor
101374485|NCT02962492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101374486|NCT00096369|Tamoxifen|tamoxifen|mesh-list
101374487|NCT00096369|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101374488|NCT00096369|Hormone Antagonists|hormone antagonists|mesh-ancestor
101374489|NCT00096369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101374490|NCT00096369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374491|NCT00096369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101374492|NCT00096369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101374493|NCT00096369|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101374494|NCT00096369|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101374495|NCT00096369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101374496|NCT00228007|Antidepressive Agents|antidepressive agents|mesh-list
101374497|NCT00228007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101374498|NCT00228046|Valproic Acid|valproic acid|mesh-list
101374499|NCT00228046|Methylphenidate|methylphenidate|mesh-list
101374500|NCT00228046|Amphetamine|amphetamine|mesh-list
101374501|NCT00228046|Dextroamphetamine|dextroamphetamine|mesh-list
101374502|NCT00228046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101374503|NCT00228046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374504|NCT00228046|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101374505|NCT00228046|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101374506|NCT00228046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101374507|NCT00228046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374508|NCT00228046|Dopamine Agents|dopamine agents|mesh-ancestor
101374509|NCT00228046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101374510|NCT00228046|Sympathomimetics|sympathomimetics|mesh-ancestor
101374511|NCT00228046|Autonomic Agents|autonomic agents|mesh-ancestor
101374534|NCT00228163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101374535|NCT00228163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374537|NCT00228163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102059761|NCT04901377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102059762|NCT04901377|Contraceptive Agents|contraceptive agents|mesh-ancestor
102059763|NCT04901377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102059764|NCT04901377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102059765|NCT04901377|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101374538|NCT00228163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101374539|NCT00228163|Immunologic Factors|immunologic factors|mesh-ancestor
101374540|NCT00063128|Insulin|insulin|mesh-list
101374541|NCT00063128|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101374542|NCT00063128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101374543|NCT00063128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374544|NCT00075465|Docetaxel|docetaxel|mesh-list
101374545|NCT00075465|Epirubicin|epirubicin|mesh-list
101374546|NCT00075465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101374547|NCT00075465|Tubulin Modulators|tubulin modulators|mesh-ancestor
101374548|NCT00075465|Antimitotic Agents|antimitotic agents|mesh-ancestor
101374549|NCT00075465|Mitosis Modulators|mitosis modulators|mesh-ancestor
101374550|NCT00075465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374551|NCT00075465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101374552|NCT00075465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101374553|NCT00075465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101374554|NCT00075465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101374555|NCT00228319|Vitamins|vitamins|mesh-list
101374556|NCT00228319|Ascorbic Acid|ascorbic acid|mesh-list
101374557|NCT00228319|Vitamin E|vitamin e|mesh-list
101374558|NCT00228319|Vitamin A|vitamin a|mesh-list
101374559|NCT00228319|Carboplatin|carboplatin|mesh-list
101374560|NCT00228319|Carotenoids|carotenoids|mesh-list
101374561|NCT00228319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101374562|NCT00228319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374563|NCT00228319|Micronutrients|micronutrients|mesh-ancestor
101374564|NCT00228319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374565|NCT00228319|Antioxidants|antioxidants|mesh-ancestor
101374566|NCT00228319|Protective Agents|protective agents|mesh-ancestor
101374567|NCT00096525|Lenalidomide|lenalidomide|mesh-list
101374568|NCT00096525|Immunologic Factors|immunologic factors|mesh-ancestor
101374569|NCT00096525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374570|NCT00096525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101374571|NCT00096525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101374572|NCT00096525|Growth Substances|growth substances|mesh-ancestor
101374573|NCT00096525|Growth Inhibitors|growth inhibitors|mesh-ancestor
101374576|NCT00228358|Interleukin-2|interleukin-2|mesh-list
101374577|NCT00228358|Denileukin diftitox|denileukin diftitox|mesh-list
101374578|NCT00228358|Immunotoxins|immunotoxins|mesh-list
101374579|NCT00228358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101374580|NCT00228358|Immunologic Factors|immunologic factors|mesh-ancestor
101374581|NCT00228358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374582|NCT00228358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101374583|NCT00228358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101374584|NCT00228358|Alkylating Agents|alkylating agents|mesh-ancestor
101374585|NCT00228358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374586|NCT00228358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101374587|NCT00228358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101374588|NCT00228358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101374589|NCT00228358|Analgesics|analgesics|mesh-ancestor
101374590|NCT00228358|Sensory System Agents|sensory system agents|mesh-ancestor
101374591|NCT00228358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101374592|NCT00228358|Immunoconjugates|immunoconjugates|mesh-ancestor
101374593|NCT00228397|Temsirolimus|temsirolimus|mesh-list
101374594|NCT00228397|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101374595|NCT00228397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101374596|NCT00228397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101374597|NCT00228397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374598|NCT00228397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101374599|NCT00228397|Immunologic Factors|immunologic factors|mesh-ancestor
101374600|NCT00228397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374601|NCT00228397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101374602|NCT00075543|Docetaxel|docetaxel|mesh-list
101374603|NCT00075543|Oxaliplatin|oxaliplatin|mesh-list
101374604|NCT00075543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101374609|NCT00228475|Budesonide|budesonide|mesh-list
101374610|NCT00228475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102059766|NCT04901377|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102059767|NCT04901377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102059768|NCT04901377|Hormone Antagonists|hormone antagonists|mesh-ancestor
102059769|NCT04901377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102059770|NCT04901377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102059771|NCT04881240|Cyclophosphamide|cyclophosphamide|mesh-list
102059772|NCT04881240|Fludarabine|fludarabine|mesh-list
102059773|NCT04881240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101361396|NCT02970539|Paclitaxel|paclitaxel|mesh-list
101374611|NCT00228475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101374612|NCT00228475|Autonomic Agents|autonomic agents|mesh-ancestor
101374613|NCT00228475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101374614|NCT00228475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374615|NCT00228475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101374616|NCT00228475|Respiratory System Agents|respiratory system agents|mesh-ancestor
101374617|NCT00228475|Glucocorticoids|glucocorticoids|mesh-ancestor
101374618|NCT00228475|Hormones|hormones|mesh-ancestor
101374619|NCT00228475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101374620|NCT00228514|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101374621|NCT00228514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101374622|NCT00228514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101374623|NCT00228514|Antimetabolites|antimetabolites|mesh-ancestor
101374624|NCT00228514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374625|NCT00228514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101374626|NCT00228514|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101374627|NCT00228514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101374628|NCT00228592|Immunoglobulins|immunoglobulins|mesh-list
101374629|NCT00228592|Antibodies|antibodies|mesh-list
101374630|NCT00228592|gamma-Globulins|gamma-globulins|mesh-list
101374631|NCT00228592|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101374632|NCT00228592|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101374633|NCT00228592|Immunologic Factors|immunologic factors|mesh-ancestor
101374634|NCT00228592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374635|NCT00075621|Melphalan|melphalan|mesh-list
101374636|NCT00075621|Immunologic Factors|immunologic factors|mesh-ancestor
101304723|NCT02014714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101374637|NCT00075621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374638|NCT00075621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101374639|NCT00075621|Alkylating Agents|alkylating agents|mesh-ancestor
101374640|NCT00075621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374641|NCT00075621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101374642|NCT00075621|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101312700|NCT00008190|Busulfan|busulfan|mesh-list
101374643|NCT00075621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101374644|NCT00228865|Insulin|insulin|mesh-list
101374645|NCT00228865|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101374646|NCT00228865|Insulin, Isophane|insulin, isophane|mesh-list
101374647|NCT00228865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101374669|NCT00229138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374671|NCT00063323|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101374672|NCT00063323|Antidepressive Agents|antidepressive agents|mesh-ancestor
101374673|NCT00063323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101374674|NCT00063323|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101374675|NCT00063323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101374676|NCT00063323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101374677|NCT00063323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374678|NCT00063323|Dopamine Agents|dopamine agents|mesh-ancestor
101374679|NCT00063323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101374680|NCT00063323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374681|NCT00063323|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101374682|NCT00063323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101374683|NCT00063323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101374684|NCT00229216|Tinidazole|tinidazole|mesh-list
101374685|NCT00229216|Alkylating Agents|alkylating agents|mesh-ancestor
101374686|NCT00229216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374687|NCT00229216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102059775|NCT04881240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059776|NCT04881240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102059777|NCT04881240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102059778|NCT04881240|Alkylating Agents|alkylating agents|mesh-ancestor
102059779|NCT04881240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059780|NCT04881240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102059781|NCT04881240|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102059782|NCT04876248|Lenalidomide|lenalidomide|mesh-list
102059783|NCT04876248|Immunologic Factors|immunologic factors|mesh-ancestor
101374688|NCT00229216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101374689|NCT00229216|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
101374690|NCT00229216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101374691|NCT00229216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101374692|NCT02967653|Atorvastatin|atorvastatin|mesh-list
101374693|NCT02967653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101374694|NCT02967653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101374750|NCT00229567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101374751|NCT00229567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101374752|NCT00229567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374753|NCT00229567|Analgesics|analgesics|mesh-ancestor
101374754|NCT00229567|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101374755|NCT00229567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101374756|NCT00229567|Anesthetics, General|anesthetics, general|mesh-ancestor
101374757|NCT00229567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101374758|NCT00229567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101374759|NCT00229567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101374760|NCT00229645|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101374761|NCT00229645|Antidepressive Agents|antidepressive agents|mesh-ancestor
101374762|NCT00229645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101374763|NCT00229645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101374764|NCT00229645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101374765|NCT00229645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101374766|NCT00229645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374767|NCT02967341|Ciprofloxacin|ciprofloxacin|mesh-list
101374768|NCT02967341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101374772|NCT02967341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101374773|NCT02967341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374774|NCT02967341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101374775|NCT02967341|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101374776|NCT02967341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101374777|NCT00229684|Pioglitazone|pioglitazone|mesh-list
101374778|NCT00229684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101374779|NCT00229684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374780|NCT00096720|Levodopa|levodopa|mesh-list
101374781|NCT00096720|Pramipexole|pramipexole|mesh-list
101374782|NCT00096720|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101374783|NCT00096720|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101374784|NCT00096720|Dopamine Agents|dopamine agents|mesh-ancestor
101374785|NCT00096720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101374786|NCT00096720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374787|NCT00096720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374794|NCT00413608|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101374796|NCT00413608|Purinergic Agents|purinergic agents|mesh-ancestor
101374797|NCT00413608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101374798|NCT00413608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374799|NCT00413608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374801|NCT00229918|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101374802|NCT00229918|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101374803|NCT00229918|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101374804|NCT00229918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101374805|NCT00229918|Glucocorticoids|glucocorticoids|mesh-ancestor
101374806|NCT00229918|Hormones|hormones|mesh-ancestor
102059784|NCT04876248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059785|NCT04876248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102059786|NCT04876248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102059787|NCT04876248|Growth Substances|growth substances|mesh-ancestor
102059788|NCT04876248|Growth Inhibitors|growth inhibitors|mesh-ancestor
102059789|NCT04876248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102059790|NCT04847557|Tirzepatide|tirzepatide|mesh-list
102059791|NCT04847557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102059792|NCT04847557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059793|NCT04847557|Incretins|incretins|mesh-ancestor
102059794|NCT04847557|Hormones|hormones|mesh-ancestor
101304726|NCT02014714|Anesthetics, General|anesthetics, general|mesh-ancestor
101304727|NCT02014714|Anesthetics|anesthetics|mesh-ancestor
101304728|NCT02014727|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101374807|NCT00229918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101374808|NCT00229918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374809|NCT00229918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101374810|NCT00229918|Immunologic Factors|immunologic factors|mesh-ancestor
101374811|NCT00229918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101374812|NCT00229918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374813|NCT00096798|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
101374814|NCT00096798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101374815|NCT00096798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101374816|NCT00229996|Leuprolide|leuprolide|mesh-list
101374817|NCT00229996|Norethindrone|norethindrone|mesh-list
101374818|NCT00229996|Norethindrone Acetate|norethindrone acetate|mesh-list
101374819|NCT00229996|Contraceptive Agents|contraceptive agents|mesh-list
101374820|NCT00229996|Contraceptives, Oral|contraceptives, oral|mesh-list
101374821|NCT00229996|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101374822|NCT00229996|Fertility Agents|fertility agents|mesh-ancestor
101374823|NCT00229996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101374824|NCT00229996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374825|NCT00229996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101374826|NCT00229996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101374827|NCT00229996|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101374828|NCT00229996|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101374829|NCT00229996|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101374830|NCT00229996|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101374831|NCT00230035|Mycophenolic Acid|mycophenolic acid|mesh-list
101374832|NCT00230035|Methylprednisolone|methylprednisolone|mesh-list
101374833|NCT00230035|Rituximab|rituximab|mesh-list
101374834|NCT00230035|Methotrexate|methotrexate|mesh-list
101374835|NCT00230035|Azathioprine|azathioprine|mesh-list
101374836|NCT00230035|Immunoglobulins|immunoglobulins|mesh-list
101374837|NCT00230035|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101374838|NCT00230035|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101374839|NCT00230035|gamma-Globulins|gamma-globulins|mesh-list
101374840|NCT00230035|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101374841|NCT00230035|Leflunomide|leflunomide|mesh-list
101374848|NCT00230035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101374849|NCT00230035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101374850|NCT00230035|Abortifacient Agents|abortifacient agents|mesh-ancestor
101374851|NCT00230035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101374852|NCT00230035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101374853|NCT00230035|Antimetabolites|antimetabolites|mesh-ancestor
101374854|NCT00230035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374855|NCT00230035|Dermatologic Agents|dermatologic agents|mesh-ancestor
101374856|NCT00230035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101374857|NCT00230035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101374858|NCT00230035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101374859|NCT00230035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101374877|NCT00063401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101374878|NCT00063401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101374879|NCT00063401|Tubulin Modulators|tubulin modulators|mesh-ancestor
102059795|NCT04847557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102059797|NCT04795245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102059798|NCT04795245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102059799|NCT04795245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102059800|NCT04795245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059801|NCT04742101|Azacitidine|azacitidine|mesh-list
102059802|NCT04742101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102059803|NCT04742101|Antimetabolites|antimetabolites|mesh-ancestor
101374880|NCT00063401|Antimitotic Agents|antimitotic agents|mesh-ancestor
101374881|NCT00063401|Mitosis Modulators|mitosis modulators|mesh-ancestor
101304729|NCT02014727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101304730|NCT02014727|Immunologic Factors|immunologic factors|mesh-ancestor
101304731|NCT02014727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304732|NCT02014727|Antacids|antacids|mesh-ancestor
101304733|NCT02014727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304734|NCT02014727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101304735|NCT02014753|Cobalt|cobalt|mesh-list
101304736|NCT02014753|Chromium|chromium|mesh-list
101304737|NCT02014753|Everolimus|everolimus|mesh-list
101304738|NCT02014753|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101304739|NCT02014753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101304740|NCT02014753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101304741|NCT02014753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304742|NCT02014753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101304743|NCT02014753|Immunologic Factors|immunologic factors|mesh-ancestor
101387717|NCT00323206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101374882|NCT00063401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374883|NCT00063401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101374884|NCT00096837|Motexafin gadolinium|motexafin gadolinium|mesh-list
101374885|NCT00096837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101374886|NCT00096837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101374887|NCT00096837|Dermatologic Agents|dermatologic agents|mesh-ancestor
101374888|NCT00230464|Vildagliptin|vildagliptin|mesh-list
101374889|NCT00230464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101374890|NCT00230464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374891|NCT00230464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101374892|NCT00230464|Protease Inhibitors|protease inhibitors|mesh-ancestor
101374893|NCT00230464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101374894|NCT00230464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374895|NCT00096915|Darbepoetin alfa|darbepoetin alfa|mesh-list
101374896|NCT00096915|Hematinics|hematinics|mesh-ancestor
101374897|NCT00230503|Adefovir|adefovir|mesh-list
101374898|NCT00230503|Pradefovir|pradefovir|mesh-list
101374899|NCT00230503|Antiviral Agents|antiviral agents|mesh-ancestor
101374900|NCT00230503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101374901|NCT00230503|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101374902|NCT00230503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101374903|NCT00230503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101374904|NCT00230503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374905|NCT00230503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101374906|NCT00424723|Pemetrexed|pemetrexed|mesh-list
101374907|NCT00424723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101374929|NCT00097032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101374930|NCT00097032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101374931|NCT00097032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101374932|NCT00097032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101374933|NCT00097032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101374934|NCT00097032|Dopamine Agents|dopamine agents|mesh-ancestor
101374935|NCT00097032|Antidepressive Agents|antidepressive agents|mesh-ancestor
101374936|NCT02962336|Amlodipine|amlodipine|mesh-list
101374937|NCT02962336|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101374938|NCT02962336|Olmesartan|olmesartan|mesh-list
101374939|NCT02962336|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101374940|NCT02962336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101374941|NCT02962336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101374942|NCT02962336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102059804|NCT04742101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059805|NCT04742101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102059806|NCT04742101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102059808|NCT04738422|Glycine Agents|glycine agents|mesh-ancestor
102059809|NCT04738422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102059810|NCT04738422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361425|NCT00124150|Magnesium Sulfate|magnesium sulfate|mesh-list
101456549|NCT00245115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101304744|NCT02014753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304745|NCT02014753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101374943|NCT02962336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374944|NCT02962336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101374945|NCT02962336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312768|NCT00008229|Melphalan|melphalan|mesh-list
101374946|NCT02962336|Vasodilator Agents|vasodilator agents|mesh-ancestor
101374947|NCT02962336|Diuretics|diuretics|mesh-ancestor
101374948|NCT02962336|Natriuretic Agents|natriuretic agents|mesh-ancestor
101374949|NCT02962336|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101374950|NCT02962336|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101374951|NCT02962336|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101374952|NCT00075738|Leucovorin|leucovorin|mesh-list
101374953|NCT00075738|Fluorouracil|fluorouracil|mesh-list
101374954|NCT00075738|Irinotecan|irinotecan|mesh-list
101374955|NCT00075738|Calcium|calcium|mesh-list
101374956|NCT00075738|Levoleucovorin|levoleucovorin|mesh-list
101374957|NCT00075738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101374958|NCT00075738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101374959|NCT00075738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374960|NCT00075738|Antimetabolites|antimetabolites|mesh-ancestor
101374961|NCT00075738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374962|NCT00075738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101374963|NCT00075738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101374964|NCT00075738|Immunologic Factors|immunologic factors|mesh-ancestor
101374965|NCT00075738|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101374966|NCT00075738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101374967|NCT00075738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101374968|NCT00075738|Antidotes|antidotes|mesh-ancestor
101374969|NCT00075738|Protective Agents|protective agents|mesh-ancestor
101374975|NCT00230698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101374976|NCT00230698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374977|NCT00230776|Pregabalin|pregabalin|mesh-list
101374978|NCT00230776|Analgesics|analgesics|mesh-ancestor
101374979|NCT00230776|Sensory System Agents|sensory system agents|mesh-ancestor
101374980|NCT00230776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101374981|NCT00230776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374982|NCT00230776|Anticonvulsants|anticonvulsants|mesh-ancestor
101374983|NCT00230776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101374984|NCT00230776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101374985|NCT00230776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374986|NCT00230776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101374987|NCT00230776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101374988|NCT00230776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101374989|NCT00230776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101374990|NCT00230776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101374991|NCT00075777|Valproic Acid|valproic acid|mesh-list
101374992|NCT00075777|Anticonvulsants|anticonvulsants|mesh-ancestor
101374993|NCT00075777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101374997|NCT00075777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374998|NCT00075777|Antimanic Agents|antimanic agents|mesh-ancestor
101374999|NCT00075777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101375000|NCT00075777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101375001|NCT00075777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101375002|NCT02967614|Timolol|timolol|mesh-list
101375003|NCT02967614|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101375004|NCT02967614|Dorzolamide|dorzolamide|mesh-list
101375005|NCT02967614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102059811|NCT04738422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059812|NCT04729114|Dexamethasone|dexamethasone|mesh-list
102059813|NCT04729114|Prednisone|prednisone|mesh-list
102059814|NCT04729114|Docetaxel|docetaxel|mesh-list
102059815|NCT04729114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102059816|NCT04729114|Antiemetics|antiemetics|mesh-ancestor
102059817|NCT04729114|Autonomic Agents|autonomic agents|mesh-ancestor
102059818|NCT04729114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102059819|NCT04729114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059820|NCT04729114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102059821|NCT04729114|Glucocorticoids|glucocorticoids|mesh-ancestor
102059822|NCT04729114|Hormones|hormones|mesh-ancestor
102059823|NCT04729114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102059824|NCT04729114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102059825|NCT04729114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102059826|NCT04729114|Tubulin Modulators|tubulin modulators|mesh-ancestor
101361433|NCT00124150|Anticonvulsants|anticonvulsants|mesh-ancestor
101375006|NCT02967614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101375007|NCT02967614|Adrenergic Agents|adrenergic agents|mesh-ancestor
101375008|NCT02967614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101375009|NCT02967614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375010|NCT02967614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375011|NCT02967614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101375012|NCT02967614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101375013|NCT02967614|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101375014|NCT02967614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101375015|NCT02967614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101375016|NCT02967614|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101375017|NCT02967614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101304747|NCT02014753|Micronutrients|micronutrients|mesh-ancestor
101304748|NCT02014831|Cetuximab|cetuximab|mesh-list
101304749|NCT02014831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101304750|NCT02014831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101304751|NCT02014922|Vitamin E|vitamin e|mesh-list
101375018|NCT00230815|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101375019|NCT00230815|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101375020|NCT00230815|Hormones|hormones|mesh-ancestor
101375021|NCT00230815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101375022|NCT00230815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375023|NCT00230815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101375024|NCT00097071|Insulin|insulin|mesh-list
101375025|NCT00097071|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101375026|NCT00097071|Insulin Aspart|insulin aspart|mesh-list
101375027|NCT00097071|Insulin Lispro|insulin lispro|mesh-list
101375028|NCT00097071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101375029|NCT00097071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375030|NCT02967380|Pentetic Acid|pentetic acid|mesh-list
101375031|NCT02967380|Antidotes|antidotes|mesh-ancestor
101375032|NCT02967380|Protective Agents|protective agents|mesh-ancestor
101375033|NCT02967380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375034|NCT02967380|Chelating Agents|chelating agents|mesh-ancestor
101375035|NCT02967380|Sequestering Agents|sequestering agents|mesh-ancestor
101375036|NCT02967380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375037|NCT02967380|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101375038|NCT00075855|Testosterone|testosterone|mesh-list
101375039|NCT00075855|Androgens|androgens|mesh-ancestor
101375040|NCT00075855|Hormones|hormones|mesh-ancestor
101312810|NCT00008307|Fludarabine phosphate|fludarabine phosphate|mesh-list
101375041|NCT00075855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101375047|NCT00231244|Sirolimus|sirolimus|mesh-list
102059827|NCT04729114|Antimitotic Agents|antimitotic agents|mesh-ancestor
102059828|NCT04729114|Mitosis Modulators|mitosis modulators|mesh-ancestor
102059829|NCT04729114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059830|NCT04704999|Chloroquine|chloroquine|mesh-list
102059831|NCT04704999|Lumefantrine|lumefantrine|mesh-list
102059832|NCT04704999|Artemether|artemether|mesh-list
102059833|NCT04704999|Tafenoquine|tafenoquine|mesh-list
102059834|NCT04704999|Amebicides|amebicides|mesh-ancestor
102059835|NCT04704999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102059836|NCT04704999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102059837|NCT04704999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102059839|NCT04704999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102059840|NCT04679402|Carbon Monoxide|carbon monoxide|mesh-list
102059841|NCT04679402|Antimetabolites|antimetabolites|mesh-ancestor
102059842|NCT04679402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059843|NCT04679402|Gasotransmitters|gasotransmitters|mesh-ancestor
102059844|NCT04679402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102059845|NCT04679402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361449|NCT02958046|Autonomic Agents|autonomic agents|mesh-ancestor
101375048|NCT00231244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101375049|NCT00231244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101375050|NCT00231244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101375051|NCT00231244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101375052|NCT00231244|Antifungal Agents|antifungal agents|mesh-ancestor
101375053|NCT00231244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101375054|NCT00231244|Immunologic Factors|immunologic factors|mesh-ancestor
101375055|NCT00231244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375056|NCT00231322|Praziquantel|praziquantel|mesh-list
101375057|NCT00231322|Anthelmintics|anthelmintics|mesh-ancestor
101375058|NCT00231322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101375059|NCT00231322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101375060|NCT00231517|Morphine|morphine|mesh-list
101375061|NCT00231517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101375062|NCT00231517|Narcotics|narcotics|mesh-ancestor
101375063|NCT00231517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101375064|NCT00231517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375065|NCT00231517|Analgesics|analgesics|mesh-ancestor
101375066|NCT00231517|Sensory System Agents|sensory system agents|mesh-ancestor
101375099|NCT00231829|Analgesics|analgesics|mesh-ancestor
101375100|NCT00231829|Sensory System Agents|sensory system agents|mesh-ancestor
101375101|NCT00231829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101375102|NCT00231829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375103|NCT00231829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101375104|NCT00231829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101375105|NCT00231829|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101375106|NCT00231829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101375107|NCT00231829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101375108|NCT00231829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375109|NCT00075933|Beta-lapachone|beta-lapachone|mesh-list
101375143|NCT00097227|Carboplatin|carboplatin|mesh-list
101375144|NCT00097227|Cetuximab|cetuximab|mesh-list
102059857|NCT04654507|Dexamethasone|dexamethasone|mesh-list
102059858|NCT04654507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102059859|NCT04654507|Antiemetics|antiemetics|mesh-ancestor
102059860|NCT04654507|Autonomic Agents|autonomic agents|mesh-ancestor
102059861|NCT04654507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102059862|NCT04654507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375145|NCT00097227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101375146|NCT00097227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101375147|NCT00097227|Tubulin Modulators|tubulin modulators|mesh-ancestor
101375148|NCT00097227|Antimitotic Agents|antimitotic agents|mesh-ancestor
101375149|NCT00097227|Mitosis Modulators|mitosis modulators|mesh-ancestor
101375150|NCT00097227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375151|NCT00097227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101375152|NCT00232336|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101375153|NCT00232336|Antidepressive Agents|antidepressive agents|mesh-ancestor
101375154|NCT00232336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101375155|NCT00232336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101375156|NCT00232336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101375157|NCT00232336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101375158|NCT00232336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375159|NCT00232375|Insulin|insulin|mesh-list
101375160|NCT00232375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101375161|NCT00232375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375162|NCT00063791|Bortezomib|bortezomib|mesh-list
101375172|NCT00232492|Analgesics|analgesics|mesh-ancestor
101375173|NCT00232492|Sensory System Agents|sensory system agents|mesh-ancestor
101375174|NCT00232492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101375175|NCT00232492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375176|NCT00232492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101375177|NCT00232492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101375178|NCT00232492|Anesthetics, General|anesthetics, general|mesh-ancestor
101375179|NCT00232492|Anesthetics|anesthetics|mesh-ancestor
101375180|NCT00232492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101375181|NCT00232492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101375182|NCT00232492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101375183|NCT00232492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101375184|NCT00232492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375185|NCT00075972|Nicotine|nicotine|mesh-list
101375186|NCT00075972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101375187|NCT00075972|Autonomic Agents|autonomic agents|mesh-ancestor
101375188|NCT00075972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101375189|NCT00075972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375190|NCT00075972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101375191|NCT00075972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101375192|NCT00075972|Cholinergic Agents|cholinergic agents|mesh-ancestor
101375193|NCT00075972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101375194|NCT00075972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375195|NCT00063869|Etanercept|etanercept|mesh-list
101456550|NCT04662385|Listerine|listerine|mesh-list
101304754|NCT02014922|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101304755|NCT02014922|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101304756|NCT02014922|Lubricant Eye Drops|lubricant eye drops|mesh-list
101304757|NCT02014922|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101304758|NCT02014922|Laxatives|laxatives|mesh-ancestor
101375196|NCT00063869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101375197|NCT00063869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101375198|NCT00063869|Analgesics|analgesics|mesh-ancestor
101375199|NCT00063869|Sensory System Agents|sensory system agents|mesh-ancestor
101375200|NCT00063869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101375201|NCT00063869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375202|NCT00063869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101375203|NCT00063869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101375204|NCT00063869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101375205|NCT00063869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102059863|NCT04654507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102059864|NCT04654507|Glucocorticoids|glucocorticoids|mesh-ancestor
102059865|NCT04654507|Hormones|hormones|mesh-ancestor
102059866|NCT04654507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102059867|NCT04654507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102059868|NCT04654507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102059869|NCT04646655|Enoxaparin|enoxaparin|mesh-list
101375206|NCT00063869|Immunologic Factors|immunologic factors|mesh-ancestor
101375207|NCT00232531|Niacin|niacin|mesh-list
101375208|NCT00232531|Nicotinic Acids|nicotinic acids|mesh-list
101375214|NCT00232531|Vitamin B Complex|vitamin b complex|mesh-ancestor
101375215|NCT00232531|Vitamins|vitamins|mesh-ancestor
101375216|NCT00232531|Micronutrients|micronutrients|mesh-ancestor
101375217|NCT00232531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375218|NCT00232570|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101375219|NCT00232570|Antidepressive Agents|antidepressive agents|mesh-ancestor
101375220|NCT00232570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101375221|NCT00232570|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101375222|NCT00232570|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101375223|NCT00232570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101375224|NCT00232570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375225|NCT00097266|Haloperidol|haloperidol|mesh-list
101375226|NCT00097266|Aripiprazole|aripiprazole|mesh-list
101375227|NCT00097266|Haloperidol decanoate|haloperidol decanoate|mesh-list
101375228|NCT00097266|Antidepressive Agents|antidepressive agents|mesh-ancestor
101375229|NCT00097266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101375234|NCT00097266|Dopamine Agonists|dopamine agonists|mesh-ancestor
101375235|NCT00097266|Dopamine Agents|dopamine agents|mesh-ancestor
101375236|NCT00097266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101375237|NCT00097266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375238|NCT00097266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101375239|NCT00097266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101375240|NCT00097266|Serotonin Agents|serotonin agents|mesh-ancestor
101375241|NCT00097266|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101375242|NCT00097266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101375243|NCT00097266|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101375244|NCT00097266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101375245|NCT00097266|Antiemetics|antiemetics|mesh-ancestor
101375246|NCT00097266|Autonomic Agents|autonomic agents|mesh-ancestor
101375247|NCT00097266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101375248|NCT00097266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101375249|NCT00097266|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101375250|NCT00063947|Gemcitabine|gemcitabine|mesh-list
101375251|NCT00063947|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101375252|NCT00063947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101375253|NCT00063947|Antimetabolites|antimetabolites|mesh-ancestor
101375254|NCT00063947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375255|NCT00063947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101375256|NCT00063947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101375257|NCT00063947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101375258|NCT00232648|Budesonide|budesonide|mesh-list
101375259|NCT00232648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101375260|NCT00232648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101375261|NCT00232648|Autonomic Agents|autonomic agents|mesh-ancestor
101375262|NCT00232648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101375263|NCT00232648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375264|NCT00232648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101375265|NCT00232648|Respiratory System Agents|respiratory system agents|mesh-ancestor
101304759|NCT02014922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101304760|NCT02014922|Antioxidants|antioxidants|mesh-ancestor
101304761|NCT02014922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304762|NCT02014922|Protective Agents|protective agents|mesh-ancestor
101304763|NCT02014922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304764|NCT02014922|Vitamins|vitamins|mesh-ancestor
101375266|NCT00232648|Glucocorticoids|glucocorticoids|mesh-ancestor
101375267|NCT00232648|Hormones|hormones|mesh-ancestor
101375268|NCT00232648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101375269|NCT00232687|Aripiprazole|aripiprazole|mesh-list
102059870|NCT04646655|Anticoagulants|anticoagulants|mesh-ancestor
102059871|NCT04646655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102059872|NCT04646655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101312895|NCT00006493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102059873|NCT04646655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059874|NCT04645550|Aspirin|aspirin|mesh-list
102059875|NCT04645550|Heparin|heparin|mesh-list
101375270|NCT00232687|Antidepressive Agents|antidepressive agents|mesh-ancestor
101375271|NCT00232687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101375272|NCT00232687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101375273|NCT00232687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101375274|NCT00232687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101375275|NCT00232687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375276|NCT00232687|Dopamine Agonists|dopamine agonists|mesh-ancestor
101375295|NCT00232765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375296|NCT02958566|Acetaminophen|acetaminophen|mesh-list
101375297|NCT02958566|Ketorolac|ketorolac|mesh-list
101375298|NCT02958566|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
101375299|NCT02958566|Lidocaine|lidocaine|mesh-list
101375328|NCT02958566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101375329|NCT02958566|Narcotics|narcotics|mesh-ancestor
101375330|NCT02958566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101375331|NCT02958566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101375332|NCT02958566|Antipyretics|antipyretics|mesh-ancestor
101375333|NCT02958566|Anticonvulsants|anticonvulsants|mesh-ancestor
101375334|NCT02958566|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101375335|NCT02958566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101375336|NCT02958566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101375337|NCT02958566|Antimanic Agents|antimanic agents|mesh-ancestor
101375338|NCT02958566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101375339|NCT02958566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101375340|NCT02958566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101375341|NCT02958566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101375342|NCT02958566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101375343|NCT02958566|Antitussive Agents|antitussive agents|mesh-ancestor
101375344|NCT02958566|Respiratory System Agents|respiratory system agents|mesh-ancestor
101375345|NCT02958566|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101375346|NCT02958566|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101375347|NCT02958566|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101375348|NCT02958566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101375349|NCT02958566|Parasympatholytics|parasympatholytics|mesh-ancestor
101375415|NCT00097383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101375416|NCT00097383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101375417|NCT00097383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375418|NCT00233155|Capsaicin|capsaicin|mesh-list
101375419|NCT00233155|Antipruritics|antipruritics|mesh-ancestor
101375420|NCT00233155|Dermatologic Agents|dermatologic agents|mesh-ancestor
101375421|NCT00233155|Sensory System Agents|sensory system agents|mesh-ancestor
101375422|NCT00233155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101304766|NCT02015156|Trastuzumab|trastuzumab|mesh-list
101375423|NCT00233155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375424|NCT00064142|Halofuginone|halofuginone|mesh-list
101378010|NCT00250042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101378011|NCT00250042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101378012|NCT00250042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378014|NCT00068315|Fludarabine|fludarabine|mesh-list
101378015|NCT00068315|Fludarabine phosphate|fludarabine phosphate|mesh-list
101378016|NCT00068315|Bortezomib|bortezomib|mesh-list
101378017|NCT00068315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101378018|NCT00068315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378019|NCT00068315|Immunologic Factors|immunologic factors|mesh-ancestor
101378020|NCT00068315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378021|NCT00068315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101378022|NCT00068315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101378023|NCT00068315|Antimetabolites|antimetabolites|mesh-ancestor
101378024|NCT00068315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378025|NCT00068315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101378026|NCT00250081|Botulinum Toxins|botulinum toxins|mesh-list
101378027|NCT00250081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101378028|NCT00250081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102059877|NCT04645550|Tinzaparin|tinzaparin|mesh-list
102059878|NCT04645550|Dalteparin|dalteparin|mesh-list
102059879|NCT04645550|Dipyridamole|dipyridamole|mesh-list
102059880|NCT04645550|Warfarin|warfarin|mesh-list
102059881|NCT04645550|Apixaban|apixaban|mesh-list
102059882|NCT04645550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102059883|NCT04645550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102059884|NCT04645550|Analgesics|analgesics|mesh-ancestor
102059885|NCT04645550|Sensory System Agents|sensory system agents|mesh-ancestor
102059886|NCT04645550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101378029|NCT00250081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378030|NCT00250081|Cholinergic Agents|cholinergic agents|mesh-ancestor
101378031|NCT00250081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101378032|NCT00250081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378033|NCT00250120|Camptothecin|camptothecin|mesh-list
101378034|NCT00250120|Rubitecan|rubitecan|mesh-list
101378035|NCT00250120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101378036|NCT00250120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378037|NCT00250120|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101378038|NCT00250120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101378039|NCT00250120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101378040|NCT00250120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378041|NCT04720573|Neostigmine|neostigmine|mesh-list
101378042|NCT04720573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101378043|NCT04720573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101378044|NCT04720573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378045|NCT04720573|Cholinergic Agents|cholinergic agents|mesh-ancestor
101378046|NCT04720573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101378047|NCT04720573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378048|NCT04720573|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101378049|NCT04720573|Autonomic Agents|autonomic agents|mesh-ancestor
101378072|NCT00250237|Haloperidol decanoate|haloperidol decanoate|mesh-list
101378073|NCT00250237|Antiemetics|antiemetics|mesh-ancestor
101378074|NCT00250237|Autonomic Agents|autonomic agents|mesh-ancestor
101378075|NCT00250237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101378076|NCT00250237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378077|NCT00250237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101378078|NCT00250237|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101378079|NCT00250237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101378080|NCT00250237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101378081|NCT00250237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101378082|NCT00250237|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101378083|NCT00250237|Dopamine Agents|dopamine agents|mesh-ancestor
101378084|NCT00250237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101378085|NCT00250237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378086|NCT00250237|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101378087|NCT00099957|Vildagliptin|vildagliptin|mesh-list
101378088|NCT00099957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101378089|NCT00099957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378090|NCT00099957|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101378091|NCT00099957|Protease Inhibitors|protease inhibitors|mesh-ancestor
101378093|NCT00099957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378095|NCT00250315|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101378096|NCT00250315|Sympathomimetics|sympathomimetics|mesh-ancestor
101378097|NCT00250315|Autonomic Agents|autonomic agents|mesh-ancestor
101378098|NCT00250315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101378099|NCT00250315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378100|NCT00250315|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101378101|NCT00250315|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101378104|NCT00250315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101378105|NCT00250315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378106|NCT00250315|Protective Agents|protective agents|mesh-ancestor
101378108|NCT00068471|Antifungal Agents|antifungal agents|mesh-ancestor
102059887|NCT04645550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059888|NCT04645550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102059889|NCT04645550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102059890|NCT04645550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102059891|NCT04645550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102059892|NCT04645550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059893|NCT04645550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102059894|NCT04645550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102059895|NCT04645550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101378109|NCT00068471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101378110|NCT00250354|Risperidone|risperidone|mesh-list
101378111|NCT00250354|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101378112|NCT00250354|Serotonin Agents|serotonin agents|mesh-ancestor
101378113|NCT00250354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101378114|NCT00250354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378115|NCT00250354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378116|NCT00250354|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101378117|NCT00250354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101378118|NCT00250354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101378119|NCT00250354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101378120|NCT00250354|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101378121|NCT00250354|Dopamine Agents|dopamine agents|mesh-ancestor
101378122|NCT00250393|Istradefylline|istradefylline|mesh-list
101378123|NCT00250393|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
101378124|NCT00250393|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101378125|NCT00250393|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101378126|NCT00250393|Purinergic Agents|purinergic agents|mesh-ancestor
101378127|NCT00250393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101378128|NCT00250393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378129|NCT00250393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378130|NCT02961634|Ciclopirox|ciclopirox|mesh-list
101378131|NCT02961634|Antifungal Agents|antifungal agents|mesh-ancestor
101378132|NCT02961634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101378133|NCT02966717|Rituximab|rituximab|mesh-list
101378134|NCT02966717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101378135|NCT02966717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378136|NCT02966717|Immunologic Factors|immunologic factors|mesh-ancestor
101378137|NCT02966717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378138|NCT02966717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101378139|NCT00099996|Ezetimibe|ezetimibe|mesh-list
101378140|NCT00099996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101378141|NCT00099996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101378142|NCT00099996|Antimetabolites|antimetabolites|mesh-ancestor
101378143|NCT00099996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378144|NCT00099996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101378145|NCT00250744|Gabapentin|gabapentin|mesh-list
101378146|NCT00250744|Aprepitant|aprepitant|mesh-list
101378147|NCT00250744|Fosaprepitant|fosaprepitant|mesh-list
101378148|NCT00250744|Analgesics|analgesics|mesh-ancestor
101378149|NCT00250744|Sensory System Agents|sensory system agents|mesh-ancestor
101378150|NCT00250744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101378151|NCT00250744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378152|NCT00250744|Anticonvulsants|anticonvulsants|mesh-ancestor
101378153|NCT00250744|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101378154|NCT00250744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101378155|NCT00250744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101378156|NCT00250744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101378157|NCT00250744|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101378158|NCT00250744|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101378159|NCT00250744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101378160|NCT00250744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378161|NCT00250744|Antimanic Agents|antimanic agents|mesh-ancestor
101378163|NCT00250744|Autonomic Agents|autonomic agents|mesh-ancestor
101304771|NCT02015169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101304772|NCT02015169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102059897|NCT04645550|Anticoagulants|anticoagulants|mesh-ancestor
102059898|NCT04645550|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102059899|NCT04645550|Antithrombins|antithrombins|mesh-ancestor
102059900|NCT04645550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102059901|NCT04645550|Protease Inhibitors|protease inhibitors|mesh-ancestor
102059902|NCT04645550|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102059903|NCT04645550|Vasodilator Agents|vasodilator agents|mesh-ancestor
102059904|NCT04629443|Azacitidine|azacitidine|mesh-list
102059905|NCT04629443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102059906|NCT04629443|Antimetabolites|antimetabolites|mesh-ancestor
102059907|NCT04629443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361524|NCT00124306|Amitriptyline|amitriptyline|mesh-list
101378164|NCT00250744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101378165|NCT00250744|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101378167|NCT00103623|Hormone Antagonists|hormone antagonists|mesh-ancestor
101378168|NCT00103623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101378169|NCT00103623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378170|NCT00250861|Aldesleukin|aldesleukin|mesh-list
101378172|NCT00250861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101378173|NCT00250861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378174|NCT00250861|Immunologic Factors|immunologic factors|mesh-ancestor
101378178|NCT00250861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101378179|NCT00250861|Antiviral Agents|antiviral agents|mesh-ancestor
101378180|NCT00250861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101378181|NCT00068549|Gemcitabine|gemcitabine|mesh-list
101378182|NCT00068549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378183|NCT00068549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101378184|NCT00068549|Antimetabolites|antimetabolites|mesh-ancestor
101378185|NCT00068549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378186|NCT04720183|Sulfasalazine|sulfasalazine|mesh-list
101378187|NCT04720183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101378188|NCT04720183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101378189|NCT04720183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101378190|NCT04720183|Analgesics|analgesics|mesh-ancestor
101378191|NCT04720183|Sensory System Agents|sensory system agents|mesh-ancestor
101378192|NCT04720183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101378193|NCT04720183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378194|NCT04720183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101378195|NCT04720183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101378196|NCT04720183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101378197|NCT00250978|Bevacizumab|bevacizumab|mesh-list
101378198|NCT00250978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101378199|NCT00250978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378200|NCT00250978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101378201|NCT00250978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101378202|NCT00250978|Growth Substances|growth substances|mesh-ancestor
101312975|NCT00007033|Tocolytic Agents|tocolytic agents|mesh-ancestor
101378203|NCT00250978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378204|NCT00250978|Growth Inhibitors|growth inhibitors|mesh-ancestor
101378205|NCT00068666|Temozolomide|temozolomide|mesh-list
101378206|NCT00068666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101378207|NCT00068666|Alkylating Agents|alkylating agents|mesh-ancestor
101378208|NCT00068666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378209|NCT00068666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378210|NCT00103701|Dasatinib|dasatinib|mesh-list
101378211|NCT00103701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378212|NCT00103701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101378213|NCT00103701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101378214|NCT00103701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378215|NCT00251017|Vancomycin|vancomycin|mesh-list
102059908|NCT04629443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102059909|NCT04629443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102059910|NCT04627922|Acetylcysteine|acetylcysteine|mesh-list
102059911|NCT04627922|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102059912|NCT04627922|Antiviral Agents|antiviral agents|mesh-ancestor
102059913|NCT04627922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101378216|NCT00251017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101378217|NCT00251017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101378218|NCT00251056|Mannitol|mannitol|mesh-list
101378219|NCT00251056|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101378220|NCT00251056|Diuretics|diuretics|mesh-ancestor
101378221|NCT00251056|Natriuretic Agents|natriuretic agents|mesh-ancestor
101378222|NCT00251056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378223|NCT00251095|Paclitaxel|paclitaxel|mesh-list
101378224|NCT00251095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101378225|NCT00251095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378226|NCT00251095|Tubulin Modulators|tubulin modulators|mesh-ancestor
101378227|NCT00251095|Antimitotic Agents|antimitotic agents|mesh-ancestor
101378228|NCT00251095|Mitosis Modulators|mitosis modulators|mesh-ancestor
101378229|NCT00251095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378230|NCT00100074|Lobeline|lobeline|mesh-list
101378231|NCT00100074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101378232|NCT00100074|Autonomic Agents|autonomic agents|mesh-ancestor
101378233|NCT00100074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101304773|NCT02015169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304774|NCT02015182|Bupivacaine|bupivacaine|mesh-list
101378239|NCT00100074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378241|NCT00068744|Fluorouracil|fluorouracil|mesh-list
101378242|NCT00068744|Mitomycins|mitomycins|mesh-list
101378243|NCT00068744|Mitomycin|mitomycin|mesh-list
101378244|NCT00068744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378245|NCT00068744|Antimetabolites|antimetabolites|mesh-ancestor
101378246|NCT00068744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378251|NCT00068744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101378252|NCT00068744|Alkylating Agents|alkylating agents|mesh-ancestor
101378253|NCT00068744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101378254|NCT00068744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101378255|NCT00100113|Vanoxerine|vanoxerine|mesh-list
101378256|NCT00100113|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101378257|NCT00100113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101378258|NCT00100113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101378259|NCT00100113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378260|NCT00100113|Dopamine Agents|dopamine agents|mesh-ancestor
101378261|NCT00100113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101312999|NCT00388219|Analgesics|analgesics|mesh-ancestor
101378262|NCT00100113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378263|NCT00068783|Imatinib Mesylate|imatinib mesylate|mesh-list
101378264|NCT00068783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378265|NCT00068783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101378266|NCT00068783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101378267|NCT00068783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378268|NCT00251368|9-aminocamptothecin|9-aminocamptothecin|mesh-list
101378269|NCT00251368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378270|NCT00103779|Dacetuzumab|dacetuzumab|mesh-list
101378271|NCT00103779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101378272|NCT00103779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378273|NCT00251407|Docetaxel|docetaxel|mesh-list
101378274|NCT00251407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378275|NCT00251407|Tubulin Modulators|tubulin modulators|mesh-ancestor
101378276|NCT00251407|Antimitotic Agents|antimitotic agents|mesh-ancestor
101378277|NCT00251407|Mitosis Modulators|mitosis modulators|mesh-ancestor
101378278|NCT00251407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378279|NCT02966522|Thalidomide|thalidomide|mesh-list
101378280|NCT02966522|Dexamethasone|dexamethasone|mesh-list
101378281|NCT02966522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101378282|NCT02966522|Antiemetics|antiemetics|mesh-ancestor
101378283|NCT02966522|Autonomic Agents|autonomic agents|mesh-ancestor
101378284|NCT02966522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101378285|NCT02966522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378286|NCT02966522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101378287|NCT02966522|Glucocorticoids|glucocorticoids|mesh-ancestor
101378288|NCT02966522|Hormones|hormones|mesh-ancestor
102059914|NCT04627922|Expectorants|expectorants|mesh-ancestor
102059915|NCT04627922|Respiratory System Agents|respiratory system agents|mesh-ancestor
102059916|NCT04627922|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102059917|NCT04627922|Antioxidants|antioxidants|mesh-ancestor
101378289|NCT02966522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101378290|NCT02966522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101378291|NCT02966522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378292|NCT02966522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101378293|NCT02966522|Immunologic Factors|immunologic factors|mesh-ancestor
101378294|NCT02966522|Leprostatic Agents|leprostatic agents|mesh-ancestor
101378295|NCT02966522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101378296|NCT02966522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101378297|NCT02966522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101378298|NCT02966522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101378299|NCT02966522|Growth Substances|growth substances|mesh-ancestor
101378300|NCT02966522|Growth Inhibitors|growth inhibitors|mesh-ancestor
101378301|NCT00251485|Cetuximab|cetuximab|mesh-list
101378302|NCT00251485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101378303|NCT00251485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378304|NCT00100152|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
101313017|NCT00007423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378307|NCT00100152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378308|NCT00251524|Bevacizumab|bevacizumab|mesh-list
101378309|NCT00251524|Oxaliplatin|oxaliplatin|mesh-list
101378310|NCT00251524|Pemetrexed|pemetrexed|mesh-list
101378311|NCT00251524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101378312|NCT00251524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378313|NCT00251524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101378314|NCT00251524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101378315|NCT00251524|Growth Substances|growth substances|mesh-ancestor
101378321|NCT00251524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101378323|NCT00068861|Clomiphene|clomiphene|mesh-list
101378324|NCT00068861|Enclomiphene|enclomiphene|mesh-list
101378325|NCT00068861|Zuclomiphene|zuclomiphene|mesh-list
101378326|NCT00068861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101378327|NCT00068861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378328|NCT00068861|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101378329|NCT00068861|Hormone Antagonists|hormone antagonists|mesh-ancestor
101378330|NCT00068861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101378331|NCT00068861|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101378332|NCT00068861|Fertility Agents|fertility agents|mesh-ancestor
101378333|NCT00068861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101378334|NCT00068861|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101378335|NCT00068861|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101378336|NCT00251602|Propranolol|propranolol|mesh-list
101378337|NCT00251602|Atropine|atropine|mesh-list
101378338|NCT00251602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101378339|NCT00251602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101378340|NCT00251602|Adrenergic Agents|adrenergic agents|mesh-ancestor
101378341|NCT00251602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101378342|NCT00251602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378343|NCT00251602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378344|NCT00251602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101378345|NCT00251602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101378346|NCT00251602|Vasodilator Agents|vasodilator agents|mesh-ancestor
101378347|NCT00251602|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101378348|NCT00251602|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101378349|NCT00251602|Autonomic Agents|autonomic agents|mesh-ancestor
101378350|NCT00251602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101378351|NCT00251602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101378352|NCT00251602|Respiratory System Agents|respiratory system agents|mesh-ancestor
101378353|NCT00251602|Mydriatics|mydriatics|mesh-ancestor
101378354|NCT00251602|Parasympatholytics|parasympatholytics|mesh-ancestor
101378355|NCT00251602|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101378356|NCT00251602|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101378357|NCT00251602|Cholinergic Agents|cholinergic agents|mesh-ancestor
101378358|NCT02961166|Immunoglobulins|immunoglobulins|mesh-list
101378359|NCT02961166|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101378360|NCT02961166|Antibodies|antibodies|mesh-list
102059918|NCT04627922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059919|NCT04627922|Protective Agents|protective agents|mesh-ancestor
102059920|NCT04627922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059922|NCT04596657|Vitamin D|vitamin d|mesh-list
102059923|NCT04596657|Vitamins|vitamins|mesh-ancestor
102059924|NCT04596657|Micronutrients|micronutrients|mesh-ancestor
101361537|NCT00124306|Adrenergic Agents|adrenergic agents|mesh-ancestor
101378361|NCT02961166|Immunologic Factors|immunologic factors|mesh-ancestor
101378362|NCT02961166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378363|NCT00103818|Gaboxadol|gaboxadol|mesh-list
101378364|NCT00103818|Analgesics|analgesics|mesh-ancestor
101378365|NCT00103818|Sensory System Agents|sensory system agents|mesh-ancestor
101378366|NCT00103818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101378367|NCT00103818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378368|NCT00103818|Anticonvulsants|anticonvulsants|mesh-ancestor
101378369|NCT00103818|GABA Agonists|gaba agonists|mesh-ancestor
101378370|NCT00103818|GABA Agents|gaba agents|mesh-ancestor
101378371|NCT00103818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101378372|NCT00103818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378373|NCT00251680|Atorvastatin|atorvastatin|mesh-list
101378374|NCT00251680|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101378375|NCT00251680|Simvastatin|simvastatin|mesh-list
101378379|NCT00251680|Antimetabolites|antimetabolites|mesh-ancestor
101378380|NCT00251680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378381|NCT00251680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101378382|NCT00251680|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101378383|NCT00251680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101378384|NCT00251797|Thalidomide|thalidomide|mesh-list
101378385|NCT00251797|Irinotecan|irinotecan|mesh-list
101378388|NCT00251797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101378389|NCT00251797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378390|NCT00251797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378391|NCT00251797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101378392|NCT00251797|Immunologic Factors|immunologic factors|mesh-ancestor
101378393|NCT00251797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378394|NCT00251797|Leprostatic Agents|leprostatic agents|mesh-ancestor
101378395|NCT00251797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101378396|NCT00251797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101378397|NCT00251797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101378398|NCT00251797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101378399|NCT00251797|Growth Substances|growth substances|mesh-ancestor
101378400|NCT00251797|Growth Inhibitors|growth inhibitors|mesh-ancestor
101378402|NCT00251914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101378403|NCT00251914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101378404|NCT00251914|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101378405|NCT00251914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101378406|NCT00251914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378407|NCT00100269|Antioxidants|antioxidants|mesh-list
101378408|NCT00100269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378409|NCT00100269|Protective Agents|protective agents|mesh-ancestor
101378410|NCT00100269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378411|NCT00399074|Pyrimethamine|pyrimethamine|mesh-list
101378412|NCT00399074|Sulfadoxine|sulfadoxine|mesh-list
101378413|NCT00399074|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101378414|NCT00399074|Antimalarials|antimalarials|mesh-ancestor
101378415|NCT00399074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101378416|NCT00399074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101378417|NCT00399074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101378418|NCT00399074|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101378419|NCT00399074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101378420|NCT00399074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378421|NCT00399074|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101378422|NCT00100308|Heparin|heparin|mesh-list
101378423|NCT00100308|Anticoagulants|anticoagulants|mesh-ancestor
101378424|NCT00100308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101378425|NCT00100308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102059925|NCT04596657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059926|NCT04596657|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102059928|NCT04577716|Fluorides|fluorides|mesh-list
102059929|NCT04577716|Sodium Fluoride|sodium fluoride|mesh-list
102059930|NCT04577716|Cariostatic Agents|cariostatic agents|mesh-ancestor
102059931|NCT04577716|Protective Agents|protective agents|mesh-ancestor
101378426|NCT00100308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378427|NCT00251953|Metformin|metformin|mesh-list
101378428|NCT00251953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101378429|NCT00251953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378430|NCT00251992|Esomeprazole|esomeprazole|mesh-list
101378431|NCT00251992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101378432|NCT00251992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101378433|NCT00251992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101378434|NCT00251992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101378435|NCT00251992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378436|NCT00103935|Exenatide|exenatide|mesh-list
101378437|NCT00103935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101378438|NCT00103935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378439|NCT00103935|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101378440|NCT00103935|Incretins|incretins|mesh-ancestor
101378441|NCT00103935|Hormones|hormones|mesh-ancestor
101378442|NCT00103935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101378443|NCT00399152|Sunitinib|sunitinib|mesh-list
101378444|NCT00399152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378445|NCT00399152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101378446|NCT00399152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101378447|NCT00399152|Growth Substances|growth substances|mesh-ancestor
101378451|NCT00399152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101378452|NCT00399152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304780|NCT02015182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101304781|NCT02015260|Citric Acid|citric acid|mesh-list
101378453|NCT00104013|Xaliproden|xaliproden|mesh-list
101378454|NCT00104013|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101378455|NCT00104013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101378456|NCT00104013|Serotonin Agents|serotonin agents|mesh-ancestor
101378457|NCT00104013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101378463|NCT00252226|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101378464|NCT00252226|Antidepressive Agents|antidepressive agents|mesh-ancestor
101378465|NCT00252226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101378466|NCT00252226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101378467|NCT00252226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101378468|NCT00252226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101378469|NCT00252226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378470|NCT00252304|Zinc Sulfate|zinc sulfate|mesh-list
101378471|NCT00252304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378472|NCT00252304|Astringents|astringents|mesh-ancestor
101378473|NCT00252304|Dermatologic Agents|dermatologic agents|mesh-ancestor
101378475|NCT00252343|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
101378476|NCT00252343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101378477|NCT00252343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101378478|NCT00252343|Adrenergic Agents|adrenergic agents|mesh-ancestor
101378479|NCT00252343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101378480|NCT00252343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378481|NCT00252343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378482|NCT00252343|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101378483|NCT00252421|Nitroglycerin|nitroglycerin|mesh-list
101378484|NCT00252421|Vasodilator Agents|vasodilator agents|mesh-ancestor
101378485|NCT00252655|Sirolimus|sirolimus|mesh-list
101378486|NCT00252655|Tacrolimus|tacrolimus|mesh-list
101378487|NCT00252655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101378488|NCT00252655|Immunologic Factors|immunologic factors|mesh-ancestor
101378489|NCT00252655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378490|NCT00252655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101378491|NCT00252655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101378492|NCT00252655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378493|NCT00252655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102059932|NCT04577716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059933|NCT04577716|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102059934|NCT04577716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102059935|NCT04551131|Dexamethasone|dexamethasone|mesh-list
102059936|NCT04551131|Etoposide|etoposide|mesh-list
101361548|NCT00077883|Cisplatin|cisplatin|mesh-list
101378494|NCT00252655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101378495|NCT00252655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101378496|NCT00252655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378497|NCT00252655|Antifungal Agents|antifungal agents|mesh-ancestor
101378498|NCT00252811|Gefitinib|gefitinib|mesh-list
101378499|NCT00252811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378500|NCT00252811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101378501|NCT00252811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101378502|NCT00252811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378503|NCT00069251|Bupropion|bupropion|mesh-list
101378504|NCT00069251|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101378505|NCT00069251|Antidepressive Agents|antidepressive agents|mesh-ancestor
101378506|NCT00069251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101378507|NCT00069251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101378508|NCT00069251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101378509|NCT00069251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101378510|NCT00069251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378511|NCT00069251|Dopamine Agents|dopamine agents|mesh-ancestor
101378512|NCT00069251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101378513|NCT00069251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378514|NCT00069251|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101378515|NCT00069251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101378516|NCT00069251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101378517|NCT00252889|Doxorubicin|doxorubicin|mesh-list
101378518|NCT00252889|Topotecan|topotecan|mesh-list
101378519|NCT00252889|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
101313104|NCT00008008|Thiotepa|thiotepa|mesh-list
101378520|NCT00252889|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101378521|NCT00252889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378522|NCT00252889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101378591|NCT00100464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101304783|NCT02015260|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101304784|NCT02015260|Chelating Agents|chelating agents|mesh-ancestor
101304785|NCT02015260|Sequestering Agents|sequestering agents|mesh-ancestor
101378592|NCT00100464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101378593|NCT00100464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378594|NCT00100464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101378595|NCT00100464|Serotonin Agents|serotonin agents|mesh-ancestor
101378596|NCT00100464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378597|NCT00100464|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101378602|NCT00100464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101378603|NCT00253396|Heparin|heparin|mesh-list
101378604|NCT00253396|Enoxaparin|enoxaparin|mesh-list
101378605|NCT00253396|Calcium heparin|calcium heparin|mesh-list
101378606|NCT00253396|Anticoagulants|anticoagulants|mesh-ancestor
101378607|NCT00253396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101378608|NCT00253396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101378609|NCT00253396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378610|NCT00253474|Interferons|interferons|mesh-list
101378611|NCT00253474|Interferon-alpha|interferon-alpha|mesh-list
101378612|NCT00253474|Interferon alpha-2|interferon alpha-2|mesh-list
101378613|NCT00253474|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101378614|NCT00253474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378615|NCT00253474|Antiviral Agents|antiviral agents|mesh-ancestor
101378616|NCT00253474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101378617|NCT00253474|Immunologic Factors|immunologic factors|mesh-ancestor
101378618|NCT00253474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378619|NCT00253552|Cyclosporine|cyclosporine|mesh-list
101378620|NCT00253552|Cyclophosphamide|cyclophosphamide|mesh-list
101378621|NCT00253552|Busulfan|busulfan|mesh-list
101378622|NCT00253552|Methotrexate|methotrexate|mesh-list
101378623|NCT00253552|Etoposide|etoposide|mesh-list
101378624|NCT00253552|Cyclosporins|cyclosporins|mesh-list
101378625|NCT00253552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101378626|NCT00253552|Immunologic Factors|immunologic factors|mesh-ancestor
102059938|NCT04551131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102059939|NCT04551131|Antiemetics|antiemetics|mesh-ancestor
102059940|NCT04551131|Autonomic Agents|autonomic agents|mesh-ancestor
102059941|NCT04551131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102059942|NCT04551131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059943|NCT04551131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102059944|NCT04551131|Glucocorticoids|glucocorticoids|mesh-ancestor
101378627|NCT00253552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378628|NCT00253552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101378629|NCT00253552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101378630|NCT00253552|Alkylating Agents|alkylating agents|mesh-ancestor
101378631|NCT00253552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378632|NCT00253552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378633|NCT00253552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101378634|NCT00253552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101378635|NCT00253552|Abortifacient Agents|abortifacient agents|mesh-ancestor
101378636|NCT00253552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101313133|NCT00008086|Carboplatin|carboplatin|mesh-list
101378637|NCT00253552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101378638|NCT00253552|Antimetabolites|antimetabolites|mesh-ancestor
101378639|NCT00253552|Dermatologic Agents|dermatologic agents|mesh-ancestor
101378640|NCT00253552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101378641|NCT00253552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101378642|NCT00253552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101378643|NCT00253552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101378644|NCT00253552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101378645|NCT00253552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101378646|NCT00253552|Antifungal Agents|antifungal agents|mesh-ancestor
101378647|NCT00253552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101378648|NCT00253552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101378649|NCT00253591|Vinorelbine|vinorelbine|mesh-list
101378650|NCT00253591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378651|NCT00253591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101378652|NCT00253591|Tubulin Modulators|tubulin modulators|mesh-ancestor
101378653|NCT00253591|Antimitotic Agents|antimitotic agents|mesh-ancestor
101378654|NCT00253591|Mitosis Modulators|mitosis modulators|mesh-ancestor
101304788|NCT02015299|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
101304790|NCT02015299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378662|NCT04719481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101378663|NCT04719481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101378664|NCT00253903|SR 46349B|sr 46349b|mesh-list
101378665|NCT00253903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101378666|NCT00253903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101378667|NCT00253903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378669|NCT00253903|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101378670|NCT00253903|Serotonin Agents|serotonin agents|mesh-ancestor
101378671|NCT00253903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101378672|NCT00253903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378673|NCT00104130|Desoxyepothilone B|desoxyepothilone b|mesh-list
101378674|NCT00104130|Tubulin Modulators|tubulin modulators|mesh-ancestor
101378675|NCT00104130|Antimitotic Agents|antimitotic agents|mesh-ancestor
101378676|NCT00104130|Mitosis Modulators|mitosis modulators|mesh-ancestor
101378677|NCT00104130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378678|NCT00104130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378679|NCT00254020|Citalopram|citalopram|mesh-list
101378680|NCT00254020|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101378681|NCT00254020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101378682|NCT00254020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101378683|NCT00254020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378684|NCT00254020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101378685|NCT00254020|Serotonin Agents|serotonin agents|mesh-ancestor
101378686|NCT00254020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378687|NCT00254020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101378688|NCT00254020|Antidepressive Agents|antidepressive agents|mesh-ancestor
102059945|NCT04551131|Hormones|hormones|mesh-ancestor
102059946|NCT04551131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102059947|NCT04551131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102059948|NCT04551131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102059949|NCT04551131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102059950|NCT04551131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102059951|NCT04551131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102059952|NCT04551131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102059953|NCT04551131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059954|NCT04540705|Nivolumab|nivolumab|mesh-list
101378689|NCT00254020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101378690|NCT00254137|Capecitabine|capecitabine|mesh-list
101378691|NCT00254137|Oxaliplatin|oxaliplatin|mesh-list
101378692|NCT00254137|Irinotecan|irinotecan|mesh-list
101378693|NCT00254137|Cetuximab|cetuximab|mesh-list
101378694|NCT00254137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101378695|NCT00254137|Antimetabolites|antimetabolites|mesh-ancestor
101378696|NCT00254137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378697|NCT00254137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378698|NCT00254137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101378699|NCT00254137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101378700|NCT00254137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101378701|NCT00254137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101378702|NCT00104169|Epoetin Alfa|epoetin alfa|mesh-list
101378703|NCT00104169|Hematinics|hematinics|mesh-ancestor
101378704|NCT00415090|Nevirapine|nevirapine|mesh-list
101378705|NCT00415090|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101378706|NCT00415090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101378707|NCT00415090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101378708|NCT00415090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378709|NCT00415090|Antiviral Agents|antiviral agents|mesh-ancestor
101378710|NCT00415090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101378711|NCT00415090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101378712|NCT00415090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101378713|NCT00415090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101378714|NCT00415090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101378721|NCT00254254|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101378722|NCT00254254|Incretins|incretins|mesh-ancestor
101378723|NCT00254254|Hormones|hormones|mesh-ancestor
101378724|NCT00254254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101378725|NCT00254371|Androgens|androgens|mesh-list
101378726|NCT00254371|Hormones|hormones|mesh-ancestor
101304791|NCT02015299|Incretins|incretins|mesh-ancestor
101304792|NCT02015299|Hormones|hormones|mesh-ancestor
101304793|NCT02015299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101378727|NCT00254371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101378728|NCT00254371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378729|NCT00254449|Capsaicin|capsaicin|mesh-list
101378730|NCT00254449|Antipruritics|antipruritics|mesh-ancestor
101378731|NCT00254449|Dermatologic Agents|dermatologic agents|mesh-ancestor
101378732|NCT00254449|Sensory System Agents|sensory system agents|mesh-ancestor
101378733|NCT00254449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101378734|NCT00254449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378735|NCT00104286|Troxacitabine|troxacitabine|mesh-list
101378736|NCT00104286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378737|NCT00104286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101378738|NCT00104286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101378739|NCT00104286|Antiviral Agents|antiviral agents|mesh-ancestor
101378740|NCT00104286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101378741|NCT00254800|Exenatide|exenatide|mesh-list
101378746|NCT00254800|Estradiol|estradiol|mesh-list
101378747|NCT00254800|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101378748|NCT00254800|Estrogens|estrogens|mesh-ancestor
101378749|NCT00254800|Hormones|hormones|mesh-ancestor
101378750|NCT00254800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102059955|NCT04540705|Axitinib|axitinib|mesh-list
102059956|NCT04540705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102059957|NCT04540705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102059958|NCT04540705|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102059959|NCT04540705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059960|NCT04540705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102059961|NCT04540705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101378751|NCT00254800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378752|NCT00254800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101378753|NCT00254800|Contraceptive Agents|contraceptive agents|mesh-ancestor
101378754|NCT00254800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101378755|NCT00254800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101378756|NCT00254800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101378757|NCT00254800|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101378758|NCT00254800|Incretins|incretins|mesh-ancestor
101378759|NCT00254800|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101378760|NCT00254800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101378761|NCT00254800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101378762|NCT00104403|Dexamethasone|dexamethasone|mesh-list
101378763|NCT00104403|Dexamethasone acetate|dexamethasone acetate|mesh-list
101378764|NCT00104403|Ondansetron|ondansetron|mesh-list
101378765|NCT00104403|Casopitant|casopitant|mesh-list
101378766|NCT00104403|BB 1101|bb 1101|mesh-list
101378767|NCT00104403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101378768|NCT00104403|Antiemetics|antiemetics|mesh-ancestor
101378769|NCT00104403|Autonomic Agents|autonomic agents|mesh-ancestor
101378770|NCT00104403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101378771|NCT00104403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378772|NCT00104403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101378773|NCT00104403|Glucocorticoids|glucocorticoids|mesh-ancestor
101378774|NCT00104403|Hormones|hormones|mesh-ancestor
101378775|NCT00104403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101378776|NCT00104403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101378777|NCT00104403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378778|NCT00104403|Protease Inhibitors|protease inhibitors|mesh-ancestor
101378779|NCT00104403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101378780|NCT00104403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378781|NCT00104403|Antipruritics|antipruritics|mesh-ancestor
101378782|NCT00104403|Dermatologic Agents|dermatologic agents|mesh-ancestor
101378783|NCT00104403|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101378784|NCT00104403|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101378785|NCT00104403|Serotonin Agents|serotonin agents|mesh-ancestor
101378791|NCT00069836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378792|NCT00254878|Methylphenidate|methylphenidate|mesh-list
101378793|NCT00254878|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101378794|NCT00254878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378795|NCT00254878|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101378796|NCT00254878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101378797|NCT00254878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101378798|NCT00254878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378799|NCT00254878|Dopamine Agents|dopamine agents|mesh-ancestor
101304794|NCT02015299|Protease Inhibitors|protease inhibitors|mesh-ancestor
101304795|NCT02015299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101304796|NCT02015299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304797|NCT02015312|Silicon|silicon|mesh-list
101378800|NCT00254878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101378801|NCT00254917|Vaccines|vaccines|mesh-list
101378802|NCT00254917|Immunologic Factors|immunologic factors|mesh-ancestor
101378803|NCT00254917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378804|NCT00254956|Ciclesonide|ciclesonide|mesh-list
101378805|NCT00254956|Glucocorticoids|glucocorticoids|mesh-ancestor
101378806|NCT00254956|Hormones|hormones|mesh-ancestor
101378807|NCT00254956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101378808|NCT00254956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378809|NCT00254956|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101378810|NCT00255073|Baclofen|baclofen|mesh-list
101378812|NCT00255073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378813|NCT00255073|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101378828|NCT00255268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378829|NCT00255268|Androgen Antagonists|androgen antagonists|mesh-ancestor
101378830|NCT00255268|Hormone Antagonists|hormone antagonists|mesh-ancestor
101378831|NCT00255268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101378832|NCT00255268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378833|NCT00104442|Rivastigmine|rivastigmine|mesh-list
101378834|NCT00104442|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101378835|NCT00104442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101378836|NCT00104442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378837|NCT00104442|Cholinergic Agents|cholinergic agents|mesh-ancestor
101378838|NCT00104442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101378839|NCT00104442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378840|NCT00104442|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101378841|NCT00104442|Protective Agents|protective agents|mesh-ancestor
101378842|NCT00255385|Micronutrients|micronutrients|mesh-list
101378843|NCT00255385|Trace Elements|trace elements|mesh-list
101378844|NCT00255385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378845|NCT00255424|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
101378846|NCT00255424|Hematinics|hematinics|mesh-ancestor
101378847|NCT00255424|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101378848|NCT00255424|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101378849|NCT00069992|Fludarabine|fludarabine|mesh-list
101378850|NCT00069992|Alemtuzumab|alemtuzumab|mesh-list
101378851|NCT00069992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378852|NCT00069992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101378854|NCT00255463|Anastrozole|anastrozole|mesh-list
101378855|NCT00255463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378856|NCT00255463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101378857|NCT00255463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101378858|NCT00255463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378859|NCT00255463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101378860|NCT00255463|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101378861|NCT00255463|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101378862|NCT00255463|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101378863|NCT00255463|Hormone Antagonists|hormone antagonists|mesh-ancestor
101378864|NCT00255463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101378870|NCT00255502|Autonomic Agents|autonomic agents|mesh-ancestor
101378871|NCT00255502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101378872|NCT00255502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378873|NCT00255502|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101378889|NCT00255658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378891|NCT00255658|Immunologic Factors|immunologic factors|mesh-ancestor
101378892|NCT00255658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378893|NCT00255658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101456551|NCT04662385|Sodium Fluoride|sodium fluoride|mesh-list
101304798|NCT02015312|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
101304800|NCT02015312|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101378894|NCT00255658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101378895|NCT00255658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102059972|NCT04521413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059973|NCT04516057|Nabilone|nabilone|mesh-list
102059974|NCT04516057|Antiemetics|antiemetics|mesh-ancestor
102059975|NCT04516057|Autonomic Agents|autonomic agents|mesh-ancestor
102059976|NCT04516057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102059977|NCT04516057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059978|NCT04516057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102059979|NCT04516057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102059980|NCT04516057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102059981|NCT04516057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101378896|NCT00255658|Antifungal Agents|antifungal agents|mesh-ancestor
101378898|NCT00070148|Megestrol Acetate|megestrol acetate|mesh-list
101378899|NCT00070148|Oxandrolone|oxandrolone|mesh-list
101378900|NCT00070148|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101378901|NCT00070148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101378902|NCT00070148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101378903|NCT00070148|Contraceptive Agents|contraceptive agents|mesh-ancestor
101378904|NCT00070148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101378905|NCT00070148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378906|NCT00070148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101378907|NCT00070148|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101378908|NCT00070148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101378909|NCT00070148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378910|NCT00070148|Appetite Stimulants|appetite stimulants|mesh-ancestor
101378911|NCT00070148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101378912|NCT00070148|Androgens|androgens|mesh-ancestor
101378913|NCT00070148|Hormones|hormones|mesh-ancestor
101378914|NCT00070148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101378915|NCT00070148|Anabolic Agents|anabolic agents|mesh-ancestor
101378916|NCT00100581|Interferons|interferons|mesh-list
101378917|NCT00100581|Ritonavir|ritonavir|mesh-list
101378918|NCT00100581|Tenofovir|tenofovir|mesh-list
101378919|NCT00100581|Ribavirin|ribavirin|mesh-list
101378920|NCT00100581|Interferon-alpha|interferon-alpha|mesh-list
101378921|NCT00100581|Lamivudine|lamivudine|mesh-list
101378922|NCT00100581|Interferon alpha-2|interferon alpha-2|mesh-list
101378923|NCT00100581|Efavirenz|efavirenz|mesh-list
101378924|NCT00100581|Lopinavir|lopinavir|mesh-list
101378925|NCT00100581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101378926|NCT00100581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378927|NCT00100581|Antiviral Agents|antiviral agents|mesh-ancestor
101378928|NCT00100581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101378929|NCT00100581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101378930|NCT00100581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101378931|NCT00100581|Protease Inhibitors|protease inhibitors|mesh-ancestor
101378932|NCT00100581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101378933|NCT00100581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378934|NCT00100581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101378935|NCT00100581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101378947|NCT00100581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101378948|NCT00070187|Interferons|interferons|mesh-list
101378949|NCT00070187|Cytarabine|cytarabine|mesh-list
101378950|NCT00070187|Aldesleukin|aldesleukin|mesh-list
101378951|NCT00070187|Interferon-gamma|interferon-gamma|mesh-list
101378952|NCT00070187|Cyclosporine|cyclosporine|mesh-list
101378953|NCT00070187|Etoposide|etoposide|mesh-list
101378954|NCT00070187|Melphalan|melphalan|mesh-list
101378955|NCT00070187|Interleukin-2|interleukin-2|mesh-list
101378956|NCT00070187|Carmustine|carmustine|mesh-list
101378957|NCT00070187|Cyclosporins|cyclosporins|mesh-list
101378958|NCT00070187|Lenograstim|lenograstim|mesh-list
101378959|NCT00070187|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101378960|NCT00070187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378961|NCT00070187|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101378962|NCT00070187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101378967|NCT00070187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101378968|NCT00070187|Antimetabolites|antimetabolites|mesh-ancestor
101378969|NCT00070187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101378970|NCT00070187|Immunologic Factors|immunologic factors|mesh-ancestor
102059982|NCT04516057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102059983|NCT04511702|Methotrexate|methotrexate|mesh-list
102059984|NCT04511702|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102059985|NCT04511702|Abortifacient Agents|abortifacient agents|mesh-ancestor
102059986|NCT04511702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102059987|NCT04511702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102059988|NCT04511702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102059989|NCT04511702|Antimetabolites|antimetabolites|mesh-ancestor
101378971|NCT00070187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378972|NCT00070187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101378973|NCT00070187|Antifungal Agents|antifungal agents|mesh-ancestor
101378974|NCT00070187|Dermatologic Agents|dermatologic agents|mesh-ancestor
101378975|NCT00070187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101378976|NCT00070187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101378977|NCT00070187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101378978|NCT00070187|Alkylating Agents|alkylating agents|mesh-ancestor
101304801|NCT02015312|Diuretics|diuretics|mesh-ancestor
101304802|NCT02015312|Natriuretic Agents|natriuretic agents|mesh-ancestor
101304803|NCT02015312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304804|NCT02015312|Trace Elements|trace elements|mesh-ancestor
101378979|NCT00070187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101378980|NCT00070187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101378981|NCT00070187|Analgesics|analgesics|mesh-ancestor
101378982|NCT00070187|Sensory System Agents|sensory system agents|mesh-ancestor
101378983|NCT00070187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101378984|NCT00070187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101378985|NCT00070187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101378986|NCT00415246|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101378987|NCT00415246|Luteolytic Agents|luteolytic agents|mesh-ancestor
101378988|NCT00415246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101378989|NCT00415246|Contraceptive Agents|contraceptive agents|mesh-ancestor
101378990|NCT00415246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101378991|NCT00415246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378992|NCT00415246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101378993|NCT00415246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101378994|NCT00415246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378995|NCT00415285|Docetaxel|docetaxel|mesh-list
101378996|NCT00415285|Capecitabine|capecitabine|mesh-list
101378997|NCT00415285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378998|NCT00415285|Tubulin Modulators|tubulin modulators|mesh-ancestor
101379011|NCT00256009|Oxytocics|oxytocics|mesh-ancestor
101379012|NCT00100620|Zoledronic Acid|zoledronic acid|mesh-list
101379013|NCT00100620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101379014|NCT00100620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379015|NCT00070265|Capecitabine|capecitabine|mesh-list
101379016|NCT00070265|Oxaliplatin|oxaliplatin|mesh-list
101379017|NCT00070265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101379018|NCT00070265|Antimetabolites|antimetabolites|mesh-ancestor
101379019|NCT00070265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379020|NCT00070265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379021|NCT00104598|Bupropion|bupropion|mesh-list
101379022|NCT00104598|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101379023|NCT00104598|Antidepressive Agents|antidepressive agents|mesh-ancestor
101379024|NCT00104598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101379025|NCT00104598|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101379026|NCT00104598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101379027|NCT00104598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101379028|NCT00104598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379029|NCT00104598|Dopamine Agents|dopamine agents|mesh-ancestor
101379030|NCT00104598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101313249|NCT00008515|Hormones|hormones|mesh-ancestor
101379031|NCT00104598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379032|NCT00104598|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101379033|NCT00104598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101379034|NCT00104598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101379035|NCT00256321|Celecoxib|celecoxib|mesh-list
101379036|NCT00256321|Capecitabine|capecitabine|mesh-list
101379037|NCT00256321|Oxaliplatin|oxaliplatin|mesh-list
102059990|NCT04511702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102059991|NCT04511702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102059992|NCT04511702|Dermatologic Agents|dermatologic agents|mesh-ancestor
102059993|NCT04511702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102059994|NCT04511702|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102059995|NCT04511702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102059996|NCT04511702|Immunologic Factors|immunologic factors|mesh-ancestor
102059997|NCT04511702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102059998|NCT04511702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101379038|NCT00256321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101379039|NCT00256321|Antimetabolites|antimetabolites|mesh-ancestor
101379040|NCT00256321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379041|NCT00256321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379047|NCT00256321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379048|NCT00256321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101379049|NCT00256321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101379050|NCT00256321|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101379051|NCT00256321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101379052|NCT00256321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101379053|NCT00070304|Gemcitabine|gemcitabine|mesh-list
101379054|NCT00070304|Vinorelbine|vinorelbine|mesh-list
101379055|NCT00070304|Lenograstim|lenograstim|mesh-list
101379056|NCT00070304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101379057|NCT00070304|Antimetabolites|antimetabolites|mesh-ancestor
101456552|NCT04662385|Cariostatic Agents|cariostatic agents|mesh-ancestor
101304805|NCT02015312|Micronutrients|micronutrients|mesh-ancestor
101304806|NCT02015312|Antioxidants|antioxidants|mesh-ancestor
101304807|NCT02015312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304808|NCT02015312|Protective Agents|protective agents|mesh-ancestor
101379058|NCT00070304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379059|NCT00070304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379063|NCT00070304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101379064|NCT00070304|Tubulin Modulators|tubulin modulators|mesh-ancestor
101379065|NCT00070304|Antimitotic Agents|antimitotic agents|mesh-ancestor
101379066|NCT00070304|Mitosis Modulators|mitosis modulators|mesh-ancestor
101379067|NCT00100737|Rituximab|rituximab|mesh-list
101379068|NCT00100737|Interleukin-2|interleukin-2|mesh-list
101379069|NCT00100737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101379070|NCT00100737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379071|NCT00100737|Immunologic Factors|immunologic factors|mesh-ancestor
101379072|NCT00100737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379073|NCT00100737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101379074|NCT00100737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101379075|NCT00100737|Analgesics|analgesics|mesh-ancestor
101379076|NCT00100737|Sensory System Agents|sensory system agents|mesh-ancestor
101379077|NCT00100737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101379078|NCT00070343|Dacarbazine|dacarbazine|mesh-list
101379079|NCT00070343|Oblimersen|oblimersen|mesh-list
101379080|NCT00070343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101313255|NCT00008554|Fosamprenavir|fosamprenavir|mesh-list
101379081|NCT00070343|Alkylating Agents|alkylating agents|mesh-ancestor
101379082|NCT00070343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379083|NCT00070343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379084|NCT00104715|Docetaxel|docetaxel|mesh-list
101379085|NCT00104715|Goserelin|goserelin|mesh-list
101379086|NCT00104715|Androgen Antagonists|androgen antagonists|mesh-list
101379087|NCT00104715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379088|NCT00104715|Tubulin Modulators|tubulin modulators|mesh-ancestor
101379089|NCT00104715|Antimitotic Agents|antimitotic agents|mesh-ancestor
101379090|NCT00104715|Mitosis Modulators|mitosis modulators|mesh-ancestor
101379091|NCT00104715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379092|NCT00104715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101379093|NCT00104715|Hormone Antagonists|hormone antagonists|mesh-ancestor
101379094|NCT00104715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101379095|NCT00104715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379096|NCT00256711|Vinorelbine|vinorelbine|mesh-list
102059999|NCT04475276|Thioctic Acid|thioctic acid|mesh-list
102060000|NCT04475276|Antioxidants|antioxidants|mesh-ancestor
102060001|NCT04475276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060002|NCT04475276|Protective Agents|protective agents|mesh-ancestor
102060003|NCT04475276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060004|NCT04475276|Vitamin B Complex|vitamin b complex|mesh-ancestor
102060005|NCT04475276|Vitamins|vitamins|mesh-ancestor
102060006|NCT04475276|Micronutrients|micronutrients|mesh-ancestor
101379097|NCT00256711|Gefitinib|gefitinib|mesh-list
101379098|NCT00256711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101379099|NCT00256711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379100|NCT00256711|Tubulin Modulators|tubulin modulators|mesh-ancestor
101379101|NCT00256711|Antimitotic Agents|antimitotic agents|mesh-ancestor
101379102|NCT00256711|Mitosis Modulators|mitosis modulators|mesh-ancestor
101379103|NCT00256711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379104|NCT00256711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101379105|NCT00256711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101379106|NCT00070382|Epoetin Alfa|epoetin alfa|mesh-list
101379107|NCT00070382|Darbepoetin alfa|darbepoetin alfa|mesh-list
101379108|NCT00070382|Hematinics|hematinics|mesh-ancestor
101379109|NCT00256828|Lamivudine|lamivudine|mesh-list
101379110|NCT00256828|Efavirenz|efavirenz|mesh-list
101379125|NCT00256828|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101379126|NCT00256828|Antimetabolites|antimetabolites|mesh-ancestor
101379127|NCT00100776|Olanzapine|olanzapine|mesh-list
101304809|NCT02015312|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101304810|NCT02015312|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101304811|NCT02015312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101304812|NCT02015312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101379128|NCT00100776|Antiemetics|antiemetics|mesh-ancestor
101379129|NCT00100776|Autonomic Agents|autonomic agents|mesh-ancestor
101379130|NCT00100776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101379131|NCT00100776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379136|NCT00100776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101379137|NCT00100776|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101379138|NCT00100776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101379139|NCT00100776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101379140|NCT00100776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379141|NCT00100776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101379142|NCT00100776|Serotonin Agents|serotonin agents|mesh-ancestor
101379144|NCT00070538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101379145|NCT00070538|Antimetabolites|antimetabolites|mesh-ancestor
101379146|NCT00070538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379147|NCT00070538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379148|NCT00070538|Antiviral Agents|antiviral agents|mesh-ancestor
101379149|NCT00070538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101379150|NCT00070538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101379151|NCT00070538|Immunologic Factors|immunologic factors|mesh-ancestor
101379152|NCT00070538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379153|NCT00257023|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101379154|NCT00257023|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101379155|NCT00257023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101379156|NCT00257023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101379157|NCT00257023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379158|NCT00257023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101379159|NCT00257023|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101379160|NCT00257023|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101379161|NCT00257023|Serotonin Agents|serotonin agents|mesh-ancestor
101379162|NCT00257023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101379163|NCT00257023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379164|NCT00257023|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101379165|NCT00257023|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101379166|NCT00257023|Dopamine Agents|dopamine agents|mesh-ancestor
101379167|NCT00257062|Levofloxacin|levofloxacin|mesh-list
101379168|NCT00257062|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101379186|NCT00100854|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101379187|NCT00100854|Hormone Antagonists|hormone antagonists|mesh-ancestor
102060007|NCT04424641|Antibodies|antibodies|mesh-list
102060008|NCT04424641|Immunoglobulins|immunoglobulins|mesh-list
102060009|NCT04424641|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102060010|NCT04424641|Immunoglobulin G|immunoglobulin g|mesh-list
102060011|NCT04424641|Antibodies, Bispecific|antibodies, bispecific|mesh-list
102060012|NCT04424641|Immunologic Factors|immunologic factors|mesh-ancestor
102060013|NCT04424641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060014|NCT04394546|Anticoagulants|anticoagulants|mesh-list
102060015|NCT04393103|Atropine|atropine|mesh-list
102060016|NCT04393103|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101379188|NCT00100854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101379189|NCT00100854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379191|NCT00257140|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101379192|NCT00257140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101379193|NCT00257140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101379194|NCT00257140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101379195|NCT00257140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101304813|NCT02015403|Acetylcysteine|acetylcysteine|mesh-list
101304814|NCT02015403|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101304815|NCT02015403|Antiviral Agents|antiviral agents|mesh-ancestor
101304816|NCT02015403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101304817|NCT02015403|Expectorants|expectorants|mesh-ancestor
101304818|NCT02015403|Respiratory System Agents|respiratory system agents|mesh-ancestor
101304819|NCT02015403|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101379196|NCT00257140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101379197|NCT00257140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379201|NCT00257257|Rimonabant|rimonabant|mesh-list
101379202|NCT00257257|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101379203|NCT00257257|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
101379204|NCT00257257|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101379205|NCT00257257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101379206|NCT00257257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379207|NCT00257257|Hormones|hormones|mesh-ancestor
101379208|NCT00257257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101379209|NCT00257257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379210|NCT00257452|Moxifloxacin|moxifloxacin|mesh-list
101379211|NCT00257452|Tiotropium Bromide|tiotropium bromide|mesh-list
101379212|NCT00257452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101379213|NCT00257452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101379214|NCT00257452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101379215|NCT00257452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101379216|NCT00257452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101379217|NCT00257452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379223|NCT00257452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101379224|NCT00257452|Respiratory System Agents|respiratory system agents|mesh-ancestor
101379225|NCT00257452|Parasympatholytics|parasympatholytics|mesh-ancestor
101379226|NCT00257452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101379227|NCT00257452|Cholinergic Agents|cholinergic agents|mesh-ancestor
101379228|NCT00257452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101379229|NCT00257491|Telmisartan|telmisartan|mesh-list
101379230|NCT00257491|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101379231|NCT00257491|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101379232|NCT00257491|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101379233|NCT00257491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379234|NCT00104793|Carboplatin|carboplatin|mesh-list
101379235|NCT00104793|Irinotecan|irinotecan|mesh-list
101379236|NCT00104793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379237|NCT00104793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101379238|NCT00104793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101379239|NCT00104793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101379240|NCT00104793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379241|NCT00070655|Vitamin K|vitamin k|mesh-list
101379242|NCT00070655|Warfarin|warfarin|mesh-list
101379243|NCT00070655|Acenocoumarol|acenocoumarol|mesh-list
101379244|NCT00070655|Idraparinux|idraparinux|mesh-list
101379245|NCT00070655|Vitamins|vitamins|mesh-ancestor
102060017|NCT04393103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102060018|NCT04393103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102060019|NCT04393103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102060020|NCT04393103|Autonomic Agents|autonomic agents|mesh-ancestor
102060021|NCT04393103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102060022|NCT04393103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060023|NCT04393103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102060024|NCT04393103|Respiratory System Agents|respiratory system agents|mesh-ancestor
102060025|NCT04393103|Mydriatics|mydriatics|mesh-ancestor
102060026|NCT04393103|Parasympatholytics|parasympatholytics|mesh-ancestor
101379246|NCT00070655|Micronutrients|micronutrients|mesh-ancestor
101379247|NCT00070655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379248|NCT00070655|Anticoagulants|anticoagulants|mesh-ancestor
101379249|NCT00070655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101379250|NCT00070655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101379251|NCT00070655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379252|NCT00070655|Hemostatics|hemostatics|mesh-ancestor
101379253|NCT00070655|Coagulants|coagulants|mesh-ancestor
101379254|NCT00070655|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101379255|NCT00070655|Antithrombins|antithrombins|mesh-ancestor
101379256|NCT00070655|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101379257|NCT00070655|Protease Inhibitors|protease inhibitors|mesh-ancestor
101379258|NCT00070655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101379259|NCT00257530|Imiquimod|imiquimod|mesh-list
101379260|NCT00257530|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101379261|NCT00257530|Immunologic Factors|immunologic factors|mesh-ancestor
101304820|NCT02015403|Antioxidants|antioxidants|mesh-ancestor
101304821|NCT02015403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304822|NCT02015403|Protective Agents|protective agents|mesh-ancestor
101304823|NCT02015403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379262|NCT00257530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379263|NCT00257530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379264|NCT00257530|Interferon Inducers|interferon inducers|mesh-ancestor
101379266|NCT00257569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101379267|NCT00257569|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101379268|NCT00257569|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101379269|NCT00257569|Histamine Antagonists|histamine antagonists|mesh-ancestor
101379270|NCT00257569|Histamine Agents|histamine agents|mesh-ancestor
101379273|NCT00257569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379274|NCT00100893|Proanthocyanidin|proanthocyanidin|mesh-list
101379275|NCT00100893|Procyanidin|procyanidin|mesh-list
101379276|NCT00100893|Antioxidants|antioxidants|mesh-ancestor
101379277|NCT00100893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379278|NCT00100893|Protective Agents|protective agents|mesh-ancestor
101379279|NCT00100893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379280|NCT00100893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101379281|NCT00100893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101379282|NCT00100893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101379283|NCT00257803|Oxytocin|oxytocin|mesh-list
101379284|NCT00257803|Oxytocics|oxytocics|mesh-ancestor
101379285|NCT00257803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101379286|NCT00257803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379287|NCT00401115|Sirolimus|sirolimus|mesh-list
101379288|NCT00401115|Temsirolimus|temsirolimus|mesh-list
101379289|NCT00401115|MTOR Inhibitors|mtor inhibitors|mesh-list
101379290|NCT00401115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101379294|NCT00401115|Antifungal Agents|antifungal agents|mesh-ancestor
101379295|NCT00401115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101379296|NCT00401115|Immunologic Factors|immunologic factors|mesh-ancestor
101379297|NCT00401115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379298|NCT00401115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101379299|NCT00401115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101379300|NCT00401115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379302|NCT00257959|Sotalol|sotalol|mesh-list
101379303|NCT00257959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101379304|NCT00257959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102060027|NCT04393103|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102060028|NCT04393103|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102060029|NCT04393103|Cholinergic Agents|cholinergic agents|mesh-ancestor
102060030|NCT04393103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102060031|NCT04393103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060032|NCT04393103|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102060033|NCT04393103|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101379305|NCT00257959|Adrenergic Agents|adrenergic agents|mesh-ancestor
101379306|NCT00257959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101379307|NCT00257959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379308|NCT00257959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379309|NCT00257959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101379310|NCT00257959|Vasodilator Agents|vasodilator agents|mesh-ancestor
101379311|NCT00257959|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101379312|NCT00257959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101379313|NCT00257959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101379314|NCT00257959|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101379315|NCT00257959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101379316|NCT00257959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101379317|NCT00257959|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101379318|NCT00257959|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101379319|NCT00257959|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101379320|NCT00257959|Sympatholytics|sympatholytics|mesh-ancestor
101379321|NCT00257959|Autonomic Agents|autonomic agents|mesh-ancestor
101379322|NCT00257959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101379323|NCT00070733|Methyltestosterone|methyltestosterone|mesh-list
101379324|NCT00070733|Testosterone|testosterone|mesh-list
101379325|NCT00070733|Testosterone undecanoate|testosterone undecanoate|mesh-list
101379326|NCT00070733|Testosterone enanthate|testosterone enanthate|mesh-list
101379327|NCT00070733|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101379328|NCT00070733|Androgens|androgens|mesh-ancestor
101379329|NCT00070733|Hormones|hormones|mesh-ancestor
101456553|NCT04662385|Protective Agents|protective agents|mesh-ancestor
101304825|NCT02015494|Hemagglutinins|hemagglutinins|mesh-list
101304826|NCT02015494|Immunologic Factors|immunologic factors|mesh-ancestor
101379330|NCT00070733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101379331|NCT00070733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379332|NCT00070733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101379333|NCT00070733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379334|NCT00070733|Anabolic Agents|anabolic agents|mesh-ancestor
101379335|NCT00258076|Contraceptive Agents|contraceptive agents|mesh-list
101379336|NCT00258076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101379337|NCT00258076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379338|NCT00258115|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
101379339|NCT00258115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101379340|NCT00258115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101379341|NCT00258115|Analgesics|analgesics|mesh-ancestor
101379342|NCT00258115|Sensory System Agents|sensory system agents|mesh-ancestor
101379347|NCT00258193|Linaclotide|linaclotide|mesh-list
101379348|NCT00258193|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
101379349|NCT00258193|Enzyme Activators|enzyme activators|mesh-ancestor
101379350|NCT00258193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379351|NCT00258193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101379352|NCT00100971|Vaccines|vaccines|mesh-list
101379353|NCT00100971|Immunologic Factors|immunologic factors|mesh-ancestor
101379354|NCT00100971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379355|NCT00258232|Celecoxib|celecoxib|mesh-list
101379356|NCT00258232|Capecitabine|capecitabine|mesh-list
101379357|NCT00258232|Irinotecan|irinotecan|mesh-list
101379358|NCT00258232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101379359|NCT00258232|Antimetabolites|antimetabolites|mesh-ancestor
101379360|NCT00258232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379361|NCT00258232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379366|NCT00258232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101379367|NCT00258232|Analgesics|analgesics|mesh-ancestor
102060034|NCT04393103|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102060035|NCT04334629|Ibuprofen|ibuprofen|mesh-list
102060036|NCT04334629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102060037|NCT04334629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102060038|NCT04334629|Analgesics|analgesics|mesh-ancestor
102060039|NCT04334629|Sensory System Agents|sensory system agents|mesh-ancestor
102060040|NCT04334629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102060041|NCT04334629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060042|NCT04334629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102060043|NCT04334629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101379368|NCT00258232|Sensory System Agents|sensory system agents|mesh-ancestor
101379369|NCT00258232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101379370|NCT00258232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379371|NCT00258232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101379372|NCT00258232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101379373|NCT00258232|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101379374|NCT00258232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101379375|NCT00258271|Cytarabine|cytarabine|mesh-list
101379376|NCT00258271|Imatinib Mesylate|imatinib mesylate|mesh-list
101379377|NCT00258271|Cladribine|cladribine|mesh-list
101379378|NCT00258271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101379379|NCT00258271|Antimetabolites|antimetabolites|mesh-ancestor
101379380|NCT00258271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379381|NCT00258271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379382|NCT00258271|Antiviral Agents|antiviral agents|mesh-ancestor
101379383|NCT00258271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101379384|NCT00258271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101379385|NCT00258271|Immunologic Factors|immunologic factors|mesh-ancestor
101379386|NCT00258271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379387|NCT00258271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101379388|NCT00258271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101379389|NCT00101088|Sirolimus|sirolimus|mesh-list
101379390|NCT00101088|Imatinib Mesylate|imatinib mesylate|mesh-list
101379391|NCT00101088|Temsirolimus|temsirolimus|mesh-list
101379392|NCT00101088|MTOR Inhibitors|mtor inhibitors|mesh-list
101379393|NCT00101088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379394|NCT00101088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101379395|NCT00101088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101379396|NCT00101088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379397|NCT00101088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101379398|NCT00101088|Immunologic Factors|immunologic factors|mesh-ancestor
101379399|NCT00101088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379400|NCT00101088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101379401|NCT00101088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101304827|NCT02015494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304828|NCT02015494|Agglutinins|agglutinins|mesh-ancestor
101304829|NCT02015494|Coagulants|coagulants|mesh-ancestor
101304830|NCT02015507|Ciprofloxacin|ciprofloxacin|mesh-list
101304831|NCT02015507|Ivacaftor|ivacaftor|mesh-list
101304832|NCT02015507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101304833|NCT02015507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101304834|NCT02015507|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101304835|NCT02015507|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101304836|NCT02015507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101304837|NCT02015507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304838|NCT02015507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101304839|NCT02015507|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101304840|NCT02015507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101304841|NCT02015507|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101304842|NCT02015507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101304843|NCT02015559|Protective Agents|protective agents|mesh-list
101379402|NCT00101088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101379403|NCT00101088|Antifungal Agents|antifungal agents|mesh-ancestor
101379404|NCT00258622|Lidocaine|lidocaine|mesh-list
101379405|NCT00258622|Anesthetics, Local|anesthetics, local|mesh-ancestor
102060044|NCT04334629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102060045|NCT04334629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102060046|NCT04334629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060047|NCT04329975|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
102060048|NCT04329975|Hemostatics|hemostatics|mesh-ancestor
102060049|NCT04329975|Coagulants|coagulants|mesh-ancestor
102060050|NCT04329975|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102060051|NCT04329975|Natriuretic Agents|natriuretic agents|mesh-ancestor
101379406|NCT00258622|Anesthetics|anesthetics|mesh-ancestor
101379407|NCT00258622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101379408|NCT00258622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379409|NCT00258622|Sensory System Agents|sensory system agents|mesh-ancestor
101379410|NCT00258622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101379411|NCT00258622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101379412|NCT00258622|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101379413|NCT00258622|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101379418|NCT00423761|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101379419|NCT00423761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101379420|NCT00423761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379421|NCT00423761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101379422|NCT00423761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101379423|NCT00423761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101379424|NCT00423761|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101379425|NCT00423761|Anesthetics, General|anesthetics, general|mesh-ancestor
101379426|NCT00423761|Anesthetics|anesthetics|mesh-ancestor
101379427|NCT00423761|GABA Modulators|gaba modulators|mesh-ancestor
101379428|NCT00423761|GABA Agents|gaba agents|mesh-ancestor
101379429|NCT00423761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101379430|NCT00423761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379431|NCT00104910|Cetuximab|cetuximab|mesh-list
101379432|NCT00104910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379433|NCT00104910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101379434|NCT00415324|Cisplatin|cisplatin|mesh-list
101379435|NCT00415324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379436|NCT00258739|Carboplatin|carboplatin|mesh-list
101379437|NCT00258739|Gemcitabine|gemcitabine|mesh-list
101379438|NCT00258739|Docetaxel|docetaxel|mesh-list
101313413|NCT00000145|Antioxidants|antioxidants|mesh-list
101379439|NCT00258739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379440|NCT00258739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101379441|NCT00258739|Antimetabolites|antimetabolites|mesh-ancestor
101379442|NCT00258739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379443|NCT00258739|Tubulin Modulators|tubulin modulators|mesh-ancestor
101304844|NCT02015559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304845|NCT02015598|Carbocysteine|carbocysteine|mesh-list
101304846|NCT02015598|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101304847|NCT02015598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101304848|NCT02015598|Expectorants|expectorants|mesh-ancestor
101304849|NCT02015598|Respiratory System Agents|respiratory system agents|mesh-ancestor
101304850|NCT02015650|Fluorouracil|fluorouracil|mesh-list
101304851|NCT02015650|Cetuximab|cetuximab|mesh-list
101304852|NCT02015650|Mitomycins|mitomycins|mesh-list
101304853|NCT02015650|Mitomycin|mitomycin|mesh-list
101304854|NCT02015650|Antimetabolites|antimetabolites|mesh-ancestor
101304855|NCT02015650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304856|NCT02015650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101304857|NCT02015650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101304858|NCT02015650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101304859|NCT02015650|Immunologic Factors|immunologic factors|mesh-ancestor
101304860|NCT02015650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304861|NCT02015650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101304862|NCT02015650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101304863|NCT02015650|Alkylating Agents|alkylating agents|mesh-ancestor
101304864|NCT02015650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101304865|NCT02015650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101304866|NCT02015728|Etoposide|etoposide|mesh-list
101304867|NCT02015728|Everolimus|everolimus|mesh-list
101304868|NCT02015728|Temozolomide|temozolomide|mesh-list
102060052|NCT04329975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060053|NCT04300647|Atezolizumab|atezolizumab|mesh-list
102060054|NCT04300647|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102060055|NCT04300647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060056|NCT04300647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102060057|NCT04300647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101304869|NCT02015728|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101304870|NCT02015728|Sorafenib|sorafenib|mesh-list
101304871|NCT02015728|Dasatinib|dasatinib|mesh-list
101304872|NCT02015728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101304873|NCT02015728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101304874|NCT02015728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101304875|NCT02015728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101304876|NCT02015728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101304877|NCT02015728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304878|NCT02015728|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101304879|NCT02015728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101304885|NCT02015780|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101304886|NCT02015780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304887|NCT02015923|Panitumumab|panitumumab|mesh-list
101304888|NCT02015923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101304889|NCT02015923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101304890|NCT02015949|Methylphenidate|methylphenidate|mesh-list
101304891|NCT02015949|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101304892|NCT02015949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304893|NCT02015949|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101304894|NCT02015949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101304898|NCT02015949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101304899|NCT02015988|Simvastatin|simvastatin|mesh-list
101379444|NCT00258739|Antimitotic Agents|antimitotic agents|mesh-ancestor
101379445|NCT00258739|Mitosis Modulators|mitosis modulators|mesh-ancestor
101379447|NCT00104949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101379448|NCT00104949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379449|NCT00101127|Gemcitabine|gemcitabine|mesh-list
101379451|NCT00101127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101379452|NCT00101127|Antimetabolites|antimetabolites|mesh-ancestor
101379453|NCT00101127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379454|NCT00101127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379455|NCT00101127|Tubulin Modulators|tubulin modulators|mesh-ancestor
101379456|NCT00101127|Antimitotic Agents|antimitotic agents|mesh-ancestor
101379457|NCT00101127|Mitosis Modulators|mitosis modulators|mesh-ancestor
101379458|NCT00259051|Omeprazole|omeprazole|mesh-list
101379459|NCT00259051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101379460|NCT00259051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101379461|NCT00259051|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101379462|NCT00259051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101379463|NCT00259051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379464|NCT00259129|Sorafenib|sorafenib|mesh-list
101379465|NCT00259129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379466|NCT00259129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101379467|NCT00259129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101379468|NCT00259129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379469|NCT00259168|Nateglinide|nateglinide|mesh-list
101379470|NCT00259168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101379471|NCT00259168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379472|NCT00259363|Oxaliplatin|oxaliplatin|mesh-list
101379473|NCT00259363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379474|NCT00104988|Thalidomide|thalidomide|mesh-list
101379475|NCT00104988|Temozolomide|temozolomide|mesh-list
101379476|NCT00104988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101379477|NCT00104988|Alkylating Agents|alkylating agents|mesh-ancestor
101379478|NCT00104988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379479|NCT00104988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379480|NCT00104988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101379481|NCT00104988|Immunologic Factors|immunologic factors|mesh-ancestor
101379482|NCT00104988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379483|NCT00104988|Leprostatic Agents|leprostatic agents|mesh-ancestor
102060058|NCT04296890|Maytansine|maytansine|mesh-list
102060059|NCT04296890|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
102060060|NCT04296890|Immunoconjugates|immunoconjugates|mesh-ancestor
102060061|NCT04296890|Immunologic Factors|immunologic factors|mesh-ancestor
102060062|NCT04296890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379484|NCT00104988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101379485|NCT00104988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101379486|NCT00104988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101379487|NCT00104988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101379488|NCT00104988|Growth Substances|growth substances|mesh-ancestor
101304900|NCT02015988|Fenofibrate|fenofibrate|mesh-list
101304901|NCT02015988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101304902|NCT02015988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101379496|NCT00415402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101379498|NCT00259402|Oxaliplatin|oxaliplatin|mesh-list
101379499|NCT00259402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379500|NCT00259402|Antimetabolites|antimetabolites|mesh-ancestor
101379501|NCT00259402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379502|NCT00259402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101379503|NCT00259402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101379504|NCT00259402|Immunologic Factors|immunologic factors|mesh-ancestor
101379505|NCT00259402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379506|NCT00259441|Simvastatin|simvastatin|mesh-list
101379507|NCT00259441|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101379508|NCT00259441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101379509|NCT00259441|Antimetabolites|antimetabolites|mesh-ancestor
101379510|NCT00259441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379511|NCT00259441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101379512|NCT00259441|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101379513|NCT00259441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101379514|NCT00071201|Adefovir|adefovir|mesh-list
101379515|NCT00071201|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101379528|NCT00259636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379529|NCT00259675|Carboplatin|carboplatin|mesh-list
101379530|NCT00259675|Gemcitabine|gemcitabine|mesh-list
101379531|NCT00259675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379532|NCT00259675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101379533|NCT00259675|Antimetabolites|antimetabolites|mesh-ancestor
101379534|NCT00259675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379535|NCT00105105|Mifepristone|mifepristone|mesh-list
101379536|NCT00105105|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101379537|NCT00105105|Abortifacient Agents|abortifacient agents|mesh-ancestor
101379538|NCT00105105|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101379539|NCT00105105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379540|NCT00105105|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101379541|NCT00105105|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101379542|NCT00105105|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101379543|NCT00105105|Contraceptive Agents|contraceptive agents|mesh-ancestor
101379544|NCT00105105|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101379545|NCT00105105|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101379546|NCT00105105|Hormone Antagonists|hormone antagonists|mesh-ancestor
101379547|NCT00105105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101379548|NCT00105105|Luteolytic Agents|luteolytic agents|mesh-ancestor
101379549|NCT00105105|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101379550|NCT00105105|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101379551|NCT00259714|Dialysis Solutions|dialysis solutions|mesh-list
101379552|NCT00259714|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101379553|NCT00071240|Hormones|hormones|mesh-list
101379554|NCT00071240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101379558|NCT00259792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101379559|NCT00259792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101379560|NCT00259792|Autonomic Agents|autonomic agents|mesh-ancestor
101379561|NCT00259792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101379562|NCT00259792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379563|NCT00259792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101379564|NCT00259792|Respiratory System Agents|respiratory system agents|mesh-ancestor
101379565|NCT00259792|Glucocorticoids|glucocorticoids|mesh-ancestor
101379566|NCT00259792|Hormones|hormones|mesh-ancestor
101304903|NCT02015988|Antimetabolites|antimetabolites|mesh-ancestor
102060063|NCT04296890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102060064|NCT04296890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102060065|NCT04296890|Tubulin Modulators|tubulin modulators|mesh-ancestor
102060066|NCT04296890|Antimitotic Agents|antimitotic agents|mesh-ancestor
102060067|NCT04296890|Mitosis Modulators|mitosis modulators|mesh-ancestor
102060068|NCT04296890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060069|NCT04276090|Dexamethasone|dexamethasone|mesh-list
102060070|NCT04276090|Floxuridine|floxuridine|mesh-list
102060071|NCT04276090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102060072|NCT04276090|Antiemetics|antiemetics|mesh-ancestor
102060073|NCT04276090|Autonomic Agents|autonomic agents|mesh-ancestor
101304904|NCT02015988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304905|NCT02015988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101304906|NCT02015988|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101304907|NCT02015988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101304908|NCT02016001|Fluorides|fluorides|mesh-list
101304909|NCT02016001|Cariostatic Agents|cariostatic agents|mesh-ancestor
101304910|NCT02016001|Protective Agents|protective agents|mesh-ancestor
101313525|NCT00000421|Hormones|hormones|mesh-ancestor
101379567|NCT00259792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101379568|NCT00259792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101379575|NCT00105144|Micafungin|micafungin|mesh-list
101379576|NCT00105144|Antifungal Agents|antifungal agents|mesh-ancestor
101379577|NCT00105144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101379578|NCT00105144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101379579|NCT00105144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379580|NCT00259870|Olanzapine|olanzapine|mesh-list
101379581|NCT00259870|Antiemetics|antiemetics|mesh-ancestor
101379582|NCT00259870|Autonomic Agents|autonomic agents|mesh-ancestor
101379583|NCT00259870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101379584|NCT00259870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379585|NCT00259870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101379586|NCT00259870|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101379587|NCT00259870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101379588|NCT00259870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101379589|NCT00259870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101379590|NCT00259870|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101379591|NCT00259870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101379592|NCT00259870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101379593|NCT00259870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379595|NCT00259870|Serotonin Agents|serotonin agents|mesh-ancestor
101379596|NCT00071279|Idraparinux|idraparinux|mesh-list
101379597|NCT00071279|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101379598|NCT00071279|Antithrombins|antithrombins|mesh-ancestor
101379599|NCT00071279|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101379600|NCT00071279|Protease Inhibitors|protease inhibitors|mesh-ancestor
101379601|NCT00071279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101379602|NCT00071279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379603|NCT00071279|Anticoagulants|anticoagulants|mesh-ancestor
101379604|NCT00259987|Lapatinib|lapatinib|mesh-list
101379605|NCT00259987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379606|NCT00259987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101379607|NCT00259987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101379608|NCT00259987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379609|NCT00260026|Docetaxel|docetaxel|mesh-list
101379610|NCT00260026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379611|NCT00260026|Tubulin Modulators|tubulin modulators|mesh-ancestor
101379612|NCT00260026|Antimitotic Agents|antimitotic agents|mesh-ancestor
101379613|NCT00260026|Mitosis Modulators|mitosis modulators|mesh-ancestor
101379614|NCT00260026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379615|NCT00260143|Methyltestosterone|methyltestosterone|mesh-list
101379616|NCT00260143|Testosterone|testosterone|mesh-list
101379617|NCT00260143|Testosterone undecanoate|testosterone undecanoate|mesh-list
102060074|NCT04276090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102060075|NCT04276090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060076|NCT04276090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102060077|NCT04276090|Glucocorticoids|glucocorticoids|mesh-ancestor
102060078|NCT04276090|Hormones|hormones|mesh-ancestor
102060079|NCT04276090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102060080|NCT04276090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102060081|NCT04276090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102060082|NCT04276090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102060083|NCT04276090|Antimetabolites|antimetabolites|mesh-ancestor
102060084|NCT04276090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060085|NCT04273139|Venetoclax|venetoclax|mesh-list
102060086|NCT04273139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102060087|NCT04081688|Atezolizumab|atezolizumab|mesh-list
101379618|NCT00260143|Testosterone enanthate|testosterone enanthate|mesh-list
101379619|NCT00260143|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101379620|NCT00260143|Androgens|androgens|mesh-ancestor
101379621|NCT00260143|Hormones|hormones|mesh-ancestor
101379622|NCT00260143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101379623|NCT00260143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379624|NCT00260143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101304911|NCT02016001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304912|NCT02016157|Moxifloxacin|moxifloxacin|mesh-list
101304913|NCT02016157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101304914|NCT02016157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101304915|NCT02016157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101304916|NCT02016157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101304917|NCT02016157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101304918|NCT02016157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304919|NCT02016157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379625|NCT00260143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379626|NCT00260143|Anabolic Agents|anabolic agents|mesh-ancestor
101379630|NCT00260260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101379638|NCT00105300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101379639|NCT00260416|Abciximab|abciximab|mesh-list
101379640|NCT00260416|Anticoagulants|anticoagulants|mesh-ancestor
101379641|NCT00260416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101379642|NCT00260611|Docetaxel|docetaxel|mesh-list
101379643|NCT00260611|Oxaliplatin|oxaliplatin|mesh-list
101379644|NCT00260611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379645|NCT00260611|Tubulin Modulators|tubulin modulators|mesh-ancestor
101379646|NCT00260611|Antimitotic Agents|antimitotic agents|mesh-ancestor
101379647|NCT00260611|Mitosis Modulators|mitosis modulators|mesh-ancestor
101379648|NCT00260611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379649|NCT00424086|Vaccines|vaccines|mesh-list
101379650|NCT00424086|Immunologic Factors|immunologic factors|mesh-ancestor
101379651|NCT00424086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379652|NCT00101205|Oxaliplatin|oxaliplatin|mesh-list
101379653|NCT00101205|Etoposide|etoposide|mesh-list
101379654|NCT00101205|Etoposide phosphate|etoposide phosphate|mesh-list
101379655|NCT00101205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379656|NCT00101205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101379657|NCT00101205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101379658|NCT00101205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101379659|NCT00101205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101379660|NCT00101205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379661|NCT00261079|Fexofenadine|fexofenadine|mesh-list
101379662|NCT00261079|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102060089|NCT04081688|Immunoglobulins|immunoglobulins|mesh-list
101477920|NCT00309855|Anastrozole|anastrozole|mesh-list
101379663|NCT00261079|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101379664|NCT00261079|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101379665|NCT00261079|Histamine Antagonists|histamine antagonists|mesh-ancestor
101379666|NCT00261079|Histamine Agents|histamine agents|mesh-ancestor
101379667|NCT00261079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101379668|NCT00261079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379669|NCT00261079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379670|NCT00261118|Rituximab|rituximab|mesh-list
101379671|NCT00261118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101379672|NCT00261118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379673|NCT00261118|Immunologic Factors|immunologic factors|mesh-ancestor
101379674|NCT00261118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379675|NCT00261118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101379676|NCT00071747|Lamotrigine|lamotrigine|mesh-list
101379677|NCT00071747|Anticonvulsants|anticonvulsants|mesh-ancestor
101379678|NCT00071747|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101379679|NCT00071747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101379680|NCT00071747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379681|NCT00071747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101379682|NCT00071747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304920|NCT02016196|Rifaximin|rifaximin|mesh-list
101304921|NCT02016196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101304922|NCT02016196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101304923|NCT02016196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101304924|NCT02016209|Paclitaxel|paclitaxel|mesh-list
101304925|NCT02016209|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101304926|NCT02016209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101304927|NCT02016209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101304928|NCT02016209|Tubulin Modulators|tubulin modulators|mesh-ancestor
101304929|NCT02016209|Antimitotic Agents|antimitotic agents|mesh-ancestor
101304930|NCT02016209|Mitosis Modulators|mitosis modulators|mesh-ancestor
101304931|NCT02016209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304932|NCT02016261|Fluvoxamine|fluvoxamine|mesh-list
101304933|NCT02016261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101304934|NCT02016261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101304939|NCT02016261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101379684|NCT00071747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101379685|NCT00071747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101379686|NCT00071747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101379687|NCT00071747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101379688|NCT00261313|Darbepoetin alfa|darbepoetin alfa|mesh-list
101379689|NCT00261313|Hematinics|hematinics|mesh-ancestor
101379690|NCT00261352|Metformin|metformin|mesh-list
101379691|NCT00261352|Fenofibrate|fenofibrate|mesh-list
101379692|NCT00261352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101379693|NCT00261352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379694|NCT00261352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101379695|NCT00261352|Antimetabolites|antimetabolites|mesh-ancestor
101379696|NCT00261352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379697|NCT00261352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101379698|NCT00261391|Marimastat|marimastat|mesh-list
101379699|NCT00261391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101379700|NCT00261391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379706|NCT00071942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101379707|NCT00071942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101379708|NCT00071942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101379709|NCT00261469|Topiramate|topiramate|mesh-list
101379710|NCT00261469|Anticonvulsants|anticonvulsants|mesh-ancestor
101379711|NCT00261469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101379712|NCT00261469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379713|NCT00261508|Risperidone|risperidone|mesh-list
101379714|NCT00261508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101379715|NCT00261508|Serotonin Agents|serotonin agents|mesh-ancestor
101379716|NCT00261508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101379717|NCT00261508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379718|NCT00261508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379719|NCT00261508|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101379720|NCT00261508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102060090|NCT04081688|Immunoglobulin G|immunoglobulin g|mesh-list
102060091|NCT04081688|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102060092|NCT04081688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060093|NCT04081688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102060094|NCT04081688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102060095|NCT04081688|Immunologic Factors|immunologic factors|mesh-ancestor
102060096|NCT04081688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060097|NCT04064814|Thioctic Acid|thioctic acid|mesh-list
102060098|NCT04064814|Flunarizine|flunarizine|mesh-list
102060099|NCT04064814|Antioxidants|antioxidants|mesh-ancestor
101379721|NCT00261508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101379722|NCT00261508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101304940|NCT02016261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101304941|NCT02016261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304942|NCT02016261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101304944|NCT02016261|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101304945|NCT02016261|Antidepressive Agents|antidepressive agents|mesh-ancestor
101304946|NCT02016261|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101304947|NCT02016261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101304948|NCT02016261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101379723|NCT00261508|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101379724|NCT00261508|Dopamine Agents|dopamine agents|mesh-ancestor
101379725|NCT00261547|Rituximab|rituximab|mesh-list
101379726|NCT00261547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101379727|NCT00261547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379728|NCT00261547|Immunologic Factors|immunologic factors|mesh-ancestor
101379729|NCT00261547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379730|NCT00261547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101379731|NCT00261586|Aspirin|aspirin|mesh-list
101379732|NCT00261586|Acetaminophen|acetaminophen|mesh-list
101379733|NCT00261586|Ibuprofen|ibuprofen|mesh-list
101379734|NCT00261586|Celecoxib|celecoxib|mesh-list
101379735|NCT00261586|Naproxen|naproxen|mesh-list
101379736|NCT00261586|Rofecoxib|rofecoxib|mesh-list
101379737|NCT00261586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101379738|NCT00261586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101379739|NCT00261586|Analgesics|analgesics|mesh-ancestor
101379740|NCT00261586|Sensory System Agents|sensory system agents|mesh-ancestor
101379741|NCT00261586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101379742|NCT00261586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379754|NCT00072020|Zoledronic Acid|zoledronic acid|mesh-list
101379755|NCT00072020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101379756|NCT00072020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379757|NCT00261625|Alendronate|alendronate|mesh-list
101379758|NCT00261625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101379759|NCT00261625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379760|NCT00261703|Cisplatin|cisplatin|mesh-list
101379761|NCT00261703|Docetaxel|docetaxel|mesh-list
101379762|NCT00261703|Fluorouracil|fluorouracil|mesh-list
101379763|NCT00261703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379764|NCT00261703|Tubulin Modulators|tubulin modulators|mesh-ancestor
101379765|NCT00261703|Antimitotic Agents|antimitotic agents|mesh-ancestor
101379766|NCT00261703|Mitosis Modulators|mitosis modulators|mesh-ancestor
101379767|NCT00261703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379768|NCT00261703|Antimetabolites|antimetabolites|mesh-ancestor
101379769|NCT00261703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101379770|NCT00261703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101379771|NCT00261703|Immunologic Factors|immunologic factors|mesh-ancestor
101379772|NCT00261703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379773|NCT00261742|Penicillins|penicillins|mesh-list
101313592|NCT00000478|Atenolol|atenolol|mesh-list
101379774|NCT00261742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101379794|NCT00261820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101379795|NCT00261820|Antifungal Agents|antifungal agents|mesh-ancestor
102060100|NCT04064814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060101|NCT04064814|Protective Agents|protective agents|mesh-ancestor
102060102|NCT04064814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060103|NCT04064814|Vitamin B Complex|vitamin b complex|mesh-ancestor
102060104|NCT04064814|Vitamins|vitamins|mesh-ancestor
102060105|NCT04064814|Micronutrients|micronutrients|mesh-ancestor
102060106|NCT04064814|Anticonvulsants|anticonvulsants|mesh-ancestor
102060107|NCT04064814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102060108|NCT04064814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102060109|NCT04064814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102060110|NCT04064814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102060111|NCT04064814|Histamine Antagonists|histamine antagonists|mesh-ancestor
101379796|NCT00261820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101379798|NCT00261820|Autonomic Agents|autonomic agents|mesh-ancestor
101379799|NCT00261820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101304949|NCT02016261|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101304951|NCT02016274|Cisplatin|cisplatin|mesh-list
101304952|NCT02016274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101304953|NCT02016274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101304954|NCT02016274|Tubulin Modulators|tubulin modulators|mesh-ancestor
101379800|NCT00261820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101379801|NCT00261820|Glucocorticoids|glucocorticoids|mesh-ancestor
101379802|NCT00261820|Hormones|hormones|mesh-ancestor
101379803|NCT00261820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101379804|NCT00261820|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101379805|NCT00261820|Protective Agents|protective agents|mesh-ancestor
101379806|NCT00261820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101379807|NCT00072098|Interleukin-12|interleukin-12|mesh-list
101379808|NCT00072098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101379809|NCT00072098|Immunologic Factors|immunologic factors|mesh-ancestor
101379810|NCT00072098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379811|NCT00072098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101379812|NCT00072098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101379813|NCT00072098|Growth Substances|growth substances|mesh-ancestor
101379814|NCT00072098|Growth Inhibitors|growth inhibitors|mesh-ancestor
101379815|NCT00072098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379816|NCT00261937|Furosemide|furosemide|mesh-list
101379817|NCT00261937|Diuretics|diuretics|mesh-ancestor
101379818|NCT00261937|Natriuretic Agents|natriuretic agents|mesh-ancestor
101379819|NCT00261937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379820|NCT00261937|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101379821|NCT00261937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101379827|NCT00105495|Sequestering Agents|sequestering agents|mesh-ancestor
101379828|NCT00105495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379829|NCT00105495|Siderophores|siderophores|mesh-ancestor
101379831|NCT00261976|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101379832|NCT00261976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101379842|NCT00072137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379843|NCT00072137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379844|NCT00072137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101379845|NCT00072137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101379846|NCT00072137|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101379847|NCT00072137|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101379848|NCT00072137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101379849|NCT00262015|Vaccines|vaccines|mesh-list
101379850|NCT00262015|Immunologic Factors|immunologic factors|mesh-ancestor
101379851|NCT00262015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379852|NCT00262054|Heparin|heparin|mesh-list
101379853|NCT00262054|Calcium heparin|calcium heparin|mesh-list
102060112|NCT04064814|Histamine Agents|histamine agents|mesh-ancestor
102060113|NCT04064814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102060114|NCT04064814|Vasodilator Agents|vasodilator agents|mesh-ancestor
102060115|NCT03972306|Ocrelizumab|ocrelizumab|mesh-list
102060116|NCT03972306|Immunologic Factors|immunologic factors|mesh-ancestor
102060117|NCT03972306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379854|NCT00262054|Bivalirudin|bivalirudin|mesh-list
101379855|NCT00262054|Anticoagulants|anticoagulants|mesh-ancestor
101379856|NCT00262054|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101379857|NCT00262054|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101379858|NCT00262054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379859|NCT00262054|Antithrombins|antithrombins|mesh-ancestor
101379860|NCT00262054|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101379861|NCT00262054|Protease Inhibitors|protease inhibitors|mesh-ancestor
101379862|NCT00262054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101379863|NCT00262132|Mycophenolic Acid|mycophenolic acid|mesh-list
101379864|NCT00262132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101379865|NCT00262132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379866|NCT00262132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101379867|NCT00262132|Antitubercular Agents|antitubercular agents|mesh-ancestor
101379868|NCT00262132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101379869|NCT00262132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101379870|NCT00262132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101379871|NCT00262132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379872|NCT00262210|Prednisolone|prednisolone|mesh-list
101304955|NCT02016274|Antimitotic Agents|antimitotic agents|mesh-ancestor
101304956|NCT02016274|Mitosis Modulators|mitosis modulators|mesh-ancestor
101379873|NCT00262210|Cyclophosphamide|cyclophosphamide|mesh-list
101379874|NCT00262210|Etoposide|etoposide|mesh-list
101379875|NCT00262210|Epirubicin|epirubicin|mesh-list
101379876|NCT00262210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101379877|NCT00262210|Immunologic Factors|immunologic factors|mesh-ancestor
101379878|NCT00262210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379879|NCT00262210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101379880|NCT00262210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101379881|NCT00262210|Alkylating Agents|alkylating agents|mesh-ancestor
101379882|NCT00262210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379883|NCT00262210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379884|NCT00262210|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101379885|NCT00262210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101379886|NCT00262210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101379887|NCT00262210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101379888|NCT00262210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101379889|NCT00262210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101379890|NCT00262210|Glucocorticoids|glucocorticoids|mesh-ancestor
101379891|NCT00262210|Hormones|hormones|mesh-ancestor
101379892|NCT00262210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101379893|NCT00262210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101379894|NCT00262210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101379895|NCT00262288|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
101379896|NCT00262288|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101379897|NCT00262288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101379898|NCT00262288|Immunologic Factors|immunologic factors|mesh-ancestor
101379899|NCT00262288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379907|NCT02966288|Ibuprofen|ibuprofen|mesh-list
101379908|NCT02966288|Ketorolac|ketorolac|mesh-list
101379909|NCT02966288|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101379910|NCT02966288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101379911|NCT02966288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101379912|NCT02966288|Analgesics|analgesics|mesh-ancestor
101379913|NCT02966288|Sensory System Agents|sensory system agents|mesh-ancestor
101379914|NCT02966288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101379915|NCT02966288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379916|NCT02966288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101379917|NCT02966288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101379918|NCT02966288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101379919|NCT02966288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101379920|NCT02966288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379921|NCT00262405|Prednisone|prednisone|mesh-list
102060118|NCT03924414|Zoledronic Acid|zoledronic acid|mesh-list
102060119|NCT03924414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102060120|NCT03924414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060122|NCT03910452|Cyclophosphamide|cyclophosphamide|mesh-list
102060123|NCT03910452|Busulfan|busulfan|mesh-list
102060124|NCT03910452|Alemtuzumab|alemtuzumab|mesh-list
102060125|NCT03910452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101379922|NCT00262405|Zileuton|zileuton|mesh-list
101379923|NCT00262405|Azathioprine|azathioprine|mesh-list
101379924|NCT00262405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101379925|NCT00262405|Glucocorticoids|glucocorticoids|mesh-ancestor
101379926|NCT00262405|Hormones|hormones|mesh-ancestor
101379927|NCT00262405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101379928|NCT00262405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379929|NCT00262405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101379930|NCT00262405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379931|NCT00262405|Antimetabolites|antimetabolites|mesh-ancestor
101379932|NCT00262405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379933|NCT00262405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101379934|NCT00262405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101379935|NCT00262405|Immunologic Factors|immunologic factors|mesh-ancestor
101379936|NCT00262405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101379937|NCT00262405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101379938|NCT00262405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101379939|NCT00262405|Analgesics|analgesics|mesh-ancestor
101379940|NCT00262405|Sensory System Agents|sensory system agents|mesh-ancestor
101379941|NCT00262405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101379942|NCT00262405|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101379943|NCT00262405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101304957|NCT02016274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304958|NCT02016287|Paclitaxel|paclitaxel|mesh-list
101304959|NCT02016287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101379944|NCT00262405|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101379945|NCT00262405|Hormone Antagonists|hormone antagonists|mesh-ancestor
101379946|NCT00262483|Ribavirin|ribavirin|mesh-list
101379947|NCT00262483|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101379948|NCT00262483|Antimetabolites|antimetabolites|mesh-ancestor
101379949|NCT00262483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379950|NCT00262483|Antiviral Agents|antiviral agents|mesh-ancestor
101379951|NCT00262483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101379952|NCT00262561|Aspirin|aspirin|mesh-list
101379953|NCT00262561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101379954|NCT00262561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101379955|NCT00262561|Analgesics|analgesics|mesh-ancestor
101379956|NCT00262561|Sensory System Agents|sensory system agents|mesh-ancestor
101379957|NCT00262561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101379958|NCT00262561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379959|NCT00262561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101379960|NCT00262561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101379961|NCT00262561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101379962|NCT00262561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101379963|NCT00262561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379964|NCT00262561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101379965|NCT00262561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101379966|NCT00262561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101379967|NCT00262561|Antipyretics|antipyretics|mesh-ancestor
101379968|NCT00072215|Paclitaxel|paclitaxel|mesh-list
101379969|NCT00072215|Vinblastine|vinblastine|mesh-list
101379970|NCT00072215|Ifosfamide|ifosfamide|mesh-list
101379977|NCT00072215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101379978|NCT00072215|Alkylating Agents|alkylating agents|mesh-ancestor
101379979|NCT00262795|Fludarabine|fludarabine|mesh-list
101379980|NCT00262795|Chlorambucil|chlorambucil|mesh-list
101379981|NCT00262795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379982|NCT00262795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060126|NCT03910452|Immunologic Factors|immunologic factors|mesh-ancestor
102060127|NCT03910452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060128|NCT03910452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102060129|NCT03910452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102060130|NCT03910452|Alkylating Agents|alkylating agents|mesh-ancestor
102060131|NCT03910452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060132|NCT03910452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102060133|NCT03910452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102060134|NCT03910452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102060135|NCT03910452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101379983|NCT00262795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101379984|NCT00262795|Alkylating Agents|alkylating agents|mesh-ancestor
101379985|NCT00072332|Cisplatin|cisplatin|mesh-list
101379986|NCT00072332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379987|NCT00263029|Capecitabine|capecitabine|mesh-list
101379988|NCT00263029|Oxaliplatin|oxaliplatin|mesh-list
101379989|NCT00263029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101379990|NCT00263029|Antimetabolites|antimetabolites|mesh-ancestor
101379991|NCT00263029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379992|NCT00263029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379993|NCT00263068|Rotigotine|rotigotine|mesh-list
101379994|NCT00263068|Dopamine Agonists|dopamine agonists|mesh-ancestor
101379995|NCT00263068|Dopamine Agents|dopamine agents|mesh-ancestor
101379996|NCT00263068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101379997|NCT00263068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379998|NCT00263068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379999|NCT00101634|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101380000|NCT00101634|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101380001|NCT00101634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101380002|NCT00101634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101380003|NCT00101634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380004|NCT00101634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101380005|NCT00101634|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101380006|NCT00101634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101380007|NCT00101634|Serotonin Agents|serotonin agents|mesh-ancestor
101380008|NCT00101634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101380009|NCT00101634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380010|NCT00101634|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101380011|NCT00101634|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101380012|NCT00101634|Dopamine Agents|dopamine agents|mesh-ancestor
101380013|NCT00263185|Vitamin D|vitamin d|mesh-list
101304960|NCT02016287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101304961|NCT02016287|Tubulin Modulators|tubulin modulators|mesh-ancestor
101304962|NCT02016287|Antimitotic Agents|antimitotic agents|mesh-ancestor
101304963|NCT02016287|Mitosis Modulators|mitosis modulators|mesh-ancestor
101380014|NCT00263185|Ergocalciferols|ergocalciferols|mesh-list
101380015|NCT00263185|Cholecalciferol|cholecalciferol|mesh-list
101380016|NCT00263185|Vitamins|vitamins|mesh-list
101380017|NCT00263185|Calcium Carbonate|calcium carbonate|mesh-list
101380018|NCT00263185|Micronutrients|micronutrients|mesh-ancestor
101380019|NCT00263185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380020|NCT00263185|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101380021|NCT00263185|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101380022|NCT00263185|Antacids|antacids|mesh-ancestor
101380023|NCT00263185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380024|NCT00263185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101380025|NCT00263263|Sirolimus|sirolimus|mesh-list
101380026|NCT00263263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101380027|NCT00263263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101380028|NCT00263263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101380029|NCT00263263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380030|NCT00263263|Antifungal Agents|antifungal agents|mesh-ancestor
101380031|NCT00263263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102060136|NCT03910452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102060137|NCT03910452|Antifungal Agents|antifungal agents|mesh-ancestor
102060138|NCT03910452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102060139|NCT03873818|Pembrolizumab|pembrolizumab|mesh-list
102060140|NCT03873818|Ipilimumab|ipilimumab|mesh-list
102060141|NCT03873818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102060142|NCT03873818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102060143|NCT03873818|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102060144|NCT03873818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060145|NCT03846388|Hormones|hormones|mesh-list
102060146|NCT03846388|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101361750|NCT00125983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101380032|NCT00263263|Immunologic Factors|immunologic factors|mesh-ancestor
101380033|NCT00263263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380034|NCT00101673|Vildagliptin|vildagliptin|mesh-list
101380035|NCT00101673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101380036|NCT00101673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380037|NCT00101673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101380045|NCT00263302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101380046|NCT00263302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380048|NCT00263302|Glucocorticoids|glucocorticoids|mesh-ancestor
101380049|NCT00263302|Hormones|hormones|mesh-ancestor
101380050|NCT00263302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101380051|NCT00263302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101380052|NCT00263302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380053|NCT00263458|Buprenorphine|buprenorphine|mesh-list
101380054|NCT00263458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101380055|NCT00263458|Narcotics|narcotics|mesh-ancestor
101380056|NCT00263458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101380057|NCT00263458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380058|NCT00263458|Analgesics|analgesics|mesh-ancestor
101380059|NCT00263458|Sensory System Agents|sensory system agents|mesh-ancestor
101380060|NCT00263458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101380061|NCT00263458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101380062|NCT00101712|Vildagliptin|vildagliptin|mesh-list
101380063|NCT00101712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101380064|NCT00101712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380065|NCT00101712|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101380066|NCT00101712|Protease Inhibitors|protease inhibitors|mesh-ancestor
101380067|NCT00101712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101380068|NCT00101712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380069|NCT00072527|Carboplatin|carboplatin|mesh-list
101380070|NCT00072527|Irinotecan|irinotecan|mesh-list
101380071|NCT00072527|Etoposide|etoposide|mesh-list
101380072|NCT00072527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380073|NCT00072527|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101380074|NCT00072527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101380075|NCT00072527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101380076|NCT00072527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380077|NCT00072527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101380078|NCT00072527|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101380079|NCT00101751|Insulin Aspart|insulin aspart|mesh-list
101380080|NCT00101751|Biphasic Insulins|biphasic insulins|mesh-list
101304964|NCT02016287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304965|NCT02016365|Doxycycline|doxycycline|mesh-list
101304966|NCT02016365|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101304967|NCT02016365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101304968|NCT02016365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101304969|NCT02016365|Antimalarials|antimalarials|mesh-ancestor
101304970|NCT02016365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101380081|NCT00101751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101380082|NCT00101751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060147|NCT03846388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102060148|NCT03846388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060149|NCT03845166|Atezolizumab|atezolizumab|mesh-list
102060150|NCT03845166|Avelumab|avelumab|mesh-list
102060151|NCT03845166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102060152|NCT03845166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060153|NCT03845166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101361764|NCT00126022|Tedisamil|tedisamil|mesh-list
101380083|NCT00263965|Metformin|metformin|mesh-list
101380084|NCT00263965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101380085|NCT00263965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380086|NCT00264082|Zoledronic Acid|zoledronic acid|mesh-list
101380087|NCT00264082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101380088|NCT00264082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380089|NCT00072683|Tolvaptan|tolvaptan|mesh-list
101380090|NCT00072683|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101380091|NCT00072683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380092|NCT00072683|Natriuretic Agents|natriuretic agents|mesh-ancestor
101380093|NCT00072683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380094|NCT00101790|Pamidronate|pamidronate|mesh-list
101380095|NCT00101790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101380096|NCT00101790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380097|NCT00264277|Vitamin K|vitamin k|mesh-list
101380098|NCT00264277|Anticoagulants|anticoagulants|mesh-list
101380099|NCT00264277|Vitamins|vitamins|mesh-ancestor
101380100|NCT00264277|Micronutrients|micronutrients|mesh-ancestor
101380106|NCT00264277|Coagulants|coagulants|mesh-ancestor
101380107|NCT00415753|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101380108|NCT00415753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101380109|NCT04709029|Dexamethasone|dexamethasone|mesh-list
101380110|NCT04709029|Dexamethasone acetate|dexamethasone acetate|mesh-list
101380111|NCT04709029|BB 1101|bb 1101|mesh-list
101380112|NCT04709029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101380113|NCT04709029|Antiemetics|antiemetics|mesh-ancestor
101380114|NCT04709029|Autonomic Agents|autonomic agents|mesh-ancestor
101380115|NCT04709029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101380116|NCT04709029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380117|NCT04709029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101380118|NCT04709029|Glucocorticoids|glucocorticoids|mesh-ancestor
101380119|NCT04709029|Hormones|hormones|mesh-ancestor
101380120|NCT04709029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101380131|NCT00072722|Growth Substances|growth substances|mesh-ancestor
101380132|NCT00072722|Growth Inhibitors|growth inhibitors|mesh-ancestor
101380133|NCT00072722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380135|NCT00264355|Cyclosporins|cyclosporins|mesh-list
101380136|NCT00264355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101380137|NCT00264355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380138|NCT00264355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101380139|NCT00264355|Immunologic Factors|immunologic factors|mesh-ancestor
101380140|NCT00264355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380141|NCT00264355|Antifungal Agents|antifungal agents|mesh-ancestor
101380142|NCT00264355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101380143|NCT00264355|Dermatologic Agents|dermatologic agents|mesh-ancestor
101380144|NCT00264355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101380145|NCT00264355|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101380146|NCT00264472|Eniluracil|eniluracil|mesh-list
101380147|NCT00264472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101380148|NCT00264472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380149|NCT00101829|Rituximab|rituximab|mesh-list
101380150|NCT00101829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101380151|NCT00101829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380152|NCT00101829|Immunologic Factors|immunologic factors|mesh-ancestor
101304971|NCT02016365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101304972|NCT02016365|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101304973|NCT02016365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101380153|NCT00101829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380154|NCT00101829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102060154|NCT03845166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102060155|NCT03816345|Nivolumab|nivolumab|mesh-list
102060156|NCT03816345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102060157|NCT03816345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102060158|NCT03816345|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102060159|NCT03816345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060160|NCT03714828|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
101380155|NCT00072839|Teduglutide|teduglutide|mesh-list
101380156|NCT00072839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101380157|NCT00072839|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101380158|NCT00072839|Protective Agents|protective agents|mesh-ancestor
101380159|NCT00072839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380160|NCT00264628|Casopitant|casopitant|mesh-list
101380161|NCT00264628|Antiemetics|antiemetics|mesh-ancestor
101380162|NCT00264628|Autonomic Agents|autonomic agents|mesh-ancestor
101380163|NCT00264628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101380164|NCT00264628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380165|NCT00264628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101380166|NCT00264628|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101380167|NCT00264628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101380168|NCT00264628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380169|NCT00264901|Insulin Detemir|insulin detemir|mesh-list
101380170|NCT00264901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101380171|NCT00264901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380172|NCT00265018|Doxorubicin|doxorubicin|mesh-list
101380173|NCT00265018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101380174|NCT00265018|Bleomycin|bleomycin|mesh-list
101380175|NCT00265018|Vinblastine|vinblastine|mesh-list
101380176|NCT00265018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101380177|NCT00265018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380178|NCT00265018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101380179|NCT00265018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101380201|NCT00106197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101380202|NCT00265252|Alendronate|alendronate|mesh-list
101380203|NCT00265252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101380204|NCT00265252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380206|NCT00265291|Desipramine|desipramine|mesh-list
101380207|NCT00265291|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101380208|NCT00265291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101380209|NCT00265291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101380210|NCT00265291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380211|NCT00265291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101380212|NCT00265291|Serotonin Agents|serotonin agents|mesh-ancestor
101380213|NCT00265291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380214|NCT00265291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101380215|NCT00265291|Antidepressive Agents|antidepressive agents|mesh-ancestor
101380216|NCT00265291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101380217|NCT00265291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101380218|NCT00265291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101380219|NCT00265291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101380220|NCT00265291|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101304974|NCT02016391|Dexmedetomidine|dexmedetomidine|mesh-list
101304975|NCT02016391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101304976|NCT02016391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101380221|NCT00265291|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101380222|NCT00265291|Adrenergic Agents|adrenergic agents|mesh-ancestor
101380223|NCT00265408|Aspirin|aspirin|mesh-list
101380224|NCT00265408|Warfarin|warfarin|mesh-list
101380225|NCT00265408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101380226|NCT00265408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101380227|NCT00265408|Analgesics|analgesics|mesh-ancestor
101380228|NCT00265408|Sensory System Agents|sensory system agents|mesh-ancestor
101380231|NCT00265408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101380233|NCT00265408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101380234|NCT00265408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102060161|NCT03714828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102060162|NCT03714828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102060163|NCT03675815|Ritonavir|ritonavir|mesh-list
102060164|NCT03675815|Darunavir|darunavir|mesh-list
102060165|NCT03675815|Tenofovir|tenofovir|mesh-list
102060166|NCT03675815|Lamivudine|lamivudine|mesh-list
102060167|NCT03675815|Emtricitabine|emtricitabine|mesh-list
102060168|NCT03675815|Dolutegravir|dolutegravir|mesh-list
101380235|NCT00265408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380236|NCT00265408|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101380237|NCT00265408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101380238|NCT00265408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101380239|NCT00265408|Antipyretics|antipyretics|mesh-ancestor
101380240|NCT00265408|Anticoagulants|anticoagulants|mesh-ancestor
101380241|NCT00265486|Epoetin Alfa|epoetin alfa|mesh-list
101380242|NCT00265486|Hematinics|hematinics|mesh-ancestor
101380243|NCT00265642|Irbesartan|irbesartan|mesh-list
101380244|NCT00265642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101380245|NCT00265642|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101380246|NCT00265642|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101380247|NCT00265642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380248|NCT00265915|Rituximab|rituximab|mesh-list
101380249|NCT00265915|Sargramostim|sargramostim|mesh-list
101380250|NCT00265915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101380251|NCT00265915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380252|NCT00265915|Immunologic Factors|immunologic factors|mesh-ancestor
101380253|NCT00265915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380254|NCT00265915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101380255|NCT00265993|Enoxaparin|enoxaparin|mesh-list
101380259|NCT00265993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380260|NCT00266149|Lamotrigine|lamotrigine|mesh-list
101380261|NCT00266149|Anticonvulsants|anticonvulsants|mesh-ancestor
101380262|NCT00266149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101380263|NCT00266149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101380264|NCT00266149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380265|NCT00266149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101380266|NCT00266149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380267|NCT00266149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101380268|NCT00266149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101380269|NCT00266149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101380270|NCT00266149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101380271|NCT00266149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101380272|NCT00106314|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101380273|NCT00106314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101380274|NCT00106314|Immunologic Factors|immunologic factors|mesh-ancestor
101380275|NCT00106314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380276|NCT00415792|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101380277|NCT00415792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101380278|NCT00415792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380280|NCT00415831|Carbidopa|carbidopa|mesh-list
101380281|NCT00415831|Entacapone|entacapone|mesh-list
101380282|NCT00415831|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101380283|NCT00415831|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101380284|NCT00415831|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101380285|NCT00415831|Dopamine Agents|dopamine agents|mesh-ancestor
101380286|NCT00415831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101380287|NCT00415831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380288|NCT00415831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380289|NCT00415831|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101380290|NCT00415831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101380291|NCT00415831|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101304977|NCT02016391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304978|NCT02016391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101304979|NCT02016391|Analgesics|analgesics|mesh-ancestor
101380292|NCT00415831|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101380293|NCT00415831|Immunologic Factors|immunologic factors|mesh-ancestor
101380294|NCT00415831|Dopamine Agonists|dopamine agonists|mesh-ancestor
101380295|NCT00102141|Drospirenone|drospirenone|mesh-list
102060169|NCT03675815|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
102060170|NCT03675815|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102060171|NCT03675815|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102060172|NCT03675815|Protease Inhibitors|protease inhibitors|mesh-ancestor
102060173|NCT03675815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102060174|NCT03675815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060175|NCT03675815|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102060176|NCT03675815|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101361787|NCT00402454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101380296|NCT00102141|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101380297|NCT00102141|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101380298|NCT00102141|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101380299|NCT00102141|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
101380307|NCT00102141|Contraceptive Agents|contraceptive agents|mesh-ancestor
101380308|NCT00102141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101380309|NCT00102141|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101380310|NCT00102141|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101380311|NCT00102141|Hormone Antagonists|hormone antagonists|mesh-ancestor
101380312|NCT00102141|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101380313|NCT00102141|Diuretics|diuretics|mesh-ancestor
101380314|NCT00102141|Natriuretic Agents|natriuretic agents|mesh-ancestor
101380315|NCT00102141|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101380316|NCT00102141|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101380317|NCT00266344|Gaboxadol|gaboxadol|mesh-list
101380318|NCT00266344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101380319|NCT00266344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380320|NCT00266344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380321|NCT00266344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101380322|NCT00266344|Analgesics|analgesics|mesh-ancestor
101380323|NCT00266344|Sensory System Agents|sensory system agents|mesh-ancestor
101380324|NCT00266344|Anticonvulsants|anticonvulsants|mesh-ancestor
101380325|NCT00266344|GABA Agonists|gaba agonists|mesh-ancestor
101380326|NCT00266344|GABA Agents|gaba agents|mesh-ancestor
101380327|NCT00266539|Fentanyl|fentanyl|mesh-list
101380335|NCT00266539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101380336|NCT00266539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101380337|NCT00266539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101380338|NCT00266539|Anesthetics, General|anesthetics, general|mesh-ancestor
101380339|NCT00266539|Anesthetics|anesthetics|mesh-ancestor
101380340|NCT00266578|Fluticasone|fluticasone|mesh-list
101380341|NCT00266578|Xhance|xhance|mesh-list
101380342|NCT00266578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101380343|NCT00266578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101380344|NCT00266578|Autonomic Agents|autonomic agents|mesh-ancestor
101380345|NCT00266578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101380346|NCT00266578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380347|NCT00266578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101380348|NCT00266578|Respiratory System Agents|respiratory system agents|mesh-ancestor
101380349|NCT00266578|Dermatologic Agents|dermatologic agents|mesh-ancestor
101380350|NCT00266578|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101380351|NCT00266617|Epoetin Alfa|epoetin alfa|mesh-list
101380352|NCT00266617|Hematinics|hematinics|mesh-ancestor
101380353|NCT00102219|Doxorubicin|doxorubicin|mesh-list
101380354|NCT00102219|Pemetrexed|pemetrexed|mesh-list
101380355|NCT00102219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101380356|NCT00102219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380357|NCT00102219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101380358|NCT00102219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101380359|NCT00102219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101380360|NCT00102219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380361|NCT00102219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101380362|NCT00102219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101380363|NCT01349569|Lenalidomide|lenalidomide|mesh-list
101380364|NCT01349569|Vaccines|vaccines|mesh-list
101380365|NCT01349569|Immunologic Factors|immunologic factors|mesh-ancestor
101380366|NCT01349569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060177|NCT03675815|Antiviral Agents|antiviral agents|mesh-ancestor
102060178|NCT03675815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102060179|NCT03675815|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101361790|NCT00402493|Ibuprofen|ibuprofen|mesh-list
101380367|NCT01349569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101380368|NCT01349569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101380369|NCT01349569|Growth Substances|growth substances|mesh-ancestor
101304980|NCT02016391|Sensory System Agents|sensory system agents|mesh-ancestor
101304981|NCT02016391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101304982|NCT02016391|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101304983|NCT02016391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101380370|NCT01349569|Growth Inhibitors|growth inhibitors|mesh-ancestor
101380371|NCT01349569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380372|NCT00267163|Donepezil|donepezil|mesh-list
101380373|NCT00267163|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101380378|NCT00267163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380379|NCT00267163|Nootropic Agents|nootropic agents|mesh-ancestor
101380380|NCT00267319|Glatiramer Acetate|glatiramer acetate|mesh-list
101380382|NCT00267319|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101380383|NCT00267319|Immunologic Factors|immunologic factors|mesh-ancestor
101380384|NCT00267319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380385|NCT00267319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101380386|NCT00267319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101380387|NCT00073385|Docetaxel|docetaxel|mesh-list
101380388|NCT00073385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380389|NCT00073385|Tubulin Modulators|tubulin modulators|mesh-ancestor
101380390|NCT00073385|Antimitotic Agents|antimitotic agents|mesh-ancestor
101380391|NCT00073385|Mitosis Modulators|mitosis modulators|mesh-ancestor
101380392|NCT00073385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380393|NCT00102258|Hormones|hormones|mesh-list
101380394|NCT00102258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101380395|NCT00102258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380396|NCT00267514|Sevelamer|sevelamer|mesh-list
101380397|NCT00267514|Chelating Agents|chelating agents|mesh-ancestor
101380398|NCT00267514|Sequestering Agents|sequestering agents|mesh-ancestor
101380404|NCT00267553|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101380405|NCT00267553|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101380406|NCT00267553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101380407|NCT00267553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380408|NCT00267553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101380409|NCT00267553|Hormone Antagonists|hormone antagonists|mesh-ancestor
101380410|NCT00267553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101380411|NCT00267553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380412|NCT00267553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101380413|NCT00267553|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101380414|NCT00267553|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101380415|NCT00267553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101380416|NCT00106548|Methotrexate|methotrexate|mesh-list
101380417|NCT00106548|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101380418|NCT00106548|Abortifacient Agents|abortifacient agents|mesh-ancestor
101380419|NCT00106548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101380420|NCT00106548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380421|NCT00106548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101380422|NCT00106548|Antimetabolites|antimetabolites|mesh-ancestor
101380423|NCT00106548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380424|NCT00106548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380425|NCT00106548|Dermatologic Agents|dermatologic agents|mesh-ancestor
101380426|NCT00106548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101380427|NCT00106548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101380428|NCT00106548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101380429|NCT00106548|Immunologic Factors|immunologic factors|mesh-ancestor
101380430|NCT00106548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101380431|NCT00106548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101380432|NCT00267709|Visilizumab|visilizumab|mesh-list
101380433|NCT00267709|Immunologic Factors|immunologic factors|mesh-ancestor
101380434|NCT00267709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380435|NCT00267826|Rituximab|rituximab|mesh-list
101380436|NCT00267826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101380437|NCT00267826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380438|NCT00267826|Immunologic Factors|immunologic factors|mesh-ancestor
102060180|NCT03675815|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102060181|NCT03675815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102060182|NCT03675815|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102060183|NCT03675815|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102060184|NCT03672695|Venetoclax|venetoclax|mesh-list
102060185|NCT03672695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102060186|NCT03669133|Vitamin E|vitamin e|mesh-list
102060187|NCT03669133|Vitamins|vitamins|mesh-ancestor
102060188|NCT03669133|Micronutrients|micronutrients|mesh-ancestor
101361795|NCT00402493|Analgesics|analgesics|mesh-ancestor
101380439|NCT00267826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304984|NCT02016391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101304985|NCT02016391|Adrenergic Agents|adrenergic agents|mesh-ancestor
101304986|NCT02016391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101304987|NCT02016391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380440|NCT00267826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101380441|NCT00425620|Amphotericin B|amphotericin b|mesh-list
101380442|NCT00425620|Amebicides|amebicides|mesh-ancestor
101380459|NCT04711265|Vaccines|vaccines|mesh-list
101380460|NCT04711265|Immunologic Factors|immunologic factors|mesh-ancestor
101380461|NCT04711265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380462|NCT00268138|Fluorides|fluorides|mesh-list
101380463|NCT00268138|Cariostatic Agents|cariostatic agents|mesh-ancestor
101380464|NCT00268138|Protective Agents|protective agents|mesh-ancestor
101380465|NCT00268138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380466|NCT00102375|Topotecan|topotecan|mesh-list
101380467|NCT00102375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101380490|NCT00268216|Fluticasone|fluticasone|mesh-list
101380492|NCT00268216|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101380493|NCT00268216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101380494|NCT00268216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101380495|NCT00268216|Autonomic Agents|autonomic agents|mesh-ancestor
101380496|NCT00268216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101380497|NCT00268216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380498|NCT00268216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101380499|NCT00268216|Respiratory System Agents|respiratory system agents|mesh-ancestor
101380500|NCT00268216|Dermatologic Agents|dermatologic agents|mesh-ancestor
101380501|NCT00268216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101380502|NCT00268216|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101380503|NCT00268216|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101380504|NCT00268216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101380505|NCT00268216|Adrenergic Agents|adrenergic agents|mesh-ancestor
101380506|NCT00268216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101380507|NCT00268216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380508|NCT00073580|Hirudins|hirudins|mesh-list
101380509|NCT00073580|Anticoagulants|anticoagulants|mesh-list
101380510|NCT00073580|Bivalirudin|bivalirudin|mesh-list
101380511|NCT00073580|Antithrombins|antithrombins|mesh-ancestor
101380512|NCT00073580|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101380513|NCT00073580|Protease Inhibitors|protease inhibitors|mesh-ancestor
101380514|NCT00073580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101380515|NCT00073580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380516|NCT00073580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101380517|NCT00073580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101380518|NCT00073658|Risperidone|risperidone|mesh-list
101380519|NCT00073658|Citalopram|citalopram|mesh-list
101380534|NCT00073658|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101380535|NCT00073658|Antidepressive Agents|antidepressive agents|mesh-ancestor
101380537|NCT00268255|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101304992|NCT02016417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101304993|NCT02016417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101304994|NCT02016417|Antimetabolites|antimetabolites|mesh-ancestor
101304995|NCT02016417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304996|NCT02016417|Tubulin Modulators|tubulin modulators|mesh-ancestor
101304997|NCT02016417|Antimitotic Agents|antimitotic agents|mesh-ancestor
101304998|NCT02016417|Mitosis Modulators|mitosis modulators|mesh-ancestor
101478791|NCT00283985|Glucocorticoids|glucocorticoids|mesh-ancestor
101304999|NCT02016417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101305000|NCT02016417|Immunologic Factors|immunologic factors|mesh-ancestor
101305001|NCT02016417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305003|NCT02016443|Analgesics|analgesics|mesh-ancestor
101305004|NCT02016443|Sensory System Agents|sensory system agents|mesh-ancestor
101305005|NCT02016443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101305006|NCT02016443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380543|NCT00102414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101380544|NCT00102414|Antimetabolites|antimetabolites|mesh-ancestor
101380545|NCT00102414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380546|NCT00102414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380547|NCT00268333|Leucovorin|leucovorin|mesh-list
101380548|NCT00268333|Fluorouracil|fluorouracil|mesh-list
101380549|NCT00268333|Oxaliplatin|oxaliplatin|mesh-list
101380550|NCT00268333|Calcium|calcium|mesh-list
101380551|NCT00268333|Levoleucovorin|levoleucovorin|mesh-list
101380552|NCT00268333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101380553|NCT00268333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380554|NCT00268333|Antimetabolites|antimetabolites|mesh-ancestor
101380555|NCT00268333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380556|NCT00268333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101380557|NCT00268333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380558|NCT00268333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101380559|NCT00268333|Immunologic Factors|immunologic factors|mesh-ancestor
101380560|NCT00268333|Antidotes|antidotes|mesh-ancestor
101380561|NCT00268333|Protective Agents|protective agents|mesh-ancestor
101380562|NCT00268333|Vitamin B Complex|vitamin b complex|mesh-ancestor
101380563|NCT00268333|Vitamins|vitamins|mesh-ancestor
101380564|NCT00268333|Micronutrients|micronutrients|mesh-ancestor
101380565|NCT00073697|Dexetimide|dexetimide|mesh-list
101380566|NCT00073697|Citalopram|citalopram|mesh-list
101380567|NCT00073697|Escitalopram|escitalopram|mesh-list
101380568|NCT00073697|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101380569|NCT00073697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101380570|NCT00073697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101380571|NCT00073697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380572|NCT00073697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101380573|NCT00073697|Serotonin Agents|serotonin agents|mesh-ancestor
101380574|NCT00073697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380575|NCT00073697|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101380576|NCT00073697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101380577|NCT00073697|Parasympatholytics|parasympatholytics|mesh-ancestor
101380588|NCT00268372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380589|NCT00268372|Tubulin Modulators|tubulin modulators|mesh-ancestor
101380590|NCT00268372|Antimitotic Agents|antimitotic agents|mesh-ancestor
101380591|NCT00268372|Mitosis Modulators|mitosis modulators|mesh-ancestor
101305007|NCT02016443|Anticonvulsants|anticonvulsants|mesh-ancestor
101305008|NCT02016443|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101305009|NCT02016443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101380592|NCT00268372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313892|NCT00000640|Dapsone|dapsone|mesh-list
101380593|NCT00268372|Antimetabolites|antimetabolites|mesh-ancestor
101380597|NCT00268372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380598|NCT00268411|Gemcitabine|gemcitabine|mesh-list
101380599|NCT00268411|Oxaliplatin|oxaliplatin|mesh-list
101380600|NCT00268411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101380601|NCT00268411|Antimetabolites|antimetabolites|mesh-ancestor
101380602|NCT00268411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380603|NCT00268411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380604|NCT00073736|Cytarabine|cytarabine|mesh-list
101380605|NCT00073736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101380606|NCT00073736|Antimetabolites|antimetabolites|mesh-ancestor
101380607|NCT00073736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380608|NCT00073736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380609|NCT00073736|Antiviral Agents|antiviral agents|mesh-ancestor
101380610|NCT00073736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101380611|NCT00073736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101380612|NCT00073736|Immunologic Factors|immunologic factors|mesh-ancestor
101380613|NCT00073736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380614|NCT00268489|Bevacizumab|bevacizumab|mesh-list
101380615|NCT00268489|Pemetrexed|pemetrexed|mesh-list
101380616|NCT00268489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101380617|NCT00268489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380618|NCT00268489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102060189|NCT03669133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060190|NCT03669133|Antioxidants|antioxidants|mesh-ancestor
102060191|NCT03669133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060192|NCT03669133|Protective Agents|protective agents|mesh-ancestor
102060193|NCT03647969|Nivolumab|nivolumab|mesh-list
102060194|NCT03647969|Ipilimumab|ipilimumab|mesh-list
102060195|NCT03647969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102060196|NCT03647969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102060197|NCT03647969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101380619|NCT00268489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101380620|NCT00268489|Growth Substances|growth substances|mesh-ancestor
101380621|NCT00268489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380622|NCT00268489|Growth Inhibitors|growth inhibitors|mesh-ancestor
101380623|NCT00268489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101380624|NCT00268489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380625|NCT00268489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101380626|NCT00268489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101380627|NCT00268528|Methotrexate|methotrexate|mesh-list
101380628|NCT00268528|Mercaptopurine|mercaptopurine|mesh-list
101380629|NCT00268528|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101380630|NCT00268528|Abortifacient Agents|abortifacient agents|mesh-ancestor
101380631|NCT00268528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101380632|NCT00268528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380633|NCT00268528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101380634|NCT00268528|Antimetabolites|antimetabolites|mesh-ancestor
101380635|NCT00268528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380636|NCT00268528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380637|NCT00268528|Dermatologic Agents|dermatologic agents|mesh-ancestor
101380638|NCT00268528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101380639|NCT00268528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101380640|NCT00268528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101380641|NCT00268528|Immunologic Factors|immunologic factors|mesh-ancestor
101380650|NCT00073814|Respiratory System Agents|respiratory system agents|mesh-ancestor
101380651|NCT00073814|Tocolytic Agents|tocolytic agents|mesh-ancestor
101380652|NCT00073814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101380653|NCT00073814|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101380654|NCT00073814|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101380655|NCT00073814|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101380656|NCT00073814|Adrenergic Agents|adrenergic agents|mesh-ancestor
101380657|NCT00073814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101380658|NCT00073814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380659|NCT00102453|Pentoxifylline|pentoxifylline|mesh-list
101380660|NCT00102453|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101380661|NCT00102453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101380662|NCT00102453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380663|NCT00102453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101380664|NCT00102453|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101380665|NCT00102453|Protective Agents|protective agents|mesh-ancestor
101305010|NCT02016443|Parasympatholytics|parasympatholytics|mesh-ancestor
101305011|NCT02016443|Autonomic Agents|autonomic agents|mesh-ancestor
101380666|NCT00102453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380667|NCT00102453|Vasodilator Agents|vasodilator agents|mesh-ancestor
101380668|NCT00102453|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101380669|NCT00102453|Antioxidants|antioxidants|mesh-ancestor
101380675|NCT00268567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101380677|NCT00268567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101380678|NCT00268567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380679|NCT00268567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101380680|NCT00268567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380681|NCT00268567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101380682|NCT00268567|Immunologic Factors|immunologic factors|mesh-ancestor
101380683|NCT00268645|Insulin Glargine|insulin glargine|mesh-list
101380684|NCT00268645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102060198|NCT03647969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060199|NCT03644186|Paclitaxel|paclitaxel|mesh-list
102060200|NCT03644186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102060201|NCT03644186|Trastuzumab|trastuzumab|mesh-list
102060202|NCT03644186|Letrozole|letrozole|mesh-list
102060203|NCT03644186|Palbociclib|palbociclib|mesh-list
102060204|NCT03644186|Pertuzumab|pertuzumab|mesh-list
102060205|NCT03644186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102060206|NCT03644186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380685|NCT00268645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380686|NCT00268684|Temozolomide|temozolomide|mesh-list
101380687|NCT00268684|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101380688|NCT00268684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101380689|NCT00268684|Alkylating Agents|alkylating agents|mesh-ancestor
101380690|NCT00268684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380691|NCT00268684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380692|NCT00268684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101380693|NCT00268684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101380694|NCT00106821|Bromides|bromides|mesh-list
101380695|NCT00106821|Tiotropium Bromide|tiotropium bromide|mesh-list
101380696|NCT00106821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101380697|NCT00106821|Autonomic Agents|autonomic agents|mesh-ancestor
101380698|NCT00106821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101380699|NCT00106821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313927|NCT00389038|Analgesics|analgesics|mesh-ancestor
101380700|NCT00106821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101380701|NCT00106821|Respiratory System Agents|respiratory system agents|mesh-ancestor
101380702|NCT00106821|Parasympatholytics|parasympatholytics|mesh-ancestor
101380703|NCT00106821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101380704|NCT00106821|Cholinergic Agents|cholinergic agents|mesh-ancestor
101380705|NCT00106821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101380706|NCT00106821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380707|NCT00106821|Anticonvulsants|anticonvulsants|mesh-ancestor
101380719|NCT00268723|Respiratory System Agents|respiratory system agents|mesh-ancestor
101380720|NCT00268723|Tocolytic Agents|tocolytic agents|mesh-ancestor
101380721|NCT00268723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101380722|NCT00268723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101380723|NCT00268723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101380724|NCT00268723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101380725|NCT00268723|Adrenergic Agents|adrenergic agents|mesh-ancestor
101380726|NCT00268723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101380727|NCT00268723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380728|NCT00268840|Gemcitabine|gemcitabine|mesh-list
101380729|NCT00268840|Docetaxel|docetaxel|mesh-list
101380730|NCT00268840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101380731|NCT00268840|Antimetabolites|antimetabolites|mesh-ancestor
101380732|NCT00268840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380733|NCT00268840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380734|NCT00268840|Tubulin Modulators|tubulin modulators|mesh-ancestor
101380735|NCT00268840|Antimitotic Agents|antimitotic agents|mesh-ancestor
101380736|NCT00268840|Mitosis Modulators|mitosis modulators|mesh-ancestor
101380737|NCT00268879|Renzapride|renzapride|mesh-list
101380738|NCT00268879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101380739|NCT00268879|Serotonin Agents|serotonin agents|mesh-ancestor
101380740|NCT00268879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101380741|NCT00268879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380742|NCT00268879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380743|NCT00268918|Docetaxel|docetaxel|mesh-list
101380744|NCT00268918|Vatalanib|vatalanib|mesh-list
101380745|NCT00268918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380746|NCT00268918|Tubulin Modulators|tubulin modulators|mesh-ancestor
101305012|NCT02016443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101305013|NCT02016443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101305014|NCT02016443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101380747|NCT00268918|Antimitotic Agents|antimitotic agents|mesh-ancestor
101380748|NCT00268918|Mitosis Modulators|mitosis modulators|mesh-ancestor
101380755|NCT00268957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060207|NCT03644186|Tubulin Modulators|tubulin modulators|mesh-ancestor
102060208|NCT03644186|Antimitotic Agents|antimitotic agents|mesh-ancestor
102060209|NCT03644186|Mitosis Modulators|mitosis modulators|mesh-ancestor
102060210|NCT03644186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060211|NCT03644186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102060212|NCT03644186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102060213|NCT03644186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102060214|NCT03644186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102060215|NCT03644186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102060216|NCT03644186|Hormone Antagonists|hormone antagonists|mesh-ancestor
101380757|NCT00073970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101380758|NCT00073970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101380759|NCT00073970|Analgesics|analgesics|mesh-ancestor
101380760|NCT00073970|Sensory System Agents|sensory system agents|mesh-ancestor
101380761|NCT00073970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101380762|NCT00073970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380763|NCT00073970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101380764|NCT00073970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101380765|NCT00073970|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101380766|NCT00073970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101380767|NCT00073970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101380768|NCT00073970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380770|NCT00102492|Antiemetics|antiemetics|mesh-ancestor
101380771|NCT00102492|Autonomic Agents|autonomic agents|mesh-ancestor
101380786|NCT00269035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101380788|NCT00269035|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101380789|NCT00269035|Dopamine Agents|dopamine agents|mesh-ancestor
101380790|NCT00074009|Bortezomib|bortezomib|mesh-list
101380791|NCT00074009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380792|NCT00269269|Antihypertensive Agents|antihypertensive agents|mesh-list
101380793|NCT00269386|Clarithromycin|clarithromycin|mesh-list
101380794|NCT00269386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101380795|NCT00269386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101380796|NCT00269386|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101380797|NCT00269386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101380798|NCT00269386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380799|NCT00269386|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101380800|NCT00269386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101380801|NCT00074087|Doxorubicin|doxorubicin|mesh-list
101380802|NCT00074087|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101380803|NCT00074087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101380804|NCT00074087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380805|NCT00074087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101380806|NCT00074087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101380807|NCT00074087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101380808|NCT00074087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380810|NCT00269542|Folic Acid|folic acid|mesh-list
101380811|NCT00269542|Vitamin B Complex|vitamin b complex|mesh-list
101380812|NCT00269542|Trace Elements|trace elements|mesh-ancestor
101380813|NCT00269542|Micronutrients|micronutrients|mesh-ancestor
101380814|NCT00269542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380815|NCT00269542|Hematinics|hematinics|mesh-ancestor
101380816|NCT00269542|Vitamins|vitamins|mesh-ancestor
101380817|NCT00269620|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101380818|NCT00269620|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101380819|NCT00269620|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101380820|NCT00269620|Etonogestrel|etonogestrel|mesh-list
101380821|NCT00269620|NuvaRing|nuvaring|mesh-list
101380822|NCT00269620|Norelgestromin|norelgestromin|mesh-list
101380823|NCT00269620|Ortho Evra|ortho evra|mesh-list
101380824|NCT00269620|Contraceptive Agents|contraceptive agents|mesh-list
101380825|NCT00269620|Estradiol|estradiol|mesh-list
101380826|NCT00269620|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101380827|NCT00269620|Estrogens|estrogens|mesh-ancestor
101380828|NCT00269620|Hormones|hormones|mesh-ancestor
102060217|NCT03644186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102060218|NCT03644186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060219|NCT03644186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101380829|NCT00269620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101380830|NCT00269620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380831|NCT00269620|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101305016|NCT02016443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101380847|NCT00416143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101380848|NCT00416143|Glucocorticoids|glucocorticoids|mesh-ancestor
101380849|NCT00416143|Hormones|hormones|mesh-ancestor
101380850|NCT00416143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101380851|NCT00416143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380852|NCT00416143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101380853|NCT00416143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380854|NCT00416221|Antidepressive Agents|antidepressive agents|mesh-list
101380855|NCT00416221|Escitalopram|escitalopram|mesh-list
101380856|NCT00416221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101380857|NCT00416221|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101380858|NCT00416221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101380859|NCT00416221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101380860|NCT00416221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380861|NCT00416221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101380862|NCT00416221|Serotonin Agents|serotonin agents|mesh-ancestor
101380863|NCT00416221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380864|NCT00269737|Fentanyl|fentanyl|mesh-list
101380865|NCT00269737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101380866|NCT00269737|Narcotics|narcotics|mesh-ancestor
101380867|NCT00269737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101380868|NCT00269737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380869|NCT00269737|Analgesics|analgesics|mesh-ancestor
101380870|NCT00269737|Sensory System Agents|sensory system agents|mesh-ancestor
101380871|NCT00269737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101380872|NCT00269737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101380873|NCT00269737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101380874|NCT00269737|Anesthetics, General|anesthetics, general|mesh-ancestor
101380876|NCT00269776|Methylphenidate|methylphenidate|mesh-list
101380877|NCT00269776|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101380878|NCT00269776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380879|NCT00269776|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101380880|NCT00269776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101380881|NCT00269776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101380882|NCT00269776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380883|NCT00269776|Dopamine Agents|dopamine agents|mesh-ancestor
101380884|NCT00269776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101380885|NCT00269815|Methylphenidate|methylphenidate|mesh-list
101380886|NCT00269815|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101380887|NCT00269815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380888|NCT00269815|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101380889|NCT00269815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101380890|NCT00269815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101380891|NCT00269815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380892|NCT00269815|Dopamine Agents|dopamine agents|mesh-ancestor
101380905|NCT00269854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101380906|NCT00269854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101380908|NCT00269893|Anticoagulants|anticoagulants|mesh-ancestor
101380909|NCT00269893|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101380910|NCT00074321|Capecitabine|capecitabine|mesh-list
101380911|NCT00074321|Oxaliplatin|oxaliplatin|mesh-list
101380912|NCT00074321|Irinotecan|irinotecan|mesh-list
101380913|NCT00074321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101380914|NCT00074321|Antimetabolites|antimetabolites|mesh-ancestor
101387718|NCT00323206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101380915|NCT00074321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380916|NCT00074321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380917|NCT00074321|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101380918|NCT00074321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102060220|NCT03593759|Prednisone|prednisone|mesh-list
102060221|NCT03593759|Prednisolone|prednisolone|mesh-list
102060222|NCT03593759|Methotrexate|methotrexate|mesh-list
102060223|NCT03593759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102060224|NCT03593759|Glucocorticoids|glucocorticoids|mesh-ancestor
102060225|NCT03593759|Hormones|hormones|mesh-ancestor
102060226|NCT03593759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102060227|NCT03593759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060228|NCT03593759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101380919|NCT00074321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101380920|NCT00102609|Dexamethasone|dexamethasone|mesh-list
101380921|NCT00102609|Doxorubicin|doxorubicin|mesh-list
101380922|NCT00102609|Trabectedin|trabectedin|mesh-list
101380925|NCT00102609|Autonomic Agents|autonomic agents|mesh-ancestor
101380926|NCT00102609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101380927|NCT00102609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380928|NCT00102609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101380929|NCT00102609|Glucocorticoids|glucocorticoids|mesh-ancestor
101380930|NCT00102609|Hormones|hormones|mesh-ancestor
101380931|NCT00102609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101380932|NCT00102609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101380933|NCT00102609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380934|NCT00102609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101380935|NCT00102609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101380936|NCT00102609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101380937|NCT00102609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101380938|NCT00102609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380939|NCT00102609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101380940|NCT00102609|Alkylating Agents|alkylating agents|mesh-ancestor
101380941|NCT00269932|Levofloxacin|levofloxacin|mesh-list
101380942|NCT00269932|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101380943|NCT00269932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101380944|NCT00269932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101380945|NCT00269932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101380946|NCT00269932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101380947|NCT00269932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101380948|NCT00269932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380949|NCT00269932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380950|NCT00269932|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101380951|NCT00269932|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101380953|NCT00269971|Hematinics|hematinics|mesh-ancestor
101380954|NCT00270010|Epoetin Alfa|epoetin alfa|mesh-list
101380955|NCT00270010|Hematinics|hematinics|mesh-ancestor
101380956|NCT00270049|Epoetin Alfa|epoetin alfa|mesh-list
101380960|NCT00107016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380961|NCT00107016|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101380962|NCT00107016|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101380963|NCT00107016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101380964|NCT00107016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380965|NCT00107016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101380966|NCT00107016|Hormone Antagonists|hormone antagonists|mesh-ancestor
101380967|NCT00107016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101380968|NCT00107016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380969|NCT00107016|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101380970|NCT00107016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101380971|NCT00107016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101380972|NCT00107016|Immunologic Factors|immunologic factors|mesh-ancestor
101380973|NCT00270088|Epoetin Alfa|epoetin alfa|mesh-list
101380974|NCT00270088|Hematinics|hematinics|mesh-ancestor
101380975|NCT00270127|Epoetin Alfa|epoetin alfa|mesh-list
101380976|NCT00270127|Hematinics|hematinics|mesh-ancestor
101380977|NCT00270166|Epoetin Alfa|epoetin alfa|mesh-list
101380978|NCT00270166|Hematinics|hematinics|mesh-ancestor
101380979|NCT00074399|Nevirapine|nevirapine|mesh-list
101380980|NCT00074399|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101380981|NCT00074399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102060229|NCT03593759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102060230|NCT03593759|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102060231|NCT03593759|Abortifacient Agents|abortifacient agents|mesh-ancestor
102060232|NCT03593759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102060233|NCT03593759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102060234|NCT03593759|Antimetabolites|antimetabolites|mesh-ancestor
102060235|NCT03593759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380982|NCT00074399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101380983|NCT00074399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380984|NCT00074399|Antiviral Agents|antiviral agents|mesh-ancestor
101380985|NCT00074399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101380986|NCT00074399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101380987|NCT00074399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101380988|NCT00074399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101380989|NCT00074399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101380990|NCT00270283|Epoetin Alfa|epoetin alfa|mesh-list
101380991|NCT00270283|Hematinics|hematinics|mesh-ancestor
101380992|NCT00270322|Fentanyl|fentanyl|mesh-list
101380993|NCT00270322|Morphine|morphine|mesh-list
101380994|NCT00270322|Bupivacaine|bupivacaine|mesh-list
101380995|NCT00270322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101380999|NCT00270322|Analgesics|analgesics|mesh-ancestor
101381000|NCT00270322|Sensory System Agents|sensory system agents|mesh-ancestor
101381001|NCT00270322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101381002|NCT00270322|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101381003|NCT00270322|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101381004|NCT00270322|Anesthetics, General|anesthetics, general|mesh-ancestor
101381005|NCT00270322|Anesthetics|anesthetics|mesh-ancestor
101381006|NCT00270322|Anesthetics, Local|anesthetics, local|mesh-ancestor
101381007|NCT00270361|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101381008|NCT00270361|Natriuretic Agents|natriuretic agents|mesh-ancestor
101381009|NCT00270361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381010|NCT02966249|Levobupivacaine|levobupivacaine|mesh-list
101381011|NCT02966249|Anesthetics, Local|anesthetics, local|mesh-ancestor
101381012|NCT02966249|Anesthetics|anesthetics|mesh-ancestor
101381013|NCT02966249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101381014|NCT02966249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381015|NCT02966249|Sensory System Agents|sensory system agents|mesh-ancestor
101381016|NCT02966249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101381017|NCT00270400|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101381018|NCT00270400|Natriuretic Agents|natriuretic agents|mesh-ancestor
101381019|NCT00270400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381020|NCT00107094|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101381021|NCT00107094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101381022|NCT00270478|Hydroxyurea|hydroxyurea|mesh-list
101381023|NCT00270478|Epoetin Alfa|epoetin alfa|mesh-list
101381024|NCT00270478|Hematinics|hematinics|mesh-ancestor
101381025|NCT00270478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101381026|NCT00270478|Antisickling Agents|antisickling agents|mesh-ancestor
101381027|NCT00270478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101381028|NCT00270478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387719|NCT00323206|Growth Substances|growth substances|mesh-ancestor
101381029|NCT00270478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101381030|NCT00270517|Telithromycin|telithromycin|mesh-list
101381031|NCT00270517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101381047|NCT00074438|Immunologic Factors|immunologic factors|mesh-ancestor
101381048|NCT00074438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381049|NCT00074438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101381050|NCT00074438|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101381051|NCT00074438|Abortifacient Agents|abortifacient agents|mesh-ancestor
101381052|NCT00074438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101381053|NCT00074438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101381055|NCT00074438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381056|NCT00074438|Dermatologic Agents|dermatologic agents|mesh-ancestor
101381057|NCT00074438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101381058|NCT00074438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101381059|NCT00074438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101381060|NCT00074438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102060236|NCT03593759|Dermatologic Agents|dermatologic agents|mesh-ancestor
102060237|NCT03593759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102060238|NCT03593759|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102060239|NCT03593759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102060240|NCT03593759|Immunologic Factors|immunologic factors|mesh-ancestor
102060241|NCT03593759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102060242|NCT03593759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101361854|NCT00126139|Abciximab|abciximab|mesh-list
101381061|NCT00270751|Minocycline|minocycline|mesh-list
101381062|NCT00270751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101381063|NCT00270751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101381064|NCT00270829|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101381065|NCT00270829|Natriuretic Agents|natriuretic agents|mesh-ancestor
101381066|NCT00270829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381067|NCT04730375|Dexmedetomidine|dexmedetomidine|mesh-list
101381068|NCT04730375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101381069|NCT04730375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101381070|NCT04730375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381071|NCT04730375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101381072|NCT04730375|Analgesics|analgesics|mesh-ancestor
101381073|NCT04730375|Sensory System Agents|sensory system agents|mesh-ancestor
101305028|NCT02016547|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101305029|NCT02016547|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101305030|NCT02016547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305031|NCT02016547|Anticoagulants|anticoagulants|mesh-ancestor
101381076|NCT04730375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101381077|NCT04730375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101381078|NCT04730375|Adrenergic Agents|adrenergic agents|mesh-ancestor
101381079|NCT04730375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101381080|NCT04730375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381081|NCT00270907|Gemcitabine|gemcitabine|mesh-list
101381082|NCT00270907|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
101381083|NCT00270907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101381084|NCT00270907|Antimetabolites|antimetabolites|mesh-ancestor
101381085|NCT00270907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381086|NCT00270907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101381087|NCT00271063|Annamycin|annamycin|mesh-list
101381088|NCT00271063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101381089|NCT00271063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101381090|NCT00107523|Cytarabine|cytarabine|mesh-list
101381096|NCT00107523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101381098|NCT00107523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101381099|NCT00107523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101381100|NCT00107523|Immunologic Factors|immunologic factors|mesh-ancestor
101381101|NCT00107523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381102|NCT00107523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101381103|NCT00107523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101381104|NCT00107523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101381105|NCT00107523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101381106|NCT00107523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101381107|NCT00107523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101381108|NCT00107523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101381109|NCT00107523|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101381110|NCT00416377|Prednisolone|prednisolone|mesh-list
101381111|NCT00416377|Doxorubicin|doxorubicin|mesh-list
101381112|NCT00416377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101381113|NCT00416377|Bleomycin|bleomycin|mesh-list
101381114|NCT00416377|Vincristine|vincristine|mesh-list
101381115|NCT00416377|Dacarbazine|dacarbazine|mesh-list
101381116|NCT00416377|Vinblastine|vinblastine|mesh-list
101381117|NCT00416377|Procarbazine|procarbazine|mesh-list
101381118|NCT00416377|Chlorambucil|chlorambucil|mesh-list
101381119|NCT00416377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101381120|NCT00416377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101381121|NCT00416377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101381122|NCT00416377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101381123|NCT00416377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101381124|NCT00416377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060243|NCT03567577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102060244|NCT03548155|Antipsychotic Agents|antipsychotic agents|mesh-list
102060245|NCT03548155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102060246|NCT03548155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102060247|NCT03548155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060248|NCT03548155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102060250|NCT03457701|Trace Elements|trace elements|mesh-ancestor
102060251|NCT03457701|Micronutrients|micronutrients|mesh-ancestor
101381125|NCT00416377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101381126|NCT00416377|Tubulin Modulators|tubulin modulators|mesh-ancestor
101381127|NCT00416377|Antimitotic Agents|antimitotic agents|mesh-ancestor
101381128|NCT00416377|Mitosis Modulators|mitosis modulators|mesh-ancestor
101381129|NCT00416377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101381130|NCT00416377|Glucocorticoids|glucocorticoids|mesh-ancestor
101381131|NCT00416377|Hormones|hormones|mesh-ancestor
101381132|NCT00416377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101381133|NCT00416377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381134|NCT00416377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101381135|NCT00416377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101381136|NCT00416377|Alkylating Agents|alkylating agents|mesh-ancestor
101381137|NCT02965859|Adefovir|adefovir|mesh-list
101381138|NCT02965859|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101381139|NCT02965859|Antiviral Agents|antiviral agents|mesh-ancestor
101381140|NCT02965859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101381141|NCT02965859|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101381142|NCT02965859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101381143|NCT02965859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101381144|NCT02965859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381145|NCT00271336|Pentoxifylline|pentoxifylline|mesh-list
101381147|NCT00271336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101381148|NCT00271336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381149|NCT00271336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101381150|NCT00271336|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101381151|NCT00271336|Protective Agents|protective agents|mesh-ancestor
101381152|NCT00271336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381153|NCT00271336|Vasodilator Agents|vasodilator agents|mesh-ancestor
101381154|NCT00271336|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101381155|NCT00271336|Antioxidants|antioxidants|mesh-ancestor
101381156|NCT00271414|Fentanyl|fentanyl|mesh-list
101381157|NCT00271414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101381158|NCT00271414|Narcotics|narcotics|mesh-ancestor
101381159|NCT00271414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101381160|NCT00271414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381166|NCT00271414|Anesthetics, General|anesthetics, general|mesh-ancestor
101381167|NCT00271414|Anesthetics|anesthetics|mesh-ancestor
101381168|NCT00271453|Fentanyl|fentanyl|mesh-list
101381169|NCT00271453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101381170|NCT00271453|Narcotics|narcotics|mesh-ancestor
101381171|NCT00271453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101381172|NCT00271453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381173|NCT00271453|Analgesics|analgesics|mesh-ancestor
101381174|NCT00271453|Sensory System Agents|sensory system agents|mesh-ancestor
101381175|NCT00271453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101381176|NCT00271453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101381177|NCT00271453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101381178|NCT00271453|Anesthetics, General|anesthetics, general|mesh-ancestor
101381179|NCT00271453|Anesthetics|anesthetics|mesh-ancestor
101381180|NCT00271492|Atrasentan|atrasentan|mesh-list
101381181|NCT00271492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101381182|NCT00271492|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101381183|NCT00271492|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101381184|NCT00271492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381185|NCT00271804|Bortezomib|bortezomib|mesh-list
101381186|NCT00271804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101381187|NCT00107601|Insulin|insulin|mesh-list
101381188|NCT00107601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102060252|NCT03457701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060253|NCT03457142|Dexamethasone|dexamethasone|mesh-list
102060254|NCT03457142|Dexamethasone acetate|dexamethasone acetate|mesh-list
102060255|NCT03457142|Abatacept|abatacept|mesh-list
102060256|NCT03457142|Ixazomib|ixazomib|mesh-list
102060257|NCT03457142|Ichthammol|ichthammol|mesh-list
102060258|NCT03457142|BB 1101|bb 1101|mesh-list
102060259|NCT03457142|Glycine|glycine|mesh-list
102060260|NCT03457142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102060261|NCT03457142|Antiemetics|antiemetics|mesh-ancestor
101381189|NCT00107601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381190|NCT00272077|Insulin Glargine|insulin glargine|mesh-list
101381191|NCT00272077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101381192|NCT00272077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381193|NCT00272116|Vitamins|vitamins|mesh-list
101381194|NCT00272116|Vitamin A|vitamin a|mesh-list
101381195|NCT00272116|Retinol palmitate|retinol palmitate|mesh-list
101314089|NCT00000754|Interferons|interferons|mesh-list
101381196|NCT00272116|Micronutrients|micronutrients|mesh-ancestor
101381197|NCT00272116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381198|NCT00272116|Antioxidants|antioxidants|mesh-ancestor
101381199|NCT00272116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381200|NCT00272116|Protective Agents|protective agents|mesh-ancestor
101381201|NCT00272116|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101381202|NCT00272116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101381203|NCT00272428|Ascorbic Acid|ascorbic acid|mesh-list
101381204|NCT00272428|Vitamin E|vitamin e|mesh-list
101381205|NCT00272428|Beta Carotene|beta carotene|mesh-list
101381206|NCT00272428|Selenium|selenium|mesh-list
101381207|NCT00272428|Carotenoids|carotenoids|mesh-list
101381208|NCT00272428|Vitamins|vitamins|mesh-ancestor
101381209|NCT00272428|Micronutrients|micronutrients|mesh-ancestor
101381210|NCT00272428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381211|NCT00272428|Antioxidants|antioxidants|mesh-ancestor
101381212|NCT00272428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381213|NCT00272428|Protective Agents|protective agents|mesh-ancestor
101381214|NCT00272428|Trace Elements|trace elements|mesh-ancestor
101381215|NCT00272428|Provitamins|provitamins|mesh-ancestor
101381216|NCT00272467|Omeprazole|omeprazole|mesh-list
101381217|NCT00272467|Rebamipide|rebamipide|mesh-list
101381218|NCT00272467|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101381219|NCT00272467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101381220|NCT00272467|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101381221|NCT00272467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101381222|NCT00272467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381223|NCT00272467|Antioxidants|antioxidants|mesh-ancestor
101381224|NCT00272467|Protective Agents|protective agents|mesh-ancestor
101305037|NCT02016664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305038|NCT02016664|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101381226|NCT00272584|Risperidone|risperidone|mesh-list
101381227|NCT00272584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101381228|NCT00272584|Serotonin Agents|serotonin agents|mesh-ancestor
101381229|NCT00272584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101381230|NCT00272584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381231|NCT00272584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381232|NCT00272584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101381233|NCT00272584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101381234|NCT00272584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101381241|NCT00272701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101381242|NCT00272701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387720|NCT00323206|Growth Inhibitors|growth inhibitors|mesh-ancestor
101381243|NCT00272701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381244|NCT00272740|Fulvestrant|fulvestrant|mesh-list
101381245|NCT00272740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101381246|NCT00272740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101381247|NCT00272740|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101381248|NCT00272740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101381249|NCT00272740|Hormone Antagonists|hormone antagonists|mesh-ancestor
101381250|NCT00272740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101381251|NCT00272740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381252|NCT00074750|Molgramostim|molgramostim|mesh-list
101381253|NCT00074750|Sargramostim|sargramostim|mesh-list
102060263|NCT03457142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102060264|NCT03457142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060265|NCT03457142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102060266|NCT03457142|Glucocorticoids|glucocorticoids|mesh-ancestor
102060267|NCT03457142|Hormones|hormones|mesh-ancestor
101381254|NCT00074750|Immunologic Factors|immunologic factors|mesh-ancestor
101381255|NCT00074750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381256|NCT00074750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101381257|NCT00416533|Prednisone|prednisone|mesh-list
101381258|NCT00416533|Docetaxel|docetaxel|mesh-list
101381259|NCT00416533|Doxorubicin|doxorubicin|mesh-list
101381260|NCT00416533|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101381261|NCT00416533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101381262|NCT00416533|Tubulin Modulators|tubulin modulators|mesh-ancestor
101381263|NCT00416533|Antimitotic Agents|antimitotic agents|mesh-ancestor
101381264|NCT00416533|Mitosis Modulators|mitosis modulators|mesh-ancestor
101381265|NCT00416533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381266|NCT00416533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101381267|NCT00416533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101381268|NCT00416533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101381269|NCT00416533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101381270|NCT00416533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101381271|NCT00416533|Glucocorticoids|glucocorticoids|mesh-ancestor
101381272|NCT00416533|Hormones|hormones|mesh-ancestor
101381273|NCT00416533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101381274|NCT00416533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314144|NCT00000793|Adrenergic Agents|adrenergic agents|mesh-ancestor
101381275|NCT00416533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101381276|NCT00107796|Modafinil|modafinil|mesh-list
101381277|NCT00107796|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101381278|NCT00107796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381279|NCT00107796|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101381280|NCT00107796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101381281|NCT00107796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101381282|NCT00107796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381283|NCT00272896|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
101381284|NCT00272896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101381285|NCT00272896|Vasodilator Agents|vasodilator agents|mesh-ancestor
101381286|NCT00272896|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101381287|NCT00272896|Protective Agents|protective agents|mesh-ancestor
101381288|NCT00272896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381289|NCT00272935|Estrogens|estrogens|mesh-list
101381290|NCT00272935|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101381291|NCT00272935|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
101381292|NCT00272935|Hormones|hormones|mesh-ancestor
101381293|NCT00272935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101381294|NCT00272935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381305|NCT00107835|Lidocaine|lidocaine|mesh-list
101381306|NCT00107835|Tetracaine|tetracaine|mesh-list
101381307|NCT00107835|Anesthetics, Local|anesthetics, local|mesh-ancestor
101381308|NCT00107835|Anesthetics|anesthetics|mesh-ancestor
101381309|NCT00107835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101381310|NCT00107835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381311|NCT00107835|Sensory System Agents|sensory system agents|mesh-ancestor
101381312|NCT00107835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101381313|NCT00107835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101381314|NCT00107835|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101381315|NCT00107835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101381316|NCT00107835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101381317|NCT00107835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381318|NCT00107874|Misoprostol|misoprostol|mesh-list
101381319|NCT00107874|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101381320|NCT00107874|Abortifacient Agents|abortifacient agents|mesh-ancestor
101381321|NCT00107874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101381322|NCT00107874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381323|NCT00107874|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101381324|NCT00107874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101381325|NCT00107874|Oxytocics|oxytocics|mesh-ancestor
102060268|NCT03457142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102060269|NCT03457142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102060270|NCT03457142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102060271|NCT03457142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060272|NCT03457142|Protease Inhibitors|protease inhibitors|mesh-ancestor
101361880|NCT00126256|Vitamins|vitamins|mesh-ancestor
101381326|NCT00074828|Enoxaparin|enoxaparin|mesh-list
101381327|NCT00074828|Anticoagulants|anticoagulants|mesh-ancestor
101381328|NCT00074828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101381329|NCT00074828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101381330|NCT00074828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381331|NCT00273247|Interferons|interferons|mesh-list
101381332|NCT00273247|Interferon-alpha|interferon-alpha|mesh-list
101381333|NCT00273247|Interferon alpha-2|interferon alpha-2|mesh-list
101381334|NCT00273247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101381335|NCT00273247|Antiviral Agents|antiviral agents|mesh-ancestor
101381336|NCT00273247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101381337|NCT00273247|Immunologic Factors|immunologic factors|mesh-ancestor
101381338|NCT00273247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381339|NCT00273442|Timolol|timolol|mesh-list
101381340|NCT00273442|Dorzolamide|dorzolamide|mesh-list
101381341|NCT00273442|Maleic acid|maleic acid|mesh-list
101381342|NCT00273442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101381343|NCT00273442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381344|NCT00273442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101381345|NCT00273442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101381346|NCT00273442|Adrenergic Agents|adrenergic agents|mesh-ancestor
101381347|NCT00273442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101381348|NCT00273442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381349|NCT00273442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101381350|NCT00273442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101381351|NCT00273442|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101381352|NCT00401427|Trastuzumab|trastuzumab|mesh-list
101381353|NCT00401427|Vinorelbine|vinorelbine|mesh-list
101381354|NCT00401427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101381355|NCT00401427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101305041|NCT02016664|Anesthetics|anesthetics|mesh-ancestor
101305042|NCT02016664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101381367|NCT00273481|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101381368|NCT00273481|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101381369|NCT00273481|Adrenergic Agents|adrenergic agents|mesh-ancestor
101381370|NCT00273481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101381371|NCT00273481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381372|NCT00273481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101381373|NCT00273481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101381374|NCT00273481|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101381375|NCT00273481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101381389|NCT00273676|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101381390|NCT00273676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101381391|NCT00273676|Antitubercular Agents|antitubercular agents|mesh-ancestor
101381392|NCT00273871|Cyclosporine|cyclosporine|mesh-list
101381393|NCT00273871|Tacrolimus|tacrolimus|mesh-list
101381394|NCT00273871|Cyclosporins|cyclosporins|mesh-list
101381395|NCT00273871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101381396|NCT00273871|Immunologic Factors|immunologic factors|mesh-ancestor
101381397|NCT00273871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381398|NCT00273871|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101381399|NCT00273871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101381400|NCT00273871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381401|NCT00273871|Antifungal Agents|antifungal agents|mesh-ancestor
101381402|NCT00273871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101381403|NCT00273871|Dermatologic Agents|dermatologic agents|mesh-ancestor
101381404|NCT00273871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101381405|NCT00273949|Lactulose|lactulose|mesh-list
101381406|NCT00273949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101381407|NCT00273988|Nevirapine|nevirapine|mesh-list
101381408|NCT00273988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101381409|NCT00273988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102060273|NCT03457142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102060274|NCT03457142|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102060275|NCT03457142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102060276|NCT03457142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102060277|NCT03457142|Immunologic Factors|immunologic factors|mesh-ancestor
102060278|NCT03457142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102060279|NCT03457142|Dermatologic Agents|dermatologic agents|mesh-ancestor
102060280|NCT03457142|Glycine Agents|glycine agents|mesh-ancestor
102060281|NCT03457142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102060282|NCT03370406|Fluorouracil|fluorouracil|mesh-list
101381410|NCT00273988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101381411|NCT00273988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381412|NCT00273988|Antiviral Agents|antiviral agents|mesh-ancestor
101381413|NCT00273988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101381414|NCT00273988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101381415|NCT00273988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101381416|NCT00273988|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101381417|NCT00273988|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101381418|NCT00274027|Bromides|bromides|mesh-list
101381419|NCT00274027|Tiotropium Bromide|tiotropium bromide|mesh-list
101381420|NCT00274027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101381421|NCT00274027|Autonomic Agents|autonomic agents|mesh-ancestor
101381422|NCT00274027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101381423|NCT00274027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381424|NCT00274027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101381425|NCT00274027|Respiratory System Agents|respiratory system agents|mesh-ancestor
101381426|NCT00274027|Parasympatholytics|parasympatholytics|mesh-ancestor
101381427|NCT00274027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101381428|NCT00274027|Cholinergic Agents|cholinergic agents|mesh-ancestor
101381429|NCT00274027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101381436|NCT00075101|Cholinergic Agents|cholinergic agents|mesh-ancestor
101381437|NCT00075101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101381442|NCT00274066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101381443|NCT00274066|Autonomic Agents|autonomic agents|mesh-ancestor
101381444|NCT00274066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101381445|NCT00274066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381446|NCT00274066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101381447|NCT00274066|Respiratory System Agents|respiratory system agents|mesh-ancestor
101381448|NCT00274066|Parasympatholytics|parasympatholytics|mesh-ancestor
101381449|NCT00274066|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101381450|NCT00274066|Cholinergic Agents|cholinergic agents|mesh-ancestor
101381451|NCT00274066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101305043|NCT02016664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101305044|NCT02016664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101305045|NCT02016664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101333844|NCT00041275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101381452|NCT00274066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381453|NCT00274066|Sympathomimetics|sympathomimetics|mesh-ancestor
101381454|NCT00274066|Tocolytic Agents|tocolytic agents|mesh-ancestor
101381455|NCT00274066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101381456|NCT00274066|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101381457|NCT00274066|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101381458|NCT00274066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101381459|NCT00274066|Adrenergic Agents|adrenergic agents|mesh-ancestor
101381460|NCT00274105|Telmisartan|telmisartan|mesh-list
101381461|NCT00274105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101381462|NCT00274105|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101381463|NCT00274105|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101381464|NCT00274105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381465|NCT00274144|Telmisartan|telmisartan|mesh-list
101381466|NCT00274144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101381467|NCT00274144|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101381468|NCT00274144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102060283|NCT03370406|Imiquimod|imiquimod|mesh-list
102060284|NCT03370406|Antimetabolites|antimetabolites|mesh-ancestor
102060285|NCT03370406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060286|NCT03370406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102060287|NCT03370406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102060288|NCT03370406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102060289|NCT03370406|Immunologic Factors|immunologic factors|mesh-ancestor
102060290|NCT03370406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381469|NCT00274144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381470|NCT00108186|Celecoxib|celecoxib|mesh-list
101381471|NCT00108186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101381472|NCT00108186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101381473|NCT00108186|Analgesics|analgesics|mesh-ancestor
101381474|NCT00108186|Sensory System Agents|sensory system agents|mesh-ancestor
101381475|NCT00108186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101381476|NCT00108186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381477|NCT00108186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101381478|NCT00108186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101381479|NCT00108186|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101381480|NCT00108186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101381481|NCT00108186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101381482|NCT00108186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381484|NCT00274339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101381485|NCT00274339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101381486|NCT00274339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101381487|NCT00274339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101381488|NCT00274339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381489|NCT00075179|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101381490|NCT00075179|Natriuretic Agents|natriuretic agents|mesh-ancestor
101381491|NCT00075179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381492|NCT00416650|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101381493|NCT00416650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101381494|NCT00416650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101381495|NCT00416650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101381502|NCT00274417|Hormone Antagonists|hormone antagonists|mesh-ancestor
101381503|NCT00274417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101381504|NCT00274417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381505|NCT00274495|Rosiglitazone|rosiglitazone|mesh-list
101381506|NCT00274495|Ribavirin|ribavirin|mesh-list
101381507|NCT00274495|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101381518|NCT00274534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101381519|NCT00274534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381520|NCT00274534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101381521|NCT00274534|Respiratory System Agents|respiratory system agents|mesh-ancestor
101381522|NCT00274534|Parasympatholytics|parasympatholytics|mesh-ancestor
101381523|NCT00274534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101381524|NCT00274534|Cholinergic Agents|cholinergic agents|mesh-ancestor
101381525|NCT00274534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101305046|NCT02016664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305047|NCT02016703|Erythritol|erythritol|mesh-list
101381526|NCT00274534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381527|NCT00274534|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101381528|NCT00274534|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101381529|NCT00274534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101381530|NCT00274534|Adrenergic Agents|adrenergic agents|mesh-ancestor
101381531|NCT00274573|Bromides|bromides|mesh-list
101381532|NCT00274573|Tiotropium Bromide|tiotropium bromide|mesh-list
101381533|NCT00274573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101381534|NCT00274573|Autonomic Agents|autonomic agents|mesh-ancestor
101381535|NCT00274573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101381536|NCT00274573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381537|NCT00274573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101381538|NCT00274573|Respiratory System Agents|respiratory system agents|mesh-ancestor
101381539|NCT00274573|Parasympatholytics|parasympatholytics|mesh-ancestor
102060291|NCT03370406|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102060292|NCT03370406|Interferon Inducers|interferon inducers|mesh-ancestor
102060293|NCT03347292|Pembrolizumab|pembrolizumab|mesh-list
102060294|NCT03347292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102060295|NCT03347292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101381540|NCT00274573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101381541|NCT00274573|Cholinergic Agents|cholinergic agents|mesh-ancestor
101381542|NCT00274573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101381543|NCT00274573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381544|NCT00274573|Anticonvulsants|anticonvulsants|mesh-ancestor
101381545|NCT00274612|Telmisartan|telmisartan|mesh-list
101381546|NCT00274612|Ramipril|ramipril|mesh-list
101381547|NCT00274612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101381548|NCT00274612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101381549|NCT00274612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101381550|NCT00274612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381551|NCT00274612|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101381552|NCT00274612|Protease Inhibitors|protease inhibitors|mesh-ancestor
101381553|NCT00274612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101381554|NCT00075374|Docetaxel|docetaxel|mesh-list
101381555|NCT00075374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101381556|NCT00075374|Tubulin Modulators|tubulin modulators|mesh-ancestor
101381557|NCT00075374|Antimitotic Agents|antimitotic agents|mesh-ancestor
101381558|NCT00075374|Mitosis Modulators|mitosis modulators|mesh-ancestor
101381559|NCT00075374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381560|NCT00274690|Casopitant|casopitant|mesh-list
101381561|NCT00274690|Antiemetics|antiemetics|mesh-ancestor
101381562|NCT00274690|Autonomic Agents|autonomic agents|mesh-ancestor
101381563|NCT00274690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101381564|NCT00274690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381565|NCT00274690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101381566|NCT00274690|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101381567|NCT00274690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101381568|NCT00274690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381569|NCT00274807|Cytarabine|cytarabine|mesh-list
101381578|NCT00274807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101381579|NCT00274807|Antimetabolites|antimetabolites|mesh-ancestor
101381580|NCT00274807|Antiviral Agents|antiviral agents|mesh-ancestor
101381581|NCT00274807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101381582|NCT00274807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101381583|NCT00274807|Immunologic Factors|immunologic factors|mesh-ancestor
101381584|NCT00274807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381585|NCT00274807|Analgesics|analgesics|mesh-ancestor
101381586|NCT00274807|Sensory System Agents|sensory system agents|mesh-ancestor
101381587|NCT00274807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101381588|NCT00274885|Oxaliplatin|oxaliplatin|mesh-list
101381589|NCT00274885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101381590|NCT00277225|Abatacept|abatacept|mesh-list
101381591|NCT00277225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101381592|NCT00277225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381593|NCT00277225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101381594|NCT00277225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101381595|NCT00277225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101381596|NCT00277225|Immunologic Factors|immunologic factors|mesh-ancestor
101381597|NCT00277225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381598|NCT00277225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101381599|NCT00277264|Tiotropium Bromide|tiotropium bromide|mesh-list
101305048|NCT02016703|Vasodilator Agents|vasodilator agents|mesh-ancestor
101305050|NCT02016729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101381600|NCT00277264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101381601|NCT00277264|Autonomic Agents|autonomic agents|mesh-ancestor
101381602|NCT00277264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101381603|NCT00277264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381604|NCT00277264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101381605|NCT00277264|Respiratory System Agents|respiratory system agents|mesh-ancestor
101381606|NCT00277264|Parasympatholytics|parasympatholytics|mesh-ancestor
101381607|NCT00277264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101381608|NCT00277264|Cholinergic Agents|cholinergic agents|mesh-ancestor
101381609|NCT00277264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102060296|NCT03347292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102060297|NCT03347292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060298|NCT03317405|Tamoxifen|tamoxifen|mesh-list
102060299|NCT03317405|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102060300|NCT03317405|Hormone Antagonists|hormone antagonists|mesh-ancestor
102060301|NCT03317405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102060302|NCT03317405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381610|NCT00277264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381611|NCT00108420|Prazosin|prazosin|mesh-list
101381612|NCT00108420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101381613|NCT00108420|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101381614|NCT00108420|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101381615|NCT00108420|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101381616|NCT00108420|Adrenergic Agents|adrenergic agents|mesh-ancestor
101381617|NCT00108420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101381618|NCT00108420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381619|NCT00108420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381620|NCT00075413|Arsenic Trioxide|arsenic trioxide|mesh-list
101381621|NCT00075413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101381622|NCT00277342|Insulin|insulin|mesh-list
101381623|NCT00277342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101381624|NCT00277342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381625|NCT00277498|Timolol|timolol|mesh-list
101381626|NCT00277498|Latanoprost|latanoprost|mesh-list
101381627|NCT00277498|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101381628|NCT00277498|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101381629|NCT00277498|Adrenergic Agents|adrenergic agents|mesh-ancestor
101381630|NCT00277498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101381631|NCT00277498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381632|NCT00277498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381633|NCT00277498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101381634|NCT00277498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101381635|NCT00277498|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101381636|NCT00277498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101381637|NCT00108498|Mirtazapine|mirtazapine|mesh-list
101381638|NCT00108498|Antidepressive Agents|antidepressive agents|mesh-ancestor
101381639|NCT00108498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101381640|NCT00108498|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101381641|NCT00108498|Histamine Antagonists|histamine antagonists|mesh-ancestor
101381648|NCT00108498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101381649|NCT00108498|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101381650|NCT00108498|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101381651|NCT00108498|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101381652|NCT00108498|Adrenergic Agents|adrenergic agents|mesh-ancestor
101381653|NCT00108498|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101381654|NCT00108498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101381655|NCT00108498|Serotonin Agents|serotonin agents|mesh-ancestor
101381656|NCT00108498|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101381657|NCT00277537|Mannitol|mannitol|mesh-list
101381658|NCT00277537|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101381659|NCT00277537|Diuretics|diuretics|mesh-ancestor
101381660|NCT00277537|Natriuretic Agents|natriuretic agents|mesh-ancestor
101381661|NCT00277537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381662|NCT00075452|Gemcitabine|gemcitabine|mesh-list
101381663|NCT00075452|Oxaliplatin|oxaliplatin|mesh-list
101381664|NCT00075452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101381665|NCT00075452|Antimetabolites|antimetabolites|mesh-ancestor
101381666|NCT00075452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381667|NCT00075452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101381668|NCT00108537|Bupropion|bupropion|mesh-list
101381669|NCT00108537|Nicotine|nicotine|mesh-list
101381670|NCT00108537|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101305051|NCT02016729|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101305052|NCT02016729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101333845|NCT00041275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060303|NCT03317405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102060304|NCT03317405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102060305|NCT03317405|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102060306|NCT03317405|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102060307|NCT03317405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102060308|NCT03198650|Obinutuzumab|obinutuzumab|mesh-list
102060309|NCT03198650|Acalabrutinib|acalabrutinib|mesh-list
102060310|NCT03198650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102060311|NCT03198650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102060312|NCT03182426|Liraglutide|liraglutide|mesh-list
102060313|NCT03182426|Plerixafor|plerixafor|mesh-list
102060314|NCT03182426|Etanercept|etanercept|mesh-list
101361915|NCT00126373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101381671|NCT00108537|Autonomic Agents|autonomic agents|mesh-ancestor
101381672|NCT00108537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101381673|NCT00108537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381674|NCT00108537|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101381675|NCT00108537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101381676|NCT00108537|Cholinergic Agents|cholinergic agents|mesh-ancestor
101381677|NCT00108537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101381678|NCT00108537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381679|NCT00108537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101381680|NCT00108537|Antidepressive Agents|antidepressive agents|mesh-ancestor
101381681|NCT00108537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101381682|NCT00108537|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101381683|NCT00108537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101381684|NCT00108537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101381685|NCT00108537|Dopamine Agents|dopamine agents|mesh-ancestor
101381686|NCT00108537|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101381687|NCT00108537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101381688|NCT00108537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101381689|NCT00277654|Risperidone|risperidone|mesh-list
101381690|NCT00277654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101381691|NCT00277654|Serotonin Agents|serotonin agents|mesh-ancestor
101381692|NCT00277654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101381693|NCT00277654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381694|NCT00277654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381695|NCT00277654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101381696|NCT00277654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101381697|NCT00277654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101381698|NCT00277654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101381699|NCT00277654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101381700|NCT00277654|Dopamine Agents|dopamine agents|mesh-ancestor
101381701|NCT00277693|Spironolactone|spironolactone|mesh-list
101381702|NCT00277693|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101381703|NCT00277693|Hormone Antagonists|hormone antagonists|mesh-ancestor
101381704|NCT00277693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101381705|NCT00277693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381706|NCT00277693|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101381707|NCT00277693|Diuretics|diuretics|mesh-ancestor
101381708|NCT00277693|Natriuretic Agents|natriuretic agents|mesh-ancestor
101381709|NCT00108576|Valproic Acid|valproic acid|mesh-list
101387721|NCT00323206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101381738|NCT00278083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381739|NCT00278083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101381740|NCT00278083|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101381741|NCT00278083|Vasodilator Agents|vasodilator agents|mesh-ancestor
101381742|NCT00278083|Gasotransmitters|gasotransmitters|mesh-ancestor
101381743|NCT00278083|Protective Agents|protective agents|mesh-ancestor
101381745|NCT00278122|Sargramostim|sargramostim|mesh-list
101381746|NCT00278122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102060316|NCT03182426|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102060317|NCT03182426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101381747|NCT00278122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101381748|NCT00278122|Tubulin Modulators|tubulin modulators|mesh-ancestor
101381749|NCT00278122|Antimitotic Agents|antimitotic agents|mesh-ancestor
101381750|NCT00278122|Mitosis Modulators|mitosis modulators|mesh-ancestor
101381751|NCT00278122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381752|NCT00278122|Immunologic Factors|immunologic factors|mesh-ancestor
101381753|NCT00278122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381754|NCT00075647|Sirolimus|sirolimus|mesh-list
101381755|NCT00075647|Temsirolimus|temsirolimus|mesh-list
101381756|NCT00075647|MTOR Inhibitors|mtor inhibitors|mesh-list
101381757|NCT00075647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101381758|NCT00075647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101381759|NCT00075647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305053|NCT02016729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381760|NCT00075647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101381761|NCT00075647|Immunologic Factors|immunologic factors|mesh-ancestor
101381762|NCT00075647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381763|NCT00075647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101381764|NCT00075647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101381765|NCT00075647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101381804|NCT00108771|Narcotics|narcotics|mesh-ancestor
101381805|NCT00108771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101381806|NCT00108771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381807|NCT00108771|Analgesics|analgesics|mesh-ancestor
101381808|NCT00108771|Sensory System Agents|sensory system agents|mesh-ancestor
101381809|NCT00108771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101381810|NCT00108771|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101381811|NCT00108771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101381812|NCT00108771|Anesthetics, General|anesthetics, general|mesh-ancestor
101381813|NCT00108771|Anesthetics|anesthetics|mesh-ancestor
101381814|NCT00278434|Zoledronic Acid|zoledronic acid|mesh-list
101381815|NCT00278434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101381816|NCT00278434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381817|NCT00075686|Gemcitabine|gemcitabine|mesh-list
101381818|NCT00075686|Cetuximab|cetuximab|mesh-list
101381819|NCT00075686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101381820|NCT00075686|Antimetabolites|antimetabolites|mesh-ancestor
101381821|NCT00075686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381822|NCT00075686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101381823|NCT00075686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101381824|NCT00278824|Fentanyl|fentanyl|mesh-list
101381825|NCT00278824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101381826|NCT00278824|Narcotics|narcotics|mesh-ancestor
101381827|NCT00278824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101381828|NCT00278824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381829|NCT00278824|Analgesics|analgesics|mesh-ancestor
101381830|NCT00278824|Sensory System Agents|sensory system agents|mesh-ancestor
101381831|NCT00278824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101381832|NCT00278824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101381833|NCT00278824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101381834|NCT00278824|Anesthetics, General|anesthetics, general|mesh-ancestor
101381835|NCT00278824|Anesthetics|anesthetics|mesh-ancestor
101381836|NCT00278941|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101381837|NCT00278941|Antidepressive Agents|antidepressive agents|mesh-ancestor
101381838|NCT00278941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101381839|NCT00278941|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101381840|NCT00278941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101381855|NCT00108849|Estradiol|estradiol|mesh-list
101381856|NCT00108849|Estrogens|estrogens|mesh-ancestor
101381857|NCT00108849|Hormones|hormones|mesh-ancestor
101381858|NCT00108849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101381859|NCT00108849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381860|NCT00279058|Immunomodulating Agents|immunomodulating agents|mesh-list
101381861|NCT00279058|Immunologic Factors|immunologic factors|mesh-ancestor
101381862|NCT00279058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381863|NCT00279253|Clonidine|clonidine|mesh-list
101381864|NCT00279253|Analgesics|analgesics|mesh-ancestor
101381865|NCT00279253|Sensory System Agents|sensory system agents|mesh-ancestor
101381866|NCT00279253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102060318|NCT03182426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060319|NCT03182426|Incretins|incretins|mesh-ancestor
102060320|NCT03182426|Hormones|hormones|mesh-ancestor
102060321|NCT03182426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101361932|NCT00126451|Vorinostat|vorinostat|mesh-list
101381867|NCT00279253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381868|NCT00279253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101305055|NCT02016807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101305056|NCT02016807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101305057|NCT02016820|Omeprazole|omeprazole|mesh-list
101381869|NCT00279253|Sympatholytics|sympatholytics|mesh-ancestor
101381870|NCT00279253|Autonomic Agents|autonomic agents|mesh-ancestor
101381874|NCT00279253|Adrenergic Agents|adrenergic agents|mesh-ancestor
101381875|NCT00279253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101381876|NCT00279253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381878|NCT00109044|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101381879|NCT00109044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101381880|NCT00109044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101381881|NCT00109044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381882|NCT00109044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101381883|NCT00109044|Serotonin Agents|serotonin agents|mesh-ancestor
101381884|NCT00109044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381885|NCT00279448|Tamoxifen|tamoxifen|mesh-list
101381886|NCT00279448|Exemestane|exemestane|mesh-list
101381887|NCT00279448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101381888|NCT00279448|Hormone Antagonists|hormone antagonists|mesh-ancestor
101381889|NCT00279448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101381890|NCT00279448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381891|NCT00279448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101381892|NCT00279448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101381893|NCT00279448|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101381894|NCT00279448|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101381895|NCT00279448|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101381896|NCT00279448|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101381899|NCT00279448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381901|NCT00075959|Antioxidants|antioxidants|mesh-ancestor
101387722|NCT04717531|Cyclophosphamide|cyclophosphamide|mesh-list
101381902|NCT00075959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381903|NCT00075959|Protective Agents|protective agents|mesh-ancestor
101381904|NCT00075959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381905|NCT00279487|Gabapentin|gabapentin|mesh-list
101381906|NCT00279487|Analgesics|analgesics|mesh-ancestor
101381907|NCT00279487|Sensory System Agents|sensory system agents|mesh-ancestor
101381908|NCT00279487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101381909|NCT00279487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381910|NCT00279487|Anticonvulsants|anticonvulsants|mesh-ancestor
101381911|NCT00279487|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101381912|NCT00279487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101381913|NCT00279487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101381914|NCT00279487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101381915|NCT00279487|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101381916|NCT00279487|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101381917|NCT00279487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101381918|NCT00279487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381919|NCT00279487|Antimanic Agents|antimanic agents|mesh-ancestor
101381920|NCT00279565|Interferons|interferons|mesh-list
101381921|NCT00279565|Ribavirin|ribavirin|mesh-list
101381922|NCT00279565|Interferon-alpha|interferon-alpha|mesh-list
101381923|NCT00279565|Interferon alpha-2|interferon alpha-2|mesh-list
101381924|NCT00279565|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101381925|NCT00279565|Buprenorphine|buprenorphine|mesh-list
101381926|NCT00279565|Methadone|methadone|mesh-list
101381927|NCT00279565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101381928|NCT00279565|Antiviral Agents|antiviral agents|mesh-ancestor
101381929|NCT00279565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101381930|NCT00279565|Antimetabolites|antimetabolites|mesh-ancestor
101381931|NCT00279565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381932|NCT00279565|Immunologic Factors|immunologic factors|mesh-ancestor
102060323|NCT03182426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102060324|NCT03182426|Analgesics|analgesics|mesh-ancestor
102060325|NCT03182426|Sensory System Agents|sensory system agents|mesh-ancestor
102060326|NCT03182426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101381933|NCT00279565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381934|NCT00279565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101381935|NCT00279565|Narcotics|narcotics|mesh-ancestor
101381936|NCT00279565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101381937|NCT00279565|Analgesics|analgesics|mesh-ancestor
101305058|NCT02016820|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101305059|NCT02016820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101305060|NCT02016820|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101305061|NCT02016820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101381938|NCT00279565|Sensory System Agents|sensory system agents|mesh-ancestor
101381939|NCT00279565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101381940|NCT00279565|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101381947|NCT00075998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101381949|NCT00109161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101381950|NCT00109161|Daclizumab|daclizumab|mesh-list
101381951|NCT00109161|Immunologic Factors|immunologic factors|mesh-ancestor
101381952|NCT00109161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381953|NCT00109161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101381954|NCT00279760|Abatacept|abatacept|mesh-list
101381955|NCT00279760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101381956|NCT00279760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381957|NCT00279760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101381958|NCT00279760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101381959|NCT00279760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101381960|NCT00279760|Immunologic Factors|immunologic factors|mesh-ancestor
101381961|NCT00279760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381962|NCT00279760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101381963|NCT00109200|Omalizumab|omalizumab|mesh-list
101381964|NCT00109200|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101381965|NCT00109200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101381966|NCT00109200|Respiratory System Agents|respiratory system agents|mesh-ancestor
101381967|NCT00416728|Valsartan|valsartan|mesh-list
101381968|NCT00416728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101381969|NCT00416728|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101381970|NCT00416728|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101381975|NCT00416767|Calcium|calcium|mesh-list
101381976|NCT00416767|Levoleucovorin|levoleucovorin|mesh-list
101381977|NCT00416767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101381978|NCT00416767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381979|NCT00416767|Antimetabolites|antimetabolites|mesh-ancestor
101381980|NCT00416767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381981|NCT00416767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101381982|NCT00416767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101381983|NCT00416767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101381984|NCT00416767|Immunologic Factors|immunologic factors|mesh-ancestor
101381985|NCT00416767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101381986|NCT00416767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101381987|NCT00416767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101381988|NCT00416767|Antidotes|antidotes|mesh-ancestor
101381989|NCT00416767|Protective Agents|protective agents|mesh-ancestor
101381990|NCT00416767|Vitamin B Complex|vitamin b complex|mesh-ancestor
101381991|NCT00416767|Vitamins|vitamins|mesh-ancestor
101381992|NCT00416767|Micronutrients|micronutrients|mesh-ancestor
101381993|NCT00076115|Risperidone|risperidone|mesh-list
101381994|NCT00076115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101381995|NCT00076115|Serotonin Agents|serotonin agents|mesh-ancestor
101381996|NCT00076115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101381997|NCT00076115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381998|NCT00076115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381999|NCT00076115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101382000|NCT00076115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101382001|NCT00076115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102060328|NCT03182426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102060329|NCT03182426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102060330|NCT03182426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102060331|NCT03182426|Immunologic Factors|immunologic factors|mesh-ancestor
102060332|NCT03182426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102060333|NCT03182426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102060334|NCT03182426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101382002|NCT00076115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101382003|NCT00076115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101382004|NCT00076115|Dopamine Agents|dopamine agents|mesh-ancestor
101382005|NCT00109239|Bevacizumab|bevacizumab|mesh-list
101387723|NCT04717531|Docetaxel|docetaxel|mesh-list
101382006|NCT00109239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101382007|NCT00109239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101382008|NCT00109239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101382009|NCT00109239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101382010|NCT00109239|Growth Substances|growth substances|mesh-ancestor
101305062|NCT02016820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305063|NCT02016846|Liraglutide|liraglutide|mesh-list
101305064|NCT02016846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101382014|NCT00280033|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101382015|NCT00280033|Immunologic Factors|immunologic factors|mesh-ancestor
101382016|NCT00280033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382018|NCT00280033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382019|NCT00280033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101382020|NCT00109278|Vaccines|vaccines|mesh-list
101382021|NCT00109278|Immunologic Factors|immunologic factors|mesh-ancestor
101382022|NCT00109278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382023|NCT00280267|Testosterone|testosterone|mesh-list
101382024|NCT00280267|Androgens|androgens|mesh-ancestor
101382025|NCT00280267|Hormones|hormones|mesh-ancestor
101382026|NCT00280267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101382027|NCT00280267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382028|NCT00076232|Acyclovir|acyclovir|mesh-list
101382029|NCT00076232|Antiviral Agents|antiviral agents|mesh-ancestor
101382030|NCT00076232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101382031|NCT00280423|Casopitant|casopitant|mesh-list
101382032|NCT00280423|Antiemetics|antiemetics|mesh-ancestor
101382033|NCT00280423|Autonomic Agents|autonomic agents|mesh-ancestor
101382034|NCT00280423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101382035|NCT00280423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382036|NCT00280423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101382037|NCT00280423|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101382038|NCT00280423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101382039|NCT00280423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382040|NCT00109356|AQ4N|aq4n|mesh-list
101382041|NCT00109356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101382042|NCT00280462|Nifedipine|nifedipine|mesh-list
101382047|NCT00280462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382048|NCT00280462|Vasodilator Agents|vasodilator agents|mesh-ancestor
101382049|NCT00280462|Tocolytic Agents|tocolytic agents|mesh-ancestor
101382050|NCT00280462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101382051|NCT00280501|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101382052|NCT00280501|Sulpiride|sulpiride|mesh-list
101382053|NCT00280501|Antidepressive Agents|antidepressive agents|mesh-ancestor
101382054|NCT00280501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101382055|NCT00280501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101382056|NCT00280501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101382057|NCT00280501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101382058|NCT00280501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382059|NCT00280501|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101382060|NCT00280501|Dopamine Agents|dopamine agents|mesh-ancestor
101382061|NCT00280501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101382062|NCT00280501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382063|NCT00280501|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101382064|NCT00280540|Valsartan|valsartan|mesh-list
101382065|NCT00280540|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102060336|NCT03182426|Antiviral Agents|antiviral agents|mesh-ancestor
102060337|NCT03182426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102060338|NCT03161379|Cyclophosphamide|cyclophosphamide|mesh-list
102060339|NCT03161379|Nivolumab|nivolumab|mesh-list
102060340|NCT03161379|Pancrelipase|pancrelipase|mesh-list
102060341|NCT03161379|Vaccines|vaccines|mesh-list
102060342|NCT03161379|Immunologic Factors|immunologic factors|mesh-ancestor
101382066|NCT00280540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101382067|NCT00280540|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101382068|NCT00280540|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101382069|NCT00280540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382070|NCT00280540|Diuretics|diuretics|mesh-ancestor
101382071|NCT00280540|Natriuretic Agents|natriuretic agents|mesh-ancestor
101382072|NCT00280540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382073|NCT00280540|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101382074|NCT00280540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101382075|NCT00076349|Rituximab|rituximab|mesh-list
101382076|NCT00076349|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101382077|NCT00076349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101382078|NCT00076349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101382079|NCT00076349|Immunologic Factors|immunologic factors|mesh-ancestor
101382080|NCT00076349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305065|NCT02016846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305066|NCT02016846|Incretins|incretins|mesh-ancestor
101305067|NCT02016846|Hormones|hormones|mesh-ancestor
101305068|NCT02016846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101305069|NCT02016976|Midazolam|midazolam|mesh-list
101305070|NCT02016976|Meperidine|meperidine|mesh-list
101305071|NCT02016976|Analgesics|analgesics|mesh-list
101305072|NCT02016976|Sensory System Agents|sensory system agents|mesh-ancestor
101305073|NCT02016976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101305074|NCT02016976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382081|NCT00076349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101382084|NCT00076349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382085|NCT00280618|Oxaliplatin|oxaliplatin|mesh-list
101382086|NCT00280618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101382087|NCT00416845|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101382088|NCT00416845|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101382089|NCT00416845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382090|NCT00416845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101382091|NCT00416845|Immunologic Factors|immunologic factors|mesh-ancestor
101382092|NCT00416845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382093|NCT00280696|Levetiracetam|levetiracetam|mesh-list
101382094|NCT00280696|Anticonvulsants|anticonvulsants|mesh-ancestor
101382095|NCT00280696|Nootropic Agents|nootropic agents|mesh-ancestor
101382096|NCT00076388|Docetaxel|docetaxel|mesh-list
101382097|NCT00076388|Gefitinib|gefitinib|mesh-list
101382098|NCT00076388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101382099|NCT00076388|Tubulin Modulators|tubulin modulators|mesh-ancestor
101382100|NCT00076388|Antimitotic Agents|antimitotic agents|mesh-ancestor
101382101|NCT00076388|Mitosis Modulators|mitosis modulators|mesh-ancestor
101382106|NCT00280774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101382107|NCT00280774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101382108|NCT00280774|Dopamine Agents|dopamine agents|mesh-ancestor
101382109|NCT00280774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101382110|NCT00280774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382111|NCT00280774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382112|NCT00280774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101382113|NCT00280774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101382114|NCT00109551|Folic Acid|folic acid|mesh-list
101382115|NCT00109551|Zinc Sulfate|zinc sulfate|mesh-list
101382116|NCT00109551|Hematinics|hematinics|mesh-ancestor
101382117|NCT00109551|Vitamin B Complex|vitamin b complex|mesh-ancestor
101382118|NCT00109551|Vitamins|vitamins|mesh-ancestor
101382119|NCT00109551|Micronutrients|micronutrients|mesh-ancestor
101382120|NCT00109551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382121|NCT00109551|Astringents|astringents|mesh-ancestor
102060343|NCT03161379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060344|NCT03161379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102060345|NCT03161379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102060346|NCT03161379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102060347|NCT03161379|Alkylating Agents|alkylating agents|mesh-ancestor
102060348|NCT03161379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060349|NCT03161379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361957|NCT00074178|Autonomic Agents|autonomic agents|mesh-ancestor
101382122|NCT00109551|Dermatologic Agents|dermatologic agents|mesh-ancestor
101382123|NCT00280930|Letrozole|letrozole|mesh-list
101382124|NCT00280930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101382125|NCT00280930|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101382126|NCT00280930|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101382127|NCT00280930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101382128|NCT00280930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382129|NCT00280930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101382130|NCT00280930|Hormone Antagonists|hormone antagonists|mesh-ancestor
101382131|NCT00280930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101382132|NCT00280930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382133|NCT00280969|Efavirenz|efavirenz|mesh-list
101382134|NCT00280969|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101382135|NCT00280969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101382136|NCT00280969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101382137|NCT00280969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101305075|NCT02016976|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101305076|NCT02016976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101305077|NCT02016976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101305078|NCT02016976|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101305079|NCT02016976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101305080|NCT02016976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101305081|NCT02016976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101305082|NCT02016976|Anesthetics, General|anesthetics, general|mesh-ancestor
101305083|NCT02016976|Anesthetics|anesthetics|mesh-ancestor
101305084|NCT02016976|GABA Modulators|gaba modulators|mesh-ancestor
101305085|NCT02016976|GABA Agents|gaba agents|mesh-ancestor
101305086|NCT02016976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101305087|NCT02016976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305088|NCT02016976|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101305089|NCT02016976|Narcotics|narcotics|mesh-ancestor
101305090|NCT02017119|Lactulose|lactulose|mesh-list
101382138|NCT00280969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382139|NCT00280969|Antiviral Agents|antiviral agents|mesh-ancestor
101382140|NCT00280969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101382141|NCT00280969|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101382142|NCT00280969|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101382143|NCT00280969|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101382144|NCT00280969|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101382145|NCT00280969|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101382146|NCT00280969|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101382147|NCT00280969|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101387724|NCT04717531|Trastuzumab|trastuzumab|mesh-list
101382148|NCT00280969|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101382149|NCT00280969|Protease Inhibitors|protease inhibitors|mesh-ancestor
101382150|NCT00280969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101382151|NCT00280969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101382152|NCT00281008|Mipomersen|mipomersen|mesh-list
101382153|NCT00281008|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101382161|NCT00281125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101382162|NCT00281125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382168|NCT00109746|Trace Elements|trace elements|mesh-ancestor
101382169|NCT00109746|Micronutrients|micronutrients|mesh-ancestor
101382170|NCT00109746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382171|NCT00109746|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101382172|NCT00109746|Chelating Agents|chelating agents|mesh-ancestor
101382173|NCT00109746|Sequestering Agents|sequestering agents|mesh-ancestor
102060351|NCT03161379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102060352|NCT03161379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102060353|NCT03161379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102060354|NCT03141359|Paclitaxel|paclitaxel|mesh-list
102060355|NCT03141359|Etoposide|etoposide|mesh-list
102060356|NCT03141359|Carboplatin|carboplatin|mesh-list
102060357|NCT03141359|Durvalumab|durvalumab|mesh-list
102060358|NCT03141359|Cisplatin|cisplatin|mesh-list
102060359|NCT03141359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102060360|NCT03141359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102060361|NCT03141359|Tubulin Modulators|tubulin modulators|mesh-ancestor
101382174|NCT00109746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382175|NCT04730297|Acetaminophen|acetaminophen|mesh-list
101382176|NCT04730297|Ibuprofen|ibuprofen|mesh-list
101382177|NCT04730297|Codeine|codeine|mesh-list
101382178|NCT04730297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101382179|NCT04730297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101382180|NCT04730297|Analgesics|analgesics|mesh-ancestor
101382181|NCT04730297|Sensory System Agents|sensory system agents|mesh-ancestor
101382182|NCT04730297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101382183|NCT04730297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382184|NCT04730297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101382185|NCT04730297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101382186|NCT04730297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101382187|NCT04730297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101305091|NCT02017119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101305092|NCT02017197|Warfarin|warfarin|mesh-list
101305093|NCT02017197|Anticoagulants|anticoagulants|mesh-ancestor
101305094|NCT02017314|Morphine|morphine|mesh-list
101305095|NCT02017314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101305096|NCT02017314|Narcotics|narcotics|mesh-ancestor
101382188|NCT04730297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382189|NCT04730297|Antipyretics|antipyretics|mesh-ancestor
101382190|NCT04730297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101382191|NCT04730297|Narcotics|narcotics|mesh-ancestor
101382192|NCT04730297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101382193|NCT04730297|Antitussive Agents|antitussive agents|mesh-ancestor
101382194|NCT04730297|Respiratory System Agents|respiratory system agents|mesh-ancestor
101382195|NCT00399269|Epoetin Alfa|epoetin alfa|mesh-list
101382196|NCT00399269|Hematinics|hematinics|mesh-ancestor
101382197|NCT00281281|Vancomycin|vancomycin|mesh-list
101382198|NCT00281281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101382199|NCT00281281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101382200|NCT00109785|Idoxuridine|idoxuridine|mesh-list
101382201|NCT00109785|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101382202|NCT00109785|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101382203|NCT00109785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382204|NCT00109785|Antiviral Agents|antiviral agents|mesh-ancestor
101382205|NCT00109785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101382206|NCT00109785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101382207|NCT00109785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101382208|NCT00281476|Simvastatin|simvastatin|mesh-list
101382209|NCT00281476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101382210|NCT00281476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101382211|NCT00281476|Antimetabolites|antimetabolites|mesh-ancestor
101382212|NCT00281476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382213|NCT00281476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101382214|NCT00281476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101382215|NCT00281476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101382216|NCT00416923|Rituximab|rituximab|mesh-list
101382217|NCT00416923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101382218|NCT00416923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101382219|NCT00416923|Immunologic Factors|immunologic factors|mesh-ancestor
101382220|NCT00416923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060362|NCT03141359|Antimitotic Agents|antimitotic agents|mesh-ancestor
102060363|NCT03141359|Mitosis Modulators|mitosis modulators|mesh-ancestor
102060364|NCT03141359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060365|NCT03141359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102060366|NCT03141359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101780070|NCT04877288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102060368|NCT03141359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102060369|NCT03078946|Midazolam|midazolam|mesh-list
101382221|NCT00416923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101382222|NCT00416962|Oseltamivir|oseltamivir|mesh-list
101382223|NCT00416962|Amantadine|amantadine|mesh-list
101382228|NCT00416962|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101382229|NCT00416962|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101382230|NCT00416962|Dopamine Agents|dopamine agents|mesh-ancestor
101382231|NCT00416962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101382232|NCT00416962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382239|NCT00109824|Valproic Acid|valproic acid|mesh-list
101382240|NCT00109824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101382241|NCT00109824|Antimetabolites|antimetabolites|mesh-ancestor
101382242|NCT00109824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382243|NCT00109824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101382244|NCT00109824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101382245|NCT00109824|Anticonvulsants|anticonvulsants|mesh-ancestor
101382246|NCT00109824|GABA Agents|gaba agents|mesh-ancestor
101382247|NCT00109824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101382248|NCT00109824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382249|NCT00109824|Antimanic Agents|antimanic agents|mesh-ancestor
101382250|NCT00109824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101382251|NCT00109824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101382252|NCT00109824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101382253|NCT00281515|Lonafarnib|lonafarnib|mesh-list
101382254|NCT00281515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101382255|NCT00281515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382256|NCT00109941|Analgesics, Opioid|analgesics, opioid|mesh-list
101382257|NCT00109941|Mitogens|mitogens|mesh-list
101382258|NCT00109941|Enkephalin, Methionine|enkephalin, methionine|mesh-list
101305097|NCT02017314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101305098|NCT02017314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305099|NCT02017314|Analgesics|analgesics|mesh-ancestor
101305100|NCT02017314|Sensory System Agents|sensory system agents|mesh-ancestor
101305101|NCT02017314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101382259|NCT00109941|Narcotics|narcotics|mesh-ancestor
101382260|NCT00109941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101382261|NCT00109941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382262|NCT00109941|Analgesics|analgesics|mesh-ancestor
101382263|NCT00109941|Sensory System Agents|sensory system agents|mesh-ancestor
101382264|NCT00109941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101382265|NCT00109941|Mitosis Modulators|mitosis modulators|mesh-ancestor
101382266|NCT00109941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382267|NCT00109941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101382268|NCT00281593|Telmisartan|telmisartan|mesh-list
101382269|NCT00281593|Ramipril|ramipril|mesh-list
101382270|NCT00281593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101382271|NCT00281593|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101382272|NCT00281593|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101382273|NCT00281593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382274|NCT00281593|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101382275|NCT00281593|Protease Inhibitors|protease inhibitors|mesh-ancestor
101382276|NCT00281593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101382277|NCT00281710|Methylprednisolone|methylprednisolone|mesh-list
101382278|NCT00281710|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101382279|NCT00281710|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101382280|NCT00281710|Prednisolone|prednisolone|mesh-list
101382281|NCT00281710|Prednisolone acetate|prednisolone acetate|mesh-list
101382282|NCT00281710|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101382283|NCT00281710|Prednisolone phosphate|prednisolone phosphate|mesh-list
101382284|NCT00281710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102060371|NCT03078946|Morphine|morphine|mesh-list
102060372|NCT03078946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102060373|NCT03078946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102060374|NCT03078946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060375|NCT03078946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101382285|NCT00281710|Antiemetics|antiemetics|mesh-ancestor
101382286|NCT00281710|Autonomic Agents|autonomic agents|mesh-ancestor
101382287|NCT00281710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101382288|NCT00281710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382289|NCT00281710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101382290|NCT00281710|Glucocorticoids|glucocorticoids|mesh-ancestor
101382291|NCT00281710|Hormones|hormones|mesh-ancestor
101382292|NCT00281710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101382293|NCT00281710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101382294|NCT00281710|Protective Agents|protective agents|mesh-ancestor
101382319|NCT00281788|Antimetabolites|antimetabolites|mesh-ancestor
101382320|NCT00281866|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101382321|NCT00281866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101382322|NCT00281866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101382323|NCT00281866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101382331|NCT00281905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382332|NCT00281905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101382333|NCT00281905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101382334|NCT00281905|Alkylating Agents|alkylating agents|mesh-ancestor
101382335|NCT00281905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382336|NCT00281905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101382337|NCT00281905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101382338|NCT00281905|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101382339|NCT00281905|Abortifacient Agents|abortifacient agents|mesh-ancestor
101382340|NCT00281905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101382341|NCT00281905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101382342|NCT00281905|Antimetabolites|antimetabolites|mesh-ancestor
101382343|NCT00281905|Dermatologic Agents|dermatologic agents|mesh-ancestor
101382344|NCT00281905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101382356|NCT00110058|Fludarabine phosphate|fludarabine phosphate|mesh-list
101382357|NCT00110058|Imatinib Mesylate|imatinib mesylate|mesh-list
101305103|NCT02017340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101305104|NCT02017340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101382359|NCT00110058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101382360|NCT00110058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101382361|NCT00110058|Antimetabolites|antimetabolites|mesh-ancestor
101382362|NCT00110058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382363|NCT00110058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101382364|NCT00110058|Immunologic Factors|immunologic factors|mesh-ancestor
101382365|NCT00110058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382366|NCT00110058|Antiviral Agents|antiviral agents|mesh-ancestor
101382367|NCT00110058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101382368|NCT00110058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101382369|NCT00110058|Antifungal Agents|antifungal agents|mesh-ancestor
101382370|NCT00110058|Dermatologic Agents|dermatologic agents|mesh-ancestor
101382371|NCT00110058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101382372|NCT00110058|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101382373|NCT00110058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101382374|NCT00110058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101382375|NCT00110058|Antitubercular Agents|antitubercular agents|mesh-ancestor
101382376|NCT00110058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101382377|NCT00110058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101382379|NCT00281944|Fluorouracil|fluorouracil|mesh-list
101382380|NCT00281944|Oxaliplatin|oxaliplatin|mesh-list
101382381|NCT00281944|Calcium|calcium|mesh-list
101382382|NCT00281944|Levoleucovorin|levoleucovorin|mesh-list
101382383|NCT00281944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101382384|NCT00281944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382385|NCT00281944|Antimetabolites|antimetabolites|mesh-ancestor
101382386|NCT00281944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382387|NCT00281944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101382388|NCT00281944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102060376|NCT03078946|Analgesics|analgesics|mesh-ancestor
102060377|NCT03078946|Sensory System Agents|sensory system agents|mesh-ancestor
102060378|NCT03078946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102060379|NCT03078946|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102060380|NCT03078946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102060381|NCT03078946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102060382|NCT03078946|Adrenergic Agents|adrenergic agents|mesh-ancestor
102060383|NCT03078946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102060384|NCT03078946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060385|NCT03078946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102060386|NCT03078946|Narcotics|narcotics|mesh-ancestor
101382389|NCT00281944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101382390|NCT00281944|Immunologic Factors|immunologic factors|mesh-ancestor
101382391|NCT00281944|Antidotes|antidotes|mesh-ancestor
101382392|NCT00281944|Protective Agents|protective agents|mesh-ancestor
101382393|NCT00281944|Vitamin B Complex|vitamin b complex|mesh-ancestor
101382394|NCT00281944|Vitamins|vitamins|mesh-ancestor
101382395|NCT00281944|Micronutrients|micronutrients|mesh-ancestor
101382396|NCT00281983|Cyclosporine|cyclosporine|mesh-list
101382397|NCT00281983|Mycophenolic Acid|mycophenolic acid|mesh-list
101382398|NCT00281983|Cyclophosphamide|cyclophosphamide|mesh-list
101382399|NCT00281983|Busulfan|busulfan|mesh-list
101382400|NCT00281983|Rituximab|rituximab|mesh-list
101382401|NCT00281983|Methotrexate|methotrexate|mesh-list
101382402|NCT00281983|Fludarabine|fludarabine|mesh-list
101382403|NCT00281983|Fludarabine phosphate|fludarabine phosphate|mesh-list
101382404|NCT00281983|Alemtuzumab|alemtuzumab|mesh-list
101382405|NCT00281983|Cyclosporins|cyclosporins|mesh-list
101382410|NCT00281983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101382411|NCT00281983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101382412|NCT00281983|Alkylating Agents|alkylating agents|mesh-ancestor
101382413|NCT00281983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382429|NCT00281983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101382430|NCT00281983|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101382431|NCT00281983|Antitubercular Agents|antitubercular agents|mesh-ancestor
101382432|NCT00281983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101382433|NCT00282061|Melatonin|melatonin|mesh-list
101382434|NCT00282061|Antioxidants|antioxidants|mesh-ancestor
101382435|NCT00282061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382436|NCT00282061|Protective Agents|protective agents|mesh-ancestor
101382437|NCT00282061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382438|NCT00282061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101382439|NCT00282100|Gefitinib|gefitinib|mesh-list
101382440|NCT00282100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101382441|NCT00282100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101382442|NCT00282100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101382443|NCT00282100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382444|NCT00282139|Aripiprazole|aripiprazole|mesh-list
101382445|NCT00282139|Antidepressive Agents|antidepressive agents|mesh-ancestor
101382446|NCT00282139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101305105|NCT02017340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101305106|NCT02017340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305107|NCT02017340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101382447|NCT00282139|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101382448|NCT00282139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101382449|NCT00282139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101382450|NCT00282139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382451|NCT00282139|Dopamine Agonists|dopamine agonists|mesh-ancestor
101382452|NCT00282139|Dopamine Agents|dopamine agents|mesh-ancestor
101382453|NCT00282139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101382454|NCT00282139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382455|NCT00282139|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101382456|NCT00282139|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102060388|NCT03078946|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102060389|NCT03078946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102060390|NCT03078946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102060391|NCT03078946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102060392|NCT03078946|Anesthetics, General|anesthetics, general|mesh-ancestor
102060393|NCT03078946|Anesthetics|anesthetics|mesh-ancestor
102060394|NCT03078946|GABA Modulators|gaba modulators|mesh-ancestor
102060395|NCT03078946|GABA Agents|gaba agents|mesh-ancestor
101382457|NCT00282139|Serotonin Agents|serotonin agents|mesh-ancestor
101382458|NCT00282139|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101382459|NCT00282139|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101382460|NCT00282139|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101382461|NCT00282139|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101382462|NCT00110253|Lidocaine|lidocaine|mesh-list
101382463|NCT00110253|Tetracaine|tetracaine|mesh-list
101382464|NCT00110253|Anesthetics, Local|anesthetics, local|mesh-ancestor
101382465|NCT00110253|Anesthetics|anesthetics|mesh-ancestor
101382466|NCT00110253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101387725|NCT04717531|Epirubicin|epirubicin|mesh-list
101382467|NCT00110253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382468|NCT00110253|Sensory System Agents|sensory system agents|mesh-ancestor
101382469|NCT00110253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101382470|NCT00110253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101382475|NCT00282178|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101382476|NCT00282178|Candesartan|candesartan|mesh-list
101382477|NCT00282178|Candesartan cilexetil|candesartan cilexetil|mesh-list
101382478|NCT00282178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101382479|NCT00282178|Diuretics|diuretics|mesh-ancestor
101382480|NCT00282178|Natriuretic Agents|natriuretic agents|mesh-ancestor
101382481|NCT00282178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382482|NCT00282178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101382483|NCT00282178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101382484|NCT00282178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382485|NCT00282178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101382486|NCT00282178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101382487|NCT00282217|Sirolimus|sirolimus|mesh-list
101382488|NCT00282217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101382498|NCT00282451|Insulin Aspart|insulin aspart|mesh-list
101382499|NCT00282451|Insulin, Long-Acting|insulin, long-acting|mesh-list
101382500|NCT00282451|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101382501|NCT00282451|Biphasic Insulins|biphasic insulins|mesh-list
101382502|NCT00282451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101382503|NCT00282451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382504|NCT00282607|Udenafil|udenafil|mesh-list
101382505|NCT00282607|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101382506|NCT00282607|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101382507|NCT00282607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101382508|NCT00282607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382509|NCT00282724|Liarozole|liarozole|mesh-list
101382510|NCT00282724|Androgen Antagonists|androgen antagonists|mesh-ancestor
101382511|NCT00282724|Hormone Antagonists|hormone antagonists|mesh-ancestor
101382512|NCT00282724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101382513|NCT00282724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305108|NCT02017340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305110|NCT02017392|Anesthetics, Local|anesthetics, local|mesh-ancestor
101305111|NCT02017392|Anesthetics|anesthetics|mesh-ancestor
101382514|NCT00282724|Dermatologic Agents|dermatologic agents|mesh-ancestor
101382515|NCT00282724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101382516|NCT00282724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382517|NCT00282724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101382518|NCT00282724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101382519|NCT00282958|Botulinum Toxins|botulinum toxins|mesh-list
101382520|NCT00282958|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101382521|NCT00282958|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101382522|NCT00282958|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102060396|NCT03071861|Darbepoetin alfa|darbepoetin alfa|mesh-list
102060397|NCT03071861|Hematinics|hematinics|mesh-ancestor
102060398|NCT02974621|Bevacizumab|bevacizumab|mesh-list
102060399|NCT02974621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102060400|NCT02974621|Olaparib|olaparib|mesh-list
101382523|NCT00282958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101382524|NCT00282958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382525|NCT00282958|Cholinergic Agents|cholinergic agents|mesh-ancestor
101382526|NCT00282958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101382527|NCT00282958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382528|NCT00282958|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101382529|NCT00282958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101382530|NCT00282997|Pregabalin|pregabalin|mesh-list
101382531|NCT00282997|Analgesics|analgesics|mesh-ancestor
101382532|NCT00282997|Sensory System Agents|sensory system agents|mesh-ancestor
101382533|NCT00282997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101382534|NCT00282997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382535|NCT00282997|Anticonvulsants|anticonvulsants|mesh-ancestor
101382536|NCT00282997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101382537|NCT00282997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101382541|NCT00282997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101382542|NCT00282997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101382543|NCT00282997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101382544|NCT00283036|Irbesartan|irbesartan|mesh-list
101382545|NCT00283036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101382546|NCT00283036|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101382547|NCT00283036|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101382548|NCT00283036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382549|NCT00110370|Insulin Glargine|insulin glargine|mesh-list
101382550|NCT00110370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101382551|NCT00110370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382552|NCT00283114|Lintuzumab|lintuzumab|mesh-list
101382556|NCT00076856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101382557|NCT00076856|Alkylating Agents|alkylating agents|mesh-ancestor
101382558|NCT00076856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382559|NCT00076856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101382561|NCT00283192|Antidepressive Agents|antidepressive agents|mesh-ancestor
101382562|NCT00283192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101382563|NCT00283192|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101382564|NCT00283192|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101382565|NCT00283192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101382566|NCT00283192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382567|NCT00283192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101382568|NCT00283192|Serotonin Agents|serotonin agents|mesh-ancestor
101382569|NCT00283192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382570|NCT00283309|Riluzole|riluzole|mesh-list
101382571|NCT00283309|Memantine|memantine|mesh-list
101382572|NCT00283309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101382573|NCT00283309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101382574|NCT00283309|Dopamine Agents|dopamine agents|mesh-ancestor
101382575|NCT00283309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101382576|NCT00283309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382577|NCT00283309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382578|NCT00283309|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101382579|NCT00283309|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101305112|NCT02017392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101305113|NCT02017392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382581|NCT00283309|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101382582|NCT00283309|Protective Agents|protective agents|mesh-ancestor
101382583|NCT00417157|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101382584|NCT00417157|Ganirelix|ganirelix|mesh-list
101382585|NCT00417157|Hormone Antagonists|hormone antagonists|mesh-ancestor
101382586|NCT00417157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101382587|NCT00417157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382588|NCT00417157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101382589|NCT00283465|Epoetin Alfa|epoetin alfa|mesh-list
101382590|NCT00283465|Hematinics|hematinics|mesh-ancestor
101382591|NCT00283543|Temozolomide|temozolomide|mesh-list
101382592|NCT00283543|Carmustine|carmustine|mesh-list
102060401|NCT02974621|Cediranib|cediranib|mesh-list
102060402|NCT02974621|Endothelial Growth Factors|endothelial growth factors|mesh-list
102060403|NCT02974621|Antibodies|antibodies|mesh-list
102060404|NCT02974621|Immunoglobulins|immunoglobulins|mesh-list
102060405|NCT02974621|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101382593|NCT00283543|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101382594|NCT00283543|Alkylating Agents|alkylating agents|mesh-ancestor
101382595|NCT00283543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382596|NCT00283543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101382597|NCT00283621|Doxorubicin|doxorubicin|mesh-list
101382598|NCT00283621|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101382599|NCT00283621|Ifosfamide|ifosfamide|mesh-list
101382600|NCT00283621|Darbepoetin alfa|darbepoetin alfa|mesh-list
101382601|NCT00283621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101382602|NCT00283621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101382603|NCT00283621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101382604|NCT00283621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101382605|NCT00283621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101382606|NCT00283621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382610|NCT00283660|Zinc Oxide|zinc oxide|mesh-list
101382611|NCT00283660|Dermatologic Agents|dermatologic agents|mesh-ancestor
101382612|NCT00283660|Sunscreening Agents|sunscreening agents|mesh-ancestor
101382613|NCT00283660|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101382614|NCT00283660|Protective Agents|protective agents|mesh-ancestor
101382615|NCT00283660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382616|NCT00077051|Tetrahydrouridine|tetrahydrouridine|mesh-list
101382617|NCT00077051|Antimetabolites|antimetabolites|mesh-ancestor
101382618|NCT00077051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382619|NCT00283699|Albendazole|albendazole|mesh-list
101382620|NCT00283699|Anthelmintics|anthelmintics|mesh-ancestor
101382621|NCT00283699|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101382622|NCT00283699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101382623|NCT00283699|Anticestodal Agents|anticestodal agents|mesh-ancestor
101382624|NCT00283699|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101382625|NCT00283699|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101382630|NCT00283699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101382631|NCT00283777|Chromium|chromium|mesh-list
101382632|NCT00283777|Picolinic acid|picolinic acid|mesh-list
101382633|NCT00283777|Trace Elements|trace elements|mesh-ancestor
101382634|NCT00283777|Micronutrients|micronutrients|mesh-ancestor
101382635|NCT00283777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382636|NCT00283777|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101382637|NCT00283777|Chelating Agents|chelating agents|mesh-ancestor
101382638|NCT00283777|Sequestering Agents|sequestering agents|mesh-ancestor
101382639|NCT00283777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382640|NCT00110448|Aspirin|aspirin|mesh-list
101382641|NCT00110448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101382642|NCT00110448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101382643|NCT00110448|Analgesics|analgesics|mesh-ancestor
101382644|NCT00110448|Sensory System Agents|sensory system agents|mesh-ancestor
101382645|NCT00110448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101382646|NCT00110448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382647|NCT00110448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101382648|NCT00110448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101382649|NCT00110448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101382650|NCT00110448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101382651|NCT00110448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382652|NCT00110448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101305114|NCT02017392|Sensory System Agents|sensory system agents|mesh-ancestor
101305115|NCT02017392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101305116|NCT02017392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101382653|NCT00110448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101382654|NCT00110448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101382655|NCT00110448|Antipyretics|antipyretics|mesh-ancestor
101382656|NCT00284206|Risperidone|risperidone|mesh-list
101382657|NCT00284206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101382658|NCT00284206|Serotonin Agents|serotonin agents|mesh-ancestor
101382659|NCT00284206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101382660|NCT00284206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382661|NCT00284206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382662|NCT00284206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101382663|NCT00284206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102060406|NCT02974621|Immunoglobulin G|immunoglobulin g|mesh-list
102060407|NCT02974621|Maleic acid|maleic acid|mesh-list
102060408|NCT02974621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102060409|NCT02974621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102060410|NCT02974621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102060411|NCT02974621|Growth Substances|growth substances|mesh-ancestor
102060412|NCT02974621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060413|NCT02974621|Growth Inhibitors|growth inhibitors|mesh-ancestor
102060414|NCT02974621|Immunologic Factors|immunologic factors|mesh-ancestor
101362021|NCT00127114|Amantadine|amantadine|mesh-list
101382664|NCT00284206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101382665|NCT00284206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101382666|NCT00284206|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101382667|NCT00284206|Dopamine Agents|dopamine agents|mesh-ancestor
101382668|NCT00284323|Adenosine|adenosine|mesh-list
101382669|NCT00284323|Analgesics|analgesics|mesh-ancestor
101382670|NCT00284323|Sensory System Agents|sensory system agents|mesh-ancestor
101382671|NCT00284323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101382672|NCT00284323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382673|NCT00284323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101382675|NCT00284323|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101382676|NCT00284323|Purinergic Agonists|purinergic agonists|mesh-ancestor
101382677|NCT00284323|Purinergic Agents|purinergic agents|mesh-ancestor
101382678|NCT00284323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101382679|NCT00284323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382680|NCT04718701|Paclitaxel|paclitaxel|mesh-list
101382686|NCT04718701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382688|NCT00077168|Anastrozole|anastrozole|mesh-list
101382689|NCT00077168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382690|NCT00077168|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101382691|NCT00077168|Hormone Antagonists|hormone antagonists|mesh-ancestor
101382692|NCT00077168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101382693|NCT00077168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382694|NCT00077168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101382695|NCT00077168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101382696|NCT00077168|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101382697|NCT00077168|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101382702|NCT00110604|Folic Acid|folic acid|mesh-list
101382703|NCT00110604|Hematinics|hematinics|mesh-ancestor
101382704|NCT00110604|Vitamin B Complex|vitamin b complex|mesh-ancestor
101382705|NCT00110604|Vitamins|vitamins|mesh-ancestor
101382706|NCT00110604|Micronutrients|micronutrients|mesh-ancestor
101382707|NCT00110604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382708|NCT00284752|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101382709|NCT00284752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101382710|NCT00284791|Lamotrigine|lamotrigine|mesh-list
101382711|NCT00284791|Sertraline|sertraline|mesh-list
101382712|NCT00284791|Fluoxetine|fluoxetine|mesh-list
101382713|NCT00284791|Antidepressive Agents|antidepressive agents|mesh-ancestor
101382714|NCT00284791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101382715|NCT00284791|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101382716|NCT00284791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101382717|NCT00284791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101382718|NCT00284791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382719|NCT00284791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101382720|NCT00284791|Serotonin Agents|serotonin agents|mesh-ancestor
101382721|NCT00284791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382722|NCT00284791|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101382723|NCT00284791|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101382724|NCT00284791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101382725|NCT00284791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101382726|NCT00284791|Anticonvulsants|anticonvulsants|mesh-ancestor
101305117|NCT02017392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102060415|NCT02974621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060416|NCT02974621|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102060417|NCT02974621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102060418|NCT02974621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102060419|NCT02970448|Temozolomide|temozolomide|mesh-list
102060420|NCT02970448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102060421|NCT02970448|Alkylating Agents|alkylating agents|mesh-ancestor
102060422|NCT02970448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305118|NCT02017392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101382727|NCT00284791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101382728|NCT00284791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101382730|NCT00284791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101382731|NCT00284791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101382732|NCT00284791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101382733|NCT00284947|Prednisone|prednisone|mesh-list
101382734|NCT00284947|Prednisolone|prednisolone|mesh-list
101382735|NCT00284947|Methylprednisolone|methylprednisolone|mesh-list
101382736|NCT00284947|Basiliximab|basiliximab|mesh-list
101382737|NCT00284947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101382738|NCT00284947|Glucocorticoids|glucocorticoids|mesh-ancestor
101382739|NCT00284947|Hormones|hormones|mesh-ancestor
101382740|NCT00284947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101382741|NCT00284947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382742|NCT00284947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101382743|NCT00284947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101382744|NCT00284947|Antiemetics|antiemetics|mesh-ancestor
101382745|NCT00284947|Autonomic Agents|autonomic agents|mesh-ancestor
101382746|NCT00284947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101382747|NCT00284947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101382748|NCT00284947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101382750|NCT00284947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101382751|NCT00284947|Immunologic Factors|immunologic factors|mesh-ancestor
101382752|NCT00110682|Imiquimod|imiquimod|mesh-list
101382753|NCT00110682|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101382754|NCT00110682|Immunologic Factors|immunologic factors|mesh-ancestor
101382755|NCT00110682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382756|NCT00110682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101382757|NCT00110682|Interferon Inducers|interferon inducers|mesh-ancestor
101382758|NCT00077246|Paclitaxel|paclitaxel|mesh-list
101382759|NCT00077246|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101382760|NCT00077246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101382761|NCT00077246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101382762|NCT00077246|Tubulin Modulators|tubulin modulators|mesh-ancestor
101382763|NCT00077246|Antimitotic Agents|antimitotic agents|mesh-ancestor
101382764|NCT00077246|Mitosis Modulators|mitosis modulators|mesh-ancestor
101382765|NCT00077246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382766|NCT00110721|Fluorouracil|fluorouracil|mesh-list
101382767|NCT00110721|Antimetabolites|antimetabolites|mesh-ancestor
101382772|NCT00110721|Immunologic Factors|immunologic factors|mesh-ancestor
101382773|NCT00110721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382774|NCT00417235|Chlorhexidine|chlorhexidine|mesh-list
101382775|NCT00417235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101382776|NCT00417235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101382777|NCT00417235|Disinfectants|disinfectants|mesh-ancestor
101382778|NCT00425035|Panitumumab|panitumumab|mesh-list
101382779|NCT00425035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101382780|NCT00425035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101382782|NCT00110760|Tetracaine|tetracaine|mesh-list
101382783|NCT00110760|Anesthetics, Local|anesthetics, local|mesh-ancestor
101382784|NCT00110760|Anesthetics|anesthetics|mesh-ancestor
101382785|NCT00110760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101382786|NCT00110760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382787|NCT00110760|Sensory System Agents|sensory system agents|mesh-ancestor
101382788|NCT00110760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102060424|NCT02875223|Itraconazole|itraconazole|mesh-list
102060425|NCT02875223|Rifampin|rifampin|mesh-list
102060426|NCT02875223|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
102060427|NCT02875223|Antifungal Agents|antifungal agents|mesh-ancestor
101480907|NCT00305409|Sulfalene|sulfalene|mesh-list
101382789|NCT00110760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101382790|NCT00110760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101382791|NCT00110760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101382792|NCT00110760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101382793|NCT00110760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382794|NCT00285142|Rosiglitazone|rosiglitazone|mesh-list
101382795|NCT00285142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101382796|NCT00285142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382797|NCT00285181|Simvastatin|simvastatin|mesh-list
101305119|NCT02017392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101382798|NCT00285181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101382799|NCT00285181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101382800|NCT00285181|Antimetabolites|antimetabolites|mesh-ancestor
101382801|NCT00285181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382802|NCT00285181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101382803|NCT00285181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101382804|NCT00285181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101382805|NCT00285298|Pentoxifylline|pentoxifylline|mesh-list
101382806|NCT00285298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101382807|NCT00285298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101382808|NCT00285298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382809|NCT00285298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101382810|NCT00285298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101382811|NCT00285298|Protective Agents|protective agents|mesh-ancestor
101382812|NCT00285298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382813|NCT00285298|Vasodilator Agents|vasodilator agents|mesh-ancestor
101382814|NCT00285298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101382815|NCT00285298|Antioxidants|antioxidants|mesh-ancestor
101382816|NCT00285376|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
101382817|NCT00285376|Antidepressive Agents|antidepressive agents|mesh-ancestor
101382819|NCT00285376|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101382820|NCT00285376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101382821|NCT00285376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101382834|NCT00285415|Carboplatin|carboplatin|mesh-list
101382835|NCT00285415|Docetaxel|docetaxel|mesh-list
101382836|NCT00285415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101382837|NCT00285415|Tubulin Modulators|tubulin modulators|mesh-ancestor
101382838|NCT00285415|Antimitotic Agents|antimitotic agents|mesh-ancestor
101382839|NCT00285415|Mitosis Modulators|mitosis modulators|mesh-ancestor
101382840|NCT00285415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382841|NCT00285493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101382842|NCT00285493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101382843|NCT00285727|Ropinirole|ropinirole|mesh-list
101382844|NCT00285727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101382845|NCT00285727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101382846|NCT00285727|Dopamine Agonists|dopamine agonists|mesh-ancestor
101382847|NCT00285727|Dopamine Agents|dopamine agents|mesh-ancestor
101382848|NCT00285727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101382853|NCT00077402|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101382854|NCT00077402|Protective Agents|protective agents|mesh-ancestor
101382855|NCT00077402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382856|NCT00285766|Selegiline|selegiline|mesh-list
101382857|NCT00285766|Antidepressive Agents|antidepressive agents|mesh-ancestor
101382858|NCT00285766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101382859|NCT00285766|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101382860|NCT00285766|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101382861|NCT00285766|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101382862|NCT00285766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101382863|NCT00285766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382864|NCT00285766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101382865|NCT00285766|Protective Agents|protective agents|mesh-ancestor
101382866|NCT00285766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382867|NCT00285805|Rosiglitazone|rosiglitazone|mesh-list
101382868|NCT00285805|Amiloride|amiloride|mesh-list
102060428|NCT02875223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102060429|NCT02875223|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102060430|NCT02875223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102060431|NCT02875223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102060432|NCT02875223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060433|NCT02875223|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102060434|NCT02875223|Hormone Antagonists|hormone antagonists|mesh-ancestor
102060435|NCT02875223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101382869|NCT00285805|Furosemide|furosemide|mesh-list
101382870|NCT00285805|Diuretics|diuretics|mesh-ancestor
101382871|NCT00285805|Natriuretic Agents|natriuretic agents|mesh-ancestor
101382872|NCT00285805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382873|NCT00285805|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101382874|NCT00285805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101382875|NCT00285805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382876|NCT00285805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101382877|NCT00285805|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
101382878|NCT00285805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101382879|NCT00285805|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101382880|NCT00285805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101305120|NCT02017392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305121|NCT02017405|Immunoglobulins|immunoglobulins|mesh-list
101305122|NCT02017405|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101382881|NCT00285844|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
101382882|NCT00285844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101382887|NCT00285883|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101382888|NCT00285883|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101382889|NCT00285883|Protease Inhibitors|protease inhibitors|mesh-ancestor
101382890|NCT00285883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101382891|NCT00285883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382892|NCT00285883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101382893|NCT00285883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101382894|NCT00285883|Antiviral Agents|antiviral agents|mesh-ancestor
101382895|NCT00285883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101382896|NCT00285883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101382897|NCT00285883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101382898|NCT00110877|Darunavir|darunavir|mesh-list
101382899|NCT00110877|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101382900|NCT00110877|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101382901|NCT00110877|Protease Inhibitors|protease inhibitors|mesh-ancestor
101382902|NCT00110877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101382903|NCT00110877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382904|NCT00110877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101382905|NCT00110877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101382906|NCT00110877|Antiviral Agents|antiviral agents|mesh-ancestor
101382907|NCT00110877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101382908|NCT00077519|Tipifarnib|tipifarnib|mesh-list
101382909|NCT00077519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101382910|NCT00286117|Tamoxifen|tamoxifen|mesh-list
101382911|NCT00286117|Anastrozole|anastrozole|mesh-list
101382912|NCT00286117|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101382913|NCT00286117|Hormone Antagonists|hormone antagonists|mesh-ancestor
101382914|NCT00286117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101382915|NCT00286117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382923|NCT00286117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101382924|NCT00286117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382925|NCT00110916|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101382926|NCT00110916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101382927|NCT00077558|Fludarabine|fludarabine|mesh-list
102060436|NCT02875223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060437|NCT02875223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102060438|NCT02875223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102060439|NCT02875223|Antitubercular Agents|antitubercular agents|mesh-ancestor
102060440|NCT02875223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102060441|NCT02875223|Leprostatic Agents|leprostatic agents|mesh-ancestor
102060442|NCT02875223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101382928|NCT00077558|Fludarabine phosphate|fludarabine phosphate|mesh-list
101382929|NCT00077558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101382930|NCT00077558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101382931|NCT00077558|Antimetabolites|antimetabolites|mesh-ancestor
101382932|NCT00077558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382933|NCT00077558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101382934|NCT00077558|Immunologic Factors|immunologic factors|mesh-ancestor
101382935|NCT00077558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382936|NCT00286273|Heparin|heparin|mesh-list
101382937|NCT00286273|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101382938|NCT00286273|Tinzaparin|tinzaparin|mesh-list
101382939|NCT00286273|Dalteparin|dalteparin|mesh-list
101382940|NCT00286273|Nadroparin|nadroparin|mesh-list
101382941|NCT00286273|Citric Acid|citric acid|mesh-list
101382942|NCT00286273|Sodium Citrate|sodium citrate|mesh-list
101382943|NCT00286273|Anticoagulants|anticoagulants|mesh-ancestor
101382944|NCT00286273|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101382945|NCT00286273|Chelating Agents|chelating agents|mesh-ancestor
101382946|NCT00286273|Sequestering Agents|sequestering agents|mesh-ancestor
101382947|NCT00286273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382948|NCT00286273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101382949|NCT00286273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101382950|NCT00286312|Atorvastatin|atorvastatin|mesh-list
101382951|NCT00286312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101305123|NCT02017405|Antibodies|antibodies|mesh-list
101305124|NCT02017405|Immunologic Factors|immunologic factors|mesh-ancestor
101305125|NCT02017405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305126|NCT02017457|Azacitidine|azacitidine|mesh-list
101305127|NCT02017457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101305128|NCT02017457|Antimetabolites|antimetabolites|mesh-ancestor
101382952|NCT00286312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101382953|NCT00286312|Antimetabolites|antimetabolites|mesh-ancestor
101382956|NCT00286312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101382957|NCT00286312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101382958|NCT00286351|Goserelin|goserelin|mesh-list
101382959|NCT00286351|Anastrozole|anastrozole|mesh-list
101382960|NCT00286351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101382961|NCT00286351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101382962|NCT00286351|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101382963|NCT00286351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101382964|NCT00286351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101382965|NCT00286351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382966|NCT00286351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101382967|NCT00286351|Hormone Antagonists|hormone antagonists|mesh-ancestor
101382968|NCT00286351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101382969|NCT00286351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382970|NCT00110955|Darbepoetin alfa|darbepoetin alfa|mesh-list
101382971|NCT00110955|Hematinics|hematinics|mesh-ancestor
101382972|NCT00286585|Propofol|propofol|mesh-list
101382973|NCT00286585|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
101382974|NCT00286585|Anesthetics|anesthetics|mesh-list
101382975|NCT00286585|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101382976|NCT00286585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101382977|NCT00286585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382978|NCT00286585|Anesthetics, General|anesthetics, general|mesh-ancestor
101382979|NCT00111072|Dexamethasone|dexamethasone|mesh-list
101382985|NCT00111072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101382986|NCT00111072|Glucocorticoids|glucocorticoids|mesh-ancestor
101382987|NCT00111072|Hormones|hormones|mesh-ancestor
101382988|NCT00111072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101382989|NCT00111072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102060443|NCT02875223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102060444|NCT02875223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102060445|NCT02875223|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102060446|NCT02875223|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102060447|NCT02875223|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102060448|NCT02875223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102060449|NCT02875223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102060450|NCT02759835|Osimertinib|osimertinib|mesh-list
101382990|NCT00111072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101382991|NCT00286624|Cyclosporine|cyclosporine|mesh-list
101382992|NCT00286624|Everolimus|everolimus|mesh-list
101382993|NCT00286624|Cyclosporins|cyclosporins|mesh-list
101382994|NCT00286624|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101382995|NCT00286624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101382996|NCT00286624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382997|NCT00286624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101382998|NCT00286624|Immunologic Factors|immunologic factors|mesh-ancestor
101382999|NCT00286624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383000|NCT00286624|Antifungal Agents|antifungal agents|mesh-ancestor
101383001|NCT00286624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101383002|NCT00286624|Dermatologic Agents|dermatologic agents|mesh-ancestor
101383003|NCT00286624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101383004|NCT00286624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101383005|NCT00286624|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101383006|NCT00286624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101383007|NCT00286624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101383008|NCT00077597|Epoetin Alfa|epoetin alfa|mesh-list
101383009|NCT00077597|Hematinics|hematinics|mesh-ancestor
101383010|NCT00286780|Gossypol acetic acid|gossypol acetic acid|mesh-list
101383011|NCT00286780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101383012|NCT00286780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101383013|NCT00286780|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101383014|NCT00286780|Contraceptive Agents|contraceptive agents|mesh-ancestor
101383015|NCT00286780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101383016|NCT00286780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383017|NCT00286780|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
101305129|NCT02017457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305130|NCT02017457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101305131|NCT02017457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101383018|NCT00286780|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
101383019|NCT00286780|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101383020|NCT00111111|Etanercept|etanercept|mesh-list
101383021|NCT00111111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101383022|NCT00111111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101383023|NCT00111111|Analgesics|analgesics|mesh-ancestor
101383024|NCT00111111|Sensory System Agents|sensory system agents|mesh-ancestor
101387726|NCT04717531|Pertuzumab|pertuzumab|mesh-list
101383025|NCT00111111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101383026|NCT00111111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383029|NCT00111111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101383030|NCT00111111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101383031|NCT00111111|Immunologic Factors|immunologic factors|mesh-ancestor
101383032|NCT00077714|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101383033|NCT00077714|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101383034|NCT00077714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101383035|NCT00077714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101383036|NCT00077714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383037|NCT00077714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101383038|NCT00077714|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101383039|NCT00077714|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101383040|NCT00077714|Serotonin Agents|serotonin agents|mesh-ancestor
101383041|NCT00077714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101383042|NCT00077714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383043|NCT00077714|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101383044|NCT00077714|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101383045|NCT00077714|Dopamine Agents|dopamine agents|mesh-ancestor
102060451|NCT02759835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362067|NCT00043823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102060452|NCT02759835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102060453|NCT02759835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102060454|NCT02759835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060455|NCT02743741|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102060456|NCT02743741|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102060457|NCT02743741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060458|NCT02694978|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102060459|NCT02694978|Hematinics|hematinics|mesh-ancestor
101383047|NCT00111150|Antiviral Agents|antiviral agents|mesh-ancestor
101383048|NCT00111150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101383049|NCT00111150|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101383060|NCT00417430|Hormone Antagonists|hormone antagonists|mesh-ancestor
101383061|NCT00417430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101383062|NCT00417430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383064|NCT00077753|Enoxaparin sodium|enoxaparin sodium|mesh-list
101383065|NCT00077753|Anticoagulants|anticoagulants|mesh-ancestor
101383066|NCT00077753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101383067|NCT00077753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101383068|NCT00077753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383069|NCT00111189|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101383070|NCT00111189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101383071|NCT00111189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101383072|NCT00111189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101383073|NCT00111189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383074|NCT00111189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101383075|NCT00111189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101383076|NCT00111189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101383077|NCT00111189|Serotonin Agents|serotonin agents|mesh-ancestor
101383078|NCT00111189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101383079|NCT00111189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383080|NCT00111189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101383081|NCT00111189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101383082|NCT00111189|Dopamine Agents|dopamine agents|mesh-ancestor
101383083|NCT00077792|Enoxaparin|enoxaparin|mesh-list
101383084|NCT00077792|Enoxaparin sodium|enoxaparin sodium|mesh-list
101383085|NCT00077792|Anticoagulants|anticoagulants|mesh-ancestor
101383086|NCT00077792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101383087|NCT00077792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101305133|NCT02017561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101305134|NCT02017561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305135|NCT02017600|Fluorouracil|fluorouracil|mesh-list
101383088|NCT00077792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383089|NCT00111267|Vitamins|vitamins|mesh-list
101383090|NCT00111267|Folic Acid|folic acid|mesh-list
101383091|NCT00111267|Hydroxocobalamin|hydroxocobalamin|mesh-list
101383092|NCT00111267|Vitamin B 12|vitamin b 12|mesh-list
101383093|NCT00111267|Vitamin B Complex|vitamin b complex|mesh-list
101383094|NCT00111267|Micronutrients|micronutrients|mesh-ancestor
101383095|NCT00111267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383096|NCT00111267|Hematinics|hematinics|mesh-ancestor
101383097|NCT00286936|Zolpidem|zolpidem|mesh-list
101383098|NCT00286936|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101383099|NCT00286936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101383100|NCT00286936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101383105|NCT00286936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101383106|NCT00286936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383107|NCT00111306|Epratuzumab|epratuzumab|mesh-list
101383108|NCT00111306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101383109|NCT00111306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101383110|NCT00077870|Ocrelizumab|ocrelizumab|mesh-list
101383111|NCT00077870|Immunologic Factors|immunologic factors|mesh-ancestor
102060460|NCT02694978|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102060461|NCT02694978|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102060462|NCT02693535|Pembrolizumab|pembrolizumab|mesh-list
102060463|NCT02693535|Nivolumab|nivolumab|mesh-list
102060464|NCT02693535|Trastuzumab|trastuzumab|mesh-list
102060465|NCT02693535|Ipilimumab|ipilimumab|mesh-list
102060466|NCT02693535|Atezolizumab|atezolizumab|mesh-list
102060467|NCT02693535|Pertuzumab|pertuzumab|mesh-list
102060468|NCT02693535|Sunitinib|sunitinib|mesh-list
102060469|NCT02693535|Olaparib|olaparib|mesh-list
102060470|NCT02693535|Palbociclib|palbociclib|mesh-list
101383112|NCT00077870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383114|NCT00287170|Mercaptopurine|mercaptopurine|mesh-list
101383115|NCT00287170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101383125|NCT00287170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101383126|NCT00287170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101383127|NCT00287170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101383128|NCT00287170|Immunologic Factors|immunologic factors|mesh-ancestor
101383129|NCT00287170|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101383130|NCT00287170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101383131|NCT00287209|Amiodarone|amiodarone|mesh-list
101383132|NCT00287209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101383133|NCT00287209|Vasodilator Agents|vasodilator agents|mesh-ancestor
101383134|NCT00287209|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101383135|NCT00287209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101383136|NCT00287209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383137|NCT00287209|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101383138|NCT00287209|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101383139|NCT00287209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101383140|NCT00287209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101383141|NCT00287209|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101383142|NCT00287209|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101383143|NCT00287209|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101383144|NCT00077948|Metoprolol|metoprolol|mesh-list
101383145|NCT00077948|Enoximone|enoximone|mesh-list
101383146|NCT00077948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101383147|NCT00077948|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101383148|NCT00077948|Sympatholytics|sympatholytics|mesh-ancestor
101383149|NCT00077948|Autonomic Agents|autonomic agents|mesh-ancestor
101383150|NCT00077948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101383151|NCT00077948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383152|NCT00077948|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101383153|NCT00077948|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101383154|NCT00077948|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101383155|NCT00077948|Adrenergic Agents|adrenergic agents|mesh-ancestor
101383156|NCT00077948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101383157|NCT00077948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383158|NCT00077948|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101383159|NCT00077948|Vasodilator Agents|vasodilator agents|mesh-ancestor
101305136|NCT02017600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101305137|NCT02017600|Antimetabolites|antimetabolites|mesh-ancestor
101305138|NCT02017600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305139|NCT02017600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101305140|NCT02017600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101383160|NCT00077948|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101383161|NCT00077948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101383162|NCT00077948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101383163|NCT00077948|Protective Agents|protective agents|mesh-ancestor
101383164|NCT00111345|Daunorubicin|daunorubicin|mesh-list
101383165|NCT00111345|Idarubicin|idarubicin|mesh-list
101383166|NCT00111345|Cladribine|cladribine|mesh-list
101383167|NCT00111345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101383168|NCT00111345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101383169|NCT00111345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101383170|NCT00111345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101383183|NCT00287326|Sensory System Agents|sensory system agents|mesh-ancestor
101383184|NCT00287326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101362085|NCT00127387|Sensory System Agents|sensory system agents|mesh-ancestor
102060471|NCT02693535|Temsirolimus|temsirolimus|mesh-list
102060472|NCT02693535|Vemurafenib|vemurafenib|mesh-list
102060473|NCT02693535|Talazoparib|talazoparib|mesh-list
102060474|NCT02693535|Tucatinib|tucatinib|mesh-list
102060475|NCT02693535|Futibatinib|futibatinib|mesh-list
102060476|NCT02693535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102060477|NCT02693535|Entrectinib|entrectinib|mesh-list
102060478|NCT02693535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102060479|NCT02693535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102060480|NCT02693535|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101362089|NCT00127387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101383185|NCT00287326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101383186|NCT00287326|Narcotics|narcotics|mesh-ancestor
101383198|NCT00287443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101383199|NCT00287443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383201|NCT00077987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101383202|NCT00077987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101383203|NCT00077987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101383204|NCT00077987|Growth Substances|growth substances|mesh-ancestor
101383205|NCT00077987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383206|NCT00077987|Growth Inhibitors|growth inhibitors|mesh-ancestor
101383207|NCT00077987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101383208|NCT00077987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101383209|NCT00077987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383210|NCT00287521|Timolol|timolol|mesh-list
101383211|NCT00287521|Latanoprost|latanoprost|mesh-list
101383212|NCT00287521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383213|NCT00287521|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101383214|NCT00287521|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101383215|NCT00287521|Adrenergic Agents|adrenergic agents|mesh-ancestor
101383216|NCT00287521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101383217|NCT00287521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383218|NCT00287521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101383219|NCT00287521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101383220|NCT00287521|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101383221|NCT00287521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101383222|NCT00287560|Propofol|propofol|mesh-list
101383223|NCT00287560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101383224|NCT00287560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101383225|NCT00287560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383226|NCT00287560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101383227|NCT00287560|Anesthetics, General|anesthetics, general|mesh-ancestor
101383228|NCT00287560|Anesthetics|anesthetics|mesh-ancestor
101383229|NCT00111462|Darbepoetin alfa|darbepoetin alfa|mesh-list
101383230|NCT00111462|Hematinics|hematinics|mesh-ancestor
101383231|NCT00287677|Hormones|hormones|mesh-list
101383232|NCT00287677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101383233|NCT00287677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383258|NCT00287794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101383259|NCT00287911|Topotecan|topotecan|mesh-list
101383260|NCT00287911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101305141|NCT02017600|Immunologic Factors|immunologic factors|mesh-ancestor
101305142|NCT02017600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305143|NCT02017613|Tenalisib|tenalisib|mesh-list
101305144|NCT02017613|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
101305145|NCT02017613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101383261|NCT00287911|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101383262|NCT00287911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101383263|NCT00287911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101383264|NCT00287911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383265|NCT00287950|Cyclophosphamide|cyclophosphamide|mesh-list
101383266|NCT00287950|Carboplatin|carboplatin|mesh-list
101383267|NCT00287950|Etoposide|etoposide|mesh-list
101383268|NCT00287950|Vincristine|vincristine|mesh-list
102060481|NCT02693535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060482|NCT02693535|Immunologic Factors|immunologic factors|mesh-ancestor
102060483|NCT02693535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060484|NCT02693535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102060485|NCT02693535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102060486|NCT02693535|Growth Substances|growth substances|mesh-ancestor
102060487|NCT02693535|Growth Inhibitors|growth inhibitors|mesh-ancestor
102060488|NCT02693535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102060489|NCT02693535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102060490|NCT02693535|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101383269|NCT00287950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101383270|NCT00287950|Immunologic Factors|immunologic factors|mesh-ancestor
101383285|NCT00288028|Bortezomib|bortezomib|mesh-list
101383286|NCT00288028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101383287|NCT00111540|Exenatide|exenatide|mesh-list
101383288|NCT00111540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101383292|NCT00111540|Hormones|hormones|mesh-ancestor
101383293|NCT00111540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101383294|NCT00288184|Allopurinol|allopurinol|mesh-list
101383295|NCT00288184|Antimetabolites|antimetabolites|mesh-ancestor
101383296|NCT00288184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383297|NCT00288184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101383298|NCT00288184|Gout Suppressants|gout suppressants|mesh-ancestor
101383299|NCT00288184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101383300|NCT00288184|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101383301|NCT00288184|Antioxidants|antioxidants|mesh-ancestor
101383302|NCT00288184|Protective Agents|protective agents|mesh-ancestor
101383303|NCT00288184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383304|NCT00288223|Telithromycin|telithromycin|mesh-list
101383305|NCT00288223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101383306|NCT00288223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101383307|NCT00288262|Melatonin|melatonin|mesh-list
101383308|NCT00288262|Antioxidants|antioxidants|mesh-ancestor
101383309|NCT00288262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383310|NCT00288262|Protective Agents|protective agents|mesh-ancestor
101383311|NCT00288262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383312|NCT00288262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101383313|NCT00288379|Budesonide|budesonide|mesh-list
101383314|NCT00288379|Formoterol Fumarate|formoterol fumarate|mesh-list
101383315|NCT00288379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101383316|NCT00288379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101383317|NCT00288379|Autonomic Agents|autonomic agents|mesh-ancestor
101383318|NCT00288379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101383319|NCT00288379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383320|NCT00288379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101383321|NCT00288379|Respiratory System Agents|respiratory system agents|mesh-ancestor
101383322|NCT00288379|Glucocorticoids|glucocorticoids|mesh-ancestor
101383323|NCT00288379|Hormones|hormones|mesh-ancestor
101383324|NCT00288379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101383325|NCT00288379|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101383326|NCT00288379|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101383327|NCT00288379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101383328|NCT00288379|Adrenergic Agents|adrenergic agents|mesh-ancestor
101383329|NCT00288379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101305146|NCT02017613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329581|NCT00027703|Antibodies|antibodies|mesh-list
101305147|NCT02017639|Simvastatin|simvastatin|mesh-list
101383330|NCT00288379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383348|NCT00399425|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101383349|NCT00399425|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101383350|NCT00399425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383351|NCT00288535|Sirolimus|sirolimus|mesh-list
101383352|NCT00288535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101383353|NCT00288535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101362105|NCT00127504|Leprostatic Agents|leprostatic agents|mesh-ancestor
102060491|NCT02693535|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102060492|NCT02693535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102060493|NCT02663518|Rituximab|rituximab|mesh-list
102060494|NCT02663518|Nivolumab|nivolumab|mesh-list
102060495|NCT02663518|Immunoglobulin G|immunoglobulin g|mesh-list
102060496|NCT02663518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102060497|NCT02663518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102060498|NCT02663518|Immunologic Factors|immunologic factors|mesh-ancestor
102060499|NCT02663518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060500|NCT02663518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102060501|NCT02663518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102060502|NCT02663518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060503|NCT02639273|Nalmefene|nalmefene|mesh-list
102060504|NCT02639273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102060505|NCT02639273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060506|NCT02639273|Sensory System Agents|sensory system agents|mesh-ancestor
102060507|NCT02639273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102060508|NCT02563002|Bevacizumab|bevacizumab|mesh-list
102060509|NCT02563002|Pembrolizumab|pembrolizumab|mesh-list
102060510|NCT02563002|Cetuximab|cetuximab|mesh-list
102060511|NCT02563002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102060512|NCT02563002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101383354|NCT00288535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101383355|NCT00288535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101383356|NCT00288535|Antifungal Agents|antifungal agents|mesh-ancestor
101383357|NCT00288535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101383358|NCT00288535|Immunologic Factors|immunologic factors|mesh-ancestor
101383359|NCT00288535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383360|NCT00399464|Alfuzosin|alfuzosin|mesh-list
101383363|NCT00399464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101383364|NCT00399464|Adrenergic Agents|adrenergic agents|mesh-ancestor
101383365|NCT00399464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101383366|NCT00399464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383367|NCT00399464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383368|NCT00399464|Urological Agents|urological agents|mesh-ancestor
101383369|NCT00288652|Reboxetine|reboxetine|mesh-list
101383370|NCT00288652|Antidepressive Agents|antidepressive agents|mesh-ancestor
101383371|NCT00288652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101383372|NCT00288652|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101383373|NCT00288652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101383374|NCT00288652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101383375|NCT00288652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383376|NCT00288652|Adrenergic Agents|adrenergic agents|mesh-ancestor
101383377|NCT00288652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101383378|NCT00288652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383379|NCT00288730|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101383380|NCT00288730|Natriuretic Agents|natriuretic agents|mesh-ancestor
101383381|NCT00288730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383382|NCT00288769|Vitamin B 12|vitamin b 12|mesh-list
101383383|NCT00288769|Hydroxocobalamin|hydroxocobalamin|mesh-list
101383384|NCT00288769|Vitamins|vitamins|mesh-ancestor
101383385|NCT00288769|Micronutrients|micronutrients|mesh-ancestor
101314923|NCT00001576|Antimetabolites|antimetabolites|mesh-ancestor
102060513|NCT02563002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102060514|NCT02563002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102060515|NCT02563002|Growth Substances|growth substances|mesh-ancestor
102060516|NCT02563002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060517|NCT02563002|Growth Inhibitors|growth inhibitors|mesh-ancestor
102060518|NCT02563002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101383386|NCT00288769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383387|NCT00288769|Vitamin B Complex|vitamin b complex|mesh-ancestor
101383388|NCT00288769|Hematinics|hematinics|mesh-ancestor
101383389|NCT00111852|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
101383390|NCT00111852|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101383391|NCT00111852|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101305149|NCT02017639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101305150|NCT02017639|Antimetabolites|antimetabolites|mesh-ancestor
101383402|NCT00111891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101383403|NCT00111891|Vasodilator Agents|vasodilator agents|mesh-ancestor
101383404|NCT00111891|Vitamin B Complex|vitamin b complex|mesh-ancestor
101383406|NCT00111891|Micronutrients|micronutrients|mesh-ancestor
101383407|NCT00111891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383408|NCT00289354|Chromium|chromium|mesh-list
101383409|NCT00289354|Biotin|biotin|mesh-list
101383410|NCT00289354|Picolinic acid|picolinic acid|mesh-list
101383411|NCT00289354|Trace Elements|trace elements|mesh-ancestor
101383412|NCT00289354|Micronutrients|micronutrients|mesh-ancestor
101383413|NCT00289354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383414|NCT00289354|Vitamin B Complex|vitamin b complex|mesh-ancestor
101383415|NCT00289354|Vitamins|vitamins|mesh-ancestor
101383416|NCT00289354|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101383417|NCT00289354|Chelating Agents|chelating agents|mesh-ancestor
101383418|NCT00289354|Sequestering Agents|sequestering agents|mesh-ancestor
101383419|NCT00289354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383420|NCT00289510|Vaccines|vaccines|mesh-list
101383421|NCT00289510|Immunologic Factors|immunologic factors|mesh-ancestor
101383422|NCT00289510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383423|NCT00289588|Mupirocin|mupirocin|mesh-list
101383424|NCT00289588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101383425|NCT00289588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101383426|NCT00289588|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101383427|NCT00289588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101383428|NCT00289588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383429|NCT00289627|Ipilimumab|ipilimumab|mesh-list
101383430|NCT00289627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101383431|NCT00289627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101383432|NCT00289627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101383433|NCT00289627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383451|NCT00289861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101383453|NCT00289861|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101383454|NCT00289861|Dopamine Agents|dopamine agents|mesh-ancestor
101383455|NCT00290017|Pemetrexed|pemetrexed|mesh-list
101383456|NCT00290017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101383457|NCT00290017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101383458|NCT00290017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383459|NCT00290017|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101383460|NCT00290017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101383461|NCT00112008|Darbepoetin alfa|darbepoetin alfa|mesh-list
101383462|NCT00112008|Hematinics|hematinics|mesh-ancestor
101383463|NCT00112086|Paclitaxel|paclitaxel|mesh-list
101383464|NCT00112086|Carboplatin|carboplatin|mesh-list
101383465|NCT00112086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101383466|NCT00112086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101383467|NCT00112086|Tubulin Modulators|tubulin modulators|mesh-ancestor
101383468|NCT00112086|Antimitotic Agents|antimitotic agents|mesh-ancestor
101383469|NCT00112086|Mitosis Modulators|mitosis modulators|mesh-ancestor
101383470|NCT00112086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383471|NCT00290173|Ritodrine|ritodrine|mesh-list
101383472|NCT00290173|Sympathomimetics|sympathomimetics|mesh-ancestor
101383481|NCT00290173|Adrenergic Agents|adrenergic agents|mesh-ancestor
101383482|NCT00290173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102060519|NCT02563002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060520|NCT02454933|Durvalumab|durvalumab|mesh-list
102060521|NCT02454933|Osimertinib|osimertinib|mesh-list
102060522|NCT02454933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102060523|NCT02454933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102060524|NCT02454933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102060525|NCT02454933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102060526|NCT02454933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060527|NCT02430480|Goserelin|goserelin|mesh-list
102060528|NCT02430480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101383483|NCT00290173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383484|NCT00290485|Imatinib Mesylate|imatinib mesylate|mesh-list
101383485|NCT00290485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101383486|NCT00290485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101383487|NCT00290485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101305151|NCT02017639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305153|NCT02017639|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101305154|NCT02017639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101383488|NCT00290485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383489|NCT00112164|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
101383502|NCT00290602|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101383503|NCT00290602|Prednisolone phosphate|prednisolone phosphate|mesh-list
101383504|NCT00290602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101383505|NCT00290602|Antiemetics|antiemetics|mesh-ancestor
101383506|NCT00290602|Autonomic Agents|autonomic agents|mesh-ancestor
101383507|NCT00290602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101383508|NCT00290602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383509|NCT00290602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101383510|NCT00290602|Glucocorticoids|glucocorticoids|mesh-ancestor
101383511|NCT00290602|Hormones|hormones|mesh-ancestor
101383512|NCT00290602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101383513|NCT00290602|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101383514|NCT00290602|Protective Agents|protective agents|mesh-ancestor
101383515|NCT00290602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101383516|NCT00290602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101383517|NCT00290641|Cyclosporine|cyclosporine|mesh-list
101383518|NCT00290641|Mycophenolic Acid|mycophenolic acid|mesh-list
101383519|NCT00290641|Cyclophosphamide|cyclophosphamide|mesh-list
101383520|NCT00290641|Fludarabine|fludarabine|mesh-list
101383521|NCT00290641|Fludarabine phosphate|fludarabine phosphate|mesh-list
101383522|NCT00290641|Cyclosporins|cyclosporins|mesh-list
101383523|NCT00290641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101383524|NCT00290641|Immunologic Factors|immunologic factors|mesh-ancestor
101383525|NCT00290641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383526|NCT00290641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101383527|NCT00290641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101383528|NCT00290641|Alkylating Agents|alkylating agents|mesh-ancestor
101383529|NCT00290641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383530|NCT00290641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101383531|NCT00290641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101383532|NCT00290641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101383533|NCT00290641|Antimetabolites|antimetabolites|mesh-ancestor
101383534|NCT00290641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101383535|NCT00290641|Antifungal Agents|antifungal agents|mesh-ancestor
101383536|NCT00290641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101383537|NCT00290641|Dermatologic Agents|dermatologic agents|mesh-ancestor
101383538|NCT00290641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101383539|NCT00290641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101383540|NCT00290641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101383541|NCT00290641|Antitubercular Agents|antitubercular agents|mesh-ancestor
101383542|NCT00290641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101383543|NCT00290680|Celecoxib|celecoxib|mesh-list
102060529|NCT02430480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102060530|NCT02359565|Pembrolizumab|pembrolizumab|mesh-list
102060531|NCT02359565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102060532|NCT02359565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102060533|NCT02359565|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102060534|NCT02359565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060535|NCT02207439|Nelfinavir|nelfinavir|mesh-list
101383544|NCT00290680|Bortezomib|bortezomib|mesh-list
101383545|NCT00290680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101383546|NCT00290680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101383547|NCT00290680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101383563|NCT02960815|Interferon Inducers|interferon inducers|mesh-ancestor
101383564|NCT00112281|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
101383565|NCT00112281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101383566|NCT00112281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383568|NCT00290719|Gefitinib|gefitinib|mesh-list
101383569|NCT00290719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101305155|NCT02017873|Carbamide Peroxide|carbamide peroxide|mesh-list
101305156|NCT02017873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101305157|NCT02017873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101383570|NCT00290719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101383571|NCT00290719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101383572|NCT00290719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101383573|NCT00290719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383574|NCT00290719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101383575|NCT00290836|Thrombin|thrombin|mesh-list
101383576|NCT00290836|Aprotinin|aprotinin|mesh-list
101383577|NCT00290836|Hemostatics|hemostatics|mesh-ancestor
101383578|NCT00290836|Coagulants|coagulants|mesh-ancestor
101383579|NCT00290836|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101383580|NCT00290836|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101383581|NCT00290836|Protease Inhibitors|protease inhibitors|mesh-ancestor
101383582|NCT00290836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101383583|NCT00290836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383584|NCT04729556|Chitosan|chitosan|mesh-list
101383585|NCT04729556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101383586|NCT04729556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101383587|NCT04729556|Antimetabolites|antimetabolites|mesh-ancestor
101383588|NCT04729556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383589|NCT04729556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101383590|NCT04729556|Chelating Agents|chelating agents|mesh-ancestor
101383591|NCT04729556|Sequestering Agents|sequestering agents|mesh-ancestor
101383592|NCT04729556|Hemostatics|hemostatics|mesh-ancestor
101383593|NCT04729556|Coagulants|coagulants|mesh-ancestor
101383594|NCT00290914|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
101383595|NCT00290914|Antidepressive Agents|antidepressive agents|mesh-ancestor
101383596|NCT00290914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101383597|NCT00290914|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101383598|NCT00290914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101383599|NCT00290914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101383600|NCT00290914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383601|NCT00290914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101383602|NCT00290914|Serotonin Agents|serotonin agents|mesh-ancestor
101383603|NCT00290914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383604|NCT00290914|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101383605|NCT00290914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101383606|NCT00290992|Rasburicase|rasburicase|mesh-list
101383607|NCT00290992|Gout Suppressants|gout suppressants|mesh-ancestor
101383608|NCT00290992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101383609|NCT00291109|Letrozole|letrozole|mesh-list
101383610|NCT00291109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101383611|NCT00291109|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101383612|NCT00291109|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101383624|NCT00291148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383626|NCT00291148|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101383627|NCT00291148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101383628|NCT00291148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060537|NCT02207439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102060538|NCT02207439|Protease Inhibitors|protease inhibitors|mesh-ancestor
102060539|NCT02207439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102060540|NCT02207439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060541|NCT02207439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102060542|NCT02207439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101362151|NCT04726657|Insulin|insulin|mesh-list
101383629|NCT00291148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101383630|NCT00291148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101383631|NCT00291148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101383632|NCT00291148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101383633|NCT00291148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101383634|NCT00291148|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101383635|NCT00291148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101383636|NCT00291148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101383638|NCT00291148|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101305159|NCT02018055|Clopidogrel|clopidogrel|mesh-list
101305160|NCT02018055|Ticagrelor|ticagrelor|mesh-list
101383639|NCT00291148|Antidepressive Agents|antidepressive agents|mesh-ancestor
101383640|NCT00291148|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101383641|NCT00291148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101383642|NCT00291148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101383643|NCT00291382|Fluticasone|fluticasone|mesh-list
101383644|NCT00291382|Xhance|xhance|mesh-list
101383645|NCT00291382|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101383646|NCT00291382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101383647|NCT00291382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101383648|NCT00291382|Autonomic Agents|autonomic agents|mesh-ancestor
101383649|NCT00291382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101383650|NCT00291382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383651|NCT00291382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101383652|NCT00291382|Respiratory System Agents|respiratory system agents|mesh-ancestor
101383653|NCT00291382|Dermatologic Agents|dermatologic agents|mesh-ancestor
101383654|NCT00291382|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101383655|NCT00291382|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101383656|NCT00291382|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101383657|NCT00291382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101383658|NCT00291382|Adrenergic Agents|adrenergic agents|mesh-ancestor
101383659|NCT00291382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101383660|NCT00291382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383661|NCT00112476|Sirolimus|sirolimus|mesh-list
101383662|NCT00112476|Temsirolimus|temsirolimus|mesh-list
101383663|NCT00112476|MTOR Inhibitors|mtor inhibitors|mesh-list
101383664|NCT00112476|Bryostatin 1|bryostatin 1|mesh-list
101383665|NCT00112476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101383666|NCT00112476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101383667|NCT00112476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383668|NCT00112476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101383669|NCT00112476|Immunologic Factors|immunologic factors|mesh-ancestor
101383670|NCT00112476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383671|NCT00112476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101383688|NCT00291616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383689|NCT00291616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101383691|NCT00078572|Lapatinib|lapatinib|mesh-list
101383692|NCT00078572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101383693|NCT00078572|Antimetabolites|antimetabolites|mesh-ancestor
101383694|NCT00078572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383695|NCT00078572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101383696|NCT00078572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101383697|NCT00078572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101383698|NCT00291733|Levetiracetam|levetiracetam|mesh-list
101383702|NCT00112515|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101383703|NCT00112515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383704|NCT00112515|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102060543|NCT02207439|Antiviral Agents|antiviral agents|mesh-ancestor
102060544|NCT02207439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102060545|NCT01983241|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
102060546|NCT01983241|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102060547|NCT01983241|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102060548|NCT01983241|Protease Inhibitors|protease inhibitors|mesh-ancestor
102060549|NCT01983241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101383705|NCT00112515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101383706|NCT00112515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101383707|NCT00112515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383708|NCT00291772|Pramlintide|pramlintide|mesh-list
101383709|NCT00291772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101383710|NCT00291772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383711|NCT00078611|Natalizumab|natalizumab|mesh-list
101305161|NCT02018055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101383712|NCT00078611|Immunologic Factors|immunologic factors|mesh-ancestor
101383713|NCT00078611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383714|NCT00291811|Plerixafor|plerixafor|mesh-list
101383715|NCT00291811|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101383716|NCT00291811|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101383717|NCT00291811|Antiviral Agents|antiviral agents|mesh-ancestor
101383718|NCT00291811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101383719|NCT00291850|Paclitaxel|paclitaxel|mesh-list
101383720|NCT00291850|Cisplatin|cisplatin|mesh-list
101383721|NCT00291850|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101383722|NCT00291850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101383723|NCT00291850|Tubulin Modulators|tubulin modulators|mesh-ancestor
101383724|NCT00291850|Antimitotic Agents|antimitotic agents|mesh-ancestor
101383725|NCT00291850|Mitosis Modulators|mitosis modulators|mesh-ancestor
101383726|NCT00291850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383727|NCT00112554|Cytarabine|cytarabine|mesh-list
101383728|NCT00112554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101383729|NCT00112554|Antimetabolites|antimetabolites|mesh-ancestor
101383730|NCT00112554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383731|NCT00112554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101383732|NCT00112554|Antiviral Agents|antiviral agents|mesh-ancestor
101383733|NCT00112554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101383745|NCT00078689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101383746|NCT00078689|Immunologic Factors|immunologic factors|mesh-ancestor
101383747|NCT00078689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383748|NCT00112632|Imatinib Mesylate|imatinib mesylate|mesh-list
101383749|NCT00112632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101383750|NCT00112632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101383751|NCT00112632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101383752|NCT00112632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383754|NCT00078845|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101383755|NCT00078845|Protective Agents|protective agents|mesh-ancestor
101383756|NCT00078845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383757|NCT00275314|Valganciclovir|valganciclovir|mesh-list
101383758|NCT00275314|Antiviral Agents|antiviral agents|mesh-ancestor
101383759|NCT00275314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101383760|NCT00275275|Pramipexole|pramipexole|mesh-list
101383761|NCT00275275|Ropinirole|ropinirole|mesh-list
101383762|NCT00275275|Antioxidants|antioxidants|mesh-ancestor
101383763|NCT00275275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383764|NCT00275275|Protective Agents|protective agents|mesh-ancestor
101383765|NCT00275275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383766|NCT00275275|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101383767|NCT00275275|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101383768|NCT00275275|Dopamine Agonists|dopamine agonists|mesh-ancestor
101383769|NCT00275275|Dopamine Agents|dopamine agents|mesh-ancestor
101383770|NCT00275275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101383771|NCT00112710|Carboplatin|carboplatin|mesh-list
101383772|NCT00112710|Gemcitabine|gemcitabine|mesh-list
101383774|NCT00112710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101383776|NCT00112710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383777|NCT00275236|Rotigotine|rotigotine|mesh-list
101383778|NCT00275236|Dopamine Agonists|dopamine agonists|mesh-ancestor
101383779|NCT00275236|Dopamine Agents|dopamine agents|mesh-ancestor
102060550|NCT01983241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060551|NCT01906814|Carboplatin|carboplatin|mesh-list
102060552|NCT01906814|Etoposide|etoposide|mesh-list
102060553|NCT01906814|Etoposide phosphate|etoposide phosphate|mesh-list
102060554|NCT01906814|Vincristine|vincristine|mesh-list
102060555|NCT01906814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102060556|NCT01906814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102060557|NCT01906814|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102060558|NCT01906814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102060559|NCT01906814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102060560|NCT01906814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060561|NCT01906814|Tubulin Modulators|tubulin modulators|mesh-ancestor
102060562|NCT01906814|Antimitotic Agents|antimitotic agents|mesh-ancestor
102060563|NCT01906814|Mitosis Modulators|mitosis modulators|mesh-ancestor
102060564|NCT01864018|Dexamethasone|dexamethasone|mesh-list
102060565|NCT01864018|Dexamethasone acetate|dexamethasone acetate|mesh-list
102060566|NCT01864018|Cyclophosphamide|cyclophosphamide|mesh-list
102060567|NCT01864018|Ixazomib|ixazomib|mesh-list
102060568|NCT01864018|Ichthammol|ichthammol|mesh-list
102060569|NCT01864018|BB 1101|bb 1101|mesh-list
102060570|NCT01864018|Glycine|glycine|mesh-list
102060571|NCT01864018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102060572|NCT01864018|Immunologic Factors|immunologic factors|mesh-ancestor
102060573|NCT01864018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060574|NCT01864018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102060575|NCT01864018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102060576|NCT01864018|Alkylating Agents|alkylating agents|mesh-ancestor
102060601|NCT01796197|Tubulin Modulators|tubulin modulators|mesh-ancestor
102060602|NCT01796197|Antimitotic Agents|antimitotic agents|mesh-ancestor
102060603|NCT01796197|Mitosis Modulators|mitosis modulators|mesh-ancestor
102060604|NCT01796197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060605|NCT01796197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102060606|NCT01796197|Immunologic Factors|immunologic factors|mesh-ancestor
102060607|NCT01796197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060608|NCT01796197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102060609|NCT01796197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102060610|NCT01796197|Alkylating Agents|alkylating agents|mesh-ancestor
102060611|NCT01796197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102060612|NCT01796197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102060613|NCT01796197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102060614|NCT01796197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102060615|NCT01796197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102060616|NCT01796197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102060617|NCT01712620|Spironolactone|spironolactone|mesh-list
102060618|NCT01712620|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102060619|NCT01712620|Hormone Antagonists|hormone antagonists|mesh-ancestor
102060620|NCT01712620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102060650|NCT00591370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102060651|NCT00591370|Alkylating Agents|alkylating agents|mesh-ancestor
102060652|NCT00591370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060653|NCT00591370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102060654|NCT00389610|Pancrelipase|pancrelipase|mesh-list
102060655|NCT00389610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102060656|NCT03064763|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
102060657|NCT03064763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102060658|NCT03064763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102060659|NCT02782676|Hyaluronic Acid|hyaluronic acid|mesh-list
102060660|NCT02782676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102060714|NCT02146976|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102060715|NCT02147054|Rocuronium|rocuronium|mesh-list
102060716|NCT02147054|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102060717|NCT02147054|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102060718|NCT02147054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102060719|NCT02147054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102060782|NCT03631901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102060783|NCT03631901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102060784|NCT03631901|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102060785|NCT03631901|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102060786|NCT03631901|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102060787|NCT03631901|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102060852|NCT02147678|Narcotics|narcotics|mesh-ancestor
102060853|NCT02147678|Analgesics|analgesics|mesh-ancestor
102060854|NCT02147678|Sensory System Agents|sensory system agents|mesh-ancestor
102060855|NCT02147678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102060856|NCT02151344|Vaccines|vaccines|mesh-list
102060857|NCT02151344|Immunologic Factors|immunologic factors|mesh-ancestor
102060859|NCT02155634|Lenalidomide|lenalidomide|mesh-list
102060923|NCT02261090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060924|NCT02261090|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102060925|NCT02261090|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102060926|NCT02261090|Dopamine Agonists|dopamine agonists|mesh-ancestor
102060927|NCT02261090|Dopamine Agents|dopamine agents|mesh-ancestor
102060928|NCT02261090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102060929|NCT01307423|Thalidomide|thalidomide|mesh-list
102060930|NCT01307423|Apremilast|apremilast|mesh-list
102060931|NCT01307423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102060932|NCT01307423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102060933|NCT01307423|Analgesics|analgesics|mesh-ancestor
102060934|NCT01307423|Sensory System Agents|sensory system agents|mesh-ancestor
102060935|NCT01307423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102060936|NCT01307423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060937|NCT01307423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102060938|NCT01307423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102060939|NCT01307423|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
102060940|NCT01307423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102060941|NCT01307423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102060942|NCT01307423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060943|NCT01307423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102060944|NCT01307423|Immunologic Factors|immunologic factors|mesh-ancestor
102060945|NCT01307423|Leprostatic Agents|leprostatic agents|mesh-ancestor
102060946|NCT01307423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102060972|NCT03542240|Sensory System Agents|sensory system agents|mesh-ancestor
102060973|NCT03542240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102060974|NCT03542240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102060975|NCT03542240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102060976|NCT03542240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102060977|NCT03542240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102060978|NCT03542240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102060979|NCT03542240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102060980|NCT00911183|Prednisone|prednisone|mesh-list
102060981|NCT00911183|Cyclophosphamide|cyclophosphamide|mesh-list
102061037|NCT05598593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061038|NCT05598593|Antiviral Agents|antiviral agents|mesh-ancestor
102061039|NCT05598593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102061040|NCT05598593|Alkylating Agents|alkylating agents|mesh-ancestor
102061041|NCT05598593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102061042|NCT05598593|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102061043|NCT05337449|Fluorides|fluorides|mesh-list
102061106|NCT03092375|Antimetabolites|antimetabolites|mesh-ancestor
102061107|NCT03092375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061108|NCT03092375|Antiviral Agents|antiviral agents|mesh-ancestor
102061110|NCT01995513|Prednisone|prednisone|mesh-list
102061179|NCT04687631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102061180|NCT04687631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102061181|NCT04687631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102061182|NCT04687631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102061183|NCT04687631|Growth Substances|growth substances|mesh-ancestor
102061246|NCT01382147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102061247|NCT01382147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102061248|NCT01382147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102061249|NCT01382147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102061250|NCT01382147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061252|NCT01382147|Sensory System Agents|sensory system agents|mesh-ancestor
102061253|NCT01382147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102061254|NCT01382147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061255|NCT01381835|Simeprevir|simeprevir|mesh-list
102061256|NCT01381835|Antiviral Agents|antiviral agents|mesh-ancestor
102061257|NCT01381835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102061258|NCT01381835|Protease Inhibitors|protease inhibitors|mesh-ancestor
102061259|NCT01381835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102061260|NCT01381835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061261|NCT04429685|Ketamine|ketamine|mesh-list
102061262|NCT04429685|Analgesics|analgesics|mesh-ancestor
102061263|NCT04429685|Sensory System Agents|sensory system agents|mesh-ancestor
102061264|NCT04429685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102061265|NCT04429685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061303|NCT04509193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102061304|NCT04509193|Protease Inhibitors|protease inhibitors|mesh-ancestor
102061305|NCT04509193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102061306|NCT04509193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061307|NCT02697383|Dexamethasone|dexamethasone|mesh-list
102061308|NCT02697383|Ixazomib|ixazomib|mesh-list
102061309|NCT02697383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102061310|NCT02697383|Antiemetics|antiemetics|mesh-ancestor
102061311|NCT02697383|Autonomic Agents|autonomic agents|mesh-ancestor
102061312|NCT02697383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102061313|NCT02697383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061314|NCT02697383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102061315|NCT02697383|Glucocorticoids|glucocorticoids|mesh-ancestor
102061360|NCT01382017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102061361|NCT01381523|Naproxen|naproxen|mesh-list
102061362|NCT01381523|Sumatriptan|sumatriptan|mesh-list
102061363|NCT01381523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102061364|NCT01381523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102061365|NCT01381523|Analgesics|analgesics|mesh-ancestor
102061366|NCT01381523|Sensory System Agents|sensory system agents|mesh-ancestor
102061367|NCT01381523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102061429|NCT01381289|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102061430|NCT01381289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102061431|NCT01381289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061497|NCT02766608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102061498|NCT02766608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102061499|NCT02766608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102061500|NCT02766608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102061501|NCT02766608|Adrenergic Agents|adrenergic agents|mesh-ancestor
102061502|NCT02766608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102061503|NCT02766608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061505|NCT01382407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102061506|NCT01382407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102061507|NCT02235857|Dextrans|dextrans|mesh-list
102061508|NCT02235857|Anticoagulants|anticoagulants|mesh-ancestor
102061509|NCT02235857|Plasma Substitutes|plasma substitutes|mesh-ancestor
102061510|NCT02235857|Blood Substitutes|blood substitutes|mesh-ancestor
102061511|NCT05082285|Vaccines|vaccines|mesh-list
102061512|NCT05082285|Immunologic Factors|immunologic factors|mesh-ancestor
102061556|NCT04200963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061557|NCT02157428|Flumazenil|flumazenil|mesh-list
102061558|NCT02157428|Antidotes|antidotes|mesh-ancestor
102061559|NCT02157428|Protective Agents|protective agents|mesh-ancestor
102061560|NCT02157428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061626|NCT00943683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102061627|NCT00943683|Respiratory System Agents|respiratory system agents|mesh-ancestor
102061628|NCT00943683|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102061629|NCT00943683|Hormone Antagonists|hormone antagonists|mesh-ancestor
102061630|NCT00943683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102061691|NCT02157818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102061692|NCT02157818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102061693|NCT02157818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102061694|NCT02157818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102061695|NCT02157818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102061696|NCT02157818|Anesthetics, General|anesthetics, general|mesh-ancestor
102061697|NCT02157818|Anesthetics|anesthetics|mesh-ancestor
102061698|NCT02157818|GABA Modulators|gaba modulators|mesh-ancestor
102061699|NCT02157818|GABA Agents|gaba agents|mesh-ancestor
102061700|NCT00899379|Rizatriptan|rizatriptan|mesh-list
102061701|NCT00899379|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102061702|NCT00899379|Serotonin Agents|serotonin agents|mesh-ancestor
102061703|NCT00899379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102061704|NCT00899379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061705|NCT00899379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061706|NCT04326439|Cytarabine|cytarabine|mesh-list
102061707|NCT04326439|Etoposide|etoposide|mesh-list
102061708|NCT04326439|Daunorubicin|daunorubicin|mesh-list
102061709|NCT04326439|Sorafenib|sorafenib|mesh-list
102061710|NCT04326439|Asparaginase|asparaginase|mesh-list
102061750|NCT00145795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102061751|NCT00145795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061753|NCT00145795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102061754|NCT00145795|Antiviral Agents|antiviral agents|mesh-ancestor
102061755|NCT00145795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102061756|NCT00145795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102061757|NCT00145795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102061818|NCT05422183|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102061819|NCT05422183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102061821|NCT05422183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102061888|NCT02160548|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102061889|NCT02160548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102061890|NCT02160548|Adrenergic Agents|adrenergic agents|mesh-ancestor
102061891|NCT02160548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102061892|NCT02160548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102061893|NCT02160548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102061958|NCT02155166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102061959|NCT02155166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102061960|NCT02155166|Sensory System Agents|sensory system agents|mesh-ancestor
102061961|NCT02155166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102061962|NCT02155166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102062025|NCT04051047|Gemcitabine|gemcitabine|mesh-list
102062026|NCT04051047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102062027|NCT04051047|Antimetabolites|antimetabolites|mesh-ancestor
102062028|NCT04051047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062029|NCT04051047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102062030|NCT00102440|Allopurinol|allopurinol|mesh-list
102062031|NCT00102440|Febuxostat|febuxostat|mesh-list
102062032|NCT00102440|Antimetabolites|antimetabolites|mesh-ancestor
102062033|NCT00102440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062034|NCT00102440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102062035|NCT00102440|Gout Suppressants|gout suppressants|mesh-ancestor
102062088|NCT03902509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102062089|NCT03902509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102062090|NCT03902509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102062091|NCT02166632|Bupivacaine|bupivacaine|mesh-list
102062093|NCT02166632|Anesthetics|anesthetics|mesh-ancestor
102062160|NCT03704181|Mitosis Modulators|mitosis modulators|mesh-ancestor
102062161|NCT03704181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062162|NCT03704181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102062163|NCT03625011|Gabapentin|gabapentin|mesh-list
102062164|NCT03625011|Analgesics|analgesics|mesh-ancestor
102062165|NCT03625011|Sensory System Agents|sensory system agents|mesh-ancestor
102062168|NCT03625011|Anticonvulsants|anticonvulsants|mesh-ancestor
102062228|NCT04553133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102062229|NCT04553133|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102062231|NCT03701451|Decitabine|decitabine|mesh-list
102062297|NCT04542135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102062298|NCT04542135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062299|NCT04542135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102062300|NCT04542135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102062301|NCT04542135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102062302|NCT04542135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102062303|NCT04542135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102062304|NCT04542135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062305|NCT04694781|Pembrolizumab|pembrolizumab|mesh-list
102062306|NCT04694781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102062307|NCT04694781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102062308|NCT04694781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102062309|NCT04694781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062310|NCT02805972|Naloxone|naloxone|mesh-list
102062311|NCT02805972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102062312|NCT02805972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782027|NCT00296335|Mitomycins|mitomycins|mesh-list
102062313|NCT02805972|Sensory System Agents|sensory system agents|mesh-ancestor
102062314|NCT02805972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102062315|NCT02052258|Oxytocin|oxytocin|mesh-list
102062316|NCT02052258|Oxytocics|oxytocics|mesh-ancestor
102062317|NCT02052258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102062351|NCT03700749|Povidone|povidone|mesh-list
102062352|NCT03700749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102062425|NCT03700359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102062426|NCT03700359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102062427|NCT03700359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102062428|NCT03700359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102062429|NCT03700359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102062431|NCT02167178|Polygeline|polygeline|mesh-list
102062494|NCT02255396|Estrogens|estrogens|mesh-ancestor
102062495|NCT02255396|Hormones|hormones|mesh-ancestor
102062496|NCT02255396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102062497|NCT02255396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062498|NCT02163980|Dexmedetomidine|dexmedetomidine|mesh-list
102062565|NCT01595321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102062566|NCT01595321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102062568|NCT01595321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102062569|NCT01595321|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102062572|NCT01595321|Antidotes|antidotes|mesh-ancestor
102062636|NCT01384331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102062637|NCT01384331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062638|NCT01384331|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102062639|NCT01384331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102062640|NCT01384331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102062641|NCT01384331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102062643|NCT01384331|Hormones|hormones|mesh-ancestor
102062644|NCT01384331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102062700|NCT00976131|Cyclophosphamide|cyclophosphamide|mesh-list
102062701|NCT00976131|Doxorubicin|doxorubicin|mesh-list
102062702|NCT00976131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102062703|NCT00976131|Immunologic Factors|immunologic factors|mesh-ancestor
102062704|NCT00976131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102062705|NCT00976131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102062706|NCT00976131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102062707|NCT00976131|Alkylating Agents|alkylating agents|mesh-ancestor
102062708|NCT00976131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062766|NCT04050267|Analgesics|analgesics|mesh-ancestor
102062767|NCT04050267|Sensory System Agents|sensory system agents|mesh-ancestor
102062791|NCT01569113|Hormones|hormones|mesh-ancestor
102062839|NCT03697161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102062840|NCT03697161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062841|NCT03164993|Cyclophosphamide|cyclophosphamide|mesh-list
102062842|NCT03164993|Doxorubicin|doxorubicin|mesh-list
102062843|NCT03164993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102062844|NCT03164993|Atezolizumab|atezolizumab|mesh-list
102062908|NCT01378481|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102062909|NCT01378481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102062910|NCT01378481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062980|NCT02171624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102062981|NCT02171624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102062982|NCT02171624|Anticoagulants|anticoagulants|mesh-ancestor
102062985|NCT02171624|Adrenergic Agents|adrenergic agents|mesh-ancestor
102063051|NCT02171780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102063052|NCT02171780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063053|NCT02171780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102063054|NCT02171780|Respiratory System Agents|respiratory system agents|mesh-ancestor
102063055|NCT02172014|Fentanyl|fentanyl|mesh-list
102063056|NCT02172014|Midazolam|midazolam|mesh-list
102063057|NCT02172014|Citric Acid|citric acid|mesh-list
102063058|NCT02172014|Sodium Citrate|sodium citrate|mesh-list
102063059|NCT02172014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102063060|NCT02172014|Narcotics|narcotics|mesh-ancestor
102063061|NCT02172014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102063063|NCT02172014|Analgesics|analgesics|mesh-ancestor
102063118|NCT03624309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102063119|NCT03624309|Tubulin Modulators|tubulin modulators|mesh-ancestor
102063120|NCT03624309|Antimitotic Agents|antimitotic agents|mesh-ancestor
102063121|NCT03624309|Mitosis Modulators|mitosis modulators|mesh-ancestor
102063122|NCT03624309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063123|NCT04327791|Baloxavir|baloxavir|mesh-list
102063124|NCT04327791|Antiviral Agents|antiviral agents|mesh-ancestor
102063125|NCT04327791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102063183|NCT02172326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102063184|NCT02172326|Autonomic Agents|autonomic agents|mesh-ancestor
102063185|NCT02172326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102063186|NCT02172326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063187|NCT02172326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102063188|NCT02172326|Respiratory System Agents|respiratory system agents|mesh-ancestor
102063189|NCT02172326|Parasympatholytics|parasympatholytics|mesh-ancestor
102063190|NCT02172326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102063191|NCT02172326|Cholinergic Agents|cholinergic agents|mesh-ancestor
102063192|NCT02172326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102063193|NCT02172326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063244|NCT02172560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063246|NCT00106808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102063247|NCT00106808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063248|NCT02166554|Hyaluronic Acid|hyaluronic acid|mesh-list
102063249|NCT02166554|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102063250|NCT02166554|Immunologic Factors|immunologic factors|mesh-ancestor
101315134|NCT05640427|Analgesics|analgesics|mesh-ancestor
102063251|NCT02166554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063313|NCT02170610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102063314|NCT02170610|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102063315|NCT02170610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102063316|NCT02170610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063317|NCT02170610|Antithrombins|antithrombins|mesh-ancestor
102063318|NCT02170610|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102063319|NCT02170610|Protease Inhibitors|protease inhibitors|mesh-ancestor
102063320|NCT02170610|Anticoagulants|anticoagulants|mesh-ancestor
102063380|NCT02175056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102063382|NCT02170766|Pantoprazole|pantoprazole|mesh-list
102063452|NCT02173652|Incretins|incretins|mesh-ancestor
102063453|NCT02173652|Hormones|hormones|mesh-ancestor
102063454|NCT02173652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102063455|NCT02173652|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102063456|NCT02173652|Protease Inhibitors|protease inhibitors|mesh-ancestor
102063457|NCT02173652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102063458|NCT02173652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063459|NCT02173730|Pantoprazole|pantoprazole|mesh-list
102063516|NCT02173964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102063517|NCT02173964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063518|NCT02173964|Parasympatholytics|parasympatholytics|mesh-ancestor
102063519|NCT02173964|Autonomic Agents|autonomic agents|mesh-ancestor
102063520|NCT02173964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102063521|NCT02175602|Sertraline|sertraline|mesh-list
102063522|NCT02175602|Escitalopram|escitalopram|mesh-list
102063523|NCT02175602|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102063524|NCT02175602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102063525|NCT02175602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102063526|NCT02175602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063527|NCT02175602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102063528|NCT02175602|Serotonin Agents|serotonin agents|mesh-ancestor
102063578|NCT02174588|Propofol|propofol|mesh-list
102063579|NCT02174588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102063580|NCT02174588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102063581|NCT02174588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063582|NCT02174588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102063583|NCT02174588|Anesthetics, General|anesthetics, general|mesh-ancestor
102063584|NCT02174588|Anesthetics|anesthetics|mesh-ancestor
102063585|NCT02174588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102063586|NCT02174588|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102063609|NCT02176304|Lidocaine|lidocaine|mesh-list
102063644|NCT02256254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102063645|NCT02256254|Antimetabolites|antimetabolites|mesh-ancestor
102063646|NCT02256254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063647|NCT02256254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102063714|NCT02182544|Antipruritics|antipruritics|mesh-ancestor
102063715|NCT02182544|Dermatologic Agents|dermatologic agents|mesh-ancestor
102063716|NCT02182544|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102063717|NCT02182544|Histamine Antagonists|histamine antagonists|mesh-ancestor
102063718|NCT02182544|Histamine Agents|histamine agents|mesh-ancestor
102063719|NCT02182544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102063720|NCT02182544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063721|NCT02182544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063722|NCT02182544|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102063723|NCT02179658|Vancomycin|vancomycin|mesh-list
102063724|NCT02179658|Fidaxomicin|fidaxomicin|mesh-list
102063777|NCT02182700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102063778|NCT02182700|Respiratory System Agents|respiratory system agents|mesh-ancestor
102063779|NCT02182700|Tocolytic Agents|tocolytic agents|mesh-ancestor
102063780|NCT02182700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102063789|NCT02182778|Cisplatin|cisplatin|mesh-list
102063848|NCT02182856|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102063849|NCT02182856|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102063850|NCT02182856|Adrenergic Agents|adrenergic agents|mesh-ancestor
102063851|NCT02182856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102063852|NCT02182856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063853|NCT02182856|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102063854|NCT02182856|Cholinergic Agents|cholinergic agents|mesh-ancestor
102063855|NCT02183012|Ibuprofen|ibuprofen|mesh-list
102063856|NCT02183012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102063857|NCT02183012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102063858|NCT02183012|Analgesics|analgesics|mesh-ancestor
102063859|NCT02183012|Sensory System Agents|sensory system agents|mesh-ancestor
102063860|NCT02183012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102063861|NCT02183012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063862|NCT02183012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102063867|NCT02180048|Caffeine|caffeine|mesh-list
102063906|NCT02183090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102063907|NCT02183090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102063908|NCT02183090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102063909|NCT02177552|Carboplatin|carboplatin|mesh-list
102063978|NCT02183402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102063979|NCT02183402|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102063980|NCT02183402|Protease Inhibitors|protease inhibitors|mesh-ancestor
102063982|NCT02183480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102063983|NCT02183480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102063984|NCT02183480|Incretins|incretins|mesh-ancestor
102064043|NCT02184260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102064044|NCT02184260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102064046|NCT02184260|Sensory System Agents|sensory system agents|mesh-ancestor
102064047|NCT02184260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102064048|NCT02184260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064049|NCT02184260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102064050|NCT02184260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102064112|NCT02181218|Oxaliplatin|oxaliplatin|mesh-list
102064113|NCT02181218|Romidepsin|romidepsin|mesh-list
102064183|NCT02186132|Cholinergic Agents|cholinergic agents|mesh-ancestor
102064184|NCT02186132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102064185|NCT02186132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064186|NCT03536780|Gemcitabine|gemcitabine|mesh-list
102064187|NCT03536780|Avelumab|avelumab|mesh-list
102064188|NCT03536780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102064193|NCT02052336|Clarithromycin|clarithromycin|mesh-list
102064251|NCT02052492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064252|NCT02052492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102064253|NCT02181998|Heparin|heparin|mesh-list
102064254|NCT02181998|Enoxaparin|enoxaparin|mesh-list
102064255|NCT02181998|Tenecteplase|tenecteplase|mesh-list
102064256|NCT02181998|Anticoagulants|anticoagulants|mesh-ancestor
102064319|NCT03561870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102064320|NCT03561870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064321|NCT03561870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102064322|NCT02186990|Propofol|propofol|mesh-list
102064323|NCT02186990|Etomidate|etomidate|mesh-list
102064324|NCT02186990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102064325|NCT02186990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102064326|NCT02186990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064327|NCT02186990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102064328|NCT02186990|Anesthetics, General|anesthetics, general|mesh-ancestor
102064329|NCT02186990|Anesthetics|anesthetics|mesh-ancestor
102064330|NCT05657028|Lidocaine|lidocaine|mesh-list
102064331|NCT05657028|Dexmedetomidine|dexmedetomidine|mesh-list
102064380|NCT02054442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102064381|NCT02054442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102064382|NCT02054442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102064383|NCT02054676|Ibuprofen|ibuprofen|mesh-list
102064384|NCT02054676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102064449|NCT02256722|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102064520|NCT02191124|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102064521|NCT02191124|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102064522|NCT02191124|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102064524|NCT02193698|Lenalidomide|lenalidomide|mesh-list
102064525|NCT02193698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102064526|NCT02193698|Antiemetics|antiemetics|mesh-ancestor
102064527|NCT02193698|Autonomic Agents|autonomic agents|mesh-ancestor
102064528|NCT02193698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102064529|NCT02193698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064530|NCT02193698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102064532|NCT02193698|Hormones|hormones|mesh-ancestor
102064582|NCT04558190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102064583|NCT04558190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064584|NCT04558190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102064653|NCT02055690|Fosbretabulin|fosbretabulin|mesh-list
102064654|NCT02055690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102064655|NCT02055690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102064656|NCT02191748|Triamcinolone|triamcinolone|mesh-list
102064722|NCT01333722|Sensory System Agents|sensory system agents|mesh-ancestor
102064723|NCT01333722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102064724|NCT01333722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064725|NCT01333722|Antipyretics|antipyretics|mesh-ancestor
102064726|NCT01333722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102064727|NCT01333722|Narcotics|narcotics|mesh-ancestor
102064728|NCT01333722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102064787|NCT02057796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102064788|NCT02057796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102064789|NCT02057796|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102064790|NCT02057796|Antitubercular Agents|antitubercular agents|mesh-ancestor
102064791|NCT02057796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102064792|NCT02057796|Leprostatic Agents|leprostatic agents|mesh-ancestor
102064793|NCT02057796|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102064794|NCT02057796|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102064795|NCT02057796|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102064796|NCT02057796|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
102064797|NCT02057796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102064798|NCT02057796|Antimetabolites|antimetabolites|mesh-ancestor
102064799|NCT02057796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102064823|NCT03676413|Xhance|xhance|mesh-list
102064846|NCT03676335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102064847|NCT01370694|Prednisolone|prednisolone|mesh-list
102064848|NCT01370694|Cyclophosphamide|cyclophosphamide|mesh-list
102064849|NCT01370694|Vincristine|vincristine|mesh-list
102064850|NCT01370694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102064851|NCT01370694|Immunologic Factors|immunologic factors|mesh-ancestor
102064852|NCT01370694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064853|NCT01370694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102064854|NCT01370694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102064855|NCT01370694|Alkylating Agents|alkylating agents|mesh-ancestor
101784578|NCT03861052|Dulaglutide|dulaglutide|mesh-list
102064856|NCT01370694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064857|NCT01370694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102064858|NCT01370694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102064859|NCT01370694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102064906|NCT02058576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102064907|NCT02058576|Adrenergic Agents|adrenergic agents|mesh-ancestor
102064908|NCT02058576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102064909|NCT02058576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102064910|NCT02058576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102064911|NCT02058576|Urological Agents|urological agents|mesh-ancestor
102064912|NCT02058576|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
102064913|NCT02058576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102064914|NCT02058576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102064915|NCT02058576|Hormone Antagonists|hormone antagonists|mesh-ancestor
102064916|NCT02058576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102064917|NCT03535220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
102064965|NCT03675555|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102064966|NCT02194166|Paclitaxel|paclitaxel|mesh-list
102064967|NCT02194166|Docetaxel|docetaxel|mesh-list
102064968|NCT02194166|Trastuzumab|trastuzumab|mesh-list
102064969|NCT02194166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102064970|NCT02194166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102064971|NCT02194166|Tubulin Modulators|tubulin modulators|mesh-ancestor
102064972|NCT02194166|Antimitotic Agents|antimitotic agents|mesh-ancestor
102064973|NCT02194166|Mitosis Modulators|mitosis modulators|mesh-ancestor
102065026|NCT02030912|Amoxicillin|amoxicillin|mesh-list
102065027|NCT02030912|Minocycline|minocycline|mesh-list
102065028|NCT02030912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102065029|NCT02030912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102065099|NCT03534674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102065100|NCT03534674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102065102|NCT02063334|Cholecalciferol|cholecalciferol|mesh-list
102065103|NCT02063334|Vitamins|vitamins|mesh-ancestor
102065104|NCT02063334|Micronutrients|micronutrients|mesh-ancestor
102065105|NCT02063334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065106|NCT02063334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102065107|NCT02063334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102065108|NCT02916927|Ketamine|ketamine|mesh-list
102065109|NCT02916927|Analgesics|analgesics|mesh-ancestor
102065110|NCT02916927|Sensory System Agents|sensory system agents|mesh-ancestor
102065111|NCT02916927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102065112|NCT02916927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065113|NCT02916927|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102065114|NCT02916927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102065115|NCT02916927|Anesthetics, General|anesthetics, general|mesh-ancestor
102065116|NCT02916927|Anesthetics|anesthetics|mesh-ancestor
102065117|NCT02916927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102065156|NCT03623529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102065157|NCT03623529|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102065158|NCT03623529|Protease Inhibitors|protease inhibitors|mesh-ancestor
102065159|NCT03623529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102065160|NCT03623529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065225|NCT02196740|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102065226|NCT02196740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102065227|NCT02196740|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102065228|NCT02196740|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102065229|NCT02196740|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102065230|NCT02195492|Hylan|hylan|mesh-list
102065231|NCT02195492|Viscosupplements|viscosupplements|mesh-ancestor
102065232|NCT02195492|Protective Agents|protective agents|mesh-ancestor
101315268|NCT05530174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102065233|NCT02195492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065234|NCT03678987|Mycophenolic Acid|mycophenolic acid|mesh-list
102065235|NCT03678987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102065236|NCT03678987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102065237|NCT03678987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102065238|NCT03678987|Antitubercular Agents|antitubercular agents|mesh-ancestor
102065239|NCT03678987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102065286|NCT03674385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102065287|NCT03674385|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102065288|NCT03674385|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102065289|NCT02574455|Gemcitabine|gemcitabine|mesh-list
102065290|NCT02574455|Capecitabine|capecitabine|mesh-list
102065291|NCT02574455|Vinorelbine|vinorelbine|mesh-list
102065292|NCT02574455|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
102065293|NCT02574455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102065294|NCT02574455|Antimetabolites|antimetabolites|mesh-ancestor
102065295|NCT02574455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065296|NCT02574455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102065297|NCT02574455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102065298|NCT02574455|Tubulin Modulators|tubulin modulators|mesh-ancestor
102065299|NCT02574455|Antimitotic Agents|antimitotic agents|mesh-ancestor
102065348|NCT01378091|Growth Substances|growth substances|mesh-ancestor
102065349|NCT01378091|Growth Inhibitors|growth inhibitors|mesh-ancestor
102065350|NCT02794974|Anesthetics|anesthetics|mesh-list
102065351|NCT02794974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102065352|NCT02794974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065353|NCT02063568|Oxytocin|oxytocin|mesh-list
102065354|NCT02063568|Oxytocics|oxytocics|mesh-ancestor
102065355|NCT02063568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102065357|NCT02257502|Aflibercept|aflibercept|mesh-list
102065412|NCT02201342|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102065413|NCT02201342|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102065414|NCT02201342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102065415|NCT02201342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065417|NCT02201576|Immunoglobulins|immunoglobulins|mesh-list
102065418|NCT02201576|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102065419|NCT02201576|Antibodies|antibodies|mesh-list
102065420|NCT02201576|gamma-Globulins|gamma-globulins|mesh-list
102065421|NCT02201576|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102065422|NCT02201576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102065423|NCT02201576|Immunologic Factors|immunologic factors|mesh-ancestor
102065424|NCT02201576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065425|NCT02198378|Acetaminophen|acetaminophen|mesh-list
102065426|NCT02198378|Morphine|morphine|mesh-list
102065427|NCT02198378|Entonox|entonox|mesh-list
102065428|NCT02198378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102065429|NCT02198378|Narcotics|narcotics|mesh-ancestor
102065471|NCT02064348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102065472|NCT02202200|Palbociclib|palbociclib|mesh-list
102065473|NCT02202200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102065474|NCT02202200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102065475|NCT02202200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102065476|NCT02202200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065477|NCT02064504|Fluticasone|fluticasone|mesh-list
102065540|NCT02065752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065541|NCT02065752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102065542|NCT02065752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065610|NCT02068170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102065611|NCT02068170|Analgesics|analgesics|mesh-ancestor
102065612|NCT02068170|Sensory System Agents|sensory system agents|mesh-ancestor
102065613|NCT02068170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102065614|NCT02068170|Antitussive Agents|antitussive agents|mesh-ancestor
102065615|NCT02068170|Respiratory System Agents|respiratory system agents|mesh-ancestor
102065616|NCT02068170|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102065618|NCT02068170|Antiemetics|antiemetics|mesh-ancestor
102065678|NCT02068560|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102065679|NCT02068560|Natriuretic Agents|natriuretic agents|mesh-ancestor
102065680|NCT02068560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065681|NCT01377103|Testosterone|testosterone|mesh-list
102065682|NCT01377103|Androgens|androgens|mesh-ancestor
102065683|NCT01377103|Hormones|hormones|mesh-ancestor
102065684|NCT01377103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102065685|NCT01377103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102065686|NCT01377025|Sorafenib|sorafenib|mesh-list
102065687|NCT01377025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102065688|NCT01377025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102065689|NCT01377025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102065691|NCT02342275|Propranolol|propranolol|mesh-list
102065740|NCT02199392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102065741|NCT02199392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102065742|NCT02199392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102065743|NCT02199392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065744|NCT05320627|Edoxaban|edoxaban|mesh-list
102065745|NCT05320627|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102065746|NCT05320627|Antithrombins|antithrombins|mesh-ancestor
102065747|NCT05320627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102065748|NCT05320627|Protease Inhibitors|protease inhibitors|mesh-ancestor
102065749|NCT05320627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102065750|NCT05320627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065751|NCT05320627|Anticoagulants|anticoagulants|mesh-ancestor
102065752|NCT03559920|Propofol|propofol|mesh-list
102065801|NCT03430531|Sensory System Agents|sensory system agents|mesh-ancestor
102065802|NCT03430531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102065803|NCT03430531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102065870|NCT02208128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102065871|NCT02208128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102065872|NCT02208128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102065873|NCT02208128|Immunologic Factors|immunologic factors|mesh-ancestor
102065874|NCT02066610|Selenium|selenium|mesh-list
102065943|NCT04311463|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102065944|NCT04311463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102065945|NCT04311463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102066013|NCT02066688|Micronutrients|micronutrients|mesh-ancestor
102066014|NCT02066688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066015|NCT02066688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102066016|NCT02066688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102066084|NCT02070120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102066085|NCT02070120|Alkylating Agents|alkylating agents|mesh-ancestor
102066089|NCT02200172|Melatonin|melatonin|mesh-list
102066156|NCT02067078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066157|NCT02067078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102066158|NCT02067078|Glucocorticoids|glucocorticoids|mesh-ancestor
102066159|NCT02067078|Hormones|hormones|mesh-ancestor
102066160|NCT02067078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102066161|NCT02067078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102066162|NCT02067078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102066163|NCT02067078|Protease Inhibitors|protease inhibitors|mesh-ancestor
102066164|NCT02067078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102066165|NCT02067078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066166|NCT02067078|Anesthetics, Local|anesthetics, local|mesh-ancestor
102066167|NCT02067078|Anesthetics|anesthetics|mesh-ancestor
102066216|NCT02200406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102066217|NCT02200406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102066218|NCT02200406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066219|NCT02200406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102066285|NCT02205164|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102066286|NCT02205164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102066287|NCT02205164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066288|NCT02205164|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102066289|NCT02205164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102066290|NCT02205164|Serotonin Agents|serotonin agents|mesh-ancestor
101315345|NCT05418868|Antiviral Agents|antiviral agents|mesh-ancestor
102066292|NCT02071212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102066351|NCT02258282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102066352|NCT02258282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101786091|NCT00796250|Infliximab|infliximab|mesh-list
102066353|NCT02258282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102066354|NCT02258282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102066355|NCT02258282|Immunologic Factors|immunologic factors|mesh-ancestor
102066356|NCT02076594|Docetaxel|docetaxel|mesh-list
102066357|NCT02076594|Capecitabine|capecitabine|mesh-list
102066358|NCT02076594|Oxaliplatin|oxaliplatin|mesh-list
102066359|NCT02076594|Epirubicin|epirubicin|mesh-list
102066360|NCT02076594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102066361|NCT02076594|Tubulin Modulators|tubulin modulators|mesh-ancestor
102066362|NCT02076594|Antimitotic Agents|antimitotic agents|mesh-ancestor
102066363|NCT02076594|Mitosis Modulators|mitosis modulators|mesh-ancestor
102066364|NCT02076594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066365|NCT02076594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102066366|NCT02076594|Antimetabolites|antimetabolites|mesh-ancestor
102066367|NCT02076594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102066368|NCT02076594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102066371|NCT04175509|Acetaminophen|acetaminophen|mesh-list
102066408|NCT01380457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102066409|NCT01380457|Analgesics|analgesics|mesh-ancestor
102066410|NCT01380457|Sensory System Agents|sensory system agents|mesh-ancestor
102066411|NCT01380457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102066412|NCT01380457|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102066413|NCT01380457|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102066414|NCT01380457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102066415|NCT01380457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066417|NCT01380457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102066418|NCT02071680|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
102066419|NCT02071680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102066420|NCT02071680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102066421|NCT02071680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066422|NCT02071680|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102066423|NCT01380301|Miltefosine|miltefosine|mesh-list
102066424|NCT01380301|Antifungal Agents|antifungal agents|mesh-ancestor
102066425|NCT01380301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102066426|NCT01380301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102066427|NCT01380301|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102066428|NCT01380301|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102066429|NCT02076828|Zinc|zinc|mesh-list
102066430|NCT02076828|Glycine|glycine|mesh-list
102066431|NCT02076828|Trace Elements|trace elements|mesh-ancestor
102066432|NCT02076828|Micronutrients|micronutrients|mesh-ancestor
102066433|NCT02076828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066434|NCT02076828|Glycine Agents|glycine agents|mesh-ancestor
101368069|NCT00054197|Paclitaxel|paclitaxel|mesh-list
101383780|NCT00275236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101383781|NCT00275236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383782|NCT00275236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383783|NCT00275197|Sertraline|sertraline|mesh-list
101383784|NCT00275197|Antidepressive Agents|antidepressive agents|mesh-ancestor
101383785|NCT00275197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101305162|NCT02018055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101383786|NCT00275197|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101383787|NCT00275197|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101383788|NCT00275197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101315386|NCT05233696|Tubulin Modulators|tubulin modulators|mesh-ancestor
101383789|NCT00275197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383790|NCT00275197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101383791|NCT00275197|Serotonin Agents|serotonin agents|mesh-ancestor
101383792|NCT00275197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383793|NCT00275119|Gemcitabine|gemcitabine|mesh-list
101383794|NCT00275119|Fluorouracil|fluorouracil|mesh-list
101383795|NCT00275119|Oxaliplatin|oxaliplatin|mesh-list
101383796|NCT00275119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102066435|NCT02076828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102066436|NCT02076828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066438|NCT02221154|Hematinics|hematinics|mesh-ancestor
102066439|NCT02221154|Vitamin B Complex|vitamin b complex|mesh-ancestor
102066440|NCT02221154|Vitamins|vitamins|mesh-ancestor
102066506|NCT02210156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066507|NCT02080026|Chloroquine|chloroquine|mesh-list
102066508|NCT02080026|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
102066580|NCT02080182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066581|NCT02080182|Antidotes|antidotes|mesh-ancestor
102066582|NCT02750930|rGLP-1 protein|rglp-1 protein|mesh-list
102066583|NCT02750930|Incretins|incretins|mesh-ancestor
102066584|NCT02750930|Hormones|hormones|mesh-ancestor
102066585|NCT02750930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102066587|NCT02080416|Nelfinavir|nelfinavir|mesh-list
102066648|NCT02225054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102066649|NCT02225054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102066650|NCT02225054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102066651|NCT02225054|Adrenergic Agents|adrenergic agents|mesh-ancestor
102066652|NCT02225054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102066653|NCT02225054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066654|NCT02225054|Anesthetics, Local|anesthetics, local|mesh-ancestor
102066655|NCT02225054|Anesthetics|anesthetics|mesh-ancestor
102066656|NCT02080728|Ropivacaine|ropivacaine|mesh-list
102066714|NCT02077920|Chlorhexidine|chlorhexidine|mesh-list
102066715|NCT02077920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102066716|NCT02077920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102066717|NCT02077920|Disinfectants|disinfectants|mesh-ancestor
102066718|NCT02225756|Cyclosporine|cyclosporine|mesh-list
102066719|NCT02225756|Cyclosporins|cyclosporins|mesh-list
102066720|NCT02225756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102066721|NCT02225756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066722|NCT02225756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102066723|NCT02225756|Immunologic Factors|immunologic factors|mesh-ancestor
102066724|NCT02225756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066725|NCT02225756|Antifungal Agents|antifungal agents|mesh-ancestor
102066726|NCT02225756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102066778|NCT04504045|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102066779|NCT04504045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102066780|NCT04504045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102066781|NCT04504045|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102066801|NCT03283488|Megestrol|megestrol|mesh-list
102066844|NCT02258204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102066845|NCT02258204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102066846|NCT02258204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102066847|NCT02258204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066848|NCT02226068|Cyclosporine|cyclosporine|mesh-list
102066849|NCT02226068|Cyclosporins|cyclosporins|mesh-list
102066850|NCT02226068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102066851|NCT02226068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066852|NCT02226068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102066853|NCT02226068|Immunologic Factors|immunologic factors|mesh-ancestor
102066854|NCT02226068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066855|NCT02226068|Antifungal Agents|antifungal agents|mesh-ancestor
102066856|NCT02226068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102066857|NCT02226068|Dermatologic Agents|dermatologic agents|mesh-ancestor
102066858|NCT02226068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102066859|NCT02226068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102066860|NCT02220218|Metformin|metformin|mesh-list
102066861|NCT02220218|Canagliflozin|canagliflozin|mesh-list
102066898|NCT02074878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102066899|NCT02074878|Growth Substances|growth substances|mesh-ancestor
102066900|NCT02074878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066901|NCT02074878|Growth Inhibitors|growth inhibitors|mesh-ancestor
102066902|NCT02074878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102066903|NCT02074878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102066904|NCT02074878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066905|NCT03075163|Ondansetron|ondansetron|mesh-list
102066906|NCT03075163|Antiemetics|antiemetics|mesh-ancestor
102066907|NCT03075163|Autonomic Agents|autonomic agents|mesh-ancestor
102066908|NCT03075163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102066909|NCT03075163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066910|NCT03075163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102066911|NCT03075163|Antipruritics|antipruritics|mesh-ancestor
102066912|NCT03075163|Dermatologic Agents|dermatologic agents|mesh-ancestor
102066913|NCT03075163|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102066914|NCT03075163|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102066915|NCT03075163|Serotonin Agents|serotonin agents|mesh-ancestor
102066916|NCT03075163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102066917|NCT03075163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102066954|NCT02220530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102066955|NCT02220530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102066956|NCT02220530|Analgesics|analgesics|mesh-ancestor
102066957|NCT02220530|Sensory System Agents|sensory system agents|mesh-ancestor
102066958|NCT02220530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102066959|NCT02220530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102066960|NCT02220530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102066961|NCT02220530|Anesthetics, General|anesthetics, general|mesh-ancestor
102066963|NCT02220530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102066964|NCT02220530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102066965|NCT02220530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102066966|NCT02220530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102066967|NCT02220530|GABA Modulators|gaba modulators|mesh-ancestor
102066968|NCT02220530|GABA Agents|gaba agents|mesh-ancestor
102066971|NCT02078232|Pancrelipase|pancrelipase|mesh-list
102067016|NCT02222636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102067017|NCT02222636|Anesthetics, General|anesthetics, general|mesh-ancestor
102067018|NCT02222636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102067019|NCT02222636|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102067021|NCT04058145|Pembrolizumab|pembrolizumab|mesh-list
102067085|NCT02082054|Chlorpheniramine|chlorpheniramine|mesh-list
102067086|NCT02082054|Atropine|atropine|mesh-list
102067087|NCT02082054|Pseudoephedrine|pseudoephedrine|mesh-list
102067088|NCT02082054|Ephedrine|ephedrine|mesh-list
102067089|NCT02082054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102067090|NCT02082054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102067091|NCT02082054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102067092|NCT02082054|Autonomic Agents|autonomic agents|mesh-ancestor
102067093|NCT02082054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102067094|NCT02082054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067095|NCT02082054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102067096|NCT02082054|Respiratory System Agents|respiratory system agents|mesh-ancestor
102067097|NCT02082054|Mydriatics|mydriatics|mesh-ancestor
102067098|NCT02082054|Parasympatholytics|parasympatholytics|mesh-ancestor
102067099|NCT02082054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102067100|NCT02082054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102067101|NCT02082054|Cholinergic Agents|cholinergic agents|mesh-ancestor
102067102|NCT02082054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102067103|NCT02082054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067139|NCT02226926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067141|NCT02226926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102067142|NCT02226926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102067143|NCT02226926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102067144|NCT02226926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067145|NCT02226926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102067146|NCT02226926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102067147|NCT02226926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102067148|NCT02226926|Antipyretics|antipyretics|mesh-ancestor
102067149|NCT02226926|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102067150|NCT02226926|Vasodilator Agents|vasodilator agents|mesh-ancestor
102067199|NCT04780321|Antibodies|antibodies|mesh-list
102067200|NCT04780321|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102067201|NCT04780321|Immunologic Factors|immunologic factors|mesh-ancestor
102067202|NCT04780321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067203|NCT03670095|Memantine|memantine|mesh-list
102067271|NCT02083536|Antimitotic Agents|antimitotic agents|mesh-ancestor
101315468|NCT00000522|Enalapril|enalapril|mesh-list
102067272|NCT02083536|Mitosis Modulators|mitosis modulators|mesh-ancestor
102067273|NCT02083536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067275|NCT02231606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102067276|NCT02231606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067277|NCT02231606|Sympathomimetics|sympathomimetics|mesh-ancestor
102067278|NCT02231606|Autonomic Agents|autonomic agents|mesh-ancestor
102067279|NCT02231606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102067280|NCT02231606|Dopamine Agents|dopamine agents|mesh-ancestor
102067288|NCT02083692|Metformin|metformin|mesh-list
102067336|NCT02258828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102067337|NCT02083068|Vaccines|vaccines|mesh-list
102067410|NCT04057755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102067411|NCT04057755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067412|NCT04057755|Cholinergic Agents|cholinergic agents|mesh-ancestor
102067413|NCT04057755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102067480|NCT01074151|Dopamine Agents|dopamine agents|mesh-ancestor
102067490|NCT02786329|Lidocaine|lidocaine|mesh-list
102067491|NCT02786329|Sevoflurane|sevoflurane|mesh-list
102067492|NCT02786329|Anesthetics, Local|anesthetics, local|mesh-ancestor
102067493|NCT02786329|Anesthetics|anesthetics|mesh-ancestor
102067494|NCT02786329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102067495|NCT02786329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067496|NCT02786329|Sensory System Agents|sensory system agents|mesh-ancestor
102067497|NCT02786329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102067498|NCT02786329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102067551|NCT01050855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067552|NCT01050855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102067553|NCT01050855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101787270|NCT00881088|Anticoagulants|anticoagulants|mesh-ancestor
102067554|NCT01050855|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102067555|NCT01050855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102067557|NCT04459286|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102067558|NCT04459286|Nitazoxanide|nitazoxanide|mesh-list
102067571|NCT00744081|Topotecan|topotecan|mesh-list
102067620|NCT02232308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102067621|NCT02232308|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102067622|NCT02232308|Histamine Antagonists|histamine antagonists|mesh-ancestor
102067623|NCT02232308|Histamine Agents|histamine agents|mesh-ancestor
102067624|NCT02232308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102067625|NCT02232386|Rituximab|rituximab|mesh-list
102067687|NCT03494504|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102067688|NCT03494504|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102067689|NCT04049864|Lenalidomide|lenalidomide|mesh-list
102067690|NCT04049864|Vaccines|vaccines|mesh-list
102067691|NCT04049864|Immunologic Factors|immunologic factors|mesh-ancestor
102067692|NCT04049864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067754|NCT03911102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102067755|NCT04789148|Oxytocin|oxytocin|mesh-list
102067756|NCT04789148|Oxytocics|oxytocics|mesh-ancestor
102067757|NCT04789148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102067758|NCT04789148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067759|NCT03172910|Rivaroxaban|rivaroxaban|mesh-list
102067760|NCT03172910|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102067761|NCT03172910|Antithrombins|antithrombins|mesh-ancestor
102067762|NCT03172910|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102067763|NCT03172910|Protease Inhibitors|protease inhibitors|mesh-ancestor
102067764|NCT03172910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102067765|NCT03172910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067766|NCT03172910|Anticoagulants|anticoagulants|mesh-ancestor
102067767|NCT03881852|Reboxetine|reboxetine|mesh-list
102067768|NCT03881852|Antidepressive Agents|antidepressive agents|mesh-ancestor
102067769|NCT03881852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102067770|NCT03881852|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102067771|NCT03881852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102067772|NCT03881852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102067777|NCT03818828|Iodine|iodine|mesh-list
102067809|NCT02234882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102067810|NCT02234882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102067811|NCT02234882|Antimetabolites|antimetabolites|mesh-ancestor
102067812|NCT02234882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067813|NCT02234882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102067814|NCT02234882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102067815|NCT02234882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102067816|NCT02234882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102067817|NCT02234882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102067818|NCT02234882|Antiviral Agents|antiviral agents|mesh-ancestor
102067819|NCT02234882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102067820|NCT02234882|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
102067872|NCT02726659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067873|NCT02726659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102067874|NCT02726659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102067875|NCT02726659|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102067876|NCT02726659|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102067877|NCT02726659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102067878|NCT02726659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102067879|NCT03660878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102067880|NCT03660878|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102067881|NCT04446962|Lenalidomide|lenalidomide|mesh-list
102067882|NCT04446962|Immunologic Factors|immunologic factors|mesh-ancestor
102067883|NCT04446962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102067933|NCT02235428|Anticonvulsants|anticonvulsants|mesh-ancestor
102067934|NCT02235428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102067935|NCT02235428|Autonomic Agents|autonomic agents|mesh-ancestor
102067936|NCT02235428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102068002|NCT02262650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102068003|NCT02262650|Purinergic Agents|purinergic agents|mesh-ancestor
102068004|NCT02262650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102068005|NCT02262650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068006|NCT02262650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068007|NCT02262650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102068008|NCT02262650|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102068009|NCT02262650|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102068010|NCT02784002|Fidaxomicin|fidaxomicin|mesh-list
102068011|NCT02784002|Ridinilazole|ridinilazole|mesh-list
102068012|NCT02784002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102068013|NCT02784002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102068014|NCT02233556|Memantine|memantine|mesh-list
102068015|NCT02233556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102068016|NCT02233556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102068017|NCT02233556|Dopamine Agents|dopamine agents|mesh-ancestor
102068027|NCT02236052|Vaccines|vaccines|mesh-list
102068060|NCT05759767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102068061|NCT05759767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068062|NCT05759767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068063|NCT05759767|Urological Agents|urological agents|mesh-ancestor
102068064|NCT02750306|Suvorexant|suvorexant|mesh-list
102068065|NCT02750306|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102068127|NCT02547818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102068128|NCT02547818|Analgesics|analgesics|mesh-ancestor
102068129|NCT02547818|Sensory System Agents|sensory system agents|mesh-ancestor
102068130|NCT02547818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102068133|NCT02547818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102068200|NCT04058158|Eculizumab|eculizumab|mesh-list
102068201|NCT04058158|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
102068202|NCT04058158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102068203|NCT04058158|Immunologic Factors|immunologic factors|mesh-ancestor
102068204|NCT04058158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068205|NCT02263196|Ethanol|ethanol|mesh-list
102068206|NCT02263196|Povidone-Iodine|povidone-iodine|mesh-list
102068207|NCT02263196|Povidone|povidone|mesh-list
102068208|NCT02263196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102068209|NCT02263196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102068210|NCT02263196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102068211|NCT02263196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068212|NCT02263196|Plasma Substitutes|plasma substitutes|mesh-ancestor
102068265|NCT03136120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068266|NCT03136120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102068267|NCT03136120|Respiratory System Agents|respiratory system agents|mesh-ancestor
102068268|NCT03136120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102068334|NCT04409509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068335|NCT04401865|Riboflavin|riboflavin|mesh-list
102068336|NCT04401865|Vitamin B Complex|vitamin b complex|mesh-ancestor
102068337|NCT04401865|Vitamins|vitamins|mesh-ancestor
102068338|NCT04401865|Micronutrients|micronutrients|mesh-ancestor
102068339|NCT04401865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068340|NCT04401865|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102068341|NCT04401865|Dermatologic Agents|dermatologic agents|mesh-ancestor
102068342|NCT02609048|Seladelpar|seladelpar|mesh-list
102068343|NCT02609048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102068344|NCT02609048|Antimetabolites|antimetabolites|mesh-ancestor
102068345|NCT02609048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068346|NCT02609048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102068347|NCT02265068|Ticagrelor|ticagrelor|mesh-list
102068348|NCT02265068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102068349|NCT02265068|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102068351|NCT02265068|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102068392|NCT01418222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068393|NCT01418222|Growth Inhibitors|growth inhibitors|mesh-ancestor
102068466|NCT03071263|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
102068467|NCT03071263|Hormone Antagonists|hormone antagonists|mesh-ancestor
102068468|NCT03071263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101315541|NCT00000531|Sympatholytics|sympatholytics|mesh-ancestor
102068469|NCT03071263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068470|NCT03071263|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
102068471|NCT03071263|Diuretics|diuretics|mesh-ancestor
102068472|NCT03071263|Natriuretic Agents|natriuretic agents|mesh-ancestor
102068533|NCT01569919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102068534|NCT01569919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068535|NCT01569919|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102068536|NCT01569919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102068537|NCT01569919|Hematinics|hematinics|mesh-ancestor
102068538|NCT01569919|Vitamin B Complex|vitamin b complex|mesh-ancestor
102068539|NCT01399580|Atrasentan|atrasentan|mesh-list
102068540|NCT01399580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102068541|NCT01399580|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
102068542|NCT01399580|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102068543|NCT01399580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068544|NCT04069585|Lidocaine|lidocaine|mesh-list
102068545|NCT04069585|Anesthetics|anesthetics|mesh-list
102068546|NCT04069585|Anesthetics, Local|anesthetics, local|mesh-ancestor
102068547|NCT04069585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102068548|NCT04069585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068588|NCT02265770|Dermatologic Agents|dermatologic agents|mesh-ancestor
102068589|NCT02265770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102068590|NCT02265770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102068591|NCT02265770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102068592|NCT02265770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102068593|NCT02265770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102068594|NCT02265770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102068595|NCT02265770|Tubulin Modulators|tubulin modulators|mesh-ancestor
102068596|NCT02265770|Antimitotic Agents|antimitotic agents|mesh-ancestor
102068598|NCT02265770|Anticonvulsants|anticonvulsants|mesh-ancestor
102068599|NCT02265770|GABA Agents|gaba agents|mesh-ancestor
102068600|NCT02265770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102068601|NCT02265770|Antimanic Agents|antimanic agents|mesh-ancestor
102068602|NCT02265770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102068603|NCT02265770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102068604|NCT02265770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102068605|NCT03066193|Palmidrol|palmidrol|mesh-list
102068647|NCT01382654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102068648|NCT01382654|Autonomic Agents|autonomic agents|mesh-ancestor
102068649|NCT01382654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102068650|NCT01382654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068651|NCT01382654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102068652|NCT01382654|Respiratory System Agents|respiratory system agents|mesh-ancestor
102068653|NCT01382654|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
102068654|NCT01382654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102068655|NCT01382654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068656|NCT01382654|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102068657|NCT01382654|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102068658|NCT01382654|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102068659|NCT01382654|Histamine Antagonists|histamine antagonists|mesh-ancestor
102068660|NCT01382654|Histamine Agents|histamine agents|mesh-ancestor
102068661|NCT01382654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102068662|NCT01378676|Riluzole|riluzole|mesh-list
102068663|NCT01378676|Anticonvulsants|anticonvulsants|mesh-ancestor
102068703|NCT01497704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102068704|NCT01497704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102068705|NCT01497704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068706|NCT02266160|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
102068707|NCT02266160|Anesthetics, Local|anesthetics, local|mesh-ancestor
102068770|NCT01180634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101315568|NCT00000555|Progestins|progestins|mesh-ancestor
102068771|NCT01180634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068772|NCT01180634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102068773|NCT01180634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102068774|NCT01180634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102068775|NCT02268890|Bortezomib|bortezomib|mesh-list
102068776|NCT02268890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102068777|NCT02268968|Lidocaine|lidocaine|mesh-list
102068778|NCT02268968|Anesthetics, Local|anesthetics, local|mesh-ancestor
102068779|NCT02268968|Anesthetics|anesthetics|mesh-ancestor
102068780|NCT02268968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102068781|NCT02268968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068831|NCT02269046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102068832|NCT02269046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102068834|NCT01483742|Ribavirin|ribavirin|mesh-list
102068835|NCT01483742|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102068836|NCT01483742|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102068837|NCT01483742|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102068838|NCT01483742|Protease Inhibitors|protease inhibitors|mesh-ancestor
102068839|NCT01483742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102068840|NCT01483742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068841|NCT01483742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102068842|NCT01483742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102068843|NCT01483742|Antiviral Agents|antiviral agents|mesh-ancestor
102068844|NCT01483742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102068845|NCT01483742|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102068846|NCT01483742|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102068847|NCT01483742|Antimetabolites|antimetabolites|mesh-ancestor
102068848|NCT04691128|Anesthetics|anesthetics|mesh-list
102068849|NCT04691128|Propofol|propofol|mesh-list
102068850|NCT04691128|Desflurane|desflurane|mesh-list
102068851|NCT04691128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102068852|NCT04691128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068853|NCT04691128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102068886|NCT05095636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102068887|NCT05095636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102068888|NCT05095636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102068889|NCT05095636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068890|NCT01343966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102068891|NCT01343966|Immunologic Factors|immunologic factors|mesh-ancestor
102068892|NCT01343966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068893|NCT05095480|Red yeast rice|red yeast rice|mesh-list
102068894|NCT05095480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102068895|NCT05095480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102068896|NCT05095480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102068898|NCT05095480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068899|NCT05095480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102068900|NCT05095480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102068901|NCT02915016|Vaccines|vaccines|mesh-list
102068902|NCT02915016|MF59 oil emulsion|mf59 oil emulsion|mesh-list
102068903|NCT02915016|Immunologic Factors|immunologic factors|mesh-ancestor
102068904|NCT02915016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102068905|NCT02915016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102068906|NCT01170650|Doxorubicin|doxorubicin|mesh-list
102068907|NCT01170650|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102068908|NCT01170650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102068909|NCT01170650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102068910|NCT01170650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102068911|NCT01170650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102068912|NCT01170650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102068934|NCT01168310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068935|NCT01472198|Gemcitabine|gemcitabine|mesh-list
102068936|NCT01472198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102068937|NCT01472198|Antimetabolites|antimetabolites|mesh-ancestor
102068938|NCT01472198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102068939|NCT01472198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102068940|NCT02269358|Methotrexate|methotrexate|mesh-list
102068941|NCT02269358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102068956|NCT04504240|Famotidine|famotidine|mesh-list
102068999|NCT01332812|Antiemetics|antiemetics|mesh-ancestor
102069074|NCT01312454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102069075|NCT01312454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102069077|NCT02084784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102069078|NCT02084784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069079|NCT03267589|Durvalumab|durvalumab|mesh-list
102069080|NCT03267589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102069081|NCT03267589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069082|NCT02091180|Mannitol|mannitol|mesh-list
102069083|NCT02091180|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102069084|NCT02091180|Diuretics|diuretics|mesh-ancestor
102069085|NCT02091180|Natriuretic Agents|natriuretic agents|mesh-ancestor
102069086|NCT02091180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069087|NCT02269748|Analgesics|analgesics|mesh-list
102069088|NCT02269748|Sensory System Agents|sensory system agents|mesh-ancestor
102069089|NCT02269748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102069090|NCT02269748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069091|NCT02269904|Fluorouracil|fluorouracil|mesh-list
102069092|NCT02269904|Antimetabolites|antimetabolites|mesh-ancestor
102069093|NCT02269904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069094|NCT02269904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102069095|NCT02269904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069096|NCT02269904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102069097|NCT02269904|Immunologic Factors|immunologic factors|mesh-ancestor
102069098|NCT02269904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069099|NCT03557112|Nimotuzumab|nimotuzumab|mesh-list
102069100|NCT03557112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069102|NCT01300208|CC-11050|cc-11050|mesh-list
102069121|NCT01442090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069122|NCT01442090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102069123|NCT01442090|Immunologic Factors|immunologic factors|mesh-ancestor
102069124|NCT01442090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069125|NCT01442090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069131|NCT02088450|Nitrendipine|nitrendipine|mesh-list
102069188|NCT03634150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069189|NCT02092038|Temozolomide|temozolomide|mesh-list
102069190|NCT02092038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102069191|NCT02092038|Alkylating Agents|alkylating agents|mesh-ancestor
102069192|NCT02092038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069193|NCT02092038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069194|NCT02272166|Propofol|propofol|mesh-list
102069195|NCT02272166|Sevoflurane|sevoflurane|mesh-list
102069196|NCT02272166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101315599|NCT00000558|Enzyme Inhibitors|enzyme inhibitors|mesh-list
102069197|NCT02272166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102069198|NCT02272166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069199|NCT02272166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102069201|NCT02272166|Anesthetics|anesthetics|mesh-ancestor
102069249|NCT01133990|Vitamin B Complex|vitamin b complex|mesh-ancestor
102069250|NCT01133990|Vitamins|vitamins|mesh-ancestor
102069251|NCT01133990|Micronutrients|micronutrients|mesh-ancestor
102069252|NCT02249910|Metformin|metformin|mesh-list
102069253|NCT02249910|Digoxin|digoxin|mesh-list
102069254|NCT02249910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102069255|NCT02249910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069256|NCT02249910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102069257|NCT02249910|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102069258|NCT02249910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102069259|NCT02249910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069260|NCT02249910|Protective Agents|protective agents|mesh-ancestor
102069267|NCT02398396|Lactitol|lactitol|mesh-list
102069314|NCT02092506|Metronidazole|metronidazole|mesh-list
102069315|NCT02092506|Clarithromycin|clarithromycin|mesh-list
102069316|NCT02092506|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
102069317|NCT02092506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102069318|NCT02092506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102069319|NCT02092506|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102069320|NCT02092506|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102069321|NCT02092506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102069322|NCT02092506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102069323|NCT02092506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069324|NCT02092506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102069376|NCT02092974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102069449|NCT02089542|Methylene Blue|methylene blue|mesh-list
102069450|NCT02089542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102069451|NCT02089542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069452|NCT01295060|Octreotide|octreotide|mesh-list
102069519|NCT02093598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069520|NCT02093598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069521|NCT02093598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102069522|NCT02093598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102069523|NCT02093598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102069525|NCT01124552|Botulinum Toxins|botulinum toxins|mesh-list
102069526|NCT01124552|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102069527|NCT01124552|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102069528|NCT01124552|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102069583|NCT03072043|Antimetabolites|antimetabolites|mesh-ancestor
102069584|NCT03072043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069585|NCT03072043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069586|NCT03072043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102069587|NCT05626010|Acetaminophen|acetaminophen|mesh-list
102069588|NCT05626010|Ibuprofen|ibuprofen|mesh-list
102069589|NCT05626010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102069590|NCT05626010|Analgesics|analgesics|mesh-ancestor
102069591|NCT05626010|Sensory System Agents|sensory system agents|mesh-ancestor
102069592|NCT05626010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102069593|NCT05626010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069594|NCT05626010|Antipyretics|antipyretics|mesh-ancestor
102069595|NCT05626010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102069596|NCT05626010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102069597|NCT05626010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101315622|NCT00000579|Ketoconazole|ketoconazole|mesh-list
102069598|NCT05626010|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102069599|NCT05626010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102069600|NCT05626010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069601|NCT02089854|Toremifene|toremifene|mesh-list
102069602|NCT02089854|Anastrozole|anastrozole|mesh-list
102069603|NCT02089854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102069604|NCT02089854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069605|NCT02089854|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102069606|NCT02089854|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102069607|NCT02089854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102069608|NCT02089854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069609|NCT02089854|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102069610|NCT02089854|Hormone Antagonists|hormone antagonists|mesh-ancestor
102069611|NCT02089854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102069612|NCT02089854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069613|NCT02089854|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102069614|NCT02089854|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102069615|NCT02089854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102069616|NCT05624840|Ritonavir|ritonavir|mesh-list
102069617|NCT05624840|Nirmatrelvir|nirmatrelvir|mesh-list
101383797|NCT00275119|Antimetabolites|antimetabolites|mesh-ancestor
102069619|NCT05624840|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102069620|NCT05624840|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102069621|NCT05624840|Protease Inhibitors|protease inhibitors|mesh-ancestor
102069622|NCT05624840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102069691|NCT05204641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102069692|NCT03069313|Vitamin B 12|vitamin b 12|mesh-list
102069693|NCT03069313|Hydroxocobalamin|hydroxocobalamin|mesh-list
102069694|NCT03069313|Vitamins|vitamins|mesh-ancestor
102069695|NCT03069313|Micronutrients|micronutrients|mesh-ancestor
102069696|NCT03069313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069697|NCT03069313|Vitamin B Complex|vitamin b complex|mesh-ancestor
102069698|NCT03069313|Hematinics|hematinics|mesh-ancestor
102069699|NCT02094066|Tranexamic Acid|tranexamic acid|mesh-list
102069700|NCT02094066|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102069701|NCT02094066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102069706|NCT01033292|Iniparib|iniparib|mesh-list
101371407|NCT02963077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102069759|NCT02268032|Androgens|androgens|mesh-list
102069760|NCT02268032|Hormones|hormones|mesh-ancestor
102069761|NCT02268032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102069762|NCT02268032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069763|NCT03019965|Meropenem|meropenem|mesh-list
102069764|NCT03019965|Tazobactam|tazobactam|mesh-list
102069765|NCT03019965|Piperacillin|piperacillin|mesh-list
102069766|NCT03019965|Imipenem|imipenem|mesh-list
102069767|NCT03019965|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
102069768|NCT03019965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102069769|NCT03019965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102069770|NCT03019965|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102069771|NCT03019965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102069772|NCT03019965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069773|NCT01468831|Minocycline|minocycline|mesh-list
102069774|NCT01468831|Bevacizumab|bevacizumab|mesh-list
102069775|NCT01468831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102069776|NCT01468831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069777|NCT01468831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102069778|NCT01468831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102069779|NCT01468831|Growth Substances|growth substances|mesh-ancestor
102069780|NCT01468831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069781|NCT01468831|Growth Inhibitors|growth inhibitors|mesh-ancestor
102069782|NCT01468831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102069783|NCT01468831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102069784|NCT05627414|Paclitaxel|paclitaxel|mesh-list
102069785|NCT05627414|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102069786|NCT05627414|Tegafur|tegafur|mesh-list
102069787|NCT05627414|Disitamab vedotin|disitamab vedotin|mesh-list
102069788|NCT05627414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102069789|NCT05627414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069790|NCT05627414|Tubulin Modulators|tubulin modulators|mesh-ancestor
102069791|NCT05627414|Antimitotic Agents|antimitotic agents|mesh-ancestor
102069792|NCT05627414|Mitosis Modulators|mitosis modulators|mesh-ancestor
102069793|NCT05627414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383811|NCT00275080|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101383812|NCT00078962|Gemcitabine|gemcitabine|mesh-list
102069794|NCT05627414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102069796|NCT05627414|Immunoconjugates|immunoconjugates|mesh-ancestor
102069797|NCT05627414|Immunologic Factors|immunologic factors|mesh-ancestor
102069798|NCT05627414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069800|NCT05617508|Niacin|niacin|mesh-list
102069801|NCT05617508|Nicotinic Acids|nicotinic acids|mesh-list
102069802|NCT05617508|Vitamin B Complex|vitamin b complex|mesh-ancestor
102069803|NCT05617508|Vitamins|vitamins|mesh-ancestor
102069862|NCT03017235|Sequestering Agents|sequestering agents|mesh-ancestor
102069863|NCT03017235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069864|NCT03017235|Cathartics|cathartics|mesh-ancestor
102069865|NCT03017235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102069866|NCT03017235|Antacids|antacids|mesh-ancestor
102069867|NCT05048134|Trametinib|trametinib|mesh-list
102069868|NCT05048134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069869|NCT05048134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101789617|NCT01073761|Ritonavir|ritonavir|mesh-list
102069870|NCT05048134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102069871|NCT05048134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069872|NCT04438928|Micronutrients|micronutrients|mesh-list
102069873|NCT04438928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069874|NCT03667677|Amlodipine|amlodipine|mesh-list
102069875|NCT03667677|Tandospirone|tandospirone|mesh-list
102069876|NCT03667677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102069877|NCT03667677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102069878|NCT03667677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102069879|NCT03667677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069917|NCT00813956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102069918|NCT00813956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102069919|NCT00813956|Antimetabolites|antimetabolites|mesh-ancestor
102069920|NCT00813956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102069921|NCT00813956|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102069922|NCT00813956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102069923|NCT01002248|Dexamethasone|dexamethasone|mesh-list
102069924|NCT01002248|Bortezomib|bortezomib|mesh-list
102069925|NCT01002248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102069926|NCT01002248|Antiemetics|antiemetics|mesh-ancestor
102069927|NCT01002248|Autonomic Agents|autonomic agents|mesh-ancestor
102069928|NCT01002248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102069929|NCT01002248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102069930|NCT01002248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101315654|NCT00000588|Vitamin B Complex|vitamin b complex|mesh-ancestor
101315655|NCT00000588|Vitamins|vitamins|mesh-ancestor
101315656|NCT00000588|Micronutrients|micronutrients|mesh-ancestor
101315657|NCT00000588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315658|NCT00000588|Chelating Agents|chelating agents|mesh-ancestor
101315659|NCT00000588|Sequestering Agents|sequestering agents|mesh-ancestor
102069931|NCT01002248|Glucocorticoids|glucocorticoids|mesh-ancestor
102069932|NCT01002248|Hormones|hormones|mesh-ancestor
102069936|NCT02837029|Nivolumab|nivolumab|mesh-list
102070043|NCT05519384|Cyclophosphamide|cyclophosphamide|mesh-list
102070044|NCT05519384|Fludarabine|fludarabine|mesh-list
102070045|NCT05519384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102070046|NCT05519384|Immunologic Factors|immunologic factors|mesh-ancestor
102070047|NCT05519384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070048|NCT05519384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102070049|NCT05519384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102070050|NCT05519384|Alkylating Agents|alkylating agents|mesh-ancestor
102070051|NCT05519384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070052|NCT05519384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102070053|NCT05519384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102070054|NCT00799292|Vasopressins|vasopressins|mesh-list
102070055|NCT00799292|Arginine Vasopressin|arginine vasopressin|mesh-list
102070056|NCT00799292|Hemostatics|hemostatics|mesh-ancestor
102070057|NCT00799292|Coagulants|coagulants|mesh-ancestor
102070058|NCT00799292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102070059|NCT00799292|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102070060|NCT00799292|Natriuretic Agents|natriuretic agents|mesh-ancestor
102070061|NCT00799292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070062|NCT02162849|Nicotine|nicotine|mesh-list
102070063|NCT02162849|Varenicline|varenicline|mesh-list
102070064|NCT02162849|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102070065|NCT02162849|Autonomic Agents|autonomic agents|mesh-ancestor
102070066|NCT02162849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102070067|NCT02162849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070068|NCT02162849|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102070069|NCT02162849|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102070073|NCT02914275|Vaccines|vaccines|mesh-list
102070092|NCT01814657|Anesthetics|anesthetics|mesh-ancestor
102070093|NCT01814657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102070094|NCT01814657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070095|NCT01814657|Sensory System Agents|sensory system agents|mesh-ancestor
102070096|NCT01814657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102070097|NCT01814657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102070098|NCT01814657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102070099|NCT01814657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102070100|NCT01814657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102070156|NCT05375188|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102070157|NCT05375188|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102070158|NCT05375188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102070159|NCT05375188|Adrenergic Agents|adrenergic agents|mesh-ancestor
102070160|NCT05375188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102070161|NCT05375188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070162|NCT00994292|Darexaban|darexaban|mesh-list
102070163|NCT00994292|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102070164|NCT00994292|Antithrombins|antithrombins|mesh-ancestor
102070165|NCT00994292|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102070166|NCT00994292|Protease Inhibitors|protease inhibitors|mesh-ancestor
102070167|NCT00994292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102070168|NCT00994292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070169|NCT00994292|Anticoagulants|anticoagulants|mesh-ancestor
102070170|NCT02604433|Luspatercept|luspatercept|mesh-list
102070171|NCT02604433|Hematinics|hematinics|mesh-ancestor
102070201|NCT03006393|Infliximab|infliximab|mesh-list
102070214|NCT01383109|Antimalarials|antimalarials|mesh-ancestor
102070215|NCT01383109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102070216|NCT01383109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102070217|NCT01383109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102070219|NCT00882440|Enalapril|enalapril|mesh-list
102070220|NCT00882440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102070221|NCT00882440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102070222|NCT00882440|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102070223|NCT00882440|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102070224|NCT00882440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070225|NCT00882440|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102070226|NCT00882440|Protease Inhibitors|protease inhibitors|mesh-ancestor
102070227|NCT00882440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102070228|NCT05214391|Zanubrutinib|zanubrutinib|mesh-list
102070229|NCT05214391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102070230|NCT05214391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102070231|NCT05214391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102070232|NCT05214391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070233|NCT00880490|Formoterol Fumarate|formoterol fumarate|mesh-list
102070234|NCT00880490|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102070235|NCT00880490|Autonomic Agents|autonomic agents|mesh-ancestor
102070265|NCT04549467|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102070266|NCT04549467|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102070267|NCT03630341|Clomiphene|clomiphene|mesh-list
102070268|NCT03630341|Enclomiphene|enclomiphene|mesh-list
102070269|NCT03630341|Zuclomiphene|zuclomiphene|mesh-list
102070270|NCT03630341|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102070271|NCT03630341|Hormone Antagonists|hormone antagonists|mesh-ancestor
102070272|NCT03630341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102070273|NCT03630341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070274|NCT03630341|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102070275|NCT03630341|Fertility Agents|fertility agents|mesh-ancestor
102070276|NCT03630341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102070277|NCT03630341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102070278|NCT03630341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102070279|NCT02632396|Rituximab|rituximab|mesh-list
102070280|NCT02632396|Ixazomib|ixazomib|mesh-list
102070281|NCT02632396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102070282|NCT02632396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102070283|NCT02632396|Immunologic Factors|immunologic factors|mesh-ancestor
102070284|NCT02632396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070285|NCT02632396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102070287|NCT02632396|Protease Inhibitors|protease inhibitors|mesh-ancestor
102070318|NCT05101954|Mitosis Modulators|mitosis modulators|mesh-ancestor
102070319|NCT05101954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070320|NCT00875108|Insulin|insulin|mesh-list
102070321|NCT00875108|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102070322|NCT00875108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102070323|NCT00875108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070385|NCT00968942|Cholinergic Agents|cholinergic agents|mesh-ancestor
102070386|NCT00968942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102070387|NCT00968942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070388|NCT00968942|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102070389|NCT00968942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102070391|NCT05283382|Anticonvulsants|anticonvulsants|mesh-ancestor
102070392|NCT00869336|Luliconazole|luliconazole|mesh-list
102070393|NCT00869336|Antifungal Agents|antifungal agents|mesh-ancestor
102070395|NCT02371889|Topiramate|topiramate|mesh-list
102070451|NCT00855764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102070452|NCT00855764|Tubulin Modulators|tubulin modulators|mesh-ancestor
102070453|NCT00855764|Antimitotic Agents|antimitotic agents|mesh-ancestor
102070454|NCT00855764|Mitosis Modulators|mitosis modulators|mesh-ancestor
102070456|NCT00959036|Methotrexate|methotrexate|mesh-list
102070520|NCT04724759|Anesthetics, General|anesthetics, general|mesh-ancestor
102070521|NCT04724759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102070522|NCT04724759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102070523|NCT04019821|Insulin|insulin|mesh-list
102070524|NCT04019821|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102070525|NCT04019821|Insulin Aspart|insulin aspart|mesh-list
102070589|NCT00840476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070591|NCT00765830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102070592|NCT00765830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070657|NCT00838136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070658|NCT00838136|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102070659|NCT00838136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102070660|NCT00838136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102070661|NCT00838136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102070662|NCT00838136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102070663|NCT00944294|Adenosine|adenosine|mesh-list
102070664|NCT00944294|Binodenoson|binodenoson|mesh-list
102070724|NCT00754988|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102070725|NCT00754988|Protease Inhibitors|protease inhibitors|mesh-ancestor
102070726|NCT00754988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102070727|NCT00754988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070728|NCT01416935|Amiodarone|amiodarone|mesh-list
102070729|NCT01416935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102070790|NCT05261464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102070791|NCT05261464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070792|NCT05261464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102070793|NCT05261464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102070859|NCT00752570|Growth Inhibitors|growth inhibitors|mesh-ancestor
102070860|NCT00752570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102070862|NCT05083000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102070863|NCT05083000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102070864|NCT05083000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102070865|NCT05083000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070928|NCT00745316|Adenosine A1 Receptor Antagonists|adenosine a1 receptor antagonists|mesh-list
102070929|NCT00745316|Analgesics|analgesics|mesh-ancestor
102070930|NCT00745316|Sensory System Agents|sensory system agents|mesh-ancestor
102070931|NCT00745316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102070932|NCT00745316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102070933|NCT00745316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102070934|NCT00745316|Vasodilator Agents|vasodilator agents|mesh-ancestor
102070935|NCT00745316|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
102070936|NCT00745316|Purinergic Agonists|purinergic agonists|mesh-ancestor
102070937|NCT00745316|Purinergic Agents|purinergic agents|mesh-ancestor
102070938|NCT00745316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101387727|NCT04717531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102070939|NCT00745316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102070940|NCT00745316|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102070987|NCT04695106|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102070988|NCT04695106|Protease Inhibitors|protease inhibitors|mesh-ancestor
102070989|NCT04695106|Anticoagulants|anticoagulants|mesh-ancestor
102070990|NCT04032665|Rivaroxaban|rivaroxaban|mesh-list
102070991|NCT04032665|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102070998|NCT03629639|Metformin|metformin|mesh-list
102071058|NCT04699357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102071059|NCT04699357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071060|NCT04699357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102071061|NCT04699357|Respiratory System Agents|respiratory system agents|mesh-ancestor
102071062|NCT04699357|Mydriatics|mydriatics|mesh-ancestor
102071063|NCT04699357|Parasympatholytics|parasympatholytics|mesh-ancestor
102071064|NCT04699357|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102071065|NCT04699357|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102071066|NCT04699357|Cholinergic Agents|cholinergic agents|mesh-ancestor
102071067|NCT04699357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102071068|NCT04699357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071077|NCT05198531|Gemcitabine|gemcitabine|mesh-list
102071118|NCT03982576|Cholinergic Agents|cholinergic agents|mesh-ancestor
102071119|NCT03982576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102071120|NCT03982576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071121|NCT04172246|Zanubrutinib|zanubrutinib|mesh-list
102071122|NCT04172246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102071123|NCT04172246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102071124|NCT04172246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102071125|NCT04172246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071183|NCT04178993|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102071184|NCT04436536|Methamphetamine|methamphetamine|mesh-list
102071185|NCT04436536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102071255|NCT03134612|Anesthetics, Local|anesthetics, local|mesh-ancestor
102071256|NCT03134612|Anesthetics|anesthetics|mesh-ancestor
102071257|NCT03134612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102071258|NCT03134612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071259|NCT03134612|Sensory System Agents|sensory system agents|mesh-ancestor
102071260|NCT03134612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102071277|NCT04365985|Naltrexone|naltrexone|mesh-list
102071323|NCT00830102|Dermatologic Agents|dermatologic agents|mesh-ancestor
102071324|NCT00830102|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102071325|NCT00830102|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102071326|NCT00830102|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102071327|NCT00830102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102071328|NCT00830102|Adrenergic Agents|adrenergic agents|mesh-ancestor
102071329|NCT00830102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102071330|NCT00830102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071331|NCT03349775|Metformin|metformin|mesh-list
102071332|NCT03349775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102071333|NCT03349775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071334|NCT00830024|Alprazolam|alprazolam|mesh-list
102071335|NCT00830024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102071337|NCT00830024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071385|NCT03479762|Liraglutide|liraglutide|mesh-list
102071386|NCT03479762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102071387|NCT03479762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071388|NCT03479762|Incretins|incretins|mesh-ancestor
102071389|NCT03479762|Hormones|hormones|mesh-ancestor
102071390|NCT03479762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102071402|NCT05079802|Chitosan|chitosan|mesh-list
102071455|NCT02560805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071456|NCT02560805|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102071457|NCT02560805|Mydriatics|mydriatics|mesh-ancestor
102071458|NCT02560805|Autonomic Agents|autonomic agents|mesh-ancestor
102071459|NCT02560805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102071460|NCT02560805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071461|NCT02560805|Sympathomimetics|sympathomimetics|mesh-ancestor
102071462|NCT02560805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102071523|NCT02283476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102071595|NCT00640484|Respiratory System Agents|respiratory system agents|mesh-ancestor
102071596|NCT00640484|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102071597|NCT00640484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102071598|NCT00640484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102071599|NCT00640484|Adrenergic Agents|adrenergic agents|mesh-ancestor
102071600|NCT00640484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102071601|NCT00640484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071602|NCT03065933|Clonidine|clonidine|mesh-list
102071603|NCT03065933|Analgesics|analgesics|mesh-ancestor
102071604|NCT03065933|Sensory System Agents|sensory system agents|mesh-ancestor
102071605|NCT03065933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102071606|NCT03065933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071607|NCT03065933|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102071608|NCT03065933|Sympatholytics|sympatholytics|mesh-ancestor
102071609|NCT03065933|Autonomic Agents|autonomic agents|mesh-ancestor
102071610|NCT03065933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102071611|NCT03065933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102071612|NCT03065933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102071613|NCT03065933|Adrenergic Agents|adrenergic agents|mesh-ancestor
102071650|NCT00625664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102071651|NCT00625664|Antimetabolites|antimetabolites|mesh-ancestor
102071652|NCT00625664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071722|NCT03272464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071723|NCT00694382|Semuloparin|semuloparin|mesh-list
102071724|NCT00694382|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102071725|NCT00694382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102071726|NCT00694382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102071727|NCT00694382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071728|NCT00694382|Anticoagulants|anticoagulants|mesh-ancestor
102071729|NCT05116228|Rituximab|rituximab|mesh-list
102071730|NCT05116228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102071731|NCT05116228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101315759|NCT00000639|Amebicides|amebicides|mesh-ancestor
102071732|NCT05116228|Immunologic Factors|immunologic factors|mesh-ancestor
102071733|NCT05116228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071734|NCT05116228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102071784|NCT04917029|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102071785|NCT04917029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102071786|NCT04917029|Analgesics|analgesics|mesh-ancestor
102071787|NCT04917029|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102071788|NCT04917029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102071789|NCT04917029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102071790|NCT04917029|Adrenergic Agents|adrenergic agents|mesh-ancestor
102071791|NCT04917029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102071792|NCT04917029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071793|NCT04189510|Pancrelipase|pancrelipase|mesh-list
102071794|NCT04189510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102071795|NCT03632759|Liraglutide|liraglutide|mesh-list
102071796|NCT03632759|Golimumab|golimumab|mesh-list
102071797|NCT03632759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102071798|NCT03632759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071799|NCT03632759|Incretins|incretins|mesh-ancestor
102071800|NCT03632759|Hormones|hormones|mesh-ancestor
102071801|NCT03632759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102071802|NCT03632759|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102071806|NCT02953093|Acarbose|acarbose|mesh-list
102071839|NCT04517110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102071840|NCT04517110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071841|NCT04517110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102071850|NCT02281058|Abatacept|abatacept|mesh-list
102071907|NCT03723772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071908|NCT02660827|Insulin|insulin|mesh-list
102071909|NCT02660827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102071910|NCT02660827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102071911|NCT00491738|Bevacizumab|bevacizumab|mesh-list
102071912|NCT00491738|Sunitinib|sunitinib|mesh-list
102071913|NCT00491738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102071914|NCT00491738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102071915|NCT00491738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102071916|NCT00491738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102071917|NCT00491738|Growth Substances|growth substances|mesh-ancestor
102071971|NCT00486512|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102071972|NCT00486512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102071973|NCT00486512|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102071974|NCT00486512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102071975|NCT00486512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102071976|NCT00486512|Antipyretics|antipyretics|mesh-ancestor
102071977|NCT00486512|Antacids|antacids|mesh-ancestor
102071978|NCT00486512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102071979|NCT00486512|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
102071980|NCT00486512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102071981|NCT00486512|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102071982|NCT00486512|Vitamins|vitamins|mesh-ancestor
102071983|NCT00486512|Micronutrients|micronutrients|mesh-ancestor
102071984|NCT04057989|Ketamine|ketamine|mesh-list
102071985|NCT04057989|Analgesics|analgesics|mesh-ancestor
102071986|NCT04057989|Sensory System Agents|sensory system agents|mesh-ancestor
102071987|NCT04057989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102071988|NCT04057989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072028|NCT00607256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102072029|NCT00607256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072030|NCT00607256|Adrenergic Agents|adrenergic agents|mesh-ancestor
101791782|NCT05046639|Lidocaine|lidocaine|mesh-list
102072031|NCT00607256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102072032|NCT00607256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072095|NCT04054713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072096|NCT04054713|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102072097|NCT04054713|Protective Agents|protective agents|mesh-ancestor
102072098|NCT04054713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102072099|NCT02568124|Tranexamic Acid|tranexamic acid|mesh-list
102072100|NCT02568124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102072101|NCT02568124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102072102|NCT02568124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072103|NCT02568124|Hemostatics|hemostatics|mesh-ancestor
101575044|NCT05215873|Abortifacient Agents|abortifacient agents|mesh-ancestor
102072104|NCT02568124|Coagulants|coagulants|mesh-ancestor
102072105|NCT03314181|Dexamethasone|dexamethasone|mesh-list
102072106|NCT03314181|Bortezomib|bortezomib|mesh-list
102072107|NCT03314181|Venetoclax|venetoclax|mesh-list
102072109|NCT03314181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102072110|NCT03314181|Antiemetics|antiemetics|mesh-ancestor
102072111|NCT03314181|Autonomic Agents|autonomic agents|mesh-ancestor
102072112|NCT03314181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102072113|NCT03314181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072114|NCT03314181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102072115|NCT03314181|Glucocorticoids|glucocorticoids|mesh-ancestor
102072116|NCT03314181|Hormones|hormones|mesh-ancestor
102072117|NCT03314181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102072118|NCT03314181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102072119|NCT03314181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102072120|NCT03133832|Praziquantel|praziquantel|mesh-list
102072144|NCT00673478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072145|NCT00673478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102072146|NCT00673478|Respiratory System Agents|respiratory system agents|mesh-ancestor
102072147|NCT00673478|Parasympatholytics|parasympatholytics|mesh-ancestor
102072148|NCT00673478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102072156|NCT02203474|Tiotropium Bromide|tiotropium bromide|mesh-list
102072215|NCT03662763|Guanfacine|guanfacine|mesh-list
102072216|NCT03662763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102072217|NCT03662763|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102072218|NCT03662763|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102072219|NCT03662763|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102072284|NCT00448058|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
102072285|NCT00448058|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102072286|NCT00448058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102072294|NCT02284412|Neostigmine|neostigmine|mesh-list
102072352|NCT00579020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102072353|NCT00579020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102072354|NCT00579020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102072355|NCT00579020|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102072356|NCT00579020|Contraceptive Agents|contraceptive agents|mesh-ancestor
102072357|NCT00579020|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102072361|NCT04530604|Defibrotide|defibrotide|mesh-list
102072421|NCT05116462|Antimitotic Agents|antimitotic agents|mesh-ancestor
102072422|NCT05116462|Mitosis Modulators|mitosis modulators|mesh-ancestor
102072491|NCT00430508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102072493|NCT04221880|Bupivacaine|bupivacaine|mesh-list
102072494|NCT04221880|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102072495|NCT04221880|Anesthetics, Local|anesthetics, local|mesh-ancestor
102072496|NCT04221880|Anesthetics|anesthetics|mesh-ancestor
102072563|NCT05204069|Cyclopentolate|cyclopentolate|mesh-list
102072564|NCT05204069|Mydriatics|mydriatics|mesh-ancestor
102072565|NCT05204069|Autonomic Agents|autonomic agents|mesh-ancestor
102072566|NCT05204069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101387728|NCT04717531|Immunologic Factors|immunologic factors|mesh-ancestor
102072567|NCT05204069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072568|NCT05204069|Parasympatholytics|parasympatholytics|mesh-ancestor
102072569|NCT05204069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102072570|NCT05204069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102072571|NCT05204069|Cholinergic Agents|cholinergic agents|mesh-ancestor
102072572|NCT05204069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102072573|NCT05204069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072574|NCT04548973|Esketamine|esketamine|mesh-list
102072575|NCT04548973|Antidepressive Agents|antidepressive agents|mesh-ancestor
102072576|NCT04548973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102072577|NCT02277938|Amantadine|amantadine|mesh-list
102072578|NCT02277938|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102072579|NCT02277938|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102072580|NCT02277938|Antiviral Agents|antiviral agents|mesh-ancestor
102072581|NCT02277938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102072582|NCT02277938|Dopamine Agents|dopamine agents|mesh-ancestor
102072583|NCT02277938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102072584|NCT02277938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072585|NCT02277938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072586|NCT02277938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102072612|NCT03016013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072613|NCT03016013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102072614|NCT03016013|Dermatologic Agents|dermatologic agents|mesh-ancestor
102072615|NCT03016013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102072616|NCT03016013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102072617|NCT03016013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102072618|NCT03016013|Immunologic Factors|immunologic factors|mesh-ancestor
102072619|NCT03016013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102072620|NCT03016013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102072621|NCT01318915|Mycophenolic Acid|mycophenolic acid|mesh-list
102072622|NCT01318915|Sirolimus|sirolimus|mesh-list
102072623|NCT01318915|Rituximab|rituximab|mesh-list
102072624|NCT01318915|Tacrolimus|tacrolimus|mesh-list
102072625|NCT01318915|Thymoglobulin|thymoglobulin|mesh-list
102072626|NCT01318915|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102072627|NCT01318915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102072671|NCT05203913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072672|NCT05203913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102072673|NCT05203913|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102072674|NCT00402428|Interferons|interferons|mesh-list
102072675|NCT00402428|Ribavirin|ribavirin|mesh-list
102072676|NCT00402428|Interferon-alpha|interferon-alpha|mesh-list
102072677|NCT00402428|Interferon alpha-2|interferon alpha-2|mesh-list
102072678|NCT00402428|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102072679|NCT00402428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102072737|NCT04471922|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102072738|NCT04471922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102072739|NCT04471922|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102072740|NCT04471922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102072741|NCT04471922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072742|NCT04368364|Morphine|morphine|mesh-list
102072743|NCT04368364|Bupivacaine|bupivacaine|mesh-list
102072744|NCT04368364|Ropivacaine|ropivacaine|mesh-list
102072745|NCT04368364|Anesthetics, Local|anesthetics, local|mesh-ancestor
102072746|NCT04368364|Anesthetics|anesthetics|mesh-ancestor
102072747|NCT04368364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102072748|NCT04368364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072749|NCT04368364|Sensory System Agents|sensory system agents|mesh-ancestor
102072750|NCT04368364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102072751|NCT04368364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102072752|NCT04368364|Narcotics|narcotics|mesh-ancestor
102072753|NCT04368364|Analgesics|analgesics|mesh-ancestor
102072754|NCT02285036|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102072755|NCT02285036|Immunologic Factors|immunologic factors|mesh-ancestor
102072792|NCT04189588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102072793|NCT04189588|Antiemetics|antiemetics|mesh-ancestor
102072794|NCT04189588|Autonomic Agents|autonomic agents|mesh-ancestor
102072795|NCT04189588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102072796|NCT04189588|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102072797|NCT04189588|Histamine Antagonists|histamine antagonists|mesh-ancestor
102072798|NCT04189588|Histamine Agents|histamine agents|mesh-ancestor
102072799|NCT04189588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102072800|NCT04189588|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102072801|NCT04189588|Antipruritics|antipruritics|mesh-ancestor
102072802|NCT04189588|Dermatologic Agents|dermatologic agents|mesh-ancestor
102072803|NCT04189588|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102072804|NCT00151892|Mesalamine|mesalamine|mesh-list
102072805|NCT00151892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102072855|NCT05008783|Antimetabolites|antimetabolites|mesh-ancestor
102072856|NCT05008783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072857|NCT05008783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102072859|NCT04450498|Immunologic Factors|immunologic factors|mesh-ancestor
102072860|NCT04450498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072861|NCT00654992|Epoetin Alfa|epoetin alfa|mesh-list
102072862|NCT00654992|Hematinics|hematinics|mesh-ancestor
102072863|NCT02921919|Talazoparib|talazoparib|mesh-list
102072864|NCT02921919|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102072865|NCT02921919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102072866|NCT02921919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102072867|NCT02921919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102072868|NCT00393068|Paclitaxel|paclitaxel|mesh-list
102072869|NCT00393068|Bevacizumab|bevacizumab|mesh-list
102072870|NCT00393068|Carboplatin|carboplatin|mesh-list
102072871|NCT00393068|Fluorouracil|fluorouracil|mesh-list
102072885|NCT00393068|Antimetabolites|antimetabolites|mesh-ancestor
102072912|NCT02090244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102072915|NCT02282774|Lidocaine|lidocaine|mesh-list
102072984|NCT02285738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102072985|NCT02285738|Antimetabolites|antimetabolites|mesh-ancestor
102072986|NCT02285738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102072987|NCT02285738|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102072988|NCT00650702|Latanoprost|latanoprost|mesh-list
102072989|NCT00650702|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
102072990|NCT00650702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102072991|NCT02090400|Bazedoxifene|bazedoxifene|mesh-list
102072992|NCT02090400|Calcium|calcium|mesh-list
102072993|NCT02090400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102072994|NCT02090400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102072995|NCT02090400|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102072996|NCT02090400|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102072997|NCT02090400|Hormone Antagonists|hormone antagonists|mesh-ancestor
102072998|NCT02090400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102072999|NCT02090400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102073000|NCT03134846|Cetuximab|cetuximab|mesh-list
101792766|NCT01813227|Rituximab|rituximab|mesh-list
102073001|NCT03134846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102073036|NCT02285972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102073038|NCT02285972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073039|NCT02096094|Chlorhexidine|chlorhexidine|mesh-list
102073040|NCT02096094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102073041|NCT02096094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102073105|NCT02094924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073107|NCT02286206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102073176|NCT02286752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102073177|NCT02286752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073178|NCT02286752|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102073179|NCT02286752|Autonomic Agents|autonomic agents|mesh-ancestor
102073180|NCT02286752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102073181|NCT04470050|Dexmedetomidine|dexmedetomidine|mesh-list
102073182|NCT04470050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102073244|NCT04087408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102073245|NCT04087408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073246|NCT04087408|Progestins|progestins|mesh-ancestor
102073247|NCT02099292|Rituximab|rituximab|mesh-list
102073248|NCT02099292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102073249|NCT02099292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102073250|NCT02099292|Immunologic Factors|immunologic factors|mesh-ancestor
102073251|NCT02099292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073252|NCT02099292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102073253|NCT02283242|Galantamine|galantamine|mesh-list
102073254|NCT02283242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
102073255|NCT02283242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102073256|NCT02283242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073257|NCT02283242|Cholinergic Agents|cholinergic agents|mesh-ancestor
102073258|NCT02283242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102073305|NCT02099604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102073307|NCT02099604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102073308|NCT02099604|Antimetabolites|antimetabolites|mesh-ancestor
102073310|NCT02099604|Immunologic Factors|immunologic factors|mesh-ancestor
102073378|NCT03530462|Antibodies|antibodies|mesh-list
102073379|NCT03530462|gamma-Globulins|gamma-globulins|mesh-list
102073380|NCT03530462|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102073381|NCT03530462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102073382|NCT03530462|Immunologic Factors|immunologic factors|mesh-ancestor
102073448|NCT00961792|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102073449|NCT00961792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102073450|NCT00961792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073451|NCT00961792|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102073452|NCT00961792|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102073453|NCT00961792|Purinergic Agents|purinergic agents|mesh-ancestor
102073454|NCT00961792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102073455|NCT00961792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102073456|NCT00961792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102073457|NCT00961792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102073458|NCT00961792|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101315872|NCT00000678|Antimetabolites|antimetabolites|mesh-ancestor
102073459|NCT00961792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102073460|NCT00961792|Anesthetics, Local|anesthetics, local|mesh-ancestor
102073461|NCT00961792|Anesthetics|anesthetics|mesh-ancestor
102073462|NCT00961792|Sensory System Agents|sensory system agents|mesh-ancestor
102073463|NCT00961792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102073464|NCT00961792|Antiemetics|antiemetics|mesh-ancestor
102073465|NCT00961792|Autonomic Agents|autonomic agents|mesh-ancestor
102073466|NCT00961792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102073467|NCT00961792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102073468|NCT00961792|Histamine Antagonists|histamine antagonists|mesh-ancestor
102073469|NCT00961792|Histamine Agents|histamine agents|mesh-ancestor
102073470|NCT00961792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102073471|NCT00961792|Antipruritics|antipruritics|mesh-ancestor
102073472|NCT00961792|Dermatologic Agents|dermatologic agents|mesh-ancestor
102073473|NCT04435912|Hydrocortisone|hydrocortisone|mesh-list
102073474|NCT04435912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102073495|NCT00057980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073496|NCT00057980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102073497|NCT00057980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102073498|NCT00057980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102073499|NCT00057980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102073500|NCT02985879|Tilavonemab|tilavonemab|mesh-list
102073501|NCT02985879|Nootropic Agents|nootropic agents|mesh-ancestor
102073502|NCT02097966|Ribavirin|ribavirin|mesh-list
102073503|NCT02097966|Sofosbuvir|sofosbuvir|mesh-list
102073563|NCT00052520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073564|NCT00052520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102073565|NCT00052520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102073566|NCT00052520|Antiviral Agents|antiviral agents|mesh-ancestor
102073568|NCT05036434|Pembrolizumab|pembrolizumab|mesh-list
102073633|NCT02788773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102073634|NCT02788773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102073635|NCT00358982|Mocetinostat|mocetinostat|mesh-list
102073636|NCT00358982|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102073637|NCT00358982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102073638|NCT00358982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073639|NCT02101164|Denosumab|denosumab|mesh-list
102073640|NCT02101164|Pamidronate|pamidronate|mesh-list
102073641|NCT02101164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102073642|NCT02101164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073643|NCT00036608|Entecavir|entecavir|mesh-list
102073644|NCT00036608|Antiviral Agents|antiviral agents|mesh-ancestor
102073645|NCT00036608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102073646|NCT02103738|Ranibizumab|ranibizumab|mesh-list
102073647|NCT02103738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102073648|NCT02103738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102073649|NCT02103738|Growth Substances|growth substances|mesh-ancestor
102073650|NCT02103738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073651|NCT02103738|Growth Inhibitors|growth inhibitors|mesh-ancestor
102073652|NCT02103738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102073653|NCT02985021|Carboplatin|carboplatin|mesh-list
102073654|NCT02985021|Docetaxel|docetaxel|mesh-list
102073655|NCT02985021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102073656|NCT02985021|Tubulin Modulators|tubulin modulators|mesh-ancestor
102073657|NCT02985021|Antimitotic Agents|antimitotic agents|mesh-ancestor
102073658|NCT02985021|Mitosis Modulators|mitosis modulators|mesh-ancestor
102073660|NCT05714540|Magnesium Sulfate|magnesium sulfate|mesh-list
102073679|NCT05714540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102073680|NCT05714540|Tocolytic Agents|tocolytic agents|mesh-ancestor
102073681|NCT05714540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102073683|NCT04385667|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102073684|NCT04385667|Contraceptive Agents|contraceptive agents|mesh-ancestor
102073685|NCT04385667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102073686|NCT04385667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073687|NCT04385667|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101375356|NCT00097344|Toremifene|toremifene|mesh-list
101383813|NCT00078962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101383814|NCT00078962|Antimetabolites|antimetabolites|mesh-ancestor
101383815|NCT00078962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383816|NCT00078962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101383817|NCT00275041|Irinotecan|irinotecan|mesh-list
101383818|NCT00275041|Cetuximab|cetuximab|mesh-list
101383819|NCT00275041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101383820|NCT00275041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101383821|NCT00275041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101383822|NCT00275041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383823|NCT00275041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101383824|NCT00275041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101383825|NCT00274963|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101383826|NCT00274963|Mitoxantrone|mitoxantrone|mesh-list
101383827|NCT00274963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101383828|NCT00274963|Alkylating Agents|alkylating agents|mesh-ancestor
101383829|NCT00274963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383830|NCT00274963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101383831|NCT00274963|Analgesics|analgesics|mesh-ancestor
101383832|NCT00274963|Sensory System Agents|sensory system agents|mesh-ancestor
101383833|NCT00274963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101383834|NCT00274963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383835|NCT00274963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101383836|NCT00274963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101383837|NCT00274963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101383838|NCT00102765|Fluticasone|fluticasone|mesh-list
101383840|NCT00102765|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101383841|NCT00102765|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101383842|NCT00102765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101383843|NCT00102765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101383844|NCT00102765|Autonomic Agents|autonomic agents|mesh-ancestor
101383845|NCT00102765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101383847|NCT00102765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101383848|NCT00102765|Respiratory System Agents|respiratory system agents|mesh-ancestor
101383850|NCT00102765|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101383851|NCT00102765|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101383852|NCT00102765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101383853|NCT00102765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101383854|NCT00102765|Adrenergic Agents|adrenergic agents|mesh-ancestor
101383855|NCT00102765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101383856|NCT00102765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383857|NCT00102765|Glucocorticoids|glucocorticoids|mesh-ancestor
101383858|NCT00102765|Hormones|hormones|mesh-ancestor
101383859|NCT00102765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101305163|NCT02018055|Analgesics|analgesics|mesh-ancestor
101383873|NCT00130312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383874|NCT00130234|Omalizumab|omalizumab|mesh-list
101383875|NCT00130234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101383876|NCT00130234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101383877|NCT00130234|Respiratory System Agents|respiratory system agents|mesh-ancestor
101383878|NCT00119301|Leucovorin|leucovorin|mesh-list
101383879|NCT00119301|Trimetrexate|trimetrexate|mesh-list
101383880|NCT00119301|Methotrexate|methotrexate|mesh-list
101383881|NCT00119301|Calcium|calcium|mesh-list
101383882|NCT00119301|Levoleucovorin|levoleucovorin|mesh-list
102073688|NCT04385667|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102073689|NCT04385667|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102073690|NCT04441424|Azithromycin|azithromycin|mesh-list
102073691|NCT04441424|Hydroxychloroquine|hydroxychloroquine|mesh-list
102073692|NCT04441424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102073693|NCT04441424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102073694|NCT04441424|Antimalarials|antimalarials|mesh-ancestor
101383883|NCT00119301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101383884|NCT00119301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383885|NCT00119301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101383886|NCT00119301|Abortifacient Agents|abortifacient agents|mesh-ancestor
101383887|NCT00119301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101383888|NCT00119301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101383889|NCT00119301|Antimetabolites|antimetabolites|mesh-ancestor
101383890|NCT00119301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383891|NCT00119301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101383892|NCT00119301|Dermatologic Agents|dermatologic agents|mesh-ancestor
101383893|NCT00119301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101383894|NCT00119301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101383895|NCT00119301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101383896|NCT00119301|Immunologic Factors|immunologic factors|mesh-ancestor
101383897|NCT00119301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101383898|NCT00119301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101383899|NCT00119301|Antidotes|antidotes|mesh-ancestor
101383900|NCT00119301|Protective Agents|protective agents|mesh-ancestor
101383901|NCT00119301|Vitamin B Complex|vitamin b complex|mesh-ancestor
101383902|NCT00119301|Vitamins|vitamins|mesh-ancestor
101383903|NCT00119301|Micronutrients|micronutrients|mesh-ancestor
101383904|NCT00119301|Antifungal Agents|antifungal agents|mesh-ancestor
101383905|NCT00119301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101383906|NCT00079118|Docetaxel|docetaxel|mesh-list
101383907|NCT00079118|Irinotecan|irinotecan|mesh-list
101383908|NCT00079118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101383909|NCT00079118|Tubulin Modulators|tubulin modulators|mesh-ancestor
101383910|NCT00079118|Antimitotic Agents|antimitotic agents|mesh-ancestor
101383911|NCT00079118|Mitosis Modulators|mitosis modulators|mesh-ancestor
101383912|NCT00079118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383913|NCT00079118|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101383914|NCT00079118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101383915|NCT00079118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101383916|NCT00130195|Cytarabine|cytarabine|mesh-list
101383917|NCT00130195|Dexamethasone|dexamethasone|mesh-list
101383935|NCT00130195|Autonomic Agents|autonomic agents|mesh-ancestor
101383936|NCT00130195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101383937|NCT00130195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101383938|NCT00130195|Glucocorticoids|glucocorticoids|mesh-ancestor
101383939|NCT00130195|Hormones|hormones|mesh-ancestor
101383940|NCT00130195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101383941|NCT00130195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101383942|NCT00130195|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101383943|NCT00130195|Abortifacient Agents|abortifacient agents|mesh-ancestor
101383944|NCT00130195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101383945|NCT00130195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101383946|NCT00130195|Antimetabolites|antimetabolites|mesh-ancestor
101383947|NCT00130195|Dermatologic Agents|dermatologic agents|mesh-ancestor
101383948|NCT00130195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101383949|NCT00130195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101383950|NCT00130195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101383951|NCT00130195|Antiviral Agents|antiviral agents|mesh-ancestor
101383952|NCT00130195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101383953|NCT00130195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101383954|NCT00130195|Tubulin Modulators|tubulin modulators|mesh-ancestor
101383955|NCT00130195|Antimitotic Agents|antimitotic agents|mesh-ancestor
101383956|NCT00130195|Mitosis Modulators|mitosis modulators|mesh-ancestor
101383957|NCT00130195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101383958|NCT00130195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101383959|NCT00130195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101383960|NCT00130195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101383961|NCT00394303|Insulin|insulin|mesh-list
102073695|NCT04441424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102073696|NCT04441424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102073697|NCT04441424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102073698|NCT04441424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383962|NCT00394303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101383963|NCT00394303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383964|NCT00119340|Cyclosporine|cyclosporine|mesh-list
101383965|NCT00119340|Mycophenolic Acid|mycophenolic acid|mesh-list
101383966|NCT00119340|Fludarabine|fludarabine|mesh-list
101383967|NCT00119340|Fludarabine phosphate|fludarabine phosphate|mesh-list
101383968|NCT00119340|Cyclosporins|cyclosporins|mesh-list
101383969|NCT00119340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101383970|NCT00119340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101383971|NCT00119340|Antimetabolites|antimetabolites|mesh-ancestor
101383972|NCT00119340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383973|NCT00119340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101383974|NCT00119340|Immunologic Factors|immunologic factors|mesh-ancestor
101383988|NCT00130156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101383989|NCT00130156|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101383990|NCT00130156|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101383991|NCT00130156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101383992|NCT00130156|Adrenergic Agents|adrenergic agents|mesh-ancestor
101383993|NCT00130156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101384005|NCT00079157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384006|NCT00079157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101384007|NCT00130000|Eculizumab|eculizumab|mesh-list
101384008|NCT00130000|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101384009|NCT00130000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101384010|NCT00130000|Immunologic Factors|immunologic factors|mesh-ancestor
101384011|NCT00130000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305170|NCT02018055|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101305171|NCT02018055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305172|NCT02018055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101384012|NCT00079235|Sirolimus|sirolimus|mesh-list
101384013|NCT00079235|Temsirolimus|temsirolimus|mesh-list
101384014|NCT00079235|MTOR Inhibitors|mtor inhibitors|mesh-list
101384015|NCT00079235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101384016|NCT00079235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384017|NCT00079235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384018|NCT00079235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101384019|NCT00079235|Immunologic Factors|immunologic factors|mesh-ancestor
101384020|NCT00079235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384021|NCT00079235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384022|NCT00079235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101384023|NCT00079235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101384024|NCT00079235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101384025|NCT00079235|Antifungal Agents|antifungal agents|mesh-ancestor
101384026|NCT00129844|Motexafin gadolinium|motexafin gadolinium|mesh-list
101384027|NCT00129844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384028|NCT00129844|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101384029|NCT00129844|Dermatologic Agents|dermatologic agents|mesh-ancestor
101384031|NCT00129805|Sarpogrelate|sarpogrelate|mesh-list
101384032|NCT00129805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101384033|NCT00129805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101384034|NCT00129805|Analgesics|analgesics|mesh-ancestor
101384035|NCT00129805|Sensory System Agents|sensory system agents|mesh-ancestor
101384036|NCT00129805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101384037|NCT00129805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384038|NCT00129805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101384039|NCT00129805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101384040|NCT00129805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101384041|NCT00129805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101384042|NCT00129805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384043|NCT00129805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101384044|NCT00129805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101384055|NCT00129727|Tubulin Modulators|tubulin modulators|mesh-ancestor
101384056|NCT00129727|Antimitotic Agents|antimitotic agents|mesh-ancestor
101384057|NCT00129727|Mitosis Modulators|mitosis modulators|mesh-ancestor
101384058|NCT00129727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073700|NCT03530228|Esomeprazole|esomeprazole|mesh-list
102073701|NCT03530228|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102073702|NCT03530228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102073703|NCT03530228|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102073704|NCT03530228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102073705|NCT03530228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073706|NCT01066923|Aspirin|aspirin|mesh-list
102073707|NCT01066923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102073708|NCT01066923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102073709|NCT01066923|Analgesics|analgesics|mesh-ancestor
102073710|NCT01066923|Sensory System Agents|sensory system agents|mesh-ancestor
102073711|NCT01066923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102073712|NCT01066923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073713|NCT01066923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102073714|NCT01066923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101375371|NCT00097344|Hormone Antagonists|hormone antagonists|mesh-ancestor
101384072|NCT00079352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101384073|NCT00079352|Antimetabolites|antimetabolites|mesh-ancestor
101384074|NCT00079352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384075|NCT00079352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384076|NCT00079352|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101384077|NCT00079352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101384078|NCT00079352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384079|NCT00079352|Growth Inhibitors|growth inhibitors|mesh-ancestor
101384080|NCT00079352|Growth Substances|growth substances|mesh-ancestor
101384081|NCT00079352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384082|NCT00079352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101384083|NCT00119496|Rosiglitazone|rosiglitazone|mesh-list
101384084|NCT00119496|Beclomethasone|beclomethasone|mesh-list
101384085|NCT00119496|Theophylline|theophylline|mesh-list
101384086|NCT00119496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384087|NCT00119496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384088|NCT00119496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101384089|NCT00119496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384090|NCT00119496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101384091|NCT00119496|Glucocorticoids|glucocorticoids|mesh-ancestor
101384092|NCT00119496|Hormones|hormones|mesh-ancestor
101305173|NCT02018055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101305174|NCT02018055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101305175|NCT02018055|Antipyretics|antipyretics|mesh-ancestor
101305176|NCT02018055|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101384093|NCT00119496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101384094|NCT00119496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101384095|NCT00119496|Respiratory System Agents|respiratory system agents|mesh-ancestor
101384096|NCT00119496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101384097|NCT00119496|Autonomic Agents|autonomic agents|mesh-ancestor
101384098|NCT00119496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101384099|NCT00119496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101384100|NCT00119496|Vasodilator Agents|vasodilator agents|mesh-ancestor
101384101|NCT00119496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101384102|NCT00119496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101384103|NCT00119496|Purinergic Agents|purinergic agents|mesh-ancestor
101384104|NCT00119496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101384105|NCT00298285|Enoxaparin|enoxaparin|mesh-list
101384106|NCT00298285|Anticoagulants|anticoagulants|mesh-ancestor
101384107|NCT00298285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102073715|NCT01066923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102073716|NCT01066923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102073717|NCT01066923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073718|NCT01066923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102073719|NCT01066923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102073720|NCT01066923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102073721|NCT01066923|Antipyretics|antipyretics|mesh-ancestor
102073722|NCT03530150|Pirfenidone|pirfenidone|mesh-list
102073723|NCT03530150|Analgesics|analgesics|mesh-ancestor
102073724|NCT03530150|Sensory System Agents|sensory system agents|mesh-ancestor
102073725|NCT03530150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102073726|NCT03530150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073727|NCT03530150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102073728|NCT03530150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102073729|NCT03530150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102073730|NCT03530150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102073731|NCT03530150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102073732|NCT02098590|Chloroquine|chloroquine|mesh-list
102073733|NCT02098590|Atovaquone|atovaquone|mesh-list
102073734|NCT02098590|Proguanil|proguanil|mesh-list
102073735|NCT02098590|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
102073736|NCT02098590|Amebicides|amebicides|mesh-ancestor
102073737|NCT02098590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102073738|NCT02098590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102073739|NCT02098590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102073740|NCT02098590|Antimalarials|antimalarials|mesh-ancestor
102073741|NCT02098590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102073742|NCT02098590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102073743|NCT02098590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073744|NCT02098590|Antimetabolites|antimetabolites|mesh-ancestor
102073745|NCT03657381|Antibodies|antibodies|mesh-list
102073749|NCT00005918|Lamivudine|lamivudine|mesh-list
102073759|NCT00005918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102073760|NCT00005918|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102073761|NCT00005918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102073762|NCT00005918|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102073763|NCT00005918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101384108|NCT00298285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101384109|NCT00298285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384110|NCT00298324|Cyclosporine|cyclosporine|mesh-list
101384111|NCT00298324|Mycophenolic Acid|mycophenolic acid|mesh-list
101384112|NCT00298324|Prednisone|prednisone|mesh-list
101384113|NCT00298324|Cyclosporins|cyclosporins|mesh-list
101384114|NCT00298324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101384115|NCT00298324|Glucocorticoids|glucocorticoids|mesh-ancestor
101384116|NCT00298324|Hormones|hormones|mesh-ancestor
101384117|NCT00298324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101384118|NCT00298324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384119|NCT00298324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101384139|NCT00079430|Immunoglobulins|immunoglobulins|mesh-list
101384140|NCT00079430|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101384141|NCT00079430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101384142|NCT00079430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384143|NCT00079430|Tubulin Modulators|tubulin modulators|mesh-ancestor
101384144|NCT00079430|Antimitotic Agents|antimitotic agents|mesh-ancestor
101384145|NCT00079430|Mitosis Modulators|mitosis modulators|mesh-ancestor
101384146|NCT00079430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384147|NCT00079430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101384148|NCT00079430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101384149|NCT00079430|Growth Substances|growth substances|mesh-ancestor
101384150|NCT00079430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384151|NCT00079430|Growth Inhibitors|growth inhibitors|mesh-ancestor
101384152|NCT00079430|Immunologic Factors|immunologic factors|mesh-ancestor
101384153|NCT00298597|Epoetin Alfa|epoetin alfa|mesh-list
101384154|NCT00298597|Hematinics|hematinics|mesh-ancestor
101384155|NCT00298636|Adenosine|adenosine|mesh-list
101384156|NCT00298636|Analgesics|analgesics|mesh-ancestor
101384157|NCT00298636|Sensory System Agents|sensory system agents|mesh-ancestor
101384158|NCT00298636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101384159|NCT00298636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384160|NCT00298636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101384161|NCT00298636|Vasodilator Agents|vasodilator agents|mesh-ancestor
101384162|NCT00298636|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101384163|NCT00298636|Purinergic Agonists|purinergic agonists|mesh-ancestor
101384164|NCT00298636|Purinergic Agents|purinergic agents|mesh-ancestor
101384165|NCT00298636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101384166|NCT00298636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384167|NCT00086112|Risperidone|risperidone|mesh-list
101384168|NCT00086112|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101384169|NCT00086112|Serotonin Agents|serotonin agents|mesh-ancestor
101384170|NCT00086112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101305177|NCT02018055|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101305178|NCT02018055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101305179|NCT02018055|Purinergic Agents|purinergic agents|mesh-ancestor
101384171|NCT00086112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384172|NCT00086112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384173|NCT00086112|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101384174|NCT00086112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101384175|NCT00086112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101384176|NCT00086112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101384177|NCT00086112|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101384178|NCT00086112|Dopamine Agents|dopamine agents|mesh-ancestor
101384180|NCT00079469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101384181|NCT00079469|Antidepressive Agents|antidepressive agents|mesh-ancestor
101384182|NCT00079469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101384183|NCT00079469|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101384184|NCT00079469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101384185|NCT00079469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102073764|NCT00005918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102073765|NCT00005918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102073766|NCT00005918|Antimetabolites|antimetabolites|mesh-ancestor
102073767|NCT02656797|Amphotericin B|amphotericin b|mesh-list
102073768|NCT02656797|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102073769|NCT02656797|Amebicides|amebicides|mesh-ancestor
102073770|NCT02656797|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102073771|NCT02656797|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102073772|NCT02656797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101384186|NCT00079469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384215|NCT00298870|Antitubercular Agents|antitubercular agents|mesh-ancestor
101384216|NCT00298870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101384217|NCT00298870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101384218|NCT00298870|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101384219|NCT00298870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101384220|NCT00298870|Antimetabolites|antimetabolites|mesh-ancestor
101384221|NCT00298870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384222|NCT00298870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101384224|NCT00298909|Niacinamide|niacinamide|mesh-list
101384225|NCT00298909|Nicotinic Acids|nicotinic acids|mesh-list
101384226|NCT00298909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101384227|NCT00298909|Antimetabolites|antimetabolites|mesh-ancestor
101384232|NCT00298909|Vitamins|vitamins|mesh-ancestor
101384235|NCT00299026|Paclitaxel|paclitaxel|mesh-list
101384236|NCT00299026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101384237|NCT00299026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384238|NCT00299026|Tubulin Modulators|tubulin modulators|mesh-ancestor
101384239|NCT00299026|Antimitotic Agents|antimitotic agents|mesh-ancestor
101384240|NCT00299026|Mitosis Modulators|mitosis modulators|mesh-ancestor
101384241|NCT00299026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384242|NCT00299065|Zileuton|zileuton|mesh-list
101384243|NCT00299065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101384244|NCT00299065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101384245|NCT00299065|Analgesics|analgesics|mesh-ancestor
101384246|NCT00299065|Sensory System Agents|sensory system agents|mesh-ancestor
101384247|NCT00299065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101384248|NCT00299065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384249|NCT00299065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101384250|NCT00299065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101384251|NCT00299065|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101384252|NCT00299065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384253|NCT00299065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384254|NCT00299065|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101384255|NCT00299065|Hormone Antagonists|hormone antagonists|mesh-ancestor
101384256|NCT00299065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101384257|NCT00079586|Heparin|heparin|mesh-list
101384258|NCT00079586|Bivalirudin|bivalirudin|mesh-list
101384259|NCT00079586|Anticoagulants|anticoagulants|mesh-ancestor
101384260|NCT00079586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101384261|NCT00079586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101384262|NCT00079586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384263|NCT00079586|Antithrombins|antithrombins|mesh-ancestor
101384264|NCT00079586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101316094|NCT04038346|Acetaminophen|acetaminophen|mesh-list
101384265|NCT00079586|Protease Inhibitors|protease inhibitors|mesh-ancestor
101384266|NCT00079586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384267|NCT00418132|Thalidomide|thalidomide|mesh-list
101384268|NCT00418132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101305180|NCT02018055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101305182|NCT02018081|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101384269|NCT00418132|Immunologic Factors|immunologic factors|mesh-ancestor
101384270|NCT00418132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384271|NCT00418132|Leprostatic Agents|leprostatic agents|mesh-ancestor
101384272|NCT00418132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101384273|NCT00418132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101384274|NCT00418132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101384275|NCT00418132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102073773|NCT02656797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102073774|NCT02656797|Antifungal Agents|antifungal agents|mesh-ancestor
102073775|NCT04443244|Botulinum Toxins|botulinum toxins|mesh-list
102073776|NCT04443244|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102073777|NCT04443244|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102073778|NCT04443244|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102073779|NCT04443244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102073780|NCT04443244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384276|NCT00418132|Growth Substances|growth substances|mesh-ancestor
101384277|NCT00418132|Growth Inhibitors|growth inhibitors|mesh-ancestor
101384278|NCT00418132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384279|NCT00119613|Darbepoetin alfa|darbepoetin alfa|mesh-list
101384280|NCT00119613|Hematinics|hematinics|mesh-ancestor
101384281|NCT00299377|Abciximab|abciximab|mesh-list
101384282|NCT00299377|Anticoagulants|anticoagulants|mesh-ancestor
101384283|NCT00299377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101384284|NCT00299455|Amoxicillin|amoxicillin|mesh-list
101384285|NCT00299455|Clavulanic Acid|clavulanic acid|mesh-list
101384286|NCT00299455|Clavulanic Acids|clavulanic acids|mesh-list
101384287|NCT00299455|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101384288|NCT00299455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101384289|NCT00299455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101384290|NCT00299455|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101384291|NCT00299455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384292|NCT00299455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384293|NCT00299572|Alendronate|alendronate|mesh-list
101384294|NCT00299572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101384295|NCT00299572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384296|NCT00299611|Levetiracetam|levetiracetam|mesh-list
101384297|NCT00299611|Sertraline|sertraline|mesh-list
101384298|NCT00299611|Antidepressive Agents|antidepressive agents|mesh-ancestor
101384305|NCT00299611|Serotonin Agents|serotonin agents|mesh-ancestor
101384322|NCT04727853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101384323|NCT04727853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101384324|NCT04727853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384325|NCT04727853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384326|NCT04727853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384327|NCT00299845|Lansoprazole|lansoprazole|mesh-list
101384328|NCT00299845|Dexlansoprazole|dexlansoprazole|mesh-list
101384329|NCT00299845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101384330|NCT00299845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101384331|NCT00299845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101384332|NCT00299845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384333|NCT00299845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384334|NCT00299884|Atorvastatin|atorvastatin|mesh-list
101384335|NCT00299884|Ezetimibe|ezetimibe|mesh-list
101384336|NCT00299884|Fenofibrate|fenofibrate|mesh-list
101384337|NCT00299884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101384338|NCT00299884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101384339|NCT00299884|Antimetabolites|antimetabolites|mesh-ancestor
101384340|NCT00299884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384341|NCT00299884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101384342|NCT00299884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101384343|NCT00299884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384344|NCT00119652|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101384345|NCT00119652|Paroxetine|paroxetine|mesh-list
101384346|NCT00119652|Antidepressive Agents|antidepressive agents|mesh-ancestor
101384347|NCT00119652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101384348|NCT00119652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101384349|NCT00119652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101384350|NCT00119652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101384351|NCT00119652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384352|NCT00119652|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101384353|NCT00119652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101305183|NCT02018081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101305184|NCT02018081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101305185|NCT02018081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102073781|NCT04443244|Cholinergic Agents|cholinergic agents|mesh-ancestor
102073782|NCT04443244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102073783|NCT04443244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073784|NCT04443244|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102073785|NCT04443244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102073786|NCT02101476|Acetaminophen|acetaminophen|mesh-list
102073787|NCT02101476|Oxycodone|oxycodone|mesh-list
101375456|NCT00064181|Antidotes|antidotes|mesh-ancestor
101384354|NCT00119652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101384355|NCT00119652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384356|NCT00119652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101384357|NCT00119652|Serotonin Agents|serotonin agents|mesh-ancestor
101384358|NCT00119652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101384359|NCT00119652|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101384360|NCT00119652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101384361|NCT00119652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384362|NCT00299923|Ribavirin|ribavirin|mesh-list
101384363|NCT00299923|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101384377|NCT00299923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101384379|NCT00299962|Interferon-beta|interferon-beta|mesh-list
101384380|NCT00299962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384381|NCT00299962|Antiviral Agents|antiviral agents|mesh-ancestor
101384382|NCT00299962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101384383|NCT00299962|Immunologic Factors|immunologic factors|mesh-ancestor
101384384|NCT00299962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384385|NCT00418171|Olanzapine|olanzapine|mesh-list
101384386|NCT00418171|Ziprasidone|ziprasidone|mesh-list
101384387|NCT00418171|Antiemetics|antiemetics|mesh-ancestor
101384388|NCT00418171|Autonomic Agents|autonomic agents|mesh-ancestor
101384389|NCT00418171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101384390|NCT00418171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384391|NCT00418171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101384397|NCT00418171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101384398|NCT00418171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101384399|NCT00418171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384400|NCT00418171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101384402|NCT00418171|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101384403|NCT00418171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101384404|NCT00418171|Dopamine Agents|dopamine agents|mesh-ancestor
101384405|NCT00119691|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101384406|NCT00119691|Natriuretic Agents|natriuretic agents|mesh-ancestor
101384407|NCT00119691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384408|NCT00300040|Chrysarobin|chrysarobin|mesh-list
101384409|NCT00300040|HBOC 201|hboc 201|mesh-list
101384410|NCT00300040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101384411|NCT00300040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101384412|NCT00300040|Analgesics|analgesics|mesh-ancestor
101384413|NCT00300040|Sensory System Agents|sensory system agents|mesh-ancestor
101384414|NCT00300040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101384415|NCT00300040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384416|NCT00300040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101384417|NCT00300040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101384418|NCT00300040|Blood Substitutes|blood substitutes|mesh-ancestor
101384419|NCT00079820|Vaccines|vaccines|mesh-list
101384420|NCT00079820|Immunologic Factors|immunologic factors|mesh-ancestor
101384421|NCT00079820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384422|NCT00300079|Brinzolamide|brinzolamide|mesh-list
101384423|NCT00300079|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101384424|NCT00300079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384425|NCT00300079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384432|NCT00300118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384433|NCT00300118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101384434|NCT00300118|Respiratory System Agents|respiratory system agents|mesh-ancestor
101384436|NCT00300118|Hormones|hormones|mesh-ancestor
101384437|NCT00300118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101384438|NCT00300118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101384439|NCT00300118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102073788|NCT02101476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102073789|NCT02101476|Analgesics|analgesics|mesh-ancestor
102073790|NCT02101476|Sensory System Agents|sensory system agents|mesh-ancestor
102073791|NCT02101476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101384440|NCT00300118|Analgesics|analgesics|mesh-ancestor
101384441|NCT00300118|Sensory System Agents|sensory system agents|mesh-ancestor
101305186|NCT02018081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101305187|NCT02018081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101305188|NCT02018081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305189|NCT02018081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384442|NCT00300118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101384443|NCT00119730|Rituximab|rituximab|mesh-list
101384444|NCT00119730|Fludarabine|fludarabine|mesh-list
101384445|NCT00119730|Mitoxantrone|mitoxantrone|mesh-list
101384446|NCT00119730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101384447|NCT00119730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384448|NCT00119730|Immunologic Factors|immunologic factors|mesh-ancestor
101384449|NCT00119730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384450|NCT00119730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101384451|NCT00119730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384452|NCT00119730|Analgesics|analgesics|mesh-ancestor
101384453|NCT00119730|Sensory System Agents|sensory system agents|mesh-ancestor
101384454|NCT00119730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101384455|NCT00119730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101384456|NCT00119730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101384457|NCT00119730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384458|NCT00300196|Ancrod|ancrod|mesh-list
101384459|NCT00300196|Anticoagulants|anticoagulants|mesh-ancestor
101384460|NCT00300196|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101384461|NCT00300196|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101384469|NCT00300313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101384470|NCT00300313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384471|NCT00300313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101384472|NCT00300313|Serotonin Agents|serotonin agents|mesh-ancestor
101384473|NCT00300313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384474|NCT00399659|Tegaserod|tegaserod|mesh-list
101384475|NCT00399659|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101384476|NCT00399659|Serotonin Agents|serotonin agents|mesh-ancestor
101384477|NCT00399659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101384478|NCT00399659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384479|NCT00399659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384480|NCT00300352|Folic Acid|folic acid|mesh-list
101384481|NCT00300352|Hematinics|hematinics|mesh-ancestor
101384482|NCT00300352|Vitamin B Complex|vitamin b complex|mesh-ancestor
101384483|NCT00300352|Vitamins|vitamins|mesh-ancestor
101384484|NCT00300352|Micronutrients|micronutrients|mesh-ancestor
101384485|NCT00300352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384486|NCT00300508|Anastrozole|anastrozole|mesh-list
101384487|NCT00300508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101384488|NCT00300508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384489|NCT00300508|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101384490|NCT00300508|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101384491|NCT00300508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384492|NCT00300508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384493|NCT00300508|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101384494|NCT00300508|Hormone Antagonists|hormone antagonists|mesh-ancestor
101384498|NCT00086463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101384499|NCT00086463|Vasodilator Agents|vasodilator agents|mesh-ancestor
101384501|NCT00079976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101384502|NCT00079976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101384503|NCT00079976|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101384504|NCT00079976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384505|NCT00079976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384506|NCT00079313|Imatinib Mesylate|imatinib mesylate|mesh-list
101384507|NCT00079313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384508|NCT00079313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101384509|NCT00079313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384510|NCT00079313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305190|NCT02018081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101305191|NCT02018081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101384511|NCT00086268|Zoledronic Acid|zoledronic acid|mesh-list
102073792|NCT02101476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073793|NCT02101476|Antipyretics|antipyretics|mesh-ancestor
102073794|NCT02101476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102073795|NCT02101476|Narcotics|narcotics|mesh-ancestor
102073796|NCT02101476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102073797|NCT02104128|Bupropion|bupropion|mesh-list
102073798|NCT02104128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101384512|NCT00086268|Carboplatin|carboplatin|mesh-list
101384513|NCT00086268|Docetaxel|docetaxel|mesh-list
101384514|NCT00086268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384515|NCT00086268|Tubulin Modulators|tubulin modulators|mesh-ancestor
101384516|NCT00086268|Antimitotic Agents|antimitotic agents|mesh-ancestor
101384517|NCT00086268|Mitosis Modulators|mitosis modulators|mesh-ancestor
101384518|NCT00086268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384519|NCT00086268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101384520|NCT00086268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384521|NCT00300586|Gemcitabine|gemcitabine|mesh-list
101384522|NCT00300586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101384523|NCT00300586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101384524|NCT00300586|Antimetabolites|antimetabolites|mesh-ancestor
101384525|NCT00300586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384526|NCT00300586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384527|NCT00300586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101384531|NCT00086541|Interferon alfacon-1|interferon alfacon-1|mesh-list
101384532|NCT00086541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384534|NCT00086541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101384535|NCT00086541|Antimetabolites|antimetabolites|mesh-ancestor
101384536|NCT00086541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384537|NCT00300664|Hormones|hormones|mesh-list
101384538|NCT00300664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101384539|NCT00300664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384540|NCT04718038|Cetuximab|cetuximab|mesh-list
101384541|NCT04718038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101384542|NCT04718038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384543|NCT00080054|Motexafin gadolinium|motexafin gadolinium|mesh-list
101384544|NCT00080054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384545|NCT00080054|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101384546|NCT00080054|Dermatologic Agents|dermatologic agents|mesh-ancestor
101384547|NCT04718233|Sildenafil Citrate|sildenafil citrate|mesh-list
101384548|NCT04718233|Vasodilator Agents|vasodilator agents|mesh-ancestor
101384549|NCT04718233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101384550|NCT04718233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101384551|NCT04718233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384552|NCT04718233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384553|NCT04718233|Urological Agents|urological agents|mesh-ancestor
101384554|NCT00119886|Botulinum Toxins|botulinum toxins|mesh-list
101384555|NCT00119886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101384556|NCT00119886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101384557|NCT00119886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384558|NCT00119886|Cholinergic Agents|cholinergic agents|mesh-ancestor
101384559|NCT00119886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101384560|NCT00119886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384561|NCT00300937|Ubiquinone|ubiquinone|mesh-list
101384562|NCT00300937|Coenzyme Q10|coenzyme q10|mesh-list
101384563|NCT00300937|Micronutrients|micronutrients|mesh-ancestor
101384564|NCT00300937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384577|NCT00418249|Antiviral Agents|antiviral agents|mesh-ancestor
101384578|NCT00418249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101384580|NCT00301054|Sulfadoxine|sulfadoxine|mesh-list
101384581|NCT00301054|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101384582|NCT00301054|Antimalarials|antimalarials|mesh-ancestor
101384583|NCT00301054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101384584|NCT00301054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101384585|NCT00301054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101384586|NCT00301054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101384587|NCT00301054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384588|NCT00301054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073800|NCT02104128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102073801|NCT02104128|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102073802|NCT02104128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102073803|NCT02104128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102073804|NCT02104128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073805|NCT02104128|Dopamine Agents|dopamine agents|mesh-ancestor
101384589|NCT00301054|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101384590|NCT00301093|Imatinib Mesylate|imatinib mesylate|mesh-list
101384591|NCT00301093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384592|NCT00301093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101305194|NCT02018094|Povidone-Iodine|povidone-iodine|mesh-list
101305195|NCT02018094|Metronidazole|metronidazole|mesh-list
101305196|NCT02018094|Clindamycin|clindamycin|mesh-list
101305197|NCT02018094|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101305198|NCT02018094|Teicoplanin|teicoplanin|mesh-list
101384593|NCT00301093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384594|NCT00301093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384595|NCT00301171|Fluticasone|fluticasone|mesh-list
101384596|NCT00301171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101384597|NCT00301171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101384598|NCT00301171|Autonomic Agents|autonomic agents|mesh-ancestor
101384599|NCT00301171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101384600|NCT00301171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384601|NCT00301171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101384602|NCT00301171|Respiratory System Agents|respiratory system agents|mesh-ancestor
101384603|NCT00301171|Dermatologic Agents|dermatologic agents|mesh-ancestor
101384604|NCT00301171|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101384605|NCT00301210|Tramadol|tramadol|mesh-list
101384606|NCT00301210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101384607|NCT00301210|Narcotics|narcotics|mesh-ancestor
101384612|NCT00301210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101384613|NCT00080327|Aripiprazole|aripiprazole|mesh-list
101384614|NCT00080327|Antidepressive Agents|antidepressive agents|mesh-ancestor
101384615|NCT00080327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101384616|NCT00080327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101384617|NCT00080327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101384618|NCT00080327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101384619|NCT00080327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384620|NCT00080327|Dopamine Agonists|dopamine agonists|mesh-ancestor
101384621|NCT00080327|Dopamine Agents|dopamine agents|mesh-ancestor
101384622|NCT00080327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101384623|NCT00080327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384624|NCT00080327|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101384645|NCT00301483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101384646|NCT00301483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101384647|NCT00301483|Analgesics|analgesics|mesh-ancestor
101384648|NCT00301483|Sensory System Agents|sensory system agents|mesh-ancestor
101384649|NCT00301483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101384650|NCT00301483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316359|NCT00000870|Lamivudine|lamivudine|mesh-list
101384651|NCT00301483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101384652|NCT00301483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101384653|NCT00301483|Blood Substitutes|blood substitutes|mesh-ancestor
101384654|NCT00301522|Paclitaxel|paclitaxel|mesh-list
101384655|NCT00301522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101384656|NCT00301522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384657|NCT00301522|Tubulin Modulators|tubulin modulators|mesh-ancestor
101384658|NCT00301522|Antimitotic Agents|antimitotic agents|mesh-ancestor
101384659|NCT00301522|Mitosis Modulators|mitosis modulators|mesh-ancestor
101384660|NCT00301522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384661|NCT00080405|Bortezomib|bortezomib|mesh-list
101384662|NCT00080405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384663|NCT00292123|Methadone|methadone|mesh-list
101384664|NCT00292123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101384665|NCT00292123|Narcotics|narcotics|mesh-ancestor
101384666|NCT00292123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102073806|NCT02104128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102073807|NCT02104128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073808|NCT02104128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102073809|NCT02104128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102073811|NCT00004916|Paclitaxel|paclitaxel|mesh-list
101384667|NCT00292123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384668|NCT00292123|Analgesics|analgesics|mesh-ancestor
101384669|NCT00292123|Sensory System Agents|sensory system agents|mesh-ancestor
101384670|NCT00292123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101384671|NCT00292123|Antitussive Agents|antitussive agents|mesh-ancestor
101384672|NCT00292123|Respiratory System Agents|respiratory system agents|mesh-ancestor
101384673|NCT00080444|Dexamethasone|dexamethasone|mesh-list
101384674|NCT00080444|Dexamethasone acetate|dexamethasone acetate|mesh-list
101384675|NCT00080444|Ondansetron|ondansetron|mesh-list
101384676|NCT00080444|Aprepitant|aprepitant|mesh-list
101384677|NCT00080444|Fosaprepitant|fosaprepitant|mesh-list
101305199|NCT02018094|Povidone|povidone|mesh-list
101305200|NCT02018094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101384678|NCT00080444|BB 1101|bb 1101|mesh-list
101384679|NCT00080444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101384680|NCT00080444|Antiemetics|antiemetics|mesh-ancestor
101384681|NCT00080444|Autonomic Agents|autonomic agents|mesh-ancestor
101384682|NCT00080444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101384683|NCT00080444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384691|NCT00080444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384692|NCT00080444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384693|NCT00080444|Antipruritics|antipruritics|mesh-ancestor
101384694|NCT00080444|Dermatologic Agents|dermatologic agents|mesh-ancestor
101384695|NCT00080444|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101384696|NCT00080444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101384697|NCT00080444|Serotonin Agents|serotonin agents|mesh-ancestor
101384698|NCT00080444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101384699|NCT00080444|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101384700|NCT00086736|Eflornithine|eflornithine|mesh-list
101384701|NCT00086736|Bicalutamide|bicalutamide|mesh-list
101384702|NCT00086736|Androgen Antagonists|androgen antagonists|mesh-ancestor
101384703|NCT00086736|Hormone Antagonists|hormone antagonists|mesh-ancestor
101384704|NCT00086736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101384709|NCT00086736|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101384710|NCT00086736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101384711|NCT00086736|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
101384712|NCT00086736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384713|NCT00086736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384714|NCT00292201|Atorvastatin|atorvastatin|mesh-list
101384715|NCT00292201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101384716|NCT00292201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101384717|NCT00292201|Antimetabolites|antimetabolites|mesh-ancestor
101384718|NCT00292201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384719|NCT00292201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101384720|NCT00292201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101384721|NCT00292201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384722|NCT00292279|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101384723|NCT00292279|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101384724|NCT00292279|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101384725|NCT00292279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101384726|NCT00080522|Ritonavir|ritonavir|mesh-list
101384727|NCT00080522|Lopinavir|lopinavir|mesh-list
101384728|NCT00080522|Lamivudine|lamivudine|mesh-list
101384729|NCT00080522|Zidovudine|zidovudine|mesh-list
101384730|NCT00080522|Didanosine|didanosine|mesh-list
101384731|NCT00080522|Stavudine|stavudine|mesh-list
101384732|NCT00080522|Efavirenz|efavirenz|mesh-list
101384733|NCT00080522|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101384734|NCT00080522|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101384735|NCT00080522|Protease Inhibitors|protease inhibitors|mesh-ancestor
101384736|NCT00080522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384737|NCT00080522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384738|NCT00080522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101384739|NCT00080522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102073813|NCT00004916|Teniposide|teniposide|mesh-list
102073814|NCT00004916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102073815|NCT00004916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102073816|NCT00004916|Tubulin Modulators|tubulin modulators|mesh-ancestor
102073817|NCT00004916|Antimitotic Agents|antimitotic agents|mesh-ancestor
102073818|NCT00004916|Mitosis Modulators|mitosis modulators|mesh-ancestor
102073819|NCT00004916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384740|NCT00080522|Antiviral Agents|antiviral agents|mesh-ancestor
101384741|NCT00080522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101384742|NCT00080522|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101384743|NCT00080522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101384744|NCT00080522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101384745|NCT00080522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101384746|NCT00080522|Antimetabolites|antimetabolites|mesh-ancestor
101384747|NCT00080522|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101384748|NCT00080522|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101384749|NCT00080522|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101384750|NCT00080522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101384751|NCT00080522|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101384752|NCT00086775|Rituximab|rituximab|mesh-list
101384753|NCT00086775|Alemtuzumab|alemtuzumab|mesh-list
101384754|NCT00086775|Fludarabine|fludarabine|mesh-list
101384755|NCT00086775|Fludarabine phosphate|fludarabine phosphate|mesh-list
101305201|NCT02018094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101384756|NCT00086775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101384757|NCT00086775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384758|NCT00086775|Immunologic Factors|immunologic factors|mesh-ancestor
101384759|NCT00086775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384760|NCT00086775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101384761|NCT00086775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101384762|NCT00086775|Antimetabolites|antimetabolites|mesh-ancestor
101384768|NCT00086892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101384769|NCT00292708|Cefmetazole|cefmetazole|mesh-list
101384770|NCT00292708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101384771|NCT00292708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101384772|NCT00086931|Capecitabine|capecitabine|mesh-list
101384773|NCT00086931|Oxaliplatin|oxaliplatin|mesh-list
101384774|NCT00086931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101384775|NCT00086931|Antimetabolites|antimetabolites|mesh-ancestor
101384781|NCT00292747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101384782|NCT00292747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101384784|NCT00292747|Sensory System Agents|sensory system agents|mesh-ancestor
101384785|NCT00292747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101384786|NCT00292747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384787|NCT00292747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101384788|NCT00292747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101384789|NCT00292747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101384790|NCT00292747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384791|NCT00292747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384792|NCT00292747|Parasympatholytics|parasympatholytics|mesh-ancestor
101384793|NCT00292747|Autonomic Agents|autonomic agents|mesh-ancestor
101384794|NCT00292747|Vasodilator Agents|vasodilator agents|mesh-ancestor
101384795|NCT00292747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101384796|NCT00292747|Urological Agents|urological agents|mesh-ancestor
101384797|NCT00120003|Candesartan|candesartan|mesh-list
101384798|NCT00120003|Candesartan cilexetil|candesartan cilexetil|mesh-list
101384799|NCT00120003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101384800|NCT00120003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101384801|NCT00120003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101384802|NCT00120003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384803|NCT00201721|Cyclophosphamide|cyclophosphamide|mesh-list
101384804|NCT00201721|Rituximab|rituximab|mesh-list
102073820|NCT00004916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102073821|NCT00004916|Alkylating Agents|alkylating agents|mesh-ancestor
102073822|NCT00004916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102073823|NCT00004916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102073824|NCT00004916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102073826|NCT02101632|Emollients|emollients|mesh-ancestor
102073827|NCT02101632|Dermatologic Agents|dermatologic agents|mesh-ancestor
102073828|NCT02101710|Isosorbide|isosorbide|mesh-list
101793582|NCT00852566|Dasatinib|dasatinib|mesh-list
102073829|NCT02101710|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
101384805|NCT00201721|Pentostatin|pentostatin|mesh-list
101384806|NCT00201721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101384807|NCT00201721|Immunologic Factors|immunologic factors|mesh-ancestor
101384808|NCT00201721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384809|NCT00201721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101384810|NCT00201721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101384811|NCT00201721|Alkylating Agents|alkylating agents|mesh-ancestor
101384812|NCT00201721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384813|NCT00201721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384814|NCT00201721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101384815|NCT00201721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101384816|NCT00201721|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
101384817|NCT00201721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384818|NCT00201799|Infliximab|infliximab|mesh-list
101384819|NCT00201799|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101384820|NCT00201799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101384821|NCT00201799|Dermatologic Agents|dermatologic agents|mesh-ancestor
101384822|NCT00201799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101384823|NCT00201799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101384824|NCT00080678|Docetaxel|docetaxel|mesh-list
101384825|NCT00080678|Imatinib Mesylate|imatinib mesylate|mesh-list
101384826|NCT00080678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384827|NCT00080678|Tubulin Modulators|tubulin modulators|mesh-ancestor
101384828|NCT00080678|Antimitotic Agents|antimitotic agents|mesh-ancestor
101384829|NCT00080678|Mitosis Modulators|mitosis modulators|mesh-ancestor
101384830|NCT00080678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305202|NCT02018094|Disinfectants|disinfectants|mesh-ancestor
101305203|NCT02018094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101305204|NCT02018094|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101305205|NCT02018094|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101305206|NCT02018094|Trace Elements|trace elements|mesh-ancestor
101384831|NCT00080678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101384832|NCT00080678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384837|NCT00086970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384838|NCT00086970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384839|NCT00086970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384841|NCT00201955|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101384842|NCT00201955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101384843|NCT00201955|Antioxidants|antioxidants|mesh-ancestor
101384844|NCT00201955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384850|NCT00080795|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101384851|NCT00080795|Ifosfamide|ifosfamide|mesh-list
101384852|NCT00080795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384853|NCT00080795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101384854|NCT00080795|Antimetabolites|antimetabolites|mesh-ancestor
101384855|NCT00080795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384856|NCT00080795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101384857|NCT00080795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101384858|NCT00080795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101384859|NCT00080795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384860|NCT00080795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101384861|NCT00080795|Alkylating Agents|alkylating agents|mesh-ancestor
101384862|NCT00120081|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101384863|NCT00120081|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102073832|NCT02101710|Diuretics|diuretics|mesh-ancestor
102073833|NCT02101710|Natriuretic Agents|natriuretic agents|mesh-ancestor
102073834|NCT02101710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073835|NCT02101710|Vasodilator Agents|vasodilator agents|mesh-ancestor
102073836|NCT02101710|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101384864|NCT00120081|Immunologic Factors|immunologic factors|mesh-ancestor
101384865|NCT00120081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384866|NCT00120081|Antacids|antacids|mesh-ancestor
101384867|NCT00120081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384868|NCT00120081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101384869|NCT00201994|Tolvaptan|tolvaptan|mesh-list
101384870|NCT00201994|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101384871|NCT00201994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384872|NCT00201994|Natriuretic Agents|natriuretic agents|mesh-ancestor
101384873|NCT00201994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384874|NCT00120120|Lenalidomide|lenalidomide|mesh-list
101384875|NCT00120120|Immunologic Factors|immunologic factors|mesh-ancestor
101384876|NCT00120120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384877|NCT00120120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101384878|NCT00120120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101384879|NCT00120120|Growth Substances|growth substances|mesh-ancestor
101384880|NCT00120120|Growth Inhibitors|growth inhibitors|mesh-ancestor
101384881|NCT00120120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384882|NCT00202189|Budesonide|budesonide|mesh-list
101384883|NCT00202189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101384884|NCT00202189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101384885|NCT00202189|Autonomic Agents|autonomic agents|mesh-ancestor
101384886|NCT00202189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101384887|NCT00202189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384888|NCT00202189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101384889|NCT00202189|Respiratory System Agents|respiratory system agents|mesh-ancestor
101384890|NCT00202189|Glucocorticoids|glucocorticoids|mesh-ancestor
101384891|NCT00202189|Hormones|hormones|mesh-ancestor
101384892|NCT00202189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101384893|NCT00202228|Riboflavin|riboflavin|mesh-list
101384894|NCT00202228|Thiamine|thiamine|mesh-list
101384895|NCT00202228|Vitamin B Complex|vitamin b complex|mesh-ancestor
101384896|NCT00202228|Vitamins|vitamins|mesh-ancestor
101384897|NCT00202228|Micronutrients|micronutrients|mesh-ancestor
101384898|NCT00202228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384899|NCT00202228|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101384900|NCT00202228|Dermatologic Agents|dermatologic agents|mesh-ancestor
101384901|NCT00087009|Rituximab|rituximab|mesh-list
101305207|NCT02018094|Micronutrients|micronutrients|mesh-ancestor
101305208|NCT02018094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384902|NCT00087009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101384903|NCT00087009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384909|NCT00306319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101384910|NCT00306319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101384911|NCT00306319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101384912|NCT00306319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384913|NCT00306319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384914|NCT00306319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384915|NCT00306358|Vitamin B 12|vitamin b 12|mesh-list
101384916|NCT00306358|Hydroxocobalamin|hydroxocobalamin|mesh-list
101384917|NCT00306358|Vitamins|vitamins|mesh-ancestor
101384936|NCT00418600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101384937|NCT00418600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101384938|NCT00087048|Topotecan|topotecan|mesh-list
101384939|NCT00087048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101316495|NCT02939365|Abatacept|abatacept|mesh-list
101384940|NCT00087048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101384941|NCT00087048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384942|NCT00087048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384943|NCT00087048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384944|NCT00080951|Leucovorin|leucovorin|mesh-list
102073837|NCT02101710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073838|NCT03878368|Sulforaphane|sulforaphane|mesh-list
102073839|NCT03878368|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102073840|NCT03878368|Protective Agents|protective agents|mesh-ancestor
102073841|NCT03878368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384945|NCT00080951|Fluorouracil|fluorouracil|mesh-list
101384946|NCT00080951|Oxaliplatin|oxaliplatin|mesh-list
101384947|NCT00080951|Irinotecan|irinotecan|mesh-list
101384948|NCT00080951|Calcium|calcium|mesh-list
101384949|NCT00080951|Levoleucovorin|levoleucovorin|mesh-list
101384950|NCT00080951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101384951|NCT00080951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384952|NCT00080951|Antimetabolites|antimetabolites|mesh-ancestor
101384953|NCT00080951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384954|NCT00080951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101384955|NCT00080951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384956|NCT00080951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101384957|NCT00080951|Immunologic Factors|immunologic factors|mesh-ancestor
101384958|NCT00080951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101384959|NCT00080951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101384960|NCT00080951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384961|NCT00080951|Antidotes|antidotes|mesh-ancestor
101384962|NCT00080951|Protective Agents|protective agents|mesh-ancestor
101384963|NCT00080951|Vitamin B Complex|vitamin b complex|mesh-ancestor
101384964|NCT00080951|Vitamins|vitamins|mesh-ancestor
101384965|NCT00080951|Micronutrients|micronutrients|mesh-ancestor
101384966|NCT00301600|Mycophenolic Acid|mycophenolic acid|mesh-list
101384967|NCT00301600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101384968|NCT00301600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384969|NCT00301600|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101384970|NCT00301600|Antitubercular Agents|antitubercular agents|mesh-ancestor
101384971|NCT00301600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101384972|NCT00301600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101384973|NCT00301600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384974|NCT00301600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384975|NCT00301639|Methylphenidate|methylphenidate|mesh-list
101384982|NCT00301639|Dopamine Agents|dopamine agents|mesh-ancestor
101384983|NCT00301639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101384984|NCT00087087|Pemetrexed|pemetrexed|mesh-list
101384985|NCT00087087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384986|NCT00087087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384987|NCT00087087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384988|NCT00087087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101384989|NCT00087087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101384990|NCT00301795|Rituximab|rituximab|mesh-list
101384991|NCT00301795|Oblimersen|oblimersen|mesh-list
101384992|NCT00301795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101384993|NCT00301795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384994|NCT00301795|Immunologic Factors|immunologic factors|mesh-ancestor
101384995|NCT00301795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384996|NCT00301795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101384997|NCT00080990|Leucovorin|leucovorin|mesh-list
101384998|NCT00080990|Fluorouracil|fluorouracil|mesh-list
101384999|NCT00080990|Oxaliplatin|oxaliplatin|mesh-list
101385000|NCT00080990|Alvocidib|alvocidib|mesh-list
101385001|NCT00080990|Calcium|calcium|mesh-list
101385002|NCT00080990|Levoleucovorin|levoleucovorin|mesh-list
101385003|NCT00080990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101385004|NCT00080990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385005|NCT00080990|Antimetabolites|antimetabolites|mesh-ancestor
101385006|NCT00080990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385007|NCT00080990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101385008|NCT00080990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385009|NCT00080990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101385010|NCT00080990|Immunologic Factors|immunologic factors|mesh-ancestor
101385011|NCT00080990|Antidotes|antidotes|mesh-ancestor
101385012|NCT00080990|Protective Agents|protective agents|mesh-ancestor
101385013|NCT00080990|Vitamin B Complex|vitamin b complex|mesh-ancestor
101385014|NCT00080990|Vitamins|vitamins|mesh-ancestor
101385015|NCT00080990|Micronutrients|micronutrients|mesh-ancestor
101385016|NCT00080990|Growth Inhibitors|growth inhibitors|mesh-ancestor
101385017|NCT00080990|Growth Substances|growth substances|mesh-ancestor
102073842|NCT03878368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102073843|NCT02910063|Blinatumomab|blinatumomab|mesh-list
102073844|NCT02910063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102073845|NCT04441762|Ketorolac|ketorolac|mesh-list
102073846|NCT04441762|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
102073847|NCT04441762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102073848|NCT04441762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102073849|NCT04441762|Analgesics|analgesics|mesh-ancestor
102073850|NCT04441762|Sensory System Agents|sensory system agents|mesh-ancestor
101385018|NCT00080990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101385019|NCT00080990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101385020|NCT00301912|Methotrexate|methotrexate|mesh-list
101385021|NCT00301912|Fludarabine phosphate|fludarabine phosphate|mesh-list
101385022|NCT00301912|Fludarabine|fludarabine|mesh-list
101385023|NCT00301912|Busulfan|busulfan|mesh-list
101385024|NCT00301912|Tacrolimus|tacrolimus|mesh-list
101385025|NCT00301912|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101385026|NCT00301912|Abortifacient Agents|abortifacient agents|mesh-ancestor
101385027|NCT00301912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101385028|NCT00301912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385029|NCT00301912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101385030|NCT00301912|Antimetabolites|antimetabolites|mesh-ancestor
101385031|NCT00301912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385032|NCT00301912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385033|NCT00301912|Dermatologic Agents|dermatologic agents|mesh-ancestor
101385034|NCT00301912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101385035|NCT00301912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101385036|NCT00301912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101385037|NCT00301912|Immunologic Factors|immunologic factors|mesh-ancestor
101385038|NCT00301912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101385039|NCT00301912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101385040|NCT00301912|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101385041|NCT00301912|Alkylating Agents|alkylating agents|mesh-ancestor
101385042|NCT00301912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101385043|NCT00301912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101385044|NCT00301951|Mycophenolic Acid|mycophenolic acid|mesh-list
101385045|NCT00301951|Fludarabine|fludarabine|mesh-list
101385046|NCT00301951|Fludarabine phosphate|fludarabine phosphate|mesh-list
101385047|NCT00301951|Busulfan|busulfan|mesh-list
101385048|NCT00301951|Tacrolimus|tacrolimus|mesh-list
101305210|NCT02018094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101305211|NCT02018094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305212|NCT02018094|Plasma Substitutes|plasma substitutes|mesh-ancestor
101385058|NCT00301951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101385059|NCT00301951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101385060|NCT00301951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101385061|NCT00301951|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101385062|NCT00301951|Antitubercular Agents|antitubercular agents|mesh-ancestor
101385063|NCT00301951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101385064|NCT00301951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101385065|NCT00301951|Alkylating Agents|alkylating agents|mesh-ancestor
101385066|NCT00301951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101385067|NCT00301951|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101385068|NCT00301990|Aldesleukin|aldesleukin|mesh-list
101385069|NCT00301990|Bevacizumab|bevacizumab|mesh-list
101385070|NCT00301990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101385071|NCT00301990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385072|NCT00301990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101385073|NCT00301990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101385074|NCT00301990|Growth Substances|growth substances|mesh-ancestor
101385075|NCT00301990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385076|NCT00301990|Growth Inhibitors|growth inhibitors|mesh-ancestor
101385077|NCT00301990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101385078|NCT00301990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101385079|NCT00301990|Antiviral Agents|antiviral agents|mesh-ancestor
101385080|NCT00301990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101385082|NCT00120198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101385083|NCT00120198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102073851|NCT04441762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102073852|NCT04441762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073853|NCT04441762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102073854|NCT04441762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102073855|NCT04441762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102073856|NCT04441762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101385084|NCT00120198|Immunologic Factors|immunologic factors|mesh-ancestor
101385085|NCT00120198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385086|NCT00120198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101385087|NCT00302224|Ketoconazole|ketoconazole|mesh-list
101385088|NCT00302224|Antifungal Agents|antifungal agents|mesh-ancestor
101385089|NCT00302224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101385090|NCT00302224|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101385091|NCT00302224|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101385092|NCT00302224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101385093|NCT00302224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385094|NCT00302224|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101385095|NCT00302224|Hormone Antagonists|hormone antagonists|mesh-ancestor
101385096|NCT00302224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101385097|NCT00302224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385098|NCT00302224|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101385099|NCT00081068|Alemtuzumab|alemtuzumab|mesh-list
101385100|NCT00081068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101385101|NCT00081068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385102|NCT00087165|Prednisone|prednisone|mesh-list
101385103|NCT00087165|Docetaxel|docetaxel|mesh-list
101385104|NCT00087165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385105|NCT00087165|Tubulin Modulators|tubulin modulators|mesh-ancestor
101385106|NCT00087165|Antimitotic Agents|antimitotic agents|mesh-ancestor
101385107|NCT00087165|Mitosis Modulators|mitosis modulators|mesh-ancestor
101385108|NCT00087165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385109|NCT00087165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101385110|NCT00087165|Glucocorticoids|glucocorticoids|mesh-ancestor
101385111|NCT00087165|Hormones|hormones|mesh-ancestor
101385112|NCT00087165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101385113|NCT00087165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385114|NCT00087165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101385115|NCT00302341|Trimethoprim|trimethoprim|mesh-list
101385116|NCT00302341|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101305213|NCT02018094|Blood Substitutes|blood substitutes|mesh-ancestor
101305214|NCT02018094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101305215|NCT02018133|Vitamin D|vitamin d|mesh-list
101305216|NCT02018133|Ergocalciferols|ergocalciferols|mesh-list
101305217|NCT02018133|Vitamins|vitamins|mesh-ancestor
101385129|NCT00302341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101385130|NCT00302341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101385131|NCT00302341|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101385132|NCT00302419|Streptokinase|streptokinase|mesh-list
101385133|NCT00302419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101385134|NCT00302419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101385135|NCT00302419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385136|NCT00302497|Basiliximab|basiliximab|mesh-list
101385137|NCT00302497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101316527|NCT02681302|Nivolumab|nivolumab|mesh-list
101385138|NCT00302497|Immunologic Factors|immunologic factors|mesh-ancestor
101385139|NCT00302497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385140|NCT00081107|Epothilones|epothilones|mesh-list
101385141|NCT00081107|Desoxyepothilone B|desoxyepothilone b|mesh-list
101385142|NCT00081107|Tubulin Modulators|tubulin modulators|mesh-ancestor
101385143|NCT00081107|Antimitotic Agents|antimitotic agents|mesh-ancestor
101385144|NCT00081107|Mitosis Modulators|mitosis modulators|mesh-ancestor
101385145|NCT00081107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385146|NCT00081107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385148|NCT00302536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101385149|NCT00302536|Immunologic Factors|immunologic factors|mesh-ancestor
101385150|NCT00302536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385151|NCT00302536|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101385152|NCT00302536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101375529|NCT00233818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102073857|NCT04441762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073858|NCT02104284|Mannitol|mannitol|mesh-list
102073859|NCT02104284|Methacholine Chloride|methacholine chloride|mesh-list
102073860|NCT02104284|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102073861|NCT02104284|Diuretics|diuretics|mesh-ancestor
102073862|NCT02104284|Natriuretic Agents|natriuretic agents|mesh-ancestor
102073863|NCT02104284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073864|NCT02104284|Miotics|miotics|mesh-ancestor
102073865|NCT02104284|Autonomic Agents|autonomic agents|mesh-ancestor
102073866|NCT02104284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102073867|NCT02104284|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102073868|NCT02104284|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
102073869|NCT02104284|Respiratory System Agents|respiratory system agents|mesh-ancestor
102073870|NCT02104284|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
102073871|NCT02104284|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102073872|NCT02104284|Cholinergic Agents|cholinergic agents|mesh-ancestor
102073873|NCT02104284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101385153|NCT00302536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385154|NCT00081224|Celecoxib|celecoxib|mesh-list
101385155|NCT00081224|Capecitabine|capecitabine|mesh-list
101385156|NCT00081224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101385157|NCT00081224|Antimetabolites|antimetabolites|mesh-ancestor
101385158|NCT00081224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385159|NCT00081224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385160|NCT00081224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101385161|NCT00081224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101385162|NCT00081224|Analgesics|analgesics|mesh-ancestor
101385163|NCT00081224|Sensory System Agents|sensory system agents|mesh-ancestor
101385164|NCT00081224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101385165|NCT00081224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385166|NCT00081224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101385167|NCT00081224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101385168|NCT00081224|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101385169|NCT00081224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101385170|NCT00081224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101385171|NCT00120237|Misoprostol|misoprostol|mesh-list
101385172|NCT00120237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101385173|NCT00120237|Abortifacient Agents|abortifacient agents|mesh-ancestor
101385174|NCT00120237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101385175|NCT00120237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385176|NCT00120237|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101385177|NCT00120237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101385178|NCT00120237|Oxytocics|oxytocics|mesh-ancestor
101385179|NCT00081302|Paclitaxel|paclitaxel|mesh-list
101385180|NCT00081302|Carboplatin|carboplatin|mesh-list
101385181|NCT00081302|Cetuximab|cetuximab|mesh-list
101385182|NCT00081302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101385183|NCT00081302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385184|NCT00081302|Tubulin Modulators|tubulin modulators|mesh-ancestor
101385185|NCT00081302|Antimitotic Agents|antimitotic agents|mesh-ancestor
101385236|NCT00081380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101385237|NCT00081380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101385238|NCT00081380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385239|NCT00081380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101385240|NCT00081380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385241|NCT00081380|Antimanic Agents|antimanic agents|mesh-ancestor
102073874|NCT02104284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073876|NCT00337532|Cisplatin|cisplatin|mesh-list
102073877|NCT00337532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102073878|NCT00337532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102073879|NCT00337532|Tubulin Modulators|tubulin modulators|mesh-ancestor
102073880|NCT00337532|Antimitotic Agents|antimitotic agents|mesh-ancestor
102073881|NCT00337532|Mitosis Modulators|mitosis modulators|mesh-ancestor
102073882|NCT00337532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073883|NCT02625441|Trastuzumab|trastuzumab|mesh-list
102073884|NCT02625441|Pertuzumab|pertuzumab|mesh-list
101375547|NCT00233896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101305218|NCT02018133|Micronutrients|micronutrients|mesh-ancestor
101305219|NCT02018133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305220|NCT02018133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101385242|NCT00081380|Anticonvulsants|anticonvulsants|mesh-ancestor
101385243|NCT00081380|GABA Agents|gaba agents|mesh-ancestor
101385244|NCT00081380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101385245|NCT00418483|Fibrinolysin|fibrinolysin|mesh-list
101385246|NCT00418483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101385247|NCT00418483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101385248|NCT00418483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385249|NCT00302692|Metoprolol|metoprolol|mesh-list
101385250|NCT00302692|Esmolol|esmolol|mesh-list
101385251|NCT00302692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101385252|NCT00302692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101385253|NCT00302692|Sympatholytics|sympatholytics|mesh-ancestor
101385254|NCT00302692|Autonomic Agents|autonomic agents|mesh-ancestor
101385255|NCT00302692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101385256|NCT00302692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385257|NCT00302692|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101385258|NCT00302692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101385259|NCT00302692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101385260|NCT00302692|Adrenergic Agents|adrenergic agents|mesh-ancestor
101385261|NCT00302692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101385262|NCT00302692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385263|NCT00302770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101385264|NCT00302770|Antidepressive Agents|antidepressive agents|mesh-ancestor
101385265|NCT00302770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101385266|NCT00302770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101385267|NCT00302770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101385268|NCT00302770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101385269|NCT00302770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385270|NCT00081536|Capecitabine|capecitabine|mesh-list
101385271|NCT00081536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101385272|NCT00081536|Antimetabolites|antimetabolites|mesh-ancestor
101385273|NCT00081536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385274|NCT00081536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385275|NCT00303004|Bosentan|bosentan|mesh-list
101385276|NCT00303004|Sildenafil Citrate|sildenafil citrate|mesh-list
101385277|NCT00303004|Vasodilator Agents|vasodilator agents|mesh-ancestor
101385278|NCT00303004|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101385279|NCT00303004|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101385280|NCT00303004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101385281|NCT00303004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385282|NCT00303004|Urological Agents|urological agents|mesh-ancestor
101385283|NCT00303004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101385284|NCT00303004|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101385285|NCT00081575|Levofloxacin|levofloxacin|mesh-list
101385286|NCT00081575|Tigecycline|tigecycline|mesh-list
101385287|NCT00081575|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101385288|NCT00081575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101375555|NCT00233935|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102073885|NCT02625441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102073886|NCT02625441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102073887|NCT04209868|Bupivacaine|bupivacaine|mesh-list
102073888|NCT04209868|Levobupivacaine|levobupivacaine|mesh-list
102073889|NCT04209868|Anesthetics, Local|anesthetics, local|mesh-ancestor
102073890|NCT04209868|Anesthetics|anesthetics|mesh-ancestor
102073891|NCT04209868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102073892|NCT04209868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375556|NCT00233935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385289|NCT00081575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101385290|NCT00081575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101385291|NCT00081575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101385292|NCT00081575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101385293|NCT00081575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385294|NCT00081575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385295|NCT00081575|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101385296|NCT00081575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101385302|NCT00087399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101385303|NCT00087399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385304|NCT00087399|Anticonvulsants|anticonvulsants|mesh-ancestor
101385305|NCT00087399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101385306|NCT00087399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101385307|NCT00087399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101385308|NCT00087399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101385309|NCT00087399|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101305221|NCT02018133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101305222|NCT02018159|Menotropins|menotropins|mesh-list
101305223|NCT02018159|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101385310|NCT00087399|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101385311|NCT00087399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101385312|NCT00087399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385313|NCT00087399|Antimanic Agents|antimanic agents|mesh-ancestor
101385314|NCT00081614|Bevacizumab|bevacizumab|mesh-list
101385315|NCT00081614|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101316584|NCT00000975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101385316|NCT00081614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101385317|NCT00081614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385318|NCT00081614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101385319|NCT00081614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101385320|NCT00081614|Growth Substances|growth substances|mesh-ancestor
101385321|NCT00081614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385322|NCT00081614|Growth Inhibitors|growth inhibitors|mesh-ancestor
101385323|NCT00081614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101385324|NCT00081614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101385325|NCT00081614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385326|NCT00303277|Simvastatin|simvastatin|mesh-list
101385327|NCT00303277|Pravastatin|pravastatin|mesh-list
101385328|NCT00303277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101385329|NCT00303277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101385330|NCT00303277|Antimetabolites|antimetabolites|mesh-ancestor
101385331|NCT00303277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385332|NCT00303277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101385333|NCT00303277|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101385334|NCT00303277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101385335|NCT00303394|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101385336|NCT00303394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101385337|NCT00303433|Memantine|memantine|mesh-list
101385338|NCT00303433|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101385339|NCT00303433|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101385340|NCT00303433|Dopamine Agents|dopamine agents|mesh-ancestor
101385341|NCT00303433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101385342|NCT00303433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073893|NCT04209868|Sensory System Agents|sensory system agents|mesh-ancestor
102073894|NCT04209868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102073895|NCT02361801|Dobutamine|dobutamine|mesh-list
102073896|NCT02361801|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102073897|NCT02361801|Sympathomimetics|sympathomimetics|mesh-ancestor
102073898|NCT02361801|Autonomic Agents|autonomic agents|mesh-ancestor
101375568|NCT00234091|Protease Inhibitors|protease inhibitors|mesh-ancestor
101385343|NCT00303433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385344|NCT00303433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101385345|NCT00303433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101385346|NCT00303550|Linezolid|linezolid|mesh-list
101385347|NCT00303550|Iclaprim|iclaprim|mesh-list
101385348|NCT00303550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101385349|NCT00303550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101385350|NCT00303550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101385351|NCT00303550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101385352|NCT00303550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385353|NCT00303550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101385354|NCT00120354|Lamivudine|lamivudine|mesh-list
101385355|NCT00120354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101385356|NCT00120354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101385357|NCT00120354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101385358|NCT00120354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385359|NCT00120354|Antiviral Agents|antiviral agents|mesh-ancestor
101385360|NCT00120354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101385361|NCT00120354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101385362|NCT00120354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101385363|NCT00399698|Risperidone|risperidone|mesh-list
101385364|NCT00399698|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101385365|NCT00399698|Serotonin Agents|serotonin agents|mesh-ancestor
101385366|NCT00399698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101385378|NCT00303589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101385379|NCT00081848|Metronidazole|metronidazole|mesh-list
101385380|NCT00081848|Celecoxib|celecoxib|mesh-list
101385381|NCT00081848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101385382|NCT00081848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101385383|NCT00081848|Analgesics|analgesics|mesh-ancestor
101305224|NCT02018159|Fertility Agents|fertility agents|mesh-ancestor
101305225|NCT02018159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101385384|NCT00081848|Sensory System Agents|sensory system agents|mesh-ancestor
101385385|NCT00081848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101385386|NCT00081848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385387|NCT00081848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101385388|NCT00081848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101385389|NCT00081848|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101385390|NCT00081848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101385391|NCT00081848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101385392|NCT00081848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385393|NCT00081848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101385394|NCT00081848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101385395|NCT00081848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101385396|NCT00081848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101385397|NCT00120432|Phenylephrine|phenylephrine|mesh-list
101385398|NCT00120432|Oxymetazoline|oxymetazoline|mesh-list
101385399|NCT00120432|Tropicamide|tropicamide|mesh-list
101385400|NCT00120432|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101385401|NCT00120432|Mydriatics|mydriatics|mesh-ancestor
101385402|NCT00120432|Autonomic Agents|autonomic agents|mesh-ancestor
101385403|NCT00120432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101385404|NCT00120432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385405|NCT00120432|Sympathomimetics|sympathomimetics|mesh-ancestor
101385406|NCT00120432|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101385407|NCT00120432|Nasal Decongestants|nasal decongestants|mesh-ancestor
101385408|NCT00120432|Respiratory System Agents|respiratory system agents|mesh-ancestor
101385409|NCT00120432|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101385410|NCT00120432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101385411|NCT00120432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101385412|NCT00120432|Adrenergic Agents|adrenergic agents|mesh-ancestor
101385413|NCT00120432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102073900|NCT02361801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073901|NCT02361801|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102073902|NCT02361801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102073903|NCT02361801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102073904|NCT02361801|Adrenergic Agents|adrenergic agents|mesh-ancestor
102073905|NCT02361801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101575047|NCT02759887|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101385414|NCT00120432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385415|NCT00120432|Protective Agents|protective agents|mesh-ancestor
101385416|NCT00120432|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101385417|NCT00120432|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101385418|NCT00120432|Cholinergic Agents|cholinergic agents|mesh-ancestor
101385419|NCT00303745|Capecitabine|capecitabine|mesh-list
101385420|NCT00303745|Irinotecan|irinotecan|mesh-list
101385421|NCT00303745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101385422|NCT00303745|Antimetabolites|antimetabolites|mesh-ancestor
101385423|NCT00303745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385424|NCT00303745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385425|NCT00303745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101385426|NCT00303745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101385427|NCT00303745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101385428|NCT00303784|Goserelin|goserelin|mesh-list
101385429|NCT00303784|Estradiol|estradiol|mesh-list
101385430|NCT00303784|Estrogens|estrogens|mesh-ancestor
101385431|NCT00303784|Hormones|hormones|mesh-ancestor
101385432|NCT00303784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101385433|NCT00303784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385434|NCT00303784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101385435|NCT00303784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385436|NCT00081887|Clofarabine|clofarabine|mesh-list
101385437|NCT00081887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101385438|NCT00081887|Antimetabolites|antimetabolites|mesh-ancestor
101385439|NCT00081887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385452|NCT00304018|Tacrolimus|tacrolimus|mesh-list
101385453|NCT00304018|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101385454|NCT00304018|Sargramostim|sargramostim|mesh-list
101385455|NCT00304018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101385456|NCT00304018|Glucocorticoids|glucocorticoids|mesh-ancestor
101385457|NCT00304018|Hormones|hormones|mesh-ancestor
101385458|NCT00304018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101385459|NCT00304018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385460|NCT00304018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101305226|NCT02018159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305227|NCT02018250|Benzyl Alcohol|benzyl alcohol|mesh-list
101305228|NCT02018250|Anesthetics, Local|anesthetics, local|mesh-ancestor
101305229|NCT02018250|Anesthetics|anesthetics|mesh-ancestor
101385461|NCT00304018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385462|NCT00304018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101385463|NCT00304018|Antimetabolites|antimetabolites|mesh-ancestor
101385464|NCT00304018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385465|NCT00304018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101385466|NCT00304018|Immunologic Factors|immunologic factors|mesh-ancestor
101385467|NCT00304018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101385468|NCT00304018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101385469|NCT00304018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101385470|NCT00304018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101385471|NCT00304018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101385472|NCT00304018|Alkylating Agents|alkylating agents|mesh-ancestor
101385473|NCT00304018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101385474|NCT00304018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101385475|NCT00081926|Imatinib Mesylate|imatinib mesylate|mesh-list
101385476|NCT00081926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385477|NCT00081926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101385478|NCT00081926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102073906|NCT02361801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073907|NCT02361801|Protective Agents|protective agents|mesh-ancestor
102073908|NCT03965728|Methotrexate|methotrexate|mesh-list
102073909|NCT03965728|Midazolam|midazolam|mesh-list
102073910|NCT03965728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102073911|NCT03965728|Abortifacient Agents|abortifacient agents|mesh-ancestor
102073912|NCT03965728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102073913|NCT03965728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375585|NCT04721704|Amoxicillin|amoxicillin|mesh-list
101385479|NCT00081926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385480|NCT00304135|Gemcitabine|gemcitabine|mesh-list
101385481|NCT00304135|Oxaliplatin|oxaliplatin|mesh-list
101385482|NCT00304135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385483|NCT00304135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101385484|NCT00304135|Antimetabolites|antimetabolites|mesh-ancestor
101385485|NCT00304135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385486|NCT00304213|Testosterone|testosterone|mesh-list
101385487|NCT00304213|Androgens|androgens|mesh-ancestor
101385488|NCT00304213|Hormones|hormones|mesh-ancestor
101385489|NCT00304213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101385490|NCT00304213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385491|NCT00304252|Interferons|interferons|mesh-list
101385492|NCT00304252|Interferon-beta|interferon-beta|mesh-list
101385493|NCT00304252|Interferon beta-1a|interferon beta-1a|mesh-list
101385494|NCT00304252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385495|NCT00304252|Antiviral Agents|antiviral agents|mesh-ancestor
101385496|NCT00304252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101385497|NCT00304252|Immunologic Factors|immunologic factors|mesh-ancestor
101385498|NCT00304252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385499|NCT00304252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101385500|NCT00120471|Tenofovir|tenofovir|mesh-list
101385501|NCT00120471|Antiviral Agents|antiviral agents|mesh-ancestor
101385502|NCT00120471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101385503|NCT00120471|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101385504|NCT00120471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101385505|NCT00120471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101385506|NCT00120471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385507|NCT00120471|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101385508|NCT00120471|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101385509|NCT00082043|Dutasteride|dutasteride|mesh-list
101385510|NCT00082043|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101385511|NCT00082043|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101385518|NCT00304291|Analgesics|analgesics|mesh-ancestor
101385519|NCT00304291|Sensory System Agents|sensory system agents|mesh-ancestor
101385520|NCT00304291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101385521|NCT00304291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385522|NCT00304291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385523|NCT00304291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101385524|NCT00304291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101385525|NCT00304291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101385526|NCT00304291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305230|NCT02018250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101385527|NCT00304369|Metronidazole|metronidazole|mesh-list
101385528|NCT00304369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101385529|NCT00304369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101385530|NCT00304369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101385531|NCT00304369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101385532|NCT00082082|Thymalfasin|thymalfasin|mesh-list
101385533|NCT00082082|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101385534|NCT00082082|Immunologic Factors|immunologic factors|mesh-ancestor
101385535|NCT00082082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385536|NCT00304447|Gemtuzumab|gemtuzumab|mesh-list
101385537|NCT00304447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101385538|NCT00304447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102073914|NCT03965728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102073915|NCT03965728|Antimetabolites|antimetabolites|mesh-ancestor
102073916|NCT03965728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073917|NCT03965728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102073918|NCT03965728|Dermatologic Agents|dermatologic agents|mesh-ancestor
102073919|NCT03965728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101385539|NCT00304447|Immunotoxins|immunotoxins|mesh-ancestor
101385540|NCT00304447|Immunoconjugates|immunoconjugates|mesh-ancestor
101385541|NCT00304447|Immunologic Factors|immunologic factors|mesh-ancestor
101385542|NCT00304447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385543|NCT00087711|Gemcitabine|gemcitabine|mesh-list
101385544|NCT00087711|Pemetrexed|pemetrexed|mesh-list
101385545|NCT00087711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385546|NCT00087711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101385547|NCT00087711|Antimetabolites|antimetabolites|mesh-ancestor
101385548|NCT00087711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385549|NCT00087711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101385550|NCT00087711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101385551|NCT00087711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101385552|NCT00304642|Dapivirine|dapivirine|mesh-list
101385553|NCT00304642|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101385554|NCT00304642|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101385555|NCT00304642|Antiviral Agents|antiviral agents|mesh-ancestor
101385556|NCT00304642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101385557|NCT00304681|Methylphenidate|methylphenidate|mesh-list
101385558|NCT00304681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101385559|NCT00304681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385560|NCT00304681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101385561|NCT00304681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101385562|NCT00304681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101385563|NCT00304681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385564|NCT00304681|Dopamine Agents|dopamine agents|mesh-ancestor
101385565|NCT00304681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101385566|NCT00304720|Tacrolimus|tacrolimus|mesh-list
101385567|NCT00304720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101385568|NCT00304720|Immunologic Factors|immunologic factors|mesh-ancestor
101385569|NCT00304720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385570|NCT00304720|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101385571|NCT00304720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101385572|NCT00304720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385573|NCT00082199|Aripiprazole|aripiprazole|mesh-list
101385574|NCT00082199|Antidepressive Agents|antidepressive agents|mesh-ancestor
101385575|NCT00082199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101385576|NCT00082199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101385577|NCT00082199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101385578|NCT00082199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101385579|NCT00082199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385580|NCT00082199|Dopamine Agonists|dopamine agonists|mesh-ancestor
101385583|NCT00082199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385587|NCT00082199|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101385588|NCT00082199|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101385589|NCT00082199|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101385590|NCT00082199|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101385592|NCT00120510|Zidovudine|zidovudine|mesh-list
101385593|NCT00120510|Efavirenz|efavirenz|mesh-list
101385594|NCT00120510|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101385595|NCT00120510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101385596|NCT00120510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101385597|NCT00120510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101385598|NCT00120510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385599|NCT00120510|Antiviral Agents|antiviral agents|mesh-ancestor
101305232|NCT02018250|Sensory System Agents|sensory system agents|mesh-ancestor
101305233|NCT02018250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101305235|NCT02018276|Anesthetics, Local|anesthetics, local|mesh-ancestor
101305236|NCT02018276|Anesthetics|anesthetics|mesh-ancestor
101385600|NCT00120510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101385601|NCT00120510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102073920|NCT03965728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102073921|NCT03965728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102073922|NCT03965728|Immunologic Factors|immunologic factors|mesh-ancestor
102073923|NCT03965728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102073924|NCT03965728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102073925|NCT03965728|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101385602|NCT00120510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101385603|NCT00120510|Antimetabolites|antimetabolites|mesh-ancestor
101385604|NCT00120510|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101385605|NCT00120510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101385606|NCT00120510|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101385607|NCT00120510|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101385608|NCT00120510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101385609|NCT00120510|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101385610|NCT00087750|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101385611|NCT00087750|Antidepressive Agents|antidepressive agents|mesh-ancestor
101385612|NCT00087750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101385613|NCT00087750|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101385614|NCT00087750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101385615|NCT00087750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101385616|NCT00087750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385618|NCT00304993|Rosiglitazone|rosiglitazone|mesh-list
101385619|NCT00304993|Fenofibrate|fenofibrate|mesh-list
101385620|NCT00304993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101385621|NCT00304993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385622|NCT00304993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101385623|NCT00304993|Antimetabolites|antimetabolites|mesh-ancestor
101385624|NCT00304993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385625|NCT00304993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101385626|NCT00304993|Vasodilator Agents|vasodilator agents|mesh-ancestor
101385627|NCT00304993|Vitamin B Complex|vitamin b complex|mesh-ancestor
101385628|NCT00304993|Vitamins|vitamins|mesh-ancestor
101385629|NCT00304993|Micronutrients|micronutrients|mesh-ancestor
101385630|NCT00082277|Risedronic Acid|risedronic acid|mesh-list
101385631|NCT00082277|Anastrozole|anastrozole|mesh-list
101385632|NCT00082277|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101385633|NCT00082277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385634|NCT00082277|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101385635|NCT00082277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101385636|NCT00082277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101385637|NCT00082277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385638|NCT00082277|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101385639|NCT00082277|Hormone Antagonists|hormone antagonists|mesh-ancestor
101385640|NCT00082277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101385641|NCT00082277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385642|NCT00082277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101385643|NCT00082277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101385644|NCT00082277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101385645|NCT00082277|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101385646|NCT00305266|gamma-Globulins|gamma-globulins|mesh-list
101385647|NCT00305266|Immunologic Factors|immunologic factors|mesh-ancestor
101385648|NCT00305266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385649|NCT00082316|Capsaicin|capsaicin|mesh-list
101385650|NCT00082316|Antipruritics|antipruritics|mesh-ancestor
101385655|NCT00305383|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101385657|NCT00305383|Antiviral Agents|antiviral agents|mesh-ancestor
101385658|NCT00305383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101385659|NCT00305422|Risperidone|risperidone|mesh-list
101385660|NCT00305422|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101385661|NCT00305422|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101385662|NCT00305422|Serotonin Agents|serotonin agents|mesh-ancestor
101385663|NCT00305422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101385664|NCT00305422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385665|NCT00305422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385666|NCT00305422|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101305237|NCT02018276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101305238|NCT02018276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073926|NCT03965728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102073927|NCT03965728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102073928|NCT03965728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102073929|NCT03965728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102073930|NCT03965728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102073931|NCT03965728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102073932|NCT03965728|Anesthetics, General|anesthetics, general|mesh-ancestor
102073933|NCT03965728|Anesthetics|anesthetics|mesh-ancestor
102073934|NCT03965728|GABA Modulators|gaba modulators|mesh-ancestor
101385667|NCT00305422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101385668|NCT00305422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101385670|NCT00305422|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101385671|NCT00305422|Dopamine Agents|dopamine agents|mesh-ancestor
101385672|NCT00305422|Antidepressive Agents|antidepressive agents|mesh-ancestor
101385673|NCT00305461|Ciclesonide|ciclesonide|mesh-list
101385674|NCT00305461|Glucocorticoids|glucocorticoids|mesh-ancestor
101385675|NCT00305461|Hormones|hormones|mesh-ancestor
101385676|NCT00305461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101385677|NCT00305461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385678|NCT00305461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101385679|NCT00082394|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101385680|NCT00082394|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101385681|NCT00082394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101385682|NCT00082394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101385683|NCT00082394|Protease Inhibitors|protease inhibitors|mesh-ancestor
101385684|NCT00082394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101385685|NCT00082394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385686|NCT00082394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101385687|NCT00082394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101385688|NCT00082394|Antiviral Agents|antiviral agents|mesh-ancestor
101385689|NCT00082394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101385690|NCT00082394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101385691|NCT00082394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101385692|NCT00305500|Escitalopram|escitalopram|mesh-list
101385693|NCT00305500|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101385694|NCT00305500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101385695|NCT00305500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101385696|NCT00305500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385697|NCT00305500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101385698|NCT00305500|Serotonin Agents|serotonin agents|mesh-ancestor
101385699|NCT00305500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385700|NCT00305539|Adalimumab|adalimumab|mesh-list
101385701|NCT00305539|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101385702|NCT00305539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101385703|NCT00305539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101385704|NCT00305617|Antineoplastic Agents|antineoplastic agents|mesh-list
101385705|NCT00305734|Gemcitabine|gemcitabine|mesh-list
101385706|NCT00305734|Bortezomib|bortezomib|mesh-list
101385707|NCT00305734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101385708|NCT00305734|Antimetabolites|antimetabolites|mesh-ancestor
101385709|NCT00305734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385710|NCT00305734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385711|NCT00082472|Docetaxel|docetaxel|mesh-list
101385712|NCT00082472|Doxorubicin|doxorubicin|mesh-list
101385713|NCT00082472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101385714|NCT00082472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385715|NCT00082472|Tubulin Modulators|tubulin modulators|mesh-ancestor
101385716|NCT00082472|Antimitotic Agents|antimitotic agents|mesh-ancestor
101385717|NCT00082472|Mitosis Modulators|mitosis modulators|mesh-ancestor
101385718|NCT00082472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385719|NCT00082472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101385737|NCT00306124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385738|NCT00306124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305239|NCT02018276|Sensory System Agents|sensory system agents|mesh-ancestor
102073935|NCT03965728|GABA Agents|gaba agents|mesh-ancestor
102073936|NCT03965728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102073937|NCT00337454|Dasatinib|dasatinib|mesh-list
102073938|NCT00337454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102073939|NCT00337454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102073940|NCT00337454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101305240|NCT02018276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101385739|NCT00082589|Eplerenone|eplerenone|mesh-list
101385740|NCT00082589|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101385741|NCT00082589|Hormone Antagonists|hormone antagonists|mesh-ancestor
101385742|NCT00082589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101385743|NCT00082589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385744|NCT00082589|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101385745|NCT00082589|Diuretics|diuretics|mesh-ancestor
101385746|NCT00082589|Natriuretic Agents|natriuretic agents|mesh-ancestor
101385747|NCT00082589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101385748|NCT00313924|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101385749|NCT00313924|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101385750|NCT00313924|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101385751|NCT00313924|Cholinergic Agents|cholinergic agents|mesh-ancestor
101385752|NCT00313924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101385753|NCT00313924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385754|NCT00313924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385755|NCT00313924|Urological Agents|urological agents|mesh-ancestor
101385756|NCT00306475|Valproic Acid|valproic acid|mesh-list
101385757|NCT00306475|Anticonvulsants|anticonvulsants|mesh-ancestor
101385758|NCT00306475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101385759|NCT00306475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385760|NCT00306475|GABA Agents|gaba agents|mesh-ancestor
101385761|NCT00306475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101385762|NCT00306475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385763|NCT00306475|Antimanic Agents|antimanic agents|mesh-ancestor
101385764|NCT00306475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101385765|NCT00306475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101385766|NCT00306475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101385767|NCT00082667|Gefitinib|gefitinib|mesh-list
101385768|NCT00082667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385769|NCT00082667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101385770|NCT00082667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101385771|NCT00082667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385772|NCT00306748|Linaclotide|linaclotide|mesh-list
101385773|NCT00306748|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
101385774|NCT00306748|Enzyme Activators|enzyme activators|mesh-ancestor
101385775|NCT00306748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385776|NCT00306748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101385777|NCT00082784|Bortezomib|bortezomib|mesh-list
101385778|NCT00082784|Alvocidib|alvocidib|mesh-list
101385779|NCT00082784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385785|NCT00082784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385787|NCT00306826|Simvastatin|simvastatin|mesh-list
101385788|NCT00306826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101385789|NCT00306826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101385790|NCT00306826|Antimetabolites|antimetabolites|mesh-ancestor
101385791|NCT00306826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385792|NCT00306826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101385793|NCT00306826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101385794|NCT00306826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101385795|NCT00306826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101385796|NCT00306826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385797|NCT00082823|Aflibercept|aflibercept|mesh-list
101385798|NCT00082823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101385802|NCT00082823|Growth Inhibitors|growth inhibitors|mesh-ancestor
101385803|NCT00082823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385804|NCT00087945|Lamivudine|lamivudine|mesh-list
101385805|NCT00087945|Zidovudine|zidovudine|mesh-list
101385806|NCT00087945|Abacavir|abacavir|mesh-list
101385807|NCT00087945|Dideoxynucleosides|dideoxynucleosides|mesh-list
101385808|NCT00087945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102073941|NCT00337454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073942|NCT02909907|Botulinum Toxins|botulinum toxins|mesh-list
102073943|NCT02909907|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102073944|NCT02909907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102073945|NCT02909907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073946|NCT02909907|Cholinergic Agents|cholinergic agents|mesh-ancestor
101385809|NCT00087945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101385810|NCT00087945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101305241|NCT02018276|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101305242|NCT02018276|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101305243|NCT02018276|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101385811|NCT00087945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385812|NCT00087945|Antiviral Agents|antiviral agents|mesh-ancestor
101385813|NCT00087945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101385814|NCT00087945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101385815|NCT00087945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101385816|NCT00087945|Antimetabolites|antimetabolites|mesh-ancestor
101385818|NCT00082862|Interferon-alpha|interferon-alpha|mesh-list
101385819|NCT00082862|Gemcitabine|gemcitabine|mesh-list
101316750|NCT00001014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101385820|NCT00082862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385821|NCT00082862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101385822|NCT00082862|Antimetabolites|antimetabolites|mesh-ancestor
101385823|NCT00082862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385824|NCT00082862|Antiviral Agents|antiviral agents|mesh-ancestor
101385825|NCT00082862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101385826|NCT00082862|Immunologic Factors|immunologic factors|mesh-ancestor
101385827|NCT00082862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385828|NCT00307099|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101385829|NCT00307099|Meropenem|meropenem|mesh-list
101385830|NCT00307099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101385831|NCT00082940|Denileukin diftitox|denileukin diftitox|mesh-list
101385832|NCT00082940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385833|NCT00307138|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
101385834|NCT00307138|Plasma Substitutes|plasma substitutes|mesh-ancestor
101385835|NCT00307138|Blood Substitutes|blood substitutes|mesh-ancestor
101385836|NCT00307177|Vaccines|vaccines|mesh-list
101385837|NCT00307177|Immunologic Factors|immunologic factors|mesh-ancestor
101385838|NCT00307177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385839|NCT00120705|Darbepoetin alfa|darbepoetin alfa|mesh-list
101385840|NCT00120705|Hematinics|hematinics|mesh-ancestor
101385841|NCT00307255|Paclitaxel|paclitaxel|mesh-list
101385842|NCT00307255|Gemcitabine|gemcitabine|mesh-list
101385843|NCT00307255|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101385844|NCT00307255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101385845|NCT00307255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385846|NCT00307255|Tubulin Modulators|tubulin modulators|mesh-ancestor
101385847|NCT00307255|Antimitotic Agents|antimitotic agents|mesh-ancestor
101385848|NCT00307255|Mitosis Modulators|mitosis modulators|mesh-ancestor
101385849|NCT00307255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385850|NCT00307255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101385854|NCT00307411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385855|NCT00307450|Levetiracetam|levetiracetam|mesh-list
101385856|NCT00307450|Anticonvulsants|anticonvulsants|mesh-ancestor
101385857|NCT00307450|Nootropic Agents|nootropic agents|mesh-ancestor
101385858|NCT00307528|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101385859|NCT00307528|Immunologic Factors|immunologic factors|mesh-ancestor
101385860|NCT00307528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385861|NCT00120744|Ondansetron|ondansetron|mesh-list
101385862|NCT00120744|Antiemetics|antiemetics|mesh-ancestor
101385863|NCT00120744|Autonomic Agents|autonomic agents|mesh-ancestor
101385864|NCT00120744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101385865|NCT00120744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385866|NCT00120744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101385867|NCT00120744|Antipruritics|antipruritics|mesh-ancestor
101385868|NCT00120744|Dermatologic Agents|dermatologic agents|mesh-ancestor
101385869|NCT00120744|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101385870|NCT00120744|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101385871|NCT00120744|Serotonin Agents|serotonin agents|mesh-ancestor
102073947|NCT02909907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102073948|NCT02909907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073949|NCT00004898|Cyclophosphamide|cyclophosphamide|mesh-list
102073950|NCT00004898|Etoposide|etoposide|mesh-list
102073951|NCT00004898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102073952|NCT00004898|Immunologic Factors|immunologic factors|mesh-ancestor
102073953|NCT00004898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073954|NCT00004898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101385872|NCT00120744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101385877|NCT00083057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385878|NCT00083057|Tubulin Modulators|tubulin modulators|mesh-ancestor
101385879|NCT00083057|Antimitotic Agents|antimitotic agents|mesh-ancestor
101385880|NCT00083057|Mitosis Modulators|mitosis modulators|mesh-ancestor
101387729|NCT04717531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385881|NCT00083057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385882|NCT00083057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101385883|NCT00083057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101385884|NCT00307606|Methylprednisolone|methylprednisolone|mesh-list
101305244|NCT02018276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101385885|NCT00307606|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101385886|NCT00307606|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101385887|NCT00307606|Prednisolone|prednisolone|mesh-list
101385888|NCT00307606|Prednisolone acetate|prednisolone acetate|mesh-list
101385889|NCT00307606|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101385890|NCT00307606|Prednisolone phosphate|prednisolone phosphate|mesh-list
101385891|NCT00307606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101385892|NCT00307606|Antiemetics|antiemetics|mesh-ancestor
101385893|NCT00307606|Autonomic Agents|autonomic agents|mesh-ancestor
101385894|NCT00307606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101385895|NCT00307606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385897|NCT00307606|Glucocorticoids|glucocorticoids|mesh-ancestor
101385898|NCT00307606|Hormones|hormones|mesh-ancestor
101385899|NCT00307606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101385900|NCT00307606|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101385901|NCT00307606|Protective Agents|protective agents|mesh-ancestor
101385902|NCT00307606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101385903|NCT00307606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385904|NCT00083096|Temozolomide|temozolomide|mesh-list
101385905|NCT00083096|Lonafarnib|lonafarnib|mesh-list
101385906|NCT00083096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101385907|NCT00083096|Alkylating Agents|alkylating agents|mesh-ancestor
101385908|NCT00083096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385909|NCT00083096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385910|NCT00083096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101385911|NCT00307645|Mycophenolic Acid|mycophenolic acid|mesh-list
101385912|NCT00307645|Prednisone|prednisone|mesh-list
101385913|NCT00307645|Methylprednisolone|methylprednisolone|mesh-list
101385914|NCT00307645|Cyclophosphamide|cyclophosphamide|mesh-list
101385915|NCT00307645|Azathioprine|azathioprine|mesh-list
101385916|NCT00307645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101385917|NCT00307645|Immunologic Factors|immunologic factors|mesh-ancestor
101385918|NCT00307645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385919|NCT00307645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101385920|NCT00307645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101385921|NCT00307645|Alkylating Agents|alkylating agents|mesh-ancestor
101385922|NCT00307645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385923|NCT00307645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385924|NCT00307645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101385925|NCT00307645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101385926|NCT00307645|Glucocorticoids|glucocorticoids|mesh-ancestor
101385927|NCT00307645|Hormones|hormones|mesh-ancestor
101385932|NCT00307645|Antitubercular Agents|antitubercular agents|mesh-ancestor
101385933|NCT00307645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101385934|NCT00307645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101385935|NCT00307645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101385936|NCT00307645|Antiemetics|antiemetics|mesh-ancestor
101385937|NCT00307645|Autonomic Agents|autonomic agents|mesh-ancestor
101385938|NCT00307645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101385939|NCT00307645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102073955|NCT00004898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102073956|NCT00004898|Alkylating Agents|alkylating agents|mesh-ancestor
102073957|NCT00004898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073958|NCT00004898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102073959|NCT00004898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101483774|NCT00338091|Losartan|losartan|mesh-list
101385940|NCT00307645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101385941|NCT00307645|Protective Agents|protective agents|mesh-ancestor
101385942|NCT00307645|Antimetabolites|antimetabolites|mesh-ancestor
101385943|NCT00307645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101385944|NCT00120783|Ritonavir|ritonavir|mesh-list
101385945|NCT00120783|Indinavir|indinavir|mesh-list
101385950|NCT00120783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101385951|NCT00120783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385952|NCT00120783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101385953|NCT00120783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101385954|NCT00120783|Antiviral Agents|antiviral agents|mesh-ancestor
101385955|NCT00120783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101385956|NCT00120783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101385957|NCT00120783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101385958|NCT00120783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101385959|NCT00120783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101385961|NCT00307723|Gemcitabine|gemcitabine|mesh-list
101385962|NCT00307723|Fluorouracil|fluorouracil|mesh-list
101385963|NCT00307723|Oxaliplatin|oxaliplatin|mesh-list
101305245|NCT02018276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305247|NCT02018289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101385964|NCT00307723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101385965|NCT00307723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385966|NCT00307723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101385967|NCT00307723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101385968|NCT00307723|Growth Substances|growth substances|mesh-ancestor
101385969|NCT00307723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385970|NCT00307723|Growth Inhibitors|growth inhibitors|mesh-ancestor
101385971|NCT00307723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101385972|NCT00307723|Antimetabolites|antimetabolites|mesh-ancestor
101385973|NCT00307723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385974|NCT00307723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101385975|NCT00307723|Immunologic Factors|immunologic factors|mesh-ancestor
101385976|NCT00083135|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
101385977|NCT00083135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385978|NCT00083135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387730|NCT04717531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101385979|NCT00083135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385980|NCT00083135|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101385981|NCT00120822|Folic Acid|folic acid|mesh-list
101385982|NCT00120822|Hematinics|hematinics|mesh-ancestor
101385983|NCT00120822|Vitamin B Complex|vitamin b complex|mesh-ancestor
101385984|NCT00120822|Vitamins|vitamins|mesh-ancestor
101385985|NCT00120822|Micronutrients|micronutrients|mesh-ancestor
101385986|NCT00120822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385987|NCT00083213|Aflibercept|aflibercept|mesh-list
101385988|NCT00083213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101385989|NCT00083213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101385990|NCT00083213|Growth Substances|growth substances|mesh-ancestor
101385991|NCT00083213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385992|NCT00083213|Growth Inhibitors|growth inhibitors|mesh-ancestor
101385993|NCT00083213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385994|NCT00307996|Ubiquinone|ubiquinone|mesh-list
101385995|NCT00307996|Coenzyme Q10|coenzyme q10|mesh-list
101385996|NCT00307996|Micronutrients|micronutrients|mesh-ancestor
101385997|NCT00307996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385998|NCT00307996|Vitamins|vitamins|mesh-ancestor
101385999|NCT00083252|Cisplatin|cisplatin|mesh-list
101386000|NCT00083252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101386001|NCT00418639|Nitazoxanide|nitazoxanide|mesh-list
101386008|NCT00418678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386009|NCT00418678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101386010|NCT00418678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101386011|NCT00418678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102073960|NCT00004898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102073961|NCT00004898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102073962|NCT00004898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101386012|NCT00418678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101386013|NCT00418678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101386014|NCT00120861|Interferons|interferons|mesh-list
101386015|NCT00120861|Ribavirin|ribavirin|mesh-list
101386016|NCT00120861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101386017|NCT00120861|Antiviral Agents|antiviral agents|mesh-ancestor
101386018|NCT00120861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101386019|NCT00120861|Antimetabolites|antimetabolites|mesh-ancestor
101386042|NCT00308191|Parasympatholytics|parasympatholytics|mesh-ancestor
101386043|NCT00308191|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101386044|NCT00308191|Cholinergic Agents|cholinergic agents|mesh-ancestor
101386045|NCT00308191|Anticonvulsants|anticonvulsants|mesh-ancestor
101386046|NCT00308269|Folic Acid|folic acid|mesh-list
101386047|NCT00308269|Vinca Alkaloids|vinca alkaloids|mesh-list
101386048|NCT00308269|Hematinics|hematinics|mesh-ancestor
101386049|NCT00308269|Vitamin B Complex|vitamin b complex|mesh-ancestor
101386050|NCT00308269|Vitamins|vitamins|mesh-ancestor
101386051|NCT00308269|Micronutrients|micronutrients|mesh-ancestor
101386052|NCT00308269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386053|NCT00308269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101386054|NCT00308269|Tubulin Modulators|tubulin modulators|mesh-ancestor
101386055|NCT00308269|Antimitotic Agents|antimitotic agents|mesh-ancestor
101386056|NCT00308269|Mitosis Modulators|mitosis modulators|mesh-ancestor
101386057|NCT00308269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316845|NCT00005843|Tipifarnib|tipifarnib|mesh-list
101305248|NCT02018289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101305249|NCT02018289|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101305250|NCT02018289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101305251|NCT02018289|Antimetabolites|antimetabolites|mesh-ancestor
101305252|NCT02018289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305253|NCT02018289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101305254|NCT02018328|Curcumin|curcumin|mesh-list
101305255|NCT02018328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101305256|NCT02018328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101305257|NCT02018328|Analgesics|analgesics|mesh-ancestor
101305258|NCT02018328|Sensory System Agents|sensory system agents|mesh-ancestor
101386058|NCT00308425|Mycophenolic Acid|mycophenolic acid|mesh-list
101386059|NCT00308425|Valsartan|valsartan|mesh-list
101386060|NCT00308425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101386061|NCT00308425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101386062|NCT00308425|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101386063|NCT00308425|Antitubercular Agents|antitubercular agents|mesh-ancestor
101386064|NCT00308425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101386065|NCT00308425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101386066|NCT00308425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101386067|NCT00308425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386068|NCT00308425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101386069|NCT00308425|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101386070|NCT00308425|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101386071|NCT00308503|SR 46349B|sr 46349b|mesh-list
101386073|NCT00308503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101386074|NCT00308503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386075|NCT00308503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101386076|NCT00308503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101386077|NCT00308503|Serotonin Agents|serotonin agents|mesh-ancestor
101386078|NCT00308503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101386079|NCT00308503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386080|NCT00308542|Dexamethasone|dexamethasone|mesh-list
101386081|NCT00308542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101386082|NCT00308542|Antiemetics|antiemetics|mesh-ancestor
101386083|NCT00308542|Autonomic Agents|autonomic agents|mesh-ancestor
101386088|NCT00308542|Hormones|hormones|mesh-ancestor
101386089|NCT00308542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101386090|NCT00308542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101386091|NCT00308542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101386092|NCT00308776|Cholecystokinin|cholecystokinin|mesh-list
101386093|NCT00308776|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101386094|NCT00308776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101386095|NCT00083408|Pamidronate|pamidronate|mesh-list
102073964|NCT02106468|Prednisone|prednisone|mesh-list
102073965|NCT02106468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102073966|NCT02106468|Glucocorticoids|glucocorticoids|mesh-ancestor
102073967|NCT02106468|Hormones|hormones|mesh-ancestor
102073968|NCT02106468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102073969|NCT02106468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073970|NCT02106468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102073971|NCT02106468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102073972|NCT03956446|Doxycycline|doxycycline|mesh-list
102073973|NCT03956446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101386096|NCT00083408|Thalidomide|thalidomide|mesh-list
101386097|NCT00083408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101386098|NCT00083408|Immunologic Factors|immunologic factors|mesh-ancestor
101386099|NCT00083408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386100|NCT00083408|Leprostatic Agents|leprostatic agents|mesh-ancestor
101386101|NCT00083408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101386102|NCT00083408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101386103|NCT00083408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101386104|NCT00083408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101386105|NCT00083408|Growth Substances|growth substances|mesh-ancestor
101386106|NCT00083408|Growth Inhibitors|growth inhibitors|mesh-ancestor
101386107|NCT00083408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101386108|NCT00083408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101386109|NCT00308971|Vitamin E|vitamin e|mesh-list
101305259|NCT02018328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101305260|NCT02018328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305261|NCT02018328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101305262|NCT02018328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101386110|NCT00308971|Tocopherols|tocopherols|mesh-list
101386111|NCT00308971|Tocotrienols|tocotrienols|mesh-list
101386112|NCT00308971|alpha-Tocopherol|alpha-tocopherol|mesh-list
101386113|NCT00308971|Thioctic Acid|thioctic acid|mesh-list
101386114|NCT00308971|Vitamins|vitamins|mesh-ancestor
101386115|NCT00308971|Micronutrients|micronutrients|mesh-ancestor
101386116|NCT00308971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386117|NCT00308971|Antioxidants|antioxidants|mesh-ancestor
101386118|NCT00308971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386119|NCT00308971|Protective Agents|protective agents|mesh-ancestor
101386120|NCT00308971|Vitamin B Complex|vitamin b complex|mesh-ancestor
101386121|NCT00120939|Motexafin gadolinium|motexafin gadolinium|mesh-list
101386122|NCT00120939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101386123|NCT00120939|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101386125|NCT00309049|Epothilones|epothilones|mesh-list
101386126|NCT00309049|Tubulin Modulators|tubulin modulators|mesh-ancestor
101386127|NCT00309049|Antimitotic Agents|antimitotic agents|mesh-ancestor
101386128|NCT00309049|Mitosis Modulators|mitosis modulators|mesh-ancestor
101386129|NCT00309049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386130|NCT00309049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101386131|NCT00309088|Tacrolimus|tacrolimus|mesh-list
101386132|NCT00309088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101386133|NCT00309088|Immunologic Factors|immunologic factors|mesh-ancestor
101386134|NCT00309088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386135|NCT00309088|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101386136|NCT00309088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101386137|NCT00309088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386138|NCT00083486|Epoetin Alfa|epoetin alfa|mesh-list
101386139|NCT00083486|Hematinics|hematinics|mesh-ancestor
101386140|NCT00120978|Fluticasone|fluticasone|mesh-list
101386141|NCT00120978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101386142|NCT00120978|Autonomic Agents|autonomic agents|mesh-ancestor
101386143|NCT00120978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101386144|NCT00120978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386145|NCT00120978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101386146|NCT00120978|Respiratory System Agents|respiratory system agents|mesh-ancestor
102073974|NCT03956446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102073975|NCT03956446|Antimalarials|antimalarials|mesh-ancestor
102073976|NCT03956446|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102073977|NCT03956446|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102073979|NCT00325364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101575048|NCT02759887|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102073980|NCT00325364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102073981|NCT00325364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073982|NCT02104674|Montelukast|montelukast|mesh-list
102073983|NCT02104674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102073984|NCT02104674|Respiratory System Agents|respiratory system agents|mesh-ancestor
102073985|NCT02104674|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102073986|NCT02104674|Hormone Antagonists|hormone antagonists|mesh-ancestor
102073987|NCT02104674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102073988|NCT02104674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375649|NCT00234598|Disinfectants|disinfectants|mesh-ancestor
101386147|NCT00120978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101386148|NCT00120978|Dermatologic Agents|dermatologic agents|mesh-ancestor
101386153|NCT00309205|Antiviral Agents|antiviral agents|mesh-ancestor
101386154|NCT00309205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101386155|NCT00309283|Somatostatin|somatostatin|mesh-list
101386156|NCT00309283|Hormones|hormones|mesh-ancestor
101386160|NCT00083525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101386161|NCT00083525|Antimetabolites|antimetabolites|mesh-ancestor
101386162|NCT00083525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386163|NCT00083525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101386164|NCT00309322|Phentolamine|phentolamine|mesh-list
101386165|NCT00309322|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101386166|NCT00309322|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101386167|NCT00309322|Adrenergic Agents|adrenergic agents|mesh-ancestor
101386168|NCT00309322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101386169|NCT00309322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386170|NCT00309322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386171|NCT00309322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101386172|NCT04727502|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101386173|NCT04727502|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101386174|NCT04727502|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101386175|NCT04727502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101386176|NCT04727502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386177|NCT04727502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101386178|NCT04727502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305263|NCT02018328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101305264|NCT02018328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101305265|NCT02018328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386179|NCT04727502|Analgesics|analgesics|mesh-ancestor
101386180|NCT04727502|Sensory System Agents|sensory system agents|mesh-ancestor
101386181|NCT04727502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101386182|NCT04727502|Antidepressive Agents|antidepressive agents|mesh-ancestor
101386183|NCT04727502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101386184|NCT04727502|Dopamine Agents|dopamine agents|mesh-ancestor
101386185|NCT00309361|Phentolamine|phentolamine|mesh-list
101386186|NCT00309361|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101386187|NCT00309361|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101386188|NCT00309361|Adrenergic Agents|adrenergic agents|mesh-ancestor
101386189|NCT00309361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102073989|NCT02104674|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102073990|NCT02104674|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102073991|NCT02104674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102073992|NCT01903330|Cyclophosphamide|cyclophosphamide|mesh-list
102073993|NCT01903330|Bevacizumab|bevacizumab|mesh-list
102073994|NCT01903330|Sargramostim|sargramostim|mesh-list
102073995|NCT01903330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102073996|NCT01903330|Immunologic Factors|immunologic factors|mesh-ancestor
101386190|NCT00309361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386191|NCT00309361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386192|NCT00309361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101386193|NCT00088491|Olanzapine|olanzapine|mesh-list
101386194|NCT00088491|Antiemetics|antiemetics|mesh-ancestor
101386195|NCT00088491|Autonomic Agents|autonomic agents|mesh-ancestor
101386196|NCT00088491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101386197|NCT00088491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386198|NCT00088491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101386199|NCT00088491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101386200|NCT00088491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101386201|NCT00088491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101386202|NCT00088491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101386203|NCT00088491|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101386204|NCT00088491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101386205|NCT00088491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101386206|NCT00088491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386207|NCT00088491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101386208|NCT00088491|Serotonin Agents|serotonin agents|mesh-ancestor
101386209|NCT00309517|Leucovorin|leucovorin|mesh-list
101386210|NCT00309517|Edrecolomab|edrecolomab|mesh-list
101386211|NCT00309517|Antidotes|antidotes|mesh-ancestor
101386212|NCT00309517|Protective Agents|protective agents|mesh-ancestor
101386213|NCT00309517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386214|NCT00309517|Vitamin B Complex|vitamin b complex|mesh-ancestor
101386215|NCT00309517|Vitamins|vitamins|mesh-ancestor
101386216|NCT00309517|Micronutrients|micronutrients|mesh-ancestor
101386217|NCT00309517|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101386218|NCT00309517|Immunologic Factors|immunologic factors|mesh-ancestor
101386219|NCT00121017|Ritonavir|ritonavir|mesh-list
101386224|NCT00121017|Efavirenz|efavirenz|mesh-list
101386225|NCT00121017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101386226|NCT00121017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101386227|NCT00121017|Protease Inhibitors|protease inhibitors|mesh-ancestor
101386235|NCT00121017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101386236|NCT00121017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101386237|NCT00121017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101386238|NCT00121017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101386239|NCT00121017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101386240|NCT00121017|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101386241|NCT00121017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101386242|NCT00121017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101386243|NCT00309556|Docetaxel|docetaxel|mesh-list
101386244|NCT00309556|Capecitabine|capecitabine|mesh-list
101386245|NCT00309556|Trastuzumab|trastuzumab|mesh-list
101386246|NCT00309556|Epirubicin|epirubicin|mesh-list
101386247|NCT00309556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101386248|NCT00309556|Tubulin Modulators|tubulin modulators|mesh-ancestor
101386249|NCT00309556|Antimitotic Agents|antimitotic agents|mesh-ancestor
101386250|NCT00309556|Mitosis Modulators|mitosis modulators|mesh-ancestor
101386251|NCT00309556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305267|NCT02018367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101305268|NCT02018367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101305269|NCT02018419|Vaccines|vaccines|mesh-list
101386252|NCT00309556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101386253|NCT00309556|Antimetabolites|antimetabolites|mesh-ancestor
101386254|NCT00309556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101386255|NCT00309556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102073997|NCT01903330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102073998|NCT01903330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102073999|NCT01903330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102074000|NCT01903330|Alkylating Agents|alkylating agents|mesh-ancestor
102074001|NCT01903330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386256|NCT00309556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101386257|NCT00309556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101386258|NCT00309556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101386259|NCT00402207|Fluticasone|fluticasone|mesh-list
101386260|NCT00402207|Beclomethasone|beclomethasone|mesh-list
101386261|NCT00402207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101386262|NCT00402207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101386263|NCT00402207|Autonomic Agents|autonomic agents|mesh-ancestor
101386264|NCT00402207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101386265|NCT00402207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386266|NCT00402207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101386267|NCT00402207|Respiratory System Agents|respiratory system agents|mesh-ancestor
101386268|NCT00402207|Dermatologic Agents|dermatologic agents|mesh-ancestor
101386269|NCT00402207|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101386270|NCT00402207|Glucocorticoids|glucocorticoids|mesh-ancestor
101386271|NCT00402207|Hormones|hormones|mesh-ancestor
101386272|NCT00402207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101386273|NCT00399737|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101386274|NCT00399737|Protease Inhibitors|protease inhibitors|mesh-ancestor
101386275|NCT00399737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101386276|NCT00399737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386277|NCT00309634|Vaccines|vaccines|mesh-list
101386278|NCT00309634|Immunologic Factors|immunologic factors|mesh-ancestor
101386279|NCT00309634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386280|NCT00309712|Simvastatin|simvastatin|mesh-list
101386281|NCT00309712|Fenofibrate|fenofibrate|mesh-list
101386282|NCT00309712|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101386283|NCT00309712|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101386284|NCT00309712|Antimetabolites|antimetabolites|mesh-ancestor
101386285|NCT00309712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386286|NCT00309712|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101386287|NCT00309712|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101386288|NCT00309712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101386293|NCT00309790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101316940|NCT00001083|Indinavir|indinavir|mesh-list
101386297|NCT00309790|Urological Agents|urological agents|mesh-ancestor
101386298|NCT00418873|Risperidone|risperidone|mesh-list
101386299|NCT00418873|Zotepine|zotepine|mesh-list
101386300|NCT00418873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101386301|NCT00418873|Serotonin Agents|serotonin agents|mesh-ancestor
101386302|NCT00418873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101386303|NCT00418873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386304|NCT00418873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386305|NCT00418873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101386306|NCT00418873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101386307|NCT00418873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101386308|NCT00418873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101386309|NCT00418873|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101386310|NCT00418873|Dopamine Agents|dopamine agents|mesh-ancestor
101386311|NCT00088608|Pasireotide|pasireotide|mesh-list
101386312|NCT00088608|Hormones|hormones|mesh-ancestor
101386313|NCT00088608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101386314|NCT00088608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386315|NCT00310024|Bortezomib|bortezomib|mesh-list
101386316|NCT00310024|Vorinostat|vorinostat|mesh-list
101386317|NCT00310024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101386318|NCT00310024|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101386319|NCT00310024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101386320|NCT00310024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386321|NCT00310141|Nicotine|nicotine|mesh-list
101386322|NCT00310141|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101305271|NCT02018419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074002|NCT01903330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102074003|NCT01903330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101386324|NCT00310141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101386325|NCT00310141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386326|NCT00310141|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101386327|NCT00310141|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101386328|NCT00310141|Cholinergic Agents|cholinergic agents|mesh-ancestor
101386329|NCT00310141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101386330|NCT00310141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386331|NCT00088686|Capsaicin|capsaicin|mesh-list
101386332|NCT00088686|Antipruritics|antipruritics|mesh-ancestor
101386333|NCT00088686|Dermatologic Agents|dermatologic agents|mesh-ancestor
101386334|NCT00088686|Sensory System Agents|sensory system agents|mesh-ancestor
101386335|NCT00088686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101386336|NCT00088686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386337|NCT00083681|Thalidomide|thalidomide|mesh-list
101386338|NCT00083681|Dexamethasone|dexamethasone|mesh-list
101386339|NCT00083681|Etoposide|etoposide|mesh-list
101386340|NCT00083681|Cyclophosphamide|cyclophosphamide|mesh-list
101386341|NCT00083681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101386342|NCT00083681|Antiemetics|antiemetics|mesh-ancestor
101386343|NCT00083681|Autonomic Agents|autonomic agents|mesh-ancestor
101386344|NCT00083681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101386345|NCT00083681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386346|NCT00083681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101386347|NCT00083681|Glucocorticoids|glucocorticoids|mesh-ancestor
101386348|NCT00083681|Hormones|hormones|mesh-ancestor
101386349|NCT00083681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101386350|NCT00083681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101386351|NCT00083681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101386352|NCT00083681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101386353|NCT00083681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101386354|NCT00083681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101386355|NCT00083681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387731|NCT04717531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101386356|NCT00083681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386357|NCT00083681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101386358|NCT00083681|Immunologic Factors|immunologic factors|mesh-ancestor
101386359|NCT00083681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101386361|NCT00083681|Alkylating Agents|alkylating agents|mesh-ancestor
101386362|NCT00083681|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101386363|NCT00083681|Leprostatic Agents|leprostatic agents|mesh-ancestor
101386364|NCT00083681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101386365|NCT00083681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101386376|NCT00121095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386377|NCT00121095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101386378|NCT00121095|Analgesics|analgesics|mesh-ancestor
101386379|NCT00121095|Sensory System Agents|sensory system agents|mesh-ancestor
101386380|NCT00121095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101386381|NCT00121095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386382|NCT00310297|Insulin glulisine|insulin glulisine|mesh-list
101386383|NCT00310297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101386384|NCT00310297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386385|NCT00310336|Interferons|interferons|mesh-list
101386386|NCT00310336|Ribavirin|ribavirin|mesh-list
101386387|NCT00310336|Interferon-alpha|interferon-alpha|mesh-list
101386388|NCT00310336|Interferon alpha-2|interferon alpha-2|mesh-list
101386389|NCT00310336|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101386390|NCT00310336|Betaine|betaine|mesh-list
101386391|NCT00310336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101386392|NCT00310336|Antiviral Agents|antiviral agents|mesh-ancestor
101386393|NCT00310336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101386394|NCT00310336|Antimetabolites|antimetabolites|mesh-ancestor
101386395|NCT00310336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386396|NCT00310336|Immunologic Factors|immunologic factors|mesh-ancestor
101305273|NCT02018523|Immunologic Factors|immunologic factors|mesh-ancestor
101386397|NCT00310336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386398|NCT00310336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101386399|NCT00310336|Lipotropic Agents|lipotropic agents|mesh-ancestor
101386400|NCT00310336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101386401|NCT00310336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101386402|NCT05568602|Dexamethasone|dexamethasone|mesh-list
101386403|NCT05568602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101386404|NCT05568602|Antiemetics|antiemetics|mesh-ancestor
102074004|NCT01903330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102074005|NCT01903330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102074006|NCT01903330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102074007|NCT01903330|Growth Substances|growth substances|mesh-ancestor
101386405|NCT05568602|Autonomic Agents|autonomic agents|mesh-ancestor
101386406|NCT05568602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101386407|NCT05568602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386408|NCT05568602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101386409|NCT05568602|Glucocorticoids|glucocorticoids|mesh-ancestor
101386410|NCT05568602|Hormones|hormones|mesh-ancestor
101386411|NCT05568602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101386412|NCT05568602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101386413|NCT05568602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101386414|NCT00310492|Immunomodulating Agents|immunomodulating agents|mesh-list
101386415|NCT00310492|Immunologic Factors|immunologic factors|mesh-ancestor
101386416|NCT00310492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386417|NCT00310531|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101386418|NCT00310531|Estradiol|estradiol|mesh-list
101386419|NCT00310531|Estrogens|estrogens|mesh-ancestor
101386420|NCT00310531|Hormones|hormones|mesh-ancestor
101386421|NCT00310531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101386422|NCT00310531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386423|NCT00310531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101386424|NCT00310531|Hormone Antagonists|hormone antagonists|mesh-ancestor
101386425|NCT00310531|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101386426|NCT00310531|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101386427|NCT00310531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101386428|NCT00309673|Lidocaine|lidocaine|mesh-list
101386429|NCT00309673|Prilocaine|prilocaine|mesh-list
101386430|NCT00309673|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
101386431|NCT00309673|Anesthetics, Local|anesthetics, local|mesh-ancestor
101386440|NCT00309673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101386441|NCT00309673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386442|NCT00309673|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
101386445|NCT00310765|Analgesics|analgesics|mesh-ancestor
101386446|NCT00310765|Sensory System Agents|sensory system agents|mesh-ancestor
101386447|NCT00310765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101386448|NCT00310765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386449|NCT00310765|Anticonvulsants|anticonvulsants|mesh-ancestor
101386450|NCT00310765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101386451|NCT00310765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101386452|NCT00310765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386453|NCT00310765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101386454|NCT00310765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101386455|NCT00310765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101386456|NCT00310765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101386457|NCT00310765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101386458|NCT00310765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101386459|NCT00310765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101386460|NCT00310765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101386461|NCT00310765|Antimanic Agents|antimanic agents|mesh-ancestor
101386462|NCT00310843|Nevirapine|nevirapine|mesh-list
101386463|NCT00310843|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101386464|NCT00310843|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101386465|NCT00310843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101386466|NCT00310843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305274|NCT02018523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305275|NCT02018523|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101305276|NCT02018523|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101305277|NCT02018523|Growth Substances|growth substances|mesh-ancestor
101305278|NCT02018523|Growth Inhibitors|growth inhibitors|mesh-ancestor
101386467|NCT00310843|Antiviral Agents|antiviral agents|mesh-ancestor
101386468|NCT00310843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101386469|NCT00310843|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101386470|NCT00310843|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101386471|NCT00310843|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101386472|NCT00310843|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102074008|NCT01903330|Growth Inhibitors|growth inhibitors|mesh-ancestor
102074009|NCT02907177|Ponesimod|ponesimod|mesh-list
102074010|NCT02907177|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102074011|NCT02907177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074012|NCT02907177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102074013|NCT02907177|Immunologic Factors|immunologic factors|mesh-ancestor
101375685|NCT00234871|Vasodilator Agents|vasodilator agents|mesh-ancestor
101386473|NCT00310921|Misoprostol|misoprostol|mesh-list
101386474|NCT00310921|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101386475|NCT00310921|Abortifacient Agents|abortifacient agents|mesh-ancestor
101386476|NCT00310921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101386477|NCT00310921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386478|NCT00310921|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101386479|NCT00310921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101386480|NCT00310921|Oxytocics|oxytocics|mesh-ancestor
101386481|NCT05568212|Durvalumab|durvalumab|mesh-list
101386482|NCT05568212|Olaparib|olaparib|mesh-list
101386483|NCT05568212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101386484|NCT05568212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101386485|NCT05568212|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101386486|NCT05568212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101386487|NCT05568212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386488|NCT00121329|Lidocaine|lidocaine|mesh-list
101386489|NCT00121329|Anesthetics, Local|anesthetics, local|mesh-ancestor
101386490|NCT00121329|Anesthetics|anesthetics|mesh-ancestor
101386491|NCT00121329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101386492|NCT00121329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386493|NCT00121329|Sensory System Agents|sensory system agents|mesh-ancestor
101386494|NCT00121329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101386499|NCT00121329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386500|NCT00311038|Landiolol|landiolol|mesh-list
101386501|NCT00311038|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101386502|NCT00311038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101386503|NCT00311038|Adrenergic Agents|adrenergic agents|mesh-ancestor
101386506|NCT00311038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386507|NCT00311038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101386508|NCT00311077|Insulin glulisine|insulin glulisine|mesh-list
101386509|NCT00311077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101386510|NCT00311077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386512|NCT00311116|Vitamins|vitamins|mesh-ancestor
101386513|NCT00311116|Micronutrients|micronutrients|mesh-ancestor
101386514|NCT00311116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386515|NCT00311116|Antioxidants|antioxidants|mesh-ancestor
101386516|NCT00311116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386517|NCT00311116|Protective Agents|protective agents|mesh-ancestor
101386518|NCT00088959|Celecoxib|celecoxib|mesh-list
101386519|NCT00088959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101386520|NCT00088959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101386521|NCT00088959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101386522|NCT00088959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101386523|NCT00088959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386524|NCT00088959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101386525|NCT00088959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101386526|NCT00088959|Analgesics|analgesics|mesh-ancestor
101386527|NCT00088959|Sensory System Agents|sensory system agents|mesh-ancestor
101386528|NCT00088959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101386529|NCT00088959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386530|NCT00088959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101386531|NCT00088959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101386532|NCT00088959|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101386533|NCT00088959|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101305279|NCT02018523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101305280|NCT02018536|Simeprevir|simeprevir|mesh-list
101305281|NCT02018536|Antiviral Agents|antiviral agents|mesh-ancestor
101386534|NCT05568017|Edotreotide|edotreotide|mesh-list
101386535|NCT05568017|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102074014|NCT02907177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074015|NCT00004172|Cyclophosphamide|cyclophosphamide|mesh-list
102074016|NCT00004172|Ifosfamide|ifosfamide|mesh-list
102074017|NCT00004172|Thiotepa|thiotepa|mesh-list
102074018|NCT00004172|Carboplatin|carboplatin|mesh-list
102074019|NCT00004172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102074020|NCT00004172|Immunologic Factors|immunologic factors|mesh-ancestor
102074021|NCT00004172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386536|NCT05568017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386537|NCT00311389|Timolol|timolol|mesh-list
101386538|NCT00311389|Travoprost|travoprost|mesh-list
101386539|NCT00311389|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101386540|NCT00311389|Latanoprost|latanoprost|mesh-list
101386541|NCT00311389|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101386542|NCT00311389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386543|NCT00311389|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101386544|NCT00311389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101386545|NCT00311389|Adrenergic Agents|adrenergic agents|mesh-ancestor
101386546|NCT00311389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101386547|NCT00311389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386548|NCT00311389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101386549|NCT00311389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101386550|NCT00088998|Bevacizumab|bevacizumab|mesh-list
101386551|NCT00088998|Docetaxel|docetaxel|mesh-list
101386552|NCT00088998|Capecitabine|capecitabine|mesh-list
101386553|NCT00088998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101386554|NCT00088998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101386555|NCT00088998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101386556|NCT00088998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101386557|NCT00088998|Growth Substances|growth substances|mesh-ancestor
101386558|NCT00088998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386559|NCT00088998|Growth Inhibitors|growth inhibitors|mesh-ancestor
101386560|NCT00088998|Tubulin Modulators|tubulin modulators|mesh-ancestor
101386561|NCT00088998|Antimitotic Agents|antimitotic agents|mesh-ancestor
101386562|NCT00088998|Mitosis Modulators|mitosis modulators|mesh-ancestor
101386563|NCT00088998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386564|NCT00088998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101386573|NCT00311467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101386574|NCT00311545|Siltuximab|siltuximab|mesh-list
101386575|NCT00311545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101386576|NCT00089037|Sirolimus|sirolimus|mesh-list
101386577|NCT00089037|Methotrexate|methotrexate|mesh-list
101386584|NCT00089037|Antimetabolites|antimetabolites|mesh-ancestor
101386585|NCT00089037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386586|NCT00089037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101386587|NCT00089037|Dermatologic Agents|dermatologic agents|mesh-ancestor
101386588|NCT00089037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101386589|NCT00089037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101386590|NCT00089037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101386591|NCT00089037|Immunologic Factors|immunologic factors|mesh-ancestor
101386592|NCT00089037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101386593|NCT00089037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101386594|NCT00089037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101386595|NCT00089037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101386596|NCT00089037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101386597|NCT00089037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101386598|NCT00089037|Antifungal Agents|antifungal agents|mesh-ancestor
101386599|NCT00311740|Valsartan|valsartan|mesh-list
101386600|NCT00311740|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101386601|NCT00311740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101386602|NCT00311740|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101386603|NCT00311740|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101386604|NCT00311740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386605|NCT00311740|Diuretics|diuretics|mesh-ancestor
101386606|NCT00311740|Natriuretic Agents|natriuretic agents|mesh-ancestor
101386607|NCT00311740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386608|NCT00311740|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101386609|NCT00311740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101375699|NCT00234910|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102074022|NCT00004172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102074023|NCT00004172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102074024|NCT00004172|Alkylating Agents|alkylating agents|mesh-ancestor
102074025|NCT00004172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074026|NCT00004172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102074027|NCT00004172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102074028|NCT04353310|Curcumin|curcumin|mesh-list
101386610|NCT00311818|Insulin Glargine|insulin glargine|mesh-list
101386611|NCT00311818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101305282|NCT02018536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101305283|NCT02018536|Protease Inhibitors|protease inhibitors|mesh-ancestor
101305284|NCT02018536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101386612|NCT00311818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386614|NCT00121407|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101386615|NCT00121407|Dermatologic Agents|dermatologic agents|mesh-ancestor
101386616|NCT00311857|Cetuximab|cetuximab|mesh-list
101386617|NCT00311857|Temozolomide|temozolomide|mesh-list
101386618|NCT00311857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101386619|NCT00311857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101386620|NCT00311857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101386621|NCT00311857|Alkylating Agents|alkylating agents|mesh-ancestor
101386622|NCT00311857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386623|NCT00311896|Bemiparin|bemiparin|mesh-list
101386624|NCT00311896|Anticoagulants|anticoagulants|mesh-ancestor
101386625|NCT00121446|Enoxaparin|enoxaparin|mesh-list
101386626|NCT00121446|Tenecteplase|tenecteplase|mesh-list
101386627|NCT00121446|Clopidogrel|clopidogrel|mesh-list
101386628|NCT00121446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101386629|NCT00121446|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101386630|NCT00121446|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101386631|NCT00121446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101386632|NCT00121446|Purinergic Agents|purinergic agents|mesh-ancestor
101386633|NCT00121446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101386634|NCT00121446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386635|NCT00121446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386636|NCT00121446|Anticoagulants|anticoagulants|mesh-ancestor
101386637|NCT00121446|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101386638|NCT00121446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101386653|NCT00121524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386655|NCT00121524|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101386656|NCT00121524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101386657|NCT00121524|Autonomic Agents|autonomic agents|mesh-ancestor
101386658|NCT00121524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101386659|NCT00121524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101386660|NCT00121524|Respiratory System Agents|respiratory system agents|mesh-ancestor
101386661|NCT00121524|Mydriatics|mydriatics|mesh-ancestor
101386662|NCT00121524|Sympathomimetics|sympathomimetics|mesh-ancestor
101386663|NCT00121524|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101386664|NCT00121524|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101386665|NCT00121524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101386666|NCT00121524|Parasympatholytics|parasympatholytics|mesh-ancestor
101386667|NCT00121524|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101386668|NCT00121524|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101386669|NCT00121524|Cholinergic Agents|cholinergic agents|mesh-ancestor
101386670|NCT00121524|Vasodilator Agents|vasodilator agents|mesh-ancestor
101386671|NCT00121524|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101386672|NCT00121524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101386673|NCT00121524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101386674|NCT00121524|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101386675|NCT00121524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101386676|NCT00121524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101386677|NCT00121524|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101386678|NCT00121524|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101386679|NCT00121524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101386680|NCT00312130|Vildagliptin|vildagliptin|mesh-list
102074029|NCT04353310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102074030|NCT04353310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102074031|NCT04353310|Analgesics|analgesics|mesh-ancestor
102074032|NCT04353310|Sensory System Agents|sensory system agents|mesh-ancestor
102074033|NCT04353310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102074034|NCT04353310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074035|NCT04353310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102074036|NCT04353310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101386681|NCT00312130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101386682|NCT00312130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386683|NCT00312130|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101386684|NCT00312130|Protease Inhibitors|protease inhibitors|mesh-ancestor
101386685|NCT00312130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101456554|NCT04662385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305285|NCT02018536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305286|NCT02018588|Tryptophan|tryptophan|mesh-list
101305287|NCT02018588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101305288|NCT02018588|Antidepressive Agents|antidepressive agents|mesh-ancestor
101386686|NCT00312130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386688|NCT00089115|Immunoglobulins|immunoglobulins|mesh-list
101386689|NCT00089115|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101386690|NCT00089115|Antibodies|antibodies|mesh-list
101386691|NCT00089115|Sargramostim|sargramostim|mesh-list
101386692|NCT00089115|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
101387732|NCT04717531|Alkylating Agents|alkylating agents|mesh-ancestor
101386693|NCT00089115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101386694|NCT00089115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101386695|NCT00089115|Immunologic Factors|immunologic factors|mesh-ancestor
101386696|NCT00089115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386697|NCT00089115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101386698|NCT00312325|Prednisolone|prednisolone|mesh-list
101386699|NCT00312325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101386700|NCT00312325|Glucocorticoids|glucocorticoids|mesh-ancestor
101386701|NCT00312325|Hormones|hormones|mesh-ancestor
101386702|NCT00312325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101386703|NCT00312325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386704|NCT00312325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101386705|NCT00312325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101386711|NCT00089154|Immunoglobulins|immunoglobulins|mesh-list
101386712|NCT00089154|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101386713|NCT00089154|Immunologic Factors|immunologic factors|mesh-ancestor
101386714|NCT00089154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386715|NCT00089154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101386716|NCT00312481|Ascorbic Acid|ascorbic acid|mesh-list
101386717|NCT00312481|Magnesium citrate|magnesium citrate|mesh-list
101386730|NCT00312520|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101386731|NCT00312520|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101386733|NCT00312520|Prednisolone acetate|prednisolone acetate|mesh-list
101386734|NCT00312520|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101386735|NCT00312520|Prednisolone phosphate|prednisolone phosphate|mesh-list
101386736|NCT00312520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101386737|NCT00312520|Antiemetics|antiemetics|mesh-ancestor
101386738|NCT00312520|Autonomic Agents|autonomic agents|mesh-ancestor
101386739|NCT00312520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101386740|NCT00312520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386741|NCT00312520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101386742|NCT00312520|Glucocorticoids|glucocorticoids|mesh-ancestor
101386743|NCT00312520|Hormones|hormones|mesh-ancestor
101386744|NCT00312520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101386745|NCT00312520|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101386746|NCT00312520|Protective Agents|protective agents|mesh-ancestor
101386747|NCT00312520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101386748|NCT00312520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101386749|NCT00089193|Sargramostim|sargramostim|mesh-list
101386750|NCT00089193|Freund's Adjuvant|freund's adjuvant|mesh-list
101386751|NCT00089193|Immunologic Factors|immunologic factors|mesh-ancestor
101386752|NCT00089193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074037|NCT04353310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102074038|NCT04353310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102074039|NCT04353310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074041|NCT00004166|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102074042|NCT00004166|Protective Agents|protective agents|mesh-ancestor
102074043|NCT00004166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074044|NCT00004106|Temozolomide|temozolomide|mesh-list
102074045|NCT00004106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102074046|NCT00004106|Alkylating Agents|alkylating agents|mesh-ancestor
101375713|NCT00234988|Appetite Depressants|appetite depressants|mesh-ancestor
101386753|NCT00089193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101386754|NCT00293098|Deferiprone|deferiprone|mesh-list
101386755|NCT00293098|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101386756|NCT00293098|Chelating Agents|chelating agents|mesh-ancestor
101386757|NCT00293098|Sequestering Agents|sequestering agents|mesh-ancestor
101386758|NCT00293098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386759|NCT00293176|Donepezil|donepezil|mesh-list
101386760|NCT00293176|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101386761|NCT00293176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101386762|NCT00293176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386763|NCT00293176|Cholinergic Agents|cholinergic agents|mesh-ancestor
101386764|NCT00293176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101386765|NCT00293176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386766|NCT00293176|Nootropic Agents|nootropic agents|mesh-ancestor
101305289|NCT02018588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101305290|NCT02018601|Acetaminophen|acetaminophen|mesh-list
101386767|NCT00121563|Thalidomide|thalidomide|mesh-list
101386768|NCT00121563|Ibuprofen|ibuprofen|mesh-list
101386769|NCT00121563|Diazepam|diazepam|mesh-list
101386770|NCT00121563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101386771|NCT00121563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101386772|NCT00121563|Analgesics|analgesics|mesh-ancestor
101386773|NCT00121563|Sensory System Agents|sensory system agents|mesh-ancestor
101386774|NCT00121563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101386775|NCT00121563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386776|NCT00121563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101386777|NCT00121563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101386778|NCT00121563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101386779|NCT00121563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101386780|NCT00121563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386781|NCT00121563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101386782|NCT00121563|Immunologic Factors|immunologic factors|mesh-ancestor
101386787|NCT00121563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101386788|NCT00121563|Growth Substances|growth substances|mesh-ancestor
101386789|NCT00121563|Growth Inhibitors|growth inhibitors|mesh-ancestor
101386790|NCT00121563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101386796|NCT00121563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101386797|NCT00121563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101386798|NCT00121563|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101386799|NCT00121563|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101386800|NCT00121563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101386801|NCT00121563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101386802|NCT00121563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101386803|NCT00121563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101386804|NCT00121563|Anesthetics, General|anesthetics, general|mesh-ancestor
101386805|NCT00121563|Anesthetics|anesthetics|mesh-ancestor
101386806|NCT00121563|GABA Modulators|gaba modulators|mesh-ancestor
101386807|NCT00121563|GABA Agents|gaba agents|mesh-ancestor
101386808|NCT00121563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101386809|NCT00293332|Bevacizumab|bevacizumab|mesh-list
101386810|NCT00293332|Carboplatin|carboplatin|mesh-list
101386811|NCT00293332|Docetaxel|docetaxel|mesh-list
101386812|NCT00293332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102074047|NCT00004106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074048|NCT00004106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102074049|NCT00002246|Stavudine|stavudine|mesh-list
102074050|NCT00002246|Antimetabolites|antimetabolites|mesh-ancestor
101375725|NCT00235105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101386813|NCT00293332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101386814|NCT00293332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101386815|NCT00293332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101386816|NCT00293332|Growth Substances|growth substances|mesh-ancestor
101386817|NCT00293332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386818|NCT00293332|Growth Inhibitors|growth inhibitors|mesh-ancestor
101386819|NCT00293332|Tubulin Modulators|tubulin modulators|mesh-ancestor
101386820|NCT00293332|Antimitotic Agents|antimitotic agents|mesh-ancestor
101386821|NCT00293332|Mitosis Modulators|mitosis modulators|mesh-ancestor
101317131|NCT00009061|Protease Inhibitors|protease inhibitors|mesh-ancestor
101386822|NCT00293332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386823|NCT00293371|Prednisone|prednisone|mesh-list
101386824|NCT00293371|Docetaxel|docetaxel|mesh-list
101386825|NCT00293371|Vatalanib|vatalanib|mesh-list
101386826|NCT00293371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101386827|NCT00293371|Tubulin Modulators|tubulin modulators|mesh-ancestor
101386828|NCT00293371|Antimitotic Agents|antimitotic agents|mesh-ancestor
101386829|NCT00293371|Mitosis Modulators|mitosis modulators|mesh-ancestor
101386830|NCT00293371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386831|NCT00293371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101386832|NCT00293371|Glucocorticoids|glucocorticoids|mesh-ancestor
101386833|NCT00293371|Hormones|hormones|mesh-ancestor
101386834|NCT00293371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101386835|NCT00293371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386836|NCT00293371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101386837|NCT00293371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101386838|NCT00293371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101386839|NCT00293410|Cyclophosphamide|cyclophosphamide|mesh-list
101386840|NCT00293410|Clofarabine|clofarabine|mesh-list
101386841|NCT00293410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101386842|NCT00293410|Immunologic Factors|immunologic factors|mesh-ancestor
101305291|NCT02018601|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
101305292|NCT02018601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101305294|NCT02018601|Sensory System Agents|sensory system agents|mesh-ancestor
101386843|NCT00293410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386844|NCT00293410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101386845|NCT00293410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101386846|NCT00293410|Alkylating Agents|alkylating agents|mesh-ancestor
101386847|NCT00293410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386848|NCT00293410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101386849|NCT00293410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101386850|NCT00293410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101386851|NCT00293410|Antimetabolites|antimetabolites|mesh-ancestor
101386852|NCT00121602|Darbepoetin alfa|darbepoetin alfa|mesh-list
101386853|NCT00121602|Hematinics|hematinics|mesh-ancestor
101386854|NCT00293527|Interferons|interferons|mesh-list
101386855|NCT00293527|Interferon-alpha|interferon-alpha|mesh-list
101386856|NCT00293527|Interferon alpha-2|interferon alpha-2|mesh-list
101386862|NCT04711161|Paclitaxel|paclitaxel|mesh-list
101386863|NCT04711161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101386864|NCT04711161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101386870|NCT00293644|Antiemetics|antiemetics|mesh-ancestor
101386871|NCT00293644|Autonomic Agents|autonomic agents|mesh-ancestor
101386872|NCT00293644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101386873|NCT00293644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386874|NCT00293644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101386875|NCT00293644|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101386876|NCT00293644|Histamine Antagonists|histamine antagonists|mesh-ancestor
101386877|NCT00293644|Histamine Agents|histamine agents|mesh-ancestor
101386878|NCT00293644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101386879|NCT00293644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386880|NCT00293761|Travoprost|travoprost|mesh-list
101386881|NCT00293761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101386882|NCT00293800|Timolol|timolol|mesh-list
101386883|NCT00293800|Travoprost|travoprost|mesh-list
101375730|NCT00235144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102074051|NCT00002246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074052|NCT00002246|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101317142|NCT00005873|Rubitecan|rubitecan|mesh-list
102074053|NCT00002246|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102074054|NCT00002246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102074055|NCT00002246|Antiviral Agents|antiviral agents|mesh-ancestor
102074056|NCT00002246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102074057|NCT00002246|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102074058|NCT00002246|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101484673|NCT00343668|Irinotecan|irinotecan|mesh-list
101386884|NCT00293800|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101386885|NCT00293800|Latanoprost|latanoprost|mesh-list
101386886|NCT00293800|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101386887|NCT00293800|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101386888|NCT00293800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101386889|NCT00293800|Adrenergic Agents|adrenergic agents|mesh-ancestor
101386890|NCT00293800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101386891|NCT00293800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386892|NCT00293800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386893|NCT00293800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101386894|NCT00293800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101386895|NCT00423969|Galantamine|galantamine|mesh-list
101386896|NCT00423969|Escitalopram|escitalopram|mesh-list
101386897|NCT00423969|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101386898|NCT00423969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101386899|NCT00423969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101386900|NCT00423969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386901|NCT00423969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101386902|NCT00423969|Serotonin Agents|serotonin agents|mesh-ancestor
101386903|NCT00423969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386904|NCT00423969|Autonomic Agents|autonomic agents|mesh-ancestor
101386905|NCT00423969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101386906|NCT00423969|Cholinergic Agents|cholinergic agents|mesh-ancestor
101386907|NCT00423969|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101386908|NCT00423969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101386909|NCT00423969|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101386910|NCT00423969|Nootropic Agents|nootropic agents|mesh-ancestor
101386911|NCT00293839|Oxybutynin|oxybutynin|mesh-list
101386912|NCT00293839|Parasympatholytics|parasympatholytics|mesh-ancestor
101305295|NCT02018601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101305296|NCT02018601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386913|NCT00293839|Autonomic Agents|autonomic agents|mesh-ancestor
101386914|NCT00293839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101386915|NCT00293839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386916|NCT00293839|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101386917|NCT00293839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101386918|NCT00293839|Cholinergic Agents|cholinergic agents|mesh-ancestor
101386919|NCT00293839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101386920|NCT00293839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386921|NCT00293839|Urological Agents|urological agents|mesh-ancestor
101386922|NCT00293917|Tacrolimus|tacrolimus|mesh-list
101317162|NCT00009217|Haloperidol|haloperidol|mesh-list
101386923|NCT00293917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101386924|NCT00293917|Immunologic Factors|immunologic factors|mesh-ancestor
101386925|NCT00293917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386929|NCT05567081|Triamcinolone|triamcinolone|mesh-list
101386930|NCT05567081|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101386931|NCT05567081|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101386932|NCT05567081|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101386933|NCT05567081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101386940|NCT05567081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101386941|NCT05567081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386942|NCT00294112|Remestemcel-l|remestemcel-l|mesh-list
101386943|NCT00294112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101386944|NCT00294112|Antiviral Agents|antiviral agents|mesh-ancestor
102074060|NCT00002240|Nelfinavir|nelfinavir|mesh-list
102074061|NCT00002240|Didanosine|didanosine|mesh-list
102074062|NCT00002240|Stavudine|stavudine|mesh-list
102074063|NCT00002240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102074064|NCT00002240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102074065|NCT00002240|Protease Inhibitors|protease inhibitors|mesh-ancestor
102074066|NCT00002240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102074067|NCT00002240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375739|NCT00064610|Bortezomib|bortezomib|mesh-list
101386945|NCT00294112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101386946|NCT00417898|Aspirin|aspirin|mesh-list
101386947|NCT00417898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101386948|NCT00417898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101386949|NCT00417898|Analgesics|analgesics|mesh-ancestor
101386950|NCT00417898|Sensory System Agents|sensory system agents|mesh-ancestor
101386951|NCT00417898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101386952|NCT00417898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386953|NCT00417898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101386954|NCT00417898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101386955|NCT00417898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101386956|NCT00417898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101386957|NCT00417898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386958|NCT00417898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101386959|NCT00417898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101386960|NCT00417898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101386961|NCT00417898|Antipyretics|antipyretics|mesh-ancestor
101386962|NCT00294190|Topotecan|topotecan|mesh-list
101386963|NCT00294190|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101386964|NCT00294190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101386965|NCT00294190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101386966|NCT00294190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386967|NCT00294190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101386968|NCT02960503|Azithromycin|azithromycin|mesh-list
101386969|NCT02960503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101386970|NCT02960503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101386971|NCT04706091|Suvorexant|suvorexant|mesh-list
101386972|NCT04706091|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101386973|NCT04706091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101386974|NCT04706091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101386975|NCT04706091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386976|NCT04706091|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
101386977|NCT04706091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101386978|NCT04706091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386979|NCT00294385|Gemcitabine|gemcitabine|mesh-list
101386980|NCT00294385|Docetaxel|docetaxel|mesh-list
101386981|NCT00294385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101386982|NCT00294385|Antimetabolites|antimetabolites|mesh-ancestor
101386983|NCT00294385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386984|NCT00294385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101386985|NCT00294385|Tubulin Modulators|tubulin modulators|mesh-ancestor
101305297|NCT02018601|Antipyretics|antipyretics|mesh-ancestor
101305298|NCT02018601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101305299|NCT02018601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101386986|NCT00294385|Antimitotic Agents|antimitotic agents|mesh-ancestor
101386987|NCT00294385|Mitosis Modulators|mitosis modulators|mesh-ancestor
101386988|NCT00294463|Tibolone|tibolone|mesh-list
101386989|NCT00294463|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101386990|NCT00294463|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101386991|NCT00294463|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101386992|NCT00294463|Medroxyprogesterone|medroxyprogesterone|mesh-list
101386993|NCT00294463|Estradiol|estradiol|mesh-list
101386994|NCT00294463|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101386995|NCT00294463|Progesterone|progesterone|mesh-list
101386996|NCT00294463|Estrogens|estrogens|mesh-ancestor
101386997|NCT00294463|Hormones|hormones|mesh-ancestor
101386999|NCT00294463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074068|NCT00002240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102074069|NCT00002240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102074070|NCT00002240|Antiviral Agents|antiviral agents|mesh-ancestor
102074071|NCT00002240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102074072|NCT00002240|Antimetabolites|antimetabolites|mesh-ancestor
101375747|NCT00235222|Antiviral Agents|antiviral agents|mesh-ancestor
101387000|NCT00294463|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101387006|NCT00294463|Hormone Antagonists|hormone antagonists|mesh-ancestor
101387007|NCT00294463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101387008|NCT00294463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101387009|NCT00294463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101387010|NCT00294463|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101387011|NCT00294463|Anabolic Agents|anabolic agents|mesh-ancestor
101387012|NCT00294463|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101387013|NCT00294463|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101387014|NCT00294463|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101387015|NCT00294463|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101387017|NCT00294502|Gentamicins|gentamicins|mesh-list
101387018|NCT00294502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387019|NCT00294502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101387020|NCT00294502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101387021|NCT00294502|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101387022|NCT00294502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387023|NCT00089349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101387024|NCT00089349|Alemtuzumab|alemtuzumab|mesh-list
101387025|NCT00089349|Methotrexate|methotrexate|mesh-list
101387026|NCT00089349|Mercaptopurine|mercaptopurine|mesh-list
101387027|NCT00089349|Antibodies|antibodies|mesh-list
101387028|NCT00089349|Immunoglobulins|immunoglobulins|mesh-list
101387029|NCT00089349|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101387030|NCT00089349|Immunologic Factors|immunologic factors|mesh-ancestor
101387031|NCT00089349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387032|NCT00089349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101387033|NCT00089349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101387034|NCT00089349|Abortifacient Agents|abortifacient agents|mesh-ancestor
101387035|NCT00089349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101387036|NCT00089349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101387037|NCT00089349|Antimetabolites|antimetabolites|mesh-ancestor
101387038|NCT00089349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387039|NCT00089349|Dermatologic Agents|dermatologic agents|mesh-ancestor
101387040|NCT00089349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387041|NCT00089349|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101387042|NCT00089349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101387043|NCT00089349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101387044|NCT00089349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101387045|NCT00294580|Maloprim|maloprim|mesh-list
101387046|NCT00294580|Antimalarials|antimalarials|mesh-ancestor
101387047|NCT00294580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101387048|NCT00294580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101387049|NCT00294580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101387050|NCT00294619|Hormones|hormones|mesh-list
101387051|NCT00294619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101387052|NCT00294619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387053|NCT00294736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101387054|NCT00294736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101387055|NCT00294736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101387056|NCT00294736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101305300|NCT02018601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101305301|NCT02018731|Metformin|metformin|mesh-list
101305302|NCT02018731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101305303|NCT02018731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387057|NCT00294736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387058|NCT00294775|Candesartan|candesartan|mesh-list
101387059|NCT00294775|Candesartan cilexetil|candesartan cilexetil|mesh-list
101387060|NCT00294775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101387061|NCT00294775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101387062|NCT00294775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101387063|NCT00294775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387064|NCT00121680|Lenvatinib|lenvatinib|mesh-list
102074073|NCT00002240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102074074|NCT00002240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102074076|NCT02250924|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102074077|NCT02250924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375754|NCT00235261|Antiemetics|antiemetics|mesh-ancestor
101387065|NCT00121680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101387074|NCT00294892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101387075|NCT00294892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101387076|NCT00294892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387077|NCT00294892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387078|NCT00294892|Antiviral Agents|antiviral agents|mesh-ancestor
101387079|NCT00294892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101387080|NCT00294892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101387081|NCT00294892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101387082|NCT00294892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101387083|NCT00294892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101387084|NCT00294892|Anticonvulsants|anticonvulsants|mesh-ancestor
101387085|NCT00294892|Antimanic Agents|antimanic agents|mesh-ancestor
101387086|NCT00294892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101387087|NCT00294892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101387088|NCT00294892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387089|NCT00294892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101387090|NCT00294892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101387091|NCT00294892|Analgesics|analgesics|mesh-ancestor
101387092|NCT00294892|Sensory System Agents|sensory system agents|mesh-ancestor
101387093|NCT00294892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101387094|NCT00294892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101387095|NCT00294892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101387097|NCT00089427|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
101387098|NCT00089427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101387099|NCT00089427|Alkylating Agents|alkylating agents|mesh-ancestor
101387100|NCT00089427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387101|NCT00089427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101387102|NCT00294931|Bevacizumab|bevacizumab|mesh-list
101387103|NCT00294931|Carboplatin|carboplatin|mesh-list
101387104|NCT00294931|Irinotecan|irinotecan|mesh-list
101387105|NCT00294931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101387106|NCT00294931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101387107|NCT00294931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101387108|NCT00294931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101387109|NCT00294931|Growth Substances|growth substances|mesh-ancestor
101387110|NCT00294931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387111|NCT00294931|Growth Inhibitors|growth inhibitors|mesh-ancestor
101387112|NCT00294931|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101387113|NCT00294931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101387114|NCT00294931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387115|NCT00294931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387116|NCT02958423|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
101387117|NCT02958423|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101387118|NCT02958423|Serotonin Agents|serotonin agents|mesh-ancestor
101387119|NCT02958423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101387120|NCT02958423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387121|NCT02958423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387122|NCT00295165|Sargramostim|sargramostim|mesh-list
101387123|NCT00295165|Immunologic Factors|immunologic factors|mesh-ancestor
101387124|NCT00295165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387125|NCT00295243|Topotecan|topotecan|mesh-list
101305304|NCT02018757|Chlorotrianisene|chlorotrianisene|mesh-list
101305305|NCT02018757|Arsenic Trioxide|arsenic trioxide|mesh-list
101387126|NCT00295243|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101387127|NCT00295243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101387128|NCT00295243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387129|NCT00295243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387130|NCT00295243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101387131|NCT00295282|Antibodies|antibodies|mesh-list
101375757|NCT00235261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074078|NCT02250924|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102074079|NCT02250924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102074080|NCT02250924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074081|NCT02250924|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102074082|NCT02250924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102074083|NCT02250924|Purinergic Agents|purinergic agents|mesh-ancestor
102074084|NCT02250924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102074085|NCT03645148|Molgramostim|molgramostim|mesh-list
102074086|NCT03645148|Sargramostim|sargramostim|mesh-list
102074087|NCT03645148|Immunologic Factors|immunologic factors|mesh-ancestor
102074088|NCT03645148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074089|NCT03645148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102074090|NCT04082728|Dipyrone|dipyrone|mesh-list
101375760|NCT00235261|Hormones|hormones|mesh-ancestor
101387132|NCT00295282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101387133|NCT00295282|Immunologic Factors|immunologic factors|mesh-ancestor
101387134|NCT00295282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387135|NCT00121797|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101387139|NCT00089622|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101387140|NCT00089622|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101387148|NCT00295555|Doxazosin|doxazosin|mesh-list
101387149|NCT00295555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101387150|NCT00295555|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101387151|NCT00295555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101387152|NCT00295555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101387153|NCT00295555|Adrenergic Agents|adrenergic agents|mesh-ancestor
101387154|NCT00295555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101387155|NCT00295555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387156|NCT00295555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387157|NCT00295594|Tacrolimus|tacrolimus|mesh-list
101387158|NCT00295594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101387159|NCT00295594|Immunologic Factors|immunologic factors|mesh-ancestor
101387160|NCT00295594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387161|NCT00295594|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101387162|NCT00295594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387163|NCT00295594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387164|NCT00121875|Hormones|hormones|mesh-list
101387165|NCT00121875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101387166|NCT00121875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387167|NCT00295672|Vinorelbine|vinorelbine|mesh-list
101387168|NCT00295672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101387169|NCT00295672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101387170|NCT00295672|Tubulin Modulators|tubulin modulators|mesh-ancestor
101387171|NCT00295672|Antimitotic Agents|antimitotic agents|mesh-ancestor
101387172|NCT00295672|Mitosis Modulators|mitosis modulators|mesh-ancestor
101387173|NCT00295672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387174|NCT00295789|Paclitaxel|paclitaxel|mesh-list
101387175|NCT00295789|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101387176|NCT00295789|Carboplatin|carboplatin|mesh-list
101387177|NCT00295789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101387178|NCT00295789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101387179|NCT00295789|Tubulin Modulators|tubulin modulators|mesh-ancestor
101387180|NCT00295789|Antimitotic Agents|antimitotic agents|mesh-ancestor
101387181|NCT00295789|Mitosis Modulators|mitosis modulators|mesh-ancestor
101387182|NCT00295789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387183|NCT00089700|Ibalizumab|ibalizumab|mesh-list
101387184|NCT00089700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101387185|NCT00089700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101387186|NCT00089700|Antiviral Agents|antiviral agents|mesh-ancestor
102074091|NCT04082728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102074093|NCT04082728|Analgesics|analgesics|mesh-ancestor
102074094|NCT04082728|Sensory System Agents|sensory system agents|mesh-ancestor
102074095|NCT04082728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102074096|NCT04082728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074097|NCT04082728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101387187|NCT00089700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101387188|NCT04718584|Antibodies|antibodies|mesh-list
101387189|NCT04718584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101387190|NCT04718584|Immunologic Factors|immunologic factors|mesh-ancestor
101387191|NCT04718584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387192|NCT00417937|Azelaic acid|azelaic acid|mesh-list
101387193|NCT00417937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101387194|NCT00417937|Dermatologic Agents|dermatologic agents|mesh-ancestor
101387195|NCT00418054|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101387196|NCT00418054|Interferon-alpha|interferon-alpha|mesh-list
101387197|NCT00418054|Nitazoxanide|nitazoxanide|mesh-list
101387198|NCT00418054|Antiviral Agents|antiviral agents|mesh-ancestor
101387199|NCT00418054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101387200|NCT00418054|Immunologic Factors|immunologic factors|mesh-ancestor
101387201|NCT00418054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387202|NCT00418054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101387203|NCT00295945|Fentanyl|fentanyl|mesh-list
101387204|NCT00295945|Hydromorphone|hydromorphone|mesh-list
101305306|NCT02018757|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101305307|NCT02018757|Estrogens|estrogens|mesh-ancestor
101387205|NCT00295945|Ropivacaine|ropivacaine|mesh-list
101387206|NCT00295945|Anesthetics, Local|anesthetics, local|mesh-ancestor
101387207|NCT00295945|Anesthetics|anesthetics|mesh-ancestor
101387208|NCT00295945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101387209|NCT00295945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387216|NCT00295945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101387217|NCT00295945|Anesthetics, General|anesthetics, general|mesh-ancestor
101387218|NCT00121914|Ethanol|ethanol|mesh-list
101387219|NCT00121914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101387220|NCT00121914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101387221|NCT00121914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101387243|NCT00296023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101387245|NCT00296023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387246|NCT00296023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101387247|NCT00296023|Dermatologic Agents|dermatologic agents|mesh-ancestor
101387248|NCT00296023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387249|NCT00296023|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101387250|NCT00296023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101387251|NCT00296023|Immunologic Factors|immunologic factors|mesh-ancestor
101387252|NCT00296023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101387253|NCT00296023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101387254|NCT00296023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101387255|NCT00296023|Alkylating Agents|alkylating agents|mesh-ancestor
101387256|NCT00296023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101387257|NCT00296023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101387258|NCT00121953|Rosiglitazone|rosiglitazone|mesh-list
101387259|NCT00121953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101387260|NCT00121953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387261|NCT00296062|Bevacizumab|bevacizumab|mesh-list
101387262|NCT00296062|Capecitabine|capecitabine|mesh-list
101387263|NCT00296062|Oxaliplatin|oxaliplatin|mesh-list
101387264|NCT00296062|Irinotecan|irinotecan|mesh-list
101387265|NCT00296062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101387266|NCT00296062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101387267|NCT00296062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101387268|NCT00296062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101387269|NCT00296062|Growth Substances|growth substances|mesh-ancestor
101387270|NCT00296062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387271|NCT00296062|Growth Inhibitors|growth inhibitors|mesh-ancestor
101387272|NCT00296062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101387273|NCT00296062|Antimetabolites|antimetabolites|mesh-ancestor
101387274|NCT00296062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074099|NCT04082728|Antipyretics|antipyretics|mesh-ancestor
102074100|NCT02906709|Insulin|insulin|mesh-list
102074101|NCT02906709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102074102|NCT02906709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074103|NCT00321308|Pemetrexed|pemetrexed|mesh-list
102074104|NCT00321308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102074105|NCT00321308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102074106|NCT00321308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074107|NCT00321308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102074108|NCT00321308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102074109|NCT02110134|Hydroquinone|hydroquinone|mesh-list
102074110|NCT02110134|Antioxidants|antioxidants|mesh-ancestor
101387278|NCT00296179|Zolpidem|zolpidem|mesh-list
101387279|NCT00296179|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101387280|NCT00296179|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101387286|NCT00296179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101387287|NCT00296179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305308|NCT02018757|Hormones|hormones|mesh-ancestor
101305309|NCT02018757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101305310|NCT02018757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387289|NCT00296218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101387290|NCT00296218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101387291|NCT00296218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101387292|NCT00296218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387293|NCT00089856|Prednisone|prednisone|mesh-list
101387294|NCT00089856|Docetaxel|docetaxel|mesh-list
101387295|NCT00089856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101387296|NCT00089856|Glucocorticoids|glucocorticoids|mesh-ancestor
101387297|NCT00089856|Hormones|hormones|mesh-ancestor
101387298|NCT00089856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101387299|NCT00089856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387300|NCT00089856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101387301|NCT00089856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101387302|NCT00089856|Tubulin Modulators|tubulin modulators|mesh-ancestor
101387303|NCT00089856|Antimitotic Agents|antimitotic agents|mesh-ancestor
101387304|NCT00089856|Mitosis Modulators|mitosis modulators|mesh-ancestor
101387305|NCT00089856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387306|NCT00296257|Rimacalib|rimacalib|mesh-list
101387307|NCT00296257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101387308|NCT00296257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387309|NCT00296257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387310|NCT00296530|Fluticasone|fluticasone|mesh-list
101387312|NCT00296530|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101387313|NCT00296530|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101387314|NCT00296530|Montelukast|montelukast|mesh-list
101387315|NCT00296530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101387316|NCT00296530|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101387317|NCT00296530|Autonomic Agents|autonomic agents|mesh-ancestor
101387318|NCT00296530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101387319|NCT00296530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387320|NCT00296530|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101387321|NCT00296530|Respiratory System Agents|respiratory system agents|mesh-ancestor
101387322|NCT00296530|Dermatologic Agents|dermatologic agents|mesh-ancestor
101387323|NCT00296530|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101387324|NCT00296530|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101387325|NCT00296530|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101387326|NCT00296530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101387327|NCT00296530|Adrenergic Agents|adrenergic agents|mesh-ancestor
101387328|NCT00296530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102074111|NCT02110134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074113|NCT02110134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074114|NCT02110134|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102074115|NCT00318656|Metformin|metformin|mesh-list
102074116|NCT00318656|Glimepiride|glimepiride|mesh-list
102074117|NCT00318656|Rosiglitazone|rosiglitazone|mesh-list
102074118|NCT00318656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102074119|NCT00318656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074120|NCT00318656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102074121|NCT00318656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102074122|NCT00318656|Immunologic Factors|immunologic factors|mesh-ancestor
101387329|NCT00296530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387330|NCT00296530|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101387331|NCT00296530|Hormone Antagonists|hormone antagonists|mesh-ancestor
101387332|NCT00296530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101387333|NCT00296530|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101387334|NCT00296530|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101387335|NCT00296530|Glucocorticoids|glucocorticoids|mesh-ancestor
101387337|NCT00296530|Sympathomimetics|sympathomimetics|mesh-ancestor
101387338|NCT00090012|Olanzapine|olanzapine|mesh-list
101387339|NCT00090012|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101387340|NCT00090012|Antiemetics|antiemetics|mesh-ancestor
101387341|NCT00090012|Autonomic Agents|autonomic agents|mesh-ancestor
101387342|NCT00090012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101387343|NCT00090012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387344|NCT00090012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101387345|NCT00090012|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101387346|NCT00090012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101387347|NCT00090012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101387348|NCT00090012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101387358|NCT00296608|Calcium|calcium|mesh-list
101305311|NCT02018757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101305312|NCT02018757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101305313|NCT02018783|Listerine|listerine|mesh-list
101305314|NCT02018783|Sodium Fluoride|sodium fluoride|mesh-list
101305315|NCT02018783|Cariostatic Agents|cariostatic agents|mesh-ancestor
101387359|NCT00296608|Levoleucovorin|levoleucovorin|mesh-list
101387360|NCT00296608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101387361|NCT00296608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387362|NCT00296608|Antimetabolites|antimetabolites|mesh-ancestor
101387363|NCT00296608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387364|NCT00296608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101387365|NCT00296608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101387366|NCT00296608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101387367|NCT00296608|Immunologic Factors|immunologic factors|mesh-ancestor
101387368|NCT00296608|Antidotes|antidotes|mesh-ancestor
101387369|NCT00296608|Protective Agents|protective agents|mesh-ancestor
101387370|NCT00296608|Vitamin B Complex|vitamin b complex|mesh-ancestor
101387371|NCT00296608|Vitamins|vitamins|mesh-ancestor
101387372|NCT00296608|Micronutrients|micronutrients|mesh-ancestor
101387373|NCT00296686|Tranylcypromine|tranylcypromine|mesh-list
101387374|NCT00296686|Dextroamphetamine|dextroamphetamine|mesh-list
101317316|NCT00010036|Carboplatin|carboplatin|mesh-list
101387375|NCT00296686|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101387376|NCT00296686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387377|NCT00296686|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101387378|NCT00296686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101387379|NCT00296686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101387380|NCT00296686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387381|NCT00296686|Dopamine Agents|dopamine agents|mesh-ancestor
101387382|NCT00296686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101387383|NCT00296686|Antidepressive Agents|antidepressive agents|mesh-ancestor
102074123|NCT02110524|Paclitaxel|paclitaxel|mesh-list
102074124|NCT02110524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102074125|NCT02110524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102074126|NCT02110524|Tubulin Modulators|tubulin modulators|mesh-ancestor
102074127|NCT02110524|Antimitotic Agents|antimitotic agents|mesh-ancestor
102074128|NCT02110524|Mitosis Modulators|mitosis modulators|mesh-ancestor
102074129|NCT02110524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387384|NCT00296686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101387385|NCT00296686|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101387386|NCT00296686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387387|NCT00296686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101387388|NCT00296686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101387389|NCT00296686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101387390|NCT00122070|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101387391|NCT00122070|Antidepressive Agents|antidepressive agents|mesh-ancestor
101387392|NCT00122070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101387393|NCT00122070|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101387394|NCT00122070|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101387395|NCT00122070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101387396|NCT00122070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387397|NCT00296803|Clopidogrel|clopidogrel|mesh-list
101387398|NCT00296803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101387399|NCT00296803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101387400|NCT00296803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101387401|NCT00296803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101387402|NCT00296803|Purinergic Agents|purinergic agents|mesh-ancestor
101387403|NCT00296803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101387404|NCT00296803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387405|NCT00296803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387406|NCT00090090|Elsamicin A|elsamicin a|mesh-list
101387407|NCT00090090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101387408|NCT00090090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101387410|NCT00296959|Anticonvulsants|anticonvulsants|mesh-ancestor
101387411|NCT00296959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101387412|NCT00296959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387418|NCT00297076|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101387419|NCT00297076|Antiviral Agents|antiviral agents|mesh-ancestor
101387420|NCT00297076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101387421|NCT00297349|Topiramate|topiramate|mesh-list
101387422|NCT00297349|Anticonvulsants|anticonvulsants|mesh-ancestor
101387423|NCT00297349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101387429|NCT00297388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305316|NCT02018783|Protective Agents|protective agents|mesh-ancestor
101305317|NCT02018783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305318|NCT02018783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101305319|NCT02018783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101305320|NCT02018874|Gemcitabine|gemcitabine|mesh-list
101305321|NCT02018874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101305322|NCT02018874|Antimetabolites|antimetabolites|mesh-ancestor
101387430|NCT00297388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387431|NCT00297388|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101387432|NCT00297388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101387433|NCT00297388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101387434|NCT00297388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101387435|NCT00297388|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101387436|NCT00297388|Dopamine Agents|dopamine agents|mesh-ancestor
101387437|NCT00297466|Nicotine|nicotine|mesh-list
101387438|NCT00297466|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101387439|NCT00297466|Autonomic Agents|autonomic agents|mesh-ancestor
101387440|NCT00297466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101387441|NCT00297466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387442|NCT00297466|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101387443|NCT00297466|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101387444|NCT00297466|Cholinergic Agents|cholinergic agents|mesh-ancestor
101387445|NCT00297466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101387446|NCT00297466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387447|NCT00297505|Citalopram|citalopram|mesh-list
102074130|NCT00317486|Bosentan|bosentan|mesh-list
102074131|NCT00317486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102074132|NCT00317486|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102074133|NCT00317486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387448|NCT00297505|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101387449|NCT00297505|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101387450|NCT00297505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101387451|NCT00297505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387452|NCT00297505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101387453|NCT00297505|Serotonin Agents|serotonin agents|mesh-ancestor
101387454|NCT00297505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387455|NCT00297505|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101387456|NCT00297505|Antidepressive Agents|antidepressive agents|mesh-ancestor
101387457|NCT00297505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101387458|NCT00297544|Sildenafil Citrate|sildenafil citrate|mesh-list
101387459|NCT00297544|Vasodilator Agents|vasodilator agents|mesh-ancestor
101387460|NCT00297544|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101387461|NCT00297544|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101387462|NCT00297544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387463|NCT00297544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387464|NCT00297544|Urological Agents|urological agents|mesh-ancestor
101387465|NCT00297583|Insulin glulisine|insulin glulisine|mesh-list
101387466|NCT00297583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101387467|NCT00297583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387468|NCT00297661|Sirolimus|sirolimus|mesh-list
101387469|NCT00297661|Paclitaxel|paclitaxel|mesh-list
101387470|NCT00297661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101387471|NCT00297661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101387472|NCT00297661|Tubulin Modulators|tubulin modulators|mesh-ancestor
101387473|NCT00297661|Antimitotic Agents|antimitotic agents|mesh-ancestor
101387474|NCT00297661|Mitosis Modulators|mitosis modulators|mesh-ancestor
101317349|NCT00010153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317350|NCT00010153|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101317351|NCT00010153|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101317352|NCT00010153|Hormone Antagonists|hormone antagonists|mesh-ancestor
101317353|NCT00010153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101317354|NCT00010153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317355|NCT00010192|Aldesleukin|aldesleukin|mesh-list
101317356|NCT00010192|Rituximab|rituximab|mesh-list
101317357|NCT00010192|Interleukin-2|interleukin-2|mesh-list
101248397|NCT05597254|Niacin|niacin|mesh-list
101387475|NCT00297661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387476|NCT00297661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101387477|NCT00297661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101387478|NCT00297661|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101387483|NCT00090207|Ondansetron|ondansetron|mesh-list
101387484|NCT00090207|Aprepitant|aprepitant|mesh-list
101387485|NCT00090207|Antiemetics|antiemetics|mesh-ancestor
101387486|NCT00090207|Autonomic Agents|autonomic agents|mesh-ancestor
101387487|NCT00090207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101387488|NCT00090207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387489|NCT00090207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101387490|NCT00090207|Antipruritics|antipruritics|mesh-ancestor
101387491|NCT00090207|Dermatologic Agents|dermatologic agents|mesh-ancestor
101387492|NCT00090207|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101387493|NCT00090207|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101387496|NCT00090207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387498|NCT00297739|Risperidone|risperidone|mesh-list
101387499|NCT00297739|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101387500|NCT00297739|Serotonin Agents|serotonin agents|mesh-ancestor
101387501|NCT00297739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101387502|NCT00297739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387503|NCT00297739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387504|NCT00297739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101387505|NCT00297739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101387506|NCT00297739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101387507|NCT00297739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101387508|NCT00297739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101387509|NCT00297739|Dopamine Agents|dopamine agents|mesh-ancestor
101387510|NCT00090246|Ondansetron|ondansetron|mesh-list
101387511|NCT00090246|Aprepitant|aprepitant|mesh-list
101387512|NCT00090246|Antiemetics|antiemetics|mesh-ancestor
101387513|NCT00090246|Autonomic Agents|autonomic agents|mesh-ancestor
101387514|NCT00090246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101387515|NCT00090246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387516|NCT00090246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101387517|NCT00090246|Antipruritics|antipruritics|mesh-ancestor
101387518|NCT00090246|Dermatologic Agents|dermatologic agents|mesh-ancestor
101387519|NCT00090246|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101387520|NCT00090246|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102074134|NCT02107170|Remifentanil|remifentanil|mesh-list
102074135|NCT02107170|Propofol|propofol|mesh-list
102074136|NCT02107170|Sevoflurane|sevoflurane|mesh-list
102074137|NCT02107170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102074138|NCT02107170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102074139|NCT02107170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074140|NCT02107170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102074141|NCT02107170|Anesthetics, General|anesthetics, general|mesh-ancestor
102074142|NCT02107170|Anesthetics|anesthetics|mesh-ancestor
102074143|NCT02107170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102074144|NCT02107170|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102074145|NCT02107170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102074146|NCT02107170|Narcotics|narcotics|mesh-ancestor
102074147|NCT02107170|Analgesics|analgesics|mesh-ancestor
102074148|NCT02107170|Sensory System Agents|sensory system agents|mesh-ancestor
102074149|NCT02107170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102074150|NCT00313196|Bosentan|bosentan|mesh-list
102074151|NCT00313196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102074152|NCT00313196|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102074153|NCT00313196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387521|NCT00090246|Serotonin Agents|serotonin agents|mesh-ancestor
101387522|NCT00090246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101387523|NCT00090246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387524|NCT00090246|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101387525|NCT00297817|Vaccines|vaccines|mesh-list
101387526|NCT00297817|Immunologic Factors|immunologic factors|mesh-ancestor
101387527|NCT00297817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387528|NCT00090324|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101387529|NCT00090324|Antidepressive Agents|antidepressive agents|mesh-ancestor
101387530|NCT00090324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101387531|NCT00090324|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101387532|NCT00090324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101387533|NCT00090324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101387534|NCT00090324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387535|NCT00122226|Ritonavir|ritonavir|mesh-list
101387536|NCT00122226|Lopinavir|lopinavir|mesh-list
101387537|NCT00122226|Lamivudine|lamivudine|mesh-list
101387538|NCT00122226|Zidovudine|zidovudine|mesh-list
101387539|NCT00122226|Nevirapine|nevirapine|mesh-list
101387540|NCT00122226|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101387541|NCT00122226|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101387542|NCT00122226|Protease Inhibitors|protease inhibitors|mesh-ancestor
101387543|NCT00122226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387544|NCT00122226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387545|NCT00122226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101387546|NCT00122226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101387547|NCT00122226|Antiviral Agents|antiviral agents|mesh-ancestor
101387548|NCT00122226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101387549|NCT00122226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101387550|NCT00122226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101387551|NCT00122226|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101387552|NCT00122226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101387553|NCT00122226|Antimetabolites|antimetabolites|mesh-ancestor
101387558|NCT05200559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101387559|NCT05200559|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102074155|NCT03656679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102074156|NCT03656679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102074157|NCT03656679|Trace Elements|trace elements|mesh-ancestor
102074158|NCT03656679|Micronutrients|micronutrients|mesh-ancestor
102074159|NCT03656679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074160|NCT03663166|Nivolumab|nivolumab|mesh-list
102074161|NCT03663166|Ipilimumab|ipilimumab|mesh-list
102074162|NCT03663166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102074163|NCT03663166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102074164|NCT03663166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101387560|NCT05200559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387561|NCT00298012|Methotrexate|methotrexate|mesh-list
101387562|NCT00298012|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101387563|NCT00298012|Abortifacient Agents|abortifacient agents|mesh-ancestor
101387564|NCT00298012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101305323|NCT02018874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305324|NCT02018874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101305325|NCT02018965|Vitamins|vitamins|mesh-list
101305326|NCT02018965|Niacin|niacin|mesh-list
101305327|NCT02018965|Niacinamide|niacinamide|mesh-list
101387565|NCT00298012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387570|NCT00298012|Dermatologic Agents|dermatologic agents|mesh-ancestor
101387571|NCT00298012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387572|NCT00298012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101387573|NCT00298012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101387574|NCT00298012|Immunologic Factors|immunologic factors|mesh-ancestor
101387575|NCT00298012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101387576|NCT00298012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101387577|NCT00298168|polysaccharide-K|polysaccharide-k|mesh-list
101387578|NCT00298168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101387579|NCT00298168|Immunologic Factors|immunologic factors|mesh-ancestor
101387580|NCT00298168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387581|NCT00298168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101387582|NCT00298168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101387583|NCT00298168|Antiviral Agents|antiviral agents|mesh-ancestor
101387584|NCT00298168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101387585|NCT00298168|Interferon Inducers|interferon inducers|mesh-ancestor
101387586|NCT00298168|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101387587|NCT00298168|Protective Agents|protective agents|mesh-ancestor
101387588|NCT00122304|Eculizumab|eculizumab|mesh-list
101387589|NCT00122304|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101387590|NCT00122304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101387591|NCT00122304|Immunologic Factors|immunologic factors|mesh-ancestor
101387592|NCT00122304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387593|NCT00322543|Pimecrolimus|pimecrolimus|mesh-list
101387594|NCT00322543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101387595|NCT00322543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101387596|NCT00322543|Analgesics|analgesics|mesh-ancestor
101387597|NCT00322543|Sensory System Agents|sensory system agents|mesh-ancestor
101387598|NCT00322543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101387599|NCT00322543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387600|NCT00322543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101387601|NCT00322543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101387602|NCT00322543|Dermatologic Agents|dermatologic agents|mesh-ancestor
101387603|NCT00322543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101387604|NCT00322543|Immunologic Factors|immunologic factors|mesh-ancestor
101387605|NCT00322543|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101387606|NCT00322543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387607|NCT00322543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387608|NCT00313963|Magnesium Sulfate|magnesium sulfate|mesh-list
101387609|NCT00313963|Analgesics|analgesics|mesh-ancestor
101387610|NCT00313963|Sensory System Agents|sensory system agents|mesh-ancestor
101387611|NCT00313963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101387612|NCT00313963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387613|NCT00313963|Anesthetics|anesthetics|mesh-ancestor
101387614|NCT00313963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102074165|NCT03663166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074166|NCT03554304|Moxifloxacin|moxifloxacin|mesh-list
102074167|NCT03554304|Cefepime-zidebactam|cefepime-zidebactam|mesh-list
102074168|NCT03554304|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102074169|NCT03554304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102074170|NCT03554304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102074171|NCT03554304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101387615|NCT00313963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101387616|NCT00313963|Anticonvulsants|anticonvulsants|mesh-ancestor
101387617|NCT00313963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101387618|NCT00313963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101387619|NCT00313963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387620|NCT00313963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101387621|NCT00313963|Tocolytic Agents|tocolytic agents|mesh-ancestor
101387733|NCT04717531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387734|NCT04717531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101387735|NCT04717531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101387736|NCT04717531|Tubulin Modulators|tubulin modulators|mesh-ancestor
101387737|NCT04717531|Antimitotic Agents|antimitotic agents|mesh-ancestor
101387738|NCT04717531|Mitosis Modulators|mitosis modulators|mesh-ancestor
101387739|NCT04717531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102074179|NCT03554304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074180|NCT03554304|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102074181|NCT03554304|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102074182|NCT03554304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102074183|NCT02107716|Lidocaine|lidocaine|mesh-list
102074184|NCT02107716|Anesthetics, Local|anesthetics, local|mesh-ancestor
102074185|NCT02107716|Anesthetics|anesthetics|mesh-ancestor
101485511|NCT00317681|Tacrolimus|tacrolimus|mesh-list
101387740|NCT04717531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101387741|NCT04717531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101387742|NCT04717531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101387743|NCT04717531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387744|NCT00323323|Prednisone|prednisone|mesh-list
101387745|NCT00323323|Cyclophosphamide|cyclophosphamide|mesh-list
101387746|NCT00323323|Doxorubicin|doxorubicin|mesh-list
101387747|NCT00323323|Vincristine|vincristine|mesh-list
101387748|NCT00323323|Alemtuzumab|alemtuzumab|mesh-list
101387749|NCT00323323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101387750|NCT00323323|Immunologic Factors|immunologic factors|mesh-ancestor
101387751|NCT00323323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387752|NCT00323323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101387753|NCT00323323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101387754|NCT00323323|Alkylating Agents|alkylating agents|mesh-ancestor
101387755|NCT00323323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387756|NCT00323323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101387757|NCT00323323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101387758|NCT00323323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101387759|NCT00323323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101387760|NCT00323323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101387761|NCT00323323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387762|NCT00323323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101387767|NCT00323323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101387768|NCT00323323|Tubulin Modulators|tubulin modulators|mesh-ancestor
101387769|NCT00323323|Antimitotic Agents|antimitotic agents|mesh-ancestor
101387770|NCT00323323|Mitosis Modulators|mitosis modulators|mesh-ancestor
101387771|NCT00323323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101387772|NCT00122499|Tadalafil|tadalafil|mesh-list
101387773|NCT00122499|Vasodilator Agents|vasodilator agents|mesh-ancestor
101387774|NCT00122499|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101305334|NCT02018965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305335|NCT02018965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101387775|NCT00122499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101387776|NCT00122499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387777|NCT00122499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387778|NCT00122499|Urological Agents|urological agents|mesh-ancestor
101387780|NCT00312598|Antidepressive Agents|antidepressive agents|mesh-ancestor
101387781|NCT00312598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101387782|NCT00312598|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101387783|NCT00312598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101387784|NCT00312598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101387785|NCT00312598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387786|NCT00312598|Dopamine Agonists|dopamine agonists|mesh-ancestor
101387792|NCT00312598|Serotonin Agents|serotonin agents|mesh-ancestor
101387793|NCT00312598|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101387794|NCT00312598|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101387795|NCT00312598|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101387796|NCT00312598|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101387797|NCT00312754|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101387798|NCT00312754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101387799|NCT00312754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101387800|NCT00312754|Protease Inhibitors|protease inhibitors|mesh-ancestor
101387801|NCT00312754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387802|NCT00312754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387803|NCT00312754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101387804|NCT00312754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101387805|NCT00312754|Antiviral Agents|antiviral agents|mesh-ancestor
101387806|NCT00312754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101387807|NCT00312871|Epoetin Alfa|epoetin alfa|mesh-list
102074187|NCT02107716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074188|NCT02107716|Sensory System Agents|sensory system agents|mesh-ancestor
102074189|NCT02107716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102074190|NCT02107716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102074191|NCT02107716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101387808|NCT00312871|Hematinics|hematinics|mesh-ancestor
101387810|NCT00090675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101387811|NCT00090675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101387812|NCT00090675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387813|NCT00090675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387814|NCT00312988|Gemcitabine|gemcitabine|mesh-list
101387815|NCT00312988|Topotecan|topotecan|mesh-list
101387816|NCT00312988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101387817|NCT00312988|Antimetabolites|antimetabolites|mesh-ancestor
101387818|NCT00312988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387819|NCT00312988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101387820|NCT00312988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101387821|NCT00312988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101387822|NCT00312988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387823|NCT00122538|Lamivudine|lamivudine|mesh-list
101387824|NCT00122538|Efavirenz|efavirenz|mesh-list
101387825|NCT00122538|Didanosine|didanosine|mesh-list
101387826|NCT00122538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101387827|NCT00122538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101387828|NCT00122538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387829|NCT00122538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387830|NCT00122538|Antiviral Agents|antiviral agents|mesh-ancestor
101387831|NCT00122538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101387832|NCT00122538|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101387833|NCT00122538|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101387834|NCT00122538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101387835|NCT00122538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101387836|NCT00122538|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101387842|NCT00313105|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101387843|NCT00313105|Autonomic Agents|autonomic agents|mesh-ancestor
101387844|NCT00313105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101387845|NCT00313105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387846|NCT00313105|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101387847|NCT00313105|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101387848|NCT00313105|Cholinergic Agents|cholinergic agents|mesh-ancestor
101387849|NCT00313105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101456555|NCT04662385|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101305336|NCT02018965|Vasodilator Agents|vasodilator agents|mesh-ancestor
101305337|NCT02018991|Everolimus|everolimus|mesh-list
101305338|NCT02018991|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101387850|NCT00313105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387851|NCT00313105|Respiratory System Agents|respiratory system agents|mesh-ancestor
101387852|NCT00313183|Pramlintide|pramlintide|mesh-list
101387853|NCT00313183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101387854|NCT00313183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387861|NCT06003283|Rituximab|rituximab|mesh-list
101387862|NCT06003283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101387863|NCT06003283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101387864|NCT06003283|Immunologic Factors|immunologic factors|mesh-ancestor
101387865|NCT06003283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387866|NCT06003283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101387867|NCT06003270|Quercetin|quercetin|mesh-list
101387868|NCT06003270|Antioxidants|antioxidants|mesh-ancestor
101387869|NCT06003270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387870|NCT06003270|Protective Agents|protective agents|mesh-ancestor
101387871|NCT06003270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387872|NCT06003231|Disitamab vedotin|disitamab vedotin|mesh-list
101387873|NCT06003231|Immunoconjugates|immunoconjugates|mesh-ancestor
101387874|NCT06003231|Immunologic Factors|immunologic factors|mesh-ancestor
101387875|NCT06003231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074196|NCT02110992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102074197|NCT02110992|Tubulin Modulators|tubulin modulators|mesh-ancestor
102074198|NCT02110992|Antimitotic Agents|antimitotic agents|mesh-ancestor
102074199|NCT02110992|Mitosis Modulators|mitosis modulators|mesh-ancestor
101375876|NCT00236431|Galantamine|galantamine|mesh-list
101375877|NCT00236431|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101387876|NCT06003179|Cyclophosphamide|cyclophosphamide|mesh-list
101387877|NCT06003179|Fludarabine|fludarabine|mesh-list
101387878|NCT06003179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101387879|NCT06003179|Immunologic Factors|immunologic factors|mesh-ancestor
101387880|NCT06003179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387881|NCT06003179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101387882|NCT06003179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101387883|NCT06003179|Alkylating Agents|alkylating agents|mesh-ancestor
101387884|NCT06003179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387885|NCT06003179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101387886|NCT06003179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101387887|NCT06003166|4-Aminopyridine|4-aminopyridine|mesh-list
101387888|NCT06003166|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101387889|NCT06003166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101387890|NCT06003166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387891|NCT06003114|Palbociclib|palbociclib|mesh-list
101387892|NCT06003114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101387893|NCT06003114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101387894|NCT06003114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387895|NCT06003114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387896|NCT06003075|Nivolumab|nivolumab|mesh-list
101387897|NCT06003075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101387898|NCT06003075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101387899|NCT06003075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101387900|NCT06003075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387901|NCT06003049|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101387902|NCT06003049|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101387903|NCT06003049|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101387904|NCT06003049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101387905|NCT06003049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387906|NCT06003049|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101387913|NCT06002854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101387914|NCT06002854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387915|NCT06002659|Cyclophosphamide|cyclophosphamide|mesh-list
101387916|NCT06002659|Fludarabine|fludarabine|mesh-list
101387917|NCT06002659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101387918|NCT06002659|Immunologic Factors|immunologic factors|mesh-ancestor
101305339|NCT02018991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101387919|NCT06002659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387920|NCT06002659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101387921|NCT06002659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101387922|NCT06002659|Alkylating Agents|alkylating agents|mesh-ancestor
101387923|NCT06002659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387924|NCT06002659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101387925|NCT06002659|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101387927|NCT06002646|Sodium Hypochlorite|sodium hypochlorite|mesh-list
101387928|NCT06002646|Eusol|eusol|mesh-list
101387929|NCT06002646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101387930|NCT06002646|Trace Elements|trace elements|mesh-ancestor
101387939|NCT06002490|Aspirin|aspirin|mesh-list
102074200|NCT02110992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074201|NCT03306394|Trifluridine|trifluridine|mesh-list
102074202|NCT03306394|Antimetabolites|antimetabolites|mesh-ancestor
102074203|NCT03306394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387940|NCT06002490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101387941|NCT06002490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101387942|NCT06002490|Analgesics|analgesics|mesh-ancestor
101387943|NCT06002490|Sensory System Agents|sensory system agents|mesh-ancestor
101387944|NCT06002490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101387945|NCT06002490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387946|NCT06002490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101387947|NCT06002490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101387948|NCT06002490|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101387949|NCT06002490|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101387950|NCT06002490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387951|NCT06002490|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101387952|NCT06002490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101387953|NCT06002490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387954|NCT06002490|Antipyretics|antipyretics|mesh-ancestor
101387955|NCT06002477|Mecamylamine|mecamylamine|mesh-list
101387956|NCT06002477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101387957|NCT06002477|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
101387958|NCT06002477|Autonomic Agents|autonomic agents|mesh-ancestor
101387959|NCT06002477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101387960|NCT06002477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387961|NCT06002477|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101387962|NCT06002477|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101387963|NCT06002477|Cholinergic Agents|cholinergic agents|mesh-ancestor
101387964|NCT06002477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101387965|NCT06002477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387966|NCT06002438|Micronutrients|micronutrients|mesh-list
101387967|NCT06002438|Trace Elements|trace elements|mesh-list
101387968|NCT06002438|Pyrimethamine|pyrimethamine|mesh-list
101387969|NCT06002438|Sulfadoxine|sulfadoxine|mesh-list
101387970|NCT06002438|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101387971|NCT06002438|Amodiaquine|amodiaquine|mesh-list
101387972|NCT06002438|Antimalarials|antimalarials|mesh-ancestor
101387973|NCT06002438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101387974|NCT06002438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101387975|NCT06002438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101387976|NCT06002438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101387977|NCT06002438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387978|NCT06002438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387981|NCT06002217|Levobupivacaine|levobupivacaine|mesh-list
101387982|NCT06002217|Anesthetics, Local|anesthetics, local|mesh-ancestor
101387983|NCT06002217|Anesthetics|anesthetics|mesh-ancestor
101387984|NCT06002217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101387985|NCT06002217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387986|NCT06002217|Sensory System Agents|sensory system agents|mesh-ancestor
101387987|NCT06002217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101387988|NCT06002035|Vitamin D|vitamin d|mesh-list
101387989|NCT06002035|Vitamins|vitamins|mesh-ancestor
101387990|NCT06002035|Micronutrients|micronutrients|mesh-ancestor
101387991|NCT06002035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387992|NCT06002035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101387993|NCT06001788|Cytarabine|cytarabine|mesh-list
101387994|NCT06001788|Fludarabine|fludarabine|mesh-list
101387995|NCT06001788|Idarubicin|idarubicin|mesh-list
101305340|NCT02018991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101305341|NCT02018991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387996|NCT06001788|Lenograstim|lenograstim|mesh-list
101387997|NCT06001788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101387998|NCT06001788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101387999|NCT06001788|Antimetabolites|antimetabolites|mesh-ancestor
101388000|NCT06001788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388001|NCT06001788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101388002|NCT06001788|Immunologic Factors|immunologic factors|mesh-ancestor
101388008|NCT06001788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101388009|NCT06001788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101375889|NCT00097929|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102074204|NCT03306394|Antiviral Agents|antiviral agents|mesh-ancestor
102074205|NCT03306394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102074206|NCT03532178|Rocuronium|rocuronium|mesh-list
102074207|NCT03532178|Succinylcholine|succinylcholine|mesh-list
102074208|NCT03532178|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102074209|NCT03532178|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102074210|NCT03532178|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102074211|NCT03532178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102074212|NCT03532178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388010|NCT06001788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101388012|NCT06001762|Letrozole|letrozole|mesh-list
101388013|NCT06001762|Anastrozole|anastrozole|mesh-list
101388014|NCT06001762|Exemestane|exemestane|mesh-list
101388015|NCT06001762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101388016|NCT06001762|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101388017|NCT06001762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101388018|NCT06001762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101388019|NCT06001762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388020|NCT06001762|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101388021|NCT06001762|Hormone Antagonists|hormone antagonists|mesh-ancestor
101388022|NCT06001762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101388023|NCT06001762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388024|NCT06001762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101388025|NCT06001762|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101388026|NCT06001762|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101388027|NCT06001762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101388028|NCT06001749|Psilocybin|psilocybin|mesh-list
101388029|NCT06001749|Hallucinogens|hallucinogens|mesh-ancestor
101388030|NCT06001749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388031|NCT06001749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101388032|NCT06001658|Gemcitabine|gemcitabine|mesh-list
101388033|NCT06001658|Pembrolizumab|pembrolizumab|mesh-list
101388034|NCT06001658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101388035|NCT06001658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101388036|NCT06001658|Antimetabolites|antimetabolites|mesh-ancestor
101388037|NCT06001658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388038|NCT06001658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101388039|NCT06001658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101388040|NCT06001619|Tamsulosin|tamsulosin|mesh-list
101388041|NCT06001619|Finasteride|finasteride|mesh-list
101388042|NCT06001619|Dutasteride|dutasteride|mesh-list
101388043|NCT06001619|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101388044|NCT06001619|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101388045|NCT06001619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101388046|NCT06001619|Adrenergic Agents|adrenergic agents|mesh-ancestor
101388047|NCT06001619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101388048|NCT06001619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388049|NCT06001619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388050|NCT06001619|Urological Agents|urological agents|mesh-ancestor
101388051|NCT06001619|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101388052|NCT06001619|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101388053|NCT06001619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101388054|NCT06001619|Hormone Antagonists|hormone antagonists|mesh-ancestor
101388061|NCT06001593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388062|NCT06001593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388064|NCT06001385|Cyclophosphamide|cyclophosphamide|mesh-list
101388065|NCT06001385|Melphalan|melphalan|mesh-list
101388066|NCT06001385|Busulfan|busulfan|mesh-list
101388067|NCT06001385|Fludarabine|fludarabine|mesh-list
101388068|NCT06001385|Tacrolimus|tacrolimus|mesh-list
101388069|NCT06001385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101388070|NCT06001385|Immunologic Factors|immunologic factors|mesh-ancestor
101388071|NCT06001385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074213|NCT03532178|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
102074215|NCT00311090|Idrabiotaparinux|idrabiotaparinux|mesh-list
102074216|NCT00311090|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102074217|NCT00311090|Antithrombins|antithrombins|mesh-ancestor
102074218|NCT00311090|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102074219|NCT00311090|Protease Inhibitors|protease inhibitors|mesh-ancestor
101388076|NCT06001385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101388077|NCT06001385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101388078|NCT06001385|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101388080|NCT06001385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101388081|NCT06001385|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101388082|NCT06001385|Antitubercular Agents|antitubercular agents|mesh-ancestor
101388083|NCT06001385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101388084|NCT06001385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101388085|NCT06001372|Ketamine|ketamine|mesh-list
101388086|NCT06001372|Analgesics|analgesics|mesh-ancestor
101388087|NCT06001372|Sensory System Agents|sensory system agents|mesh-ancestor
101388088|NCT06001372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101388089|NCT06001372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388090|NCT06001372|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101388091|NCT06001372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101388092|NCT06001372|Anesthetics, General|anesthetics, general|mesh-ancestor
101388093|NCT06001372|Anesthetics|anesthetics|mesh-ancestor
101388094|NCT06001372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101388095|NCT06001372|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101388096|NCT06001372|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101388097|NCT06001372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101388098|NCT06001372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388099|NCT06001320|Letermovir|letermovir|mesh-list
101388100|NCT06001320|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101388101|NCT06001320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101388102|NCT06001320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388103|NCT06001320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101388104|NCT06001320|Antiviral Agents|antiviral agents|mesh-ancestor
101388105|NCT06001320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101388106|NCT06001151|Carboplatin|carboplatin|mesh-list
101388107|NCT06001151|Pemetrexed|pemetrexed|mesh-list
101388108|NCT06001151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101388109|NCT06001151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101388110|NCT06001151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388111|NCT06001151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101388112|NCT06001151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101388113|NCT06001125|Methotrexate|methotrexate|mesh-list
101388114|NCT06001125|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101388115|NCT06001125|Abortifacient Agents|abortifacient agents|mesh-ancestor
101388116|NCT06001125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101388117|NCT06001125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388118|NCT06001125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101388119|NCT06001125|Antimetabolites|antimetabolites|mesh-ancestor
101388120|NCT06001125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388121|NCT06001125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101388122|NCT06001125|Dermatologic Agents|dermatologic agents|mesh-ancestor
101388123|NCT06001125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101388124|NCT06001125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101388125|NCT06001125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101388126|NCT06001125|Immunologic Factors|immunologic factors|mesh-ancestor
101388134|NCT06001112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101388135|NCT06001112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388136|NCT06001112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101388137|NCT06001112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101388138|NCT06001112|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101388139|NCT06001112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101388148|NCT06001047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388151|NCT06000917|Trastuzumab|trastuzumab|mesh-list
101388152|NCT06000917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101388153|NCT06000917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102074220|NCT00311090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102074221|NCT00311090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074222|NCT00311090|Anticoagulants|anticoagulants|mesh-ancestor
102074223|NCT02105610|Anesthetics|anesthetics|mesh-list
102074224|NCT02105610|Sevoflurane|sevoflurane|mesh-list
102074225|NCT02105610|Desflurane|desflurane|mesh-list
102074226|NCT02105610|Isoflurane|isoflurane|mesh-list
102074227|NCT02105610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
101388154|NCT06000917|Tubulin Modulators|tubulin modulators|mesh-ancestor
101388155|NCT06000917|Antimitotic Agents|antimitotic agents|mesh-ancestor
101388156|NCT06000917|Mitosis Modulators|mitosis modulators|mesh-ancestor
101305343|NCT02018991|Immunologic Factors|immunologic factors|mesh-ancestor
101305344|NCT02018991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305345|NCT02018991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101388157|NCT06000917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388158|NCT06000917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101388159|NCT06000787|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
101388160|NCT06000787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101388161|NCT06000787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101388162|NCT06000787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388163|NCT06000787|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101388164|NCT06000709|Phenol|phenol|mesh-list
101388165|NCT06000709|Methylprednisolone|methylprednisolone|mesh-list
101388166|NCT06000709|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101388167|NCT06000709|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101388168|NCT06000709|Prednisolone|prednisolone|mesh-list
101388169|NCT06000709|Prednisolone acetate|prednisolone acetate|mesh-list
101388170|NCT06000709|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101388171|NCT06000709|Prednisolone phosphate|prednisolone phosphate|mesh-list
101388172|NCT06000709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101388173|NCT06000709|Antiemetics|antiemetics|mesh-ancestor
101388174|NCT06000709|Autonomic Agents|autonomic agents|mesh-ancestor
101388175|NCT06000709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101388176|NCT06000709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388177|NCT06000709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101388178|NCT06000709|Glucocorticoids|glucocorticoids|mesh-ancestor
101388179|NCT06000709|Hormones|hormones|mesh-ancestor
101388180|NCT06000709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101388181|NCT06000709|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101388182|NCT06000709|Protective Agents|protective agents|mesh-ancestor
101388183|NCT06000709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101388184|NCT06000709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101388185|NCT06000709|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101388186|NCT06000709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101388187|NCT06000709|Disinfectants|disinfectants|mesh-ancestor
101388188|NCT06000709|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
101388189|NCT06000709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101388190|NCT06000657|Entecavir|entecavir|mesh-list
101388191|NCT06000657|Antiviral Agents|antiviral agents|mesh-ancestor
101388192|NCT06000657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101388193|NCT06000501|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
101388194|NCT06000501|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101388195|NCT06000501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388196|NCT06000501|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101388197|NCT06000501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101388198|NCT06000501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101388202|NCT06000462|Metformin|metformin|mesh-list
101388203|NCT06000462|Dapagliflozin|dapagliflozin|mesh-list
101388204|NCT06000462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101388205|NCT06000462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388206|NCT06000462|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101388211|NCT06000423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388213|NCT06000423|Coagulants|coagulants|mesh-ancestor
101388214|NCT06000358|Pembrolizumab|pembrolizumab|mesh-list
101388215|NCT06000358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101388216|NCT06000358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101388217|NCT06000358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102074228|NCT02105610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102074229|NCT02105610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074230|NCT02105610|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102074231|NCT02105610|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101388218|NCT06000358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388220|NCT06000137|Sufentanil|sufentanil|mesh-list
101388222|NCT06000137|Dezocine|dezocine|mesh-list
101388223|NCT06000137|Granisetron|granisetron|mesh-list
101388224|NCT06000137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101388225|NCT06000137|Narcotics|narcotics|mesh-ancestor
101388226|NCT06000137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101388227|NCT06000137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388228|NCT06000137|Analgesics|analgesics|mesh-ancestor
101388229|NCT06000137|Sensory System Agents|sensory system agents|mesh-ancestor
101388230|NCT06000137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101388231|NCT06000137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101305346|NCT02019017|Botulinum Toxins|botulinum toxins|mesh-list
101305347|NCT02019017|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101305348|NCT02019017|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101305349|NCT02019017|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101305350|NCT02019017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101305351|NCT02019017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388232|NCT06000137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101388233|NCT06000137|Anesthetics, General|anesthetics, general|mesh-ancestor
101388234|NCT06000137|Anesthetics|anesthetics|mesh-ancestor
101388235|NCT06000137|Antiemetics|antiemetics|mesh-ancestor
101388236|NCT06000137|Autonomic Agents|autonomic agents|mesh-ancestor
101388237|NCT06000137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101388238|NCT06000137|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101388239|NCT06000137|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101388240|NCT06000137|Serotonin Agents|serotonin agents|mesh-ancestor
101388241|NCT06000137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101388242|NCT06000137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388243|NCT06000137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101388244|NCT06000137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101388245|NCT06000137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101388246|NCT06000137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101388247|NCT06000137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101388248|NCT06000137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101388249|NCT06000033|Disitamab vedotin|disitamab vedotin|mesh-list
101388250|NCT06000033|Immunoconjugates|immunoconjugates|mesh-ancestor
101388251|NCT06000033|Immunologic Factors|immunologic factors|mesh-ancestor
101388252|NCT06000033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388253|NCT05999994|Cyclophosphamide|cyclophosphamide|mesh-list
101388254|NCT05999994|Temozolomide|temozolomide|mesh-list
101388255|NCT05999994|Gemcitabine|gemcitabine|mesh-list
101388256|NCT05999994|Docetaxel|docetaxel|mesh-list
101388257|NCT05999994|Irinotecan|irinotecan|mesh-list
101388258|NCT05999994|Vinorelbine|vinorelbine|mesh-list
101388259|NCT05999994|Ramucirumab|ramucirumab|mesh-list
101388260|NCT05999994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101388261|NCT05999994|Immunologic Factors|immunologic factors|mesh-ancestor
101388262|NCT05999994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388263|NCT05999994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101388264|NCT05999994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101388265|NCT05999994|Alkylating Agents|alkylating agents|mesh-ancestor
101388266|NCT05999994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388267|NCT05999994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101388268|NCT05999994|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101388269|NCT05999994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101388270|NCT05999994|Antimetabolites|antimetabolites|mesh-ancestor
101388271|NCT05999994|Tubulin Modulators|tubulin modulators|mesh-ancestor
101388276|NCT05999994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101388277|NCT05999994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101388278|NCT05999955|Neomycin|neomycin|mesh-list
101388279|NCT05999955|Dexamethasone|dexamethasone|mesh-list
101388284|NCT05999955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388285|NCT05999955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101388287|NCT05999955|Hormones|hormones|mesh-ancestor
101388288|NCT05999955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102074232|NCT02105610|Anesthetics, General|anesthetics, general|mesh-ancestor
102074233|NCT00301262|Sildenafil Citrate|sildenafil citrate|mesh-list
102074234|NCT00301262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074235|NCT00301262|Vasodilator Agents|vasodilator agents|mesh-ancestor
102074236|NCT00301262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102074237|NCT00301262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102074238|NCT00301262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101388289|NCT05999955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101388290|NCT05999955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101388291|NCT05999955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101388292|NCT05999955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101388293|NCT05999955|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101388294|NCT05999955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101388295|NCT05999955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388297|NCT05999942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101388298|NCT05999942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101388299|NCT05999890|Tapentadol|tapentadol|mesh-list
101305352|NCT02019017|Cholinergic Agents|cholinergic agents|mesh-ancestor
101305353|NCT02019017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101305354|NCT02019017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305355|NCT02019017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101305356|NCT02019017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101388301|NCT05999890|Sensory System Agents|sensory system agents|mesh-ancestor
101388302|NCT05999890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101388303|NCT05999890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388304|NCT05999890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101388305|NCT05999890|Narcotics|narcotics|mesh-ancestor
101388306|NCT05999890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101388307|NCT05999890|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101388308|NCT05999890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101388309|NCT05999890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101388310|NCT05999890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388311|NCT05999890|Adrenergic Agents|adrenergic agents|mesh-ancestor
101388312|NCT05999890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101388313|NCT05999812|Bevacizumab|bevacizumab|mesh-list
101388314|NCT05999812|Atezolizumab|atezolizumab|mesh-list
101388315|NCT05999812|Tretinoin|tretinoin|mesh-list
101388316|NCT05999812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101388317|NCT05999812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101388318|NCT05999812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101388319|NCT05999812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101388320|NCT05999812|Growth Substances|growth substances|mesh-ancestor
101388321|NCT05999812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388322|NCT05999812|Growth Inhibitors|growth inhibitors|mesh-ancestor
101388323|NCT05999812|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101388324|NCT05999812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388325|NCT05999812|Keratolytic Agents|keratolytic agents|mesh-ancestor
101388326|NCT05999812|Dermatologic Agents|dermatologic agents|mesh-ancestor
101388331|NCT05999734|Bupivacaine|bupivacaine|mesh-list
101388332|NCT05999734|Anesthetics, Local|anesthetics, local|mesh-ancestor
101388333|NCT05999734|Anesthetics|anesthetics|mesh-ancestor
101388334|NCT05999734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101388335|NCT05999734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388336|NCT05999734|Sensory System Agents|sensory system agents|mesh-ancestor
101388337|NCT05999734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101388338|NCT05999708|Indomethacin|indomethacin|mesh-list
101388339|NCT05999708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101388340|NCT05999708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101388341|NCT05999708|Analgesics|analgesics|mesh-ancestor
101388342|NCT05999708|Sensory System Agents|sensory system agents|mesh-ancestor
101388343|NCT05999708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101388344|NCT05999708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388345|NCT05999708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101388346|NCT05999708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101388347|NCT05999708|Gout Suppressants|gout suppressants|mesh-ancestor
102074239|NCT00301262|Urological Agents|urological agents|mesh-ancestor
102074240|NCT02254941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102074242|NCT02254941|Immunoglobulins|immunoglobulins|mesh-list
102074243|NCT02254941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102074244|NCT02254941|Immunologic Factors|immunologic factors|mesh-ancestor
102074245|NCT02254941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388360|NCT05999487|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101388361|NCT05999487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101388362|NCT05999487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101388363|NCT05999487|Adrenergic Agents|adrenergic agents|mesh-ancestor
101388364|NCT05999487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101388365|NCT05999487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388366|NCT05999487|Protective Agents|protective agents|mesh-ancestor
101388367|NCT05999487|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101388368|NCT05999487|Vasodilator Agents|vasodilator agents|mesh-ancestor
101305358|NCT02019056|Metadoxine|metadoxine|mesh-list
101388369|NCT05999487|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101388370|NCT05999487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101388371|NCT05999487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101388372|NCT05999474|Tioconazole|tioconazole|mesh-list
101388373|NCT05999474|Antifungal Agents|antifungal agents|mesh-ancestor
101388374|NCT05999474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101388375|NCT05999474|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101388376|NCT05999474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101388377|NCT05999474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101388378|NCT05999474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388379|NCT05999474|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101388380|NCT05999474|Hormone Antagonists|hormone antagonists|mesh-ancestor
101388381|NCT05999474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101388382|NCT05999474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388383|NCT05999435|Fenretinide|fenretinide|mesh-list
101388384|NCT05999435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101388385|NCT05999435|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101388386|NCT05999435|Protective Agents|protective agents|mesh-ancestor
101388387|NCT05999435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388389|NCT05999383|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101388390|NCT05999383|Autonomic Agents|autonomic agents|mesh-ancestor
101388391|NCT05999383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101388392|NCT05999383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388393|NCT05999383|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101388394|NCT05999383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101388395|NCT05999383|Cholinergic Agents|cholinergic agents|mesh-ancestor
101388396|NCT05999383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101388397|NCT05999383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388398|NCT05999331|N-Methylaspartate|n-methylaspartate|mesh-list
101388399|NCT05999331|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
101388400|NCT05999331|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101388401|NCT05999331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101388402|NCT05999331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388403|NCT05999331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388404|NCT05999240|Pimavanserin|pimavanserin|mesh-list
101388405|NCT05999240|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101388406|NCT05999240|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101388407|NCT05999240|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101388408|NCT05999240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101388409|NCT05999240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101388410|NCT05999240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388411|NCT05999240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101388412|NCT05999240|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101388413|NCT05999240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101388414|NCT05999240|Serotonin Agents|serotonin agents|mesh-ancestor
101388415|NCT05999240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101388416|NCT05999240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388422|NCT05999084|Immunologic Factors|immunologic factors|mesh-ancestor
102074246|NCT02254941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102074247|NCT03598270|Paclitaxel|paclitaxel|mesh-list
102074248|NCT03598270|Carboplatin|carboplatin|mesh-list
102074249|NCT03598270|Gemcitabine|gemcitabine|mesh-list
102074250|NCT03598270|Doxorubicin|doxorubicin|mesh-list
102074251|NCT03598270|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102074252|NCT03598270|Atezolizumab|atezolizumab|mesh-list
102074253|NCT03598270|Niraparib|niraparib|mesh-list
102074254|NCT03598270|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102074255|NCT03598270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101486190|NCT00352170|Vitamin D|vitamin d|mesh-list
101388423|NCT05999084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388424|NCT05998941|Paclitaxel|paclitaxel|mesh-list
101388425|NCT05998941|Bevacizumab|bevacizumab|mesh-list
101388429|NCT05998941|Tubulin Modulators|tubulin modulators|mesh-ancestor
101388430|NCT05998941|Antimitotic Agents|antimitotic agents|mesh-ancestor
101388431|NCT05998941|Mitosis Modulators|mitosis modulators|mesh-ancestor
101388432|NCT05998941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388433|NCT05998941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101388434|NCT05998941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101388435|NCT05998941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101388436|NCT05998941|Growth Substances|growth substances|mesh-ancestor
101388437|NCT05998941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388438|NCT05998941|Growth Inhibitors|growth inhibitors|mesh-ancestor
101388439|NCT05998928|Cyclophosphamide|cyclophosphamide|mesh-list
101388440|NCT05998928|Fludarabine|fludarabine|mesh-list
101388441|NCT05998928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101388442|NCT05998928|Immunologic Factors|immunologic factors|mesh-ancestor
101388443|NCT05998928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305359|NCT02019056|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101305360|NCT02019056|Vitamin B Complex|vitamin b complex|mesh-ancestor
101388444|NCT05998928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101388445|NCT05998928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101388446|NCT05998928|Alkylating Agents|alkylating agents|mesh-ancestor
101388447|NCT05998928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388448|NCT05998928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101388449|NCT05998928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101388450|NCT05998876|Methadone|methadone|mesh-list
101388451|NCT05998876|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101388452|NCT05998876|Narcotics|narcotics|mesh-ancestor
101388453|NCT05998876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101388454|NCT05998876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388455|NCT05998876|Analgesics|analgesics|mesh-ancestor
101388456|NCT05998876|Sensory System Agents|sensory system agents|mesh-ancestor
101388457|NCT05998876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101388458|NCT05998876|Antitussive Agents|antitussive agents|mesh-ancestor
101388459|NCT05998876|Respiratory System Agents|respiratory system agents|mesh-ancestor
101388460|NCT05998863|Magnesium citrate|magnesium citrate|mesh-list
101388461|NCT05998863|Cathartics|cathartics|mesh-ancestor
101388462|NCT05998863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101388463|NCT05998837|Dapagliflozin|dapagliflozin|mesh-list
101388464|NCT05998837|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101388465|NCT05998837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388466|NCT05998837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101388467|NCT05998837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388468|NCT05998642|Rituximab|rituximab|mesh-list
101388469|NCT05998642|Methotrexate|methotrexate|mesh-list
101388470|NCT05998642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101388471|NCT05998642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101388472|NCT05998642|Immunologic Factors|immunologic factors|mesh-ancestor
101388473|NCT05998642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388474|NCT05998642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101388475|NCT05998642|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101388476|NCT05998642|Abortifacient Agents|abortifacient agents|mesh-ancestor
101388477|NCT05998642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101388478|NCT05998642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101388479|NCT05998642|Antimetabolites|antimetabolites|mesh-ancestor
102074256|NCT03598270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102074257|NCT03598270|Tubulin Modulators|tubulin modulators|mesh-ancestor
102074258|NCT03598270|Antimitotic Agents|antimitotic agents|mesh-ancestor
102074259|NCT03598270|Mitosis Modulators|mitosis modulators|mesh-ancestor
102074260|NCT03598270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074261|NCT03598270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102074262|NCT03598270|Antimetabolites|antimetabolites|mesh-ancestor
102074263|NCT03598270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102074264|NCT03598270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102074265|NCT03598270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101388480|NCT05998642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388481|NCT05998642|Dermatologic Agents|dermatologic agents|mesh-ancestor
101388482|NCT05998642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101388483|NCT05998642|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101388484|NCT05998642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101388485|NCT05998642|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101388486|NCT05998551|Fentanyl|fentanyl|mesh-list
101388498|NCT05998551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101388499|NCT05998551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101388500|NCT05998551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101388501|NCT05998551|Adrenergic Agents|adrenergic agents|mesh-ancestor
101388502|NCT05998551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101388503|NCT05998551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388504|NCT05998551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101388506|NCT05998551|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101388513|NCT05998525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388514|NCT05998447|Pembrolizumab|pembrolizumab|mesh-list
101388515|NCT05998447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101388516|NCT05998447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101388517|NCT05998447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101388518|NCT05998447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388519|NCT05998421|Aspirin|aspirin|mesh-list
101388520|NCT05998421|Heparin|heparin|mesh-list
101388521|NCT05998421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101388522|NCT05998421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101388523|NCT05998421|Analgesics|analgesics|mesh-ancestor
101305362|NCT02019056|Micronutrients|micronutrients|mesh-ancestor
101388524|NCT05998421|Sensory System Agents|sensory system agents|mesh-ancestor
101388525|NCT05998421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101388526|NCT05998421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388527|NCT05998421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101388528|NCT05998421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101388529|NCT05998421|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101388530|NCT05998421|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101388531|NCT05998421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388532|NCT05998421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101388533|NCT05998421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101388534|NCT05998421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101388535|NCT05998421|Antipyretics|antipyretics|mesh-ancestor
101388536|NCT05998421|Anticoagulants|anticoagulants|mesh-ancestor
101388537|NCT05998356|Anesthetics|anesthetics|mesh-list
101388538|NCT05998356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101388539|NCT05998356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388540|NCT05998239|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
101388541|NCT05998239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101388542|NCT05998239|Immunologic Factors|immunologic factors|mesh-ancestor
101388543|NCT05998239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388544|NCT05998226|Anti-Infective Agents|anti-infective agents|mesh-list
101388545|NCT05998226|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101388546|NCT05998200|Glycolic acid|glycolic acid|mesh-list
101388547|NCT05998200|Keratolytic Agents|keratolytic agents|mesh-ancestor
102074266|NCT03598270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102074267|NCT03598270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102074268|NCT03598270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102074269|NCT03598270|Immunologic Factors|immunologic factors|mesh-ancestor
102074270|NCT03598270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074271|NCT03598270|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102074272|NCT03077620|Suvorexant|suvorexant|mesh-list
101375946|NCT00236626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388548|NCT05998200|Dermatologic Agents|dermatologic agents|mesh-ancestor
101388552|NCT05998187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388554|NCT05998187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101388555|NCT05998187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388556|NCT05998135|Atovaquone|atovaquone|mesh-list
101388557|NCT05998135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101388558|NCT05998135|Antimalarials|antimalarials|mesh-ancestor
101388559|NCT05998135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101388560|NCT05998135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101388561|NCT05998135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101388562|NCT05998135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388563|NCT05998096|Caffeine|caffeine|mesh-list
101388564|NCT05998096|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101388565|NCT05998096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388566|NCT05998096|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101388567|NCT05998096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101388568|NCT05998096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388569|NCT05998096|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101388570|NCT05998096|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101388571|NCT05998096|Purinergic Agents|purinergic agents|mesh-ancestor
101388572|NCT05998096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101388573|NCT05997979|Capsaicin|capsaicin|mesh-list
101388574|NCT05997979|Antipruritics|antipruritics|mesh-ancestor
101388575|NCT05997979|Dermatologic Agents|dermatologic agents|mesh-ancestor
101388585|NCT05997901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388587|NCT05997784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101388588|NCT05997784|Autonomic Agents|autonomic agents|mesh-ancestor
101388589|NCT05997784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101388590|NCT05997784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388591|NCT05997784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101388592|NCT05997784|Respiratory System Agents|respiratory system agents|mesh-ancestor
101388593|NCT05997784|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101388594|NCT05997784|Antioxidants|antioxidants|mesh-ancestor
101388595|NCT05997784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388596|NCT05997784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101388597|NCT05997784|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101388598|NCT05997784|Vasodilator Agents|vasodilator agents|mesh-ancestor
101305365|NCT02019095|Chelating Agents|chelating agents|mesh-ancestor
101305366|NCT02019095|Sequestering Agents|sequestering agents|mesh-ancestor
101305367|NCT02019095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305368|NCT02019160|Silver Nitrate|silver nitrate|mesh-list
101305369|NCT02019160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101305370|NCT02019160|Fluorides|fluorides|mesh-list
101305371|NCT02019160|Sodium Fluoride|sodium fluoride|mesh-list
101305372|NCT02019160|Cariostatic Agents|cariostatic agents|mesh-ancestor
101305373|NCT02019160|Protective Agents|protective agents|mesh-ancestor
101388599|NCT05997784|Gasotransmitters|gasotransmitters|mesh-ancestor
101388600|NCT05997784|Protective Agents|protective agents|mesh-ancestor
101388601|NCT05997693|Ticagrelor|ticagrelor|mesh-list
101388602|NCT05997693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101388603|NCT05997693|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101388604|NCT05997693|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101388605|NCT05997693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101388606|NCT05997693|Purinergic Agents|purinergic agents|mesh-ancestor
101388607|NCT05997693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101334315|NCT00043810|Fludarabine|fludarabine|mesh-list
101388608|NCT05997693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074273|NCT03077620|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102074274|NCT03077620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102074275|NCT03077620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102074276|NCT03077620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388609|NCT05997693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388615|NCT05997524|Capecitabine|capecitabine|mesh-list
101388616|NCT05997524|Oxaliplatin|oxaliplatin|mesh-list
101388617|NCT05997524|Trastuzumab|trastuzumab|mesh-list
101388622|NCT05997524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101388623|NCT05997485|Ritonavir|ritonavir|mesh-list
101388624|NCT05997485|Nirmatrelvir|nirmatrelvir|mesh-list
101388625|NCT05997485|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
101388626|NCT05997485|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101388627|NCT05997485|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101388628|NCT05997485|Protease Inhibitors|protease inhibitors|mesh-ancestor
101388629|NCT05997485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101388630|NCT05997485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388631|NCT05997485|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101388632|NCT05997485|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101388633|NCT05997485|Antiviral Agents|antiviral agents|mesh-ancestor
101388634|NCT05997485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101388635|NCT05997485|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101388636|NCT05997485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101388637|NCT05997433|Amoxicillin|amoxicillin|mesh-list
101388638|NCT05997433|Tetracycline|tetracycline|mesh-list
101388639|NCT05997433|Bismuth|bismuth|mesh-list
101388640|NCT05997433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101388643|NCT05997433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388645|NCT05997433|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101388646|NCT05997433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101388647|NCT05997355|Gabapentin|gabapentin|mesh-list
101388648|NCT05997355|Analgesics|analgesics|mesh-ancestor
101388649|NCT05997355|Sensory System Agents|sensory system agents|mesh-ancestor
101388650|NCT05997355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101388651|NCT05997355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388652|NCT05997355|Anticonvulsants|anticonvulsants|mesh-ancestor
101388653|NCT05997355|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101388654|NCT05997355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101388655|NCT05997355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101388656|NCT05997355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101388657|NCT05997355|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101388658|NCT05997355|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101388659|NCT05997355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101388660|NCT05997355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388661|NCT05997355|Antimanic Agents|antimanic agents|mesh-ancestor
101388662|NCT05997303|Norepinephrine|norepinephrine|mesh-list
101388663|NCT05997303|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101388665|NCT05997303|Adrenergic Agents|adrenergic agents|mesh-ancestor
101388666|NCT05997303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101388667|NCT05997303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388668|NCT05997303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388669|NCT05997303|Sympathomimetics|sympathomimetics|mesh-ancestor
101388670|NCT05997303|Autonomic Agents|autonomic agents|mesh-ancestor
101388671|NCT05997303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101388672|NCT05997303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101388673|NCT05997277|Deucravacitinib|deucravacitinib|mesh-list
101388674|NCT05997277|Dermatologic Agents|dermatologic agents|mesh-ancestor
101388675|NCT05997277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101388676|NCT05997277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101388677|NCT05997277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388678|NCT05997238|Triamcinolone|triamcinolone|mesh-list
101388679|NCT05997238|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101388680|NCT05997238|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101388681|NCT05997238|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101388682|NCT05997238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101388683|NCT05997238|Glucocorticoids|glucocorticoids|mesh-ancestor
101388684|NCT05997238|Hormones|hormones|mesh-ancestor
101388685|NCT05997238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101388686|NCT05997238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388687|NCT05997238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102074277|NCT03077620|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
102074278|NCT03077620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102074279|NCT03077620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074280|NCT03656445|Tranexamic Acid|tranexamic acid|mesh-list
102074281|NCT03656445|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102074282|NCT03656445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101375959|NCT00236704|Anticonvulsants|anticonvulsants|mesh-ancestor
101388688|NCT05997238|Immunologic Factors|immunologic factors|mesh-ancestor
101388712|NCT05997056|Sirolimus|sirolimus|mesh-list
101388713|NCT05997056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101388714|NCT05997056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101388715|NCT05997056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101388716|NCT05997056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101388717|NCT05997056|Antifungal Agents|antifungal agents|mesh-ancestor
101388718|NCT05997056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101388719|NCT05997056|Immunologic Factors|immunologic factors|mesh-ancestor
101388720|NCT05997056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388721|NCT05997043|Antiparkinson Agents|antiparkinson agents|mesh-list
101388722|NCT05997043|Botulinum Toxins|botulinum toxins|mesh-list
101388723|NCT05997043|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101388724|NCT05997043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101388725|NCT05997043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388726|NCT05997043|Cholinergic Agents|cholinergic agents|mesh-ancestor
101388731|NCT05997017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101388732|NCT05997017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101388733|NCT05997017|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101388734|NCT05997017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101388736|NCT05997017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101388737|NCT05997017|Immunologic Factors|immunologic factors|mesh-ancestor
101388738|NCT05997017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388748|NCT05996588|Anesthetics|anesthetics|mesh-list
101388749|NCT05996588|Sevoflurane|sevoflurane|mesh-list
101388750|NCT05996588|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
101388751|NCT05996588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101305374|NCT02019160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305375|NCT02019160|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101305376|NCT02019160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101305377|NCT02019186|Vitamins|vitamins|mesh-list
101388752|NCT05996588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101388753|NCT05996588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388754|NCT05996588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101388755|NCT05996588|Anesthetics, General|anesthetics, general|mesh-ancestor
101388756|NCT05996588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101388757|NCT05996549|Vaccines|vaccines|mesh-list
101388760|NCT05996484|Paclitaxel|paclitaxel|mesh-list
101388761|NCT05996484|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101388762|NCT05996484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101388763|NCT05996484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101388764|NCT05996484|Tubulin Modulators|tubulin modulators|mesh-ancestor
101388765|NCT05996484|Antimitotic Agents|antimitotic agents|mesh-ancestor
101388766|NCT05996484|Mitosis Modulators|mitosis modulators|mesh-ancestor
101388767|NCT05996484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388777|NCT05996445|Pembrolizumab|pembrolizumab|mesh-list
101388778|NCT05996445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101388779|NCT05996445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101388780|NCT05996445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101388781|NCT05996445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074283|NCT03656445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074284|NCT03656445|Hemostatics|hemostatics|mesh-ancestor
102074285|NCT03656445|Coagulants|coagulants|mesh-ancestor
102074286|NCT01903486|Prednisone|prednisone|mesh-list
102074287|NCT01903486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102074288|NCT01903486|Glucocorticoids|glucocorticoids|mesh-ancestor
102074289|NCT01903486|Hormones|hormones|mesh-ancestor
101375966|NCT00236782|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101388782|NCT05996406|Dexamethasone|dexamethasone|mesh-list
101388783|NCT05996406|Venetoclax|venetoclax|mesh-list
101388784|NCT05996406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101388785|NCT05996406|Antiemetics|antiemetics|mesh-ancestor
101388786|NCT05996406|Autonomic Agents|autonomic agents|mesh-ancestor
101388787|NCT05996406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101388788|NCT05996406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388789|NCT05996406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101388790|NCT05996406|Glucocorticoids|glucocorticoids|mesh-ancestor
101388791|NCT05996406|Hormones|hormones|mesh-ancestor
101388792|NCT05996406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101388793|NCT05996406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101388794|NCT05996406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101388795|NCT05996393|Cyclosporine|cyclosporine|mesh-list
101388796|NCT05996393|Cyclosporins|cyclosporins|mesh-list
101388797|NCT05996393|Thymoglobulin|thymoglobulin|mesh-list
101388798|NCT05996393|Immunoglobulins|immunoglobulins|mesh-list
101388799|NCT05996393|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101388800|NCT05996393|Antibodies|antibodies|mesh-list
101388801|NCT05996393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101388802|NCT05996393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388803|NCT05996393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101388804|NCT05996393|Immunologic Factors|immunologic factors|mesh-ancestor
101388805|NCT05996393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388806|NCT05996393|Antifungal Agents|antifungal agents|mesh-ancestor
101388807|NCT05996393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101388808|NCT05996393|Dermatologic Agents|dermatologic agents|mesh-ancestor
101388809|NCT05996393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101388810|NCT05996393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101388811|NCT05996224|Hyaluronic Acid|hyaluronic acid|mesh-list
101388812|NCT05996224|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101388813|NCT05996224|Immunologic Factors|immunologic factors|mesh-ancestor
101388816|NCT05996224|Protective Agents|protective agents|mesh-ancestor
101388817|NCT05996185|Prednisone|prednisone|mesh-list
101388818|NCT05996185|Cyclophosphamide|cyclophosphamide|mesh-list
101388819|NCT05996185|Doxorubicin|doxorubicin|mesh-list
101388820|NCT05996185|Etoposide|etoposide|mesh-list
101388821|NCT05996185|Vincristine|vincristine|mesh-list
101388822|NCT05996185|Mogamulizumab|mogamulizumab|mesh-list
101305379|NCT02019186|Micronutrients|micronutrients|mesh-ancestor
101305380|NCT02019186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388823|NCT05996185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101388824|NCT05996185|Immunologic Factors|immunologic factors|mesh-ancestor
101388825|NCT05996185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388826|NCT05996185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101388827|NCT05996185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101388828|NCT05996185|Alkylating Agents|alkylating agents|mesh-ancestor
101388829|NCT05996185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388830|NCT05996185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101388831|NCT05996185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101388835|NCT05996185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101388836|NCT05996185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101388837|NCT05996185|Glucocorticoids|glucocorticoids|mesh-ancestor
101388839|NCT05996185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101388840|NCT05996185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101388841|NCT05996185|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101388842|NCT05996185|Tubulin Modulators|tubulin modulators|mesh-ancestor
101388843|NCT05996185|Antimitotic Agents|antimitotic agents|mesh-ancestor
101388844|NCT05996185|Mitosis Modulators|mitosis modulators|mesh-ancestor
101388845|NCT05995600|Warfarin|warfarin|mesh-list
101388846|NCT05995600|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
101388847|NCT05995600|Anticoagulants|anticoagulants|mesh-ancestor
102074290|NCT01903486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102074291|NCT01903486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074292|NCT01903486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102074293|NCT01903486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102074294|NCT03656289|Etonogestrel|etonogestrel|mesh-list
101388848|NCT05995535|Lofexidine|lofexidine|mesh-list
101388849|NCT05995535|Clonidine|clonidine|mesh-list
101388850|NCT05995535|Pregabalin|pregabalin|mesh-list
101388851|NCT05995535|Analgesics|analgesics|mesh-ancestor
101388852|NCT05995535|Sensory System Agents|sensory system agents|mesh-ancestor
101388853|NCT05995535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101388854|NCT05995535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388855|NCT05995535|Anticonvulsants|anticonvulsants|mesh-ancestor
101388856|NCT05995535|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101388857|NCT05995535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101388858|NCT05995535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388859|NCT05995535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101388860|NCT05995535|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101388861|NCT05995535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101388862|NCT05995535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101388863|NCT05995535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101388864|NCT05995535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101388865|NCT05995535|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101388866|NCT05995535|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101388867|NCT05995535|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101388868|NCT05995535|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101388869|NCT05995535|Adrenergic Agents|adrenergic agents|mesh-ancestor
101388870|NCT05995535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101388871|NCT05995535|Sympatholytics|sympatholytics|mesh-ancestor
101388872|NCT05995535|Autonomic Agents|autonomic agents|mesh-ancestor
101388881|NCT05995392|Spironolactone|spironolactone|mesh-list
101388882|NCT05995392|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101388883|NCT05995392|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101388884|NCT05995392|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101388885|NCT05995392|Hormone Antagonists|hormone antagonists|mesh-ancestor
101388886|NCT05995392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101388887|NCT05995392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388888|NCT05995392|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101388889|NCT05995392|Diuretics|diuretics|mesh-ancestor
101388890|NCT05995392|Natriuretic Agents|natriuretic agents|mesh-ancestor
101388891|NCT05995314|Caffeine|caffeine|mesh-list
101388892|NCT05995314|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101388893|NCT05995314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388894|NCT05995314|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101305381|NCT02019186|Antioxidants|antioxidants|mesh-ancestor
101388895|NCT05995314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101388900|NCT05995314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101388901|NCT05995119|Apixaban|apixaban|mesh-list
101388902|NCT05995119|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101388907|NCT05995119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388909|NCT05994820|Vaccines|vaccines|mesh-list
101388910|NCT05994820|Immunologic Factors|immunologic factors|mesh-ancestor
101388911|NCT05994820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388912|NCT05994534|Acetylcysteine|acetylcysteine|mesh-list
101388913|NCT05994534|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101388914|NCT05994534|Cysteamine|cysteamine|mesh-list
101388915|NCT05994534|Antiviral Agents|antiviral agents|mesh-ancestor
101388916|NCT05994534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101388917|NCT05994534|Expectorants|expectorants|mesh-ancestor
101388918|NCT05994534|Respiratory System Agents|respiratory system agents|mesh-ancestor
101388919|NCT05994534|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101388920|NCT05994534|Antioxidants|antioxidants|mesh-ancestor
101388921|NCT05994534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388922|NCT05994534|Protective Agents|protective agents|mesh-ancestor
101388923|NCT05994534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388924|NCT05994534|Antidotes|antidotes|mesh-ancestor
101388925|NCT05994534|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
101388926|NCT05993039|Remifentanil|remifentanil|mesh-list
101388927|NCT05993039|Propofol|propofol|mesh-list
101388928|NCT05993039|Sevoflurane|sevoflurane|mesh-list
102074295|NCT03656289|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102074296|NCT03656289|Contraceptive Agents|contraceptive agents|mesh-ancestor
102074297|NCT03656289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102074298|NCT03656289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074299|NCT03656289|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102074300|NCT00599170|Rituximab|rituximab|mesh-list
101375979|NCT00097968|Everolimus|everolimus|mesh-list
101388929|NCT05993039|Isoflurane|isoflurane|mesh-list
101388930|NCT05993039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101388931|NCT05993039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101388932|NCT05993039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388933|NCT05993039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101388934|NCT05993039|Anesthetics, General|anesthetics, general|mesh-ancestor
101388935|NCT05993039|Anesthetics|anesthetics|mesh-ancestor
101388936|NCT05993039|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101388937|NCT05993039|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101388938|NCT05993039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101388939|NCT05993039|Narcotics|narcotics|mesh-ancestor
101388940|NCT05993039|Analgesics|analgesics|mesh-ancestor
101388941|NCT05993039|Sensory System Agents|sensory system agents|mesh-ancestor
101334332|NCT00043849|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101388942|NCT05993039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101388943|NCT05990985|Prednisolone|prednisolone|mesh-list
101388944|NCT05990985|Cyclophosphamide|cyclophosphamide|mesh-list
101388945|NCT05990985|Rituximab|rituximab|mesh-list
101388946|NCT05990985|Vincristine|vincristine|mesh-list
101388947|NCT05990985|Mitoxantrone|mitoxantrone|mesh-list
101388948|NCT05990985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101388949|NCT05990985|Immunologic Factors|immunologic factors|mesh-ancestor
101388950|NCT05990985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388951|NCT05990985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101388952|NCT05990985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101388953|NCT05990985|Alkylating Agents|alkylating agents|mesh-ancestor
101388954|NCT05990985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388955|NCT05990985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101388956|NCT05990985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101388957|NCT05990985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101388958|NCT05990985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101388959|NCT05990985|Tubulin Modulators|tubulin modulators|mesh-ancestor
101388960|NCT05990985|Antimitotic Agents|antimitotic agents|mesh-ancestor
101388961|NCT05990985|Mitosis Modulators|mitosis modulators|mesh-ancestor
101388962|NCT05990985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101388963|NCT05990985|Glucocorticoids|glucocorticoids|mesh-ancestor
101388964|NCT05990985|Hormones|hormones|mesh-ancestor
101388965|NCT05990985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101388966|NCT05990985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101388967|NCT05990985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101388968|NCT05990985|Analgesics|analgesics|mesh-ancestor
101388969|NCT05990985|Sensory System Agents|sensory system agents|mesh-ancestor
101388970|NCT05990985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101388971|NCT05990985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101388972|NCT05990985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101388978|NCT05989503|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101388979|NCT05989503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388980|NCT05989503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101388981|NCT05989503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388982|NCT05989074|Fexofenadine|fexofenadine|mesh-list
101388983|NCT05989074|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101388984|NCT05989074|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101388985|NCT05989074|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101388986|NCT05989074|Histamine Antagonists|histamine antagonists|mesh-ancestor
101388987|NCT05989074|Histamine Agents|histamine agents|mesh-ancestor
101388988|NCT05989074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101388989|NCT05989074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388990|NCT05989074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388991|NCT05987956|Afatinib|afatinib|mesh-list
101388992|NCT05987956|Crizotinib|crizotinib|mesh-list
101388993|NCT05987956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101388994|NCT05987956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101375988|NCT00236821|Levofloxacin|levofloxacin|mesh-list
102074301|NCT00599170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102074302|NCT00599170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102074303|NCT00599170|Immunologic Factors|immunologic factors|mesh-ancestor
102074304|NCT00599170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074305|NCT00599170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102074306|NCT04256434|Nalbuphine|nalbuphine|mesh-list
102074307|NCT04256434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102074308|NCT04256434|Narcotics|narcotics|mesh-ancestor
102074309|NCT04256434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102074310|NCT04256434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074311|NCT04256434|Analgesics|analgesics|mesh-ancestor
102074312|NCT04256434|Sensory System Agents|sensory system agents|mesh-ancestor
102074313|NCT04256434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101388995|NCT05987956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101388996|NCT05987956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388997|NCT05985681|Vaccines|vaccines|mesh-list
101388998|NCT05985681|Immunologic Factors|immunologic factors|mesh-ancestor
101388999|NCT05985681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389000|NCT05984550|Niacinamide|niacinamide|mesh-list
101389001|NCT05984550|Vitamin B Complex|vitamin b complex|mesh-ancestor
101389002|NCT05984550|Vitamins|vitamins|mesh-ancestor
101389003|NCT05984550|Micronutrients|micronutrients|mesh-ancestor
101389004|NCT05984550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389005|NCT05980546|Dexamethasone|dexamethasone|mesh-list
101389006|NCT05980546|Dexamethasone acetate|dexamethasone acetate|mesh-list
101389007|NCT05980546|Fentanyl|fentanyl|mesh-list
101389008|NCT05980546|Bupivacaine|bupivacaine|mesh-list
101389009|NCT05980546|Mepivacaine|mepivacaine|mesh-list
101389010|NCT05980546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101389011|NCT05980546|Antiemetics|antiemetics|mesh-ancestor
101389012|NCT05980546|Autonomic Agents|autonomic agents|mesh-ancestor
101389013|NCT05980546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101389014|NCT05980546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389015|NCT05980546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101389016|NCT05980546|Glucocorticoids|glucocorticoids|mesh-ancestor
101389017|NCT05980546|Hormones|hormones|mesh-ancestor
101389018|NCT05980546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101389019|NCT05980546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101389020|NCT05980546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101389021|NCT05980546|Anesthetics, Local|anesthetics, local|mesh-ancestor
101389022|NCT05980546|Anesthetics|anesthetics|mesh-ancestor
101389023|NCT05980546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101389024|NCT05980546|Sensory System Agents|sensory system agents|mesh-ancestor
101389025|NCT05980546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101389026|NCT05980546|Narcotics|narcotics|mesh-ancestor
101389027|NCT05980546|Analgesics|analgesics|mesh-ancestor
101389028|NCT05980546|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101389029|NCT05980546|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101389030|NCT05980546|Anesthetics, General|anesthetics, general|mesh-ancestor
101389031|NCT05975463|Bevacizumab|bevacizumab|mesh-list
101389032|NCT05975463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101389033|NCT05975463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101389034|NCT05975463|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101389035|NCT05975463|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101389036|NCT05975463|Growth Substances|growth substances|mesh-ancestor
101389037|NCT05975463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389038|NCT05975463|Growth Inhibitors|growth inhibitors|mesh-ancestor
101389039|NCT05972993|Vaccines|vaccines|mesh-list
101389040|NCT05972993|Immunologic Factors|immunologic factors|mesh-ancestor
101389041|NCT05972993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389042|NCT05971602|Rifampin|rifampin|mesh-list
101389043|NCT05971602|Isoniazid|isoniazid|mesh-list
101389044|NCT05971602|Pyrazinamide|pyrazinamide|mesh-list
102074314|NCT02588326|Mometasone Furoate|mometasone furoate|mesh-list
102074315|NCT02588326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102074316|NCT02588326|Dermatologic Agents|dermatologic agents|mesh-ancestor
102074317|NCT02588326|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101305385|NCT02019290|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101305386|NCT02019290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101305387|NCT02019290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101389054|NCT05971602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101389055|NCT05971602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101389056|NCT05971602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389057|NCT05971602|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101389058|NCT05971602|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101389059|NCT05971602|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101389060|NCT05971602|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101389061|NCT05971602|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101389062|NCT05971602|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101389063|NCT05971602|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101389064|NCT05971602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101389065|NCT05971602|Antimetabolites|antimetabolites|mesh-ancestor
101389066|NCT05971602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101389067|NCT05971602|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101389069|NCT05971251|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
101389070|NCT05971251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101389071|NCT05971251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101389072|NCT05966246|Prucalopride|prucalopride|mesh-list
101389074|NCT05966246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389075|NCT05966246|Laxatives|laxatives|mesh-ancestor
101389076|NCT05966246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101389077|NCT05966246|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101389078|NCT05966246|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101389079|NCT05966246|Serotonin Agents|serotonin agents|mesh-ancestor
101389080|NCT05966246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101389081|NCT05966246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389082|NCT05966194|Cisplatin|cisplatin|mesh-list
101389083|NCT05966194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101389084|NCT05962151|Nalbuphine|nalbuphine|mesh-list
101389085|NCT05962151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101389086|NCT05962151|Narcotics|narcotics|mesh-ancestor
101389087|NCT05962151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101389088|NCT05962151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389089|NCT05962151|Analgesics|analgesics|mesh-ancestor
101389090|NCT05962151|Sensory System Agents|sensory system agents|mesh-ancestor
101389091|NCT05962151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101389092|NCT05959356|Leucovorin|leucovorin|mesh-list
101389093|NCT05959356|Oxaliplatin|oxaliplatin|mesh-list
101389094|NCT05959356|Irinotecan|irinotecan|mesh-list
101389095|NCT05959356|Cetuximab|cetuximab|mesh-list
101389096|NCT05959356|Levoleucovorin|levoleucovorin|mesh-list
101389097|NCT05959356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101389098|NCT05959356|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101389099|NCT05959356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101389100|NCT05959356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101389101|NCT05959356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389102|NCT05959356|Antidotes|antidotes|mesh-ancestor
101389103|NCT05959356|Protective Agents|protective agents|mesh-ancestor
101389104|NCT05959356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389105|NCT05959356|Vitamin B Complex|vitamin b complex|mesh-ancestor
101389106|NCT05959356|Vitamins|vitamins|mesh-ancestor
101389107|NCT05959356|Micronutrients|micronutrients|mesh-ancestor
101389108|NCT05959356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101389109|NCT05954871|Cetuximab|cetuximab|mesh-list
101389110|NCT05954871|Osimertinib|osimertinib|mesh-list
101389111|NCT05954871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101389112|NCT05954871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101389113|NCT05954871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101389114|NCT05954871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101389115|NCT05954871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389116|NCT05952713|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101389117|NCT05952713|Amitriptyline|amitriptyline|mesh-list
101389118|NCT05952713|Vortioxetine|vortioxetine|mesh-list
102074319|NCT02107950|Gemcitabine|gemcitabine|mesh-list
102074320|NCT02107950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102074321|NCT02107950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102074322|NCT02107950|Antimetabolites|antimetabolites|mesh-ancestor
102074323|NCT02107950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074324|NCT02108106|Mitapivat|mitapivat|mesh-list
102074325|NCT02108106|Enzyme Activators|enzyme activators|mesh-ancestor
101389131|NCT05952713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101389132|NCT05952713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101389133|NCT05952713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389134|NCT05952713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101389135|NCT05952713|Serotonin Agents|serotonin agents|mesh-ancestor
101389136|NCT05952713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389137|NCT05952713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101389138|NCT05952713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101389139|NCT05952713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101389140|NCT05952713|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101389141|NCT05952713|Analgesics|analgesics|mesh-ancestor
101389142|NCT05952713|Sensory System Agents|sensory system agents|mesh-ancestor
101389143|NCT05952713|Dopamine Agents|dopamine agents|mesh-ancestor
101389144|NCT05952713|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101389145|NCT05952713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101389146|NCT05952713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101389147|NCT05952713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101389148|NCT05952713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101389149|NCT05952713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101389150|NCT05952713|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101389151|NCT05952713|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101389152|NCT05952713|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101389153|NCT05952713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101389154|NCT05952713|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101389155|NCT05952713|Histamine Antagonists|histamine antagonists|mesh-ancestor
101389156|NCT05952713|Histamine Agents|histamine agents|mesh-ancestor
101389157|NCT05952713|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101389158|NCT05952713|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101389159|NCT05952713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101389160|NCT05952713|Adrenergic Agents|adrenergic agents|mesh-ancestor
101389161|NCT05952713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101389162|NCT05952713|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101389163|NCT05952713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101389164|NCT05952713|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101389165|NCT05952713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101389173|NCT05945927|Trastuzumab|trastuzumab|mesh-list
101389174|NCT05945927|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101389175|NCT05945927|Maytansine|maytansine|mesh-list
101389176|NCT05945927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101389177|NCT05945927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101389178|NCT05945927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101389179|NCT05945927|Tubulin Modulators|tubulin modulators|mesh-ancestor
101389180|NCT05945927|Antimitotic Agents|antimitotic agents|mesh-ancestor
101389181|NCT05945927|Mitosis Modulators|mitosis modulators|mesh-ancestor
101389182|NCT05945927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389183|NCT05945927|Immunotoxins|immunotoxins|mesh-ancestor
101389184|NCT05945927|Immunoconjugates|immunoconjugates|mesh-ancestor
101389185|NCT05945927|Immunologic Factors|immunologic factors|mesh-ancestor
101389186|NCT05945927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389200|NCT05943795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389201|NCT05925023|Sirolimus|sirolimus|mesh-list
102074326|NCT02108106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074327|NCT02113800|Everolimus|everolimus|mesh-list
102074328|NCT02113800|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102074329|NCT02113800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102074330|NCT02113800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102074331|NCT02113800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074332|NCT02113800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101389202|NCT05925023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101389203|NCT05925023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101389204|NCT05925023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101389205|NCT05925023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101305403|NCT02019329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305405|NCT02019329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101305406|NCT02019329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101305407|NCT02019329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101389209|NCT05925023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389223|NCT05908799|Pembrolizumab|pembrolizumab|mesh-list
101389224|NCT05908799|Pemetrexed|pemetrexed|mesh-list
101389225|NCT05908799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101389226|NCT05908799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101389227|NCT05908799|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101389228|NCT05908799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389229|NCT05908799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101389230|NCT05908799|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101389231|NCT05908799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101389232|NCT05908786|Bevacizumab|bevacizumab|mesh-list
101389233|NCT05908786|Atezolizumab|atezolizumab|mesh-list
101389234|NCT05908786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101389235|NCT05908786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334359|NCT00043888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101389236|NCT05908786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101389237|NCT05908786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101389238|NCT05908786|Growth Substances|growth substances|mesh-ancestor
101389239|NCT05908786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389240|NCT05908786|Growth Inhibitors|growth inhibitors|mesh-ancestor
101389241|NCT05908786|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101389242|NCT05908786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389243|NCT05905419|Analgesics, Opioid|analgesics, opioid|mesh-list
101389244|NCT05905419|Narcotics|narcotics|mesh-ancestor
101389245|NCT05905419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101389246|NCT05905419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389247|NCT05905419|Analgesics|analgesics|mesh-ancestor
101305408|NCT02019329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101305409|NCT02019329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101305410|NCT02019329|Dopamine Agents|dopamine agents|mesh-ancestor
101389248|NCT05905419|Sensory System Agents|sensory system agents|mesh-ancestor
101389249|NCT05905419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101389255|NCT05896566|Anastrozole|anastrozole|mesh-list
101389256|NCT05896566|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101389257|NCT05896566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101389264|NCT05896566|Hormone Antagonists|hormone antagonists|mesh-ancestor
101389265|NCT05896566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101389266|NCT05896566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389267|NCT05896566|Luteolytic Agents|luteolytic agents|mesh-ancestor
101389268|NCT05896566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101389269|NCT05896566|Contraceptive Agents|contraceptive agents|mesh-ancestor
101389270|NCT05896566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101389271|NCT05896566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101389272|NCT05896228|Acetaminophen|acetaminophen|mesh-list
101389273|NCT05896228|Diphenhydramine|diphenhydramine|mesh-list
101389274|NCT05896228|Promethazine|promethazine|mesh-list
101389275|NCT05896228|Dexamethasone|dexamethasone|mesh-list
101389276|NCT05896228|Daratumumab|daratumumab|mesh-list
101389277|NCT05896228|Montelukast|montelukast|mesh-list
101389278|NCT05896228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101389279|NCT05896228|Antiemetics|antiemetics|mesh-ancestor
101389280|NCT05896228|Autonomic Agents|autonomic agents|mesh-ancestor
101389281|NCT05896228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102074333|NCT02113800|Immunologic Factors|immunologic factors|mesh-ancestor
102074334|NCT02113800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074335|NCT02113800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102074336|NCT01066143|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102074337|NCT01066143|Antidepressive Agents|antidepressive agents|mesh-ancestor
102074338|NCT01066143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101389282|NCT05896228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389283|NCT05896228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101389284|NCT05896228|Glucocorticoids|glucocorticoids|mesh-ancestor
101389285|NCT05896228|Hormones|hormones|mesh-ancestor
101389286|NCT05896228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101389287|NCT05896228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101389288|NCT05896228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101389289|NCT05896228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101389290|NCT05896228|Analgesics|analgesics|mesh-ancestor
101389291|NCT05896228|Sensory System Agents|sensory system agents|mesh-ancestor
101389292|NCT05896228|Antipyretics|antipyretics|mesh-ancestor
101389293|NCT05896228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101389302|NCT05896228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101389304|NCT05896228|Anesthetics|anesthetics|mesh-ancestor
101389305|NCT05896228|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101389306|NCT05896228|Histamine Antagonists|histamine antagonists|mesh-ancestor
101389307|NCT05896228|Histamine Agents|histamine agents|mesh-ancestor
101389308|NCT05896228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101389309|NCT05896228|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101389310|NCT05896228|Antipruritics|antipruritics|mesh-ancestor
101389311|NCT05896228|Dermatologic Agents|dermatologic agents|mesh-ancestor
101389312|NCT05894928|Cholestyramine Resin|cholestyramine resin|mesh-list
101389313|NCT05894928|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101389314|NCT05894928|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101389315|NCT05894928|Antimetabolites|antimetabolites|mesh-ancestor
101389316|NCT05894928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389317|NCT05894928|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101389318|NCT05891548|Aflibercept|aflibercept|mesh-list
101389319|NCT05891548|Axitinib|axitinib|mesh-list
101389320|NCT05891548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101389321|NCT05891548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101389322|NCT05891548|Growth Substances|growth substances|mesh-ancestor
101389323|NCT05891548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389324|NCT05891548|Growth Inhibitors|growth inhibitors|mesh-ancestor
101389325|NCT05891548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101389326|NCT05891548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101389331|NCT05890638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101389332|NCT05890638|Autonomic Agents|autonomic agents|mesh-ancestor
101305412|NCT02019355|Calcipotriene|calcipotriene|mesh-list
101305413|NCT02019355|Petrolatum|petrolatum|mesh-list
101305414|NCT02019355|Antimetabolites|antimetabolites|mesh-ancestor
101305415|NCT02019355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389333|NCT05890638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101389334|NCT05890638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389335|NCT05890638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101389336|NCT05890638|Respiratory System Agents|respiratory system agents|mesh-ancestor
101389337|NCT05890638|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101389338|NCT05890638|Cholinergic Agents|cholinergic agents|mesh-ancestor
101389339|NCT05890638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101389340|NCT05890638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389341|NCT05890638|Tocolytic Agents|tocolytic agents|mesh-ancestor
101389342|NCT05890638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101389343|NCT05890638|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101389344|NCT05890638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101389345|NCT05890638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101389346|NCT05890638|Adrenergic Agents|adrenergic agents|mesh-ancestor
101389347|NCT05888493|Prednisone|prednisone|mesh-list
101389348|NCT05888493|Prednisolone|prednisolone|mesh-list
101389349|NCT05888493|Cyclophosphamide|cyclophosphamide|mesh-list
101389350|NCT05888493|Rituximab|rituximab|mesh-list
101389351|NCT05888493|Doxorubicin|doxorubicin|mesh-list
101389352|NCT05888493|Vincristine|vincristine|mesh-list
101389353|NCT05888493|Lenalidomide|lenalidomide|mesh-list
101389354|NCT05888493|Tisagenlecleucel|tisagenlecleucel|mesh-list
102074339|NCT01066143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102074340|NCT01066143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102074341|NCT01066143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102074342|NCT01066143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074343|NCT02111928|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101389355|NCT05888493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101389356|NCT05888493|Immunologic Factors|immunologic factors|mesh-ancestor
101389357|NCT05888493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389358|NCT05888493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101389365|NCT05888493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101389366|NCT05888493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101389367|NCT05888493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101389368|NCT05888493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101389369|NCT05888493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101389370|NCT05888493|Glucocorticoids|glucocorticoids|mesh-ancestor
101389371|NCT05888493|Hormones|hormones|mesh-ancestor
101389372|NCT05888493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101389373|NCT05888493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101389374|NCT05888493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101389375|NCT05888493|Tubulin Modulators|tubulin modulators|mesh-ancestor
101389376|NCT05888493|Antimitotic Agents|antimitotic agents|mesh-ancestor
101389377|NCT05888493|Mitosis Modulators|mitosis modulators|mesh-ancestor
101389378|NCT05888493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101334372|NCT00018018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101389379|NCT05888493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101389380|NCT05888493|Growth Substances|growth substances|mesh-ancestor
101389381|NCT05888493|Growth Inhibitors|growth inhibitors|mesh-ancestor
101305416|NCT02019355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101305417|NCT02019355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101389402|NCT05884242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101389403|NCT05884242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101389404|NCT05877313|Nitric Oxide|nitric oxide|mesh-list
101389405|NCT05877313|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101389406|NCT05877313|Autonomic Agents|autonomic agents|mesh-ancestor
101389407|NCT05877313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101389408|NCT05877313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389409|NCT05877313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101389410|NCT05877313|Respiratory System Agents|respiratory system agents|mesh-ancestor
101389411|NCT05877313|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101389412|NCT05877313|Antioxidants|antioxidants|mesh-ancestor
101389413|NCT05877313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389414|NCT05877313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101389415|NCT05877313|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101389416|NCT05877313|Vasodilator Agents|vasodilator agents|mesh-ancestor
101389417|NCT05877313|Gasotransmitters|gasotransmitters|mesh-ancestor
101389418|NCT05877313|Protective Agents|protective agents|mesh-ancestor
101389419|NCT05874154|Botulinum Toxins|botulinum toxins|mesh-list
101389420|NCT05874154|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101389421|NCT05874154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101389422|NCT05874154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389423|NCT05874154|Cholinergic Agents|cholinergic agents|mesh-ancestor
101389424|NCT05874154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101389425|NCT05874154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389426|NCT05868122|Acetaminophen|acetaminophen|mesh-list
101389427|NCT05868122|Naproxen|naproxen|mesh-list
101389428|NCT05868122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101389429|NCT05868122|Analgesics|analgesics|mesh-ancestor
101389430|NCT05868122|Sensory System Agents|sensory system agents|mesh-ancestor
101389431|NCT05868122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101389432|NCT05868122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389433|NCT05868122|Antipyretics|antipyretics|mesh-ancestor
101389434|NCT05868122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101389435|NCT05868122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101389436|NCT05868122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101389437|NCT05868122|Gout Suppressants|gout suppressants|mesh-ancestor
101389438|NCT05868122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101389439|NCT05868122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101389440|NCT05868122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389441|NCT05861999|Risdiplam|risdiplam|mesh-list
102074344|NCT02111928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102074345|NCT02112006|Bupivacaine|bupivacaine|mesh-list
102074346|NCT02112006|Anesthetics, Local|anesthetics, local|mesh-ancestor
101389442|NCT05861999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101389451|NCT05860296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101389452|NCT05860296|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101389453|NCT05860296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389455|NCT05846659|Nivolumab|nivolumab|mesh-list
101389456|NCT05846659|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101389457|NCT05846659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101389458|NCT05846659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101389459|NCT05846659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389460|NCT05846646|Pembrolizumab|pembrolizumab|mesh-list
101389461|NCT05846646|Nivolumab|nivolumab|mesh-list
101389462|NCT05846646|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101389463|NCT05846646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101389466|NCT05844332|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
101389467|NCT05844332|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101389468|NCT05844332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389469|NCT05843188|Leucovorin|leucovorin|mesh-list
101389470|NCT05843188|Hydroxychloroquine|hydroxychloroquine|mesh-list
101389471|NCT05843188|Bevacizumab|bevacizumab|mesh-list
101305418|NCT02019355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101305419|NCT02019355|Immunologic Factors|immunologic factors|mesh-ancestor
101305420|NCT02019355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305421|NCT02019355|Dermatologic Agents|dermatologic agents|mesh-ancestor
101389472|NCT05843188|Fluorouracil|fluorouracil|mesh-list
101389473|NCT05843188|Irinotecan|irinotecan|mesh-list
101389474|NCT05843188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101389475|NCT05843188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101389476|NCT05843188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101389477|NCT05843188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101389478|NCT05843188|Growth Substances|growth substances|mesh-ancestor
101389479|NCT05843188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389480|NCT05843188|Growth Inhibitors|growth inhibitors|mesh-ancestor
101389481|NCT05843188|Antimetabolites|antimetabolites|mesh-ancestor
101389482|NCT05843188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389483|NCT05843188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101389484|NCT05843188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101389485|NCT05843188|Immunologic Factors|immunologic factors|mesh-ancestor
101389486|NCT05843188|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101389487|NCT05843188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101389488|NCT05843188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101389490|NCT05843188|Protective Agents|protective agents|mesh-ancestor
101389491|NCT05843188|Vitamin B Complex|vitamin b complex|mesh-ancestor
101389492|NCT05843188|Vitamins|vitamins|mesh-ancestor
101389493|NCT05843188|Micronutrients|micronutrients|mesh-ancestor
101389494|NCT05843188|Antimalarials|antimalarials|mesh-ancestor
101389495|NCT05843188|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101389496|NCT05843188|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101389497|NCT05843188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101389498|NCT05843188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101389499|NCT05838573|Metformin|metformin|mesh-list
101389500|NCT05838573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101389501|NCT05838573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389502|NCT05836584|Calcium, Dietary|calcium, dietary|mesh-list
101389503|NCT05836584|Leucovorin|leucovorin|mesh-list
101389504|NCT05836584|Folic Acid|folic acid|mesh-list
101389505|NCT05836584|Docetaxel|docetaxel|mesh-list
101389506|NCT05836584|Fluorouracil|fluorouracil|mesh-list
101389507|NCT05836584|Capecitabine|capecitabine|mesh-list
101389508|NCT05836584|Oxaliplatin|oxaliplatin|mesh-list
101389509|NCT05836584|Atezolizumab|atezolizumab|mesh-list
101389510|NCT05836584|Calcium|calcium|mesh-list
101389513|NCT05836584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101389514|NCT05836584|Tubulin Modulators|tubulin modulators|mesh-ancestor
101389515|NCT05836584|Antimitotic Agents|antimitotic agents|mesh-ancestor
101389516|NCT05836584|Mitosis Modulators|mitosis modulators|mesh-ancestor
101389517|NCT05836584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389518|NCT05836584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101389519|NCT05836584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389520|NCT05836584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101389521|NCT05836584|Antimetabolites|antimetabolites|mesh-ancestor
101389522|NCT05836584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102074347|NCT02112006|Anesthetics|anesthetics|mesh-ancestor
102074348|NCT02112006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102074349|NCT02112006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074350|NCT02112006|Sensory System Agents|sensory system agents|mesh-ancestor
102074351|NCT02112006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102074352|NCT02251158|Ritonavir|ritonavir|mesh-list
101389523|NCT05836584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101389524|NCT05836584|Immunologic Factors|immunologic factors|mesh-ancestor
101389525|NCT05836584|Antidotes|antidotes|mesh-ancestor
101389526|NCT05836584|Protective Agents|protective agents|mesh-ancestor
101389527|NCT05836584|Vitamin B Complex|vitamin b complex|mesh-ancestor
101389528|NCT05836584|Vitamins|vitamins|mesh-ancestor
101389529|NCT05836584|Micronutrients|micronutrients|mesh-ancestor
101389530|NCT05836584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101389531|NCT05836584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101389532|NCT05836584|Hematinics|hematinics|mesh-ancestor
101389533|NCT05834738|Atrasentan|atrasentan|mesh-list
101389534|NCT05834738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101389535|NCT05834738|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101389536|NCT05834738|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101389537|NCT05834738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389538|NCT05831358|Myeloma Proteins|myeloma proteins|mesh-list
101389539|NCT05831358|Paraproteins|paraproteins|mesh-list
101389540|NCT05831358|Immunologic Factors|immunologic factors|mesh-ancestor
101389546|NCT05829434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389547|NCT05829434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101389548|NCT05829434|Antiviral Agents|antiviral agents|mesh-ancestor
101389549|NCT05829434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101389550|NCT05829434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101389551|NCT05829434|Immunologic Factors|immunologic factors|mesh-ancestor
101389552|NCT05829434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389553|NCT05829434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101389554|NCT05828966|Magnesium Sulfate|magnesium sulfate|mesh-list
101389555|NCT05828966|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101389556|NCT05828966|Analgesics|analgesics|mesh-ancestor
101389557|NCT05828966|Sensory System Agents|sensory system agents|mesh-ancestor
101389558|NCT05828966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101389559|NCT05828966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389560|NCT05828966|Anesthetics|anesthetics|mesh-ancestor
101389561|NCT05828966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101389562|NCT05828966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101389563|NCT05828966|Anticonvulsants|anticonvulsants|mesh-ancestor
101389564|NCT05828966|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101389565|NCT05828966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101389566|NCT05828966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389567|NCT05828966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101389569|NCT05828966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101389570|NCT05827042|Tenecteplase|tenecteplase|mesh-list
101389571|NCT05827042|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101389572|NCT05827042|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101389573|NCT05827042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389574|NCT05826964|Tamoxifen|tamoxifen|mesh-list
101389575|NCT05826964|Sirolimus|sirolimus|mesh-list
101389576|NCT05826964|Capecitabine|capecitabine|mesh-list
101389577|NCT05826964|Everolimus|everolimus|mesh-list
101389578|NCT05826964|Letrozole|letrozole|mesh-list
101389579|NCT05826964|Vinorelbine|vinorelbine|mesh-list
101389580|NCT05826964|Fulvestrant|fulvestrant|mesh-list
101389581|NCT05826964|Palbociclib|palbociclib|mesh-list
101389582|NCT05826964|Anastrozole|anastrozole|mesh-list
101389583|NCT05826964|Exemestane|exemestane|mesh-list
101389584|NCT05826964|Temsirolimus|temsirolimus|mesh-list
101389585|NCT05826964|MTOR Inhibitors|mtor inhibitors|mesh-list
101389586|NCT05826964|Elafin|elafin|mesh-list
101389587|NCT05826964|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101389588|NCT05826964|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-list
101389589|NCT05826964|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
101389590|NCT05826964|Estrogens|estrogens|mesh-list
101389591|NCT05826964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101389598|NCT05826964|Immunologic Factors|immunologic factors|mesh-ancestor
101389599|NCT05826964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376033|NCT00237133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794110|NCT04041362|UB-421|ub-421|mesh-list
102074354|NCT02251158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102074355|NCT02251158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102074356|NCT02251158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102074357|NCT02251158|Protease Inhibitors|protease inhibitors|mesh-ancestor
102074358|NCT02251158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102074359|NCT02251158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074360|NCT02251158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102074361|NCT02251158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102074362|NCT02251158|Antiviral Agents|antiviral agents|mesh-ancestor
102074363|NCT02251158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102074364|NCT02251158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102074365|NCT02251158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102074366|NCT02652130|Remestemcel-l|remestemcel-l|mesh-list
102074367|NCT02652130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102074368|NCT02652130|Antiviral Agents|antiviral agents|mesh-ancestor
102074369|NCT02652130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102074370|NCT05404516|Cytarabine|cytarabine|mesh-list
102074371|NCT05404516|Sorafenib|sorafenib|mesh-list
102074372|NCT05404516|Idarubicin|idarubicin|mesh-list
102074373|NCT05404516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101376034|NCT00237172|Imatinib Mesylate|imatinib mesylate|mesh-list
101389600|NCT05826964|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101389601|NCT05826964|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101389602|NCT05826964|Hormone Antagonists|hormone antagonists|mesh-ancestor
101389603|NCT05826964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101389604|NCT05826964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101389605|NCT05826964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101389606|NCT05826964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101389607|NCT05826964|Antifungal Agents|antifungal agents|mesh-ancestor
101389608|NCT05826964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101389609|NCT05826964|Tubulin Modulators|tubulin modulators|mesh-ancestor
101389610|NCT05826964|Antimitotic Agents|antimitotic agents|mesh-ancestor
101389611|NCT05826964|Mitosis Modulators|mitosis modulators|mesh-ancestor
101389612|NCT05826964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101389613|NCT05826964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101389623|NCT05826574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389624|NCT05826574|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101389625|NCT05826574|Antitubercular Agents|antitubercular agents|mesh-ancestor
101389626|NCT05826574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101389627|NCT05826574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101389628|NCT05826574|Leprostatic Agents|leprostatic agents|mesh-ancestor
101389629|NCT05826574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101389630|NCT05826574|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101305423|NCT02019381|Vitamin D|vitamin d|mesh-list
101305424|NCT02019381|Ergocalciferols|ergocalciferols|mesh-list
101305425|NCT02019381|Cholecalciferol|cholecalciferol|mesh-list
101305426|NCT02019381|Vitamins|vitamins|mesh-list
101389631|NCT05826574|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101389632|NCT05826574|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102074376|NCT05404516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102074377|NCT05404516|Antiviral Agents|antiviral agents|mesh-ancestor
102074378|NCT05404516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102074379|NCT05404516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102074380|NCT05404516|Immunologic Factors|immunologic factors|mesh-ancestor
102074381|NCT05404516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074382|NCT05404516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102074383|NCT05404516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102074384|NCT05404516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102074385|NCT05404516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102074386|NCT05404516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102074387|NCT02114346|Atorvastatin|atorvastatin|mesh-list
102074388|NCT02114346|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102074389|NCT02114346|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101389633|NCT05826574|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101389634|NCT05826574|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101389635|NCT05826574|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101389642|NCT05814666|Pembrolizumab|pembrolizumab|mesh-list
101389643|NCT05814666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101389644|NCT05814666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101389645|NCT05814666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101389646|NCT05814666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389647|NCT05807126|Olaparib|olaparib|mesh-list
101389648|NCT05807126|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
101389649|NCT05807126|Magrolimab|magrolimab|mesh-list
101389650|NCT05807126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101389651|NCT05807126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389652|NCT05807126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101389653|NCT05807126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101389654|NCT05806749|Belumosudil|belumosudil|mesh-list
101389655|NCT05806749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101389656|NCT05806749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101389657|NCT05806749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389658|NCT05798663|Atezolizumab|atezolizumab|mesh-list
101389659|NCT05798663|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101389660|NCT05798663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389661|NCT05798663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101389662|NCT05798663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101389663|NCT05797246|Bevacizumab|bevacizumab|mesh-list
101389664|NCT05797246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101389665|NCT05797246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101389666|NCT05797246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101389667|NCT05797246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101389675|NCT05787613|Carboplatin|carboplatin|mesh-list
101389676|NCT05787613|Pemetrexed|pemetrexed|mesh-list
101389677|NCT05787613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101389678|NCT05787613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101389679|NCT05787613|Tubulin Modulators|tubulin modulators|mesh-ancestor
101389684|NCT05787613|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101389685|NCT05787613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102074395|NCT02112162|Deoxyglucose|deoxyglucose|mesh-list
102074396|NCT02112162|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102074397|NCT02112162|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102074398|NCT02112162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074399|NCT02112162|Antimetabolites|antimetabolites|mesh-ancestor
101389694|NCT05776953|Ketorolac|ketorolac|mesh-list
101389695|NCT05776953|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101389696|NCT05776953|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101389697|NCT05776953|Analgesics|analgesics|mesh-ancestor
101389698|NCT05776953|Sensory System Agents|sensory system agents|mesh-ancestor
101389699|NCT05776953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101389700|NCT05776953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389701|NCT05776953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101305427|NCT02019381|Micronutrients|micronutrients|mesh-ancestor
101389702|NCT05776953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101389703|NCT05776953|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101389704|NCT05776953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101389705|NCT05776953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389706|NCT05776056|Methylphenidate|methylphenidate|mesh-list
101389707|NCT05776056|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101389708|NCT05776056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389709|NCT05776056|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101389710|NCT05776056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101389711|NCT05776056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101389712|NCT05776056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389713|NCT05776056|Dopamine Agents|dopamine agents|mesh-ancestor
101389714|NCT05776056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101389716|NCT05768139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101389717|NCT05768139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101389718|NCT05768139|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101389719|NCT05768139|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101389720|NCT05768139|Hormone Antagonists|hormone antagonists|mesh-ancestor
101389721|NCT05768139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101389722|NCT05768139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389724|NCT05767736|Dermatologic Agents|dermatologic agents|mesh-ancestor
101389725|NCT05767736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101389726|NCT05767736|Immunologic Factors|immunologic factors|mesh-ancestor
101334428|NCT00044395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101389727|NCT05767736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389728|NCT05757167|Lumefantrine|lumefantrine|mesh-list
101389729|NCT05757167|Artemether|artemether|mesh-list
101389730|NCT05757167|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101389731|NCT05757167|Antimalarials|antimalarials|mesh-ancestor
101389732|NCT05757167|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101389733|NCT05757167|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101389734|NCT05757167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101389735|NCT05756673|Listerine|listerine|mesh-list
101389736|NCT05756673|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
101389737|NCT05756673|Sodium Fluoride|sodium fluoride|mesh-list
101389738|NCT05756673|Cariostatic Agents|cariostatic agents|mesh-ancestor
101389739|NCT05756673|Protective Agents|protective agents|mesh-ancestor
101389740|NCT05756673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389746|NCT05756569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102074400|NCT02112162|Antiviral Agents|antiviral agents|mesh-ancestor
102074401|NCT02112162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102074402|NCT02108808|Clopidogrel|clopidogrel|mesh-list
101389747|NCT05756569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389749|NCT05756569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389756|NCT05750459|Antimalarials|antimalarials|mesh-ancestor
101389757|NCT05750459|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101389758|NCT05750459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101389759|NCT05750459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101389760|NCT05750459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101389761|NCT05750459|Antiviral Agents|antiviral agents|mesh-ancestor
101389762|NCT05750459|Schistosomicides|schistosomicides|mesh-ancestor
101389763|NCT05750459|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101389764|NCT05750459|Anthelmintics|anthelmintics|mesh-ancestor
101389766|NCT05744375|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
101389767|NCT05744375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101389768|NCT05744375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101389769|NCT05744375|Immunoconjugates|immunoconjugates|mesh-ancestor
101389770|NCT05744375|Immunologic Factors|immunologic factors|mesh-ancestor
101389771|NCT05744375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389772|NCT05743244|Abrocitinib|abrocitinib|mesh-list
101389773|NCT05743244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101389774|NCT05743244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101389775|NCT05743244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389776|NCT05742607|Paclitaxel|paclitaxel|mesh-list
101389777|NCT05742607|Cisplatin|cisplatin|mesh-list
101389778|NCT05742607|Carboplatin|carboplatin|mesh-list
101389779|NCT05742607|Pemetrexed|pemetrexed|mesh-list
101389780|NCT05742607|Durvalumab|durvalumab|mesh-list
101389781|NCT05742607|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101389782|NCT05742607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101389783|NCT05742607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101305428|NCT02019381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305429|NCT02019381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101305430|NCT02019381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101389784|NCT05742607|Tubulin Modulators|tubulin modulators|mesh-ancestor
101389785|NCT05742607|Antimitotic Agents|antimitotic agents|mesh-ancestor
101389786|NCT05742607|Mitosis Modulators|mitosis modulators|mesh-ancestor
101389787|NCT05742607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389788|NCT05742607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101389789|NCT05742607|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101389790|NCT05742607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101389791|NCT05742607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101389792|NCT05742607|Immunologic Factors|immunologic factors|mesh-ancestor
101389793|NCT05742607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389794|NCT05741866|Chlorhexidine|chlorhexidine|mesh-list
101389795|NCT05741866|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101389796|NCT05741866|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101389797|NCT05741866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101389798|NCT05741866|Disinfectants|disinfectants|mesh-ancestor
101389799|NCT05741866|Dermatologic Agents|dermatologic agents|mesh-ancestor
101389800|NCT05733351|Docetaxel|docetaxel|mesh-list
101389801|NCT05733351|Antibodies|antibodies|mesh-list
101389802|NCT05733351|Immunoglobulins|immunoglobulins|mesh-list
101389803|NCT05733351|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101389804|NCT05733351|Immunologic Factors|immunologic factors|mesh-ancestor
101389805|NCT05733351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389806|NCT05733351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101389807|NCT05733351|Tubulin Modulators|tubulin modulators|mesh-ancestor
101389808|NCT05733351|Antimitotic Agents|antimitotic agents|mesh-ancestor
101389809|NCT05733351|Mitosis Modulators|mitosis modulators|mesh-ancestor
101389810|NCT05733351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389811|NCT05731895|BI 425809|bi 425809|mesh-list
101389812|NCT05731895|Nootropic Agents|nootropic agents|mesh-ancestor
101389813|NCT05726383|Viscum album peptide|viscum album peptide|mesh-list
101389814|NCT05726383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101389815|NCT05726383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101389860|NCT05718856|Antibodies|antibodies|mesh-list
101389861|NCT05718856|Immunoglobulins|immunoglobulins|mesh-list
101389862|NCT05718856|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101389863|NCT05718856|Immunologic Factors|immunologic factors|mesh-ancestor
101389864|NCT05718856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389865|NCT05718856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101389866|NCT05714865|Pulmonary Surfactants|pulmonary surfactants|mesh-list
101389867|NCT05714865|Respiratory System Agents|respiratory system agents|mesh-ancestor
102074404|NCT02108808|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102074405|NCT02108808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102074406|NCT02108808|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102074407|NCT02108808|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102074408|NCT02108808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102074409|NCT02108808|Purinergic Agents|purinergic agents|mesh-ancestor
101376087|NCT00065273|Olanzapine|olanzapine|mesh-list
101389868|NCT05712707|Lofexidine|lofexidine|mesh-list
101389869|NCT05712707|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101389870|NCT05712707|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101389871|NCT05712707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389872|NCT05712707|Sensory System Agents|sensory system agents|mesh-ancestor
101389873|NCT05712707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101389874|NCT05712707|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101389875|NCT05712707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101389876|NCT05712707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101389877|NCT05712707|Adrenergic Agents|adrenergic agents|mesh-ancestor
101389878|NCT05712707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101389879|NCT05712707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389880|NCT05706753|Drospirenone|drospirenone|mesh-list
101389881|NCT05706753|Midazolam|midazolam|mesh-list
101389882|NCT05706753|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101389883|NCT05706753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101305431|NCT02019394|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
101305432|NCT02019394|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101305433|NCT02019394|Serotonin Agents|serotonin agents|mesh-ancestor
101389884|NCT05706753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101389885|NCT05706753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101389886|NCT05706753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389887|NCT05706753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101389888|NCT05706753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101389889|NCT05706753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101389890|NCT05706753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101389891|NCT05706753|Anesthetics, General|anesthetics, general|mesh-ancestor
101389892|NCT05706753|Anesthetics|anesthetics|mesh-ancestor
101389893|NCT05706753|GABA Modulators|gaba modulators|mesh-ancestor
101389894|NCT05706753|GABA Agents|gaba agents|mesh-ancestor
101389895|NCT05706753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101389896|NCT05706753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389901|NCT05706753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101389902|NCT05706753|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101389903|NCT05706753|Estrogens|estrogens|mesh-ancestor
101389904|NCT05706753|Hormones|hormones|mesh-ancestor
101389905|NCT05706753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101389906|NCT05706753|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101389907|NCT05706753|Hormone Antagonists|hormone antagonists|mesh-ancestor
101389912|NCT05704985|Carboplatin|carboplatin|mesh-list
101389913|NCT05704985|Pembrolizumab|pembrolizumab|mesh-list
101389914|NCT05704985|Fluorouracil|fluorouracil|mesh-list
101389915|NCT05704985|Capecitabine|capecitabine|mesh-list
101389916|NCT05704985|Oxaliplatin|oxaliplatin|mesh-list
101389917|NCT05704985|Nivolumab|nivolumab|mesh-list
101389918|NCT05704985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101389919|NCT05704985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101389920|NCT05704985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101389921|NCT05704985|Tubulin Modulators|tubulin modulators|mesh-ancestor
101389922|NCT05704985|Antimitotic Agents|antimitotic agents|mesh-ancestor
101389923|NCT05704985|Mitosis Modulators|mitosis modulators|mesh-ancestor
101389924|NCT05704985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389925|NCT05704985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101389926|NCT05704985|Antimetabolites|antimetabolites|mesh-ancestor
101389927|NCT05704985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101389928|NCT05704985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101389929|NCT05704985|Immunologic Factors|immunologic factors|mesh-ancestor
101389930|NCT05704985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074412|NCT02108808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074413|NCT02108886|Montelukast|montelukast|mesh-list
102074414|NCT02108886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102074415|NCT02108886|Respiratory System Agents|respiratory system agents|mesh-ancestor
102074416|NCT02108886|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
102074417|NCT02108886|Hormone Antagonists|hormone antagonists|mesh-ancestor
101376091|NCT00065273|Serotonin Agents|serotonin agents|mesh-ancestor
101389934|NCT05700903|Leuprolide|leuprolide|mesh-list
101389935|NCT05700903|Goserelin|goserelin|mesh-list
101389936|NCT05700903|Flutamide|flutamide|mesh-list
101389937|NCT05700903|Bicalutamide|bicalutamide|mesh-list
101389938|NCT05700903|Hormones|hormones|mesh-list
101389939|NCT05700903|Androgens|androgens|mesh-list
101389940|NCT05700903|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
101389941|NCT05700903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101389942|NCT05700903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389943|NCT05700903|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101389944|NCT05700903|Fertility Agents|fertility agents|mesh-ancestor
101389945|NCT05700903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101389946|NCT05700903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101389947|NCT05700903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101389948|NCT05700903|Androgen Antagonists|androgen antagonists|mesh-ancestor
101389949|NCT05700903|Hormone Antagonists|hormone antagonists|mesh-ancestor
101389950|NCT05694013|Atezolizumab|atezolizumab|mesh-list
101389951|NCT05694013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101389952|NCT05694013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389953|NCT05694013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101389954|NCT05694013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101389955|NCT05688098|Amlodipine|amlodipine|mesh-list
101305434|NCT02019394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101305435|NCT02019394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305436|NCT02019394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305437|NCT02019446|Terbinafine|terbinafine|mesh-list
101389956|NCT05688098|Irbesartan|irbesartan|mesh-list
101389957|NCT05688098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101389958|NCT05688098|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101389959|NCT05688098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101389960|NCT05688098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389961|NCT05688098|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101389962|NCT05688098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389963|NCT05688098|Vasodilator Agents|vasodilator agents|mesh-ancestor
101389964|NCT05688098|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101389965|NCT05688098|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101389966|NCT05688085|Amlodipine|amlodipine|mesh-list
101389967|NCT05688085|Irbesartan|irbesartan|mesh-list
101389968|NCT05688085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101389971|NCT05688085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389972|NCT05688085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101389973|NCT05688085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389974|NCT05688085|Vasodilator Agents|vasodilator agents|mesh-ancestor
101389975|NCT05688085|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101389976|NCT05688085|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101389977|NCT05686863|Remifentanil|remifentanil|mesh-list
101389984|NCT05686863|Anesthetics, General|anesthetics, general|mesh-ancestor
101389985|NCT05686863|Anesthetics|anesthetics|mesh-ancestor
101389986|NCT05686863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101389987|NCT05686863|Narcotics|narcotics|mesh-ancestor
101389988|NCT05686863|Analgesics|analgesics|mesh-ancestor
101389989|NCT05686863|Sensory System Agents|sensory system agents|mesh-ancestor
101389990|NCT05686863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101389991|NCT05686863|Antidepressive Agents|antidepressive agents|mesh-ancestor
101390036|NCT05677373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101390037|NCT05677373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390038|NCT05670106|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101390039|NCT05670106|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101390040|NCT05670106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390041|NCT05665699|Allopurinol|allopurinol|mesh-list
101390042|NCT05665699|Antimetabolites|antimetabolites|mesh-ancestor
101390048|NCT05665699|Antioxidants|antioxidants|mesh-ancestor
101390049|NCT05665699|Protective Agents|protective agents|mesh-ancestor
101390050|NCT05665699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390051|NCT05663073|Amlodipine|amlodipine|mesh-list
101390062|NCT05661578|Atezolizumab|atezolizumab|mesh-list
101390063|NCT05661578|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102074425|NCT02114502|Gemcitabine|gemcitabine|mesh-list
102074426|NCT02114502|Melphalan|melphalan|mesh-list
102074427|NCT02114502|Busulfan|busulfan|mesh-list
102074428|NCT02114502|Vorinostat|vorinostat|mesh-list
102074429|NCT02114502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102074430|NCT02114502|Antiemetics|antiemetics|mesh-ancestor
102074431|NCT02114502|Autonomic Agents|autonomic agents|mesh-ancestor
101390064|NCT05661578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390065|NCT05661578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101390066|NCT05661578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390067|NCT05660538|Pregabalin|pregabalin|mesh-list
101390068|NCT05660538|Analgesics|analgesics|mesh-ancestor
101390069|NCT05660538|Sensory System Agents|sensory system agents|mesh-ancestor
101390070|NCT05660538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101390071|NCT05660538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390072|NCT05660538|Anticonvulsants|anticonvulsants|mesh-ancestor
101390073|NCT05660538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101390074|NCT05660538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101390075|NCT05660538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390076|NCT05660538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101390077|NCT05660538|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101390078|NCT05660538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101390079|NCT05660538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101390080|NCT05660538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101390081|NCT05658003|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101390082|NCT05658003|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101390083|NCT05658003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390084|NCT05656911|Zabedosertib|zabedosertib|mesh-list
101390085|NCT05656911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101390086|NCT05656911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101390087|NCT05656911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390088|NCT05656534|Suvorexant|suvorexant|mesh-list
101390089|NCT05656534|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101390090|NCT05656534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101390091|NCT05656534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101390092|NCT05656534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390093|NCT05656534|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
101390094|NCT05656534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101305441|NCT02019446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305442|NCT02019459|Nicotine|nicotine|mesh-list
101305443|NCT02019459|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101390095|NCT05656534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390096|NCT05654506|Daratumumab|daratumumab|mesh-list
101390097|NCT05654506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390100|NCT05647564|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101390101|NCT05647564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101390102|NCT05647564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390103|NCT05646862|Fulvestrant|fulvestrant|mesh-list
101390104|NCT05646862|Inavolisib|inavolisib|mesh-list
101390105|NCT05646862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101390106|NCT05646862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390107|NCT05646862|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101390108|NCT05646862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101390109|NCT05646862|Hormone Antagonists|hormone antagonists|mesh-ancestor
101390115|NCT05646459|Cannabidiol|cannabidiol|mesh-list
101390116|NCT05646459|Anticonvulsants|anticonvulsants|mesh-ancestor
101390117|NCT05645692|Atezolizumab|atezolizumab|mesh-list
101390118|NCT05645692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101390119|NCT05645692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390120|NCT05645692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101390121|NCT05645692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390122|NCT05620862|Irinotecan|irinotecan|mesh-list
101390123|NCT05620862|Vincristine|vincristine|mesh-list
101390124|NCT05620862|Mitoxantrone|mitoxantrone|mesh-list
101390125|NCT05620862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101390126|NCT05620862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102074432|NCT02114502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102074433|NCT02114502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074434|NCT02114502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102074435|NCT02114502|Glucocorticoids|glucocorticoids|mesh-ancestor
102074436|NCT02114502|Hormones|hormones|mesh-ancestor
102074437|NCT02114502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102074438|NCT02114502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101376112|NCT00237445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101376114|NCT00237484|Interferons|interferons|mesh-list
101390127|NCT05620862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101390128|NCT05620862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390129|NCT05620862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390130|NCT05620862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101390131|NCT05620862|Tubulin Modulators|tubulin modulators|mesh-ancestor
101390132|NCT05620862|Antimitotic Agents|antimitotic agents|mesh-ancestor
101390133|NCT05620862|Mitosis Modulators|mitosis modulators|mesh-ancestor
101390134|NCT05620862|Analgesics|analgesics|mesh-ancestor
101390135|NCT05620862|Sensory System Agents|sensory system agents|mesh-ancestor
101390136|NCT05620862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101390137|NCT05620862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390138|NCT05620862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101390139|NCT05617859|Lenvatinib|lenvatinib|mesh-list
101390140|NCT05617859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390141|NCT05617859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101390142|NCT05617859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101390143|NCT05617859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390144|NCT05615844|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101390145|NCT05615844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101390146|NCT05609968|Pembrolizumab|pembrolizumab|mesh-list
101390147|NCT05609968|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
101390148|NCT05609968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101390149|NCT05609968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390150|NCT05609968|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101390151|NCT05609968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390152|NCT05609968|Immunoconjugates|immunoconjugates|mesh-ancestor
101390153|NCT05609968|Immunologic Factors|immunologic factors|mesh-ancestor
101390154|NCT05609968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390155|NCT05605964|Leuprolide|leuprolide|mesh-list
101390156|NCT05605964|Relugolix|relugolix|mesh-list
101390157|NCT05605964|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101390158|NCT05605964|Fertility Agents|fertility agents|mesh-ancestor
101390159|NCT05605964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101390160|NCT05605964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390161|NCT05605964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101390162|NCT05605964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390163|NCT05605964|Androgen Antagonists|androgen antagonists|mesh-ancestor
101390164|NCT05605964|Hormone Antagonists|hormone antagonists|mesh-ancestor
101305445|NCT02019459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101305446|NCT02019459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305447|NCT02019459|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101305448|NCT02019459|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101390165|NCT05605964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101390166|NCT05605899|Prednisone|prednisone|mesh-list
101390167|NCT05605899|Cyclophosphamide|cyclophosphamide|mesh-list
101390168|NCT05605899|Rituximab|rituximab|mesh-list
101390170|NCT05605899|Fludarabine|fludarabine|mesh-list
101390171|NCT05605899|Etoposide|etoposide|mesh-list
101390172|NCT05605899|Vincristine|vincristine|mesh-list
101390173|NCT05605899|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
101390174|NCT05605899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101390175|NCT05605899|Immunologic Factors|immunologic factors|mesh-ancestor
101390176|NCT05605899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390177|NCT05605899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101390178|NCT05605899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102074439|NCT02114502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102074440|NCT02114502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102074441|NCT02114502|Antimetabolites|antimetabolites|mesh-ancestor
102074442|NCT02114502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074443|NCT02114502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102074444|NCT02114502|Alkylating Agents|alkylating agents|mesh-ancestor
102074445|NCT02114502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102074446|NCT02114502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102074447|NCT02114502|Immunologic Factors|immunologic factors|mesh-ancestor
102074448|NCT02114502|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
102074449|NCT02114502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102074450|NCT02114502|Vitamin B Complex|vitamin b complex|mesh-ancestor
102074451|NCT02114502|Vitamins|vitamins|mesh-ancestor
102074452|NCT02114502|Micronutrients|micronutrients|mesh-ancestor
102074453|NCT03654027|Docetaxel|docetaxel|mesh-list
102074454|NCT03654027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102074455|NCT03654027|Tubulin Modulators|tubulin modulators|mesh-ancestor
102074456|NCT03654027|Antimitotic Agents|antimitotic agents|mesh-ancestor
101376123|NCT00237484|Antimetabolites|antimetabolites|mesh-ancestor
101376125|NCT00237484|Immunologic Factors|immunologic factors|mesh-ancestor
101390190|NCT05605899|Hormones|hormones|mesh-ancestor
101390191|NCT05605899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101390192|NCT05605899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101390193|NCT05605899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101390194|NCT05605899|Tubulin Modulators|tubulin modulators|mesh-ancestor
101390195|NCT05605899|Antimitotic Agents|antimitotic agents|mesh-ancestor
101390196|NCT05605899|Mitosis Modulators|mitosis modulators|mesh-ancestor
101390197|NCT05604560|Tislelizumab|tislelizumab|mesh-list
101390198|NCT05604560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101390199|NCT05604560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390200|NCT05597878|Acetaminophen|acetaminophen|mesh-list
101390201|NCT05597878|Ketorolac|ketorolac|mesh-list
101390202|NCT05597878|Ketamine|ketamine|mesh-list
101390203|NCT05597878|Oxycodone|oxycodone|mesh-list
101390204|NCT05597878|Analgesics|analgesics|mesh-ancestor
101390205|NCT05597878|Sensory System Agents|sensory system agents|mesh-ancestor
101390206|NCT05597878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101390207|NCT05597878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390208|NCT05597878|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101390209|NCT05597878|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101390210|NCT05597878|Anesthetics, General|anesthetics, general|mesh-ancestor
101390211|NCT05597878|Anesthetics|anesthetics|mesh-ancestor
101390212|NCT05597878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101390213|NCT05597878|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101390214|NCT05597878|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101390215|NCT05597878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101390216|NCT05597878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390217|NCT05597878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101390218|NCT05597878|Antipyretics|antipyretics|mesh-ancestor
101390219|NCT05597878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101390220|NCT05597878|Narcotics|narcotics|mesh-ancestor
101390221|NCT05597878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101390222|NCT05597878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101390223|NCT05597878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102074457|NCT03654027|Mitosis Modulators|mitosis modulators|mesh-ancestor
102074458|NCT03654027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074459|NCT02114658|Sorafenib|sorafenib|mesh-list
102074460|NCT02114658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102074461|NCT02114658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102074462|NCT02114658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102074463|NCT02114658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074464|NCT05126602|Vitamin D|vitamin d|mesh-list
102074465|NCT05126602|Ergocalciferols|ergocalciferols|mesh-list
102074466|NCT05126602|Cholecalciferol|cholecalciferol|mesh-list
102074467|NCT05126602|Vitamins|vitamins|mesh-list
102074468|NCT05126602|Micronutrients|micronutrients|mesh-ancestor
102074469|NCT05126602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074470|NCT05126602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102074471|NCT05126602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101376141|NCT00098124|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101390224|NCT05597878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101390225|NCT05597878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101390226|NCT05594043|Pembrolizumab|pembrolizumab|mesh-list
101390227|NCT05594043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101390228|NCT05594043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390229|NCT05594043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101390230|NCT05594043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390231|NCT05590728|Apramycin|apramycin|mesh-list
101390232|NCT05590728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101390233|NCT05590728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101305450|NCT02019459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101305451|NCT02019459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305452|NCT02019485|Tapentadol|tapentadol|mesh-list
101305453|NCT02019485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101305454|NCT02019485|Narcotics|narcotics|mesh-ancestor
101305455|NCT02019485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101177423|NCT01887990|Anesthetics, General|anesthetics, general|mesh-ancestor
101390234|NCT05590624|Phentermine|phentermine|mesh-list
101390235|NCT05590624|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101390236|NCT05590624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390237|NCT05590624|Appetite Depressants|appetite depressants|mesh-ancestor
101390238|NCT05590624|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101390239|NCT05590624|Sympathomimetics|sympathomimetics|mesh-ancestor
101390240|NCT05590624|Autonomic Agents|autonomic agents|mesh-ancestor
101390241|NCT05590624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101390245|NCT05583721|Regadenoson|regadenoson|mesh-list
101390246|NCT05583721|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
101390247|NCT05583721|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101390248|NCT05583721|Purinergic Agonists|purinergic agonists|mesh-ancestor
101390249|NCT05583721|Purinergic Agents|purinergic agents|mesh-ancestor
101390250|NCT05583721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101390251|NCT05583721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390252|NCT05583721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390261|NCT05579574|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
101390263|NCT05579574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101390264|NCT05579574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101390265|NCT05579574|Contraceptive Agents|contraceptive agents|mesh-ancestor
101390266|NCT05579574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101390267|NCT05579574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390268|NCT05579574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
102074475|NCT02114736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102074476|NCT02114736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074477|NCT02114736|Cholinergic Agents|cholinergic agents|mesh-ancestor
102074478|NCT02114736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102074479|NCT02114736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376155|NCT04710160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390269|NCT05579574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101390270|NCT05579574|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
101390271|NCT05579574|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101390273|NCT05576662|Nirmatrelvir|nirmatrelvir|mesh-list
101390274|NCT05576662|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101390275|NCT05576662|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101390276|NCT05576662|Protease Inhibitors|protease inhibitors|mesh-ancestor
101390277|NCT05576662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101390278|NCT05576662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390279|NCT05576662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101390280|NCT05576662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101390281|NCT05576662|Antiviral Agents|antiviral agents|mesh-ancestor
101390282|NCT05576662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101390283|NCT05576662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101390284|NCT05576662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101390285|NCT05573724|Itraconazole|itraconazole|mesh-list
101390286|NCT05573724|Antifungal Agents|antifungal agents|mesh-ancestor
101390287|NCT05573724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101390288|NCT05573724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101390289|NCT05573724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101390290|NCT05573724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101390291|NCT05573724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390292|NCT05573724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101390293|NCT05573724|Hormone Antagonists|hormone antagonists|mesh-ancestor
101390294|NCT05573724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101390295|NCT05573724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390296|NCT05573724|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101390297|NCT05569746|Immunoglobulins|immunoglobulins|mesh-list
101305457|NCT02019485|Analgesics|analgesics|mesh-ancestor
101305458|NCT02019485|Sensory System Agents|sensory system agents|mesh-ancestor
101177491|NCT01907334|Miotics|miotics|mesh-ancestor
101390298|NCT05569746|Immunoglobulin Fragments|immunoglobulin fragments|mesh-list
101390299|NCT05569746|Shiga Toxins|shiga toxins|mesh-list
101390300|NCT05569746|Immunologic Factors|immunologic factors|mesh-ancestor
101390301|NCT05569746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390302|NCT05569746|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101390303|NCT05569746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101390304|NCT05569746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390305|NCT05567406|Belumosudil|belumosudil|mesh-list
101390306|NCT05567406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101390307|NCT05567406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101390308|NCT05567406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390309|NCT05566756|Ofatumumab|ofatumumab|mesh-list
101390310|NCT05566756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390311|NCT05564650|Azacitidine|azacitidine|mesh-list
101390312|NCT05564650|Decitabine|decitabine|mesh-list
101390313|NCT05564650|Venetoclax|venetoclax|mesh-list
101390314|NCT05564650|Navitoclax|navitoclax|mesh-list
101390315|NCT05564650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101390316|NCT05564650|Antimetabolites|antimetabolites|mesh-ancestor
102074481|NCT02114736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102074482|NCT02112552|Paclitaxel|paclitaxel|mesh-list
102074483|NCT02112552|Carboplatin|carboplatin|mesh-list
102074484|NCT02112552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101376166|NCT04709770|Antifoaming Agents|antifoaming agents|mesh-ancestor
101390371|NCT05562466|Budesonide|budesonide|mesh-list
101390372|NCT05562466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101305459|NCT02019485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101305460|NCT02019485|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101177567|NCT01929642|Sirolimus|sirolimus|mesh-list
101390373|NCT05562466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101390374|NCT05562466|Autonomic Agents|autonomic agents|mesh-ancestor
101390375|NCT05562466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101390376|NCT05562466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390377|NCT05562466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101390378|NCT05562466|Respiratory System Agents|respiratory system agents|mesh-ancestor
101390379|NCT05562466|Glucocorticoids|glucocorticoids|mesh-ancestor
101390380|NCT05562466|Hormones|hormones|mesh-ancestor
101390381|NCT05562466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101390382|NCT05562063|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
101390383|NCT05562063|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101390384|NCT05562063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390385|NCT05562063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101390389|NCT05561751|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101390390|NCT05561751|Adrenergic Agents|adrenergic agents|mesh-ancestor
101390391|NCT05561751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101390392|NCT05561751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390393|NCT05561751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390394|NCT05561751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101390395|NCT05561751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101390396|NCT05561751|Vasodilator Agents|vasodilator agents|mesh-ancestor
101390397|NCT05558982|Pembrolizumab|pembrolizumab|mesh-list
101390398|NCT05558982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101390399|NCT05558982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390400|NCT05558982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101390401|NCT05558982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390402|NCT05556798|Pomalidomide|pomalidomide|mesh-list
101390403|NCT05556798|Nirogacestat|nirogacestat|mesh-list
101390404|NCT05556798|Immunologic Factors|immunologic factors|mesh-ancestor
101390405|NCT05556798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390406|NCT05556798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101390407|NCT05556798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101390408|NCT05556798|Growth Substances|growth substances|mesh-ancestor
101390409|NCT05556798|Growth Inhibitors|growth inhibitors|mesh-ancestor
101390410|NCT05556798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390411|NCT05556798|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101390412|NCT05556798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101390413|NCT05556798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390414|NCT05553938|Empagliflozin|empagliflozin|mesh-list
101390415|NCT05553938|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101390416|NCT05553938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390417|NCT05553938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101390418|NCT05553938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390419|NCT05553366|Acetaminophen|acetaminophen|mesh-list
101390420|NCT05553366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101390421|NCT05553366|Analgesics|analgesics|mesh-ancestor
101390422|NCT05553366|Sensory System Agents|sensory system agents|mesh-ancestor
101390423|NCT05553366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101390424|NCT05553366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074485|NCT02112552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102074486|NCT02112552|Tubulin Modulators|tubulin modulators|mesh-ancestor
101390425|NCT05553366|Antipyretics|antipyretics|mesh-ancestor
101390426|NCT05546411|Leucovorin|leucovorin|mesh-list
101390427|NCT05546411|Fluorouracil|fluorouracil|mesh-list
101390428|NCT05546411|Oxaliplatin|oxaliplatin|mesh-list
101390429|NCT05546411|Irinotecan|irinotecan|mesh-list
101390430|NCT05546411|Camptothecin|camptothecin|mesh-list
101390431|NCT05546411|Levoleucovorin|levoleucovorin|mesh-list
101390432|NCT05546411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390437|NCT05546411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101390438|NCT05546411|Immunologic Factors|immunologic factors|mesh-ancestor
101390439|NCT05546411|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101390440|NCT05546411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101305461|NCT02019485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101305462|NCT02019485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101305463|NCT02019485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305464|NCT02019485|Adrenergic Agents|adrenergic agents|mesh-ancestor
101390441|NCT05546411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101390442|NCT05546411|Antidotes|antidotes|mesh-ancestor
101390443|NCT05546411|Protective Agents|protective agents|mesh-ancestor
101390444|NCT05546411|Vitamin B Complex|vitamin b complex|mesh-ancestor
101390445|NCT05546411|Vitamins|vitamins|mesh-ancestor
101390446|NCT05546411|Micronutrients|micronutrients|mesh-ancestor
101390447|NCT05546411|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101390448|NCT05543629|Paclitaxel|paclitaxel|mesh-list
101390449|NCT05543629|Docetaxel|docetaxel|mesh-list
101390450|NCT05543629|Carboplatin|carboplatin|mesh-list
101390451|NCT05543629|Nivolumab|nivolumab|mesh-list
101390453|NCT05543629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101390454|NCT05543629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390455|NCT05543629|Tubulin Modulators|tubulin modulators|mesh-ancestor
101390456|NCT05543629|Antimitotic Agents|antimitotic agents|mesh-ancestor
101390457|NCT05543629|Mitosis Modulators|mitosis modulators|mesh-ancestor
101390458|NCT05543629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390468|NCT05536154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101390469|NCT05536154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101390470|NCT05536154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101390471|NCT05536154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390472|NCT05536154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101390473|NCT05536154|Antimetabolites|antimetabolites|mesh-ancestor
101390474|NCT05536154|Antiviral Agents|antiviral agents|mesh-ancestor
101390475|NCT05536154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101390476|NCT05536154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101390477|NCT05536154|Immunologic Factors|immunologic factors|mesh-ancestor
101390478|NCT05536154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390479|NCT05535309|Sulbactam|sulbactam|mesh-list
101390480|NCT05535309|Cefoperazone|cefoperazone|mesh-list
101390481|NCT05535309|Sulperazone|sulperazone|mesh-list
101390482|NCT05535309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101390483|NCT05535309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101390484|NCT05535309|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101390485|NCT05535309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101390486|NCT05535309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390487|NCT05535309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101390488|NCT05518877|Ketamine|ketamine|mesh-list
101390489|NCT05518877|Analgesics|analgesics|mesh-ancestor
101390490|NCT05518877|Sensory System Agents|sensory system agents|mesh-ancestor
101390491|NCT05518877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101390492|NCT05518877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390493|NCT05518877|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101390494|NCT05518877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101390495|NCT05518877|Anesthetics, General|anesthetics, general|mesh-ancestor
101390496|NCT05518877|Anesthetics|anesthetics|mesh-ancestor
101390497|NCT05518877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101390498|NCT05518877|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101390499|NCT05518877|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101390500|NCT05518877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101390501|NCT05518877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390502|NCT05516498|Dapagliflozin|dapagliflozin|mesh-list
101390503|NCT05516498|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101390504|NCT05516498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390505|NCT05516498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102074492|NCT02109354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074493|NCT03165136|Hydroxychloroquine|hydroxychloroquine|mesh-list
102074494|NCT03165136|Antimalarials|antimalarials|mesh-ancestor
102074495|NCT03165136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102074496|NCT03165136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102074497|NCT03165136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101376172|NCT04709731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101390506|NCT05516498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390507|NCT05514444|Pembrolizumab|pembrolizumab|mesh-list
101390511|NCT05514444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390512|NCT05513027|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101390513|NCT05513027|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101390514|NCT05513027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305465|NCT02019485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101305467|NCT02019524|Vitamin B Complex|vitamin b complex|mesh-list
101305468|NCT02019524|Molgramostim|molgramostim|mesh-list
101305469|NCT02019524|Vaccines|vaccines|mesh-list
101305470|NCT02019524|Sargramostim|sargramostim|mesh-list
101305471|NCT02019524|Immunologic Factors|immunologic factors|mesh-ancestor
101305472|NCT02019524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305473|NCT02019524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101305474|NCT02019524|Hematinics|hematinics|mesh-ancestor
101305475|NCT02019524|Vitamins|vitamins|mesh-ancestor
101305476|NCT02019524|Micronutrients|micronutrients|mesh-ancestor
101305477|NCT02019784|Rifaximin|rifaximin|mesh-list
101305478|NCT02019784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101390515|NCT05512039|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101390516|NCT05512039|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101390517|NCT05512039|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101390518|NCT05512039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101390519|NCT05512039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390520|NCT05512039|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101390521|NCT05512039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101390522|NCT05512039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390523|NCT05512039|Cholinergic Agents|cholinergic agents|mesh-ancestor
101390527|NCT05511038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101390528|NCT05511038|Growth Substances|growth substances|mesh-ancestor
101390529|NCT05511038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390530|NCT05511038|Growth Inhibitors|growth inhibitors|mesh-ancestor
101390531|NCT05511038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390533|NCT05510089|Etoposide|etoposide|mesh-list
101390534|NCT05510089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101390535|NCT05510089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390536|NCT05510089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101390537|NCT05510089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101390538|NCT05510089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101390539|NCT05510089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390540|NCT05510089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101390541|NCT05510089|Antimetabolites|antimetabolites|mesh-ancestor
101390542|NCT05510089|Antiviral Agents|antiviral agents|mesh-ancestor
101390543|NCT05510089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101390544|NCT05510089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101390545|NCT05510089|Immunologic Factors|immunologic factors|mesh-ancestor
101390546|NCT05510089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074498|NCT03165136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102074499|NCT03165136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074500|NCT03165136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102074501|NCT02109510|Lidocaine|lidocaine|mesh-list
102074502|NCT02109510|Dexmedetomidine|dexmedetomidine|mesh-list
101794246|NCT00864812|Glucocorticoids|glucocorticoids|mesh-ancestor
101390554|NCT05491317|Pembrolizumab|pembrolizumab|mesh-list
101390555|NCT05491317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101390556|NCT05491317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390557|NCT05491317|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101390558|NCT05491317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390559|NCT05488457|Oxytocin|oxytocin|mesh-list
101390560|NCT05488457|Oxytocics|oxytocics|mesh-ancestor
101390561|NCT05488457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101390562|NCT05488457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390563|NCT05483933|Doxorubicin|doxorubicin|mesh-list
101390564|NCT05483933|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101390565|NCT05483933|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101390566|NCT05483933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390567|NCT05483933|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101390568|NCT05483933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101390569|NCT05483933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101305479|NCT02019784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101390572|NCT05480865|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101390573|NCT05480865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390574|NCT05480865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101390575|NCT05480865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390576|NCT05477576|Everolimus|everolimus|mesh-list
101390577|NCT05477576|Sunitinib|sunitinib|mesh-list
101390578|NCT05477576|Octreotide|octreotide|mesh-list
101390579|NCT05477576|Lanreotide|lanreotide|mesh-list
101390580|NCT05477576|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101390581|NCT05477576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101390582|NCT05477576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101390583|NCT05477576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390584|NCT05477576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101390585|NCT05477576|Immunologic Factors|immunologic factors|mesh-ancestor
101390586|NCT05477576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390587|NCT05477576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390588|NCT05477576|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101390589|NCT05477576|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101390590|NCT05477576|Growth Substances|growth substances|mesh-ancestor
101390591|NCT05477576|Growth Inhibitors|growth inhibitors|mesh-ancestor
101390592|NCT05477576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101390593|NCT05477576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101390594|NCT05476354|Amlodipine|amlodipine|mesh-list
101390595|NCT05476354|Irbesartan|irbesartan|mesh-list
101390596|NCT05476354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101390600|NCT05476354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101390601|NCT05476354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390602|NCT05476354|Vasodilator Agents|vasodilator agents|mesh-ancestor
101390603|NCT05476354|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101390604|NCT05476354|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101390606|NCT05475665|Irbesartan|irbesartan|mesh-list
101390607|NCT05475665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101390608|NCT05475665|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101390609|NCT05475665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101390610|NCT05475665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390611|NCT05475665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101390612|NCT05475665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390613|NCT05475665|Vasodilator Agents|vasodilator agents|mesh-ancestor
101390614|NCT05475665|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101390615|NCT05475665|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101390616|NCT05467670|Doxorubicin|doxorubicin|mesh-list
101390617|NCT05467670|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101390618|NCT05467670|Pembrolizumab|pembrolizumab|mesh-list
101390619|NCT05467670|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102074504|NCT02109510|Anesthetics|anesthetics|mesh-list
102074505|NCT02109510|Propofol|propofol|mesh-list
102074506|NCT02109510|Sevoflurane|sevoflurane|mesh-list
102074507|NCT02109510|Rocuronium|rocuronium|mesh-list
102074508|NCT02109510|Anesthetics, Local|anesthetics, local|mesh-ancestor
102074509|NCT02109510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101390620|NCT05467670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390621|NCT05467670|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101390622|NCT05467670|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101390623|NCT05467670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101390624|NCT05467670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390625|NCT05467670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101390626|NCT05467670|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101390627|NCT05467176|Relugolix|relugolix|mesh-list
101390628|NCT05467176|Androgen Antagonists|androgen antagonists|mesh-ancestor
101390629|NCT05467176|Hormone Antagonists|hormone antagonists|mesh-ancestor
101390630|NCT05467176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101390631|NCT05467176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390632|NCT05460533|Tisagenlecleucel|tisagenlecleucel|mesh-list
101390633|NCT05460533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101390634|NCT05460533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390635|NCT05447910|Letrozole|letrozole|mesh-list
101390636|NCT05447910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390637|NCT05447910|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101390638|NCT05447910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101390639|NCT05447910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101305482|NCT02019797|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101390641|NCT05447910|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101390642|NCT05447910|Hormone Antagonists|hormone antagonists|mesh-ancestor
101390643|NCT05447910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101390644|NCT05447910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390662|NCT05442515|Cyclophosphamide|cyclophosphamide|mesh-list
101390663|NCT05442515|Fludarabine|fludarabine|mesh-list
101390664|NCT05442515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101390669|NCT05442515|Alkylating Agents|alkylating agents|mesh-ancestor
101390670|NCT05442515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390671|NCT05442515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390672|NCT05442515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101390673|NCT05432388|Remibrutinib|remibrutinib|mesh-list
101390674|NCT05432388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101390675|NCT05432388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101390676|NCT05432388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390677|NCT05429762|Maytansine|maytansine|mesh-list
101390678|NCT05429762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101390679|NCT05429762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390680|NCT05429762|Tubulin Modulators|tubulin modulators|mesh-ancestor
101390681|NCT05429762|Antimitotic Agents|antimitotic agents|mesh-ancestor
101390682|NCT05429762|Mitosis Modulators|mitosis modulators|mesh-ancestor
101390683|NCT05429762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390684|NCT05429268|Lenalidomide|lenalidomide|mesh-list
101390685|NCT05429268|Immunologic Factors|immunologic factors|mesh-ancestor
101390686|NCT05429268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390687|NCT05429268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101390688|NCT05429268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101390689|NCT05429268|Growth Substances|growth substances|mesh-ancestor
101390690|NCT05429268|Growth Inhibitors|growth inhibitors|mesh-ancestor
101390691|NCT05429268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390692|NCT05424445|Misoprostol|misoprostol|mesh-list
101390693|NCT05424445|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101390694|NCT05424445|Abortifacient Agents|abortifacient agents|mesh-ancestor
101390695|NCT05424445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101390696|NCT05424445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390697|NCT05424445|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101390698|NCT05424445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101390699|NCT05424445|Oxytocics|oxytocics|mesh-ancestor
101390700|NCT05423379|Everolimus|everolimus|mesh-list
101390701|NCT05423379|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101390702|NCT05423379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102074510|NCT02109510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074511|NCT02109510|Sensory System Agents|sensory system agents|mesh-ancestor
102074512|NCT02109510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102074513|NCT02109510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101376193|NCT00237874|Antidepressive Agents|antidepressive agents|mesh-ancestor
101390703|NCT05423379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101390704|NCT05423379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390705|NCT05423379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101390706|NCT05423379|Immunologic Factors|immunologic factors|mesh-ancestor
101390707|NCT05423379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390708|NCT05423379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390709|NCT05411081|Atezolizumab|atezolizumab|mesh-list
101390710|NCT05411081|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101305485|NCT02019797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101305486|NCT02019797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305487|NCT02019810|Dobutamine|dobutamine|mesh-list
101390711|NCT05411081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101390712|NCT05411081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390713|NCT05411081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101390714|NCT05411081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390715|NCT05411081|Immunologic Factors|immunologic factors|mesh-ancestor
101390716|NCT05411081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390717|NCT05407636|Aflibercept|aflibercept|mesh-list
101390718|NCT05407636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101390719|NCT05407636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101390720|NCT05407636|Growth Substances|growth substances|mesh-ancestor
101390721|NCT05407636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390722|NCT05407636|Growth Inhibitors|growth inhibitors|mesh-ancestor
101390723|NCT05407636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390724|NCT05406700|Niraparib|niraparib|mesh-list
101390725|NCT05406700|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101390726|NCT05406700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101390740|NCT05401916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101390742|NCT05401916|Sensory System Agents|sensory system agents|mesh-ancestor
101390743|NCT05401916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101390744|NCT05401916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390745|NCT05401916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101390746|NCT05401916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101390747|NCT05401916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101390748|NCT05401916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101390749|NCT05401916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390750|NCT05401916|Antipyretics|antipyretics|mesh-ancestor
101390751|NCT05401916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101390752|NCT05401916|Narcotics|narcotics|mesh-ancestor
101390753|NCT05401916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101390754|NCT05400265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101390755|NCT05400265|Antibodies|antibodies|mesh-list
101390756|NCT05400265|Immunoglobulins|immunoglobulins|mesh-list
101390757|NCT05400265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101390758|NCT05400265|Immunologic Factors|immunologic factors|mesh-ancestor
101390759|NCT05400265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390760|NCT05400265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390761|NCT05400109|Cyclophosphamide|cyclophosphamide|mesh-list
101390762|NCT05400109|Fludarabine|fludarabine|mesh-list
101390763|NCT05400109|Fludarabine phosphate|fludarabine phosphate|mesh-list
101390764|NCT05400109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101390765|NCT05400109|Immunologic Factors|immunologic factors|mesh-ancestor
101390766|NCT05400109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390767|NCT05400109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101390768|NCT05400109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101390769|NCT05400109|Alkylating Agents|alkylating agents|mesh-ancestor
101390770|NCT05400109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390771|NCT05400109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390772|NCT05400109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101390773|NCT05400109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101390774|NCT05400109|Antimetabolites|antimetabolites|mesh-ancestor
101390780|NCT05384691|Luspatercept|luspatercept|mesh-list
101390781|NCT05384691|Hematinics|hematinics|mesh-ancestor
101390782|NCT05384496|Nivolumab|nivolumab|mesh-list
101376199|NCT00237874|Dopamine Agonists|dopamine agonists|mesh-ancestor
102074514|NCT02109510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102074515|NCT02109510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102074516|NCT02109510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102074517|NCT02109510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074518|NCT02109510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102074519|NCT02109510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102074520|NCT02109510|Analgesics|analgesics|mesh-ancestor
102074521|NCT02109510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101390783|NCT05384496|Ipilimumab|ipilimumab|mesh-list
101390784|NCT05384496|Axitinib|axitinib|mesh-list
101305488|NCT02019810|Norepinephrine|norepinephrine|mesh-list
101305489|NCT02019810|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101305490|NCT02019810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101305491|NCT02019810|Adrenergic Agents|adrenergic agents|mesh-ancestor
101177983|NCT02534376|Ezetimibe|ezetimibe|mesh-list
101390785|NCT05384496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101390786|NCT05384496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390787|NCT05384496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101390788|NCT05384496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390789|NCT05384496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101390790|NCT05384496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101390791|NCT05383495|Midazolam|midazolam|mesh-list
101390792|NCT05383495|Dexmedetomidine|dexmedetomidine|mesh-list
101390793|NCT05383495|Nitrous Oxide|nitrous oxide|mesh-list
101390794|NCT05383495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101390795|NCT05383495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101390796|NCT05383495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390797|NCT05383495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101390822|NCT05382650|Immunologic Factors|immunologic factors|mesh-ancestor
101390823|NCT05382650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390824|NCT05382299|Paclitaxel|paclitaxel|mesh-list
101390825|NCT05382299|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101390826|NCT05382299|Carboplatin|carboplatin|mesh-list
101390827|NCT05382299|Gemcitabine|gemcitabine|mesh-list
101390828|NCT05382299|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
101390829|NCT05382299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101390830|NCT05382299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390831|NCT05382299|Tubulin Modulators|tubulin modulators|mesh-ancestor
101390832|NCT05382299|Antimitotic Agents|antimitotic agents|mesh-ancestor
101390833|NCT05382299|Mitosis Modulators|mitosis modulators|mesh-ancestor
101390834|NCT05382299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390835|NCT05382299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101390836|NCT05382299|Antimetabolites|antimetabolites|mesh-ancestor
101390837|NCT05382299|Immunoconjugates|immunoconjugates|mesh-ancestor
101390838|NCT05382299|Immunologic Factors|immunologic factors|mesh-ancestor
101390839|NCT05382299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390840|NCT05377333|Dulaglutide|dulaglutide|mesh-list
101390841|NCT05377333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101390842|NCT05377333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390843|NCT05375903|Gemcitabine|gemcitabine|mesh-list
101390844|NCT05375903|Imiquimod|imiquimod|mesh-list
101390845|NCT05375903|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101390846|NCT05375903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101390847|NCT05375903|Antimetabolites|antimetabolites|mesh-ancestor
101390848|NCT05375903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390849|NCT05375903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390850|NCT05375903|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101390851|NCT05375903|Immunologic Factors|immunologic factors|mesh-ancestor
101390852|NCT05375903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390853|NCT05375903|Interferon Inducers|interferon inducers|mesh-ancestor
101390854|NCT05375084|Nivolumab|nivolumab|mesh-list
101390855|NCT05375084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101390856|NCT05375084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390857|NCT05375084|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102074522|NCT02109510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102074523|NCT02109510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102074524|NCT02109510|Adrenergic Agents|adrenergic agents|mesh-ancestor
102074525|NCT02109510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102074526|NCT02109510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102074527|NCT02109510|Anesthetics, General|anesthetics, general|mesh-ancestor
102074528|NCT02109510|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101376210|NCT00237913|Olanzapine|olanzapine|mesh-list
101390858|NCT05375084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390859|NCT05370885|Vancomycin|vancomycin|mesh-list
101390860|NCT05370885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101390861|NCT05370885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101390868|NCT05362760|Fulvestrant|fulvestrant|mesh-list
101390869|NCT05362760|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101305493|NCT02019810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305494|NCT02019810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305495|NCT02019810|Sympathomimetics|sympathomimetics|mesh-ancestor
101305496|NCT02019810|Autonomic Agents|autonomic agents|mesh-ancestor
101305497|NCT02019810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101390870|NCT05362760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101390871|NCT05362760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390872|NCT05362760|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101390873|NCT05362760|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101390874|NCT05362760|Hormone Antagonists|hormone antagonists|mesh-ancestor
101390889|NCT05357482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390890|NCT05357482|Antifungal Agents|antifungal agents|mesh-ancestor
101390891|NCT05357482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101390892|NCT05357482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101390893|NCT05357482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390894|NCT05357482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101390895|NCT05357482|Antisickling Agents|antisickling agents|mesh-ancestor
101390896|NCT05357482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101390897|NCT05357482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101390898|NCT05357482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101390899|NCT05357482|Antiviral Agents|antiviral agents|mesh-ancestor
101390900|NCT05356741|Pembrolizumab|pembrolizumab|mesh-list
101390901|NCT05356741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101390902|NCT05356741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390903|NCT05356741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101390904|NCT05356741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390905|NCT05346354|Ravulizumab|ravulizumab|mesh-list
101390906|NCT05346354|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101390907|NCT05346354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101390908|NCT05346354|Immunologic Factors|immunologic factors|mesh-ancestor
101390909|NCT05346354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390910|NCT05342636|Paclitaxel|paclitaxel|mesh-list
101390911|NCT05342636|Pembrolizumab|pembrolizumab|mesh-list
101390912|NCT05342636|Irinotecan|irinotecan|mesh-list
101390913|NCT05342636|Lenvatinib|lenvatinib|mesh-list
101390914|NCT05342636|Immunoglobulins|immunoglobulins|mesh-list
101390915|NCT05342636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101390916|NCT05342636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390917|NCT05342636|Tubulin Modulators|tubulin modulators|mesh-ancestor
101390918|NCT05342636|Antimitotic Agents|antimitotic agents|mesh-ancestor
101390919|NCT05342636|Mitosis Modulators|mitosis modulators|mesh-ancestor
101390920|NCT05342636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390921|NCT05342636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101390922|NCT05342636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101390923|NCT05342636|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101390924|NCT05342636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101390925|NCT05342636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101390926|NCT05342636|Immunologic Factors|immunologic factors|mesh-ancestor
101390927|NCT05342636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390928|NCT05342636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101390929|NCT05342519|Sirolimus|sirolimus|mesh-list
101390930|NCT05342519|Temsirolimus|temsirolimus|mesh-list
101390931|NCT05342519|MTOR Inhibitors|mtor inhibitors|mesh-list
102074529|NCT02109510|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102074530|NCT02109510|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102074531|NCT02109510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102074532|NCT02109510|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102074533|NCT02109510|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101376213|NCT00237913|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101390932|NCT05342519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101390933|NCT05342519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101390934|NCT05342519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101390935|NCT05342519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101305498|NCT02019810|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101390936|NCT05342519|Antifungal Agents|antifungal agents|mesh-ancestor
101390937|NCT05342519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101390938|NCT05342519|Immunologic Factors|immunologic factors|mesh-ancestor
101390939|NCT05342519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390940|NCT05342519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101390941|NCT05342519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101390942|NCT05342519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391147|NCT05263284|Purinergic Agonists|purinergic agonists|mesh-ancestor
101391229|NCT05250973|Hormones|hormones|mesh-ancestor
101391230|NCT05250973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101391231|NCT05250973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101305510|NCT02020005|Autonomic Agents|autonomic agents|mesh-ancestor
101305511|NCT02020005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101305512|NCT02020005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305513|NCT02020005|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101391232|NCT05232929|Risdiplam|risdiplam|mesh-list
101391233|NCT05232929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101391599|NCT05039619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101391600|NCT05039619|Protective Agents|protective agents|mesh-ancestor
101391601|NCT05039619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101391602|NCT05039619|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101391603|NCT05039619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101391604|NCT05039619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101391605|NCT05039619|Anesthetics, Local|anesthetics, local|mesh-ancestor
101391606|NCT05039619|Anesthetics|anesthetics|mesh-ancestor
101391607|NCT05039619|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101391608|NCT05039619|Histamine Antagonists|histamine antagonists|mesh-ancestor
101305536|NCT02020122|Antidepressive Agents|antidepressive agents|mesh-ancestor
101305537|NCT02020122|Dopamine Agents|dopamine agents|mesh-ancestor
101305538|NCT02020161|Methotrexate|methotrexate|mesh-list
101305539|NCT02020161|Idarubicin|idarubicin|mesh-list
101178681|NCT02160990|Incretins|incretins|mesh-ancestor
101391646|NCT05017012|Tubulin Modulators|tubulin modulators|mesh-ancestor
101391647|NCT05017012|Antimitotic Agents|antimitotic agents|mesh-ancestor
101391648|NCT05017012|Mitosis Modulators|mitosis modulators|mesh-ancestor
101391684|NCT04998812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391685|NCT04994717|Blinatumomab|blinatumomab|mesh-list
101391686|NCT04994717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391687|NCT04989491|Rituximab|rituximab|mesh-list
101391688|NCT04989491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101391689|NCT04989491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391724|NCT04980222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101391725|NCT04980222|Tubulin Modulators|tubulin modulators|mesh-ancestor
101391726|NCT04980222|Antimitotic Agents|antimitotic agents|mesh-ancestor
101391727|NCT04980222|Mitosis Modulators|mitosis modulators|mesh-ancestor
101391948|NCT04898894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101391949|NCT04898894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101391950|NCT04898894|Immunologic Factors|immunologic factors|mesh-ancestor
101391951|NCT04898894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101391952|NCT04898894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101391953|NCT04898894|Antiviral Agents|antiviral agents|mesh-ancestor
101391954|NCT04898894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101392234|NCT04740918|Atezolizumab|atezolizumab|mesh-list
101392235|NCT04740918|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101392236|NCT04740918|Maytansine|maytansine|mesh-list
101392237|NCT04740918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101392238|NCT04740918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392239|NCT04740918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102074534|NCT02109510|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102074535|NCT02109510|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102074536|NCT02109666|Abatacept|abatacept|mesh-list
102074537|NCT02109666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102074538|NCT02109666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074539|NCT02109666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102074540|NCT02109666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102074541|NCT02109666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102074542|NCT02109666|Immunologic Factors|immunologic factors|mesh-ancestor
101392240|NCT04740918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392241|NCT04740918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101392242|NCT04740918|Tubulin Modulators|tubulin modulators|mesh-ancestor
101392243|NCT04740918|Antimitotic Agents|antimitotic agents|mesh-ancestor
101392244|NCT04740918|Mitosis Modulators|mitosis modulators|mesh-ancestor
101392245|NCT04740918|Immunotoxins|immunotoxins|mesh-ancestor
101392246|NCT04740918|Immunoconjugates|immunoconjugates|mesh-ancestor
101392614|NCT04580121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392615|NCT04580121|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101392616|NCT04580121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101392617|NCT04580121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101392618|NCT04580121|Anesthetics, Local|anesthetics, local|mesh-ancestor
101392620|NCT04580121|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101392621|NCT04580121|Histamine Antagonists|histamine antagonists|mesh-ancestor
101392622|NCT04580121|Histamine Agents|histamine agents|mesh-ancestor
101392623|NCT04580121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101392624|NCT04580121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101392625|NCT04580121|Antipruritics|antipruritics|mesh-ancestor
101392626|NCT04580121|Dermatologic Agents|dermatologic agents|mesh-ancestor
101392627|NCT04574778|Acetaminophen|acetaminophen|mesh-list
101392628|NCT04574778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101392629|NCT04574778|Analgesics|analgesics|mesh-ancestor
101392630|NCT04574778|Sensory System Agents|sensory system agents|mesh-ancestor
101392631|NCT04574778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101392640|NCT04569747|Exemestane|exemestane|mesh-list
101392641|NCT04569747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101392642|NCT04569747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392643|NCT04569747|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101392644|NCT04569747|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101392645|NCT04569747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101392646|NCT04569747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392647|NCT04569747|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101392648|NCT04569747|Hormone Antagonists|hormone antagonists|mesh-ancestor
101392649|NCT04569747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101392650|NCT04569747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392651|NCT04569747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101392652|NCT04569747|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101392653|NCT04569747|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101392655|NCT04569747|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101392656|NCT04569747|Fertility Agents|fertility agents|mesh-ancestor
101392657|NCT04569747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101392658|NCT04566133|Hydroxychloroquine|hydroxychloroquine|mesh-list
101392659|NCT04566133|Trametinib|trametinib|mesh-list
101392660|NCT04566133|Antimalarials|antimalarials|mesh-ancestor
101392661|NCT04566133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101392662|NCT04566133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101392663|NCT04566133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101392664|NCT04566133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101392665|NCT04566133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392687|NCT04543617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392688|NCT04543617|Immunologic Factors|immunologic factors|mesh-ancestor
101392689|NCT04543617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392690|NCT04533451|Carboplatin|carboplatin|mesh-list
101376228|NCT00237913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102074543|NCT02109666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074544|NCT02109666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102074545|NCT02865928|Bupivacaine|bupivacaine|mesh-list
102074546|NCT02865928|Anesthetics, Local|anesthetics, local|mesh-ancestor
102074547|NCT02865928|Anesthetics|anesthetics|mesh-ancestor
102074548|NCT02865928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102074549|NCT02865928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074550|NCT02865928|Sensory System Agents|sensory system agents|mesh-ancestor
101392691|NCT04533451|Pembrolizumab|pembrolizumab|mesh-list
101392692|NCT04533451|Pemetrexed|pemetrexed|mesh-list
101392693|NCT04533451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392694|NCT04533451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101392695|NCT04533451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101392696|NCT04533451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392697|NCT04533451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101392698|NCT04533451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101392699|NCT04533451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101392700|NCT04528082|Apremilast|apremilast|mesh-list
101392701|NCT04528082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101392708|NCT04528082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101392709|NCT04528082|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101189635|NCT00003930|Antimetabolites|antimetabolites|mesh-ancestor
101392742|NCT04520451|Hormones|hormones|mesh-ancestor
101392743|NCT04520451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101392744|NCT04520451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392745|NCT04513925|Atezolizumab|atezolizumab|mesh-list
101392746|NCT04513925|Durvalumab|durvalumab|mesh-list
101392747|NCT04513925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101392748|NCT04513925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392749|NCT04513925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101189687|NCT00003960|Hormones|hormones|mesh-ancestor
101392783|NCT04449874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392785|NCT04449874|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
101392786|NCT04447027|Dexamethasone|dexamethasone|mesh-list
101392787|NCT04447027|Lenalidomide|lenalidomide|mesh-list
101392788|NCT04447027|Azacitidine|azacitidine|mesh-list
101392789|NCT04447027|Romidepsin|romidepsin|mesh-list
101392790|NCT04447027|Cc-486|cc-486|mesh-list
101392791|NCT04447027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101392792|NCT04447027|Antiemetics|antiemetics|mesh-ancestor
101392793|NCT04447027|Autonomic Agents|autonomic agents|mesh-ancestor
101392794|NCT04447027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101392795|NCT04447027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392796|NCT04447027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101392797|NCT04447027|Glucocorticoids|glucocorticoids|mesh-ancestor
101392798|NCT04447027|Hormones|hormones|mesh-ancestor
101392799|NCT04447027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101392800|NCT04447027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101392801|NCT04447027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392802|NCT04447027|Immunologic Factors|immunologic factors|mesh-ancestor
101392825|NCT04434664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101392826|NCT04434664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392827|NCT04434664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101392828|NCT04434664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392829|NCT04434664|Vasodilator Agents|vasodilator agents|mesh-ancestor
101305591|NCT02020551|Anesthetics, Local|anesthetics, local|mesh-ancestor
101305592|NCT02020551|Anesthetics|anesthetics|mesh-ancestor
101305593|NCT02020551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101305594|NCT02020551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305595|NCT02020551|Sensory System Agents|sensory system agents|mesh-ancestor
101392830|NCT04434664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101392831|NCT04434664|Sympatholytics|sympatholytics|mesh-ancestor
101392832|NCT04434664|Autonomic Agents|autonomic agents|mesh-ancestor
102074551|NCT02865928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102074552|NCT02109900|Progesterone|progesterone|mesh-list
102074553|NCT02109900|Progestins|progestins|mesh-ancestor
102074554|NCT02109900|Hormones|hormones|mesh-ancestor
102074555|NCT02109900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101376238|NCT00237952|Chelating Agents|chelating agents|mesh-list
101392833|NCT04434664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101392834|NCT04434664|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101392835|NCT04434664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101392836|NCT04434664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101392862|NCT04409314|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
101392863|NCT04409314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101392864|NCT04409314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392879|NCT04404088|Rituximab|rituximab|mesh-list
101392880|NCT04404088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101392881|NCT04404088|Lenalidomide|lenalidomide|mesh-list
101392882|NCT04404088|Acalabrutinib|acalabrutinib|mesh-list
101392883|NCT04404088|Antibodies|antibodies|mesh-list
101392884|NCT04404088|Immunoglobulins|immunoglobulins|mesh-list
101392885|NCT04404088|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101392896|NCT04404088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101392928|NCT04302025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101392929|NCT04302025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305596|NCT02020551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101392930|NCT04302025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101392931|NCT04302025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392932|NCT04302025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101392933|NCT04302025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101392934|NCT04294810|Atezolizumab|atezolizumab|mesh-list
101392935|NCT04294810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101189826|NCT00004086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101392962|NCT04288778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392963|NCT04279847|INCB057643|incb057643|mesh-list
101392964|NCT04279847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392965|NCT04278781|Ivosidenib|ivosidenib|mesh-list
101392966|NCT04278781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392967|NCT04278781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101392968|NCT04278781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392969|NCT04270409|Dexamethasone|dexamethasone|mesh-list
101392970|NCT04270409|Lenalidomide|lenalidomide|mesh-list
101392971|NCT04270409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101392972|NCT04270409|Antiemetics|antiemetics|mesh-ancestor
101392973|NCT04270409|Autonomic Agents|autonomic agents|mesh-ancestor
101392974|NCT04270409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101392975|NCT04270409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392976|NCT04270409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101392977|NCT04270409|Glucocorticoids|glucocorticoids|mesh-ancestor
101392978|NCT04270409|Hormones|hormones|mesh-ancestor
101392979|NCT04270409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101392980|NCT04270409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101392981|NCT04270409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392982|NCT04270409|Immunologic Factors|immunologic factors|mesh-ancestor
101392983|NCT04270409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101392984|NCT04270409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101392985|NCT04270409|Growth Substances|growth substances|mesh-ancestor
101189871|NCT00004128|Aldesleukin|aldesleukin|mesh-list
101393016|NCT04246697|Analgesics|analgesics|mesh-ancestor
101393017|NCT04246697|Anticonvulsants|anticonvulsants|mesh-ancestor
101393018|NCT04246697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101393019|NCT04246697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101393020|NCT04246697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101393021|NCT04246697|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101393022|NCT04246697|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101393023|NCT04246697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101393033|NCT04240002|Cytarabine|cytarabine|mesh-list
101393034|NCT04240002|Fludarabine|fludarabine|mesh-list
101393035|NCT04240002|Lenograstim|lenograstim|mesh-list
101393036|NCT04240002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393104|NCT04222023|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101393105|NCT04222023|Immunologic Factors|immunologic factors|mesh-ancestor
102074556|NCT02109900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074557|NCT02112630|Interferons|interferons|mesh-list
102074558|NCT02112630|Ribavirin|ribavirin|mesh-list
102074559|NCT02112630|Interferon-alpha|interferon-alpha|mesh-list
102074560|NCT02112630|Interferon alpha-2|interferon alpha-2|mesh-list
101393106|NCT04222023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393107|NCT04216316|Carboplatin|carboplatin|mesh-list
101393108|NCT04216316|Gemcitabine|gemcitabine|mesh-list
101393109|NCT04216316|Pembrolizumab|pembrolizumab|mesh-list
101393110|NCT04216316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393111|NCT04216316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101393112|NCT04216316|Antimetabolites|antimetabolites|mesh-ancestor
101393113|NCT04216316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393114|NCT04216316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101393115|NCT04216316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101393116|NCT04209660|Pembrolizumab|pembrolizumab|mesh-list
101393117|NCT04209660|Lenvatinib|lenvatinib|mesh-list
101393118|NCT04209660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101393119|NCT04209660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393120|NCT04209660|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101393121|NCT04209660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393122|NCT04209660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101393123|NCT04209660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101393124|NCT04209504|Bupivacaine|bupivacaine|mesh-list
101393125|NCT04209504|Ropivacaine|ropivacaine|mesh-list
101393126|NCT04209504|Anesthetics, Local|anesthetics, local|mesh-ancestor
101393127|NCT04209504|Anesthetics|anesthetics|mesh-ancestor
101393128|NCT04209504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101393129|NCT04209504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393130|NCT04209504|Sensory System Agents|sensory system agents|mesh-ancestor
101190006|NCT00004206|Vitamins|vitamins|mesh-ancestor
101305602|NCT02020603|Epinephrine|epinephrine|mesh-list
101393163|NCT04177706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393164|NCT04177706|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101393165|NCT04177706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101393166|NCT04177706|Anesthetics, General|anesthetics, general|mesh-ancestor
101393167|NCT04177706|Anesthetics|anesthetics|mesh-ancestor
101393168|NCT04177706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101393169|NCT04177706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101393202|NCT04177004|Antimitotic Agents|antimitotic agents|mesh-ancestor
101393203|NCT04175613|Apremilast|apremilast|mesh-list
101393204|NCT04175613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101393205|NCT04175613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101393206|NCT04175613|Analgesics|analgesics|mesh-ancestor
101393207|NCT04175613|Sensory System Agents|sensory system agents|mesh-ancestor
101393208|NCT04175613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101393209|NCT04175613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393210|NCT04175613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101393211|NCT04175613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101393212|NCT04175613|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101305609|NCT02020603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101305610|NCT02020603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305611|NCT02020603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305612|NCT02020603|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101305613|NCT02020603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101305614|NCT02020603|Autonomic Agents|autonomic agents|mesh-ancestor
101305615|NCT02020603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101305616|NCT02020603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101305617|NCT02020603|Respiratory System Agents|respiratory system agents|mesh-ancestor
101305619|NCT02020603|Sympathomimetics|sympathomimetics|mesh-ancestor
101393243|NCT04164069|Immunologic Factors|immunologic factors|mesh-ancestor
101393244|NCT04164069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101393245|NCT04164069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101393246|NCT04164069|Antimetabolites|antimetabolites|mesh-ancestor
101393247|NCT04164069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393248|NCT04164069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101393249|NCT04164069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101393250|NCT04164069|Antidotes|antidotes|mesh-ancestor
101393251|NCT04164069|Protective Agents|protective agents|mesh-ancestor
101393289|NCT04119336|Alkylating Agents|alkylating agents|mesh-ancestor
101305627|NCT02020681|Protective Agents|protective agents|mesh-ancestor
101393363|NCT04092101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393365|NCT04090879|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101393366|NCT04090879|Autonomic Agents|autonomic agents|mesh-ancestor
101393367|NCT04090879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101393368|NCT04090879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393369|NCT04090879|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101393370|NCT04090879|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101393371|NCT04090879|Cholinergic Agents|cholinergic agents|mesh-ancestor
101393372|NCT04090879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101393391|NCT04047797|Protease Inhibitors|protease inhibitors|mesh-ancestor
101190286|NCT00004488|Vitamin D|vitamin d|mesh-list
101393435|NCT04024436|Futibatinib|futibatinib|mesh-list
101393436|NCT04024436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101393437|NCT04024436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393438|NCT04024436|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101393439|NCT04024436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101393440|NCT04024436|Hormone Antagonists|hormone antagonists|mesh-ancestor
101393441|NCT04024436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101393442|NCT04024436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393443|NCT04019288|Durvalumab|durvalumab|mesh-list
101393444|NCT04019288|Immunoglobulins|immunoglobulins|mesh-list
101393445|NCT04019288|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101393446|NCT04019288|Immunoglobulin G|immunoglobulin g|mesh-list
101393447|NCT04019288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101393448|NCT04019288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393449|NCT04019288|Immunologic Factors|immunologic factors|mesh-ancestor
101393450|NCT04019288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393451|NCT03996772|Rivaroxaban|rivaroxaban|mesh-list
101393452|NCT03996772|Apixaban|apixaban|mesh-list
101393453|NCT03996772|Edoxaban|edoxaban|mesh-list
101393454|NCT03996772|Dabigatran|dabigatran|mesh-list
101393455|NCT03996772|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101393471|NCT03984448|Vincristine|vincristine|mesh-list
101393472|NCT03984448|Etoposide phosphate|etoposide phosphate|mesh-list
101393473|NCT03984448|Venetoclax|venetoclax|mesh-list
101393474|NCT03984448|Podophyllotoxin|podophyllotoxin|mesh-list
101393475|NCT03984448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101393476|NCT03984448|Antibodies|antibodies|mesh-list
101393477|NCT03984448|Immunoglobulins|immunoglobulins|mesh-list
101393478|NCT03984448|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101393479|NCT03984448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101393480|NCT03984448|Immunologic Factors|immunologic factors|mesh-ancestor
102074568|NCT02112630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074569|NCT02112630|Immunologic Factors|immunologic factors|mesh-ancestor
102074570|NCT02112630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074571|NCT04873375|Cemiplimab|cemiplimab|mesh-list
102074572|NCT04873375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102074573|NCT04873375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102074574|NCT05125588|Meloxicam|meloxicam|mesh-list
102074575|NCT05125588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101376249|NCT00098241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393481|NCT03984448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393483|NCT03984448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101393484|NCT03984448|Alkylating Agents|alkylating agents|mesh-ancestor
101393485|NCT03984448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393486|NCT03984448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393487|NCT03984448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101393488|NCT03984448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101393489|NCT03984448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101393490|NCT03984448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101393491|NCT03984448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101393492|NCT03984448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101393493|NCT03984448|Glucocorticoids|glucocorticoids|mesh-ancestor
101393494|NCT03984448|Hormones|hormones|mesh-ancestor
101334546|NCT00044707|Pramlintide|pramlintide|mesh-list
101393495|NCT03984448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101393496|NCT03984448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101393497|NCT03984448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101393498|NCT03984448|Tubulin Modulators|tubulin modulators|mesh-ancestor
101393499|NCT03984448|Antimitotic Agents|antimitotic agents|mesh-ancestor
101393500|NCT03984448|Mitosis Modulators|mitosis modulators|mesh-ancestor
101393501|NCT03984448|Keratolytic Agents|keratolytic agents|mesh-ancestor
101393502|NCT03984448|Dermatologic Agents|dermatologic agents|mesh-ancestor
101393503|NCT03977467|Atezolizumab|atezolizumab|mesh-list
101393504|NCT03977467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101393505|NCT03977467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393506|NCT03977467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101393510|NCT03971422|Immunologic Factors|immunologic factors|mesh-ancestor
101393526|NCT03905694|Lumasiran|lumasiran|mesh-list
101393527|NCT03905694|Renal Agents|renal agents|mesh-ancestor
101393528|NCT03901612|Ropivacaine|ropivacaine|mesh-list
101393529|NCT03901612|Anesthetics, Local|anesthetics, local|mesh-ancestor
101393530|NCT03901612|Anesthetics|anesthetics|mesh-ancestor
101393531|NCT03901612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101393532|NCT03901612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393533|NCT03901612|Sensory System Agents|sensory system agents|mesh-ancestor
101393534|NCT03901612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101393535|NCT03874884|Olaparib|olaparib|mesh-list
101393536|NCT03874884|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101393537|NCT03874884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101393538|NCT03874884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393539|NCT03874884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393540|NCT03840915|Paclitaxel|paclitaxel|mesh-list
101393541|NCT03840915|Docetaxel|docetaxel|mesh-list
101393542|NCT03840915|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101393543|NCT03840915|Carboplatin|carboplatin|mesh-list
101393544|NCT03840915|Gemcitabine|gemcitabine|mesh-list
101393545|NCT03840915|Pemetrexed|pemetrexed|mesh-list
101393546|NCT03840915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101393547|NCT03840915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393548|NCT03840915|Tubulin Modulators|tubulin modulators|mesh-ancestor
101393549|NCT03840915|Antimitotic Agents|antimitotic agents|mesh-ancestor
101393550|NCT03840915|Mitosis Modulators|mitosis modulators|mesh-ancestor
101393551|NCT03840915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393552|NCT03840915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101393553|NCT03840915|Antimetabolites|antimetabolites|mesh-ancestor
101393554|NCT03840915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102074576|NCT05125588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102074578|NCT05125588|Sensory System Agents|sensory system agents|mesh-ancestor
102074579|NCT05125588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102074580|NCT05125588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376263|NCT00065390|Pyrimethamine|pyrimethamine|mesh-list
101393555|NCT03840915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101393556|NCT03840915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101393557|NCT03829501|Atezolizumab|atezolizumab|mesh-list
101393558|NCT03829501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101393559|NCT03829501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393617|NCT03765788|Hormones|hormones|mesh-ancestor
101305639|NCT02018796|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101305640|NCT02018796|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101180528|NCT00281658|Paclitaxel|paclitaxel|mesh-list
101393618|NCT03765788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101393619|NCT03765788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393620|NCT03765788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101393621|NCT03765788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393622|NCT03760822|Paclitaxel|paclitaxel|mesh-list
101393629|NCT03760822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393630|NCT03754725|Deferiprone|deferiprone|mesh-list
101393631|NCT03754725|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101393632|NCT03754725|Chelating Agents|chelating agents|mesh-ancestor
101393633|NCT03754725|Sequestering Agents|sequestering agents|mesh-ancestor
101190482|NCT00004854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101393660|NCT03744793|Immunologic Factors|immunologic factors|mesh-ancestor
101393661|NCT03744793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393662|NCT03731923|Liver Extracts|liver extracts|mesh-list
101393663|NCT03731923|Hematinics|hematinics|mesh-ancestor
101393664|NCT03726268|Fentanyl|fentanyl|mesh-list
101393665|NCT03726268|Sufentanil|sufentanil|mesh-list
101393666|NCT03726268|Morphine|morphine|mesh-list
101393667|NCT03726268|Methadone|methadone|mesh-list
101393668|NCT03726268|Hydromorphone|hydromorphone|mesh-list
101393669|NCT03726268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101393670|NCT03726268|Narcotics|narcotics|mesh-ancestor
101393671|NCT03726268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101393672|NCT03726268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393673|NCT03726268|Analgesics|analgesics|mesh-ancestor
101393674|NCT03726268|Sensory System Agents|sensory system agents|mesh-ancestor
101393675|NCT03726268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101393676|NCT03726268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101393677|NCT03726268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101393678|NCT03726268|Anesthetics, General|anesthetics, general|mesh-ancestor
101393679|NCT03726268|Anesthetics|anesthetics|mesh-ancestor
101393680|NCT03726268|Antitussive Agents|antitussive agents|mesh-ancestor
101393681|NCT03726268|Respiratory System Agents|respiratory system agents|mesh-ancestor
101393715|NCT03699995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101393716|NCT03699995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101393717|NCT03699995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101393718|NCT03699995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393719|NCT03693677|Paclitaxel|paclitaxel|mesh-list
101393749|NCT03681184|Renal Agents|renal agents|mesh-ancestor
101393750|NCT03653507|Capecitabine|capecitabine|mesh-list
101393751|NCT03653507|Oxaliplatin|oxaliplatin|mesh-list
101393752|NCT03653507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101305649|NCT02018796|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101305650|NCT02021097|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101305651|NCT02021097|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101393753|NCT03653507|Antimetabolites|antimetabolites|mesh-ancestor
101393754|NCT03653507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393755|NCT03653507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393756|NCT03649230|Palonosetron|palonosetron|mesh-list
101393757|NCT03649230|Antiemetics|antiemetics|mesh-ancestor
101393758|NCT03649230|Autonomic Agents|autonomic agents|mesh-ancestor
101393759|NCT03649230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101393760|NCT03649230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393761|NCT03649230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101393789|NCT03587662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101393790|NCT03587662|Antimetabolites|antimetabolites|mesh-ancestor
102074586|NCT05125588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074587|NCT02115204|Cyclophosphamide|cyclophosphamide|mesh-list
102074589|NCT02115204|Fluorouracil|fluorouracil|mesh-list
102074590|NCT02115204|Methotrexate|methotrexate|mesh-list
101393791|NCT03587662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393792|NCT03587662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393793|NCT03587662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101393794|NCT03587662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101393795|NCT03587662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101393796|NCT03587662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101393797|NCT03587662|Protease Inhibitors|protease inhibitors|mesh-ancestor
101393798|NCT03587662|Glycine Agents|glycine agents|mesh-ancestor
101393799|NCT03587662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101393800|NCT03587662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393801|NCT03584711|Panitumumab|panitumumab|mesh-list
101393802|NCT03584711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101393803|NCT03584711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393804|NCT03578367|Niacinamide|niacinamide|mesh-list
101393805|NCT03578367|Imatinib Mesylate|imatinib mesylate|mesh-list
101393806|NCT03578367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393807|NCT03578367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101393808|NCT03578367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101393809|NCT03578367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393810|NCT03578367|Vitamin B Complex|vitamin b complex|mesh-ancestor
101393811|NCT03578367|Vitamins|vitamins|mesh-ancestor
101393812|NCT03578367|Micronutrients|micronutrients|mesh-ancestor
101393836|NCT03548064|Immunologic Factors|immunologic factors|mesh-ancestor
101393837|NCT03548064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393838|NCT03535350|Temozolomide|temozolomide|mesh-list
101393844|NCT03527108|Ramucirumab|ramucirumab|mesh-list
101393845|NCT03527108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101393846|NCT03527108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393847|NCT03527108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101393848|NCT03527108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393849|NCT03514069|Temozolomide|temozolomide|mesh-list
101393850|NCT03514069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101393851|NCT03514069|Alkylating Agents|alkylating agents|mesh-ancestor
101393852|NCT03514069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393853|NCT03514069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393854|NCT03512197|Midostaurin|midostaurin|mesh-list
101393855|NCT03512197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393856|NCT03512197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101393857|NCT03512197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101190715|NCT00005574|Gentamicins|gentamicins|mesh-list
101393870|NCT03492177|Selexipag|selexipag|mesh-list
101393871|NCT03492177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101393872|NCT03471260|Azacitidine|azacitidine|mesh-list
101393873|NCT03471260|Venetoclax|venetoclax|mesh-list
101393874|NCT03471260|Ivosidenib|ivosidenib|mesh-list
101393875|NCT03471260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101393876|NCT03471260|Antimetabolites|antimetabolites|mesh-ancestor
101393877|NCT03471260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393878|NCT03471260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393879|NCT03471260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102074592|NCT02115204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102074593|NCT02115204|Immunologic Factors|immunologic factors|mesh-ancestor
102074594|NCT02115204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074595|NCT02115204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102074596|NCT02115204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102074597|NCT02115204|Alkylating Agents|alkylating agents|mesh-ancestor
102074598|NCT02115204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393886|NCT03467373|Prednisone|prednisone|mesh-list
101393887|NCT03467373|Cyclophosphamide|cyclophosphamide|mesh-list
101393888|NCT03467373|Rituximab|rituximab|mesh-list
101393889|NCT03467373|Doxorubicin|doxorubicin|mesh-list
101393890|NCT03467373|Vincristine|vincristine|mesh-list
101393891|NCT03467373|Obinutuzumab|obinutuzumab|mesh-list
101393892|NCT03467373|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
101393893|NCT03467373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101305657|NCT02021097|Hormones|hormones|mesh-ancestor
101305658|NCT02021097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101305659|NCT02021097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333850|NCT00041275|Appetite Stimulants|appetite stimulants|mesh-ancestor
101393894|NCT03467373|Immunologic Factors|immunologic factors|mesh-ancestor
101393895|NCT03467373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393896|NCT03467373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101393897|NCT03467373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101393898|NCT03467373|Alkylating Agents|alkylating agents|mesh-ancestor
101393899|NCT03467373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393900|NCT03467373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393901|NCT03467373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101393902|NCT03467373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101393903|NCT03467373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101393904|NCT03467373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101393905|NCT03467373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101393906|NCT03467373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101393907|NCT03467373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101393911|NCT03467373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101393912|NCT03467373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101393913|NCT03467373|Tubulin Modulators|tubulin modulators|mesh-ancestor
101393914|NCT03467373|Antimitotic Agents|antimitotic agents|mesh-ancestor
101393915|NCT03467373|Mitosis Modulators|mitosis modulators|mesh-ancestor
101393916|NCT03467373|Immunoconjugates|immunoconjugates|mesh-ancestor
101393917|NCT03463057|Atezolizumab|atezolizumab|mesh-list
101393918|NCT03463057|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101393922|NCT03460756|Ganaxolone|ganaxolone|mesh-list
101393923|NCT03460756|Neurosteroids|neurosteroids|mesh-ancestor
101393924|NCT03460756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101393925|NCT03460756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393926|NCT03460756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393927|NCT03460756|GABA Modulators|gaba modulators|mesh-ancestor
101393928|NCT03460756|GABA Agents|gaba agents|mesh-ancestor
101393929|NCT03457948|Pembrolizumab|pembrolizumab|mesh-list
101393930|NCT03457948|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
101393931|NCT03457948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101393932|NCT03457948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393933|NCT03457948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101393934|NCT03457948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393935|NCT03457948|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101393936|NCT03451851|Etanercept|etanercept|mesh-list
101393937|NCT03451851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101393938|NCT03451851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101393939|NCT03451851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101393940|NCT03451851|Analgesics|analgesics|mesh-ancestor
101393941|NCT03451851|Sensory System Agents|sensory system agents|mesh-ancestor
101393942|NCT03451851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102074599|NCT02115204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102074600|NCT02115204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102074601|NCT02115204|Tubulin Modulators|tubulin modulators|mesh-ancestor
102074602|NCT02115204|Antimitotic Agents|antimitotic agents|mesh-ancestor
101489358|NCT00437892|Atorvastatin|atorvastatin|mesh-list
101393943|NCT03451851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393944|NCT03451851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101393945|NCT03451851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101393946|NCT03451851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101393947|NCT03451851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101393948|NCT03451851|Immunologic Factors|immunologic factors|mesh-ancestor
101393949|NCT03443999|Sirolimus|sirolimus|mesh-list
101393950|NCT03443999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101393951|NCT03443999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101393952|NCT03443999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101393953|NCT03443999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393954|NCT03443999|Antifungal Agents|antifungal agents|mesh-ancestor
101393955|NCT03443999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101393956|NCT03443999|Immunologic Factors|immunologic factors|mesh-ancestor
101393957|NCT03443999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393958|NCT03431350|Prednisone|prednisone|mesh-list
101393959|NCT03431350|Abiraterone Acetate|abiraterone acetate|mesh-list
101393960|NCT03431350|Niraparib|niraparib|mesh-list
101393961|NCT03431350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101305660|NCT02021097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101393962|NCT03431350|Glucocorticoids|glucocorticoids|mesh-ancestor
101393963|NCT03431350|Hormones|hormones|mesh-ancestor
101393964|NCT03431350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101393965|NCT03431350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393966|NCT03431350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101393967|NCT03431350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393968|NCT03431350|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101393969|NCT03431350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101393970|NCT03431350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393971|NCT03431350|Hormone Antagonists|hormone antagonists|mesh-ancestor
101393972|NCT03431350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101393973|NCT03431350|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101393974|NCT03430297|Dacarbazine|dacarbazine|mesh-list
101393975|NCT03430297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101393976|NCT03430297|Alkylating Agents|alkylating agents|mesh-ancestor
101393977|NCT03430297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393979|NCT03425838|Letrozole|letrozole|mesh-list
101393980|NCT03425838|Fulvestrant|fulvestrant|mesh-list
101393981|NCT03425838|Palbociclib|palbociclib|mesh-list
101393982|NCT03425838|Anastrozole|anastrozole|mesh-list
101393983|NCT03425838|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101393984|NCT03425838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393985|NCT03425838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101393986|NCT03425838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101393987|NCT03425838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393988|NCT03425838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101394017|NCT03407144|Dacarbazine|dacarbazine|mesh-list
101394018|NCT03407144|Doxorubicin|doxorubicin|mesh-list
101394019|NCT03407144|Pembrolizumab|pembrolizumab|mesh-list
101394020|NCT03407144|Etoposide|etoposide|mesh-list
101394021|NCT03407144|Etoposide phosphate|etoposide phosphate|mesh-list
101394022|NCT03407144|Vincristine|vincristine|mesh-list
101394023|NCT03407144|Bleomycin|bleomycin|mesh-list
101394024|NCT03407144|Vinblastine|vinblastine|mesh-list
101394025|NCT03407144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101394026|NCT03407144|Immunologic Factors|immunologic factors|mesh-ancestor
101394027|NCT03407144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394028|NCT03407144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101394029|NCT03407144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101394030|NCT03407144|Alkylating Agents|alkylating agents|mesh-ancestor
101334557|NCT00044785|Leucovorin|leucovorin|mesh-list
101394031|NCT03407144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394032|NCT03407144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394033|NCT03407144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101305661|NCT02021097|Contraceptive Agents|contraceptive agents|mesh-ancestor
101180940|NCT02530476|Sorafenib|sorafenib|mesh-list
101394034|NCT03407144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101394035|NCT03407144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102074603|NCT02115204|Mitosis Modulators|mitosis modulators|mesh-ancestor
102074604|NCT02115204|Antimetabolites|antimetabolites|mesh-ancestor
102074605|NCT02115204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102074606|NCT02115204|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102074607|NCT02115204|Abortifacient Agents|abortifacient agents|mesh-ancestor
102074608|NCT02115204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102074609|NCT02115204|Dermatologic Agents|dermatologic agents|mesh-ancestor
102074610|NCT02115204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101394036|NCT03407144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101394037|NCT03407144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101394038|NCT03407144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101394039|NCT03407144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101394040|NCT03407144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101394041|NCT03407144|Glucocorticoids|glucocorticoids|mesh-ancestor
101394042|NCT03407144|Hormones|hormones|mesh-ancestor
101394043|NCT03407144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101394044|NCT03407144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101394045|NCT03407144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101394046|NCT03407144|Tubulin Modulators|tubulin modulators|mesh-ancestor
101394047|NCT03407144|Antimitotic Agents|antimitotic agents|mesh-ancestor
101394048|NCT03407144|Mitosis Modulators|mitosis modulators|mesh-ancestor
101394049|NCT03399981|Natalizumab|natalizumab|mesh-list
101394050|NCT03399981|Immunologic Factors|immunologic factors|mesh-ancestor
101394051|NCT03399981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394061|NCT03382834|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101394062|NCT03382834|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101394063|NCT03382834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101394064|NCT03382834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101394065|NCT03382834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101394066|NCT03382834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394067|NCT03382834|Antiviral Agents|antiviral agents|mesh-ancestor
101394068|NCT03382834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101394069|NCT03374800|Pantoprazole|pantoprazole|mesh-list
101394070|NCT03374800|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101394071|NCT03374800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101394072|NCT03374800|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101394073|NCT03374800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101394074|NCT03374800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394075|NCT03374085|Dexamethasone|dexamethasone|mesh-list
101394077|NCT03374085|Antiemetics|antiemetics|mesh-ancestor
101394078|NCT03374085|Autonomic Agents|autonomic agents|mesh-ancestor
101394079|NCT03374085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101394080|NCT03374085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394081|NCT03374085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101394082|NCT03374085|Glucocorticoids|glucocorticoids|mesh-ancestor
101394083|NCT03374085|Hormones|hormones|mesh-ancestor
101394084|NCT03374085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101394085|NCT03374085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101394086|NCT03374085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394087|NCT03367156|Dexamethasone|dexamethasone|mesh-list
101394088|NCT03367156|Dexamethasone acetate|dexamethasone acetate|mesh-list
101394089|NCT03367156|Ichthammol|ichthammol|mesh-list
101394090|NCT03367156|BB 1101|bb 1101|mesh-list
101394091|NCT03367156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101394092|NCT03367156|Antiemetics|antiemetics|mesh-ancestor
101394093|NCT03367156|Autonomic Agents|autonomic agents|mesh-ancestor
101394094|NCT03367156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101334567|NCT00044785|Antidotes|antidotes|mesh-ancestor
101394095|NCT03367156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394096|NCT03367156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101394097|NCT03367156|Glucocorticoids|glucocorticoids|mesh-ancestor
101394098|NCT03367156|Hormones|hormones|mesh-ancestor
101394099|NCT03367156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101394100|NCT03367156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101394101|NCT03367156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394102|NCT03367156|Protease Inhibitors|protease inhibitors|mesh-ancestor
102074611|NCT02115204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102074612|NCT02115204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102074613|NCT02115204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102074614|NCT02115204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101394103|NCT03367156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101394104|NCT03367156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394105|NCT03367156|Dermatologic Agents|dermatologic agents|mesh-ancestor
101394106|NCT03367013|Lactoferrin|lactoferrin|mesh-list
101394107|NCT03367013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101394108|NCT03336398|Ketamine|ketamine|mesh-list
101394109|NCT03336398|Analgesics|analgesics|mesh-ancestor
101305662|NCT02021097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101305663|NCT02021097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101305664|NCT02021097|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101394110|NCT03336398|Sensory System Agents|sensory system agents|mesh-ancestor
101394111|NCT03336398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101394112|NCT03336398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394113|NCT03336398|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101394114|NCT03336398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101394115|NCT03336398|Anesthetics, General|anesthetics, general|mesh-ancestor
101394116|NCT03336398|Anesthetics|anesthetics|mesh-ancestor
101394117|NCT03336398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101394118|NCT03336398|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101394119|NCT03336398|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101394120|NCT03336398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101394121|NCT03336398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394129|NCT03332667|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101394130|NCT03332667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101394131|NCT03332667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394132|NCT03332667|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101394133|NCT03331731|Pembrolizumab|pembrolizumab|mesh-list
101394134|NCT03331731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101394135|NCT03331731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394136|NCT03331731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101394137|NCT03331731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394138|NCT03322995|Fluorouracil|fluorouracil|mesh-list
101394139|NCT03322995|Antimetabolites|antimetabolites|mesh-ancestor
101394140|NCT03322995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394141|NCT03322995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101394142|NCT03322995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394143|NCT03322995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101394144|NCT03322995|Immunologic Factors|immunologic factors|mesh-ancestor
101394145|NCT03322995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394146|NCT03319498|Peppermint oil|peppermint oil|mesh-list
101394147|NCT03319498|Mineral Oil|mineral oil|mesh-list
101394148|NCT03319498|Antiemetics|antiemetics|mesh-ancestor
101394149|NCT03319498|Autonomic Agents|autonomic agents|mesh-ancestor
101394150|NCT03319498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101394151|NCT03319498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394152|NCT03319498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101394153|NCT03319498|Parasympatholytics|parasympatholytics|mesh-ancestor
101394154|NCT03319498|Emollients|emollients|mesh-ancestor
101394155|NCT03319498|Dermatologic Agents|dermatologic agents|mesh-ancestor
101394156|NCT03291847|Buprenorphine|buprenorphine|mesh-list
101394157|NCT03291847|Methadone|methadone|mesh-list
101394158|NCT03291847|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101394159|NCT03291847|Naloxone|naloxone|mesh-list
101394160|NCT03291847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101394161|NCT03291847|Narcotics|narcotics|mesh-ancestor
101394162|NCT03291847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101394163|NCT03291847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394164|NCT03291847|Analgesics|analgesics|mesh-ancestor
101394165|NCT03291847|Sensory System Agents|sensory system agents|mesh-ancestor
101394166|NCT03291847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101394167|NCT03291847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101394168|NCT03291847|Antitussive Agents|antitussive agents|mesh-ancestor
101394169|NCT03291847|Respiratory System Agents|respiratory system agents|mesh-ancestor
101394170|NCT03289962|Atezolizumab|atezolizumab|mesh-list
101394171|NCT03289962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102074615|NCT02115204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102074616|NCT02115360|Calcitonin|calcitonin|mesh-list
102074617|NCT02115360|Salmon calcitonin|salmon calcitonin|mesh-list
102074618|NCT02115360|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
102074619|NCT02115360|Fentanyl|fentanyl|mesh-list
102074620|NCT02115360|Katacalcin|katacalcin|mesh-list
102074621|NCT02115360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102074622|NCT02115360|Narcotics|narcotics|mesh-ancestor
102074623|NCT02115360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102074624|NCT02115360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074625|NCT02115360|Analgesics|analgesics|mesh-ancestor
102074626|NCT02115360|Sensory System Agents|sensory system agents|mesh-ancestor
102074627|NCT02115360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102074628|NCT02115360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102074629|NCT02115360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102074630|NCT02115360|Anesthetics, General|anesthetics, general|mesh-ancestor
102074631|NCT02115360|Anesthetics|anesthetics|mesh-ancestor
102074632|NCT02115360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102074633|NCT02115360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102074634|NCT02115360|Vasodilator Agents|vasodilator agents|mesh-ancestor
102074635|NCT02432404|NuvaRing|nuvaring|mesh-list
102074636|NCT02432404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102074637|NCT02432404|Contraceptive Agents|contraceptive agents|mesh-ancestor
102074638|NCT02432404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101376298|NCT00238225|Vitamins|vitamins|mesh-ancestor
101394172|NCT03289962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394173|NCT03289962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101394174|NCT03289962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394175|NCT03283384|Letrozole|letrozole|mesh-list
101394176|NCT03283384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394177|NCT03283384|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101394178|NCT03283384|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101305665|NCT02021097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101305666|NCT02021097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101305667|NCT02021110|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101305668|NCT02021110|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101394179|NCT03283384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101394180|NCT03283384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394181|NCT03283384|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101394182|NCT03283384|Hormone Antagonists|hormone antagonists|mesh-ancestor
101394183|NCT03283384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101394184|NCT03283384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394185|NCT03260504|Aldesleukin|aldesleukin|mesh-list
101394186|NCT03260504|Pembrolizumab|pembrolizumab|mesh-list
101394187|NCT03260504|Interleukin-2|interleukin-2|mesh-list
101394188|NCT03260504|Immunoglobulins|immunoglobulins|mesh-list
101394189|NCT03260504|Immunoglobulin G|immunoglobulin g|mesh-list
101394193|NCT03260504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394194|NCT03260504|Immunologic Factors|immunologic factors|mesh-ancestor
101394195|NCT03260504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394196|NCT03260504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102074639|NCT02432404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074640|NCT02113176|Minocycline|minocycline|mesh-list
102074641|NCT02113176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102074642|NCT02113176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102074643|NCT02118870|Aspirin|aspirin|mesh-list
102074644|NCT02118870|Clopidogrel|clopidogrel|mesh-list
102074645|NCT02118870|Ticagrelor|ticagrelor|mesh-list
102074646|NCT02118870|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102074647|NCT02118870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102074648|NCT02118870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102074649|NCT02118870|Analgesics|analgesics|mesh-ancestor
102074650|NCT02118870|Sensory System Agents|sensory system agents|mesh-ancestor
101376322|NCT00098280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394212|NCT03247088|Cyclophosphamide|cyclophosphamide|mesh-list
101394213|NCT03247088|Busulfan|busulfan|mesh-list
101394214|NCT03247088|Fludarabine|fludarabine|mesh-list
101394215|NCT03247088|Sorafenib|sorafenib|mesh-list
101394216|NCT03247088|Tacrolimus|tacrolimus|mesh-list
101394217|NCT03247088|Lenograstim|lenograstim|mesh-list
101394218|NCT03247088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101394219|NCT03247088|Immunologic Factors|immunologic factors|mesh-ancestor
101394220|NCT03247088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394221|NCT03247088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101394222|NCT03247088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101394223|NCT03247088|Alkylating Agents|alkylating agents|mesh-ancestor
101394224|NCT03247088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394225|NCT03247088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394226|NCT03247088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101394227|NCT03247088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101394228|NCT03247088|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101394229|NCT03247088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101394230|NCT03247088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101394231|NCT03247088|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101394232|NCT03247088|Antitubercular Agents|antitubercular agents|mesh-ancestor
101394233|NCT03247088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101394234|NCT03247088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101394235|NCT03247088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101394236|NCT03246074|Paclitaxel|paclitaxel|mesh-list
101394237|NCT03246074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101394238|NCT03246074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394239|NCT03246074|Tubulin Modulators|tubulin modulators|mesh-ancestor
101394240|NCT03246074|Antimitotic Agents|antimitotic agents|mesh-ancestor
101394241|NCT03246074|Mitosis Modulators|mitosis modulators|mesh-ancestor
101394242|NCT03246074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394243|NCT03225664|Pembrolizumab|pembrolizumab|mesh-list
101394244|NCT03225664|Trametinib|trametinib|mesh-list
101394245|NCT03225664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101394246|NCT03225664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394247|NCT03225664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101394248|NCT03225664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394249|NCT03225664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101394250|NCT03225664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101394251|NCT03216967|Everolimus|everolimus|mesh-list
101394252|NCT03216967|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101394253|NCT03216967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101394254|NCT03216967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101394255|NCT03216967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394256|NCT03216967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101394257|NCT03216967|Immunologic Factors|immunologic factors|mesh-ancestor
101394258|NCT03216967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394259|NCT03216967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394293|NCT03201965|Alkylating Agents|alkylating agents|mesh-ancestor
101305669|NCT02021110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101305670|NCT02021123|Anidulafungin|anidulafungin|mesh-list
102074651|NCT02118870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102074652|NCT02118870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074653|NCT02118870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102074654|NCT02118870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102074655|NCT02118870|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102074656|NCT02118870|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102074657|NCT02118870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074658|NCT02118870|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102074659|NCT02118870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102074660|NCT02118870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102074661|NCT02118870|Antipyretics|antipyretics|mesh-ancestor
102074662|NCT02118870|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102074663|NCT02118870|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102074664|NCT02118870|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102074665|NCT02118870|Purinergic Agents|purinergic agents|mesh-ancestor
102074666|NCT02118870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102074667|NCT03552666|Vitamin D|vitamin d|mesh-list
102074668|NCT03552666|Cholecalciferol|cholecalciferol|mesh-list
102074669|NCT03552666|Vitamins|vitamins|mesh-ancestor
102074670|NCT03552666|Micronutrients|micronutrients|mesh-ancestor
102074671|NCT03552666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074672|NCT03552666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101305671|NCT02021123|Antifungal Agents|antifungal agents|mesh-ancestor
101305672|NCT02021123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101305673|NCT02021201|Risperidone|risperidone|mesh-list
101305674|NCT02021201|Sertindole|sertindole|mesh-list
101305675|NCT02021201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101181170|NCT05249556|Ganaxolone|ganaxolone|mesh-list
101394294|NCT03201965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394295|NCT03201965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394296|NCT03201965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101394297|NCT03201965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101394298|NCT03201965|Antiemetics|antiemetics|mesh-ancestor
101394299|NCT03201965|Autonomic Agents|autonomic agents|mesh-ancestor
101394300|NCT03201965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101394301|NCT03201965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101394308|NCT03182244|Etoposide|etoposide|mesh-list
101394309|NCT03182244|Mitoxantrone|mitoxantrone|mesh-list
101394310|NCT03182244|Lenograstim|lenograstim|mesh-list
101394311|NCT03182244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394312|NCT03182244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101394313|NCT03182244|Antimetabolites|antimetabolites|mesh-ancestor
101394314|NCT03182244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394315|NCT03182244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101394316|NCT03182244|Immunologic Factors|immunologic factors|mesh-ancestor
101394317|NCT03182244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394318|NCT03182244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101394319|NCT03182244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101394320|NCT03182244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101394321|NCT03182244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101394322|NCT03182244|Antiviral Agents|antiviral agents|mesh-ancestor
101394323|NCT03182244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101394324|NCT03182244|Analgesics|analgesics|mesh-ancestor
102074686|NCT05125042|Amiodarone|amiodarone|mesh-list
102074687|NCT05125042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102074688|NCT05125042|Vasodilator Agents|vasodilator agents|mesh-ancestor
102074689|NCT05125042|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102074690|NCT05125042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102074691|NCT05125042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074692|NCT05125042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101394325|NCT03182244|Sensory System Agents|sensory system agents|mesh-ancestor
101394326|NCT03182244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101394327|NCT03182244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101394328|NCT03164928|Denosumab|denosumab|mesh-list
101394329|NCT03164928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101394330|NCT03164928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394331|NCT03132467|Durvalumab|durvalumab|mesh-list
101394332|NCT03132467|Ipilimumab|ipilimumab|mesh-list
101394333|NCT03132467|Tremelimumab|tremelimumab|mesh-list
101394334|NCT03132467|Immunoglobulins|immunoglobulins|mesh-list
101394339|NCT03132467|Immunologic Factors|immunologic factors|mesh-ancestor
101394340|NCT03132467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394341|NCT03132467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101394342|NCT03132467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394391|NCT03118492|Immunologic Factors|immunologic factors|mesh-ancestor
101394392|NCT03118492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394393|NCT03118492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101394394|NCT03118492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101394395|NCT03118492|Alkylating Agents|alkylating agents|mesh-ancestor
101394396|NCT03118492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394397|NCT03118492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394398|NCT03118492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101394399|NCT03118492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101394400|NCT03118492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101394401|NCT03118492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101394402|NCT03118492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101394403|NCT03118492|Antitubercular Agents|antitubercular agents|mesh-ancestor
101394404|NCT03118492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101394405|NCT03118492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101394406|NCT03107793|Ustekinumab|ustekinumab|mesh-list
101394407|NCT03107793|Dermatologic Agents|dermatologic agents|mesh-ancestor
101394435|NCT02973789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101394436|NCT02973789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394437|NCT02973789|Tubulin Modulators|tubulin modulators|mesh-ancestor
101394439|NCT02973789|Mitosis Modulators|mitosis modulators|mesh-ancestor
101394440|NCT02973789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305677|NCT02021201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101305678|NCT02021201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394441|NCT02973789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101394442|NCT02971748|Pembrolizumab|pembrolizumab|mesh-list
101394443|NCT02971748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101394444|NCT02971748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394445|NCT02971748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101394446|NCT02971748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394461|NCT02959619|Ensartinib|ensartinib|mesh-list
101394462|NCT02959619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394463|NCT02959619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101394464|NCT02959619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101394465|NCT02959619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394466|NCT02912715|Paclitaxel|paclitaxel|mesh-list
101394467|NCT02912715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101394468|NCT02912715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394469|NCT02912715|Tubulin Modulators|tubulin modulators|mesh-ancestor
101394470|NCT02912715|Antimitotic Agents|antimitotic agents|mesh-ancestor
101394471|NCT02912715|Mitosis Modulators|mitosis modulators|mesh-ancestor
101394472|NCT02912715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394473|NCT02908685|Risdiplam|risdiplam|mesh-list
101394474|NCT02908685|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101394475|NCT02908685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101394476|NCT02908685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394477|NCT02886962|Vitamin K|vitamin k|mesh-list
101394478|NCT02886962|Vitamins|vitamins|mesh-ancestor
101394496|NCT02885753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101394497|NCT02885753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101394498|NCT02885753|Growth Substances|growth substances|mesh-ancestor
101394499|NCT02885753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394500|NCT02885753|Growth Inhibitors|growth inhibitors|mesh-ancestor
101334613|NCT00001649|Valacyclovir|valacyclovir|mesh-list
101394501|NCT02885753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101394502|NCT02885753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101394503|NCT02885753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101394504|NCT02885753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376418|NCT00239161|Levofloxacin|levofloxacin|mesh-list
102074713|NCT02918877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102074714|NCT02918877|Anesthetics, General|anesthetics, general|mesh-ancestor
102074715|NCT02918877|Anesthetics|anesthetics|mesh-ancestor
102074716|NCT02918877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102074717|NCT02918877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102074718|NCT03652857|Apatinib|apatinib|mesh-list
102074719|NCT03652857|Vinorelbine|vinorelbine|mesh-list
102074720|NCT03652857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102074721|NCT03652857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102074722|NCT03652857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102074723|NCT03652857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074724|NCT03652857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102074725|NCT03652857|Tubulin Modulators|tubulin modulators|mesh-ancestor
102074726|NCT03652857|Antimitotic Agents|antimitotic agents|mesh-ancestor
101794475|NCT00866216|Azithromycin|azithromycin|mesh-list
102074727|NCT03652857|Mitosis Modulators|mitosis modulators|mesh-ancestor
102074728|NCT05129410|Mycophenolic Acid|mycophenolic acid|mesh-list
102074729|NCT05129410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102074730|NCT05129410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102074731|NCT05129410|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102074732|NCT05129410|Antitubercular Agents|antitubercular agents|mesh-ancestor
102074733|NCT05129410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101394505|NCT02885753|Antimetabolites|antimetabolites|mesh-ancestor
101394506|NCT02885753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101394507|NCT02885753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101394508|NCT02885753|Immunologic Factors|immunologic factors|mesh-ancestor
101394510|NCT02885753|Protective Agents|protective agents|mesh-ancestor
101394511|NCT02885753|Vitamin B Complex|vitamin b complex|mesh-ancestor
101394512|NCT02885753|Vitamins|vitamins|mesh-ancestor
101394513|NCT02885753|Micronutrients|micronutrients|mesh-ancestor
101394514|NCT02885753|Hematinics|hematinics|mesh-ancestor
101394515|NCT02861573|Dexamethasone|dexamethasone|mesh-list
101394516|NCT02861573|Prednisone|prednisone|mesh-list
101394517|NCT02861573|Carboplatin|carboplatin|mesh-list
101394518|NCT02861573|Docetaxel|docetaxel|mesh-list
101394519|NCT02861573|Pembrolizumab|pembrolizumab|mesh-list
101394520|NCT02861573|Etoposide|etoposide|mesh-list
101394521|NCT02861573|Lenvatinib|lenvatinib|mesh-list
101394522|NCT02861573|Olaparib|olaparib|mesh-list
101394523|NCT02861573|Abiraterone Acetate|abiraterone acetate|mesh-list
101394524|NCT02861573|Belzutifan|belzutifan|mesh-list
101394525|NCT02861573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101394526|NCT02861573|Antiemetics|antiemetics|mesh-ancestor
101394527|NCT02861573|Autonomic Agents|autonomic agents|mesh-ancestor
101394528|NCT02861573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101394529|NCT02861573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305679|NCT02021201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305680|NCT02021201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101305681|NCT02021201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101394530|NCT02861573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101394531|NCT02861573|Glucocorticoids|glucocorticoids|mesh-ancestor
101394533|NCT02861573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101394534|NCT02861573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101394535|NCT02861573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102074734|NCT05129410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102074735|NCT05129410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102074736|NCT05129410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074737|NCT04221555|Docetaxel|docetaxel|mesh-list
102074738|NCT04221555|Oxaliplatin|oxaliplatin|mesh-list
102074739|NCT04221555|Durvalumab|durvalumab|mesh-list
102074740|NCT04221555|Tremelimumab|tremelimumab|mesh-list
102074741|NCT04221555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102074742|NCT04221555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334631|NCT00018291|Antimanic Agents|antimanic agents|mesh-ancestor
102074743|NCT04221555|Tubulin Modulators|tubulin modulators|mesh-ancestor
102074744|NCT04221555|Antimitotic Agents|antimitotic agents|mesh-ancestor
102074745|NCT04221555|Mitosis Modulators|mitosis modulators|mesh-ancestor
102074746|NCT04221555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074747|NCT04221555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102074748|NCT04221555|Immunologic Factors|immunologic factors|mesh-ancestor
102074749|NCT04221555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074750|NCT02113566|Acetaminophen|acetaminophen|mesh-list
102074751|NCT02113566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102074752|NCT02113566|Analgesics|analgesics|mesh-ancestor
101394536|NCT02861573|Tubulin Modulators|tubulin modulators|mesh-ancestor
101394537|NCT02861573|Antimitotic Agents|antimitotic agents|mesh-ancestor
101394538|NCT02861573|Mitosis Modulators|mitosis modulators|mesh-ancestor
101394539|NCT02861573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394554|NCT02854436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394556|NCT02815592|Carboplatin|carboplatin|mesh-list
101394557|NCT02815592|Etoposide|etoposide|mesh-list
101394558|NCT02815592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394559|NCT02815592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101394560|NCT02815592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101394561|NCT02815592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101394562|NCT02815592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101394563|NCT02815592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394564|NCT02790853|Proflavine|proflavine|mesh-list
101394565|NCT02790853|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101394566|NCT02790853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101394567|NCT02780583|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101394568|NCT02780583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101394569|NCT02759419|Riociguat|riociguat|mesh-list
101394570|NCT02759419|Enzyme Activators|enzyme activators|mesh-ancestor
101394571|NCT02759419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394572|NCT02754583|Azithromycin|azithromycin|mesh-list
101394573|NCT02754583|Tetracycline|tetracycline|mesh-list
101394574|NCT02754583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101394575|NCT02754583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101394576|NCT02754583|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101394577|NCT02754583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101394578|NCT02754583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394579|NCT02741323|Maraviroc|maraviroc|mesh-list
101394580|NCT02741323|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101394581|NCT02741323|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101394582|NCT02741323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394583|NCT02741323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101394584|NCT02741323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101394585|NCT02741323|Antiviral Agents|antiviral agents|mesh-ancestor
101394586|NCT02741323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101394587|NCT02741323|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
102074753|NCT02113566|Sensory System Agents|sensory system agents|mesh-ancestor
102074754|NCT02113566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102074755|NCT02113566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074756|NCT02113566|Antipyretics|antipyretics|mesh-ancestor
102074757|NCT05124730|Metformin|metformin|mesh-list
102074758|NCT05124730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102074759|NCT05124730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074760|NCT02251626|Ubiquinone|ubiquinone|mesh-list
102074761|NCT02251626|Coenzyme Q10|coenzyme q10|mesh-list
102074762|NCT02251626|Micronutrients|micronutrients|mesh-ancestor
102074763|NCT02251626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074764|NCT02251626|Vitamins|vitamins|mesh-ancestor
102074765|NCT02123004|Clopidogrel|clopidogrel|mesh-list
102074766|NCT02123004|Ticagrelor|ticagrelor|mesh-list
102074767|NCT02123004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102074768|NCT02123004|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102074769|NCT02123004|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102074770|NCT02123004|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102074771|NCT02123004|Purinergic Agents|purinergic agents|mesh-ancestor
102074772|NCT02123004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102074773|NCT02123004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074774|NCT02123004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074775|NCT01674712|Simvastatin|simvastatin|mesh-list
102074776|NCT01674712|Fenofibrate|fenofibrate|mesh-list
102074777|NCT01674712|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102074778|NCT01674712|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102074779|NCT01674712|Antimetabolites|antimetabolites|mesh-ancestor
102074780|NCT01674712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074781|NCT01674712|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102074782|NCT01674712|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102074783|NCT01674712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102074784|NCT01368432|Escitalopram|escitalopram|mesh-list
101376438|NCT02961829|Vaccines|vaccines|mesh-list
101394588|NCT02726997|Paclitaxel|paclitaxel|mesh-list
101394589|NCT02726997|Carboplatin|carboplatin|mesh-list
101394590|NCT02726997|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101394591|NCT02726997|Durvalumab|durvalumab|mesh-list
101394592|NCT02726997|Immunoglobulins|immunoglobulins|mesh-list
101394593|NCT02726997|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101394594|NCT02726997|Immunoglobulin G|immunoglobulin g|mesh-list
101394595|NCT02726997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101394596|NCT02726997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394597|NCT02726997|Tubulin Modulators|tubulin modulators|mesh-ancestor
102074785|NCT01368432|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102074786|NCT01368432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102074787|NCT01368432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102074788|NCT01368432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074789|NCT01368432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102074790|NCT01368432|Serotonin Agents|serotonin agents|mesh-ancestor
102074791|NCT01368432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074792|NCT05122780|Acetylcholine|acetylcholine|mesh-list
102074793|NCT05122780|Anticoagulants|anticoagulants|mesh-list
102074794|NCT05122780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
102074795|NCT05122780|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
102074796|NCT05122780|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101376474|NCT00239278|Prednisolone|prednisolone|mesh-list
101394598|NCT02726997|Antimitotic Agents|antimitotic agents|mesh-ancestor
101394599|NCT02726997|Mitosis Modulators|mitosis modulators|mesh-ancestor
101394600|NCT02726997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394601|NCT02726997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101394602|NCT02726997|Immunologic Factors|immunologic factors|mesh-ancestor
101394603|NCT02726997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394604|NCT02703220|Acetazolamide|acetazolamide|mesh-list
101394605|NCT02703220|Finasteride|finasteride|mesh-list
101394616|NCT02703220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101394617|NCT02703220|Urological Agents|urological agents|mesh-ancestor
101305682|NCT02021201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101305683|NCT02021201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101305684|NCT02021201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101305685|NCT02021201|Dopamine Agents|dopamine agents|mesh-ancestor
101305686|NCT02021214|Methylphenidate|methylphenidate|mesh-list
101394618|NCT02677051|Sulforaphane|sulforaphane|mesh-list
101394619|NCT02677051|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101394620|NCT02677051|Protective Agents|protective agents|mesh-ancestor
101394621|NCT02677051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394622|NCT02677051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394624|NCT02638701|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101394635|NCT02615184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394636|NCT02595866|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101394637|NCT02595866|Pembrolizumab|pembrolizumab|mesh-list
101394638|NCT02595866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101394639|NCT02595866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394640|NCT02595866|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101394641|NCT02595866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394642|NCT02595866|Antiviral Agents|antiviral agents|mesh-ancestor
101394643|NCT02595866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101394651|NCT02520063|Everolimus|everolimus|mesh-list
101394652|NCT02520063|Letrozole|letrozole|mesh-list
101394653|NCT02520063|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101394654|NCT02520063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101394655|NCT02520063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101394656|NCT02520063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394657|NCT02520063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101394658|NCT02520063|Immunologic Factors|immunologic factors|mesh-ancestor
101394659|NCT02520063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394660|NCT02520063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394661|NCT02520063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101394662|NCT02520063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101394663|NCT02520063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101394664|NCT02520063|Hormone Antagonists|hormone antagonists|mesh-ancestor
101394665|NCT02520063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101394666|NCT02494258|Azacitidine|azacitidine|mesh-list
102074797|NCT05122780|Adrenergic Agents|adrenergic agents|mesh-ancestor
102074798|NCT05122780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102074799|NCT05122780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074800|NCT05122780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794546|NCT05355597|Analgesics|analgesics|mesh-ancestor
102074801|NCT05122780|Vasodilator Agents|vasodilator agents|mesh-ancestor
102074802|NCT05122780|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102074803|NCT05122780|Cholinergic Agents|cholinergic agents|mesh-ancestor
102074804|NCT02119806|Fentanyl|fentanyl|mesh-list
102074805|NCT02119806|Midazolam|midazolam|mesh-list
102074806|NCT02119806|Propofol|propofol|mesh-list
102074807|NCT02119806|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102074808|NCT02119806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102074809|NCT02119806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074810|NCT02119806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102074811|NCT02119806|Anesthetics, General|anesthetics, general|mesh-ancestor
102074812|NCT02119806|Anesthetics|anesthetics|mesh-ancestor
102074813|NCT02119806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102074814|NCT02119806|Narcotics|narcotics|mesh-ancestor
102074815|NCT02119806|Analgesics|analgesics|mesh-ancestor
102074816|NCT02119806|Sensory System Agents|sensory system agents|mesh-ancestor
102074817|NCT02119806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102074818|NCT02119806|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101376495|NCT00239395|Meloxicam|meloxicam|mesh-list
101394667|NCT02494258|Cc-486|cc-486|mesh-list
101394668|NCT02494258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101394669|NCT02494258|Antimetabolites|antimetabolites|mesh-ancestor
101394670|NCT02494258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394683|NCT02484404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101394684|NCT02484404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394685|NCT02484404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101394687|NCT02480803|Carbidopa|carbidopa|mesh-list
101394688|NCT02480803|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101394689|NCT02480803|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101394690|NCT02480803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101394691|NCT02480803|Dopamine Agents|dopamine agents|mesh-ancestor
101394692|NCT02480803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101394693|NCT02480803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394694|NCT02480803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305688|NCT02021214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394695|NCT02480803|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101394696|NCT02480803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101394697|NCT02480803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101394698|NCT02480803|Immunologic Factors|immunologic factors|mesh-ancestor
101394699|NCT02480803|Dopamine Agonists|dopamine agonists|mesh-ancestor
101394700|NCT02475681|Obinutuzumab|obinutuzumab|mesh-list
101394701|NCT02475681|Acalabrutinib|acalabrutinib|mesh-list
101394702|NCT02475681|Chlorambucil|chlorambucil|mesh-list
101394703|NCT02475681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101394704|NCT02475681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394705|NCT02475681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101394706|NCT02475681|Alkylating Agents|alkylating agents|mesh-ancestor
102074819|NCT02119806|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102074820|NCT02119806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102074821|NCT02119806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102074822|NCT02119806|GABA Modulators|gaba modulators|mesh-ancestor
102074823|NCT02119806|GABA Agents|gaba agents|mesh-ancestor
102074824|NCT02119806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102074825|NCT02119806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074826|NCT02119884|Octreotide|octreotide|mesh-list
102074827|NCT02119884|Terlipressin|terlipressin|mesh-list
102074828|NCT02119884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102074829|NCT02119884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102074830|NCT02119884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102074831|NCT02119884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102074832|NCT02119884|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102074833|NCT05104918|Vortioxetine|vortioxetine|mesh-list
102074834|NCT05104918|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101376508|NCT00076635|Interferons|interferons|mesh-list
101394707|NCT02475681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394708|NCT02471391|Venetoclax|venetoclax|mesh-list
101394726|NCT02426125|Mitosis Modulators|mitosis modulators|mesh-ancestor
101394727|NCT02426125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394729|NCT02395497|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101394730|NCT02395497|Tacrolimus|tacrolimus|mesh-list
101394731|NCT02395497|Immunologic Factors|immunologic factors|mesh-ancestor
101394732|NCT02395497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394733|NCT02395497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101394734|NCT02395497|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101394735|NCT02395497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101394736|NCT02395497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394737|NCT02362594|Pembrolizumab|pembrolizumab|mesh-list
101394738|NCT02362594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101394739|NCT02362594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394740|NCT02362594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101394741|NCT02362594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394742|NCT02355379|Capecitabine|capecitabine|mesh-list
101394746|NCT02355379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394747|NCT02355379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394748|NCT02355379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101394749|NCT02355379|Immunologic Factors|immunologic factors|mesh-ancestor
101394750|NCT02355379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394752|NCT02354014|Diarylquinolines|diarylquinolines|mesh-list
101394753|NCT02354014|Antitubercular Agents|antitubercular agents|mesh-ancestor
101394754|NCT02354014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101394755|NCT02354014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101394756|NCT02346747|Immunomodulating Agents|immunomodulating agents|mesh-list
101394757|NCT02346747|Immunologic Factors|immunologic factors|mesh-ancestor
101394758|NCT02346747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394759|NCT02316106|Daratumumab|daratumumab|mesh-list
101394760|NCT02316106|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101394761|NCT02316106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394762|NCT02316106|Immunologic Factors|immunologic factors|mesh-ancestor
101394763|NCT02316106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394764|NCT02277444|Golimumab|golimumab|mesh-list
101394765|NCT02277444|Methotrexate|methotrexate|mesh-list
101394766|NCT02277444|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101394767|NCT02277444|Abortifacient Agents|abortifacient agents|mesh-ancestor
101394768|NCT02277444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101394769|NCT02277444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074835|NCT05104918|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102074836|NCT05104918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102074837|NCT05104918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102074838|NCT05104918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074839|NCT05104918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102074840|NCT05104918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074841|NCT05104918|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102074842|NCT05104918|Antidepressive Agents|antidepressive agents|mesh-ancestor
102074843|NCT05104918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102074844|NCT05104918|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102074845|NCT05104918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102074846|NCT05104918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102074847|NCT05104918|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102074848|NCT05104918|Serotonin Agents|serotonin agents|mesh-ancestor
101394770|NCT02277444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101394771|NCT02277444|Antimetabolites|antimetabolites|mesh-ancestor
101394772|NCT02277444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394773|NCT02277444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394774|NCT02277444|Dermatologic Agents|dermatologic agents|mesh-ancestor
101394775|NCT02277444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101394776|NCT02277444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101394777|NCT02277444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101394778|NCT02277444|Immunologic Factors|immunologic factors|mesh-ancestor
101394779|NCT02277444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101305689|NCT02021214|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101305690|NCT02021214|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101305691|NCT02021214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101394780|NCT02277444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101394781|NCT02277444|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101394782|NCT02277444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101394783|NCT02257736|Prednisone|prednisone|mesh-list
101394784|NCT02257736|Abiraterone Acetate|abiraterone acetate|mesh-list
101394785|NCT02257736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101394786|NCT02257736|Glucocorticoids|glucocorticoids|mesh-ancestor
101394787|NCT02257736|Hormones|hormones|mesh-ancestor
101394788|NCT02257736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101191532|NCT00368862|Memantine|memantine|mesh-list
101394791|NCT02257736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334715|NCT00045682|Antimitotic Agents|antimitotic agents|mesh-ancestor
101394792|NCT02257736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101394793|NCT02257736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101394794|NCT02257736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394795|NCT02257736|Hormone Antagonists|hormone antagonists|mesh-ancestor
101394796|NCT02257736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101394797|NCT02157974|Exenatide|exenatide|mesh-list
101394798|NCT02157974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101394799|NCT02157974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394800|NCT02157974|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101394801|NCT02157974|Incretins|incretins|mesh-ancestor
101394802|NCT02157974|Hormones|hormones|mesh-ancestor
101394803|NCT02157974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101394804|NCT02140255|Ritonavir|ritonavir|mesh-list
101394805|NCT02140255|Lopinavir|lopinavir|mesh-list
101394806|NCT02140255|Raltegravir Potassium|raltegravir potassium|mesh-list
101394807|NCT02140255|Nevirapine|nevirapine|mesh-list
101394808|NCT02140255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
101394809|NCT02140255|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101394810|NCT02140255|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101376545|NCT00239512|Analgesics|analgesics|mesh-ancestor
102074849|NCT05104918|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102074850|NCT05104918|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102074851|NCT05104918|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102074852|NCT05104918|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102074853|NCT05089942|Insulin|insulin|mesh-list
102074854|NCT05089942|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102074855|NCT05089942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102074856|NCT05089942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074857|NCT04941508|Dexmedetomidine|dexmedetomidine|mesh-list
102074858|NCT04941508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102074859|NCT04941508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102074860|NCT04941508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394811|NCT02140255|Protease Inhibitors|protease inhibitors|mesh-ancestor
101394812|NCT02140255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101394813|NCT02140255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394814|NCT02140255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101394825|NCT02136134|Dexamethasone|dexamethasone|mesh-list
101394826|NCT02136134|Bortezomib|bortezomib|mesh-list
101394827|NCT02136134|Daratumumab|daratumumab|mesh-list
101394828|NCT02136134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101394829|NCT02136134|Antiemetics|antiemetics|mesh-ancestor
101394830|NCT02136134|Autonomic Agents|autonomic agents|mesh-ancestor
101394831|NCT02136134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101394832|NCT02136134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394833|NCT02136134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101394834|NCT02136134|Glucocorticoids|glucocorticoids|mesh-ancestor
101394835|NCT02136134|Hormones|hormones|mesh-ancestor
101394836|NCT02136134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101394837|NCT02136134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101394838|NCT02136134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394839|NCT02120365|Anticonvulsants|anticonvulsants|mesh-list
101394840|NCT02118584|Etrolizumab|etrolizumab|mesh-list
101394841|NCT02118584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101394842|NCT02118584|Immunologic Factors|immunologic factors|mesh-ancestor
101394843|NCT02118584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394844|NCT02085148|Irinotecan|irinotecan|mesh-list
101394845|NCT02085148|Vincristine|vincristine|mesh-list
101394846|NCT02085148|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101394847|NCT02085148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101394848|NCT02085148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101394849|NCT02085148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394850|NCT02085148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394851|NCT02085148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101394852|NCT02085148|Tubulin Modulators|tubulin modulators|mesh-ancestor
101394853|NCT02085148|Antimitotic Agents|antimitotic agents|mesh-ancestor
101394854|NCT02085148|Mitosis Modulators|mitosis modulators|mesh-ancestor
101394855|NCT02081378|Imatinib Mesylate|imatinib mesylate|mesh-list
101394856|NCT02081378|Dasatinib|dasatinib|mesh-list
101394857|NCT02081378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394858|NCT02081378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101305692|NCT02021214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305693|NCT02021214|Dopamine Agents|dopamine agents|mesh-ancestor
101305694|NCT02021214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101305695|NCT02021240|Dexamethasone|dexamethasone|mesh-list
101305696|NCT02021240|Ketamine|ketamine|mesh-list
101394859|NCT02081378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101394860|NCT02081378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394861|NCT02046395|Amlodipine|amlodipine|mesh-list
101394862|NCT02046395|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101394863|NCT02046395|Hydralazine|hydralazine|mesh-list
101394864|NCT02046395|Terazosin|terazosin|mesh-list
101394865|NCT02046395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101376554|NCT00239512|Gout Suppressants|gout suppressants|mesh-ancestor
102074861|NCT04941508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102074862|NCT04941508|Analgesics|analgesics|mesh-ancestor
102074863|NCT04941508|Sensory System Agents|sensory system agents|mesh-ancestor
102074864|NCT04941508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102074865|NCT04941508|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102074866|NCT04941508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102074867|NCT04941508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102074868|NCT04941508|Adrenergic Agents|adrenergic agents|mesh-ancestor
102074869|NCT04941508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102074870|NCT04941508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074871|NCT01062555|Cyclosporine|cyclosporine|mesh-list
102074872|NCT01062555|Sirolimus|sirolimus|mesh-list
102074873|NCT01062555|Mycophenolic Acid|mycophenolic acid|mesh-list
102074874|NCT01062555|Tacrolimus|tacrolimus|mesh-list
101794625|NCT00993057|Insulin|insulin|mesh-list
102074875|NCT01062555|Cyclosporins|cyclosporins|mesh-list
102074876|NCT01062555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102074877|NCT01062555|Immunologic Factors|immunologic factors|mesh-ancestor
102074878|NCT01062555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074879|NCT01062555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102074880|NCT01062555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102074881|NCT01062555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376557|NCT00076674|Levodopa|levodopa|mesh-list
101394866|NCT02046395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101394867|NCT02046395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101191607|NCT00370656|Pregabalin|pregabalin|mesh-list
101394870|NCT02046395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394871|NCT02046395|Vasodilator Agents|vasodilator agents|mesh-ancestor
101394872|NCT02046395|Diuretics|diuretics|mesh-ancestor
101394873|NCT02046395|Natriuretic Agents|natriuretic agents|mesh-ancestor
101394874|NCT02046395|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101394875|NCT02046395|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101394876|NCT02046395|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101394877|NCT02046395|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101394878|NCT02046395|Adrenergic Agents|adrenergic agents|mesh-ancestor
101394884|NCT02043678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101394885|NCT02043678|Glucocorticoids|glucocorticoids|mesh-ancestor
101394887|NCT02043678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101394888|NCT02043678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394889|NCT02043678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101394890|NCT02043678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394891|NCT02037126|Diphenhydramine|diphenhydramine|mesh-list
101394892|NCT02037126|Promethazine|promethazine|mesh-list
101394893|NCT02037126|Psilocybin|psilocybin|mesh-list
101394894|NCT02037126|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101394895|NCT02037126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101394896|NCT02037126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101394897|NCT02037126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394898|NCT02037126|Anesthetics, Local|anesthetics, local|mesh-ancestor
101394899|NCT02037126|Anesthetics|anesthetics|mesh-ancestor
101394900|NCT02037126|Sensory System Agents|sensory system agents|mesh-ancestor
102074882|NCT01062555|Antifungal Agents|antifungal agents|mesh-ancestor
102074883|NCT01062555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102074884|NCT01062555|Dermatologic Agents|dermatologic agents|mesh-ancestor
102074885|NCT01062555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102074886|NCT01062555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102074887|NCT01062555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102074888|NCT01062555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102074889|NCT01062555|Antitubercular Agents|antitubercular agents|mesh-ancestor
102074890|NCT01062555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102074891|NCT03622047|Sufentanil|sufentanil|mesh-list
102074892|NCT03622047|Dexmedetomidine|dexmedetomidine|mesh-list
102074893|NCT03622047|Ropivacaine|ropivacaine|mesh-list
102074894|NCT03622047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102074895|NCT03622047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102074896|NCT03622047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074897|NCT03622047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101376583|NCT00239707|Hormones|hormones|mesh-ancestor
101394901|NCT02037126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101394902|NCT02037126|Antiemetics|antiemetics|mesh-ancestor
101394903|NCT02037126|Autonomic Agents|autonomic agents|mesh-ancestor
101394904|NCT02037126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101394905|NCT02037126|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101394906|NCT02037126|Histamine Antagonists|histamine antagonists|mesh-ancestor
101394907|NCT02037126|Histamine Agents|histamine agents|mesh-ancestor
101394908|NCT02037126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101394909|NCT02037126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394910|NCT02037126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101394911|NCT02037126|Antipruritics|antipruritics|mesh-ancestor
101394912|NCT02037126|Dermatologic Agents|dermatologic agents|mesh-ancestor
101394913|NCT02037126|Hallucinogens|hallucinogens|mesh-ancestor
101394914|NCT02037126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101394915|NCT01961375|Levonorgestrel|levonorgestrel|mesh-list
101394916|NCT01961375|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101394917|NCT01961375|Contraceptive Agents|contraceptive agents|mesh-ancestor
101394918|NCT01961375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101394919|NCT01961375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394920|NCT01961375|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101394921|NCT01961375|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101394922|NCT01961375|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101394923|NCT01954979|Abatacept|abatacept|mesh-list
101394924|NCT01954979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101394925|NCT01954979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394926|NCT01954979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101394927|NCT01954979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394928|NCT01954979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101394929|NCT01954979|Immunologic Factors|immunologic factors|mesh-ancestor
101305697|NCT02021240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101305698|NCT02021240|Antiemetics|antiemetics|mesh-ancestor
101305699|NCT02021240|Autonomic Agents|autonomic agents|mesh-ancestor
101394930|NCT01954979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394931|NCT01954979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101394932|NCT01932125|Bevacizumab|bevacizumab|mesh-list
101394933|NCT01932125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101394934|NCT01932125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394935|NCT01932125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101394936|NCT01932125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101394937|NCT01932125|Growth Substances|growth substances|mesh-ancestor
101394938|NCT01932125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394939|NCT01932125|Growth Inhibitors|growth inhibitors|mesh-ancestor
101376592|NCT00239746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074899|NCT03622047|Sensory System Agents|sensory system agents|mesh-ancestor
102074900|NCT03622047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102074901|NCT03622047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102074902|NCT03622047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102074903|NCT03622047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102074904|NCT03622047|Adrenergic Agents|adrenergic agents|mesh-ancestor
102074905|NCT03622047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102074906|NCT03622047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074907|NCT03622047|Anesthetics, Local|anesthetics, local|mesh-ancestor
102074908|NCT03622047|Anesthetics|anesthetics|mesh-ancestor
102074909|NCT03622047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102074910|NCT03622047|Narcotics|narcotics|mesh-ancestor
102074911|NCT03622047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102074912|NCT03622047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102074913|NCT03622047|Anesthetics, General|anesthetics, general|mesh-ancestor
102074914|NCT05128630|Durvalumab|durvalumab|mesh-list
101394940|NCT01861106|Mycophenolic Acid|mycophenolic acid|mesh-list
101394941|NCT01861106|Cyclophosphamide|cyclophosphamide|mesh-list
101394942|NCT01861106|Busulfan|busulfan|mesh-list
101394946|NCT01861106|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101394947|NCT01861106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101394948|NCT01861106|Immunologic Factors|immunologic factors|mesh-ancestor
101394949|NCT01861106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394950|NCT01861106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101394972|NCT01851642|Autonomic Agents|autonomic agents|mesh-ancestor
101394973|NCT01851642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101394974|NCT01851642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394975|NCT01851642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101394976|NCT01851642|Respiratory System Agents|respiratory system agents|mesh-ancestor
101394977|NCT01851642|Tocolytic Agents|tocolytic agents|mesh-ancestor
101394978|NCT01851642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101394979|NCT01851642|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101394980|NCT01851642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101394981|NCT01851642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101394982|NCT01851642|Adrenergic Agents|adrenergic agents|mesh-ancestor
101394983|NCT01851642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101394984|NCT01851642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394986|NCT01842386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101394987|NCT01842386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394988|NCT01842386|Immunologic Factors|immunologic factors|mesh-ancestor
101394989|NCT01842386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394990|NCT01842386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101394991|NCT01838187|Vorinostat|vorinostat|mesh-list
101394992|NCT01838187|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
101394993|NCT01838187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394994|NCT01838187|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101394995|NCT01838187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101394996|NCT01838187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394997|NCT01838187|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101394998|NCT01828099|Carboplatin|carboplatin|mesh-list
101394999|NCT01828099|Pemetrexed|pemetrexed|mesh-list
101395000|NCT01828099|Ceritinib|ceritinib|mesh-list
101395001|NCT01828099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334772|NCT00001703|Freund's Adjuvant|freund's adjuvant|mesh-list
101395002|NCT01828099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101395005|NCT01828099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102074915|NCT05128630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102074917|NCT05073562|Folic Acid|folic acid|mesh-list
102074918|NCT05073562|Mebendazole|mebendazole|mesh-list
102074919|NCT05073562|Piperazine|piperazine|mesh-list
102074920|NCT05073562|Piperazine citrate|piperazine citrate|mesh-list
102074921|NCT05073562|DMP 777|dmp 777|mesh-list
102074922|NCT05073562|Hematinics|hematinics|mesh-ancestor
102074923|NCT05073562|Vitamin B Complex|vitamin b complex|mesh-ancestor
102074924|NCT05073562|Vitamins|vitamins|mesh-ancestor
102074925|NCT05073562|Micronutrients|micronutrients|mesh-ancestor
101376606|NCT00239863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395006|NCT01828099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101395008|NCT01776840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101395009|NCT01776840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101395010|NCT01776840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101395011|NCT01776840|Immunologic Factors|immunologic factors|mesh-ancestor
101395012|NCT01776840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395013|NCT01776840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101395014|NCT01776840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101395015|NCT01776840|Alkylating Agents|alkylating agents|mesh-ancestor
101395016|NCT01776840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395017|NCT01615029|Dexamethasone|dexamethasone|mesh-list
101395018|NCT01615029|Lenalidomide|lenalidomide|mesh-list
101395019|NCT01615029|Daratumumab|daratumumab|mesh-list
101395020|NCT01615029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101395021|NCT01615029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101395022|NCT01615029|Antiemetics|antiemetics|mesh-ancestor
101395023|NCT01615029|Autonomic Agents|autonomic agents|mesh-ancestor
101395024|NCT01615029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101305700|NCT02021240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101305701|NCT02021240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305702|NCT02021240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101305703|NCT02021240|Glucocorticoids|glucocorticoids|mesh-ancestor
101305704|NCT02021240|Hormones|hormones|mesh-ancestor
101305705|NCT02021240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101305706|NCT02021240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101305707|NCT02021240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101305708|NCT02021240|Analgesics|analgesics|mesh-ancestor
101305709|NCT02021240|Sensory System Agents|sensory system agents|mesh-ancestor
101305710|NCT02021240|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101305711|NCT02021240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101305712|NCT02021240|Anesthetics, General|anesthetics, general|mesh-ancestor
101305713|NCT02021240|Anesthetics|anesthetics|mesh-ancestor
101191745|NCT00373620|Tubulin Modulators|tubulin modulators|mesh-ancestor
101395027|NCT01615029|Glucocorticoids|glucocorticoids|mesh-ancestor
101395028|NCT01615029|Hormones|hormones|mesh-ancestor
101395029|NCT01615029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101395030|NCT01615029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101395031|NCT01615029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101395032|NCT01615029|Immunologic Factors|immunologic factors|mesh-ancestor
101395033|NCT01615029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101395034|NCT01615029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101395035|NCT01615029|Growth Substances|growth substances|mesh-ancestor
101395036|NCT01615029|Growth Inhibitors|growth inhibitors|mesh-ancestor
101395037|NCT01515527|Cytarabine|cytarabine|mesh-list
101395038|NCT01515527|Decitabine|decitabine|mesh-list
101395039|NCT01515527|Cladribine|cladribine|mesh-list
101395040|NCT01515527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101395041|NCT01515527|Antimetabolites|antimetabolites|mesh-ancestor
101395042|NCT01515527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395043|NCT01515527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101395044|NCT01515527|Antiviral Agents|antiviral agents|mesh-ancestor
101395045|NCT01515527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101395046|NCT01515527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101395047|NCT01515527|Immunologic Factors|immunologic factors|mesh-ancestor
102074926|NCT05073562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074927|NCT05073562|Antinematodal Agents|antinematodal agents|mesh-ancestor
102074928|NCT05073562|Anthelmintics|anthelmintics|mesh-ancestor
102074929|NCT05073562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102074930|NCT05073562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102074931|NCT05073562|Tubulin Modulators|tubulin modulators|mesh-ancestor
102074932|NCT05073562|Antimitotic Agents|antimitotic agents|mesh-ancestor
102074933|NCT05073562|Mitosis Modulators|mitosis modulators|mesh-ancestor
101828094|NCT05997004|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102074934|NCT05073562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074935|NCT05073562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102074936|NCT05073562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102074937|NCT01368276|Molgramostim|molgramostim|mesh-list
102074938|NCT01368276|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
102074939|NCT01368276|Sargramostim|sargramostim|mesh-list
102074940|NCT01368276|Immunologic Factors|immunologic factors|mesh-ancestor
102074941|NCT01368276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074942|NCT01368276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102074943|NCT01368276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102074944|NCT02116842|Fentanyl|fentanyl|mesh-list
102074945|NCT02116842|Bupivacaine|bupivacaine|mesh-list
102074946|NCT02116842|Anesthetics, Local|anesthetics, local|mesh-ancestor
101395048|NCT01515527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395049|NCT01515527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101395050|NCT01454154|Glyburide|glyburide|mesh-list
101395051|NCT01454154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101395052|NCT01454154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395053|NCT01445509|Bevacizumab|bevacizumab|mesh-list
101395054|NCT01445509|Dasatinib|dasatinib|mesh-list
101395055|NCT01445509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101395056|NCT01445509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101395057|NCT01445509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101395058|NCT01445509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101395059|NCT01445509|Growth Substances|growth substances|mesh-ancestor
101305718|NCT02021240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305720|NCT02021409|Hematinics|hematinics|mesh-ancestor
101305721|NCT02020980|Botulinum Toxins|botulinum toxins|mesh-list
101305722|NCT02020980|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101305723|NCT02020980|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101305724|NCT02020980|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101305725|NCT02020980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101305726|NCT02020980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305727|NCT02020980|Cholinergic Agents|cholinergic agents|mesh-ancestor
101305728|NCT02020980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101305729|NCT02020980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305730|NCT02020980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101305731|NCT02020980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101305732|NCT02021422|Fluorouracil|fluorouracil|mesh-list
101305733|NCT02021422|Oxaliplatin|oxaliplatin|mesh-list
101305734|NCT02021422|Irinotecan|irinotecan|mesh-list
101395060|NCT01445509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395061|NCT01445509|Growth Inhibitors|growth inhibitors|mesh-ancestor
101395062|NCT01445509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101395063|NCT01445509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101395064|NCT01445509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074947|NCT02116842|Anesthetics|anesthetics|mesh-ancestor
102074948|NCT02116842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102074949|NCT02116842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102074950|NCT02116842|Sensory System Agents|sensory system agents|mesh-ancestor
102074951|NCT02116842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102074952|NCT02116842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101395065|NCT01367301|Paclitaxel|paclitaxel|mesh-list
101395066|NCT01367301|Carboplatin|carboplatin|mesh-list
101395067|NCT01367301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101395068|NCT01367301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101395069|NCT01367301|Tubulin Modulators|tubulin modulators|mesh-ancestor
101395081|NCT01352962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395082|NCT01352962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101395083|NCT01352962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101395084|NCT01352962|Growth Substances|growth substances|mesh-ancestor
101395085|NCT01352962|Growth Inhibitors|growth inhibitors|mesh-ancestor
101395086|NCT01314118|Prednisone|prednisone|mesh-list
101395087|NCT01314118|Abiraterone Acetate|abiraterone acetate|mesh-list
101395088|NCT01314118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101395089|NCT01314118|Glucocorticoids|glucocorticoids|mesh-ancestor
101395090|NCT01314118|Hormones|hormones|mesh-ancestor
101395091|NCT01314118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101395092|NCT01314118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395093|NCT01314118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101395094|NCT01314118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101395095|NCT01314118|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101395096|NCT01314118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101395097|NCT01314118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395098|NCT01314118|Hormone Antagonists|hormone antagonists|mesh-ancestor
101395099|NCT01314118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101395100|NCT01294020|Tacrolimus|tacrolimus|mesh-list
101395101|NCT01294020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101395102|NCT01294020|Immunologic Factors|immunologic factors|mesh-ancestor
101395103|NCT01294020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305735|NCT02021422|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101305736|NCT02021422|Antimetabolites|antimetabolites|mesh-ancestor
101305737|NCT02021422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305738|NCT02021422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101305739|NCT02021422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101305740|NCT02021422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101305741|NCT02021422|Immunologic Factors|immunologic factors|mesh-ancestor
101305742|NCT02021422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305743|NCT02021422|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101305744|NCT02021422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101305745|NCT02021422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101305746|NCT02021422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101305747|NCT02021500|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101305748|NCT02021500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101305749|NCT02021539|Tocolytic Agents|tocolytic agents|mesh-list
101305750|NCT02021539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101305751|NCT02021539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395104|NCT01294020|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101395105|NCT01294020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101395106|NCT01294020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395107|NCT01220583|Cisplatin|cisplatin|mesh-list
101395108|NCT01220583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101395109|NCT01199575|Rituximab|rituximab|mesh-list
101395110|NCT01199575|Lenalidomide|lenalidomide|mesh-list
101395111|NCT01199575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101395112|NCT01199575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101395113|NCT01199575|Immunologic Factors|immunologic factors|mesh-ancestor
101395114|NCT01199575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395115|NCT01199575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101395116|NCT01199575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101395117|NCT01199575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101395118|NCT01199575|Growth Substances|growth substances|mesh-ancestor
101395119|NCT01199575|Growth Inhibitors|growth inhibitors|mesh-ancestor
101395120|NCT01166594|Bevacizumab|bevacizumab|mesh-list
102074955|NCT02116842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102074956|NCT02116842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102074957|NCT02116842|Anesthetics, General|anesthetics, general|mesh-ancestor
102074958|NCT02120118|Docetaxel|docetaxel|mesh-list
102074959|NCT02120118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102074960|NCT02120118|Tubulin Modulators|tubulin modulators|mesh-ancestor
102074961|NCT02120118|Antimitotic Agents|antimitotic agents|mesh-ancestor
102074962|NCT02120118|Mitosis Modulators|mitosis modulators|mesh-ancestor
102074963|NCT02120118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074964|NCT04054089|Tenofovir|tenofovir|mesh-list
102074965|NCT04054089|Lamivudine|lamivudine|mesh-list
102074966|NCT04054089|Emtricitabine|emtricitabine|mesh-list
102074967|NCT04054089|Dolutegravir|dolutegravir|mesh-list
102074968|NCT04054089|Antiviral Agents|antiviral agents|mesh-ancestor
102074969|NCT04054089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101395121|NCT01166594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101395122|NCT01166594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101395128|NCT01064466|Etoposide|etoposide|mesh-list
101395129|NCT01064466|Etoposide phosphate|etoposide phosphate|mesh-list
101395130|NCT01064466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101395131|NCT01064466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101395132|NCT01064466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101395133|NCT01064466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101395134|NCT01064466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101395135|NCT01064466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395136|NCT00980954|Paclitaxel|paclitaxel|mesh-list
101395137|NCT00980954|Carboplatin|carboplatin|mesh-list
101395138|NCT00980954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101395139|NCT00980954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101395140|NCT00980954|Tubulin Modulators|tubulin modulators|mesh-ancestor
101395141|NCT00980954|Antimitotic Agents|antimitotic agents|mesh-ancestor
101395142|NCT00980954|Mitosis Modulators|mitosis modulators|mesh-ancestor
101456560|NCT00216827|Betamethasone benzoate|betamethasone benzoate|mesh-list
101305752|NCT02021825|Mitoxantrone|mitoxantrone|mesh-list
101305753|NCT02021825|Analgesics|analgesics|mesh-ancestor
101305754|NCT02021825|Sensory System Agents|sensory system agents|mesh-ancestor
101305755|NCT02021825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101305756|NCT02021825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305757|NCT02021825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101305758|NCT02021825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101305759|NCT02021825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101305760|NCT02021825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101305761|NCT02021825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305762|NCT02021851|Dexamethasone|dexamethasone|mesh-list
101305763|NCT02021851|Dexamethasone acetate|dexamethasone acetate|mesh-list
101305764|NCT02021851|Ondansetron|ondansetron|mesh-list
101305765|NCT02021851|Aprepitant|aprepitant|mesh-list
101305766|NCT02021851|BB 1101|bb 1101|mesh-list
101395143|NCT00980954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395144|NCT00980538|Etravirine|etravirine|mesh-list
101395145|NCT00980538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101395148|NCT00980538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395150|NCT00980538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101395151|NCT00871013|Thalidomide|thalidomide|mesh-list
101395152|NCT00871013|Dexamethasone|dexamethasone|mesh-list
101395153|NCT00871013|Cyclophosphamide|cyclophosphamide|mesh-list
101395154|NCT00871013|Melphalan|melphalan|mesh-list
101395155|NCT00871013|Doxorubicin|doxorubicin|mesh-list
101395156|NCT00871013|Etoposide|etoposide|mesh-list
101395157|NCT00871013|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101395158|NCT00871013|Bortezomib|bortezomib|mesh-list
101395159|NCT00871013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101395160|NCT00871013|Immunologic Factors|immunologic factors|mesh-ancestor
101395161|NCT00871013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395162|NCT00871013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101395163|NCT00871013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101395164|NCT00871013|Alkylating Agents|alkylating agents|mesh-ancestor
101395165|NCT00871013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395166|NCT00871013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101395167|NCT00871013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101395168|NCT00871013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101395169|NCT00871013|Antiemetics|antiemetics|mesh-ancestor
101395170|NCT00871013|Autonomic Agents|autonomic agents|mesh-ancestor
101395171|NCT00871013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101395172|NCT00871013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101395173|NCT00871013|Glucocorticoids|glucocorticoids|mesh-ancestor
101395174|NCT00871013|Hormones|hormones|mesh-ancestor
101395175|NCT00871013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101395176|NCT00871013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101395177|NCT00871013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101395178|NCT00871013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101395179|NCT00871013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101191967|NCT00381030|Carvedilol|carvedilol|mesh-list
101305767|NCT02021851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101305768|NCT02021851|Antiemetics|antiemetics|mesh-ancestor
101305769|NCT02021851|Autonomic Agents|autonomic agents|mesh-ancestor
101395199|NCT00781612|Paclitaxel|paclitaxel|mesh-list
101395200|NCT00781612|Maytansine|maytansine|mesh-list
101395201|NCT00781612|Docetaxel|docetaxel|mesh-list
101395202|NCT00781612|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101395203|NCT00781612|Trastuzumab|trastuzumab|mesh-list
101395204|NCT00781612|Atezolizumab|atezolizumab|mesh-list
101395205|NCT00781612|Pertuzumab|pertuzumab|mesh-list
101395206|NCT00781612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101395207|NCT00781612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101395208|NCT00781612|Tubulin Modulators|tubulin modulators|mesh-ancestor
101395209|NCT00781612|Antimitotic Agents|antimitotic agents|mesh-ancestor
101395210|NCT00781612|Mitosis Modulators|mitosis modulators|mesh-ancestor
101395211|NCT00781612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395212|NCT00781612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101395213|NCT00781612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101395214|NCT00781612|Immunotoxins|immunotoxins|mesh-ancestor
101395215|NCT00781612|Immunoconjugates|immunoconjugates|mesh-ancestor
101395216|NCT00781612|Immunologic Factors|immunologic factors|mesh-ancestor
101395217|NCT00781612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395218|NCT00694850|Riociguat|riociguat|mesh-list
101395219|NCT00694850|Enzyme Activators|enzyme activators|mesh-ancestor
101395220|NCT00694850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395226|NCT00585650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101395227|NCT00585650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395228|NCT00585650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101395229|NCT00585650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101395230|NCT00585650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101395231|NCT00585650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101395232|NCT00585650|Immunologic Factors|immunologic factors|mesh-ancestor
102074977|NCT04054089|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102074979|NCT02120196|Norfloxacin|norfloxacin|mesh-list
102074980|NCT02120196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102074981|NCT02120196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102074982|NCT02120196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102074983|NCT02120196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101376665|NCT00240214|Sirolimus|sirolimus|mesh-list
101395233|NCT00172029|Zoledronic Acid|zoledronic acid|mesh-list
101395234|NCT00172029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101395235|NCT00172029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395236|NCT00085202|Cyclophosphamide|cyclophosphamide|mesh-list
101395238|NCT00085202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101395239|NCT00085202|Immunologic Factors|immunologic factors|mesh-ancestor
101395240|NCT00085202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395241|NCT00085202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101395242|NCT00085202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101395243|NCT00085202|Alkylating Agents|alkylating agents|mesh-ancestor
101395244|NCT00085202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395245|NCT00085202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101395246|NCT00085202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101395247|NCT00085202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101192022|NCT00382668|Dasatinib|dasatinib|mesh-list
101395256|NCT00076310|Antimitotic Agents|antimitotic agents|mesh-ancestor
101395257|NCT00076310|Mitosis Modulators|mitosis modulators|mesh-ancestor
101395258|NCT00076310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395259|NCT00076310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101395260|NCT00076310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101395262|NCT00039130|Cytarabine|cytarabine|mesh-list
101395263|NCT00039130|Dexamethasone|dexamethasone|mesh-list
101395264|NCT00039130|Prednisone|prednisone|mesh-list
101395265|NCT00039130|Cyclophosphamide|cyclophosphamide|mesh-list
101395266|NCT00039130|Ifosfamide|ifosfamide|mesh-list
101395267|NCT00039130|Rituximab|rituximab|mesh-list
101395268|NCT00039130|Doxorubicin|doxorubicin|mesh-list
101395269|NCT00039130|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101395270|NCT00039130|Methotrexate|methotrexate|mesh-list
101395271|NCT00039130|Etoposide|etoposide|mesh-list
101395272|NCT00039130|Vincristine|vincristine|mesh-list
101305770|NCT02021851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101305771|NCT02021851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305772|NCT02021851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101305773|NCT02021851|Glucocorticoids|glucocorticoids|mesh-ancestor
101395273|NCT00039130|Allopurinol|allopurinol|mesh-list
101395274|NCT00039130|Levoleucovorin|levoleucovorin|mesh-list
101395275|NCT00039130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101395276|NCT00039130|Immunologic Factors|immunologic factors|mesh-ancestor
101395277|NCT00039130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395278|NCT00039130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101395279|NCT00039130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101395280|NCT00039130|Alkylating Agents|alkylating agents|mesh-ancestor
101395281|NCT00039130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395282|NCT00039130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101395283|NCT00039130|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101395284|NCT00039130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101395285|NCT00039130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101395286|NCT00039130|Antiemetics|antiemetics|mesh-ancestor
101395287|NCT00039130|Autonomic Agents|autonomic agents|mesh-ancestor
101395288|NCT00039130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101395289|NCT00039130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101395290|NCT00039130|Glucocorticoids|glucocorticoids|mesh-ancestor
101395291|NCT00039130|Hormones|hormones|mesh-ancestor
101395292|NCT00039130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101395303|NCT00039130|Dermatologic Agents|dermatologic agents|mesh-ancestor
101395304|NCT00039130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101395305|NCT00039130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101395306|NCT00039130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101395307|NCT00039130|Antiviral Agents|antiviral agents|mesh-ancestor
101395308|NCT00039130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102074984|NCT02120196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102074985|NCT02120196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102074986|NCT02120196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102074987|NCT02120196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102074988|NCT02120196|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102074989|NCT02120196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101395309|NCT00039130|Antidotes|antidotes|mesh-ancestor
101395310|NCT00039130|Protective Agents|protective agents|mesh-ancestor
101395311|NCT00039130|Vitamin B Complex|vitamin b complex|mesh-ancestor
101395312|NCT00039130|Vitamins|vitamins|mesh-ancestor
101395313|NCT00039130|Micronutrients|micronutrients|mesh-ancestor
101395314|NCT00039130|Tubulin Modulators|tubulin modulators|mesh-ancestor
101395315|NCT00039130|Antimitotic Agents|antimitotic agents|mesh-ancestor
101395316|NCT00039130|Mitosis Modulators|mitosis modulators|mesh-ancestor
101395317|NCT00039130|Gout Suppressants|gout suppressants|mesh-ancestor
101395318|NCT00039130|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101395319|NCT00039130|Antioxidants|antioxidants|mesh-ancestor
101395320|NCT00002889|Leuprolide|leuprolide|mesh-list
101395321|NCT00002889|Goserelin|goserelin|mesh-list
101395322|NCT00002889|Flutamide|flutamide|mesh-list
101395323|NCT00002889|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101395324|NCT00002889|Fertility Agents|fertility agents|mesh-ancestor
101395325|NCT00002889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101395330|NCT00002889|Hormone Antagonists|hormone antagonists|mesh-ancestor
101395331|NCT00002889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101395332|NCT00001521|Hydrocortisone|hydrocortisone|mesh-list
101395333|NCT00001521|Fludrocortisone|fludrocortisone|mesh-list
101395334|NCT00001521|Letrozole|letrozole|mesh-list
101395335|NCT00001521|Flutamide|flutamide|mesh-list
101395336|NCT00001521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101395337|NCT00001521|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101395338|NCT00001521|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101395339|NCT00001521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101395340|NCT00001521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395341|NCT00001521|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101395342|NCT00001521|Hormone Antagonists|hormone antagonists|mesh-ancestor
101395343|NCT00001521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101395344|NCT00001521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395345|NCT00001521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101395346|NCT00001521|Androgen Antagonists|androgen antagonists|mesh-ancestor
101395347|NCT00001521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101395348|NCT00122577|Ritonavir|ritonavir|mesh-list
101395349|NCT00122577|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101395350|NCT00122577|Tenofovir|tenofovir|mesh-list
101305774|NCT02021851|Hormones|hormones|mesh-ancestor
101305775|NCT02021851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101305776|NCT02021851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101395351|NCT00122577|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101395352|NCT00122577|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101395353|NCT00122577|Protease Inhibitors|protease inhibitors|mesh-ancestor
101395354|NCT00122577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101395355|NCT00122577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395356|NCT00122577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101395357|NCT00122577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101395358|NCT00122577|Antiviral Agents|antiviral agents|mesh-ancestor
101395361|NCT00122577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101395362|NCT00122577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101395363|NCT00122577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101395365|NCT00313261|Antiviral Agents|antiviral agents|mesh-ancestor
101395366|NCT00313261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101395367|NCT00425074|Aspirin|aspirin|mesh-list
101395368|NCT00425074|Salicylic Acid|salicylic acid|mesh-list
101395369|NCT00425074|Salicylates|salicylates|mesh-list
101395370|NCT00425074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101395371|NCT00425074|Antifungal Agents|antifungal agents|mesh-ancestor
101395372|NCT00425074|Keratolytic Agents|keratolytic agents|mesh-ancestor
101395373|NCT00425074|Dermatologic Agents|dermatologic agents|mesh-ancestor
101395374|NCT00425074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102074991|NCT05001802|Anesthetics, Local|anesthetics, local|mesh-ancestor
102074992|NCT05001802|Anesthetics|anesthetics|mesh-ancestor
102074993|NCT05001802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102074994|NCT05001802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376678|NCT00065936|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101395375|NCT00425074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101395376|NCT00425074|Analgesics|analgesics|mesh-ancestor
101395377|NCT00425074|Sensory System Agents|sensory system agents|mesh-ancestor
101395378|NCT00425074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101395379|NCT00425074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395380|NCT00425074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101395381|NCT00425074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101395382|NCT00425074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101395383|NCT00425074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101395384|NCT00425074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395385|NCT00425074|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101395386|NCT00425074|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101395387|NCT00425074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101395388|NCT00425074|Antipyretics|antipyretics|mesh-ancestor
101395390|NCT00425152|Levamisole|levamisole|mesh-list
101395391|NCT00425152|Fluorouracil|fluorouracil|mesh-list
101395392|NCT00425152|Calcium|calcium|mesh-list
101395393|NCT00425152|Levoleucovorin|levoleucovorin|mesh-list
101395394|NCT00425152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101395395|NCT00425152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395396|NCT00425152|Antimetabolites|antimetabolites|mesh-ancestor
101395403|NCT00425152|Protective Agents|protective agents|mesh-ancestor
101395404|NCT00425152|Vitamin B Complex|vitamin b complex|mesh-ancestor
101395405|NCT00425152|Vitamins|vitamins|mesh-ancestor
101395406|NCT00425152|Micronutrients|micronutrients|mesh-ancestor
101395407|NCT00425152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101395408|NCT00425152|Antinematodal Agents|antinematodal agents|mesh-ancestor
101395409|NCT00425152|Anthelmintics|anthelmintics|mesh-ancestor
101395410|NCT00425152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101395411|NCT00425152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101395412|NCT00425152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101395413|NCT00314314|Insulin|insulin|mesh-list
101395414|NCT00314314|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101395415|NCT00314314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395416|NCT00122616|Ribavirin|ribavirin|mesh-list
101395417|NCT00122616|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101395418|NCT00122616|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101395419|NCT00122616|Antimetabolites|antimetabolites|mesh-ancestor
101395420|NCT00122616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395421|NCT00122616|Antiviral Agents|antiviral agents|mesh-ancestor
101395422|NCT00122616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101395423|NCT04984070|Metformin|metformin|mesh-list
101395424|NCT04984070|Drospirenone|drospirenone|mesh-list
101395425|NCT04984070|Contraceptive Agents|contraceptive agents|mesh-list
101395426|NCT04984070|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101395427|NCT04984070|Contraceptives, Oral|contraceptives, oral|mesh-list
101395428|NCT04984070|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
101395429|NCT04984070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
101395430|NCT04984070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101395431|NCT04984070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395432|NCT04984070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101395433|NCT04984070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101395435|NCT04984070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101395436|NCT04984070|Estrogens|estrogens|mesh-ancestor
101395437|NCT04984070|Hormones|hormones|mesh-ancestor
101395438|NCT04984070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101395439|NCT04984070|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101395440|NCT04984070|Hormone Antagonists|hormone antagonists|mesh-ancestor
101395441|NCT04984070|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101395442|NCT04984070|Diuretics|diuretics|mesh-ancestor
101395443|NCT04984070|Natriuretic Agents|natriuretic agents|mesh-ancestor
101395444|NCT00314509|Ciclesonide|ciclesonide|mesh-list
101395445|NCT00314509|Formoterol Fumarate|formoterol fumarate|mesh-list
101395446|NCT00314509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101395447|NCT00314509|Autonomic Agents|autonomic agents|mesh-ancestor
101395448|NCT00314509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102074995|NCT05001802|Sensory System Agents|sensory system agents|mesh-ancestor
102074996|NCT05001802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102074997|NCT02120274|Vitamin D|vitamin d|mesh-list
102074998|NCT02120274|Vitamins|vitamins|mesh-list
102074999|NCT02120274|Vitamin B 12|vitamin b 12|mesh-list
102075000|NCT02120274|Hydroxocobalamin|hydroxocobalamin|mesh-list
102075001|NCT02120274|Micronutrients|micronutrients|mesh-ancestor
101395449|NCT00314509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395450|NCT00314509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101395451|NCT00314509|Respiratory System Agents|respiratory system agents|mesh-ancestor
101395452|NCT00314509|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101395453|NCT00314509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101395454|NCT00314509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101395455|NCT00314509|Adrenergic Agents|adrenergic agents|mesh-ancestor
101395456|NCT00314509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101395457|NCT00314509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395458|NCT00314509|Glucocorticoids|glucocorticoids|mesh-ancestor
101395459|NCT00314509|Hormones|hormones|mesh-ancestor
101395460|NCT00314509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101395461|NCT00314509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101395462|NCT00314548|Epoprostenol|epoprostenol|mesh-list
101395463|NCT00314548|Alprostadil|alprostadil|mesh-list
101395464|NCT00314548|Tezosentan|tezosentan|mesh-list
101395465|NCT00314548|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101395466|NCT00314548|Vasodilator Agents|vasodilator agents|mesh-ancestor
101395474|NCT00314626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101395475|NCT00314626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395476|NCT00314626|Antiviral Agents|antiviral agents|mesh-ancestor
101395477|NCT00314626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101395478|NCT00314626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101395479|NCT00314626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101395480|NCT00314626|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101395481|NCT00314626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101395482|NCT00314626|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101395483|NCT00314626|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101395484|NCT00314626|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101395485|NCT00314626|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101395486|NCT00314665|Thalidomide|thalidomide|mesh-list
101395487|NCT00314665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101395488|NCT00314665|Immunologic Factors|immunologic factors|mesh-ancestor
101395489|NCT00314665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395490|NCT00314665|Leprostatic Agents|leprostatic agents|mesh-ancestor
101395491|NCT00314665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101395492|NCT00314665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101395493|NCT00314665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101395494|NCT00314665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101395495|NCT00314665|Growth Substances|growth substances|mesh-ancestor
101395496|NCT00314665|Growth Inhibitors|growth inhibitors|mesh-ancestor
101395497|NCT00314665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101395498|NCT00314704|Dopamine|dopamine|mesh-list
101395499|NCT00314704|Norepinephrine|norepinephrine|mesh-list
101395500|NCT00314704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101395501|NCT00314704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101395502|NCT00314704|Adrenergic Agents|adrenergic agents|mesh-ancestor
101395503|NCT00314704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101395504|NCT00314704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395505|NCT00314704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395506|NCT00314704|Sympathomimetics|sympathomimetics|mesh-ancestor
101395509|NCT00314704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101395510|NCT00314704|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101395511|NCT00314704|Dopamine Agents|dopamine agents|mesh-ancestor
101395512|NCT00314704|Protective Agents|protective agents|mesh-ancestor
101395513|NCT00090909|Dexamethasone|dexamethasone|mesh-list
101395514|NCT00090909|Gemcitabine|gemcitabine|mesh-list
101395515|NCT00090909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101395517|NCT00090909|Autonomic Agents|autonomic agents|mesh-ancestor
101395518|NCT00090909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101395519|NCT00090909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395520|NCT00090909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101395521|NCT00090909|Glucocorticoids|glucocorticoids|mesh-ancestor
102075002|NCT02120274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075003|NCT02120274|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102075004|NCT02120274|Vitamin B Complex|vitamin b complex|mesh-ancestor
102075005|NCT02120274|Hematinics|hematinics|mesh-ancestor
102075006|NCT02402842|Docetaxel|docetaxel|mesh-list
102075007|NCT02402842|Fluorouracil|fluorouracil|mesh-list
102075008|NCT02402842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102075009|NCT02402842|Tubulin Modulators|tubulin modulators|mesh-ancestor
101395522|NCT00090909|Hormones|hormones|mesh-ancestor
101395523|NCT00090909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101395524|NCT00090909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101395525|NCT00090909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101395526|NCT00090909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101395527|NCT00090909|Antimetabolites|antimetabolites|mesh-ancestor
101395528|NCT00090909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395529|NCT04943627|Gemcitabine|gemcitabine|mesh-list
101395530|NCT04943627|Irinotecan|irinotecan|mesh-list
101395531|NCT04943627|Pemetrexed|pemetrexed|mesh-list
101395532|NCT04943627|Topotecan|topotecan|mesh-list
101395533|NCT04943627|Vinorelbine|vinorelbine|mesh-list
101395534|NCT04943627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101395535|NCT04943627|Antimetabolites|antimetabolites|mesh-ancestor
101395536|NCT04943627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395537|NCT04943627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101395538|NCT04943627|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101434709|NCT00548080|Caspofungin|caspofungin|mesh-list
101395543|NCT04943627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101395544|NCT04943627|Tubulin Modulators|tubulin modulators|mesh-ancestor
101395545|NCT04943627|Antimitotic Agents|antimitotic agents|mesh-ancestor
101395546|NCT04943627|Mitosis Modulators|mitosis modulators|mesh-ancestor
101395547|NCT00314743|Dexamethasone|dexamethasone|mesh-list
101395548|NCT00314743|Ondansetron|ondansetron|mesh-list
101395550|NCT00314743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101395551|NCT00314743|Antiemetics|antiemetics|mesh-ancestor
101395552|NCT00314743|Autonomic Agents|autonomic agents|mesh-ancestor
101395553|NCT00314743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101395554|NCT00314743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395555|NCT00314743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101395556|NCT00314743|Glucocorticoids|glucocorticoids|mesh-ancestor
101395557|NCT00314743|Hormones|hormones|mesh-ancestor
101395558|NCT00314743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101395559|NCT00314743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101395560|NCT00314743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101395561|NCT00314743|Antipruritics|antipruritics|mesh-ancestor
101395562|NCT00314743|Dermatologic Agents|dermatologic agents|mesh-ancestor
101395563|NCT00314743|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101395564|NCT00314743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101395565|NCT00314743|Serotonin Agents|serotonin agents|mesh-ancestor
101395566|NCT00314743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101395567|NCT00314743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395568|NCT00314743|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101395569|NCT00314782|Docetaxel|docetaxel|mesh-list
101395570|NCT00314782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101395571|NCT00314782|Tubulin Modulators|tubulin modulators|mesh-ancestor
101395572|NCT00314782|Antimitotic Agents|antimitotic agents|mesh-ancestor
101395573|NCT00314782|Mitosis Modulators|mitosis modulators|mesh-ancestor
101305780|NCT02021851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305781|NCT02021851|Antipruritics|antipruritics|mesh-ancestor
101305782|NCT02021851|Dermatologic Agents|dermatologic agents|mesh-ancestor
101333852|NCT00017355|Lenograstim|lenograstim|mesh-list
101395574|NCT00314782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395575|NCT00122655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
101395576|NCT00122655|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
101395577|NCT00122655|Protease Inhibitors|protease inhibitors|mesh-list
101395578|NCT00122655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101395579|NCT00122655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101395580|NCT00122655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395582|NCT00122655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102075010|NCT02402842|Antimitotic Agents|antimitotic agents|mesh-ancestor
102075011|NCT02402842|Mitosis Modulators|mitosis modulators|mesh-ancestor
102075012|NCT02402842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075013|NCT02402842|Antimetabolites|antimetabolites|mesh-ancestor
102075014|NCT02402842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102075015|NCT02402842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101395583|NCT00122655|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101395585|NCT00122655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101395586|NCT00314821|Ropinirole|ropinirole|mesh-list
101395587|NCT00314821|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101395588|NCT00314821|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101395589|NCT00314821|Dopamine Agonists|dopamine agonists|mesh-ancestor
101395590|NCT00314821|Dopamine Agents|dopamine agents|mesh-ancestor
101395591|NCT00314821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101395592|NCT00314821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395593|NCT00314821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395594|NCT00314860|Ropinirole|ropinirole|mesh-list
101395595|NCT00314860|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101395596|NCT00314860|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101395597|NCT00314860|Dopamine Agonists|dopamine agonists|mesh-ancestor
101395598|NCT00314860|Dopamine Agents|dopamine agents|mesh-ancestor
101395599|NCT00314860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101395600|NCT00314860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395601|NCT00314860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395602|NCT04928339|Bupivacaine|bupivacaine|mesh-list
101395603|NCT04928339|Anesthetics, Local|anesthetics, local|mesh-ancestor
101395604|NCT04928339|Anesthetics|anesthetics|mesh-ancestor
101395605|NCT04928339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101395606|NCT04928339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395622|NCT00091104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101395623|NCT00091104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101395624|NCT00091104|Antimetabolites|antimetabolites|mesh-ancestor
101395625|NCT00091104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101395626|NCT00091104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101395627|NCT00091104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101395628|NCT00091104|Antiviral Agents|antiviral agents|mesh-ancestor
101395629|NCT00091104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101395630|NCT00122694|Carbon Monoxide|carbon monoxide|mesh-list
101395631|NCT00122694|Antimetabolites|antimetabolites|mesh-ancestor
101395632|NCT00122694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395633|NCT00122694|Gasotransmitters|gasotransmitters|mesh-ancestor
101395634|NCT00122694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101395635|NCT00122694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395636|NCT00313456|Satraplatin|satraplatin|mesh-list
101395637|NCT00313456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101395638|NCT00313534|Masoprocol|masoprocol|mesh-list
101395639|NCT00313534|Antioxidants|antioxidants|mesh-ancestor
101395640|NCT00313534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305783|NCT02021851|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101305784|NCT02021851|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101305786|NCT02021851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101305787|NCT02021851|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101305788|NCT02021864|Vitamin D|vitamin d|mesh-list
101395641|NCT00313534|Protective Agents|protective agents|mesh-ancestor
101395642|NCT00313534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395643|NCT00313534|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101395644|NCT00313534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101395645|NCT00313534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101395646|NCT00313534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101395647|NCT00313534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101395648|NCT00313534|Analgesics|analgesics|mesh-ancestor
101395649|NCT00313534|Sensory System Agents|sensory system agents|mesh-ancestor
101395650|NCT00313534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101395651|NCT00313534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101395652|NCT00313534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101395653|NCT00313690|Docetaxel|docetaxel|mesh-list
101395654|NCT00313690|Bortezomib|bortezomib|mesh-list
101395655|NCT00313690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101395662|NCT00313885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102075016|NCT02402842|Immunologic Factors|immunologic factors|mesh-ancestor
102075017|NCT02402842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075018|NCT02741570|Cisplatin|cisplatin|mesh-list
102075019|NCT02741570|Carboplatin|carboplatin|mesh-list
102075020|NCT02741570|Fluorouracil|fluorouracil|mesh-list
102075021|NCT02741570|Nivolumab|nivolumab|mesh-list
102075022|NCT02741570|Cetuximab|cetuximab|mesh-list
102075023|NCT02741570|Ipilimumab|ipilimumab|mesh-list
102075024|NCT02741570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101376704|NCT00240448|Valsartan|valsartan|mesh-list
101395663|NCT00313885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395664|NCT00313885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101395665|NCT00313885|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101395667|NCT00313885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101395668|NCT00313885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395673|NCT00091143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101395674|NCT00091143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101395675|NCT00091143|Antimetabolites|antimetabolites|mesh-ancestor
101395676|NCT00091143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395677|NCT00091143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101395678|NCT00091143|Immunologic Factors|immunologic factors|mesh-ancestor
101395679|NCT00091143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395680|NCT00091143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101395681|NCT00091182|Oxaliplatin|oxaliplatin|mesh-list
101395682|NCT00091182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101395683|NCT04635280|Pancrelipase|pancrelipase|mesh-list
101395684|NCT04635280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101395685|NCT00122733|Loxapine|loxapine|mesh-list
101395686|NCT00122733|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101395687|NCT00122733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101395688|NCT00122733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101395689|NCT00122733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395690|NCT00122733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101395691|NCT00122733|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101395692|NCT00122733|Dopamine Agents|dopamine agents|mesh-ancestor
101395693|NCT00122733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101395694|NCT00122733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395695|NCT04432012|Dexamethasone|dexamethasone|mesh-list
101395696|NCT04432012|Dexamethasone acetate|dexamethasone acetate|mesh-list
101395697|NCT04432012|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101395698|NCT04432012|BB 1101|bb 1101|mesh-list
101395699|NCT04432012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101395700|NCT04432012|Antiemetics|antiemetics|mesh-ancestor
101395701|NCT04432012|Autonomic Agents|autonomic agents|mesh-ancestor
101395702|NCT04432012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101395703|NCT04432012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395704|NCT04432012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101395705|NCT04432012|Glucocorticoids|glucocorticoids|mesh-ancestor
101395706|NCT04432012|Hormones|hormones|mesh-ancestor
101395707|NCT04432012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101395708|NCT04432012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101395709|NCT04432012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101395710|NCT04432012|Protease Inhibitors|protease inhibitors|mesh-ancestor
101395711|NCT04432012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101305789|NCT02021864|Cholecalciferol|cholecalciferol|mesh-list
101305790|NCT02021864|Vitamins|vitamins|mesh-ancestor
101305791|NCT02021864|Micronutrients|micronutrients|mesh-ancestor
101305792|NCT02021864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305793|NCT02021864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101333853|NCT00017355|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101395712|NCT04432012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395713|NCT00091299|Warfarin|warfarin|mesh-list
101395714|NCT00091299|Anticoagulants|anticoagulants|mesh-ancestor
101395715|NCT04607603|Cannabidiol|cannabidiol|mesh-list
101395716|NCT04607603|Anticonvulsants|anticonvulsants|mesh-ancestor
101395717|NCT00122772|Cisplatin|cisplatin|mesh-list
101395718|NCT00122772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101395719|NCT00091338|Freund's Adjuvant|freund's adjuvant|mesh-list
101395720|NCT00091338|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102075025|NCT02741570|Antimetabolites|antimetabolites|mesh-ancestor
102075026|NCT02741570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075027|NCT02741570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102075028|NCT02741570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102075029|NCT02741570|Immunologic Factors|immunologic factors|mesh-ancestor
101794778|NCT00872144|Nabiximols|nabiximols|mesh-list
102075030|NCT02741570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075031|NCT02741570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101395721|NCT00091338|Immunologic Factors|immunologic factors|mesh-ancestor
101395722|NCT00091338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395723|NCT00122811|Perindopril|perindopril|mesh-list
101395724|NCT00122811|Indapamide|indapamide|mesh-list
101395725|NCT00122811|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101395726|NCT00122811|Protease Inhibitors|protease inhibitors|mesh-ancestor
101395732|NCT00122811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395733|NCT00122811|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101395734|NCT00122811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101395735|NCT04551170|Theophylline|theophylline|mesh-list
101395736|NCT04551170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101395737|NCT04551170|Autonomic Agents|autonomic agents|mesh-ancestor
101395738|NCT04551170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101395739|NCT04551170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395740|NCT04551170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101395744|NCT04551170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395745|NCT04551170|Vasodilator Agents|vasodilator agents|mesh-ancestor
101395746|NCT04551170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101395747|NCT04551170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101395748|NCT04551170|Purinergic Agents|purinergic agents|mesh-ancestor
101395749|NCT04551170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101395750|NCT00122850|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101395751|NCT00122850|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101395752|NCT00122850|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101395753|NCT00122850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101395754|NCT00122850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101395755|NCT00122850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395756|NCT00122850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101395757|NCT00122850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395758|NCT00122850|Analgesics|analgesics|mesh-ancestor
101395759|NCT00122850|Sensory System Agents|sensory system agents|mesh-ancestor
101395760|NCT00122850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101395761|NCT00122850|Antidepressive Agents|antidepressive agents|mesh-ancestor
101395762|NCT00122850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101395763|NCT00122850|Dopamine Agents|dopamine agents|mesh-ancestor
101395764|NCT00122850|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101395766|NCT04542278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101395767|NCT04542278|Glucocorticoids|glucocorticoids|mesh-ancestor
101395769|NCT04542278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101395770|NCT04542278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395771|NCT04542278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101395772|NCT04542278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101395773|NCT03975439|Chrysarobin|chrysarobin|mesh-list
101395774|NCT03975439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101395775|NCT03975439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101395776|NCT03975439|Analgesics|analgesics|mesh-ancestor
101395777|NCT03975439|Sensory System Agents|sensory system agents|mesh-ancestor
101395778|NCT03975439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101305794|NCT02021864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101305795|NCT02022163|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101305796|NCT02022163|Vaccines|vaccines|mesh-list
101305797|NCT02022163|Immunologic Factors|immunologic factors|mesh-ancestor
101305798|NCT02022163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182604|NCT02765256|Vancomycin|vancomycin|mesh-list
101395779|NCT03975439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075032|NCT02741570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102075033|NCT01061775|Exenatide|exenatide|mesh-list
102075034|NCT01061775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102075035|NCT01061775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075036|NCT01061775|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102075037|NCT01061775|Incretins|incretins|mesh-ancestor
102075038|NCT01061775|Hormones|hormones|mesh-ancestor
102075039|NCT01061775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101395780|NCT03975439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101395781|NCT03975439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101395782|NCT00091377|Paclitaxel|paclitaxel|mesh-list
101395783|NCT00091377|Cisplatin|cisplatin|mesh-list
101395784|NCT00091377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101395785|NCT00091377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101395786|NCT00091377|Tubulin Modulators|tubulin modulators|mesh-ancestor
101395787|NCT00091377|Antimitotic Agents|antimitotic agents|mesh-ancestor
101395788|NCT00091377|Mitosis Modulators|mitosis modulators|mesh-ancestor
101395789|NCT00091377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395790|NCT03897868|Losartan|losartan|mesh-list
101395791|NCT03897868|Amlodipine|amlodipine|mesh-list
101395792|NCT03897868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101395793|NCT03897868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101395797|NCT03897868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395798|NCT03897868|Vasodilator Agents|vasodilator agents|mesh-ancestor
101395799|NCT03897868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101395800|NCT03897868|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101395801|NCT03897868|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101395802|NCT00122889|Allicin|allicin|mesh-list
101395803|NCT00122889|Allyl sulfide|allyl sulfide|mesh-list
101395804|NCT00122889|Antioxidants|antioxidants|mesh-ancestor
101395805|NCT00122889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395806|NCT00122889|Protective Agents|protective agents|mesh-ancestor
101395807|NCT00122889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395808|NCT00122889|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101395823|NCT04729868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101395824|NCT04729868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395825|NCT04729868|Sensory System Agents|sensory system agents|mesh-ancestor
101395826|NCT04729868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101395827|NCT04729868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101395828|NCT04729868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101395830|NCT04729868|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101395831|NCT04729868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101395832|NCT04729868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101395833|NCT04729868|Adrenergic Agents|adrenergic agents|mesh-ancestor
101395834|NCT04729868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101395835|NCT04729868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395836|NCT00419887|Vildagliptin|vildagliptin|mesh-list
101395837|NCT00419887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101395838|NCT00419887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395839|NCT00419887|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101395840|NCT00419887|Protease Inhibitors|protease inhibitors|mesh-ancestor
101395841|NCT00419887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101395842|NCT00419887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395843|NCT03690544|Apremilast|apremilast|mesh-list
101395844|NCT03690544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101305799|NCT02022163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101305801|NCT02022163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305802|NCT02022163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101305803|NCT02022215|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101305804|NCT02022228|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101305805|NCT02022228|Luteolytic Agents|luteolytic agents|mesh-ancestor
101305806|NCT02022228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101182670|NCT02774226|Vitamins|vitamins|mesh-list
101395845|NCT03690544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101395846|NCT03690544|Analgesics|analgesics|mesh-ancestor
101395847|NCT03690544|Sensory System Agents|sensory system agents|mesh-ancestor
102075040|NCT02123628|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102075042|NCT02123628|Ciprofloxacin|ciprofloxacin|mesh-list
102075043|NCT02123628|Levofloxacin|levofloxacin|mesh-list
102075044|NCT02123628|Rifampin|rifampin|mesh-list
102075045|NCT02123628|Ceftriaxone|ceftriaxone|mesh-list
102075046|NCT02123628|Linezolid|linezolid|mesh-list
102075047|NCT02123628|Cefepime|cefepime|mesh-list
102075048|NCT02123628|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102075049|NCT02123628|Cefotaxime|cefotaxime|mesh-list
102075050|NCT02123628|Fusidic Acid|fusidic acid|mesh-list
102075051|NCT02123628|Trimethoprim|trimethoprim|mesh-list
101395848|NCT03690544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101395849|NCT03690544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395850|NCT03690544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101395851|NCT03690544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101395852|NCT03690544|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101395853|NCT03690544|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101395854|NCT03690544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101395855|NCT03690544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395856|NCT00314977|Cyclophosphamide|cyclophosphamide|mesh-list
101395857|NCT00314977|Docetaxel|docetaxel|mesh-list
101395858|NCT00314977|Doxorubicin|doxorubicin|mesh-list
101395859|NCT00314977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101395860|NCT00314977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101395861|NCT00314977|Immunologic Factors|immunologic factors|mesh-ancestor
101395878|NCT00315016|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101395879|NCT00315016|Hormone Antagonists|hormone antagonists|mesh-ancestor
101395880|NCT00315016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101395881|NCT00315016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395882|NCT00315016|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101395883|NCT00315016|Diuretics|diuretics|mesh-ancestor
101395884|NCT00315016|Natriuretic Agents|natriuretic agents|mesh-ancestor
101395885|NCT00315016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101395886|NCT00315016|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101395887|NCT00315016|Protease Inhibitors|protease inhibitors|mesh-ancestor
101395888|NCT00315016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101395889|NCT00315016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395890|NCT00419068|Cholecalciferol|cholecalciferol|mesh-list
101395891|NCT00419068|Vitamin D|vitamin d|mesh-list
101395892|NCT00419068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101395893|NCT00419068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395894|NCT00419068|Vitamins|vitamins|mesh-ancestor
101395895|NCT00419068|Micronutrients|micronutrients|mesh-ancestor
101395896|NCT00419068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101395897|NCT00419146|Vitamins|vitamins|mesh-list
101395898|NCT00419146|Vitamin E|vitamin e|mesh-list
101395899|NCT00419146|Tocopherols|tocopherols|mesh-list
101395900|NCT00419146|Tocotrienols|tocotrienols|mesh-list
101395901|NCT00419146|alpha-Tocopherol|alpha-tocopherol|mesh-list
101395902|NCT00419146|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
101395903|NCT00419146|Micronutrients|micronutrients|mesh-ancestor
101395904|NCT00419146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395905|NCT00419146|Antioxidants|antioxidants|mesh-ancestor
101395906|NCT00419146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395907|NCT00419146|Protective Agents|protective agents|mesh-ancestor
101395908|NCT00419146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101395909|NCT00419146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101395910|NCT02965196|Dexamethasone|dexamethasone|mesh-list
101395911|NCT02965196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101395912|NCT02965196|Antiemetics|antiemetics|mesh-ancestor
101395913|NCT02965196|Autonomic Agents|autonomic agents|mesh-ancestor
101395914|NCT02965196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101305807|NCT02022228|Contraceptive Agents|contraceptive agents|mesh-ancestor
101305808|NCT02022228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101395915|NCT02965196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395916|NCT02965196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102075053|NCT02123628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102075054|NCT02123628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102075055|NCT02123628|Antitubercular Agents|antitubercular agents|mesh-ancestor
102075056|NCT02123628|Antimalarials|antimalarials|mesh-ancestor
102075057|NCT02123628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102075058|NCT02123628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102075059|NCT02123628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101376734|NCT00076791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101395917|NCT02965196|Glucocorticoids|glucocorticoids|mesh-ancestor
101395918|NCT02965196|Hormones|hormones|mesh-ancestor
101395919|NCT02965196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101395920|NCT02965196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101395921|NCT02965196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101395922|NCT00091611|Cyclophosphamide|cyclophosphamide|mesh-list
101395923|NCT00091611|Fludarabine|fludarabine|mesh-list
101395924|NCT00091611|Interleukin-2|interleukin-2|mesh-list
101395925|NCT00091611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101395926|NCT00091611|Immunologic Factors|immunologic factors|mesh-ancestor
101395936|NCT00091611|Sensory System Agents|sensory system agents|mesh-ancestor
101395937|NCT00091611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101395939|NCT00123201|Hallucinogens|hallucinogens|mesh-ancestor
101395940|NCT00123201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395941|NCT00123201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101395942|NCT00123201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101395943|NCT00123201|Analgesics|analgesics|mesh-ancestor
101395944|NCT00123201|Sensory System Agents|sensory system agents|mesh-ancestor
101395945|NCT00123201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101395946|NCT00123201|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101395947|NCT00123201|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101395948|NCT00123201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101395949|NCT00123201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395950|NCT00123201|Hormones|hormones|mesh-ancestor
101395951|NCT00123201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101395952|NCT03031483|Clarithromycin|clarithromycin|mesh-list
101395953|NCT03031483|Lenalidomide|lenalidomide|mesh-list
101395964|NCT03031483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101395965|NCT03031483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395966|NCT03031483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101395967|NCT03031483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101395968|NCT00091650|Olanzapine|olanzapine|mesh-list
101395969|NCT00091650|Antiemetics|antiemetics|mesh-ancestor
101395970|NCT00091650|Autonomic Agents|autonomic agents|mesh-ancestor
101395971|NCT00091650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101395972|NCT00091650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395973|NCT00091650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101395974|NCT00091650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101395975|NCT00091650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101395976|NCT00091650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101395977|NCT00091650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101395978|NCT00091650|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101395979|NCT00091650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101395980|NCT00091650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101395981|NCT00091650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395982|NCT00091650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101395983|NCT00091650|Serotonin Agents|serotonin agents|mesh-ancestor
101395995|NCT00091728|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101395996|NCT00091728|Contraceptive Agents|contraceptive agents|mesh-list
101395997|NCT00091728|Medroxyprogesterone|medroxyprogesterone|mesh-list
101395998|NCT00091728|Contraceptives, Oral|contraceptives, oral|mesh-list
101456561|NCT00216827|Calcipotriene|calcipotriene|mesh-list
101305809|NCT02022228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305810|NCT02022228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101305811|NCT02022228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101305812|NCT02022228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102075060|NCT02123628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102075061|NCT02123628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102075062|NCT02123628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075063|NCT02123628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102075064|NCT02123628|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102075065|NCT02123628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101395999|NCT00091728|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
101396000|NCT00091728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101396001|NCT00091728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396002|NCT00091728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101396003|NCT00091728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101396004|NCT00091728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101396005|NCT00091728|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101396006|NCT00091728|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101396007|NCT00091728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101396008|NCT00091728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396010|NCT00123279|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101396011|NCT00123279|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101396012|NCT00123279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396014|NCT00091806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101396015|NCT00091806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396016|NCT01589302|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101396017|NCT01589302|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101396018|NCT01589302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101396019|NCT01589302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396020|NCT00123318|Cisplatin|cisplatin|mesh-list
101396021|NCT00123318|Fluorouracil|fluorouracil|mesh-list
101396024|NCT00123318|Antimetabolites|antimetabolites|mesh-ancestor
101396025|NCT00123318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396026|NCT00123318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101396027|NCT00123318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101396028|NCT00123318|Immunologic Factors|immunologic factors|mesh-ancestor
101396029|NCT00123318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396030|NCT00123318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101396031|NCT00123318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101396032|NCT00123318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101396033|NCT00123318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101396034|NCT00327535|Epoetin Alfa|epoetin alfa|mesh-list
101396035|NCT00327535|Darbepoetin alfa|darbepoetin alfa|mesh-list
101396036|NCT00327535|Hematinics|hematinics|mesh-ancestor
101396037|NCT00327691|Atorvastatin|atorvastatin|mesh-list
101396038|NCT00327691|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101396039|NCT00327691|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101396040|NCT00327691|Antimetabolites|antimetabolites|mesh-ancestor
101396041|NCT00327691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396042|NCT00327691|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101396043|NCT00327691|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101396044|NCT00327691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101396045|NCT03913832|Sirolimus|sirolimus|mesh-list
101396046|NCT03913832|Paclitaxel|paclitaxel|mesh-list
101396047|NCT03913832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101396048|NCT03913832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396049|NCT03913832|Tubulin Modulators|tubulin modulators|mesh-ancestor
101396050|NCT03913832|Antimitotic Agents|antimitotic agents|mesh-ancestor
101396051|NCT03913832|Mitosis Modulators|mitosis modulators|mesh-ancestor
101334951|NCT00397735|Protective Agents|protective agents|mesh-ancestor
101396052|NCT03913832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396053|NCT03913832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101396054|NCT03913832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101396055|NCT03913832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101396069|NCT00327730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101396071|NCT00327730|Autonomic Agents|autonomic agents|mesh-ancestor
101396072|NCT00327730|Vasodilator Agents|vasodilator agents|mesh-ancestor
101396073|NCT04716868|Levan|levan|mesh-list
101396074|NCT04716868|Psyllium|psyllium|mesh-list
101396075|NCT04716868|Cathartics|cathartics|mesh-ancestor
102075066|NCT02123628|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102075067|NCT02123628|Leprostatic Agents|leprostatic agents|mesh-ancestor
102075068|NCT02123628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102075069|NCT02123628|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102075070|NCT02123628|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102075071|NCT02123628|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101396076|NCT04716868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101396077|NCT04716868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101305813|NCT02022241|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101305814|NCT02022241|Luteolytic Agents|luteolytic agents|mesh-ancestor
101333854|NCT00017355|Immunologic Factors|immunologic factors|mesh-ancestor
101396079|NCT00327769|Anastrozole|anastrozole|mesh-list
101396080|NCT00327769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101396081|NCT00327769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396082|NCT00327769|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101396083|NCT00327769|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101396084|NCT00327769|Hormone Antagonists|hormone antagonists|mesh-ancestor
101396085|NCT00327769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101396086|NCT00327769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396087|NCT00327769|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101396088|NCT00327769|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101396089|NCT00327769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101396090|NCT00327769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396092|NCT00092001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396093|NCT00092001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101396094|NCT00092001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101396095|NCT00092001|Growth Substances|growth substances|mesh-ancestor
101396096|NCT00092001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396097|NCT00092001|Growth Inhibitors|growth inhibitors|mesh-ancestor
101396098|NCT00092001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101396099|NCT00092001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101396100|NCT00092001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396101|NCT03883919|Vitamin D|vitamin d|mesh-list
101396102|NCT03883919|Leucovorin|leucovorin|mesh-list
101396103|NCT03883919|Fluorouracil|fluorouracil|mesh-list
101396104|NCT03883919|Irinotecan|irinotecan|mesh-list
101396105|NCT03883919|Vitamins|vitamins|mesh-ancestor
101396106|NCT03883919|Micronutrients|micronutrients|mesh-ancestor
101396107|NCT03883919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396110|NCT03883919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396111|NCT03883919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101396112|NCT03883919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396113|NCT03883919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101396114|NCT03883919|Immunologic Factors|immunologic factors|mesh-ancestor
101396115|NCT03883919|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101396116|NCT03883919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101396131|NCT00327808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101396134|NCT00092079|Alendronate|alendronate|mesh-list
101396135|NCT00092079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101396136|NCT00092079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396137|NCT00092079|Vitamins|vitamins|mesh-ancestor
101396138|NCT00092079|Micronutrients|micronutrients|mesh-ancestor
101396139|NCT00092079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101396140|NCT00327847|Vitamin D|vitamin d|mesh-list
101396141|NCT00327847|Vitamins|vitamins|mesh-ancestor
101396142|NCT00327847|Micronutrients|micronutrients|mesh-ancestor
101396143|NCT00327847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396144|NCT00327847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101396145|NCT00327925|Antibodies|antibodies|mesh-list
101396146|NCT00327925|Immunologic Factors|immunologic factors|mesh-ancestor
101396147|NCT00327925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396148|NCT03709550|Decitabine|decitabine|mesh-list
101396149|NCT03709550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101396150|NCT03709550|Antimetabolites|antimetabolites|mesh-ancestor
101396151|NCT03709550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396152|NCT03709550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102075072|NCT02123628|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102075073|NCT02123628|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102075074|NCT02123628|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102075075|NCT02123628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102075076|NCT02123628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102075077|NCT02123628|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102075078|NCT02123628|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102075080|NCT02651116|Antitussive Agents|antitussive agents|mesh-ancestor
102075081|NCT02651116|Respiratory System Agents|respiratory system agents|mesh-ancestor
101376755|NCT04720807|Letrozole|letrozole|mesh-list
101491610|NCT00352235|KRN 7000|krn 7000|mesh-list
101396153|NCT03709550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101396154|NCT00315211|Docetaxel|docetaxel|mesh-list
101396155|NCT00315211|Topotecan|topotecan|mesh-list
101396156|NCT00315211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396157|NCT00315211|Tubulin Modulators|tubulin modulators|mesh-ancestor
101396158|NCT00315211|Antimitotic Agents|antimitotic agents|mesh-ancestor
101396159|NCT00315211|Mitosis Modulators|mitosis modulators|mesh-ancestor
101396160|NCT00315211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396161|NCT00315211|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101396162|NCT00315211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101396163|NCT00315211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101305815|NCT02022241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101305816|NCT02022241|Contraceptive Agents|contraceptive agents|mesh-ancestor
101305817|NCT02022241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101305818|NCT02022241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305819|NCT02022241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101305820|NCT02022241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101305821|NCT02022241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101305822|NCT02022254|Metformin|metformin|mesh-list
101305823|NCT02022254|Warfarin|warfarin|mesh-list
101305824|NCT02022254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101305825|NCT02022254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305826|NCT02022254|Anticoagulants|anticoagulants|mesh-ancestor
101396164|NCT00315367|Donepezil|donepezil|mesh-list
101396165|NCT00315367|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101396166|NCT00315367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101396167|NCT00315367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396168|NCT00315367|Cholinergic Agents|cholinergic agents|mesh-ancestor
101396169|NCT00315367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101396170|NCT00315367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396171|NCT00315367|Nootropic Agents|nootropic agents|mesh-ancestor
101396172|NCT00315484|Epoetin Alfa|epoetin alfa|mesh-list
101396173|NCT00315484|Darbepoetin alfa|darbepoetin alfa|mesh-list
101396174|NCT00315484|Hematinics|hematinics|mesh-ancestor
101396175|NCT00315523|Levocetirizine|levocetirizine|mesh-list
101396176|NCT00315523|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101396177|NCT00315523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101396178|NCT00315523|Histamine Antagonists|histamine antagonists|mesh-ancestor
101396179|NCT00315523|Histamine Agents|histamine agents|mesh-ancestor
101396180|NCT00315523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101396181|NCT00315523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396187|NCT00092196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396188|NCT00092196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101396190|NCT00092196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101396191|NCT00092196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396193|NCT00315601|Telithromycin|telithromycin|mesh-list
101396194|NCT00315601|Dimercaprol|dimercaprol|mesh-list
101396195|NCT00315601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101396196|NCT00315601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101396197|NCT00315601|Chelating Agents|chelating agents|mesh-ancestor
101396198|NCT00315601|Sequestering Agents|sequestering agents|mesh-ancestor
102075082|NCT02651116|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101335018|NCT00046735|Lenalidomide|lenalidomide|mesh-list
102075083|NCT02651116|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102075084|NCT02651116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102075085|NCT02651116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075086|NCT02651116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075087|NCT03652467|Chlorotrianisene|chlorotrianisene|mesh-list
102075088|NCT03652467|Deferoxamine|deferoxamine|mesh-list
102075089|NCT03652467|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102075090|NCT03652467|Estrogens|estrogens|mesh-ancestor
102075092|NCT03652467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102075093|NCT03652467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075094|NCT03652467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102075095|NCT03652467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102075096|NCT03652467|Siderophores|siderophores|mesh-ancestor
102075097|NCT03652467|Iron Chelating Agents|iron chelating agents|mesh-ancestor
102075098|NCT03652467|Chelating Agents|chelating agents|mesh-ancestor
102075099|NCT03652467|Sequestering Agents|sequestering agents|mesh-ancestor
102075100|NCT03652467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396199|NCT00315601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396200|NCT00315679|Pentoxifylline|pentoxifylline|mesh-list
101396201|NCT00315679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101396202|NCT00315679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101396203|NCT00315679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396204|NCT00315679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101396205|NCT00315679|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101396206|NCT00315679|Protective Agents|protective agents|mesh-ancestor
101396207|NCT00315679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396208|NCT00315679|Vasodilator Agents|vasodilator agents|mesh-ancestor
101396209|NCT00315679|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101396210|NCT00315679|Antioxidants|antioxidants|mesh-ancestor
101396211|NCT00092274|Ofatumumab|ofatumumab|mesh-list
101396212|NCT00092274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396213|NCT00315835|Buprenorphine|buprenorphine|mesh-list
101396214|NCT00315835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101396215|NCT00315835|Narcotics|narcotics|mesh-ancestor
101396216|NCT00315835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101396217|NCT00315835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396218|NCT00315835|Analgesics|analgesics|mesh-ancestor
101396219|NCT00315835|Sensory System Agents|sensory system agents|mesh-ancestor
101396220|NCT00315835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101305828|NCT02022293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101305829|NCT02022293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101305830|NCT02022293|Antimetabolites|antimetabolites|mesh-ancestor
101333855|NCT00017355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396221|NCT00315835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101396222|NCT00315874|Buprenorphine|buprenorphine|mesh-list
101396223|NCT00315874|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101396224|NCT00315874|Narcotics|narcotics|mesh-ancestor
101396225|NCT00315874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101396226|NCT00315874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396227|NCT00315874|Analgesics|analgesics|mesh-ancestor
101396228|NCT00315874|Sensory System Agents|sensory system agents|mesh-ancestor
101396229|NCT00315874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102075101|NCT03528824|Diclofenac|diclofenac|mesh-list
102075102|NCT03528824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102075103|NCT03528824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102075104|NCT03528824|Analgesics|analgesics|mesh-ancestor
101335063|NCT00047047|Gemcitabine|gemcitabine|mesh-list
102075105|NCT03528824|Sensory System Agents|sensory system agents|mesh-ancestor
101376786|NCT00240955|Antitubercular Agents|antitubercular agents|mesh-ancestor
101396230|NCT00315874|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101396231|NCT00315913|Propranolol|propranolol|mesh-list
101396232|NCT00315913|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101396233|NCT00315913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101396234|NCT00315913|Adrenergic Agents|adrenergic agents|mesh-ancestor
101396235|NCT00315913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101396236|NCT00315913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396237|NCT00315913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396238|NCT00315913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101396239|NCT00315913|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101396240|NCT00315913|Vasodilator Agents|vasodilator agents|mesh-ancestor
101396241|NCT00092313|Acetaminophen|acetaminophen|mesh-list
101396242|NCT00092313|Rofecoxib|rofecoxib|mesh-list
101396243|NCT00092313|Oxycodone|oxycodone|mesh-list
101396244|NCT00092313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101396245|NCT00092313|Analgesics|analgesics|mesh-ancestor
101396246|NCT00092313|Sensory System Agents|sensory system agents|mesh-ancestor
101396247|NCT00092313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101396248|NCT00092313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396249|NCT00092313|Antipyretics|antipyretics|mesh-ancestor
101396250|NCT00092313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101396251|NCT00092313|Narcotics|narcotics|mesh-ancestor
101396256|NCT00092313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396257|NCT00092313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101396258|NCT00092313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101396260|NCT00399971|Immunomodulating Agents|immunomodulating agents|mesh-list
101396261|NCT00399971|Immunologic Factors|immunologic factors|mesh-list
101396262|NCT00399971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396263|NCT00316030|Bexarotene|bexarotene|mesh-list
101396264|NCT00316030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396265|NCT00123552|Artesunate|artesunate|mesh-list
101396272|NCT00123552|Antimalarials|antimalarials|mesh-ancestor
101396273|NCT00123552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101396274|NCT00123552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101396275|NCT00123552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101396276|NCT00123552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396277|NCT00123552|Antiviral Agents|antiviral agents|mesh-ancestor
101396278|NCT00123552|Schistosomicides|schistosomicides|mesh-ancestor
101396279|NCT00123552|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101396280|NCT00123552|Anthelmintics|anthelmintics|mesh-ancestor
101396281|NCT00123552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101396282|NCT00123552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101396283|NCT00123552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396284|NCT00123552|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101396286|NCT03352427|Dasatinib|dasatinib|mesh-list
101396287|NCT03352427|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101396288|NCT03352427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101396289|NCT03352427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101396290|NCT03352427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396291|NCT03352427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101396292|NCT03352427|Immunologic Factors|immunologic factors|mesh-ancestor
101396293|NCT03352427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305831|NCT02022293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305832|NCT02022293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101305833|NCT02022293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101305834|NCT02022293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101305836|NCT02022358|Folic Acid|folic acid|mesh-list
101305837|NCT02022358|Methotrexate|methotrexate|mesh-list
101305838|NCT02022358|Levoleucovorin|levoleucovorin|mesh-list
101305839|NCT02022358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101305840|NCT02022358|Abortifacient Agents|abortifacient agents|mesh-ancestor
101305841|NCT02022358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101305842|NCT02022358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075106|NCT03528824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102075107|NCT03528824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075108|NCT03528824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102075109|NCT03528824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102075110|NCT03528824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102075111|NCT03528824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102075112|NCT03528824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075113|NCT00289640|Ipilimumab|ipilimumab|mesh-list
102075114|NCT00289640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102075115|NCT00289640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102075116|NCT00289640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101305843|NCT02022358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101305844|NCT02022358|Antimetabolites|antimetabolites|mesh-ancestor
101305845|NCT02022358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305846|NCT02022358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101305847|NCT02022358|Dermatologic Agents|dermatologic agents|mesh-ancestor
101305848|NCT02022358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101305849|NCT02022358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101305850|NCT02022358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101305851|NCT02022358|Immunologic Factors|immunologic factors|mesh-ancestor
101305852|NCT02022358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101305853|NCT02022358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101305854|NCT02022358|Antidotes|antidotes|mesh-ancestor
101305855|NCT02022358|Protective Agents|protective agents|mesh-ancestor
101305856|NCT02022358|Vitamin B Complex|vitamin b complex|mesh-ancestor
101396294|NCT03352427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396295|NCT00316420|Gemcitabine|gemcitabine|mesh-list
101396296|NCT00316420|Capecitabine|capecitabine|mesh-list
101396297|NCT00316420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101396298|NCT00316420|Antimetabolites|antimetabolites|mesh-ancestor
101396299|NCT00316420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396300|NCT00316420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396301|NCT00092352|Celecoxib|celecoxib|mesh-list
101396302|NCT00092352|Rofecoxib|rofecoxib|mesh-list
101396303|NCT00092352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101396304|NCT00092352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101396305|NCT00092352|Analgesics|analgesics|mesh-ancestor
101396306|NCT00092352|Sensory System Agents|sensory system agents|mesh-ancestor
101396307|NCT00092352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101396308|NCT00092352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396309|NCT00092352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101396310|NCT00092352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101305859|NCT02022358|Hematinics|hematinics|mesh-ancestor
101396316|NCT00316498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101396317|NCT00316498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396318|NCT00316498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101396319|NCT00316498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101396320|NCT00316498|Antiviral Agents|antiviral agents|mesh-ancestor
101396321|NCT00316498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101396322|NCT00316498|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101396329|NCT00316810|Immunologic Factors|immunologic factors|mesh-ancestor
101396330|NCT00316810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396331|NCT00316810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101396332|NCT00092391|Vaccines|vaccines|mesh-list
101396333|NCT00092391|Immunologic Factors|immunologic factors|mesh-ancestor
101396334|NCT00092391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396335|NCT00316849|Sirolimus|sirolimus|mesh-list
101396336|NCT00316849|Temozolomide|temozolomide|mesh-list
101396337|NCT00316849|Temsirolimus|temsirolimus|mesh-list
101396338|NCT00316849|MTOR Inhibitors|mtor inhibitors|mesh-list
101396339|NCT00316849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101396340|NCT00316849|Alkylating Agents|alkylating agents|mesh-ancestor
102075117|NCT00289640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075118|NCT05039086|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
102075119|NCT05039086|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
102075120|NCT05039086|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102075121|NCT05039086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102075122|NCT05039086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075123|NCT03552432|Alirocumab|alirocumab|mesh-list
102075124|NCT03552432|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102075125|NCT03552432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101396341|NCT00316849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396342|NCT00316849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396343|NCT00316849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101396345|NCT00316849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101396346|NCT00316849|Immunologic Factors|immunologic factors|mesh-ancestor
101396347|NCT00316849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396348|NCT00316849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101396349|NCT00316849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101396350|NCT00316849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101396351|NCT00316849|Antifungal Agents|antifungal agents|mesh-ancestor
101396352|NCT03272477|Tamoxifen|tamoxifen|mesh-list
101396353|NCT03272477|Paclitaxel|paclitaxel|mesh-list
101396354|NCT03272477|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101396355|NCT03272477|Cyclophosphamide|cyclophosphamide|mesh-list
101396356|NCT03272477|Trastuzumab|trastuzumab|mesh-list
101396357|NCT03272477|Letrozole|letrozole|mesh-list
101396358|NCT03272477|Epirubicin|epirubicin|mesh-list
101396359|NCT03272477|Pertuzumab|pertuzumab|mesh-list
101396360|NCT03272477|Anastrozole|anastrozole|mesh-list
101396361|NCT03272477|Exemestane|exemestane|mesh-list
101396362|NCT03272477|Goserelin|goserelin|mesh-list
101396363|NCT03272477|Leuprolide|leuprolide|mesh-list
101396364|NCT03272477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101396365|NCT03272477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396366|NCT03272477|Tubulin Modulators|tubulin modulators|mesh-ancestor
101396367|NCT03272477|Antimitotic Agents|antimitotic agents|mesh-ancestor
101396368|NCT03272477|Mitosis Modulators|mitosis modulators|mesh-ancestor
101396369|NCT03272477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396370|NCT03272477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101396371|NCT03272477|Immunologic Factors|immunologic factors|mesh-ancestor
101396372|NCT03272477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396373|NCT03272477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101396374|NCT03272477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101396375|NCT03272477|Alkylating Agents|alkylating agents|mesh-ancestor
101396376|NCT03272477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101396377|NCT03272477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101396378|NCT03272477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101396379|NCT03272477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101396380|NCT03272477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101396381|NCT03272477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101396382|NCT03272477|Hormone Antagonists|hormone antagonists|mesh-ancestor
101396383|NCT03272477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101396384|NCT03272477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101396391|NCT03272477|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101396392|NCT03272477|Fertility Agents|fertility agents|mesh-ancestor
101335160|NCT00047554|Travoprost|travoprost|mesh-list
101396393|NCT03272477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101305860|NCT02022475|Vitamin D|vitamin d|mesh-list
101305861|NCT02022475|Cholecalciferol|cholecalciferol|mesh-list
101305862|NCT02022475|Vitamins|vitamins|mesh-ancestor
101396399|NCT00316927|Aspirin|aspirin|mesh-list
101396400|NCT00316927|Dexamethasone|dexamethasone|mesh-list
101396401|NCT00316927|Fosfestrol|fosfestrol|mesh-list
101396402|NCT00316927|Diethylstilbestrol|diethylstilbestrol|mesh-list
101396403|NCT00316927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101396404|NCT00316927|Antiemetics|antiemetics|mesh-ancestor
101396405|NCT00316927|Autonomic Agents|autonomic agents|mesh-ancestor
101396406|NCT00316927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101396407|NCT00316927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075126|NCT03552432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102075127|NCT03552432|Antimetabolites|antimetabolites|mesh-ancestor
102075128|NCT03552432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075129|NCT03552432|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101376815|NCT00066248|Cyproheptadine|cyproheptadine|mesh-list
101396408|NCT00316927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101396409|NCT00316927|Glucocorticoids|glucocorticoids|mesh-ancestor
101396410|NCT00316927|Hormones|hormones|mesh-ancestor
101396411|NCT00316927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101396412|NCT00316927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101396413|NCT00316927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396414|NCT00316927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101396415|NCT00316927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101396416|NCT00316927|Analgesics|analgesics|mesh-ancestor
101396417|NCT00316927|Sensory System Agents|sensory system agents|mesh-ancestor
101396418|NCT00316927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101396419|NCT00316927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101396420|NCT00316927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101396421|NCT00316927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396422|NCT00316927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101396423|NCT00316927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101396424|NCT00316927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101396425|NCT00316927|Antipyretics|antipyretics|mesh-ancestor
101396426|NCT00316927|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101396427|NCT00316927|Estrogens|estrogens|mesh-ancestor
101396428|NCT00123669|Progesterone|progesterone|mesh-list
101396429|NCT00123669|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
101396430|NCT00123669|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
101396431|NCT00123669|Progestins|progestins|mesh-ancestor
101396432|NCT00123669|Hormones|hormones|mesh-ancestor
101396433|NCT00123669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101396434|NCT00123669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396435|NCT00123669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101396436|NCT00123669|Hormone Antagonists|hormone antagonists|mesh-ancestor
101396437|NCT00317200|Paclitaxel|paclitaxel|mesh-list
101396438|NCT00317200|Bevacizumab|bevacizumab|mesh-list
101396439|NCT00317200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101396440|NCT00317200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396441|NCT00317200|Tubulin Modulators|tubulin modulators|mesh-ancestor
101396442|NCT00317200|Antimitotic Agents|antimitotic agents|mesh-ancestor
101396443|NCT00317200|Mitosis Modulators|mitosis modulators|mesh-ancestor
101396444|NCT00317200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396445|NCT00317200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101396446|NCT00317200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101396447|NCT00317200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101396448|NCT00317200|Growth Substances|growth substances|mesh-ancestor
101396449|NCT00317200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396450|NCT00317200|Growth Inhibitors|growth inhibitors|mesh-ancestor
101396451|NCT02960035|Etanercept|etanercept|mesh-list
101396452|NCT02960035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101396453|NCT02960035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101396454|NCT02960035|Analgesics|analgesics|mesh-ancestor
101396457|NCT02960035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396458|NCT02960035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101396459|NCT02960035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101396460|NCT02960035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101396461|NCT02960035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101396462|NCT02960035|Immunologic Factors|immunologic factors|mesh-ancestor
101396464|NCT00317434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335338|NCT00048880|Antibodies|antibodies|mesh-list
101396465|NCT00317434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101396470|NCT00328120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396471|NCT00328120|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101396472|NCT00328120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101396473|NCT00328120|Hormone Antagonists|hormone antagonists|mesh-ancestor
101305863|NCT02022475|Micronutrients|micronutrients|mesh-ancestor
101305864|NCT02022475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305865|NCT02022475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101305866|NCT02022475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102075131|NCT03552432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102075132|NCT03552432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102075133|NCT03765632|Busulfan|busulfan|mesh-list
102075134|NCT03765632|Alkylating Agents|alkylating agents|mesh-ancestor
102075135|NCT03765632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075136|NCT03765632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102075137|NCT03765632|Immunologic Factors|immunologic factors|mesh-ancestor
102075138|NCT03765632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396474|NCT00328120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101396475|NCT00328120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396476|NCT00328393|Pioglitazone|pioglitazone|mesh-list
101396477|NCT00328393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101396478|NCT00328393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396480|NCT00328432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101396481|NCT00328432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101396482|NCT00328432|Analgesics|analgesics|mesh-ancestor
101396483|NCT00328432|Sensory System Agents|sensory system agents|mesh-ancestor
101396484|NCT00328432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101396485|NCT00328432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396486|NCT00328432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101396487|NCT00328432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101396488|NCT00328432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101396489|NCT00328432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101396490|NCT00328432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101396491|NCT00328432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396492|NCT02571725|Olaparib|olaparib|mesh-list
101396493|NCT02571725|Tremelimumab|tremelimumab|mesh-list
101396494|NCT02571725|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101396495|NCT02571725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101396496|NCT02571725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396497|NCT02571725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396498|NCT00328549|Interferons|interferons|mesh-list
101396499|NCT00328549|Ribavirin|ribavirin|mesh-list
101396500|NCT00328549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396501|NCT00328549|Antiviral Agents|antiviral agents|mesh-ancestor
101396502|NCT00328549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101396503|NCT00328549|Antimetabolites|antimetabolites|mesh-ancestor
101396504|NCT00328549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396505|NCT00092508|Mesalamine|mesalamine|mesh-list
101396506|NCT00092508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101396507|NCT00092508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101396508|NCT00092508|Analgesics|analgesics|mesh-ancestor
101396509|NCT00092508|Sensory System Agents|sensory system agents|mesh-ancestor
101396510|NCT00092508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101396511|NCT00092508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396512|NCT00092508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101396513|NCT00092508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101396514|NCT00328822|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101396515|NCT00328822|Antidepressive Agents|antidepressive agents|mesh-ancestor
101396516|NCT00328822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101396517|NCT00328822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101396518|NCT00328822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101396519|NCT00328822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101396520|NCT00328822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396521|NCT00420043|Imatinib Mesylate|imatinib mesylate|mesh-list
101396522|NCT00420043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396523|NCT00420043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101396524|NCT00420043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101396525|NCT00420043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396526|NCT00420082|Cetirizine|cetirizine|mesh-list
101396530|NCT00420082|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101396531|NCT00420082|Histamine Antagonists|histamine antagonists|mesh-ancestor
101396532|NCT00420082|Histamine Agents|histamine agents|mesh-ancestor
101396533|NCT00420082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102075139|NCT03765632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102075140|NCT03765632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102075141|NCT03765632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102075142|NCT02973477|Dapagliflozin|dapagliflozin|mesh-list
102075143|NCT02973477|Glimepiride|glimepiride|mesh-list
102075144|NCT02973477|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101335439|NCT00049660|Tubulin Modulators|tubulin modulators|mesh-ancestor
101396534|NCT00420082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396557|NCT00328900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101396558|NCT00328900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396560|NCT00328939|PENTA|penta|mesh-list
101305868|NCT02022488|Ketamine|ketamine|mesh-list
101305869|NCT02022488|Alfentanil|alfentanil|mesh-list
101305870|NCT02022488|Analgesics|analgesics|mesh-ancestor
101305871|NCT02022488|Sensory System Agents|sensory system agents|mesh-ancestor
101396561|NCT00328939|Fondaparinux|fondaparinux|mesh-list
101396562|NCT00328939|Anticoagulants|anticoagulants|mesh-ancestor
101396563|NCT00328939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101396564|NCT00328939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101396565|NCT00328939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396566|NCT00328939|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101396567|NCT00328939|Antithrombins|antithrombins|mesh-ancestor
101396568|NCT00328939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101396569|NCT00328939|Protease Inhibitors|protease inhibitors|mesh-ancestor
101396570|NCT00328939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101396571|NCT00328978|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101396572|NCT00328978|Antidepressive Agents|antidepressive agents|mesh-ancestor
101396573|NCT00328978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101396574|NCT00328978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101396575|NCT00328978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101396576|NCT00328978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101396577|NCT00328978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396578|NCT00329095|Bimatoprost|bimatoprost|mesh-list
101396579|NCT00329095|Travoprost|travoprost|mesh-list
101396580|NCT00329095|Antihypertensive Agents|antihypertensive agents|mesh-list
101396581|NCT00329095|Latanoprost|latanoprost|mesh-list
101396582|NCT00329095|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101396583|NCT00329095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101396584|NCT00329134|Quinine|quinine|mesh-list
101396585|NCT00329134|Antimalarials|antimalarials|mesh-ancestor
101396586|NCT00329134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101396587|NCT00329134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101396588|NCT00329134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101396589|NCT00329134|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101396593|NCT00329134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101396594|NCT00329134|Analgesics|analgesics|mesh-ancestor
101396595|NCT00329134|Sensory System Agents|sensory system agents|mesh-ancestor
101396596|NCT00329173|Atorvastatin|atorvastatin|mesh-list
101396597|NCT00329173|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101396598|NCT00329173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101396599|NCT00329173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101396600|NCT00329173|Antimetabolites|antimetabolites|mesh-ancestor
101396601|NCT00329173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396602|NCT00329173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101396603|NCT00329173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101396604|NCT00329173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101396605|NCT00123825|Gemcitabine|gemcitabine|mesh-list
101396606|NCT00123825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396607|NCT00123825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101396608|NCT00123825|Antimetabolites|antimetabolites|mesh-ancestor
101396609|NCT00123825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396610|NCT00329329|Capecitabine|capecitabine|mesh-list
101396611|NCT00329329|Satraplatin|satraplatin|mesh-list
101396612|NCT00329329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101396613|NCT00329329|Antimetabolites|antimetabolites|mesh-ancestor
101396614|NCT00329329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396615|NCT00329329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396616|NCT00329368|Folic Acid|folic acid|mesh-list
101396617|NCT00329368|Vitamin B Complex|vitamin b complex|mesh-list
101396618|NCT00329368|Interferons|interferons|mesh-list
101396619|NCT00329368|Interferon-alpha|interferon-alpha|mesh-list
101396620|NCT00329368|Interleukin-2|interleukin-2|mesh-list
102075145|NCT02973477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075146|NCT02973477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102075147|NCT02973477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075148|NCT02973477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102075149|NCT02973477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102075150|NCT02973477|Immunologic Factors|immunologic factors|mesh-ancestor
102075151|NCT03552354|Argatroban|argatroban|mesh-list
102075152|NCT03552354|Antithrombins|antithrombins|mesh-ancestor
102075153|NCT03552354|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101456856|NCT00558337|Levodopa|levodopa|mesh-list
102075154|NCT03552354|Protease Inhibitors|protease inhibitors|mesh-ancestor
101396621|NCT00329368|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
101396622|NCT00329368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396623|NCT00329368|Antiviral Agents|antiviral agents|mesh-ancestor
101396628|NCT00329368|Analgesics|analgesics|mesh-ancestor
101396629|NCT00329368|Sensory System Agents|sensory system agents|mesh-ancestor
101396630|NCT00329368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101396631|NCT00329368|Hematinics|hematinics|mesh-ancestor
101396632|NCT00329368|Vitamins|vitamins|mesh-ancestor
101396633|NCT00329368|Micronutrients|micronutrients|mesh-ancestor
101396634|NCT00329368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101396635|NCT00329446|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101305872|NCT02022488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101305873|NCT02022488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305874|NCT02022488|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101396636|NCT00329446|Escitalopram|escitalopram|mesh-list
101396637|NCT00329446|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101396638|NCT00329446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101396639|NCT00329446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101396640|NCT00329446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396641|NCT00329446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101396642|NCT00329446|Serotonin Agents|serotonin agents|mesh-ancestor
101396643|NCT00329446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396645|NCT00329446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101396646|NCT00329446|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101396647|NCT00329446|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101396648|NCT00329446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101396649|NCT00092937|Busulfan|busulfan|mesh-list
101396650|NCT00092937|Alkylating Agents|alkylating agents|mesh-ancestor
101396651|NCT00092937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396652|NCT00092937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101396653|NCT00092937|Immunologic Factors|immunologic factors|mesh-ancestor
101396654|NCT00092937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396655|NCT00092937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101396656|NCT00092937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396657|NCT00092937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101396658|NCT00420277|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
101396659|NCT00420277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101396660|NCT00420277|Plasma Substitutes|plasma substitutes|mesh-ancestor
101396661|NCT00420277|Blood Substitutes|blood substitutes|mesh-ancestor
101396662|NCT04716751|Paclitaxel|paclitaxel|mesh-list
101396666|NCT04716751|Tubulin Modulators|tubulin modulators|mesh-ancestor
101396667|NCT04716751|Antimitotic Agents|antimitotic agents|mesh-ancestor
101396668|NCT04716751|Mitosis Modulators|mitosis modulators|mesh-ancestor
101396669|NCT04716751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396670|NCT00123903|Metoprolol|metoprolol|mesh-list
101396671|NCT00123903|Carvedilol|carvedilol|mesh-list
101396672|NCT00123903|Lisinopril|lisinopril|mesh-list
101396673|NCT00123903|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101396674|NCT00123903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101396675|NCT00123903|Sympatholytics|sympatholytics|mesh-ancestor
101396676|NCT00123903|Autonomic Agents|autonomic agents|mesh-ancestor
101396677|NCT00123903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101396678|NCT00123903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396679|NCT00123903|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102075155|NCT03552354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102075156|NCT03552354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075157|NCT03552354|Anticoagulants|anticoagulants|mesh-ancestor
102075158|NCT03552354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102075159|NCT02288000|Memantine|memantine|mesh-list
102075160|NCT02288000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102075161|NCT02288000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102075162|NCT02288000|Dopamine Agents|dopamine agents|mesh-ancestor
102075163|NCT02288000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101396680|NCT00123903|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101396681|NCT00123903|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101396682|NCT00123903|Adrenergic Agents|adrenergic agents|mesh-ancestor
101396683|NCT00123903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101396684|NCT00123903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396685|NCT00123903|Antioxidants|antioxidants|mesh-ancestor
101396686|NCT00123903|Protective Agents|protective agents|mesh-ancestor
101396687|NCT00123903|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101396688|NCT00123903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101396689|NCT00123903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101396690|NCT00123903|Vasodilator Agents|vasodilator agents|mesh-ancestor
101396691|NCT00123903|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101457176|NCT04639804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101396692|NCT00123903|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101396693|NCT00123903|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101305877|NCT02022488|Anesthetics|anesthetics|mesh-ancestor
101396706|NCT00329680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101396707|NCT00329680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101457242|NCT00561496|Tenofovir|tenofovir|mesh-list
101396708|NCT00329680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101396709|NCT00329680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101396710|NCT00329680|Antimetabolites|antimetabolites|mesh-ancestor
101396711|NCT00329680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101396712|NCT00329680|Dermatologic Agents|dermatologic agents|mesh-ancestor
101396713|NCT00329758|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101396714|NCT00329758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101396715|NCT00329758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101396716|NCT00329758|Antimetabolites|antimetabolites|mesh-ancestor
101396717|NCT00329758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396718|NCT00329758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101396719|NCT00329758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101396720|NCT00329758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101396721|NCT00329914|Progesterone|progesterone|mesh-list
101396722|NCT00329914|Progestins|progestins|mesh-ancestor
101396723|NCT00329914|Hormones|hormones|mesh-ancestor
101396724|NCT00329914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101396725|NCT00329914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396726|NCT00092976|Factor VIII|factor viii|mesh-list
101396727|NCT00092976|Coagulants|coagulants|mesh-ancestor
101396728|NCT00083876|Thalidomide|thalidomide|mesh-list
101396729|NCT00083876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101396730|NCT00083876|Immunologic Factors|immunologic factors|mesh-ancestor
101396731|NCT00083876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396732|NCT00083876|Leprostatic Agents|leprostatic agents|mesh-ancestor
101396733|NCT00083876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101396734|NCT00083876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101396739|NCT00083876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396740|NCT00330148|Eflornithine|eflornithine|mesh-list
101396741|NCT00330148|Nifurtimox|nifurtimox|mesh-list
101396742|NCT00330148|Melarsoprol|melarsoprol|mesh-list
101396743|NCT00330148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396744|NCT00330148|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101396745|NCT00330148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101396746|NCT00330148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101396747|NCT00330148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101396748|NCT00330148|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
101396749|NCT00330148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101396750|NCT00330148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396751|NCT00093093|Interferons|interferons|mesh-list
102075164|NCT02288000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075165|NCT02288000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075166|NCT02288000|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102075167|NCT02288000|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102075169|NCT02788656|Angiotensin II|angiotensin ii|mesh-list
102075170|NCT02788656|Giapreza|giapreza|mesh-list
102075171|NCT02788656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
102075172|NCT02788656|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101376850|NCT00241189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101492275|NCT00459615|Artesunate|artesunate|mesh-list
101396752|NCT00093093|Ribavirin|ribavirin|mesh-list
101396753|NCT00093093|Interferon-alpha|interferon-alpha|mesh-list
101396754|NCT00093093|Interferon alpha-2|interferon alpha-2|mesh-list
101396755|NCT00093093|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101396756|NCT00093093|Taribavirin|taribavirin|mesh-list
101396757|NCT00093093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396761|NCT00093093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396763|NCT00093093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396764|NCT00330304|Isoniazid|isoniazid|mesh-list
101396765|NCT00330304|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101396766|NCT00330304|Antitubercular Agents|antitubercular agents|mesh-ancestor
101396767|NCT00330304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101396768|NCT00330304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101396769|NCT00330304|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101396770|NCT00330304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101396771|NCT00330304|Antimetabolites|antimetabolites|mesh-ancestor
101396772|NCT00330304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396773|NCT00330304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101396774|NCT00330304|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101396775|NCT00330304|Antimalarials|antimalarials|mesh-ancestor
101396776|NCT00330304|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101396777|NCT00330304|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101396778|NCT00330499|Cisplatin|cisplatin|mesh-list
101396779|NCT00330499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396780|NCT00083954|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101305878|NCT02022488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101183573|NCT03107754|Lidocaine|lidocaine|mesh-list
101396781|NCT00083954|Antidepressive Agents|antidepressive agents|mesh-ancestor
101396782|NCT00083954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101396783|NCT00083954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101396784|NCT00083954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101396785|NCT00083954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101396786|NCT00083954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396787|NCT00330577|Timolol|timolol|mesh-list
101396788|NCT00330577|Latanoprost|latanoprost|mesh-list
101396789|NCT00330577|Lubricant Eye Drops|lubricant eye drops|mesh-list
101396790|NCT00330577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396791|NCT00330577|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101396792|NCT00330577|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101396793|NCT00330577|Adrenergic Agents|adrenergic agents|mesh-ancestor
101396794|NCT00330577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101396795|NCT00330577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396796|NCT00330577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101396797|NCT00330577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101396798|NCT00330577|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101396799|NCT00330577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101396800|NCT00083993|Sirolimus|sirolimus|mesh-list
101396801|NCT00083993|Letrozole|letrozole|mesh-list
101396802|NCT00083993|Temsirolimus|temsirolimus|mesh-list
101396803|NCT00083993|MTOR Inhibitors|mtor inhibitors|mesh-list
101396804|NCT00083993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396805|NCT00083993|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101396806|NCT00083993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102075173|NCT02788656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
102075175|NCT02788656|Angiotensinogen|angiotensinogen|mesh-list
101457753|NCT00220298|Testosterone undecanoate|testosterone undecanoate|mesh-list
102075176|NCT02788656|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101794924|NCT00994539|Analgesics|analgesics|mesh-ancestor
102075177|NCT02788656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102075178|NCT02788656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075179|NCT02788656|Protease Inhibitors|protease inhibitors|mesh-ancestor
102075180|NCT02788656|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102075181|NCT02788656|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102075183|NCT05258110|BI 425809|bi 425809|mesh-list
102075184|NCT05258110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101376861|NCT00241189|Antifungal Agents|antifungal agents|mesh-ancestor
101492345|NCT01058642|Pregabalin|pregabalin|mesh-list
101396807|NCT00083993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101457821|NCT04621513|Montelukast|montelukast|mesh-list
101396810|NCT00083993|Hormone Antagonists|hormone antagonists|mesh-ancestor
101396811|NCT00083993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101396812|NCT00083993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396813|NCT00083993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101396814|NCT00083993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101396815|NCT00083993|Immunologic Factors|immunologic factors|mesh-ancestor
101396816|NCT00083993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101396817|NCT00083993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101396818|NCT00083993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101396819|NCT00083993|Antifungal Agents|antifungal agents|mesh-ancestor
101396820|NCT00323791|Gemcitabine|gemcitabine|mesh-list
101396821|NCT00323791|Imatinib Mesylate|imatinib mesylate|mesh-list
101396822|NCT00323791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101396823|NCT00323791|Antimetabolites|antimetabolites|mesh-ancestor
101396824|NCT00323791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396825|NCT00323791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396826|NCT00323791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101396827|NCT00323791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101396828|NCT00323830|Capecitabine|capecitabine|mesh-list
101193544|NCT01839864|Chrysarobin|chrysarobin|mesh-list
101396832|NCT00323830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396834|NCT00317512|HBOC 201|hboc 201|mesh-list
101828111|NCT05995301|Sensory System Agents|sensory system agents|mesh-ancestor
101396835|NCT00317512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101396836|NCT00317512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101396837|NCT00317512|Analgesics|analgesics|mesh-ancestor
101396838|NCT00317512|Sensory System Agents|sensory system agents|mesh-ancestor
101396839|NCT00317512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101396840|NCT00317512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396841|NCT00317512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101396842|NCT00317512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101396843|NCT00317512|Blood Substitutes|blood substitutes|mesh-ancestor
101396844|NCT00124059|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101396845|NCT00124059|Antidepressive Agents|antidepressive agents|mesh-ancestor
101396846|NCT00124059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101396847|NCT00124059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101396848|NCT00124059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101396849|NCT00124059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101396850|NCT00124059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396851|NCT00084032|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101396852|NCT00084032|Antiviral Agents|antiviral agents|mesh-ancestor
101396853|NCT00084032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101305879|NCT02022488|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101305880|NCT02022488|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101333856|NCT00397072|Sagopilone|sagopilone|mesh-list
101396854|NCT00323947|Methylphenidate|methylphenidate|mesh-list
101396855|NCT00323947|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102075185|NCT05258110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102075186|NCT05258110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102075187|NCT05258110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075188|NCT05258110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101396856|NCT00323947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396857|NCT00323947|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101396858|NCT00323947|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101396859|NCT00323947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101396860|NCT00323947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396861|NCT00323947|Dopamine Agents|dopamine agents|mesh-ancestor
101396862|NCT00323947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101396863|NCT00323986|Azithromycin|azithromycin|mesh-list
101396864|NCT00323986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101396865|NCT00323986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101396866|NCT00324025|Efungumab|efungumab|mesh-list
101396867|NCT00324025|Antifungal Agents|antifungal agents|mesh-ancestor
101396868|NCT00324025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101396869|NCT00317629|Meglumine Antimoniate|meglumine antimoniate|mesh-list
101396871|NCT00317629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101396872|NCT00317629|Autonomic Agents|autonomic agents|mesh-ancestor
101396873|NCT00317629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101396874|NCT00317629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396875|NCT00317629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101458086|NCT00247650|Letrozole|letrozole|mesh-list
101396876|NCT00317629|Respiratory System Agents|respiratory system agents|mesh-ancestor
101396877|NCT00317629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101396878|NCT00317629|Antioxidants|antioxidants|mesh-ancestor
101396879|NCT00317629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396881|NCT00317629|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101396883|NCT00317629|Gasotransmitters|gasotransmitters|mesh-ancestor
101396884|NCT00317629|Protective Agents|protective agents|mesh-ancestor
101396885|NCT00317629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101396886|NCT00317629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101396887|NCT00317629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101396888|NCT00093249|Clevidipine|clevidipine|mesh-list
101396889|NCT00093249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101396890|NCT00093249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101396891|NCT00093249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396892|NCT00093249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101396893|NCT00093249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396894|NCT00124098|Darbepoetin alfa|darbepoetin alfa|mesh-list
101396895|NCT00124098|Hematinics|hematinics|mesh-ancestor
101396896|NCT00324142|Tinidazole|tinidazole|mesh-list
101396897|NCT00324142|Alkylating Agents|alkylating agents|mesh-ancestor
101396898|NCT00324142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396906|NCT00324298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396907|NCT00324298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101396908|NCT00324298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101396909|NCT00324298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101396910|NCT00324298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101396911|NCT00324298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396912|NCT00324298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101396913|NCT00124137|Diuretics|diuretics|mesh-list
101396914|NCT00124137|Natriuretic Agents|natriuretic agents|mesh-ancestor
101396915|NCT00124137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396916|NCT00324376|Sevelamer|sevelamer|mesh-list
101396917|NCT00324376|Chelating Agents|chelating agents|mesh-ancestor
101396918|NCT00324376|Sequestering Agents|sequestering agents|mesh-ancestor
101396919|NCT00324376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396920|NCT00084227|Azithromycin|azithromycin|mesh-list
101396921|NCT00084227|Chloroquine|chloroquine|mesh-list
101396922|NCT00084227|Atovaquone|atovaquone|mesh-list
101396923|NCT00084227|Proguanil|proguanil|mesh-list
101396924|NCT00084227|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
101396925|NCT00084227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101305881|NCT02022488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101305882|NCT02022488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305883|NCT02022488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101305884|NCT02022488|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101305885|NCT02022488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102075189|NCT05258110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102075190|NCT05258110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102075191|NCT05258110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102075192|NCT05258110|Anesthetics, General|anesthetics, general|mesh-ancestor
102075193|NCT05258110|Anesthetics|anesthetics|mesh-ancestor
102075194|NCT05258110|GABA Modulators|gaba modulators|mesh-ancestor
102075195|NCT05258110|GABA Agents|gaba agents|mesh-ancestor
102075196|NCT05258110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101828112|NCT05995301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101458291|NCT04613869|Hydromorphone|hydromorphone|mesh-list
101458292|NCT04613869|Esketamine|esketamine|mesh-list
101458293|NCT04613869|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101458294|NCT04613869|Narcotics|narcotics|mesh-ancestor
101458295|NCT04613869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101458296|NCT04613869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458297|NCT04613869|Analgesics|analgesics|mesh-ancestor
101458298|NCT04613869|Sensory System Agents|sensory system agents|mesh-ancestor
101458299|NCT04613869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101335776|NCT00052312|Mitosis Modulators|mitosis modulators|mesh-ancestor
101335777|NCT00052312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335778|NCT00052312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101335779|NCT00052312|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101335782|NCT00052351|Metronidazole|metronidazole|mesh-list
102075197|NCT05258110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075198|NCT05258110|Nootropic Agents|nootropic agents|mesh-ancestor
102075199|NCT03652233|Nivolumab|nivolumab|mesh-list
101376874|NCT00241345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305886|NCT02022488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101305887|NCT02022488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101305888|NCT02022488|GABA Modulators|gaba modulators|mesh-ancestor
101305889|NCT02022488|GABA Agents|gaba agents|mesh-ancestor
101305890|NCT02022488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101305891|NCT02022488|Narcotics|narcotics|mesh-ancestor
101305892|NCT02022527|Aspirin|aspirin|mesh-list
101305893|NCT02022527|Salicylic Acid|salicylic acid|mesh-list
101305894|NCT02022527|Salicylates|salicylates|mesh-list
101305895|NCT02022527|Warfarin|warfarin|mesh-list
101305896|NCT02022527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101305897|NCT02022527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101305898|NCT02022527|Analgesics|analgesics|mesh-ancestor
101305899|NCT02022527|Sensory System Agents|sensory system agents|mesh-ancestor
101305900|NCT02022527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101305901|NCT02022527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305902|NCT02022527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101396926|NCT00084227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101396927|NCT00084227|Amebicides|amebicides|mesh-ancestor
101396928|NCT00084227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101396929|NCT00084227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101396930|NCT00084227|Antimalarials|antimalarials|mesh-ancestor
101396931|NCT00084227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101396932|NCT00084227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101396933|NCT00084227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396934|NCT00084227|Antimetabolites|antimetabolites|mesh-ancestor
101396935|NCT00317746|Citalopram|citalopram|mesh-list
101396936|NCT00317746|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101396937|NCT00317746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101396938|NCT00317746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101335837|NCT00052507|Bortezomib|bortezomib|mesh-list
101396939|NCT00317746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396940|NCT00317746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101396941|NCT00317746|Serotonin Agents|serotonin agents|mesh-ancestor
101396942|NCT00317746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396943|NCT00317746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101396944|NCT00317746|Antidepressive Agents|antidepressive agents|mesh-ancestor
101396945|NCT00317746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101396946|NCT00317785|Cyclosporine|cyclosporine|mesh-list
101396947|NCT00317785|Sirolimus|sirolimus|mesh-list
101396962|NCT00317785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101396963|NCT00317785|Abortifacient Agents|abortifacient agents|mesh-ancestor
101396964|NCT00317785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101396965|NCT00317785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101396966|NCT00317785|Antimetabolites|antimetabolites|mesh-ancestor
101305903|NCT02022527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101305904|NCT02022527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101305905|NCT02022527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101305906|NCT02022527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335859|NCT00052585|Vitamins|vitamins|mesh-ancestor
101305907|NCT02022527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101305908|NCT02022527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101305909|NCT02022527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101305910|NCT02022527|Antipyretics|antipyretics|mesh-ancestor
101305911|NCT02022527|Anticoagulants|anticoagulants|mesh-ancestor
102075200|NCT03652233|Afatinib|afatinib|mesh-list
102075201|NCT03652233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102075202|NCT03652233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102075203|NCT03652233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102075204|NCT03652233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075205|NCT03652233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102075206|NCT03652233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101305912|NCT02022527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101305913|NCT02022527|Antifungal Agents|antifungal agents|mesh-ancestor
101305914|NCT02022527|Keratolytic Agents|keratolytic agents|mesh-ancestor
101305915|NCT02022527|Dermatologic Agents|dermatologic agents|mesh-ancestor
101305916|NCT02022540|Ranibizumab|ranibizumab|mesh-list
101305917|NCT02022540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101305918|NCT02022540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101305919|NCT02022540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101305920|NCT02022540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101305921|NCT02022540|Growth Substances|growth substances|mesh-ancestor
101305922|NCT02022540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305923|NCT02022540|Growth Inhibitors|growth inhibitors|mesh-ancestor
101305924|NCT02022540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101305925|NCT02022722|Triamcinolone|triamcinolone|mesh-list
101305926|NCT02022722|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101305927|NCT02022722|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101305928|NCT02022722|Bupivacaine|bupivacaine|mesh-list
101305929|NCT02022722|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101396967|NCT00317785|Dermatologic Agents|dermatologic agents|mesh-ancestor
101396968|NCT00317785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101396969|NCT00317785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101396970|NCT00317785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101396971|NCT00317785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101396972|NCT00317785|Antifungal Agents|antifungal agents|mesh-ancestor
101396973|NCT00317785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101396974|NCT00317785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101396975|NCT00317785|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101396976|NCT00317785|Antitubercular Agents|antitubercular agents|mesh-ancestor
101336407|NCT00056329|Vitamin E|vitamin e|mesh-list
101396977|NCT00317785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101396979|NCT00093288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101396980|NCT00093288|Antidepressive Agents|antidepressive agents|mesh-ancestor
101396981|NCT00093288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101396982|NCT00093288|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101396983|NCT00093288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101396984|NCT00093288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101396985|NCT00093288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396986|NCT00093288|Dopamine Agents|dopamine agents|mesh-ancestor
101396987|NCT00093288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101396988|NCT00093288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305930|NCT02022722|Anesthetics, Local|anesthetics, local|mesh-ancestor
101305931|NCT02022722|Anesthetics|anesthetics|mesh-ancestor
101305932|NCT02022722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101305933|NCT02022722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336524|NCT02969980|Immunologic Factors|immunologic factors|mesh-ancestor
101305934|NCT02022722|Sensory System Agents|sensory system agents|mesh-ancestor
101305935|NCT02022722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101305936|NCT02022722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101305937|NCT02022722|Glucocorticoids|glucocorticoids|mesh-ancestor
101305938|NCT02022722|Hormones|hormones|mesh-ancestor
101193755|NCT01725048|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101305949|NCT02022852|Antimetabolites|antimetabolites|mesh-ancestor
101305950|NCT02022852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305951|NCT02022852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101305952|NCT02022917|Bevacizumab|bevacizumab|mesh-list
101396989|NCT00093288|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101396990|NCT00093288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101396991|NCT00093288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101396992|NCT00324454|Levetiracetam|levetiracetam|mesh-list
101396993|NCT00324454|Anticonvulsants|anticonvulsants|mesh-ancestor
101396994|NCT00324454|Nootropic Agents|nootropic agents|mesh-ancestor
101396995|NCT00317902|Epoetin Alfa|epoetin alfa|mesh-list
101376891|NCT00076986|Alkylating Agents|alkylating agents|mesh-ancestor
102075208|NCT02117466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102075209|NCT02117466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102075210|NCT02117622|Insulin|insulin|mesh-list
102075211|NCT02117622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102075212|NCT02117622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075213|NCT04529902|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
102075214|NCT04529902|Abatacept|abatacept|mesh-list
101396996|NCT00317902|Hematinics|hematinics|mesh-ancestor
101396997|NCT00317980|Meglumine Antimoniate|meglumine antimoniate|mesh-list
101396998|NCT00317980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101396999|NCT00317980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101397000|NCT00317980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101397001|NCT00324571|Calcium|calcium|mesh-list
101397002|NCT00324571|Sevelamer|sevelamer|mesh-list
101397003|NCT00324571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101397004|NCT00324571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397005|NCT00324571|Chelating Agents|chelating agents|mesh-ancestor
101397006|NCT00324571|Sequestering Agents|sequestering agents|mesh-ancestor
101397007|NCT00324571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397008|NCT00084461|Romidepsin|romidepsin|mesh-list
101397009|NCT00084461|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101397010|NCT00084461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397011|NCT00084461|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101397012|NCT00084461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101397013|NCT00084461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397014|NCT00324610|Capecitabine|capecitabine|mesh-list
101397015|NCT00324610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101397016|NCT00324610|Antimetabolites|antimetabolites|mesh-ancestor
101397017|NCT00324610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305953|NCT02022917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101305954|NCT02022917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101305955|NCT02022917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101305956|NCT02022917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101305957|NCT02022917|Growth Substances|growth substances|mesh-ancestor
101305958|NCT02022917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305959|NCT02022917|Growth Inhibitors|growth inhibitors|mesh-ancestor
101305960|NCT02022930|Triamcinolone|triamcinolone|mesh-list
101305961|NCT02022930|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101305962|NCT02022930|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101305963|NCT02022930|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101305964|NCT02022930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101305965|NCT02022930|Glucocorticoids|glucocorticoids|mesh-ancestor
101397018|NCT00324610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397019|NCT00093366|Etanercept|etanercept|mesh-list
101397020|NCT00093366|Arsenic Trioxide|arsenic trioxide|mesh-list
101397030|NCT00093366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101397031|NCT00093366|Immunologic Factors|immunologic factors|mesh-ancestor
101397032|NCT00093366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397033|NCT00324688|Tenofovir|tenofovir|mesh-list
101397034|NCT00324688|Antiviral Agents|antiviral agents|mesh-ancestor
101193831|NCT01728480|Cisplatin|cisplatin|mesh-list
101397067|NCT00084578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397068|NCT00084578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101397069|NCT00084578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101397070|NCT00084578|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101397071|NCT00084578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101397072|NCT00084578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101397073|NCT00084578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193899|NCT01048944|Bupropion|bupropion|mesh-list
101305970|NCT02022930|Immunologic Factors|immunologic factors|mesh-ancestor
101305971|NCT02022930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101305972|NCT02022930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305974|NCT02023021|Gemcitabine|gemcitabine|mesh-list
101305975|NCT02023021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101305976|NCT02023021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102075215|NCT04529902|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102075216|NCT04529902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075217|NCT04529902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102075218|NCT04529902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102075219|NCT04529902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101376903|NCT00098982|Bortezomib|bortezomib|mesh-list
101305977|NCT02023021|Tubulin Modulators|tubulin modulators|mesh-ancestor
101305978|NCT02023021|Antimitotic Agents|antimitotic agents|mesh-ancestor
101305979|NCT02023021|Mitosis Modulators|mitosis modulators|mesh-ancestor
101305980|NCT02023021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305981|NCT02023021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101305982|NCT02023021|Antimetabolites|antimetabolites|mesh-ancestor
101305983|NCT02023047|Nifedipine|nifedipine|mesh-list
101305984|NCT02023047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101305985|NCT02023047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101305986|NCT02023047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305987|NCT02023047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101305988|NCT02023047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305990|NCT02023047|Tocolytic Agents|tocolytic agents|mesh-ancestor
101305991|NCT02023047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101305992|NCT02023086|Tropicamide|tropicamide|mesh-list
101305993|NCT02023086|Mydriatics|mydriatics|mesh-list
101305994|NCT02023086|Autonomic Agents|autonomic agents|mesh-ancestor
101305995|NCT02023086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101305996|NCT02023086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305997|NCT02023086|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101305998|NCT02023086|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101305999|NCT02023086|Cholinergic Agents|cholinergic agents|mesh-ancestor
101397074|NCT00084578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101397075|NCT00318175|Bosentan|bosentan|mesh-list
101397076|NCT00318175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101397077|NCT00318175|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101397078|NCT00318175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397079|NCT00093444|Doxorubicin|doxorubicin|mesh-list
101397080|NCT00093444|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101306000|NCT02023086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101306001|NCT02023086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306002|NCT02023164|Diphenhydramine|diphenhydramine|mesh-list
101306003|NCT02023164|Promethazine|promethazine|mesh-list
101306004|NCT02023164|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101306005|NCT02023164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101306006|NCT02023164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101306007|NCT02023164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306008|NCT02023164|Anesthetics, Local|anesthetics, local|mesh-ancestor
101306009|NCT02023164|Anesthetics|anesthetics|mesh-ancestor
101306010|NCT02023164|Sensory System Agents|sensory system agents|mesh-ancestor
101306011|NCT02023164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101306012|NCT02023164|Antiemetics|antiemetics|mesh-ancestor
101306013|NCT02023164|Autonomic Agents|autonomic agents|mesh-ancestor
101306014|NCT02023164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101306015|NCT02023164|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101306016|NCT02023164|Histamine Antagonists|histamine antagonists|mesh-ancestor
101306017|NCT02023164|Histamine Agents|histamine agents|mesh-ancestor
101306018|NCT02023164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101306019|NCT02023164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306020|NCT02023164|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101306021|NCT02023164|Antipruritics|antipruritics|mesh-ancestor
101306022|NCT02023164|Dermatologic Agents|dermatologic agents|mesh-ancestor
101306024|NCT02023359|Exemestane|exemestane|mesh-list
101306025|NCT02023359|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101306026|NCT02023359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101306027|NCT02023359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101306028|NCT02023359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306029|NCT02023359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101397081|NCT00093444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101397082|NCT00093444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102075220|NCT04529902|Immunologic Factors|immunologic factors|mesh-ancestor
102075221|NCT04529902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075222|NCT04529902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102075223|NCT04529902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102075224|NCT04693468|Palbociclib|palbociclib|mesh-list
102075225|NCT04693468|Axitinib|axitinib|mesh-list
102075226|NCT04693468|Crizotinib|crizotinib|mesh-list
102075227|NCT04693468|Talazoparib|talazoparib|mesh-list
102075228|NCT04693468|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
102075229|NCT04693468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102075230|NCT04693468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102075231|NCT04693468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102075232|NCT04693468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075233|NCT04693468|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102075234|NCT02288078|Dexamethasone|dexamethasone|mesh-list
102075235|NCT02288078|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
102075236|NCT02288078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102075237|NCT02288078|Antiemetics|antiemetics|mesh-ancestor
102075238|NCT02288078|Autonomic Agents|autonomic agents|mesh-ancestor
101376904|NCT00098982|Calcium|calcium|mesh-list
101397104|NCT00325000|Adrenergic Agents|adrenergic agents|mesh-ancestor
101397106|NCT00318448|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101397107|NCT00318448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101397108|NCT00318448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101397109|NCT00318448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397110|NCT00318448|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101397111|NCT00318448|GABA Agonists|gaba agonists|mesh-ancestor
101397112|NCT00318448|GABA Agents|gaba agents|mesh-ancestor
101397113|NCT00318448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101306030|NCT02023359|Immunologic Factors|immunologic factors|mesh-ancestor
101306031|NCT02023359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397114|NCT00318448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397115|NCT00325117|Vildagliptin|vildagliptin|mesh-list
101397116|NCT00325117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101397117|NCT00325117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397118|NCT00325117|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101397119|NCT00325117|Protease Inhibitors|protease inhibitors|mesh-ancestor
101397120|NCT00325117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101338422|NCT00072319|Paclitaxel|paclitaxel|mesh-list
101397121|NCT00325117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397122|NCT00084695|Methylprednisolone|methylprednisolone|mesh-list
101397123|NCT00084695|Cyclophosphamide|cyclophosphamide|mesh-list
101397124|NCT00084695|Melphalan|melphalan|mesh-list
101397125|NCT00084695|Busulfan|busulfan|mesh-list
101397126|NCT00084695|Fludarabine|fludarabine|mesh-list
101397127|NCT00084695|Fludarabine phosphate|fludarabine phosphate|mesh-list
101397128|NCT00084695|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101397129|NCT00084695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101397130|NCT00084695|Immunologic Factors|immunologic factors|mesh-ancestor
101397131|NCT00084695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397132|NCT00084695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101397133|NCT00084695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101397134|NCT00084695|Alkylating Agents|alkylating agents|mesh-ancestor
101397135|NCT00084695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397136|NCT00084695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397137|NCT00084695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101397138|NCT00084695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102075239|NCT02288078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102075240|NCT02288078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075241|NCT02288078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102075242|NCT02288078|Glucocorticoids|glucocorticoids|mesh-ancestor
101397139|NCT00084695|Antimetabolites|antimetabolites|mesh-ancestor
101397140|NCT00084695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101397141|NCT00084695|Antiemetics|antiemetics|mesh-ancestor
101397142|NCT00084695|Autonomic Agents|autonomic agents|mesh-ancestor
101397150|NCT00325351|Carboplatin|carboplatin|mesh-list
101397151|NCT00325351|Sagopilone|sagopilone|mesh-list
101397152|NCT00325351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397153|NCT00093483|Cytarabine|cytarabine|mesh-list
101397154|NCT00093483|Idarubicin|idarubicin|mesh-list
101397155|NCT00093483|Arsenic Trioxide|arsenic trioxide|mesh-list
101397156|NCT00093483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101397157|NCT00093483|Antimetabolites|antimetabolites|mesh-ancestor
101397158|NCT00093483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397159|NCT00093483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397160|NCT00093483|Antiviral Agents|antiviral agents|mesh-ancestor
101397161|NCT00093483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101397162|NCT00093483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101397163|NCT00093483|Immunologic Factors|immunologic factors|mesh-ancestor
101397164|NCT00093483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397165|NCT00093483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101338490|NCT00072592|Rituximab|rituximab|mesh-list
101397166|NCT00093483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101397167|NCT00093483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101397168|NCT00093483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101397170|NCT00325390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101397171|NCT00325390|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101397172|NCT00325390|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101397173|NCT00325390|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101397174|NCT00325390|Purinergic Agents|purinergic agents|mesh-ancestor
101397175|NCT00325390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101397176|NCT00325390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194002|NCT03407196|Dapagliflozin|dapagliflozin|mesh-list
101397179|NCT00325429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101397180|NCT00325429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397181|NCT00325429|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101397182|NCT00325429|Protease Inhibitors|protease inhibitors|mesh-ancestor
101397183|NCT00325429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101397184|NCT00325429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397185|NCT00093522|Fludarabine|fludarabine|mesh-list
101397186|NCT00093522|Fludarabine phosphate|fludarabine phosphate|mesh-list
101397187|NCT00093522|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
101397188|NCT00093522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397189|NCT00093522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101397190|NCT00093522|Antimetabolites|antimetabolites|mesh-ancestor
101397191|NCT00093522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306032|NCT02023359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101306033|NCT02023359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101306034|NCT02023359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101306035|NCT02023359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101306036|NCT02023359|Hormone Antagonists|hormone antagonists|mesh-ancestor
101397192|NCT00093522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101397193|NCT00093522|Immunologic Factors|immunologic factors|mesh-ancestor
101397194|NCT00093522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397195|NCT00093522|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101397196|NCT00084773|Fluorouracil|fluorouracil|mesh-list
101397197|NCT00084773|Cetuximab|cetuximab|mesh-list
101397198|NCT00084773|Antimetabolites|antimetabolites|mesh-ancestor
101397199|NCT00084773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397200|NCT00084773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101397201|NCT00084773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397202|NCT00084773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101397203|NCT00084773|Immunologic Factors|immunologic factors|mesh-ancestor
101397204|NCT00084773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397205|NCT00084773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101397206|NCT00325546|Rimonabant|rimonabant|mesh-list
101397207|NCT00325546|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102075244|NCT02288078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102075245|NCT02288078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102075246|NCT02288078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102075247|NCT02288078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102075248|NCT02288078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075249|NCT02288234|Telavancin|telavancin|mesh-list
102075250|NCT02288234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101397208|NCT00325546|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
101397209|NCT00325546|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101397221|NCT04717609|Anesthetics, Local|anesthetics, local|mesh-ancestor
101397222|NCT04717609|Anesthetics|anesthetics|mesh-ancestor
101397223|NCT04717609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101397224|NCT04717609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397225|NCT04717609|Sensory System Agents|sensory system agents|mesh-ancestor
101397226|NCT04717609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101397227|NCT00318760|Clonidine|clonidine|mesh-list
101397228|NCT00318760|Analgesics|analgesics|mesh-ancestor
101397229|NCT00318760|Sensory System Agents|sensory system agents|mesh-ancestor
101397230|NCT00318760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101397231|NCT00318760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397232|NCT00318760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101397233|NCT00318760|Sympatholytics|sympatholytics|mesh-ancestor
101397234|NCT00318760|Autonomic Agents|autonomic agents|mesh-ancestor
101397235|NCT00318760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101397236|NCT00318760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101397237|NCT00318760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101397238|NCT00318760|Adrenergic Agents|adrenergic agents|mesh-ancestor
101397239|NCT00318760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101397240|NCT00318760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397241|NCT00093561|Lycopene|lycopene|mesh-list
101397242|NCT00093561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101397243|NCT00093561|Antioxidants|antioxidants|mesh-ancestor
101397244|NCT00093561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397245|NCT00093561|Protective Agents|protective agents|mesh-ancestor
101397246|NCT00093561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397247|NCT00093561|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101397248|NCT00093561|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101397249|NCT00093561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397250|NCT00084890|Carboplatin|carboplatin|mesh-list
101397251|NCT00084890|Docetaxel|docetaxel|mesh-list
101397252|NCT00084890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397253|NCT00084890|Tubulin Modulators|tubulin modulators|mesh-ancestor
101397254|NCT00084890|Antimitotic Agents|antimitotic agents|mesh-ancestor
101397255|NCT00084890|Mitosis Modulators|mitosis modulators|mesh-ancestor
101397258|NCT00318838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101397259|NCT00318838|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101397260|NCT00318838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101397261|NCT00318838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397262|NCT00318838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101397263|NCT00318838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397264|NCT00085124|Cytarabine|cytarabine|mesh-list
101397265|NCT00085124|Daunorubicin|daunorubicin|mesh-list
101397266|NCT00085124|Oblimersen|oblimersen|mesh-list
101306037|NCT02023359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101306038|NCT02023424|Glatiramer Acetate|glatiramer acetate|mesh-list
101306039|NCT02023424|(T,G)-A-L|(t,g)-a-l|mesh-list
101306040|NCT02023424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101184163|NCT03615534|Fenofibrate|fenofibrate|mesh-list
101397267|NCT00085124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101397268|NCT00085124|Antimetabolites|antimetabolites|mesh-ancestor
101397269|NCT00085124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397270|NCT00085124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397271|NCT00085124|Antiviral Agents|antiviral agents|mesh-ancestor
101397272|NCT00085124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101397276|NCT00085124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101397277|NCT00085124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102075251|NCT02288234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102075252|NCT04654312|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102075253|NCT04654312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102075254|NCT04654312|Diuretics|diuretics|mesh-ancestor
102075255|NCT04654312|Natriuretic Agents|natriuretic agents|mesh-ancestor
102075256|NCT04654312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075257|NCT04654312|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102075258|NCT04654312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101397278|NCT00085124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101397279|NCT00085124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101397280|NCT00402441|Risedronic Acid|risedronic acid|mesh-list
101397281|NCT00402441|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101397282|NCT00402441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101397283|NCT00402441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397284|NCT00402441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101397285|NCT00402441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397286|NCT00402441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101397287|NCT00325858|Tramadol|tramadol|mesh-list
101397288|NCT00325858|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101397289|NCT00325858|Narcotics|narcotics|mesh-ancestor
101397290|NCT00325858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101397291|NCT00325858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397292|NCT00325858|Analgesics|analgesics|mesh-ancestor
101397293|NCT00325858|Sensory System Agents|sensory system agents|mesh-ancestor
101397294|NCT00325858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101397295|NCT00318955|Dexmedetomidine|dexmedetomidine|mesh-list
101397296|NCT00318955|Propofol|propofol|mesh-list
101397297|NCT00318955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101397298|NCT00318955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101397299|NCT00318955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397300|NCT00318955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101397301|NCT00318955|Analgesics|analgesics|mesh-ancestor
101397302|NCT00318955|Sensory System Agents|sensory system agents|mesh-ancestor
101397303|NCT00318955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101397304|NCT00318955|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101397305|NCT00318955|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101397306|NCT00318955|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101397307|NCT00318955|Adrenergic Agents|adrenergic agents|mesh-ancestor
101397308|NCT00318955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101397309|NCT00318955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397310|NCT00318955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101397311|NCT00318955|Anesthetics, General|anesthetics, general|mesh-ancestor
101397312|NCT00318955|Anesthetics|anesthetics|mesh-ancestor
101397313|NCT00325936|Cilnidipine|cilnidipine|mesh-list
101397314|NCT00325936|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101397315|NCT00325936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101397316|NCT00325936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397317|NCT00325936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101397318|NCT00325936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397319|NCT00318994|Meropenem|meropenem|mesh-list
101397320|NCT00318994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101397321|NCT00318994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101397322|NCT00093600|Cytarabine|cytarabine|mesh-list
101397323|NCT00093600|Daunorubicin|daunorubicin|mesh-list
101397324|NCT00093600|Midostaurin|midostaurin|mesh-list
101194146|NCT02240160|Nabiximols|nabiximols|mesh-list
101397336|NCT00093600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101397337|NCT00093600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101397338|NCT00093600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101397339|NCT00319033|Bosentan|bosentan|mesh-list
101397340|NCT00319033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101397341|NCT00319033|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101397342|NCT00319033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397343|NCT00085163|Leucovorin|leucovorin|mesh-list
101397350|NCT00085163|Antimetabolites|antimetabolites|mesh-ancestor
101397351|NCT00085163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075259|NCT04654312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075260|NCT02973087|Factor VIII|factor viii|mesh-list
102075261|NCT02973087|Coagulants|coagulants|mesh-ancestor
102075262|NCT05284656|Folic Acid|folic acid|mesh-list
102075263|NCT05284656|Vitamin B Complex|vitamin b complex|mesh-list
101397352|NCT00085163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101397353|NCT00085163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397354|NCT00085163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101397355|NCT00085163|Immunologic Factors|immunologic factors|mesh-ancestor
101397356|NCT00085163|Antidotes|antidotes|mesh-ancestor
101397357|NCT00085163|Protective Agents|protective agents|mesh-ancestor
101397358|NCT00085163|Vitamin B Complex|vitamin b complex|mesh-ancestor
101397359|NCT00085163|Vitamins|vitamins|mesh-ancestor
101397360|NCT00085163|Micronutrients|micronutrients|mesh-ancestor
101397361|NCT00085163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101397362|NCT00085163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101397363|NCT00085163|Analgesics|analgesics|mesh-ancestor
101397364|NCT00085163|Sensory System Agents|sensory system agents|mesh-ancestor
101397365|NCT00085163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101397366|NCT00085163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101397367|NCT00085163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101397368|NCT00085163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101397369|NCT00085163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101397370|NCT00085163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101397371|NCT00319072|Hormones|hormones|mesh-list
101397372|NCT00319072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101397373|NCT00319072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397374|NCT00093639|Everolimus|everolimus|mesh-list
101397375|NCT00093639|Imatinib Mesylate|imatinib mesylate|mesh-list
101397376|NCT00093639|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101397377|NCT00093639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101397378|NCT00093639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101397379|NCT00093639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397380|NCT00093639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101397381|NCT00093639|Immunologic Factors|immunologic factors|mesh-ancestor
101397382|NCT00093639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397383|NCT00093639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397384|NCT00319150|Epoetin Alfa|epoetin alfa|mesh-list
101397385|NCT00319150|Hematinics|hematinics|mesh-ancestor
101397386|NCT00326053|Budesonide|budesonide|mesh-list
101397387|NCT00326053|Formoterol Fumarate|formoterol fumarate|mesh-list
101397392|NCT00326053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397393|NCT00326053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101397394|NCT00326053|Respiratory System Agents|respiratory system agents|mesh-ancestor
101397395|NCT00326053|Glucocorticoids|glucocorticoids|mesh-ancestor
101397397|NCT00326053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101397398|NCT00326053|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101397399|NCT00326053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101397400|NCT00326053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101397401|NCT00326053|Adrenergic Agents|adrenergic agents|mesh-ancestor
101397402|NCT00326053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101397403|NCT00326053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397404|NCT00400088|Lithium Carbonate|lithium carbonate|mesh-list
101397406|NCT00400088|Antidepressive Agents|antidepressive agents|mesh-ancestor
101397407|NCT00400088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101306046|NCT02023450|Saquinavir|saquinavir|mesh-list
101306047|NCT02023450|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101306048|NCT02023450|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101306049|NCT02023450|Protease Inhibitors|protease inhibitors|mesh-ancestor
101306050|NCT02023450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101306051|NCT02023450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306052|NCT02023450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101306053|NCT02023450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101306054|NCT02023450|Antiviral Agents|antiviral agents|mesh-ancestor
101306055|NCT02023450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101306056|NCT02023450|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101306057|NCT02023450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101306058|NCT02023554|Azithromycin|azithromycin|mesh-list
101306059|NCT02023554|Theophylline|theophylline|mesh-list
101306060|NCT02023554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101306061|NCT02023554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102075264|NCT05284656|Pentoxifylline|pentoxifylline|mesh-list
102075265|NCT05284656|Hematinics|hematinics|mesh-ancestor
102075266|NCT05284656|Vitamins|vitamins|mesh-ancestor
102075267|NCT05284656|Micronutrients|micronutrients|mesh-ancestor
102075268|NCT05284656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075269|NCT05284656|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102075270|NCT05284656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102075271|NCT05284656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075272|NCT05284656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102075273|NCT05284656|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102075274|NCT05284656|Protective Agents|protective agents|mesh-ancestor
102075275|NCT05284656|Vasodilator Agents|vasodilator agents|mesh-ancestor
102075276|NCT05284656|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102075277|NCT05284656|Antioxidants|antioxidants|mesh-ancestor
101306062|NCT02023554|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101306063|NCT02023554|Autonomic Agents|autonomic agents|mesh-ancestor
101306064|NCT02023554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101306065|NCT02023554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306066|NCT02023554|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101306067|NCT02023554|Respiratory System Agents|respiratory system agents|mesh-ancestor
101306068|NCT02023554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101306069|NCT02023554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101306070|NCT02023554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306071|NCT02023554|Vasodilator Agents|vasodilator agents|mesh-ancestor
101306072|NCT02023554|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101306073|NCT02023554|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101306074|NCT02023554|Purinergic Agents|purinergic agents|mesh-ancestor
101306075|NCT02023554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101306076|NCT02023567|Serotonin|serotonin|mesh-list
101306077|NCT02023567|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
101306078|NCT02023567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101306079|NCT02023567|Serotonin Agents|serotonin agents|mesh-ancestor
101184302|NCT04204200|Vitamins|vitamins|mesh-list
101397408|NCT00400088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101306080|NCT02023567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101306081|NCT02023567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397409|NCT00400088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397410|NCT00400088|Antimanic Agents|antimanic agents|mesh-ancestor
101397411|NCT00400088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101397412|NCT00400088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101397413|NCT00400088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397415|NCT00400088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101397416|NCT00400088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101397417|NCT00400088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101397418|NCT00400088|Serotonin Agents|serotonin agents|mesh-ancestor
101397419|NCT00400088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101397421|NCT00400088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101397423|NCT00326092|Brinzolamide|brinzolamide|mesh-list
101397424|NCT00326092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101397425|NCT00326092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101397426|NCT00326092|Adrenergic Agents|adrenergic agents|mesh-ancestor
101397427|NCT00326092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101397428|NCT00326092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397429|NCT00326092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397430|NCT00326092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101397431|NCT00326092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101397432|NCT00326092|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101397433|NCT00326092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101397434|NCT00326131|Taxane|taxane|mesh-list
102075278|NCT02124174|Azacitidine|azacitidine|mesh-list
102075279|NCT02124174|Valproic Acid|valproic acid|mesh-list
102075280|NCT02124174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102075281|NCT02124174|Antimetabolites|antimetabolites|mesh-ancestor
102075282|NCT02124174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075283|NCT02124174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102075284|NCT02124174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102075285|NCT02124174|Anticonvulsants|anticonvulsants|mesh-ancestor
102075286|NCT02124174|GABA Agents|gaba agents|mesh-ancestor
101376962|NCT00066599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101397435|NCT00326131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397436|NCT00319189|Nateglinide|nateglinide|mesh-list
101397437|NCT00319189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101397438|NCT00319189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397439|NCT00319267|Bosentan|bosentan|mesh-list
101397440|NCT00319267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101397441|NCT00319267|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101397442|NCT00319267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397443|NCT00085280|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101397444|NCT00085280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397445|NCT00085280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101397446|NCT00085280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101397447|NCT00085280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397448|NCT00326248|Casopitant|casopitant|mesh-list
101397449|NCT00326248|Antiemetics|antiemetics|mesh-ancestor
101397450|NCT00326248|Autonomic Agents|autonomic agents|mesh-ancestor
101397451|NCT00326248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101397452|NCT00326248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397453|NCT00326248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101397454|NCT00326248|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101397455|NCT00326248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101397456|NCT00326248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397457|NCT00319306|Budesonide|budesonide|mesh-list
101397458|NCT00319306|Formoterol Fumarate|formoterol fumarate|mesh-list
101397459|NCT00319306|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101397460|NCT00319306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101397461|NCT00319306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101397462|NCT00319306|Autonomic Agents|autonomic agents|mesh-ancestor
101397463|NCT00319306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101397464|NCT00319306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397465|NCT00319306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101397466|NCT00319306|Respiratory System Agents|respiratory system agents|mesh-ancestor
101397467|NCT00319306|Glucocorticoids|glucocorticoids|mesh-ancestor
101397468|NCT00319306|Hormones|hormones|mesh-ancestor
101339242|NCT01350128|Bromides|bromides|mesh-list
101397469|NCT00319306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101397470|NCT00319306|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101397471|NCT00319306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101397472|NCT00319306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101397473|NCT00319306|Adrenergic Agents|adrenergic agents|mesh-ancestor
101397474|NCT00319306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101397475|NCT00319306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397476|NCT00085358|Paclitaxel|paclitaxel|mesh-list
101397477|NCT00085358|Docetaxel|docetaxel|mesh-list
101306082|NCT02023567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184419|NCT03856164|Hemostatics|hemostatics|mesh-ancestor
101397478|NCT00085358|Bevacizumab|bevacizumab|mesh-list
101397479|NCT00085358|Carboplatin|carboplatin|mesh-list
101397480|NCT00085358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101397481|NCT00085358|Antibodies|antibodies|mesh-list
101397482|NCT00085358|Immunoglobulins|immunoglobulins|mesh-list
101397483|NCT00085358|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101397484|NCT00085358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101397485|NCT00085358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397505|NCT00093678|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101397506|NCT00093678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101376970|NCT00242008|Dopamine Agonists|dopamine agonists|mesh-ancestor
102075287|NCT02124174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102075288|NCT02124174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075289|NCT02124174|Antimanic Agents|antimanic agents|mesh-ancestor
102075290|NCT02124174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102075291|NCT02124174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102075292|NCT02124174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102075293|NCT03956368|Atorvastatin|atorvastatin|mesh-list
102075294|NCT03956368|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102075295|NCT03956368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102075296|NCT03956368|Antimetabolites|antimetabolites|mesh-ancestor
102075297|NCT03956368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075298|NCT03956368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102075299|NCT03956368|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102075300|NCT03956368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102075301|NCT02124330|Bentonite|bentonite|mesh-list
102075302|NCT02124330|Antidotes|antidotes|mesh-ancestor
102075303|NCT02124330|Protective Agents|protective agents|mesh-ancestor
102075304|NCT02124330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075305|NCT02118090|Chloroquine|chloroquine|mesh-list
102075306|NCT02118090|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
102075307|NCT02118090|Amebicides|amebicides|mesh-ancestor
102075308|NCT02118090|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102075309|NCT02118090|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102075310|NCT02118090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102075311|NCT02118090|Antimalarials|antimalarials|mesh-ancestor
102075312|NCT02118090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102075313|NCT02118090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102075314|NCT02118090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102075315|NCT02118090|Analgesics|analgesics|mesh-ancestor
102075316|NCT02118090|Sensory System Agents|sensory system agents|mesh-ancestor
102075317|NCT02118090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102075318|NCT02118090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075319|NCT02118090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101376971|NCT00242008|Dopamine Agents|dopamine agents|mesh-ancestor
101397507|NCT00093678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101397508|NCT00093678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397514|NCT00419536|Panobinostat|panobinostat|mesh-list
101397515|NCT00419536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339316|NCT00079105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101397516|NCT00419536|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101377006|NCT00242203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075320|NCT02118090|Filaricides|filaricides|mesh-ancestor
102075321|NCT02118090|Antinematodal Agents|antinematodal agents|mesh-ancestor
102075322|NCT02118090|Anthelmintics|anthelmintics|mesh-ancestor
102075323|NCT04235114|Nimotuzumab|nimotuzumab|mesh-list
102075324|NCT04235114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101795079|NCT00919919|Hormones|hormones|mesh-ancestor
102075325|NCT04235114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102075326|NCT03551808|Ketorolac|ketorolac|mesh-list
102075327|NCT03551808|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101397517|NCT00419536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101397518|NCT00419536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397519|NCT00326404|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101397520|NCT00326404|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101397521|NCT00326404|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101397522|NCT00326404|Desogestrel|desogestrel|mesh-list
101397523|NCT00326404|Estradiol|estradiol|mesh-list
101397524|NCT00326404|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101397525|NCT00326404|Estrogens|estrogens|mesh-ancestor
101397526|NCT00326404|Hormones|hormones|mesh-ancestor
101397527|NCT00326404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101397528|NCT00326404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397529|NCT00326404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101397530|NCT00326404|Contraceptive Agents|contraceptive agents|mesh-ancestor
101397531|NCT00326404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101397532|NCT00326404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101397533|NCT00326404|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101397534|NCT00326404|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101397535|NCT00326404|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101397536|NCT00326404|Progestins|progestins|mesh-ancestor
101397537|NCT00085475|Imatinib Mesylate|imatinib mesylate|mesh-list
101397538|NCT00085475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397539|NCT00085475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101397540|NCT00085475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101397557|NCT00124332|Hormones|hormones|mesh-ancestor
101397558|NCT00124332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101397559|NCT00124332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397560|NCT00085553|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101397561|NCT00085553|Tipifarnib|tipifarnib|mesh-list
101397562|NCT00085553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397563|NCT00085553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101397564|NCT00085553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101397565|NCT00085553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397566|NCT00400335|Methyltestosterone|methyltestosterone|mesh-list
101339551|NCT00080158|Sertraline|sertraline|mesh-list
101397567|NCT00400335|Testosterone|testosterone|mesh-list
101397568|NCT00400335|Testosterone undecanoate|testosterone undecanoate|mesh-list
101397569|NCT00400335|Testosterone enanthate|testosterone enanthate|mesh-list
101397570|NCT00400335|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101397571|NCT00400335|Dutasteride|dutasteride|mesh-list
101397572|NCT00400335|Androgens|androgens|mesh-ancestor
101397573|NCT00400335|Hormones|hormones|mesh-ancestor
101397574|NCT00400335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101397575|NCT00400335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397576|NCT00400335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101397577|NCT00400335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397578|NCT00400335|Anabolic Agents|anabolic agents|mesh-ancestor
101397579|NCT00400335|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101397580|NCT00400335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101397581|NCT00400335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101397582|NCT00400335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306083|NCT02023567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101306084|NCT02023567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101306085|NCT02023684|Lidocaine|lidocaine|mesh-list
101306086|NCT02023684|Ropivacaine|ropivacaine|mesh-list
101397583|NCT00400335|Hormone Antagonists|hormone antagonists|mesh-ancestor
101397584|NCT00319852|Vaccines|vaccines|mesh-list
102075328|NCT03551808|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102075329|NCT03551808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102075330|NCT03551808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102075331|NCT03551808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102075332|NCT03551808|Analgesics|analgesics|mesh-ancestor
102075333|NCT03551808|Sensory System Agents|sensory system agents|mesh-ancestor
102075334|NCT03551808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102075335|NCT03551808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075336|NCT03551808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102075337|NCT03551808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102075338|NCT03551808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102075339|NCT03551808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101397585|NCT00319852|Immunologic Factors|immunologic factors|mesh-ancestor
101397586|NCT00319852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397587|NCT00326833|Vitamin B 12|vitamin b 12|mesh-list
101397588|NCT00326833|Hydroxocobalamin|hydroxocobalamin|mesh-list
101397589|NCT00326833|Vitamins|vitamins|mesh-ancestor
101397590|NCT00326833|Micronutrients|micronutrients|mesh-ancestor
101397591|NCT00326833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397592|NCT00326833|Vitamin B Complex|vitamin b complex|mesh-ancestor
101397597|NCT00085748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101397598|NCT00085748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397599|NCT00085748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101397609|NCT04717102|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101397610|NCT04717102|Anesthetics, General|anesthetics, general|mesh-ancestor
101397611|NCT04717102|Anesthetics|anesthetics|mesh-ancestor
101397612|NCT04717102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101397613|NCT04717102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397615|NCT00320047|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101397616|NCT00320047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397617|NCT00320047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101397618|NCT00320047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101397619|NCT00320047|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101397620|NCT00320047|GABA Agonists|gaba agonists|mesh-ancestor
101397621|NCT00320047|GABA Agents|gaba agents|mesh-ancestor
101397622|NCT00320047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101397623|NCT00320047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397624|NCT00085826|Sulindac sulfone|sulindac sulfone|mesh-list
101397625|NCT00085826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397626|NCT00085826|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101397627|NCT00085826|Protective Agents|protective agents|mesh-ancestor
101397628|NCT00085826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397629|NCT00085826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101397630|NCT00085826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101397631|NCT00085826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397632|NCT00085826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101397633|NCT00085826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101397634|NCT00085826|Analgesics|analgesics|mesh-ancestor
101397635|NCT00085826|Sensory System Agents|sensory system agents|mesh-ancestor
101397636|NCT00085826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101397637|NCT00085826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101397638|NCT00085826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101397639|NCT00320125|Calcium|calcium|mesh-list
101397640|NCT00320125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101397641|NCT00320125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397642|NCT00093873|Motesanib diphosphate|motesanib diphosphate|mesh-list
101397643|NCT00093873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101397644|NCT00093873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101397645|NCT00093873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397646|NCT00320320|Irinotecan|irinotecan|mesh-list
101397647|NCT00320320|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102075340|NCT03551808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075342|NCT04053543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102075343|NCT04202458|Tenecteplase|tenecteplase|mesh-list
102075344|NCT04202458|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102075345|NCT04202458|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102075346|NCT04202458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075347|NCT00273650|Vitamin B 12|vitamin b 12|mesh-list
102075348|NCT00273650|Vitamins|vitamins|mesh-ancestor
101377027|NCT00242359|Omalizumab|omalizumab|mesh-list
101397648|NCT00320320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101397649|NCT00320320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101397650|NCT00320320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397651|NCT00320320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397652|NCT00327106|Tranexamic Acid|tranexamic acid|mesh-list
101397653|NCT00327106|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101397654|NCT00327106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101397655|NCT00327106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397656|NCT00327106|Hemostatics|hemostatics|mesh-ancestor
101397657|NCT00327106|Coagulants|coagulants|mesh-ancestor
101397658|NCT00320359|Cisplatin|cisplatin|mesh-list
101397659|NCT00320359|Etoposide|etoposide|mesh-list
101397660|NCT00320359|Topotecan|topotecan|mesh-list
101339668|NCT00080743|Tamoxifen|tamoxifen|mesh-list
101306087|NCT02023684|Anesthetics, Local|anesthetics, local|mesh-ancestor
101306089|NCT02023684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101397661|NCT00320359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397662|NCT00320359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101397663|NCT00320359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101397664|NCT00320359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101397665|NCT00320359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101397677|NCT00093912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397678|NCT00327145|Amlodipine|amlodipine|mesh-list
101397679|NCT00327145|Valsartan|valsartan|mesh-list
101397680|NCT00327145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101397681|NCT00327145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101397682|NCT00327145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101397684|NCT00327145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397685|NCT00327145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101397686|NCT00327145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397687|NCT00327145|Vasodilator Agents|vasodilator agents|mesh-ancestor
101397688|NCT00327145|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101397689|NCT00327145|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101397691|NCT00327145|Natriuretic Agents|natriuretic agents|mesh-ancestor
101397692|NCT00327145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101397694|NCT00085943|Fosamprenavir|fosamprenavir|mesh-list
101397695|NCT00085943|Lamivudine|lamivudine|mesh-list
101397696|NCT00085943|Abacavir|abacavir|mesh-list
101397697|NCT00085943|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101397698|NCT00085943|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101397699|NCT00085943|Protease Inhibitors|protease inhibitors|mesh-ancestor
101397700|NCT00085943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101397701|NCT00085943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397702|NCT00085943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101397703|NCT00085943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101397704|NCT00085943|Antiviral Agents|antiviral agents|mesh-ancestor
101397705|NCT00085943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101397706|NCT00085943|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101397707|NCT00085943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101397708|NCT00085943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101397709|NCT00085943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101397711|NCT00327184|Anticoagulants|anticoagulants|mesh-ancestor
101397712|NCT00327184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101397713|NCT00327184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101397714|NCT00327184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397715|NCT00419302|Insulin|insulin|mesh-list
102075349|NCT00273650|Micronutrients|micronutrients|mesh-ancestor
102075350|NCT00273650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075351|NCT00273650|Vitamin B Complex|vitamin b complex|mesh-ancestor
102075352|NCT02121288|Clopidogrel|clopidogrel|mesh-list
102075353|NCT02121288|Ticagrelor|ticagrelor|mesh-list
102075354|NCT02121288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102075355|NCT02121288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101397716|NCT00419302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101397717|NCT00419302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397718|NCT00093951|(3-aminopropyl)(n-butyl)phosphinic acid|(3-aminopropyl)(n-butyl)phosphinic acid|mesh-list
101397719|NCT00093951|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101397720|NCT00093951|Protective Agents|protective agents|mesh-ancestor
101397721|NCT00093951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397722|NCT00093951|GABA Antagonists|gaba antagonists|mesh-ancestor
101397723|NCT00093951|GABA Agents|gaba agents|mesh-ancestor
101397724|NCT00093951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101397725|NCT00093951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397726|NCT00419419|Nitroglycerin|nitroglycerin|mesh-list
101397727|NCT00419419|Vasodilator Agents|vasodilator agents|mesh-ancestor
101397728|NCT00320476|Bortezomib|bortezomib|mesh-list
101397749|NCT00327418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397750|NCT00327418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101397751|NCT00327418|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101397752|NCT00327418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101397754|NCT00094029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397755|NCT00094029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101397756|NCT00094029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101397757|NCT00094029|Growth Substances|growth substances|mesh-ancestor
101397758|NCT00094029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397759|NCT00094029|Growth Inhibitors|growth inhibitors|mesh-ancestor
101397760|NCT00094029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101397761|NCT00094029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101306090|NCT02023684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397762|NCT00094029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397764|NCT00086099|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101397765|NCT00086099|Protective Agents|protective agents|mesh-ancestor
101397766|NCT00086099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397767|NCT00320632|Desipramine|desipramine|mesh-list
101397768|NCT00320632|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101397769|NCT00320632|Antidepressive Agents|antidepressive agents|mesh-ancestor
101397770|NCT00320632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101397771|NCT00320632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101397772|NCT00320632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397773|NCT00320632|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101339926|NCT00083083|Tubulin Modulators|tubulin modulators|mesh-ancestor
101397774|NCT00320632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101397775|NCT00320632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101397780|NCT00320827|Immunologic Factors|immunologic factors|mesh-ancestor
101397781|NCT00320827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397783|NCT00320983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397784|NCT00320983|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101397794|NCT00094146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101397795|NCT00094146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101397796|NCT00094146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397797|NCT00086255|Tiagabine|tiagabine|mesh-list
101397798|NCT00086255|Anticonvulsants|anticonvulsants|mesh-ancestor
101397799|NCT00086255|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
101397800|NCT00086255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101397801|NCT00086255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101397802|NCT00086255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397803|NCT00086255|GABA Agents|gaba agents|mesh-ancestor
101397804|NCT00086255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101397805|NCT00086255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397806|NCT00321178|Clarithromycin|clarithromycin|mesh-list
101397807|NCT00321178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101397808|NCT00321178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101377040|NCT00066716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102075356|NCT02121288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102075357|NCT02121288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102075358|NCT02121288|Purinergic Agents|purinergic agents|mesh-ancestor
102075359|NCT02121288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102075360|NCT02121288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075361|NCT02121288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075362|NCT01525329|Fluorouracil|fluorouracil|mesh-list
101397809|NCT00321178|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101397810|NCT00321178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101397811|NCT00321178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397812|NCT00321178|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101397813|NCT00321178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101397814|NCT00124527|Capecitabine|capecitabine|mesh-list
101397815|NCT00124527|Irofulven|irofulven|mesh-list
101397816|NCT00124527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101397817|NCT00124527|Antimetabolites|antimetabolites|mesh-ancestor
101397818|NCT00124527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397819|NCT00124527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397820|NCT00124527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101397821|NCT00124527|Alkylating Agents|alkylating agents|mesh-ancestor
101397822|NCT00086294|Levodopa|levodopa|mesh-list
101397823|NCT00086294|Pimavanserin|pimavanserin|mesh-list
101397824|NCT00086294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101397825|NCT00086294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101397826|NCT00086294|Dopamine Agents|dopamine agents|mesh-ancestor
101397827|NCT00086294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101397828|NCT00086294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397829|NCT00086294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397830|NCT00086294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101397831|NCT00086294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101397832|NCT00086294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101397833|NCT00086294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101397834|NCT00086294|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101397835|NCT00086294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101397836|NCT00086294|Serotonin Agents|serotonin agents|mesh-ancestor
101397837|NCT05458492|Sirolimus|sirolimus|mesh-list
101397838|NCT05458492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101397839|NCT05458492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101397840|NCT05458492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101397841|NCT05458492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397842|NCT05458492|Antifungal Agents|antifungal agents|mesh-ancestor
101397843|NCT05458492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101397844|NCT05458492|Immunologic Factors|immunologic factors|mesh-ancestor
101397845|NCT05458492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397847|NCT00086333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397848|NCT00086333|Tubulin Modulators|tubulin modulators|mesh-ancestor
101397849|NCT00086333|Antimitotic Agents|antimitotic agents|mesh-ancestor
101397850|NCT00086333|Mitosis Modulators|mitosis modulators|mesh-ancestor
101397860|NCT05458180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101397861|NCT05458180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101397862|NCT05458180|Alkylating Agents|alkylating agents|mesh-ancestor
101397863|NCT05458180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397864|NCT05458180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397869|NCT05458180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101397871|NCT05458180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101397872|NCT05458180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101397873|NCT05458180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101397874|NCT05458180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101397875|NCT05458180|Tubulin Modulators|tubulin modulators|mesh-ancestor
101397876|NCT05458180|Antimitotic Agents|antimitotic agents|mesh-ancestor
101397877|NCT05458180|Mitosis Modulators|mitosis modulators|mesh-ancestor
101397878|NCT05458180|Analgesics|analgesics|mesh-ancestor
101397879|NCT05458180|Sensory System Agents|sensory system agents|mesh-ancestor
102075363|NCT01525329|Antimetabolites|antimetabolites|mesh-ancestor
102075364|NCT01525329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075365|NCT01525329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102075366|NCT01525329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102075367|NCT01525329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102075368|NCT01525329|Immunologic Factors|immunologic factors|mesh-ancestor
102075369|NCT01525329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075370|NCT02121366|Ethanol|ethanol|mesh-list
101377051|NCT00077103|Doxorubicin|doxorubicin|mesh-list
101397880|NCT05458180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101397881|NCT00419653|Haloperidol|haloperidol|mesh-list
101397882|NCT00419653|Olanzapine|olanzapine|mesh-list
101397883|NCT00419653|Haloperidol decanoate|haloperidol decanoate|mesh-list
101397884|NCT00419653|Amisulpride|amisulpride|mesh-list
101397885|NCT00419653|Antiemetics|antiemetics|mesh-ancestor
101397886|NCT00419653|Autonomic Agents|autonomic agents|mesh-ancestor
101397887|NCT00419653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101397888|NCT00419653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397889|NCT00419653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101397890|NCT00419653|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101397891|NCT00419653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101397892|NCT00419653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101397893|NCT00419653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101397894|NCT00419653|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101397895|NCT00419653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101397896|NCT00419653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101397897|NCT00419653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397898|NCT00419653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101397899|NCT00419653|Serotonin Agents|serotonin agents|mesh-ancestor
101397900|NCT00419653|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101397901|NCT00419653|Dopamine Agents|dopamine agents|mesh-ancestor
101397902|NCT00419653|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101397903|NCT00419653|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101397904|NCT00419653|Antidepressive Agents|antidepressive agents|mesh-ancestor
101397905|NCT00094341|Etanercept|etanercept|mesh-list
101397906|NCT00094341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101397907|NCT00094341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101397908|NCT00094341|Analgesics|analgesics|mesh-ancestor
101397909|NCT00094341|Sensory System Agents|sensory system agents|mesh-ancestor
101397910|NCT00094341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101397911|NCT00094341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397912|NCT00094341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101397913|NCT00094341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101397914|NCT00094341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101397915|NCT00094341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101397916|NCT00094341|Immunologic Factors|immunologic factors|mesh-ancestor
101397924|NCT00094380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101397926|NCT00094380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397927|NCT00094380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101397928|NCT00094380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101397929|NCT00094380|Alkylating Agents|alkylating agents|mesh-ancestor
101397930|NCT00094380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306092|NCT02023684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101306093|NCT02023684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101397931|NCT00094380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397932|NCT00094380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101397933|NCT00321490|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101397934|NCT00321490|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101397935|NCT00321490|Antidepressive Agents|antidepressive agents|mesh-ancestor
101397936|NCT00321490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101397937|NCT00321490|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101397938|NCT00321490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101397939|NCT00321490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101397943|NCT00321490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102075371|NCT02121366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102075372|NCT02121366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102075373|NCT02121366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102075374|NCT02121366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075375|NCT02121444|Interferons|interferons|mesh-list
102075376|NCT02121444|Interferon-beta|interferon-beta|mesh-list
102075377|NCT02121444|Interferon beta-1b|interferon beta-1b|mesh-list
101397944|NCT00321490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397945|NCT00321490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101397947|NCT00321490|Sensory System Agents|sensory system agents|mesh-ancestor
101397948|NCT00321490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101397949|NCT00321490|Dopamine Agents|dopamine agents|mesh-ancestor
101397950|NCT00086528|XL647|xl647|mesh-list
101397951|NCT00086528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397952|NCT00086528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101397953|NCT00086528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101397954|NCT00086528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397955|NCT05457829|Doxorubicin|doxorubicin|mesh-list
101397956|NCT05457829|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101397957|NCT05457829|Irinotecan|irinotecan|mesh-list
101397958|NCT05457829|Vincristine|vincristine|mesh-list
101397959|NCT05457829|Temozolomide|temozolomide|mesh-list
101397960|NCT05457829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101397961|NCT05457829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397962|NCT05457829|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101397963|NCT05457829|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101397964|NCT05457829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101397965|NCT05457829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397966|NCT05457829|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101397967|NCT05457829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101397968|NCT05457829|Tubulin Modulators|tubulin modulators|mesh-ancestor
101397969|NCT05457829|Antimitotic Agents|antimitotic agents|mesh-ancestor
101397970|NCT05457829|Mitosis Modulators|mitosis modulators|mesh-ancestor
101397971|NCT05457829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101397972|NCT05457829|Alkylating Agents|alkylating agents|mesh-ancestor
101397973|NCT05457751|Rocuronium|rocuronium|mesh-list
101397974|NCT05457751|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101397975|NCT05457751|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101397976|NCT05457751|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101397977|NCT05457751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101397978|NCT05457751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397979|NCT00086606|Omalizumab|omalizumab|mesh-list
101397980|NCT00086606|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101397981|NCT00086606|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101397982|NCT00086606|Respiratory System Agents|respiratory system agents|mesh-ancestor
101397987|NCT00124566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101397988|NCT00124566|Glucocorticoids|glucocorticoids|mesh-ancestor
101397989|NCT00124566|Hormones|hormones|mesh-ancestor
101397990|NCT00124566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101397991|NCT00124566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397992|NCT00124566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101397993|NCT00124566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397994|NCT00124566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101397995|NCT00124566|Antimetabolites|antimetabolites|mesh-ancestor
101397996|NCT00124566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397997|NCT00124566|Analgesics|analgesics|mesh-ancestor
101340280|NCT00136786|Memantine|memantine|mesh-list
101397998|NCT00124566|Sensory System Agents|sensory system agents|mesh-ancestor
101397999|NCT00124566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101398000|NCT00124566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101398001|NCT00124566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101398002|NCT00124566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101398003|NCT00124566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101306094|NCT02023684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101184857|NCT01302444|Tadalafil|tadalafil|mesh-list
101398004|NCT00124566|Alkylating Agents|alkylating agents|mesh-ancestor
101398005|NCT00321724|Cediranib|cediranib|mesh-list
101398006|NCT00321724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102075378|NCT02121444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102075379|NCT02121444|Antiviral Agents|antiviral agents|mesh-ancestor
102075380|NCT02121444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102075381|NCT02121444|Immunologic Factors|immunologic factors|mesh-ancestor
102075382|NCT02121444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075383|NCT02121444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102075384|NCT04413526|Chlorotrianisene|chlorotrianisene|mesh-list
102075385|NCT04413526|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102075386|NCT04413526|Estrogens|estrogens|mesh-ancestor
101398007|NCT00321724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398008|NCT00321724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101398009|NCT00321724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101398010|NCT00086645|Dexetimide|dexetimide|mesh-list
101398015|NCT00086645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101398016|NCT00086645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398017|NCT00086645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101398018|NCT00086645|Serotonin Agents|serotonin agents|mesh-ancestor
101398019|NCT00086645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398020|NCT00086645|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101398021|NCT00086645|Antidepressive Agents|antidepressive agents|mesh-ancestor
101398022|NCT00086645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101398023|NCT00086645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101398024|NCT00086645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101398025|NCT00086645|Parasympatholytics|parasympatholytics|mesh-ancestor
101398026|NCT00086645|Autonomic Agents|autonomic agents|mesh-ancestor
101398027|NCT00086645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101398028|NCT00086645|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101398029|NCT00086645|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101398030|NCT00086645|Cholinergic Agents|cholinergic agents|mesh-ancestor
101398032|NCT00321802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101398033|NCT00321802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101398034|NCT00321802|Antimetabolites|antimetabolites|mesh-ancestor
101398035|NCT00321802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398036|NCT00321802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101398037|NCT00321802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101398038|NCT00321802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101398039|NCT00124605|Pamidronate|pamidronate|mesh-list
101398040|NCT00124605|Arsenic Trioxide|arsenic trioxide|mesh-list
101398041|NCT00124605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101398042|NCT00124605|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101398043|NCT00124605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398044|NCT05457361|Azacitidine|azacitidine|mesh-list
101398045|NCT05457361|Homoharringtonine|homoharringtonine|mesh-list
101398046|NCT05457361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101398047|NCT05457361|Antimetabolites|antimetabolites|mesh-ancestor
101398048|NCT05457361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398049|NCT05457361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101398050|NCT05457361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101398051|NCT05457361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101398052|NCT05457361|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101398053|NCT00086801|Gemcitabine|gemcitabine|mesh-list
101398054|NCT00086801|Doxorubicin|doxorubicin|mesh-list
101398060|NCT00086801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398062|NCT00086801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101398063|NCT00086801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101398064|NCT00086801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101398065|NCT00086801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101398066|NCT00086801|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101398067|NCT00086801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101398068|NCT00086801|Tubulin Modulators|tubulin modulators|mesh-ancestor
101398069|NCT00086801|Antimitotic Agents|antimitotic agents|mesh-ancestor
101398070|NCT00086801|Mitosis Modulators|mitosis modulators|mesh-ancestor
101398071|NCT05456113|Cannabidiol|cannabidiol|mesh-list
101398072|NCT05456113|Anticonvulsants|anticonvulsants|mesh-ancestor
101398073|NCT00124644|Cytarabine|cytarabine|mesh-list
101398074|NCT00124644|Etoposide|etoposide|mesh-list
102075387|NCT04413526|Hormones|hormones|mesh-ancestor
102075388|NCT04413526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102075389|NCT04413526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075390|NCT04413526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102075391|NCT04413526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102075392|NCT03665506|Trifluridine|trifluridine|mesh-list
102075393|NCT03665506|Antimetabolites|antimetabolites|mesh-ancestor
101398075|NCT00124644|Daunorubicin|daunorubicin|mesh-list
101398076|NCT00124644|Tipifarnib|tipifarnib|mesh-list
101398077|NCT00124644|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101398078|NCT00124644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101398079|NCT00124644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101398080|NCT00124644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101398081|NCT00124644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101306095|NCT02023684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101306096|NCT02023684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101306097|NCT02023684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306098|NCT02023710|Paclitaxel|paclitaxel|mesh-list
101398082|NCT00124644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398092|NCT00086840|Temsirolimus|temsirolimus|mesh-list
101398093|NCT00086840|MTOR Inhibitors|mtor inhibitors|mesh-list
101398094|NCT00086840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101398095|NCT00086840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101398096|NCT00086840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398097|NCT00086840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101398098|NCT00086840|Immunologic Factors|immunologic factors|mesh-ancestor
101398099|NCT00086840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398100|NCT00086840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101398101|NCT00086840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101398102|NCT00086840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101398103|NCT00086840|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101398104|NCT00086840|Antifungal Agents|antifungal agents|mesh-ancestor
101398106|NCT00124683|Nicotine|nicotine|mesh-list
101398107|NCT00124683|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101398108|NCT00124683|Autonomic Agents|autonomic agents|mesh-ancestor
101398109|NCT00124683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101398110|NCT00124683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398111|NCT00124683|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101398112|NCT00124683|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101398113|NCT00124683|Cholinergic Agents|cholinergic agents|mesh-ancestor
101398114|NCT00124683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101398115|NCT00124683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398116|NCT00124683|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101398117|NCT00124683|Antidepressive Agents|antidepressive agents|mesh-ancestor
101398118|NCT00124683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101398119|NCT00124683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101398120|NCT00124683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101398121|NCT00124683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101398122|NCT00124683|Dopamine Agents|dopamine agents|mesh-ancestor
101398123|NCT00124683|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101398124|NCT00124683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101398139|NCT00124722|Rocuronium|rocuronium|mesh-list
101398140|NCT00124722|Anticonvulsants|anticonvulsants|mesh-ancestor
101398141|NCT00124722|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101398142|NCT00124722|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101398143|NCT00124722|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101398144|NCT00124722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101398145|NCT00124722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398146|NCT00322036|Flurbiprofen|flurbiprofen|mesh-list
101398147|NCT00322036|Tarenflurbil|tarenflurbil|mesh-list
101398148|NCT00322036|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101398149|NCT00322036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101398150|NCT00322036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398151|NCT00322036|Analgesics|analgesics|mesh-ancestor
101398152|NCT00322036|Sensory System Agents|sensory system agents|mesh-ancestor
102075394|NCT03665506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075395|NCT03665506|Antiviral Agents|antiviral agents|mesh-ancestor
102075396|NCT03665506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102075397|NCT03318874|Hyaluronic Acid|hyaluronic acid|mesh-list
102075398|NCT03318874|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101398153|NCT00322036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101398154|NCT00322036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398155|NCT00322036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101398156|NCT00322036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101398157|NCT00322036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101398158|NCT00322036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101398159|NCT00322036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101398160|NCT00094614|Atropine|atropine|mesh-list
101306099|NCT02023710|Bevacizumab|bevacizumab|mesh-list
101398169|NCT00094614|Mydriatics|mydriatics|mesh-ancestor
101398170|NCT00094614|Parasympatholytics|parasympatholytics|mesh-ancestor
101398171|NCT00094614|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101398172|NCT00094614|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101398173|NCT00094614|Cholinergic Agents|cholinergic agents|mesh-ancestor
101398174|NCT00094614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101398175|NCT00094614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398176|NCT00087035|Docetaxel|docetaxel|mesh-list
101398177|NCT00087035|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101398178|NCT00087035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101398179|NCT00087035|Tubulin Modulators|tubulin modulators|mesh-ancestor
101398180|NCT00087035|Antimitotic Agents|antimitotic agents|mesh-ancestor
101340582|NCT00138970|Methylprednisolone|methylprednisolone|mesh-list
101398181|NCT00087035|Mitosis Modulators|mitosis modulators|mesh-ancestor
101398182|NCT00087035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398183|NCT00087035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101398184|NCT00087035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101398185|NCT00322075|Insulin Glargine|insulin glargine|mesh-list
101398186|NCT00322075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101398187|NCT00322075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398199|NCT00087074|MTOR Inhibitors|mtor inhibitors|mesh-list
101398200|NCT00087074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101398201|NCT00087074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101398202|NCT00087074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398203|NCT00087074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101398204|NCT00087074|Immunologic Factors|immunologic factors|mesh-ancestor
101398205|NCT00087074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398206|NCT00087074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101398208|NCT00087074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101398209|NCT00087074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101398210|NCT00087074|Antifungal Agents|antifungal agents|mesh-ancestor
101398211|NCT00332176|Ribavirin|ribavirin|mesh-list
101398212|NCT00332176|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101398213|NCT00332176|Antimetabolites|antimetabolites|mesh-ancestor
101398214|NCT00332176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398215|NCT00332176|Antiviral Agents|antiviral agents|mesh-ancestor
101398216|NCT00332176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101398217|NCT00087113|Pemetrexed|pemetrexed|mesh-list
101398218|NCT00087113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101398219|NCT00087113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101398220|NCT00087113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398221|NCT00087113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101398222|NCT00087113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101398223|NCT00332254|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101398224|NCT00332254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101398225|NCT00332293|Moxifloxacin|moxifloxacin|mesh-list
101398226|NCT00332293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101398227|NCT00332293|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101398228|NCT00332293|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101398229|NCT00332293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101398230|NCT00332293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101398231|NCT00332293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101398232|NCT00332293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101398236|NCT00332293|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101398237|NCT00332293|Contraceptive Agents|contraceptive agents|mesh-ancestor
101398238|NCT00332293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102075400|NCT03318874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075401|NCT03318874|Viscosupplements|viscosupplements|mesh-ancestor
102075402|NCT03318874|Protective Agents|protective agents|mesh-ancestor
102075403|NCT03551652|Rocuronium|rocuronium|mesh-list
102075404|NCT03551652|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102075405|NCT03551652|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101306103|NCT02023710|Tubulin Modulators|tubulin modulators|mesh-ancestor
101306104|NCT02023710|Antimitotic Agents|antimitotic agents|mesh-ancestor
101306105|NCT02023710|Mitosis Modulators|mitosis modulators|mesh-ancestor
101185063|NCT00676026|Hormones|hormones|mesh-ancestor
101398239|NCT00332293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398240|NCT00332293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101398241|NCT00332293|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101398242|NCT00332293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101398243|NCT00087191|Motexafin lutetium|motexafin lutetium|mesh-list
101398244|NCT00087191|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101398245|NCT00087191|Dermatologic Agents|dermatologic agents|mesh-ancestor
101398246|NCT05222152|Hydrocortisone|hydrocortisone|mesh-list
101398247|NCT05222152|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101398248|NCT05222152|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101398249|NCT05222152|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101398250|NCT05222152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101398251|NCT00094692|Atropine|atropine|mesh-list
101398252|NCT00094692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101398264|NCT00094692|Cholinergic Agents|cholinergic agents|mesh-ancestor
101398265|NCT00094692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101398266|NCT00094692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398267|NCT05181007|Valproic Acid|valproic acid|mesh-list
101398268|NCT05181007|Anticonvulsants|anticonvulsants|mesh-ancestor
101398269|NCT05181007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101398270|NCT05181007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398271|NCT05181007|GABA Agents|gaba agents|mesh-ancestor
101398272|NCT05181007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101398273|NCT05181007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398274|NCT05181007|Antimanic Agents|antimanic agents|mesh-ancestor
101398275|NCT05181007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101398276|NCT05181007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101398277|NCT05181007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101398278|NCT00124839|Naltrexone|naltrexone|mesh-list
101398279|NCT00124839|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101398280|NCT00124839|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101398281|NCT00124839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398282|NCT00124839|Sensory System Agents|sensory system agents|mesh-ancestor
101398283|NCT00124839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101398284|NCT00087269|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101398285|NCT00087269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101398286|NCT00087269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101398287|NCT00087269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101398288|NCT00087269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398289|NCT00087347|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
101398290|NCT00087347|Hematinics|hematinics|mesh-ancestor
101398291|NCT00087347|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101398292|NCT00087347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101398293|NCT04960930|Minocycline|minocycline|mesh-list
101398294|NCT04960930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101398295|NCT04960930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101398296|NCT00419692|Ropinirole|ropinirole|mesh-list
101398297|NCT00419692|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101398298|NCT00419692|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101398299|NCT00419692|Dopamine Agonists|dopamine agonists|mesh-ancestor
101398300|NCT00419692|Dopamine Agents|dopamine agents|mesh-ancestor
101398301|NCT00419692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101398302|NCT00419692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398303|NCT00419692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398304|NCT00419731|Naltrexone|naltrexone|mesh-list
101398305|NCT00419731|Bupropion|bupropion|mesh-list
101398306|NCT00419731|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101398307|NCT00419731|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102075407|NCT03551652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102075408|NCT03551652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075409|NCT00263042|Rimonabant|rimonabant|mesh-list
102075410|NCT00263042|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102075411|NCT00263042|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
102075412|NCT00263042|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102075413|NCT00263042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101398308|NCT00419731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398309|NCT00419731|Sensory System Agents|sensory system agents|mesh-ancestor
101398310|NCT00419731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101398311|NCT00419731|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101398337|NCT00087425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398338|NCT00087425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101398339|NCT00087425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101398341|NCT00330655|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101398342|NCT00330655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101398343|NCT00330655|Dopamine Agents|dopamine agents|mesh-ancestor
101398344|NCT00330655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101398345|NCT00330655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398346|NCT00330655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398347|NCT00330655|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101398348|NCT00330655|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101398349|NCT00330772|Aspirin|aspirin|mesh-list
101398350|NCT00330772|Clopidogrel|clopidogrel|mesh-list
101398351|NCT00330772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101398352|NCT00330772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101398353|NCT00330772|Analgesics|analgesics|mesh-ancestor
101398354|NCT00330772|Sensory System Agents|sensory system agents|mesh-ancestor
101398355|NCT00330772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101398356|NCT00330772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398357|NCT00330772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101398358|NCT00330772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101398359|NCT00330772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101398360|NCT00330772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101398361|NCT00330772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398362|NCT00330772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101398363|NCT00330772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101398364|NCT00330772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101398365|NCT00330772|Antipyretics|antipyretics|mesh-ancestor
101398366|NCT00330772|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101398367|NCT00330772|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101398368|NCT00330772|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101398369|NCT00330772|Purinergic Agents|purinergic agents|mesh-ancestor
101398370|NCT00330772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101398371|NCT00094926|Risperidone|risperidone|mesh-list
101398372|NCT00094926|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101398373|NCT00094926|Serotonin Agents|serotonin agents|mesh-ancestor
101398374|NCT00094926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101398403|NCT00331084|BB 1101|bb 1101|mesh-list
101398404|NCT00331084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101398405|NCT00331084|Antiemetics|antiemetics|mesh-ancestor
101398406|NCT00331084|Autonomic Agents|autonomic agents|mesh-ancestor
101398407|NCT00331084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101398408|NCT00331084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398409|NCT00331084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101398410|NCT00331084|Glucocorticoids|glucocorticoids|mesh-ancestor
101398411|NCT00331084|Hormones|hormones|mesh-ancestor
101398412|NCT00331084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101398413|NCT00331084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101398414|NCT00331084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101398415|NCT00331084|Protease Inhibitors|protease inhibitors|mesh-ancestor
101398416|NCT00331084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101398417|NCT00331084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398418|NCT00331084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101377096|NCT00242749|Gefitinib|gefitinib|mesh-list
102075414|NCT00263042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075415|NCT00263042|Hormones|hormones|mesh-ancestor
102075416|NCT00263042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102075417|NCT00263042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075418|NCT05002192|Eucalyptol|eucalyptol|mesh-list
102075419|NCT05002192|Ambroxol|ambroxol|mesh-list
102075420|NCT05002192|Expectorants|expectorants|mesh-list
102075421|NCT05002192|Respiratory System Agents|respiratory system agents|mesh-ancestor
102075422|NCT05002192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102075423|NCT05002192|Antitussive Agents|antitussive agents|mesh-ancestor
102075424|NCT05002192|Insect Repellents|insect repellents|mesh-ancestor
101195134|NCT05604599|Fentanyl|fentanyl|mesh-list
101398431|NCT00420355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101398432|NCT00420355|Protease Inhibitors|protease inhibitors|mesh-ancestor
101398433|NCT00420355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101398434|NCT00420355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398436|NCT00420355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101398437|NCT00420355|Antiviral Agents|antiviral agents|mesh-ancestor
101306107|NCT02023710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101398438|NCT00420355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101398439|NCT00420355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101398440|NCT00420355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101398441|NCT00331123|Testosterone|testosterone|mesh-list
101398442|NCT00331123|Androgens|androgens|mesh-ancestor
101398443|NCT00331123|Hormones|hormones|mesh-ancestor
101398444|NCT00331123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101398445|NCT00331123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398446|NCT00087542|Pimavanserin|pimavanserin|mesh-list
101340995|NCT00141232|Atorvastatin|atorvastatin|mesh-list
101398447|NCT00087542|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101398448|NCT00087542|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101398449|NCT00087542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101398450|NCT00087542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101398451|NCT00087542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101398452|NCT00087542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398453|NCT00087542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101398454|NCT00087542|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101398455|NCT00087542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101398456|NCT00087542|Serotonin Agents|serotonin agents|mesh-ancestor
101398457|NCT00087542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101398458|NCT00087542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398459|NCT00331240|Timolol|timolol|mesh-list
101398460|NCT00331240|Travoprost|travoprost|mesh-list
101398461|NCT00331240|Lubricant Eye Drops|lubricant eye drops|mesh-list
101398462|NCT00331240|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101398463|NCT00331240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101398464|NCT00331240|Adrenergic Agents|adrenergic agents|mesh-ancestor
101398465|NCT00331240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101398466|NCT00331240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398467|NCT00331240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398468|NCT00331240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101398469|NCT00331240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101398470|NCT00331240|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101398471|NCT00331240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101398472|NCT00124956|Doxorubicin|doxorubicin|mesh-list
101398473|NCT00124956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101398474|NCT00124956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101398475|NCT00124956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101398476|NCT00124956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101398477|NCT00124956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101398478|NCT00124956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398479|NCT00087581|Cyclosporine|cyclosporine|mesh-list
102075425|NCT05002192|Protective Agents|protective agents|mesh-ancestor
102075426|NCT05002192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075427|NCT04973020|Efavirenz|efavirenz|mesh-list
102075428|NCT04973020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102075429|NCT04973020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102075430|NCT04973020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101377107|NCT00242788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101398480|NCT00087581|Mycophenolic Acid|mycophenolic acid|mesh-list
101398481|NCT00087581|Tacrolimus|tacrolimus|mesh-list
101398482|NCT00087581|Cyclosporins|cyclosporins|mesh-list
101398483|NCT00087581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101398484|NCT00087581|Immunologic Factors|immunologic factors|mesh-ancestor
101398485|NCT00087581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398486|NCT00087581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101398488|NCT00087581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398489|NCT00087581|Antifungal Agents|antifungal agents|mesh-ancestor
101398490|NCT00087581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101398491|NCT00087581|Dermatologic Agents|dermatologic agents|mesh-ancestor
101398492|NCT00087581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101398493|NCT00087581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101398506|NCT00331513|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101398507|NCT00331513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101398508|NCT00331513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341115|NCT00141895|Abortifacient Agents|abortifacient agents|mesh-ancestor
101398509|NCT00331513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101398510|NCT00331513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101398511|NCT00331513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101398512|NCT00087620|Capecitabine|capecitabine|mesh-list
101398513|NCT00087620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101398514|NCT00087620|Antimetabolites|antimetabolites|mesh-ancestor
101398515|NCT00087620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398516|NCT00087620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101398517|NCT00124995|Terbutaline|terbutaline|mesh-list
101398518|NCT00124995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101398519|NCT00124995|Autonomic Agents|autonomic agents|mesh-ancestor
101306109|NCT02023710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101306110|NCT02023710|Growth Substances|growth substances|mesh-ancestor
101306111|NCT02023710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398520|NCT00124995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101398521|NCT00124995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398522|NCT00124995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101398523|NCT00124995|Respiratory System Agents|respiratory system agents|mesh-ancestor
101398524|NCT00124995|Sympathomimetics|sympathomimetics|mesh-ancestor
101398525|NCT00124995|Tocolytic Agents|tocolytic agents|mesh-ancestor
101398526|NCT00124995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101398527|NCT00124995|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101398528|NCT00124995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101398529|NCT00124995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101398530|NCT00124995|Adrenergic Agents|adrenergic agents|mesh-ancestor
101398531|NCT00124995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101398532|NCT00124995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398533|NCT00331708|Artesunate|artesunate|mesh-list
101398534|NCT00331708|Pyrimethamine|pyrimethamine|mesh-list
101398535|NCT00331708|Sulfadoxine|sulfadoxine|mesh-list
101398536|NCT00331708|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101398537|NCT00331708|Antimalarials|antimalarials|mesh-ancestor
101398538|NCT00331708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101398539|NCT00331708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101398540|NCT00331708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101398541|NCT00331708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101398542|NCT00331708|Antiviral Agents|antiviral agents|mesh-ancestor
101398543|NCT00331708|Schistosomicides|schistosomicides|mesh-ancestor
101398544|NCT00331708|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101398545|NCT00331708|Anthelmintics|anthelmintics|mesh-ancestor
101398546|NCT00331708|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101398547|NCT00331708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101398548|NCT00331708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398549|NCT00331708|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102075431|NCT04973020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075432|NCT04973020|Antiviral Agents|antiviral agents|mesh-ancestor
102075433|NCT04973020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102075434|NCT04973020|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102075435|NCT04973020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102075436|NCT04973020|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101341246|NCT02780427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102075437|NCT04973020|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102075438|NCT04973020|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102075439|NCT04973020|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101377113|NCT00066872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101398550|NCT00331747|Glatiramer Acetate|glatiramer acetate|mesh-list
101398551|NCT00331747|(T,G)-A-L|(t,g)-a-l|mesh-list
101398552|NCT00331747|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101398553|NCT00331747|Immunologic Factors|immunologic factors|mesh-ancestor
101398554|NCT00331747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398555|NCT00331747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101398556|NCT00331747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101398563|NCT00331786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101398564|NCT00331786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101398565|NCT00331786|Analgesics|analgesics|mesh-ancestor
101398566|NCT00331786|Sensory System Agents|sensory system agents|mesh-ancestor
101398567|NCT00331786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101398568|NCT00331786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398569|NCT00331786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101398570|NCT00331786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101398571|NCT00331786|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101398572|NCT00331786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101398573|NCT00331786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398574|NCT00331786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101398583|NCT00331786|Antioxidants|antioxidants|mesh-ancestor
101398584|NCT00331786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101398585|NCT00331786|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101398586|NCT00331786|Vasodilator Agents|vasodilator agents|mesh-ancestor
101398587|NCT00331786|Gasotransmitters|gasotransmitters|mesh-ancestor
101398588|NCT00331786|Protective Agents|protective agents|mesh-ancestor
101398589|NCT00331786|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
101398590|NCT00331786|Protease Inhibitors|protease inhibitors|mesh-ancestor
101398591|NCT00331825|Olanzapine|olanzapine|mesh-list
101398592|NCT00331825|Risperidone|risperidone|mesh-list
101398593|NCT00331825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101398594|NCT00331825|Serotonin Agents|serotonin agents|mesh-ancestor
101398595|NCT00331825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101398596|NCT00331825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398597|NCT00331825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398598|NCT00331825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101398599|NCT00331825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101398600|NCT00331825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101398601|NCT00331825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101398602|NCT00331825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101398603|NCT00331825|Dopamine Agents|dopamine agents|mesh-ancestor
101398604|NCT00331825|Antiemetics|antiemetics|mesh-ancestor
101341322|NCT00143338|Insulin|insulin|mesh-list
101398605|NCT00331825|Autonomic Agents|autonomic agents|mesh-ancestor
101398606|NCT00331825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101398607|NCT00331825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101398608|NCT00331825|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101398609|NCT00331825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101398610|NCT00331825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101398611|NCT00420472|Mycophenolic Acid|mycophenolic acid|mesh-list
101398612|NCT00420472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101398613|NCT00420472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101398614|NCT00420472|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102075440|NCT05724446|Prednisolone|prednisolone|mesh-list
102075441|NCT05724446|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102075442|NCT05724446|Methylprednisolone|methylprednisolone|mesh-list
102075443|NCT05724446|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102075444|NCT05724446|Prednisolone acetate|prednisolone acetate|mesh-list
102075445|NCT05724446|Clobetasol|clobetasol|mesh-list
102075446|NCT05724446|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102075447|NCT05724446|Prednisolone phosphate|prednisolone phosphate|mesh-list
102075448|NCT05724446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102075449|NCT05724446|Glucocorticoids|glucocorticoids|mesh-ancestor
102075450|NCT05724446|Hormones|hormones|mesh-ancestor
102075451|NCT05724446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102075452|NCT05724446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377125|NCT00243100|Vorinostat|vorinostat|mesh-list
101398615|NCT00420472|Antitubercular Agents|antitubercular agents|mesh-ancestor
101398616|NCT00420472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101398617|NCT00420472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101398618|NCT00420472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101398619|NCT00420472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398620|NCT00087737|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101398621|NCT00087737|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101398622|NCT00087737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101398623|NCT00087737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101398628|NCT00087737|Antidepressive Agents|antidepressive agents|mesh-ancestor
101398630|NCT00331981|Amisulpride|amisulpride|mesh-list
101398631|NCT00331981|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101398632|NCT00331981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101398633|NCT00331981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101398634|NCT00331981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398635|NCT00331981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101398636|NCT00331981|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101398637|NCT00331981|Dopamine Agents|dopamine agents|mesh-ancestor
101398638|NCT00331981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101398639|NCT00331981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398640|NCT00331981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101398641|NCT00331981|Antidepressive Agents|antidepressive agents|mesh-ancestor
101398642|NCT00126633|Bevacizumab|bevacizumab|mesh-list
101398643|NCT00126633|Gemcitabine|gemcitabine|mesh-list
101398663|NCT00332020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101398664|NCT00332020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101398665|NCT02965274|Fluoxetine|fluoxetine|mesh-list
101398666|NCT02965274|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101398667|NCT02965274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101398668|NCT02965274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101456562|NCT00216827|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101398669|NCT02965274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398670|NCT02965274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101398671|NCT02965274|Serotonin Agents|serotonin agents|mesh-ancestor
101398672|NCT02965274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398673|NCT02965274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101398674|NCT02965274|Antidepressive Agents|antidepressive agents|mesh-ancestor
101398675|NCT02965274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101398676|NCT02965274|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101398677|NCT02965274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101398678|NCT02965274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101398679|NCT00332059|Timolol|timolol|mesh-list
101398680|NCT00332059|Bimatoprost|bimatoprost|mesh-list
101398681|NCT00332059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101398682|NCT00332059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101398683|NCT00332059|Adrenergic Agents|adrenergic agents|mesh-ancestor
102075453|NCT05724446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102075454|NCT05724446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102075456|NCT05724446|Autonomic Agents|autonomic agents|mesh-ancestor
102075457|NCT05724446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102075458|NCT05724446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102075459|NCT05724446|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102075460|NCT05724446|Protective Agents|protective agents|mesh-ancestor
102075461|NCT02124642|Folic Acid|folic acid|mesh-list
102075462|NCT02124642|Vitamin B Complex|vitamin b complex|mesh-list
102075463|NCT02124642|Hematinics|hematinics|mesh-ancestor
102075464|NCT02124642|Vitamins|vitamins|mesh-ancestor
102075465|NCT02124642|Micronutrients|micronutrients|mesh-ancestor
102075466|NCT02124642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075467|NCT03094234|Propranolol|propranolol|mesh-list
102075468|NCT03094234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102075469|NCT03094234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102075470|NCT03094234|Adrenergic Agents|adrenergic agents|mesh-ancestor
102075471|NCT03094234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102075472|NCT03094234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075473|NCT03094234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075474|NCT03094234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101377137|NCT00099216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101398684|NCT00332059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101398685|NCT00332059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398686|NCT00332059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398687|NCT00332059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101398688|NCT00332059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101398689|NCT00332137|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101398690|NCT00332137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101398691|NCT00332137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101398699|NCT00126789|Narcotics|narcotics|mesh-ancestor
101398700|NCT00126789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101398701|NCT00126789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398702|NCT00126789|Analgesics|analgesics|mesh-ancestor
101398703|NCT00126789|Sensory System Agents|sensory system agents|mesh-ancestor
101398704|NCT00126789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101398728|NCT05831761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101398729|NCT05831761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398731|NCT05831566|Formoterol Fumarate|formoterol fumarate|mesh-list
101398732|NCT05831566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101398733|NCT05831566|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101398734|NCT05831566|Autonomic Agents|autonomic agents|mesh-ancestor
101398735|NCT05831566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101398736|NCT05831566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398737|NCT05831566|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101398738|NCT05831566|Respiratory System Agents|respiratory system agents|mesh-ancestor
101398739|NCT05831566|Glucocorticoids|glucocorticoids|mesh-ancestor
101398740|NCT05831566|Hormones|hormones|mesh-ancestor
101398741|NCT05831566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101398742|NCT05831566|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101377159|NCT00243256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102075475|NCT03094234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102075476|NCT03094234|Vasodilator Agents|vasodilator agents|mesh-ancestor
102075477|NCT00260156|Vildagliptin|vildagliptin|mesh-list
102075478|NCT00260156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102075479|NCT00260156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075480|NCT00260156|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102075481|NCT00260156|Protease Inhibitors|protease inhibitors|mesh-ancestor
102075482|NCT00260156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101398743|NCT05831566|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101398744|NCT05831566|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101398745|NCT05831566|Adrenergic Agents|adrenergic agents|mesh-ancestor
101398746|NCT05831566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101398747|NCT05831566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306114|NCT02023840|Erythritol|erythritol|mesh-list
101306115|NCT02023840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101306116|NCT02023840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101306117|NCT02023840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101398748|NCT05831462|Ticagrelor|ticagrelor|mesh-list
101398749|NCT05831462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101398750|NCT05831462|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101398751|NCT05831462|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101398786|NCT05830916|Antibodies|antibodies|mesh-list
101398787|NCT05830916|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
101398788|NCT05830916|Immunologic Factors|immunologic factors|mesh-ancestor
101398789|NCT05830916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398790|NCT05830864|Isoflurane|isoflurane|mesh-list
101398791|NCT05830864|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101398792|NCT05830864|Anesthetics, General|anesthetics, general|mesh-ancestor
101398793|NCT05830864|Anesthetics|anesthetics|mesh-ancestor
101398794|NCT05830864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101398795|NCT05830864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398796|NCT05830747|Prednisone|prednisone|mesh-list
101398797|NCT05830747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101398798|NCT05830747|Glucocorticoids|glucocorticoids|mesh-ancestor
101398799|NCT05830747|Hormones|hormones|mesh-ancestor
101398800|NCT05830747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101398801|NCT05830747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398802|NCT05830747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101398803|NCT05830747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101398805|NCT05830604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101398806|NCT05830604|Antifungal Agents|antifungal agents|mesh-ancestor
101398807|NCT05830604|Keratolytic Agents|keratolytic agents|mesh-ancestor
101398808|NCT05830604|Dermatologic Agents|dermatologic agents|mesh-ancestor
101398809|NCT05830136|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101398810|NCT05830071|Moxifloxacin|moxifloxacin|mesh-list
101398811|NCT05830071|Beclomethasone|beclomethasone|mesh-list
101398812|NCT05830071|Glycopyrrolate|glycopyrrolate|mesh-list
101398813|NCT05830071|Bromides|bromides|mesh-list
101398814|NCT05830071|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101398815|NCT05830071|Formoterol Fumarate|formoterol fumarate|mesh-list
101398816|NCT05830071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101398817|NCT05830071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101398821|NCT05830071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398822|NCT05830071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101398823|NCT05830071|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101398825|NCT05830071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101398826|NCT05830071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398827|NCT05830071|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101398828|NCT05830071|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101398829|NCT05830071|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101398830|NCT05830071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101398831|NCT05830071|Autonomic Agents|autonomic agents|mesh-ancestor
101398832|NCT05830071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101398833|NCT05830071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101377167|NCT00243646|Androgen Antagonists|androgen antagonists|mesh-ancestor
102075483|NCT00260156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075484|NCT04367103|Phenylephrine|phenylephrine|mesh-list
102075485|NCT04367103|Oxymetazoline|oxymetazoline|mesh-list
102075486|NCT04367103|Norepinephrine|norepinephrine|mesh-list
102075487|NCT04367103|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102075488|NCT04367103|Mydriatics|mydriatics|mesh-ancestor
102075489|NCT04367103|Autonomic Agents|autonomic agents|mesh-ancestor
102075490|NCT04367103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102075491|NCT04367103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075492|NCT04367103|Sympathomimetics|sympathomimetics|mesh-ancestor
101398834|NCT05830071|Respiratory System Agents|respiratory system agents|mesh-ancestor
101398835|NCT05830071|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101398836|NCT05830071|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101398837|NCT05830071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101398838|NCT05830071|Adrenergic Agents|adrenergic agents|mesh-ancestor
101398839|NCT05830071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101398840|NCT05830071|Anticonvulsants|anticonvulsants|mesh-ancestor
101398841|NCT05830071|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101195511|NCT04512105|Venetoclax|venetoclax|mesh-list
101398869|NCT05814523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398870|NCT05814523|GABA Modulators|gaba modulators|mesh-ancestor
101398871|NCT05814523|GABA Agents|gaba agents|mesh-ancestor
101398872|NCT05793905|Lidocaine|lidocaine|mesh-list
101398873|NCT05793905|Anesthetics, Local|anesthetics, local|mesh-ancestor
101398874|NCT05793905|Anesthetics|anesthetics|mesh-ancestor
101398875|NCT05793905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101398876|NCT05793905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398877|NCT05793905|Sensory System Agents|sensory system agents|mesh-ancestor
101398878|NCT05793905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101398879|NCT05793905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101398880|NCT05793905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101398881|NCT05793905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101398882|NCT05793905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101398883|NCT05793905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398884|NCT05776017|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101398885|NCT05776017|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101398886|NCT05776017|Immunologic Factors|immunologic factors|mesh-ancestor
101398887|NCT05776017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398893|NCT05744648|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101398894|NCT05744648|Protective Agents|protective agents|mesh-ancestor
101398895|NCT05744648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398905|NCT05735353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101398906|NCT05735353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398907|NCT05735353|Adrenergic Agents|adrenergic agents|mesh-ancestor
101398908|NCT05735353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101341666|NCT01807377|Anesthetics, General|anesthetics, general|mesh-ancestor
101398909|NCT05735353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101398910|NCT05735353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101398911|NCT05735353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101398913|NCT05691517|Camptothecin|camptothecin|mesh-list
101398914|NCT05691517|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101398915|NCT05691517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101398916|NCT05691517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101398917|NCT05691517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306121|NCT02023853|Erythritol|erythritol|mesh-list
101306122|NCT02023853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101398918|NCT05691517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101398919|NCT05691517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101398920|NCT05670379|Exenatide|exenatide|mesh-list
101398921|NCT05670379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101398922|NCT05670379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398923|NCT05670379|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101398924|NCT05670379|Incretins|incretins|mesh-ancestor
101398925|NCT05670379|Hormones|hormones|mesh-ancestor
102075494|NCT04367103|Nasal Decongestants|nasal decongestants|mesh-ancestor
102075495|NCT04367103|Respiratory System Agents|respiratory system agents|mesh-ancestor
102075496|NCT04367103|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
102075497|NCT04367103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101398926|NCT05670379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101398927|NCT05665270|Prednisolone|prednisolone|mesh-list
101398928|NCT05665270|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101398929|NCT05665270|Methylprednisolone|methylprednisolone|mesh-list
101398930|NCT05665270|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101398931|NCT05665270|Prednisolone acetate|prednisolone acetate|mesh-list
101398932|NCT05665270|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101398933|NCT05665270|Prednisolone phosphate|prednisolone phosphate|mesh-list
101398934|NCT05665270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101398935|NCT05665270|Glucocorticoids|glucocorticoids|mesh-ancestor
101398936|NCT05665270|Hormones|hormones|mesh-ancestor
101398937|NCT05665270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101398938|NCT05665270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398939|NCT05665270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101398940|NCT05665270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101398941|NCT05665270|Antiemetics|antiemetics|mesh-ancestor
101398942|NCT05665270|Autonomic Agents|autonomic agents|mesh-ancestor
101398943|NCT05665270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101398944|NCT05665270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101398945|NCT05665270|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101398946|NCT05665270|Protective Agents|protective agents|mesh-ancestor
101398947|NCT05660447|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101398948|NCT05660447|Lubricant Eye Drops|lubricant eye drops|mesh-list
101398949|NCT05660447|Glycerol|glycerol|mesh-list
101398950|NCT05660447|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101398951|NCT05660447|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101398952|NCT05660447|Protective Agents|protective agents|mesh-ancestor
101341698|NCT05468671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101398953|NCT05660447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398954|NCT05653973|Acetylcholine|acetylcholine|mesh-list
101398955|NCT05653973|Vasodilator Agents|vasodilator agents|mesh-ancestor
101398956|NCT05653973|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101398957|NCT05653973|Cholinergic Agents|cholinergic agents|mesh-ancestor
101398958|NCT05653973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101398962|NCT05628363|Hormones|hormones|mesh-ancestor
101195627|NCT04263064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398969|NCT05574400|Anticoagulants|anticoagulants|mesh-ancestor
101398970|NCT05574400|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101398971|NCT05574400|Chelating Agents|chelating agents|mesh-ancestor
101398972|NCT05574400|Sequestering Agents|sequestering agents|mesh-ancestor
101398973|NCT05574400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398974|NCT05574400|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101398975|NCT05574400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398976|NCT05574400|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101398977|NCT05574400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101398978|NCT05574400|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101398979|NCT05574400|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101398980|NCT05574400|Purinergic Agents|purinergic agents|mesh-ancestor
101398981|NCT05574400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101398983|NCT05555862|Artenimol|artenimol|mesh-list
101398984|NCT05555862|Artemisinins|artemisinins|mesh-list
101398985|NCT05555862|Artemisinin|artemisinin|mesh-list
101398986|NCT05555862|Antimalarials|antimalarials|mesh-ancestor
101398987|NCT05555862|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101398988|NCT05555862|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101398989|NCT05555862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101398990|NCT05555862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101398991|NCT05555862|Antiviral Agents|antiviral agents|mesh-ancestor
101398992|NCT05555862|Schistosomicides|schistosomicides|mesh-ancestor
101306123|NCT02023853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101306124|NCT02023853|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101185718|NCT00000450|Naltrexone|naltrexone|mesh-list
101398993|NCT05555862|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101398994|NCT05555862|Anthelmintics|anthelmintics|mesh-ancestor
101398995|NCT05546359|Dexamethasone|dexamethasone|mesh-list
101398996|NCT05546359|Amisulpride|amisulpride|mesh-list
101398997|NCT05546359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102075498|NCT04367103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102075499|NCT04367103|Adrenergic Agents|adrenergic agents|mesh-ancestor
102075500|NCT04367103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102075501|NCT04367103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075502|NCT04367103|Protective Agents|protective agents|mesh-ancestor
102075503|NCT00260078|Ritonavir|ritonavir|mesh-list
102075504|NCT00260078|Atazanavir Sulfate|atazanavir sulfate|mesh-list
102075505|NCT00260078|Darunavir|darunavir|mesh-list
102075506|NCT00260078|Tenofovir|tenofovir|mesh-list
102075507|NCT00260078|Nevirapine|nevirapine|mesh-list
102075508|NCT00260078|Efavirenz|efavirenz|mesh-list
102075509|NCT00260078|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102075510|NCT00260078|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102075511|NCT00260078|Protease Inhibitors|protease inhibitors|mesh-ancestor
102075512|NCT00260078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102075513|NCT00260078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075514|NCT00260078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102075515|NCT00260078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102075516|NCT00260078|Antiviral Agents|antiviral agents|mesh-ancestor
102075517|NCT00260078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102075518|NCT00260078|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102075519|NCT00260078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102075520|NCT00260078|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102075521|NCT00260078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102075522|NCT00260078|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102075523|NCT00260078|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102075524|NCT00260078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102075525|NCT00260078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102075526|NCT00260078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101377181|NCT00243724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101398998|NCT05546359|Antiemetics|antiemetics|mesh-ancestor
101398999|NCT05546359|Autonomic Agents|autonomic agents|mesh-ancestor
101399000|NCT05546359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101399001|NCT05546359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399002|NCT05546359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101399003|NCT05546359|Glucocorticoids|glucocorticoids|mesh-ancestor
101399004|NCT05546359|Hormones|hormones|mesh-ancestor
101399005|NCT05546359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101399006|NCT05546359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101399007|NCT05546359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399008|NCT05546359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101399009|NCT05546359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101399010|NCT05546359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102075527|NCT03034564|Droxidopa|droxidopa|mesh-list
102075528|NCT03034564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102075529|NCT03034564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102075530|NCT05342532|Amoxicillin|amoxicillin|mesh-list
102075531|NCT05342532|Clarithromycin|clarithromycin|mesh-list
102075532|NCT05342532|Omeprazole|omeprazole|mesh-list
102075533|NCT05342532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102075534|NCT05342532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102075535|NCT05342532|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101399011|NCT05546359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101399012|NCT05546359|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101399013|NCT05546359|Dopamine Agents|dopamine agents|mesh-ancestor
101399014|NCT05546359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101399015|NCT05546359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399016|NCT05546359|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101399017|NCT05546359|Antidepressive Agents|antidepressive agents|mesh-ancestor
101399018|NCT05510115|Empagliflozin|empagliflozin|mesh-list
101399019|NCT05510115|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101399020|NCT05510115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399021|NCT05510115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101399022|NCT05510115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399023|NCT05413330|Triamcinolone|triamcinolone|mesh-list
101399024|NCT05413330|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101399025|NCT05413330|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101399026|NCT05413330|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101399027|NCT05413330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101399028|NCT05413330|Glucocorticoids|glucocorticoids|mesh-ancestor
101195694|NCT03965689|Carboplatin|carboplatin|mesh-list
101399040|NCT05271630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399042|NCT05271630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399043|NCT05254639|Donepezil|donepezil|mesh-list
101399044|NCT05254639|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101399045|NCT05254639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101399046|NCT05254639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399047|NCT05254639|Cholinergic Agents|cholinergic agents|mesh-ancestor
101399048|NCT05254639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101399049|NCT05254639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399050|NCT05254639|Nootropic Agents|nootropic agents|mesh-ancestor
101399051|NCT05243940|Lidocaine|lidocaine|mesh-list
101399052|NCT05243940|Dexmedetomidine|dexmedetomidine|mesh-list
101399053|NCT05243940|Ketamine|ketamine|mesh-list
101399054|NCT05243940|Remifentanil|remifentanil|mesh-list
101399055|NCT05243940|Anesthetics, Local|anesthetics, local|mesh-ancestor
101399056|NCT05243940|Anesthetics|anesthetics|mesh-ancestor
101399057|NCT05243940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101399058|NCT05243940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399059|NCT05243940|Sensory System Agents|sensory system agents|mesh-ancestor
101399060|NCT05243940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101399061|NCT05243940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101399062|NCT05243940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101399063|NCT05243940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101399064|NCT05243940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101399065|NCT05243940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306125|NCT02023853|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101306126|NCT02023853|Vasodilator Agents|vasodilator agents|mesh-ancestor
101306127|NCT02023892|Atorvastatin|atorvastatin|mesh-list
101185792|NCT00000660|Etoposide|etoposide|mesh-list
101399066|NCT05243940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101399067|NCT05243940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101399068|NCT05243940|Analgesics|analgesics|mesh-ancestor
101399069|NCT05243940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101399070|NCT05243940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101399071|NCT05243940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101399072|NCT05243940|Adrenergic Agents|adrenergic agents|mesh-ancestor
101399073|NCT05243940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101399074|NCT05243940|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101399075|NCT05243940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101399076|NCT05243940|Anesthetics, General|anesthetics, general|mesh-ancestor
102075536|NCT05342532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102075537|NCT05342532|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102075538|NCT05342532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102075539|NCT05342532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075540|NCT05342532|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102075541|NCT05342532|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102075542|NCT05342532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102075543|NCT04469114|Tofacitinib|tofacitinib|mesh-list
102075544|NCT04469114|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
102075545|NCT04469114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102075546|NCT04469114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102075547|NCT04469114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075548|NCT02400567|Cyclophosphamide|cyclophosphamide|mesh-list
102075549|NCT02400567|Letrozole|letrozole|mesh-list
101399077|NCT05243940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101399078|NCT05243940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101399079|NCT05243940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101399080|NCT05243940|Narcotics|narcotics|mesh-ancestor
101399081|NCT05209347|Carbon Fiber|carbon fiber|mesh-list
101399082|NCT05209347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101399083|NCT05209347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101399084|NCT05198544|Hyaluronic Acid|hyaluronic acid|mesh-list
101399085|NCT05198544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101399086|NCT05198544|Immunologic Factors|immunologic factors|mesh-ancestor
101341886|NCT04958044|Calcium|calcium|mesh-list
101399087|NCT05198544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399088|NCT05198544|Viscosupplements|viscosupplements|mesh-ancestor
101399089|NCT05198544|Protective Agents|protective agents|mesh-ancestor
101399090|NCT05167734|Dextrans|dextrans|mesh-list
101399091|NCT05167734|Epoetin Alfa|epoetin alfa|mesh-list
101399092|NCT05167734|Iron-Dextran Complex|iron-dextran complex|mesh-list
101399093|NCT05167734|Hematinics|hematinics|mesh-ancestor
101399094|NCT05167734|Anticoagulants|anticoagulants|mesh-ancestor
101399095|NCT05167734|Plasma Substitutes|plasma substitutes|mesh-ancestor
101399096|NCT05167734|Blood Substitutes|blood substitutes|mesh-ancestor
101195772|NCT03785587|Bromides|bromides|mesh-list
101399100|NCT05142241|Temozolomide|temozolomide|mesh-list
101399101|NCT05142241|Talazoparib|talazoparib|mesh-list
101399102|NCT05142241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101399103|NCT05142241|Alkylating Agents|alkylating agents|mesh-ancestor
101399105|NCT05142241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399106|NCT05142241|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101399107|NCT05142241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101399108|NCT05141474|Aldesleukin|aldesleukin|mesh-list
101399109|NCT05141474|Cyclophosphamide|cyclophosphamide|mesh-list
101399110|NCT05141474|Fludarabine|fludarabine|mesh-list
101399111|NCT05141474|Interleukin-2|interleukin-2|mesh-list
101399112|NCT05141474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101399113|NCT05141474|Immunologic Factors|immunologic factors|mesh-ancestor
101399114|NCT05141474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399115|NCT05141474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101399116|NCT05141474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101399117|NCT05141474|Alkylating Agents|alkylating agents|mesh-ancestor
101399118|NCT05141474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399119|NCT05141474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399120|NCT05141474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101399121|NCT05141474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101399122|NCT05141474|Analgesics|analgesics|mesh-ancestor
101399123|NCT05141474|Sensory System Agents|sensory system agents|mesh-ancestor
101399124|NCT05141474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101399125|NCT05141474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101399126|NCT05141474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101399127|NCT05141474|Antiviral Agents|antiviral agents|mesh-ancestor
102075550|NCT02400567|Epirubicin|epirubicin|mesh-list
102075551|NCT02400567|Palbociclib|palbociclib|mesh-list
102075552|NCT02400567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102075553|NCT02400567|Immunologic Factors|immunologic factors|mesh-ancestor
102075554|NCT02400567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075555|NCT02400567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102075556|NCT02400567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102075557|NCT02400567|Alkylating Agents|alkylating agents|mesh-ancestor
101377233|NCT00244192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101399128|NCT05141474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101399129|NCT05126719|Docetaxel|docetaxel|mesh-list
101399130|NCT05126719|Capecitabine|capecitabine|mesh-list
101399131|NCT05126719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399132|NCT05126719|Tubulin Modulators|tubulin modulators|mesh-ancestor
101399133|NCT05126719|Antimitotic Agents|antimitotic agents|mesh-ancestor
101399134|NCT05126719|Mitosis Modulators|mitosis modulators|mesh-ancestor
101399135|NCT05126719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399136|NCT05126719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101306128|NCT02023892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101306129|NCT02023892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101306130|NCT02023892|Antimetabolites|antimetabolites|mesh-ancestor
101306131|NCT02023892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306132|NCT02023892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101399137|NCT05126719|Antimetabolites|antimetabolites|mesh-ancestor
101399138|NCT05119140|Hydroxychloroquine|hydroxychloroquine|mesh-list
101399139|NCT05119140|Mesalamine|mesalamine|mesh-list
101399140|NCT05119140|Antimalarials|antimalarials|mesh-ancestor
101399141|NCT05119140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101399142|NCT05119140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101399143|NCT05119140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101399144|NCT05119140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101399145|NCT05119140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399146|NCT05119140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101399147|NCT05119140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101399148|NCT05119140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101399149|NCT05119140|Analgesics|analgesics|mesh-ancestor
101399150|NCT05119140|Sensory System Agents|sensory system agents|mesh-ancestor
101399151|NCT05119140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101399152|NCT05119140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399153|NCT05119140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101399154|NCT05107050|Anti-Infective Agents|anti-infective agents|mesh-list
101399155|NCT05107050|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101399156|NCT05097261|Ketamine|ketamine|mesh-list
101399157|NCT05097261|Analgesics|analgesics|mesh-ancestor
101399158|NCT05097261|Sensory System Agents|sensory system agents|mesh-ancestor
101399159|NCT05097261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101399160|NCT05097261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399161|NCT05097261|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101399162|NCT05097261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101399163|NCT05097261|Anesthetics, General|anesthetics, general|mesh-ancestor
101399164|NCT05097261|Anesthetics|anesthetics|mesh-ancestor
101399165|NCT05097261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101195838|NCT03441061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399169|NCT05097261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399171|NCT05037032|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101399172|NCT05037032|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101399173|NCT05037032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399174|NCT05037032|Sensory System Agents|sensory system agents|mesh-ancestor
101399175|NCT05037032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101399176|NCT04857931|Colchicine|colchicine|mesh-list
101399177|NCT04857931|Gout Suppressants|gout suppressants|mesh-ancestor
101399182|NCT04857931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399185|NCT04840199|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101399186|NCT04840199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101828114|NCT05985954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101399187|NCT04840199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399188|NCT04840199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102075558|NCT02400567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075559|NCT02400567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102075560|NCT02400567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102075561|NCT02400567|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102075562|NCT02400567|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101399189|NCT04840199|Antiviral Agents|antiviral agents|mesh-ancestor
101399190|NCT04840199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101399192|NCT04800393|Sevoflurane|sevoflurane|mesh-list
101399193|NCT04800393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101399194|NCT04800393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101399195|NCT04800393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399196|NCT04800393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101399197|NCT04800393|Anesthetics, General|anesthetics, general|mesh-ancestor
101399198|NCT04800393|Anesthetics|anesthetics|mesh-ancestor
101399199|NCT04800393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101399200|NCT04800393|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101399201|NCT04718220|Antibodies|antibodies|mesh-list
101399202|NCT04718220|Immunologic Factors|immunologic factors|mesh-ancestor
101399203|NCT04718220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399204|NCT04668300|Durvalumab|durvalumab|mesh-list
101399205|NCT04668300|Immunoglobulins|immunoglobulins|mesh-list
101399206|NCT04668300|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101399207|NCT04668300|Immunoglobulin G|immunoglobulin g|mesh-list
101306133|NCT02023892|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101306134|NCT02023892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101306136|NCT02023931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101306137|NCT02023931|Protective Agents|protective agents|mesh-ancestor
101306138|NCT02023931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306139|NCT02023931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101306141|NCT02024009|Paclitaxel|paclitaxel|mesh-list
101306142|NCT02024009|Gemcitabine|gemcitabine|mesh-list
101306143|NCT02024009|Capecitabine|capecitabine|mesh-list
101306144|NCT02024009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101306145|NCT02024009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101306146|NCT02024009|Tubulin Modulators|tubulin modulators|mesh-ancestor
101306147|NCT02024009|Antimitotic Agents|antimitotic agents|mesh-ancestor
101306148|NCT02024009|Mitosis Modulators|mitosis modulators|mesh-ancestor
101306149|NCT02024009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306150|NCT02024009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101306151|NCT02024009|Antimetabolites|antimetabolites|mesh-ancestor
101306152|NCT02024009|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101399208|NCT04668300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101399209|NCT04668300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399210|NCT04668300|Immunologic Factors|immunologic factors|mesh-ancestor
101399211|NCT04668300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399212|NCT04521868|Sulforaphane|sulforaphane|mesh-list
101399213|NCT04521868|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101399214|NCT04521868|Protective Agents|protective agents|mesh-ancestor
101399215|NCT04521868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399216|NCT04521868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399217|NCT04514484|Nivolumab|nivolumab|mesh-list
101399218|NCT04514484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101399219|NCT04514484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399220|NCT04514484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101399221|NCT04514484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399222|NCT04481204|Leucovorin|leucovorin|mesh-list
101399223|NCT04481204|Paclitaxel|paclitaxel|mesh-list
101399224|NCT04481204|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101399234|NCT04481204|Mitosis Modulators|mitosis modulators|mesh-ancestor
101399235|NCT04481204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399236|NCT04481204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101399237|NCT04481204|Antimetabolites|antimetabolites|mesh-ancestor
101399238|NCT04481204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101399239|NCT04481204|Immunologic Factors|immunologic factors|mesh-ancestor
101399240|NCT04481204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399241|NCT04481204|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101399242|NCT04481204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101399243|NCT04481204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101399244|NCT04481204|Antidotes|antidotes|mesh-ancestor
102075563|NCT02400567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102075564|NCT02400567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102075565|NCT02400567|Hormone Antagonists|hormone antagonists|mesh-ancestor
102075566|NCT02400567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101377246|NCT00244309|Dutasteride|dutasteride|mesh-list
101399245|NCT04481204|Protective Agents|protective agents|mesh-ancestor
101306153|NCT02024009|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101306154|NCT02024009|Protease Inhibitors|protease inhibitors|mesh-ancestor
101399246|NCT04481204|Vitamin B Complex|vitamin b complex|mesh-ancestor
101399247|NCT04481204|Vitamins|vitamins|mesh-ancestor
101399248|NCT04481204|Micronutrients|micronutrients|mesh-ancestor
101399265|NCT04401748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399266|NCT04401748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399267|NCT04401748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101399268|NCT04395183|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
101399269|NCT04395183|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101399270|NCT04395183|Antidepressive Agents|antidepressive agents|mesh-ancestor
101399271|NCT04395183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101399272|NCT04394975|Sunitinib|sunitinib|mesh-list
101399273|NCT04394975|Axitinib|axitinib|mesh-list
101399274|NCT04394975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399275|NCT04394975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101399276|NCT04394975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101399277|NCT04394975|Growth Substances|growth substances|mesh-ancestor
101399278|NCT04394975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399279|NCT04394975|Growth Inhibitors|growth inhibitors|mesh-ancestor
101399280|NCT04394975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101399281|NCT04394975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101399282|NCT04394975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399283|NCT04381910|Irinotecan|irinotecan|mesh-list
101399284|NCT04381910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101399285|NCT04381910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101399286|NCT04381910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101399287|NCT04381910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399288|NCT04381910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399289|NCT04340843|Decitabine|decitabine|mesh-list
101399290|NCT04340843|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
101399291|NCT04340843|Azacitidine|azacitidine|mesh-list
101399292|NCT04340843|Belinostat|belinostat|mesh-list
101399293|NCT04340843|Guadecitabine|guadecitabine|mesh-list
101399294|NCT04340843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101399295|NCT04340843|Antimetabolites|antimetabolites|mesh-ancestor
101399296|NCT04340843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399297|NCT04340843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342086|NCT01805856|Cefazolin|cefazolin|mesh-list
101399298|NCT04340843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101399299|NCT04340843|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101399300|NCT04334876|Antibodies|antibodies|mesh-list
101399301|NCT04334876|Immunoglobulin G|immunoglobulin g|mesh-list
101399302|NCT04334876|Immunologic Factors|immunologic factors|mesh-ancestor
101399303|NCT04334876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399304|NCT04302870|Amantadine|amantadine|mesh-list
101399305|NCT04302870|Memantine|memantine|mesh-list
101399306|NCT04302870|Trazodone|trazodone|mesh-list
101399307|NCT04302870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101399308|NCT04302870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101399324|NCT04302870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101399325|NCT04302870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101399326|NCT04302870|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101399327|NCT04302870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101399328|NCT04302870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101399329|NCT04302870|Serotonin Agents|serotonin agents|mesh-ancestor
101399330|NCT04302870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101399331|NCT04302870|Antidepressive Agents|antidepressive agents|mesh-ancestor
101399332|NCT04231214|Tiotropium Bromide|tiotropium bromide|mesh-list
101399333|NCT04231214|Olodaterol|olodaterol|mesh-list
101399334|NCT04231214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101399335|NCT04231214|Autonomic Agents|autonomic agents|mesh-ancestor
101399336|NCT04231214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101399337|NCT04231214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377248|NCT00244309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102075567|NCT02400567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102075568|NCT02400567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102075569|NCT02400567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102075570|NCT02400567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102075571|NCT00228176|Rimonabant|rimonabant|mesh-list
102075572|NCT00228176|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102075573|NCT00228176|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
101399338|NCT04231214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101306155|NCT02024009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101306156|NCT02024009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101306157|NCT02024009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101306158|NCT02024009|Antiviral Agents|antiviral agents|mesh-ancestor
101399339|NCT04231214|Respiratory System Agents|respiratory system agents|mesh-ancestor
101399340|NCT04231214|Parasympatholytics|parasympatholytics|mesh-ancestor
101399341|NCT04231214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101399342|NCT04231214|Cholinergic Agents|cholinergic agents|mesh-ancestor
101399343|NCT04231214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101399344|NCT04231214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399345|NCT04229095|Suvorexant|suvorexant|mesh-list
101399346|NCT04229095|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101399347|NCT04229095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101399348|NCT04229095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101399349|NCT04229095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399350|NCT04229095|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
101399351|NCT04229095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101399352|NCT04229095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399353|NCT04098744|Artesunate|artesunate|mesh-list
101399354|NCT04098744|Artemisinins|artemisinins|mesh-list
101399355|NCT04098744|Artemisinin|artemisinin|mesh-list
101399356|NCT04098744|Antimalarials|antimalarials|mesh-ancestor
101399357|NCT04098744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101399358|NCT04098744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101399359|NCT04098744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101399360|NCT04098744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399361|NCT04098744|Antiviral Agents|antiviral agents|mesh-ancestor
101399362|NCT04098744|Schistosomicides|schistosomicides|mesh-ancestor
101399363|NCT04098744|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101399364|NCT04098744|Anthelmintics|anthelmintics|mesh-ancestor
101342213|NCT01723839|Rituximab|rituximab|mesh-list
101399365|NCT04088604|Fluorouracil|fluorouracil|mesh-list
101399366|NCT04088604|Irinotecan|irinotecan|mesh-list
101399367|NCT04088604|Antimetabolites|antimetabolites|mesh-ancestor
101399368|NCT04088604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399369|NCT04088604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101399370|NCT04088604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399371|NCT04088604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101399372|NCT04088604|Immunologic Factors|immunologic factors|mesh-ancestor
101399373|NCT04088604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399374|NCT04088604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101399387|NCT04006288|Clopidogrel|clopidogrel|mesh-list
101399388|NCT04006288|Ticagrelor|ticagrelor|mesh-list
101399389|NCT04006288|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101399390|NCT04006288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101399391|NCT04006288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101399392|NCT04006288|Analgesics|analgesics|mesh-ancestor
101399393|NCT04006288|Sensory System Agents|sensory system agents|mesh-ancestor
101399394|NCT04006288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101399395|NCT04006288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399396|NCT04006288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101399400|NCT04006288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399401|NCT04006288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101399402|NCT04006288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101399403|NCT04006288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101399404|NCT04006288|Antipyretics|antipyretics|mesh-ancestor
101399405|NCT04006288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101399406|NCT04006288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101399407|NCT04006288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102075574|NCT00228176|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102075575|NCT00228176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102075576|NCT00228176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075577|NCT00228176|Hormones|hormones|mesh-ancestor
101399408|NCT04006288|Purinergic Agents|purinergic agents|mesh-ancestor
101399409|NCT04006288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101399410|NCT04006288|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101399411|NCT04006288|Antithrombins|antithrombins|mesh-ancestor
101399412|NCT04006288|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101399413|NCT04006288|Protease Inhibitors|protease inhibitors|mesh-ancestor
101399414|NCT04006288|Anticoagulants|anticoagulants|mesh-ancestor
101399415|NCT03979131|Avelumab|avelumab|mesh-list
101399416|NCT03979131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101399417|NCT03979131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399418|NCT03958045|Nivolumab|nivolumab|mesh-list
101399419|NCT03958045|Rucaparib|rucaparib|mesh-list
101306159|NCT02024009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101306160|NCT02024022|Magnesium citrate|magnesium citrate|mesh-list
101306161|NCT02024022|Picosulfate sodium|picosulfate sodium|mesh-list
101306162|NCT02024022|Cathartics|cathartics|mesh-ancestor
101399420|NCT03958045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101399421|NCT03958045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399422|NCT03958045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101399423|NCT03958045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399424|NCT03958045|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101399425|NCT03958045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101399426|NCT03956680|Nivolumab|nivolumab|mesh-list
101399427|NCT03956680|Ipilimumab|ipilimumab|mesh-list
101399428|NCT03956680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101399429|NCT03956680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399430|NCT03956680|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101399431|NCT03956680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399432|NCT03952273|Sirolimus|sirolimus|mesh-list
101399433|NCT03952273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101399434|NCT03952273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101399435|NCT03952273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101399436|NCT03952273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399437|NCT03952273|Antifungal Agents|antifungal agents|mesh-ancestor
101399438|NCT03952273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101399469|NCT03803787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101399470|NCT03803787|Respiratory System Agents|respiratory system agents|mesh-ancestor
101399472|NCT03803787|Hormones|hormones|mesh-ancestor
101399473|NCT03803787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101399474|NCT03728881|Vaccines|vaccines|mesh-list
101399475|NCT03728881|Immunologic Factors|immunologic factors|mesh-ancestor
101399476|NCT03728881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399477|NCT03711253|Tenofovir|tenofovir|mesh-list
101399478|NCT03711253|Emtricitabine|emtricitabine|mesh-list
101399479|NCT03711253|Antiviral Agents|antiviral agents|mesh-ancestor
101399480|NCT03711253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101399481|NCT03711253|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101399482|NCT03711253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101399485|NCT03711253|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101399486|NCT03711253|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101399487|NCT03643822|Dexamethasone|dexamethasone|mesh-list
101399488|NCT03643822|Dexamethasone acetate|dexamethasone acetate|mesh-list
101399489|NCT03643822|Dexmedetomidine|dexmedetomidine|mesh-list
101399490|NCT03643822|BB 1101|bb 1101|mesh-list
101399491|NCT03643822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101399492|NCT03643822|Antiemetics|antiemetics|mesh-ancestor
101399493|NCT03643822|Autonomic Agents|autonomic agents|mesh-ancestor
101399494|NCT03643822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101399495|NCT03643822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399496|NCT03643822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101399497|NCT03643822|Glucocorticoids|glucocorticoids|mesh-ancestor
101399498|NCT03643822|Hormones|hormones|mesh-ancestor
101399501|NCT03643822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399502|NCT03643822|Protease Inhibitors|protease inhibitors|mesh-ancestor
101399503|NCT03643822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101399504|NCT03643822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399505|NCT03643822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102075578|NCT00228176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102075579|NCT00228176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075580|NCT05131984|Ocrelizumab|ocrelizumab|mesh-list
102075581|NCT05131984|Immunologic Factors|immunologic factors|mesh-ancestor
102075582|NCT05131984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075583|NCT01308190|Capecitabine|capecitabine|mesh-list
102075584|NCT01308190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102075585|NCT01308190|Antimetabolites|antimetabolites|mesh-ancestor
102075586|NCT01308190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075587|NCT01308190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102075588|NCT01210768|Cyclophosphamide|cyclophosphamide|mesh-list
102075589|NCT01210768|Doxorubicin|doxorubicin|mesh-list
102075590|NCT01210768|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102075591|NCT01210768|Epirubicin|epirubicin|mesh-list
102075592|NCT01210768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101399506|NCT03643822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101399507|NCT03643822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101399508|NCT03643822|Analgesics|analgesics|mesh-ancestor
101399509|NCT03643822|Sensory System Agents|sensory system agents|mesh-ancestor
101399510|NCT03643822|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101399511|NCT03643822|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101399512|NCT03643822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101399513|NCT03643822|Adrenergic Agents|adrenergic agents|mesh-ancestor
101399514|NCT03643822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101399515|NCT03603964|Guadecitabine|guadecitabine|mesh-list
101399516|NCT03603964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399517|NCT03575000|Bromocriptine|bromocriptine|mesh-list
101399518|NCT03575000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101399519|NCT03575000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101186210|NCT00001422|Fludarabine|fludarabine|mesh-list
101399520|NCT03575000|Hormone Antagonists|hormone antagonists|mesh-ancestor
101399521|NCT03575000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101399522|NCT03575000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399523|NCT03575000|Dopamine Agonists|dopamine agonists|mesh-ancestor
101399524|NCT03575000|Dopamine Agents|dopamine agents|mesh-ancestor
101399525|NCT03575000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101399526|NCT03575000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399527|NCT03513952|Atezolizumab|atezolizumab|mesh-list
101399528|NCT03513952|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101399529|NCT03513952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101399530|NCT03513952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399531|NCT03513952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101399532|NCT03513952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399533|NCT03513952|Immunologic Factors|immunologic factors|mesh-ancestor
101399534|NCT03513952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399536|NCT03498261|Analgesics|analgesics|mesh-ancestor
101399537|NCT03498261|Sensory System Agents|sensory system agents|mesh-ancestor
101399538|NCT03498261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101399539|NCT03498261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399540|NCT03498261|Anticonvulsants|anticonvulsants|mesh-ancestor
101399541|NCT03498261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101399542|NCT03498261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101399543|NCT03498261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101399544|NCT03498261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101399545|NCT03498261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101399546|NCT03498261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101399547|NCT03498261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101399548|NCT03498261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075593|NCT01210768|Immunologic Factors|immunologic factors|mesh-ancestor
102075594|NCT01210768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075595|NCT01210768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102075596|NCT01210768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102075597|NCT01210768|Alkylating Agents|alkylating agents|mesh-ancestor
102075598|NCT01210768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075599|NCT01210768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399549|NCT03498261|Antimanic Agents|antimanic agents|mesh-ancestor
101399550|NCT03495921|Irinotecan|irinotecan|mesh-list
101399551|NCT03495921|Camptothecin|camptothecin|mesh-list
101399552|NCT03495921|Temozolomide|temozolomide|mesh-list
101399553|NCT03495921|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101399554|NCT03495921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101399559|NCT03495921|Alkylating Agents|alkylating agents|mesh-ancestor
101399560|NCT03495921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101399562|NCT03191864|Xhance|xhance|mesh-list
101399563|NCT03191864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101399564|NCT03191864|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101399565|NCT03191864|Autonomic Agents|autonomic agents|mesh-ancestor
101399566|NCT03191864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101399567|NCT03191864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399568|NCT03191864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101399569|NCT03191864|Respiratory System Agents|respiratory system agents|mesh-ancestor
101399570|NCT03191864|Dermatologic Agents|dermatologic agents|mesh-ancestor
101399571|NCT03191864|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101399572|NCT03123978|Niclosamide|niclosamide|mesh-list
101399573|NCT03123978|Anticestodal Agents|anticestodal agents|mesh-ancestor
101399574|NCT03123978|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101399580|NCT03114072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101399581|NCT03114072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399582|NCT03114072|Sympathomimetics|sympathomimetics|mesh-ancestor
101399583|NCT03114072|Autonomic Agents|autonomic agents|mesh-ancestor
101399584|NCT03114072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101399585|NCT03114072|Dopamine Agents|dopamine agents|mesh-ancestor
101399586|NCT03114072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101399587|NCT03114072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399588|NCT03114072|Adrenergic Agents|adrenergic agents|mesh-ancestor
101399589|NCT03114072|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101399590|NCT03114072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101399591|NCT03114072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101399592|NCT03114072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101399593|NCT03063619|Tamoxifen|tamoxifen|mesh-list
101399594|NCT03063619|Afimoxifene|afimoxifene|mesh-list
101399595|NCT03063619|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101399596|NCT03063619|Hormone Antagonists|hormone antagonists|mesh-ancestor
101399597|NCT03063619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101306163|NCT02024022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101306164|NCT02024152|Cetirizine|cetirizine|mesh-list
101306165|NCT02024152|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101306166|NCT02024152|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101306167|NCT02024152|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101306168|NCT02024152|Histamine Antagonists|histamine antagonists|mesh-ancestor
101306169|NCT02024152|Histamine Agents|histamine agents|mesh-ancestor
101306170|NCT02024152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101306171|NCT02024152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306172|NCT02024152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306173|NCT02024217|Oxaliplatin|oxaliplatin|mesh-list
101399598|NCT03063619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399599|NCT03063619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101399600|NCT03063619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399601|NCT03063619|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101399602|NCT03063619|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101399603|NCT03063619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101399604|NCT03002103|Paclitaxel|paclitaxel|mesh-list
101399605|NCT03002103|Gemcitabine|gemcitabine|mesh-list
101399606|NCT03002103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102075600|NCT01210768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102075601|NCT01210768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102075602|NCT01210768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102075603|NCT01210768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102075604|NCT01210768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102075605|NCT02971605|Psilocybin|psilocybin|mesh-list
102075606|NCT02971605|Hallucinogens|hallucinogens|mesh-ancestor
101399607|NCT03002103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399608|NCT03002103|Tubulin Modulators|tubulin modulators|mesh-ancestor
101399609|NCT03002103|Antimitotic Agents|antimitotic agents|mesh-ancestor
101399610|NCT03002103|Mitosis Modulators|mitosis modulators|mesh-ancestor
101399611|NCT03002103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399612|NCT03002103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101399613|NCT03002103|Antimetabolites|antimetabolites|mesh-ancestor
101399614|NCT02975882|Sirolimus|sirolimus|mesh-list
101399615|NCT02975882|Irinotecan|irinotecan|mesh-list
101399616|NCT02975882|Camptothecin|camptothecin|mesh-list
101399617|NCT02975882|Temozolomide|temozolomide|mesh-list
101399618|NCT02975882|Temsirolimus|temsirolimus|mesh-list
101399619|NCT02975882|MTOR Inhibitors|mtor inhibitors|mesh-list
101399620|NCT02975882|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101399621|NCT02975882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101399622|NCT02975882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101399623|NCT02975882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399624|NCT02975882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399639|NCT02968810|Antimetabolites|antimetabolites|mesh-ancestor
101399640|NCT02968810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399641|NCT02968810|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101399642|NCT02968810|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101399643|NCT02968810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101399644|NCT02935205|Indomethacin|indomethacin|mesh-list
101399645|NCT02935205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101399646|NCT02935205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101399647|NCT02935205|Analgesics|analgesics|mesh-ancestor
101399654|NCT02935205|Tocolytic Agents|tocolytic agents|mesh-ancestor
101399655|NCT02935205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101399656|NCT02935205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101399657|NCT02935205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101399658|NCT02935205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399659|NCT02898207|Olaparib|olaparib|mesh-list
101399660|NCT02898207|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
101399661|NCT02898207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101399662|NCT02898207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399663|NCT02898207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101306174|NCT02024217|Tegafur|tegafur|mesh-list
101306175|NCT02024217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101306176|NCT02024217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101306177|NCT02024217|Antimetabolites|antimetabolites|mesh-ancestor
101306178|NCT02024217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306179|NCT02024256|Magnesium Sulfate|magnesium sulfate|mesh-list
101306180|NCT02024256|Analgesics|analgesics|mesh-ancestor
101306181|NCT02024256|Sensory System Agents|sensory system agents|mesh-ancestor
101306182|NCT02024256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101306183|NCT02024256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306184|NCT02024256|Anesthetics|anesthetics|mesh-ancestor
101342663|NCT00010361|Cyclosporine|cyclosporine|mesh-list
101306185|NCT02024256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101306186|NCT02024256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101306187|NCT02024256|Anticonvulsants|anticonvulsants|mesh-ancestor
101306188|NCT02024256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101306189|NCT02024256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101306190|NCT02024256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306191|NCT02024256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101306192|NCT02024256|Tocolytic Agents|tocolytic agents|mesh-ancestor
101306193|NCT02024256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101306194|NCT02024295|Choline|choline|mesh-list
101306195|NCT02024295|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
101306196|NCT02024295|Lipotropic Agents|lipotropic agents|mesh-ancestor
101399664|NCT02862275|Atezolizumab|atezolizumab|mesh-list
102075607|NCT02971605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075608|NCT02971605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102075609|NCT04410874|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
102075611|NCT04410874|Immunologic Factors|immunologic factors|mesh-ancestor
102075612|NCT04410874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075613|NCT04410874|Antiviral Agents|antiviral agents|mesh-ancestor
102075614|NCT04410874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102075615|NCT02124954|Digoxin|digoxin|mesh-list
102075616|NCT02124954|Midazolam|midazolam|mesh-list
102075617|NCT02124954|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102075618|NCT02124954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102075619|NCT02124954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102075620|NCT02124954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075621|NCT02124954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102075622|NCT02124954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102075623|NCT02124954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102075624|NCT02124954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101377292|NCT00244426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101399665|NCT02862275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101399666|NCT02862275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101399667|NCT02862275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399668|NCT02862275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101399669|NCT02862275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399670|NCT02862275|Immunologic Factors|immunologic factors|mesh-ancestor
101399671|NCT02862275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399672|NCT02807805|Niclosamide|niclosamide|mesh-list
101399673|NCT02807805|Prednisone|prednisone|mesh-list
101399674|NCT02807805|Cortisone|cortisone|mesh-list
101399675|NCT02807805|Abiraterone Acetate|abiraterone acetate|mesh-list
101399676|NCT02807805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101399677|NCT02807805|Glucocorticoids|glucocorticoids|mesh-ancestor
101399678|NCT02807805|Hormones|hormones|mesh-ancestor
101399679|NCT02807805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101399680|NCT02807805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399681|NCT02807805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101399682|NCT02807805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399686|NCT02807805|Hormone Antagonists|hormone antagonists|mesh-ancestor
101399687|NCT02807805|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101399688|NCT02807805|Anticestodal Agents|anticestodal agents|mesh-ancestor
101399689|NCT02807805|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101399690|NCT02807805|Anthelmintics|anthelmintics|mesh-ancestor
101399691|NCT02807805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101342752|NCT00011297|Gabapentin|gabapentin|mesh-list
101399692|NCT02807805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101399693|NCT02807805|Antinematodal Agents|antinematodal agents|mesh-ancestor
101399694|NCT02737046|Interferons|interferons|mesh-list
101399695|NCT02737046|Interferon-alpha|interferon-alpha|mesh-list
101399696|NCT02737046|Interferon alpha-2|interferon alpha-2|mesh-list
101399697|NCT02737046|Zidovudine|zidovudine|mesh-list
101399698|NCT02737046|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101399699|NCT02737046|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
101399700|NCT02737046|Belinostat|belinostat|mesh-list
101399701|NCT02737046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399702|NCT02737046|Antiviral Agents|antiviral agents|mesh-ancestor
101399703|NCT02737046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101399704|NCT02737046|Immunologic Factors|immunologic factors|mesh-ancestor
101399705|NCT02737046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399706|NCT02737046|Antimetabolites|antimetabolites|mesh-ancestor
101399707|NCT02737046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399708|NCT02737046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101399709|NCT02737046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101399710|NCT02737046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101399711|NCT02737046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101399712|NCT02737046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101399713|NCT02737046|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101399714|NCT02682485|Metronidazole|metronidazole|mesh-list
101399715|NCT02682485|Ciprofloxacin|ciprofloxacin|mesh-list
101399717|NCT02682485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101399718|NCT02682485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101399719|NCT02682485|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101399720|NCT02682485|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101399721|NCT02682485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101399722|NCT02682485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101399723|NCT02682485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101399724|NCT02682485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399725|NCT02682485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399726|NCT02682485|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101399727|NCT02682485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101399728|NCT02682485|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101399745|NCT02636725|Pembrolizumab|pembrolizumab|mesh-list
101399746|NCT02636725|Axitinib|axitinib|mesh-list
102075641|NCT04441112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075643|NCT04441112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075644|NCT04441112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102075645|NCT04441112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102075646|NCT04441112|Analgesics|analgesics|mesh-ancestor
101399747|NCT02636725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101399748|NCT02636725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399749|NCT02636725|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101399750|NCT02636725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399751|NCT02636725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101399752|NCT02636725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101399753|NCT02573493|Paclitaxel|paclitaxel|mesh-list
101399754|NCT02573493|Cisplatin|cisplatin|mesh-list
101399761|NCT02573493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399762|NCT02573493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101399764|NCT02521493|Etoposide|etoposide|mesh-list
101399765|NCT02521493|Podophyllotoxin|podophyllotoxin|mesh-list
101306208|NCT02024308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306209|NCT02024308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101306210|NCT02024308|Immunologic Factors|immunologic factors|mesh-ancestor
101306211|NCT02024308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306212|NCT02024308|Antiviral Agents|antiviral agents|mesh-ancestor
101306213|NCT02024308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101306214|NCT02024334|Leflunomide|leflunomide|mesh-list
101306215|NCT02024334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101306216|NCT02024334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399766|NCT02521493|Daunorubicin|daunorubicin|mesh-list
101399767|NCT02521493|Mitoxantrone|mitoxantrone|mesh-list
101399768|NCT02521493|Etoposide phosphate|etoposide phosphate|mesh-list
101399769|NCT02521493|Asparaginase|asparaginase|mesh-list
101399770|NCT02521493|Mercaptopurine|mercaptopurine|mesh-list
101399771|NCT02521493|Thioguanine|thioguanine|mesh-list
101399772|NCT02521493|2-Aminopurine|2-aminopurine|mesh-list
101399773|NCT02521493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101399774|NCT02521493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399775|NCT02521493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101399776|NCT02521493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101399777|NCT02521493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101399778|NCT02521493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399779|NCT02521493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101399780|NCT02521493|Antimetabolites|antimetabolites|mesh-ancestor
101399781|NCT02521493|Antiviral Agents|antiviral agents|mesh-ancestor
101399782|NCT02521493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101342961|NCT00012311|Carboplatin|carboplatin|mesh-list
101399783|NCT02521493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101399784|NCT02521493|Immunologic Factors|immunologic factors|mesh-ancestor
101399785|NCT02521493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399786|NCT02521493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101399787|NCT02521493|Analgesics|analgesics|mesh-ancestor
101399788|NCT02521493|Sensory System Agents|sensory system agents|mesh-ancestor
101399789|NCT02521493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101399790|NCT02521493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101399791|NCT02521493|Keratolytic Agents|keratolytic agents|mesh-ancestor
101399792|NCT02521493|Dermatologic Agents|dermatologic agents|mesh-ancestor
101399793|NCT02521493|Tubulin Modulators|tubulin modulators|mesh-ancestor
101399794|NCT02521493|Antimitotic Agents|antimitotic agents|mesh-ancestor
101399795|NCT02521493|Mitosis Modulators|mitosis modulators|mesh-ancestor
101399796|NCT02496208|Nivolumab|nivolumab|mesh-list
101399797|NCT02496208|Ipilimumab|ipilimumab|mesh-list
101399798|NCT02496208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101399799|NCT02496208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399800|NCT02496208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101399801|NCT02496208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399802|NCT02465268|Molgramostim|molgramostim|mesh-list
101399803|NCT02465268|Sargramostim|sargramostim|mesh-list
101399804|NCT02465268|Immunologic Factors|immunologic factors|mesh-ancestor
101399805|NCT02465268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399806|NCT02465268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102075647|NCT04441112|Sensory System Agents|sensory system agents|mesh-ancestor
102075648|NCT04441112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102075649|NCT04441112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102075650|NCT04441112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102075651|NCT02121990|Paclitaxel|paclitaxel|mesh-list
102075652|NCT02121990|Bevacizumab|bevacizumab|mesh-list
102075653|NCT02121990|Olaparib|olaparib|mesh-list
102075654|NCT02121990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102075655|NCT02121990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102075656|NCT02121990|Tubulin Modulators|tubulin modulators|mesh-ancestor
101399807|NCT02408861|Nivolumab|nivolumab|mesh-list
101399808|NCT02408861|Ipilimumab|ipilimumab|mesh-list
101399809|NCT02408861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101399810|NCT02408861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399811|NCT02408861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101399812|NCT02408861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399813|NCT02394834|Calcium, Dietary|calcium, dietary|mesh-list
101399814|NCT02394834|Leucovorin|leucovorin|mesh-list
101306217|NCT02024334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101306218|NCT02024334|Immunologic Factors|immunologic factors|mesh-ancestor
101399815|NCT02394834|Bevacizumab|bevacizumab|mesh-list
101399816|NCT02394834|Panitumumab|panitumumab|mesh-list
101399817|NCT02394834|Oxaliplatin|oxaliplatin|mesh-list
101399818|NCT02394834|Fluorouracil|fluorouracil|mesh-list
101399819|NCT02394834|Calcium|calcium|mesh-list
101399820|NCT02394834|Levoleucovorin|levoleucovorin|mesh-list
101399821|NCT02394834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101399822|NCT02394834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399823|NCT02394834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101399824|NCT02394834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101399831|NCT02394834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399832|NCT02394834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101399833|NCT02394834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101399834|NCT02394834|Immunologic Factors|immunologic factors|mesh-ancestor
101399835|NCT02394834|Antidotes|antidotes|mesh-ancestor
101399836|NCT02394834|Protective Agents|protective agents|mesh-ancestor
101399837|NCT02394834|Vitamin B Complex|vitamin b complex|mesh-ancestor
101399838|NCT02394834|Vitamins|vitamins|mesh-ancestor
101399839|NCT02394834|Micronutrients|micronutrients|mesh-ancestor
101399840|NCT02381561|Ropidoxuridine|ropidoxuridine|mesh-list
101399841|NCT02381561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399842|NCT02381535|Cisplatin|cisplatin|mesh-list
101399843|NCT02381535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399844|NCT02327078|Nivolumab|nivolumab|mesh-list
101399845|NCT02327078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101399846|NCT02327078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399847|NCT02327078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101399848|NCT02327078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399849|NCT02314169|Nivolumab|nivolumab|mesh-list
101399850|NCT02314169|Ipilimumab|ipilimumab|mesh-list
101399851|NCT02314169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101399852|NCT02314169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399853|NCT02314169|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101399854|NCT02314169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399856|NCT02304458|Ipilimumab|ipilimumab|mesh-list
101399857|NCT02304458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101399858|NCT02304458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399859|NCT02304458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101399860|NCT02304458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399861|NCT02219373|Oxcarbazepine|oxcarbazepine|mesh-list
101399862|NCT02219373|Gabapentin|gabapentin|mesh-list
101399863|NCT02219373|Analgesics|analgesics|mesh-ancestor
101399864|NCT02219373|Sensory System Agents|sensory system agents|mesh-ancestor
101399865|NCT02219373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101399866|NCT02219373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399867|NCT02219373|Anticonvulsants|anticonvulsants|mesh-ancestor
101399868|NCT02219373|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102075657|NCT02121990|Antimitotic Agents|antimitotic agents|mesh-ancestor
102075658|NCT02121990|Mitosis Modulators|mitosis modulators|mesh-ancestor
102075659|NCT02121990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075660|NCT02121990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102075661|NCT02121990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102075662|NCT02121990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102075663|NCT02121990|Growth Substances|growth substances|mesh-ancestor
101377340|NCT00077259|Antimitotic Agents|antimitotic agents|mesh-ancestor
101399869|NCT02219373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101399870|NCT02219373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101399871|NCT02219373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101399872|NCT02219373|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101399873|NCT02219373|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101343203|NCT00845910|Bevacizumab|bevacizumab|mesh-list
101399874|NCT02219373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101399875|NCT02219373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399876|NCT02219373|Antimanic Agents|antimanic agents|mesh-ancestor
101399877|NCT02219373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101399878|NCT02219373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101399879|NCT02219373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101399880|NCT02219373|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101399881|NCT02219373|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101399883|NCT02187224|Progestins|progestins|mesh-ancestor
101399884|NCT02187224|Hormones|hormones|mesh-ancestor
101399885|NCT02187224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101399886|NCT02187224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399887|NCT02159066|Infigratinib|infigratinib|mesh-list
101399888|NCT02159066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399889|NCT02099825|Cycloserine|cycloserine|mesh-list
101306219|NCT02024334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306220|NCT02024373|Atorvastatin|atorvastatin|mesh-list
101306221|NCT02024373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101306222|NCT02024373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101399890|NCT02099825|Mifepristone|mifepristone|mesh-list
101399891|NCT02099825|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101399892|NCT02099825|Abortifacient Agents|abortifacient agents|mesh-ancestor
101399893|NCT02099825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101399894|NCT02099825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196558|NCT01386398|Bortezomib|bortezomib|mesh-list
101399910|NCT02099825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101399911|NCT02099825|Antimetabolites|antimetabolites|mesh-ancestor
101399912|NCT02099825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399914|NCT02057978|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101399915|NCT02057978|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101399916|NCT02057978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101399917|NCT02057978|Disinfectants|disinfectants|mesh-ancestor
101399918|NCT02057978|Dermatologic Agents|dermatologic agents|mesh-ancestor
101399919|NCT02032823|Olaparib|olaparib|mesh-list
101399920|NCT02032823|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101399921|NCT02032823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101399922|NCT02032823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399923|NCT02032823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399924|NCT01958021|Letrozole|letrozole|mesh-list
101399925|NCT01958021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399926|NCT01958021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101399927|NCT01958021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101399928|NCT01958021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101399929|NCT01958021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399930|NCT01958021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101399931|NCT01958021|Hormone Antagonists|hormone antagonists|mesh-ancestor
101399932|NCT01958021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101399933|NCT01958021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399934|NCT01946477|Dexamethasone|dexamethasone|mesh-list
101399935|NCT01946477|Daratumumab|daratumumab|mesh-list
101399936|NCT01946477|Pomalidomide|pomalidomide|mesh-list
102075664|NCT02121990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075665|NCT02121990|Growth Inhibitors|growth inhibitors|mesh-ancestor
102075666|NCT02121990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102075667|NCT02121990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102075668|NCT05724056|Hyaluronic Acid|hyaluronic acid|mesh-list
102075669|NCT05724056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102075670|NCT05724056|Immunologic Factors|immunologic factors|mesh-ancestor
102075671|NCT05724056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399937|NCT01946477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101399938|NCT01946477|Antiemetics|antiemetics|mesh-ancestor
101399939|NCT01946477|Autonomic Agents|autonomic agents|mesh-ancestor
101399940|NCT01946477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101399941|NCT01946477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399942|NCT01946477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101399943|NCT01946477|Glucocorticoids|glucocorticoids|mesh-ancestor
101399944|NCT01946477|Hormones|hormones|mesh-ancestor
101399945|NCT01946477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101399946|NCT01946477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101399947|NCT01946477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399948|NCT01946477|Immunologic Factors|immunologic factors|mesh-ancestor
101399949|NCT01946477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101399950|NCT01946477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101399951|NCT01946477|Growth Substances|growth substances|mesh-ancestor
101399952|NCT01946477|Growth Inhibitors|growth inhibitors|mesh-ancestor
101399953|NCT01742299|Imatinib Mesylate|imatinib mesylate|mesh-list
101399954|NCT01742299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399955|NCT01742299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101399956|NCT01742299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101399957|NCT01742299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399958|NCT05953168|Trastuzumab|trastuzumab|mesh-list
101399959|NCT05953168|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
101399972|NCT05953142|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101399973|NCT05953142|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101399974|NCT05953142|Adrenergic Agents|adrenergic agents|mesh-ancestor
101399975|NCT05953142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101399976|NCT05953142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399977|NCT05953142|Protective Agents|protective agents|mesh-ancestor
101399978|NCT05953038|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
101306223|NCT02024373|Antimetabolites|antimetabolites|mesh-ancestor
101306224|NCT02024373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306225|NCT02024373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101306226|NCT02024373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101306227|NCT02024373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101306228|NCT02024425|Antioxidants|antioxidants|mesh-list
101306229|NCT02024425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306237|NCT02024555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101306238|NCT02024555|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101306239|NCT02024555|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101306240|NCT02024555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101306241|NCT02024555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101306242|NCT02024555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306243|NCT02024555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101306244|NCT02024555|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101306245|NCT02024555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101306246|NCT02024555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101306247|NCT02024555|Antitubercular Agents|antitubercular agents|mesh-ancestor
101306248|NCT02024555|Leprostatic Agents|leprostatic agents|mesh-ancestor
101306249|NCT02024555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101306250|NCT02024555|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101186671|NCT00002202|Amprenavir|amprenavir|mesh-list
101399979|NCT05953038|Hallucinogens|hallucinogens|mesh-ancestor
101399980|NCT05953038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399981|NCT05953038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101399982|NCT05953038|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102075672|NCT05724056|Viscosupplements|viscosupplements|mesh-ancestor
102075673|NCT05724056|Protective Agents|protective agents|mesh-ancestor
102075674|NCT02609737|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
102075675|NCT02609737|Chelating Agents|chelating agents|mesh-ancestor
102075676|NCT02609737|Sequestering Agents|sequestering agents|mesh-ancestor
101377355|NCT00244972|Sorafenib|sorafenib|mesh-list
101399983|NCT05953038|Serotonin Agents|serotonin agents|mesh-ancestor
101399984|NCT05953038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101399985|NCT05953038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399986|NCT05953038|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101399987|NCT05952947|Cyclophosphamide|cyclophosphamide|mesh-list
101399988|NCT05952947|Fludarabine|fludarabine|mesh-list
101399989|NCT05952947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101399990|NCT05952947|Immunologic Factors|immunologic factors|mesh-ancestor
101399991|NCT05952947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399992|NCT05952947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101399993|NCT05952947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101306251|NCT02024555|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101306252|NCT02024555|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101306253|NCT02024555|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101306254|NCT02024555|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101306255|NCT02024555|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101306256|NCT02024568|Pregabalin|pregabalin|mesh-list
101306257|NCT02024568|Analgesics|analgesics|mesh-ancestor
101306258|NCT02024568|Sensory System Agents|sensory system agents|mesh-ancestor
101306259|NCT02024568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101306260|NCT02024568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306261|NCT02024568|Anticonvulsants|anticonvulsants|mesh-ancestor
101306262|NCT02024568|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101306263|NCT02024568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101306264|NCT02024568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306265|NCT02024568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101306266|NCT02024568|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101306267|NCT02024568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101306268|NCT02024568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101306269|NCT02024568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101306270|NCT02024594|Nitrous Oxide|nitrous oxide|mesh-list
101306271|NCT02024594|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101306272|NCT02024594|Anesthetics, General|anesthetics, general|mesh-ancestor
101306273|NCT02024594|Anesthetics|anesthetics|mesh-ancestor
101399994|NCT05952947|Alkylating Agents|alkylating agents|mesh-ancestor
101399995|NCT05952947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399996|NCT05952947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399997|NCT05952947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101399998|NCT05952921|Chlorhexidine|chlorhexidine|mesh-list
101399999|NCT05952921|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101400000|NCT05952921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101196696|NCT01386996|Hormones|hormones|mesh-ancestor
101400014|NCT05952557|Anastrozole|anastrozole|mesh-list
101400015|NCT05952557|Exemestane|exemestane|mesh-list
101400016|NCT05952557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101400017|NCT05952557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101400018|NCT05952557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101400019|NCT05952557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101400020|NCT05952557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400021|NCT05952557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101400022|NCT05952557|Hormone Antagonists|hormone antagonists|mesh-ancestor
101306274|NCT02024594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101306275|NCT02024594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306276|NCT02024594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101306277|NCT02024594|Analgesics|analgesics|mesh-ancestor
101306278|NCT02024594|Sensory System Agents|sensory system agents|mesh-ancestor
101306279|NCT02024594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101487388|NCT05198960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400028|NCT05952557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101400029|NCT05952505|Vaccines|vaccines|mesh-list
101400030|NCT05952505|Immunologic Factors|immunologic factors|mesh-ancestor
101400031|NCT05952505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075677|NCT02609737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075678|NCT01060059|Exenatide|exenatide|mesh-list
102075679|NCT01060059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102075680|NCT01060059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075681|NCT01060059|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102075682|NCT01060059|Incretins|incretins|mesh-ancestor
102075683|NCT01060059|Hormones|hormones|mesh-ancestor
101377361|NCT00245089|Dactinomycin|dactinomycin|mesh-list
101400034|NCT05952206|Sirolimus|sirolimus|mesh-list
101400035|NCT05952206|Temsirolimus|temsirolimus|mesh-list
101400036|NCT05952206|MTOR Inhibitors|mtor inhibitors|mesh-list
101400037|NCT05952206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101400038|NCT05952206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101400039|NCT05952206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101400040|NCT05952206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101400041|NCT05952206|Antifungal Agents|antifungal agents|mesh-ancestor
101400042|NCT05952206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101400043|NCT05952206|Immunologic Factors|immunologic factors|mesh-ancestor
101400044|NCT05952206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400045|NCT05952206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101400046|NCT05952206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101400047|NCT05952206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400048|NCT05952128|Fluzoparib|fluzoparib|mesh-list
101400049|NCT05952128|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101400050|NCT05952128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101400051|NCT05952128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400052|NCT05952128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101400053|NCT05952089|Midazolam|midazolam|mesh-list
101400054|NCT05952089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101400055|NCT05952089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101400056|NCT05952089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101400057|NCT05952089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400058|NCT05952089|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101400059|NCT05952089|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101400060|NCT05952089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101400061|NCT05952089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101400062|NCT05952089|Anesthetics, General|anesthetics, general|mesh-ancestor
101400063|NCT05952089|Anesthetics|anesthetics|mesh-ancestor
101400068|NCT05952050|Dexmedetomidine|dexmedetomidine|mesh-list
101400069|NCT05952050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101400070|NCT05952050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101400071|NCT05952050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400072|NCT05952050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101400073|NCT05952050|Analgesics|analgesics|mesh-ancestor
101400074|NCT05952050|Sensory System Agents|sensory system agents|mesh-ancestor
101400075|NCT05952050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101400076|NCT05952050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101343801|NCT00275106|Vitamins|vitamins|mesh-ancestor
101400077|NCT05952050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101400078|NCT05952050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101400079|NCT05952050|Adrenergic Agents|adrenergic agents|mesh-ancestor
101400080|NCT05952050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101400081|NCT05952050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400082|NCT05952024|Rituximab|rituximab|mesh-list
101400083|NCT05952024|Acalabrutinib|acalabrutinib|mesh-list
101400084|NCT05952024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101400085|NCT05952024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101400086|NCT05952024|Immunologic Factors|immunologic factors|mesh-ancestor
101400087|NCT05952024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400088|NCT05952024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101306281|NCT02024633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101306282|NCT02024633|Antimetabolites|antimetabolites|mesh-ancestor
101306283|NCT02024633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306284|NCT02024633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101306285|NCT02024659|Budesonide|budesonide|mesh-list
101306286|NCT02024659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101306287|NCT02024659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101306289|NCT02024659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102075684|NCT01060059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102075685|NCT04318015|Hydroxychloroquine|hydroxychloroquine|mesh-list
102075686|NCT04318015|Antimalarials|antimalarials|mesh-ancestor
102075687|NCT04318015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102075688|NCT04318015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102075689|NCT04318015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102075690|NCT04318015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101495660|NCT00479661|Propofol|propofol|mesh-list
101306290|NCT02024659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306291|NCT02024659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101306292|NCT02024659|Respiratory System Agents|respiratory system agents|mesh-ancestor
101400089|NCT05951959|Rituximab|rituximab|mesh-list
101400090|NCT05951959|Venetoclax|venetoclax|mesh-list
101400096|NCT05951959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101400097|NCT05951842|Anesthetics|anesthetics|mesh-list
101400098|NCT05951842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101400099|NCT05951842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400100|NCT05951816|Technetium Tc 99m Pyrophosphate|technetium tc 99m pyrophosphate|mesh-list
101400101|NCT05951816|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101400102|NCT05951816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400103|NCT05951725|Vaccines|vaccines|mesh-list
101400104|NCT05951725|Immunologic Factors|immunologic factors|mesh-ancestor
101400105|NCT05951725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400106|NCT05951686|Remifentanil|remifentanil|mesh-list
101400107|NCT05951686|Propofol|propofol|mesh-list
101400108|NCT05951686|Desflurane|desflurane|mesh-list
101400109|NCT05951686|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101400110|NCT05951686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101400111|NCT05951686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400112|NCT05951686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101400113|NCT05951686|Anesthetics, General|anesthetics, general|mesh-ancestor
101400114|NCT05951686|Anesthetics|anesthetics|mesh-ancestor
101400115|NCT05951686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101400116|NCT05951686|Narcotics|narcotics|mesh-ancestor
101400117|NCT05951686|Analgesics|analgesics|mesh-ancestor
101400118|NCT05951686|Sensory System Agents|sensory system agents|mesh-ancestor
101400119|NCT05951686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101400120|NCT05951686|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101400121|NCT05951569|Insulin|insulin|mesh-list
101400122|NCT05951569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101400123|NCT05951569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400124|NCT05951465|Propofol|propofol|mesh-list
101400125|NCT05951465|Esketamine|esketamine|mesh-list
101400126|NCT05951465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101400127|NCT05951465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101400128|NCT05951465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400129|NCT05951465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101400137|NCT05951452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101400138|NCT05951452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400139|NCT05951452|Androgens|androgens|mesh-ancestor
101400140|NCT05951452|Hormones|hormones|mesh-ancestor
101400141|NCT05951452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101400142|NCT05951413|Sildenafil Citrate|sildenafil citrate|mesh-list
101400143|NCT05951413|Estradiol|estradiol|mesh-list
101400144|NCT05951413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400145|NCT05951413|Estrogens|estrogens|mesh-ancestor
101400146|NCT05951413|Hormones|hormones|mesh-ancestor
101306293|NCT02024659|Glucocorticoids|glucocorticoids|mesh-ancestor
101306294|NCT02024659|Hormones|hormones|mesh-ancestor
101400147|NCT05951413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101400148|NCT05951413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400149|NCT05951413|Vasodilator Agents|vasodilator agents|mesh-ancestor
101400150|NCT05951413|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101400151|NCT05951413|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101400152|NCT05951413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101400153|NCT05951413|Urological Agents|urological agents|mesh-ancestor
101400154|NCT05951361|Triamcinolone|triamcinolone|mesh-list
101400155|NCT05951361|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102075691|NCT04318015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075693|NCT04307797|Exenatide|exenatide|mesh-list
102075694|NCT04307797|Glucagon|glucagon|mesh-list
102075695|NCT04307797|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102075696|NCT04307797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102075697|NCT04307797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075698|NCT04307797|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102075699|NCT04307797|Incretins|incretins|mesh-ancestor
102075700|NCT04307797|Hormones|hormones|mesh-ancestor
101377383|NCT00067340|Chlorhexidine|chlorhexidine|mesh-list
101400156|NCT05951361|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101400158|NCT05951361|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101400159|NCT05951361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101400160|NCT05951361|Glucocorticoids|glucocorticoids|mesh-ancestor
101400161|NCT05951361|Hormones|hormones|mesh-ancestor
101400162|NCT05951361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101400175|NCT05951309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400176|NCT05951283|Insulin|insulin|mesh-list
101400177|NCT05951283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101400178|NCT05951283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400179|NCT05950646|Dexmedetomidine|dexmedetomidine|mesh-list
101400180|NCT05950646|Esketamine|esketamine|mesh-list
101400181|NCT05950646|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101400182|NCT05950646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101400183|NCT05950646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400184|NCT05950646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101400185|NCT05950646|Analgesics|analgesics|mesh-ancestor
101400186|NCT05950646|Sensory System Agents|sensory system agents|mesh-ancestor
101400187|NCT05950646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101400188|NCT05950646|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101400189|NCT05950646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101400190|NCT05950646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101400191|NCT05950646|Adrenergic Agents|adrenergic agents|mesh-ancestor
101400192|NCT05950646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101400193|NCT05950646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400194|NCT05950646|Antidepressive Agents|antidepressive agents|mesh-ancestor
101400195|NCT05950646|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101400196|NCT05949632|Axitinib|axitinib|mesh-list
101400197|NCT05949632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101400198|NCT05949632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101400199|NCT05949632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101400200|NCT05949632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400201|NCT05949008|Metformin|metformin|mesh-list
101400202|NCT05949008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101400203|NCT05949008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400204|NCT05947435|Tranexamic Acid|tranexamic acid|mesh-list
101400205|NCT05947435|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101400206|NCT05947435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101400207|NCT05947435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400208|NCT05947435|Hemostatics|hemostatics|mesh-ancestor
101400209|NCT05947435|Coagulants|coagulants|mesh-ancestor
101400210|NCT05938699|Bimatoprost|bimatoprost|mesh-list
101306298|NCT02024841|Tubulin Modulators|tubulin modulators|mesh-ancestor
101306299|NCT02024841|Antimitotic Agents|antimitotic agents|mesh-ancestor
101306300|NCT02024841|Mitosis Modulators|mitosis modulators|mesh-ancestor
101306301|NCT02024841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306303|NCT02024906|Chelating Agents|chelating agents|mesh-ancestor
101306304|NCT02024906|Sequestering Agents|sequestering agents|mesh-ancestor
101333857|NCT00397072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101400233|NCT05936671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101400234|NCT05936671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400235|NCT05936671|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101400236|NCT05936671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101400237|NCT05936671|Anesthetics, General|anesthetics, general|mesh-ancestor
101828115|NCT05985954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102075701|NCT04307797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102075702|NCT04307797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101795449|NCT04080323|Dinoprostone|dinoprostone|mesh-list
102075703|NCT02125188|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
102075705|NCT02125188|Coagulants|coagulants|mesh-ancestor
102075706|NCT02125188|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101377387|NCT00245206|Olanzapine|olanzapine|mesh-list
101400238|NCT05936671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101400239|NCT05936671|Narcotics|narcotics|mesh-ancestor
101400240|NCT05936671|Analgesics|analgesics|mesh-ancestor
101400241|NCT05936671|Sensory System Agents|sensory system agents|mesh-ancestor
101400242|NCT05936671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101400243|NCT05933499|Vitamin D|vitamin d|mesh-list
101400244|NCT05933499|Calcium|calcium|mesh-list
101400245|NCT05933499|Vitamins|vitamins|mesh-ancestor
101400246|NCT05933499|Micronutrients|micronutrients|mesh-ancestor
101400247|NCT05933499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400248|NCT05933499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101400249|NCT05933499|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101400250|NCT05925179|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101400251|NCT05925179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101400252|NCT05925179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101196971|NCT01388855|Vitamins|vitamins|mesh-ancestor
101400268|NCT05912062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101400269|NCT05912062|Tubulin Modulators|tubulin modulators|mesh-ancestor
101400270|NCT05912062|Antimitotic Agents|antimitotic agents|mesh-ancestor
101400271|NCT05912062|Mitosis Modulators|mitosis modulators|mesh-ancestor
101400272|NCT05912062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400273|NCT05912062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101400275|NCT05904379|Docetaxel|docetaxel|mesh-list
101400276|NCT05904379|Pemetrexed|pemetrexed|mesh-list
101400277|NCT05904379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101400278|NCT05904379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101400279|NCT05904379|Tubulin Modulators|tubulin modulators|mesh-ancestor
101400280|NCT05904379|Antimitotic Agents|antimitotic agents|mesh-ancestor
101400281|NCT05904379|Mitosis Modulators|mitosis modulators|mesh-ancestor
101400282|NCT05904379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400283|NCT05904379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101400284|NCT05904379|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101400285|NCT05904379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101400286|NCT05901974|Venetoclax|venetoclax|mesh-list
101400287|NCT05901974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101306305|NCT02024906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306306|NCT02024919|Diltiazem|diltiazem|mesh-list
101306307|NCT02024919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101306308|NCT02024919|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101400288|NCT05901467|Hormones|hormones|mesh-list
101400289|NCT05901467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101400290|NCT05901467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400291|NCT05898724|Zinc Oxide|zinc oxide|mesh-list
101400292|NCT05898724|Dermatologic Agents|dermatologic agents|mesh-ancestor
101400293|NCT05898724|Sunscreening Agents|sunscreening agents|mesh-ancestor
101400294|NCT05898724|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101400295|NCT05898724|Protective Agents|protective agents|mesh-ancestor
101400296|NCT05898724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400297|NCT05890898|Nitrous Oxide|nitrous oxide|mesh-list
101400298|NCT05890898|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101400299|NCT05890898|Anesthetics, General|anesthetics, general|mesh-ancestor
101400300|NCT05890898|Anesthetics|anesthetics|mesh-ancestor
101400301|NCT05890898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101400313|NCT05878522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101400314|NCT05878522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101400315|NCT05878522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101400316|NCT05878522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101400317|NCT05878522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400318|NCT05878522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101400319|NCT05871333|Losartan|losartan|mesh-list
101400320|NCT05871333|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101400321|NCT05871333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102075707|NCT02125188|Natriuretic Agents|natriuretic agents|mesh-ancestor
102075708|NCT02125188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075709|NCT02125344|Paclitaxel|paclitaxel|mesh-list
102075710|NCT02125344|Cyclophosphamide|cyclophosphamide|mesh-list
102075711|NCT02125344|Carboplatin|carboplatin|mesh-list
102075712|NCT02125344|Doxorubicin|doxorubicin|mesh-list
101197026|NCT01389388|Antimetabolites|antimetabolites|mesh-ancestor
101400327|NCT05860933|Antifungal Agents|antifungal agents|mesh-ancestor
101400328|NCT05860933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101400329|NCT05860933|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101400330|NCT05860933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101400331|NCT05860933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101400332|NCT05860933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400333|NCT05860933|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101400334|NCT05860933|Hormone Antagonists|hormone antagonists|mesh-ancestor
101400335|NCT05860933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101400336|NCT05860933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400337|NCT05860933|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101400338|NCT05860933|Anticonvulsants|anticonvulsants|mesh-ancestor
101400339|NCT05860933|Antimanic Agents|antimanic agents|mesh-ancestor
101400340|NCT05860933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101344135|NCT00016601|Nevirapine|nevirapine|mesh-list
101400341|NCT05860933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101400342|NCT05860933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101400343|NCT05860933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101400344|NCT05860933|Analgesics|analgesics|mesh-ancestor
101400345|NCT05860933|Sensory System Agents|sensory system agents|mesh-ancestor
101400346|NCT05860933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101400347|NCT05860933|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101400348|NCT05860933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101400349|NCT05860933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101400350|NCT05860933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101400351|NCT05846750|Lenalidomide|lenalidomide|mesh-list
101400352|NCT05846750|Obinutuzumab|obinutuzumab|mesh-list
101400353|NCT05846750|Immunologic Factors|immunologic factors|mesh-ancestor
101400354|NCT05846750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400355|NCT05846750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101400356|NCT05846750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101400357|NCT05846750|Growth Substances|growth substances|mesh-ancestor
101400358|NCT05846750|Growth Inhibitors|growth inhibitors|mesh-ancestor
101400359|NCT05846750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101400360|NCT05846750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101400361|NCT05819892|Paclitaxel|paclitaxel|mesh-list
101400362|NCT05819892|Cisplatin|cisplatin|mesh-list
101400363|NCT05819892|Carboplatin|carboplatin|mesh-list
101400364|NCT05819892|Dostarlimab|dostarlimab|mesh-list
101306309|NCT02024919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101306310|NCT02024919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306311|NCT02024919|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101306312|NCT02024919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306313|NCT02024919|Vasodilator Agents|vasodilator agents|mesh-ancestor
101306314|NCT02024945|Propiverine|propiverine|mesh-list
101306315|NCT02024945|Parasympatholytics|parasympatholytics|mesh-ancestor
101306316|NCT02024945|Autonomic Agents|autonomic agents|mesh-ancestor
101306317|NCT02024945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101306318|NCT02024945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306319|NCT02024945|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101306320|NCT02024945|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101306321|NCT02024945|Cholinergic Agents|cholinergic agents|mesh-ancestor
101306322|NCT02024945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101306323|NCT02024945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306324|NCT02024945|Urological Agents|urological agents|mesh-ancestor
101306325|NCT02024984|Clomiphene|clomiphene|mesh-list
101306326|NCT02024984|Enclomiphene|enclomiphene|mesh-list
101306327|NCT02024984|Zuclomiphene|zuclomiphene|mesh-list
101306328|NCT02024984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101306329|NCT02024984|Hormone Antagonists|hormone antagonists|mesh-ancestor
101333858|NCT00017394|Bevacizumab|bevacizumab|mesh-list
101400365|NCT05819892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101400366|NCT05819892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101400375|NCT05794997|Sotalol|sotalol|mesh-list
102075713|NCT02125344|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102075714|NCT02125344|Trastuzumab|trastuzumab|mesh-list
102075715|NCT02125344|Epirubicin|epirubicin|mesh-list
102075716|NCT02125344|Pertuzumab|pertuzumab|mesh-list
102075717|NCT02125344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102075718|NCT02125344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102075719|NCT02125344|Tubulin Modulators|tubulin modulators|mesh-ancestor
101400376|NCT05794997|Carvedilol|carvedilol|mesh-list
101400383|NCT05794997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400384|NCT05794997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101400385|NCT05794997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101400386|NCT05794997|Vasodilator Agents|vasodilator agents|mesh-ancestor
101400387|NCT05794997|Antioxidants|antioxidants|mesh-ancestor
101400388|NCT05794997|Protective Agents|protective agents|mesh-ancestor
101400389|NCT05794997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101400390|NCT05794997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101400391|NCT05794997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101400392|NCT05794997|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101400393|NCT05794997|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101400394|NCT05794997|Sympatholytics|sympatholytics|mesh-ancestor
101400395|NCT05794997|Autonomic Agents|autonomic agents|mesh-ancestor
101400396|NCT05794997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101400397|NCT05794997|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101400398|NCT05794828|Bupivacaine|bupivacaine|mesh-list
101400399|NCT05794828|Anesthetics, Local|anesthetics, local|mesh-ancestor
101400400|NCT05794828|Anesthetics|anesthetics|mesh-ancestor
101400401|NCT05794828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101400402|NCT05794828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400403|NCT05794828|Sensory System Agents|sensory system agents|mesh-ancestor
101306330|NCT02024984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101306331|NCT02024984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400404|NCT05794828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101400405|NCT05789524|Protein C|protein c|mesh-list
101400406|NCT05789524|Anticoagulants|anticoagulants|mesh-ancestor
101400407|NCT05789524|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101400408|NCT05789524|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101400409|NCT05789524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400410|NCT05788328|Dabigatran|dabigatran|mesh-list
101400411|NCT05788328|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101400412|NCT05788328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101400413|NCT05788328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101400414|NCT05788328|Antimetabolites|antimetabolites|mesh-ancestor
101400415|NCT05788328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400416|NCT05788328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101400417|NCT05788328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101400418|NCT05788328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101400419|NCT05788328|Antithrombins|antithrombins|mesh-ancestor
101400420|NCT05788328|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101400421|NCT05788328|Protease Inhibitors|protease inhibitors|mesh-ancestor
101400422|NCT05788328|Anticoagulants|anticoagulants|mesh-ancestor
101400432|NCT05752526|Diclofenac|diclofenac|mesh-list
101400433|NCT05752526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101400434|NCT05752526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101400444|NCT05742399|Hyaluronic Acid|hyaluronic acid|mesh-list
101400445|NCT05742399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101400446|NCT05742399|Immunologic Factors|immunologic factors|mesh-ancestor
101400447|NCT05742399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400448|NCT05742399|Viscosupplements|viscosupplements|mesh-ancestor
101400449|NCT05742399|Protective Agents|protective agents|mesh-ancestor
101400450|NCT05734560|D2C7-(scdsFv)-PE38KDEL|d2c7-(scdsfv)-pe38kdel|mesh-list
101400451|NCT05734560|Immunoconjugates|immunoconjugates|mesh-ancestor
101400452|NCT05734560|Immunologic Factors|immunologic factors|mesh-ancestor
101400453|NCT05734560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400454|NCT05726110|Cytarabine|cytarabine|mesh-list
101400455|NCT05726110|Daunorubicin|daunorubicin|mesh-list
101400456|NCT05726110|Homoharringtonine|homoharringtonine|mesh-list
101400457|NCT05726110|Aclacinomycins|aclacinomycins|mesh-list
101400458|NCT05726110|Lenograstim|lenograstim|mesh-list
101400459|NCT05726110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101400460|NCT05726110|Antimetabolites|antimetabolites|mesh-ancestor
102075720|NCT02125344|Antimitotic Agents|antimitotic agents|mesh-ancestor
102075721|NCT02125344|Mitosis Modulators|mitosis modulators|mesh-ancestor
101828116|NCT05981131|BCG Vaccine|bcg vaccine|mesh-list
102075722|NCT02125344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075723|NCT02125344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102075724|NCT02125344|Immunologic Factors|immunologic factors|mesh-ancestor
102075725|NCT02125344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197156|NCT01389791|Magnesium Sulfate|magnesium sulfate|mesh-list
101400467|NCT05726110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400468|NCT05726110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101400469|NCT05726110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101400470|NCT05726110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101400471|NCT05726110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101400472|NCT05726110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101400473|NCT05726110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101400474|NCT05726110|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101400476|NCT05716516|Estrogens|estrogens|mesh-ancestor
101400477|NCT05716516|Hormones|hormones|mesh-ancestor
101400478|NCT05716516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101400479|NCT05716516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400480|NCT05694286|Hyaluronic Acid|hyaluronic acid|mesh-list
101400481|NCT05694286|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101400482|NCT05694286|Immunologic Factors|immunologic factors|mesh-ancestor
101400483|NCT05694286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306332|NCT02024984|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101306334|NCT02024984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101306335|NCT02024984|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101306336|NCT02024984|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101306337|NCT02025023|Triamcinolone|triamcinolone|mesh-list
101306338|NCT02025023|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101306339|NCT02025023|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101306340|NCT02025023|Fluorouracil|fluorouracil|mesh-list
101400484|NCT05694286|Viscosupplements|viscosupplements|mesh-ancestor
101400485|NCT05694286|Protective Agents|protective agents|mesh-ancestor
101400486|NCT05692180|Benralizumab|benralizumab|mesh-list
101400487|NCT05692180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101400488|NCT05692180|Respiratory System Agents|respiratory system agents|mesh-ancestor
101400489|NCT05679024|Apixaban|apixaban|mesh-list
101400490|NCT05679024|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101400491|NCT05679024|Antithrombins|antithrombins|mesh-ancestor
101400492|NCT05679024|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101400493|NCT05679024|Protease Inhibitors|protease inhibitors|mesh-ancestor
101400494|NCT05679024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101400495|NCT05679024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400496|NCT05679024|Anticoagulants|anticoagulants|mesh-ancestor
101400497|NCT05645718|Cytarabine|cytarabine|mesh-list
101400498|NCT05645718|Dexamethasone|dexamethasone|mesh-list
101400499|NCT05645718|Prednisone|prednisone|mesh-list
101400500|NCT05645718|Cyclophosphamide|cyclophosphamide|mesh-list
101400501|NCT05645718|Rituximab|rituximab|mesh-list
101400502|NCT05645718|Methotrexate|methotrexate|mesh-list
101400507|NCT05645718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101400508|NCT05645718|Immunologic Factors|immunologic factors|mesh-ancestor
101400509|NCT05645718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400510|NCT05645718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101400511|NCT05645718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101400512|NCT05645718|Alkylating Agents|alkylating agents|mesh-ancestor
101400513|NCT05645718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400514|NCT05645718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101400515|NCT05645718|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101400516|NCT05645718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101400517|NCT05645718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101400519|NCT05645718|Autonomic Agents|autonomic agents|mesh-ancestor
101400520|NCT05645718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101400521|NCT05645718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101400522|NCT05645718|Glucocorticoids|glucocorticoids|mesh-ancestor
101400523|NCT05645718|Hormones|hormones|mesh-ancestor
101400524|NCT05645718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101400525|NCT05645718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102075726|NCT02125344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102075727|NCT02125344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102075728|NCT02125344|Alkylating Agents|alkylating agents|mesh-ancestor
102075729|NCT02125344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102075730|NCT02125344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102075731|NCT02125344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101400526|NCT05645718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101400527|NCT05645718|Abortifacient Agents|abortifacient agents|mesh-ancestor
101400532|NCT05645718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101400533|NCT05645718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101400534|NCT05645718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101400535|NCT05645718|Antiviral Agents|antiviral agents|mesh-ancestor
101400536|NCT05645718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101400537|NCT05645718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101400538|NCT05645718|Tubulin Modulators|tubulin modulators|mesh-ancestor
101400539|NCT05645718|Antimitotic Agents|antimitotic agents|mesh-ancestor
101400540|NCT05645718|Mitosis Modulators|mitosis modulators|mesh-ancestor
101400541|NCT05645718|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101400542|NCT05645718|Immunotoxins|immunotoxins|mesh-ancestor
101400543|NCT05645718|Immunoconjugates|immunoconjugates|mesh-ancestor
101400544|NCT05641298|Fusidic Acid|fusidic acid|mesh-list
101400545|NCT05641298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101400546|NCT05641298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101400547|NCT05641298|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101306342|NCT02025023|Antimetabolites|antimetabolites|mesh-ancestor
101306343|NCT02025023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306344|NCT02025023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101306345|NCT02025023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101306346|NCT02025023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101306347|NCT02025023|Immunologic Factors|immunologic factors|mesh-ancestor
101306348|NCT02025023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306349|NCT02025023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101400548|NCT05641298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101400549|NCT05641298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400551|NCT05635370|Pentoxifylline|pentoxifylline|mesh-list
101400552|NCT05635370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101400553|NCT05635370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101400554|NCT05635370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400555|NCT05635370|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101400556|NCT05635370|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101400557|NCT05635370|Protective Agents|protective agents|mesh-ancestor
101344413|NCT00128739|Glucocorticoids|glucocorticoids|mesh-ancestor
101400558|NCT05635370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400559|NCT05635370|Vasodilator Agents|vasodilator agents|mesh-ancestor
101400560|NCT05635370|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101400561|NCT05635370|Antioxidants|antioxidants|mesh-ancestor
101400562|NCT05635370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101400563|NCT05635370|Autonomic Agents|autonomic agents|mesh-ancestor
101400564|NCT05635370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101400565|NCT05635370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101400566|NCT05635370|Respiratory System Agents|respiratory system agents|mesh-ancestor
101400567|NCT05635370|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101400568|NCT05635370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101400569|NCT05635370|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101400570|NCT05635370|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101400571|NCT05635357|Letrozole|letrozole|mesh-list
101400572|NCT05635357|Anastrozole|anastrozole|mesh-list
101400573|NCT05635357|Exemestane|exemestane|mesh-list
101400574|NCT05635357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101400578|NCT05635357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400580|NCT05635357|Hormone Antagonists|hormone antagonists|mesh-ancestor
101400581|NCT05635357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101400582|NCT05635357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400583|NCT05635357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101400584|NCT05633966|Hormones|hormones|mesh-list
101400585|NCT05633966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101400586|NCT05633966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400587|NCT05614089|Insulin|insulin|mesh-list
102075732|NCT02125344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102075733|NCT02125344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102075734|NCT02125344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102075735|NCT05468840|Ketamine|ketamine|mesh-list
102075736|NCT05468840|Analgesics|analgesics|mesh-ancestor
102075737|NCT05468840|Sensory System Agents|sensory system agents|mesh-ancestor
101400588|NCT05614089|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101400589|NCT05614089|Insulin Glargine|insulin glargine|mesh-list
101400590|NCT05614089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101400591|NCT05614089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400592|NCT05559931|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
101400593|NCT05559931|Hallucinogens|hallucinogens|mesh-ancestor
101400599|NCT05559931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400601|NCT05559879|Dostarlimab|dostarlimab|mesh-list
101400602|NCT05559879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101400603|NCT05491083|Pembrolizumab|pembrolizumab|mesh-list
101400604|NCT05491083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101400605|NCT05491083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101400606|NCT05491083|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101306350|NCT02025023|Glucocorticoids|glucocorticoids|mesh-ancestor
101306351|NCT02025023|Hormones|hormones|mesh-ancestor
101306352|NCT02025023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101306353|NCT02025023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101306354|NCT02025140|Anesthetics|anesthetics|mesh-list
101306355|NCT02025140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101306356|NCT02025140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306357|NCT02025166|Acetaminophen|acetaminophen|mesh-list
101306358|NCT02025166|Lornoxicam|lornoxicam|mesh-list
101306359|NCT02025166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101306360|NCT02025166|Analgesics|analgesics|mesh-ancestor
101306361|NCT02025166|Sensory System Agents|sensory system agents|mesh-ancestor
101306362|NCT02025166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101306363|NCT02025166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306365|NCT02025166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101306366|NCT02025166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101306367|NCT02025166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101400607|NCT05491083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400608|NCT05481112|Buprenorphine|buprenorphine|mesh-list
101400609|NCT05481112|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101400610|NCT05481112|Narcotics|narcotics|mesh-ancestor
101400611|NCT05481112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101400612|NCT05481112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400613|NCT05481112|Analgesics|analgesics|mesh-ancestor
101400614|NCT05481112|Sensory System Agents|sensory system agents|mesh-ancestor
101400615|NCT05481112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101400616|NCT05481112|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101400617|NCT05473585|Nicotine|nicotine|mesh-list
101400618|NCT05473585|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101400619|NCT05473585|Autonomic Agents|autonomic agents|mesh-ancestor
101400620|NCT05473585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101400621|NCT05473585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400622|NCT05473585|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101400623|NCT05473585|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101400624|NCT05473585|Cholinergic Agents|cholinergic agents|mesh-ancestor
101400625|NCT05473585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101400626|NCT05473585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400627|NCT05457855|Fluticasone|fluticasone|mesh-list
101400628|NCT05457855|Montelukast|montelukast|mesh-list
101400629|NCT05457855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101400630|NCT05457855|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101400631|NCT05457855|Autonomic Agents|autonomic agents|mesh-ancestor
101400632|NCT05457855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101400633|NCT05457855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400634|NCT05457855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101400635|NCT05457855|Respiratory System Agents|respiratory system agents|mesh-ancestor
101400636|NCT05457855|Dermatologic Agents|dermatologic agents|mesh-ancestor
101400637|NCT05457855|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101400638|NCT05457855|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101400639|NCT05457855|Hormone Antagonists|hormone antagonists|mesh-ancestor
101439422|NCT05365451|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101400641|NCT05457855|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101400642|NCT05457855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101400643|NCT05457855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306370|NCT02025192|Tucatinib|tucatinib|mesh-list
101306371|NCT02025192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101400650|NCT05381948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101400651|NCT05381948|Growth Substances|growth substances|mesh-ancestor
101400652|NCT05381948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400653|NCT05381948|Growth Inhibitors|growth inhibitors|mesh-ancestor
101400654|NCT05381948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101400655|NCT05379491|Linaclotide|linaclotide|mesh-list
101400656|NCT05379491|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
101400657|NCT05379491|Enzyme Activators|enzyme activators|mesh-ancestor
101400658|NCT05379491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400659|NCT05379491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101400660|NCT05376111|Azacitidine|azacitidine|mesh-list
101400661|NCT05376111|Venetoclax|venetoclax|mesh-list
101400662|NCT05376111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101400663|NCT05376111|Antimetabolites|antimetabolites|mesh-ancestor
101400664|NCT05376111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400665|NCT05376111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101400666|NCT05376111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101400667|NCT05363670|Albuterol|albuterol|mesh-list
101400668|NCT05363670|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101400669|NCT05363670|Autonomic Agents|autonomic agents|mesh-ancestor
101400670|NCT05363670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101400671|NCT05363670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400672|NCT05363670|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101400673|NCT05363670|Respiratory System Agents|respiratory system agents|mesh-ancestor
101400674|NCT05363670|Tocolytic Agents|tocolytic agents|mesh-ancestor
101400675|NCT05363670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101400676|NCT05363670|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101400677|NCT05363670|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101400678|NCT05363670|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101400679|NCT05363670|Adrenergic Agents|adrenergic agents|mesh-ancestor
101400680|NCT05363670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101400681|NCT05363670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400692|NCT05343312|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101400693|NCT05343312|Antimalarials|antimalarials|mesh-ancestor
101400694|NCT05343312|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101400695|NCT05343312|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101400696|NCT05343312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101400697|NCT05322902|Propofol|propofol|mesh-list
101400698|NCT05322902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101400699|NCT05322902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102075745|NCT05468840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102075746|NCT05468840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102075747|NCT05468840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102075748|NCT05468840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075749|NCT05723900|Castor Oil|castor oil|mesh-list
102075750|NCT05723900|Cathartics|cathartics|mesh-ancestor
102075751|NCT05723900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102075752|NCT02127138|Sirolimus|sirolimus|mesh-list
102075753|NCT02127138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102075754|NCT02127138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102075755|NCT02127138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101377426|NCT00077298|Growth Substances|growth substances|mesh-ancestor
101400700|NCT05322902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400701|NCT05322902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101400702|NCT05322902|Anesthetics, General|anesthetics, general|mesh-ancestor
101400703|NCT05322902|Anesthetics|anesthetics|mesh-ancestor
101400704|NCT05291299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101400705|NCT05287906|Cardiac Glycosides|cardiac glycosides|mesh-list
101400706|NCT05287906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101400707|NCT05287906|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101400708|NCT05287906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101400709|NCT05287906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400710|NCT05287906|Protective Agents|protective agents|mesh-ancestor
101400711|NCT05287906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400712|NCT05286060|Pembrolizumab|pembrolizumab|mesh-list
101400730|NCT05222971|Olaparib|olaparib|mesh-list
101400731|NCT05222971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101400732|NCT05222971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101400733|NCT05222971|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101400734|NCT05222971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101400735|NCT05222971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400754|NCT05170893|Ubiquinone|ubiquinone|mesh-list
101400755|NCT05170893|Coenzyme Q10|coenzyme q10|mesh-list
101400756|NCT05170893|Micronutrients|micronutrients|mesh-ancestor
101400757|NCT05170893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400758|NCT05170893|Vitamins|vitamins|mesh-ancestor
101400759|NCT05167864|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101400760|NCT05167864|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
101400761|NCT05167864|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101400762|NCT05167864|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101400763|NCT05167864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101400764|NCT05167864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400765|NCT05167864|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101400766|NCT05167864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101400767|NCT05167864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400768|NCT05167864|Cholinergic Agents|cholinergic agents|mesh-ancestor
101400769|NCT05167864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101400770|NCT05125276|Aspirin|aspirin|mesh-list
101400771|NCT05125276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101400772|NCT05125276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101400773|NCT05125276|Analgesics|analgesics|mesh-ancestor
101400774|NCT05125276|Sensory System Agents|sensory system agents|mesh-ancestor
101400775|NCT05125276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101400776|NCT05125276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400777|NCT05125276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101400778|NCT05125276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101400779|NCT05125276|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101400800|NCT05083780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101400801|NCT05083780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400802|NCT05083780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101400803|NCT05083780|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101400804|NCT05083780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075756|NCT02127138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102075757|NCT02127138|Antifungal Agents|antifungal agents|mesh-ancestor
102075758|NCT02127138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102075759|NCT02127138|Immunologic Factors|immunologic factors|mesh-ancestor
102075760|NCT02127138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075762|NCT03651531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102075763|NCT03651531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075764|NCT02903511|Metformin|metformin|mesh-list
101400805|NCT05083780|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101400806|NCT05083780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101400807|NCT05074823|Ketamine|ketamine|mesh-list
101400808|NCT05074823|Analgesics|analgesics|mesh-ancestor
101400809|NCT05074823|Sensory System Agents|sensory system agents|mesh-ancestor
101400810|NCT05074823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101400811|NCT05074823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400812|NCT05074823|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101400813|NCT05074823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101400814|NCT05074823|Anesthetics, General|anesthetics, general|mesh-ancestor
101400815|NCT05074823|Anesthetics|anesthetics|mesh-ancestor
101400816|NCT05074823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101400817|NCT05074823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101400818|NCT05074823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101400819|NCT05074823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101400820|NCT05074823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400821|NCT05059600|Pregnanolone|pregnanolone|mesh-list
101400822|NCT05059600|Brexanolone|brexanolone|mesh-list
101400823|NCT05059600|Anesthetics|anesthetics|mesh-ancestor
101400824|NCT05059600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101400825|NCT05059600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400826|NCT05059600|Neurosteroids|neurosteroids|mesh-ancestor
101400827|NCT05059600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101197505|NCT01392144|Vasodilator Agents|vasodilator agents|mesh-ancestor
101400832|NCT05049902|Metronidazole|metronidazole|mesh-list
101400833|NCT05049902|Clarithromycin|clarithromycin|mesh-list
101400834|NCT05049902|Tetracycline|tetracycline|mesh-list
101400835|NCT05049902|Potassium Citrate|potassium citrate|mesh-list
101400853|NCT05026593|Carboplatin|carboplatin|mesh-list
101400854|NCT05026593|Etoposide|etoposide|mesh-list
101400855|NCT05026593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101306373|NCT02025192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306374|NCT02025192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101306375|NCT02025192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101400856|NCT05026593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101400857|NCT05026593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101400858|NCT05026593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101400859|NCT05026593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101400860|NCT05026593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400861|NCT04977986|Cannabidiol|cannabidiol|mesh-list
101400862|NCT04977986|Anticonvulsants|anticonvulsants|mesh-ancestor
101400863|NCT04976855|Buprenorphine|buprenorphine|mesh-list
101400864|NCT04976855|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101400865|NCT04976855|Naloxone|naloxone|mesh-list
101400866|NCT04976855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101400867|NCT04976855|Narcotics|narcotics|mesh-ancestor
101400868|NCT04976855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101400869|NCT04976855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400870|NCT04976855|Analgesics|analgesics|mesh-ancestor
101400871|NCT04976855|Sensory System Agents|sensory system agents|mesh-ancestor
101400872|NCT04976855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101400873|NCT04976855|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101400874|NCT04974398|Cisplatin|cisplatin|mesh-list
101400875|NCT04974398|Gemcitabine|gemcitabine|mesh-list
101400876|NCT04974398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101400877|NCT04974398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101400878|NCT04974398|Antimetabolites|antimetabolites|mesh-ancestor
101400879|NCT04974398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400880|NCT04971785|Firsocostat|firsocostat|mesh-list
102075765|NCT02903511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102075766|NCT02903511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075767|NCT05325528|Oxaliplatin|oxaliplatin|mesh-list
102075768|NCT05325528|Tislelizumab|tislelizumab|mesh-list
102075770|NCT05325528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101377449|NCT00400608|Autonomic Agents|autonomic agents|mesh-ancestor
101400881|NCT04971785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101400882|NCT04971785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400883|NCT04971109|Tecovirimat|tecovirimat|mesh-list
101400884|NCT04971109|Antiviral Agents|antiviral agents|mesh-ancestor
101400885|NCT04971109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101400886|NCT04957485|Tecovirimat|tecovirimat|mesh-list
101400887|NCT04957485|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
101400888|NCT04957485|Antiviral Agents|antiviral agents|mesh-ancestor
101400889|NCT04957485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101400890|NCT04943900|Nivolumab|nivolumab|mesh-list
101400891|NCT04943900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101400892|NCT04943900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101400893|NCT04943900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101400896|NCT04893798|Medroxyprogesterone|medroxyprogesterone|mesh-list
101400897|NCT04893798|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101400898|NCT04893798|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101400899|NCT04893798|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101400900|NCT04893798|Contraceptive Agents|contraceptive agents|mesh-ancestor
101400901|NCT04893798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101400902|NCT04893798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400903|NCT04893798|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101400904|NCT04893798|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101400905|NCT04893798|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101400906|NCT04893798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101400907|NCT04893798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101400909|NCT04833959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101400910|NCT04833959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101400911|NCT04795661|Pembrolizumab|pembrolizumab|mesh-list
101400912|NCT04795661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101400913|NCT04795661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101400914|NCT04795661|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101400917|NCT04793906|Trace Elements|trace elements|mesh-ancestor
101400918|NCT04793906|Micronutrients|micronutrients|mesh-ancestor
101400919|NCT04793906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400920|NCT04784715|Trastuzumab|trastuzumab|mesh-list
101400922|NCT04784715|Taxane|taxane|mesh-list
101400923|NCT04784715|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
101306376|NCT02025192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101306377|NCT02025192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101344848|NCT00019890|Immunologic Factors|immunologic factors|mesh-ancestor
101400924|NCT04784715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101400925|NCT04784715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101400926|NCT04784715|Immunoconjugates|immunoconjugates|mesh-ancestor
101400927|NCT04784715|Immunologic Factors|immunologic factors|mesh-ancestor
101400928|NCT04784715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400929|NCT04750954|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
101400930|NCT04750954|Peposertib|peposertib|mesh-list
101400931|NCT04750954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400932|NCT04750954|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101400933|NCT04750954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101400934|NCT04750954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101400935|NCT04716413|Dsuvia|dsuvia|mesh-list
101400936|NCT04716413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101400937|NCT04716413|Narcotics|narcotics|mesh-ancestor
101400938|NCT04716413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101400939|NCT04716413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400940|NCT04716413|Analgesics|analgesics|mesh-ancestor
101400941|NCT04716413|Sensory System Agents|sensory system agents|mesh-ancestor
101400942|NCT04716413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101400943|NCT04696042|Lanreotide|lanreotide|mesh-list
101400944|NCT04696042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101400945|NCT04684212|Warfarin|warfarin|mesh-list
101400946|NCT04684212|Rivaroxaban|rivaroxaban|mesh-list
102075771|NCT05325528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102075772|NCT05325528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102075773|NCT05325528|Antimetabolites|antimetabolites|mesh-ancestor
102075774|NCT05325528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075775|NCT02125500|Sofosbuvir|sofosbuvir|mesh-list
102075776|NCT02125500|Ledipasvir|ledipasvir|mesh-list
102075777|NCT02125500|Antiviral Agents|antiviral agents|mesh-ancestor
102075778|NCT02125500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102075779|NCT02125578|Interferons|interferons|mesh-list
102075780|NCT02125578|Interferon-beta|interferon-beta|mesh-list
102075781|NCT02125578|Interferon beta-1a|interferon beta-1a|mesh-list
102075782|NCT02125578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102075783|NCT02125578|Antiviral Agents|antiviral agents|mesh-ancestor
102075784|NCT02125578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102075785|NCT02125578|Immunologic Factors|immunologic factors|mesh-ancestor
102075786|NCT02125578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075787|NCT02125578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102075788|NCT02122536|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102075789|NCT02122536|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102075790|NCT02122536|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102075791|NCT02122536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101377455|NCT00400608|Hormones|hormones|mesh-ancestor
101400947|NCT04684212|Dabigatran|dabigatran|mesh-list
101400948|NCT04684212|Edoxaban|edoxaban|mesh-list
101400949|NCT04684212|Apixaban|apixaban|mesh-list
101400950|NCT04684212|Betrixaban|betrixaban|mesh-list
101400951|NCT04684212|Anticoagulants|anticoagulants|mesh-ancestor
101400952|NCT04684212|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101400953|NCT04684212|Antithrombins|antithrombins|mesh-ancestor
101400954|NCT04684212|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101400955|NCT04684212|Protease Inhibitors|protease inhibitors|mesh-ancestor
101400956|NCT04684212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101400957|NCT04684212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400958|NCT04635189|Dexamethasone|dexamethasone|mesh-list
101400959|NCT04635189|Lenalidomide|lenalidomide|mesh-list
101400960|NCT04635189|Daratumumab|daratumumab|mesh-list
101400961|NCT04635189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101400962|NCT04635189|Antiemetics|antiemetics|mesh-ancestor
101400963|NCT04635189|Autonomic Agents|autonomic agents|mesh-ancestor
101400964|NCT04635189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101400965|NCT04635189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400966|NCT04635189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101400967|NCT04635189|Glucocorticoids|glucocorticoids|mesh-ancestor
101400968|NCT04635189|Hormones|hormones|mesh-ancestor
101400973|NCT04635189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101400974|NCT04635189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101400975|NCT04635189|Growth Substances|growth substances|mesh-ancestor
101400976|NCT04635189|Growth Inhibitors|growth inhibitors|mesh-ancestor
101400977|NCT04608448|Sirolimus|sirolimus|mesh-list
101400978|NCT04608448|Petrolatum|petrolatum|mesh-list
101400979|NCT04608448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101400980|NCT04608448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101400981|NCT04608448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101400982|NCT04608448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101400983|NCT04608448|Antifungal Agents|antifungal agents|mesh-ancestor
101400984|NCT04608448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101400985|NCT04608448|Immunologic Factors|immunologic factors|mesh-ancestor
101400986|NCT04608448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075792|NCT02122536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102075793|NCT02122536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075794|NCT02122536|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102075795|NCT02122536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102075796|NCT02122536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075797|NCT02122536|Cholinergic Agents|cholinergic agents|mesh-ancestor
102075798|NCT02122536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101377471|NCT00245674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101400987|NCT04608448|Emollients|emollients|mesh-ancestor
101400988|NCT04608448|Dermatologic Agents|dermatologic agents|mesh-ancestor
101400989|NCT04592653|Pembrolizumab|pembrolizumab|mesh-list
101400990|NCT04592653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101400991|NCT04592653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101400992|NCT04592653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101400993|NCT04592653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400994|NCT04562285|Antibodies|antibodies|mesh-list
101400995|NCT04562285|Immunologic Factors|immunologic factors|mesh-ancestor
101401011|NCT04528004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101401012|NCT04528004|Antimetabolites|antimetabolites|mesh-ancestor
101401013|NCT04528004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401014|NCT04528004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101401015|NCT04528004|Vasodilator Agents|vasodilator agents|mesh-ancestor
101401017|NCT04500899|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101401018|NCT04500899|Mydriatics|mydriatics|mesh-ancestor
101401019|NCT04500899|Autonomic Agents|autonomic agents|mesh-ancestor
101401020|NCT04500899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101401021|NCT04500899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401022|NCT04500899|Sympathomimetics|sympathomimetics|mesh-ancestor
101401023|NCT04500899|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101401024|NCT04500899|Nasal Decongestants|nasal decongestants|mesh-ancestor
101401025|NCT04500899|Respiratory System Agents|respiratory system agents|mesh-ancestor
101401026|NCT04500899|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101401027|NCT04500899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101401028|NCT04500899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101401029|NCT04500899|Adrenergic Agents|adrenergic agents|mesh-ancestor
101401030|NCT04500899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101401031|NCT04500899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401032|NCT04500899|Protective Agents|protective agents|mesh-ancestor
101401033|NCT04485039|Tecovirimat|tecovirimat|mesh-list
101401034|NCT04485039|Sevelamer|sevelamer|mesh-list
101401035|NCT04485039|Calcium acetate|calcium acetate|mesh-list
101401036|NCT04485039|Chelating Agents|chelating agents|mesh-ancestor
101401037|NCT04485039|Sequestering Agents|sequestering agents|mesh-ancestor
101401038|NCT04485039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401039|NCT04485039|Antiviral Agents|antiviral agents|mesh-ancestor
101401040|NCT04485039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101401046|NCT04413890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101401047|NCT04413890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401048|NCT04318405|Iron|iron|mesh-list
101401049|NCT04318405|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
101401050|NCT04318405|Trace Elements|trace elements|mesh-ancestor
101401051|NCT04318405|Micronutrients|micronutrients|mesh-ancestor
101401052|NCT04318405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401053|NCT04318405|Hematinics|hematinics|mesh-ancestor
101401054|NCT04313790|Heparin|heparin|mesh-list
101401055|NCT04313790|Calcium heparin|calcium heparin|mesh-list
101401056|NCT04313790|Anticoagulants|anticoagulants|mesh-ancestor
101401057|NCT04313790|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101401058|NCT04313790|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101401059|NCT04313790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401060|NCT04293393|Paclitaxel|paclitaxel|mesh-list
101401061|NCT04293393|Docetaxel|docetaxel|mesh-list
101401062|NCT04293393|Cyclophosphamide|cyclophosphamide|mesh-list
101401063|NCT04293393|Doxorubicin|doxorubicin|mesh-list
101401064|NCT04293393|Letrozole|letrozole|mesh-list
101401065|NCT04293393|Leuprolide|leuprolide|mesh-list
101401066|NCT04293393|Goserelin|goserelin|mesh-list
101401067|NCT04293393|Taxane|taxane|mesh-list
101496604|NCT00495339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101496610|NCT00460148|Ropinirole|ropinirole|mesh-list
101401068|NCT04293393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101401069|NCT04293393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101401070|NCT04293393|Tubulin Modulators|tubulin modulators|mesh-ancestor
101401073|NCT04293393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401075|NCT04293393|Immunologic Factors|immunologic factors|mesh-ancestor
101401076|NCT04293393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401077|NCT04293393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101306382|NCT02025218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306384|NCT02025348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101187810|NCT00002772|Tamoxifen|tamoxifen|mesh-list
101401078|NCT04293393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101401079|NCT04293393|Alkylating Agents|alkylating agents|mesh-ancestor
101401080|NCT04293393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101401081|NCT04293393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101401082|NCT04293393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101401083|NCT04293393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101401084|NCT04293393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101401085|NCT04293393|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101401086|NCT04293393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101401087|NCT04293393|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101401088|NCT04293393|Hormone Antagonists|hormone antagonists|mesh-ancestor
101401089|NCT04293393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101401090|NCT04293393|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101401091|NCT04293393|Fertility Agents|fertility agents|mesh-ancestor
101401092|NCT04293393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101401093|NCT04293393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101401094|NCT04285567|Cyclophosphamide|cyclophosphamide|mesh-list
101401095|NCT04285567|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101401096|NCT04285567|Rituximab|rituximab|mesh-list
101401097|NCT04285567|Fludarabine|fludarabine|mesh-list
101401098|NCT04285567|Venetoclax|venetoclax|mesh-list
101401099|NCT04285567|Obinutuzumab|obinutuzumab|mesh-list
101401100|NCT04285567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101401101|NCT04285567|Immunologic Factors|immunologic factors|mesh-ancestor
101401102|NCT04285567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401103|NCT04285567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101401104|NCT04285567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101401105|NCT04285567|Alkylating Agents|alkylating agents|mesh-ancestor
101401106|NCT04285567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401107|NCT04285567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101401108|NCT04285567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101401109|NCT04285567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101401110|NCT04276480|Tazobactam|tazobactam|mesh-list
101401111|NCT04276480|Piperacillin|piperacillin|mesh-list
101401112|NCT04276480|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101401113|NCT04276480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101401114|NCT04276480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101401125|NCT04182373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101401126|NCT04182373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401127|NCT04182373|Anticoagulants|anticoagulants|mesh-ancestor
101401128|NCT04161898|Prednisolone|prednisolone|mesh-list
101401129|NCT04161898|Upadacitinib|upadacitinib|mesh-list
101401130|NCT04161898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101401131|NCT04161898|Glucocorticoids|glucocorticoids|mesh-ancestor
101401132|NCT04161898|Hormones|hormones|mesh-ancestor
101401133|NCT04161898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101401134|NCT04161898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401135|NCT04161898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101401136|NCT04161898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101401137|NCT04161898|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101401138|NCT04161898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101401139|NCT04161898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101401140|NCT04161898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401141|NCT04161898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101401142|NCT04153487|Ascorbic Acid|ascorbic acid|mesh-list
101401143|NCT04153487|Vitamins|vitamins|mesh-ancestor
101401144|NCT04153487|Micronutrients|micronutrients|mesh-ancestor
101401145|NCT04153487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401146|NCT04153487|Antioxidants|antioxidants|mesh-ancestor
101401147|NCT04153487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401148|NCT04153487|Protective Agents|protective agents|mesh-ancestor
102075801|NCT05606965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075802|NCT03830359|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102075803|NCT03830359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102075804|NCT00141284|Lamivudine|lamivudine|mesh-list
102075805|NCT00141284|Zidovudine|zidovudine|mesh-list
102075806|NCT00141284|Nelfinavir|nelfinavir|mesh-list
102075807|NCT00141284|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102075808|NCT00141284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102075809|NCT00141284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101377479|NCT00245713|Nootropic Agents|nootropic agents|mesh-ancestor
101377480|NCT00067457|Alosetron|alosetron|mesh-list
101401149|NCT04153032|Diltiazem|diltiazem|mesh-list
101456563|NCT00216827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101306385|NCT02025348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101306387|NCT02025348|Autonomic Agents|autonomic agents|mesh-ancestor
101306388|NCT02025348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101401154|NCT04153032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101401155|NCT04153032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401156|NCT04153032|Vasodilator Agents|vasodilator agents|mesh-ancestor
101401157|NCT04116437|Zanubrutinib|zanubrutinib|mesh-list
101401158|NCT04116437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101401159|NCT04116437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101401160|NCT04116437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101401161|NCT04116437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401163|NCT04092179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101401164|NCT04085445|Paclitaxel|paclitaxel|mesh-list
101401165|NCT04085445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101401166|NCT04085445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101401167|NCT04085445|Tubulin Modulators|tubulin modulators|mesh-ancestor
101401168|NCT04085445|Antimitotic Agents|antimitotic agents|mesh-ancestor
101401169|NCT04085445|Mitosis Modulators|mitosis modulators|mesh-ancestor
101401170|NCT04085445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401171|NCT04065841|Licogliflozin|licogliflozin|mesh-list
101401172|NCT04065841|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101401173|NCT04065841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401174|NCT04065841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101401175|NCT04065841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401176|NCT03895567|Ceftriaxone|ceftriaxone|mesh-list
101401177|NCT03895567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101401178|NCT03895567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101401188|NCT03833167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101401189|NCT03833167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401190|NCT03800134|Paclitaxel|paclitaxel|mesh-list
101401191|NCT03800134|Cisplatin|cisplatin|mesh-list
101401192|NCT03800134|Carboplatin|carboplatin|mesh-list
101401193|NCT03800134|Gemcitabine|gemcitabine|mesh-list
101401194|NCT03800134|Pemetrexed|pemetrexed|mesh-list
101401195|NCT03800134|Durvalumab|durvalumab|mesh-list
101401196|NCT03800134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101401197|NCT03800134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101401198|NCT03800134|Tubulin Modulators|tubulin modulators|mesh-ancestor
101401199|NCT03800134|Antimitotic Agents|antimitotic agents|mesh-ancestor
101401200|NCT03800134|Mitosis Modulators|mitosis modulators|mesh-ancestor
101401201|NCT03800134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401202|NCT03800134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101401203|NCT03800134|Antimetabolites|antimetabolites|mesh-ancestor
101401204|NCT03800134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101401205|NCT03800134|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101401206|NCT03800134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101401207|NCT03800134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101401208|NCT03774810|Zolpidem|zolpidem|mesh-list
101401209|NCT03774810|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101401210|NCT03774810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102075810|NCT00141284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075811|NCT00141284|Antiviral Agents|antiviral agents|mesh-ancestor
102075812|NCT00141284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102075813|NCT00141284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102075814|NCT00141284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102075815|NCT00141284|Antimetabolites|antimetabolites|mesh-ancestor
102075816|NCT00141284|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101401211|NCT03774810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101401212|NCT03774810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401213|NCT03774810|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101401214|NCT03774810|GABA Agonists|gaba agonists|mesh-ancestor
101401215|NCT03774810|GABA Agents|gaba agents|mesh-ancestor
101401216|NCT03774810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101401217|NCT03774810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401218|NCT03688178|Temozolomide|temozolomide|mesh-list
101401219|NCT03688178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101401220|NCT03688178|Alkylating Agents|alkylating agents|mesh-ancestor
101401221|NCT03688178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401222|NCT03688178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101401230|NCT03678883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101306389|NCT02025348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306390|NCT02025348|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101306391|NCT02025348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101306392|NCT02025348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101306393|NCT02025348|Adrenergic Agents|adrenergic agents|mesh-ancestor
101306394|NCT02025348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101306395|NCT02025348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306396|NCT02025361|Lidocaine|lidocaine|mesh-list
101306397|NCT02025361|Anesthetics, Local|anesthetics, local|mesh-ancestor
101306398|NCT02025361|Anesthetics|anesthetics|mesh-ancestor
101401231|NCT03678883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101401232|NCT03678883|Tubulin Modulators|tubulin modulators|mesh-ancestor
101401233|NCT03678883|Antimitotic Agents|antimitotic agents|mesh-ancestor
101401234|NCT03678883|Mitosis Modulators|mitosis modulators|mesh-ancestor
101401235|NCT03678883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401236|NCT03678883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101401237|NCT03678883|Antimetabolites|antimetabolites|mesh-ancestor
101401238|NCT03678883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101401239|NCT03678883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101401240|NCT03678883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101401241|NCT03678883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101401242|NCT03678883|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101401243|NCT03678883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101401244|NCT03678883|Alkylating Agents|alkylating agents|mesh-ancestor
101401245|NCT03671109|Piperaquine|piperaquine|mesh-list
101401246|NCT03671109|Artenimol|artenimol|mesh-list
101401275|NCT03582774|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101401276|NCT03532399|Bivalirudin|bivalirudin|mesh-list
101401277|NCT03532399|Antithrombins|antithrombins|mesh-ancestor
101401278|NCT03532399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101401279|NCT03532399|Protease Inhibitors|protease inhibitors|mesh-ancestor
101401280|NCT03532399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101401281|NCT03532399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401282|NCT03532399|Anticoagulants|anticoagulants|mesh-ancestor
101401283|NCT03504956|Metoprolol|metoprolol|mesh-list
101401284|NCT03504956|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101401285|NCT03504956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101401286|NCT03504956|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101401287|NCT03504956|Sympatholytics|sympatholytics|mesh-ancestor
101401288|NCT03504956|Autonomic Agents|autonomic agents|mesh-ancestor
101401289|NCT03504956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101401290|NCT03504956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345206|NCT00021489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101401291|NCT03504956|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101401292|NCT03504956|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101401293|NCT03504956|Adrenergic Agents|adrenergic agents|mesh-ancestor
101401294|NCT03504956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102075817|NCT00141284|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102075818|NCT00141284|Protease Inhibitors|protease inhibitors|mesh-ancestor
102075819|NCT04328506|Vorolanib|vorolanib|mesh-list
102075820|NCT04328506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102075821|NCT04328506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102075822|NCT04328506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075823|NCT02125812|Moxifloxacin|moxifloxacin|mesh-list
102075824|NCT02125812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102075825|NCT02125812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102075826|NCT02125812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101377497|NCT00102843|Antimetabolites|antimetabolites|mesh-ancestor
101496840|NCT00461747|Bortezomib|bortezomib|mesh-list
101401295|NCT03504956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401296|NCT03464942|Atezolizumab|atezolizumab|mesh-list
101401297|NCT03464942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101401298|NCT03464942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401299|NCT03464942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101401300|NCT03464942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101401301|NCT03431831|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
101401302|NCT03431831|Naltrexone|naltrexone|mesh-list
101401303|NCT03431831|Bupropion|bupropion|mesh-list
101401304|NCT03431831|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101401305|NCT03431831|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101401306|NCT03431831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101401307|NCT03431831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401308|NCT03431831|Sensory System Agents|sensory system agents|mesh-ancestor
101401309|NCT03431831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101401313|NCT03431831|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101306402|NCT02025361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101306403|NCT02025361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101306404|NCT02025361|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101401314|NCT03431831|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101401315|NCT03431831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101401316|NCT03431831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401317|NCT03431831|Dopamine Agents|dopamine agents|mesh-ancestor
101401318|NCT03431831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101401319|NCT03431831|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101401320|NCT03431831|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101401321|NCT03431831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101401322|NCT03426891|Pembrolizumab|pembrolizumab|mesh-list
101401323|NCT03426891|Temozolomide|temozolomide|mesh-list
101401324|NCT03426891|Vorinostat|vorinostat|mesh-list
101401325|NCT03426891|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
101401326|NCT03426891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101401327|NCT03426891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101401328|NCT03426891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101401329|NCT03426891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401330|NCT03426891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101401331|NCT03426891|Alkylating Agents|alkylating agents|mesh-ancestor
101401332|NCT03426891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101401333|NCT03422536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101401334|NCT03422536|Cetuximab|cetuximab|mesh-list
101401335|NCT03422536|Antibodies|antibodies|mesh-list
101401336|NCT03422536|Immunoglobulins|immunoglobulins|mesh-list
101401337|NCT03422536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101401338|NCT03422536|Immunologic Factors|immunologic factors|mesh-ancestor
101401339|NCT03422536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401340|NCT03422536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101401341|NCT03397966|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101401342|NCT03397966|Natriuretic Agents|natriuretic agents|mesh-ancestor
101401343|NCT03397966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377507|NCT00245791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075827|NCT02125812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102075828|NCT02125812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102075829|NCT02125812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075830|NCT02125812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102075831|NCT02125890|Tranexamic Acid|tranexamic acid|mesh-list
102075832|NCT02125890|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102075833|NCT02125890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102075834|NCT02125890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075835|NCT02125890|Hemostatics|hemostatics|mesh-ancestor
101401344|NCT03382977|Carmustine|carmustine|mesh-list
101401345|NCT03382977|Lomustine|lomustine|mesh-list
101401346|NCT03382977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101401347|NCT03382977|Alkylating Agents|alkylating agents|mesh-ancestor
101401348|NCT03382977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401349|NCT03382977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101401350|NCT03358693|Infliximab|infliximab|mesh-list
101401351|NCT03358693|Upadacitinib|upadacitinib|mesh-list
101401352|NCT03358693|Ustekinumab|ustekinumab|mesh-list
101401353|NCT03358693|Ixekizumab|ixekizumab|mesh-list
101401354|NCT03358693|Brodalumab|brodalumab|mesh-list
101401355|NCT03358693|Abrocitinib|abrocitinib|mesh-list
101401356|NCT03358693|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101401357|NCT03358693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101401358|NCT03358693|Dermatologic Agents|dermatologic agents|mesh-ancestor
101401359|NCT03358693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101401360|NCT03358693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101401361|NCT03358693|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101401362|NCT03358693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101401363|NCT03358693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101401364|NCT03358693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401365|NCT03228394|Ganaxolone|ganaxolone|mesh-list
101401366|NCT03228394|Neurosteroids|neurosteroids|mesh-ancestor
101401367|NCT03228394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101401368|NCT03228394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401369|NCT03228394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401370|NCT03228394|GABA Modulators|gaba modulators|mesh-ancestor
101401371|NCT03228394|GABA Agents|gaba agents|mesh-ancestor
101401372|NCT03213977|Prednisone|prednisone|mesh-list
101401373|NCT03213977|Cyclophosphamide|cyclophosphamide|mesh-list
101401374|NCT03213977|Doxorubicin|doxorubicin|mesh-list
101401375|NCT03213977|Etoposide|etoposide|mesh-list
101401376|NCT03213977|Vincristine|vincristine|mesh-list
101345371|NCT00022581|Thalidomide|thalidomide|mesh-list
101306405|NCT02025361|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101306406|NCT02025361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101306411|NCT02025374|Anesthetics|anesthetics|mesh-ancestor
101306412|NCT02025374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101306413|NCT02025374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306414|NCT02025374|Sensory System Agents|sensory system agents|mesh-ancestor
101306415|NCT02025374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101306417|NCT02025465|Diltiazem|diltiazem|mesh-list
101306418|NCT02025465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101306419|NCT02025465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101306420|NCT02025465|Sympatholytics|sympatholytics|mesh-ancestor
101306421|NCT02025465|Autonomic Agents|autonomic agents|mesh-ancestor
101306422|NCT02025465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101306423|NCT02025465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306424|NCT02025465|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101306425|NCT02025465|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101188082|NCT04705818|Durvalumab|durvalumab|mesh-list
101401377|NCT03213977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101401378|NCT03213977|Immunologic Factors|immunologic factors|mesh-ancestor
101401379|NCT03213977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401380|NCT03213977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101401381|NCT03213977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101377518|NCT00400647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102075836|NCT02125890|Coagulants|coagulants|mesh-ancestor
102075837|NCT05433116|Pembrolizumab|pembrolizumab|mesh-list
102075838|NCT05433116|Lenvatinib|lenvatinib|mesh-list
102075839|NCT05433116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102075840|NCT05433116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102075841|NCT05433116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102075842|NCT05433116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075843|NCT05433116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102075844|NCT05433116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102075845|NCT05287984|Cyclophosphamide|cyclophosphamide|mesh-list
101401382|NCT03213977|Alkylating Agents|alkylating agents|mesh-ancestor
101401403|NCT03043872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101401404|NCT03043872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101401405|NCT03043872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101401406|NCT03043872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101401407|NCT03043872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101401408|NCT03043872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401409|NCT03043872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101401410|NCT02978625|Nivolumab|nivolumab|mesh-list
101401411|NCT02978625|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
101401412|NCT02978625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101401413|NCT02978625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101401414|NCT02978625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101401415|NCT02978625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401416|NCT02956447|Hormones|hormones|mesh-list
101401417|NCT02956447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101401418|NCT02956447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401419|NCT02953834|Insulin|insulin|mesh-list
101401420|NCT02953834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101401421|NCT02953834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401422|NCT02849639|Scopolamine|scopolamine|mesh-list
101401423|NCT02849639|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101401424|NCT02849639|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101401425|NCT02849639|Antiemetics|antiemetics|mesh-ancestor
101401426|NCT02849639|Autonomic Agents|autonomic agents|mesh-ancestor
101306426|NCT02025465|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101306427|NCT02025465|Adrenergic Agents|adrenergic agents|mesh-ancestor
101306428|NCT02025465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101401427|NCT02849639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101401428|NCT02849639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401429|NCT02849639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101401430|NCT02849639|Mydriatics|mydriatics|mesh-ancestor
101401431|NCT02849639|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101401432|NCT02849639|Cholinergic Agents|cholinergic agents|mesh-ancestor
101401433|NCT02849639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101401434|NCT02849639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401435|NCT02849639|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101401436|NCT02849639|Parasympatholytics|parasympatholytics|mesh-ancestor
101401447|NCT02594384|Immunologic Factors|immunologic factors|mesh-ancestor
101401448|NCT02594384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401449|NCT02594384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101401450|NCT02594384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101401451|NCT02594384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401452|NCT02592707|Dexamethasone|dexamethasone|mesh-list
101401453|NCT02592707|Ondansetron|ondansetron|mesh-list
101401454|NCT02592707|Antiemetics|antiemetics|mesh-list
101306429|NCT02025465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306431|NCT02025465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101401510|NCT02310321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101401511|NCT02310321|Antimetabolites|antimetabolites|mesh-ancestor
101401512|NCT02310321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075846|NCT05287984|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102075848|NCT05287984|Fludarabine|fludarabine|mesh-list
102075849|NCT05287984|Zanubrutinib|zanubrutinib|mesh-list
102075850|NCT05287984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102075851|NCT05287984|Immunologic Factors|immunologic factors|mesh-ancestor
102075852|NCT05287984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075853|NCT05287984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102075854|NCT05287984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102075855|NCT05287984|Alkylating Agents|alkylating agents|mesh-ancestor
101401513|NCT02310321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101401514|NCT02310321|Antiviral Agents|antiviral agents|mesh-ancestor
101401515|NCT02310321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101401516|NCT02310321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101401517|NCT02310321|Immunologic Factors|immunologic factors|mesh-ancestor
101401518|NCT02310321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401519|NCT02310321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101401520|NCT02310321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101401521|NCT02310321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101401522|NCT02310321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101401523|NCT02288247|Prednisolone|prednisolone|mesh-list
101401525|NCT02288247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101198150|NCT01395433|Autonomic Agents|autonomic agents|mesh-ancestor
101345489|NCT02971878|Acetylcarnitine|acetylcarnitine|mesh-list
101401529|NCT02288247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401531|NCT02288247|Glucocorticoids|glucocorticoids|mesh-ancestor
101401532|NCT02288247|Hormones|hormones|mesh-ancestor
101401533|NCT02288247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101401534|NCT02288247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401535|NCT02288247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101401536|NCT02275533|Nivolumab|nivolumab|mesh-list
101401537|NCT02275533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101401538|NCT02275533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101401539|NCT02275533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101401540|NCT02275533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401541|NCT02108964|Nazartinib|nazartinib|mesh-list
101401542|NCT02108964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101401543|NCT01952782|Naloxone|naloxone|mesh-list
101401544|NCT01952782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401545|NCT01952782|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101401546|NCT01952782|Sensory System Agents|sensory system agents|mesh-ancestor
101401547|NCT01952782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101401548|NCT01423812|Ritonavir|ritonavir|mesh-list
101401549|NCT01423812|Darunavir|darunavir|mesh-list
101401550|NCT01423812|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101401551|NCT01423812|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101401552|NCT01423812|Protease Inhibitors|protease inhibitors|mesh-ancestor
101401553|NCT01423812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101401554|NCT01423812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401555|NCT01423812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101401556|NCT01423812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101401557|NCT01423812|Antiviral Agents|antiviral agents|mesh-ancestor
101401558|NCT01423812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101401559|NCT01423812|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101401560|NCT01423812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101401561|NCT01291719|Insulin|insulin|mesh-list
101401562|NCT01291719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101401563|NCT01291719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401564|NCT01176474|Nivolumab|nivolumab|mesh-list
101401565|NCT01176474|Ipilimumab|ipilimumab|mesh-list
101401566|NCT01176474|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101401567|NCT01176474|Immunologic Factors|immunologic factors|mesh-ancestor
101401568|NCT01176474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401569|NCT01176474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101401570|NCT01176474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101401571|NCT01176474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101401572|NCT01176474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075856|NCT05287984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075858|NCT05287984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102075859|NCT05287984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102075860|NCT05287984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102075861|NCT05287984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102075862|NCT00134264|Atorvastatin|atorvastatin|mesh-list
102075863|NCT00134264|Torcetrapib|torcetrapib|mesh-list
102075864|NCT00134264|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102075865|NCT00134264|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102075866|NCT00134264|Antimetabolites|antimetabolites|mesh-ancestor
102075867|NCT00134264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075868|NCT00134264|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102075869|NCT00134264|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102075870|NCT00134264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102075871|NCT05285800|Bupivacaine|bupivacaine|mesh-list
102075872|NCT05285800|Anesthetics, Local|anesthetics, local|mesh-ancestor
102075873|NCT05285800|Anesthetics|anesthetics|mesh-ancestor
102075874|NCT05285800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102075875|NCT05285800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345624|NCT00023751|Fluorouracil|fluorouracil|mesh-list
102075876|NCT05285800|Sensory System Agents|sensory system agents|mesh-ancestor
102075877|NCT05285800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102075878|NCT02122692|Itraconazole|itraconazole|mesh-list
102075879|NCT02122692|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
102075880|NCT02122692|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
102075881|NCT02122692|Antifungal Agents|antifungal agents|mesh-ancestor
101377536|NCT00246103|Cyclophosphamide|cyclophosphamide|mesh-list
101401573|NCT01176474|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101401574|NCT01141309|Everolimus|everolimus|mesh-list
101401575|NCT01141309|Sorafenib|sorafenib|mesh-list
101401576|NCT01141309|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101306432|NCT02025465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101306433|NCT02025465|Vasodilator Agents|vasodilator agents|mesh-ancestor
101306435|NCT02025491|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101401577|NCT01141309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101401582|NCT01141309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401583|NCT01141309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101401585|NCT00914823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101401586|NCT00914823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401587|NCT00859781|Ketoconazole|ketoconazole|mesh-list
101401588|NCT00859781|Hydrocortisone|hydrocortisone|mesh-list
101401589|NCT00859781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101401590|NCT00859781|Antifungal Agents|antifungal agents|mesh-ancestor
101401591|NCT00859781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102075882|NCT02122692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102075883|NCT02122692|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102075884|NCT02122692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102075885|NCT02122692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102075886|NCT02122692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075887|NCT02122692|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102075888|NCT02122692|Hormone Antagonists|hormone antagonists|mesh-ancestor
102075889|NCT02122692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102075890|NCT02122692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075891|NCT02122692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102075892|NCT02122692|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102075893|NCT02122692|Serotonin Agents|serotonin agents|mesh-ancestor
102075894|NCT02122692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102075895|NCT00131924|Estrogens|estrogens|mesh-list
102075896|NCT00131924|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
102075897|NCT00131924|Hormones|hormones|mesh-ancestor
101401592|NCT00859781|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101401593|NCT00859781|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101401594|NCT00859781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101401595|NCT00859781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401596|NCT00859781|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101401597|NCT00859781|Hormone Antagonists|hormone antagonists|mesh-ancestor
101401602|NCT00792740|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101345635|NCT00023751|Antidotes|antidotes|mesh-ancestor
101401604|NCT00792740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401606|NCT00729300|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101401607|NCT00729300|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
101401608|NCT00729300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101401609|NCT00729300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401610|NCT00099086|Docetaxel|docetaxel|mesh-list
101401611|NCT00099086|Leuprolide|leuprolide|mesh-list
101401612|NCT00099086|Goserelin|goserelin|mesh-list
101401613|NCT00099086|Bicalutamide|bicalutamide|mesh-list
101401614|NCT00099086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101401615|NCT00099086|Tubulin Modulators|tubulin modulators|mesh-ancestor
101401616|NCT00099086|Antimitotic Agents|antimitotic agents|mesh-ancestor
101401617|NCT00099086|Mitosis Modulators|mitosis modulators|mesh-ancestor
101401618|NCT00099086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401619|NCT00099086|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101401620|NCT00099086|Fertility Agents|fertility agents|mesh-ancestor
101401621|NCT00099086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101401622|NCT00099086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401623|NCT00099086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101401624|NCT00099086|Androgen Antagonists|androgen antagonists|mesh-ancestor
101401625|NCT00099086|Hormone Antagonists|hormone antagonists|mesh-ancestor
101401626|NCT00099086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101401627|NCT00856947|Vitamin D|vitamin d|mesh-list
101401628|NCT00856947|Cholecalciferol|cholecalciferol|mesh-list
101401629|NCT00856947|Vitamins|vitamins|mesh-ancestor
101401630|NCT00856947|Micronutrients|micronutrients|mesh-ancestor
101401631|NCT00856947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401632|NCT00856947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101401633|NCT00856947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101401634|NCT00655993|Simvastatin|simvastatin|mesh-list
101401635|NCT00655993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101401636|NCT00655993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101377580|NCT00067535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102075898|NCT00131924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102075899|NCT00131924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075901|NCT05284474|Mitosis Modulators|mitosis modulators|mesh-ancestor
102075902|NCT05284474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075903|NCT05609695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102075904|NCT05609695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075905|NCT05609695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102075906|NCT05609695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102075907|NCT04246060|Cysteamine|cysteamine|mesh-list
102075908|NCT04246060|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
102075909|NCT04246060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075910|NCT05129176|Metronidazole|metronidazole|mesh-list
102075911|NCT05129176|Levofloxacin|levofloxacin|mesh-list
101401637|NCT00655993|Antimetabolites|antimetabolites|mesh-ancestor
101401638|NCT00655993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401639|NCT00655993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101401640|NCT00655993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101401641|NCT00655993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101401642|NCT00567580|Leuprolide|leuprolide|mesh-list
101401643|NCT00567580|Goserelin|goserelin|mesh-list
101401644|NCT00567580|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101401645|NCT00567580|Flutamide|flutamide|mesh-list
101401646|NCT00567580|Bicalutamide|bicalutamide|mesh-list
101401647|NCT00567580|Buserelin|buserelin|mesh-list
101456565|NCT00216827|Hormones|hormones|mesh-ancestor
101306436|NCT02025491|Amebicides|amebicides|mesh-ancestor
101306437|NCT02025491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101306438|NCT02025491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101306439|NCT02025491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101306440|NCT02025491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101306441|NCT02025491|Antifungal Agents|antifungal agents|mesh-ancestor
101401652|NCT00567580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101401653|NCT00567580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101401654|NCT00567580|Androgen Antagonists|androgen antagonists|mesh-ancestor
101401655|NCT00567580|Hormone Antagonists|hormone antagonists|mesh-ancestor
101401656|NCT00567580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101401657|NCT00567580|Luteolytic Agents|luteolytic agents|mesh-ancestor
101401658|NCT00567580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101401659|NCT00567580|Contraceptive Agents|contraceptive agents|mesh-ancestor
101401660|NCT00567580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101401661|NCT00125151|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
101401662|NCT00125151|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101401663|NCT00125151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101401664|NCT00125151|Immunologic Factors|immunologic factors|mesh-ancestor
101401673|NCT00087815|Glucocorticoids|glucocorticoids|mesh-ancestor
101401674|NCT00087815|Hormones|hormones|mesh-ancestor
101401675|NCT00087815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101401676|NCT00087815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101401677|NCT00087815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101401678|NCT00087854|Amonafide|amonafide|mesh-list
101401679|NCT00087854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101401680|NCT00087854|Antiviral Agents|antiviral agents|mesh-ancestor
101401681|NCT00087854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101401682|NCT00087854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101401683|NCT00087854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401684|NCT04715620|Niraparib|niraparib|mesh-list
102075912|NCT05129176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102075913|NCT05129176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102075914|NCT05129176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102075915|NCT05129176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102075916|NCT05129176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101377598|NCT00102882|Dermatologic Agents|dermatologic agents|mesh-ancestor
101401685|NCT04715620|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101401686|NCT04715620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101401687|NCT04715620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401688|NCT04715620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101401690|NCT00125229|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101401691|NCT00125229|Diuretics|diuretics|mesh-ancestor
101401692|NCT00125229|Natriuretic Agents|natriuretic agents|mesh-ancestor
101401693|NCT00125229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401694|NCT00126906|Pyrimethamine|pyrimethamine|mesh-list
101401695|NCT00126906|Sulfadoxine|sulfadoxine|mesh-list
101401696|NCT00126906|Antimalarials|antimalarials|mesh-ancestor
101401697|NCT00126906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101401698|NCT00126906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101401699|NCT00126906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101401700|NCT00126906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101401701|NCT00126906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101401702|NCT00126906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401703|NCT00126906|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101401704|NCT00088049|Olanzapine|olanzapine|mesh-list
101401705|NCT00088049|Aripiprazole|aripiprazole|mesh-list
101401706|NCT00088049|Antiemetics|antiemetics|mesh-ancestor
101401707|NCT00088049|Autonomic Agents|autonomic agents|mesh-ancestor
101401708|NCT00088049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101401709|NCT00088049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401710|NCT00088049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101401711|NCT00088049|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101401712|NCT00088049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101401713|NCT00088049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101401714|NCT00088049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101401715|NCT00088049|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101401716|NCT00088049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101401717|NCT00088049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101401726|NCT00088049|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101401727|NCT00088049|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101401728|NCT00088049|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101401729|NCT00088049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101401730|NCT00088088|Paclitaxel|paclitaxel|mesh-list
101401731|NCT00088088|Carboplatin|carboplatin|mesh-list
101401732|NCT00088088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101401733|NCT00088088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101401734|NCT00088088|Tubulin Modulators|tubulin modulators|mesh-ancestor
101401735|NCT00088088|Antimitotic Agents|antimitotic agents|mesh-ancestor
101401736|NCT00088088|Mitosis Modulators|mitosis modulators|mesh-ancestor
101401737|NCT00088088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401738|NCT00125307|Tacrolimus|tacrolimus|mesh-list
101401739|NCT00125307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101401740|NCT00125307|Immunologic Factors|immunologic factors|mesh-ancestor
101401741|NCT00125307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401747|NCT00127023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401748|NCT00332761|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
101401749|NCT00332761|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101401750|NCT00332761|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101401751|NCT00332761|Antimetabolites|antimetabolites|mesh-ancestor
101401752|NCT00332761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401753|NCT00332761|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101401754|NCT00332761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101401755|NCT00332761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101401756|NCT00332761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101401757|NCT00332761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101401758|NCT00332761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401759|NCT00332761|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101377599|NCT00102882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102075917|NCT05129176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102075918|NCT05129176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102075919|NCT05129176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102075920|NCT05129176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075921|NCT05129176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102075922|NCT05129176|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102075923|NCT05129176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102075924|NCT02127684|Ranibizumab|ranibizumab|mesh-list
102075925|NCT02127684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101377606|NCT00102882|Glucocorticoids|glucocorticoids|mesh-ancestor
101401760|NCT00332761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101401762|NCT00332995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101401763|NCT00332995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101401764|NCT00332995|Antiviral Agents|antiviral agents|mesh-ancestor
101401765|NCT00332995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101401766|NCT00333034|Etanercept|etanercept|mesh-list
101401767|NCT00333034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101401768|NCT00333034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101401769|NCT00333034|Analgesics|analgesics|mesh-ancestor
101401770|NCT00333034|Sensory System Agents|sensory system agents|mesh-ancestor
101401771|NCT00333034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101401772|NCT00333034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401773|NCT00333034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101401774|NCT00333034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101401775|NCT00333034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101401776|NCT00333034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101401777|NCT00333034|Immunologic Factors|immunologic factors|mesh-ancestor
101401778|NCT00088478|Olanzapine|olanzapine|mesh-list
101401779|NCT00088478|Antiemetics|antiemetics|mesh-ancestor
101401780|NCT00088478|Autonomic Agents|autonomic agents|mesh-ancestor
101401781|NCT00088478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101401782|NCT00088478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401783|NCT00088478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101401784|NCT00088478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101401789|NCT00088478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101401790|NCT00088478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101401791|NCT00088478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401792|NCT00088478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101401793|NCT00088478|Serotonin Agents|serotonin agents|mesh-ancestor
101401794|NCT00125346|Tobramycin|tobramycin|mesh-list
101401795|NCT00125346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101401796|NCT00125346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101401797|NCT00333112|Tamsulosin|tamsulosin|mesh-list
101401798|NCT00333112|Solifenacin Succinate|solifenacin succinate|mesh-list
101401799|NCT00333112|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101401800|NCT00333112|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101306443|NCT02025608|Antioxidants|antioxidants|mesh-ancestor
101306444|NCT02025608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401801|NCT00333112|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101401802|NCT00333112|Adrenergic Agents|adrenergic agents|mesh-ancestor
101401803|NCT00333112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101401804|NCT00333112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401805|NCT00333112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401806|NCT00333112|Urological Agents|urological agents|mesh-ancestor
101401807|NCT00333112|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101401808|NCT00333112|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101401809|NCT00333112|Cholinergic Agents|cholinergic agents|mesh-ancestor
101401810|NCT00333151|Metformin|metformin|mesh-list
101401811|NCT00333151|Liraglutide|liraglutide|mesh-list
101401812|NCT00333151|Rosiglitazone|rosiglitazone|mesh-list
101401813|NCT00333151|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101401814|NCT00333151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377609|NCT00102882|Sympathomimetics|sympathomimetics|mesh-ancestor
102075926|NCT02127684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102075927|NCT02127684|Growth Substances|growth substances|mesh-ancestor
102075928|NCT02127684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075929|NCT02127684|Growth Inhibitors|growth inhibitors|mesh-ancestor
102075930|NCT02127684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102075931|NCT02126358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102075932|NCT02126358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102075933|NCT02126358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101401818|NCT00125385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101401819|NCT00125385|Immunologic Factors|immunologic factors|mesh-ancestor
101401820|NCT00125385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401821|NCT00088556|Paclitaxel|paclitaxel|mesh-list
101401822|NCT00088556|Carboplatin|carboplatin|mesh-list
101401823|NCT00088556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101401824|NCT00088556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101401825|NCT00088556|Tubulin Modulators|tubulin modulators|mesh-ancestor
101401826|NCT00088556|Antimitotic Agents|antimitotic agents|mesh-ancestor
101401827|NCT00088556|Mitosis Modulators|mitosis modulators|mesh-ancestor
101401828|NCT00088556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401829|NCT00127140|Vorinostat|vorinostat|mesh-list
101401830|NCT00127140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101401831|NCT00127140|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101401832|NCT00127140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101401833|NCT00127140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401834|NCT00333307|Methocarbamol|methocarbamol|mesh-list
101401835|NCT00333307|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101401836|NCT00333307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401837|NCT00333307|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101401838|NCT00333307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101401839|NCT00125424|Midazolam|midazolam|mesh-list
101401840|NCT00125424|Fospropofol|fospropofol|mesh-list
101401841|NCT00125424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101401842|NCT00125424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101401843|NCT00125424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101401844|NCT00125424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401845|NCT00125424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101401846|NCT00125424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101401847|NCT00125424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101401848|NCT00125424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101401849|NCT00125424|Anesthetics, General|anesthetics, general|mesh-ancestor
101401850|NCT00125424|Anesthetics|anesthetics|mesh-ancestor
101401851|NCT00125424|GABA Modulators|gaba modulators|mesh-ancestor
101401852|NCT00125424|GABA Agents|gaba agents|mesh-ancestor
101401853|NCT00125424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101401854|NCT00125424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401855|NCT00333346|Tramadol|tramadol|mesh-list
101401856|NCT00333346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101401860|NCT00333346|Analgesics|analgesics|mesh-ancestor
101401861|NCT00333346|Sensory System Agents|sensory system agents|mesh-ancestor
101401862|NCT00333346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101401863|NCT00333385|Ceftazidime|ceftazidime|mesh-list
101401864|NCT00333385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101401865|NCT00333385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101401866|NCT00127257|Diazepam|diazepam|mesh-list
101401867|NCT00127257|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101401868|NCT00127257|Anticonvulsants|anticonvulsants|mesh-ancestor
101401869|NCT00127257|Antiemetics|antiemetics|mesh-ancestor
101401870|NCT00127257|Autonomic Agents|autonomic agents|mesh-ancestor
101401871|NCT00127257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101401872|NCT00127257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401873|NCT00127257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101401874|NCT00127257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101401875|NCT00127257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101306445|NCT02025608|Protective Agents|protective agents|mesh-ancestor
101306446|NCT02025608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306447|NCT02025608|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102075935|NCT02126358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075936|NCT02126358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102075937|NCT02126358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102075938|NCT02126358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102075939|NCT02127840|Epinephrine|epinephrine|mesh-list
102075940|NCT02127840|Racepinephrine|racepinephrine|mesh-list
102075941|NCT02127840|Epinephryl borate|epinephryl borate|mesh-list
101377614|NCT00246220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101401876|NCT00127257|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101401877|NCT00127257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101401878|NCT00127257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101401879|NCT00127257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101401880|NCT00127257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101401881|NCT00127257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101401882|NCT00127257|Anesthetics, General|anesthetics, general|mesh-ancestor
101401884|NCT00127257|GABA Modulators|gaba modulators|mesh-ancestor
101401885|NCT00127257|GABA Agents|gaba agents|mesh-ancestor
101401886|NCT00127257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101401887|NCT00127257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401888|NCT00333424|Vaccines|vaccines|mesh-list
101401889|NCT00333424|Immunologic Factors|immunologic factors|mesh-ancestor
101198501|NCT05268627|Hormones|hormones|mesh-ancestor
101401898|NCT00088946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101401899|NCT00088946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101401900|NCT00088946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101401901|NCT00088946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401903|NCT00421018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101401904|NCT00421018|Respiratory System Agents|respiratory system agents|mesh-ancestor
101401905|NCT00421018|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101401906|NCT00421018|Hormone Antagonists|hormone antagonists|mesh-ancestor
101401907|NCT00421018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101401908|NCT00421018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401909|NCT00421018|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101401910|NCT00421018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101401911|NCT00421018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401912|NCT00421096|Gemcitabine|gemcitabine|mesh-list
101401913|NCT00421096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101401914|NCT00421096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101401915|NCT00421096|Antimetabolites|antimetabolites|mesh-ancestor
101401916|NCT00421096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401917|NCT00089063|Sargramostim|sargramostim|mesh-list
101401918|NCT00089063|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101401919|NCT00089063|Freund's Adjuvant|freund's adjuvant|mesh-list
101401920|NCT00089063|Immunologic Factors|immunologic factors|mesh-ancestor
101401921|NCT00089063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401922|NCT00089063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101401923|NCT00333931|Phenytoin|phenytoin|mesh-list
101401924|NCT00333931|Anticonvulsants|anticonvulsants|mesh-ancestor
101401925|NCT00333931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101401926|NCT00333931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101401927|NCT00333931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101401931|NCT00334048|Ropinirole|ropinirole|mesh-list
101401932|NCT00334048|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101401933|NCT00334048|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101346022|NCT00025545|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101346023|NCT00025545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101401934|NCT00334048|Dopamine Agonists|dopamine agonists|mesh-ancestor
101401935|NCT00334048|Dopamine Agents|dopamine agents|mesh-ancestor
101401936|NCT00334048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101401937|NCT00334048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401938|NCT00334048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401939|NCT00334126|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101401940|NCT00334126|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101401941|NCT00334126|Antidepressive Agents|antidepressive agents|mesh-ancestor
101401942|NCT00334126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102075942|NCT02127840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102075944|NCT02127840|Adrenergic Agents|adrenergic agents|mesh-ancestor
102075945|NCT02127840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102075946|NCT02127840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075947|NCT02127840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075948|NCT02127840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102075949|NCT02127840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102075950|NCT02127840|Autonomic Agents|autonomic agents|mesh-ancestor
102075951|NCT02127840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102075952|NCT02127840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101401943|NCT00334126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101401944|NCT00334126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101401945|NCT00334126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101401946|NCT00334126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306448|NCT02025608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101306449|NCT02025608|Dopamine Agonists|dopamine agonists|mesh-ancestor
101306450|NCT02025608|Dopamine Agents|dopamine agents|mesh-ancestor
101306451|NCT02025608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101306453|NCT02025712|Exemestane|exemestane|mesh-list
101306454|NCT02025712|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101306455|NCT02025712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101306456|NCT02025712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101306457|NCT02025712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306458|NCT02025712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101401947|NCT00334126|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101401951|NCT00334126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401953|NCT00334126|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101401954|NCT00334126|Dopamine Agents|dopamine agents|mesh-ancestor
101401955|NCT00089219|Sargramostim|sargramostim|mesh-list
101401956|NCT00089219|Freund's Adjuvant|freund's adjuvant|mesh-list
101401957|NCT00089219|Immunologic Factors|immunologic factors|mesh-ancestor
101401958|NCT00089219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401959|NCT00089219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101401960|NCT00334321|Paclitaxel|paclitaxel|mesh-list
101401961|NCT00334321|Carboplatin|carboplatin|mesh-list
101401962|NCT00334321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101401963|NCT00334321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101401964|NCT00334321|Tubulin Modulators|tubulin modulators|mesh-ancestor
101401965|NCT00334321|Antimitotic Agents|antimitotic agents|mesh-ancestor
101401966|NCT00334321|Mitosis Modulators|mitosis modulators|mesh-ancestor
101401967|NCT00334321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401968|NCT00334360|Dexmedetomidine|dexmedetomidine|mesh-list
101401969|NCT00334360|Buspirone|buspirone|mesh-list
101401970|NCT00334360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101401971|NCT00334360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101401972|NCT00334360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401973|NCT00334360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101401974|NCT00334360|Analgesics|analgesics|mesh-ancestor
101401975|NCT00334360|Sensory System Agents|sensory system agents|mesh-ancestor
101401976|NCT00334360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101401977|NCT00334360|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101401978|NCT00334360|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101401979|NCT00334360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101401980|NCT00334360|Adrenergic Agents|adrenergic agents|mesh-ancestor
101401981|NCT00334360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101401982|NCT00334360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401983|NCT00334360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101401984|NCT00334360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101401985|NCT00334360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101401986|NCT00334360|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101401987|NCT00334360|Serotonin Agents|serotonin agents|mesh-ancestor
101401988|NCT00334399|Miglitol|miglitol|mesh-list
102075953|NCT02127840|Respiratory System Agents|respiratory system agents|mesh-ancestor
102075954|NCT02127840|Mydriatics|mydriatics|mesh-ancestor
102075955|NCT02127840|Sympathomimetics|sympathomimetics|mesh-ancestor
102075956|NCT02127840|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102075957|NCT05031442|Zinc Oxide|zinc oxide|mesh-list
102075958|NCT05031442|Dermatologic Agents|dermatologic agents|mesh-ancestor
102075959|NCT05031442|Sunscreening Agents|sunscreening agents|mesh-ancestor
102075960|NCT05031442|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101401989|NCT00334399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101401990|NCT00334399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401991|NCT00334399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101401992|NCT00334399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401993|NCT00334399|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101401994|NCT00334438|Rituximab|rituximab|mesh-list
101401995|NCT00334438|Bortezomib|bortezomib|mesh-list
101401996|NCT00334438|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101401997|NCT00334438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101401998|NCT00334438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402006|NCT00334477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101402007|NCT00334477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306459|NCT02025712|Immunologic Factors|immunologic factors|mesh-ancestor
101306460|NCT02025712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402008|NCT00334477|Urological Agents|urological agents|mesh-ancestor
101402009|NCT04715269|Alprazolam|alprazolam|mesh-list
101402010|NCT04715269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101402011|NCT04715269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101402012|NCT04715269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402013|NCT04715269|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101402014|NCT04715269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101402015|NCT04715269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101402016|NCT04715269|GABA Modulators|gaba modulators|mesh-ancestor
101402017|NCT04715269|GABA Agents|gaba agents|mesh-ancestor
101402018|NCT04715269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101402019|NCT04715269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402020|NCT00125541|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
101402021|NCT00125541|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101402022|NCT00125541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101402023|NCT00125541|Immunologic Factors|immunologic factors|mesh-ancestor
101402028|NCT00089258|Sargramostim|sargramostim|mesh-list
101402029|NCT00089258|Immunologic Factors|immunologic factors|mesh-ancestor
101402030|NCT00089258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402031|NCT00089258|Dermatologic Agents|dermatologic agents|mesh-ancestor
101402032|NCT00127569|Rituximab|rituximab|mesh-list
101402033|NCT00127569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101402034|NCT00127569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402035|NCT00127569|Immunologic Factors|immunologic factors|mesh-ancestor
101402036|NCT00127569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402037|NCT00127569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101402038|NCT00334594|Pemetrexed|pemetrexed|mesh-list
101402039|NCT00334594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402040|NCT00334594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101402041|NCT00334594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402042|NCT00334594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101402043|NCT00334594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101402044|NCT00334672|Cyclosporine|cyclosporine|mesh-list
101402045|NCT00334672|Mycophenolic Acid|mycophenolic acid|mesh-list
101402046|NCT00334672|Dexamethasone|dexamethasone|mesh-list
101402047|NCT00334672|Hydrocortisone|hydrocortisone|mesh-list
101402048|NCT00334672|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101402049|NCT00334672|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101402050|NCT00334672|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101402051|NCT00334672|Cyclophosphamide|cyclophosphamide|mesh-list
101402052|NCT00334672|Busulfan|busulfan|mesh-list
101402053|NCT00334672|Methotrexate|methotrexate|mesh-list
101402054|NCT00334672|Etoposide|etoposide|mesh-list
101402055|NCT00334672|Cyclosporins|cyclosporins|mesh-list
101402056|NCT00334672|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101402057|NCT00334672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101402058|NCT00334672|Immunologic Factors|immunologic factors|mesh-ancestor
101497599|NCT00491634|Busulfan|busulfan|mesh-list
102075961|NCT05031442|Protective Agents|protective agents|mesh-ancestor
102075962|NCT05031442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075963|NCT02127918|Clobazam|clobazam|mesh-list
102075964|NCT02127918|Anticonvulsants|anticonvulsants|mesh-ancestor
102075965|NCT02127918|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102075966|NCT02127918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102075967|NCT02127918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102075968|NCT02127918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402059|NCT00334672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402060|NCT00334672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101402061|NCT00334672|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101402062|NCT00334672|Alkylating Agents|alkylating agents|mesh-ancestor
101402063|NCT00334672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402064|NCT00334672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402065|NCT00334672|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101402066|NCT00334672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101402067|NCT00334672|Antiemetics|antiemetics|mesh-ancestor
101402073|NCT00334672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101402075|NCT00334672|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101402076|NCT00334672|Abortifacient Agents|abortifacient agents|mesh-ancestor
101402077|NCT00334672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101402078|NCT00334672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101402079|NCT00334672|Antimetabolites|antimetabolites|mesh-ancestor
101402080|NCT00334672|Dermatologic Agents|dermatologic agents|mesh-ancestor
101402081|NCT00334672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101402082|NCT00334672|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101402083|NCT00334672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101306461|NCT02025712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101306462|NCT02025712|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101306463|NCT02025712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101402084|NCT00334672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101402085|NCT00334672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101402086|NCT00334672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101402087|NCT00334672|Antifungal Agents|antifungal agents|mesh-ancestor
101402088|NCT00334672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101346360|NCT00027885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101402089|NCT00334672|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101402090|NCT00334672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101402091|NCT00334672|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101402092|NCT00334672|Antitubercular Agents|antitubercular agents|mesh-ancestor
101402093|NCT00334672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101402094|NCT00089453|Dexamethasone|dexamethasone|mesh-list
101402095|NCT00089453|Cyclophosphamide|cyclophosphamide|mesh-list
101402096|NCT00089453|Melphalan|melphalan|mesh-list
101402097|NCT00089453|Fludarabine|fludarabine|mesh-list
101402098|NCT00089453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101198712|NCT05274191|Maleic acid|maleic acid|mesh-list
101402103|NCT00089453|Alkylating Agents|alkylating agents|mesh-ancestor
101402104|NCT00089453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402105|NCT00089453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402106|NCT00089453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101402107|NCT00089453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101402109|NCT00089453|Autonomic Agents|autonomic agents|mesh-ancestor
101402110|NCT00089453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101402111|NCT00089453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101402112|NCT00089453|Glucocorticoids|glucocorticoids|mesh-ancestor
101402113|NCT00089453|Hormones|hormones|mesh-ancestor
101402114|NCT00089453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101402115|NCT00089453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101402116|NCT00089492|Enfuvirtide|enfuvirtide|mesh-list
101402117|NCT00089492|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101402118|NCT00089492|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101402119|NCT00089492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402120|NCT00089492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101402121|NCT00089492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102075969|NCT02127918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102075970|NCT02127918|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
102075971|NCT02127918|GABA Agonists|gaba agonists|mesh-ancestor
102075972|NCT02127918|GABA Agents|gaba agents|mesh-ancestor
102075973|NCT02127918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102075974|NCT02127918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102075975|NCT00127634|Insulin|insulin|mesh-list
102075976|NCT00127634|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102075977|NCT00127634|Insulin Glargine|insulin glargine|mesh-list
101402122|NCT00089492|Antiviral Agents|antiviral agents|mesh-ancestor
101402123|NCT00089492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101402124|NCT00127686|Dextromethorphan|dextromethorphan|mesh-list
101402125|NCT00127686|Antitussive Agents|antitussive agents|mesh-ancestor
101402126|NCT00127686|Respiratory System Agents|respiratory system agents|mesh-ancestor
101402127|NCT00127686|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101402128|NCT00127686|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101402129|NCT00127686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101402130|NCT00127686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402131|NCT00127686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402132|NCT00334789|Vitamin A|vitamin a|mesh-list
101402133|NCT00334789|Tretinoin|tretinoin|mesh-list
101402134|NCT00334789|Belinostat|belinostat|mesh-list
101402135|NCT00334789|Isotretinoin|isotretinoin|mesh-list
101402136|NCT00334789|Vitamins|vitamins|mesh-ancestor
101402140|NCT00334789|Keratolytic Agents|keratolytic agents|mesh-ancestor
101402141|NCT00334789|Dermatologic Agents|dermatologic agents|mesh-ancestor
101402142|NCT00334789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402143|NCT00334789|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101402144|NCT00334789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101402145|NCT00334867|Cyclophosphamide|cyclophosphamide|mesh-list
101402146|NCT00334867|Ifosfamide|ifosfamide|mesh-list
101402147|NCT00334867|Doxorubicin|doxorubicin|mesh-list
101402148|NCT00334867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101402149|NCT00334867|Etoposide|etoposide|mesh-list
101402150|NCT00334867|Vincristine|vincristine|mesh-list
101402151|NCT00334867|Topotecan|topotecan|mesh-list
101402152|NCT00334867|Dexrazoxane|dexrazoxane|mesh-list
101402153|NCT00334867|Razoxane|razoxane|mesh-list
101402154|NCT00334867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101402155|NCT00334867|Immunologic Factors|immunologic factors|mesh-ancestor
101306465|NCT02025712|Hormone Antagonists|hormone antagonists|mesh-ancestor
101306466|NCT02025712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101402156|NCT00334867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402157|NCT00334867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101402158|NCT00334867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101402159|NCT00334867|Alkylating Agents|alkylating agents|mesh-ancestor
101402160|NCT00334867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402161|NCT00334867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402162|NCT00334867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101402163|NCT00334867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101402164|NCT00334867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101402165|NCT00334867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101402166|NCT00334867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101402167|NCT00334867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101402168|NCT00334867|Tubulin Modulators|tubulin modulators|mesh-ancestor
101402169|NCT00334867|Antimitotic Agents|antimitotic agents|mesh-ancestor
101402177|NCT04715152|BB 1101|bb 1101|mesh-list
101402178|NCT04715152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101402179|NCT04715152|Antiemetics|antiemetics|mesh-ancestor
101402180|NCT04715152|Autonomic Agents|autonomic agents|mesh-ancestor
101402181|NCT04715152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101402182|NCT04715152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402183|NCT04715152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101402184|NCT04715152|Glucocorticoids|glucocorticoids|mesh-ancestor
101402185|NCT04715152|Hormones|hormones|mesh-ancestor
101402186|NCT04715152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101402187|NCT04715152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101377652|NCT00424801|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102075978|NCT00127634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102075979|NCT00127634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075980|NCT02127996|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102075981|NCT02127996|Incretins|incretins|mesh-ancestor
102075982|NCT02127996|Hormones|hormones|mesh-ancestor
102075983|NCT02127996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102075984|NCT02127996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075985|NCT02131350|Ranibizumab|ranibizumab|mesh-list
101377653|NCT00424801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101402188|NCT04715152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402189|NCT04715152|Protease Inhibitors|protease inhibitors|mesh-ancestor
101402190|NCT04715152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101402191|NCT04715152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402192|NCT04715152|Anesthetics, Local|anesthetics, local|mesh-ancestor
101402193|NCT04715152|Anesthetics|anesthetics|mesh-ancestor
101402194|NCT04715152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101402195|NCT04715152|Sensory System Agents|sensory system agents|mesh-ancestor
101402196|NCT00334906|Memantine|memantine|mesh-list
101346540|NCT00028587|Bortezomib|bortezomib|mesh-list
101402197|NCT00334906|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101402198|NCT00334906|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101402199|NCT00334906|Dopamine Agents|dopamine agents|mesh-ancestor
101402200|NCT00334906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101402201|NCT00334906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402202|NCT00334906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402203|NCT00334906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101402204|NCT00334906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101402205|NCT00089570|Terlipressin|terlipressin|mesh-list
101402206|NCT00089570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101402207|NCT00089570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101402208|NCT00342862|Alefacept|alefacept|mesh-list
101402209|NCT00342862|Dermatologic Agents|dermatologic agents|mesh-ancestor
101402213|NCT00089687|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101402214|NCT00089687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101402215|NCT00089687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101402216|NCT00089687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402217|NCT00089687|Dopamine Agents|dopamine agents|mesh-ancestor
101402218|NCT00089687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101402219|NCT00089687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402220|NCT00127764|Dexamethasone|dexamethasone|mesh-list
101402221|NCT00127764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101402222|NCT00127764|Antiemetics|antiemetics|mesh-ancestor
101402223|NCT00127764|Autonomic Agents|autonomic agents|mesh-ancestor
101402224|NCT00127764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101402225|NCT00127764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402226|NCT00127764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101402227|NCT00127764|Glucocorticoids|glucocorticoids|mesh-ancestor
101402228|NCT00127764|Hormones|hormones|mesh-ancestor
101402229|NCT00127764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101402230|NCT00127764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101402231|NCT00127764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402232|NCT00089726|Cyclophosphamide|cyclophosphamide|mesh-list
101402233|NCT00089726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101402234|NCT00089726|Immunologic Factors|immunologic factors|mesh-ancestor
101402235|NCT00089726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402236|NCT00089726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101402237|NCT00089726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101402238|NCT00089726|Alkylating Agents|alkylating agents|mesh-ancestor
101402239|NCT00089726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402243|NCT00343096|Anticonvulsants|anticonvulsants|mesh-ancestor
101402244|NCT00343096|Antiemetics|antiemetics|mesh-ancestor
101402245|NCT00343096|Autonomic Agents|autonomic agents|mesh-ancestor
101402246|NCT00343096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102075986|NCT02131350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102075987|NCT02131350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102075988|NCT02131350|Growth Substances|growth substances|mesh-ancestor
102075989|NCT02131350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102075990|NCT02131350|Growth Inhibitors|growth inhibitors|mesh-ancestor
102075991|NCT02131350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402247|NCT00343096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402248|NCT00343096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101402249|NCT00343096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101346595|NCT03959501|Dapagliflozin|dapagliflozin|mesh-list
101402250|NCT00343096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101402251|NCT00343096|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101402252|NCT00343096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101402253|NCT00343096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101402255|NCT00343096|GABA Agents|gaba agents|mesh-ancestor
101402256|NCT00343096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101402257|NCT00343096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402259|NCT00335179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101402260|NCT00335179|Immunologic Factors|immunologic factors|mesh-ancestor
101402261|NCT00335179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402262|NCT00335179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402263|NCT00335179|Interferon Inducers|interferon inducers|mesh-ancestor
101402264|NCT00089765|Ranibizumab|ranibizumab|mesh-list
101402265|NCT00089765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101402266|NCT00089765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101402267|NCT00089765|Growth Substances|growth substances|mesh-ancestor
101402268|NCT00089765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402269|NCT00089765|Growth Inhibitors|growth inhibitors|mesh-ancestor
101402270|NCT00089765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402271|NCT00343135|Amoxicillin|amoxicillin|mesh-list
101402272|NCT00343135|Clavulanic Acid|clavulanic acid|mesh-list
101402273|NCT00343135|Clavulanic Acids|clavulanic acids|mesh-list
101402274|NCT00343135|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101402275|NCT00343135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101402276|NCT00343135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101402277|NCT00343135|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101402278|NCT00343135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101402279|NCT00343135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402280|NCT00343174|Ancrod|ancrod|mesh-list
101402281|NCT00343174|Anticoagulants|anticoagulants|mesh-ancestor
101402289|NCT00343369|Doxorubicin|doxorubicin|mesh-list
101402290|NCT00343369|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101402291|NCT00343369|Methotrexate|methotrexate|mesh-list
101402292|NCT00343369|Vincristine|vincristine|mesh-list
101402293|NCT00343369|Daunorubicin|daunorubicin|mesh-list
101402294|NCT00343369|Asparaginase|asparaginase|mesh-list
101402295|NCT00343369|Mercaptopurine|mercaptopurine|mesh-list
101402296|NCT00343369|Pegaspargase|pegaspargase|mesh-list
101402297|NCT00343369|Thioguanine|thioguanine|mesh-list
101402298|NCT00343369|Teniposide|teniposide|mesh-list
101402299|NCT00343369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101402300|NCT00343369|Immunologic Factors|immunologic factors|mesh-ancestor
101402301|NCT00343369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402302|NCT00343369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101402303|NCT00343369|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101402304|NCT00343369|Alkylating Agents|alkylating agents|mesh-ancestor
101306469|NCT02025803|Antimetabolites|antimetabolites|mesh-ancestor
101306470|NCT02025803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306471|NCT02025803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101306472|NCT02025855|Methadone|methadone|mesh-list
101306473|NCT02025855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101306474|NCT02025855|Narcotics|narcotics|mesh-ancestor
101402305|NCT00343369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402306|NCT00343369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402307|NCT00343369|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101402308|NCT00343369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101402309|NCT00343369|Antiemetics|antiemetics|mesh-ancestor
101402310|NCT00343369|Autonomic Agents|autonomic agents|mesh-ancestor
101402311|NCT00343369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101402312|NCT00343369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101402313|NCT00343369|Glucocorticoids|glucocorticoids|mesh-ancestor
102075992|NCT02128308|Moxifloxacin|moxifloxacin|mesh-list
102075993|NCT02128308|Levofloxacin|levofloxacin|mesh-list
102075994|NCT02128308|Ofloxacin|ofloxacin|mesh-list
102075995|NCT02128308|Cycloserine|cycloserine|mesh-list
102075996|NCT02128308|Pyrazinamide|pyrazinamide|mesh-list
102075997|NCT02128308|Aminosalicylic Acid|aminosalicylic acid|mesh-list
102075998|NCT02128308|Streptomycin|streptomycin|mesh-list
102075999|NCT02128308|Kanamycin|kanamycin|mesh-list
102076000|NCT02128308|Prothionamide|prothionamide|mesh-list
101377664|NCT00246415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101402314|NCT00343369|Hormones|hormones|mesh-ancestor
101402315|NCT00343369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101402327|NCT00343369|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101402328|NCT00343369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101402329|NCT00343369|Antiviral Agents|antiviral agents|mesh-ancestor
101402330|NCT00343369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101402331|NCT00343369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101402332|NCT00343369|Tubulin Modulators|tubulin modulators|mesh-ancestor
101402333|NCT00343369|Antimitotic Agents|antimitotic agents|mesh-ancestor
101402334|NCT00343369|Mitosis Modulators|mitosis modulators|mesh-ancestor
101402335|NCT02958111|Capecitabine|capecitabine|mesh-list
101402336|NCT02958111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101402337|NCT02958111|Antimetabolites|antimetabolites|mesh-ancestor
101402338|NCT02958111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402339|NCT02958111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402340|NCT00343447|Cyclophosphamide|cyclophosphamide|mesh-list
101402341|NCT00343447|Rituximab|rituximab|mesh-list
101402342|NCT00343447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101402343|NCT00343447|Immunologic Factors|immunologic factors|mesh-ancestor
101402344|NCT00343447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402345|NCT00343447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101402346|NCT00343447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101402347|NCT00343447|Alkylating Agents|alkylating agents|mesh-ancestor
101402348|NCT00343447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402349|NCT00343447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402350|NCT00343447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101402351|NCT00343447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101402357|NCT00343486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101402358|NCT00343486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402359|NCT00343486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402360|NCT00089804|Abetimus|abetimus|mesh-list
101402361|NCT00089804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101402362|NCT00089804|Immunologic Factors|immunologic factors|mesh-ancestor
101402363|NCT00089804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402364|NCT00343525|Bavituximab|bavituximab|mesh-list
101402365|NCT00343525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101402366|NCT00343525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101306475|NCT02025855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101306476|NCT02025855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402367|NCT00127881|Zanolimumab|zanolimumab|mesh-list
101402368|NCT00127881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101402369|NCT00127881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402370|NCT00343720|Bortezomib|bortezomib|mesh-list
101402371|NCT00343720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402372|NCT00343759|Lapatinib|lapatinib|mesh-list
101402373|NCT00343759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402374|NCT00343759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101402375|NCT00343759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101402376|NCT00343759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402377|NCT00127920|Bevacizumab|bevacizumab|mesh-list
101402378|NCT00127920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101402379|NCT00127920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402380|NCT00127920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101402388|NCT00343798|Fludarabine|fludarabine|mesh-list
101402389|NCT00343798|Fludarabine phosphate|fludarabine phosphate|mesh-list
101402390|NCT00343798|Cyclosporins|cyclosporins|mesh-list
101402391|NCT00343798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102076001|NCT02128308|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102076002|NCT02128308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102076003|NCT02128308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101795744|NCT00534495|Rilonacept|rilonacept|mesh-list
102076004|NCT02128308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102076005|NCT02128308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102076006|NCT02128308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101377674|NCT00246610|Nelfinavir|nelfinavir|mesh-list
101402392|NCT00343798|Immunologic Factors|immunologic factors|mesh-ancestor
101402393|NCT00343798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402394|NCT00343798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101402395|NCT00343798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101402396|NCT00343798|Alkylating Agents|alkylating agents|mesh-ancestor
101402397|NCT00343798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402398|NCT00343798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402399|NCT00343798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101402400|NCT00343798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101402401|NCT00343798|Antimetabolites|antimetabolites|mesh-ancestor
101402402|NCT00343798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101402403|NCT00343798|Antifungal Agents|antifungal agents|mesh-ancestor
101402404|NCT00343798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101402405|NCT00343798|Dermatologic Agents|dermatologic agents|mesh-ancestor
101402406|NCT00343798|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101402407|NCT00343798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101402408|NCT00343798|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101402409|NCT00343798|Antitubercular Agents|antitubercular agents|mesh-ancestor
101402410|NCT00343798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101402411|NCT00343876|Aspirin|aspirin|mesh-list
101402412|NCT00343876|Clopidogrel|clopidogrel|mesh-list
101402413|NCT00343876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101402414|NCT00343876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101402415|NCT00343876|Analgesics|analgesics|mesh-ancestor
101402416|NCT00343876|Sensory System Agents|sensory system agents|mesh-ancestor
101402417|NCT00343876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101402418|NCT00343876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402419|NCT00343876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101402420|NCT00343876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101402421|NCT00343876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101402422|NCT00343876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101402423|NCT00343876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402424|NCT00343876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101402426|NCT00343876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101402427|NCT00343876|Antipyretics|antipyretics|mesh-ancestor
101402428|NCT00343876|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101402429|NCT00343876|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101402430|NCT00343876|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101402431|NCT00343876|Purinergic Agents|purinergic agents|mesh-ancestor
101402432|NCT00343876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101402433|NCT00402636|Sirolimus|sirolimus|mesh-list
101402434|NCT00402636|Temsirolimus|temsirolimus|mesh-list
101402435|NCT00402636|MTOR Inhibitors|mtor inhibitors|mesh-list
101402436|NCT00402636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101402437|NCT00402636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101306478|NCT02025855|Sensory System Agents|sensory system agents|mesh-ancestor
101306479|NCT02025855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101306480|NCT02025855|Antitussive Agents|antitussive agents|mesh-ancestor
101402438|NCT00402636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101402439|NCT00402636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402440|NCT00402636|Antifungal Agents|antifungal agents|mesh-ancestor
101402441|NCT00402636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101402442|NCT00402636|Immunologic Factors|immunologic factors|mesh-ancestor
101402443|NCT00402636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402444|NCT00402636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101402445|NCT00402636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101402446|NCT00402636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402447|NCT00344149|Rituximab|rituximab|mesh-list
101402450|NCT00344149|Immunologic Factors|immunologic factors|mesh-ancestor
102076007|NCT02128308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076008|NCT02128308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102076009|NCT02128308|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102076010|NCT02128308|Contraceptive Agents|contraceptive agents|mesh-ancestor
102076011|NCT02128308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102076012|NCT02128308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076013|NCT02128308|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101402451|NCT00344149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402452|NCT00344149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101402453|NCT00089960|Motesanib diphosphate|motesanib diphosphate|mesh-list
101402454|NCT00089960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101402455|NCT00089960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101402456|NCT00089960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402457|NCT00344227|Ranibizumab|ranibizumab|mesh-list
101402458|NCT00344227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101402459|NCT00344227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101402460|NCT00344227|Growth Substances|growth substances|mesh-ancestor
101402461|NCT00344227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402462|NCT00344227|Growth Inhibitors|growth inhibitors|mesh-ancestor
101402463|NCT00344227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402464|NCT00344383|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101402465|NCT00344383|Norgestimate|norgestimate|mesh-list
101402466|NCT00344383|Estradiol|estradiol|mesh-list
101402467|NCT00344383|Estrogens|estrogens|mesh-ancestor
101402468|NCT00344383|Hormones|hormones|mesh-ancestor
101402469|NCT00344383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101402470|NCT00344383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402471|NCT00344383|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101402472|NCT00344383|Contraceptive Agents|contraceptive agents|mesh-ancestor
101402473|NCT00344383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101402474|NCT00344383|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101402475|NCT00344383|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101402476|NCT00344383|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101402477|NCT00344383|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101402478|NCT00344422|Dexamethasone|dexamethasone|mesh-list
101402479|NCT00344422|Dexamethasone acetate|dexamethasone acetate|mesh-list
101402480|NCT00344422|Doxorubicin|doxorubicin|mesh-list
101402481|NCT00344422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101402482|NCT00344422|Vincristine|vincristine|mesh-list
101402483|NCT00344422|BB 1101|bb 1101|mesh-list
101402484|NCT00344422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101402485|NCT00344422|Antiemetics|antiemetics|mesh-ancestor
101402486|NCT00344422|Autonomic Agents|autonomic agents|mesh-ancestor
101402487|NCT00344422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101402488|NCT00344422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402489|NCT00344422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101402490|NCT00344422|Glucocorticoids|glucocorticoids|mesh-ancestor
101402491|NCT00344422|Hormones|hormones|mesh-ancestor
101402492|NCT00344422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101402493|NCT00344422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101402494|NCT00344422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402495|NCT00344422|Protease Inhibitors|protease inhibitors|mesh-ancestor
101402496|NCT00344422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101402499|NCT00344422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101402500|NCT00344422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101402501|NCT00344422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101402502|NCT00344422|Tubulin Modulators|tubulin modulators|mesh-ancestor
101402503|NCT00344422|Antimitotic Agents|antimitotic agents|mesh-ancestor
101402504|NCT00344422|Mitosis Modulators|mitosis modulators|mesh-ancestor
101402506|NCT00090038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101306481|NCT02025855|Respiratory System Agents|respiratory system agents|mesh-ancestor
101306482|NCT02025868|Raltegravir Potassium|raltegravir potassium|mesh-list
101306483|NCT02025868|Darunavir|darunavir|mesh-list
101402507|NCT00090038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402508|NCT00090038|Immunologic Factors|immunologic factors|mesh-ancestor
101402509|NCT00090038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402510|NCT00090038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102076014|NCT02128308|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102076015|NCT02128308|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102076016|NCT02128308|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102076017|NCT02128308|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102076018|NCT02128308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102076019|NCT02128308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102076020|NCT02128308|Antitubercular Agents|antitubercular agents|mesh-ancestor
102076021|NCT02128308|Antimetabolites|antimetabolites|mesh-ancestor
101402511|NCT00402792|Acetaminophen|acetaminophen|mesh-list
101402512|NCT00402792|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
101402513|NCT00402792|Hydrocodone|hydrocodone|mesh-list
101402514|NCT00402792|Oxycodone|oxycodone|mesh-list
101402515|NCT00402792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101402516|NCT00402792|Analgesics|analgesics|mesh-ancestor
101347015|NCT03559985|Acetaminophen|acetaminophen|mesh-list
101402517|NCT00402792|Sensory System Agents|sensory system agents|mesh-ancestor
101402518|NCT00402792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101402519|NCT00402792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402520|NCT00402792|Antipyretics|antipyretics|mesh-ancestor
101402521|NCT00402792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101402526|NCT00402792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101402527|NCT00402792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101402528|NCT00402792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101402529|NCT00127959|Tenofovir|tenofovir|mesh-list
101402530|NCT00127959|Emtricitabine|emtricitabine|mesh-list
101402531|NCT00127959|Zidovudine|zidovudine|mesh-list
101402532|NCT00127959|Efavirenz|efavirenz|mesh-list
101402533|NCT00127959|Antiviral Agents|antiviral agents|mesh-ancestor
101402534|NCT00127959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101402535|NCT00127959|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101402536|NCT00127959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101402537|NCT00127959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101402538|NCT00127959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402539|NCT00127959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101402540|NCT00127959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101402541|NCT00127959|Antimetabolites|antimetabolites|mesh-ancestor
101402542|NCT00127959|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101402543|NCT00127959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101402544|NCT00127959|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101402545|NCT00127959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101402546|NCT00127959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101402547|NCT00127959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101402548|NCT00344539|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101402549|NCT00344539|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101402550|NCT00344539|Immunologic Factors|immunologic factors|mesh-ancestor
101402551|NCT00344539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402552|NCT00344539|Antacids|antacids|mesh-ancestor
101402553|NCT00344539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402554|NCT00344539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101402555|NCT04715503|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101402556|NCT04715503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101402557|NCT04715503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402558|NCT00344617|Bevacizumab|bevacizumab|mesh-list
101402559|NCT00344617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101402560|NCT00344617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402561|NCT00344617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101402562|NCT00344617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101402563|NCT00344617|Growth Substances|growth substances|mesh-ancestor
101402564|NCT00344617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402565|NCT00344617|Growth Inhibitors|growth inhibitors|mesh-ancestor
101402566|NCT00127998|Artesunate|artesunate|mesh-list
101402567|NCT00127998|Chloroquine|chloroquine|mesh-list
101402591|NCT00420589|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
101402592|NCT00420589|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101347055|NCT04712058|Antiviral Agents|antiviral agents|mesh-ancestor
102076022|NCT02128308|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102076023|NCT02131506|Lapatinib|lapatinib|mesh-list
102076024|NCT02131506|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102076025|NCT02131506|Doxorubicin|doxorubicin|mesh-list
102076026|NCT02131506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102076027|NCT02131506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101402593|NCT00420589|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101402595|NCT00420589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306484|NCT02025868|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101306485|NCT02025868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101306486|NCT02025868|Antiviral Agents|antiviral agents|mesh-ancestor
101306487|NCT02025868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101306488|NCT02025868|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101306489|NCT02025868|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101306490|NCT02025868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101306491|NCT02025868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306492|NCT02025868|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101402596|NCT00420589|Hormones|hormones|mesh-ancestor
101402597|NCT00420589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101402598|NCT00420589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402599|NCT00344695|Bupropion|bupropion|mesh-list
101402600|NCT00344695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101402601|NCT00344695|Antidepressive Agents|antidepressive agents|mesh-ancestor
101402602|NCT00344695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101402603|NCT00344695|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101402606|NCT00344695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402608|NCT00344695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101402609|NCT00344695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402610|NCT00344695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101402611|NCT00344695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101402612|NCT00344695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101402613|NCT00128037|Mitomycins|mitomycins|mesh-list
101402614|NCT00128037|Mitomycin|mitomycin|mesh-list
101402615|NCT00128037|Vindesine|vindesine|mesh-list
101402616|NCT00128037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402617|NCT00128037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101402618|NCT00128037|Alkylating Agents|alkylating agents|mesh-ancestor
101402621|NCT00128037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101402622|NCT00128037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101402623|NCT00128037|Tubulin Modulators|tubulin modulators|mesh-ancestor
101402624|NCT00128037|Antimitotic Agents|antimitotic agents|mesh-ancestor
101402625|NCT00128037|Mitosis Modulators|mitosis modulators|mesh-ancestor
101402626|NCT00344734|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
101402627|NCT00344734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101402628|NCT00344734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402629|NCT00344812|Buprenorphine|buprenorphine|mesh-list
101402630|NCT00344812|Methadone|methadone|mesh-list
101402631|NCT00344812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101402632|NCT00344812|Narcotics|narcotics|mesh-ancestor
101402633|NCT00344812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101402634|NCT00344812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402635|NCT00344812|Analgesics|analgesics|mesh-ancestor
101402636|NCT00344812|Sensory System Agents|sensory system agents|mesh-ancestor
101402637|NCT00344812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101402638|NCT00344812|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101402639|NCT00344812|Antitussive Agents|antitussive agents|mesh-ancestor
101402640|NCT00344812|Respiratory System Agents|respiratory system agents|mesh-ancestor
101402641|NCT00344851|Metformin|metformin|mesh-list
101402642|NCT00344851|Exenatide|exenatide|mesh-list
101402643|NCT00344851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101402644|NCT00344851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402645|NCT00344851|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101402646|NCT00344851|Incretins|incretins|mesh-ancestor
101402647|NCT00344851|Hormones|hormones|mesh-ancestor
101402648|NCT00344851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101402649|NCT00090155|Ondansetron|ondansetron|mesh-list
101402650|NCT00090155|Aprepitant|aprepitant|mesh-list
101402651|NCT00090155|Antiemetics|antiemetics|mesh-ancestor
101402652|NCT00090155|Autonomic Agents|autonomic agents|mesh-ancestor
101402653|NCT00090155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102076029|NCT02131506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076030|NCT02131506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102076031|NCT02131506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101402654|NCT00090155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402655|NCT00090155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101306493|NCT02025868|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101306494|NCT02025868|Protease Inhibitors|protease inhibitors|mesh-ancestor
101306495|NCT02025881|Cyclophosphamide|cyclophosphamide|mesh-list
101306496|NCT02025881|Thiotepa|thiotepa|mesh-list
101306497|NCT02025881|Carboplatin|carboplatin|mesh-list
101306498|NCT02025881|Etoposide|etoposide|mesh-list
101306499|NCT02025881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101402656|NCT00090155|Antipruritics|antipruritics|mesh-ancestor
101402657|NCT00090155|Dermatologic Agents|dermatologic agents|mesh-ancestor
101402658|NCT00090155|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101402659|NCT00090155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101402660|NCT00090155|Serotonin Agents|serotonin agents|mesh-ancestor
101402661|NCT00090155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101402662|NCT00090155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402663|NCT00090155|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101402664|NCT00335413|Spironolactone|spironolactone|mesh-list
101402665|NCT00335413|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101402666|NCT00335413|Hormone Antagonists|hormone antagonists|mesh-ancestor
101402667|NCT00335413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101402668|NCT00335413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402669|NCT00335413|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101402670|NCT00335413|Diuretics|diuretics|mesh-ancestor
101402671|NCT00335413|Natriuretic Agents|natriuretic agents|mesh-ancestor
101402677|NCT00090194|Immunologic Factors|immunologic factors|mesh-ancestor
101402678|NCT00090194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402679|NCT00345163|Bevacizumab|bevacizumab|mesh-list
101402680|NCT00345163|Irinotecan|irinotecan|mesh-list
101402681|NCT00345163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101402682|NCT00345163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402683|NCT00345163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101402684|NCT00345163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101402685|NCT00345163|Growth Substances|growth substances|mesh-ancestor
101402686|NCT00345163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402687|NCT00345163|Growth Inhibitors|growth inhibitors|mesh-ancestor
101402688|NCT00345163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101402689|NCT00345163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101402690|NCT00345163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101402696|NCT00345202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402697|NCT00345202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101402698|NCT00345202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101402699|NCT00345202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101402700|NCT00335647|Fluphenazine|fluphenazine|mesh-list
101402701|NCT00335647|Fluphenazine depot|fluphenazine depot|mesh-list
101402702|NCT00335647|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
101402703|NCT00335647|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101402704|NCT00335647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101402705|NCT00335647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101402706|NCT00335647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402707|NCT00335647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101402708|NCT00335647|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101402709|NCT00335647|Dopamine Agents|dopamine agents|mesh-ancestor
101402710|NCT00335647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101402711|NCT00335647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402712|NCT00128154|Chromium|chromium|mesh-list
101402713|NCT00128154|Picolinic acid|picolinic acid|mesh-list
101402714|NCT00128154|Trace Elements|trace elements|mesh-ancestor
101402715|NCT00128154|Micronutrients|micronutrients|mesh-ancestor
101402716|NCT00128154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402717|NCT00128154|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101402718|NCT00128154|Chelating Agents|chelating agents|mesh-ancestor
101402719|NCT00128154|Sequestering Agents|sequestering agents|mesh-ancestor
101402720|NCT00128154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402721|NCT00335686|Lopinavir|lopinavir|mesh-list
101402722|NCT00335686|Nevirapine|nevirapine|mesh-list
102076032|NCT02131506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102076033|NCT01674010|Inositol|inositol|mesh-list
102076034|NCT01674010|Lamotrigine|lamotrigine|mesh-list
102076035|NCT01674010|Valproic Acid|valproic acid|mesh-list
102076036|NCT01674010|Anticonvulsants|anticonvulsants|mesh-ancestor
102076037|NCT01674010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102076038|NCT01674010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102076039|NCT01674010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377704|NCT00400998|Dermatologic Agents|dermatologic agents|mesh-ancestor
101306500|NCT02025881|Immunologic Factors|immunologic factors|mesh-ancestor
101306501|NCT02025881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402723|NCT00335686|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101402724|NCT00335686|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101402725|NCT00335686|Protease Inhibitors|protease inhibitors|mesh-ancestor
101402726|NCT00335686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101402727|NCT00335686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402728|NCT00335686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101402729|NCT00335686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101402730|NCT00335686|Antiviral Agents|antiviral agents|mesh-ancestor
101402731|NCT00335686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101402732|NCT00335686|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101402733|NCT00335686|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101402734|NCT00335686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101402735|NCT00335686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101402736|NCT00335686|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101402737|NCT00335686|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101402738|NCT00128232|Octreotide|octreotide|mesh-list
101402739|NCT00128232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101402740|NCT00128232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101402741|NCT00128232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402742|NCT04708249|Inositol|inositol|mesh-list
101402743|NCT04708249|Vitamin B Complex|vitamin b complex|mesh-ancestor
101402744|NCT04708249|Vitamins|vitamins|mesh-ancestor
101402745|NCT04708249|Micronutrients|micronutrients|mesh-ancestor
101199360|NCT04391608|Tenofovir|tenofovir|mesh-list
101402749|NCT00090272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101402750|NCT00090272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101402751|NCT00345787|Buprenorphine|buprenorphine|mesh-list
101402752|NCT00345787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101402753|NCT00345787|Narcotics|narcotics|mesh-ancestor
101402754|NCT00345787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101402755|NCT00345787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402756|NCT00345787|Analgesics|analgesics|mesh-ancestor
101402757|NCT00345787|Sensory System Agents|sensory system agents|mesh-ancestor
101402758|NCT00345787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101402759|NCT00345787|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101402760|NCT00128271|Bavituximab|bavituximab|mesh-list
101402761|NCT00128271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101402767|NCT00090311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101402768|NCT00090311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101402769|NCT00090311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402771|NCT02959762|Vitamin K|vitamin k|mesh-list
101402772|NCT02959762|Vitamin K 2|vitamin k 2|mesh-list
101402773|NCT02959762|Menaquinone 7|menaquinone 7|mesh-list
101402774|NCT02959762|Micronutrients|micronutrients|mesh-ancestor
101402775|NCT02959762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402776|NCT02959762|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101402777|NCT02959762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101402778|NCT02959762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402779|NCT02959762|Hemostatics|hemostatics|mesh-ancestor
101402780|NCT02959762|Coagulants|coagulants|mesh-ancestor
101402781|NCT00345826|Dasatinib|dasatinib|mesh-list
101402782|NCT00345826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402783|NCT00345826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101402784|NCT00345826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101402785|NCT00345826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402786|NCT00345982|Sertindole|sertindole|mesh-list
102076040|NCT01674010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102076041|NCT01674010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076042|NCT01674010|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102076043|NCT01674010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102076044|NCT01674010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102076045|NCT01674010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102076046|NCT01674010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102076047|NCT01674010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102076048|NCT01674010|GABA Agents|gaba agents|mesh-ancestor
101498375|NCT01605721|Everolimus|everolimus|mesh-list
101402787|NCT00345982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101402788|NCT00345982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101402789|NCT00345982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101402790|NCT00345982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402791|NCT00345982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101402792|NCT00346099|Capecitabine|capecitabine|mesh-list
101402793|NCT00346099|Oxaliplatin|oxaliplatin|mesh-list
101402794|NCT00346099|Panitumumab|panitumumab|mesh-list
101402795|NCT00346099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101402796|NCT00346099|Antimetabolites|antimetabolites|mesh-ancestor
101402797|NCT00346099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402798|NCT00346099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101306502|NCT02025881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101306503|NCT02025881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101306504|NCT02025881|Alkylating Agents|alkylating agents|mesh-ancestor
101402799|NCT00346099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101402800|NCT00125736|Rabeprazole|rabeprazole|mesh-list
101402801|NCT00125736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101402802|NCT00125736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101402803|NCT00125736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101402804|NCT00125736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101402805|NCT00125736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402806|NCT00090428|Caseins|caseins|mesh-list
101402807|NCT00090428|Chelating Agents|chelating agents|mesh-ancestor
101402808|NCT00090428|Sequestering Agents|sequestering agents|mesh-ancestor
101402809|NCT00090428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402810|NCT00346255|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
101402811|NCT00346255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101402812|NCT00346255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402813|NCT00346255|Immunotoxins|immunotoxins|mesh-ancestor
101402814|NCT00346255|Immunoconjugates|immunoconjugates|mesh-ancestor
101402815|NCT00346255|Immunologic Factors|immunologic factors|mesh-ancestor
101402816|NCT00346255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402817|NCT00346255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101402818|NCT00346294|Etanercept|etanercept|mesh-list
101402819|NCT00346294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101402820|NCT00346294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101402821|NCT00346294|Analgesics|analgesics|mesh-ancestor
101402822|NCT00346294|Sensory System Agents|sensory system agents|mesh-ancestor
101402832|NCT00346489|Mitomycin|mitomycin|mesh-list
101402833|NCT00346489|Antimetabolites|antimetabolites|mesh-ancestor
101402839|NCT00346489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402840|NCT00346489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101402841|NCT00346489|Alkylating Agents|alkylating agents|mesh-ancestor
101402842|NCT00346489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101402843|NCT00346489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101402844|NCT00125814|Interferons|interferons|mesh-list
101402845|NCT00125814|Interferon-alpha|interferon-alpha|mesh-list
101402846|NCT00125814|Interferon alpha-2|interferon alpha-2|mesh-list
101402847|NCT00125814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402848|NCT00125814|Antiviral Agents|antiviral agents|mesh-ancestor
101402849|NCT00125814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101402850|NCT00125814|Immunologic Factors|immunologic factors|mesh-ancestor
101402851|NCT00125814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402852|NCT00346567|Tenofovir|tenofovir|mesh-list
101402853|NCT00346567|Lamivudine|lamivudine|mesh-list
102076049|NCT01674010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102076050|NCT01674010|Antimanic Agents|antimanic agents|mesh-ancestor
102076051|NCT01674010|Vitamin B Complex|vitamin b complex|mesh-ancestor
102076053|NCT01674010|Micronutrients|micronutrients|mesh-ancestor
101402854|NCT00346567|Emtricitabine|emtricitabine|mesh-list
101402855|NCT00346567|Zidovudine|zidovudine|mesh-list
101402856|NCT00346567|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101402857|NCT00346567|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101402858|NCT00346567|Antiviral Agents|antiviral agents|mesh-ancestor
101402859|NCT00346567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101402860|NCT00346567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101347454|NCT03150836|Tremelimumab|tremelimumab|mesh-list
101402861|NCT00346567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101402862|NCT00346567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101402863|NCT00346567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402864|NCT00346567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101402865|NCT00346567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101402866|NCT00346567|Antimetabolites|antimetabolites|mesh-ancestor
101402867|NCT00090623|Ranibizumab|ranibizumab|mesh-list
101402868|NCT00090623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101402869|NCT00090623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101402870|NCT00090623|Growth Substances|growth substances|mesh-ancestor
101306505|NCT02025881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402871|NCT00090623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402872|NCT00090623|Growth Inhibitors|growth inhibitors|mesh-ancestor
101402873|NCT00090623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402874|NCT02957994|Tenofovir|tenofovir|mesh-list
101402875|NCT02957994|Antiviral Agents|antiviral agents|mesh-ancestor
101402876|NCT02957994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101402877|NCT02957994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101402878|NCT02957994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101402879|NCT02957994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101402880|NCT02957994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402881|NCT02957994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101402882|NCT02957994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101402883|NCT00346645|Bortezomib|bortezomib|mesh-list
101402884|NCT00346645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402885|NCT00346684|Rituximab|rituximab|mesh-list
101402886|NCT00346684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101402887|NCT00346684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402888|NCT00346684|Immunologic Factors|immunologic factors|mesh-ancestor
101402889|NCT00346684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402890|NCT00346684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101402891|NCT04728932|Simendan|simendan|mesh-list
101402892|NCT04728932|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101402893|NCT04728932|Vasodilator Agents|vasodilator agents|mesh-ancestor
101402906|NCT00125892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402907|NCT00125892|Analgesics|analgesics|mesh-ancestor
101402908|NCT00125892|Sensory System Agents|sensory system agents|mesh-ancestor
101402909|NCT00125892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101402910|NCT00125892|Antidepressive Agents|antidepressive agents|mesh-ancestor
101402911|NCT00125892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101402912|NCT00125892|Dopamine Agents|dopamine agents|mesh-ancestor
101402913|NCT00346801|Celecoxib|celecoxib|mesh-list
101402914|NCT00346801|Cisplatin|cisplatin|mesh-list
101402915|NCT00346801|Irinotecan|irinotecan|mesh-list
101402916|NCT00346801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402917|NCT00346801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101402918|NCT00346801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101402919|NCT00346801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101402920|NCT00346801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402921|NCT00346801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101402922|NCT00346801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101402923|NCT00346801|Analgesics|analgesics|mesh-ancestor
101402924|NCT00346801|Sensory System Agents|sensory system agents|mesh-ancestor
101402925|NCT00346801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101402926|NCT00346801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402927|NCT00346801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101402928|NCT00346801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101402929|NCT00346801|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101377727|NCT00247507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076054|NCT02252328|Simvastatin|simvastatin|mesh-list
102076055|NCT02252328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102076056|NCT02252328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102076057|NCT02252328|Antimetabolites|antimetabolites|mesh-ancestor
102076058|NCT02252328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076059|NCT02252328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102076060|NCT02252328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102076061|NCT02252328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102076062|NCT04656964|Midazolam|midazolam|mesh-list
102076063|NCT04656964|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102076064|NCT04656964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102076065|NCT04656964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102076066|NCT04656964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402930|NCT00346801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101402931|NCT00346840|Misoprostol|misoprostol|mesh-list
101402932|NCT00346840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101402933|NCT00346840|Abortifacient Agents|abortifacient agents|mesh-ancestor
101402934|NCT00346840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101402935|NCT00346840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402936|NCT00346840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101402937|NCT00346840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101402938|NCT00346840|Oxytocics|oxytocics|mesh-ancestor
101402939|NCT00346879|PENTA|penta|mesh-list
101402940|NCT00346879|Fondaparinux|fondaparinux|mesh-list
101402941|NCT00346879|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101402942|NCT00346879|Antithrombins|antithrombins|mesh-ancestor
101402943|NCT00346879|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101402944|NCT00346879|Protease Inhibitors|protease inhibitors|mesh-ancestor
101402945|NCT00346879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101402946|NCT00346879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402947|NCT00346879|Anticoagulants|anticoagulants|mesh-ancestor
101402948|NCT00346879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101402949|NCT00346879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101402950|NCT00126009|Amisulpride|amisulpride|mesh-list
101402951|NCT00126009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101402952|NCT00126009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101402953|NCT00126009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101402954|NCT00126009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402955|NCT00126009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101402956|NCT00126009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101402957|NCT00126009|Dopamine Agents|dopamine agents|mesh-ancestor
101402958|NCT00126009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101402959|NCT00126009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347580|NCT00033306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101402960|NCT00126009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101402966|NCT00346918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402967|NCT00346918|Antifungal Agents|antifungal agents|mesh-ancestor
101402968|NCT00346918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101402969|NCT00346918|Immunologic Factors|immunologic factors|mesh-ancestor
101402970|NCT00346918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402971|NCT00346957|Hydrocortisone|hydrocortisone|mesh-list
101402972|NCT00346957|Anecortave|anecortave|mesh-list
101402973|NCT00346957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101402976|NCT00346957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402977|NCT00346957|Growth Inhibitors|growth inhibitors|mesh-ancestor
101402978|NCT00346957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402979|NCT00346957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101402980|NCT00346996|Insulin|insulin|mesh-list
101402981|NCT00346996|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101402982|NCT00346996|Insulin Detemir|insulin detemir|mesh-list
101402983|NCT00346996|Isophane Insulin, Human|isophane insulin, human|mesh-list
102076067|NCT04656964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102076068|NCT04656964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102076069|NCT04656964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102076070|NCT04656964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102076071|NCT04656964|Anesthetics, General|anesthetics, general|mesh-ancestor
102076072|NCT04656964|Anesthetics|anesthetics|mesh-ancestor
102076073|NCT04656964|GABA Modulators|gaba modulators|mesh-ancestor
102076074|NCT04656964|GABA Agents|gaba agents|mesh-ancestor
102076075|NCT04656964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102076076|NCT04656964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076077|NCT02136030|Amphotericin B|amphotericin b|mesh-list
101402984|NCT00346996|Insulin, Isophane|insulin, isophane|mesh-list
101402985|NCT00346996|Isophane insulin, beef|isophane insulin, beef|mesh-list
101402986|NCT00346996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101402987|NCT00346996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402988|NCT00402480|Hydroxyurea|hydroxyurea|mesh-list
101402989|NCT00402480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402990|NCT00402480|Antisickling Agents|antisickling agents|mesh-ancestor
101402991|NCT00402480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101402992|NCT00402480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402993|NCT00402480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101402994|NCT00347035|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101402995|NCT00347035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101402996|NCT00347035|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101402997|NCT00347035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101402998|NCT00347035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101402999|NCT00347035|Adrenergic Agents|adrenergic agents|mesh-ancestor
101403000|NCT00347035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101403001|NCT00347035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403002|NCT00347035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403003|NCT00347113|Albendazole|albendazole|mesh-list
101403004|NCT00347113|Praziquantel|praziquantel|mesh-list
101403005|NCT00347113|Anthelmintics|anthelmintics|mesh-ancestor
101403006|NCT00347113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101403007|NCT00347113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101403008|NCT00347113|Anticestodal Agents|anticestodal agents|mesh-ancestor
101403009|NCT00347113|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101403010|NCT00347113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101403011|NCT00347113|Tubulin Modulators|tubulin modulators|mesh-ancestor
101403012|NCT00347113|Antimitotic Agents|antimitotic agents|mesh-ancestor
101403013|NCT00347113|Mitosis Modulators|mitosis modulators|mesh-ancestor
101403014|NCT00347113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403015|NCT00347113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101403016|NCT00347152|Valproic Acid|valproic acid|mesh-list
101403017|NCT00347152|Anticonvulsants|anticonvulsants|mesh-ancestor
101403018|NCT00347152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101403019|NCT00347152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403020|NCT00347152|GABA Agents|gaba agents|mesh-ancestor
101403021|NCT00347152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101306506|NCT02025881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101306507|NCT02025881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101306508|NCT02025881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101306509|NCT02025881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101403022|NCT00347152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403023|NCT00347152|Antimanic Agents|antimanic agents|mesh-ancestor
101403024|NCT00347152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101403025|NCT00347152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101403026|NCT00347152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101403027|NCT00090896|Ipilimumab|ipilimumab|mesh-list
101403028|NCT00090896|Antibodies|antibodies|mesh-list
101403029|NCT00090896|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101199652|NCT03276533|Analgesics|analgesics|mesh-ancestor
101403035|NCT00090896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403036|NCT00402558|Aldesleukin|aldesleukin|mesh-list
101403037|NCT00402558|Methotrexate|methotrexate|mesh-list
101403038|NCT00402558|Fludarabine phosphate|fludarabine phosphate|mesh-list
102076078|NCT02136030|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102076079|NCT02136030|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
102076080|NCT02136030|Deoxycholic Acid|deoxycholic acid|mesh-list
102076081|NCT02136030|Amebicides|amebicides|mesh-ancestor
102076082|NCT02136030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102076083|NCT02136030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102076084|NCT02136030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102076085|NCT02136030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102076086|NCT02136030|Antifungal Agents|antifungal agents|mesh-ancestor
101403039|NCT00402558|Fludarabine|fludarabine|mesh-list
101403040|NCT00402558|Busulfan|busulfan|mesh-list
101403041|NCT00402558|Interleukin-2|interleukin-2|mesh-list
101403042|NCT00402558|Tacrolimus|tacrolimus|mesh-list
101403043|NCT00402558|Thymoglobulin|thymoglobulin|mesh-list
101403044|NCT00402558|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101403045|NCT00402558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101403046|NCT00402558|Abortifacient Agents|abortifacient agents|mesh-ancestor
101403047|NCT00402558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101403048|NCT00402558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403055|NCT00402558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101403056|NCT00402558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101403057|NCT00402558|Immunologic Factors|immunologic factors|mesh-ancestor
101403058|NCT00402558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101403059|NCT00402558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101403060|NCT00402558|Antiviral Agents|antiviral agents|mesh-ancestor
101403061|NCT00402558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101403062|NCT00402558|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101403063|NCT00402558|Alkylating Agents|alkylating agents|mesh-ancestor
101403064|NCT00402558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101403065|NCT00402558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101403066|NCT00402558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101403067|NCT00402558|Analgesics|analgesics|mesh-ancestor
101403068|NCT00402558|Sensory System Agents|sensory system agents|mesh-ancestor
101403069|NCT00402558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101403070|NCT00402558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101403071|NCT00402558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101403072|NCT00347386|Zinc Sulfate|zinc sulfate|mesh-list
101403073|NCT00347386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403074|NCT00347386|Astringents|astringents|mesh-ancestor
101403075|NCT00347386|Dermatologic Agents|dermatologic agents|mesh-ancestor
101403076|NCT00347425|Olanzapine|olanzapine|mesh-list
101403077|NCT00347425|Risperidone|risperidone|mesh-list
101403078|NCT00347425|Aripiprazole|aripiprazole|mesh-list
101403079|NCT00347425|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101403080|NCT00347425|Ziprasidone|ziprasidone|mesh-list
101403081|NCT00347425|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101403082|NCT00347425|Serotonin Agents|serotonin agents|mesh-ancestor
101403083|NCT00347425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101403084|NCT00347425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403085|NCT00347425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403086|NCT00347425|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101403087|NCT00347425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101403088|NCT00347425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101403089|NCT00347425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101403090|NCT00347425|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101403091|NCT00347425|Dopamine Agents|dopamine agents|mesh-ancestor
101403092|NCT00347425|Antiemetics|antiemetics|mesh-ancestor
101403093|NCT00347425|Autonomic Agents|autonomic agents|mesh-ancestor
101403094|NCT00347425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101403095|NCT00347425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101306510|NCT02025881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101306511|NCT02025881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101403096|NCT00347425|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101403097|NCT00347425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101403098|NCT00347425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101403099|NCT00347425|Antidepressive Agents|antidepressive agents|mesh-ancestor
101403100|NCT00347425|Dopamine Agonists|dopamine agonists|mesh-ancestor
101403101|NCT00347425|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102076087|NCT02136030|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102076088|NCT02136030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102076090|NCT02131818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102076091|NCT02131818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102076092|NCT04605796|Bevacizumab|bevacizumab|mesh-list
102076093|NCT04605796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102076094|NCT04605796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101403102|NCT00347425|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101403103|NCT00347425|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101199710|NCT03071601|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101403115|NCT00126087|Sympathomimetics|sympathomimetics|mesh-ancestor
101403116|NCT00126087|Autonomic Agents|autonomic agents|mesh-ancestor
101403117|NCT00126087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101403124|NCT00347503|Bromfenac|bromfenac|mesh-list
101403125|NCT00347503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101403126|NCT00347503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101403127|NCT00347503|Analgesics|analgesics|mesh-ancestor
101403128|NCT00347503|Sensory System Agents|sensory system agents|mesh-ancestor
101403129|NCT00347503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101403130|NCT00347503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403131|NCT00347503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101403132|NCT00347503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101403133|NCT00347503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101403134|NCT00347503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101403135|NCT00347503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403136|NCT00347542|Vitamin D|vitamin d|mesh-list
101403137|NCT00347542|Vitamins|vitamins|mesh-ancestor
101403138|NCT00347542|Micronutrients|micronutrients|mesh-ancestor
101403139|NCT00347542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403140|NCT00347542|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101403141|NCT00091052|Sargramostim|sargramostim|mesh-list
101403142|NCT00091052|Immunologic Factors|immunologic factors|mesh-ancestor
101403143|NCT00091052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403144|NCT00347581|Methamphetamine|methamphetamine|mesh-list
101403145|NCT00347581|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101403146|NCT00347581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403147|NCT00347581|Sympathomimetics|sympathomimetics|mesh-ancestor
101403148|NCT00347581|Autonomic Agents|autonomic agents|mesh-ancestor
101403149|NCT00347581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101403150|NCT00347581|Dopamine Agents|dopamine agents|mesh-ancestor
101403151|NCT00347581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101403152|NCT00347581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403153|NCT00347581|Adrenergic Agents|adrenergic agents|mesh-ancestor
101403154|NCT00347581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101403155|NCT00347581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101403156|NCT00347581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101403157|NCT00347581|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101403158|NCT00421252|Clopidogrel|clopidogrel|mesh-list
101403159|NCT00421252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101403160|NCT00421252|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101403161|NCT00421252|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101403162|NCT00421252|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101403163|NCT00421252|Purinergic Agents|purinergic agents|mesh-ancestor
101403164|NCT00421252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101403165|NCT00421252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348060|NCT00035607|Darbepoetin alfa|darbepoetin alfa|mesh-list
101403166|NCT00421252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403167|NCT00126204|Doxycycline|doxycycline|mesh-list
101306513|NCT02025998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101306514|NCT02025998|Autonomic Agents|autonomic agents|mesh-ancestor
101306515|NCT02025998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101403168|NCT00126204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101403170|NCT00126204|Antimalarials|antimalarials|mesh-ancestor
101403171|NCT00126204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101403172|NCT00126204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101403174|NCT04705402|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101403175|NCT04705402|Diuretics|diuretics|mesh-ancestor
102076095|NCT04605796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102076096|NCT04605796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101403176|NCT04705402|Natriuretic Agents|natriuretic agents|mesh-ancestor
101403177|NCT04705402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403178|NCT00091130|Vaccines|vaccines|mesh-list
101403179|NCT00091130|Immunologic Factors|immunologic factors|mesh-ancestor
101403180|NCT00091130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403181|NCT00126243|Rituximab|rituximab|mesh-list
101403182|NCT00126243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101403183|NCT00126243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101403184|NCT00126243|Immunologic Factors|immunologic factors|mesh-ancestor
101403185|NCT00126243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403186|NCT00126243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101403192|NCT00426439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101403193|NCT00426439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101403194|NCT00426439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101403195|NCT00426439|Antimalarials|antimalarials|mesh-ancestor
101403196|NCT00426439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101403197|NCT00426478|Amlodipine|amlodipine|mesh-list
101403198|NCT00426478|Valsartan|valsartan|mesh-list
101403199|NCT00426478|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101403200|NCT00426478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101403201|NCT00426478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101403202|NCT00426478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101403203|NCT00426478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403204|NCT00426478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101403205|NCT00426478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403206|NCT00426478|Vasodilator Agents|vasodilator agents|mesh-ancestor
101403207|NCT00426478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101403208|NCT00426478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101403209|NCT00426478|Diuretics|diuretics|mesh-ancestor
101403210|NCT00426478|Natriuretic Agents|natriuretic agents|mesh-ancestor
101403211|NCT00426478|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101403212|NCT04705519|Paclitaxel|paclitaxel|mesh-list
101403213|NCT04705519|Bevacizumab|bevacizumab|mesh-list
101403214|NCT04705519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101403215|NCT04705519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101403216|NCT04705519|Tubulin Modulators|tubulin modulators|mesh-ancestor
101403217|NCT04705519|Antimitotic Agents|antimitotic agents|mesh-ancestor
101403218|NCT04705519|Mitosis Modulators|mitosis modulators|mesh-ancestor
101403219|NCT04705519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403220|NCT04705519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101403221|NCT04705519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101403222|NCT04705519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101403223|NCT04705519|Growth Substances|growth substances|mesh-ancestor
101403224|NCT04705519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403225|NCT04705519|Growth Inhibitors|growth inhibitors|mesh-ancestor
101403226|NCT00126282|Cycloserine|cycloserine|mesh-list
101403227|NCT00126282|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101403228|NCT00126282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101403229|NCT00126282|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101403230|NCT00126282|Antitubercular Agents|antitubercular agents|mesh-ancestor
101403231|NCT00126282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101403232|NCT00126282|Antimetabolites|antimetabolites|mesh-ancestor
101403233|NCT00126282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403234|NCT04705129|Tislelizumab|tislelizumab|mesh-list
101403235|NCT04705129|Zanubrutinib|zanubrutinib|mesh-list
101403236|NCT04705129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101403237|NCT04705129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101403238|NCT04705129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101403239|NCT04705129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101403240|NCT04705129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403241|NCT00126321|Cladribine|cladribine|mesh-list
101306516|NCT02025998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306517|NCT02025998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101403242|NCT00126321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101403243|NCT00126321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101403244|NCT00126321|Immunologic Factors|immunologic factors|mesh-ancestor
101403245|NCT00126321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403247|NCT00426595|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101403268|NCT00126360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101403269|NCT00126360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102076097|NCT04605796|Growth Substances|growth substances|mesh-ancestor
102076098|NCT04605796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076099|NCT04605796|Growth Inhibitors|growth inhibitors|mesh-ancestor
102076100|NCT01345669|Afatinib|afatinib|mesh-list
102076101|NCT01345669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102076102|NCT01345669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102076103|NCT01345669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102076104|NCT01345669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403270|NCT00126360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403271|NCT00126360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101403272|NCT00126360|Hormone Antagonists|hormone antagonists|mesh-ancestor
101403273|NCT00126360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101403274|NCT00126360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403275|NCT01058863|Albuterol|albuterol|mesh-list
101403276|NCT01058863|Procaterol|procaterol|mesh-list
101403277|NCT01058863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101403278|NCT01058863|Autonomic Agents|autonomic agents|mesh-ancestor
101403279|NCT01058863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101403280|NCT01058863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403281|NCT01058863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101403282|NCT01058863|Respiratory System Agents|respiratory system agents|mesh-ancestor
101403283|NCT01058863|Tocolytic Agents|tocolytic agents|mesh-ancestor
101403284|NCT01058863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101403285|NCT01058863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101403286|NCT01058863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101403287|NCT01058863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101403288|NCT01058863|Adrenergic Agents|adrenergic agents|mesh-ancestor
101403289|NCT01058863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101403290|NCT01058863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403291|NCT01058863|Sympathomimetics|sympathomimetics|mesh-ancestor
101403292|NCT00091286|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101403293|NCT00091286|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101403294|NCT00091286|Immunologic Factors|immunologic factors|mesh-ancestor
101403295|NCT00091286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403296|NCT00126399|Doxycycline|doxycycline|mesh-list
101403297|NCT00126399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101403298|NCT00126399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101403299|NCT00126399|Antimalarials|antimalarials|mesh-ancestor
101403300|NCT00126399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101403301|NCT00126399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101403302|NCT01058395|Minocycline|minocycline|mesh-list
101403303|NCT01058395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101403304|NCT01058395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101403305|NCT00091325|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
101403306|NCT00091325|Antioxidants|antioxidants|mesh-ancestor
101403307|NCT00091325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403308|NCT00091325|Protective Agents|protective agents|mesh-ancestor
101403309|NCT00091325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403310|NCT00091325|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101403311|NCT00091325|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101403312|NCT00091325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101403313|NCT00091325|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101403314|NCT00126516|Angiotensin II|angiotensin ii|mesh-list
101403315|NCT00126516|Giapreza|giapreza|mesh-list
101403316|NCT00126516|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101403317|NCT00126516|Angiotensinogen|angiotensinogen|mesh-list
101403318|NCT00126516|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101403319|NCT00126516|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
101348358|NCT00036855|Rituximab|rituximab|mesh-list
101403320|NCT00126516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403334|NCT01058005|Interferon-beta|interferon-beta|mesh-list
101403335|NCT01058005|Interferon beta-1a|interferon beta-1a|mesh-list
101403336|NCT01058005|Glatiramer Acetate|glatiramer acetate|mesh-list
101403337|NCT01058005|Natalizumab|natalizumab|mesh-list
101403338|NCT01058005|(T,G)-A-L|(t,g)-a-l|mesh-list
101403339|NCT01058005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101403340|NCT01058005|Antiviral Agents|antiviral agents|mesh-ancestor
101403341|NCT01058005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102076105|NCT04313608|Gemcitabine|gemcitabine|mesh-list
102076106|NCT04313608|Oxaliplatin|oxaliplatin|mesh-list
102076107|NCT04313608|Obinutuzumab|obinutuzumab|mesh-list
102076108|NCT04313608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102076109|NCT04313608|Antimetabolites|antimetabolites|mesh-ancestor
102076110|NCT04313608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076111|NCT04313608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102076112|NCT04313608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102076113|NCT04502264|Botulinum Toxins|botulinum toxins|mesh-list
102076114|NCT04502264|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102076115|NCT04502264|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101377773|NCT00247741|Anesthetics|anesthetics|mesh-ancestor
101498893|NCT00600145|Mirtazapine|mirtazapine|mesh-list
101403342|NCT01058005|Immunologic Factors|immunologic factors|mesh-ancestor
101403343|NCT01058005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403344|NCT01058005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101403345|NCT01058005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101403346|NCT01058005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101403347|NCT00091559|Vorinostat|vorinostat|mesh-list
101403348|NCT00091559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101403349|NCT00091559|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101403350|NCT00091559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101403351|NCT00091559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403352|NCT00426829|Bevacizumab|bevacizumab|mesh-list
101403353|NCT00426829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101403354|NCT00426829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101403355|NCT00426829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101403356|NCT00426829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101403357|NCT00426829|Growth Substances|growth substances|mesh-ancestor
101403358|NCT00426829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403359|NCT00426829|Growth Inhibitors|growth inhibitors|mesh-ancestor
101403360|NCT00426946|Reboxetine|reboxetine|mesh-list
101403361|NCT00426946|Antidepressive Agents|antidepressive agents|mesh-ancestor
101403362|NCT00426946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101403363|NCT00426946|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101403364|NCT00426946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101403365|NCT00426946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101403366|NCT00426946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403367|NCT00426946|Adrenergic Agents|adrenergic agents|mesh-ancestor
101403368|NCT00426946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101403369|NCT00426946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403370|NCT00091598|Ambrisentan|ambrisentan|mesh-list
101403371|NCT00091598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101403372|NCT00426985|Ketoprofen|ketoprofen|mesh-list
101403373|NCT00426985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101403374|NCT00426985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101403375|NCT00426985|Analgesics|analgesics|mesh-ancestor
101403376|NCT00426985|Sensory System Agents|sensory system agents|mesh-ancestor
101403377|NCT00426985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101403378|NCT00426985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403379|NCT00426985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101403380|NCT00426985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101403381|NCT00426985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101403382|NCT00426985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101403383|NCT00426985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403384|NCT00427102|Cisplatin|cisplatin|mesh-list
101403385|NCT00427102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101403386|NCT00427414|Daunorubicin|daunorubicin|mesh-list
101403387|NCT00427414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403388|NCT00427414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101403389|NCT00427414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101403390|NCT00427414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101377783|NCT00099684|Ezetimibe|ezetimibe|mesh-list
102076116|NCT04502264|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102076117|NCT04502264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102076118|NCT04502264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076119|NCT04502264|Cholinergic Agents|cholinergic agents|mesh-ancestor
102076120|NCT04502264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102076121|NCT04502264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076122|NCT04502264|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102076123|NCT04502264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102076124|NCT03527732|Ivermectin|ivermectin|mesh-list
102076125|NCT03527732|Albendazole|albendazole|mesh-list
101403391|NCT00427414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101403392|NCT00427414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101403393|NCT03929718|Spironolactone|spironolactone|mesh-list
101403394|NCT03929718|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101306524|NCT02026050|Dexamethasone|dexamethasone|mesh-list
101306525|NCT02026050|Dexamethasone acetate|dexamethasone acetate|mesh-list
101306526|NCT02026050|BB 1101|bb 1101|mesh-list
101306527|NCT02026050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101306528|NCT02026050|Antiemetics|antiemetics|mesh-ancestor
101306529|NCT02026050|Autonomic Agents|autonomic agents|mesh-ancestor
101306530|NCT02026050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101306531|NCT02026050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403404|NCT01056523|Antimetabolites|antimetabolites|mesh-ancestor
101403405|NCT01056523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403406|NCT01056523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101403407|NCT01056523|Antiviral Agents|antiviral agents|mesh-ancestor
101403408|NCT01056523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101403409|NCT01056523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101403410|NCT01056523|Immunologic Factors|immunologic factors|mesh-ancestor
101403411|NCT01056523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403412|NCT00091715|Bosentan|bosentan|mesh-list
101403413|NCT00091715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101403414|NCT00091715|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101403415|NCT00091715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403416|NCT00427492|Magnesium Oxide|magnesium oxide|mesh-list
101403417|NCT00427492|Antacids|antacids|mesh-ancestor
101403418|NCT00427492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403419|NCT00427492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101403420|NCT00427570|Fluorouracil|fluorouracil|mesh-list
101403421|NCT00427570|Vincristine|vincristine|mesh-list
101403422|NCT00427570|Semustine|semustine|mesh-list
101403423|NCT00427570|BCG Vaccine|bcg vaccine|mesh-list
101403424|NCT00427570|Antimetabolites|antimetabolites|mesh-ancestor
101403425|NCT00427570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403426|NCT00427570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101403427|NCT00427570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101403428|NCT00427570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101403429|NCT00427570|Immunologic Factors|immunologic factors|mesh-ancestor
101403430|NCT00427570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403431|NCT00427570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101403432|NCT00427570|Tubulin Modulators|tubulin modulators|mesh-ancestor
101403433|NCT00427570|Antimitotic Agents|antimitotic agents|mesh-ancestor
101403434|NCT00427570|Mitosis Modulators|mitosis modulators|mesh-ancestor
101403435|NCT00427570|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101403436|NCT00427570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101403437|NCT00427570|Alkylating Agents|alkylating agents|mesh-ancestor
101403438|NCT00427609|Penicillin G Benzathine|penicillin g benzathine|mesh-list
101403439|NCT00427609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101403440|NCT00427609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101403441|NCT00091910|Epoetin Alfa|epoetin alfa|mesh-list
101403442|NCT00091910|Hematinics|hematinics|mesh-ancestor
101403443|NCT00427882|Alfuzosin|alfuzosin|mesh-list
101403444|NCT00427882|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101377793|NCT00248053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102076126|NCT03527732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102076127|NCT03527732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102076128|NCT03527732|Anthelmintics|anthelmintics|mesh-ancestor
102076129|NCT03527732|Anticestodal Agents|anticestodal agents|mesh-ancestor
102076130|NCT03527732|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102076131|NCT03527732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102076132|NCT03527732|Tubulin Modulators|tubulin modulators|mesh-ancestor
102076133|NCT03527732|Antimitotic Agents|antimitotic agents|mesh-ancestor
102076134|NCT03527732|Mitosis Modulators|mitosis modulators|mesh-ancestor
102076135|NCT03527732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076136|NCT03527732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102076137|NCT01673854|Ipilimumab|ipilimumab|mesh-list
102076138|NCT01673854|Vemurafenib|vemurafenib|mesh-list
102076139|NCT01673854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102076140|NCT01673854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102076141|NCT01673854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102076142|NCT01673854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499012|NCT00623077|Mesna|mesna|mesh-list
101403445|NCT00427882|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101403446|NCT00427882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101403447|NCT00427882|Adrenergic Agents|adrenergic agents|mesh-ancestor
101403448|NCT00427882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101403449|NCT00427882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403450|NCT00427882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403451|NCT00427882|Urological Agents|urological agents|mesh-ancestor
101403452|NCT04704622|Midazolam|midazolam|mesh-list
101403453|NCT04704622|Dexmedetomidine|dexmedetomidine|mesh-list
101403454|NCT04704622|Ketamine|ketamine|mesh-list
101306532|NCT02026050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101306534|NCT02026050|Hormones|hormones|mesh-ancestor
101306535|NCT02026050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101403460|NCT04704622|Sensory System Agents|sensory system agents|mesh-ancestor
101403461|NCT04704622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101403462|NCT04704622|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101403463|NCT04704622|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101403464|NCT04704622|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101403465|NCT04704622|Adrenergic Agents|adrenergic agents|mesh-ancestor
101403466|NCT04704622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101403481|NCT00428194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101403482|NCT00428194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101403483|NCT00428194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101403484|NCT00428194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403485|NCT03769467|Pembrolizumab|pembrolizumab|mesh-list
101403486|NCT03769467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101403487|NCT03769467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101403488|NCT03769467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101403489|NCT03769467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403490|NCT00092183|Ondansetron|ondansetron|mesh-list
101403492|NCT00092183|Antiemetics|antiemetics|mesh-ancestor
101403493|NCT00092183|Autonomic Agents|autonomic agents|mesh-ancestor
101403494|NCT00092183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101403495|NCT00092183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403496|NCT00092183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101403497|NCT00092183|Antipruritics|antipruritics|mesh-ancestor
102076147|NCT03549702|Plasma Substitutes|plasma substitutes|mesh-ancestor
102076148|NCT03549702|Blood Substitutes|blood substitutes|mesh-ancestor
102076149|NCT03549702|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102076150|NCT03549702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102076151|NCT02529904|Vaccines|vaccines|mesh-list
102076152|NCT02529904|Immunologic Factors|immunologic factors|mesh-ancestor
102076153|NCT02529904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403498|NCT00092183|Dermatologic Agents|dermatologic agents|mesh-ancestor
101403499|NCT00092183|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101403500|NCT00092183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101403501|NCT00092183|Serotonin Agents|serotonin agents|mesh-ancestor
101403502|NCT00092183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101403503|NCT00092183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403504|NCT00092183|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101403505|NCT00428272|Interferons|interferons|mesh-list
101403506|NCT00428272|Interferon-gamma|interferon-gamma|mesh-list
101403507|NCT00428272|Lexatumumab|lexatumumab|mesh-list
101403508|NCT00428272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101403509|NCT00428272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101403510|NCT00428272|Antiviral Agents|antiviral agents|mesh-ancestor
101403511|NCT00428272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101403512|NCT00428272|Immunologic Factors|immunologic factors|mesh-ancestor
101403513|NCT00428272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403514|NCT01580254|Latanoprost|latanoprost|mesh-list
101403515|NCT01580254|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101403516|NCT01580254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101403517|NCT00428311|Metformin|metformin|mesh-list
101403518|NCT00428311|Cyproterone Acetate|cyproterone acetate|mesh-list
101403519|NCT00428311|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101403520|NCT00428311|Estradiol|estradiol|mesh-list
101403521|NCT00428311|Cyproterone|cyproterone|mesh-list
101403522|NCT00428311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101403523|NCT00428311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403524|NCT00428311|Estrogens|estrogens|mesh-ancestor
101403525|NCT00428311|Hormones|hormones|mesh-ancestor
101403526|NCT00428311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101403527|NCT00428311|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101403528|NCT00428311|Contraceptive Agents|contraceptive agents|mesh-ancestor
101403529|NCT00428311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101403544|NCT00092300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101403546|NCT00092300|Sensory System Agents|sensory system agents|mesh-ancestor
101403547|NCT00092300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101403548|NCT00092300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403549|NCT00092300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101403550|NCT00092300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101403551|NCT00428350|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101306536|NCT02026050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101306537|NCT02026050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101200132|NCT02293109|Antidotes|antidotes|mesh-ancestor
101306540|NCT02026050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403553|NCT00428350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101403554|NCT00428350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101403555|NCT00428350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101403556|NCT00428350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101403557|NCT00428350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403565|NCT00428428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101403566|NCT00428428|Autonomic Agents|autonomic agents|mesh-ancestor
101403567|NCT00428428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101403568|NCT00428428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101403569|NCT00428428|Respiratory System Agents|respiratory system agents|mesh-ancestor
101403570|NCT00428428|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101403571|NCT00428428|Sympathomimetics|sympathomimetics|mesh-ancestor
101403572|NCT00428428|Protective Agents|protective agents|mesh-ancestor
101403574|NCT00092339|Rofecoxib|rofecoxib|mesh-list
101403575|NCT00092339|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101403576|NCT00092339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101403577|NCT00092339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101403578|NCT00092339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403579|NCT00092339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101403580|NCT00092339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101403581|NCT00092339|Analgesics|analgesics|mesh-ancestor
101403582|NCT00092339|Sensory System Agents|sensory system agents|mesh-ancestor
101403583|NCT00092339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101403584|NCT00092339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403585|NCT00092339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101403586|NCT00092339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101403587|NCT00428545|Bevacizumab|bevacizumab|mesh-list
101403588|NCT00428545|Bortezomib|bortezomib|mesh-list
101403589|NCT00428545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101403590|NCT00428545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101403602|NCT00092378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101348699|NCT05432934|Hormones|hormones|mesh-ancestor
101403603|NCT00092378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403605|NCT00092378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101403606|NCT00092378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101403607|NCT00092378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101403608|NCT00092378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403609|NCT00092378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101403610|NCT00092846|Lovastatin|lovastatin|mesh-list
101403611|NCT00092846|L 647318|l 647318|mesh-list
101403612|NCT00092846|Dihydromevinolin|dihydromevinolin|mesh-list
101403613|NCT00092846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101403614|NCT00092846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101403615|NCT00092846|Antimetabolites|antimetabolites|mesh-ancestor
101403616|NCT00092846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403617|NCT00092846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101403618|NCT00092846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101403619|NCT00092846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101403620|NCT00092924|Mapatumumab|mapatumumab|mesh-list
101403621|NCT00092924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101403622|NCT00093002|Fulvestrant|fulvestrant|mesh-list
101403623|NCT00093002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101403624|NCT00093002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101403625|NCT00093002|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101403626|NCT00093002|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101403627|NCT00093002|Hormone Antagonists|hormone antagonists|mesh-ancestor
102076172|NCT01367886|Cholinergic Agents|cholinergic agents|mesh-ancestor
102076173|NCT01367886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102076174|NCT01367886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306541|NCT02026219|Clopidogrel|clopidogrel|mesh-list
101306543|NCT02026219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101306544|NCT02026219|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101403628|NCT00093002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101403634|NCT00093158|Antithrombins|antithrombins|mesh-ancestor
101403635|NCT00093158|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101403636|NCT00093158|Protease Inhibitors|protease inhibitors|mesh-ancestor
101403637|NCT00093158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101403638|NCT00093158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403639|NCT03501498|Loperamide|loperamide|mesh-list
101403640|NCT03501498|Antidiarrheals|antidiarrheals|mesh-list
101403641|NCT03501498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101403642|NCT05561049|Thalidomide|thalidomide|mesh-list
101403643|NCT05561049|Dexamethasone|dexamethasone|mesh-list
101403644|NCT05561049|Bortezomib|bortezomib|mesh-list
101403645|NCT05561049|Daratumumab|daratumumab|mesh-list
101403646|NCT05561049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101403647|NCT05561049|Antiemetics|antiemetics|mesh-ancestor
101403648|NCT05561049|Autonomic Agents|autonomic agents|mesh-ancestor
101403649|NCT05561049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101403650|NCT05561049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403651|NCT05561049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101403652|NCT05561049|Glucocorticoids|glucocorticoids|mesh-ancestor
101403653|NCT05561049|Hormones|hormones|mesh-ancestor
101403654|NCT05561049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101404262|NCT00430144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404263|NCT00430144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404553|NCT00431236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404555|NCT00431236|Dermatologic Agents|dermatologic agents|mesh-ancestor
101404556|NCT00431236|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101404557|NCT00431236|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101404558|NCT00431236|Serotonin Agents|serotonin agents|mesh-ancestor
101404559|NCT00431236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101404560|NCT00431236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404561|NCT00431236|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101404562|NCT00431275|Tremelimumab|tremelimumab|mesh-list
101404563|NCT00431275|Ipilimumab|ipilimumab|mesh-list
101404564|NCT00431275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404565|NCT00431275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101404566|NCT00431275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101404567|NCT00431275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404568|NCT00431353|Valganciclovir|valganciclovir|mesh-list
101404569|NCT00431353|Ganciclovir|ganciclovir|mesh-list
101404570|NCT00431353|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101404571|NCT00431353|Antiviral Agents|antiviral agents|mesh-ancestor
101404572|NCT00431353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101404573|NCT00431353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101404574|NCT00431353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404575|NCT00431353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404576|NCT00130845|Octreotide|octreotide|mesh-list
101404577|NCT00130845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101404578|NCT00130845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102076175|NCT01367886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076176|NCT01367886|Urological Agents|urological agents|mesh-ancestor
102076178|NCT05706337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102076179|NCT05706337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102076180|NCT05706337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076181|NCT05706337|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101404579|NCT00130845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404840|NCT00433069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101404841|NCT00433069|Antimetabolites|antimetabolites|mesh-ancestor
101404842|NCT00433069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404843|NCT00433069|Immunologic Factors|immunologic factors|mesh-ancestor
101404844|NCT00433069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405005|NCT00433576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405006|NCT00433576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101405007|NCT00433615|Epoetin Alfa|epoetin alfa|mesh-list
101405008|NCT00433615|Hematinics|hematinics|mesh-ancestor
101405034|NCT00098423|Antimetabolites|antimetabolites|mesh-ancestor
101405035|NCT00098423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306545|NCT02026219|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101306546|NCT02026219|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101306547|NCT02026219|Purinergic Agents|purinergic agents|mesh-ancestor
101306548|NCT02026219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101306549|NCT02026219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405046|NCT01050790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101405047|NCT01050790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101405048|NCT01050790|Growth Substances|growth substances|mesh-ancestor
101405049|NCT01050790|Growth Inhibitors|growth inhibitors|mesh-ancestor
101405050|NCT01050790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405051|NCT01050790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101405052|NCT01050790|Antimetabolites|antimetabolites|mesh-ancestor
101405053|NCT01050790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405054|NCT01050790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405056|NCT00433927|Folic Acid|folic acid|mesh-list
101405057|NCT00433927|Bevacizumab|bevacizumab|mesh-list
101405058|NCT00433927|Cetuximab|cetuximab|mesh-list
101405059|NCT00433927|Irinotecan|irinotecan|mesh-list
101405434|NCT00132210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405435|NCT00132210|Antiviral Agents|antiviral agents|mesh-ancestor
101405436|NCT00132210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101405437|NCT00099944|Glimepiride|glimepiride|mesh-list
101405438|NCT00099944|Vildagliptin|vildagliptin|mesh-list
101405439|NCT00099944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101405440|NCT00099944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101405441|NCT00099944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405442|NCT00099944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101405443|NCT00099944|Immunologic Factors|immunologic factors|mesh-ancestor
101405444|NCT00099944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101405445|NCT00099944|Protease Inhibitors|protease inhibitors|mesh-ancestor
101405446|NCT00099944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405447|NCT00099944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405448|NCT04333914|Avdoralimab|avdoralimab|mesh-list
101405449|NCT04333914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101405450|NCT04333914|Antiviral Agents|antiviral agents|mesh-ancestor
101405451|NCT04333914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101405452|NCT00100100|Modafinil|modafinil|mesh-list
101405453|NCT00100100|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101405590|NCT00100646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101405591|NCT00100646|Antiviral Agents|antiviral agents|mesh-ancestor
101405592|NCT00100646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101405593|NCT00100646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101405594|NCT00100646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101405595|NCT00100646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101405596|NCT00100646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101405597|NCT00100646|Antimetabolites|antimetabolites|mesh-ancestor
101405598|NCT00100685|Volociximab|volociximab|mesh-list
101405599|NCT00100685|Antibodies|antibodies|mesh-list
101405600|NCT00100685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102076183|NCT05706337|Anesthetics|anesthetics|mesh-ancestor
102076184|NCT05222113|Remdesivir|remdesivir|mesh-list
102076185|NCT05222113|Favipiravir|favipiravir|mesh-list
102076186|NCT05222113|Antimetabolites|antimetabolites|mesh-ancestor
102076187|NCT05222113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076188|NCT05222113|Antiviral Agents|antiviral agents|mesh-ancestor
102076189|NCT05222113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101405601|NCT00100685|Immunologic Factors|immunologic factors|mesh-ancestor
101405602|NCT00100685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405603|NCT00100685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101405604|NCT00100685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101405907|NCT00102284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101405908|NCT00102284|Protective Agents|protective agents|mesh-ancestor
101405909|NCT00135525|Paroxetine|paroxetine|mesh-list
101406035|NCT00133458|Antimitotic Agents|antimitotic agents|mesh-ancestor
101406036|NCT00133458|Mitosis Modulators|mitosis modulators|mesh-ancestor
101406037|NCT00133458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406202|NCT00103298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101406204|NCT00103298|Antimetabolites|antimetabolites|mesh-ancestor
101406205|NCT00103298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406206|NCT00103298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101406207|NCT00103298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101406208|NCT00103298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101406209|NCT00103298|Immunologic Factors|immunologic factors|mesh-ancestor
101406210|NCT00103298|Antidotes|antidotes|mesh-ancestor
101406211|NCT00103298|Protective Agents|protective agents|mesh-ancestor
101406212|NCT00103298|Vitamin B Complex|vitamin b complex|mesh-ancestor
101406213|NCT00103298|Vitamins|vitamins|mesh-ancestor
101406214|NCT00103298|Micronutrients|micronutrients|mesh-ancestor
101406215|NCT00103298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101406216|NCT00103298|Alkylating Agents|alkylating agents|mesh-ancestor
101406217|NCT00103298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101406218|NCT00136461|Tretinoin|tretinoin|mesh-list
101406219|NCT00136461|Bryostatin 1|bryostatin 1|mesh-list
101406220|NCT00136461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101406221|NCT00136461|Keratolytic Agents|keratolytic agents|mesh-ancestor
101406222|NCT00136461|Dermatologic Agents|dermatologic agents|mesh-ancestor
101406223|NCT00136461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101406224|NCT00136461|Immunologic Factors|immunologic factors|mesh-ancestor
101406225|NCT00136461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406226|NCT00133770|Pantoprazole|pantoprazole|mesh-list
101406227|NCT00133770|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101406228|NCT00133770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101406229|NCT00133770|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101406230|NCT00133770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101406231|NCT00133770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406232|NCT00133848|Retapamulin|retapamulin|mesh-list
101406667|NCT00105287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101406668|NCT00105287|Anesthetics, General|anesthetics, general|mesh-ancestor
101406669|NCT00105287|Anesthetics|anesthetics|mesh-ancestor
101406670|NCT00137514|Chloroquine|chloroquine|mesh-list
101406671|NCT00137514|Amodiaquine|amodiaquine|mesh-list
101409217|NCT00144222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101409218|NCT00144222|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101409219|NCT00144222|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101409220|NCT00144222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409221|NCT00466180|Nevirapine|nevirapine|mesh-list
101409222|NCT00466180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101409223|NCT00466180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101409224|NCT00466180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101409225|NCT00466180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409226|NCT00466180|Antiviral Agents|antiviral agents|mesh-ancestor
101409227|NCT00466180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101409228|NCT00466180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101409229|NCT00466180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101409230|NCT00466180|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101409231|NCT00466180|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101377850|NCT00248482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076190|NCT03854578|Citalopram|citalopram|mesh-list
102076191|NCT03854578|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102076192|NCT03854578|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102076193|NCT03854578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102076194|NCT03854578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076195|NCT03854578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102076196|NCT03854578|Serotonin Agents|serotonin agents|mesh-ancestor
101409232|NCT00466219|Interferons|interferons|mesh-list
101409233|NCT00466219|Ribavirin|ribavirin|mesh-list
101409234|NCT00466219|Interferon-alpha|interferon-alpha|mesh-list
101409235|NCT00466219|Interferon alpha-2|interferon alpha-2|mesh-list
101409236|NCT00466219|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101409237|NCT00466219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101409238|NCT00466219|Antiviral Agents|antiviral agents|mesh-ancestor
101409239|NCT00466219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101409240|NCT00466219|Antimetabolites|antimetabolites|mesh-ancestor
101409241|NCT00466219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409242|NCT00466219|Immunologic Factors|immunologic factors|mesh-ancestor
101409246|NCT00144261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101409247|NCT00144261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101417444|NCT00141414|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101417445|NCT00141414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101417446|NCT00141414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417447|NCT00141414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101417449|NCT00141414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101417450|NCT00141414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101417451|NCT00141414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101417452|NCT00145002|Lenograstim|lenograstim|mesh-list
101417453|NCT00145002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101417454|NCT00145002|Immunologic Factors|immunologic factors|mesh-ancestor
101417810|NCT00152724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101417811|NCT00152724|Analgesics|analgesics|mesh-ancestor
101417812|NCT00152724|Sensory System Agents|sensory system agents|mesh-ancestor
101417813|NCT00152724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101417814|NCT00152724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417815|NCT00152724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101417816|NCT00152724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101417817|NCT00152724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101417818|NCT00152724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101417819|NCT00152724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417820|NCT00152724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101417821|NCT00152724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101417822|NCT00152724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101417823|NCT00152724|Antipyretics|antipyretics|mesh-ancestor
101417824|NCT00152724|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101417825|NCT00152724|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101417826|NCT00152724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101417827|NCT00152724|Purinergic Agents|purinergic agents|mesh-ancestor
101417828|NCT00152724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101417829|NCT00152724|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101417830|NCT00152724|Antipruritics|antipruritics|mesh-ancestor
101417831|NCT00152724|Dermatologic Agents|dermatologic agents|mesh-ancestor
101417832|NCT00152724|Gout Suppressants|gout suppressants|mesh-ancestor
101417833|NCT00152724|Tocolytic Agents|tocolytic agents|mesh-ancestor
101417834|NCT00152724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101417835|NCT00152724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101417836|NCT00152724|Vasodilator Agents|vasodilator agents|mesh-ancestor
101417837|NCT00152724|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101417838|NCT00152724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101417839|NCT00152724|Cholinergic Agents|cholinergic agents|mesh-ancestor
101417840|NCT00135668|Nitroprusside|nitroprusside|mesh-list
101417841|NCT00135668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101417842|NCT00135668|Vasodilator Agents|vasodilator agents|mesh-ancestor
102076197|NCT03854578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076198|NCT03854578|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101348854|NCT00277043|Paclitaxel|paclitaxel|mesh-list
102076199|NCT03854578|Antidepressive Agents|antidepressive agents|mesh-ancestor
102076200|NCT03854578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102076201|NCT03038594|Hormones|hormones|mesh-list
102076202|NCT03038594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102076203|NCT03038594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076204|NCT02136888|Moxifloxacin|moxifloxacin|mesh-list
102076205|NCT02136888|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
102076206|NCT02136888|Ponesimod|ponesimod|mesh-list
101417843|NCT00135668|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101417844|NCT00135668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417845|NCT00152802|Vaccines|vaccines|mesh-list
101417846|NCT00152802|Immunologic Factors|immunologic factors|mesh-ancestor
101417847|NCT00152802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417848|NCT00135746|Nicotine|nicotine|mesh-list
101417849|NCT00135746|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101417850|NCT00135746|Autonomic Agents|autonomic agents|mesh-ancestor
101417851|NCT00135746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101417852|NCT00135746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417853|NCT00135746|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101417854|NCT00135746|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101417855|NCT00135746|Cholinergic Agents|cholinergic agents|mesh-ancestor
101417856|NCT00135746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101417857|NCT00135746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417858|NCT00135785|Bupropion|bupropion|mesh-list
101417890|NCT00159081|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101417891|NCT00152841|Vitamin E|vitamin e|mesh-list
101417892|NCT00152841|Vitamins|vitamins|mesh-ancestor
101417893|NCT00152841|Micronutrients|micronutrients|mesh-ancestor
101417894|NCT00152841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417895|NCT00152841|Antioxidants|antioxidants|mesh-ancestor
101417896|NCT00152841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417897|NCT00152841|Protective Agents|protective agents|mesh-ancestor
101200566|NCT01398384|Nitric Oxide|nitric oxide|mesh-list
101417901|NCT00159120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417902|NCT00159120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101417903|NCT00159159|Cyclosporine|cyclosporine|mesh-list
101417904|NCT00159159|Cyclosporins|cyclosporins|mesh-list
101417905|NCT00159159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101417906|NCT00159159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417907|NCT00159159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101417908|NCT00159159|Immunologic Factors|immunologic factors|mesh-ancestor
101417909|NCT00159159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417910|NCT00159159|Antifungal Agents|antifungal agents|mesh-ancestor
101417911|NCT00159159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101417912|NCT00159159|Dermatologic Agents|dermatologic agents|mesh-ancestor
101417913|NCT00159159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101417914|NCT00159159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101417915|NCT00135824|Povidone|povidone|mesh-list
101417916|NCT00135824|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101417917|NCT00135824|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101417918|NCT00135824|Plasma Substitutes|plasma substitutes|mesh-ancestor
101417919|NCT00135824|Blood Substitutes|blood substitutes|mesh-ancestor
101417920|NCT00135863|Tinzaparin|tinzaparin|mesh-list
101417921|NCT00135863|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101417922|NCT00135863|Dalteparin|dalteparin|mesh-list
101417923|NCT00135863|Anticoagulants|anticoagulants|mesh-ancestor
101417924|NCT00135863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101417925|NCT00135863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101417926|NCT00135863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417927|NCT00135902|Progesterone|progesterone|mesh-list
101417928|NCT00135902|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
101417929|NCT00135902|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
102076207|NCT02136888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102076208|NCT02136888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102076209|NCT02136888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102076210|NCT02136888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102076211|NCT02136888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102076212|NCT02136888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076213|NCT02136888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102076214|NCT02136888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102076215|NCT02136888|Contraceptive Agents|contraceptive agents|mesh-ancestor
101417930|NCT00135902|Progestins|progestins|mesh-ancestor
101417931|NCT00135902|Hormones|hormones|mesh-ancestor
101417932|NCT00135902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101306563|NCT02026479|Antiemetics|antiemetics|mesh-ancestor
101306564|NCT02026479|Autonomic Agents|autonomic agents|mesh-ancestor
101417933|NCT00135902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417934|NCT00135902|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101417935|NCT00135902|Hormone Antagonists|hormone antagonists|mesh-ancestor
101417936|NCT00135941|Insulin|insulin|mesh-list
101417937|NCT00135941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101417938|NCT00135941|Insulin Glargine|insulin glargine|mesh-list
101417939|NCT00135941|Insulin glulisine|insulin glulisine|mesh-list
101417940|NCT00135941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101417941|NCT00135941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417942|NCT00152919|Meloxicam|meloxicam|mesh-list
101417943|NCT00152919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101417944|NCT00152919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101417945|NCT00152919|Analgesics|analgesics|mesh-ancestor
101417946|NCT00152919|Sensory System Agents|sensory system agents|mesh-ancestor
101417947|NCT00152919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101417948|NCT00152919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417949|NCT00152919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101417958|NCT00406146|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101417959|NCT00406146|Amodiaquine|amodiaquine|mesh-list
101417960|NCT00406146|Antimalarials|antimalarials|mesh-ancestor
101417961|NCT00406146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101417962|NCT00406146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101417963|NCT00406146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101417964|NCT00406146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101417965|NCT00406146|Antiviral Agents|antiviral agents|mesh-ancestor
101417966|NCT00406146|Schistosomicides|schistosomicides|mesh-ancestor
101417967|NCT00406146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101417968|NCT00406146|Anthelmintics|anthelmintics|mesh-ancestor
101417969|NCT00136058|Alendronate|alendronate|mesh-list
101417970|NCT00136058|Risedronic Acid|risedronic acid|mesh-list
101417971|NCT00136058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101417972|NCT00136058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417973|NCT00136058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101417974|NCT00136058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101417975|NCT00136058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417976|NCT00136058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101417977|NCT00152958|Pramipexole|pramipexole|mesh-list
101348947|NCT00276770|Fluorides|fluorides|mesh-list
101417981|NCT00152958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417982|NCT00152958|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101417983|NCT00152958|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101417984|NCT00152958|Dopamine Agonists|dopamine agonists|mesh-ancestor
101417985|NCT00152958|Dopamine Agents|dopamine agents|mesh-ancestor
101417986|NCT00152958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101417988|NCT00136175|Carboplatin|carboplatin|mesh-list
101417989|NCT00136175|Gemcitabine|gemcitabine|mesh-list
101417990|NCT00136175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101417991|NCT00136175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101417992|NCT00136175|Tubulin Modulators|tubulin modulators|mesh-ancestor
101417993|NCT00136175|Antimitotic Agents|antimitotic agents|mesh-ancestor
101417994|NCT00136175|Mitosis Modulators|mitosis modulators|mesh-ancestor
101377877|NCT00068042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102076216|NCT02136888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102076217|NCT02136888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076218|NCT02136888|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
102076219|NCT02136888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102076220|NCT02136888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102076221|NCT02136888|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102076222|NCT02136888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102076223|NCT02136888|Immunologic Factors|immunologic factors|mesh-ancestor
102076224|NCT02132286|Quetiapine Fumarate|quetiapine fumarate|mesh-list
102076225|NCT02132286|Antidepressive Agents|antidepressive agents|mesh-ancestor
102076226|NCT02132286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101795967|NCT00997815|Botulinum Toxins|botulinum toxins|mesh-list
102076227|NCT02132286|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102076228|NCT02132286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102076229|NCT02132286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102076230|NCT02132286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417995|NCT00136175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417996|NCT00136175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101417997|NCT00136175|Antimetabolites|antimetabolites|mesh-ancestor
101417998|NCT00152997|Pramipexole|pramipexole|mesh-list
101417999|NCT00152997|Antioxidants|antioxidants|mesh-ancestor
101418000|NCT00152997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418001|NCT00152997|Protective Agents|protective agents|mesh-ancestor
101418002|NCT00152997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418003|NCT00152997|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101418004|NCT00152997|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101418005|NCT00152997|Dopamine Agonists|dopamine agonists|mesh-ancestor
101418006|NCT00152997|Dopamine Agents|dopamine agents|mesh-ancestor
101418007|NCT00152997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101418008|NCT00136292|Daptomycin|daptomycin|mesh-list
101418009|NCT00136292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101418010|NCT00136292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101418011|NCT00153075|Fenoterol|fenoterol|mesh-list
101306565|NCT02026479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101306566|NCT02026479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306567|NCT02026479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101418012|NCT00153075|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
101418013|NCT00153075|Ipratropium|ipratropium|mesh-list
101418014|NCT00153075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101418015|NCT00153075|Autonomic Agents|autonomic agents|mesh-ancestor
101418016|NCT00153075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101418017|NCT00153075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418018|NCT00153075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101418024|NCT00153075|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101418025|NCT00153075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101418026|NCT00153075|Adrenergic Agents|adrenergic agents|mesh-ancestor
101418027|NCT00153075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101418028|NCT00153075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418029|NCT00153075|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101418030|NCT00153075|Cholinergic Agents|cholinergic agents|mesh-ancestor
101418031|NCT00159471|Gemcitabine|gemcitabine|mesh-list
101418032|NCT00159471|Capecitabine|capecitabine|mesh-list
101418033|NCT00159471|Docetaxel|docetaxel|mesh-list
101418034|NCT00159471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101418035|NCT00159471|Antimetabolites|antimetabolites|mesh-ancestor
102076231|NCT05252754|Indomethacin|indomethacin|mesh-list
102076232|NCT05252754|Tacrolimus|tacrolimus|mesh-list
102076233|NCT05252754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102076234|NCT05252754|Immunologic Factors|immunologic factors|mesh-ancestor
102076235|NCT05252754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076236|NCT05252754|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102076237|NCT05252754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101377896|NCT00099801|Immunologic Factors|immunologic factors|mesh-ancestor
101418036|NCT00159471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418037|NCT00159471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101418038|NCT00159471|Tubulin Modulators|tubulin modulators|mesh-ancestor
101418039|NCT00159471|Antimitotic Agents|antimitotic agents|mesh-ancestor
101418040|NCT00159471|Mitosis Modulators|mitosis modulators|mesh-ancestor
101418041|NCT00136370|Chlorhexidine|chlorhexidine|mesh-list
101418042|NCT00136370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101418043|NCT00136370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101418044|NCT00136370|Disinfectants|disinfectants|mesh-ancestor
101418045|NCT00159510|Nitric Oxide|nitric oxide|mesh-list
101418046|NCT00159510|Methylene Blue|methylene blue|mesh-list
101418047|NCT00159510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101418048|NCT00159510|Autonomic Agents|autonomic agents|mesh-ancestor
101418049|NCT00159510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101418050|NCT00159510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418051|NCT00159510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101200660|NCT01399242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101418055|NCT00159510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418056|NCT00159510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101418057|NCT00159510|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101418058|NCT00159510|Vasodilator Agents|vasodilator agents|mesh-ancestor
101418059|NCT00159510|Gasotransmitters|gasotransmitters|mesh-ancestor
101418060|NCT00159510|Protective Agents|protective agents|mesh-ancestor
101418061|NCT00159510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101418062|NCT00136409|Imatinib Mesylate|imatinib mesylate|mesh-list
101418063|NCT00136409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101418064|NCT00136409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101418065|NCT00136409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101418066|NCT00136409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418067|NCT00153114|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101418068|NCT00153114|Laxatives|laxatives|mesh-ancestor
101418069|NCT00153114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101418070|NCT00136448|Cytarabine|cytarabine|mesh-list
101418071|NCT00136448|Interleukin-2|interleukin-2|mesh-list
101418072|NCT00136448|Daunorubicin|daunorubicin|mesh-list
101418073|NCT00136448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101418074|NCT00136448|Antimetabolites|antimetabolites|mesh-ancestor
101418075|NCT00136448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418076|NCT00136448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101418077|NCT00136448|Antiviral Agents|antiviral agents|mesh-ancestor
101418078|NCT00136448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101418079|NCT00136448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101418080|NCT00136448|Immunologic Factors|immunologic factors|mesh-ancestor
101418081|NCT00136448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418082|NCT00136448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101418083|NCT00136448|Analgesics|analgesics|mesh-ancestor
101418084|NCT00136448|Sensory System Agents|sensory system agents|mesh-ancestor
101418085|NCT00136448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101306568|NCT02026479|Glucocorticoids|glucocorticoids|mesh-ancestor
101306569|NCT02026479|Hormones|hormones|mesh-ancestor
101306570|NCT02026479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101306571|NCT02026479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101418086|NCT00136448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101418087|NCT00136448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101418088|NCT00136448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101418110|NCT00153192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101418111|NCT00153192|Analgesics|analgesics|mesh-ancestor
101418112|NCT00153192|Sensory System Agents|sensory system agents|mesh-ancestor
101418113|NCT00153192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101418114|NCT00153192|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102076238|NCT05252754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076239|NCT05252754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102076240|NCT05252754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102076241|NCT05252754|Analgesics|analgesics|mesh-ancestor
102076242|NCT05252754|Sensory System Agents|sensory system agents|mesh-ancestor
102076243|NCT05252754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102076244|NCT05252754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101418115|NCT00153192|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101418116|NCT00153192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101418117|NCT00153192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418118|NCT00153192|Hormones|hormones|mesh-ancestor
101418119|NCT00153192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101418120|NCT00136526|Docetaxel|docetaxel|mesh-list
101418121|NCT00136526|Fosfestrol|fosfestrol|mesh-list
101418122|NCT00136526|Diethylstilbestrol|diethylstilbestrol|mesh-list
101418123|NCT00136526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101418124|NCT00136526|Tubulin Modulators|tubulin modulators|mesh-ancestor
101418125|NCT00136526|Antimitotic Agents|antimitotic agents|mesh-ancestor
101418126|NCT00136526|Mitosis Modulators|mitosis modulators|mesh-ancestor
101418127|NCT00136526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418128|NCT00136526|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101418129|NCT00136526|Estrogens|estrogens|mesh-ancestor
101418130|NCT00136526|Hormones|hormones|mesh-ancestor
101418131|NCT00136526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101418132|NCT00136526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418133|NCT00136526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101418134|NCT00136565|Prednisone|prednisone|mesh-list
101418135|NCT00136565|Cyclophosphamide|cyclophosphamide|mesh-list
101418136|NCT00136565|Doxorubicin|doxorubicin|mesh-list
101418137|NCT00136565|Bortezomib|bortezomib|mesh-list
101418138|NCT00136565|Bleomycin|bleomycin|mesh-list
101418139|NCT00136565|Vindesine|vindesine|mesh-list
101418140|NCT00136565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101200730|NCT01400022|Cortisone|cortisone|mesh-list
101418168|NCT00159666|Sensory System Agents|sensory system agents|mesh-ancestor
101418169|NCT00159666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101418170|NCT00159666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418171|NCT00159666|Anticonvulsants|anticonvulsants|mesh-ancestor
101418172|NCT00159666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101418173|NCT00159666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101418174|NCT00159666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418175|NCT00159666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101418176|NCT00159666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101418177|NCT00159666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101418178|NCT00159666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101418179|NCT00159666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101418180|NCT00153270|Valproic Acid|valproic acid|mesh-list
101418181|NCT00153270|Anticonvulsants|anticonvulsants|mesh-ancestor
101418182|NCT00153270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101418183|NCT00153270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418184|NCT00153270|GABA Agents|gaba agents|mesh-ancestor
101418185|NCT00153270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101418186|NCT00153270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418187|NCT00153270|Antimanic Agents|antimanic agents|mesh-ancestor
101418188|NCT00153270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101418189|NCT00153270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101418190|NCT00153270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101418191|NCT00159705|Pregabalin|pregabalin|mesh-list
101418192|NCT00159705|Analgesics|analgesics|mesh-ancestor
101306572|NCT02026479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101306573|NCT02026479|Protease Inhibitors|protease inhibitors|mesh-ancestor
101306574|NCT02026479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101306575|NCT02026479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306576|NCT02026492|Methacholine Chloride|methacholine chloride|mesh-list
101418193|NCT00159705|Sensory System Agents|sensory system agents|mesh-ancestor
101418194|NCT00159705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102076245|NCT05252754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102076246|NCT05252754|Gout Suppressants|gout suppressants|mesh-ancestor
102076248|NCT05252754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102076249|NCT05252754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102076250|NCT03548246|Hydrocortisone|hydrocortisone|mesh-list
102076251|NCT03548246|Fludrocortisone|fludrocortisone|mesh-list
102076252|NCT03548246|Abiraterone Acetate|abiraterone acetate|mesh-list
102076253|NCT03548246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101377907|NCT00249223|Risperidone|risperidone|mesh-list
101418208|NCT00136994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101418209|NCT00136994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418210|NCT00136994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418211|NCT00136994|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101418212|NCT00136994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101418213|NCT00136994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101418214|NCT00136994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101418215|NCT00136994|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101418216|NCT00136994|Dopamine Agents|dopamine agents|mesh-ancestor
101418217|NCT00137033|Celecoxib|celecoxib|mesh-list
101418218|NCT00137033|Naproxen|naproxen|mesh-list
101418219|NCT00137033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101418220|NCT00137033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101418221|NCT00137033|Analgesics|analgesics|mesh-ancestor
101349287|NCT00275015|Antiemetics|antiemetics|mesh-ancestor
101418222|NCT00137033|Sensory System Agents|sensory system agents|mesh-ancestor
101418223|NCT00137033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101418224|NCT00137033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418225|NCT00137033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101418226|NCT00137033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101418227|NCT00137033|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101418228|NCT00137033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101418229|NCT00137033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101418230|NCT00137033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418231|NCT00137033|Gout Suppressants|gout suppressants|mesh-ancestor
101418232|NCT00137072|Sildenafil Citrate|sildenafil citrate|mesh-list
101418233|NCT00137072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418234|NCT00137072|Vasodilator Agents|vasodilator agents|mesh-ancestor
101418235|NCT00137072|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101418239|NCT04724538|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
101418240|NCT04724538|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101418241|NCT04724538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418242|NCT00159900|Sildenafil Citrate|sildenafil citrate|mesh-list
101418243|NCT00159900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418244|NCT00159900|Vasodilator Agents|vasodilator agents|mesh-ancestor
101418245|NCT00159900|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101418246|NCT00159900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101418247|NCT00159900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101418248|NCT00159900|Urological Agents|urological agents|mesh-ancestor
101418249|NCT00159978|Alovudine|alovudine|mesh-list
101418250|NCT00159978|Antiviral Agents|antiviral agents|mesh-ancestor
101418251|NCT00159978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101418252|NCT00137345|Sirolimus|sirolimus|mesh-list
101418253|NCT00137345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101418254|NCT00137345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101418259|NCT00137345|Immunologic Factors|immunologic factors|mesh-ancestor
101418260|NCT00137345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418261|NCT00137462|Atorvastatin|atorvastatin|mesh-list
101418262|NCT00137462|Torcetrapib|torcetrapib|mesh-list
101418263|NCT00137462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101418264|NCT00137462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101418265|NCT00137462|Antimetabolites|antimetabolites|mesh-ancestor
101418266|NCT00137462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418267|NCT00137462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101418268|NCT00137462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101418269|NCT00137462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102076254|NCT03548246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102076255|NCT03548246|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102076256|NCT03548246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102076257|NCT03548246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076258|NCT03548246|Hormone Antagonists|hormone antagonists|mesh-ancestor
101349541|NCT00128804|Vitamins|vitamins|mesh-ancestor
102076259|NCT03548246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102076260|NCT03548246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418271|NCT00153543|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101418272|NCT00153543|Immunologic Factors|immunologic factors|mesh-ancestor
101306577|NCT02026492|Miotics|miotics|mesh-ancestor
101306578|NCT02026492|Autonomic Agents|autonomic agents|mesh-ancestor
101306579|NCT02026492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101306580|NCT02026492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418273|NCT00153543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418274|NCT00137501|Nifedipine|nifedipine|mesh-list
101418275|NCT00137501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101418276|NCT00137501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101418277|NCT00137501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418278|NCT00137501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101418279|NCT00137501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418280|NCT00137501|Vasodilator Agents|vasodilator agents|mesh-ancestor
101418281|NCT00137501|Tocolytic Agents|tocolytic agents|mesh-ancestor
101418282|NCT00137501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101418283|NCT00137540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
101418284|NCT00153660|Celecoxib|celecoxib|mesh-list
101418285|NCT00153660|Naproxen|naproxen|mesh-list
101418286|NCT00153660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101418287|NCT00153660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101418288|NCT00153660|Analgesics|analgesics|mesh-ancestor
101418289|NCT00153660|Sensory System Agents|sensory system agents|mesh-ancestor
101418290|NCT00153660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101418291|NCT00153660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418292|NCT00153660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101418293|NCT00153660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101418294|NCT00153660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101418295|NCT00153660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101418296|NCT00153660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101418297|NCT00153660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418298|NCT00153660|Gout Suppressants|gout suppressants|mesh-ancestor
101418299|NCT00137657|Trimethoprim|trimethoprim|mesh-list
101418300|NCT00137657|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101418301|NCT00137657|Sulfamethoxazole|sulfamethoxazole|mesh-list
101418302|NCT00137657|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101418303|NCT00137657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101418304|NCT00137657|Antimalarials|antimalarials|mesh-ancestor
101418305|NCT00137657|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101418306|NCT00137657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101418307|NCT00137657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101418312|NCT00137657|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101418313|NCT00137657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101418314|NCT00153699|Topiramate|topiramate|mesh-list
101418315|NCT00153699|Anticonvulsants|anticonvulsants|mesh-ancestor
101418316|NCT00153699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101418317|NCT00153699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418318|NCT00160290|Lactulose|lactulose|mesh-list
101418319|NCT00160290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101418320|NCT00137735|Gabapentin|gabapentin|mesh-list
101418321|NCT00137735|Analgesics|analgesics|mesh-ancestor
101418322|NCT00137735|Sensory System Agents|sensory system agents|mesh-ancestor
101418323|NCT00137735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101418324|NCT00137735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418325|NCT00137735|Anticonvulsants|anticonvulsants|mesh-ancestor
101418330|NCT00137735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101418331|NCT00137735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101418332|NCT00137735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102076261|NCT03548246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102076263|NCT02132442|Ergocalciferols|ergocalciferols|mesh-list
102076264|NCT02132442|Vitamins|vitamins|mesh-ancestor
102076265|NCT02132442|Micronutrients|micronutrients|mesh-ancestor
102076266|NCT02132442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076267|NCT02132442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101418333|NCT00137735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418335|NCT00137774|Bevacizumab|bevacizumab|mesh-list
101418336|NCT00137774|Temozolomide|temozolomide|mesh-list
101418337|NCT00137774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101418338|NCT00137774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101418339|NCT00137774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101418340|NCT00137774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101418341|NCT00137774|Growth Substances|growth substances|mesh-ancestor
101418342|NCT00137774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306581|NCT02026492|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101306582|NCT02026492|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
101306583|NCT02026492|Respiratory System Agents|respiratory system agents|mesh-ancestor
101306584|NCT02026492|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101306585|NCT02026492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101418343|NCT00137774|Growth Inhibitors|growth inhibitors|mesh-ancestor
101418344|NCT00137774|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101418345|NCT00137774|Alkylating Agents|alkylating agents|mesh-ancestor
101418346|NCT00137774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418347|NCT00160329|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101418348|NCT00160329|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101418349|NCT00160329|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101418350|NCT00160329|Protease Inhibitors|protease inhibitors|mesh-ancestor
101418351|NCT00160329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101418352|NCT00160329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418353|NCT00160329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101418354|NCT00160329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101418355|NCT00160329|Antiviral Agents|antiviral agents|mesh-ancestor
101418356|NCT00160329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101418357|NCT00137813|Bevacizumab|bevacizumab|mesh-list
101418358|NCT00137813|Docetaxel|docetaxel|mesh-list
101418359|NCT00137813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101418360|NCT00137813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101418361|NCT00137813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101418362|NCT00137813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101418363|NCT00137813|Growth Substances|growth substances|mesh-ancestor
101418364|NCT00137813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418365|NCT00137813|Growth Inhibitors|growth inhibitors|mesh-ancestor
101418366|NCT00137813|Tubulin Modulators|tubulin modulators|mesh-ancestor
101418367|NCT00137813|Antimitotic Agents|antimitotic agents|mesh-ancestor
101418368|NCT00137813|Mitosis Modulators|mitosis modulators|mesh-ancestor
101418369|NCT00137813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418370|NCT00137852|Celecoxib|celecoxib|mesh-list
101418371|NCT00137852|Irinotecan|irinotecan|mesh-list
101418372|NCT00137852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101418373|NCT00137852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101418374|NCT00137852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101418375|NCT00137852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101418376|NCT00137852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418386|NCT00137852|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101418387|NCT00160407|Orlistat|orlistat|mesh-list
101418388|NCT00160407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101418389|NCT00160407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418390|NCT00160407|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101418391|NCT00160407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101418392|NCT00153933|Lenalidomide|lenalidomide|mesh-list
101418393|NCT00153933|Bortezomib|bortezomib|mesh-list
101418394|NCT00153933|Immunologic Factors|immunologic factors|mesh-ancestor
101418397|NCT00153933|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101418399|NCT00153933|Growth Inhibitors|growth inhibitors|mesh-ancestor
101418400|NCT00153933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102076268|NCT02132442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102076269|NCT05010148|Lidocaine|lidocaine|mesh-list
102076270|NCT05010148|Anesthetics, Local|anesthetics, local|mesh-ancestor
102076271|NCT05010148|Anesthetics|anesthetics|mesh-ancestor
102076272|NCT05010148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102076273|NCT05010148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076274|NCT05010148|Sensory System Agents|sensory system agents|mesh-ancestor
102076275|NCT05010148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101418401|NCT00138164|Denileukin diftitox|denileukin diftitox|mesh-list
101418402|NCT00138164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101418403|NCT00153972|Levodopa|levodopa|mesh-list
101418404|NCT00153972|Cabergoline|cabergoline|mesh-list
101418405|NCT00153972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101418406|NCT00153972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101418407|NCT00153972|Dopamine Agents|dopamine agents|mesh-ancestor
101418408|NCT00153972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101418409|NCT00153972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418410|NCT00153972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306587|NCT02026492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101418411|NCT00153972|Dopamine Agonists|dopamine agonists|mesh-ancestor
101418412|NCT00160485|Glyburide|glyburide|mesh-list
101418413|NCT00160485|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101418414|NCT00160485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418415|NCT00404183|Acetaminophen|acetaminophen|mesh-list
101418416|NCT00404183|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
101418417|NCT00404183|Hydrocodone|hydrocodone|mesh-list
101418418|NCT00404183|Oxycodone|oxycodone|mesh-list
101418419|NCT00404183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101418420|NCT00404183|Analgesics|analgesics|mesh-ancestor
101418421|NCT00404183|Sensory System Agents|sensory system agents|mesh-ancestor
101418422|NCT00404183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101418423|NCT00404183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418424|NCT00404183|Antipyretics|antipyretics|mesh-ancestor
101418425|NCT00404183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101418426|NCT00404183|Narcotics|narcotics|mesh-ancestor
101418427|NCT00404183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101350097|NCT04864366|Tenofovir|tenofovir|mesh-list
101418428|NCT00404183|Antitussive Agents|antitussive agents|mesh-ancestor
101418429|NCT00404183|Respiratory System Agents|respiratory system agents|mesh-ancestor
101418430|NCT00404183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101418431|NCT00404183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101418432|NCT00404183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101418433|NCT00154011|Rosiglitazone|rosiglitazone|mesh-list
101418434|NCT00154011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101418435|NCT00154011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418436|NCT00404222|Acetaminophen|acetaminophen|mesh-list
101418437|NCT00404222|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
101418438|NCT00404222|Hydrocodone|hydrocodone|mesh-list
101418439|NCT00404222|Oxycodone|oxycodone|mesh-list
101418440|NCT00404222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101418441|NCT00404222|Analgesics|analgesics|mesh-ancestor
101418442|NCT00404222|Sensory System Agents|sensory system agents|mesh-ancestor
101418443|NCT00404222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101418458|NCT00160602|Immunologic Factors|immunologic factors|mesh-ancestor
101418459|NCT00160602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418460|NCT00160602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101418462|NCT00138242|Docetaxel|docetaxel|mesh-list
101418463|NCT00138242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101418464|NCT00138242|Tubulin Modulators|tubulin modulators|mesh-ancestor
101418465|NCT00138242|Antimitotic Agents|antimitotic agents|mesh-ancestor
101418466|NCT00138242|Mitosis Modulators|mitosis modulators|mesh-ancestor
101418467|NCT00138242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418468|NCT00154050|Candesartan|candesartan|mesh-list
101418476|NCT00154050|Protease Inhibitors|protease inhibitors|mesh-ancestor
101418477|NCT00154050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101418478|NCT00154089|Masoprocol|masoprocol|mesh-list
101418479|NCT00154089|Antioxidants|antioxidants|mesh-ancestor
101418480|NCT00154089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418481|NCT00154089|Protective Agents|protective agents|mesh-ancestor
101418482|NCT00154089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377939|NCT00249574|Naloxone|naloxone|mesh-list
102076276|NCT05010148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102076277|NCT05010148|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102076278|NCT05010148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102076279|NCT05010148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102076280|NCT05010148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076281|NCT05138146|Doxorubicin|doxorubicin|mesh-list
102076282|NCT05138146|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102076283|NCT05138146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102076284|NCT05138146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101418483|NCT00154089|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101418484|NCT00154089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101418485|NCT00154089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101418486|NCT00154089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101418487|NCT00154089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101418488|NCT00154089|Analgesics|analgesics|mesh-ancestor
101418489|NCT00154089|Sensory System Agents|sensory system agents|mesh-ancestor
101418490|NCT00154089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101306588|NCT02026492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306589|NCT02026505|Bortezomib|bortezomib|mesh-list
101306590|NCT02026505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101306591|NCT02026518|Vitamin D|vitamin d|mesh-list
101418491|NCT00154089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101418492|NCT00154089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101418493|NCT00138359|Niclosamide|niclosamide|mesh-list
101418494|NCT00138359|Anticestodal Agents|anticestodal agents|mesh-ancestor
101418495|NCT00138359|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101418496|NCT00138359|Anthelmintics|anthelmintics|mesh-ancestor
101418497|NCT00138359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101418498|NCT00138359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101418499|NCT00138359|Antinematodal Agents|antinematodal agents|mesh-ancestor
101418500|NCT00154128|Salicylic Acid|salicylic acid|mesh-list
101418501|NCT00154128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101418502|NCT00154128|Antifungal Agents|antifungal agents|mesh-ancestor
101418503|NCT00154128|Keratolytic Agents|keratolytic agents|mesh-ancestor
101418504|NCT00154128|Dermatologic Agents|dermatologic agents|mesh-ancestor
101418505|NCT00154167|Phentolamine|phentolamine|mesh-list
101418506|NCT00154167|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101418507|NCT00154167|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101418511|NCT00154167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418512|NCT00154167|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101418514|NCT00138515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101418515|NCT00138515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418516|NCT00138515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101418517|NCT00138515|Protease Inhibitors|protease inhibitors|mesh-ancestor
101418518|NCT00138515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101418519|NCT00138515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418520|NCT00154206|Mycophenolic Acid|mycophenolic acid|mesh-list
101418521|NCT00154206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101418522|NCT00154206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101418523|NCT00154206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101418524|NCT00154206|Antitubercular Agents|antitubercular agents|mesh-ancestor
101418525|NCT00154206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101418526|NCT00154206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101418527|NCT00154206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101418528|NCT00154206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418529|NCT00138554|Pioglitazone|pioglitazone|mesh-list
101418530|NCT00138554|Vildagliptin|vildagliptin|mesh-list
101418531|NCT00138554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101418532|NCT00138554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418533|NCT00138554|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101418534|NCT00138554|Protease Inhibitors|protease inhibitors|mesh-ancestor
101418543|NCT00138593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076285|NCT05138146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102076286|NCT05138146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102076287|NCT05138146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102076288|NCT05138146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076289|NCT05221879|Enoxaparin|enoxaparin|mesh-list
102076290|NCT05221879|Anticoagulants|anticoagulants|mesh-ancestor
102076291|NCT05221879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102076292|NCT05221879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102076293|NCT05221879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418545|NCT00154245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101418546|NCT00154245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101418547|NCT00154245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101418548|NCT00154245|Antitubercular Agents|antitubercular agents|mesh-ancestor
101418549|NCT00154245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101418550|NCT00154245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101418551|NCT00154245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101418552|NCT00154245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418553|NCT00138632|Vatalanib|vatalanib|mesh-list
101418554|NCT00138632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101418555|NCT00138632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101418556|NCT00138632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418557|NCT00160875|Irinotecan|irinotecan|mesh-list
101418558|NCT00160875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101418559|NCT00160875|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101418560|NCT00160875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101418561|NCT00160875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101418562|NCT00160875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418563|NCT00138710|Letrozole|letrozole|mesh-list
101418564|NCT00138710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101418565|NCT00138710|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101306593|NCT02026518|Vitamins|vitamins|mesh-ancestor
101306594|NCT02026518|Micronutrients|micronutrients|mesh-ancestor
101418566|NCT00138710|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101418567|NCT00138710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101418568|NCT00138710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418569|NCT00138710|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101418570|NCT00138710|Hormone Antagonists|hormone antagonists|mesh-ancestor
101418571|NCT00138710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101418572|NCT00138710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418573|NCT01243762|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
101418574|NCT01243762|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101418575|NCT01243762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101418576|NCT01243762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418577|NCT00154323|Oxcarbazepine|oxcarbazepine|mesh-list
101418578|NCT00154323|Anticonvulsants|anticonvulsants|mesh-ancestor
101418579|NCT00154323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101418580|NCT00154323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101418581|NCT00154323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101418583|NCT00154323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101418584|NCT00154323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101418585|NCT00138866|Risedronic Acid|risedronic acid|mesh-list
101418586|NCT00138866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101418587|NCT00138866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101418588|NCT00138866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418589|NCT00138866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101418590|NCT00138866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418591|NCT00138866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101418592|NCT00154362|Oxcarbazepine|oxcarbazepine|mesh-list
101418593|NCT00154362|Anticonvulsants|anticonvulsants|mesh-ancestor
101418594|NCT00154362|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101418599|NCT00154362|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102076295|NCT03450772|Pancreatin|pancreatin|mesh-list
102076296|NCT03450772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102076297|NCT02129088|Esketamine|esketamine|mesh-list
102076298|NCT02129088|Antidepressive Agents|antidepressive agents|mesh-ancestor
102076299|NCT02129088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102076300|NCT05137522|Methylprednisolone|methylprednisolone|mesh-list
101796044|NCT04282187|Azacitidine|azacitidine|mesh-list
102076301|NCT05137522|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102076302|NCT05137522|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102076303|NCT05137522|Prednisolone|prednisolone|mesh-list
102076304|NCT05137522|Prednisolone acetate|prednisolone acetate|mesh-list
102076305|NCT05137522|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102076306|NCT05137522|Prednisolone phosphate|prednisolone phosphate|mesh-list
101377959|NCT00249847|Paroxetine|paroxetine|mesh-list
101418600|NCT00161031|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101418601|NCT00161031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101418602|NCT00161031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101418603|NCT00161031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101418604|NCT00161031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418605|NCT00161031|Adrenergic Agents|adrenergic agents|mesh-ancestor
101418606|NCT00161031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101418607|NCT00161031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418608|NCT00154401|Liraglutide|liraglutide|mesh-list
101418609|NCT00154401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101418610|NCT00154401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418611|NCT00154401|Incretins|incretins|mesh-ancestor
101418612|NCT00154401|Hormones|hormones|mesh-ancestor
101418613|NCT00154401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101418614|NCT00138944|Eplerenone|eplerenone|mesh-list
101418615|NCT00138944|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101418616|NCT00138944|Hormone Antagonists|hormone antagonists|mesh-ancestor
101418617|NCT00138944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101418618|NCT00138944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418619|NCT00138944|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101418620|NCT00138944|Diuretics|diuretics|mesh-ancestor
101418621|NCT00138944|Natriuretic Agents|natriuretic agents|mesh-ancestor
101418622|NCT00138944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101418623|NCT00161070|Aspirin|aspirin|mesh-list
101418624|NCT00161070|Dipyridamole|dipyridamole|mesh-list
101418625|NCT00161070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101418626|NCT00161070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101418627|NCT00161070|Analgesics|analgesics|mesh-ancestor
101418628|NCT00161070|Sensory System Agents|sensory system agents|mesh-ancestor
101418629|NCT00161070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101418630|NCT00161070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418631|NCT00161070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101418632|NCT00161070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101418633|NCT00161070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101418634|NCT00161070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101418635|NCT00161070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418636|NCT00161070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101418637|NCT00161070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101418638|NCT00161070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101418639|NCT00161070|Antipyretics|antipyretics|mesh-ancestor
101418640|NCT00161070|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101418641|NCT00161070|Vasodilator Agents|vasodilator agents|mesh-ancestor
101418643|NCT00138983|Alendronate|alendronate|mesh-list
101418644|NCT00138983|Alfacalcidol|alfacalcidol|mesh-list
101418645|NCT00138983|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
101418646|NCT00138983|Vitamins|vitamins|mesh-ancestor
101418647|NCT00138983|Micronutrients|micronutrients|mesh-ancestor
101418648|NCT00138983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076307|NCT05137522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102076308|NCT05137522|Antiemetics|antiemetics|mesh-ancestor
102076309|NCT05137522|Autonomic Agents|autonomic agents|mesh-ancestor
102076310|NCT05137522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102076311|NCT05137522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076312|NCT05137522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102076313|NCT05137522|Glucocorticoids|glucocorticoids|mesh-ancestor
102076314|NCT05137522|Hormones|hormones|mesh-ancestor
102076315|NCT05137522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102076316|NCT05137522|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102076317|NCT05137522|Protective Agents|protective agents|mesh-ancestor
102076318|NCT05137522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102076319|NCT05137522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101418649|NCT00138983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101418650|NCT01243177|Lacosamide|lacosamide|mesh-list
101418651|NCT01243177|Carbamazepine|carbamazepine|mesh-list
101418652|NCT01243177|Anticonvulsants|anticonvulsants|mesh-ancestor
101418653|NCT01243177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101418654|NCT01243177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101418655|NCT01243177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101418656|NCT01243177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418657|NCT01243177|Antimanic Agents|antimanic agents|mesh-ancestor
101418660|NCT01243177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418661|NCT01243177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101418662|NCT01243177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101418663|NCT01243177|Analgesics|analgesics|mesh-ancestor
101418668|NCT00154440|Amoxicillin|amoxicillin|mesh-list
101418669|NCT00154440|Metronidazole|metronidazole|mesh-list
101418670|NCT00154440|Clarithromycin|clarithromycin|mesh-list
101418671|NCT00154440|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101418672|NCT00154440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101418673|NCT00154440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101418674|NCT00154440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101418675|NCT00154440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101418676|NCT00154440|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101418677|NCT00154440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101418678|NCT00154440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418679|NCT00154440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101418680|NCT00154440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101418681|NCT00139061|Atorvastatin|atorvastatin|mesh-list
101418682|NCT00139061|Torcetrapib|torcetrapib|mesh-list
101418683|NCT00139061|Fenofibrate|fenofibrate|mesh-list
101418684|NCT00139061|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101418685|NCT00139061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101418686|NCT00139061|Antimetabolites|antimetabolites|mesh-ancestor
101418687|NCT00139061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418688|NCT00139061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101418689|NCT00139061|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101418690|NCT00139061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101418691|NCT00139100|Anti-Infective Agents|anti-infective agents|mesh-list
101418692|NCT00139100|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101418693|NCT04705584|Cyclosporine|cyclosporine|mesh-list
101418694|NCT04705584|Prednisolone|prednisolone|mesh-list
101350712|NCT03017131|Decitabine|decitabine|mesh-list
101418695|NCT04705584|Cyclosporins|cyclosporins|mesh-list
101418696|NCT04705584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101418697|NCT04705584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418698|NCT04705584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101418699|NCT04705584|Immunologic Factors|immunologic factors|mesh-ancestor
101418700|NCT04705584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418701|NCT04705584|Antifungal Agents|antifungal agents|mesh-ancestor
101418702|NCT04705584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101418703|NCT04705584|Dermatologic Agents|dermatologic agents|mesh-ancestor
101377982|NCT00249886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102076320|NCT02129166|Imatinib Mesylate|imatinib mesylate|mesh-list
102076322|NCT02129166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102076323|NCT02129166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102076324|NCT02129166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102076325|NCT02129166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076326|NCT02137278|Antihypertensive Agents|antihypertensive agents|mesh-list
102076327|NCT02137278|Levodopa|levodopa|mesh-list
102076328|NCT02137278|Antipsychotic Agents|antipsychotic agents|mesh-list
102076329|NCT02137278|Antidepressive Agents|antidepressive agents|mesh-list
102076330|NCT02137278|Diuretics|diuretics|mesh-list
101377988|NCT00249964|Paclitaxel|paclitaxel|mesh-list
101418704|NCT04705584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101418705|NCT04705584|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101418706|NCT04705584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101418707|NCT04705584|Glucocorticoids|glucocorticoids|mesh-ancestor
101418708|NCT04705584|Hormones|hormones|mesh-ancestor
101418709|NCT04705584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101418710|NCT04705584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101418711|NCT04705584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101418712|NCT00139217|Nitric Oxide|nitric oxide|mesh-list
101306595|NCT02026518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418713|NCT00139217|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101418714|NCT00139217|Autonomic Agents|autonomic agents|mesh-ancestor
101418715|NCT00139217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101418716|NCT00139217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418717|NCT00139217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101418718|NCT00139217|Respiratory System Agents|respiratory system agents|mesh-ancestor
101418719|NCT00139217|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101418720|NCT00139217|Antioxidants|antioxidants|mesh-ancestor
101418721|NCT00139217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418722|NCT00139217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101418723|NCT00139217|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101418724|NCT00139217|Vasodilator Agents|vasodilator agents|mesh-ancestor
101418725|NCT00139217|Gasotransmitters|gasotransmitters|mesh-ancestor
101418726|NCT00139217|Protective Agents|protective agents|mesh-ancestor
101418727|NCT00161226|Levonorgestrel|levonorgestrel|mesh-list
101418728|NCT00161226|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101418729|NCT00161226|Contraceptive Agents|contraceptive agents|mesh-ancestor
101418730|NCT00161226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101418731|NCT00161226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201244|NCT01403415|Glucocorticoids|glucocorticoids|mesh-ancestor
101418740|NCT00139256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418741|NCT00139256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101418742|NCT00139256|Respiratory System Agents|respiratory system agents|mesh-ancestor
101418744|NCT00161304|Testosterone|testosterone|mesh-list
101418745|NCT00161304|Testosterone undecanoate|testosterone undecanoate|mesh-list
101418746|NCT00161304|Testosterone enanthate|testosterone enanthate|mesh-list
101418747|NCT00161304|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101418748|NCT00161304|Androgens|androgens|mesh-ancestor
101418749|NCT00161304|Hormones|hormones|mesh-ancestor
101418750|NCT00161304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101418751|NCT00161304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418752|NCT00161304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101418753|NCT00161304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101418754|NCT00161304|Anabolic Agents|anabolic agents|mesh-ancestor
101418755|NCT01242748|Goserelin|goserelin|mesh-list
101418756|NCT01242748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101418757|NCT01242748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101418758|NCT00139373|Donepezil|donepezil|mesh-list
101418759|NCT00139373|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101418760|NCT00139373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102076331|NCT02137278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102076332|NCT02137278|Natriuretic Agents|natriuretic agents|mesh-ancestor
102076333|NCT02137278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076334|NCT02137278|Dopamine Agents|dopamine agents|mesh-ancestor
102076335|NCT02137278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102076336|NCT02137278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076337|NCT02137278|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102076338|NCT02137278|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102076339|NCT02137278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102076340|NCT02137278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102076341|NCT05705635|Docetaxel|docetaxel|mesh-list
102076342|NCT05705635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102076343|NCT05705635|Tubulin Modulators|tubulin modulators|mesh-ancestor
102076344|NCT05705635|Antimitotic Agents|antimitotic agents|mesh-ancestor
102076345|NCT05705635|Mitosis Modulators|mitosis modulators|mesh-ancestor
102076389|NCT04491682|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102076390|NCT05193968|Nitroprusside|nitroprusside|mesh-list
102076391|NCT05193968|Norepinephrine|norepinephrine|mesh-list
102076392|NCT05193968|Acetylcholine|acetylcholine|mesh-list
102076393|NCT05193968|Terbutaline|terbutaline|mesh-list
102076394|NCT05193968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102076395|NCT05193968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102076396|NCT05193968|Adrenergic Agents|adrenergic agents|mesh-ancestor
102076397|NCT05193968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102076398|NCT05193968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076399|NCT05193968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076400|NCT05193968|Sympathomimetics|sympathomimetics|mesh-ancestor
102076401|NCT05193968|Autonomic Agents|autonomic agents|mesh-ancestor
102076402|NCT05193968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102076403|NCT05193968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102076404|NCT05193968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102076405|NCT05193968|Vasodilator Agents|vasodilator agents|mesh-ancestor
102076406|NCT05193968|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102076407|NCT05193968|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102076408|NCT05193968|Cholinergic Agents|cholinergic agents|mesh-ancestor
102076409|NCT05193968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102076410|NCT05193968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102076411|NCT05193968|Respiratory System Agents|respiratory system agents|mesh-ancestor
102076442|NCT05137288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102076443|NCT05137288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102076516|NCT01062399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102076517|NCT01062399|Immunologic Factors|immunologic factors|mesh-ancestor
102076518|NCT01062399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351092|NCT05750875|Loratadine|loratadine|mesh-list
102076589|NCT02129400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076590|NCT02129400|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102076591|NCT02129400|Anesthetics, General|anesthetics, general|mesh-ancestor
102076592|NCT05305768|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102076658|NCT03522194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102076659|NCT03522194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076660|NCT03522194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102076661|NCT03522194|Anesthetics, General|anesthetics, general|mesh-ancestor
102076662|NCT03522194|Anesthetics|anesthetics|mesh-ancestor
102076663|NCT03522194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102076728|NCT05304598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102076729|NCT05304598|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102076735|NCT03524846|Vitamins|vitamins|mesh-list
102076799|NCT02130414|Cyclosporine|cyclosporine|mesh-list
102076800|NCT02130414|Cyclosporins|cyclosporins|mesh-list
102076801|NCT02130414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102076802|NCT02130414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076803|NCT02130414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102076804|NCT02130414|Immunologic Factors|immunologic factors|mesh-ancestor
102076814|NCT02134470|Testosterone|testosterone|mesh-list
102076869|NCT02130804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102076870|NCT02130804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102076871|NCT02130804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102076872|NCT02130804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102076873|NCT02130804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076874|NCT05303272|Mycophenolic Acid|mycophenolic acid|mesh-list
102076875|NCT05303272|Abatacept|abatacept|mesh-list
102076876|NCT05303272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102076877|NCT05303272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102076878|NCT05303272|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102076879|NCT05303272|Antitubercular Agents|antitubercular agents|mesh-ancestor
102076880|NCT05303272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102076881|NCT05303272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102076882|NCT05303272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102076883|NCT05303272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076884|NCT05303272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102076885|NCT05303272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102076886|NCT05303272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102076887|NCT05303272|Immunologic Factors|immunologic factors|mesh-ancestor
102076888|NCT05303272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076889|NCT05303272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102076890|NCT03549312|Tenofovir|tenofovir|mesh-list
102076891|NCT03549312|Emtricitabine|emtricitabine|mesh-list
102076892|NCT03549312|Sofosbuvir|sofosbuvir|mesh-list
102076893|NCT03549312|Cobicistat|cobicistat|mesh-list
102076894|NCT03549312|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102076895|NCT03549312|Velpatasvir|velpatasvir|mesh-list
102076896|NCT03549312|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
102076897|NCT03549312|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101418761|NCT00139373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418762|NCT00139373|Cholinergic Agents|cholinergic agents|mesh-ancestor
101418763|NCT00139373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101418764|NCT00139373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418765|NCT00139373|Nootropic Agents|nootropic agents|mesh-ancestor
101418766|NCT00161421|Leuprolide|leuprolide|mesh-list
101418767|NCT00161421|Testosterone|testosterone|mesh-list
101418768|NCT00161421|Dutasteride|dutasteride|mesh-list
101418769|NCT00161421|Androgens|androgens|mesh-ancestor
101418770|NCT00161421|Hormones|hormones|mesh-ancestor
101351241|NCT05375942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101418771|NCT00161421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101418772|NCT00161421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418773|NCT00161421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101418774|NCT00161421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102076899|NCT03549312|Antiviral Agents|antiviral agents|mesh-ancestor
102076900|NCT03549312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101796647|NCT03582917|Alfacalcidol|alfacalcidol|mesh-list
102076901|NCT03549312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102076902|NCT03549312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102076903|NCT03549312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102076904|NCT03549312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076905|NCT03549312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102076906|NCT03549312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102076907|NCT03549312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102076908|NCT03549312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102076909|NCT03549312|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102076910|NCT03649269|Bezafibrate|bezafibrate|mesh-list
102076911|NCT03649269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102076912|NCT03649269|Antimetabolites|antimetabolites|mesh-ancestor
102076913|NCT03649269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076914|NCT03649269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102076915|NCT02134938|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
102076916|NCT02134938|Cathartics|cathartics|mesh-ancestor
102076917|NCT02134938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102076918|NCT05373446|Ritonavir|ritonavir|mesh-list
102076919|NCT05373446|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102076920|NCT05373446|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102076921|NCT05373446|Protease Inhibitors|protease inhibitors|mesh-ancestor
102076922|NCT05373446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102076923|NCT05373446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102076924|NCT05373446|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102076925|NCT05373446|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102076926|NCT05373446|Antiviral Agents|antiviral agents|mesh-ancestor
102076927|NCT05373446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102076928|NCT05373446|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102076938|NCT04734028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102076939|NCT05285397|Liraglutide|liraglutide|mesh-list
102076940|NCT05285397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102076941|NCT05285397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102076942|NCT05285397|Incretins|incretins|mesh-ancestor
102077009|NCT04166474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102077011|NCT04166474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102077084|NCT03049735|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102077086|NCT03049735|Norethindrone|norethindrone|mesh-list
102077087|NCT03049735|Norethindrone Acetate|norethindrone acetate|mesh-list
102077155|NCT02140632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077156|NCT02140632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102077157|NCT02140632|Glucocorticoids|glucocorticoids|mesh-ancestor
102077158|NCT02140632|Hormones|hormones|mesh-ancestor
102077159|NCT02140632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102077160|NCT02140632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102077161|NCT02140632|Protective Agents|protective agents|mesh-ancestor
102077162|NCT02140632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102077163|NCT02140632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102077164|NCT05578404|Cholecalciferol|cholecalciferol|mesh-list
102077165|NCT05578404|Vitamin D|vitamin d|mesh-list
102077166|NCT05578404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102077167|NCT05578404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077168|NCT05578404|Vitamins|vitamins|mesh-ancestor
102077215|NCT05363462|Vancomycin|vancomycin|mesh-list
102077216|NCT05363462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102077217|NCT04853628|Ethanol|ethanol|mesh-list
102077218|NCT04853628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102077219|NCT04853628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102077220|NCT04853628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102077221|NCT04853628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077222|NCT03521726|Amoxicillin|amoxicillin|mesh-list
102077223|NCT03521726|Rabeprazole|rabeprazole|mesh-list
102077224|NCT03521726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102077225|NCT03521726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102077226|NCT03521726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102077227|NCT03521726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102077228|NCT03521726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102077229|NCT03521726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102077231|NCT03546426|Pembrolizumab|pembrolizumab|mesh-list
102077274|NCT05434104|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102077275|NCT05434104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102077276|NCT05434104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077277|NCT05434104|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102077278|NCT05434104|Hormone Antagonists|hormone antagonists|mesh-ancestor
102077279|NCT05434104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102077280|NCT05434104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077281|NCT05434104|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102077282|NCT05434104|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102077283|NCT00488072|Mirtazapine|mirtazapine|mesh-list
102077288|NCT00488072|Histamine Agents|histamine agents|mesh-ancestor
102077334|NCT05577624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102077335|NCT05577624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077336|NCT05577624|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102077337|NCT05577624|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102077338|NCT05577624|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102077339|NCT05577624|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102077340|NCT05577624|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102077341|NCT05577624|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102077342|NCT05577624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102077343|NCT05577624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102077344|NCT05577624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102077395|NCT01316419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102077396|NCT01316419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102077400|NCT01316419|Vasodilator Agents|vasodilator agents|mesh-ancestor
102077464|NCT02028364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102077465|NCT02028364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102077466|NCT02028364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102077467|NCT02028364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102077533|NCT02253966|Sensory System Agents|sensory system agents|mesh-ancestor
102077534|NCT02253966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102077535|NCT02253966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102077604|NCT03521492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102077605|NCT03521492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102077678|NCT00072358|Immunoglobulin G|immunoglobulin g|mesh-list
102077679|NCT00072358|Immunologic Factors|immunologic factors|mesh-ancestor
102077680|NCT00072358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077681|NCT00072358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102077682|NCT00072358|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102077749|NCT04481724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102077750|NCT04481724|Antimetabolites|antimetabolites|mesh-ancestor
102077822|NCT02291666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102077823|NCT02291666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102077825|NCT02291666|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102077826|NCT02291666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102077827|NCT02291666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102077828|NCT03102658|Micafungin|micafungin|mesh-list
102077889|NCT05574036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102077892|NCT05574036|Protective Agents|protective agents|mesh-ancestor
102077963|NCT05573802|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102077964|NCT05573802|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102078035|NCT05051436|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102078036|NCT05051436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102078037|NCT05051436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102078038|NCT05051436|Adrenergic Agents|adrenergic agents|mesh-ancestor
102078104|NCT05885269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102078105|NCT05885269|Immunologic Factors|immunologic factors|mesh-ancestor
102078106|NCT05885269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078107|NCT05885269|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102078108|NCT05885269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102078109|NCT05885269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078110|NCT05885269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102078111|NCT05885269|Glucocorticoids|glucocorticoids|mesh-ancestor
102078113|NCT05885269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102078114|NCT05885035|Calcium|calcium|mesh-list
102078115|NCT05885035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102078116|NCT05885035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078117|NCT05884983|Vaccines|vaccines|mesh-list
102078118|NCT05884983|Immunologic Factors|immunologic factors|mesh-ancestor
102078119|NCT05884983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078120|NCT05884970|Albuterol|albuterol|mesh-list
102078121|NCT05884970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102078158|NCT05884671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102078159|NCT05884671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078160|NCT05884671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102078161|NCT05884671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102078162|NCT05884671|Dopamine Agents|dopamine agents|mesh-ancestor
102078163|NCT05884671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102078164|NCT05884671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078223|NCT05883709|Growth Inhibitors|growth inhibitors|mesh-ancestor
102078224|NCT05883709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078225|NCT05883449|Cyclophosphamide|cyclophosphamide|mesh-list
102078294|NCT05830799|Caffeine|caffeine|mesh-list
102078299|NCT05830799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102078367|NCT05650476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078443|NCT05351541|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102078445|NCT05334056|Anesthetics, Local|anesthetics, local|mesh-ancestor
102078446|NCT05334056|Anesthetics|anesthetics|mesh-ancestor
102078447|NCT05334056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102078448|NCT05334056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078449|NCT05334056|Sensory System Agents|sensory system agents|mesh-ancestor
102078450|NCT05334056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102078451|NCT05334056|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102078452|NCT05334056|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102078453|NCT05334056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102078506|NCT05190432|Ergothioneine|ergothioneine|mesh-list
102078507|NCT05190432|Antioxidants|antioxidants|mesh-ancestor
102078583|NCT05065866|Antimetabolites|antimetabolites|mesh-ancestor
102078584|NCT05065866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078585|NCT05065866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078655|NCT04764344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102078656|NCT04764344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102078657|NCT04764344|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102078658|NCT04764344|Dopamine Agents|dopamine agents|mesh-ancestor
102078659|NCT04764344|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102078660|NCT04745026|Cannabidiol|cannabidiol|mesh-list
102078661|NCT04745026|Anticonvulsants|anticonvulsants|mesh-ancestor
102078723|NCT04504331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078724|NCT04481919|Diuretics|diuretics|mesh-list
102078725|NCT04481919|Natriuretic Agents|natriuretic agents|mesh-ancestor
102078726|NCT04481919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078797|NCT04060030|Levoleucovorin|levoleucovorin|mesh-list
102078798|NCT04060030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102078799|NCT04060030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078800|NCT04060030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102078801|NCT04060030|Antidotes|antidotes|mesh-ancestor
102078802|NCT04060030|Protective Agents|protective agents|mesh-ancestor
102078803|NCT04060030|Vitamin B Complex|vitamin b complex|mesh-ancestor
102078804|NCT04060030|Vitamins|vitamins|mesh-ancestor
102078805|NCT04060030|Micronutrients|micronutrients|mesh-ancestor
102078806|NCT04005352|Aflibercept|aflibercept|mesh-list
102078807|NCT04005352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102078808|NCT04005352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102078809|NCT04005352|Growth Substances|growth substances|mesh-ancestor
102078810|NCT04005352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078811|NCT04005352|Growth Inhibitors|growth inhibitors|mesh-ancestor
102078812|NCT04005352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078813|NCT03913819|Cholinergic Antagonists|cholinergic antagonists|mesh-list
102078814|NCT03913819|Cholinergic Agents|cholinergic agents|mesh-ancestor
102078815|NCT03913819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102078816|NCT03913819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078817|NCT03913819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102078818|NCT03819465|Paclitaxel|paclitaxel|mesh-list
102078819|NCT03819465|Carboplatin|carboplatin|mesh-list
102078850|NCT03567720|Pembrolizumab|pembrolizumab|mesh-list
102078851|NCT03567720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102078852|NCT03567720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078853|NCT03567720|Tubulin Modulators|tubulin modulators|mesh-ancestor
102078854|NCT03567720|Antimitotic Agents|antimitotic agents|mesh-ancestor
102078855|NCT03567720|Mitosis Modulators|mitosis modulators|mesh-ancestor
102078856|NCT03567720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078857|NCT03567720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102078858|NCT03567720|Antimetabolites|antimetabolites|mesh-ancestor
102078859|NCT03567720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102078860|NCT03567720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102078861|NCT03519906|Metoprolol|metoprolol|mesh-list
102078862|NCT03519906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102078863|NCT03519906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102078906|NCT03330847|Adavosertib|adavosertib|mesh-list
102078907|NCT03330847|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102078908|NCT03330847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102078909|NCT03330847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078910|NCT03330847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102078911|NCT03215927|Abatacept|abatacept|mesh-list
102078912|NCT03215927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102078913|NCT03215927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078920|NCT03073967|Foscarnet|foscarnet|mesh-list
102078970|NCT02918721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102078971|NCT02918721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102078972|NCT02918721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102078973|NCT02918721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102078974|NCT02918721|Immunologic Factors|immunologic factors|mesh-ancestor
102078975|NCT02918721|Viscosupplements|viscosupplements|mesh-ancestor
102078976|NCT02918721|Protective Agents|protective agents|mesh-ancestor
102078977|NCT02884180|Dexamethasone|dexamethasone|mesh-list
102079036|NCT02243709|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102079037|NCT02027935|Aldesleukin|aldesleukin|mesh-list
102079038|NCT02027935|Cyclophosphamide|cyclophosphamide|mesh-list
102079040|NCT02027935|Interleukin-2|interleukin-2|mesh-list
102079041|NCT02027935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102079042|NCT02027935|Immunologic Factors|immunologic factors|mesh-ancestor
102079043|NCT02027935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079044|NCT02027935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102079045|NCT02027935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102079046|NCT02027935|Alkylating Agents|alkylating agents|mesh-ancestor
102079053|NCT02027935|Analgesics|analgesics|mesh-ancestor
102079101|NCT01746225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079103|NCT01716806|Brentuximab Vedotin|brentuximab vedotin|mesh-list
102079104|NCT01716806|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
102079105|NCT01716806|Dacarbazine|dacarbazine|mesh-list
102079106|NCT01716806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102079107|NCT01716806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102079108|NCT01716806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102079109|NCT01716806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079110|NCT01716806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101351805|NCT03585686|Cytarabine|cytarabine|mesh-list
102079111|NCT01716806|Alkylating Agents|alkylating agents|mesh-ancestor
102079112|NCT01716806|Immunotoxins|immunotoxins|mesh-ancestor
102079113|NCT01716806|Immunoconjugates|immunoconjugates|mesh-ancestor
102079114|NCT01716806|Immunologic Factors|immunologic factors|mesh-ancestor
102079115|NCT01716806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079116|NCT01650545|Cyclosporine|cyclosporine|mesh-list
102079159|NCT00821587|Antifungal Agents|antifungal agents|mesh-ancestor
102079160|NCT00821587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102079161|NCT00821587|Dermatologic Agents|dermatologic agents|mesh-ancestor
102079162|NCT00821587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102079163|NCT00751829|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102079164|NCT00751829|Olmesartan|olmesartan|mesh-list
102079165|NCT00751829|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
102079166|NCT00751829|Nitrendipine|nitrendipine|mesh-list
102079167|NCT00751829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102079168|NCT00751829|Diuretics|diuretics|mesh-ancestor
102079169|NCT00751829|Natriuretic Agents|natriuretic agents|mesh-ancestor
102079170|NCT00751829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079176|NCT00751829|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102079220|NCT03517670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102079221|NCT03517670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102079222|NCT03517670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079223|NCT03517670|Protective Agents|protective agents|mesh-ancestor
102079224|NCT03517670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079225|NCT03316573|Pembrolizumab|pembrolizumab|mesh-list
102079226|NCT03316573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102079227|NCT03316573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102079228|NCT03316573|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102079229|NCT03316573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079230|NCT00109668|Beclomethasone|beclomethasone|mesh-list
102079233|NCT00109668|Hormones|hormones|mesh-ancestor
102079282|NCT02253888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102079283|NCT02253888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102079354|NCT02963493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102079355|NCT02963493|Antiemetics|antiemetics|mesh-ancestor
102079356|NCT02963493|Autonomic Agents|autonomic agents|mesh-ancestor
102079357|NCT02963493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102079358|NCT02963493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079359|NCT02963493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102079360|NCT02963493|Glucocorticoids|glucocorticoids|mesh-ancestor
102079361|NCT02963493|Hormones|hormones|mesh-ancestor
102079362|NCT02963493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102079363|NCT02963493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102079364|NCT02963493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102079365|NCT02963493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102079366|NCT02963493|Alkylating Agents|alkylating agents|mesh-ancestor
102079367|NCT02963493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079371|NCT02299310|Valsartan|valsartan|mesh-list
102079412|NCT03738397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079413|NCT03738397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102079414|NCT03643497|Meropenem|meropenem|mesh-list
102079415|NCT03643497|Linezolid|linezolid|mesh-list
102079416|NCT03643497|Anti-Infective Agents|anti-infective agents|mesh-list
102079417|NCT03643497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102079480|NCT03512834|Tubulin Modulators|tubulin modulators|mesh-ancestor
102079481|NCT03512834|Antimitotic Agents|antimitotic agents|mesh-ancestor
102079482|NCT03512834|Mitosis Modulators|mitosis modulators|mesh-ancestor
102079483|NCT03512834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079486|NCT03640221|Ertugliflozin|ertugliflozin|mesh-list
102079549|NCT02956629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351860|NCT03338790|Prednisone|prednisone|mesh-list
102079550|NCT02956629|Antiviral Agents|antiviral agents|mesh-ancestor
102079551|NCT02956629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102079552|NCT02297204|Aflibercept|aflibercept|mesh-list
102079553|NCT02297204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102079555|NCT02297204|Growth Substances|growth substances|mesh-ancestor
102079619|NCT02301026|Hematinics|hematinics|mesh-ancestor
102079620|NCT01952574|Erenumab|erenumab|mesh-list
102079694|NCT03511820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102079695|NCT03511820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102079696|NCT03511820|Antifungal Agents|antifungal agents|mesh-ancestor
102079697|NCT02957331|Propranolol|propranolol|mesh-list
102079698|NCT02957331|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102079699|NCT02957331|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102079700|NCT02957331|Adrenergic Agents|adrenergic agents|mesh-ancestor
102079701|NCT02957331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102079702|NCT02957331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079703|NCT02957331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102079704|NCT02957331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102079705|NCT02957331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102079706|NCT02957331|Vasodilator Agents|vasodilator agents|mesh-ancestor
102079757|NCT05891132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102079758|NCT05891132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102079764|NCT05891119|Vitamin K|vitamin k|mesh-list
102079829|NCT05891093|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102079830|NCT05891080|Paclitaxel|paclitaxel|mesh-list
102079831|NCT05891080|Carboplatin|carboplatin|mesh-list
102079832|NCT05891080|Pemetrexed|pemetrexed|mesh-list
102079833|NCT05891080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102079834|NCT05891080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102079835|NCT05891080|Tubulin Modulators|tubulin modulators|mesh-ancestor
102079836|NCT05891080|Antimitotic Agents|antimitotic agents|mesh-ancestor
102079837|NCT05891080|Mitosis Modulators|mitosis modulators|mesh-ancestor
102079838|NCT05891080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102079893|NCT05890495|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102079894|NCT05890495|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102079895|NCT05890495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102079965|NCT05874570|Antacids|antacids|mesh-ancestor
102079966|NCT05874570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102080039|NCT05733689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102080040|NCT05733689|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102080041|NCT05733689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102080042|NCT05733689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080043|NCT05723874|Bosentan|bosentan|mesh-list
102080044|NCT05723874|BI 425809|bi 425809|mesh-list
102080045|NCT05723874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102080046|NCT05723874|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
102080047|NCT05723874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080048|NCT05723874|Nootropic Agents|nootropic agents|mesh-ancestor
102080049|NCT05663957|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
102080050|NCT05663957|Antiviral Agents|antiviral agents|mesh-ancestor
102080051|NCT05663957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102080052|NCT05650164|Avelumab|avelumab|mesh-list
102080053|NCT05650164|Axitinib|axitinib|mesh-list
102080054|NCT05650164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102080055|NCT05650164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080056|NCT05650164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102080057|NCT05650164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080058|NCT05650164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080059|NCT05610826|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
102080060|NCT05610826|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102080091|NCT05489887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080093|NCT05466799|Irinotecan|irinotecan|mesh-list
102080094|NCT05466799|Folfirinox|folfirinox|mesh-list
102080095|NCT05466799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080096|NCT05466799|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102080097|NCT05466799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102080098|NCT05466799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080099|NCT05466799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080100|NCT05446727|Ropivacaine|ropivacaine|mesh-list
102080101|NCT05446727|Anesthetics, Local|anesthetics, local|mesh-ancestor
102080102|NCT05446727|Anesthetics|anesthetics|mesh-ancestor
102080103|NCT05446727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102080104|NCT05446727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080105|NCT05446727|Sensory System Agents|sensory system agents|mesh-ancestor
102080106|NCT05446727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102080107|NCT05354102|Nivolumab|nivolumab|mesh-list
102080108|NCT05354102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102080109|NCT05354102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080110|NCT05354102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102080111|NCT05354102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080112|NCT05349890|Pembrolizumab|pembrolizumab|mesh-list
102080113|NCT05349890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102080114|NCT05349890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080115|NCT05349890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102080116|NCT05349890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080117|NCT05301517|Epoetin Alfa|epoetin alfa|mesh-list
102080118|NCT05301517|Hematinics|hematinics|mesh-ancestor
102080119|NCT05296304|Bexarotene|bexarotene|mesh-list
102080120|NCT05296304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080121|NCT05271448|Losartan|losartan|mesh-list
102080122|NCT05271448|Valsartan|valsartan|mesh-list
102080123|NCT05271448|Candesartan|candesartan|mesh-list
102080124|NCT05271448|Candesartan cilexetil|candesartan cilexetil|mesh-list
101418775|NCT00161421|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101418776|NCT00161421|Fertility Agents|fertility agents|mesh-ancestor
101418777|NCT00161421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101418778|NCT00161421|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101418779|NCT00161421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101418780|NCT00161421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101418781|NCT00161421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080125|NCT05271448|Ramipril|ramipril|mesh-list
102080126|NCT05271448|Enalapril|enalapril|mesh-list
102080127|NCT05271448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
102080128|NCT05271448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102080199|NCT05054348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102080200|NCT05054348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080201|NCT05029960|Brivaracetam|brivaracetam|mesh-list
102080270|NCT04774406|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102080271|NCT04774406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080272|NCT04774406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080273|NCT04774406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080274|NCT04759833|Prucalopride|prucalopride|mesh-list
102080275|NCT04759833|Laxatives|laxatives|mesh-ancestor
102080337|NCT04713657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102080338|NCT04713657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102080339|NCT04713657|Vasodilator Agents|vasodilator agents|mesh-ancestor
102080340|NCT04706546|Sildenafil Citrate|sildenafil citrate|mesh-list
102080408|NCT04500847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102080409|NCT04500847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102080482|NCT04231877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102080483|NCT04231877|Alkylating Agents|alkylating agents|mesh-ancestor
102080484|NCT04231877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080485|NCT04231877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080486|NCT04231877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102080487|NCT04231877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102080549|NCT03831113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080550|NCT03831113|Analgesics|analgesics|mesh-ancestor
102080551|NCT03831113|Sensory System Agents|sensory system agents|mesh-ancestor
102080552|NCT03831113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102080553|NCT03831113|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102080620|NCT03399773|Cyclophosphamide|cyclophosphamide|mesh-list
102080621|NCT03399773|Thiotepa|thiotepa|mesh-list
102080622|NCT03399773|Fludarabine|fludarabine|mesh-list
102080623|NCT03399773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102080624|NCT03399773|Immunologic Factors|immunologic factors|mesh-ancestor
102080625|NCT03399773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080626|NCT03399773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102080627|NCT03399773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102080628|NCT03399773|Alkylating Agents|alkylating agents|mesh-ancestor
102080629|NCT03399773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080630|NCT03399773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080631|NCT03399773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102080632|NCT03370172|Factor VIII|factor viii|mesh-list
102080633|NCT03370172|Coagulants|coagulants|mesh-ancestor
102080634|NCT03345784|Cisplatin|cisplatin|mesh-list
102080635|NCT03345784|Adavosertib|adavosertib|mesh-list
102080636|NCT03345784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080637|NCT03345784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080638|NCT03345784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080639|NCT03342196|Fludarabine|fludarabine|mesh-list
102080640|NCT03342196|Melphalan|melphalan|mesh-list
102080641|NCT03342196|Thiotepa|thiotepa|mesh-list
102080642|NCT03342196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080643|NCT03342196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080644|NCT03342196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102080650|NCT03319537|Pemetrexed|pemetrexed|mesh-list
102080734|NCT02932956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080735|NCT02932956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080736|NCT02932956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102080737|NCT02932956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102080738|NCT02932956|Antimetabolites|antimetabolites|mesh-ancestor
102080739|NCT02923778|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
102080740|NCT02923778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102080741|NCT02923778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102080742|NCT02843165|Immunomodulating Agents|immunomodulating agents|mesh-list
102080743|NCT02843165|Immunologic Factors|immunologic factors|mesh-list
102080744|NCT02843165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080745|NCT02807467|Dexmedetomidine|dexmedetomidine|mesh-list
102080746|NCT02807467|Propofol|propofol|mesh-list
102080747|NCT02807467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102080748|NCT02807467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102080792|NCT02650986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102080793|NCT02650986|Immunologic Factors|immunologic factors|mesh-ancestor
102080794|NCT02650986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102080795|NCT02650986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102080796|NCT02650986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102080863|NCT02453373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102080864|NCT02453373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102080865|NCT02453373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102080935|NCT00909051|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102080936|NCT00909051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102080940|NCT00750841|Cediranib|cediranib|mesh-list
102081007|NCT02301494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081008|NCT02301494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102081009|NCT02301494|Interferon Inducers|interferon inducers|mesh-ancestor
102081010|NCT02301494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102081011|NCT02301494|Glucocorticoids|glucocorticoids|mesh-ancestor
102081012|NCT02301494|Hormones|hormones|mesh-ancestor
102081077|NCT02301650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081151|NCT02639650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102081152|NCT02639650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102081153|NCT02639650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102081154|NCT02639650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102081155|NCT02639650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102081156|NCT02639650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102081157|NCT02639650|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102081159|NCT03581734|Immunologic Factors|immunologic factors|mesh-ancestor
102081160|NCT03581734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081161|NCT02306798|Mesalamine|mesalamine|mesh-list
102081162|NCT02306798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102081210|NCT04463342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102081211|NCT04463342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102081212|NCT04463342|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102081284|NCT02143518|Immunologic Factors|immunologic factors|mesh-ancestor
102081285|NCT02143518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081357|NCT05072938|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102081358|NCT05072938|Histamine Antagonists|histamine antagonists|mesh-ancestor
102081428|NCT03504566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102081429|NCT03504566|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102081430|NCT03504566|Protease Inhibitors|protease inhibitors|mesh-ancestor
102081439|NCT05070520|Artemether|artemether|mesh-list
102081500|NCT02305550|Autonomic Agents|autonomic agents|mesh-ancestor
102081501|NCT02305550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102081502|NCT02305550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081503|NCT02305550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102081504|NCT02305550|Respiratory System Agents|respiratory system agents|mesh-ancestor
102081505|NCT02305550|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102081506|NCT02305550|Antioxidants|antioxidants|mesh-ancestor
102081507|NCT02305550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081508|NCT02305550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102081509|NCT02305550|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
102081510|NCT02305550|Vasodilator Agents|vasodilator agents|mesh-ancestor
102081562|NCT05515627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102081563|NCT02178436|Paclitaxel|paclitaxel|mesh-list
102081564|NCT02178436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102081565|NCT02178436|Gemcitabine|gemcitabine|mesh-list
102081566|NCT02178436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102081567|NCT02178436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102081568|NCT02178436|Tubulin Modulators|tubulin modulators|mesh-ancestor
102081569|NCT02178436|Antimitotic Agents|antimitotic agents|mesh-ancestor
102081570|NCT02178436|Mitosis Modulators|mitosis modulators|mesh-ancestor
102081571|NCT02178436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081572|NCT02178436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102081573|NCT02178436|Antimetabolites|antimetabolites|mesh-ancestor
102081574|NCT02144064|Heparin|heparin|mesh-list
102081575|NCT02144064|Calcium heparin|calcium heparin|mesh-list
101352555|NCT00020189|Aspirin|aspirin|mesh-list
102081576|NCT02144064|Anticoagulants|anticoagulants|mesh-ancestor
102081577|NCT02144064|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102081578|NCT02144064|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102081579|NCT02144064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081580|NCT02144142|Anti-Infective Agents|anti-infective agents|mesh-list
102081581|NCT02144142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102081582|NCT02305862|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
102081583|NCT02305862|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102081584|NCT02305862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102081596|NCT02312804|Paclitaxel|paclitaxel|mesh-list
102081616|NCT04463966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102081618|NCT04463966|Hemostatics|hemostatics|mesh-ancestor
102081688|NCT03473977|Respiratory System Agents|respiratory system agents|mesh-ancestor
102081689|NCT01361464|Tipifarnib|tipifarnib|mesh-list
102081691|NCT04051255|Metronidazole|metronidazole|mesh-list
102081760|NCT05063578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102081761|NCT05063578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102081762|NCT05063578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081763|NCT05063422|Trimethoprim|trimethoprim|mesh-list
102081764|NCT05063422|Polymyxins|polymyxins|mesh-list
102081765|NCT05063422|Polymyxin B|polymyxin b|mesh-list
102081766|NCT05063422|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
102081767|NCT05063422|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102081768|NCT05063422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102081769|NCT05063422|Antimalarials|antimalarials|mesh-ancestor
102081770|NCT05063422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102081771|NCT05063422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102081772|NCT05063422|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102081773|NCT05063422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102081774|NCT05063422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102081775|NCT05063422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
102081776|NCT05063422|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
102081777|NCT05063422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102081818|NCT03098680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102081819|NCT03098680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102081820|NCT03098680|Vasodilator Agents|vasodilator agents|mesh-ancestor
102081821|NCT03098680|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
102081822|NCT03098680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102081823|NCT03098680|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102081824|NCT03098680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102081825|NCT03098368|Rotigotine|rotigotine|mesh-list
102081826|NCT03098368|Dopamine Agonists|dopamine agonists|mesh-ancestor
102081827|NCT03098368|Dopamine Agents|dopamine agents|mesh-ancestor
102081831|NCT05062486|Curcumin|curcumin|mesh-list
102081880|NCT02311010|Immunologic Factors|immunologic factors|mesh-ancestor
102081881|NCT02311010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102081882|NCT02311010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102081883|NCT02311010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102081950|NCT02314754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102081952|NCT02314754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102082022|NCT05046262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102082024|NCT05036824|Tinzaparin|tinzaparin|mesh-list
102082092|NCT05035498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102082094|NCT05035498|Protective Agents|protective agents|mesh-ancestor
102082163|NCT03500432|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102082164|NCT03500432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102082237|NCT03497702|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102082243|NCT03497702|Fertility Agents|fertility agents|mesh-ancestor
102082306|NCT02145546|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102082307|NCT02145546|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102082308|NCT02145546|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102082309|NCT02145546|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102082310|NCT02145546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102082311|NCT02145546|Adrenergic Agents|adrenergic agents|mesh-ancestor
102082312|NCT02145546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102082313|NCT02145546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082314|NCT02145546|Sympatholytics|sympatholytics|mesh-ancestor
102082315|NCT02145546|Autonomic Agents|autonomic agents|mesh-ancestor
102082318|NCT03039673|Interleukin-2|interleukin-2|mesh-list
102082370|NCT03095326|Dermatologic Agents|dermatologic agents|mesh-ancestor
102082372|NCT02318810|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102082373|NCT02318810|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
102082374|NCT02318810|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102082375|NCT02318810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102082376|NCT02318810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082377|NCT03500120|Fludrocortisone|fludrocortisone|mesh-list
102082378|NCT03500120|Captopril|captopril|mesh-list
102082379|NCT03500120|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
102082380|NCT03500120|Protease Inhibitors|protease inhibitors|mesh-ancestor
102082381|NCT03500120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102082436|NCT02324582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082437|NCT01255891|Androgens|androgens|mesh-list
102082438|NCT01255891|Hormones|hormones|mesh-ancestor
102082439|NCT01255891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102082440|NCT01255891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082442|NCT02777190|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102082443|NCT02777190|Abortifacient Agents|abortifacient agents|mesh-ancestor
102082444|NCT02777190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102082445|NCT02777190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082446|NCT02777190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102082447|NCT02777190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102082501|NCT02324738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102082502|NCT02324738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102082503|NCT02321852|Mannitol|mannitol|mesh-list
102082504|NCT02321852|Triflusal|triflusal|mesh-list
102082505|NCT02321852|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102082506|NCT02321852|Diuretics|diuretics|mesh-ancestor
102082507|NCT02321852|Natriuretic Agents|natriuretic agents|mesh-ancestor
102082508|NCT02321852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082509|NCT02321852|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102082510|NCT03499886|Ketamine|ketamine|mesh-list
102082511|NCT03499886|Analgesics|analgesics|mesh-ancestor
102082512|NCT03499886|Sensory System Agents|sensory system agents|mesh-ancestor
102082513|NCT03499886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102082514|NCT03499886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082515|NCT03499886|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102082516|NCT03499886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102082517|NCT03499886|Anesthetics, General|anesthetics, general|mesh-ancestor
102082518|NCT03499886|Anesthetics|anesthetics|mesh-ancestor
102082519|NCT03499886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102082520|NCT03499886|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102082521|NCT03499886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102082522|NCT03499886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102082523|NCT03499886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082524|NCT05084430|Pembrolizumab|pembrolizumab|mesh-list
102082525|NCT05084430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102082526|NCT05084430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102082527|NCT05084430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102082528|NCT05084430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082529|NCT02716038|Paclitaxel|paclitaxel|mesh-list
102082545|NCT02322008|Adalimumab|adalimumab|mesh-list
102082546|NCT02322008|Infliximab|infliximab|mesh-list
102082552|NCT02647554|Urinastatin|urinastatin|mesh-list
102082618|NCT02325440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102082619|NCT03499184|Metronidazole|metronidazole|mesh-list
102082620|NCT03499184|Amoxicillin|amoxicillin|mesh-list
102082621|NCT03499184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102082622|NCT03499184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102082623|NCT03499184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102082624|NCT03499184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102082625|NCT00107952|Vancomycin|vancomycin|mesh-list
102082626|NCT00107952|Telavancin|telavancin|mesh-list
102082627|NCT00107952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102082628|NCT00107952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102082629|NCT03499106|Itraconazole|itraconazole|mesh-list
102082630|NCT03499106|Praliciguat|praliciguat|mesh-list
102082631|NCT03499106|Antifungal Agents|antifungal agents|mesh-ancestor
102082632|NCT03499106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102082633|NCT03499106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102082634|NCT03499106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102082635|NCT03499106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102082677|NCT03493568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082679|NCT03493568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102082680|NCT03493568|Antiviral Agents|antiviral agents|mesh-ancestor
102082681|NCT03493568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102082682|NCT01366638|Ribavirin|ribavirin|mesh-list
102082683|NCT01366638|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
102082684|NCT01366638|Simeprevir|simeprevir|mesh-list
102082685|NCT01366638|Antimetabolites|antimetabolites|mesh-ancestor
102082686|NCT01366638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082687|NCT01366638|Antiviral Agents|antiviral agents|mesh-ancestor
102082688|NCT01366638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102082689|NCT01366638|Protease Inhibitors|protease inhibitors|mesh-ancestor
102082691|NCT02147808|Midazolam|midazolam|mesh-list
102082740|NCT02780700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082741|NCT02780700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102082742|NCT02780700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101802527|NCT00927602|PENTA|penta|mesh-list
102082743|NCT02780700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102082744|NCT02147262|Doxycycline|doxycycline|mesh-list
102082809|NCT03491696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082810|NCT03491696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102082811|NCT03492866|Gentamicins|gentamicins|mesh-list
102082812|NCT03492866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102082878|NCT02151630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082879|NCT03494972|Tetracycline|tetracycline|mesh-list
102082880|NCT03494972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102082881|NCT03494972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102082882|NCT03494972|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102082883|NCT03494972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102082884|NCT03494972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082885|NCT02224573|Cannabidiol|cannabidiol|mesh-list
102082886|NCT02224573|Anticonvulsants|anticonvulsants|mesh-ancestor
102082887|NCT03490058|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
102082888|NCT03490058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102082889|NCT03490058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102082938|NCT03756961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102082939|NCT03756961|Narcotics|narcotics|mesh-ancestor
102082940|NCT03756961|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102082941|NCT03756961|Antidepressive Agents|antidepressive agents|mesh-ancestor
102082942|NCT03756961|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102082943|NCT03350984|Insulin|insulin|mesh-list
102082944|NCT03350984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102082945|NCT03350984|Insulin Glargine|insulin glargine|mesh-list
102082946|NCT03350984|Insulin Lispro|insulin lispro|mesh-list
102082947|NCT03350984|Insulin, Isophane|insulin, isophane|mesh-list
102082948|NCT03350984|Isophane Insulin, Human|isophane insulin, human|mesh-list
102082949|NCT03350984|Isophane insulin, beef|isophane insulin, beef|mesh-list
102082950|NCT03350984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102082951|NCT03350984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102082952|NCT05033314|Rivaroxaban|rivaroxaban|mesh-list
102082953|NCT05033314|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102082954|NCT05033314|Antithrombins|antithrombins|mesh-ancestor
102082955|NCT05033314|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102082956|NCT05033314|Protease Inhibitors|protease inhibitors|mesh-ancestor
102082957|NCT05033314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102082960|NCT03504423|Leucovorin|leucovorin|mesh-list
102082997|NCT02770248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102082998|NCT02770248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102082999|NCT02770248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083000|NCT02770248|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
102083001|NCT02770248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384685|NCT00080444|Glucocorticoids|glucocorticoids|mesh-ancestor
101418782|NCT00161421|Hormone Antagonists|hormone antagonists|mesh-ancestor
101418783|NCT00139568|Tegaserod|tegaserod|mesh-list
101418784|NCT00139568|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101418785|NCT00139568|Serotonin Agents|serotonin agents|mesh-ancestor
101306596|NCT02026518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101306597|NCT02026518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101306598|NCT02026583|Simvastatin|simvastatin|mesh-list
101418787|NCT00139568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418788|NCT00139568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418789|NCT00139646|Diclofenac|diclofenac|mesh-list
101418790|NCT00139646|Parecoxib|parecoxib|mesh-list
101418791|NCT00139646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101418792|NCT00139646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101418793|NCT00139646|Analgesics|analgesics|mesh-ancestor
101418794|NCT00139646|Sensory System Agents|sensory system agents|mesh-ancestor
101418795|NCT00139646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101418796|NCT00139646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418797|NCT00139646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101418798|NCT00139646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101201317|NCT01403740|Dermatologic Agents|dermatologic agents|mesh-ancestor
101418803|NCT00406302|Docetaxel|docetaxel|mesh-list
101418804|NCT00406302|Oxaliplatin|oxaliplatin|mesh-list
101418805|NCT00406302|Cetuximab|cetuximab|mesh-list
101418806|NCT00406302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101418807|NCT00406302|Tubulin Modulators|tubulin modulators|mesh-ancestor
101418811|NCT00406302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101418812|NCT00139685|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101418813|NCT00139685|Contraceptive Agents|contraceptive agents|mesh-list
101418814|NCT00139685|Medroxyprogesterone|medroxyprogesterone|mesh-list
101418815|NCT00139685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101418816|NCT00139685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418817|NCT00139685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101418818|NCT00139685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101418819|NCT00139685|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101418820|NCT00139685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101418821|NCT00139685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101418822|NCT00139685|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101418823|NCT00139685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101418824|NCT00139685|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101418825|NCT00406341|Difluprednate|difluprednate|mesh-list
101418826|NCT00406341|Glucocorticoids|glucocorticoids|mesh-ancestor
101418827|NCT00406341|Hormones|hormones|mesh-ancestor
101418828|NCT00406341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101418829|NCT00406341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418830|NCT00139724|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101418831|NCT00139724|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101418832|NCT00139724|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101418833|NCT00139724|Cholinergic Agents|cholinergic agents|mesh-ancestor
101418834|NCT00139724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101418835|NCT00139724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418836|NCT00139724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418837|NCT00139724|Urological Agents|urological agents|mesh-ancestor
101418838|NCT00161577|Ketorolac|ketorolac|mesh-list
101418839|NCT00161577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101418840|NCT00161577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101418841|NCT00161577|Analgesics|analgesics|mesh-ancestor
101418842|NCT00161577|Sensory System Agents|sensory system agents|mesh-ancestor
101418843|NCT00161577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101418844|NCT00161577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418845|NCT00161577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101418846|NCT00161577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102083002|NCT03619005|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
102083079|NCT04382924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102083080|NCT04382924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083081|NCT04382924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083082|NCT04382924|Vasodilator Agents|vasodilator agents|mesh-ancestor
102083085|NCT00002601|Doxorubicin|doxorubicin|mesh-list
102083148|NCT02155530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102083149|NCT02155530|Antimetabolites|antimetabolites|mesh-ancestor
101354266|NCT00025493|Docetaxel|docetaxel|mesh-list
102083150|NCT02155530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083151|NCT02155530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102083217|NCT03492242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102083218|NCT03492242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102083219|NCT03572283|Bethanechol|bethanechol|mesh-list
102083220|NCT03572283|Parasympathomimetics|parasympathomimetics|mesh-ancestor
102083221|NCT03572283|Autonomic Agents|autonomic agents|mesh-ancestor
102083285|NCT02152332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102083286|NCT02152332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102083287|NCT05118308|Liver Extracts|liver extracts|mesh-list
102083288|NCT05118308|Hematinics|hematinics|mesh-ancestor
102083361|NCT03488186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083362|NCT03488186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083363|NCT05103644|Atorvastatin|atorvastatin|mesh-list
102083432|NCT02259777|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102083433|NCT02259777|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102083434|NCT03261375|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
102083435|NCT03261375|Antihypertensive Agents|antihypertensive agents|mesh-list
102083500|NCT05030116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102083501|NCT05030116|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102083502|NCT05030116|Dopamine Agents|dopamine agents|mesh-ancestor
102083503|NCT05030116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102083504|NCT05030116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083505|NCT03015129|Durvalumab|durvalumab|mesh-list
102083506|NCT03015129|Tremelimumab|tremelimumab|mesh-list
102083507|NCT03015129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102083508|NCT03015129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102083509|NCT02148978|Saxagliptin|saxagliptin|mesh-list
102083510|NCT02148978|Incretins|incretins|mesh-ancestor
101385190|NCT00302653|Gout Suppressants|gout suppressants|mesh-ancestor
101385191|NCT00302653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101385192|NCT00418288|Glucagon|glucagon|mesh-list
101385193|NCT00418288|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101385194|NCT00418288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101385195|NCT00418288|Hormones|hormones|mesh-ancestor
101385196|NCT00418288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101418847|NCT00161577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101418848|NCT00161577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101418849|NCT00161577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418850|NCT00404261|Fluticasone|fluticasone|mesh-list
101418851|NCT00404261|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101418852|NCT00404261|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101418853|NCT00404261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101418854|NCT00404261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101418855|NCT00404261|Autonomic Agents|autonomic agents|mesh-ancestor
101418856|NCT00404261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101306599|NCT02026583|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101306600|NCT02026583|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101306601|NCT02026583|Antimetabolites|antimetabolites|mesh-ancestor
101418857|NCT00404261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418858|NCT00404261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101418859|NCT00404261|Respiratory System Agents|respiratory system agents|mesh-ancestor
101418860|NCT00404261|Dermatologic Agents|dermatologic agents|mesh-ancestor
101418861|NCT00404261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101418862|NCT00404261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101418863|NCT00404261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101418864|NCT00404261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101418865|NCT00404261|Adrenergic Agents|adrenergic agents|mesh-ancestor
101418866|NCT00404261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101418873|NCT00406380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101418874|NCT00406380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101418875|NCT00406380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101418890|NCT00161655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418891|NCT00161655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101418892|NCT00161655|Antimetabolites|antimetabolites|mesh-ancestor
101418893|NCT00161655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418894|NCT00161655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101418895|NCT00161655|Dermatologic Agents|dermatologic agents|mesh-ancestor
101418896|NCT00161655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101418897|NCT00161655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101418898|NCT00161655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101418899|NCT00161655|Immunologic Factors|immunologic factors|mesh-ancestor
101418900|NCT00161655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101385201|NCT00418327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102083511|NCT02148978|Hormones|hormones|mesh-ancestor
102083512|NCT02148978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102083513|NCT02148978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083514|NCT02148978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102083515|NCT02148978|Protease Inhibitors|protease inhibitors|mesh-ancestor
102083516|NCT02148978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083517|NCT02148978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083518|NCT02148978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102083519|NCT05048914|Acetaminophen|acetaminophen|mesh-list
102083520|NCT05048914|Dipyrone|dipyrone|mesh-list
102083521|NCT05048914|Ibuprofen|ibuprofen|mesh-list
102083522|NCT05048914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102083523|NCT05048914|Analgesics|analgesics|mesh-ancestor
102083524|NCT05048914|Sensory System Agents|sensory system agents|mesh-ancestor
102083525|NCT05048914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102083526|NCT05048914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083527|NCT05048914|Antipyretics|antipyretics|mesh-ancestor
102083528|NCT05048914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102083529|NCT05048914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102083530|NCT05048914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102083531|NCT05048914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102083532|NCT05048914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083533|NCT05048914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083534|NCT03046017|Lidocaine|lidocaine|mesh-list
102083535|NCT03046017|Anesthetics, Local|anesthetics, local|mesh-ancestor
102083536|NCT03046017|Anesthetics|anesthetics|mesh-ancestor
102083537|NCT03046017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102083538|NCT03046017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102083539|NCT03046017|Sensory System Agents|sensory system agents|mesh-ancestor
101418901|NCT00161655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101418902|NCT00161655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101418903|NCT00161655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101418904|NCT00161655|Analgesics|analgesics|mesh-ancestor
101418905|NCT00161655|Sensory System Agents|sensory system agents|mesh-ancestor
101418906|NCT00161655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101418907|NCT00161655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101418908|NCT00161655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101418909|NCT00161733|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101418910|NCT00161733|Hemostatics|hemostatics|mesh-ancestor
101418911|NCT00161733|Coagulants|coagulants|mesh-ancestor
101418912|NCT00139841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101418913|NCT00139841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102083540|NCT03046017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102083541|NCT03046017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102083542|NCT03046017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102083543|NCT03046017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102083544|NCT03046017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102083545|NCT03046017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083551|NCT02149212|Aminaftone|aminaftone|mesh-list
102083552|NCT02149212|Hemostatics|hemostatics|mesh-ancestor
102083553|NCT02149212|Coagulants|coagulants|mesh-ancestor
102083554|NCT04667013|Tetramethylpyrazine|tetramethylpyrazine|mesh-list
102083556|NCT03611985|Taxane|taxane|mesh-list
102083609|NCT00354835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102083610|NCT00354835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102083682|NCT02157012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102083683|NCT02157012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102083684|NCT03096028|Vitamin B 12|vitamin b 12|mesh-list
102083685|NCT03096028|Hydroxocobalamin|hydroxocobalamin|mesh-list
102083686|NCT03096028|Vitamins|vitamins|mesh-ancestor
102083687|NCT03096028|Micronutrients|micronutrients|mesh-ancestor
102083753|NCT04434430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102083754|NCT04434430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102083755|NCT04434430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102083756|NCT04434430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102083819|NCT02773368|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102083820|NCT02773368|Insulin Glargine|insulin glargine|mesh-list
102083896|NCT02157792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102083897|NCT02157792|Antimetabolites|antimetabolites|mesh-ancestor
102083899|NCT02157792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102083967|NCT02150616|Sevoflurane|sevoflurane|mesh-list
102084042|NCT02033031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102084043|NCT02033031|Growth Substances|growth substances|mesh-ancestor
102084044|NCT02033031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084114|NCT02520921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084115|NCT02520921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102084116|NCT02520921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102084185|NCT04287790|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
102084186|NCT04287790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102084187|NCT04287790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084256|NCT01077817|Ibandronic Acid|ibandronic acid|mesh-list
102084257|NCT01077817|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
102084258|NCT01077817|Etidronic Acid|etidronic acid|mesh-list
102084259|NCT01077817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102084280|NCT00103506|Bortezomib|bortezomib|mesh-list
102084327|NCT02762370|Triamcinolone|triamcinolone|mesh-list
102084328|NCT02762370|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102084329|NCT02762370|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102084330|NCT02762370|FX006|fx006|mesh-list
102084331|NCT02762370|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102084332|NCT02762370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102084333|NCT02762370|Glucocorticoids|glucocorticoids|mesh-ancestor
102084334|NCT02762370|Hormones|hormones|mesh-ancestor
102084335|NCT02762370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102084336|NCT02762370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084337|NCT02762370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102084338|NCT02762370|Immunologic Factors|immunologic factors|mesh-ancestor
102084339|NCT02762370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102084340|NCT02762370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084341|NCT02639182|Axitinib|axitinib|mesh-list
102084342|NCT02639182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102084343|NCT02639182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102084344|NCT02639182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102084345|NCT02639182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084346|NCT02863419|Liraglutide|liraglutide|mesh-list
102084347|NCT02863419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102084348|NCT02863419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084350|NCT02863419|Hormones|hormones|mesh-ancestor
102084378|NCT03091894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102084452|NCT02159820|Carboplatin|carboplatin|mesh-list
102084453|NCT02159820|Decitabine|decitabine|mesh-list
102084454|NCT02159820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102084463|NCT02862171|Dapivirine|dapivirine|mesh-list
102084524|NCT05019586|Levofloxacin|levofloxacin|mesh-list
102084525|NCT05019586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102084526|NCT05019586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102084527|NCT05019586|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102084597|NCT05018962|Tubulin Modulators|tubulin modulators|mesh-ancestor
102084598|NCT05018962|Antimitotic Agents|antimitotic agents|mesh-ancestor
102084599|NCT05018962|Mitosis Modulators|mitosis modulators|mesh-ancestor
102084601|NCT02160054|Tacrolimus|tacrolimus|mesh-list
102084667|NCT02637856|Ocrelizumab|ocrelizumab|mesh-list
102084668|NCT02637856|Immunologic Factors|immunologic factors|mesh-ancestor
102084741|NCT01242267|Immunologic Factors|immunologic factors|mesh-ancestor
102084742|NCT01242267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102084743|NCT01242267|Leprostatic Agents|leprostatic agents|mesh-ancestor
102084813|NCT05004142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102084814|NCT05004142|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102084815|NCT05004142|Hormone Antagonists|hormone antagonists|mesh-ancestor
102084882|NCT05003596|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102084883|NCT05003596|Prednisolone|prednisolone|mesh-list
102084884|NCT05003596|Prednisolone acetate|prednisolone acetate|mesh-list
102084885|NCT05003596|Narcotics|narcotics|mesh-list
102084886|NCT05003596|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102084887|NCT05003596|Prednisolone phosphate|prednisolone phosphate|mesh-list
102084895|NCT05003596|Hormones|hormones|mesh-ancestor
102084951|NCT03608241|Contraceptive Agents|contraceptive agents|mesh-list
102084952|NCT03608241|Contraceptives, Oral|contraceptives, oral|mesh-list
102084953|NCT03608241|Estradiol|estradiol|mesh-list
102084954|NCT03608241|Estrogens|estrogens|mesh-ancestor
102084955|NCT03608241|Hormones|hormones|mesh-ancestor
102084957|NCT03608241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085019|NCT03607071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102085020|NCT03607071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085021|NCT03607071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102085022|NCT03607071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102085023|NCT02035215|Atorvastatin|atorvastatin|mesh-list
102085024|NCT02035215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102085025|NCT02035215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102085026|NCT02035215|Antimetabolites|antimetabolites|mesh-ancestor
102085027|NCT02035215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085028|NCT02035215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102085030|NCT02035215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102085083|NCT04991896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102085084|NCT04991896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102085086|NCT04991896|Autonomic Agents|autonomic agents|mesh-ancestor
102085154|NCT03072082|Diuretics|diuretics|mesh-ancestor
102085155|NCT03072082|Natriuretic Agents|natriuretic agents|mesh-ancestor
102085156|NCT03072082|Vasodilator Agents|vasodilator agents|mesh-ancestor
102085157|NCT03072082|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
102085158|NCT04934020|Metronidazole|metronidazole|mesh-list
102085224|NCT03074344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085225|NCT03074344|Viscosupplements|viscosupplements|mesh-ancestor
102085226|NCT03074344|Protective Agents|protective agents|mesh-ancestor
102085227|NCT03605511|Complement System Proteins|complement system proteins|mesh-list
102085296|NCT02635204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102085298|NCT00102804|Pemetrexed|pemetrexed|mesh-list
102085368|NCT04682288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102085369|NCT00968149|Montelukast|montelukast|mesh-list
102085370|NCT00968149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102085438|NCT00897949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102085439|NCT00897949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085440|NCT05119855|Vaccines|vaccines|mesh-list
102085441|NCT05119855|Immunologic Factors|immunologic factors|mesh-ancestor
102085442|NCT05119855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085443|NCT03487406|Aspirin|aspirin|mesh-list
102085444|NCT03487406|Ticagrelor|ticagrelor|mesh-list
102085447|NCT03487406|Analgesics|analgesics|mesh-ancestor
102085504|NCT02164578|Antithrombins|antithrombins|mesh-ancestor
102085505|NCT02164578|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102085506|NCT02164578|Protease Inhibitors|protease inhibitors|mesh-ancestor
102085507|NCT02164578|Anticoagulants|anticoagulants|mesh-ancestor
102085509|NCT03893318|Anesthetics, Local|anesthetics, local|mesh-ancestor
102085510|NCT03893318|Anesthetics|anesthetics|mesh-ancestor
102085573|NCT02164734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102085574|NCT02164734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085576|NCT02164734|Sensory System Agents|sensory system agents|mesh-ancestor
102085577|NCT02164734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102085643|NCT02161614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102085644|NCT02161614|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102085717|NCT04988932|Gasotransmitters|gasotransmitters|mesh-ancestor
102085718|NCT04988932|Protective Agents|protective agents|mesh-ancestor
102085719|NCT03625466|Ivacaftor|ivacaftor|mesh-list
102085720|NCT03625466|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102085721|NCT03625466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102085785|NCT02255370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102085786|NCT02255370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102085792|NCT04984408|Vaccines|vaccines|mesh-list
101828117|NCT05981131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101828118|NCT05981131|Immunologic Factors|immunologic factors|mesh-ancestor
102085855|NCT03070678|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
102085856|NCT03070678|Mefenamic Acid|mefenamic acid|mesh-list
102085857|NCT03070678|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102085924|NCT03597945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102085999|NCT05379166|Venetoclax|venetoclax|mesh-list
102086074|NCT03068260|Narcotics|narcotics|mesh-ancestor
102086075|NCT03068260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102086076|NCT03068260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086077|NCT03068260|Analgesics|analgesics|mesh-ancestor
102086078|NCT03068260|Sensory System Agents|sensory system agents|mesh-ancestor
102086079|NCT03068260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102086144|NCT03539718|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102086220|NCT02169804|Fertility Agents|fertility agents|mesh-ancestor
102086221|NCT02169804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102086222|NCT02169804|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102086224|NCT02170974|Dabigatran|dabigatran|mesh-list
102086290|NCT03602469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102086291|NCT03602469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102086292|NCT03602469|Anesthetics, General|anesthetics, general|mesh-ancestor
102086293|NCT03602469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102086294|NCT03602469|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102086312|NCT05001373|Vaccines|vaccines|mesh-list
102086358|NCT02237937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102086359|NCT02237937|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102086360|NCT02237937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102086361|NCT02237937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102086363|NCT02237937|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
102086428|NCT03598959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102086429|NCT03598959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102086430|NCT03598959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086431|NCT02238717|Pregabalin|pregabalin|mesh-list
102086432|NCT02238717|PF-06372865|pf-06372865|mesh-list
102086433|NCT02238717|Analgesics|analgesics|mesh-ancestor
102086434|NCT02238717|Sensory System Agents|sensory system agents|mesh-ancestor
102086435|NCT02238717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102086494|NCT03579927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102086495|NCT03579927|Alkylating Agents|alkylating agents|mesh-ancestor
102086496|NCT03579927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102086497|NCT03579927|Keratolytic Agents|keratolytic agents|mesh-ancestor
102086498|NCT03579927|Dermatologic Agents|dermatologic agents|mesh-ancestor
102086499|NCT03579927|Tubulin Modulators|tubulin modulators|mesh-ancestor
102086563|NCT02171442|Antithrombins|antithrombins|mesh-ancestor
102086564|NCT02171442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102086565|NCT02171442|Protease Inhibitors|protease inhibitors|mesh-ancestor
102086566|NCT02171442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102086632|NCT03577899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101354980|NCT00028496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102086633|NCT03577899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102086634|NCT03577899|Growth Substances|growth substances|mesh-ancestor
102086635|NCT03577899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086636|NCT03577899|Growth Inhibitors|growth inhibitors|mesh-ancestor
102086637|NCT03577899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102086701|NCT03209401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102086702|NCT02175420|BCG Vaccine|bcg vaccine|mesh-list
102086703|NCT02175420|Immunologic Factors|immunologic factors|mesh-ancestor
102086704|NCT02175420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086705|NCT02175420|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101806553|NCT00741767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102086772|NCT03577743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102086773|NCT03577743|Growth Substances|growth substances|mesh-ancestor
102086774|NCT03577743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086775|NCT03577743|Growth Inhibitors|growth inhibitors|mesh-ancestor
102086777|NCT04794790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
102086778|NCT04794790|Naloxone|naloxone|mesh-list
102086779|NCT04794790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102086780|NCT04794790|Narcotics|narcotics|mesh-ancestor
102086781|NCT04794790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102086783|NCT04794790|Analgesics|analgesics|mesh-ancestor
102086834|NCT00778999|Hormones|hormones|mesh-ancestor
102086835|NCT00778999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102086836|NCT02171988|Propranolol|propranolol|mesh-list
102086837|NCT02171988|Bisoprolol|bisoprolol|mesh-list
102086905|NCT02967757|Hormones|hormones|mesh-ancestor
102086906|NCT02967757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102086907|NCT02261298|Nivolumab|nivolumab|mesh-list
102086908|NCT02261298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102086912|NCT02176200|Fenoterol|fenoterol|mesh-list
102086975|NCT05729074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102086976|NCT05729074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102086977|NCT05729074|Analgesics|analgesics|mesh-ancestor
102086978|NCT05729074|Sensory System Agents|sensory system agents|mesh-ancestor
102086979|NCT05729074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102086980|NCT05729074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102086981|NCT05729074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102086982|NCT05729074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102086983|NCT05729074|Dermatologic Agents|dermatologic agents|mesh-ancestor
102086984|NCT05729074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102086985|NCT05729074|Immunologic Factors|immunologic factors|mesh-ancestor
102086986|NCT05729074|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102086987|NCT05729074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102086988|NCT05729074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087033|NCT03066076|Antithyroid Agents|antithyroid agents|mesh-list
102087034|NCT03066076|Antimetabolites|antimetabolites|mesh-ancestor
102087107|NCT00431431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102087108|NCT00431431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087109|NCT00431431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102087114|NCT00431431|Hormones|hormones|mesh-ancestor
102087177|NCT03065998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102087178|NCT03065998|Adrenergic Agents|adrenergic agents|mesh-ancestor
102087179|NCT02172378|Tiotropium Bromide|tiotropium bromide|mesh-list
102087180|NCT02172378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102087181|NCT02172378|Autonomic Agents|autonomic agents|mesh-ancestor
102087248|NCT02172534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102087249|NCT02172534|Cholinergic Agents|cholinergic agents|mesh-ancestor
102087250|NCT02172534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102087251|NCT02172534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087320|NCT02256150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102087321|NCT02256150|Alkylating Agents|alkylating agents|mesh-ancestor
102087322|NCT02256150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087323|NCT02256150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102087327|NCT02256150|Analgesics|analgesics|mesh-ancestor
102087390|NCT03537144|Sensory System Agents|sensory system agents|mesh-ancestor
102087391|NCT03537144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102087392|NCT03537144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087393|NCT03537144|Antipyretics|antipyretics|mesh-ancestor
102087394|NCT03537144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102087395|NCT03537144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102087396|NCT03537144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102087458|NCT05717374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102087459|NCT05717374|Glucocorticoids|glucocorticoids|mesh-ancestor
102087460|NCT05717374|Hormones|hormones|mesh-ancestor
102087461|NCT05717374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102087462|NCT05717374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102087463|NCT05717374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102087464|NCT05717374|Protease Inhibitors|protease inhibitors|mesh-ancestor
102087465|NCT05717374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102087466|NCT05717374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087467|NCT05717374|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102087524|NCT02180334|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102087525|NCT02180334|Protease Inhibitors|protease inhibitors|mesh-ancestor
102087526|NCT02180334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102087527|NCT02180334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102087528|NCT02180334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102087529|NCT02180334|Serotonin Agents|serotonin agents|mesh-ancestor
102087590|NCT02178150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102087591|NCT02178150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102087592|NCT04411030|Itraconazole|itraconazole|mesh-list
102087593|NCT04411030|Midazolam|midazolam|mesh-list
102087660|NCT02657889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389400|NCT05884242|Adalimumab|adalimumab|mesh-list
101389401|NCT05884242|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102087731|NCT02182518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102087732|NCT02182518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087804|NCT02186106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102087805|NCT02186106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087806|NCT02186106|Vitamins|vitamins|mesh-ancestor
102087807|NCT02186106|Micronutrients|micronutrients|mesh-ancestor
102087809|NCT03943147|Mycophenolic Acid|mycophenolic acid|mesh-list
102087874|NCT05615194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102087875|NCT05615194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102087876|NCT05615194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102087877|NCT05615194|Analgesics|analgesics|mesh-ancestor
102087878|NCT05615194|Sensory System Agents|sensory system agents|mesh-ancestor
102087879|NCT05615194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102087880|NCT05615194|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102087941|NCT03576651|Bevacizumab|bevacizumab|mesh-list
102087942|NCT03576651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102087943|NCT03576651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102087944|NCT03576651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102087949|NCT04116112|Labetalol|labetalol|mesh-list
102088014|NCT03571737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102088015|NCT03571737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102088016|NCT03571737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102088017|NCT03571737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102088018|NCT03573999|Mannitol|mannitol|mesh-list
102088019|NCT03573999|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102088083|NCT03418779|Immunologic Factors|immunologic factors|mesh-ancestor
102088084|NCT03418779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088085|NCT03418779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102088086|NCT03418779|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102088087|NCT03418779|Alkylating Agents|alkylating agents|mesh-ancestor
102088088|NCT03418779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088089|NCT03418779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102088090|NCT03418779|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102088091|NCT03418779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102088092|NCT03418779|Glucocorticoids|glucocorticoids|mesh-ancestor
102088093|NCT03418779|Hormones|hormones|mesh-ancestor
102088094|NCT03418779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102088095|NCT03418779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102088096|NCT03573063|Androgens|androgens|mesh-list
102088097|NCT03573063|Hormones|hormones|mesh-ancestor
102088141|NCT03572595|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102088142|NCT03572595|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102088143|NCT03572595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088161|NCT03570645|Hormones|hormones|mesh-ancestor
102088211|NCT04740580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088212|NCT04740580|Protective Agents|protective agents|mesh-ancestor
102088284|NCT03698227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088285|NCT03698227|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102088286|NCT03698227|Protective Agents|protective agents|mesh-ancestor
102088287|NCT03698227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088288|NCT03698227|Antimitotic Agents|antimitotic agents|mesh-ancestor
102088354|NCT02183064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102088355|NCT02183064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102088356|NCT02183064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102088426|NCT02187588|Sensory System Agents|sensory system agents|mesh-ancestor
102088427|NCT02187588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102088428|NCT02187588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390254|NCT05581030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102088496|NCT03062644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102088497|NCT03062644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102088498|NCT03062644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088499|NCT03062644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102088500|NCT03062644|Narcotics|narcotics|mesh-ancestor
101390317|NCT05564650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088561|NCT03569631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102088563|NCT02629822|Tenofovir|tenofovir|mesh-list
102088632|NCT03397654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102088633|NCT03397654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102088634|NCT03397654|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102088705|NCT04432714|Antimitotic Agents|antimitotic agents|mesh-ancestor
102088706|NCT04432714|Mitosis Modulators|mitosis modulators|mesh-ancestor
102088707|NCT04432714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102088708|NCT04432714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102088709|NCT04432714|Growth Substances|growth substances|mesh-ancestor
102088710|NCT04432714|Growth Inhibitors|growth inhibitors|mesh-ancestor
101808507|NCT00981786|Timolol|timolol|mesh-list
102088711|NCT02752074|Pembrolizumab|pembrolizumab|mesh-list
102088716|NCT03564795|Sulfadiazine|sulfadiazine|mesh-list
102088769|NCT05353101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102088770|NCT05353101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102088771|NCT05353101|Immunologic Factors|immunologic factors|mesh-ancestor
102088781|NCT03700333|Pemetrexed|pemetrexed|mesh-list
102088840|NCT02190708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102088841|NCT02190708|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102088842|NCT02190708|Anesthetics, General|anesthetics, general|mesh-ancestor
102088843|NCT02190708|Anesthetics|anesthetics|mesh-ancestor
102088844|NCT02190708|GABA Modulators|gaba modulators|mesh-ancestor
102088911|NCT02259855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102088912|NCT02259855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
102088913|NCT02259855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
102088914|NCT02259855|Protease Inhibitors|protease inhibitors|mesh-ancestor
102088984|NCT03694873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102088985|NCT03694873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102088986|NCT03694873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102088988|NCT03694873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102089055|NCT04301011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102089056|NCT04301011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102089057|NCT04301011|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102089058|NCT04301011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089060|NCT02191332|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102089061|NCT02191332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102089062|NCT02191332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102089063|NCT02191332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089064|NCT02191332|Antiviral Agents|antiviral agents|mesh-ancestor
102089066|NCT02191332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102089115|NCT02184858|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102089116|NCT02184858|Protective Agents|protective agents|mesh-ancestor
102089117|NCT02184858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089118|NCT03535662|Itraconazole|itraconazole|mesh-list
102089130|NCT03702205|Betaine|betaine|mesh-list
102089185|NCT02257008|Protease Inhibitors|protease inhibitors|mesh-ancestor
102089186|NCT02257008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102089258|NCT02194374|Alkylating Agents|alkylating agents|mesh-ancestor
101828119|NCT05981131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089259|NCT02194374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089260|NCT02194374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102089261|NCT02194374|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102089262|NCT02194374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102089263|NCT02194374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102089264|NCT02194374|Antimetabolites|antimetabolites|mesh-ancestor
102089265|NCT02194452|Octreotide|octreotide|mesh-list
102089266|NCT02194452|Edotreotide|edotreotide|mesh-list
102089267|NCT02194452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102089268|NCT02194452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102089269|NCT02194452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102089270|NCT02194452|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102089271|NCT02194452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089272|NCT01358721|Nivolumab|nivolumab|mesh-list
102089273|NCT01358721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102089274|NCT01358721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102089275|NCT01358721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102089276|NCT01358721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089277|NCT02194686|Cilostazol|cilostazol|mesh-list
102089278|NCT02194686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102089279|NCT02194686|Autonomic Agents|autonomic agents|mesh-ancestor
102089280|NCT02194686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102089294|NCT04622995|Diazepam|diazepam|mesh-list
102089306|NCT04622995|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102089307|NCT04622995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102089308|NCT04622995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102089379|NCT02197026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089381|NCT02197104|Lipotropic Agents|lipotropic agents|mesh-ancestor
102089383|NCT02197104|Antimetabolites|antimetabolites|mesh-ancestor
102089384|NCT02197104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089385|NCT02197104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102089386|NCT02197104|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102089387|NCT02197104|Nootropic Agents|nootropic agents|mesh-ancestor
102089388|NCT02197182|Copper|copper|mesh-list
102089389|NCT02197182|Metronidazole|metronidazole|mesh-list
102089390|NCT02197182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102089391|NCT02197182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102089392|NCT02197182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102089445|NCT02753686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102089446|NCT02753686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102089447|NCT02753686|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102089448|NCT02753686|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102089449|NCT02753686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102089450|NCT02753686|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
102089451|NCT04216927|Nitric Oxide|nitric oxide|mesh-list
102089452|NCT04216927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102089453|NCT04216927|Autonomic Agents|autonomic agents|mesh-ancestor
102089454|NCT04216927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101828120|NCT05966090|Vaccines|vaccines|mesh-list
102089455|NCT04216927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089504|NCT01340937|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
102089506|NCT01340937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089507|NCT03692299|Metronidazole|metronidazole|mesh-list
102089508|NCT03692299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102089509|NCT03692299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102089510|NCT03692299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102089513|NCT02197650|Eryaspase|eryaspase|mesh-list
101391384|NCT05137067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089568|NCT02197884|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102089569|NCT02197884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102089630|NCT02201316|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102089631|NCT02201316|Serotonin Agents|serotonin agents|mesh-ancestor
102089632|NCT02201316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102089645|NCT02257476|Hormones|hormones|mesh-ancestor
102089699|NCT02198352|Sensory System Agents|sensory system agents|mesh-ancestor
102089700|NCT02198352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102089701|NCT02198352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089702|NCT02202564|Ganciclovir|ganciclovir|mesh-list
102089703|NCT02202564|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
102089704|NCT02202564|Antiviral Agents|antiviral agents|mesh-ancestor
102089705|NCT02202564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102089768|NCT02206854|Tarenflurbil|tarenflurbil|mesh-list
102089769|NCT02206854|Analgesics|analgesics|mesh-ancestor
102089770|NCT02206854|Sensory System Agents|sensory system agents|mesh-ancestor
102089771|NCT02206854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102089838|NCT02203656|Androgens|androgens|mesh-ancestor
102089839|NCT02203656|Hormones|hormones|mesh-ancestor
102089841|NCT02203656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102089912|NCT02199678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102089913|NCT02199678|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102089985|NCT02208882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102089986|NCT02208882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102089987|NCT02208882|Anesthetics, General|anesthetics, general|mesh-ancestor
102089988|NCT02208882|Anesthetics|anesthetics|mesh-ancestor
102089989|NCT02208882|GABA Modulators|gaba modulators|mesh-ancestor
102089990|NCT02208882|GABA Agents|gaba agents|mesh-ancestor
102089991|NCT02208882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102089992|NCT02208882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089993|NCT02208882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102089994|NCT03690115|Ponatinib|ponatinib|mesh-list
102089995|NCT03690115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102089996|NCT03690115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102089997|NCT03690115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102089998|NCT03690115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102089999|NCT02204202|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102090000|NCT02204202|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102090002|NCT01886794|Estrogens|estrogens|mesh-list
102090003|NCT01886794|Hormones|hormones|mesh-ancestor
102090040|NCT02200848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102090041|NCT02200848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102090042|NCT02200848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102090043|NCT02200848|Growth Substances|growth substances|mesh-ancestor
102090044|NCT02200848|Growth Inhibitors|growth inhibitors|mesh-ancestor
102090045|NCT02200848|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102090046|NCT02200848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102090047|NCT02200848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090108|NCT02209974|Respiratory System Agents|respiratory system agents|mesh-ancestor
102090109|NCT02209974|Dermatologic Agents|dermatologic agents|mesh-ancestor
102090110|NCT02209974|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102090111|NCT02212392|Meropenem|meropenem|mesh-list
102090112|NCT02212392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102090113|NCT02212392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102090114|NCT03679897|Ropivacaine|ropivacaine|mesh-list
102090115|NCT03679897|Levobupivacaine|levobupivacaine|mesh-list
102090116|NCT03679897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102090117|NCT03679897|Anesthetics, Local|anesthetics, local|mesh-ancestor
102090176|NCT02220036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090177|NCT02220036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102090178|NCT02220114|Vigabatrin|vigabatrin|mesh-list
102090179|NCT02220114|Anticonvulsants|anticonvulsants|mesh-ancestor
102090180|NCT02220114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102090246|NCT03039114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102090247|NCT04970602|Methylene Blue|methylene blue|mesh-list
102090248|NCT04970602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102090322|NCT04425382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090323|NCT04425382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102090324|NCT04425382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102090325|NCT04425382|Antiviral Agents|antiviral agents|mesh-ancestor
102090391|NCT02222220|Dopamine Agents|dopamine agents|mesh-ancestor
102090392|NCT02222220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102090393|NCT02222220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090394|NCT03677323|Sufentanil|sufentanil|mesh-list
102090395|NCT03677323|Droperidol|droperidol|mesh-list
102090396|NCT03677323|Propofol|propofol|mesh-list
101356370|NCT00033683|Epirubicin|epirubicin|mesh-list
102090397|NCT03677323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102090398|NCT03677323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102090399|NCT03677323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090400|NCT03677323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102090401|NCT03677323|Anesthetics, General|anesthetics, general|mesh-ancestor
102090402|NCT03677323|Anesthetics|anesthetics|mesh-ancestor
102090403|NCT03677323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102090404|NCT03677323|Narcotics|narcotics|mesh-ancestor
102090405|NCT03677323|Analgesics|analgesics|mesh-ancestor
102090452|NCT02222376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102090454|NCT02231658|Lixisenatide|lixisenatide|mesh-list
102090455|NCT02231658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102090456|NCT02231658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090457|NCT02231658|Incretins|incretins|mesh-ancestor
102090458|NCT02231658|Hormones|hormones|mesh-ancestor
102090459|NCT02231658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102090460|NCT04542408|Heparin|heparin|mesh-list
102090461|NCT04542408|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
102090462|NCT04542408|Tinzaparin|tinzaparin|mesh-list
102090463|NCT04542408|Dalteparin|dalteparin|mesh-list
102090464|NCT04542408|Edoxaban|edoxaban|mesh-list
102090465|NCT04542408|Anticoagulants|anticoagulants|mesh-list
102090466|NCT04542408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102090467|NCT04542408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102090469|NCT04542408|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102090513|NCT03623425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090514|NCT04957420|Rotigotine|rotigotine|mesh-list
102090515|NCT04957420|Dopamine Agonists|dopamine agonists|mesh-ancestor
102090584|NCT03671707|Cholinergic Agents|cholinergic agents|mesh-ancestor
102090585|NCT03671707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102090586|NCT03671707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090594|NCT02226588|Oxytocics|oxytocics|mesh-ancestor
102090655|NCT03058744|Dermatologic Agents|dermatologic agents|mesh-ancestor
102090656|NCT03058744|Keratolytic Agents|keratolytic agents|mesh-ancestor
102090657|NCT03058744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102090660|NCT03058744|Hormones|hormones|mesh-ancestor
102090730|NCT04161456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101810515|NCT03028103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090731|NCT04161456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102090732|NCT04161456|Analgesics|analgesics|mesh-ancestor
102090733|NCT04161456|Sensory System Agents|sensory system agents|mesh-ancestor
102090734|NCT04161456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102090735|NCT04161456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090736|NCT04161456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102090742|NCT02224014|Brotizolam|brotizolam|mesh-list
102090800|NCT05956639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102090801|NCT05956639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090802|NCT05956600|Amisulpride|amisulpride|mesh-list
102090803|NCT05956600|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102090804|NCT05956600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102090814|NCT05956561|Vitamin D|vitamin d|mesh-list
102090869|NCT05956145|Tubulin Modulators|tubulin modulators|mesh-ancestor
102090870|NCT05956145|Antimitotic Agents|antimitotic agents|mesh-ancestor
102090871|NCT05956145|Mitosis Modulators|mitosis modulators|mesh-ancestor
102090872|NCT05956145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102090873|NCT05956145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102090874|NCT05956041|Pembrolizumab|pembrolizumab|mesh-list
102090937|NCT05952310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102090938|NCT05951504|Methylprednisolone|methylprednisolone|mesh-list
102090939|NCT05951504|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102090940|NCT05951504|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102090941|NCT05951504|Prednisolone|prednisolone|mesh-list
102090942|NCT05951504|Prednisolone acetate|prednisolone acetate|mesh-list
102090943|NCT05951504|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102091005|NCT05881928|GABA Agents|gaba agents|mesh-ancestor
102091006|NCT05881928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102091007|NCT05881928|Antimanic Agents|antimanic agents|mesh-ancestor
102091008|NCT05872893|Dexamethasone|dexamethasone|mesh-list
102091009|NCT05872893|Ondansetron|ondansetron|mesh-list
102091010|NCT05872893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102091011|NCT05872893|Antiemetics|antiemetics|mesh-ancestor
102091012|NCT05872893|Autonomic Agents|autonomic agents|mesh-ancestor
102091013|NCT05872893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102091014|NCT05872893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091015|NCT05872893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102091016|NCT05872893|Glucocorticoids|glucocorticoids|mesh-ancestor
102091017|NCT05872893|Hormones|hormones|mesh-ancestor
102091018|NCT05872893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102091019|NCT05872893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102091020|NCT05872893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102091021|NCT05872893|Antipruritics|antipruritics|mesh-ancestor
102091022|NCT05872893|Dermatologic Agents|dermatologic agents|mesh-ancestor
102091023|NCT05872893|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102091024|NCT05872893|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102091025|NCT05872893|Serotonin Agents|serotonin agents|mesh-ancestor
102091026|NCT05872893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101810816|NCT00490971|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102091027|NCT05872893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091028|NCT05853575|Adagrasib|adagrasib|mesh-list
102091029|NCT05853575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102091030|NCT05826275|Pembrolizumab|pembrolizumab|mesh-list
102091052|NCT05773053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102091053|NCT05773053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091054|NCT05773053|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102091055|NCT05773053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102091056|NCT05773053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091057|NCT05773053|Cholinergic Agents|cholinergic agents|mesh-ancestor
102091058|NCT05773053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102091059|NCT05767398|Zanubrutinib|zanubrutinib|mesh-list
102091060|NCT05767398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102091062|NCT05767398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102091117|NCT05730751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102091119|NCT05685225|Acetaminophen|acetaminophen|mesh-list
102091261|NCT05590234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102091262|NCT05590234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102091263|NCT05590234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102091264|NCT05590234|Analgesics|analgesics|mesh-ancestor
102091265|NCT05590234|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102091266|NCT05590234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102091267|NCT05590234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102091268|NCT05590234|Adrenergic Agents|adrenergic agents|mesh-ancestor
102091271|NCT05572749|Metformin|metformin|mesh-list
102091325|NCT05413096|Propolis|propolis|mesh-list
102091399|NCT05279937|Anesthetics|anesthetics|mesh-ancestor
102091400|NCT05279937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102091401|NCT05279937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091402|NCT05279937|Sensory System Agents|sensory system agents|mesh-ancestor
102091403|NCT05279937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102091404|NCT05279937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102091467|NCT05227001|Dermatologic Agents|dermatologic agents|mesh-ancestor
102091468|NCT05226871|Cetuximab|cetuximab|mesh-list
102091469|NCT05226871|Letrozole|letrozole|mesh-list
102091470|NCT05226871|Fulvestrant|fulvestrant|mesh-list
102091471|NCT05226871|Palbociclib|palbociclib|mesh-list
102091472|NCT05226871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102091473|NCT05226871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102091537|NCT05108688|Mirtazapine|mirtazapine|mesh-list
102091538|NCT05108688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102091539|NCT05108688|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
102091540|NCT05108688|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102091541|NCT05108688|Serotonin Agents|serotonin agents|mesh-ancestor
102091542|NCT05108688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102091543|NCT05108688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091544|NCT05108688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091545|NCT05108688|Antidepressive Agents|antidepressive agents|mesh-ancestor
102091546|NCT05108688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102091547|NCT05108688|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102091548|NCT05108688|Histamine Antagonists|histamine antagonists|mesh-ancestor
102091549|NCT05108688|Histamine Agents|histamine agents|mesh-ancestor
102091550|NCT05108688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102091551|NCT05108688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102091552|NCT05108688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102091556|NCT05108688|Adrenergic Agents|adrenergic agents|mesh-ancestor
102091592|NCT05076617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102091593|NCT05076617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102091666|NCT04946825|Cholinergic Agents|cholinergic agents|mesh-ancestor
102091667|NCT04946825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102091669|NCT04908579|Ketamine|ketamine|mesh-list
102091742|NCT04772222|Narcotics|narcotics|mesh-ancestor
102091748|NCT04766021|Mirabegron|mirabegron|mesh-list
102091749|NCT04766021|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
102091750|NCT04766021|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102091751|NCT04766021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102091752|NCT04766021|Adrenergic Agents|adrenergic agents|mesh-ancestor
102091753|NCT04766021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102091754|NCT04766021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091755|NCT04766021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091756|NCT04766021|Urological Agents|urological agents|mesh-ancestor
102091757|NCT04760613|Cannabidiol|cannabidiol|mesh-list
102091758|NCT04760613|Anticonvulsants|anticonvulsants|mesh-ancestor
102091759|NCT04728360|Ustekinumab|ustekinumab|mesh-list
102091760|NCT04728360|Dermatologic Agents|dermatologic agents|mesh-ancestor
102091762|NCT04677049|Nicotinic Acids|nicotinic acids|mesh-list
102091763|NCT04677049|Vitamins|vitamins|mesh-ancestor
102091764|NCT04677049|Micronutrients|micronutrients|mesh-ancestor
102091765|NCT04677049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091766|NCT04677049|Vitamin B Complex|vitamin b complex|mesh-ancestor
102091767|NCT04677049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102091784|NCT04562129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102091785|NCT04562129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102091786|NCT04562129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102091787|NCT04562129|Analgesics|analgesics|mesh-ancestor
102091788|NCT04562129|Sensory System Agents|sensory system agents|mesh-ancestor
102091854|NCT04348448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102091855|NCT04345796|Empagliflozin|empagliflozin|mesh-list
102091926|NCT04021043|Nivolumab|nivolumab|mesh-list
102091927|NCT04021043|Ipilimumab|ipilimumab|mesh-list
102092000|NCT03869996|Abortifacient Agents|abortifacient agents|mesh-ancestor
102092001|NCT03869996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102092002|NCT03869996|Dermatologic Agents|dermatologic agents|mesh-ancestor
102092003|NCT03869996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101811787|NCT03996993|Hormone Antagonists|hormone antagonists|mesh-ancestor
102092071|NCT03576547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102092072|NCT03576547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102092221|NCT03179904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092222|NCT03179904|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102092223|NCT03179904|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102092294|NCT02955758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102092368|NCT02723994|Autonomic Agents|autonomic agents|mesh-ancestor
102092369|NCT02723994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102092370|NCT02723994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102092371|NCT02723994|Glucocorticoids|glucocorticoids|mesh-ancestor
102092372|NCT02723994|Hormones|hormones|mesh-ancestor
102092373|NCT02723994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102092374|NCT02723994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102092375|NCT02723994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102092376|NCT02723994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102092377|NCT02723994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102092378|NCT02723994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102092379|NCT02723994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102092380|NCT02723994|Abortifacient Agents|abortifacient agents|mesh-ancestor
102092431|NCT02547662|Glycine|glycine|mesh-list
102092432|NCT02547662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102092433|NCT02547662|Antiemetics|antiemetics|mesh-ancestor
102092434|NCT02547662|Autonomic Agents|autonomic agents|mesh-ancestor
102092435|NCT02547662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102092436|NCT02547662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092437|NCT02547662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102092438|NCT02547662|Glucocorticoids|glucocorticoids|mesh-ancestor
102092439|NCT02547662|Hormones|hormones|mesh-ancestor
102092440|NCT02547662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102092441|NCT02547662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102092442|NCT02547662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092444|NCT02547662|Protease Inhibitors|protease inhibitors|mesh-ancestor
102092491|NCT02252172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102092492|NCT02252172|Growth Substances|growth substances|mesh-ancestor
102092493|NCT02252172|Growth Inhibitors|growth inhibitors|mesh-ancestor
102092495|NCT02215265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092564|NCT01664910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102092565|NCT01664910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102092566|NCT01664910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102092636|NCT00390793|Antiemetics|antiemetics|mesh-ancestor
102092637|NCT00390793|Autonomic Agents|autonomic agents|mesh-ancestor
102092638|NCT00390793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102092639|NCT00390793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102092640|NCT00390793|Glucocorticoids|glucocorticoids|mesh-ancestor
102092641|NCT00390793|Hormones|hormones|mesh-ancestor
102092642|NCT00390793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102092643|NCT00390793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102092644|NCT00390793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102092645|NCT00390793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102092646|NCT00390793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102092647|NCT00390793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102092648|NCT00390793|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102092649|NCT00390793|Abortifacient Agents|abortifacient agents|mesh-ancestor
102092650|NCT00390793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102092694|NCT04948372|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102092695|NCT04947748|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102092696|NCT04947748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102092697|NCT04947826|Antibodies|antibodies|mesh-list
102092698|NCT04947826|Immunoglobulins|immunoglobulins|mesh-list
102092699|NCT04947826|Immunologic Factors|immunologic factors|mesh-ancestor
102092700|NCT04947826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092701|NCT05059977|Immunoglobulins|immunoglobulins|mesh-list
102092702|NCT05059977|gamma-Globulins|gamma-globulins|mesh-list
102092703|NCT05059977|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
102092704|NCT05059977|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102092760|NCT03646968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092761|NCT02228850|Alprostadil|alprostadil|mesh-list
102092762|NCT02228850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102092763|NCT02228850|Vasodilator Agents|vasodilator agents|mesh-ancestor
102092764|NCT02228850|Urological Agents|urological agents|mesh-ancestor
102092765|NCT02822508|Laxatives|laxatives|mesh-list
102092766|NCT02822508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102092767|NCT03563001|Budesonide|budesonide|mesh-list
102092768|NCT03563001|Formoterol Fumarate|formoterol fumarate|mesh-list
102092769|NCT03563001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102092826|NCT04946734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102092827|NCT04946734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102092828|NCT04946734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102092829|NCT04946734|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102092830|NCT04946734|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102092831|NCT04946734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092832|NCT04946734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102092833|NCT04946734|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102092834|NCT04946734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102092835|NCT04946734|Antipyretics|antipyretics|mesh-ancestor
102092836|NCT04946734|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102092837|NCT04946734|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101812620|NCT00973154|Prednisone|prednisone|mesh-list
102092890|NCT02587598|Azacitidine|azacitidine|mesh-list
102092891|NCT02587598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102092892|NCT02587598|Antimetabolites|antimetabolites|mesh-ancestor
102092893|NCT02587598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102092960|NCT01291004|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102092962|NCT01291004|Levonorgestrel|levonorgestrel|mesh-list
102092963|NCT01291004|Ethinyl Estradiol|ethinyl estradiol|mesh-list
102092964|NCT01291004|Desogestrel|desogestrel|mesh-list
102092965|NCT01291004|Contraceptive Agents|contraceptive agents|mesh-list
102092966|NCT01291004|Contraceptives, Oral|contraceptives, oral|mesh-list
102092967|NCT01291004|Estradiol|estradiol|mesh-list
102092968|NCT01291004|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102092969|NCT01291004|Estrogens|estrogens|mesh-ancestor
102092970|NCT01291004|Hormones|hormones|mesh-ancestor
102092972|NCT01291004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093025|NCT03483350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102093026|NCT03483350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102093027|NCT03483350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102093028|NCT03483350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093034|NCT03483350|Anesthetics|anesthetics|mesh-ancestor
102093097|NCT04936282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093098|NCT04936282|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102093099|NCT04936282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102093100|NCT04936282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093101|NCT02524184|Sildenafil Citrate|sildenafil citrate|mesh-list
102093102|NCT02524184|Vasodilator Agents|vasodilator agents|mesh-ancestor
102093103|NCT02524184|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102093104|NCT02524184|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102093105|NCT02524184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102093106|NCT02524184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093107|NCT02524184|Urological Agents|urological agents|mesh-ancestor
102093108|NCT04936204|Hyaluronic Acid|hyaluronic acid|mesh-list
102093109|NCT04936204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102093110|NCT04936204|Immunologic Factors|immunologic factors|mesh-ancestor
102093111|NCT04936204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093112|NCT04936204|Viscosupplements|viscosupplements|mesh-ancestor
102093113|NCT04936204|Protective Agents|protective agents|mesh-ancestor
102093114|NCT03486236|Ivacaftor|ivacaftor|mesh-list
102093115|NCT03486236|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
102093116|NCT03486236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102093117|NCT03486236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093149|NCT03479450|Pulmonary Surfactants|pulmonary surfactants|mesh-list
102093150|NCT03479450|Respiratory System Agents|respiratory system agents|mesh-ancestor
102093221|NCT03482180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102093222|NCT04390646|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
102093223|NCT04390646|Hormones|hormones|mesh-ancestor
102093231|NCT03476564|Pentoxifylline|pentoxifylline|mesh-list
102093297|NCT03478280|Dermatologic Agents|dermatologic agents|mesh-ancestor
102093370|NCT05257148|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102093371|NCT05257148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102093372|NCT05257148|Adrenergic Agents|adrenergic agents|mesh-ancestor
102093373|NCT05257148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102093374|NCT05257148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093441|NCT03473210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102093442|NCT03473210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102093443|NCT03473210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102093444|NCT03473132|Thrombin|thrombin|mesh-list
102093445|NCT03473132|Hemostatics|hemostatics|mesh-ancestor
102093446|NCT03473132|Coagulants|coagulants|mesh-ancestor
102093447|NCT03475160|Sildenafil Citrate|sildenafil citrate|mesh-list
102093448|NCT03475160|Citric Acid|citric acid|mesh-list
102093449|NCT03475160|Sodium Citrate|sodium citrate|mesh-list
102093450|NCT03475160|Anticoagulants|anticoagulants|mesh-ancestor
102093451|NCT03475160|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102093508|NCT05052710|Midazolam|midazolam|mesh-list
102093509|NCT05052710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102093510|NCT05052710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102093518|NCT05052710|Anesthetics|anesthetics|mesh-ancestor
102093580|NCT03473600|Triamcinolone|triamcinolone|mesh-list
102093653|NCT04929652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102093655|NCT04929652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102093725|NCT03842709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093800|NCT04921306|Respiratory System Agents|respiratory system agents|mesh-ancestor
102093801|NCT04921306|Sympathomimetics|sympathomimetics|mesh-ancestor
102093802|NCT04920760|Vitamin A|vitamin a|mesh-list
102093803|NCT04920760|Vitamins|vitamins|mesh-ancestor
102093804|NCT04920760|Micronutrients|micronutrients|mesh-ancestor
102093805|NCT04920760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093833|NCT03061006|Warfarin|warfarin|mesh-list
102093872|NCT04979650|Autonomic Agents|autonomic agents|mesh-ancestor
102093873|NCT04979650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102093874|NCT04979650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102093875|NCT04979650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102093876|NCT04979650|Glucocorticoids|glucocorticoids|mesh-ancestor
102093877|NCT04979650|Hormones|hormones|mesh-ancestor
102093940|NCT04918576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102093941|NCT04918576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094012|NCT06016556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094013|NCT06016556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102094014|NCT06016556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102094015|NCT06016556|Antiviral Agents|antiviral agents|mesh-ancestor
102094016|NCT06016556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101828121|NCT05966090|Immunologic Factors|immunologic factors|mesh-ancestor
102094017|NCT06016556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102094018|NCT06016556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102094019|NCT06016530|Dexamethasone|dexamethasone|mesh-list
102094020|NCT06016530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102094021|NCT06016530|Antiemetics|antiemetics|mesh-ancestor
102094022|NCT06016530|Autonomic Agents|autonomic agents|mesh-ancestor
102094023|NCT06016530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102094026|NCT06016530|Glucocorticoids|glucocorticoids|mesh-ancestor
102094075|NCT06016387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094076|NCT06016387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102094077|NCT06016387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102094078|NCT06016387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102094079|NCT06016387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102094080|NCT06016270|Paclitaxel|paclitaxel|mesh-list
102094081|NCT06016270|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102094082|NCT06016270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102094083|NCT06016270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102094141|NCT06015750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102094142|NCT06015750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102094143|NCT06015750|Hematinics|hematinics|mesh-ancestor
102094144|NCT06015750|Vitamin B Complex|vitamin b complex|mesh-ancestor
102094146|NCT06015750|Micronutrients|micronutrients|mesh-ancestor
102094147|NCT06015724|Nivolumab|nivolumab|mesh-list
102094148|NCT06015724|Daratumumab|daratumumab|mesh-list
102094153|NCT06015659|Gemcitabine|gemcitabine|mesh-list
102094210|NCT06015100|Capecitabine|capecitabine|mesh-list
102094211|NCT06015100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102094212|NCT06015100|Antimetabolites|antimetabolites|mesh-ancestor
102094213|NCT06015100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094214|NCT06015100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102094215|NCT06015074|Propofol|propofol|mesh-list
102094216|NCT06015074|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102094217|NCT06015074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102094218|NCT06015074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094219|NCT06015074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102094220|NCT06015074|Anesthetics, General|anesthetics, general|mesh-ancestor
102094221|NCT06015074|Anesthetics|anesthetics|mesh-ancestor
102094222|NCT06015022|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
102094223|NCT06015022|Antioxidants|antioxidants|mesh-ancestor
102094225|NCT06015022|Protective Agents|protective agents|mesh-ancestor
102094271|NCT05946941|Deucravacitinib|deucravacitinib|mesh-list
102094272|NCT05946941|Dermatologic Agents|dermatologic agents|mesh-ancestor
102094273|NCT05946941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102094274|NCT05946941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102094275|NCT05946941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094276|NCT05933395|Everolimus|everolimus|mesh-list
102094277|NCT05933395|Fulvestrant|fulvestrant|mesh-list
102094278|NCT05933395|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102094279|NCT05933395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102094280|NCT05933395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102094281|NCT05933395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094282|NCT05933395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102094283|NCT05933395|Immunologic Factors|immunologic factors|mesh-ancestor
102094342|NCT05903820|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102094343|NCT05903820|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102094344|NCT05903820|Estradiol|estradiol|mesh-list
102094345|NCT05903820|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102094346|NCT05903820|Progesterone|progesterone|mesh-list
102094347|NCT05903820|Estrogens|estrogens|mesh-ancestor
102094348|NCT05903820|Hormones|hormones|mesh-ancestor
102094349|NCT05903820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102094350|NCT05903820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094351|NCT05903820|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102094352|NCT05903820|Contraceptive Agents|contraceptive agents|mesh-ancestor
102094353|NCT05903820|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102094354|NCT05903820|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102094355|NCT05903820|Progestins|progestins|mesh-ancestor
102094368|NCT05888402|Immunomodulating Agents|immunomodulating agents|mesh-list
102094369|NCT05888402|Immunologic Factors|immunologic factors|mesh-ancestor
102094370|NCT05888402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094371|NCT05888207|Fluvoxamine|fluvoxamine|mesh-list
102094372|NCT05888207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102094397|NCT05887843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094398|NCT05887843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102094399|NCT05887843|Respiratory System Agents|respiratory system agents|mesh-ancestor
102094400|NCT05887843|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
102094401|NCT05887843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102094402|NCT05887843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094403|NCT05887843|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102094404|NCT05887843|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102094405|NCT05887843|Histamine Antagonists|histamine antagonists|mesh-ancestor
102094406|NCT05887843|Histamine Agents|histamine agents|mesh-ancestor
102094466|NCT05822765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094467|NCT05822765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102094468|NCT05822765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102094469|NCT05822765|Autonomic Agents|autonomic agents|mesh-ancestor
102094470|NCT05822765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102094471|NCT05822765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102094472|NCT05822765|Respiratory System Agents|respiratory system agents|mesh-ancestor
102094473|NCT05822765|Mydriatics|mydriatics|mesh-ancestor
102094474|NCT05822765|Sympathomimetics|sympathomimetics|mesh-ancestor
102094475|NCT05822765|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102094487|NCT05795504|Vitamin D|vitamin d|mesh-list
102094488|NCT05795504|Calcium|calcium|mesh-list
102094489|NCT05795504|Vitamins|vitamins|mesh-ancestor
102094490|NCT05795504|Micronutrients|micronutrients|mesh-ancestor
102094491|NCT05795504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094492|NCT05795504|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102094493|NCT05795504|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101814294|NCT05361278|Eusol|eusol|mesh-list
102094534|NCT05766514|Cladribine|cladribine|mesh-list
102094535|NCT05766514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102094536|NCT05766514|Antimetabolites|antimetabolites|mesh-ancestor
102094537|NCT05766514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094538|NCT05766514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102094539|NCT05766514|Antiviral Agents|antiviral agents|mesh-ancestor
102094540|NCT05766514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102094541|NCT05766514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102094542|NCT05766514|Immunologic Factors|immunologic factors|mesh-ancestor
102094543|NCT05766514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094544|NCT05766514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102094545|NCT05741658|Dapagliflozin|dapagliflozin|mesh-list
102094546|NCT05741658|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102094547|NCT05741658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094548|NCT05741658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102094549|NCT05741658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094606|NCT05708625|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102094607|NCT05708625|Antifungal Agents|antifungal agents|mesh-ancestor
102094608|NCT05708625|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102094609|NCT05708625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102094610|NCT05708625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102094611|NCT05708625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094612|NCT05708625|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102094613|NCT05708625|Hormone Antagonists|hormone antagonists|mesh-ancestor
102094614|NCT05708625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102094615|NCT05708625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094616|NCT05708625|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102094617|NCT05708625|Schistosomicides|schistosomicides|mesh-ancestor
102094618|NCT05708625|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
102094619|NCT05708625|Anthelmintics|anthelmintics|mesh-ancestor
102094620|NCT05697276|Lidocaine|lidocaine|mesh-list
102094621|NCT05697276|Bupivacaine|bupivacaine|mesh-list
102094622|NCT05697276|Anesthetics, Local|anesthetics, local|mesh-ancestor
102094623|NCT05697276|Anesthetics|anesthetics|mesh-ancestor
102094624|NCT05697276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102094625|NCT05697276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094626|NCT05697276|Sensory System Agents|sensory system agents|mesh-ancestor
102094627|NCT05697276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102094628|NCT05697276|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102094629|NCT05697276|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102094630|NCT05697276|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102094675|NCT05672784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102094676|NCT05672784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102094677|NCT05672784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102094678|NCT05672784|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102094679|NCT05672784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102094680|NCT05672784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102094681|NCT05672784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094682|NCT05669989|Dexamethasone|dexamethasone|mesh-list
102094683|NCT05669989|Lenalidomide|lenalidomide|mesh-list
102094684|NCT05669989|Pomalidomide|pomalidomide|mesh-list
102094685|NCT05669989|Cemiplimab|cemiplimab|mesh-list
102094686|NCT05669989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102094687|NCT05669989|Antiemetics|antiemetics|mesh-ancestor
102094688|NCT05669989|Autonomic Agents|autonomic agents|mesh-ancestor
102094689|NCT05669989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102094690|NCT05669989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094691|NCT05669989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102094692|NCT05669989|Glucocorticoids|glucocorticoids|mesh-ancestor
102094693|NCT05669989|Hormones|hormones|mesh-ancestor
102094694|NCT05669989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102094695|NCT05669989|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102094696|NCT05669989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102094697|NCT05669989|Immunologic Factors|immunologic factors|mesh-ancestor
102094726|NCT05660850|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
102094727|NCT05660850|Diuretics|diuretics|mesh-ancestor
102094728|NCT05660850|Natriuretic Agents|natriuretic agents|mesh-ancestor
102094729|NCT05660850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102094747|NCT05624918|Gemcitabine|gemcitabine|mesh-list
102094748|NCT05624918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102094749|NCT05624918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102094750|NCT05624918|Tubulin Modulators|tubulin modulators|mesh-ancestor
102094751|NCT05624918|Antimitotic Agents|antimitotic agents|mesh-ancestor
102094752|NCT05624918|Mitosis Modulators|mitosis modulators|mesh-ancestor
102094753|NCT05624918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102094754|NCT05624918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102094755|NCT05624918|Antimetabolites|antimetabolites|mesh-ancestor
102094756|NCT05617885|Leuprolide|leuprolide|mesh-list
102094800|NCT05601492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102094801|NCT05601492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102094874|NCT05564403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102094875|NCT05564403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102094876|NCT05564403|Immunologic Factors|immunologic factors|mesh-ancestor
102094877|NCT05564403|Antidotes|antidotes|mesh-ancestor
102094948|NCT05519579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102094949|NCT05519579|Dermatologic Agents|dermatologic agents|mesh-ancestor
102094950|NCT05519579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102094951|NCT05519579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102094952|NCT05519579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102094953|NCT05519579|Immunologic Factors|immunologic factors|mesh-ancestor
102094954|NCT05519579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102094955|NCT05519579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101814710|NCT00671879|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102095019|NCT05396833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102095020|NCT05396833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095021|NCT05390515|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102095022|NCT05390515|Immunologic Factors|immunologic factors|mesh-ancestor
102095023|NCT05390515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095162|NCT05190315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095163|NCT05190315|Antiemetics|antiemetics|mesh-ancestor
102095164|NCT05190315|Autonomic Agents|autonomic agents|mesh-ancestor
102095165|NCT05190315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102095166|NCT05190315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095167|NCT05190315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102095168|NCT05190315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102095169|NCT05190315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102095170|NCT05190315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102095177|NCT05143840|Dasatinib|dasatinib|mesh-list
102095228|NCT05096481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102095229|NCT05096481|Alkylating Agents|alkylating agents|mesh-ancestor
102095230|NCT05096481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095231|NCT05096481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095232|NCT05070650|Acetaminophen|acetaminophen|mesh-list
102095233|NCT05070650|Acetylcysteine|acetylcysteine|mesh-list
102095234|NCT05070650|Phenylephrine|phenylephrine|mesh-list
102095235|NCT05070650|Oxymetazoline|oxymetazoline|mesh-list
102095236|NCT05070650|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102095237|NCT05070650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102095238|NCT05070650|Analgesics|analgesics|mesh-ancestor
102095239|NCT05070650|Sensory System Agents|sensory system agents|mesh-ancestor
102095240|NCT05070650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102095241|NCT05070650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095242|NCT05070650|Antipyretics|antipyretics|mesh-ancestor
102095243|NCT05070650|Antiviral Agents|antiviral agents|mesh-ancestor
102095244|NCT05070650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102095245|NCT05070650|Expectorants|expectorants|mesh-ancestor
102095293|NCT04912492|Ethanol|ethanol|mesh-list
102095294|NCT04912492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102095295|NCT04912492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102095296|NCT04912492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102095297|NCT04912492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095298|NCT04906278|Oxytocin|oxytocin|mesh-list
102095299|NCT04906278|Oxytocics|oxytocics|mesh-ancestor
102095300|NCT04906278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102095301|NCT04906278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095302|NCT04905693|Treprostinil|treprostinil|mesh-list
102095303|NCT04905693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102095304|NCT04903197|Lenalidomide|lenalidomide|mesh-list
102095305|NCT04903197|Immunologic Factors|immunologic factors|mesh-ancestor
102095306|NCT04903197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095307|NCT04903197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102095312|NCT04900038|Lamivudine|lamivudine|mesh-list
102095353|NCT04781322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102095354|NCT04781322|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102095355|NCT04766853|Dexamethasone|dexamethasone|mesh-list
102095356|NCT04766853|Hyaluronic Acid|hyaluronic acid|mesh-list
102095357|NCT04766853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102095358|NCT04766853|Antiemetics|antiemetics|mesh-ancestor
102095359|NCT04766853|Autonomic Agents|autonomic agents|mesh-ancestor
102095360|NCT04766853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102095361|NCT04766853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095362|NCT04766853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102095363|NCT04766853|Glucocorticoids|glucocorticoids|mesh-ancestor
102095372|NCT04765059|Cisplatin|cisplatin|mesh-list
102095438|NCT04755218|Misoprostol|misoprostol|mesh-list
102095439|NCT04755218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102095440|NCT04755218|Abortifacient Agents|abortifacient agents|mesh-ancestor
102095441|NCT04755218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102095442|NCT04755218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095443|NCT04755218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102095444|NCT04755218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102095445|NCT04755218|Oxytocics|oxytocics|mesh-ancestor
102095446|NCT04749628|Cannabidiol|cannabidiol|mesh-list
102095447|NCT04749628|Anticonvulsants|anticonvulsants|mesh-ancestor
102095448|NCT04744831|Camptothecin|camptothecin|mesh-list
102095449|NCT04744831|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
102095450|NCT04744831|Immunoconjugates|immunoconjugates|mesh-list
102095451|NCT04744831|Immunologic Factors|immunologic factors|mesh-ancestor
102095452|NCT04744831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095453|NCT04744831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102095454|NCT04744831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095455|NCT04744831|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102095456|NCT04744831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102095457|NCT04744831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102095458|NCT04744831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095459|NCT04736966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102095492|NCT04697628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102095493|NCT04697628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102095494|NCT04697628|Tubulin Modulators|tubulin modulators|mesh-ancestor
102095495|NCT04697628|Antimitotic Agents|antimitotic agents|mesh-ancestor
102095496|NCT04697628|Mitosis Modulators|mitosis modulators|mesh-ancestor
102095498|NCT04693715|RNS60|rns60|mesh-list
102095561|NCT04613453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102095637|NCT04404283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102095638|NCT04404283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095639|NCT04404283|Immunologic Factors|immunologic factors|mesh-ancestor
102095640|NCT04404283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095641|NCT04404283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102095642|NCT04404283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102095643|NCT04404283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102095644|NCT04404283|Growth Substances|growth substances|mesh-ancestor
102095645|NCT04404283|Growth Inhibitors|growth inhibitors|mesh-ancestor
102095646|NCT04404283|Immunotoxins|immunotoxins|mesh-ancestor
102095647|NCT04404283|Immunoconjugates|immunoconjugates|mesh-ancestor
102095648|NCT04402788|Atezolizumab|atezolizumab|mesh-list
102095649|NCT04402788|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102095650|NCT04402788|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102095651|NCT04402788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095652|NCT04402788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102095653|NCT04402788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095654|NCT04402788|Immunologic Factors|immunologic factors|mesh-ancestor
102095691|NCT04370587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095692|NCT04370587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102095693|NCT04370587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095694|NCT04368559|Fluconazole|fluconazole|mesh-list
102095695|NCT04368559|Posaconazole|posaconazole|mesh-list
102095696|NCT04368559|Rezafungin|rezafungin|mesh-list
102095697|NCT04368559|Trimethoprim|trimethoprim|mesh-list
102095698|NCT04368559|Sulfamethoxazole|sulfamethoxazole|mesh-list
102095699|NCT04368559|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
102095700|NCT04368559|Antifungal Agents|antifungal agents|mesh-ancestor
102095701|NCT04368559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102095702|NCT04368559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102095703|NCT04368559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102095704|NCT04368559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102095705|NCT04368559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095706|NCT04368559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102095748|NCT04323956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102095749|NCT04323956|Lenograstim|lenograstim|mesh-list
102095750|NCT04323956|Immunoconjugates|immunoconjugates|mesh-list
102095751|NCT04323956|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
102095752|NCT04323956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102095753|NCT04323956|Immunologic Factors|immunologic factors|mesh-ancestor
102095754|NCT04323956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095755|NCT04323956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102095756|NCT04323956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102095814|NCT04248569|Ipilimumab|ipilimumab|mesh-list
102095815|NCT04248569|Poly ICLC|poly iclc|mesh-list
102095816|NCT04248569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102095817|NCT04248569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102095818|NCT04248569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102095819|NCT04248569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102095820|NCT04248569|Interferon Inducers|interferon inducers|mesh-ancestor
102095821|NCT04248569|Immunologic Factors|immunologic factors|mesh-ancestor
102095822|NCT04248569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095823|NCT04238754|Cannabidiol|cannabidiol|mesh-list
102095824|NCT04238754|Anticonvulsants|anticonvulsants|mesh-ancestor
102095825|NCT04237649|Spartalizumab|spartalizumab|mesh-list
102095830|NCT04232358|Anesthetics|anesthetics|mesh-list
102095932|NCT04075266|Ocrelizumab|ocrelizumab|mesh-list
102095933|NCT04075266|Immunologic Factors|immunologic factors|mesh-ancestor
102095934|NCT04075266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102095935|NCT03950739|Treprostinil|treprostinil|mesh-list
102095936|NCT03950739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102095937|NCT03944772|Carboplatin|carboplatin|mesh-list
102095938|NCT03944772|Etoposide|etoposide|mesh-list
102095939|NCT03944772|Pemetrexed|pemetrexed|mesh-list
102095940|NCT03944772|Durvalumab|durvalumab|mesh-list
102095941|NCT03944772|Gefitinib|gefitinib|mesh-list
102095942|NCT03944772|Osimertinib|osimertinib|mesh-list
102095999|NCT03910387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096000|NCT03910387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102096001|NCT03910387|Antimetabolites|antimetabolites|mesh-ancestor
102096010|NCT03850574|Venetoclax|venetoclax|mesh-list
102096011|NCT03850574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096012|NCT03844815|Decitabine|decitabine|mesh-list
102096013|NCT03844815|Venetoclax|venetoclax|mesh-list
102096014|NCT03844815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101815777|NCT00536198|Sertraline|sertraline|mesh-list
102096065|NCT03638141|Immunologic Factors|immunologic factors|mesh-ancestor
102096066|NCT03638141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096067|NCT03638141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102096068|NCT03638141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096069|NCT03602586|Pembrolizumab|pembrolizumab|mesh-list
102096070|NCT03602586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102096071|NCT03602586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096133|NCT03412565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102096134|NCT03412565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102096135|NCT03412565|Growth Substances|growth substances|mesh-ancestor
102096206|NCT03274492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102096207|NCT03274492|Glucocorticoids|glucocorticoids|mesh-ancestor
102096209|NCT03274492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102096210|NCT03274492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102096279|NCT03125811|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102096280|NCT03125811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102096281|NCT03125811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102096282|NCT03125811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096283|NCT03125811|Antiemetics|antiemetics|mesh-ancestor
102096284|NCT03125811|Autonomic Agents|autonomic agents|mesh-ancestor
102096285|NCT03125811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102096286|NCT03125811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102096287|NCT03125811|Antipruritics|antipruritics|mesh-ancestor
102096288|NCT03125811|Dermatologic Agents|dermatologic agents|mesh-ancestor
102096289|NCT03125811|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
102096296|NCT03096782|Melphalan|melphalan|mesh-list
102096359|NCT02962401|Idelalisib|idelalisib|mesh-list
102096360|NCT02962401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102096361|NCT02962401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096362|NCT02962401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102096363|NCT02962401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096364|NCT02921256|Leucovorin|leucovorin|mesh-list
102096365|NCT02921256|Pembrolizumab|pembrolizumab|mesh-list
102096366|NCT02921256|Fluorouracil|fluorouracil|mesh-list
102096367|NCT02921256|Capecitabine|capecitabine|mesh-list
102096368|NCT02921256|Oxaliplatin|oxaliplatin|mesh-list
102096369|NCT02921256|Veliparib|veliparib|mesh-list
102096410|NCT02711826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096411|NCT02711826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102096412|NCT02711826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102096413|NCT02711826|Antitubercular Agents|antitubercular agents|mesh-ancestor
102096414|NCT02711826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102096415|NCT02711826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102096416|NCT02711826|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
102096417|NCT02711826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102096418|NCT02711826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102096419|NCT02711826|Anesthetics, Local|anesthetics, local|mesh-ancestor
102096475|NCT02621021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102096476|NCT02621021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102096477|NCT02621021|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102096479|NCT02621021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102096480|NCT02621021|Antiviral Agents|antiviral agents|mesh-ancestor
102096481|NCT02621021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102096482|NCT02568566|Vaccines|vaccines|mesh-list
102096483|NCT02568566|Immunologic Factors|immunologic factors|mesh-ancestor
102096484|NCT02568566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096485|NCT02536183|Doxorubicin|doxorubicin|mesh-list
102096486|NCT02536183|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102096487|NCT02536183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102096488|NCT02536183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096489|NCT02536183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102096490|NCT02536183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102096491|NCT02536183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102096492|NCT02536183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096509|NCT02317874|Paclitaxel|paclitaxel|mesh-list
102096532|NCT02221999|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
102096533|NCT02221999|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102096534|NCT02221999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102096535|NCT02221999|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102096536|NCT02221999|Hormone Antagonists|hormone antagonists|mesh-ancestor
102096537|NCT02195479|Dexamethasone|dexamethasone|mesh-list
102096538|NCT02195479|Prednisone|prednisone|mesh-list
102096539|NCT02195479|Melphalan|melphalan|mesh-list
102096540|NCT02195479|Bortezomib|bortezomib|mesh-list
102096541|NCT02195479|Daratumumab|daratumumab|mesh-list
102096542|NCT02195479|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102096543|NCT02195479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102096544|NCT02195479|Antiemetics|antiemetics|mesh-ancestor
102096545|NCT02195479|Autonomic Agents|autonomic agents|mesh-ancestor
102096546|NCT02195479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102096547|NCT02195479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102096548|NCT02195479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102096549|NCT02195479|Glucocorticoids|glucocorticoids|mesh-ancestor
102096550|NCT02195479|Hormones|hormones|mesh-ancestor
102096551|NCT02195479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102096552|NCT02195479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102096553|NCT02195479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102096554|NCT02195479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102096555|NCT02195479|Alkylating Agents|alkylating agents|mesh-ancestor
102096556|NCT02195479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102096557|NCT02195479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102096558|NCT02195479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102096559|NCT02195479|Immunologic Factors|immunologic factors|mesh-ancestor
102096560|NCT02143414|Prednisone|prednisone|mesh-list
102096561|NCT02143414|Cortisone|cortisone|mesh-list
102096581|NCT02143414|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102096582|NCT02143414|Abortifacient Agents|abortifacient agents|mesh-ancestor
102096583|NCT02143414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102096599|NCT02112916|Leucovorin|leucovorin|mesh-list
102096656|NCT02112916|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102096657|NCT02112916|Antimetabolites|antimetabolites|mesh-ancestor
102096658|NCT02112916|Dermatologic Agents|dermatologic agents|mesh-ancestor
102096659|NCT02112916|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102096660|NCT02112916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102096661|NCT02112916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102096662|NCT02112916|Antiviral Agents|antiviral agents|mesh-ancestor
102096663|NCT02112916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102096664|NCT02112916|Antidotes|antidotes|mesh-ancestor
102096665|NCT02112916|Protective Agents|protective agents|mesh-ancestor
102096666|NCT02112916|Vitamin B Complex|vitamin b complex|mesh-ancestor
102096667|NCT02112916|Vitamins|vitamins|mesh-ancestor
102096720|NCT01517100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102096721|NCT01517100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102096723|NCT01517100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102096724|NCT01517100|Analgesics|analgesics|mesh-ancestor
102096730|NCT01517100|Hormones|hormones|mesh-ancestor
101825313|NCT00858377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825463|NCT00573755|Letrozole|letrozole|mesh-list
101825765|NCT01009944|Atenolol|atenolol|mesh-list
101826208|NCT00867737|Respiratory System Agents|respiratory system agents|mesh-ancestor
101826291|NCT00420303|Etanercept|etanercept|mesh-list
101826509|NCT03994965|Pimavanserin|pimavanserin|mesh-list
101826957|NCT05880732|Anesthetics|anesthetics|mesh-ancestor
101550246|NCT00598169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101550247|NCT00598169|Immunologic Factors|immunologic factors|mesh-ancestor
101550248|NCT00598169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550249|NCT00598169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101550250|NCT00598169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101550251|NCT00598169|Antiemetics|antiemetics|mesh-ancestor
101550252|NCT00598169|Autonomic Agents|autonomic agents|mesh-ancestor
101550314|NCT00598793|Pioglitazone|pioglitazone|mesh-list
101550315|NCT00598793|Insulin Aspart|insulin aspart|mesh-list
101550316|NCT00598793|Biphasic Insulins|biphasic insulins|mesh-list
101550317|NCT00598793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101550318|NCT00598793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550319|NCT01326845|Deferasirox|deferasirox|mesh-list
101550320|NCT01326845|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101550321|NCT01326845|Chelating Agents|chelating agents|mesh-ancestor
101550322|NCT01326845|Sequestering Agents|sequestering agents|mesh-ancestor
101550323|NCT01326845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550324|NCT01062763|Spironolactone|spironolactone|mesh-list
101550325|NCT01062763|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101550326|NCT01062763|Hormone Antagonists|hormone antagonists|mesh-ancestor
101813794|NCT00749021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550327|NCT01062763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101550328|NCT01062763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550329|NCT01062763|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101550330|NCT01062763|Diuretics|diuretics|mesh-ancestor
101550331|NCT01062763|Natriuretic Agents|natriuretic agents|mesh-ancestor
101550332|NCT00599417|Broncho-Vaxom|broncho-vaxom|mesh-list
101550352|NCT01048099|Pertuzumab|pertuzumab|mesh-list
101550369|NCT01303965|Lenalidomide|lenalidomide|mesh-list
101550370|NCT01303965|Tacrolimus|tacrolimus|mesh-list
101550371|NCT01303965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101550372|NCT01303965|Immunologic Factors|immunologic factors|mesh-ancestor
101550443|NCT00600977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101550444|NCT00600977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101550445|NCT00600977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550512|NCT05643651|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101550513|NCT05643651|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101550517|NCT05643651|Anticoagulants|anticoagulants|mesh-ancestor
101550585|NCT05271721|Dexamethasone acetate|dexamethasone acetate|mesh-list
101550586|NCT05271721|BB 1101|bb 1101|mesh-list
101550587|NCT05271721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101550588|NCT05271721|Antiemetics|antiemetics|mesh-ancestor
101550657|NCT01300923|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101550667|NCT02890173|Diuretics|diuretics|mesh-ancestor
101550731|NCT01100320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550732|NCT01100320|Analgesics|analgesics|mesh-ancestor
101550733|NCT01100320|Sensory System Agents|sensory system agents|mesh-ancestor
101550734|NCT01100320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101550743|NCT01100086|Oxycodone|oxycodone|mesh-list
101550803|NCT04307290|Adrenergic Agents|adrenergic agents|mesh-ancestor
101550804|NCT04307290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101550805|NCT04307290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550806|NCT01325207|Trastuzumab|trastuzumab|mesh-list
101550807|NCT01325207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101550808|NCT01325207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101550809|NCT01324349|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101550810|NCT01324349|Hemostatics|hemostatics|mesh-list
101550811|NCT01324349|Coagulants|coagulants|mesh-ancestor
101550812|NCT01095250|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101550813|NCT01095250|Immunologic Factors|immunologic factors|mesh-ancestor
101550814|NCT01095250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550815|NCT01095094|Ritonavir|ritonavir|mesh-list
101550816|NCT01095094|Lopinavir|lopinavir|mesh-list
101550819|NCT01095094|Protease Inhibitors|protease inhibitors|mesh-ancestor
101550867|NCT01320683|Immunoglobulins|immunoglobulins|mesh-list
101550868|NCT01320683|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101550869|NCT01320683|Levoleucovorin|levoleucovorin|mesh-list
101550870|NCT01320683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101550871|NCT01320683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101458644|NCT04609033|Ketamine|ketamine|mesh-list
101550872|NCT01320683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101550873|NCT01320683|Growth Substances|growth substances|mesh-ancestor
101550874|NCT01320683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550875|NCT01320683|Growth Inhibitors|growth inhibitors|mesh-ancestor
101550876|NCT01320683|Immunologic Factors|immunologic factors|mesh-ancestor
101550877|NCT01320683|Antimetabolites|antimetabolites|mesh-ancestor
101550932|NCT02878018|Hormones|hormones|mesh-list
101550933|NCT02878018|Adrenergic Agents|adrenergic agents|mesh-list
101550934|NCT02878018|Immunosuppressive Agents|immunosuppressive agents|mesh-list
101550935|NCT02878018|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101550936|NCT02878018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101550937|NCT02878018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550938|NCT02878018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101550939|NCT02878018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550940|NCT02878018|Immunologic Factors|immunologic factors|mesh-ancestor
101550941|NCT02878018|Protease Inhibitors|protease inhibitors|mesh-ancestor
101550994|NCT01091974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550995|NCT01313117|Thioctic Acid|thioctic acid|mesh-list
101550996|NCT01313117|Antioxidants|antioxidants|mesh-ancestor
101550997|NCT01313117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550998|NCT01313117|Protective Agents|protective agents|mesh-ancestor
101550999|NCT01313117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551000|NCT01313117|Vitamin B Complex|vitamin b complex|mesh-ancestor
101551001|NCT01313117|Vitamins|vitamins|mesh-ancestor
101551002|NCT01313117|Micronutrients|micronutrients|mesh-ancestor
101551003|NCT01091662|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
101551004|NCT01091662|Anticonvulsants|anticonvulsants|mesh-ancestor
101551005|NCT01091662|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101551006|NCT01091662|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101551007|NCT01091662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101551008|NCT01091662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551009|NCT01312961|Fluticasone|fluticasone|mesh-list
101551010|NCT01312961|Xhance|xhance|mesh-list
101551011|NCT01312961|Albuterol|albuterol|mesh-list
101551012|NCT01312961|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101551013|NCT01312961|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101551014|NCT01312961|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101551015|NCT01312961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101551016|NCT01312961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101551017|NCT01312961|Autonomic Agents|autonomic agents|mesh-ancestor
101551018|NCT01312961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101551019|NCT01312961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551020|NCT01312961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101551021|NCT01312961|Respiratory System Agents|respiratory system agents|mesh-ancestor
101551022|NCT01312961|Dermatologic Agents|dermatologic agents|mesh-ancestor
101551023|NCT01312961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101551025|NCT01312961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101551037|NCT00626158|Gemcitabine|gemcitabine|mesh-list
101551038|NCT00626158|Capecitabine|capecitabine|mesh-list
101551057|NCT01309997|Rituximab|rituximab|mesh-list
101551107|NCT01307579|Antifungal Agents|antifungal agents|mesh-ancestor
101551108|NCT01307579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101551109|NCT01307579|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101551110|NCT01307579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101551111|NCT01307579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101551172|NCT02875093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101551174|NCT02875093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513085|NCT01286077|Bortezomib|bortezomib|mesh-list
101551175|NCT02875093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101551176|NCT02875093|Antiviral Agents|antiviral agents|mesh-ancestor
101551177|NCT02875093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101551178|NCT02875093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101551179|NCT02875093|Immunologic Factors|immunologic factors|mesh-ancestor
101551180|NCT02875093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551181|NCT01033825|Ciclesonide|ciclesonide|mesh-list
101551182|NCT01033825|Dexamethasone|dexamethasone|mesh-list
101551183|NCT01033825|Dexamethasone acetate|dexamethasone acetate|mesh-list
101551184|NCT01033825|BB 1101|bb 1101|mesh-list
101551185|NCT01033825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101551186|NCT01033825|Antiemetics|antiemetics|mesh-ancestor
101551229|NCT01096186|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101551230|NCT01096186|Carbidopa|carbidopa|mesh-list
101551231|NCT01096186|Levodopa|levodopa|mesh-list
101551233|NCT01096186|Immunologic Factors|immunologic factors|mesh-ancestor
101551300|NCT01023061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101551301|NCT01023061|Glucocorticoids|glucocorticoids|mesh-ancestor
101551303|NCT01023061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101551304|NCT01023061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551305|NCT01023061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101551369|NCT01293123|Tenofovir|tenofovir|mesh-list
101551370|NCT01293123|Emtricitabine|emtricitabine|mesh-list
101551371|NCT01293123|Efavirenz|efavirenz|mesh-list
101551372|NCT01293123|Raltegravir Potassium|raltegravir potassium|mesh-list
101551439|NCT01025635|Azelaic acid|azelaic acid|mesh-list
101551440|NCT01025635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101551441|NCT01025635|Dermatologic Agents|dermatologic agents|mesh-ancestor
101551442|NCT01021423|Lenalidomide|lenalidomide|mesh-list
101551443|NCT01021423|Immunologic Factors|immunologic factors|mesh-ancestor
101551444|NCT01021423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551445|NCT01021423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101551446|NCT01021423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101551447|NCT01021423|Growth Substances|growth substances|mesh-ancestor
101551448|NCT01021423|Growth Inhibitors|growth inhibitors|mesh-ancestor
101551449|NCT01021423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101551450|NCT01020877|Metronidazole|metronidazole|mesh-list
101551451|NCT01020877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101551503|NCT02873065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101551504|NCT02873065|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101551505|NCT02873065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101551507|NCT02873065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101551508|NCT02873065|Diuretics|diuretics|mesh-ancestor
101551509|NCT02873065|Natriuretic Agents|natriuretic agents|mesh-ancestor
101551510|NCT02873065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551511|NCT02873065|Expectorants|expectorants|mesh-ancestor
101551512|NCT02873065|Respiratory System Agents|respiratory system agents|mesh-ancestor
101551513|NCT00628225|Bupropion|bupropion|mesh-list
101551514|NCT00628225|Nicotine|nicotine|mesh-list
101551516|NCT00628225|Autonomic Agents|autonomic agents|mesh-ancestor
101551565|NCT01020019|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101551566|NCT01020019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101551567|NCT01020019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101551568|NCT01020019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101551569|NCT01020019|Adrenergic Agents|adrenergic agents|mesh-ancestor
101551570|NCT00627835|Cisplatin|cisplatin|mesh-list
101551637|NCT01287117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101551638|NCT01287117|Respiratory System Agents|respiratory system agents|mesh-ancestor
101551639|NCT01287039|Reslizumab|reslizumab|mesh-list
101551640|NCT01287039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101458680|NCT04608253|Choline|choline|mesh-list
101551707|NCT01090102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101551708|NCT01090102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101551710|NCT01281189|Antioxidants|antioxidants|mesh-ancestor
101551711|NCT01281189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551712|NCT01281189|Protective Agents|protective agents|mesh-ancestor
101551713|NCT01281189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551714|NCT01281189|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101551715|NCT01281189|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101551716|NCT01281189|Dopamine Agonists|dopamine agonists|mesh-ancestor
101551717|NCT01281189|Dopamine Agents|dopamine agents|mesh-ancestor
101551718|NCT01281189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101551719|NCT04306666|Anesthetics|anesthetics|mesh-list
101551771|NCT01086358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551772|NCT01086358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101551844|NCT01313676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101551845|NCT01313676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101551846|NCT01313676|Autonomic Agents|autonomic agents|mesh-ancestor
101551847|NCT01313676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101551848|NCT01313676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551849|NCT01313676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101551850|NCT01313676|Respiratory System Agents|respiratory system agents|mesh-ancestor
101551851|NCT01313676|Dermatologic Agents|dermatologic agents|mesh-ancestor
101551853|NCT00623376|Dronabinol|dronabinol|mesh-list
101551854|NCT00623376|Nabilone|nabilone|mesh-list
101551910|NCT01012999|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101551911|NCT01012999|Narcotics|narcotics|mesh-ancestor
101551912|NCT01012999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101551913|NCT01012999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551914|NCT01012999|Analgesics|analgesics|mesh-ancestor
101551915|NCT01012999|Sensory System Agents|sensory system agents|mesh-ancestor
101551920|NCT01012999|Anesthetics|anesthetics|mesh-ancestor
101551979|NCT00627913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101551980|NCT00627913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101551982|NCT00627991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101551983|NCT00627991|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101551984|NCT00627991|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101551985|NCT00627991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101551986|NCT01006291|Insulin|insulin|mesh-list
101551987|NCT01006291|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101551988|NCT01006291|Insulin Glargine|insulin glargine|mesh-list
101552044|NCT01012219|Antipyretics|antipyretics|mesh-ancestor
101552045|NCT01012219|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101552046|NCT01012219|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101552047|NCT01012219|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101552116|NCT01310868|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101552117|NCT01310868|Levulinic acid|levulinic acid|mesh-list
101552118|NCT01310868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101552119|NCT01310868|Alkylating Agents|alkylating agents|mesh-ancestor
101552186|NCT01266603|Analgesics|analgesics|mesh-ancestor
101552187|NCT01266603|Sensory System Agents|sensory system agents|mesh-ancestor
101552188|NCT01266603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101552260|NCT01264887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101813795|NCT00749021|Growth Inhibitors|growth inhibitors|mesh-ancestor
101552261|NCT01264887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101552262|NCT01264887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552263|NCT01264887|Adrenergic Agents|adrenergic agents|mesh-ancestor
101552264|NCT01264887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101552265|NCT01011283|Azacitidine|azacitidine|mesh-list
101552266|NCT01011283|Decitabine|decitabine|mesh-list
101552267|NCT01011283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101552268|NCT01011283|Antimetabolites|antimetabolites|mesh-ancestor
101552269|NCT01011283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552270|NCT01011283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101552323|NCT01003639|Sensory System Agents|sensory system agents|mesh-ancestor
101552324|NCT01003639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101552325|NCT01003639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552326|NCT01003639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101552327|NCT01003639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101552328|NCT01003639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101552329|NCT01003639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101552330|NCT01003639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552331|NCT01003639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101552332|NCT01003639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101552333|NCT01003639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101552334|NCT01003639|Antipyretics|antipyretics|mesh-ancestor
101552335|NCT01003639|Gout Suppressants|gout suppressants|mesh-ancestor
101552336|NCT01003639|Anticonvulsants|anticonvulsants|mesh-ancestor
101552337|NCT01003639|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101552338|NCT01003639|Diuretics|diuretics|mesh-ancestor
101552339|NCT01003639|Natriuretic Agents|natriuretic agents|mesh-ancestor
101552340|NCT01003639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101552341|NCT01003639|Narcotics|narcotics|mesh-ancestor
101552343|NCT01003639|Antitussive Agents|antitussive agents|mesh-ancestor
101514282|NCT00534573|Amisulpride|amisulpride|mesh-list
101552378|NCT01306032|Alkylating Agents|alkylating agents|mesh-ancestor
101552379|NCT01306032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552380|NCT01306032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101552381|NCT01306032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101552382|NCT01306032|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101552383|NCT01306032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101552385|NCT01263015|Abacavir|abacavir|mesh-list
101552386|NCT01263015|Dideoxynucleosides|dideoxynucleosides|mesh-list
101552387|NCT01263015|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101552388|NCT01263015|Dolutegravir|dolutegravir|mesh-list
101552389|NCT01263015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101552390|NCT01263015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101552391|NCT01263015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101552392|NCT01263015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552393|NCT01263015|Antiviral Agents|antiviral agents|mesh-ancestor
101552433|NCT01305408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101552434|NCT01305408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552435|NCT01261611|Botulinum Toxins|botulinum toxins|mesh-list
101552436|NCT01261611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101552437|NCT01261611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101552438|NCT01261611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101552507|NCT04901169|Protease Inhibitors|protease inhibitors|mesh-ancestor
101552508|NCT04901169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101552509|NCT04901169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552510|NCT04479267|Prednisone|prednisone|mesh-list
101552511|NCT04479267|Methylprednisolone|methylprednisolone|mesh-list
101552579|NCT03916185|Immunologic Factors|immunologic factors|mesh-ancestor
101552580|NCT03916185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552581|NCT03764553|Leucovorin|leucovorin|mesh-list
101552582|NCT03764553|Carboplatin|carboplatin|mesh-list
101552583|NCT03764553|Fluorouracil|fluorouracil|mesh-list
101552652|NCT02890602|Immunologic Factors|immunologic factors|mesh-ancestor
101552653|NCT02890602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552654|NCT02890602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101552655|NCT02890602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101552656|NCT02890602|Alkylating Agents|alkylating agents|mesh-ancestor
101552657|NCT02890602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552658|NCT02890602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101552659|NCT02890602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101552660|NCT02890602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101552716|NCT01300572|Antimetabolites|antimetabolites|mesh-ancestor
101552717|NCT01300572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552718|NCT01300572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101552719|NCT01300572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101552720|NCT01300572|Antifungal Agents|antifungal agents|mesh-ancestor
101552721|NCT01300572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101552722|NCT01300572|Dermatologic Agents|dermatologic agents|mesh-ancestor
101552723|NCT01300572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101552729|NCT01077154|Denosumab|denosumab|mesh-list
101552784|NCT00637182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101552785|NCT00637182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552786|NCT00637182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101552787|NCT00637182|Hormone Antagonists|hormone antagonists|mesh-ancestor
101552788|NCT00637182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101552789|NCT00637182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552790|NCT01298778|Acetaminophen|acetaminophen|mesh-list
101552791|NCT01298778|Morphine|morphine|mesh-list
101552792|NCT01298778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101552793|NCT01298778|Analgesics|analgesics|mesh-ancestor
101552848|NCT01296672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552849|NCT01296672|Urological Agents|urological agents|mesh-ancestor
101552850|NCT01254669|Vaccines|vaccines|mesh-list
101552921|NCT02876224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101552922|NCT02876224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101552923|NCT02876224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101552924|NCT02876224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101552925|NCT02876224|Growth Substances|growth substances|mesh-ancestor
101552926|NCT02876224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552927|NCT02876224|Growth Inhibitors|growth inhibitors|mesh-ancestor
101552928|NCT02876224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101552929|NCT02876224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101552930|NCT01294644|Deoxycholic Acid|deoxycholic acid|mesh-list
101552931|NCT01294644|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101552932|NCT01294644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101552933|NCT01253265|Ixekizumab|ixekizumab|mesh-list
101552934|NCT01253265|Dermatologic Agents|dermatologic agents|mesh-ancestor
101552935|NCT01293006|Suvorexant|suvorexant|mesh-list
101552936|NCT01293006|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101552937|NCT01293006|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101552938|NCT01293006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101552939|NCT01293006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101552975|NCT01292226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101552976|NCT01292226|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101552977|NCT01292226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101514898|NCT02888899|Loperamide|loperamide|mesh-list
101552978|NCT01292226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101552979|NCT01292226|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101552980|NCT01292226|Antitubercular Agents|antitubercular agents|mesh-ancestor
101552981|NCT01292226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101552982|NCT01075048|Irinotecan|irinotecan|mesh-list
101552983|NCT01075048|Cetuximab|cetuximab|mesh-list
101553038|NCT04303312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101553039|NCT01285908|Norepinephrine|norepinephrine|mesh-list
101553040|NCT01285908|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101553113|NCT02874820|Idazoxan|idazoxan|mesh-list
101553114|NCT02874820|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101553115|NCT02874820|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101553116|NCT02874820|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101553117|NCT02874820|Adrenergic Agents|adrenergic agents|mesh-ancestor
101553182|NCT02889822|Vasodilator Agents|vasodilator agents|mesh-ancestor
101553183|NCT02889822|Urological Agents|urological agents|mesh-ancestor
101553184|NCT01282164|Insulin|insulin|mesh-list
101553185|NCT01282164|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101553186|NCT01282164|Glucagon|glucagon|mesh-list
101553187|NCT01282164|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101553250|NCT04319601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101553251|NCT04640896|Lidocaine|lidocaine|mesh-list
101553252|NCT04640896|Bupivacaine|bupivacaine|mesh-list
101553253|NCT04640896|Anesthetics, Local|anesthetics, local|mesh-ancestor
101553254|NCT04640896|Anesthetics|anesthetics|mesh-ancestor
101553255|NCT04640896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101553256|NCT04640896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553257|NCT04640896|Sensory System Agents|sensory system agents|mesh-ancestor
101553258|NCT04640896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101553317|NCT01036594|Antifungal Agents|antifungal agents|mesh-ancestor
101553318|NCT01036594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101553319|NCT01036594|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101553320|NCT01036594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101553389|NCT01033942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101553390|NCT01033942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101553392|NCT01033942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101553462|NCT01029652|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101553463|NCT01029652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101553464|NCT01029652|Glucocorticoids|glucocorticoids|mesh-ancestor
101553465|NCT01029652|Hormones|hormones|mesh-ancestor
101553534|NCT01028014|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101553535|NCT01028014|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101553536|NCT01028014|Sympathomimetics|sympathomimetics|mesh-ancestor
101553537|NCT01028014|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101553538|NCT01028014|Antidepressive Agents|antidepressive agents|mesh-ancestor
101553539|NCT01028014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101553540|NCT01028014|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101553599|NCT01263444|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101553600|NCT01263444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101553601|NCT01031836|Sifalimumab|sifalimumab|mesh-list
101553602|NCT01031836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101553603|NCT01031836|Immunologic Factors|immunologic factors|mesh-ancestor
101553605|NCT01237587|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101553668|NCT01030822|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101553669|NCT01030822|Immunologic Factors|immunologic factors|mesh-ancestor
101553670|NCT01030822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101553742|NCT01058668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101553743|NCT01058668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101553744|NCT01058668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101553815|NCT02890238|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101553816|NCT02890238|Fertility Agents|fertility agents|mesh-ancestor
101553817|NCT02890238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101553818|NCT02890238|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101553819|NCT02890238|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101553820|NCT00627796|Lanreotide|lanreotide|mesh-list
101553882|NCT04322760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101553883|NCT04322760|Analgesics|analgesics|mesh-ancestor
101553884|NCT04322760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101553885|NCT04322760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101553889|NCT04322214|Cobicistat|cobicistat|mesh-list
101553951|NCT01261338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554026|NCT01259856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554027|NCT01259856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101554028|NCT01259856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101554029|NCT01259856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101554030|NCT01259856|Antipyretics|antipyretics|mesh-ancestor
101554031|NCT01259856|Immunologic Factors|immunologic factors|mesh-ancestor
101554032|NCT01259856|Antisickling Agents|antisickling agents|mesh-ancestor
101554033|NCT01259856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101554034|NCT00624000|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101554035|NCT00624000|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101554036|NCT00624000|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101554037|NCT00624000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554038|NCT01259466|Nicotine|nicotine|mesh-list
101554039|NCT01259466|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101516010|NCT04397692|Antioxidants|antioxidants|mesh-ancestor
101554105|NCT04554732|Mitogens|mitogens|mesh-list
101554106|NCT04554732|Mitosis Modulators|mitosis modulators|mesh-ancestor
101554107|NCT04554732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554108|NCT04481256|Paclitaxel|paclitaxel|mesh-list
101554109|NCT04481256|Carboplatin|carboplatin|mesh-list
101554110|NCT04481256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101554111|NCT04481256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101554112|NCT04481256|Tubulin Modulators|tubulin modulators|mesh-ancestor
101554113|NCT04481256|Antimitotic Agents|antimitotic agents|mesh-ancestor
101554114|NCT04481256|Mitosis Modulators|mitosis modulators|mesh-ancestor
101554115|NCT04481256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554116|NCT04387110|Ocrelizumab|ocrelizumab|mesh-list
101554117|NCT04387110|Immunologic Factors|immunologic factors|mesh-ancestor
101554118|NCT04387110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554119|NCT03434418|Osimertinib|osimertinib|mesh-list
101554120|NCT03434418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101554121|NCT03434418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101554122|NCT03434418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101554123|NCT03434418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554124|NCT03377478|Sofosbuvir|sofosbuvir|mesh-list
101554125|NCT03377478|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
101554126|NCT03377478|Velpatasvir|velpatasvir|mesh-list
101554149|NCT01598298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101554150|NCT01598298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101554152|NCT01598298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101554221|NCT01234467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554222|NCT01233999|Botulinum Toxins|botulinum toxins|mesh-list
101554223|NCT01233999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101554224|NCT01233999|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101554228|NCT01233999|Cholinergic Agents|cholinergic agents|mesh-ancestor
101554291|NCT01258608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101554292|NCT01258608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101554293|NCT01258608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554295|NCT01231659|Letrozole|letrozole|mesh-list
101554360|NCT01257204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101554361|NCT01257204|Antiviral Agents|antiviral agents|mesh-ancestor
101554362|NCT01257204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101554363|NCT01257204|Antimetabolites|antimetabolites|mesh-ancestor
101554364|NCT01257204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554365|NCT01257204|Immunologic Factors|immunologic factors|mesh-ancestor
101554431|NCT01228071|Androgens|androgens|mesh-ancestor
101554432|NCT01228071|Hormones|hormones|mesh-ancestor
101458847|NCT00251823|Eptifibatide|eptifibatide|mesh-list
101554433|NCT01228071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101554435|NCT04319289|Vitamin D|vitamin d|mesh-list
101554500|NCT01001221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101554501|NCT01296152|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101554573|NCT02871505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101554574|NCT02871505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101554575|NCT01294670|Etoposide|etoposide|mesh-list
101554576|NCT01294670|Vorinostat|vorinostat|mesh-list
101554577|NCT01294670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101554578|NCT01294670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101554579|NCT01294670|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101554641|NCT02869321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101554642|NCT02869321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554644|NCT02869321|Sensory System Agents|sensory system agents|mesh-ancestor
101554645|NCT02869321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101554646|NCT02869321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101554710|NCT01223937|Coagulants|coagulants|mesh-ancestor
101554711|NCT01223937|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101554712|NCT01223937|Natriuretic Agents|natriuretic agents|mesh-ancestor
101554713|NCT01223937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554783|NCT00993499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101554784|NCT00993499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101554785|NCT00993499|Antifungal Agents|antifungal agents|mesh-ancestor
101554786|NCT00993499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101554787|NCT00993499|Immunologic Factors|immunologic factors|mesh-ancestor
101554788|NCT00993499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554789|NCT00993499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101554790|NCT00993499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101554792|NCT01014442|Mycophenolic Acid|mycophenolic acid|mesh-list
101554848|NCT00991939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101554849|NCT00991939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554850|NCT00991939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101554919|NCT04291729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554920|NCT04291729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101554921|NCT04291729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101554922|NCT04291729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101554992|NCT00986245|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101554993|NCT00986245|Dopamine Agonists|dopamine agonists|mesh-ancestor
101554994|NCT00986245|Dopamine Agents|dopamine agents|mesh-ancestor
101554995|NCT00986245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101554996|NCT00986245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101554997|NCT00986245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101554998|NCT00989833|Budesonide|budesonide|mesh-list
101554999|NCT00989833|Terbutaline|terbutaline|mesh-list
101555000|NCT00989833|Formoterol Fumarate|formoterol fumarate|mesh-list
101492373|NCT00427076|Vancomycin|vancomycin|mesh-list
101555001|NCT00989833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101555002|NCT00989833|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101555003|NCT00989833|Autonomic Agents|autonomic agents|mesh-ancestor
101555004|NCT00989833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101555006|NCT00989833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101555051|NCT02868151|Protective Agents|protective agents|mesh-ancestor
101555052|NCT01217307|Metformin|metformin|mesh-list
101555053|NCT01217307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101555054|NCT01217307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555055|NCT02868073|Vaccines|vaccines|mesh-list
101555056|NCT02868073|Immunologic Factors|immunologic factors|mesh-ancestor
101555057|NCT02868073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555058|NCT01013740|Capecitabine|capecitabine|mesh-list
101555059|NCT01013740|Vinorelbine|vinorelbine|mesh-list
101555060|NCT01013740|Lapatinib|lapatinib|mesh-list
101555061|NCT01013740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101555062|NCT01013740|Antimetabolites|antimetabolites|mesh-ancestor
101555063|NCT01013740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555064|NCT01013740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101555065|NCT01013740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101555071|NCT01217073|Metformin|metformin|mesh-list
101555112|NCT01017874|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101555113|NCT01017874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101555114|NCT01017874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101555115|NCT00627952|Amlodipine|amlodipine|mesh-list
101555116|NCT00627952|Manidipine|manidipine|mesh-list
101555117|NCT00627952|Delapril|delapril|mesh-list
101555118|NCT00627952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101555119|NCT00627952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101555120|NCT00627952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101555121|NCT00627952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555122|NCT00627952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101555128|NCT01009840|Bortezomib|bortezomib|mesh-list
101555175|NCT01005316|Mycophenolic Acid|mycophenolic acid|mesh-list
101555177|NCT01005316|Tacrolimus|tacrolimus|mesh-list
101555178|NCT01005316|Immunoglobulins|immunoglobulins|mesh-list
101555179|NCT01005316|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101555180|NCT01005316|Antibodies|antibodies|mesh-list
101555181|NCT01005316|gamma-Globulins|gamma-globulins|mesh-list
101555182|NCT01005316|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101555183|NCT01005316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101555184|NCT01005316|Glucocorticoids|glucocorticoids|mesh-ancestor
101555185|NCT01005316|Hormones|hormones|mesh-ancestor
101555186|NCT01005316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101555187|NCT01005316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555188|NCT01005316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101555189|NCT01005316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101555190|NCT01005316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101555191|NCT01005316|Immunologic Factors|immunologic factors|mesh-ancestor
101555192|NCT01005316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101555193|NCT01005316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101555194|NCT01005316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555195|NCT01005316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101555196|NCT01005316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101418914|NCT00139841|Alkylating Agents|alkylating agents|mesh-ancestor
101418915|NCT00139841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418916|NCT00139841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101418917|NCT00139880|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101418918|NCT00139880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101418919|NCT00139880|Immunologic Factors|immunologic factors|mesh-ancestor
101418920|NCT00139880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418921|NCT00139880|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101418922|NCT00139880|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101418923|NCT00139880|Dopamine Agonists|dopamine agonists|mesh-ancestor
101418924|NCT00139880|Dopamine Agents|dopamine agents|mesh-ancestor
101418925|NCT00139880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101418926|NCT00139880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418927|NCT04724187|Misoprostol|misoprostol|mesh-list
101418928|NCT04724187|Oxytocin|oxytocin|mesh-list
101418929|NCT04724187|Oxytocics|oxytocics|mesh-ancestor
101418930|NCT04724187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101418931|NCT04724187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418932|NCT04724187|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101418933|NCT04724187|Abortifacient Agents|abortifacient agents|mesh-ancestor
101418934|NCT04724187|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101418935|NCT04724187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101306602|NCT02026583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306603|NCT02026583|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101813796|NCT00749021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101306604|NCT02026583|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101418937|NCT04727021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101418938|NCT04727021|Antithrombins|antithrombins|mesh-ancestor
101418939|NCT04727021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101418940|NCT04727021|Protease Inhibitors|protease inhibitors|mesh-ancestor
101418941|NCT04727021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101555197|NCT01005316|Antitubercular Agents|antitubercular agents|mesh-ancestor
101555198|NCT01005316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101555199|NCT01005316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101555200|NCT00988429|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
101555202|NCT00988429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101555203|NCT00988429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101555204|NCT00988429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101555205|NCT00988429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555206|NCT01008904|Magnesium Oxide|magnesium oxide|mesh-list
101555207|NCT01008904|Antacids|antacids|mesh-ancestor
101403677|NCT03448107|Cariostatic Agents|cariostatic agents|mesh-ancestor
101418942|NCT04727021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418943|NCT04727021|Anticoagulants|anticoagulants|mesh-ancestor
101418944|NCT04724226|Apatinib|apatinib|mesh-list
101418945|NCT04724226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101418946|NCT04724226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101418948|NCT04724226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418950|NCT04724343|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101418951|NCT04724343|Cetrorelix|cetrorelix|mesh-list
101418952|NCT04724343|Menotropins|menotropins|mesh-list
101418953|NCT04724343|Luteolytic Agents|luteolytic agents|mesh-ancestor
101418954|NCT04724343|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101418955|NCT04724343|Contraceptive Agents|contraceptive agents|mesh-ancestor
101418956|NCT04724343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101418957|NCT04724343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418958|NCT04724343|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101418959|NCT04724343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101418960|NCT04724343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101418961|NCT04724343|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101418962|NCT04724343|Fertility Agents|fertility agents|mesh-ancestor
101418963|NCT04724343|Hormone Antagonists|hormone antagonists|mesh-ancestor
101418964|NCT04724343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101418965|NCT00140075|Cyclophosphamide|cyclophosphamide|mesh-list
101418966|NCT00140075|Epirubicin|epirubicin|mesh-list
101418967|NCT00140075|Taxane|taxane|mesh-list
101418968|NCT00140075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101418969|NCT00140075|Immunologic Factors|immunologic factors|mesh-ancestor
101418970|NCT00140075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418971|NCT00140075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101418972|NCT00140075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101418973|NCT00140075|Alkylating Agents|alkylating agents|mesh-ancestor
101418974|NCT00140075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418975|NCT00140075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101418976|NCT00140075|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101418977|NCT00140075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101418978|NCT00140075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101418979|NCT00140075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101418980|NCT00140075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101418981|NCT00140114|Misoprostol|misoprostol|mesh-list
101418982|NCT00140114|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101418983|NCT00140114|Abortifacient Agents|abortifacient agents|mesh-ancestor
101418984|NCT00140114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101418985|NCT00140114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418986|NCT00140114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101418987|NCT00140114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101418988|NCT00140114|Oxytocics|oxytocics|mesh-ancestor
101418989|NCT00140153|Testosterone|testosterone|mesh-list
101418990|NCT00140153|Androgens|androgens|mesh-ancestor
101418991|NCT00140153|Hormones|hormones|mesh-ancestor
101418992|NCT00140153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101418993|NCT00140153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555208|NCT01008904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555209|NCT01008904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101555210|NCT04290793|Cyclophosphamide|cyclophosphamide|mesh-list
101555211|NCT04290793|Trastuzumab|trastuzumab|mesh-list
101555212|NCT04290793|Epirubicin|epirubicin|mesh-list
101555213|NCT04290793|Taxane|taxane|mesh-list
101555214|NCT04290793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101555215|NCT04290793|Immunologic Factors|immunologic factors|mesh-ancestor
101555216|NCT04290793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555217|NCT04290793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101555218|NCT04290793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101555219|NCT04290793|Alkylating Agents|alkylating agents|mesh-ancestor
101555220|NCT04290793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555221|NCT04290793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101555222|NCT04290793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101555223|NCT04290793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101555224|NCT04290793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101492606|NCT00460707|Casopitant|casopitant|mesh-list
101555225|NCT04290793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101555226|NCT04290793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101555227|NCT04290793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101555229|NCT01004614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101555230|NCT01004614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101555231|NCT01004614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101418994|NCT00140309|Moxifloxacin|moxifloxacin|mesh-list
101418995|NCT00140309|Rifampin|rifampin|mesh-list
101418996|NCT00140309|Isoniazid|isoniazid|mesh-list
101418997|NCT00140309|Pyrazinamide|pyrazinamide|mesh-list
101418998|NCT00140309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101418999|NCT00140309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101419000|NCT00140309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101419001|NCT00140309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101419002|NCT00140309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101419003|NCT00140309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419004|NCT00140309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101306605|NCT02026583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101306606|NCT02026765|Heparin|heparin|mesh-list
101306607|NCT02026765|Anticoagulants|anticoagulants|mesh-ancestor
101306608|NCT02026765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101306609|NCT02026765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101333859|NCT00017394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101419005|NCT00140309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101419006|NCT00140309|Antitubercular Agents|antitubercular agents|mesh-ancestor
101419007|NCT00140309|Leprostatic Agents|leprostatic agents|mesh-ancestor
101419008|NCT00140309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101419009|NCT00140309|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101419010|NCT00140309|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101419018|NCT00140309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101419019|NCT00161811|Vaccines|vaccines|mesh-list
101419020|NCT00161811|Immunologic Factors|immunologic factors|mesh-ancestor
101419021|NCT00161811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555232|NCT01004614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555233|NCT01004614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101555234|NCT01004614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555235|NCT01004614|Vasodilator Agents|vasodilator agents|mesh-ancestor
101555236|NCT04297462|Oseltamivir|oseltamivir|mesh-list
101555237|NCT04297462|Antiviral Agents|antiviral agents|mesh-ancestor
101555238|NCT04297462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101555239|NCT04297462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101555240|NCT04297462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555242|NCT00981409|Calcium heparin|calcium heparin|mesh-list
101555243|NCT00981409|PENTA|penta|mesh-list
101555244|NCT00981409|Fondaparinux|fondaparinux|mesh-list
101555245|NCT00981409|Anticoagulants|anticoagulants|mesh-ancestor
101555246|NCT00981409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101555247|NCT00981409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101419025|NCT00140348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419026|NCT01240759|Metformin|metformin|mesh-list
101419027|NCT01240759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101419028|NCT01240759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419029|NCT01241734|Lenalidomide|lenalidomide|mesh-list
101419030|NCT01241734|Immunologic Factors|immunologic factors|mesh-ancestor
101419031|NCT01241734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419032|NCT01241734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101419033|NCT01241734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101419034|NCT01241734|Growth Substances|growth substances|mesh-ancestor
101419035|NCT01241734|Growth Inhibitors|growth inhibitors|mesh-ancestor
101419036|NCT01241734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101419037|NCT00140387|Immunomodulating Agents|immunomodulating agents|mesh-list
101419038|NCT00140387|Immunologic Factors|immunologic factors|mesh-ancestor
101419039|NCT00140387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419040|NCT00504634|Bortezomib|bortezomib|mesh-list
101419041|NCT00504634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101419042|NCT00140465|Clopidogrel|clopidogrel|mesh-list
101419043|NCT00140465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101419044|NCT00140465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101419045|NCT00140465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101419046|NCT00140465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101419047|NCT00140465|Purinergic Agents|purinergic agents|mesh-ancestor
101419048|NCT00140465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101419049|NCT00140465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419050|NCT00140465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419051|NCT00504673|Insulin|insulin|mesh-list
101419052|NCT00504673|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101419053|NCT00504673|Insulin Aspart|insulin aspart|mesh-list
101419054|NCT00504673|Insulin Detemir|insulin detemir|mesh-list
101419055|NCT00504673|Isophane Insulin, Human|isophane insulin, human|mesh-list
101419056|NCT00504673|Insulin, Isophane|insulin, isophane|mesh-list
101419057|NCT00504673|Isophane insulin, beef|isophane insulin, beef|mesh-list
101419058|NCT00504673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101419059|NCT00504673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419060|NCT01247701|Cyclophosphamide|cyclophosphamide|mesh-list
101419061|NCT01247701|Busulfan|busulfan|mesh-list
101419062|NCT01247701|Fludarabine|fludarabine|mesh-list
101419063|NCT01247701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101419064|NCT01247701|Immunologic Factors|immunologic factors|mesh-ancestor
101419065|NCT01247701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419066|NCT01247701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101419067|NCT01247701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101419068|NCT01247701|Alkylating Agents|alkylating agents|mesh-ancestor
101555248|NCT00981409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555250|NCT00981409|Antithrombins|antithrombins|mesh-ancestor
101555251|NCT00981409|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101555252|NCT00981409|Protease Inhibitors|protease inhibitors|mesh-ancestor
101555253|NCT00981409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101555254|NCT04297072|Rivaroxaban|rivaroxaban|mesh-list
101458859|NCT04719507|Meperidine|meperidine|mesh-list
101555255|NCT04297072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101555256|NCT04297072|Antithrombins|antithrombins|mesh-ancestor
101555257|NCT04297072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101555258|NCT04297072|Protease Inhibitors|protease inhibitors|mesh-ancestor
101555259|NCT04297072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101555260|NCT04297072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555261|NCT04297072|Anticoagulants|anticoagulants|mesh-ancestor
101555262|NCT01008748|Nicotine|nicotine|mesh-list
101419069|NCT01247701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419070|NCT01247701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101419071|NCT01247701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101419072|NCT00140543|Mycophenolic Acid|mycophenolic acid|mesh-list
101419073|NCT00140543|Sirolimus|sirolimus|mesh-list
101419074|NCT00140543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101419075|NCT00140543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101306610|NCT02026765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306611|NCT02026778|Betahistine|betahistine|mesh-list
101306612|NCT02026778|Ondansetron|ondansetron|mesh-list
101306613|NCT02026778|Antiemetics|antiemetics|mesh-ancestor
101419076|NCT00140543|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101419077|NCT00140543|Antitubercular Agents|antitubercular agents|mesh-ancestor
101419078|NCT00140543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101419085|NCT00140543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419088|NCT00154791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101419089|NCT00154791|Antimetabolites|antimetabolites|mesh-ancestor
101419090|NCT00154791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419091|NCT00154791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101419093|NCT00140582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101419094|NCT00140582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101419095|NCT00140582|Immunologic Factors|immunologic factors|mesh-ancestor
101419096|NCT00140582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419097|NCT00140582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101419098|NCT00154869|Ribavirin|ribavirin|mesh-list
101419099|NCT00154869|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101419108|NCT00140660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419109|NCT00140660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101419110|NCT00162006|Immunoglobulins|immunoglobulins|mesh-list
101419111|NCT00162006|Antibodies|antibodies|mesh-list
101419112|NCT00162006|gamma-Globulins|gamma-globulins|mesh-list
101419113|NCT00162006|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101419114|NCT00162006|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101419115|NCT00162006|Immunologic Factors|immunologic factors|mesh-ancestor
101419116|NCT00162006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419117|NCT00162045|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
101419118|NCT00162045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101419119|NCT00162045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419120|NCT02964572|Empagliflozin|empagliflozin|mesh-list
101419121|NCT02964572|Glimepiride|glimepiride|mesh-list
101419122|NCT02964572|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101419123|NCT02964572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419124|NCT02964572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101419125|NCT02964572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419126|NCT02964572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101555263|NCT01008748|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101555264|NCT01008748|Autonomic Agents|autonomic agents|mesh-ancestor
101555265|NCT01008748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101555266|NCT01008748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555267|NCT01008748|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101555268|NCT01008748|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101555269|NCT01008748|Cholinergic Agents|cholinergic agents|mesh-ancestor
101555270|NCT01008748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101555271|NCT01008748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555272|NCT00628732|Cyclophosphamide|cyclophosphamide|mesh-list
101555273|NCT00628732|Topotecan|topotecan|mesh-list
101555274|NCT00628732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101555275|NCT00628732|Immunologic Factors|immunologic factors|mesh-ancestor
101555276|NCT00628732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555277|NCT00628732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101555278|NCT00628732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101555279|NCT00628732|Alkylating Agents|alkylating agents|mesh-ancestor
101555280|NCT00628732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555281|NCT00628732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101555282|NCT00628732|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101555283|NCT00628732|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101555284|NCT00628732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101555285|NCT00628732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101419127|NCT02964572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101419128|NCT02964572|Immunologic Factors|immunologic factors|mesh-ancestor
101419129|NCT00162201|Abatacept|abatacept|mesh-list
101419130|NCT00162201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101419131|NCT00162201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419132|NCT00162201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101419133|NCT00162201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101419134|NCT00162201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101419135|NCT00162201|Immunologic Factors|immunologic factors|mesh-ancestor
101419136|NCT00162201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419137|NCT00162201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101419138|NCT01248247|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101419139|NCT01248247|Sorafenib|sorafenib|mesh-list
101419140|NCT01248247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101419141|NCT01248247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101419142|NCT01248247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101419143|NCT01248247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419144|NCT00140894|Rofecoxib|rofecoxib|mesh-list
101419145|NCT00140894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419146|NCT00140894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419158|NCT00155064|Captopril|captopril|mesh-list
101419159|NCT00155064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101306614|NCT02026778|Autonomic Agents|autonomic agents|mesh-ancestor
101306615|NCT02026778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101419160|NCT00155064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101419161|NCT00155064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101555287|NCT04131829|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101555288|NCT04131829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101555289|NCT04131829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101555290|NCT04131829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555291|NCT04131829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101555292|NCT04131829|Serotonin Agents|serotonin agents|mesh-ancestor
101555293|NCT04131829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555294|NCT04131829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101555295|NCT04131829|Antidepressive Agents|antidepressive agents|mesh-ancestor
101555296|NCT04131829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101555297|NCT04131829|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101419162|NCT00155064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101419163|NCT00155064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419164|NCT00155064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101419165|NCT00155064|Protease Inhibitors|protease inhibitors|mesh-ancestor
101419166|NCT00155064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101419167|NCT02483260|Ribavirin|ribavirin|mesh-list
101419168|NCT02483260|Antimetabolites|antimetabolites|mesh-ancestor
101419169|NCT02483260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419170|NCT02483260|Antiviral Agents|antiviral agents|mesh-ancestor
101419171|NCT02483260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101419172|NCT00140933|Diclofenac|diclofenac|mesh-list
101419173|NCT00140933|Rofecoxib|rofecoxib|mesh-list
101201672|NCT01405144|Fluorouracil|fluorouracil|mesh-list
101419184|NCT00140933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419185|NCT00140933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101419186|NCT04515628|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101419187|NCT04515628|Branebrutinib|branebrutinib|mesh-list
101419188|NCT04515628|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101419189|NCT04515628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101419190|NCT04515628|Antimetabolites|antimetabolites|mesh-ancestor
101419191|NCT04515628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419192|NCT04515628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101419193|NCT04515628|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101419194|NCT04515628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101419195|NCT04515628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101419196|NCT00407043|Loteprednol Etabonate|loteprednol etabonate|mesh-list
101419197|NCT00407043|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101419199|NCT00141011|Anticoagulants|anticoagulants|mesh-ancestor
101419200|NCT00141011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101419201|NCT00141011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101419202|NCT00141011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419203|NCT00504946|Cholecalciferol|cholecalciferol|mesh-list
101419204|NCT00504946|Vitamin D|vitamin d|mesh-list
101419205|NCT00504946|Prednisone|prednisone|mesh-list
101419206|NCT00504946|Budesonide|budesonide|mesh-list
101419207|NCT00504946|Montelukast|montelukast|mesh-list
101419208|NCT00504946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101419209|NCT00504946|Glucocorticoids|glucocorticoids|mesh-ancestor
101419219|NCT00504946|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101419220|NCT00504946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101419221|NCT00504946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419222|NCT00504946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101419223|NCT00504946|Autonomic Agents|autonomic agents|mesh-ancestor
101419224|NCT00504946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101419225|NCT00504946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101419226|NCT00504946|Vitamins|vitamins|mesh-ancestor
101419227|NCT00504946|Micronutrients|micronutrients|mesh-ancestor
101555298|NCT04131829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101555300|NCT04205344|Bupivacaine|bupivacaine|mesh-list
101555301|NCT04205344|Anesthetics, Local|anesthetics, local|mesh-ancestor
101555302|NCT04205344|Anesthetics|anesthetics|mesh-ancestor
101555303|NCT04205344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101555304|NCT04205344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555305|NCT04205344|Sensory System Agents|sensory system agents|mesh-ancestor
101555306|NCT04205344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101555307|NCT00629317|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101555308|NCT00629317|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
101555309|NCT00629317|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101555310|NCT00629317|Dermatologic Agents|dermatologic agents|mesh-ancestor
101555311|NCT00978757|Ketamine|ketamine|mesh-list
101555312|NCT00978757|Analgesics|analgesics|mesh-ancestor
101555313|NCT00978757|Sensory System Agents|sensory system agents|mesh-ancestor
101555314|NCT00978757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101555315|NCT00978757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403787|NCT00093704|Ganciclovir|ganciclovir|mesh-list
101419228|NCT00504946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101419229|NCT00141050|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
101419230|NCT00141050|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101419231|NCT00141050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419232|NCT00141050|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101419233|NCT00141050|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101419234|NCT00141050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101419235|NCT00141050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419236|NCT00141050|Dopamine Agents|dopamine agents|mesh-ancestor
101419237|NCT00141050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101306616|NCT02026778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306617|NCT02026778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101306618|NCT02026778|Antipruritics|antipruritics|mesh-ancestor
101419239|NCT04511416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101419240|NCT04511416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419241|NCT00407082|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
101419242|NCT00407082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101419249|NCT00141089|Serotonin Agents|serotonin agents|mesh-ancestor
101419250|NCT00141089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101419251|NCT00141089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419252|NCT00141089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419253|NCT00407121|Bevacizumab|bevacizumab|mesh-list
101419254|NCT00407121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101419255|NCT00407121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101419256|NCT00407121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101419257|NCT00407121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101419258|NCT00407121|Growth Substances|growth substances|mesh-ancestor
101813797|NCT04048889|Ropivacaine|ropivacaine|mesh-list
101419259|NCT00407121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419260|NCT00407121|Growth Inhibitors|growth inhibitors|mesh-ancestor
101419261|NCT00141167|Varenicline|varenicline|mesh-list
101419262|NCT00141167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101419263|NCT00141167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101419264|NCT00141167|Cholinergic Agents|cholinergic agents|mesh-ancestor
101419265|NCT00141167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101419266|NCT00141167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555316|NCT00978757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101555317|NCT00978757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101555318|NCT00978757|Anesthetics, General|anesthetics, general|mesh-ancestor
101555319|NCT00978757|Anesthetics|anesthetics|mesh-ancestor
101555320|NCT00978757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101555321|NCT00978757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101555322|NCT00978757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101555323|NCT00978757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101555324|NCT00978757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555325|NCT01214421|Tolvaptan|tolvaptan|mesh-list
101555326|NCT01214421|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101555327|NCT01214421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555328|NCT01214421|Natriuretic Agents|natriuretic agents|mesh-ancestor
101555329|NCT01214421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555330|NCT01214187|Carbon Monoxide|carbon monoxide|mesh-list
101555331|NCT01214187|Antimetabolites|antimetabolites|mesh-ancestor
101555332|NCT01214187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555333|NCT01214187|Gasotransmitters|gasotransmitters|mesh-ancestor
101403804|NCT01055314|Etoposide|etoposide|mesh-list
101403805|NCT01055314|Vincristine|vincristine|mesh-list
101419267|NCT00141167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419268|NCT00141206|Varenicline|varenicline|mesh-list
101419269|NCT00141206|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101419270|NCT00141206|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101419271|NCT00141206|Cholinergic Agents|cholinergic agents|mesh-ancestor
101419272|NCT00141206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101419277|NCT00141245|Sensory System Agents|sensory system agents|mesh-ancestor
101419278|NCT00141245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101419279|NCT00141245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419280|NCT00141245|Anticonvulsants|anticonvulsants|mesh-ancestor
101419281|NCT00141245|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101419282|NCT00141245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101419283|NCT00141245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419284|NCT00141245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101419285|NCT00141245|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101419286|NCT00141245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101419287|NCT00141245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101419288|NCT00141245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101419289|NCT00141362|Pregabalin|pregabalin|mesh-list
101419290|NCT00141362|Analgesics|analgesics|mesh-ancestor
101419291|NCT00141362|Sensory System Agents|sensory system agents|mesh-ancestor
101419292|NCT00141362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101419293|NCT00141362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419294|NCT00141362|Anticonvulsants|anticonvulsants|mesh-ancestor
101458963|NCT04603729|Prednisolone|prednisolone|mesh-list
101419295|NCT00141362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101419296|NCT00141362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101419297|NCT00141362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419298|NCT00141362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101419299|NCT00141362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101419300|NCT00141362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101419301|NCT00141362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101555334|NCT01214187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101555335|NCT01214187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555336|NCT02866903|Bevacizumab|bevacizumab|mesh-list
101555337|NCT02866903|Oxaliplatin|oxaliplatin|mesh-list
101555338|NCT02866903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101555339|NCT02866903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101555340|NCT02866903|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101555341|NCT02866903|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101555342|NCT02866903|Growth Substances|growth substances|mesh-ancestor
101555343|NCT02866903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555344|NCT02866903|Growth Inhibitors|growth inhibitors|mesh-ancestor
101555345|NCT03945019|Infliximab|infliximab|mesh-list
101555346|NCT03945019|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101555347|NCT03945019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101555348|NCT03945019|Dermatologic Agents|dermatologic agents|mesh-ancestor
101555349|NCT03945019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101555350|NCT03945019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101555351|NCT01003990|Ritonavir|ritonavir|mesh-list
101555352|NCT01003990|Lopinavir|lopinavir|mesh-list
101555353|NCT01003990|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101555354|NCT01003990|Tenofovir|tenofovir|mesh-list
101419302|NCT00141362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101419303|NCT00155259|Docetaxel|docetaxel|mesh-list
101419304|NCT00155259|Capecitabine|capecitabine|mesh-list
101419305|NCT00155259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101419306|NCT00155259|Tubulin Modulators|tubulin modulators|mesh-ancestor
101419307|NCT00155259|Antimitotic Agents|antimitotic agents|mesh-ancestor
101419308|NCT00155259|Mitosis Modulators|mitosis modulators|mesh-ancestor
101419309|NCT00155259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306619|NCT02026778|Dermatologic Agents|dermatologic agents|mesh-ancestor
101306620|NCT02026778|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101306621|NCT02026778|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101419310|NCT00155259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101419315|NCT04518124|Adrenergic Agents|adrenergic agents|mesh-ancestor
101419316|NCT04518124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101419317|NCT04518124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419318|NCT04518124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419319|NCT04518124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101419320|NCT04518124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101419321|NCT04518124|Vasodilator Agents|vasodilator agents|mesh-ancestor
101419322|NCT00141401|Pregabalin|pregabalin|mesh-list
101419323|NCT00141401|Analgesics|analgesics|mesh-ancestor
101419324|NCT00141401|Sensory System Agents|sensory system agents|mesh-ancestor
101419325|NCT00141401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101419326|NCT00141401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419327|NCT00141401|Anticonvulsants|anticonvulsants|mesh-ancestor
101419328|NCT00141401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101419329|NCT00141401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101419330|NCT00141401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419331|NCT00141401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101419332|NCT00141401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101419333|NCT00141401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101419334|NCT00141401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101419335|NCT00141401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101419336|NCT00505102|Everolimus|everolimus|mesh-list
101555355|NCT01003990|Emtricitabine|emtricitabine|mesh-list
101555356|NCT01003990|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101555357|NCT01003990|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101555358|NCT01003990|Protease Inhibitors|protease inhibitors|mesh-ancestor
101555359|NCT01003990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101555360|NCT01003990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555361|NCT01003990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101555362|NCT01003990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101555363|NCT01003990|Antiviral Agents|antiviral agents|mesh-ancestor
101555364|NCT01003990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101555365|NCT01003990|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101555366|NCT01003990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101555367|NCT01003990|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101555368|NCT01003990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101555369|NCT01002820|Ganaxolone|ganaxolone|mesh-list
101555370|NCT01002820|Neurosteroids|neurosteroids|mesh-ancestor
101555371|NCT01002820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101403845|NCT00093743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501007|NCT04325191|Melatonin|melatonin|mesh-list
101419337|NCT00505102|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101419338|NCT00505102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101419339|NCT00505102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101419340|NCT00505102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419341|NCT00505102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101419344|NCT00505102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101419345|NCT00404378|Ketoconazole|ketoconazole|mesh-list
101419346|NCT00404378|Casopitant|casopitant|mesh-list
101419347|NCT00404378|Antifungal Agents|antifungal agents|mesh-ancestor
101419348|NCT00404378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101419349|NCT00404378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101459010|NCT04603456|Calcium Carbonate|calcium carbonate|mesh-list
101459011|NCT04603456|Antacids|antacids|mesh-ancestor
101459012|NCT04603456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459013|NCT04603456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101419350|NCT00404378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101419351|NCT00404378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101419352|NCT00404378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419353|NCT00404378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101419354|NCT00404378|Hormone Antagonists|hormone antagonists|mesh-ancestor
101419355|NCT00404378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101419356|NCT00404378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419357|NCT00404378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101419358|NCT00404378|Antiemetics|antiemetics|mesh-ancestor
101419359|NCT00404378|Autonomic Agents|autonomic agents|mesh-ancestor
101419360|NCT00404378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101419361|NCT00404378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101419362|NCT00404378|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101419363|NCT00404378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101419364|NCT04511728|Propofol|propofol|mesh-list
101419365|NCT04511728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101419366|NCT04511728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101419367|NCT04511728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419368|NCT04511728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101419369|NCT04511728|Anesthetics, General|anesthetics, general|mesh-ancestor
101419370|NCT04511728|Anesthetics|anesthetics|mesh-ancestor
101419371|NCT00162318|Cetuximab|cetuximab|mesh-list
101419372|NCT00162318|Gefitinib|gefitinib|mesh-list
101419373|NCT00162318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101555372|NCT01002820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555373|NCT01002820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555374|NCT01002820|GABA Modulators|gaba modulators|mesh-ancestor
101555376|NCT01012258|Cetuximab|cetuximab|mesh-list
101555377|NCT01012258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101555378|NCT01012258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101555379|NCT00628810|Leucovorin|leucovorin|mesh-list
101555380|NCT00628810|Bevacizumab|bevacizumab|mesh-list
101403865|NCT00093860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419374|NCT00162318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101419375|NCT00162318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101459055|NCT00252291|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101459056|NCT00252291|Cholinergic Agents|cholinergic agents|mesh-ancestor
101459057|NCT00252291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101358813|NCT00039611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358814|NCT00039611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101419376|NCT00162318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101419377|NCT00162318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419378|NCT00404417|Botulinum Toxins|botulinum toxins|mesh-list
101306622|NCT02026778|Serotonin Agents|serotonin agents|mesh-ancestor
101306623|NCT02026778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101419379|NCT00404417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101419380|NCT00404417|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101419391|NCT00162357|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
101419393|NCT00162357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419394|NCT00404456|Melatonin|melatonin|mesh-list
101419395|NCT00404456|Antioxidants|antioxidants|mesh-ancestor
101419396|NCT00404456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419397|NCT00404456|Protective Agents|protective agents|mesh-ancestor
101419398|NCT00404456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419399|NCT00404456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101419400|NCT00404534|Amoxicillin|amoxicillin|mesh-list
101419401|NCT00404534|Clarithromycin|clarithromycin|mesh-list
101419402|NCT00404534|Omeprazole|omeprazole|mesh-list
101419403|NCT00404534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101419404|NCT00404534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101419405|NCT00404534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101419406|NCT00404534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101419407|NCT00404534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101419408|NCT00404534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101419409|NCT00404534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419410|NCT00404534|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101419411|NCT00404534|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101419412|NCT00404534|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101419416|NCT00505258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101419417|NCT00162396|Albuterol|albuterol|mesh-list
101419418|NCT00162396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101419419|NCT00162396|Autonomic Agents|autonomic agents|mesh-ancestor
101419420|NCT00162396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101419421|NCT00162396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419422|NCT00162396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101419423|NCT00162396|Respiratory System Agents|respiratory system agents|mesh-ancestor
101419424|NCT00162396|Tocolytic Agents|tocolytic agents|mesh-ancestor
101419425|NCT00162396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101419426|NCT00162396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101419427|NCT00162396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101419428|NCT00162396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101419429|NCT00162396|Adrenergic Agents|adrenergic agents|mesh-ancestor
101419430|NCT00162396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101419431|NCT00162396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419432|NCT00162435|Warfarin|warfarin|mesh-list
101419433|NCT00162435|Anticoagulants|anticoagulants|mesh-ancestor
101419434|NCT04518982|Lenalidomide|lenalidomide|mesh-list
101419435|NCT04518982|Immunologic Factors|immunologic factors|mesh-ancestor
101419436|NCT04518982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419437|NCT04518982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101419438|NCT04518982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101419439|NCT04518982|Growth Substances|growth substances|mesh-ancestor
101419440|NCT04518982|Growth Inhibitors|growth inhibitors|mesh-ancestor
101419441|NCT04518982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101419442|NCT00155376|Morphine|morphine|mesh-list
101555382|NCT00628810|Irinotecan|irinotecan|mesh-list
101555383|NCT00628810|Calcium|calcium|mesh-list
101555384|NCT00628810|Levoleucovorin|levoleucovorin|mesh-list
101555385|NCT00628810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101555386|NCT00628810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101555387|NCT00628810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101555388|NCT00628810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101555389|NCT00628810|Growth Substances|growth substances|mesh-ancestor
101555390|NCT00628810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555391|NCT00628810|Growth Inhibitors|growth inhibitors|mesh-ancestor
101555392|NCT00628810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101555393|NCT00628810|Antimetabolites|antimetabolites|mesh-ancestor
101555394|NCT00628810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555395|NCT00628810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101555396|NCT00628810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101555397|NCT00628810|Immunologic Factors|immunologic factors|mesh-ancestor
101555398|NCT00628810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101555399|NCT00628810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101555400|NCT00628810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101555401|NCT00628810|Antidotes|antidotes|mesh-ancestor
101555402|NCT00628810|Protective Agents|protective agents|mesh-ancestor
101419443|NCT00155376|Glucagon|glucagon|mesh-list
101419444|NCT00155376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101419445|NCT00155376|Narcotics|narcotics|mesh-ancestor
101201940|NCT01406431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101306624|NCT02026778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306625|NCT02026778|Vasodilator Agents|vasodilator agents|mesh-ancestor
101306626|NCT02026778|Histamine Agonists|histamine agonists|mesh-ancestor
101306627|NCT02026778|Histamine Agents|histamine agents|mesh-ancestor
101306628|NCT02026817|Metformin|metformin|mesh-list
101306629|NCT02026817|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101419451|NCT00155376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101419452|NCT00155376|Hormones|hormones|mesh-ancestor
101419453|NCT00155376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101419454|NCT00141557|Methyltestosterone|methyltestosterone|mesh-list
101419455|NCT00141557|Estrogens|estrogens|mesh-list
101419456|NCT00141557|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
101419457|NCT00141557|Estrone|estrone|mesh-list
101419458|NCT00141557|Testosterone|testosterone|mesh-list
101419459|NCT00141557|Testosterone undecanoate|testosterone undecanoate|mesh-list
101419460|NCT00141557|Testosterone enanthate|testosterone enanthate|mesh-list
101419461|NCT00141557|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101419462|NCT00141557|Hormones|hormones|mesh-ancestor
101419463|NCT00141557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101419464|NCT00141557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419465|NCT00141557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101419466|NCT00141557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101419467|NCT00141557|Anabolic Agents|anabolic agents|mesh-ancestor
101419468|NCT00141557|Androgens|androgens|mesh-ancestor
101419469|NCT00162474|Phenytoin|phenytoin|mesh-list
101419470|NCT00162474|Warfarin|warfarin|mesh-list
101419471|NCT00162474|Anticoagulants|anticoagulants|mesh-ancestor
101419472|NCT00162474|Anticonvulsants|anticonvulsants|mesh-ancestor
101419473|NCT00162474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101555403|NCT00628810|Vitamin B Complex|vitamin b complex|mesh-ancestor
101555404|NCT00628810|Vitamins|vitamins|mesh-ancestor
101555405|NCT00628810|Micronutrients|micronutrients|mesh-ancestor
101555406|NCT00975481|Alprazolam|alprazolam|mesh-list
101555407|NCT00975481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101555408|NCT00975481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101555409|NCT00975481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555410|NCT00975481|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101555411|NCT00975481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101555412|NCT00975481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101555413|NCT00975481|GABA Modulators|gaba modulators|mesh-ancestor
101555414|NCT00975481|GABA Agents|gaba agents|mesh-ancestor
101555415|NCT00975481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101555416|NCT00975481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555417|NCT01011868|Empagliflozin|empagliflozin|mesh-list
101555418|NCT01011868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101555419|NCT01011868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555420|NCT01011868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101555421|NCT01011868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555422|NCT04290013|Tranexamic Acid|tranexamic acid|mesh-list
101555423|NCT04290013|Norethindrone|norethindrone|mesh-list
101555424|NCT04290013|Norethindrone Acetate|norethindrone acetate|mesh-list
101555425|NCT04290013|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101555426|NCT04290013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101555427|NCT04290013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555428|NCT04290013|Hemostatics|hemostatics|mesh-ancestor
101555429|NCT04290013|Coagulants|coagulants|mesh-ancestor
101555430|NCT04290013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101555431|NCT04290013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101419474|NCT00162474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101419475|NCT00162474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101419476|NCT00162474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419477|NCT00162474|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101419478|NCT00162474|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101419479|NCT04518553|Antiviral Agents|antiviral agents|mesh-list
101419480|NCT04518553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101419481|NCT00505336|Eplerenone|eplerenone|mesh-list
101419482|NCT00505336|Atorvastatin|atorvastatin|mesh-list
101419483|NCT00505336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101419484|NCT00505336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101419485|NCT00505336|Antimetabolites|antimetabolites|mesh-ancestor
101419486|NCT00505336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419490|NCT00505336|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101419491|NCT00505336|Hormone Antagonists|hormone antagonists|mesh-ancestor
101439423|NCT05365451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101555432|NCT04290013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101555433|NCT04290013|Contraceptive Agents|contraceptive agents|mesh-ancestor
101555434|NCT04290013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101555435|NCT04290013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555436|NCT04290013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101555437|NCT04290013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101555438|NCT04288999|Capecitabine|capecitabine|mesh-list
101555439|NCT04288999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101555440|NCT04288999|Antimetabolites|antimetabolites|mesh-ancestor
101555441|NCT04288999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555442|NCT04288999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101555443|NCT01213173|Metoprolol|metoprolol|mesh-list
101555444|NCT01213173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101555445|NCT01213173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101517358|NCT01262677|Pregabalin|pregabalin|mesh-list
101555446|NCT01213173|Sympatholytics|sympatholytics|mesh-ancestor
101555447|NCT01213173|Autonomic Agents|autonomic agents|mesh-ancestor
101555448|NCT01213173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101403941|NCT00094640|Olanzapine|olanzapine|mesh-list
101419492|NCT00505336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101419493|NCT00505336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419494|NCT00505336|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101419495|NCT00505336|Diuretics|diuretics|mesh-ancestor
101419496|NCT00505336|Natriuretic Agents|natriuretic agents|mesh-ancestor
101419497|NCT00505336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101419498|NCT04518202|Lidocaine|lidocaine|mesh-list
101419499|NCT04518202|Anesthetics, Local|anesthetics, local|mesh-ancestor
101419500|NCT04518202|Anesthetics|anesthetics|mesh-ancestor
101419501|NCT04518202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101419502|NCT04518202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419503|NCT04518202|Sensory System Agents|sensory system agents|mesh-ancestor
101419504|NCT04518202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101419505|NCT04518202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101419506|NCT04518202|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101419507|NCT04518202|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101419508|NCT04518202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101419509|NCT04518202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419510|NCT04517890|Lidocaine|lidocaine|mesh-list
101419511|NCT04517890|Anesthetics, Local|anesthetics, local|mesh-ancestor
101419516|NCT04517890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101306630|NCT02026817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101306631|NCT02026817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419517|NCT04517890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101419518|NCT04517890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101419519|NCT04517890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101419520|NCT04517890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101419521|NCT04517890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419522|NCT00141596|Amiloride|amiloride|mesh-list
101419524|NCT00141596|Diuretics|diuretics|mesh-ancestor
101419525|NCT00141596|Natriuretic Agents|natriuretic agents|mesh-ancestor
101419526|NCT00141596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419527|NCT00141596|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101419528|NCT00141596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101555449|NCT01213173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555450|NCT01213173|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101555451|NCT01213173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101555452|NCT01213173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101419529|NCT00141596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419530|NCT00141596|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
101419531|NCT00141596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101419532|NCT00141596|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101419533|NCT00141596|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101419534|NCT02275663|Cytarabine|cytarabine|mesh-list
101419535|NCT02275663|Fludarabine|fludarabine|mesh-list
101419536|NCT02275663|Azacitidine|azacitidine|mesh-list
101419537|NCT02275663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101419538|NCT02275663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101419539|NCT02275663|Antimetabolites|antimetabolites|mesh-ancestor
101419540|NCT02275663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419541|NCT02275663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101419542|NCT02275663|Immunologic Factors|immunologic factors|mesh-ancestor
101419543|NCT02275663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419544|NCT02275663|Antiviral Agents|antiviral agents|mesh-ancestor
101419545|NCT02275663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101419546|NCT02275663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101419547|NCT02275702|Dexamethasone|dexamethasone|mesh-list
101419548|NCT02275702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101419549|NCT02275702|Antiemetics|antiemetics|mesh-ancestor
101419550|NCT02275702|Autonomic Agents|autonomic agents|mesh-ancestor
101419551|NCT02275702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101419552|NCT02275702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419553|NCT02275702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101419554|NCT02275702|Glucocorticoids|glucocorticoids|mesh-ancestor
101419555|NCT02275702|Hormones|hormones|mesh-ancestor
101487401|NCT00432549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419558|NCT02275702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101419559|NCT04518163|Tranexamic Acid|tranexamic acid|mesh-list
101419560|NCT04518163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101419561|NCT04518163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101419562|NCT04518163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419563|NCT04518163|Hemostatics|hemostatics|mesh-ancestor
101419564|NCT04518163|Coagulants|coagulants|mesh-ancestor
101419565|NCT04517227|Durvalumab|durvalumab|mesh-list
101419566|NCT04517227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101419567|NCT04517227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101419568|NCT00141713|Etanercept|etanercept|mesh-list
101419569|NCT00141713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101419570|NCT00141713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101419571|NCT00141713|Analgesics|analgesics|mesh-ancestor
101419572|NCT00141713|Sensory System Agents|sensory system agents|mesh-ancestor
101419573|NCT00141713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101419574|NCT00141713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419575|NCT00141713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101419576|NCT00141713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101419577|NCT00141713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101419578|NCT00141713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101419579|NCT00141713|Immunologic Factors|immunologic factors|mesh-ancestor
101419580|NCT04517188|Iodine|iodine|mesh-list
101419581|NCT04517188|Povidone-Iodine|povidone-iodine|mesh-list
101306635|NCT02026817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419588|NCT04517188|Plasma Substitutes|plasma substitutes|mesh-ancestor
101419589|NCT04517188|Blood Substitutes|blood substitutes|mesh-ancestor
101419590|NCT00162552|Pentoxifylline|pentoxifylline|mesh-list
101419591|NCT00162552|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101419592|NCT00162552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101419593|NCT00162552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419594|NCT00162552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101419595|NCT00162552|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101419596|NCT00162552|Protective Agents|protective agents|mesh-ancestor
101419597|NCT00162552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419598|NCT00162552|Vasodilator Agents|vasodilator agents|mesh-ancestor
101419599|NCT00162552|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101419600|NCT00162552|Antioxidants|antioxidants|mesh-ancestor
101555453|NCT01213173|Adrenergic Agents|adrenergic agents|mesh-ancestor
101555454|NCT01213173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101555455|NCT01213173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555456|NCT04095715|Hemostatics|hemostatics|mesh-list
101419601|NCT04516681|Ascorbic Acid|ascorbic acid|mesh-list
101419602|NCT04516681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419603|NCT04516681|Vitamins|vitamins|mesh-ancestor
101419604|NCT04516681|Micronutrients|micronutrients|mesh-ancestor
101419605|NCT04516681|Antioxidants|antioxidants|mesh-ancestor
101419606|NCT04516681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419607|NCT04516681|Protective Agents|protective agents|mesh-ancestor
101419608|NCT00141791|Etanercept|etanercept|mesh-list
101419609|NCT00141791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101419610|NCT00141791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101419611|NCT00141791|Analgesics|analgesics|mesh-ancestor
101419612|NCT00141791|Sensory System Agents|sensory system agents|mesh-ancestor
101419613|NCT00141791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101419614|NCT00141791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419615|NCT00141791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101419616|NCT00141791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101419617|NCT00141791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101419618|NCT00141791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101419619|NCT00141791|Immunologic Factors|immunologic factors|mesh-ancestor
101419620|NCT04516603|4-Aminopyridine|4-aminopyridine|mesh-list
101419621|NCT04516603|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101419622|NCT04516603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101419623|NCT04516603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419624|NCT00162591|Remifentanil|remifentanil|mesh-list
101419625|NCT00162591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101419626|NCT00162591|Narcotics|narcotics|mesh-ancestor
101419627|NCT00162591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101419631|NCT00162591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101419633|NCT00505492|Cisplatin|cisplatin|mesh-list
101419634|NCT00505492|Carboplatin|carboplatin|mesh-list
101419635|NCT00505492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101419636|NCT00505492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101419637|NCT00505492|Tubulin Modulators|tubulin modulators|mesh-ancestor
101419638|NCT00505492|Antimitotic Agents|antimitotic agents|mesh-ancestor
101419639|NCT00505492|Mitosis Modulators|mitosis modulators|mesh-ancestor
101419640|NCT00505492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419641|NCT00141830|Methotrexate|methotrexate|mesh-list
101419642|NCT00141830|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101419643|NCT00141830|Abortifacient Agents|abortifacient agents|mesh-ancestor
101419644|NCT00141830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101419645|NCT00141830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419646|NCT00141830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101419647|NCT00141830|Antimetabolites|antimetabolites|mesh-ancestor
101202150|NCT01408186|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101419652|NCT00141830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101419653|NCT00141830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101419654|NCT00141830|Immunologic Factors|immunologic factors|mesh-ancestor
101419655|NCT00141830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101459227|NCT05055128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101419656|NCT00141830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101419657|NCT04516174|Dexmedetomidine|dexmedetomidine|mesh-list
101306636|NCT02026817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101306637|NCT02026817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101306638|NCT02026817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101419658|NCT04516174|Ropivacaine|ropivacaine|mesh-list
101419659|NCT04516174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101419660|NCT04516174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101419661|NCT04516174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419662|NCT04516174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101419663|NCT04516174|Analgesics|analgesics|mesh-ancestor
101419664|NCT04516174|Sensory System Agents|sensory system agents|mesh-ancestor
101419665|NCT04516174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101419666|NCT04516174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101419667|NCT04516174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101419668|NCT04516174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101419669|NCT04516174|Adrenergic Agents|adrenergic agents|mesh-ancestor
101419670|NCT04516174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101555458|NCT02866435|Potassium phosphate|potassium phosphate|mesh-list
101555459|NCT02866435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555460|NCT02866435|Cariostatic Agents|cariostatic agents|mesh-ancestor
101555461|NCT02866435|Protective Agents|protective agents|mesh-ancestor
101555462|NCT00973765|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101555463|NCT00973765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101555464|NCT00973765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101555465|NCT00973765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101555466|NCT00973765|Antimalarials|antimalarials|mesh-ancestor
101555467|NCT00973765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101555468|NCT00973765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101555470|NCT01211769|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101555471|NCT01211769|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101555472|NCT01211769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555473|NCT01211769|Sensory System Agents|sensory system agents|mesh-ancestor
101555474|NCT01211769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101555475|NCT04288765|Dexamethasone|dexamethasone|mesh-list
101555476|NCT04288765|Lenalidomide|lenalidomide|mesh-list
101555477|NCT04288765|Daratumumab|daratumumab|mesh-list
101555478|NCT04288765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101555479|NCT04288765|Antiemetics|antiemetics|mesh-ancestor
101403955|NCT00094640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101419671|NCT04516174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419672|NCT04516174|Anesthetics, Local|anesthetics, local|mesh-ancestor
101419673|NCT04516174|Anesthetics|anesthetics|mesh-ancestor
101419674|NCT04515979|Pembrolizumab|pembrolizumab|mesh-list
101419675|NCT04515979|Vactosertib|vactosertib|mesh-list
101419676|NCT04515979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101419677|NCT04515979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101419678|NCT04515979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101419679|NCT04515979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419680|NCT04515979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101419681|NCT04515979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101419682|NCT00505531|Diphenhydramine|diphenhydramine|mesh-list
101419683|NCT00505531|Tramadol|tramadol|mesh-list
101419684|NCT00505531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101419685|NCT00505531|Narcotics|narcotics|mesh-ancestor
101419686|NCT00505531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101419687|NCT00505531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419688|NCT00505531|Analgesics|analgesics|mesh-ancestor
101419689|NCT00505531|Sensory System Agents|sensory system agents|mesh-ancestor
101419690|NCT00505531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101419691|NCT00505531|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101419692|NCT00505531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101419693|NCT00505531|Anesthetics, Local|anesthetics, local|mesh-ancestor
101419694|NCT00505531|Anesthetics|anesthetics|mesh-ancestor
101419695|NCT00505531|Antiemetics|antiemetics|mesh-ancestor
101419696|NCT00505531|Autonomic Agents|autonomic agents|mesh-ancestor
101419697|NCT00505531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101419698|NCT00505531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101419699|NCT00505531|Histamine Antagonists|histamine antagonists|mesh-ancestor
101419702|NCT00505531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555480|NCT04288765|Autonomic Agents|autonomic agents|mesh-ancestor
101555481|NCT04288765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101555482|NCT04288765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555483|NCT04288765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101555484|NCT04288765|Glucocorticoids|glucocorticoids|mesh-ancestor
101555485|NCT04288765|Hormones|hormones|mesh-ancestor
101555486|NCT04288765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101555487|NCT04288765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101555488|NCT04288765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101555489|NCT04288765|Immunologic Factors|immunologic factors|mesh-ancestor
101555490|NCT04288765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101555491|NCT04288765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101403971|NCT05393817|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101419704|NCT00141908|Castor Oil|castor oil|mesh-list
101358860|NCT00411034|Narcotics|narcotics|mesh-ancestor
101419705|NCT00141908|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
101419706|NCT00141908|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
101419707|NCT00141908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101419708|NCT00141908|Hormone Antagonists|hormone antagonists|mesh-ancestor
101419709|NCT00141908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101419710|NCT00141908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419711|NCT00141908|Progestins|progestins|mesh-ancestor
101419712|NCT00141908|Hormones|hormones|mesh-ancestor
101419713|NCT00141908|Cathartics|cathartics|mesh-ancestor
101419714|NCT00141908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101419715|NCT00162669|Bevacizumab|bevacizumab|mesh-list
101419716|NCT00162669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101419717|NCT00162669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101202218|NCT01408680|Vitamins|vitamins|mesh-ancestor
101419721|NCT00162669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419722|NCT00162669|Growth Inhibitors|growth inhibitors|mesh-ancestor
101419723|NCT00141947|Bexarotene|bexarotene|mesh-list
101419724|NCT00141947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101419725|NCT04514770|Misoprostol|misoprostol|mesh-list
101419726|NCT04514770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101419727|NCT04514770|Abortifacient Agents|abortifacient agents|mesh-ancestor
101306640|NCT02026856|Sodium Selenite|sodium selenite|mesh-list
101306641|NCT02026856|Trace Elements|trace elements|mesh-ancestor
101306642|NCT02026856|Micronutrients|micronutrients|mesh-ancestor
101306643|NCT02026856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419728|NCT04514770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101419729|NCT04514770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419730|NCT04514770|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101419731|NCT04514770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101419732|NCT04514770|Oxytocics|oxytocics|mesh-ancestor
101419734|NCT00141986|Ergocalciferols|ergocalciferols|mesh-list
101419735|NCT00141986|Cholecalciferol|cholecalciferol|mesh-list
101419736|NCT00141986|Vitamins|vitamins|mesh-list
101419737|NCT00141986|Micronutrients|micronutrients|mesh-ancestor
101419738|NCT00141986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419739|NCT00141986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101419740|NCT00141986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101419741|NCT04514731|Magnesium Sulfate|magnesium sulfate|mesh-list
101419742|NCT04514731|Analgesics|analgesics|mesh-ancestor
101419743|NCT04514731|Sensory System Agents|sensory system agents|mesh-ancestor
101419744|NCT04514731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101419745|NCT04514731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419746|NCT04514731|Anesthetics|anesthetics|mesh-ancestor
101419747|NCT04514731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101419748|NCT04514731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101419749|NCT04514731|Anticonvulsants|anticonvulsants|mesh-ancestor
101419750|NCT04514731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101419751|NCT04514731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101555492|NCT04288765|Growth Substances|growth substances|mesh-ancestor
101555493|NCT04288765|Growth Inhibitors|growth inhibitors|mesh-ancestor
101555494|NCT01211535|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101555495|NCT02863861|Dexmedetomidine|dexmedetomidine|mesh-list
101555497|NCT02863861|Propofol|propofol|mesh-list
101555498|NCT02863861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101555499|NCT02863861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101555500|NCT02863861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555501|NCT02863861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101555502|NCT02863861|Analgesics|analgesics|mesh-ancestor
101555503|NCT02863861|Sensory System Agents|sensory system agents|mesh-ancestor
101555504|NCT02863861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101555505|NCT02863861|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101555506|NCT02863861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101555507|NCT02863861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101459307|NCT04995263|Caffeine|caffeine|mesh-list
101555508|NCT02863861|Adrenergic Agents|adrenergic agents|mesh-ancestor
101555509|NCT02863861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101555510|NCT02863861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555511|NCT02863861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101555512|NCT02863861|Anesthetics, General|anesthetics, general|mesh-ancestor
101419752|NCT04514731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419753|NCT04514731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101419755|NCT04514731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101419756|NCT04514419|Docetaxel|docetaxel|mesh-list
101419757|NCT04514419|Trastuzumab|trastuzumab|mesh-list
101419758|NCT04514419|Pertuzumab|pertuzumab|mesh-list
101419759|NCT04514419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101419760|NCT04514419|Tubulin Modulators|tubulin modulators|mesh-ancestor
101419761|NCT04514419|Antimitotic Agents|antimitotic agents|mesh-ancestor
101419762|NCT04514419|Mitosis Modulators|mitosis modulators|mesh-ancestor
101419763|NCT04514419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419764|NCT04514419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101419765|NCT00142025|Oxcarbazepine|oxcarbazepine|mesh-list
101419766|NCT00142025|Anticonvulsants|anticonvulsants|mesh-ancestor
101419767|NCT00142025|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101419768|NCT00142025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101419769|NCT00142025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101419770|NCT00142025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419771|NCT00142025|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101419772|NCT00142025|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101419791|NCT00162786|Histamine Antagonists|histamine antagonists|mesh-ancestor
101419792|NCT00162786|Histamine Agents|histamine agents|mesh-ancestor
101419793|NCT00162786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101419794|NCT00162786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419795|NCT00162786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419796|NCT00142181|Alemtuzumab|alemtuzumab|mesh-list
101419797|NCT00142181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101419798|NCT00142181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101419799|NCT00505804|Dexmedetomidine|dexmedetomidine|mesh-list
101419800|NCT00505804|Haloperidol|haloperidol|mesh-list
101419801|NCT00505804|Haloperidol decanoate|haloperidol decanoate|mesh-list
101555514|NCT02863861|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101555515|NCT02863861|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101555516|NCT02863861|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101555517|NCT05406765|Bupivacaine|bupivacaine|mesh-list
101555518|NCT05406765|Anesthetics, Local|anesthetics, local|mesh-ancestor
101555519|NCT05406765|Anesthetics|anesthetics|mesh-ancestor
101555520|NCT05406765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101517430|NCT04083118|Sodium Fluoride|sodium fluoride|mesh-list
101555522|NCT05406765|Sensory System Agents|sensory system agents|mesh-ancestor
101555523|NCT05406765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101555524|NCT01011556|Teriparatide|teriparatide|mesh-list
101419802|NCT00505804|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101419803|NCT00505804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101419804|NCT00505804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419808|NCT00505804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101419809|NCT00505804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101419810|NCT00505804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101419811|NCT00505804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101419812|NCT00505804|Adrenergic Agents|adrenergic agents|mesh-ancestor
101419813|NCT00505804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101306644|NCT02026869|Metformin|metformin|mesh-list
101306645|NCT02026869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101306646|NCT02026869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306647|NCT02026921|Carboplatin|carboplatin|mesh-list
101306648|NCT02026921|Docetaxel|docetaxel|mesh-list
101419814|NCT00505804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419815|NCT00505804|Antiemetics|antiemetics|mesh-ancestor
101419816|NCT00505804|Autonomic Agents|autonomic agents|mesh-ancestor
101419817|NCT00505804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101419818|NCT00505804|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101419819|NCT00505804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101419820|NCT00505804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101419821|NCT00505804|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101419822|NCT00505804|Dopamine Agents|dopamine agents|mesh-ancestor
101419823|NCT00505804|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101419824|NCT00505843|Levodopa|levodopa|mesh-list
101419825|NCT00505843|Carbidopa|carbidopa|mesh-list
101419826|NCT00505843|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101419827|NCT00505843|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101419828|NCT00505843|Dopamine Agents|dopamine agents|mesh-ancestor
101419829|NCT00505843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101419837|NCT00142337|Zidovudine|zidovudine|mesh-list
101419838|NCT00142337|Didanosine|didanosine|mesh-list
101419839|NCT00142337|Antimetabolites|antimetabolites|mesh-ancestor
101419840|NCT00142337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419841|NCT00142337|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101419842|NCT00142337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101419843|NCT00142337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101419844|NCT00142337|Antiviral Agents|antiviral agents|mesh-ancestor
101419845|NCT00142337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101419846|NCT00142337|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101419847|NCT00142337|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101419848|NCT00162864|Montelukast|montelukast|mesh-list
101419849|NCT00162864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101419850|NCT00162864|Respiratory System Agents|respiratory system agents|mesh-ancestor
101419851|NCT00162864|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101419852|NCT00162864|Hormone Antagonists|hormone antagonists|mesh-ancestor
101419853|NCT00162864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101419854|NCT00162864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419855|NCT00162864|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101419856|NCT00162864|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101419857|NCT00162864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419858|NCT04512313|Rocuronium|rocuronium|mesh-list
101555525|NCT01011556|Hormones|hormones|mesh-list
101555526|NCT01011556|Parathyroid Hormone|parathyroid hormone|mesh-list
101555527|NCT01011556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101555528|NCT01011556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404016|NCT01054729|Antiviral Agents|antiviral agents|mesh-ancestor
101419859|NCT04512313|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101419860|NCT04512313|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101419861|NCT04512313|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101419862|NCT04512313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101419863|NCT04512313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419864|NCT00142493|Midazolam|midazolam|mesh-list
101419865|NCT00142493|Dexmedetomidine|dexmedetomidine|mesh-list
101419866|NCT00142493|Thiopental|thiopental|mesh-list
101419867|NCT00142493|Propofol|propofol|mesh-list
101419868|NCT00142493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101419869|NCT00142493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101419870|NCT00142493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419871|NCT00142493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101419872|NCT00142493|Analgesics|analgesics|mesh-ancestor
101419873|NCT00142493|Sensory System Agents|sensory system agents|mesh-ancestor
101419874|NCT00142493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101419875|NCT00142493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101419876|NCT00142493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101419877|NCT00142493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101419878|NCT00142493|Adrenergic Agents|adrenergic agents|mesh-ancestor
101419879|NCT00142493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101202366|NCT01409369|Charcoal|charcoal|mesh-list
101419886|NCT00142493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101306649|NCT02026921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101306650|NCT02026921|Tubulin Modulators|tubulin modulators|mesh-ancestor
101419887|NCT00142493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101419888|NCT00142493|GABA Modulators|gaba modulators|mesh-ancestor
101419889|NCT00142493|GABA Agents|gaba agents|mesh-ancestor
101419890|NCT00142493|Anticonvulsants|anticonvulsants|mesh-ancestor
101419892|NCT04511923|Anticoagulants|anticoagulants|mesh-ancestor
101419893|NCT04511923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101419894|NCT04511923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101419895|NCT04511923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419912|NCT00142571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419913|NCT00142571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101419914|NCT00142571|Tubulin Modulators|tubulin modulators|mesh-ancestor
101419915|NCT00142571|Antimitotic Agents|antimitotic agents|mesh-ancestor
101419916|NCT00142571|Mitosis Modulators|mitosis modulators|mesh-ancestor
101419917|NCT00142610|Vitamins|vitamins|mesh-list
101419918|NCT00142610|Vitamin E|vitamin e|mesh-list
101419919|NCT00142610|Micronutrients|micronutrients|mesh-ancestor
101419920|NCT00142610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419921|NCT00142610|Antioxidants|antioxidants|mesh-ancestor
101419922|NCT00142610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419923|NCT00142610|Protective Agents|protective agents|mesh-ancestor
101419924|NCT04510870|Ferric Compounds|ferric compounds|mesh-list
101419925|NCT04510870|Hematinics|hematinics|mesh-ancestor
101419926|NCT00406575|Methocarbamol|methocarbamol|mesh-list
101419927|NCT00406575|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101419928|NCT00406575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419929|NCT00406575|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101419930|NCT00406575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101419931|NCT02275975|Fluconazole|fluconazole|mesh-list
101419932|NCT02275975|Antifungal Agents|antifungal agents|mesh-ancestor
101419933|NCT02275975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101419934|NCT02275975|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101419935|NCT02275975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101419936|NCT02275975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101419937|NCT02275975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419938|NCT02275975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101419939|NCT02275975|Hormone Antagonists|hormone antagonists|mesh-ancestor
101419940|NCT02275975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101419941|NCT02275975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419942|NCT02275975|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101555529|NCT01011556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101555530|NCT01011556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101555531|NCT01211145|Oxazolidinones|oxazolidinones|mesh-list
101555532|NCT01211145|Zolmitriptan|zolmitriptan|mesh-list
101555533|NCT01211145|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101555534|NCT01211145|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101555535|NCT01211145|Serotonin Agents|serotonin agents|mesh-ancestor
101555536|NCT01211145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101404022|NCT00428896|Gefitinib|gefitinib|mesh-list
101404027|NCT01990911|Diuretics|diuretics|mesh-list
101419943|NCT02275975|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101419944|NCT02276092|Anti-Infective Agents|anti-infective agents|mesh-list
101419945|NCT02276092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101419946|NCT00142727|Analgesics, Opioid|analgesics, opioid|mesh-list
101419947|NCT00142727|Methadone|methadone|mesh-list
101419948|NCT00142727|Narcotic Antagonists|narcotic antagonists|mesh-list
101419949|NCT00142727|Narcotics|narcotics|mesh-ancestor
101419950|NCT00142727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101419951|NCT00142727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419952|NCT00142727|Analgesics|analgesics|mesh-ancestor
101419953|NCT00142727|Sensory System Agents|sensory system agents|mesh-ancestor
101419954|NCT00142727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101419955|NCT00142727|Antitussive Agents|antitussive agents|mesh-ancestor
101419960|NCT00506194|Gliclazide|gliclazide|mesh-list
101419961|NCT00506194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101419962|NCT00506194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419963|NCT00404573|Cariprazine|cariprazine|mesh-list
101419964|NCT00404573|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101419965|NCT00404573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101419966|NCT00404573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101419967|NCT00404573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419973|NCT00506311|Hemostatics|hemostatics|mesh-ancestor
101419974|NCT00506311|Coagulants|coagulants|mesh-ancestor
101419975|NCT04519645|Lacosamide|lacosamide|mesh-list
101419976|NCT04519645|Anticonvulsants|anticonvulsants|mesh-ancestor
101419977|NCT04519645|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101306651|NCT02026921|Antimitotic Agents|antimitotic agents|mesh-ancestor
101306652|NCT02026921|Mitosis Modulators|mitosis modulators|mesh-ancestor
101419978|NCT04519645|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101419979|NCT04519645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101419980|NCT04519645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419981|NCT00406731|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
101419982|NCT00406731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101419983|NCT00406731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419984|NCT00142844|Naltrexone|naltrexone|mesh-list
101419985|NCT00142844|Disulfiram|disulfiram|mesh-list
101419986|NCT00142844|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101419987|NCT00142844|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101419988|NCT00142844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419989|NCT00142844|Sensory System Agents|sensory system agents|mesh-ancestor
101419990|NCT00142844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101419991|NCT00142844|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
101419992|NCT00142844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101419993|NCT00142844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419994|NCT00163137|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101419995|NCT00163137|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101419996|NCT00163137|Hormone Antagonists|hormone antagonists|mesh-ancestor
101419997|NCT00163137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101419998|NCT00163137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419999|NCT00163137|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101420000|NCT00163137|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101420001|NCT00163137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101420002|NCT00142883|Pregabalin|pregabalin|mesh-list
101420003|NCT00142883|Analgesics|analgesics|mesh-ancestor
101420004|NCT00142883|Sensory System Agents|sensory system agents|mesh-ancestor
101555537|NCT01211145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555538|NCT01211145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555539|NCT01211145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101555540|NCT01211145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101555541|NCT01211145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101555542|NCT00977665|Rasagiline|rasagiline|mesh-list
101555543|NCT00977665|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101501752|NCT00484926|Antipyretics|antipyretics|mesh-ancestor
101420005|NCT00142883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101420006|NCT00142883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420007|NCT00142883|Anticonvulsants|anticonvulsants|mesh-ancestor
101420008|NCT00142883|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101420009|NCT00142883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101420010|NCT00142883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420011|NCT00142883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101420012|NCT00142883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101420013|NCT00142883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101420014|NCT00142883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101420015|NCT00142883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101420016|NCT04515238|Venetoclax|venetoclax|mesh-list
101420017|NCT04515238|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101420018|NCT04515238|Obinutuzumab|obinutuzumab|mesh-list
101420019|NCT04515238|Zanubrutinib|zanubrutinib|mesh-list
101420020|NCT04515238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101420021|NCT04515238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101420022|NCT04515238|Alkylating Agents|alkylating agents|mesh-ancestor
101420023|NCT04515238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487402|NCT00427947|Ropivacaine|ropivacaine|mesh-list
101420027|NCT00142961|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101420028|NCT00142961|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101420029|NCT00142961|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101420030|NCT00142961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101420031|NCT00142961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420032|NCT00142961|Adrenergic Agents|adrenergic agents|mesh-ancestor
101420033|NCT00142961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101420034|NCT00142961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420040|NCT00143000|Antimetabolites|antimetabolites|mesh-ancestor
101420041|NCT00143000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420042|NCT00143000|Antiviral Agents|antiviral agents|mesh-ancestor
101420043|NCT00143000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101420044|NCT04514029|Dexamethasone|dexamethasone|mesh-list
101420045|NCT04514029|Simvastatin|simvastatin|mesh-list
101420046|NCT04514029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101420047|NCT04514029|Antiemetics|antiemetics|mesh-ancestor
101420048|NCT04514029|Autonomic Agents|autonomic agents|mesh-ancestor
101333861|NCT00017394|Antibodies|antibodies|mesh-list
101420049|NCT04514029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101420050|NCT04514029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420051|NCT04514029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101420052|NCT04514029|Glucocorticoids|glucocorticoids|mesh-ancestor
101420053|NCT04514029|Hormones|hormones|mesh-ancestor
101420054|NCT04514029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101420055|NCT04514029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101459381|NCT00414921|Autonomic Agents|autonomic agents|mesh-ancestor
101420056|NCT04514029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101420057|NCT04514029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101420058|NCT04514029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101420059|NCT04514029|Antimetabolites|antimetabolites|mesh-ancestor
101420060|NCT04514029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420061|NCT04514029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101420062|NCT04514029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101420063|NCT04514029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101420064|NCT02590393|Nicotine|nicotine|mesh-list
101420065|NCT02590393|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101420066|NCT02590393|Autonomic Agents|autonomic agents|mesh-ancestor
101555544|NCT00977665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101555545|NCT00977665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555546|NCT00977665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101555547|NCT00977665|Protective Agents|protective agents|mesh-ancestor
101555548|NCT00977665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555549|NCT04298008|Durvalumab|durvalumab|mesh-list
101555550|NCT04298008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101555551|NCT04298008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101555552|NCT00628342|Esomeprazole|esomeprazole|mesh-list
101404037|NCT00429091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420067|NCT02590393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101420068|NCT02590393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420069|NCT02590393|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101420070|NCT02590393|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101420071|NCT02590393|Cholinergic Agents|cholinergic agents|mesh-ancestor
101420072|NCT02590393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101420073|NCT02590393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420074|NCT00506506|Acetylcysteine|acetylcysteine|mesh-list
101420075|NCT00506506|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101420076|NCT00506506|Antiviral Agents|antiviral agents|mesh-ancestor
101420077|NCT00506506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101420078|NCT00506506|Expectorants|expectorants|mesh-ancestor
101420079|NCT00506506|Respiratory System Agents|respiratory system agents|mesh-ancestor
101420080|NCT00506506|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101420081|NCT00506506|Antioxidants|antioxidants|mesh-ancestor
101420082|NCT00506506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420083|NCT00506506|Protective Agents|protective agents|mesh-ancestor
101420084|NCT00506506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420085|NCT00506506|Antidotes|antidotes|mesh-ancestor
101420086|NCT02594254|Anti-Infective Agents|anti-infective agents|mesh-list
101420087|NCT02594254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101420088|NCT00163332|Ciclesonide|ciclesonide|mesh-list
101420089|NCT00163332|Glucocorticoids|glucocorticoids|mesh-ancestor
101420090|NCT00163332|Hormones|hormones|mesh-ancestor
101420091|NCT00163332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101420092|NCT00163332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420093|NCT00163332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101420094|NCT00163371|Ciclesonide|ciclesonide|mesh-list
101420098|NCT00163371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420100|NCT00143156|Pregabalin|pregabalin|mesh-list
101420101|NCT00143156|Analgesics|analgesics|mesh-ancestor
101420102|NCT00143156|Sensory System Agents|sensory system agents|mesh-ancestor
101420103|NCT00143156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101420104|NCT00143156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420105|NCT00143156|Anticonvulsants|anticonvulsants|mesh-ancestor
101420106|NCT00143156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101420107|NCT00143156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101420108|NCT00143156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420113|NCT00143156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101420114|NCT00163410|Ciclesonide|ciclesonide|mesh-list
101420115|NCT00163410|Glucocorticoids|glucocorticoids|mesh-ancestor
101420116|NCT00163410|Hormones|hormones|mesh-ancestor
101420117|NCT00163410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101420118|NCT00163410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420119|NCT00163410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101420120|NCT00143195|Amlodipine|amlodipine|mesh-list
101420121|NCT00143195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101420122|NCT00143195|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101420123|NCT00143195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101420124|NCT00143195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306653|NCT02026921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420125|NCT00143195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101420126|NCT00143195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555553|NCT00628342|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101555554|NCT00628342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101555555|NCT00628342|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101555556|NCT00628342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101555557|NCT00628342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555558|NCT01210443|Sitaxsentan|sitaxsentan|mesh-list
101555559|NCT01210443|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101555560|NCT01210443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555561|NCT04287361|Clonazepam|clonazepam|mesh-list
101555562|NCT04287361|Anticonvulsants|anticonvulsants|mesh-ancestor
101555563|NCT04287361|GABA Modulators|gaba modulators|mesh-ancestor
101555564|NCT04287361|GABA Agents|gaba agents|mesh-ancestor
101555565|NCT04287361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101555566|NCT04287361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555567|NCT04287361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555568|NCT00624429|Budesonide|budesonide|mesh-list
101420127|NCT00143195|Vasodilator Agents|vasodilator agents|mesh-ancestor
101420129|NCT00163449|Glucocorticoids|glucocorticoids|mesh-ancestor
101420130|NCT00163449|Hormones|hormones|mesh-ancestor
101420131|NCT00163449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101420132|NCT00163449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420133|NCT00163449|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101420134|NCT00143234|Amlodipine|amlodipine|mesh-list
101420135|NCT00143234|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
101420136|NCT00143234|Atorvastatin|atorvastatin|mesh-list
101420137|NCT00143234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101420138|NCT00143234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101420139|NCT00143234|Antimetabolites|antimetabolites|mesh-ancestor
101420140|NCT00143234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420141|NCT00143234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101420142|NCT00143234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101420143|NCT00143234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101420144|NCT00143234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101420145|NCT00143234|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101420146|NCT00143234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101420147|NCT00143234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101420148|NCT00143234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420149|NCT00143234|Vasodilator Agents|vasodilator agents|mesh-ancestor
101420150|NCT00163488|Ciclesonide|ciclesonide|mesh-list
101420151|NCT00163488|Glucocorticoids|glucocorticoids|mesh-ancestor
101420152|NCT00163488|Hormones|hormones|mesh-ancestor
101420153|NCT00163488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101420154|NCT00163488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420155|NCT00163488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101420156|NCT00143351|Ziprasidone|ziprasidone|mesh-list
101420157|NCT00143351|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101420158|NCT00143351|Serotonin Agents|serotonin agents|mesh-ancestor
101420159|NCT00143351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101813798|NCT04048889|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101420160|NCT00143351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420161|NCT00143351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420162|NCT00143351|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101420163|NCT00143351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101420165|NCT00143351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101420166|NCT00143351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101420167|NCT00143351|Dopamine Agents|dopamine agents|mesh-ancestor
101420168|NCT00163605|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101420170|NCT00163605|Calcium|calcium|mesh-list
101555569|NCT00624429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101555570|NCT00624429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101555572|NCT00624429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101555573|NCT00624429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555574|NCT00624429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101555575|NCT00624429|Respiratory System Agents|respiratory system agents|mesh-ancestor
101555576|NCT00624429|Glucocorticoids|glucocorticoids|mesh-ancestor
101555577|NCT00624429|Hormones|hormones|mesh-ancestor
101555578|NCT00624429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101555579|NCT01001572|Amlodipine|amlodipine|mesh-list
101555580|NCT01001572|Valsartan|valsartan|mesh-list
101555581|NCT01001572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101555582|NCT01001572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101555583|NCT01001572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101404063|NCT00095654|Rosiglitazone|rosiglitazone|mesh-list
101420171|NCT00163605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101420172|NCT00163605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420173|NCT00163605|Hemostatics|hemostatics|mesh-ancestor
101420174|NCT00163605|Coagulants|coagulants|mesh-ancestor
101420175|NCT02598583|Ravulizumab|ravulizumab|mesh-list
101420176|NCT02598583|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101420177|NCT02598583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101420178|NCT02598583|Immunologic Factors|immunologic factors|mesh-ancestor
101420179|NCT02598583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420185|NCT02598895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101420186|NCT02598895|Tubulin Modulators|tubulin modulators|mesh-ancestor
101420187|NCT02598895|Antimitotic Agents|antimitotic agents|mesh-ancestor
101420188|NCT02598895|Mitosis Modulators|mitosis modulators|mesh-ancestor
101420189|NCT02598895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420190|NCT00143546|Defibrotide|defibrotide|mesh-list
101420191|NCT00143546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101420192|NCT00143546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101420193|NCT00143546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420194|NCT00143546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101420195|NCT00155883|Leucovorin|leucovorin|mesh-list
101420196|NCT00155883|Fluorouracil|fluorouracil|mesh-list
101420197|NCT00155883|Antimetabolites|antimetabolites|mesh-ancestor
101420198|NCT00155883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306654|NCT02026947|Sodium Benzoate|sodium benzoate|mesh-list
101306655|NCT02026947|Antifungal Agents|antifungal agents|mesh-ancestor
101306656|NCT02026947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101306657|NCT02026973|Fulvestrant|fulvestrant|mesh-list
101420199|NCT00155883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101420200|NCT00155883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101420201|NCT00155883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101420202|NCT00155883|Immunologic Factors|immunologic factors|mesh-ancestor
101420203|NCT00155883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420204|NCT00155883|Antidotes|antidotes|mesh-ancestor
101420205|NCT00155883|Protective Agents|protective agents|mesh-ancestor
101420206|NCT00155883|Vitamin B Complex|vitamin b complex|mesh-ancestor
101420208|NCT00155883|Micronutrients|micronutrients|mesh-ancestor
101420209|NCT00506545|Rolapitant|rolapitant|mesh-list
101420210|NCT00506545|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101420211|NCT00506545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101420212|NCT00506545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420213|NCT00506545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420214|NCT04696393|Mitapivat|mitapivat|mesh-list
101420215|NCT04696393|Enzyme Activators|enzyme activators|mesh-ancestor
101555584|NCT01001572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555585|NCT01001572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101555586|NCT01001572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555587|NCT01001572|Vasodilator Agents|vasodilator agents|mesh-ancestor
101555588|NCT01001572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101555589|NCT01001572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101555590|NCT04287205|Dydrogesterone|dydrogesterone|mesh-list
101555591|NCT04287205|Progestins|progestins|mesh-ancestor
101555592|NCT04287205|Hormones|hormones|mesh-ancestor
101517508|NCT02899169|Tretinoin|tretinoin|mesh-list
101555593|NCT04287205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101555594|NCT04287205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555596|NCT00628576|Calcium heparin|calcium heparin|mesh-list
101555597|NCT00628576|Tinzaparin|tinzaparin|mesh-list
101420216|NCT04696393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420217|NCT05143723|Hormones|hormones|mesh-list
101420218|NCT05143723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101420219|NCT05143723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420220|NCT00143624|Rosiglitazone|rosiglitazone|mesh-list
101420221|NCT00143624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101420222|NCT00143624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420223|NCT05142865|Carboplatin|carboplatin|mesh-list
101420224|NCT05142865|Etoposide|etoposide|mesh-list
101420225|NCT05142865|Apatinib|apatinib|mesh-list
101420226|NCT05142865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101420227|NCT05142865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101420228|NCT05142865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101420229|NCT05142865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101420230|NCT05142865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101420231|NCT05142865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420232|NCT05142865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101420233|NCT00143702|Riboflavin|riboflavin|mesh-list
101420234|NCT00143702|Thiamine|thiamine|mesh-list
101420235|NCT00143702|Abacavir|abacavir|mesh-list
101420236|NCT00143702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101420237|NCT00143702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101420238|NCT00143702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101487403|NCT00427947|Anesthetics, Local|anesthetics, local|mesh-ancestor
101420241|NCT00143702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101420242|NCT00143702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101420243|NCT00143702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101420244|NCT00143702|Vitamin B Complex|vitamin b complex|mesh-ancestor
101420245|NCT00143702|Vitamins|vitamins|mesh-ancestor
101420246|NCT00143702|Micronutrients|micronutrients|mesh-ancestor
101420247|NCT00143702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420248|NCT00143702|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101420249|NCT00143702|Dermatologic Agents|dermatologic agents|mesh-ancestor
101420250|NCT00156078|Pregabalin|pregabalin|mesh-list
101420262|NCT00156078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101420263|NCT00156078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101420264|NCT00506623|Capecitabine|capecitabine|mesh-list
101420265|NCT00506623|Irinotecan|irinotecan|mesh-list
101420266|NCT00506623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101420267|NCT00506623|Antimetabolites|antimetabolites|mesh-ancestor
101420268|NCT00506623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306659|NCT02026973|Somatostatin|somatostatin|mesh-list
101306660|NCT02026973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101306661|NCT02026973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333862|NCT00017394|Immunoglobulins|immunoglobulins|mesh-list
101420269|NCT00506623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101420270|NCT00506623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101555598|NCT00628576|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101555600|NCT00628576|Anticoagulants|anticoagulants|mesh-ancestor
101555601|NCT00628576|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101555602|NCT00628576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101555603|NCT00628576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555604|NCT01208337|Alemtuzumab|alemtuzumab|mesh-list
101555605|NCT01208337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101555606|NCT01208337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101555607|NCT04370548|Clindamycin|clindamycin|mesh-list
101555608|NCT04370548|Clindamycin palmitate|clindamycin palmitate|mesh-list
101555609|NCT04370548|Clindamycin phosphate|clindamycin phosphate|mesh-list
101555610|NCT04370548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101555611|NCT04370548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101555612|NCT04370548|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101555613|NCT04370548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101555614|NCT04370548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555615|NCT01208181|Etoricoxib|etoricoxib|mesh-list
101555616|NCT01208181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101555617|NCT01208181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101555618|NCT01208181|Analgesics|analgesics|mesh-ancestor
101555619|NCT01208181|Sensory System Agents|sensory system agents|mesh-ancestor
101555620|NCT01208181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101555621|NCT01208181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555622|NCT01208181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101555623|NCT01208181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101404095|NCT00429442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101420271|NCT00506623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101420273|NCT00143741|Atorvastatin|atorvastatin|mesh-list
101420274|NCT00143741|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101420275|NCT00143741|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101420276|NCT00143741|Antimetabolites|antimetabolites|mesh-ancestor
101420277|NCT00143741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420278|NCT00143741|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101420279|NCT00143741|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101420280|NCT00143741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101420281|NCT00143780|Vaccines|vaccines|mesh-list
101420282|NCT00143780|Immunologic Factors|immunologic factors|mesh-ancestor
101420283|NCT00143780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420284|NCT02276365|Pioglitazone|pioglitazone|mesh-list
101420285|NCT02276365|Empagliflozin|empagliflozin|mesh-list
101420286|NCT02276365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101420287|NCT02276365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420288|NCT02276365|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101420289|NCT02276365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420290|NCT05145634|Anticoagulants|anticoagulants|mesh-list
101420291|NCT00143975|Cytarabine|cytarabine|mesh-list
101555624|NCT01208181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101555625|NCT01208181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101555626|NCT01208181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101555627|NCT01208181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555628|NCT01208103|Bevacizumab|bevacizumab|mesh-list
101555629|NCT01208103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101555630|NCT01208103|Capecitabine|capecitabine|mesh-list
101420292|NCT00143975|Mitoxantrone|mitoxantrone|mesh-list
101420293|NCT00143975|Gemtuzumab|gemtuzumab|mesh-list
101420294|NCT00143975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101420295|NCT00143975|Antimetabolites|antimetabolites|mesh-ancestor
101420296|NCT00143975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420297|NCT00143975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101420298|NCT00143975|Antiviral Agents|antiviral agents|mesh-ancestor
101420299|NCT00143975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101420300|NCT00143975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101420301|NCT00143975|Immunologic Factors|immunologic factors|mesh-ancestor
101420302|NCT00143975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420303|NCT00143975|Analgesics|analgesics|mesh-ancestor
101420304|NCT00143975|Sensory System Agents|sensory system agents|mesh-ancestor
101420305|NCT00143975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101420306|NCT00143975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101420307|NCT00143975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101420308|NCT00143975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101420309|NCT00143975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101420310|NCT00143975|Immunotoxins|immunotoxins|mesh-ancestor
101420319|NCT00156312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101420320|NCT00156312|Antimetabolites|antimetabolites|mesh-ancestor
101420321|NCT00506701|Tadalafil|tadalafil|mesh-list
101420322|NCT00506701|Vasodilator Agents|vasodilator agents|mesh-ancestor
101420323|NCT00506701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101420324|NCT00506701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101420325|NCT00506701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101420326|NCT00506701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420327|NCT00506701|Urological Agents|urological agents|mesh-ancestor
101420328|NCT05147857|Misoprostol|misoprostol|mesh-list
101420329|NCT05147857|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101420330|NCT05147857|Abortifacient Agents|abortifacient agents|mesh-ancestor
101420331|NCT05147857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101420332|NCT05147857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420333|NCT05147857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101420334|NCT05147857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101420335|NCT05147857|Oxytocics|oxytocics|mesh-ancestor
101420336|NCT00144053|Paclitaxel|paclitaxel|mesh-list
101420337|NCT00144053|Vindesine|vindesine|mesh-list
101420338|NCT00144053|Carboplatin|carboplatin|mesh-list
101420339|NCT00144053|Irinotecan|irinotecan|mesh-list
101306662|NCT02026973|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101420340|NCT00144053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101420341|NCT00144053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101420342|NCT00144053|Tubulin Modulators|tubulin modulators|mesh-ancestor
101420343|NCT00144053|Antimitotic Agents|antimitotic agents|mesh-ancestor
101420344|NCT00144053|Mitosis Modulators|mitosis modulators|mesh-ancestor
101420345|NCT00144053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420346|NCT00144053|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101420347|NCT00144053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101420348|NCT00144053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101420349|NCT05147194|Trimetazidine|trimetazidine|mesh-list
101420350|NCT05147194|Vasodilator Agents|vasodilator agents|mesh-ancestor
101420351|NCT00144131|Darbepoetin alfa|darbepoetin alfa|mesh-list
101420352|NCT00144131|Hematinics|hematinics|mesh-ancestor
101420353|NCT00144209|Levodopa|levodopa|mesh-list
101420354|NCT00144209|Pramipexole|pramipexole|mesh-list
101420355|NCT00144209|Benserazide|benserazide|mesh-list
101420356|NCT00144209|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101420357|NCT00144209|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101420358|NCT00144209|Dopamine Agents|dopamine agents|mesh-ancestor
101420359|NCT00144209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101420360|NCT00144209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555631|NCT01208103|Oxaliplatin|oxaliplatin|mesh-list
101555632|NCT01208103|Endothelial Growth Factors|endothelial growth factors|mesh-list
101555633|NCT01208103|Antibodies|antibodies|mesh-list
101555634|NCT01208103|Immunoglobulins|immunoglobulins|mesh-list
101555635|NCT01208103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101555636|NCT01208103|Immunoglobulin G|immunoglobulin g|mesh-list
101555637|NCT01208103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101420361|NCT00144209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420362|NCT00144209|Antioxidants|antioxidants|mesh-ancestor
101420363|NCT00144209|Protective Agents|protective agents|mesh-ancestor
101420364|NCT00144209|Dopamine Agonists|dopamine agonists|mesh-ancestor
101420365|NCT00144209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101420366|NCT05149339|Cholecalciferol|cholecalciferol|mesh-list
101420367|NCT05149339|Vitamin D|vitamin d|mesh-list
101420368|NCT05149339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101420369|NCT05149339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420370|NCT05149339|Vitamins|vitamins|mesh-ancestor
101420371|NCT05149339|Micronutrients|micronutrients|mesh-ancestor
101420372|NCT05149339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101420373|NCT00144248|Nevirapine|nevirapine|mesh-list
101420374|NCT00144248|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101420375|NCT00144248|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101420376|NCT00144248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101420377|NCT00144248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420378|NCT00144248|Antiviral Agents|antiviral agents|mesh-ancestor
101420379|NCT00144248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101420380|NCT00144248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101420381|NCT00144248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101420382|NCT00144248|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101420383|NCT00144248|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101202857|NCT01413048|Adrenergic Agents|adrenergic agents|mesh-ancestor
101487404|NCT00427947|Anesthetics|anesthetics|mesh-ancestor
101420390|NCT00144287|Tipranavir|tipranavir|mesh-list
101420391|NCT00144287|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101420392|NCT00144287|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101420393|NCT00144287|Protease Inhibitors|protease inhibitors|mesh-ancestor
101420394|NCT00144287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101420395|NCT00144287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420396|NCT00144287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101420397|NCT00144287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101420398|NCT00144287|Antiviral Agents|antiviral agents|mesh-ancestor
101420399|NCT00144287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101420400|NCT00144287|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101420401|NCT00144287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101420402|NCT00144326|Bromides|bromides|mesh-list
101420403|NCT00144326|Tiotropium Bromide|tiotropium bromide|mesh-list
101420404|NCT00144326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101420405|NCT00144326|Autonomic Agents|autonomic agents|mesh-ancestor
101420406|NCT00144326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101420407|NCT00144326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420408|NCT00144326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101420409|NCT00144326|Respiratory System Agents|respiratory system agents|mesh-ancestor
101420410|NCT00144326|Parasympatholytics|parasympatholytics|mesh-ancestor
101420411|NCT00144326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101420412|NCT00144326|Cholinergic Agents|cholinergic agents|mesh-ancestor
101420413|NCT00144326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101306663|NCT02026973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101306664|NCT02026973|Hormone Antagonists|hormone antagonists|mesh-ancestor
101306665|NCT02026973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101459470|NCT04595812|Oxytocin|oxytocin|mesh-list
101306666|NCT02026973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420414|NCT00144326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420416|NCT02954692|Metformin|metformin|mesh-list
101420417|NCT02954692|Insulin Glargine|insulin glargine|mesh-list
101420418|NCT02954692|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
101420419|NCT02954692|Meglitinide|meglitinide|mesh-list
101420420|NCT02954692|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
101420421|NCT02954692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101420422|NCT02954692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420423|NCT02954692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101555638|NCT01208103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101555639|NCT01208103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101555640|NCT01208103|Growth Substances|growth substances|mesh-ancestor
101555641|NCT01208103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555642|NCT01208103|Growth Inhibitors|growth inhibitors|mesh-ancestor
101555643|NCT01208103|Immunologic Factors|immunologic factors|mesh-ancestor
101555644|NCT01208103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101555645|NCT01208103|Antimetabolites|antimetabolites|mesh-ancestor
101555646|NCT01208103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555647|NCT01206777|Rituximab|rituximab|mesh-list
101555648|NCT01206777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101555649|NCT01206777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101555650|NCT01206777|Immunologic Factors|immunologic factors|mesh-ancestor
101555651|NCT01206777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555652|NCT01206777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101555653|NCT01001494|Bromides|bromides|mesh-list
101555654|NCT01001494|Anticonvulsants|anticonvulsants|mesh-ancestor
101555655|NCT01205685|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101555656|NCT01205685|Letrozole|letrozole|mesh-list
101555657|NCT01205685|Goserelin|goserelin|mesh-list
101555658|NCT01205685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101555659|NCT01205685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101404133|NCT01054300|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101420424|NCT02954692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420425|NCT00506935|Vigabatrin|vigabatrin|mesh-list
101420426|NCT00506935|Anticonvulsants|anticonvulsants|mesh-ancestor
101420427|NCT00506935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101420428|NCT00506935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420429|NCT00506935|GABA Agents|gaba agents|mesh-ancestor
101420430|NCT00506935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101420431|NCT00506935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420432|NCT00144365|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101420433|NCT00144365|Antiviral Agents|antiviral agents|mesh-ancestor
101420434|NCT00144365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101420435|NCT00506974|Sodium Oxybate|sodium oxybate|mesh-list
101420436|NCT00506974|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101420437|NCT00506974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101420438|NCT00506974|Anesthetics, General|anesthetics, general|mesh-ancestor
101420439|NCT00506974|Anesthetics|anesthetics|mesh-ancestor
101420440|NCT00506974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101420441|NCT00506974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420442|NCT00156546|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101420443|NCT00156546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101420444|NCT00507052|Acetylcysteine|acetylcysteine|mesh-list
101420445|NCT00507052|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101420446|NCT00507052|Antiviral Agents|antiviral agents|mesh-ancestor
101420447|NCT00507052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101420448|NCT00507052|Expectorants|expectorants|mesh-ancestor
101420449|NCT00507052|Respiratory System Agents|respiratory system agents|mesh-ancestor
101420450|NCT00507052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101420451|NCT00507052|Antioxidants|antioxidants|mesh-ancestor
101420452|NCT00507052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555660|NCT01205685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101555661|NCT01205685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555662|NCT01205685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101555663|NCT01205685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101555664|NCT01205685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101555665|NCT01205685|Hormone Antagonists|hormone antagonists|mesh-ancestor
101555666|NCT01205685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101555667|NCT01205685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555668|NCT01205685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101555670|NCT01205529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101555671|NCT01205529|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101555672|NCT01205529|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101555673|NCT01205529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101555674|NCT01205529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555675|NCT04294966|Dronabinol|dronabinol|mesh-list
101555676|NCT04294966|Hallucinogens|hallucinogens|mesh-ancestor
101420453|NCT00507052|Protective Agents|protective agents|mesh-ancestor
101420454|NCT00507052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420455|NCT00507052|Antidotes|antidotes|mesh-ancestor
101420466|NCT00507091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101420467|NCT00507091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101420468|NCT00507091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101420469|NCT00507091|Antidotes|antidotes|mesh-ancestor
101420470|NCT00507091|Protective Agents|protective agents|mesh-ancestor
101420471|NCT00507091|Vitamin B Complex|vitamin b complex|mesh-ancestor
101420472|NCT00507091|Vitamins|vitamins|mesh-ancestor
101420473|NCT00507091|Micronutrients|micronutrients|mesh-ancestor
101420474|NCT05148910|Copper|copper|mesh-list
101420475|NCT05148910|Trace Elements|trace elements|mesh-ancestor
101420476|NCT05148910|Micronutrients|micronutrients|mesh-ancestor
101420477|NCT05148910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420478|NCT00148083|Risperidone|risperidone|mesh-list
101420479|NCT00148083|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101420480|NCT00148083|Serotonin Agents|serotonin agents|mesh-ancestor
101420481|NCT00148083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101420482|NCT00148083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420483|NCT00148083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420484|NCT00148083|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101420485|NCT00148083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101420486|NCT00148083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101306667|NCT02026973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101306668|NCT02026973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101306669|NCT02026973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101420487|NCT00148083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101420488|NCT00148083|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101420490|NCT05148442|Azacitidine|azacitidine|mesh-list
101420491|NCT05148442|Decitabine|decitabine|mesh-list
101420492|NCT05148442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101420493|NCT05148442|Antimetabolites|antimetabolites|mesh-ancestor
101420494|NCT05148442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420495|NCT05148442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101420496|NCT05148442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101420497|NCT05148403|Glyburide|glyburide|mesh-list
101420498|NCT05148403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101420499|NCT05148403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420500|NCT05148208|Dialysis Solutions|dialysis solutions|mesh-list
101420501|NCT05148208|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101555677|NCT04294966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555678|NCT04294966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101555679|NCT04294966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101555681|NCT04294966|Sensory System Agents|sensory system agents|mesh-ancestor
101555682|NCT04294966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101555683|NCT04294966|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101555684|NCT04294966|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101555685|NCT04294966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101555686|NCT04294966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555687|NCT04294966|Hormones|hormones|mesh-ancestor
101555688|NCT04294966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101555689|NCT01205451|Botulinum Toxins|botulinum toxins|mesh-list
101555690|NCT01205451|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101555691|NCT01205451|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101555692|NCT01205451|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101555693|NCT01205451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101555694|NCT01205451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404173|NCT00095927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420502|NCT05148169|Sulforaphane|sulforaphane|mesh-list
101420503|NCT05148169|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
101420504|NCT05148169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101420505|NCT05148169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101420506|NCT05148169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420507|NCT05148169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101420508|NCT05148169|Serotonin Agents|serotonin agents|mesh-ancestor
101420509|NCT05148169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420510|NCT05148169|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101420511|NCT05148169|Protective Agents|protective agents|mesh-ancestor
101420512|NCT05148169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101420513|NCT00144482|Epoetin Alfa|epoetin alfa|mesh-list
101420514|NCT00144482|Hematinics|hematinics|mesh-ancestor
101420515|NCT05148754|Elsulfavirine|elsulfavirine|mesh-list
101420516|NCT05148754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101420517|NCT05148754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101420518|NCT05148754|Antiviral Agents|antiviral agents|mesh-ancestor
101420519|NCT05148754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101420520|NCT00404729|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
101420521|NCT00404729|Nootropic Agents|nootropic agents|mesh-ancestor
101420522|NCT05146687|Bevacizumab|bevacizumab|mesh-list
101420523|NCT05146687|Ranibizumab|ranibizumab|mesh-list
101420524|NCT05146687|Aflibercept|aflibercept|mesh-list
101420525|NCT05146687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101420526|NCT05146687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101420527|NCT05146687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101420528|NCT05146687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101420529|NCT05146687|Growth Substances|growth substances|mesh-ancestor
101420530|NCT05146687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421367|NCT00470743|Sensory System Agents|sensory system agents|mesh-ancestor
101202999|NCT01414608|Tubulin Modulators|tubulin modulators|mesh-ancestor
101421372|NCT00470743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101421374|NCT00470743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555695|NCT01205451|Cholinergic Agents|cholinergic agents|mesh-ancestor
101555696|NCT01205451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101555697|NCT01205451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555698|NCT01205451|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101555699|NCT01205451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101555700|NCT04294732|Bupivacaine|bupivacaine|mesh-list
101555701|NCT04294732|Anesthetics, Local|anesthetics, local|mesh-ancestor
101555702|NCT04294732|Anesthetics|anesthetics|mesh-ancestor
101555703|NCT04294732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101555704|NCT04294732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555705|NCT04294732|Sensory System Agents|sensory system agents|mesh-ancestor
101555706|NCT04294732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101555707|NCT02887677|Dapagliflozin|dapagliflozin|mesh-list
101555708|NCT02887677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101555709|NCT02887677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555710|NCT02887677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101555711|NCT02887677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555712|NCT01001104|Dulaglutide|dulaglutide|mesh-list
101555713|NCT01001104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101404193|NCT00429832|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101421375|NCT00470743|Gout Suppressants|gout suppressants|mesh-ancestor
101421376|NCT00470743|Tocolytic Agents|tocolytic agents|mesh-ancestor
101421377|NCT00470743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101421378|NCT00470821|Melatonin|melatonin|mesh-list
101421379|NCT00470821|Antioxidants|antioxidants|mesh-ancestor
101421380|NCT00470821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421381|NCT00470821|Protective Agents|protective agents|mesh-ancestor
101421382|NCT00470821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421383|NCT00470821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101421384|NCT00335920|Dexamethasone|dexamethasone|mesh-list
101421385|NCT00335920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101421386|NCT00335920|Antiemetics|antiemetics|mesh-ancestor
101421387|NCT00335920|Autonomic Agents|autonomic agents|mesh-ancestor
101421388|NCT00335920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101421389|NCT00335920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421390|NCT00335920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101421391|NCT00335920|Glucocorticoids|glucocorticoids|mesh-ancestor
101421392|NCT00335920|Hormones|hormones|mesh-ancestor
101421393|NCT00335920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101306670|NCT02026973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306672|NCT02027064|Interferons|interferons|mesh-list
101306673|NCT02027064|Interferon-alpha|interferon-alpha|mesh-list
101421394|NCT00335920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101421395|NCT00335920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101421396|NCT00335998|Cisplatin|cisplatin|mesh-list
101421397|NCT00335998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101421398|NCT00470977|Ranibizumab|ranibizumab|mesh-list
101421399|NCT00470977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101421400|NCT00470977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101421401|NCT00470977|Growth Substances|growth substances|mesh-ancestor
101421402|NCT00470977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421403|NCT00470977|Growth Inhibitors|growth inhibitors|mesh-ancestor
101421404|NCT00470977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101555714|NCT01001104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555715|NCT04204954|Ciprofloxacin|ciprofloxacin|mesh-list
101555716|NCT04204954|Tea Tree Oil|tea tree oil|mesh-list
101555717|NCT04204954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101555718|NCT04204954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101555719|NCT04204954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101555720|NCT04204954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101555721|NCT04204954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101555722|NCT04204954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555723|NCT04204954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101555724|NCT04204954|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101555725|NCT04204954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101421405|NCT05350592|Dobutamine|dobutamine|mesh-list
101421406|NCT05350592|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101421410|NCT05350592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421411|NCT05350592|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101421412|NCT05350592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101421413|NCT05350592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101421414|NCT05350592|Adrenergic Agents|adrenergic agents|mesh-ancestor
101421415|NCT05350592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101421416|NCT05350592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421417|NCT05350592|Protective Agents|protective agents|mesh-ancestor
101421418|NCT00471055|Capsaicin|capsaicin|mesh-list
101421419|NCT00471055|Antipruritics|antipruritics|mesh-ancestor
101421420|NCT00471055|Dermatologic Agents|dermatologic agents|mesh-ancestor
101421421|NCT00471055|Sensory System Agents|sensory system agents|mesh-ancestor
101421422|NCT00471055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101421423|NCT00471055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421424|NCT00471094|Lansoprazole|lansoprazole|mesh-list
101421425|NCT00471094|Dexlansoprazole|dexlansoprazole|mesh-list
101421426|NCT00471094|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101421427|NCT00471094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101421428|NCT00471094|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101421429|NCT00471094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101421430|NCT00471094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421431|NCT00157872|Naproxen|naproxen|mesh-list
101421432|NCT00157872|Rofecoxib|rofecoxib|mesh-list
101421433|NCT00157872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101421434|NCT00157872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101421435|NCT00157872|Analgesics|analgesics|mesh-ancestor
101421436|NCT00157872|Sensory System Agents|sensory system agents|mesh-ancestor
101421437|NCT00157872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101421438|NCT00157872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421439|NCT00157872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101421444|NCT00157872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421445|NCT00157872|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101421447|NCT03271255|Apatinib|apatinib|mesh-list
101421448|NCT03271255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101421449|NCT03271255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101421450|NCT03271255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101421451|NCT03271255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101421452|NCT03271255|Growth Substances|growth substances|mesh-ancestor
101421453|NCT03271255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421454|NCT03271255|Growth Inhibitors|growth inhibitors|mesh-ancestor
101421455|NCT03271255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101421456|NCT03271255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101421457|NCT03271255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421458|NCT00471289|Paclitaxel|paclitaxel|mesh-list
101421459|NCT00471289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101421460|NCT00471289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101421461|NCT00471289|Tubulin Modulators|tubulin modulators|mesh-ancestor
101555726|NCT04204954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101555728|NCT01204671|Immunologic Factors|immunologic factors|mesh-ancestor
101555729|NCT01204671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555730|NCT01202955|Tolcapone|tolcapone|mesh-list
101555731|NCT01202955|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101555732|NCT01202955|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101555733|NCT01202955|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101555734|NCT01202955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101555735|NCT01202955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555736|NCT01202877|Azacitidine|azacitidine|mesh-list
101555737|NCT01202877|Midostaurin|midostaurin|mesh-list
101555738|NCT01202877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101555739|NCT01202877|Antimetabolites|antimetabolites|mesh-ancestor
101555740|NCT01202877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555741|NCT01202877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101555742|NCT01202877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101555743|NCT01202877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101555744|NCT01202409|Panitumumab|panitumumab|mesh-list
101555745|NCT01202409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101555746|NCT01202409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101555747|NCT01202175|Nebivolol|nebivolol|mesh-list
101555748|NCT01202175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101555749|NCT01202175|Vasodilator Agents|vasodilator agents|mesh-ancestor
101555750|NCT01202175|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101555751|NCT01202175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101555752|NCT01202175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101555753|NCT01202175|Adrenergic Agents|adrenergic agents|mesh-ancestor
101555754|NCT01202175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101555755|NCT01202175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555756|NCT01202175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555757|NCT01201785|Aspirin|aspirin|mesh-list
101555758|NCT01201785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101555759|NCT01201785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101555760|NCT01201785|Analgesics|analgesics|mesh-ancestor
101555761|NCT01201785|Sensory System Agents|sensory system agents|mesh-ancestor
101555763|NCT01201785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555764|NCT01201785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101555765|NCT01201785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101555766|NCT01201785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101555767|NCT01201785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101555768|NCT01201785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555769|NCT01201785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101555770|NCT01201785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101555771|NCT01201785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101555772|NCT01201785|Antipyretics|antipyretics|mesh-ancestor
101555773|NCT01200069|Ibuprofen|ibuprofen|mesh-list
101555774|NCT01200069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101404265|NCT00430261|Sunitinib|sunitinib|mesh-list
101421462|NCT00471289|Antimitotic Agents|antimitotic agents|mesh-ancestor
101421463|NCT00471289|Mitosis Modulators|mitosis modulators|mesh-ancestor
101421464|NCT00471289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421465|NCT00336154|Tetracycline|tetracycline|mesh-list
101306674|NCT02027064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101306676|NCT02027064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101421466|NCT00336154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101421467|NCT00336154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101421468|NCT00336154|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101421469|NCT00336154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101421470|NCT00336154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421471|NCT00158028|Risperidone|risperidone|mesh-list
101421472|NCT00158028|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101421473|NCT00158028|Serotonin Agents|serotonin agents|mesh-ancestor
101421474|NCT00158028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101421475|NCT00158028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421476|NCT00158028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421477|NCT00158028|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101421499|NCT00471484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101421501|NCT00471484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101813799|NCT04048889|Anesthetics, Local|anesthetics, local|mesh-ancestor
101421502|NCT00471484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421503|NCT00471484|Antimetabolites|antimetabolites|mesh-ancestor
101421504|NCT00471484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101421505|NCT00471484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101421506|NCT00471484|Immunologic Factors|immunologic factors|mesh-ancestor
101421507|NCT00471484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421508|NCT00471484|Antiviral Agents|antiviral agents|mesh-ancestor
101421509|NCT00471484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101421510|NCT00471523|Metformin|metformin|mesh-list
101421511|NCT00471523|Clomiphene|clomiphene|mesh-list
101421512|NCT00471523|Enclomiphene|enclomiphene|mesh-list
101421513|NCT00471523|Zuclomiphene|zuclomiphene|mesh-list
101421514|NCT00471523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101421515|NCT00471523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421516|NCT00471523|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101421517|NCT00471523|Hormone Antagonists|hormone antagonists|mesh-ancestor
101421518|NCT00471523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101421519|NCT00471523|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101421520|NCT00471523|Fertility Agents|fertility agents|mesh-ancestor
101421521|NCT00471523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101421522|NCT00471523|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101421523|NCT00471523|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101421524|NCT00471562|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
101421525|NCT00471562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101421526|NCT00471562|Vasodilator Agents|vasodilator agents|mesh-ancestor
101421527|NCT00471640|Dexamethasone|dexamethasone|mesh-list
101421528|NCT00471640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101421529|NCT00471640|Antiemetics|antiemetics|mesh-ancestor
101421535|NCT00471640|Hormones|hormones|mesh-ancestor
101555775|NCT01200069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101555777|NCT01200069|Sensory System Agents|sensory system agents|mesh-ancestor
101555778|NCT01200069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101555779|NCT01200069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555780|NCT01200069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101555781|NCT01200069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101555782|NCT01200069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101555783|NCT01200069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101555784|NCT01200069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555785|NCT01199289|Brodalumab|brodalumab|mesh-list
101555786|NCT01199289|Dermatologic Agents|dermatologic agents|mesh-ancestor
101555787|NCT01199055|Paclitaxel|paclitaxel|mesh-list
101555788|NCT01199055|Carboplatin|carboplatin|mesh-list
101555789|NCT01199055|Efatutazone|efatutazone|mesh-list
101555790|NCT01199055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101555791|NCT01199055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101555792|NCT01199055|Tubulin Modulators|tubulin modulators|mesh-ancestor
101487405|NCT00427947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101421558|NCT00471952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421559|NCT00471952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101421560|NCT00471952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101421561|NCT00471952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421562|NCT00471952|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101421563|NCT00471952|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101421564|NCT00471952|Purinergic Agents|purinergic agents|mesh-ancestor
101421565|NCT00471952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101421566|NCT00471952|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101421567|NCT00471952|Serotonin Agents|serotonin agents|mesh-ancestor
101421569|NCT00471991|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101421570|NCT00471991|Estradiol|estradiol|mesh-list
101421571|NCT00471991|Estrogens|estrogens|mesh-ancestor
101421572|NCT00471991|Hormones|hormones|mesh-ancestor
101813800|NCT04048889|Anesthetics|anesthetics|mesh-ancestor
101421573|NCT00471991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101421574|NCT00471991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421575|NCT00471991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101421576|NCT00471991|Contraceptive Agents|contraceptive agents|mesh-ancestor
101421577|NCT00471991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101421578|NCT00471991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101306677|NCT02027064|Immunologic Factors|immunologic factors|mesh-ancestor
101306678|NCT02027064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306679|NCT02027103|Metformin|metformin|mesh-list
101306680|NCT02027103|Pioglitazone|pioglitazone|mesh-list
101421579|NCT00471991|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101421580|NCT00471991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101421581|NCT00471991|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101421582|NCT00471991|Hormone Antagonists|hormone antagonists|mesh-ancestor
101421583|NCT00471991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101421584|NCT00471991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101421601|NCT00336349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101421603|NCT00472225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101421604|NCT00472225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101421605|NCT00472225|Immunologic Factors|immunologic factors|mesh-ancestor
101421606|NCT00472225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421607|NCT00472225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101421608|NCT00336466|Epoetin Alfa|epoetin alfa|mesh-list
101421609|NCT00336466|Hematinics|hematinics|mesh-ancestor
101555794|NCT01199055|Mitosis Modulators|mitosis modulators|mesh-ancestor
101555795|NCT01199055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555796|NCT01198587|Zinc Sulfate|zinc sulfate|mesh-list
101421610|NCT00472381|Insulin|insulin|mesh-list
101421611|NCT00472381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101421612|NCT00472381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421613|NCT00472459|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
101421614|NCT00472459|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101421615|NCT00472459|Dermatologic Agents|dermatologic agents|mesh-ancestor
101421616|NCT00336739|Cinacalcet|cinacalcet|mesh-list
101421617|NCT00336739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101421618|NCT00336739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421619|NCT00336739|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101421620|NCT00336739|Hormone Antagonists|hormone antagonists|mesh-ancestor
101421621|NCT00336739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101421622|NCT00424151|Rituximab|rituximab|mesh-list
101421623|NCT00424151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101421624|NCT00424151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101421625|NCT00424151|Immunologic Factors|immunologic factors|mesh-ancestor
101421626|NCT00424151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421627|NCT00424151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101421628|NCT00472810|Mitomycins|mitomycins|mesh-list
101421629|NCT00472810|Mitomycin|mitomycin|mesh-list
101421630|NCT00472810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101421631|NCT00472810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101421632|NCT00472810|Alkylating Agents|alkylating agents|mesh-ancestor
101421633|NCT00472810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203213|NCT01415895|Autonomic Agents|autonomic agents|mesh-ancestor
101421657|NCT00337090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421659|NCT00337090|Urological Agents|urological agents|mesh-ancestor
101421660|NCT05262452|Folfirinox|folfirinox|mesh-list
101421661|NCT05262452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101421662|NCT00337246|Cyclophosphamide|cyclophosphamide|mesh-list
101421663|NCT00337246|Rituximab|rituximab|mesh-list
101421664|NCT00337246|Fludarabine|fludarabine|mesh-list
101421665|NCT00337246|Fludarabine phosphate|fludarabine phosphate|mesh-list
101421666|NCT00337246|Mitoxantrone|mitoxantrone|mesh-list
101421667|NCT00337246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101421668|NCT00337246|Immunologic Factors|immunologic factors|mesh-ancestor
101421669|NCT00337246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421670|NCT00337246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101421671|NCT00337246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101421672|NCT00337246|Alkylating Agents|alkylating agents|mesh-ancestor
101421673|NCT00337246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421674|NCT00337246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101421675|NCT00337246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101421676|NCT00337246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101421677|NCT00337246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101421678|NCT00337246|Antimetabolites|antimetabolites|mesh-ancestor
101306681|NCT02027103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101306682|NCT02027103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306684|NCT02027220|Cyclophosphamide|cyclophosphamide|mesh-list
101421679|NCT00337246|Analgesics|analgesics|mesh-ancestor
101421680|NCT00337246|Sensory System Agents|sensory system agents|mesh-ancestor
101421681|NCT00337246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101421682|NCT00337246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101421683|NCT00337246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101421684|NCT00337246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101421685|NCT00158301|Fluoxetine|fluoxetine|mesh-list
101421686|NCT00158301|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101421687|NCT00158301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101421688|NCT00158301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101421689|NCT00158301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421690|NCT00158301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101421691|NCT00158301|Serotonin Agents|serotonin agents|mesh-ancestor
101421692|NCT00158301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421693|NCT00158301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101421694|NCT00158301|Antidepressive Agents|antidepressive agents|mesh-ancestor
101421695|NCT00158301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101555797|NCT01198587|Astringents|astringents|mesh-ancestor
101555798|NCT01198587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555799|NCT01198587|Dermatologic Agents|dermatologic agents|mesh-ancestor
101555800|NCT01198509|Vancomycin|vancomycin|mesh-list
101555801|NCT01198509|Doxycycline|doxycycline|mesh-list
101555802|NCT01198509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101555803|NCT01198509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101555804|NCT01198509|Antimalarials|antimalarials|mesh-ancestor
101555805|NCT01198509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101555806|NCT01198509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101421696|NCT00158301|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101421697|NCT00158301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101421698|NCT00158301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101421699|NCT00473005|Capecitabine|capecitabine|mesh-list
101421700|NCT00473005|Everolimus|everolimus|mesh-list
101421711|NCT00149877|Tegaserod|tegaserod|mesh-list
101421712|NCT00149877|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101421713|NCT00149877|Serotonin Agents|serotonin agents|mesh-ancestor
101421714|NCT00149877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101421715|NCT00149877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421716|NCT00149877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421717|NCT00473239|Vitamin D|vitamin d|mesh-list
101421718|NCT00473239|Cholecalciferol|cholecalciferol|mesh-list
101421719|NCT00473239|Vitamins|vitamins|mesh-ancestor
101203283|NCT01416350|Azithromycin|azithromycin|mesh-list
101421723|NCT00473239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101421724|NCT00149916|Mycophenolic Acid|mycophenolic acid|mesh-list
101421725|NCT00149916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101421726|NCT00149916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101421727|NCT00149916|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101421728|NCT00149916|Antitubercular Agents|antitubercular agents|mesh-ancestor
101421729|NCT00149916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101421730|NCT00149916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101421731|NCT00149916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101421732|NCT00149916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421733|NCT00337441|Epoetin Alfa|epoetin alfa|mesh-list
101421734|NCT00337441|Hematinics|hematinics|mesh-ancestor
101421735|NCT05183048|Panitumumab|panitumumab|mesh-list
101421736|NCT05183048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101421737|NCT05183048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101421738|NCT00337519|Alemtuzumab|alemtuzumab|mesh-list
101421739|NCT00337519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101421740|NCT00337519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101421741|NCT00337558|Solifenacin Succinate|solifenacin succinate|mesh-list
101421742|NCT00337558|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101421743|NCT00337558|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101421744|NCT00337558|Cholinergic Agents|cholinergic agents|mesh-ancestor
101421745|NCT00337558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101421746|NCT00337558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421747|NCT00337558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421748|NCT00337558|Urological Agents|urological agents|mesh-ancestor
101421749|NCT00508963|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
101421750|NCT00508963|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101421751|NCT00508963|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101421752|NCT00508963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101421753|NCT00508963|Schistosomicides|schistosomicides|mesh-ancestor
101421754|NCT00508963|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101306685|NCT02027220|Bortezomib|bortezomib|mesh-list
101306686|NCT02027220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101306687|NCT02027220|Immunologic Factors|immunologic factors|mesh-ancestor
101306688|NCT02027220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306689|NCT02027220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101421755|NCT00508963|Anthelmintics|anthelmintics|mesh-ancestor
101421756|NCT02964104|Insulin|insulin|mesh-list
101421757|NCT02964104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101421758|NCT02964104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101421759|NCT02964104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421760|NCT00158457|Tenofovir|tenofovir|mesh-list
101555808|NCT01198275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101555809|NCT01198275|Vasodilator Agents|vasodilator agents|mesh-ancestor
101555810|NCT01198275|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101555811|NCT01198275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101555812|NCT01198275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555813|NCT01198275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101555814|NCT01198275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101555815|NCT01198275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101555816|NCT01198275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101555817|NCT01198275|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101555818|NCT01198275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101555819|NCT01198275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101421761|NCT00158457|Emtricitabine|emtricitabine|mesh-list
101421762|NCT00158457|Efavirenz|efavirenz|mesh-list
101421763|NCT00158457|Antiviral Agents|antiviral agents|mesh-ancestor
101421764|NCT00158457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101421781|NCT00509158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421782|NCT00509158|Antacids|antacids|mesh-ancestor
101421783|NCT00509158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421784|NCT00509158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101421785|NCT00405080|Rifampin|rifampin|mesh-list
101421787|NCT00405080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101421788|NCT00405080|Antitubercular Agents|antitubercular agents|mesh-ancestor
101421789|NCT00405080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101421790|NCT00405080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101421791|NCT00405080|Leprostatic Agents|leprostatic agents|mesh-ancestor
101421792|NCT00405080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101421793|NCT00405080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101421794|NCT00405080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421795|NCT00405080|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101421796|NCT00405080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101421797|NCT00405080|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101421798|NCT00405080|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101421799|NCT00405080|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101421800|NCT00405080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101421801|NCT00405080|Antiemetics|antiemetics|mesh-ancestor
101421802|NCT00405080|Autonomic Agents|autonomic agents|mesh-ancestor
101203347|NCT01416948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101421808|NCT00158496|Interferons|interferons|mesh-list
101421809|NCT00158496|Ribavirin|ribavirin|mesh-list
101421810|NCT00158496|Interferon-alpha|interferon-alpha|mesh-list
101421811|NCT00158496|Interferon alpha-2|interferon alpha-2|mesh-list
101421812|NCT00158496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101421813|NCT00158496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101421814|NCT00158496|Antiviral Agents|antiviral agents|mesh-ancestor
101421815|NCT00158496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101421816|NCT00158496|Antimetabolites|antimetabolites|mesh-ancestor
101421817|NCT00158496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421818|NCT00158496|Immunologic Factors|immunologic factors|mesh-ancestor
101421819|NCT00158496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421820|NCT00337792|Fentanyl|fentanyl|mesh-list
101421832|NCT00337792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101421833|NCT00337792|Anesthetics, General|anesthetics, general|mesh-ancestor
101421834|NCT00337792|Anesthetics|anesthetics|mesh-ancestor
101421835|NCT00337792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101421836|NCT00337792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101421837|NCT00337792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101421838|NCT00337792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101421839|NCT00337792|GABA Modulators|gaba modulators|mesh-ancestor
101555821|NCT01197417|Analgesics|analgesics|mesh-ancestor
101555822|NCT01197417|Sensory System Agents|sensory system agents|mesh-ancestor
101555823|NCT01197417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101555824|NCT01197417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555825|NCT01197417|Anesthetics|anesthetics|mesh-ancestor
101555826|NCT01197417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101555827|NCT01197417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101555828|NCT01197417|Anticonvulsants|anticonvulsants|mesh-ancestor
101555829|NCT01197417|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101404324|NCT00096395|Gemcitabine|gemcitabine|mesh-list
101421840|NCT00337792|GABA Agents|gaba agents|mesh-ancestor
101421841|NCT00337792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101421842|NCT00337792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421843|NCT00337792|Anticonvulsants|anticonvulsants|mesh-ancestor
101421844|NCT00337792|Antiemetics|antiemetics|mesh-ancestor
101421845|NCT00337792|Autonomic Agents|autonomic agents|mesh-ancestor
101421846|NCT00337792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101421847|NCT00509353|Irinotecan|irinotecan|mesh-list
101421848|NCT00509353|Vincristine|vincristine|mesh-list
101421849|NCT00509353|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
101421850|NCT00509353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101306690|NCT02027220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101421851|NCT00509353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101421852|NCT00509353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101459635|NCT04593160|Acetaminophen|acetaminophen|mesh-list
101421853|NCT00509353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421854|NCT00509353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101421855|NCT00509353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101421856|NCT00509353|Tubulin Modulators|tubulin modulators|mesh-ancestor
101421857|NCT00509353|Antimitotic Agents|antimitotic agents|mesh-ancestor
101421858|NCT00509353|Mitosis Modulators|mitosis modulators|mesh-ancestor
101421859|NCT00509353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101421860|NCT00405119|Esomeprazole|esomeprazole|mesh-list
101421861|NCT00405119|Ranitidine|ranitidine|mesh-list
101421862|NCT00405119|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
101421864|NCT00405119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101421865|NCT00405119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101421866|NCT00405119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101421867|NCT00405119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101421868|NCT00405119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421869|NCT00405119|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101421870|NCT00405119|Histamine Antagonists|histamine antagonists|mesh-ancestor
101421871|NCT00405119|Histamine Agents|histamine agents|mesh-ancestor
101421872|NCT00405119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101421873|NCT00405119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421874|NCT04715737|Vasopressins|vasopressins|mesh-list
101421875|NCT04715737|Arginine Vasopressin|arginine vasopressin|mesh-list
101421876|NCT04715737|Oxytocin|oxytocin|mesh-list
101421877|NCT04715737|Oxytocics|oxytocics|mesh-ancestor
101421878|NCT04715737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101421879|NCT04715737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421880|NCT04715737|Hemostatics|hemostatics|mesh-ancestor
101421881|NCT04715737|Coagulants|coagulants|mesh-ancestor
101421882|NCT04715737|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101421883|NCT04715737|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101421884|NCT04715737|Natriuretic Agents|natriuretic agents|mesh-ancestor
101421885|NCT00509431|Sirolimus|sirolimus|mesh-list
101421911|NCT00509470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101421912|NCT00509470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101421914|NCT00405158|Antipyretics|antipyretics|mesh-list
101421915|NCT00405158|Penicillins|penicillins|mesh-list
101421916|NCT00405158|Floxacillin|floxacillin|mesh-list
101421917|NCT00405158|Cefadroxil|cefadroxil|mesh-list
101421918|NCT00405158|Oxytocin|oxytocin|mesh-list
101421919|NCT00405158|Oxytocics|oxytocics|mesh-ancestor
101421920|NCT00405158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101421921|NCT00405158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555830|NCT01197417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101555831|NCT01197417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459660|NCT00253149|Dopamine Agents|dopamine agents|mesh-ancestor
101555832|NCT01197417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101555833|NCT01197417|Tocolytic Agents|tocolytic agents|mesh-ancestor
101555834|NCT01197417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101555835|NCT00977431|Temozolomide|temozolomide|mesh-list
101421922|NCT00405158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101421923|NCT00405158|Analgesics|analgesics|mesh-ancestor
101421924|NCT00405158|Sensory System Agents|sensory system agents|mesh-ancestor
101421925|NCT00405158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101421926|NCT00405158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101421927|NCT00405158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101421928|NCT00150072|Imatinib Mesylate|imatinib mesylate|mesh-list
101421929|NCT00150072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101421930|NCT00150072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101421931|NCT00150072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101421932|NCT00150072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421933|NCT02953366|Mometasone Furoate|mometasone furoate|mesh-list
101421934|NCT02953366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101421935|NCT02953366|Dermatologic Agents|dermatologic agents|mesh-ancestor
101421936|NCT02953366|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101421937|NCT00150111|Rituximab|rituximab|mesh-list
101421938|NCT00150111|Methimazole|methimazole|mesh-list
101421939|NCT00150111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101421940|NCT00150111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101421962|NCT02953210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101421963|NCT02953210|Antiemetics|antiemetics|mesh-ancestor
101421964|NCT02953210|Autonomic Agents|autonomic agents|mesh-ancestor
101421965|NCT02953210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101421966|NCT02953210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421967|NCT02953210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101421968|NCT02953210|Glucocorticoids|glucocorticoids|mesh-ancestor
101306691|NCT02027220|Alkylating Agents|alkylating agents|mesh-ancestor
101306692|NCT02027220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306693|NCT02027220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101306694|NCT02027220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101306695|NCT02027220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101421969|NCT02953210|Hormones|hormones|mesh-ancestor
101421970|NCT02953210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101421971|NCT02953210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101421972|NCT02953210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101421973|NCT02953210|Anesthetics, Local|anesthetics, local|mesh-ancestor
101421974|NCT02953210|Anesthetics|anesthetics|mesh-ancestor
101421975|NCT02953210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101421976|NCT02953210|Sensory System Agents|sensory system agents|mesh-ancestor
101421977|NCT02953210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101421978|NCT02953210|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101421979|NCT02953210|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101421980|NCT02953210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101421981|NCT02953210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421982|NCT02953210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101421983|NCT02953210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101421984|NCT02953210|Anesthetics, General|anesthetics, general|mesh-ancestor
101421985|NCT02953210|Analgesics|analgesics|mesh-ancestor
101421986|NCT02953210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101421987|NCT02953210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101421988|NCT02953210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101421989|NCT02953210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101421990|NCT02953210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101421991|NCT02953210|Narcotics|narcotics|mesh-ancestor
101421992|NCT02953210|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101421993|NCT02953210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101421994|NCT02953210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101421995|NCT02953210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101422012|NCT02953210|Sympatholytics|sympatholytics|mesh-ancestor
101422013|NCT02953210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101422014|NCT02953210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101555836|NCT00977431|Afatinib|afatinib|mesh-list
101358936|NCT00206635|Interferons|interferons|mesh-list
101555837|NCT00977431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101555838|NCT00977431|Alkylating Agents|alkylating agents|mesh-ancestor
101555839|NCT00977431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555840|NCT00977431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101555841|NCT00977431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101555842|NCT00977431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101555843|NCT04290169|Botulinum Toxins|botulinum toxins|mesh-list
101555844|NCT04290169|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101555845|NCT04290169|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
101555846|NCT04290169|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101555847|NCT04290169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101555848|NCT04290169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555849|NCT04290169|Cholinergic Agents|cholinergic agents|mesh-ancestor
101404348|NCT00096512|Sorafenib|sorafenib|mesh-list
101422015|NCT02953210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101422016|NCT02953210|Adrenergic Agents|adrenergic agents|mesh-ancestor
101422017|NCT02953210|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101422018|NCT02953210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101422019|NCT02953210|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101422020|NCT02953210|Histamine Antagonists|histamine antagonists|mesh-ancestor
101422021|NCT02953210|Histamine Agents|histamine agents|mesh-ancestor
101422023|NCT00509743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101422024|NCT00509743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101422025|NCT00509743|Analgesics|analgesics|mesh-ancestor
101422026|NCT00509743|Sensory System Agents|sensory system agents|mesh-ancestor
101422027|NCT00509743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101422028|NCT00509743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422029|NCT00509743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101422030|NCT00509743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101422031|NCT00509743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101422032|NCT00509743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101422033|NCT00509743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422034|NCT00509860|Irinotecan|irinotecan|mesh-list
101422035|NCT00509860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101422036|NCT00509860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101422037|NCT00509860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101422038|NCT00509860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422039|NCT00509860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422040|NCT00509938|Lactoferrin|lactoferrin|mesh-list
101422041|NCT00509938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101422042|NCT00337948|Epoetin Alfa|epoetin alfa|mesh-list
101422043|NCT00337948|Hematinics|hematinics|mesh-ancestor
101306697|NCT02027220|Autonomic Agents|autonomic agents|mesh-ancestor
101306698|NCT02027220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101306699|NCT02027220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101306700|NCT02027220|Glucocorticoids|glucocorticoids|mesh-ancestor
101306701|NCT02027220|Hormones|hormones|mesh-ancestor
101306702|NCT02027220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101306703|NCT02027220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101306704|NCT02027298|Abatacept|abatacept|mesh-list
101306705|NCT02027298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101306706|NCT02027298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306707|NCT02027298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101306708|NCT02027298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101306709|NCT02027298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101306710|NCT02027298|Immunologic Factors|immunologic factors|mesh-ancestor
101306711|NCT02027298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459694|NCT04592380|Clevidipine|clevidipine|mesh-list
101555850|NCT04290169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101555851|NCT04290169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555852|NCT04290169|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101555853|NCT04290169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101555854|NCT02864095|Epinephrine|epinephrine|mesh-list
101555855|NCT02864095|Tranexamic Acid|tranexamic acid|mesh-list
101555856|NCT02864095|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101555857|NCT02864095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101555858|NCT02864095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555859|NCT02864095|Hemostatics|hemostatics|mesh-ancestor
101555860|NCT02864095|Coagulants|coagulants|mesh-ancestor
101555861|NCT02864095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101555862|NCT02864095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101555863|NCT02864095|Adrenergic Agents|adrenergic agents|mesh-ancestor
101555864|NCT02864095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101555865|NCT02864095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555866|NCT02864095|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101306712|NCT02027298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101306713|NCT02027324|Chlorhexidine|chlorhexidine|mesh-list
101306714|NCT02027324|Povidone-Iodine|povidone-iodine|mesh-list
101422044|NCT02958215|Phenylephrine|phenylephrine|mesh-list
101422045|NCT02958215|Oxymetazoline|oxymetazoline|mesh-list
101422046|NCT02958215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101422047|NCT02958215|Mydriatics|mydriatics|mesh-ancestor
101422048|NCT02958215|Autonomic Agents|autonomic agents|mesh-ancestor
101422049|NCT02958215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101422050|NCT02958215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422051|NCT02958215|Sympathomimetics|sympathomimetics|mesh-ancestor
101422052|NCT02958215|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101422053|NCT02958215|Nasal Decongestants|nasal decongestants|mesh-ancestor
101422054|NCT02958215|Respiratory System Agents|respiratory system agents|mesh-ancestor
101422055|NCT02958215|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101422056|NCT02958215|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101422057|NCT02958215|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101422058|NCT02958215|Adrenergic Agents|adrenergic agents|mesh-ancestor
101422059|NCT02958215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101422062|NCT00158574|Pyrimethamine|pyrimethamine|mesh-list
101422063|NCT00158574|Sulfadoxine|sulfadoxine|mesh-list
101422073|NCT00158574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101422074|NCT00158574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101422075|NCT00158574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422076|NCT00158574|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101422077|NCT00158574|Leprostatic Agents|leprostatic agents|mesh-ancestor
101422078|NCT00158574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101422079|NCT00158574|Antimetabolites|antimetabolites|mesh-ancestor
101422080|NCT00338221|Glycine|glycine|mesh-list
101422081|NCT00338221|Glycine Agents|glycine agents|mesh-ancestor
101422082|NCT00338221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101422083|NCT00338221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422084|NCT00338221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422085|NCT00338299|Epoetin Alfa|epoetin alfa|mesh-list
101422086|NCT00338299|Hematinics|hematinics|mesh-ancestor
101422087|NCT00510016|Clonidine|clonidine|mesh-list
101422088|NCT00510016|Analgesics|analgesics|mesh-ancestor
101422089|NCT00510016|Sensory System Agents|sensory system agents|mesh-ancestor
101306715|NCT02027324|Povidone|povidone|mesh-list
101306716|NCT02027324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101306717|NCT02027324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101306718|NCT02027324|Disinfectants|disinfectants|mesh-ancestor
101422090|NCT00510016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101555867|NCT02864095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101555868|NCT02864095|Autonomic Agents|autonomic agents|mesh-ancestor
101555869|NCT02864095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101555870|NCT02864095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101555871|NCT02864095|Respiratory System Agents|respiratory system agents|mesh-ancestor
101555872|NCT02864095|Mydriatics|mydriatics|mesh-ancestor
101555873|NCT02864095|Sympathomimetics|sympathomimetics|mesh-ancestor
101555874|NCT02864095|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101555875|NCT00977197|Pregabalin|pregabalin|mesh-list
101555876|NCT00977197|Analgesics|analgesics|mesh-ancestor
101555877|NCT00977197|Sensory System Agents|sensory system agents|mesh-ancestor
101555878|NCT00977197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101555879|NCT00977197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555880|NCT00977197|Anticonvulsants|anticonvulsants|mesh-ancestor
101555881|NCT00977197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101555882|NCT00977197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101555883|NCT00977197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555884|NCT00977197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101555885|NCT00977197|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101555886|NCT00977197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101555887|NCT00977197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101422091|NCT00510016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422092|NCT00510016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101422093|NCT00510016|Sympatholytics|sympatholytics|mesh-ancestor
101422094|NCT00510016|Autonomic Agents|autonomic agents|mesh-ancestor
101422095|NCT00510016|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101422096|NCT00510016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101422097|NCT00510016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101422098|NCT00510016|Adrenergic Agents|adrenergic agents|mesh-ancestor
101422099|NCT00510016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101422100|NCT00510016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422102|NCT00150228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101422103|NCT00150228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101422104|NCT00150228|Cholinergic Agents|cholinergic agents|mesh-ancestor
101422105|NCT00150228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101422106|NCT00150228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422107|NCT00150228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422108|NCT00338338|Amlodipine|amlodipine|mesh-list
101422109|NCT00338338|Lacidipine|lacidipine|mesh-list
101422110|NCT00338338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101422111|NCT00338338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101422112|NCT00338338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101422113|NCT00338338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422114|NCT00338338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101422115|NCT00338338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422116|NCT00338338|Vasodilator Agents|vasodilator agents|mesh-ancestor
101422117|NCT00338416|Epoetin Alfa|epoetin alfa|mesh-list
101422118|NCT00338416|Hematinics|hematinics|mesh-ancestor
101422119|NCT00338494|Clofarabine|clofarabine|mesh-list
101422120|NCT00338494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101422121|NCT00338494|Antimetabolites|antimetabolites|mesh-ancestor
101422122|NCT00338494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555888|NCT00977197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101555889|NCT04288219|Nifedipine|nifedipine|mesh-list
101555890|NCT04288219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101555891|NCT04288219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101555892|NCT04288219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555893|NCT04288219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101555894|NCT04288219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555895|NCT04288219|Vasodilator Agents|vasodilator agents|mesh-ancestor
101555896|NCT04288219|Tocolytic Agents|tocolytic agents|mesh-ancestor
101555897|NCT04288219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101555898|NCT00974233|Rituximab|rituximab|mesh-list
101555899|NCT00974233|Lenalidomide|lenalidomide|mesh-list
101555900|NCT00974233|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101555901|NCT00974233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101555902|NCT00974233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101555903|NCT00974233|Immunologic Factors|immunologic factors|mesh-ancestor
101555904|NCT00974233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555905|NCT00974233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101404396|NCT00096668|Tubulin Modulators|tubulin modulators|mesh-ancestor
101422123|NCT00338494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422124|NCT02953015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101422125|NCT02953015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101422126|NCT02953015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101422127|NCT02953015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101422128|NCT02953015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422129|NCT02953015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101422130|NCT02953015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101422131|NCT02953015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422143|NCT00158691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422145|NCT00338767|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101422146|NCT00338767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101422147|NCT00338767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101203631|NCT01418534|Natriuretic Agents|natriuretic agents|mesh-ancestor
101422162|NCT00150306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101422163|NCT00150306|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101422164|NCT00150306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101422165|NCT00150306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101422166|NCT00150306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306719|NCT02027324|Plasma Substitutes|plasma substitutes|mesh-ancestor
101459727|NCT04591795|Diclofenac|diclofenac|mesh-list
101306720|NCT02027324|Blood Substitutes|blood substitutes|mesh-ancestor
101422167|NCT00150306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101422169|NCT00150306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422170|NCT00510172|Epoprostenol|epoprostenol|mesh-list
101422171|NCT00510172|Tezosentan|tezosentan|mesh-list
101422172|NCT00510172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101422173|NCT00510172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101422174|NCT00510172|Vasodilator Agents|vasodilator agents|mesh-ancestor
101422175|NCT00420901|Sildenafil Citrate|sildenafil citrate|mesh-list
101422176|NCT00420901|Vasodilator Agents|vasodilator agents|mesh-ancestor
101422177|NCT00420901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101422178|NCT00420901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101422179|NCT00420901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101555906|NCT00974233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101555907|NCT00974233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101555908|NCT00974233|Growth Substances|growth substances|mesh-ancestor
101555909|NCT00974233|Growth Inhibitors|growth inhibitors|mesh-ancestor
101555910|NCT00974233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101555911|NCT00974233|Alkylating Agents|alkylating agents|mesh-ancestor
101555912|NCT00974233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422180|NCT00420901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422181|NCT00420901|Urological Agents|urological agents|mesh-ancestor
101422183|NCT00150384|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
101422184|NCT00150384|Atorvastatin|atorvastatin|mesh-list
101422185|NCT00150384|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101422186|NCT00150384|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101422187|NCT00150384|Antimetabolites|antimetabolites|mesh-ancestor
101422188|NCT00150384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422189|NCT00150384|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101422190|NCT00150384|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101422191|NCT00150384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101422192|NCT00150384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101422193|NCT00150384|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101422195|NCT00150384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101422196|NCT00150384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422197|NCT00150384|Vasodilator Agents|vasodilator agents|mesh-ancestor
101422198|NCT00425191|Gemcitabine|gemcitabine|mesh-list
101422200|NCT00425191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422201|NCT00425191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101422202|NCT00425191|Antimetabolites|antimetabolites|mesh-ancestor
101422203|NCT00425191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422204|NCT00425191|Tubulin Modulators|tubulin modulators|mesh-ancestor
101422213|NCT00339118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101422214|NCT00339118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422215|NCT00339118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101422216|NCT00339118|Immunologic Factors|immunologic factors|mesh-ancestor
101422217|NCT00339118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422218|NCT00339118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101422219|NCT00339118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101422220|NCT00339118|Alkylating Agents|alkylating agents|mesh-ancestor
101422221|NCT00339118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101422222|NCT00339157|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101422223|NCT00339157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101422224|NCT00339196|Azacitidine|azacitidine|mesh-list
101422226|NCT00339196|Valproic Acid|valproic acid|mesh-list
101422227|NCT00339196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101422228|NCT00339196|Antimetabolites|antimetabolites|mesh-ancestor
101422229|NCT00339196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422230|NCT00339196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422231|NCT00339196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101422232|NCT00339196|Keratolytic Agents|keratolytic agents|mesh-ancestor
101422233|NCT00339196|Dermatologic Agents|dermatologic agents|mesh-ancestor
101422234|NCT00339196|Anticonvulsants|anticonvulsants|mesh-ancestor
101422235|NCT00339196|GABA Agents|gaba agents|mesh-ancestor
101422236|NCT00339196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101422237|NCT00339196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422238|NCT00339196|Antimanic Agents|antimanic agents|mesh-ancestor
101306721|NCT02027337|Cyproterone Acetate|cyproterone acetate|mesh-list
101306722|NCT02027337|Drospirenone|drospirenone|mesh-list
101306723|NCT02027337|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101422239|NCT00339196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101422240|NCT00339196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101422241|NCT00339196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101422242|NCT00158730|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101422243|NCT00158730|Antifungal Agents|antifungal agents|mesh-ancestor
101422244|NCT00158730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101422245|NCT00158730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101555914|NCT00972595|Antiemetics|antiemetics|mesh-ancestor
101555915|NCT00972595|Autonomic Agents|autonomic agents|mesh-ancestor
101555916|NCT00972595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101555917|NCT00972595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555918|NCT00972595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101555919|NCT00972595|Antipruritics|antipruritics|mesh-ancestor
101555920|NCT00972595|Dermatologic Agents|dermatologic agents|mesh-ancestor
101555921|NCT00972595|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101555922|NCT00972595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101555923|NCT00972595|Serotonin Agents|serotonin agents|mesh-ancestor
101555924|NCT00972595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101555925|NCT00972595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555926|NCT01196091|Antimalarials|antimalarials|mesh-list
101555927|NCT01196091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101503246|NCT01244009|Niraparib|niraparib|mesh-list
101422246|NCT00158730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101422247|NCT00510211|Olanzapine|olanzapine|mesh-list
101422248|NCT00510211|Antiemetics|antiemetics|mesh-ancestor
101422249|NCT00510211|Autonomic Agents|autonomic agents|mesh-ancestor
101422250|NCT00510211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101422251|NCT00510211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422252|NCT00510211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101422253|NCT00510211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101422254|NCT00510211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101422255|NCT00510211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101422256|NCT00510211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101422257|NCT00510211|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101422258|NCT00510211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101422259|NCT00510211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101422260|NCT00510211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422261|NCT00510211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101422262|NCT00510211|Serotonin Agents|serotonin agents|mesh-ancestor
101422263|NCT00150423|Pregabalin|pregabalin|mesh-list
101422264|NCT00150423|Analgesics|analgesics|mesh-ancestor
101422265|NCT00150423|Sensory System Agents|sensory system agents|mesh-ancestor
101422266|NCT00150423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101422271|NCT00150423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203764|NCT01419353|Estradiol|estradiol|mesh-list
101422274|NCT00150423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101422275|NCT00150423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101422276|NCT00150423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101422277|NCT04988282|Methylprednisolone|methylprednisolone|mesh-list
101422278|NCT04988282|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101422279|NCT04988282|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101422280|NCT04988282|Prednisolone|prednisolone|mesh-list
101422281|NCT04988282|Prednisolone acetate|prednisolone acetate|mesh-list
101422282|NCT04988282|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101422283|NCT04988282|Prednisolone phosphate|prednisolone phosphate|mesh-list
101422284|NCT04988282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101422285|NCT04988282|Antiemetics|antiemetics|mesh-ancestor
101422286|NCT04988282|Autonomic Agents|autonomic agents|mesh-ancestor
101422287|NCT04988282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101422288|NCT04988282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422289|NCT04988282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101422290|NCT04988282|Glucocorticoids|glucocorticoids|mesh-ancestor
101422291|NCT04988282|Hormones|hormones|mesh-ancestor
101422292|NCT04988282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101422293|NCT04988282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101422294|NCT04988282|Protective Agents|protective agents|mesh-ancestor
101555928|NCT01196091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101555929|NCT01196091|Immunosuppressive Agents|immunosuppressive agents|mesh-list
101555930|NCT01196091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101555931|NCT01196091|Analgesics|analgesics|mesh-ancestor
101555932|NCT01196091|Sensory System Agents|sensory system agents|mesh-ancestor
101555933|NCT01196091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101555934|NCT01196091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555935|NCT01196091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101555936|NCT01196091|Immunologic Factors|immunologic factors|mesh-ancestor
101555937|NCT01196091|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101555938|NCT01196091|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101555939|NCT01196091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101555940|NCT00972283|Insulin|insulin|mesh-list
101555941|NCT00972283|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101555942|NCT00972283|Insulin Glargine|insulin glargine|mesh-list
101555943|NCT00972283|Insulin Aspart|insulin aspart|mesh-list
101555944|NCT00972283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101555945|NCT00972283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555946|NCT05366049|Acetaminophen|acetaminophen|mesh-list
101555947|NCT05366049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101555948|NCT05366049|Analgesics|analgesics|mesh-ancestor
101555949|NCT05366049|Sensory System Agents|sensory system agents|mesh-ancestor
101555950|NCT05366049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101555951|NCT05366049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555952|NCT05366049|Antipyretics|antipyretics|mesh-ancestor
101555953|NCT00969709|Milnacipran|milnacipran|mesh-list
101555954|NCT00969709|Levomilnacipran|levomilnacipran|mesh-list
101628312|NCT00720343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101422295|NCT04988282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101422296|NCT04988282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422297|NCT00510250|Sorafenib|sorafenib|mesh-list
101422298|NCT00510250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422299|NCT00510250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101422300|NCT00510250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101422301|NCT00510250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422302|NCT04981067|Ropivacaine|ropivacaine|mesh-list
101422303|NCT04981067|Anesthetics, Local|anesthetics, local|mesh-ancestor
101422304|NCT04981067|Anesthetics|anesthetics|mesh-ancestor
101422305|NCT04981067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101422306|NCT04981067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422307|NCT04981067|Sensory System Agents|sensory system agents|mesh-ancestor
101422308|NCT04981067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101422309|NCT00510367|Cyclophosphamide|cyclophosphamide|mesh-list
101422310|NCT00510367|Doxorubicin|doxorubicin|mesh-list
101422311|NCT00510367|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101422312|NCT00510367|Fluorouracil|fluorouracil|mesh-list
101306724|NCT02027337|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
101306725|NCT02027337|Cyproterone|cyproterone|mesh-list
101333863|NCT00017394|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101555955|NCT00969709|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101555956|NCT00969709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101555957|NCT00969709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101555958|NCT00969709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555959|NCT00969709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101555960|NCT00969709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555961|NCT00969709|Antidepressive Agents|antidepressive agents|mesh-ancestor
101517894|NCT03455764|Trametinib|trametinib|mesh-list
101555962|NCT00969709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101555963|NCT00969709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101555965|NCT00969709|Sensory System Agents|sensory system agents|mesh-ancestor
101555966|NCT00969709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101555967|NCT01193517|Capecitabine|capecitabine|mesh-list
101555968|NCT01193517|Azacitidine|azacitidine|mesh-list
101555969|NCT01193517|Decitabine|decitabine|mesh-list
101555970|NCT01193517|Oxaliplatin|oxaliplatin|mesh-list
101555971|NCT01193517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101555972|NCT01193517|Antimetabolites|antimetabolites|mesh-ancestor
101555973|NCT01193517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422313|NCT00510367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101422314|NCT00510367|Immunologic Factors|immunologic factors|mesh-ancestor
101422315|NCT00510367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422316|NCT00510367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101422317|NCT00510367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101422318|NCT00510367|Alkylating Agents|alkylating agents|mesh-ancestor
101422319|NCT00510367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422320|NCT00510367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422321|NCT00510367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101422322|NCT00510367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101422323|NCT00510367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101422324|NCT00510367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101422325|NCT00510367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101422326|NCT00510367|Antimetabolites|antimetabolites|mesh-ancestor
101422327|NCT00510367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101422328|NCT00158847|Fluticasone|fluticasone|mesh-list
101422329|NCT00158847|Xhance|xhance|mesh-list
101422330|NCT00158847|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101422331|NCT00158847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101422332|NCT00158847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101422333|NCT00158847|Autonomic Agents|autonomic agents|mesh-ancestor
101422334|NCT00158847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101422335|NCT00158847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422336|NCT00158847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101422341|NCT00158847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101422342|NCT00158847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101422343|NCT00158847|Adrenergic Agents|adrenergic agents|mesh-ancestor
101422344|NCT00158847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101422345|NCT00158847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422346|NCT00339586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101422347|NCT00339586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422361|NCT00510406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101422362|NCT00510406|Adrenergic Agents|adrenergic agents|mesh-ancestor
101422363|NCT00510406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101555974|NCT01193517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101555975|NCT01193517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101555976|NCT02863705|Timolol|timolol|mesh-list
101555977|NCT02863705|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101555978|NCT02863705|Bimatoprost|bimatoprost|mesh-list
101555979|NCT02863705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101555980|NCT02863705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101555981|NCT02863705|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101555982|NCT02863705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101555983|NCT02863705|Adrenergic Agents|adrenergic agents|mesh-ancestor
101555984|NCT02863705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101555985|NCT02863705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101555986|NCT02863705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101555987|NCT02863705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101555988|NCT02863705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101555989|NCT02863705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101555990|NCT02863705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101555991|NCT02863705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101555992|NCT01193283|Cyclosporine|cyclosporine|mesh-list
101555993|NCT01193283|Cyclophosphamide|cyclophosphamide|mesh-list
101555994|NCT01193283|Cyclosporins|cyclosporins|mesh-list
101555995|NCT01193283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101555996|NCT01193283|Immunologic Factors|immunologic factors|mesh-ancestor
101555997|NCT01193283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422364|NCT00510406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422365|NCT00510406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422366|NCT00510406|Urological Agents|urological agents|mesh-ancestor
101422367|NCT00510406|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101422368|NCT00510406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101422369|NCT00510406|Cholinergic Agents|cholinergic agents|mesh-ancestor
101422370|NCT00165555|Sodium thiosulfate|sodium thiosulfate|mesh-list
101422371|NCT00165555|Antidotes|antidotes|mesh-ancestor
101422372|NCT00165555|Protective Agents|protective agents|mesh-ancestor
101422373|NCT00165555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422374|NCT00165555|Antioxidants|antioxidants|mesh-ancestor
101422375|NCT00165555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422376|NCT00165555|Antitubercular Agents|antitubercular agents|mesh-ancestor
101422377|NCT00165555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101422378|NCT00165555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101422379|NCT00165555|Chelating Agents|chelating agents|mesh-ancestor
101422380|NCT00165555|Sequestering Agents|sequestering agents|mesh-ancestor
101422381|NCT00150579|Amphetamine|amphetamine|mesh-list
101422382|NCT00150579|Dextroamphetamine|dextroamphetamine|mesh-list
101422383|NCT00150579|Adderall|adderall|mesh-list
101422384|NCT00150579|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101306726|NCT02027337|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
101306727|NCT02027337|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101306728|NCT02027337|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101422385|NCT00150579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422386|NCT00150579|Sympathomimetics|sympathomimetics|mesh-ancestor
101422387|NCT00150579|Autonomic Agents|autonomic agents|mesh-ancestor
101555998|NCT01193283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101555999|NCT01193283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101556000|NCT01193283|Alkylating Agents|alkylating agents|mesh-ancestor
101556001|NCT01193283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556002|NCT01193283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101556003|NCT01193283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101422388|NCT00150579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101422389|NCT00150579|Dopamine Agents|dopamine agents|mesh-ancestor
101422390|NCT00150579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101422391|NCT00150579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422392|NCT00150579|Adrenergic Agents|adrenergic agents|mesh-ancestor
101422393|NCT00150579|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101422394|NCT00150579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101422395|NCT00150579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101422396|NCT00150579|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101422397|NCT00511732|Insulin|insulin|mesh-list
101422398|NCT00511732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101422399|NCT00511732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422400|NCT00510445|Imetelstat|imetelstat|mesh-list
101422401|NCT00510445|Motesanib diphosphate|motesanib diphosphate|mesh-list
101422402|NCT00510445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101422403|NCT00510445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422421|NCT00511771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101422422|NCT00511771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422423|NCT00511771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422424|NCT00165594|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
101422425|NCT00165594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422426|NCT00165594|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101422427|NCT00165594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101422428|NCT00165594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422429|NCT00511849|Paclitaxel|paclitaxel|mesh-list
101422430|NCT00511849|Carboplatin|carboplatin|mesh-list
101422431|NCT00511849|Sunitinib|sunitinib|mesh-list
101422432|NCT00511849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101422433|NCT00511849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422434|NCT00511849|Tubulin Modulators|tubulin modulators|mesh-ancestor
101422435|NCT00511849|Antimitotic Agents|antimitotic agents|mesh-ancestor
101422436|NCT00511849|Mitosis Modulators|mitosis modulators|mesh-ancestor
101422437|NCT00511849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422438|NCT00511849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101422439|NCT00511849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101422440|NCT00511849|Growth Substances|growth substances|mesh-ancestor
101422441|NCT00511849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422442|NCT00511849|Growth Inhibitors|growth inhibitors|mesh-ancestor
101422443|NCT00511849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101422444|NCT00511849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101422445|NCT00510640|Sunitinib|sunitinib|mesh-list
101422446|NCT00510640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422447|NCT00510640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101422448|NCT00510640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101422449|NCT00510640|Growth Substances|growth substances|mesh-ancestor
101422450|NCT00510640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422451|NCT00510640|Growth Inhibitors|growth inhibitors|mesh-ancestor
101422452|NCT00510640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101422453|NCT00510640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101306729|NCT02027337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101306730|NCT02027337|Contraceptive Agents|contraceptive agents|mesh-ancestor
101306731|NCT02027337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101422454|NCT00510640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422455|NCT00150696|Risedronic Acid|risedronic acid|mesh-list
101422456|NCT00150696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101422457|NCT00150696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101422458|NCT00150696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422459|NCT00150696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101556004|NCT01193283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101556005|NCT01193283|Antifungal Agents|antifungal agents|mesh-ancestor
101556006|NCT01193283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101556007|NCT01193283|Dermatologic Agents|dermatologic agents|mesh-ancestor
101556008|NCT01193283|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101556009|NCT02863471|Gemcitabine|gemcitabine|mesh-list
101556010|NCT02863471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101556011|NCT02863471|Antimetabolites|antimetabolites|mesh-ancestor
101556012|NCT02863471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422460|NCT00150696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422461|NCT00150696|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101422463|NCT00165633|Menatetrenone|menatetrenone|mesh-list
101422464|NCT00165633|Hemostatics|hemostatics|mesh-ancestor
101422465|NCT00165633|Coagulants|coagulants|mesh-ancestor
101422508|NCT00511225|Vitamins|vitamins|mesh-ancestor
101422509|NCT00511225|Micronutrients|micronutrients|mesh-ancestor
101422510|NCT00511225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101422511|NCT00150774|Levetiracetam|levetiracetam|mesh-list
101422512|NCT00150774|Anticonvulsants|anticonvulsants|mesh-ancestor
101422513|NCT00150774|Nootropic Agents|nootropic agents|mesh-ancestor
101422514|NCT04864067|Leucovorin|leucovorin|mesh-list
101422515|NCT04864067|Capecitabine|capecitabine|mesh-list
101422516|NCT04864067|Oxaliplatin|oxaliplatin|mesh-list
101422517|NCT04864067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101422518|NCT04864067|Antimetabolites|antimetabolites|mesh-ancestor
101422519|NCT04864067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422520|NCT04864067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422521|NCT04864067|Antidotes|antidotes|mesh-ancestor
101422526|NCT04864067|Micronutrients|micronutrients|mesh-ancestor
101422527|NCT00511303|Imatinib Mesylate|imatinib mesylate|mesh-list
101422528|NCT00511303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422529|NCT00511303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101422530|NCT00511303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101422531|NCT00511303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422532|NCT00165828|Zonisamide|zonisamide|mesh-list
101422533|NCT00165828|Anticonvulsants|anticonvulsants|mesh-ancestor
101306732|NCT02027337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306733|NCT02027337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101306735|NCT02027337|Hormones|hormones|mesh-ancestor
101306736|NCT02027337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101306737|NCT02027337|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101422534|NCT00165828|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101422535|NCT00165828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101422536|NCT00165828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422537|NCT00165828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101422538|NCT00165828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422549|NCT00511576|Tubulin Modulators|tubulin modulators|mesh-ancestor
101422550|NCT00511576|Antimitotic Agents|antimitotic agents|mesh-ancestor
101422551|NCT00511576|Mitosis Modulators|mitosis modulators|mesh-ancestor
101422552|NCT00511576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422553|NCT00511576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101422554|NCT00511576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101422555|NCT00511654|Midazolam|midazolam|mesh-list
101422556|NCT00511654|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101422557|NCT00511654|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101422558|NCT00511654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101422559|NCT00511654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422560|NCT00511654|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101422561|NCT00511654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101422562|NCT00511654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101422563|NCT00511654|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101422564|NCT00511654|Anesthetics, General|anesthetics, general|mesh-ancestor
101422565|NCT00511654|Anesthetics|anesthetics|mesh-ancestor
101422566|NCT00511654|GABA Modulators|gaba modulators|mesh-ancestor
101556013|NCT02863471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101556014|NCT01193127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101556015|NCT01193127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101556017|NCT01193127|Autonomic Agents|autonomic agents|mesh-ancestor
101556018|NCT01193127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101404524|NCT00097019|Growth Inhibitors|growth inhibitors|mesh-ancestor
101422567|NCT00511654|GABA Agents|gaba agents|mesh-ancestor
101422568|NCT00511654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101422569|NCT00511654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422570|NCT00150852|Vancomycin|vancomycin|mesh-list
101422571|NCT00150852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101422572|NCT00150852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101422573|NCT02952235|Sunscreening Agents|sunscreening agents|mesh-list
101422574|NCT02952235|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101422575|NCT02952235|Protective Agents|protective agents|mesh-ancestor
101422576|NCT02952235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422577|NCT02952235|Dermatologic Agents|dermatologic agents|mesh-ancestor
101422578|NCT00165867|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
101422579|NCT00165867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422580|NCT00165867|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101422581|NCT00165867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101422582|NCT00165867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422583|NCT02951806|Fentanyl|fentanyl|mesh-list
101422584|NCT02951806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101422585|NCT02951806|Narcotics|narcotics|mesh-ancestor
101422586|NCT02951806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101422587|NCT02951806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422588|NCT02951806|Analgesics|analgesics|mesh-ancestor
101422589|NCT02951806|Sensory System Agents|sensory system agents|mesh-ancestor
101422590|NCT02951806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101422591|NCT02951806|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101422592|NCT02951806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101422593|NCT02951806|Anesthetics, General|anesthetics, general|mesh-ancestor
101422594|NCT02951806|Anesthetics|anesthetics|mesh-ancestor
101422595|NCT00512980|Prednisone|prednisone|mesh-list
101422600|NCT00512980|Antimetabolites|antimetabolites|mesh-ancestor
101422601|NCT00512980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422602|NCT00512980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101306738|NCT02027337|Hormone Antagonists|hormone antagonists|mesh-ancestor
101306739|NCT02027337|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101306741|NCT02027337|Natriuretic Agents|natriuretic agents|mesh-ancestor
101306742|NCT02027337|Androgen Antagonists|androgen antagonists|mesh-ancestor
101422603|NCT00512980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101422604|NCT00512980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101422632|NCT00150891|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101422633|NCT00150891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422634|NCT00150891|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101422635|NCT00150891|Antitubercular Agents|antitubercular agents|mesh-ancestor
101422636|NCT00150891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101422637|NCT00150891|Antimetabolites|antimetabolites|mesh-ancestor
101422638|NCT00150891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101422639|NCT00513058|Vinorelbine|vinorelbine|mesh-list
101422640|NCT00513058|Lapatinib|lapatinib|mesh-list
101422641|NCT00513058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101422642|NCT00513058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422643|NCT00513058|Tubulin Modulators|tubulin modulators|mesh-ancestor
101422644|NCT00513058|Antimitotic Agents|antimitotic agents|mesh-ancestor
101422645|NCT00513058|Mitosis Modulators|mitosis modulators|mesh-ancestor
101422646|NCT00513058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422647|NCT00513058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101422648|NCT00513058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101422649|NCT02951962|Amlodipine|amlodipine|mesh-list
101422650|NCT02951962|Telmisartan|telmisartan|mesh-list
101422651|NCT02951962|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
101422652|NCT02951962|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101422653|NCT02951962|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101422661|NCT02951962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101422662|NCT02951962|Antimetabolites|antimetabolites|mesh-ancestor
101556019|NCT01193127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556020|NCT01192815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101556021|NCT01192815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101556022|NCT01192815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101556023|NCT01192815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101556024|NCT01192815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556025|NCT01192191|Fluticasone|fluticasone|mesh-list
101556027|NCT01192191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101556028|NCT01192191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101556029|NCT01192191|Autonomic Agents|autonomic agents|mesh-ancestor
101556030|NCT01192191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101556031|NCT01192191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556032|NCT01192191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101556033|NCT01192191|Respiratory System Agents|respiratory system agents|mesh-ancestor
101556034|NCT01192191|Dermatologic Agents|dermatologic agents|mesh-ancestor
101556035|NCT01192191|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101556036|NCT01307267|Rituximab|rituximab|mesh-list
101556037|NCT01307267|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101556038|NCT01307267|Immunoglobulin G|immunoglobulin g|mesh-list
101556039|NCT01307267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101556040|NCT01307267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101556041|NCT01307267|Immunologic Factors|immunologic factors|mesh-ancestor
101556042|NCT01307267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556043|NCT01307267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101556071|NCT01306331|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
101556072|NCT01306331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556073|NCT01306331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101556074|NCT01306331|Contraceptive Agents|contraceptive agents|mesh-ancestor
101556075|NCT01306331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101556076|NCT01306331|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101556077|NCT00624663|Rivastigmine|rivastigmine|mesh-list
101556078|NCT00624663|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101556079|NCT00624663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101556080|NCT00624663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556081|NCT00624663|Cholinergic Agents|cholinergic agents|mesh-ancestor
101556082|NCT00624663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101556083|NCT00624663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556084|NCT00624663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101556085|NCT00624663|Protective Agents|protective agents|mesh-ancestor
101556086|NCT02890823|Cholecalciferol|cholecalciferol|mesh-list
101556087|NCT02890823|Vitamin D|vitamin d|mesh-list
101556088|NCT02890823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101404580|NCT00431392|Atropine|atropine|mesh-list
101422663|NCT02951962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101422664|NCT02951962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101422665|NCT02951962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101422666|NCT02951962|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101422667|NCT02951962|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101422668|NCT00513253|Lapatinib|lapatinib|mesh-list
101422669|NCT00513253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422670|NCT00513253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101422671|NCT00513253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101422672|NCT00513253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422673|NCT00513487|Fluticasone|fluticasone|mesh-list
101422674|NCT00513487|Methacholine Chloride|methacholine chloride|mesh-list
101422675|NCT00513487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101422676|NCT00513487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101422677|NCT00513487|Autonomic Agents|autonomic agents|mesh-ancestor
101422678|NCT00513487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101422679|NCT00513487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422680|NCT00513487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101422681|NCT00513487|Respiratory System Agents|respiratory system agents|mesh-ancestor
101422682|NCT00513487|Dermatologic Agents|dermatologic agents|mesh-ancestor
101422683|NCT00513487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101422684|NCT00513487|Miotics|miotics|mesh-ancestor
101422685|NCT00513487|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101422686|NCT00513487|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
101422687|NCT00513487|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101422688|NCT00513487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101422689|NCT00513487|Cholinergic Agents|cholinergic agents|mesh-ancestor
101422690|NCT00513487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101422691|NCT00513487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422692|NCT00405236|Tiotropium Bromide|tiotropium bromide|mesh-list
101422693|NCT00405236|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101422694|NCT00405236|Autonomic Agents|autonomic agents|mesh-ancestor
101422695|NCT00405236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101422696|NCT00405236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556089|NCT02890823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556090|NCT02890823|Vitamins|vitamins|mesh-ancestor
101556091|NCT02890823|Micronutrients|micronutrients|mesh-ancestor
101556092|NCT02890823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101556093|NCT02887443|Midazolam|midazolam|mesh-list
101556094|NCT02887443|Idebenone|idebenone|mesh-list
101556095|NCT02887443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101556096|NCT02887443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101556097|NCT02887443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101556098|NCT02887443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556099|NCT02887443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101556100|NCT02887443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101556101|NCT02887443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101422698|NCT00405236|Respiratory System Agents|respiratory system agents|mesh-ancestor
101422699|NCT00405236|Parasympatholytics|parasympatholytics|mesh-ancestor
101422700|NCT00405236|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101422701|NCT00405236|Cholinergic Agents|cholinergic agents|mesh-ancestor
101422702|NCT00405236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101306743|NCT02027337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101306744|NCT02027337|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101422703|NCT00405236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422705|NCT00403949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422706|NCT00403949|Dermatologic Agents|dermatologic agents|mesh-ancestor
101422707|NCT00513643|Insulin|insulin|mesh-list
101422708|NCT00513643|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101422709|NCT00513643|Insulin Aspart|insulin aspart|mesh-list
101422710|NCT00513643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101422711|NCT00513643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422712|NCT00151008|Bexarotene|bexarotene|mesh-list
101422713|NCT00151008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422714|NCT00513877|Bortezomib|bortezomib|mesh-list
101422715|NCT00513877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422716|NCT04695613|Magnesium Sulfate|magnesium sulfate|mesh-list
101422717|NCT04695613|Analgesics|analgesics|mesh-ancestor
101422718|NCT04695613|Sensory System Agents|sensory system agents|mesh-ancestor
101422726|NCT04695613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101422727|NCT04695613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422728|NCT04695613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101422730|NCT04695613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101422731|NCT00151047|Docetaxel|docetaxel|mesh-list
101422732|NCT00151047|Capecitabine|capecitabine|mesh-list
101422733|NCT00151047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422734|NCT00151047|Tubulin Modulators|tubulin modulators|mesh-ancestor
101422735|NCT00151047|Antimitotic Agents|antimitotic agents|mesh-ancestor
101422736|NCT00151047|Mitosis Modulators|mitosis modulators|mesh-ancestor
101422737|NCT00151047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422738|NCT00151047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101422739|NCT00151047|Antimetabolites|antimetabolites|mesh-ancestor
101422740|NCT00513955|Prednisolone|prednisolone|mesh-list
101422741|NCT00513955|Cyclophosphamide|cyclophosphamide|mesh-list
101422742|NCT00513955|Doxorubicin|doxorubicin|mesh-list
101422743|NCT00513955|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101422744|NCT00513955|Vincristine|vincristine|mesh-list
101422745|NCT00513955|Bortezomib|bortezomib|mesh-list
101422746|NCT00513955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101422747|NCT00513955|Immunologic Factors|immunologic factors|mesh-ancestor
101422748|NCT00513955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422749|NCT00513955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101422750|NCT00513955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101422751|NCT00513955|Alkylating Agents|alkylating agents|mesh-ancestor
101422752|NCT00513955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422753|NCT00513955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422754|NCT00513955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101422755|NCT00513955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101556102|NCT02887443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101556103|NCT02887443|Anesthetics, General|anesthetics, general|mesh-ancestor
101556104|NCT02887443|Anesthetics|anesthetics|mesh-ancestor
101556105|NCT02887443|GABA Modulators|gaba modulators|mesh-ancestor
101556106|NCT02887443|GABA Agents|gaba agents|mesh-ancestor
101556107|NCT02887443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101556108|NCT02887443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556109|NCT02887443|Antioxidants|antioxidants|mesh-ancestor
101556110|NCT02887443|Protective Agents|protective agents|mesh-ancestor
101556111|NCT05359263|Dapagliflozin|dapagliflozin|mesh-list
101556112|NCT05359263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101556113|NCT05359263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556114|NCT05359263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101556115|NCT05359263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556116|NCT01305941|Trastuzumab|trastuzumab|mesh-list
101404615|NCT00130884|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101422756|NCT00513955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101422757|NCT00513955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101422758|NCT00513955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101422759|NCT00513955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101422760|NCT00513955|Tubulin Modulators|tubulin modulators|mesh-ancestor
101422761|NCT00513955|Antimitotic Agents|antimitotic agents|mesh-ancestor
101422762|NCT00513955|Mitosis Modulators|mitosis modulators|mesh-ancestor
101422763|NCT00513955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101422764|NCT00513955|Glucocorticoids|glucocorticoids|mesh-ancestor
101422765|NCT00513955|Hormones|hormones|mesh-ancestor
101422766|NCT00513955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101422767|NCT00513955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101422768|NCT00513994|Nitroglycerin|nitroglycerin|mesh-list
101422769|NCT00513994|Vasodilator Agents|vasodilator agents|mesh-ancestor
101422770|NCT00514072|Vaccines|vaccines|mesh-list
101422771|NCT00514072|BCG Vaccine|bcg vaccine|mesh-list
101422772|NCT00514072|Immunologic Factors|immunologic factors|mesh-ancestor
101422773|NCT00514072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422774|NCT00514072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101422775|NCT00514111|Interferons|interferons|mesh-list
101422776|NCT00514111|Ribavirin|ribavirin|mesh-list
101422777|NCT00514111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422778|NCT00514111|Antiviral Agents|antiviral agents|mesh-ancestor
101422779|NCT00514111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101422780|NCT00514111|Antimetabolites|antimetabolites|mesh-ancestor
101422781|NCT00514111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422782|NCT00151086|Vinorelbine|vinorelbine|mesh-list
101422783|NCT00151086|Estramustine|estramustine|mesh-list
101306746|NCT02027363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101422784|NCT00151086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101422785|NCT00151086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422786|NCT00151086|Tubulin Modulators|tubulin modulators|mesh-ancestor
101422788|NCT00151086|Mitosis Modulators|mitosis modulators|mesh-ancestor
101422789|NCT00151086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422790|NCT00151086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101422791|NCT00151086|Alkylating Agents|alkylating agents|mesh-ancestor
101422792|NCT00151086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101422793|NCT00514228|Sunitinib|sunitinib|mesh-list
101422794|NCT00514228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422795|NCT00514228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101422796|NCT00514228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101422797|NCT00514228|Growth Substances|growth substances|mesh-ancestor
101422798|NCT00514228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422799|NCT00514228|Growth Inhibitors|growth inhibitors|mesh-ancestor
101556117|NCT01305941|Everolimus|everolimus|mesh-list
101556118|NCT01305941|Vinorelbine|vinorelbine|mesh-list
101556119|NCT01305941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101556120|NCT01305941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101556121|NCT01305941|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101556122|NCT01305941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101493522|NCT03270969|Tenofovir|tenofovir|mesh-list
101556124|NCT01305941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556125|NCT01305941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101556126|NCT01305941|Immunologic Factors|immunologic factors|mesh-ancestor
101556127|NCT01305941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404633|NCT00097214|Cetuximab|cetuximab|mesh-list
101422800|NCT00514228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101422801|NCT00514228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101422802|NCT00514228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422803|NCT00151125|Oprelvekin|oprelvekin|mesh-list
101422804|NCT00151125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422805|NCT00514618|Misoprostol|misoprostol|mesh-list
101422806|NCT00514618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101422807|NCT00514618|Abortifacient Agents|abortifacient agents|mesh-ancestor
101422808|NCT00514618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101422809|NCT00514618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422810|NCT00514618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101422811|NCT00514618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101422812|NCT00514618|Oxytocics|oxytocics|mesh-ancestor
101422813|NCT00514657|Mitogens|mitogens|mesh-list
101422814|NCT00514657|Mitosis Modulators|mitosis modulators|mesh-ancestor
101422815|NCT00514657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422816|NCT00514774|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101422817|NCT00514774|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101422818|NCT00514774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101422819|NCT02951260|Metformin|metformin|mesh-list
101422820|NCT02951260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101422821|NCT02951260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422822|NCT02951299|Pentoxifylline|pentoxifylline|mesh-list
101422823|NCT02951299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101422824|NCT02951299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101422825|NCT02951299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422826|NCT02951299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101422827|NCT02951299|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101422828|NCT02951299|Protective Agents|protective agents|mesh-ancestor
101422829|NCT02951299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422830|NCT02951299|Vasodilator Agents|vasodilator agents|mesh-ancestor
101422831|NCT02951299|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101422832|NCT02951299|Antioxidants|antioxidants|mesh-ancestor
101422833|NCT00514891|Vitamin A|vitamin a|mesh-list
101422834|NCT00514891|Vitamins|vitamins|mesh-ancestor
101422835|NCT00514891|Micronutrients|micronutrients|mesh-ancestor
101422836|NCT00514891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422837|NCT00514969|Imatinib Mesylate|imatinib mesylate|mesh-list
101422838|NCT00514969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422839|NCT00514969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101422840|NCT00514969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101422841|NCT00514969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422842|NCT02950948|Progesterone|progesterone|mesh-list
101422843|NCT02950948|Progestins|progestins|mesh-ancestor
101422844|NCT02950948|Hormones|hormones|mesh-ancestor
101422845|NCT02950948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101422846|NCT02950948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422847|NCT00515320|Fluoxetine|fluoxetine|mesh-list
101422848|NCT00515320|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101422849|NCT00515320|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101422850|NCT00515320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101556128|NCT01305941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101556129|NCT01305941|Tubulin Modulators|tubulin modulators|mesh-ancestor
101556130|NCT01305941|Antimitotic Agents|antimitotic agents|mesh-ancestor
101556131|NCT01305941|Mitosis Modulators|mitosis modulators|mesh-ancestor
101556132|NCT05658549|Acetylcysteine|acetylcysteine|mesh-list
101556133|NCT05658549|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101556134|NCT05658549|Antiviral Agents|antiviral agents|mesh-ancestor
101556135|NCT05658549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101556136|NCT05658549|Expectorants|expectorants|mesh-ancestor
101556137|NCT05658549|Respiratory System Agents|respiratory system agents|mesh-ancestor
101556138|NCT05658549|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101556139|NCT05658549|Antioxidants|antioxidants|mesh-ancestor
101556140|NCT05658549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556141|NCT05658549|Protective Agents|protective agents|mesh-ancestor
101556142|NCT05658549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556143|NCT05658549|Antidotes|antidotes|mesh-ancestor
101556144|NCT02887365|Tegafur|tegafur|mesh-list
101556145|NCT02887365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101556146|NCT02887365|Antimetabolites|antimetabolites|mesh-ancestor
101556147|NCT02887365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422851|NCT00515320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422865|NCT00515359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101422866|NCT00515359|Anesthetics, General|anesthetics, general|mesh-ancestor
101422867|NCT00515359|Anesthetics|anesthetics|mesh-ancestor
101422868|NCT00515554|Rituximab|rituximab|mesh-list
101422869|NCT00515554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101422870|NCT00515554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422871|NCT00515554|Immunologic Factors|immunologic factors|mesh-ancestor
101422872|NCT00515554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422873|NCT00515554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101422874|NCT00151203|Clarithromycin|clarithromycin|mesh-list
101422875|NCT00151203|Dexamethasone|dexamethasone|mesh-list
101422876|NCT00151203|Lenalidomide|lenalidomide|mesh-list
101422877|NCT00151203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101422878|NCT00151203|Antiemetics|antiemetics|mesh-ancestor
101422879|NCT00151203|Autonomic Agents|autonomic agents|mesh-ancestor
101422880|NCT00151203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101422881|NCT00151203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422882|NCT00151203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101422883|NCT00151203|Glucocorticoids|glucocorticoids|mesh-ancestor
101422884|NCT00151203|Hormones|hormones|mesh-ancestor
101459908|NCT00253500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101422885|NCT00151203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101422886|NCT00151203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101422887|NCT00151203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422888|NCT00151203|Immunologic Factors|immunologic factors|mesh-ancestor
101422889|NCT00151203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101422890|NCT00151203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101422891|NCT00151203|Growth Substances|growth substances|mesh-ancestor
101422892|NCT00151203|Growth Inhibitors|growth inhibitors|mesh-ancestor
101422893|NCT00151203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101422894|NCT00151203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101422895|NCT00151203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101422896|NCT00151203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101422897|NCT00151203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422898|NCT00151203|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101556148|NCT02887365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101556149|NCT05658159|Vitamin D|vitamin d|mesh-list
101556150|NCT05658159|Ergocalciferols|ergocalciferols|mesh-list
101556151|NCT05658159|Cholecalciferol|cholecalciferol|mesh-list
101556152|NCT05658159|Vitamins|vitamins|mesh-list
101556153|NCT05658159|Micronutrients|micronutrients|mesh-ancestor
101556154|NCT05658159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556155|NCT05658159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101556156|NCT05658159|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101556157|NCT01305239|Exemestane|exemestane|mesh-list
101404661|NCT04727073|Spironolactone|spironolactone|mesh-list
101404669|NCT00432016|Zidovudine|zidovudine|mesh-list
101422899|NCT00151203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101422900|NCT04620200|Nivolumab|nivolumab|mesh-list
101422901|NCT04620200|Ipilimumab|ipilimumab|mesh-list
101422902|NCT04620200|Immunomodulating Agents|immunomodulating agents|mesh-list
101422903|NCT04620200|Immunologic Factors|immunologic factors|mesh-list
101422904|NCT04620200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101422905|NCT04620200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422906|NCT04620200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101422907|NCT04620200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422908|NCT04620200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422909|NCT00515593|Hormones|hormones|mesh-list
101422912|NCT00515593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422913|NCT00515593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101422914|NCT00515788|Cytarabine|cytarabine|mesh-list
101422915|NCT00515788|Temozolomide|temozolomide|mesh-list
101422916|NCT00515788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101422917|NCT00515788|Antimetabolites|antimetabolites|mesh-ancestor
101422918|NCT00515788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422919|NCT00515788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422920|NCT00515788|Antiviral Agents|antiviral agents|mesh-ancestor
101422921|NCT00515788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101306750|NCT02027454|Moxifloxacin|moxifloxacin|mesh-list
101306751|NCT02027454|Cabotegravir|cabotegravir|mesh-list
101306752|NCT02027454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101422922|NCT00515788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101422923|NCT00515788|Immunologic Factors|immunologic factors|mesh-ancestor
101459930|NCT04588636|Salicylic Acid|salicylic acid|mesh-list
101422924|NCT00515788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422925|NCT00515788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101422926|NCT00515788|Alkylating Agents|alkylating agents|mesh-ancestor
101422927|NCT02950870|Ritonavir|ritonavir|mesh-list
101422928|NCT02950870|Ribavirin|ribavirin|mesh-list
101422938|NCT02950870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101422939|NCT02950870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101422940|NCT02950870|Antimetabolites|antimetabolites|mesh-ancestor
101422941|NCT00515866|Gemcitabine|gemcitabine|mesh-list
101422942|NCT00515866|Olaparib|olaparib|mesh-list
101422943|NCT00515866|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
101422944|NCT00515866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101422945|NCT00515866|Antimetabolites|antimetabolites|mesh-ancestor
101422946|NCT00515866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422947|NCT00515866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422948|NCT00515866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101422949|NCT00515905|Propofol|propofol|mesh-list
101422950|NCT00515905|Sevoflurane|sevoflurane|mesh-list
101422951|NCT00515905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101422952|NCT00515905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101422953|NCT00515905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422954|NCT00515905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101422955|NCT00515905|Anesthetics, General|anesthetics, general|mesh-ancestor
101422956|NCT00515905|Anesthetics|anesthetics|mesh-ancestor
101422957|NCT00515905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101422958|NCT00515905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101422959|NCT00515944|Botulinum Toxins|botulinum toxins|mesh-list
101422960|NCT00515944|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101556158|NCT01305239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101556159|NCT01305239|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101556160|NCT01305239|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101556161|NCT01305239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101556162|NCT01305239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556163|NCT01305239|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101556164|NCT01305239|Hormone Antagonists|hormone antagonists|mesh-ancestor
101556165|NCT01305239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101556166|NCT01305239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556167|NCT04317183|Miconazole|miconazole|mesh-list
101556168|NCT04317183|Antifungal Agents|antifungal agents|mesh-ancestor
101422961|NCT00515944|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101422962|NCT00515944|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101422963|NCT00515944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101422964|NCT00515944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422965|NCT00515944|Cholinergic Agents|cholinergic agents|mesh-ancestor
101422966|NCT00515944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101422967|NCT00515944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422968|NCT00515944|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101422969|NCT00515944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101422970|NCT00151242|Cytarabine|cytarabine|mesh-list
101422971|NCT00151242|Etoposide|etoposide|mesh-list
101422972|NCT00151242|Idarubicin|idarubicin|mesh-list
101422973|NCT00151242|Tretinoin|tretinoin|mesh-list
101422974|NCT00151242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101422975|NCT00151242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422976|NCT00151242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101422977|NCT00151242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101422978|NCT00151242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101422979|NCT00151242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422980|NCT00151242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101422981|NCT00151242|Antimetabolites|antimetabolites|mesh-ancestor
101422982|NCT00151242|Antiviral Agents|antiviral agents|mesh-ancestor
101422983|NCT00151242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101422984|NCT00151242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101422985|NCT00151242|Immunologic Factors|immunologic factors|mesh-ancestor
101422986|NCT00151242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422992|NCT00516100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422993|NCT00516100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101487406|NCT00427947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423005|NCT00166413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101423006|NCT00166413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101423007|NCT00166413|Growth Substances|growth substances|mesh-ancestor
101423008|NCT00166413|Growth Inhibitors|growth inhibitors|mesh-ancestor
101423009|NCT00166413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423010|NCT02950441|Niacinamide|niacinamide|mesh-list
101306753|NCT02027454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101306754|NCT02027454|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101423012|NCT02950441|Nicotinic Acids|nicotinic acids|mesh-list
101423013|NCT02950441|Vitamin B Complex|vitamin b complex|mesh-ancestor
101423014|NCT02950441|Vitamins|vitamins|mesh-ancestor
101423015|NCT02950441|Micronutrients|micronutrients|mesh-ancestor
101423016|NCT02950441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423017|NCT02950441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101423018|NCT02950441|Antimetabolites|antimetabolites|mesh-ancestor
101423019|NCT02950441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423020|NCT02950441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101423021|NCT02950441|Vasodilator Agents|vasodilator agents|mesh-ancestor
101423022|NCT02950246|Chlorhexidine|chlorhexidine|mesh-list
101423023|NCT02950246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101423024|NCT02950246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101423025|NCT02950246|Disinfectants|disinfectants|mesh-ancestor
101423026|NCT02950168|Edoxaban|edoxaban|mesh-list
101423027|NCT02950168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101556169|NCT04317183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101556170|NCT04317183|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101556171|NCT04317183|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101556172|NCT04317183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101556173|NCT04317183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556174|NCT04317183|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101556175|NCT04317183|Hormone Antagonists|hormone antagonists|mesh-ancestor
101556176|NCT04317183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101556177|NCT04317183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556178|NCT04317183|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101556179|NCT04317183|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101556180|NCT01194219|Apremilast|apremilast|mesh-list
101556181|NCT01194219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101556182|NCT01194219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101556183|NCT01194219|Analgesics|analgesics|mesh-ancestor
101556184|NCT01194219|Sensory System Agents|sensory system agents|mesh-ancestor
101556185|NCT01194219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101556186|NCT01194219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556187|NCT01194219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101556188|NCT01194219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101423028|NCT02950168|Antithrombins|antithrombins|mesh-ancestor
101423029|NCT02950168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101423030|NCT02950168|Protease Inhibitors|protease inhibitors|mesh-ancestor
101423031|NCT02950168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101423032|NCT02950168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423033|NCT02950168|Anticoagulants|anticoagulants|mesh-ancestor
101423034|NCT04695223|Arsenic Trioxide|arsenic trioxide|mesh-list
101423035|NCT04695223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423036|NCT00166491|Insulin|insulin|mesh-list
101423037|NCT00166491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101423038|NCT00166491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423039|NCT00508885|Niacinamide|niacinamide|mesh-list
101423041|NCT00508885|Nicotinic Acids|nicotinic acids|mesh-list
101423042|NCT00508885|Vitamin B Complex|vitamin b complex|mesh-ancestor
101423043|NCT00508885|Vitamins|vitamins|mesh-ancestor
101423044|NCT00508885|Micronutrients|micronutrients|mesh-ancestor
101423045|NCT00508885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423046|NCT00508885|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101423047|NCT00508885|Antimetabolites|antimetabolites|mesh-ancestor
101423048|NCT00508885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423049|NCT00508885|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101423050|NCT00508885|Vasodilator Agents|vasodilator agents|mesh-ancestor
101423051|NCT02953405|Clopidogrel|clopidogrel|mesh-list
101423052|NCT02953405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101423053|NCT02953405|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101423054|NCT02953405|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101423055|NCT02953405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101423056|NCT02953405|Purinergic Agents|purinergic agents|mesh-ancestor
101423057|NCT02953405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101423058|NCT02953405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556189|NCT01194219|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101556190|NCT01194219|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101556191|NCT01194219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101556192|NCT01194219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556194|NCT01304693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101423063|NCT00516802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101423064|NCT00516802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423065|NCT00516802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423066|NCT00516802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101423067|NCT00516802|Alkylating Agents|alkylating agents|mesh-ancestor
101423068|NCT05861466|Ranibizumab|ranibizumab|mesh-list
101423069|NCT05861466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101460001|NCT04587505|Morphine|morphine|mesh-list
101423070|NCT05861466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101423071|NCT05861466|Growth Substances|growth substances|mesh-ancestor
101423076|NCT05861336|Gemcitabine|gemcitabine|mesh-list
101423077|NCT05861336|Losartan|losartan|mesh-list
101423078|NCT05861336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101423079|NCT05861336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423080|NCT05861336|Tubulin Modulators|tubulin modulators|mesh-ancestor
101423081|NCT05861336|Antimitotic Agents|antimitotic agents|mesh-ancestor
101423082|NCT05861336|Mitosis Modulators|mitosis modulators|mesh-ancestor
101423083|NCT05861336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423084|NCT05861336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101306756|NCT02027454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101333864|NCT00017394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423085|NCT05861336|Antimetabolites|antimetabolites|mesh-ancestor
101423086|NCT05861336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101423087|NCT05861336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101423088|NCT05861336|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101423089|NCT05861336|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101423090|NCT05861310|Metronidazole|metronidazole|mesh-list
101423091|NCT05861310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101423092|NCT05861310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101423093|NCT05861310|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101423094|NCT05861310|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101423095|NCT05861297|Dexamethasone|dexamethasone|mesh-list
101423096|NCT05861297|Prednisolone|prednisolone|mesh-list
101423097|NCT05861297|Rituximab|rituximab|mesh-list
101423098|NCT05861297|Azathioprine|azathioprine|mesh-list
101423099|NCT05861297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101423100|NCT05861297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423101|NCT05861297|Immunologic Factors|immunologic factors|mesh-ancestor
101423102|NCT05861297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423103|NCT05861297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101423104|NCT05861297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101423105|NCT05861297|Antiemetics|antiemetics|mesh-ancestor
101423106|NCT05861297|Autonomic Agents|autonomic agents|mesh-ancestor
101423107|NCT05861297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101423108|NCT05861297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101423109|NCT05861297|Glucocorticoids|glucocorticoids|mesh-ancestor
101423110|NCT05861297|Hormones|hormones|mesh-ancestor
101423111|NCT05861297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101423112|NCT05861297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101423113|NCT05861297|Antimetabolites|antimetabolites|mesh-ancestor
101423114|NCT05861297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423115|NCT05861297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101423116|NCT05861297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101423117|NCT05861271|Capecitabine|capecitabine|mesh-list
101423118|NCT05861271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101423119|NCT05861271|Antimetabolites|antimetabolites|mesh-ancestor
101423120|NCT05861271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423121|NCT05861271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423122|NCT05861206|Listerine|listerine|mesh-list
101423123|NCT05861206|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101423124|NCT05861206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101423125|NCT05861154|Benzocaine|benzocaine|mesh-list
101423126|NCT05861154|Anesthetics, Local|anesthetics, local|mesh-ancestor
101423127|NCT05861154|Anesthetics|anesthetics|mesh-ancestor
101556195|NCT01304693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101556196|NCT01304693|Growth Substances|growth substances|mesh-ancestor
101556197|NCT01304693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556198|NCT01304693|Growth Inhibitors|growth inhibitors|mesh-ancestor
101556199|NCT01304693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101556200|NCT01304147|Ketamine|ketamine|mesh-list
101556201|NCT01304147|Analgesics|analgesics|mesh-ancestor
101556202|NCT01304147|Sensory System Agents|sensory system agents|mesh-ancestor
101423128|NCT05861154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101359004|NCT00040157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101423129|NCT05861154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423130|NCT05861154|Sensory System Agents|sensory system agents|mesh-ancestor
101423139|NCT05861063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101423140|NCT05861063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101423141|NCT05861063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101423142|NCT05861063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101423143|NCT05861063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101423144|NCT05861063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423146|NCT05861063|Narcotics|narcotics|mesh-ancestor
101423147|NCT05861063|Analgesics|analgesics|mesh-ancestor
101423148|NCT05860699|Ethanol|ethanol|mesh-list
101423149|NCT05860699|Cannabidiol|cannabidiol|mesh-list
101423150|NCT05860699|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101423163|NCT05860244|Albuterol|albuterol|mesh-list
101306757|NCT02027454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306758|NCT02027454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101306759|NCT02027454|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101423164|NCT05860244|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101423165|NCT05860244|Autonomic Agents|autonomic agents|mesh-ancestor
101423166|NCT05860244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101423167|NCT05860244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423168|NCT05860244|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101423169|NCT05860244|Respiratory System Agents|respiratory system agents|mesh-ancestor
101423170|NCT05860244|Tocolytic Agents|tocolytic agents|mesh-ancestor
101423171|NCT05860244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101423172|NCT05860244|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101423173|NCT05860244|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101423174|NCT05860244|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101423175|NCT05860244|Adrenergic Agents|adrenergic agents|mesh-ancestor
101423176|NCT05860244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101423177|NCT05860244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423178|NCT05860153|Diazepam|diazepam|mesh-list
101423179|NCT05860153|Levetiracetam|levetiracetam|mesh-list
101423180|NCT05860153|Anticonvulsants|anticonvulsants|mesh-ancestor
101423181|NCT05860153|Nootropic Agents|nootropic agents|mesh-ancestor
101423182|NCT05860153|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101423183|NCT05860153|Antiemetics|antiemetics|mesh-ancestor
101423184|NCT05860153|Autonomic Agents|autonomic agents|mesh-ancestor
101423185|NCT05860153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101423186|NCT05860153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423187|NCT05860153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101423188|NCT05860153|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101423189|NCT05860153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101423190|NCT05860153|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101423191|NCT05860153|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101423192|NCT05860153|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101423193|NCT05860153|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101423194|NCT05860153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101423195|NCT05860153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101423196|NCT05860153|Anesthetics, General|anesthetics, general|mesh-ancestor
101423202|NCT05860114|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
101423203|NCT05860114|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101423204|NCT05860114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101423205|NCT05860114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423206|NCT05860062|Vitamin D|vitamin d|mesh-list
101423207|NCT05860062|Calcium|calcium|mesh-list
101423208|NCT05860062|Vitamins|vitamins|mesh-ancestor
101423209|NCT05860062|Micronutrients|micronutrients|mesh-ancestor
101556203|NCT01304147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101556204|NCT01304147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556205|NCT01304147|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101556206|NCT01304147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101556207|NCT01304147|Anesthetics, General|anesthetics, general|mesh-ancestor
101556208|NCT01304147|Anesthetics|anesthetics|mesh-ancestor
101556209|NCT01304147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101556210|NCT01304147|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101556211|NCT01304147|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101556212|NCT01304147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101556213|NCT01304147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556214|NCT05661227|Dexmedetomidine|dexmedetomidine|mesh-list
101404714|NCT00432055|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101423210|NCT05860062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423211|NCT05860062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101423212|NCT05860062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101423213|NCT05860010|Epinephrine|epinephrine|mesh-list
101423214|NCT05860010|Dexmedetomidine|dexmedetomidine|mesh-list
101423215|NCT05860010|Bupivacaine|bupivacaine|mesh-list
101423220|NCT05860010|Sensory System Agents|sensory system agents|mesh-ancestor
101423221|NCT05860010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101423222|NCT05860010|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101423223|NCT05860010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101423224|NCT05860010|Analgesics|analgesics|mesh-ancestor
101423225|NCT05860010|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101423226|NCT05860010|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101423227|NCT05860010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101423228|NCT05860010|Adrenergic Agents|adrenergic agents|mesh-ancestor
101423229|NCT05860010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101423230|NCT05860010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423231|NCT05860010|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101423232|NCT05860010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101423233|NCT05860010|Autonomic Agents|autonomic agents|mesh-ancestor
101423234|NCT05860010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101423235|NCT05860010|Respiratory System Agents|respiratory system agents|mesh-ancestor
101423236|NCT05860010|Mydriatics|mydriatics|mesh-ancestor
101423237|NCT05860010|Sympathomimetics|sympathomimetics|mesh-ancestor
101306760|NCT02027454|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101306761|NCT02027454|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101306762|NCT02027454|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101423238|NCT05860010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101423239|NCT05859984|Interferons|interferons|mesh-list
101423240|NCT05859984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423241|NCT05859984|Antiviral Agents|antiviral agents|mesh-ancestor
101423242|NCT05859984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101423243|NCT05859802|4-Aminopyridine|4-aminopyridine|mesh-list
101423244|NCT05859802|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101423245|NCT05859802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101423246|NCT05859802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423247|NCT05859750|Paclitaxel|paclitaxel|mesh-list
101423248|NCT05859750|Gemcitabine|gemcitabine|mesh-list
101423249|NCT05859750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101423250|NCT05859750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423251|NCT05859750|Tubulin Modulators|tubulin modulators|mesh-ancestor
101423252|NCT05859750|Antimitotic Agents|antimitotic agents|mesh-ancestor
101423253|NCT05859750|Mitosis Modulators|mitosis modulators|mesh-ancestor
101423254|NCT05859750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423255|NCT05859750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101423256|NCT05859750|Antimetabolites|antimetabolites|mesh-ancestor
101423257|NCT05859477|Capecitabine|capecitabine|mesh-list
101423258|NCT05859477|Oxaliplatin|oxaliplatin|mesh-list
101556217|NCT05661227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556218|NCT05661227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101556219|NCT05661227|Analgesics|analgesics|mesh-ancestor
101556220|NCT05661227|Sensory System Agents|sensory system agents|mesh-ancestor
101556221|NCT05661227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101556222|NCT05661227|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101556223|NCT05661227|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101556224|NCT05661227|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101404726|NCT04711044|Dermatologic Agents|dermatologic agents|mesh-ancestor
101404727|NCT04711044|Histamine Agonists|histamine agonists|mesh-ancestor
101404728|NCT04711044|Histamine Agents|histamine agents|mesh-ancestor
101404729|NCT04711044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101404730|NCT04711044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404731|NCT04711044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404732|NCT01051960|Ambrisentan|ambrisentan|mesh-list
101423259|NCT05859477|Nivolumab|nivolumab|mesh-list
101423260|NCT05859477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101423261|NCT05859477|Antimetabolites|antimetabolites|mesh-ancestor
101423262|NCT05859477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423263|NCT05859477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423264|NCT05859477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101423265|NCT05859477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101423266|NCT05859412|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101423267|NCT05859412|Methylprednisolone|methylprednisolone|mesh-list
101423273|NCT05859412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101423274|NCT05859412|Antiemetics|antiemetics|mesh-ancestor
101423275|NCT05859412|Autonomic Agents|autonomic agents|mesh-ancestor
101423276|NCT05859412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101423277|NCT05859412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423278|NCT05859412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101423279|NCT05859412|Glucocorticoids|glucocorticoids|mesh-ancestor
101423280|NCT05859412|Hormones|hormones|mesh-ancestor
101423281|NCT05859412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101423282|NCT05859412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101423283|NCT05859412|Protective Agents|protective agents|mesh-ancestor
101423284|NCT05859412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101423285|NCT05859412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423286|NCT05858918|Clopidogrel|clopidogrel|mesh-list
101423287|NCT05858918|Ticagrelor|ticagrelor|mesh-list
101423288|NCT05858918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101423294|NCT05858918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423295|NCT05858918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423296|NCT05856877|Insulin|insulin|mesh-list
101423297|NCT05856877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101423298|NCT05856877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423299|NCT05856864|Ramucirumab|ramucirumab|mesh-list
101423300|NCT05856864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423304|NCT05851924|Capecitabine|capecitabine|mesh-list
101423305|NCT05851924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101423306|NCT05851924|Antimetabolites|antimetabolites|mesh-ancestor
101556225|NCT05661227|Adrenergic Agents|adrenergic agents|mesh-ancestor
101556226|NCT05661227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101556227|NCT05661227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556228|NCT01303445|Omeprazole|omeprazole|mesh-list
101556229|NCT01303445|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
101556230|NCT01303445|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101556231|NCT01303445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101556232|NCT01303445|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101556233|NCT01303445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101556234|NCT01303445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556235|NCT01303445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101556236|NCT01188681|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101556237|NCT01188681|Immunoglobulin G|immunoglobulin g|mesh-list
101556238|NCT01188681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101556239|NCT01188681|Alkylating Agents|alkylating agents|mesh-ancestor
101556240|NCT01188681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556241|NCT01188681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101556242|NCT01188681|Immunologic Factors|immunologic factors|mesh-ancestor
101404738|NCT00432367|Amodiaquine|amodiaquine|mesh-list
101423307|NCT05851924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423308|NCT05851924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423309|NCT05829187|Piperaquine|piperaquine|mesh-list
101423310|NCT05829187|Primaquine|primaquine|mesh-list
101423311|NCT05829187|Artenimol|artenimol|mesh-list
101423312|NCT05829187|Antimalarials|antimalarials|mesh-ancestor
101306763|NCT02027454|Antiviral Agents|antiviral agents|mesh-ancestor
101306764|NCT02027493|Interferons|interferons|mesh-list
101306765|NCT02027493|Ribavirin|ribavirin|mesh-list
101306766|NCT02027493|Interferon-alpha|interferon-alpha|mesh-list
101423313|NCT05829187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101423314|NCT05829187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101423315|NCT05829187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101423334|NCT05779644|Metformin|metformin|mesh-list
101423335|NCT05779644|Liraglutide|liraglutide|mesh-list
101423336|NCT05779644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101423337|NCT05779644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423338|NCT05779644|Incretins|incretins|mesh-ancestor
101423339|NCT05779644|Hormones|hormones|mesh-ancestor
101423342|NCT05749211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101423344|NCT05749211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423345|NCT05749211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423346|NCT05748093|Cobicistat|cobicistat|mesh-list
101423347|NCT05748093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101423348|NCT05748093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101423349|NCT05748093|Antiviral Agents|antiviral agents|mesh-ancestor
101423350|NCT05748093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101423351|NCT05748093|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101423352|NCT05748093|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101423353|NCT05748093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101423354|NCT05748093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423355|NCT05731596|Ubiquinone|ubiquinone|mesh-list
101423356|NCT05731596|Coenzyme Q10|coenzyme q10|mesh-list
101423357|NCT05731596|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101423358|NCT05731596|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101423359|NCT05731596|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101423360|NCT05731596|Antimetabolites|antimetabolites|mesh-ancestor
101556243|NCT01188681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556244|NCT01302899|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101556245|NCT01302899|Ramipril|ramipril|mesh-list
101556246|NCT01302899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101556247|NCT01302899|Diuretics|diuretics|mesh-ancestor
101556248|NCT01302899|Natriuretic Agents|natriuretic agents|mesh-ancestor
101556249|NCT01302899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556250|NCT01302899|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101556251|NCT01302899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101556252|NCT01302899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556253|NCT01302899|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101556254|NCT01302899|Protease Inhibitors|protease inhibitors|mesh-ancestor
101556255|NCT01302899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101556256|NCT01187901|Sulindac|sulindac|mesh-list
101556257|NCT01187901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101404764|NCT00432406|Analgesics|analgesics|mesh-ancestor
101423361|NCT05731596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423362|NCT05731596|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101423363|NCT05731596|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101423365|NCT05731596|Micronutrients|micronutrients|mesh-ancestor
101423366|NCT05731596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423367|NCT05731596|Vitamins|vitamins|mesh-ancestor
101423368|NCT05722782|Acetaminophen|acetaminophen|mesh-list
101423369|NCT05722782|Piroxicam|piroxicam|mesh-list
101423370|NCT05722782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101423371|NCT05722782|Analgesics|analgesics|mesh-ancestor
101423372|NCT05722782|Sensory System Agents|sensory system agents|mesh-ancestor
101423373|NCT05722782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101423374|NCT05722782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423375|NCT05722782|Antipyretics|antipyretics|mesh-ancestor
101423376|NCT05722782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101423377|NCT05722782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101423380|NCT05722782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101423381|NCT05722782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423382|NCT05710328|Deoxyglucose|deoxyglucose|mesh-list
101423383|NCT05710328|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101423384|NCT05710328|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101423385|NCT05710328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306767|NCT02027493|Interferon alpha-2|interferon alpha-2|mesh-list
101306768|NCT02027493|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101423386|NCT05710328|Antimetabolites|antimetabolites|mesh-ancestor
101423387|NCT05710328|Antiviral Agents|antiviral agents|mesh-ancestor
101423388|NCT05710328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101423390|NCT05709990|Cholecalciferol|cholecalciferol|mesh-list
101423391|NCT05709990|Solifenacin Succinate|solifenacin succinate|mesh-list
101423392|NCT05709990|Vitamins|vitamins|mesh-ancestor
101423393|NCT05709990|Micronutrients|micronutrients|mesh-ancestor
101423394|NCT05709990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423395|NCT05709990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101423396|NCT05709990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101423397|NCT05709990|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101423398|NCT05709990|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101423399|NCT05709990|Cholinergic Agents|cholinergic agents|mesh-ancestor
101423400|NCT05709990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101423401|NCT05709990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423402|NCT05709990|Urological Agents|urological agents|mesh-ancestor
101423403|NCT05684744|Methotrexate|methotrexate|mesh-list
101556258|NCT01187901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101556259|NCT01187901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101556261|NCT01187901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556262|NCT01187901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101556263|NCT01187901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101556264|NCT01187901|Analgesics|analgesics|mesh-ancestor
101556265|NCT01187901|Sensory System Agents|sensory system agents|mesh-ancestor
101556266|NCT01187901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101556267|NCT01187901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556268|NCT01187901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101556269|NCT01187901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101556270|NCT01187901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101556271|NCT01302119|Tavaborole|tavaborole|mesh-list
101556272|NCT01302119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101556273|NCT01302119|Antifungal Agents|antifungal agents|mesh-ancestor
101460107|NCT04585438|Diclofenac|diclofenac|mesh-list
101556274|NCT01302119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101556275|NCT05927922|Ibuprofen|ibuprofen|mesh-list
101556276|NCT05927922|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101556277|NCT05927922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101556278|NCT05927922|Analgesics|analgesics|mesh-ancestor
101556279|NCT05927922|Sensory System Agents|sensory system agents|mesh-ancestor
101556280|NCT05927922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101556281|NCT05927922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556282|NCT05927922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101556283|NCT05927922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101423404|NCT05684744|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101423405|NCT05684744|Abortifacient Agents|abortifacient agents|mesh-ancestor
101423406|NCT05684744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101423407|NCT05684744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423408|NCT05684744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101423409|NCT05684744|Antimetabolites|antimetabolites|mesh-ancestor
101423410|NCT05684744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423416|NCT05684744|Immunologic Factors|immunologic factors|mesh-ancestor
101423417|NCT05684744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101423418|NCT05684744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101423420|NCT05678114|Vitamin B Complex|vitamin b complex|mesh-ancestor
101423421|NCT05678114|Vitamins|vitamins|mesh-ancestor
101423422|NCT05678114|Micronutrients|micronutrients|mesh-ancestor
101423423|NCT05678114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423424|NCT05675787|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101423425|NCT05675787|Atorvastatin|atorvastatin|mesh-list
101423426|NCT05675787|Medroxyprogesterone|medroxyprogesterone|mesh-list
101423427|NCT05675787|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101423428|NCT05675787|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101423429|NCT05675787|Antimetabolites|antimetabolites|mesh-ancestor
101423430|NCT05675787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423431|NCT05675787|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101556284|NCT05927922|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101556285|NCT05927922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101556286|NCT05927922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556287|NCT05927857|Trifluridine|trifluridine|mesh-list
101556288|NCT05927857|Ramucirumab|ramucirumab|mesh-list
101556289|NCT05927857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101556290|NCT05927857|Antimetabolites|antimetabolites|mesh-ancestor
101556291|NCT05927857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556292|NCT05927857|Antiviral Agents|antiviral agents|mesh-ancestor
101556293|NCT05927857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101556294|NCT05927831|Grape Seed Extract|grape seed extract|mesh-list
101556295|NCT05927831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101556296|NCT05927831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101556297|NCT05927831|Antioxidants|antioxidants|mesh-ancestor
101556298|NCT05927831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556299|NCT05927831|Protective Agents|protective agents|mesh-ancestor
101556300|NCT05927831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556301|NCT05927818|Charcoal|charcoal|mesh-list
101556302|NCT05927818|Antidotes|antidotes|mesh-ancestor
101556303|NCT05927818|Protective Agents|protective agents|mesh-ancestor
101556304|NCT05927818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556305|NCT05927428|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101556306|NCT05927428|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101556307|NCT05927259|Acetylcysteine|acetylcysteine|mesh-list
101556308|NCT05927259|Atropine|atropine|mesh-list
101556309|NCT05927259|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101556310|NCT05927259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101556311|NCT05927259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101556312|NCT05927259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101556313|NCT05927259|Autonomic Agents|autonomic agents|mesh-ancestor
101556314|NCT05927259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101556315|NCT05927259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556316|NCT05927259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101556317|NCT05927259|Respiratory System Agents|respiratory system agents|mesh-ancestor
101556318|NCT05927259|Mydriatics|mydriatics|mesh-ancestor
101556324|NCT05927259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556325|NCT05927259|Antiviral Agents|antiviral agents|mesh-ancestor
101556326|NCT05927259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101556327|NCT05927259|Expectorants|expectorants|mesh-ancestor
101556328|NCT05927259|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101556329|NCT05927259|Antioxidants|antioxidants|mesh-ancestor
101556330|NCT05927259|Protective Agents|protective agents|mesh-ancestor
101556331|NCT05927259|Antidotes|antidotes|mesh-ancestor
101556332|NCT05927155|Tiotropium Bromide|tiotropium bromide|mesh-list
101556333|NCT05927155|Olodaterol|olodaterol|mesh-list
101556334|NCT05927155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101556335|NCT05927155|Autonomic Agents|autonomic agents|mesh-ancestor
101556336|NCT05927155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101556337|NCT05927155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556338|NCT05927155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101556339|NCT05927155|Respiratory System Agents|respiratory system agents|mesh-ancestor
101556341|NCT05927155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101556342|NCT05927155|Cholinergic Agents|cholinergic agents|mesh-ancestor
101556343|NCT05927155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101556344|NCT05927155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556345|NCT05927142|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
101556346|NCT05927142|Durvalumab|durvalumab|mesh-list
101556347|NCT05927142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101556348|NCT05927142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101556349|NCT05927142|Antiviral Agents|antiviral agents|mesh-ancestor
101556350|NCT05927142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101556351|NCT05927129|Antidepressive Agents|antidepressive agents|mesh-list
101556352|NCT05927129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101556354|NCT05926895|Betamethasone Valerate|betamethasone valerate|mesh-list
101404845|NCT00433069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101423432|NCT05675787|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101423433|NCT05675787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101423434|NCT05675787|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101423435|NCT05675787|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101423436|NCT05675787|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101423437|NCT05675787|Contraceptive Agents|contraceptive agents|mesh-ancestor
101423438|NCT05675787|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101423439|NCT05675787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423440|NCT05675787|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101423441|NCT05675787|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101423442|NCT05675787|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101423443|NCT05675787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101423444|NCT05675787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423445|NCT05662527|Pembrolizumab|pembrolizumab|mesh-list
101423446|NCT05662527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101556355|NCT05926895|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101556356|NCT05926895|Betamethasone benzoate|betamethasone benzoate|mesh-list
101556357|NCT05926895|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
101556359|NCT05926895|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101556360|NCT05926895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101556361|NCT05926895|Glucocorticoids|glucocorticoids|mesh-ancestor
101556362|NCT05926895|Hormones|hormones|mesh-ancestor
101556363|NCT05926895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101556364|NCT05926895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556365|NCT05926895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101556366|NCT05926895|Respiratory System Agents|respiratory system agents|mesh-ancestor
101556367|NCT05926895|Anesthetics, Local|anesthetics, local|mesh-ancestor
101556368|NCT05926895|Anesthetics|anesthetics|mesh-ancestor
101556369|NCT05926895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101556370|NCT05926895|Sensory System Agents|sensory system agents|mesh-ancestor
101556371|NCT05926895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101556372|NCT05926882|Apremilast|apremilast|mesh-list
101556373|NCT05926882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101556374|NCT05926882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101556375|NCT05926882|Analgesics|analgesics|mesh-ancestor
101556376|NCT05926882|Sensory System Agents|sensory system agents|mesh-ancestor
101556377|NCT05926882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101556378|NCT05926882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556379|NCT05926882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101556380|NCT05926882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101423447|NCT05662527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423448|NCT05662527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101423449|NCT05662527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423450|NCT05576792|Ranibizumab|ranibizumab|mesh-list
101423451|NCT05576792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101423452|NCT05576792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101423453|NCT05576792|Growth Substances|growth substances|mesh-ancestor
101423456|NCT05576792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423457|NCT05501665|Deoxyglucose|deoxyglucose|mesh-list
101423458|NCT05501665|Paclitaxel|paclitaxel|mesh-list
101423459|NCT05501665|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101423460|NCT05501665|Carboplatin|carboplatin|mesh-list
101423461|NCT05501665|Pembrolizumab|pembrolizumab|mesh-list
101306769|NCT02027493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423462|NCT05501665|Pemetrexed|pemetrexed|mesh-list
101423463|NCT05501665|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101423464|NCT05501665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101423465|NCT05501665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423466|NCT05501665|Tubulin Modulators|tubulin modulators|mesh-ancestor
101423467|NCT05501665|Antimitotic Agents|antimitotic agents|mesh-ancestor
101423468|NCT05501665|Mitosis Modulators|mitosis modulators|mesh-ancestor
101556381|NCT05926882|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101556382|NCT05926882|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101556383|NCT05926882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101556384|NCT05926882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556385|NCT05926869|Clindamycin|clindamycin|mesh-list
101556386|NCT05926869|Clindamycin palmitate|clindamycin palmitate|mesh-list
101556387|NCT05926869|Clindamycin phosphate|clindamycin phosphate|mesh-list
101556388|NCT05926869|Dapsone|dapsone|mesh-list
101556389|NCT05926869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101556390|NCT05926869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101556391|NCT05926869|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101556392|NCT05926869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101556393|NCT05926869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556394|NCT05926869|Antimalarials|antimalarials|mesh-ancestor
101556395|NCT05926869|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101556396|NCT05926869|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101556397|NCT05926869|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101556398|NCT05926869|Leprostatic Agents|leprostatic agents|mesh-ancestor
101556399|NCT05926804|Amoxicillin|amoxicillin|mesh-list
101556400|NCT05926804|Metronidazole|metronidazole|mesh-list
101556401|NCT05926804|Clarithromycin|clarithromycin|mesh-list
101404902|NCT00131313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101404903|NCT00433186|Mycophenolic Acid|mycophenolic acid|mesh-list
101404904|NCT00433186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101423469|NCT05501665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423470|NCT05501665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101423471|NCT05501665|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101423472|NCT05501665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101423473|NCT05501665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101423474|NCT05501665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101423475|NCT05501665|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101423476|NCT05501665|Antimetabolites|antimetabolites|mesh-ancestor
101423477|NCT05501665|Antiviral Agents|antiviral agents|mesh-ancestor
101423478|NCT05501665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101423479|NCT05494398|Acetylcysteine|acetylcysteine|mesh-list
101423480|NCT05494398|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101423485|NCT05494398|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101423487|NCT05494398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423488|NCT05494398|Protective Agents|protective agents|mesh-ancestor
101423489|NCT05494398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423490|NCT05494398|Antidotes|antidotes|mesh-ancestor
101423491|NCT05491278|Remifentanil|remifentanil|mesh-list
101423492|NCT05491278|Propofol|propofol|mesh-list
101423493|NCT05491278|Fospropofol|fospropofol|mesh-list
101423494|NCT05491278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101423495|NCT05491278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101423496|NCT05491278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423497|NCT05491278|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101423498|NCT05491278|Anesthetics, General|anesthetics, general|mesh-ancestor
101423499|NCT05491278|Anesthetics|anesthetics|mesh-ancestor
101423500|NCT05491278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101423501|NCT05491278|Narcotics|narcotics|mesh-ancestor
101556403|NCT05926804|Dexlansoprazole|dexlansoprazole|mesh-list
101556404|NCT05926804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101556405|NCT05926804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101556406|NCT05926804|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101556407|NCT05926804|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101556408|NCT05926804|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101556409|NCT05926804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101556410|NCT05926804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556411|NCT05926804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101556412|NCT05926804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101556413|NCT05926804|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101556414|NCT05926804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101556415|NCT05926804|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101556416|NCT05926466|Moxifloxacin|moxifloxacin|mesh-list
101404923|NCT00433225|Hormones|hormones|mesh-ancestor
101404924|NCT00433225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101404925|NCT00433225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404926|NCT00433225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101404927|NCT00433225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404928|NCT00433225|Antiemetics|antiemetics|mesh-ancestor
101404929|NCT00433225|Autonomic Agents|autonomic agents|mesh-ancestor
101404930|NCT00433225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101404931|NCT00433225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101404932|NCT00433225|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101404933|NCT00433225|Protective Agents|protective agents|mesh-ancestor
101404934|NCT00433225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101404935|NCT00433225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101404936|NCT00433225|Analgesics|analgesics|mesh-ancestor
101423502|NCT05491278|Analgesics|analgesics|mesh-ancestor
101423503|NCT05491278|Sensory System Agents|sensory system agents|mesh-ancestor
101423504|NCT05491278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101423505|NCT05463783|Tenofovir|tenofovir|mesh-list
101423506|NCT05463783|Emtricitabine|emtricitabine|mesh-list
101423507|NCT05463783|Darunavir|darunavir|mesh-list
101423508|NCT05463783|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101423509|NCT05463783|Cobicistat|cobicistat|mesh-list
101423510|NCT05463783|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
101423511|NCT05463783|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
101423512|NCT05463783|Antiviral Agents|antiviral agents|mesh-ancestor
101423513|NCT05463783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101423514|NCT05463783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101556417|NCT05926466|Bedaquiline|bedaquiline|mesh-list
101556418|NCT05926466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101556419|NCT05926466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101556420|NCT05926466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101556421|NCT05926466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101556422|NCT05926466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101556423|NCT05926466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556424|NCT05926466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101556425|NCT05926466|Antitubercular Agents|antitubercular agents|mesh-ancestor
101556426|NCT05926271|Clopidogrel|clopidogrel|mesh-list
101556427|NCT05926271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101556428|NCT05926271|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101556429|NCT05926271|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101556430|NCT05926271|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101556431|NCT05926271|Purinergic Agents|purinergic agents|mesh-ancestor
101556432|NCT05926271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101556433|NCT05926271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556434|NCT05926271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556435|NCT05926258|Chloroprocaine|chloroprocaine|mesh-list
101556436|NCT05926258|Benoxinate|benoxinate|mesh-list
101556437|NCT05926258|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101556438|NCT05926258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101556439|NCT05926258|Anesthetics, Local|anesthetics, local|mesh-ancestor
101556440|NCT05926258|Anesthetics|anesthetics|mesh-ancestor
101556441|NCT05926258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101556442|NCT05926258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556443|NCT05926258|Sensory System Agents|sensory system agents|mesh-ancestor
101556444|NCT05926258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101556445|NCT05926245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101556446|NCT05926206|Folfirinox|folfirinox|mesh-list
101556447|NCT05926206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101556448|NCT05926180|Digoxin|digoxin|mesh-list
101556449|NCT05926180|Midazolam|midazolam|mesh-list
101404938|NCT00433225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101423515|NCT05463783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101423516|NCT05463783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101423517|NCT05463783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423518|NCT05463783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101423519|NCT05463783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101423520|NCT05463783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101556450|NCT05926180|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101556451|NCT05926180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101556452|NCT05926180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101556453|NCT05926180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101556454|NCT05926180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556455|NCT05926180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101556456|NCT05926180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101556457|NCT05926180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101556458|NCT05926180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101556459|NCT05926180|Anesthetics, General|anesthetics, general|mesh-ancestor
101556460|NCT05926180|Anesthetics|anesthetics|mesh-ancestor
101556461|NCT05926180|GABA Modulators|gaba modulators|mesh-ancestor
101556462|NCT05926180|GABA Agents|gaba agents|mesh-ancestor
101556463|NCT05926180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101556464|NCT05926180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556465|NCT05926180|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101556466|NCT05926180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101556467|NCT05926180|Antimetabolites|antimetabolites|mesh-ancestor
101556468|NCT05926180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101556469|NCT05926180|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101556470|NCT05926180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101556471|NCT05926180|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101556472|NCT05926180|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101556473|NCT05926180|Protective Agents|protective agents|mesh-ancestor
101556474|NCT05926128|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101556475|NCT05926128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101556476|NCT05926128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101556477|NCT05926128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556478|NCT05924152|Adagrasib|adagrasib|mesh-list
101556479|NCT05924152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101556480|NCT05922176|Immunomodulating Agents|immunomodulating agents|mesh-list
101556481|NCT05922176|Immunologic Factors|immunologic factors|mesh-list
101556482|NCT05922176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556483|NCT05920798|Pembrolizumab|pembrolizumab|mesh-list
101556484|NCT05920798|Vaccines|vaccines|mesh-list
101556488|NCT05920798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101556491|NCT05914467|Teicoplanin|teicoplanin|mesh-list
101556492|NCT05914467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101556493|NCT05914467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101556494|NCT05880862|Mirabegron|mirabegron|mesh-list
101556495|NCT05880862|Trospium chloride|trospium chloride|mesh-list
101556496|NCT05880862|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101556497|NCT05880862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101556498|NCT05880862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101556499|NCT05880862|Adrenergic Agents|adrenergic agents|mesh-ancestor
101556500|NCT05880862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101556501|NCT05880862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556502|NCT05880862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556503|NCT05880862|Urological Agents|urological agents|mesh-ancestor
101556504|NCT05880862|Parasympatholytics|parasympatholytics|mesh-ancestor
101556505|NCT05880862|Autonomic Agents|autonomic agents|mesh-ancestor
101556506|NCT05880862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101556507|NCT05880862|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101556508|NCT05880862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101556509|NCT05880862|Cholinergic Agents|cholinergic agents|mesh-ancestor
101556511|NCT05876182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101556512|NCT05876182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101556513|NCT05835011|Decitabine|decitabine|mesh-list
101556514|NCT05835011|Magrolimab|magrolimab|mesh-list
101556515|NCT05835011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101556516|NCT05835011|Antimetabolites|antimetabolites|mesh-ancestor
101556519|NCT05835011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101556542|NCT05790486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556546|NCT05736341|Midazolam|midazolam|mesh-list
101556547|NCT05736341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101556548|NCT05736341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101556549|NCT05736341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101556550|NCT05736341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556551|NCT05736341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101556552|NCT05736341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101556553|NCT05736341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101556554|NCT05736341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101556555|NCT05736341|Anesthetics, General|anesthetics, general|mesh-ancestor
101556556|NCT05736341|Anesthetics|anesthetics|mesh-ancestor
101556557|NCT05736341|GABA Modulators|gaba modulators|mesh-ancestor
101556558|NCT05736341|GABA Agents|gaba agents|mesh-ancestor
101556559|NCT05736341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101518484|NCT03850301|Etifoxine|etifoxine|mesh-list
101556560|NCT05736341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556561|NCT05691010|Paclitaxel|paclitaxel|mesh-list
101556562|NCT05691010|Carboplatin|carboplatin|mesh-list
101556563|NCT05691010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101556564|NCT05691010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101556565|NCT05691010|Tubulin Modulators|tubulin modulators|mesh-ancestor
101556566|NCT05691010|Antimitotic Agents|antimitotic agents|mesh-ancestor
101556567|NCT05691010|Mitosis Modulators|mitosis modulators|mesh-ancestor
101556568|NCT05691010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556569|NCT05690984|Dexamethasone|dexamethasone|mesh-list
101556570|NCT05690984|Lenalidomide|lenalidomide|mesh-list
101556571|NCT05690984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101556572|NCT05690984|Antiemetics|antiemetics|mesh-ancestor
101556573|NCT05690984|Autonomic Agents|autonomic agents|mesh-ancestor
101556574|NCT05690984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101556575|NCT05690984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405060|NCT00433927|Levoleucovorin|levoleucovorin|mesh-list
101405061|NCT00433927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101405062|NCT00433927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405072|NCT00433927|Antidotes|antidotes|mesh-ancestor
101423521|NCT05463783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101423522|NCT05463783|Protease Inhibitors|protease inhibitors|mesh-ancestor
101423523|NCT05463783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101423524|NCT05463783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101556576|NCT05690984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101556578|NCT05690984|Hormones|hormones|mesh-ancestor
101556607|NCT05645536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556608|NCT05645536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101556609|NCT05645536|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101556610|NCT05645536|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101556611|NCT05645536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101556612|NCT05642962|Pancrelipase|pancrelipase|mesh-list
101556613|NCT05642962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101556614|NCT05641142|Anticoagulants|anticoagulants|mesh-list
101556620|NCT05605509|Gemcitabine|gemcitabine|mesh-list
101556621|NCT05605509|Trastuzumab|trastuzumab|mesh-list
101556622|NCT05605509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101556623|NCT05605509|Antimetabolites|antimetabolites|mesh-ancestor
101556624|NCT05605509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556625|NCT05605509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101556626|NCT05605509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101556651|NCT05597735|Tecovirimat|tecovirimat|mesh-list
101556652|NCT05597735|Antiviral Agents|antiviral agents|mesh-ancestor
101556653|NCT05597735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101556655|NCT05589363|Anesthetics, Local|anesthetics, local|mesh-ancestor
101556656|NCT05589363|Anesthetics|anesthetics|mesh-ancestor
101405090|NCT00098462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101405091|NCT00098462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405092|NCT00098462|Antifungal Agents|antifungal agents|mesh-ancestor
101405093|NCT00098462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101405094|NCT00098462|Immunologic Factors|immunologic factors|mesh-ancestor
101423525|NCT05457582|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
101423526|NCT05457582|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
101423527|NCT05457582|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101423528|NCT05457582|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101423529|NCT05457582|Antimetabolites|antimetabolites|mesh-ancestor
101423530|NCT05457582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423552|NCT05313529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101423562|NCT05287633|Esomeprazole|esomeprazole|mesh-list
101423563|NCT05287633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101423564|NCT05287633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101423565|NCT05287633|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101423566|NCT05287633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101423567|NCT05287633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423568|NCT05285449|Cannabidiol|cannabidiol|mesh-list
101423569|NCT05285449|Anticonvulsants|anticonvulsants|mesh-ancestor
101423570|NCT05238597|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101423571|NCT05238597|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101423572|NCT05226598|Paclitaxel|paclitaxel|mesh-list
101423573|NCT05226598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101423574|NCT05226598|Carboplatin|carboplatin|mesh-list
101405113|NCT00098501|Antifungal Agents|antifungal agents|mesh-ancestor
101556657|NCT05589363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101556658|NCT05589363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556659|NCT05589363|Sensory System Agents|sensory system agents|mesh-ancestor
101556660|NCT05589363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101556661|NCT05582434|Clindamycin|clindamycin|mesh-list
101556662|NCT05582434|Clindamycin palmitate|clindamycin palmitate|mesh-list
101556663|NCT05582434|Clindamycin phosphate|clindamycin phosphate|mesh-list
101556664|NCT05582434|Adapalene|adapalene|mesh-list
101556665|NCT05582434|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101556666|NCT05582434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101556667|NCT05582434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101556668|NCT05582434|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101556669|NCT05582434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101556670|NCT05582434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556671|NCT05582434|Dermatologic Agents|dermatologic agents|mesh-ancestor
101556672|NCT05582434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101556673|NCT05582434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101556674|NCT05582434|Analgesics|analgesics|mesh-ancestor
101556675|NCT05582434|Sensory System Agents|sensory system agents|mesh-ancestor
101556676|NCT05582434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101556677|NCT05582434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556678|NCT05582434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101556679|NCT05582434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101556680|NCT05554133|Proflavine|proflavine|mesh-list
101556681|NCT05554133|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101556682|NCT05554133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101556683|NCT05549661|Onvansertib|onvansertib|mesh-list
101556684|NCT05549661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101556685|NCT05549661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101556686|NCT05549661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556687|NCT05528588|Furosemide|furosemide|mesh-list
101556688|NCT05528588|Diuretics|diuretics|mesh-ancestor
101405114|NCT00434005|Acetylcysteine|acetylcysteine|mesh-list
101405115|NCT00434005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101405116|NCT00434005|Antiviral Agents|antiviral agents|mesh-ancestor
101423575|NCT05226598|Pembrolizumab|pembrolizumab|mesh-list
101423576|NCT05226598|Pemetrexed|pemetrexed|mesh-list
101423577|NCT05226598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101556699|NCT05488431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101556700|NCT05488431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101556701|NCT05488431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556714|NCT05465954|Pembrolizumab|pembrolizumab|mesh-list
101556715|NCT05465954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101556716|NCT05465954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101556717|NCT05465954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101405146|NCT00434083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101423578|NCT05226598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423579|NCT05226598|Tubulin Modulators|tubulin modulators|mesh-ancestor
101423580|NCT05226598|Antimitotic Agents|antimitotic agents|mesh-ancestor
101423581|NCT05226598|Mitosis Modulators|mitosis modulators|mesh-ancestor
101423582|NCT05226598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423583|NCT05226598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101423584|NCT05226598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101423585|NCT05226598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101423586|NCT05226598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101556718|NCT05465954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556719|NCT05435235|Dapagliflozin|dapagliflozin|mesh-list
101556720|NCT05435235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101556721|NCT05435235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556722|NCT05435235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101556723|NCT05435235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556724|NCT05421858|Fluconazole|fluconazole|mesh-list
101556725|NCT05421858|Caspofungin|caspofungin|mesh-list
101494092|NCT00436709|Paclitaxel|paclitaxel|mesh-list
101556726|NCT05421858|Antifungal Agents|antifungal agents|mesh-ancestor
101556727|NCT05421858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101556728|NCT05421858|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101556729|NCT05421858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101556730|NCT05421858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101556731|NCT05421858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556732|NCT05421858|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101556733|NCT05421858|Hormone Antagonists|hormone antagonists|mesh-ancestor
101556734|NCT05421858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101556735|NCT05421858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556736|NCT05421858|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101556737|NCT05421858|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101556738|NCT05394337|Atezolizumab|atezolizumab|mesh-list
101556739|NCT05394337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101556740|NCT05394337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556741|NCT05394337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101556742|NCT05394337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101556743|NCT05392946|Dexamethasone|dexamethasone|mesh-list
101556744|NCT05392946|Dexamethasone acetate|dexamethasone acetate|mesh-list
101423587|NCT05226598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101423588|NCT05221320|Hydroxychloroquine|hydroxychloroquine|mesh-list
101423589|NCT05221320|Antimalarials|antimalarials|mesh-ancestor
101423590|NCT05221320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101423591|NCT05221320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101423592|NCT05221320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101423593|NCT05221320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101423594|NCT05221320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423595|NCT05221320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101423596|NCT05190705|Dexamethasone|dexamethasone|mesh-list
101423597|NCT05190705|Dexamethasone acetate|dexamethasone acetate|mesh-list
101423598|NCT05190705|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
101423599|NCT05190705|BB 1101|bb 1101|mesh-list
101423602|NCT05190705|Autonomic Agents|autonomic agents|mesh-ancestor
101556747|NCT05392946|Ichthammol|ichthammol|mesh-list
101556748|NCT05392946|BB 1101|bb 1101|mesh-list
101556749|NCT05392946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101556750|NCT05392946|Antiemetics|antiemetics|mesh-ancestor
101556751|NCT05392946|Autonomic Agents|autonomic agents|mesh-ancestor
101556752|NCT05392946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101556753|NCT05392946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405212|NCT00099008|Genistein|genistein|mesh-list
101423603|NCT05190705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101423604|NCT05190705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423605|NCT05190705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101423606|NCT05190705|Glucocorticoids|glucocorticoids|mesh-ancestor
101423607|NCT05190705|Hormones|hormones|mesh-ancestor
101423608|NCT05190705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101423609|NCT05190705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101423610|NCT05190705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423611|NCT05190705|Protease Inhibitors|protease inhibitors|mesh-ancestor
101423612|NCT05190705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101423613|NCT05190705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423614|NCT05190705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101423615|NCT05188118|Nivolumab|nivolumab|mesh-list
101423616|NCT05188118|Ipilimumab|ipilimumab|mesh-list
101423617|NCT05188118|Everolimus|everolimus|mesh-list
101423621|NCT05188118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101423622|NCT05188118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423624|NCT05188118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101423625|NCT05188118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101306773|NCT02027493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306774|NCT02027493|Immunologic Factors|immunologic factors|mesh-ancestor
101306775|NCT02027493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423626|NCT05188118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101423627|NCT05188118|Immunologic Factors|immunologic factors|mesh-ancestor
101423628|NCT05188118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423629|NCT05172908|Dexamethasone|dexamethasone|mesh-list
101423630|NCT05172908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101423631|NCT05172908|Antiemetics|antiemetics|mesh-ancestor
101423632|NCT05172908|Autonomic Agents|autonomic agents|mesh-ancestor
101423633|NCT05172908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101423634|NCT05172908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423635|NCT05172908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101423636|NCT05172908|Glucocorticoids|glucocorticoids|mesh-ancestor
101423637|NCT05172908|Hormones|hormones|mesh-ancestor
101423638|NCT05172908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101423639|NCT05172908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101423640|NCT05172908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423641|NCT05140512|Goserelin|goserelin|mesh-list
101423642|NCT05140512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101423643|NCT05140512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423644|NCT05110170|Goserelin|goserelin|mesh-list
101423645|NCT05110170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101423646|NCT05110170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423647|NCT04971499|Dapansutrile|dapansutrile|mesh-list
101423648|NCT04971499|Pembrolizumab|pembrolizumab|mesh-list
101423649|NCT04971499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101423650|NCT04971499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423651|NCT04971499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101423652|NCT04971499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423653|NCT04971499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101423654|NCT04918017|Esomeprazole|esomeprazole|mesh-list
101423655|NCT04918017|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101423656|NCT04918017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101423657|NCT04918017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101423658|NCT04918017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101423659|NCT04918017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423660|NCT04898231|Methylprednisolone|methylprednisolone|mesh-list
101423661|NCT04898231|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101556754|NCT05392946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101556755|NCT05392946|Glucocorticoids|glucocorticoids|mesh-ancestor
101556756|NCT05392946|Hormones|hormones|mesh-ancestor
101556757|NCT05392946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101556758|NCT05392946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101556759|NCT05392946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101556760|NCT05392946|Protease Inhibitors|protease inhibitors|mesh-ancestor
101556761|NCT05392946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101556762|NCT05392946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423662|NCT04898231|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101423663|NCT04898231|Prednisolone|prednisolone|mesh-list
101423664|NCT04898231|Prednisolone acetate|prednisolone acetate|mesh-list
101423665|NCT04898231|Infliximab|infliximab|mesh-list
101423666|NCT04898231|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101423667|NCT04898231|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101423668|NCT04898231|Prednisolone phosphate|prednisolone phosphate|mesh-list
101423669|NCT04898231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101423670|NCT04898231|Antiemetics|antiemetics|mesh-ancestor
101423671|NCT04898231|Autonomic Agents|autonomic agents|mesh-ancestor
101423672|NCT04898231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101423673|NCT04898231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423675|NCT04898231|Glucocorticoids|glucocorticoids|mesh-ancestor
101423676|NCT04898231|Hormones|hormones|mesh-ancestor
101423677|NCT04898231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101423678|NCT04898231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101423679|NCT04898231|Protective Agents|protective agents|mesh-ancestor
101423680|NCT04898231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101423681|NCT04898231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423682|NCT04898231|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101423683|NCT04898231|Dermatologic Agents|dermatologic agents|mesh-ancestor
101423684|NCT04898231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101423685|NCT04849026|Clozapine|clozapine|mesh-list
101423686|NCT04849026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101423687|NCT04849026|Serotonin Agents|serotonin agents|mesh-ancestor
101423688|NCT04849026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101487407|NCT00427947|Sensory System Agents|sensory system agents|mesh-ancestor
101423693|NCT04849026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101423694|NCT04849026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101423695|NCT04849026|GABA Antagonists|gaba antagonists|mesh-ancestor
101306777|NCT02027532|Cefazolin|cefazolin|mesh-list
101306778|NCT02027532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101306779|NCT02027532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101306780|NCT02027675|Micronutrients|micronutrients|mesh-list
101423696|NCT04849026|GABA Agents|gaba agents|mesh-ancestor
101423698|NCT04841980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101423699|NCT04841980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101423700|NCT04841980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101423701|NCT04831736|Ketamine|ketamine|mesh-list
101423702|NCT04831736|Analgesics|analgesics|mesh-ancestor
101423703|NCT04831736|Sensory System Agents|sensory system agents|mesh-ancestor
101423704|NCT04831736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101423705|NCT04831736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423706|NCT04831736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101423707|NCT04831736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101423708|NCT04831736|Anesthetics, General|anesthetics, general|mesh-ancestor
101423709|NCT04831736|Anesthetics|anesthetics|mesh-ancestor
101423710|NCT04831736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101423711|NCT04831736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101423712|NCT04831736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101423713|NCT04831736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101423714|NCT04831736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423715|NCT04830462|Rifampin|rifampin|mesh-list
101423716|NCT04830462|Isoniazid|isoniazid|mesh-list
101423717|NCT04830462|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101423718|NCT04830462|Antitubercular Agents|antitubercular agents|mesh-ancestor
101423719|NCT04830462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101556763|NCT05392946|Dermatologic Agents|dermatologic agents|mesh-ancestor
101556764|NCT05382208|Doxycycline|doxycycline|mesh-list
101556765|NCT05382208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101556766|NCT05382208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101556767|NCT05382208|Antimalarials|antimalarials|mesh-ancestor
101556768|NCT05382208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101556769|NCT05382208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101556770|NCT05356936|Vitamin D|vitamin d|mesh-list
101423720|NCT04830462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101423721|NCT04830462|Leprostatic Agents|leprostatic agents|mesh-ancestor
101423722|NCT04830462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101423723|NCT04830462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101423724|NCT04830462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423725|NCT04830462|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101423726|NCT04830462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101423727|NCT04830462|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101423728|NCT04830462|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101423729|NCT04830462|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101423730|NCT04830462|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101460231|NCT00250068|Rubitecan|rubitecan|mesh-list
101423731|NCT04830462|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101423732|NCT04830462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101423733|NCT04830462|Antimetabolites|antimetabolites|mesh-ancestor
101423734|NCT04830462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101423735|NCT04797767|Cytarabine|cytarabine|mesh-list
101423736|NCT04797767|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
101423737|NCT04797767|Venetoclax|venetoclax|mesh-list
101423738|NCT04797767|Mitoxantrone|mitoxantrone|mesh-list
101423739|NCT04797767|Cladribine|cladribine|mesh-list
101423740|NCT04797767|Lenograstim|lenograstim|mesh-list
101423741|NCT04797767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101423742|NCT04797767|Antimetabolites|antimetabolites|mesh-ancestor
101423743|NCT04797767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423744|NCT04797767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423745|NCT04797767|Antiviral Agents|antiviral agents|mesh-ancestor
101423746|NCT04797767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101423747|NCT04797767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101423748|NCT04797767|Immunologic Factors|immunologic factors|mesh-ancestor
101423769|NCT04775381|Vitamin D|vitamin d|mesh-list
101423770|NCT04775381|Vitamins|vitamins|mesh-ancestor
101423771|NCT04775381|Micronutrients|micronutrients|mesh-ancestor
101423772|NCT04775381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423773|NCT04775381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101423774|NCT04760275|Fluoxetine|fluoxetine|mesh-list
101423775|NCT04760275|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101423776|NCT04760275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101423777|NCT04760275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101423778|NCT04760275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423779|NCT04760275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101423780|NCT04760275|Serotonin Agents|serotonin agents|mesh-ancestor
101423781|NCT04760275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423782|NCT04760275|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101423783|NCT04760275|Antidepressive Agents|antidepressive agents|mesh-ancestor
101423784|NCT04760275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101423785|NCT04760275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101423786|NCT04760275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101423787|NCT04760275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101423788|NCT04721873|Topiramate|topiramate|mesh-list
101423789|NCT04721873|Phentermine|phentermine|mesh-list
101423790|NCT04721873|Anticonvulsants|anticonvulsants|mesh-ancestor
101423791|NCT04721873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101423792|NCT04721873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423793|NCT04721873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101423794|NCT04721873|Appetite Depressants|appetite depressants|mesh-ancestor
101423795|NCT04721873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101423796|NCT04721873|Sympathomimetics|sympathomimetics|mesh-ancestor
101423797|NCT04721873|Autonomic Agents|autonomic agents|mesh-ancestor
101423798|NCT04721873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101423799|NCT04721873|Adrenergic Agents|adrenergic agents|mesh-ancestor
101556771|NCT05356936|Cholecalciferol|cholecalciferol|mesh-list
101556772|NCT05356936|Vitamins|vitamins|mesh-list
101556773|NCT05356936|Vitamin K|vitamin k|mesh-list
101556774|NCT05356936|Vitamin K 2|vitamin k 2|mesh-list
101556775|NCT05356936|Micronutrients|micronutrients|mesh-ancestor
101556776|NCT05356936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556777|NCT05356936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101556778|NCT05356936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101556779|NCT05356936|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101556780|NCT05356936|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101556781|NCT05356936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556782|NCT05356936|Hemostatics|hemostatics|mesh-ancestor
101556783|NCT05356936|Coagulants|coagulants|mesh-ancestor
101556784|NCT05354453|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
101556785|NCT05354453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101556786|NCT05354453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556787|NCT05354453|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101556788|NCT05354453|Protective Agents|protective agents|mesh-ancestor
101556789|NCT05354453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556790|NCT05354453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405232|NCT00434239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423800|NCT04721873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101423801|NCT04721873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423802|NCT04721015|Docetaxel|docetaxel|mesh-list
101423803|NCT04721015|Osimertinib|osimertinib|mesh-list
101423804|NCT04721015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423805|NCT04721015|Tubulin Modulators|tubulin modulators|mesh-ancestor
101423806|NCT04721015|Antimitotic Agents|antimitotic agents|mesh-ancestor
101423807|NCT04721015|Mitosis Modulators|mitosis modulators|mesh-ancestor
101423832|NCT04644016|Clofarabine|clofarabine|mesh-list
101423833|NCT04644016|Cyclosporins|cyclosporins|mesh-list
101423834|NCT04644016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423835|NCT04644016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101423836|NCT04644016|Antimetabolites|antimetabolites|mesh-ancestor
101423837|NCT04644016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423838|NCT04644016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101423839|NCT04644016|Immunologic Factors|immunologic factors|mesh-ancestor
101306786|NCT02027753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101423840|NCT04644016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423841|NCT04644016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101423842|NCT04644016|Antifungal Agents|antifungal agents|mesh-ancestor
101423843|NCT04644016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101423844|NCT04644016|Dermatologic Agents|dermatologic agents|mesh-ancestor
101423845|NCT04644016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101423846|NCT04644016|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101423847|NCT04644016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101423848|NCT04644016|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101423849|NCT04644016|Antitubercular Agents|antitubercular agents|mesh-ancestor
101423850|NCT04644016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101423851|NCT04644016|Alkylating Agents|alkylating agents|mesh-ancestor
101423852|NCT04644016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101423853|NCT04644016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101423854|NCT04634162|Cangrelor|cangrelor|mesh-list
101556809|NCT05264974|Immunologic Factors|immunologic factors|mesh-ancestor
101556810|NCT05264974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556811|NCT05153239|Irinotecan|irinotecan|mesh-list
101556812|NCT05153239|Topotecan|topotecan|mesh-list
101556813|NCT05153239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101556814|NCT05153239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101556815|NCT05153239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101556816|NCT05153239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556817|NCT05153239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423855|NCT04634162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101423856|NCT04634162|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101423857|NCT04634162|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101423858|NCT04634162|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101423859|NCT04634162|Purinergic Agents|purinergic agents|mesh-ancestor
101423860|NCT04634162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101423861|NCT04634162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423862|NCT04634162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423863|NCT04616196|Cetuximab|cetuximab|mesh-list
101423871|NCT04541407|Temozolomide|temozolomide|mesh-list
101423872|NCT04541407|Osimertinib|osimertinib|mesh-list
101423873|NCT04541407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101423874|NCT04541407|Alkylating Agents|alkylating agents|mesh-ancestor
101423875|NCT04541407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423876|NCT04541407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423877|NCT04541407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101423878|NCT04541407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101423879|NCT04552795|Lamivudine|lamivudine|mesh-list
101423880|NCT04552795|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101423881|NCT04552795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101423882|NCT04552795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101423883|NCT04552795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423884|NCT04552795|Antiviral Agents|antiviral agents|mesh-ancestor
101423885|NCT04552795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101423886|NCT04552795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101423887|NCT04552795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101423888|NCT04522336|Docetaxel|docetaxel|mesh-list
101423889|NCT04522336|Pembrolizumab|pembrolizumab|mesh-list
101423890|NCT04522336|Fluorouracil|fluorouracil|mesh-list
101423891|NCT04522336|Oxaliplatin|oxaliplatin|mesh-list
101423892|NCT04522336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423893|NCT04522336|Tubulin Modulators|tubulin modulators|mesh-ancestor
101423894|NCT04522336|Antimitotic Agents|antimitotic agents|mesh-ancestor
101423895|NCT04522336|Mitosis Modulators|mitosis modulators|mesh-ancestor
101423896|NCT04522336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423897|NCT04522336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101423911|NCT04463680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101423912|NCT04463680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556819|NCT05111353|Interferon Inducers|interferon inducers|mesh-ancestor
101556820|NCT05111353|Immunologic Factors|immunologic factors|mesh-ancestor
101556821|NCT05111353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556822|NCT05053087|Ropivacaine|ropivacaine|mesh-list
101556823|NCT05053087|Anesthetics, Local|anesthetics, local|mesh-ancestor
101556824|NCT05053087|Anesthetics|anesthetics|mesh-ancestor
101556825|NCT05053087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101556826|NCT05053087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556827|NCT05053087|Sensory System Agents|sensory system agents|mesh-ancestor
101556828|NCT05053087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101556829|NCT05050942|Octreotide|octreotide|mesh-list
101556830|NCT05050942|Lanreotide|lanreotide|mesh-list
101556831|NCT05050942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101405278|NCT00099164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101423913|NCT04463680|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101423914|NCT04463680|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101423915|NCT04463680|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101423916|NCT04463680|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101423917|NCT04463680|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101423918|NCT04463680|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101423919|NCT04438655|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101423920|NCT04438655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101423921|NCT04428333|Pembrolizumab|pembrolizumab|mesh-list
101423922|NCT04428333|Fluorouracil|fluorouracil|mesh-list
101306787|NCT02027753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306788|NCT02027753|Protease Inhibitors|protease inhibitors|mesh-ancestor
101423923|NCT04428333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101423924|NCT04428333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423925|NCT04428333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101423926|NCT04428333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423927|NCT04428333|Antimetabolites|antimetabolites|mesh-ancestor
101423928|NCT04428333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101423929|NCT04428333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101423930|NCT04428333|Immunologic Factors|immunologic factors|mesh-ancestor
101423931|NCT04428333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423932|NCT04395989|Paclitaxel|paclitaxel|mesh-list
101460277|NCT00254007|Serotonin Agents|serotonin agents|mesh-ancestor
101423933|NCT04395989|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101423934|NCT04395989|Capecitabine|capecitabine|mesh-list
101423935|NCT04395989|Everolimus|everolimus|mesh-list
101423936|NCT04395989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101423937|NCT04395989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423938|NCT04395989|Tubulin Modulators|tubulin modulators|mesh-ancestor
101423939|NCT04395989|Antimitotic Agents|antimitotic agents|mesh-ancestor
101423940|NCT04395989|Mitosis Modulators|mitosis modulators|mesh-ancestor
101423945|NCT04395989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101423946|NCT04395989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101423947|NCT04395989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101423948|NCT04395989|Immunologic Factors|immunologic factors|mesh-ancestor
101423949|NCT04395989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423951|NCT04393454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101423952|NCT04393454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101423953|NCT04393454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101423954|NCT04393454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423955|NCT04393454|Antifungal Agents|antifungal agents|mesh-ancestor
101423956|NCT04393454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101423957|NCT04393454|Immunologic Factors|immunologic factors|mesh-ancestor
101423961|NCT04341311|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101556832|NCT05050942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101556833|NCT05050942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101556834|NCT05038982|Abrocitinib|abrocitinib|mesh-list
101556835|NCT05038982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101556836|NCT05038982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101556837|NCT05038982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556838|NCT04983966|Desflurane|desflurane|mesh-list
101556839|NCT04983966|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101556840|NCT04983966|Anesthetics, General|anesthetics, general|mesh-ancestor
101556841|NCT04983966|Anesthetics|anesthetics|mesh-ancestor
101556842|NCT04983966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101556843|NCT04983966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556844|NCT04972942|Daratumumab|daratumumab|mesh-list
101556845|NCT04972942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101556846|NCT04964128|Insulin|insulin|mesh-list
101556847|NCT04964128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101556848|NCT04964128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556849|NCT04953910|Decitabine|decitabine|mesh-list
101556850|NCT04953910|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
101556851|NCT04953910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101556852|NCT04953910|Antimetabolites|antimetabolites|mesh-ancestor
101556853|NCT04953910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556854|NCT04953910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101556855|NCT04953910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101556856|NCT04953897|Decitabine|decitabine|mesh-list
101556857|NCT04953897|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
101405292|NCT04621149|Lactoferrin|lactoferrin|mesh-list
101423962|NCT04341311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101423963|NCT04341311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423965|NCT04304014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101423966|NCT04304014|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101423967|NCT04304014|Antimalarials|antimalarials|mesh-ancestor
101423968|NCT04304014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101423969|NCT04304014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101423970|NCT04300231|Hydromorphone|hydromorphone|mesh-list
101423971|NCT04300231|Bupivacaine|bupivacaine|mesh-list
101423972|NCT04300231|Anesthetics, Local|anesthetics, local|mesh-ancestor
101423973|NCT04300231|Anesthetics|anesthetics|mesh-ancestor
101423974|NCT04300231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101423975|NCT04300231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423976|NCT04300231|Sensory System Agents|sensory system agents|mesh-ancestor
101423977|NCT04300231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101423978|NCT04300231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101423979|NCT04300231|Narcotics|narcotics|mesh-ancestor
101423980|NCT04300231|Analgesics|analgesics|mesh-ancestor
101423981|NCT04230148|Triclabendazole|triclabendazole|mesh-list
101423982|NCT04230148|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101423983|NCT04230148|Anthelmintics|anthelmintics|mesh-ancestor
101556858|NCT04953897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101556860|NCT04953897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556861|NCT04953897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101556862|NCT04953897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101556863|NCT04931017|Metformin|metformin|mesh-list
101556864|NCT04931017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101556865|NCT04931017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556866|NCT04917406|Dexamethasone|dexamethasone|mesh-list
101556867|NCT04917406|Lidocaine|lidocaine|mesh-list
101556868|NCT04917406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101556869|NCT04917406|Antiemetics|antiemetics|mesh-ancestor
101556870|NCT04917406|Autonomic Agents|autonomic agents|mesh-ancestor
101556871|NCT04917406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101556872|NCT04917406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556873|NCT04917406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101556874|NCT04917406|Glucocorticoids|glucocorticoids|mesh-ancestor
101556875|NCT04917406|Hormones|hormones|mesh-ancestor
101494224|NCT00482313|Methylphenidate|methylphenidate|mesh-list
101556876|NCT04917406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101556877|NCT04917406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101556878|NCT04917406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101556879|NCT04917406|Anesthetics, Local|anesthetics, local|mesh-ancestor
101556880|NCT04917406|Anesthetics|anesthetics|mesh-ancestor
101556881|NCT04917406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101423984|NCT04230148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101423985|NCT04230148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101423986|NCT04205630|Trastuzumab|trastuzumab|mesh-list
101423987|NCT04205630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101423988|NCT04205630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423989|NCT04195633|Cyclosporine|cyclosporine|mesh-list
101423990|NCT04195633|Mycophenolic Acid|mycophenolic acid|mesh-list
101423991|NCT04195633|Cyclophosphamide|cyclophosphamide|mesh-list
101423992|NCT04195633|Treosulfan|treosulfan|mesh-list
101423993|NCT04195633|Busulfan|busulfan|mesh-list
101423994|NCT04195633|Fludarabine|fludarabine|mesh-list
101423995|NCT04195633|Cyclosporins|cyclosporins|mesh-list
101423996|NCT04195633|Lenograstim|lenograstim|mesh-list
101423997|NCT04195633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101306790|NCT02027753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306792|NCT02027792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101306793|NCT02027792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101306794|NCT02027792|Analgesics|analgesics|mesh-ancestor
101306795|NCT02027792|Sensory System Agents|sensory system agents|mesh-ancestor
101306796|NCT02027792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101306797|NCT02027792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306798|NCT02027792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101306799|NCT02027792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101306800|NCT02027792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101306801|NCT02027792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101556882|NCT04917406|Sensory System Agents|sensory system agents|mesh-ancestor
101556883|NCT04917406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101556884|NCT04917406|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101556885|NCT04917406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101556886|NCT04917406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101556887|NCT04917406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556889|NCT04867785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101556890|NCT04867785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556891|NCT04840589|Nivolumab|nivolumab|mesh-list
101556892|NCT04840589|Ipilimumab|ipilimumab|mesh-list
101556893|NCT04840589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101556894|NCT04840589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101556895|NCT04840589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101628313|NCT00720343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101306802|NCT02027792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306803|NCT02027870|Sirolimus|sirolimus|mesh-list
101306804|NCT02027870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101306805|NCT02027870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101306806|NCT02027870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101423998|NCT04195633|Immunologic Factors|immunologic factors|mesh-ancestor
101423999|NCT04195633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424000|NCT04195633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101424016|NCT04171050|Anesthetics|anesthetics|mesh-list
101424017|NCT04171050|Anesthetics, Local|anesthetics, local|mesh-list
101424018|NCT04171050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101424019|NCT04171050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424020|NCT04171050|Sensory System Agents|sensory system agents|mesh-ancestor
101424021|NCT04171050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101424022|NCT04128696|Pembrolizumab|pembrolizumab|mesh-list
101424023|NCT04128696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101424024|NCT04128696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424025|NCT04128696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101424026|NCT04128696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424027|NCT04098081|Gemcitabine|gemcitabine|mesh-list
101424028|NCT04098081|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
101424029|NCT04098081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101424030|NCT04098081|Antimetabolites|antimetabolites|mesh-ancestor
101424048|NCT04028986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424049|NCT04028986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101306807|NCT02027870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424050|NCT03914612|Paclitaxel|paclitaxel|mesh-list
101424051|NCT03914612|Carboplatin|carboplatin|mesh-list
101424052|NCT03914612|Pembrolizumab|pembrolizumab|mesh-list
101424053|NCT03914612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101424054|NCT03914612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101424055|NCT03914612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424056|NCT03914612|Tubulin Modulators|tubulin modulators|mesh-ancestor
101424057|NCT03914612|Antimitotic Agents|antimitotic agents|mesh-ancestor
101424058|NCT03914612|Mitosis Modulators|mitosis modulators|mesh-ancestor
101424059|NCT03914612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424060|NCT03914612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101424061|NCT03914612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101424062|NCT03900793|Sunitinib|sunitinib|mesh-list
101424063|NCT03900793|Losartan|losartan|mesh-list
101424064|NCT03900793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424065|NCT03900793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101556896|NCT04840589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556898|NCT04812912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101556899|NCT04812912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556900|NCT04785820|Nivolumab|nivolumab|mesh-list
101556901|NCT04785820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101556902|NCT04785820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101556903|NCT04785820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101556904|NCT04785820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556905|NCT04767061|Propranolol|propranolol|mesh-list
101556906|NCT04767061|Metoprolol|metoprolol|mesh-list
101556907|NCT04767061|Atenolol|atenolol|mesh-list
101556908|NCT04767061|Sotalol|sotalol|mesh-list
101556909|NCT04767061|Nadolol|nadolol|mesh-list
101556910|NCT04767061|Acebutolol|acebutolol|mesh-list
101556911|NCT04767061|Carvedilol|carvedilol|mesh-list
101556912|NCT04767061|Nebivolol|nebivolol|mesh-list
101556913|NCT04767061|Bisoprolol|bisoprolol|mesh-list
101556914|NCT04767061|Labetalol|labetalol|mesh-list
101556915|NCT04767061|Pindolol|pindolol|mesh-list
101556916|NCT04767061|Betaxolol|betaxolol|mesh-list
101556917|NCT04767061|Penbutolol|penbutolol|mesh-list
101556918|NCT04767061|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101556919|NCT04767061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101556920|NCT04767061|Adrenergic Agents|adrenergic agents|mesh-ancestor
101556921|NCT04767061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101556922|NCT04767061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405362|NCT00400595|Mupirocin|mupirocin|mesh-list
101424066|NCT03900793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101424067|NCT03900793|Growth Substances|growth substances|mesh-ancestor
101424068|NCT03900793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424069|NCT03900793|Growth Inhibitors|growth inhibitors|mesh-ancestor
101424070|NCT03900793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101424071|NCT03900793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101424072|NCT03900793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424073|NCT03900793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101424093|NCT03896880|Hormone Antagonists|hormone antagonists|mesh-ancestor
101424094|NCT03896880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101424095|NCT03896880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424096|NCT03896880|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101424097|NCT03896880|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101424098|NCT03854019|Quinidine|quinidine|mesh-list
101424099|NCT03854019|Dextromethorphan|dextromethorphan|mesh-list
101424100|NCT03854019|Antitussive Agents|antitussive agents|mesh-ancestor
101424101|NCT03854019|Respiratory System Agents|respiratory system agents|mesh-ancestor
101424102|NCT03854019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101424103|NCT03854019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101424104|NCT03854019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101424105|NCT03854019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556923|NCT04767061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556925|NCT04767061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101556926|NCT04767061|Vasodilator Agents|vasodilator agents|mesh-ancestor
101556927|NCT04767061|Sympatholytics|sympatholytics|mesh-ancestor
101556928|NCT04767061|Autonomic Agents|autonomic agents|mesh-ancestor
101556929|NCT04767061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101556930|NCT04767061|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101556931|NCT04767061|Antioxidants|antioxidants|mesh-ancestor
101556932|NCT04767061|Protective Agents|protective agents|mesh-ancestor
101556933|NCT04767061|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101556934|NCT04767061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101556935|NCT04767061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101556936|NCT04767061|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101556937|NCT04767061|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101556938|NCT04767061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101556939|NCT04767061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101556941|NCT04767061|Sympathomimetics|sympathomimetics|mesh-ancestor
101556942|NCT04767061|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101556943|NCT04767061|Serotonin Agents|serotonin agents|mesh-ancestor
101556944|NCT04761302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101405387|NCT00099710|Curcumin|curcumin|mesh-list
101424106|NCT03854019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424107|NCT03854019|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101424108|NCT03854019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101424109|NCT03854019|Adrenergic Agents|adrenergic agents|mesh-ancestor
101424110|NCT03854019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101424111|NCT03854019|Antimalarials|antimalarials|mesh-ancestor
101424112|NCT03854019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101424113|NCT03854019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101424114|NCT03854019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101424115|NCT03854019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101424116|NCT03854019|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101424117|NCT03854019|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101424118|NCT03854019|Cholinergic Agents|cholinergic agents|mesh-ancestor
101424119|NCT03854019|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101424120|NCT03854019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101424121|NCT03854019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101424122|NCT03854019|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101306808|NCT02027870|Antifungal Agents|antifungal agents|mesh-ancestor
101306809|NCT02027870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101306810|NCT02027870|Immunologic Factors|immunologic factors|mesh-ancestor
101306811|NCT02027870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424123|NCT03854019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101424125|NCT03815019|Megestrol Acetate|megestrol acetate|mesh-list
101424126|NCT03815019|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101424127|NCT03815019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101424128|NCT03815019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101424129|NCT03815019|Contraceptive Agents|contraceptive agents|mesh-ancestor
101424130|NCT03815019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101424131|NCT03815019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556962|NCT04691375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101556963|NCT04691375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556964|NCT04666038|Rituximab|rituximab|mesh-list
101556965|NCT04666038|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101556966|NCT04666038|Idelalisib|idelalisib|mesh-list
101556967|NCT04666038|Pirtobrutinib|pirtobrutinib|mesh-list
101556968|NCT04666038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101556969|NCT04666038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101556970|NCT04666038|Immunologic Factors|immunologic factors|mesh-ancestor
101556971|NCT04666038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101556972|NCT04666038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101556973|NCT04666038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101556974|NCT04666038|Alkylating Agents|alkylating agents|mesh-ancestor
101556989|NCT04592913|Durvalumab|durvalumab|mesh-list
101556994|NCT04511039|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101556995|NCT04511039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101556996|NCT04511039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101556997|NCT04511039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101556998|NCT04511039|Antimetabolites|antimetabolites|mesh-ancestor
101556999|NCT04511039|Antiviral Agents|antiviral agents|mesh-ancestor
101557000|NCT04511039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101557001|NCT04466917|Paclitaxel|paclitaxel|mesh-list
101557002|NCT04466917|Bevacizumab|bevacizumab|mesh-list
101557003|NCT04466917|Carboplatin|carboplatin|mesh-list
101557004|NCT04466917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101557005|NCT04466917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557006|NCT04466917|Tubulin Modulators|tubulin modulators|mesh-ancestor
101557007|NCT04466917|Antimitotic Agents|antimitotic agents|mesh-ancestor
101557008|NCT04466917|Mitosis Modulators|mitosis modulators|mesh-ancestor
101424136|NCT03815019|Appetite Stimulants|appetite stimulants|mesh-ancestor
101424137|NCT03815019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101424138|NCT03767218|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101424140|NCT03767218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101424141|NCT03767218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424142|NCT03739645|Metronidazole|metronidazole|mesh-list
101460340|NCT00223691|Purinergic Agents|purinergic agents|mesh-ancestor
101424143|NCT03739645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101424144|NCT03739645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101424145|NCT03739645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101424146|NCT03739645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101424147|NCT03705585|Vaccines|vaccines|mesh-list
101424148|NCT03705585|Immunologic Factors|immunologic factors|mesh-ancestor
101424149|NCT03705585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424150|NCT03695237|Leuprolide|leuprolide|mesh-list
101424151|NCT03695237|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101424152|NCT03695237|Fertility Agents|fertility agents|mesh-ancestor
101424153|NCT03695237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101424154|NCT03695237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424157|NCT03603509|Vaccines|vaccines|mesh-list
101424158|NCT03603509|Immunologic Factors|immunologic factors|mesh-ancestor
101424159|NCT03603509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424160|NCT03517969|Carboplatin|carboplatin|mesh-list
101424161|NCT03517969|Docetaxel|docetaxel|mesh-list
101424162|NCT03517969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424163|NCT03517969|Tubulin Modulators|tubulin modulators|mesh-ancestor
101424164|NCT03517969|Antimitotic Agents|antimitotic agents|mesh-ancestor
101424165|NCT03517969|Mitosis Modulators|mitosis modulators|mesh-ancestor
101424166|NCT03517969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424167|NCT03405792|Pembrolizumab|pembrolizumab|mesh-list
101424168|NCT03405792|Temozolomide|temozolomide|mesh-list
101424169|NCT03405792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101424170|NCT03405792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424171|NCT03405792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101424172|NCT03405792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424173|NCT03405792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101424174|NCT03405792|Alkylating Agents|alkylating agents|mesh-ancestor
101424175|NCT03361345|Tranexamic Acid|tranexamic acid|mesh-list
101424176|NCT03361345|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101424177|NCT03361345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101424178|NCT03361345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424179|NCT03361345|Hemostatics|hemostatics|mesh-ancestor
101424180|NCT03361345|Coagulants|coagulants|mesh-ancestor
101424181|NCT03275285|Dexamethasone|dexamethasone|mesh-list
101424182|NCT03275285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101424183|NCT03275285|Antiemetics|antiemetics|mesh-ancestor
101424184|NCT03275285|Autonomic Agents|autonomic agents|mesh-ancestor
101557009|NCT04466917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557010|NCT04466917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101557011|NCT04466917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101557012|NCT04466917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101557013|NCT04466917|Growth Substances|growth substances|mesh-ancestor
101557014|NCT04466917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557015|NCT04466917|Growth Inhibitors|growth inhibitors|mesh-ancestor
101557016|NCT04462471|Vemurafenib|vemurafenib|mesh-list
101557017|NCT04462471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557018|NCT04462471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101557019|NCT04462471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101557020|NCT04462471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557024|NCT04370483|Leflunomide|leflunomide|mesh-list
101557025|NCT04370483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101557026|NCT04370483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557027|NCT04370483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101557028|NCT04370483|Immunologic Factors|immunologic factors|mesh-ancestor
101557029|NCT04370483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557030|NCT04339777|Mycophenolic Acid|mycophenolic acid|mesh-list
101424185|NCT03275285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101424186|NCT03275285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424187|NCT03275285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101424188|NCT03275285|Glucocorticoids|glucocorticoids|mesh-ancestor
101424189|NCT03275285|Hormones|hormones|mesh-ancestor
101424190|NCT03275285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101424191|NCT03275285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101306812|NCT02027922|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
101424192|NCT03275285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424195|NCT03216187|Sensory System Agents|sensory system agents|mesh-ancestor
101424196|NCT03216187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101424197|NCT03216187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424198|NCT03216187|Anticonvulsants|anticonvulsants|mesh-ancestor
101424199|NCT03216187|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101424200|NCT03216187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101424201|NCT03216187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424202|NCT03216187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101424203|NCT03216187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101424204|NCT03216187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101424214|NCT03172754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101424215|NCT03172754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424216|NCT03172754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101424217|NCT03172754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101424218|NCT03137888|Temozolomide|temozolomide|mesh-list
101424219|NCT03137888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101424220|NCT03137888|Alkylating Agents|alkylating agents|mesh-ancestor
101424221|NCT03137888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424222|NCT03137888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424223|NCT03123913|Methyltestosterone|methyltestosterone|mesh-list
101424224|NCT03123913|Testosterone|testosterone|mesh-list
101424225|NCT03123913|Testosterone undecanoate|testosterone undecanoate|mesh-list
101424226|NCT03123913|Testosterone enanthate|testosterone enanthate|mesh-list
101557031|NCT04339777|Cyclophosphamide|cyclophosphamide|mesh-list
101557033|NCT04339777|Fludarabine|fludarabine|mesh-list
101557034|NCT04339777|Alemtuzumab|alemtuzumab|mesh-list
101557036|NCT04339777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101557037|NCT04339777|Immunologic Factors|immunologic factors|mesh-ancestor
101557038|NCT04339777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557039|NCT04339777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101557040|NCT04339777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101557041|NCT04339777|Alkylating Agents|alkylating agents|mesh-ancestor
101424227|NCT03123913|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101424239|NCT03039985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424240|NCT03039985|Antimanic Agents|antimanic agents|mesh-ancestor
101424241|NCT03039985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101424242|NCT03039985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101424243|NCT03039985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424244|NCT03007238|Aldesleukin|aldesleukin|mesh-list
101424245|NCT03007238|Interleukin-2|interleukin-2|mesh-list
101424246|NCT03007238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424247|NCT03007238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101424248|NCT03007238|Analgesics|analgesics|mesh-ancestor
101424249|NCT03007238|Sensory System Agents|sensory system agents|mesh-ancestor
101424250|NCT03007238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101424251|NCT03007238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424252|NCT03007238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101424253|NCT03007238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101424254|NCT03007238|Antiviral Agents|antiviral agents|mesh-ancestor
101424255|NCT03007238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101424256|NCT02902198|Quinine|quinine|mesh-list
101424257|NCT02902198|Antimalarials|antimalarials|mesh-ancestor
101424258|NCT02902198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101424259|NCT02902198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101424260|NCT02902198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101424261|NCT02902198|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101424262|NCT02902198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424263|NCT02902198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101424264|NCT02902198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101424265|NCT02902198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101424266|NCT02902198|Analgesics|analgesics|mesh-ancestor
101424267|NCT02902198|Sensory System Agents|sensory system agents|mesh-ancestor
101424268|NCT02858869|Pembrolizumab|pembrolizumab|mesh-list
101424269|NCT02858869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101424270|NCT02858869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424271|NCT02858869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101424272|NCT02858869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424273|NCT02811523|Doxorubicin|doxorubicin|mesh-list
101306814|NCT02027922|Protective Agents|protective agents|mesh-ancestor
101306815|NCT02027922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306817|NCT02027961|Trametinib|trametinib|mesh-list
101424274|NCT02811523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101424275|NCT02811523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424276|NCT02811523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101424277|NCT02811523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101424278|NCT02811523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101424281|NCT02750319|Amiodarone|amiodarone|mesh-list
101424282|NCT02750319|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101424283|NCT02750319|Antiviral Agents|antiviral agents|mesh-ancestor
101424284|NCT02750319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101424285|NCT02750319|Expectorants|expectorants|mesh-ancestor
101424286|NCT02750319|Respiratory System Agents|respiratory system agents|mesh-ancestor
101424287|NCT02750319|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101424288|NCT02750319|Antioxidants|antioxidants|mesh-ancestor
101424289|NCT02750319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424290|NCT02750319|Protective Agents|protective agents|mesh-ancestor
101424291|NCT02750319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424292|NCT02750319|Antidotes|antidotes|mesh-ancestor
101424296|NCT02750319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101557042|NCT04339777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557043|NCT04339777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557044|NCT04339777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101557045|NCT04339777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101557046|NCT04339777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101557047|NCT04339777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101557048|NCT04339777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101557049|NCT04339777|Antitubercular Agents|antitubercular agents|mesh-ancestor
101557050|NCT04339777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101557051|NCT04339777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101557052|NCT04339777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101557054|NCT04337970|Talazoparib|talazoparib|mesh-list
101557055|NCT04337970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557056|NCT04337970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101557057|NCT04337970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101557058|NCT04337970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557059|NCT04337970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101557060|NCT04297254|Lenvatinib|lenvatinib|mesh-list
101557061|NCT04297254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557062|NCT04297254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101557063|NCT04297254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101557064|NCT04297254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557065|NCT04283656|Tenofovir|tenofovir|mesh-list
101557066|NCT04283656|Lamivudine|lamivudine|mesh-list
101557067|NCT04283656|Spironolactone|spironolactone|mesh-list
101405499|NCT04244058|Sensory System Agents|sensory system agents|mesh-ancestor
101405500|NCT04244058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101405501|NCT00132444|UC-781|uc-781|mesh-list
101424297|NCT02750319|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101424298|NCT02750319|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101424299|NCT02750319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101424300|NCT02750319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101424301|NCT02750319|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101424302|NCT02750319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101424303|NCT02750319|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101424305|NCT02636582|Vaccines|vaccines|mesh-list
101424306|NCT02636582|Sargramostim|sargramostim|mesh-list
101424307|NCT02636582|Immunologic Factors|immunologic factors|mesh-ancestor
101424308|NCT02636582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424309|NCT02636582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424310|NCT02611258|Tadalafil|tadalafil|mesh-list
101424311|NCT02611258|Vasodilator Agents|vasodilator agents|mesh-ancestor
101424312|NCT02611258|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101557069|NCT04283656|Antiviral Agents|antiviral agents|mesh-ancestor
101557070|NCT04283656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101557071|NCT04283656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101557072|NCT04283656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101557073|NCT04283656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101557074|NCT04283656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557075|NCT04283656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101557076|NCT04283656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101557077|NCT04283656|Estrogens|estrogens|mesh-ancestor
101557078|NCT04283656|Hormones|hormones|mesh-ancestor
101557079|NCT04283656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101557080|NCT04283656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557081|NCT04283656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101557082|NCT04283656|Hormone Antagonists|hormone antagonists|mesh-ancestor
101557083|NCT04283656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101557084|NCT04283656|Diuretics|diuretics|mesh-ancestor
101557085|NCT04283656|Natriuretic Agents|natriuretic agents|mesh-ancestor
101557086|NCT04275999|Ivermectin|ivermectin|mesh-list
101557087|NCT04275999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101424313|NCT02611258|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101424314|NCT02611258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101424315|NCT02611258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424316|NCT02611258|Urological Agents|urological agents|mesh-ancestor
101424317|NCT02532231|Nivolumab|nivolumab|mesh-list
101424318|NCT02532231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101424319|NCT02532231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424320|NCT02532231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101424321|NCT02532231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424322|NCT02367040|Rituximab|rituximab|mesh-list
101424323|NCT02367040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101424324|NCT02367040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424325|NCT02367040|Immunologic Factors|immunologic factors|mesh-ancestor
101424326|NCT02367040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424327|NCT02367040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101424328|NCT02172651|Vitamin D|vitamin d|mesh-list
101424329|NCT02172651|Ergocalciferols|ergocalciferols|mesh-list
101424330|NCT02172651|Cholecalciferol|cholecalciferol|mesh-list
101424331|NCT02172651|Vitamins|vitamins|mesh-list
101424332|NCT02172651|Micronutrients|micronutrients|mesh-ancestor
101424333|NCT02172651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424334|NCT02172651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101424335|NCT02172651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101424336|NCT02144857|Cyclosporine|cyclosporine|mesh-list
101424337|NCT02144857|Etanercept|etanercept|mesh-list
101424338|NCT02144857|Apremilast|apremilast|mesh-list
101424339|NCT02144857|Ustekinumab|ustekinumab|mesh-list
101424340|NCT02144857|Cyclosporins|cyclosporins|mesh-list
101424341|NCT02144857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101424342|NCT02144857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424343|NCT02144857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101424344|NCT02144857|Immunologic Factors|immunologic factors|mesh-ancestor
101306818|NCT02027961|Dabrafenib|dabrafenib|mesh-list
101306819|NCT02027961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101557088|NCT04275999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101557089|NCT04268277|Rituximab|rituximab|mesh-list
101557090|NCT04268277|Pembrolizumab|pembrolizumab|mesh-list
101557091|NCT04268277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101557092|NCT04268277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557093|NCT04268277|Immunologic Factors|immunologic factors|mesh-ancestor
101557094|NCT04268277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557095|NCT04268277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101557096|NCT04268277|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101557097|NCT04268277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306820|NCT02027961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101306821|NCT02027961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101306822|NCT02027961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101306823|NCT02027961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306824|NCT02027987|Valproic Acid|valproic acid|mesh-list
101424345|NCT02144857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424346|NCT02144857|Antifungal Agents|antifungal agents|mesh-ancestor
101424347|NCT02144857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101424384|NCT01252953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424385|NCT01252953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101424386|NCT01252953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101424387|NCT01252953|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101424388|NCT01252953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101424389|NCT00937131|Rituximab|rituximab|mesh-list
101424390|NCT00937131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101424404|NCT00837616|Contraceptive Agents|contraceptive agents|mesh-ancestor
101424405|NCT00837616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101424406|NCT00837616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101424408|NCT00610051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101306826|NCT02027987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101306827|NCT02027987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306828|NCT02027987|GABA Agents|gaba agents|mesh-ancestor
101306829|NCT02027987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101306830|NCT02027987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306831|NCT02027987|Antimanic Agents|antimanic agents|mesh-ancestor
101306832|NCT02027987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101424409|NCT00610051|Vasodilator Agents|vasodilator agents|mesh-ancestor
101424410|NCT00610051|Urological Agents|urological agents|mesh-ancestor
101424411|NCT00176254|Paclitaxel|paclitaxel|mesh-list
101424412|NCT00176254|Carboplatin|carboplatin|mesh-list
101424413|NCT00176254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101424414|NCT00176254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424415|NCT00176254|Tubulin Modulators|tubulin modulators|mesh-ancestor
101424416|NCT00176254|Antimitotic Agents|antimitotic agents|mesh-ancestor
101424417|NCT00176254|Mitosis Modulators|mitosis modulators|mesh-ancestor
101424418|NCT00176254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424419|NCT02949895|Etoposide|etoposide|mesh-list
101424420|NCT02949895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424421|NCT02949895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101424422|NCT02949895|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101424423|NCT02949895|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101424424|NCT02949895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101424425|NCT02949895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424426|NCT02949583|Chlorhexidine|chlorhexidine|mesh-list
101424427|NCT02949583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101424428|NCT02949583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101424429|NCT02949583|Disinfectants|disinfectants|mesh-ancestor
101424430|NCT00516841|Volociximab|volociximab|mesh-list
101424431|NCT00516841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101424432|NCT00516841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101424433|NCT00516841|Growth Substances|growth substances|mesh-ancestor
101424434|NCT00516841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424443|NCT04694677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101557098|NCT04238624|Trametinib|trametinib|mesh-list
101557099|NCT04238624|Dabrafenib|dabrafenib|mesh-list
101557100|NCT04238624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557101|NCT04238624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101557102|NCT04238624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101557103|NCT04238624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557104|NCT04207931|Fluocinonide|fluocinonide|mesh-list
101557105|NCT04207931|Triamcinolone|triamcinolone|mesh-list
101557106|NCT04207931|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101557107|NCT04207931|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101557108|NCT04207931|Betamethasone|betamethasone|mesh-list
101557109|NCT04207931|Betamethasone Valerate|betamethasone valerate|mesh-list
101557110|NCT04207931|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101557111|NCT04207931|Betamethasone benzoate|betamethasone benzoate|mesh-list
101557112|NCT04207931|Clobetasol|clobetasol|mesh-list
101557113|NCT04207931|Minoxidil|minoxidil|mesh-list
101557114|NCT04207931|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101557115|NCT04207931|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101557116|NCT04207931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101557117|NCT04207931|Glucocorticoids|glucocorticoids|mesh-ancestor
101557118|NCT04207931|Hormones|hormones|mesh-ancestor
101557119|NCT04207931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101557120|NCT04207931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557121|NCT04207931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101557122|NCT04207931|Immunologic Factors|immunologic factors|mesh-ancestor
101557123|NCT04207931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101557124|NCT04207931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557125|NCT04207931|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101557126|NCT04207931|Respiratory System Agents|respiratory system agents|mesh-ancestor
101557127|NCT04207931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101557128|NCT04207931|Vasodilator Agents|vasodilator agents|mesh-ancestor
101557142|NCT04153136|Valsartan|valsartan|mesh-list
101557143|NCT04153136|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101557144|NCT04153136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101557145|NCT04153136|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101557146|NCT04153136|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101557147|NCT04153136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557148|NCT04128072|Mogamulizumab|mogamulizumab|mesh-list
101557149|NCT04128072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557150|NCT04106414|Nivolumab|nivolumab|mesh-list
101557151|NCT04106414|Linrodostat|linrodostat|mesh-list
101557152|NCT04106414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101557153|NCT04106414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405605|NCT00100685|Growth Substances|growth substances|mesh-ancestor
101405608|NCT00132756|Estramustine|estramustine|mesh-list
101424444|NCT04694677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424445|NCT04694677|Hemostatics|hemostatics|mesh-ancestor
101424446|NCT04694677|Coagulants|coagulants|mesh-ancestor
101424447|NCT04694677|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101424448|NCT04694677|Abortifacient Agents|abortifacient agents|mesh-ancestor
101424449|NCT04694677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101424450|NCT04694677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424451|NCT04694677|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101424452|NCT04694677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101424458|NCT00516958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101424459|NCT00516958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101424460|NCT00516958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101424461|NCT00516958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101424462|NCT00516958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101424463|NCT00516958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424464|NCT00516958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101460411|NCT04583020|Temozolomide|temozolomide|mesh-list
101424465|NCT00516958|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101424466|NCT00516958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101424467|NCT00516958|Disinfectants|disinfectants|mesh-ancestor
101424468|NCT00517114|Rabeprazole|rabeprazole|mesh-list
101424469|NCT00517114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101424470|NCT00517114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101424471|NCT00517114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101424472|NCT00517114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101424473|NCT00517114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306833|NCT02027987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101306834|NCT02027987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101306835|NCT02028026|Citalopram|citalopram|mesh-list
101306836|NCT02028026|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
101424474|NCT00517270|Rabeprazole|rabeprazole|mesh-list
101424475|NCT00517270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101424476|NCT00517270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101424477|NCT00517270|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101424478|NCT00517270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101424479|NCT00517270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424480|NCT00517309|Vaccines|vaccines|mesh-list
101424481|NCT00517309|Immunologic Factors|immunologic factors|mesh-ancestor
101424482|NCT00517309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424483|NCT00517387|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101424484|NCT00517387|Antidepressive Agents|antidepressive agents|mesh-ancestor
101424485|NCT00517387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101424486|NCT00517387|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101424487|NCT00517387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101424488|NCT00517387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101424489|NCT00517387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557154|NCT04106414|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101557155|NCT04106414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557156|NCT04106414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101557157|NCT04063267|Nicotine|nicotine|mesh-list
101557158|NCT04063267|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101557159|NCT04063267|Autonomic Agents|autonomic agents|mesh-ancestor
101557160|NCT04063267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101557161|NCT04063267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557162|NCT04063267|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101557163|NCT04063267|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101557164|NCT04063267|Cholinergic Agents|cholinergic agents|mesh-ancestor
101557165|NCT04063267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101557166|NCT04063267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557167|NCT04047914|Anti-Infective Agents|anti-infective agents|mesh-list
101557168|NCT04047914|Mupirocin|mupirocin|mesh-list
101557169|NCT04047914|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101557170|NCT04047914|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101557171|NCT04047914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101557172|NCT04047914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557173|NCT04042753|Nivolumab|nivolumab|mesh-list
101557174|NCT04042753|Ipilimumab|ipilimumab|mesh-list
101557175|NCT04042753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101557176|NCT04042753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557177|NCT04042753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101628314|NCT00720343|Nootropic Agents|nootropic agents|mesh-ancestor
101424490|NCT00517426|Acetazolamide|acetazolamide|mesh-list
101424491|NCT00517426|Anticonvulsants|anticonvulsants|mesh-ancestor
101424492|NCT00517426|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101424493|NCT00517426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101424494|NCT00517426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424495|NCT00517426|Diuretics|diuretics|mesh-ancestor
101424496|NCT00517426|Natriuretic Agents|natriuretic agents|mesh-ancestor
101359052|NCT00207064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101424497|NCT00517426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424498|NCT00517504|Methylphenidate|methylphenidate|mesh-list
101424499|NCT00517504|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101424500|NCT00517504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424501|NCT00517504|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101424511|NCT00517582|Sensory System Agents|sensory system agents|mesh-ancestor
101424512|NCT00517582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101424513|NCT00517582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424514|NCT00517582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101424515|NCT00517582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101424516|NCT00517582|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
101424517|NCT00517582|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
101424518|NCT00517582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424519|NCT00517582|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101424520|NCT00517582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101424521|NCT00517582|Immunologic Factors|immunologic factors|mesh-ancestor
101557178|NCT04042753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557180|NCT03999710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101557181|NCT03999710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557182|NCT03995355|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101557183|NCT03995355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101557184|NCT03945591|Cyclophosphamide|cyclophosphamide|mesh-list
101557186|NCT03945591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101557187|NCT03945591|Immunologic Factors|immunologic factors|mesh-ancestor
101557188|NCT03945591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557189|NCT03945591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101557190|NCT03945591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101557191|NCT03945591|Alkylating Agents|alkylating agents|mesh-ancestor
101557192|NCT03945591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557193|NCT03945591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405645|NCT00101114|Interferons|interferons|mesh-list
101424522|NCT00517621|Paclitaxel|paclitaxel|mesh-list
101424523|NCT00517621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101424524|NCT00517621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424525|NCT00517621|Tubulin Modulators|tubulin modulators|mesh-ancestor
101424526|NCT00517621|Antimitotic Agents|antimitotic agents|mesh-ancestor
101424527|NCT00517621|Mitosis Modulators|mitosis modulators|mesh-ancestor
101424529|NCT00151515|Minoxidil|minoxidil|mesh-list
101424530|NCT00151515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101424531|NCT00151515|Vasodilator Agents|vasodilator agents|mesh-ancestor
101424532|NCT00166686|Clonidine|clonidine|mesh-list
101424533|NCT00166686|Analgesics|analgesics|mesh-ancestor
101424534|NCT00166686|Sensory System Agents|sensory system agents|mesh-ancestor
101424535|NCT00166686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101424536|NCT00166686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424537|NCT00166686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101424538|NCT00166686|Sympatholytics|sympatholytics|mesh-ancestor
101424539|NCT00166686|Autonomic Agents|autonomic agents|mesh-ancestor
101424540|NCT00166686|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101424541|NCT00166686|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101424542|NCT00166686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101424543|NCT00166686|Adrenergic Agents|adrenergic agents|mesh-ancestor
101424544|NCT00166686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101424545|NCT00166686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424546|NCT02949778|Ropivacaine|ropivacaine|mesh-list
101424547|NCT02949778|Anesthetics, Local|anesthetics, local|mesh-ancestor
101424548|NCT02949778|Anesthetics|anesthetics|mesh-ancestor
101306837|NCT02028026|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101424549|NCT02949778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101424550|NCT02949778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424551|NCT02949778|Sensory System Agents|sensory system agents|mesh-ancestor
101424552|NCT02949778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101424553|NCT00518245|Enoxaparin|enoxaparin|mesh-list
101424554|NCT00518245|Anticoagulants|anticoagulants|mesh-ancestor
101424555|NCT00518245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101424556|NCT00518245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101424557|NCT00518245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424558|NCT02957903|Ropivacaine|ropivacaine|mesh-list
101424559|NCT02957903|Anesthetics, Local|anesthetics, local|mesh-ancestor
101424560|NCT02957903|Anesthetics|anesthetics|mesh-ancestor
101424561|NCT02957903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101424562|NCT02957903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557194|NCT03945591|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101557195|NCT03942211|Selexipag|selexipag|mesh-list
101557196|NCT03942211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101557197|NCT03933397|Morphine|morphine|mesh-list
101557198|NCT03933397|Hydromorphone|hydromorphone|mesh-list
101557199|NCT03933397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101557200|NCT03933397|Narcotics|narcotics|mesh-ancestor
101557201|NCT03933397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101557202|NCT03933397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557203|NCT03933397|Analgesics|analgesics|mesh-ancestor
101557204|NCT03933397|Sensory System Agents|sensory system agents|mesh-ancestor
101557205|NCT03933397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101557206|NCT03925090|Cisplatin|cisplatin|mesh-list
101557207|NCT03925090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557208|NCT03919266|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101557209|NCT03919266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101557210|NCT03829436|Nivolumab|nivolumab|mesh-list
101557211|NCT03829436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101557212|NCT03829436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557213|NCT03829436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101557214|NCT03829436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557215|NCT03819296|Prednisone|prednisone|mesh-list
101557216|NCT03819296|Infliximab|infliximab|mesh-list
101424563|NCT02957903|Sensory System Agents|sensory system agents|mesh-ancestor
101424564|NCT02957903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101424592|NCT00151632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101424593|NCT00151632|Immunologic Factors|immunologic factors|mesh-ancestor
101424594|NCT00151632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424595|NCT00151632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101424596|NCT00151632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101424597|NCT00151632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424598|NCT00151632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101424599|NCT00151632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424600|NCT00151632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101424601|NCT00151632|Antitubercular Agents|antitubercular agents|mesh-ancestor
101424602|NCT00151632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101424603|NCT00151632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101424604|NCT02949232|Prednisolone|prednisolone|mesh-list
101424605|NCT02949232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101424606|NCT02949232|Glucocorticoids|glucocorticoids|mesh-ancestor
101424608|NCT02949232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101424609|NCT02949232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424610|NCT02949232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101424611|NCT02949232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424612|NCT00518908|Sevoflurane|sevoflurane|mesh-list
101424629|NCT00518947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101424630|NCT00518947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101424631|NCT00518947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101813801|NCT04048889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101424632|NCT00518947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101424633|NCT00518947|Vasodilator Agents|vasodilator agents|mesh-ancestor
101424634|NCT02949466|Triamcinolone|triamcinolone|mesh-list
101424635|NCT02949466|Hyaluronic Acid|hyaluronic acid|mesh-list
101557217|NCT03819296|Cortisone|cortisone|mesh-list
101557218|NCT03819296|Vedolizumab|vedolizumab|mesh-list
101557219|NCT03819296|Immunoglobulins|immunoglobulins|mesh-list
101557220|NCT03819296|Immunoglobulin G|immunoglobulin g|mesh-list
101557221|NCT03819296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101557222|NCT03819296|Glucocorticoids|glucocorticoids|mesh-ancestor
101557223|NCT03819296|Hormones|hormones|mesh-ancestor
101557224|NCT03819296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101557225|NCT03819296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557226|NCT03819296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101557227|NCT03819296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557228|NCT03819296|Immunologic Factors|immunologic factors|mesh-ancestor
101557229|NCT03819296|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101557230|NCT03819296|Dermatologic Agents|dermatologic agents|mesh-ancestor
101557231|NCT03819296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101557232|NCT03819296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101557233|NCT03790488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101557234|NCT03790488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424636|NCT02949466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101424637|NCT02949466|Glucocorticoids|glucocorticoids|mesh-ancestor
101424638|NCT02949466|Hormones|hormones|mesh-ancestor
101424639|NCT02949466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101424640|NCT02949466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424653|NCT00519181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101424654|NCT00519181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424655|NCT00519181|Antimanic Agents|antimanic agents|mesh-ancestor
101424656|NCT00519181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101424657|NCT00519181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101424658|NCT00519181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101424660|NCT00166803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101424661|NCT00166803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424662|NCT02949310|Nefopam|nefopam|mesh-list
101306838|NCT02028026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101306839|NCT02028026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101306840|NCT02028026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306841|NCT02028026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101424663|NCT02949310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101424664|NCT02949310|Analgesics|analgesics|mesh-ancestor
101424665|NCT02949310|Sensory System Agents|sensory system agents|mesh-ancestor
101424666|NCT02949310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101424667|NCT02949310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424668|NCT02949349|Mycophenolic Acid|mycophenolic acid|mesh-list
101424669|NCT02949349|Prednisolone|prednisolone|mesh-list
101424670|NCT02949349|Azathioprine|azathioprine|mesh-list
101424675|NCT02949349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101424676|NCT02949349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101424677|NCT02949349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101424678|NCT02949349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424679|NCT02949349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101424680|NCT02949349|Glucocorticoids|glucocorticoids|mesh-ancestor
101424681|NCT02949349|Hormones|hormones|mesh-ancestor
101424682|NCT02949349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101424683|NCT02949349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424684|NCT02949349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101424685|NCT02949349|Antimetabolites|antimetabolites|mesh-ancestor
101557235|NCT03790488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101557236|NCT03790488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557237|NCT03775486|Paclitaxel|paclitaxel|mesh-list
101557238|NCT03775486|Cisplatin|cisplatin|mesh-list
101557239|NCT03775486|Carboplatin|carboplatin|mesh-list
101557240|NCT03775486|Gemcitabine|gemcitabine|mesh-list
101557241|NCT03775486|Pemetrexed|pemetrexed|mesh-list
101557242|NCT03775486|Durvalumab|durvalumab|mesh-list
101557243|NCT03775486|Olaparib|olaparib|mesh-list
101557244|NCT03775486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101557245|NCT03775486|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101557246|NCT03775486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557247|NCT03775486|Tubulin Modulators|tubulin modulators|mesh-ancestor
101557248|NCT03775486|Antimitotic Agents|antimitotic agents|mesh-ancestor
101405702|NCT00135408|Hormones|hormones|mesh-ancestor
101424686|NCT02949349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101424687|NCT02949349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101424688|NCT02949349|Immunologic Factors|immunologic factors|mesh-ancestor
101424689|NCT02949349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101424690|NCT00166842|Cyclosporine|cyclosporine|mesh-list
101424691|NCT00166842|Sirolimus|sirolimus|mesh-list
101424692|NCT00166842|Tacrolimus|tacrolimus|mesh-list
101424693|NCT00166842|Cyclosporins|cyclosporins|mesh-list
101424694|NCT00166842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101424695|NCT00166842|Immunologic Factors|immunologic factors|mesh-ancestor
101424696|NCT00166842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424697|NCT00166842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101424698|NCT00166842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101424699|NCT00166842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424700|NCT00166842|Antifungal Agents|antifungal agents|mesh-ancestor
101424701|NCT00166842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101424702|NCT00166842|Dermatologic Agents|dermatologic agents|mesh-ancestor
101424703|NCT00166842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101424704|NCT00166842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101424711|NCT02949193|Hormones|hormones|mesh-ancestor
101424712|NCT02949193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101424713|NCT02949193|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101424714|NCT02949193|Protease Inhibitors|protease inhibitors|mesh-ancestor
101424715|NCT02949193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101424716|NCT02949193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424717|NCT00519259|Lobeline|lobeline|mesh-list
101424718|NCT00519259|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101424719|NCT00519259|Autonomic Agents|autonomic agents|mesh-ancestor
101424720|NCT00519259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101424721|NCT00519259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424722|NCT00519259|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101424723|NCT00519259|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101424724|NCT00519259|Cholinergic Agents|cholinergic agents|mesh-ancestor
101424725|NCT00519259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101424726|NCT00519259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424727|NCT00519259|Respiratory System Agents|respiratory system agents|mesh-ancestor
101424728|NCT00519298|Donepezil|donepezil|mesh-list
101424729|NCT00519298|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101424730|NCT00519298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101306842|NCT02028026|Serotonin Agents|serotonin agents|mesh-ancestor
101306843|NCT02028026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460474|NCT00223964|Ferric gluconate|ferric gluconate|mesh-list
101424731|NCT00519298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424732|NCT00519298|Cholinergic Agents|cholinergic agents|mesh-ancestor
101424733|NCT00519298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101424734|NCT00519298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424735|NCT00519298|Nootropic Agents|nootropic agents|mesh-ancestor
101424736|NCT00519337|Ascorbic Acid|ascorbic acid|mesh-list
101424737|NCT00519337|Vitamins|vitamins|mesh-ancestor
101557249|NCT03775486|Mitosis Modulators|mitosis modulators|mesh-ancestor
101557250|NCT03775486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557251|NCT03775486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101557252|NCT03775486|Antimetabolites|antimetabolites|mesh-ancestor
101557253|NCT03775486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101557254|NCT03775486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101557255|NCT03775486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101557256|NCT03775486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101557257|NCT03775486|Immunologic Factors|immunologic factors|mesh-ancestor
101557258|NCT03775486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557259|NCT03775486|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101557260|NCT03767257|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
101557261|NCT03767257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101557262|NCT03767257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101557263|NCT03767257|Antimetabolites|antimetabolites|mesh-ancestor
101557264|NCT03767257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557265|NCT03767257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101557266|NCT03606499|Ustekinumab|ustekinumab|mesh-list
101557267|NCT03606499|Dermatologic Agents|dermatologic agents|mesh-ancestor
101557268|NCT03576690|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
101557269|NCT03576690|Atoltivimab|atoltivimab|mesh-list
101557270|NCT03576690|Odesivimab|odesivimab|mesh-list
101557271|NCT03576690|Maftivimab|maftivimab|mesh-list
101557272|NCT03576690|Antiviral Agents|antiviral agents|mesh-ancestor
101557273|NCT03576690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101424738|NCT00519337|Micronutrients|micronutrients|mesh-ancestor
101424739|NCT00519337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424754|NCT00166881|Mitosis Modulators|mitosis modulators|mesh-ancestor
101424755|NCT00166881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424756|NCT00166881|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101424757|NCT00166881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101424758|NCT00166881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101424759|NCT02948998|Spironolactone|spironolactone|mesh-list
101424760|NCT02948998|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101424761|NCT02948998|Hormone Antagonists|hormone antagonists|mesh-ancestor
101424762|NCT02948998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101424763|NCT02948998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424764|NCT02948998|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101424765|NCT02948998|Diuretics|diuretics|mesh-ancestor
101424766|NCT02948998|Natriuretic Agents|natriuretic agents|mesh-ancestor
101424767|NCT00519688|Thalidomide|thalidomide|mesh-list
101424768|NCT00519688|Tegafur|tegafur|mesh-list
101424769|NCT00519688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101424770|NCT00519688|Immunologic Factors|immunologic factors|mesh-ancestor
101424771|NCT00519688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424772|NCT00519688|Leprostatic Agents|leprostatic agents|mesh-ancestor
101424773|NCT00519688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101557274|NCT03573947|Paclitaxel|paclitaxel|mesh-list
101557275|NCT03573947|Nivolumab|nivolumab|mesh-list
101557276|NCT03573947|Ipilimumab|ipilimumab|mesh-list
101557277|NCT03573947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101557278|NCT03573947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557279|NCT03573947|Tubulin Modulators|tubulin modulators|mesh-ancestor
101557280|NCT03573947|Antimitotic Agents|antimitotic agents|mesh-ancestor
101557281|NCT03573947|Mitosis Modulators|mitosis modulators|mesh-ancestor
101557282|NCT03573947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460499|NCT00568711|Doxycycline|doxycycline|mesh-list
101557283|NCT03573947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101557284|NCT03573947|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101557285|NCT03567642|Etoposide|etoposide|mesh-list
101557286|NCT03567642|Osimertinib|osimertinib|mesh-list
101557287|NCT03567642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101557288|NCT03567642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557289|NCT03567642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101557290|NCT03567642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101557291|NCT03567642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101557292|NCT03567642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557293|NCT03567642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101557294|NCT03532880|Olaparib|olaparib|mesh-list
101557295|NCT03532880|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101557296|NCT03532880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101557297|NCT03532880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557298|NCT03532880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557299|NCT03520647|Cyclophosphamide|cyclophosphamide|mesh-list
101557300|NCT03520647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101557301|NCT03520647|Immunologic Factors|immunologic factors|mesh-ancestor
101405739|NCT00101348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101424774|NCT00519688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101424775|NCT00519688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101424776|NCT00519688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101424777|NCT00519688|Growth Substances|growth substances|mesh-ancestor
101424778|NCT00519688|Growth Inhibitors|growth inhibitors|mesh-ancestor
101424779|NCT00519688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424780|NCT00519688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101424781|NCT00519688|Antimetabolites|antimetabolites|mesh-ancestor
101424782|NCT00519688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424783|NCT02948920|Ephedrine|ephedrine|mesh-list
101424805|NCT00151827|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101424806|NCT00151827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101424808|NCT00519805|Tinzaparin|tinzaparin|mesh-list
101424809|NCT00519805|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101557302|NCT03520647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557303|NCT03520647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101557304|NCT03520647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101557305|NCT03520647|Alkylating Agents|alkylating agents|mesh-ancestor
101557306|NCT03520647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557307|NCT03520647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557308|NCT03520647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101424810|NCT00519805|Anticoagulants|anticoagulants|mesh-ancestor
101424811|NCT00519805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101424812|NCT00519805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101424813|NCT00519805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424814|NCT02948881|Ibandronic Acid|ibandronic acid|mesh-list
101306844|NCT02028026|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101306845|NCT02028026|Antidepressive Agents|antidepressive agents|mesh-ancestor
101424815|NCT02948881|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101424816|NCT02948881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424817|NCT04457180|Repaglinide|repaglinide|mesh-list
101424818|NCT04457180|Apatinib|apatinib|mesh-list
101424819|NCT04457180|Bupropion|bupropion|mesh-list
101424820|NCT04457180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424821|NCT04457180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101424822|NCT04457180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101460532|NCT00568750|Dasatinib|dasatinib|mesh-list
101424823|NCT04457180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424824|NCT04457180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101424825|NCT04457180|Antidepressive Agents|antidepressive agents|mesh-ancestor
101424826|NCT04457180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101424827|NCT04457180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101424828|NCT04457180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101424829|NCT04457180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101424830|NCT04457180|Dopamine Agents|dopamine agents|mesh-ancestor
101424831|NCT04457180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101424832|NCT04457180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424833|NCT04457180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101424850|NCT00151944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101424851|NCT00151944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424852|NCT00151944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101424853|NCT00151944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101424855|NCT00520507|Antiemetics|antiemetics|mesh-ancestor
101424856|NCT00520507|Autonomic Agents|autonomic agents|mesh-ancestor
101424857|NCT00520507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101424858|NCT00520507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424859|NCT00520507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101424860|NCT00520507|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101424861|NCT00520507|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101424862|NCT00520507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101424863|NCT00520507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101424864|NCT00520507|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101424865|NCT00520507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101424866|NCT00520507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101424867|NCT00520507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424868|NCT00520507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101424869|NCT00520507|Serotonin Agents|serotonin agents|mesh-ancestor
101424870|NCT04694404|Oxaliplatin|oxaliplatin|mesh-list
101424871|NCT04694404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424878|NCT00151983|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101424879|NCT00151983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424880|NCT00151983|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101557317|NCT03420508|Ensartinib|ensartinib|mesh-list
101557318|NCT03420508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557319|NCT03420508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101557320|NCT03420508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101557321|NCT03420508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557322|NCT03410875|Obinutuzumab|obinutuzumab|mesh-list
101557323|NCT03410875|Vemurafenib|vemurafenib|mesh-list
101557324|NCT03410875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101557325|NCT03410875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557326|NCT03410875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101557327|NCT03410875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101557328|NCT03410875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557330|NCT03295240|Venetoclax|venetoclax|mesh-list
101557331|NCT03295240|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101557332|NCT03295240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101557333|NCT03295240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557334|NCT03295240|Immunologic Factors|immunologic factors|mesh-ancestor
101557335|NCT03295240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557336|NCT03295240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101557337|NCT03295240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101557338|NCT03295240|Alkylating Agents|alkylating agents|mesh-ancestor
101405781|NCT00101738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101424881|NCT00151983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101460537|NCT00568789|Zolpidem|zolpidem|mesh-list
101424882|NCT00151983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101424883|NCT00151983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424884|NCT00151983|Dopamine Agents|dopamine agents|mesh-ancestor
101424885|NCT00151983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101424886|NCT00520585|Atorvastatin|atorvastatin|mesh-list
101424887|NCT00520585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101424888|NCT00520585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101424889|NCT00520585|Antimetabolites|antimetabolites|mesh-ancestor
101306846|NCT02028026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101424890|NCT00520585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424891|NCT00520585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101424892|NCT00520585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101424893|NCT00520585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101424894|NCT00152022|Amphetamine|amphetamine|mesh-list
101424895|NCT00152022|Dextroamphetamine|dextroamphetamine|mesh-list
101424901|NCT00152022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101424902|NCT00152022|Dopamine Agents|dopamine agents|mesh-ancestor
101424903|NCT00152022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101424904|NCT00152022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424905|NCT00152022|Adrenergic Agents|adrenergic agents|mesh-ancestor
101424906|NCT00152022|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101424907|NCT00152022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101424908|NCT00152022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101424909|NCT00152022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101424910|NCT00520819|Antioxidants|antioxidants|mesh-list
101557339|NCT03295240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557340|NCT03207945|Alirocumab|alirocumab|mesh-list
101557341|NCT03207945|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101557342|NCT03207945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101557343|NCT03207945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101557344|NCT03207945|Antimetabolites|antimetabolites|mesh-ancestor
101557345|NCT03207945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557346|NCT03207945|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101557347|NCT03207945|Protease Inhibitors|protease inhibitors|mesh-ancestor
101557348|NCT03207945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101557349|NCT03207945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101557350|NCT03134703|Morphine|morphine|mesh-list
101557351|NCT03134703|Methadone|methadone|mesh-list
101557352|NCT03134703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101557353|NCT03134703|Narcotics|narcotics|mesh-ancestor
101557354|NCT03134703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101557355|NCT03134703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557356|NCT03134703|Analgesics|analgesics|mesh-ancestor
101424911|NCT00520819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424912|NCT00520819|Protective Agents|protective agents|mesh-ancestor
101424913|NCT00520819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424914|NCT00520897|Raltegravir Potassium|raltegravir potassium|mesh-list
101424915|NCT00520897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101424916|NCT00520897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101424917|NCT00520897|Antiviral Agents|antiviral agents|mesh-ancestor
101424918|NCT00520897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101424919|NCT00520897|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101424920|NCT00520897|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101424921|NCT00520897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101424922|NCT00520897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424923|NCT00521092|Sunitinib|sunitinib|mesh-list
101424924|NCT00521092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424925|NCT00521092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101424926|NCT00521092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101424927|NCT00521092|Growth Substances|growth substances|mesh-ancestor
101424928|NCT00521092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424929|NCT00521092|Growth Inhibitors|growth inhibitors|mesh-ancestor
101424930|NCT00521092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101424931|NCT00521092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101424932|NCT00521092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424933|NCT00521131|Levocetirizine|levocetirizine|mesh-list
101424934|NCT00521131|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101424935|NCT00521131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101424936|NCT00521131|Histamine Antagonists|histamine antagonists|mesh-ancestor
101424937|NCT00521131|Histamine Agents|histamine agents|mesh-ancestor
101424938|NCT00521131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101424957|NCT00521248|Morphine|morphine|mesh-list
101424958|NCT00521248|Buprenorphine|buprenorphine|mesh-list
101424959|NCT00521248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101424960|NCT00521248|Narcotics|narcotics|mesh-ancestor
101424961|NCT00521248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101424962|NCT00521248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424963|NCT00521248|Analgesics|analgesics|mesh-ancestor
101424964|NCT00521248|Sensory System Agents|sensory system agents|mesh-ancestor
101424965|NCT00521248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101424966|NCT00521248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101424967|NCT00167154|Risperidone|risperidone|mesh-list
101424968|NCT00167154|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101557357|NCT03134703|Sensory System Agents|sensory system agents|mesh-ancestor
101557358|NCT03134703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101557359|NCT03134703|Antitussive Agents|antitussive agents|mesh-ancestor
101557360|NCT03134703|Respiratory System Agents|respiratory system agents|mesh-ancestor
101557361|NCT03118674|Sofosbuvir|sofosbuvir|mesh-list
101557362|NCT03118674|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
101557363|NCT03118674|Ledipasvir|ledipasvir|mesh-list
101557364|NCT03118674|Antiviral Agents|antiviral agents|mesh-ancestor
101557365|NCT03118674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101557366|NCT03085056|Paclitaxel|paclitaxel|mesh-list
101557367|NCT03085056|Trametinib|trametinib|mesh-list
101557368|NCT03085056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101424969|NCT00167154|Serotonin Agents|serotonin agents|mesh-ancestor
101424970|NCT00167154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101424971|NCT00167154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424972|NCT00167154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424973|NCT00167154|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101424974|NCT00167154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101424975|NCT00167154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101424976|NCT00167154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101306847|NCT02028026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101306848|NCT02028026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101306849|NCT02028078|Insulin|insulin|mesh-list
101306850|NCT02028078|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101306851|NCT02028078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101424977|NCT00167154|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101424978|NCT00167154|Dopamine Agents|dopamine agents|mesh-ancestor
101425005|NCT00522184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101425006|NCT00522184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101425007|NCT00522184|Analgesics|analgesics|mesh-ancestor
101425008|NCT00522184|Sensory System Agents|sensory system agents|mesh-ancestor
101425009|NCT00522184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101460564|NCT00254241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101425010|NCT00522184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425011|NCT00522184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101425012|NCT00522184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101425013|NCT00522184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101425014|NCT00522184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101425015|NCT00522184|Immunologic Factors|immunologic factors|mesh-ancestor
101425016|NCT03458923|Diclofenac|diclofenac|mesh-list
101425017|NCT03458923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101425018|NCT03458923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101425019|NCT03458923|Ranibizumab|ranibizumab|mesh-list
101425020|NCT03458923|Endothelial Growth Factors|endothelial growth factors|mesh-list
101425021|NCT03458923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101425022|NCT03458923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101425023|NCT03458923|Growth Substances|growth substances|mesh-ancestor
101425024|NCT03458923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425025|NCT03458923|Growth Inhibitors|growth inhibitors|mesh-ancestor
101425026|NCT03458923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101425027|NCT03458923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425028|NCT03458923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101425029|NCT03458923|Analgesics|analgesics|mesh-ancestor
101425042|NCT00152139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306852|NCT02028078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306854|NCT02028234|Pantoprazole|pantoprazole|mesh-list
101306855|NCT02028234|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101425043|NCT04725162|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101425044|NCT04725162|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101425045|NCT04725162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425046|NCT00405431|Lubricant Eye Drops|lubricant eye drops|mesh-list
101425047|NCT00405431|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101425048|NCT00405431|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101425049|NCT00167232|Naltrexone|naltrexone|mesh-list
101557369|NCT03085056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557370|NCT03085056|Tubulin Modulators|tubulin modulators|mesh-ancestor
101557371|NCT03085056|Antimitotic Agents|antimitotic agents|mesh-ancestor
101557372|NCT03085056|Mitosis Modulators|mitosis modulators|mesh-ancestor
101557373|NCT03085056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557374|NCT03085056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101557375|NCT03085056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101557376|NCT03069352|Cytarabine|cytarabine|mesh-list
101557377|NCT03069352|Venetoclax|venetoclax|mesh-list
101557378|NCT03069352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101557379|NCT03069352|Antimetabolites|antimetabolites|mesh-ancestor
101557380|NCT03069352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557381|NCT03069352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557382|NCT03069352|Antiviral Agents|antiviral agents|mesh-ancestor
101557383|NCT03069352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101557384|NCT03069352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101460591|NCT00224354|Interleukin-2|interleukin-2|mesh-list
101557385|NCT03069352|Immunologic Factors|immunologic factors|mesh-ancestor
101557386|NCT03069352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519311|NCT04665284|Empagliflozin|empagliflozin|mesh-list
101557387|NCT03037437|Hydroxychloroquine|hydroxychloroquine|mesh-list
101557388|NCT03037437|Sorafenib|sorafenib|mesh-list
101557389|NCT03037437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557390|NCT03037437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101557391|NCT03037437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101557392|NCT03037437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557393|NCT03037437|Antimalarials|antimalarials|mesh-ancestor
101557394|NCT03037437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101557395|NCT03037437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101557396|NCT03037437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101557397|NCT03037437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101557398|NCT03036488|Paclitaxel|paclitaxel|mesh-list
101557399|NCT03036488|Cyclophosphamide|cyclophosphamide|mesh-list
101557400|NCT03036488|Carboplatin|carboplatin|mesh-list
101557401|NCT03036488|Doxorubicin|doxorubicin|mesh-list
101425050|NCT00167232|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101425051|NCT00167232|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101425052|NCT00167232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425053|NCT00167232|Sensory System Agents|sensory system agents|mesh-ancestor
101425054|NCT00167232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101425055|NCT00522886|Cetuximab|cetuximab|mesh-list
101425056|NCT00522886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101425057|NCT00522886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101425058|NCT04083560|Hydroxocobalamin|hydroxocobalamin|mesh-list
101557402|NCT03036488|Pembrolizumab|pembrolizumab|mesh-list
101557403|NCT03036488|Epirubicin|epirubicin|mesh-list
101557404|NCT03036488|Lenograstim|lenograstim|mesh-list
101557405|NCT03036488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101557406|NCT03036488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557407|NCT03036488|Tubulin Modulators|tubulin modulators|mesh-ancestor
101557408|NCT03036488|Antimitotic Agents|antimitotic agents|mesh-ancestor
101557409|NCT03036488|Mitosis Modulators|mitosis modulators|mesh-ancestor
101557410|NCT03036488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557411|NCT03036488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101557412|NCT03036488|Immunologic Factors|immunologic factors|mesh-ancestor
101557413|NCT03036488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557414|NCT03036488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101557415|NCT03036488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101557416|NCT03036488|Alkylating Agents|alkylating agents|mesh-ancestor
101557417|NCT03036488|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101557418|NCT03036488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101557419|NCT03036488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101557420|NCT03036488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101557421|NCT03036488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101557422|NCT03036488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101557423|NCT03036488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101557424|NCT03036488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101557425|NCT03023631|Vaccines|vaccines|mesh-list
101557426|NCT03023631|Immunologic Factors|immunologic factors|mesh-ancestor
101557427|NCT03023631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557428|NCT02993523|Azacitidine|azacitidine|mesh-list
101557429|NCT02993523|Venetoclax|venetoclax|mesh-list
101557430|NCT02993523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101557431|NCT02993523|Antimetabolites|antimetabolites|mesh-ancestor
101557432|NCT02993523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557433|NCT02993523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557434|NCT02993523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101557435|NCT02989584|Gemcitabine|gemcitabine|mesh-list
101557436|NCT02989584|Atezolizumab|atezolizumab|mesh-list
101557437|NCT02989584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557440|NCT02989584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557441|NCT02989584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101557442|NCT02989584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101557443|NCT02884219|Ibuprofen|ibuprofen|mesh-list
101557444|NCT02884219|Indomethacin|indomethacin|mesh-list
101557445|NCT02884219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
101557446|NCT02884219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101557447|NCT02884219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101557448|NCT02884219|Analgesics|analgesics|mesh-ancestor
101557449|NCT02884219|Sensory System Agents|sensory system agents|mesh-ancestor
101557450|NCT02884219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101557451|NCT02884219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557452|NCT02884219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101557453|NCT02884219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101557454|NCT02884219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101557455|NCT02884219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557456|NCT02884219|Gout Suppressants|gout suppressants|mesh-ancestor
101557457|NCT02884219|Tocolytic Agents|tocolytic agents|mesh-ancestor
101425059|NCT04083560|Vitamin B 12|vitamin b 12|mesh-list
101425060|NCT04083560|Hematinics|hematinics|mesh-ancestor
101425061|NCT04083560|Vitamin B Complex|vitamin b complex|mesh-ancestor
101425062|NCT04083560|Vitamins|vitamins|mesh-ancestor
101425063|NCT04083560|Micronutrients|micronutrients|mesh-ancestor
101425064|NCT04083560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425065|NCT00511966|Rabeprazole|rabeprazole|mesh-list
101425070|NCT00511966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425071|NCT00152178|Tamoxifen|tamoxifen|mesh-list
101425072|NCT00152178|Cyclophosphamide|cyclophosphamide|mesh-list
101425073|NCT00152178|Fluorouracil|fluorouracil|mesh-list
101425074|NCT00152178|Methotrexate|methotrexate|mesh-list
101425075|NCT00152178|Tegafur|tegafur|mesh-list
101425076|NCT00152178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101425077|NCT00152178|Immunologic Factors|immunologic factors|mesh-ancestor
101425078|NCT00152178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425079|NCT00152178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101425080|NCT00152178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101425081|NCT00152178|Alkylating Agents|alkylating agents|mesh-ancestor
101425082|NCT00152178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425083|NCT00152178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101425084|NCT00152178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101425085|NCT00152178|Antimetabolites|antimetabolites|mesh-ancestor
101425086|NCT00152178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101425087|NCT00152178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101425088|NCT00152178|Abortifacient Agents|abortifacient agents|mesh-ancestor
101425089|NCT00152178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101425090|NCT00152178|Dermatologic Agents|dermatologic agents|mesh-ancestor
101425091|NCT00152178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101425092|NCT00152178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101425093|NCT00152178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101425098|NCT00152178|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101425099|NCT00152178|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101425100|NCT00152178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101425102|NCT00523120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101425103|NCT00523120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101425104|NCT00523120|Analgesics|analgesics|mesh-ancestor
101557458|NCT02884219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101557459|NCT02861417|Vidarabine|vidarabine|mesh-list
101557460|NCT02861417|Mycophenolic Acid|mycophenolic acid|mesh-list
101557461|NCT02861417|Cyclophosphamide|cyclophosphamide|mesh-list
101557462|NCT02861417|Busulfan|busulfan|mesh-list
101557463|NCT02861417|Thiotepa|thiotepa|mesh-list
101557464|NCT02861417|Fludarabine|fludarabine|mesh-list
101557465|NCT02861417|Fludarabine phosphate|fludarabine phosphate|mesh-list
101557466|NCT02861417|Tacrolimus|tacrolimus|mesh-list
101557467|NCT02861417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101557468|NCT02861417|Immunologic Factors|immunologic factors|mesh-ancestor
101557469|NCT02861417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557470|NCT02861417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101557471|NCT02861417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101557472|NCT02861417|Alkylating Agents|alkylating agents|mesh-ancestor
101557473|NCT02861417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557474|NCT02861417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557475|NCT02861417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101557476|NCT02861417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101557477|NCT02861417|Antimetabolites|antimetabolites|mesh-ancestor
101557478|NCT02861417|Antiviral Agents|antiviral agents|mesh-ancestor
101557479|NCT02861417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101557480|NCT02861417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101405929|NCT00403962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101425105|NCT00523120|Sensory System Agents|sensory system agents|mesh-ancestor
101425106|NCT00523120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101425107|NCT00523120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425108|NCT00523120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101425109|NCT00523120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101425110|NCT00523120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101425111|NCT00523120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101425112|NCT00523120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425113|NCT00523159|Sargramostim|sargramostim|mesh-list
101425114|NCT00523159|Immunologic Factors|immunologic factors|mesh-ancestor
101306856|NCT02028234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101306857|NCT02028234|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101306858|NCT02028234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101306859|NCT02028234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306860|NCT02028260|Modafinil|modafinil|mesh-list
101306861|NCT02028260|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101425115|NCT00523159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425116|NCT04693897|Solifenacin Succinate|solifenacin succinate|mesh-list
101425117|NCT04693897|Mirabegron|mirabegron|mesh-list
101425118|NCT04693897|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101425119|NCT04693897|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101425120|NCT04693897|Cholinergic Agents|cholinergic agents|mesh-ancestor
101425121|NCT04693897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101425122|NCT04693897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425123|NCT04693897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425124|NCT04693897|Urological Agents|urological agents|mesh-ancestor
101425125|NCT04693897|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101425126|NCT04693897|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101557481|NCT02861417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101557482|NCT02861417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101460637|NCT00569881|Gatifloxacin|gatifloxacin|mesh-list
101557483|NCT02861417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101557484|NCT02861417|Antitubercular Agents|antitubercular agents|mesh-ancestor
101557485|NCT02861417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101557486|NCT02795429|Spartalizumab|spartalizumab|mesh-list
101557487|NCT02795429|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101557488|NCT02795429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557489|NCT02795429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101557490|NCT02795429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557491|NCT02792114|Cyclophosphamide|cyclophosphamide|mesh-list
101557492|NCT02792114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101557493|NCT02792114|Immunologic Factors|immunologic factors|mesh-ancestor
101557494|NCT02792114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557495|NCT02792114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101557496|NCT02792114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101557497|NCT02792114|Alkylating Agents|alkylating agents|mesh-ancestor
101557498|NCT02792114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557499|NCT02792114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557500|NCT02792114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101557501|NCT02783625|Bortezomib|bortezomib|mesh-list
101557502|NCT02783625|Romidepsin|romidepsin|mesh-list
101557503|NCT02783625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557504|NCT02783625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101557505|NCT02783625|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101557506|NCT02783625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101557507|NCT02783625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425127|NCT04693897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101425128|NCT04693897|Adrenergic Agents|adrenergic agents|mesh-ancestor
101425129|NCT00424242|Pemetrexed|pemetrexed|mesh-list
101425130|NCT00424242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101425131|NCT00424242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101425132|NCT00424242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425133|NCT00424242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101425134|NCT00424242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101425139|NCT04726553|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101425140|NCT04726553|Abortifacient Agents|abortifacient agents|mesh-ancestor
101425141|NCT04726553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101425142|NCT04726553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425143|NCT04726553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101425144|NCT04726553|Antimetabolites|antimetabolites|mesh-ancestor
101425145|NCT04726553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425146|NCT04726553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101425147|NCT04726553|Dermatologic Agents|dermatologic agents|mesh-ancestor
101557508|NCT02752685|Paclitaxel|paclitaxel|mesh-list
101557509|NCT02752685|Pembrolizumab|pembrolizumab|mesh-list
101557510|NCT02752685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101557511|NCT02752685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557512|NCT02752685|Tubulin Modulators|tubulin modulators|mesh-ancestor
101557513|NCT02752685|Antimitotic Agents|antimitotic agents|mesh-ancestor
101557514|NCT02752685|Mitosis Modulators|mitosis modulators|mesh-ancestor
101557515|NCT02752685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557516|NCT02752685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101557517|NCT02752685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101557518|NCT02689427|Paclitaxel|paclitaxel|mesh-list
101557519|NCT02689427|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101557520|NCT02689427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101557521|NCT02689427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557522|NCT02689427|Tubulin Modulators|tubulin modulators|mesh-ancestor
101557523|NCT02689427|Antimitotic Agents|antimitotic agents|mesh-ancestor
101557524|NCT02689427|Mitosis Modulators|mitosis modulators|mesh-ancestor
101557525|NCT02689427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557526|NCT02632344|Pembrolizumab|pembrolizumab|mesh-list
101557527|NCT02632344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101405981|NCT00102635|Fenretinide|fenretinide|mesh-list
101425148|NCT04726553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101425149|NCT04726553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101425150|NCT04726553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101425151|NCT04726553|Immunologic Factors|immunologic factors|mesh-ancestor
101425152|NCT04726553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101425153|NCT04726553|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101425154|NCT04726553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101425155|NCT04726553|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101425156|NCT04726553|Antitubercular Agents|antitubercular agents|mesh-ancestor
101425157|NCT04726553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101425158|NCT04726553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101425185|NCT02952157|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101425186|NCT02952157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101425187|NCT02952157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425188|NCT02951728|Prednisone|prednisone|mesh-list
101425189|NCT02951728|Cyclophosphamide|cyclophosphamide|mesh-list
101425190|NCT02951728|Rituximab|rituximab|mesh-list
101425191|NCT02951728|Doxorubicin|doxorubicin|mesh-list
101425192|NCT02951728|Vincristine|vincristine|mesh-list
101425193|NCT02951728|Decitabine|decitabine|mesh-list
101425194|NCT02951728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101425195|NCT02951728|Immunologic Factors|immunologic factors|mesh-ancestor
101425196|NCT02951728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425197|NCT02951728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101425198|NCT02951728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101425199|NCT02951728|Alkylating Agents|alkylating agents|mesh-ancestor
101425200|NCT02951728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425201|NCT02951728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101425202|NCT02951728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101425240|NCT00523432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101425241|NCT00523432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101425242|NCT00523432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101557528|NCT02632344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557529|NCT02632344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101557530|NCT02632344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557531|NCT02628067|Pembrolizumab|pembrolizumab|mesh-list
101557532|NCT02628067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101557533|NCT02628067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557534|NCT02628067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101557535|NCT02628067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557536|NCT02605486|Palbociclib|palbociclib|mesh-list
101557537|NCT02605486|Bicalutamide|bicalutamide|mesh-list
101557538|NCT02605486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557539|NCT02605486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101557541|NCT02605486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557542|NCT02605486|Androgen Antagonists|androgen antagonists|mesh-ancestor
101557543|NCT02605486|Hormone Antagonists|hormone antagonists|mesh-ancestor
101557544|NCT02605486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101557545|NCT02605486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557546|NCT02576509|Nivolumab|nivolumab|mesh-list
101557547|NCT02576509|Sorafenib|sorafenib|mesh-list
101557548|NCT02576509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101557549|NCT02576509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557550|NCT02576509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101557551|NCT02576509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557552|NCT02576509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101557553|NCT02576509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101557554|NCT02538198|Lenalidomide|lenalidomide|mesh-list
101557555|NCT02538198|Immunologic Factors|immunologic factors|mesh-ancestor
101557556|NCT02538198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557557|NCT02538198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101557558|NCT02538198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101557559|NCT02538198|Growth Substances|growth substances|mesh-ancestor
101557560|NCT02538198|Growth Inhibitors|growth inhibitors|mesh-ancestor
101557568|NCT02506959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101557569|NCT02506959|Antimetabolites|antimetabolites|mesh-ancestor
101557570|NCT02506959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557571|NCT02506959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557572|NCT02506959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101557573|NCT02506959|Alkylating Agents|alkylating agents|mesh-ancestor
101557574|NCT02506959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101557575|NCT02506959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101557576|NCT02506959|Immunologic Factors|immunologic factors|mesh-ancestor
101557577|NCT02506959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557578|NCT02506959|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101557579|NCT02506959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101557580|NCT02484287|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101557581|NCT02484287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101557582|NCT02477696|Acalabrutinib|acalabrutinib|mesh-list
101557583|NCT02477696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557584|NCT02471144|Etanercept|etanercept|mesh-list
101557585|NCT02471144|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101557586|NCT02471144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101557587|NCT02471144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101557588|NCT02471144|Analgesics|analgesics|mesh-ancestor
101557589|NCT02471144|Sensory System Agents|sensory system agents|mesh-ancestor
101557590|NCT02471144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101557591|NCT02471144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557592|NCT02471144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101557593|NCT02471144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101557594|NCT02471144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101557595|NCT02471144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101557596|NCT02471144|Immunologic Factors|immunologic factors|mesh-ancestor
101557597|NCT02470585|Paclitaxel|paclitaxel|mesh-list
101557598|NCT02470585|Carboplatin|carboplatin|mesh-list
101425244|NCT00523432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425295|NCT03943511|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101425296|NCT03943511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101425297|NCT00172809|Interferons|interferons|mesh-list
101425298|NCT00172809|Interferon-alpha|interferon-alpha|mesh-list
101425299|NCT00172809|Interferon alpha-2|interferon alpha-2|mesh-list
101425300|NCT00172809|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101425301|NCT00172809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101425302|NCT00172809|Antiviral Agents|antiviral agents|mesh-ancestor
101425303|NCT00172809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101425304|NCT00172809|Immunologic Factors|immunologic factors|mesh-ancestor
101425305|NCT00172809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425306|NCT04696120|Apixaban|apixaban|mesh-list
101557600|NCT02470585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101557601|NCT02470585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557602|NCT02470585|Tubulin Modulators|tubulin modulators|mesh-ancestor
101557603|NCT02470585|Antimitotic Agents|antimitotic agents|mesh-ancestor
101557604|NCT02470585|Mitosis Modulators|mitosis modulators|mesh-ancestor
101557605|NCT02470585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557606|NCT02470585|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101557607|NCT02470585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101557608|NCT02429570|Meclofenamic Acid|meclofenamic acid|mesh-list
101557609|NCT02429570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101557610|NCT02429570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101557611|NCT02429570|Analgesics|analgesics|mesh-ancestor
101519538|NCT03776136|Lenvatinib|lenvatinib|mesh-list
101557612|NCT02429570|Sensory System Agents|sensory system agents|mesh-ancestor
101557613|NCT02429570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101557614|NCT02429570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557615|NCT02429570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101557616|NCT02429570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101557617|NCT02429570|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101557618|NCT02429570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101425307|NCT04696120|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101425308|NCT04696120|Antithrombins|antithrombins|mesh-ancestor
101425309|NCT04696120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101425310|NCT04696120|Protease Inhibitors|protease inhibitors|mesh-ancestor
101425311|NCT04696120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101425312|NCT04696120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425313|NCT04696120|Anticoagulants|anticoagulants|mesh-ancestor
101425314|NCT00512395|Fentanyl|fentanyl|mesh-list
101425315|NCT00512395|Ropivacaine|ropivacaine|mesh-list
101425316|NCT00512395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101425317|NCT00512395|Narcotics|narcotics|mesh-ancestor
101306870|NCT02028312|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101306871|NCT02028312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101306872|NCT02028312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101306873|NCT02028403|BMS-936559|bms-936559|mesh-list
101425318|NCT00512395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101425319|NCT00512395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425327|NCT00512395|Anesthetics, Local|anesthetics, local|mesh-ancestor
101425329|NCT00512473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101425330|NCT00512473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425331|NCT00524095|Fluticasone|fluticasone|mesh-list
101425332|NCT00524095|Xhance|xhance|mesh-list
101425333|NCT00524095|Azithromycin|azithromycin|mesh-list
101425334|NCT00524095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101425335|NCT00524095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101425336|NCT00524095|Autonomic Agents|autonomic agents|mesh-ancestor
101425337|NCT00524095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101425338|NCT00524095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425339|NCT00524095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101425340|NCT00524095|Respiratory System Agents|respiratory system agents|mesh-ancestor
101425341|NCT00524095|Dermatologic Agents|dermatologic agents|mesh-ancestor
101425342|NCT00524095|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101425343|NCT00524095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101557619|NCT02429570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557620|NCT02341144|Ropivacaine|ropivacaine|mesh-list
101557621|NCT02341144|Anesthetics, Local|anesthetics, local|mesh-ancestor
101557622|NCT02341144|Anesthetics|anesthetics|mesh-ancestor
101557623|NCT02341144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101557624|NCT02341144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557625|NCT02341144|Sensory System Agents|sensory system agents|mesh-ancestor
101557626|NCT02341144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101557627|NCT02332668|Pembrolizumab|pembrolizumab|mesh-list
101557628|NCT02332668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101557650|NCT02204241|Alkylating Agents|alkylating agents|mesh-ancestor
101557651|NCT02204241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557652|NCT02204241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557653|NCT02204241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101359093|NCT00040391|Vitamins|vitamins|mesh-ancestor
101557654|NCT02204241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101557655|NCT02204241|Antiemetics|antiemetics|mesh-ancestor
101557656|NCT02204241|Autonomic Agents|autonomic agents|mesh-ancestor
101557657|NCT02204241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101557658|NCT02204241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101557659|NCT02204241|Glucocorticoids|glucocorticoids|mesh-ancestor
101557660|NCT02204241|Hormones|hormones|mesh-ancestor
101557661|NCT02204241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101557662|NCT02204241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101557686|NCT02185820|Dexamethasone|dexamethasone|mesh-list
101557687|NCT02185820|Pomalidomide|pomalidomide|mesh-list
101557688|NCT02185820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101557689|NCT02185820|Antiemetics|antiemetics|mesh-ancestor
101557690|NCT02185820|Autonomic Agents|autonomic agents|mesh-ancestor
101557691|NCT02185820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101557692|NCT02185820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557693|NCT02185820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101557694|NCT02185820|Glucocorticoids|glucocorticoids|mesh-ancestor
101557695|NCT02185820|Hormones|hormones|mesh-ancestor
101557696|NCT02185820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101425344|NCT00524095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101425345|NCT00512629|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101425346|NCT00512629|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101425347|NCT00512629|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101425348|NCT00512629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101557697|NCT02185820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101557698|NCT02185820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557699|NCT02185820|Immunologic Factors|immunologic factors|mesh-ancestor
101557700|NCT02185820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101557701|NCT02185820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101557702|NCT02185820|Growth Substances|growth substances|mesh-ancestor
101557703|NCT02185820|Growth Inhibitors|growth inhibitors|mesh-ancestor
101557704|NCT02150967|Infigratinib|infigratinib|mesh-list
101557705|NCT02150967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557706|NCT02085408|Cytarabine|cytarabine|mesh-list
101557707|NCT02085408|Decitabine|decitabine|mesh-list
101557708|NCT02085408|Clofarabine|clofarabine|mesh-list
101557709|NCT02085408|Azacitidine|azacitidine|mesh-list
101557710|NCT02085408|Daunorubicin|daunorubicin|mesh-list
101557711|NCT02085408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101557712|NCT02085408|Antimetabolites|antimetabolites|mesh-ancestor
101557713|NCT02085408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557714|NCT02085408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557715|NCT02085408|Antiviral Agents|antiviral agents|mesh-ancestor
101557716|NCT02085408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101557717|NCT02085408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101557718|NCT02085408|Immunologic Factors|immunologic factors|mesh-ancestor
101557719|NCT02085408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557720|NCT02085408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101557721|NCT02085408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101557722|NCT02085408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101557723|NCT02085408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101557724|NCT02004782|Prednisolone|prednisolone|mesh-list
101557725|NCT02004782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101557726|NCT02004782|Glucocorticoids|glucocorticoids|mesh-ancestor
101557727|NCT02004782|Hormones|hormones|mesh-ancestor
101557728|NCT02004782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101557729|NCT02004782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406140|NCT00103103|Leucovorin|leucovorin|mesh-list
101425349|NCT00512668|Sirolimus|sirolimus|mesh-list
101425350|NCT00512668|Leuprolide|leuprolide|mesh-list
101425351|NCT00512668|Goserelin|goserelin|mesh-list
101425352|NCT00512668|Flutamide|flutamide|mesh-list
101425353|NCT00512668|Temsirolimus|temsirolimus|mesh-list
101425354|NCT00512668|Bicalutamide|bicalutamide|mesh-list
101425355|NCT00512668|Nilutamide|nilutamide|mesh-list
101425356|NCT00512668|MTOR Inhibitors|mtor inhibitors|mesh-list
101425357|NCT00512668|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101425377|NCT00167739|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101557730|NCT02004782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101557731|NCT02004782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557733|NCT01908777|Etoposide|etoposide|mesh-list
101557734|NCT01908777|Melphalan|melphalan|mesh-list
101557735|NCT01908777|Carmustine|carmustine|mesh-list
101557736|NCT01908777|Romidepsin|romidepsin|mesh-list
101557737|NCT01908777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101557738|NCT01908777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557739|NCT01908777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101557740|NCT01908777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101557741|NCT01908777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101557742|NCT01908777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557743|NCT01908777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101557744|NCT01908777|Antimetabolites|antimetabolites|mesh-ancestor
101557745|NCT01908777|Antiviral Agents|antiviral agents|mesh-ancestor
101557746|NCT01908777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101425378|NCT00167739|Quinine|quinine|mesh-list
101425379|NCT00167739|Antimalarials|antimalarials|mesh-ancestor
101425380|NCT00167739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101425381|NCT00167739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101425382|NCT00167739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101425383|NCT00167739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101425384|NCT00167739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101425385|NCT00167739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425386|NCT00167739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101425387|NCT00167739|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101425388|NCT00167739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425389|NCT00167739|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101425390|NCT00167739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101425391|NCT00167739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101425392|NCT00167739|Analgesics|analgesics|mesh-ancestor
101425393|NCT00167739|Sensory System Agents|sensory system agents|mesh-ancestor
101425394|NCT00524251|Esomeprazole|esomeprazole|mesh-list
101425395|NCT00524251|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101425396|NCT00524251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101425397|NCT00524251|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101425398|NCT00524251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101425399|NCT00524251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425400|NCT00512824|Calcium Carbonate|calcium carbonate|mesh-list
101425402|NCT00512824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101306874|NCT02028403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101306875|NCT02028403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101306876|NCT02028403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101425403|NCT00512824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425404|NCT00512824|Antacids|antacids|mesh-ancestor
101425418|NCT00525889|Antifungal Agents|antifungal agents|mesh-ancestor
101425419|NCT00525889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101425420|NCT00525889|Immunologic Factors|immunologic factors|mesh-ancestor
101425421|NCT00525889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425422|NCT00524524|Beta-lapachone|beta-lapachone|mesh-list
101425423|NCT00524524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101425424|NCT00524524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101425425|NCT00524524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101425426|NCT00524524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101425427|NCT00524524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425428|NCT00524524|Antiviral Agents|antiviral agents|mesh-ancestor
101557747|NCT01908777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101557748|NCT01908777|Immunologic Factors|immunologic factors|mesh-ancestor
101557749|NCT01908777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557750|NCT01908777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101557751|NCT01908777|Alkylating Agents|alkylating agents|mesh-ancestor
101557752|NCT01908777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101557753|NCT01908777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101557754|NCT01908777|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101557755|NCT01873326|Paclitaxel|paclitaxel|mesh-list
101557756|NCT01873326|Etoposide|etoposide|mesh-list
101557757|NCT01873326|Ifosfamide|ifosfamide|mesh-list
101557758|NCT01873326|Bleomycin|bleomycin|mesh-list
101557759|NCT01873326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101557760|NCT01873326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557761|NCT01873326|Tubulin Modulators|tubulin modulators|mesh-ancestor
101519692|NCT01206517|Asenapine|asenapine|mesh-list
101557762|NCT01873326|Antimitotic Agents|antimitotic agents|mesh-ancestor
101557763|NCT01873326|Mitosis Modulators|mitosis modulators|mesh-ancestor
101557764|NCT01873326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557765|NCT01873326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101557766|NCT01873326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101557767|NCT01873326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101557768|NCT01873326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101557800|NCT01864109|Tubulin Modulators|tubulin modulators|mesh-ancestor
101557801|NCT01864109|Antimitotic Agents|antimitotic agents|mesh-ancestor
101557802|NCT01864109|Mitosis Modulators|mitosis modulators|mesh-ancestor
101557803|NCT01864109|Protective Agents|protective agents|mesh-ancestor
101557804|NCT01864109|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101557805|NCT01862315|Dexamethasone|dexamethasone|mesh-list
101557806|NCT01862315|Gemcitabine|gemcitabine|mesh-list
101557807|NCT01862315|Oxaliplatin|oxaliplatin|mesh-list
101557808|NCT01862315|Floxuridine|floxuridine|mesh-list
101557809|NCT01862315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101557810|NCT01862315|Antiemetics|antiemetics|mesh-ancestor
101557811|NCT01862315|Autonomic Agents|autonomic agents|mesh-ancestor
101557812|NCT01862315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101557813|NCT01862315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557814|NCT01862315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101425430|NCT03879122|Nivolumab|nivolumab|mesh-list
101425431|NCT03879122|Ipilimumab|ipilimumab|mesh-list
101425432|NCT03879122|Androgens|androgens|mesh-list
101425433|NCT03879122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101425434|NCT03879122|Tubulin Modulators|tubulin modulators|mesh-ancestor
101425435|NCT03879122|Antimitotic Agents|antimitotic agents|mesh-ancestor
101425436|NCT03879122|Mitosis Modulators|mitosis modulators|mesh-ancestor
101425437|NCT03879122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425438|NCT03879122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101425439|NCT03879122|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101425440|NCT03879122|Hormones|hormones|mesh-ancestor
101425441|NCT03879122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101425442|NCT03879122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425443|NCT00525928|Varenicline|varenicline|mesh-list
101425444|NCT00525928|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101425445|NCT00525928|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101425446|NCT00525928|Cholinergic Agents|cholinergic agents|mesh-ancestor
101425447|NCT00525928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101425448|NCT00525928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425449|NCT00525928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425450|NCT00167817|Aripiprazole|aripiprazole|mesh-list
101425451|NCT00167817|Antidepressive Agents|antidepressive agents|mesh-ancestor
101425452|NCT00167817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101425453|NCT00167817|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101425454|NCT00167817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101425455|NCT00167817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101425456|NCT00167817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425457|NCT00167817|Dopamine Agonists|dopamine agonists|mesh-ancestor
101425458|NCT00167817|Dopamine Agents|dopamine agents|mesh-ancestor
101425459|NCT00167817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101813802|NCT04048889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425460|NCT00167817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425461|NCT00167817|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101425462|NCT00167817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101425464|NCT00167817|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101425465|NCT00167817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101425466|NCT00167817|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101425467|NCT00167817|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101425468|NCT02947711|Diltiazem|diltiazem|mesh-list
101425469|NCT02947711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101425470|NCT02947711|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101425471|NCT02947711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101425472|NCT02947711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425473|NCT02947711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101425474|NCT02947711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425475|NCT02947711|Vasodilator Agents|vasodilator agents|mesh-ancestor
101557816|NCT01862315|Hormones|hormones|mesh-ancestor
101557817|NCT01862315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101557818|NCT01862315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101557819|NCT01862315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101425476|NCT03845348|Ketoconazole|ketoconazole|mesh-list
101425477|NCT03845348|Antifungal Agents|antifungal agents|mesh-ancestor
101306877|NCT02028403|Immunologic Factors|immunologic factors|mesh-ancestor
101425501|NCT00525967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101425502|NCT00525967|Narcotics|narcotics|mesh-ancestor
101425503|NCT00525967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101425504|NCT00525967|Antitussive Agents|antitussive agents|mesh-ancestor
101425505|NCT00525967|Respiratory System Agents|respiratory system agents|mesh-ancestor
101425506|NCT00167856|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101425507|NCT00167856|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101425508|NCT00167856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101425509|NCT00167856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101425510|NCT00167856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425511|NCT00167856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101425512|NCT00167856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425513|NCT00167856|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101425514|NCT00167856|Antidepressive Agents|antidepressive agents|mesh-ancestor
101425515|NCT00167856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101425516|NCT00526006|Esomeprazole|esomeprazole|mesh-list
101425517|NCT00526006|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101425518|NCT00526006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101425519|NCT00526006|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101425520|NCT00526006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101425521|NCT00526006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425522|NCT03681275|Tofacitinib|tofacitinib|mesh-list
101425523|NCT03681275|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101425524|NCT03681275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101425525|NCT03681275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101425526|NCT03681275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425527|NCT02946814|Listerine|listerine|mesh-list
101425528|NCT02946814|Sodium Fluoride|sodium fluoride|mesh-list
101425529|NCT02946814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101425530|NCT02946814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101425531|NCT02946814|Cariostatic Agents|cariostatic agents|mesh-ancestor
101425532|NCT02946814|Protective Agents|protective agents|mesh-ancestor
101425533|NCT02946814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425534|NCT00524836|Levocetirizine|levocetirizine|mesh-list
101425535|NCT00524836|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101425536|NCT00524836|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101425537|NCT00524836|Histamine Antagonists|histamine antagonists|mesh-ancestor
101425558|NCT00524914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101425559|NCT00524914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425560|NCT02957864|Tenofovir|tenofovir|mesh-list
101425561|NCT02957864|Abacavir|abacavir|mesh-list
101425562|NCT02957864|Antiviral Agents|antiviral agents|mesh-ancestor
101425563|NCT02957864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101425564|NCT02957864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101425565|NCT02957864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101425566|NCT02957864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101425567|NCT02957864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425568|NCT02957864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101425569|NCT02957864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101425570|NCT00168012|Immunoglobulins|immunoglobulins|mesh-list
101425571|NCT00168012|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101425572|NCT00168012|Antibodies|antibodies|mesh-list
101425573|NCT00168012|Immunologic Factors|immunologic factors|mesh-ancestor
101425574|NCT00168012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425575|NCT03585452|Dexmedetomidine|dexmedetomidine|mesh-list
101425576|NCT03585452|Propofol|propofol|mesh-list
101425577|NCT03585452|Anesthetics|anesthetics|mesh-ancestor
101425578|NCT03585452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101425579|NCT03585452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425580|NCT03585452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101557820|NCT01862315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101557821|NCT01862315|Antimetabolites|antimetabolites|mesh-ancestor
101557822|NCT01862315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557824|NCT01745588|Dexamethasone|dexamethasone|mesh-list
101557825|NCT01745588|Pomalidomide|pomalidomide|mesh-list
101557826|NCT01745588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101557827|NCT01745588|Antiemetics|antiemetics|mesh-ancestor
101557828|NCT01745588|Autonomic Agents|autonomic agents|mesh-ancestor
101557829|NCT01745588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101557830|NCT01745588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425581|NCT03585452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101425582|NCT03585452|Analgesics|analgesics|mesh-ancestor
101425583|NCT03585452|Sensory System Agents|sensory system agents|mesh-ancestor
101425584|NCT03585452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101425585|NCT03585452|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101425586|NCT03585452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101425587|NCT03585452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101425588|NCT03585452|Adrenergic Agents|adrenergic agents|mesh-ancestor
101425589|NCT03585452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101425590|NCT03585452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425591|NCT03585452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101425592|NCT03585452|Anesthetics, General|anesthetics, general|mesh-ancestor
101425593|NCT02947672|Dexamethasone|dexamethasone|mesh-list
101425594|NCT02947672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101425595|NCT02947672|Antiemetics|antiemetics|mesh-ancestor
101425611|NCT02946268|Anesthetics|anesthetics|mesh-ancestor
101425612|NCT02946268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101425613|NCT02946268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425614|NCT02946268|Sensory System Agents|sensory system agents|mesh-ancestor
101425615|NCT02946268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101425638|NCT00526318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425639|NCT00526318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101425640|NCT00526318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101425641|NCT00526318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101425642|NCT00526318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101425643|NCT00526318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101425644|NCT00526318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101425645|NCT00526318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101306883|NCT02028429|Sildenafil Citrate|sildenafil citrate|mesh-list
101425646|NCT00526318|Tubulin Modulators|tubulin modulators|mesh-ancestor
101425647|NCT00526318|Antimitotic Agents|antimitotic agents|mesh-ancestor
101425648|NCT00526318|Mitosis Modulators|mitosis modulators|mesh-ancestor
101425649|NCT00526318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101425650|NCT00526318|Dermatologic Agents|dermatologic agents|mesh-ancestor
101425651|NCT00526318|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101425652|NCT04693312|Methylprednisolone|methylprednisolone|mesh-list
101425653|NCT04693312|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101425654|NCT04693312|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101425655|NCT04693312|Prednisolone|prednisolone|mesh-list
101425656|NCT04693312|Prednisolone acetate|prednisolone acetate|mesh-list
101460837|NCT00571675|Prednisone|prednisone|mesh-list
101425657|NCT04693312|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101425658|NCT04693312|Prednisolone phosphate|prednisolone phosphate|mesh-list
101425659|NCT04693312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101425660|NCT04693312|Antiemetics|antiemetics|mesh-ancestor
101425661|NCT04693312|Autonomic Agents|autonomic agents|mesh-ancestor
101425662|NCT04693312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101425663|NCT04693312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425664|NCT04693312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101425665|NCT04693312|Glucocorticoids|glucocorticoids|mesh-ancestor
101425666|NCT04693312|Hormones|hormones|mesh-ancestor
101425667|NCT04693312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101425668|NCT04693312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101425669|NCT04693312|Protective Agents|protective agents|mesh-ancestor
101557832|NCT01745588|Glucocorticoids|glucocorticoids|mesh-ancestor
101557833|NCT01745588|Hormones|hormones|mesh-ancestor
101557834|NCT01745588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101557835|NCT01745588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101557836|NCT01745588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557837|NCT01745588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101557838|NCT01745588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101557839|NCT01745588|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101557840|NCT01745588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101557841|NCT01745588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557842|NCT01745588|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101557843|NCT01745588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101557844|NCT01745588|Immunologic Factors|immunologic factors|mesh-ancestor
101557845|NCT01745588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101557846|NCT01745588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101557847|NCT01745588|Growth Substances|growth substances|mesh-ancestor
101557848|NCT01745588|Growth Inhibitors|growth inhibitors|mesh-ancestor
101425670|NCT04693312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101425671|NCT04693312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101425672|NCT00168090|Factor VIII|factor viii|mesh-list
101425673|NCT00168090|Coagulants|coagulants|mesh-ancestor
101425674|NCT00525382|Levocetirizine|levocetirizine|mesh-list
101425711|NCT03186755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101425712|NCT03186755|Analgesics|analgesics|mesh-ancestor
101425713|NCT03186755|Sensory System Agents|sensory system agents|mesh-ancestor
101425714|NCT03186755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101425715|NCT03186755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101425716|NCT03186755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101425717|NCT03186755|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101425718|NCT03186755|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101425719|NCT03186755|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101425720|NCT03186755|Histamine Antagonists|histamine antagonists|mesh-ancestor
101425721|NCT03186755|Histamine Agents|histamine agents|mesh-ancestor
101425722|NCT03186755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101425723|NCT03186755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425724|NCT00525616|Rituximab|rituximab|mesh-list
101425725|NCT00525616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101425726|NCT00525616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101425727|NCT00525616|Immunologic Factors|immunologic factors|mesh-ancestor
101425759|NCT02946970|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101425760|NCT02946970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101425761|NCT02946970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101425763|NCT02946970|Sensory System Agents|sensory system agents|mesh-ancestor
101425764|NCT00527020|Nicotine|nicotine|mesh-list
101425765|NCT00527020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101425766|NCT00527020|Autonomic Agents|autonomic agents|mesh-ancestor
101425767|NCT00527020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101425768|NCT00527020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425769|NCT00527020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101425770|NCT00527020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101425771|NCT00527020|Cholinergic Agents|cholinergic agents|mesh-ancestor
101425772|NCT00527020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101425773|NCT00527020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425774|NCT00407277|Nicotine|nicotine|mesh-list
101557849|NCT01730937|Sorafenib|sorafenib|mesh-list
101557850|NCT01730937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557851|NCT01730937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101557852|NCT01730937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101557853|NCT01730937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557854|NCT01496976|Methylprednisolone|methylprednisolone|mesh-list
101557855|NCT01496976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101557856|NCT01496976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101557857|NCT01496976|Prednisolone|prednisolone|mesh-list
101557858|NCT01496976|Prednisolone acetate|prednisolone acetate|mesh-list
101557859|NCT01496976|Lenalidomide|lenalidomide|mesh-list
101557860|NCT01496976|Ofatumumab|ofatumumab|mesh-list
101557861|NCT01496976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101557862|NCT01496976|Prednisolone phosphate|prednisolone phosphate|mesh-list
101557863|NCT01496976|Immunologic Factors|immunologic factors|mesh-ancestor
101628316|NCT00720109|Leucovorin|leucovorin|mesh-list
101406281|NCT00103571|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101425807|NCT03156452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101425808|NCT03156452|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101425809|NCT03156452|Antitubercular Agents|antitubercular agents|mesh-ancestor
101425810|NCT03156452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101425811|NCT03156452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101425812|NCT03156452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101487408|NCT00427947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101425817|NCT03156452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101425818|NCT03156452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425819|NCT03156452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101425821|NCT00525772|Glucocorticoids|glucocorticoids|mesh-ancestor
101425822|NCT00525772|Hormones|hormones|mesh-ancestor
101425823|NCT00525772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101425824|NCT00525772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425825|NCT00525772|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101425826|NCT02945956|Entecavir|entecavir|mesh-list
101425827|NCT02945956|Antiviral Agents|antiviral agents|mesh-ancestor
101425828|NCT02945956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101425829|NCT03122639|Atorvastatin|atorvastatin|mesh-list
101425830|NCT03122639|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101425831|NCT03122639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101425832|NCT03122639|Antimetabolites|antimetabolites|mesh-ancestor
101425833|NCT03122639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425834|NCT03122639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101425835|NCT03122639|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101425836|NCT03122639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101425837|NCT00527137|Darbepoetin alfa|darbepoetin alfa|mesh-list
101425838|NCT00527137|Hematinics|hematinics|mesh-ancestor
101425839|NCT02945839|Topiramate|topiramate|mesh-list
101425840|NCT02945839|Anticonvulsants|anticonvulsants|mesh-ancestor
101425841|NCT02945839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101425842|NCT02945839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425843|NCT02957786|Varenicline|varenicline|mesh-list
101425844|NCT02957786|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101425845|NCT02957786|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101425846|NCT02957786|Cholinergic Agents|cholinergic agents|mesh-ancestor
101425847|NCT02957786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101425848|NCT02957786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359118|NCT00040469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101425849|NCT02957786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425850|NCT00407394|Amoxicillin|amoxicillin|mesh-list
101425851|NCT00407394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101425852|NCT00407394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101557864|NCT01496976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557865|NCT01496976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101557866|NCT01496976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101557867|NCT01496976|Growth Substances|growth substances|mesh-ancestor
101557868|NCT01496976|Growth Inhibitors|growth inhibitors|mesh-ancestor
101557869|NCT01496976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557870|NCT01496976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101557872|NCT01496976|Autonomic Agents|autonomic agents|mesh-ancestor
101557873|NCT01496976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101557874|NCT01496976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101557875|NCT01496976|Glucocorticoids|glucocorticoids|mesh-ancestor
101557876|NCT01496976|Hormones|hormones|mesh-ancestor
101557877|NCT01496976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101557878|NCT01496976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101557879|NCT01496976|Protective Agents|protective agents|mesh-ancestor
101557880|NCT01496976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101557881|NCT01290692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
101557882|NCT01290692|Immunologic Factors|immunologic factors|mesh-ancestor
101557883|NCT01290692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557884|NCT00996866|Vitamin D|vitamin d|mesh-list
101557885|NCT00996866|Cholecalciferol|cholecalciferol|mesh-list
101557886|NCT00996866|Vitamins|vitamins|mesh-ancestor
101557887|NCT00996866|Micronutrients|micronutrients|mesh-ancestor
101557888|NCT00996866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557889|NCT00996866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101557890|NCT00996866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101557891|NCT00876993|Bevacizumab|bevacizumab|mesh-list
101557892|NCT00876993|Irinotecan|irinotecan|mesh-list
101557893|NCT00876993|Temozolomide|temozolomide|mesh-list
101406296|NCT00136578|Carboplatin|carboplatin|mesh-list
101425853|NCT03109964|Hemostatics|hemostatics|mesh-list
101425854|NCT03109964|Surgiflo|surgiflo|mesh-list
101425855|NCT03109964|Coagulants|coagulants|mesh-ancestor
101425856|NCT00407433|Gemcitabine|gemcitabine|mesh-list
101425857|NCT00407433|Oxaliplatin|oxaliplatin|mesh-list
101425858|NCT00407433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101425859|NCT00407433|Antimetabolites|antimetabolites|mesh-ancestor
101425860|NCT00407433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425861|NCT00407433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101425862|NCT00516412|Everolimus|everolimus|mesh-list
101425863|NCT00516412|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101425864|NCT00516412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101425865|NCT00516412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101425866|NCT00516412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425867|NCT00516412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101557894|NCT00876993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101557895|NCT00876993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557896|NCT00876993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101557897|NCT00876993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101557898|NCT00876993|Growth Substances|growth substances|mesh-ancestor
101557899|NCT00876993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557900|NCT00876993|Growth Inhibitors|growth inhibitors|mesh-ancestor
101557901|NCT00876993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101557902|NCT00876993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101557903|NCT00876993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628317|NCT00720109|Folic Acid|folic acid|mesh-list
101425868|NCT00516412|Immunologic Factors|immunologic factors|mesh-ancestor
101425869|NCT00516412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425870|NCT00516412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101425871|NCT03058835|Tenofovir|tenofovir|mesh-list
101425872|NCT03058835|Emtricitabine|emtricitabine|mesh-list
101425873|NCT03058835|Antiviral Agents|antiviral agents|mesh-ancestor
101306886|NCT02028429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101306887|NCT02028429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101813803|NCT04048889|Sensory System Agents|sensory system agents|mesh-ancestor
101306888|NCT02028429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306889|NCT02028429|Urological Agents|urological agents|mesh-ancestor
101306891|NCT02028494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101306892|NCT02028494|Antimetabolites|antimetabolites|mesh-ancestor
101425874|NCT03058835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101425875|NCT03058835|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101425876|NCT03058835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101425879|NCT03058835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101425880|NCT03058835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101425881|NCT00516490|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101425882|NCT00516490|Luteolytic Agents|luteolytic agents|mesh-ancestor
101425883|NCT00516490|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101425884|NCT00516490|Contraceptive Agents|contraceptive agents|mesh-ancestor
101425889|NCT00516490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101425891|NCT00516607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101425892|NCT00516607|Alkylating Agents|alkylating agents|mesh-ancestor
101425893|NCT00516607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425894|NCT00516607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101425896|NCT00173667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101425897|NCT00173667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101425898|NCT00173667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425899|NCT00173667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101425900|NCT00173667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425901|NCT00173667|Vasodilator Agents|vasodilator agents|mesh-ancestor
101425902|NCT00173667|Tocolytic Agents|tocolytic agents|mesh-ancestor
101425903|NCT00173667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101425904|NCT00516685|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101425905|NCT00516685|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101425906|NCT00516685|Immunologic Factors|immunologic factors|mesh-ancestor
101425907|NCT00516685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425908|NCT03016871|Carboplatin|carboplatin|mesh-list
101425909|NCT03016871|Nivolumab|nivolumab|mesh-list
101425910|NCT03016871|Etoposide|etoposide|mesh-list
101425911|NCT03016871|Etoposide phosphate|etoposide phosphate|mesh-list
101425912|NCT03016871|Ifosfamide|ifosfamide|mesh-list
101425913|NCT03016871|Isophosphamide mustard|isophosphamide mustard|mesh-list
101425914|NCT03016871|Podophyllotoxin|podophyllotoxin|mesh-list
101425915|NCT03016871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101425916|NCT03016871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101425917|NCT03016871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101425918|NCT03016871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425919|NCT03016871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101425920|NCT03016871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101425921|NCT03016871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101557904|NCT00876993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557905|NCT00876993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101557906|NCT00876993|Alkylating Agents|alkylating agents|mesh-ancestor
101557908|NCT00700882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557909|NCT00700882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101557910|NCT00700882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101557911|NCT00700882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557912|NCT00673309|Insulin|insulin|mesh-list
101557913|NCT00673309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101557914|NCT00673309|Itraconazole|itraconazole|mesh-list
101519839|NCT04657484|Hormones|hormones|mesh-ancestor
101557915|NCT00673309|Propranolol|propranolol|mesh-list
101557916|NCT00673309|Hormones|hormones|mesh-list
101557917|NCT00673309|Oxandrolone|oxandrolone|mesh-list
101557918|NCT00673309|Nandrolone|nandrolone|mesh-list
101557919|NCT00673309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101557920|NCT00673309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557921|NCT00673309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101425922|NCT03016871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101425923|NCT03016871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101425924|NCT03016871|Alkylating Agents|alkylating agents|mesh-ancestor
101425925|NCT03016871|Keratolytic Agents|keratolytic agents|mesh-ancestor
101425926|NCT03016871|Dermatologic Agents|dermatologic agents|mesh-ancestor
101425927|NCT03016871|Tubulin Modulators|tubulin modulators|mesh-ancestor
101425928|NCT03016871|Antimitotic Agents|antimitotic agents|mesh-ancestor
101425929|NCT03016871|Mitosis Modulators|mitosis modulators|mesh-ancestor
101425930|NCT03458689|Analgesics|analgesics|mesh-list
101425931|NCT03458689|Sensory System Agents|sensory system agents|mesh-ancestor
101425932|NCT03458689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101425933|NCT03458689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425934|NCT00527215|Darbepoetin alfa|darbepoetin alfa|mesh-list
101425935|NCT00527215|Hematinics|hematinics|mesh-ancestor
101425936|NCT00173745|Botulinum Toxins|botulinum toxins|mesh-list
101425937|NCT00173745|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101425938|NCT00173745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101425939|NCT00173745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101306893|NCT02028494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306894|NCT02028494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101306895|NCT02028507|Capecitabine|capecitabine|mesh-list
101306896|NCT02028507|Fulvestrant|fulvestrant|mesh-list
101425940|NCT00173745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101425941|NCT00173745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425942|NCT00173745|Cholinergic Agents|cholinergic agents|mesh-ancestor
101425943|NCT00173745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101425944|NCT00173745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425945|NCT00173745|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101425946|NCT00173745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101425947|NCT02945644|Trazodone|trazodone|mesh-list
101425948|NCT02945644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101425949|NCT02945644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101425966|NCT02460887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425968|NCT02945527|Acetazolamide|acetazolamide|mesh-list
101425969|NCT02945527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101425970|NCT02945527|Antiemetics|antiemetics|mesh-ancestor
101425971|NCT02945527|Autonomic Agents|autonomic agents|mesh-ancestor
101425972|NCT02945527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101557922|NCT00673309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557924|NCT00673309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101557925|NCT00673309|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101557926|NCT00673309|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101557927|NCT00673309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101557928|NCT00673309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101557929|NCT00673309|Hormone Antagonists|hormone antagonists|mesh-ancestor
101557930|NCT00673309|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101557931|NCT00673309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101557932|NCT00673309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101557933|NCT00673309|Adrenergic Agents|adrenergic agents|mesh-ancestor
101557934|NCT00673309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101557935|NCT00673309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101557936|NCT00673309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101557937|NCT00673309|Vasodilator Agents|vasodilator agents|mesh-ancestor
101557938|NCT00673309|Androgens|androgens|mesh-ancestor
101557939|NCT00673309|Anabolic Agents|anabolic agents|mesh-ancestor
101557940|NCT00666835|Epoetin Alfa|epoetin alfa|mesh-list
101557941|NCT00666835|Hematinics|hematinics|mesh-ancestor
101557942|NCT00600496|Sirolimus|sirolimus|mesh-list
101557943|NCT00600496|Docetaxel|docetaxel|mesh-list
101557944|NCT00600496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101557945|NCT00600496|Temsirolimus|temsirolimus|mesh-list
101557946|NCT00600496|Dacarbazine|dacarbazine|mesh-list
101557947|NCT00600496|MTOR Inhibitors|mtor inhibitors|mesh-list
101557948|NCT00600496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557949|NCT00600496|Tubulin Modulators|tubulin modulators|mesh-ancestor
101557950|NCT00600496|Antimitotic Agents|antimitotic agents|mesh-ancestor
101557951|NCT00600496|Mitosis Modulators|mitosis modulators|mesh-ancestor
101425973|NCT02945527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425974|NCT02945527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101425975|NCT02945527|Glucocorticoids|glucocorticoids|mesh-ancestor
101425976|NCT02945527|Hormones|hormones|mesh-ancestor
101425977|NCT02945527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101425978|NCT02945527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101425979|NCT02945527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101425980|NCT02945527|Anticonvulsants|anticonvulsants|mesh-ancestor
101425981|NCT02945527|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101425982|NCT02945527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101425983|NCT02945527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425984|NCT02945527|Diuretics|diuretics|mesh-ancestor
101425985|NCT02945527|Natriuretic Agents|natriuretic agents|mesh-ancestor
101425986|NCT00168363|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101425987|NCT00168363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101425988|NCT00168363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101557952|NCT00600496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557954|NCT00600496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101557955|NCT00600496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101557956|NCT00600496|Immunologic Factors|immunologic factors|mesh-ancestor
101557957|NCT00600496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557958|NCT00600496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101557959|NCT00600496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101557960|NCT00600496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101557961|NCT00600496|Antifungal Agents|antifungal agents|mesh-ancestor
101557962|NCT00600496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101557963|NCT00600496|Alkylating Agents|alkylating agents|mesh-ancestor
101557964|NCT00551759|Docetaxel|docetaxel|mesh-list
101557965|NCT00551759|Fluorouracil|fluorouracil|mesh-list
101557966|NCT00551759|Oxaliplatin|oxaliplatin|mesh-list
101557967|NCT00551759|Cetuximab|cetuximab|mesh-list
101557968|NCT00551759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557969|NCT00551759|Tubulin Modulators|tubulin modulators|mesh-ancestor
101557970|NCT00551759|Antimitotic Agents|antimitotic agents|mesh-ancestor
101557971|NCT00551759|Mitosis Modulators|mitosis modulators|mesh-ancestor
101557972|NCT00551759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101557973|NCT00551759|Antimetabolites|antimetabolites|mesh-ancestor
101557974|NCT00551759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101557975|NCT00551759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101557976|NCT00551759|Immunologic Factors|immunologic factors|mesh-ancestor
101628318|NCT00720109|Cytarabine|cytarabine|mesh-list
101406388|NCT00136734|Dopamine Agents|dopamine agents|mesh-ancestor
101425989|NCT00168363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101425990|NCT00168363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101425991|NCT00168363|Adrenergic Agents|adrenergic agents|mesh-ancestor
101425992|NCT00168363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101425993|NCT00168363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425994|NCT00168363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425995|NCT02448095|Ponatinib|ponatinib|mesh-list
101425996|NCT02448095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101425997|NCT02448095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101425998|NCT02448095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101425999|NCT02448095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426000|NCT00168402|Botulinum Toxins|botulinum toxins|mesh-list
101426001|NCT00168402|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101426002|NCT00168402|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101426003|NCT00168402|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101426004|NCT00168402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101426005|NCT00168402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426006|NCT00168402|Cholinergic Agents|cholinergic agents|mesh-ancestor
101426007|NCT00168402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101306898|NCT02028507|Exemestane|exemestane|mesh-list
101306899|NCT02028507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101557977|NCT00551759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557978|NCT00551759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101557979|NCT00335140|Leucovorin|leucovorin|mesh-list
101557980|NCT00335140|Cytarabine|cytarabine|mesh-list
101557981|NCT00335140|Dexamethasone|dexamethasone|mesh-list
101557982|NCT00335140|Dexamethasone acetate|dexamethasone acetate|mesh-list
101557983|NCT00335140|Rituximab|rituximab|mesh-list
101557984|NCT00335140|Methotrexate|methotrexate|mesh-list
101557985|NCT00335140|Vincristine|vincristine|mesh-list
101557986|NCT00335140|Procarbazine|procarbazine|mesh-list
101557987|NCT00335140|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101557988|NCT00335140|BB 1101|bb 1101|mesh-list
101557989|NCT00335140|Levoleucovorin|levoleucovorin|mesh-list
101557990|NCT00335140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101406414|NCT00104273|Rasagiline|rasagiline|mesh-list
101306900|NCT02028507|Antimetabolites|antimetabolites|mesh-ancestor
101306901|NCT02028507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426021|NCT00529594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101426023|NCT00529594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426025|NCT00173862|Ifosfamide|ifosfamide|mesh-list
101426026|NCT00173862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101426027|NCT00173862|Antimetabolites|antimetabolites|mesh-ancestor
101426028|NCT00173862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426029|NCT00173862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101426030|NCT00173862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101426031|NCT00173862|Alkylating Agents|alkylating agents|mesh-ancestor
101426032|NCT00529750|Atenolol|atenolol|mesh-list
101426033|NCT00529750|Irbesartan|irbesartan|mesh-list
101426034|NCT00529750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101426035|NCT00529750|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101426036|NCT00529750|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101426037|NCT00529750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426038|NCT00529750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101426039|NCT00529750|Sympatholytics|sympatholytics|mesh-ancestor
101426040|NCT00529750|Autonomic Agents|autonomic agents|mesh-ancestor
101426041|NCT00529750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101426042|NCT00529750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426043|NCT00529750|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101426044|NCT00529750|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101426045|NCT00529750|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101426046|NCT00529750|Adrenergic Agents|adrenergic agents|mesh-ancestor
101426047|NCT00529750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101426048|NCT00529867|Lumefantrine|lumefantrine|mesh-list
101426049|NCT00529867|Artemether|artemether|mesh-list
101426050|NCT00529867|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101426051|NCT00529867|Antimalarials|antimalarials|mesh-ancestor
101426052|NCT00529867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101426053|NCT00529867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101426054|NCT00529867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101426055|NCT00168441|Botulinum Toxins|botulinum toxins|mesh-list
101426056|NCT00168441|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101426057|NCT00168441|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101426058|NCT00168441|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101426059|NCT00168441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101426060|NCT00168441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426061|NCT00168441|Cholinergic Agents|cholinergic agents|mesh-ancestor
101426062|NCT00168441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101426063|NCT00168441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426064|NCT00168441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101426065|NCT00168441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101426066|NCT00168480|Botulinum Toxins|botulinum toxins|mesh-list
101426067|NCT00168480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101557991|NCT00335140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101557992|NCT00335140|Immunologic Factors|immunologic factors|mesh-ancestor
101557993|NCT00335140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101557995|NCT00335140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101557996|NCT00335140|Antiemetics|antiemetics|mesh-ancestor
101557997|NCT00335140|Autonomic Agents|autonomic agents|mesh-ancestor
101557998|NCT00335140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101557999|NCT00335140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101558000|NCT00335140|Glucocorticoids|glucocorticoids|mesh-ancestor
101558001|NCT00335140|Hormones|hormones|mesh-ancestor
101628319|NCT00720109|Dexamethasone|dexamethasone|mesh-list
101426068|NCT00168480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101426074|NCT00168480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426075|NCT00168480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101426076|NCT00168480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101426078|NCT00527449|Docetaxel|docetaxel|mesh-list
101426079|NCT00527449|Epirubicin|epirubicin|mesh-list
101426080|NCT00527449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101426081|NCT00527449|Tubulin Modulators|tubulin modulators|mesh-ancestor
101426082|NCT00527449|Antimitotic Agents|antimitotic agents|mesh-ancestor
101426083|NCT00527449|Mitosis Modulators|mitosis modulators|mesh-ancestor
101426084|NCT00527449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426085|NCT00527449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101426086|NCT00527449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101426087|NCT00527449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101426088|NCT00527449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101426089|NCT00168519|Nitroprusside|nitroprusside|mesh-list
101426090|NCT00168519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101426091|NCT00168519|Vasodilator Agents|vasodilator agents|mesh-ancestor
101426092|NCT00168519|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101426093|NCT00168519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426094|NCT04692376|Cyclosporine|cyclosporine|mesh-list
101426099|NCT04692376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101426100|NCT04692376|Immunologic Factors|immunologic factors|mesh-ancestor
101426101|NCT04692376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426102|NCT04692376|Antifungal Agents|antifungal agents|mesh-ancestor
101426103|NCT04692376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101426104|NCT04692376|Dermatologic Agents|dermatologic agents|mesh-ancestor
101426105|NCT04692376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101426106|NCT04692376|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101426107|NCT04692376|Hormones|hormones|mesh-ancestor
101426108|NCT04692376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101426109|NCT00527683|Vigabatrin|vigabatrin|mesh-list
101426110|NCT00527683|Anticonvulsants|anticonvulsants|mesh-ancestor
101426111|NCT00527683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101426112|NCT00527683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426113|NCT00527683|GABA Agents|gaba agents|mesh-ancestor
101426114|NCT00527683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101426115|NCT00527683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426116|NCT00173901|Ceftazidime|ceftazidime|mesh-list
101426117|NCT00173901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101426118|NCT00173901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101426119|NCT00527761|Cisplatin|cisplatin|mesh-list
101426120|NCT00527761|Docetaxel|docetaxel|mesh-list
101426121|NCT00527761|Temozolomide|temozolomide|mesh-list
101426122|NCT00527761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101426123|NCT00527761|Tubulin Modulators|tubulin modulators|mesh-ancestor
101426124|NCT00527761|Antimitotic Agents|antimitotic agents|mesh-ancestor
101426125|NCT00527761|Mitosis Modulators|mitosis modulators|mesh-ancestor
101426126|NCT00527761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426127|NCT00527761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101426129|NCT00527800|Lumefantrine|lumefantrine|mesh-list
101426130|NCT00527800|Artemether|artemether|mesh-list
101426131|NCT00527800|Piperaquine|piperaquine|mesh-list
101426132|NCT00527800|Trimethoprim|trimethoprim|mesh-list
101426133|NCT00527800|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101426134|NCT00527800|Artenimol|artenimol|mesh-list
101558002|NCT00335140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101558003|NCT00335140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101558004|NCT00335140|Protease Inhibitors|protease inhibitors|mesh-ancestor
101558005|NCT00335140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101558006|NCT00335140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558007|NCT00335140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101558008|NCT00335140|Abortifacient Agents|abortifacient agents|mesh-ancestor
101558009|NCT00335140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101460914|NCT00572065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101558010|NCT00335140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101558012|NCT00335140|Dermatologic Agents|dermatologic agents|mesh-ancestor
101558013|NCT00335140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101558014|NCT00335140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101406430|NCT00104429|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101426135|NCT00527800|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101426136|NCT00527800|Sulfamethoxazole|sulfamethoxazole|mesh-list
101426137|NCT00527800|Antimalarials|antimalarials|mesh-ancestor
101426138|NCT00527800|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101426148|NCT00527800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101426149|NCT02945293|Oxycodone|oxycodone|mesh-list
101426150|NCT02945293|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101426151|NCT02945293|Narcotics|narcotics|mesh-ancestor
101426152|NCT02945293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101426153|NCT02945293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426154|NCT02945293|Analgesics|analgesics|mesh-ancestor
101426155|NCT02945293|Sensory System Agents|sensory system agents|mesh-ancestor
101426156|NCT02945293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101426157|NCT04692415|Insulin Glargine|insulin glargine|mesh-list
101426158|NCT04692415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101426159|NCT04692415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426160|NCT02945215|Rituximab|rituximab|mesh-list
101426161|NCT02945215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101426162|NCT02945215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101426163|NCT02945215|Immunologic Factors|immunologic factors|mesh-ancestor
101426164|NCT02945215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426165|NCT02945215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101426166|NCT00144677|Sirolimus|sirolimus|mesh-list
101426167|NCT00144677|Tacrolimus|tacrolimus|mesh-list
101426168|NCT00144677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101426181|NCT00531076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101426182|NCT00531076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101426183|NCT00531076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101426184|NCT00531076|Growth Substances|growth substances|mesh-ancestor
101426185|NCT00531076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426186|NCT00531076|Growth Inhibitors|growth inhibitors|mesh-ancestor
101426187|NCT00531115|Cetuximab|cetuximab|mesh-list
101426188|NCT00531115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101426189|NCT00531115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101426190|NCT00144716|Insect Repellents|insect repellents|mesh-list
101426191|NCT00144716|Protective Agents|protective agents|mesh-ancestor
101426192|NCT00144716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426193|NCT00531193|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
101426194|NCT00531193|SCH 442416|sch 442416|mesh-list
101426195|NCT00531193|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
101426196|NCT00531193|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101426197|NCT00531193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101426198|NCT00531193|Purinergic Agents|purinergic agents|mesh-ancestor
101426199|NCT00531193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101426200|NCT00531193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558015|NCT00335140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101558016|NCT00335140|Antiviral Agents|antiviral agents|mesh-ancestor
101558017|NCT00335140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101558018|NCT00335140|Antidotes|antidotes|mesh-ancestor
101558019|NCT00335140|Protective Agents|protective agents|mesh-ancestor
101558020|NCT00335140|Vitamin B Complex|vitamin b complex|mesh-ancestor
101558021|NCT00335140|Vitamins|vitamins|mesh-ancestor
101558022|NCT00335140|Micronutrients|micronutrients|mesh-ancestor
101558023|NCT00335140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101558024|NCT00335140|Tubulin Modulators|tubulin modulators|mesh-ancestor
101426201|NCT00531193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426203|NCT00144755|Hematinics|hematinics|mesh-ancestor
101426204|NCT00531271|Docetaxel|docetaxel|mesh-list
101426205|NCT00531271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101426206|NCT00531271|Tubulin Modulators|tubulin modulators|mesh-ancestor
101426207|NCT00531271|Antimitotic Agents|antimitotic agents|mesh-ancestor
101426208|NCT00531271|Mitosis Modulators|mitosis modulators|mesh-ancestor
101426209|NCT00531271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426210|NCT00531310|Fludarabine|fludarabine|mesh-list
101426211|NCT00531310|Busulfan|busulfan|mesh-list
101426226|NCT00407862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426228|NCT00527995|Vasodilator Agents|vasodilator agents|mesh-ancestor
101306907|NCT02028507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101306908|NCT02028507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426242|NCT00144833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101426243|NCT00144833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101426244|NCT00144833|Antiviral Agents|antiviral agents|mesh-ancestor
101426245|NCT00144833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101426246|NCT00144833|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101426247|NCT00144833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101426248|NCT02944942|Anesthetics|anesthetics|mesh-list
101426249|NCT02944942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101426250|NCT02944942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426251|NCT00144872|Lamotrigine|lamotrigine|mesh-list
101426252|NCT00144872|Anticonvulsants|anticonvulsants|mesh-ancestor
101426253|NCT00144872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101426254|NCT00144872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101426255|NCT00144872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426256|NCT00144872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101426257|NCT00144872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426258|NCT00144872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101426259|NCT00144872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101426260|NCT00144872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101426261|NCT00144872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101426262|NCT00144872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101426263|NCT02945020|Simeprevir|simeprevir|mesh-list
101426264|NCT02945020|Odalasvir|odalasvir|mesh-list
101426265|NCT02945020|Dabigatran|dabigatran|mesh-list
101426266|NCT02945020|Antithrombins|antithrombins|mesh-ancestor
101426267|NCT02945020|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101426268|NCT02945020|Protease Inhibitors|protease inhibitors|mesh-ancestor
101426269|NCT02945020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101426270|NCT02945020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426271|NCT02945020|Anticoagulants|anticoagulants|mesh-ancestor
101426272|NCT02945020|Antiviral Agents|antiviral agents|mesh-ancestor
101426273|NCT02945020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101426274|NCT00528073|Rifaximin|rifaximin|mesh-list
101426275|NCT00528073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101426276|NCT00528073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101426277|NCT00528073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101426278|NCT00528151|Curcumin|curcumin|mesh-list
101426284|NCT00528151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426285|NCT00528151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101426286|NCT00528151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101558025|NCT00335140|Antimitotic Agents|antimitotic agents|mesh-ancestor
101558026|NCT00335140|Mitosis Modulators|mitosis modulators|mesh-ancestor
101558027|NCT00304239|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
101558028|NCT00304239|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101558029|NCT00304239|Dermatologic Agents|dermatologic agents|mesh-ancestor
101558030|NCT00101283|Carboplatin|carboplatin|mesh-list
101558031|NCT00101283|Gemcitabine|gemcitabine|mesh-list
101558032|NCT00101283|Pemetrexed|pemetrexed|mesh-list
101558033|NCT00101283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101558034|NCT00101283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101558035|NCT00101283|Antimetabolites|antimetabolites|mesh-ancestor
101426287|NCT00528151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101426288|NCT00528151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101426289|NCT00528151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426294|NCT00144911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101426295|NCT00144911|Autonomic Agents|autonomic agents|mesh-ancestor
101426296|NCT00144911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101426297|NCT00144911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426298|NCT00144911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101426299|NCT00144911|Respiratory System Agents|respiratory system agents|mesh-ancestor
101426300|NCT00144911|Dermatologic Agents|dermatologic agents|mesh-ancestor
101426301|NCT00144911|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101426302|NCT00144911|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101426303|NCT00144911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101426304|NCT00144911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101426305|NCT00144911|Adrenergic Agents|adrenergic agents|mesh-ancestor
101426306|NCT00144911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101426307|NCT00144911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426309|NCT00168597|Vitamins|vitamins|mesh-ancestor
101426310|NCT00168597|Micronutrients|micronutrients|mesh-ancestor
101426311|NCT00168597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426312|NCT00528385|Spironolactone|spironolactone|mesh-list
101306909|NCT02028507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101306910|NCT02028507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101306911|NCT02028507|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101426313|NCT00528385|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101426314|NCT00528385|Hormone Antagonists|hormone antagonists|mesh-ancestor
101426315|NCT00528385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101426316|NCT00528385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426317|NCT00528385|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101426319|NCT00528385|Natriuretic Agents|natriuretic agents|mesh-ancestor
101426320|NCT02944981|Gabapentin|gabapentin|mesh-list
101426321|NCT02944981|Analgesics|analgesics|mesh-ancestor
101426322|NCT02944981|Sensory System Agents|sensory system agents|mesh-ancestor
101426323|NCT02944981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101426324|NCT02944981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426325|NCT02944981|Anticonvulsants|anticonvulsants|mesh-ancestor
101426326|NCT02944981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101426327|NCT02944981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101426328|NCT02944981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101426329|NCT02944981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101426330|NCT02944981|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101426331|NCT02944981|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101426332|NCT02944981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101426333|NCT02944981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426334|NCT02944981|Antimanic Agents|antimanic agents|mesh-ancestor
101426335|NCT00168636|Vitamin A|vitamin a|mesh-list
101426336|NCT00168636|Vitamins|vitamins|mesh-ancestor
101426337|NCT00168636|Micronutrients|micronutrients|mesh-ancestor
101426338|NCT00168636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426339|NCT00144989|Cisplatin|cisplatin|mesh-list
101426340|NCT00144989|Irinotecan|irinotecan|mesh-list
101426341|NCT00144989|Etoposide|etoposide|mesh-list
101426342|NCT00144989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101426343|NCT00144989|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101558036|NCT00101283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558037|NCT00101283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101558038|NCT00101283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101558039|NCT00101283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101558040|NCT01301729|Paclitaxel|paclitaxel|mesh-list
101558041|NCT01301729|Docetaxel|docetaxel|mesh-list
101558042|NCT01301729|Trastuzumab|trastuzumab|mesh-list
101558043|NCT01301729|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101426344|NCT00144989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101426345|NCT00144989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101426346|NCT00144989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426347|NCT00144989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101426348|NCT00144989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101426349|NCT00528502|Lidocaine|lidocaine|mesh-list
101426378|NCT00168714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101426380|NCT00168714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101426381|NCT00168714|Immunologic Factors|immunologic factors|mesh-ancestor
101426382|NCT00168714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426383|NCT00168714|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101426384|NCT00528658|Acetaminophen|acetaminophen|mesh-list
101426385|NCT00528658|Ibuprofen|ibuprofen|mesh-list
101426386|NCT00528658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101426387|NCT00528658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101426388|NCT00528658|Analgesics|analgesics|mesh-ancestor
101306912|NCT02028507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101306913|NCT02028533|Oxytocin|oxytocin|mesh-list
101306914|NCT02028533|Oxytocics|oxytocics|mesh-ancestor
101306915|NCT02028533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101306916|NCT02028533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306917|NCT02028598|Sildenafil Citrate|sildenafil citrate|mesh-list
101306918|NCT02028598|Clomipramine|clomipramine|mesh-list
101426389|NCT00528658|Sensory System Agents|sensory system agents|mesh-ancestor
101426390|NCT00528658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101426391|NCT00528658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426392|NCT00528658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101426393|NCT00528658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101426394|NCT00528658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101426395|NCT00528658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101426396|NCT00528658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426397|NCT00528658|Antipyretics|antipyretics|mesh-ancestor
101426398|NCT00145028|Carboplatin|carboplatin|mesh-list
101426399|NCT00145028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101426400|NCT00528814|Hand Sanitizers|hand sanitizers|mesh-list
101426401|NCT00528814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101426417|NCT00531349|Propofol|propofol|mesh-list
101426418|NCT00531349|Sevoflurane|sevoflurane|mesh-list
101426419|NCT00531349|Anesthetics|anesthetics|mesh-ancestor
101426420|NCT00531349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101426421|NCT00531349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426422|NCT00531349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101426423|NCT00531349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101426424|NCT00531349|Anesthetics, General|anesthetics, general|mesh-ancestor
101426425|NCT00531349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101426426|NCT00531349|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101426427|NCT00531466|Tolperisone|tolperisone|mesh-list
101426428|NCT00531466|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101426429|NCT00531466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426434|NCT00168792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101426435|NCT00168792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426436|NCT00531544|Sunitinib|sunitinib|mesh-list
101426437|NCT00531544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101426438|NCT00531544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101426439|NCT00531544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101426440|NCT00531544|Growth Substances|growth substances|mesh-ancestor
101426441|NCT00531544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426442|NCT00531544|Growth Inhibitors|growth inhibitors|mesh-ancestor
101426443|NCT00531544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101558044|NCT01301729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101558045|NCT01301729|Tubulin Modulators|tubulin modulators|mesh-ancestor
101558046|NCT01301729|Antimitotic Agents|antimitotic agents|mesh-ancestor
101558047|NCT01301729|Mitosis Modulators|mitosis modulators|mesh-ancestor
101558048|NCT01301729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558049|NCT01301729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101426444|NCT00531544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101426445|NCT00531544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426446|NCT00145106|Minocycline|minocycline|mesh-list
101426447|NCT00145106|Tazarotene|tazarotene|mesh-list
101426448|NCT00145106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101426449|NCT00145106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101426450|NCT00145106|Dermatologic Agents|dermatologic agents|mesh-ancestor
101426451|NCT00145106|Keratolytic Agents|keratolytic agents|mesh-ancestor
101426452|NCT00145184|Vitamins|vitamins|mesh-list
101426453|NCT00145184|Vitamin B Complex|vitamin b complex|mesh-list
101426454|NCT00145184|Micronutrients|micronutrients|mesh-ancestor
101426455|NCT00145184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426456|NCT02944357|Cisplatin|cisplatin|mesh-list
101306920|NCT02028598|Sodium Citrate|sodium citrate|mesh-list
101306921|NCT02028598|Anticoagulants|anticoagulants|mesh-ancestor
101306922|NCT02028598|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101426457|NCT02944357|Gemcitabine|gemcitabine|mesh-list
101426458|NCT02944357|Vaccines|vaccines|mesh-list
101426459|NCT02944357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101426460|NCT02944357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101426461|NCT02944357|Antimetabolites|antimetabolites|mesh-ancestor
101426462|NCT02944357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426463|NCT02944357|Immunologic Factors|immunologic factors|mesh-ancestor
101426464|NCT02944357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426471|NCT02944396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101426472|NCT02944396|Tubulin Modulators|tubulin modulators|mesh-ancestor
101426473|NCT02944396|Antimitotic Agents|antimitotic agents|mesh-ancestor
101426474|NCT02944396|Mitosis Modulators|mitosis modulators|mesh-ancestor
101426475|NCT02944396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426476|NCT02944396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101426477|NCT02944396|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101426478|NCT02944396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101426479|NCT02944396|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101426480|NCT02944396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101426481|NCT02944396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101426482|NCT00174174|Modafinil|modafinil|mesh-list
101426483|NCT00174174|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101426484|NCT00174174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426485|NCT00174174|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101426486|NCT00174174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101426487|NCT00174174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101426488|NCT00174174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426489|NCT00530101|Doxorubicin|doxorubicin|mesh-list
101426490|NCT00530101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101426491|NCT00530101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101426492|NCT00530101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101426493|NCT00530101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101426494|NCT00530101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101426495|NCT00530101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426496|NCT00530140|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
101426497|NCT00530140|Immunologic Factors|immunologic factors|mesh-ancestor
101426498|NCT00530140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426499|NCT02944552|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
101426500|NCT02944552|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101426514|NCT00145301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426515|NCT00145301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101359138|NCT00072930|Docetaxel|docetaxel|mesh-list
101426516|NCT00145301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101426517|NCT00168870|Gemcitabine|gemcitabine|mesh-list
101426518|NCT00168870|Treosulfan|treosulfan|mesh-list
101426519|NCT00168870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101426520|NCT00168870|Antimetabolites|antimetabolites|mesh-ancestor
101558050|NCT05643677|Irinotecan|irinotecan|mesh-list
101558051|NCT05643677|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101558052|NCT05643677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101558053|NCT05643677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101558054|NCT05643677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558055|NCT05643677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101558056|NCT02890589|Chromium|chromium|mesh-list
101558057|NCT02890589|Everolimus|everolimus|mesh-list
101558058|NCT02890589|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101558059|NCT02890589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101406478|NCT00137085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101426521|NCT00168870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426522|NCT00168870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101426523|NCT00168870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101426524|NCT00168870|Alkylating Agents|alkylating agents|mesh-ancestor
101426525|NCT02944201|Carvedilol|carvedilol|mesh-list
101426526|NCT02944201|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101426527|NCT02944201|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101426528|NCT02944201|Adrenergic Agents|adrenergic agents|mesh-ancestor
101426529|NCT02944201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101426530|NCT02944201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426531|NCT02944201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426532|NCT02944201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101426533|NCT02944201|Antioxidants|antioxidants|mesh-ancestor
101426534|NCT02944201|Protective Agents|protective agents|mesh-ancestor
101306923|NCT02028598|Chelating Agents|chelating agents|mesh-ancestor
101426535|NCT02944201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101426536|NCT02944201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101426537|NCT02944201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101426538|NCT02944201|Vasodilator Agents|vasodilator agents|mesh-ancestor
101426539|NCT02944201|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101426540|NCT02944201|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101426541|NCT00145340|Pioglitazone|pioglitazone|mesh-list
101426542|NCT00145340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101426543|NCT00145340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426544|NCT00168909|Alfacalcidol|alfacalcidol|mesh-list
101426545|NCT00168909|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
101426579|NCT00174330|Antimetabolites|antimetabolites|mesh-ancestor
101426580|NCT00174330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426581|NCT00174330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101426582|NCT00174330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101426583|NCT00174330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101426584|NCT00174330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101426585|NCT00174330|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101426586|NCT00174330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101426587|NCT00174330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101426588|NCT00174330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426589|NCT00174330|Vasodilator Agents|vasodilator agents|mesh-ancestor
101426590|NCT00531856|Carbon Monoxide|carbon monoxide|mesh-list
101426591|NCT00531856|Antimetabolites|antimetabolites|mesh-ancestor
101426592|NCT00531856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426593|NCT00531856|Gasotransmitters|gasotransmitters|mesh-ancestor
101426594|NCT00531856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101426595|NCT00531856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426596|NCT00531895|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101426597|NCT00531895|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101426598|NCT00531895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101426599|NCT00531895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101813804|NCT04048889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101426600|NCT00531895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426601|NCT00531895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101426602|NCT00531895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558060|NCT02890589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101558061|NCT02890589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558062|NCT02890589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101558063|NCT02890589|Immunologic Factors|immunologic factors|mesh-ancestor
101558064|NCT02890589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558065|NCT02890589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101558066|NCT02890589|Trace Elements|trace elements|mesh-ancestor
101558067|NCT02890589|Micronutrients|micronutrients|mesh-ancestor
101558068|NCT01301027|Pioglitazone|pioglitazone|mesh-list
101558069|NCT01301027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101558070|NCT01301027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406488|NCT00104546|Hemostatics|hemostatics|mesh-ancestor
101426603|NCT00531895|Analgesics|analgesics|mesh-ancestor
101426631|NCT00531973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101426632|NCT00531973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101426633|NCT00531973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101426634|NCT00531973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101426635|NCT00531973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426636|NCT00145652|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101426637|NCT00145652|Hematinics|hematinics|mesh-ancestor
101426638|NCT00174486|Tadalafil|tadalafil|mesh-list
101426639|NCT00174486|Vasodilator Agents|vasodilator agents|mesh-ancestor
101426640|NCT00174486|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101426641|NCT00174486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101426642|NCT00174486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101426643|NCT00174486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426644|NCT00174486|Urological Agents|urological agents|mesh-ancestor
101426645|NCT00145691|Oxcarbazepine|oxcarbazepine|mesh-list
101426646|NCT00145691|Anticonvulsants|anticonvulsants|mesh-ancestor
101426647|NCT00145691|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101426648|NCT00145691|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101426649|NCT00145691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101426650|NCT00145691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426651|NCT00145691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101426652|NCT00145691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101426653|NCT05319340|Anticoagulants|anticoagulants|mesh-list
101426664|NCT00169065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101426665|NCT00169065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426667|NCT00169065|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101426668|NCT00169065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101426669|NCT00169065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101426670|NCT00169065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101426671|NCT00169065|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101426672|NCT00169065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101426673|NCT00169065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101426674|NCT00169065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426675|NCT00169065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101426676|NCT00169065|Serotonin Agents|serotonin agents|mesh-ancestor
101426677|NCT00169065|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101426678|NCT00169065|GABA Antagonists|gaba antagonists|mesh-ancestor
101426679|NCT00169065|GABA Agents|gaba agents|mesh-ancestor
101426680|NCT00145730|Ibuprofen|ibuprofen|mesh-list
101426681|NCT00145730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101426682|NCT00145730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101426683|NCT00145730|Analgesics|analgesics|mesh-ancestor
101426684|NCT00145730|Sensory System Agents|sensory system agents|mesh-ancestor
101426685|NCT00145730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101306928|NCT02028598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101306929|NCT02028598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101306930|NCT02028598|Urological Agents|urological agents|mesh-ancestor
101306931|NCT02028598|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101558071|NCT04207385|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101558072|NCT04207385|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101558073|NCT04207385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101558074|NCT04207385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101558075|NCT04207385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558076|NCT04207385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101558077|NCT04207385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558078|NCT04207385|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101426686|NCT00145730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426687|NCT00145730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101426688|NCT00145730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101426689|NCT00145730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101426690|NCT00145730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101426691|NCT00145730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487409|NCT00432588|Misoprostol|misoprostol|mesh-list
101426696|NCT00169143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426697|NCT00169143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101426698|NCT02942680|Aspirin|aspirin|mesh-list
101426699|NCT02942680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101426700|NCT02942680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101426701|NCT02942680|Analgesics|analgesics|mesh-ancestor
101426702|NCT02942680|Sensory System Agents|sensory system agents|mesh-ancestor
101426703|NCT02942680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101426704|NCT02942680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426705|NCT02942680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101426706|NCT02942680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101426707|NCT02942680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101426708|NCT02942680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101426709|NCT02942680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426710|NCT02942680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101426711|NCT02942680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101426712|NCT02942680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101426713|NCT02942680|Antipyretics|antipyretics|mesh-ancestor
101426714|NCT00174564|Oxaliplatin|oxaliplatin|mesh-list
101426715|NCT00174564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101426716|NCT02276911|Ibuprofen|ibuprofen|mesh-list
101426720|NCT02276911|Sensory System Agents|sensory system agents|mesh-ancestor
101426721|NCT02276911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101426722|NCT02276911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426723|NCT02276911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101426724|NCT02276911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101426725|NCT02276911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101426726|NCT02276911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101426727|NCT02276911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426729|NCT00145847|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101426730|NCT00145847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101426731|NCT00145847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426732|NCT00145847|Sensory System Agents|sensory system agents|mesh-ancestor
101426733|NCT00145847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101426734|NCT00169182|Nicotinic Acids|nicotinic acids|mesh-list
101426735|NCT00169182|Niacin|niacin|mesh-list
101426736|NCT00169182|Docetaxel|docetaxel|mesh-list
101426737|NCT00169182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101426738|NCT00169182|Tubulin Modulators|tubulin modulators|mesh-ancestor
101426739|NCT00169182|Antimitotic Agents|antimitotic agents|mesh-ancestor
101426740|NCT00169182|Mitosis Modulators|mitosis modulators|mesh-ancestor
101426741|NCT00169182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426742|NCT00169182|Vitamin B Complex|vitamin b complex|mesh-ancestor
101426743|NCT00169182|Vitamins|vitamins|mesh-ancestor
101426744|NCT00169182|Micronutrients|micronutrients|mesh-ancestor
101426745|NCT00169182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426746|NCT00169182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101558079|NCT04207385|Antidepressive Agents|antidepressive agents|mesh-ancestor
101558080|NCT04207385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101558081|NCT05641883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
101558082|NCT02886897|Antibodies|antibodies|mesh-list
101558083|NCT02886897|Immunologic Factors|immunologic factors|mesh-ancestor
101558084|NCT02886897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558085|NCT05641649|Valproic Acid|valproic acid|mesh-list
101558086|NCT05641649|Anticonvulsants|anticonvulsants|mesh-ancestor
101406508|NCT00104624|Tubulin Modulators|tubulin modulators|mesh-ancestor
101426747|NCT00169182|Antimetabolites|antimetabolites|mesh-ancestor
101426748|NCT00169182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101426749|NCT00169182|Vasodilator Agents|vasodilator agents|mesh-ancestor
101426750|NCT02944825|Ciprofloxacin|ciprofloxacin|mesh-list
101426751|NCT02944825|Trimethoprim|trimethoprim|mesh-list
101426752|NCT02944825|Sulfamethoxazole|sulfamethoxazole|mesh-list
101426753|NCT02944825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101306932|NCT02028598|Antidepressive Agents|antidepressive agents|mesh-ancestor
101306934|NCT02028598|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101306935|NCT02028598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101306936|NCT02028598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101306937|NCT02028598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101306938|NCT02028598|Serotonin Agents|serotonin agents|mesh-ancestor
101306939|NCT02028598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306940|NCT02028663|Esomeprazole|esomeprazole|mesh-list
101306941|NCT02028663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101306942|NCT02028663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101426754|NCT02944825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101426755|NCT02944825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101426756|NCT02944825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101426757|NCT02944825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101426758|NCT02944825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426759|NCT02944825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101426760|NCT02944825|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101426761|NCT02944825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101426762|NCT02944825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101426763|NCT02944825|Antimalarials|antimalarials|mesh-ancestor
101426764|NCT02944825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101426766|NCT02944825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101426767|NCT02944825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101426768|NCT02944825|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101426769|NCT02942758|Pioglitazone|pioglitazone|mesh-list
101426770|NCT02942758|Azacitidine|azacitidine|mesh-list
101426772|NCT02942758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101426773|NCT02942758|Antimetabolites|antimetabolites|mesh-ancestor
101426774|NCT02942758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426775|NCT02942758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101426776|NCT02942758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101426777|NCT02942758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101426778|NCT02942758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426779|NCT02942758|Keratolytic Agents|keratolytic agents|mesh-ancestor
101426780|NCT02942758|Dermatologic Agents|dermatologic agents|mesh-ancestor
101426796|NCT02942563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426798|NCT02942563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101426799|NCT02942563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101426800|NCT02942563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101426802|NCT00145925|Perindopril|perindopril|mesh-list
101426803|NCT00145925|Indapamide|indapamide|mesh-list
101426804|NCT00145925|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
101426805|NCT00145925|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101461024|NCT00225056|Docetaxel|docetaxel|mesh-list
101426806|NCT00145925|Protease Inhibitors|protease inhibitors|mesh-ancestor
101426807|NCT00145925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101306943|NCT02028663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101306944|NCT02028663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101426808|NCT00145925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426809|NCT00145925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101426810|NCT00145925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101558087|NCT05641649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101558088|NCT05641649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558089|NCT05641649|GABA Agents|gaba agents|mesh-ancestor
101558090|NCT05641649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101558091|NCT05641649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558092|NCT05641649|Antimanic Agents|antimanic agents|mesh-ancestor
101558093|NCT05641649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101558094|NCT05641649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101530862|NCT04600089|Ketamine|ketamine|mesh-list
101426811|NCT00145925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426812|NCT00145925|Diuretics|diuretics|mesh-ancestor
101426813|NCT00145925|Natriuretic Agents|natriuretic agents|mesh-ancestor
101426814|NCT00145925|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101426815|NCT00145925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101426816|NCT00529321|Immunomodulating Agents|immunomodulating agents|mesh-list
101426817|NCT00529321|Immunologic Factors|immunologic factors|mesh-ancestor
101426818|NCT00529321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426819|NCT00169221|Gefitinib|gefitinib|mesh-list
101426820|NCT00169221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101426821|NCT00169221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101426822|NCT00169221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101426823|NCT00169221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426824|NCT00529360|Clofarabine|clofarabine|mesh-list
101426825|NCT00529360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101426826|NCT00529360|Antimetabolites|antimetabolites|mesh-ancestor
101426827|NCT00529360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426828|NCT00529360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101426829|NCT00174642|Insulin|insulin|mesh-list
101426830|NCT00174642|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101426831|NCT00174642|Metformin|metformin|mesh-list
101426832|NCT00174642|Insulin Glargine|insulin glargine|mesh-list
101426833|NCT00174642|Insulin glulisine|insulin glulisine|mesh-list
101426834|NCT00174642|Secretagogues|secretagogues|mesh-list
101426835|NCT00174642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101426836|NCT00174642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426837|NCT00174681|Insulin Glargine|insulin glargine|mesh-list
101426849|NCT00146042|Mitosis Modulators|mitosis modulators|mesh-ancestor
101426850|NCT00146042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426851|NCT00146042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101426852|NCT00146042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101426853|NCT00146042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101426854|NCT00146042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101426855|NCT00146042|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101426856|NCT00146042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101426857|NCT00169299|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101426858|NCT00169299|Medroxyprogesterone|medroxyprogesterone|mesh-list
101426859|NCT00169299|Estrogens|estrogens|mesh-list
101426860|NCT00169299|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101426861|NCT00169299|Hormones|hormones|mesh-ancestor
101426862|NCT00169299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101426863|NCT00169299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426864|NCT00169299|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101426865|NCT00169299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101426866|NCT00169299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101426867|NCT00169299|Contraceptive Agents|contraceptive agents|mesh-ancestor
101461034|NCT00225173|Cyclophosphamide|cyclophosphamide|mesh-list
101426868|NCT00169299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101426869|NCT00169299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101426870|NCT00169299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101426871|NCT00169299|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101426872|NCT00169299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101426873|NCT00169299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101426875|NCT02942602|Ezetimibe|ezetimibe|mesh-list
101426876|NCT02942602|Cholestyramine Resin|cholestyramine resin|mesh-list
101426877|NCT02942602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101426878|NCT02942602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101558095|NCT05641649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101558096|NCT01184859|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101558098|NCT01184859|Coagulants|coagulants|mesh-ancestor
101558099|NCT01184859|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101558100|NCT01184859|Natriuretic Agents|natriuretic agents|mesh-ancestor
101558101|NCT01184859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558102|NCT02890511|Paclitaxel|paclitaxel|mesh-list
101558103|NCT02890511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101558104|NCT02890511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101558105|NCT02890511|Tubulin Modulators|tubulin modulators|mesh-ancestor
101406525|NCT00104741|Flutamide|flutamide|mesh-list
101426879|NCT02942602|Antimetabolites|antimetabolites|mesh-ancestor
101426880|NCT02942602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426881|NCT02942602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101426882|NCT02942602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101426883|NCT02942602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101306945|NCT02028663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306946|NCT02028689|Metformin|metformin|mesh-list
101306947|NCT02028689|Lesinurad|lesinurad|mesh-list
101306948|NCT02028689|Furosemide|furosemide|mesh-list
101426884|NCT02942329|Apatinib|apatinib|mesh-list
101426885|NCT02942329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101426886|NCT02942329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101426887|NCT02942329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101426888|NCT02942329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426889|NCT00174720|Ciclesonide|ciclesonide|mesh-list
101426890|NCT00174720|Glucocorticoids|glucocorticoids|mesh-ancestor
101426891|NCT00174720|Hormones|hormones|mesh-ancestor
101426892|NCT00174720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101426893|NCT00174720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426894|NCT00174720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101426895|NCT05318794|Doxorubicin|doxorubicin|mesh-list
101426896|NCT05318794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101426897|NCT05318794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101426898|NCT05318794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101426899|NCT05318794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101426900|NCT05318794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101359145|NCT00072930|Glucocorticoids|glucocorticoids|mesh-ancestor
101426901|NCT05318794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426902|NCT02942212|Nicotine|nicotine|mesh-list
101426903|NCT02942212|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101426904|NCT02942212|Autonomic Agents|autonomic agents|mesh-ancestor
101426905|NCT02942212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101426906|NCT02942212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426907|NCT02942212|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101426909|NCT02942212|Cholinergic Agents|cholinergic agents|mesh-ancestor
101426910|NCT02942212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101426913|NCT00146120|Idarubicin|idarubicin|mesh-list
101426914|NCT00146120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101426915|NCT00146120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101426916|NCT00146120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101426917|NCT00146120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101426918|NCT00146120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101426919|NCT00146120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426920|NCT00146120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101426921|NCT00146159|Mitoxantrone|mitoxantrone|mesh-list
101426922|NCT00146159|Analgesics|analgesics|mesh-ancestor
101426923|NCT00146159|Sensory System Agents|sensory system agents|mesh-ancestor
101426924|NCT00146159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101426925|NCT00146159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426926|NCT00146159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101426927|NCT00146159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101426928|NCT00146159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101558106|NCT02890511|Antimitotic Agents|antimitotic agents|mesh-ancestor
101558107|NCT02890511|Mitosis Modulators|mitosis modulators|mesh-ancestor
101558108|NCT02890511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558109|NCT01184079|Vaccines|vaccines|mesh-list
101558110|NCT01184079|Immunologic Factors|immunologic factors|mesh-ancestor
101558111|NCT01184079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558112|NCT05333289|Vaccines|vaccines|mesh-list
101558113|NCT05333289|Immunologic Factors|immunologic factors|mesh-ancestor
101558114|NCT05333289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426929|NCT00146159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101426930|NCT00146159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426931|NCT02276989|Riboflavin|riboflavin|mesh-list
101426932|NCT02276989|Quinine|quinine|mesh-list
101426933|NCT02276989|Acetazolamide|acetazolamide|mesh-list
101426934|NCT02276989|Vitamins|vitamins|mesh-ancestor
101426935|NCT02276989|Micronutrients|micronutrients|mesh-ancestor
101426936|NCT02276989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426937|NCT02276989|Vitamin B Complex|vitamin b complex|mesh-ancestor
101426938|NCT02276989|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101426939|NCT02276989|Dermatologic Agents|dermatologic agents|mesh-ancestor
101426940|NCT02276989|Anticonvulsants|anticonvulsants|mesh-ancestor
101426941|NCT02276989|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101426942|NCT02276989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101426943|NCT02276989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426944|NCT02276989|Diuretics|diuretics|mesh-ancestor
101426945|NCT02276989|Natriuretic Agents|natriuretic agents|mesh-ancestor
101426946|NCT02276989|Antimalarials|antimalarials|mesh-ancestor
101426947|NCT02276989|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101426948|NCT02276989|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101426949|NCT02276989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101426950|NCT02276989|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101426951|NCT02276989|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101426952|NCT02276989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101306949|NCT02028689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101306950|NCT02028689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306951|NCT02028689|Diuretics|diuretics|mesh-ancestor
101426953|NCT02276989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101426955|NCT02276989|Sensory System Agents|sensory system agents|mesh-ancestor
101426956|NCT00174759|Clopidogrel|clopidogrel|mesh-list
101426957|NCT00174759|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101426958|NCT00174759|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101461072|NCT00234975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101426959|NCT00174759|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101426960|NCT00174759|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101426961|NCT00174759|Purinergic Agents|purinergic agents|mesh-ancestor
101426962|NCT00174759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101426963|NCT00174759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426964|NCT00174759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426965|NCT00146237|Phenytoin|phenytoin|mesh-list
101426966|NCT00146237|Anticonvulsants|anticonvulsants|mesh-ancestor
101426967|NCT00146237|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101426968|NCT00146237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101426969|NCT00146237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101426970|NCT00146237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426971|NCT00146237|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101426972|NCT00146237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101426973|NCT02277067|Misoprostol|misoprostol|mesh-list
101426974|NCT02277067|Carbetocin|carbetocin|mesh-list
101426975|NCT02277067|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101426976|NCT02277067|Abortifacient Agents|abortifacient agents|mesh-ancestor
101426977|NCT02277067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101426978|NCT02277067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426979|NCT02277067|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101426980|NCT02277067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101427024|NCT00174876|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101427025|NCT00174876|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101427026|NCT00146471|Levetiracetam|levetiracetam|mesh-list
101558115|NCT01289990|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101558116|NCT01289990|Empagliflozin|empagliflozin|mesh-list
101558117|NCT01289990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101558118|NCT01289990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558119|NCT01289990|Incretins|incretins|mesh-ancestor
101558120|NCT01289990|Hormones|hormones|mesh-ancestor
101558121|NCT01289990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101558122|NCT01289990|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101406550|NCT00134550|Atorvastatin|atorvastatin|mesh-list
101427027|NCT00146471|Anticonvulsants|anticonvulsants|mesh-ancestor
101427028|NCT00146471|Nootropic Agents|nootropic agents|mesh-ancestor
101427029|NCT00174993|Pioglitazone|pioglitazone|mesh-list
101427030|NCT00174993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101427031|NCT00174993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306952|NCT02028689|Natriuretic Agents|natriuretic agents|mesh-ancestor
101427062|NCT00146549|Docetaxel|docetaxel|mesh-list
101427063|NCT00146549|Trastuzumab|trastuzumab|mesh-list
101427064|NCT00146549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101427065|NCT00146549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101427066|NCT00146549|Tubulin Modulators|tubulin modulators|mesh-ancestor
101427067|NCT00146549|Antimitotic Agents|antimitotic agents|mesh-ancestor
101427068|NCT00146549|Mitosis Modulators|mitosis modulators|mesh-ancestor
101427069|NCT00146549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427070|NCT00146549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101427071|NCT02940535|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101427072|NCT02940535|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101427073|NCT02940535|Menotropins|menotropins|mesh-list
101427074|NCT02940535|Luteolytic Agents|luteolytic agents|mesh-ancestor
101427075|NCT02940535|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101427076|NCT02940535|Contraceptive Agents|contraceptive agents|mesh-ancestor
101427077|NCT02940535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101427078|NCT02940535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427079|NCT02940535|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101427080|NCT02940535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101427081|NCT02940535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101427082|NCT02940535|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101427083|NCT02940535|Fertility Agents|fertility agents|mesh-ancestor
101427084|NCT00146588|Cyclophosphamide|cyclophosphamide|mesh-list
101427109|NCT00175032|Analgesics|analgesics|mesh-ancestor
101427110|NCT00175032|Sensory System Agents|sensory system agents|mesh-ancestor
101427111|NCT00175032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101427115|NCT00175032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101427116|NCT00175032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101427117|NCT00175032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427118|NCT00175032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101427119|NCT00175032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101427120|NCT00175032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101427121|NCT00175032|Antipyretics|antipyretics|mesh-ancestor
101427122|NCT00175032|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101427123|NCT00175032|Gout Suppressants|gout suppressants|mesh-ancestor
101427124|NCT00175032|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101427125|NCT00175032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101427126|NCT00175032|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101427144|NCT00424229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427145|NCT00424229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101427146|NCT00424229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101427147|NCT00424229|Growth Substances|growth substances|mesh-ancestor
101427148|NCT00424229|Growth Inhibitors|growth inhibitors|mesh-ancestor
101427149|NCT00424229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101427150|NCT02944123|Clopidogrel|clopidogrel|mesh-list
101427151|NCT02944123|Ticagrelor|ticagrelor|mesh-list
101427152|NCT02944123|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101427153|NCT02944123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101427154|NCT02944123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101427155|NCT02944123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101558123|NCT01289990|Protease Inhibitors|protease inhibitors|mesh-ancestor
101558124|NCT01289990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101558125|NCT01289990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558126|NCT01289990|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101558127|NCT01190007|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
101558128|NCT01190007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101558129|NCT01190007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101427156|NCT02944123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101427157|NCT02944123|Purinergic Agents|purinergic agents|mesh-ancestor
101427158|NCT02944123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101427159|NCT02944123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427160|NCT02944123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427161|NCT02944045|Methylprednisolone|methylprednisolone|mesh-list
101427162|NCT02944045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101427163|NCT02944045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101427164|NCT02944045|Prednisolone|prednisolone|mesh-list
101427165|NCT02944045|Prednisolone acetate|prednisolone acetate|mesh-list
101427166|NCT02944045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101427167|NCT02944045|Prednisolone phosphate|prednisolone phosphate|mesh-list
101427168|NCT02944045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101427170|NCT02944045|Autonomic Agents|autonomic agents|mesh-ancestor
101427171|NCT02944045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101306961|NCT02028819|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101306962|NCT02028819|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101306963|NCT02028819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101427172|NCT02944045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427173|NCT02944045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101427174|NCT02944045|Glucocorticoids|glucocorticoids|mesh-ancestor
101427175|NCT02944045|Hormones|hormones|mesh-ancestor
101427176|NCT02944045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101427177|NCT02944045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101427178|NCT02944045|Protective Agents|protective agents|mesh-ancestor
101427179|NCT02944045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101427180|NCT02944045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101427181|NCT00169572|Dexamethasone|dexamethasone|mesh-list
101427200|NCT00169572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101427201|NCT00169572|Serotonin Agents|serotonin agents|mesh-ancestor
101427202|NCT00169572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101427203|NCT00169572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427204|NCT00169572|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101427206|NCT00146783|Sulfadoxine|sulfadoxine|mesh-list
101427207|NCT00146783|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101427208|NCT00146783|Amodiaquine|amodiaquine|mesh-list
101427209|NCT00146783|Antimalarials|antimalarials|mesh-ancestor
101427210|NCT00146783|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101427211|NCT00146783|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101427212|NCT00146783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101427213|NCT00146783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101427214|NCT00146783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101427215|NCT00146783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427216|NCT00146783|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101427217|NCT00169611|Methylphenidate|methylphenidate|mesh-list
101427218|NCT00169611|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101427219|NCT00169611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427220|NCT00169611|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101427221|NCT00169611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101427222|NCT00169611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101427223|NCT00169611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427224|NCT00169611|Dopamine Agents|dopamine agents|mesh-ancestor
101427225|NCT00169611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101427226|NCT02943655|Mefenamic Acid|mefenamic acid|mesh-list
101427227|NCT02943655|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101427228|NCT02943655|Contraceptive Agents|contraceptive agents|mesh-list
101427229|NCT02943655|Medroxyprogesterone|medroxyprogesterone|mesh-list
101558130|NCT01190007|Antimetabolites|antimetabolites|mesh-ancestor
101427230|NCT02943655|Progesterone|progesterone|mesh-list
101427231|NCT02943655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101427232|NCT02943655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427233|NCT02943655|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101427234|NCT02943655|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101427235|NCT02943655|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101427236|NCT02943655|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101427237|NCT02943655|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101427238|NCT02943655|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101427239|NCT02943655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101427240|NCT02943655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101427241|NCT02943655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101427242|NCT02943655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101427243|NCT02943655|Analgesics|analgesics|mesh-ancestor
101427244|NCT02943655|Sensory System Agents|sensory system agents|mesh-ancestor
101427245|NCT02943655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101427246|NCT02943655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101427255|NCT05085067|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101427256|NCT05085067|Immunologic Factors|immunologic factors|mesh-ancestor
101306964|NCT02028819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306966|NCT02028819|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101306967|NCT02028819|Antiviral Agents|antiviral agents|mesh-ancestor
101427257|NCT05085067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427258|NCT05085067|Viscosupplements|viscosupplements|mesh-ancestor
101427259|NCT05085067|Protective Agents|protective agents|mesh-ancestor
101427260|NCT00175227|Furosemide|furosemide|mesh-list
101427261|NCT00175227|Mannitol|mannitol|mesh-list
101427262|NCT00175227|Diuretics|diuretics|mesh-ancestor
101427263|NCT00175227|Natriuretic Agents|natriuretic agents|mesh-ancestor
101427264|NCT00175227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427269|NCT02940262|Edetic Acid|edetic acid|mesh-list
101427270|NCT02940262|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101427271|NCT02940262|Chelating Agents|chelating agents|mesh-ancestor
101427272|NCT02940262|Sequestering Agents|sequestering agents|mesh-ancestor
101427273|NCT02940262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427274|NCT02940262|Anticoagulants|anticoagulants|mesh-ancestor
101427275|NCT02940262|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101427276|NCT02940262|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101427277|NCT00146900|Escitalopram|escitalopram|mesh-list
101427278|NCT00146900|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101427279|NCT00146900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101427280|NCT00146900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101427281|NCT00146900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427282|NCT00146900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101427283|NCT00146900|Serotonin Agents|serotonin agents|mesh-ancestor
101427284|NCT00146900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427285|NCT02939482|Triamcinolone|triamcinolone|mesh-list
101427286|NCT02939482|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101427287|NCT02939482|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101427288|NCT02939482|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101427289|NCT02939482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101427290|NCT02939482|Glucocorticoids|glucocorticoids|mesh-ancestor
101427291|NCT02939482|Hormones|hormones|mesh-ancestor
101427292|NCT02939482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101427293|NCT02939482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427294|NCT02939482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101427295|NCT02939482|Immunologic Factors|immunologic factors|mesh-ancestor
101427296|NCT02939482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101427297|NCT02939482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427298|NCT00175266|Infliximab|infliximab|mesh-list
101427299|NCT00175266|Alemtuzumab|alemtuzumab|mesh-list
101427300|NCT00175266|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101427301|NCT00175266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101427302|NCT00175266|Dermatologic Agents|dermatologic agents|mesh-ancestor
101427303|NCT00175266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101427304|NCT00175266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101427305|NCT00175266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101427306|NCT00175266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101427307|NCT05013892|Memantine|memantine|mesh-list
101427308|NCT05013892|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101427309|NCT05013892|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101427310|NCT05013892|Dopamine Agents|dopamine agents|mesh-ancestor
101427311|NCT05013892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101558131|NCT01190007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558132|NCT01190007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101558133|NCT01190007|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101558134|NCT01190007|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101558135|NCT01190007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101558136|NCT01190007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101406559|NCT00104819|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101531382|NCT01159912|Xhance|xhance|mesh-list
101427312|NCT05013892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427314|NCT05013892|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101427315|NCT05013892|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101427317|NCT02939248|Naloxone|naloxone|mesh-list
101427318|NCT02939248|Ticagrelor|ticagrelor|mesh-list
101427319|NCT02939248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101427320|NCT02939248|Narcotics|narcotics|mesh-ancestor
101427321|NCT02939248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101427322|NCT02939248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427323|NCT02939248|Analgesics|analgesics|mesh-ancestor
101427324|NCT02939248|Sensory System Agents|sensory system agents|mesh-ancestor
101306968|NCT02028819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101306969|NCT02028910|Ondansetron|ondansetron|mesh-list
101306970|NCT02028910|Antiemetics|antiemetics|mesh-ancestor
101306971|NCT02028910|Autonomic Agents|autonomic agents|mesh-ancestor
101427325|NCT02939248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101427326|NCT02939248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101427327|NCT02939248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101427328|NCT02939248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101427329|NCT02939248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101427330|NCT02939248|Purinergic Agents|purinergic agents|mesh-ancestor
101427331|NCT02939248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101427345|NCT00175305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101427346|NCT00175305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101427347|NCT00175305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101427348|NCT02938741|Thymoglobulin|thymoglobulin|mesh-list
101427349|NCT02938741|Immunologic Factors|immunologic factors|mesh-ancestor
101427350|NCT02938741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427351|NCT02938741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101427352|NCT00407589|Besifloxacin|besifloxacin|mesh-list
101427353|NCT00407589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101427354|NCT00407589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101427355|NCT00407589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101427356|NCT00407589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101427357|NCT00407589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101427358|NCT00407589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427359|NCT00407589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101427360|NCT02938546|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101427361|NCT02938546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101427362|NCT02938546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427363|NCT00175383|Hormones|hormones|mesh-list
101427364|NCT00175383|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101427365|NCT00175383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101427366|NCT00175383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427367|NCT02938468|Dexamethasone|dexamethasone|mesh-list
101427368|NCT02938468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101427369|NCT02938468|Antiemetics|antiemetics|mesh-ancestor
101427370|NCT02938468|Autonomic Agents|autonomic agents|mesh-ancestor
101427371|NCT02938468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101427372|NCT02938468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427373|NCT02938468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101427374|NCT02938468|Glucocorticoids|glucocorticoids|mesh-ancestor
101427375|NCT02938468|Hormones|hormones|mesh-ancestor
101427376|NCT02938468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101359201|NCT00040586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101427377|NCT02938468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101427378|NCT02938468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101558137|NCT01190007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558138|NCT01190007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101558139|NCT01190007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101558140|NCT01300247|Cyclophosphamide|cyclophosphamide|mesh-list
101558141|NCT01300247|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101558142|NCT01300247|Fludarabine|fludarabine|mesh-list
101558143|NCT01300247|Obinutuzumab|obinutuzumab|mesh-list
101558144|NCT01300247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101558145|NCT01300247|Immunologic Factors|immunologic factors|mesh-ancestor
101558146|NCT01300247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558147|NCT01300247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101427379|NCT02938507|Solabegron|solabegron|mesh-list
101427380|NCT02938507|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101427381|NCT02938507|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101427382|NCT02938507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101427383|NCT02938507|Adrenergic Agents|adrenergic agents|mesh-ancestor
101427384|NCT02938507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101427392|NCT04836910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427393|NCT04836910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101427394|NCT04836910|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101427396|NCT00169728|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101427397|NCT00169728|Immunologic Factors|immunologic factors|mesh-ancestor
101427398|NCT00169728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306972|NCT02028910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101427408|NCT00147563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101427409|NCT00147563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427410|NCT00147563|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101427411|NCT00147563|Diuretics|diuretics|mesh-ancestor
101427412|NCT00147563|Natriuretic Agents|natriuretic agents|mesh-ancestor
101427413|NCT00147563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101427414|NCT02938273|Cetuximab|cetuximab|mesh-list
101427415|NCT02938273|Avelumab|avelumab|mesh-list
101427416|NCT02938273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101427417|NCT02938273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101427418|NCT00147602|Atorvastatin|atorvastatin|mesh-list
101427419|NCT00147602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101427420|NCT00147602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101427421|NCT00147602|Antimetabolites|antimetabolites|mesh-ancestor
101427422|NCT00147602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427423|NCT00147602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101427424|NCT00147602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101427425|NCT00147602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101427426|NCT02941744|Nivolumab|nivolumab|mesh-list
101427427|NCT02941744|Ipilimumab|ipilimumab|mesh-list
101427428|NCT02941744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101427429|NCT02941744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101427430|NCT02941744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101427431|NCT02941744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427432|NCT02941822|Ambroxol|ambroxol|mesh-list
101427433|NCT02941822|Expectorants|expectorants|mesh-ancestor
101427434|NCT02941822|Respiratory System Agents|respiratory system agents|mesh-ancestor
101427435|NCT02941510|Budesonide|budesonide|mesh-list
101427436|NCT02941510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101427437|NCT02941510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101427438|NCT02941510|Autonomic Agents|autonomic agents|mesh-ancestor
101427439|NCT02941510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101427440|NCT02941510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427441|NCT02941510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101461119|NCT00573664|Gabapentin|gabapentin|mesh-list
101427442|NCT02941510|Respiratory System Agents|respiratory system agents|mesh-ancestor
101427443|NCT02941510|Glucocorticoids|glucocorticoids|mesh-ancestor
101427444|NCT02941510|Hormones|hormones|mesh-ancestor
101427445|NCT02941510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101427446|NCT00147680|Paclitaxel|paclitaxel|mesh-list
101427447|NCT00147680|Carboplatin|carboplatin|mesh-list
101558148|NCT01300247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101558149|NCT01300247|Alkylating Agents|alkylating agents|mesh-ancestor
101558150|NCT01300247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558151|NCT01300247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101558152|NCT01300247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101558153|NCT01300247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101531457|NCT04631627|Antipyretics|antipyretics|mesh-ancestor
101427448|NCT00147680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101427449|NCT00147680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101427450|NCT00147680|Tubulin Modulators|tubulin modulators|mesh-ancestor
101427455|NCT02940184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101427456|NCT02940184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427458|NCT02940184|Hormones|hormones|mesh-ancestor
101427459|NCT02940184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101427460|NCT02940184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101427461|NCT02940184|Protease Inhibitors|protease inhibitors|mesh-ancestor
101427462|NCT02940184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101427463|NCT02940184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427464|NCT03458143|Ketamine|ketamine|mesh-list
101427465|NCT03458143|Remifentanil|remifentanil|mesh-list
101427466|NCT03458143|Analgesics|analgesics|mesh-ancestor
101427467|NCT03458143|Sensory System Agents|sensory system agents|mesh-ancestor
101306973|NCT02028910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306974|NCT02028910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101306975|NCT02028910|Antipruritics|antipruritics|mesh-ancestor
101306976|NCT02028910|Dermatologic Agents|dermatologic agents|mesh-ancestor
101306977|NCT02028910|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101427474|NCT03458143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101427475|NCT03458143|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101427476|NCT03458143|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101427477|NCT03458143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101427478|NCT03458143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427479|NCT03458143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101427480|NCT03458143|Narcotics|narcotics|mesh-ancestor
101427482|NCT02941198|Trace Elements|trace elements|mesh-ancestor
101427483|NCT02941198|Micronutrients|micronutrients|mesh-ancestor
101427484|NCT02941198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427485|NCT00147719|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
101427486|NCT00147719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101427487|NCT00147719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101427488|NCT00147719|Antimetabolites|antimetabolites|mesh-ancestor
101427489|NCT00147719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427490|NCT00147719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101427491|NCT05273671|Dexmedetomidine|dexmedetomidine|mesh-list
101427492|NCT05273671|Nalbuphine|nalbuphine|mesh-list
101427493|NCT05273671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101427494|NCT05273671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101427495|NCT05273671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427496|NCT05273671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101427497|NCT05273671|Analgesics|analgesics|mesh-ancestor
101427498|NCT05273671|Sensory System Agents|sensory system agents|mesh-ancestor
101427499|NCT05273671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101427500|NCT05273671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101427501|NCT05273671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101427502|NCT05273671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101427503|NCT05273671|Adrenergic Agents|adrenergic agents|mesh-ancestor
101427504|NCT05273671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101427505|NCT05273671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427506|NCT05273671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101427507|NCT05273671|Narcotics|narcotics|mesh-ancestor
101427508|NCT00147758|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
101427509|NCT00147758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101427510|NCT00147758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101427511|NCT00147758|Antimetabolites|antimetabolites|mesh-ancestor
101558154|NCT02890277|Anti-Infective Agents|anti-infective agents|mesh-list
101558155|NCT02890277|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101558157|NCT02890277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101558158|NCT02890277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101558159|NCT02890277|Antimetabolites|antimetabolites|mesh-ancestor
101558160|NCT02890277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558161|NCT02890277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101558162|NCT02890277|Chelating Agents|chelating agents|mesh-ancestor
101558163|NCT02890277|Sequestering Agents|sequestering agents|mesh-ancestor
101406584|NCT00137202|Anesthetics|anesthetics|mesh-ancestor
101427512|NCT00147758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427513|NCT00147758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101427514|NCT02931526|Tigecycline|tigecycline|mesh-list
101427515|NCT02931526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101427516|NCT02931526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101427517|NCT02931526|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101427518|NCT02931526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101427519|NCT02931526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427520|NCT00169845|Tocopherols|tocopherols|mesh-list
101427527|NCT00169845|Protective Agents|protective agents|mesh-ancestor
101427528|NCT00169845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427530|NCT00169845|Micronutrients|micronutrients|mesh-ancestor
101427531|NCT00169845|Provitamins|provitamins|mesh-ancestor
101427532|NCT00147836|Insulin|insulin|mesh-list
101427533|NCT00147836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101427534|NCT00147836|Metformin|metformin|mesh-list
101427535|NCT00147836|Gliclazide|gliclazide|mesh-list
101427536|NCT00147836|Isophane Insulin, Human|isophane insulin, human|mesh-list
101427537|NCT00147836|Insulin, Isophane|insulin, isophane|mesh-list
101427538|NCT00147836|Isophane insulin, beef|isophane insulin, beef|mesh-list
101427539|NCT00147836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101306981|NCT02028910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427548|NCT02931136|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101427550|NCT02931175|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101427551|NCT02931175|Hormones|hormones|mesh-ancestor
101427552|NCT02931175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101427553|NCT02931175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427554|NCT00147875|Prednisone|prednisone|mesh-list
101427555|NCT00147875|Gemcitabine|gemcitabine|mesh-list
101427556|NCT00147875|Doxorubicin|doxorubicin|mesh-list
101427557|NCT00147875|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101427558|NCT00147875|Vinblastine|vinblastine|mesh-list
101427559|NCT00147875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101427560|NCT00147875|Antimetabolites|antimetabolites|mesh-ancestor
101427561|NCT00147875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427562|NCT00147875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101427563|NCT00147875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101427564|NCT00147875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101427565|NCT00147875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101427566|NCT00147875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101427567|NCT00147875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101427568|NCT00147875|Glucocorticoids|glucocorticoids|mesh-ancestor
101427569|NCT00147875|Hormones|hormones|mesh-ancestor
101427570|NCT00147875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101461141|NCT00254865|Norelgestromin|norelgestromin|mesh-list
101427571|NCT00147875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427572|NCT00147875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101427573|NCT00147875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101427574|NCT00147875|Tubulin Modulators|tubulin modulators|mesh-ancestor
101427575|NCT00147875|Antimitotic Agents|antimitotic agents|mesh-ancestor
101427576|NCT00147875|Mitosis Modulators|mitosis modulators|mesh-ancestor
101427577|NCT00169923|Rosiglitazone|rosiglitazone|mesh-list
101427578|NCT00169923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101427579|NCT00169923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427580|NCT00147914|Amoxicillin|amoxicillin|mesh-list
101427581|NCT00147914|Clavulanic Acid|clavulanic acid|mesh-list
101558164|NCT02890277|Hemostatics|hemostatics|mesh-ancestor
101558165|NCT02890277|Coagulants|coagulants|mesh-ancestor
101558166|NCT01289678|Interleukin-2|interleukin-2|mesh-list
101558167|NCT01289678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101558168|NCT01289678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101558169|NCT01289678|Analgesics|analgesics|mesh-ancestor
101558170|NCT01289678|Sensory System Agents|sensory system agents|mesh-ancestor
101558171|NCT01289678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101558172|NCT01289678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558173|NCT01183221|Oxytocin|oxytocin|mesh-list
101558174|NCT01183221|Oxytocics|oxytocics|mesh-ancestor
101558175|NCT01183221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101406596|NCT00104975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101427582|NCT00147914|Clavulanic Acids|clavulanic acids|mesh-list
101427583|NCT00147914|Cefdinir|cefdinir|mesh-list
101427584|NCT00147914|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101427585|NCT00147914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101427586|NCT00147914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101427587|NCT00147914|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101427588|NCT00147914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101427589|NCT00147914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427590|NCT00147953|Rituximab|rituximab|mesh-list
101427591|NCT00147953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101427592|NCT00147953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101427595|NCT00147953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101427596|NCT02930551|Lidocaine|lidocaine|mesh-list
101427597|NCT02930551|Anesthetics, Local|anesthetics, local|mesh-ancestor
101427598|NCT02930551|Anesthetics|anesthetics|mesh-ancestor
101427599|NCT02930551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101427600|NCT02930551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427601|NCT02930551|Sensory System Agents|sensory system agents|mesh-ancestor
101427607|NCT02930551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427608|NCT00175617|Minoxidil|minoxidil|mesh-list
101427609|NCT00175617|Spironolactone|spironolactone|mesh-list
101427610|NCT00175617|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101427611|NCT00175617|Hormone Antagonists|hormone antagonists|mesh-ancestor
101427612|NCT00175617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101427613|NCT00175617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306983|NCT02028923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101306984|NCT02028923|Narcotics|narcotics|mesh-ancestor
101427614|NCT00175617|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101427615|NCT00175617|Diuretics|diuretics|mesh-ancestor
101427616|NCT00175617|Natriuretic Agents|natriuretic agents|mesh-ancestor
101427617|NCT00175617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101427618|NCT00175617|Vasodilator Agents|vasodilator agents|mesh-ancestor
101427619|NCT02930707|Magnesium Sulfate|magnesium sulfate|mesh-list
101427620|NCT02930707|Bupivacaine|bupivacaine|mesh-list
101427621|NCT02930707|Anesthetics, Local|anesthetics, local|mesh-ancestor
101427622|NCT02930707|Anesthetics|anesthetics|mesh-ancestor
101427623|NCT02930707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101427624|NCT02930707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427625|NCT02930707|Sensory System Agents|sensory system agents|mesh-ancestor
101427626|NCT02930707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101427627|NCT02930707|Analgesics|analgesics|mesh-ancestor
101427628|NCT02930707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101427629|NCT02930707|Anticonvulsants|anticonvulsants|mesh-ancestor
101427630|NCT02930707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101427631|NCT02930707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101427632|NCT02930707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427633|NCT02930707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101427634|NCT02930707|Tocolytic Agents|tocolytic agents|mesh-ancestor
101427635|NCT02930707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101427636|NCT00148031|Interferons|interferons|mesh-list
101427637|NCT00148031|Ribavirin|ribavirin|mesh-list
101558176|NCT01183221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558177|NCT01183143|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101558178|NCT01183143|Hormones|hormones|mesh-ancestor
101558179|NCT01183143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101558180|NCT01183143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558181|NCT01183065|Folic Acid|folic acid|mesh-list
101558182|NCT01183065|Vitamin B 12|vitamin b 12|mesh-list
101558183|NCT01183065|Hydroxocobalamin|hydroxocobalamin|mesh-list
101558184|NCT01183065|Vitamins|vitamins|mesh-ancestor
101558185|NCT01183065|Micronutrients|micronutrients|mesh-ancestor
101558186|NCT01183065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558187|NCT01183065|Hematinics|hematinics|mesh-ancestor
101558188|NCT01183065|Vitamin B Complex|vitamin b complex|mesh-ancestor
101558189|NCT01182441|Warfarin|warfarin|mesh-list
101558190|NCT01182441|Anticoagulants|anticoagulants|mesh-ancestor
101558191|NCT01182285|Valproic Acid|valproic acid|mesh-list
101558192|NCT01182285|Anticonvulsants|anticonvulsants|mesh-ancestor
101558193|NCT01182285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101558194|NCT01182285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558195|NCT01182285|GABA Agents|gaba agents|mesh-ancestor
101558196|NCT01182285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101558197|NCT01182285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558198|NCT01182285|Antimanic Agents|antimanic agents|mesh-ancestor
101558199|NCT01182285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101558200|NCT01182285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101406607|NCT00104975|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101427638|NCT00148031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101427639|NCT00148031|Antiviral Agents|antiviral agents|mesh-ancestor
101427640|NCT00148031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101427641|NCT00148031|Antimetabolites|antimetabolites|mesh-ancestor
101427642|NCT00148031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427643|NCT02930473|Psychotropic Drugs|psychotropic drugs|mesh-list
101427644|NCT02930434|Vitamin D|vitamin d|mesh-list
101427645|NCT02930434|Cholecalciferol|cholecalciferol|mesh-list
101427646|NCT02930434|Vitamins|vitamins|mesh-ancestor
101427647|NCT02930434|Micronutrients|micronutrients|mesh-ancestor
101427648|NCT02930434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427649|NCT02930434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101427650|NCT02930434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101427651|NCT00148070|Erythromycin|erythromycin|mesh-list
101427652|NCT00148070|Erythromycin Estolate|erythromycin estolate|mesh-list
101427653|NCT00148070|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101427654|NCT00148070|Erythromycin stearate|erythromycin stearate|mesh-list
101427655|NCT00148070|Docetaxel|docetaxel|mesh-list
101427656|NCT00148070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101427657|NCT00148070|Tubulin Modulators|tubulin modulators|mesh-ancestor
101427658|NCT00148070|Antimitotic Agents|antimitotic agents|mesh-ancestor
101427659|NCT00148070|Mitosis Modulators|mitosis modulators|mesh-ancestor
101427660|NCT00148070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461153|NCT00235053|Fluticasone|fluticasone|mesh-list
101427661|NCT00148070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101427662|NCT00148070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101558201|NCT01182285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101558202|NCT04315935|Fentanyl|fentanyl|mesh-list
101558203|NCT04315935|Butorphanol|butorphanol|mesh-list
101558204|NCT04315935|Propofol|propofol|mesh-list
101558205|NCT04315935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101558206|NCT04315935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101558207|NCT04315935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558208|NCT04315935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101558209|NCT04315935|Anesthetics, General|anesthetics, general|mesh-ancestor
101558210|NCT04315935|Anesthetics|anesthetics|mesh-ancestor
101558211|NCT04315935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101558212|NCT04315935|Narcotics|narcotics|mesh-ancestor
101558213|NCT04315935|Analgesics|analgesics|mesh-ancestor
101558214|NCT04315935|Sensory System Agents|sensory system agents|mesh-ancestor
101558215|NCT04315935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101558216|NCT04315935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101558217|NCT04315935|Antitussive Agents|antitussive agents|mesh-ancestor
101520142|NCT01854684|Temoporfin|temoporfin|mesh-list
101558218|NCT04315935|Respiratory System Agents|respiratory system agents|mesh-ancestor
101558219|NCT04315935|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101558220|NCT01182207|Drospirenone|drospirenone|mesh-list
101558221|NCT01182207|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101558222|NCT01182207|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101558223|NCT01182207|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101558224|NCT01182207|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
101558225|NCT01182207|Estradiol|estradiol|mesh-list
101558226|NCT01182207|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101558227|NCT01182207|Estrogens|estrogens|mesh-ancestor
101558228|NCT01182207|Hormones|hormones|mesh-ancestor
101558229|NCT01182207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101558230|NCT01182207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558231|NCT01182207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101558232|NCT01182207|Contraceptive Agents|contraceptive agents|mesh-ancestor
101558233|NCT01182207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101558234|NCT01182207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101558235|NCT01182207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101558240|NCT01182207|Diuretics|diuretics|mesh-ancestor
101558241|NCT01182207|Natriuretic Agents|natriuretic agents|mesh-ancestor
101558242|NCT01181895|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101558243|NCT01181895|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101558244|NCT01181895|Autonomic Agents|autonomic agents|mesh-ancestor
101558245|NCT01181895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101558246|NCT01181895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558247|NCT01181895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101406672|NCT00137514|Amebicides|amebicides|mesh-ancestor
101427663|NCT00148070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101427664|NCT00148070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101427665|NCT00148070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101427669|NCT00175695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101427670|NCT00175695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101427671|NCT00175695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427677|NCT00148148|Caspofungin|caspofungin|mesh-list
101427678|NCT00148148|Amebicides|amebicides|mesh-ancestor
101427679|NCT00148148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101427680|NCT00148148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101427681|NCT00148148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101427682|NCT00148148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101427683|NCT00148148|Antifungal Agents|antifungal agents|mesh-ancestor
101427684|NCT00148148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101427685|NCT00148148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427686|NCT00170001|Esomeprazole|esomeprazole|mesh-list
101427687|NCT00170001|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101427688|NCT00170001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101427689|NCT00170001|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101427690|NCT00170001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101306985|NCT02028923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101306986|NCT02028923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427691|NCT00170001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427692|NCT00148265|Triamcinolone|triamcinolone|mesh-list
101427693|NCT00148265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101427694|NCT00148265|Glucocorticoids|glucocorticoids|mesh-ancestor
101427696|NCT00148265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101427697|NCT00148265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427699|NCT02929693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101427700|NCT02929693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101427701|NCT02929693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101427702|NCT02929693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427703|NCT00175734|Chrysarobin|chrysarobin|mesh-list
101427704|NCT00175734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101427705|NCT00175734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101427706|NCT00175734|Analgesics|analgesics|mesh-ancestor
101427707|NCT00175734|Sensory System Agents|sensory system agents|mesh-ancestor
101427708|NCT00175734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101427709|NCT00175734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427710|NCT00175734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101427711|NCT00175734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101427712|NCT00148382|Cetilistat|cetilistat|mesh-list
101427713|NCT00148382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101427714|NCT00148382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427715|NCT00148382|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101427716|NCT00148382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101427717|NCT00148421|Epoetin Alfa|epoetin alfa|mesh-list
101427718|NCT00148421|Darbepoetin alfa|darbepoetin alfa|mesh-list
101427719|NCT00148421|Hematinics|hematinics|mesh-ancestor
101427720|NCT02929888|Aspirin|aspirin|mesh-list
101427721|NCT02929888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101427722|NCT02929888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101427723|NCT02929888|Analgesics|analgesics|mesh-ancestor
101427724|NCT02929888|Sensory System Agents|sensory system agents|mesh-ancestor
101427725|NCT02929888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101427726|NCT02929888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427727|NCT02929888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101558248|NCT01181895|Respiratory System Agents|respiratory system agents|mesh-ancestor
101558249|NCT01181895|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101558250|NCT01181895|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101558251|NCT01181895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101558252|NCT01181895|Adrenergic Agents|adrenergic agents|mesh-ancestor
101558253|NCT01181895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101558254|NCT01181895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558256|NCT01181271|Cyclophosphamide|cyclophosphamide|mesh-list
101558257|NCT01181271|Busulfan|busulfan|mesh-list
101558258|NCT01181271|Methotrexate|methotrexate|mesh-list
101427728|NCT02929888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101427729|NCT02929888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101427730|NCT02929888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101427731|NCT02929888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427732|NCT02929888|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101427733|NCT02929888|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101427734|NCT02929888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101427735|NCT02929888|Antipyretics|antipyretics|mesh-ancestor
101427736|NCT04689412|Resveratrol|resveratrol|mesh-list
101427737|NCT04689412|Antioxidants|antioxidants|mesh-ancestor
101427738|NCT04689412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427739|NCT04689412|Protective Agents|protective agents|mesh-ancestor
101427747|NCT00170196|Prednisone|prednisone|mesh-list
101427748|NCT00170196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101427752|NCT00170196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427753|NCT00170196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101427754|NCT00170196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101427755|NCT02929459|Vitamins|vitamins|mesh-list
101427756|NCT02929459|Riboflavin|riboflavin|mesh-list
101427757|NCT02929459|Vitamin B Complex|vitamin b complex|mesh-list
101427758|NCT02929459|Micronutrients|micronutrients|mesh-ancestor
101427759|NCT02929459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427760|NCT02929459|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101427761|NCT02929459|Dermatologic Agents|dermatologic agents|mesh-ancestor
101427762|NCT02929576|Paclitaxel|paclitaxel|mesh-list
101427763|NCT02929576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101427764|NCT02929576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101427765|NCT02929576|Tubulin Modulators|tubulin modulators|mesh-ancestor
101427766|NCT02929576|Antimitotic Agents|antimitotic agents|mesh-ancestor
101427767|NCT02929576|Mitosis Modulators|mitosis modulators|mesh-ancestor
101427768|NCT02929576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427769|NCT00175812|Tretinoin|tretinoin|mesh-list
101306987|NCT02028923|Analgesics|analgesics|mesh-ancestor
101306988|NCT02028923|Sensory System Agents|sensory system agents|mesh-ancestor
101306989|NCT02028923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101306990|NCT02028949|Idarubicin|idarubicin|mesh-list
101306991|NCT02028949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101427770|NCT00175812|Theophylline|theophylline|mesh-list
101427771|NCT00175812|Valproic Acid|valproic acid|mesh-list
101427772|NCT00175812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101427773|NCT00175812|Keratolytic Agents|keratolytic agents|mesh-ancestor
101427774|NCT00175812|Dermatologic Agents|dermatologic agents|mesh-ancestor
101427775|NCT00175812|Anticonvulsants|anticonvulsants|mesh-ancestor
101427776|NCT00175812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101427777|NCT00175812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427778|NCT00175812|GABA Agents|gaba agents|mesh-ancestor
101427779|NCT00175812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101427780|NCT00175812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427781|NCT00175812|Antimanic Agents|antimanic agents|mesh-ancestor
101427782|NCT00175812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101427783|NCT00175812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101427784|NCT00175812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101427785|NCT00175812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101427786|NCT00175812|Autonomic Agents|autonomic agents|mesh-ancestor
101427787|NCT00175812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101558259|NCT01181271|Fludarabine|fludarabine|mesh-list
101558260|NCT01181271|Etoposide|etoposide|mesh-list
101558261|NCT01181271|Tacrolimus|tacrolimus|mesh-list
101558262|NCT01181271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101558263|NCT01181271|Immunologic Factors|immunologic factors|mesh-ancestor
101558264|NCT01181271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558265|NCT01181271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101558266|NCT01181271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101427788|NCT00175812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101427789|NCT00175812|Respiratory System Agents|respiratory system agents|mesh-ancestor
101427790|NCT00175812|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101427791|NCT00175812|Vasodilator Agents|vasodilator agents|mesh-ancestor
101427792|NCT00175812|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101427793|NCT00175812|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101427794|NCT00175812|Purinergic Agents|purinergic agents|mesh-ancestor
101427795|NCT00148499|Benzocaine|benzocaine|mesh-list
101427796|NCT00148499|Ambroxol|ambroxol|mesh-list
101427797|NCT00148499|Anesthetics, Local|anesthetics, local|mesh-ancestor
101427798|NCT00148499|Anesthetics|anesthetics|mesh-ancestor
101427799|NCT00148499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101427800|NCT00148499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427801|NCT00148499|Sensory System Agents|sensory system agents|mesh-ancestor
101427802|NCT00148499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101427803|NCT00148499|Expectorants|expectorants|mesh-ancestor
101427804|NCT00148499|Respiratory System Agents|respiratory system agents|mesh-ancestor
101427805|NCT03457597|Pioglitazone|pioglitazone|mesh-list
101427806|NCT03457597|Tolbutamide|tolbutamide|mesh-list
101427807|NCT03457597|Metoprolol|metoprolol|mesh-list
101427808|NCT03457597|Midazolam|midazolam|mesh-list
101427809|NCT03457597|Omeprazole|omeprazole|mesh-list
101427820|NCT03457597|GABA Modulators|gaba modulators|mesh-ancestor
101427821|NCT03457597|GABA Agents|gaba agents|mesh-ancestor
101427822|NCT03457597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101427823|NCT03457597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427824|NCT03457597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101427825|NCT03457597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101427826|NCT03457597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101427827|NCT03457597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101427828|NCT03457597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101427844|NCT02929147|Analgesics|analgesics|mesh-ancestor
101427845|NCT02929147|Sensory System Agents|sensory system agents|mesh-ancestor
101427846|NCT02929147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101427847|NCT02929147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101306992|NCT02028949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101306993|NCT02028949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101306994|NCT02028949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101306995|NCT02028949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101333865|NCT00017394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101427848|NCT02929147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101427849|NCT02929147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101427850|NCT02929147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101427852|NCT00175890|Anticonvulsants|anticonvulsants|mesh-ancestor
101427853|NCT00175890|Nootropic Agents|nootropic agents|mesh-ancestor
101427854|NCT00148616|Memantine|memantine|mesh-list
101427855|NCT00148616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101427856|NCT00148616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101427857|NCT00148616|Dopamine Agents|dopamine agents|mesh-ancestor
101427858|NCT00148616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101427859|NCT00148616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427860|NCT00148616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427861|NCT00148616|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101427862|NCT00148616|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101427863|NCT00175929|Brivaracetam|brivaracetam|mesh-list
101427864|NCT00175929|Anticonvulsants|anticonvulsants|mesh-ancestor
101427865|NCT02928679|Liraglutide|liraglutide|mesh-list
101427866|NCT02928679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101427867|NCT02928679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427868|NCT02928679|Incretins|incretins|mesh-ancestor
101427869|NCT02928679|Hormones|hormones|mesh-ancestor
101427870|NCT02928679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101558267|NCT01181271|Alkylating Agents|alkylating agents|mesh-ancestor
101558268|NCT01181271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558269|NCT01181271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101558270|NCT01181271|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101558271|NCT01181271|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101558272|NCT01181271|Abortifacient Agents|abortifacient agents|mesh-ancestor
101558273|NCT01181271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101406697|NCT00137553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101531960|NCT00565383|Fentanyl|fentanyl|mesh-list
101427871|NCT02928601|Ondansetron|ondansetron|mesh-list
101427872|NCT02928601|Antiemetics|antiemetics|mesh-ancestor
101427873|NCT02928601|Autonomic Agents|autonomic agents|mesh-ancestor
101427874|NCT02928601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101427879|NCT02928601|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101427880|NCT02928601|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101427882|NCT02928601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101427883|NCT02928601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427884|NCT02928328|Lidocaine|lidocaine|mesh-list
101427885|NCT02928328|Lorazepam|lorazepam|mesh-list
101427886|NCT02928328|Capsaicin|capsaicin|mesh-list
101427887|NCT02928328|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
101427888|NCT02928328|Butyric Acid|butyric acid|mesh-list
101427889|NCT02928328|Anesthetics, Local|anesthetics, local|mesh-ancestor
101427893|NCT02928328|Sensory System Agents|sensory system agents|mesh-ancestor
101427894|NCT02928328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101427895|NCT02928328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101427896|NCT02928328|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101427897|NCT02928328|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101427898|NCT02928328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101427899|NCT02928328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427900|NCT02928328|Antipruritics|antipruritics|mesh-ancestor
101427901|NCT02928328|Dermatologic Agents|dermatologic agents|mesh-ancestor
101427902|NCT02928328|Anticonvulsants|anticonvulsants|mesh-ancestor
101427903|NCT02928328|Antiemetics|antiemetics|mesh-ancestor
101427904|NCT02928328|Autonomic Agents|autonomic agents|mesh-ancestor
101427905|NCT02928328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101427906|NCT02928328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101427907|NCT02928328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101427908|NCT02928328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101427909|NCT02928328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101427910|NCT02928328|GABA Modulators|gaba modulators|mesh-ancestor
101427911|NCT02928328|GABA Agents|gaba agents|mesh-ancestor
101427912|NCT02928328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101427913|NCT02928328|Histamine Antagonists|histamine antagonists|mesh-ancestor
101427914|NCT02928328|Histamine Agents|histamine agents|mesh-ancestor
101427915|NCT00148694|Cisplatin|cisplatin|mesh-list
101427916|NCT00148694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101427917|NCT00148772|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101427918|NCT00148772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101306996|NCT02028949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306997|NCT02029105|Hyaluronic Acid|hyaluronic acid|mesh-list
101427919|NCT00148772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101427920|NCT00148772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101427921|NCT00148772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427922|NCT00176046|Viscum album peptide|viscum album peptide|mesh-list
101427923|NCT00176046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101427924|NCT00176046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101427925|NCT00176046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101427926|NCT00176046|Antiviral Agents|antiviral agents|mesh-ancestor
101427927|NCT00176046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101427929|NCT02927587|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101427930|NCT02927587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101427931|NCT02927587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427932|NCT02927587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101427933|NCT02927587|Anesthetics, General|anesthetics, general|mesh-ancestor
101427934|NCT02927587|Anesthetics|anesthetics|mesh-ancestor
101558275|NCT01181271|Antimetabolites|antimetabolites|mesh-ancestor
101558276|NCT01181271|Dermatologic Agents|dermatologic agents|mesh-ancestor
101558277|NCT01181271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101558278|NCT01181271|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101427935|NCT00148850|Pioglitazone|pioglitazone|mesh-list
101427936|NCT00148850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101427937|NCT00148850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427938|NCT02927353|Adalimumab|adalimumab|mesh-list
101427939|NCT02927353|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101427940|NCT02927353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101427941|NCT02927353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101427942|NCT02927509|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
101427943|NCT02927509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101427944|NCT02927509|Adrenergic Agents|adrenergic agents|mesh-ancestor
101427945|NCT02927509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101427946|NCT02927509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461215|NCT00574366|Everolimus|everolimus|mesh-list
101427956|NCT02926846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427958|NCT02926183|Gemcitabine|gemcitabine|mesh-list
101427959|NCT02926183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101427960|NCT02926183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101427961|NCT02926183|Tubulin Modulators|tubulin modulators|mesh-ancestor
101427962|NCT02926183|Antimitotic Agents|antimitotic agents|mesh-ancestor
101427963|NCT02926183|Mitosis Modulators|mitosis modulators|mesh-ancestor
101427964|NCT02926183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427965|NCT02926183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101427966|NCT02926183|Antimetabolites|antimetabolites|mesh-ancestor
101427967|NCT02925832|Bupivacaine|bupivacaine|mesh-list
101427968|NCT02925832|Ropivacaine|ropivacaine|mesh-list
101427969|NCT02925832|Anesthetics, Local|anesthetics, local|mesh-list
101427977|NCT00170430|Antifungal Agents|antifungal agents|mesh-ancestor
101427978|NCT00170430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101427979|NCT00170430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101427980|NCT00170430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101427981|NCT00170430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101427982|NCT00170430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427983|NCT00170430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101427984|NCT00170430|Hormone Antagonists|hormone antagonists|mesh-ancestor
101427985|NCT00170430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101427986|NCT00170430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427987|NCT00170430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101427988|NCT00170430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101427989|NCT00149084|Amoxicillin|amoxicillin|mesh-list
101427990|NCT00149084|Clarithromycin|clarithromycin|mesh-list
101427991|NCT00149084|Lansoprazole|lansoprazole|mesh-list
101427992|NCT00149084|Dexlansoprazole|dexlansoprazole|mesh-list
101427993|NCT00149084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101427994|NCT00149084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101427995|NCT00149084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101427997|NCT00149084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306999|NCT02029105|Immunologic Factors|immunologic factors|mesh-ancestor
101307000|NCT02029105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307001|NCT02029105|Viscosupplements|viscosupplements|mesh-ancestor
101307002|NCT02029105|Protective Agents|protective agents|mesh-ancestor
101307003|NCT02029118|Aspirin|aspirin|mesh-list
101307004|NCT02029118|Metoprolol|metoprolol|mesh-list
101427998|NCT00149084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101427999|NCT00149084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101428000|NCT00149084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101428001|NCT00149084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101428002|NCT00149084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101428003|NCT00170469|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101428004|NCT00170469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101428005|NCT00170469|Immunologic Factors|immunologic factors|mesh-ancestor
101428006|NCT00170469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428007|NCT00170469|Antacids|antacids|mesh-ancestor
101428008|NCT00170469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428009|NCT00170469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101428010|NCT00149123|Hydrocortisone|hydrocortisone|mesh-list
101558279|NCT01181271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101558280|NCT01181271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101558281|NCT01181271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101558282|NCT01181271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101558283|NCT01181271|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101558284|NCT01181271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101428011|NCT00149123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101428012|NCT00149162|Aldesleukin|aldesleukin|mesh-list
101428013|NCT00149162|Interleukin-2|interleukin-2|mesh-list
101428022|NCT00149162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101428023|NCT00149162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428024|NCT00170547|Vaccines|vaccines|mesh-list
101428025|NCT00170547|Immunologic Factors|immunologic factors|mesh-ancestor
101428026|NCT00170547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428027|NCT00149201|Fluorouracil|fluorouracil|mesh-list
101428028|NCT00149201|Antimetabolites|antimetabolites|mesh-ancestor
101428029|NCT00149201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428030|NCT00149201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101428031|NCT00149201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101428032|NCT00149201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101428033|NCT00149201|Immunologic Factors|immunologic factors|mesh-ancestor
101428034|NCT00149201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428035|NCT02925559|Dapagliflozin|dapagliflozin|mesh-list
101428036|NCT02925559|Gliclazide|gliclazide|mesh-list
101428037|NCT02925559|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101428038|NCT02925559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428039|NCT02925559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101428045|NCT00149240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101428046|NCT00149240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428047|NCT00149240|Cholinergic Agents|cholinergic agents|mesh-ancestor
101428048|NCT00149240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101428049|NCT00149240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428050|NCT00149240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101428051|NCT00149240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101428052|NCT02925247|Anticoagulants|anticoagulants|mesh-list
101428053|NCT00170664|Paclitaxel|paclitaxel|mesh-list
101428054|NCT00170664|Carboplatin|carboplatin|mesh-list
101428055|NCT00170664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101428056|NCT00170664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101428057|NCT00170664|Tubulin Modulators|tubulin modulators|mesh-ancestor
101428058|NCT00170664|Antimitotic Agents|antimitotic agents|mesh-ancestor
101428059|NCT00170664|Mitosis Modulators|mitosis modulators|mesh-ancestor
101428060|NCT00170664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428061|NCT00170742|Octreotide|octreotide|mesh-list
101428062|NCT00170742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101428063|NCT00170742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101428064|NCT00170742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101428065|NCT02917525|Vitamin K|vitamin k|mesh-list
101428066|NCT02917525|Vitamin K 2|vitamin k 2|mesh-list
101428067|NCT02917525|Vitamins|vitamins|mesh-ancestor
101428068|NCT02917525|Micronutrients|micronutrients|mesh-ancestor
101307005|NCT02029118|Ramipril|ramipril|mesh-list
101307006|NCT02029118|Atorvastatin|atorvastatin|mesh-list
101307007|NCT02029118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101307008|NCT02029118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101428069|NCT02917525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428070|NCT02917525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101428071|NCT02917525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101428072|NCT02917525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428073|NCT02917525|Hemostatics|hemostatics|mesh-ancestor
101428074|NCT02917525|Coagulants|coagulants|mesh-ancestor
101428075|NCT00170781|Lumiracoxib|lumiracoxib|mesh-list
101428076|NCT00170781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101428077|NCT00170781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101428078|NCT00170781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101428079|NCT00170781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428090|NCT00170820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101558285|NCT01181271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101558286|NCT01181271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101558287|NCT01181271|Antifungal Agents|antifungal agents|mesh-ancestor
101558288|NCT00624741|Pergolide|pergolide|mesh-list
101558289|NCT00624741|Dopamine Agonists|dopamine agonists|mesh-ancestor
101558290|NCT00624741|Dopamine Agents|dopamine agents|mesh-ancestor
101558291|NCT00624741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101558292|NCT00624741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558293|NCT00624741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406716|NCT00134979|Formoterol Fumarate|formoterol fumarate|mesh-list
101428091|NCT00170820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101428092|NCT00170820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428093|NCT00170820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101428094|NCT00170820|Immunologic Factors|immunologic factors|mesh-ancestor
101428095|NCT00170820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428096|NCT00170820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101428097|NCT02917018|Dexmedetomidine|dexmedetomidine|mesh-list
101428098|NCT02917018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101428099|NCT02917018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101428100|NCT02917018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428101|NCT02917018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101428102|NCT02917018|Analgesics|analgesics|mesh-ancestor
101428103|NCT02917018|Sensory System Agents|sensory system agents|mesh-ancestor
101428104|NCT02917018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101428105|NCT02917018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101428106|NCT02917018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101428107|NCT02917018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101428108|NCT02917018|Adrenergic Agents|adrenergic agents|mesh-ancestor
101428109|NCT02917018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101428110|NCT02917018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428111|NCT00170859|Everolimus|everolimus|mesh-list
101428112|NCT00170859|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101428113|NCT00170859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101428114|NCT00170859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101428121|NCT02917057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101428122|NCT02917057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428123|NCT02917057|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101428125|NCT02917057|Hormones|hormones|mesh-ancestor
101428126|NCT02917057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101828122|NCT05966090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428127|NCT02916940|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
101428128|NCT02916940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101428129|NCT02916940|Glucocorticoids|glucocorticoids|mesh-ancestor
101428130|NCT02916940|Hormones|hormones|mesh-ancestor
101428131|NCT02916940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101428132|NCT02916940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428133|NCT00170898|Lumiracoxib|lumiracoxib|mesh-list
101428134|NCT00170898|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101428135|NCT00170898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101428136|NCT00170898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101428137|NCT00170898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428138|NCT00170898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101428139|NCT00170898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101428140|NCT00170898|Analgesics|analgesics|mesh-ancestor
101307009|NCT02029118|Analgesics|analgesics|mesh-ancestor
101307010|NCT02029118|Sensory System Agents|sensory system agents|mesh-ancestor
101307011|NCT02029118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101307012|NCT02029118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428141|NCT00170898|Sensory System Agents|sensory system agents|mesh-ancestor
101428142|NCT00170898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101428146|NCT02916355|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101428148|NCT02916511|Paclitaxel|paclitaxel|mesh-list
101428149|NCT02916511|Carboplatin|carboplatin|mesh-list
101558294|NCT01180647|Naltrexone|naltrexone|mesh-list
101558295|NCT01180647|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101558297|NCT01180647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558298|NCT01180647|Sensory System Agents|sensory system agents|mesh-ancestor
101558299|NCT01180647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101558300|NCT01178853|Warfarin|warfarin|mesh-list
101558301|NCT01178853|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101558302|NCT01178853|Pitavastatin|pitavastatin|mesh-list
101558303|NCT01178853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101558304|NCT01178853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101558305|NCT01178853|Antimetabolites|antimetabolites|mesh-ancestor
101428150|NCT02916511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101428151|NCT02916511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101428152|NCT02916511|Tubulin Modulators|tubulin modulators|mesh-ancestor
101428153|NCT02916511|Antimitotic Agents|antimitotic agents|mesh-ancestor
101428154|NCT02916511|Mitosis Modulators|mitosis modulators|mesh-ancestor
101461700|NCT00226538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101428155|NCT02916511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428156|NCT00170937|Valsartan|valsartan|mesh-list
101428157|NCT00170937|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101428158|NCT00170937|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101428159|NCT00170937|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101428160|NCT00170937|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101428161|NCT00170937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428162|NCT00170937|Diuretics|diuretics|mesh-ancestor
101428163|NCT00170937|Natriuretic Agents|natriuretic agents|mesh-ancestor
101428164|NCT00170937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428165|NCT00170937|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101428166|NCT00170937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101428167|NCT02916238|Fluoxetine|fluoxetine|mesh-list
101428168|NCT02916238|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101428169|NCT02916238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101428170|NCT02916238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101428171|NCT02916238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428172|NCT02916238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101428173|NCT02916238|Serotonin Agents|serotonin agents|mesh-ancestor
101461849|NCT00235794|Immunologic Factors|immunologic factors|mesh-ancestor
101428174|NCT02916238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428175|NCT02916238|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101428176|NCT02916238|Antidepressive Agents|antidepressive agents|mesh-ancestor
101428177|NCT02916238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101428178|NCT02916238|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101428180|NCT02916238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101428182|NCT00149708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101428183|NCT00149708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428184|NCT00163761|Gemcitabine|gemcitabine|mesh-list
101428185|NCT00163761|Vinorelbine|vinorelbine|mesh-list
101428186|NCT00163761|Ifosfamide|ifosfamide|mesh-list
101428187|NCT00163761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101428188|NCT00163761|Antimetabolites|antimetabolites|mesh-ancestor
101428189|NCT00163761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428190|NCT00163761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101428191|NCT00163761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101428192|NCT00163761|Tubulin Modulators|tubulin modulators|mesh-ancestor
101428193|NCT00163761|Antimitotic Agents|antimitotic agents|mesh-ancestor
101428194|NCT00163761|Mitosis Modulators|mitosis modulators|mesh-ancestor
101428195|NCT00163761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101428196|NCT00163761|Alkylating Agents|alkylating agents|mesh-ancestor
101428197|NCT02916160|Valsartan|valsartan|mesh-list
101428198|NCT02916160|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101428199|NCT02916160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101428200|NCT02916160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101428201|NCT02916160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101558306|NCT01178853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558307|NCT01178853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101558308|NCT01178853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101558309|NCT01178853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101558310|NCT01178853|Anticoagulants|anticoagulants|mesh-ancestor
101558311|NCT04286035|Bupivacaine|bupivacaine|mesh-list
101558312|NCT04286035|Anesthetics, Local|anesthetics, local|mesh-ancestor
101406733|NCT00135018|Sensory System Agents|sensory system agents|mesh-ancestor
101428202|NCT02916160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428203|NCT02916121|Folic Acid|folic acid|mesh-list
101428204|NCT02916121|Vitamin B 12|vitamin b 12|mesh-list
101428205|NCT02916121|Vitamins|vitamins|mesh-ancestor
101428206|NCT02916121|Micronutrients|micronutrients|mesh-ancestor
101307013|NCT02029118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101307014|NCT02029118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101307015|NCT02029118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101307016|NCT02029118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101428207|NCT02916121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428208|NCT02916121|Hematinics|hematinics|mesh-ancestor
101428209|NCT02916121|Vitamin B Complex|vitamin b complex|mesh-ancestor
101428210|NCT00170976|Amlodipine|amlodipine|mesh-list
101428211|NCT00170976|Valsartan|valsartan|mesh-list
101428215|NCT00170976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428216|NCT00170976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101428217|NCT00170976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428218|NCT00170976|Vasodilator Agents|vasodilator agents|mesh-ancestor
101428219|NCT00170976|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101428220|NCT00170976|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101428221|NCT00149864|Mycophenolic Acid|mycophenolic acid|mesh-list
101428222|NCT00149864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101428223|NCT00149864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101428224|NCT00149864|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101428225|NCT00149864|Antitubercular Agents|antitubercular agents|mesh-ancestor
101428226|NCT00149864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101428227|NCT00149864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101428228|NCT00149864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101462237|NCT00229424|Famotidine|famotidine|mesh-list
101428229|NCT00149864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428230|NCT00149903|Mycophenolic Acid|mycophenolic acid|mesh-list
101428231|NCT00149903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101428232|NCT00149903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101428233|NCT00149903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101428234|NCT00149903|Antitubercular Agents|antitubercular agents|mesh-ancestor
101428235|NCT00149903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101428236|NCT00149903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101428237|NCT00149903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101428238|NCT00149903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428239|NCT04688632|Moxifloxacin|moxifloxacin|mesh-list
101428240|NCT04688632|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101428241|NCT04688632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101428242|NCT04688632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101428243|NCT04688632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101359451|NCT00041054|Analgesics|analgesics|mesh-ancestor
101428244|NCT04688632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101428245|NCT04688632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101428246|NCT04688632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428247|NCT04688632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101428248|NCT04688632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101428260|NCT00171015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428261|NCT00171015|Diuretics|diuretics|mesh-ancestor
101428262|NCT00171015|Natriuretic Agents|natriuretic agents|mesh-ancestor
101428263|NCT00171015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428264|NCT00171015|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101428265|NCT00171015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101428266|NCT05786677|Serotonin|serotonin|mesh-list
101428267|NCT05786677|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
101558314|NCT04286035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101558315|NCT04286035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558316|NCT04286035|Sensory System Agents|sensory system agents|mesh-ancestor
101558317|NCT04286035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101558318|NCT00629473|Dexamethasone|dexamethasone|mesh-list
101558319|NCT00629473|Proteasome Inhibitors|proteasome inhibitors|mesh-list
101558320|NCT00629473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101558321|NCT00629473|Antiemetics|antiemetics|mesh-ancestor
101462489|NCT00199511|Mannitol|mannitol|mesh-list
101558322|NCT00629473|Autonomic Agents|autonomic agents|mesh-ancestor
101558323|NCT00629473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101558324|NCT00629473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558325|NCT00629473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101558326|NCT00629473|Glucocorticoids|glucocorticoids|mesh-ancestor
101558327|NCT00629473|Hormones|hormones|mesh-ancestor
101558328|NCT00629473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101558329|NCT00629473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101558330|NCT00629473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101558331|NCT00629473|Protease Inhibitors|protease inhibitors|mesh-ancestor
101558332|NCT00629473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101558333|NCT00629473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428268|NCT05786677|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101428269|NCT05786677|Serotonin Agents|serotonin agents|mesh-ancestor
101428270|NCT05786677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101428271|NCT05786677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307017|NCT02029118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307018|NCT02029118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101428272|NCT05786677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428273|NCT05786677|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101428274|NCT05786677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101428275|NCT05786612|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101428277|NCT05786612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101428278|NCT05786495|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101428284|NCT05786430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101428285|NCT05786430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428286|NCT05786430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101428287|NCT05786430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101428288|NCT05786430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101428290|NCT05786365|Analgesics|analgesics|mesh-ancestor
101428291|NCT05786365|Sensory System Agents|sensory system agents|mesh-ancestor
101428292|NCT05786365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101428293|NCT05786365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428294|NCT05786365|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101428295|NCT05786365|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101428296|NCT05786365|Anesthetics, General|anesthetics, general|mesh-ancestor
101428297|NCT05786365|Anesthetics|anesthetics|mesh-ancestor
101428298|NCT05786365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101428299|NCT05786365|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101428300|NCT05786365|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101428301|NCT05786365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101558335|NCT04286503|Lopinavir|lopinavir|mesh-list
101558336|NCT04286503|Chloroquine|chloroquine|mesh-list
101558337|NCT04286503|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
101558338|NCT04286503|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101558339|NCT04286503|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101558340|NCT04286503|Protease Inhibitors|protease inhibitors|mesh-ancestor
101558341|NCT04286503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101558342|NCT04286503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558343|NCT04286503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101558344|NCT04286503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101558345|NCT04286503|Antiviral Agents|antiviral agents|mesh-ancestor
101428302|NCT05786365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428303|NCT05786339|Irbesartan|irbesartan|mesh-list
101428304|NCT05786339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101428305|NCT05786339|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101428306|NCT05786339|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101428307|NCT05786339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428308|NCT05785585|Vitamin B 12|vitamin b 12|mesh-list
101428309|NCT05785585|Hydroxocobalamin|hydroxocobalamin|mesh-list
101462535|NCT00199745|Atorvastatin|atorvastatin|mesh-list
101428310|NCT05785585|Vitamin B Complex|vitamin b complex|mesh-ancestor
101428311|NCT05785585|Vitamins|vitamins|mesh-ancestor
101428312|NCT05785585|Micronutrients|micronutrients|mesh-ancestor
101428319|NCT05785429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101428320|NCT05785429|Tubulin Modulators|tubulin modulators|mesh-ancestor
101428321|NCT05785429|Antimitotic Agents|antimitotic agents|mesh-ancestor
101428322|NCT05785429|Mitosis Modulators|mitosis modulators|mesh-ancestor
101428323|NCT05785429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428324|NCT05785429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101428326|NCT05785377|Neostigmine|neostigmine|mesh-list
101428327|NCT05785377|Anesthetics, Local|anesthetics, local|mesh-ancestor
101428328|NCT05785377|Anesthetics|anesthetics|mesh-ancestor
101428329|NCT05785377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101428330|NCT05785377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428331|NCT05785377|Sensory System Agents|sensory system agents|mesh-ancestor
101428332|NCT05785377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101428333|NCT05785377|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101428334|NCT05785377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101428335|NCT05785377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428336|NCT05785377|Cholinergic Agents|cholinergic agents|mesh-ancestor
101428337|NCT05785377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101428338|NCT05785377|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101428339|NCT05785377|Autonomic Agents|autonomic agents|mesh-ancestor
101428340|NCT05785325|Bevacizumab|bevacizumab|mesh-list
101428341|NCT05785325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101428342|NCT05785325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101428343|NCT05785325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101428344|NCT05785325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101428345|NCT05785325|Growth Substances|growth substances|mesh-ancestor
101307019|NCT02029118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101307020|NCT02029118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101307021|NCT02029118|Antipyretics|antipyretics|mesh-ancestor
101428346|NCT05785325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428347|NCT05785325|Growth Inhibitors|growth inhibitors|mesh-ancestor
101428348|NCT05785234|Sufentanil|sufentanil|mesh-list
101428349|NCT05785234|Remifentanil|remifentanil|mesh-list
101428353|NCT05785234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428354|NCT05785234|Analgesics|analgesics|mesh-ancestor
101428355|NCT05785234|Sensory System Agents|sensory system agents|mesh-ancestor
101428356|NCT05785234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101428357|NCT05785234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101428358|NCT05785234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101428359|NCT05785234|Anesthetics, General|anesthetics, general|mesh-ancestor
101428360|NCT05785234|Anesthetics|anesthetics|mesh-ancestor
101428361|NCT05785208|Osimertinib|osimertinib|mesh-list
101558346|NCT04286503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101558347|NCT04286503|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101558348|NCT04286503|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101558349|NCT04286503|Amebicides|amebicides|mesh-ancestor
101558350|NCT04286503|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101558351|NCT04286503|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101558352|NCT04286503|Antimalarials|antimalarials|mesh-ancestor
101558353|NCT04286503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101558354|NCT04286503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101558355|NCT04286503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101558356|NCT04286503|Analgesics|analgesics|mesh-ancestor
101558357|NCT04286503|Sensory System Agents|sensory system agents|mesh-ancestor
101558358|NCT04286503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101558359|NCT04286503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406774|NCT01054144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101428362|NCT05785208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101428363|NCT05785208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101428364|NCT05785208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101428365|NCT05785208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428366|NCT05785026|Menthol|menthol|mesh-list
101428367|NCT05785026|Antipruritics|antipruritics|mesh-ancestor
101428368|NCT05785026|Dermatologic Agents|dermatologic agents|mesh-ancestor
101428369|NCT05784987|Rituximab|rituximab|mesh-list
101428370|NCT05784987|Etoposide|etoposide|mesh-list
101428371|NCT05784987|Lenalidomide|lenalidomide|mesh-list
101428372|NCT05784987|Mitoxantrone|mitoxantrone|mesh-list
101428373|NCT05784987|Ifosfamide|ifosfamide|mesh-list
101428374|NCT05784987|Isophosphamide mustard|isophosphamide mustard|mesh-list
101428375|NCT05784987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101428376|NCT05784987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101428377|NCT05784987|Immunologic Factors|immunologic factors|mesh-ancestor
101428378|NCT05784987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428379|NCT05784987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101428380|NCT05784987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101428381|NCT05784987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101428382|NCT05784987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101428383|NCT05784987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101428392|NCT05784987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101428393|NCT05784987|Alkylating Agents|alkylating agents|mesh-ancestor
101428394|NCT05784519|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101428395|NCT05784519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101428396|NCT05784467|Methamphetamine|methamphetamine|mesh-list
101428397|NCT05784467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101428398|NCT05784467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428399|NCT05784467|Sympathomimetics|sympathomimetics|mesh-ancestor
101428400|NCT05784467|Autonomic Agents|autonomic agents|mesh-ancestor
101428401|NCT05784467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101428402|NCT05784467|Dopamine Agents|dopamine agents|mesh-ancestor
101428403|NCT05784467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101428404|NCT05784467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428405|NCT05784467|Adrenergic Agents|adrenergic agents|mesh-ancestor
101428406|NCT05784467|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101428407|NCT05784467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101428408|NCT05784467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101428409|NCT05784467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101428410|NCT05782894|Remifentanil|remifentanil|mesh-list
101428411|NCT05782894|Propofol|propofol|mesh-list
101428412|NCT05782894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101428413|NCT05782894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101558360|NCT04286503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101558361|NCT04286503|Filaricides|filaricides|mesh-ancestor
101558362|NCT04286503|Antinematodal Agents|antinematodal agents|mesh-ancestor
101558363|NCT04286503|Anthelmintics|anthelmintics|mesh-ancestor
101558364|NCT00968617|Darbepoetin alfa|darbepoetin alfa|mesh-list
101558365|NCT00968617|Hematinics|hematinics|mesh-ancestor
101558366|NCT00968539|Vaccines|vaccines|mesh-list
101558367|NCT00968539|Immunologic Factors|immunologic factors|mesh-ancestor
101558368|NCT00968539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558369|NCT00976573|Paclitaxel|paclitaxel|mesh-list
101406789|NCT04702048|Aflibercept|aflibercept|mesh-list
101428414|NCT05782894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428415|NCT05782894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101428416|NCT05782894|Anesthetics, General|anesthetics, general|mesh-ancestor
101428417|NCT05782894|Anesthetics|anesthetics|mesh-ancestor
101428418|NCT05782894|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101428419|NCT05782894|Narcotics|narcotics|mesh-ancestor
101307022|NCT02029118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101307023|NCT02029118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101307024|NCT02029118|Antimetabolites|antimetabolites|mesh-ancestor
101307025|NCT02029118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101428420|NCT05782894|Analgesics|analgesics|mesh-ancestor
101428421|NCT05782894|Sensory System Agents|sensory system agents|mesh-ancestor
101428422|NCT05782894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101428429|NCT05782712|Vasodilator Agents|vasodilator agents|mesh-ancestor
101428430|NCT05782712|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101428431|NCT05782712|Purinergic Agonists|purinergic agonists|mesh-ancestor
101428432|NCT05782712|Purinergic Agents|purinergic agents|mesh-ancestor
101428433|NCT05782712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101428434|NCT05782712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428436|NCT05781516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101428438|NCT05781516|Hormones|hormones|mesh-ancestor
101428439|NCT05781516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101428440|NCT05781516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428441|NCT05781516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101428442|NCT05781516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101428443|NCT05781321|Temozolomide|temozolomide|mesh-list
101428444|NCT05781321|Levodopa|levodopa|mesh-list
101428445|NCT05781321|Fluorides|fluorides|mesh-list
101428446|NCT05781321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101428447|NCT05781321|Alkylating Agents|alkylating agents|mesh-ancestor
101428448|NCT05781321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428449|NCT05781321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101428450|NCT05781321|Cariostatic Agents|cariostatic agents|mesh-ancestor
101428451|NCT05781321|Protective Agents|protective agents|mesh-ancestor
101428452|NCT05781321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428461|NCT05780437|Antiviral Agents|antiviral agents|mesh-ancestor
101428462|NCT05780437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101428463|NCT05780424|Remdesivir|remdesivir|mesh-list
101428464|NCT05780424|Antimetabolites|antimetabolites|mesh-ancestor
101428465|NCT05780424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428466|NCT05780424|Antiviral Agents|antiviral agents|mesh-ancestor
101428467|NCT05780424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101428468|NCT05778266|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101428469|NCT05778266|Laxatives|laxatives|mesh-ancestor
101428470|NCT05778266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101428471|NCT05774405|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101428472|NCT05774405|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101428473|NCT05774405|Estradiol|estradiol|mesh-list
101428474|NCT05774405|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101428475|NCT05774405|Estrogens|estrogens|mesh-ancestor
101428476|NCT05774405|Hormones|hormones|mesh-ancestor
101428477|NCT05774405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101428478|NCT05774405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428479|NCT05774405|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101428480|NCT05774405|Contraceptive Agents|contraceptive agents|mesh-ancestor
101558371|NCT00976573|Carboplatin|carboplatin|mesh-list
101558372|NCT00976573|Everolimus|everolimus|mesh-list
101558373|NCT00976573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101558374|NCT00976573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101558375|NCT00976573|Tubulin Modulators|tubulin modulators|mesh-ancestor
101558376|NCT00976573|Antimitotic Agents|antimitotic agents|mesh-ancestor
101558377|NCT00976573|Mitosis Modulators|mitosis modulators|mesh-ancestor
101558378|NCT00976573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558379|NCT00976573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101406798|NCT00135057|Insulin|insulin|mesh-list
101428481|NCT05774405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101428482|NCT05774405|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101428483|NCT05766683|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101428484|NCT05766683|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101428485|NCT05766683|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101428486|NCT05766683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101428487|NCT05766683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428488|NCT05766683|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101428489|NCT05766683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101428490|NCT05766683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428495|NCT05764941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101428496|NCT05764941|Tubulin Modulators|tubulin modulators|mesh-ancestor
101428497|NCT05764941|Antimitotic Agents|antimitotic agents|mesh-ancestor
101307026|NCT02029118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101307027|NCT02029118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101307028|NCT02029118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101428498|NCT05764941|Mitosis Modulators|mitosis modulators|mesh-ancestor
101428499|NCT05764941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428500|NCT05750017|Vaccines|vaccines|mesh-list
101428501|NCT05750017|Immunologic Factors|immunologic factors|mesh-ancestor
101428502|NCT05750017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428503|NCT05734105|Sunitinib|sunitinib|mesh-list
101428504|NCT05734105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101428505|NCT05734105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101428506|NCT05734105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101428507|NCT05734105|Growth Substances|growth substances|mesh-ancestor
101428508|NCT05734105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428509|NCT05734105|Growth Inhibitors|growth inhibitors|mesh-ancestor
101428510|NCT05734105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101428511|NCT05734105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101428512|NCT05734105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428513|NCT05724316|Vitamin D|vitamin d|mesh-list
101428514|NCT05724316|Cholecalciferol|cholecalciferol|mesh-list
101428515|NCT05724316|Vitamins|vitamins|mesh-ancestor
101428516|NCT05724316|Micronutrients|micronutrients|mesh-ancestor
101428517|NCT05724316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428518|NCT05724316|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101428534|NCT05616260|Diuretics|diuretics|mesh-ancestor
101428535|NCT05616260|Natriuretic Agents|natriuretic agents|mesh-ancestor
101428536|NCT05616260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428537|NCT05611034|Oxaliplatin|oxaliplatin|mesh-list
101428538|NCT05611034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101428539|NCT05592509|Vitamins|vitamins|mesh-list
101428540|NCT05592509|Micronutrients|micronutrients|mesh-ancestor
101428541|NCT05592509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428542|NCT05582213|Anesthetics|anesthetics|mesh-list
101428543|NCT05582213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101428544|NCT05582213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428545|NCT05550597|Fentanyl|fentanyl|mesh-list
101428546|NCT05550597|Bupivacaine|bupivacaine|mesh-list
101428547|NCT05550597|Anesthetics, Local|anesthetics, local|mesh-ancestor
101428548|NCT05550597|Anesthetics|anesthetics|mesh-ancestor
101428549|NCT05550597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101558380|NCT00976573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101558381|NCT00976573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101558382|NCT00976573|Growth Substances|growth substances|mesh-ancestor
101558383|NCT00976573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558384|NCT00976573|Growth Inhibitors|growth inhibitors|mesh-ancestor
101558385|NCT00976573|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101558386|NCT00976573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101558387|NCT00976573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101428550|NCT05550597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428551|NCT05550597|Sensory System Agents|sensory system agents|mesh-ancestor
101428552|NCT05550597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101428553|NCT05550597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101428554|NCT05550597|Narcotics|narcotics|mesh-ancestor
101428555|NCT05550597|Analgesics|analgesics|mesh-ancestor
101428556|NCT05550597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101428557|NCT05550597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101428558|NCT05550597|Anesthetics, General|anesthetics, general|mesh-ancestor
101428559|NCT05495269|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101428560|NCT05495269|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101428561|NCT05355935|Moxifloxacin|moxifloxacin|mesh-list
101428562|NCT05355935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101428563|NCT05355935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101428566|NCT05355935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101428567|NCT05355935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307029|NCT02029118|Sympatholytics|sympatholytics|mesh-ancestor
101307030|NCT02029118|Autonomic Agents|autonomic agents|mesh-ancestor
101307031|NCT02029118|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101307032|NCT02029118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101359588|NCT00209833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101307033|NCT02029118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101307034|NCT02029118|Adrenergic Agents|adrenergic agents|mesh-ancestor
101307035|NCT02029118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101307036|NCT02029118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101307037|NCT02029118|Protease Inhibitors|protease inhibitors|mesh-ancestor
101307038|NCT02029313|Montelukast|montelukast|mesh-list
101307039|NCT02029313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101307040|NCT02029313|Respiratory System Agents|respiratory system agents|mesh-ancestor
101428570|NCT05334017|Xylometazoline|xylometazoline|mesh-list
101428571|NCT05334017|Anesthetics, Local|anesthetics, local|mesh-ancestor
101428572|NCT05334017|Anesthetics|anesthetics|mesh-ancestor
101428573|NCT05334017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101428574|NCT05334017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428575|NCT05334017|Sensory System Agents|sensory system agents|mesh-ancestor
101428576|NCT05334017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101428577|NCT05334017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101428578|NCT05334017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101428579|NCT05334017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101428580|NCT05334017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101428581|NCT05334017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428582|NCT05334017|Dopamine Agents|dopamine agents|mesh-ancestor
101428583|NCT05334017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101428584|NCT05334017|Nasal Decongestants|nasal decongestants|mesh-ancestor
101428585|NCT05334017|Respiratory System Agents|respiratory system agents|mesh-ancestor
101428586|NCT05319639|Leucovorin|leucovorin|mesh-list
101428587|NCT05319639|Paclitaxel|paclitaxel|mesh-list
101428588|NCT05319639|Fluorouracil|fluorouracil|mesh-list
101428589|NCT05319639|Oxaliplatin|oxaliplatin|mesh-list
101428590|NCT05319639|Irinotecan|irinotecan|mesh-list
101428591|NCT05319639|Tislelizumab|tislelizumab|mesh-list
101428592|NCT05319639|Levoleucovorin|levoleucovorin|mesh-list
101428593|NCT05319639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101428594|NCT05319639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101428595|NCT05319639|Tubulin Modulators|tubulin modulators|mesh-ancestor
101428596|NCT05319639|Antimitotic Agents|antimitotic agents|mesh-ancestor
101428597|NCT05319639|Mitosis Modulators|mitosis modulators|mesh-ancestor
101428598|NCT05319639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428599|NCT05319639|Antimetabolites|antimetabolites|mesh-ancestor
101558389|NCT00976573|Immunologic Factors|immunologic factors|mesh-ancestor
101558390|NCT03661723|Bevacizumab|bevacizumab|mesh-list
101558391|NCT03661723|Pembrolizumab|pembrolizumab|mesh-list
101558392|NCT03661723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101558393|NCT03661723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101558394|NCT03661723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101558395|NCT03661723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101558396|NCT03661723|Growth Substances|growth substances|mesh-ancestor
101558397|NCT03661723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558398|NCT03661723|Growth Inhibitors|growth inhibitors|mesh-ancestor
101428600|NCT05319639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101428601|NCT05319639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101428602|NCT05319639|Immunologic Factors|immunologic factors|mesh-ancestor
101428603|NCT05319639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428604|NCT05319639|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101428605|NCT05319639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101428606|NCT05319639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101428607|NCT05319639|Antidotes|antidotes|mesh-ancestor
101307045|NCT02029313|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101307046|NCT02029313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101307047|NCT02029313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428608|NCT05319639|Protective Agents|protective agents|mesh-ancestor
101428609|NCT05319639|Vitamin B Complex|vitamin b complex|mesh-ancestor
101428610|NCT05319639|Vitamins|vitamins|mesh-ancestor
101428611|NCT05319639|Micronutrients|micronutrients|mesh-ancestor
101428612|NCT05319639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101428613|NCT05292339|Triamcinolone|triamcinolone|mesh-list
101428614|NCT05292339|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101428615|NCT05292339|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101428616|NCT05292339|Ketorolac|ketorolac|mesh-list
101428617|NCT05292339|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101428618|NCT05292339|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101428619|NCT05292339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101428620|NCT05292339|Glucocorticoids|glucocorticoids|mesh-ancestor
101428621|NCT05292339|Hormones|hormones|mesh-ancestor
101428622|NCT05292339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101428623|NCT05292339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428624|NCT05292339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101428625|NCT05292339|Immunologic Factors|immunologic factors|mesh-ancestor
101428626|NCT05292339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101428627|NCT05292339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428628|NCT05292339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101428629|NCT05292339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101428642|NCT05291650|Hormones|hormones|mesh-ancestor
101428643|NCT05291650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101428644|NCT05266027|Nalbuphine|nalbuphine|mesh-list
101428645|NCT05266027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101428646|NCT05266027|Narcotics|narcotics|mesh-ancestor
101428647|NCT05266027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101428648|NCT05266027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428649|NCT05266027|Analgesics|analgesics|mesh-ancestor
101428650|NCT05266027|Sensory System Agents|sensory system agents|mesh-ancestor
101428651|NCT05266027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101428652|NCT05157867|Trypsin Inhibitors|trypsin inhibitors|mesh-list
101428653|NCT05157867|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101428654|NCT05157867|Protease Inhibitors|protease inhibitors|mesh-ancestor
101428655|NCT05157867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101428656|NCT05157867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428657|NCT05131386|Trabectedin|trabectedin|mesh-list
101428658|NCT05131386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101428659|NCT05131386|Alkylating Agents|alkylating agents|mesh-ancestor
101428660|NCT05131386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558399|NCT03661723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101558400|NCT03661723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558401|NCT00629863|Fluorouracil|fluorouracil|mesh-list
101558402|NCT00629863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101558403|NCT00629863|Antimetabolites|antimetabolites|mesh-ancestor
101558404|NCT00629863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558405|NCT00629863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101558406|NCT00629863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101558407|NCT00629863|Immunologic Factors|immunologic factors|mesh-ancestor
101558408|NCT00629863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558409|NCT02865733|Treprostinil|treprostinil|mesh-list
101558410|NCT02865733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101406829|NCT00434824|Testosterone undecanoate|testosterone undecanoate|mesh-list
101406832|NCT00434824|Androgens|androgens|mesh-ancestor
101428661|NCT05131386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101428662|NCT05129332|Vitamin E|vitamin e|mesh-list
101428663|NCT05129332|Vitamins|vitamins|mesh-ancestor
101428664|NCT05129332|Micronutrients|micronutrients|mesh-ancestor
101428665|NCT05129332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428666|NCT05129332|Antioxidants|antioxidants|mesh-ancestor
101428667|NCT05129332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428668|NCT05129332|Protective Agents|protective agents|mesh-ancestor
101428669|NCT05111262|Budesonide|budesonide|mesh-list
101428670|NCT05111262|Formoterol Fumarate|formoterol fumarate|mesh-list
101428671|NCT05111262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101428672|NCT05111262|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101428673|NCT05111262|Autonomic Agents|autonomic agents|mesh-ancestor
101428674|NCT05111262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101428675|NCT05111262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428676|NCT05111262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101428677|NCT05111262|Respiratory System Agents|respiratory system agents|mesh-ancestor
101428678|NCT05111262|Glucocorticoids|glucocorticoids|mesh-ancestor
101428679|NCT05111262|Hormones|hormones|mesh-ancestor
101307048|NCT02029378|Eculizumab|eculizumab|mesh-list
101307049|NCT02029378|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101428680|NCT05111262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101428681|NCT05111262|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101428682|NCT05111262|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101428683|NCT05111262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101428684|NCT05111262|Adrenergic Agents|adrenergic agents|mesh-ancestor
101428685|NCT05111262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101428686|NCT05111262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428687|NCT05091242|Clonidine|clonidine|mesh-list
101428688|NCT05091242|Analgesics|analgesics|mesh-ancestor
101428689|NCT05091242|Sensory System Agents|sensory system agents|mesh-ancestor
101428690|NCT05091242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101428691|NCT05091242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428692|NCT05091242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101428693|NCT05091242|Sympatholytics|sympatholytics|mesh-ancestor
101428694|NCT05091242|Autonomic Agents|autonomic agents|mesh-ancestor
101428695|NCT05091242|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101428696|NCT05091242|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101428697|NCT05091242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101428698|NCT05091242|Adrenergic Agents|adrenergic agents|mesh-ancestor
101428699|NCT05091242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101428707|NCT05027516|Azithromycin|azithromycin|mesh-list
101428708|NCT05027516|Ceftriaxone|ceftriaxone|mesh-list
101428719|NCT04947124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101428720|NCT04947124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101428721|NCT04933630|Norepinephrine|norepinephrine|mesh-list
101428722|NCT04933630|Serotonin|serotonin|mesh-list
101558411|NCT00976495|Dapagliflozin|dapagliflozin|mesh-list
101558412|NCT00976495|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101558413|NCT00976495|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101558414|NCT00976495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558415|NCT00976495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101428723|NCT04933630|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
101428724|NCT04933630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101428725|NCT04933630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101428726|NCT04933630|Adrenergic Agents|adrenergic agents|mesh-ancestor
101428727|NCT04933630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101428728|NCT04933630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428729|NCT04933630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428730|NCT04933630|Sympathomimetics|sympathomimetics|mesh-ancestor
101428731|NCT04933630|Autonomic Agents|autonomic agents|mesh-ancestor
101428732|NCT04933630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101428733|NCT04933630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101428734|NCT04933630|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101428735|NCT04933630|Serotonin Agents|serotonin agents|mesh-ancestor
101428736|NCT04933630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101428737|NCT04933630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101428739|NCT04923841|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101428740|NCT04923841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101428741|NCT04923841|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101428742|NCT04923841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101428743|NCT04923841|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101428744|NCT04923841|Autonomic Agents|autonomic agents|mesh-ancestor
101428745|NCT04923841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101428746|NCT04923841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428747|NCT04923841|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101428748|NCT04923841|Respiratory System Agents|respiratory system agents|mesh-ancestor
101428749|NCT04923841|Mydriatics|mydriatics|mesh-ancestor
101428750|NCT04923841|Parasympatholytics|parasympatholytics|mesh-ancestor
101428751|NCT04923841|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101428752|NCT04923841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101428753|NCT04923841|Cholinergic Agents|cholinergic agents|mesh-ancestor
101428754|NCT04923841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101428755|NCT04923841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428756|NCT04838808|Rivaroxaban|rivaroxaban|mesh-list
101428757|NCT04838808|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101428758|NCT04838808|Antithrombins|antithrombins|mesh-ancestor
101428759|NCT04838808|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101428760|NCT04838808|Protease Inhibitors|protease inhibitors|mesh-ancestor
101307050|NCT02029378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101307051|NCT02029378|Immunologic Factors|immunologic factors|mesh-ancestor
101307052|NCT02029378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428761|NCT04838808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101428762|NCT04838808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428763|NCT04838808|Anticoagulants|anticoagulants|mesh-ancestor
101428764|NCT04803877|Nivolumab|nivolumab|mesh-list
101428765|NCT04803877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101428766|NCT04803877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101428767|NCT04803877|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101428768|NCT04803877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428769|NCT04792502|Lenalidomide|lenalidomide|mesh-list
101428770|NCT04792502|Immunologic Factors|immunologic factors|mesh-ancestor
101428771|NCT04792502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428772|NCT04792502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101428780|NCT04777422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428782|NCT04761198|Nivolumab|nivolumab|mesh-list
101428783|NCT04761198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101428784|NCT04761198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101428785|NCT04761198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101428786|NCT04761198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428787|NCT04748276|Norepinephrine|norepinephrine|mesh-list
101428788|NCT04748276|Serotonin|serotonin|mesh-list
101428789|NCT04748276|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
101558416|NCT00976495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558417|NCT00976495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101558418|NCT00976495|Diuretics|diuretics|mesh-ancestor
101558419|NCT00976495|Natriuretic Agents|natriuretic agents|mesh-ancestor
101558420|NCT00976495|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101558421|NCT00976495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101558422|NCT00630019|Moxifloxacin|moxifloxacin|mesh-list
101558423|NCT00630019|Levofloxacin|levofloxacin|mesh-list
101558424|NCT00630019|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101558425|NCT00630019|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101558426|NCT00630019|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101558427|NCT00630019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101558428|NCT00630019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101558429|NCT00630019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101558430|NCT00630019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101558431|NCT00630019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101558432|NCT00630019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558433|NCT00630019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101558434|NCT00630019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101558435|NCT00630019|Contraceptive Agents|contraceptive agents|mesh-ancestor
101558436|NCT00630019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101558437|NCT00630019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558438|NCT00630019|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101558439|NCT00630019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101406855|NCT00434941|Capecitabine|capecitabine|mesh-list
101428790|NCT04748276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101428791|NCT04748276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101428792|NCT04748276|Adrenergic Agents|adrenergic agents|mesh-ancestor
101428793|NCT04748276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101428794|NCT04748276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428795|NCT04748276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428796|NCT04748276|Sympathomimetics|sympathomimetics|mesh-ancestor
101428797|NCT04748276|Autonomic Agents|autonomic agents|mesh-ancestor
101428798|NCT04748276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101428799|NCT04748276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101428800|NCT04748276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101428801|NCT04748276|Serotonin Agents|serotonin agents|mesh-ancestor
101428802|NCT04748276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101428803|NCT04748276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101428804|NCT04659811|Pembrolizumab|pembrolizumab|mesh-list
101428805|NCT04659811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101428806|NCT04659811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101428807|NCT04659811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101428808|NCT04659811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428809|NCT04610658|Nivolumab|nivolumab|mesh-list
101428810|NCT04610658|Ipilimumab|ipilimumab|mesh-list
101558440|NCT00630019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101558441|NCT00630019|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101558442|NCT00630019|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101558443|NCT00630019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101558444|NCT00998296|Nintedanib|nintedanib|mesh-list
101558445|NCT00998296|Afatinib|afatinib|mesh-list
101558447|NCT00998296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101428811|NCT04610658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101428812|NCT04610658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101428813|NCT04610658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101428814|NCT04610658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428815|NCT04595994|Gemcitabine|gemcitabine|mesh-list
101428816|NCT04595994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101428817|NCT04595994|Antimetabolites|antimetabolites|mesh-ancestor
101428818|NCT04595994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428819|NCT04595994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101428820|NCT04587791|Cannabidiol|cannabidiol|mesh-list
101428821|NCT04587791|Anticonvulsants|anticonvulsants|mesh-ancestor
101428822|NCT04538066|Bryostatin 1|bryostatin 1|mesh-list
101428823|NCT04538066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101428824|NCT04538066|Immunologic Factors|immunologic factors|mesh-ancestor
101428825|NCT04538066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428826|NCT04538066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101428827|NCT04532918|Cyclosporine|cyclosporine|mesh-list
101428828|NCT04532918|Rifampin|rifampin|mesh-list
101428829|NCT04532918|Allopurinol|allopurinol|mesh-list
101307053|NCT02029456|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101307054|NCT02029456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101307055|NCT02029456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101307056|NCT02029456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428830|NCT04532918|Verinurad|verinurad|mesh-list
101428831|NCT04532918|Cyclosporins|cyclosporins|mesh-list
101428832|NCT04532918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101462616|NCT00199979|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101428833|NCT04532918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428834|NCT04532918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101428835|NCT04532918|Immunologic Factors|immunologic factors|mesh-ancestor
101428836|NCT04532918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428837|NCT04532918|Antifungal Agents|antifungal agents|mesh-ancestor
101428838|NCT04532918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101428839|NCT04532918|Dermatologic Agents|dermatologic agents|mesh-ancestor
101428840|NCT04532918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101428841|NCT04532918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101428852|NCT04532918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101428853|NCT04532918|Antimetabolites|antimetabolites|mesh-ancestor
101428854|NCT04532918|Gout Suppressants|gout suppressants|mesh-ancestor
101428855|NCT04532918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101428857|NCT04532918|Protective Agents|protective agents|mesh-ancestor
101428858|NCT04511247|Sirolimus|sirolimus|mesh-list
101428859|NCT04511247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101428860|NCT04511247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101428861|NCT04511247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101428862|NCT04511247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101428863|NCT04511247|Antifungal Agents|antifungal agents|mesh-ancestor
101428864|NCT04511247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101428865|NCT04511247|Immunologic Factors|immunologic factors|mesh-ancestor
101428866|NCT04511247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428867|NCT04387084|Pembrolizumab|pembrolizumab|mesh-list
101428868|NCT04387084|Nivolumab|nivolumab|mesh-list
101428869|NCT04387084|Atezolizumab|atezolizumab|mesh-list
101428870|NCT04387084|Durvalumab|durvalumab|mesh-list
101428871|NCT04387084|Avelumab|avelumab|mesh-list
101428872|NCT04387084|Cemiplimab|cemiplimab|mesh-list
101428873|NCT04387084|Immunoglobulins|immunoglobulins|mesh-list
101428874|NCT04387084|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101428875|NCT04387084|Immunoglobulin G|immunoglobulin g|mesh-list
101428876|NCT04387084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101428877|NCT04387084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101428878|NCT04387084|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101428879|NCT04387084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428880|NCT04387084|Immunologic Factors|immunologic factors|mesh-ancestor
101558448|NCT00998296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101558449|NCT00998296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558450|NCT01178073|Ambrisentan|ambrisentan|mesh-list
101558451|NCT01178073|Tadalafil|tadalafil|mesh-list
101558452|NCT01178073|Vasodilator Agents|vasodilator agents|mesh-ancestor
101558453|NCT01178073|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101558454|NCT01178073|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101558455|NCT01178073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101558456|NCT01178073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558457|NCT01178073|Urological Agents|urological agents|mesh-ancestor
101558458|NCT01178073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101558459|NCT00997984|Guanfacine|guanfacine|mesh-list
101406880|NCT00435175|Estradiol|estradiol|mesh-list
101428881|NCT04387084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428882|NCT04347798|Hydroxychloroquine|hydroxychloroquine|mesh-list
101428883|NCT04347798|Chloroquine|chloroquine|mesh-list
101428884|NCT04347798|Antimalarials|antimalarials|mesh-ancestor
101428885|NCT04347798|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101428886|NCT04347798|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101428887|NCT04347798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101428888|NCT04347798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101428889|NCT04347798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428890|NCT04347798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101428891|NCT04347798|Amebicides|amebicides|mesh-ancestor
101428892|NCT04335669|Paclitaxel|paclitaxel|mesh-list
101428893|NCT04335669|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101428894|NCT04335669|Cyclophosphamide|cyclophosphamide|mesh-list
101428895|NCT04335669|Carboplatin|carboplatin|mesh-list
101428896|NCT04335669|Pembrolizumab|pembrolizumab|mesh-list
101428897|NCT04335669|Capecitabine|capecitabine|mesh-list
101428898|NCT04335669|Epirubicin|epirubicin|mesh-list
101428899|NCT04335669|Taxane|taxane|mesh-list
101428900|NCT04335669|Antimetabolites|antimetabolites|mesh-list
101462629|NCT00236847|Topiramate|topiramate|mesh-list
101428901|NCT04335669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101428902|NCT04335669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101428903|NCT04335669|Tubulin Modulators|tubulin modulators|mesh-ancestor
101428904|NCT04335669|Antimitotic Agents|antimitotic agents|mesh-ancestor
101307058|NCT02029482|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101307059|NCT02029482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307061|NCT02029482|Immunologic Factors|immunologic factors|mesh-ancestor
101307062|NCT02029482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307063|NCT02029534|Atorvastatin|atorvastatin|mesh-list
101307064|NCT02029534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101307065|NCT02029534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101428905|NCT04335669|Mitosis Modulators|mitosis modulators|mesh-ancestor
101428906|NCT04335669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428907|NCT04335669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101428908|NCT04335669|Immunologic Factors|immunologic factors|mesh-ancestor
101428909|NCT04335669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428910|NCT04335669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101428911|NCT04335669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101428912|NCT04335669|Alkylating Agents|alkylating agents|mesh-ancestor
101428913|NCT04335669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101428935|NCT04310176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101428936|NCT04310176|Immunologic Factors|immunologic factors|mesh-ancestor
101428937|NCT04310176|Anticonvulsants|anticonvulsants|mesh-ancestor
101428938|NCT04310176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101428939|NCT04310176|GABA Agents|gaba agents|mesh-ancestor
101428940|NCT04310176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101428941|NCT04310176|Antimanic Agents|antimanic agents|mesh-ancestor
101428942|NCT04310176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101428943|NCT04310176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101428944|NCT04310176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101428945|NCT04298983|Androgens|androgens|mesh-list
101428946|NCT04298983|Hormones|hormones|mesh-ancestor
101558460|NCT00997984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101558461|NCT00997984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101558462|NCT00997984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101558463|NCT00997984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101558464|NCT00997984|Adrenergic Agents|adrenergic agents|mesh-ancestor
101558465|NCT00997984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101558466|NCT00997984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428947|NCT04298983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101428948|NCT04298983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428949|NCT04251416|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
101428950|NCT04251416|Immunoconjugates|immunoconjugates|mesh-ancestor
101428951|NCT04251416|Immunologic Factors|immunologic factors|mesh-ancestor
101428952|NCT04251416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428953|NCT04236609|Sirolimus|sirolimus|mesh-list
101428954|NCT04236609|Everolimus|everolimus|mesh-list
101428955|NCT04236609|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101428956|NCT04236609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101428957|NCT04236609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101428958|NCT04236609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428959|NCT04236609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101428960|NCT04236609|Immunologic Factors|immunologic factors|mesh-ancestor
101428961|NCT04236609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428962|NCT04236609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101428963|NCT04236609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101428964|NCT04236609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101428965|NCT04236609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101428966|NCT04236609|Antifungal Agents|antifungal agents|mesh-ancestor
101428968|NCT04232657|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101428969|NCT04232657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428970|NCT04173585|Bortezomib|bortezomib|mesh-list
101428971|NCT04173585|Gemtuzumab|gemtuzumab|mesh-list
101428972|NCT04173585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101428986|NCT04138381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101428987|NCT04138381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101428988|NCT04138381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428996|NCT04127786|Vaccines|vaccines|mesh-list
101428997|NCT04127786|Immunologic Factors|immunologic factors|mesh-ancestor
101428998|NCT04127786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428999|NCT04049331|Methyltestosterone|methyltestosterone|mesh-list
101429000|NCT04049331|Testosterone|testosterone|mesh-list
101307066|NCT02029534|Antimetabolites|antimetabolites|mesh-ancestor
101307067|NCT02029534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307068|NCT02029534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101307069|NCT02029534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101307070|NCT02029534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101307071|NCT02029573|Temozolomide|temozolomide|mesh-list
101307072|NCT02029573|Atorvastatin|atorvastatin|mesh-list
101307073|NCT02029573|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101307074|NCT02029573|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101307075|NCT02029573|Antimetabolites|antimetabolites|mesh-ancestor
101429001|NCT04049331|Testosterone undecanoate|testosterone undecanoate|mesh-list
101429002|NCT04049331|Testosterone enanthate|testosterone enanthate|mesh-list
101429003|NCT04049331|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101429004|NCT04049331|Androgens|androgens|mesh-ancestor
101429005|NCT04049331|Hormones|hormones|mesh-ancestor
101429006|NCT04049331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101429007|NCT04049331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429008|NCT04049331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101429009|NCT04049331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101429010|NCT04049331|Anabolic Agents|anabolic agents|mesh-ancestor
101429011|NCT04033055|Ropivacaine|ropivacaine|mesh-list
101429012|NCT04033055|Anesthetics, Local|anesthetics, local|mesh-ancestor
101429013|NCT04033055|Anesthetics|anesthetics|mesh-ancestor
101429014|NCT04033055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101429020|NCT04015596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101429021|NCT04015596|Analgesics|analgesics|mesh-ancestor
101429022|NCT04015596|Sensory System Agents|sensory system agents|mesh-ancestor
101558467|NCT00997984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558469|NCT01177293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101558470|NCT01177293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101558471|NCT01177293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101429023|NCT04015596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101429024|NCT04015596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429025|NCT04015596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101429026|NCT04015596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101429027|NCT04015596|Gout Suppressants|gout suppressants|mesh-ancestor
101429028|NCT04015596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101429029|NCT04015596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101429030|NCT04015596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429032|NCT03985722|Olaratumab|olaratumab|mesh-list
101429033|NCT03985722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101429034|NCT03985722|Alkylating Agents|alkylating agents|mesh-ancestor
101429035|NCT03985722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429036|NCT03985722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101429037|NCT03954327|Tenofovir|tenofovir|mesh-list
101429038|NCT03954327|Emtricitabine|emtricitabine|mesh-list
101429039|NCT03954327|Raltegravir Potassium|raltegravir potassium|mesh-list
101429040|NCT03954327|Antiviral Agents|antiviral agents|mesh-ancestor
101429041|NCT03954327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101429042|NCT03954327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101429048|NCT03954327|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101429049|NCT03954327|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101429051|NCT03762096|Antioxidants|antioxidants|mesh-ancestor
101429052|NCT03762096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429053|NCT03762096|Protective Agents|protective agents|mesh-ancestor
101429054|NCT03762096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429055|NCT03762096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101429056|NCT03762096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101429057|NCT03737955|Gemtuzumab|gemtuzumab|mesh-list
101429058|NCT03737955|Calicheamicins|calicheamicins|mesh-list
101429059|NCT03737955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101429060|NCT03737955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101429061|NCT03737955|Immunotoxins|immunotoxins|mesh-ancestor
101307076|NCT02029573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307077|NCT02029573|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101429062|NCT03737955|Immunoconjugates|immunoconjugates|mesh-ancestor
101429063|NCT03737955|Immunologic Factors|immunologic factors|mesh-ancestor
101429064|NCT03737955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429065|NCT03737955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101429066|NCT03736720|Leucovorin|leucovorin|mesh-list
101429067|NCT03736720|Fluorouracil|fluorouracil|mesh-list
101429068|NCT03736720|Irinotecan|irinotecan|mesh-list
101429069|NCT03736720|Antimetabolites|antimetabolites|mesh-ancestor
101429070|NCT03736720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429071|NCT03736720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101429072|NCT03736720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101429073|NCT03736720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101429074|NCT03736720|Immunologic Factors|immunologic factors|mesh-ancestor
101429075|NCT03736720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429076|NCT03736720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101429077|NCT03736720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101429078|NCT03736720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101429079|NCT03736720|Antidotes|antidotes|mesh-ancestor
101429080|NCT03736720|Protective Agents|protective agents|mesh-ancestor
101429081|NCT03736720|Vitamin B Complex|vitamin b complex|mesh-ancestor
101429082|NCT03736720|Vitamins|vitamins|mesh-ancestor
101429083|NCT03736720|Micronutrients|micronutrients|mesh-ancestor
101429084|NCT03490344|Lenalidomide|lenalidomide|mesh-list
101429085|NCT03490344|Daratumumab|daratumumab|mesh-list
101429086|NCT03490344|Immunologic Factors|immunologic factors|mesh-ancestor
101429087|NCT03490344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429088|NCT03490344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101429092|NCT03490344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101429093|NCT03460379|Citalopram|citalopram|mesh-list
101429094|NCT03460379|Escitalopram|escitalopram|mesh-list
101429095|NCT03460379|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101558472|NCT01177293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558473|NCT01177293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101558474|NCT01177293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558475|NCT01177293|Vasodilator Agents|vasodilator agents|mesh-ancestor
101558476|NCT02886429|Dexmedetomidine|dexmedetomidine|mesh-list
101558477|NCT02886429|Bupivacaine|bupivacaine|mesh-list
101558478|NCT02886429|Anesthetics, Local|anesthetics, local|mesh-ancestor
101558479|NCT02886429|Anesthetics|anesthetics|mesh-ancestor
101558480|NCT02886429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101558481|NCT02886429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462644|NCT00410306|Anabolic Agents|anabolic agents|mesh-ancestor
101558482|NCT02886429|Sensory System Agents|sensory system agents|mesh-ancestor
101558483|NCT02886429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101558484|NCT02886429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101558485|NCT02886429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101558486|NCT02886429|Analgesics|analgesics|mesh-ancestor
101558487|NCT02886429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101558488|NCT02886429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101406905|NCT00135135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101429096|NCT03460379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101429097|NCT03460379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101429098|NCT03460379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429099|NCT03460379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101429100|NCT03460379|Serotonin Agents|serotonin agents|mesh-ancestor
101429101|NCT03460379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429102|NCT03460379|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101429103|NCT03460379|Antidepressive Agents|antidepressive agents|mesh-ancestor
101429104|NCT03460379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101429105|NCT03460366|Enalapril|enalapril|mesh-list
101429106|NCT03460366|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101429107|NCT03460366|Protease Inhibitors|protease inhibitors|mesh-ancestor
101429108|NCT03460366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101429109|NCT03460366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429110|NCT03460366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101429111|NCT03460353|Dextroamphetamine|dextroamphetamine|mesh-list
101429112|NCT03460353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101429113|NCT03460353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429120|NCT03460327|Candesartan|candesartan|mesh-list
101429121|NCT03460327|Candesartan cilexetil|candesartan cilexetil|mesh-list
101429122|NCT03460327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101429123|NCT03460327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101429124|NCT03460327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101429125|NCT03460327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429126|NCT03460314|Buprenorphine|buprenorphine|mesh-list
101429127|NCT03460314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101429128|NCT03460314|Narcotics|narcotics|mesh-ancestor
101429129|NCT03460314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101429130|NCT03460314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429131|NCT03460314|Analgesics|analgesics|mesh-ancestor
101429132|NCT03460314|Sensory System Agents|sensory system agents|mesh-ancestor
101429133|NCT03460314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101429134|NCT03460314|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101429135|NCT03460210|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101429136|NCT03460210|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101558489|NCT02886429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101558490|NCT02886429|Adrenergic Agents|adrenergic agents|mesh-ancestor
101558491|NCT02886429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101558492|NCT02886429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558493|NCT01299389|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101558494|NCT01299389|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101558495|NCT01299389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101406924|NCT00435331|Verapamil|verapamil|mesh-list
101429137|NCT03460210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101307078|NCT02029573|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101307079|NCT02029573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101307080|NCT02029573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101307081|NCT02029573|Alkylating Agents|alkylating agents|mesh-ancestor
101307082|NCT02029573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101307083|NCT02029586|Beta-lapachone|beta-lapachone|mesh-list
101307084|NCT02029586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101429138|NCT03460210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101429139|NCT03460210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429140|NCT03460210|Adrenergic Agents|adrenergic agents|mesh-ancestor
101429141|NCT03460210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101429142|NCT03460210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429143|NCT03449472|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101429144|NCT03449472|Antidepressive Agents|antidepressive agents|mesh-ancestor
101429145|NCT03449472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101429146|NCT03449472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101429147|NCT03449472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101429148|NCT03449472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101429149|NCT03449472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429150|NCT03440879|Goserelin|goserelin|mesh-list
101429151|NCT03440879|Androgens|androgens|mesh-list
101429152|NCT03440879|Hormones|hormones|mesh-ancestor
101429153|NCT03440879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101429154|NCT03440879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429155|NCT03440879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101429156|NCT03440879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101429168|NCT03406507|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101429169|NCT03406507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101429170|NCT03406507|Immunologic Factors|immunologic factors|mesh-ancestor
101429171|NCT03406507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429172|NCT03283150|Dexmedetomidine|dexmedetomidine|mesh-list
101429173|NCT03283150|Remifentanil|remifentanil|mesh-list
101429174|NCT03283150|Propofol|propofol|mesh-list
101429175|NCT03283150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101429176|NCT03283150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101429177|NCT03283150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429178|NCT03283150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101429179|NCT03283150|Analgesics|analgesics|mesh-ancestor
101429180|NCT03283150|Sensory System Agents|sensory system agents|mesh-ancestor
101429185|NCT03283150|Adrenergic Agents|adrenergic agents|mesh-ancestor
101429186|NCT03283150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101429187|NCT03283150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429188|NCT03283150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101429189|NCT03283150|Anesthetics, General|anesthetics, general|mesh-ancestor
101429190|NCT03283150|Anesthetics|anesthetics|mesh-ancestor
101429191|NCT03283150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101429192|NCT03283150|Narcotics|narcotics|mesh-ancestor
101429193|NCT03249792|Pembrolizumab|pembrolizumab|mesh-list
101429194|NCT03249792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101429195|NCT03249792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101429196|NCT03249792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101429197|NCT03249792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429198|NCT03132675|Pembrolizumab|pembrolizumab|mesh-list
101429199|NCT03132675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101429200|NCT03132675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101307085|NCT02029586|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101558496|NCT01299389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101558497|NCT01299389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558498|NCT01299389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101558499|NCT01299389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101558500|NCT01299389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101558501|NCT01299389|Serotonin Agents|serotonin agents|mesh-ancestor
101558502|NCT01299389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101558503|NCT01299389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558504|NCT01299389|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101558505|NCT01299389|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101558506|NCT01299389|Dopamine Agents|dopamine agents|mesh-ancestor
101558507|NCT02886351|Nitrous Oxide|nitrous oxide|mesh-list
101307086|NCT02029586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101307087|NCT02029586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101429201|NCT03132675|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101429202|NCT03132675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429211|NCT03110744|Palbociclib|palbociclib|mesh-list
101429212|NCT03110744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101429213|NCT03110744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101429214|NCT03110744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101429215|NCT03110744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429216|NCT03056040|Eculizumab|eculizumab|mesh-list
101429217|NCT03056040|Ravulizumab|ravulizumab|mesh-list
101429218|NCT03056040|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101429219|NCT03056040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101429220|NCT03056040|Immunologic Factors|immunologic factors|mesh-ancestor
101429221|NCT03056040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429222|NCT02924038|Poly ICLC|poly iclc|mesh-list
101429223|NCT02924038|Interferon Inducers|interferon inducers|mesh-ancestor
101429224|NCT02924038|Immunologic Factors|immunologic factors|mesh-ancestor
101429225|NCT02924038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429226|NCT02726581|Dexamethasone|dexamethasone|mesh-list
101429227|NCT02726581|Nivolumab|nivolumab|mesh-list
101429228|NCT02726581|Pomalidomide|pomalidomide|mesh-list
101429229|NCT02726581|Elotuzumab|elotuzumab|mesh-list
101429268|NCT02406209|Prednisolone phosphate|prednisolone phosphate|mesh-list
101429269|NCT02406209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101429270|NCT02406209|Glucocorticoids|glucocorticoids|mesh-ancestor
101429272|NCT02406209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101429273|NCT02406209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429274|NCT02406209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101429275|NCT02406209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101429276|NCT02406209|Antiemetics|antiemetics|mesh-ancestor
101429277|NCT02406209|Autonomic Agents|autonomic agents|mesh-ancestor
101429278|NCT02406209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101429279|NCT02406209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101429280|NCT02406209|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101429281|NCT02406209|Protective Agents|protective agents|mesh-ancestor
101429282|NCT02295722|Gemcitabine|gemcitabine|mesh-list
101429283|NCT02295722|Melphalan|melphalan|mesh-list
101307088|NCT02029586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307090|NCT02029599|Acetaminophen|acetaminophen|mesh-list
101307091|NCT02029599|Methotrexate|methotrexate|mesh-list
101429284|NCT02295722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101429285|NCT02295722|Antimetabolites|antimetabolites|mesh-ancestor
101429286|NCT02295722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429287|NCT02295722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101429288|NCT02295722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101429289|NCT02295722|Alkylating Agents|alkylating agents|mesh-ancestor
101429293|NCT02295722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429294|NCT02282059|Sunitinib|sunitinib|mesh-list
101429295|NCT02282059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101558508|NCT02886351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101558509|NCT02886351|Anesthetics, General|anesthetics, general|mesh-ancestor
101558511|NCT02886351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101558512|NCT02886351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558513|NCT02886351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101558514|NCT02886351|Analgesics|analgesics|mesh-ancestor
101558515|NCT02886351|Sensory System Agents|sensory system agents|mesh-ancestor
101558516|NCT02886351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101558517|NCT00976027|Vaccines|vaccines|mesh-list
101558518|NCT00976027|Immunologic Factors|immunologic factors|mesh-ancestor
101558519|NCT00976027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558520|NCT01298765|Buprenorphine|buprenorphine|mesh-list
101558521|NCT01298765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101558522|NCT01298765|Narcotics|narcotics|mesh-ancestor
101558523|NCT01298765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101558524|NCT01298765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558525|NCT01298765|Analgesics|analgesics|mesh-ancestor
101558526|NCT01298765|Sensory System Agents|sensory system agents|mesh-ancestor
101558527|NCT01298765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101406943|NCT00435760|Bromides|bromides|mesh-list
101429296|NCT02282059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101429297|NCT02282059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101429298|NCT02282059|Growth Substances|growth substances|mesh-ancestor
101429299|NCT02282059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429300|NCT02282059|Growth Inhibitors|growth inhibitors|mesh-ancestor
101429301|NCT02282059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101429302|NCT02282059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101429303|NCT02282059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429304|NCT01964989|Vaccines|vaccines|mesh-list
101429305|NCT01964989|Immunologic Factors|immunologic factors|mesh-ancestor
101429306|NCT01964989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429307|NCT01711554|Vitamin A|vitamin a|mesh-list
101429308|NCT01711554|Lenalidomide|lenalidomide|mesh-list
101429309|NCT01711554|Tretinoin|tretinoin|mesh-list
101429310|NCT01711554|Dinutuximab|dinutuximab|mesh-list
101429311|NCT01711554|Isotretinoin|isotretinoin|mesh-list
101429320|NCT01711554|Growth Inhibitors|growth inhibitors|mesh-ancestor
101429321|NCT01711554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101429322|NCT01711554|Keratolytic Agents|keratolytic agents|mesh-ancestor
101429323|NCT01711554|Dermatologic Agents|dermatologic agents|mesh-ancestor
101429324|NCT01575860|Lenalidomide|lenalidomide|mesh-list
101429325|NCT01575860|Immunologic Factors|immunologic factors|mesh-ancestor
101429326|NCT01575860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429327|NCT01575860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101429328|NCT01575860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101429329|NCT01575860|Growth Substances|growth substances|mesh-ancestor
101429330|NCT01575860|Growth Inhibitors|growth inhibitors|mesh-ancestor
101429331|NCT01575860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101429332|NCT01416831|Interleukin-2|interleukin-2|mesh-list
101429333|NCT01416831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101429334|NCT01416831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101429335|NCT01416831|Analgesics|analgesics|mesh-ancestor
101429336|NCT01416831|Sensory System Agents|sensory system agents|mesh-ancestor
101429337|NCT01416831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101429338|NCT01416831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429339|NCT01364051|Cediranib|cediranib|mesh-list
101558528|NCT01298765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101558529|NCT04296214|Azacitidine|azacitidine|mesh-list
101558530|NCT04296214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101558531|NCT04296214|Antimetabolites|antimetabolites|mesh-ancestor
101558532|NCT04296214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558533|NCT04296214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101558534|NCT04296214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101558535|NCT04296370|Apatinib|apatinib|mesh-list
101429340|NCT01364051|Maleic acid|maleic acid|mesh-list
101429341|NCT01364051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101429342|NCT01364051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429343|NCT01364051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101429344|NCT01364051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101429345|NCT01303341|Sorafenib|sorafenib|mesh-list
101429346|NCT01303341|Riluzole|riluzole|mesh-list
101429347|NCT01303341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101429348|NCT01303341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101429349|NCT01303341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101429350|NCT01303341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429351|NCT01303341|Anticonvulsants|anticonvulsants|mesh-ancestor
101429352|NCT01303341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101429353|NCT01303341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101429354|NCT01303341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101429355|NCT01303341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429356|NCT01303341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101429357|NCT01303341|Protective Agents|protective agents|mesh-ancestor
101429358|NCT01064648|Cisplatin|cisplatin|mesh-list
101429359|NCT01064648|Pemetrexed|pemetrexed|mesh-list
101307093|NCT02029599|Abortifacient Agents|abortifacient agents|mesh-ancestor
101307094|NCT02029599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101429360|NCT01064648|Cediranib|cediranib|mesh-list
101429361|NCT01064648|Maleic acid|maleic acid|mesh-list
101429362|NCT01064648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101429363|NCT01064648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101429364|NCT01064648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429365|NCT01064648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101429366|NCT01064648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101429367|NCT01064648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101429368|NCT00635700|Ziprasidone|ziprasidone|mesh-list
101429369|NCT00635700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101429370|NCT00635700|Serotonin Agents|serotonin agents|mesh-ancestor
101429380|NCT00582075|Temozolomide|temozolomide|mesh-list
101429395|NCT00542451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101429396|NCT00542451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101429397|NCT00542451|Tubulin Modulators|tubulin modulators|mesh-ancestor
101429398|NCT00542451|Antimitotic Agents|antimitotic agents|mesh-ancestor
101429399|NCT00542451|Mitosis Modulators|mitosis modulators|mesh-ancestor
101429400|NCT00542451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429401|NCT00542451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101429402|NCT00392353|Azacitidine|azacitidine|mesh-list
101429403|NCT00392353|Vorinostat|vorinostat|mesh-list
101429404|NCT00392353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101429405|NCT00392353|Antimetabolites|antimetabolites|mesh-ancestor
101429406|NCT00392353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429407|NCT00392353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101429408|NCT00392353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101429409|NCT00392353|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101429410|NCT00382070|Letrozole|letrozole|mesh-list
101429411|NCT00382070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101429412|NCT00382070|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101429413|NCT00382070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101429414|NCT00382070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101429415|NCT00382070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429416|NCT00382070|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101429417|NCT00382070|Hormone Antagonists|hormone antagonists|mesh-ancestor
101429418|NCT00382070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101429419|NCT00382070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558537|NCT04296370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101558538|NCT04296370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101558539|NCT04296370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101558540|NCT04296370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558541|NCT04296370|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101558542|NCT00997438|Thioctic Acid|thioctic acid|mesh-list
101558543|NCT00997438|Antioxidants|antioxidants|mesh-ancestor
101558544|NCT00997438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558545|NCT00997438|Protective Agents|protective agents|mesh-ancestor
101406973|NCT00142467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101429420|NCT00326456|Paclitaxel|paclitaxel|mesh-list
101429421|NCT00326456|Carboplatin|carboplatin|mesh-list
101429422|NCT00326456|Doxorubicin|doxorubicin|mesh-list
101429423|NCT00326456|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101429424|NCT00326456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101429425|NCT00326456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101429426|NCT00326456|Tubulin Modulators|tubulin modulators|mesh-ancestor
101429427|NCT00326456|Antimitotic Agents|antimitotic agents|mesh-ancestor
101429428|NCT00326456|Mitosis Modulators|mitosis modulators|mesh-ancestor
101429429|NCT00326456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429430|NCT00326456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101429431|NCT00326456|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101429432|NCT00326456|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101429433|NCT00326456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101429434|NCT00149942|Mycophenolic Acid|mycophenolic acid|mesh-list
101429435|NCT00149942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101429436|NCT00149942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101429437|NCT00149942|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101429438|NCT00149942|Antitubercular Agents|antitubercular agents|mesh-ancestor
101429439|NCT00149942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101429450|NCT00149981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307095|NCT02029599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307096|NCT02029599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101307097|NCT02029599|Antimetabolites|antimetabolites|mesh-ancestor
101429451|NCT00149981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101429453|NCT02915731|Vitamins|vitamins|mesh-ancestor
101429454|NCT02915731|Micronutrients|micronutrients|mesh-ancestor
101429455|NCT02915731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429456|NCT02915809|Vaccines|vaccines|mesh-list
101429457|NCT02915809|Immunologic Factors|immunologic factors|mesh-ancestor
101429460|NCT00405860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101429461|NCT00405860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101429462|NCT00405860|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101429463|NCT00405860|Antitubercular Agents|antitubercular agents|mesh-ancestor
101429464|NCT00405860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101429465|NCT00405860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101429466|NCT00405860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101429467|NCT00405860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429468|NCT02914678|Fentanyl|fentanyl|mesh-list
101429469|NCT02914678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101429470|NCT02914678|Narcotics|narcotics|mesh-ancestor
101429471|NCT02914678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101429472|NCT02914678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429473|NCT02914678|Analgesics|analgesics|mesh-ancestor
101429474|NCT02914678|Sensory System Agents|sensory system agents|mesh-ancestor
101429475|NCT02914678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101429476|NCT02914678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101429477|NCT02914678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101429478|NCT02914678|Anesthetics, General|anesthetics, general|mesh-ancestor
101429479|NCT02914678|Anesthetics|anesthetics|mesh-ancestor
101429480|NCT00405977|Magnesium Sulfate|magnesium sulfate|mesh-list
101429481|NCT00405977|Analgesics|analgesics|mesh-ancestor
101429482|NCT00405977|Sensory System Agents|sensory system agents|mesh-ancestor
101558546|NCT00997438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558547|NCT00997438|Vitamin B Complex|vitamin b complex|mesh-ancestor
101558548|NCT00997438|Vitamins|vitamins|mesh-ancestor
101558549|NCT00997438|Micronutrients|micronutrients|mesh-ancestor
101558550|NCT00997126|Alfentanil|alfentanil|mesh-list
101558551|NCT00997126|Propofol|propofol|mesh-list
101558552|NCT00997126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101628320|NCT00720109|Dexamethasone acetate|dexamethasone acetate|mesh-list
101429483|NCT00405977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101429484|NCT00405977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429485|NCT00405977|Anesthetics|anesthetics|mesh-ancestor
101429486|NCT00405977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101429487|NCT00405977|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101429489|NCT00405977|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101429490|NCT00405977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101429491|NCT00405977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429492|NCT00405977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101429493|NCT00405977|Tocolytic Agents|tocolytic agents|mesh-ancestor
101429494|NCT00405977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101429495|NCT00150020|Mycophenolic Acid|mycophenolic acid|mesh-list
101429496|NCT00150020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101429497|NCT00150020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101429498|NCT00150020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101462720|NCT00177307|Antimetabolites|antimetabolites|mesh-ancestor
101429499|NCT00150020|Antitubercular Agents|antitubercular agents|mesh-ancestor
101429500|NCT00150020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101429501|NCT00150020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101429502|NCT00150020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101429503|NCT00150020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429504|NCT02914015|Morphine|morphine|mesh-list
101429509|NCT02914015|Narcotics|narcotics|mesh-ancestor
101429510|NCT02914015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101429511|NCT02914015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429512|NCT02914015|Analgesics|analgesics|mesh-ancestor
101429513|NCT02914015|Sensory System Agents|sensory system agents|mesh-ancestor
101429514|NCT02914015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101429516|NCT00171093|Simvastatin|simvastatin|mesh-list
101429517|NCT00171093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101429518|NCT00171093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101429519|NCT00171093|Antimetabolites|antimetabolites|mesh-ancestor
101429520|NCT00171093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429521|NCT00171093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101429522|NCT00171093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101429523|NCT00171093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101429524|NCT00171093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101429525|NCT00171093|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101307098|NCT02029599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307099|NCT02029599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101307100|NCT02029599|Dermatologic Agents|dermatologic agents|mesh-ancestor
101307101|NCT02029599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101307102|NCT02029599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101307103|NCT02029599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101429526|NCT00171093|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101429527|NCT02914054|Dexamethasone|dexamethasone|mesh-list
101429528|NCT02914054|Prednisone|prednisone|mesh-list
101429529|NCT02914054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101429533|NCT02914054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429535|NCT02914054|Glucocorticoids|glucocorticoids|mesh-ancestor
101429536|NCT02914054|Hormones|hormones|mesh-ancestor
101429537|NCT02914054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101429538|NCT02914054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101429539|NCT02914054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101429540|NCT00150059|Pimecrolimus|pimecrolimus|mesh-list
101429541|NCT00150059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101429542|NCT00150059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101429543|NCT00150059|Analgesics|analgesics|mesh-ancestor
101429544|NCT00150059|Sensory System Agents|sensory system agents|mesh-ancestor
101429545|NCT00150059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101558553|NCT00997126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101558554|NCT00997126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558555|NCT00997126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101558556|NCT00997126|Anesthetics, General|anesthetics, general|mesh-ancestor
101558558|NCT00997126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101429546|NCT00150059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429547|NCT00150059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101429548|NCT00150059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101429549|NCT00150059|Dermatologic Agents|dermatologic agents|mesh-ancestor
101429550|NCT00150059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101429551|NCT00150059|Immunologic Factors|immunologic factors|mesh-ancestor
101429552|NCT00150059|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101429553|NCT00150059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101429554|NCT00150059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429555|NCT00171132|Atenolol|atenolol|mesh-list
101429556|NCT00171132|Valsartan|valsartan|mesh-list
101429557|NCT00171132|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101429558|NCT00171132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101429559|NCT00171132|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101429560|NCT00171132|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101429561|NCT00171132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429562|NCT00171132|Diuretics|diuretics|mesh-ancestor
101429563|NCT00171132|Natriuretic Agents|natriuretic agents|mesh-ancestor
101429564|NCT00171132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429565|NCT00171132|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101429566|NCT00171132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101429567|NCT00171132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101429568|NCT00171132|Sympatholytics|sympatholytics|mesh-ancestor
101429569|NCT00171132|Autonomic Agents|autonomic agents|mesh-ancestor
101429570|NCT00171132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101429571|NCT00171132|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101429572|NCT00171132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101429573|NCT00171132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101429574|NCT00171132|Adrenergic Agents|adrenergic agents|mesh-ancestor
101429578|NCT02913859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101429579|NCT02913859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429581|NCT00150137|Antithyroid Agents|antithyroid agents|mesh-ancestor
101429582|NCT00150137|Hormone Antagonists|hormone antagonists|mesh-ancestor
101429583|NCT00150137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101429584|NCT00150137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429585|NCT00150215|Olanzapine|olanzapine|mesh-list
101429586|NCT00150215|Antiemetics|antiemetics|mesh-ancestor
101429587|NCT00150215|Autonomic Agents|autonomic agents|mesh-ancestor
101429588|NCT00150215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101429589|NCT00150215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307104|NCT02029599|Immunologic Factors|immunologic factors|mesh-ancestor
101307105|NCT02029599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101307106|NCT02029599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101429590|NCT00150215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101429591|NCT00150215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101429592|NCT00150215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101429593|NCT00150215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101429594|NCT00150215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101429595|NCT00150215|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101429596|NCT00150215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101429597|NCT00150215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101429605|NCT00171171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429606|NCT02913430|Tamoxifen|tamoxifen|mesh-list
101429607|NCT02913430|Fulvestrant|fulvestrant|mesh-list
101429608|NCT02913430|Palbociclib|palbociclib|mesh-list
101429609|NCT02913430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101429610|NCT02913430|Hormone Antagonists|hormone antagonists|mesh-ancestor
101429611|NCT02913430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101558559|NCT00997126|Narcotics|narcotics|mesh-ancestor
101558560|NCT00997126|Analgesics|analgesics|mesh-ancestor
101558561|NCT00997126|Sensory System Agents|sensory system agents|mesh-ancestor
101558562|NCT00997126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101558563|NCT01000636|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
101558564|NCT01000636|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101558565|NCT01000636|Dermatologic Agents|dermatologic agents|mesh-ancestor
101558566|NCT04433494|Tamoxifen|tamoxifen|mesh-list
101558567|NCT04433494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101558568|NCT04433494|Hormone Antagonists|hormone antagonists|mesh-ancestor
101628321|NCT00720109|Prednisone|prednisone|mesh-list
101628322|NCT00720109|Methylprednisolone|methylprednisolone|mesh-list
101429612|NCT02913430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429613|NCT02913430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101429614|NCT02913430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101429615|NCT02913430|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101429616|NCT02913430|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101429617|NCT02913430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101429618|NCT02913430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101429619|NCT02913430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101429620|NCT02913430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101429621|NCT02913430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429622|NCT02913469|Morphine|morphine|mesh-list
101429623|NCT02913469|Metoclopramide|metoclopramide|mesh-list
101429624|NCT02913469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101429625|NCT02913469|Narcotics|narcotics|mesh-ancestor
101429626|NCT02913469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101429627|NCT02913469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429628|NCT02913469|Analgesics|analgesics|mesh-ancestor
101429629|NCT02913469|Sensory System Agents|sensory system agents|mesh-ancestor
101429630|NCT02913469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101429631|NCT02913469|Antiemetics|antiemetics|mesh-ancestor
101429632|NCT02913469|Autonomic Agents|autonomic agents|mesh-ancestor
101429633|NCT02913469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101429634|NCT02913469|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101429635|NCT02913469|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101429636|NCT02913469|Dopamine Agents|dopamine agents|mesh-ancestor
101429637|NCT02913469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101429638|NCT02913469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429639|NCT00150254|Varenicline|varenicline|mesh-list
101429640|NCT00150254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101429641|NCT00150254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101429642|NCT00150254|Cholinergic Agents|cholinergic agents|mesh-ancestor
101429643|NCT00150254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101429646|NCT02913508|Vedolizumab|vedolizumab|mesh-list
101429647|NCT02913508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101429648|NCT02913157|Hydroxychloroquine|hydroxychloroquine|mesh-list
101429649|NCT02913157|Antimalarials|antimalarials|mesh-ancestor
101429650|NCT02913157|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101429651|NCT02913157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101429652|NCT02913157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101429653|NCT02913157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101429654|NCT02913157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429655|NCT02913157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101429656|NCT00150293|Pregabalin|pregabalin|mesh-list
101429657|NCT00150293|Analgesics|analgesics|mesh-ancestor
101429658|NCT00150293|Sensory System Agents|sensory system agents|mesh-ancestor
101429659|NCT00150293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101307107|NCT02029599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101307108|NCT02029599|Analgesics|analgesics|mesh-ancestor
101307109|NCT02029599|Sensory System Agents|sensory system agents|mesh-ancestor
101307110|NCT02029599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101307112|NCT02029612|Nicotine|nicotine|mesh-list
101429660|NCT00150293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429661|NCT00150293|Anticonvulsants|anticonvulsants|mesh-ancestor
101429662|NCT00150293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101558569|NCT04433494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101558570|NCT04433494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558571|NCT04433494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101558572|NCT04433494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101558573|NCT04433494|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101558574|NCT04433494|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101558575|NCT04433494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101462757|NCT00176605|Etoposide|etoposide|mesh-list
101429663|NCT00150293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101429685|NCT00150332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101429686|NCT00150332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101429687|NCT00150332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101429688|NCT00150332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101429689|NCT00150332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429690|NCT00150371|Atorvastatin|atorvastatin|mesh-list
101429691|NCT00150371|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101429692|NCT00150371|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101429693|NCT00150371|Antimetabolites|antimetabolites|mesh-ancestor
101429694|NCT00150371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429695|NCT00150371|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101429696|NCT00150371|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101429697|NCT00150371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101429698|NCT02912494|Darbepoetin alfa|darbepoetin alfa|mesh-list
101429699|NCT02912494|Hematinics|hematinics|mesh-ancestor
101429700|NCT00150410|Insulin|insulin|mesh-list
101429701|NCT00150410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101429702|NCT00150410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429703|NCT00171288|Ezetimibe|ezetimibe|mesh-list
101429704|NCT00171288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101429705|NCT00171288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101429706|NCT00171288|Antimetabolites|antimetabolites|mesh-ancestor
101429707|NCT00171288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429708|NCT00171288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101429709|NCT00150449|Pregabalin|pregabalin|mesh-list
101429711|NCT00150449|Sensory System Agents|sensory system agents|mesh-ancestor
101429712|NCT00150449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101429713|NCT00150449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429714|NCT00150449|Anticonvulsants|anticonvulsants|mesh-ancestor
101429715|NCT00150449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101429716|NCT00150449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101429721|NCT00150449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101429722|NCT00150449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101429727|NCT02912182|Prednisolone acetate|prednisolone acetate|mesh-list
101429728|NCT02912182|Betamethasone|betamethasone|mesh-list
101307113|NCT02029612|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101307114|NCT02029612|Autonomic Agents|autonomic agents|mesh-ancestor
101307115|NCT02029612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101307116|NCT02029612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429729|NCT02912182|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101429730|NCT02912182|Prednisolone phosphate|prednisolone phosphate|mesh-list
101429731|NCT02912182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101429732|NCT02912182|Glucocorticoids|glucocorticoids|mesh-ancestor
101429734|NCT02912182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101429735|NCT02912182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429736|NCT02912182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101429737|NCT02912182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101429738|NCT02912182|Antiemetics|antiemetics|mesh-ancestor
101429739|NCT02912182|Autonomic Agents|autonomic agents|mesh-ancestor
101429740|NCT02912182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101429741|NCT02912182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101429742|NCT02912182|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101429743|NCT02912182|Protective Agents|protective agents|mesh-ancestor
101429744|NCT02912182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101429745|NCT02912182|Respiratory System Agents|respiratory system agents|mesh-ancestor
101429746|NCT02912026|Olorofim|olorofim|mesh-list
101429747|NCT02912026|Antifungal Agents|antifungal agents|mesh-ancestor
101558576|NCT01000480|Pemetrexed|pemetrexed|mesh-list
101558577|NCT01000480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101558578|NCT01000480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101558579|NCT01000480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558580|NCT01000480|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101558581|NCT01000480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101558582|NCT02862691|Acetaminophen|acetaminophen|mesh-list
101558583|NCT02862691|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
101558584|NCT02862691|Oxycodone|oxycodone|mesh-list
101558585|NCT02862691|Analgesics|analgesics|mesh-list
101558586|NCT02862691|Bupivacaine|bupivacaine|mesh-list
101558587|NCT02862691|Anesthetics, Local|anesthetics, local|mesh-list
101558588|NCT02862691|Anesthetics|anesthetics|mesh-list
101407013|NCT03273322|Rivaroxaban|rivaroxaban|mesh-list
101429748|NCT02912026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101429749|NCT02911870|Moxifloxacin|moxifloxacin|mesh-list
101429750|NCT02911870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101429751|NCT02911870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101429752|NCT02911870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101429753|NCT02911870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101429754|NCT02911870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101429755|NCT02911870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429756|NCT02911870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101429757|NCT02843230|Bevacizumab|bevacizumab|mesh-list
101429758|NCT02843230|Temozolomide|temozolomide|mesh-list
101429759|NCT02843230|Lomustine|lomustine|mesh-list
101429760|NCT02843230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101429761|NCT02843230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101429762|NCT02843230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101429763|NCT02843230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101429764|NCT02843230|Growth Substances|growth substances|mesh-ancestor
101429765|NCT02843230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429766|NCT02843230|Growth Inhibitors|growth inhibitors|mesh-ancestor
101429767|NCT02843230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101429768|NCT02843230|Alkylating Agents|alkylating agents|mesh-ancestor
101429769|NCT02843230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429770|NCT02712814|Estrogens|estrogens|mesh-list
101429771|NCT02712814|Hormones|hormones|mesh-ancestor
101429772|NCT02712814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101429773|NCT02712814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429774|NCT00150527|Dexamethasone|dexamethasone|mesh-list
101429775|NCT00150527|Citalopram|citalopram|mesh-list
101429776|NCT00150527|Escitalopram|escitalopram|mesh-list
101429777|NCT00150527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101429778|NCT00150527|Antiemetics|antiemetics|mesh-ancestor
101429779|NCT00150527|Autonomic Agents|autonomic agents|mesh-ancestor
101429780|NCT00150527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101429781|NCT00150527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429782|NCT00150527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101429783|NCT00150527|Glucocorticoids|glucocorticoids|mesh-ancestor
101429784|NCT00150527|Hormones|hormones|mesh-ancestor
101429785|NCT00150527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101429786|NCT00150527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101429790|NCT00150527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101429791|NCT00150527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429793|NCT00150527|Serotonin Agents|serotonin agents|mesh-ancestor
101429798|NCT00171327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101429799|NCT00171327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101307117|NCT02029612|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101307118|NCT02029612|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101307119|NCT02029612|Cholinergic Agents|cholinergic agents|mesh-ancestor
101558589|NCT02862691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101558590|NCT02862691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558591|NCT02862691|Sensory System Agents|sensory system agents|mesh-ancestor
101558592|NCT02862691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101558593|NCT02862691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101558594|NCT02862691|Antipyretics|antipyretics|mesh-ancestor
101558595|NCT02862691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101558596|NCT02862691|Narcotics|narcotics|mesh-ancestor
101558597|NCT02862691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101558598|NCT02862691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101558599|NCT02862691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101558600|NCT00965341|Methyltestosterone|methyltestosterone|mesh-list
101558601|NCT00965341|Testosterone|testosterone|mesh-list
101558602|NCT00965341|Testosterone undecanoate|testosterone undecanoate|mesh-list
101558603|NCT00965341|Testosterone enanthate|testosterone enanthate|mesh-list
101407026|NCT04702204|Denosumab|denosumab|mesh-list
101307120|NCT02029612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101429800|NCT00171327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101429801|NCT00171327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429803|NCT02911597|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101429804|NCT02911597|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101429805|NCT02911597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429806|NCT02911597|Sensory System Agents|sensory system agents|mesh-ancestor
101429807|NCT02911597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101429808|NCT02911480|Oxytocin|oxytocin|mesh-list
101429809|NCT02911480|Oxytocics|oxytocics|mesh-ancestor
101429810|NCT02911480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101429811|NCT02911480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429812|NCT00171366|Amlodipine|amlodipine|mesh-list
101429813|NCT00171366|Benazepril|benazepril|mesh-list
101429814|NCT00171366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101429815|NCT00171366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101429816|NCT00171366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101429817|NCT00171366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429818|NCT00171366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101429819|NCT00171366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429820|NCT00171366|Vasodilator Agents|vasodilator agents|mesh-ancestor
101429821|NCT00171366|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101429822|NCT00171366|Protease Inhibitors|protease inhibitors|mesh-ancestor
101429823|NCT00171366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101429824|NCT00150605|Carbamazepine|carbamazepine|mesh-list
101429825|NCT00150605|Anticonvulsants|anticonvulsants|mesh-ancestor
101429826|NCT00150605|Antimanic Agents|antimanic agents|mesh-ancestor
101429827|NCT00150605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101429828|NCT00150605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101429829|NCT00150605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429830|NCT00150605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101429831|NCT00150605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101429832|NCT00150605|Analgesics|analgesics|mesh-ancestor
101429833|NCT00150605|Sensory System Agents|sensory system agents|mesh-ancestor
101429834|NCT00150605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101429835|NCT00150605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101429836|NCT00150605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101429837|NCT00150605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429838|NCT00150605|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101429839|NCT00150605|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101429840|NCT02910778|Ticagrelor|ticagrelor|mesh-list
101429841|NCT02910778|Atorvastatin|atorvastatin|mesh-list
101429842|NCT02910778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101558604|NCT00965341|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101558606|NCT00965341|Hormones|hormones|mesh-ancestor
101558607|NCT00965341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101558608|NCT00965341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558609|NCT00965341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101558610|NCT00965341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101429843|NCT02910778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101429844|NCT02910778|Antimetabolites|antimetabolites|mesh-ancestor
101429845|NCT02910778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429846|NCT02910778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101429847|NCT02910778|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101429848|NCT02910778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101429849|NCT02910778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101429850|NCT02910778|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101429851|NCT02910778|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101429852|NCT02910778|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101429853|NCT02910778|Purinergic Agents|purinergic agents|mesh-ancestor
101429854|NCT02910778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101429855|NCT02910778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429875|NCT00150722|Antimetabolites|antimetabolites|mesh-ancestor
101429876|NCT00150722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429881|NCT00150761|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101429882|NCT00150761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101307121|NCT02029612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307122|NCT02029625|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101307123|NCT02029625|Ezetimibe|ezetimibe|mesh-list
101307124|NCT02029625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101429883|NCT00150761|Histamine Antagonists|histamine antagonists|mesh-ancestor
101429884|NCT00150761|Histamine Agents|histamine agents|mesh-ancestor
101429885|NCT00150761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101429886|NCT00150761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429887|NCT00150761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429888|NCT00171483|Tegaserod|tegaserod|mesh-list
101429889|NCT00171483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101429890|NCT00171483|Serotonin Agents|serotonin agents|mesh-ancestor
101429891|NCT00171483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101429892|NCT00171483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429893|NCT00171483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429894|NCT03777904|Iron|iron|mesh-list
101429895|NCT03777904|Trace Elements|trace elements|mesh-ancestor
101429896|NCT03777904|Micronutrients|micronutrients|mesh-ancestor
101429897|NCT03777904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429898|NCT00150839|Mirtazapine|mirtazapine|mesh-list
101429899|NCT00150839|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101429900|NCT00150839|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101429901|NCT00150839|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101429902|NCT00150839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101429903|NCT00150839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429904|NCT00150839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101429905|NCT00150839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429906|NCT00150839|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101429907|NCT00150839|Antidepressive Agents|antidepressive agents|mesh-ancestor
101429908|NCT00150839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101429909|NCT00150839|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101429925|NCT03782740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429926|NCT03782740|Protective Agents|protective agents|mesh-ancestor
101429927|NCT03782740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429928|NCT03782740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101429929|NCT00532168|Ritonavir|ritonavir|mesh-list
101429930|NCT00532168|Lopinavir|lopinavir|mesh-list
101429931|NCT00532168|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101429932|NCT00532168|Tenofovir|tenofovir|mesh-list
101558611|NCT00965341|Anabolic Agents|anabolic agents|mesh-ancestor
101558612|NCT01175811|Insulin|insulin|mesh-list
101558613|NCT01175811|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101558614|NCT01175811|Insulin Glargine|insulin glargine|mesh-list
101558615|NCT01175811|Insulin Lispro|insulin lispro|mesh-list
101558616|NCT01175811|Insulin, Isophane|insulin, isophane|mesh-list
101558617|NCT01175811|Biphasic Insulins|biphasic insulins|mesh-list
101558618|NCT01175811|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
101558619|NCT01175811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101429933|NCT00532168|Emtricitabine|emtricitabine|mesh-list
101429934|NCT00532168|Efavirenz|efavirenz|mesh-list
101429935|NCT00532168|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101429936|NCT00532168|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101429937|NCT00532168|Protease Inhibitors|protease inhibitors|mesh-ancestor
101429938|NCT00532168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101429939|NCT00532168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429940|NCT00532168|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101429941|NCT00532168|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101429942|NCT00532168|Antiviral Agents|antiviral agents|mesh-ancestor
101429943|NCT00532168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101429944|NCT00532168|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101429945|NCT00532168|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101429946|NCT00532168|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101429947|NCT00532168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101429948|NCT00532168|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101429949|NCT00532168|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101429950|NCT00532168|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101429951|NCT00532168|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101429952|NCT00532168|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101429953|NCT00532207|Teriparatide|teriparatide|mesh-list
101429954|NCT00532207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101429960|NCT04723836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429961|NCT04723836|Vitamin B Complex|vitamin b complex|mesh-ancestor
101307126|NCT02029625|Antimetabolites|antimetabolites|mesh-ancestor
101307127|NCT02029625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307128|NCT02029625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101307129|NCT02029625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101307130|NCT02029625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101307131|NCT02029794|Acetic Acid|acetic acid|mesh-list
101307132|NCT02029794|Retinol acetate|retinol acetate|mesh-list
101307133|NCT02029794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101307134|NCT02029794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101307135|NCT02029794|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101429962|NCT04723836|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101429963|NCT04723836|Dermatologic Agents|dermatologic agents|mesh-ancestor
101429964|NCT00150995|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
101429965|NCT00150995|Chelating Agents|chelating agents|mesh-ancestor
101429966|NCT00150995|Sequestering Agents|sequestering agents|mesh-ancestor
101429967|NCT00150995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429968|NCT00150995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101429971|NCT00150995|Growth Substances|growth substances|mesh-ancestor
101429972|NCT00150995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429973|NCT00150995|Growth Inhibitors|growth inhibitors|mesh-ancestor
101429974|NCT00150995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101429975|NCT00532246|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101429976|NCT00532246|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101429977|NCT00532246|Hormone Antagonists|hormone antagonists|mesh-ancestor
101429978|NCT00532246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101429979|NCT00532246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429980|NCT00532246|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101429981|NCT00532246|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101429982|NCT00532246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101429983|NCT00532285|Paclitaxel|paclitaxel|mesh-list
101429984|NCT00532285|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101558620|NCT01175811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558622|NCT00965263|Anesthetics, Local|anesthetics, local|mesh-ancestor
101558623|NCT00965263|Anesthetics|anesthetics|mesh-ancestor
101558624|NCT00965263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101558625|NCT00965263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558626|NCT00965263|Sensory System Agents|sensory system agents|mesh-ancestor
101558627|NCT00965263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101558628|NCT00965263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101558629|NCT00965263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101558630|NCT00965263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101407055|NCT00142545|Dopamine Agonists|dopamine agonists|mesh-ancestor
101429985|NCT00532285|Gemcitabine|gemcitabine|mesh-list
101429986|NCT00532285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101429987|NCT00532285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101429988|NCT00532285|Tubulin Modulators|tubulin modulators|mesh-ancestor
101429989|NCT00532285|Antimitotic Agents|antimitotic agents|mesh-ancestor
101429990|NCT00532285|Mitosis Modulators|mitosis modulators|mesh-ancestor
101429991|NCT00532285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429992|NCT00532285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101429993|NCT00532285|Antimetabolites|antimetabolites|mesh-ancestor
101429994|NCT00151034|Paclitaxel|paclitaxel|mesh-list
101429995|NCT00151034|Carboplatin|carboplatin|mesh-list
101429996|NCT00151034|Gemcitabine|gemcitabine|mesh-list
101429997|NCT00151034|Trastuzumab|trastuzumab|mesh-list
101429998|NCT00151034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101429999|NCT00151034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101430000|NCT00151034|Tubulin Modulators|tubulin modulators|mesh-ancestor
101430001|NCT00151034|Antimitotic Agents|antimitotic agents|mesh-ancestor
101430003|NCT00151034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430004|NCT00151034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101430005|NCT00151034|Antimetabolites|antimetabolites|mesh-ancestor
101430006|NCT00151034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101430007|NCT02817451|Vaccines|vaccines|mesh-list
101430008|NCT02817451|Immunologic Factors|immunologic factors|mesh-ancestor
101462996|NCT00265824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101430009|NCT02817451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430010|NCT00171522|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101430011|NCT00171522|Tegaserod|tegaserod|mesh-list
101430012|NCT00171522|Laxatives|laxatives|mesh-ancestor
101430013|NCT00171522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101430014|NCT00171522|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101430015|NCT00171522|Serotonin Agents|serotonin agents|mesh-ancestor
101430016|NCT00171522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101307136|NCT02029794|Immunologic Factors|immunologic factors|mesh-ancestor
101359704|NCT00073164|Olanzapine|olanzapine|mesh-list
101307137|NCT02029794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430021|NCT02716012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101430023|NCT02716012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430024|NCT00151073|Zoledronic Acid|zoledronic acid|mesh-list
101430025|NCT00151073|Docetaxel|docetaxel|mesh-list
101430026|NCT00151073|Estramustine|estramustine|mesh-list
101430027|NCT00151073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101430028|NCT00151073|Tubulin Modulators|tubulin modulators|mesh-ancestor
101430029|NCT00151073|Antimitotic Agents|antimitotic agents|mesh-ancestor
101430030|NCT00151073|Mitosis Modulators|mitosis modulators|mesh-ancestor
101430031|NCT00151073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463202|NCT00266058|Antimalarials|antimalarials|mesh-ancestor
101430032|NCT00151073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101430033|NCT00151073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430034|NCT00151073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101430035|NCT00151073|Alkylating Agents|alkylating agents|mesh-ancestor
101430036|NCT00151073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101430037|NCT00171561|Valsartan|valsartan|mesh-list
101430038|NCT00171561|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101558631|NCT00965263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101558632|NCT00965263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558633|NCT00965263|Dopamine Agents|dopamine agents|mesh-ancestor
101558634|NCT00965263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101558636|NCT02886195|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101558637|NCT02886195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101558638|NCT02886195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101558639|NCT02886195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558640|NCT02886195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101430039|NCT00171561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101430040|NCT00171561|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101430049|NCT00151112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101430050|NCT00151112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430051|NCT00532324|Chlorhexidine|chlorhexidine|mesh-list
101430052|NCT00532324|Mupirocin|mupirocin|mesh-list
101430053|NCT00532324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101430054|NCT00532324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101430055|NCT00532324|Disinfectants|disinfectants|mesh-ancestor
101430056|NCT00532324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101430057|NCT00532324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101463478|NCT00477490|Hemostatics|hemostatics|mesh-ancestor
101430058|NCT00532324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101430059|NCT00532324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430060|NCT00171600|Valsartan|valsartan|mesh-list
101430061|NCT00171600|Lisinopril|lisinopril|mesh-list
101430062|NCT00171600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101430063|NCT00171600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101430064|NCT00171600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101430065|NCT00171600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430066|NCT00171600|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101430067|NCT00171600|Protease Inhibitors|protease inhibitors|mesh-ancestor
101430068|NCT00171600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101430069|NCT00171600|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101430070|NCT00171600|Protective Agents|protective agents|mesh-ancestor
101430071|NCT00171600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430072|NCT05467384|Amlodipine|amlodipine|mesh-list
101430073|NCT05467384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101430074|NCT05467384|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101430075|NCT05467384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101430076|NCT05467384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430077|NCT05467384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101463755|NCT04557475|Antipyretics|antipyretics|mesh-ancestor
101430078|NCT05467384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430079|NCT05467384|Vasodilator Agents|vasodilator agents|mesh-ancestor
101430080|NCT05467189|Paclitaxel|paclitaxel|mesh-list
101430081|NCT05467189|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101430082|NCT05467189|Busulfan|busulfan|mesh-list
101430083|NCT05467189|Lapatinib|lapatinib|mesh-list
101430084|NCT05467189|Afatinib|afatinib|mesh-list
101430085|NCT05467189|Crizotinib|crizotinib|mesh-list
101430086|NCT05467189|Ceritinib|ceritinib|mesh-list
101430087|NCT05467189|Antineoplastic Agents|antineoplastic agents|mesh-list
101430088|NCT05467189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101430089|NCT05467189|Tubulin Modulators|tubulin modulators|mesh-ancestor
101430090|NCT05467189|Antimitotic Agents|antimitotic agents|mesh-ancestor
101430091|NCT05467189|Mitosis Modulators|mitosis modulators|mesh-ancestor
101307139|NCT02029794|Protective Agents|protective agents|mesh-ancestor
101430094|NCT05467189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101430095|NCT05467189|Immunologic Factors|immunologic factors|mesh-ancestor
101430096|NCT05467189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430097|NCT05467189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101430098|NCT05467189|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101430099|NCT05467189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101430100|NCT05467189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101430101|NCT00171639|Zoledronic Acid|zoledronic acid|mesh-list
101558641|NCT02886195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101558642|NCT02886195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101558643|NCT02862769|Lidocaine|lidocaine|mesh-list
101558644|NCT02862769|Anesthetics, Local|anesthetics, local|mesh-ancestor
101558645|NCT02862769|Anesthetics|anesthetics|mesh-ancestor
101558646|NCT02862769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101558647|NCT02862769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558648|NCT02862769|Sensory System Agents|sensory system agents|mesh-ancestor
101430102|NCT00171639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101430103|NCT00171639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430104|NCT05466604|Dexamethasone|dexamethasone|mesh-list
101430105|NCT05466604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101430106|NCT05466604|Antiemetics|antiemetics|mesh-ancestor
101430109|NCT05466604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430110|NCT05466604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101430111|NCT05466604|Glucocorticoids|glucocorticoids|mesh-ancestor
101430112|NCT05466604|Hormones|hormones|mesh-ancestor
101430113|NCT05466604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101430114|NCT05466604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101430115|NCT05466604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101430116|NCT04723875|Paclitaxel|paclitaxel|mesh-list
101430117|NCT04723875|Docetaxel|docetaxel|mesh-list
101430118|NCT04723875|Carboplatin|carboplatin|mesh-list
101464374|NCT04552093|Floxuridine|floxuridine|mesh-list
101430119|NCT04723875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101430120|NCT04723875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101430121|NCT04723875|Tubulin Modulators|tubulin modulators|mesh-ancestor
101430122|NCT04723875|Antimitotic Agents|antimitotic agents|mesh-ancestor
101430123|NCT04723875|Mitosis Modulators|mitosis modulators|mesh-ancestor
101464441|NCT02211118|Adrenergic Agents|adrenergic agents|mesh-ancestor
101430124|NCT04723875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430125|NCT05466019|Leucovorin|leucovorin|mesh-list
101430126|NCT05466019|Docetaxel|docetaxel|mesh-list
101430127|NCT05466019|Oxaliplatin|oxaliplatin|mesh-list
101464507|NCT04561960|Fluorides|fluorides|mesh-list
101430128|NCT05466019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101430129|NCT05466019|Tubulin Modulators|tubulin modulators|mesh-ancestor
101430130|NCT05466019|Antimitotic Agents|antimitotic agents|mesh-ancestor
101430131|NCT05466019|Mitosis Modulators|mitosis modulators|mesh-ancestor
101430132|NCT05466019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430133|NCT05466019|Antidotes|antidotes|mesh-ancestor
101430134|NCT05466019|Protective Agents|protective agents|mesh-ancestor
101430135|NCT05466019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430136|NCT05466019|Vitamin B Complex|vitamin b complex|mesh-ancestor
101430137|NCT05466019|Vitamins|vitamins|mesh-ancestor
101430138|NCT05466019|Micronutrients|micronutrients|mesh-ancestor
101430139|NCT05465902|Vaccines|vaccines|mesh-list
101430140|NCT05465902|Immunologic Factors|immunologic factors|mesh-ancestor
101430141|NCT05465902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430142|NCT00151346|Fentanyl|fentanyl|mesh-list
101430143|NCT00151346|Bupivacaine|bupivacaine|mesh-list
101430144|NCT00151346|Anesthetics, Local|anesthetics, local|mesh-ancestor
101430145|NCT00151346|Anesthetics|anesthetics|mesh-ancestor
101359891|NCT00210925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101430146|NCT00151346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101430147|NCT00151346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430148|NCT00151346|Sensory System Agents|sensory system agents|mesh-ancestor
101359905|NCT00211315|Growth Substances|growth substances|mesh-ancestor
101430149|NCT00151346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101430150|NCT00151346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101430151|NCT00151346|Narcotics|narcotics|mesh-ancestor
101430153|NCT00151346|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101430154|NCT00151346|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101430155|NCT00151346|Anesthetics, General|anesthetics, general|mesh-ancestor
101430156|NCT00164424|Acyclovir|acyclovir|mesh-list
101430157|NCT00164424|Antiviral Agents|antiviral agents|mesh-ancestor
101430158|NCT00164424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101430159|NCT00532519|Citalopram|citalopram|mesh-list
101430160|NCT00532519|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101430161|NCT00532519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101359928|NCT00211432|Anecortave|anecortave|mesh-list
101430162|NCT00532519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101430163|NCT00532519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430164|NCT00532519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101558649|NCT02862769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101558650|NCT02862769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101465049|NCT02212990|Acetaminophen|acetaminophen|mesh-list
101558651|NCT02862769|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101558652|NCT02862769|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101558653|NCT02862769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101558654|NCT02862769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558655|NCT00965185|Atorvastatin|atorvastatin|mesh-list
101558656|NCT00965185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101558657|NCT00965185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101558658|NCT00965185|Antimetabolites|antimetabolites|mesh-ancestor
101430167|NCT00532519|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101430168|NCT00532519|Antidepressive Agents|antidepressive agents|mesh-ancestor
101430170|NCT00171678|Diclofenac|diclofenac|mesh-list
101430171|NCT00171678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101465181|NCT00236054|Tiagabine|tiagabine|mesh-list
101430172|NCT00171678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101430173|NCT00171678|Analgesics|analgesics|mesh-ancestor
101430174|NCT00171678|Sensory System Agents|sensory system agents|mesh-ancestor
101430175|NCT00171678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101430176|NCT00171678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430177|NCT00171678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101430178|NCT00171678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101465329|NCT00236288|Bupropion|bupropion|mesh-list
101430179|NCT00171678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101430180|NCT00171678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101430186|NCT00151463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101430187|NCT00151463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101430188|NCT00151463|Urological Agents|urological agents|mesh-ancestor
101430189|NCT00171717|Cyclosporine|cyclosporine|mesh-list
101430190|NCT00171717|Cyclosporins|cyclosporins|mesh-list
101430191|NCT00171717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101430192|NCT00171717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430193|NCT00171717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101430194|NCT00171717|Immunologic Factors|immunologic factors|mesh-ancestor
101430195|NCT00171717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430196|NCT00171717|Antifungal Agents|antifungal agents|mesh-ancestor
101430197|NCT00171717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101465389|NCT00269217|Niacin|niacin|mesh-list
101430198|NCT00171717|Dermatologic Agents|dermatologic agents|mesh-ancestor
101430199|NCT00171717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101430200|NCT00171717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101430201|NCT00151502|Atorvastatin|atorvastatin|mesh-list
101430202|NCT00151502|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101430203|NCT00151502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101430204|NCT00151502|Antimetabolites|antimetabolites|mesh-ancestor
101430205|NCT00151502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430206|NCT00151502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101430207|NCT00151502|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101430208|NCT00151502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101430209|NCT00164463|Moxifloxacin|moxifloxacin|mesh-list
101430210|NCT00164463|Isoniazid|isoniazid|mesh-list
101430211|NCT00164463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101430212|NCT00164463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101430213|NCT00164463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101430214|NCT00164463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101430215|NCT00164463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101430216|NCT00164463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430217|NCT00164463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101430218|NCT00164463|Antitubercular Agents|antitubercular agents|mesh-ancestor
101430219|NCT00164463|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101430220|NCT00164463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101430221|NCT00164463|Antimetabolites|antimetabolites|mesh-ancestor
101430222|NCT00164463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101430223|NCT00171756|Atenolol|atenolol|mesh-list
101430224|NCT00171756|Valsartan|valsartan|mesh-list
101430225|NCT00171756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101430226|NCT00171756|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101558659|NCT00965185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558661|NCT00965185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101558662|NCT00965185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101558663|NCT01174563|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101558664|NCT01174563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101430227|NCT00171756|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101430228|NCT00171756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465591|NCT04540627|Palivizumab|palivizumab|mesh-list
101430229|NCT00171756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101430230|NCT00171756|Sympatholytics|sympatholytics|mesh-ancestor
101430231|NCT00171756|Autonomic Agents|autonomic agents|mesh-ancestor
101430232|NCT00171756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101430233|NCT00171756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465632|NCT00236990|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
101465699|NCT00262275|Aspirin|aspirin|mesh-list
101430234|NCT00171756|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101430235|NCT00171756|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101430238|NCT00171756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101430239|NCT00171795|Rivastigmine|rivastigmine|mesh-list
101430240|NCT00171795|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101430241|NCT00171795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101430242|NCT00171795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430243|NCT00171795|Cholinergic Agents|cholinergic agents|mesh-ancestor
101430244|NCT00171795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101430245|NCT00171795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430246|NCT00171795|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101430247|NCT00171795|Protective Agents|protective agents|mesh-ancestor
101430248|NCT00151541|Dapsone|dapsone|mesh-list
101430253|NCT00151541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101430254|NCT00151541|Analgesics|analgesics|mesh-ancestor
101430255|NCT00151541|Sensory System Agents|sensory system agents|mesh-ancestor
101430256|NCT00151541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101430257|NCT00151541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430258|NCT00151541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101430259|NCT00151541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101430260|NCT00151541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101430261|NCT00151541|Antimalarials|antimalarials|mesh-ancestor
101430262|NCT00151541|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101430263|NCT00151541|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101430264|NCT00151541|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101430265|NCT00151541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101430266|NCT00151541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430267|NCT00151541|Leprostatic Agents|leprostatic agents|mesh-ancestor
101430268|NCT00151541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101430269|NCT00151580|Ribavirin|ribavirin|mesh-list
101430270|NCT00151580|Antimetabolites|antimetabolites|mesh-ancestor
101466121|NCT04536922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101430271|NCT00151580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430272|NCT00151580|Antiviral Agents|antiviral agents|mesh-ancestor
101430273|NCT00151580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101430274|NCT00171912|Imatinib Mesylate|imatinib mesylate|mesh-list
101430275|NCT00171912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101430276|NCT00171912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101430277|NCT00171912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101466347|NCT00262977|Sensory System Agents|sensory system agents|mesh-ancestor
101430278|NCT00171912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430279|NCT00151619|Amlodipine|amlodipine|mesh-list
101430280|NCT00151619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101430281|NCT00151619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101430282|NCT00151619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101430283|NCT00151619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430284|NCT00151619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101430285|NCT00151619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430286|NCT00151619|Vasodilator Agents|vasodilator agents|mesh-ancestor
101430287|NCT00532675|Lenalidomide|lenalidomide|mesh-list
101430288|NCT00532675|Panobinostat|panobinostat|mesh-list
101430289|NCT00532675|Immunologic Factors|immunologic factors|mesh-ancestor
101430290|NCT00532675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430291|NCT00532675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101430292|NCT00532675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101558665|NCT01174563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101558666|NCT01174563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101558667|NCT01174563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558668|NCT01298531|Etanercept|etanercept|mesh-list
101558669|NCT01298531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101558670|NCT01298531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101558671|NCT01298531|Analgesics|analgesics|mesh-ancestor
101466703|NCT05896462|Povidone|povidone|mesh-list
101430293|NCT00532675|Growth Substances|growth substances|mesh-ancestor
101430294|NCT00532675|Growth Inhibitors|growth inhibitors|mesh-ancestor
101430295|NCT00532675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101430296|NCT00532675|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101430297|NCT00532675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101466832|NCT05669547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430298|NCT00532675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430299|NCT05308030|Aspirin|aspirin|mesh-list
101430300|NCT05308030|Rivaroxaban|rivaroxaban|mesh-list
101430301|NCT05308030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101430302|NCT05308030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101430303|NCT05308030|Analgesics|analgesics|mesh-ancestor
101430304|NCT05308030|Sensory System Agents|sensory system agents|mesh-ancestor
101430305|NCT05308030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101307148|NCT02029898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101307149|NCT02029924|Insulin Lispro|insulin lispro|mesh-list
101307150|NCT02029924|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101430309|NCT05308030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101430310|NCT05308030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101430311|NCT05308030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430312|NCT05308030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101430313|NCT05308030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101430314|NCT05308030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101430315|NCT05308030|Antipyretics|antipyretics|mesh-ancestor
101430316|NCT05308030|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101430317|NCT05308030|Antithrombins|antithrombins|mesh-ancestor
101430318|NCT05308030|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101430319|NCT05308030|Protease Inhibitors|protease inhibitors|mesh-ancestor
101430321|NCT05293600|Acetazolamide|acetazolamide|mesh-list
101430322|NCT05293600|Eszopiclone|eszopiclone|mesh-list
101430323|NCT05293600|Trazodone|trazodone|mesh-list
101430324|NCT05293600|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101430325|NCT05293600|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101430326|NCT05293600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101430327|NCT05293600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101467176|NCT04381143|Antipyretics|antipyretics|mesh-ancestor
101430328|NCT05293600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467249|NCT04023331|Copper|copper|mesh-list
101430329|NCT05293600|Adrenergic Agents|adrenergic agents|mesh-ancestor
101430330|NCT05293600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101430331|NCT05293600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430332|NCT05293600|Anticonvulsants|anticonvulsants|mesh-ancestor
101430333|NCT05293600|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101430334|NCT05293600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101430335|NCT05293600|Diuretics|diuretics|mesh-ancestor
101430336|NCT05293600|Natriuretic Agents|natriuretic agents|mesh-ancestor
101430337|NCT05293600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101430338|NCT05293600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101430339|NCT05293600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101430340|NCT05293600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101430341|NCT05293600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101430342|NCT05293600|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101430343|NCT05293600|Serotonin Agents|serotonin agents|mesh-ancestor
101430344|NCT05293600|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101430345|NCT05293600|Antidepressive Agents|antidepressive agents|mesh-ancestor
101430346|NCT00151697|Insulin Aspart|insulin aspart|mesh-list
101430347|NCT00151697|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101430348|NCT00151697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101430349|NCT00151697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430350|NCT00532714|Capecitabine|capecitabine|mesh-list
101430351|NCT00532714|Irinotecan|irinotecan|mesh-list
101430352|NCT00532714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101558672|NCT01298531|Sensory System Agents|sensory system agents|mesh-ancestor
101558673|NCT01298531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101558674|NCT01298531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558675|NCT01298531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101558676|NCT01298531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101558677|NCT01298531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101558678|NCT01298531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101558679|NCT01298531|Immunologic Factors|immunologic factors|mesh-ancestor
101558680|NCT02862145|Dexamethasone|dexamethasone|mesh-list
101558681|NCT02862145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101407111|NCT00436657|Cisplatin|cisplatin|mesh-list
101430353|NCT00532714|Antimetabolites|antimetabolites|mesh-ancestor
101430354|NCT00532714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430355|NCT00532714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101430356|NCT00532714|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101430357|NCT00532714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101430358|NCT00532714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101430359|NCT00151736|Etodolac|etodolac|mesh-list
101430360|NCT00151736|Chlorambucil|chlorambucil|mesh-list
101430361|NCT00151736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101430362|NCT00151736|Alkylating Agents|alkylating agents|mesh-ancestor
101430363|NCT00151736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430364|NCT00151736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101430365|NCT00151736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101430366|NCT00151736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101430367|NCT00151736|Analgesics|analgesics|mesh-ancestor
101430368|NCT00151736|Sensory System Agents|sensory system agents|mesh-ancestor
101430369|NCT00151736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101430370|NCT00151736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430371|NCT00151736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101430372|NCT00151736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101430373|NCT00151736|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101430374|NCT00151736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101307156|NCT02029950|Etoposide|etoposide|mesh-list
101307157|NCT02029950|Podophyllotoxin|podophyllotoxin|mesh-list
101307158|NCT02029950|Daunorubicin|daunorubicin|mesh-list
101307159|NCT02029950|Idarubicin|idarubicin|mesh-list
101307160|NCT02029950|Etoposide phosphate|etoposide phosphate|mesh-list
101307161|NCT02029950|Pomalidomide|pomalidomide|mesh-list
101307162|NCT02029950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101430378|NCT00171990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101430379|NCT00171990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101430380|NCT00171990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101430381|NCT00171990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430382|NCT00406094|Montelukast|montelukast|mesh-list
101430383|NCT00406094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101430384|NCT00406094|Respiratory System Agents|respiratory system agents|mesh-ancestor
101430385|NCT00406094|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101430386|NCT00406094|Hormone Antagonists|hormone antagonists|mesh-ancestor
101430387|NCT00406094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101430388|NCT00406094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430389|NCT00406094|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101430390|NCT00406094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101487411|NCT00432588|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101430402|NCT00164736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101430403|NCT00164736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101430404|NCT00164736|Antiviral Agents|antiviral agents|mesh-ancestor
101430405|NCT00164736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101430406|NCT00164736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101430407|NCT00164736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101430408|NCT00164736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101430409|NCT00164736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101430410|NCT00164736|Antimetabolites|antimetabolites|mesh-ancestor
101558683|NCT02862145|Autonomic Agents|autonomic agents|mesh-ancestor
101558684|NCT02862145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101558685|NCT02862145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558686|NCT02862145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101558688|NCT02862145|Hormones|hormones|mesh-ancestor
101558689|NCT02862145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101534483|NCT04591743|Nicotine|nicotine|mesh-list
101430411|NCT00164736|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101430412|NCT00164736|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101430413|NCT00532909|Bevacizumab|bevacizumab|mesh-list
101430414|NCT00532909|Capecitabine|capecitabine|mesh-list
101430415|NCT00532909|Oxaliplatin|oxaliplatin|mesh-list
101430416|NCT00532909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101430417|NCT00532909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101430418|NCT00532909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101430419|NCT00532909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101430420|NCT00532909|Growth Substances|growth substances|mesh-ancestor
101430421|NCT00532909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430422|NCT00532909|Growth Inhibitors|growth inhibitors|mesh-ancestor
101430423|NCT00532909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101430424|NCT00532909|Antimetabolites|antimetabolites|mesh-ancestor
101430425|NCT00532909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430427|NCT00172068|Zoledronic Acid|zoledronic acid|mesh-list
101430428|NCT00172068|Calcium|calcium|mesh-list
101430429|NCT00172068|Vitamins|vitamins|mesh-ancestor
101430430|NCT00172068|Micronutrients|micronutrients|mesh-ancestor
101430431|NCT00172068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430432|NCT00172068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101430433|NCT00172068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101430434|NCT00151970|Methylphenidate|methylphenidate|mesh-list
101430435|NCT00151970|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101430436|NCT00151970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430437|NCT00151970|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101430438|NCT00151970|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101307163|NCT02029950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101307164|NCT02029950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101307165|NCT02029950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101307166|NCT02029950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101430446|NCT00152048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101430447|NCT00152048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101430448|NCT00152048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101430449|NCT00152048|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
101430450|NCT00152048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101430451|NCT00152048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430453|NCT04687111|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101430454|NCT04687111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101467663|NCT02217163|Antiemetics|antiemetics|mesh-ancestor
101430457|NCT04687111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430459|NCT00164775|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101430460|NCT00164775|Antidepressive Agents|antidepressive agents|mesh-ancestor
101430461|NCT00164775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101430462|NCT00164775|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101430463|NCT00164775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101430464|NCT00164775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101430465|NCT00164775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430466|NCT00164775|Adrenergic Agents|adrenergic agents|mesh-ancestor
101430467|NCT00164775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101430468|NCT00164775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430469|NCT00533026|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101430471|NCT00533026|Anticoagulants|anticoagulants|mesh-ancestor
101430472|NCT00533026|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101430473|NCT00533026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101430474|NCT00533026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101558690|NCT02862145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101558691|NCT02862145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101558692|NCT01174173|Ranolazine|ranolazine|mesh-list
101558693|NCT01174173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101558694|NCT01174173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101558695|NCT01174173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558696|NCT00964795|Aflibercept|aflibercept|mesh-list
101407129|NCT00437086|Bortezomib|bortezomib|mesh-list
101430475|NCT00533026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430476|NCT00533026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101430477|NCT00533026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430478|NCT00533026|Analgesics|analgesics|mesh-ancestor
101430479|NCT00533026|Sensory System Agents|sensory system agents|mesh-ancestor
101430480|NCT00533026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101430481|NCT00533026|Antidepressive Agents|antidepressive agents|mesh-ancestor
101430482|NCT00533026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101430483|NCT00533026|Dopamine Agents|dopamine agents|mesh-ancestor
101430484|NCT00152126|Melphalan|melphalan|mesh-list
101430485|NCT00152126|Busulfan|busulfan|mesh-list
101430486|NCT00152126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101430487|NCT00152126|Alkylating Agents|alkylating agents|mesh-ancestor
101430488|NCT00152126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430489|NCT00152126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101430490|NCT00152126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101430491|NCT00152126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101430492|NCT00152126|Immunologic Factors|immunologic factors|mesh-ancestor
101430493|NCT00152126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430494|NCT05039593|Chlorhexidine|chlorhexidine|mesh-list
101430495|NCT05039593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101430496|NCT05039593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101430497|NCT05039593|Disinfectants|disinfectants|mesh-ancestor
101430498|NCT00425451|Chlorhexidine|chlorhexidine|mesh-list
101430499|NCT00425451|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101430500|NCT00425451|Flurbiprofen|flurbiprofen|mesh-list
101430501|NCT00425451|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101430502|NCT00425451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101430503|NCT00425451|Disinfectants|disinfectants|mesh-ancestor
101430504|NCT00425451|Dermatologic Agents|dermatologic agents|mesh-ancestor
101430505|NCT00425451|Analgesics|analgesics|mesh-ancestor
101430506|NCT00425451|Sensory System Agents|sensory system agents|mesh-ancestor
101307167|NCT02029950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430508|NCT00425451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430509|NCT00425451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101430510|NCT00425451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101430511|NCT00425451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101430512|NCT00425451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101430513|NCT00425451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101430514|NCT00425451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101430515|NCT00425451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430516|NCT00152204|Pyrimethamine|pyrimethamine|mesh-list
101430517|NCT00152204|Sulfadoxine|sulfadoxine|mesh-list
101430518|NCT00152204|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101430519|NCT00152204|Antimalarials|antimalarials|mesh-ancestor
101430520|NCT00152204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101430521|NCT00152204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101430522|NCT00152204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101430523|NCT00152204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101430524|NCT00152204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101430526|NCT00152204|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101430527|NCT00533065|Donepezil|donepezil|mesh-list
101430528|NCT00533065|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101430529|NCT00533065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101430530|NCT00533065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430531|NCT00533065|Cholinergic Agents|cholinergic agents|mesh-ancestor
101430532|NCT00533065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101430533|NCT00533065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558697|NCT00964795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101558698|NCT00964795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101558699|NCT00964795|Growth Substances|growth substances|mesh-ancestor
101558700|NCT00964795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558701|NCT00964795|Growth Inhibitors|growth inhibitors|mesh-ancestor
101558702|NCT00964795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101558703|NCT01173471|Niacinamide|niacinamide|mesh-list
101558704|NCT01173471|Vitamin B Complex|vitamin b complex|mesh-ancestor
101430534|NCT00533065|Nootropic Agents|nootropic agents|mesh-ancestor
101430535|NCT00152243|Tegafur|tegafur|mesh-list
101430536|NCT00152243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101430537|NCT00152243|Antimetabolites|antimetabolites|mesh-ancestor
101430538|NCT00152243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430539|NCT00152243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101430540|NCT00172107|Parathyroid Hormone|parathyroid hormone|mesh-list
101430541|NCT00172107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101430542|NCT00172107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430543|NCT00152282|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101430544|NCT00152282|Estrogens|estrogens|mesh-ancestor
101430545|NCT00152282|Hormones|hormones|mesh-ancestor
101430546|NCT00152282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101430547|NCT00152282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430548|NCT04922983|Botulinum Toxins|botulinum toxins|mesh-list
101430549|NCT04922983|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101430550|NCT04922983|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101430551|NCT04922983|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101430552|NCT04922983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101430553|NCT04922983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430554|NCT04922983|Cholinergic Agents|cholinergic agents|mesh-ancestor
101430555|NCT04922983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101430556|NCT04922983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430557|NCT04922983|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101430558|NCT04922983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101430559|NCT00152360|Orlistat|orlistat|mesh-list
101430560|NCT00152360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101430561|NCT00152360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430562|NCT00152360|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101430563|NCT00152360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101430564|NCT00164892|Rofecoxib|rofecoxib|mesh-list
101430565|NCT00164892|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101430566|NCT00164892|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101430567|NCT00164892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101430568|NCT00164892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430569|NCT00164892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101430570|NCT00164892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101307171|NCT02029950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101307172|NCT02029950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101430578|NCT00152399|Hormones|hormones|mesh-ancestor
101430579|NCT00152399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101430580|NCT00152399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430581|NCT00164931|Omeprazole|omeprazole|mesh-list
101430582|NCT00164931|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101430583|NCT00164931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101430584|NCT00164931|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101430585|NCT00164931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101430586|NCT00164931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430587|NCT00152438|Progesterone|progesterone|mesh-list
101430588|NCT00152438|Progestins|progestins|mesh-ancestor
101430589|NCT00152438|Hormones|hormones|mesh-ancestor
101430590|NCT00152438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101430591|NCT00152438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430592|NCT00164970|Vitamin B 12|vitamin b 12|mesh-list
101430593|NCT00164970|Hydroxocobalamin|hydroxocobalamin|mesh-list
101430594|NCT00164970|Vitamins|vitamins|mesh-ancestor
101430597|NCT00164970|Vitamin B Complex|vitamin b complex|mesh-ancestor
101558706|NCT01173471|Micronutrients|micronutrients|mesh-ancestor
101558707|NCT01173471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558708|NCT01172847|Oseltamivir|oseltamivir|mesh-list
101558709|NCT01172847|Rimantadine|rimantadine|mesh-list
101558710|NCT01172847|Antiviral Agents|antiviral agents|mesh-ancestor
101558711|NCT01172847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101558712|NCT01172847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101558713|NCT01172847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558714|NCT01172847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101558715|NCT00966355|Octreotide|octreotide|mesh-list
101558716|NCT00966355|Terlipressin|terlipressin|mesh-list
101558717|NCT00966355|Somatostatin|somatostatin|mesh-list
101407140|NCT00106496|Immunologic Factors|immunologic factors|mesh-ancestor
101430598|NCT00164970|Hematinics|hematinics|mesh-ancestor
101430599|NCT02937844|Cyclophosphamide|cyclophosphamide|mesh-list
101430600|NCT02937844|Fludarabine|fludarabine|mesh-list
101430601|NCT02937844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101430602|NCT02937844|Immunologic Factors|immunologic factors|mesh-ancestor
101430603|NCT02937844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430604|NCT02937844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101430605|NCT02937844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101430606|NCT02937844|Alkylating Agents|alkylating agents|mesh-ancestor
101430607|NCT02937844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430608|NCT02937844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101430609|NCT02937844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101430610|NCT02937415|Antioxidants|antioxidants|mesh-list
101430611|NCT02937415|Carbon Monoxide|carbon monoxide|mesh-list
101430612|NCT02937415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430613|NCT02937415|Protective Agents|protective agents|mesh-ancestor
101430614|NCT02937415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430615|NCT02937415|Antimetabolites|antimetabolites|mesh-ancestor
101430616|NCT02937415|Gasotransmitters|gasotransmitters|mesh-ancestor
101430617|NCT02937415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101430618|NCT00152594|Voriconazole|voriconazole|mesh-list
101430619|NCT00152594|Antifungal Agents|antifungal agents|mesh-ancestor
101430620|NCT00152594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101430621|NCT00152594|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101430622|NCT00152594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101430623|NCT00152594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101430624|NCT00152594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430625|NCT00152594|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101430626|NCT00152594|Hormone Antagonists|hormone antagonists|mesh-ancestor
101430627|NCT00152594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101430628|NCT00152594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430629|NCT00152594|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101430630|NCT00407199|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101430631|NCT00407199|Antidepressive Agents|antidepressive agents|mesh-ancestor
101430632|NCT00407199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101430633|NCT00407199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101430634|NCT00407199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101430635|NCT00407199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101430636|NCT00407199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430637|NCT04725422|Zoledronic Acid|zoledronic acid|mesh-list
101430638|NCT04725422|Pamidronate|pamidronate|mesh-list
101430639|NCT04725422|Sulfasalazine|sulfasalazine|mesh-list
101430640|NCT04725422|Adalimumab|adalimumab|mesh-list
101430641|NCT04725422|Infliximab|infliximab|mesh-list
101430642|NCT04725422|Golimumab|golimumab|mesh-list
101430648|NCT04725422|Abortifacient Agents|abortifacient agents|mesh-ancestor
101430649|NCT04725422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101430650|NCT04725422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430651|NCT04725422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101558719|NCT00966355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101558720|NCT00966355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101558721|NCT00966355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101558722|NCT00966355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101558723|NCT00966355|Hormones|hormones|mesh-ancestor
101558724|NCT00966355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101558725|NCT00966355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558726|NCT01172535|Ritonavir|ritonavir|mesh-list
101558727|NCT01172535|Lopinavir|lopinavir|mesh-list
101558728|NCT01172535|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101430652|NCT04725422|Antimetabolites|antimetabolites|mesh-ancestor
101430653|NCT04725422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430654|NCT04725422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101430655|NCT04725422|Dermatologic Agents|dermatologic agents|mesh-ancestor
101430656|NCT04725422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101430657|NCT04725422|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101430658|NCT04725422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101430659|NCT04725422|Immunologic Factors|immunologic factors|mesh-ancestor
101430660|NCT04725422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101430661|NCT04725422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101430662|NCT04725422|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101430663|NCT04725422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101430664|NCT04725422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101430665|NCT04725422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101430666|NCT04725422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101430667|NCT04725422|Analgesics|analgesics|mesh-ancestor
101430671|NCT04725422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101430672|NCT00152633|Losartan|losartan|mesh-list
101430673|NCT00152633|Metoprolol|metoprolol|mesh-list
101430674|NCT00152633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101430675|NCT00152633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101430676|NCT00152633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101430677|NCT00152633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101430678|NCT00152633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430679|NCT00152633|Sympatholytics|sympatholytics|mesh-ancestor
101430680|NCT00152633|Autonomic Agents|autonomic agents|mesh-ancestor
101430681|NCT00152633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101430682|NCT00152633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430683|NCT00152633|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101430684|NCT00152633|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101430685|NCT00152633|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101430686|NCT00152633|Adrenergic Agents|adrenergic agents|mesh-ancestor
101430687|NCT00152633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101430688|NCT02937181|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
101430689|NCT02937181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101430690|NCT02937181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101430691|NCT00425490|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101430692|NCT00425490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101430693|NCT00425490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430694|NCT00425490|Incretins|incretins|mesh-ancestor
101430695|NCT00425490|Hormones|hormones|mesh-ancestor
101430696|NCT00425490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101430697|NCT00425490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101430698|NCT00425490|Protease Inhibitors|protease inhibitors|mesh-ancestor
101430699|NCT00425490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101467706|NCT04531228|Lenvatinib|lenvatinib|mesh-list
101430700|NCT00425490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430701|NCT03457753|Riluzole|riluzole|mesh-list
101430702|NCT03457753|Anticonvulsants|anticonvulsants|mesh-ancestor
101430703|NCT03457753|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101430704|NCT03457753|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101430705|NCT03457753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101558729|NCT01172535|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101558730|NCT01172535|Protease Inhibitors|protease inhibitors|mesh-ancestor
101558731|NCT01172535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101558732|NCT01172535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558733|NCT01172535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101558734|NCT01172535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101558735|NCT01172535|Antiviral Agents|antiviral agents|mesh-ancestor
101558736|NCT01172535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101558737|NCT01172535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101407163|NCT00437476|Antimetabolites|antimetabolites|mesh-ancestor
101430706|NCT03457753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430707|NCT03457753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430708|NCT03457753|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101430709|NCT03457753|Protective Agents|protective agents|mesh-ancestor
101430711|NCT02936830|Fluorides|fluorides|mesh-list
101430712|NCT02936830|Sodium Fluoride|sodium fluoride|mesh-list
101430713|NCT02936830|Fluorides, Topical|fluorides, topical|mesh-list
101430714|NCT02936830|Glycerol|glycerol|mesh-list
101430715|NCT02936830|Cariostatic Agents|cariostatic agents|mesh-ancestor
101430727|NCT00165048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101430729|NCT00165048|Sensory System Agents|sensory system agents|mesh-ancestor
101430730|NCT00165048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101430731|NCT00165048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430732|NCT00165048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101430733|NCT00165048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101430734|NCT04690270|Sumatriptan|sumatriptan|mesh-list
101430735|NCT04690270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101430736|NCT04690270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101430737|NCT04690270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101430738|NCT04690270|Serotonin Agents|serotonin agents|mesh-ancestor
101430740|NCT04690270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430741|NCT04690270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430743|NCT00165087|Dexrazoxane|dexrazoxane|mesh-list
101430744|NCT00165087|Asparaginase|asparaginase|mesh-list
101430745|NCT00165087|Razoxane|razoxane|mesh-list
101430746|NCT00165087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101430747|NCT00165087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101430748|NCT00165087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101430749|NCT00165087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101430750|NCT00165087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101430751|NCT00165087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430752|NCT00165087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101430753|NCT00165087|Protective Agents|protective agents|mesh-ancestor
101430754|NCT00165087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430755|NCT00165087|Antimitotic Agents|antimitotic agents|mesh-ancestor
101430756|NCT00165087|Mitosis Modulators|mitosis modulators|mesh-ancestor
101430757|NCT00152750|Clonidine|clonidine|mesh-list
101430758|NCT00152750|Analgesics|analgesics|mesh-ancestor
101430759|NCT00152750|Sensory System Agents|sensory system agents|mesh-ancestor
101430760|NCT00152750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101430761|NCT00152750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430762|NCT00152750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101430763|NCT00152750|Sympatholytics|sympatholytics|mesh-ancestor
101430764|NCT00152750|Autonomic Agents|autonomic agents|mesh-ancestor
101467714|NCT04531072|Artemether|artemether|mesh-list
101430765|NCT00152750|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101430766|NCT00152750|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101430767|NCT00152750|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101430768|NCT00152750|Adrenergic Agents|adrenergic agents|mesh-ancestor
101430769|NCT00152750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101430770|NCT00152750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430771|NCT02936167|Plasma-lyte 148|plasma-lyte 148|mesh-list
101430772|NCT02936167|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101430773|NCT02936167|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101430783|NCT00152828|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101558738|NCT01172535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101558739|NCT05160493|Pregabalin|pregabalin|mesh-list
101558740|NCT05160493|Ketamine|ketamine|mesh-list
101558741|NCT05160493|Esketamine|esketamine|mesh-list
101558742|NCT05160493|Analgesics|analgesics|mesh-ancestor
101558743|NCT05160493|Sensory System Agents|sensory system agents|mesh-ancestor
101558744|NCT05160493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101558745|NCT05160493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558746|NCT05160493|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101558747|NCT05160493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101407175|NCT00437632|Caffeine|caffeine|mesh-list
101430784|NCT00152828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101430785|NCT00152828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101307177|NCT02029950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101430786|NCT00152828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430787|NCT02935933|Dexmedetomidine|dexmedetomidine|mesh-list
101430788|NCT02935933|Morphine|morphine|mesh-list
101430789|NCT02935933|Bupivacaine|bupivacaine|mesh-list
101430790|NCT02935933|Anesthetics, Local|anesthetics, local|mesh-ancestor
101430791|NCT02935933|Anesthetics|anesthetics|mesh-ancestor
101430792|NCT02935933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101430793|NCT02935933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430794|NCT02935933|Sensory System Agents|sensory system agents|mesh-ancestor
101430795|NCT02935933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101430796|NCT02935933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101430797|NCT02935933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101430798|NCT02935933|Analgesics|analgesics|mesh-ancestor
101430799|NCT02935933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101430800|NCT02935933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101430801|NCT02935933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101430802|NCT02935933|Adrenergic Agents|adrenergic agents|mesh-ancestor
101430803|NCT02935933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101430804|NCT02935933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430805|NCT02935933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101430806|NCT02935933|Narcotics|narcotics|mesh-ancestor
101430807|NCT00152867|Dexamethasone|dexamethasone|mesh-list
101430808|NCT00152867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101430809|NCT00152867|Antiemetics|antiemetics|mesh-ancestor
101430810|NCT00152867|Autonomic Agents|autonomic agents|mesh-ancestor
101430811|NCT00152867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101430812|NCT00152867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430816|NCT00152867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101430817|NCT00152867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101430818|NCT00152867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101430819|NCT02935972|Lidocaine|lidocaine|mesh-list
101430820|NCT02935972|Diazepam|diazepam|mesh-list
101430821|NCT02935972|Anesthetics, Local|anesthetics, local|mesh-ancestor
101430822|NCT02935972|Anesthetics|anesthetics|mesh-ancestor
101430823|NCT02935972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101430824|NCT02935972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430825|NCT02935972|Sensory System Agents|sensory system agents|mesh-ancestor
101430826|NCT02935972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101430827|NCT02935972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101430828|NCT02935972|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101467731|NCT00414323|Escitalopram|escitalopram|mesh-list
101430829|NCT02935972|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101430830|NCT02935972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101430831|NCT02935972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430832|NCT02935972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101430833|NCT02935972|Anticonvulsants|anticonvulsants|mesh-ancestor
101430834|NCT02935972|Antiemetics|antiemetics|mesh-ancestor
101430835|NCT02935972|Autonomic Agents|autonomic agents|mesh-ancestor
101430836|NCT02935972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101430837|NCT02935972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101430838|NCT02935972|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101430839|NCT02935972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101558748|NCT05160493|Anesthetics, General|anesthetics, general|mesh-ancestor
101558749|NCT05160493|Anesthetics|anesthetics|mesh-ancestor
101558750|NCT05160493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101558751|NCT05160493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101558752|NCT05160493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101558753|NCT05160493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101558754|NCT05160493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558755|NCT05160493|Anticonvulsants|anticonvulsants|mesh-ancestor
101558756|NCT05160493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101558757|NCT05160493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101558758|NCT05160493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101558759|NCT05160493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101558760|NCT05160493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101558761|NCT05160493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101558762|NCT05160493|Antidepressive Agents|antidepressive agents|mesh-ancestor
101430840|NCT02935972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101430846|NCT02935972|GABA Agents|gaba agents|mesh-ancestor
101430847|NCT02935972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101430848|NCT02935855|Warfarin|warfarin|mesh-list
101430849|NCT02935855|Rivaroxaban|rivaroxaban|mesh-list
101430850|NCT02935855|Dabigatran|dabigatran|mesh-list
101430851|NCT02935855|Apixaban|apixaban|mesh-list
101430852|NCT02935855|Edoxaban|edoxaban|mesh-list
101430853|NCT02935855|Anticoagulants|anticoagulants|mesh-ancestor
101430854|NCT02935855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101430855|NCT02935855|Antithrombins|antithrombins|mesh-ancestor
101430856|NCT02935855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101430857|NCT02935855|Protease Inhibitors|protease inhibitors|mesh-ancestor
101430858|NCT02935855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101430859|NCT02935855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430860|NCT02935582|Betamethasone|betamethasone|mesh-list
101430861|NCT02935582|Betamethasone Valerate|betamethasone valerate|mesh-list
101307178|NCT02029950|Growth Substances|growth substances|mesh-ancestor
101307179|NCT02029950|Growth Inhibitors|growth inhibitors|mesh-ancestor
101307180|NCT02029950|Keratolytic Agents|keratolytic agents|mesh-ancestor
101430862|NCT02935582|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101430863|NCT02935582|Betamethasone benzoate|betamethasone benzoate|mesh-list
101430864|NCT02935582|Calcipotriene|calcipotriene|mesh-list
101430865|NCT02935582|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101430866|NCT02935582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101430867|NCT02935582|Glucocorticoids|glucocorticoids|mesh-ancestor
101430868|NCT02935582|Hormones|hormones|mesh-ancestor
101430869|NCT02935582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101430870|NCT02935582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430871|NCT02935582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101467758|NCT00263484|Hormones|hormones|mesh-ancestor
101430872|NCT02935582|Respiratory System Agents|respiratory system agents|mesh-ancestor
101430873|NCT02935582|Dermatologic Agents|dermatologic agents|mesh-ancestor
101430874|NCT00406172|Bevacizumab|bevacizumab|mesh-list
101430875|NCT00406172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101430876|NCT00406172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101430877|NCT00406172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101430878|NCT00406172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101430879|NCT00406172|Growth Substances|growth substances|mesh-ancestor
101430880|NCT00406172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430881|NCT00406172|Growth Inhibitors|growth inhibitors|mesh-ancestor
101430882|NCT00152945|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101430883|NCT00152945|Glycerol|glycerol|mesh-list
101430884|NCT00152945|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101430885|NCT00152945|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101430886|NCT00152945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101558763|NCT00966277|Dalteparin|dalteparin|mesh-list
101558764|NCT00966277|Tinzaparin|tinzaparin|mesh-list
101558765|NCT00966277|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101558766|NCT00966277|Anticoagulants|anticoagulants|mesh-ancestor
101558767|NCT00966277|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101558768|NCT00966277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101558769|NCT00966277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558770|NCT04324307|Paclitaxel|paclitaxel|mesh-list
101558771|NCT04324307|Gemcitabine|gemcitabine|mesh-list
101558772|NCT04324307|Fluorouracil|fluorouracil|mesh-list
101558773|NCT04324307|Oxaliplatin|oxaliplatin|mesh-list
101558774|NCT04324307|Irinotecan|irinotecan|mesh-list
101558775|NCT04324307|Folfirinox|folfirinox|mesh-list
101558776|NCT04324307|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101558777|NCT04324307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101430889|NCT00152945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430890|NCT02935114|Hydrogen Peroxide|hydrogen peroxide|mesh-list
101430891|NCT02935114|Carbamide Peroxide|carbamide peroxide|mesh-list
101430892|NCT02935114|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101430893|NCT02935114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101430894|NCT02935231|Nicotine|nicotine|mesh-list
101430895|NCT02935231|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101430896|NCT02935231|Autonomic Agents|autonomic agents|mesh-ancestor
101430897|NCT02935231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101430898|NCT02935231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430899|NCT02935231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101430900|NCT02935231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101430901|NCT02935231|Cholinergic Agents|cholinergic agents|mesh-ancestor
101430902|NCT02935231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101430903|NCT02935231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430904|NCT00172380|Docetaxel|docetaxel|mesh-list
101430905|NCT00172380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101430906|NCT00172380|Tubulin Modulators|tubulin modulators|mesh-ancestor
101430907|NCT00172380|Antimitotic Agents|antimitotic agents|mesh-ancestor
101430908|NCT00172380|Mitosis Modulators|mitosis modulators|mesh-ancestor
101430909|NCT00172380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430910|NCT00152984|Tiotropium Bromide|tiotropium bromide|mesh-list
101430911|NCT00152984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101430912|NCT00152984|Autonomic Agents|autonomic agents|mesh-ancestor
101430919|NCT00152984|Cholinergic Agents|cholinergic agents|mesh-ancestor
101467775|NCT02217319|Sevoflurane|sevoflurane|mesh-list
101430920|NCT00152984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101430921|NCT00152984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430922|NCT02935075|Tenofovir|tenofovir|mesh-list
101430923|NCT02935075|Lamivudine|lamivudine|mesh-list
101430924|NCT02935075|Efavirenz|efavirenz|mesh-list
101430925|NCT02935075|Antiviral Agents|antiviral agents|mesh-ancestor
101430926|NCT02935075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101430927|NCT02935075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101430928|NCT02935075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101430929|NCT02935075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101430930|NCT02935075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430931|NCT02935075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101430932|NCT02935075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101307181|NCT02029950|Dermatologic Agents|dermatologic agents|mesh-ancestor
101307182|NCT02029950|Tubulin Modulators|tubulin modulators|mesh-ancestor
101430933|NCT02935075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101430934|NCT02935075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101430935|NCT02935075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101430936|NCT02935075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101430937|NCT02935075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101430938|NCT02935075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101430939|NCT02934919|Nalmefene|nalmefene|mesh-list
101430940|NCT02934919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101558778|NCT04324307|Tubulin Modulators|tubulin modulators|mesh-ancestor
101558779|NCT04324307|Antimitotic Agents|antimitotic agents|mesh-ancestor
101558780|NCT04324307|Mitosis Modulators|mitosis modulators|mesh-ancestor
101558781|NCT04324307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558782|NCT04324307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101558784|NCT04324307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558785|NCT04324307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101558786|NCT04324307|Immunologic Factors|immunologic factors|mesh-ancestor
101430941|NCT02934919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430942|NCT02934919|Sensory System Agents|sensory system agents|mesh-ancestor
101430943|NCT02934919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101430944|NCT00172419|Atorvastatin|atorvastatin|mesh-list
101430945|NCT00172419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101430946|NCT00172419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101430947|NCT00172419|Antimetabolites|antimetabolites|mesh-ancestor
101430948|NCT00172419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430949|NCT00172419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101430950|NCT00172419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101430951|NCT00172419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101430952|NCT00153023|Valsartan|valsartan|mesh-list
101430953|NCT00153023|Telmisartan|telmisartan|mesh-list
101430954|NCT00153023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101430955|NCT00153023|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101430956|NCT00153023|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101430957|NCT00153023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430958|NCT00165204|Tibolone|tibolone|mesh-list
101430962|NCT00165204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430963|NCT00165204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101430964|NCT00165204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101430965|NCT00165204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101430966|NCT00165204|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101430967|NCT00165204|Anabolic Agents|anabolic agents|mesh-ancestor
101430968|NCT00165204|Hormones|hormones|mesh-ancestor
101430969|NCT02934763|Propranolol|propranolol|mesh-list
101430970|NCT02934763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101430971|NCT02934763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101430972|NCT02934763|Adrenergic Agents|adrenergic agents|mesh-ancestor
101430973|NCT02934763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101430974|NCT02934763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430975|NCT02934763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430976|NCT02934763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101430977|NCT02934763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101430978|NCT02934763|Vasodilator Agents|vasodilator agents|mesh-ancestor
101430979|NCT04689958|Vitamin D|vitamin d|mesh-list
101430980|NCT04689958|Vitamins|vitamins|mesh-ancestor
101430981|NCT04689958|Micronutrients|micronutrients|mesh-ancestor
101430987|NCT04684420|Metformin|metformin|mesh-list
101430988|NCT04684420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101430989|NCT04684420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430990|NCT02934607|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101430991|NCT02934607|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101430992|NCT02934607|Respiratory System Agents|respiratory system agents|mesh-ancestor
101430993|NCT00153296|Carbamazepine|carbamazepine|mesh-list
101430994|NCT00153296|Anticonvulsants|anticonvulsants|mesh-ancestor
101430995|NCT00153296|Antimanic Agents|antimanic agents|mesh-ancestor
101430996|NCT00153296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101430997|NCT00153296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101430998|NCT00153296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430999|NCT00153296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101431000|NCT00153296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101431001|NCT00153296|Analgesics|analgesics|mesh-ancestor
101431002|NCT00153296|Sensory System Agents|sensory system agents|mesh-ancestor
101431003|NCT00153296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101431004|NCT00153296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101558787|NCT04324307|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101558788|NCT04324307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101558789|NCT04324307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101558790|NCT01297517|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101558791|NCT01297517|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101558792|NCT01297517|Brinzolamide|brinzolamide|mesh-list
101558793|NCT01297517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101558794|NCT01297517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101407221|NCT00438139|Dronabinol|dronabinol|mesh-list
101307184|NCT02029950|Mitosis Modulators|mitosis modulators|mesh-ancestor
101307185|NCT02030561|Trastuzumab|trastuzumab|mesh-list
101307186|NCT02030561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101431005|NCT00153296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101431006|NCT00153296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431007|NCT00153296|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101431008|NCT00153296|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101431009|NCT02934295|Antibodies|antibodies|mesh-list
101431010|NCT02934295|Immunologic Factors|immunologic factors|mesh-ancestor
101431011|NCT02934295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431012|NCT02934022|Maraviroc|maraviroc|mesh-list
101431013|NCT02934022|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101431014|NCT02934022|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101431015|NCT02934022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431016|NCT02934022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101431017|NCT02934022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101431018|NCT02934022|Antiviral Agents|antiviral agents|mesh-ancestor
101431019|NCT02934022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101431020|NCT02934022|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101431021|NCT02934061|Tizanidine|tizanidine|mesh-list
101431022|NCT02934061|Analgesics|analgesics|mesh-ancestor
101431023|NCT02934061|Sensory System Agents|sensory system agents|mesh-ancestor
101431024|NCT02934061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101431025|NCT02934061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431026|NCT02934061|Anticonvulsants|anticonvulsants|mesh-ancestor
101431027|NCT02934061|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101431028|NCT02934061|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101431029|NCT02934061|Parasympatholytics|parasympatholytics|mesh-ancestor
101431030|NCT02934061|Autonomic Agents|autonomic agents|mesh-ancestor
101431036|NCT02934061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431037|NCT02934217|Cyclosporine|cyclosporine|mesh-list
101431038|NCT02934217|Cyclosporins|cyclosporins|mesh-list
101431039|NCT02934217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101431040|NCT02934217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431041|NCT02934217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101431042|NCT02934217|Immunologic Factors|immunologic factors|mesh-ancestor
101431043|NCT02934217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431044|NCT02934217|Antifungal Agents|antifungal agents|mesh-ancestor
101431045|NCT02934217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101431046|NCT02934217|Dermatologic Agents|dermatologic agents|mesh-ancestor
101431047|NCT02934217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101431048|NCT02934217|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101431049|NCT00165360|Temozolomide|temozolomide|mesh-list
101431050|NCT00165360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101431051|NCT00165360|Alkylating Agents|alkylating agents|mesh-ancestor
101431056|NCT02933905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101431057|NCT02933905|Growth Substances|growth substances|mesh-ancestor
101431058|NCT02933905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431059|NCT02933905|Growth Inhibitors|growth inhibitors|mesh-ancestor
101431060|NCT02933905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101431062|NCT02933788|Cilostazol|cilostazol|mesh-list
101431063|NCT02933788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101431064|NCT02933788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101431065|NCT02933788|Analgesics|analgesics|mesh-ancestor
101431066|NCT02933788|Sensory System Agents|sensory system agents|mesh-ancestor
101431067|NCT02933788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101558795|NCT01297517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101558796|NCT01297517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101558797|NCT01297517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101558798|NCT01297517|Adrenergic Agents|adrenergic agents|mesh-ancestor
101558799|NCT01297517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101431068|NCT02933788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431069|NCT02933788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101431070|NCT02933788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101431071|NCT02933788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101431072|NCT02933788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101431073|NCT02933788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307187|NCT02030561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101307189|NCT02031367|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101431074|NCT02933788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101431075|NCT02933788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101431076|NCT02933788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101431077|NCT02933788|Antipyretics|antipyretics|mesh-ancestor
101431078|NCT02933788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101431079|NCT02933788|Autonomic Agents|autonomic agents|mesh-ancestor
101431080|NCT02933788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101431081|NCT02933788|Respiratory System Agents|respiratory system agents|mesh-ancestor
101431082|NCT02933788|Vasodilator Agents|vasodilator agents|mesh-ancestor
101431083|NCT02933788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101431084|NCT02933788|Protective Agents|protective agents|mesh-ancestor
101431085|NCT02933788|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101431086|NCT02933788|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101431087|NCT00165399|Docetaxel|docetaxel|mesh-list
101431088|NCT00165399|Goserelin|goserelin|mesh-list
101431089|NCT00165399|Bicalutamide|bicalutamide|mesh-list
101431090|NCT00165399|Estramustine|estramustine|mesh-list
101431091|NCT00165399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101431092|NCT00165399|Tubulin Modulators|tubulin modulators|mesh-ancestor
101431093|NCT00165399|Antimitotic Agents|antimitotic agents|mesh-ancestor
101431094|NCT00165399|Mitosis Modulators|mitosis modulators|mesh-ancestor
101431095|NCT00165399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431096|NCT00165399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101431097|NCT00165399|Androgen Antagonists|androgen antagonists|mesh-ancestor
101431098|NCT00165399|Hormone Antagonists|hormone antagonists|mesh-ancestor
101431099|NCT00165399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101431105|NCT02933593|Nifedipine|nifedipine|mesh-list
101431106|NCT02933593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101431107|NCT02933593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101431108|NCT02933593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431109|NCT02933593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101431110|NCT02933593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431111|NCT02933593|Vasodilator Agents|vasodilator agents|mesh-ancestor
101431112|NCT02933593|Tocolytic Agents|tocolytic agents|mesh-ancestor
101431113|NCT02933593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101431114|NCT02933593|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101431115|NCT02933593|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101431116|NCT02933593|Adrenergic Agents|adrenergic agents|mesh-ancestor
101431117|NCT02933593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101431118|NCT02933593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101431119|NCT02933593|Sympathomimetics|sympathomimetics|mesh-ancestor
101431120|NCT02933593|Autonomic Agents|autonomic agents|mesh-ancestor
101431121|NCT02933593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101431122|NCT02933593|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101431123|NCT02933593|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101431133|NCT02933437|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101431134|NCT02933437|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101431135|NCT02933437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101431136|NCT02933437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431137|NCT00153530|Methotrexate|methotrexate|mesh-list
101431138|NCT00153530|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101431139|NCT00153530|Abortifacient Agents|abortifacient agents|mesh-ancestor
101431140|NCT00153530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101431141|NCT00153530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558800|NCT01297517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558801|NCT01297517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558802|NCT01297517|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101558803|NCT01297517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101558805|NCT01296347|Analgesics|analgesics|mesh-ancestor
101467838|NCT02217826|Octreotide|octreotide|mesh-list
101558806|NCT01296347|Sensory System Agents|sensory system agents|mesh-ancestor
101558807|NCT01296347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101558808|NCT01296347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558809|NCT01296347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101558810|NCT01296347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101558811|NCT01296347|Anesthetics, General|anesthetics, general|mesh-ancestor
101558812|NCT01296347|Anesthetics|anesthetics|mesh-ancestor
101558813|NCT01296347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101558814|NCT01296347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101558815|NCT01296347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101558816|NCT01296347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101520744|NCT04647773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101558817|NCT01296347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407235|NCT00438178|Obatoclax|obatoclax|mesh-list
101431142|NCT00153530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101431143|NCT00153530|Antimetabolites|antimetabolites|mesh-ancestor
101431144|NCT00153530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431145|NCT00153530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101431146|NCT00153530|Dermatologic Agents|dermatologic agents|mesh-ancestor
101431147|NCT00153530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101307190|NCT02031367|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101307191|NCT02031367|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101431148|NCT00153530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101431149|NCT00153530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101431150|NCT00153530|Immunologic Factors|immunologic factors|mesh-ancestor
101431151|NCT00153530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101431152|NCT00153530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101431153|NCT00165477|Lenalidomide|lenalidomide|mesh-list
101431154|NCT00165477|Immunologic Factors|immunologic factors|mesh-ancestor
101431155|NCT00165477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431156|NCT00165477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101431157|NCT00165477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101431158|NCT00165477|Growth Substances|growth substances|mesh-ancestor
101431159|NCT00165477|Growth Inhibitors|growth inhibitors|mesh-ancestor
101431160|NCT00165477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101431161|NCT02932930|Ropivacaine|ropivacaine|mesh-list
101431162|NCT02932930|Anesthetics, Local|anesthetics, local|mesh-ancestor
101431163|NCT02932930|Anesthetics|anesthetics|mesh-ancestor
101431164|NCT02932930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101431165|NCT02932930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431166|NCT02932930|Sensory System Agents|sensory system agents|mesh-ancestor
101431167|NCT02932930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101431168|NCT00165516|Sodium thiosulfate|sodium thiosulfate|mesh-list
101431172|NCT00165516|Antioxidants|antioxidants|mesh-ancestor
101431173|NCT00165516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431174|NCT00165516|Antitubercular Agents|antitubercular agents|mesh-ancestor
101558818|NCT01296035|Panitumumab|panitumumab|mesh-list
101558819|NCT01296035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101558820|NCT01296035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101558821|NCT01294787|Glycopyrrolate|glycopyrrolate|mesh-list
101558822|NCT01294787|Bromides|bromides|mesh-list
101558823|NCT01294787|Tiotropium Bromide|tiotropium bromide|mesh-list
101558824|NCT01294787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101558825|NCT01294787|Autonomic Agents|autonomic agents|mesh-ancestor
101407255|NCT03279757|Racepinephrine|racepinephrine|mesh-list
101407256|NCT03279757|Tetracaine|tetracaine|mesh-list
101431175|NCT00165516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101431176|NCT00165516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101431177|NCT00165516|Chelating Agents|chelating agents|mesh-ancestor
101431178|NCT00165516|Sequestering Agents|sequestering agents|mesh-ancestor
101431179|NCT04642378|Insulin|insulin|mesh-list
101431180|NCT04642378|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101431181|NCT04642378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101431182|NCT04642378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431183|NCT00407784|Eplerenone|eplerenone|mesh-list
101431184|NCT00407784|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101431185|NCT00407784|Hormone Antagonists|hormone antagonists|mesh-ancestor
101431186|NCT00407784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101431187|NCT00407784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431188|NCT00407784|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101431189|NCT00407784|Diuretics|diuretics|mesh-ancestor
101431190|NCT00407784|Natriuretic Agents|natriuretic agents|mesh-ancestor
101431191|NCT00407784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101431212|NCT00153725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101431213|NCT00153725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431214|NCT00153725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101431215|NCT00153725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101431216|NCT00153725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101431217|NCT00153725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101431218|NCT00153725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431219|NCT00153725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101431220|NCT00153725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101431221|NCT00153725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101307192|NCT02031367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101307193|NCT02031367|Glucocorticoids|glucocorticoids|mesh-ancestor
101431223|NCT00153764|Vitamins|vitamins|mesh-list
101431224|NCT00153764|Micronutrients|micronutrients|mesh-ancestor
101431225|NCT00153764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431226|NCT00180102|Cytarabine|cytarabine|mesh-list
101431227|NCT00180102|Mitoxantrone|mitoxantrone|mesh-list
101431228|NCT00180102|Amsacrine|amsacrine|mesh-list
101431229|NCT00180102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101431230|NCT00180102|Antimetabolites|antimetabolites|mesh-ancestor
101431231|NCT00180102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431232|NCT00180102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101431233|NCT00180102|Antiviral Agents|antiviral agents|mesh-ancestor
101431234|NCT00180102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101431235|NCT00180102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101431236|NCT00180102|Immunologic Factors|immunologic factors|mesh-ancestor
101431237|NCT00180102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431238|NCT00180102|Analgesics|analgesics|mesh-ancestor
101431239|NCT00180102|Sensory System Agents|sensory system agents|mesh-ancestor
101431240|NCT00180102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101431241|NCT00180102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101431247|NCT04690309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431248|NCT00153881|Carboplatin|carboplatin|mesh-list
101431249|NCT00153881|Docetaxel|docetaxel|mesh-list
101431250|NCT00153881|Capecitabine|capecitabine|mesh-list
101431251|NCT00153881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101431252|NCT00153881|Tubulin Modulators|tubulin modulators|mesh-ancestor
101431253|NCT00153881|Antimitotic Agents|antimitotic agents|mesh-ancestor
101431256|NCT00153881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101431257|NCT00153881|Antimetabolites|antimetabolites|mesh-ancestor
101431258|NCT00180141|Pimecrolimus|pimecrolimus|mesh-list
101558826|NCT01294787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101558827|NCT01294787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558828|NCT01294787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101558829|NCT01294787|Respiratory System Agents|respiratory system agents|mesh-ancestor
101558830|NCT01294787|Parasympatholytics|parasympatholytics|mesh-ancestor
101558831|NCT01294787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101558832|NCT01294787|Cholinergic Agents|cholinergic agents|mesh-ancestor
101558833|NCT01294787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101431259|NCT00180141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101431260|NCT00180141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101431261|NCT00180141|Analgesics|analgesics|mesh-ancestor
101431262|NCT00180141|Sensory System Agents|sensory system agents|mesh-ancestor
101431263|NCT00180141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101431264|NCT00180141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431265|NCT00180141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101431266|NCT00180141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101431267|NCT00180141|Dermatologic Agents|dermatologic agents|mesh-ancestor
101431268|NCT00180141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101431269|NCT00180141|Immunologic Factors|immunologic factors|mesh-ancestor
101431270|NCT00180141|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101431271|NCT00180141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101431272|NCT00180141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431273|NCT02931877|Propofol|propofol|mesh-list
101431274|NCT02931877|Sevoflurane|sevoflurane|mesh-list
101431275|NCT02931877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101431276|NCT02931877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101431277|NCT02931877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431278|NCT02931877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101431279|NCT02931877|Anesthetics, General|anesthetics, general|mesh-ancestor
101431280|NCT02931877|Anesthetics|anesthetics|mesh-ancestor
101431281|NCT02931877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101431282|NCT02931877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101431283|NCT00153998|Leucovorin|leucovorin|mesh-list
101431284|NCT00153998|Folic Acid|folic acid|mesh-list
101431285|NCT00153998|Fluorouracil|fluorouracil|mesh-list
101431286|NCT00153998|Oxaliplatin|oxaliplatin|mesh-list
101431287|NCT00153998|Irinotecan|irinotecan|mesh-list
101431288|NCT00153998|Cetuximab|cetuximab|mesh-list
101431289|NCT00153998|Levoleucovorin|levoleucovorin|mesh-list
101431290|NCT00153998|Antimetabolites|antimetabolites|mesh-ancestor
101431291|NCT00153998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431292|NCT00153998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101431293|NCT00153998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101431294|NCT00153998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101431295|NCT00153998|Immunologic Factors|immunologic factors|mesh-ancestor
101431296|NCT00153998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431297|NCT00153998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101431298|NCT00153998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101431299|NCT00153998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101431300|NCT00153998|Antidotes|antidotes|mesh-ancestor
101307194|NCT02031367|Hormones|hormones|mesh-ancestor
101307195|NCT02031367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101431301|NCT00153998|Protective Agents|protective agents|mesh-ancestor
101431302|NCT00153998|Vitamin B Complex|vitamin b complex|mesh-ancestor
101431303|NCT00153998|Vitamins|vitamins|mesh-ancestor
101431304|NCT00153998|Micronutrients|micronutrients|mesh-ancestor
101431305|NCT00153998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101431306|NCT00153998|Hematinics|hematinics|mesh-ancestor
101431307|NCT02925130|Albuterol|albuterol|mesh-list
101431308|NCT02925130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101431309|NCT02925130|Autonomic Agents|autonomic agents|mesh-ancestor
101431310|NCT02925130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101431311|NCT02925130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431312|NCT02925130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101431313|NCT02925130|Respiratory System Agents|respiratory system agents|mesh-ancestor
101431314|NCT02925130|Tocolytic Agents|tocolytic agents|mesh-ancestor
101431317|NCT02925130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101558834|NCT01294787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558835|NCT01294787|Anticonvulsants|anticonvulsants|mesh-ancestor
101558836|NCT01294787|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101558837|NCT01294787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101558838|NCT01294553|Metformin|metformin|mesh-list
101558839|NCT01294553|Rosiglitazone|rosiglitazone|mesh-list
101558840|NCT01294553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101407271|NCT03279757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101431319|NCT02925130|Adrenergic Agents|adrenergic agents|mesh-ancestor
101431320|NCT02925130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101431321|NCT02925130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431322|NCT02924974|Lidocaine|lidocaine|mesh-list
101431323|NCT02924974|Morphine|morphine|mesh-list
101431324|NCT02924974|Anesthetics, Local|anesthetics, local|mesh-ancestor
101431325|NCT02924974|Anesthetics|anesthetics|mesh-ancestor
101431326|NCT02924974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101431327|NCT02924974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431328|NCT02924974|Sensory System Agents|sensory system agents|mesh-ancestor
101431331|NCT02924974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101431332|NCT02924974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101431333|NCT02924974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101431334|NCT02924974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431335|NCT02924974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101431336|NCT02924974|Narcotics|narcotics|mesh-ancestor
101431337|NCT02924974|Analgesics|analgesics|mesh-ancestor
101431338|NCT00154037|Pioglitazone|pioglitazone|mesh-list
101431339|NCT00154037|Candesartan|candesartan|mesh-list
101431340|NCT00154037|Candesartan cilexetil|candesartan cilexetil|mesh-list
101431341|NCT00154037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101431342|NCT00154037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431343|NCT00154037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101431344|NCT00154037|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101431345|NCT00154037|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101431346|NCT00154037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431348|NCT02924857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101431349|NCT02924857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101431350|NCT02924857|Tubulin Modulators|tubulin modulators|mesh-ancestor
101431351|NCT02924857|Antimitotic Agents|antimitotic agents|mesh-ancestor
101431352|NCT02924857|Mitosis Modulators|mitosis modulators|mesh-ancestor
101431353|NCT02924857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431355|NCT00154076|Zonisamide|zonisamide|mesh-list
101431356|NCT00154076|Anticonvulsants|anticonvulsants|mesh-ancestor
101431357|NCT00154076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101431358|NCT00154076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431359|NCT00154076|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101431360|NCT00154076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101431361|NCT00154076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431362|NCT00154076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101431363|NCT00154115|Simendan|simendan|mesh-list
101431364|NCT00154115|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101431365|NCT00154115|Vasodilator Agents|vasodilator agents|mesh-ancestor
101431366|NCT00154115|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101431367|NCT00154115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101431368|NCT00154115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101431369|NCT00154115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431370|NCT00154115|Protective Agents|protective agents|mesh-ancestor
101431371|NCT00154115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431372|NCT02924506|Meloxicam|meloxicam|mesh-list
101431373|NCT02924506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101431374|NCT02924506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101307196|NCT02031367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307197|NCT02031367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101307199|NCT02031367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101307200|NCT02031367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307201|NCT02031692|Cholecalciferol|cholecalciferol|mesh-list
101558841|NCT01294553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558842|NCT04326023|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
101558843|NCT04326023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101558844|NCT04326023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558845|NCT04326023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101558846|NCT01294397|Denosumab|denosumab|mesh-list
101558847|NCT01294397|Etanercept|etanercept|mesh-list
101307202|NCT02031692|Vitamin D|vitamin d|mesh-list
101307203|NCT02031692|Calcium Carbonate|calcium carbonate|mesh-list
101307204|NCT02031692|Calcium|calcium|mesh-list
101307205|NCT02031692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101307206|NCT02031692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307207|NCT02031692|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101307208|NCT02031692|Vitamins|vitamins|mesh-ancestor
101307209|NCT02031692|Micronutrients|micronutrients|mesh-ancestor
101307210|NCT02031692|Antacids|antacids|mesh-ancestor
101307211|NCT02031692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307212|NCT02031692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101307213|NCT02031991|Bevacizumab|bevacizumab|mesh-list
101307214|NCT02031991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101307215|NCT02031991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101307216|NCT02031991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101431375|NCT02924506|Analgesics|analgesics|mesh-ancestor
101431376|NCT02924506|Sensory System Agents|sensory system agents|mesh-ancestor
101431377|NCT02924506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101431378|NCT02924506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431379|NCT02924506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101431380|NCT02924506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101431396|NCT02924233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431397|NCT02923999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101431399|NCT02923999|Immunoglobulins|immunoglobulins|mesh-list
101431400|NCT02923999|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101431401|NCT02923999|Immunologic Factors|immunologic factors|mesh-ancestor
101431402|NCT02923999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431403|NCT02923999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101431404|NCT00154193|Cyclosporine|cyclosporine|mesh-list
101431405|NCT00154193|Cyclosporins|cyclosporins|mesh-list
101431406|NCT00154193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101431407|NCT00154193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431408|NCT00154193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101431409|NCT00154193|Immunologic Factors|immunologic factors|mesh-ancestor
101431410|NCT00154193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431411|NCT00154193|Antifungal Agents|antifungal agents|mesh-ancestor
101431412|NCT00154193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101431413|NCT00154193|Dermatologic Agents|dermatologic agents|mesh-ancestor
101431414|NCT00154193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101431415|NCT00154193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101431416|NCT00154232|Mycophenolic Acid|mycophenolic acid|mesh-list
101307217|NCT02031991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101307218|NCT02031991|Growth Substances|growth substances|mesh-ancestor
101307219|NCT02031991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431417|NCT00154232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101431418|NCT00154232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101431419|NCT00154232|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101431420|NCT00154232|Antitubercular Agents|antitubercular agents|mesh-ancestor
101431421|NCT00154232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101431422|NCT00154232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101431423|NCT00154232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101431424|NCT00154232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431425|NCT00154271|Valsartan|valsartan|mesh-list
101431426|NCT00154271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101431427|NCT00154271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101431428|NCT00154271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101431429|NCT00154271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431430|NCT00154349|Imatinib Mesylate|imatinib mesylate|mesh-list
101431431|NCT00154349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101431432|NCT00154349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101558848|NCT01294397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101558849|NCT01294397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101558850|NCT01294397|Analgesics|analgesics|mesh-ancestor
101558851|NCT01294397|Sensory System Agents|sensory system agents|mesh-ancestor
101558852|NCT01294397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101558853|NCT01294397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431433|NCT00154349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101431434|NCT00154349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431435|NCT00187941|Mycophenolic Acid|mycophenolic acid|mesh-list
101431436|NCT00187941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101431437|NCT00187941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101431438|NCT00187941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101431439|NCT00187941|Antitubercular Agents|antitubercular agents|mesh-ancestor
101431440|NCT00187941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101431441|NCT00187941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101431442|NCT00187941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101431443|NCT00187941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431444|NCT02923687|Ketorolac|ketorolac|mesh-list
101431445|NCT02923687|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101431446|NCT02923687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101431447|NCT02923687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101431448|NCT02923687|Analgesics|analgesics|mesh-ancestor
101431449|NCT02923687|Sensory System Agents|sensory system agents|mesh-ancestor
101431454|NCT02923687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101431455|NCT02923687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101431456|NCT02923687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431460|NCT00154388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101431461|NCT00154388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431463|NCT02923258|Cisplatin|cisplatin|mesh-list
101431464|NCT02923258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101431465|NCT02923258|Tubulin Modulators|tubulin modulators|mesh-ancestor
101431466|NCT02923258|Antimitotic Agents|antimitotic agents|mesh-ancestor
101431467|NCT02923258|Mitosis Modulators|mitosis modulators|mesh-ancestor
101431468|NCT02923258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431469|NCT02923336|Propranolol|propranolol|mesh-list
101431470|NCT02923336|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101431471|NCT02923336|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101431472|NCT02923336|Adrenergic Agents|adrenergic agents|mesh-ancestor
101431473|NCT02923336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101431474|NCT02923336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431475|NCT02923336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431476|NCT02923336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101431477|NCT02923336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101431478|NCT02923336|Vasodilator Agents|vasodilator agents|mesh-ancestor
101431479|NCT02922946|Entinostat|entinostat|mesh-list
101431480|NCT02922946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101431481|NCT02922946|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101431482|NCT02922946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101431483|NCT02922946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431484|NCT02922712|Nimesulide|nimesulide|mesh-list
101307220|NCT02031991|Growth Inhibitors|growth inhibitors|mesh-ancestor
101307221|NCT02032043|Ivermectin|ivermectin|mesh-list
101307222|NCT02032043|Albendazole|albendazole|mesh-list
101307223|NCT02032043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101307224|NCT02032043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101307225|NCT02032043|Anthelmintics|anthelmintics|mesh-ancestor
101431485|NCT02922712|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101431486|NCT02922712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101431487|NCT02922712|Analgesics|analgesics|mesh-ancestor
101431488|NCT02922712|Sensory System Agents|sensory system agents|mesh-ancestor
101431489|NCT02922712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101431490|NCT02922712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431491|NCT02922712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101431492|NCT02922712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101431493|NCT02922712|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101431494|NCT02922712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101558854|NCT01294397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101558855|NCT01294397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101558856|NCT01294397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101558857|NCT01294397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101558858|NCT01294397|Immunologic Factors|immunologic factors|mesh-ancestor
101558859|NCT01294397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101558860|NCT01293695|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
101558861|NCT01293695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101407294|NCT00106847|Infliximab|infliximab|mesh-list
101431495|NCT02922712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431496|NCT02922673|Aspirin|aspirin|mesh-list
101431497|NCT02922673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101431498|NCT02922673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101431499|NCT02922673|Analgesics|analgesics|mesh-ancestor
101431500|NCT02922673|Sensory System Agents|sensory system agents|mesh-ancestor
101431501|NCT02922673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101431502|NCT02922673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431503|NCT02922673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101431504|NCT02922673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101431505|NCT02922673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101431506|NCT02922673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101431507|NCT02922673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431508|NCT02922673|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101431509|NCT02922673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101431510|NCT02922673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101431511|NCT02922673|Antipyretics|antipyretics|mesh-ancestor
101431512|NCT02922283|Interleukin-2|interleukin-2|mesh-list
101431513|NCT02922283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101431514|NCT02922283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101431515|NCT02922283|Analgesics|analgesics|mesh-ancestor
101431516|NCT02922283|Sensory System Agents|sensory system agents|mesh-ancestor
101431517|NCT02922283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101431518|NCT02922283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431523|NCT02922166|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101431524|NCT02922166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431525|NCT02922166|Natriuretic Agents|natriuretic agents|mesh-ancestor
101431528|NCT02922127|Ulipristal acetate|ulipristal acetate|mesh-list
101431529|NCT02922127|Contraceptives, Oral|contraceptives, oral|mesh-list
101431530|NCT02922127|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
101431531|NCT02922127|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101431532|NCT02922127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431533|NCT02922127|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101431534|NCT02922127|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101431535|NCT02921659|Niacinamide|niacinamide|mesh-list
101431536|NCT02921659|Vitamin B Complex|vitamin b complex|mesh-ancestor
101431537|NCT02921659|Vitamins|vitamins|mesh-ancestor
101431538|NCT02921659|Micronutrients|micronutrients|mesh-ancestor
101431539|NCT02921659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431540|NCT04689100|Leucovorin|leucovorin|mesh-list
101431541|NCT04689100|Fluorouracil|fluorouracil|mesh-list
101431542|NCT04689100|Oxaliplatin|oxaliplatin|mesh-list
101431543|NCT04689100|Irinotecan|irinotecan|mesh-list
101431544|NCT04689100|Calcium|calcium|mesh-list
101431545|NCT04689100|Levoleucovorin|levoleucovorin|mesh-list
101431546|NCT04689100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101431547|NCT04689100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431548|NCT04689100|Antimetabolites|antimetabolites|mesh-ancestor
101431549|NCT04689100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431550|NCT04689100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101431551|NCT04689100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101431552|NCT04689100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101307226|NCT02032043|Anticestodal Agents|anticestodal agents|mesh-ancestor
101307227|NCT02032043|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101307228|NCT02032043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101307229|NCT02032043|Tubulin Modulators|tubulin modulators|mesh-ancestor
101307230|NCT02032043|Antimitotic Agents|antimitotic agents|mesh-ancestor
101558862|NCT01293695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558863|NCT01293539|Melphalan|melphalan|mesh-list
101558864|NCT01293539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101558865|NCT01293539|Alkylating Agents|alkylating agents|mesh-ancestor
101558866|NCT01293539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558867|NCT01293539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101558868|NCT01293539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101558869|NCT01293539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101558870|NCT01293539|Immunologic Factors|immunologic factors|mesh-ancestor
101558871|NCT01293539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558872|NCT01292837|Levetiracetam|levetiracetam|mesh-list
101558873|NCT01292837|Anticonvulsants|anticonvulsants|mesh-ancestor
101558874|NCT01292837|Nootropic Agents|nootropic agents|mesh-ancestor
101558875|NCT00965731|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101431553|NCT04689100|Immunologic Factors|immunologic factors|mesh-ancestor
101431554|NCT04689100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101431555|NCT04689100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101431556|NCT04689100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101431557|NCT04689100|Antidotes|antidotes|mesh-ancestor
101431558|NCT04689100|Protective Agents|protective agents|mesh-ancestor
101431559|NCT04689100|Vitamin B Complex|vitamin b complex|mesh-ancestor
101431560|NCT04689100|Vitamins|vitamins|mesh-ancestor
101431561|NCT04689100|Micronutrients|micronutrients|mesh-ancestor
101431562|NCT00188136|Fludarabine|fludarabine|mesh-list
101431563|NCT00188136|Melphalan|melphalan|mesh-list
101431564|NCT00188136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101431565|NCT00188136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431566|NCT00188136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101431567|NCT00188136|Immunologic Factors|immunologic factors|mesh-ancestor
101431568|NCT00188136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431569|NCT00188136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101431570|NCT00188136|Alkylating Agents|alkylating agents|mesh-ancestor
101431571|NCT00188136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101431572|NCT00406250|Bevacizumab|bevacizumab|mesh-list
101431573|NCT00406250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101431574|NCT00406250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101431575|NCT00406250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101431576|NCT00406250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101431577|NCT00406250|Growth Substances|growth substances|mesh-ancestor
101431578|NCT00406250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431579|NCT00406250|Growth Inhibitors|growth inhibitors|mesh-ancestor
101431580|NCT00406289|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101431581|NCT00406289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101431582|NCT00406289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431583|NCT02921269|Bevacizumab|bevacizumab|mesh-list
101431584|NCT02921269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101431585|NCT02921269|Atezolizumab|atezolizumab|mesh-list
101431586|NCT02921269|Endothelial Growth Factors|endothelial growth factors|mesh-list
101431588|NCT02921269|Immunoglobulins|immunoglobulins|mesh-list
101431589|NCT02921269|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101431590|NCT02921269|Immunoglobulin G|immunoglobulin g|mesh-list
101431591|NCT02921269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101431592|NCT02921269|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101431595|NCT02921269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431596|NCT02921269|Growth Inhibitors|growth inhibitors|mesh-ancestor
101431597|NCT02921269|Immunologic Factors|immunologic factors|mesh-ancestor
101431598|NCT02921269|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101431604|NCT02920801|Incretins|incretins|mesh-ancestor
101431605|NCT02920801|Hormones|hormones|mesh-ancestor
101431606|NCT02920801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101431607|NCT02920801|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101558877|NCT00965731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101558878|NCT00965731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101558879|NCT00965731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101558880|NCT00965731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558881|NCT00630175|Zolpidem|zolpidem|mesh-list
101558882|NCT00630175|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101558883|NCT00630175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101558884|NCT00630175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101558885|NCT00630175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558886|NCT00630175|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101558887|NCT00630175|GABA Agonists|gaba agonists|mesh-ancestor
101558888|NCT00630175|GABA Agents|gaba agents|mesh-ancestor
101558889|NCT00630175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101558890|NCT00630175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558891|NCT00965575|Melatonin|melatonin|mesh-list
101558892|NCT00965575|Antioxidants|antioxidants|mesh-ancestor
101558893|NCT00965575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558894|NCT00965575|Protective Agents|protective agents|mesh-ancestor
101558895|NCT00965575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407318|NCT00438841|Alkylating Agents|alkylating agents|mesh-ancestor
101431608|NCT02920801|Protease Inhibitors|protease inhibitors|mesh-ancestor
101431609|NCT02920801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101431610|NCT02920801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431611|NCT00180843|Bromides|bromides|mesh-list
101431612|NCT00180843|Albuterol|albuterol|mesh-list
101431613|NCT00180843|Ipratropium|ipratropium|mesh-list
101431614|NCT00180843|Anticonvulsants|anticonvulsants|mesh-ancestor
101431615|NCT00180843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101431616|NCT00180843|Autonomic Agents|autonomic agents|mesh-ancestor
101431617|NCT00180843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101431618|NCT00180843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431619|NCT00180843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101431620|NCT00180843|Respiratory System Agents|respiratory system agents|mesh-ancestor
101431621|NCT00180843|Tocolytic Agents|tocolytic agents|mesh-ancestor
101431622|NCT00180843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101307231|NCT02032043|Mitosis Modulators|mitosis modulators|mesh-ancestor
101307232|NCT02032043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467964|NCT01642108|Hormones|hormones|mesh-ancestor
101307233|NCT02032043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101307234|NCT02032134|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
101307235|NCT02032134|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101307236|NCT02032134|Protective Agents|protective agents|mesh-ancestor
101307237|NCT02032134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307238|NCT02032134|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101307239|NCT02032134|Antioxidants|antioxidants|mesh-ancestor
101307240|NCT02032134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307241|NCT02032186|Magnesium citrate|magnesium citrate|mesh-list
101307242|NCT02032186|Cathartics|cathartics|mesh-ancestor
101307243|NCT02032186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101307244|NCT02033356|Lidocaine|lidocaine|mesh-list
101307245|NCT02033356|Anesthetics, Local|anesthetics, local|mesh-ancestor
101307246|NCT02033356|Anesthetics|anesthetics|mesh-ancestor
101307247|NCT02033356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101558896|NCT00965575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101558897|NCT00965497|Escitalopram|escitalopram|mesh-list
101558898|NCT00965497|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101558899|NCT00965497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101558900|NCT00965497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101558901|NCT00965497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558902|NCT00965497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101558903|NCT00965497|Serotonin Agents|serotonin agents|mesh-ancestor
101558904|NCT00965497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558905|NCT00963937|Sumatriptan|sumatriptan|mesh-list
101407338|NCT00438958|Lenograstim|lenograstim|mesh-list
101307248|NCT02033356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307249|NCT02033356|Sensory System Agents|sensory system agents|mesh-ancestor
101307250|NCT02033356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101307251|NCT02033356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101307252|NCT02033356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101307253|NCT02033356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101307254|NCT02033356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101307255|NCT02033356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307256|NCT02033733|Cisatracurium|cisatracurium|mesh-list
101307257|NCT02033733|Atracurium|atracurium|mesh-list
101307258|NCT02033733|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
101307259|NCT02033733|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101307260|NCT02033733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101431623|NCT00180843|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101431624|NCT00180843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101431625|NCT00180843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101431626|NCT00180843|Adrenergic Agents|adrenergic agents|mesh-ancestor
101431627|NCT00180843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101431628|NCT00180843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431629|NCT00180843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101431630|NCT00180843|Cholinergic Agents|cholinergic agents|mesh-ancestor
101431631|NCT02920567|Octreotide|octreotide|mesh-list
101431632|NCT02920567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101431633|NCT02920567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101431634|NCT02920567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101431635|NCT00180882|Rituximab|rituximab|mesh-list
101431636|NCT00180882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101307261|NCT02033733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307262|NCT02033733|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101307263|NCT02033733|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101467997|NCT01643083|Rifaximin|rifaximin|mesh-list
101431642|NCT00180921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101431643|NCT00180921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101431644|NCT00180921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101431645|NCT00180921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431646|NCT02920489|Sufentanil|sufentanil|mesh-list
101431647|NCT02920489|Dsuvia|dsuvia|mesh-list
101431648|NCT02920489|Ropivacaine|ropivacaine|mesh-list
101431649|NCT02920489|Anesthetics, Local|anesthetics, local|mesh-ancestor
101431650|NCT02920489|Anesthetics|anesthetics|mesh-ancestor
101431651|NCT02920489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101431652|NCT02920489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431653|NCT02920489|Sensory System Agents|sensory system agents|mesh-ancestor
101431654|NCT02920489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101431655|NCT02920489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101431656|NCT02920489|Narcotics|narcotics|mesh-ancestor
101431657|NCT02920489|Analgesics|analgesics|mesh-ancestor
101431658|NCT02920489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101431659|NCT02920489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101431660|NCT02920489|Anesthetics, General|anesthetics, general|mesh-ancestor
101431661|NCT02920372|Epoetin Alfa|epoetin alfa|mesh-list
101431662|NCT02920372|Hematinics|hematinics|mesh-ancestor
101558906|NCT00963937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101558907|NCT00963937|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101558908|NCT00963937|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101558909|NCT00963937|Serotonin Agents|serotonin agents|mesh-ancestor
101558910|NCT00963937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101558911|NCT00963937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558912|NCT00963937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558915|NCT01170663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101558916|NCT01170663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101558917|NCT01170663|Tubulin Modulators|tubulin modulators|mesh-ancestor
101558918|NCT01170663|Antimitotic Agents|antimitotic agents|mesh-ancestor
101558919|NCT01170663|Mitosis Modulators|mitosis modulators|mesh-ancestor
101558920|NCT01170663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558922|NCT04315155|Ipilimumab|ipilimumab|mesh-list
101558923|NCT04315155|Belinostat|belinostat|mesh-list
101558924|NCT04315155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101407350|NCT00107081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101407353|NCT00107081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101431663|NCT00154661|Pentoxifylline|pentoxifylline|mesh-list
101431664|NCT00154661|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101431665|NCT00154661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101431666|NCT00154661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431670|NCT00154661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431671|NCT00154661|Vasodilator Agents|vasodilator agents|mesh-ancestor
101431672|NCT00154661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101431673|NCT00154661|Antioxidants|antioxidants|mesh-ancestor
101431674|NCT00180960|Oxaliplatin|oxaliplatin|mesh-list
101431675|NCT00180960|Irinotecan|irinotecan|mesh-list
101431676|NCT00180960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101431677|NCT00180960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101431678|NCT00180960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101431679|NCT00180960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101431680|NCT00180960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431681|NCT00154700|Folic Acid|folic acid|mesh-list
101431682|NCT00154700|Paclitaxel|paclitaxel|mesh-list
101431683|NCT00154700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101431684|NCT00154700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101431685|NCT00154700|Tubulin Modulators|tubulin modulators|mesh-ancestor
101431686|NCT00154700|Antimitotic Agents|antimitotic agents|mesh-ancestor
101431687|NCT00154700|Mitosis Modulators|mitosis modulators|mesh-ancestor
101431688|NCT00154700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431689|NCT00154700|Hematinics|hematinics|mesh-ancestor
101431690|NCT00154700|Vitamin B Complex|vitamin b complex|mesh-ancestor
101431691|NCT00154700|Vitamins|vitamins|mesh-ancestor
101431692|NCT00154700|Micronutrients|micronutrients|mesh-ancestor
101431693|NCT00154700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431694|NCT04688983|Imatinib Mesylate|imatinib mesylate|mesh-list
101431695|NCT04688983|Blinatumomab|blinatumomab|mesh-list
101431696|NCT04688983|Ponatinib|ponatinib|mesh-list
101431697|NCT04688983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101431698|NCT04688983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101431699|NCT04688983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101431700|NCT04688983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431701|NCT02920060|Levetiracetam|levetiracetam|mesh-list
101431702|NCT02920060|Valproic Acid|valproic acid|mesh-list
101558925|NCT04315155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101558926|NCT04315155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101558927|NCT04315155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558928|NCT04315155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101558929|NCT04315155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101558930|NCT01170273|Vitamin D|vitamin d|mesh-list
101558931|NCT01170273|Vitamins|vitamins|mesh-ancestor
101558932|NCT01170273|Micronutrients|micronutrients|mesh-ancestor
101558933|NCT01170273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558934|NCT01170273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101558935|NCT01170039|Lubiprostone|lubiprostone|mesh-list
101558936|NCT01170039|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101558937|NCT01170039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101558938|NCT01170039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558939|NCT01286558|Amlodipine|amlodipine|mesh-list
101558940|NCT01286558|Telmisartan|telmisartan|mesh-list
101558941|NCT01286558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101558942|NCT01286558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101558943|NCT01286558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101558944|NCT01286558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407369|NCT00439426|Antimetabolites|antimetabolites|mesh-ancestor
101431703|NCT02920060|Anticonvulsants|anticonvulsants|mesh-ancestor
101431704|NCT02920060|Nootropic Agents|nootropic agents|mesh-ancestor
101431705|NCT02920060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101431706|NCT02920060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431707|NCT02920060|GABA Agents|gaba agents|mesh-ancestor
101431708|NCT02920060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101431709|NCT02920060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307264|NCT02033733|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101307265|NCT02033733|Cholinergic Agents|cholinergic agents|mesh-ancestor
101307266|NCT02033733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101431710|NCT02920060|Antimanic Agents|antimanic agents|mesh-ancestor
101431711|NCT02920060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101431716|NCT00154739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101431717|NCT00154739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101431718|NCT00154739|Antimetabolites|antimetabolites|mesh-ancestor
101431719|NCT00154739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431720|NCT00154739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101431721|NCT00154739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101431722|NCT00154739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101431723|NCT00154739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101431724|NCT00154778|Leucovorin|leucovorin|mesh-list
101431725|NCT00154778|Antidotes|antidotes|mesh-ancestor
101431726|NCT00154778|Protective Agents|protective agents|mesh-ancestor
101431727|NCT00154778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431728|NCT00154778|Vitamin B Complex|vitamin b complex|mesh-ancestor
101431729|NCT00154778|Vitamins|vitamins|mesh-ancestor
101431730|NCT00154778|Micronutrients|micronutrients|mesh-ancestor
101431731|NCT02919202|Listerine|listerine|mesh-list
101431732|NCT02919202|Fluorides|fluorides|mesh-list
101431733|NCT02919202|Sodium Fluoride|sodium fluoride|mesh-list
101431734|NCT02919202|Fluorides, Topical|fluorides, topical|mesh-list
101431735|NCT02919202|Cariostatic Agents|cariostatic agents|mesh-ancestor
101431736|NCT02919202|Protective Agents|protective agents|mesh-ancestor
101558945|NCT01286558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101558946|NCT01286558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558947|NCT01286558|Vasodilator Agents|vasodilator agents|mesh-ancestor
101558948|NCT01286558|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101558949|NCT01286558|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101431737|NCT02919202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431738|NCT02919202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101431739|NCT02919202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101431740|NCT00154895|Minocycline|minocycline|mesh-list
101431741|NCT00154895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101431747|NCT02918812|Lidocaine|lidocaine|mesh-list
101431748|NCT02918812|Anesthetics, Local|anesthetics, local|mesh-ancestor
101431749|NCT02918812|Anesthetics|anesthetics|mesh-ancestor
101431750|NCT02918812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101431751|NCT02918812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431752|NCT02918812|Sensory System Agents|sensory system agents|mesh-ancestor
101431753|NCT02918812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101431754|NCT02918812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101431755|NCT02918812|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101431756|NCT02918812|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101431757|NCT02918812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101431758|NCT02918812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431759|NCT02918812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101431760|NCT02918812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101431761|NCT02918812|Analgesics|analgesics|mesh-ancestor
101431762|NCT02918812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101431763|NCT02918812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101431764|NCT02918812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101431765|NCT02918812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101431766|NCT02918110|Misoprostol|misoprostol|mesh-list
101431767|NCT02918110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101431768|NCT02918110|Abortifacient Agents|abortifacient agents|mesh-ancestor
101431769|NCT02918110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101431770|NCT02918110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431771|NCT02918110|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101431772|NCT02918110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101431773|NCT02918110|Oxytocics|oxytocics|mesh-ancestor
101431774|NCT00181272|Azithromycin|azithromycin|mesh-list
101431775|NCT00181272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101431776|NCT00181272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101431777|NCT02910076|Hydroxychloroquine|hydroxychloroquine|mesh-list
101431778|NCT02910076|Antimalarials|antimalarials|mesh-ancestor
101431779|NCT02910076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101431780|NCT02910076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101431781|NCT02910076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101431782|NCT02910076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101431783|NCT02910076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307267|NCT02033733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307268|NCT02034253|Risperidone|risperidone|mesh-list
101307269|NCT02034253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101307270|NCT02034253|Serotonin Agents|serotonin agents|mesh-ancestor
101307271|NCT02034253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101431787|NCT02910115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101431788|NCT02910115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431789|NCT00188565|Celecoxib|celecoxib|mesh-list
101431790|NCT00188565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101431791|NCT00188565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101431792|NCT00188565|Analgesics|analgesics|mesh-ancestor
101431793|NCT00188565|Sensory System Agents|sensory system agents|mesh-ancestor
101431794|NCT00188565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101431795|NCT00188565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431796|NCT00188565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101431797|NCT00188565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101431798|NCT00188565|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101431799|NCT00188565|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101431800|NCT00188565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101558951|NCT01169103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101558952|NCT01169103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558953|NCT01286168|Chlorhexidine|chlorhexidine|mesh-list
101558954|NCT01286168|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101558955|NCT01286168|Sodium Hypochlorite|sodium hypochlorite|mesh-list
101558956|NCT01286168|Eusol|eusol|mesh-list
101558957|NCT01286168|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101558958|NCT01286168|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101431801|NCT00188565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431802|NCT00155246|Pentoxifylline|pentoxifylline|mesh-list
101431803|NCT00155246|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101431804|NCT00155246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101431805|NCT00155246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431806|NCT00155246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101431807|NCT00155246|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101431808|NCT00155246|Protective Agents|protective agents|mesh-ancestor
101431809|NCT00155246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431810|NCT00155246|Vasodilator Agents|vasodilator agents|mesh-ancestor
101431811|NCT00155246|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101431816|NCT02909413|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101431817|NCT02909413|Anesthetics, General|anesthetics, general|mesh-ancestor
101431819|NCT02909413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101431820|NCT02909413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431821|NCT02909257|Bupivacaine|bupivacaine|mesh-list
101431822|NCT02909257|Anesthetics, Local|anesthetics, local|mesh-ancestor
101431823|NCT02909257|Anesthetics|anesthetics|mesh-ancestor
101431824|NCT02909257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101431825|NCT02909257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431826|NCT02909257|Sensory System Agents|sensory system agents|mesh-ancestor
101431827|NCT02909257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101431828|NCT02908945|Ketamine|ketamine|mesh-list
101431829|NCT02908945|Analgesics|analgesics|mesh-ancestor
101431830|NCT02908945|Sensory System Agents|sensory system agents|mesh-ancestor
101431831|NCT02908945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101431832|NCT02908945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431833|NCT02908945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101431834|NCT02908945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101431835|NCT02908945|Anesthetics, General|anesthetics, general|mesh-ancestor
101431836|NCT02908945|Anesthetics|anesthetics|mesh-ancestor
101431837|NCT02908945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101431838|NCT02908945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101431839|NCT02908945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101431840|NCT02908945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101431841|NCT02908945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431842|NCT02939833|Ropivacaine|ropivacaine|mesh-list
101431843|NCT02939833|Anesthetics, Local|anesthetics, local|mesh-ancestor
101431844|NCT02939833|Anesthetics|anesthetics|mesh-ancestor
101431845|NCT02939833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101431846|NCT02939833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307274|NCT02034253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101307275|NCT02034253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101431847|NCT02939833|Sensory System Agents|sensory system agents|mesh-ancestor
101431848|NCT02939833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101431849|NCT00188604|Selenious Acid|selenious acid|mesh-list
101431850|NCT00188604|Sodium Selenite|sodium selenite|mesh-list
101431851|NCT00188604|Trace Elements|trace elements|mesh-ancestor
101431852|NCT00188604|Micronutrients|micronutrients|mesh-ancestor
101468046|NCT01644838|Promethazine|promethazine|mesh-list
101431858|NCT00188643|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101431859|NCT00188643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101431860|NCT00188643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101431861|NCT00188643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101431862|NCT00188643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558959|NCT01286168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101558960|NCT01286168|Disinfectants|disinfectants|mesh-ancestor
101558961|NCT01286168|Dermatologic Agents|dermatologic agents|mesh-ancestor
101558962|NCT02889692|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101558963|NCT02889692|Gefitinib|gefitinib|mesh-list
101558964|NCT02889692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101558965|NCT02889692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101520891|NCT02906514|Plasma Substitutes|plasma substitutes|mesh-ancestor
101558966|NCT02889692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101558967|NCT02889692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431863|NCT00188643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101431864|NCT00188643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431865|NCT00188643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101431866|NCT00188643|Antidepressive Agents|antidepressive agents|mesh-ancestor
101431867|NCT00188643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101431868|NCT00188643|Anticonvulsants|anticonvulsants|mesh-ancestor
101431869|NCT00188643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101431870|NCT00188643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101431871|NCT00188643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101431872|NCT00188643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101431873|NCT00188643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101431874|NCT00188643|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101431875|NCT00533299|Hydralazine|hydralazine|mesh-list
101431876|NCT00533299|Valproic Acid|valproic acid|mesh-list
101431877|NCT00533299|Anticonvulsants|anticonvulsants|mesh-ancestor
101431878|NCT00533299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101431879|NCT00533299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431880|NCT00533299|GABA Agents|gaba agents|mesh-ancestor
101431881|NCT00533299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101431882|NCT00533299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431888|NCT00533299|Vasodilator Agents|vasodilator agents|mesh-ancestor
101431889|NCT04788823|Prednisone|prednisone|mesh-list
101431890|NCT04788823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101431891|NCT04788823|Glucocorticoids|glucocorticoids|mesh-ancestor
101431892|NCT04788823|Hormones|hormones|mesh-ancestor
101431893|NCT04788823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101431894|NCT04788823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431895|NCT04788823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101431896|NCT04788823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101431897|NCT00181584|Zoledronic Acid|zoledronic acid|mesh-list
101431898|NCT00181584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101431899|NCT00181584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431900|NCT00181662|Curcumin|curcumin|mesh-list
101431901|NCT00181662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101431902|NCT00181662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101431903|NCT00181662|Analgesics|analgesics|mesh-ancestor
101431904|NCT00181662|Sensory System Agents|sensory system agents|mesh-ancestor
101431905|NCT00181662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101431906|NCT00181662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431907|NCT00181662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101431908|NCT00181662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101431909|NCT00181662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101431910|NCT00181662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101431911|NCT00181662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431912|NCT00533416|ON 01910|on 01910|mesh-list
101431913|NCT00533416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101431914|NCT00533416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101431915|NCT00533416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101431916|NCT00533416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431917|NCT00155558|Leucovorin|leucovorin|mesh-list
101431918|NCT00155558|Fluorouracil|fluorouracil|mesh-list
101431919|NCT00155558|Antimetabolites|antimetabolites|mesh-ancestor
101307276|NCT02034253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101307277|NCT02034253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101307278|NCT02034253|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101558968|NCT05569382|Verapamil|verapamil|mesh-list
101558969|NCT05569382|Bisoprolol|bisoprolol|mesh-list
101558970|NCT05569382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101558971|NCT05569382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101558972|NCT05569382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101558973|NCT05569382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558974|NCT05569382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101558975|NCT05569382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101558976|NCT05569382|Vasodilator Agents|vasodilator agents|mesh-ancestor
101558977|NCT05569382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101558978|NCT05569382|Sympatholytics|sympatholytics|mesh-ancestor
101558979|NCT05569382|Autonomic Agents|autonomic agents|mesh-ancestor
101407413|NCT00439855|Heparin|heparin|mesh-list
101307279|NCT02034253|Dopamine Agents|dopamine agents|mesh-ancestor
101307280|NCT02035020|Interferons|interferons|mesh-list
101307281|NCT02035020|Interferon-gamma|interferon-gamma|mesh-list
101307282|NCT02035020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101307283|NCT02035020|Antiviral Agents|antiviral agents|mesh-ancestor
101431929|NCT00155558|Vitamins|vitamins|mesh-ancestor
101431930|NCT00155558|Micronutrients|micronutrients|mesh-ancestor
101431931|NCT00533455|Gabapentin|gabapentin|mesh-list
101431932|NCT00533455|Analgesics|analgesics|mesh-ancestor
101431933|NCT00533455|Sensory System Agents|sensory system agents|mesh-ancestor
101431934|NCT00533455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101431935|NCT00533455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431936|NCT00533455|Anticonvulsants|anticonvulsants|mesh-ancestor
101431937|NCT00533455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101431938|NCT00533455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101431939|NCT00533455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101431940|NCT00533455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101431941|NCT00533455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101431942|NCT00533455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101431943|NCT00533455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101431944|NCT00533455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431945|NCT00533455|Antimanic Agents|antimanic agents|mesh-ancestor
101431946|NCT00533533|Docetaxel|docetaxel|mesh-list
101431947|NCT00533533|Oxaliplatin|oxaliplatin|mesh-list
101431948|NCT00533533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101431949|NCT00533533|Tubulin Modulators|tubulin modulators|mesh-ancestor
101431950|NCT00533533|Antimitotic Agents|antimitotic agents|mesh-ancestor
101431951|NCT00533533|Mitosis Modulators|mitosis modulators|mesh-ancestor
101431952|NCT00533533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468068|NCT01644838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101431955|NCT00533611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431956|NCT00533611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101431957|NCT00533611|Antimetabolites|antimetabolites|mesh-ancestor
101431958|NCT00533611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101431959|NCT00533611|Vasodilator Agents|vasodilator agents|mesh-ancestor
101431960|NCT00533611|Vitamin B Complex|vitamin b complex|mesh-ancestor
101431961|NCT00533611|Vitamins|vitamins|mesh-ancestor
101431962|NCT00533611|Micronutrients|micronutrients|mesh-ancestor
101431963|NCT04575844|Liraglutide|liraglutide|mesh-list
101431964|NCT04575844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101431965|NCT04575844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431966|NCT04575844|Incretins|incretins|mesh-ancestor
101431967|NCT04575844|Hormones|hormones|mesh-ancestor
101431968|NCT04575844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101431969|NCT00155714|Sildenafil Citrate|sildenafil citrate|mesh-list
101431970|NCT00155714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
101431971|NCT00155714|Vasodilator Agents|vasodilator agents|mesh-ancestor
101431972|NCT00155714|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101431973|NCT00155714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101431974|NCT00155714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431975|NCT00155714|Urological Agents|urological agents|mesh-ancestor
101558980|NCT05569382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101558981|NCT05569382|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101558982|NCT05569382|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101558983|NCT05569382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101558984|NCT05569382|Adrenergic Agents|adrenergic agents|mesh-ancestor
101558985|NCT05569382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101558986|NCT00963547|Trastuzumab|trastuzumab|mesh-list
101431976|NCT00181740|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101431977|NCT00181740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101431978|NCT00181740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101431979|NCT00181740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101431980|NCT00181740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431981|NCT00181740|Adrenergic Agents|adrenergic agents|mesh-ancestor
101307284|NCT02035020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101307286|NCT02035709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101307287|NCT02035709|Narcotics|narcotics|mesh-ancestor
101307288|NCT02035709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101431982|NCT00181740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101431989|NCT00181779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101431990|NCT00181779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431991|NCT00181779|Dopamine Agonists|dopamine agonists|mesh-ancestor
101431992|NCT00181779|Dopamine Agents|dopamine agents|mesh-ancestor
101431993|NCT00181779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101431994|NCT00181779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431995|NCT00181779|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101431996|NCT00181779|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101431997|NCT00181779|Serotonin Agents|serotonin agents|mesh-ancestor
101431998|NCT00181779|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101431999|NCT00181779|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101432000|NCT00181779|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101432001|NCT00181779|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101432002|NCT00533923|Cyclosporine|cyclosporine|mesh-list
101432003|NCT00533923|Cyclophosphamide|cyclophosphamide|mesh-list
101432004|NCT00533923|Fludarabine|fludarabine|mesh-list
101432005|NCT00533923|Alemtuzumab|alemtuzumab|mesh-list
101432006|NCT00533923|Cyclosporins|cyclosporins|mesh-list
101432007|NCT00533923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101432008|NCT00533923|Immunologic Factors|immunologic factors|mesh-ancestor
101432009|NCT00533923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432010|NCT00533923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101432011|NCT00533923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101432012|NCT00533923|Alkylating Agents|alkylating agents|mesh-ancestor
101360326|NCT00215371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432013|NCT00533923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432014|NCT00533923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101432015|NCT00533923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101432016|NCT00533923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101432017|NCT00533923|Antifungal Agents|antifungal agents|mesh-ancestor
101432018|NCT00533923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101432019|NCT00533923|Dermatologic Agents|dermatologic agents|mesh-ancestor
101432020|NCT00533923|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101432021|NCT00533923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101432023|NCT00409227|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
101432024|NCT00409227|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101432025|NCT00409227|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101432029|NCT00409227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432030|NCT00409227|Urological Agents|urological agents|mesh-ancestor
101432031|NCT00533962|Anecortave|anecortave|mesh-list
101432032|NCT00533962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101432033|NCT00533962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101432034|NCT00533962|Growth Substances|growth substances|mesh-ancestor
101432035|NCT00533962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432036|NCT00533962|Growth Inhibitors|growth inhibitors|mesh-ancestor
101558988|NCT00963547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101558989|NCT00963547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101558990|NCT00963547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101558991|NCT00963547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101558992|NCT00963547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101558994|NCT01285310|Apremilast|apremilast|mesh-list
101558995|NCT01285310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101558996|NCT01285310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101558997|NCT01285310|Analgesics|analgesics|mesh-ancestor
101558998|NCT01285310|Sensory System Agents|sensory system agents|mesh-ancestor
101558999|NCT01285310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101407432|NCT00107354|Antiviral Agents|antiviral agents|mesh-ancestor
101432037|NCT00533962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101432038|NCT00181818|Bupropion|bupropion|mesh-list
101432039|NCT00181818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101432040|NCT00181818|Antidepressive Agents|antidepressive agents|mesh-ancestor
101432041|NCT00181818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101432042|NCT00181818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101432043|NCT00181818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101432044|NCT00181818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101432045|NCT00181818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432046|NCT00181818|Dopamine Agents|dopamine agents|mesh-ancestor
101432047|NCT00181818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101432048|NCT00181818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432049|NCT00181818|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101468099|NCT01645384|Atorvastatin|atorvastatin|mesh-list
101307289|NCT02035709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307290|NCT02035709|Analgesics|analgesics|mesh-ancestor
101432050|NCT00181818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101432051|NCT00181818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101432052|NCT04462627|Antibodies|antibodies|mesh-list
101432057|NCT00406601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101432058|NCT00406601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101432059|NCT00406601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432060|NCT00409305|Betahistine|betahistine|mesh-list
101432061|NCT00409305|Vasodilator Agents|vasodilator agents|mesh-ancestor
101432062|NCT00409305|Histamine Agonists|histamine agonists|mesh-ancestor
101432063|NCT00409305|Histamine Agents|histamine agents|mesh-ancestor
101432064|NCT00409305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101432065|NCT00409305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432066|NCT00409305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432067|NCT00406679|Acetaminophen|acetaminophen|mesh-list
101432068|NCT00406679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101432069|NCT00406679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101432070|NCT00406679|Analgesics|analgesics|mesh-ancestor
101432071|NCT00406679|Sensory System Agents|sensory system agents|mesh-ancestor
101432072|NCT00406679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101432073|NCT00406679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432074|NCT00406679|Antipyretics|antipyretics|mesh-ancestor
101432075|NCT00181896|Bupropion|bupropion|mesh-list
101432076|NCT00181896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101432077|NCT00181896|Antidepressive Agents|antidepressive agents|mesh-ancestor
101432078|NCT00181896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101432079|NCT00181896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101432080|NCT00181896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101432081|NCT00181896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101432082|NCT00181896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432083|NCT00181896|Dopamine Agents|dopamine agents|mesh-ancestor
101432084|NCT00181896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101559000|NCT01285310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559001|NCT01285310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101559002|NCT01285310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101559003|NCT01285310|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101559004|NCT01285310|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101559005|NCT01285310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101559006|NCT01285310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407447|NCT00138177|Levoleucovorin|levoleucovorin|mesh-list
101432085|NCT00181896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432086|NCT00181896|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101432087|NCT00181896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101432088|NCT00181896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101432089|NCT04686448|Fentanyl|fentanyl|mesh-list
101432090|NCT04686448|Ketamine|ketamine|mesh-list
101432091|NCT04686448|Propofol|propofol|mesh-list
101432092|NCT04686448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101432093|NCT04686448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101432095|NCT04686448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101432096|NCT04686448|Anesthetics, General|anesthetics, general|mesh-ancestor
101432101|NCT04686448|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101432102|NCT04686448|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101432103|NCT04686448|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101432104|NCT04686448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101432105|NCT04686448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432106|NCT04686448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101432107|NCT04686448|Narcotics|narcotics|mesh-ancestor
101432108|NCT04686448|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101432109|NCT00181935|Olanzapine|olanzapine|mesh-list
101432110|NCT00181935|Risperidone|risperidone|mesh-list
101432111|NCT00181935|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101432112|NCT00181935|Serotonin Agents|serotonin agents|mesh-ancestor
101432113|NCT00181935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101432114|NCT00181935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432115|NCT00181935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432116|NCT00181935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101432117|NCT00181935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101432118|NCT00181935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101432119|NCT00181935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101432120|NCT00181935|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101432121|NCT00181935|Dopamine Agents|dopamine agents|mesh-ancestor
101432122|NCT00181935|Antiemetics|antiemetics|mesh-ancestor
101432123|NCT00181935|Autonomic Agents|autonomic agents|mesh-ancestor
101432124|NCT00181935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101307291|NCT02035709|Sensory System Agents|sensory system agents|mesh-ancestor
101307292|NCT02035709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101307293|NCT02035891|Colchicine|colchicine|mesh-list
101432125|NCT00181935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101432130|NCT00409383|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101432131|NCT00409383|Temozolomide|temozolomide|mesh-list
101432132|NCT00409383|Oblimersen|oblimersen|mesh-list
101432133|NCT00409383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101432134|NCT00409383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101432135|NCT00409383|Tubulin Modulators|tubulin modulators|mesh-ancestor
101432136|NCT00409383|Antimitotic Agents|antimitotic agents|mesh-ancestor
101432137|NCT00409383|Mitosis Modulators|mitosis modulators|mesh-ancestor
101432138|NCT00409383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432139|NCT00409383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101432140|NCT00409383|Alkylating Agents|alkylating agents|mesh-ancestor
101432141|NCT04893148|Insulin Glargine|insulin glargine|mesh-list
101432142|NCT04893148|Dulaglutide|dulaglutide|mesh-list
101432143|NCT04893148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101432144|NCT04893148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432145|NCT04883632|Lidocaine|lidocaine|mesh-list
101432146|NCT04883632|Anesthetics, Local|anesthetics, local|mesh-ancestor
101432147|NCT04883632|Anesthetics|anesthetics|mesh-ancestor
101432148|NCT04883632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101432149|NCT04883632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559008|NCT01285310|Immunologic Factors|immunologic factors|mesh-ancestor
101559009|NCT01285310|Leprostatic Agents|leprostatic agents|mesh-ancestor
101559010|NCT01285310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101559011|NCT01285310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101559012|NCT01285310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101559013|NCT01285310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101559014|NCT01285310|Growth Substances|growth substances|mesh-ancestor
101432150|NCT04883632|Sensory System Agents|sensory system agents|mesh-ancestor
101432151|NCT04883632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101432152|NCT04883632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101432153|NCT04883632|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101432154|NCT04883632|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101432155|NCT04883632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101432156|NCT04883632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432157|NCT00181974|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101432158|NCT00181974|Hemostatics|hemostatics|mesh-ancestor
101432159|NCT00181974|Coagulants|coagulants|mesh-ancestor
101432160|NCT02569645|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101432161|NCT02569645|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101432162|NCT02569645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101432163|NCT02569645|Antimetabolites|antimetabolites|mesh-ancestor
101432164|NCT02569645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432165|NCT02569645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101432166|NCT02569645|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101432173|NCT00182013|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101432174|NCT00182013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101432175|NCT00182013|Serotonin Agents|serotonin agents|mesh-ancestor
101432176|NCT00182013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101468155|NCT01646554|Oxaliplatin|oxaliplatin|mesh-list
101432177|NCT00182013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432178|NCT00182013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432179|NCT00182013|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101432180|NCT00182013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101432181|NCT00182013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101432182|NCT00182013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101432183|NCT00182013|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101432184|NCT00182013|Dopamine Agents|dopamine agents|mesh-ancestor
101432185|NCT00182013|Antiemetics|antiemetics|mesh-ancestor
101432186|NCT00182013|Autonomic Agents|autonomic agents|mesh-ancestor
101432187|NCT00182013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101432188|NCT00182013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101432189|NCT00182013|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101432190|NCT00182013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101432191|NCT00182013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101432192|NCT00182013|Antidepressive Agents|antidepressive agents|mesh-ancestor
101432193|NCT00182052|Rosiglitazone|rosiglitazone|mesh-list
101432194|NCT00182052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101432195|NCT00182052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432196|NCT02081755|Mycophenolic Acid|mycophenolic acid|mesh-list
101307294|NCT02035891|Gout Suppressants|gout suppressants|mesh-ancestor
101307295|NCT02035891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101432197|NCT02081755|Everolimus|everolimus|mesh-list
101432198|NCT02081755|Azathioprine|azathioprine|mesh-list
101432199|NCT02081755|Tacrolimus|tacrolimus|mesh-list
101432205|NCT02081755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432206|NCT02081755|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101432207|NCT02081755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101432208|NCT02081755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101432209|NCT02081755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101432210|NCT02081755|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101432211|NCT02081755|Antitubercular Agents|antitubercular agents|mesh-ancestor
101432212|NCT02081755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101432213|NCT02081755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101432214|NCT02081755|Antimetabolites|antimetabolites|mesh-ancestor
101432215|NCT02081755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101559016|NCT01285310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101559017|NCT01254630|Vaccines|vaccines|mesh-list
101559018|NCT01254630|Immunologic Factors|immunologic factors|mesh-ancestor
101559019|NCT01254630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559020|NCT01253304|Dulaglutide|dulaglutide|mesh-list
101559021|NCT01253304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101559022|NCT01253304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559023|NCT04319484|Lenvatinib|lenvatinib|mesh-list
101559024|NCT04319484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101559025|NCT04319484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101559026|NCT04319484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101432216|NCT02081755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101432217|NCT01715974|Molgramostim|molgramostim|mesh-list
101432218|NCT01715974|Sargramostim|sargramostim|mesh-list
101432219|NCT01715974|Immunologic Factors|immunologic factors|mesh-ancestor
101432220|NCT01715974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432221|NCT01715974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101432222|NCT05471479|Charcoal|charcoal|mesh-list
101432223|NCT05471479|Antidotes|antidotes|mesh-ancestor
101432224|NCT05471479|Protective Agents|protective agents|mesh-ancestor
101432225|NCT05471479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432226|NCT00188877|Fluorouracil|fluorouracil|mesh-list
101432227|NCT00188877|Antimetabolites|antimetabolites|mesh-ancestor
101432228|NCT00188877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432229|NCT00188877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101432230|NCT00188877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101432231|NCT00188877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101432232|NCT00188877|Immunologic Factors|immunologic factors|mesh-ancestor
101432233|NCT00188877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432234|NCT00182169|Hormones|hormones|mesh-list
101432235|NCT00182169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101432236|NCT00182169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432237|NCT05471050|Danazol|danazol|mesh-list
101432238|NCT05471050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101432239|NCT05471050|Hormone Antagonists|hormone antagonists|mesh-ancestor
101432255|NCT04686058|Anesthetics|anesthetics|mesh-ancestor
101432256|NCT04686058|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101432257|NCT04686058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101432258|NCT04686058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101432259|NCT04686058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101432260|NCT04686058|GABA Modulators|gaba modulators|mesh-ancestor
101432261|NCT04686058|GABA Agents|gaba agents|mesh-ancestor
101432262|NCT04686058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101432263|NCT04686058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432264|NCT04686058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101432265|NCT04686058|Narcotics|narcotics|mesh-ancestor
101432266|NCT04686058|Analgesics|analgesics|mesh-ancestor
101432267|NCT04686058|Sensory System Agents|sensory system agents|mesh-ancestor
101432268|NCT04686058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101432269|NCT00156299|Dexamethasone|dexamethasone|mesh-list
101432270|NCT00156299|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
101432272|NCT00156299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101432273|NCT00156299|Antiemetics|antiemetics|mesh-ancestor
101432274|NCT00156299|Autonomic Agents|autonomic agents|mesh-ancestor
101432275|NCT00156299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101432276|NCT00156299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432277|NCT00156299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101432278|NCT00156299|Glucocorticoids|glucocorticoids|mesh-ancestor
101432279|NCT00156299|Hormones|hormones|mesh-ancestor
101432280|NCT00156299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101432281|NCT00156299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101432282|NCT00156299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101432283|NCT00156299|Lipotropic Agents|lipotropic agents|mesh-ancestor
101432284|NCT00156299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101432285|NCT00156299|Antimetabolites|antimetabolites|mesh-ancestor
101559027|NCT04319484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559028|NCT01253226|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101559029|NCT01253226|Immunologic Factors|immunologic factors|mesh-ancestor
101559030|NCT01253226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559031|NCT01252134|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101559032|NCT00624312|Epoetin Alfa|epoetin alfa|mesh-list
101559033|NCT00624312|Hematinics|hematinics|mesh-ancestor
101559034|NCT01250418|Ketamine|ketamine|mesh-list
101559035|NCT01250418|Analgesics|analgesics|mesh-ancestor
101559036|NCT01250418|Sensory System Agents|sensory system agents|mesh-ancestor
101307297|NCT02035891|Antimitotic Agents|antimitotic agents|mesh-ancestor
101432288|NCT00156299|Nootropic Agents|nootropic agents|mesh-ancestor
101432289|NCT00156299|Analgesics|analgesics|mesh-ancestor
101432290|NCT00156299|Sensory System Agents|sensory system agents|mesh-ancestor
101468172|NCT01646788|Paclitaxel|paclitaxel|mesh-list
101432291|NCT00156299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101432292|NCT00156299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101432293|NCT00156299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101432294|NCT00535951|Panobinostat|panobinostat|mesh-list
101432295|NCT00535951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101432296|NCT00535951|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101432297|NCT00535951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101432298|NCT00535951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432299|NCT00188955|Sirolimus|sirolimus|mesh-list
101432300|NCT00188955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101432308|NCT00536068|Acetaminophen|acetaminophen|mesh-list
101432309|NCT00536068|Aspirin|aspirin|mesh-list
101432310|NCT00536068|Diclofenac|diclofenac|mesh-list
101432311|NCT00536068|Naproxen|naproxen|mesh-list
101432312|NCT00536068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101432313|NCT00536068|Analgesics|analgesics|mesh-ancestor
101432314|NCT00536068|Sensory System Agents|sensory system agents|mesh-ancestor
101432315|NCT00536068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101432316|NCT00536068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432317|NCT00536068|Antipyretics|antipyretics|mesh-ancestor
101432318|NCT00536068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101432319|NCT00536068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101432320|NCT00536068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101432321|NCT00536068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101432322|NCT00536068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101432323|NCT00536068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432324|NCT00536068|Gout Suppressants|gout suppressants|mesh-ancestor
101432325|NCT00536068|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101432326|NCT00536068|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101432327|NCT00536068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101432328|NCT05470582|Vaccines|vaccines|mesh-list
101432329|NCT05470582|Immunologic Factors|immunologic factors|mesh-ancestor
101432330|NCT05470582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432331|NCT00156377|Mupirocin|mupirocin|mesh-list
101432332|NCT00156377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101432333|NCT00156377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101432334|NCT00156377|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101432335|NCT00156377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101432336|NCT00156377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432337|NCT00188994|Insulin|insulin|mesh-list
101432338|NCT00188994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101432339|NCT00188994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432340|NCT05469880|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101432341|NCT05469880|Dermatologic Agents|dermatologic agents|mesh-ancestor
101432342|NCT00408525|Donepezil|donepezil|mesh-list
101432343|NCT00408525|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101432344|NCT00408525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101432345|NCT00408525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432346|NCT00408525|Cholinergic Agents|cholinergic agents|mesh-ancestor
101432347|NCT00408525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101432348|NCT00408525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432349|NCT00408525|Nootropic Agents|nootropic agents|mesh-ancestor
101432350|NCT05469529|Dexmedetomidine|dexmedetomidine|mesh-list
101559037|NCT01250418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101559038|NCT01250418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559039|NCT01250418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101559040|NCT01250418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101559041|NCT01250418|Anesthetics, General|anesthetics, general|mesh-ancestor
101559042|NCT01250418|Anesthetics|anesthetics|mesh-ancestor
101559043|NCT01250418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101432351|NCT05469529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101432352|NCT05469529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101468192|NCT04528927|Azithromycin|azithromycin|mesh-list
101432353|NCT05469529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432354|NCT05469529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101432355|NCT05469529|Analgesics|analgesics|mesh-ancestor
101432356|NCT05469529|Sensory System Agents|sensory system agents|mesh-ancestor
101432357|NCT05469529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101432358|NCT05469529|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101432359|NCT05469529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101432360|NCT05469529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101432361|NCT05469529|Adrenergic Agents|adrenergic agents|mesh-ancestor
101432362|NCT05469529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101307299|NCT02035891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432363|NCT05469529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432364|NCT00189033|Psyllium|psyllium|mesh-list
101432365|NCT00189033|Cathartics|cathartics|mesh-ancestor
101432366|NCT00189033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101432367|NCT05469061|Cisplatin|cisplatin|mesh-list
101432368|NCT05469061|Tislelizumab|tislelizumab|mesh-list
101432369|NCT05469061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101432374|NCT05469022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432376|NCT00189072|Analgesics|analgesics|mesh-ancestor
101432377|NCT00189072|Sensory System Agents|sensory system agents|mesh-ancestor
101432378|NCT00189072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101432379|NCT00189072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432380|NCT00189072|Anticonvulsants|anticonvulsants|mesh-ancestor
101432381|NCT00189072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101432382|NCT00189072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101432383|NCT00189072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101432384|NCT00189072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101432385|NCT00189072|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101432386|NCT00189072|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101432387|NCT00189072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101432388|NCT00189072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432389|NCT00189072|Antimanic Agents|antimanic agents|mesh-ancestor
101432390|NCT00156611|Abciximab|abciximab|mesh-list
101432391|NCT00156611|Anticoagulants|anticoagulants|mesh-ancestor
101432392|NCT00156611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101432393|NCT00156650|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101432394|NCT00156650|Medroxyprogesterone|medroxyprogesterone|mesh-list
101432395|NCT00156650|Testosterone|testosterone|mesh-list
101432396|NCT00156650|Acyline|acyline|mesh-list
101432397|NCT00156650|Androgens|androgens|mesh-ancestor
101432398|NCT00156650|Hormones|hormones|mesh-ancestor
101432399|NCT00156650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101432400|NCT00156650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432401|NCT00156650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101432402|NCT00156650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101432403|NCT00156650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101432404|NCT00156650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101432405|NCT00156650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101432406|NCT00156650|Contraceptive Agents|contraceptive agents|mesh-ancestor
101432407|NCT00156650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101432408|NCT00156650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101432409|NCT00156650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101432410|NCT00156650|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101432411|NCT00156650|Hormone Antagonists|hormone antagonists|mesh-ancestor
101432412|NCT00536419|Methylphenidate|methylphenidate|mesh-list
101432413|NCT00536419|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101559044|NCT01250418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101559045|NCT01250418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101559046|NCT01250418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101559047|NCT01250418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559048|NCT05491356|Plasminogen|plasminogen|mesh-list
101407489|NCT00138216|Antimitotic Agents|antimitotic agents|mesh-ancestor
101432414|NCT00536419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432415|NCT00536419|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101432416|NCT00536419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101432417|NCT00536419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101432418|NCT00536419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432419|NCT00536419|Dopamine Agents|dopamine agents|mesh-ancestor
101432420|NCT00536419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101432421|NCT00189150|Mycophenolic Acid|mycophenolic acid|mesh-list
101432422|NCT00189150|Valganciclovir|valganciclovir|mesh-list
101432423|NCT00189150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101432424|NCT00189150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101432425|NCT00189150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101432426|NCT00189150|Antitubercular Agents|antitubercular agents|mesh-ancestor
101432427|NCT00189150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101432428|NCT00189150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101432429|NCT00189150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101307305|NCT02036151|Fluorides, Topical|fluorides, topical|mesh-list
101307306|NCT02036151|Cariostatic Agents|cariostatic agents|mesh-ancestor
101307307|NCT02036151|Protective Agents|protective agents|mesh-ancestor
101432430|NCT00189150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432431|NCT00189150|Antiviral Agents|antiviral agents|mesh-ancestor
101432438|NCT05468164|Omeprazole|omeprazole|mesh-list
101432449|NCT05468047|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101432450|NCT05468047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101432451|NCT05468047|Anesthetics, General|anesthetics, general|mesh-ancestor
101432452|NCT05468047|Anesthetics|anesthetics|mesh-ancestor
101432453|NCT05468047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101432454|NCT05468047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101432455|NCT05468047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101432456|NCT05468047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101432457|NCT05468047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432458|NCT00182364|Heparin|heparin|mesh-list
101432459|NCT00182364|Calcium heparin|calcium heparin|mesh-list
101432460|NCT00182364|Dalteparin|dalteparin|mesh-list
101432461|NCT00182364|Tinzaparin|tinzaparin|mesh-list
101432462|NCT00182364|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101432463|NCT00182364|Anticoagulants|anticoagulants|mesh-ancestor
101432464|NCT00182364|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101432465|NCT00182364|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101432466|NCT00182364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432467|NCT00536653|Calcium, Dietary|calcium, dietary|mesh-list
101432468|NCT00536653|Vitamin D|vitamin d|mesh-list
101432469|NCT00536653|Ergocalciferols|ergocalciferols|mesh-list
101432470|NCT00536653|Cholecalciferol|cholecalciferol|mesh-list
101432471|NCT00536653|Vitamins|vitamins|mesh-list
101432472|NCT00536653|Goserelin|goserelin|mesh-list
101432473|NCT00536653|Bicalutamide|bicalutamide|mesh-list
101432474|NCT00536653|Calcium|calcium|mesh-list
101432475|NCT00536653|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101432476|NCT00536653|Micronutrients|micronutrients|mesh-ancestor
101432477|NCT00536653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432478|NCT00536653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101432479|NCT00536653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101432480|NCT00536653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101432481|NCT00536653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101432482|NCT00536653|Androgen Antagonists|androgen antagonists|mesh-ancestor
101432483|NCT00536653|Hormone Antagonists|hormone antagonists|mesh-ancestor
101432484|NCT00536653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101432485|NCT00536653|Hormones|hormones|mesh-ancestor
101432486|NCT05467852|Dydrogesterone|dydrogesterone|mesh-list
101432487|NCT05467852|Progestins|progestins|mesh-ancestor
101432488|NCT05467852|Hormones|hormones|mesh-ancestor
101432489|NCT05467852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101559049|NCT05491356|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101559050|NCT05491356|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101559051|NCT05491356|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101559052|NCT05491356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559053|NCT01292603|Cyclophosphamide|cyclophosphamide|mesh-list
101559054|NCT01292603|Rituximab|rituximab|mesh-list
101559055|NCT01292603|Fludarabine|fludarabine|mesh-list
101559056|NCT01292603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101559057|NCT01292603|Immunologic Factors|immunologic factors|mesh-ancestor
101559058|NCT01292603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559059|NCT01292603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101559060|NCT01292603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101432490|NCT05467852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432491|NCT00536692|Mecamylamine|mecamylamine|mesh-list
101432492|NCT00536692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101432493|NCT00536692|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
101432494|NCT00536692|Autonomic Agents|autonomic agents|mesh-ancestor
101432495|NCT00536692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101432496|NCT00536692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432497|NCT00536692|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101432498|NCT00536692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101432499|NCT00536692|Cholinergic Agents|cholinergic agents|mesh-ancestor
101432500|NCT00536692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101432501|NCT00536692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432502|NCT00189345|Catumaxomab|catumaxomab|mesh-list
101432503|NCT00189345|Muromonab-CD3|muromonab-cd3|mesh-list
101432504|NCT00189345|Immunologic Factors|immunologic factors|mesh-ancestor
101432520|NCT00182442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101432521|NCT00182442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101432522|NCT00182442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101432523|NCT00182442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101432524|NCT00182442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101307308|NCT02036151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307309|NCT02036255|Taurolidine|taurolidine|mesh-list
101307310|NCT02036255|Heparin|heparin|mesh-list
101432525|NCT00182442|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101432536|NCT00536770|Antimetabolites|antimetabolites|mesh-ancestor
101432537|NCT00536770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432538|NCT00536770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101432539|NCT00536770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101432540|NCT00536770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101432541|NCT00536770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101432542|NCT00536770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432543|NCT00536770|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101432544|NCT00536770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101432545|NCT00536770|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101432546|NCT00536770|Vitamins|vitamins|mesh-ancestor
101432547|NCT00536770|Micronutrients|micronutrients|mesh-ancestor
101432548|NCT00536770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101432549|NCT04685512|Tenofovir|tenofovir|mesh-list
101432550|NCT04685512|Emtricitabine|emtricitabine|mesh-list
101432551|NCT04685512|Antiviral Agents|antiviral agents|mesh-ancestor
101432552|NCT04685512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101432553|NCT04685512|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101432554|NCT04685512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101432555|NCT04685512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101432556|NCT04685512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432557|NCT04685512|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101432558|NCT04685512|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101432559|NCT00157040|Factor VIII|factor viii|mesh-list
101432560|NCT00157040|Coagulants|coagulants|mesh-ancestor
101432561|NCT00189384|Gentamicins|gentamicins|mesh-list
101432562|NCT00189384|Ceftriaxone|ceftriaxone|mesh-list
101432563|NCT00189384|Penicillins|penicillins|mesh-list
101559061|NCT01292603|Alkylating Agents|alkylating agents|mesh-ancestor
101559062|NCT01292603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559063|NCT01292603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101559064|NCT01292603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101559065|NCT01292603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101559066|NCT01292057|Aripiprazole|aripiprazole|mesh-list
101559067|NCT01292057|Antidepressive Agents|antidepressive agents|mesh-ancestor
101559068|NCT01292057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101559069|NCT01292057|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101559070|NCT01292057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101559071|NCT01292057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101559072|NCT01292057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559073|NCT01292057|Dopamine Agonists|dopamine agonists|mesh-ancestor
101559074|NCT01292057|Dopamine Agents|dopamine agents|mesh-ancestor
101559075|NCT01292057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101559076|NCT01292057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559077|NCT01292057|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101559078|NCT01292057|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101559079|NCT01292057|Serotonin Agents|serotonin agents|mesh-ancestor
101559080|NCT01292057|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101559081|NCT01292057|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101559082|NCT01292057|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101407507|NCT00439972|Ortho Evra|ortho evra|mesh-list
101432564|NCT00189384|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101432565|NCT00189384|Penicillin G Procaine|penicillin g procaine|mesh-list
101432566|NCT00189384|Penicillin G|penicillin g|mesh-list
101432573|NCT00189384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432574|NCT00189384|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101432576|NCT00189384|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101432577|NCT00189384|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101432578|NCT00189384|Anesthetics, Local|anesthetics, local|mesh-ancestor
101432579|NCT00189384|Anesthetics|anesthetics|mesh-ancestor
101432580|NCT00189384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101432581|NCT00189384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432582|NCT00189384|Sensory System Agents|sensory system agents|mesh-ancestor
101432583|NCT00189384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101432584|NCT00536848|Metronidazole|metronidazole|mesh-list
101432585|NCT00536848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101432586|NCT00536848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101432587|NCT00536848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101432588|NCT00536848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101432589|NCT00157079|Immunoglobulins|immunoglobulins|mesh-list
101432590|NCT00157079|Antibodies|antibodies|mesh-list
101432591|NCT00157079|gamma-Globulins|gamma-globulins|mesh-list
101432592|NCT00157079|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101432593|NCT00157079|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101432594|NCT00157079|Immunologic Factors|immunologic factors|mesh-ancestor
101432595|NCT00157079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432596|NCT00189501|Cinacalcet|cinacalcet|mesh-list
101559083|NCT01292057|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101559084|NCT01290887|Reslizumab|reslizumab|mesh-list
101559085|NCT01290887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101559086|NCT01290887|Respiratory System Agents|respiratory system agents|mesh-ancestor
101559087|NCT01290731|Interferons|interferons|mesh-list
101559088|NCT01290731|Ribavirin|ribavirin|mesh-list
101559089|NCT01290731|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101559090|NCT01290731|Simeprevir|simeprevir|mesh-list
101559091|NCT01290731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101559092|NCT01290731|Antiviral Agents|antiviral agents|mesh-ancestor
101559093|NCT01290731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101407530|NCT00440128|Antiemetics|antiemetics|mesh-ancestor
101432597|NCT00189501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101307312|NCT02036255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101307313|NCT02036255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101432601|NCT00189501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101432602|NCT00157118|Protein C|protein c|mesh-list
101432603|NCT00157118|Anticoagulants|anticoagulants|mesh-ancestor
101432604|NCT00157118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101432605|NCT00157118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101432606|NCT00157118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432607|NCT00189579|Trastuzumab|trastuzumab|mesh-list
101432608|NCT00189579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101432609|NCT00189579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101432610|NCT00157235|Bromides|bromides|mesh-list
101432611|NCT00157235|Tiotropium Bromide|tiotropium bromide|mesh-list
101432612|NCT00157235|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101432613|NCT00157235|Autonomic Agents|autonomic agents|mesh-ancestor
101432614|NCT00157235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101432615|NCT00157235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432616|NCT00157235|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101432617|NCT00157235|Respiratory System Agents|respiratory system agents|mesh-ancestor
101432618|NCT00157235|Parasympatholytics|parasympatholytics|mesh-ancestor
101432619|NCT00157235|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101432620|NCT00157235|Cholinergic Agents|cholinergic agents|mesh-ancestor
101432621|NCT00157235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101432622|NCT00157235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432624|NCT00182520|Topiramate|topiramate|mesh-list
101432625|NCT00182520|Anticonvulsants|anticonvulsants|mesh-ancestor
101432626|NCT00182520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101432627|NCT00182520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432628|NCT00157274|Alemtuzumab|alemtuzumab|mesh-list
101432629|NCT00157274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101432630|NCT00157274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101432631|NCT04257487|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
101432632|NCT04257487|Anticoagulants|anticoagulants|mesh-ancestor
101432633|NCT04257487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101432634|NCT04257487|Antimetabolites|antimetabolites|mesh-ancestor
101432635|NCT04257487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432636|NCT04257487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101432653|NCT00182559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101432654|NCT00425568|Testosterone|testosterone|mesh-list
101432655|NCT00425568|Androgens|androgens|mesh-ancestor
101432656|NCT00425568|Hormones|hormones|mesh-ancestor
101432657|NCT00425568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101432658|NCT00425568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432659|NCT00157508|Nitroaspirin|nitroaspirin|mesh-list
101432660|NCT00157508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101432661|NCT00157508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101432662|NCT00157508|Analgesics|analgesics|mesh-ancestor
101432663|NCT00157508|Sensory System Agents|sensory system agents|mesh-ancestor
101432664|NCT00157508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101432665|NCT00157508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432666|NCT00157508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101432667|NCT00157508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101559094|NCT01290731|Antimetabolites|antimetabolites|mesh-ancestor
101559095|NCT01290731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559096|NCT01290731|Protease Inhibitors|protease inhibitors|mesh-ancestor
101559097|NCT01290731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101559098|NCT01290341|Naftifine|naftifine|mesh-list
101559099|NCT01290341|Antifungal Agents|antifungal agents|mesh-ancestor
101432668|NCT00157508|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101432669|NCT00157508|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101432670|NCT00157508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432671|NCT00157508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101432672|NCT00157508|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
101432673|NCT00157508|Protease Inhibitors|protease inhibitors|mesh-ancestor
101432674|NCT00157508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101432675|NCT00189618|Aspirin|aspirin|mesh-list
101432676|NCT00189618|Clopidogrel|clopidogrel|mesh-list
101432677|NCT00189618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101432678|NCT00189618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101432679|NCT00189618|Analgesics|analgesics|mesh-ancestor
101432680|NCT00189618|Sensory System Agents|sensory system agents|mesh-ancestor
101432681|NCT00189618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101432682|NCT00189618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432688|NCT00189618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101432689|NCT00189618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101432690|NCT00189618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101432691|NCT00189618|Antipyretics|antipyretics|mesh-ancestor
101432692|NCT00189618|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101432693|NCT00189618|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101432702|NCT00406796|Growth Inhibitors|growth inhibitors|mesh-ancestor
101432703|NCT00406796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101432704|NCT00534391|Polymyxins|polymyxins|mesh-list
101432705|NCT00534391|Neomycin|neomycin|mesh-list
101432706|NCT00534391|Polymyxin B|polymyxin b|mesh-list
101432707|NCT00534391|Gramicidin|gramicidin|mesh-list
101432708|NCT00534391|Lubricant Eye Drops|lubricant eye drops|mesh-list
101432709|NCT00534391|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101432710|NCT00534391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101432711|NCT00534391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101432712|NCT00534391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101432713|NCT00534391|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101432714|NCT00534391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101432715|NCT00534391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432716|NCT00534391|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101432717|NCT00534508|Tacrolimus|tacrolimus|mesh-list
101432718|NCT00534508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101432719|NCT00534508|Immunologic Factors|immunologic factors|mesh-ancestor
101432720|NCT00534508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432721|NCT00534508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101432722|NCT00534508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101432723|NCT00534508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432724|NCT00182715|Leucovorin|leucovorin|mesh-list
101432725|NCT00182715|Fluorouracil|fluorouracil|mesh-list
101432726|NCT00182715|Capecitabine|capecitabine|mesh-list
101432727|NCT00182715|Oxaliplatin|oxaliplatin|mesh-list
101432728|NCT00182715|Cetuximab|cetuximab|mesh-list
101432729|NCT00182715|Calcium|calcium|mesh-list
101432730|NCT00182715|Levoleucovorin|levoleucovorin|mesh-list
101432731|NCT00182715|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101432732|NCT00182715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432733|NCT00182715|Antimetabolites|antimetabolites|mesh-ancestor
101432734|NCT00182715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432735|NCT00182715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101432736|NCT00182715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101432737|NCT00182715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101432738|NCT00182715|Immunologic Factors|immunologic factors|mesh-ancestor
101432739|NCT00182715|Antidotes|antidotes|mesh-ancestor
101432740|NCT00182715|Protective Agents|protective agents|mesh-ancestor
101432741|NCT00182715|Vitamin B Complex|vitamin b complex|mesh-ancestor
101432742|NCT00182715|Vitamins|vitamins|mesh-ancestor
101432743|NCT00182715|Micronutrients|micronutrients|mesh-ancestor
101432744|NCT00182715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101559100|NCT01290341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101559101|NCT01290263|Bevacizumab|bevacizumab|mesh-list
101559102|NCT01290263|Trebananib|trebananib|mesh-list
101559103|NCT01290263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101559104|NCT01290263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101559105|NCT01290263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101559106|NCT01290263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101559107|NCT01290263|Growth Substances|growth substances|mesh-ancestor
101559108|NCT01290263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559109|NCT01290263|Growth Inhibitors|growth inhibitors|mesh-ancestor
101559110|NCT01290029|Cinacalcet|cinacalcet|mesh-list
101559111|NCT01290029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101432745|NCT00534586|Ketamine|ketamine|mesh-list
101432746|NCT00534586|Remifentanil|remifentanil|mesh-list
101432747|NCT00534586|Propofol|propofol|mesh-list
101432748|NCT00534586|Sevoflurane|sevoflurane|mesh-list
101432749|NCT00534586|Esketamine|esketamine|mesh-list
101432750|NCT00534586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101432751|NCT00534586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101432752|NCT00534586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432753|NCT00534586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101432754|NCT00534586|Anesthetics, General|anesthetics, general|mesh-ancestor
101432755|NCT00534586|Anesthetics|anesthetics|mesh-ancestor
101432756|NCT00534586|Analgesics|analgesics|mesh-ancestor
101432757|NCT00534586|Sensory System Agents|sensory system agents|mesh-ancestor
101432758|NCT00534586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101432759|NCT00534586|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101432763|NCT00534586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432764|NCT00534586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101307317|NCT02036255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101307318|NCT02038062|Sevoflurane|sevoflurane|mesh-list
101307319|NCT02038062|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101307320|NCT02038062|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101307321|NCT02038062|Anesthetics, General|anesthetics, general|mesh-ancestor
101307322|NCT02038062|Anesthetics|anesthetics|mesh-ancestor
101432765|NCT00534586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101432768|NCT00534586|Antidepressive Agents|antidepressive agents|mesh-ancestor
101432769|NCT00534586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101432770|NCT00534625|Zileuton|zileuton|mesh-list
101432771|NCT00534625|Hydroxyurea|hydroxyurea|mesh-list
101432772|NCT00534625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101432773|NCT00534625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101432774|NCT00534625|Analgesics|analgesics|mesh-ancestor
101432775|NCT00534625|Sensory System Agents|sensory system agents|mesh-ancestor
101432776|NCT00534625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101432777|NCT00534625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432778|NCT00534625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101432779|NCT00534625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101468292|NCT01647685|Protective Agents|protective agents|mesh-ancestor
101432780|NCT00534625|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101432781|NCT00534625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101432782|NCT00534625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432783|NCT00534625|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101432784|NCT00534625|Hormone Antagonists|hormone antagonists|mesh-ancestor
101432785|NCT00534625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101432786|NCT00534625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101432787|NCT00534625|Antisickling Agents|antisickling agents|mesh-ancestor
101432788|NCT00534625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101432789|NCT00406874|Folic Acid|folic acid|mesh-list
101432790|NCT00406874|Hematinics|hematinics|mesh-ancestor
101432791|NCT00406874|Vitamin B Complex|vitamin b complex|mesh-ancestor
101432792|NCT00406874|Vitamins|vitamins|mesh-ancestor
101432793|NCT00406874|Micronutrients|micronutrients|mesh-ancestor
101432794|NCT00406874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432795|NCT04106830|Mycophenolic Acid|mycophenolic acid|mesh-list
101432796|NCT04106830|Azathioprine|azathioprine|mesh-list
101559112|NCT01290029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559113|NCT01290029|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101559114|NCT01290029|Hormone Antagonists|hormone antagonists|mesh-ancestor
101559115|NCT01290029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101559116|NCT02890199|Lidocaine|lidocaine|mesh-list
101559117|NCT02890199|Bupivacaine|bupivacaine|mesh-list
101559118|NCT02890199|Anesthetics, Local|anesthetics, local|mesh-ancestor
101559119|NCT02890199|Anesthetics|anesthetics|mesh-ancestor
101407556|NCT00404157|Rituximab|rituximab|mesh-list
101432797|NCT04106830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101432798|NCT04106830|Immunologic Factors|immunologic factors|mesh-ancestor
101432799|NCT04106830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432800|NCT04106830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101432801|NCT04106830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101432802|NCT04106830|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101432803|NCT04106830|Antitubercular Agents|antitubercular agents|mesh-ancestor
101432804|NCT04106830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101432805|NCT04106830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101432806|NCT04106830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101432807|NCT04106830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432808|NCT04106830|Antimetabolites|antimetabolites|mesh-ancestor
101432809|NCT04106830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101432810|NCT04106830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101432811|NCT00189657|Irinotecan|irinotecan|mesh-list
101432812|NCT00189657|Fluorouracil|fluorouracil|mesh-list
101432813|NCT00189657|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101432814|NCT00189657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101432815|NCT00189657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101432816|NCT00189657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432817|NCT00189657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101432818|NCT00189657|Antimetabolites|antimetabolites|mesh-ancestor
101432819|NCT00189657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101432820|NCT00189657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101432821|NCT00189657|Immunologic Factors|immunologic factors|mesh-ancestor
101432822|NCT00189657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432823|NCT00406913|Mupirocin|mupirocin|mesh-list
101432824|NCT00406913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101432831|NCT00406952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101432832|NCT00406952|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101432833|NCT00406952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101432834|NCT00406952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101432835|NCT00406952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432836|NCT00406952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101432837|NCT00406952|Serotonin Agents|serotonin agents|mesh-ancestor
101487412|NCT00432588|Abortifacient Agents|abortifacient agents|mesh-ancestor
101432843|NCT00157547|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101432845|NCT00157547|Escitalopram|escitalopram|mesh-list
101432846|NCT00157547|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
101432847|NCT00157547|Serotonin|serotonin|mesh-list
101432848|NCT00157547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101432849|NCT00157547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101432850|NCT00157547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432851|NCT00157547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101432852|NCT00157547|Serotonin Agents|serotonin agents|mesh-ancestor
101432853|NCT00157547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432854|NCT00157547|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101432855|NCT00157547|Antidepressive Agents|antidepressive agents|mesh-ancestor
101432856|NCT00157547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101432857|NCT00157547|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101432858|NCT00157547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101432859|NCT00157547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101432860|NCT00157547|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101432861|NCT00157547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101559120|NCT02890199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101559121|NCT02890199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468349|NCT00240422|Ramipril|ramipril|mesh-list
101559122|NCT02890199|Sensory System Agents|sensory system agents|mesh-ancestor
101559123|NCT02890199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101559124|NCT02890199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101559125|NCT02890199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101559126|NCT02890199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101559127|NCT02890199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101559128|NCT02890199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559129|NCT01289639|Pioglitazone|pioglitazone|mesh-list
101432862|NCT00157547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101432863|NCT00157547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101432864|NCT00157547|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101432865|NCT00157547|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101432866|NCT00157547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101432867|NCT04061161|Bromides|bromides|mesh-list
101432868|NCT04061161|Tiotropium Bromide|tiotropium bromide|mesh-list
101432869|NCT04061161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101432870|NCT04061161|Autonomic Agents|autonomic agents|mesh-ancestor
101432871|NCT04061161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101432872|NCT04061161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432873|NCT04061161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101432874|NCT04061161|Respiratory System Agents|respiratory system agents|mesh-ancestor
101432875|NCT04061161|Parasympatholytics|parasympatholytics|mesh-ancestor
101432876|NCT04061161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101432877|NCT04061161|Cholinergic Agents|cholinergic agents|mesh-ancestor
101432878|NCT04061161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101432879|NCT04061161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432880|NCT04061161|Anticonvulsants|anticonvulsants|mesh-ancestor
101432881|NCT00157586|Manidipine|manidipine|mesh-list
101432882|NCT00157586|Delapril|delapril|mesh-list
101432883|NCT00157586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101432884|NCT00157586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101432885|NCT00157586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101432886|NCT00157586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432887|NCT00157586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101432888|NCT00157586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432889|NCT00157586|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101432890|NCT00157586|Protease Inhibitors|protease inhibitors|mesh-ancestor
101432891|NCT00157586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101432892|NCT00182871|Testosterone|testosterone|mesh-list
101432901|NCT04686643|Amlodipine|amlodipine|mesh-list
101468362|NCT00264225|Analgesics|analgesics|mesh-ancestor
101307324|NCT02038062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307325|NCT02039453|Fentanyl|fentanyl|mesh-list
101432902|NCT04686643|Valsartan|valsartan|mesh-list
101432903|NCT04686643|Indapamide|indapamide|mesh-list
101432904|NCT04686643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101432905|NCT04686643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101432906|NCT04686643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101432907|NCT04686643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432915|NCT04686643|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101432917|NCT04686643|Antimetabolites|antimetabolites|mesh-ancestor
101432918|NCT04686643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101432919|NCT04686643|Vitamin B Complex|vitamin b complex|mesh-ancestor
101432920|NCT04686643|Vitamins|vitamins|mesh-ancestor
101432921|NCT04686643|Micronutrients|micronutrients|mesh-ancestor
101432922|NCT00534898|Fenretinide|fenretinide|mesh-list
101432923|NCT00534898|Bexarotene|bexarotene|mesh-list
101432924|NCT00534898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101432925|NCT00534898|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101432926|NCT00534898|Protective Agents|protective agents|mesh-ancestor
101432927|NCT00534898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559130|NCT01289639|Fenofibrate|fenofibrate|mesh-list
101559131|NCT01289639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101559132|NCT01289639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559133|NCT01289639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101559134|NCT01289639|Antimetabolites|antimetabolites|mesh-ancestor
101559135|NCT01289639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432928|NCT03748810|Metformin|metformin|mesh-list
101432929|NCT03748810|Dapagliflozin|dapagliflozin|mesh-list
101432930|NCT03748810|Empagliflozin|empagliflozin|mesh-list
101432931|NCT03748810|Glimepiride|glimepiride|mesh-list
101432932|NCT03748810|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
101432933|NCT03748810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101432934|NCT03748810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432935|NCT03748810|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101432936|NCT03748810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432937|NCT03748810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101432938|NCT03748810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101432939|NCT03748810|Immunologic Factors|immunologic factors|mesh-ancestor
101432940|NCT03748810|Protease Inhibitors|protease inhibitors|mesh-ancestor
101432941|NCT03748810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101432942|NCT00157859|Chloroquine|chloroquine|mesh-list
101432943|NCT00157859|Pyrimethamine|pyrimethamine|mesh-list
101432944|NCT00157859|Sulfadoxine|sulfadoxine|mesh-list
101432945|NCT00157859|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101432946|NCT00157859|Amebicides|amebicides|mesh-ancestor
101432947|NCT00157859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101432948|NCT00157859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101432949|NCT00157859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101432950|NCT00157859|Antimalarials|antimalarials|mesh-ancestor
101432951|NCT00157859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101432952|NCT00157859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101432953|NCT00157859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101432954|NCT00157859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432955|NCT00157859|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101432956|NCT00157898|Metronidazole|metronidazole|mesh-list
101432957|NCT00157898|Ceftriaxone|ceftriaxone|mesh-list
101432958|NCT00157898|Ertapenem|ertapenem|mesh-list
101432959|NCT00157898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101432960|NCT00157898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101432961|NCT00157898|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101432962|NCT00157898|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101432963|NCT03669523|Denosumab|denosumab|mesh-list
101432964|NCT03669523|Nivolumab|nivolumab|mesh-list
101432965|NCT03669523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101432966|NCT03669523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101432967|NCT03669523|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101432968|NCT03669523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432972|NCT00157976|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101432987|NCT00158093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101432988|NCT00158093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432989|NCT00158093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101432990|NCT00158093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101432991|NCT00158093|Sympatholytics|sympatholytics|mesh-ancestor
101432992|NCT00158093|Autonomic Agents|autonomic agents|mesh-ancestor
101432993|NCT00158093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101432994|NCT00158093|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101307326|NCT02039453|Meperidine|meperidine|mesh-list
101307327|NCT02039453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101307328|NCT02039453|Narcotics|narcotics|mesh-ancestor
101307329|NCT02039453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101307330|NCT02039453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307331|NCT02039453|Analgesics|analgesics|mesh-ancestor
101307332|NCT02039453|Sensory System Agents|sensory system agents|mesh-ancestor
101307333|NCT02039453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101307334|NCT02039453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101307335|NCT02039453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101432995|NCT00158093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101432996|NCT00158093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101432997|NCT00158093|Adrenergic Agents|adrenergic agents|mesh-ancestor
101432998|NCT00158093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101559136|NCT01289639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101559137|NCT01288937|Milnacipran|milnacipran|mesh-list
101432999|NCT00158093|Vasodilator Agents|vasodilator agents|mesh-ancestor
101433000|NCT00158093|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101433001|NCT00158093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101433002|NCT00158093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101433003|NCT03429946|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101433004|NCT03429946|Spironolactone|spironolactone|mesh-list
101433005|NCT03429946|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101433006|NCT03429946|Hormone Antagonists|hormone antagonists|mesh-ancestor
101433007|NCT03429946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101433008|NCT03429946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433009|NCT03429946|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101433010|NCT03429946|Diuretics|diuretics|mesh-ancestor
101433011|NCT03429946|Natriuretic Agents|natriuretic agents|mesh-ancestor
101433012|NCT00189930|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
101433013|NCT00189930|Antiviral Agents|antiviral agents|mesh-ancestor
101433014|NCT00189930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101433016|NCT00158132|Propranolol|propranolol|mesh-list
101433017|NCT00158132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101433018|NCT00158132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101433019|NCT00158132|Adrenergic Agents|adrenergic agents|mesh-ancestor
101433020|NCT00158132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101433021|NCT00158132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433022|NCT00158132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433023|NCT00158132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101433024|NCT00158132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101433025|NCT00158132|Vasodilator Agents|vasodilator agents|mesh-ancestor
101433026|NCT00158132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101433027|NCT00158132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101433028|NCT00158132|Antiviral Agents|antiviral agents|mesh-ancestor
101433029|NCT00158132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101433030|NCT00158132|Dopamine Agents|dopamine agents|mesh-ancestor
101433031|NCT00158132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101433032|NCT00158132|Analgesics|analgesics|mesh-ancestor
101433033|NCT00158132|Sensory System Agents|sensory system agents|mesh-ancestor
101433034|NCT00158132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101433036|NCT00158171|Nicotine|nicotine|mesh-list
101433037|NCT00158171|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101433038|NCT00158171|Autonomic Agents|autonomic agents|mesh-ancestor
101433039|NCT00158171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101433040|NCT00158171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433041|NCT00158171|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101433042|NCT00158171|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101433043|NCT00158171|Cholinergic Agents|cholinergic agents|mesh-ancestor
101433052|NCT03370783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101433053|NCT03370783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101307336|NCT02039453|Anesthetics, General|anesthetics, general|mesh-ancestor
101307337|NCT02039453|Anesthetics|anesthetics|mesh-ancestor
101433054|NCT03370783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433055|NCT00158210|Rivastigmine|rivastigmine|mesh-list
101433056|NCT00158210|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101433057|NCT00158210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101433058|NCT00158210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433059|NCT00158210|Cholinergic Agents|cholinergic agents|mesh-ancestor
101433060|NCT00158210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101433061|NCT00158210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433062|NCT00158210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101433063|NCT00158210|Protective Agents|protective agents|mesh-ancestor
101433064|NCT00190008|Piracetam|piracetam|mesh-list
101433065|NCT00190008|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101433066|NCT00190008|Protective Agents|protective agents|mesh-ancestor
101433067|NCT00190008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433068|NCT00190008|Nootropic Agents|nootropic agents|mesh-ancestor
101433069|NCT00183222|Naltrexone|naltrexone|mesh-list
101433070|NCT00183222|Ondansetron|ondansetron|mesh-list
101433071|NCT00183222|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101433072|NCT00183222|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101433073|NCT00183222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433074|NCT00183222|Sensory System Agents|sensory system agents|mesh-ancestor
101433075|NCT00183222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101559138|NCT01288937|Levomilnacipran|levomilnacipran|mesh-list
101559139|NCT01288937|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101559140|NCT01288937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101559141|NCT01288937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101407584|NCT00440245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101433077|NCT00183222|Autonomic Agents|autonomic agents|mesh-ancestor
101433078|NCT00183222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101433079|NCT00183222|Antipruritics|antipruritics|mesh-ancestor
101433080|NCT00183222|Dermatologic Agents|dermatologic agents|mesh-ancestor
101433081|NCT00183222|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101433082|NCT00183222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101433083|NCT00183222|Serotonin Agents|serotonin agents|mesh-ancestor
101433084|NCT00183222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101433085|NCT00183222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433086|NCT00158405|Ritonavir|ritonavir|mesh-list
101433087|NCT00158405|Indinavir|indinavir|mesh-list
101433088|NCT00158405|Lamivudine|lamivudine|mesh-list
101433089|NCT00158405|Zidovudine|zidovudine|mesh-list
101433090|NCT00158405|Efavirenz|efavirenz|mesh-list
101433091|NCT00158405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101433092|NCT00158405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101433093|NCT00158405|Protease Inhibitors|protease inhibitors|mesh-ancestor
101433094|NCT00158405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101433095|NCT00158405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433096|NCT00158405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101433097|NCT00158405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101433098|NCT00158405|Antiviral Agents|antiviral agents|mesh-ancestor
101433099|NCT00158405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101433100|NCT00158405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101433101|NCT00158405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101433102|NCT00158405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101433103|NCT00158405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101433104|NCT00158405|Antimetabolites|antimetabolites|mesh-ancestor
101433105|NCT00158405|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101433106|NCT00158405|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101433107|NCT00158405|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101433108|NCT00158405|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101433109|NCT00158405|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101433110|NCT00158483|Acyclovir|acyclovir|mesh-list
101433111|NCT00158483|Antiviral Agents|antiviral agents|mesh-ancestor
101433112|NCT00158483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101433113|NCT00158522|Interferons|interferons|mesh-list
101433114|NCT00158522|Interferon-alpha|interferon-alpha|mesh-list
101433115|NCT00158522|Interferon alpha-2|interferon alpha-2|mesh-list
101433142|NCT00538018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101360368|NCT00215839|Antimetabolites|antimetabolites|mesh-ancestor
101433143|NCT00538018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101433144|NCT00538096|Blinatumomab|blinatumomab|mesh-list
101433145|NCT00538096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101433147|NCT00158678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101307339|NCT02039492|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101433148|NCT00538174|Dapagliflozin|dapagliflozin|mesh-list
101433149|NCT00538174|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101433150|NCT00538174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433151|NCT00538174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101433152|NCT00538174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433153|NCT04724486|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101433154|NCT04724486|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101433156|NCT04724486|Menotropins|menotropins|mesh-list
101433157|NCT04724486|Luteolytic Agents|luteolytic agents|mesh-ancestor
101433158|NCT04724486|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101433159|NCT04724486|Contraceptive Agents|contraceptive agents|mesh-ancestor
101433160|NCT04724486|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101433161|NCT04724486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433162|NCT04724486|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101433163|NCT04724486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101433164|NCT04724486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101433165|NCT04724486|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101433166|NCT04724486|Fertility Agents|fertility agents|mesh-ancestor
101559142|NCT01288937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559143|NCT01288937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101559144|NCT01288937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559145|NCT01288937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101559146|NCT01288937|Analgesics|analgesics|mesh-ancestor
101559147|NCT01288937|Sensory System Agents|sensory system agents|mesh-ancestor
101559148|NCT01288937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101559149|NCT01288937|Antidepressive Agents|antidepressive agents|mesh-ancestor
101559150|NCT01288937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101433167|NCT04724486|Hormone Antagonists|hormone antagonists|mesh-ancestor
101433168|NCT04724486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101433169|NCT00538330|Tamoxifen|tamoxifen|mesh-list
101433170|NCT00538330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101433171|NCT00538330|Hormone Antagonists|hormone antagonists|mesh-ancestor
101433172|NCT00538330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101433173|NCT00538330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433195|NCT00538486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101433196|NCT00538486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433197|NCT00538486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101433198|NCT00538486|Vasodilator Agents|vasodilator agents|mesh-ancestor
101433199|NCT00538486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101433200|NCT00538486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101433201|NCT00538525|Docetaxel|docetaxel|mesh-list
101433202|NCT00538525|Doxorubicin|doxorubicin|mesh-list
101433203|NCT00538525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101433204|NCT00538525|Tubulin Modulators|tubulin modulators|mesh-ancestor
101433205|NCT00538525|Antimitotic Agents|antimitotic agents|mesh-ancestor
101433206|NCT00538525|Mitosis Modulators|mitosis modulators|mesh-ancestor
101433207|NCT00538525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433208|NCT00538525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101433209|NCT00538525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101433210|NCT00538525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101433211|NCT00538525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101433212|NCT00538564|Tadalafil|tadalafil|mesh-list
101433213|NCT00538564|Vasodilator Agents|vasodilator agents|mesh-ancestor
101433214|NCT00538564|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101468524|NCT04720248|Dipyrone|dipyrone|mesh-list
101433215|NCT00538564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101433216|NCT00538564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101433217|NCT00538564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433218|NCT00538564|Urological Agents|urological agents|mesh-ancestor
101433219|NCT00538603|Paclitaxel|paclitaxel|mesh-list
101433220|NCT00538603|Carboplatin|carboplatin|mesh-list
101433221|NCT00538603|Doxorubicin|doxorubicin|mesh-list
101433222|NCT00538603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101433223|NCT00538603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101433224|NCT00538603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101433225|NCT00538603|Tubulin Modulators|tubulin modulators|mesh-ancestor
101433231|NCT00538603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101433232|NCT00538603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101433233|NCT00158834|Fluticasone|fluticasone|mesh-list
101433234|NCT00158834|Xhance|xhance|mesh-list
101433235|NCT00158834|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101433236|NCT00158834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101433237|NCT00158834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101433238|NCT00158834|Autonomic Agents|autonomic agents|mesh-ancestor
101433239|NCT00158834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101433240|NCT00158834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433241|NCT00158834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101307340|NCT02039492|Hormone Antagonists|hormone antagonists|mesh-ancestor
101307341|NCT02039492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101307342|NCT02039492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307343|NCT02039492|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101559152|NCT01288469|Alirocumab|alirocumab|mesh-list
101559153|NCT01288469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101559154|NCT01288469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101559155|NCT01288469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101559156|NCT01288469|Antimetabolites|antimetabolites|mesh-ancestor
101559157|NCT01288469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559158|NCT01288469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101433242|NCT00158834|Respiratory System Agents|respiratory system agents|mesh-ancestor
101433243|NCT00158834|Dermatologic Agents|dermatologic agents|mesh-ancestor
101433244|NCT00158834|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101433245|NCT00158834|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101433246|NCT00158834|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101433247|NCT00158834|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101433248|NCT00158834|Adrenergic Agents|adrenergic agents|mesh-ancestor
101433249|NCT00158834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101433250|NCT00158834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433251|NCT00538720|Vitamin D|vitamin d|mesh-list
101433252|NCT00538720|Ergocalciferols|ergocalciferols|mesh-list
101433253|NCT00538720|Vitamins|vitamins|mesh-ancestor
101433254|NCT00538720|Micronutrients|micronutrients|mesh-ancestor
101433255|NCT00538720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433256|NCT00538720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101433257|NCT00538720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101433258|NCT00536887|Atorvastatin|atorvastatin|mesh-list
101433259|NCT00536887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101433260|NCT00536887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101433261|NCT00536887|Antimetabolites|antimetabolites|mesh-ancestor
101433262|NCT00536887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433263|NCT00536887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101433264|NCT00536887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101433265|NCT00536887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101433266|NCT00158873|Fentanyl|fentanyl|mesh-list
101433267|NCT00158873|Midazolam|midazolam|mesh-list
101433268|NCT00158873|Morphine|morphine|mesh-list
101433269|NCT00158873|Remifentanil|remifentanil|mesh-list
101433270|NCT00158873|Lorazepam|lorazepam|mesh-list
101433271|NCT00158873|Propofol|propofol|mesh-list
101433272|NCT00158873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101433273|NCT00158873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101433274|NCT00158873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433275|NCT00158873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101433276|NCT00158873|Anesthetics, General|anesthetics, general|mesh-ancestor
101433277|NCT00158873|Anesthetics|anesthetics|mesh-ancestor
101433278|NCT00158873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101433279|NCT00158873|Narcotics|narcotics|mesh-ancestor
101433280|NCT00158873|Analgesics|analgesics|mesh-ancestor
101433281|NCT00158873|Sensory System Agents|sensory system agents|mesh-ancestor
101433282|NCT00158873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101433283|NCT00158873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101433284|NCT00158873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101433285|NCT00158873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101433286|NCT00158873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101433287|NCT00158873|GABA Modulators|gaba modulators|mesh-ancestor
101433288|NCT00158873|GABA Agents|gaba agents|mesh-ancestor
101433289|NCT00158873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101433290|NCT00158873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433291|NCT00158873|Anticonvulsants|anticonvulsants|mesh-ancestor
101433292|NCT00158873|Antiemetics|antiemetics|mesh-ancestor
101433293|NCT00158873|Autonomic Agents|autonomic agents|mesh-ancestor
101433294|NCT00158873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101433295|NCT00537121|Leucovorin|leucovorin|mesh-list
101433296|NCT00537121|Fluorouracil|fluorouracil|mesh-list
101433297|NCT00537121|Irinotecan|irinotecan|mesh-list
101433298|NCT00537121|Vorinostat|vorinostat|mesh-list
101433299|NCT00537121|Calcium|calcium|mesh-list
101433300|NCT00537121|Levoleucovorin|levoleucovorin|mesh-list
101433322|NCT00406991|Analgesics|analgesics|mesh-ancestor
101433323|NCT00406991|Sensory System Agents|sensory system agents|mesh-ancestor
101433324|NCT00406991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101307344|NCT02039492|Diuretics|diuretics|mesh-ancestor
101559159|NCT01288469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101559160|NCT01288469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101559162|NCT01288469|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101559163|NCT01288469|Protease Inhibitors|protease inhibitors|mesh-ancestor
101307345|NCT02039492|Natriuretic Agents|natriuretic agents|mesh-ancestor
101307346|NCT02039869|Omeprazole|omeprazole|mesh-list
101307347|NCT02039869|Sucralfate|sucralfate|mesh-list
101307348|NCT02039869|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101307349|NCT02039869|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101307350|NCT02039869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101307351|NCT02039869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101433325|NCT00406991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433326|NCT00406991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101433327|NCT00406991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101433328|NCT00406991|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101433329|NCT00406991|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101433330|NCT00406991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433331|NCT00406991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101433332|NCT00406991|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101433333|NCT00406991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101433334|NCT00406991|Antipyretics|antipyretics|mesh-ancestor
101433335|NCT00406991|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101433336|NCT00406991|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101433337|NCT00406991|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101433338|NCT00406991|Purinergic Agents|purinergic agents|mesh-ancestor
101433339|NCT00406991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101433340|NCT05432947|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101433341|NCT05432947|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101433342|NCT05432947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433343|NCT00158990|Sertraline|sertraline|mesh-list
101433344|NCT00158990|Antidepressive Agents|antidepressive agents|mesh-ancestor
101433345|NCT00158990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101433346|NCT00158990|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101433347|NCT00158990|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101433348|NCT00158990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101433349|NCT00158990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433350|NCT00158990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101433351|NCT00158990|Serotonin Agents|serotonin agents|mesh-ancestor
101433352|NCT00158990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433353|NCT00537355|Histamine|histamine|mesh-list
101433354|NCT00537355|Histamine Agonists|histamine agonists|mesh-ancestor
101433355|NCT00537355|Histamine Agents|histamine agents|mesh-ancestor
101433356|NCT00537355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101433357|NCT00537355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433358|NCT00537355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433359|NCT00183612|Olanzapine|olanzapine|mesh-list
101433364|NCT00183612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101433366|NCT00183612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101433367|NCT00183612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101433368|NCT00183612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101433369|NCT00183612|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101433370|NCT00183612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101433371|NCT00183612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101433372|NCT00183612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433373|NCT00183612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101433374|NCT00183612|Serotonin Agents|serotonin agents|mesh-ancestor
101433375|NCT05381623|Hemostatics|hemostatics|mesh-list
101433376|NCT05381623|Coagulants|coagulants|mesh-ancestor
101433377|NCT00537472|Bupivacaine|bupivacaine|mesh-list
101433378|NCT00537472|Anesthetics|anesthetics|mesh-list
101433379|NCT00537472|Anesthetics, Local|anesthetics, local|mesh-ancestor
101433383|NCT00537472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101433384|NCT00159107|Acamprosate|acamprosate|mesh-list
101433385|NCT00159107|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101433386|NCT00537550|Methotrexate|methotrexate|mesh-list
101433387|NCT00537550|Vincristine|vincristine|mesh-list
101433388|NCT00537550|Asparaginase|asparaginase|mesh-list
101559164|NCT01288469|Immunologic Factors|immunologic factors|mesh-ancestor
101559165|NCT01288469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559166|NCT01288079|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101559167|NCT01288079|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101559168|NCT01288079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101407613|NCT00440323|Zolpidem|zolpidem|mesh-list
101307352|NCT02039869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307353|NCT02040064|Gefitinib|gefitinib|mesh-list
101433389|NCT00537550|Daunorubicin|daunorubicin|mesh-list
101433390|NCT00537550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101433391|NCT00537550|Abortifacient Agents|abortifacient agents|mesh-ancestor
101433392|NCT00537550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101433393|NCT00537550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433394|NCT00537550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101433395|NCT00537550|Antimetabolites|antimetabolites|mesh-ancestor
101433396|NCT00537550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433397|NCT00537550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101433398|NCT00537550|Dermatologic Agents|dermatologic agents|mesh-ancestor
101433399|NCT00537550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101433400|NCT00537550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101433401|NCT00537550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101433402|NCT00537550|Immunologic Factors|immunologic factors|mesh-ancestor
101433403|NCT00537550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101433404|NCT00537550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101433405|NCT00537550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101433406|NCT00537550|Tubulin Modulators|tubulin modulators|mesh-ancestor
101433407|NCT00537550|Antimitotic Agents|antimitotic agents|mesh-ancestor
101433408|NCT00537550|Mitosis Modulators|mitosis modulators|mesh-ancestor
101433409|NCT00537550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101433410|NCT00537550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101433411|NCT00537550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101433412|NCT00159146|Pindolol|pindolol|mesh-list
101433413|NCT00159146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101433414|NCT00159146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101433415|NCT00159146|Adrenergic Agents|adrenergic agents|mesh-ancestor
101433416|NCT00159146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101433417|NCT00159146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433418|NCT00159146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433419|NCT00159146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101433420|NCT00159146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101433421|NCT00159146|Serotonin Agents|serotonin agents|mesh-ancestor
101433422|NCT00159146|Vasodilator Agents|vasodilator agents|mesh-ancestor
101433423|NCT00537667|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101433424|NCT00537667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101433425|NCT00538876|Decitabine|decitabine|mesh-list
101433426|NCT00538876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101433427|NCT00538876|Antimetabolites|antimetabolites|mesh-ancestor
101433428|NCT00538876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433429|NCT00538876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101433435|NCT00539071|Risperidone|risperidone|mesh-list
101433436|NCT00539071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101433437|NCT00539071|Serotonin Agents|serotonin agents|mesh-ancestor
101433438|NCT00539071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101433439|NCT00539071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433440|NCT00539071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433441|NCT00539071|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101433442|NCT00539071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101433443|NCT00539071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101433444|NCT00539071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101433445|NCT00539071|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101433446|NCT00539071|Dopamine Agents|dopamine agents|mesh-ancestor
101433447|NCT00539149|Amoxicillin|amoxicillin|mesh-list
101433448|NCT00539149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101433449|NCT00539149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101433450|NCT00183807|Celecoxib|celecoxib|mesh-list
101433451|NCT00183807|Irinotecan|irinotecan|mesh-list
101433452|NCT00183807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101559169|NCT01288079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101559170|NCT01288079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559171|NCT01288079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101559172|NCT01288079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559173|NCT01288079|Analgesics|analgesics|mesh-ancestor
101559174|NCT01288079|Sensory System Agents|sensory system agents|mesh-ancestor
101559175|NCT01288079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101559176|NCT01288079|Antidepressive Agents|antidepressive agents|mesh-ancestor
101433453|NCT00183807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101433458|NCT00183807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101433460|NCT00183807|Sensory System Agents|sensory system agents|mesh-ancestor
101433461|NCT00183807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101433462|NCT00183807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307354|NCT02040064|Tremelimumab|tremelimumab|mesh-list
101307355|NCT02040064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101307356|NCT02040064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101433463|NCT00183807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101433464|NCT00183807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101433465|NCT00183807|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101433466|NCT00183807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101433467|NCT00539773|Interferons|interferons|mesh-list
101433468|NCT00539773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101433469|NCT00539773|Antiviral Agents|antiviral agents|mesh-ancestor
101433470|NCT00539773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101433471|NCT00409461|Sirolimus|sirolimus|mesh-list
101433472|NCT00409461|Tacrolimus|tacrolimus|mesh-list
101433473|NCT00409461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101433474|NCT00409461|Immunologic Factors|immunologic factors|mesh-ancestor
101433475|NCT00409461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433476|NCT00409461|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101433477|NCT00409461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101433478|NCT00409461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433479|NCT00409461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101433480|NCT00409461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101433481|NCT00409461|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101433482|NCT00409461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101433483|NCT00409461|Antifungal Agents|antifungal agents|mesh-ancestor
101433484|NCT00539890|Insulin|insulin|mesh-list
101433485|NCT00539890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101433486|NCT00539890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433487|NCT00539968|Docetaxel|docetaxel|mesh-list
101433488|NCT00539968|Lonafarnib|lonafarnib|mesh-list
101433489|NCT00539968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101433490|NCT00539968|Tubulin Modulators|tubulin modulators|mesh-ancestor
101433491|NCT00539968|Antimitotic Agents|antimitotic agents|mesh-ancestor
101433492|NCT00539968|Mitosis Modulators|mitosis modulators|mesh-ancestor
101433493|NCT00539968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433494|NCT00539968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101433495|NCT00183846|Irinotecan|irinotecan|mesh-list
101433496|NCT00183846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101433497|NCT00183846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101433498|NCT00183846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101433499|NCT00183846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433504|NCT00540085|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101433505|NCT00540085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101433506|NCT00540085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433507|NCT00540202|Lumefantrine|lumefantrine|mesh-list
101433508|NCT00540202|Artemether|artemether|mesh-list
101433509|NCT00540202|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101433510|NCT00540202|Quinine|quinine|mesh-list
101433511|NCT00540202|Antimalarials|antimalarials|mesh-ancestor
101433512|NCT00540202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101433513|NCT00540202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101433514|NCT00540202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101433515|NCT00540202|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101433516|NCT00540202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433517|NCT00540202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101559177|NCT01288079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101559178|NCT01288079|Dopamine Agents|dopamine agents|mesh-ancestor
101559179|NCT01287221|Riboflavin|riboflavin|mesh-list
101559180|NCT01287221|Rifampin|rifampin|mesh-list
101559181|NCT01287221|Vitamins|vitamins|mesh-ancestor
101559182|NCT01287221|Micronutrients|micronutrients|mesh-ancestor
101559183|NCT01287221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559184|NCT01287221|Vitamin B Complex|vitamin b complex|mesh-ancestor
101407625|NCT00440440|Hormones|hormones|mesh-ancestor
101433518|NCT00540202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101433519|NCT00540202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101433520|NCT00540202|Analgesics|analgesics|mesh-ancestor
101433521|NCT00540202|Sensory System Agents|sensory system agents|mesh-ancestor
101433522|NCT00540241|Pemetrexed|pemetrexed|mesh-list
101433523|NCT00540241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101433525|NCT00540241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433534|NCT00159224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433535|NCT00159224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101433536|NCT00159224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101433537|NCT00159224|Antiviral Agents|antiviral agents|mesh-ancestor
101307357|NCT02040064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101307358|NCT02040064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433538|NCT00159224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101433539|NCT00159224|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101433540|NCT00159224|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101433541|NCT00540280|Gemcitabine|gemcitabine|mesh-list
101433542|NCT00540280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101433543|NCT00540280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101433544|NCT00540280|Antimetabolites|antimetabolites|mesh-ancestor
101433545|NCT00540280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433546|NCT00183924|Carboplatin|carboplatin|mesh-list
101433548|NCT00183924|Estramustine|estramustine|mesh-list
101433549|NCT00183924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101433550|NCT00183924|Tubulin Modulators|tubulin modulators|mesh-ancestor
101433551|NCT00183924|Antimitotic Agents|antimitotic agents|mesh-ancestor
101433552|NCT00183924|Mitosis Modulators|mitosis modulators|mesh-ancestor
101433553|NCT00183924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433554|NCT00183924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101433555|NCT00183924|Alkylating Agents|alkylating agents|mesh-ancestor
101433556|NCT00183924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101433557|NCT00159302|Nitric Oxide|nitric oxide|mesh-list
101433558|NCT00159302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101433559|NCT00159302|Autonomic Agents|autonomic agents|mesh-ancestor
101433560|NCT00159302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101433561|NCT00159302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433562|NCT00159302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101433563|NCT00159302|Respiratory System Agents|respiratory system agents|mesh-ancestor
101433564|NCT00159302|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101433565|NCT00159302|Antioxidants|antioxidants|mesh-ancestor
101433566|NCT00159302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433567|NCT00159302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101360387|NCT00216034|polysaccharide-K|polysaccharide-k|mesh-list
101433568|NCT00159302|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101433569|NCT00159302|Vasodilator Agents|vasodilator agents|mesh-ancestor
101433570|NCT00159302|Gasotransmitters|gasotransmitters|mesh-ancestor
101433573|NCT00540631|Immunologic Factors|immunologic factors|mesh-ancestor
101433574|NCT00540631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433575|NCT00183885|Mitomycins|mitomycins|mesh-list
101433576|NCT00183885|Mitomycin|mitomycin|mesh-list
101433577|NCT00183885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101433578|NCT00183885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101433579|NCT00183885|Alkylating Agents|alkylating agents|mesh-ancestor
101433580|NCT00183885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433581|NCT00183885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101433582|NCT00183885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101433583|NCT00540709|Insulin Glargine|insulin glargine|mesh-list
101433584|NCT00540709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101559185|NCT01287221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101559186|NCT01287221|Antitubercular Agents|antitubercular agents|mesh-ancestor
101559187|NCT01287221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101559188|NCT01287221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101559189|NCT01287221|Leprostatic Agents|leprostatic agents|mesh-ancestor
101559190|NCT01287221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101433585|NCT00540709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433586|NCT00540748|Oxytocin|oxytocin|mesh-list
101433587|NCT00540748|Oxytocics|oxytocics|mesh-ancestor
101433588|NCT00540748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101433589|NCT00540748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433590|NCT00540787|Quinidine|quinidine|mesh-list
101433591|NCT00540787|Amiodarone|amiodarone|mesh-list
101433592|NCT00540787|Sotalol|sotalol|mesh-list
101433593|NCT00540787|Flecainide|flecainide|mesh-list
101433599|NCT00540787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101433600|NCT00540787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433601|NCT00540787|Vasodilator Agents|vasodilator agents|mesh-ancestor
101433602|NCT00540787|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101433603|NCT00540787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101433604|NCT00540787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433605|NCT00540787|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101433606|NCT00540787|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101433607|NCT00540787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101433608|NCT00540787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101433609|NCT00540787|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101307359|NCT02040142|Mitomycins|mitomycins|mesh-list
101307360|NCT02040142|Mitomycin|mitomycin|mesh-list
101307361|NCT02040142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101307362|NCT02040142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101307363|NCT02040142|Alkylating Agents|alkylating agents|mesh-ancestor
101468623|NCT01688518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101433610|NCT00540787|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101433611|NCT00540787|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101433612|NCT00540787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101433613|NCT00540787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101433614|NCT00540787|Adrenergic Agents|adrenergic agents|mesh-ancestor
101433615|NCT00540787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101433617|NCT00540787|Autonomic Agents|autonomic agents|mesh-ancestor
101433618|NCT00540787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101433619|NCT00540787|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101433620|NCT00540787|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101433621|NCT00540787|Antimalarials|antimalarials|mesh-ancestor
101433622|NCT00540787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101433623|NCT00540787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101433624|NCT00540787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101433625|NCT00540787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101433626|NCT00540787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101433627|NCT00540787|Cholinergic Agents|cholinergic agents|mesh-ancestor
101433628|NCT00159380|Pimagedine|pimagedine|mesh-list
101433629|NCT00159380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101433630|NCT00159380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433631|NCT00540826|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101433632|NCT00540826|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101433633|NCT00540826|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101433634|NCT00540826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101433635|NCT00540826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433636|NCT00540826|Adrenergic Agents|adrenergic agents|mesh-ancestor
101433637|NCT00540826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101433638|NCT00540826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433639|NCT00540943|Irinotecan|irinotecan|mesh-list
101433640|NCT00540943|Cetuximab|cetuximab|mesh-list
101433641|NCT00540943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101433642|NCT00540943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101433643|NCT00540943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101433644|NCT00540943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433661|NCT00541138|Tamoxifen|tamoxifen|mesh-list
101433662|NCT00541138|Carboplatin|carboplatin|mesh-list
101433663|NCT00541138|Topotecan|topotecan|mesh-list
101559191|NCT01287221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101559192|NCT01287221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559193|NCT01287221|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101559194|NCT01287221|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101559195|NCT01287221|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101407637|NCT00142896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101433664|NCT00541138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101433665|NCT00541138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433666|NCT00541138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101468656|NCT01688947|Pregabalin|pregabalin|mesh-list
101433667|NCT00541138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101433668|NCT00541138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101433669|NCT00541138|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101433670|NCT00541138|Hormone Antagonists|hormone antagonists|mesh-ancestor
101433671|NCT00541138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101433673|NCT00541138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101433674|NCT00541138|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101433675|NCT00541138|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101433684|NCT00541177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433686|NCT00541177|Respiratory System Agents|respiratory system agents|mesh-ancestor
101433687|NCT00541177|Mydriatics|mydriatics|mesh-ancestor
101433688|NCT00541177|Parasympatholytics|parasympatholytics|mesh-ancestor
101433689|NCT00541177|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101433690|NCT00541177|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101433691|NCT00541177|Cholinergic Agents|cholinergic agents|mesh-ancestor
101433692|NCT00541177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101307364|NCT02040142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307365|NCT02040142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101433693|NCT00541177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433694|NCT00541216|Ephedrine|ephedrine|mesh-list
101433695|NCT00541216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101433696|NCT00541216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433697|NCT00541216|Sympathomimetics|sympathomimetics|mesh-ancestor
101433698|NCT00541216|Autonomic Agents|autonomic agents|mesh-ancestor
101433699|NCT00541216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101433700|NCT00541216|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101433701|NCT00541216|Adrenergic Agents|adrenergic agents|mesh-ancestor
101433702|NCT00541216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101433705|NCT00541333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101433706|NCT00541333|Immunologic Factors|immunologic factors|mesh-ancestor
101433707|NCT00541333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433708|NCT00541333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101433709|NCT00541333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101433710|NCT00541372|Insulin|insulin|mesh-list
101433711|NCT00541372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101433712|NCT00541372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433713|NCT00159536|Metformin|metformin|mesh-list
101433714|NCT00159536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101433715|NCT00159536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433716|NCT00541411|Dactinomycin|dactinomycin|mesh-list
101433717|NCT00541411|Vincristine|vincristine|mesh-list
101433718|NCT00541411|Ifosfamide|ifosfamide|mesh-list
101433719|NCT00541411|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101433720|NCT00541411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101433721|NCT00541411|Tubulin Modulators|tubulin modulators|mesh-ancestor
101433722|NCT00541411|Antimitotic Agents|antimitotic agents|mesh-ancestor
101433723|NCT00541411|Mitosis Modulators|mitosis modulators|mesh-ancestor
101433724|NCT00541411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433725|NCT00541411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101433726|NCT00541411|Alkylating Agents|alkylating agents|mesh-ancestor
101433727|NCT00541411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101433728|NCT00541411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101433729|NCT00541411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101433730|NCT00541411|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101433731|NCT00541411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101433732|NCT00541411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101559196|NCT01287221|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101559197|NCT01287221|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101559198|NCT01287221|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101559199|NCT01287221|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101559200|NCT01287221|Dermatologic Agents|dermatologic agents|mesh-ancestor
101559201|NCT05660213|Bevacizumab|bevacizumab|mesh-list
101559202|NCT05660213|Atezolizumab|atezolizumab|mesh-list
101559203|NCT05660213|Apatinib|apatinib|mesh-list
101559204|NCT05660213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101559205|NCT05660213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101559206|NCT05660213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101407646|NCT00440674|Tubulin Modulators|tubulin modulators|mesh-ancestor
101433733|NCT00541489|Naproxen|naproxen|mesh-list
101433734|NCT00541489|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
101433735|NCT00541489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101433736|NCT00541489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101433737|NCT00541489|Analgesics|analgesics|mesh-ancestor
101433738|NCT00541489|Sensory System Agents|sensory system agents|mesh-ancestor
101433739|NCT00541489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101433740|NCT00541489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433741|NCT00541489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101433749|NCT00190437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101433750|NCT00190437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101433751|NCT00159575|Metformin|metformin|mesh-list
101433752|NCT00159575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101433753|NCT00159575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433754|NCT00541567|Ibipinabant|ibipinabant|mesh-list
101433755|NCT00541567|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
101433756|NCT00541567|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101433757|NCT00541567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101433758|NCT00541567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433759|NCT00541567|Hormones|hormones|mesh-ancestor
101433760|NCT00541567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101307367|NCT02040220|Aflibercept|aflibercept|mesh-list
101307368|NCT02040220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101433761|NCT00541567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433762|NCT00408798|Botulinum Toxins|botulinum toxins|mesh-list
101433763|NCT00408798|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101433764|NCT00408798|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101433765|NCT00408798|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101433766|NCT00408798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101433767|NCT00408798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433768|NCT00408798|Cholinergic Agents|cholinergic agents|mesh-ancestor
101433769|NCT00408798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101433770|NCT00408798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433771|NCT00408798|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101433772|NCT00408798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101433773|NCT00541723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
101433776|NCT00541723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433777|NCT00541723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101433778|NCT00541723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101433779|NCT00541723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433780|NCT00541723|Cholinergic Agents|cholinergic agents|mesh-ancestor
101433781|NCT00541723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101433782|NCT00159614|Rolofylline|rolofylline|mesh-list
101433783|NCT00159614|Diuretics|diuretics|mesh-ancestor
101433784|NCT00159614|Natriuretic Agents|natriuretic agents|mesh-ancestor
101433785|NCT00159614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433786|NCT00541840|Sorafenib|sorafenib|mesh-list
101433787|NCT00541840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101433788|NCT00541840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101433789|NCT00541840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101559207|NCT05660213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101559208|NCT05660213|Growth Substances|growth substances|mesh-ancestor
101559209|NCT05660213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559210|NCT05660213|Growth Inhibitors|growth inhibitors|mesh-ancestor
101559211|NCT05660213|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101433790|NCT00541840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433792|NCT00190476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101433793|NCT00190476|Tubulin Modulators|tubulin modulators|mesh-ancestor
101433794|NCT00190476|Antimitotic Agents|antimitotic agents|mesh-ancestor
101433795|NCT00190476|Mitosis Modulators|mitosis modulators|mesh-ancestor
101433796|NCT00190476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433797|NCT00159653|Timolol|timolol|mesh-list
101433798|NCT00159653|Latanoprost|latanoprost|mesh-list
101433799|NCT00159653|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101433800|NCT00159653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101433801|NCT00159653|Adrenergic Agents|adrenergic agents|mesh-ancestor
101433802|NCT00159653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101433803|NCT00159653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433804|NCT00159653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433805|NCT00159653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101433806|NCT00159653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101433807|NCT00159653|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101433808|NCT00159653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101433816|NCT00541918|Anesthetics|anesthetics|mesh-ancestor
101433817|NCT00541918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101433818|NCT00541918|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101433819|NCT00190515|Leucovorin|leucovorin|mesh-list
101433820|NCT00190515|Levoleucovorin|levoleucovorin|mesh-list
101433821|NCT00190515|Antidotes|antidotes|mesh-ancestor
101433822|NCT00190515|Protective Agents|protective agents|mesh-ancestor
101433823|NCT00190515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433824|NCT00190515|Vitamin B Complex|vitamin b complex|mesh-ancestor
101433825|NCT00190515|Vitamins|vitamins|mesh-ancestor
101433826|NCT00190515|Micronutrients|micronutrients|mesh-ancestor
101433827|NCT00159692|Amlodipine|amlodipine|mesh-list
101433828|NCT00159692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101433829|NCT00159692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101433830|NCT00159692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101433831|NCT00159692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433832|NCT00159692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101307369|NCT02040220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101307370|NCT02040220|Growth Substances|growth substances|mesh-ancestor
101433833|NCT00159692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433834|NCT00159692|Vasodilator Agents|vasodilator agents|mesh-ancestor
101433835|NCT00542074|Ethanol|ethanol|mesh-list
101433836|NCT00542074|Emollients|emollients|mesh-list
101433837|NCT00542074|Dermatologic Agents|dermatologic agents|mesh-ancestor
101433838|NCT00542074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101433839|NCT00542074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101433840|NCT00542074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101433841|NCT00542074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433842|NCT00542152|Cyclosporine|cyclosporine|mesh-list
101433843|NCT00542152|Infliximab|infliximab|mesh-list
101433844|NCT00542152|Cyclosporins|cyclosporins|mesh-list
101433845|NCT00542152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101433846|NCT00542152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433847|NCT00542152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101433851|NCT00542152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101433852|NCT00542152|Dermatologic Agents|dermatologic agents|mesh-ancestor
101433853|NCT00542152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101433854|NCT00542152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101433855|NCT00542152|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101433856|NCT00542152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101433857|NCT00542152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101433859|NCT00159731|Analgesics|analgesics|mesh-ancestor
101433860|NCT00159731|Sensory System Agents|sensory system agents|mesh-ancestor
101433861|NCT00159731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101433862|NCT00159731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433863|NCT00159731|Anticonvulsants|anticonvulsants|mesh-ancestor
101559212|NCT05660213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559213|NCT05660213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101559214|NCT05660213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101559215|NCT01167153|Amlodipine|amlodipine|mesh-list
101559216|NCT01167153|Valsartan|valsartan|mesh-list
101559217|NCT01167153|Nifedipine|nifedipine|mesh-list
101559218|NCT01167153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101559219|NCT01167153|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101559220|NCT01167153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101559221|NCT01167153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559222|NCT01167153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101559223|NCT01167153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559224|NCT01167153|Vasodilator Agents|vasodilator agents|mesh-ancestor
101559225|NCT01167153|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101559226|NCT01167153|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101433864|NCT00159731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101433865|NCT00159731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101433866|NCT00159731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433867|NCT00159731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101433868|NCT00159731|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101433869|NCT00159731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101433870|NCT00159731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101433871|NCT00159731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101433872|NCT00408915|Lisuride|lisuride|mesh-list
101433873|NCT00408915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101433874|NCT00408915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101433875|NCT00408915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101433876|NCT00408915|Serotonin Agents|serotonin agents|mesh-ancestor
101433877|NCT00408915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101433878|NCT00408915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433890|NCT00190554|Fluorouracil|fluorouracil|mesh-list
101433891|NCT00190554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101433892|NCT00190554|Antimetabolites|antimetabolites|mesh-ancestor
101433893|NCT00190554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433894|NCT00190554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101433895|NCT00190554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101433896|NCT00190554|Immunologic Factors|immunologic factors|mesh-ancestor
101433897|NCT00190554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433899|NCT00159770|Risperidone|risperidone|mesh-list
101433900|NCT00159770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101433901|NCT00159770|Ziprasidone|ziprasidone|mesh-list
101433902|NCT00159770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101433903|NCT00159770|Serotonin Agents|serotonin agents|mesh-ancestor
101433904|NCT00159770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101433905|NCT00159770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433906|NCT00159770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307371|NCT02040220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307372|NCT02040220|Growth Inhibitors|growth inhibitors|mesh-ancestor
101468716|NCT00241124|Valsartan|valsartan|mesh-list
101307373|NCT02040220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101433907|NCT00159770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101433908|NCT00159770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101433909|NCT00159770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101433910|NCT00159770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101433911|NCT00159770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101433913|NCT00159770|Antiemetics|antiemetics|mesh-ancestor
101433914|NCT00159770|Autonomic Agents|autonomic agents|mesh-ancestor
101559227|NCT01167153|Tocolytic Agents|tocolytic agents|mesh-ancestor
101559228|NCT01167153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101559229|NCT01166763|Vitamin D|vitamin d|mesh-list
101559230|NCT01166763|Cholecalciferol|cholecalciferol|mesh-list
101559231|NCT01166763|Vitamins|vitamins|mesh-ancestor
101559232|NCT01166763|Micronutrients|micronutrients|mesh-ancestor
101559233|NCT01166763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559234|NCT01166763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101559235|NCT01166763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101559236|NCT02885961|Dabigatran|dabigatran|mesh-list
101433915|NCT00159770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101433916|NCT00159770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101433917|NCT00159770|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101433918|NCT00159770|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101433922|NCT00190593|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101433923|NCT00190593|Hormone Antagonists|hormone antagonists|mesh-ancestor
101433924|NCT00190593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101433925|NCT00190593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433926|NCT00190593|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101433927|NCT00190593|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101433928|NCT00190593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101433930|NCT00542893|Oblimersen|oblimersen|mesh-list
101433931|NCT00542893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101433932|NCT00542893|Alkylating Agents|alkylating agents|mesh-ancestor
101433933|NCT00542893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433934|NCT00542893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101433935|NCT00184041|Cytarabine|cytarabine|mesh-list
101433936|NCT00184041|Prednisone|prednisone|mesh-list
101433937|NCT00184041|Methotrexate|methotrexate|mesh-list
101433938|NCT00184041|Cyclophosphamide|cyclophosphamide|mesh-list
101433939|NCT00184041|Vincristine|vincristine|mesh-list
101433940|NCT00184041|Daunorubicin|daunorubicin|mesh-list
101433941|NCT00184041|Asparaginase|asparaginase|mesh-list
101433942|NCT00184041|Mercaptopurine|mercaptopurine|mesh-list
101433943|NCT00184041|Thioguanine|thioguanine|mesh-list
101433944|NCT00184041|Pegaspargase|pegaspargase|mesh-list
101433945|NCT00184041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101433949|NCT00184041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433950|NCT00184041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101433951|NCT00184041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101433952|NCT00184041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101433953|NCT00184041|Abortifacient Agents|abortifacient agents|mesh-ancestor
101433954|NCT00184041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101433955|NCT00184041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101433956|NCT00184041|Antimetabolites|antimetabolites|mesh-ancestor
101433957|NCT00184041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433958|NCT00184041|Dermatologic Agents|dermatologic agents|mesh-ancestor
101433959|NCT00184041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101433960|NCT00184041|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101433961|NCT00184041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101433962|NCT00184041|Immunologic Factors|immunologic factors|mesh-ancestor
101433963|NCT00184041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101433964|NCT00184041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101433965|NCT00184041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101433966|NCT00184041|Alkylating Agents|alkylating agents|mesh-ancestor
101433967|NCT00184041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101433968|NCT00184041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101433969|NCT00184041|Tubulin Modulators|tubulin modulators|mesh-ancestor
101433970|NCT00184041|Antimitotic Agents|antimitotic agents|mesh-ancestor
101433971|NCT00184041|Mitosis Modulators|mitosis modulators|mesh-ancestor
101433972|NCT00184041|Antiviral Agents|antiviral agents|mesh-ancestor
101433973|NCT00184041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101433974|NCT00184041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101433975|NCT00184041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101433976|NCT00184041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101433977|NCT00543049|Sunitinib|sunitinib|mesh-list
101559238|NCT02885961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101559239|NCT02885961|Protease Inhibitors|protease inhibitors|mesh-ancestor
101559240|NCT02885961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101559241|NCT02885961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559242|NCT02885961|Anticoagulants|anticoagulants|mesh-ancestor
101559243|NCT02885727|Durvalumab|durvalumab|mesh-list
101433978|NCT00543049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101307374|NCT02040246|Metformin|metformin|mesh-list
101307375|NCT02040246|Repaglinide|repaglinide|mesh-list
101307376|NCT02040246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101433979|NCT00543049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101433980|NCT00543049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101433981|NCT00543049|Growth Substances|growth substances|mesh-ancestor
101433982|NCT00543049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433983|NCT00543049|Growth Inhibitors|growth inhibitors|mesh-ancestor
101433984|NCT00543049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101433985|NCT00543049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101433986|NCT00543049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433987|NCT04685005|Caffeine|caffeine|mesh-list
101433988|NCT04685005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101433989|NCT04685005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433993|NCT04685005|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101433994|NCT04685005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101433995|NCT04685005|Purinergic Agents|purinergic agents|mesh-ancestor
101433996|NCT04685005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101433997|NCT00190632|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101433998|NCT00190632|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101433999|NCT00190632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101434000|NCT00190632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101434001|NCT00190632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434002|NCT00190632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101434003|NCT00190632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434004|NCT00190632|Analgesics|analgesics|mesh-ancestor
101434005|NCT00190632|Sensory System Agents|sensory system agents|mesh-ancestor
101434006|NCT00190632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101434007|NCT00190632|Antidepressive Agents|antidepressive agents|mesh-ancestor
101434008|NCT00190632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101434009|NCT00190632|Dopamine Agents|dopamine agents|mesh-ancestor
101434010|NCT00543166|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101434011|NCT00543166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101434012|NCT00543166|Immunologic Factors|immunologic factors|mesh-ancestor
101434013|NCT00543166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434014|NCT00543205|Oblimersen|oblimersen|mesh-list
101434015|NCT00543205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101434021|NCT00159809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101434022|NCT00159809|Urological Agents|urological agents|mesh-ancestor
101434023|NCT00543244|Interferons|interferons|mesh-list
101434024|NCT00543244|Ribavirin|ribavirin|mesh-list
101434025|NCT00543244|Interferon-alpha|interferon-alpha|mesh-list
101434026|NCT00543244|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101434027|NCT00543244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101434028|NCT00543244|Antiviral Agents|antiviral agents|mesh-ancestor
101360397|NCT00216034|Antiviral Agents|antiviral agents|mesh-ancestor
101434029|NCT00543244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101434030|NCT00543244|Antimetabolites|antimetabolites|mesh-ancestor
101434031|NCT00543244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434032|NCT00543244|Immunologic Factors|immunologic factors|mesh-ancestor
101434033|NCT00543244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434034|NCT00190710|Carboplatin|carboplatin|mesh-list
101434035|NCT00190710|Gemcitabine|gemcitabine|mesh-list
101434036|NCT00190710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101434037|NCT00190710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101434038|NCT00190710|Antimetabolites|antimetabolites|mesh-ancestor
101434039|NCT00190710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434040|NCT03456661|Dexmedetomidine|dexmedetomidine|mesh-list
101434041|NCT03456661|Levobupivacaine|levobupivacaine|mesh-list
101434042|NCT03456661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101434043|NCT03456661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101559244|NCT02885727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101559245|NCT02885727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101559246|NCT00963235|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101559247|NCT00963235|Immunologic Factors|immunologic factors|mesh-ancestor
101559248|NCT00963235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559249|NCT00630097|Modafinil|modafinil|mesh-list
101434044|NCT03456661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434045|NCT03456661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101434046|NCT03456661|Analgesics|analgesics|mesh-ancestor
101434047|NCT03456661|Sensory System Agents|sensory system agents|mesh-ancestor
101434048|NCT03456661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101434049|NCT03456661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101434050|NCT03456661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101434051|NCT03456661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101434052|NCT03456661|Adrenergic Agents|adrenergic agents|mesh-ancestor
101434053|NCT03456661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101434054|NCT03456661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434055|NCT03456661|Anesthetics, Local|anesthetics, local|mesh-ancestor
101434056|NCT03456661|Anesthetics|anesthetics|mesh-ancestor
101434057|NCT03456544|Vancomycin|vancomycin|mesh-list
101434058|NCT03456544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101434059|NCT03456544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101434066|NCT00159887|Urological Agents|urological agents|mesh-ancestor
101434068|NCT00543361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101434069|NCT00543361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434070|NCT00190788|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
101434071|NCT00190788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101434072|NCT00543634|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101434073|NCT00543634|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101434074|NCT00543634|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101434075|NCT00543634|Contraceptive Agents|contraceptive agents|mesh-ancestor
101434076|NCT00543634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101434077|NCT00543634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434078|NCT00543634|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101434079|NCT00543634|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101434080|NCT00543634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101434081|NCT00543634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101434082|NCT00543634|Estrogens|estrogens|mesh-ancestor
101434083|NCT00543634|Hormones|hormones|mesh-ancestor
101434084|NCT00543634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101434085|NCT00184197|Botulinum Toxins|botulinum toxins|mesh-list
101434086|NCT00184197|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101434087|NCT00184197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101434088|NCT00184197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434089|NCT00184197|Cholinergic Agents|cholinergic agents|mesh-ancestor
101434090|NCT00184197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101434096|NCT00543829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101434098|NCT00543829|Antimitotic Agents|antimitotic agents|mesh-ancestor
101434099|NCT00543829|Mitosis Modulators|mitosis modulators|mesh-ancestor
101434100|NCT00543829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434101|NCT00543829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101434102|NCT00543829|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101434103|NCT00543829|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101434104|NCT00543829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101434105|NCT00543829|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101434106|NCT00543829|Hormone Antagonists|hormone antagonists|mesh-ancestor
101434107|NCT00543829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101434108|NCT00543829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434109|NCT00543829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101434110|NCT00543829|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101434111|NCT00543829|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101434112|NCT00543829|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101434113|NCT00190827|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101434114|NCT00190827|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101559250|NCT00630097|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101559251|NCT00630097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559252|NCT00630097|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101559253|NCT00630097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101559254|NCT00630097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101559255|NCT00630097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559256|NCT01165281|Oxycodone|oxycodone|mesh-list
101407697|NCT00441415|Analgesics|analgesics|mesh-ancestor
101434115|NCT00190827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101434116|NCT00190827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101434117|NCT00190827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434118|NCT00190827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101434119|NCT00190827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434120|NCT00190827|Analgesics|analgesics|mesh-ancestor
101434121|NCT00190827|Sensory System Agents|sensory system agents|mesh-ancestor
101434122|NCT00190827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101434123|NCT00190827|Antidepressive Agents|antidepressive agents|mesh-ancestor
101434125|NCT00190827|Dopamine Agents|dopamine agents|mesh-ancestor
101434126|NCT00160043|Vatalanib|vatalanib|mesh-list
101307377|NCT02040246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307378|NCT02040285|Metoclopramide|metoclopramide|mesh-list
101434127|NCT00160043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101434128|NCT00160043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101434129|NCT00160043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434130|NCT00544063|Oxaliplatin|oxaliplatin|mesh-list
101434131|NCT00544063|Irinotecan|irinotecan|mesh-list
101434132|NCT00544063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101434133|NCT00544063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101434134|NCT00544063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101434135|NCT00544063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101434136|NCT00544063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434137|NCT00544180|Risedronic Acid|risedronic acid|mesh-list
101434138|NCT00544180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101434139|NCT00544180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101434140|NCT00544180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434141|NCT00544180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101434142|NCT00544180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434143|NCT00544180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101434144|NCT00544219|Prednisone|prednisone|mesh-list
101434145|NCT00544219|Cyclophosphamide|cyclophosphamide|mesh-list
101434146|NCT00544219|Rituximab|rituximab|mesh-list
101434147|NCT00544219|Doxorubicin|doxorubicin|mesh-list
101434148|NCT00544219|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101434149|NCT00544219|Vincristine|vincristine|mesh-list
101434150|NCT00544219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101434151|NCT00544219|Immunologic Factors|immunologic factors|mesh-ancestor
101434152|NCT00544219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434153|NCT00544219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101434154|NCT00544219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101434155|NCT00544219|Alkylating Agents|alkylating agents|mesh-ancestor
101434156|NCT00544219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434157|NCT00544219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101434165|NCT00544219|Glucocorticoids|glucocorticoids|mesh-ancestor
101434166|NCT00544219|Hormones|hormones|mesh-ancestor
101434167|NCT00544219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101434168|NCT00544219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101434169|NCT00544219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101434170|NCT00544219|Tubulin Modulators|tubulin modulators|mesh-ancestor
101434171|NCT00544219|Antimitotic Agents|antimitotic agents|mesh-ancestor
101434172|NCT00544219|Mitosis Modulators|mitosis modulators|mesh-ancestor
101434173|NCT00190866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101434174|NCT00190866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101434175|NCT00190866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101559257|NCT01165281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101559258|NCT01165281|Narcotics|narcotics|mesh-ancestor
101559259|NCT01165281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101559260|NCT01165281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559261|NCT01165281|Analgesics|analgesics|mesh-ancestor
101559262|NCT01165281|Sensory System Agents|sensory system agents|mesh-ancestor
101559263|NCT01165281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101434176|NCT00190866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101434177|NCT00190866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434178|NCT00190866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101434179|NCT00190866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434180|NCT00190866|Analgesics|analgesics|mesh-ancestor
101434181|NCT00190866|Sensory System Agents|sensory system agents|mesh-ancestor
101434182|NCT00190866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101434183|NCT00190866|Antidepressive Agents|antidepressive agents|mesh-ancestor
101434184|NCT00190866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101434185|NCT00190866|Dopamine Agents|dopamine agents|mesh-ancestor
101434186|NCT00160160|Eprosartan|eprosartan|mesh-list
101434187|NCT00160160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101434188|NCT00160160|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
101434189|NCT00160160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101434190|NCT00160160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434191|NCT00544570|Cyclophosphamide|cyclophosphamide|mesh-list
101434192|NCT00544570|Melphalan|melphalan|mesh-list
101434193|NCT00544570|Carmustine|carmustine|mesh-list
101434194|NCT00544570|Etoposide|etoposide|mesh-list
101434195|NCT00544570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101307379|NCT02040285|Bisacodyl|bisacodyl|mesh-list
101307380|NCT02040285|Antiemetics|antiemetics|mesh-ancestor
101307381|NCT02040285|Autonomic Agents|autonomic agents|mesh-ancestor
101434196|NCT00544570|Immunologic Factors|immunologic factors|mesh-ancestor
101434198|NCT00544570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101434199|NCT00544570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101434200|NCT00544570|Alkylating Agents|alkylating agents|mesh-ancestor
101434201|NCT00544570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434202|NCT00544570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101434203|NCT00544570|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101434204|NCT00544570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101434205|NCT00544570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101434206|NCT00544570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101434207|NCT00544570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101434208|NCT00190905|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101434209|NCT00190905|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101434210|NCT00190905|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101434211|NCT00190905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101434212|NCT00190905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434213|NCT00190905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101434214|NCT00190905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434216|NCT00190905|Sensory System Agents|sensory system agents|mesh-ancestor
101434217|NCT00190905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101434218|NCT00190905|Antidepressive Agents|antidepressive agents|mesh-ancestor
101434219|NCT00190905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101434220|NCT00190905|Dopamine Agents|dopamine agents|mesh-ancestor
101434221|NCT00544609|Sorafenib|sorafenib|mesh-list
101434222|NCT00544609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101434227|NCT00544687|Nortriptyline|nortriptyline|mesh-list
101434228|NCT00544687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101434229|NCT00544687|Dermatologic Agents|dermatologic agents|mesh-ancestor
101434230|NCT00544687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101434231|NCT00544687|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101434232|NCT00544687|Antidepressive Agents|antidepressive agents|mesh-ancestor
101434233|NCT00544687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101434234|NCT00544687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101434235|NCT00544687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101434236|NCT00544687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101434237|NCT00544687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559264|NCT02860897|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101559265|NCT02860897|Estrogens|estrogens|mesh-ancestor
101559267|NCT02860897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101559268|NCT02860897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559269|NCT02860819|Carboplatin|carboplatin|mesh-list
101559270|NCT02860819|Gemcitabine|gemcitabine|mesh-list
101559271|NCT02860819|Veliparib|veliparib|mesh-list
101559272|NCT02860819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101559273|NCT02860819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101559274|NCT02860819|Antimetabolites|antimetabolites|mesh-ancestor
101559275|NCT02860819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434238|NCT00544687|Adrenergic Agents|adrenergic agents|mesh-ancestor
101434239|NCT00544687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101434240|NCT00544687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434241|NCT00160238|Betahistine|betahistine|mesh-list
101434242|NCT00160238|Vasodilator Agents|vasodilator agents|mesh-ancestor
101434243|NCT00160238|Histamine Agonists|histamine agonists|mesh-ancestor
101434244|NCT00160238|Histamine Agents|histamine agents|mesh-ancestor
101434245|NCT00160238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101434246|NCT00160238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434247|NCT00160238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434248|NCT00544804|Lapatinib|lapatinib|mesh-list
101434249|NCT00544804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101434250|NCT00544804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101434251|NCT00544804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101434252|NCT00544804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434253|NCT00160277|Moxonidine|moxonidine|mesh-list
101434254|NCT00160277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101434255|NCT02963181|Melatonin|melatonin|mesh-list
101434256|NCT02963181|Yohimbine|yohimbine|mesh-list
101434257|NCT02963181|Antioxidants|antioxidants|mesh-ancestor
101434258|NCT02963181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434259|NCT02963181|Protective Agents|protective agents|mesh-ancestor
101189262|NCT00003594|Antidotes|antidotes|mesh-ancestor
101434260|NCT02963181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434261|NCT02963181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101434262|NCT02963181|Mydriatics|mydriatics|mesh-ancestor
101434263|NCT02963181|Autonomic Agents|autonomic agents|mesh-ancestor
101434264|NCT02963181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101434265|NCT02963181|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101307382|NCT02040285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101307383|NCT02040285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307384|NCT02040285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101307385|NCT02040285|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101434266|NCT02963181|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101434267|NCT02963181|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101434272|NCT00544999|Everolimus|everolimus|mesh-list
101434273|NCT00544999|Daunorubicin|daunorubicin|mesh-list
101434274|NCT00544999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101434275|NCT00544999|Antimetabolites|antimetabolites|mesh-ancestor
101434276|NCT00544999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434277|NCT00544999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101434278|NCT00544999|Antiviral Agents|antiviral agents|mesh-ancestor
101434279|NCT00544999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101434280|NCT00544999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101434281|NCT00544999|Immunologic Factors|immunologic factors|mesh-ancestor
101434282|NCT00544999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434283|NCT00544999|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101434284|NCT00544999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101434285|NCT00544999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101434286|NCT00544999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101434287|NCT00544999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101559276|NCT02860819|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101559277|NCT02860819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101559278|NCT04284007|Dexamethasone|dexamethasone|mesh-list
101559279|NCT04284007|Dexamethasone acetate|dexamethasone acetate|mesh-list
101559280|NCT04284007|Levobupivacaine|levobupivacaine|mesh-list
101559282|NCT04284007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101559283|NCT04284007|Antiemetics|antiemetics|mesh-ancestor
101559284|NCT04284007|Autonomic Agents|autonomic agents|mesh-ancestor
101559285|NCT04284007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101434288|NCT00544999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101434289|NCT00160316|Estradiol|estradiol|mesh-list
101434290|NCT00160316|Dydrogesterone|dydrogesterone|mesh-list
101434291|NCT00160316|Estrogens|estrogens|mesh-ancestor
101434292|NCT00160316|Hormones|hormones|mesh-ancestor
101434297|NCT00545194|Oxytocics|oxytocics|mesh-ancestor
101434298|NCT00545194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101434299|NCT00545194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434300|NCT00190944|Teriparatide|teriparatide|mesh-list
101434301|NCT00190944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101434302|NCT00190944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434303|NCT00190944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101434304|NCT03456466|Rituximab|rituximab|mesh-list
101434305|NCT03456466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101434306|NCT03456466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101434307|NCT03456466|Immunologic Factors|immunologic factors|mesh-ancestor
101434308|NCT03456466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434309|NCT03456466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101434310|NCT00160355|Fludarabine|fludarabine|mesh-list
101434311|NCT00160355|Melphalan|melphalan|mesh-list
101434312|NCT00160355|Thiotepa|thiotepa|mesh-list
101434313|NCT00160355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101434314|NCT00160355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434315|NCT00160355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101434316|NCT00160355|Immunologic Factors|immunologic factors|mesh-ancestor
101434317|NCT00160355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434318|NCT00160355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101434319|NCT00160355|Alkylating Agents|alkylating agents|mesh-ancestor
101434320|NCT00160355|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101434321|NCT00545311|Glycopyrrolate|glycopyrrolate|mesh-list
101434322|NCT00545311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101434323|NCT00545311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101434324|NCT00545311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101434325|NCT00545311|Cholinergic Agents|cholinergic agents|mesh-ancestor
101434326|NCT00545311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101434327|NCT00545311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434328|NCT00545311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434329|NCT00160394|Adapalene|adapalene|mesh-list
101434330|NCT00160394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101434331|NCT00160394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101434332|NCT00160394|Analgesics|analgesics|mesh-ancestor
101434333|NCT00160394|Sensory System Agents|sensory system agents|mesh-ancestor
101434334|NCT00160394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101434335|NCT00160394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434336|NCT00160394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101307386|NCT02040285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101307387|NCT02040285|Dopamine Agents|dopamine agents|mesh-ancestor
101307388|NCT02040285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101307389|NCT02040285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307390|NCT02040285|Cathartics|cathartics|mesh-ancestor
101307391|NCT02040285|Laxatives|laxatives|mesh-ancestor
101434337|NCT00160394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101434338|NCT00160394|Dermatologic Agents|dermatologic agents|mesh-ancestor
101434340|NCT00191022|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101434342|NCT00191022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101434343|NCT00191022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559286|NCT04284007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559287|NCT04284007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101559288|NCT04284007|Glucocorticoids|glucocorticoids|mesh-ancestor
101559289|NCT04284007|Hormones|hormones|mesh-ancestor
101559290|NCT04284007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101559291|NCT04284007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101559292|NCT04284007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101559293|NCT04284007|Protease Inhibitors|protease inhibitors|mesh-ancestor
101559294|NCT04284007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101468832|NCT00264615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101559295|NCT04284007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559296|NCT04284007|Anesthetics, Local|anesthetics, local|mesh-ancestor
101559297|NCT04284007|Anesthetics|anesthetics|mesh-ancestor
101559298|NCT04284007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101559299|NCT04284007|Sensory System Agents|sensory system agents|mesh-ancestor
101559300|NCT01165203|Vaccines|vaccines|mesh-list
101559301|NCT01165203|Immunologic Factors|immunologic factors|mesh-ancestor
101559302|NCT01165203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559303|NCT00960661|Insulin|insulin|mesh-list
101559304|NCT00960661|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101559305|NCT00960661|Metformin|metformin|mesh-list
101559306|NCT00960661|Exenatide|exenatide|mesh-list
101559307|NCT00960661|Insulin Lispro|insulin lispro|mesh-list
101434344|NCT00191022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101434345|NCT00191022|Serotonin Agents|serotonin agents|mesh-ancestor
101434346|NCT00191022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434347|NCT00191022|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101434348|NCT00191022|Antidepressive Agents|antidepressive agents|mesh-ancestor
101434349|NCT00191022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101434350|NCT00191022|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101434351|NCT00191022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101434352|NCT00191022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101434354|NCT00545389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101434355|NCT00545389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101434356|NCT00545389|Analgesics|analgesics|mesh-ancestor
101434357|NCT00545389|Sensory System Agents|sensory system agents|mesh-ancestor
101434358|NCT00545389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101434361|NCT00545389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101434363|NCT00545467|Antidepressive Agents|antidepressive agents|mesh-ancestor
101434364|NCT00545467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101434365|NCT00545467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101434366|NCT00545467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101434367|NCT00545467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101434368|NCT00545467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434369|NCT00545467|Dopamine Agonists|dopamine agonists|mesh-ancestor
101434370|NCT00545467|Dopamine Agents|dopamine agents|mesh-ancestor
101434371|NCT00545467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101434372|NCT00545467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434373|NCT00545467|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101434374|NCT00545467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101434375|NCT00545467|Serotonin Agents|serotonin agents|mesh-ancestor
101434376|NCT00545467|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101434377|NCT00545467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101559308|NCT00960661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101559309|NCT00960661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559310|NCT00960661|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101559311|NCT00960661|Incretins|incretins|mesh-ancestor
101559312|NCT00960661|Hormones|hormones|mesh-ancestor
101434378|NCT00545467|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101434379|NCT00545467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101434380|NCT00545857|Pioglitazone|pioglitazone|mesh-list
101434381|NCT00545857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101434382|NCT00545857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434384|NCT00545935|Amodiaquine|amodiaquine|mesh-list
101434385|NCT00545935|Antimalarials|antimalarials|mesh-ancestor
101434386|NCT00545935|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101434387|NCT00545935|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101434388|NCT00545935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101434389|NCT00545935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101434390|NCT00545935|Antiviral Agents|antiviral agents|mesh-ancestor
101434391|NCT00545935|Schistosomicides|schistosomicides|mesh-ancestor
101434392|NCT00545935|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101434393|NCT00545935|Anthelmintics|anthelmintics|mesh-ancestor
101434394|NCT00160511|Levetiracetam|levetiracetam|mesh-list
101434395|NCT00160511|Anticonvulsants|anticonvulsants|mesh-ancestor
101434396|NCT00160511|Nootropic Agents|nootropic agents|mesh-ancestor
101434397|NCT00191061|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101434398|NCT00191061|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101434399|NCT00191061|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101434400|NCT00191061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101434401|NCT00191061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307393|NCT02040311|Anticonvulsants|anticonvulsants|mesh-ancestor
101307394|NCT02040311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101307395|NCT02040311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307396|NCT02040350|Pralidoxime|pralidoxime|mesh-list
101434402|NCT00191061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101434403|NCT00191061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434404|NCT00191061|Analgesics|analgesics|mesh-ancestor
101434405|NCT00191061|Sensory System Agents|sensory system agents|mesh-ancestor
101434406|NCT00191061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101434407|NCT00191061|Antidepressive Agents|antidepressive agents|mesh-ancestor
101434408|NCT00191061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101434409|NCT00191061|Dopamine Agents|dopamine agents|mesh-ancestor
101434410|NCT00160550|Levetiracetam|levetiracetam|mesh-list
101434411|NCT00160550|Anticonvulsants|anticonvulsants|mesh-ancestor
101434412|NCT00160550|Nootropic Agents|nootropic agents|mesh-ancestor
101434413|NCT00160589|Levocetirizine|levocetirizine|mesh-list
101434416|NCT00160589|Histamine Antagonists|histamine antagonists|mesh-ancestor
101434417|NCT00160589|Histamine Agents|histamine agents|mesh-ancestor
101434418|NCT00160589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101434419|NCT00160589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434420|NCT00160589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434421|NCT00546130|polysaccharide-K|polysaccharide-k|mesh-list
101434423|NCT00546130|Irinotecan|irinotecan|mesh-list
101434424|NCT00546130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101434425|NCT00546130|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101434426|NCT00546130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101434427|NCT00546130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101434428|NCT00546130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434429|NCT00546130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101434430|NCT00546130|Immunologic Factors|immunologic factors|mesh-ancestor
101434431|NCT00546130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434434|NCT00546130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101434435|NCT00546130|Interferon Inducers|interferon inducers|mesh-ancestor
101434436|NCT00546130|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101434437|NCT00546130|Protective Agents|protective agents|mesh-ancestor
101434439|NCT00191178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101434440|NCT00191178|Insulin Glargine|insulin glargine|mesh-list
101434441|NCT00191178|Insulin Lispro|insulin lispro|mesh-list
101434442|NCT00191178|Protamines|protamines|mesh-list
101434443|NCT00191178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101434444|NCT00191178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434445|NCT00191178|Heparin Antagonists|heparin antagonists|mesh-ancestor
101434446|NCT00191178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434447|NCT00191178|Coagulants|coagulants|mesh-ancestor
101434448|NCT00546169|Thrombin|thrombin|mesh-list
101559313|NCT00960661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101559315|NCT00960193|Gout Suppressants|gout suppressants|mesh-ancestor
101559316|NCT00960193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101559317|NCT00960193|Tubulin Modulators|tubulin modulators|mesh-ancestor
101559318|NCT00960193|Antimitotic Agents|antimitotic agents|mesh-ancestor
101434449|NCT00546169|Hemostatics|hemostatics|mesh-ancestor
101434450|NCT00546169|Coagulants|coagulants|mesh-ancestor
101434451|NCT00160628|Levetiracetam|levetiracetam|mesh-list
101434452|NCT00160628|Anticonvulsants|anticonvulsants|mesh-ancestor
101434453|NCT00160628|Nootropic Agents|nootropic agents|mesh-ancestor
101434454|NCT00546286|Timolol|timolol|mesh-list
101434455|NCT00546286|Dorzolamide|dorzolamide|mesh-list
101434456|NCT00546286|Maleic acid|maleic acid|mesh-list
101434457|NCT00546286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101434458|NCT00546286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434459|NCT00546286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101434460|NCT00546286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101434461|NCT00546286|Adrenergic Agents|adrenergic agents|mesh-ancestor
101434462|NCT00546286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101434463|NCT00546286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434464|NCT00546286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101434465|NCT00546286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101434466|NCT00546286|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101434467|NCT00546325|Rimonabant|rimonabant|mesh-list
101434468|NCT00546325|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101434469|NCT00546325|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
101434470|NCT00546325|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101434471|NCT00546325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101434472|NCT00546325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434473|NCT00546325|Hormones|hormones|mesh-ancestor
101307398|NCT02040350|Protective Agents|protective agents|mesh-ancestor
101307399|NCT02040350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307400|NCT02040350|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
101307401|NCT02040350|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
101434474|NCT00546325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101434475|NCT00546325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434476|NCT00546403|Modafinil|modafinil|mesh-list
101434477|NCT00546403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101434478|NCT00546403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434479|NCT00546403|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101434480|NCT00546403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101434481|NCT00546403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101434482|NCT00546403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434483|NCT00546442|Metformin|metformin|mesh-list
101434484|NCT00546442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101434485|NCT00546442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434492|NCT00191256|Antimitotic Agents|antimitotic agents|mesh-ancestor
101434493|NCT00191256|Mitosis Modulators|mitosis modulators|mesh-ancestor
101434494|NCT00191256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434495|NCT00191256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101434496|NCT00191256|Antimetabolites|antimetabolites|mesh-ancestor
101434497|NCT00546520|Ciclesonide|ciclesonide|mesh-list
101434498|NCT00546520|Glucocorticoids|glucocorticoids|mesh-ancestor
101434499|NCT00546520|Hormones|hormones|mesh-ancestor
101434500|NCT00546520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101434501|NCT00546520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434502|NCT00546520|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101434503|NCT00546559|Simvastatin|simvastatin|mesh-list
101434504|NCT00546559|Pravastatin|pravastatin|mesh-list
101434505|NCT00546559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101434506|NCT00546559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101434511|NCT00546559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101434512|NCT00160745|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101434513|NCT00160745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101434514|NCT00160745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101434515|NCT00160745|Antimetabolites|antimetabolites|mesh-ancestor
101434516|NCT00160745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559319|NCT00960193|Mitosis Modulators|mitosis modulators|mesh-ancestor
101559320|NCT00960193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559321|NCT00960193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101559323|NCT00960115|Immunologic Factors|immunologic factors|mesh-ancestor
101559324|NCT00960115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434517|NCT00160745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101434518|NCT00160745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101434519|NCT00160745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101434520|NCT00546676|Telithromycin|telithromycin|mesh-list
101434521|NCT00546676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101434522|NCT00546676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101434523|NCT00546832|Celecoxib|celecoxib|mesh-list
101434524|NCT00546832|Diclofenac|diclofenac|mesh-list
101434525|NCT00546832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101434526|NCT00546832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101434527|NCT00546832|Analgesics|analgesics|mesh-ancestor
101434528|NCT00546832|Sensory System Agents|sensory system agents|mesh-ancestor
101434529|NCT00546832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101434530|NCT00546832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434531|NCT00546832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101434532|NCT00546832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101434533|NCT00546832|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101434534|NCT00546832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101434535|NCT00546832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101434536|NCT00546832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434537|NCT00184587|Candesartan|candesartan|mesh-list
101434538|NCT00184587|Candesartan cilexetil|candesartan cilexetil|mesh-list
101434539|NCT00184587|Angiotensin II|angiotensin ii|mesh-list
101434540|NCT00184587|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
101434541|NCT00184587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101307402|NCT02040350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307403|NCT02040350|Cholinergic Agents|cholinergic agents|mesh-ancestor
101307404|NCT02040350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101307405|NCT02040402|Vaccines|vaccines|mesh-list
101307406|NCT02040402|Immunologic Factors|immunologic factors|mesh-ancestor
101307407|NCT02040402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307408|NCT02040415|Eperisone|eperisone|mesh-list
101307409|NCT02040415|Anticonvulsants|anticonvulsants|mesh-ancestor
101307410|NCT02040415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101307411|NCT02040415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101307412|NCT02040415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307413|NCT02040415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101307414|NCT02040415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434542|NCT00184587|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101434543|NCT00184587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434544|NCT00184587|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101434545|NCT00547144|Gemcitabine|gemcitabine|mesh-list
101434546|NCT00547144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101434547|NCT00547144|Antimetabolites|antimetabolites|mesh-ancestor
101434548|NCT00547144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434549|NCT00547144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101434550|NCT00547183|Tadalafil|tadalafil|mesh-list
101434551|NCT00547183|Vasodilator Agents|vasodilator agents|mesh-ancestor
101434552|NCT00547183|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101434553|NCT00547183|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101434554|NCT00547183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101434558|NCT00184626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101434559|NCT00184626|Metformin|metformin|mesh-list
101434560|NCT00184626|Insulin Glargine|insulin glargine|mesh-list
101434561|NCT00184626|Insulin Aspart|insulin aspart|mesh-list
101434562|NCT00184626|Biphasic Insulins|biphasic insulins|mesh-list
101434563|NCT00184626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101434564|NCT00184626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434571|NCT00547417|Urological Agents|urological agents|mesh-ancestor
101434572|NCT00191295|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101434573|NCT00191295|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101559325|NCT00960115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101559326|NCT00960115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101559327|NCT00960115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101468886|NCT02219737|Immunologic Factors|immunologic factors|mesh-ancestor
101434574|NCT00191295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101434575|NCT00191295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101434576|NCT00191295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434577|NCT00191295|Adrenergic Agents|adrenergic agents|mesh-ancestor
101434578|NCT00191295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101434579|NCT00191295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434581|NCT00547495|Vasodilator Agents|vasodilator agents|mesh-ancestor
101434582|NCT00547495|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101434583|NCT00547495|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101434584|NCT00547495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101434585|NCT00547495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434586|NCT00547495|Urological Agents|urological agents|mesh-ancestor
101434587|NCT02277223|Curcumin|curcumin|mesh-list
101434588|NCT02277223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101434589|NCT02277223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101434590|NCT02277223|Analgesics|analgesics|mesh-ancestor
101307416|NCT02040415|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101307417|NCT02040415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101307418|NCT02040415|Parasympatholytics|parasympatholytics|mesh-ancestor
101434591|NCT02277223|Sensory System Agents|sensory system agents|mesh-ancestor
101434592|NCT02277223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101434593|NCT02277223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434594|NCT02277223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101434595|NCT02277223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101434596|NCT02277223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101434597|NCT02277223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101434598|NCT02277223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434599|NCT00547573|Tadalafil|tadalafil|mesh-list
101434600|NCT00547573|Vasodilator Agents|vasodilator agents|mesh-ancestor
101434601|NCT00547573|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101434602|NCT00547573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101434603|NCT00547573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101434604|NCT00547573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434605|NCT00547573|Urological Agents|urological agents|mesh-ancestor
101434606|NCT00191373|Gemcitabine|gemcitabine|mesh-list
101434607|NCT00191373|Trastuzumab|trastuzumab|mesh-list
101434608|NCT00191373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101434609|NCT00191373|Antimetabolites|antimetabolites|mesh-ancestor
101434610|NCT00191373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434611|NCT00191373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101434612|NCT00191373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101434613|NCT00547612|Substance P|substance p|mesh-list
101434614|NCT00547612|Neurokinin A|neurokinin a|mesh-list
101434615|NCT00547612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101434616|NCT00547612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434617|NCT00547612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434618|NCT00547768|Fexofenadine|fexofenadine|mesh-list
101434619|NCT00547768|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101434620|NCT00547768|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101434621|NCT00547768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101434622|NCT00547768|Histamine Antagonists|histamine antagonists|mesh-ancestor
101434623|NCT00547768|Histamine Agents|histamine agents|mesh-ancestor
101434624|NCT00547768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101434628|NCT00184665|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101434629|NCT00184665|Insulin Aspart|insulin aspart|mesh-list
101434630|NCT00184665|Insulin Detemir|insulin detemir|mesh-list
101434631|NCT00184665|Isophane Insulin, Human|isophane insulin, human|mesh-list
101434639|NCT04983238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101434641|NCT04983238|Protective Agents|protective agents|mesh-ancestor
101434642|NCT04983238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434643|NCT04983238|Antioxidants|antioxidants|mesh-ancestor
101434644|NCT04983238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434645|NCT04983238|Antitubercular Agents|antitubercular agents|mesh-ancestor
101434646|NCT04983238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101434647|NCT04983238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101434648|NCT04983238|Chelating Agents|chelating agents|mesh-ancestor
101434649|NCT04983238|Sequestering Agents|sequestering agents|mesh-ancestor
101559328|NCT00960115|Alkylating Agents|alkylating agents|mesh-ancestor
101559329|NCT00960115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559330|NCT00960115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101559331|NCT00960115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101559332|NCT00959647|Bevacizumab|bevacizumab|mesh-list
101559333|NCT00959647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101559334|NCT00959647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101434650|NCT04974385|Bupivacaine|bupivacaine|mesh-list
101434651|NCT04974385|Anesthetics, Local|anesthetics, local|mesh-ancestor
101434652|NCT04974385|Anesthetics|anesthetics|mesh-ancestor
101434653|NCT04974385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101434654|NCT04974385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434655|NCT04974385|Sensory System Agents|sensory system agents|mesh-ancestor
101434656|NCT04974385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101434657|NCT00547885|Dihydrocodeine|dihydrocodeine|mesh-list
101434658|NCT00547885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101434659|NCT00547885|Narcotics|narcotics|mesh-ancestor
101434660|NCT00547885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101434661|NCT00547885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434662|NCT00547885|Analgesics|analgesics|mesh-ancestor
101307419|NCT02040415|Autonomic Agents|autonomic agents|mesh-ancestor
101307420|NCT02040415|Vasodilator Agents|vasodilator agents|mesh-ancestor
101307421|NCT02040441|Spironolactone|spironolactone|mesh-list
101307422|NCT02040441|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101434663|NCT00547885|Sensory System Agents|sensory system agents|mesh-ancestor
101434664|NCT00547885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101434665|NCT00161018|Risperidone|risperidone|mesh-list
101434666|NCT00161018|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101434667|NCT00161018|Fluphenazine|fluphenazine|mesh-list
101434668|NCT00161018|Fluphenazine depot|fluphenazine depot|mesh-list
101434669|NCT00161018|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
101434670|NCT00161018|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101434671|NCT00161018|Serotonin Agents|serotonin agents|mesh-ancestor
101434672|NCT00161018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101434673|NCT00161018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434674|NCT00161018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434675|NCT00161018|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101434676|NCT00161018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101434677|NCT00161018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101434678|NCT00161018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101434679|NCT00161018|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101434680|NCT00161018|Dopamine Agents|dopamine agents|mesh-ancestor
101434681|NCT00161018|Antidepressive Agents|antidepressive agents|mesh-ancestor
101434682|NCT00191412|Pemetrexed|pemetrexed|mesh-list
101434683|NCT00191412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101434684|NCT00191412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101434685|NCT00191412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434686|NCT00191412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101434687|NCT00191412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101434688|NCT00548002|Levofloxacin|levofloxacin|mesh-list
101434689|NCT00548002|Trovafloxacin|trovafloxacin|mesh-list
101434690|NCT00548002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101434691|NCT00548002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101434692|NCT00548002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101434693|NCT00548002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101434694|NCT00548002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101434695|NCT00548002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101468911|NCT02218606|Hormones|hormones|mesh-ancestor
101434696|NCT00548002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434730|NCT00184821|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101434731|NCT00184821|Purinergic Agonists|purinergic agonists|mesh-ancestor
101434732|NCT00184821|Purinergic Agents|purinergic agents|mesh-ancestor
101434733|NCT00184821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101434734|NCT00184821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434735|NCT00184821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101434736|NCT00184821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101434737|NCT00184821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101434739|NCT00548509|Vitamin K 2|vitamin k 2|mesh-list
101434740|NCT00548509|Menatetrenone|menatetrenone|mesh-list
101559336|NCT00959647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101559337|NCT00959647|Growth Substances|growth substances|mesh-ancestor
101559338|NCT00959647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559339|NCT00959647|Growth Inhibitors|growth inhibitors|mesh-ancestor
101559341|NCT00957853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101434741|NCT00548509|Vitamins|vitamins|mesh-ancestor
101434742|NCT00548509|Micronutrients|micronutrients|mesh-ancestor
101434743|NCT00548509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434744|NCT00548509|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101434745|NCT00548509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101434774|NCT00184899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434776|NCT00548821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101434777|NCT00161291|Bevacizumab|bevacizumab|mesh-list
101434778|NCT00161291|Letrozole|letrozole|mesh-list
101434779|NCT00161291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101434780|NCT00161291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101434781|NCT00161291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101434782|NCT00161291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101434783|NCT00161291|Growth Substances|growth substances|mesh-ancestor
101434784|NCT00161291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434785|NCT00161291|Growth Inhibitors|growth inhibitors|mesh-ancestor
101307423|NCT02040441|Hormone Antagonists|hormone antagonists|mesh-ancestor
101333866|NCT00017394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101434786|NCT00161291|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101434787|NCT00161291|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101434788|NCT00161291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101434789|NCT00161291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434790|NCT00161291|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101434791|NCT00161291|Hormone Antagonists|hormone antagonists|mesh-ancestor
101434793|NCT00548899|Sorafenib|sorafenib|mesh-list
101434794|NCT00548899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101434795|NCT00548899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101434796|NCT00548899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101434797|NCT00548899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434798|NCT00191568|Gemcitabine|gemcitabine|mesh-list
101434799|NCT00191568|Oxaliplatin|oxaliplatin|mesh-list
101434800|NCT00191568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101434801|NCT00191568|Antimetabolites|antimetabolites|mesh-ancestor
101434802|NCT00191568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434803|NCT00191568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101434804|NCT00548938|Temozolomide|temozolomide|mesh-list
101434805|NCT00548938|Carmustine|carmustine|mesh-list
101434806|NCT00548938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101434807|NCT00548938|Alkylating Agents|alkylating agents|mesh-ancestor
101434808|NCT00548938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434809|NCT00548938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101434810|NCT00161330|Amoxicillin|amoxicillin|mesh-list
101434811|NCT00161330|Ceftriaxone|ceftriaxone|mesh-list
101434812|NCT00161330|Clavulanic Acids|clavulanic acids|mesh-list
101434813|NCT00161330|Clavulanic Acid|clavulanic acid|mesh-list
101434814|NCT00161330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101434815|NCT00161330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101434816|NCT00161330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101434817|NCT00161330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434818|NCT00161330|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101434819|NCT00184938|Morphine|morphine|mesh-list
101434820|NCT00184938|Naloxone|naloxone|mesh-list
101434821|NCT00184938|Annexin A5|annexin a5|mesh-list
101434822|NCT00184938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101434826|NCT00184938|Analgesics|analgesics|mesh-ancestor
101434827|NCT00184938|Sensory System Agents|sensory system agents|mesh-ancestor
101434828|NCT00184938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101434829|NCT00184938|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101434830|NCT00184938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101434831|NCT00184938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434833|NCT00549133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101434834|NCT00549133|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101559342|NCT00957853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101559344|NCT02725567|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101559345|NCT02725567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101559346|NCT02725567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559347|NCT02859571|Oxytocin|oxytocin|mesh-list
101559348|NCT02859571|Oxytocics|oxytocics|mesh-ancestor
101559349|NCT02859571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101559350|NCT02859571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559351|NCT00956839|Vitamin D|vitamin d|mesh-list
101559352|NCT00956839|Ergocalciferols|ergocalciferols|mesh-list
101434835|NCT00549133|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101434836|NCT00549133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434837|NCT00191607|Gemcitabine|gemcitabine|mesh-list
101434838|NCT00191607|Doxorubicin|doxorubicin|mesh-list
101434839|NCT00191607|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101434840|NCT00191607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101434841|NCT00191607|Antimetabolites|antimetabolites|mesh-ancestor
101434842|NCT00191607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434843|NCT00191607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101434844|NCT00191607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101434845|NCT00191607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101434846|NCT00191607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101434847|NCT00191607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101434848|NCT00549289|Cyclosporine|cyclosporine|mesh-list
101434849|NCT00549289|Cyclosporins|cyclosporins|mesh-list
101434850|NCT00549289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101434851|NCT00549289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434852|NCT00549289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101434853|NCT00549289|Immunologic Factors|immunologic factors|mesh-ancestor
101434854|NCT00549289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434855|NCT00549289|Antifungal Agents|antifungal agents|mesh-ancestor
101434856|NCT00549289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101434857|NCT00549289|Dermatologic Agents|dermatologic agents|mesh-ancestor
101307424|NCT02040441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101307425|NCT02040441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434859|NCT00549289|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101434860|NCT00184977|Fluticasone|fluticasone|mesh-list
101434861|NCT00184977|Xhance|xhance|mesh-list
101434862|NCT00184977|Acetylcysteine|acetylcysteine|mesh-list
101434863|NCT00184977|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101434864|NCT00184977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101434865|NCT00184977|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101434873|NCT00184977|Antiviral Agents|antiviral agents|mesh-ancestor
101434874|NCT00184977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101434875|NCT00184977|Expectorants|expectorants|mesh-ancestor
101434876|NCT00184977|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101434877|NCT00184977|Antioxidants|antioxidants|mesh-ancestor
101434878|NCT00184977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434879|NCT00184977|Protective Agents|protective agents|mesh-ancestor
101434880|NCT00184977|Antidotes|antidotes|mesh-ancestor
101434881|NCT03456154|Salicylic Acid|salicylic acid|mesh-list
101434882|NCT03456154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101434883|NCT03456154|Antifungal Agents|antifungal agents|mesh-ancestor
101434884|NCT03456154|Keratolytic Agents|keratolytic agents|mesh-ancestor
101434885|NCT03456154|Dermatologic Agents|dermatologic agents|mesh-ancestor
101434886|NCT00161447|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101434887|NCT00161447|Medroxyprogesterone|medroxyprogesterone|mesh-list
101434888|NCT00161447|Testosterone|testosterone|mesh-list
101434890|NCT00161447|Androgens|androgens|mesh-ancestor
101434891|NCT00161447|Hormones|hormones|mesh-ancestor
101434892|NCT00161447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101434893|NCT00161447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434894|NCT00161447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101434895|NCT00161447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101559353|NCT00956839|Cholecalciferol|cholecalciferol|mesh-list
101559354|NCT00956839|Vitamins|vitamins|mesh-list
101559355|NCT00956839|Micronutrients|micronutrients|mesh-ancestor
101559356|NCT00956839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559358|NCT00956839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101559359|NCT00956293|Cyclosporine|cyclosporine|mesh-list
101559360|NCT00956293|Mycophenolic Acid|mycophenolic acid|mesh-list
101559361|NCT00956293|Everolimus|everolimus|mesh-list
101559362|NCT00956293|Cyclosporins|cyclosporins|mesh-list
101559363|NCT00956293|Basiliximab|basiliximab|mesh-list
101559364|NCT00956293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101559365|NCT00956293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559366|NCT00956293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101434896|NCT00161447|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101434897|NCT00161447|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101434898|NCT00161447|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101434899|NCT00161447|Contraceptive Agents|contraceptive agents|mesh-ancestor
101434900|NCT00161447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101434907|NCT00191685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101434908|NCT00191685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101434909|NCT00191685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434910|NCT00191685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101434911|NCT00191685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434912|NCT00191685|Analgesics|analgesics|mesh-ancestor
101434913|NCT00191685|Sensory System Agents|sensory system agents|mesh-ancestor
101434914|NCT00191685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101434915|NCT00191685|Antidepressive Agents|antidepressive agents|mesh-ancestor
101434916|NCT00191685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101434917|NCT00191685|Dopamine Agents|dopamine agents|mesh-ancestor
101434918|NCT00161486|Methyltestosterone|methyltestosterone|mesh-list
101434919|NCT00161486|Testosterone|testosterone|mesh-list
101434920|NCT00161486|Testosterone undecanoate|testosterone undecanoate|mesh-list
101434921|NCT00161486|Testosterone enanthate|testosterone enanthate|mesh-list
101434922|NCT00161486|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101434923|NCT00161486|Acyline|acyline|mesh-list
101434924|NCT00161486|Androgens|androgens|mesh-ancestor
101434925|NCT00161486|Hormones|hormones|mesh-ancestor
101434926|NCT00161486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101434927|NCT00161486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434928|NCT00161486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101434929|NCT00161486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101434930|NCT00161486|Anabolic Agents|anabolic agents|mesh-ancestor
101434931|NCT00161486|Hormone Antagonists|hormone antagonists|mesh-ancestor
101434932|NCT00549874|Rosiglitazone|rosiglitazone|mesh-list
101434933|NCT00549874|Glyburide|glyburide|mesh-list
101434936|NCT00191763|Gemcitabine|gemcitabine|mesh-list
101434937|NCT00191763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101434938|NCT00191763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101307426|NCT02040441|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101307427|NCT02040441|Diuretics|diuretics|mesh-ancestor
101307428|NCT02040441|Natriuretic Agents|natriuretic agents|mesh-ancestor
101307429|NCT02040454|Paclitaxel|paclitaxel|mesh-list
101307430|NCT02040454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101307431|NCT02040454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101434939|NCT00191763|Antimetabolites|antimetabolites|mesh-ancestor
101434940|NCT00191763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434941|NCT00161564|Rituximab|rituximab|mesh-list
101434942|NCT00161564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101434943|NCT00161564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101434944|NCT00161564|Immunologic Factors|immunologic factors|mesh-ancestor
101434945|NCT00161564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434946|NCT00161564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101559367|NCT00956293|Immunologic Factors|immunologic factors|mesh-ancestor
101559368|NCT00956293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559369|NCT00956293|Antifungal Agents|antifungal agents|mesh-ancestor
101559370|NCT00956293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101559371|NCT00956293|Dermatologic Agents|dermatologic agents|mesh-ancestor
101559372|NCT00956293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101559373|NCT00956293|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101559374|NCT00956293|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101559375|NCT00956293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101434947|NCT00185055|Valsartan|valsartan|mesh-list
101434948|NCT00185055|Olmesartan|olmesartan|mesh-list
101434949|NCT00185055|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101434950|NCT00185055|Irbesartan|irbesartan|mesh-list
101434951|NCT00185055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101434952|NCT00185055|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101434953|NCT00185055|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101434954|NCT00185055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434955|NCT00550108|Ethanol|ethanol|mesh-list
101434956|NCT00550108|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101434957|NCT00550108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101434958|NCT00550108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101434959|NCT00550108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434960|NCT00185094|Losartan|losartan|mesh-list
101434961|NCT00185094|Atenolol|atenolol|mesh-list
101434962|NCT00185094|Olmesartan|olmesartan|mesh-list
101434963|NCT00185094|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101434964|NCT00185094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101434965|NCT00185094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101434978|NCT00550303|Bazedoxifene|bazedoxifene|mesh-list
101434979|NCT00550303|Estrogens|estrogens|mesh-list
101434980|NCT00550303|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101434981|NCT00550303|Hormones|hormones|mesh-ancestor
101434982|NCT00550303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101434983|NCT00550303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434984|NCT00550303|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101434985|NCT00550303|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101434986|NCT00550303|Hormone Antagonists|hormone antagonists|mesh-ancestor
101434987|NCT00550303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101434988|NCT00550342|Rituximab|rituximab|mesh-list
101434989|NCT00550342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101434990|NCT00550342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101434991|NCT00550342|Immunologic Factors|immunologic factors|mesh-ancestor
101434992|NCT00550342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434993|NCT00550342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101434994|NCT00161681|Levonorgestrel|levonorgestrel|mesh-list
101434995|NCT00161681|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101434996|NCT00161681|Estradiol|estradiol|mesh-list
101434997|NCT00161681|Estrogens|estrogens|mesh-ancestor
101434998|NCT00161681|Hormones|hormones|mesh-ancestor
101434999|NCT00161681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101435000|NCT00161681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435001|NCT00161681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101307432|NCT02040454|Tubulin Modulators|tubulin modulators|mesh-ancestor
101468939|NCT00264654|Paroxetine|paroxetine|mesh-list
101307433|NCT02040454|Antimitotic Agents|antimitotic agents|mesh-ancestor
101307434|NCT02040454|Mitosis Modulators|mitosis modulators|mesh-ancestor
101307435|NCT02040454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435002|NCT00161681|Contraceptive Agents|contraceptive agents|mesh-ancestor
101435003|NCT00161681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101435004|NCT00161681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101435005|NCT00161681|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101435012|NCT02963454|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101435013|NCT02963454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101435014|NCT02963454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101435015|NCT02963454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435016|NCT02963454|Protective Agents|protective agents|mesh-ancestor
101435017|NCT02963454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559376|NCT00956293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101559377|NCT00956293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101559378|NCT00956293|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101559379|NCT00956293|Antitubercular Agents|antitubercular agents|mesh-ancestor
101559380|NCT00956293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101559381|NCT04282291|Morphine|morphine|mesh-list
101559382|NCT04282291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101559383|NCT04282291|Narcotics|narcotics|mesh-ancestor
101559384|NCT04282291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101435018|NCT02963454|Sympathomimetics|sympathomimetics|mesh-ancestor
101435019|NCT02963454|Autonomic Agents|autonomic agents|mesh-ancestor
101435020|NCT02963454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101435021|NCT02963454|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101435022|NCT02963454|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101435023|NCT02963454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101435024|NCT02963454|Adrenergic Agents|adrenergic agents|mesh-ancestor
101435025|NCT02963454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101435026|NCT00191802|Teriparatide|teriparatide|mesh-list
101435027|NCT00191802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101435033|NCT00550693|Disinfectants|disinfectants|mesh-ancestor
101435034|NCT00550810|Sunitinib|sunitinib|mesh-list
101435035|NCT00550810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101435036|NCT00550810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101435037|NCT00550810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101435038|NCT00550810|Growth Substances|growth substances|mesh-ancestor
101435039|NCT00550810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435040|NCT00550810|Growth Inhibitors|growth inhibitors|mesh-ancestor
101435041|NCT00550810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101435042|NCT00550810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101435043|NCT00550810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435044|NCT00191841|Gemcitabine|gemcitabine|mesh-list
101435045|NCT00191841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101435046|NCT00191841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101435047|NCT00191841|Antimetabolites|antimetabolites|mesh-ancestor
101435048|NCT00191841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435049|NCT00550927|Bevacizumab|bevacizumab|mesh-list
101435050|NCT00550927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101435051|NCT00550927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101435052|NCT00550927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101435053|NCT00550927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101435054|NCT00550927|Growth Substances|growth substances|mesh-ancestor
101435055|NCT00550927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435056|NCT00550927|Growth Inhibitors|growth inhibitors|mesh-ancestor
101435057|NCT00161720|Protein C|protein c|mesh-list
101435058|NCT00161720|Anticoagulants|anticoagulants|mesh-ancestor
101435059|NCT00161720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101435060|NCT00161720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101435061|NCT00161720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435062|NCT00185133|Amlodipine|amlodipine|mesh-list
101435063|NCT00185133|Olmesartan|olmesartan|mesh-list
101435064|NCT00185133|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101435065|NCT00185133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101435066|NCT00185133|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101435067|NCT00185133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101435068|NCT00185133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435069|NCT00185133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101435070|NCT00185133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435071|NCT00185133|Vasodilator Agents|vasodilator agents|mesh-ancestor
101435072|NCT00185133|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101307436|NCT02040571|Insulin|insulin|mesh-list
101307437|NCT02040571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101307438|NCT02040571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435073|NCT00185133|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101435074|NCT00551005|Celecoxib|celecoxib|mesh-list
101435091|NCT00551005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101435092|NCT00551044|Bicalutamide|bicalutamide|mesh-list
101559385|NCT04282291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559387|NCT04282291|Sensory System Agents|sensory system agents|mesh-ancestor
101559388|NCT04282291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101559389|NCT00955825|Immunomodulating Agents|immunomodulating agents|mesh-list
101559390|NCT00955825|Immunologic Factors|immunologic factors|mesh-ancestor
101559391|NCT00955825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559392|NCT02859103|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101559393|NCT02859103|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101559394|NCT02859103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101559395|NCT02859103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101559396|NCT02859103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435093|NCT00551044|Androgen Antagonists|androgen antagonists|mesh-ancestor
101435094|NCT00551044|Hormone Antagonists|hormone antagonists|mesh-ancestor
101435095|NCT00551044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101435096|NCT00551044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435097|NCT00551044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101435098|NCT00161759|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101435099|NCT00161759|Thrombin|thrombin|mesh-list
101435100|NCT00161759|Hemostatics|hemostatics|mesh-ancestor
101435101|NCT00161759|Coagulants|coagulants|mesh-ancestor
101435102|NCT00551122|Paclitaxel|paclitaxel|mesh-list
101435103|NCT00551122|Gemcitabine|gemcitabine|mesh-list
101435104|NCT00551122|Ifosfamide|ifosfamide|mesh-list
101435105|NCT00551122|Lenograstim|lenograstim|mesh-list
101435106|NCT00551122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101435107|NCT00551122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101435108|NCT00551122|Tubulin Modulators|tubulin modulators|mesh-ancestor
101435109|NCT00551122|Antimitotic Agents|antimitotic agents|mesh-ancestor
101435110|NCT00551122|Mitosis Modulators|mitosis modulators|mesh-ancestor
101435114|NCT00551122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101435115|NCT00551122|Immunologic Factors|immunologic factors|mesh-ancestor
101435116|NCT00551122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435117|NCT00551122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101435118|NCT00551122|Alkylating Agents|alkylating agents|mesh-ancestor
101435119|NCT00551239|Rituximab|rituximab|mesh-list
101435120|NCT00551239|Fludarabine|fludarabine|mesh-list
101435121|NCT00551239|Fludarabine phosphate|fludarabine phosphate|mesh-list
101435122|NCT00551239|Pixantrone|pixantrone|mesh-list
101435123|NCT00551239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101435124|NCT00551239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101435125|NCT00551239|Immunologic Factors|immunologic factors|mesh-ancestor
101435126|NCT00551239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435127|NCT00551239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101435128|NCT00551239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101435129|NCT00551239|Antimetabolites|antimetabolites|mesh-ancestor
101435130|NCT00551239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435131|NCT00551239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101435132|NCT00551239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101435133|NCT00551239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101435134|NCT00551239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101435138|NCT00191880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101435139|NCT00191880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435140|NCT00191880|Adrenergic Agents|adrenergic agents|mesh-ancestor
101435141|NCT00191880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101435142|NCT00191880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435143|NCT00551317|Darapladib|darapladib|mesh-list
101435144|NCT00551317|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
101435145|NCT00551317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101559397|NCT02859103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101559398|NCT02859103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559399|NCT02859103|Antidepressive Agents|antidepressive agents|mesh-ancestor
101559400|NCT02859103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101559402|NCT02869009|Clopidogrel|clopidogrel|mesh-list
101559403|NCT02869009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101559404|NCT02869009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101559405|NCT02869009|Analgesics|analgesics|mesh-ancestor
101559406|NCT02869009|Sensory System Agents|sensory system agents|mesh-ancestor
101559407|NCT02869009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101559408|NCT02869009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559409|NCT02869009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101559410|NCT02869009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101407837|NCT03278938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101435146|NCT00551317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435147|NCT00551356|Insulin Lispro|insulin lispro|mesh-list
101435148|NCT00551356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101435149|NCT00551356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435150|NCT02963337|Remifentanil|remifentanil|mesh-list
101435151|NCT02963337|Bupivacaine|bupivacaine|mesh-list
101435152|NCT02963337|Anesthetics, Local|anesthetics, local|mesh-ancestor
101435153|NCT02963337|Anesthetics|anesthetics|mesh-ancestor
101435154|NCT02963337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101435155|NCT02963337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435156|NCT02963337|Sensory System Agents|sensory system agents|mesh-ancestor
101435157|NCT02963337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101435158|NCT02963337|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101435159|NCT02963337|Narcotics|narcotics|mesh-ancestor
101435160|NCT02963337|Analgesics|analgesics|mesh-ancestor
101435161|NCT00191919|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101307439|NCT02040597|Beclomethasone|beclomethasone|mesh-list
101307440|NCT02040597|Glycopyrrolate|glycopyrrolate|mesh-list
101307441|NCT02040597|Formoterol Fumarate|formoterol fumarate|mesh-list
101307442|NCT02040597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101435162|NCT00191919|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101435163|NCT00191919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101435164|NCT00191919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101435165|NCT00191919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435166|NCT00191919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101435167|NCT00191919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435168|NCT00191919|Analgesics|analgesics|mesh-ancestor
101435169|NCT00191919|Sensory System Agents|sensory system agents|mesh-ancestor
101435170|NCT00191919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101435171|NCT00191919|Antidepressive Agents|antidepressive agents|mesh-ancestor
101435172|NCT00191919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101435173|NCT00191919|Dopamine Agents|dopamine agents|mesh-ancestor
101435175|NCT00161837|Immunologic Factors|immunologic factors|mesh-ancestor
101435176|NCT00161837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435177|NCT00551512|Cisplatin|cisplatin|mesh-list
101435178|NCT00551512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101435179|NCT00551590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101435180|NCT00551590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101435181|NCT00551590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435192|NCT00185172|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101435193|NCT00185172|Olmesartan|olmesartan|mesh-list
101435194|NCT00185172|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101435195|NCT00185172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101435196|NCT00185172|Diuretics|diuretics|mesh-ancestor
101435197|NCT00185172|Natriuretic Agents|natriuretic agents|mesh-ancestor
101435198|NCT00185172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559411|NCT02869009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101559412|NCT02869009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101559413|NCT02869009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559414|NCT02869009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101559415|NCT02869009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101559416|NCT02869009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101559418|NCT02869009|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101435199|NCT00185172|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101435200|NCT00185172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101435201|NCT00185172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435202|NCT00185172|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101435203|NCT00185172|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101435204|NCT00191997|Olanzapine|olanzapine|mesh-list
101435205|NCT00191997|Antiemetics|antiemetics|mesh-ancestor
101435206|NCT00191997|Autonomic Agents|autonomic agents|mesh-ancestor
101435220|NCT00551824|Mitomycins|mitomycins|mesh-list
101435221|NCT00551824|Mitomycin|mitomycin|mesh-list
101435222|NCT00551824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101435223|NCT00551824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101435224|NCT00551824|Alkylating Agents|alkylating agents|mesh-ancestor
101435225|NCT00551824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435226|NCT00551824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101435227|NCT00551824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101435228|NCT00185250|Interferons|interferons|mesh-list
101435229|NCT00185250|Interferon-beta|interferon-beta|mesh-list
101435230|NCT00185250|Interferon beta-1b|interferon beta-1b|mesh-list
101435231|NCT00185250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101435232|NCT00185250|Antiviral Agents|antiviral agents|mesh-ancestor
101435233|NCT00185250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101435234|NCT00185250|Immunologic Factors|immunologic factors|mesh-ancestor
101435235|NCT00185250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435236|NCT00185250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101435237|NCT00161993|Immunoglobulins|immunoglobulins|mesh-list
101435239|NCT00161993|gamma-Globulins|gamma-globulins|mesh-list
101435240|NCT00161993|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101435241|NCT00161993|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101435242|NCT00161993|Immunologic Factors|immunologic factors|mesh-ancestor
101307443|NCT02040597|Autonomic Agents|autonomic agents|mesh-ancestor
101307444|NCT02040597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101307445|NCT02040597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435243|NCT00161993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435244|NCT00185328|Estradiol|estradiol|mesh-list
101435245|NCT00185328|Estrogens|estrogens|mesh-ancestor
101435246|NCT00185328|Hormones|hormones|mesh-ancestor
101435247|NCT00185328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101435248|NCT00185328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435249|NCT00162110|Cetuximab|cetuximab|mesh-list
101435250|NCT00162110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101435251|NCT00162110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101435252|NCT00552370|Insulin Glargine|insulin glargine|mesh-list
101435253|NCT00552370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101435254|NCT00552370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435255|NCT00162149|Ritonavir|ritonavir|mesh-list
101435256|NCT00162149|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101435257|NCT00162149|Nevirapine|nevirapine|mesh-list
101435258|NCT00162149|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101435259|NCT00162149|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101435266|NCT00162149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101435267|NCT00162149|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101435277|NCT00162188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101435278|NCT00162188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435279|NCT00162188|Antiviral Agents|antiviral agents|mesh-ancestor
101435280|NCT00162188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101435281|NCT00162188|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101435282|NCT00162188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101435283|NCT00162188|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101559419|NCT02869009|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101559420|NCT02869009|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101435284|NCT00162188|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101435285|NCT00162188|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101435286|NCT00162188|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101435288|NCT00162227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101435289|NCT00162227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101435290|NCT00162227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101435291|NCT00162227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435292|NCT00162227|Antiviral Agents|antiviral agents|mesh-ancestor
101435293|NCT00162227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101435294|NCT00162227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101435295|NCT00162227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101435296|NCT00162227|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101435297|NCT00162227|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101435298|NCT00162227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101435299|NCT00162227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101435300|NCT04701580|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101435301|NCT04701580|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101435302|NCT04701580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435303|NCT00552682|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101435304|NCT00552682|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101435305|NCT00552682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101435306|NCT00552682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101435307|NCT00552682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435308|NCT00552682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101435309|NCT00552682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435310|NCT00552682|Analgesics|analgesics|mesh-ancestor
101435311|NCT00552682|Sensory System Agents|sensory system agents|mesh-ancestor
101435312|NCT00552682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101435313|NCT00552682|Antidepressive Agents|antidepressive agents|mesh-ancestor
101435314|NCT00552682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101435315|NCT00552682|Dopamine Agents|dopamine agents|mesh-ancestor
101435316|NCT04652089|Simvastatin|simvastatin|mesh-list
101307446|NCT02040597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101307447|NCT02040597|Respiratory System Agents|respiratory system agents|mesh-ancestor
101307448|NCT02040597|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101307449|NCT02040597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101307450|NCT02040597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101307451|NCT02040597|Adrenergic Agents|adrenergic agents|mesh-ancestor
101307452|NCT02040597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101307453|NCT02040597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307454|NCT02040597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101307455|NCT02040597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101307456|NCT02040597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101307457|NCT02040597|Cholinergic Agents|cholinergic agents|mesh-ancestor
101307458|NCT02040597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101307459|NCT02040597|Glucocorticoids|glucocorticoids|mesh-ancestor
101307460|NCT02040597|Hormones|hormones|mesh-ancestor
101307461|NCT02040597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101307467|NCT02040649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101307468|NCT02040649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101435317|NCT04652089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101435318|NCT04652089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101435319|NCT04652089|Antimetabolites|antimetabolites|mesh-ancestor
101435320|NCT04652089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435321|NCT04652089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101435322|NCT04652089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101435323|NCT04652089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101435324|NCT04609306|Hydrogen Peroxide|hydrogen peroxide|mesh-list
101435325|NCT04609306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101435326|NCT04609306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101435327|NCT04684498|Oseltamivir|oseltamivir|mesh-list
101435330|NCT04684498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101559422|NCT02869009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101559423|NCT01164579|Methotrexate|methotrexate|mesh-list
101559424|NCT01164579|Tofacitinib|tofacitinib|mesh-list
101559425|NCT01164579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101559426|NCT01164579|Abortifacient Agents|abortifacient agents|mesh-ancestor
101559427|NCT01164579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101559428|NCT01164579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559429|NCT01164579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101559430|NCT01164579|Antimetabolites|antimetabolites|mesh-ancestor
101559431|NCT01164579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559432|NCT01164579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101435331|NCT04684498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435332|NCT00552799|Penicillins|penicillins|mesh-list
101435333|NCT00552799|Penicillin V|penicillin v|mesh-list
101435334|NCT00552799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101435335|NCT00552799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101435337|NCT00409071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101435338|NCT00162305|Dapagliflozin|dapagliflozin|mesh-list
101435339|NCT00162305|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101435340|NCT00162305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435341|NCT00162305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101435342|NCT00162305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435343|NCT04513015|Antioxidants|antioxidants|mesh-list
101435344|NCT04513015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435345|NCT04513015|Protective Agents|protective agents|mesh-ancestor
101435346|NCT04513015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307469|NCT02040649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307470|NCT02040649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101307471|NCT02040649|Anesthetics, General|anesthetics, general|mesh-ancestor
101307472|NCT02040649|Anesthetics|anesthetics|mesh-ancestor
101307473|NCT02040649|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101307474|NCT02040649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101307475|NCT02040649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101307476|NCT02040649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101307477|NCT02040649|GABA Modulators|gaba modulators|mesh-ancestor
101435347|NCT00162344|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
101435348|NCT00162344|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101469010|NCT02961842|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101435349|NCT00162344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435350|NCT04382326|Vaccines|vaccines|mesh-list
101435351|NCT04382326|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101435352|NCT04382326|Immunologic Factors|immunologic factors|mesh-ancestor
101435353|NCT04382326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435354|NCT00162383|Dapsone|dapsone|mesh-list
101435355|NCT00162383|Debrisoquin|debrisoquin|mesh-list
101435356|NCT00162383|Mephenytoin|mephenytoin|mesh-list
101435357|NCT00162383|Caffeine|caffeine|mesh-list
101435358|NCT00162383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101435359|NCT00162383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435360|NCT00162383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101435361|NCT00162383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101435362|NCT00162383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435363|NCT00162383|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101435364|NCT00162383|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101435365|NCT00162383|Purinergic Agents|purinergic agents|mesh-ancestor
101435366|NCT00162383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101435367|NCT00162383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101435368|NCT00162383|Antimalarials|antimalarials|mesh-ancestor
101435369|NCT00162383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101435370|NCT00162383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101435371|NCT00162383|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101435372|NCT00162383|Leprostatic Agents|leprostatic agents|mesh-ancestor
101435373|NCT00162383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101559433|NCT01164579|Dermatologic Agents|dermatologic agents|mesh-ancestor
101559434|NCT01164579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101559435|NCT01164579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101559436|NCT01164579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101559437|NCT01164579|Immunologic Factors|immunologic factors|mesh-ancestor
101435388|NCT00162422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101435389|NCT00162422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101435390|NCT00162422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101435391|NCT00162422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101435392|NCT00162422|Adrenergic Agents|adrenergic agents|mesh-ancestor
101435393|NCT00162422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101435394|NCT00162422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435396|NCT04355143|Gout Suppressants|gout suppressants|mesh-ancestor
101435397|NCT04355143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101435398|NCT04355143|Tubulin Modulators|tubulin modulators|mesh-ancestor
101435399|NCT04355143|Antimitotic Agents|antimitotic agents|mesh-ancestor
101435400|NCT04355143|Mitosis Modulators|mitosis modulators|mesh-ancestor
101435401|NCT04355143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435406|NCT00185445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101435407|NCT00185445|Antimetabolites|antimetabolites|mesh-ancestor
101435408|NCT00185445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435409|NCT00185445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101307478|NCT02040649|GABA Agents|gaba agents|mesh-ancestor
101435410|NCT00185445|Immunologic Factors|immunologic factors|mesh-ancestor
101435411|NCT00185445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435412|NCT00552838|Anti-Infective Agents|anti-infective agents|mesh-list
101435413|NCT00552838|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101435415|NCT04233034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101435416|NCT04233034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101435417|NCT04233034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101435418|NCT04233034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435419|NCT04233034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101435420|NCT04233034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435421|NCT04233034|Vasodilator Agents|vasodilator agents|mesh-ancestor
101435422|NCT04187053|Methylene Blue|methylene blue|mesh-list
101435423|NCT04187053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101435424|NCT04187053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435425|NCT00162461|Phenytoin|phenytoin|mesh-list
101435426|NCT00162461|Anticonvulsants|anticonvulsants|mesh-ancestor
101435427|NCT00162461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101435428|NCT00162461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101435429|NCT00162461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101435430|NCT00162461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435431|NCT00162461|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101435432|NCT00162461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101435433|NCT00185562|Adalimumab|adalimumab|mesh-list
101435434|NCT00185562|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101435435|NCT00185562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101435436|NCT00185562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101435437|NCT04095364|Paclitaxel|paclitaxel|mesh-list
101435438|NCT04095364|Carboplatin|carboplatin|mesh-list
101435439|NCT04095364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101435443|NCT04095364|Tubulin Modulators|tubulin modulators|mesh-ancestor
101435444|NCT04095364|Antimitotic Agents|antimitotic agents|mesh-ancestor
101435445|NCT04095364|Mitosis Modulators|mitosis modulators|mesh-ancestor
101435446|NCT04095364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435447|NCT04095364|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101435448|NCT04095364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101435449|NCT04095364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101435450|NCT04095364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101435451|NCT04095364|Hormone Antagonists|hormone antagonists|mesh-ancestor
101435452|NCT04095364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101435453|NCT04095364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435454|NCT00162656|Cyclophosphamide|cyclophosphamide|mesh-list
101435455|NCT00162656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101435456|NCT00162656|Immunologic Factors|immunologic factors|mesh-ancestor
101559439|NCT01164579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101559440|NCT01164579|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101559441|NCT01164579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101559442|NCT02859259|Fostemsavir|fostemsavir|mesh-list
101559443|NCT02859259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101559444|NCT02859259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101559445|NCT02859259|Antiviral Agents|antiviral agents|mesh-ancestor
101407876|NCT00442585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101435457|NCT00162656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435458|NCT00162656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101435459|NCT00162656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101435460|NCT00162656|Alkylating Agents|alkylating agents|mesh-ancestor
101435461|NCT00162656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435462|NCT00162656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101435463|NCT00162656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101435465|NCT00162695|Vincristine|vincristine|mesh-list
101435466|NCT00162695|Epirubicin|epirubicin|mesh-list
101435467|NCT00162695|Ifosfamide|ifosfamide|mesh-list
101435468|NCT00162695|Carboplatin|carboplatin|mesh-list
101435469|NCT00162695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101435470|NCT00162695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101435471|NCT00162695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101435474|NCT00162695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435475|NCT00162695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101435477|NCT00162695|Tubulin Modulators|tubulin modulators|mesh-ancestor
101435478|NCT00162695|Antimitotic Agents|antimitotic agents|mesh-ancestor
101435479|NCT00162695|Mitosis Modulators|mitosis modulators|mesh-ancestor
101435480|NCT00162695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101435481|NCT00162734|Interferons|interferons|mesh-list
101435482|NCT00162734|Ribavirin|ribavirin|mesh-list
101435483|NCT00162734|Interferon alfacon-1|interferon alfacon-1|mesh-list
101435484|NCT00162734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101435485|NCT00162734|Antiviral Agents|antiviral agents|mesh-ancestor
101435486|NCT00162734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101307480|NCT02040649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307481|NCT02040662|Morphine|morphine|mesh-list
101307482|NCT02040662|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101307483|NCT02040662|Narcotics|narcotics|mesh-ancestor
101307484|NCT02040662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101307485|NCT02040662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307486|NCT02040662|Analgesics|analgesics|mesh-ancestor
101307487|NCT02040662|Sensory System Agents|sensory system agents|mesh-ancestor
101307488|NCT02040662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101307489|NCT02040818|Acetylcysteine|acetylcysteine|mesh-list
101307490|NCT02040818|Tigecycline|tigecycline|mesh-list
101307491|NCT02040818|Heparin|heparin|mesh-list
101307492|NCT02040818|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101307493|NCT02040818|Anticoagulants|anticoagulants|mesh-ancestor
101307494|NCT02040818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101307495|NCT02040818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101307496|NCT02040818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307497|NCT02040818|Antiviral Agents|antiviral agents|mesh-ancestor
101307498|NCT02040818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101307499|NCT02040818|Expectorants|expectorants|mesh-ancestor
101307500|NCT02040818|Respiratory System Agents|respiratory system agents|mesh-ancestor
101307501|NCT02040818|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101307502|NCT02040818|Antioxidants|antioxidants|mesh-ancestor
101307503|NCT02040818|Protective Agents|protective agents|mesh-ancestor
101307504|NCT02040818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307505|NCT02040818|Antidotes|antidotes|mesh-ancestor
101307506|NCT02040818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101307507|NCT02040818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101435494|NCT00162812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101435496|NCT00162812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101435497|NCT00162812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101435498|NCT00162812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101559446|NCT02859259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101559447|NCT02859259|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101559448|NCT02859259|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101559449|NCT02859259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559451|NCT02857777|Antidepressive Agents|antidepressive agents|mesh-ancestor
101559452|NCT02857777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101559453|NCT00630643|Muromonab-CD3|muromonab-cd3|mesh-list
101435499|NCT00162812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435500|NCT00162851|Alemtuzumab|alemtuzumab|mesh-list
101435501|NCT00162851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101307508|NCT02040818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101307509|NCT02040831|Vaccines|vaccines|mesh-list
101307510|NCT02040831|Immunologic Factors|immunologic factors|mesh-ancestor
101307511|NCT02040831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307512|NCT02040883|Olanzapine|olanzapine|mesh-list
101307513|NCT02040883|Risperidone|risperidone|mesh-list
101307514|NCT02040883|Aripiprazole|aripiprazole|mesh-list
101307515|NCT02040883|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101435502|NCT00162851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101435503|NCT04015414|Varenicline|varenicline|mesh-list
101435504|NCT04015414|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101435505|NCT04015414|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101435506|NCT04015414|Cholinergic Agents|cholinergic agents|mesh-ancestor
101435507|NCT04015414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101435508|NCT04015414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435509|NCT04015414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435510|NCT00185835|Gefitinib|gefitinib|mesh-list
101435511|NCT00185835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101435512|NCT00185835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101435513|NCT00185835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101435514|NCT00185835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435515|NCT00162968|Escitalopram|escitalopram|mesh-list
101435516|NCT00162968|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101435517|NCT00162968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101435518|NCT00162968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101435519|NCT00162968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435520|NCT00162968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101435521|NCT00162968|Serotonin Agents|serotonin agents|mesh-ancestor
101435522|NCT00162968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435523|NCT03970330|Naltrexone|naltrexone|mesh-list
101435524|NCT03970330|Norethindrone|norethindrone|mesh-list
101435525|NCT03970330|Norethindrone Acetate|norethindrone acetate|mesh-list
101435526|NCT03970330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101435527|NCT03970330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101435528|NCT03970330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435529|NCT03970330|Sensory System Agents|sensory system agents|mesh-ancestor
101435530|NCT03970330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101435531|NCT03970330|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101435532|NCT03970330|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101435533|NCT03970330|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101435534|NCT03970330|Contraceptive Agents|contraceptive agents|mesh-ancestor
101435535|NCT03970330|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101435536|NCT03970330|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101435537|NCT03970330|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101435538|NCT00185874|Immunomodulating Agents|immunomodulating agents|mesh-list
101435539|NCT00185874|Immunologic Factors|immunologic factors|mesh-ancestor
101435540|NCT00185874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435541|NCT03757585|Inositol|inositol|mesh-list
101435542|NCT03757585|Acetylcysteine|acetylcysteine|mesh-list
101435551|NCT03757585|Protective Agents|protective agents|mesh-ancestor
101435552|NCT03757585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435559|NCT00163046|Sensory System Agents|sensory system agents|mesh-ancestor
101435560|NCT00163046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101559455|NCT00630643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559456|NCT00630643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101559457|NCT03202849|Vitamin D|vitamin d|mesh-list
101559458|NCT03202849|Ergocalciferols|ergocalciferols|mesh-list
101559459|NCT03202849|Cholecalciferol|cholecalciferol|mesh-list
101559460|NCT03202849|Vitamins|vitamins|mesh-list
101559461|NCT03202849|Micronutrients|micronutrients|mesh-ancestor
101559462|NCT03202849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559463|NCT03202849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101559464|NCT03202849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101559465|NCT04277533|Calcium|calcium|mesh-list
101559466|NCT04277533|Bilirubin|bilirubin|mesh-list
101559467|NCT04277533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101407895|NCT00442780|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101435561|NCT00163046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435562|NCT00163046|Anticonvulsants|anticonvulsants|mesh-ancestor
101435563|NCT00163046|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101435564|NCT00163046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101435565|NCT00163046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101435566|NCT00163046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101435567|NCT00163046|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101435568|NCT00163046|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101307516|NCT02040883|Ziprasidone|ziprasidone|mesh-list
101435569|NCT00163046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101435570|NCT00163046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435571|NCT00163046|Antimanic Agents|antimanic agents|mesh-ancestor
101435573|NCT00185952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101435574|NCT00185952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101435575|NCT00185952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435576|NCT00185952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101435577|NCT00185952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435578|NCT00185952|Vasodilator Agents|vasodilator agents|mesh-ancestor
101435579|NCT00185952|Tocolytic Agents|tocolytic agents|mesh-ancestor
101435580|NCT00185952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101435581|NCT03541447|Octreotide|octreotide|mesh-list
101435582|NCT03541447|Tolvaptan|tolvaptan|mesh-list
101435583|NCT03541447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101435584|NCT03541447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101435585|NCT03541447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101435586|NCT03541447|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101435587|NCT03541447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435588|NCT03541447|Natriuretic Agents|natriuretic agents|mesh-ancestor
101435589|NCT03541447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435590|NCT00192621|Lamivudine|lamivudine|mesh-list
101435591|NCT00192621|Zidovudine|zidovudine|mesh-list
101435592|NCT00192621|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101435593|NCT00192621|Lopinavir|lopinavir|mesh-list
101435594|NCT00192621|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101435595|NCT00192621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101435596|NCT00192621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101435597|NCT00192621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435598|NCT00192621|Antiviral Agents|antiviral agents|mesh-ancestor
101435599|NCT00192621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101435600|NCT00192621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101435601|NCT00192621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101435602|NCT00192621|Antimetabolites|antimetabolites|mesh-ancestor
101435603|NCT00192621|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101435604|NCT00192621|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101435605|NCT00192621|Protease Inhibitors|protease inhibitors|mesh-ancestor
101559468|NCT04277533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559469|NCT04277533|Antioxidants|antioxidants|mesh-ancestor
101559470|NCT04277533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559471|NCT04277533|Protective Agents|protective agents|mesh-ancestor
101559472|NCT02445391|Cisplatin|cisplatin|mesh-list
101559473|NCT02445391|Carboplatin|carboplatin|mesh-list
101559474|NCT02445391|Capecitabine|capecitabine|mesh-list
101559475|NCT02445391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101559476|NCT02445391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101559477|NCT02445391|Antimetabolites|antimetabolites|mesh-ancestor
101559478|NCT02445391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435606|NCT00192621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101435607|NCT00192621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101435609|NCT03516604|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101435613|NCT03516604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101435614|NCT03516604|Serotonin Agents|serotonin agents|mesh-ancestor
101435615|NCT03516604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435616|NCT03516604|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101435617|NCT03516604|Antidepressive Agents|antidepressive agents|mesh-ancestor
101435618|NCT03516604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101435619|NCT00185991|Gentamicins|gentamicins|mesh-list
101435620|NCT00185991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101435621|NCT00185991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101435622|NCT00185991|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101435623|NCT00185991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101435624|NCT00185991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435627|NCT03434158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101435628|NCT03434158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435629|NCT03434158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101435630|NCT00163202|Atorvastatin|atorvastatin|mesh-list
101435631|NCT00163202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101435632|NCT00163202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101435633|NCT00163202|Antimetabolites|antimetabolites|mesh-ancestor
101435634|NCT00163202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435635|NCT00163202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101435636|NCT00163202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101435637|NCT00163202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101435638|NCT03318952|Lidocaine|lidocaine|mesh-list
101435639|NCT03318952|Anesthetics, Local|anesthetics, local|mesh-list
101435640|NCT03318952|Carticaine|carticaine|mesh-list
101435641|NCT03318952|Anesthetics|anesthetics|mesh-list
101435642|NCT03318952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101435643|NCT03318952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307517|NCT02040883|Tandospirone|tandospirone|mesh-list
101307518|NCT02040883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101307519|NCT02040883|Serotonin Agents|serotonin agents|mesh-ancestor
101435644|NCT03318952|Sensory System Agents|sensory system agents|mesh-ancestor
101435645|NCT03318952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101435646|NCT03318952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101435647|NCT03318952|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101435648|NCT03318952|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101435649|NCT03318952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101435650|NCT03318952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435651|NCT00192660|Ritonavir|ritonavir|mesh-list
101435652|NCT00192660|Nelfinavir|nelfinavir|mesh-list
101435653|NCT00192660|Indinavir|indinavir|mesh-list
101435654|NCT00192660|Saquinavir|saquinavir|mesh-list
101435655|NCT00192660|Amprenavir|amprenavir|mesh-list
101435656|NCT00192660|Tenofovir|tenofovir|mesh-list
101435657|NCT00192660|Lamivudine|lamivudine|mesh-list
101435658|NCT00192660|Zidovudine|zidovudine|mesh-list
101435659|NCT00192660|Nevirapine|nevirapine|mesh-list
101435660|NCT00192660|Abacavir|abacavir|mesh-list
101435661|NCT00192660|Didanosine|didanosine|mesh-list
101435662|NCT00192660|Stavudine|stavudine|mesh-list
101435663|NCT00192660|Tipranavir|tipranavir|mesh-list
101559479|NCT01246986|Sorafenib|sorafenib|mesh-list
101559480|NCT01246986|Ramucirumab|ramucirumab|mesh-list
101559481|NCT01246986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101559482|NCT01246986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101559483|NCT01246986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101559484|NCT01246986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559485|NCT01164501|Empagliflozin|empagliflozin|mesh-list
101559486|NCT01164501|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101435664|NCT00192660|Enfuvirtide|enfuvirtide|mesh-list
101435665|NCT00192660|Efavirenz|efavirenz|mesh-list
101435666|NCT00192660|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101435667|NCT00192660|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101435668|NCT00192660|Protease Inhibitors|protease inhibitors|mesh-ancestor
101435669|NCT00192660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101435670|NCT00192660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435671|NCT00192660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101435672|NCT00192660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101435673|NCT00192660|Antiviral Agents|antiviral agents|mesh-ancestor
101435674|NCT00192660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101435675|NCT00192660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101435676|NCT00192660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101435677|NCT00192660|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101435678|NCT00192660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101435679|NCT00192660|Antimetabolites|antimetabolites|mesh-ancestor
101435680|NCT00192660|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101435681|NCT00192660|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101435696|NCT00163241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435697|NCT00163241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101435698|NCT00163241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101435699|NCT00163241|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101435700|NCT00163241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101435701|NCT00163241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101435702|NCT00163241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435704|NCT02916316|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101435705|NCT02916316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101435706|NCT02916316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101435707|NCT02916316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101435708|NCT02916316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101435709|NCT02916316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101435710|NCT02916316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435711|NCT00186264|Hydrocortisone|hydrocortisone|mesh-list
101307522|NCT02040883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307524|NCT02040883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101307525|NCT02040883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101307526|NCT02040883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101307527|NCT02040883|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101307528|NCT02040883|Dopamine Agents|dopamine agents|mesh-ancestor
101307530|NCT02040883|Autonomic Agents|autonomic agents|mesh-ancestor
101307531|NCT02040883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101307532|NCT02040883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101307533|NCT02040883|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101307534|NCT02040883|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101435729|NCT02812420|Durvalumab|durvalumab|mesh-list
101435730|NCT02812420|Ipilimumab|ipilimumab|mesh-list
101435731|NCT02812420|Tremelimumab|tremelimumab|mesh-list
101435732|NCT02812420|Immunoglobulins|immunoglobulins|mesh-list
101435733|NCT02812420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101435734|NCT02812420|Immunoglobulin G|immunoglobulin g|mesh-list
101435735|NCT02812420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101435736|NCT02812420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101435737|NCT02812420|Immunologic Factors|immunologic factors|mesh-ancestor
101435738|NCT02812420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435741|NCT02556931|Mycophenolic Acid|mycophenolic acid|mesh-list
101435742|NCT02556931|Cyclophosphamide|cyclophosphamide|mesh-list
101435743|NCT02556931|Fludarabine|fludarabine|mesh-list
101435744|NCT02556931|Tacrolimus|tacrolimus|mesh-list
101435745|NCT02556931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101559487|NCT01164501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559488|NCT01164501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101559489|NCT01164501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559490|NCT01163721|Ranolazine|ranolazine|mesh-list
101559491|NCT01163721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101559492|NCT01163721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101559493|NCT01163721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435746|NCT02556931|Immunologic Factors|immunologic factors|mesh-ancestor
101435747|NCT02556931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435748|NCT02556931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101435749|NCT02556931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101435750|NCT02556931|Alkylating Agents|alkylating agents|mesh-ancestor
101435758|NCT02556931|Antitubercular Agents|antitubercular agents|mesh-ancestor
101435759|NCT02556931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101435760|NCT02556931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101435761|NCT00163358|Ciclesonide|ciclesonide|mesh-list
101435762|NCT00163358|Glucocorticoids|glucocorticoids|mesh-ancestor
101435763|NCT00163358|Hormones|hormones|mesh-ancestor
101435764|NCT00163358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101435765|NCT00163358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435766|NCT00163358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101435767|NCT00163397|Ciclesonide|ciclesonide|mesh-list
101435768|NCT00163397|Glucocorticoids|glucocorticoids|mesh-ancestor
101435769|NCT00163397|Hormones|hormones|mesh-ancestor
101435770|NCT00163397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101435771|NCT00163397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435772|NCT00163397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101435773|NCT00163436|Ciclesonide|ciclesonide|mesh-list
101435774|NCT00163436|Glucocorticoids|glucocorticoids|mesh-ancestor
101435775|NCT00163436|Hormones|hormones|mesh-ancestor
101307535|NCT02040883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101307536|NCT02040883|Antidepressive Agents|antidepressive agents|mesh-ancestor
101435776|NCT00163436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101435777|NCT00163436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435778|NCT00163436|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101435779|NCT00186420|Docetaxel|docetaxel|mesh-list
101435780|NCT00186420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101435781|NCT00186420|Tubulin Modulators|tubulin modulators|mesh-ancestor
101435782|NCT00186420|Antimitotic Agents|antimitotic agents|mesh-ancestor
101435783|NCT00186420|Mitosis Modulators|mitosis modulators|mesh-ancestor
101435784|NCT00186420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435785|NCT00163514|Ciclesonide|ciclesonide|mesh-list
101435786|NCT00163514|Glucocorticoids|glucocorticoids|mesh-ancestor
101435787|NCT00163514|Hormones|hormones|mesh-ancestor
101435788|NCT00163514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101435789|NCT00163514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435790|NCT00163514|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101435791|NCT00717652|Triamcinolone|triamcinolone|mesh-list
101435792|NCT00717652|Tretinoin|tretinoin|mesh-list
101435793|NCT00717652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101435794|NCT00717652|Glucocorticoids|glucocorticoids|mesh-ancestor
101435795|NCT00717652|Hormones|hormones|mesh-ancestor
101435796|NCT00717652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101435797|NCT00717652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435798|NCT00717652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101435799|NCT00717652|Keratolytic Agents|keratolytic agents|mesh-ancestor
101435800|NCT00717652|Dermatologic Agents|dermatologic agents|mesh-ancestor
101435801|NCT00066040|Chlorhexidine|chlorhexidine|mesh-list
101435802|NCT00066040|Chlorhexidine, thymol drug combination|chlorhexidine, thymol drug combination|mesh-list
101435803|NCT00066040|Fluorides|fluorides|mesh-list
101435804|NCT00066040|Fluorides, Topical|fluorides, topical|mesh-list
101435805|NCT00066040|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
101435806|NCT00066040|Cariostatic Agents|cariostatic agents|mesh-ancestor
101435807|NCT00066040|Protective Agents|protective agents|mesh-ancestor
101435808|NCT00066040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435809|NCT00066040|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101559494|NCT00958243|Vaccines|vaccines|mesh-list
101559495|NCT00958243|Immunologic Factors|immunologic factors|mesh-ancestor
101559496|NCT00958243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559497|NCT01241760|Interferons|interferons|mesh-list
101559498|NCT01241760|Ribavirin|ribavirin|mesh-list
101559499|NCT01241760|Interferon-alpha|interferon-alpha|mesh-list
101559500|NCT01241760|Interferon alpha-2|interferon alpha-2|mesh-list
101559501|NCT01241760|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101559502|NCT01241760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101559503|NCT01241760|Antiviral Agents|antiviral agents|mesh-ancestor
101559504|NCT01241760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101559505|NCT01241760|Antimetabolites|antimetabolites|mesh-ancestor
101435810|NCT00066040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101435814|NCT00163553|Narcotics|narcotics|mesh-ancestor
101435815|NCT00163553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101435816|NCT00163553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435817|NCT00163553|Analgesics|analgesics|mesh-ancestor
101435825|NCT04683445|Trastuzumab|trastuzumab|mesh-list
101435826|NCT04683445|Pertuzumab|pertuzumab|mesh-list
101435827|NCT04683445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101435828|NCT04683445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101435829|NCT04683445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101435830|NCT04683445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435832|NCT00192777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101435833|NCT00192777|Antimetabolites|antimetabolites|mesh-ancestor
101435834|NCT00192777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435835|NCT00192777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101435836|NCT00553072|Magnesium Sulfate|magnesium sulfate|mesh-list
101435837|NCT00553072|Analgesics|analgesics|mesh-ancestor
101435838|NCT00553072|Sensory System Agents|sensory system agents|mesh-ancestor
101435839|NCT00553072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101435840|NCT00553072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435841|NCT00553072|Anesthetics|anesthetics|mesh-ancestor
101435842|NCT00553072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101435843|NCT00553072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101435844|NCT00553072|Anticonvulsants|anticonvulsants|mesh-ancestor
101435845|NCT00553072|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101435846|NCT00553072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101435847|NCT00553072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307537|NCT02040883|Dopamine Agonists|dopamine agonists|mesh-ancestor
101307538|NCT02040883|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101307539|NCT02040883|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101435848|NCT00553072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101435849|NCT00553072|Tocolytic Agents|tocolytic agents|mesh-ancestor
101435850|NCT00553072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101435851|NCT05808608|Axitinib|axitinib|mesh-list
101435852|NCT05808608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101435853|NCT05808608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101435854|NCT05808608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101435855|NCT05808608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435856|NCT05808387|Resveratrol|resveratrol|mesh-list
101435857|NCT05808387|Antioxidants|antioxidants|mesh-ancestor
101435858|NCT05808387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435859|NCT05808387|Protective Agents|protective agents|mesh-ancestor
101435860|NCT05808387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435861|NCT05808387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101435862|NCT05808387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101435863|NCT05808231|Quinine|quinine|mesh-list
101435864|NCT05808231|Antimalarials|antimalarials|mesh-ancestor
101435865|NCT05808231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101435866|NCT05808231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101435867|NCT05808231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101435868|NCT05808231|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101435869|NCT05808231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559506|NCT01241760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559507|NCT01241760|Immunologic Factors|immunologic factors|mesh-ancestor
101559508|NCT01241760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559509|NCT04280263|Caffeine|caffeine|mesh-list
101559510|NCT04280263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101559511|NCT04280263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559512|NCT04280263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101559513|NCT04280263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101559514|NCT04280263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559515|NCT04280263|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101559516|NCT04280263|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101559517|NCT04280263|Purinergic Agents|purinergic agents|mesh-ancestor
101559518|NCT04280263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101559519|NCT00953329|Alefacept|alefacept|mesh-list
101559520|NCT00953329|Dermatologic Agents|dermatologic agents|mesh-ancestor
101407943|NCT00443170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435870|NCT05808231|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101435871|NCT05808231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101435872|NCT05808231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101435873|NCT05808231|Analgesics|analgesics|mesh-ancestor
101435874|NCT05808231|Sensory System Agents|sensory system agents|mesh-ancestor
101435875|NCT05808192|Immunosuppressive Agents|immunosuppressive agents|mesh-list
101435876|NCT05808192|Immunologic Factors|immunologic factors|mesh-ancestor
101435877|NCT05808192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435878|NCT05808049|Antioxidants|antioxidants|mesh-list
101435879|NCT05808049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435880|NCT05808049|Protective Agents|protective agents|mesh-ancestor
101435881|NCT05808049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435882|NCT05807945|Ropivacaine|ropivacaine|mesh-list
101435883|NCT05807945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101435899|NCT05807880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101435900|NCT05807880|Antimetabolites|antimetabolites|mesh-ancestor
101435901|NCT05807880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435902|NCT05807880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101435903|NCT05807776|Lenvatinib|lenvatinib|mesh-list
101435904|NCT05807776|Tislelizumab|tislelizumab|mesh-list
101435905|NCT05807776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101435906|NCT05807776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101435907|NCT05807776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101435908|NCT05807776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435909|NCT05807776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101435910|NCT05807711|Vitamin B 12|vitamin b 12|mesh-list
101435911|NCT05807711|Vitamin B Complex|vitamin b complex|mesh-ancestor
101435912|NCT05807711|Vitamins|vitamins|mesh-ancestor
101435913|NCT05807711|Micronutrients|micronutrients|mesh-ancestor
101435914|NCT05807711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435915|NCT05807659|Busulfan|busulfan|mesh-list
101435916|NCT05807659|Alkylating Agents|alkylating agents|mesh-ancestor
101435917|NCT05807659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435918|NCT05807659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101435919|NCT05807659|Immunologic Factors|immunologic factors|mesh-ancestor
101435920|NCT05807659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435921|NCT05807659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101435922|NCT05807659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101435923|NCT05807659|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101435924|NCT05807542|Paclitaxel|paclitaxel|mesh-list
101559521|NCT00953329|Immunologic Factors|immunologic factors|mesh-ancestor
101559522|NCT00953329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559523|NCT02857153|Urapidil|urapidil|mesh-list
101559524|NCT02857153|Phenylephrine|phenylephrine|mesh-list
101559525|NCT02857153|Oxymetazoline|oxymetazoline|mesh-list
101559526|NCT02857153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101559527|NCT02857153|Mydriatics|mydriatics|mesh-ancestor
101435925|NCT05807542|Carboplatin|carboplatin|mesh-list
101435926|NCT05807542|Tislelizumab|tislelizumab|mesh-list
101307540|NCT02040883|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101307541|NCT02040883|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101307542|NCT02040883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101307543|NCT02040909|Propofol|propofol|mesh-list
101435927|NCT05807542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101435928|NCT05807542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101435929|NCT05807542|Tubulin Modulators|tubulin modulators|mesh-ancestor
101435930|NCT05807542|Antimitotic Agents|antimitotic agents|mesh-ancestor
101435931|NCT05807542|Mitosis Modulators|mitosis modulators|mesh-ancestor
101435932|NCT05807542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435933|NCT05807542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101435934|NCT05807503|Cerebrolysin|cerebrolysin|mesh-list
101435935|NCT05807503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101435936|NCT05807503|Protective Agents|protective agents|mesh-ancestor
101435937|NCT05807503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435938|NCT05807503|Nootropic Agents|nootropic agents|mesh-ancestor
101435939|NCT05807425|Polidocanol|polidocanol|mesh-list
101435940|NCT05807425|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
101435941|NCT05807425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101435942|NCT05807347|Cytarabine|cytarabine|mesh-list
101435943|NCT05807347|Azacitidine|azacitidine|mesh-list
101435944|NCT05807347|Venetoclax|venetoclax|mesh-list
101435945|NCT05807347|Aclacinomycins|aclacinomycins|mesh-list
101435946|NCT05807347|Lenograstim|lenograstim|mesh-list
101435947|NCT05807347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101435948|NCT05807347|Antimetabolites|antimetabolites|mesh-ancestor
101435949|NCT05807347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435950|NCT05807347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101435956|NCT05807347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101435957|NCT05807347|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101435958|NCT05807347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101435959|NCT05807165|Memantine|memantine|mesh-list
101435960|NCT05807165|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101435961|NCT05807165|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101435962|NCT05807165|Dopamine Agents|dopamine agents|mesh-ancestor
101435963|NCT05807165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101435964|NCT05807165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435965|NCT05807165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435982|NCT05781698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101435983|NCT05781698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101435985|NCT05781698|Sensory System Agents|sensory system agents|mesh-ancestor
101435986|NCT05781698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101435987|NCT05781698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435988|NCT05781698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101435990|NCT05709509|Aspirin|aspirin|mesh-list
101435991|NCT05709509|Colchicine|colchicine|mesh-list
101435992|NCT05709509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101435993|NCT05709509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101435994|NCT05709509|Analgesics|analgesics|mesh-ancestor
101435995|NCT05709509|Sensory System Agents|sensory system agents|mesh-ancestor
101435996|NCT05709509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101435997|NCT05709509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435998|NCT05709509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101435999|NCT05709509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101436000|NCT05709509|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101307544|NCT02040909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101307545|NCT02040909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101307546|NCT02040909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436001|NCT05709509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101436002|NCT05709509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436003|NCT05709509|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101559528|NCT02857153|Autonomic Agents|autonomic agents|mesh-ancestor
101559529|NCT02857153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101559530|NCT02857153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559531|NCT02857153|Sympathomimetics|sympathomimetics|mesh-ancestor
101559532|NCT02857153|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101559533|NCT02857153|Nasal Decongestants|nasal decongestants|mesh-ancestor
101559534|NCT02857153|Respiratory System Agents|respiratory system agents|mesh-ancestor
101559535|NCT02857153|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101559536|NCT02857153|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101559537|NCT02857153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101559538|NCT02857153|Adrenergic Agents|adrenergic agents|mesh-ancestor
101559539|NCT02857153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101559540|NCT02857153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436004|NCT05709509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101436005|NCT05709509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101436006|NCT05709509|Antipyretics|antipyretics|mesh-ancestor
101436007|NCT05709509|Gout Suppressants|gout suppressants|mesh-ancestor
101436008|NCT05709509|Tubulin Modulators|tubulin modulators|mesh-ancestor
101436009|NCT05709509|Antimitotic Agents|antimitotic agents|mesh-ancestor
101436010|NCT05709509|Mitosis Modulators|mitosis modulators|mesh-ancestor
101436011|NCT05709509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436013|NCT05693844|Cyclophosphamide|cyclophosphamide|mesh-list
101436014|NCT05693844|Fludarabine|fludarabine|mesh-list
101436015|NCT05693844|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101436016|NCT05693844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101436017|NCT05693844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436018|NCT05693844|Tubulin Modulators|tubulin modulators|mesh-ancestor
101436019|NCT05693844|Antimitotic Agents|antimitotic agents|mesh-ancestor
101436020|NCT05693844|Mitosis Modulators|mitosis modulators|mesh-ancestor
101436021|NCT05693844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436022|NCT05693844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101436028|NCT05693844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101436054|NCT05644340|Sympathomimetics|sympathomimetics|mesh-ancestor
101436055|NCT05644340|Autonomic Agents|autonomic agents|mesh-ancestor
101436056|NCT05644340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101436058|NCT05644340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101436059|NCT05644340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436060|NCT05644340|Adrenergic Agents|adrenergic agents|mesh-ancestor
101436061|NCT05644340|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101436062|NCT05644340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101436063|NCT05644340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101436064|NCT05644340|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101436065|NCT05627947|Cyclosporine|cyclosporine|mesh-list
101436066|NCT05627947|Mitomycins|mitomycins|mesh-list
101436067|NCT05627947|Mitomycin|mitomycin|mesh-list
101436068|NCT05627947|Cyclosporins|cyclosporins|mesh-list
101436069|NCT05627947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101436070|NCT05627947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436071|NCT05627947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101436072|NCT05627947|Immunologic Factors|immunologic factors|mesh-ancestor
101436073|NCT05627947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307547|NCT02040909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101307548|NCT02040909|Anesthetics, General|anesthetics, general|mesh-ancestor
101307549|NCT02040909|Anesthetics|anesthetics|mesh-ancestor
101307550|NCT02040935|Trastuzumab|trastuzumab|mesh-list
101333867|NCT00017394|Growth Substances|growth substances|mesh-ancestor
101436074|NCT05627947|Antifungal Agents|antifungal agents|mesh-ancestor
101436075|NCT05627947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101436076|NCT05627947|Dermatologic Agents|dermatologic agents|mesh-ancestor
101436077|NCT05627947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101559541|NCT02857153|Protective Agents|protective agents|mesh-ancestor
101559542|NCT02857153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101559543|NCT02857153|Vasodilator Agents|vasodilator agents|mesh-ancestor
101559544|NCT02857153|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101559546|NCT02857153|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101559547|NCT02857153|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101559548|NCT02857153|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101559549|NCT00953017|Bisacodyl|bisacodyl|mesh-list
101559550|NCT00953017|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101559551|NCT00953017|Lubiprostone|lubiprostone|mesh-list
101436078|NCT05627947|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101436079|NCT05627947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101436080|NCT05627947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436081|NCT05627947|Alkylating Agents|alkylating agents|mesh-ancestor
101436082|NCT05627947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101436083|NCT05617118|Baclofen|baclofen|mesh-list
101436084|NCT05617118|Botulinum Toxins|botulinum toxins|mesh-list
101436085|NCT05617118|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101436086|NCT05617118|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101436087|NCT05617118|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101436088|NCT05617118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101436089|NCT05617118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436090|NCT05617118|Cholinergic Agents|cholinergic agents|mesh-ancestor
101436091|NCT05617118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101436104|NCT05591105|Dipyrone|dipyrone|mesh-list
101436105|NCT05591105|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
101436106|NCT05591105|Lidocaine|lidocaine|mesh-list
101436107|NCT05591105|Ketamine|ketamine|mesh-list
101436108|NCT05591105|Morphine|morphine|mesh-list
101436109|NCT05591105|Anesthetics, Local|anesthetics, local|mesh-ancestor
101436110|NCT05591105|Anesthetics|anesthetics|mesh-ancestor
101436111|NCT05591105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101436112|NCT05591105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436113|NCT05591105|Sensory System Agents|sensory system agents|mesh-ancestor
101436114|NCT05591105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101436115|NCT05591105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101436116|NCT05591105|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101436117|NCT05591105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101436122|NCT05591105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101436123|NCT05591105|Anesthetics, General|anesthetics, general|mesh-ancestor
101436124|NCT05591105|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101436125|NCT05591105|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101436126|NCT05591105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101436127|NCT05591105|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101436128|NCT05591105|Narcotics|narcotics|mesh-ancestor
101436129|NCT05591105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101436130|NCT05591105|Antipyretics|antipyretics|mesh-ancestor
101436131|NCT05591105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101436132|NCT05591105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101436133|NCT05591105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101436134|NCT05550662|Xenon|xenon|mesh-list
101436135|NCT05550662|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101436136|NCT05550662|Anesthetics, General|anesthetics, general|mesh-ancestor
101436137|NCT05550662|Anesthetics|anesthetics|mesh-ancestor
101436138|NCT05550662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101436139|NCT05550662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436140|NCT05546658|Psilocybin|psilocybin|mesh-list
101436141|NCT05546658|Hallucinogens|hallucinogens|mesh-ancestor
101436142|NCT05546658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436143|NCT05546658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101436144|NCT05494580|Pamiparib|pamiparib|mesh-list
101436145|NCT05494580|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
101436146|NCT05494580|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101436147|NCT05494580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101436148|NCT05494580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101559552|NCT00953017|Cathartics|cathartics|mesh-ancestor
101559553|NCT00953017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101559554|NCT00953017|Laxatives|laxatives|mesh-ancestor
101559555|NCT00953017|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101559556|NCT00953017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101559557|NCT00953017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436149|NCT05494580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436150|NCT05494580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436151|NCT05464654|Estrogens|estrogens|mesh-list
101307551|NCT02040935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101307552|NCT02040935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436152|NCT05464654|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101436153|NCT05464654|Hormones|hormones|mesh-ancestor
101436154|NCT05464654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101436155|NCT05464654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436177|NCT05267873|Sensory System Agents|sensory system agents|mesh-ancestor
101436178|NCT05267873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101436179|NCT05267873|Antidepressive Agents|antidepressive agents|mesh-ancestor
101436181|NCT05267873|Dopamine Agents|dopamine agents|mesh-ancestor
101436182|NCT05267873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101436183|NCT05267873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101436184|NCT05267873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101436185|NCT05267873|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101436186|NCT05267873|Serotonin Agents|serotonin agents|mesh-ancestor
101436187|NCT05267873|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101436188|NCT05267873|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101436189|NCT05267873|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101436190|NCT05267873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101436191|NCT05113901|Methylprednisolone|methylprednisolone|mesh-list
101436192|NCT05113901|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101436193|NCT05113901|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101436194|NCT05113901|Prednisolone|prednisolone|mesh-list
101436195|NCT05113901|Prednisolone acetate|prednisolone acetate|mesh-list
101436196|NCT05113901|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101436197|NCT05113901|Prednisolone phosphate|prednisolone phosphate|mesh-list
101436198|NCT05113901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101436199|NCT05113901|Antiemetics|antiemetics|mesh-ancestor
101436200|NCT05113901|Autonomic Agents|autonomic agents|mesh-ancestor
101436201|NCT05113901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101436202|NCT05113901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436203|NCT05113901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101436204|NCT05113901|Glucocorticoids|glucocorticoids|mesh-ancestor
101436205|NCT05113901|Hormones|hormones|mesh-ancestor
101436206|NCT05113901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101436214|NCT05075603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436216|NCT05065216|Coagulants|coagulants|mesh-ancestor
101436217|NCT05065216|Fertility Agents, Male|fertility agents, male|mesh-ancestor
101436218|NCT05065216|Fertility Agents|fertility agents|mesh-ancestor
101436219|NCT05065216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101436220|NCT05065216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436221|NCT05024214|Sunitinib|sunitinib|mesh-list
101436222|NCT05024214|Lenvatinib|lenvatinib|mesh-list
101436223|NCT05024214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436224|NCT05024214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101436225|NCT05024214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101436229|NCT05024214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101436231|NCT05024214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436232|NCT05018091|Dexamethasone|dexamethasone|mesh-list
101436233|NCT05018091|Dexamethasone acetate|dexamethasone acetate|mesh-list
101436234|NCT05018091|BB 1101|bb 1101|mesh-list
101436235|NCT05018091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101436236|NCT05018091|Antiemetics|antiemetics|mesh-ancestor
101436237|NCT05018091|Autonomic Agents|autonomic agents|mesh-ancestor
101436238|NCT05018091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101436239|NCT05018091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436240|NCT05018091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101559558|NCT00955357|Lacosamide|lacosamide|mesh-list
101559559|NCT00955357|Anticonvulsants|anticonvulsants|mesh-ancestor
101559560|NCT00955357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101559561|NCT00955357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101559562|NCT00955357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101559563|NCT00955357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559564|NCT00955279|Golimumab|golimumab|mesh-list
101559565|NCT00955279|Ustekinumab|ustekinumab|mesh-list
101559566|NCT00955279|Dermatologic Agents|dermatologic agents|mesh-ancestor
101559567|NCT00955279|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101559568|NCT00955279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101559569|NCT00955279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101559570|NCT00955279|Immunologic Factors|immunologic factors|mesh-ancestor
101469259|NCT00283101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101559571|NCT00955279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436241|NCT05018091|Glucocorticoids|glucocorticoids|mesh-ancestor
101436242|NCT05018091|Hormones|hormones|mesh-ancestor
101436243|NCT05018091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101436244|NCT05018091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101436245|NCT05018091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436246|NCT05018091|Protease Inhibitors|protease inhibitors|mesh-ancestor
101436247|NCT05018091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101307553|NCT02040987|Moxifloxacin|moxifloxacin|mesh-list
101307554|NCT02040987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101307555|NCT02040987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101307556|NCT02040987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101307557|NCT02040987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101307558|NCT02040987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101436248|NCT05018091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436249|NCT04999644|Nicotine|nicotine|mesh-list
101436250|NCT04999644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101436251|NCT04999644|Autonomic Agents|autonomic agents|mesh-ancestor
101436252|NCT04999644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101436253|NCT04999644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436254|NCT04999644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101436255|NCT04999644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101436256|NCT04999644|Cholinergic Agents|cholinergic agents|mesh-ancestor
101436257|NCT04999644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101436258|NCT04999644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436259|NCT04962503|Afamelanotide|afamelanotide|mesh-list
101436260|NCT04962503|Dermatologic Agents|dermatologic agents|mesh-ancestor
101436261|NCT04916080|Acetylcysteine|acetylcysteine|mesh-list
101436262|NCT04916080|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101436263|NCT04916080|Antiviral Agents|antiviral agents|mesh-ancestor
101436264|NCT04916080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101436265|NCT04916080|Expectorants|expectorants|mesh-ancestor
101436266|NCT04916080|Respiratory System Agents|respiratory system agents|mesh-ancestor
101436267|NCT04916080|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101436268|NCT04916080|Antioxidants|antioxidants|mesh-ancestor
101436269|NCT04916080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436270|NCT04916080|Protective Agents|protective agents|mesh-ancestor
101436271|NCT04916080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436272|NCT04916080|Antidotes|antidotes|mesh-ancestor
101436273|NCT04854369|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101436277|NCT04833140|Estrogens|estrogens|mesh-ancestor
101436278|NCT04833140|Hormones|hormones|mesh-ancestor
101436279|NCT04833140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101436280|NCT04833140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436281|NCT04826562|Lamivudine|lamivudine|mesh-list
101436282|NCT04826562|Dolutegravir|dolutegravir|mesh-list
101436283|NCT04826562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101559572|NCT02857309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
101559573|NCT02857309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
101559574|NCT02857309|Mineralocorticoids|mineralocorticoids|mesh-list
101559575|NCT02857309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559576|NCT02857309|Hormone Antagonists|hormone antagonists|mesh-ancestor
101628323|NCT00720109|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101436284|NCT04826562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101436285|NCT04826562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101436286|NCT04826562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436287|NCT04826562|Antiviral Agents|antiviral agents|mesh-ancestor
101436288|NCT04826562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101436289|NCT04826562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101436290|NCT04826562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101436291|NCT04826562|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101436292|NCT04826562|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101436293|NCT04778618|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101436294|NCT04778618|Immunologic Factors|immunologic factors|mesh-ancestor
101436295|NCT04778618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436296|NCT04778618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101436301|NCT04761861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101436302|NCT04761861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436303|NCT04761861|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101436304|NCT04761861|Protease Inhibitors|protease inhibitors|mesh-ancestor
101436305|NCT04761861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101436306|NCT04761861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436307|NCT04716699|Lidocaine|lidocaine|mesh-list
101436308|NCT04716699|Anesthetics, Local|anesthetics, local|mesh-ancestor
101436309|NCT04716699|Anesthetics|anesthetics|mesh-ancestor
101436310|NCT04716699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101436311|NCT04716699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436312|NCT04716699|Sensory System Agents|sensory system agents|mesh-ancestor
101307559|NCT02040987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307560|NCT02040987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436313|NCT04716699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101436314|NCT04716699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101436315|NCT04716699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101436316|NCT04716699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101436317|NCT04716699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101436318|NCT04716699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436320|NCT04685980|Anesthetics|anesthetics|mesh-list
101436321|NCT04685980|Anesthetics, Local|anesthetics, local|mesh-list
101436322|NCT04685980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101436323|NCT04685980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436324|NCT04685980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101436325|NCT04685980|Narcotics|narcotics|mesh-ancestor
101436326|NCT04685980|Analgesics|analgesics|mesh-ancestor
101436327|NCT04685980|Sensory System Agents|sensory system agents|mesh-ancestor
101436328|NCT04685980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101436329|NCT04657692|Anesthetics|anesthetics|mesh-list
101436330|NCT04657692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101436331|NCT04657692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436332|NCT04577690|Epinephrine|epinephrine|mesh-list
101436333|NCT04577690|Racepinephrine|racepinephrine|mesh-list
101436334|NCT04577690|Bupivacaine|bupivacaine|mesh-list
101436335|NCT04577690|Epinephryl borate|epinephryl borate|mesh-list
101436336|NCT04577690|Anesthetics, Local|anesthetics, local|mesh-ancestor
101436337|NCT04577690|Anesthetics|anesthetics|mesh-ancestor
101436338|NCT04577690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101436339|NCT04577690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436340|NCT04577690|Sensory System Agents|sensory system agents|mesh-ancestor
101436341|NCT04577690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101436342|NCT04577690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101436343|NCT04577690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101436344|NCT04577690|Adrenergic Agents|adrenergic agents|mesh-ancestor
101436345|NCT04577690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101436346|NCT04577690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559577|NCT02857309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101559578|NCT02857309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559579|NCT02857309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101559581|NCT02857309|Natriuretic Agents|natriuretic agents|mesh-ancestor
101436350|NCT04577690|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101436351|NCT04577690|Respiratory System Agents|respiratory system agents|mesh-ancestor
101436352|NCT04577690|Mydriatics|mydriatics|mesh-ancestor
101436353|NCT04577690|Sympathomimetics|sympathomimetics|mesh-ancestor
101436355|NCT04531176|Liraglutide|liraglutide|mesh-list
101436356|NCT04531176|Topiramate|topiramate|mesh-list
101436357|NCT04531176|Orlistat|orlistat|mesh-list
101436358|NCT04531176|Phentermine|phentermine|mesh-list
101436359|NCT04531176|Naltrexone|naltrexone|mesh-list
101436360|NCT04531176|Bupropion|bupropion|mesh-list
101436361|NCT04531176|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101436362|NCT04531176|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101436363|NCT04531176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436364|NCT04531176|Sensory System Agents|sensory system agents|mesh-ancestor
101436365|NCT04531176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101436366|NCT04531176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101436367|NCT04531176|Incretins|incretins|mesh-ancestor
101436368|NCT04531176|Hormones|hormones|mesh-ancestor
101436369|NCT04531176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101436370|NCT04531176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101436374|NCT04531176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101436375|NCT04531176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101436376|NCT04531176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436377|NCT04531176|Dopamine Agents|dopamine agents|mesh-ancestor
101436378|NCT04531176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101436379|NCT04531176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101436380|NCT04531176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101436381|NCT04531176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101436382|NCT04531176|Anticonvulsants|anticonvulsants|mesh-ancestor
101436383|NCT04531176|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101436384|NCT04531176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101436385|NCT04531176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101436386|NCT04531176|Appetite Depressants|appetite depressants|mesh-ancestor
101436387|NCT04531176|Sympathomimetics|sympathomimetics|mesh-ancestor
101307561|NCT02041117|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101307562|NCT02041117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101307563|NCT02041117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101307564|NCT02041117|Antimetabolites|antimetabolites|mesh-ancestor
101436388|NCT04531176|Autonomic Agents|autonomic agents|mesh-ancestor
101436389|NCT04531176|Adrenergic Agents|adrenergic agents|mesh-ancestor
101436390|NCT04472767|Nivolumab|nivolumab|mesh-list
101436391|NCT04472767|Ipilimumab|ipilimumab|mesh-list
101436392|NCT04472767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101436393|NCT04472767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436394|NCT04472767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101436395|NCT04472767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436396|NCT04456946|Salicylic Acid|salicylic acid|mesh-list
101436397|NCT04456946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101436398|NCT04456946|Antifungal Agents|antifungal agents|mesh-ancestor
101436399|NCT04456946|Keratolytic Agents|keratolytic agents|mesh-ancestor
101436400|NCT04456946|Dermatologic Agents|dermatologic agents|mesh-ancestor
101436401|NCT04409860|Paclitaxel|paclitaxel|mesh-list
101436402|NCT04409860|Cisplatin|cisplatin|mesh-list
101436403|NCT04409860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101436404|NCT04409860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436405|NCT04409860|Tubulin Modulators|tubulin modulators|mesh-ancestor
101436406|NCT04409860|Antimitotic Agents|antimitotic agents|mesh-ancestor
101436407|NCT04409860|Mitosis Modulators|mitosis modulators|mesh-ancestor
101436408|NCT04409860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436409|NCT04311099|Ropivacaine|ropivacaine|mesh-list
101436410|NCT04311099|Anesthetics, Local|anesthetics, local|mesh-ancestor
101436411|NCT04311099|Anesthetics|anesthetics|mesh-ancestor
101436412|NCT04311099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101436413|NCT04311099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436414|NCT04311099|Sensory System Agents|sensory system agents|mesh-ancestor
101436415|NCT04311099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101559582|NCT02857309|Hormones|hormones|mesh-ancestor
101559583|NCT04261231|Anesthetics|anesthetics|mesh-list
101559584|NCT04261231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101360474|NCT00216424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101559585|NCT04261231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559586|NCT02857465|Dexamethasone|dexamethasone|mesh-list
101436416|NCT04303559|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101436417|NCT04303559|Immunologic Factors|immunologic factors|mesh-ancestor
101436418|NCT04303559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436419|NCT04303390|Cefazolin|cefazolin|mesh-list
101436420|NCT04303390|Cefuroxime|cefuroxime|mesh-list
101436421|NCT04303390|Cefuroxime axetil|cefuroxime axetil|mesh-list
101436427|NCT04075110|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101436428|NCT04075110|Hormone Antagonists|hormone antagonists|mesh-ancestor
101436429|NCT04075110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101436430|NCT04075110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436431|NCT04075110|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101436432|NCT04075110|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101436433|NCT04075110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436434|NCT04055909|Nangibotide|nangibotide|mesh-list
101436435|NCT04055909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101436436|NCT03978689|Pembrolizumab|pembrolizumab|mesh-list
101436437|NCT03978689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101436438|NCT03978689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436439|NCT03978689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101436440|NCT03978689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436452|NCT03861793|Pembrolizumab|pembrolizumab|mesh-list
101436453|NCT03861793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101436454|NCT03861793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436455|NCT03861793|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101436456|NCT03861793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307565|NCT02041117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307566|NCT02041117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101307567|NCT02041117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101307568|NCT02041117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101307570|NCT02041143|Chelating Agents|chelating agents|mesh-ancestor
101307571|NCT02041143|Sequestering Agents|sequestering agents|mesh-ancestor
101307572|NCT02041143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307573|NCT02041273|Palbociclib|palbociclib|mesh-list
101307574|NCT02041273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101307575|NCT02041273|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101307576|NCT02041273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101307577|NCT02041273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436457|NCT03816553|Apatinib|apatinib|mesh-list
101436458|NCT03816553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436459|NCT03816553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101436460|NCT03816553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101436461|NCT03816553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436462|NCT03729245|Nivolumab|nivolumab|mesh-list
101436463|NCT03729245|Sunitinib|sunitinib|mesh-list
101436464|NCT03729245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101436465|NCT03729245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436466|NCT03729245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101436467|NCT03729245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436468|NCT03729245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101436469|NCT03729245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101436470|NCT03729245|Growth Substances|growth substances|mesh-ancestor
101436471|NCT03729245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436472|NCT03729245|Growth Inhibitors|growth inhibitors|mesh-ancestor
101436473|NCT03729245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101436474|NCT03729245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101436475|NCT03712397|Irinotecan|irinotecan|mesh-list
101436476|NCT03712397|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101436477|NCT03712397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101436478|NCT03712397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101436479|NCT03712397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436480|NCT03712397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101559587|NCT02857465|Dexamethasone acetate|dexamethasone acetate|mesh-list
101559588|NCT02857465|Sufentanil|sufentanil|mesh-list
101559589|NCT02857465|Dsuvia|dsuvia|mesh-list
101559590|NCT02857465|Ropivacaine|ropivacaine|mesh-list
101559591|NCT02857465|BB 1101|bb 1101|mesh-list
101559592|NCT02857465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101559593|NCT02857465|Antiemetics|antiemetics|mesh-ancestor
101559594|NCT02857465|Autonomic Agents|autonomic agents|mesh-ancestor
101559595|NCT02857465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101559596|NCT02857465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408027|NCT00443482|Autonomic Agents|autonomic agents|mesh-ancestor
101436481|NCT03557918|Tremelimumab|tremelimumab|mesh-list
101436482|NCT03557918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436483|NCT03544099|Pembrolizumab|pembrolizumab|mesh-list
101436484|NCT03544099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101436485|NCT03544099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436486|NCT03544099|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101436488|NCT03528408|Nivolumab|nivolumab|mesh-list
101436489|NCT03528408|Ipilimumab|ipilimumab|mesh-list
101436490|NCT03528408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101436491|NCT03528408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436492|NCT03528408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101436493|NCT03528408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436494|NCT03501381|Aldesleukin|aldesleukin|mesh-list
101436495|NCT03501381|Interleukin-2|interleukin-2|mesh-list
101436496|NCT03501381|Entinostat|entinostat|mesh-list
101436497|NCT03501381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436498|NCT03501381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101436499|NCT03501381|Analgesics|analgesics|mesh-ancestor
101436500|NCT03501381|Sensory System Agents|sensory system agents|mesh-ancestor
101436501|NCT03501381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101436502|NCT03501381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436503|NCT03501381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101307578|NCT02041338|Paclitaxel|paclitaxel|mesh-list
101307579|NCT02041338|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101307580|NCT02041338|Carboplatin|carboplatin|mesh-list
101307581|NCT02041338|Epirubicin|epirubicin|mesh-list
101436504|NCT03501381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101436505|NCT03501381|Antiviral Agents|antiviral agents|mesh-ancestor
101436506|NCT03501381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101436507|NCT03501381|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101436508|NCT03501381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101436509|NCT03501381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436510|NCT03478488|Gemcitabine|gemcitabine|mesh-list
101436511|NCT03478488|Oxaliplatin|oxaliplatin|mesh-list
101436512|NCT03478488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101436513|NCT03478488|Antimetabolites|antimetabolites|mesh-ancestor
101436519|NCT03406299|Tegafur|tegafur|mesh-list
101436520|NCT03406299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436521|NCT03406299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101436522|NCT03406299|Antimetabolites|antimetabolites|mesh-ancestor
101436523|NCT03406299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436524|NCT03406299|Antidotes|antidotes|mesh-ancestor
101436525|NCT03406299|Protective Agents|protective agents|mesh-ancestor
101436526|NCT03406299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436527|NCT03406299|Vitamin B Complex|vitamin b complex|mesh-ancestor
101436528|NCT03406299|Vitamins|vitamins|mesh-ancestor
101436529|NCT03406299|Micronutrients|micronutrients|mesh-ancestor
101436530|NCT03396445|Paclitaxel|paclitaxel|mesh-list
101436531|NCT03396445|Carboplatin|carboplatin|mesh-list
101436532|NCT03396445|Pembrolizumab|pembrolizumab|mesh-list
101436533|NCT03396445|Pemetrexed|pemetrexed|mesh-list
101436534|NCT03396445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101436535|NCT03396445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436536|NCT03396445|Tubulin Modulators|tubulin modulators|mesh-ancestor
101436537|NCT03396445|Antimitotic Agents|antimitotic agents|mesh-ancestor
101436538|NCT03396445|Mitosis Modulators|mitosis modulators|mesh-ancestor
101436539|NCT03396445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436540|NCT03396445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101559598|NCT02857465|Glucocorticoids|glucocorticoids|mesh-ancestor
101559599|NCT02857465|Hormones|hormones|mesh-ancestor
101559600|NCT02857465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101559601|NCT02857465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101559602|NCT02857465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101559603|NCT02857465|Protease Inhibitors|protease inhibitors|mesh-ancestor
101559604|NCT02857465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101559605|NCT02857465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436541|NCT03396445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101436542|NCT03396445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101436543|NCT03396445|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101436544|NCT03396445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101436545|NCT03355469|Metformin|metformin|mesh-list
101436546|NCT03355469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101436547|NCT03355469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436548|NCT03330028|Diphenhydramine|diphenhydramine|mesh-list
101436549|NCT03330028|Promethazine|promethazine|mesh-list
101436550|NCT03330028|Dexamethasone|dexamethasone|mesh-list
101436551|NCT03330028|Paclitaxel|paclitaxel|mesh-list
101436552|NCT03330028|Cisplatin|cisplatin|mesh-list
101436553|NCT03330028|Mitomycins|mitomycins|mesh-list
101436554|NCT03330028|Mitomycin|mitomycin|mesh-list
101436555|NCT03330028|Famotidine|famotidine|mesh-list
101436556|NCT03330028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101436557|NCT03330028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436558|NCT03330028|Tubulin Modulators|tubulin modulators|mesh-ancestor
101436559|NCT03330028|Antimitotic Agents|antimitotic agents|mesh-ancestor
101436560|NCT03330028|Mitosis Modulators|mitosis modulators|mesh-ancestor
101436561|NCT03330028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436562|NCT03330028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101436563|NCT03330028|Antiemetics|antiemetics|mesh-ancestor
101436564|NCT03330028|Autonomic Agents|autonomic agents|mesh-ancestor
101436565|NCT03330028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101436576|NCT03330028|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101436577|NCT03330028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101436578|NCT03330028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101436579|NCT03330028|Anesthetics, Local|anesthetics, local|mesh-ancestor
101307582|NCT02041338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101436580|NCT03330028|Anesthetics|anesthetics|mesh-ancestor
101436581|NCT03330028|Sensory System Agents|sensory system agents|mesh-ancestor
101436582|NCT03330028|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101436583|NCT03330028|Histamine Antagonists|histamine antagonists|mesh-ancestor
101436584|NCT03330028|Histamine Agents|histamine agents|mesh-ancestor
101436585|NCT03330028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101436586|NCT03330028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101436589|NCT03330028|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101436590|NCT03330028|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101436592|NCT03311555|Androgens|androgens|mesh-list
101436593|NCT03311555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436594|NCT03311555|Tubulin Modulators|tubulin modulators|mesh-ancestor
101436595|NCT03311555|Antimitotic Agents|antimitotic agents|mesh-ancestor
101436596|NCT03311555|Mitosis Modulators|mitosis modulators|mesh-ancestor
101469349|NCT00244127|Rituximab|rituximab|mesh-list
101436597|NCT03311555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436598|NCT03311555|Hormones|hormones|mesh-ancestor
101436599|NCT03311555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101436600|NCT03311555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436601|NCT03271866|Metformin|metformin|mesh-list
101436602|NCT03271866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101436603|NCT03271866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436604|NCT03217565|Tedizolid|tedizolid|mesh-list
101436605|NCT03217565|Tedizolid phosphate|tedizolid phosphate|mesh-list
101436606|NCT03217565|Oxazolidinones|oxazolidinones|mesh-list
101436607|NCT03217565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101436608|NCT03217565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101436609|NCT03217565|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101436610|NCT03217565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101559606|NCT02857465|Anesthetics, Local|anesthetics, local|mesh-ancestor
101559607|NCT02857465|Anesthetics|anesthetics|mesh-ancestor
101559608|NCT02857465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101559609|NCT02857465|Sensory System Agents|sensory system agents|mesh-ancestor
101436611|NCT03217565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436612|NCT03196180|Fluorouracil|fluorouracil|mesh-list
101436613|NCT03196180|Imiquimod|imiquimod|mesh-list
101436614|NCT03196180|Antimetabolites|antimetabolites|mesh-ancestor
101436615|NCT03196180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436616|NCT03196180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101436617|NCT03196180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436618|NCT03196180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101436619|NCT03196180|Immunologic Factors|immunologic factors|mesh-ancestor
101436620|NCT03196180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436621|NCT03196180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101436622|NCT03196180|Interferon Inducers|interferon inducers|mesh-ancestor
101436623|NCT03162627|Olaparib|olaparib|mesh-list
101436624|NCT03162627|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101436625|NCT03162627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101436626|NCT03162627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436627|NCT03162627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436628|NCT02992743|Cyclophosphamide|cyclophosphamide|mesh-list
101436629|NCT02992743|Fludarabine|fludarabine|mesh-list
101436630|NCT02992743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101436631|NCT02992743|Immunologic Factors|immunologic factors|mesh-ancestor
101436639|NCT02853344|Pembrolizumab|pembrolizumab|mesh-list
101436640|NCT02853344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101436641|NCT02853344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436642|NCT02853344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101436643|NCT02853344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436644|NCT02738229|Valacyclovir|valacyclovir|mesh-list
101436645|NCT02738229|Antiviral Agents|antiviral agents|mesh-ancestor
101436646|NCT02738229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101436647|NCT02675426|Upadacitinib|upadacitinib|mesh-list
101436648|NCT02675426|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101436649|NCT02675426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101436650|NCT02675426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101436651|NCT02675426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436652|NCT02675426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101436653|NCT02579473|Rotigotine|rotigotine|mesh-list
101307583|NCT02041338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101307584|NCT02041338|Tubulin Modulators|tubulin modulators|mesh-ancestor
101307585|NCT02041338|Antimitotic Agents|antimitotic agents|mesh-ancestor
101436654|NCT02579473|Dopamine Agonists|dopamine agonists|mesh-ancestor
101436655|NCT02579473|Dopamine Agents|dopamine agents|mesh-ancestor
101436656|NCT02579473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101436657|NCT02579473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436658|NCT02579473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436659|NCT02427620|Cytarabine|cytarabine|mesh-list
101436675|NCT02427620|Immunologic Factors|immunologic factors|mesh-ancestor
101436676|NCT02427620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436677|NCT02427620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101436678|NCT02427620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101436679|NCT02427620|Alkylating Agents|alkylating agents|mesh-ancestor
101436680|NCT02427620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436681|NCT02427620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436682|NCT02427620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101436683|NCT02427620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101436684|NCT02427620|Antiemetics|antiemetics|mesh-ancestor
101436685|NCT02427620|Autonomic Agents|autonomic agents|mesh-ancestor
101436686|NCT02427620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101436687|NCT02427620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101436688|NCT02427620|Glucocorticoids|glucocorticoids|mesh-ancestor
101436689|NCT02427620|Hormones|hormones|mesh-ancestor
101436690|NCT02427620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101436691|NCT02427620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101436692|NCT02427620|Protease Inhibitors|protease inhibitors|mesh-ancestor
101436693|NCT02427620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101436694|NCT02427620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101436695|NCT02427620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101559610|NCT02857465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101559611|NCT02857465|Narcotics|narcotics|mesh-ancestor
101559612|NCT02857465|Analgesics|analgesics|mesh-ancestor
101559613|NCT02857465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101559614|NCT02857465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101559615|NCT02857465|Anesthetics, General|anesthetics, general|mesh-ancestor
101559616|NCT04260139|Metronidazole|metronidazole|mesh-list
101559617|NCT04260139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101436696|NCT02427620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101436697|NCT02427620|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101436698|NCT02427620|Abortifacient Agents|abortifacient agents|mesh-ancestor
101436699|NCT02427620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101436700|NCT02427620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101436701|NCT02427620|Antimetabolites|antimetabolites|mesh-ancestor
101436702|NCT02427620|Dermatologic Agents|dermatologic agents|mesh-ancestor
101436703|NCT02427620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101436704|NCT02427620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101436705|NCT02427620|Antiviral Agents|antiviral agents|mesh-ancestor
101436706|NCT02427620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101436707|NCT02427620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101436708|NCT02427620|Tubulin Modulators|tubulin modulators|mesh-ancestor
101436752|NCT02153944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101436753|NCT02153944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101436754|NCT02153944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101436755|NCT02153944|Adrenergic Agents|adrenergic agents|mesh-ancestor
101436756|NCT02153944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101436757|NCT02153944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101436758|NCT02153944|Vasodilator Agents|vasodilator agents|mesh-ancestor
101436760|NCT02060721|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101436761|NCT02060721|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101436762|NCT02060721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436763|NCT02060721|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
101436779|NCT01527149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101436781|NCT01527149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436782|NCT01527149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436783|NCT01527149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101436784|NCT01527149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101436789|NCT01527149|Glucocorticoids|glucocorticoids|mesh-ancestor
101436791|NCT01527149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101436792|NCT01527149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101436793|NCT01527149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101436794|NCT01527149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101436795|NCT01527149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101436796|NCT01527149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101436797|NCT01527149|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101436798|NCT01527149|Abortifacient Agents|abortifacient agents|mesh-ancestor
101436799|NCT01527149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101436800|NCT01527149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101436801|NCT01527149|Antimetabolites|antimetabolites|mesh-ancestor
101436802|NCT01527149|Dermatologic Agents|dermatologic agents|mesh-ancestor
101436803|NCT01527149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101436804|NCT01527149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101436805|NCT01527149|Antiviral Agents|antiviral agents|mesh-ancestor
101436806|NCT01527149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101436807|NCT01527149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101436808|NCT01527149|Tubulin Modulators|tubulin modulators|mesh-ancestor
101436809|NCT01527149|Antimitotic Agents|antimitotic agents|mesh-ancestor
101436810|NCT01527149|Mitosis Modulators|mitosis modulators|mesh-ancestor
101436811|NCT01527149|Protease Inhibitors|protease inhibitors|mesh-ancestor
101436813|NCT01359956|Interferon-alpha|interferon-alpha|mesh-list
101436814|NCT01359956|Interferon alpha-2|interferon alpha-2|mesh-list
101436815|NCT01359956|Dacarbazine|dacarbazine|mesh-list
101436816|NCT01359956|Fotemustine|fotemustine|mesh-list
101436817|NCT01359956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436818|NCT01359956|Antiviral Agents|antiviral agents|mesh-ancestor
101307589|NCT02041338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101559618|NCT04260139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101559619|NCT04260139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101559620|NCT04260139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101559621|NCT04206618|Denosumab|denosumab|mesh-list
101559622|NCT04206618|Teriparatide|teriparatide|mesh-list
101559623|NCT04206618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101559624|NCT04206618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559625|NCT04206618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101559626|NCT01239732|Paclitaxel|paclitaxel|mesh-list
101559627|NCT01239732|Bevacizumab|bevacizumab|mesh-list
101559628|NCT01239732|Carboplatin|carboplatin|mesh-list
101307590|NCT02041338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101307591|NCT02041338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101307592|NCT02041351|Docetaxel|docetaxel|mesh-list
101436819|NCT01359956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101436820|NCT01359956|Immunologic Factors|immunologic factors|mesh-ancestor
101436821|NCT01359956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436822|NCT01359956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101436823|NCT01359956|Alkylating Agents|alkylating agents|mesh-ancestor
101436824|NCT01359956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436825|NCT01306045|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101436826|NCT01306045|Sunitinib|sunitinib|mesh-list
101436827|NCT01306045|Lapatinib|lapatinib|mesh-list
101436828|NCT01306045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436868|NCT01075971|Narcotics|narcotics|mesh-ancestor
101436883|NCT00775749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101436884|NCT00775749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436886|NCT00324922|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101436887|NCT00324922|Trimethoprim|trimethoprim|mesh-list
101436888|NCT00324922|Sulfamethoxazole|sulfamethoxazole|mesh-list
101307593|NCT02041351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101307594|NCT02041351|Tubulin Modulators|tubulin modulators|mesh-ancestor
101307595|NCT02041351|Antimitotic Agents|antimitotic agents|mesh-ancestor
101307596|NCT02041351|Mitosis Modulators|mitosis modulators|mesh-ancestor
101307597|NCT02041351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436889|NCT00324922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101436890|NCT00324922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101436891|NCT00324922|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101436892|NCT00324922|Antimalarials|antimalarials|mesh-ancestor
101436893|NCT00324922|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101436894|NCT00324922|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101436895|NCT00324922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101436896|NCT00324922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101436897|NCT00324922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436898|NCT00324922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101436899|NCT00324922|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101436900|NCT00324922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101436901|NCT00192855|Entacapone|entacapone|mesh-list
101436902|NCT00192855|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101436903|NCT00192855|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101436904|NCT00192855|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101436905|NCT00192855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101436906|NCT00192855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436907|NCT00407186|Cisplatin|cisplatin|mesh-list
101436908|NCT00407186|Capecitabine|capecitabine|mesh-list
101436909|NCT00407186|Epirubicin|epirubicin|mesh-list
101436910|NCT00407186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436911|NCT00407186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101436912|NCT00407186|Antimetabolites|antimetabolites|mesh-ancestor
101436913|NCT00407186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436914|NCT00407186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101436915|NCT00407186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101436916|NCT00407186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101436917|NCT00407186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101436918|NCT00163748|Gemcitabine|gemcitabine|mesh-list
101559629|NCT01239732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101559630|NCT01239732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101559631|NCT01239732|Tubulin Modulators|tubulin modulators|mesh-ancestor
101559632|NCT01239732|Antimitotic Agents|antimitotic agents|mesh-ancestor
101559633|NCT01239732|Mitosis Modulators|mitosis modulators|mesh-ancestor
101408070|NCT03278431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436920|NCT00163748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101436921|NCT00163748|Antimetabolites|antimetabolites|mesh-ancestor
101436922|NCT00163748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436923|NCT00163748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436948|NCT00193011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101436949|NCT00193011|Dermatologic Agents|dermatologic agents|mesh-ancestor
101436950|NCT00193011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101436951|NCT00193011|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101436952|NCT00193011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101436954|NCT00193089|Trastuzumab|trastuzumab|mesh-list
101436955|NCT00193089|Vinorelbine|vinorelbine|mesh-list
101307598|NCT02041455|Amitriptyline|amitriptyline|mesh-list
101307599|NCT02041455|Melatonin|melatonin|mesh-list
101307600|NCT02041455|Antioxidants|antioxidants|mesh-ancestor
101307601|NCT02041455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307602|NCT02041455|Protective Agents|protective agents|mesh-ancestor
101307603|NCT02041455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307604|NCT02041455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101307605|NCT02041455|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101436956|NCT00193089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436958|NCT00193089|Antimitotic Agents|antimitotic agents|mesh-ancestor
101436959|NCT00193089|Mitosis Modulators|mitosis modulators|mesh-ancestor
101436960|NCT00193089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436961|NCT00193089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101436962|NCT00193089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101436963|NCT00193167|Topotecan|topotecan|mesh-list
101436964|NCT00193167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101436965|NCT00193167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101436966|NCT00193167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101436967|NCT00193167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436968|NCT00193167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436969|NCT00193245|Docetaxel|docetaxel|mesh-list
101436970|NCT00193245|Topotecan|topotecan|mesh-list
101436971|NCT00193245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436972|NCT00193245|Tubulin Modulators|tubulin modulators|mesh-ancestor
101436981|NCT00193284|Fluorouracil|fluorouracil|mesh-list
101436982|NCT00193284|Gefitinib|gefitinib|mesh-list
101436983|NCT00193284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436984|NCT00193284|Tubulin Modulators|tubulin modulators|mesh-ancestor
101436985|NCT00193284|Antimitotic Agents|antimitotic agents|mesh-ancestor
101436986|NCT00193284|Mitosis Modulators|mitosis modulators|mesh-ancestor
101436987|NCT00193284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436988|NCT00193284|Antimetabolites|antimetabolites|mesh-ancestor
101436989|NCT00193284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101436990|NCT00193284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101436991|NCT00193284|Immunologic Factors|immunologic factors|mesh-ancestor
101436992|NCT00193284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436993|NCT00193284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101436994|NCT00193284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101436995|NCT00163982|Norfloxacin|norfloxacin|mesh-list
101436996|NCT00163982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101436997|NCT00163982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101436998|NCT00163982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101436999|NCT00163982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101437000|NCT00163982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101437001|NCT00163982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437002|NCT00163982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437008|NCT00193323|Antimetabolites|antimetabolites|mesh-ancestor
101437009|NCT00193323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437010|NCT00193323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101559634|NCT01239732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559635|NCT01239732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101559637|NCT01239732|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101559638|NCT01239732|Growth Substances|growth substances|mesh-ancestor
101408075|NCT03278431|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101437011|NCT00193323|Tubulin Modulators|tubulin modulators|mesh-ancestor
101437012|NCT00193323|Antimitotic Agents|antimitotic agents|mesh-ancestor
101437013|NCT00193323|Mitosis Modulators|mitosis modulators|mesh-ancestor
101437014|NCT00193362|Paclitaxel|paclitaxel|mesh-list
101437015|NCT00193362|Vinorelbine|vinorelbine|mesh-list
101469429|NCT00244439|Permethrin|permethrin|mesh-list
101437016|NCT00193362|Carboplatin|carboplatin|mesh-list
101437017|NCT00193362|Gemcitabine|gemcitabine|mesh-list
101437018|NCT00193362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101437019|NCT00193362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437020|NCT00193362|Tubulin Modulators|tubulin modulators|mesh-ancestor
101437021|NCT00193362|Antimitotic Agents|antimitotic agents|mesh-ancestor
101307606|NCT02041455|Antidepressive Agents|antidepressive agents|mesh-ancestor
101307607|NCT02041455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101307608|NCT02041455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101437022|NCT00193362|Mitosis Modulators|mitosis modulators|mesh-ancestor
101437023|NCT00193362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437024|NCT00193362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101437026|NCT00193401|Topotecan|topotecan|mesh-list
101437027|NCT00193401|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101437028|NCT00193401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101437029|NCT00193401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101437030|NCT00193401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437031|NCT00193401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437032|NCT00553189|Topotecan|topotecan|mesh-list
101437033|NCT00553189|Veliparib|veliparib|mesh-list
101437034|NCT00553189|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101437035|NCT00553189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101437036|NCT00553189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101437037|NCT00553189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437038|NCT00553189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437039|NCT00553189|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101437040|NCT00193440|Rituximab|rituximab|mesh-list
101437041|NCT00193440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101437042|NCT00193440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437043|NCT00193440|Immunologic Factors|immunologic factors|mesh-ancestor
101437086|NCT00164255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101437087|NCT00164255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101437088|NCT00164255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437089|NCT00164255|Antiviral Agents|antiviral agents|mesh-ancestor
101437090|NCT00164255|Schistosomicides|schistosomicides|mesh-ancestor
101437091|NCT00164255|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101437092|NCT00164255|Anthelmintics|anthelmintics|mesh-ancestor
101437093|NCT00164255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101437094|NCT00164255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101307610|NCT02041455|Sensory System Agents|sensory system agents|mesh-ancestor
101307611|NCT02041455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101437095|NCT00164255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437096|NCT00164255|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101437097|NCT00409656|Basiliximab|basiliximab|mesh-list
101437098|NCT00409656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101437099|NCT00409656|Immunologic Factors|immunologic factors|mesh-ancestor
101437100|NCT00409656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437101|NCT00409695|Thymoglobulin|thymoglobulin|mesh-list
101437102|NCT00409695|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101437103|NCT00409695|Immunologic Factors|immunologic factors|mesh-ancestor
101437104|NCT00409695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437105|NCT00409695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101437106|NCT04977232|Escitalopram|escitalopram|mesh-list
101360496|NCT00216580|Serotonin Agents|serotonin agents|mesh-ancestor
101437107|NCT04977232|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101437108|NCT04977232|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101437109|NCT04977232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101559639|NCT01239732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559640|NCT01239732|Growth Inhibitors|growth inhibitors|mesh-ancestor
101559641|NCT02856919|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101559642|NCT02856919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101559643|NCT02856919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101559644|NCT02856919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101559645|NCT02856919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101559646|NCT02856919|Adrenergic Agents|adrenergic agents|mesh-ancestor
101437110|NCT04977232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437111|NCT04977232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101437112|NCT04977232|Serotonin Agents|serotonin agents|mesh-ancestor
101437113|NCT04977232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437127|NCT00193635|Mycophenolic Acid|mycophenolic acid|mesh-list
101437128|NCT00193635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101437129|NCT00193635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437130|NCT00193635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101437131|NCT00193635|Antitubercular Agents|antitubercular agents|mesh-ancestor
101437132|NCT00193635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101437133|NCT00193635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101437134|NCT00193635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101437135|NCT00193635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437137|NCT04902703|Sargramostim|sargramostim|mesh-list
101437138|NCT04902703|Immunologic Factors|immunologic factors|mesh-ancestor
101437139|NCT04902703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437140|NCT04902703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437141|NCT00193674|Dydrogesterone|dydrogesterone|mesh-list
101437142|NCT00193674|Progestins|progestins|mesh-ancestor
101437143|NCT00193674|Hormones|hormones|mesh-ancestor
101437144|NCT00193674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101437145|NCT00193674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437147|NCT04899778|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101437148|NCT04899778|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101437151|NCT04899778|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
101437152|NCT04899778|Estradiol|estradiol|mesh-list
101437153|NCT04899778|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101437154|NCT04899778|Trace Elements|trace elements|mesh-ancestor
101437155|NCT04899778|Micronutrients|micronutrients|mesh-ancestor
101437156|NCT04899778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437157|NCT04899778|Estrogens|estrogens|mesh-ancestor
101437158|NCT04899778|Hormones|hormones|mesh-ancestor
101437159|NCT04899778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101437160|NCT04899778|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101437161|NCT04899778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101437162|NCT04899778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101437163|NCT00164450|Isoniazid|isoniazid|mesh-list
101307612|NCT02041455|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101307613|NCT02041455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101437164|NCT00164450|Rifapentine|rifapentine|mesh-list
101437165|NCT00164450|Antitubercular Agents|antitubercular agents|mesh-ancestor
101437166|NCT00164450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101437167|NCT00164450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101437168|NCT00164450|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101437169|NCT00164450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101437170|NCT00164450|Antimetabolites|antimetabolites|mesh-ancestor
101437171|NCT00164450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437172|NCT00164450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101437173|NCT00164450|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101469462|NCT00417183|Ganirelix|ganirelix|mesh-list
101437174|NCT00164450|Leprostatic Agents|leprostatic agents|mesh-ancestor
101437200|NCT04742959|Tubulin Modulators|tubulin modulators|mesh-ancestor
101437201|NCT04742959|Antimitotic Agents|antimitotic agents|mesh-ancestor
101437202|NCT04742959|Mitosis Modulators|mitosis modulators|mesh-ancestor
101437203|NCT04742959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437205|NCT00164801|Baclofen|baclofen|mesh-list
101437206|NCT00164801|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101437207|NCT00164801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437208|NCT00164801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101559647|NCT02856919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101559648|NCT02856919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559649|NCT02856919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559650|NCT00947011|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101559651|NCT00947011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101559652|NCT00947011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559653|NCT00947011|Incretins|incretins|mesh-ancestor
101559655|NCT00947011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101559656|NCT00947011|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101559657|NCT00947011|Protease Inhibitors|protease inhibitors|mesh-ancestor
101559658|NCT00947011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101559659|NCT00947011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559660|NCT02856685|Mitoxantrone|mitoxantrone|mesh-list
101437209|NCT00164801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101437210|NCT00164801|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101437211|NCT00164801|GABA Agonists|gaba agonists|mesh-ancestor
101437212|NCT00164801|GABA Agents|gaba agents|mesh-ancestor
101437213|NCT00164801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101437214|NCT00164801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437215|NCT00164801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101437216|NCT00164801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101437217|NCT00164801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101437218|NCT00164801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101437219|NCT00164801|Vasodilator Agents|vasodilator agents|mesh-ancestor
101437220|NCT00176280|Dexamethasone|dexamethasone|mesh-list
101437221|NCT00176280|Sargramostim|sargramostim|mesh-list
101437222|NCT00176280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101437244|NCT04723940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101437245|NCT04723940|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101307616|NCT02041455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101437254|NCT00164840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437255|NCT04641247|Niraparib|niraparib|mesh-list
101437256|NCT04641247|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101437257|NCT04641247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101437258|NCT04641247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437259|NCT04641247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437260|NCT04635007|Misoprostol|misoprostol|mesh-list
101437261|NCT04635007|Tranexamic Acid|tranexamic acid|mesh-list
101437262|NCT04635007|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101437263|NCT04635007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101437264|NCT04635007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437265|NCT04635007|Hemostatics|hemostatics|mesh-ancestor
101437266|NCT04635007|Coagulants|coagulants|mesh-ancestor
101437267|NCT04635007|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101437268|NCT04635007|Abortifacient Agents|abortifacient agents|mesh-ancestor
101437269|NCT04635007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101437270|NCT04635007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437271|NCT04635007|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101437272|NCT04635007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101437273|NCT04635007|Oxytocics|oxytocics|mesh-ancestor
101437274|NCT00194064|Olanzapine|olanzapine|mesh-list
101437275|NCT00194064|Antiemetics|antiemetics|mesh-ancestor
101437276|NCT00194064|Autonomic Agents|autonomic agents|mesh-ancestor
101437279|NCT00194064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101437280|NCT00194064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101437281|NCT00194064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101437282|NCT00194064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101437283|NCT00194064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101559661|NCT02856685|Analgesics|analgesics|mesh-ancestor
101559662|NCT02856685|Sensory System Agents|sensory system agents|mesh-ancestor
101559663|NCT02856685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101559664|NCT02856685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559665|NCT02856685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101559666|NCT02856685|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101559667|NCT02856685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101437284|NCT00194064|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101437285|NCT00194064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101437286|NCT00194064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101437287|NCT00194064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437288|NCT00194064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101437289|NCT00194064|Serotonin Agents|serotonin agents|mesh-ancestor
101437290|NCT00164996|Anesthetics|anesthetics|mesh-list
101437291|NCT00164996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101437292|NCT00164996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437293|NCT04418557|Antibodies|antibodies|mesh-list
101437294|NCT04418557|Immunologic Factors|immunologic factors|mesh-ancestor
101437295|NCT04418557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437296|NCT04682782|Esketamine|esketamine|mesh-list
101437297|NCT04682782|Antidepressive Agents|antidepressive agents|mesh-ancestor
101437298|NCT04682782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101437299|NCT04682665|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
101437300|NCT04682665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101437301|NCT04682665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101437302|NCT00165035|Paclitaxel|paclitaxel|mesh-list
101437303|NCT00165035|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101437304|NCT00165035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101437305|NCT00165035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437306|NCT00165035|Tubulin Modulators|tubulin modulators|mesh-ancestor
101437307|NCT00165035|Antimitotic Agents|antimitotic agents|mesh-ancestor
101437308|NCT00165035|Mitosis Modulators|mitosis modulators|mesh-ancestor
101437309|NCT00165035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437310|NCT04326673|Methyltestosterone|methyltestosterone|mesh-list
101437324|NCT00165074|Respiratory System Agents|respiratory system agents|mesh-ancestor
101307618|NCT02041481|Fluorouracil|fluorouracil|mesh-list
101307619|NCT02041481|Oxaliplatin|oxaliplatin|mesh-list
101437325|NCT04307953|Saracatinib|saracatinib|mesh-list
101437326|NCT04307953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437327|NCT04307953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101437328|NCT04307953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437329|NCT04297267|Gemcitabine|gemcitabine|mesh-list
101437330|NCT04297267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437331|NCT04297267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101437332|NCT04297267|Antimetabolites|antimetabolites|mesh-ancestor
101437333|NCT04297267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437334|NCT00176475|Rituximab|rituximab|mesh-list
101437335|NCT00176475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101437336|NCT00176475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437337|NCT00176475|Immunologic Factors|immunologic factors|mesh-ancestor
101437338|NCT00176475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437339|NCT00176475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101437340|NCT00165191|Doxorubicin|doxorubicin|mesh-list
101437341|NCT00165191|Fluorouracil|fluorouracil|mesh-list
101437342|NCT00165191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437343|NCT00165191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101437344|NCT00165191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101469482|NCT00244517|Anesthetics, General|anesthetics, general|mesh-ancestor
101437345|NCT00165191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101437346|NCT00165191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101437347|NCT00165191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437348|NCT00165191|Antimetabolites|antimetabolites|mesh-ancestor
101437351|NCT00165191|Immunologic Factors|immunologic factors|mesh-ancestor
101437352|NCT00165191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437360|NCT00176514|Antineoplastic Agents|antineoplastic agents|mesh-list
101437361|NCT00165230|Thalidomide|thalidomide|mesh-list
101437362|NCT00165230|Temozolomide|temozolomide|mesh-list
101437363|NCT00165230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101559668|NCT02856685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101559669|NCT02856685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559670|NCT01962415|Fludarabine|fludarabine|mesh-list
101559671|NCT01962415|Melphalan|melphalan|mesh-list
101559672|NCT01962415|Alemtuzumab|alemtuzumab|mesh-list
101559673|NCT01962415|Thiotepa|thiotepa|mesh-list
101559674|NCT01962415|Hydroxyurea|hydroxyurea|mesh-list
101559675|NCT01962415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101408111|NCT00443794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101437364|NCT00165230|Immunologic Factors|immunologic factors|mesh-ancestor
101437365|NCT00165230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437366|NCT00165230|Leprostatic Agents|leprostatic agents|mesh-ancestor
101437367|NCT00165230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101437368|NCT00165230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101437369|NCT00165230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101437370|NCT00165230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101437371|NCT00165230|Growth Substances|growth substances|mesh-ancestor
101437372|NCT00165230|Growth Inhibitors|growth inhibitors|mesh-ancestor
101437373|NCT00165230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437374|NCT00165230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101437375|NCT00165230|Alkylating Agents|alkylating agents|mesh-ancestor
101437376|NCT00165230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437377|NCT00176553|Dextromethorphan|dextromethorphan|mesh-list
101437378|NCT00176553|Antitussive Agents|antitussive agents|mesh-ancestor
101437379|NCT00176553|Respiratory System Agents|respiratory system agents|mesh-ancestor
101437383|NCT00176553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437384|NCT00176553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437386|NCT00165308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101437387|NCT00165308|Hormone Antagonists|hormone antagonists|mesh-ancestor
101437388|NCT00165308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101437389|NCT00165308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437390|NCT00165308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101437391|NCT00165308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437392|NCT00165308|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101437393|NCT00165308|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101437394|NCT00165308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101437395|NCT00165347|Vatalanib|vatalanib|mesh-list
101307620|NCT02041481|Calcium|calcium|mesh-list
101307621|NCT02041481|Levoleucovorin|levoleucovorin|mesh-list
101307622|NCT02041481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101437396|NCT00165347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101437397|NCT00165347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101437398|NCT00165347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437399|NCT00176670|Midazolam|midazolam|mesh-list
101437400|NCT00176670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101437401|NCT00176670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101437402|NCT00176670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101437403|NCT00176670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437404|NCT00176670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101437405|NCT00176670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101437406|NCT00176670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101437407|NCT00176670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101437408|NCT00176670|Anesthetics, General|anesthetics, general|mesh-ancestor
101437409|NCT00176670|Anesthetics|anesthetics|mesh-ancestor
101437410|NCT00176670|GABA Modulators|gaba modulators|mesh-ancestor
101437411|NCT00176670|GABA Agents|gaba agents|mesh-ancestor
101437412|NCT00176670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101437413|NCT00176670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437414|NCT00165464|Irinotecan|irinotecan|mesh-list
101437415|NCT00165464|Docetaxel|docetaxel|mesh-list
101437416|NCT00165464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437417|NCT00165464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101437418|NCT00165464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101437419|NCT00165464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101437422|NCT00165464|Antimitotic Agents|antimitotic agents|mesh-ancestor
101437423|NCT00165464|Mitosis Modulators|mitosis modulators|mesh-ancestor
101559676|NCT01962415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559677|NCT01962415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101559678|NCT01962415|Immunologic Factors|immunologic factors|mesh-ancestor
101559679|NCT01962415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559680|NCT01962415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101559681|NCT01962415|Alkylating Agents|alkylating agents|mesh-ancestor
101559682|NCT01962415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101408116|NCT00443794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101437425|NCT04082650|Vitamins|vitamins|mesh-ancestor
101437426|NCT04082650|Micronutrients|micronutrients|mesh-ancestor
101437427|NCT04082650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437428|NCT04082650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101437429|NCT00176787|Capecitabine|capecitabine|mesh-list
101437430|NCT00176787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101437431|NCT00176787|Antimetabolites|antimetabolites|mesh-ancestor
101437432|NCT00176787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437433|NCT00176787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437434|NCT00176943|Imiquimod|imiquimod|mesh-list
101437435|NCT00176943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101437436|NCT00176943|Immunologic Factors|immunologic factors|mesh-ancestor
101437437|NCT00176943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437438|NCT00176943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437439|NCT00176943|Interferon Inducers|interferon inducers|mesh-ancestor
101437440|NCT03978208|Naproxen|naproxen|mesh-list
101437441|NCT03978208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101437442|NCT03978208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101437443|NCT03978208|Analgesics|analgesics|mesh-ancestor
101437444|NCT03978208|Sensory System Agents|sensory system agents|mesh-ancestor
101437445|NCT03978208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101437446|NCT03978208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437447|NCT03978208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101437448|NCT03978208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101437449|NCT03978208|Gout Suppressants|gout suppressants|mesh-ancestor
101437450|NCT03978208|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101437459|NCT00165659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437460|NCT00165659|Nootropic Agents|nootropic agents|mesh-ancestor
101437461|NCT00176982|Hydroxychloroquine|hydroxychloroquine|mesh-list
101437462|NCT00176982|Antimalarials|antimalarials|mesh-ancestor
101437463|NCT00176982|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101437464|NCT00176982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101437465|NCT00176982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101437466|NCT00176982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101437467|NCT00176982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307623|NCT02041481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307624|NCT02041481|Antimetabolites|antimetabolites|mesh-ancestor
101333868|NCT00017394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437468|NCT00176982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101437469|NCT00165737|Donepezil|donepezil|mesh-list
101437470|NCT00165737|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101437471|NCT00165737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101437472|NCT00165737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437473|NCT00165737|Cholinergic Agents|cholinergic agents|mesh-ancestor
101437474|NCT00165737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101437475|NCT00165737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437476|NCT00165737|Nootropic Agents|nootropic agents|mesh-ancestor
101437477|NCT04682899|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101437478|NCT04682899|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101437479|NCT04682899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101437480|NCT04682899|Antitubercular Agents|antitubercular agents|mesh-ancestor
101437481|NCT03789916|Aspirin|aspirin|mesh-list
101437482|NCT03789916|Ticagrelor|ticagrelor|mesh-list
101437483|NCT03789916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101437484|NCT03789916|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101437485|NCT03789916|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101437486|NCT03789916|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101437487|NCT03789916|Purinergic Agents|purinergic agents|mesh-ancestor
101559683|NCT01962415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101559685|NCT01962415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101559686|NCT01962415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101559687|NCT02860663|Vitamin D|vitamin d|mesh-list
101559688|NCT02860663|Ergocalciferols|ergocalciferols|mesh-list
101559689|NCT02860663|Cholecalciferol|cholecalciferol|mesh-list
101437488|NCT03789916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101437489|NCT03789916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437490|NCT03789916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437496|NCT03789916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101437497|NCT03789916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101437498|NCT03789916|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101437499|NCT03789916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101437500|NCT03789916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101437501|NCT03789916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101437502|NCT03789916|Antipyretics|antipyretics|mesh-ancestor
101437503|NCT00165815|Donepezil|donepezil|mesh-list
101437504|NCT00165815|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101437505|NCT00165815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101437506|NCT00165815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437507|NCT00165815|Cholinergic Agents|cholinergic agents|mesh-ancestor
101437508|NCT00165815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101437509|NCT00165815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437510|NCT00165815|Nootropic Agents|nootropic agents|mesh-ancestor
101437511|NCT00177021|Imiquimod|imiquimod|mesh-list
101437512|NCT00177021|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101437513|NCT00177021|Immunologic Factors|immunologic factors|mesh-ancestor
101437514|NCT00177021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437515|NCT00177021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437516|NCT00177021|Interferon Inducers|interferon inducers|mesh-ancestor
101437517|NCT03697603|Brexpiprazole|brexpiprazole|mesh-list
101437532|NCT00177060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101437533|NCT00177060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437535|NCT00177060|Sensory System Agents|sensory system agents|mesh-ancestor
101437536|NCT00177060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101437537|NCT03421639|Leuprolide|leuprolide|mesh-list
101437538|NCT03421639|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101437539|NCT03421639|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101437540|NCT03421639|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101307625|NCT02041481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307626|NCT02041481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101307627|NCT02041481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437541|NCT03421639|Fertility Agents|fertility agents|mesh-ancestor
101437542|NCT03421639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101437543|NCT03421639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437544|NCT03421639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101437545|NCT03421639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437546|NCT03421639|Hormones|hormones|mesh-ancestor
101437547|NCT03421639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101437548|NCT03421639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101437549|NCT03421639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101437550|NCT03421639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437551|NCT03421639|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101437552|NCT03421639|Hormone Antagonists|hormone antagonists|mesh-ancestor
101437553|NCT00177099|Tacrolimus|tacrolimus|mesh-list
101437554|NCT00177099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101437555|NCT00177099|Immunologic Factors|immunologic factors|mesh-ancestor
101437556|NCT00177099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437557|NCT00177099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101437558|NCT00177099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101437559|NCT00177099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437560|NCT03413800|Dexamethasone|dexamethasone|mesh-list
101437569|NCT03413800|Hormones|hormones|mesh-ancestor
101437570|NCT03413800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101437571|NCT03413800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101559691|NCT02860663|Micronutrients|micronutrients|mesh-ancestor
101559692|NCT02860663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559693|NCT02860663|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101437572|NCT03413800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437573|NCT03413800|Immunologic Factors|immunologic factors|mesh-ancestor
101437574|NCT03413800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101437575|NCT03413800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101437576|NCT03413800|Growth Substances|growth substances|mesh-ancestor
101437577|NCT03413800|Growth Inhibitors|growth inhibitors|mesh-ancestor
101437583|NCT00166010|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101437590|NCT05336812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437591|NCT05336812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101437592|NCT05336812|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101437593|NCT05336812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101437594|NCT05336812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437595|NCT00537862|Mycophenolic Acid|mycophenolic acid|mesh-list
101437596|NCT00537862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101437597|NCT00537862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437598|NCT00537862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101437599|NCT00537862|Antitubercular Agents|antitubercular agents|mesh-ancestor
101437600|NCT00537862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101437601|NCT00537862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101437602|NCT00537862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101437603|NCT00537862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437604|NCT00537901|Bevacizumab|bevacizumab|mesh-list
101437605|NCT00537901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101437606|NCT00537901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437607|NCT00537901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101437608|NCT00537901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101437609|NCT00537901|Growth Substances|growth substances|mesh-ancestor
101437610|NCT00537901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437611|NCT00537901|Growth Inhibitors|growth inhibitors|mesh-ancestor
101437612|NCT00166127|Simendan|simendan|mesh-list
101437613|NCT00166127|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101437614|NCT00166127|Vasodilator Agents|vasodilator agents|mesh-ancestor
101437615|NCT00166127|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101437616|NCT00166127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101437617|NCT00166127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101437618|NCT00166127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307628|NCT02041481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101307629|NCT02041481|Immunologic Factors|immunologic factors|mesh-ancestor
101307630|NCT02041481|Antidotes|antidotes|mesh-ancestor
101437619|NCT00166127|Protective Agents|protective agents|mesh-ancestor
101437620|NCT00166127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437621|NCT00194649|Miglustat|miglustat|mesh-list
101437622|NCT00194649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101437623|NCT00194649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437624|NCT00194649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101437625|NCT00194649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101437626|NCT00194649|Antiviral Agents|antiviral agents|mesh-ancestor
101437627|NCT00194649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101437628|NCT00194649|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101437629|NCT00194649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101437630|NCT00194649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437632|NCT00166244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101437635|NCT00166244|Antitubercular Agents|antitubercular agents|mesh-ancestor
101437636|NCT00166244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101437637|NCT00166244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101437638|NCT00166244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101437639|NCT00166244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437640|NCT00177138|Alemtuzumab|alemtuzumab|mesh-list
101437641|NCT00177138|Tacrolimus|tacrolimus|mesh-list
101437642|NCT00177138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101437643|NCT00177138|Immunologic Factors|immunologic factors|mesh-ancestor
101437644|NCT00177138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437645|NCT00177138|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101437646|NCT00177138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101559694|NCT02860663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101559695|NCT02854345|Parathyroid Hormone|parathyroid hormone|mesh-list
101559696|NCT02854345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101559697|NCT02854345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437647|NCT00177138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437648|NCT00177138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101437649|NCT00177138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437650|NCT05311774|Tramadol|tramadol|mesh-list
101437651|NCT05311774|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101437652|NCT05311774|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101437668|NCT00194727|Vinorelbine|vinorelbine|mesh-list
101437669|NCT00194727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101437670|NCT00194727|Antimetabolites|antimetabolites|mesh-ancestor
101437671|NCT00194727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437672|NCT00194727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437673|NCT00194727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101437674|NCT00194727|Tubulin Modulators|tubulin modulators|mesh-ancestor
101437675|NCT00194727|Antimitotic Agents|antimitotic agents|mesh-ancestor
101437676|NCT00194727|Mitosis Modulators|mitosis modulators|mesh-ancestor
101437677|NCT00166400|Metoprolol|metoprolol|mesh-list
101437678|NCT00166400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101437679|NCT00166400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101437680|NCT00166400|Sympatholytics|sympatholytics|mesh-ancestor
101437681|NCT00166400|Autonomic Agents|autonomic agents|mesh-ancestor
101437682|NCT00166400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101437683|NCT00166400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437684|NCT00166400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101437685|NCT00166400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101437686|NCT00166400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101437687|NCT00166400|Adrenergic Agents|adrenergic agents|mesh-ancestor
101307631|NCT02041481|Protective Agents|protective agents|mesh-ancestor
101307632|NCT02041481|Vitamin B Complex|vitamin b complex|mesh-ancestor
101437688|NCT00166400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101437689|NCT00166400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437690|NCT02042287|Metronidazole|metronidazole|mesh-list
101437691|NCT02042287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101437692|NCT02042287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101437693|NCT02042287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101437694|NCT02042287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101437695|NCT05296213|Calcium|calcium|mesh-list
101437696|NCT05296213|Fluorides|fluorides|mesh-list
101437697|NCT05296213|Caseins|caseins|mesh-list
101437698|NCT05296213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101437699|NCT05296213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437700|NCT05296213|Cariostatic Agents|cariostatic agents|mesh-ancestor
101437701|NCT05296213|Protective Agents|protective agents|mesh-ancestor
101437702|NCT05296213|Chelating Agents|chelating agents|mesh-ancestor
101437703|NCT05296213|Sequestering Agents|sequestering agents|mesh-ancestor
101437704|NCT05296213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437710|NCT00166478|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101437712|NCT00166478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437713|NCT00166478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101437714|NCT00166478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101437727|NCT00194766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437729|NCT00166556|Tacrolimus|tacrolimus|mesh-list
101437730|NCT00166556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101437731|NCT00166556|Immunologic Factors|immunologic factors|mesh-ancestor
101437732|NCT00166556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437733|NCT00166556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101437734|NCT00166556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101437735|NCT00166556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437736|NCT00166556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101437737|NCT00166556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437738|NCT00166595|Risperidone|risperidone|mesh-list
101437739|NCT00166595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101437740|NCT00166595|Serotonin Agents|serotonin agents|mesh-ancestor
101559700|NCT01239342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101559701|NCT01239342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101559702|NCT01239342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559703|NCT01239342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101559704|NCT01239342|Immunologic Factors|immunologic factors|mesh-ancestor
101559705|NCT01239342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559706|NCT01239342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101559707|NCT00946309|Sulforaphane|sulforaphane|mesh-list
101559708|NCT00946309|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101559709|NCT00946309|Protective Agents|protective agents|mesh-ancestor
101559710|NCT00946309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559711|NCT00946309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101559712|NCT02853799|Insulin|insulin|mesh-list
101559713|NCT02853799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101437741|NCT00166595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101437742|NCT00166595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437743|NCT00166595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437744|NCT00166595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101437745|NCT00166595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101437746|NCT00166595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101437747|NCT00166595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101437748|NCT00166595|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101437749|NCT00166595|Dopamine Agents|dopamine agents|mesh-ancestor
101437750|NCT05259631|Propofol|propofol|mesh-list
101437751|NCT05259631|Sevoflurane|sevoflurane|mesh-list
101437752|NCT05259631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101437753|NCT05259631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101437754|NCT05259631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437755|NCT05259631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101437756|NCT05259631|Anesthetics, General|anesthetics, general|mesh-ancestor
101437757|NCT05259631|Anesthetics|anesthetics|mesh-ancestor
101437758|NCT05259631|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101437759|NCT05259631|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101437760|NCT00408135|Telithromycin|telithromycin|mesh-list
101437761|NCT00408135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101437762|NCT00408135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101437763|NCT00407225|Difluprednate|difluprednate|mesh-list
101437764|NCT00407225|Glucocorticoids|glucocorticoids|mesh-ancestor
101437765|NCT00407225|Hormones|hormones|mesh-ancestor
101307633|NCT02041481|Vitamins|vitamins|mesh-ancestor
101307634|NCT02041481|Micronutrients|micronutrients|mesh-ancestor
101307635|NCT02041546|Pulmonary Surfactants|pulmonary surfactants|mesh-list
101437766|NCT00407225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101437767|NCT00407225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437768|NCT05124067|Dexamethasone|dexamethasone|mesh-list
101437769|NCT05124067|Dexamethasone acetate|dexamethasone acetate|mesh-list
101437770|NCT05124067|Dexmedetomidine|dexmedetomidine|mesh-list
101437771|NCT05124067|Ondansetron|ondansetron|mesh-list
101437772|NCT05124067|BB 1101|bb 1101|mesh-list
101437773|NCT05124067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101437774|NCT05124067|Antiemetics|antiemetics|mesh-ancestor
101437776|NCT05124067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101437782|NCT05124067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101437784|NCT05124067|Protease Inhibitors|protease inhibitors|mesh-ancestor
101437785|NCT05124067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101437786|NCT05124067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437787|NCT05124067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101437788|NCT05124067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101437789|NCT05124067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101437790|NCT05124067|Analgesics|analgesics|mesh-ancestor
101559714|NCT02853799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559716|NCT01236534|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101559717|NCT01236534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101559718|NCT01236534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559719|NCT01235598|Certolizumab Pegol|certolizumab pegol|mesh-list
101559720|NCT01235598|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101559721|NCT01235598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101437791|NCT05124067|Sensory System Agents|sensory system agents|mesh-ancestor
101437792|NCT05124067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101437793|NCT05124067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101437794|NCT05124067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101437795|NCT05124067|Adrenergic Agents|adrenergic agents|mesh-ancestor
101437796|NCT05124067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101437797|NCT05124067|Antipruritics|antipruritics|mesh-ancestor
101437798|NCT05124067|Dermatologic Agents|dermatologic agents|mesh-ancestor
101437799|NCT05124067|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101437800|NCT05124067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101437801|NCT05124067|Serotonin Agents|serotonin agents|mesh-ancestor
101437802|NCT00194883|Hormones|hormones|mesh-list
101437803|NCT00194883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101437804|NCT00194883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437805|NCT02277184|Cisplatin|cisplatin|mesh-list
101437806|NCT02277184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437807|NCT00166829|Mycophenolic Acid|mycophenolic acid|mesh-list
101437808|NCT00166829|Sirolimus|sirolimus|mesh-list
101437809|NCT00166829|Tacrolimus|tacrolimus|mesh-list
101437810|NCT00166829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101437811|NCT00166829|Immunologic Factors|immunologic factors|mesh-ancestor
101437812|NCT00166829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437813|NCT00166829|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101437814|NCT00166829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101437815|NCT00166829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437816|NCT00166829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101437817|NCT00166829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437818|NCT00166829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101437819|NCT00166829|Antitubercular Agents|antitubercular agents|mesh-ancestor
101437820|NCT00166829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101437821|NCT00166829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101437822|NCT00166829|Antifungal Agents|antifungal agents|mesh-ancestor
101437823|NCT00177333|Doxycycline|doxycycline|mesh-list
101437824|NCT00177333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101437825|NCT00177333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101437826|NCT00177333|Antimalarials|antimalarials|mesh-ancestor
101437827|NCT00177333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101437828|NCT00177333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101437829|NCT00166868|Neomycin|neomycin|mesh-list
101437830|NCT00166868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101437831|NCT00166868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101437832|NCT00166868|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101437833|NCT00166868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101437834|NCT00166868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437835|NCT00194961|Hormones|hormones|mesh-list
101437836|NCT00194961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101437837|NCT00194961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437838|NCT00177372|Misoprostol|misoprostol|mesh-list
101307636|NCT02041546|Poractant alfa|poractant alfa|mesh-list
101307637|NCT02041546|Respiratory System Agents|respiratory system agents|mesh-ancestor
101307638|NCT02041650|Ticagrelor|ticagrelor|mesh-list
101307639|NCT02041650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101437839|NCT00177372|Mifepristone|mifepristone|mesh-list
101437840|NCT00177372|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101437841|NCT00177372|Abortifacient Agents|abortifacient agents|mesh-ancestor
101437842|NCT00177372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101437843|NCT00177372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437844|NCT00177372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101559722|NCT01235598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101559723|NCT01235598|Immunologic Factors|immunologic factors|mesh-ancestor
101559724|NCT01235598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559725|NCT01235598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101559726|NCT01235442|Etanercept|etanercept|mesh-list
101559727|NCT01235442|Clobetasol|clobetasol|mesh-list
101559728|NCT01235442|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101559729|NCT01235442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101559730|NCT01235442|Analgesics|analgesics|mesh-ancestor
101559731|NCT01235442|Sensory System Agents|sensory system agents|mesh-ancestor
101437875|NCT00167141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437876|NCT04660045|Acalabrutinib|acalabrutinib|mesh-list
101437877|NCT04660045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437878|NCT00177528|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101437879|NCT00177528|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101437880|NCT00177528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101437881|NCT00177528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101437882|NCT00177528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437883|NCT00177528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101437884|NCT00177528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437885|NCT00177528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101437886|NCT00177528|Antidepressive Agents|antidepressive agents|mesh-ancestor
101437887|NCT00177528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101437888|NCT04566250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
101437889|NCT04566250|Analgesics|analgesics|mesh-ancestor
101437890|NCT04566250|Sensory System Agents|sensory system agents|mesh-ancestor
101437891|NCT04566250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101437892|NCT04566250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437893|NCT04548583|Remestemcel-l|remestemcel-l|mesh-list
101437894|NCT04548583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101437895|NCT04548583|Antiviral Agents|antiviral agents|mesh-ancestor
101437896|NCT04548583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101437897|NCT00167297|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101437898|NCT00167297|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101437899|NCT00167297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101437900|NCT00167297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101437901|NCT00167297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437902|NCT00167297|Adrenergic Agents|adrenergic agents|mesh-ancestor
101437903|NCT00167297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101437904|NCT00167297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437905|NCT00177567|Lamotrigine|lamotrigine|mesh-list
101437906|NCT00177567|Valproic Acid|valproic acid|mesh-list
101437925|NCT00177567|Dopamine Agents|dopamine agents|mesh-ancestor
101437926|NCT00177567|Antiemetics|antiemetics|mesh-ancestor
101437927|NCT00177567|Autonomic Agents|autonomic agents|mesh-ancestor
101437928|NCT00177567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101437929|NCT00177567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101437930|NCT00177567|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101437931|NCT00177567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101437932|NCT00177567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101437933|NCT00177567|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101437934|NCT00177567|Antidepressive Agents|antidepressive agents|mesh-ancestor
101437935|NCT00177567|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101437936|NCT00177567|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101437937|NCT00177567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101437938|NCT00177567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101437939|NCT00177567|Antimanic Agents|antimanic agents|mesh-ancestor
101437940|NCT00177567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101437941|NCT00177567|Anticonvulsants|anticonvulsants|mesh-ancestor
101437942|NCT00177567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101437943|NCT00177567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101559732|NCT01235442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101559733|NCT01235442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559734|NCT01235442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101559735|NCT01235442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101559736|NCT01235442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101559737|NCT01235442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101559738|NCT01235442|Immunologic Factors|immunologic factors|mesh-ancestor
101559739|NCT01235442|Glucocorticoids|glucocorticoids|mesh-ancestor
101628324|NCT00720109|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101437944|NCT00177567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101437945|NCT00177567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101437946|NCT00177567|Histamine Antagonists|histamine antagonists|mesh-ancestor
101437947|NCT00177567|Histamine Agents|histamine agents|mesh-ancestor
101437948|NCT00177567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101437949|NCT00177567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101437955|NCT00177567|GABA Agents|gaba agents|mesh-ancestor
101437956|NCT00177567|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101437957|NCT00195156|Valproic Acid|valproic acid|mesh-list
101437958|NCT00195156|Anticonvulsants|anticonvulsants|mesh-ancestor
101437959|NCT00195156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101437960|NCT00195156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437961|NCT00195156|GABA Agents|gaba agents|mesh-ancestor
101437962|NCT00195156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101437963|NCT00195156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437964|NCT00195156|Antimanic Agents|antimanic agents|mesh-ancestor
101437965|NCT00195156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101437966|NCT00195156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101437967|NCT00195156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101437968|NCT00167375|Eszopiclone|eszopiclone|mesh-list
101437969|NCT00167375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101437970|NCT00167375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101307651|NCT02041819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101307652|NCT02041819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101307653|NCT02042027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101307654|NCT02042027|Immunologic Factors|immunologic factors|mesh-ancestor
101307655|NCT02042027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307656|NCT02042170|Hormones|hormones|mesh-list
101307657|NCT02042170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101307658|NCT02042170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307659|NCT02042196|Cetrorelix|cetrorelix|mesh-list
101307660|NCT02042196|Estradiol|estradiol|mesh-list
101307661|NCT02042196|Estrogens|estrogens|mesh-ancestor
101307662|NCT02042196|Hormones|hormones|mesh-ancestor
101307663|NCT02042196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101307664|NCT02042196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437971|NCT00167375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437972|NCT00195000|Cytarabine|cytarabine|mesh-list
101437973|NCT00195000|Gemtuzumab|gemtuzumab|mesh-list
101437974|NCT00195000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101437980|NCT00195000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101437981|NCT00195000|Immunologic Factors|immunologic factors|mesh-ancestor
101437982|NCT00195000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437983|NCT00195000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101437984|NCT00195000|Immunotoxins|immunotoxins|mesh-ancestor
101437985|NCT00195000|Immunoconjugates|immunoconjugates|mesh-ancestor
101437986|NCT00195195|Sirolimus|sirolimus|mesh-list
101437987|NCT00195195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101437988|NCT00195195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101437989|NCT00195195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101437990|NCT00195195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437991|NCT00195195|Antifungal Agents|antifungal agents|mesh-ancestor
101559741|NCT01235442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101559743|NCT01163253|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101559744|NCT01163253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101559745|NCT01163253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101559746|NCT01163253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559747|NCT01162863|Lubiprostone|lubiprostone|mesh-list
101559748|NCT01162863|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101559749|NCT01162863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101559750|NCT01162863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559751|NCT05304039|Nitric Oxide|nitric oxide|mesh-list
101559752|NCT05304039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101559753|NCT05304039|Autonomic Agents|autonomic agents|mesh-ancestor
101559754|NCT05304039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101437992|NCT00195195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101437993|NCT00195195|Immunologic Factors|immunologic factors|mesh-ancestor
101437994|NCT00195195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437995|NCT04299880|Leucovorin|leucovorin|mesh-list
101437996|NCT04299880|Paclitaxel|paclitaxel|mesh-list
101437997|NCT04299880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101437998|NCT04299880|Bevacizumab|bevacizumab|mesh-list
101437999|NCT04299880|Gemcitabine|gemcitabine|mesh-list
101438000|NCT04299880|Fluorouracil|fluorouracil|mesh-list
101438001|NCT04299880|Nivolumab|nivolumab|mesh-list
101438002|NCT04299880|Irinotecan|irinotecan|mesh-list
101438003|NCT04299880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101438004|NCT04299880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101438005|NCT04299880|Tubulin Modulators|tubulin modulators|mesh-ancestor
101438006|NCT04299880|Antimitotic Agents|antimitotic agents|mesh-ancestor
101438007|NCT04299880|Mitosis Modulators|mitosis modulators|mesh-ancestor
101438008|NCT04299880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438009|NCT04299880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101438010|NCT04299880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101438011|NCT04299880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101438018|NCT04299880|Immunologic Factors|immunologic factors|mesh-ancestor
101438019|NCT04299880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101438020|NCT04299880|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101438021|NCT04299880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101438022|NCT04299880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101438023|NCT04299880|Antidotes|antidotes|mesh-ancestor
101307665|NCT02042196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101307666|NCT02042196|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101307667|NCT02042196|Fertility Agents|fertility agents|mesh-ancestor
101307668|NCT02042196|Hormone Antagonists|hormone antagonists|mesh-ancestor
101307669|NCT02042222|Hydroxyurea|hydroxyurea|mesh-list
101307670|NCT02042222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101307671|NCT02042222|Antisickling Agents|antisickling agents|mesh-ancestor
101307672|NCT02042222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101307673|NCT02042222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307674|NCT02042222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101307675|NCT02042482|Ubiquinone|ubiquinone|mesh-list
101438024|NCT04299880|Protective Agents|protective agents|mesh-ancestor
101438025|NCT04299880|Vitamin B Complex|vitamin b complex|mesh-ancestor
101438026|NCT04299880|Vitamins|vitamins|mesh-ancestor
101438027|NCT04299880|Micronutrients|micronutrients|mesh-ancestor
101438028|NCT00167492|Mycophenolic Acid|mycophenolic acid|mesh-list
101438029|NCT00167492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101438030|NCT00167492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101438031|NCT00167492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101438032|NCT00167492|Antitubercular Agents|antitubercular agents|mesh-ancestor
101559755|NCT05304039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559756|NCT05304039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101559757|NCT05304039|Respiratory System Agents|respiratory system agents|mesh-ancestor
101559758|NCT05304039|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101559759|NCT05304039|Antioxidants|antioxidants|mesh-ancestor
101559760|NCT05304039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559761|NCT05304039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101438033|NCT00167492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101438034|NCT00167492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101438035|NCT00167492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101438036|NCT00167492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438037|NCT04087096|Zoledronic Acid|zoledronic acid|mesh-list
101438038|NCT04087096|Denosumab|denosumab|mesh-list
101438039|NCT04087096|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101438040|NCT04087096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438041|NCT00177684|Amphotericin B|amphotericin b|mesh-list
101438042|NCT00177684|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101438043|NCT00177684|Amebicides|amebicides|mesh-ancestor
101438044|NCT00177684|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101438045|NCT00177684|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101438046|NCT00177684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101438059|NCT00195312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101438060|NCT00167609|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101438061|NCT00167609|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101438062|NCT00167609|Immunologic Factors|immunologic factors|mesh-ancestor
101438063|NCT00167609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438065|NCT03888079|Anesthetics, Local|anesthetics, local|mesh-list
101438066|NCT03888079|Anesthetics, General|anesthetics, general|mesh-list
101438067|NCT03888079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101438068|NCT03888079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438069|NCT03888079|Sensory System Agents|sensory system agents|mesh-ancestor
101438070|NCT03888079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101438071|NCT00167648|Leuprolide|leuprolide|mesh-list
101438072|NCT00167648|Goserelin|goserelin|mesh-list
101438074|NCT00167648|Estrogens|estrogens|mesh-ancestor
101438075|NCT00167648|Hormones|hormones|mesh-ancestor
101438076|NCT00167648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101438077|NCT00167648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438078|NCT00167648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101438079|NCT00167648|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101438080|NCT00167648|Fertility Agents|fertility agents|mesh-ancestor
101438081|NCT00167648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101438082|NCT00167648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101438083|NCT02906722|Colistin|colistin|mesh-list
101438084|NCT02906722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101307682|NCT02042495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307683|NCT02042573|Sertraline|sertraline|mesh-list
101307684|NCT02042573|Antidepressive Agents|antidepressive agents|mesh-ancestor
101307685|NCT02042573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101438092|NCT00167687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101438093|NCT00167687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438094|NCT00167687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438095|NCT02906995|Nicotine|nicotine|mesh-list
101438096|NCT02906995|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101438097|NCT02906995|Autonomic Agents|autonomic agents|mesh-ancestor
101438098|NCT02906995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101438099|NCT02906995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438100|NCT02906995|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101438101|NCT02906995|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101438102|NCT02906995|Cholinergic Agents|cholinergic agents|mesh-ancestor
101438103|NCT02906995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101438104|NCT02906995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438108|NCT02906800|Digoxin|digoxin|mesh-list
101438109|NCT02906800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101438110|NCT02906800|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101438111|NCT02906800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101559762|NCT05304039|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101559763|NCT05304039|Vasodilator Agents|vasodilator agents|mesh-ancestor
101559765|NCT05304039|Protective Agents|protective agents|mesh-ancestor
101559766|NCT01162473|Caseins|caseins|mesh-list
101559767|NCT01162473|Chelating Agents|chelating agents|mesh-ancestor
101559768|NCT01162473|Sequestering Agents|sequestering agents|mesh-ancestor
101628325|NCT00720109|Prednisolone|prednisolone|mesh-list
101438112|NCT02906800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438113|NCT02906800|Protective Agents|protective agents|mesh-ancestor
101438114|NCT02906800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438115|NCT00195468|Cyclosporine|cyclosporine|mesh-list
101438116|NCT00195468|Cyclosporins|cyclosporins|mesh-list
101438117|NCT00195468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101438118|NCT00195468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438119|NCT00195468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101438120|NCT00195468|Immunologic Factors|immunologic factors|mesh-ancestor
101438121|NCT00195468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438122|NCT00195468|Antifungal Agents|antifungal agents|mesh-ancestor
101438123|NCT00195468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101438124|NCT00195468|Dermatologic Agents|dermatologic agents|mesh-ancestor
101438125|NCT00195468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101438126|NCT00195468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101438127|NCT00167765|Abciximab|abciximab|mesh-list
101438128|NCT00167765|Anticoagulants|anticoagulants|mesh-ancestor
101438129|NCT00167765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101438130|NCT02906254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101438131|NCT02906254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101438132|NCT00167843|Pyrimethamine|pyrimethamine|mesh-list
101438133|NCT00167843|Sulfadoxine|sulfadoxine|mesh-list
101438134|NCT00167843|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101438135|NCT00167843|Antimalarials|antimalarials|mesh-ancestor
101438136|NCT00167843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101438137|NCT00167843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101438138|NCT00167843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101438139|NCT00167843|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101438140|NCT00167843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101438141|NCT00167843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438142|NCT00167843|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101438143|NCT02906059|Irinotecan|irinotecan|mesh-list
101438150|NCT02906176|Voriconazole|voriconazole|mesh-list
101438151|NCT02906176|Antifungal Agents|antifungal agents|mesh-ancestor
101307686|NCT02042573|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101307687|NCT02042573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101307688|NCT02042573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101307689|NCT02042573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438152|NCT02906176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101438153|NCT02906176|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101438154|NCT02906176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101438155|NCT02906176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101438156|NCT02906176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438157|NCT02906176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101438158|NCT02906176|Hormone Antagonists|hormone antagonists|mesh-ancestor
101438159|NCT02906176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101438160|NCT02906176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438161|NCT02906176|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101438162|NCT02905864|Liraglutide|liraglutide|mesh-list
101438163|NCT02905864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101438164|NCT02905864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438165|NCT02905864|Incretins|incretins|mesh-ancestor
101438166|NCT02905864|Hormones|hormones|mesh-ancestor
101438167|NCT02905864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101438168|NCT00167882|Mesalamine|mesalamine|mesh-list
101438169|NCT00167882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101438170|NCT00167882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101438171|NCT00167882|Analgesics|analgesics|mesh-ancestor
101559769|NCT01162473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559770|NCT01162239|Varenicline|varenicline|mesh-list
101559771|NCT01162239|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101559772|NCT01162239|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101559773|NCT01162239|Cholinergic Agents|cholinergic agents|mesh-ancestor
101559774|NCT01162239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101559775|NCT01162239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559776|NCT01162239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559777|NCT01161537|Ivacaftor|ivacaftor|mesh-list
101438172|NCT00167882|Sensory System Agents|sensory system agents|mesh-ancestor
101438173|NCT00167882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101438177|NCT02905708|Charcoal|charcoal|mesh-list
101438178|NCT02905708|Antidotes|antidotes|mesh-ancestor
101438179|NCT02905708|Protective Agents|protective agents|mesh-ancestor
101438180|NCT02905708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438181|NCT00167921|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101438182|NCT00167921|Estrogens|estrogens|mesh-ancestor
101438183|NCT00167921|Hormones|hormones|mesh-ancestor
101438184|NCT00167921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101438185|NCT00167921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438186|NCT00167960|Tazobactam|tazobactam|mesh-list
101438187|NCT00167960|Piperacillin|piperacillin|mesh-list
101438188|NCT00167960|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101438189|NCT00167960|Lactams|lactams|mesh-list
101438190|NCT00167960|beta-Lactams|beta-lactams|mesh-list
101438191|NCT00167960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101438192|NCT00167960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101438193|NCT00167960|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101438194|NCT00167960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101438195|NCT00167960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438196|NCT02905513|Contraceptive Agents|contraceptive agents|mesh-list
101438197|NCT02905513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101438198|NCT02905513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438199|NCT00167999|Tazobactam|tazobactam|mesh-list
101438200|NCT00167999|Piperacillin|piperacillin|mesh-list
101438201|NCT00167999|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101438202|NCT00167999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101438203|NCT00167999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101438204|NCT00167999|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101438205|NCT00167999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101438206|NCT00167999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438207|NCT00177996|Sertraline|sertraline|mesh-list
101438211|NCT00177996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101438212|NCT00177996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101438213|NCT00177996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438214|NCT00177996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101307690|NCT02042573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101307692|NCT02042573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307693|NCT02042599|Sevoflurane|sevoflurane|mesh-list
101307694|NCT02042599|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101307695|NCT02042599|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101307696|NCT02042599|Anesthetics, General|anesthetics, general|mesh-ancestor
101438215|NCT00177996|Serotonin Agents|serotonin agents|mesh-ancestor
101438216|NCT00177996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438217|NCT00168077|Thrombin|thrombin|mesh-list
101438218|NCT00168077|Hemostatics|hemostatics|mesh-ancestor
101438219|NCT00168077|Coagulants|coagulants|mesh-ancestor
101438220|NCT00195585|Leucovorin|leucovorin|mesh-list
101438221|NCT00195585|Levoleucovorin|levoleucovorin|mesh-list
101438222|NCT00195585|Antidotes|antidotes|mesh-ancestor
101438223|NCT00195585|Protective Agents|protective agents|mesh-ancestor
101438224|NCT00195585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438225|NCT00195585|Vitamin B Complex|vitamin b complex|mesh-ancestor
101438226|NCT00195585|Vitamins|vitamins|mesh-ancestor
101438227|NCT00195585|Micronutrients|micronutrients|mesh-ancestor
101438228|NCT02905045|Ketoprofen|ketoprofen|mesh-list
101438229|NCT02905045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101559778|NCT01161537|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101559779|NCT01161537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101559780|NCT01161537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559781|NCT04314297|Durvalumab|durvalumab|mesh-list
101559782|NCT04314297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101559783|NCT04314297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101559784|NCT04124133|Hyaluronic Acid|hyaluronic acid|mesh-list
101559785|NCT04124133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101559786|NCT04124133|Immunologic Factors|immunologic factors|mesh-ancestor
101559787|NCT04124133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521719|NCT04317235|Anesthetics|anesthetics|mesh-ancestor
101559788|NCT04124133|Viscosupplements|viscosupplements|mesh-ancestor
101559789|NCT04124133|Protective Agents|protective agents|mesh-ancestor
101559790|NCT01233258|Factor VIII|factor viii|mesh-list
101559791|NCT01233258|Coagulants|coagulants|mesh-ancestor
101438230|NCT02905045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101438231|NCT02905045|Analgesics|analgesics|mesh-ancestor
101438232|NCT02905045|Sensory System Agents|sensory system agents|mesh-ancestor
101438233|NCT02905045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101438234|NCT02905045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438235|NCT02905045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101438236|NCT02905045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101438237|NCT02905045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101438238|NCT02905045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101438239|NCT02905045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438240|NCT02904772|Cyclosporine|cyclosporine|mesh-list
101438241|NCT02904772|Mycophenolic Acid|mycophenolic acid|mesh-list
101438242|NCT02904772|Prednisolone|prednisolone|mesh-list
101438243|NCT02904772|Cyclosporins|cyclosporins|mesh-list
101438244|NCT02904772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101438245|NCT02904772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438246|NCT02904772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101438256|NCT02904772|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101438257|NCT02904772|Antitubercular Agents|antitubercular agents|mesh-ancestor
101438258|NCT02904772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101438259|NCT02904772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101438260|NCT02904772|Glucocorticoids|glucocorticoids|mesh-ancestor
101438261|NCT02904772|Hormones|hormones|mesh-ancestor
101438262|NCT02904772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101438263|NCT02904772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101438264|NCT00195741|Valproic Acid|valproic acid|mesh-list
101438265|NCT00195741|Anticonvulsants|anticonvulsants|mesh-ancestor
101438266|NCT00195741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101438267|NCT00195741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438268|NCT00195741|GABA Agents|gaba agents|mesh-ancestor
101438269|NCT00195741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101438270|NCT00195741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438271|NCT00195741|Antimanic Agents|antimanic agents|mesh-ancestor
101438272|NCT00195741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101438273|NCT00195741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101438274|NCT00195741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101438275|NCT00178035|Paroxetine|paroxetine|mesh-list
101438276|NCT00178035|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101438277|NCT00178035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101438278|NCT00178035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101438279|NCT00178035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438280|NCT00178035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101438281|NCT00178035|Serotonin Agents|serotonin agents|mesh-ancestor
101438282|NCT00178035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559792|NCT01232790|Acetylcysteine|acetylcysteine|mesh-list
101559793|NCT01232790|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101559794|NCT01232790|Antiviral Agents|antiviral agents|mesh-ancestor
101559795|NCT01232790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101559796|NCT01232790|Expectorants|expectorants|mesh-ancestor
101559797|NCT01232790|Respiratory System Agents|respiratory system agents|mesh-ancestor
101559798|NCT01232790|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101559799|NCT01232790|Antioxidants|antioxidants|mesh-ancestor
101559800|NCT01232790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559801|NCT01232790|Protective Agents|protective agents|mesh-ancestor
101559802|NCT01232790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559803|NCT01232790|Antidotes|antidotes|mesh-ancestor
101559804|NCT01232556|Rituximab|rituximab|mesh-list
101559805|NCT01232556|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
101559806|NCT01232556|Gemcitabine|gemcitabine|mesh-list
101559807|NCT01232556|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101559808|NCT01232556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101559809|NCT01232556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101559810|NCT01232556|Immunologic Factors|immunologic factors|mesh-ancestor
101438287|NCT00178035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101438288|NCT00178035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101438289|NCT02904538|Dexamethasone|dexamethasone|mesh-list
101438290|NCT02904538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101438291|NCT02904538|Antiemetics|antiemetics|mesh-ancestor
101438292|NCT02904538|Autonomic Agents|autonomic agents|mesh-ancestor
101438293|NCT02904538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101438294|NCT02904538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438295|NCT02904538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101438296|NCT02904538|Glucocorticoids|glucocorticoids|mesh-ancestor
101438297|NCT02904538|Hormones|hormones|mesh-ancestor
101438298|NCT02904538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101438299|NCT02904538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101438300|NCT02904538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101438301|NCT02963103|Tacrolimus|tacrolimus|mesh-list
101438302|NCT02963103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101438303|NCT02963103|Immunologic Factors|immunologic factors|mesh-ancestor
101438304|NCT02963103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438305|NCT02963103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101438306|NCT02963103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101438307|NCT02963103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438308|NCT00407264|Fluticasone|fluticasone|mesh-list
101438309|NCT00407264|Xhance|xhance|mesh-list
101438310|NCT00407264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101438311|NCT00407264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101438325|NCT02904499|Anticoagulants|anticoagulants|mesh-ancestor
101438326|NCT00195780|Valproic Acid|valproic acid|mesh-list
101438327|NCT00195780|Anticonvulsants|anticonvulsants|mesh-ancestor
101438328|NCT00195780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101438329|NCT00195780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438330|NCT00195780|GABA Agents|gaba agents|mesh-ancestor
101438331|NCT00195780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101438332|NCT00195780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438333|NCT00195780|Antimanic Agents|antimanic agents|mesh-ancestor
101438334|NCT00195780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101438335|NCT00195780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101438336|NCT00195780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101438338|NCT00407342|Dermatologic Agents|dermatologic agents|mesh-ancestor
101438339|NCT00407342|Immunologic Factors|immunologic factors|mesh-ancestor
101559811|NCT01232556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559812|NCT01232556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101559813|NCT01232556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101559814|NCT01232556|Antimetabolites|antimetabolites|mesh-ancestor
101559815|NCT01232556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559816|NCT01232556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101559817|NCT01232556|Alkylating Agents|alkylating agents|mesh-ancestor
101559818|NCT01232556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101559819|NCT01232556|Immunotoxins|immunotoxins|mesh-ancestor
101559820|NCT01232556|Immunoconjugates|immunoconjugates|mesh-ancestor
101559821|NCT00946153|Lenvatinib|lenvatinib|mesh-list
101559822|NCT00946153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101559823|NCT00946153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101408251|NCT00451711|Amphotericin B|amphotericin b|mesh-list
101438340|NCT00407342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438341|NCT00553423|Lactulose|lactulose|mesh-list
101438342|NCT00553423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101438343|NCT02904304|Ibuprofen|ibuprofen|mesh-list
101438344|NCT02904304|Phenylephrine|phenylephrine|mesh-list
101438345|NCT02904304|Oxymetazoline|oxymetazoline|mesh-list
101438346|NCT02904304|Desloratadine|desloratadine|mesh-list
101438347|NCT02904304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101438348|NCT02904304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101438349|NCT02904304|Analgesics|analgesics|mesh-ancestor
101438350|NCT02904304|Sensory System Agents|sensory system agents|mesh-ancestor
101438351|NCT02904304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101438352|NCT02904304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438353|NCT02904304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101438354|NCT02904304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101438355|NCT02904304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101438356|NCT02904304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101438357|NCT02904304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438358|NCT02904304|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101438359|NCT02904304|Mydriatics|mydriatics|mesh-ancestor
101438360|NCT02904304|Autonomic Agents|autonomic agents|mesh-ancestor
101438364|NCT02904304|Respiratory System Agents|respiratory system agents|mesh-ancestor
101438365|NCT02904304|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101438366|NCT02904304|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101438367|NCT02904304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101438368|NCT02904304|Adrenergic Agents|adrenergic agents|mesh-ancestor
101307701|NCT02042612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101307702|NCT02042612|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101307703|NCT02042612|Anesthetics, General|anesthetics, general|mesh-ancestor
101307704|NCT02042612|Anesthetics|anesthetics|mesh-ancestor
101307705|NCT02042612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101307706|NCT02042612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307707|NCT02042638|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101307708|NCT02042638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101307709|NCT02042638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438369|NCT02904304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101438370|NCT02904304|Protective Agents|protective agents|mesh-ancestor
101438371|NCT02904304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101438372|NCT02904304|Cholinergic Agents|cholinergic agents|mesh-ancestor
101438373|NCT02904304|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101438376|NCT02904304|Histamine Agents|histamine agents|mesh-ancestor
101438377|NCT00407459|Bevacizumab|bevacizumab|mesh-list
101438378|NCT00407459|Carboplatin|carboplatin|mesh-list
101438380|NCT00407459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101438381|NCT00407459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101438382|NCT00407459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101559825|NCT00946153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559826|NCT01914367|Vaccines|vaccines|mesh-list
101559827|NCT01914367|Immunologic Factors|immunologic factors|mesh-ancestor
101559828|NCT01914367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559829|NCT01160289|Tadalafil|tadalafil|mesh-list
101559830|NCT01160289|Vasodilator Agents|vasodilator agents|mesh-ancestor
101559831|NCT01160289|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101559832|NCT01160289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101559833|NCT01160289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101438383|NCT00407459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101438384|NCT00407459|Growth Substances|growth substances|mesh-ancestor
101438385|NCT00407459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438386|NCT00407459|Growth Inhibitors|growth inhibitors|mesh-ancestor
101438387|NCT00407459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101438388|NCT00407459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438389|NCT00407459|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101438390|NCT00407459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101438391|NCT02904031|Leucovorin|leucovorin|mesh-list
101438392|NCT02904031|Fluorouracil|fluorouracil|mesh-list
101438393|NCT02904031|Oxaliplatin|oxaliplatin|mesh-list
101438394|NCT02904031|Panitumumab|panitumumab|mesh-list
101438395|NCT02904031|Levoleucovorin|levoleucovorin|mesh-list
101438396|NCT02904031|Antimetabolites|antimetabolites|mesh-ancestor
101438397|NCT02904031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438398|NCT02904031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101438399|NCT02904031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101438400|NCT02904031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101438401|NCT02904031|Immunologic Factors|immunologic factors|mesh-ancestor
101438402|NCT02904031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438403|NCT02904031|Antidotes|antidotes|mesh-ancestor
101438404|NCT02904031|Protective Agents|protective agents|mesh-ancestor
101438405|NCT02904031|Vitamin B Complex|vitamin b complex|mesh-ancestor
101438406|NCT02904031|Vitamins|vitamins|mesh-ancestor
101438407|NCT02904031|Micronutrients|micronutrients|mesh-ancestor
101438408|NCT02904031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101438409|NCT02904109|Mannitol|mannitol|mesh-list
101438410|NCT02904109|Triflusal|triflusal|mesh-list
101438411|NCT02904109|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101438412|NCT02904109|Diuretics|diuretics|mesh-ancestor
101438413|NCT02904109|Natriuretic Agents|natriuretic agents|mesh-ancestor
101438414|NCT02904109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438415|NCT02904109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101438416|NCT00178113|Lycopene|lycopene|mesh-list
101438417|NCT00178113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101438418|NCT00178113|Antioxidants|antioxidants|mesh-ancestor
101438419|NCT00178113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438420|NCT00178113|Protective Agents|protective agents|mesh-ancestor
101438421|NCT00178113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438422|NCT00178113|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101438423|NCT00178113|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101438424|NCT00178113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101438425|NCT02903524|Cyclophosphamide|cyclophosphamide|mesh-list
101438426|NCT02903524|Doxorubicin|doxorubicin|mesh-list
101438427|NCT02903524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101438433|NCT02903524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101438434|NCT02903524|Alkylating Agents|alkylating agents|mesh-ancestor
101438435|NCT02903524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438436|NCT02903524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101438437|NCT02903524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101438438|NCT02903524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101438439|NCT02903524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101438440|NCT02903524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101438441|NCT02903524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101438443|NCT00168350|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101438444|NCT00168350|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101559834|NCT01160289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559835|NCT01160289|Urological Agents|urological agents|mesh-ancestor
101559836|NCT01159665|Plasminogen|plasminogen|mesh-list
101559837|NCT01159665|Fibrinolysin|fibrinolysin|mesh-list
101559838|NCT01159665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101559839|NCT01159665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101559840|NCT01159665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408274|NCT00451750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101438445|NCT00168350|Dopamine Agents|dopamine agents|mesh-ancestor
101438446|NCT00168350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101438447|NCT00168350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438448|NCT00168350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438459|NCT05995912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101438460|NCT05995912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438461|NCT05995912|Analgesics|analgesics|mesh-ancestor
101438462|NCT05995912|Sensory System Agents|sensory system agents|mesh-ancestor
101438463|NCT05995912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101438464|NCT05995912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101438465|NCT05995912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101438466|NCT05995912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101438467|NCT05995912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101438468|NCT05995912|Gout Suppressants|gout suppressants|mesh-ancestor
101438469|NCT05995912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101438470|NCT05995912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101438471|NCT05995912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438472|NCT05995912|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101438473|NCT05995704|Acetaminophen|acetaminophen|mesh-list
101438474|NCT05995704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101438475|NCT05995704|Analgesics|analgesics|mesh-ancestor
101438476|NCT05995704|Sensory System Agents|sensory system agents|mesh-ancestor
101438477|NCT05995704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101469678|NCT00274521|Autonomic Agents|autonomic agents|mesh-ancestor
101438478|NCT05995704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438479|NCT05995704|Antipyretics|antipyretics|mesh-ancestor
101438481|NCT05995691|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101438482|NCT05995691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101438483|NCT05995691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101438484|NCT05995522|Vitamin K|vitamin k|mesh-list
101438485|NCT05995522|Vitamin K 2|vitamin k 2|mesh-list
101438486|NCT05995522|Vitamins|vitamins|mesh-ancestor
101438487|NCT05995522|Micronutrients|micronutrients|mesh-ancestor
101438488|NCT05995522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438489|NCT05995522|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101438490|NCT05995522|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101438491|NCT05995522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438492|NCT05995522|Hemostatics|hemostatics|mesh-ancestor
101438493|NCT05995522|Coagulants|coagulants|mesh-ancestor
101438494|NCT05995405|Nimodipine|nimodipine|mesh-list
101438495|NCT05995405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101438496|NCT05995405|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101438497|NCT05995405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101438498|NCT05995405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438499|NCT05995405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101438500|NCT05995405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438501|NCT05995405|Vasodilator Agents|vasodilator agents|mesh-ancestor
101438502|NCT05995353|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101307714|NCT02042690|Cyclophosphamide|cyclophosphamide|mesh-list
101307715|NCT02042690|Methotrexate|methotrexate|mesh-list
101307716|NCT02042690|Epirubicin|epirubicin|mesh-list
101307717|NCT02042690|Mercaptopurine|mercaptopurine|mesh-list
101438517|NCT05995249|Erythromycin stearate|erythromycin stearate|mesh-list
101438518|NCT05995249|Phenytoin|phenytoin|mesh-list
101438519|NCT05995249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101438520|NCT05995249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101438521|NCT05995249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101438522|NCT05995249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438524|NCT05995249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101559841|NCT01158261|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101559842|NCT01158261|Hemostatics|hemostatics|mesh-ancestor
101559843|NCT01158261|Coagulants|coagulants|mesh-ancestor
101559844|NCT01157169|Buprenorphine|buprenorphine|mesh-list
101559845|NCT01157169|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101559846|NCT01157169|Narcotics|narcotics|mesh-ancestor
101559847|NCT01157169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101559848|NCT01157169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559849|NCT01157169|Analgesics|analgesics|mesh-ancestor
101438525|NCT05995249|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101438526|NCT05995249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101438527|NCT05995249|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101438528|NCT05995249|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101438529|NCT05995249|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101438530|NCT05995249|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101438531|NCT05995249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101438532|NCT05995249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101438533|NCT05995249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101438535|NCT05995249|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101438536|NCT05995249|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101438537|NCT05995249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101438538|NCT05995249|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101438539|NCT05995054|Obinutuzumab|obinutuzumab|mesh-list
101438540|NCT05995054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101438541|NCT05995054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101438542|NCT05994807|Itraconazole|itraconazole|mesh-list
101438543|NCT05994807|Carbamazepine|carbamazepine|mesh-list
101438544|NCT05994807|Antifungal Agents|antifungal agents|mesh-ancestor
101438545|NCT05994807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101438546|NCT05994807|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101438547|NCT05994807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101438548|NCT05994807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101438549|NCT05994807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438550|NCT05994807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101438551|NCT05994807|Hormone Antagonists|hormone antagonists|mesh-ancestor
101438552|NCT05994807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101438553|NCT05994807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438554|NCT05994807|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101438555|NCT05994807|Anticonvulsants|anticonvulsants|mesh-ancestor
101438556|NCT05994807|Antimanic Agents|antimanic agents|mesh-ancestor
101438557|NCT05994807|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101438558|NCT05994807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101438559|NCT05994807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101438560|NCT05994807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101438561|NCT05994807|Analgesics|analgesics|mesh-ancestor
101438562|NCT05994807|Sensory System Agents|sensory system agents|mesh-ancestor
101438563|NCT05994807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101438564|NCT05994807|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101438565|NCT05994807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101438566|NCT05994807|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101438567|NCT05994807|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101438568|NCT05994768|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101438569|NCT05994768|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101438570|NCT05994768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438571|NCT05994742|Pyridoxine|pyridoxine|mesh-list
101438572|NCT05994742|Vitamin B 6|vitamin b 6|mesh-list
101438573|NCT05994742|Azithromycin|azithromycin|mesh-list
101438574|NCT05994742|Rifampin|rifampin|mesh-list
101438603|NCT05994703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101438604|NCT05994703|Antimetabolites|antimetabolites|mesh-ancestor
101438605|NCT05994703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438607|NCT05994599|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101438608|NCT05994599|Contraceptive Agents|contraceptive agents|mesh-ancestor
101438609|NCT05994599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101559850|NCT01157169|Sensory System Agents|sensory system agents|mesh-ancestor
101559851|NCT01157169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101559852|NCT01157169|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101559853|NCT04313907|Clonazepam|clonazepam|mesh-list
101559854|NCT04313907|Anticonvulsants|anticonvulsants|mesh-ancestor
101559855|NCT04313907|GABA Modulators|gaba modulators|mesh-ancestor
101559856|NCT04313907|GABA Agents|gaba agents|mesh-ancestor
101559857|NCT04313907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101438610|NCT05994599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438611|NCT05994547|Midazolam|midazolam|mesh-list
101438612|NCT05994547|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101438613|NCT05994547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101438614|NCT05994547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101438615|NCT05994547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438616|NCT05994547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101438617|NCT05994547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101438618|NCT05994547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101438619|NCT05994547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101438620|NCT05994547|Anesthetics, General|anesthetics, general|mesh-ancestor
101438621|NCT05994547|Anesthetics|anesthetics|mesh-ancestor
101438622|NCT05994547|GABA Modulators|gaba modulators|mesh-ancestor
101438631|NCT05994378|Hormone Antagonists|hormone antagonists|mesh-ancestor
101438632|NCT05994378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101438633|NCT05994378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438634|NCT05994287|Aspirin|aspirin|mesh-list
101438635|NCT05994287|Celecoxib|celecoxib|mesh-list
101438636|NCT05994287|Ketorolac|ketorolac|mesh-list
101438637|NCT05994287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101438638|NCT05994287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101438639|NCT05994287|Analgesics|analgesics|mesh-ancestor
101438640|NCT05994287|Sensory System Agents|sensory system agents|mesh-ancestor
101438641|NCT05994287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101438642|NCT05994287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438643|NCT05994287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101438644|NCT05994287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101438645|NCT05994287|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101438646|NCT05994287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101438647|NCT05994287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438648|NCT05994287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101438649|NCT05994287|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101438650|NCT05994287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101307722|NCT02042690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101307723|NCT02042690|Alkylating Agents|alkylating agents|mesh-ancestor
101307724|NCT02042690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307725|NCT02042690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101307726|NCT02042690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101307727|NCT02042690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101307728|NCT02042690|Antiemetics|antiemetics|mesh-ancestor
101307729|NCT02042690|Autonomic Agents|autonomic agents|mesh-ancestor
101307730|NCT02042690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101307731|NCT02042690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101438651|NCT05994287|Antipyretics|antipyretics|mesh-ancestor
101438652|NCT05994287|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101438653|NCT05994183|Dexamethasone|dexamethasone|mesh-list
101438654|NCT05994183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101438655|NCT05994183|Antiemetics|antiemetics|mesh-ancestor
101438656|NCT05994183|Autonomic Agents|autonomic agents|mesh-ancestor
101438657|NCT05994183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101438658|NCT05994183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438659|NCT05994183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101438660|NCT05994183|Glucocorticoids|glucocorticoids|mesh-ancestor
101438661|NCT05994183|Hormones|hormones|mesh-ancestor
101438665|NCT05994131|Aflutinib|aflutinib|mesh-list
101438666|NCT05994131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101438667|NCT05994131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101438668|NCT05994131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438669|NCT05994001|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101438670|NCT05994001|Immunologic Factors|immunologic factors|mesh-ancestor
101559858|NCT04313907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559859|NCT04313907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559861|NCT01231620|Zanamivir|zanamivir|mesh-list
101559862|NCT01231620|Antiviral Agents|antiviral agents|mesh-ancestor
101559863|NCT01231620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101559864|NCT01231620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101408295|NCT00143091|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101438671|NCT05994001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438673|NCT05993975|Bupivacaine|bupivacaine|mesh-list
101438674|NCT05993975|Anesthetics, Local|anesthetics, local|mesh-ancestor
101438675|NCT05993975|Anesthetics|anesthetics|mesh-ancestor
101438676|NCT05993975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101438677|NCT05993975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438678|NCT05993975|Sensory System Agents|sensory system agents|mesh-ancestor
101438679|NCT05993975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101438680|NCT05993975|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101438681|NCT05993975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101438687|NCT05993975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101438688|NCT05993975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438689|NCT05987332|Pembrolizumab|pembrolizumab|mesh-list
101438690|NCT05987332|Nivolumab|nivolumab|mesh-list
101438691|NCT05987332|Ipilimumab|ipilimumab|mesh-list
101438692|NCT05987332|Dacarbazine|dacarbazine|mesh-list
101438693|NCT05987332|Crizotinib|crizotinib|mesh-list
101438694|NCT05987332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101438695|NCT05987332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101438696|NCT05987332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101438697|NCT05987332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438698|NCT05987332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101438699|NCT05987332|Alkylating Agents|alkylating agents|mesh-ancestor
101438700|NCT05987332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101438701|NCT05987332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101438702|NCT05983224|Quercetin|quercetin|mesh-list
101438703|NCT05983224|Antioxidants|antioxidants|mesh-ancestor
101438704|NCT05983224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438705|NCT05983224|Protective Agents|protective agents|mesh-ancestor
101438706|NCT05983224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438707|NCT05926960|Pembrolizumab|pembrolizumab|mesh-list
101307732|NCT02042690|Glucocorticoids|glucocorticoids|mesh-ancestor
101307733|NCT02042690|Hormones|hormones|mesh-ancestor
101307734|NCT02042690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101438708|NCT05926960|Nivolumab|nivolumab|mesh-list
101438709|NCT05926960|Ipilimumab|ipilimumab|mesh-list
101438710|NCT05926960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101438711|NCT05926960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101438712|NCT05926960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101438713|NCT05926960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438714|NCT05910801|Lenalidomide|lenalidomide|mesh-list
101438715|NCT05910801|Venetoclax|venetoclax|mesh-list
101438716|NCT05910801|Immunoglobulins|immunoglobulins|mesh-list
101438717|NCT05910801|Immunologic Factors|immunologic factors|mesh-ancestor
101438718|NCT05910801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438719|NCT05910801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101438720|NCT05910801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101438721|NCT05910801|Growth Substances|growth substances|mesh-ancestor
101438722|NCT05910801|Growth Inhibitors|growth inhibitors|mesh-ancestor
101438723|NCT05910801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101438724|NCT05909397|Letrozole|letrozole|mesh-list
101438725|NCT05909397|Palbociclib|palbociclib|mesh-list
101438726|NCT05909397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101438727|NCT05909397|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101469727|NCT00245609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101438728|NCT05909397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101438729|NCT05909397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101438730|NCT05909397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438731|NCT05909397|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101438732|NCT05909397|Hormone Antagonists|hormone antagonists|mesh-ancestor
101559865|NCT01231620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559867|NCT01231464|Xhance|xhance|mesh-list
101559868|NCT01231464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101559869|NCT01231464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101559870|NCT01231464|Autonomic Agents|autonomic agents|mesh-ancestor
101559871|NCT01231464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101559872|NCT01231464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559873|NCT01231464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101408301|NCT00143091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408302|NCT00451984|Interleukin-2|interleukin-2|mesh-list
101408303|NCT00451984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101408304|NCT00451984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101408305|NCT00451984|Analgesics|analgesics|mesh-ancestor
101408306|NCT00451984|Sensory System Agents|sensory system agents|mesh-ancestor
101408307|NCT00451984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101408308|NCT00451984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438733|NCT05909397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101438738|NCT05908734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101438740|NCT05904496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101438741|NCT05904496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101438742|NCT05884398|Androgens|androgens|mesh-list
101438743|NCT05884398|Hormones|hormones|mesh-ancestor
101438744|NCT05884398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101438745|NCT05884398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438746|NCT05880459|Magnesium Sulfate|magnesium sulfate|mesh-list
101438748|NCT05880459|Propofol|propofol|mesh-list
101438749|NCT05880459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101438750|NCT05880459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101438751|NCT05880459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438752|NCT05880459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101438753|NCT05880459|Anesthetics, General|anesthetics, general|mesh-ancestor
101438754|NCT05880459|Anesthetics|anesthetics|mesh-ancestor
101438755|NCT05880459|Analgesics|analgesics|mesh-ancestor
101438761|NCT05880459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101438762|NCT05880459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438763|NCT05880459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101438765|NCT05880459|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101438766|NCT05880459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101438767|NCT05880459|Narcotics|narcotics|mesh-ancestor
101438768|NCT05866315|Remifentanil|remifentanil|mesh-list
101438769|NCT05866315|Desflurane|desflurane|mesh-list
101438770|NCT05866315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101438771|NCT05866315|Narcotics|narcotics|mesh-ancestor
101438772|NCT05866315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101438773|NCT05866315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438774|NCT05866315|Analgesics|analgesics|mesh-ancestor
101438775|NCT05866315|Sensory System Agents|sensory system agents|mesh-ancestor
101438776|NCT05866315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101438777|NCT05866315|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101438778|NCT05866315|Anesthetics, General|anesthetics, general|mesh-ancestor
101438779|NCT05866315|Anesthetics|anesthetics|mesh-ancestor
101438780|NCT05864417|Sunscreening Agents|sunscreening agents|mesh-list
101438781|NCT05864417|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101438782|NCT05864417|Protective Agents|protective agents|mesh-ancestor
101307735|NCT02042690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101559875|NCT01231464|Dermatologic Agents|dermatologic agents|mesh-ancestor
101559876|NCT01231464|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101559877|NCT01156311|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101559878|NCT01156311|Dermatologic Agents|dermatologic agents|mesh-ancestor
101559879|NCT01156311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101559880|NCT01156311|Immunologic Factors|immunologic factors|mesh-ancestor
101559881|NCT01156311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307736|NCT02042690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101333870|NCT00017394|Immunologic Factors|immunologic factors|mesh-ancestor
101438783|NCT05864417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438784|NCT05864417|Dermatologic Agents|dermatologic agents|mesh-ancestor
101438785|NCT05856331|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
101438786|NCT05856331|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101438787|NCT05856331|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101438788|NCT05856331|Protease Inhibitors|protease inhibitors|mesh-ancestor
101438789|NCT05856331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101438790|NCT05856331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438791|NCT05856136|Fentanyl|fentanyl|mesh-list
101438792|NCT05856136|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101438793|NCT05856136|Narcotics|narcotics|mesh-ancestor
101438794|NCT05856136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101438795|NCT05856136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438796|NCT05856136|Analgesics|analgesics|mesh-ancestor
101438797|NCT05856136|Sensory System Agents|sensory system agents|mesh-ancestor
101438798|NCT05856136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101438799|NCT05856136|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101438800|NCT05856136|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101438801|NCT05856136|Anesthetics, General|anesthetics, general|mesh-ancestor
101438802|NCT05856136|Anesthetics|anesthetics|mesh-ancestor
101438803|NCT05850520|Aflibercept|aflibercept|mesh-list
101438804|NCT05850520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101438805|NCT05850520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101438811|NCT05845008|Naproxen|naproxen|mesh-list
101438812|NCT05845008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101438813|NCT05845008|Analgesics|analgesics|mesh-ancestor
101438814|NCT05845008|Sensory System Agents|sensory system agents|mesh-ancestor
101438815|NCT05845008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101438816|NCT05845008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438817|NCT05845008|Antipyretics|antipyretics|mesh-ancestor
101438818|NCT05845008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101438819|NCT05845008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101438820|NCT05845008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101438821|NCT05845008|Gout Suppressants|gout suppressants|mesh-ancestor
101438822|NCT05845008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101438823|NCT05845008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101438824|NCT05845008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438825|NCT05844995|Acetaminophen|acetaminophen|mesh-list
101438826|NCT05844995|Naproxen|naproxen|mesh-list
101438827|NCT05844995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101438833|NCT05844995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101438834|NCT05844995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101438835|NCT05844995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101438836|NCT05844995|Gout Suppressants|gout suppressants|mesh-ancestor
101438837|NCT05844995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101438838|NCT05844995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101438839|NCT05844995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438840|NCT05840211|Paclitaxel|paclitaxel|mesh-list
101438841|NCT05840211|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101438842|NCT05840211|Capecitabine|capecitabine|mesh-list
101438843|NCT05840211|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
101438844|NCT05840211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101438845|NCT05840211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101438846|NCT05840211|Tubulin Modulators|tubulin modulators|mesh-ancestor
101438847|NCT05840211|Antimitotic Agents|antimitotic agents|mesh-ancestor
101438848|NCT05840211|Mitosis Modulators|mitosis modulators|mesh-ancestor
101438849|NCT05840211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559882|NCT04281745|Botulinum Toxins|botulinum toxins|mesh-list
101559883|NCT04281745|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101559884|NCT04281745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101559885|NCT04281745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101559886|NCT04281745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101559887|NCT04281745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559888|NCT04281745|Cholinergic Agents|cholinergic agents|mesh-ancestor
101559889|NCT04281745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101559890|NCT04281745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559891|NCT04281745|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101559892|NCT04281745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101559893|NCT01155531|Sertraline|sertraline|mesh-list
101559894|NCT01155531|Telenzepine|telenzepine|mesh-list
101559895|NCT01155531|Antidepressive Agents|antidepressive agents|mesh-ancestor
101559896|NCT01155531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101559897|NCT01155531|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101408316|NCT00452062|Glucocorticoids|glucocorticoids|mesh-ancestor
101438850|NCT05840211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101438851|NCT05840211|Antimetabolites|antimetabolites|mesh-ancestor
101438852|NCT05840211|Immunoconjugates|immunoconjugates|mesh-ancestor
101438853|NCT05840211|Immunologic Factors|immunologic factors|mesh-ancestor
101438854|NCT05840211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438855|NCT05827874|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101438856|NCT05827874|Immunologic Factors|immunologic factors|mesh-ancestor
101307737|NCT02042690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101307738|NCT02042690|Abortifacient Agents|abortifacient agents|mesh-ancestor
101307739|NCT02042690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101307740|NCT02042690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101438857|NCT05827874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438858|NCT05819853|Metformin|metformin|mesh-list
101438859|NCT05819853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101438860|NCT05819853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438861|NCT05813288|Pramipexole|pramipexole|mesh-list
101438862|NCT05813288|Antioxidants|antioxidants|mesh-ancestor
101438863|NCT05813288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438864|NCT05813288|Protective Agents|protective agents|mesh-ancestor
101438865|NCT05813288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438866|NCT05813288|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101438867|NCT05813288|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101438868|NCT05813288|Dopamine Agonists|dopamine agonists|mesh-ancestor
101438869|NCT05813288|Dopamine Agents|dopamine agents|mesh-ancestor
101438870|NCT05813288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101438871|NCT05812300|Hyaluronic Acid|hyaluronic acid|mesh-list
101438872|NCT05812300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101438873|NCT05812300|Immunologic Factors|immunologic factors|mesh-ancestor
101438874|NCT05812300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438875|NCT05812300|Viscosupplements|viscosupplements|mesh-ancestor
101438879|NCT05811351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101438881|NCT05811351|Hormones|hormones|mesh-ancestor
101438882|NCT05811351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101438883|NCT05811351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438884|NCT05811351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101438885|NCT05811351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101438886|NCT05788016|Analgesics, Opioid|analgesics, opioid|mesh-list
101438887|NCT05788016|Narcotics|narcotics|mesh-ancestor
101438888|NCT05788016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101438889|NCT05788016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559898|NCT01155531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101559899|NCT01155531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101559900|NCT01155531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559901|NCT01155531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101438890|NCT05788016|Analgesics|analgesics|mesh-ancestor
101438891|NCT05788016|Sensory System Agents|sensory system agents|mesh-ancestor
101438892|NCT05788016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101438893|NCT05785767|Cemiplimab|cemiplimab|mesh-list
101438894|NCT05785767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101438895|NCT05785767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101438896|NCT05763121|Pramipexole|pramipexole|mesh-list
101438897|NCT05763121|Antioxidants|antioxidants|mesh-ancestor
101438905|NCT05763121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101438906|NCT05761574|Acetaminophen|acetaminophen|mesh-list
101438907|NCT05761574|Naproxen|naproxen|mesh-list
101438908|NCT05761574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101438909|NCT05761574|Analgesics|analgesics|mesh-ancestor
101438910|NCT05761574|Sensory System Agents|sensory system agents|mesh-ancestor
101438911|NCT05761574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101438912|NCT05761574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438913|NCT05761574|Antipyretics|antipyretics|mesh-ancestor
101438914|NCT05761574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101438915|NCT05761574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101438916|NCT05761574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101438917|NCT05761574|Gout Suppressants|gout suppressants|mesh-ancestor
101438918|NCT05761574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101438919|NCT05761574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101438920|NCT05761574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438921|NCT05757869|Apixaban|apixaban|mesh-list
101438922|NCT05757869|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101438923|NCT05757869|Antithrombins|antithrombins|mesh-ancestor
101438924|NCT05757869|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101438925|NCT05757869|Protease Inhibitors|protease inhibitors|mesh-ancestor
101438926|NCT05757869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101438927|NCT05757869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307741|NCT02042690|Antimetabolites|antimetabolites|mesh-ancestor
101307742|NCT02042690|Dermatologic Agents|dermatologic agents|mesh-ancestor
101307743|NCT02042690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101307744|NCT02042690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101438928|NCT05757869|Anticoagulants|anticoagulants|mesh-ancestor
101438929|NCT05755048|Trastuzumab|trastuzumab|mesh-list
101438930|NCT05755048|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101438931|NCT05755048|Maytansine|maytansine|mesh-list
101438932|NCT05755048|Antibodies|antibodies|mesh-list
101438933|NCT05755048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101438934|NCT05755048|Immunologic Factors|immunologic factors|mesh-ancestor
101438935|NCT05755048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438936|NCT05755048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101438937|NCT05755048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101438938|NCT05755048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101438939|NCT05755048|Tubulin Modulators|tubulin modulators|mesh-ancestor
101438940|NCT05755048|Antimitotic Agents|antimitotic agents|mesh-ancestor
101438941|NCT05755048|Mitosis Modulators|mitosis modulators|mesh-ancestor
101438942|NCT05755048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438943|NCT05755048|Immunotoxins|immunotoxins|mesh-ancestor
101438944|NCT05755048|Immunoconjugates|immunoconjugates|mesh-ancestor
101438945|NCT05750199|Immunomodulating Agents|immunomodulating agents|mesh-list
101438946|NCT05750199|Immunologic Factors|immunologic factors|mesh-ancestor
101438947|NCT05750199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438948|NCT05748600|Pramipexole|pramipexole|mesh-list
101438949|NCT05748600|Antioxidants|antioxidants|mesh-ancestor
101438955|NCT05748600|Dopamine Agonists|dopamine agonists|mesh-ancestor
101438956|NCT05748600|Dopamine Agents|dopamine agents|mesh-ancestor
101438957|NCT05748600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101438958|NCT05731492|Macitentan|macitentan|mesh-list
101438959|NCT05731492|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101438960|NCT05731492|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101438961|NCT05731492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438962|NCT05731492|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
101438963|NCT05712941|Letrozole|letrozole|mesh-list
101438964|NCT05712941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101559902|NCT01155531|Serotonin Agents|serotonin agents|mesh-ancestor
101559903|NCT01155531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559904|NCT01155531|Parasympatholytics|parasympatholytics|mesh-ancestor
101559905|NCT01155531|Autonomic Agents|autonomic agents|mesh-ancestor
101559906|NCT01155531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101559907|NCT01155219|Latanoprost|latanoprost|mesh-list
101559908|NCT01155219|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101559909|NCT01155219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101559910|NCT01098955|Varenicline|varenicline|mesh-list
101559911|NCT01098955|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101559912|NCT01098955|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101559913|NCT01098955|Cholinergic Agents|cholinergic agents|mesh-ancestor
101559914|NCT01098955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101559915|NCT01098955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559916|NCT01098955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559917|NCT00631033|Metformin|metformin|mesh-list
101559918|NCT00631033|Diazoxide|diazoxide|mesh-list
101438965|NCT05712941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101438966|NCT05712941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101438967|NCT05712941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101438971|NCT05712941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101438972|NCT05712941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438986|NCT05706779|Cetuximab|cetuximab|mesh-list
101438987|NCT05706779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101438988|NCT05706779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101438989|NCT05686356|Acetylcysteine|acetylcysteine|mesh-list
101438990|NCT05686356|Bedaquiline|bedaquiline|mesh-list
101438991|NCT05686356|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101438992|NCT05686356|Antiviral Agents|antiviral agents|mesh-ancestor
101438993|NCT05686356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101438994|NCT05686356|Expectorants|expectorants|mesh-ancestor
101438995|NCT05686356|Respiratory System Agents|respiratory system agents|mesh-ancestor
101438996|NCT05686356|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101438997|NCT05686356|Antioxidants|antioxidants|mesh-ancestor
101438998|NCT05686356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438999|NCT05686356|Protective Agents|protective agents|mesh-ancestor
101439000|NCT05686356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307745|NCT02042690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101307746|NCT02042690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101307747|NCT02042690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101307748|NCT02042742|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
101439001|NCT05686356|Antidotes|antidotes|mesh-ancestor
101439002|NCT05686356|Antitubercular Agents|antitubercular agents|mesh-ancestor
101439003|NCT05686356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101439004|NCT05676112|Pirfenidone|pirfenidone|mesh-list
101439005|NCT05676112|Nintedanib|nintedanib|mesh-list
101439006|NCT05676112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439007|NCT05676112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101439008|NCT05676112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101439009|NCT05676112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439010|NCT05676112|Analgesics|analgesics|mesh-ancestor
101439011|NCT05676112|Sensory System Agents|sensory system agents|mesh-ancestor
101439012|NCT05676112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101439013|NCT05676112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439014|NCT05676112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101439015|NCT05676112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101439016|NCT05676112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101439017|NCT05676112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101439018|NCT05668091|Ritonavir|ritonavir|mesh-list
101559919|NCT00631033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101559920|NCT00631033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559921|NCT00631033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101559922|NCT00631033|Vasodilator Agents|vasodilator agents|mesh-ancestor
101559923|NCT01155063|Exemestane|exemestane|mesh-list
101559924|NCT01155063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101559925|NCT01155063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101439036|NCT05663866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101439037|NCT05663866|Antiemetics|antiemetics|mesh-ancestor
101439038|NCT05663866|Autonomic Agents|autonomic agents|mesh-ancestor
101439039|NCT05663866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101439040|NCT05663866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439041|NCT05663866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101439042|NCT05663866|Glucocorticoids|glucocorticoids|mesh-ancestor
101439043|NCT05663866|Hormones|hormones|mesh-ancestor
101439044|NCT05663866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101439045|NCT05663866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101439046|NCT05663866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439047|NCT05663866|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101439048|NCT05663866|Abortifacient Agents|abortifacient agents|mesh-ancestor
101439049|NCT05663866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101439050|NCT05663866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101439051|NCT05663866|Antimetabolites|antimetabolites|mesh-ancestor
101439052|NCT05663866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439053|NCT05663866|Dermatologic Agents|dermatologic agents|mesh-ancestor
101439054|NCT05663866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101439055|NCT05663866|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101439056|NCT05663866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101439057|NCT05663866|Immunologic Factors|immunologic factors|mesh-ancestor
101439058|NCT05663866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101439059|NCT05663866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101439060|NCT05663866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101439061|NCT05663866|Respiratory System Agents|respiratory system agents|mesh-ancestor
101439062|NCT05663866|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101439063|NCT05663866|Hormone Antagonists|hormone antagonists|mesh-ancestor
101439064|NCT05663866|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101439093|NCT05642026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101439094|NCT05642026|Analgesics|analgesics|mesh-ancestor
101439095|NCT05642026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101439096|NCT05642026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101439097|NCT05622201|Rituximab|rituximab|mesh-list
101307749|NCT02042742|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
101439098|NCT05622201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101439099|NCT05622201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439100|NCT05622201|Immunologic Factors|immunologic factors|mesh-ancestor
101439101|NCT05622201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439102|NCT05622201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101439103|NCT05603754|Lorecivivint|lorecivivint|mesh-list
101439104|NCT05603754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101439105|NCT05583708|Pembrolizumab|pembrolizumab|mesh-list
101439106|NCT05583708|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
101439107|NCT05583708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101439108|NCT05583708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439109|NCT05583708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101439110|NCT05583708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439111|NCT05583708|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101439112|NCT05575063|Hyaluronic Acid|hyaluronic acid|mesh-list
101439113|NCT05575063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101439114|NCT05575063|Immunologic Factors|immunologic factors|mesh-ancestor
101439115|NCT05575063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439116|NCT05575063|Viscosupplements|viscosupplements|mesh-ancestor
101439117|NCT05575063|Protective Agents|protective agents|mesh-ancestor
101439118|NCT05572515|Dexamethasone|dexamethasone|mesh-list
101439119|NCT05572515|Bortezomib|bortezomib|mesh-list
101439120|NCT05572515|Pomalidomide|pomalidomide|mesh-list
101439121|NCT05572515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101439122|NCT05572515|Antiemetics|antiemetics|mesh-ancestor
101439123|NCT05572515|Autonomic Agents|autonomic agents|mesh-ancestor
101559926|NCT01155063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101559927|NCT01155063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101559928|NCT01155063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559929|NCT01155063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101559930|NCT01155063|Hormone Antagonists|hormone antagonists|mesh-ancestor
101559931|NCT01155063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101628326|NCT00720109|Prednisolone acetate|prednisolone acetate|mesh-list
101439124|NCT05572515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101439125|NCT05572515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439126|NCT05572515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101439129|NCT05572515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101439130|NCT05572515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101439131|NCT05572515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439132|NCT05572515|Immunologic Factors|immunologic factors|mesh-ancestor
101439133|NCT05572515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101439134|NCT05572515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101439135|NCT05572515|Growth Substances|growth substances|mesh-ancestor
101439136|NCT05572515|Growth Inhibitors|growth inhibitors|mesh-ancestor
101439145|NCT05552222|Dexamethasone|dexamethasone|mesh-list
101439154|NCT05552222|Glucocorticoids|glucocorticoids|mesh-ancestor
101439155|NCT05552222|Hormones|hormones|mesh-ancestor
101439156|NCT05552222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101439157|NCT05552222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101439158|NCT05552222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439159|NCT05552222|Immunologic Factors|immunologic factors|mesh-ancestor
101439160|NCT05552222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101439161|NCT05552222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101439162|NCT05552222|Growth Substances|growth substances|mesh-ancestor
101439163|NCT05552222|Growth Inhibitors|growth inhibitors|mesh-ancestor
101439164|NCT05550532|Aticaprant|aticaprant|mesh-list
101439165|NCT05550532|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101439166|NCT05550532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439167|NCT05550532|Sensory System Agents|sensory system agents|mesh-ancestor
101439168|NCT05550532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101439169|NCT05528510|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101439170|NCT05528510|Immunologic Factors|immunologic factors|mesh-ancestor
101439171|NCT05528510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439172|NCT05526157|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
101439173|NCT05526157|Glucagon|glucagon|mesh-list
101439174|NCT05526157|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101439175|NCT05526157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101439176|NCT05526157|Hormones|hormones|mesh-ancestor
101439177|NCT05526157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101439178|NCT05526157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439179|NCT05526157|Incretins|incretins|mesh-ancestor
101439180|NCT05526157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439181|NCT05526157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101439182|NCT05525078|Nicotine|nicotine|mesh-list
101439183|NCT05525078|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101439184|NCT05525078|Autonomic Agents|autonomic agents|mesh-ancestor
101307750|NCT02042742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101439185|NCT05525078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101439186|NCT05525078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439187|NCT05525078|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101439188|NCT05525078|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101439189|NCT05525078|Cholinergic Agents|cholinergic agents|mesh-ancestor
101439190|NCT05525078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101439191|NCT05525078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439192|NCT05521087|Cytarabine|cytarabine|mesh-list
101439193|NCT05521087|Dexamethasone|dexamethasone|mesh-list
101439194|NCT05521087|Fludarabine|fludarabine|mesh-list
101439195|NCT05521087|Vincristine|vincristine|mesh-list
101439196|NCT05521087|Pegaspargase|pegaspargase|mesh-list
101439197|NCT05521087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101439198|NCT05521087|Antiemetics|antiemetics|mesh-ancestor
101559932|NCT01155063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559933|NCT01154673|Ritonavir|ritonavir|mesh-list
101559934|NCT01154673|Lopinavir|lopinavir|mesh-list
101559935|NCT01154673|Tenofovir|tenofovir|mesh-list
101559936|NCT01154673|Emtricitabine|emtricitabine|mesh-list
101559937|NCT01154673|Raltegravir Potassium|raltegravir potassium|mesh-list
101439199|NCT05521087|Autonomic Agents|autonomic agents|mesh-ancestor
101439200|NCT05521087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101439201|NCT05521087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439202|NCT05521087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101439203|NCT05521087|Glucocorticoids|glucocorticoids|mesh-ancestor
101439204|NCT05521087|Hormones|hormones|mesh-ancestor
101439205|NCT05521087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101439206|NCT05521087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101439207|NCT05521087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439208|NCT05521087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101439209|NCT05521087|Antimetabolites|antimetabolites|mesh-ancestor
101439210|NCT05521087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439211|NCT05521087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101439212|NCT05521087|Immunologic Factors|immunologic factors|mesh-ancestor
101439213|NCT05521087|Antiviral Agents|antiviral agents|mesh-ancestor
101439214|NCT05521087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101439215|NCT05521087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101439216|NCT05521087|Tubulin Modulators|tubulin modulators|mesh-ancestor
101439217|NCT05521087|Antimitotic Agents|antimitotic agents|mesh-ancestor
101439222|NCT05518149|Sensory System Agents|sensory system agents|mesh-ancestor
101439223|NCT05518149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101439224|NCT05515575|Niraparib|niraparib|mesh-list
101439225|NCT05515575|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101439226|NCT05515575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101439240|NCT05498428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439241|NCT05498428|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101439242|NCT05498428|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101439243|NCT05498428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101439244|NCT05498428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101439245|NCT05498428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101439246|NCT05498428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101439247|NCT05488314|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
101439248|NCT05488314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101439249|NCT05488314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439250|NCT05470699|Fluorides|fluorides|mesh-list
101439251|NCT05470699|Cariostatic Agents|cariostatic agents|mesh-ancestor
101439252|NCT05470699|Protective Agents|protective agents|mesh-ancestor
101439253|NCT05470699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439254|NCT05458453|Esketamine|esketamine|mesh-list
101439255|NCT05458453|Antidepressive Agents|antidepressive agents|mesh-ancestor
101439256|NCT05458453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101439257|NCT05455684|Aticaprant|aticaprant|mesh-list
101439258|NCT05455684|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101439259|NCT05455684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439260|NCT05455684|Sensory System Agents|sensory system agents|mesh-ancestor
101469850|NCT00274872|Protective Agents|protective agents|mesh-ancestor
101307752|NCT02042742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307753|NCT02042742|Protective Agents|protective agents|mesh-ancestor
101307754|NCT02042742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307755|NCT02042742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101307756|NCT02042742|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101307757|NCT02042742|Disinfectants|disinfectants|mesh-ancestor
101307758|NCT02043002|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101307759|NCT02043002|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101307760|NCT02043002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439261|NCT05455684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101439262|NCT05455320|Dexamethasone|dexamethasone|mesh-list
101439263|NCT05455320|Daratumumab|daratumumab|mesh-list
101439264|NCT05455320|Pomalidomide|pomalidomide|mesh-list
101439265|NCT05455320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101439266|NCT05455320|Antiemetics|antiemetics|mesh-ancestor
101439267|NCT05455320|Autonomic Agents|autonomic agents|mesh-ancestor
101439268|NCT05455320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101439269|NCT05455320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439270|NCT05455320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101559939|NCT01154673|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101559940|NCT01154673|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101559941|NCT01154673|Protease Inhibitors|protease inhibitors|mesh-ancestor
101559942|NCT01154673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101559943|NCT01154673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559944|NCT01154673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101439271|NCT05455320|Glucocorticoids|glucocorticoids|mesh-ancestor
101439272|NCT05455320|Hormones|hormones|mesh-ancestor
101439273|NCT05455320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101439274|NCT05455320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101439275|NCT05455320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439276|NCT05455320|Immunologic Factors|immunologic factors|mesh-ancestor
101439277|NCT05455320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101439278|NCT05455320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101439279|NCT05455320|Growth Substances|growth substances|mesh-ancestor
101439280|NCT05455320|Growth Inhibitors|growth inhibitors|mesh-ancestor
101439282|NCT05453903|Azacitidine|azacitidine|mesh-list
101439289|NCT05453903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439290|NCT05453903|Antiviral Agents|antiviral agents|mesh-ancestor
101439291|NCT05453903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101439292|NCT05453903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101439297|NCT05453903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101439298|NCT05453903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101439299|NCT05452772|Niacin|niacin|mesh-list
101439300|NCT05452772|Psilocybin|psilocybin|mesh-list
101439301|NCT05452772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101439302|NCT05452772|Antimetabolites|antimetabolites|mesh-ancestor
101439303|NCT05452772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439304|NCT05452772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101439305|NCT05452772|Vasodilator Agents|vasodilator agents|mesh-ancestor
101439306|NCT05452772|Vitamin B Complex|vitamin b complex|mesh-ancestor
101439307|NCT05452772|Vitamins|vitamins|mesh-ancestor
101439308|NCT05452772|Micronutrients|micronutrients|mesh-ancestor
101439309|NCT05452772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439310|NCT05452772|Hallucinogens|hallucinogens|mesh-ancestor
101439311|NCT05452772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101439312|NCT05444530|Ipilimumab|ipilimumab|mesh-list
101439313|NCT05444530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101439314|NCT05444530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439315|NCT05444530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101439316|NCT05444530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439317|NCT05438979|Calcium|calcium|mesh-list
101439318|NCT05438979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101439319|NCT05438979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439320|NCT05438043|Dexamethasone|dexamethasone|mesh-list
101307761|NCT02043054|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101307762|NCT02043054|Liraglutide|liraglutide|mesh-list
101307763|NCT02043054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101439321|NCT05438043|Lenalidomide|lenalidomide|mesh-list
101439322|NCT05438043|Daratumumab|daratumumab|mesh-list
101439323|NCT05438043|Pomalidomide|pomalidomide|mesh-list
101439324|NCT05438043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101439325|NCT05438043|Antiemetics|antiemetics|mesh-ancestor
101439326|NCT05438043|Autonomic Agents|autonomic agents|mesh-ancestor
101439327|NCT05438043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101439328|NCT05438043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439329|NCT05438043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101439330|NCT05438043|Glucocorticoids|glucocorticoids|mesh-ancestor
101439331|NCT05438043|Hormones|hormones|mesh-ancestor
101439332|NCT05438043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101439333|NCT05438043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101439334|NCT05438043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439335|NCT05438043|Immunologic Factors|immunologic factors|mesh-ancestor
101439336|NCT05438043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101439337|NCT05438043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101439338|NCT05438043|Growth Substances|growth substances|mesh-ancestor
101439339|NCT05438043|Growth Inhibitors|growth inhibitors|mesh-ancestor
101439340|NCT05427162|Epoprostenol|epoprostenol|mesh-list
101439341|NCT05427162|Tezosentan|tezosentan|mesh-list
101559945|NCT01154673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101559946|NCT01154673|Antiviral Agents|antiviral agents|mesh-ancestor
101559947|NCT01154673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101559948|NCT01154673|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101559949|NCT01154673|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101628327|NCT00720109|Hydrocortisone|hydrocortisone|mesh-list
101439342|NCT05427162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101439343|NCT05427162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101439344|NCT05427162|Vasodilator Agents|vasodilator agents|mesh-ancestor
101439345|NCT05427084|Canagliflozin|canagliflozin|mesh-list
101439346|NCT05427084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101439347|NCT05427084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439348|NCT05427084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101439349|NCT05427084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439350|NCT05414136|Trastuzumab|trastuzumab|mesh-list
101439351|NCT05414136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101439352|NCT05414136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439359|NCT05403580|Olanzapine|olanzapine|mesh-list
101439360|NCT05403580|Antiemetics|antiemetics|mesh-ancestor
101439361|NCT05403580|Autonomic Agents|autonomic agents|mesh-ancestor
101439362|NCT05403580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101439363|NCT05403580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439364|NCT05403580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101439375|NCT05388669|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
101439377|NCT05388669|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101439378|NCT05388669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101439379|NCT05388669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101439380|NCT05388669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439381|NCT05388669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101439382|NCT05388669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439383|NCT05388669|Immunologic Factors|immunologic factors|mesh-ancestor
101439384|NCT05388669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439385|NCT05379803|Aflutinib|aflutinib|mesh-list
101439386|NCT05379803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101439387|NCT05379803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101439388|NCT05379803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439389|NCT05379634|Glucocorticoids|glucocorticoids|mesh-list
101439390|NCT05379634|Hormones|hormones|mesh-ancestor
101439391|NCT05379634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101439392|NCT05379634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439393|NCT05379595|Leucovorin|leucovorin|mesh-list
101439394|NCT05379595|Fluorouracil|fluorouracil|mesh-list
101439395|NCT05379595|Oxaliplatin|oxaliplatin|mesh-list
101439396|NCT05379595|Irinotecan|irinotecan|mesh-list
101439397|NCT05379595|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
101439398|NCT05379595|Antimetabolites|antimetabolites|mesh-ancestor
101439399|NCT05379595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439400|NCT05379595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101307764|NCT02043054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307765|NCT02043054|Incretins|incretins|mesh-ancestor
101307766|NCT02043054|Hormones|hormones|mesh-ancestor
101439401|NCT05379595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439402|NCT05379595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101439403|NCT05379595|Immunologic Factors|immunologic factors|mesh-ancestor
101439404|NCT05379595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439405|NCT05379595|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101439406|NCT05379595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101439407|NCT05379595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101439408|NCT05379595|Antidotes|antidotes|mesh-ancestor
101439409|NCT05379595|Protective Agents|protective agents|mesh-ancestor
101439410|NCT05379595|Vitamin B Complex|vitamin b complex|mesh-ancestor
101439411|NCT05379595|Vitamins|vitamins|mesh-ancestor
101439412|NCT05379595|Micronutrients|micronutrients|mesh-ancestor
101439413|NCT05379595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101439414|NCT05365451|Metformin|metformin|mesh-list
101439415|NCT05365451|Probenecid|probenecid|mesh-list
101439416|NCT05365451|Furosemide|furosemide|mesh-list
101439417|NCT05365451|Cimetidine|cimetidine|mesh-list
101559950|NCT01154673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101559951|NCT01154673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101559952|NCT01154673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101559954|NCT01154673|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101559955|NCT01154673|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101737373|NCT00761462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737374|NCT00761462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101737375|NCT00761462|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101737376|NCT00761462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101737378|NCT00761306|Antidepressive Agents|antidepressive agents|mesh-ancestor
101737379|NCT00761306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101737380|NCT00761306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101737381|NCT00761306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101737382|NCT00761306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101737383|NCT00761306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737384|NCT00761306|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101737385|NCT00761306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101737386|NCT00761306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101737387|NCT00761306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488913|NCT03279978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101737398|NCT00772538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737399|NCT00772538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101737400|NCT00772538|Respiratory System Agents|respiratory system agents|mesh-ancestor
101737401|NCT00772538|Parasympatholytics|parasympatholytics|mesh-ancestor
101737402|NCT00772538|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101737403|NCT00772538|Cholinergic Agents|cholinergic agents|mesh-ancestor
101737404|NCT00772538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101737405|NCT00772538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737406|NCT04079517|Tamoxifen|tamoxifen|mesh-list
101737407|NCT04079517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101737408|NCT04079517|Hormone Antagonists|hormone antagonists|mesh-ancestor
101737409|NCT04079517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101737410|NCT04079517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737411|NCT04079517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101737412|NCT04079517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101469881|NCT00284271|Glucocorticoids|glucocorticoids|mesh-ancestor
101737413|NCT04079517|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101737414|NCT04079517|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101737415|NCT04079517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101737416|NCT00761150|Acetaminophen|acetaminophen|mesh-list
101737417|NCT00761150|Hydrocodone|hydrocodone|mesh-list
101737418|NCT00761150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101737419|NCT00761150|Analgesics|analgesics|mesh-ancestor
101737420|NCT00761150|Sensory System Agents|sensory system agents|mesh-ancestor
101737421|NCT00761150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101737422|NCT00761150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737423|NCT00761150|Antipyretics|antipyretics|mesh-ancestor
101737424|NCT00761150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101737425|NCT00761150|Narcotics|narcotics|mesh-ancestor
101737426|NCT00761150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101737427|NCT00761150|Antitussive Agents|antitussive agents|mesh-ancestor
101737428|NCT00761150|Respiratory System Agents|respiratory system agents|mesh-ancestor
101737429|NCT00583557|Belimumab|belimumab|mesh-list
101737430|NCT00583557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101737431|NCT00583557|Immunologic Factors|immunologic factors|mesh-ancestor
101737432|NCT00583557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737433|NCT00586820|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
101737434|NCT00586820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101737435|NCT00586820|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101737436|NCT00586820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737437|NCT00760838|Azithromycin|azithromycin|mesh-list
101737438|NCT00760838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101737439|NCT00760838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101737440|NCT00586664|Bepotastine besilate|bepotastine besilate|mesh-list
101559956|NCT01154673|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101559957|NCT02884713|Doxycycline|doxycycline|mesh-list
101559958|NCT02884713|Levofloxacin|levofloxacin|mesh-list
101559959|NCT02884713|Esomeprazole|esomeprazole|mesh-list
101559960|NCT02884713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101559961|NCT02884713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101559962|NCT02884713|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101559963|NCT02884713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101559964|NCT02884713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559965|NCT02884713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101559966|NCT02884713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101559967|NCT02884713|Antimalarials|antimalarials|mesh-ancestor
101559968|NCT02884713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101737441|NCT00586664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101737442|NCT00586664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101737443|NCT00586664|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101737444|NCT02584335|Lidocaine|lidocaine|mesh-list
101737445|NCT02584335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101737446|NCT02584335|Anesthetics, Local|anesthetics, local|mesh-ancestor
101737447|NCT02584335|Anesthetics|anesthetics|mesh-ancestor
101737448|NCT02584335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101737449|NCT02584335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737450|NCT02584335|Sensory System Agents|sensory system agents|mesh-ancestor
101488993|NCT00334646|Casopitant|casopitant|mesh-list
101737456|NCT02584335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737458|NCT00437281|Analgesics|analgesics|mesh-ancestor
101737459|NCT00437281|Sensory System Agents|sensory system agents|mesh-ancestor
101737460|NCT00437281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101737461|NCT00437281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737462|NCT00437281|Anticonvulsants|anticonvulsants|mesh-ancestor
101737463|NCT00437281|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101737464|NCT00437281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101737465|NCT00437281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737466|NCT00437281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101737467|NCT00437281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101737468|NCT00437281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101737469|NCT00437281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101737470|NCT00437281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101737471|NCT04544007|Poly ICLC|poly iclc|mesh-list
101737472|NCT04544007|Interferon Inducers|interferon inducers|mesh-ancestor
101469889|NCT00284271|Hematinics|hematinics|mesh-ancestor
101737473|NCT04544007|Immunologic Factors|immunologic factors|mesh-ancestor
101737474|NCT04544007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737475|NCT05468073|Aldesleukin|aldesleukin|mesh-list
101737476|NCT05468073|Interleukin-2|interleukin-2|mesh-list
101737477|NCT05468073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101737478|NCT05468073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101737479|NCT05468073|Analgesics|analgesics|mesh-ancestor
101737480|NCT05468073|Sensory System Agents|sensory system agents|mesh-ancestor
101737481|NCT05468073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101737482|NCT05468073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737483|NCT05468073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101737484|NCT05468073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101737485|NCT05468073|Antiviral Agents|antiviral agents|mesh-ancestor
101737486|NCT05468073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101737487|NCT05674695|Omalizumab|omalizumab|mesh-list
101737488|NCT05674695|Cyclosporine|cyclosporine|mesh-list
101737489|NCT05674695|Methotrexate|methotrexate|mesh-list
101737490|NCT05674695|Upadacitinib|upadacitinib|mesh-list
101737491|NCT05674695|Cyclosporins|cyclosporins|mesh-list
101737492|NCT05674695|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101737493|NCT05674695|Abortifacient Agents|abortifacient agents|mesh-ancestor
101737494|NCT05674695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101737495|NCT05674695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737496|NCT05674695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101559970|NCT02884713|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101559971|NCT02884713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101559972|NCT02884713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101559973|NCT02884713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101559974|NCT02884713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101559975|NCT02884713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101559976|NCT01154127|Glycopyrrolate|glycopyrrolate|mesh-list
101559977|NCT01154127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101559978|NCT01154127|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101559979|NCT01154127|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101737497|NCT05674695|Antimetabolites|antimetabolites|mesh-ancestor
101737498|NCT05674695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737499|NCT05674695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101737500|NCT05674695|Dermatologic Agents|dermatologic agents|mesh-ancestor
101737501|NCT05674695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101737502|NCT05674695|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101737503|NCT05674695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101737504|NCT05674695|Immunologic Factors|immunologic factors|mesh-ancestor
101737505|NCT05674695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101737506|NCT05674695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101737507|NCT05674695|Antifungal Agents|antifungal agents|mesh-ancestor
101737508|NCT05674695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101737509|NCT05674695|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101737510|NCT05674695|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101737511|NCT05674695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101737512|NCT05674695|Respiratory System Agents|respiratory system agents|mesh-ancestor
101394985|NCT01842386|Rituximab|rituximab|mesh-list
101737513|NCT05674695|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101737514|NCT05674695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101737515|NCT02596269|Nefopam|nefopam|mesh-list
101737516|NCT02596269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101737518|NCT02596269|Sensory System Agents|sensory system agents|mesh-ancestor
101489052|NCT00436371|Antidepressive Agents|antidepressive agents|mesh-ancestor
101737546|NCT04078659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737547|NCT04078659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101737548|NCT04078659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101737549|NCT04078659|Anesthetics, General|anesthetics, general|mesh-ancestor
101737550|NCT04078659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101737551|NCT04078659|Narcotics|narcotics|mesh-ancestor
101737552|NCT04078659|Analgesics|analgesics|mesh-ancestor
101737553|NCT04078659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101737554|NCT04078659|Anticonvulsants|anticonvulsants|mesh-ancestor
101737555|NCT04078659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101737556|NCT04078659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101737557|NCT04078659|Tocolytic Agents|tocolytic agents|mesh-ancestor
101737558|NCT04078659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101737559|NCT04078659|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101737560|NCT04078659|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101737561|NCT04078659|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101737562|NCT04078659|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101737563|NCT04078659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101737564|NCT04078659|Cholinergic Agents|cholinergic agents|mesh-ancestor
101737565|NCT04078659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101737566|NCT02583243|Buprenorphine|buprenorphine|mesh-list
101737576|NCT00798707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101737577|NCT00798707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101737578|NCT00798707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101737579|NCT00798707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737580|NCT00798707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101737581|NCT00798707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737582|NCT00798707|Antidepressive Agents|antidepressive agents|mesh-ancestor
101559980|NCT01154127|Cholinergic Agents|cholinergic agents|mesh-ancestor
101559981|NCT01154127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101559982|NCT01154127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559983|NCT01154127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559985|NCT01228734|Folic Acid|folic acid|mesh-list
101559986|NCT01228734|Fluorouracil|fluorouracil|mesh-list
101559987|NCT01228734|Oxaliplatin|oxaliplatin|mesh-list
101559988|NCT01228734|Cetuximab|cetuximab|mesh-list
101559989|NCT01228734|Levoleucovorin|levoleucovorin|mesh-list
101559990|NCT01228734|Antimetabolites|antimetabolites|mesh-ancestor
101559991|NCT01228734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101559992|NCT01228734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101559993|NCT01228734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101559994|NCT01228734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101559995|NCT01228734|Immunologic Factors|immunologic factors|mesh-ancestor
101559996|NCT01228734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101559997|NCT01228734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101559998|NCT01228734|Antidotes|antidotes|mesh-ancestor
101559999|NCT01228734|Protective Agents|protective agents|mesh-ancestor
101560000|NCT01228734|Vitamin B Complex|vitamin b complex|mesh-ancestor
101737583|NCT00798707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101737584|NCT00760214|Ramipril|ramipril|mesh-list
101737585|NCT00760214|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
101737586|NCT00760214|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101737587|NCT00760214|Protease Inhibitors|protease inhibitors|mesh-ancestor
101737588|NCT00760214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101737589|NCT00760214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737590|NCT00760214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101737592|NCT00760214|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101737593|NCT04078425|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
101737594|NCT04078425|Hormone Antagonists|hormone antagonists|mesh-ancestor
101737595|NCT04078425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101737596|NCT04078425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737597|NCT04078425|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101737598|NCT04078425|Diuretics|diuretics|mesh-ancestor
101737599|NCT04078425|Natriuretic Agents|natriuretic agents|mesh-ancestor
101737600|NCT00638391|Anastrozole|anastrozole|mesh-list
101737601|NCT00638391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101737602|NCT00638391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101737603|NCT00638391|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101737604|NCT00638391|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101737605|NCT00638391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101737606|NCT00638391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737607|NCT00638391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101737608|NCT00638391|Hormone Antagonists|hormone antagonists|mesh-ancestor
101469906|NCT00274911|Antimitotic Agents|antimitotic agents|mesh-ancestor
101737609|NCT00638391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101737610|NCT00638391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737611|NCT02583633|Nifedipine|nifedipine|mesh-list
101737612|NCT02583633|Nitroglycerin|nitroglycerin|mesh-list
101737613|NCT02583633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101737614|NCT02583633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101737615|NCT02583633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560001|NCT01228734|Vitamins|vitamins|mesh-ancestor
101560002|NCT01228734|Micronutrients|micronutrients|mesh-ancestor
101560003|NCT01228734|Hematinics|hematinics|mesh-ancestor
101560004|NCT01153971|Rituximab|rituximab|mesh-list
101560005|NCT01153971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101560006|NCT01153971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101560007|NCT01153971|Immunologic Factors|immunologic factors|mesh-ancestor
101560008|NCT01153971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560009|NCT01153971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101560010|NCT01153893|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101737616|NCT02583633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101737617|NCT02583633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737618|NCT02583633|Vasodilator Agents|vasodilator agents|mesh-ancestor
101737619|NCT02583633|Tocolytic Agents|tocolytic agents|mesh-ancestor
101737620|NCT02583633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101737621|NCT02582307|Acetaminophen|acetaminophen|mesh-list
101737622|NCT02582307|Scopolamine|scopolamine|mesh-list
101737623|NCT02582307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
101737624|NCT02582307|Analgesics|analgesics|mesh-list
101737625|NCT02582307|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101737626|NCT02582307|Sensory System Agents|sensory system agents|mesh-ancestor
101737627|NCT02582307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101737628|NCT02582307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737629|NCT02582307|Antipyretics|antipyretics|mesh-ancestor
101737630|NCT02582307|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101737635|NCT02582307|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101737636|NCT02582307|Cholinergic Agents|cholinergic agents|mesh-ancestor
101737637|NCT02582307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101737638|NCT02582307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737639|NCT02582307|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101737640|NCT02582307|Parasympatholytics|parasympatholytics|mesh-ancestor
101737641|NCT02689245|Tenofovir|tenofovir|mesh-list
101737642|NCT02689245|Antiviral Agents|antiviral agents|mesh-ancestor
101737643|NCT02689245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101737644|NCT02689245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101737645|NCT02689245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101737646|NCT02689245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101737647|NCT02689245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737648|NCT02689245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101737649|NCT02689245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101737650|NCT00802841|Imatinib Mesylate|imatinib mesylate|mesh-list
101737651|NCT00802841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101737652|NCT00802841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101737653|NCT00802841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101737654|NCT00802841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737655|NCT00772148|Tacrolimus|tacrolimus|mesh-list
101737656|NCT00772148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101737657|NCT00772148|Immunologic Factors|immunologic factors|mesh-ancestor
101737658|NCT00772148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737659|NCT00772148|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101737660|NCT00772148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101737661|NCT00772148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737663|NCT02689089|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101737664|NCT02689089|Antitubercular Agents|antitubercular agents|mesh-ancestor
101737665|NCT02689089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101737666|NCT02689089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101737667|NCT02689089|Leprostatic Agents|leprostatic agents|mesh-ancestor
101737668|NCT00759902|Morphine|morphine|mesh-list
101737669|NCT00759902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101737670|NCT00759902|Narcotics|narcotics|mesh-ancestor
101737671|NCT00759902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101737672|NCT00759902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737673|NCT00759902|Analgesics|analgesics|mesh-ancestor
101737674|NCT00759902|Sensory System Agents|sensory system agents|mesh-ancestor
101737675|NCT00759902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101560011|NCT01153893|Immunologic Factors|immunologic factors|mesh-ancestor
101560012|NCT01153893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560014|NCT00951379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101560015|NCT00951379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560016|NCT01153815|Botulinum Toxins|botulinum toxins|mesh-list
101408441|NCT00452608|Atorvastatin|atorvastatin|mesh-list
101737676|NCT04077957|Hydroxychloroquine|hydroxychloroquine|mesh-list
101737677|NCT04077957|Sulfasalazine|sulfasalazine|mesh-list
101737678|NCT04077957|Etanercept|etanercept|mesh-list
101737679|NCT04077957|Methotrexate|methotrexate|mesh-list
101737680|NCT04077957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101737681|NCT04077957|Abortifacient Agents|abortifacient agents|mesh-ancestor
101737682|NCT04077957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101737683|NCT04077957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737684|NCT04077957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101737685|NCT04077957|Antimetabolites|antimetabolites|mesh-ancestor
101737686|NCT04077957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737687|NCT04077957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101737688|NCT04077957|Dermatologic Agents|dermatologic agents|mesh-ancestor
101737689|NCT04077957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101737690|NCT04077957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101737691|NCT04077957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101737692|NCT04077957|Immunologic Factors|immunologic factors|mesh-ancestor
101737693|NCT04077957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101737694|NCT04077957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101737695|NCT04077957|Antimalarials|antimalarials|mesh-ancestor
101737696|NCT04077957|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101737697|NCT04077957|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101737698|NCT04077957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101737699|NCT04077957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101737700|NCT04077957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101737701|NCT04077957|Analgesics|analgesics|mesh-ancestor
101737702|NCT04077957|Sensory System Agents|sensory system agents|mesh-ancestor
101737703|NCT04077957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101737711|NCT04102670|Protective Agents|protective agents|mesh-ancestor
101737712|NCT04114097|Betamethasone|betamethasone|mesh-list
101737713|NCT04114097|Betamethasone Valerate|betamethasone valerate|mesh-list
101737714|NCT04114097|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101737715|NCT04114097|Betamethasone benzoate|betamethasone benzoate|mesh-list
101737716|NCT04114097|Tacrolimus|tacrolimus|mesh-list
101737717|NCT04114097|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101737718|NCT04114097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101737719|NCT04114097|Immunologic Factors|immunologic factors|mesh-ancestor
101737720|NCT04114097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737721|NCT04114097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101737722|NCT04114097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101737723|NCT04114097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737724|NCT04114097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101737725|NCT04114097|Glucocorticoids|glucocorticoids|mesh-ancestor
101737726|NCT04114097|Hormones|hormones|mesh-ancestor
101737727|NCT04114097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101737728|NCT04114097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101737729|NCT04114097|Respiratory System Agents|respiratory system agents|mesh-ancestor
101737730|NCT04323189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101737731|NCT04323189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101737732|NCT04323189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737733|NCT04323189|Incretins|incretins|mesh-ancestor
101737734|NCT04323189|Hormones|hormones|mesh-ancestor
101737735|NCT04323189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101737736|NCT04323189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101737737|NCT04323189|Protease Inhibitors|protease inhibitors|mesh-ancestor
101737738|NCT04323189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101737739|NCT04323189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737741|NCT00772070|Immunologic Factors|immunologic factors|mesh-ancestor
101737742|NCT00772070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737743|NCT00796757|Interferons|interferons|mesh-list
101737744|NCT00796757|Interferon-alpha|interferon-alpha|mesh-list
101737745|NCT00796757|Interferon alpha-2|interferon alpha-2|mesh-list
101560017|NCT01153815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101560019|NCT01153815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101560020|NCT01153815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101560021|NCT01153815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560022|NCT01153815|Cholinergic Agents|cholinergic agents|mesh-ancestor
101560023|NCT01153815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101560024|NCT01153815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737746|NCT00796757|Bevacizumab|bevacizumab|mesh-list
101737747|NCT00796757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101737748|NCT00796757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101737749|NCT00796757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101737750|NCT00796757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101737751|NCT00796757|Growth Substances|growth substances|mesh-ancestor
101737752|NCT00796757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737753|NCT00796757|Growth Inhibitors|growth inhibitors|mesh-ancestor
101737754|NCT00796757|Antiviral Agents|antiviral agents|mesh-ancestor
101737755|NCT00796757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101737756|NCT00796757|Immunologic Factors|immunologic factors|mesh-ancestor
101737758|NCT00759356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101737759|NCT00759356|Narcotics|narcotics|mesh-ancestor
101737760|NCT00759356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101737761|NCT00759356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737762|NCT00759356|Analgesics|analgesics|mesh-ancestor
101737763|NCT00759356|Sensory System Agents|sensory system agents|mesh-ancestor
101737764|NCT00759356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101737765|NCT05637515|Adalimumab|adalimumab|mesh-list
101737766|NCT05637515|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101737767|NCT05637515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101737768|NCT05637515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101737769|NCT04113941|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101737770|NCT04113941|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101737771|NCT04113941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101737772|NCT04113941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737773|NCT04113941|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101737778|NCT04102592|Permethrin|permethrin|mesh-list
101737779|NCT04102592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101737780|NCT04102592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737781|NCT04113551|Guanfacine|guanfacine|mesh-list
101737782|NCT04113551|Methylphenidate|methylphenidate|mesh-list
101737783|NCT04113551|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101737784|NCT04113551|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101737785|NCT04113551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101737786|NCT04113551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101737787|NCT04113551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737788|NCT04113551|Adrenergic Agents|adrenergic agents|mesh-ancestor
101737789|NCT04113551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101737790|NCT04113551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737791|NCT04113551|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101737792|NCT04113551|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101737793|NCT04113551|Dopamine Agents|dopamine agents|mesh-ancestor
101737794|NCT04113551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101737795|NCT04113551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101737796|NCT04113551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101737797|NCT04113551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101737798|NCT00798317|Plasminogen|plasminogen|mesh-list
101737799|NCT00798317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101737800|NCT00798317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101737801|NCT00798317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737802|NCT00077285|Cyclophosphamide|cyclophosphamide|mesh-list
101737803|NCT00077285|Ifosfamide|ifosfamide|mesh-list
101737804|NCT00077285|Carboplatin|carboplatin|mesh-list
101737805|NCT00077285|Doxorubicin|doxorubicin|mesh-list
101737806|NCT00077285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101737807|NCT00077285|Irinotecan|irinotecan|mesh-list
101737808|NCT00077285|Etoposide|etoposide|mesh-list
101560025|NCT01153815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101560026|NCT01153815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101560027|NCT01153425|Zoledronic Acid|zoledronic acid|mesh-list
101560028|NCT01153425|Teriparatide|teriparatide|mesh-list
101560029|NCT01153425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101560030|NCT01153425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560031|NCT01153425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101560032|NCT01153269|Ritonavir|ritonavir|mesh-list
101737809|NCT00077285|Vincristine|vincristine|mesh-list
101737810|NCT00077285|Dexrazoxane|dexrazoxane|mesh-list
101737811|NCT00077285|Razoxane|razoxane|mesh-list
101737812|NCT00077285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101737813|NCT00077285|Immunologic Factors|immunologic factors|mesh-ancestor
101737814|NCT00077285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737815|NCT00077285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101737816|NCT00077285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101737817|NCT00077285|Alkylating Agents|alkylating agents|mesh-ancestor
101737818|NCT00077285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737819|NCT00077285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101737820|NCT00077285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101737821|NCT00077285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101737822|NCT00077285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101737823|NCT00077285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101737824|NCT00077285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101737825|NCT00077285|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101737826|NCT00077285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101737827|NCT00077285|Tubulin Modulators|tubulin modulators|mesh-ancestor
101737828|NCT00077285|Antimitotic Agents|antimitotic agents|mesh-ancestor
101737829|NCT00077285|Mitosis Modulators|mitosis modulators|mesh-ancestor
101737830|NCT00077285|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101737831|NCT00077285|Protective Agents|protective agents|mesh-ancestor
101737833|NCT00771914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101737834|NCT00771914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101737835|NCT00771914|Analgesics|analgesics|mesh-ancestor
101737836|NCT00771914|Sensory System Agents|sensory system agents|mesh-ancestor
101737837|NCT00771914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101737838|NCT00771914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737839|NCT00771914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101737840|NCT00771914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101737841|NCT00771914|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101737842|NCT00771914|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101737843|NCT00771914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737844|NCT00771914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101737855|NCT04307511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737856|NCT04307511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101737857|NCT04307511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101737858|NCT04307511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101737859|NCT04307511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101737860|NCT04307511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737861|NCT04307511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101737862|NCT04307511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101737863|NCT04307511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101737864|NCT04307511|Antipyretics|antipyretics|mesh-ancestor
101737865|NCT04307511|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101737866|NCT04307511|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101737867|NCT04307511|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101737868|NCT04307511|Purinergic Agents|purinergic agents|mesh-ancestor
101737869|NCT04307511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101737870|NCT00779324|Amantadine|amantadine|mesh-list
101737871|NCT00779324|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101737872|NCT00779324|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101737873|NCT00779324|Antiviral Agents|antiviral agents|mesh-ancestor
101737874|NCT00779324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101737875|NCT00779324|Dopamine Agents|dopamine agents|mesh-ancestor
101737876|NCT00779324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101737877|NCT00779324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408460|NCT00109265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101560033|NCT01153269|Lopinavir|lopinavir|mesh-list
101560034|NCT01153269|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101560035|NCT01153269|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101560036|NCT01153269|Protease Inhibitors|protease inhibitors|mesh-ancestor
101560037|NCT01153269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101560038|NCT01153269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560039|NCT01153269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101560040|NCT01153269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101737878|NCT00779324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737879|NCT00779324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101737880|NCT00779324|Analgesics|analgesics|mesh-ancestor
101737881|NCT00779324|Sensory System Agents|sensory system agents|mesh-ancestor
101737882|NCT00779324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101737883|NCT00779246|Chlorhexidine|chlorhexidine|mesh-list
101737884|NCT00779246|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101737885|NCT00779246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101737886|NCT00779246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101737887|NCT00779246|Disinfectants|disinfectants|mesh-ancestor
101737888|NCT00779246|Dermatologic Agents|dermatologic agents|mesh-ancestor
101737890|NCT02581761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101737891|NCT02581761|Abortifacient Agents|abortifacient agents|mesh-ancestor
101737892|NCT02581761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101737893|NCT02581761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737894|NCT02581761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101737895|NCT02581761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101737896|NCT02581761|Oxytocics|oxytocics|mesh-ancestor
101737897|NCT00771758|Oxycodone|oxycodone|mesh-list
101737898|NCT00771758|Tapentadol|tapentadol|mesh-list
101737899|NCT00771758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101737900|NCT00771758|Narcotics|narcotics|mesh-ancestor
101737901|NCT00771758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101737902|NCT00771758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737903|NCT00771758|Analgesics|analgesics|mesh-ancestor
101737904|NCT00771758|Sensory System Agents|sensory system agents|mesh-ancestor
101737905|NCT00771758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101737906|NCT00771758|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101737907|NCT00771758|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101737908|NCT00771758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101737909|NCT00771758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489443|NCT00347490|Anticoagulants|anticoagulants|mesh-ancestor
101737919|NCT02688465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737921|NCT02688465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101737922|NCT02688465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101737923|NCT02688465|Dopamine Agonists|dopamine agonists|mesh-ancestor
101737924|NCT02688465|Dopamine Agents|dopamine agents|mesh-ancestor
101737925|NCT02688465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101737926|NCT02688465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737927|NCT00758498|Modafinil|modafinil|mesh-list
101737928|NCT00758498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101737929|NCT00758498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737930|NCT00758498|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101737931|NCT00758498|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101737932|NCT00758498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101737933|NCT00758498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737934|NCT00798161|Metformin|metformin|mesh-list
101737935|NCT00798161|Linagliptin|linagliptin|mesh-list
101737936|NCT00798161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101737937|NCT00798161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737938|NCT00798161|Incretins|incretins|mesh-ancestor
101737939|NCT00798161|Hormones|hormones|mesh-ancestor
101737940|NCT00798161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101737941|NCT00798161|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101737942|NCT00798161|Protease Inhibitors|protease inhibitors|mesh-ancestor
101737943|NCT00798161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101560041|NCT01153269|Antiviral Agents|antiviral agents|mesh-ancestor
101560042|NCT01153269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101560043|NCT01153269|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101560044|NCT01153269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101560045|NCT02884635|Methotrexate|methotrexate|mesh-list
101560046|NCT02884635|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101737944|NCT00798161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737945|NCT02581683|Magnesium Sulfate|magnesium sulfate|mesh-list
101737946|NCT02581683|Ropivacaine|ropivacaine|mesh-list
101737947|NCT02581683|Anesthetics, Local|anesthetics, local|mesh-ancestor
101737948|NCT02581683|Anesthetics|anesthetics|mesh-ancestor
101737949|NCT02581683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101737950|NCT02581683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737951|NCT02581683|Sensory System Agents|sensory system agents|mesh-ancestor
101737952|NCT02581683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101737953|NCT02581683|Analgesics|analgesics|mesh-ancestor
101737954|NCT02581683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101737955|NCT02581683|Anticonvulsants|anticonvulsants|mesh-ancestor
101737956|NCT02581683|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101737957|NCT02581683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101737958|NCT02581683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737959|NCT02581683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101737960|NCT02581683|Tocolytic Agents|tocolytic agents|mesh-ancestor
101737961|NCT02581683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101737963|NCT04170855|Diuretics|diuretics|mesh-ancestor
101737964|NCT04170855|Natriuretic Agents|natriuretic agents|mesh-ancestor
101737965|NCT04170855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737966|NCT04170855|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101737967|NCT04170855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101737968|NCT04170855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737969|NCT04076709|Anesthetics|anesthetics|mesh-list
101737970|NCT04076709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101737971|NCT04076709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469988|NCT00284583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101737972|NCT00638781|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
101737973|NCT00638781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101737986|NCT04115423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101737987|NCT04115423|Analgesics|analgesics|mesh-ancestor
101737988|NCT04115423|Sensory System Agents|sensory system agents|mesh-ancestor
101737989|NCT04115423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101737990|NCT04115423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737991|NCT04115423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101737992|NCT04115423|Immunologic Factors|immunologic factors|mesh-ancestor
101737993|NCT04113005|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101737994|NCT04113005|Hemostatics|hemostatics|mesh-ancestor
101737995|NCT04113005|Coagulants|coagulants|mesh-ancestor
101737996|NCT04113005|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101737997|NCT04113005|Natriuretic Agents|natriuretic agents|mesh-ancestor
101737998|NCT04113005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737999|NCT00588341|Temozolomide|temozolomide|mesh-list
101738000|NCT00588341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101738001|NCT00588341|Alkylating Agents|alkylating agents|mesh-ancestor
101738002|NCT00588341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738003|NCT00588341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738004|NCT00914693|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101738005|NCT00914693|Gestodene|gestodene|mesh-list
101738006|NCT00914693|Femovan|femovan|mesh-list
101738007|NCT00914693|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101738008|NCT00914693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101738009|NCT00914693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101738010|NCT00914693|Contraceptive Agents|contraceptive agents|mesh-ancestor
101738011|NCT00914693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101738012|NCT00914693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738013|NCT00914693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101738014|NCT00914693|Estrogens|estrogens|mesh-ancestor
101738015|NCT00914693|Hormones|hormones|mesh-ancestor
101439418|NCT05365451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101560047|NCT02884635|Abortifacient Agents|abortifacient agents|mesh-ancestor
101560048|NCT02884635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101560049|NCT02884635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560050|NCT02884635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101560051|NCT02884635|Antimetabolites|antimetabolites|mesh-ancestor
101738016|NCT00914693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101738017|NCT00914693|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101738018|NCT00914693|Progestins|progestins|mesh-ancestor
101738019|NCT00914693|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101738020|NCT00915083|Amrubicin|amrubicin|mesh-list
101738021|NCT00915083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738022|NCT00802529|Gentamicins|gentamicins|mesh-list
101738023|NCT00802529|Methylprednisolone|methylprednisolone|mesh-list
101738024|NCT00802529|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101738025|NCT00802529|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101738026|NCT00802529|Prednisolone|prednisolone|mesh-list
101738027|NCT00802529|Prednisolone acetate|prednisolone acetate|mesh-list
101738028|NCT00802529|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101738029|NCT00802529|Prednisolone phosphate|prednisolone phosphate|mesh-list
101738030|NCT00802529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101738031|NCT00802529|Antiemetics|antiemetics|mesh-ancestor
101738032|NCT00802529|Autonomic Agents|autonomic agents|mesh-ancestor
101738033|NCT00802529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101395516|NCT00090909|Antiemetics|antiemetics|mesh-ancestor
101738034|NCT00802529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738035|NCT00802529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101738036|NCT00802529|Glucocorticoids|glucocorticoids|mesh-ancestor
101738038|NCT00802529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101469993|NCT00247052|Analgesics|analgesics|mesh-ancestor
101738047|NCT00802529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738048|NCT02605811|Temozolomide|temozolomide|mesh-list
101738049|NCT02605811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101738050|NCT02605811|Alkylating Agents|alkylating agents|mesh-ancestor
101738051|NCT02605811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738052|NCT02605811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738053|NCT00758264|Vaccines|vaccines|mesh-list
101738054|NCT00758264|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101738055|NCT00758264|Immunologic Factors|immunologic factors|mesh-ancestor
101738056|NCT00758264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738057|NCT04027517|Darbepoetin alfa|darbepoetin alfa|mesh-list
101738058|NCT04027517|Hematinics|hematinics|mesh-ancestor
101738059|NCT00588731|Cannabidiol|cannabidiol|mesh-list
101738060|NCT00588731|Anticonvulsants|anticonvulsants|mesh-ancestor
101738061|NCT04111367|Sofosbuvir|sofosbuvir|mesh-list
101738062|NCT04111367|Antiviral Agents|antiviral agents|mesh-ancestor
101738063|NCT04111367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101738064|NCT05629949|Docetaxel|docetaxel|mesh-list
101738065|NCT05629949|Trastuzumab|trastuzumab|mesh-list
101738066|NCT05629949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738067|NCT05629949|Tubulin Modulators|tubulin modulators|mesh-ancestor
101738068|NCT05629949|Antimitotic Agents|antimitotic agents|mesh-ancestor
101738069|NCT05629949|Mitosis Modulators|mitosis modulators|mesh-ancestor
101738070|NCT05629949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738071|NCT05629949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101738072|NCT05628233|Azasetron|azasetron|mesh-list
101738073|NCT05628233|Antiemetics|antiemetics|mesh-ancestor
101738074|NCT05628233|Autonomic Agents|autonomic agents|mesh-ancestor
101738075|NCT05628233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101738076|NCT05628233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738077|NCT05628233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101738078|NCT05628233|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101738079|NCT05628233|Serotonin Agents|serotonin agents|mesh-ancestor
101738080|NCT05628233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101738081|NCT05628233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738082|NCT04109261|Palbociclib|palbociclib|mesh-list
101738083|NCT04109261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738084|NCT04109261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101738085|NCT04109261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101738086|NCT04109261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738087|NCT04109339|Oxytocin|oxytocin|mesh-list
101738088|NCT04109339|Oxytocics|oxytocics|mesh-ancestor
101560052|NCT02884635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560053|NCT02884635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101560054|NCT02884635|Dermatologic Agents|dermatologic agents|mesh-ancestor
101560055|NCT02884635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101560056|NCT02884635|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101560057|NCT02884635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101560058|NCT02884635|Immunologic Factors|immunologic factors|mesh-ancestor
101560059|NCT02884635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101560060|NCT02884635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101738089|NCT04109339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101738090|NCT04109339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738091|NCT00757172|Docetaxel|docetaxel|mesh-list
101738092|NCT00757172|Panitumumab|panitumumab|mesh-list
101738093|NCT00757172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738094|NCT00757172|Tubulin Modulators|tubulin modulators|mesh-ancestor
101738095|NCT00757172|Antimitotic Agents|antimitotic agents|mesh-ancestor
101738096|NCT00757172|Mitosis Modulators|mitosis modulators|mesh-ancestor
101738097|NCT00757172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738098|NCT00757172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101738099|NCT00797225|Leuprolide|leuprolide|mesh-list
101738100|NCT00797225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101738101|NCT00797225|Fertility Agents|fertility agents|mesh-ancestor
101738102|NCT00797225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101738103|NCT00797225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738104|NCT00797225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101738105|NCT00797225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101489640|NCT00337922|Lamivudine|lamivudine|mesh-list
101738130|NCT04110665|Antipyretics|antipyretics|mesh-ancestor
101738131|NCT04077333|Pulmonary Surfactants|pulmonary surfactants|mesh-list
101738132|NCT04077333|Respiratory System Agents|respiratory system agents|mesh-ancestor
101738133|NCT00638859|Telithromycin|telithromycin|mesh-list
101738134|NCT00638859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101738135|NCT00638859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101738136|NCT02537847|Ertapenem|ertapenem|mesh-list
101738137|NCT02537847|Fluoroquinolones|fluoroquinolones|mesh-list
101738138|NCT02537847|Sitafloxacin|sitafloxacin|mesh-list
101738139|NCT02537847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101738140|NCT02537847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101738141|NCT02537847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101738142|NCT02537847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101738143|NCT02537847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738144|NCT02537847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101738145|NCT02537847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101738146|NCT02537847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738147|NCT04033029|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101738148|NCT04033029|Tazobactam|tazobactam|mesh-list
101738149|NCT04033029|Piperacillin|piperacillin|mesh-list
101738150|NCT04033029|Daptomycin|daptomycin|mesh-list
101738151|NCT04033029|Ceftazidime|ceftazidime|mesh-list
101738152|NCT04033029|Cefepime|cefepime|mesh-list
101738153|NCT04033029|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101738154|NCT04033029|Ceftolozane|ceftolozane|mesh-list
101738155|NCT04033029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101738156|NCT04033029|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101738157|NCT04033029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101738158|NCT04033029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738159|NCT02687841|Pentoxifylline|pentoxifylline|mesh-list
101738160|NCT02687841|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101738161|NCT02687841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101738162|NCT02687841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738178|NCT04236141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101738179|NCT04236141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738180|NCT04236141|Immunologic Factors|immunologic factors|mesh-ancestor
101738181|NCT04236141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738182|NCT04236141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101560062|NCT02884479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101560063|NCT02884479|Tubulin Modulators|tubulin modulators|mesh-ancestor
101560064|NCT02884479|Antimitotic Agents|antimitotic agents|mesh-ancestor
101560065|NCT02884479|Mitosis Modulators|mitosis modulators|mesh-ancestor
101560066|NCT02884479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738183|NCT04236141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101738184|NCT04236141|Alkylating Agents|alkylating agents|mesh-ancestor
101738185|NCT04236141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395666|NCT00313885|Serotonin Agents|serotonin agents|mesh-ancestor
101738186|NCT04236141|Immunoconjugates|immunoconjugates|mesh-ancestor
101738187|NCT04097444|Leucovorin|leucovorin|mesh-list
101738188|NCT04097444|Bevacizumab|bevacizumab|mesh-list
101738189|NCT04097444|Fluorouracil|fluorouracil|mesh-list
101738190|NCT04097444|Capecitabine|capecitabine|mesh-list
101738191|NCT04097444|Oxaliplatin|oxaliplatin|mesh-list
101738192|NCT04097444|Irinotecan|irinotecan|mesh-list
101738193|NCT04097444|Calcium|calcium|mesh-list
101738194|NCT04097444|Levoleucovorin|levoleucovorin|mesh-list
101738195|NCT04097444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101738196|NCT04097444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738197|NCT04097444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101738198|NCT04097444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101738199|NCT04097444|Growth Substances|growth substances|mesh-ancestor
101738200|NCT04097444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738201|NCT04097444|Growth Inhibitors|growth inhibitors|mesh-ancestor
101738202|NCT04097444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101738203|NCT04097444|Antimetabolites|antimetabolites|mesh-ancestor
101738204|NCT04097444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738205|NCT04097444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101738206|NCT04097444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101738207|NCT04097444|Immunologic Factors|immunologic factors|mesh-ancestor
101738208|NCT04097444|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101738209|NCT04097444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101738210|NCT04097444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101738211|NCT04097444|Antidotes|antidotes|mesh-ancestor
101738212|NCT04097444|Protective Agents|protective agents|mesh-ancestor
101738213|NCT04097444|Vitamin B Complex|vitamin b complex|mesh-ancestor
101738214|NCT04097444|Vitamins|vitamins|mesh-ancestor
101738215|NCT04097444|Micronutrients|micronutrients|mesh-ancestor
101738216|NCT04097288|Dexetimide|dexetimide|mesh-list
101738217|NCT04097288|Citalopram|citalopram|mesh-list
101738218|NCT04097288|Reboxetine|reboxetine|mesh-list
101738219|NCT04097288|Escitalopram|escitalopram|mesh-list
101738220|NCT04097288|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101738221|NCT04097288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101738222|NCT04097288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101738223|NCT04097288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489759|NCT00338624|Oxybutynin|oxybutynin|mesh-list
101738227|NCT04097288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101738228|NCT04097288|Antidepressive Agents|antidepressive agents|mesh-ancestor
101738229|NCT04097288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101738230|NCT04097288|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101738231|NCT04097288|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101738232|NCT04097288|Parasympatholytics|parasympatholytics|mesh-ancestor
101738233|NCT04097288|Autonomic Agents|autonomic agents|mesh-ancestor
101738234|NCT04097288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101738235|NCT04097288|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101738236|NCT04097288|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101738237|NCT04097288|Cholinergic Agents|cholinergic agents|mesh-ancestor
101738238|NCT04097288|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101738239|NCT04097288|Adrenergic Agents|adrenergic agents|mesh-ancestor
101738240|NCT04219449|Protein C|protein c|mesh-list
101738241|NCT04219449|Anticoagulants|anticoagulants|mesh-ancestor
101738242|NCT04219449|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101738243|NCT04219449|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101738244|NCT04219449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738245|NCT04209855|Paclitaxel|paclitaxel|mesh-list
101738246|NCT04209855|Maytansine|maytansine|mesh-list
101738247|NCT04209855|Doxorubicin|doxorubicin|mesh-list
101738248|NCT04209855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101738249|NCT04209855|Topotecan|topotecan|mesh-list
101738250|NCT04209855|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
101560067|NCT01152021|Dexmedetomidine|dexmedetomidine|mesh-list
101560068|NCT01152021|Propofol|propofol|mesh-list
101560069|NCT01152021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101560070|NCT01152021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101560071|NCT01152021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560072|NCT01152021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101560073|NCT01152021|Analgesics|analgesics|mesh-ancestor
101738251|NCT04209855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101738252|NCT04209855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738253|NCT04209855|Tubulin Modulators|tubulin modulators|mesh-ancestor
101738254|NCT04209855|Antimitotic Agents|antimitotic agents|mesh-ancestor
101738255|NCT04209855|Mitosis Modulators|mitosis modulators|mesh-ancestor
101738256|NCT04209855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738257|NCT04209855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101738258|NCT04209855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101470024|NCT00247130|Ranitidine|ranitidine|mesh-list
101738259|NCT04209855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101738260|NCT04209855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101738261|NCT04209855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101738262|NCT04209855|Immunoconjugates|immunoconjugates|mesh-ancestor
101738263|NCT04209855|Immunologic Factors|immunologic factors|mesh-ancestor
101738264|NCT04209855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738265|NCT00756938|Losartan|losartan|mesh-list
101738266|NCT00756938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101738267|NCT00756938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101738268|NCT00756938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101738269|NCT00756938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101738270|NCT00756938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738272|NCT04076865|Histamine|histamine|mesh-list
101738273|NCT04076865|Anesthetics, Local|anesthetics, local|mesh-ancestor
101738274|NCT04076865|Anesthetics|anesthetics|mesh-ancestor
101738275|NCT04076865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101738276|NCT04076865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738277|NCT04076865|Sensory System Agents|sensory system agents|mesh-ancestor
101738278|NCT04076865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101738279|NCT04076865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101738280|NCT04076865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101738281|NCT04076865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101738282|NCT04076865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101738283|NCT04076865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738284|NCT04076865|Histamine Agonists|histamine agonists|mesh-ancestor
101738285|NCT04076865|Histamine Agents|histamine agents|mesh-ancestor
101738286|NCT04076865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101738287|NCT00770588|Gefitinib|gefitinib|mesh-list
101738288|NCT00770588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738289|NCT00770588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101738290|NCT00770588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101738291|NCT00770588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738292|NCT02604719|Tranexamic Acid|tranexamic acid|mesh-list
101738293|NCT02604719|Ethamsylate|ethamsylate|mesh-list
101738294|NCT02604719|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101738295|NCT02604719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101489817|NCT00445575|Etidronic Acid|etidronic acid|mesh-list
101738305|NCT02604797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101738306|NCT02604797|Narcotics|narcotics|mesh-ancestor
101738307|NCT02604797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101738308|NCT02604797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738309|NCT02604797|Analgesics|analgesics|mesh-ancestor
101738310|NCT02604797|Sensory System Agents|sensory system agents|mesh-ancestor
101738311|NCT02604797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101738312|NCT02604797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101738313|NCT02604797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101738314|NCT02604797|Anesthetics, General|anesthetics, general|mesh-ancestor
101738315|NCT02604797|Anesthetics|anesthetics|mesh-ancestor
101738316|NCT02604797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101738317|NCT02604797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101738318|NCT02604797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101738319|NCT02604797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101560074|NCT01152021|Sensory System Agents|sensory system agents|mesh-ancestor
101560075|NCT01152021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101560076|NCT01152021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101560077|NCT01152021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101560078|NCT01152021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101560079|NCT01152021|Adrenergic Agents|adrenergic agents|mesh-ancestor
101560080|NCT01152021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101560081|NCT01152021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470060|NCT00277758|Interferons|interferons|mesh-list
101560082|NCT01152021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101738320|NCT02604797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101738321|NCT02604797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101738322|NCT02604797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738323|NCT02604797|Antiemetics|antiemetics|mesh-ancestor
101738324|NCT02604797|Autonomic Agents|autonomic agents|mesh-ancestor
101738325|NCT02604797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101738326|NCT02604797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101738327|NCT02604797|Serotonin Agents|serotonin agents|mesh-ancestor
101738328|NCT02604797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101738330|NCT00777608|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101738331|NCT00777608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101738332|NCT00777608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738333|NCT00777608|Cholinergic Agents|cholinergic agents|mesh-ancestor
101738334|NCT00777608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101738335|NCT00777608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738336|NCT00777608|Nootropic Agents|nootropic agents|mesh-ancestor
101738337|NCT00792935|Metformin|metformin|mesh-list
101738338|NCT00792935|Glimepiride|glimepiride|mesh-list
101738339|NCT00792935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101738340|NCT00792935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738341|NCT00792935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101738342|NCT00792935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101738343|NCT00792935|Immunologic Factors|immunologic factors|mesh-ancestor
101738345|NCT03904563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101738346|NCT03904563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738347|NCT03904563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101738348|NCT03904563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101738349|NCT03904563|Growth Substances|growth substances|mesh-ancestor
101738350|NCT03904563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738351|NCT03904563|Growth Inhibitors|growth inhibitors|mesh-ancestor
101738352|NCT00770510|Zolpidem|zolpidem|mesh-list
101738353|NCT00770510|Eszopiclone|eszopiclone|mesh-list
101738354|NCT00770510|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101738355|NCT00770510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101738356|NCT00770510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101738357|NCT00770510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738358|NCT00770510|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101738359|NCT00770510|GABA Agonists|gaba agonists|mesh-ancestor
101738360|NCT00770510|GABA Agents|gaba agents|mesh-ancestor
101738361|NCT00770510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101738362|NCT00770510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738363|NCT04077255|Paclitaxel|paclitaxel|mesh-list
101738364|NCT04077255|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101738365|NCT04077255|Antibodies|antibodies|mesh-list
101738366|NCT04077255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101738368|NCT04077255|Tubulin Modulators|tubulin modulators|mesh-ancestor
101738369|NCT04077255|Antimitotic Agents|antimitotic agents|mesh-ancestor
101738370|NCT04077255|Mitosis Modulators|mitosis modulators|mesh-ancestor
101738371|NCT04077255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738372|NCT04077255|Immunologic Factors|immunologic factors|mesh-ancestor
101738373|NCT04077255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738374|NCT00770432|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101738375|NCT00770432|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101738377|NCT00770432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101738378|NCT00792701|Gemcitabine|gemcitabine|mesh-list
101560083|NCT01152021|Anesthetics, General|anesthetics, general|mesh-ancestor
101560084|NCT01152021|Anesthetics|anesthetics|mesh-ancestor
101560085|NCT01151085|Voriconazole|voriconazole|mesh-list
101560086|NCT01151085|Antifungal Agents|antifungal agents|mesh-ancestor
101560087|NCT01151085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101560088|NCT01151085|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101738379|NCT00792701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738380|NCT00792701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101738381|NCT00792701|Antimetabolites|antimetabolites|mesh-ancestor
101738382|NCT00792701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738383|NCT03772353|Letrozole|letrozole|mesh-list
101738384|NCT03772353|Fulvestrant|fulvestrant|mesh-list
101738385|NCT03772353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738386|NCT03772353|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101738387|NCT03772353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101738388|NCT03772353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101738389|NCT03772353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738390|NCT03772353|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101738391|NCT03772353|Hormone Antagonists|hormone antagonists|mesh-ancestor
101738392|NCT03772353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101738393|NCT03772353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738394|NCT03772353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101738395|NCT03772353|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101738396|NCT05559983|Aluminum phosphate|aluminum phosphate|mesh-list
101738397|NCT05559983|Vaccines|vaccines|mesh-list
101738398|NCT05559983|Immunologic Factors|immunologic factors|mesh-ancestor
101738399|NCT05559983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738400|NCT05559983|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101738401|NCT05559983|Antacids|antacids|mesh-ancestor
101738402|NCT05559983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738403|NCT05559983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101738404|NCT03765567|Vancomycin|vancomycin|mesh-list
101738405|NCT03765567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101738406|NCT03765567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101738407|NCT00777296|Amikacin|amikacin|mesh-list
101738408|NCT00777296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101738409|NCT00777296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101738410|NCT00756470|Paclitaxel|paclitaxel|mesh-list
101738411|NCT00756470|Cyclophosphamide|cyclophosphamide|mesh-list
101738412|NCT00756470|Fluorouracil|fluorouracil|mesh-list
101738413|NCT00756470|Epirubicin|epirubicin|mesh-list
101738414|NCT00756470|Lapatinib|lapatinib|mesh-list
101738415|NCT00756470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101738416|NCT00756470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738417|NCT00756470|Tubulin Modulators|tubulin modulators|mesh-ancestor
101738418|NCT00756470|Antimitotic Agents|antimitotic agents|mesh-ancestor
101738419|NCT00756470|Mitosis Modulators|mitosis modulators|mesh-ancestor
101738420|NCT00756470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738421|NCT00756470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101738422|NCT00756470|Immunologic Factors|immunologic factors|mesh-ancestor
101738423|NCT00756470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738424|NCT00756470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101738425|NCT00756470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101738426|NCT00756470|Alkylating Agents|alkylating agents|mesh-ancestor
101738427|NCT00756470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101738428|NCT00756470|Antimetabolites|antimetabolites|mesh-ancestor
101738429|NCT00756470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101738430|NCT00756470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101738431|NCT00756470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101738432|NCT00756470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101738433|NCT00756470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101738434|NCT00756470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101738435|NCT00756314|Contraceptive Agents|contraceptive agents|mesh-list
101738436|NCT00756314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101738437|NCT00756314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738438|NCT00727506|Afatinib|afatinib|mesh-list
101738439|NCT00727506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738440|NCT00727506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101738446|NCT00789815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101560089|NCT01151085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101560090|NCT01151085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101522031|NCT00446771|Mannitol|mannitol|mesh-list
101560091|NCT01151085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560092|NCT01151085|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101560093|NCT01151085|Hormone Antagonists|hormone antagonists|mesh-ancestor
101560094|NCT01151085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101560095|NCT01151085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560096|NCT01151085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101560097|NCT01149369|Aprepitant|aprepitant|mesh-list
101560098|NCT01149369|Antiemetics|antiemetics|mesh-ancestor
101738447|NCT00789815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738448|NCT00789815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101738449|NCT00789815|Anesthetics, General|anesthetics, general|mesh-ancestor
101738450|NCT00789815|Anesthetics|anesthetics|mesh-ancestor
101738451|NCT00789815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101738452|NCT00789815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101738453|NCT00789815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101738454|NCT00789815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101738455|NCT00789815|GABA Modulators|gaba modulators|mesh-ancestor
101738456|NCT00789815|GABA Agents|gaba agents|mesh-ancestor
101738457|NCT00789815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101738458|NCT00789815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738459|NCT00721578|Voriconazole|voriconazole|mesh-list
101738460|NCT00721578|Antifungal Agents|antifungal agents|mesh-ancestor
101738461|NCT00721578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101738462|NCT00721578|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101738463|NCT00721578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101738464|NCT00721578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101738465|NCT00721578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738466|NCT00721578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101738467|NCT00721578|Hormone Antagonists|hormone antagonists|mesh-ancestor
101738468|NCT00721578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101738469|NCT00721578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738470|NCT00721578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101738471|NCT00789737|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
101738472|NCT00789737|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101738473|NCT00789737|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101738474|NCT00789737|Antimetabolites|antimetabolites|mesh-ancestor
101738475|NCT00789737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738476|NCT00789737|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101738477|NCT04019574|Moxifloxacin|moxifloxacin|mesh-list
101738478|NCT04019574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101738479|NCT04019574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101738480|NCT04019574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101738481|NCT04019574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101738482|NCT04019574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101738483|NCT04019574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738484|NCT04019574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738485|NCT00792467|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
101738486|NCT00792467|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
101738487|NCT00792467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101738488|NCT00792467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738489|NCT00585468|Mycophenolic Acid|mycophenolic acid|mesh-list
101738490|NCT00585468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101738491|NCT00585468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738492|NCT00585468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101738493|NCT00585468|Antitubercular Agents|antitubercular agents|mesh-ancestor
101738494|NCT00585468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101738495|NCT00585468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101560099|NCT01149369|Autonomic Agents|autonomic agents|mesh-ancestor
101560100|NCT01149369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101560101|NCT01149369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560102|NCT01149369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101560103|NCT01149369|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101560104|NCT01149369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101560105|NCT01149369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560106|NCT01740427|Letrozole|letrozole|mesh-list
101560107|NCT01740427|Palbociclib|palbociclib|mesh-list
101560108|NCT01740427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101560109|NCT01740427|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101560110|NCT01740427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101738496|NCT00585468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101738497|NCT00585468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738498|NCT05600387|Empagliflozin|empagliflozin|mesh-list
101738499|NCT05600387|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101738500|NCT05600387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738501|NCT05600387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101738502|NCT05600387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738503|NCT00721110|Lidocaine|lidocaine|mesh-list
101738504|NCT00721110|Ketamine|ketamine|mesh-list
101738505|NCT00721110|Anesthetics, Local|anesthetics, local|mesh-ancestor
101738506|NCT00721110|Anesthetics|anesthetics|mesh-ancestor
101738507|NCT00721110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101490026|NCT00452634|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101738510|NCT00721110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101738511|NCT00721110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101738512|NCT00721110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101738513|NCT00721110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101738514|NCT00721110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101738515|NCT00721110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738516|NCT00721110|Analgesics|analgesics|mesh-ancestor
101738517|NCT00721110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101738518|NCT00721110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101738519|NCT00721110|Anesthetics, General|anesthetics, general|mesh-ancestor
101738520|NCT00721110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101738521|NCT00721110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101738522|NCT00721110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101738523|NCT02592096|Carbamide Peroxide|carbamide peroxide|mesh-list
101738524|NCT02592096|Pazufloxacin|pazufloxacin|mesh-list
101738525|NCT02592096|Fluoroquinolones|fluoroquinolones|mesh-list
101738526|NCT02592096|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101738527|NCT02592096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101738528|NCT02592096|Antitubercular Agents|antitubercular agents|mesh-ancestor
101738529|NCT02592096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101738530|NCT02592096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101738531|NCT02592096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101738532|NCT02592096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101738533|NCT02592096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738534|NCT02592096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738535|NCT02592096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101738536|NCT00791999|Certolizumab Pegol|certolizumab pegol|mesh-list
101738537|NCT00791999|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101738538|NCT00791999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101738539|NCT00791999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101738540|NCT00791999|Immunologic Factors|immunologic factors|mesh-ancestor
101738541|NCT00791999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738542|NCT00791999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101738543|NCT04085484|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-list
101738544|NCT04085484|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101738545|NCT04033263|Fluorides|fluorides|mesh-list
101560112|NCT01740427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560113|NCT01740427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101560114|NCT01740427|Hormone Antagonists|hormone antagonists|mesh-ancestor
101560115|NCT01740427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101560116|NCT01740427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560117|NCT01740427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101560118|NCT00879931|Methylprednisolone|methylprednisolone|mesh-list
101560119|NCT00879931|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101560120|NCT00879931|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101560121|NCT00879931|Prednisolone|prednisolone|mesh-list
101560122|NCT00879931|Prednisolone acetate|prednisolone acetate|mesh-list
101560123|NCT00879931|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101560124|NCT00879931|Prednisolone phosphate|prednisolone phosphate|mesh-list
101408538|NCT00143481|Cholinergic Agents|cholinergic agents|mesh-ancestor
101738546|NCT04033263|Cariostatic Agents|cariostatic agents|mesh-ancestor
101738547|NCT04033263|Protective Agents|protective agents|mesh-ancestor
101738548|NCT04033263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738549|NCT04075227|Loteprednol Etabonate|loteprednol etabonate|mesh-list
101738550|NCT04075227|Dexamethasone|dexamethasone|mesh-list
101738551|NCT04075227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101738552|NCT04075227|Antiemetics|antiemetics|mesh-ancestor
101738553|NCT04075227|Autonomic Agents|autonomic agents|mesh-ancestor
101738554|NCT04075227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101738555|NCT04075227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738557|NCT04075227|Glucocorticoids|glucocorticoids|mesh-ancestor
101738558|NCT04075227|Hormones|hormones|mesh-ancestor
101738559|NCT04075227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101738560|NCT04075227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101738561|NCT04075227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738562|NCT04075227|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101738563|NCT00585078|Capecitabine|capecitabine|mesh-list
101738564|NCT00585078|Oxaliplatin|oxaliplatin|mesh-list
101738565|NCT00585078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101738566|NCT00585078|Antimetabolites|antimetabolites|mesh-ancestor
101738567|NCT00585078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738568|NCT00585078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738569|NCT00720876|Rituximab|rituximab|mesh-list
101738570|NCT00720876|Vorinostat|vorinostat|mesh-list
101738571|NCT00720876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101738572|NCT00720876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738573|NCT00720876|Immunologic Factors|immunologic factors|mesh-ancestor
101738574|NCT00720876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738575|NCT00720876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101738576|NCT00720876|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101738577|NCT00720876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101738578|NCT00720876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738579|NCT00789581|Paclitaxel|paclitaxel|mesh-list
101738580|NCT00789581|Cyclophosphamide|cyclophosphamide|mesh-list
101738586|NCT00789581|Antimitotic Agents|antimitotic agents|mesh-ancestor
101738587|NCT00789581|Mitosis Modulators|mitosis modulators|mesh-ancestor
101738588|NCT00789581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738589|NCT00789581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101738590|NCT00789581|Immunologic Factors|immunologic factors|mesh-ancestor
101738591|NCT00789581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738592|NCT00789581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101738593|NCT00789581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101738594|NCT00789581|Alkylating Agents|alkylating agents|mesh-ancestor
101560125|NCT00879931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101560126|NCT00879931|Antiemetics|antiemetics|mesh-ancestor
101560127|NCT00879931|Autonomic Agents|autonomic agents|mesh-ancestor
101560128|NCT00879931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101560129|NCT00879931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560130|NCT00879931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101560131|NCT00879931|Glucocorticoids|glucocorticoids|mesh-ancestor
101560132|NCT00879931|Hormones|hormones|mesh-ancestor
101560133|NCT00879931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101560134|NCT00879931|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101560135|NCT00879931|Protective Agents|protective agents|mesh-ancestor
101560136|NCT00879931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101738595|NCT00789581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101738596|NCT00789581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101738597|NCT00789581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101738598|NCT00789581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101738599|NCT00789581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101738600|NCT00717756|Lenalidomide|lenalidomide|mesh-list
101738601|NCT00717756|Immunologic Factors|immunologic factors|mesh-ancestor
101738602|NCT00717756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738603|NCT00717756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101738604|NCT00717756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101738605|NCT00717756|Growth Substances|growth substances|mesh-ancestor
101738606|NCT00717756|Growth Inhibitors|growth inhibitors|mesh-ancestor
101738607|NCT00717756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738608|NCT04111289|Tirofiban|tirofiban|mesh-list
101738609|NCT04111289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101738610|NCT04111289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101738611|NCT04111289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738612|NCT04111289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101738613|NCT04108637|Penicillins|penicillins|mesh-list
101738614|NCT04108637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101738615|NCT04108637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101738616|NCT05674539|Vidarabine|vidarabine|mesh-list
101738617|NCT05674539|Fludarabine|fludarabine|mesh-list
101738618|NCT05674539|Fludarabine phosphate|fludarabine phosphate|mesh-list
101738619|NCT05674539|Melphalan|melphalan|mesh-list
101738620|NCT05674539|Busulfan|busulfan|mesh-list
101738621|NCT05674539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738622|NCT05674539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101738623|NCT05674539|Antimetabolites|antimetabolites|mesh-ancestor
101738624|NCT05674539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738625|NCT05674539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101738626|NCT05674539|Immunologic Factors|immunologic factors|mesh-ancestor
101738627|NCT05674539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738628|NCT05674539|Antiviral Agents|antiviral agents|mesh-ancestor
101738629|NCT05674539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101738630|NCT05674539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101738631|NCT05674539|Alkylating Agents|alkylating agents|mesh-ancestor
101738632|NCT05674539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101738633|NCT00717522|Pomalidomide|pomalidomide|mesh-list
101738634|NCT00717522|Immunologic Factors|immunologic factors|mesh-ancestor
101738635|NCT00717522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738636|NCT00717522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101738637|NCT00717522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101738638|NCT00717522|Growth Substances|growth substances|mesh-ancestor
101738639|NCT00717522|Growth Inhibitors|growth inhibitors|mesh-ancestor
101396118|NCT03883919|Antidotes|antidotes|mesh-ancestor
101738640|NCT00717522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738641|NCT00791921|Certolizumab Pegol|certolizumab pegol|mesh-list
101738642|NCT00791921|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101738643|NCT00791921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101470127|NCT00285051|Ondansetron|ondansetron|mesh-list
101738644|NCT00791921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101738645|NCT00791921|Immunologic Factors|immunologic factors|mesh-ancestor
101560137|NCT00879931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101560138|NCT01737619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101560140|NCT01227564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101560141|NCT01227564|Immunologic Factors|immunologic factors|mesh-ancestor
101560142|NCT01227564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560143|NCT00739141|Cyclophosphamide|cyclophosphamide|mesh-list
101738646|NCT00791921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738647|NCT00791921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101738648|NCT04106843|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
101738649|NCT04106843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738650|NCT04106843|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101738654|NCT03475953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738655|NCT03475953|Immunologic Factors|immunologic factors|mesh-ancestor
101738656|NCT03475953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738657|NCT00582933|Vidarabine|vidarabine|mesh-list
101738658|NCT00582933|Fludarabine|fludarabine|mesh-list
101738659|NCT00582933|Fludarabine phosphate|fludarabine phosphate|mesh-list
101738660|NCT00582933|Melphalan|melphalan|mesh-list
101738661|NCT00582933|Busulfan|busulfan|mesh-list
101738662|NCT00582933|Lenograstim|lenograstim|mesh-list
101738663|NCT00582933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738664|NCT00582933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101738665|NCT00582933|Antimetabolites|antimetabolites|mesh-ancestor
101738666|NCT00582933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738667|NCT00582933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101738668|NCT00582933|Immunologic Factors|immunologic factors|mesh-ancestor
101738669|NCT00582933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738670|NCT00582933|Antiviral Agents|antiviral agents|mesh-ancestor
101738671|NCT00582933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101738672|NCT00582933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101738673|NCT00582933|Alkylating Agents|alkylating agents|mesh-ancestor
101738674|NCT00582933|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101738675|NCT00582933|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101738676|NCT00791765|Etanercept|etanercept|mesh-list
101738677|NCT00791765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101738678|NCT00791765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101738679|NCT00791765|Analgesics|analgesics|mesh-ancestor
101738680|NCT00791765|Sensory System Agents|sensory system agents|mesh-ancestor
101738681|NCT00791765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101738682|NCT00791765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738683|NCT00791765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101738684|NCT00791765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101738685|NCT00791765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101738686|NCT00791765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101738687|NCT00791765|Immunologic Factors|immunologic factors|mesh-ancestor
101738688|NCT00789191|Metformin|metformin|mesh-list
101738689|NCT00789191|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101738690|NCT00789191|Insulin Detemir|insulin detemir|mesh-list
101738691|NCT00789191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101738692|NCT00789191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738693|NCT00789191|Incretins|incretins|mesh-ancestor
101738694|NCT00789191|Hormones|hormones|mesh-ancestor
101738695|NCT00789191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101738696|NCT00789191|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101738697|NCT00789191|Protease Inhibitors|protease inhibitors|mesh-ancestor
101738698|NCT00789191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101738699|NCT00789191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738700|NCT02603315|Mitogens|mitogens|mesh-list
101738701|NCT02603315|Endothelial Growth Factors|endothelial growth factors|mesh-list
101738702|NCT02603315|Mitosis Modulators|mitosis modulators|mesh-ancestor
101738703|NCT02603315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738704|NCT02603315|Growth Substances|growth substances|mesh-ancestor
101738705|NCT02603315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738707|NCT00789035|Empagliflozin|empagliflozin|mesh-list
101738708|NCT00789035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101738709|NCT00789035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738710|NCT00789035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101560144|NCT00739141|Thiotepa|thiotepa|mesh-list
101560145|NCT00739141|Fludarabine|fludarabine|mesh-list
101560146|NCT00739141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101560147|NCT00739141|Immunologic Factors|immunologic factors|mesh-ancestor
101560148|NCT00739141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738711|NCT00789035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738712|NCT04108013|Paclitaxel|paclitaxel|mesh-list
101738713|NCT04108013|Carboplatin|carboplatin|mesh-list
101738714|NCT04108013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101738715|NCT04108013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738716|NCT04108013|Tubulin Modulators|tubulin modulators|mesh-ancestor
101738717|NCT04108013|Antimitotic Agents|antimitotic agents|mesh-ancestor
101738718|NCT04108013|Mitosis Modulators|mitosis modulators|mesh-ancestor
101738719|NCT04108013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738720|NCT04105985|Oxymetazoline|oxymetazoline|mesh-list
101738721|NCT04105985|Tetracaine|tetracaine|mesh-list
101738722|NCT04105985|Carticaine|carticaine|mesh-list
101738723|NCT04105985|Anesthetics, Local|anesthetics, local|mesh-ancestor
101738724|NCT04105985|Anesthetics|anesthetics|mesh-ancestor
101490240|NCT00447369|Pregabalin|pregabalin|mesh-list
101738738|NCT04105985|Respiratory System Agents|respiratory system agents|mesh-ancestor
101738739|NCT04074213|Clozapine|clozapine|mesh-list
101738740|NCT04074213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101738741|NCT04074213|Serotonin Agents|serotonin agents|mesh-ancestor
101738742|NCT04074213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101738743|NCT04074213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738744|NCT04074213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738745|NCT04074213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101738746|NCT04074213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101738747|NCT04074213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101738748|NCT04074213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101738749|NCT04074213|GABA Antagonists|gaba antagonists|mesh-ancestor
101738750|NCT04074213|GABA Agents|gaba agents|mesh-ancestor
101738751|NCT04110587|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101738752|NCT04110587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101738753|NCT04110587|Analgesics|analgesics|mesh-list
101738754|NCT04110587|Hyaluronic Acid|hyaluronic acid|mesh-list
101738755|NCT04110587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101738756|NCT04110587|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101738757|NCT04110587|Immunologic Factors|immunologic factors|mesh-ancestor
101738758|NCT04110587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738759|NCT04110587|Viscosupplements|viscosupplements|mesh-ancestor
101738760|NCT04110587|Protective Agents|protective agents|mesh-ancestor
101738761|NCT04110587|Sensory System Agents|sensory system agents|mesh-ancestor
101738762|NCT04110587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101738763|NCT03534453|Olaparib|olaparib|mesh-list
101738764|NCT03534453|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101738765|NCT03534453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101738766|NCT03534453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738767|NCT03534453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738768|NCT04074915|Chlorhexidine|chlorhexidine|mesh-list
101738769|NCT04074915|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101738770|NCT04074915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101738771|NCT04074915|Disinfectants|disinfectants|mesh-ancestor
101738772|NCT02579733|Azathioprine|azathioprine|mesh-list
101738773|NCT02579733|Antimetabolites|antimetabolites|mesh-ancestor
101738774|NCT02579733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738775|NCT02579733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101738776|NCT02579733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738777|NCT02579733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101738778|NCT02579733|Immunologic Factors|immunologic factors|mesh-ancestor
101738779|NCT02579733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738780|NCT02579733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101738781|NCT03326193|Bevacizumab|bevacizumab|mesh-list
101738782|NCT03326193|Niraparib|niraparib|mesh-list
101738783|NCT03326193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101738784|NCT03326193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738785|NCT03326193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101738797|NCT02517099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101738798|NCT02517099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101738799|NCT02517099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101738800|NCT02517099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560149|NCT00739141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101560150|NCT00739141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101560151|NCT00739141|Alkylating Agents|alkylating agents|mesh-ancestor
101560152|NCT00739141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560153|NCT00739141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101560154|NCT00739141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101560155|NCT01148979|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101408572|NCT00453778|Dermatologic Agents|dermatologic agents|mesh-ancestor
101738801|NCT02517099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101738804|NCT02517099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101738805|NCT02517099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738806|NCT02517099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101738807|NCT02517099|Respiratory System Agents|respiratory system agents|mesh-ancestor
101738808|NCT02478099|Atezolizumab|atezolizumab|mesh-list
101738809|NCT02478099|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101738810|NCT02478099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738811|NCT02478099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101738812|NCT02478099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738813|NCT02473263|Ceftriaxone|ceftriaxone|mesh-list
101738814|NCT02473263|Tazobactam|tazobactam|mesh-list
101738815|NCT02473263|Piperacillin|piperacillin|mesh-list
101738816|NCT02473263|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101738817|NCT02473263|Hydrocortisone|hydrocortisone|mesh-list
101738818|NCT02473263|Norepinephrine|norepinephrine|mesh-list
101738819|NCT02473263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101738820|NCT02473263|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101738821|NCT02473263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101738822|NCT02473263|Adrenergic Agents|adrenergic agents|mesh-ancestor
101738823|NCT02473263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101738824|NCT02473263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738825|NCT02473263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738826|NCT02473263|Sympathomimetics|sympathomimetics|mesh-ancestor
101738827|NCT02473263|Autonomic Agents|autonomic agents|mesh-ancestor
101738828|NCT02473263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101738829|NCT02473263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101738830|NCT02473263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101738831|NCT02473263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101738832|NCT02473263|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101738833|NCT02473263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101738834|NCT03249831|Mycophenolic Acid|mycophenolic acid|mesh-list
101738835|NCT03249831|Cyclophosphamide|cyclophosphamide|mesh-list
101738836|NCT03249831|Pentostatin|pentostatin|mesh-list
101738837|NCT03249831|Tacrolimus|tacrolimus|mesh-list
101738838|NCT03249831|Thymoglobulin|thymoglobulin|mesh-list
101738839|NCT03249831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101738840|NCT03249831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101738841|NCT03249831|Immunologic Factors|immunologic factors|mesh-ancestor
101738842|NCT03249831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738843|NCT03249831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101738844|NCT03249831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101738845|NCT03249831|Alkylating Agents|alkylating agents|mesh-ancestor
101738846|NCT03249831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738847|NCT03249831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738848|NCT03249831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101738852|NCT03249831|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101738853|NCT03249831|Antitubercular Agents|antitubercular agents|mesh-ancestor
101738854|NCT03249831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101738855|NCT03249831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101738856|NCT03249831|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
101738857|NCT03222609|Navitoclax|navitoclax|mesh-list
101738858|NCT03222609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738859|NCT00437203|Gemcitabine|gemcitabine|mesh-list
101738860|NCT00437203|PF 00477736|pf 00477736|mesh-list
101738861|NCT00437203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101738862|NCT00437203|Antimetabolites|antimetabolites|mesh-ancestor
101560156|NCT01148979|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101560157|NCT01148979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560158|NCT01148979|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101560159|NCT01148979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101560160|NCT01148979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101560161|NCT01148979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560162|NCT01148979|Dopamine Agents|dopamine agents|mesh-ancestor
101560163|NCT01148979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101408581|NCT00453856|Pyrimethamine|pyrimethamine|mesh-list
101738863|NCT00437203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738864|NCT00437203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396344|NCT00316849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101738865|NCT00437203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101738866|NCT00437203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101738867|NCT02419287|Crizotinib|crizotinib|mesh-list
101738868|NCT02419287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738869|NCT02419287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101738870|NCT02419287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101738871|NCT02419287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738872|NCT00437125|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101738873|NCT00437125|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101738874|NCT00437125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101738875|NCT00437125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101738876|NCT00437125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738877|NCT00437125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101738878|NCT00437125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738879|NCT00437125|Analgesics|analgesics|mesh-ancestor
101738880|NCT00437125|Sensory System Agents|sensory system agents|mesh-ancestor
101738881|NCT00437125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101738882|NCT00437125|Antidepressive Agents|antidepressive agents|mesh-ancestor
101738883|NCT00437125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101738884|NCT00437125|Dopamine Agents|dopamine agents|mesh-ancestor
101738885|NCT01028287|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101738886|NCT01028287|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
101738887|NCT01028287|beta-Endorphin|beta-endorphin|mesh-list
101738888|NCT01028287|Hormones|hormones|mesh-ancestor
101738889|NCT01028287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101738890|NCT01028287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738891|NCT01028287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101738892|NCT01028287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738893|NCT01028443|Cyclosporine|cyclosporine|mesh-list
101738894|NCT01028443|Antifungal Agents|antifungal agents|mesh-ancestor
101738895|NCT01028443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101738896|NCT01028443|Dermatologic Agents|dermatologic agents|mesh-ancestor
101738897|NCT01028443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101738898|NCT01028443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738899|NCT01028443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101738900|NCT01028443|Immunologic Factors|immunologic factors|mesh-ancestor
101738901|NCT01028443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738902|NCT01028443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101738903|NCT01028443|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101738904|NCT03116997|Glycopyrrolate|glycopyrrolate|mesh-list
101738905|NCT03116997|Neostigmine|neostigmine|mesh-list
101738906|NCT03116997|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101738907|NCT03116997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101738908|NCT03116997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738909|NCT03116997|Cholinergic Agents|cholinergic agents|mesh-ancestor
101738910|NCT03116997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101738911|NCT03116997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738912|NCT03116997|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101738913|NCT03116997|Autonomic Agents|autonomic agents|mesh-ancestor
101560165|NCT01735825|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101560166|NCT01735825|Everolimus|everolimus|mesh-list
101560167|NCT01735825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101560168|NCT01735825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101560169|NCT01735825|Tubulin Modulators|tubulin modulators|mesh-ancestor
101560170|NCT01735825|Antimitotic Agents|antimitotic agents|mesh-ancestor
101560171|NCT01735825|Mitosis Modulators|mitosis modulators|mesh-ancestor
101560172|NCT01735825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560173|NCT01735825|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101560174|NCT01735825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101560175|NCT01735825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101560176|NCT01735825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101738914|NCT03116997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101738915|NCT03116997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101738916|NCT03116997|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101738917|NCT03116997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101738934|NCT00443053|Fondaparinux|fondaparinux|mesh-list
101738935|NCT00443053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101738936|NCT00443053|Antithrombins|antithrombins|mesh-ancestor
101738937|NCT00443053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101738938|NCT00443053|Protease Inhibitors|protease inhibitors|mesh-ancestor
101738939|NCT00443053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101738940|NCT00443053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738941|NCT00443053|Anticoagulants|anticoagulants|mesh-ancestor
101738942|NCT00443053|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101738943|NCT00443053|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101738944|NCT00720798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101738945|NCT00720798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101738946|NCT00720798|Antirheumatic Agents|antirheumatic agents|mesh-list
101738947|NCT00720798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101738948|NCT00720798|Analgesics|analgesics|mesh-ancestor
101738949|NCT00720798|Sensory System Agents|sensory system agents|mesh-ancestor
101738950|NCT00720798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101738951|NCT00720798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738952|NCT01816971|Dexamethasone|dexamethasone|mesh-list
101738953|NCT01816971|Lenalidomide|lenalidomide|mesh-list
101738954|NCT01816971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101738955|NCT01816971|Antiemetics|antiemetics|mesh-ancestor
101738956|NCT01816971|Autonomic Agents|autonomic agents|mesh-ancestor
101738957|NCT01816971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101738958|NCT01816971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738959|NCT01816971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101738960|NCT01816971|Glucocorticoids|glucocorticoids|mesh-ancestor
101738961|NCT01816971|Hormones|hormones|mesh-ancestor
101738962|NCT01816971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101738963|NCT01816971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101738964|NCT01816971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738965|NCT01816971|Immunologic Factors|immunologic factors|mesh-ancestor
101738966|NCT01816971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101738967|NCT01816971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101738968|NCT01816971|Growth Substances|growth substances|mesh-ancestor
101738969|NCT01816971|Growth Inhibitors|growth inhibitors|mesh-ancestor
101738970|NCT01021267|Saw palmetto extract|saw palmetto extract|mesh-list
101738971|NCT01021267|Urological Agents|urological agents|mesh-ancestor
101738972|NCT00717366|Epoetin Alfa|epoetin alfa|mesh-list
101738973|NCT00717366|Hematinics|hematinics|mesh-ancestor
101738974|NCT02939989|Ribavirin|ribavirin|mesh-list
101738975|NCT02939989|Sofosbuvir|sofosbuvir|mesh-list
101738976|NCT02939989|Antimetabolites|antimetabolites|mesh-ancestor
101738977|NCT02939989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738978|NCT02939989|Antiviral Agents|antiviral agents|mesh-ancestor
101738979|NCT02939989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101738980|NCT04096742|Tretinoin|tretinoin|mesh-list
101560177|NCT01735825|Immunologic Factors|immunologic factors|mesh-ancestor
101560178|NCT01735825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560179|NCT01148511|Ranibizumab|ranibizumab|mesh-list
101560180|NCT01148511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101560182|NCT01148511|Growth Substances|growth substances|mesh-ancestor
101408604|NCT00454402|Alfuzosin|alfuzosin|mesh-list
101738981|NCT04096742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101490512|NCT00454350|Vitamins|vitamins|mesh-ancestor
101738990|NCT04085640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101738991|NCT01031719|Vaccines|vaccines|mesh-list
101738992|NCT01031719|Immunologic Factors|immunologic factors|mesh-ancestor
101738993|NCT01031719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738994|NCT00723606|Haloperidol|haloperidol|mesh-list
101738995|NCT00723606|Haloperidol decanoate|haloperidol decanoate|mesh-list
101738996|NCT00723606|Ziprasidone|ziprasidone|mesh-list
101738997|NCT00723606|Antiemetics|antiemetics|mesh-ancestor
101738998|NCT00723606|Autonomic Agents|autonomic agents|mesh-ancestor
101738999|NCT00723606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101739000|NCT00723606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739001|NCT00723606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101739002|NCT00723606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101739003|NCT00723606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101739004|NCT00723606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101739005|NCT00723606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101739006|NCT00723606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101739007|NCT00723606|Dopamine Agents|dopamine agents|mesh-ancestor
101739008|NCT00723606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101739009|NCT00723606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739010|NCT00723606|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101739011|NCT00723606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101739012|NCT00723606|Serotonin Agents|serotonin agents|mesh-ancestor
101739014|NCT01021501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101739015|NCT01021501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101739016|NCT01021501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739017|NCT01021501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101739018|NCT01021501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739019|NCT01021501|Vasodilator Agents|vasodilator agents|mesh-ancestor
101739020|NCT01021501|Tocolytic Agents|tocolytic agents|mesh-ancestor
101739021|NCT01021501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101739023|NCT01021579|Simvastatin|simvastatin|mesh-list
101739024|NCT01021579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101739025|NCT01021579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739026|NCT01021579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101739027|NCT01021579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101739028|NCT01021579|Antimetabolites|antimetabolites|mesh-ancestor
101739029|NCT01021579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739030|NCT01021579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101739031|NCT01021579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101739032|NCT01021579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101739033|NCT01031875|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101739034|NCT01031875|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101739035|NCT01031875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739036|NCT01021735|Adalimumab|adalimumab|mesh-list
101739037|NCT01021735|Etanercept|etanercept|mesh-list
101739038|NCT01021735|Rituximab|rituximab|mesh-list
101739039|NCT01021735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101739040|NCT01021735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101739041|NCT01021735|Immunologic Factors|immunologic factors|mesh-ancestor
101739042|NCT01021735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739043|NCT01021735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101739044|NCT01021735|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101739045|NCT01021735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101739046|NCT01021735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101739047|NCT01021735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101739048|NCT01021735|Analgesics|analgesics|mesh-ancestor
101739049|NCT01021735|Sensory System Agents|sensory system agents|mesh-ancestor
101739050|NCT01021735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101739054|NCT00442351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101739055|NCT00442351|Dermatologic Agents|dermatologic agents|mesh-ancestor
101739056|NCT00442351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101560183|NCT01148511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560184|NCT01148511|Growth Inhibitors|growth inhibitors|mesh-ancestor
101560185|NCT01148511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101560186|NCT02860117|Ketamine|ketamine|mesh-list
101560187|NCT02860117|Analgesics|analgesics|mesh-ancestor
101560188|NCT02860117|Sensory System Agents|sensory system agents|mesh-ancestor
101560189|NCT02860117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101560190|NCT02860117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408606|NCT00454402|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101739057|NCT00436501|Docetaxel|docetaxel|mesh-list
101739058|NCT00436501|Aflibercept|aflibercept|mesh-list
101739059|NCT00436501|Endothelial Growth Factors|endothelial growth factors|mesh-list
101739060|NCT00436501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101739061|NCT00436501|Tubulin Modulators|tubulin modulators|mesh-ancestor
101739062|NCT00436501|Antimitotic Agents|antimitotic agents|mesh-ancestor
101739063|NCT00436501|Mitosis Modulators|mitosis modulators|mesh-ancestor
101739064|NCT00436501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739065|NCT00436501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101739066|NCT00436501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101739067|NCT00436501|Growth Substances|growth substances|mesh-ancestor
101739068|NCT00436501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739069|NCT00436501|Growth Inhibitors|growth inhibitors|mesh-ancestor
101739070|NCT00755846|Alogliptin|alogliptin|mesh-list
101739071|NCT00755846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101739072|NCT00755846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739073|NCT00755846|Incretins|incretins|mesh-ancestor
101739074|NCT00755846|Hormones|hormones|mesh-ancestor
101739075|NCT00755846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101739076|NCT00755846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101739077|NCT00755846|Protease Inhibitors|protease inhibitors|mesh-ancestor
101739078|NCT00755846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101739079|NCT00755846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739080|NCT03850093|Bisoprolol|bisoprolol|mesh-list
101739081|NCT03850093|Gabapentin|gabapentin|mesh-list
101739082|NCT03850093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739083|NCT03850093|Analgesics|analgesics|mesh-ancestor
101739084|NCT03850093|Sensory System Agents|sensory system agents|mesh-ancestor
101739085|NCT03850093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101739086|NCT03850093|Anticonvulsants|anticonvulsants|mesh-ancestor
101739087|NCT03850093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101739088|NCT03850093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101739089|NCT03850093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101739090|NCT03850093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101739091|NCT03850093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101739092|NCT03850093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101739093|NCT03850093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101739094|NCT03850093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739095|NCT03850093|Antimanic Agents|antimanic agents|mesh-ancestor
101739096|NCT03850093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101739097|NCT03850093|Sympatholytics|sympatholytics|mesh-ancestor
101739098|NCT03850093|Autonomic Agents|autonomic agents|mesh-ancestor
101739099|NCT03850093|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101739100|NCT03850093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101739101|NCT03850093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101739102|NCT03850093|Adrenergic Agents|adrenergic agents|mesh-ancestor
101739103|NCT00442117|Mometasone Furoate|mometasone furoate|mesh-list
101739104|NCT00442117|Budesonide|budesonide|mesh-list
101739105|NCT00442117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101739106|NCT00442117|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101739107|NCT00442117|Autonomic Agents|autonomic agents|mesh-ancestor
101739108|NCT00442117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101739109|NCT00442117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739110|NCT00442117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101739111|NCT00442117|Respiratory System Agents|respiratory system agents|mesh-ancestor
101739112|NCT00442117|Glucocorticoids|glucocorticoids|mesh-ancestor
101739113|NCT00442117|Hormones|hormones|mesh-ancestor
101560192|NCT02860117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101560193|NCT02860117|Anesthetics, General|anesthetics, general|mesh-ancestor
101560194|NCT02860117|Anesthetics|anesthetics|mesh-ancestor
101560195|NCT02860117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101560196|NCT02860117|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101560197|NCT02860117|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101560198|NCT02860117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101408621|NCT00454480|Cytarabine|cytarabine|mesh-list
101739114|NCT00442117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101739115|NCT00442117|Dermatologic Agents|dermatologic agents|mesh-ancestor
101739116|NCT00442117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101739117|NCT00752726|Orlistat|orlistat|mesh-list
101739118|NCT00752726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101739119|NCT00752726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739120|NCT00752726|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101739121|NCT00752726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101739122|NCT04072497|Vaccines|vaccines|mesh-list
101739123|NCT04072497|Immunologic Factors|immunologic factors|mesh-ancestor
101739139|NCT04072263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739141|NCT00441727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101739142|NCT00441727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101739143|NCT00441727|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101739144|NCT00441727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101739145|NCT00441727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739146|NCT00770120|Everolimus|everolimus|mesh-list
101739147|NCT00770120|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101739148|NCT00770120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101739149|NCT00770120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101739150|NCT00770120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739151|NCT00770120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101739152|NCT00770120|Immunologic Factors|immunologic factors|mesh-ancestor
101739153|NCT00770120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739154|NCT00770120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101739155|NCT03996655|Neostigmine|neostigmine|mesh-list
101739156|NCT03996655|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101739157|NCT03996655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101739158|NCT03996655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739159|NCT03996655|Cholinergic Agents|cholinergic agents|mesh-ancestor
101739160|NCT03996655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101739161|NCT03996655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739162|NCT03996655|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101739163|NCT03996655|Autonomic Agents|autonomic agents|mesh-ancestor
101739164|NCT03996655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101739165|NCT01032109|Bevacizumab|bevacizumab|mesh-list
101396644|NCT00329446|Antidepressive Agents|antidepressive agents|mesh-ancestor
101739166|NCT01032109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101739168|NCT01032109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101739169|NCT01032109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101739170|NCT01032109|Growth Substances|growth substances|mesh-ancestor
101739171|NCT01032109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739172|NCT01032109|Growth Inhibitors|growth inhibitors|mesh-ancestor
101739173|NCT04100330|Cytarabine|cytarabine|mesh-list
101739174|NCT04100330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101739175|NCT04100330|Antimetabolites|antimetabolites|mesh-ancestor
101739176|NCT04100330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739177|NCT04100330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101739178|NCT04100330|Antiviral Agents|antiviral agents|mesh-ancestor
101739179|NCT04100330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101739180|NCT04100330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101739181|NCT04100330|Immunologic Factors|immunologic factors|mesh-ancestor
101739182|NCT04100330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739183|NCT00436345|Remifentanil|remifentanil|mesh-list
101739203|NCT00916448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101739204|NCT00916448|Antiviral Agents|antiviral agents|mesh-ancestor
101560199|NCT02860117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560201|NCT02853253|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101560202|NCT02853253|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101560203|NCT02853253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101560204|NCT04269187|Theophylline|theophylline|mesh-list
101560205|NCT04269187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101560206|NCT04269187|Autonomic Agents|autonomic agents|mesh-ancestor
101560207|NCT04269187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101560208|NCT04269187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408625|NCT00454480|Melphalan|melphalan|mesh-list
101739205|NCT00916448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101739206|NCT01032187|Amphotericin B|amphotericin b|mesh-list
101739207|NCT01032187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101739208|NCT01032187|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
101739209|NCT01032187|Meglumine Antimoniate|meglumine antimoniate|mesh-list
101739210|NCT01032187|Deoxycholic Acid|deoxycholic acid|mesh-list
101739211|NCT01032187|Amebicides|amebicides|mesh-ancestor
101739212|NCT01032187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101739213|NCT01032187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101739214|NCT01032187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101739215|NCT01032187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101739216|NCT01032187|Antifungal Agents|antifungal agents|mesh-ancestor
101739217|NCT01032187|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101739218|NCT01032187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101739219|NCT00769184|Clobetasol|clobetasol|mesh-list
101739220|NCT00769184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101739221|NCT00769184|Glucocorticoids|glucocorticoids|mesh-ancestor
101739222|NCT00769184|Hormones|hormones|mesh-ancestor
101739223|NCT00769184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101739224|NCT00769184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739225|NCT00768560|Nifedipine|nifedipine|mesh-list
101739227|NCT00768560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101739228|NCT00768560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739229|NCT00768560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101739230|NCT00768560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739231|NCT00768560|Vasodilator Agents|vasodilator agents|mesh-ancestor
101739232|NCT00768560|Tocolytic Agents|tocolytic agents|mesh-ancestor
101739233|NCT00768560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101739234|NCT00468559|Esomeprazole|esomeprazole|mesh-list
101739235|NCT00468559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101739236|NCT00468559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101739237|NCT00468559|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101739238|NCT00468559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101739239|NCT00468559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739240|NCT00754442|Teriparatide|teriparatide|mesh-list
101490768|NCT04698213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101739255|NCT04095182|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101739256|NCT04095182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101739257|NCT04095182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739259|NCT02927067|Maribavir|maribavir|mesh-list
101739260|NCT02927067|Antiviral Agents|antiviral agents|mesh-ancestor
101739261|NCT02927067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101739262|NCT02600468|Abatacept|abatacept|mesh-list
101739263|NCT02600468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101739264|NCT02600468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470231|NCT00278265|Immunologic Factors|immunologic factors|mesh-ancestor
101739265|NCT02600468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101739266|NCT02600468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101739267|NCT02600468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101739268|NCT02600468|Immunologic Factors|immunologic factors|mesh-ancestor
101739269|NCT02600468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739270|NCT02600468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101739271|NCT02598596|Azathioprine|azathioprine|mesh-list
101560209|NCT04269187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101560210|NCT04269187|Respiratory System Agents|respiratory system agents|mesh-ancestor
101560211|NCT04269187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101560212|NCT04269187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101560213|NCT04269187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560214|NCT04269187|Vasodilator Agents|vasodilator agents|mesh-ancestor
101560215|NCT04269187|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101560216|NCT04269187|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101560217|NCT04269187|Purinergic Agents|purinergic agents|mesh-ancestor
101560218|NCT04269187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101560219|NCT04269109|Analgesics, Opioid|analgesics, opioid|mesh-list
101560220|NCT04269109|Narcotics|narcotics|mesh-ancestor
101560221|NCT04269109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101739272|NCT02598596|Antimetabolites|antimetabolites|mesh-ancestor
101739273|NCT02598596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739274|NCT02598596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101739275|NCT02598596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101739276|NCT02598596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101739277|NCT02598596|Immunologic Factors|immunologic factors|mesh-ancestor
101739278|NCT02598596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739279|NCT02598596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101739280|NCT00586508|Bevacizumab|bevacizumab|mesh-list
101739281|NCT00586508|Anticonvulsants|anticonvulsants|mesh-list
101739282|NCT00586508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101739283|NCT00586508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101739284|NCT00586508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101739285|NCT00586508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101739286|NCT00586508|Growth Substances|growth substances|mesh-ancestor
101739287|NCT00586508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739288|NCT00586508|Growth Inhibitors|growth inhibitors|mesh-ancestor
101739289|NCT00581919|Acetylcarnitine|acetylcarnitine|mesh-list
101739290|NCT00581919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739291|NCT00581919|Vitamin B Complex|vitamin b complex|mesh-ancestor
101739292|NCT00581919|Vitamins|vitamins|mesh-ancestor
101739293|NCT00581919|Micronutrients|micronutrients|mesh-ancestor
101739294|NCT00581919|Nootropic Agents|nootropic agents|mesh-ancestor
101739295|NCT00723528|Ustekinumab|ustekinumab|mesh-list
101739296|NCT00723528|Dermatologic Agents|dermatologic agents|mesh-ancestor
101739297|NCT00751790|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101739298|NCT00751790|Luteolytic Agents|luteolytic agents|mesh-ancestor
101739299|NCT00751790|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101739301|NCT00751790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101739302|NCT00751790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739331|NCT00723450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101739332|NCT00723450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101739333|NCT00723450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101739335|NCT02599532|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101739336|NCT02599532|Antithrombins|antithrombins|mesh-ancestor
101739337|NCT02599532|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101739338|NCT02599532|Protease Inhibitors|protease inhibitors|mesh-ancestor
101739339|NCT02599532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101739340|NCT02599532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739341|NCT02599532|Anticoagulants|anticoagulants|mesh-ancestor
101739342|NCT04085094|Pilocarpine|pilocarpine|mesh-list
101739343|NCT04085094|Miotics|miotics|mesh-ancestor
101739344|NCT04085094|Autonomic Agents|autonomic agents|mesh-ancestor
101739345|NCT04085094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101739346|NCT04085094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739347|NCT04085094|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101739348|NCT04085094|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101739356|NCT00751400|Sensory System Agents|sensory system agents|mesh-ancestor
101739359|NCT00751400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101739360|NCT00751400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101739361|NCT00751400|Gout Suppressants|gout suppressants|mesh-ancestor
101739362|NCT00751400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101739363|NCT00751400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101739364|NCT00751400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739377|NCT00585312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101739378|NCT00585312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101739379|NCT00585312|Analgesics|analgesics|mesh-ancestor
101739380|NCT00585312|Sensory System Agents|sensory system agents|mesh-ancestor
101739381|NCT00585312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101739382|NCT00585312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739383|NCT00585312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101739384|NCT00585312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101739385|NCT00585312|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101739386|NCT00585312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101739387|NCT00585312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101739388|NCT00585312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396870|NCT00317629|Nitric Oxide|nitric oxide|mesh-list
101739389|NCT00753506|Artemisinins|artemisinins|mesh-list
101739390|NCT00753506|Artemisinin|artemisinin|mesh-list
101739391|NCT00753506|Antimalarials|antimalarials|mesh-ancestor
101739392|NCT00753506|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101739393|NCT00753506|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101739394|NCT00753506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101739395|NCT00720096|Doxorubicin|doxorubicin|mesh-list
101739396|NCT00720096|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101739397|NCT00720096|Topotecan|topotecan|mesh-list
101739398|NCT00720096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101739399|NCT00720096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101739400|NCT00720096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101739401|NCT00720096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101739402|NCT00720096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101739403|NCT00720096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739404|NCT00720096|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101739405|NCT04086108|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
101739406|NCT04086108|GABA Agents|gaba agents|mesh-ancestor
101739407|NCT04086108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101739408|NCT04086108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739409|NCT04086108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739410|NCT02577783|Dexamethasone|dexamethasone|mesh-list
101739411|NCT02577783|Dexamethasone acetate|dexamethasone acetate|mesh-list
101739412|NCT02577783|Doxorubicin|doxorubicin|mesh-list
101739413|NCT02577783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101560231|NCT04268563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560232|NCT04268563|Incretins|incretins|mesh-ancestor
101560233|NCT04268563|Hormones|hormones|mesh-ancestor
101560234|NCT04268563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101739414|NCT02577783|BB 1101|bb 1101|mesh-list
101739415|NCT02577783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101739422|NCT02577783|Hormones|hormones|mesh-ancestor
101739423|NCT02577783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101739424|NCT02577783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101739425|NCT02577783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101470267|NCT00278382|Sorafenib|sorafenib|mesh-list
101739426|NCT02577783|Protease Inhibitors|protease inhibitors|mesh-ancestor
101739427|NCT02577783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101739428|NCT02577783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739429|NCT02577783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101739430|NCT02577783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101739431|NCT02577783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101739432|NCT00918450|Navitoclax|navitoclax|mesh-list
101739433|NCT00918450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101739434|NCT02591628|Chlorthalidone|chlorthalidone|mesh-list
101739435|NCT02591628|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101739436|NCT02591628|Diuretics|diuretics|mesh-ancestor
101739437|NCT02591628|Natriuretic Agents|natriuretic agents|mesh-ancestor
101739438|NCT02591628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739439|NCT02591628|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101739440|NCT02591628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101739441|NCT02591628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739442|NCT04090112|Lidocaine|lidocaine|mesh-list
101739443|NCT04090112|Anesthetics, Local|anesthetics, local|mesh-ancestor
101739444|NCT04090112|Anesthetics|anesthetics|mesh-ancestor
101739445|NCT04090112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101739446|NCT04090112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739448|NCT04090112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101739449|NCT04090112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101739450|NCT04090112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101739451|NCT04090112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101739452|NCT04090112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101739453|NCT04090112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739454|NCT00747344|Ustekinumab|ustekinumab|mesh-list
101739455|NCT00747344|Dermatologic Agents|dermatologic agents|mesh-ancestor
101739456|NCT00580983|Paclitaxel|paclitaxel|mesh-list
101739457|NCT00580983|Carboplatin|carboplatin|mesh-list
101739458|NCT00580983|Fluorouracil|fluorouracil|mesh-list
101739459|NCT00580983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101739460|NCT00580983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101739461|NCT00580983|Tubulin Modulators|tubulin modulators|mesh-ancestor
101739462|NCT00580983|Antimitotic Agents|antimitotic agents|mesh-ancestor
101739463|NCT00580983|Mitosis Modulators|mitosis modulators|mesh-ancestor
101739464|NCT00580983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739466|NCT00580983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101739467|NCT00580983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101739468|NCT00580983|Immunologic Factors|immunologic factors|mesh-ancestor
101739469|NCT00580983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739470|NCT02576223|Ropivacaine|ropivacaine|mesh-list
101739471|NCT02576223|Anesthetics, Local|anesthetics, local|mesh-ancestor
101739472|NCT02576223|Anesthetics|anesthetics|mesh-ancestor
101739473|NCT02576223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101739474|NCT02576223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739475|NCT02576223|Sensory System Agents|sensory system agents|mesh-ancestor
101739476|NCT02576223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101739477|NCT02309931|Antidiarrheals|antidiarrheals|mesh-list
101739478|NCT02309931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101739479|NCT02577393|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
101739480|NCT02577393|Antioxidants|antioxidants|mesh-ancestor
101739481|NCT02577393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739482|NCT02577393|Protective Agents|protective agents|mesh-ancestor
101739483|NCT02577393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739484|NCT02577393|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101739485|NCT02577393|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101739517|NCT00743444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560235|NCT04268563|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101560236|NCT04268563|Protease Inhibitors|protease inhibitors|mesh-ancestor
101560237|NCT04268563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101560238|NCT04268563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560239|NCT01225146|Ranibizumab|ranibizumab|mesh-list
101560240|NCT01225146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101560241|NCT01225146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101560242|NCT01225146|Growth Substances|growth substances|mesh-ancestor
101560243|NCT01225146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560244|NCT01225146|Growth Inhibitors|growth inhibitors|mesh-ancestor
101739518|NCT00743366|Riboflavin|riboflavin|mesh-list
101739519|NCT00743366|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101739520|NCT00743366|Antidepressive Agents|antidepressive agents|mesh-ancestor
101739521|NCT00743366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101739522|NCT00743366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101739523|NCT00743366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101739524|NCT00743366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101739525|NCT00743366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739526|NCT00743366|Vitamin B Complex|vitamin b complex|mesh-ancestor
101739527|NCT00743366|Vitamins|vitamins|mesh-ancestor
101739528|NCT00743366|Micronutrients|micronutrients|mesh-ancestor
101739529|NCT00743366|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101739530|NCT00743366|Dermatologic Agents|dermatologic agents|mesh-ancestor
101739531|NCT01760655|Mycophenolic Acid|mycophenolic acid|mesh-list
101739557|NCT00743288|Panobinostat|panobinostat|mesh-list
101739558|NCT00743288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101739559|NCT00743288|Alkylating Agents|alkylating agents|mesh-ancestor
101739560|NCT00743288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739561|NCT00743288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101739562|NCT00743288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101739563|NCT00743288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101739564|NCT00743288|Immunologic Factors|immunologic factors|mesh-ancestor
101739565|NCT00743288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739566|NCT00743288|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101739567|NCT00743288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101739568|NCT02579187|Anesthetics|anesthetics|mesh-list
101739569|NCT02579187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101739570|NCT02579187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739571|NCT02598440|Alendronate|alendronate|mesh-list
101739572|NCT02598440|Ibandronic Acid|ibandronic acid|mesh-list
101739573|NCT02598440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101739574|NCT02598440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739575|NCT00750308|Ramipril|ramipril|mesh-list
101739576|NCT00750308|Tadalafil|tadalafil|mesh-list
101739577|NCT00750308|Vasodilator Agents|vasodilator agents|mesh-ancestor
101739578|NCT00750308|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101739579|NCT00750308|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101739580|NCT00750308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101739581|NCT00750308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739590|NCT02597036|Paclitaxel|paclitaxel|mesh-list
101739591|NCT02597036|Ramucirumab|ramucirumab|mesh-list
101739592|NCT02597036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101739593|NCT02597036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101739594|NCT02597036|Tubulin Modulators|tubulin modulators|mesh-ancestor
101739595|NCT02597036|Antimitotic Agents|antimitotic agents|mesh-ancestor
101739596|NCT02597036|Mitosis Modulators|mitosis modulators|mesh-ancestor
101739597|NCT02597036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739598|NCT02597036|Antiviral Agents|antiviral agents|mesh-ancestor
101739599|NCT02597036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101739600|NCT04071639|Ubiquinone|ubiquinone|mesh-list
101739601|NCT04071639|Haloperidol|haloperidol|mesh-list
101739602|NCT04071639|Risperidone|risperidone|mesh-list
101739603|NCT04071639|Haloperidol decanoate|haloperidol decanoate|mesh-list
101739604|NCT04071639|Sertraline|sertraline|mesh-list
101739605|NCT04071639|Tetrabenazine|tetrabenazine|mesh-list
101560245|NCT01225146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101560246|NCT01223196|Pioglitazone|pioglitazone|mesh-list
101560247|NCT01223196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101560248|NCT01223196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560249|NCT01222416|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
101560250|NCT01222416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560251|NCT00950911|Denosumab|denosumab|mesh-list
101560252|NCT00950911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101560253|NCT00950911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739606|NCT04071639|Idebenone|idebenone|mesh-list
101739607|NCT04071639|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101739608|NCT04071639|Serotonin Agents|serotonin agents|mesh-ancestor
101739609|NCT04071639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101739610|NCT04071639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739611|NCT04071639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739612|NCT04071639|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101739613|NCT04071639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101739614|NCT04071639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101739615|NCT04071639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101397105|NCT00318448|Zolpidem|zolpidem|mesh-list
101739616|NCT04071639|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101739617|NCT04071639|Dopamine Agents|dopamine agents|mesh-ancestor
101739618|NCT04071639|Antidepressive Agents|antidepressive agents|mesh-ancestor
101739619|NCT04071639|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101739620|NCT04071639|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101739621|NCT04071639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101739622|NCT04071639|Antiemetics|antiemetics|mesh-ancestor
101739623|NCT04071639|Autonomic Agents|autonomic agents|mesh-ancestor
101739624|NCT04071639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101739625|NCT04071639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101739626|NCT04071639|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101739627|NCT04071639|Antioxidants|antioxidants|mesh-ancestor
101739628|NCT04071639|Protective Agents|protective agents|mesh-ancestor
101739629|NCT04071639|Micronutrients|micronutrients|mesh-ancestor
101739630|NCT04071639|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101739631|NCT04071639|Adrenergic Agents|adrenergic agents|mesh-ancestor
101739632|NCT04089176|Oxytocin|oxytocin|mesh-list
101739633|NCT04089176|Carbetocin|carbetocin|mesh-list
101739634|NCT04089176|Oxytocics|oxytocics|mesh-ancestor
101739635|NCT04089176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101739636|NCT04089176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739637|NCT02577159|Dapagliflozin|dapagliflozin|mesh-list
101739638|NCT02577159|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101739639|NCT02577159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739640|NCT02577159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101739641|NCT02577159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739642|NCT00749684|Interferons|interferons|mesh-list
101739643|NCT00749684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101739644|NCT00749684|Antiviral Agents|antiviral agents|mesh-ancestor
101739645|NCT00749684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101739646|NCT02575755|Azithromycin|azithromycin|mesh-list
101739647|NCT02575755|Pyrimethamine|pyrimethamine|mesh-list
101739648|NCT02575755|Piperaquine|piperaquine|mesh-list
101739649|NCT02575755|Sulfadoxine|sulfadoxine|mesh-list
101739650|NCT02575755|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101739683|NCT01298193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101739684|NCT01298193|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101739685|NCT01298193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101739686|NCT01298193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739687|NCT01298193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101739688|NCT01298193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101397169|NCT00325390|Clopidogrel|clopidogrel|mesh-list
101739689|NCT01298193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101739690|NCT01298193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101739691|NCT01298193|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101739693|NCT01298193|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101560254|NCT02855515|Anesthetics|anesthetics|mesh-list
101560255|NCT02855515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101560256|NCT02855515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560257|NCT04206228|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
101560258|NCT04206228|Hematinics|hematinics|mesh-ancestor
101560259|NCT01218594|Endostatins|endostatins|mesh-list
101560260|NCT01218594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101408683|NCT00454519|Mitomycins|mitomycins|mesh-list
101739696|NCT01298193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101739697|NCT01298193|Serotonin Agents|serotonin agents|mesh-ancestor
101739698|NCT01298193|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101739699|NCT01298193|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101739700|NCT01298193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101739701|NCT02590536|Sildenafil Citrate|sildenafil citrate|mesh-list
101739702|NCT02590536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739703|NCT02590536|Vasodilator Agents|vasodilator agents|mesh-ancestor
101739704|NCT02590536|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101739705|NCT02590536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101739706|NCT02590536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101739707|NCT02590536|Urological Agents|urological agents|mesh-ancestor
101739708|NCT00719862|Azelastine|azelastine|mesh-list
101739709|NCT00719862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101739710|NCT00719862|Autonomic Agents|autonomic agents|mesh-ancestor
101739711|NCT00719862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101739712|NCT00719862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739713|NCT00719862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101739714|NCT00719862|Respiratory System Agents|respiratory system agents|mesh-ancestor
101739715|NCT00719862|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101739716|NCT00719862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101739717|NCT00719862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739718|NCT00719862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101739719|NCT00719862|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101739720|NCT00719862|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101739721|NCT00719862|Histamine Antagonists|histamine antagonists|mesh-ancestor
101739722|NCT00719862|Histamine Agents|histamine agents|mesh-ancestor
101739723|NCT00719862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101739724|NCT02578953|Dutasteride|dutasteride|mesh-list
101739725|NCT02578953|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101739726|NCT02578953|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101739727|NCT02578953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101739728|NCT02578953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739729|NCT02578953|Hormone Antagonists|hormone antagonists|mesh-ancestor
101739730|NCT02578953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101739731|NCT02578953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739732|NCT02578719|Bupivacaine|bupivacaine|mesh-list
101739733|NCT02578719|Anesthetics, Local|anesthetics, local|mesh-ancestor
101739734|NCT02578719|Anesthetics|anesthetics|mesh-ancestor
101739735|NCT02578719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101739736|NCT02578719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739737|NCT02578719|Sensory System Agents|sensory system agents|mesh-ancestor
101739738|NCT02578719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101739739|NCT00742508|Carvedilol|carvedilol|mesh-list
101739740|NCT00742508|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101739741|NCT00742508|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101739742|NCT00742508|Adrenergic Agents|adrenergic agents|mesh-ancestor
101739743|NCT00742508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101739744|NCT00742508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263324|NCT01761214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101739745|NCT00742508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739746|NCT00742508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101739747|NCT00742508|Antioxidants|antioxidants|mesh-ancestor
101739748|NCT00742508|Protective Agents|protective agents|mesh-ancestor
101739749|NCT00742508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101739750|NCT00742508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101739751|NCT00742508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101739752|NCT00742508|Vasodilator Agents|vasodilator agents|mesh-ancestor
101560261|NCT01218594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101560263|NCT01218594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560264|NCT01218594|Growth Inhibitors|growth inhibitors|mesh-ancestor
101560265|NCT01218594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101560266|NCT01610557|Bevacizumab|bevacizumab|mesh-list
101560267|NCT01610557|Ranibizumab|ranibizumab|mesh-list
101560268|NCT01610557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101739753|NCT00742508|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101739754|NCT00742508|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101739755|NCT02590614|Vitamin D|vitamin d|mesh-list
101739756|NCT02590614|Vitamins|vitamins|mesh-ancestor
101739757|NCT02590614|Micronutrients|micronutrients|mesh-ancestor
101739758|NCT02590614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739759|NCT02590614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101739760|NCT02575443|Rocuronium|rocuronium|mesh-list
101739761|NCT02575443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101739762|NCT02575443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101739763|NCT02575443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101739768|NCT02596334|Dolutegravir|dolutegravir|mesh-list
101739769|NCT02596334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101739770|NCT02596334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101739771|NCT02596334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101739772|NCT02596334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739773|NCT02596334|Antiviral Agents|antiviral agents|mesh-ancestor
101739774|NCT02596334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101739775|NCT02596334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101739776|NCT02596334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101739777|NCT02596334|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101739778|NCT02596334|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101739779|NCT00719706|Acetylcarnitine|acetylcarnitine|mesh-list
101739780|NCT00719706|Vitamin B Complex|vitamin b complex|mesh-ancestor
101739781|NCT00719706|Vitamins|vitamins|mesh-ancestor
101739782|NCT00719706|Micronutrients|micronutrients|mesh-ancestor
101739783|NCT00719706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739784|NCT00719706|Nootropic Agents|nootropic agents|mesh-ancestor
101739785|NCT02575521|Dexmedetomidine|dexmedetomidine|mesh-list
101739786|NCT02575521|Propofol|propofol|mesh-list
101739787|NCT02575521|Sevoflurane|sevoflurane|mesh-list
101739788|NCT02575521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101739789|NCT02575521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101739790|NCT02575521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739791|NCT02575521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101739792|NCT02575521|Analgesics|analgesics|mesh-ancestor
101739793|NCT02575521|Sensory System Agents|sensory system agents|mesh-ancestor
101739794|NCT02575521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101739795|NCT02575521|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101739796|NCT02575521|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101739797|NCT02575521|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101739798|NCT02575521|Adrenergic Agents|adrenergic agents|mesh-ancestor
101739799|NCT02575521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101739800|NCT02575521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739801|NCT02575521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101739802|NCT02575521|Anesthetics, General|anesthetics, general|mesh-ancestor
101739803|NCT02575521|Anesthetics|anesthetics|mesh-ancestor
101739804|NCT02575521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101739805|NCT02575521|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101739806|NCT02576457|BMS-936559|bms-936559|mesh-list
101739807|NCT02576457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101739808|NCT02576457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101739809|NCT05276102|Emollients|emollients|mesh-list
101739810|NCT05276102|Dermatologic Agents|dermatologic agents|mesh-ancestor
101739811|NCT01192971|Apatinib|apatinib|mesh-list
101739812|NCT01192971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101739813|NCT01192971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101739814|NCT01192971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101739815|NCT01192971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739816|NCT00719472|Antipyretics|antipyretics|mesh-list
101560269|NCT01610557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101560270|NCT01610557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101560271|NCT01610557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101560272|NCT01610557|Growth Substances|growth substances|mesh-ancestor
101560273|NCT01610557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560274|NCT01610557|Growth Inhibitors|growth inhibitors|mesh-ancestor
101560275|NCT00943735|Fesoterodine|fesoterodine|mesh-list
101560276|NCT00943735|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101408697|NCT00110045|Caspofungin|caspofungin|mesh-list
101739817|NCT00719472|Prednisone|prednisone|mesh-list
101739818|NCT00719472|Cyclophosphamide|cyclophosphamide|mesh-list
101739819|NCT00719472|Rituximab|rituximab|mesh-list
101739821|NCT00719472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101739822|NCT00719472|Vincristine|vincristine|mesh-list
101739823|NCT00719472|Analgesics|analgesics|mesh-list
101739824|NCT00719472|Histamine Antagonists|histamine antagonists|mesh-list
101739825|NCT00719472|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
101739826|NCT00719472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101739827|NCT00719472|Immunologic Factors|immunologic factors|mesh-ancestor
101739828|NCT00719472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739829|NCT00719472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101739830|NCT00719472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101739831|NCT00719472|Alkylating Agents|alkylating agents|mesh-ancestor
101739832|NCT00719472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739833|NCT00719472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101739834|NCT00719472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101739835|NCT00719472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101739836|NCT00719472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101739837|NCT00719472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101739851|NCT00719472|Histamine Agents|histamine agents|mesh-ancestor
101739852|NCT00719472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101739853|NCT00579501|Dexamethasone|dexamethasone|mesh-list
101739854|NCT00579501|Trabectedin|trabectedin|mesh-list
101739855|NCT00579501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101739856|NCT00579501|Antiemetics|antiemetics|mesh-ancestor
101739857|NCT00579501|Autonomic Agents|autonomic agents|mesh-ancestor
101739858|NCT00579501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101739859|NCT00579501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739860|NCT00579501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101739861|NCT00579501|Glucocorticoids|glucocorticoids|mesh-ancestor
101739863|NCT00579501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101739864|NCT00579501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101739865|NCT00579501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101739866|NCT00579501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101739867|NCT00579501|Alkylating Agents|alkylating agents|mesh-ancestor
101739868|NCT00579501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739869|NCT02598362|Ciprofloxacin|ciprofloxacin|mesh-list
101739870|NCT02598362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101739871|NCT02598362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101739872|NCT02598362|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101739873|NCT02598362|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101739874|NCT02598362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101739875|NCT02598362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739876|NCT02598362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101739877|NCT02598362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101739878|NCT02598362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101739879|NCT02576301|Cytarabine|cytarabine|mesh-list
101739880|NCT02576301|Combretastatin|combretastatin|mesh-list
101739881|NCT02576301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101739882|NCT02576301|Antimetabolites|antimetabolites|mesh-ancestor
101739883|NCT02576301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739884|NCT02576301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101739885|NCT02576301|Antiviral Agents|antiviral agents|mesh-ancestor
101739886|NCT02576301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101739887|NCT02576301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101739888|NCT02576301|Immunologic Factors|immunologic factors|mesh-ancestor
101560277|NCT00943735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101560278|NCT00943735|Cholinergic Agents|cholinergic agents|mesh-ancestor
101560279|NCT00943735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101560280|NCT00943735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560281|NCT00943735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560282|NCT00943735|Urological Agents|urological agents|mesh-ancestor
101560283|NCT00943111|Eliglustat|eliglustat|mesh-list
101560284|NCT00943111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101739889|NCT02576301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739890|NCT02576301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101739891|NCT02576301|Tubulin Modulators|tubulin modulators|mesh-ancestor
101739892|NCT02576301|Antimitotic Agents|antimitotic agents|mesh-ancestor
101739893|NCT02576301|Mitosis Modulators|mitosis modulators|mesh-ancestor
101739895|NCT04086186|Anesthetics, Local|anesthetics, local|mesh-ancestor
101739896|NCT04086186|Anesthetics|anesthetics|mesh-ancestor
101739897|NCT04086186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101739898|NCT04086186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739899|NCT04086186|Sensory System Agents|sensory system agents|mesh-ancestor
101739912|NCT00741338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101739913|NCT00741338|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101397396|NCT00326053|Hormones|hormones|mesh-ancestor
101739915|NCT00741338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101739916|NCT00741338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101739918|NCT02598830|Cholecalciferol|cholecalciferol|mesh-list
101739919|NCT02598830|Vitamins|vitamins|mesh-ancestor
101739920|NCT02598830|Micronutrients|micronutrients|mesh-ancestor
101739921|NCT02598830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739922|NCT02598830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101739923|NCT02598830|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101739924|NCT02578251|Acetaminophen|acetaminophen|mesh-list
101739925|NCT02578251|Meperidine|meperidine|mesh-list
101739926|NCT02578251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101739927|NCT02578251|Analgesics|analgesics|mesh-ancestor
101739928|NCT02578251|Sensory System Agents|sensory system agents|mesh-ancestor
101739929|NCT02578251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101739930|NCT02578251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739931|NCT02578251|Antipyretics|antipyretics|mesh-ancestor
101739932|NCT02578251|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101739933|NCT02578251|Narcotics|narcotics|mesh-ancestor
101739934|NCT02578251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101739935|NCT02578251|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101739936|NCT05285358|Paclitaxel|paclitaxel|mesh-list
101739937|NCT05285358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101739938|NCT05285358|Cisplatin|cisplatin|mesh-list
101739939|NCT05285358|Gemcitabine|gemcitabine|mesh-list
101739940|NCT05285358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101739941|NCT05285358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101739942|NCT05285358|Tubulin Modulators|tubulin modulators|mesh-ancestor
101739943|NCT05285358|Antimitotic Agents|antimitotic agents|mesh-ancestor
101739944|NCT05285358|Mitosis Modulators|mitosis modulators|mesh-ancestor
101739945|NCT05285358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739946|NCT05285358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101739947|NCT05285358|Antimetabolites|antimetabolites|mesh-ancestor
101739948|NCT00746330|Mometasone Furoate|mometasone furoate|mesh-list
101739949|NCT00746330|Formoterol Fumarate|formoterol fumarate|mesh-list
101739950|NCT00746330|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101739951|NCT00746330|Autonomic Agents|autonomic agents|mesh-ancestor
101739952|NCT00746330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101739953|NCT00746330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739954|NCT00746330|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101739955|NCT00746330|Respiratory System Agents|respiratory system agents|mesh-ancestor
101739956|NCT00746330|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101739957|NCT00746330|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101739958|NCT00746330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101739959|NCT00746330|Adrenergic Agents|adrenergic agents|mesh-ancestor
101739960|NCT00746330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101739961|NCT00746330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560285|NCT00943111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560286|NCT01147497|Misoprostol|misoprostol|mesh-list
101560287|NCT01147497|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101560288|NCT01147497|Abortifacient Agents|abortifacient agents|mesh-ancestor
101560289|NCT01147497|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101560290|NCT01147497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560291|NCT01147497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101560292|NCT01147497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101560293|NCT01147497|Oxytocics|oxytocics|mesh-ancestor
101739962|NCT00746330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101491478|NCT00421538|Nadroparin|nadroparin|mesh-list
101739968|NCT02590224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739969|NCT02590224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739970|NCT00709449|Papaverine|papaverine|mesh-list
101739971|NCT00709449|Moxaverine|moxaverine|mesh-list
101739972|NCT00709449|Parasympatholytics|parasympatholytics|mesh-ancestor
101739973|NCT00709449|Autonomic Agents|autonomic agents|mesh-ancestor
101739974|NCT00709449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101739975|NCT00709449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739976|NCT00709449|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101739977|NCT00709449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101739978|NCT00709449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739979|NCT00709449|Vasodilator Agents|vasodilator agents|mesh-ancestor
101739980|NCT00709449|Urological Agents|urological agents|mesh-ancestor
101739981|NCT00746252|Risperidone|risperidone|mesh-list
101739982|NCT00746252|Aripiprazole|aripiprazole|mesh-list
101739983|NCT00746252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101739984|NCT00746252|Serotonin Agents|serotonin agents|mesh-ancestor
101739985|NCT00746252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101739986|NCT00746252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739987|NCT00746252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739988|NCT00746252|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101739989|NCT00746252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101739990|NCT00746252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101739991|NCT00746252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101739992|NCT00746252|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101739993|NCT00746252|Dopamine Agents|dopamine agents|mesh-ancestor
101739994|NCT00746252|Antidepressive Agents|antidepressive agents|mesh-ancestor
101739995|NCT00746252|Dopamine Agonists|dopamine agonists|mesh-ancestor
101739996|NCT00746252|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101739997|NCT00746252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101739998|NCT00746252|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101739999|NCT00746252|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101740000|NCT02574975|Budesonide|budesonide|mesh-list
101740001|NCT02574975|Adenosine|adenosine|mesh-list
101740002|NCT02574975|Formoterol Fumarate|formoterol fumarate|mesh-list
101740003|NCT02574975|Methacholine Chloride|methacholine chloride|mesh-list
101740004|NCT02574975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101740005|NCT02574975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101740006|NCT02574975|Autonomic Agents|autonomic agents|mesh-ancestor
101740007|NCT02574975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101740008|NCT02574975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740009|NCT02574975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101740010|NCT02574975|Respiratory System Agents|respiratory system agents|mesh-ancestor
101740011|NCT02574975|Glucocorticoids|glucocorticoids|mesh-ancestor
101740012|NCT02574975|Hormones|hormones|mesh-ancestor
101740013|NCT02574975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101740014|NCT02574975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101740015|NCT02574975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101740016|NCT02574975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101740017|NCT02574975|Adrenergic Agents|adrenergic agents|mesh-ancestor
101740018|NCT02574975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101740019|NCT02574975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740020|NCT02574975|Analgesics|analgesics|mesh-ancestor
101740021|NCT02574975|Sensory System Agents|sensory system agents|mesh-ancestor
101560294|NCT01147341|Certolizumab Pegol|certolizumab pegol|mesh-list
101560295|NCT01147341|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101560296|NCT01147341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101560297|NCT01147341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101560298|NCT01147341|Immunologic Factors|immunologic factors|mesh-ancestor
101560299|NCT01147341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560300|NCT01147341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101560301|NCT00950755|Tositumomab I-131|tositumomab i-131|mesh-list
101560303|NCT00950755|Immunologic Factors|immunologic factors|mesh-ancestor
101560304|NCT00950755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560305|NCT00950755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101740022|NCT02574975|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101740023|NCT02574975|Vasodilator Agents|vasodilator agents|mesh-ancestor
101740024|NCT02574975|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101740025|NCT02574975|Purinergic Agonists|purinergic agonists|mesh-ancestor
101740026|NCT02574975|Purinergic Agents|purinergic agents|mesh-ancestor
101740027|NCT02574975|Miotics|miotics|mesh-ancestor
101740028|NCT02574975|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101740029|NCT02574975|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
101740030|NCT02574975|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101740031|NCT02574975|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101740032|NCT02574975|Cholinergic Agents|cholinergic agents|mesh-ancestor
101740033|NCT00718770|Bexarotene|bexarotene|mesh-list
101491531|NCT00457509|Vaccines|vaccines|mesh-list
101740039|NCT04084158|Tubulin Modulators|tubulin modulators|mesh-ancestor
101740040|NCT04084158|Antimitotic Agents|antimitotic agents|mesh-ancestor
101740041|NCT04084158|Mitosis Modulators|mitosis modulators|mesh-ancestor
101740042|NCT04084158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740043|NCT00714519|Castor Oil|castor oil|mesh-list
101740044|NCT00714519|Cathartics|cathartics|mesh-ancestor
101740045|NCT00714519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101740046|NCT00714948|Gemcitabine|gemcitabine|mesh-list
101740047|NCT00714948|Sorafenib|sorafenib|mesh-list
101740048|NCT00714948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101740049|NCT00714948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101740050|NCT00714948|Antimetabolites|antimetabolites|mesh-ancestor
101740051|NCT00714948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740052|NCT00714948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101740053|NCT00714948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101740054|NCT00714714|Adapalene|adapalene|mesh-list
101740055|NCT00714714|Tretinoin|tretinoin|mesh-list
101740056|NCT00714714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101740057|NCT00714714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101740058|NCT00714714|Analgesics|analgesics|mesh-ancestor
101740059|NCT00714714|Sensory System Agents|sensory system agents|mesh-ancestor
101740060|NCT00714714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101740061|NCT00714714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740062|NCT00714714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101740063|NCT00714714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101740064|NCT00714714|Dermatologic Agents|dermatologic agents|mesh-ancestor
101740065|NCT00714714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101740066|NCT00714714|Keratolytic Agents|keratolytic agents|mesh-ancestor
101740067|NCT00441337|Nivolumab|nivolumab|mesh-list
101740068|NCT00441337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101740069|NCT00441337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101740070|NCT00441337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101740071|NCT00441337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740072|NCT00578877|Nonoxynol|nonoxynol|mesh-list
101740073|NCT00578877|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
101740074|NCT00578877|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
101740075|NCT00578877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740076|NCT00578877|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101740077|NCT00578877|Contraceptive Agents|contraceptive agents|mesh-ancestor
101740078|NCT00578877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101560307|NCT01147107|Raltegravir Potassium|raltegravir potassium|mesh-list
101560308|NCT01147107|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101560309|NCT01147107|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101740079|NCT00578877|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101740080|NCT02573727|Terlipressin|terlipressin|mesh-list
101740081|NCT02573727|Epinephrine|epinephrine|mesh-list
101740082|NCT02573727|Racepinephrine|racepinephrine|mesh-list
101740083|NCT02573727|Norepinephrine|norepinephrine|mesh-list
101740084|NCT02573727|Epinephryl borate|epinephryl borate|mesh-list
101740085|NCT02573727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101740086|NCT02573727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101740087|NCT02573727|Adrenergic Agents|adrenergic agents|mesh-ancestor
101740088|NCT02573727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101740089|NCT02573727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740090|NCT02573727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740091|NCT02573727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101740092|NCT02573727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101740093|NCT02573727|Autonomic Agents|autonomic agents|mesh-ancestor
101740094|NCT02573727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101740095|NCT02573727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101740096|NCT02573727|Respiratory System Agents|respiratory system agents|mesh-ancestor
101740097|NCT02573727|Mydriatics|mydriatics|mesh-ancestor
101740098|NCT02573727|Sympathomimetics|sympathomimetics|mesh-ancestor
101740099|NCT02573727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101740100|NCT02573727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101740101|NCT00709683|Insulin Aspart|insulin aspart|mesh-list
101740102|NCT00709683|Biphasic Insulins|biphasic insulins|mesh-list
101740103|NCT00709683|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101740104|NCT00709683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101740105|NCT00709683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740106|NCT00918840|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101740107|NCT00918840|Antiviral Agents|antiviral agents|mesh-ancestor
101740139|NCT02574819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101740141|NCT00709839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101397614|NCT00320047|Baclofen|baclofen|mesh-list
101740142|NCT03949153|Nivolumab|nivolumab|mesh-list
101740143|NCT03949153|Ipilimumab|ipilimumab|mesh-list
101740144|NCT03949153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101740145|NCT03949153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101740146|NCT03949153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101740147|NCT03949153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740148|NCT00709917|Repaglinide|repaglinide|mesh-list
101740153|NCT02574741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101740154|NCT02574741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101740155|NCT02574741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101740156|NCT02574741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101740157|NCT02574741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740158|NCT02574741|Dopamine Agonists|dopamine agonists|mesh-ancestor
101740159|NCT02574741|Dopamine Agents|dopamine agents|mesh-ancestor
101740160|NCT02574741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101740161|NCT02574741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740162|NCT02574741|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101740163|NCT02574741|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101740164|NCT02574741|Serotonin Agents|serotonin agents|mesh-ancestor
101740165|NCT02574741|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101740166|NCT02574741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101740167|NCT02574741|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101740168|NCT02574741|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101740169|NCT00468169|Cetuximab|cetuximab|mesh-list
101740170|NCT00468169|Hydroxyurea|hydroxyurea|mesh-list
101740171|NCT00468169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101740172|NCT00468169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101740173|NCT00468169|Antisickling Agents|antisickling agents|mesh-ancestor
101740174|NCT00468169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101740175|NCT00468169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740176|NCT00468169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101740177|NCT05251974|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101740178|NCT05251974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101740179|NCT05251974|Adrenergic Agents|adrenergic agents|mesh-ancestor
101740180|NCT05251974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101560310|NCT01147107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101560311|NCT01147107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560312|NCT01147107|Antiviral Agents|antiviral agents|mesh-ancestor
101560313|NCT01147107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101560314|NCT01147107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101560315|NCT01147107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101560316|NCT01147107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101560317|NCT01147107|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101560318|NCT01147107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101560319|NCT01147107|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101560320|NCT01147107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101560321|NCT01147107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101560322|NCT01147107|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101560323|NCT01147107|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101740181|NCT05251974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740182|NCT05251974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740183|NCT02589444|Vitamin D|vitamin d|mesh-list
101740184|NCT02589444|Cholecalciferol|cholecalciferol|mesh-list
101740185|NCT02589444|Vitamins|vitamins|mesh-ancestor
101740186|NCT02589444|Micronutrients|micronutrients|mesh-ancestor
101740187|NCT02589444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740188|NCT02589444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101740189|NCT02589444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101740190|NCT05325684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101740191|NCT05325684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740192|NCT05325684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101740193|NCT05325684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101740194|NCT00435487|Heparin|heparin|mesh-list
101740195|NCT00435487|Calcium heparin|calcium heparin|mesh-list
101740196|NCT00435487|Dalteparin|dalteparin|mesh-list
101740197|NCT00435487|Tinzaparin|tinzaparin|mesh-list
101740198|NCT00435487|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101740199|NCT00435487|Anticoagulants|anticoagulants|mesh-ancestor
101740200|NCT00435487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101740201|NCT00435487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101740202|NCT00435487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740203|NCT02589678|Vaccines|vaccines|mesh-list
101740204|NCT02589678|Immunologic Factors|immunologic factors|mesh-ancestor
101740205|NCT02589678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740206|NCT05328258|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101740207|NCT05328258|Luteolytic Agents|luteolytic agents|mesh-ancestor
101740208|NCT05328258|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101470376|NCT00285519|Doxazosin|doxazosin|mesh-list
101740209|NCT05328258|Contraceptive Agents|contraceptive agents|mesh-ancestor
101740210|NCT05328258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101740211|NCT05328258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740212|NCT05328258|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101740213|NCT05328258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101740214|NCT05328258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101740215|NCT02591004|Nifedipine|nifedipine|mesh-list
101740216|NCT02591004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101397690|NCT00327145|Diuretics|diuretics|mesh-ancestor
101740217|NCT02591004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101740238|NCT04085562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740239|NCT04085562|Vasodilator Agents|vasodilator agents|mesh-ancestor
101740240|NCT04085562|Sympatholytics|sympatholytics|mesh-ancestor
101740241|NCT04085562|Autonomic Agents|autonomic agents|mesh-ancestor
101740242|NCT04085562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101560326|NCT01146951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101560327|NCT01146951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101560328|NCT01146951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101560329|NCT01146951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560331|NCT01146873|Lopinavir|lopinavir|mesh-list
101560332|NCT01146873|Abacavir|abacavir|mesh-list
101560333|NCT01146873|Stavudine|stavudine|mesh-list
101560334|NCT01146873|Efavirenz|efavirenz|mesh-list
101740243|NCT04085562|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101740244|NCT04085562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101740245|NCT04085562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101740246|NCT04085562|Adrenergic Agents|adrenergic agents|mesh-ancestor
101740247|NCT04085562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101740248|NCT05048238|Tofacitinib|tofacitinib|mesh-list
101740249|NCT05048238|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101740250|NCT05048238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101740251|NCT05048238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101740252|NCT05048238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740253|NCT05683626|Adalimumab|adalimumab|mesh-list
101740254|NCT05683626|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101740255|NCT05683626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101740256|NCT05683626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101740257|NCT04082988|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101740258|NCT04082988|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101740259|NCT04082988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740260|NCT02588196|Dexamethasone|dexamethasone|mesh-list
101740261|NCT02588196|Dexamethasone acetate|dexamethasone acetate|mesh-list
101740262|NCT02588196|BB 1101|bb 1101|mesh-list
101740263|NCT02588196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101740264|NCT02588196|Antiemetics|antiemetics|mesh-ancestor
101740265|NCT02588196|Autonomic Agents|autonomic agents|mesh-ancestor
101740266|NCT02588196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101740267|NCT02588196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740268|NCT02588196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101740269|NCT02588196|Glucocorticoids|glucocorticoids|mesh-ancestor
101740270|NCT02588196|Hormones|hormones|mesh-ancestor
101740303|NCT00715455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101740304|NCT00715455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740305|NCT02574663|Leucovorin|leucovorin|mesh-list
101740306|NCT02574663|Folic Acid|folic acid|mesh-list
101740307|NCT02574663|Paclitaxel|paclitaxel|mesh-list
101740308|NCT02574663|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101740309|NCT02574663|Bevacizumab|bevacizumab|mesh-list
101740310|NCT02574663|Gemcitabine|gemcitabine|mesh-list
101740311|NCT02574663|Fluorouracil|fluorouracil|mesh-list
101740312|NCT02574663|Oxaliplatin|oxaliplatin|mesh-list
101740313|NCT02574663|Levoleucovorin|levoleucovorin|mesh-list
101740315|NCT02574663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101740316|NCT02574663|Tubulin Modulators|tubulin modulators|mesh-ancestor
101740317|NCT02574663|Antimitotic Agents|antimitotic agents|mesh-ancestor
101740318|NCT02574663|Mitosis Modulators|mitosis modulators|mesh-ancestor
101740319|NCT02574663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740320|NCT02574663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101740321|NCT02574663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101740322|NCT02574663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101740323|NCT02574663|Growth Substances|growth substances|mesh-ancestor
101740324|NCT02574663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740325|NCT02574663|Growth Inhibitors|growth inhibitors|mesh-ancestor
101740326|NCT02574663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101740327|NCT02574663|Antimetabolites|antimetabolites|mesh-ancestor
101740328|NCT02574663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101740329|NCT02574663|Immunologic Factors|immunologic factors|mesh-ancestor
101740331|NCT02574663|Protective Agents|protective agents|mesh-ancestor
101740332|NCT02574663|Vitamin B Complex|vitamin b complex|mesh-ancestor
101740333|NCT02574663|Vitamins|vitamins|mesh-ancestor
101740334|NCT02574663|Micronutrients|micronutrients|mesh-ancestor
101740335|NCT02574663|Hematinics|hematinics|mesh-ancestor
101740336|NCT04069845|Doxorubicin|doxorubicin|mesh-list
101740337|NCT04069845|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101560335|NCT01146873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101560336|NCT01146873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101560337|NCT01146873|Protease Inhibitors|protease inhibitors|mesh-ancestor
101560338|NCT01146873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101560339|NCT01146873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560340|NCT01146873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101560341|NCT01146873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101560342|NCT01146873|Antiviral Agents|antiviral agents|mesh-ancestor
101740338|NCT04069845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101740339|NCT04069845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101740340|NCT04069845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101740341|NCT04069845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101740342|NCT04069845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101740343|NCT04069845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740344|NCT05158140|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101740345|NCT05158140|Immunologic Factors|immunologic factors|mesh-ancestor
101740346|NCT05158140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740347|NCT00715689|Hormones|hormones|mesh-list
101740348|NCT00715689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101740349|NCT00715689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740350|NCT00919542|Cyclosporine|cyclosporine|mesh-list
101740351|NCT00919542|Prednisolone|prednisolone|mesh-list
101740352|NCT00919542|Cyclosporins|cyclosporins|mesh-list
101740353|NCT00919542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101740354|NCT00919542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740355|NCT00919542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101740356|NCT00919542|Immunologic Factors|immunologic factors|mesh-ancestor
101740357|NCT00919542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740358|NCT00919542|Antifungal Agents|antifungal agents|mesh-ancestor
101740359|NCT00919542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101740360|NCT00919542|Dermatologic Agents|dermatologic agents|mesh-ancestor
101740361|NCT00919542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101740362|NCT00919542|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101740363|NCT00919542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101740364|NCT00919542|Glucocorticoids|glucocorticoids|mesh-ancestor
101740365|NCT00919542|Hormones|hormones|mesh-ancestor
101740366|NCT00919542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101740367|NCT00919542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101740368|NCT00919542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101740369|NCT00719121|Adapalene|adapalene|mesh-list
101740370|NCT00719121|R 115866|r 115866|mesh-list
101740371|NCT00719121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101740372|NCT00719121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101740373|NCT00719121|Analgesics|analgesics|mesh-ancestor
101740374|NCT00719121|Sensory System Agents|sensory system agents|mesh-ancestor
101740375|NCT00719121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101740376|NCT00719121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740377|NCT00719121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101740378|NCT00719121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101740379|NCT00719121|Dermatologic Agents|dermatologic agents|mesh-ancestor
101740380|NCT00719121|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101740381|NCT00719121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101740382|NCT00719121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740383|NCT00719199|Cetuximab|cetuximab|mesh-list
101740384|NCT00719199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101740385|NCT00719199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101740386|NCT02589288|Ropivacaine|ropivacaine|mesh-list
101740392|NCT02589288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101740393|NCT00716001|Acetylcysteine|acetylcysteine|mesh-list
101740394|NCT00716001|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101740395|NCT00716001|Antiviral Agents|antiviral agents|mesh-ancestor
101740396|NCT00716001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101740397|NCT00716001|Expectorants|expectorants|mesh-ancestor
101740398|NCT00716001|Respiratory System Agents|respiratory system agents|mesh-ancestor
101740399|NCT00716001|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101740400|NCT00716001|Antioxidants|antioxidants|mesh-ancestor
101560343|NCT01146873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101560344|NCT01146873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101560345|NCT01146873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101560346|NCT01146873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101560347|NCT01146873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101408769|NCT02273791|Enclomiphene|enclomiphene|mesh-list
101740401|NCT00716001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740402|NCT00716001|Protective Agents|protective agents|mesh-ancestor
101740403|NCT00716001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740404|NCT00716001|Antidotes|antidotes|mesh-ancestor
101740405|NCT05136846|Paclitaxel|paclitaxel|mesh-list
101740406|NCT05136846|Carboplatin|carboplatin|mesh-list
101740407|NCT05136846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101740409|NCT05136846|Papaverine|papaverine|mesh-list
101740410|NCT05136846|Immunoglobulins|immunoglobulins|mesh-list
101740411|NCT05136846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101740412|NCT05136846|Immunoglobulin G|immunoglobulin g|mesh-list
101740413|NCT05136846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101740414|NCT05136846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101740415|NCT05136846|Tubulin Modulators|tubulin modulators|mesh-ancestor
101740416|NCT05136846|Antimitotic Agents|antimitotic agents|mesh-ancestor
101740417|NCT05136846|Mitosis Modulators|mitosis modulators|mesh-ancestor
101740418|NCT05136846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740419|NCT05136846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101740420|NCT05136846|Immunologic Factors|immunologic factors|mesh-ancestor
101740421|NCT05136846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740422|NCT05136846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101740423|NCT05136846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101740424|NCT05136846|Vasodilator Agents|vasodilator agents|mesh-ancestor
101740425|NCT05136846|Urological Agents|urological agents|mesh-ancestor
101740426|NCT00710229|Bevacizumab|bevacizumab|mesh-list
101740427|NCT00710229|Ranibizumab|ranibizumab|mesh-list
101740428|NCT00710229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101740429|NCT00710229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101740430|NCT00710229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101740431|NCT00710229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101740432|NCT00710229|Growth Substances|growth substances|mesh-ancestor
101740433|NCT00710229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740434|NCT00710229|Growth Inhibitors|growth inhibitors|mesh-ancestor
101740435|NCT00710619|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
101740436|NCT00710619|Coagulants|coagulants|mesh-ancestor
101740437|NCT05192460|Vaccines|vaccines|mesh-list
101740438|NCT05192460|Immunologic Factors|immunologic factors|mesh-ancestor
101740439|NCT05192460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740440|NCT00719433|Armin|armin|mesh-list
101740441|NCT00719433|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101740442|NCT00719433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101740443|NCT00719433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740444|NCT00719433|Cholinergic Agents|cholinergic agents|mesh-ancestor
101740445|NCT00719433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101740446|NCT00719433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740447|NCT04068519|Tislelizumab|tislelizumab|mesh-list
101740448|NCT04068519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101740449|NCT04068519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101740450|NCT04978272|Piperaquine|piperaquine|mesh-list
101740451|NCT04978272|Artenimol|artenimol|mesh-list
101740452|NCT04978272|Antimalarials|antimalarials|mesh-ancestor
101740453|NCT04978272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101740454|NCT04978272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101740455|NCT04978272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101740456|NCT04973124|Dexmedetomidine|dexmedetomidine|mesh-list
101740457|NCT04973124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101740458|NCT04973124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101491955|NCT00354419|Alkylating Agents|alkylating agents|mesh-ancestor
101740466|NCT04973124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101740467|NCT04973124|Adrenergic Agents|adrenergic agents|mesh-ancestor
101740468|NCT04973124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101740469|NCT04973124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740470|NCT04971720|Valsartan|valsartan|mesh-list
101560348|NCT01146873|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101560349|NCT01146873|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101560350|NCT01146873|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101560351|NCT01146873|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101560352|NCT01146873|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101560353|NCT01146873|Antimetabolites|antimetabolites|mesh-ancestor
101560354|NCT01146795|Paclitaxel|paclitaxel|mesh-list
101740471|NCT04971720|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101740472|NCT04971720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101740473|NCT04971720|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101740474|NCT04971720|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101740475|NCT04971720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740476|NCT00711165|Mometasone Furoate|mometasone furoate|mesh-list
101740477|NCT00711165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101740478|NCT00711165|Dermatologic Agents|dermatologic agents|mesh-ancestor
101740479|NCT00711165|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101740480|NCT00719745|Tacrolimus|tacrolimus|mesh-list
101740481|NCT00719745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101740482|NCT00719745|Immunologic Factors|immunologic factors|mesh-ancestor
101740483|NCT00719745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740484|NCT00719745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101740485|NCT00719745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101740486|NCT00719745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740487|NCT02587416|Atorvastatin|atorvastatin|mesh-list
101740488|NCT02587416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101740489|NCT02587416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101740490|NCT02587416|Antimetabolites|antimetabolites|mesh-ancestor
101470427|NCT00249197|Levofloxacin|levofloxacin|mesh-list
101740491|NCT02587416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740492|NCT02587416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101740493|NCT02587416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101740494|NCT02587416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101740495|NCT00719823|Maraviroc|maraviroc|mesh-list
101740496|NCT00719823|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101740497|NCT00719823|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101740498|NCT00719823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740499|NCT00719823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101740500|NCT00719823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101740501|NCT00719823|Antiviral Agents|antiviral agents|mesh-ancestor
101740502|NCT00719823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101740503|NCT00719823|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101740504|NCT00919776|Cyclosporine|cyclosporine|mesh-list
101740505|NCT00919776|Prednisolone|prednisolone|mesh-list
101740506|NCT00919776|Cyclosporins|cyclosporins|mesh-list
101740507|NCT00919776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101740508|NCT00919776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740509|NCT00919776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101740510|NCT00919776|Immunologic Factors|immunologic factors|mesh-ancestor
101740511|NCT00919776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740512|NCT00919776|Antifungal Agents|antifungal agents|mesh-ancestor
101740513|NCT00919776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101740514|NCT00919776|Dermatologic Agents|dermatologic agents|mesh-ancestor
101740515|NCT00919776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101740516|NCT00919776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101740517|NCT00919776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101740519|NCT00919776|Hormones|hormones|mesh-ancestor
101740520|NCT00919776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101740521|NCT00919776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101740522|NCT00919776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101740523|NCT00720135|Rituximab|rituximab|mesh-list
101740524|NCT00720135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101740525|NCT00720135|Interleukin-2|interleukin-2|mesh-list
101740540|NCT02588118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101740541|NCT02588118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740542|NCT02588118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101740543|NCT02588118|Anesthetics, General|anesthetics, general|mesh-ancestor
101560355|NCT01146795|Bevacizumab|bevacizumab|mesh-list
101560356|NCT01146795|Carboplatin|carboplatin|mesh-list
101560357|NCT01146795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101560358|NCT01146795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101560359|NCT01146795|Tubulin Modulators|tubulin modulators|mesh-ancestor
101560360|NCT01146795|Antimitotic Agents|antimitotic agents|mesh-ancestor
101560361|NCT01146795|Mitosis Modulators|mitosis modulators|mesh-ancestor
101560362|NCT01146795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740544|NCT02588118|Anesthetics|anesthetics|mesh-ancestor
101740545|NCT02588118|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101740546|NCT02588118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101740547|NCT02588118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101740548|NCT00716391|Cisplatin|cisplatin|mesh-list
101740549|NCT00716391|Cetuximab|cetuximab|mesh-list
101740550|NCT00716391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101740551|NCT00716391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101740552|NCT00716469|Talaporfin|talaporfin|mesh-list
101740553|NCT00716469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101740554|NCT00716469|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101740555|NCT00716469|Dermatologic Agents|dermatologic agents|mesh-ancestor
101740556|NCT04082598|Amoxicillin|amoxicillin|mesh-list
101740557|NCT04082598|Clavulanic Acid|clavulanic acid|mesh-list
101740558|NCT04082598|Clavulanic Acids|clavulanic acids|mesh-list
101740559|NCT04082598|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101740560|NCT04082598|Lactoferrin|lactoferrin|mesh-list
101740561|NCT04082598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101740562|NCT04082598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101740563|NCT04082598|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101740564|NCT04082598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101740565|NCT04082598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740566|NCT03895203|Adalimumab|adalimumab|mesh-list
101740567|NCT03895203|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101740568|NCT03895203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101740569|NCT03895203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101740570|NCT04958226|Midazolam|midazolam|mesh-list
101740571|NCT04958226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101740572|NCT04958226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101740573|NCT04958226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101740574|NCT04958226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740575|NCT04958226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101740576|NCT04958226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101740577|NCT04958226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101740578|NCT04958226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101740579|NCT04958226|Anesthetics, General|anesthetics, general|mesh-ancestor
101740580|NCT04958226|Anesthetics|anesthetics|mesh-ancestor
101740581|NCT04958226|GABA Modulators|gaba modulators|mesh-ancestor
101740582|NCT04958226|GABA Agents|gaba agents|mesh-ancestor
101740583|NCT04958226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101740584|NCT04958226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740585|NCT00716547|Celecoxib|celecoxib|mesh-list
101740586|NCT00716547|Ketoprofen|ketoprofen|mesh-list
101740587|NCT00716547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101740588|NCT00716547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101740589|NCT00716547|Analgesics|analgesics|mesh-ancestor
101740590|NCT00716547|Sensory System Agents|sensory system agents|mesh-ancestor
101740595|NCT00716547|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101740596|NCT00716547|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101740597|NCT00716547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101740598|NCT00716547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740599|NCT02573025|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101740600|NCT02573025|Interferon-alpha|interferon-alpha|mesh-list
101740601|NCT02573025|Interferon alpha-2|interferon alpha-2|mesh-list
101740602|NCT02573025|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
101740603|NCT02573025|Antiviral Agents|antiviral agents|mesh-ancestor
101740604|NCT02573025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101740605|NCT02573025|Immunologic Factors|immunologic factors|mesh-ancestor
101740606|NCT02573025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740607|NCT02573025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101740608|NCT00720291|Metronidazole|metronidazole|mesh-list
101560363|NCT01146795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101560364|NCT01146795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101560365|NCT01146795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101560367|NCT01146795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560368|NCT01146795|Growth Inhibitors|growth inhibitors|mesh-ancestor
101740609|NCT00720291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101740610|NCT00720291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101740611|NCT00720291|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101740612|NCT00720291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101740613|NCT00578643|Cyclosporine|cyclosporine|mesh-list
101740614|NCT00578643|Cyclophosphamide|cyclophosphamide|mesh-list
101740616|NCT00578643|Fludarabine|fludarabine|mesh-list
101470454|NCT00285675|Calcitriol|calcitriol|mesh-list
101740617|NCT00578643|Alemtuzumab|alemtuzumab|mesh-list
101740618|NCT00578643|Cyclosporins|cyclosporins|mesh-list
101740619|NCT00578643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101740620|NCT00578643|Immunologic Factors|immunologic factors|mesh-ancestor
101740621|NCT00578643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740622|NCT00578643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101740623|NCT00578643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101740624|NCT00578643|Alkylating Agents|alkylating agents|mesh-ancestor
101740625|NCT00578643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740626|NCT00578643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101740627|NCT00578643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101740628|NCT00578643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101740629|NCT00578643|Antifungal Agents|antifungal agents|mesh-ancestor
101740630|NCT00578643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101740631|NCT00578643|Dermatologic Agents|dermatologic agents|mesh-ancestor
101740632|NCT00578643|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101740633|NCT00578643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101740634|NCT04082286|Antibodies|antibodies|mesh-list
101740635|NCT04082286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101740636|NCT04082286|Immunologic Factors|immunologic factors|mesh-ancestor
101740637|NCT04082286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740639|NCT00720447|Etoposide|etoposide|mesh-list
101740640|NCT00720447|Melphalan|melphalan|mesh-list
101740641|NCT00720447|Alemtuzumab|alemtuzumab|mesh-list
101740642|NCT00720447|Carmustine|carmustine|mesh-list
101740643|NCT00720447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101740644|NCT00720447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101740645|NCT00720447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101740646|NCT00720447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101740647|NCT00720447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101740648|NCT00720447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740649|NCT00720447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101740650|NCT00720447|Antimetabolites|antimetabolites|mesh-ancestor
101740651|NCT00720447|Antiviral Agents|antiviral agents|mesh-ancestor
101740652|NCT00720447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101740653|NCT00720447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101740654|NCT00720447|Immunologic Factors|immunologic factors|mesh-ancestor
101740655|NCT00720447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740656|NCT00720447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101740657|NCT00720447|Alkylating Agents|alkylating agents|mesh-ancestor
101740658|NCT00720447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101740659|NCT00720447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101740660|NCT04828824|Moxifloxacin|moxifloxacin|mesh-list
101740661|NCT04828824|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101740662|NCT04828824|Norgestimate|norgestimate|mesh-list
101740663|NCT04828824|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101740664|NCT04828824|Estradiol|estradiol|mesh-list
101740665|NCT04828824|Estrogens|estrogens|mesh-ancestor
101740669|NCT04828824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101740671|NCT04828824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101740672|NCT04828824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101740673|NCT04828824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101740674|NCT04828824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101740675|NCT04828824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101740676|NCT04828824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101740677|NCT04828824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101560369|NCT01146561|Tanezumab|tanezumab|mesh-list
101560370|NCT01146561|Analgesics|analgesics|mesh-ancestor
101560371|NCT01146561|Sensory System Agents|sensory system agents|mesh-ancestor
101560372|NCT01146561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101560373|NCT01146561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560374|NCT00942175|Esomeprazole|esomeprazole|mesh-list
101560375|NCT00942175|Omeprazole|omeprazole|mesh-list
101560376|NCT00942175|Lansoprazole|lansoprazole|mesh-list
101560377|NCT00942175|Dexlansoprazole|dexlansoprazole|mesh-list
101560378|NCT00942175|Clopidogrel|clopidogrel|mesh-list
101560379|NCT00942175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101740678|NCT04828824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101740679|NCT04828824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101740680|NCT04828824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101470456|NCT00285675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740681|NCT04828824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740682|NCT04828824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101740683|NCT04828824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101740685|NCT00578565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101740686|NCT00578565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101740687|NCT00578565|Immunologic Factors|immunologic factors|mesh-ancestor
101740688|NCT00578565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740689|NCT00578565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101740690|NCT02572089|Naloxone|naloxone|mesh-list
101740691|NCT02572089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101740692|NCT02572089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740693|NCT02572089|Sensory System Agents|sensory system agents|mesh-ancestor
101740694|NCT02572089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101740695|NCT02588742|Melatonin|melatonin|mesh-list
101740696|NCT02588742|Antioxidants|antioxidants|mesh-ancestor
101740697|NCT02588742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740698|NCT02588742|Protective Agents|protective agents|mesh-ancestor
101740699|NCT02588742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740700|NCT02588742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101740701|NCT00720603|Plerixafor|plerixafor|mesh-list
101740702|NCT00720603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101740703|NCT00720603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101740704|NCT00720603|Antiviral Agents|antiviral agents|mesh-ancestor
101740705|NCT00720603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101740706|NCT04936854|Sirolimus|sirolimus|mesh-list
101740707|NCT04936854|Methylprednisolone|methylprednisolone|mesh-list
101740708|NCT04936854|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101740709|NCT04936854|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101740710|NCT04936854|Prednisolone|prednisolone|mesh-list
101740711|NCT04936854|Prednisolone acetate|prednisolone acetate|mesh-list
101740712|NCT04936854|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101740713|NCT04936854|Prednisolone phosphate|prednisolone phosphate|mesh-list
101740714|NCT04936854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101740715|NCT04936854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101740716|NCT04936854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101740717|NCT04936854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101740718|NCT04936854|Antifungal Agents|antifungal agents|mesh-ancestor
101740719|NCT04936854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101740720|NCT04936854|Immunologic Factors|immunologic factors|mesh-ancestor
101740721|NCT04936854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740722|NCT04936854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101740723|NCT04936854|Antiemetics|antiemetics|mesh-ancestor
101740724|NCT04936854|Autonomic Agents|autonomic agents|mesh-ancestor
101740725|NCT04936854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101740726|NCT04936854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101740727|NCT04936854|Glucocorticoids|glucocorticoids|mesh-ancestor
101740728|NCT04936854|Hormones|hormones|mesh-ancestor
101740729|NCT04936854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101740730|NCT04936854|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101740731|NCT04936854|Protective Agents|protective agents|mesh-ancestor
101740732|NCT04936854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101740733|NCT00711789|Angiotensin II|angiotensin ii|mesh-list
101740734|NCT00711789|Giapreza|giapreza|mesh-list
101560380|NCT00942175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101560381|NCT00942175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101560382|NCT00942175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101560383|NCT00942175|Purinergic Agents|purinergic agents|mesh-ancestor
101560384|NCT00942175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101560385|NCT00942175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560386|NCT00942175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560387|NCT00942175|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101560388|NCT00942175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101560389|NCT00942175|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101560390|NCT00942175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101560391|NCT01145625|Minoxidil|minoxidil|mesh-list
101560392|NCT01145625|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101740735|NCT00711789|Angiotensinogen|angiotensinogen|mesh-list
101740745|NCT00741260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101740746|NCT02587260|Clopidogrel|clopidogrel|mesh-list
101740747|NCT02587260|Ticagrelor|ticagrelor|mesh-list
101740748|NCT02587260|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101740749|NCT02587260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101740750|NCT02587260|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101740751|NCT02587260|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101740752|NCT02587260|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101740753|NCT02587260|Purinergic Agents|purinergic agents|mesh-ancestor
101740754|NCT02587260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101740755|NCT02587260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740756|NCT02587260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740757|NCT02596256|Docetaxel|docetaxel|mesh-list
101740758|NCT02596256|Apatinib|apatinib|mesh-list
101740759|NCT02596256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101740760|NCT02596256|Tubulin Modulators|tubulin modulators|mesh-ancestor
101740761|NCT02596256|Antimitotic Agents|antimitotic agents|mesh-ancestor
101740762|NCT02596256|Mitosis Modulators|mitosis modulators|mesh-ancestor
101740763|NCT02596256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740764|NCT02596256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101740765|NCT02596256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101740766|NCT04089722|Deoxycholic Acid|deoxycholic acid|mesh-list
101740767|NCT04089722|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101740768|NCT04089722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101740769|NCT00717561|Amoxicillin|amoxicillin|mesh-list
101740770|NCT00717561|Azithromycin|azithromycin|mesh-list
101740771|NCT00717561|Moxifloxacin|moxifloxacin|mesh-list
101740772|NCT00717561|Clarithromycin|clarithromycin|mesh-list
101740773|NCT00717561|Ceftriaxone|ceftriaxone|mesh-list
101740774|NCT00717561|Clavulanic Acid|clavulanic acid|mesh-list
101740775|NCT00717561|Clavulanic Acids|clavulanic acids|mesh-list
101740776|NCT00717561|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101740777|NCT00717561|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101740778|NCT00717561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101740779|NCT00717561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101740780|NCT00717561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101740781|NCT00717561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101740782|NCT00717561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101740783|NCT00717561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740784|NCT00717561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101740785|NCT00717561|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101740786|NCT00717561|Contraceptive Agents|contraceptive agents|mesh-ancestor
101740787|NCT00717561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101740788|NCT00717561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740789|NCT00717561|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101740790|NCT00717561|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101560393|NCT01145625|Vasodilator Agents|vasodilator agents|mesh-ancestor
101560394|NCT02852083|Pioglitazone|pioglitazone|mesh-list
101560395|NCT02852083|Clarithromycin|clarithromycin|mesh-list
101560396|NCT02852083|Nivolumab|nivolumab|mesh-list
101560397|NCT02852083|Treosulfan|treosulfan|mesh-list
101560398|NCT02852083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101560399|NCT02852083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101560400|NCT02852083|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101560401|NCT02852083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560402|NCT02852083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101560403|NCT02852083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560404|NCT02852083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101740791|NCT00717561|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101740792|NCT00717561|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101740793|NCT00717561|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101740794|NCT00717561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101740795|NCT00717561|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101740796|NCT00720915|Anticoagulants|anticoagulants|mesh-list
101740797|NCT00720915|Fibrin fragment D|fibrin fragment d|mesh-list
101740813|NCT00740792|Azelastine|azelastine|mesh-list
101740814|NCT00740792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101740815|NCT00740792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101740816|NCT00740792|Autonomic Agents|autonomic agents|mesh-ancestor
101740817|NCT00740792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101740818|NCT00740792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740819|NCT00740792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101740820|NCT00740792|Respiratory System Agents|respiratory system agents|mesh-ancestor
101740821|NCT00740792|Dermatologic Agents|dermatologic agents|mesh-ancestor
101740822|NCT00740792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101740823|NCT00740792|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101740824|NCT00740792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101740825|NCT00740792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740826|NCT00740792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101740827|NCT00740792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101740828|NCT00740792|Histamine Antagonists|histamine antagonists|mesh-ancestor
101740829|NCT00740792|Histamine Agents|histamine agents|mesh-ancestor
101740830|NCT00740792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101740831|NCT00721305|Lovastatin|lovastatin|mesh-list
101740832|NCT00721305|L 647318|l 647318|mesh-list
101740833|NCT00721305|Dihydromevinolin|dihydromevinolin|mesh-list
101740834|NCT00721305|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101740835|NCT00721305|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101740836|NCT00721305|Antimetabolites|antimetabolites|mesh-ancestor
101740837|NCT00721305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740838|NCT00721305|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101740839|NCT00721305|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101740840|NCT00721305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101740841|NCT00717951|Capecitabine|capecitabine|mesh-list
101740842|NCT00717951|Docetaxel|docetaxel|mesh-list
101740843|NCT00717951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101740844|NCT00717951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101740845|NCT00717951|Antimetabolites|antimetabolites|mesh-ancestor
101263340|NCT01761487|Polymyxins|polymyxins|mesh-list
101740846|NCT00717951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740847|NCT00717951|Tubulin Modulators|tubulin modulators|mesh-ancestor
101740848|NCT00717951|Antimitotic Agents|antimitotic agents|mesh-ancestor
101740849|NCT00717951|Mitosis Modulators|mitosis modulators|mesh-ancestor
101740850|NCT02572947|Dolutegravir|dolutegravir|mesh-list
101740851|NCT02572947|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101740852|NCT02572947|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101740853|NCT02572947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101740854|NCT02572947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740855|NCT02572947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101740856|NCT02572947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101560405|NCT02852083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101560406|NCT02852083|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101740857|NCT02572947|Antiviral Agents|antiviral agents|mesh-ancestor
101740858|NCT02572947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101740873|NCT04083066|Cytarabine|cytarabine|mesh-list
101740874|NCT04083066|Dexamethasone|dexamethasone|mesh-list
101740875|NCT04083066|Rituximab|rituximab|mesh-list
101740876|NCT04083066|Methotrexate|methotrexate|mesh-list
101740877|NCT04083066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101740878|NCT04083066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101740879|NCT04083066|Immunologic Factors|immunologic factors|mesh-ancestor
101740880|NCT04083066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740881|NCT04083066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101740882|NCT04083066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101740883|NCT04083066|Antiemetics|antiemetics|mesh-ancestor
101740884|NCT04083066|Autonomic Agents|autonomic agents|mesh-ancestor
101740885|NCT04083066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101740886|NCT04083066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101740887|NCT04083066|Glucocorticoids|glucocorticoids|mesh-ancestor
101740888|NCT04083066|Hormones|hormones|mesh-ancestor
101740889|NCT04083066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101740890|NCT04083066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101740891|NCT04083066|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101740892|NCT04083066|Abortifacient Agents|abortifacient agents|mesh-ancestor
101740893|NCT04083066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101740894|NCT04083066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101740895|NCT04083066|Antimetabolites|antimetabolites|mesh-ancestor
101740896|NCT04083066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740897|NCT04083066|Dermatologic Agents|dermatologic agents|mesh-ancestor
101740898|NCT04083066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101740899|NCT04083066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101740900|NCT04083066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101740901|NCT04083066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101740902|NCT04083066|Antiviral Agents|antiviral agents|mesh-ancestor
101740903|NCT04083066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101740904|NCT05683782|Chitosan|chitosan|mesh-list
101740905|NCT05683782|Epoetin Alfa|epoetin alfa|mesh-list
101740906|NCT05683782|Hematinics|hematinics|mesh-ancestor
101740907|NCT05683782|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101740908|NCT05683782|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101740909|NCT05683782|Antimetabolites|antimetabolites|mesh-ancestor
101740910|NCT05683782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740911|NCT05683782|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101740912|NCT05683782|Chelating Agents|chelating agents|mesh-ancestor
101740913|NCT05683782|Sequestering Agents|sequestering agents|mesh-ancestor
101740914|NCT05683782|Hemostatics|hemostatics|mesh-ancestor
101740915|NCT05683782|Coagulants|coagulants|mesh-ancestor
101740916|NCT00740714|Vitamins|vitamins|mesh-list
101740917|NCT00740714|Vitamin E|vitamin e|mesh-list
101740918|NCT00740714|Tocopherols|tocopherols|mesh-list
101740919|NCT00740714|Tocotrienols|tocotrienols|mesh-list
101740920|NCT00740714|alpha-Tocopherol|alpha-tocopherol|mesh-list
101740922|NCT00740714|Ubiquinone|ubiquinone|mesh-list
101740923|NCT00740714|Micronutrients|micronutrients|mesh-ancestor
101740924|NCT00740714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740930|NCT00721773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101740931|NCT00721773|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101740932|NCT00721773|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101740933|NCT00721773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740934|NCT00721773|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101740935|NCT00721773|Protease Inhibitors|protease inhibitors|mesh-ancestor
101740936|NCT00721773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101740937|NCT05676684|Dapagliflozin|dapagliflozin|mesh-list
101740938|NCT05676684|Spironolactone|spironolactone|mesh-list
101740939|NCT05676684|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101740940|NCT05676684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740941|NCT05676684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101740942|NCT05676684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740943|NCT05676684|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101740944|NCT05676684|Hormone Antagonists|hormone antagonists|mesh-ancestor
101740945|NCT05676684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101740946|NCT05676684|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101740947|NCT05676684|Diuretics|diuretics|mesh-ancestor
101560407|NCT02852083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101560408|NCT02852083|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101560409|NCT02852083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101560410|NCT02852083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101560411|NCT02852083|Alkylating Agents|alkylating agents|mesh-ancestor
101560413|NCT00602407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101560414|NCT00602407|Autonomic Agents|autonomic agents|mesh-ancestor
101560415|NCT00602407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101560416|NCT00602407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560417|NCT00602407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101408837|NCT00455806|Esomeprazole|esomeprazole|mesh-list
101408842|NCT00455806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101740948|NCT05676684|Natriuretic Agents|natriuretic agents|mesh-ancestor
101740949|NCT04070469|Amoxicillin|amoxicillin|mesh-list
101740950|NCT04070469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101740951|NCT04070469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101740952|NCT00712647|Beta Carotene|beta carotene|mesh-list
101740953|NCT00712647|Vitamin A|vitamin a|mesh-list
101740954|NCT00712647|Carotenoids|carotenoids|mesh-list
101740955|NCT00712647|Antioxidants|antioxidants|mesh-ancestor
101740956|NCT00712647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740957|NCT00712647|Protective Agents|protective agents|mesh-ancestor
101740958|NCT00712647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740959|NCT00712647|Provitamins|provitamins|mesh-ancestor
101740960|NCT00712647|Vitamins|vitamins|mesh-ancestor
101740961|NCT00712647|Micronutrients|micronutrients|mesh-ancestor
101740962|NCT00788957|Panitumumab|panitumumab|mesh-list
101740963|NCT00788957|Rilotumumab|rilotumumab|mesh-list
101740964|NCT00788957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101740965|NCT00788957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101740966|NCT04067817|Phenylephrine|phenylephrine|mesh-list
101740967|NCT04067817|Oxymetazoline|oxymetazoline|mesh-list
101740968|NCT04067817|Norepinephrine|norepinephrine|mesh-list
101740969|NCT04067817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
101740970|NCT04067817|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101740971|NCT04067817|Mydriatics|mydriatics|mesh-ancestor
101740972|NCT04067817|Autonomic Agents|autonomic agents|mesh-ancestor
101740973|NCT04067817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101740974|NCT04067817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740975|NCT04067817|Sympathomimetics|sympathomimetics|mesh-ancestor
101740976|NCT04067817|Nasal Decongestants|nasal decongestants|mesh-ancestor
101740977|NCT04067817|Respiratory System Agents|respiratory system agents|mesh-ancestor
101740978|NCT04067817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101740979|NCT04067817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101740980|NCT04067817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101740981|NCT04067817|Adrenergic Agents|adrenergic agents|mesh-ancestor
101740982|NCT04067817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101740983|NCT04067817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740984|NCT04067817|Protective Agents|protective agents|mesh-ancestor
101740985|NCT00740636|Temozolomide|temozolomide|mesh-list
101740986|NCT00740636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101740987|NCT00740636|Alkylating Agents|alkylating agents|mesh-ancestor
101740988|NCT00740636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740989|NCT00740636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101740990|NCT02603159|Capecitabine|capecitabine|mesh-list
101740991|NCT02603159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101740992|NCT02603159|Antimetabolites|antimetabolites|mesh-ancestor
101740993|NCT02603159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740994|NCT02603159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101740995|NCT02595554|Paclitaxel|paclitaxel|mesh-list
101740997|NCT02595554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101740998|NCT02595554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101740999|NCT02595554|Tubulin Modulators|tubulin modulators|mesh-ancestor
101741000|NCT02595554|Antimitotic Agents|antimitotic agents|mesh-ancestor
101560418|NCT00602407|Respiratory System Agents|respiratory system agents|mesh-ancestor
101560419|NCT00602407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101560420|NCT00602407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101560421|NCT00602407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560422|NCT00602407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101560423|NCT00602407|Vasodilator Agents|vasodilator agents|mesh-ancestor
101560424|NCT00602407|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101560425|NCT00602407|Protective Agents|protective agents|mesh-ancestor
101560426|NCT00602407|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101560427|NCT00602407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101741001|NCT02595554|Mitosis Modulators|mitosis modulators|mesh-ancestor
101741002|NCT02595554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741003|NCT04069065|Tacrolimus|tacrolimus|mesh-list
101741004|NCT04069065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101741005|NCT04069065|Immunologic Factors|immunologic factors|mesh-ancestor
101741006|NCT04069065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741007|NCT04069065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101741008|NCT04069065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101741009|NCT04069065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741010|NCT04070391|Vitamin B 6|vitamin b 6|mesh-list
101741011|NCT04070391|Pyridoxal|pyridoxal|mesh-list
101741012|NCT04070391|Pyridoxine|pyridoxine|mesh-list
101741013|NCT04070391|Vitamins|vitamins|mesh-ancestor
101741014|NCT04070391|Micronutrients|micronutrients|mesh-ancestor
101741015|NCT04070391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741016|NCT04070391|Vitamin B Complex|vitamin b complex|mesh-ancestor
101741017|NCT05615051|Hydrogen Peroxide|hydrogen peroxide|mesh-list
101741018|NCT05615051|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101741019|NCT05615051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101741020|NCT00795509|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101741021|NCT00795509|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101741022|NCT00795509|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101741023|NCT00795509|Cholinergic Agents|cholinergic agents|mesh-ancestor
101741024|NCT00795509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101741025|NCT00795509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741026|NCT00795509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741027|NCT00795509|Urological Agents|urological agents|mesh-ancestor
101741028|NCT02603003|Pemetrexed|pemetrexed|mesh-list
101741029|NCT02603003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101741030|NCT02603003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101741031|NCT02603003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741032|NCT02603003|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101741033|NCT02603003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101741034|NCT04106297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101741035|NCT02603081|Ebselen|ebselen|mesh-list
101741036|NCT02603081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101741037|NCT02603081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101741038|NCT02603081|Analgesics|analgesics|mesh-ancestor
101741039|NCT02603081|Sensory System Agents|sensory system agents|mesh-ancestor
101741040|NCT02603081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101741041|NCT02603081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741042|NCT02603081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101741043|NCT02603081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101741044|NCT02603081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101741045|NCT02603081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101741046|NCT02603081|Antioxidants|antioxidants|mesh-ancestor
101470533|NCT00279123|Pantoprazole|pantoprazole|mesh-list
101741047|NCT02603081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741048|NCT02603081|Protective Agents|protective agents|mesh-ancestor
101741049|NCT02603081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101741050|NCT02603081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101741051|NCT02603081|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101741053|NCT00787787|Sunitinib|sunitinib|mesh-list
101741054|NCT00787787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101741055|NCT00787787|Antimetabolites|antimetabolites|mesh-ancestor
101560428|NCT00602407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101560429|NCT00950599|Saxagliptin|saxagliptin|mesh-list
101560430|NCT00950599|Incretins|incretins|mesh-ancestor
101560431|NCT00950599|Hormones|hormones|mesh-ancestor
101560432|NCT00950599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101560433|NCT00950599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560434|NCT00950599|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101560435|NCT00950599|Protease Inhibitors|protease inhibitors|mesh-ancestor
101560436|NCT00950599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101560437|NCT00950599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741056|NCT00787787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741057|NCT00787787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101741058|NCT00787787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101741059|NCT00787787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101741060|NCT00787787|Growth Substances|growth substances|mesh-ancestor
101741061|NCT00787787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741062|NCT00787787|Growth Inhibitors|growth inhibitors|mesh-ancestor
101741063|NCT00787787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101741064|NCT00787787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101741065|NCT00722475|Immunoglobulins|immunoglobulins|mesh-list
101741066|NCT00722475|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101741067|NCT00722475|Antibodies|antibodies|mesh-list
101741068|NCT00722475|gamma-Globulins|gamma-globulins|mesh-list
101741070|NCT00722475|Immunologic Factors|immunologic factors|mesh-ancestor
101741071|NCT00722475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741072|NCT05549297|Pembrolizumab|pembrolizumab|mesh-list
101741094|NCT02604095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741095|NCT02604095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101741097|NCT02571543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101741098|NCT02571543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101741099|NCT02571543|Analgesics|analgesics|mesh-ancestor
101741100|NCT02571543|Sensory System Agents|sensory system agents|mesh-ancestor
101741101|NCT02571543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101741102|NCT02571543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741103|NCT02571543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101741104|NCT02571543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101741105|NCT02571543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101741106|NCT02571543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101741107|NCT02571543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741108|NCT04107779|Menthol|menthol|mesh-list
101741109|NCT04107779|Nicotine|nicotine|mesh-list
101741110|NCT04107779|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101741111|NCT04107779|Autonomic Agents|autonomic agents|mesh-ancestor
101741112|NCT04107779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101741113|NCT04107779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741114|NCT04107779|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101741115|NCT04107779|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101741116|NCT04107779|Cholinergic Agents|cholinergic agents|mesh-ancestor
101741117|NCT04107779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101741118|NCT04107779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741119|NCT04107779|Antipruritics|antipruritics|mesh-ancestor
101741120|NCT04107779|Dermatologic Agents|dermatologic agents|mesh-ancestor
101741121|NCT04067505|Nadroparin|nadroparin|mesh-list
101741122|NCT04067505|Warfarin|warfarin|mesh-list
101741123|NCT04067505|Rivaroxaban|rivaroxaban|mesh-list
101741124|NCT04067505|Anticoagulants|anticoagulants|mesh-ancestor
101741125|NCT04067505|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101741140|NCT00794963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101741141|NCT00794963|Antimetabolites|antimetabolites|mesh-ancestor
101741142|NCT00794963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741143|NCT00794963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101741144|NCT00794963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101741145|NCT00794963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101560438|NCT00950599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101560439|NCT01143207|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101560440|NCT01143207|Medroxyprogesterone|medroxyprogesterone|mesh-list
101560441|NCT01143207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101560442|NCT01143207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101560443|NCT01143207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101560444|NCT01143207|Contraceptive Agents|contraceptive agents|mesh-ancestor
101560445|NCT01143207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101560446|NCT01143207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560447|NCT01143207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101741147|NCT00794963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101741148|NCT00794963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101741149|NCT00794963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101741150|NCT00794963|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101741151|NCT00713271|AZD-3199|azd-3199|mesh-list
101741152|NCT00713271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101741153|NCT00713271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101741154|NCT00713271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101741155|NCT00713271|Adrenergic Agents|adrenergic agents|mesh-ancestor
101741156|NCT00713271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101741157|NCT00713271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741158|NCT00713271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741159|NCT05673135|Antihypertensive Agents|antihypertensive agents|mesh-list
101741160|NCT00722709|Ropivacaine|ropivacaine|mesh-list
101741161|NCT00722709|Anesthetics, Local|anesthetics, local|mesh-ancestor
101741162|NCT00722709|Anesthetics|anesthetics|mesh-ancestor
101741163|NCT00722709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101741164|NCT00722709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741165|NCT00722709|Sensory System Agents|sensory system agents|mesh-ancestor
101741166|NCT00722709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101741167|NCT04105205|Apramycin|apramycin|mesh-list
101741168|NCT04105205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101741169|NCT04105205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101741170|NCT00794573|Varenicline|varenicline|mesh-list
101741171|NCT00794573|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101741172|NCT00794573|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101741173|NCT00794573|Cholinergic Agents|cholinergic agents|mesh-ancestor
101741174|NCT00794573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101741175|NCT00794573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741176|NCT00794573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741177|NCT04070079|Tenofovir|tenofovir|mesh-list
101741178|NCT04070079|Antiviral Agents|antiviral agents|mesh-ancestor
101741179|NCT04070079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101741180|NCT04070079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101741181|NCT04070079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101741182|NCT04070079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101741183|NCT04070079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741184|NCT04070079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101741185|NCT04070079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101741186|NCT00739934|Voriconazole|voriconazole|mesh-list
101741187|NCT00739934|Antifungal Agents|antifungal agents|mesh-ancestor
101741188|NCT00739934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101741197|NCT00739934|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101741198|NCT00723411|Aluminum sulfate|aluminum sulfate|mesh-list
101741199|NCT00723411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101398654|NCT00332020|Enoxaparin|enoxaparin|mesh-list
101741201|NCT00723411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741202|NCT02586636|Metformin|metformin|mesh-list
101741203|NCT02586636|Omeprazole|omeprazole|mesh-list
101741204|NCT02586636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101741205|NCT02586636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741206|NCT02586636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101741207|NCT02586636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101741208|NCT02586636|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101560448|NCT01143207|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101560449|NCT01143207|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101560450|NCT01143207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101560451|NCT01143207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101560453|NCT01143051|Racepinephrine|racepinephrine|mesh-list
101560454|NCT01143051|Epinephryl borate|epinephryl borate|mesh-list
101560455|NCT01143051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101560456|NCT01143051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101741209|NCT02586636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101741210|NCT02586636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741211|NCT00713739|Prazosin|prazosin|mesh-list
101741212|NCT00713739|Doxazosin|doxazosin|mesh-list
101741213|NCT00713739|Nifedipine|nifedipine|mesh-list
101741214|NCT00713739|Alfuzosin|alfuzosin|mesh-list
101741215|NCT00713739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101741216|NCT00713739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101741217|NCT00713739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741218|NCT00713739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101741219|NCT00713739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741220|NCT00713739|Vasodilator Agents|vasodilator agents|mesh-ancestor
101741221|NCT00713739|Tocolytic Agents|tocolytic agents|mesh-ancestor
101741222|NCT00713739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101741223|NCT00713739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101741224|NCT00713739|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101741225|NCT00713739|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101741226|NCT00713739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101741227|NCT00713739|Adrenergic Agents|adrenergic agents|mesh-ancestor
101741228|NCT00713739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101741229|NCT00713739|Urological Agents|urological agents|mesh-ancestor
101741230|NCT02595476|Remifentanil|remifentanil|mesh-list
101741231|NCT02595476|Propofol|propofol|mesh-list
101741232|NCT02595476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101741233|NCT02595476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101741234|NCT02595476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741235|NCT02595476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101741236|NCT02595476|Anesthetics, General|anesthetics, general|mesh-ancestor
101741237|NCT02595476|Anesthetics|anesthetics|mesh-ancestor
101741238|NCT02595476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101741239|NCT02595476|Narcotics|narcotics|mesh-ancestor
101741240|NCT02595476|Analgesics|analgesics|mesh-ancestor
101741241|NCT02595476|Sensory System Agents|sensory system agents|mesh-ancestor
101741242|NCT02595476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101741243|NCT02586402|Epoetin Alfa|epoetin alfa|mesh-list
101741244|NCT02586402|Hematinics|hematinics|mesh-ancestor
101741245|NCT00734630|Losartan|losartan|mesh-list
101741246|NCT00734630|Lisinopril|lisinopril|mesh-list
101741247|NCT00734630|Nebivolol|nebivolol|mesh-list
101741248|NCT00734630|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101741249|NCT00734630|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101741250|NCT00734630|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101741251|NCT00734630|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101741252|NCT00734630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741253|NCT00734630|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101741256|NCT00734630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101741257|NCT00734630|Protective Agents|protective agents|mesh-ancestor
101741258|NCT00734630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741259|NCT00734630|Vasodilator Agents|vasodilator agents|mesh-ancestor
101741260|NCT00734630|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101741261|NCT00734630|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101741262|NCT00734630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101741263|NCT00734630|Adrenergic Agents|adrenergic agents|mesh-ancestor
101741264|NCT00734630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101741266|NCT05636514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101741267|NCT05636514|Antimetabolites|antimetabolites|mesh-ancestor
101741268|NCT05636514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741269|NCT05636514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101560457|NCT01143051|Adrenergic Agents|adrenergic agents|mesh-ancestor
101560458|NCT01143051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101560459|NCT01143051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741270|NCT05636514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101741271|NCT02586246|Certolizumab Pegol|certolizumab pegol|mesh-list
101741272|NCT02586246|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101741273|NCT02586246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101741274|NCT02586246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101741275|NCT02586246|Immunologic Factors|immunologic factors|mesh-ancestor
101360666|NCT00217711|Oxaliplatin|oxaliplatin|mesh-list
101741276|NCT02586246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741277|NCT02586246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101741279|NCT00920244|Amiodarone|amiodarone|mesh-list
101741280|NCT00920244|Epinephrine|epinephrine|mesh-list
101741281|NCT00920244|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101741282|NCT00920244|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101741283|NCT00920244|Adrenergic Agents|adrenergic agents|mesh-ancestor
101741284|NCT00920244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101741285|NCT00920244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741286|NCT00920244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741287|NCT00920244|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101741288|NCT00920244|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101741289|NCT00920244|Autonomic Agents|autonomic agents|mesh-ancestor
101741290|NCT00920244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101741291|NCT00920244|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101741292|NCT00920244|Respiratory System Agents|respiratory system agents|mesh-ancestor
101741293|NCT00920244|Mydriatics|mydriatics|mesh-ancestor
101741294|NCT00920244|Sympathomimetics|sympathomimetics|mesh-ancestor
101741295|NCT00920244|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101741296|NCT00920244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101741297|NCT00920244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101741298|NCT00920244|Parasympatholytics|parasympatholytics|mesh-ancestor
101741299|NCT00920244|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101741300|NCT00920244|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101741301|NCT00920244|Cholinergic Agents|cholinergic agents|mesh-ancestor
101741302|NCT00920244|Vasodilator Agents|vasodilator agents|mesh-ancestor
101741303|NCT00920244|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101741304|NCT00920244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101741305|NCT00920244|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101741306|NCT00920244|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101741307|NCT00920244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101741308|NCT00920244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101741309|NCT00920244|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101741310|NCT00920244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101741311|NCT00920244|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101741312|NCT00578175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101741313|NCT00578175|Immunologic Factors|immunologic factors|mesh-ancestor
101741314|NCT00578175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741315|NCT00723879|Ribavirin|ribavirin|mesh-list
101741316|NCT00723879|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101741317|NCT00723879|Antimetabolites|antimetabolites|mesh-ancestor
101741318|NCT00723879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741319|NCT00723879|Antiviral Agents|antiviral agents|mesh-ancestor
101741320|NCT00723879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101741321|NCT03907605|Hormones|hormones|mesh-list
101828123|NCT05965726|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
101741322|NCT03907605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101741323|NCT03907605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741324|NCT00435409|Capecitabine|capecitabine|mesh-list
101741325|NCT00435409|Sunitinib|sunitinib|mesh-list
101741326|NCT00435409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101741331|NCT00435409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101741332|NCT00435409|Growth Substances|growth substances|mesh-ancestor
101741333|NCT00435409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741334|NCT00435409|Growth Inhibitors|growth inhibitors|mesh-ancestor
101741335|NCT00435409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101741336|NCT00435409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101741337|NCT00724035|Fentanyl|fentanyl|mesh-list
101741338|NCT00724035|Midazolam|midazolam|mesh-list
101741339|NCT00724035|Analgesics|analgesics|mesh-list
101741340|NCT00724035|Anesthetics|anesthetics|mesh-list
101741341|NCT00724035|Ropivacaine|ropivacaine|mesh-list
101741342|NCT00724035|Anesthetics, Local|anesthetics, local|mesh-list
101560460|NCT01143051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560461|NCT01143051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101560462|NCT01143051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101560463|NCT01143051|Autonomic Agents|autonomic agents|mesh-ancestor
101560464|NCT01143051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101560465|NCT01143051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101560466|NCT01143051|Respiratory System Agents|respiratory system agents|mesh-ancestor
101741343|NCT00724035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101741344|NCT00724035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741345|NCT00724035|Sensory System Agents|sensory system agents|mesh-ancestor
101741346|NCT00724035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101741347|NCT00724035|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101741348|NCT00724035|Narcotics|narcotics|mesh-ancestor
101741349|NCT00724035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101398804|NCT05830604|Salicylic Acid|salicylic acid|mesh-list
101741350|NCT00724035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101741351|NCT00724035|Anesthetics, General|anesthetics, general|mesh-ancestor
101741352|NCT00724035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101741353|NCT00724035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101741354|NCT00724035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101741355|NCT00724035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101741357|NCT00724035|GABA Agents|gaba agents|mesh-ancestor
101741358|NCT00724035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101741359|NCT00724035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741360|NCT04126824|Triamcinolone|triamcinolone|mesh-list
101741361|NCT04126824|Bupivacaine|bupivacaine|mesh-list
101741362|NCT04126824|Anesthetics, Local|anesthetics, local|mesh-ancestor
101741363|NCT04126824|Anesthetics|anesthetics|mesh-ancestor
101741364|NCT04126824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101741365|NCT04126824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741366|NCT04126824|Sensory System Agents|sensory system agents|mesh-ancestor
101741367|NCT04126824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101741368|NCT04126824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101741369|NCT04126824|Glucocorticoids|glucocorticoids|mesh-ancestor
101741370|NCT04126824|Hormones|hormones|mesh-ancestor
101741371|NCT04126824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101741372|NCT00724113|Lidocaine|lidocaine|mesh-list
101741373|NCT00724113|Anesthetics, Local|anesthetics, local|mesh-ancestor
101741374|NCT00724113|Anesthetics|anesthetics|mesh-ancestor
101741375|NCT00724113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101741376|NCT00724113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741377|NCT00724113|Sensory System Agents|sensory system agents|mesh-ancestor
101741378|NCT00724113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101741379|NCT00724113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101741380|NCT00724113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101741381|NCT00724113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101741382|NCT00724113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101741383|NCT00724113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741384|NCT04070001|Ibuprofen|ibuprofen|mesh-list
101741385|NCT04070001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101741386|NCT04070001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101741387|NCT04070001|Analgesics|analgesics|mesh-ancestor
101741388|NCT04070001|Sensory System Agents|sensory system agents|mesh-ancestor
101741389|NCT04070001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101741390|NCT04070001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741391|NCT04070001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101741392|NCT04070001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101741393|NCT04070001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101741394|NCT04070001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101741395|NCT04070001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741396|NCT00435019|Insulin|insulin|mesh-list
101492881|NCT00430586|Botulinum Toxins|botulinum toxins|mesh-list
101741413|NCT00724581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101741414|NCT00724581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101741415|NCT00724581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101741416|NCT00724581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101560467|NCT01143051|Mydriatics|mydriatics|mesh-ancestor
101560468|NCT01143051|Sympathomimetics|sympathomimetics|mesh-ancestor
101560469|NCT01143051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101560471|NCT05199597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101560472|NCT05199597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101560473|NCT05199597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101560474|NCT05199597|Autonomic Agents|autonomic agents|mesh-ancestor
101560475|NCT05199597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101560476|NCT05199597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408897|NCT00456235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101741417|NCT00724581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101741418|NCT02570841|Capsaicin|capsaicin|mesh-list
101741419|NCT02570841|Antipruritics|antipruritics|mesh-ancestor
101741420|NCT02570841|Dermatologic Agents|dermatologic agents|mesh-ancestor
101741421|NCT02570841|Sensory System Agents|sensory system agents|mesh-ancestor
101741422|NCT02570841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101398888|NCT05776017|Antacids|antacids|mesh-ancestor
101741423|NCT02570841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741424|NCT00577863|Teriparatide|teriparatide|mesh-list
101741425|NCT00577863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101741426|NCT00577863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741427|NCT00577863|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101741428|NCT04956627|Itraconazole|itraconazole|mesh-list
101741429|NCT04956627|Phenytoin|phenytoin|mesh-list
101741430|NCT04956627|Gemfibrozil|gemfibrozil|mesh-list
101741431|NCT04956627|Antifungal Agents|antifungal agents|mesh-ancestor
101741432|NCT04956627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101741433|NCT04956627|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101741434|NCT04956627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101741435|NCT04956627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101741436|NCT04956627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741437|NCT04956627|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101741438|NCT04956627|Hormone Antagonists|hormone antagonists|mesh-ancestor
101741439|NCT04956627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101741440|NCT04956627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741441|NCT04956627|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101741442|NCT04956627|Anticonvulsants|anticonvulsants|mesh-ancestor
101741443|NCT04956627|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101741444|NCT04956627|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101741445|NCT04956627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101741446|NCT04956627|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101741447|NCT04956627|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101741448|NCT04956627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101741449|NCT04956627|Antimetabolites|antimetabolites|mesh-ancestor
101741450|NCT04956627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101741451|NCT04956627|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101741452|NCT00920088|Ritonavir|ritonavir|mesh-list
101741457|NCT00920088|Dextromethorphan|dextromethorphan|mesh-list
101470650|NCT00286260|Nootropic Agents|nootropic agents|mesh-ancestor
101741458|NCT00920088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101741459|NCT00920088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101741460|NCT00920088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101741461|NCT00920088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741462|NCT00920088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101741463|NCT00920088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101741464|NCT00920088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101741465|NCT00920088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101741466|NCT00920088|Anesthetics, General|anesthetics, general|mesh-ancestor
101741467|NCT00920088|Anesthetics|anesthetics|mesh-ancestor
101741468|NCT00920088|GABA Modulators|gaba modulators|mesh-ancestor
101741469|NCT00920088|GABA Agents|gaba agents|mesh-ancestor
101741470|NCT00920088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101741471|NCT00920088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741472|NCT00920088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101560477|NCT05199597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101560478|NCT05199597|Respiratory System Agents|respiratory system agents|mesh-ancestor
101560479|NCT05199597|Mydriatics|mydriatics|mesh-ancestor
101560480|NCT05199597|Parasympatholytics|parasympatholytics|mesh-ancestor
101560481|NCT05199597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101560482|NCT05199597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101560483|NCT05199597|Cholinergic Agents|cholinergic agents|mesh-ancestor
101560484|NCT05199597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101560485|NCT05199597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560486|NCT01142193|Topiramate|topiramate|mesh-list
101741473|NCT00920088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101741474|NCT00920088|Protease Inhibitors|protease inhibitors|mesh-ancestor
101741475|NCT00920088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101741476|NCT00920088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101741477|NCT00920088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101741478|NCT00920088|Antiviral Agents|antiviral agents|mesh-ancestor
101741479|NCT00920088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101741480|NCT00920088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101741481|NCT00920088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101741482|NCT00920088|Antitussive Agents|antitussive agents|mesh-ancestor
101741483|NCT00920088|Respiratory System Agents|respiratory system agents|mesh-ancestor
101741484|NCT00920088|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101741485|NCT00920088|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101741486|NCT00920088|Analgesics|analgesics|mesh-ancestor
101741487|NCT00920088|Sensory System Agents|sensory system agents|mesh-ancestor
101741488|NCT00920088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101741489|NCT00920088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101741490|NCT00920088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101741491|NCT00920088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101741492|NCT00920088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101741493|NCT00920088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101741494|NCT04018833|Ranibizumab|ranibizumab|mesh-list
101741495|NCT04018833|Aflibercept|aflibercept|mesh-list
101741496|NCT04018833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101741497|NCT04018833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101741498|NCT04018833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101741499|NCT04018833|Growth Substances|growth substances|mesh-ancestor
101741500|NCT04018833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741501|NCT04018833|Growth Inhibitors|growth inhibitors|mesh-ancestor
101741502|NCT04018833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101741503|NCT04066803|Folic Acid|folic acid|mesh-list
101741504|NCT04066803|Hematinics|hematinics|mesh-ancestor
101741505|NCT04066803|Vitamin B Complex|vitamin b complex|mesh-ancestor
101741506|NCT04066803|Vitamins|vitamins|mesh-ancestor
101741507|NCT04066803|Micronutrients|micronutrients|mesh-ancestor
101741508|NCT04066803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741509|NCT04921371|Listerine|listerine|mesh-list
101741510|NCT04921371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101741511|NCT04921371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101741512|NCT00725439|R 115866|r 115866|mesh-list
101741513|NCT00725439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101741514|NCT00725439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101828124|NCT05965726|Antiviral Agents|antiviral agents|mesh-ancestor
101741515|NCT00725439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741516|NCT03205761|Olaparib|olaparib|mesh-list
101741517|NCT03205761|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101741518|NCT03205761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101741519|NCT03205761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741520|NCT03205761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101741521|NCT00725517|Icodextrin|icodextrin|mesh-list
101741522|NCT00725517|Dialysis Solutions|dialysis solutions|mesh-ancestor
101741523|NCT00725517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101741524|NCT04066881|Vaccines|vaccines|mesh-list
101741525|NCT04066881|Immunologic Factors|immunologic factors|mesh-ancestor
101741526|NCT04066881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741532|NCT00794417|Aflibercept|aflibercept|mesh-list
101560487|NCT01142193|Anticonvulsants|anticonvulsants|mesh-ancestor
101560488|NCT01142193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101560489|NCT01142193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560491|NCT01139775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101741533|NCT00794417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101741534|NCT00794417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101741535|NCT00794417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741536|NCT00794417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101741537|NCT00794417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101741538|NCT00794417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101741539|NCT00794417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101741540|NCT00794417|Growth Substances|growth substances|mesh-ancestor
101741541|NCT00794417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741542|NCT00794417|Growth Inhibitors|growth inhibitors|mesh-ancestor
101741543|NCT04483206|Melphalan|melphalan|mesh-list
101741544|NCT04483206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101741545|NCT04483206|Alkylating Agents|alkylating agents|mesh-ancestor
101741546|NCT04483206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741547|NCT04483206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101741548|NCT04483206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101741549|NCT04483206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101741550|NCT04483206|Immunologic Factors|immunologic factors|mesh-ancestor
101741551|NCT04483206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741552|NCT00725829|Simvastatin|simvastatin|mesh-list
101741553|NCT00725829|Ezetimibe|ezetimibe|mesh-list
101741554|NCT00725829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101741555|NCT00725829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101741556|NCT00725829|Antimetabolites|antimetabolites|mesh-ancestor
101741557|NCT00725829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741558|NCT00725829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101741559|NCT00725829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101741560|NCT00725829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101741561|NCT02583438|Saxagliptin|saxagliptin|mesh-list
101741562|NCT02583438|Incretins|incretins|mesh-ancestor
101741563|NCT02583438|Hormones|hormones|mesh-ancestor
101741564|NCT02583438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101741565|NCT02583438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741566|NCT02583438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101741567|NCT02583438|Protease Inhibitors|protease inhibitors|mesh-ancestor
101741568|NCT02583438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101741569|NCT02583438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741570|NCT02583438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101741571|NCT02603861|Modafinil|modafinil|mesh-list
101741572|NCT02603861|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101399029|NCT05413330|Hormones|hormones|mesh-ancestor
101741573|NCT02603861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741574|NCT02603861|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101741575|NCT02603861|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101741576|NCT02603861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101741577|NCT02603861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741578|NCT02569905|Flurbiprofen|flurbiprofen|mesh-list
101741579|NCT02569905|Parecoxib|parecoxib|mesh-list
101741580|NCT02569905|Analgesics|analgesics|mesh-ancestor
101741581|NCT02569905|Sensory System Agents|sensory system agents|mesh-ancestor
101741582|NCT02569905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101741583|NCT02569905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741584|NCT02569905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101741585|NCT02569905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101741586|NCT02569905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101741587|NCT02569905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101741588|NCT02569905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101741589|NCT02569905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101741590|NCT02569905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741591|NCT02569905|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101741593|NCT02603783|Antipruritics|antipruritics|mesh-ancestor
101741594|NCT02603783|Dermatologic Agents|dermatologic agents|mesh-ancestor
101741595|NCT02603783|Sensory System Agents|sensory system agents|mesh-ancestor
101560492|NCT01139775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101560493|NCT01139775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560494|NCT01139775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101560495|NCT01139775|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101560496|NCT01283516|Ceritinib|ceritinib|mesh-list
101560497|NCT01283516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101560498|NCT01283516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101560499|NCT01283516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101560500|NCT01283516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560501|NCT01283282|Clopidogrel|clopidogrel|mesh-list
101741596|NCT02603783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101741597|NCT02603783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741606|NCT04250883|Trace Elements|trace elements|mesh-ancestor
101741607|NCT04250883|Micronutrients|micronutrients|mesh-ancestor
101741608|NCT04250883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741609|NCT04469634|Antibodies|antibodies|mesh-list
101741610|NCT04469634|Immunologic Factors|immunologic factors|mesh-ancestor
101741611|NCT04469634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741612|NCT04209543|Progesterone|progesterone|mesh-list
101741613|NCT04209543|Progestins|progestins|mesh-ancestor
101741614|NCT04209543|Hormones|hormones|mesh-ancestor
101741615|NCT04209543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101741616|NCT04209543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741617|NCT04465500|Androgens|androgens|mesh-list
101741618|NCT04465500|Hormones|hormones|mesh-ancestor
101741619|NCT04465500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101741620|NCT04465500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741621|NCT04080726|Esomeprazole|esomeprazole|mesh-list
101741622|NCT04080726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101741623|NCT04080726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101741624|NCT04080726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101741625|NCT04080726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101741626|NCT04080726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741627|NCT04639986|Gemcitabine|gemcitabine|mesh-list
101741628|NCT04639986|Capecitabine|capecitabine|mesh-list
101741629|NCT04639986|Vinorelbine|vinorelbine|mesh-list
101741630|NCT04639986|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
101741631|NCT04639986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101741632|NCT04639986|Antimetabolites|antimetabolites|mesh-ancestor
101741633|NCT04639986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741634|NCT04639986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101741635|NCT04639986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101741636|NCT04639986|Tubulin Modulators|tubulin modulators|mesh-ancestor
101741637|NCT04639986|Antimitotic Agents|antimitotic agents|mesh-ancestor
101741638|NCT04639986|Mitosis Modulators|mitosis modulators|mesh-ancestor
101741639|NCT04639986|Immunoconjugates|immunoconjugates|mesh-ancestor
101741640|NCT04639986|Immunologic Factors|immunologic factors|mesh-ancestor
101741641|NCT04639986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741642|NCT02583516|Vemurafenib|vemurafenib|mesh-list
101741643|NCT02583516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101741644|NCT02583516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101741645|NCT02583516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101741646|NCT02583516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741647|NCT00790907|Heparin|heparin|mesh-list
101741648|NCT00790907|PENTA|penta|mesh-list
101741649|NCT00790907|Fondaparinux|fondaparinux|mesh-list
101741650|NCT00790907|Anticoagulants|anticoagulants|mesh-ancestor
101741651|NCT00790907|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101741652|NCT00790907|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101741653|NCT00790907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741654|NCT00790907|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101741655|NCT00790907|Antithrombins|antithrombins|mesh-ancestor
101741656|NCT00790907|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101741657|NCT00790907|Protease Inhibitors|protease inhibitors|mesh-ancestor
101741658|NCT00790907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101560502|NCT01283282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101560503|NCT01283282|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101560504|NCT01283282|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101560505|NCT01283282|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101560506|NCT01283282|Purinergic Agents|purinergic agents|mesh-ancestor
101560507|NCT01283282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101560508|NCT01283282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408929|NCT00110630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101741659|NCT03109353|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101741660|NCT03109353|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101741661|NCT03109353|Dermatologic Agents|dermatologic agents|mesh-ancestor
101741662|NCT04066179|Prednisolone|prednisolone|mesh-list
101741663|NCT04066179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101741664|NCT04066179|Glucocorticoids|glucocorticoids|mesh-ancestor
101741665|NCT04066179|Hormones|hormones|mesh-ancestor
101741666|NCT04066179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101741684|NCT00726687|Antimetabolites|antimetabolites|mesh-ancestor
101741685|NCT00726687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741686|NCT00726687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101741687|NCT00727077|Interferons|interferons|mesh-list
101741689|NCT00727077|Interferon-alpha|interferon-alpha|mesh-list
101741690|NCT00727077|Interferon alpha-2|interferon alpha-2|mesh-list
101741691|NCT00727077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101741692|NCT00727077|Antiviral Agents|antiviral agents|mesh-ancestor
101741693|NCT00727077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101741694|NCT00727077|Antimetabolites|antimetabolites|mesh-ancestor
101741695|NCT00727077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741696|NCT00727077|Immunologic Factors|immunologic factors|mesh-ancestor
101741697|NCT00727077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741698|NCT02585388|Letrozole|letrozole|mesh-list
101741699|NCT02585388|Vinorelbine|vinorelbine|mesh-list
101741700|NCT02585388|Anastrozole|anastrozole|mesh-list
101741701|NCT02585388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101741702|NCT02585388|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101741703|NCT02585388|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101741704|NCT02585388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101741705|NCT02585388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741706|NCT02585388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101741707|NCT02585388|Hormone Antagonists|hormone antagonists|mesh-ancestor
101470701|NCT00250796|Interferons|interferons|mesh-list
101741708|NCT02585388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101741709|NCT02585388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741710|NCT02585388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101741711|NCT02585388|Tubulin Modulators|tubulin modulators|mesh-ancestor
101741712|NCT02585388|Antimitotic Agents|antimitotic agents|mesh-ancestor
101741713|NCT02585388|Mitosis Modulators|mitosis modulators|mesh-ancestor
101741714|NCT02585388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101741715|NCT04080336|Misoprostol|misoprostol|mesh-list
101741716|NCT04080336|Dinoprostone|dinoprostone|mesh-list
101741717|NCT04080336|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101741718|NCT04080336|Abortifacient Agents|abortifacient agents|mesh-ancestor
101741719|NCT04080336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101741720|NCT04080336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741721|NCT04080336|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101741722|NCT04080336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101741733|NCT00793871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741734|NCT05466474|Tislelizumab|tislelizumab|mesh-list
101741735|NCT05466474|Dacarbazine|dacarbazine|mesh-list
101741736|NCT05466474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101741737|NCT05466474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101741738|NCT05466474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101741739|NCT05466474|Alkylating Agents|alkylating agents|mesh-ancestor
101741740|NCT05466474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741741|NCT00727233|Sorafenib|sorafenib|mesh-list
101741742|NCT00727233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101560509|NCT01283282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560510|NCT01282814|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101560511|NCT01282814|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101560512|NCT01282814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101560513|NCT01282814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101560514|NCT01282814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560515|NCT01282814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101741743|NCT00727233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101741744|NCT00727233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101741745|NCT00727233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741746|NCT04105283|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
101741747|NCT04105283|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101741748|NCT04105283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741749|NCT04066257|Metronidazole|metronidazole|mesh-list
101741750|NCT04066257|Tetracycline|tetracycline|mesh-list
101741751|NCT04066257|Bismuth|bismuth|mesh-list
101741752|NCT04066257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101741753|NCT04066257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101741754|NCT04066257|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101741755|NCT04066257|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101741756|NCT04066257|Antacids|antacids|mesh-ancestor
101741757|NCT04066257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741758|NCT04066257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101741759|NCT04066257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101741760|NCT04066257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101741761|NCT03655821|Pemetrexed|pemetrexed|mesh-list
101741762|NCT03655821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101741763|NCT03655821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101741764|NCT03655821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741765|NCT03655821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101741766|NCT03655821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101741767|NCT04524702|Hydroxychloroquine|hydroxychloroquine|mesh-list
101741768|NCT04524702|Paclitaxel|paclitaxel|mesh-list
101470710|NCT00250796|Immunologic Factors|immunologic factors|mesh-ancestor
101741769|NCT04524702|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101741770|NCT04524702|Gemcitabine|gemcitabine|mesh-list
101741771|NCT04524702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101741772|NCT04524702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101741773|NCT04524702|Tubulin Modulators|tubulin modulators|mesh-ancestor
101741774|NCT04524702|Antimitotic Agents|antimitotic agents|mesh-ancestor
101741775|NCT04524702|Mitosis Modulators|mitosis modulators|mesh-ancestor
101741776|NCT04524702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741777|NCT04524702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101741778|NCT04524702|Antimetabolites|antimetabolites|mesh-ancestor
101741779|NCT04524702|Antimalarials|antimalarials|mesh-ancestor
101741780|NCT04524702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101741781|NCT04524702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101741782|NCT04524702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101741783|NCT04524702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101741784|NCT04524702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101741785|NCT00730197|Albuterol|albuterol|mesh-list
101741786|NCT00730197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101741796|NCT00730197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101741797|NCT00730197|Adrenergic Agents|adrenergic agents|mesh-ancestor
101741798|NCT00730197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101741799|NCT00730197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741800|NCT00727545|Chelating Agents|chelating agents|mesh-list
101741801|NCT00727545|Sequestering Agents|sequestering agents|mesh-ancestor
101741802|NCT00727545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741804|NCT02582892|Vitamins|vitamins|mesh-ancestor
101741805|NCT02582892|Micronutrients|micronutrients|mesh-ancestor
101741806|NCT02582892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741807|NCT02582892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101741808|NCT00730509|Vitamin B 12|vitamin b 12|mesh-list
101741809|NCT00730509|Hydroxocobalamin|hydroxocobalamin|mesh-list
101741810|NCT00730509|Vitamins|vitamins|mesh-ancestor
101741811|NCT00730509|Micronutrients|micronutrients|mesh-ancestor
101560516|NCT01282814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560517|NCT01282814|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101560518|NCT01282814|Antidepressive Agents|antidepressive agents|mesh-ancestor
101560520|NCT00941863|Sorafenib|sorafenib|mesh-list
101560521|NCT00941863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101560522|NCT00941863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101560523|NCT00941863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101408945|NCT00456586|Purinergic Agents|purinergic agents|mesh-ancestor
101741812|NCT00730509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741813|NCT00730509|Vitamin B Complex|vitamin b complex|mesh-ancestor
101741814|NCT00730509|Hematinics|hematinics|mesh-ancestor
101741815|NCT02582736|Methotrimeprazine|methotrimeprazine|mesh-list
101741816|NCT02582736|Haloperidol|haloperidol|mesh-list
101741817|NCT02582736|Pimozide|pimozide|mesh-list
101741818|NCT02582736|Olanzapine|olanzapine|mesh-list
101741819|NCT02582736|Chlorpromazine|chlorpromazine|mesh-list
101741820|NCT02582736|Trifluoperazine|trifluoperazine|mesh-list
101741821|NCT02582736|Risperidone|risperidone|mesh-list
101741822|NCT02582736|Aripiprazole|aripiprazole|mesh-list
101741823|NCT02582736|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101741824|NCT02582736|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101741825|NCT02582736|Ziprasidone|ziprasidone|mesh-list
101741826|NCT02582736|Antipsychotic Agents|antipsychotic agents|mesh-list
101741827|NCT02582736|Clozapine|clozapine|mesh-list
101741828|NCT02582736|Loxapine|loxapine|mesh-list
101741829|NCT02582736|Perphenazine|perphenazine|mesh-list
101741830|NCT02582736|Fluphenazine|fluphenazine|mesh-list
101741831|NCT02582736|Thioridazine|thioridazine|mesh-list
101741832|NCT02582736|Flupenthixol|flupenthixol|mesh-list
101741833|NCT02582736|Clopenthixol|clopenthixol|mesh-list
101741834|NCT02582736|Chlorprothixene|chlorprothixene|mesh-list
101741835|NCT02582736|Fluspirilene|fluspirilene|mesh-list
101741836|NCT02582736|Thiothixene|thiothixene|mesh-list
101741837|NCT02582736|Mesoridazine|mesoridazine|mesh-list
101741838|NCT02582736|Chlormezanone|chlormezanone|mesh-list
101741839|NCT02582736|Tetrabenazine|tetrabenazine|mesh-list
101741840|NCT02582736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101741841|NCT02582736|Serotonin Agents|serotonin agents|mesh-ancestor
101741842|NCT02582736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101741843|NCT02582736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741844|NCT02582736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741845|NCT02582736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101741846|NCT02582736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101741847|NCT02582736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101741848|NCT02582736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101741849|NCT02582736|Dopamine Agents|dopamine agents|mesh-ancestor
101741850|NCT02582736|Antiemetics|antiemetics|mesh-ancestor
101741851|NCT02582736|Autonomic Agents|autonomic agents|mesh-ancestor
101741852|NCT02582736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101741853|NCT02582736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101741854|NCT02582736|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101741855|NCT02582736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101741856|NCT02582736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101741857|NCT02582736|Antidepressive Agents|antidepressive agents|mesh-ancestor
101741870|NCT02582736|Sensory System Agents|sensory system agents|mesh-ancestor
101741871|NCT02582736|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101741872|NCT02582736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101741873|NCT02582736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101741874|NCT04019652|Moxifloxacin|moxifloxacin|mesh-list
101741875|NCT04019652|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101741876|NCT04019652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101741877|NCT04019652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101741878|NCT04019652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101741879|NCT04019652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101741880|NCT04019652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101741881|NCT04019652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741882|NCT04019652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101741883|NCT04019652|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101741884|NCT04019652|Contraceptive Agents|contraceptive agents|mesh-ancestor
101560524|NCT00941863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560525|NCT00602173|Cilostazol|cilostazol|mesh-list
101560526|NCT00602173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101560527|NCT00602173|Autonomic Agents|autonomic agents|mesh-ancestor
101560528|NCT00602173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101560529|NCT00602173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560530|NCT00602173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101560531|NCT00602173|Respiratory System Agents|respiratory system agents|mesh-ancestor
101560532|NCT00602173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101560533|NCT00602173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101741885|NCT04019652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101741886|NCT04019652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741887|NCT04019652|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101741888|NCT04019652|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101741889|NCT04019652|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101741890|NCT00735345|Docetaxel|docetaxel|mesh-list
101741891|NCT00735345|Cetuximab|cetuximab|mesh-list
101741892|NCT00735345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101741893|NCT00735345|Tubulin Modulators|tubulin modulators|mesh-ancestor
101741894|NCT00735345|Antimitotic Agents|antimitotic agents|mesh-ancestor
101741895|NCT00735345|Mitosis Modulators|mitosis modulators|mesh-ancestor
101741896|NCT00735345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741897|NCT00735345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101741898|NCT00735501|Insulin Detemir|insulin detemir|mesh-list
101741899|NCT00735501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101741900|NCT00735501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741901|NCT00727935|Lidocaine|lidocaine|mesh-list
101741902|NCT00727935|Ropivacaine|ropivacaine|mesh-list
101741903|NCT00727935|Anesthetics, Local|anesthetics, local|mesh-ancestor
101741904|NCT00727935|Anesthetics|anesthetics|mesh-ancestor
101741905|NCT00727935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101741906|NCT00727935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741907|NCT00727935|Sensory System Agents|sensory system agents|mesh-ancestor
101741908|NCT00727935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101741909|NCT00727935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101741910|NCT00727935|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101741911|NCT00727935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101741912|NCT00727935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101741913|NCT00727935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741914|NCT00728013|Atorvastatin|atorvastatin|mesh-list
101741915|NCT00728013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101741916|NCT00728013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101741917|NCT00728013|Antimetabolites|antimetabolites|mesh-ancestor
101741918|NCT00728013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493398|NCT01051661|Vaccines|vaccines|mesh-list
101741926|NCT00577707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741928|NCT00577707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101741929|NCT00577707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101741930|NCT00730821|Nintedanib|nintedanib|mesh-list
101741931|NCT00730821|Afatinib|afatinib|mesh-list
101741932|NCT00730821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101741933|NCT00730821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101741934|NCT00730821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101741935|NCT00730821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741936|NCT00728559|Bupivacaine|bupivacaine|mesh-list
101741937|NCT00728559|Anesthetics, Local|anesthetics, local|mesh-ancestor
101741938|NCT00728559|Anesthetics|anesthetics|mesh-ancestor
101741939|NCT00728559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101741940|NCT00728559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263379|NCT01761656|Atorvastatin|atorvastatin|mesh-list
101741941|NCT00728559|Sensory System Agents|sensory system agents|mesh-ancestor
101741942|NCT00728559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101741943|NCT00735813|Heparin|heparin|mesh-list
101741944|NCT00735813|Anticoagulants|anticoagulants|mesh-ancestor
101560534|NCT00602173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560535|NCT00602173|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101560536|NCT00602173|Vasodilator Agents|vasodilator agents|mesh-ancestor
101560537|NCT00602173|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101560538|NCT00602173|Protective Agents|protective agents|mesh-ancestor
101560539|NCT00602173|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101560540|NCT00602173|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101560541|NCT00602173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101560542|NCT02852239|Dabrafenib|dabrafenib|mesh-list
101560543|NCT02852239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101560544|NCT02852239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101560545|NCT02852239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101560546|NCT02852239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560547|NCT01282424|Idelalisib|idelalisib|mesh-list
101560548|NCT01282424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101741945|NCT00735813|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101741946|NCT00735813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101741947|NCT00735813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741948|NCT04064619|Solifenacin Succinate|solifenacin succinate|mesh-list
101741949|NCT04064619|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101741950|NCT04064619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101741951|NCT04064619|Cholinergic Agents|cholinergic agents|mesh-ancestor
101741952|NCT04064619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101741953|NCT04064619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741954|NCT04064619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741955|NCT04064619|Urological Agents|urological agents|mesh-ancestor
101741956|NCT00730977|Mannitol|mannitol|mesh-list
101741957|NCT00730977|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101741958|NCT00730977|Diuretics|diuretics|mesh-ancestor
101741959|NCT00730977|Natriuretic Agents|natriuretic agents|mesh-ancestor
101741960|NCT00730977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741961|NCT00728715|Budesonide|budesonide|mesh-list
101741962|NCT00728715|Formoterol Fumarate|formoterol fumarate|mesh-list
101741963|NCT00728715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101741964|NCT00728715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101741965|NCT00728715|Autonomic Agents|autonomic agents|mesh-ancestor
101741966|NCT00728715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101741967|NCT00728715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741968|NCT00728715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101741969|NCT00728715|Respiratory System Agents|respiratory system agents|mesh-ancestor
101741970|NCT00728715|Glucocorticoids|glucocorticoids|mesh-ancestor
101741971|NCT00728715|Hormones|hormones|mesh-ancestor
101741972|NCT00728715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101741973|NCT00728715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101741974|NCT00728715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101741975|NCT00728715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101741976|NCT00728715|Adrenergic Agents|adrenergic agents|mesh-ancestor
101741977|NCT00728715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101741978|NCT00728715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741979|NCT00731289|Triamcinolone|triamcinolone|mesh-list
101741980|NCT00731289|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101741981|NCT00731289|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101741982|NCT00731289|Hyaluronic Acid|hyaluronic acid|mesh-list
101741983|NCT00731289|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101493458|NCT00463671|Expectorants|expectorants|mesh-ancestor
101741997|NCT00736515|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101741998|NCT00736515|Insulin Glargine|insulin glargine|mesh-list
101741999|NCT00736515|Gliclazide|gliclazide|mesh-list
101742000|NCT00736515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101560549|NCT01282424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101560550|NCT01282424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560551|NCT00602251|Terbinafine|terbinafine|mesh-list
101560552|NCT00602251|Antifungal Agents|antifungal agents|mesh-ancestor
101560553|NCT00602251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101560554|NCT00602251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101560555|NCT00602251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560556|NCT01281956|Naluzotan|naluzotan|mesh-list
101560557|NCT01281956|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101742001|NCT00736515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742002|NCT00731367|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101742003|NCT00731367|Laxatives|laxatives|mesh-ancestor
101742004|NCT00731367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101742005|NCT00731523|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101742006|NCT00731523|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101742007|NCT00731523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742008|NCT00731523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101742009|NCT00731523|Immunologic Factors|immunologic factors|mesh-ancestor
101742010|NCT00731523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742011|NCT05601531|Calcitriol|calcitriol|mesh-list
101742012|NCT05601531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101304275|NCT02012088|Prednisone|prednisone|mesh-list
101742013|NCT05601531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742014|NCT05601531|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101742015|NCT05601531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101828125|NCT05965726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101742016|NCT05601531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742017|NCT05601531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101742018|NCT05601531|Vitamins|vitamins|mesh-ancestor
101742019|NCT05601531|Micronutrients|micronutrients|mesh-ancestor
101742020|NCT05601531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101742021|NCT02569125|Everolimus|everolimus|mesh-list
101742022|NCT02569125|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101742023|NCT02569125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101742024|NCT02569125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101742025|NCT02569125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742026|NCT02569125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101742027|NCT02569125|Immunologic Factors|immunologic factors|mesh-ancestor
101742028|NCT02569125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742029|NCT02569125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101742030|NCT00731601|Pantoprazole|pantoprazole|mesh-list
101742031|NCT00731601|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101742032|NCT00731601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101742033|NCT00731601|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101742034|NCT00731601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101742035|NCT00731601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742036|NCT00736905|Rilpivirine|rilpivirine|mesh-list
101742037|NCT00736905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101742038|NCT00736905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101742039|NCT00736905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101742040|NCT00736905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742041|NCT00736905|Antiviral Agents|antiviral agents|mesh-ancestor
101742042|NCT00736905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101742043|NCT00736905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101742051|NCT00736983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101742052|NCT00736983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101742053|NCT00736983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101742054|NCT00736983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101742055|NCT00736983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742056|NCT00736983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101742057|NCT00736983|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101742058|NCT00736983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101742059|NCT00729339|Mosapride|mosapride|mesh-list
101560558|NCT01281956|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101560559|NCT01281956|Serotonin Agents|serotonin agents|mesh-ancestor
101560560|NCT01281956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101560561|NCT01281956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560562|NCT01281956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560563|NCT01279850|Pregabalin|pregabalin|mesh-list
101560564|NCT01279850|Analgesics|analgesics|mesh-ancestor
101560565|NCT01279850|Sensory System Agents|sensory system agents|mesh-ancestor
101560566|NCT01279850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101560567|NCT01279850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560568|NCT01279850|Anticonvulsants|anticonvulsants|mesh-ancestor
101560569|NCT01279850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101560570|NCT01279850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101560571|NCT01279850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560572|NCT01279850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101560573|NCT01279850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101560574|NCT01279850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101560575|NCT01279850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101560576|NCT01279850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101560577|NCT00604357|Sirolimus|sirolimus|mesh-list
101560578|NCT00604357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101560579|NCT00604357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101742060|NCT00729339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101742061|NCT00729339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101742062|NCT00729339|Serotonin Agents|serotonin agents|mesh-ancestor
101742063|NCT00729339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101742064|NCT00729339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742065|NCT00729339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742066|NCT00737139|Epinephrine|epinephrine|mesh-list
101742067|NCT00737139|Bupivacaine|bupivacaine|mesh-list
101742068|NCT00737139|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101742069|NCT00737139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101742070|NCT00737139|Adrenergic Agents|adrenergic agents|mesh-ancestor
101742071|NCT00737139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101742072|NCT00737139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742073|NCT00737139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742074|NCT00737139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101742075|NCT00737139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101742076|NCT00737139|Autonomic Agents|autonomic agents|mesh-ancestor
101742077|NCT00737139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101742078|NCT00737139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101742079|NCT00737139|Respiratory System Agents|respiratory system agents|mesh-ancestor
101742080|NCT00737139|Mydriatics|mydriatics|mesh-ancestor
101742081|NCT00737139|Sympathomimetics|sympathomimetics|mesh-ancestor
101742082|NCT00737139|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101742083|NCT00737139|Anesthetics, Local|anesthetics, local|mesh-ancestor
101742084|NCT00737139|Anesthetics|anesthetics|mesh-ancestor
101742085|NCT00737139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101742086|NCT00737139|Sensory System Agents|sensory system agents|mesh-ancestor
101742087|NCT00732147|Pramlintide|pramlintide|mesh-list
101742088|NCT00732147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101560580|NCT00604357|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101560581|NCT00604357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101560582|NCT00604357|Antifungal Agents|antifungal agents|mesh-ancestor
101560583|NCT00604357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101560584|NCT00604357|Immunologic Factors|immunologic factors|mesh-ancestor
101560585|NCT00604357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560586|NCT00602719|Zolpidem|zolpidem|mesh-list
101560587|NCT00602719|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101409010|NCT03274102|Vaccines|vaccines|mesh-list
101742089|NCT00732147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742090|NCT02569515|Epoetin Alfa|epoetin alfa|mesh-list
101742091|NCT02569515|Hematinics|hematinics|mesh-ancestor
101742092|NCT00737373|Leucovorin|leucovorin|mesh-list
101742093|NCT00737373|Folic Acid|folic acid|mesh-list
101742094|NCT00737373|Docetaxel|docetaxel|mesh-list
101742095|NCT00737373|Fluorouracil|fluorouracil|mesh-list
101742096|NCT00737373|Oxaliplatin|oxaliplatin|mesh-list
101742097|NCT00737373|Levoleucovorin|levoleucovorin|mesh-list
101742098|NCT00737373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101742099|NCT00737373|Tubulin Modulators|tubulin modulators|mesh-ancestor
101742100|NCT00737373|Antimitotic Agents|antimitotic agents|mesh-ancestor
101742101|NCT00737373|Mitosis Modulators|mitosis modulators|mesh-ancestor
101742102|NCT00737373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742103|NCT00737373|Antimetabolites|antimetabolites|mesh-ancestor
101742104|NCT00737373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101742105|NCT00737373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101742106|NCT00737373|Immunologic Factors|immunologic factors|mesh-ancestor
101742107|NCT00737373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742108|NCT00737373|Antidotes|antidotes|mesh-ancestor
101742109|NCT00737373|Protective Agents|protective agents|mesh-ancestor
101742110|NCT00737373|Vitamin B Complex|vitamin b complex|mesh-ancestor
101742112|NCT00737373|Micronutrients|micronutrients|mesh-ancestor
101742113|NCT00737373|Hematinics|hematinics|mesh-ancestor
101742114|NCT00729495|Celecoxib|celecoxib|mesh-list
101493585|NCT00464295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101742117|NCT00729495|Analgesics|analgesics|mesh-ancestor
101742118|NCT00729495|Sensory System Agents|sensory system agents|mesh-ancestor
101742119|NCT00729495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101742120|NCT00729495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742121|NCT00729495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101742122|NCT00729495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101742123|NCT00729495|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101742124|NCT00729495|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101742125|NCT00729495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101828132|NCT05945485|Vaccines|vaccines|mesh-list
101742126|NCT00729495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742127|NCT00737685|Cyclophosphamide|cyclophosphamide|mesh-list
101742128|NCT00737685|Fludarabine|fludarabine|mesh-list
101742129|NCT00737685|Thymoglobulin|thymoglobulin|mesh-list
101742130|NCT00737685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101742131|NCT00737685|Immunologic Factors|immunologic factors|mesh-ancestor
101742132|NCT00737685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742133|NCT00737685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101742134|NCT00737685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101742135|NCT00737685|Alkylating Agents|alkylating agents|mesh-ancestor
101742136|NCT00737685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742137|NCT00737685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101742138|NCT00737685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101742139|NCT00732537|Nitric Oxide|nitric oxide|mesh-list
101742140|NCT00732537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101742141|NCT00732537|Autonomic Agents|autonomic agents|mesh-ancestor
101742142|NCT00732537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101742143|NCT00732537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742144|NCT00732537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101742145|NCT00732537|Respiratory System Agents|respiratory system agents|mesh-ancestor
101742146|NCT00732537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101742147|NCT00732537|Antioxidants|antioxidants|mesh-ancestor
101742148|NCT00732537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742149|NCT00732537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101560588|NCT00602719|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101560589|NCT00602719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101560590|NCT00602719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560591|NCT00602719|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101560592|NCT00602719|GABA Agonists|gaba agonists|mesh-ancestor
101560593|NCT00602719|GABA Agents|gaba agents|mesh-ancestor
101560594|NCT00602719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101560595|NCT00602719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560596|NCT00604435|Docetaxel|docetaxel|mesh-list
101742150|NCT00732537|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101742151|NCT00732537|Vasodilator Agents|vasodilator agents|mesh-ancestor
101742152|NCT00732537|Gasotransmitters|gasotransmitters|mesh-ancestor
101742153|NCT00732537|Protective Agents|protective agents|mesh-ancestor
101742154|NCT00732693|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101742155|NCT00732693|Norethindrone|norethindrone|mesh-list
101742156|NCT00732693|Norethindrone Acetate|norethindrone acetate|mesh-list
101742158|NCT00732693|Progesterone|progesterone|mesh-list
101742159|NCT00732693|Estrogens|estrogens|mesh-ancestor
101742160|NCT00732693|Hormones|hormones|mesh-ancestor
101742161|NCT00732693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101742162|NCT00732693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742163|NCT00732693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101742164|NCT00732693|Contraceptive Agents|contraceptive agents|mesh-ancestor
101742165|NCT00732693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101742166|NCT00732693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101742168|NCT00732693|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101742169|NCT00732693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101742170|NCT00732693|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101742171|NCT00729963|Sibutramine|sibutramine|mesh-list
101742172|NCT00729963|Antidepressive Agents|antidepressive agents|mesh-ancestor
101742173|NCT00729963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101742174|NCT00729963|Appetite Depressants|appetite depressants|mesh-ancestor
101742175|NCT00729963|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101742176|NCT00737997|Morphine|morphine|mesh-list
101742177|NCT00737997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101742178|NCT00737997|Narcotics|narcotics|mesh-ancestor
101742179|NCT00737997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101742180|NCT00737997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742181|NCT00737997|Analgesics|analgesics|mesh-ancestor
101742182|NCT00737997|Sensory System Agents|sensory system agents|mesh-ancestor
101742183|NCT00737997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101742184|NCT00732927|Aspirin|aspirin|mesh-list
101742185|NCT00732927|Parnaparin|parnaparin|mesh-list
101742186|NCT00732927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101742187|NCT00732927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101742188|NCT00732927|Analgesics|analgesics|mesh-ancestor
101742196|NCT00732927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742197|NCT00732927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101742198|NCT00732927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101742199|NCT00732927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101742200|NCT00732927|Antipyretics|antipyretics|mesh-ancestor
101742201|NCT00732927|Anticoagulants|anticoagulants|mesh-ancestor
101742202|NCT00733083|Dexamethasone|dexamethasone|mesh-list
101742203|NCT00733083|Morphine|morphine|mesh-list
101742204|NCT00733083|Oxycodone|oxycodone|mesh-list
101742205|NCT00733083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101742206|NCT00733083|Antiemetics|antiemetics|mesh-ancestor
101742207|NCT00733083|Autonomic Agents|autonomic agents|mesh-ancestor
101742208|NCT00733083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101742209|NCT00733083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742210|NCT00733083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101742211|NCT00733083|Glucocorticoids|glucocorticoids|mesh-ancestor
101742212|NCT00733083|Hormones|hormones|mesh-ancestor
101742213|NCT00733083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101742214|NCT00733083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101742215|NCT00733083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101742216|NCT00733083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101742217|NCT00733083|Narcotics|narcotics|mesh-ancestor
101560597|NCT00604435|Epirubicin|epirubicin|mesh-list
101560598|NCT00604435|Endostatins|endostatins|mesh-list
101560599|NCT00604435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101560600|NCT00604435|Tubulin Modulators|tubulin modulators|mesh-ancestor
101560601|NCT00604435|Antimitotic Agents|antimitotic agents|mesh-ancestor
101560602|NCT00604435|Mitosis Modulators|mitosis modulators|mesh-ancestor
101560603|NCT00604435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409026|NCT00456937|Escitalopram|escitalopram|mesh-list
101742218|NCT00733083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101742219|NCT00733083|Analgesics|analgesics|mesh-ancestor
101742220|NCT00733083|Sensory System Agents|sensory system agents|mesh-ancestor
101742221|NCT00712335|Fluticasone|fluticasone|mesh-list
101742223|NCT00712335|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101742224|NCT00712335|Montelukast|montelukast|mesh-list
101742225|NCT00712335|Leukotriene Antagonists|leukotriene antagonists|mesh-list
101742226|NCT00712335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101742227|NCT00712335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101742228|NCT00712335|Autonomic Agents|autonomic agents|mesh-ancestor
101742229|NCT00712335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101742230|NCT00712335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742231|NCT00712335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101742232|NCT00712335|Respiratory System Agents|respiratory system agents|mesh-ancestor
101742233|NCT00712335|Dermatologic Agents|dermatologic agents|mesh-ancestor
101742234|NCT00712335|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101742235|NCT00712335|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101742236|NCT00712335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101742237|NCT00712335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101742238|NCT00712335|Adrenergic Agents|adrenergic agents|mesh-ancestor
101742239|NCT00712335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101304277|NCT02012088|Rituximab|rituximab|mesh-list
101742240|NCT00712335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742241|NCT00712335|Hormone Antagonists|hormone antagonists|mesh-ancestor
101742242|NCT00712335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101742243|NCT00712335|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101742244|NCT00712335|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101742245|NCT00738621|Dexamethasone|dexamethasone|mesh-list
101742246|NCT00738621|Dexamethasone acetate|dexamethasone acetate|mesh-list
101742247|NCT00738621|Ondansetron|ondansetron|mesh-list
101742248|NCT00738621|Aprepitant|aprepitant|mesh-list
101742249|NCT00738621|Fosaprepitant|fosaprepitant|mesh-list
101742250|NCT00738621|BB 1101|bb 1101|mesh-list
101742251|NCT00738621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101742252|NCT00738621|Antiemetics|antiemetics|mesh-ancestor
101742253|NCT00738621|Autonomic Agents|autonomic agents|mesh-ancestor
101742254|NCT00738621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101742255|NCT00738621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742256|NCT00738621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101742257|NCT00738621|Glucocorticoids|glucocorticoids|mesh-ancestor
101742258|NCT00738621|Hormones|hormones|mesh-ancestor
101742262|NCT00738621|Protease Inhibitors|protease inhibitors|mesh-ancestor
101742263|NCT00738621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101742264|NCT00738621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742265|NCT00738621|Antipruritics|antipruritics|mesh-ancestor
101742266|NCT00738621|Dermatologic Agents|dermatologic agents|mesh-ancestor
101742267|NCT00738621|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101742268|NCT00738621|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101742269|NCT00738621|Serotonin Agents|serotonin agents|mesh-ancestor
101742270|NCT00738621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101742271|NCT00738621|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101742272|NCT00733239|Cycloserine|cycloserine|mesh-list
101742273|NCT00733239|Verapamil|verapamil|mesh-list
101742274|NCT00733239|Diltiazem|diltiazem|mesh-list
101742275|NCT00733239|Isradipine|isradipine|mesh-list
101742276|NCT00733239|Nifedipine|nifedipine|mesh-list
101742277|NCT00733239|Gabapentin|gabapentin|mesh-list
101742278|NCT00733239|Naloxone|naloxone|mesh-list
101742279|NCT00733239|Analgesics|analgesics|mesh-ancestor
101742280|NCT00733239|Sensory System Agents|sensory system agents|mesh-ancestor
101742281|NCT00733239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101742282|NCT00733239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742283|NCT00733239|Anticonvulsants|anticonvulsants|mesh-ancestor
101560604|NCT00604435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101560605|NCT00604435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101560606|NCT00604435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101560607|NCT00604435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101560608|NCT00604435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101560609|NCT00604435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101560611|NCT00604435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560612|NCT00604435|Growth Inhibitors|growth inhibitors|mesh-ancestor
101560613|NCT01136967|Lenvatinib|lenvatinib|mesh-list
101560614|NCT01136967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101742284|NCT00733239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101742285|NCT00733239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101742286|NCT00733239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101742287|NCT00733239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101742288|NCT00733239|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101742289|NCT00733239|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101742290|NCT00733239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101742291|NCT00733239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742292|NCT00733239|Antimanic Agents|antimanic agents|mesh-ancestor
101742293|NCT00733239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101742294|NCT00733239|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101742295|NCT00733239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101742296|NCT00733239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101742297|NCT00733239|Vasodilator Agents|vasodilator agents|mesh-ancestor
101742298|NCT00733239|Tocolytic Agents|tocolytic agents|mesh-ancestor
101742299|NCT00733239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101742300|NCT00733239|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101742301|NCT00733239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101742302|NCT00733239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101742303|NCT00733239|Antitubercular Agents|antitubercular agents|mesh-ancestor
101742304|NCT00733239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101742305|NCT00733239|Antimetabolites|antimetabolites|mesh-ancestor
101742306|NCT00733239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101742307|NCT00733239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101742308|NCT00738153|Insulin Detemir|insulin detemir|mesh-list
101742309|NCT00738153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101742310|NCT00738153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742311|NCT04065165|Lanreotide|lanreotide|mesh-list
101742312|NCT04065165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101742313|NCT00577629|Cytarabine|cytarabine|mesh-list
101742314|NCT00577629|Cyclophosphamide|cyclophosphamide|mesh-list
101742315|NCT00577629|Rituximab|rituximab|mesh-list
101742316|NCT00577629|Doxorubicin|doxorubicin|mesh-list
101742317|NCT00577629|Etoposide|etoposide|mesh-list
101742318|NCT00577629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101742319|NCT00577629|Immunologic Factors|immunologic factors|mesh-ancestor
101742320|NCT00577629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742321|NCT00577629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101742322|NCT00577629|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101742323|NCT00577629|Alkylating Agents|alkylating agents|mesh-ancestor
101742324|NCT00577629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742325|NCT00577629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101742326|NCT00577629|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101742327|NCT00577629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101742328|NCT00577629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101742329|NCT00577629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101742330|NCT00577629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101742342|NCT00733317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742343|NCT00733317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101742344|NCT00733317|Respiratory System Agents|respiratory system agents|mesh-ancestor
101742346|NCT00733317|Hormones|hormones|mesh-ancestor
101742347|NCT00733317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101742348|NCT02568735|Etoricoxib|etoricoxib|mesh-list
101742349|NCT02568735|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
101560615|NCT01136967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101560616|NCT01136967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101560617|NCT01136967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560619|NCT01218516|Carboplatin|carboplatin|mesh-list
101560620|NCT01218516|Pemetrexed|pemetrexed|mesh-list
101560621|NCT01218516|Farletuzumab|farletuzumab|mesh-list
101560622|NCT01218516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101560623|NCT01218516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101742350|NCT02568735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101742351|NCT02568735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101742352|NCT02568735|Analgesics|analgesics|mesh-ancestor
101742353|NCT02568735|Sensory System Agents|sensory system agents|mesh-ancestor
101742354|NCT02568735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101742355|NCT02568735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742356|NCT02568735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101742357|NCT02568735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101742358|NCT02568735|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101742359|NCT02568735|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101742360|NCT02568735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101742361|NCT02568735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742362|NCT00733473|Budesonide|budesonide|mesh-list
101742363|NCT00733473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101742364|NCT00733473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101742365|NCT00733473|Autonomic Agents|autonomic agents|mesh-ancestor
101742366|NCT00733473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101742367|NCT00733473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742368|NCT00733473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101742369|NCT00733473|Respiratory System Agents|respiratory system agents|mesh-ancestor
101742370|NCT00733473|Glucocorticoids|glucocorticoids|mesh-ancestor
101742371|NCT00733473|Hormones|hormones|mesh-ancestor
101742372|NCT00733473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101742373|NCT00710385|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101742374|NCT00710385|Buprenorphine|buprenorphine|mesh-list
101742375|NCT00710385|Heroin|heroin|mesh-list
101742376|NCT00710385|Naloxone|naloxone|mesh-list
101742377|NCT00710385|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101742378|NCT00710385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742379|NCT00710385|Sensory System Agents|sensory system agents|mesh-ancestor
101742380|NCT00710385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101742381|NCT00710385|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101742382|NCT00710385|Narcotics|narcotics|mesh-ancestor
101742383|NCT00710385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101742384|NCT00710385|Analgesics|analgesics|mesh-ancestor
101742385|NCT04063527|Paclitaxel|paclitaxel|mesh-list
101742386|NCT04063527|Carboplatin|carboplatin|mesh-list
101742387|NCT04063527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101742388|NCT04063527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101742389|NCT04063527|Tubulin Modulators|tubulin modulators|mesh-ancestor
101742390|NCT04063527|Antimitotic Agents|antimitotic agents|mesh-ancestor
101742391|NCT04063527|Mitosis Modulators|mitosis modulators|mesh-ancestor
101742392|NCT04063527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742394|NCT00738777|Fulvestrant|fulvestrant|mesh-list
101742395|NCT00738777|Anastrozole|anastrozole|mesh-list
101742399|NCT00738777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742400|NCT00738777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101742401|NCT00738777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101742402|NCT00738777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101399855|NCT02304458|Nivolumab|nivolumab|mesh-list
101742403|NCT00738777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101742404|NCT00738777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101742405|NCT00738777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101742407|NCT00738777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101742408|NCT00738777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101742409|NCT00738777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742410|NCT00733785|Rosiglitazone|rosiglitazone|mesh-list
101560624|NCT01218516|Tubulin Modulators|tubulin modulators|mesh-ancestor
101560626|NCT01218516|Mitosis Modulators|mitosis modulators|mesh-ancestor
101560627|NCT01218516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560628|NCT01218516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101560629|NCT01218516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101560630|NCT01218516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101560631|NCT00938431|Lacosamide|lacosamide|mesh-list
101560632|NCT00938431|Anticonvulsants|anticonvulsants|mesh-ancestor
101560633|NCT00938431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101409050|NCT00457054|Lithium Carbonate|lithium carbonate|mesh-list
101742411|NCT00733785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101742412|NCT00733785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742413|NCT04063449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101742414|NCT04063449|Endostar protein|endostar protein|mesh-list
101742415|NCT04063449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742416|NCT04063449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101742417|NCT04063449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101742418|NCT04063449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101742419|NCT04063449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101742420|NCT04063449|Growth Substances|growth substances|mesh-ancestor
101742421|NCT04063449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742422|NCT04063449|Growth Inhibitors|growth inhibitors|mesh-ancestor
101742423|NCT00700011|Clofarabine|clofarabine|mesh-list
101742424|NCT00700011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101742425|NCT00700011|Antimetabolites|antimetabolites|mesh-ancestor
101470849|NCT01640275|Isoflurane|isoflurane|mesh-list
101742426|NCT00700011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742427|NCT00700011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101742428|NCT05512767|Capecitabine|capecitabine|mesh-list
101742429|NCT05512767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101742430|NCT05512767|Antimetabolites|antimetabolites|mesh-ancestor
101742431|NCT05512767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742432|NCT05512767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101742433|NCT02567955|Vaccines|vaccines|mesh-list
101742434|NCT02567955|Immunologic Factors|immunologic factors|mesh-ancestor
101742435|NCT02567955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742436|NCT02568423|Mirikizumab|mirikizumab|mesh-list
101742437|NCT02568423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101742438|NCT02568423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101742439|NCT02568423|Analgesics|analgesics|mesh-ancestor
101742440|NCT02568423|Sensory System Agents|sensory system agents|mesh-ancestor
101742441|NCT02568423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101742442|NCT02568423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742443|NCT02568423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101742444|NCT02568423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101742445|NCT02568423|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101742446|NCT02568423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101742447|NCT00921063|Alprazolam|alprazolam|mesh-list
101742448|NCT00921063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101742449|NCT00921063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101742450|NCT00921063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742451|NCT00921063|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101742452|NCT00921063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101742453|NCT00921063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101742454|NCT00921063|GABA Modulators|gaba modulators|mesh-ancestor
101742455|NCT00921063|GABA Agents|gaba agents|mesh-ancestor
101742456|NCT00921063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101742457|NCT00921063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742458|NCT00707031|Metformin|metformin|mesh-list
101742459|NCT00707031|Exenatide|exenatide|mesh-list
101742460|NCT00707031|Lixisenatide|lixisenatide|mesh-list
101742461|NCT00707031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101742462|NCT00707031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742463|NCT00707031|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101742464|NCT00707031|Incretins|incretins|mesh-ancestor
101560634|NCT00938431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101560635|NCT00938431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101560636|NCT00938431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560637|NCT05381389|Bupivacaine|bupivacaine|mesh-list
101560638|NCT05381389|Anesthetics, Local|anesthetics, local|mesh-ancestor
101560639|NCT05381389|Anesthetics|anesthetics|mesh-ancestor
101560640|NCT05381389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101560641|NCT05381389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560642|NCT05381389|Sensory System Agents|sensory system agents|mesh-ancestor
101560643|NCT05381389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101560644|NCT00949117|Cyproheptadine|cyproheptadine|mesh-list
101560645|NCT00949117|Antipruritics|antipruritics|mesh-ancestor
101560646|NCT00949117|Dermatologic Agents|dermatologic agents|mesh-ancestor
101560647|NCT00949117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101742466|NCT00707031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101742470|NCT00711477|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101742471|NCT00711477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742472|NCT00711477|Sensory System Agents|sensory system agents|mesh-ancestor
101742473|NCT00711477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101742474|NCT00711477|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101742475|NCT00711477|Antidepressive Agents|antidepressive agents|mesh-ancestor
101742476|NCT00711477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101742477|NCT00711477|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101742478|NCT00711477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101742479|NCT00711477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101742480|NCT00711477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742482|NCT00711477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101742483|NCT00711477|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101742484|NCT00711477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101742485|NCT00711477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101742486|NCT00734474|Metformin|metformin|mesh-list
101742487|NCT00734474|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101742488|NCT00734474|Dulaglutide|dulaglutide|mesh-list
101742489|NCT00734474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101742490|NCT00734474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742491|NCT00734474|Incretins|incretins|mesh-ancestor
101742492|NCT00734474|Hormones|hormones|mesh-ancestor
101742493|NCT00734474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101742494|NCT00734474|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101742495|NCT00734474|Protease Inhibitors|protease inhibitors|mesh-ancestor
101742496|NCT00734474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101742497|NCT00734474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742498|NCT00583362|Belimumab|belimumab|mesh-list
101742499|NCT00583362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101742500|NCT00583362|Immunologic Factors|immunologic factors|mesh-ancestor
101742501|NCT00583362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742502|NCT00577473|Mesalamine|mesalamine|mesh-list
101742503|NCT00577473|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101742504|NCT00577473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101742505|NCT00577473|Analgesics|analgesics|mesh-ancestor
101742506|NCT00577473|Sensory System Agents|sensory system agents|mesh-ancestor
101742507|NCT00577473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101742508|NCT00577473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742509|NCT00577473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101742510|NCT00577473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101742511|NCT00740103|Semapimod|semapimod|mesh-list
101742512|NCT00740103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101742513|NCT00740103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101742514|NCT00740103|Analgesics|analgesics|mesh-ancestor
101742529|NCT02583828|Alkylating Agents|alkylating agents|mesh-ancestor
101742530|NCT02583828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742531|NCT02583828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101742532|NCT02583828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101742533|NCT02583828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101742534|NCT02583828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101742535|NCT02583828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101742536|NCT02583828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101742537|NCT02583828|Hormone Antagonists|hormone antagonists|mesh-ancestor
101742555|NCT02568111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101742556|NCT05711667|Acetic Acid|acetic acid|mesh-list
101742558|NCT05711667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101742559|NCT05711667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101742560|NCT05711667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101742561|NCT05711667|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101742562|NCT05711667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101742563|NCT05711667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742564|NCT05711667|Antiviral Agents|antiviral agents|mesh-ancestor
101560662|NCT04312347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101560663|NCT04312347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101560664|NCT04312347|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101560665|NCT04312347|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101742603|NCT00785291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101470859|NCT04529356|Analgesics|analgesics|mesh-ancestor
101742604|NCT00785291|Endothelial Growth Factors|endothelial growth factors|mesh-list
101742605|NCT00785291|Antibodies|antibodies|mesh-list
101742606|NCT00785291|Immunoglobulins|immunoglobulins|mesh-list
101742607|NCT00785291|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101742608|NCT00785291|Immunoglobulin G|immunoglobulin g|mesh-list
101742609|NCT00785291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101742610|NCT00785291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101742611|NCT00785291|Tubulin Modulators|tubulin modulators|mesh-ancestor
101742612|NCT00785291|Antimitotic Agents|antimitotic agents|mesh-ancestor
101742613|NCT00785291|Mitosis Modulators|mitosis modulators|mesh-ancestor
101742614|NCT00785291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742615|NCT00785291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101742616|NCT00785291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101742617|NCT00785291|Growth Substances|growth substances|mesh-ancestor
101742618|NCT00785291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742619|NCT00785291|Growth Inhibitors|growth inhibitors|mesh-ancestor
101742620|NCT00785291|Immunologic Factors|immunologic factors|mesh-ancestor
101742621|NCT00740259|Flunarizine|flunarizine|mesh-list
101742622|NCT00740259|Anticonvulsants|anticonvulsants|mesh-ancestor
101742623|NCT00740259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101742624|NCT00740259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101742625|NCT00740259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742626|NCT00740259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101742627|NCT00740259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742628|NCT00740259|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101742629|NCT00740259|Histamine Antagonists|histamine antagonists|mesh-ancestor
101742630|NCT00740259|Histamine Agents|histamine agents|mesh-ancestor
101742631|NCT00740259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101742632|NCT00740259|Vasodilator Agents|vasodilator agents|mesh-ancestor
101742633|NCT04063839|Sofosbuvir|sofosbuvir|mesh-list
101742634|NCT04063839|Grazoprevir|grazoprevir|mesh-list
101742635|NCT04063839|Ledipasvir|ledipasvir|mesh-list
101742636|NCT04063839|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
101742637|NCT04063839|Antiviral Agents|antiviral agents|mesh-ancestor
101742638|NCT04063839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101742639|NCT00785213|Rosiglitazone|rosiglitazone|mesh-list
101742640|NCT00785213|Quinine|quinine|mesh-list
101742641|NCT00785213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101742642|NCT00785213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742643|NCT00785213|Antimalarials|antimalarials|mesh-ancestor
101742644|NCT00785213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101742645|NCT00785213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101742646|NCT00785213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101742647|NCT00785213|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101742648|NCT00785213|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101742649|NCT00785213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101742650|NCT00785213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101742651|NCT00785213|Analgesics|analgesics|mesh-ancestor
101742652|NCT00785213|Sensory System Agents|sensory system agents|mesh-ancestor
101560666|NCT04312347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101560667|NCT00938041|Tositumomab I-131|tositumomab i-131|mesh-list
101560668|NCT00938041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101560669|NCT05379283|Lidocaine|lidocaine|mesh-list
101560670|NCT05379283|Anesthetics, Local|anesthetics, local|mesh-ancestor
101560671|NCT05379283|Anesthetics|anesthetics|mesh-ancestor
101560672|NCT05379283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101560673|NCT05379283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560674|NCT05379283|Sensory System Agents|sensory system agents|mesh-ancestor
101560675|NCT05379283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101409087|NCT00457678|Autonomic Agents|autonomic agents|mesh-ancestor
101742653|NCT02583594|Loratadine|loratadine|mesh-list
101742654|NCT02583594|Acyclovir|acyclovir|mesh-list
101742655|NCT02583594|Methylprednisolone|methylprednisolone|mesh-list
101742656|NCT02583594|Alemtuzumab|alemtuzumab|mesh-list
101742657|NCT02583594|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
101742658|NCT02583594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101742659|NCT02583594|Antiemetics|antiemetics|mesh-ancestor
101742660|NCT02583594|Autonomic Agents|autonomic agents|mesh-ancestor
101742661|NCT02583594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101742662|NCT02583594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742663|NCT02583594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101742664|NCT02583594|Glucocorticoids|glucocorticoids|mesh-ancestor
101742665|NCT02583594|Hormones|hormones|mesh-ancestor
101742666|NCT02583594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101742669|NCT02583594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101742670|NCT02583594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101742671|NCT02583594|Antiviral Agents|antiviral agents|mesh-ancestor
101742672|NCT02583594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101742673|NCT02583594|Antipruritics|antipruritics|mesh-ancestor
101742674|NCT02583594|Dermatologic Agents|dermatologic agents|mesh-ancestor
101742675|NCT02583594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101742676|NCT02583594|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101742677|NCT02583594|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101742678|NCT02583594|Histamine Antagonists|histamine antagonists|mesh-ancestor
101742679|NCT02583594|Histamine Agents|histamine agents|mesh-ancestor
101742680|NCT02583594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101742681|NCT02583594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742682|NCT00740415|Dexamethasone|dexamethasone|mesh-list
101742683|NCT00740415|Rituximab|rituximab|mesh-list
101742684|NCT00740415|Bortezomib|bortezomib|mesh-list
101742685|NCT00740415|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101742686|NCT00740415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101742687|NCT00740415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101742688|NCT00740415|Immunologic Factors|immunologic factors|mesh-ancestor
101742689|NCT00740415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742690|NCT00740415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101742691|NCT00740415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101742692|NCT00740415|Antiemetics|antiemetics|mesh-ancestor
101742693|NCT00740415|Autonomic Agents|autonomic agents|mesh-ancestor
101742694|NCT00740415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101742695|NCT00740415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101742696|NCT00740415|Glucocorticoids|glucocorticoids|mesh-ancestor
101742697|NCT00740415|Hormones|hormones|mesh-ancestor
101742698|NCT00740415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101742699|NCT00740415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101742700|NCT00740415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101742701|NCT00740415|Alkylating Agents|alkylating agents|mesh-ancestor
101742702|NCT00740415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742703|NCT00734162|Tenofovir|tenofovir|mesh-list
101742704|NCT00734162|Antiviral Agents|antiviral agents|mesh-ancestor
101400157|NCT05951361|Benzocaine|benzocaine|mesh-list
101742705|NCT00734162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101742706|NCT00734162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101742707|NCT00734162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101560676|NCT05379283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101560677|NCT05379283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101560678|NCT05379283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101742708|NCT00734162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101742709|NCT00734162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742710|NCT00734162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101742711|NCT00734162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101742712|NCT00740493|Warfarin|warfarin|mesh-list
101742713|NCT00740493|Anticoagulants|anticoagulants|mesh-ancestor
101742714|NCT00740571|Pregabalin|pregabalin|mesh-list
101742715|NCT00740571|Amitriptyline|amitriptyline|mesh-list
101742716|NCT00740571|Analgesics|analgesics|mesh-ancestor
101742717|NCT00740571|Sensory System Agents|sensory system agents|mesh-ancestor
101742718|NCT00740571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101742719|NCT00740571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742720|NCT00740571|Anticonvulsants|anticonvulsants|mesh-ancestor
101742721|NCT00740571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101742722|NCT00740571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101742723|NCT00740571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742724|NCT00740571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101742725|NCT00740571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101742726|NCT00740571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101742727|NCT00740571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101742728|NCT00740571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101742729|NCT00740571|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101742730|NCT00740571|Antidepressive Agents|antidepressive agents|mesh-ancestor
101742731|NCT00740571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101742732|NCT00740571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101742733|NCT00740571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101742734|NCT00740571|Adrenergic Agents|adrenergic agents|mesh-ancestor
101742735|NCT00740571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101742736|NCT00784979|Immunoglobulins|immunoglobulins|mesh-list
101742737|NCT00784979|Immunologic Factors|immunologic factors|mesh-ancestor
101494191|NCT00437333|Metformin|metformin|mesh-list
101742743|NCT02595242|Immunologic Factors|immunologic factors|mesh-ancestor
101742744|NCT02595242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742745|NCT02595242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101742746|NCT02595242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101742747|NCT02595242|Alkylating Agents|alkylating agents|mesh-ancestor
101742748|NCT02595242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742749|NCT02595242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101742750|NCT02595242|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101742751|NCT02595242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101742752|NCT02595242|Glucocorticoids|glucocorticoids|mesh-ancestor
101742753|NCT02595242|Hormones|hormones|mesh-ancestor
101742754|NCT02595242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101742755|NCT02595242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101742756|NCT02595242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101742757|NCT02595242|Tubulin Modulators|tubulin modulators|mesh-ancestor
101742758|NCT02595242|Antimitotic Agents|antimitotic agents|mesh-ancestor
101742759|NCT02595242|Mitosis Modulators|mitosis modulators|mesh-ancestor
101742760|NCT04487106|Azacitidine|azacitidine|mesh-list
101742761|NCT04487106|Venetoclax|venetoclax|mesh-list
101742762|NCT04487106|Trametinib|trametinib|mesh-list
101742763|NCT04487106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101742764|NCT04487106|Antimetabolites|antimetabolites|mesh-ancestor
101742765|NCT04487106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742766|NCT04487106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101742767|NCT04487106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101742768|NCT04487106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101742769|NCT00740883|Warfarin|warfarin|mesh-list
101742770|NCT00740883|Anticoagulants|anticoagulants|mesh-ancestor
101742771|NCT02568033|Paclitaxel|paclitaxel|mesh-list
101742772|NCT02568033|Docetaxel|docetaxel|mesh-list
101742773|NCT02568033|Carboplatin|carboplatin|mesh-list
101742774|NCT02568033|Pemetrexed|pemetrexed|mesh-list
101742775|NCT02568033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101742776|NCT02568033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101742777|NCT02568033|Tubulin Modulators|tubulin modulators|mesh-ancestor
101742778|NCT02568033|Antimitotic Agents|antimitotic agents|mesh-ancestor
101742779|NCT02568033|Mitosis Modulators|mitosis modulators|mesh-ancestor
101560679|NCT05379283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101560680|NCT05379283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560681|NCT01218438|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101560682|NCT01218438|Immunoglobulins|immunoglobulins|mesh-list
101560684|NCT01218438|gamma-Globulins|gamma-globulins|mesh-list
101560685|NCT01218438|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101560686|NCT01218438|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101742780|NCT02568033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742781|NCT02568033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101742782|NCT02568033|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101742783|NCT02568033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101742784|NCT00582972|Omeprazole|omeprazole|mesh-list
101742785|NCT00582972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101742786|NCT00582972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101742787|NCT00582972|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101742788|NCT00582972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101742789|NCT00582972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742790|NCT05224401|Amoxicillin|amoxicillin|mesh-list
101742791|NCT05224401|Ciprofloxacin|ciprofloxacin|mesh-list
101742792|NCT05224401|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101742793|NCT05224401|Clavulanic Acids|clavulanic acids|mesh-list
101742794|NCT05224401|Clavulanic Acid|clavulanic acid|mesh-list
101742795|NCT05224401|Ertapenem|ertapenem|mesh-list
101742796|NCT05224401|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
101742797|NCT05224401|Trimethoprim|trimethoprim|mesh-list
101742798|NCT05224401|Sulfamethoxazole|sulfamethoxazole|mesh-list
101742799|NCT05224401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101742800|NCT05224401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101742801|NCT05224401|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101742802|NCT05224401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101742803|NCT05224401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101742804|NCT05224401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742805|NCT05224401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101742806|NCT05224401|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101742807|NCT05224401|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101742808|NCT05224401|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101742809|NCT05224401|Antimalarials|antimalarials|mesh-ancestor
101742815|NCT05224401|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101742816|NCT00918086|Vitamin D|vitamin d|mesh-list
101742817|NCT00918086|Vitamins|vitamins|mesh-ancestor
101742818|NCT00918086|Micronutrients|micronutrients|mesh-ancestor
101742819|NCT00918086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742820|NCT00918086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101742821|NCT02567487|Levobupivacaine|levobupivacaine|mesh-list
101742822|NCT02567487|Anesthetics, Local|anesthetics, local|mesh-ancestor
101742823|NCT02567487|Anesthetics|anesthetics|mesh-ancestor
101742824|NCT02567487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101742825|NCT02567487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742826|NCT02567487|Sensory System Agents|sensory system agents|mesh-ancestor
101742827|NCT02567487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101742828|NCT04317066|Pembrolizumab|pembrolizumab|mesh-list
101742829|NCT04317066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101742830|NCT04317066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101742831|NCT04317066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101742832|NCT04317066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742833|NCT04366908|Calcifediol|calcifediol|mesh-list
101742834|NCT04366908|Vitamins|vitamins|mesh-ancestor
101742835|NCT04366908|Micronutrients|micronutrients|mesh-ancestor
101742836|NCT04366908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742837|NCT04366908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101742838|NCT00711243|Docetaxel|docetaxel|mesh-list
101742839|NCT00711243|Fluorouracil|fluorouracil|mesh-list
101742840|NCT00711243|Oxaliplatin|oxaliplatin|mesh-list
101742841|NCT00711243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101742842|NCT00711243|Tubulin Modulators|tubulin modulators|mesh-ancestor
101742843|NCT00711243|Antimitotic Agents|antimitotic agents|mesh-ancestor
101742844|NCT00711243|Mitosis Modulators|mitosis modulators|mesh-ancestor
101742845|NCT00711243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560687|NCT01218438|Immunoglobulin G|immunoglobulin g|mesh-list
101560688|NCT01218438|Immunologic Factors|immunologic factors|mesh-ancestor
101560689|NCT01218438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560690|NCT00604591|Tolcapone|tolcapone|mesh-list
101560691|NCT00604591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101560692|NCT00604591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101560693|NCT00604591|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101560694|NCT00604591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101409108|NCT00457717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742846|NCT00711243|Antimetabolites|antimetabolites|mesh-ancestor
101742847|NCT00711243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101742848|NCT00711243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101742849|NCT00711243|Immunologic Factors|immunologic factors|mesh-ancestor
101742850|NCT00711243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742851|NCT04366518|Scopolamine|scopolamine|mesh-list
101742852|NCT04366518|Rivastigmine|rivastigmine|mesh-list
101742853|NCT04366518|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101742854|NCT04366518|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101742855|NCT04366518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101400307|NCT05878717|Belimumab|belimumab|mesh-list
101742856|NCT04366518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742857|NCT04366518|Cholinergic Agents|cholinergic agents|mesh-ancestor
101742858|NCT04366518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101742859|NCT04366518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742860|NCT04366518|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101742861|NCT04366518|Protective Agents|protective agents|mesh-ancestor
101742862|NCT04366518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101742863|NCT04366518|Antiemetics|antiemetics|mesh-ancestor
101742864|NCT04366518|Autonomic Agents|autonomic agents|mesh-ancestor
101742865|NCT04366518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101742866|NCT04366518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101742867|NCT04366518|Mydriatics|mydriatics|mesh-ancestor
101742868|NCT04366518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101742869|NCT04366518|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101742870|NCT04366518|Parasympatholytics|parasympatholytics|mesh-ancestor
101742871|NCT00733226|Broncho-Vaxom|broncho-vaxom|mesh-list
101742872|NCT00733226|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101742873|NCT00733226|Immunologic Factors|immunologic factors|mesh-ancestor
101742874|NCT00733226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742875|NCT04076436|Fosfomycin|fosfomycin|mesh-list
101742876|NCT04076436|Lactams|lactams|mesh-list
101742877|NCT04076436|beta-Lactams|beta-lactams|mesh-list
101742878|NCT04076436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101742879|NCT04076436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101742880|NCT05526417|Coal Tar|coal tar|mesh-list
101742881|NCT05526417|Keratolytic Agents|keratolytic agents|mesh-ancestor
101742886|NCT04096170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101742887|NCT04096170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742888|NCT04096170|Sensory System Agents|sensory system agents|mesh-ancestor
101742889|NCT04096170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101742890|NCT04096170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101742891|NCT04096170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101742892|NCT04096170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101742893|NCT04096170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101742894|NCT04096170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742896|NCT00741117|Antioxidants|antioxidants|mesh-ancestor
101742897|NCT00741117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742898|NCT00741117|Protective Agents|protective agents|mesh-ancestor
101742899|NCT00741117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742900|NCT00732992|Pemetrexed|pemetrexed|mesh-list
101742901|NCT00732992|Sunitinib|sunitinib|mesh-list
101742902|NCT00732992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101742903|NCT00732992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101742904|NCT00732992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742905|NCT00732992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101742906|NCT00732992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101560695|NCT00604591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560697|NCT02691156|Bilirubin|bilirubin|mesh-list
101560698|NCT02691156|Antimetabolites|antimetabolites|mesh-ancestor
101560699|NCT02691156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560700|NCT02691156|Gasotransmitters|gasotransmitters|mesh-ancestor
101560701|NCT02691156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101560702|NCT02691156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560703|NCT02691156|Antioxidants|antioxidants|mesh-ancestor
101560704|NCT02691156|Protective Agents|protective agents|mesh-ancestor
101742907|NCT00732992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101742908|NCT00732992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101742909|NCT00732992|Growth Substances|growth substances|mesh-ancestor
101742910|NCT00732992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742911|NCT00732992|Growth Inhibitors|growth inhibitors|mesh-ancestor
101742912|NCT00732992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101742913|NCT00741195|Bevacizumab|bevacizumab|mesh-list
101742914|NCT00741195|Docetaxel|docetaxel|mesh-list
101742915|NCT00741195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101742916|NCT00741195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101742917|NCT00741195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101742918|NCT00741195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101742919|NCT00741195|Growth Substances|growth substances|mesh-ancestor
101742920|NCT00741195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742921|NCT00741195|Growth Inhibitors|growth inhibitors|mesh-ancestor
101742922|NCT00741195|Tubulin Modulators|tubulin modulators|mesh-ancestor
101742923|NCT00741195|Antimitotic Agents|antimitotic agents|mesh-ancestor
101742924|NCT00741195|Mitosis Modulators|mitosis modulators|mesh-ancestor
101742925|NCT00741195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742926|NCT05338632|Naloxone|naloxone|mesh-list
101742927|NCT05338632|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101742928|NCT05338632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742929|NCT05338632|Sensory System Agents|sensory system agents|mesh-ancestor
101742930|NCT05338632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101742931|NCT00732758|Vitamin D|vitamin d|mesh-list
101742932|NCT00732758|Cholecalciferol|cholecalciferol|mesh-list
101742933|NCT00732758|Vitamins|vitamins|mesh-ancestor
101742934|NCT00732758|Micronutrients|micronutrients|mesh-ancestor
101742935|NCT00732758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742936|NCT00732758|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101742937|NCT00732758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101742938|NCT00741351|Fentanyl|fentanyl|mesh-list
101742939|NCT00741351|Remifentanil|remifentanil|mesh-list
101742940|NCT00741351|Propofol|propofol|mesh-list
101742941|NCT00741351|Sevoflurane|sevoflurane|mesh-list
101742942|NCT00741351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101742943|NCT00741351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101742944|NCT00741351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742945|NCT00741351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101742946|NCT00741351|Anesthetics, General|anesthetics, general|mesh-ancestor
101742947|NCT00741351|Anesthetics|anesthetics|mesh-ancestor
101742948|NCT00741351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101742949|NCT00741351|Narcotics|narcotics|mesh-ancestor
101742950|NCT00741351|Analgesics|analgesics|mesh-ancestor
101742951|NCT00741351|Sensory System Agents|sensory system agents|mesh-ancestor
101742952|NCT00741351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101742953|NCT00741351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101742961|NCT02582190|Mitosis Modulators|mitosis modulators|mesh-ancestor
101742962|NCT02582190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742963|NCT02582190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101742964|NCT00699153|Loteprednol Etabonate|loteprednol etabonate|mesh-list
101742965|NCT00699153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101742966|NCT04277442|Nivolumab|nivolumab|mesh-list
101742967|NCT04277442|Decitabine|decitabine|mesh-list
101742968|NCT04277442|Venetoclax|venetoclax|mesh-list
101742969|NCT04277442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101742970|NCT04277442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101560705|NCT00603031|Glucagon|glucagon|mesh-list
101560706|NCT00603031|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
101560707|NCT00603031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101560708|NCT00603031|Hormones|hormones|mesh-ancestor
101560709|NCT00603031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101560710|NCT00603031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560711|NCT00603031|Incretins|incretins|mesh-ancestor
101560712|NCT05379049|Adalimumab|adalimumab|mesh-list
101742971|NCT04277442|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101742972|NCT04277442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742973|NCT04277442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101742974|NCT04277442|Antimetabolites|antimetabolites|mesh-ancestor
101742975|NCT04277442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101742976|NCT05742243|Insulin|insulin|mesh-list
101742977|NCT05742243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101742978|NCT05742243|Abatacept|abatacept|mesh-list
101742979|NCT05742243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101742980|NCT05742243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742981|NCT05742243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101742982|NCT05742243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742983|NCT05742243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101742984|NCT05742243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101742985|NCT05742243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101263394|NCT01761916|Analgesics|analgesics|mesh-ancestor
101742987|NCT05742243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101742988|NCT04076748|Sufentanil|sufentanil|mesh-list
101742989|NCT04076748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101742990|NCT04076748|Narcotics|narcotics|mesh-ancestor
101742991|NCT04076748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101742992|NCT04076748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742993|NCT04076748|Analgesics|analgesics|mesh-ancestor
101742994|NCT04076748|Sensory System Agents|sensory system agents|mesh-ancestor
101742995|NCT04076748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101742996|NCT04076748|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101742997|NCT04076748|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101742998|NCT04076748|Anesthetics, General|anesthetics, general|mesh-ancestor
101742999|NCT04076748|Anesthetics|anesthetics|mesh-ancestor
101743000|NCT00711087|Botulinum Toxins|botulinum toxins|mesh-list
101743001|NCT00711087|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101743002|NCT00711087|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101743003|NCT00711087|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101743004|NCT00711087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101743005|NCT00711087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743006|NCT00711087|Cholinergic Agents|cholinergic agents|mesh-ancestor
101743007|NCT00711087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101743008|NCT00711087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743009|NCT00711087|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101400475|NCT05716516|Estradiol|estradiol|mesh-list
101743010|NCT00711087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101743011|NCT04262466|Pembrolizumab|pembrolizumab|mesh-list
101743012|NCT04262466|Atezolizumab|atezolizumab|mesh-list
101743013|NCT04262466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101743014|NCT04262466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101743015|NCT04262466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101743016|NCT04262466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743017|NCT04255602|Ticagrelor|ticagrelor|mesh-list
101743018|NCT04255602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101743019|NCT04255602|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101743020|NCT04255602|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101494472|NCT00475098|Tinzaparin|tinzaparin|mesh-list
101743026|NCT00738530|Interferons|interferons|mesh-list
101743027|NCT00738530|Interferon-alpha|interferon-alpha|mesh-list
101743028|NCT00738530|Interferon alpha-2|interferon alpha-2|mesh-list
101743029|NCT00738530|Bevacizumab|bevacizumab|mesh-list
101828133|NCT05945485|Immunologic Factors|immunologic factors|mesh-ancestor
101743030|NCT00738530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101743031|NCT00738530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101743032|NCT00738530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101560713|NCT05379049|Infliximab|infliximab|mesh-list
101560714|NCT05379049|Etanercept|etanercept|mesh-list
101560715|NCT05379049|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101560716|NCT05379049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101560717|NCT05379049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101560718|NCT05379049|Dermatologic Agents|dermatologic agents|mesh-ancestor
101560719|NCT05379049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101560720|NCT05379049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101560721|NCT05379049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101560722|NCT05379049|Analgesics|analgesics|mesh-ancestor
101560723|NCT05379049|Sensory System Agents|sensory system agents|mesh-ancestor
101560724|NCT05379049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101560725|NCT05379049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560726|NCT05379049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101743033|NCT00738530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101743034|NCT00738530|Growth Substances|growth substances|mesh-ancestor
101743035|NCT00738530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743036|NCT00738530|Growth Inhibitors|growth inhibitors|mesh-ancestor
101743037|NCT00738530|Antiviral Agents|antiviral agents|mesh-ancestor
101743038|NCT00738530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101743039|NCT00738530|Immunologic Factors|immunologic factors|mesh-ancestor
101743040|NCT04077684|Interleukin-2|interleukin-2|mesh-list
101743041|NCT04077684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101743042|NCT04077684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101743043|NCT04077684|Analgesics|analgesics|mesh-ancestor
101743044|NCT04077684|Sensory System Agents|sensory system agents|mesh-ancestor
101743045|NCT04077684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101743046|NCT04077684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743047|NCT00711009|Ritonavir|ritonavir|mesh-list
101743048|NCT00711009|Lopinavir|lopinavir|mesh-list
101743049|NCT00711009|Tenofovir|tenofovir|mesh-list
101743050|NCT00711009|Emtricitabine|emtricitabine|mesh-list
101743051|NCT00711009|Raltegravir Potassium|raltegravir potassium|mesh-list
101743052|NCT00711009|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101743053|NCT00711009|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101743054|NCT00711009|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101743055|NCT00711009|Protease Inhibitors|protease inhibitors|mesh-ancestor
101743056|NCT00711009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101743057|NCT00711009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743058|NCT00711009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101743059|NCT00711009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101743060|NCT00711009|Antiviral Agents|antiviral agents|mesh-ancestor
101743061|NCT00711009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101743062|NCT00711009|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101743063|NCT00711009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101743064|NCT00711009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101743065|NCT00711009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101743066|NCT00711009|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101743067|NCT00711009|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101743069|NCT02567799|Carboplatin|carboplatin|mesh-list
101743070|NCT02567799|Genistein|genistein|mesh-list
101743071|NCT02567799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101743072|NCT02567799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101743073|NCT02567799|Tubulin Modulators|tubulin modulators|mesh-ancestor
101743074|NCT02567799|Antimitotic Agents|antimitotic agents|mesh-ancestor
101743075|NCT02567799|Mitosis Modulators|mitosis modulators|mesh-ancestor
101743076|NCT02567799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470955|NCT01641796|Paromomycin|paromomycin|mesh-list
101743077|NCT02567799|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101743078|NCT02567799|Protective Agents|protective agents|mesh-ancestor
101743079|NCT02567799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743080|NCT02567799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101560727|NCT05379049|Immunologic Factors|immunologic factors|mesh-ancestor
101560728|NCT02851459|Vaccines|vaccines|mesh-list
101560729|NCT02851459|Immunologic Factors|immunologic factors|mesh-ancestor
101560730|NCT02851459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560731|NCT00603343|Propiverine|propiverine|mesh-list
101560732|NCT00603343|Parasympatholytics|parasympatholytics|mesh-ancestor
101560733|NCT00603343|Autonomic Agents|autonomic agents|mesh-ancestor
101560734|NCT00603343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101560735|NCT00603343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560736|NCT00603343|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101743081|NCT02567799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101743082|NCT02567799|Phytoestrogens|phytoestrogens|mesh-ancestor
101743083|NCT02567799|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101743084|NCT02567799|Estrogens|estrogens|mesh-ancestor
101743085|NCT02567799|Hormones|hormones|mesh-ancestor
101743086|NCT02567799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101743087|NCT00921219|Ivermectin|ivermectin|mesh-list
101743088|NCT00921219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101743089|NCT00921219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101743090|NCT02567331|Capecitabine|capecitabine|mesh-list
101743091|NCT02567331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101743099|NCT02581566|Bupivacaine|bupivacaine|mesh-list
101743100|NCT02581566|Anesthetics, Local|anesthetics, local|mesh-ancestor
101743101|NCT02581566|Anesthetics|anesthetics|mesh-ancestor
101743102|NCT02581566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101743103|NCT02581566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743104|NCT02581566|Sensory System Agents|sensory system agents|mesh-ancestor
101743105|NCT02581566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101743106|NCT02581566|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101743107|NCT02581566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101743108|NCT02581566|Analgesics|analgesics|mesh-ancestor
101743109|NCT02581566|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101743110|NCT02581566|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101743111|NCT02581566|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101743112|NCT02581566|Adrenergic Agents|adrenergic agents|mesh-ancestor
101743113|NCT02581566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101743114|NCT02581566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743115|NCT04003506|Bupivacaine|bupivacaine|mesh-list
101743116|NCT04003506|Anesthetics, Local|anesthetics, local|mesh-ancestor
101743117|NCT04003506|Anesthetics|anesthetics|mesh-ancestor
101743118|NCT04003506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101743119|NCT04003506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743120|NCT04003506|Sensory System Agents|sensory system agents|mesh-ancestor
101743121|NCT04003506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101743122|NCT00698841|Cetuximab|cetuximab|mesh-list
101743123|NCT00698841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101743124|NCT00698841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101743125|NCT00577395|Risedronic Acid|risedronic acid|mesh-list
101743126|NCT00577395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101743127|NCT00577395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101743128|NCT00577395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743129|NCT00577395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101743130|NCT00577395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743131|NCT00577395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101743132|NCT04062357|Lidocaine|lidocaine|mesh-list
101743133|NCT04062357|Anesthetics, Local|anesthetics, local|mesh-ancestor
101743134|NCT04062357|Anesthetics|anesthetics|mesh-ancestor
101743135|NCT04062357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101743136|NCT04062357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743137|NCT04062357|Sensory System Agents|sensory system agents|mesh-ancestor
101743138|NCT04062357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101743139|NCT04062357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101743140|NCT04062357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101743141|NCT04062357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101743142|NCT04062357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101560737|NCT00603343|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101560738|NCT00603343|Cholinergic Agents|cholinergic agents|mesh-ancestor
101560739|NCT00603343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101560740|NCT00603343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560741|NCT00603343|Urological Agents|urological agents|mesh-ancestor
101560742|NCT01277510|Cinacalcet|cinacalcet|mesh-list
101560743|NCT01277510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101560744|NCT01277510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560745|NCT01277510|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101560746|NCT01277510|Hormone Antagonists|hormone antagonists|mesh-ancestor
101743143|NCT04062357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743144|NCT05190120|Ropivacaine|ropivacaine|mesh-list
101743145|NCT05190120|Anesthetics, Local|anesthetics, local|mesh-ancestor
101743146|NCT05190120|Anesthetics|anesthetics|mesh-ancestor
101743147|NCT05190120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101743148|NCT05190120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743149|NCT05190120|Sensory System Agents|sensory system agents|mesh-ancestor
101743150|NCT05190120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101743151|NCT00738374|Rituximab|rituximab|mesh-list
101743152|NCT00738374|Chlorambucil|chlorambucil|mesh-list
101743153|NCT00738374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101743154|NCT00738374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101743155|NCT00738374|Immunologic Factors|immunologic factors|mesh-ancestor
101743156|NCT00738374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743157|NCT00738374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101743158|NCT00738374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101743167|NCT02581176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743169|NCT00697593|Antibodies|antibodies|mesh-list
101743170|NCT00697593|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101743171|NCT00697593|Immunologic Factors|immunologic factors|mesh-ancestor
101743172|NCT00697593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743173|NCT04075578|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101743174|NCT04075578|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101743175|NCT04075578|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101743176|NCT04075578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101743177|NCT04075578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743178|NCT04075578|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101743179|NCT04075578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101743180|NCT04075578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743181|NCT04075578|Cholinergic Agents|cholinergic agents|mesh-ancestor
101743182|NCT04075578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101743183|NCT04445025|Leuprolide|leuprolide|mesh-list
101743184|NCT04445025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101743185|NCT04445025|Fertility Agents|fertility agents|mesh-ancestor
101743186|NCT04445025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101743187|NCT04445025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743188|NCT04445025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101743189|NCT04445025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101743190|NCT02580474|Asunaprevir|asunaprevir|mesh-list
101743191|NCT02580474|Protease Inhibitors|protease inhibitors|mesh-ancestor
101743192|NCT02580474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101743193|NCT02580474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743194|NCT04166604|Trifluridine|trifluridine|mesh-list
101743195|NCT04166604|Antimetabolites|antimetabolites|mesh-ancestor
101743196|NCT04166604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743197|NCT04166604|Antiviral Agents|antiviral agents|mesh-ancestor
101743198|NCT04166604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101743199|NCT00738062|Droxidopa|droxidopa|mesh-list
101743200|NCT00738062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101743201|NCT00738062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101743202|NCT04156074|Vitamin D|vitamin d|mesh-list
101743203|NCT04156074|Ergocalciferols|ergocalciferols|mesh-list
101743204|NCT04156074|Cholecalciferol|cholecalciferol|mesh-list
101560747|NCT01277510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101560749|NCT00937495|Vorinostat|vorinostat|mesh-list
101560750|NCT00937495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101560751|NCT00937495|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101560752|NCT00937495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101560753|NCT00937495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560754|NCT04265833|Calcium|calcium|mesh-list
101560755|NCT04265833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101522703|NCT00450203|Bevacizumab|bevacizumab|mesh-list
101560756|NCT04265833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560757|NCT00606541|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101560758|NCT00606541|Antidepressive Agents|antidepressive agents|mesh-ancestor
101560759|NCT00606541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101560760|NCT00606541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101560761|NCT00606541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101560762|NCT00606541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101560763|NCT00606541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560764|NCT00936715|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101560765|NCT00936715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101560766|NCT00936715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101560767|NCT00936715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101560768|NCT00936715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560769|NCT00936715|Antiviral Agents|antiviral agents|mesh-ancestor
101560770|NCT00936715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101560771|NCT00936715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101560772|NCT00936715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101560773|NCT05378503|Topiramate|topiramate|mesh-list
101560774|NCT05378503|Phentermine|phentermine|mesh-list
101560775|NCT05378503|Anticonvulsants|anticonvulsants|mesh-ancestor
101743205|NCT04156074|Vitamins|vitamins|mesh-list
101743206|NCT04156074|Micronutrients|micronutrients|mesh-ancestor
101743207|NCT04156074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743208|NCT04156074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101743209|NCT04156074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101743210|NCT04062045|Ropivacaine|ropivacaine|mesh-list
101743211|NCT04062045|Anesthetics, Local|anesthetics, local|mesh-ancestor
101743212|NCT04062045|Anesthetics|anesthetics|mesh-ancestor
101743213|NCT04062045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101743214|NCT04062045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743215|NCT04062045|Sensory System Agents|sensory system agents|mesh-ancestor
101743216|NCT04062045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101560777|NCT05378503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560778|NCT05378503|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101560779|NCT05378503|Appetite Depressants|appetite depressants|mesh-ancestor
101560780|NCT05378503|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101560781|NCT05378503|Sympathomimetics|sympathomimetics|mesh-ancestor
101560782|NCT05378503|Autonomic Agents|autonomic agents|mesh-ancestor
101560783|NCT05378503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101560784|NCT05378503|Adrenergic Agents|adrenergic agents|mesh-ancestor
101560785|NCT05378503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101560786|NCT05378503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560787|NCT05378191|Vaccines|vaccines|mesh-list
101560788|NCT05378191|Immunologic Factors|immunologic factors|mesh-ancestor
101560789|NCT05378191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560790|NCT00605137|Insulin|insulin|mesh-list
101560791|NCT00605137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101560792|NCT00605137|Insulin Detemir|insulin detemir|mesh-list
101560793|NCT00605137|Isophane Insulin, Human|isophane insulin, human|mesh-list
101560794|NCT00605137|Insulin, Isophane|insulin, isophane|mesh-list
101560795|NCT00605137|Isophane insulin, beef|isophane insulin, beef|mesh-list
101560796|NCT00605137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101560829|NCT02850913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101560830|NCT02850913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101560831|NCT02850913|Antimalarials|antimalarials|mesh-ancestor
101560832|NCT02850913|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101560833|NCT02850913|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101560834|NCT00934843|Methylprednisolone|methylprednisolone|mesh-list
101560835|NCT00934843|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101560836|NCT00934843|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101560838|NCT00934843|Prednisolone acetate|prednisolone acetate|mesh-list
101560839|NCT00934843|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101560840|NCT00934843|Prednisolone phosphate|prednisolone phosphate|mesh-list
101560841|NCT00934843|Glucocorticoids|glucocorticoids|mesh-list
101560842|NCT00934843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101560843|NCT00934843|Antiemetics|antiemetics|mesh-ancestor
101743217|NCT03733314|Quetmolimab|quetmolimab|mesh-list
101743218|NCT03733314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101743219|NCT04064073|Metformin|metformin|mesh-list
101743220|NCT04064073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101743221|NCT04064073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743222|NCT04137354|Vitamins|vitamins|mesh-list
101743223|NCT04137354|Vitamin A|vitamin a|mesh-list
101743225|NCT04137354|Retinol palmitate|retinol palmitate|mesh-list
101743226|NCT04137354|Micronutrients|micronutrients|mesh-ancestor
101743227|NCT04137354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743230|NCT04137354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743232|NCT04137354|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101743233|NCT04137354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101743234|NCT04902729|Oxytocin|oxytocin|mesh-list
101743235|NCT04902729|Carbetocin|carbetocin|mesh-list
101743236|NCT04902729|Oxytocics|oxytocics|mesh-ancestor
101743237|NCT04902729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101743238|NCT04902729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743239|NCT03498378|Cetuximab|cetuximab|mesh-list
101743240|NCT03498378|Avelumab|avelumab|mesh-list
101743241|NCT03498378|Palbociclib|palbociclib|mesh-list
101743242|NCT03498378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101743243|NCT03498378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101743244|NCT03498378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101743245|NCT03498378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101743246|NCT03498378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743247|NCT03493932|Nivolumab|nivolumab|mesh-list
101743248|NCT03493932|Relatlimab|relatlimab|mesh-list
101743249|NCT03493932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101743250|NCT03493932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101743251|NCT03493932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101743252|NCT03493932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743253|NCT00698685|Alemtuzumab|alemtuzumab|mesh-list
101743254|NCT00698685|Pentostatin|pentostatin|mesh-list
101743255|NCT00698685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101743256|NCT00698685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101743257|NCT00698685|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
101743258|NCT00698685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101743259|NCT00698685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743260|NCT00737438|Bevacizumab|bevacizumab|mesh-list
101743261|NCT00737438|Docetaxel|docetaxel|mesh-list
101743262|NCT00737438|Capecitabine|capecitabine|mesh-list
101743263|NCT00737438|Irinotecan|irinotecan|mesh-list
101743264|NCT00737438|Epirubicin|epirubicin|mesh-list
101743265|NCT00737438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101743266|NCT00737438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101743267|NCT00737438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101743268|NCT00737438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101743269|NCT00737438|Growth Substances|growth substances|mesh-ancestor
101743270|NCT00737438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560844|NCT00934843|Autonomic Agents|autonomic agents|mesh-ancestor
101560845|NCT00934843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101560846|NCT00934843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560847|NCT00934843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101471066|NCT00280371|Formoterol Fumarate|formoterol fumarate|mesh-list
101560849|NCT00934843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101560851|NCT00934843|Protective Agents|protective agents|mesh-ancestor
101560852|NCT00934843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101560853|NCT00934843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101560854|NCT00605605|Dextromethorphan|dextromethorphan|mesh-list
101560855|NCT00605605|Antitussive Agents|antitussive agents|mesh-ancestor
101743271|NCT00737438|Growth Inhibitors|growth inhibitors|mesh-ancestor
101743272|NCT00737438|Tubulin Modulators|tubulin modulators|mesh-ancestor
101743273|NCT00737438|Antimitotic Agents|antimitotic agents|mesh-ancestor
101743274|NCT00737438|Mitosis Modulators|mitosis modulators|mesh-ancestor
101743275|NCT00737438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743276|NCT00737438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101743277|NCT00737438|Antimetabolites|antimetabolites|mesh-ancestor
101743278|NCT00737438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101743279|NCT00737438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101743280|NCT00737438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101263398|NCT01761916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101743281|NCT00737438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101743282|NCT00737438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101743283|NCT00737048|Acetaminophen|acetaminophen|mesh-list
101743284|NCT00737048|Tramadol|tramadol|mesh-list
101743285|NCT00737048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101743286|NCT00737048|Analgesics|analgesics|mesh-ancestor
101743287|NCT00737048|Sensory System Agents|sensory system agents|mesh-ancestor
101743288|NCT00737048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101743289|NCT00737048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743290|NCT00737048|Antipyretics|antipyretics|mesh-ancestor
101743291|NCT00737048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101743292|NCT00737048|Narcotics|narcotics|mesh-ancestor
101743293|NCT00737048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101743294|NCT02593448|Anesthetics|anesthetics|mesh-list
101743295|NCT02593448|Propofol|propofol|mesh-list
101743296|NCT02593448|Sevoflurane|sevoflurane|mesh-list
101743297|NCT02593448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101743298|NCT02593448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743299|NCT02593448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101743300|NCT02593448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101743301|NCT02593448|Anesthetics, General|anesthetics, general|mesh-ancestor
101743312|NCT02592746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101743313|NCT02592746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101743314|NCT02592746|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101743315|NCT02592746|Fertility Agents|fertility agents|mesh-ancestor
101743316|NCT02592746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101743317|NCT02592746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743318|NCT02592746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101743319|NCT02592746|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101743320|NCT02592746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101743321|NCT02592746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101743322|NCT02592746|Hormone Antagonists|hormone antagonists|mesh-ancestor
101743323|NCT02592746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101743324|NCT03365622|Acetaminophen|acetaminophen|mesh-list
101743325|NCT03365622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101743326|NCT03365622|Analgesics|analgesics|mesh-ancestor
101743327|NCT03365622|Sensory System Agents|sensory system agents|mesh-ancestor
101743328|NCT03365622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101743329|NCT03365622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743330|NCT03365622|Antipyretics|antipyretics|mesh-ancestor
101743331|NCT00731120|Vortioxetine|vortioxetine|mesh-list
101743332|NCT00731120|Antidepressive Agents|antidepressive agents|mesh-ancestor
101560856|NCT00605605|Respiratory System Agents|respiratory system agents|mesh-ancestor
101560857|NCT00605605|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101560858|NCT00605605|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101560859|NCT00605605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101560860|NCT00605605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560861|NCT00605605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743333|NCT00731120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101743334|NCT00731120|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101743335|NCT00731120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101743336|NCT00731120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101743337|NCT00731120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743338|NCT00731120|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101743339|NCT00731120|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101743340|NCT00731120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101743341|NCT00731120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471146|NCT01805284|Linezolid|linezolid|mesh-list
101743342|NCT00731120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101743343|NCT00731120|Serotonin Agents|serotonin agents|mesh-ancestor
101743344|NCT00731120|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101743345|NCT00731120|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101743346|NCT00731120|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101743347|NCT00731120|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101743348|NCT02580006|Epoetin Alfa|epoetin alfa|mesh-list
101743349|NCT02580006|Hematinics|hematinics|mesh-ancestor
101743350|NCT00731042|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101743351|NCT00731042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101743352|NCT00731042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101743353|NCT00731042|Dermatologic Agents|dermatologic agents|mesh-ancestor
101743354|NCT02787642|Olaparib|olaparib|mesh-list
101743355|NCT02787642|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101743356|NCT02787642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101743357|NCT02787642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743358|NCT02787642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101743360|NCT04075188|Verteporfin|verteporfin|mesh-list
101743361|NCT04075188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101743362|NCT04075188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101743363|NCT04075188|Growth Substances|growth substances|mesh-ancestor
101743364|NCT04075188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743365|NCT04075188|Growth Inhibitors|growth inhibitors|mesh-ancestor
101743366|NCT04075188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101743371|NCT00726986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101743372|NCT00726986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101743373|NCT00726986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101743374|NCT00726986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101743376|NCT00726986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743377|NCT00726986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101743378|NCT00696657|Liraglutide|liraglutide|mesh-list
101743379|NCT00696657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101743380|NCT00696657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743381|NCT00696657|Incretins|incretins|mesh-ancestor
101743382|NCT00696657|Hormones|hormones|mesh-ancestor
101743383|NCT00696657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101743384|NCT00726752|Axitinib|axitinib|mesh-list
101743385|NCT00726752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101743386|NCT00726752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101743387|NCT00726752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101743388|NCT00726752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743390|NCT02594462|Etonogestrel|etonogestrel|mesh-list
101743391|NCT02594462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101743392|NCT02594462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743393|NCT02594462|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101743394|NCT02594462|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101743395|NCT02664558|Ubenimex|ubenimex|mesh-list
101743396|NCT02664558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101743397|NCT02664558|Immunologic Factors|immunologic factors|mesh-ancestor
101560863|NCT04267237|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101560864|NCT04267237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560865|NCT04267237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101560866|NCT04267237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101560867|NCT00605995|Simvastatin|simvastatin|mesh-list
101560868|NCT00605995|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101560869|NCT00605995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101560870|NCT00605995|Antimetabolites|antimetabolites|mesh-ancestor
101471256|NCT00252434|Adrenergic Agents|adrenergic agents|mesh-ancestor
101560871|NCT00605995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560872|NCT00605995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101560873|NCT00605995|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101560874|NCT00605995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101560875|NCT00605683|Cabergoline|cabergoline|mesh-list
101560876|NCT00605683|Pramipexole|pramipexole|mesh-list
101560877|NCT00605683|Ropinirole|ropinirole|mesh-list
101560878|NCT00605683|Bromocriptine|bromocriptine|mesh-list
101560879|NCT00605683|Lisuride|lisuride|mesh-list
101743398|NCT02664558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743399|NCT02664558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101743400|NCT02664558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101471534|NCT00252863|Xhance|xhance|mesh-list
101743401|NCT02664558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101743402|NCT02664558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101743403|NCT02664558|Protease Inhibitors|protease inhibitors|mesh-ancestor
101743404|NCT02664558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101743405|NCT02664558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743406|NCT02664558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101743407|NCT02664558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101743408|NCT02664558|Antiviral Agents|antiviral agents|mesh-ancestor
101743409|NCT02566707|Lamivudine|lamivudine|mesh-list
101743410|NCT02566707|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101743411|NCT02566707|Dolutegravir|dolutegravir|mesh-list
101743412|NCT02566707|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101743413|NCT02566707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101743414|NCT02566707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101743415|NCT02566707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743416|NCT02566707|Antiviral Agents|antiviral agents|mesh-ancestor
101471650|NCT01682902|Insulin|insulin|mesh-list
101743417|NCT02566707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101743418|NCT02566707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101743419|NCT02566707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101743420|NCT02566707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101743421|NCT02566707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101743422|NCT02566707|Protease Inhibitors|protease inhibitors|mesh-ancestor
101743423|NCT02566707|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101743424|NCT02566707|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101743425|NCT04063683|Paclitaxel|paclitaxel|mesh-list
101743426|NCT04063683|Cisplatin|cisplatin|mesh-list
101743427|NCT04063683|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101743428|NCT04063683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101743429|NCT04063683|Tubulin Modulators|tubulin modulators|mesh-ancestor
101743430|NCT04063683|Antimitotic Agents|antimitotic agents|mesh-ancestor
101743431|NCT04063683|Mitosis Modulators|mitosis modulators|mesh-ancestor
101743432|NCT04063683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743433|NCT00921531|Thalidomide|thalidomide|mesh-list
101743434|NCT00921531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101743435|NCT00921531|Immunologic Factors|immunologic factors|mesh-ancestor
101743436|NCT00921531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743437|NCT00921531|Leprostatic Agents|leprostatic agents|mesh-ancestor
101560881|NCT00605683|Pergolide|pergolide|mesh-list
101560882|NCT00605683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101560883|NCT00605683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101560884|NCT00605683|Dopamine Agonists|dopamine agonists|mesh-ancestor
101560885|NCT00605683|Dopamine Agents|dopamine agents|mesh-ancestor
101560886|NCT00605683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101409295|NCT00347854|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101743438|NCT00921531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101494898|NCT00440414|Pemetrexed|pemetrexed|mesh-list
101743440|NCT00921531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101743441|NCT00921531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101743442|NCT00921531|Growth Substances|growth substances|mesh-ancestor
101743443|NCT00921531|Growth Inhibitors|growth inhibitors|mesh-ancestor
101743444|NCT00921531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101743445|NCT00730028|Clindamycin|clindamycin|mesh-list
101743446|NCT00730028|Clindamycin palmitate|clindamycin palmitate|mesh-list
101743447|NCT00730028|Clindamycin phosphate|clindamycin phosphate|mesh-list
101743448|NCT00730028|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101743449|NCT00730028|Trimethoprim|trimethoprim|mesh-list
101743450|NCT00730028|Sulfamethoxazole|sulfamethoxazole|mesh-list
101743451|NCT00730028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101743452|NCT00730028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101743453|NCT00730028|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101743454|NCT00730028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101743455|NCT00730028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743456|NCT00730028|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101743457|NCT00730028|Antimalarials|antimalarials|mesh-ancestor
101743458|NCT00730028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101743459|NCT00730028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101743460|NCT00730028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101743461|NCT00730028|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101743462|NCT00730028|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101743463|NCT00730028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101743464|NCT04088084|Palmidrol|palmidrol|mesh-list
101743465|NCT04088084|Analgesics|analgesics|mesh-ancestor
101743466|NCT04088084|Sensory System Agents|sensory system agents|mesh-ancestor
101743467|NCT04088084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101743468|NCT04088084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743469|NCT04088084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101743470|NCT04088084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101743471|NCT04088084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101743472|NCT04088084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101743473|NCT04088084|Antiviral Agents|antiviral agents|mesh-ancestor
101743474|NCT04088084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101472187|NCT01688206|Atezolizumab|atezolizumab|mesh-list
101743475|NCT04088084|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101743476|NCT04088084|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101743477|NCT04088084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101743478|NCT04088084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743479|NCT04088084|Hormones|hormones|mesh-ancestor
101743480|NCT04088084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101743481|NCT02593370|Lidocaine|lidocaine|mesh-list
101743482|NCT02593370|Epinephrine|epinephrine|mesh-list
101743483|NCT02593370|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
101743484|NCT02593370|Anesthetics, Local|anesthetics, local|mesh-ancestor
101743485|NCT02593370|Anesthetics|anesthetics|mesh-ancestor
101743486|NCT02593370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101743487|NCT02593370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743488|NCT02593370|Sensory System Agents|sensory system agents|mesh-ancestor
101743489|NCT02593370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101743490|NCT02593370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101743491|NCT02593370|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101743492|NCT02593370|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101743493|NCT02593370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101743494|NCT02593370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743495|NCT02593370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101560887|NCT00605683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560888|NCT00605683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560890|NCT00605683|Protective Agents|protective agents|mesh-ancestor
101560891|NCT00605683|Hormone Antagonists|hormone antagonists|mesh-ancestor
101560892|NCT00605683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101560893|NCT00605683|Emetics|emetics|mesh-ancestor
101743496|NCT02593370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101743497|NCT02593370|Adrenergic Agents|adrenergic agents|mesh-ancestor
101743498|NCT02593370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101743499|NCT02593370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101743500|NCT02593370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101743501|NCT02593370|Autonomic Agents|autonomic agents|mesh-ancestor
101743502|NCT02593370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101743503|NCT02593370|Respiratory System Agents|respiratory system agents|mesh-ancestor
101743504|NCT02593370|Mydriatics|mydriatics|mesh-ancestor
101743505|NCT02593370|Sympathomimetics|sympathomimetics|mesh-ancestor
101743506|NCT02593370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101743507|NCT02593370|Chelating Agents|chelating agents|mesh-ancestor
101743508|NCT02593370|Sequestering Agents|sequestering agents|mesh-ancestor
101743509|NCT00918320|Temozolomide|temozolomide|mesh-list
101743510|NCT00918320|Topotecan|topotecan|mesh-list
101494950|NCT00440804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101743523|NCT00729560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101743524|NCT00729560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101743525|NCT00736190|Tenofovir|tenofovir|mesh-list
101743526|NCT00736190|Antiviral Agents|antiviral agents|mesh-ancestor
101743527|NCT00736190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101743528|NCT00736190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101743529|NCT00736190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101743530|NCT00736190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101743531|NCT00736190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743532|NCT00736190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101743533|NCT00736190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101743534|NCT04686279|Tenofovir|tenofovir|mesh-list
101743535|NCT04686279|Antiviral Agents|antiviral agents|mesh-ancestor
101743536|NCT04686279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101743537|NCT04686279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101743538|NCT04686279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101743539|NCT04686279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101743540|NCT04686279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743541|NCT04686279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101743542|NCT04686279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101743543|NCT00729326|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101743544|NCT00729326|Exenatide|exenatide|mesh-list
101743545|NCT00729326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101743546|NCT00729326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743547|NCT00729326|Incretins|incretins|mesh-ancestor
101743548|NCT00729326|Hormones|hormones|mesh-ancestor
101743549|NCT00729326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101743550|NCT00729326|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101743551|NCT00729326|Protease Inhibitors|protease inhibitors|mesh-ancestor
101743552|NCT00729326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101743553|NCT00729326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743554|NCT00729326|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101743555|NCT02565303|Ropivacaine|ropivacaine|mesh-list
101743556|NCT02565303|Anesthetics, Local|anesthetics, local|mesh-ancestor
101743557|NCT02565303|Anesthetics|anesthetics|mesh-ancestor
101743558|NCT02565303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101743559|NCT02565303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472334|NCT00288483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101743560|NCT02565303|Sensory System Agents|sensory system agents|mesh-ancestor
101743561|NCT02565303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101743562|NCT00698451|Bevacizumab|bevacizumab|mesh-list
101743563|NCT00698451|Carboplatin|carboplatin|mesh-list
101743564|NCT00698451|Doxorubicin|doxorubicin|mesh-list
101743565|NCT00698451|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101743566|NCT00698451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101743567|NCT00698451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101560895|NCT00605683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101560896|NCT00605683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101560897|NCT00605683|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101560898|NCT00605683|Serotonin Agents|serotonin agents|mesh-ancestor
101560899|NCT01266902|Rilpivirine|rilpivirine|mesh-list
101560900|NCT01266902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101560901|NCT01266902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101743568|NCT00698451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101743569|NCT00698451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101743570|NCT00698451|Growth Substances|growth substances|mesh-ancestor
101743571|NCT00698451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743586|NCT03980925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101743587|NCT03980925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101743588|NCT03980925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101743589|NCT00693693|Hydrocortisone|hydrocortisone|mesh-list
101743590|NCT00693693|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101743591|NCT00693693|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101743592|NCT00693693|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101743593|NCT00693693|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
101743594|NCT00693693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101743595|NCT00693693|Dermatologic Agents|dermatologic agents|mesh-ancestor
101743596|NCT03966807|Nicotine|nicotine|mesh-list
101743597|NCT03966807|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101743598|NCT03966807|Autonomic Agents|autonomic agents|mesh-ancestor
101743599|NCT03966807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101743600|NCT03966807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743601|NCT03966807|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101743602|NCT03966807|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101743603|NCT03966807|Cholinergic Agents|cholinergic agents|mesh-ancestor
101743604|NCT03966807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101743605|NCT03966807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743606|NCT02565693|Aspirin|aspirin|mesh-list
101743607|NCT02565693|Carbaspirin calcium|carbaspirin calcium|mesh-list
101743608|NCT02565693|Dipyridamole|dipyridamole|mesh-list
101743609|NCT02565693|Apixaban|apixaban|mesh-list
101743610|NCT02565693|Clopidogrel|clopidogrel|mesh-list
101743611|NCT02565693|Calcium|calcium|mesh-list
101743612|NCT02565693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101743613|NCT02565693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743614|NCT02565693|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101743615|NCT02565693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101743616|NCT02565693|Analgesics|analgesics|mesh-ancestor
101743617|NCT02565693|Sensory System Agents|sensory system agents|mesh-ancestor
101743618|NCT02565693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101472578|NCT00254930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101743619|NCT02565693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101743620|NCT02565693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101743621|NCT02565693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101743622|NCT02565693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101743623|NCT02565693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743624|NCT02565693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101743625|NCT02565693|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101743626|NCT02565693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101743627|NCT02565693|Antipyretics|antipyretics|mesh-ancestor
101743628|NCT02565693|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101743629|NCT02565693|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101743630|NCT02565693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101743631|NCT02565693|Purinergic Agents|purinergic agents|mesh-ancestor
101743632|NCT02565693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101743638|NCT02565693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101743639|NCT02565693|Vasodilator Agents|vasodilator agents|mesh-ancestor
101743641|NCT04061655|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
101743642|NCT04061655|Trace Elements|trace elements|mesh-ancestor
101743643|NCT04061655|Micronutrients|micronutrients|mesh-ancestor
101743644|NCT04061655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743645|NCT04061655|Hematinics|hematinics|mesh-ancestor
101743646|NCT04061265|Lidocaine|lidocaine|mesh-list
101743647|NCT04061265|Epinephrine|epinephrine|mesh-list
101560902|NCT01266902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101560903|NCT01266902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560904|NCT01266902|Antiviral Agents|antiviral agents|mesh-ancestor
101560905|NCT01266902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101560906|NCT01266902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101560907|NCT01266902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101560908|NCT01266824|Proxymetacaine|proxymetacaine|mesh-list
101743648|NCT04061265|Carticaine|carticaine|mesh-list
101743649|NCT04061265|Anesthetics, Local|anesthetics, local|mesh-ancestor
101743650|NCT04061265|Anesthetics|anesthetics|mesh-ancestor
101743651|NCT04061265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101743652|NCT04061265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743653|NCT04061265|Sensory System Agents|sensory system agents|mesh-ancestor
101743654|NCT04061265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101743655|NCT04061265|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101743656|NCT04061265|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101743657|NCT04061265|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101743658|NCT04061265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101743659|NCT04061265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743660|NCT04061265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101743661|NCT04061265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101743662|NCT04061265|Adrenergic Agents|adrenergic agents|mesh-ancestor
101743663|NCT04061265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101743664|NCT04061265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101743665|NCT04061265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101743667|NCT04061265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101743668|NCT04061265|Respiratory System Agents|respiratory system agents|mesh-ancestor
101743669|NCT04061265|Mydriatics|mydriatics|mesh-ancestor
101743670|NCT04061265|Sympathomimetics|sympathomimetics|mesh-ancestor
101743671|NCT04061265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101743672|NCT02592980|Warfarin|warfarin|mesh-list
101743673|NCT02592980|Anticoagulants|anticoagulants|mesh-ancestor
101743674|NCT00727844|Linezolid|linezolid|mesh-list
101743675|NCT00727844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101743676|NCT00727844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101743677|NCT00727844|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101743678|NCT00727844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101743679|NCT00727844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743680|NCT00735878|Carboplatin|carboplatin|mesh-list
101743681|NCT00735878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101743682|NCT00695955|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101743683|NCT00695955|Chlorthalidone|chlorthalidone|mesh-list
101743684|NCT00695955|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
101743685|NCT00695955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101743686|NCT00695955|Diuretics|diuretics|mesh-ancestor
101743687|NCT00695955|Natriuretic Agents|natriuretic agents|mesh-ancestor
101743688|NCT00695955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743689|NCT00695955|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101743690|NCT00695955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101743691|NCT00695955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743692|NCT00695955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101743693|NCT00695955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101743694|NCT00693225|Omeprazole|omeprazole|mesh-list
101743695|NCT00693225|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
101743696|NCT00693225|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101743697|NCT00693225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101743698|NCT00693225|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101743699|NCT00693225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101743700|NCT00693225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743701|NCT00735644|Vaccines|vaccines|mesh-list
101743702|NCT00735644|Immunologic Factors|immunologic factors|mesh-ancestor
101743703|NCT00735644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743704|NCT02591888|Bupivacaine|bupivacaine|mesh-list
101743714|NCT00724958|Dermatologic Agents|dermatologic agents|mesh-ancestor
101743715|NCT00724958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101743716|NCT00724958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101743718|NCT04088006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101743719|NCT04088006|Immunologic Factors|immunologic factors|mesh-ancestor
101560909|NCT01266824|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101560910|NCT01266824|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101560911|NCT01266824|Anesthetics, Local|anesthetics, local|mesh-ancestor
101560912|NCT01266824|Anesthetics|anesthetics|mesh-ancestor
101560913|NCT01266824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101560914|NCT01266824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560915|NCT01266824|Sensory System Agents|sensory system agents|mesh-ancestor
101743720|NCT04088006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743721|NCT04088006|Viscosupplements|viscosupplements|mesh-ancestor
101743722|NCT04088006|Protective Agents|protective agents|mesh-ancestor
101743723|NCT00695565|Clonidine|clonidine|mesh-list
101743724|NCT00695565|Analgesics|analgesics|mesh-ancestor
101743725|NCT00695565|Sensory System Agents|sensory system agents|mesh-ancestor
101743726|NCT00695565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101743727|NCT00695565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743728|NCT00695565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101743729|NCT00695565|Sympatholytics|sympatholytics|mesh-ancestor
101743730|NCT00695565|Autonomic Agents|autonomic agents|mesh-ancestor
101473189|NCT00257075|Risperidone|risperidone|mesh-list
101743731|NCT00695565|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101743732|NCT00695565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101743733|NCT00695565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101743734|NCT00695565|Adrenergic Agents|adrenergic agents|mesh-ancestor
101743735|NCT00695565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101743736|NCT00695565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743737|NCT00727532|Sorafenib|sorafenib|mesh-list
101743738|NCT00727532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101743739|NCT00727532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101743740|NCT00727532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101743741|NCT00727532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743742|NCT00721214|Azacitidine|azacitidine|mesh-list
101743743|NCT00721214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101743744|NCT00721214|Antimetabolites|antimetabolites|mesh-ancestor
101743745|NCT00721214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743746|NCT00721214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101743747|NCT00721214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101743748|NCT03543813|CX-2029|cx-2029|mesh-list
101743749|NCT03543813|Immunoconjugates|immunoconjugates|mesh-ancestor
101743750|NCT03543813|Immunologic Factors|immunologic factors|mesh-ancestor
101743751|NCT03543813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743752|NCT00720902|Hormones|hormones|mesh-list
101743753|NCT00720902|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
101743754|NCT00720902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101743755|NCT00720902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743756|NCT02592278|Listerine|listerine|mesh-list
101743757|NCT02592278|Fluorides|fluorides|mesh-list
101743758|NCT02592278|Fluorides, Topical|fluorides, topical|mesh-list
101743759|NCT02592278|Sodium Fluoride|sodium fluoride|mesh-list
101743760|NCT02592278|Cariostatic Agents|cariostatic agents|mesh-ancestor
101473605|NCT01603108|Rifaximin|rifaximin|mesh-list
101743761|NCT02592278|Protective Agents|protective agents|mesh-ancestor
101743762|NCT02592278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743763|NCT02592278|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101743764|NCT02592278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101743765|NCT00695019|Interferons|interferons|mesh-list
101743766|NCT00695019|Interferon-alpha|interferon-alpha|mesh-list
101743767|NCT00695019|Interferon alpha-2|interferon alpha-2|mesh-list
101743768|NCT00695019|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
101743769|NCT00695019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101743770|NCT00695019|Antiviral Agents|antiviral agents|mesh-ancestor
101473730|NCT00257972|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101743785|NCT00742911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743786|NCT00694707|Risperidone|risperidone|mesh-list
101743787|NCT00694707|Cariprazine|cariprazine|mesh-list
101361119|NCT00073710|Vitamins|vitamins|mesh-ancestor
101743788|NCT00694707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101743789|NCT00694707|Serotonin Agents|serotonin agents|mesh-ancestor
101743790|NCT00694707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101743791|NCT00694707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743792|NCT00694707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743793|NCT00694707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101743794|NCT00694707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101560916|NCT01266824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101560917|NCT04253119|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101560918|NCT04253119|Antiviral Agents|antiviral agents|mesh-ancestor
101560919|NCT04253119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101560920|NCT01266590|Digoxin|digoxin|mesh-list
101560921|NCT01266590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101560922|NCT01266590|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101560923|NCT01266590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101560924|NCT01266590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560925|NCT01266590|Protective Agents|protective agents|mesh-ancestor
101560926|NCT01266590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560927|NCT01265498|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
101560928|NCT01265498|Cathartics|cathartics|mesh-ancestor
101743795|NCT00694707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101743796|NCT00694707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101474125|NCT00291759|Tamoxifen|tamoxifen|mesh-list
101743797|NCT00694707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101743798|NCT00694707|Dopamine Agents|dopamine agents|mesh-ancestor
101743799|NCT00692913|Cholecalciferol|cholecalciferol|mesh-list
101743800|NCT00692913|Vitamin D|vitamin d|mesh-list
101743801|NCT00692913|Alendronate|alendronate|mesh-list
101743802|NCT00692913|Calcium|calcium|mesh-list
101743803|NCT00692913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101743804|NCT00692913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743805|NCT00692913|Vitamins|vitamins|mesh-ancestor
101743806|NCT00692913|Micronutrients|micronutrients|mesh-ancestor
101743807|NCT00692913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101743808|NCT00694551|Poly I-C|poly i-c|mesh-list
101743809|NCT00694551|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101743810|NCT00694551|Vaccines|vaccines|mesh-list
101743811|NCT00694551|Poly ICLC|poly iclc|mesh-list
101743812|NCT00694551|Immunologic Factors|immunologic factors|mesh-ancestor
101743813|NCT00694551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743814|NCT00694551|Interferon Inducers|interferon inducers|mesh-ancestor
101743815|NCT00694551|Laxatives|laxatives|mesh-ancestor
101474404|NCT00292929|Artesunate|artesunate|mesh-list
101743816|NCT00694551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101743817|NCT00694551|Antiviral Agents|antiviral agents|mesh-ancestor
101743818|NCT00694551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101743819|NCT02603705|Oxycodone|oxycodone|mesh-list
101474462|NCT00298545|Vitamins|vitamins|mesh-ancestor
101743820|NCT02603705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101743821|NCT02603705|Narcotics|narcotics|mesh-ancestor
101743822|NCT02603705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101743823|NCT02603705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743824|NCT02603705|Analgesics|analgesics|mesh-ancestor
101743825|NCT02603705|Sensory System Agents|sensory system agents|mesh-ancestor
101743826|NCT02603705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101743827|NCT00776555|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101743828|NCT00776555|Dextroamphetamine|dextroamphetamine|mesh-list
101743829|NCT00776555|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101743830|NCT00776555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743831|NCT00776555|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101743832|NCT00776555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101743833|NCT00776555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101743839|NCT00915785|Antimetabolites|antimetabolites|mesh-ancestor
101743840|NCT00915785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743841|NCT00915785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101743842|NCT00915785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101474592|NCT00261170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101743844|NCT00776009|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
101743845|NCT00776009|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101743846|NCT00776009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743847|NCT00776009|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101743848|NCT00776009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101743849|NCT00776009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101439419|NCT05365451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560929|NCT01265498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101560930|NCT00607711|Isophosphamide mustard|isophosphamide mustard|mesh-list
101560931|NCT00607711|Ifosfamide|ifosfamide|mesh-list
101560932|NCT00607711|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101560933|NCT00607711|Alkylating Agents|alkylating agents|mesh-ancestor
101560934|NCT00607711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560935|NCT00607711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101560936|NCT01263782|Bevacizumab|bevacizumab|mesh-list
101409344|NCT00144417|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101743850|NCT00776009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743851|NCT00776009|Dopamine Agents|dopamine agents|mesh-ancestor
101743852|NCT00776009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101743853|NCT00720356|Bevacizumab|bevacizumab|mesh-list
101743854|NCT00720356|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101743855|NCT00720356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101743856|NCT00720356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101743857|NCT00720356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101743858|NCT00720356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101743859|NCT00720356|Growth Substances|growth substances|mesh-ancestor
101743860|NCT00720356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743861|NCT00720356|Growth Inhibitors|growth inhibitors|mesh-ancestor
101743862|NCT00720356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101743863|NCT00720356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101743864|NCT00720356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743865|NCT00745953|Valsartan|valsartan|mesh-list
101743866|NCT00745953|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101743867|NCT00745953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101743868|NCT00745953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101474760|NCT00293475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101743869|NCT00745953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101743870|NCT00745953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743871|NCT00745953|Diuretics|diuretics|mesh-ancestor
101743872|NCT00745953|Natriuretic Agents|natriuretic agents|mesh-ancestor
101743873|NCT00745953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743874|NCT00745953|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101743875|NCT00745953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101743876|NCT00720278|Azelastine|azelastine|mesh-list
101743877|NCT00720278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101743878|NCT00720278|Autonomic Agents|autonomic agents|mesh-ancestor
101743879|NCT00720278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101743880|NCT00720278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743881|NCT00720278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101743882|NCT00720278|Respiratory System Agents|respiratory system agents|mesh-ancestor
101743883|NCT00720278|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101743884|NCT00720278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101743885|NCT00720278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743886|NCT00720278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101743887|NCT00720278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101743888|NCT00720278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101743889|NCT00720278|Histamine Antagonists|histamine antagonists|mesh-ancestor
101743890|NCT00720278|Histamine Agents|histamine agents|mesh-ancestor
101743891|NCT00720278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101743892|NCT00746031|Goserelin|goserelin|mesh-list
101743893|NCT00746031|Cetrorelix|cetrorelix|mesh-list
101743894|NCT00746031|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101743895|NCT00746031|Hormones|hormones|mesh-ancestor
101743896|NCT00746031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101743897|NCT00746031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743898|NCT00746031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101743899|NCT00746031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101743900|NCT00746031|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101743911|NCT00720122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743912|NCT00720122|Growth Substances|growth substances|mesh-ancestor
101743913|NCT04085744|Mometasone Furoate|mometasone furoate|mesh-list
101743914|NCT04085744|Lidocaine|lidocaine|mesh-list
101560937|NCT01263782|Carboplatin|carboplatin|mesh-list
101560938|NCT01263782|Pemetrexed|pemetrexed|mesh-list
101560939|NCT01263782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101560940|NCT01263782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101560941|NCT01263782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101560942|NCT01263782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101560943|NCT01263782|Growth Substances|growth substances|mesh-ancestor
101560944|NCT01263782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560945|NCT01263782|Growth Inhibitors|growth inhibitors|mesh-ancestor
101560946|NCT01263782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101560947|NCT01263782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560948|NCT01263782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101743915|NCT04085744|Anesthetics, Local|anesthetics, local|mesh-ancestor
101743916|NCT04085744|Anesthetics|anesthetics|mesh-ancestor
101743917|NCT04085744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101743918|NCT04085744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743919|NCT04085744|Sensory System Agents|sensory system agents|mesh-ancestor
101743920|NCT04085744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101361320|NCT00123331|Sirolimus|sirolimus|mesh-list
101743921|NCT04085744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101743922|NCT04085744|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101743923|NCT04085744|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101743924|NCT04085744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101743925|NCT04085744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743926|NCT04085744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101743927|NCT04085744|Dermatologic Agents|dermatologic agents|mesh-ancestor
101743928|NCT04085744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101743929|NCT00743847|Varenicline|varenicline|mesh-list
101743930|NCT00743847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101743931|NCT00743847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101743932|NCT00743847|Cholinergic Agents|cholinergic agents|mesh-ancestor
101743933|NCT00743847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101743934|NCT00743847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743935|NCT00743847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743936|NCT00717860|Caspofungin|caspofungin|mesh-list
101743937|NCT00717860|Micafungin|micafungin|mesh-list
101743938|NCT00717860|Antifungal Agents|antifungal agents|mesh-ancestor
101743939|NCT00717860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101743940|NCT00717860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101743941|NCT00717860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743942|NCT00746499|Raltegravir Potassium|raltegravir potassium|mesh-list
101743943|NCT00746499|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101743944|NCT00746499|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101743945|NCT00746499|Antiviral Agents|antiviral agents|mesh-ancestor
101743946|NCT00746499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101743947|NCT00746499|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101743948|NCT00746499|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101743949|NCT00746499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101743950|NCT00746499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743952|NCT02592122|Albuterol|albuterol|mesh-list
101743953|NCT02592122|Anticonvulsants|anticonvulsants|mesh-ancestor
101743954|NCT02592122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101743955|NCT02592122|Autonomic Agents|autonomic agents|mesh-ancestor
101743956|NCT02592122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101743957|NCT02592122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743958|NCT02592122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101743959|NCT02592122|Respiratory System Agents|respiratory system agents|mesh-ancestor
101743960|NCT02592122|Tocolytic Agents|tocolytic agents|mesh-ancestor
101743961|NCT02592122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101743962|NCT02592122|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101743963|NCT02592122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101560949|NCT01263782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101560950|NCT01263704|Cyclophosphamide|cyclophosphamide|mesh-list
101560951|NCT01263704|Rituximab|rituximab|mesh-list
101560952|NCT01263704|Fludarabine|fludarabine|mesh-list
101560953|NCT01263704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101560954|NCT01263704|Immunologic Factors|immunologic factors|mesh-ancestor
101560955|NCT01263704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560956|NCT01263704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101560957|NCT01263704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101560958|NCT01263704|Alkylating Agents|alkylating agents|mesh-ancestor
101560959|NCT01263704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560960|NCT01263704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101560961|NCT01263704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101560962|NCT01263704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101743964|NCT02592122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101743965|NCT02592122|Adrenergic Agents|adrenergic agents|mesh-ancestor
101743966|NCT02592122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101743967|NCT02592122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743972|NCT00923637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743973|NCT00923637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101743974|NCT00923637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101743975|NCT00717314|Mycophenolic Acid|mycophenolic acid|mesh-list
101743976|NCT00717314|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101743977|NCT00717314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101743978|NCT00717314|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101743979|NCT00717314|Antitubercular Agents|antitubercular agents|mesh-ancestor
101743980|NCT00717314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101743981|NCT00717314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101743982|NCT00717314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101743983|NCT00717314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743984|NCT01090089|Dexamethasone|dexamethasone|mesh-list
101743985|NCT01090089|Dexamethasone acetate|dexamethasone acetate|mesh-list
101743986|NCT01090089|Lenalidomide|lenalidomide|mesh-list
101743987|NCT01090089|BB 1101|bb 1101|mesh-list
101743988|NCT01090089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101743989|NCT01090089|Antiemetics|antiemetics|mesh-ancestor
101743990|NCT01090089|Autonomic Agents|autonomic agents|mesh-ancestor
101743991|NCT01090089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101743992|NCT01090089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743993|NCT01090089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101743994|NCT01090089|Glucocorticoids|glucocorticoids|mesh-ancestor
101743995|NCT01090089|Hormones|hormones|mesh-ancestor
101743996|NCT01090089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101743997|NCT01090089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101743998|NCT01090089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101743999|NCT01090089|Protease Inhibitors|protease inhibitors|mesh-ancestor
101744000|NCT01090089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101744001|NCT01090089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475688|NCT00266318|Ribavirin|ribavirin|mesh-list
101744002|NCT01090089|Immunologic Factors|immunologic factors|mesh-ancestor
101744003|NCT01090089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101744004|NCT01090089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101744005|NCT01090089|Growth Substances|growth substances|mesh-ancestor
101744006|NCT01090089|Growth Inhibitors|growth inhibitors|mesh-ancestor
101744007|NCT00689793|Iron|iron|mesh-list
101744008|NCT00689793|Trace Elements|trace elements|mesh-ancestor
101744009|NCT00689793|Micronutrients|micronutrients|mesh-ancestor
101744010|NCT00689793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744011|NCT04086290|Androgens|androgens|mesh-list
101744012|NCT04086290|Hormones|hormones|mesh-ancestor
101439420|NCT05365451|Diuretics|diuretics|mesh-ancestor
101560963|NCT01263470|Alogliptin|alogliptin|mesh-list
101560964|NCT01263470|Voglibose|voglibose|mesh-list
101560965|NCT01263470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101560966|NCT01263470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560967|NCT01263470|Incretins|incretins|mesh-ancestor
101560968|NCT01263470|Hormones|hormones|mesh-ancestor
101744013|NCT04086290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101744014|NCT04086290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744016|NCT00744393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101744017|NCT00744393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101744018|NCT00744393|Anesthetics, General|anesthetics, general|mesh-ancestor
101744019|NCT00744393|Anesthetics|anesthetics|mesh-ancestor
101744020|NCT00744393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101744021|NCT00744393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744022|NCT02563353|Teriparatide|teriparatide|mesh-list
101744023|NCT02563353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101744024|NCT02563353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744025|NCT02563353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101744026|NCT00688701|Lixisenatide|lixisenatide|mesh-list
101744027|NCT00688701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101744028|NCT00688701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744029|NCT00744549|Vitamin D|vitamin d|mesh-list
101744030|NCT00744549|Cholecalciferol|cholecalciferol|mesh-list
101744031|NCT00744549|Vitamins|vitamins|mesh-list
101744032|NCT00744549|Vitamin E|vitamin e|mesh-list
101744033|NCT00744549|Selenium|selenium|mesh-list
101744034|NCT00744549|Lycopene|lycopene|mesh-list
101744035|NCT00744549|Micronutrients|micronutrients|mesh-ancestor
101744036|NCT00744549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744037|NCT00744549|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101744038|NCT00744549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101744039|NCT00744549|Antioxidants|antioxidants|mesh-ancestor
101744040|NCT00744549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744041|NCT00744549|Protective Agents|protective agents|mesh-ancestor
101744052|NCT00741507|Ethanol|ethanol|mesh-list
101744053|NCT00741507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101744054|NCT00741507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101744055|NCT00741507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101744056|NCT00741507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744057|NCT00688623|Everolimus|everolimus|mesh-list
101744058|NCT00688623|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101744059|NCT00688623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101744060|NCT00688623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101744061|NCT00688623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401524|NCT02288247|Docetaxel|docetaxel|mesh-list
101744062|NCT00688623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101744063|NCT00688623|Immunologic Factors|immunologic factors|mesh-ancestor
101744064|NCT00688623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744065|NCT00688623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101744066|NCT02563821|Clonidine|clonidine|mesh-list
101744067|NCT02563821|Sufentanil|sufentanil|mesh-list
101744068|NCT02563821|Levobupivacaine|levobupivacaine|mesh-list
101744069|NCT02563821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101744070|NCT02563821|Narcotics|narcotics|mesh-ancestor
101476106|NCT00296634|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101744071|NCT02563821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101744072|NCT02563821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744073|NCT02563821|Analgesics|analgesics|mesh-ancestor
101744074|NCT02563821|Sensory System Agents|sensory system agents|mesh-ancestor
101744075|NCT02563821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101744076|NCT02563821|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101744077|NCT02563821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101744078|NCT02563821|Anesthetics, General|anesthetics, general|mesh-ancestor
101744079|NCT02563821|Anesthetics|anesthetics|mesh-ancestor
101744080|NCT02563821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101744081|NCT02563821|Sympatholytics|sympatholytics|mesh-ancestor
101744082|NCT02563821|Autonomic Agents|autonomic agents|mesh-ancestor
101744083|NCT02563821|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101744084|NCT02563821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101744085|NCT02563821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101744086|NCT02563821|Adrenergic Agents|adrenergic agents|mesh-ancestor
101744087|NCT02563821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101744088|NCT02563821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560969|NCT01263470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101476228|NCT00296946|Autonomic Agents|autonomic agents|mesh-ancestor
101560970|NCT01263470|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101560971|NCT01263470|Protease Inhibitors|protease inhibitors|mesh-ancestor
101560972|NCT01263470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101560973|NCT01263470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409383|NCT00348244|Antiemetics|antiemetics|mesh-ancestor
101744089|NCT02563821|Anesthetics, Local|anesthetics, local|mesh-ancestor
101744090|NCT00717236|Certolizumab Pegol|certolizumab pegol|mesh-list
101744091|NCT00717236|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101744092|NCT00717236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101744093|NCT00717236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101744094|NCT00717236|Immunologic Factors|immunologic factors|mesh-ancestor
101744095|NCT00717236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744096|NCT00717236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101744097|NCT04085354|Vitamins|vitamins|mesh-list
101744098|NCT04085354|Folic Acid|folic acid|mesh-list
101744099|NCT04085354|Vitamin B 12|vitamin b 12|mesh-list
101744100|NCT04085354|Hydroxocobalamin|hydroxocobalamin|mesh-list
101744101|NCT04085354|Micronutrients|micronutrients|mesh-ancestor
101744102|NCT04085354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744103|NCT04085354|Hematinics|hematinics|mesh-ancestor
101744104|NCT04085354|Vitamin B Complex|vitamin b complex|mesh-ancestor
101744105|NCT00719810|Tigecycline|tigecycline|mesh-list
101744106|NCT00719810|Fluoroquinolones|fluoroquinolones|mesh-list
101744107|NCT00719810|Delafloxacin|delafloxacin|mesh-list
101744108|NCT00719810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101744109|NCT00719810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101401605|NCT00729300|Disulfiram|disulfiram|mesh-list
101744136|NCT04060407|Ipilimumab|ipilimumab|mesh-list
101744137|NCT04060407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101476290|NCT00297141|Capecitabine|capecitabine|mesh-list
101744138|NCT04060407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101744139|NCT04060407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101744140|NCT04060407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744142|NCT00741585|Amlodipine|amlodipine|mesh-list
101744143|NCT00741585|Valsartan|valsartan|mesh-list
101744144|NCT00741585|Telmisartan|telmisartan|mesh-list
101744145|NCT00741585|Carvedilol|carvedilol|mesh-list
101744146|NCT00741585|Candesartan|candesartan|mesh-list
101744147|NCT00741585|Candesartan cilexetil|candesartan cilexetil|mesh-list
101744148|NCT00741585|Ramipril|ramipril|mesh-list
101744149|NCT00741585|Olmesartan|olmesartan|mesh-list
101744150|NCT00741585|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101744151|NCT00741585|Enalapril|enalapril|mesh-list
101744152|NCT00741585|Enalaprilat|enalaprilat|mesh-list
101744153|NCT00741585|Lisinopril|lisinopril|mesh-list
101744154|NCT00741585|Irbesartan|irbesartan|mesh-list
101744155|NCT00741585|Antihypertensive Agents|antihypertensive agents|mesh-list
101744156|NCT00741585|Quinapril|quinapril|mesh-list
101744157|NCT00741585|Lercanidipine|lercanidipine|mesh-list
101744158|NCT00741585|Manidipine|manidipine|mesh-list
101744159|NCT00741585|Doxazosin|doxazosin|mesh-list
101744160|NCT00741585|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101744161|NCT00741585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101744172|NCT00741585|Antioxidants|antioxidants|mesh-ancestor
101744173|NCT00741585|Protective Agents|protective agents|mesh-ancestor
101744174|NCT00741585|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101744175|NCT00741585|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101744176|NCT00741585|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101744177|NCT00741585|Protease Inhibitors|protease inhibitors|mesh-ancestor
101744178|NCT00741585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101744179|NCT00741585|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101476444|NCT00297336|Topiramate|topiramate|mesh-list
101744180|NCT00741585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101744181|NCT00741585|Sympatholytics|sympatholytics|mesh-ancestor
101744182|NCT00741585|Autonomic Agents|autonomic agents|mesh-ancestor
101744183|NCT00741585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101744184|NCT00741585|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101744185|NCT00746967|Sildenafil Citrate|sildenafil citrate|mesh-list
101744186|NCT00746967|Vasodilator Agents|vasodilator agents|mesh-ancestor
101744187|NCT00746967|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101744188|NCT00746967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101744189|NCT00746967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101744190|NCT00746967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744191|NCT00746967|Urological Agents|urological agents|mesh-ancestor
101560974|NCT01263470|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101560975|NCT04322786|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101560976|NCT04322786|Protease Inhibitors|protease inhibitors|mesh-ancestor
101560977|NCT04322786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101828134|NCT05945485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560978|NCT04322786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522926|NCT03993132|Empagliflozin|empagliflozin|mesh-list
101560979|NCT04322240|Thioctic Acid|thioctic acid|mesh-list
101560980|NCT04322240|Antioxidants|antioxidants|mesh-ancestor
101560981|NCT04322240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101560982|NCT04322240|Protective Agents|protective agents|mesh-ancestor
101560983|NCT04322240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560984|NCT04322240|Vitamin B Complex|vitamin b complex|mesh-ancestor
101560985|NCT04322240|Vitamins|vitamins|mesh-ancestor
101409391|NCT00348244|Analgesics|analgesics|mesh-ancestor
101744192|NCT02563041|Heparin|heparin|mesh-list
101744193|NCT02563041|Calcium heparin|calcium heparin|mesh-list
101744194|NCT02563041|Anticoagulants|anticoagulants|mesh-ancestor
101744195|NCT02563041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744196|NCT02563041|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101744197|NCT02563041|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101744198|NCT00741663|Furosemide|furosemide|mesh-list
101744199|NCT00741663|Spironolactone|spironolactone|mesh-list
101744200|NCT00741663|Diuretics|diuretics|mesh-ancestor
101744201|NCT00741663|Natriuretic Agents|natriuretic agents|mesh-ancestor
101744202|NCT00741663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744203|NCT00741663|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101744204|NCT00741663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101744205|NCT00741663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744206|NCT00741663|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101744207|NCT00741663|Hormone Antagonists|hormone antagonists|mesh-ancestor
101744208|NCT00741663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101744209|NCT00741663|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101744210|NCT00745017|Antidepressive Agents|antidepressive agents|mesh-list
101744211|NCT00745017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101744212|NCT00741741|Rilpivirine|rilpivirine|mesh-list
101744213|NCT00741741|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101744214|NCT00741741|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101744215|NCT00741741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101744216|NCT00741741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744218|NCT00741741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101744219|NCT00741741|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101744220|NCT00741741|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101744221|NCT00745173|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101744222|NCT00745173|Estrogens|estrogens|mesh-ancestor
101744223|NCT00745173|Hormones|hormones|mesh-ancestor
101744236|NCT00741897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744237|NCT00741897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744238|NCT00745407|Fenofibrate|fenofibrate|mesh-list
101744239|NCT00745407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101744240|NCT00745407|Antimetabolites|antimetabolites|mesh-ancestor
101744241|NCT00745407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744242|NCT00745407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101744243|NCT00745485|Zoledronic Acid|zoledronic acid|mesh-list
101744244|NCT00745485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101744245|NCT00745485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744247|NCT00747279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101744248|NCT00747279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744249|NCT00742287|Proanthocyanidin|proanthocyanidin|mesh-list
101744250|NCT00742287|Procyanidin|procyanidin|mesh-list
101560987|NCT01262456|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101560988|NCT01262456|Hemostatics|hemostatics|mesh-ancestor
101560989|NCT01262456|Coagulants|coagulants|mesh-ancestor
101560990|NCT01262456|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101560991|NCT01262456|Natriuretic Agents|natriuretic agents|mesh-ancestor
101560992|NCT01262456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101560993|NCT04321694|Mogamulizumab|mogamulizumab|mesh-list
101560994|NCT04321694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101560995|NCT04321850|Zinc|zinc|mesh-list
101744251|NCT00742287|Antioxidants|antioxidants|mesh-ancestor
101744252|NCT00742287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744253|NCT00742287|Protective Agents|protective agents|mesh-ancestor
101744254|NCT00742287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744255|NCT00742287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101476757|NCT00271973|Analgesics|analgesics|mesh-ancestor
101744256|NCT00742287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101744257|NCT00742287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101744258|NCT00747669|Lidocaine|lidocaine|mesh-list
101744259|NCT00747669|Tetracaine|tetracaine|mesh-list
101744260|NCT00747669|Anesthetics, Local|anesthetics, local|mesh-ancestor
101744261|NCT00747669|Anesthetics|anesthetics|mesh-ancestor
101744262|NCT00747669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101744263|NCT00747669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744264|NCT00747669|Sensory System Agents|sensory system agents|mesh-ancestor
101744265|NCT00747669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101744266|NCT00747669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101744267|NCT00747669|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101744268|NCT00747669|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101744269|NCT00747669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101744270|NCT00747669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744271|NCT00690573|Adalimumab|adalimumab|mesh-list
101744272|NCT00690573|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101744273|NCT00690573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101744274|NCT00690573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101744275|NCT00719264|Interferons|interferons|mesh-list
101744276|NCT00719264|Interferon-alpha|interferon-alpha|mesh-list
101744277|NCT00719264|Interferon alpha-2|interferon alpha-2|mesh-list
101744278|NCT00719264|Bevacizumab|bevacizumab|mesh-list
101744279|NCT00719264|Everolimus|everolimus|mesh-list
101744280|NCT00719264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101744281|NCT00719264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101828141|NCT05926570|Cinacalcet|cinacalcet|mesh-list
101744282|NCT00719264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101744283|NCT00719264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101744284|NCT00719264|Growth Substances|growth substances|mesh-ancestor
101744298|NCT00687609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101744299|NCT00687609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744300|NCT00687609|Adrenergic Agents|adrenergic agents|mesh-ancestor
101744301|NCT00687609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101744302|NCT00687609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744303|NCT00751959|Poractant alfa|poractant alfa|mesh-list
101744304|NCT00751959|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
101744305|NCT00751959|Respiratory System Agents|respiratory system agents|mesh-ancestor
101744306|NCT00723554|Iloprost|iloprost|mesh-list
101744307|NCT00723554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101744308|NCT00723554|Vasodilator Agents|vasodilator agents|mesh-ancestor
101744309|NCT00687219|Ribavirin|ribavirin|mesh-list
101744310|NCT00687219|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101744311|NCT00687219|Antimetabolites|antimetabolites|mesh-ancestor
101744312|NCT00687219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744313|NCT00687219|Antiviral Agents|antiviral agents|mesh-ancestor
101744314|NCT00687219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101744315|NCT04085120|Dexamethasone|dexamethasone|mesh-list
101744316|NCT04085120|Dexamethasone acetate|dexamethasone acetate|mesh-list
101744317|NCT04085120|Lidocaine|lidocaine|mesh-list
101744318|NCT04085120|Ropivacaine|ropivacaine|mesh-list
101744319|NCT04085120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101744320|NCT04085120|Antiemetics|antiemetics|mesh-ancestor
101744321|NCT04085120|Autonomic Agents|autonomic agents|mesh-ancestor
101439421|NCT05365451|Natriuretic Agents|natriuretic agents|mesh-ancestor
101560997|NCT04321850|Trace Elements|trace elements|mesh-ancestor
101560998|NCT04321850|Micronutrients|micronutrients|mesh-ancestor
101560999|NCT04321850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561000|NCT04321850|Astringents|astringents|mesh-ancestor
101561001|NCT04321850|Dermatologic Agents|dermatologic agents|mesh-ancestor
101477300|NCT00308451|Vitamins|vitamins|mesh-ancestor
101561002|NCT04321616|Hydroxychloroquine|hydroxychloroquine|mesh-list
101561003|NCT04321616|Remdesivir|remdesivir|mesh-list
101561004|NCT04321616|Antimalarials|antimalarials|mesh-ancestor
101561005|NCT04321616|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101409409|NCT00348361|Dermatologic Agents|dermatologic agents|mesh-ancestor
101409412|NCT00348400|Dorzolamide|dorzolamide|mesh-list
101744322|NCT04085120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101744323|NCT04085120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744324|NCT04085120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101744325|NCT04085120|Glucocorticoids|glucocorticoids|mesh-ancestor
101744326|NCT04085120|Hormones|hormones|mesh-ancestor
101828142|NCT05926570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101744327|NCT04085120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101744328|NCT04085120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101744329|NCT04085120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101744330|NCT04085120|Anesthetics, Local|anesthetics, local|mesh-ancestor
101744331|NCT04085120|Anesthetics|anesthetics|mesh-ancestor
101744332|NCT04085120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101744333|NCT04085120|Sensory System Agents|sensory system agents|mesh-ancestor
101744334|NCT04085120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101744335|NCT04085120|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101744336|NCT04085120|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101744337|NCT04085120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101744338|NCT04085120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744339|NCT00747903|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101744340|NCT00747903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101744341|NCT00747903|Dermatologic Agents|dermatologic agents|mesh-ancestor
101744342|NCT02562183|Kallikreins|kallikreins|mesh-list
101744343|NCT02562183|Coagulants|coagulants|mesh-ancestor
101477495|NCT00274820|Glucocorticoids|glucocorticoids|mesh-ancestor
101744344|NCT02562183|Fertility Agents, Male|fertility agents, male|mesh-ancestor
101744345|NCT02562183|Fertility Agents|fertility agents|mesh-ancestor
101495793|NCT00445250|Calcipotriene|calcipotriene|mesh-list
101744350|NCT00723398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101744351|NCT00723398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101744352|NCT00723398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101744353|NCT00723398|Antimetabolites|antimetabolites|mesh-ancestor
101744354|NCT00723398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744355|NCT00723398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101744356|NCT00723398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101744357|NCT00723398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101744358|NCT00723398|Hormone Antagonists|hormone antagonists|mesh-ancestor
101361652|NCT00125203|Cholinergic Agents|cholinergic agents|mesh-ancestor
101744359|NCT00723398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101744360|NCT00723398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744361|NCT00723398|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101401816|NCT00333151|Hormones|hormones|mesh-ancestor
101744362|NCT00723398|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101744363|NCT00723398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101744365|NCT00716456|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101744366|NCT00716456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101744367|NCT00716456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101744368|NCT00716456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101744369|NCT00716456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101744370|NCT00716456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744371|NCT00684645|Sunitinib|sunitinib|mesh-list
101744372|NCT00684645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101744373|NCT00684645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101744374|NCT00684645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101744375|NCT00684645|Growth Substances|growth substances|mesh-ancestor
101561006|NCT04321616|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101561007|NCT04321616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101561008|NCT04321616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101561009|NCT04321616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561010|NCT04321616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101561011|NCT04321616|Antimetabolites|antimetabolites|mesh-ancestor
101561012|NCT04321616|Antiviral Agents|antiviral agents|mesh-ancestor
101561013|NCT00932893|Docetaxel|docetaxel|mesh-list
101561014|NCT00932893|Pemetrexed|pemetrexed|mesh-list
101477776|NCT00315744|Xhance|xhance|mesh-list
101561015|NCT00932893|Crizotinib|crizotinib|mesh-list
101561016|NCT00932893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561017|NCT00932893|Tubulin Modulators|tubulin modulators|mesh-ancestor
101561018|NCT00932893|Antimitotic Agents|antimitotic agents|mesh-ancestor
101561019|NCT00932893|Mitosis Modulators|mitosis modulators|mesh-ancestor
101561020|NCT00932893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561021|NCT00932893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101561022|NCT00932893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101561023|NCT00932893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101561024|NCT00932893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101561025|NCT04321070|Clindamycin|clindamycin|mesh-list
101561026|NCT04321070|Clindamycin palmitate|clindamycin palmitate|mesh-list
101561027|NCT04321070|Clindamycin phosphate|clindamycin phosphate|mesh-list
101561028|NCT04321070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101561029|NCT04321070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101561030|NCT04321070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101561031|NCT04321070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101561032|NCT04321070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561033|NCT02889224|Hydrocortisone|hydrocortisone|mesh-list
101561034|NCT02889224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101561035|NCT01260896|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101561036|NCT01260896|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101561037|NCT01260896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101561038|NCT01260896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101561039|NCT01260896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561040|NCT01260896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101744376|NCT00684645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744377|NCT00684645|Growth Inhibitors|growth inhibitors|mesh-ancestor
101561041|NCT01260896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561042|NCT01260896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101561043|NCT01260896|Antidepressive Agents|antidepressive agents|mesh-ancestor
101561044|NCT01260896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101561045|NCT00939523|Lapatinib|lapatinib|mesh-list
101561046|NCT00939523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561047|NCT00939523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101561048|NCT00939523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101561049|NCT00939523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561050|NCT01260584|Clopidogrel|clopidogrel|mesh-list
101561051|NCT01260584|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101561052|NCT01260584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101522997|NCT04679142|GABA Agonists|gaba agonists|mesh-ancestor
101561053|NCT01260584|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101561054|NCT01260584|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101561055|NCT01260584|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101409461|NCT00348985|Bortezomib|bortezomib|mesh-list
101744378|NCT00684645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101744379|NCT00684645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101744380|NCT00684645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744381|NCT00752037|Ritonavir|ritonavir|mesh-list
101744382|NCT00752037|Lopinavir|lopinavir|mesh-list
101744383|NCT00752037|Raltegravir Potassium|raltegravir potassium|mesh-list
101744384|NCT00752037|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101744385|NCT00752037|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101744386|NCT00752037|Protease Inhibitors|protease inhibitors|mesh-ancestor
101744387|NCT00752037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101744388|NCT00752037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744389|NCT00752037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101744390|NCT00752037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101744391|NCT00752037|Antiviral Agents|antiviral agents|mesh-ancestor
101744392|NCT00752037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101744393|NCT00752037|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101744394|NCT00752037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101744395|NCT00752037|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101744396|NCT00752037|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101744397|NCT00716144|R 115866|r 115866|mesh-list
101744398|NCT00716144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101744399|NCT00716144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101744400|NCT00716144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744401|NCT00752115|Paclitaxel|paclitaxel|mesh-list
101744402|NCT00752115|Carboplatin|carboplatin|mesh-list
101744403|NCT00752115|Sildenafil Citrate|sildenafil citrate|mesh-list
101744404|NCT00752115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101744405|NCT00752115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101744406|NCT00752115|Tubulin Modulators|tubulin modulators|mesh-ancestor
101744407|NCT00752115|Antimitotic Agents|antimitotic agents|mesh-ancestor
101744408|NCT00752115|Mitosis Modulators|mitosis modulators|mesh-ancestor
101744409|NCT00752115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744410|NCT00752115|Vasodilator Agents|vasodilator agents|mesh-ancestor
101744411|NCT00752115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101744412|NCT00752115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101744413|NCT00752115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101744414|NCT00752115|Urological Agents|urological agents|mesh-ancestor
101744432|NCT00749385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744433|NCT00749385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101561056|NCT01260584|Purinergic Agents|purinergic agents|mesh-ancestor
101561057|NCT01260584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101561058|NCT01260584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561059|NCT01260584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561060|NCT00607945|Rosiglitazone|rosiglitazone|mesh-list
101561061|NCT00607945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101561062|NCT00607945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744434|NCT00749385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101744435|NCT00749385|Gout Suppressants|gout suppressants|mesh-ancestor
101744436|NCT00749385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101744437|NCT00748059|Propranolol|propranolol|mesh-list
101744438|NCT00748059|Atropine|atropine|mesh-list
101744439|NCT00748059|Clonidine|clonidine|mesh-list
101744440|NCT00748059|Nitroprusside|nitroprusside|mesh-list
101744441|NCT00748059|Methyldopa|methyldopa|mesh-list
101744442|NCT00748059|Phenylephrine|phenylephrine|mesh-list
101744443|NCT00748059|Isoproterenol|isoproterenol|mesh-list
101744444|NCT00748059|Metoclopramide|metoclopramide|mesh-list
101744445|NCT00748059|Yohimbine|yohimbine|mesh-list
101744446|NCT00748059|Tyramine|tyramine|mesh-list
101744447|NCT00748059|Edrophonium|edrophonium|mesh-list
101744448|NCT00748059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101744449|NCT00748059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101744450|NCT00748059|Adrenergic Agents|adrenergic agents|mesh-ancestor
101744451|NCT00748059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101744452|NCT00748059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744453|NCT00748059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744454|NCT00748059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101744455|NCT00748059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101744456|NCT00748059|Vasodilator Agents|vasodilator agents|mesh-ancestor
101478072|NCT00310128|Antiemetics|antiemetics|mesh-ancestor
101744457|NCT00748059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101744458|NCT00748059|Mydriatics|mydriatics|mesh-ancestor
101744459|NCT00748059|Autonomic Agents|autonomic agents|mesh-ancestor
101744460|NCT00748059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101744461|NCT00748059|Sympathomimetics|sympathomimetics|mesh-ancestor
101744462|NCT00748059|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101744463|NCT00748059|Nasal Decongestants|nasal decongestants|mesh-ancestor
101744464|NCT00748059|Respiratory System Agents|respiratory system agents|mesh-ancestor
101744465|NCT00748059|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101744466|NCT00748059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101744467|NCT00748059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101744468|NCT00748059|Protective Agents|protective agents|mesh-ancestor
101744469|NCT00748059|Analgesics|analgesics|mesh-ancestor
101744470|NCT00748059|Sensory System Agents|sensory system agents|mesh-ancestor
101744471|NCT00748059|Sympatholytics|sympatholytics|mesh-ancestor
101744472|NCT00748059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101495931|NCT02956655|Insulin|insulin|mesh-list
101744475|NCT00748059|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101744476|NCT00748059|Parasympatholytics|parasympatholytics|mesh-ancestor
101744477|NCT00748059|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101744478|NCT00748059|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101744479|NCT00748059|Cholinergic Agents|cholinergic agents|mesh-ancestor
101744481|NCT00748059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101744482|NCT00748059|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101744483|NCT00748059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101744484|NCT00748059|Dopamine Agents|dopamine agents|mesh-ancestor
101744485|NCT00748059|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101744486|NCT00748059|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101744487|NCT00748059|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101744488|NCT00748059|Urological Agents|urological agents|mesh-ancestor
101744489|NCT00748059|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101744490|NCT00748059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101744491|NCT00748059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101744492|NCT00748059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101744493|NCT00748059|Antidotes|antidotes|mesh-ancestor
101744494|NCT00748059|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101744495|NCT00748059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101744496|NCT00576381|Dexmedetomidine|dexmedetomidine|mesh-list
101744497|NCT00576381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101744498|NCT00576381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101561063|NCT04262635|Capecitabine|capecitabine|mesh-list
101561064|NCT04262635|Cetuximab|cetuximab|mesh-list
101561065|NCT04262635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101561066|NCT04262635|Antimetabolites|antimetabolites|mesh-ancestor
101561067|NCT04262635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561068|NCT04262635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561069|NCT04262635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101561070|NCT00608101|Dexamethasone|dexamethasone|mesh-list
101561071|NCT00608101|Fludrocortisone|fludrocortisone|mesh-list
101561072|NCT00608101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101561073|NCT00608101|Antiemetics|antiemetics|mesh-ancestor
101561074|NCT00608101|Autonomic Agents|autonomic agents|mesh-ancestor
101561075|NCT00608101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101561076|NCT00608101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561077|NCT00608101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101561078|NCT00608101|Glucocorticoids|glucocorticoids|mesh-ancestor
101561079|NCT00608101|Hormones|hormones|mesh-ancestor
101561080|NCT00608101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101561081|NCT00608101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101561082|NCT00608101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561083|NCT04264039|Fludarabine|fludarabine|mesh-list
101561084|NCT04264039|Cyclophosphamide|cyclophosphamide|mesh-list
101561085|NCT04264039|Melphalan|melphalan|mesh-list
101561086|NCT04264039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101744499|NCT00576381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744500|NCT00576381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101744501|NCT00576381|Analgesics|analgesics|mesh-ancestor
101744502|NCT00576381|Sensory System Agents|sensory system agents|mesh-ancestor
101744503|NCT00576381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101744504|NCT00576381|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101744505|NCT00576381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101744506|NCT00576381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101744507|NCT00576381|Adrenergic Agents|adrenergic agents|mesh-ancestor
101744508|NCT00576381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101744509|NCT00576381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744510|NCT02562417|Dexamethasone|dexamethasone|mesh-list
101744511|NCT02562417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101744512|NCT02562417|Antiemetics|antiemetics|mesh-ancestor
101744513|NCT02562417|Autonomic Agents|autonomic agents|mesh-ancestor
101744514|NCT02562417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101744515|NCT02562417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744516|NCT02562417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101744517|NCT02562417|Glucocorticoids|glucocorticoids|mesh-ancestor
101744518|NCT02562417|Hormones|hormones|mesh-ancestor
101744519|NCT02562417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101744520|NCT02562417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101744521|NCT02562417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101744522|NCT00749619|Taurolidine|taurolidine|mesh-list
101744523|NCT00749619|Heparin|heparin|mesh-list
101744524|NCT00749619|Calcium heparin|calcium heparin|mesh-list
101744525|NCT00749619|Citric Acid|citric acid|mesh-list
101744526|NCT00749619|Sodium Citrate|sodium citrate|mesh-list
101744527|NCT00749619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101561087|NCT04264039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561088|NCT04264039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101561089|NCT04264039|Immunologic Factors|immunologic factors|mesh-ancestor
101561090|NCT04264039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561091|NCT04264039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101561092|NCT04264039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101561093|NCT04264039|Alkylating Agents|alkylating agents|mesh-ancestor
101561094|NCT04264039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101561095|NCT00608179|Glimepiride|glimepiride|mesh-list
101561096|NCT00608179|Glyburide|glyburide|mesh-list
101561097|NCT00608179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101561098|NCT00608179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101561099|NCT00608179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561100|NCT00608179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101561101|NCT00608179|Immunologic Factors|immunologic factors|mesh-ancestor
101561102|NCT00608335|Micafungin|micafungin|mesh-list
101561103|NCT00608335|Antifungal Agents|antifungal agents|mesh-ancestor
101744528|NCT00749619|Anticoagulants|anticoagulants|mesh-ancestor
101744529|NCT00749619|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101744530|NCT00749619|Chelating Agents|chelating agents|mesh-ancestor
101744531|NCT00749619|Sequestering Agents|sequestering agents|mesh-ancestor
101744532|NCT00749619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744533|NCT00749619|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101744534|NCT00749619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101744535|NCT00749619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101744536|NCT00749619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101744537|NCT00749619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101744538|NCT00748371|Aspirin|aspirin|mesh-list
101744539|NCT00748371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101744540|NCT00748371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101744541|NCT00748371|Analgesics|analgesics|mesh-ancestor
101744542|NCT00748371|Sensory System Agents|sensory system agents|mesh-ancestor
101744543|NCT00748371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101744544|NCT00748371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495980|NCT00455234|Antipruritics|antipruritics|mesh-ancestor
101744554|NCT00749853|Buserelin|buserelin|mesh-list
101744555|NCT00749853|Hormones|hormones|mesh-list
101744556|NCT00749853|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101744557|NCT00749853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101744558|NCT00749853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744559|NCT00749853|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101744560|NCT00749853|Fertility Agents|fertility agents|mesh-ancestor
101744561|NCT00749853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101744562|NCT00684567|Temozolomide|temozolomide|mesh-list
101744563|NCT00684567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101744564|NCT00684567|Alkylating Agents|alkylating agents|mesh-ancestor
101744565|NCT00684567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744566|NCT00684567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101744567|NCT00752427|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101744568|NCT00752427|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101744569|NCT00752427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101744570|NCT00752427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101744571|NCT00752427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744572|NCT00752427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101744573|NCT00752427|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101744574|NCT00752427|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101744575|NCT00752427|Serotonin Agents|serotonin agents|mesh-ancestor
101561104|NCT00608335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101561106|NCT00927589|Docetaxel|docetaxel|mesh-list
101561107|NCT00927589|Trastuzumab|trastuzumab|mesh-list
101561108|NCT00927589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561109|NCT00927589|Tubulin Modulators|tubulin modulators|mesh-ancestor
101561110|NCT00927589|Antimitotic Agents|antimitotic agents|mesh-ancestor
101561111|NCT00927589|Mitosis Modulators|mitosis modulators|mesh-ancestor
101561112|NCT00927589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744576|NCT00752427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101744577|NCT00752427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744578|NCT00752427|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101744579|NCT00752427|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101744580|NCT00752427|Dopamine Agents|dopamine agents|mesh-ancestor
101744581|NCT04053621|Thiamine|thiamine|mesh-list
101744582|NCT04053621|Thiamine Pyrophosphate|thiamine pyrophosphate|mesh-list
101744583|NCT04053621|Metformin|metformin|mesh-list
101744584|NCT04053621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101744585|NCT04053621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744586|NCT04053621|Vitamin B Complex|vitamin b complex|mesh-ancestor
101744587|NCT04053621|Vitamins|vitamins|mesh-ancestor
101744588|NCT04053621|Micronutrients|micronutrients|mesh-ancestor
101744589|NCT00684411|Imatinib Mesylate|imatinib mesylate|mesh-list
101744590|NCT00684411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101744591|NCT00684411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101744592|NCT00684411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101744593|NCT00684411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744594|NCT02562651|Doxycycline|doxycycline|mesh-list
101744595|NCT02562651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101744596|NCT02562651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101744597|NCT02562651|Antimalarials|antimalarials|mesh-ancestor
101744598|NCT02562651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101744599|NCT02562651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101744600|NCT00748527|Carboplatin|carboplatin|mesh-list
101744601|NCT00748527|Decitabine|decitabine|mesh-list
101744602|NCT00748527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101744603|NCT00748527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101744604|NCT00748527|Antimetabolites|antimetabolites|mesh-ancestor
101478665|NCT00318318|Hormones|hormones|mesh-ancestor
101744605|NCT00748527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744606|NCT00748527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101744607|NCT00686829|Maleic acid|maleic acid|mesh-list
101744608|NCT00686829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101744609|NCT00686829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744610|NCT00687297|Carboplatin|carboplatin|mesh-list
101744624|NCT00752661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744625|NCT00752661|Analgesics|analgesics|mesh-ancestor
101744626|NCT00752661|Sensory System Agents|sensory system agents|mesh-ancestor
101744627|NCT00752661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101744628|NCT00576303|Epoetin Alfa|epoetin alfa|mesh-list
101744629|NCT00576303|Hematinics|hematinics|mesh-ancestor
101744631|NCT00752739|Antioxidants|antioxidants|mesh-ancestor
101744632|NCT00752739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744633|NCT00752739|Protective Agents|protective agents|mesh-ancestor
101744634|NCT00752739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744635|NCT00752739|Trace Elements|trace elements|mesh-ancestor
101744636|NCT00752739|Micronutrients|micronutrients|mesh-ancestor
101744637|NCT00755781|Cyclosporine|cyclosporine|mesh-list
101744638|NCT00755781|Cyclosporins|cyclosporins|mesh-list
101744639|NCT00755781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101744640|NCT00755781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744641|NCT00755781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101744642|NCT00755781|Immunologic Factors|immunologic factors|mesh-ancestor
101744643|NCT00755781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744644|NCT00755781|Antifungal Agents|antifungal agents|mesh-ancestor
101744645|NCT00755781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101744646|NCT00755781|Dermatologic Agents|dermatologic agents|mesh-ancestor
101744647|NCT00755781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101744648|NCT00755781|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101744649|NCT00755859|Prednisone|prednisone|mesh-list
101561113|NCT00927589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101561114|NCT05938725|Cyclophosphamide|cyclophosphamide|mesh-list
101561115|NCT05938725|Fludarabine|fludarabine|mesh-list
101561116|NCT05938725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101561117|NCT05938725|Immunologic Factors|immunologic factors|mesh-ancestor
101744650|NCT00755859|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101744651|NCT00755859|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101744652|NCT00755859|Methylprednisolone|methylprednisolone|mesh-list
101744653|NCT00755859|Prednisolone|prednisolone|mesh-list
101744654|NCT00755859|Prednisolone acetate|prednisolone acetate|mesh-list
101744655|NCT00755859|Azathioprine|azathioprine|mesh-list
101744656|NCT00755859|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101744657|NCT00755859|Prednisolone phosphate|prednisolone phosphate|mesh-list
101744658|NCT00755859|Antimetabolites|antimetabolites|mesh-ancestor
101744659|NCT00755859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744660|NCT00755859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101744661|NCT00755859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101744662|NCT00755859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101744663|NCT00755859|Immunologic Factors|immunologic factors|mesh-ancestor
101744664|NCT00755859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744665|NCT00755859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101744666|NCT00755859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101744668|NCT00755859|Hormones|hormones|mesh-ancestor
101744669|NCT00755859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101744670|NCT00755859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101744671|NCT00755859|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101744672|NCT00755859|Protective Agents|protective agents|mesh-ancestor
101744673|NCT00755859|Antiemetics|antiemetics|mesh-ancestor
101744674|NCT00755859|Autonomic Agents|autonomic agents|mesh-ancestor
101744675|NCT00755859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101744693|NCT00571701|Sensory System Agents|sensory system agents|mesh-ancestor
101744694|NCT00571701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101744695|NCT00571701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744696|NCT00571701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101744697|NCT00571701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101744698|NCT00571701|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101744699|NCT00571701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101744700|NCT00571701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101744701|NCT00571701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744702|NCT00686127|Lidocaine|lidocaine|mesh-list
101744703|NCT00686127|Anesthetics, Local|anesthetics, local|mesh-ancestor
101744704|NCT00686127|Anesthetics|anesthetics|mesh-ancestor
101744705|NCT00686127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101744706|NCT00686127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744707|NCT00686127|Sensory System Agents|sensory system agents|mesh-ancestor
101744708|NCT00686127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101744709|NCT00686127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101744710|NCT00686127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101744711|NCT00686127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101744712|NCT00686127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101744713|NCT00686127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744714|NCT00718718|Methotrexate|methotrexate|mesh-list
101744715|NCT00718718|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101744716|NCT00718718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101744717|NCT00718718|Abortifacient Agents|abortifacient agents|mesh-ancestor
101744718|NCT00718718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101744719|NCT00718718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744720|NCT00718718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101744721|NCT00718718|Antimetabolites|antimetabolites|mesh-ancestor
101744722|NCT00718718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744723|NCT00718718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101744724|NCT00718718|Dermatologic Agents|dermatologic agents|mesh-ancestor
101744725|NCT00718718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101744726|NCT00718718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101744727|NCT00718718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101744728|NCT00718718|Immunologic Factors|immunologic factors|mesh-ancestor
101744729|NCT00718718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101478969|NCT00319215|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101744730|NCT00718718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101744731|NCT00683787|Docetaxel|docetaxel|mesh-list
101561118|NCT05938725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561119|NCT05938725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101561120|NCT05938725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101561121|NCT05938725|Alkylating Agents|alkylating agents|mesh-ancestor
101561122|NCT05938725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561123|NCT05938725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561124|NCT05938725|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101561125|NCT05938712|Dapagliflozin|dapagliflozin|mesh-list
101561126|NCT05938712|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101561127|NCT05938712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561128|NCT05938712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101744732|NCT00683787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101744733|NCT00683787|Tubulin Modulators|tubulin modulators|mesh-ancestor
101744738|NCT02560935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101744739|NCT02560935|Antisickling Agents|antisickling agents|mesh-ancestor
101744740|NCT02560935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101479058|NCT00319488|Hormone Antagonists|hormone antagonists|mesh-ancestor
101744741|NCT02560935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744742|NCT02560935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101744744|NCT00750399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101744745|NCT00750399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101744746|NCT00750399|Growth Substances|growth substances|mesh-ancestor
101744747|NCT00750399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744748|NCT00750399|Growth Inhibitors|growth inhibitors|mesh-ancestor
101744749|NCT00750399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101744750|NCT00756171|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
101744751|NCT00756171|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101744752|NCT00756171|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101744753|NCT00756171|Antimetabolites|antimetabolites|mesh-ancestor
101744754|NCT00756171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744755|NCT00756171|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101744756|NCT00718640|Dexamethasone|dexamethasone|mesh-list
101744757|NCT00718640|Bortezomib|bortezomib|mesh-list
101744758|NCT00718640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101744759|NCT00718640|Antiemetics|antiemetics|mesh-ancestor
101744760|NCT00718640|Autonomic Agents|autonomic agents|mesh-ancestor
101744761|NCT00718640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101744762|NCT00718640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744763|NCT00718640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101744764|NCT00718640|Glucocorticoids|glucocorticoids|mesh-ancestor
101744765|NCT00718640|Hormones|hormones|mesh-ancestor
101744766|NCT00718640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101744767|NCT00718640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101744768|NCT00718640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101744769|NCT00753051|Haloperidol|haloperidol|mesh-list
101744770|NCT00753051|Haloperidol decanoate|haloperidol decanoate|mesh-list
101744771|NCT00753051|Clozapine|clozapine|mesh-list
101744772|NCT00753051|Antiemetics|antiemetics|mesh-ancestor
101744773|NCT00753051|Autonomic Agents|autonomic agents|mesh-ancestor
101744774|NCT00753051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101744775|NCT00753051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744776|NCT00753051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101744777|NCT00753051|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101744778|NCT00753051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101744779|NCT00753051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101744780|NCT00753051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101744781|NCT00753051|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101744782|NCT00753051|Dopamine Agents|dopamine agents|mesh-ancestor
101744783|NCT00753051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101744784|NCT00753051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744785|NCT00753051|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101744786|NCT00753051|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101744787|NCT00753051|Serotonin Agents|serotonin agents|mesh-ancestor
101561129|NCT05938712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561130|NCT05938374|Fluzoparib|fluzoparib|mesh-list
101561131|NCT05938374|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101561132|NCT05938374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101561133|NCT05938374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561134|NCT05938374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561135|NCT05938140|Ritonavir|ritonavir|mesh-list
101561136|NCT05938140|Nirmatrelvir|nirmatrelvir|mesh-list
101561137|NCT05938140|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
101561138|NCT05938140|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101561139|NCT05938140|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101561140|NCT05938140|Protease Inhibitors|protease inhibitors|mesh-ancestor
101561141|NCT05938140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101561142|NCT05938140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561143|NCT05938140|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101561144|NCT05938140|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101561145|NCT05938140|Antiviral Agents|antiviral agents|mesh-ancestor
101561146|NCT05938140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101479401|NCT00313599|Lapatinib|lapatinib|mesh-list
101561147|NCT05938140|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101561148|NCT05938140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101561149|NCT05937880|Leflunomide|leflunomide|mesh-list
101561150|NCT05937880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101561151|NCT05937880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561152|NCT05937880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101561153|NCT05937880|Immunologic Factors|immunologic factors|mesh-ancestor
101561154|NCT05937880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561155|NCT05937841|Compound 21|compound 21|mesh-list
101561156|NCT05937841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101561157|NCT05937789|Vitamin D|vitamin d|mesh-list
101561158|NCT05937789|Vitamins|vitamins|mesh-ancestor
101561159|NCT05937789|Micronutrients|micronutrients|mesh-ancestor
101561160|NCT05937789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744788|NCT00753051|GABA Antagonists|gaba antagonists|mesh-ancestor
101744789|NCT00753051|GABA Agents|gaba agents|mesh-ancestor
101744790|NCT00753207|Epirubicin|epirubicin|mesh-list
101744791|NCT00753207|Lapatinib|lapatinib|mesh-list
101744792|NCT00753207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101744793|NCT00753207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101744794|NCT00753207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101744795|NCT00753207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101744796|NCT00753207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101744797|NCT00753207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561161|NCT05937789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101561162|NCT05937711|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101561163|NCT05937711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101561164|NCT05937711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101561165|NCT05937711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101561166|NCT05937711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409581|NCT00349531|Dopamine Agents|dopamine agents|mesh-ancestor
101744798|NCT00753207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101744799|NCT00715910|Vaccines|vaccines|mesh-list
101744800|NCT00715910|Immunologic Factors|immunologic factors|mesh-ancestor
101744801|NCT00715910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744802|NCT00715676|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
101744803|NCT00715676|Vitamins|vitamins|mesh-ancestor
101744804|NCT00715676|Micronutrients|micronutrients|mesh-ancestor
101744805|NCT00715676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496239|NCT00457067|Ranibizumab|ranibizumab|mesh-list
101744808|NCT00718328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101744810|NCT00718328|Antimetabolites|antimetabolites|mesh-ancestor
101744811|NCT00718328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744812|NCT00718328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101744813|NCT00718328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101744814|NCT00718328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101744815|NCT02590874|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101744816|NCT02590874|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101744817|NCT02590874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101744818|NCT02590874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101744819|NCT02590874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744820|NCT02590874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101744821|NCT02590874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744822|NCT02590874|Analgesics|analgesics|mesh-ancestor
101744823|NCT02590874|Sensory System Agents|sensory system agents|mesh-ancestor
101744824|NCT02590874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101744825|NCT02590874|Antidepressive Agents|antidepressive agents|mesh-ancestor
101479638|NCT00322569|Paclitaxel|paclitaxel|mesh-list
101744826|NCT02590874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101744827|NCT02590874|Dopamine Agents|dopamine agents|mesh-ancestor
101744828|NCT00715520|Levodopa|levodopa|mesh-list
101744829|NCT00715520|Carbidopa|carbidopa|mesh-list
101744830|NCT00715520|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101744831|NCT00715520|Methylphenidate|methylphenidate|mesh-list
101744832|NCT00715520|Amphetamine|amphetamine|mesh-list
101744833|NCT00715520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101744834|NCT00715520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744835|NCT00715520|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101744836|NCT00715520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101744837|NCT00715520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101744838|NCT00715520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744839|NCT00715520|Dopamine Agents|dopamine agents|mesh-ancestor
101744840|NCT00715520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101744841|NCT00715520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101744842|NCT00715520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101744843|NCT00715520|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101744844|NCT00715520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101744845|NCT00715520|Sympathomimetics|sympathomimetics|mesh-ancestor
101744846|NCT00715520|Autonomic Agents|autonomic agents|mesh-ancestor
101744847|NCT00715520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101744848|NCT00715520|Adrenergic Agents|adrenergic agents|mesh-ancestor
101744849|NCT00715520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101744850|NCT00715520|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101744851|NCT00715520|Immunologic Factors|immunologic factors|mesh-ancestor
101744852|NCT00715520|Dopamine Agonists|dopamine agonists|mesh-ancestor
101744853|NCT00756873|Etoricoxib|etoricoxib|mesh-list
101744854|NCT00756873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101744855|NCT00756873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101744856|NCT00756873|Analgesics|analgesics|mesh-ancestor
101561168|NCT05937711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561169|NCT05937711|Analgesics|analgesics|mesh-ancestor
101561170|NCT05937711|Sensory System Agents|sensory system agents|mesh-ancestor
101561171|NCT05937711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101561172|NCT05937711|Antidepressive Agents|antidepressive agents|mesh-ancestor
101561173|NCT05937711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101744857|NCT00756873|Sensory System Agents|sensory system agents|mesh-ancestor
101744858|NCT00756873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101744859|NCT00756873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744860|NCT00756873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101744861|NCT00756873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101744862|NCT00756873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101744863|NCT00756873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101744864|NCT00756873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101744865|NCT00756873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744866|NCT00790205|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101744867|NCT00790205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101744868|NCT00790205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744869|NCT00790205|Incretins|incretins|mesh-ancestor
101744870|NCT00790205|Hormones|hormones|mesh-ancestor
101744871|NCT00790205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101744872|NCT00790205|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101744873|NCT00790205|Protease Inhibitors|protease inhibitors|mesh-ancestor
101744874|NCT00790205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101496306|NCT03278379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101744881|NCT04056039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744882|NCT04056039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101744883|NCT04056039|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101744884|NCT04056039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101744885|NCT04056039|Gout Suppressants|gout suppressants|mesh-ancestor
101744886|NCT04056039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101744887|NCT04056039|Tubulin Modulators|tubulin modulators|mesh-ancestor
101744888|NCT04056039|Antimitotic Agents|antimitotic agents|mesh-ancestor
101744889|NCT04056039|Mitosis Modulators|mitosis modulators|mesh-ancestor
101744890|NCT04056039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101744891|NCT00715208|Prednisone|prednisone|mesh-list
101744892|NCT00715208|Cyclophosphamide|cyclophosphamide|mesh-list
101744893|NCT00715208|Rituximab|rituximab|mesh-list
101744894|NCT00715208|Doxorubicin|doxorubicin|mesh-list
101744895|NCT00715208|Bortezomib|bortezomib|mesh-list
101744896|NCT00715208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101744897|NCT00715208|Immunologic Factors|immunologic factors|mesh-ancestor
101744898|NCT00715208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744899|NCT00715208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101744900|NCT00715208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101744901|NCT00715208|Alkylating Agents|alkylating agents|mesh-ancestor
101744902|NCT00715208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744903|NCT00715208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101744904|NCT00715208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101744905|NCT00715208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101744906|NCT00715208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101744907|NCT00715208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101744908|NCT00715208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101744909|NCT00715208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101744910|NCT00715208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101744911|NCT00715208|Glucocorticoids|glucocorticoids|mesh-ancestor
101744912|NCT00715208|Hormones|hormones|mesh-ancestor
101744913|NCT00715208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101744914|NCT00715208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101744915|NCT00919178|Vaccines|vaccines|mesh-list
101744916|NCT00919178|Immunologic Factors|immunologic factors|mesh-ancestor
101744917|NCT00919178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744918|NCT02590250|Botulinum Toxins|botulinum toxins|mesh-list
101744919|NCT02590250|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101744920|NCT02590250|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101744921|NCT02590250|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101561175|NCT05937568|Imetelstat|imetelstat|mesh-list
101561176|NCT05937568|Motesanib diphosphate|motesanib diphosphate|mesh-list
101561177|NCT05937568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101409593|NCT00349726|Inositol|inositol|mesh-list
101744922|NCT02590250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101744923|NCT02590250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744924|NCT02590250|Cholinergic Agents|cholinergic agents|mesh-ancestor
101744925|NCT02590250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101744926|NCT02590250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744927|NCT02590250|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101744928|NCT02590250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101744929|NCT00775463|Treprostinil|treprostinil|mesh-list
101744930|NCT00775463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101744931|NCT02589782|Moxifloxacin|moxifloxacin|mesh-list
101744932|NCT02589782|Linezolid|linezolid|mesh-list
101744933|NCT02589782|Bedaquiline|bedaquiline|mesh-list
101744934|NCT02589782|Clofazimine|clofazimine|mesh-list
101744935|NCT02589782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101744936|NCT02589782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101744937|NCT02589782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101744938|NCT02589782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101744939|NCT02589782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101744940|NCT02589782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744941|NCT02589782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101744942|NCT02589782|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101744943|NCT02589782|Antitubercular Agents|antitubercular agents|mesh-ancestor
101744944|NCT02589782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101744949|NCT00918554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101744950|NCT00918554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744951|NCT00918554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101744952|NCT00918554|Antimetabolites|antimetabolites|mesh-ancestor
101744953|NCT00918554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744954|NCT00918554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101744955|NCT00918554|Dermatologic Agents|dermatologic agents|mesh-ancestor
101744956|NCT00918554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101744957|NCT00918554|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101744958|NCT00918554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101744959|NCT00918554|Immunologic Factors|immunologic factors|mesh-ancestor
101744960|NCT00918554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101744961|NCT00918554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101744963|NCT02590016|Insulin Aspart|insulin aspart|mesh-list
101744964|NCT02590016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101744965|NCT02590016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744966|NCT00768053|Etanercept|etanercept|mesh-list
101744967|NCT00768053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101744968|NCT00768053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101744969|NCT00768053|Analgesics|analgesics|mesh-ancestor
101744970|NCT00768053|Sensory System Agents|sensory system agents|mesh-ancestor
101744971|NCT00768053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101744972|NCT00768053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744973|NCT00768053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101744974|NCT00768053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101744975|NCT00768053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101744976|NCT00768053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101744977|NCT00768053|Immunologic Factors|immunologic factors|mesh-ancestor
101744978|NCT00683475|Prednisone|prednisone|mesh-list
101744979|NCT00683475|Mitoxantrone|mitoxantrone|mesh-list
101744980|NCT00683475|Ramucirumab|ramucirumab|mesh-list
101744981|NCT00683475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101744982|NCT00683475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101744983|NCT00683475|Glucocorticoids|glucocorticoids|mesh-ancestor
101744984|NCT00683475|Hormones|hormones|mesh-ancestor
101744985|NCT00683475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101744986|NCT00683475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744987|NCT00683475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101744988|NCT00683475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101744989|NCT00683475|Analgesics|analgesics|mesh-ancestor
101744990|NCT00683475|Sensory System Agents|sensory system agents|mesh-ancestor
101744991|NCT00683475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101744992|NCT00683475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101744993|NCT00683475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101561178|NCT05937568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561179|NCT05937568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101561180|NCT05937490|Leuprolide|leuprolide|mesh-list
101561181|NCT05937490|Dienogest|dienogest|mesh-list
101561182|NCT05937490|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101561183|NCT05937490|Fertility Agents|fertility agents|mesh-ancestor
101561184|NCT05937490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101409596|NCT00349726|Micronutrients|micronutrients|mesh-ancestor
101744994|NCT00683475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101480385|NCT00304200|Temozolomide|temozolomide|mesh-list
101744995|NCT00683475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744996|NCT00683475|Immunologic Factors|immunologic factors|mesh-ancestor
101744997|NCT02589158|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101744998|NCT02589158|Darunavir|darunavir|mesh-list
101744999|NCT02589158|Cobicistat|cobicistat|mesh-list
101745000|NCT02589158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101745001|NCT02589158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101745002|NCT02589158|Protease Inhibitors|protease inhibitors|mesh-ancestor
101745003|NCT02589158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101745004|NCT02589158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745005|NCT02589158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101745006|NCT02589158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101745007|NCT02589158|Antiviral Agents|antiviral agents|mesh-ancestor
101745008|NCT02589158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101745009|NCT02589158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101745010|NCT02589158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101745011|NCT00916253|Modafinil|modafinil|mesh-list
101745012|NCT00916253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101745013|NCT00916253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745014|NCT00916253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101745015|NCT00916253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101745020|NCT00757029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101745021|NCT00757029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745022|NCT00757029|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101745023|NCT00757029|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101745024|NCT00757029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101745025|NCT00757029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745026|NCT00757029|Dopamine Agents|dopamine agents|mesh-ancestor
101745027|NCT00757029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101745028|NCT00757029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101745029|NCT00757029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101745030|NCT00757029|Adrenergic Agents|adrenergic agents|mesh-ancestor
101745031|NCT00757029|Sympathomimetics|sympathomimetics|mesh-ancestor
101745032|NCT00757029|Autonomic Agents|autonomic agents|mesh-ancestor
101745033|NCT00757029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101745034|NCT00757029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101745035|NCT04101929|Irinotecan|irinotecan|mesh-list
101745036|NCT04101929|Apatinib|apatinib|mesh-list
101745037|NCT04101929|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101745038|NCT04101929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101745039|NCT04101929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101745040|NCT04101929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745041|NCT04101929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101745042|NCT04101929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101745043|NCT00918632|Axitinib|axitinib|mesh-list
101745044|NCT00918632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101745045|NCT00918632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101745046|NCT00918632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101745047|NCT00918632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745048|NCT00751257|Acetylcysteine|acetylcysteine|mesh-list
101745049|NCT00751257|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101745050|NCT00751257|Antiviral Agents|antiviral agents|mesh-ancestor
101745051|NCT00751257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101745052|NCT00751257|Expectorants|expectorants|mesh-ancestor
101745053|NCT00751257|Respiratory System Agents|respiratory system agents|mesh-ancestor
101745054|NCT00751257|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101745055|NCT00751257|Antioxidants|antioxidants|mesh-ancestor
101561185|NCT05937490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561186|NCT05937490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101561187|NCT05937490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561188|NCT05937490|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101561189|NCT05937490|Contraceptive Agents|contraceptive agents|mesh-ancestor
101561190|NCT05937490|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101561191|NCT05937490|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101561192|NCT05937490|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101561193|NCT05937490|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101561194|NCT05937490|Hormone Antagonists|hormone antagonists|mesh-ancestor
101561195|NCT05937490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101745056|NCT00751257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745057|NCT00751257|Protective Agents|protective agents|mesh-ancestor
101745058|NCT00751257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745059|NCT00751257|Antidotes|antidotes|mesh-ancestor
101745060|NCT00757185|Methyltestosterone|methyltestosterone|mesh-list
101745061|NCT00757185|Testosterone|testosterone|mesh-list
101745062|NCT00757185|Testosterone undecanoate|testosterone undecanoate|mesh-list
101745063|NCT00757185|Testosterone enanthate|testosterone enanthate|mesh-list
101745064|NCT00757185|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101745065|NCT00757185|Ganirelix|ganirelix|mesh-list
101745066|NCT00757185|Androgens|androgens|mesh-ancestor
101745067|NCT00757185|Hormones|hormones|mesh-ancestor
101745068|NCT00757185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101745069|NCT00757185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745070|NCT00757185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101480671|NCT00293228|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101745071|NCT00757185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101745072|NCT00757185|Anabolic Agents|anabolic agents|mesh-ancestor
101745073|NCT00757185|Hormone Antagonists|hormone antagonists|mesh-ancestor
101745074|NCT00751491|Clopidogrel|clopidogrel|mesh-list
101745075|NCT00751491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101745076|NCT00751491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101745077|NCT00751491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101745078|NCT00751491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101745079|NCT00751491|Purinergic Agents|purinergic agents|mesh-ancestor
101745080|NCT00751491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101362016|NCT00127075|Estradiol|estradiol|mesh-list
101745081|NCT00751491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745082|NCT00751491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745083|NCT02561169|Oseltamivir|oseltamivir|mesh-list
101745084|NCT02561169|Calcium Carbonate|calcium carbonate|mesh-list
101745085|NCT02561169|Antiviral Agents|antiviral agents|mesh-ancestor
101745091|NCT00753597|Rituximab|rituximab|mesh-list
101745092|NCT00753597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101745093|NCT00753597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101745094|NCT00753597|Immunologic Factors|immunologic factors|mesh-ancestor
101745095|NCT00753597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745096|NCT00753597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101745097|NCT00757419|Lesogaberan|lesogaberan|mesh-list
101745098|NCT00757419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101745099|NCT00757419|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101745100|NCT00757419|GABA Agonists|gaba agonists|mesh-ancestor
101745101|NCT00757419|GABA Agents|gaba agents|mesh-ancestor
101745102|NCT00757419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101745103|NCT00757419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745104|NCT00757419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745105|NCT00757731|Milnacipran|milnacipran|mesh-list
101745106|NCT00757731|Levomilnacipran|levomilnacipran|mesh-list
101745107|NCT00757731|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101745108|NCT00757731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101745109|NCT00757731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101745110|NCT00757731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561196|NCT05937438|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101480896|NCT00305370|Serotonin Agents|serotonin agents|mesh-ancestor
101561197|NCT05937438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561198|NCT05937438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101561199|NCT05937438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561200|NCT05937191|Leflunomide|leflunomide|mesh-list
101561201|NCT05937191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101561202|NCT05937191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561203|NCT05937191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101745111|NCT00757731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101745112|NCT00757731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745113|NCT00757731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101745115|NCT00757731|Sensory System Agents|sensory system agents|mesh-ancestor
101745116|NCT00757731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101745117|NCT00757731|Antidepressive Agents|antidepressive agents|mesh-ancestor
101745118|NCT00757731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101745119|NCT00753909|Paclitaxel|paclitaxel|mesh-list
101745120|NCT00753909|Bevacizumab|bevacizumab|mesh-list
101745121|NCT00753909|Carboplatin|carboplatin|mesh-list
101745122|NCT00753909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101745123|NCT00753909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101745124|NCT00753909|Tubulin Modulators|tubulin modulators|mesh-ancestor
101745125|NCT00753909|Antimitotic Agents|antimitotic agents|mesh-ancestor
101745126|NCT00753909|Mitosis Modulators|mitosis modulators|mesh-ancestor
101481032|NCT00419601|Analgesics|analgesics|mesh-ancestor
101745127|NCT00753909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745133|NCT00753909|Growth Inhibitors|growth inhibitors|mesh-ancestor
101745135|NCT02560155|Mupirocin|mupirocin|mesh-list
101745136|NCT02560155|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101745137|NCT02560155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101745138|NCT02560155|Disinfectants|disinfectants|mesh-ancestor
101745139|NCT02560155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101745140|NCT02560155|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101745141|NCT02560155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101745142|NCT02560155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745143|NCT02559921|Vaccines|vaccines|mesh-list
101745144|NCT02559921|Immunologic Factors|immunologic factors|mesh-ancestor
101745145|NCT02559921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745146|NCT00754143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101745147|NCT00754143|Immunologic Factors|immunologic factors|mesh-ancestor
101745148|NCT00754143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745149|NCT05266040|Valacyclovir|valacyclovir|mesh-list
101745150|NCT05266040|Antiviral Agents|antiviral agents|mesh-ancestor
101745151|NCT05266040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101745152|NCT00773747|Bortezomib|bortezomib|mesh-list
101745153|NCT00773747|Vorinostat|vorinostat|mesh-list
101745154|NCT00773747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101745155|NCT00773747|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101745156|NCT00773747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101828143|NCT05926570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745157|NCT00773747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745158|NCT00784277|Oxycodone|oxycodone|mesh-list
101745159|NCT00784277|Tapentadol|tapentadol|mesh-list
101745160|NCT00784277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101745161|NCT00784277|Narcotics|narcotics|mesh-ancestor
101745162|NCT00784277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101496587|NCT00488709|Antiviral Agents|antiviral agents|mesh-ancestor
101745180|NCT02588534|Sensory System Agents|sensory system agents|mesh-ancestor
101745181|NCT02588534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101745182|NCT02588534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745183|NCT02588534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101745184|NCT02588534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101745185|NCT02588534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101745186|NCT02588534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101745187|NCT02588534|Immunologic Factors|immunologic factors|mesh-ancestor
101745194|NCT00682929|Dronabinol|dronabinol|mesh-list
101745195|NCT00682929|Hallucinogens|hallucinogens|mesh-ancestor
101745196|NCT00682929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745197|NCT00682929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101745198|NCT00682929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101561205|NCT05937191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561206|NCT05937126|Anti-Infective Agents|anti-infective agents|mesh-list
101561207|NCT05937126|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101561208|NCT05937100|Hyaluronic Acid|hyaluronic acid|mesh-list
101561209|NCT05937100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101481202|NCT00296387|Atorvastatin|atorvastatin|mesh-list
101561210|NCT05937100|Immunologic Factors|immunologic factors|mesh-ancestor
101561211|NCT05937100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409625|NCT00350116|Vitamin B 12|vitamin b 12|mesh-list
101409626|NCT00350116|Hydroxocobalamin|hydroxocobalamin|mesh-list
101745199|NCT00682929|Analgesics|analgesics|mesh-ancestor
101745200|NCT00682929|Sensory System Agents|sensory system agents|mesh-ancestor
101481278|NCT00296894|Adalimumab|adalimumab|mesh-list
101745201|NCT00682929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101745202|NCT00682929|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101745203|NCT00682929|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101745205|NCT00682929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745206|NCT00682929|Hormones|hormones|mesh-ancestor
101745207|NCT00682929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101745208|NCT00758199|Moxifloxacin|moxifloxacin|mesh-list
101745209|NCT00758199|Prednisolone|prednisolone|mesh-list
101745210|NCT00758199|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101745211|NCT00758199|Methylprednisolone|methylprednisolone|mesh-list
101745212|NCT00758199|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101745213|NCT00758199|Prednisolone acetate|prednisolone acetate|mesh-list
101745214|NCT00758199|Bromfenac|bromfenac|mesh-list
101745215|NCT00758199|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101745216|NCT00758199|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101745217|NCT00758199|Prednisolone phosphate|prednisolone phosphate|mesh-list
101745218|NCT00758199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101745219|NCT00758199|Glucocorticoids|glucocorticoids|mesh-ancestor
101745220|NCT00758199|Hormones|hormones|mesh-ancestor
101745221|NCT00758199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101745222|NCT00758199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745223|NCT00758199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101745224|NCT00758199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101745225|NCT00758199|Antiemetics|antiemetics|mesh-ancestor
101745226|NCT00758199|Autonomic Agents|autonomic agents|mesh-ancestor
101745234|NCT00758199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101745235|NCT00758199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101745236|NCT00758199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745237|NCT00758199|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101745238|NCT00758199|Contraceptive Agents|contraceptive agents|mesh-ancestor
101745239|NCT00758199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101745240|NCT00758199|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101481561|NCT00298922|Azithromycin|azithromycin|mesh-list
101745241|NCT00758199|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101745242|NCT00758199|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101745243|NCT00758199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101745244|NCT00758199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101745245|NCT00758199|Analgesics|analgesics|mesh-ancestor
101745246|NCT00758199|Sensory System Agents|sensory system agents|mesh-ancestor
101745247|NCT00758199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101745248|NCT05683808|Apixaban|apixaban|mesh-list
101745249|NCT05683808|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101745250|NCT05683808|Antithrombins|antithrombins|mesh-ancestor
101745251|NCT05683808|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101481693|NCT00300404|Leucovorin|leucovorin|mesh-list
101745252|NCT05683808|Protease Inhibitors|protease inhibitors|mesh-ancestor
101745253|NCT05683808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101745254|NCT05683808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745255|NCT05683808|Anticoagulants|anticoagulants|mesh-ancestor
101745256|NCT00680745|Metformin|metformin|mesh-list
101745257|NCT00680745|Pioglitazone|pioglitazone|mesh-list
101745258|NCT00680745|Dapagliflozin|dapagliflozin|mesh-list
101745259|NCT00680745|Glimepiride|glimepiride|mesh-list
101745260|NCT00680745|Rosiglitazone|rosiglitazone|mesh-list
101745261|NCT00680745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101745262|NCT00680745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561212|NCT05937100|Viscosupplements|viscosupplements|mesh-ancestor
101561213|NCT05937100|Protective Agents|protective agents|mesh-ancestor
101561214|NCT05936853|Anesthetics|anesthetics|mesh-list
101561215|NCT05936853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101561216|NCT05936853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561217|NCT05936710|Dialysis Solutions|dialysis solutions|mesh-list
101362180|NCT00402766|Cisplatin|cisplatin|mesh-list
101561218|NCT05936710|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101409635|NCT00350155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101745263|NCT00680745|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101745264|NCT00680745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745265|NCT00680745|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101745266|NCT00680745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101745267|NCT00680745|Immunologic Factors|immunologic factors|mesh-ancestor
101745269|NCT05434377|Ergocalciferols|ergocalciferols|mesh-list
101745270|NCT05434377|Vitamins|vitamins|mesh-ancestor
101362471|NCT00074841|Analgesics|analgesics|mesh-ancestor
101745271|NCT05434377|Micronutrients|micronutrients|mesh-ancestor
101745272|NCT05434377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745273|NCT05434377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101745274|NCT05434377|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101745275|NCT05428293|Acetaminophen|acetaminophen|mesh-list
101745276|NCT05428293|Ibuprofen|ibuprofen|mesh-list
101745277|NCT05428293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101745278|NCT05428293|Analgesics|analgesics|mesh-ancestor
101745279|NCT05428293|Sensory System Agents|sensory system agents|mesh-ancestor
101745280|NCT05428293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101745281|NCT05428293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745282|NCT05428293|Antipyretics|antipyretics|mesh-ancestor
101745283|NCT05428293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101745284|NCT05428293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101745285|NCT05428293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101745286|NCT05428293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101745287|NCT05428293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101745288|NCT05428293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745289|NCT05427825|Anesthetics|anesthetics|mesh-list
101745290|NCT05427825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101745291|NCT05427825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745292|NCT00680121|Benphothiamine|benphothiamine|mesh-list
101745293|NCT00680121|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101745294|NCT00680121|Immunologic Factors|immunologic factors|mesh-ancestor
101745309|NCT00754689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101745311|NCT00767819|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101745312|NCT00767819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101745313|NCT00767819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101745314|NCT00767819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745315|NCT00767819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101745316|NCT00767819|Immunologic Factors|immunologic factors|mesh-ancestor
101745317|NCT00767819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745318|NCT00767819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101745319|NCT00758277|Levetiracetam|levetiracetam|mesh-list
101745320|NCT00758277|Anticonvulsants|anticonvulsants|mesh-ancestor
101745321|NCT00758277|Nootropic Agents|nootropic agents|mesh-ancestor
101745322|NCT00584870|Naproxen|naproxen|mesh-list
101745323|NCT00584870|Tanezumab|tanezumab|mesh-list
101745324|NCT00584870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101745325|NCT00584870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101745326|NCT00584870|Analgesics|analgesics|mesh-ancestor
101745327|NCT00584870|Sensory System Agents|sensory system agents|mesh-ancestor
101745328|NCT00584870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101745329|NCT00584870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745330|NCT00584870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101745331|NCT00584870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101745332|NCT00584870|Gout Suppressants|gout suppressants|mesh-ancestor
101745333|NCT00584870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101745334|NCT00584870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101409641|NCT00350155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101745335|NCT00584870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745337|NCT00679341|Trastuzumab|trastuzumab|mesh-list
101745338|NCT00679341|Maytansine|maytansine|mesh-list
101745339|NCT00679341|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101745340|NCT00679341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101745341|NCT00679341|Tubulin Modulators|tubulin modulators|mesh-ancestor
101745342|NCT00679341|Antimitotic Agents|antimitotic agents|mesh-ancestor
101745343|NCT00679341|Mitosis Modulators|mitosis modulators|mesh-ancestor
101745344|NCT00679341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363652|NCT00133744|Micronutrients|micronutrients|mesh-ancestor
101745345|NCT00679341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101745346|NCT00679341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101745347|NCT00679341|Immunotoxins|immunotoxins|mesh-ancestor
101745348|NCT00679341|Immunoconjugates|immunoconjugates|mesh-ancestor
101745349|NCT00679341|Immunologic Factors|immunologic factors|mesh-ancestor
101745350|NCT00679341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745351|NCT00680043|Epoetin Alfa|epoetin alfa|mesh-list
101745352|NCT00680043|Hematinics|hematinics|mesh-ancestor
101205593|NCT01426906|Rifampin|rifampin|mesh-list
101745353|NCT05436093|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101745354|NCT05436093|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101745355|NCT05436093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745367|NCT00682539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101745368|NCT00682539|Glucocorticoids|glucocorticoids|mesh-ancestor
101745369|NCT00682539|Hormones|hormones|mesh-ancestor
101745370|NCT00682539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101745371|NCT00682461|Nicotine|nicotine|mesh-list
101745372|NCT00682461|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101745373|NCT00682461|Autonomic Agents|autonomic agents|mesh-ancestor
101745374|NCT00682461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101745375|NCT00682461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745376|NCT00682461|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101745377|NCT00682461|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101745378|NCT00682461|Cholinergic Agents|cholinergic agents|mesh-ancestor
101745379|NCT00682461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101745380|NCT00682461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745381|NCT00921765|Ketamine|ketamine|mesh-list
101745382|NCT00921765|Naloxone|naloxone|mesh-list
101745383|NCT00921765|Analgesics|analgesics|mesh-ancestor
101745384|NCT00921765|Sensory System Agents|sensory system agents|mesh-ancestor
101745385|NCT00921765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101745386|NCT00921765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745387|NCT00921765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101745388|NCT00921765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101745389|NCT00921765|Anesthetics, General|anesthetics, general|mesh-ancestor
101745390|NCT00921765|Anesthetics|anesthetics|mesh-ancestor
101745391|NCT00921765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101745392|NCT00921765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101745393|NCT00921765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101745394|NCT00921765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101745395|NCT00921765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745396|NCT00921765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101745397|NCT05435781|Hydrocortisone|hydrocortisone|mesh-list
101745398|NCT05435781|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101745399|NCT05435781|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101745400|NCT05435781|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101745401|NCT05435781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101745402|NCT00755157|Bevacizumab|bevacizumab|mesh-list
101745403|NCT00755157|Docetaxel|docetaxel|mesh-list
101745404|NCT00755157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101745405|NCT00755157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101745406|NCT00755157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101745407|NCT00755157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101745408|NCT00755157|Growth Substances|growth substances|mesh-ancestor
101561228|NCT05936489|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101561230|NCT05936489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101561231|NCT05936489|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101561232|NCT05936489|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101561233|NCT05936489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101561234|NCT05936489|Adrenergic Agents|adrenergic agents|mesh-ancestor
101561235|NCT05936489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101561236|NCT05936489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561237|NCT05936489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561238|NCT05936489|Miotics|miotics|mesh-ancestor
101561239|NCT05936489|Autonomic Agents|autonomic agents|mesh-ancestor
101561240|NCT05936489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101561241|NCT05936489|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101561242|NCT05936229|Interferons|interferons|mesh-list
101561243|NCT05936229|Interferon-beta|interferon-beta|mesh-list
101561244|NCT05936229|Interferon beta-1a|interferon beta-1a|mesh-list
101561245|NCT05936229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561246|NCT05936229|Antiviral Agents|antiviral agents|mesh-ancestor
101561247|NCT05936229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101561248|NCT05936229|Immunologic Factors|immunologic factors|mesh-ancestor
101561249|NCT05936229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561250|NCT05936229|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101561251|NCT05935202|Mitapivat|mitapivat|mesh-list
101561252|NCT05935202|Enzyme Activators|enzyme activators|mesh-ancestor
101745409|NCT00755157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745410|NCT00755157|Growth Inhibitors|growth inhibitors|mesh-ancestor
101745411|NCT00755157|Tubulin Modulators|tubulin modulators|mesh-ancestor
101745412|NCT00755157|Antimitotic Agents|antimitotic agents|mesh-ancestor
101745413|NCT00755157|Mitosis Modulators|mitosis modulators|mesh-ancestor
101745414|NCT00755157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745415|NCT00919880|Paclitaxel|paclitaxel|mesh-list
101745416|NCT00919880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101745417|NCT00919880|Carboplatin|carboplatin|mesh-list
101745418|NCT00919880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101365534|NCT00397826|Simvastatin|simvastatin|mesh-list
101745419|NCT00919880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101745420|NCT00919880|Tubulin Modulators|tubulin modulators|mesh-ancestor
101745421|NCT00919880|Antimitotic Agents|antimitotic agents|mesh-ancestor
101745427|NCT00755313|Doxorubicin|doxorubicin|mesh-list
101745428|NCT00755313|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101745429|NCT00755313|Trastuzumab|trastuzumab|mesh-list
101745430|NCT00755313|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101745431|NCT00755313|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101745432|NCT00755313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101745433|NCT00755313|Immunologic Factors|immunologic factors|mesh-ancestor
101745434|NCT00755313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745435|NCT00755313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101745436|NCT00755313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101745437|NCT00755313|Alkylating Agents|alkylating agents|mesh-ancestor
101745438|NCT00755313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745439|NCT00755313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561253|NCT05935202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561254|NCT05935059|Pregabalin|pregabalin|mesh-list
101561255|NCT05935059|Anticonvulsants|anticonvulsants|mesh-list
101561256|NCT05935059|Tianeptine|tianeptine|mesh-list
101561257|NCT05935059|Antidepressive Agents|antidepressive agents|mesh-list
101561258|NCT05935059|Analgesics|analgesics|mesh-ancestor
101561259|NCT05935059|Sensory System Agents|sensory system agents|mesh-ancestor
101561260|NCT05935059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101561261|NCT05935059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745440|NCT00755313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101745441|NCT00755313|Tubulin Modulators|tubulin modulators|mesh-ancestor
101745442|NCT00755313|Antimitotic Agents|antimitotic agents|mesh-ancestor
101745443|NCT00755313|Mitosis Modulators|mitosis modulators|mesh-ancestor
101745444|NCT00755313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101745445|NCT00755313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101745446|NCT00755313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101745447|NCT00755313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101745448|NCT00755313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101745449|NCT00755313|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101745450|NCT00755313|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101745451|NCT00755313|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101745452|NCT00755313|Hormone Antagonists|hormone antagonists|mesh-ancestor
101745453|NCT00755313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101745454|NCT04082858|Midazolam|midazolam|mesh-list
101745455|NCT04082858|Ketamine|ketamine|mesh-list
101745456|NCT04082858|Analgesics|analgesics|mesh-ancestor
101745457|NCT04082858|Sensory System Agents|sensory system agents|mesh-ancestor
101745458|NCT04082858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101745459|NCT04082858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745460|NCT04082858|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101745461|NCT04082858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101745462|NCT04082858|Anesthetics, General|anesthetics, general|mesh-ancestor
101745463|NCT04082858|Anesthetics|anesthetics|mesh-ancestor
101745464|NCT04082858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101745465|NCT04082858|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101745466|NCT04082858|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101745467|NCT04082858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101745468|NCT04082858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745469|NCT04082858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101745470|NCT04082858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101745471|NCT04082858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101745472|NCT04082858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101745473|NCT04082858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101745474|NCT04082858|GABA Modulators|gaba modulators|mesh-ancestor
101745475|NCT04082858|GABA Agents|gaba agents|mesh-ancestor
101745476|NCT00679029|Cyclophosphamide|cyclophosphamide|mesh-list
101745477|NCT00679029|Bevacizumab|bevacizumab|mesh-list
101745478|NCT00679029|Gemcitabine|gemcitabine|mesh-list
101745479|NCT00679029|Doxorubicin|doxorubicin|mesh-list
101745480|NCT00679029|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101745481|NCT00679029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101745482|NCT00679029|Antibodies|antibodies|mesh-list
101745483|NCT00679029|Immunoglobulins|immunoglobulins|mesh-list
101745484|NCT00679029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101745485|NCT00679029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101745486|NCT00679029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745487|NCT00679029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101745488|NCT00679029|Immunologic Factors|immunologic factors|mesh-ancestor
101745489|NCT00679029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745490|NCT00679029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101745491|NCT00679029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101745492|NCT00679029|Alkylating Agents|alkylating agents|mesh-ancestor
101745497|NCT00679029|Growth Inhibitors|growth inhibitors|mesh-ancestor
101745498|NCT00679029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101745499|NCT00679029|Antimetabolites|antimetabolites|mesh-ancestor
101745500|NCT00679029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101745501|NCT00679029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101561262|NCT05935059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101561263|NCT05935059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101561264|NCT05935059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561265|NCT05935059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101561266|NCT05935059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101561267|NCT05935059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101745502|NCT00679029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101745503|NCT00679029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101745504|NCT00919022|Cyproterone Acetate|cyproterone acetate|mesh-list
101745506|NCT00919022|Androgen Antagonists|androgen antagonists|mesh-ancestor
101745507|NCT00919022|Hormone Antagonists|hormone antagonists|mesh-ancestor
101745508|NCT00919022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101745509|NCT00919022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745510|NCT00919022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101745511|NCT00919022|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101745512|NCT00919022|Contraceptive Agents|contraceptive agents|mesh-ancestor
101745513|NCT00919022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101745515|NCT05004350|Irinotecan|irinotecan|mesh-list
101745516|NCT05004350|Cetuximab|cetuximab|mesh-list
101745517|NCT05004350|Antimetabolites|antimetabolites|mesh-ancestor
101745518|NCT05004350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745519|NCT05004350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101745520|NCT05004350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101745521|NCT05004350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101745522|NCT05004350|Immunologic Factors|immunologic factors|mesh-ancestor
101745523|NCT05004350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745524|NCT05004350|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101745525|NCT05004350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101745526|NCT05004350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101745527|NCT05004350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101745528|NCT05122221|Cyclophosphamide|cyclophosphamide|mesh-list
101745529|NCT05122221|Fludarabine|fludarabine|mesh-list
101745530|NCT05122221|Interleukin-2|interleukin-2|mesh-list
101745531|NCT05122221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101745532|NCT05122221|Immunologic Factors|immunologic factors|mesh-ancestor
101745533|NCT05122221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745534|NCT05122221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101745535|NCT05122221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101745536|NCT05122221|Alkylating Agents|alkylating agents|mesh-ancestor
101745537|NCT05122221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745538|NCT05122221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101745539|NCT05122221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101745540|NCT05122221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101745541|NCT05122221|Analgesics|analgesics|mesh-ancestor
101745542|NCT05122221|Sensory System Agents|sensory system agents|mesh-ancestor
101745543|NCT05122221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101745544|NCT03802305|Anesthetics|anesthetics|mesh-list
101745545|NCT03802305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101745546|NCT03802305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745547|NCT02587052|Tacrolimus|tacrolimus|mesh-list
101745548|NCT02587052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101745549|NCT02587052|Immunologic Factors|immunologic factors|mesh-ancestor
101745550|NCT02587052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745551|NCT02587052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101745552|NCT02587052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101745553|NCT02587052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745554|NCT02587130|Ketamine|ketamine|mesh-list
101745555|NCT02587130|Analgesics|analgesics|mesh-ancestor
101745556|NCT02587130|Sensory System Agents|sensory system agents|mesh-ancestor
101745557|NCT02587130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101745558|NCT02587130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745559|NCT02587130|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101745560|NCT02587130|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101745561|NCT02587130|Anesthetics, General|anesthetics, general|mesh-ancestor
101745562|NCT02587130|Anesthetics|anesthetics|mesh-ancestor
101561268|NCT05935059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101561269|NCT05935059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101561270|NCT05935059|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101561271|NCT05928962|Tremelimumab|tremelimumab|mesh-list
101561272|NCT05928962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561273|NCT05924997|Apatinib|apatinib|mesh-list
101561274|NCT05924997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561275|NCT05924997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101561276|NCT05924997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101561277|NCT05924997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745563|NCT02587130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101496979|NCT00497172|Sirolimus|sirolimus|mesh-list
101745570|NCT02559141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101745571|NCT02559141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101745572|NCT02559141|Adrenergic Agents|adrenergic agents|mesh-ancestor
101745573|NCT02559141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101745574|NCT02559141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745575|NCT02559141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745577|NCT02559141|Autonomic Agents|autonomic agents|mesh-ancestor
101745578|NCT02559141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101745579|NCT02559141|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101745580|NCT02559141|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101745581|NCT02559141|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101745582|NCT02559141|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101745583|NCT02559141|Protective Agents|protective agents|mesh-ancestor
101745584|NCT02561013|Monensin|monensin|mesh-list
101745585|NCT02561013|Antifungal Agents|antifungal agents|mesh-ancestor
101745586|NCT02561013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101745587|NCT02561013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101745588|NCT02561013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101745589|NCT02561013|Coccidiostats|coccidiostats|mesh-ancestor
101745590|NCT02561013|Proton Ionophores|proton ionophores|mesh-ancestor
101745591|NCT02561013|Uncoupling Agents|uncoupling agents|mesh-ancestor
101745592|NCT02561013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101745593|NCT02561013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745594|NCT02561013|Ionophores|ionophores|mesh-ancestor
101745595|NCT02561013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101745596|NCT02561013|Sodium Ionophores|sodium ionophores|mesh-ancestor
101745597|NCT00678795|Nabiximols|nabiximols|mesh-list
101745598|NCT00678795|Analgesics|analgesics|mesh-ancestor
101745599|NCT00678795|Sensory System Agents|sensory system agents|mesh-ancestor
101745600|NCT00678795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101745601|NCT00678795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745602|NCT03417687|Xenon|xenon|mesh-list
101745603|NCT03417687|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101745604|NCT03417687|Anesthetics, General|anesthetics, general|mesh-ancestor
101745605|NCT03417687|Anesthetics|anesthetics|mesh-ancestor
101745606|NCT03417687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101745607|NCT03417687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745608|NCT04767698|Belimumab|belimumab|mesh-list
101745609|NCT04767698|Ocrelizumab|ocrelizumab|mesh-list
101745610|NCT04767698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101745611|NCT04767698|Immunologic Factors|immunologic factors|mesh-ancestor
101745612|NCT04767698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745613|NCT04049253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101745614|NCT03205137|Amlodipine|amlodipine|mesh-list
101745615|NCT03205137|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101745616|NCT03205137|Telmisartan|telmisartan|mesh-list
101745617|NCT03205137|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
101745618|NCT03205137|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
101745619|NCT03205137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101745620|NCT03205137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101745621|NCT03205137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101745622|NCT03205137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745623|NCT03205137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101561278|NCT05910190|Buprenorphine|buprenorphine|mesh-list
101561279|NCT05910190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101561280|NCT05910190|Narcotics|narcotics|mesh-ancestor
101561281|NCT05910190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101561282|NCT05910190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561283|NCT05910190|Analgesics|analgesics|mesh-ancestor
101561284|NCT05910190|Sensory System Agents|sensory system agents|mesh-ancestor
101561285|NCT05910190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101561286|NCT05910190|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101561287|NCT05898919|Neostigmine|neostigmine|mesh-list
101561288|NCT05898919|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101745624|NCT03205137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745625|NCT03205137|Vasodilator Agents|vasodilator agents|mesh-ancestor
101745626|NCT03205137|Diuretics|diuretics|mesh-ancestor
101745627|NCT03205137|Natriuretic Agents|natriuretic agents|mesh-ancestor
101745628|NCT03205137|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101745629|NCT03205137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101745630|NCT03205137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101745631|NCT00678561|Tofacitinib|tofacitinib|mesh-list
101745636|NCT05683340|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
101745638|NCT05683340|Antimetabolites|antimetabolites|mesh-ancestor
101745639|NCT05683340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745640|NCT05683340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101745641|NCT05683340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101745642|NCT05683340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101745643|NCT05683340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745644|NCT04081376|Hydromorphone|hydromorphone|mesh-list
101745645|NCT04081376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101745646|NCT04081376|Narcotics|narcotics|mesh-ancestor
101745647|NCT04081376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101745648|NCT04081376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745649|NCT04081376|Analgesics|analgesics|mesh-ancestor
101745650|NCT04081376|Sensory System Agents|sensory system agents|mesh-ancestor
101745651|NCT04081376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101745652|NCT02584400|Imidazole|imidazole|mesh-list
101745653|NCT02584400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101745654|NCT02584400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745655|NCT02586194|Peficitinib|peficitinib|mesh-list
101745656|NCT02586194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101745657|NCT02586194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368948|NCT00171691|Diclofenac|diclofenac|mesh-list
101745658|NCT02586194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101745659|NCT02586194|Immunologic Factors|immunologic factors|mesh-ancestor
101745660|NCT02586194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745661|NCT00761241|Interferons|interferons|mesh-list
101745662|NCT00761241|Interferon-alpha|interferon-alpha|mesh-list
101745663|NCT00761241|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
101745664|NCT00761241|Gemcitabine|gemcitabine|mesh-list
101745665|NCT00761241|Docetaxel|docetaxel|mesh-list
101745666|NCT00761241|Oxaliplatin|oxaliplatin|mesh-list
101745667|NCT00761241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101745668|NCT00761241|Antimetabolites|antimetabolites|mesh-ancestor
101745669|NCT00761241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745670|NCT00761241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101745671|NCT00761241|Tubulin Modulators|tubulin modulators|mesh-ancestor
101745672|NCT00761241|Antimitotic Agents|antimitotic agents|mesh-ancestor
101745673|NCT00761241|Mitosis Modulators|mitosis modulators|mesh-ancestor
101745674|NCT00761241|Antiviral Agents|antiviral agents|mesh-ancestor
101745675|NCT00761241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101745676|NCT00761241|Immunologic Factors|immunologic factors|mesh-ancestor
101745677|NCT00761241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745678|NCT04585022|Cimetidine|cimetidine|mesh-list
101745679|NCT04585022|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101745680|NCT04585022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101745681|NCT04585022|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101745682|NCT04585022|Histamine Antagonists|histamine antagonists|mesh-ancestor
101561289|NCT05898919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101561290|NCT05898919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561291|NCT05898919|Cholinergic Agents|cholinergic agents|mesh-ancestor
101561292|NCT05898919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101561293|NCT05898919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561294|NCT05898919|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101561295|NCT05898919|Autonomic Agents|autonomic agents|mesh-ancestor
101828144|NCT05926570|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101561296|NCT05898919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101561297|NCT05881291|Alfentanil|alfentanil|mesh-list
101561298|NCT05881291|Propofol|propofol|mesh-list
101561299|NCT05881291|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101561300|NCT05881291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101561301|NCT05881291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561302|NCT05881291|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101561303|NCT05881291|Anesthetics, General|anesthetics, general|mesh-ancestor
101561304|NCT05881291|Anesthetics|anesthetics|mesh-ancestor
101561305|NCT05881291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101561306|NCT05881291|Narcotics|narcotics|mesh-ancestor
101561307|NCT05881291|Analgesics|analgesics|mesh-ancestor
101561308|NCT05881291|Sensory System Agents|sensory system agents|mesh-ancestor
101561309|NCT05881291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101745683|NCT04585022|Histamine Agents|histamine agents|mesh-ancestor
101745684|NCT04585022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101745685|NCT04585022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745686|NCT04585022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745687|NCT04585022|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101745688|NCT04585022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101745689|NCT04585022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101745690|NCT02981979|Prednisone|prednisone|mesh-list
101745691|NCT02981979|Leflunomide|leflunomide|mesh-list
101745692|NCT02981979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101745693|NCT02981979|Glucocorticoids|glucocorticoids|mesh-ancestor
101745694|NCT02981979|Hormones|hormones|mesh-ancestor
101745695|NCT02981979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101745696|NCT02981979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745697|NCT02981979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101745698|NCT02981979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101745699|NCT02981979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101745700|NCT02981979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745708|NCT00920660|Glucocorticoids|glucocorticoids|mesh-ancestor
101745709|NCT00920660|Hormones|hormones|mesh-ancestor
101745710|NCT00920660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101745711|NCT00920660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745712|NCT00920660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101745713|NCT00920660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101745714|NCT02583464|Tenofovir|tenofovir|mesh-list
101745715|NCT02583464|Emtricitabine|emtricitabine|mesh-list
101745716|NCT02583464|Antiviral Agents|antiviral agents|mesh-ancestor
101745717|NCT02583464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101745718|NCT02583464|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101745719|NCT02583464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101745720|NCT02583464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101745721|NCT02583464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561310|NCT05867342|Lidocaine|lidocaine|mesh-list
101561311|NCT05867342|Epinephrine|epinephrine|mesh-list
101561312|NCT05867342|Racepinephrine|racepinephrine|mesh-list
101561313|NCT05867342|Epinephryl borate|epinephryl borate|mesh-list
101561314|NCT05867342|Anesthetics, Local|anesthetics, local|mesh-ancestor
101561315|NCT05867342|Anesthetics|anesthetics|mesh-ancestor
101561316|NCT05867342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101561317|NCT05867342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561318|NCT05867342|Sensory System Agents|sensory system agents|mesh-ancestor
101561319|NCT05867342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101745722|NCT02583464|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101745723|NCT02583464|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101745724|NCT00675597|Bevacizumab|bevacizumab|mesh-list
101745725|NCT00675597|Docetaxel|docetaxel|mesh-list
101745726|NCT00675597|Vinorelbine|vinorelbine|mesh-list
101745727|NCT00675597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101745728|NCT00675597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101745729|NCT00675597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101745730|NCT00675597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101745731|NCT00675597|Growth Substances|growth substances|mesh-ancestor
101745732|NCT00675597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745733|NCT00675597|Growth Inhibitors|growth inhibitors|mesh-ancestor
101745734|NCT00675597|Tubulin Modulators|tubulin modulators|mesh-ancestor
101745735|NCT00675597|Antimitotic Agents|antimitotic agents|mesh-ancestor
101745736|NCT00675597|Mitosis Modulators|mitosis modulators|mesh-ancestor
101745737|NCT00675597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745738|NCT00675597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101745739|NCT02677545|Aspirin|aspirin|mesh-list
101745740|NCT02677545|Clopidogrel|clopidogrel|mesh-list
101745741|NCT02677545|Ticagrelor|ticagrelor|mesh-list
101745742|NCT02677545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101745743|NCT02677545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101745744|NCT02677545|Analgesics|analgesics|mesh-ancestor
101745745|NCT02677545|Sensory System Agents|sensory system agents|mesh-ancestor
101745746|NCT02677545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101745747|NCT02677545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745748|NCT02677545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101745749|NCT02677545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101745750|NCT02677545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101745751|NCT02677545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101745752|NCT02677545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745753|NCT02677545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101745754|NCT02677545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101745755|NCT02677545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101745756|NCT02677545|Antipyretics|antipyretics|mesh-ancestor
101745757|NCT02677545|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101745758|NCT02677545|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101745759|NCT02677545|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101745760|NCT02677545|Purinergic Agents|purinergic agents|mesh-ancestor
101745761|NCT02677545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101745762|NCT04079426|Dimercaprol|dimercaprol|mesh-list
101745763|NCT04079426|Chelating Agents|chelating agents|mesh-ancestor
101745764|NCT04079426|Sequestering Agents|sequestering agents|mesh-ancestor
101745765|NCT04079426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745766|NCT00675441|Lenalidomide|lenalidomide|mesh-list
101745767|NCT00675441|Immunologic Factors|immunologic factors|mesh-ancestor
101745768|NCT00675441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745786|NCT02558517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101745787|NCT02558517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745788|NCT02558517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101745789|NCT02558517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101745790|NCT00674973|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101403246|NCT00426595|Omeprazole|omeprazole|mesh-list
101745791|NCT00674973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101745792|NCT00674973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101370192|NCT00181870|Analgesics|analgesics|mesh-ancestor
101745793|NCT00674973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101561320|NCT05867342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101561321|NCT05867342|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101561322|NCT05867342|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101561323|NCT05867342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101561324|NCT05867342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561325|NCT05867342|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101561326|NCT05867342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101561327|NCT05867342|Adrenergic Agents|adrenergic agents|mesh-ancestor
101561328|NCT05867342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101561329|NCT05867342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101561330|NCT05867342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101561331|NCT05867342|Autonomic Agents|autonomic agents|mesh-ancestor
101745794|NCT00674973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745795|NCT00673179|Leucovorin|leucovorin|mesh-list
101745796|NCT00673179|Gemcitabine|gemcitabine|mesh-list
101745798|NCT00673179|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101745799|NCT00673179|Methotrexate|methotrexate|mesh-list
101745800|NCT00673179|Ifosfamide|ifosfamide|mesh-list
101745801|NCT00673179|Dexrazoxane|dexrazoxane|mesh-list
101745802|NCT00673179|Razoxane|razoxane|mesh-list
101745803|NCT00673179|Sargramostim|sargramostim|mesh-list
101745804|NCT00673179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101745805|NCT00673179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101745806|NCT00673179|Antimetabolites|antimetabolites|mesh-ancestor
101745807|NCT00673179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745808|NCT00673179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101745809|NCT00673179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101745810|NCT00673179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101745811|NCT00673179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101745812|NCT00673179|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101745813|NCT00673179|Abortifacient Agents|abortifacient agents|mesh-ancestor
101745814|NCT00673179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101745815|NCT00673179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745816|NCT00673179|Dermatologic Agents|dermatologic agents|mesh-ancestor
101745817|NCT00673179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101745818|NCT00673179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101745819|NCT00673179|Immunologic Factors|immunologic factors|mesh-ancestor
101745820|NCT00673179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101745821|NCT00673179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101745822|NCT00673179|Antidotes|antidotes|mesh-ancestor
101370727|NCT00185419|Progestins|progestins|mesh-ancestor
101745823|NCT00673179|Protective Agents|protective agents|mesh-ancestor
101745824|NCT00673179|Vitamin B Complex|vitamin b complex|mesh-ancestor
101745825|NCT00673179|Vitamins|vitamins|mesh-ancestor
101745826|NCT00673179|Micronutrients|micronutrients|mesh-ancestor
101745827|NCT00673179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101745828|NCT00673179|Alkylating Agents|alkylating agents|mesh-ancestor
101745842|NCT00584012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101745843|NCT00584012|Tubulin Modulators|tubulin modulators|mesh-ancestor
101745844|NCT00584012|Antimitotic Agents|antimitotic agents|mesh-ancestor
101745845|NCT00584012|Mitosis Modulators|mitosis modulators|mesh-ancestor
101745846|NCT00584012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745847|NCT00584012|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101745848|NCT00584012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101745849|NCT00584012|Antimetabolites|antimetabolites|mesh-ancestor
101745850|NCT00584012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101745851|NCT00584012|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101745852|NCT00584012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101745853|NCT05435846|Trametinib|trametinib|mesh-list
101745854|NCT05435846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101745855|NCT05435846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101745856|NCT05435846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101561332|NCT05867342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101561333|NCT05867342|Respiratory System Agents|respiratory system agents|mesh-ancestor
101561334|NCT05867342|Mydriatics|mydriatics|mesh-ancestor
101561335|NCT05867342|Sympathomimetics|sympathomimetics|mesh-ancestor
101561336|NCT05867342|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101561337|NCT05843448|Pembrolizumab|pembrolizumab|mesh-list
101561338|NCT05843448|Vaccines|vaccines|mesh-list
101561339|NCT05843448|Immunologic Factors|immunologic factors|mesh-ancestor
101561340|NCT05843448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561341|NCT05843448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101561342|NCT05843448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561343|NCT05843448|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101745857|NCT05435846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745858|NCT00920270|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101745859|NCT00920270|Colistin|colistin|mesh-list
101745860|NCT00920270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101745861|NCT04078724|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
101745862|NCT04078724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101745863|NCT04078724|Antidepressive Agents|antidepressive agents|mesh-ancestor
101745864|NCT04078724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101403321|NCT00126516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101745865|NCT02585882|Fluorides|fluorides|mesh-list
101745866|NCT02585882|Cariostatic Agents|cariostatic agents|mesh-ancestor
101745867|NCT02585882|Protective Agents|protective agents|mesh-ancestor
101745868|NCT02585882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745870|NCT02585648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101745871|NCT02584010|Silicon|silicon|mesh-list
101745872|NCT02584010|Trace Elements|trace elements|mesh-ancestor
101745873|NCT02584010|Micronutrients|micronutrients|mesh-ancestor
101745874|NCT02584010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745875|NCT02585804|Dapagliflozin|dapagliflozin|mesh-list
101745876|NCT02585804|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101745877|NCT02585804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745878|NCT02585804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101745879|NCT02585804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745880|NCT02582996|Acetaminophen|acetaminophen|mesh-list
101745881|NCT02582996|Dihydroergotamine|dihydroergotamine|mesh-list
101745882|NCT02582996|Metoclopramide|metoclopramide|mesh-list
101745884|NCT02582996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101745885|NCT02582996|Analgesics|analgesics|mesh-ancestor
101745886|NCT02582996|Sensory System Agents|sensory system agents|mesh-ancestor
101745887|NCT02582996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101745888|NCT02582996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745889|NCT02582996|Antipyretics|antipyretics|mesh-ancestor
101745890|NCT02582996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101745891|NCT02582996|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101745892|NCT02582996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101745893|NCT02582996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745894|NCT02582996|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101745898|NCT02582996|Antiemetics|antiemetics|mesh-ancestor
101745899|NCT02582996|Autonomic Agents|autonomic agents|mesh-ancestor
101745900|NCT02582996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101745901|NCT02582996|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101745902|NCT02582996|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101745903|NCT02582996|Dopamine Agents|dopamine agents|mesh-ancestor
101745904|NCT02582996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101745905|NCT02582996|Dopamine Agonists|dopamine agonists|mesh-ancestor
101745906|NCT02585570|Phenylephrine|phenylephrine|mesh-list
101745907|NCT02585570|Oxymetazoline|oxymetazoline|mesh-list
101745908|NCT02585570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101745909|NCT02585570|Mydriatics|mydriatics|mesh-ancestor
101745910|NCT02585570|Autonomic Agents|autonomic agents|mesh-ancestor
101745911|NCT02585570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101745912|NCT02585570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745913|NCT02585570|Sympathomimetics|sympathomimetics|mesh-ancestor
101561344|NCT05843448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561345|NCT05827016|Lenalidomide|lenalidomide|mesh-list
101561346|NCT05827016|Immunologic Factors|immunologic factors|mesh-ancestor
101561347|NCT05827016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561348|NCT05827016|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101561349|NCT05827016|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101561350|NCT05827016|Growth Substances|growth substances|mesh-ancestor
101561351|NCT05827016|Growth Inhibitors|growth inhibitors|mesh-ancestor
101523298|NCT01228656|Analgesics|analgesics|mesh-ancestor
101561352|NCT05827016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561353|NCT05810480|Immunoglobulins|immunoglobulins|mesh-list
101561354|NCT05810480|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101561355|NCT05810480|Antibodies|antibodies|mesh-list
101561356|NCT05810480|Immunoglobulin G|immunoglobulin g|mesh-list
101561357|NCT05810480|Autoantibodies|autoantibodies|mesh-list
101409768|NCT00114270|Letrozole|letrozole|mesh-list
101745914|NCT02585570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101745915|NCT02585570|Nasal Decongestants|nasal decongestants|mesh-ancestor
101745916|NCT02585570|Respiratory System Agents|respiratory system agents|mesh-ancestor
101745917|NCT02585570|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101745918|NCT02585570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101745919|NCT02585570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101745920|NCT02585570|Adrenergic Agents|adrenergic agents|mesh-ancestor
101745921|NCT02585570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101745922|NCT02585570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745923|NCT02585570|Protective Agents|protective agents|mesh-ancestor
101745924|NCT02583854|Hemostatics|hemostatics|mesh-list
101745925|NCT02583854|Coagulants|coagulants|mesh-ancestor
101745926|NCT00764907|Leucovorin|leucovorin|mesh-list
101745927|NCT00764907|Cytarabine|cytarabine|mesh-list
101745928|NCT00764907|Dexamethasone|dexamethasone|mesh-list
101745929|NCT00764907|Prednisone|prednisone|mesh-list
101745930|NCT00764907|Cyclophosphamide|cyclophosphamide|mesh-list
101745931|NCT00764907|Ifosfamide|ifosfamide|mesh-list
101745932|NCT00764907|Doxorubicin|doxorubicin|mesh-list
101745933|NCT00764907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101745934|NCT00764907|Methotrexate|methotrexate|mesh-list
101745935|NCT00764907|Etoposide|etoposide|mesh-list
101745936|NCT00764907|Vincristine|vincristine|mesh-list
101745937|NCT00764907|Daunorubicin|daunorubicin|mesh-list
101745938|NCT00764907|Asparaginase|asparaginase|mesh-list
101745939|NCT00764907|Mercaptopurine|mercaptopurine|mesh-list
101745940|NCT00764907|Thioguanine|thioguanine|mesh-list
101745941|NCT00764907|Vindesine|vindesine|mesh-list
101403399|NCT03929718|Diuretics|diuretics|mesh-ancestor
101745942|NCT00764907|Levoleucovorin|levoleucovorin|mesh-list
101745943|NCT00764907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101745944|NCT00764907|Immunologic Factors|immunologic factors|mesh-ancestor
101745945|NCT00764907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745946|NCT00764907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101745947|NCT00764907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101745949|NCT00764907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745950|NCT00764907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101745951|NCT00764907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101745952|NCT00764907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101745953|NCT00764907|Antiemetics|antiemetics|mesh-ancestor
101745954|NCT00764907|Autonomic Agents|autonomic agents|mesh-ancestor
101745955|NCT00764907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101745956|NCT00764907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101745957|NCT00764907|Glucocorticoids|glucocorticoids|mesh-ancestor
101745958|NCT00764907|Hormones|hormones|mesh-ancestor
101745959|NCT00764907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101745960|NCT00764907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101745961|NCT00764907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101561358|NCT05810480|Immunologic Factors|immunologic factors|mesh-ancestor
101561359|NCT05810480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561360|NCT05809830|Doxorubicin|doxorubicin|mesh-list
101561361|NCT05809830|LB100|lb100|mesh-list
101561362|NCT05809830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101561363|NCT05809830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561364|NCT05809830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101561365|NCT05809830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101561366|NCT05809830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101561367|NCT05809830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561368|NCT05806346|Tranexamic Acid|tranexamic acid|mesh-list
101409774|NCT00114270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101745962|NCT00764907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101745963|NCT00764907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101745964|NCT00764907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101745965|NCT00764907|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101745966|NCT00764907|Abortifacient Agents|abortifacient agents|mesh-ancestor
101745967|NCT00764907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101373371|NCT00222469|Gemcitabine|gemcitabine|mesh-list
101745968|NCT00764907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101745969|NCT00764907|Antimetabolites|antimetabolites|mesh-ancestor
101745970|NCT00764907|Dermatologic Agents|dermatologic agents|mesh-ancestor
101745971|NCT00764907|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101745977|NCT00764907|Protective Agents|protective agents|mesh-ancestor
101745978|NCT00764907|Vitamin B Complex|vitamin b complex|mesh-ancestor
101745979|NCT00764907|Vitamins|vitamins|mesh-ancestor
101745980|NCT00764907|Micronutrients|micronutrients|mesh-ancestor
101745981|NCT00764907|Tubulin Modulators|tubulin modulators|mesh-ancestor
101745982|NCT00764907|Antimitotic Agents|antimitotic agents|mesh-ancestor
101745983|NCT00764907|Mitosis Modulators|mitosis modulators|mesh-ancestor
101745984|NCT02583698|Carvedilol|carvedilol|mesh-list
101745985|NCT02583698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101745986|NCT02583698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101745987|NCT02583698|Adrenergic Agents|adrenergic agents|mesh-ancestor
101745988|NCT02583698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101745989|NCT02583698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745990|NCT02583698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745991|NCT02583698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101745992|NCT02583698|Antioxidants|antioxidants|mesh-ancestor
101745993|NCT02583698|Protective Agents|protective agents|mesh-ancestor
101745994|NCT02583698|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101745995|NCT02583698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101745996|NCT02583698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101745997|NCT02583698|Vasodilator Agents|vasodilator agents|mesh-ancestor
101745998|NCT02583698|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101745999|NCT02583698|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101746000|NCT00762099|Pregabalin|pregabalin|mesh-list
101746001|NCT00762099|Analgesics|analgesics|mesh-ancestor
101746002|NCT00762099|Sensory System Agents|sensory system agents|mesh-ancestor
101746003|NCT00762099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101746004|NCT00762099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746005|NCT00762099|Anticonvulsants|anticonvulsants|mesh-ancestor
101746006|NCT00762099|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101746007|NCT00762099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101374221|NCT00413296|Levetiracetam|levetiracetam|mesh-list
101746008|NCT00762099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746009|NCT00762099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101746010|NCT00762099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101746011|NCT00762099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101746012|NCT00762099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101746013|NCT00762099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101746014|NCT00762255|Bevacizumab|bevacizumab|mesh-list
101746015|NCT00762255|Irinotecan|irinotecan|mesh-list
101746016|NCT00762255|Vorinostat|vorinostat|mesh-list
101746017|NCT00762255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101746018|NCT00762255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561369|NCT05806346|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101561370|NCT05806346|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101561371|NCT05806346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561372|NCT05806346|Hemostatics|hemostatics|mesh-ancestor
101561373|NCT05806346|Coagulants|coagulants|mesh-ancestor
101561374|NCT05798533|Tislelizumab|tislelizumab|mesh-list
101561375|NCT05798533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101561376|NCT05798533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561377|NCT05793632|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101561378|NCT05793632|Antidepressive Agents|antidepressive agents|mesh-ancestor
101561379|NCT05793632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101561380|NCT05793632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101561381|NCT05793632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101561382|NCT05793632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101374277|NCT00226798|Antimetabolites|antimetabolites|mesh-ancestor
101561383|NCT05793632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561384|NCT05780073|Dasatinib|dasatinib|mesh-list
101561385|NCT05780073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561386|NCT05780073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101561387|NCT05780073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101409798|NCT00401609|Etoposide|etoposide|mesh-list
101746019|NCT00762255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101403491|NCT00092183|Aprepitant|aprepitant|mesh-list
101746020|NCT00762255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101746021|NCT00762255|Growth Substances|growth substances|mesh-ancestor
101746022|NCT00762255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746023|NCT00762255|Growth Inhibitors|growth inhibitors|mesh-ancestor
101746024|NCT00762255|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101746025|NCT00762255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101746026|NCT00762255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101746027|NCT00762255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746028|NCT00762255|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101746029|NCT02585180|Silver Sulfadiazine|silver sulfadiazine|mesh-list
101746030|NCT02585180|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101374517|NCT00228046|GABA Agents|gaba agents|mesh-ancestor
101746031|NCT02585180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101746032|NCT02557971|Botulinum Toxins|botulinum toxins|mesh-list
101746033|NCT02557971|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101746034|NCT02557971|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101746035|NCT02557971|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101746036|NCT02557971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101746037|NCT02557971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746038|NCT02557971|Cholinergic Agents|cholinergic agents|mesh-ancestor
101746039|NCT02557971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101746049|NCT05332730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746050|NCT02581826|Silodosin|silodosin|mesh-list
101746051|NCT02581826|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101746052|NCT02581826|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101746053|NCT02581826|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101746054|NCT02581826|Adrenergic Agents|adrenergic agents|mesh-ancestor
101746055|NCT02581826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101746056|NCT02581826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746057|NCT02581826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746058|NCT02581826|Urological Agents|urological agents|mesh-ancestor
101746059|NCT04340882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101746060|NCT04340882|Pembrolizumab|pembrolizumab|mesh-list
101561388|NCT05780073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561389|NCT05768191|Insulin|insulin|mesh-list
101561390|NCT05768191|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101561391|NCT05768191|Isophane Insulin, Human|isophane insulin, human|mesh-list
101561392|NCT05768191|Insulin, Isophane|insulin, isophane|mesh-list
101561393|NCT05768191|Isophane insulin, beef|isophane insulin, beef|mesh-list
101561394|NCT05768191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101561395|NCT05768191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561396|NCT05759481|Propofol|propofol|mesh-list
101561397|NCT05759481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101561398|NCT05759481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101561399|NCT05759481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561400|NCT05759481|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101561401|NCT05759481|Anesthetics, General|anesthetics, general|mesh-ancestor
101561402|NCT05759481|Anesthetics|anesthetics|mesh-ancestor
101561403|NCT05677282|Azithromycin|azithromycin|mesh-list
101561404|NCT05677282|Rifaximin|rifaximin|mesh-list
101561405|NCT05677282|Loperamide|loperamide|mesh-list
101561406|NCT05677282|Antidiarrheals|antidiarrheals|mesh-list
101561407|NCT05677282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101561408|NCT05677282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101561409|NCT05677282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101746061|NCT04340882|Docetaxel|docetaxel|mesh-list
101746062|NCT04340882|Ramucirumab|ramucirumab|mesh-list
101746063|NCT04340882|Antibodies|antibodies|mesh-list
101746064|NCT04340882|Immunoglobulins|immunoglobulins|mesh-list
101746065|NCT04340882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101746066|NCT04340882|Lexatumumab|lexatumumab|mesh-list
101746067|NCT04340882|Immunologic Factors|immunologic factors|mesh-ancestor
101746068|NCT04340882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746069|NCT04340882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101746070|NCT04340882|Tubulin Modulators|tubulin modulators|mesh-ancestor
101746071|NCT04340882|Antimitotic Agents|antimitotic agents|mesh-ancestor
101746072|NCT04340882|Mitosis Modulators|mitosis modulators|mesh-ancestor
101746073|NCT04340882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746074|NCT04340882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101746075|NCT00765921|Ranibizumab|ranibizumab|mesh-list
101746076|NCT00765921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101746077|NCT00765921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101746078|NCT00765921|Growth Substances|growth substances|mesh-ancestor
101746079|NCT00765921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746080|NCT00765921|Growth Inhibitors|growth inhibitors|mesh-ancestor
101746081|NCT00765921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101746082|NCT02583308|Silver Sulfadiazine|silver sulfadiazine|mesh-list
101746083|NCT02583308|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101746084|NCT02583308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101746085|NCT00672477|Methylnaltrexone|methylnaltrexone|mesh-list
101746086|NCT00672477|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101746087|NCT00672477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746088|NCT00672477|Sensory System Agents|sensory system agents|mesh-ancestor
101746089|NCT00672477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101746090|NCT00766155|Capecitabine|capecitabine|mesh-list
101746091|NCT00766155|Oxaliplatin|oxaliplatin|mesh-list
101746092|NCT00766155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101746093|NCT00766155|Antimetabolites|antimetabolites|mesh-ancestor
101403545|NCT00092300|Analgesics|analgesics|mesh-ancestor
101746094|NCT00766155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561410|NCT05657613|Fluconazole|fluconazole|mesh-list
101561411|NCT05657613|Bosentan|bosentan|mesh-list
101561412|NCT05657613|Antifungal Agents|antifungal agents|mesh-ancestor
101561413|NCT05657613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101561414|NCT05657613|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101561415|NCT05657613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101481874|NCT00301730|Aldesleukin|aldesleukin|mesh-list
101561416|NCT05657613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101561417|NCT05657613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561418|NCT05657613|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101561419|NCT05657613|Hormone Antagonists|hormone antagonists|mesh-ancestor
101561420|NCT05657613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101561421|NCT05657613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561422|NCT05657613|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101561423|NCT05657613|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101561424|NCT05657613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101561425|NCT05657613|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101561426|NCT05635110|Rifampin|rifampin|mesh-list
101746095|NCT00766155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101746096|NCT00762567|Phenylephrine|phenylephrine|mesh-list
101746097|NCT00762567|Oxymetazoline|oxymetazoline|mesh-list
101746098|NCT00762567|Nasal Decongestants|nasal decongestants|mesh-list
101746099|NCT00762567|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101746100|NCT00762567|Mydriatics|mydriatics|mesh-ancestor
101746101|NCT00762567|Autonomic Agents|autonomic agents|mesh-ancestor
101746102|NCT00762567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101746103|NCT00762567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746104|NCT00762567|Sympathomimetics|sympathomimetics|mesh-ancestor
101746105|NCT00762567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101481991|NCT00302627|Antacids|antacids|mesh-ancestor
101746106|NCT00762567|Respiratory System Agents|respiratory system agents|mesh-ancestor
101497519|NCT02893384|Sensory System Agents|sensory system agents|mesh-ancestor
101746118|NCT04338620|Tubulin Modulators|tubulin modulators|mesh-ancestor
101746119|NCT04338620|Antimitotic Agents|antimitotic agents|mesh-ancestor
101746120|NCT04338620|Mitosis Modulators|mitosis modulators|mesh-ancestor
101746121|NCT04338620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746122|NCT00923234|Lenalidomide|lenalidomide|mesh-list
101746123|NCT00923234|Azacitidine|azacitidine|mesh-list
101746124|NCT00923234|Immunologic Factors|immunologic factors|mesh-ancestor
101746125|NCT00923234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746126|NCT00923234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101746127|NCT00923234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101746128|NCT00923234|Growth Substances|growth substances|mesh-ancestor
101746129|NCT00923234|Growth Inhibitors|growth inhibitors|mesh-ancestor
101746130|NCT00923234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101746131|NCT00923234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101746132|NCT00923234|Antimetabolites|antimetabolites|mesh-ancestor
101746133|NCT00923234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746134|NCT00923234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101746135|NCT00674661|Riboflavin|riboflavin|mesh-list
101746136|NCT00674661|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101746137|NCT00674661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101746138|NCT00674661|Vitamin B Complex|vitamin b complex|mesh-ancestor
101746139|NCT00674661|Vitamins|vitamins|mesh-ancestor
101746140|NCT00674661|Micronutrients|micronutrients|mesh-ancestor
101746141|NCT00674661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746142|NCT00674661|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101746143|NCT00674661|Dermatologic Agents|dermatologic agents|mesh-ancestor
101746144|NCT00766545|Cilostazol|cilostazol|mesh-list
101561427|NCT05635110|Omeprazole|omeprazole|mesh-list
101561428|NCT05635110|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101561429|NCT05635110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101561430|NCT05635110|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101561431|NCT05635110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101561432|NCT05635110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561433|NCT05635110|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101561434|NCT05635110|Antitubercular Agents|antitubercular agents|mesh-ancestor
101561435|NCT05635110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101561436|NCT05635110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101561437|NCT05635110|Leprostatic Agents|leprostatic agents|mesh-ancestor
101561438|NCT05635110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101561439|NCT05635110|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101561440|NCT05635110|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101746145|NCT00766545|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101746146|NCT00766545|Autonomic Agents|autonomic agents|mesh-ancestor
101746147|NCT00766545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101746148|NCT00766545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746149|NCT00766545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101746150|NCT00766545|Respiratory System Agents|respiratory system agents|mesh-ancestor
101746151|NCT00766545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101746152|NCT00766545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101746153|NCT00766545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746154|NCT00766545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101746155|NCT00766545|Vasodilator Agents|vasodilator agents|mesh-ancestor
101746156|NCT00766545|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101746157|NCT00766545|Protective Agents|protective agents|mesh-ancestor
101746158|NCT00766545|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101746159|NCT00766545|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101746160|NCT00766545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101746161|NCT02558205|Liver Extracts|liver extracts|mesh-list
101746162|NCT02558205|Hematinics|hematinics|mesh-ancestor
101746163|NCT02557737|Botulinum Toxins|botulinum toxins|mesh-list
101746164|NCT02557737|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101746165|NCT02557737|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101746166|NCT02557737|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101746167|NCT02557737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101746168|NCT02557737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746170|NCT02557737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101746176|NCT00766857|Insulin Glargine|insulin glargine|mesh-list
101746177|NCT00766857|Exenatide|exenatide|mesh-list
101746178|NCT00766857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101746179|NCT00766857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746180|NCT00766857|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101746181|NCT00766857|Incretins|incretins|mesh-ancestor
101746182|NCT00766857|Hormones|hormones|mesh-ancestor
101746183|NCT00766857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101746184|NCT02558283|Lidocaine|lidocaine|mesh-list
101746185|NCT02558283|Anesthetics, Local|anesthetics, local|mesh-ancestor
101746186|NCT02558283|Anesthetics|anesthetics|mesh-ancestor
101746187|NCT02558283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101746188|NCT02558283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746189|NCT02558283|Sensory System Agents|sensory system agents|mesh-ancestor
101746190|NCT02558283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101746191|NCT02558283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101746192|NCT02558283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101746193|NCT02558283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101746194|NCT02558283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101561441|NCT05635110|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101561442|NCT05635110|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101561443|NCT05635110|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101561444|NCT05635110|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101561445|NCT05624281|Nintedanib|nintedanib|mesh-list
101561446|NCT05624281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561447|NCT05624281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101561448|NCT05624281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101561449|NCT05624281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561450|NCT05615025|Propofol|propofol|mesh-list
101482193|NCT00303758|Vitamins|vitamins|mesh-ancestor
101561451|NCT05615025|Sevoflurane|sevoflurane|mesh-list
101561452|NCT05615025|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101746195|NCT02558283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746196|NCT00767091|Rivastigmine|rivastigmine|mesh-list
101746197|NCT00767091|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
101746198|NCT00767091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101746199|NCT00767091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746200|NCT00767091|Cholinergic Agents|cholinergic agents|mesh-ancestor
101746201|NCT00767091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101746202|NCT00767091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746203|NCT00767091|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101746204|NCT00767091|Protective Agents|protective agents|mesh-ancestor
101746205|NCT00767169|Ibandronic Acid|ibandronic acid|mesh-list
101746206|NCT00767169|Pamidronate|pamidronate|mesh-list
101746207|NCT00767169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101746208|NCT00767169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746209|NCT05256381|Pembrolizumab|pembrolizumab|mesh-list
101746210|NCT05256381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101746211|NCT05256381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101746212|NCT05256381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101828145|NCT05926570|Hormone Antagonists|hormone antagonists|mesh-ancestor
101746213|NCT05256381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746214|NCT00767481|Travoprost|travoprost|mesh-list
101746215|NCT00767481|Brinzolamide|brinzolamide|mesh-list
101746216|NCT00767481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101746217|NCT00767481|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101746218|NCT00767481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101746219|NCT00767481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746220|NCT00671931|Dexmedetomidine|dexmedetomidine|mesh-list
101746221|NCT00671931|Propofol|propofol|mesh-list
101746222|NCT00671931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101746223|NCT00671931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101746224|NCT00671931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746225|NCT00671931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101746226|NCT00671931|Analgesics|analgesics|mesh-ancestor
101746227|NCT00671931|Sensory System Agents|sensory system agents|mesh-ancestor
101746228|NCT00671931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101746229|NCT00671931|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101746230|NCT00671931|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101746231|NCT00671931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101746232|NCT00671931|Adrenergic Agents|adrenergic agents|mesh-ancestor
101746233|NCT00671931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101746234|NCT00671931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746235|NCT00671931|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101746236|NCT00671931|Anesthetics, General|anesthetics, general|mesh-ancestor
101746237|NCT00671931|Anesthetics|anesthetics|mesh-ancestor
101746238|NCT00767559|PENTA|penta|mesh-list
101746239|NCT00767559|Warfarin|warfarin|mesh-list
101746240|NCT00767559|Fondaparinux|fondaparinux|mesh-list
101746255|NCT00767715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101746256|NCT00767715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746258|NCT00767715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101746259|NCT00767715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101561453|NCT05615025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101561454|NCT05615025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561455|NCT05615025|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101561456|NCT05615025|Anesthetics, General|anesthetics, general|mesh-ancestor
101561457|NCT05615025|Anesthetics|anesthetics|mesh-ancestor
101561458|NCT05615025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101561459|NCT05615025|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101561460|NCT05468697|Palbociclib|palbociclib|mesh-list
101561461|NCT05468697|Belzutifan|belzutifan|mesh-list
101561462|NCT05468697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561463|NCT05468697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101409864|NCT00112034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746260|NCT00767715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101746261|NCT00767715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101746262|NCT00767715|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101746263|NCT00767715|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101746264|NCT00767715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101482423|NCT00304772|Hormone Antagonists|hormone antagonists|mesh-ancestor
101746265|NCT00767715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746266|NCT00767715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101746267|NCT00767715|Serotonin Agents|serotonin agents|mesh-ancestor
101746268|NCT00767715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101746269|NCT00767715|Dopamine Agents|dopamine agents|mesh-ancestor
101746270|NCT00767715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101746271|NCT00762957|Metformin|metformin|mesh-list
101746272|NCT00762957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101746273|NCT00762957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746274|NCT00759993|Chromium|chromium|mesh-list
101746275|NCT00759993|Trace Elements|trace elements|mesh-ancestor
101746276|NCT00759993|Micronutrients|micronutrients|mesh-ancestor
101746277|NCT00759993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746278|NCT00673881|Choline|choline|mesh-list
101746279|NCT00673881|Fenofibrate|fenofibrate|mesh-list
101746280|NCT00673881|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101482474|NCT00329316|Progesterone|progesterone|mesh-list
101746281|NCT00673881|Antimetabolites|antimetabolites|mesh-ancestor
101746282|NCT00673881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746283|NCT00673881|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101746284|NCT00673881|Lipotropic Agents|lipotropic agents|mesh-ancestor
101746285|NCT00673881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101746286|NCT00673881|Nootropic Agents|nootropic agents|mesh-ancestor
101746287|NCT00763347|Alogliptin|alogliptin|mesh-list
101746288|NCT00763347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101746289|NCT00763347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746290|NCT00763347|Incretins|incretins|mesh-ancestor
101746291|NCT00763347|Hormones|hormones|mesh-ancestor
101746292|NCT00763347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101746293|NCT00763347|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101746294|NCT00763347|Protease Inhibitors|protease inhibitors|mesh-ancestor
101746295|NCT00763347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101746296|NCT00763347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746297|NCT00767871|Escitalopram|escitalopram|mesh-list
101746298|NCT00767871|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101746299|NCT00767871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101746300|NCT00767871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101746301|NCT00767871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746306|NCT00760149|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101746307|NCT00760149|Antitubercular Agents|antitubercular agents|mesh-ancestor
101746308|NCT00760149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101746309|NCT00760149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101746311|NCT00760149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101746312|NCT00760149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101746313|NCT00760149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561464|NCT05468697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101561465|NCT05468697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561466|NCT05467891|Letrozole|letrozole|mesh-list
101561467|NCT05467891|Fulvestrant|fulvestrant|mesh-list
101561468|NCT05467891|Anastrozole|anastrozole|mesh-list
101561469|NCT05467891|Exemestane|exemestane|mesh-list
101561470|NCT05467891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561471|NCT05467891|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101561472|NCT05467891|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101561473|NCT05467891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101561474|NCT05467891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561475|NCT05467891|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101561476|NCT05467891|Hormone Antagonists|hormone antagonists|mesh-ancestor
101561477|NCT05467891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101561478|NCT05467891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561479|NCT05467891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101409876|NCT00112034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101746314|NCT00760149|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101746315|NCT00760149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101746316|NCT00760149|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101746317|NCT00760149|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101746318|NCT00760149|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101746319|NCT00760149|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101746321|NCT00671853|Antidepressive Agents|antidepressive agents|mesh-ancestor
101746322|NCT00671853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101746323|NCT00671853|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101746324|NCT00671853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101746325|NCT00671853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101746326|NCT00671853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746327|NCT00768183|Ethanol|ethanol|mesh-list
101746328|NCT00768183|Morphine|morphine|mesh-list
101746329|NCT00768183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101746330|NCT00768183|Narcotics|narcotics|mesh-ancestor
101746331|NCT00768183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101746332|NCT00768183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746333|NCT00768183|Analgesics|analgesics|mesh-ancestor
101746334|NCT00768183|Sensory System Agents|sensory system agents|mesh-ancestor
101746335|NCT00768183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101746336|NCT00768183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101746337|NCT00768183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101746338|NCT02557581|Terbutaline|terbutaline|mesh-list
101746339|NCT02557581|Clenbuterol|clenbuterol|mesh-list
101746340|NCT02557581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101746341|NCT02557581|Autonomic Agents|autonomic agents|mesh-ancestor
101746342|NCT02557581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101746343|NCT02557581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746344|NCT02557581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101746345|NCT02557581|Respiratory System Agents|respiratory system agents|mesh-ancestor
101746346|NCT02557581|Sympathomimetics|sympathomimetics|mesh-ancestor
101746347|NCT02557581|Tocolytic Agents|tocolytic agents|mesh-ancestor
101746348|NCT02557581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101482646|NCT00329628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101746349|NCT02557581|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101746350|NCT02557581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101746351|NCT02557581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101746352|NCT02557581|Adrenergic Agents|adrenergic agents|mesh-ancestor
101746353|NCT02557581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101561480|NCT05467891|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101561481|NCT05408065|Triamcinolone|triamcinolone|mesh-list
101561482|NCT05408065|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101561483|NCT05408065|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101561484|NCT05408065|Cortisone|cortisone|mesh-list
101561485|NCT05408065|Hyaluronic Acid|hyaluronic acid|mesh-list
101561486|NCT05408065|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101561487|NCT05408065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101561488|NCT05408065|Glucocorticoids|glucocorticoids|mesh-ancestor
101561489|NCT05408065|Hormones|hormones|mesh-ancestor
101561490|NCT05408065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101561491|NCT05408065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561492|NCT05408065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101561493|NCT05408065|Immunologic Factors|immunologic factors|mesh-ancestor
101561494|NCT05408065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101561495|NCT05408065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409895|NCT00114387|Vitamins|vitamins|mesh-ancestor
101482729|NCT00329823|Analgesics|analgesics|mesh-ancestor
101746354|NCT02557581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746355|NCT04077944|Trace Elements|trace elements|mesh-list
101746356|NCT04077944|Micronutrients|micronutrients|mesh-list
101746357|NCT04077944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746358|NCT02558751|Vaccines|vaccines|mesh-list
101746359|NCT02558751|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101746360|NCT02558751|Immunologic Factors|immunologic factors|mesh-ancestor
101746361|NCT02558751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746362|NCT00768573|Sildenafil Citrate|sildenafil citrate|mesh-list
101746363|NCT00768573|Vasodilator Agents|vasodilator agents|mesh-ancestor
101746364|NCT00768573|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101746365|NCT00768573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101746366|NCT00768573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101746367|NCT00768573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746368|NCT00768573|Urological Agents|urological agents|mesh-ancestor
101746369|NCT02558361|Apremilast|apremilast|mesh-list
101746370|NCT02558361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101746371|NCT02558361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101746372|NCT02558361|Analgesics|analgesics|mesh-ancestor
101746385|NCT02558595|Vitamins|vitamins|mesh-ancestor
101746386|NCT02558595|Micronutrients|micronutrients|mesh-ancestor
101746387|NCT02558595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375523|NCT00233818|Sirolimus|sirolimus|mesh-list
101746388|NCT02558595|Vitamin B Complex|vitamin b complex|mesh-ancestor
101746389|NCT02558595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101746390|NCT02558595|Antimetabolites|antimetabolites|mesh-ancestor
101746391|NCT02558595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403849|NCT00093743|Dermatologic Agents|dermatologic agents|mesh-ancestor
101746392|NCT02558595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101746393|NCT02558595|Vasodilator Agents|vasodilator agents|mesh-ancestor
101746395|NCT00760695|Hallucinogens|hallucinogens|mesh-ancestor
101746396|NCT00760695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746397|NCT00760695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101746398|NCT00760695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101746399|NCT00760695|Analgesics|analgesics|mesh-ancestor
101746400|NCT00760695|Sensory System Agents|sensory system agents|mesh-ancestor
101746401|NCT00760695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101746402|NCT00760695|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101746403|NCT00760695|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101746404|NCT00760695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101746405|NCT00760695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746406|NCT00760695|Hormones|hormones|mesh-ancestor
101561496|NCT05408065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101482928|NCT00333918|Bromfenac|bromfenac|mesh-list
101561497|NCT05408065|Viscosupplements|viscosupplements|mesh-ancestor
101561498|NCT05408065|Protective Agents|protective agents|mesh-ancestor
101561499|NCT05381753|Sunitinib|sunitinib|mesh-list
101561500|NCT05381753|Imatinib Mesylate|imatinib mesylate|mesh-list
101561501|NCT05381753|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101561502|NCT05381753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561503|NCT05381753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101561504|NCT05381753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101561505|NCT05381753|Growth Substances|growth substances|mesh-ancestor
101561506|NCT05381753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561507|NCT05381753|Growth Inhibitors|growth inhibitors|mesh-ancestor
101561508|NCT05381753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101561509|NCT05381753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101746407|NCT00760695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101746408|NCT02582372|Fentanyl|fentanyl|mesh-list
101746409|NCT02582372|Dexmedetomidine|dexmedetomidine|mesh-list
101746410|NCT02582372|Bupivacaine|bupivacaine|mesh-list
101746411|NCT02582372|Anesthetics, Local|anesthetics, local|mesh-ancestor
101746412|NCT02582372|Anesthetics|anesthetics|mesh-ancestor
101746413|NCT02582372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101746414|NCT02582372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483177|NCT00334698|Histamine Agents|histamine agents|mesh-ancestor
101746415|NCT02582372|Sensory System Agents|sensory system agents|mesh-ancestor
101746416|NCT02582372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101746417|NCT02582372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101746418|NCT02582372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101746419|NCT02582372|Analgesics|analgesics|mesh-ancestor
101746420|NCT02582372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101746421|NCT02582372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101746422|NCT02582372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101746423|NCT02582372|Adrenergic Agents|adrenergic agents|mesh-ancestor
101746424|NCT02582372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101746425|NCT02582372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746426|NCT02582372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101746427|NCT02582372|Narcotics|narcotics|mesh-ancestor
101746428|NCT02582372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101746429|NCT02582372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101746430|NCT02582372|Anesthetics, General|anesthetics, general|mesh-ancestor
101746431|NCT00768729|Sirolimus|sirolimus|mesh-list
101746432|NCT00768729|Azathioprine|azathioprine|mesh-list
101746433|NCT00768729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101746434|NCT00768729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101746435|NCT00768729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101746440|NCT00768729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746441|NCT00768729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746442|NCT00768729|Antimetabolites|antimetabolites|mesh-ancestor
101746443|NCT00768729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101746444|NCT00768729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101746446|NCT00768963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101746447|NCT00768963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101746448|NCT00768963|Growth Substances|growth substances|mesh-ancestor
101746449|NCT00768963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746450|NCT00768963|Growth Inhibitors|growth inhibitors|mesh-ancestor
101746451|NCT00768963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101746452|NCT00769041|Moxifloxacin|moxifloxacin|mesh-list
101746453|NCT00769041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101746454|NCT00769041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101746455|NCT00769041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101746456|NCT00769041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101746457|NCT00769041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101746458|NCT00769041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561510|NCT05381753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561513|NCT05276206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101561514|NCT05276206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561515|NCT05276206|Sensory System Agents|sensory system agents|mesh-ancestor
101561516|NCT05276206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101561517|NCT05246111|Topotecan|topotecan|mesh-list
101561519|NCT05246111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101561520|NCT05246111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101483510|NCT00230477|Lamivudine|lamivudine|mesh-list
101561521|NCT05246111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561522|NCT05246111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561523|NCT05207436|Oxytocin|oxytocin|mesh-list
101561524|NCT05207436|Oxytocics|oxytocics|mesh-ancestor
101561525|NCT05207436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101561526|NCT05207436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561527|NCT05183828|Letrozole|letrozole|mesh-list
101561528|NCT05183828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561529|NCT05183828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101561530|NCT05183828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101746459|NCT00769041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101746460|NCT00770445|Insulin|insulin|mesh-list
101746461|NCT00770445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101746462|NCT00770445|Metformin|metformin|mesh-list
101746463|NCT00770445|Pioglitazone|pioglitazone|mesh-list
101746464|NCT00770445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101403925|NCT00428818|Doxycycline|doxycycline|mesh-list
101746465|NCT00770445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746466|NCT04077398|Ropivacaine|ropivacaine|mesh-list
101746467|NCT04077398|Anesthetics, Local|anesthetics, local|mesh-ancestor
101746468|NCT04077398|Anesthetics|anesthetics|mesh-ancestor
101746469|NCT04077398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101746470|NCT04077398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746471|NCT04077398|Sensory System Agents|sensory system agents|mesh-ancestor
101746472|NCT04077398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101746473|NCT04239716|Anesthetics|anesthetics|mesh-list
101746474|NCT04239716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101746475|NCT04239716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746476|NCT04048707|Octreotide|octreotide|mesh-list
101746477|NCT04048707|Midodrine|midodrine|mesh-list
101746478|NCT04048707|Angiotensin II|angiotensin ii|mesh-list
101746479|NCT04048707|Giapreza|giapreza|mesh-list
101746480|NCT04048707|Angiotensinogen|angiotensinogen|mesh-list
101746481|NCT04048707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101746482|NCT04048707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101746483|NCT04048707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101746484|NCT04048707|Sympathomimetics|sympathomimetics|mesh-ancestor
101746485|NCT04048707|Autonomic Agents|autonomic agents|mesh-ancestor
101746486|NCT04048707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101746487|NCT04048707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746488|NCT04048707|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101746489|NCT04048707|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101746490|NCT04048707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101746491|NCT04048707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101746492|NCT04048707|Adrenergic Agents|adrenergic agents|mesh-ancestor
101746493|NCT04048707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101746494|NCT04048707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561531|NCT05183828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101561532|NCT05183828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561533|NCT05183828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101561534|NCT05183828|Hormone Antagonists|hormone antagonists|mesh-ancestor
101375630|NCT00064415|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101561535|NCT05183828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101409940|NCT00351832|Protease Inhibitors|protease inhibitors|mesh-ancestor
101746495|NCT04048707|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101746496|NCT04048707|Protease Inhibitors|protease inhibitors|mesh-ancestor
101746497|NCT04048707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101746498|NCT00763893|Losartan|losartan|mesh-list
101746499|NCT00763893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101746500|NCT00763893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101746501|NCT00763893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101746502|NCT00763893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101746503|NCT00763893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746504|NCT00770835|Metformin|metformin|mesh-list
101746505|NCT00770835|Pioglitazone|pioglitazone|mesh-list
101746506|NCT00770835|Glyburide|glyburide|mesh-list
101746522|NCT00570921|Fulvestrant|fulvestrant|mesh-list
101746523|NCT00570921|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101746524|NCT00570921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101746525|NCT00570921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101746526|NCT00570921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746527|NCT00570921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101746528|NCT00570921|Immunologic Factors|immunologic factors|mesh-ancestor
101746529|NCT00570921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746530|NCT00570921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101746531|NCT00570921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101746532|NCT00570921|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101746533|NCT00570921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101746534|NCT00570921|Hormone Antagonists|hormone antagonists|mesh-ancestor
101746535|NCT00570921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101746536|NCT04076930|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101483958|NCT00309491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101746537|NCT04076930|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101746538|NCT04076930|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
101746539|NCT04076930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746540|NCT04076930|Protease Inhibitors|protease inhibitors|mesh-ancestor
101746541|NCT04048317|Doxorubicin|doxorubicin|mesh-list
101746542|NCT04048317|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101746543|NCT04048317|Ethiodized Oil|ethiodized oil|mesh-list
101746544|NCT04048317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101746545|NCT04048317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101746546|NCT04048317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101746547|NCT04048317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101746548|NCT04048317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101746549|NCT04048317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746550|NCT04353986|Sofosbuvir|sofosbuvir|mesh-list
101746551|NCT04353986|Ledipasvir|ledipasvir|mesh-list
101746552|NCT04353986|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
101746553|NCT04353986|Antiviral Agents|antiviral agents|mesh-ancestor
101746554|NCT04353986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101746555|NCT00670449|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101746556|NCT00670449|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101746557|NCT00670449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746558|NCT00670449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101746559|NCT00670449|Immunologic Factors|immunologic factors|mesh-ancestor
101746560|NCT00670449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746561|NCT00771147|Sorafenib|sorafenib|mesh-list
101746562|NCT00771147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101746563|NCT00771147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101746564|NCT00771147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101497986|NCT00593008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101746569|NCT04155710|Analgesics|analgesics|mesh-ancestor
101746570|NCT04155710|Sensory System Agents|sensory system agents|mesh-ancestor
101746571|NCT04155710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101484121|NCT00309998|Growth Inhibitors|growth inhibitors|mesh-ancestor
101746572|NCT04155710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561536|NCT05183828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561537|NCT05181527|Dextromethorphan|dextromethorphan|mesh-list
101561538|NCT05181527|Serotonin|serotonin|mesh-list
101561539|NCT05181527|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
101561540|NCT05181527|Antitussive Agents|antitussive agents|mesh-ancestor
101561541|NCT05181527|Respiratory System Agents|respiratory system agents|mesh-ancestor
101561542|NCT05181527|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101561543|NCT05181527|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101561544|NCT05181527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101561545|NCT05181527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561546|NCT05181527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561547|NCT05181527|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101561548|NCT05181527|Serotonin Agents|serotonin agents|mesh-ancestor
101561549|NCT05181527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101746573|NCT00775047|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101746574|NCT00775047|Medroxyprogesterone|medroxyprogesterone|mesh-list
101746575|NCT00775047|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101746576|NCT00775047|Contraceptive Agents|contraceptive agents|mesh-ancestor
101746577|NCT00775047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101746578|NCT00775047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746579|NCT00775047|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101746580|NCT00775047|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101746581|NCT00775047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101746582|NCT00775047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101746583|NCT00775047|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101746584|NCT00775047|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101746585|NCT00775047|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101746586|NCT00775125|Ritonavir|ritonavir|mesh-list
101746587|NCT00775125|Darunavir|darunavir|mesh-list
101746588|NCT00775125|Fosamprenavir|fosamprenavir|mesh-list
101746589|NCT00775125|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101746590|NCT00775125|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101746591|NCT00775125|Protease Inhibitors|protease inhibitors|mesh-ancestor
101746592|NCT00775125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101746593|NCT00775125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746594|NCT00775125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101746595|NCT00775125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101746596|NCT00775125|Antiviral Agents|antiviral agents|mesh-ancestor
101746597|NCT00775125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101746598|NCT00775125|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101746599|NCT00775125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101746600|NCT02557503|Fluorouracil|fluorouracil|mesh-list
101746601|NCT02557503|Oxaliplatin|oxaliplatin|mesh-list
101746602|NCT02557503|Antimetabolites|antimetabolites|mesh-ancestor
101746603|NCT02557503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746604|NCT02557503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101746605|NCT02557503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101746606|NCT02557503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101746607|NCT02557503|Immunologic Factors|immunologic factors|mesh-ancestor
101484448|NCT00343005|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101746608|NCT02557503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746609|NCT00764439|Nicotine|nicotine|mesh-list
101746610|NCT00764439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101746611|NCT00764439|Autonomic Agents|autonomic agents|mesh-ancestor
101746612|NCT00764439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101746613|NCT00764439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746614|NCT00764439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101746615|NCT00764439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101746616|NCT00764439|Cholinergic Agents|cholinergic agents|mesh-ancestor
101561550|NCT05181527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101561551|NCT05168813|Vaccines|vaccines|mesh-list
101561552|NCT05168813|Immunologic Factors|immunologic factors|mesh-ancestor
101561553|NCT05168813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561554|NCT05141305|Clopidogrel|clopidogrel|mesh-list
101561555|NCT05141305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561556|NCT05141305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561557|NCT05141305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101561558|NCT05141305|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101561559|NCT05141305|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101561560|NCT05141305|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101561561|NCT05141305|Purinergic Agents|purinergic agents|mesh-ancestor
101561562|NCT05141305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101746617|NCT00764439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101746618|NCT00764439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746619|NCT00771303|Fibrin fragment D|fibrin fragment d|mesh-list
101746620|NCT00771303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101746621|NCT00771303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101746622|NCT00771303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746623|NCT00771303|Hemostatics|hemostatics|mesh-ancestor
101746624|NCT00771303|Coagulants|coagulants|mesh-ancestor
101746625|NCT05674526|Cetuximab|cetuximab|mesh-list
101746626|NCT05674526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101746627|NCT05674526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101746628|NCT00771381|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
101746629|NCT00771381|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101746630|NCT00771381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746631|NCT00771459|Ropivacaine|ropivacaine|mesh-list
101746632|NCT00771459|Anesthetics, Local|anesthetics, local|mesh-ancestor
101746633|NCT00771459|Anesthetics|anesthetics|mesh-ancestor
101746634|NCT00771459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101746639|NCT00775359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101746640|NCT00775359|Antimetabolites|antimetabolites|mesh-ancestor
101484701|NCT00313391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101746641|NCT00775359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746642|NCT00775359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101746643|NCT05338502|Omeprazole|omeprazole|mesh-list
101746644|NCT05338502|Ranitidine|ranitidine|mesh-list
101746645|NCT05338502|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
101746646|NCT05338502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101746647|NCT05338502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101746648|NCT05338502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101484766|NCT00343980|Insulin|insulin|mesh-list
101746649|NCT05338502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101746650|NCT05338502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746651|NCT05338502|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101746652|NCT05338502|Histamine Antagonists|histamine antagonists|mesh-ancestor
101746653|NCT05338502|Histamine Agents|histamine agents|mesh-ancestor
101746654|NCT05338502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101746655|NCT05338502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746656|NCT02557269|Mometasone Furoate|mometasone furoate|mesh-list
101746657|NCT02557269|Azelastine|azelastine|mesh-list
101746658|NCT02557269|Prednisolone|prednisolone|mesh-list
101746659|NCT02557269|Xylometazoline|xylometazoline|mesh-list
101746660|NCT02557269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101746661|NCT02557269|Glucocorticoids|glucocorticoids|mesh-ancestor
101746662|NCT02557269|Hormones|hormones|mesh-ancestor
101746663|NCT02557269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101484967|NCT00344526|Alkylating Agents|alkylating agents|mesh-ancestor
101746664|NCT02557269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746665|NCT02557269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101746666|NCT02557269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101746667|NCT02557269|Autonomic Agents|autonomic agents|mesh-ancestor
101561563|NCT05138822|Nitrofurantoin|nitrofurantoin|mesh-list
101561564|NCT05138822|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101561565|NCT05138822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101561566|NCT05138822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101409979|NCT00351910|Analgesics|analgesics|mesh-ancestor
101746668|NCT02557269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101746669|NCT02557269|Dermatologic Agents|dermatologic agents|mesh-ancestor
101746670|NCT02557269|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101746671|NCT02557269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101746672|NCT02557269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101746673|NCT02557269|Respiratory System Agents|respiratory system agents|mesh-ancestor
101746674|NCT02557269|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101746675|NCT02557269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101746676|NCT02557269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746677|NCT02557269|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101746678|NCT02557269|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101746679|NCT02557269|Histamine Antagonists|histamine antagonists|mesh-ancestor
101746680|NCT02557269|Histamine Agents|histamine agents|mesh-ancestor
101746681|NCT02557269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101746682|NCT02557269|Nasal Decongestants|nasal decongestants|mesh-ancestor
101375810|NCT00097812|Zoledronic Acid|zoledronic acid|mesh-list
101746683|NCT02557269|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101746684|NCT02556411|Levonorgestrel|levonorgestrel|mesh-list
101746685|NCT02556411|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101746686|NCT02556411|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101746687|NCT02556411|Contraceptive Agents|contraceptive agents|mesh-ancestor
101746688|NCT02556411|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101746689|NCT02556411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263447|NCT01762163|Analgesics|analgesics|mesh-ancestor
101746690|NCT02556411|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101746691|NCT02556411|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101746692|NCT02556411|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101485218|NCT00316238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101746693|NCT02556411|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101746694|NCT02556411|Estrogens|estrogens|mesh-ancestor
101746695|NCT02556411|Hormones|hormones|mesh-ancestor
101746696|NCT02556411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101746697|NCT04085276|Paclitaxel|paclitaxel|mesh-list
101746698|NCT04085276|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101746699|NCT04085276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101746700|NCT04085276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101746701|NCT04085276|Tubulin Modulators|tubulin modulators|mesh-ancestor
101746702|NCT04085276|Antimitotic Agents|antimitotic agents|mesh-ancestor
101746703|NCT04085276|Mitosis Modulators|mitosis modulators|mesh-ancestor
101746704|NCT04085276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746710|NCT00775905|Amlodipine|amlodipine|mesh-list
101746711|NCT00775905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101746712|NCT00775905|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101746713|NCT00775905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101746714|NCT00775905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746715|NCT00775905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101746716|NCT00775905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746717|NCT00775905|Vasodilator Agents|vasodilator agents|mesh-ancestor
101746718|NCT00772161|Methylphenidate|methylphenidate|mesh-list
101746719|NCT00772161|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101746720|NCT00772161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746721|NCT00772161|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101746722|NCT00772161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101746723|NCT00772161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101746724|NCT00772161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746725|NCT00772161|Dopamine Agents|dopamine agents|mesh-ancestor
101746726|NCT00772161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101746727|NCT00776139|Cetirizine|cetirizine|mesh-list
101746728|NCT00776139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101746729|NCT00776139|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101746730|NCT00776139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101746731|NCT00776139|Histamine Antagonists|histamine antagonists|mesh-ancestor
101746732|NCT00776139|Histamine Agents|histamine agents|mesh-ancestor
101561575|NCT05090124|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101561576|NCT05090124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101561577|NCT05090124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101409982|NCT00351910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101746733|NCT00776139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101746734|NCT00776139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746735|NCT00776139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746736|NCT00779493|Curcumin|curcumin|mesh-list
101375848|NCT00414037|Eszopiclone|eszopiclone|mesh-list
101746737|NCT00779493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746738|NCT00779493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101746739|NCT00779493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101746740|NCT00779493|Analgesics|analgesics|mesh-ancestor
101746741|NCT00779493|Sensory System Agents|sensory system agents|mesh-ancestor
101746742|NCT00779493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101746743|NCT00779493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101746744|NCT00779493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101746745|NCT00779493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101746746|NCT00779493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101746747|NCT00779493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746748|NCT02580344|Ibuprofen|ibuprofen|mesh-list
101485441|NCT00317408|Antiemetics|antiemetics|mesh-ancestor
101746749|NCT02580344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101746750|NCT02580344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101746751|NCT02580344|Analgesics|analgesics|mesh-ancestor
101746752|NCT02580344|Sensory System Agents|sensory system agents|mesh-ancestor
101746753|NCT02580344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101746754|NCT02580344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485501|NCT02959554|Growth Substances|growth substances|mesh-ancestor
101746755|NCT02580344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101746756|NCT02580344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101746757|NCT02580344|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101746758|NCT02580344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101746759|NCT02580344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746760|NCT00779649|Bisacodyl|bisacodyl|mesh-list
101746762|NCT00779649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101746763|NCT00779649|Laxatives|laxatives|mesh-ancestor
101746764|NCT00776217|Loratadine|loratadine|mesh-list
101746765|NCT00776217|Antipruritics|antipruritics|mesh-ancestor
101746766|NCT00776217|Dermatologic Agents|dermatologic agents|mesh-ancestor
101746767|NCT00776217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101746768|NCT00776217|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101746769|NCT00776217|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101746770|NCT00776217|Histamine Antagonists|histamine antagonists|mesh-ancestor
101746771|NCT00776217|Histamine Agents|histamine agents|mesh-ancestor
101746772|NCT00776217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101746773|NCT00776217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746787|NCT00667875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101746788|NCT00667875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101746789|NCT00667875|Dopamine Agonists|dopamine agonists|mesh-ancestor
101746790|NCT00667875|Dopamine Agents|dopamine agents|mesh-ancestor
101746791|NCT00667875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101746792|NCT00667875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746793|NCT00667875|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101746794|NCT00667875|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101746795|NCT00667875|Serotonin Agents|serotonin agents|mesh-ancestor
101746796|NCT00667875|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101746797|NCT00667875|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101746798|NCT00667875|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101746799|NCT00667875|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101746801|NCT02579642|Analgesics|analgesics|mesh-ancestor
101746802|NCT02579642|Sensory System Agents|sensory system agents|mesh-ancestor
101746803|NCT02579642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101746804|NCT02579642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746805|NCT02579642|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101746806|NCT02579642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101561580|NCT05054842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561581|NCT05022927|Bevacizumab|bevacizumab|mesh-list
101485637|NCT00317993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101561582|NCT05022927|Atezolizumab|atezolizumab|mesh-list
101561583|NCT05022927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101561584|NCT05022927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561585|NCT05022927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101561586|NCT05022927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101485687|NCT02959749|Docetaxel|docetaxel|mesh-list
101561587|NCT05022927|Growth Substances|growth substances|mesh-ancestor
101561588|NCT05022927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561589|NCT05022927|Growth Inhibitors|growth inhibitors|mesh-ancestor
101561590|NCT05022927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101561591|NCT05022927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561592|NCT04984317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101561593|NCT04984317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101561594|NCT04984317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101561595|NCT04984317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101561596|NCT04984317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561597|NCT04984317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101561598|NCT04984317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101561599|NCT04984317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561600|NCT04984317|Cholinergic Agents|cholinergic agents|mesh-ancestor
101561601|NCT04984317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101561602|NCT04915508|Hormones|hormones|mesh-list
101561603|NCT04915508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101561604|NCT04915508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561605|NCT04844866|Rituximab|rituximab|mesh-list
101561606|NCT04844866|Gemcitabine|gemcitabine|mesh-list
101561607|NCT04844866|Oxaliplatin|oxaliplatin|mesh-list
101561608|NCT04844866|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101561609|NCT04844866|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101561610|NCT04844866|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
101485882|NCT00351195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561611|NCT04844866|Immunoconjugates|immunoconjugates|mesh-list
101561612|NCT04844866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101561613|NCT04844866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561614|NCT04844866|Immunologic Factors|immunologic factors|mesh-ancestor
101561615|NCT04844866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561616|NCT04844866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101561617|NCT04844866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101561618|NCT04844866|Antimetabolites|antimetabolites|mesh-ancestor
101561619|NCT04844866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561620|NCT04844866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101561621|NCT04844866|Alkylating Agents|alkylating agents|mesh-ancestor
101561622|NCT04793867|Xenon|xenon|mesh-list
101746807|NCT02579642|Anesthetics, General|anesthetics, general|mesh-ancestor
101746808|NCT02579642|Anesthetics|anesthetics|mesh-ancestor
101746809|NCT02579642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101746810|NCT02579642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101746811|NCT02579642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101746812|NCT02579642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101746813|NCT02579642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746814|NCT00779805|Pseudoephedrine|pseudoephedrine|mesh-list
101746815|NCT00779805|Ephedrine|ephedrine|mesh-list
101746816|NCT00779805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101746817|NCT00779805|Autonomic Agents|autonomic agents|mesh-ancestor
101486038|NCT00351546|Protease Inhibitors|protease inhibitors|mesh-ancestor
101746818|NCT00779805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101746819|NCT00779805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746820|NCT00779805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101746821|NCT00779805|Respiratory System Agents|respiratory system agents|mesh-ancestor
101746822|NCT00779805|Nasal Decongestants|nasal decongestants|mesh-ancestor
101746823|NCT00779805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101746824|NCT00779805|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101746825|NCT00779805|Sympathomimetics|sympathomimetics|mesh-ancestor
101746826|NCT00779805|Adrenergic Agents|adrenergic agents|mesh-ancestor
101746827|NCT00779805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101746828|NCT00779805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746829|NCT00772395|Risedronic Acid|risedronic acid|mesh-list
101486091|NCT00321113|Antitubercular Agents|antitubercular agents|mesh-ancestor
101746830|NCT00772395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101746831|NCT00772395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101746832|NCT00772395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498259|NCT00473915|Fluticasone|fluticasone|mesh-list
101746848|NCT00667251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101746849|NCT04063124|Dasatinib|dasatinib|mesh-list
101746850|NCT04063124|Quercetin|quercetin|mesh-list
101746851|NCT04063124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101746852|NCT04063124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101746853|NCT04063124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101746854|NCT04063124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746855|NCT04063124|Antioxidants|antioxidants|mesh-ancestor
101746856|NCT04063124|Protective Agents|protective agents|mesh-ancestor
101746857|NCT04063124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746858|NCT00772473|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
101746859|NCT00772473|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101746860|NCT00772473|Serotonin Agents|serotonin agents|mesh-ancestor
101746861|NCT00772473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101746862|NCT00772473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746863|NCT00772473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746864|NCT00776607|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101746865|NCT00776607|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101746866|NCT00776607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746867|NCT00780039|Carboplatin|carboplatin|mesh-list
101746868|NCT00780039|Doxorubicin|doxorubicin|mesh-list
101746869|NCT00780039|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101746870|NCT00780039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101746871|NCT00780039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101746872|NCT00780039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101746873|NCT00780039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101746874|NCT00780039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101486261|NCT00322595|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101746875|NCT00780039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746876|NCT00776763|Bevacizumab|bevacizumab|mesh-list
101561623|NCT04793867|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101561624|NCT04793867|Anesthetics, General|anesthetics, general|mesh-ancestor
101561625|NCT04793867|Anesthetics|anesthetics|mesh-ancestor
101561626|NCT04793867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101561627|NCT04793867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561628|NCT04729387|Paclitaxel|paclitaxel|mesh-list
101561629|NCT04729387|Doxorubicin|doxorubicin|mesh-list
101561630|NCT04729387|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101561631|NCT04729387|Olaparib|olaparib|mesh-list
101410038|NCT00112658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101746877|NCT00776763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101746878|NCT00776763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101746879|NCT00776763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101746880|NCT00776763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101746881|NCT00776763|Growth Substances|growth substances|mesh-ancestor
101746882|NCT00776763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746883|NCT00776763|Growth Inhibitors|growth inhibitors|mesh-ancestor
101746884|NCT00772551|Raltegravir Potassium|raltegravir potassium|mesh-list
101746885|NCT00772551|Ezetimibe|ezetimibe|mesh-list
101746886|NCT00772551|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101746887|NCT00772551|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101746888|NCT00772551|Antimetabolites|antimetabolites|mesh-ancestor
101746889|NCT00772551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746890|NCT00772551|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101746891|NCT00772551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101746892|NCT00772551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101746893|NCT00772551|Antiviral Agents|antiviral agents|mesh-ancestor
101486472|NCT00331851|Metformin|metformin|mesh-list
101746896|NCT00772551|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101746897|NCT00772551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101746898|NCT00776841|Cholic Acids|cholic acids|mesh-list
101746899|NCT00776841|Bile Acids and Salts|bile acids and salts|mesh-list
101746900|NCT00776841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101746901|NCT02556879|Liver Extracts|liver extracts|mesh-list
101746902|NCT02556879|Antibodies|antibodies|mesh-list
101486525|NCT00324194|Mocetinostat|mocetinostat|mesh-list
101746903|NCT02556879|Immunologic Factors|immunologic factors|mesh-ancestor
101746904|NCT02556879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746905|NCT02556879|Hematinics|hematinics|mesh-ancestor
101746906|NCT00772863|Docetaxel|docetaxel|mesh-list
101746907|NCT00772863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101746908|NCT00772863|Tubulin Modulators|tubulin modulators|mesh-ancestor
101746909|NCT00772863|Antimitotic Agents|antimitotic agents|mesh-ancestor
101746910|NCT00772863|Mitosis Modulators|mitosis modulators|mesh-ancestor
101486634|NCT00332124|Choline|choline|mesh-list
101746911|NCT00772863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746912|NCT04075760|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101746913|NCT04075760|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101746914|NCT04075760|Adrenergic Agents|adrenergic agents|mesh-ancestor
101746915|NCT04075760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101746916|NCT04075760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746917|NCT04075760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746918|NCT00667719|Amlodipine|amlodipine|mesh-list
101746919|NCT00667719|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101746920|NCT00667719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101746921|NCT00667719|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101746922|NCT00667719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101746923|NCT00667719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746924|NCT00667719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101746925|NCT00667719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746926|NCT00667719|Vasodilator Agents|vasodilator agents|mesh-ancestor
101746927|NCT00667719|Diuretics|diuretics|mesh-ancestor
101746928|NCT00667719|Natriuretic Agents|natriuretic agents|mesh-ancestor
101746929|NCT00667719|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101746930|NCT00669669|Plerixafor|plerixafor|mesh-list
101746931|NCT00669669|Temozolomide|temozolomide|mesh-list
101746932|NCT00669669|Carmustine|carmustine|mesh-list
101746933|NCT00669669|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
101746934|NCT00669669|Lenograstim|lenograstim|mesh-list
101561632|NCT04729387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101561633|NCT04729387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561634|NCT04729387|Tubulin Modulators|tubulin modulators|mesh-ancestor
101561635|NCT04729387|Antimitotic Agents|antimitotic agents|mesh-ancestor
101561636|NCT04729387|Mitosis Modulators|mitosis modulators|mesh-ancestor
101561637|NCT04729387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561638|NCT04729387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101376016|NCT00065117|Vitamins|vitamins|mesh-ancestor
101410046|NCT00112658|Antidotes|antidotes|mesh-ancestor
101746935|NCT00669669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101746936|NCT00669669|Immunologic Factors|immunologic factors|mesh-ancestor
101746937|NCT00669669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746938|NCT00669669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101746939|NCT00669669|Alkylating Agents|alkylating agents|mesh-ancestor
101746940|NCT00669669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746941|NCT00669669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101746942|NCT00669669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101746943|NCT00669669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101746944|NCT00669669|Antiviral Agents|antiviral agents|mesh-ancestor
101746945|NCT00669669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101746946|NCT00669669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101746947|NCT02579564|Paclitaxel|paclitaxel|mesh-list
101746948|NCT02579564|Vinorelbine|vinorelbine|mesh-list
101746949|NCT02579564|Gemcitabine|gemcitabine|mesh-list
101746950|NCT02579564|Pemetrexed|pemetrexed|mesh-list
101746951|NCT02579564|Endostar protein|endostar protein|mesh-list
101746952|NCT02579564|Endostatins|endostatins|mesh-list
101746953|NCT02579564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101746954|NCT02579564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101487116|NCT00425724|Autonomic Agents|autonomic agents|mesh-ancestor
101746955|NCT02579564|Tubulin Modulators|tubulin modulators|mesh-ancestor
101746956|NCT02579564|Antimitotic Agents|antimitotic agents|mesh-ancestor
101746957|NCT02579564|Mitosis Modulators|mitosis modulators|mesh-ancestor
101746958|NCT02579564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746959|NCT02579564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101746960|NCT02579564|Antimetabolites|antimetabolites|mesh-ancestor
101746961|NCT02579564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101746962|NCT02579564|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101746963|NCT02579564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101746964|NCT02579564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101746965|NCT02579564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101746966|NCT02579564|Growth Substances|growth substances|mesh-ancestor
101746967|NCT02579564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746968|NCT02579564|Growth Inhibitors|growth inhibitors|mesh-ancestor
101746971|NCT00467779|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101746972|NCT00467779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101746973|NCT00467779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101746974|NCT00467779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746975|NCT00467779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101746976|NCT00467779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101746977|NCT00467779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101746978|NCT00467779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101746979|NCT00467779|Anesthetics, General|anesthetics, general|mesh-ancestor
101746981|NCT00467779|GABA Modulators|gaba modulators|mesh-ancestor
101207217|NCT01436422|Vaccines|vaccines|mesh-list
101746982|NCT00467779|GABA Agents|gaba agents|mesh-ancestor
101746983|NCT00467779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101746984|NCT00467779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746985|NCT00467779|Antitussive Agents|antitussive agents|mesh-ancestor
101487348|NCT02273505|Salicylic Acid|salicylic acid|mesh-list
101746986|NCT00467779|Respiratory System Agents|respiratory system agents|mesh-ancestor
101746987|NCT00467779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101746988|NCT00467779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101746990|NCT03704480|Tremelimumab|tremelimumab|mesh-list
101746991|NCT03704480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101746992|NCT03704480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101746993|NCT03699254|Valganciclovir|valganciclovir|mesh-list
101746994|NCT03699254|Ganciclovir|ganciclovir|mesh-list
101746995|NCT03699254|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101746996|NCT03699254|Antiviral Agents|antiviral agents|mesh-ancestor
101561639|NCT04729387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101561640|NCT04729387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101561641|NCT04729387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101561642|NCT04729387|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101487468|NCT00428181|Ethanol|ethanol|mesh-list
101746997|NCT03699254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101746998|NCT03699254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101746999|NCT03699254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101747000|NCT03699254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747001|NCT00570687|Insulin|insulin|mesh-list
101747002|NCT00570687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101747003|NCT00570687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747004|NCT01021891|Insulin|insulin|mesh-list
101747005|NCT01021891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101747006|NCT01021891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747007|NCT01029223|Metoprolol|metoprolol|mesh-list
101747008|NCT01029223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101747009|NCT01029223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101747010|NCT01029223|Sympatholytics|sympatholytics|mesh-ancestor
101487605|NCT00428727|Nitric Oxide|nitric oxide|mesh-list
101747011|NCT01029223|Autonomic Agents|autonomic agents|mesh-ancestor
101747012|NCT01029223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101747013|NCT01029223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747014|NCT01029223|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101747015|NCT01029223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101747016|NCT01029223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101747017|NCT01029223|Adrenergic Agents|adrenergic agents|mesh-ancestor
101747018|NCT01029223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101747019|NCT01029223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747020|NCT02556723|Aflibercept|aflibercept|mesh-list
101747021|NCT02556723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101747022|NCT02556723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101747023|NCT02556723|Growth Substances|growth substances|mesh-ancestor
101747024|NCT02556723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747025|NCT02556723|Growth Inhibitors|growth inhibitors|mesh-ancestor
101747026|NCT02556723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101747027|NCT00777543|Ferulic acid|ferulic acid|mesh-list
101747028|NCT00777543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101747029|NCT00777543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101747030|NCT00777543|Analgesics|analgesics|mesh-ancestor
101747031|NCT00777543|Sensory System Agents|sensory system agents|mesh-ancestor
101747032|NCT00777543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101747033|NCT00777543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487813|NCT04703088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747034|NCT00777543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101747035|NCT00777543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101747036|NCT00777543|Anticoagulants|anticoagulants|mesh-ancestor
101747037|NCT00777543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101747038|NCT00777543|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101747039|NCT00777543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101747040|NCT00777543|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101747041|NCT00777543|Antioxidants|antioxidants|mesh-ancestor
101498457|NCT01243788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101747049|NCT03410654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101747050|NCT03410654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747051|NCT04006262|Nivolumab|nivolumab|mesh-list
101747052|NCT04006262|Ipilimumab|ipilimumab|mesh-list
101747053|NCT04006262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101747054|NCT04006262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101747055|NCT04006262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101747056|NCT04006262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747057|NCT01032499|Oxytetracycline|oxytetracycline|mesh-list
101747058|NCT01032499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101747059|NCT01032499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101747060|NCT01022047|Budesonide|budesonide|mesh-list
101747061|NCT01022047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101747062|NCT01022047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101747063|NCT01022047|Autonomic Agents|autonomic agents|mesh-ancestor
101747064|NCT01022047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101747065|NCT01022047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561644|NCT04659603|Maytansine|maytansine|mesh-list
101561645|NCT04659603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101561646|NCT04659603|Antimetabolites|antimetabolites|mesh-ancestor
101561647|NCT04659603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561648|NCT04659603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561649|NCT04659603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101747066|NCT01022047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101747067|NCT01022047|Respiratory System Agents|respiratory system agents|mesh-ancestor
101747068|NCT01022047|Glucocorticoids|glucocorticoids|mesh-ancestor
101747069|NCT01022047|Hormones|hormones|mesh-ancestor
101747070|NCT01022047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101747071|NCT01022125|Simeprevir|simeprevir|mesh-list
101747072|NCT01022125|Antiviral Agents|antiviral agents|mesh-ancestor
101747073|NCT01022125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101747074|NCT01022125|Protease Inhibitors|protease inhibitors|mesh-ancestor
101747075|NCT01022125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101747076|NCT01022125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747077|NCT03385928|Tranexamic Acid|tranexamic acid|mesh-list
101747078|NCT03385928|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101747079|NCT03385928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101488242|NCT00330785|Vasodilator Agents|vasodilator agents|mesh-ancestor
101747080|NCT03385928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747081|NCT03385928|Hemostatics|hemostatics|mesh-ancestor
101747082|NCT03385928|Coagulants|coagulants|mesh-ancestor
101747083|NCT05673980|Vitamin D|vitamin d|mesh-list
101747084|NCT05673980|Cholecalciferol|cholecalciferol|mesh-list
101747085|NCT05673980|Ergocalciferols|ergocalciferols|mesh-list
101747086|NCT05673980|Vitamins|vitamins|mesh-ancestor
101747087|NCT05673980|Micronutrients|micronutrients|mesh-ancestor
101747088|NCT05673980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747089|NCT05673980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101488322|NCT00331058|Hormones|hormones|mesh-ancestor
101747090|NCT05673980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101747091|NCT02581124|Lapatinib|lapatinib|mesh-list
101747092|NCT02581124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101747093|NCT02581124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101747094|NCT02581124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101488366|NCT00431028|Hormones|hormones|mesh-ancestor
101747095|NCT02581124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747096|NCT02580968|Flunarizine|flunarizine|mesh-list
101747097|NCT02580968|Anticonvulsants|anticonvulsants|mesh-ancestor
101488470|NCT00332033|Pirfenidone|pirfenidone|mesh-list
101747098|NCT02580968|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101747099|NCT02580968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101747100|NCT02580968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747101|NCT02580968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101747102|NCT02580968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747103|NCT02580968|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101488519|NCT00431691|Nitroglycerin|nitroglycerin|mesh-list
101747104|NCT02580968|Histamine Antagonists|histamine antagonists|mesh-ancestor
101747105|NCT02580968|Histamine Agents|histamine agents|mesh-ancestor
101747106|NCT02580968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101747107|NCT02580968|Vasodilator Agents|vasodilator agents|mesh-ancestor
101747108|NCT00441103|Interferon beta-1a|interferon beta-1a|mesh-list
101498530|NCT00500604|Irbesartan|irbesartan|mesh-list
101747122|NCT03540212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101747123|NCT03268057|Avelumab|avelumab|mesh-list
101747124|NCT03268057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101747125|NCT03268057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101747126|NCT01033903|Misoprostol|misoprostol|mesh-list
101747127|NCT01033903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101747128|NCT01033903|Abortifacient Agents|abortifacient agents|mesh-ancestor
101747129|NCT01033903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101747130|NCT01033903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747131|NCT01033903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101747132|NCT01033903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101747133|NCT01033903|Oxytocics|oxytocics|mesh-ancestor
101747134|NCT03281954|Atezolizumab|atezolizumab|mesh-list
101747135|NCT03281954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101747136|NCT03281954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747137|NCT03281954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101404600|NCT00431392|Protective Agents|protective agents|mesh-ancestor
101747138|NCT03281954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101747139|NCT00433537|Dexamethasone|dexamethasone|mesh-list
101523599|NCT01628094|Ritonavir|ritonavir|mesh-list
101561650|NCT04659603|Tubulin Modulators|tubulin modulators|mesh-ancestor
101561651|NCT04659603|Antimitotic Agents|antimitotic agents|mesh-ancestor
101561652|NCT04659603|Mitosis Modulators|mitosis modulators|mesh-ancestor
101488744|NCT00333281|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101561654|NCT04616534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101561655|NCT04616534|Antimetabolites|antimetabolites|mesh-ancestor
101561656|NCT04616534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747140|NCT00433537|Cyclophosphamide|cyclophosphamide|mesh-list
101747142|NCT00433537|Doxorubicin|doxorubicin|mesh-list
101747143|NCT00433537|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101747144|NCT00433537|Vincristine|vincristine|mesh-list
101747145|NCT00433537|Bortezomib|bortezomib|mesh-list
101488808|NCT00333632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101747146|NCT00433537|Lenograstim|lenograstim|mesh-list
101747147|NCT00433537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101747148|NCT00433537|Immunologic Factors|immunologic factors|mesh-ancestor
101747149|NCT00433537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747150|NCT00433537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101747151|NCT00433537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101747152|NCT00433537|Alkylating Agents|alkylating agents|mesh-ancestor
101747153|NCT00433537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747154|NCT00433537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101747155|NCT00433537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101747156|NCT00433537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101747157|NCT00433537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101747158|NCT00433537|Antiemetics|antiemetics|mesh-ancestor
101488896|NCT04701528|Tacrolimus|tacrolimus|mesh-list
101747159|NCT00433537|Autonomic Agents|autonomic agents|mesh-ancestor
101747160|NCT00433537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101747161|NCT00433537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101747162|NCT00433537|Glucocorticoids|glucocorticoids|mesh-ancestor
101747163|NCT00433537|Hormones|hormones|mesh-ancestor
101489015|NCT04701606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101747164|NCT00433537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101747165|NCT00433537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101747166|NCT00433537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101747167|NCT00433537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101747168|NCT00433537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101747169|NCT00433537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101747170|NCT00433537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101747171|NCT00433537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101747172|NCT00433537|Tubulin Modulators|tubulin modulators|mesh-ancestor
101747184|NCT05118477|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101747185|NCT05118477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747186|NCT05118477|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101747187|NCT05118477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101747188|NCT05118477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747189|NCT05118477|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101747190|NCT05118477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101747191|NCT05118477|Purinergic Agents|purinergic agents|mesh-ancestor
101747192|NCT05118477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101747193|NCT00667095|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101747194|NCT00667095|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
101747195|NCT00667095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101747196|NCT00667095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101747197|NCT00667095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747198|NCT00667095|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101489328|NCT00335582|Autonomic Agents|autonomic agents|mesh-ancestor
101747199|NCT00667095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101747200|NCT00667095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747201|NCT00667095|Cholinergic Agents|cholinergic agents|mesh-ancestor
101747202|NCT00667095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101747203|NCT00667095|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101747204|NCT00667095|Protective Agents|protective agents|mesh-ancestor
101747205|NCT00667095|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101747206|NCT00667095|Antioxidants|antioxidants|mesh-ancestor
101747207|NCT00777933|Cyclosporine|cyclosporine|mesh-list
101747208|NCT00777933|Tacrolimus|tacrolimus|mesh-list
101747209|NCT00777933|Cyclosporins|cyclosporins|mesh-list
101747210|NCT00777933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101747211|NCT00777933|Immunologic Factors|immunologic factors|mesh-ancestor
101561657|NCT04616534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561658|NCT04600921|Ertugliflozin|ertugliflozin|mesh-list
101561659|NCT04600921|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101489539|NCT00337298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101561660|NCT04600921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561661|NCT04600921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101561662|NCT04600921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561663|NCT04526288|Cytarabine|cytarabine|mesh-list
101561664|NCT04526288|Daunorubicin|daunorubicin|mesh-list
101747212|NCT00777933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747213|NCT00777933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101404681|NCT00131040|Aprotinin|aprotinin|mesh-list
101747214|NCT00777933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101747215|NCT00777933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747216|NCT00777933|Antifungal Agents|antifungal agents|mesh-ancestor
101747217|NCT00777933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101747218|NCT00777933|Dermatologic Agents|dermatologic agents|mesh-ancestor
101747219|NCT00777933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101747220|NCT00773331|Epoetin Alfa|epoetin alfa|mesh-list
101747221|NCT00773331|Hematinics|hematinics|mesh-ancestor
101747222|NCT00778011|Ondansetron|ondansetron|mesh-list
101747223|NCT00778011|Metoclopramide|metoclopramide|mesh-list
101747224|NCT00778011|Antiemetics|antiemetics|mesh-ancestor
101747225|NCT00778011|Autonomic Agents|autonomic agents|mesh-ancestor
101747226|NCT00778011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101747227|NCT00778011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747228|NCT00778011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101747229|NCT00778011|Antipruritics|antipruritics|mesh-ancestor
101747230|NCT00778011|Dermatologic Agents|dermatologic agents|mesh-ancestor
101747231|NCT00778011|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101747232|NCT00778011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101747233|NCT00778011|Serotonin Agents|serotonin agents|mesh-ancestor
101747234|NCT00778011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101747235|NCT00778011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498658|NCT00469781|Methylprednisolone|methylprednisolone|mesh-list
101747238|NCT00778011|Dopamine Agents|dopamine agents|mesh-ancestor
101747239|NCT00778089|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
101747240|NCT00778089|Vasodilator Agents|vasodilator agents|mesh-ancestor
101747241|NCT00778089|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101747242|NCT00778089|Protective Agents|protective agents|mesh-ancestor
101747243|NCT00778089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747244|NCT00433381|Bevacizumab|bevacizumab|mesh-list
101747245|NCT00433381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101747246|NCT00433381|Irinotecan|irinotecan|mesh-list
101747247|NCT00433381|Temozolomide|temozolomide|mesh-list
101747248|NCT00433381|Camptothecin|camptothecin|mesh-list
101747249|NCT00433381|Endothelial Growth Factors|endothelial growth factors|mesh-list
101747250|NCT00433381|Antibodies|antibodies|mesh-list
101747251|NCT00433381|Immunoglobulins|immunoglobulins|mesh-list
101747252|NCT00433381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101747253|NCT00433381|Immunoglobulin G|immunoglobulin g|mesh-list
101747254|NCT00433381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101747255|NCT00433381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101747256|NCT00433381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101747257|NCT00433381|Growth Substances|growth substances|mesh-ancestor
101747258|NCT00433381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747259|NCT00433381|Growth Inhibitors|growth inhibitors|mesh-ancestor
101747260|NCT00433381|Immunologic Factors|immunologic factors|mesh-ancestor
101747261|NCT00433381|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101747262|NCT00433381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101747263|NCT00433381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101747264|NCT00433381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489687|NCT00338195|Purinergic Agents|purinergic agents|mesh-ancestor
101747265|NCT00433381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101747266|NCT00433381|Alkylating Agents|alkylating agents|mesh-ancestor
101747267|NCT00433381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101747268|NCT00667017|Immunotoxins|immunotoxins|mesh-list
101747269|NCT00667017|Immunoconjugates|immunoconjugates|mesh-ancestor
101747270|NCT00667017|Immunologic Factors|immunologic factors|mesh-ancestor
101747271|NCT00667017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747272|NCT00781131|Pregabalin|pregabalin|mesh-list
101561665|NCT04526288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101561667|NCT04526288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561668|NCT04526288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561669|NCT04526288|Antiviral Agents|antiviral agents|mesh-ancestor
101561670|NCT04526288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101489811|NCT00338936|Diuretics|diuretics|mesh-ancestor
101561671|NCT04526288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101561672|NCT04526288|Immunologic Factors|immunologic factors|mesh-ancestor
101561673|NCT04526288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410080|NCT00352378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101747273|NCT00781131|Analgesics|analgesics|mesh-ancestor
101747274|NCT00781131|Sensory System Agents|sensory system agents|mesh-ancestor
101747275|NCT00781131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101747276|NCT00781131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747277|NCT00781131|Anticonvulsants|anticonvulsants|mesh-ancestor
101489858|NCT00425243|Zolpidem|zolpidem|mesh-list
101747278|NCT00781131|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101747279|NCT00781131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101747280|NCT00781131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747281|NCT00781131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101747282|NCT00781131|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101747283|NCT00781131|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101489912|NCT00446316|Antacids|antacids|mesh-list
101747284|NCT00781131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101747285|NCT00781131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101747287|NCT00778245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101747288|NCT00778245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101747289|NCT00778401|Gabapentin|gabapentin|mesh-list
101404752|NCT00097760|Natalizumab|natalizumab|mesh-list
101747290|NCT00778401|Analgesics|analgesics|mesh-ancestor
101747291|NCT00778401|Sensory System Agents|sensory system agents|mesh-ancestor
101747292|NCT00778401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101747293|NCT00778401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747294|NCT00778401|Anticonvulsants|anticonvulsants|mesh-ancestor
101747295|NCT00778401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101747296|NCT00778401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101747297|NCT00778401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101747298|NCT00778401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101747299|NCT00778401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101747300|NCT00778401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101747301|NCT00778401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101489985|NCT00452556|Fertility Agents|fertility agents|mesh-ancestor
101747302|NCT00778401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747303|NCT00778401|Antimanic Agents|antimanic agents|mesh-ancestor
101747304|NCT00666705|Raltegravir Potassium|raltegravir potassium|mesh-list
101747306|NCT00666705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101747307|NCT00666705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101747308|NCT00666705|Antiviral Agents|antiviral agents|mesh-ancestor
101747309|NCT00666705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101747310|NCT00666705|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101747322|NCT00778557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101747323|NCT00778557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101747324|NCT00778713|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101747326|NCT00778713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101747327|NCT00778713|Diuretics|diuretics|mesh-ancestor
101747328|NCT00778713|Natriuretic Agents|natriuretic agents|mesh-ancestor
101747329|NCT00778713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747330|NCT00778713|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101747331|NCT00778713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101747332|NCT00778713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747333|NCT00778713|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101747334|NCT00778713|Protease Inhibitors|protease inhibitors|mesh-ancestor
101747335|NCT00778713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101747336|NCT00781287|Raltegravir Potassium|raltegravir potassium|mesh-list
101747337|NCT00781287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101747338|NCT00781287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101747339|NCT00781287|Antiviral Agents|antiviral agents|mesh-ancestor
101561674|NCT04526288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101561675|NCT04526288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101561676|NCT04526288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101561677|NCT04526288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101561678|NCT04520490|Exenatide|exenatide|mesh-list
101561679|NCT04520490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101561680|NCT04520490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561681|NCT04520490|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101410089|NCT00352378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101747340|NCT00781287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101747341|NCT00781287|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101747342|NCT00781287|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101747343|NCT00781287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101747344|NCT00781287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747345|NCT00774111|Dolutegravir|dolutegravir|mesh-list
101747346|NCT00774111|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101747347|NCT00774111|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101747348|NCT00774111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101747349|NCT00774111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747350|NCT00774111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101747351|NCT00774111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101747353|NCT00774111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101747354|NCT00778791|Metformin|metformin|mesh-list
101747355|NCT00778791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101747356|NCT00778791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747357|NCT00774189|Clarithromycin|clarithromycin|mesh-list
101747358|NCT00774189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101490161|NCT00446979|UC-781|uc-781|mesh-list
101747359|NCT00774189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101747360|NCT00774189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101747361|NCT00774189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101747362|NCT00774189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404825|NCT00097916|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101747363|NCT00774189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101490168|NCT00447018|Mannitol|mannitol|mesh-list
101747364|NCT00774189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101747366|NCT00774423|Anticonvulsants|anticonvulsants|mesh-ancestor
101747367|NCT00774423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101747368|NCT00774423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101747369|NCT00774423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101747370|NCT00774423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747371|NCT00774423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490226|NCT00453648|Vitamins|vitamins|mesh-ancestor
101747372|NCT00774423|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101747373|NCT00774423|Protective Agents|protective agents|mesh-ancestor
101747374|NCT00781521|Ofloxacin|ofloxacin|mesh-list
101747383|NCT00781521|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101747384|NCT00781521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101747386|NCT00774501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101747387|NCT00774501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747388|NCT00784485|Omalizumab|omalizumab|mesh-list
101747389|NCT00784485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101747390|NCT00784485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101747391|NCT00784485|Respiratory System Agents|respiratory system agents|mesh-ancestor
101747392|NCT00781755|Varenicline|varenicline|mesh-list
101747393|NCT00781755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101747394|NCT00781755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101376631|NCT00240058|Oxymetazoline|oxymetazoline|mesh-list
101376632|NCT00240058|Nitric Oxide|nitric oxide|mesh-list
101747395|NCT00781755|Cholinergic Agents|cholinergic agents|mesh-ancestor
101747396|NCT00781755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101747397|NCT00781755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747398|NCT00781755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747399|NCT00774735|Dolutegravir|dolutegravir|mesh-list
101747400|NCT00774735|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101747401|NCT00774735|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101747402|NCT00774735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101747403|NCT00774735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747404|NCT00774735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101561682|NCT04520490|Incretins|incretins|mesh-ancestor
101561683|NCT04520490|Hormones|hormones|mesh-ancestor
101490475|NCT00448110|Diclofenac|diclofenac|mesh-list
101561684|NCT04520490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101561685|NCT04483778|Pembrolizumab|pembrolizumab|mesh-list
101561686|NCT04483778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101490547|NCT00454545|Atorvastatin|atorvastatin|mesh-list
101561687|NCT04483778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561688|NCT04483778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101561689|NCT04483778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561690|NCT04482309|Trastuzumab|trastuzumab|mesh-list
101561691|NCT04482309|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
101490621|NCT00454701|Alefacept|alefacept|mesh-list
101561692|NCT04482309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101561693|NCT04482309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101747405|NCT00774735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101747406|NCT00774735|Antiviral Agents|antiviral agents|mesh-ancestor
101747407|NCT00774735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101747408|NCT00666237|Mitomycins|mitomycins|mesh-list
101747409|NCT00666237|Mitomycin|mitomycin|mesh-list
101747410|NCT00666237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101747411|NCT00666237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101747412|NCT00666237|Alkylating Agents|alkylating agents|mesh-ancestor
101747413|NCT00666237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747414|NCT00666237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101747415|NCT00666237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101747416|NCT00774813|Citalopram|citalopram|mesh-list
101490763|NCT02959658|Immunologic Factors|immunologic factors|mesh-ancestor
101747417|NCT00774813|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101747418|NCT00774813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101747419|NCT00774813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101747420|NCT00774813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490864|NCT00455286|Hormones|hormones|mesh-ancestor
101747421|NCT00774813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101747422|NCT00774813|Serotonin Agents|serotonin agents|mesh-ancestor
101747423|NCT00774813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747424|NCT00774813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101747425|NCT00774813|Antidepressive Agents|antidepressive agents|mesh-ancestor
101747426|NCT00774813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101747428|NCT00784797|Mifepristone|mifepristone|mesh-list
101747429|NCT00784797|Oxytocics|oxytocics|mesh-ancestor
101747430|NCT00784797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101747431|NCT00784797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747432|NCT00784797|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101747433|NCT00784797|Abortifacient Agents|abortifacient agents|mesh-ancestor
101747434|NCT00784797|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101747435|NCT00784797|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101747436|NCT00784797|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101747437|NCT00784797|Contraceptive Agents|contraceptive agents|mesh-ancestor
101747438|NCT00784797|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101498856|NCT00599833|Cetuximab|cetuximab|mesh-list
101747441|NCT00784797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101491037|NCT00455910|Thalidomide|thalidomide|mesh-list
101747443|NCT00784797|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101747444|NCT00784797|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101747445|NCT00774969|Metronidazole|metronidazole|mesh-list
101747446|NCT00774969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101747447|NCT00774969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101747448|NCT00774969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101747449|NCT00774969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101747450|NCT00785109|Vitamin K|vitamin k|mesh-list
101747451|NCT00785109|Vitamins|vitamins|mesh-ancestor
101747452|NCT00785109|Micronutrients|micronutrients|mesh-ancestor
101747453|NCT00785109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747454|NCT00785109|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101747455|NCT00785109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101747456|NCT00785109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561694|NCT04482309|Immunoconjugates|immunoconjugates|mesh-ancestor
101561695|NCT04482309|Immunologic Factors|immunologic factors|mesh-ancestor
101561696|NCT04482309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561698|NCT04480554|Buprenorphine|buprenorphine|mesh-list
101561699|NCT04480554|Methadone|methadone|mesh-list
101561700|NCT04480554|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101561701|NCT04480554|Naloxone|naloxone|mesh-list
101561702|NCT04480554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101747457|NCT00785109|Hemostatics|hemostatics|mesh-ancestor
101747458|NCT00785109|Coagulants|coagulants|mesh-ancestor
101747459|NCT00662025|Capecitabine|capecitabine|mesh-list
101747460|NCT00662025|Sunitinib|sunitinib|mesh-list
101747461|NCT00662025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101747462|NCT00662025|Antimetabolites|antimetabolites|mesh-ancestor
101747463|NCT00662025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747464|NCT00662025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101747465|NCT00662025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101747466|NCT00662025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101747467|NCT00662025|Growth Substances|growth substances|mesh-ancestor
101747468|NCT00662025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747469|NCT00662025|Growth Inhibitors|growth inhibitors|mesh-ancestor
101747470|NCT00662025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101747471|NCT00662025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101747472|NCT00789945|Insulin|insulin|mesh-list
101747473|NCT00789945|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101747474|NCT00789945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101747475|NCT00789945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747476|NCT00790101|Risedronic Acid|risedronic acid|mesh-list
101491509|NCT00351143|Xhance|xhance|mesh-list
101747477|NCT00790101|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101747478|NCT00790101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101747479|NCT00790101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101747480|NCT00790101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747481|NCT00790101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101747482|NCT00790101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747483|NCT00790101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101747484|NCT00790101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101747485|NCT00790101|Hormone Antagonists|hormone antagonists|mesh-ancestor
101747486|NCT00790101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101747487|NCT00790101|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101747488|NCT00790101|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101747489|NCT00782301|Maraviroc|maraviroc|mesh-list
101747490|NCT00782301|Etravirine|etravirine|mesh-list
101747491|NCT00782301|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101747492|NCT00782301|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101747493|NCT00782301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747494|NCT00782301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101747495|NCT00782301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101747496|NCT00782301|Antiviral Agents|antiviral agents|mesh-ancestor
101491722|NCT00353015|Cisplatin|cisplatin|mesh-list
101747497|NCT00782301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101747498|NCT00782301|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101747499|NCT00782301|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101376796|NCT00241111|Zoledronic Acid|zoledronic acid|mesh-list
101747500|NCT00782301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101747501|NCT00782301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101747502|NCT00785421|Leucovorin|leucovorin|mesh-list
101747503|NCT00785421|Folic Acid|folic acid|mesh-list
101747504|NCT00785421|Cisplatin|cisplatin|mesh-list
101747505|NCT00785421|Gemcitabine|gemcitabine|mesh-list
101747506|NCT00785421|Enoxaparin|enoxaparin|mesh-list
101747507|NCT00785421|Enoxaparin sodium|enoxaparin sodium|mesh-list
101747508|NCT00785421|Levoleucovorin|levoleucovorin|mesh-list
101747509|NCT00785421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404971|NCT00433459|Alkylating Agents|alkylating agents|mesh-ancestor
101498917|NCT00470015|Analgesics|analgesics|mesh-ancestor
101747525|NCT00790179|Anesthetics|anesthetics|mesh-ancestor
101747526|NCT00790179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101747527|NCT00790179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747528|NCT00790179|Sensory System Agents|sensory system agents|mesh-ancestor
101561703|NCT04480554|Narcotics|narcotics|mesh-ancestor
101561704|NCT04480554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101561705|NCT04480554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561706|NCT04480554|Analgesics|analgesics|mesh-ancestor
101561707|NCT04480554|Sensory System Agents|sensory system agents|mesh-ancestor
101561708|NCT04480554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101747529|NCT00790179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101747530|NCT00790413|Rituximab|rituximab|mesh-list
101747531|NCT00790413|Fludarabine|fludarabine|mesh-list
101747532|NCT00790413|Thiotepa|thiotepa|mesh-list
101747533|NCT00790413|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
101747534|NCT00790413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101747535|NCT00790413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101747536|NCT00790413|Immunologic Factors|immunologic factors|mesh-ancestor
101747537|NCT00790413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492107|NCT01059617|Immunologic Factors|immunologic factors|mesh-ancestor
101747538|NCT00790413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101747539|NCT00790413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747540|NCT00790413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101492164|NCT03271905|Cholinergic Agents|cholinergic agents|mesh-ancestor
101747541|NCT00790413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101747542|NCT00790413|Alkylating Agents|alkylating agents|mesh-ancestor
101747543|NCT00790413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101747544|NCT00790413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101747545|NCT00790413|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101747546|NCT00785811|N-Methylaspartate|n-methylaspartate|mesh-list
101747547|NCT00785811|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
101747548|NCT00785811|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101492235|NCT00426608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101492236|NCT00426608|GABA Modulators|gaba modulators|mesh-ancestor
101492237|NCT00426608|GABA Agents|gaba agents|mesh-ancestor
101492238|NCT00426608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101492239|NCT00426608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492240|NCT00426608|Antimetabolites|antimetabolites|mesh-ancestor
101492241|NCT00426608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101492242|NCT00426647|Buprenorphine|buprenorphine|mesh-list
101492243|NCT00426647|Tramadol|tramadol|mesh-list
101492244|NCT00426647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101492245|NCT00426647|Narcotics|narcotics|mesh-ancestor
101747549|NCT00785811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101747550|NCT00785811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747551|NCT00785811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747552|NCT00440947|Ritonavir|ritonavir|mesh-list
101747553|NCT00440947|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101747554|NCT00440947|Lamivudine|lamivudine|mesh-list
101747555|NCT00440947|Abacavir|abacavir|mesh-list
101747556|NCT00440947|Dideoxynucleosides|dideoxynucleosides|mesh-list
101747557|NCT00440947|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101747558|NCT00440947|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101747559|NCT00440947|Protease Inhibitors|protease inhibitors|mesh-ancestor
101747560|NCT00440947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101747561|NCT00440947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492381|NCT00427232|BQ 788|bq 788|mesh-list
101747562|NCT00440947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101747563|NCT00440947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101747564|NCT00440947|Antiviral Agents|antiviral agents|mesh-ancestor
101747565|NCT00440947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101747566|NCT00440947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101747567|NCT00440947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101747568|NCT00440947|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101747569|NCT00440947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101747571|NCT00790881|Lumefantrine|lumefantrine|mesh-list
101747572|NCT00790881|Artemether|artemether|mesh-list
101747578|NCT01029769|Olanzapine|olanzapine|mesh-list
101747579|NCT01029769|Amisulpride|amisulpride|mesh-list
101747580|NCT01029769|Antiemetics|antiemetics|mesh-ancestor
101747581|NCT01029769|Autonomic Agents|autonomic agents|mesh-ancestor
101747582|NCT01029769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101747583|NCT01029769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747584|NCT01029769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101492521|NCT00428480|Methamphetamine|methamphetamine|mesh-list
101747585|NCT01029769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101747586|NCT01029769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101747587|NCT01029769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101747588|NCT01029769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101747589|NCT01029769|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101747590|NCT01029769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101747591|NCT01029769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101747592|NCT01029769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747593|NCT01029769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101747594|NCT01029769|Serotonin Agents|serotonin agents|mesh-ancestor
101747595|NCT01029769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101747596|NCT01029769|Dopamine Agents|dopamine agents|mesh-ancestor
101492671|NCT00469443|Antidotes|antidotes|mesh-ancestor
101561709|NCT04480554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101561710|NCT04480554|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101561711|NCT04480554|Antitussive Agents|antitussive agents|mesh-ancestor
101561712|NCT04480554|Respiratory System Agents|respiratory system agents|mesh-ancestor
101561713|NCT04454476|Trametinib|trametinib|mesh-list
101561714|NCT04454476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561715|NCT04454476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101561716|NCT04454476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101747597|NCT01029769|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101747598|NCT01029769|Antidepressive Agents|antidepressive agents|mesh-ancestor
101747599|NCT02557945|Gabapentin|gabapentin|mesh-list
101747600|NCT02557945|Analgesics|analgesics|mesh-ancestor
101747601|NCT02557945|Sensory System Agents|sensory system agents|mesh-ancestor
101747602|NCT02557945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101747603|NCT02557945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492823|NCT00430196|Tizanidine|tizanidine|mesh-list
101747604|NCT02557945|Anticonvulsants|anticonvulsants|mesh-ancestor
101747605|NCT02557945|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101747606|NCT02557945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101747607|NCT02557945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101747608|NCT02557945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101747609|NCT02557945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101747610|NCT02557945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101747611|NCT02557945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101747612|NCT02557945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747613|NCT02557945|Antimanic Agents|antimanic agents|mesh-ancestor
101747614|NCT00664521|Rituximab|rituximab|mesh-list
101747615|NCT00664521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101492937|NCT00461916|Fertility Agents|fertility agents|mesh-ancestor
101747616|NCT00664521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101747617|NCT00664521|Immunologic Factors|immunologic factors|mesh-ancestor
101747618|NCT00664521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747619|NCT00664521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101747620|NCT02581046|Dexamethasone|dexamethasone|mesh-list
101747621|NCT02581046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101747622|NCT02581046|Antiemetics|antiemetics|mesh-ancestor
101747623|NCT02581046|Autonomic Agents|autonomic agents|mesh-ancestor
101747624|NCT02581046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101747625|NCT02581046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747626|NCT02581046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101747627|NCT02581046|Glucocorticoids|glucocorticoids|mesh-ancestor
101747628|NCT02581046|Hormones|hormones|mesh-ancestor
101493079|NCT00462540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101747629|NCT02581046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101747630|NCT02581046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101747631|NCT02581046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101747632|NCT00664209|Amoxicillin|amoxicillin|mesh-list
101747633|NCT00664209|Omeprazole|omeprazole|mesh-list
101747634|NCT00664209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101747635|NCT00664209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101747636|NCT00664209|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101747637|NCT00664209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101747638|NCT00664209|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101747639|NCT00664209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101747640|NCT00664209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747641|NCT03192332|Plasminogen|plasminogen|mesh-list
101747642|NCT03192332|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101747647|NCT02555943|Tenofovir|tenofovir|mesh-list
101747648|NCT02555943|Sofosbuvir|sofosbuvir|mesh-list
101747649|NCT02555943|Entecavir|entecavir|mesh-list
101747650|NCT02555943|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
101747651|NCT02555943|Ledipasvir|ledipasvir|mesh-list
101493260|NCT00463203|Bevacizumab|bevacizumab|mesh-list
101747652|NCT02555943|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101747653|NCT02555943|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101747654|NCT02555943|Protease Inhibitors|protease inhibitors|mesh-ancestor
101747655|NCT02555943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101747656|NCT02555943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747657|NCT02555943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101747658|NCT02555943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101747659|NCT02555943|Antiviral Agents|antiviral agents|mesh-ancestor
101747660|NCT02555943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101561717|NCT04454476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561718|NCT04428866|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101561719|NCT04428866|Glucagon|glucagon|mesh-list
101561720|NCT04428866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101561721|NCT04428866|Hormones|hormones|mesh-ancestor
101561722|NCT04428866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101561723|NCT04428866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561724|NCT04410042|Tranexamic Acid|tranexamic acid|mesh-list
101493471|NCT00591526|Antiviral Agents|antiviral agents|mesh-ancestor
101561725|NCT04410042|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101561726|NCT04410042|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101561727|NCT04410042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561728|NCT04410042|Hemostatics|hemostatics|mesh-ancestor
101561729|NCT04410042|Coagulants|coagulants|mesh-ancestor
101561730|NCT04408638|Gemcitabine|gemcitabine|mesh-list
101561731|NCT04408638|Oxaliplatin|oxaliplatin|mesh-list
101561732|NCT04408638|Obinutuzumab|obinutuzumab|mesh-list
101561733|NCT04408638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101561734|NCT04408638|Antimetabolites|antimetabolites|mesh-ancestor
101747661|NCT02555943|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101747662|NCT02555943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101747663|NCT02555943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101747664|NCT02555943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101747665|NCT00782847|Cyproterone Acetate|cyproterone acetate|mesh-list
101747666|NCT00782847|Cyproterone|cyproterone|mesh-list
101747667|NCT00782847|Androgen Antagonists|androgen antagonists|mesh-ancestor
101747668|NCT00782847|Hormone Antagonists|hormone antagonists|mesh-ancestor
101377061|NCT00077103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101747669|NCT00782847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101747670|NCT00782847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747671|NCT00782847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101747672|NCT00782847|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101747673|NCT00782847|Contraceptive Agents|contraceptive agents|mesh-ancestor
101747674|NCT00782847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101493809|NCT01055444|Sensory System Agents|sensory system agents|mesh-ancestor
101747675|NCT00785967|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101747676|NCT00785967|Immunologic Factors|immunologic factors|mesh-ancestor
101747677|NCT00785967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747678|NCT00440557|Epoetin Alfa|epoetin alfa|mesh-list
101747679|NCT00440557|Hematinics|hematinics|mesh-ancestor
101747680|NCT05673590|Docetaxel|docetaxel|mesh-list
101747681|NCT05673590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101747682|NCT05673590|Tubulin Modulators|tubulin modulators|mesh-ancestor
101747683|NCT05673590|Antimitotic Agents|antimitotic agents|mesh-ancestor
101747684|NCT05673590|Mitosis Modulators|mitosis modulators|mesh-ancestor
101747685|NCT05673590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747686|NCT01029847|Adalimumab|adalimumab|mesh-list
101747687|NCT01029847|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101747688|NCT01029847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101747689|NCT01029847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101747690|NCT02452268|Spartalizumab|spartalizumab|mesh-list
101747691|NCT02452268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101747692|NCT02452268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494013|NCT00436241|Oxaliplatin|oxaliplatin|mesh-list
101747693|NCT02452268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101747694|NCT02452268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101747695|NCT02524249|Caffeine|caffeine|mesh-list
101747696|NCT02524249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101747697|NCT02524249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747698|NCT02524249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101494139|NCT00436943|Bupropion|bupropion|mesh-list
101561735|NCT04408638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561736|NCT04408638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101494163|NCT00481884|Petrolatum|petrolatum|mesh-list
101561737|NCT04408638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101561738|NCT04396574|Lasmiditan|lasmiditan|mesh-list
101561739|NCT04396574|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101561740|NCT04396574|Serotonin Agents|serotonin agents|mesh-ancestor
101561741|NCT04396574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101561742|NCT04396574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561743|NCT04396574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747699|NCT02524249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101747700|NCT02524249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747701|NCT02524249|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101747702|NCT02524249|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101747703|NCT02524249|Purinergic Agents|purinergic agents|mesh-ancestor
101747704|NCT02524249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101747705|NCT01033981|Sunitinib|sunitinib|mesh-list
101377170|NCT00099333|Exenatide|exenatide|mesh-list
101747706|NCT01033981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101747707|NCT01033981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101747708|NCT01033981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101747709|NCT01033981|Growth Substances|growth substances|mesh-ancestor
101747710|NCT01033981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747711|NCT01033981|Growth Inhibitors|growth inhibitors|mesh-ancestor
101747712|NCT01033981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101747733|NCT02430194|Immunologic Factors|immunologic factors|mesh-ancestor
101747734|NCT02430194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747735|NCT00582608|N-(2-aminoethyl)-5-isoquinolinesulfonamide|n-(2-aminoethyl)-5-isoquinolinesulfonamide|mesh-list
101747736|NCT00582608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101747737|NCT00582608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101747738|NCT00582608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747740|NCT02400242|Pomalidomide|pomalidomide|mesh-list
101747741|NCT02400242|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
101747742|NCT02400242|Immunomodulating Agents|immunomodulating agents|mesh-list
101747743|NCT02400242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101747744|NCT02400242|Antiemetics|antiemetics|mesh-ancestor
101747745|NCT02400242|Autonomic Agents|autonomic agents|mesh-ancestor
101747746|NCT02400242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101747747|NCT02400242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747748|NCT02400242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101747749|NCT02400242|Glucocorticoids|glucocorticoids|mesh-ancestor
101747750|NCT02400242|Hormones|hormones|mesh-ancestor
101747751|NCT02400242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101747752|NCT02400242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101747753|NCT02400242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101747754|NCT02400242|Immunologic Factors|immunologic factors|mesh-ancestor
101747755|NCT02400242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101747756|NCT02400242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101747757|NCT02400242|Growth Substances|growth substances|mesh-ancestor
101747758|NCT02400242|Growth Inhibitors|growth inhibitors|mesh-ancestor
101747759|NCT02400242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101747760|NCT02400242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747761|NCT03087656|Levofloxacin|levofloxacin|mesh-list
101747762|NCT03087656|Ceftriaxone|ceftriaxone|mesh-list
101747763|NCT03087656|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101747764|NCT03087656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101747765|NCT03087656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101747766|NCT03087656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101747769|NCT03087656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747770|NCT03087656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101747771|NCT03087656|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101747772|NCT03087656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101747773|NCT04076228|Pembrolizumab|pembrolizumab|mesh-list
101747774|NCT04076228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101561745|NCT04396236|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101561746|NCT04396236|Serotonin Agents|serotonin agents|mesh-ancestor
101561747|NCT04396236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101561748|NCT04396236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561749|NCT04396236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561750|NCT04375605|Leucovorin|leucovorin|mesh-list
101561751|NCT04375605|Docetaxel|docetaxel|mesh-list
101561752|NCT04375605|Fluorouracil|fluorouracil|mesh-list
101561753|NCT04375605|Oxaliplatin|oxaliplatin|mesh-list
101561754|NCT04375605|Calcium|calcium|mesh-list
101561755|NCT04375605|Levoleucovorin|levoleucovorin|mesh-list
101561756|NCT04375605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561757|NCT04375605|Tubulin Modulators|tubulin modulators|mesh-ancestor
101561758|NCT04375605|Antimitotic Agents|antimitotic agents|mesh-ancestor
101561759|NCT04375605|Mitosis Modulators|mitosis modulators|mesh-ancestor
101561760|NCT04375605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561761|NCT04375605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101561762|NCT04375605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561763|NCT04375605|Antimetabolites|antimetabolites|mesh-ancestor
101561764|NCT04375605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101747775|NCT04076228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101747776|NCT04076228|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101747777|NCT04076228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747779|NCT02580734|Antioxidants|antioxidants|mesh-ancestor
101747780|NCT02580734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747781|NCT02580734|Protective Agents|protective agents|mesh-ancestor
101747782|NCT02580734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747783|NCT02580734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101747784|NCT00427999|Pioglitazone|pioglitazone|mesh-list
101747785|NCT00427999|Dexamethasone|dexamethasone|mesh-list
101747786|NCT00427999|Dexamethasone acetate|dexamethasone acetate|mesh-list
101747788|NCT00427999|Imatinib Mesylate|imatinib mesylate|mesh-list
101747789|NCT00427999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101747790|NCT00427999|Antiemetics|antiemetics|mesh-ancestor
101747791|NCT00427999|Autonomic Agents|autonomic agents|mesh-ancestor
101747792|NCT00427999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101747793|NCT00427999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495404|NCT00440622|Capecitabine|capecitabine|mesh-list
101747794|NCT00427999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101747795|NCT00427999|Glucocorticoids|glucocorticoids|mesh-ancestor
101747796|NCT00427999|Hormones|hormones|mesh-ancestor
101747797|NCT00427999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101495482|NCT00441051|Diclofenac|diclofenac|mesh-list
101747798|NCT00427999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101747799|NCT00427999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101747800|NCT00427999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101747801|NCT00427999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101747802|NCT00427999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101747803|NCT00427999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747804|NCT00427999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101747805|NCT00427999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101747806|NCT00427999|Analgesics|analgesics|mesh-ancestor
101747807|NCT00427999|Sensory System Agents|sensory system agents|mesh-ancestor
101747808|NCT00427999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101747809|NCT00427999|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101561765|NCT04375605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101561766|NCT04375605|Immunologic Factors|immunologic factors|mesh-ancestor
101561767|NCT04375605|Antidotes|antidotes|mesh-ancestor
101561768|NCT04375605|Protective Agents|protective agents|mesh-ancestor
101495725|NCT00445055|Dopamine Agents|dopamine agents|mesh-ancestor
101561769|NCT04375605|Vitamin B Complex|vitamin b complex|mesh-ancestor
101561771|NCT04375605|Micronutrients|micronutrients|mesh-ancestor
101561772|NCT04268498|Acetaminophen|acetaminophen|mesh-list
101561773|NCT04268498|Diphenhydramine|diphenhydramine|mesh-list
101561774|NCT04268498|Promethazine|promethazine|mesh-list
101747810|NCT00427999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101747811|NCT04825652|177Lu-PSMA-617|177lu-psma-617|mesh-list
101747812|NCT04825652|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101377388|NCT00245206|Risperidone|risperidone|mesh-list
101747813|NCT04825652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747814|NCT00661713|Vaccines|vaccines|mesh-list
101747815|NCT00661713|Immunologic Factors|immunologic factors|mesh-ancestor
101747816|NCT00661713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747817|NCT02578472|Zolpidem|zolpidem|mesh-list
101747818|NCT02578472|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101747819|NCT02578472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101747820|NCT02578472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101747821|NCT02578472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747822|NCT02578472|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101747823|NCT02578472|GABA Agonists|gaba agonists|mesh-ancestor
101747824|NCT02578472|GABA Agents|gaba agents|mesh-ancestor
101747825|NCT02578472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101747826|NCT02578472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747827|NCT03840902|Paclitaxel|paclitaxel|mesh-list
101747828|NCT03840902|Etoposide|etoposide|mesh-list
101747829|NCT03840902|Carboplatin|carboplatin|mesh-list
101747830|NCT03840902|Pemetrexed|pemetrexed|mesh-list
101747831|NCT03840902|Durvalumab|durvalumab|mesh-list
101747832|NCT03840902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101747833|NCT03840902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101747834|NCT03840902|Tubulin Modulators|tubulin modulators|mesh-ancestor
101747835|NCT03840902|Antimitotic Agents|antimitotic agents|mesh-ancestor
101747836|NCT03840902|Mitosis Modulators|mitosis modulators|mesh-ancestor
101747837|NCT03840902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747838|NCT03840902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101747839|NCT03840902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101747846|NCT03835975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747847|NCT04038086|Insulin|insulin|mesh-list
101747848|NCT04038086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101747849|NCT04038086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747850|NCT04072640|Voriconazole|voriconazole|mesh-list
101747851|NCT04072640|Amphotericin B|amphotericin b|mesh-list
101747852|NCT04072640|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101747853|NCT04072640|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
101747854|NCT04072640|Deoxycholic Acid|deoxycholic acid|mesh-list
101377416|NCT00077298|Bevacizumab|bevacizumab|mesh-list
101747855|NCT04072640|Antifungal Agents|antifungal agents|mesh-ancestor
101747856|NCT04072640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101747857|NCT04072640|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101747858|NCT04072640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101747859|NCT04072640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101263465|NCT01762202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747860|NCT04072640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377434|NCT00245401|Sirolimus|sirolimus|mesh-list
101747861|NCT04072640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101747862|NCT04072640|Hormone Antagonists|hormone antagonists|mesh-ancestor
101747863|NCT04072640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101496377|NCT00481182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101747864|NCT04072640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747865|NCT04072640|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101496471|NCT00459173|Rimonabant|rimonabant|mesh-list
101747866|NCT04072640|Amebicides|amebicides|mesh-ancestor
101747867|NCT04072640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101747868|NCT04072640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101747869|NCT04072640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101747870|NCT04072640|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101747871|NCT04072640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101561775|NCT04268498|Dexamethasone|dexamethasone|mesh-list
101561776|NCT04268498|Lenalidomide|lenalidomide|mesh-list
101561777|NCT04268498|Bortezomib|bortezomib|mesh-list
101561778|NCT04268498|Daratumumab|daratumumab|mesh-list
101561779|NCT04268498|Montelukast|montelukast|mesh-list
101561780|NCT04268498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101561781|NCT04268498|Antiemetics|antiemetics|mesh-ancestor
101561782|NCT04268498|Autonomic Agents|autonomic agents|mesh-ancestor
101561783|NCT04268498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101561784|NCT04268498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561785|NCT04268498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101561786|NCT04268498|Glucocorticoids|glucocorticoids|mesh-ancestor
101561787|NCT04268498|Hormones|hormones|mesh-ancestor
101561788|NCT04268498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101561789|NCT04268498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101561790|NCT04268498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561791|NCT04268498|Immunologic Factors|immunologic factors|mesh-ancestor
101561792|NCT04268498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101561793|NCT04268498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101561794|NCT04268498|Growth Substances|growth substances|mesh-ancestor
101561795|NCT04268498|Growth Inhibitors|growth inhibitors|mesh-ancestor
101561796|NCT04268498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101561797|NCT04268498|Analgesics|analgesics|mesh-ancestor
101410183|NCT00353002|Anesthetics, Local|anesthetics, local|mesh-ancestor
101747872|NCT01566487|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101747873|NCT01566487|Antidepressive Agents|antidepressive agents|mesh-ancestor
101747874|NCT01566487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101747875|NCT01566487|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101747876|NCT01566487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101747877|NCT01566487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101747878|NCT01566487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747879|NCT02576288|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101747880|NCT02576288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101747881|NCT02576288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747882|NCT02576288|Incretins|incretins|mesh-ancestor
101747883|NCT02576288|Hormones|hormones|mesh-ancestor
101747884|NCT02576288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101747885|NCT02576288|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101747886|NCT02576288|Protease Inhibitors|protease inhibitors|mesh-ancestor
101747887|NCT02576288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101747888|NCT02576288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747889|NCT00427921|Adalimumab|adalimumab|mesh-list
101747890|NCT00427921|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101747891|NCT00427921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101747892|NCT00427921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101747893|NCT00432991|Ephedrine|ephedrine|mesh-list
101747894|NCT00432991|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101747895|NCT00432991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747896|NCT00432991|Sympathomimetics|sympathomimetics|mesh-ancestor
101747897|NCT00432991|Autonomic Agents|autonomic agents|mesh-ancestor
101747898|NCT00432991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101747899|NCT00432991|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101747900|NCT00432991|Adrenergic Agents|adrenergic agents|mesh-ancestor
101561799|NCT04268498|Antipyretics|antipyretics|mesh-ancestor
101561800|NCT04268498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101561801|NCT04268498|Respiratory System Agents|respiratory system agents|mesh-ancestor
101561802|NCT04268498|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101561803|NCT04268498|Hormone Antagonists|hormone antagonists|mesh-ancestor
101561804|NCT04268498|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101561805|NCT04268498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101561806|NCT04268498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747901|NCT00432991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101747902|NCT00432991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747903|NCT00580970|Lovastatin|lovastatin|mesh-list
101747904|NCT00580970|L 647318|l 647318|mesh-list
101747905|NCT00580970|Dihydromevinolin|dihydromevinolin|mesh-list
101747913|NCT01030081|Amlodipine|amlodipine|mesh-list
101747914|NCT01030081|Nifedipine|nifedipine|mesh-list
101747915|NCT01030081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101747916|NCT01030081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101747917|NCT01030081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101747918|NCT01030081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747919|NCT01030081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101747920|NCT01030081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747921|NCT01030081|Vasodilator Agents|vasodilator agents|mesh-ancestor
101747922|NCT01030081|Tocolytic Agents|tocolytic agents|mesh-ancestor
101747923|NCT01030081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101747924|NCT00426751|Abciximab|abciximab|mesh-list
101747925|NCT00426751|Eptifibatide|eptifibatide|mesh-list
101747926|NCT00426751|Anticoagulants|anticoagulants|mesh-ancestor
101747927|NCT00426751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101747928|NCT02576366|Rifampin|rifampin|mesh-list
101747929|NCT02576366|Voriconazole|voriconazole|mesh-list
101747930|NCT02576366|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101747931|NCT02576366|Antitubercular Agents|antitubercular agents|mesh-ancestor
101208159|NCT00330759|Denosumab|denosumab|mesh-list
101747932|NCT02576366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101747933|NCT02576366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101497218|NCT00490659|Antimetabolites|antimetabolites|mesh-ancestor
101747934|NCT02576366|Leprostatic Agents|leprostatic agents|mesh-ancestor
101747935|NCT02576366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101747936|NCT02576366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101747937|NCT02576366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747938|NCT02576366|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101747939|NCT02576366|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101497298|NCT03272126|Micronutrients|micronutrients|mesh-ancestor
101747940|NCT02576366|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101747941|NCT02576366|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101747942|NCT02576366|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101747943|NCT02576366|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101497371|NCT00498108|Rotigotine|rotigotine|mesh-list
101747944|NCT02576366|Antifungal Agents|antifungal agents|mesh-ancestor
101747945|NCT02576366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101747946|NCT02576366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101181101|NCT02563860|Antimetabolites|antimetabolites|mesh-ancestor
101747947|NCT02576366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101747948|NCT02576366|Hormone Antagonists|hormone antagonists|mesh-ancestor
101747949|NCT02576366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101747950|NCT02576366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747951|NCT02576366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101747952|NCT01030237|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101747953|NCT01030237|Lubricant Eye Drops|lubricant eye drops|mesh-list
101747954|NCT01030237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101747955|NCT04046679|Bleomycin|bleomycin|mesh-list
101747956|NCT04046679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101497579|NCT03272867|Mannitol|mannitol|mesh-list
101747957|NCT04046679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101747958|NCT00786279|Ethanol|ethanol|mesh-list
101747959|NCT00786279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101747960|NCT00786279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101561807|NCT04268498|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101561808|NCT04268498|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101497661|NCT00592111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101561809|NCT04268498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101561810|NCT04268498|Anesthetics, Local|anesthetics, local|mesh-ancestor
101561812|NCT04268498|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101561813|NCT04268498|Histamine Antagonists|histamine antagonists|mesh-ancestor
101561814|NCT04268498|Histamine Agents|histamine agents|mesh-ancestor
101497734|NCT00498888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101747961|NCT00786279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101747962|NCT00786279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747963|NCT00791193|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101747964|NCT00791193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101747965|NCT00791193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101747966|NCT00791193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101747967|NCT00791193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747968|NCT00791193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101747969|NCT00791193|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101747976|NCT00791193|Dopamine Agents|dopamine agents|mesh-ancestor
101747977|NCT00791271|Interferons|interferons|mesh-list
101747978|NCT00791271|Interferon-alpha|interferon-alpha|mesh-list
101747979|NCT00791271|Interferon alpha-2|interferon alpha-2|mesh-list
101747980|NCT00791271|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101747981|NCT00791271|Decitabine|decitabine|mesh-list
101747982|NCT00791271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101747983|NCT00791271|Antiviral Agents|antiviral agents|mesh-ancestor
101747984|NCT00791271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101747985|NCT00791271|Immunologic Factors|immunologic factors|mesh-ancestor
101747986|NCT00791271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747987|NCT00791271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101747988|NCT00791271|Antimetabolites|antimetabolites|mesh-ancestor
101747989|NCT00791271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747990|NCT00791271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101747991|NCT00791349|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101747992|NCT00791349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101747993|NCT00791349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101747994|NCT00791349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101747995|NCT00791349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747996|NCT00791349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101747997|NCT00791349|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101747998|NCT00791349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101747999|NCT00791349|Serotonin Agents|serotonin agents|mesh-ancestor
101748000|NCT00791349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101748001|NCT00791349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748002|NCT00791349|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101748003|NCT00791349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101748004|NCT00791349|Dopamine Agents|dopamine agents|mesh-ancestor
101748006|NCT00440401|Hemostatics|hemostatics|mesh-list
101748007|NCT00440401|Coagulants|coagulants|mesh-ancestor
101748008|NCT00791427|Ranibizumab|ranibizumab|mesh-list
101748009|NCT00791427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101748010|NCT00791427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101748011|NCT00791427|Growth Substances|growth substances|mesh-ancestor
101748012|NCT00791427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748013|NCT00791427|Growth Inhibitors|growth inhibitors|mesh-ancestor
101748014|NCT00791427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101748015|NCT00786513|Anti-Infective Agents|anti-infective agents|mesh-list
101748016|NCT00786513|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101748017|NCT00791505|Ciprofloxacin|ciprofloxacin|mesh-list
101748018|NCT00791505|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101748019|NCT00791505|Fluoroquinolones|fluoroquinolones|mesh-list
101748020|NCT00791505|Trimethoprim|trimethoprim|mesh-list
101748021|NCT00791505|Sulfamethoxazole|sulfamethoxazole|mesh-list
101498516|NCT00500565|Anesthetics|anesthetics|mesh-ancestor
101748022|NCT00791505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101748023|NCT00791505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101748024|NCT00791505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101748025|NCT00791505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101748026|NCT00791505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101748027|NCT00791505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748028|NCT00791505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561815|NCT04268498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101561816|NCT04268498|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101561817|NCT04268498|Antipruritics|antipruritics|mesh-ancestor
101561818|NCT04268498|Dermatologic Agents|dermatologic agents|mesh-ancestor
101561819|NCT04220931|Botulinum Toxins|botulinum toxins|mesh-list
101561826|NCT04194775|Lenvatinib|lenvatinib|mesh-list
101561827|NCT04194775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561828|NCT04194775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101561829|NCT04194775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101561830|NCT04194775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561838|NCT04144023|Molgramostim|molgramostim|mesh-list
101561839|NCT04144023|Vaccines|vaccines|mesh-list
101561840|NCT04144023|Sargramostim|sargramostim|mesh-list
101748029|NCT00791505|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101748030|NCT00791505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101748031|NCT00791505|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101748032|NCT00791505|Antimalarials|antimalarials|mesh-ancestor
101748033|NCT00791505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101748034|NCT00791505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101748035|NCT00791505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101748036|NCT00791505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101748037|NCT00791505|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101748038|NCT00791505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101748057|NCT00783081|Cilostazol|cilostazol|mesh-list
101748058|NCT00783081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101748059|NCT00783081|Autonomic Agents|autonomic agents|mesh-ancestor
101498637|NCT01244100|Aspirin|aspirin|mesh-list
101748060|NCT00783081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101748061|NCT00783081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748062|NCT00783081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101748063|NCT00783081|Respiratory System Agents|respiratory system agents|mesh-ancestor
101748064|NCT00783081|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101748065|NCT00783081|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101748066|NCT00783081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748067|NCT00783081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101748068|NCT00783081|Vasodilator Agents|vasodilator agents|mesh-ancestor
101748069|NCT00783081|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101748070|NCT00783081|Protective Agents|protective agents|mesh-ancestor
101748071|NCT00783081|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101748072|NCT00783081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101748073|NCT00783081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101748074|NCT00426127|Docetaxel|docetaxel|mesh-list
101748075|NCT00426127|Doxorubicin|doxorubicin|mesh-list
101748076|NCT00426127|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101748077|NCT00426127|Enoxaparin|enoxaparin|mesh-list
101748078|NCT00426127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101748079|NCT00426127|Tubulin Modulators|tubulin modulators|mesh-ancestor
101748080|NCT00426127|Antimitotic Agents|antimitotic agents|mesh-ancestor
101748081|NCT00426127|Mitosis Modulators|mitosis modulators|mesh-ancestor
101748082|NCT00426127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748083|NCT00426127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101748084|NCT00426127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101748085|NCT00426127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101748086|NCT00426127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101748087|NCT00426127|Anticoagulants|anticoagulants|mesh-ancestor
101748088|NCT00426127|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101748089|NCT00426127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101748090|NCT02535078|Durvalumab|durvalumab|mesh-list
101748091|NCT02535078|Tremelimumab|tremelimumab|mesh-list
101748092|NCT02535078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101748093|NCT02535078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101748094|NCT00425503|Bortezomib|bortezomib|mesh-list
101748110|NCT00786669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101748111|NCT00786669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101748112|NCT00786669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101561841|NCT04144023|Immunologic Factors|immunologic factors|mesh-ancestor
101561842|NCT04144023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561843|NCT04144023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561844|NCT04098432|Nivolumab|nivolumab|mesh-list
101561845|NCT04098432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101561846|NCT04098432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561847|NCT04098432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101499255|NCT00601159|Antimetabolites|antimetabolites|mesh-ancestor
101561848|NCT04098432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561849|NCT04024462|Cyclophosphamide|cyclophosphamide|mesh-list
101561850|NCT04024462|Docetaxel|docetaxel|mesh-list
101748113|NCT00786669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748114|NCT00786669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101748115|NCT00786669|Tubulin Modulators|tubulin modulators|mesh-ancestor
101748116|NCT00786669|Antimitotic Agents|antimitotic agents|mesh-ancestor
101748117|NCT00786669|Mitosis Modulators|mitosis modulators|mesh-ancestor
101748118|NCT00786669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101748119|NCT00786669|Alkylating Agents|alkylating agents|mesh-ancestor
101748120|NCT00786669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101748121|NCT00786669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101748122|NCT00791739|Pregabalin|pregabalin|mesh-list
101748123|NCT00791739|Trazodone|trazodone|mesh-list
101748124|NCT00791739|Analgesics|analgesics|mesh-ancestor
101748125|NCT00791739|Sensory System Agents|sensory system agents|mesh-ancestor
101748126|NCT00791739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101499564|NCT01324141|Tempol|tempol|mesh-list
101748127|NCT00791739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748128|NCT00791739|Anticonvulsants|anticonvulsants|mesh-ancestor
101748129|NCT00791739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101748130|NCT00791739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101748131|NCT00791739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377895|NCT00099801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101748132|NCT00791739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101748133|NCT00791739|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101748134|NCT00791739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101748135|NCT00791739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101748136|NCT00791739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101748137|NCT00791739|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101748138|NCT00791739|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101748139|NCT00791739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101748140|NCT00791739|Serotonin Agents|serotonin agents|mesh-ancestor
101748141|NCT00791739|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101748142|NCT00791739|Antidepressive Agents|antidepressive agents|mesh-ancestor
101748143|NCT00791895|Insulin Aspart|insulin aspart|mesh-list
101748144|NCT00791895|Biphasic Insulins|biphasic insulins|mesh-list
101499853|NCT01323478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101748145|NCT00791895|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101748146|NCT00791895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101748147|NCT00791895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748148|NCT02503722|Osimertinib|osimertinib|mesh-list
101748149|NCT02503722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101748150|NCT02503722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101748151|NCT02503722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101263468|NCT01762202|Alkylating Agents|alkylating agents|mesh-ancestor
101748152|NCT02503722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748154|NCT00430573|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101499575|NCT01324141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101748171|NCT00783471|Mitosis Modulators|mitosis modulators|mesh-ancestor
101748172|NCT00783471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748173|NCT00783471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101748174|NCT00783471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101748175|NCT02460900|Varenicline|varenicline|mesh-list
101748176|NCT02460900|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101748177|NCT02460900|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101748178|NCT02460900|Cholinergic Agents|cholinergic agents|mesh-ancestor
101748179|NCT02460900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101561851|NCT04024462|Doxorubicin|doxorubicin|mesh-list
101561852|NCT04024462|Trastuzumab|trastuzumab|mesh-list
101561853|NCT04024462|Pertuzumab|pertuzumab|mesh-list
101561854|NCT04024462|Hormones|hormones|mesh-list
101561855|NCT04024462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101561856|NCT04024462|Immunologic Factors|immunologic factors|mesh-ancestor
101561857|NCT04024462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561858|NCT04024462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101561859|NCT04024462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101561860|NCT04024462|Alkylating Agents|alkylating agents|mesh-ancestor
101500353|NCT01315249|Xhance|xhance|mesh-list
101561861|NCT04024462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561862|NCT04024462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561863|NCT04024462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101561864|NCT04024462|Tubulin Modulators|tubulin modulators|mesh-ancestor
101561865|NCT04024462|Antimitotic Agents|antimitotic agents|mesh-ancestor
101561866|NCT04024462|Mitosis Modulators|mitosis modulators|mesh-ancestor
101561867|NCT04024462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101410240|NCT05594784|Venetoclax|venetoclax|mesh-list
101748180|NCT02460900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748181|NCT02460900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748182|NCT00787371|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101748183|NCT00787371|Interferon-alpha|interferon-alpha|mesh-list
101748184|NCT00787371|Antiviral Agents|antiviral agents|mesh-ancestor
101748185|NCT00787371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101748186|NCT00787371|Immunologic Factors|immunologic factors|mesh-ancestor
101748187|NCT00787371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748188|NCT02075840|Crizotinib|crizotinib|mesh-list
101748189|NCT02075840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101748190|NCT02075840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101748191|NCT02075840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101748192|NCT02075840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748193|NCT02554695|Denosumab|denosumab|mesh-list
101748194|NCT02554695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101748195|NCT02554695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748196|NCT00792363|Irinotecan|irinotecan|mesh-list
101748197|NCT00792363|Panitumumab|panitumumab|mesh-list
101748198|NCT00792363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101748199|NCT00792363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101748200|NCT00792363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101748201|NCT00792363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748202|NCT00792363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101748203|NCT00792363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101748204|NCT00425113|Metronidazole|metronidazole|mesh-list
101748205|NCT00425113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101748206|NCT00425113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101748207|NCT00425113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101748208|NCT00425113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101748209|NCT04895280|Triamcinolone|triamcinolone|mesh-list
101748210|NCT04895280|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101748211|NCT04895280|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101748212|NCT04895280|Ketorolac|ketorolac|mesh-list
101499641|NCT00471809|Hormones|hormones|mesh-ancestor
101748232|NCT04895280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101748233|NCT04895280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101748234|NCT03994783|Methylprednisolone|methylprednisolone|mesh-list
101748235|NCT03994783|Rituximab|rituximab|mesh-list
101748236|NCT03994783|Immunoglobulins|immunoglobulins|mesh-list
101748237|NCT03994783|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101748238|NCT03994783|gamma-Globulins|gamma-globulins|mesh-list
101748239|NCT03994783|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101561868|NCT04024462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101561869|NCT04024462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101561870|NCT04024462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101561871|NCT04024462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101561872|NCT04024462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101561873|NCT04011410|Hydroxychloroquine|hydroxychloroquine|mesh-list
101561874|NCT04011410|Antimalarials|antimalarials|mesh-ancestor
101382159|NCT00281125|Vatalanib|vatalanib|mesh-list
101748240|NCT03994783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101748241|NCT03994783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101748242|NCT03994783|Immunologic Factors|immunologic factors|mesh-ancestor
101748243|NCT03994783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748244|NCT03994783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101748245|NCT03994783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101748246|NCT03994783|Antiemetics|antiemetics|mesh-ancestor
101748247|NCT03994783|Autonomic Agents|autonomic agents|mesh-ancestor
101748248|NCT03994783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101748249|NCT03994783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101748250|NCT03994783|Glucocorticoids|glucocorticoids|mesh-ancestor
101748251|NCT03994783|Hormones|hormones|mesh-ancestor
101748252|NCT03994783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101748253|NCT03994783|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101748254|NCT03994783|Protective Agents|protective agents|mesh-ancestor
101748255|NCT00440011|Bimatoprost|bimatoprost|mesh-list
101748256|NCT00440011|Travoprost|travoprost|mesh-list
101748257|NCT00440011|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101384500|NCT00079976|Tigecycline|tigecycline|mesh-list
101748258|NCT00440011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101748259|NCT00440011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101748260|NCT03105102|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101748261|NCT03105102|Immunologic Factors|immunologic factors|mesh-ancestor
101748262|NCT03105102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748263|NCT01937468|Interleukin-2|interleukin-2|mesh-list
101748264|NCT01937468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500496|NCT04516317|Artesunate|artesunate|mesh-list
101748265|NCT01937468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101748266|NCT01937468|Analgesics|analgesics|mesh-ancestor
101748267|NCT01937468|Sensory System Agents|sensory system agents|mesh-ancestor
101748268|NCT01937468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101748277|NCT04072328|Propofol|propofol|mesh-list
101748278|NCT04072328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101748279|NCT04072328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101748280|NCT04072328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748281|NCT04072328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101748282|NCT04072328|Anesthetics, General|anesthetics, general|mesh-ancestor
101748283|NCT04072328|Anesthetics|anesthetics|mesh-ancestor
101386222|NCT00121017|Emtricitabine|emtricitabine|mesh-list
101748284|NCT04072328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101748285|NCT04072328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101748286|NCT04072328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101748287|NCT04072328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101748288|NCT04072328|GABA Modulators|gaba modulators|mesh-ancestor
101748289|NCT04072328|GABA Agents|gaba agents|mesh-ancestor
101748290|NCT04072328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101748291|NCT04072328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748292|NCT00495716|Acyclovir|acyclovir|mesh-list
101748293|NCT00495716|Antiviral Agents|antiviral agents|mesh-ancestor
101748294|NCT00495716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101748295|NCT00784017|Asparaginase|asparaginase|mesh-list
101388493|NCT05998551|Sensory System Agents|sensory system agents|mesh-ancestor
101388494|NCT05998551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101388495|NCT05998551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101388496|NCT05998551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101388497|NCT05998551|Analgesics|analgesics|mesh-ancestor
101748296|NCT00784017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101748297|NCT04074122|Adenosine|adenosine|mesh-list
101748298|NCT04074122|Isoproterenol|isoproterenol|mesh-list
101748299|NCT04074122|Epinephrine|epinephrine|mesh-list
101748300|NCT04074122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101748301|NCT04074122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101748302|NCT04074122|Adrenergic Agents|adrenergic agents|mesh-ancestor
101748303|NCT04074122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101748304|NCT04074122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748305|NCT04074122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748306|NCT04074122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101748307|NCT04074122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101748308|NCT04074122|Autonomic Agents|autonomic agents|mesh-ancestor
101748309|NCT04074122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101561875|NCT04011410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101561876|NCT04011410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101561877|NCT04011410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101561878|NCT04011410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101561879|NCT04011410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561880|NCT04011410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101561881|NCT03996850|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
101391092|NCT05281471|Mitosis Modulators|mitosis modulators|mesh-ancestor
101391093|NCT05281471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561882|NCT03996850|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101748310|NCT04074122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101748311|NCT04074122|Respiratory System Agents|respiratory system agents|mesh-ancestor
101748312|NCT04074122|Mydriatics|mydriatics|mesh-ancestor
101748313|NCT04074122|Sympathomimetics|sympathomimetics|mesh-ancestor
101748314|NCT04074122|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101748315|NCT04074122|Analgesics|analgesics|mesh-ancestor
101748316|NCT04074122|Sensory System Agents|sensory system agents|mesh-ancestor
101748317|NCT04074122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101748318|NCT04074122|Vasodilator Agents|vasodilator agents|mesh-ancestor
101748319|NCT04074122|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101748320|NCT04074122|Purinergic Agonists|purinergic agonists|mesh-ancestor
101748321|NCT04074122|Purinergic Agents|purinergic agents|mesh-ancestor
101748322|NCT04074122|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101392635|NCT04569747|Trastuzumab|trastuzumab|mesh-list
101748323|NCT04074122|Protective Agents|protective agents|mesh-ancestor
101748324|NCT02578550|Tenofovir|tenofovir|mesh-list
101748325|NCT02578550|Emtricitabine|emtricitabine|mesh-list
101748326|NCT02578550|Darunavir|darunavir|mesh-list
101748327|NCT02578550|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101748328|NCT02578550|Cobicistat|cobicistat|mesh-list
101393232|NCT04164069|Immunoglobulins|immunoglobulins|mesh-list
101748329|NCT02578550|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
101748330|NCT02578550|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
101748331|NCT02578550|Antiviral Agents|antiviral agents|mesh-ancestor
101748332|NCT02578550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101748333|NCT02578550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101748334|NCT02578550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101748335|NCT02578550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101748336|NCT02578550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748337|NCT02578550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101748350|NCT00788463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101748351|NCT00788463|Respiratory System Agents|respiratory system agents|mesh-ancestor
101748352|NCT00579254|Amlodipine|amlodipine|mesh-list
101748353|NCT00579254|Atorvastatin|atorvastatin|mesh-list
101748354|NCT00579254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101394606|NCT02703220|Anticonvulsants|anticonvulsants|mesh-ancestor
101748355|NCT00579254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101748356|NCT00579254|Antimetabolites|antimetabolites|mesh-ancestor
101748357|NCT00579254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748358|NCT00579254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101395224|NCT00585650|Analgesics|analgesics|mesh-ancestor
101748359|NCT00579254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101748360|NCT00579254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101396009|NCT00123279|Plasminogen|plasminogen|mesh-list
101748361|NCT00579254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101748362|NCT00579254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101748363|NCT00579254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101748364|NCT00579254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101748365|NCT00579254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748366|NCT00579254|Vasodilator Agents|vasodilator agents|mesh-ancestor
101748367|NCT00793221|Sirolimus|sirolimus|mesh-list
101748368|NCT00793221|Everolimus|everolimus|mesh-list
101748369|NCT00793221|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101748370|NCT00793221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101748371|NCT00793221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101748372|NCT00793221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748373|NCT00793221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101748374|NCT00793221|Immunologic Factors|immunologic factors|mesh-ancestor
101748375|NCT00793221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748376|NCT00793221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101748377|NCT00793221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101748378|NCT00793221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101748379|NCT00793221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101398332|NCT00087425|Rituximab|rituximab|mesh-list
101748380|NCT00793221|Antifungal Agents|antifungal agents|mesh-ancestor
101561883|NCT03996850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561885|NCT03994627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561886|NCT03971409|Doxorubicin|doxorubicin|mesh-list
101561887|NCT03971409|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101561888|NCT03971409|Avelumab|avelumab|mesh-list
101561889|NCT03971409|Camptothecin|camptothecin|mesh-list
101748381|NCT00661089|Botulinum Toxins|botulinum toxins|mesh-list
101748382|NCT00661089|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101748383|NCT00661089|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101399383|NCT04036435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101748384|NCT00661089|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101748385|NCT00661089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101748386|NCT00661089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748387|NCT00661089|Cholinergic Agents|cholinergic agents|mesh-ancestor
101748388|NCT00661089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101399913|NCT02057978|Chlorhexidine|chlorhexidine|mesh-list
101748389|NCT00661089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748390|NCT00661089|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101748391|NCT00661089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101748392|NCT01773278|Antioxidants|antioxidants|mesh-list
101748393|NCT01773278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748394|NCT01773278|Protective Agents|protective agents|mesh-ancestor
101748395|NCT01773278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748396|NCT00788931|Paclitaxel|paclitaxel|mesh-list
101748397|NCT00788931|Trastuzumab|trastuzumab|mesh-list
101748398|NCT00788931|Panobinostat|panobinostat|mesh-list
101748399|NCT00788931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101499812|NCT01323634|Xhance|xhance|mesh-list
101748414|NCT00582426|Octreotide|octreotide|mesh-list
101748415|NCT00582426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101748416|NCT00582426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101748417|NCT00582426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101748418|NCT00709982|Folic Acid|folic acid|mesh-list
101748419|NCT00709982|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101748420|NCT00709982|Norgestimate|norgestimate|mesh-list
101748421|NCT00709982|Estradiol|estradiol|mesh-list
101748422|NCT00709982|Estrogens|estrogens|mesh-ancestor
101748423|NCT00709982|Hormones|hormones|mesh-ancestor
101748424|NCT00709982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101748425|NCT00709982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748426|NCT00709982|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101402581|NCT00127998|Antiviral Agents|antiviral agents|mesh-ancestor
101748427|NCT00709982|Contraceptive Agents|contraceptive agents|mesh-ancestor
101748428|NCT00709982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101748429|NCT00709982|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101748430|NCT00709982|Hematinics|hematinics|mesh-ancestor
101748431|NCT00709982|Vitamin B Complex|vitamin b complex|mesh-ancestor
101748432|NCT00709982|Vitamins|vitamins|mesh-ancestor
101748433|NCT00709982|Micronutrients|micronutrients|mesh-ancestor
101748434|NCT00709982|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101748435|NCT00709982|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101748436|NCT00709982|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101748437|NCT04070690|Dialysis Solutions|dialysis solutions|mesh-list
101748438|NCT04070690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101748439|NCT00710138|Vitamins|vitamins|mesh-list
101748440|NCT00710138|Vitamin B 12|vitamin b 12|mesh-list
101748441|NCT00710138|Hydroxocobalamin|hydroxocobalamin|mesh-list
101748442|NCT00710138|Vitamin B Complex|vitamin b complex|mesh-list
101748443|NCT00710138|Micronutrients|micronutrients|mesh-ancestor
101748444|NCT00710138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748445|NCT00710138|Hematinics|hematinics|mesh-ancestor
101748446|NCT00580034|Alemtuzumab|alemtuzumab|mesh-list
101748447|NCT00580034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101748448|NCT00580034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101748449|NCT00710216|Lamivudine|lamivudine|mesh-list
101748450|NCT00710216|Telbivudine|telbivudine|mesh-list
101748451|NCT00710216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101748452|NCT00710216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101748453|NCT00710216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101500694|NCT00482222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748454|NCT00710216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748456|NCT00710216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101748457|NCT00710216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101748458|NCT00710216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101748459|NCT00773513|Epoetin Alfa|epoetin alfa|mesh-list
101561891|NCT03971409|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101561892|NCT03971409|Immunoglobulin G|immunoglobulin g|mesh-list
101561893|NCT03971409|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
101561894|NCT03971409|Immunoconjugates|immunoconjugates|mesh-list
101561895|NCT03971409|Immunologic Factors|immunologic factors|mesh-ancestor
101561896|NCT03971409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561897|NCT03971409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101561898|NCT03971409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101748460|NCT00773513|Darbepoetin alfa|darbepoetin alfa|mesh-list
101748461|NCT00773513|Hematinics|hematinics|mesh-ancestor
101748462|NCT00710528|Idelalisib|idelalisib|mesh-list
101499876|NCT04325581|Liraglutide|liraglutide|mesh-list
101748497|NCT02601911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101748499|NCT02601911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101748500|NCT02601911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101748501|NCT02601911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101500865|NCT00480896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101748502|NCT02601911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748517|NCT02577458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101748518|NCT00767039|Poractant alfa|poractant alfa|mesh-list
101748519|NCT00767039|Beractant|beractant|mesh-list
101748520|NCT00767039|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
101748521|NCT00767039|Respiratory System Agents|respiratory system agents|mesh-ancestor
101748522|NCT00662649|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101748523|NCT00662649|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101748524|NCT00662649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748525|NCT00662649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101748526|NCT00662649|Immunologic Factors|immunologic factors|mesh-ancestor
101748527|NCT00662649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748528|NCT02577770|Caffeine|caffeine|mesh-list
101748529|NCT02577770|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101748530|NCT02577770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748531|NCT02577770|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101748532|NCT02577770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101748533|NCT02577770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501093|NCT01240941|Hormone Antagonists|hormone antagonists|mesh-ancestor
101748534|NCT02577770|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101748535|NCT02577770|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101748536|NCT02577770|Purinergic Agents|purinergic agents|mesh-ancestor
101748537|NCT02577770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101748538|NCT00129896|Docetaxel|docetaxel|mesh-list
101748539|NCT00129896|Doxorubicin|doxorubicin|mesh-list
101748540|NCT00129896|Trastuzumab|trastuzumab|mesh-list
101748541|NCT00129896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101748542|NCT00129896|Tubulin Modulators|tubulin modulators|mesh-ancestor
101748543|NCT00129896|Antimitotic Agents|antimitotic agents|mesh-ancestor
101748544|NCT00129896|Mitosis Modulators|mitosis modulators|mesh-ancestor
101748545|NCT00129896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748546|NCT00129896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101748547|NCT00129896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101748548|NCT00129896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101748549|NCT00129896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101748550|NCT00129896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101748551|NCT02574338|Alprostadil|alprostadil|mesh-list
101748552|NCT02574338|Misoprostol|misoprostol|mesh-list
101748553|NCT02574338|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101748554|NCT02574338|Abortifacient Agents|abortifacient agents|mesh-ancestor
101748555|NCT02574338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101748556|NCT02574338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748557|NCT02574338|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101748558|NCT02574338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101748559|NCT02574338|Oxytocics|oxytocics|mesh-ancestor
101748560|NCT02574338|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101748561|NCT02574338|Vasodilator Agents|vasodilator agents|mesh-ancestor
101748562|NCT02574338|Urological Agents|urological agents|mesh-ancestor
101748563|NCT03070392|Pembrolizumab|pembrolizumab|mesh-list
101748568|NCT03070392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101748569|NCT03070392|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101561899|NCT03971409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101561900|NCT03971409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101561901|NCT03971409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101561902|NCT03971409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561903|NCT03971409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101410285|NCT00114816|Docetaxel|docetaxel|mesh-list
101501551|NCT05643820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101748570|NCT03070392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748571|NCT03070392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101748572|NCT03070392|Alkylating Agents|alkylating agents|mesh-ancestor
101748573|NCT03070392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101748575|NCT00711698|Narcotics|narcotics|mesh-ancestor
101748576|NCT00711698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101748577|NCT00711698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748578|NCT00711698|Analgesics|analgesics|mesh-ancestor
101748579|NCT00711698|Sensory System Agents|sensory system agents|mesh-ancestor
101748580|NCT00711698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101748581|NCT00795171|Docetaxel|docetaxel|mesh-list
101748582|NCT00795171|Sunitinib|sunitinib|mesh-list
101748583|NCT00795171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101748584|NCT00795171|Tubulin Modulators|tubulin modulators|mesh-ancestor
101748585|NCT00795171|Antimitotic Agents|antimitotic agents|mesh-ancestor
101748586|NCT00795171|Mitosis Modulators|mitosis modulators|mesh-ancestor
101748587|NCT00795171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748588|NCT00795171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101748589|NCT00795171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101748590|NCT00795171|Growth Substances|growth substances|mesh-ancestor
101748591|NCT00795171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748592|NCT00795171|Growth Inhibitors|growth inhibitors|mesh-ancestor
101748593|NCT00795171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101748594|NCT00795171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101748595|NCT00711854|Rifampin|rifampin|mesh-list
101748596|NCT00711854|Linezolid|linezolid|mesh-list
101748597|NCT00711854|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101748598|NCT00711854|Trimethoprim|trimethoprim|mesh-list
101748599|NCT00711854|Sulfamethoxazole|sulfamethoxazole|mesh-list
101748600|NCT00711854|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101748601|NCT00711854|Antitubercular Agents|antitubercular agents|mesh-ancestor
101748602|NCT00711854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101748603|NCT00711854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101748604|NCT00711854|Leprostatic Agents|leprostatic agents|mesh-ancestor
101748605|NCT00711854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101748606|NCT00711854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101501765|NCT02275806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101748607|NCT00711854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748608|NCT00711854|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101748609|NCT00711854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101748610|NCT00711854|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101501823|NCT00485160|Ibuprofen|ibuprofen|mesh-list
101748611|NCT00711854|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101748612|NCT00711854|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101748613|NCT00711854|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101748614|NCT00711854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101748615|NCT00711854|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101748616|NCT00711854|Antimalarials|antimalarials|mesh-ancestor
101748617|NCT00711854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101748618|NCT00711854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101748619|NCT00711854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101748620|NCT00711854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101748621|NCT00711854|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101748622|NCT00711854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101748623|NCT00795483|Zoledronic Acid|zoledronic acid|mesh-list
101748624|NCT00795483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101748625|NCT00795483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748626|NCT00712400|Latanoprost|latanoprost|mesh-list
101748627|NCT00712400|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101748628|NCT00712400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101748630|NCT00712478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101748631|NCT00712478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748632|NCT03015792|Dexamethasone|dexamethasone|mesh-list
101561904|NCT03971409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101502170|NCT00485810|Serotonin Agents|serotonin agents|mesh-ancestor
101561905|NCT03971409|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101561906|NCT03920007|Trimethoprim|trimethoprim|mesh-list
101561907|NCT03920007|Polymyxins|polymyxins|mesh-list
101561908|NCT03920007|Polymyxin B|polymyxin b|mesh-list
101561909|NCT03920007|Prednisone|prednisone|mesh-list
101561910|NCT03920007|Prednisolone|prednisolone|mesh-list
101561911|NCT03920007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101561912|NCT03920007|Glucocorticoids|glucocorticoids|mesh-ancestor
101561913|NCT03920007|Hormones|hormones|mesh-ancestor
101561914|NCT03920007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101748633|NCT03015792|Dexamethasone acetate|dexamethasone acetate|mesh-list
101406107|NCT00102986|Ritonavir|ritonavir|mesh-list
101748634|NCT03015792|Lenalidomide|lenalidomide|mesh-list
101748662|NCT00789165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748663|NCT00789165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748664|NCT00789165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101748665|NCT00789165|Antimalarials|antimalarials|mesh-ancestor
101748666|NCT00789165|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101748667|NCT00789165|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101748668|NCT00789165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101748669|NCT00789165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101748670|NCT00789165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101748671|NCT00789165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101748672|NCT00789165|Cholinergic Agents|cholinergic agents|mesh-ancestor
101748673|NCT00789165|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101404231|NCT01803594|Niacin|niacin|mesh-list
101748674|NCT00789165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101748675|NCT00789165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101748676|NCT00789165|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101748677|NCT00789165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101748679|NCT00712556|Cariostatic Agents|cariostatic agents|mesh-ancestor
101748680|NCT00712556|Protective Agents|protective agents|mesh-ancestor
101748681|NCT00712556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748682|NCT00772967|Naproxen|naproxen|mesh-list
101500111|NCT00478634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101748686|NCT00772967|Sensory System Agents|sensory system agents|mesh-ancestor
101748687|NCT00772967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101748688|NCT00772967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748689|NCT00772967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101748690|NCT00772967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101748691|NCT00772967|Gout Suppressants|gout suppressants|mesh-ancestor
101748692|NCT00772967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101748693|NCT00772967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101748694|NCT00772967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748696|NCT00793377|Cyclophosphamide|cyclophosphamide|mesh-list
101748697|NCT00793377|Docetaxel|docetaxel|mesh-list
101748698|NCT00793377|Doxorubicin|doxorubicin|mesh-list
101748699|NCT00793377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101404287|NCT01726452|Carboplatin|carboplatin|mesh-list
101748700|NCT00793377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101748701|NCT00793377|Immunologic Factors|immunologic factors|mesh-ancestor
101748702|NCT00793377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748703|NCT00793377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101502660|NCT00487110|Acetaminophen|acetaminophen|mesh-list
101748704|NCT00793377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101748705|NCT00793377|Alkylating Agents|alkylating agents|mesh-ancestor
101748706|NCT00793377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748707|NCT00793377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101748708|NCT00793377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101748710|NCT00793377|Antimitotic Agents|antimitotic agents|mesh-ancestor
101748711|NCT00793377|Mitosis Modulators|mitosis modulators|mesh-ancestor
101748712|NCT00793377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101748713|NCT00793377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101748714|NCT00793377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101748715|NCT00793377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101748716|NCT00793377|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101748717|NCT00793377|Hormone Antagonists|hormone antagonists|mesh-ancestor
101502965|NCT00492245|Mitomycins|mitomycins|mesh-list
101561915|NCT03920007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561916|NCT03920007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101561917|NCT03920007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561918|NCT03920007|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101561919|NCT03920007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101561920|NCT03920007|Antimalarials|antimalarials|mesh-ancestor
101561921|NCT03920007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101561922|NCT03920007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101748718|NCT00793377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101748719|NCT00793377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101404375|NCT00096629|Vaccines|vaccines|mesh-list
101748720|NCT00793377|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101748721|NCT00793377|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101748722|NCT00793377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101748723|NCT00662259|Alprazolam|alprazolam|mesh-list
101748724|NCT00662259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101748725|NCT00662259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101503104|NCT00492518|Vasodilator Agents|vasodilator agents|mesh-ancestor
101748726|NCT00662259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748727|NCT00662259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101748728|NCT00662259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101748729|NCT00662259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101748730|NCT00662259|GABA Modulators|gaba modulators|mesh-ancestor
101748731|NCT00662259|GABA Agents|gaba agents|mesh-ancestor
101748732|NCT00662259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101748733|NCT00662259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748734|NCT00712790|Sorafenib|sorafenib|mesh-list
101748735|NCT00712790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101748736|NCT00712790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101748737|NCT00712790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101748738|NCT00712790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748739|NCT00660699|Gemcitabine|gemcitabine|mesh-list
101748740|NCT00660699|Docetaxel|docetaxel|mesh-list
101503336|NCT02274506|Antimetabolites|antimetabolites|mesh-ancestor
101748741|NCT00660699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101748742|NCT00660699|Antimetabolites|antimetabolites|mesh-ancestor
101748743|NCT00660699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748744|NCT00660699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101748745|NCT00660699|Tubulin Modulators|tubulin modulators|mesh-ancestor
101748746|NCT00660699|Antimitotic Agents|antimitotic agents|mesh-ancestor
101748747|NCT00660699|Mitosis Modulators|mitosis modulators|mesh-ancestor
101748748|NCT02577068|Propacetamol|propacetamol|mesh-list
101748749|NCT02577068|Nefopam|nefopam|mesh-list
101748750|NCT02577068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101748751|NCT02577068|Analgesics|analgesics|mesh-ancestor
101748752|NCT02577068|Sensory System Agents|sensory system agents|mesh-ancestor
101748753|NCT02577068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101748754|NCT02577068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748755|NCT02577068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101748757|NCT02577068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101748758|NCT00582114|Atenolol|atenolol|mesh-list
101748759|NCT00582114|Lisinopril|lisinopril|mesh-list
101503519|NCT02595372|Omeprazole|omeprazole|mesh-list
101748760|NCT00582114|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101748761|NCT00582114|Protease Inhibitors|protease inhibitors|mesh-ancestor
101748762|NCT00582114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101748763|NCT00582114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748764|NCT00582114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101748765|NCT00582114|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101748766|NCT00582114|Protective Agents|protective agents|mesh-ancestor
101748767|NCT00582114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748768|NCT00582114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101748769|NCT00582114|Sympatholytics|sympatholytics|mesh-ancestor
101748770|NCT00582114|Autonomic Agents|autonomic agents|mesh-ancestor
101748771|NCT00582114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101748772|NCT00582114|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101748773|NCT00582114|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101748774|NCT00582114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101748775|NCT00582114|Adrenergic Agents|adrenergic agents|mesh-ancestor
101748776|NCT00582114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101561923|NCT03920007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101561924|NCT03920007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101561925|NCT03920007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561926|NCT03920007|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101503827|NCT00498251|Tocolytic Agents|tocolytic agents|mesh-ancestor
101561927|NCT03920007|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101561928|NCT03920007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101561929|NCT03920007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101561931|NCT03909165|Glycopyrrolate|glycopyrrolate|mesh-list
101561932|NCT03909165|Neostigmine|neostigmine|mesh-list
101561933|NCT03909165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101748777|NCT00582036|Insulin|insulin|mesh-list
101748778|NCT00582036|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101748779|NCT00582036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101748780|NCT00582036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748781|NCT00581360|Doxorubicin|doxorubicin|mesh-list
101748782|NCT00581360|Bortezomib|bortezomib|mesh-list
101406252|NCT00136539|Cyclophosphamide|cyclophosphamide|mesh-list
101503992|NCT05145270|Dexetimide|dexetimide|mesh-list
101748783|NCT00581360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101748784|NCT00581360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101748785|NCT00581360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101748786|NCT00581360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101748787|NCT00581360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101748788|NCT00581360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748790|NCT01650792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101748791|NCT01650792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101748792|NCT01650792|Analgesics|analgesics|mesh-ancestor
101748793|NCT01650792|Sensory System Agents|sensory system agents|mesh-ancestor
101748794|NCT01650792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101504173|NCT02274740|Metformin|metformin|mesh-list
101748795|NCT01650792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748796|NCT01650792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101504243|NCT00503828|Analgesics|analgesics|mesh-ancestor
101748797|NCT01650792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101748798|NCT01650792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101748799|NCT01650792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101748800|NCT01650792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748801|NCT01650792|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101748802|NCT01650792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101748803|NCT01650792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101748804|NCT01650792|Antipyretics|antipyretics|mesh-ancestor
101748805|NCT00660387|Levodopa|levodopa|mesh-list
101748806|NCT00660387|Carbidopa|carbidopa|mesh-list
101748807|NCT00660387|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101748808|NCT00660387|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101748809|NCT00660387|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101748810|NCT00660387|Dopamine Agents|dopamine agents|mesh-ancestor
101748811|NCT00660387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101748812|NCT00660387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748813|NCT00660387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748814|NCT00660387|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101748815|NCT00660387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101748816|NCT00660387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101748817|NCT00660387|Immunologic Factors|immunologic factors|mesh-ancestor
101748818|NCT00660387|Dopamine Agonists|dopamine agonists|mesh-ancestor
101748819|NCT00582738|Everolimus|everolimus|mesh-list
101748820|NCT00582738|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101748821|NCT00582738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101748822|NCT00582738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101748823|NCT00582738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748824|NCT00582738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101404868|NCT00403065|Dexamethasone|dexamethasone|mesh-list
101748825|NCT00582738|Immunologic Factors|immunologic factors|mesh-ancestor
101748826|NCT00582738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748827|NCT00582738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101748828|NCT00713336|Moxifloxacin|moxifloxacin|mesh-list
101561934|NCT03909165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101561935|NCT03909165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101561937|NCT03909165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101561938|NCT03909165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561939|NCT03909165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101561940|NCT03909165|Respiratory System Agents|respiratory system agents|mesh-ancestor
101561941|NCT03909165|Mydriatics|mydriatics|mesh-ancestor
101561942|NCT03909165|Parasympatholytics|parasympatholytics|mesh-ancestor
101561943|NCT03909165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101561944|NCT03909165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101561945|NCT03909165|Cholinergic Agents|cholinergic agents|mesh-ancestor
101561946|NCT03909165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101561947|NCT03909165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561948|NCT03909165|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101561949|NCT03909165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101561950|NCT03909165|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101561951|NCT03906136|Adalimumab|adalimumab|mesh-list
101748832|NCT00713336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101748833|NCT00713336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101748834|NCT00713336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101748835|NCT00713336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748836|NCT00713336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101748837|NCT00713336|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101748838|NCT00713336|Contraceptive Agents|contraceptive agents|mesh-ancestor
101748839|NCT00713336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101748840|NCT00713336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748841|NCT00713336|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101748842|NCT00713336|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101748843|NCT00713336|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101748844|NCT00789711|Insulin|insulin|mesh-list
101748845|NCT00789711|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101748846|NCT00789711|Insulin Aspart|insulin aspart|mesh-list
101748847|NCT00789711|Insulin Detemir|insulin detemir|mesh-list
101748848|NCT00789711|Biphasic Insulins|biphasic insulins|mesh-list
101748849|NCT00789711|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101748850|NCT00789711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101748851|NCT00789711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748852|NCT00713726|Fentanyl|fentanyl|mesh-list
101748853|NCT00713726|Tramadol|tramadol|mesh-list
101748854|NCT00713726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101748855|NCT00713726|Narcotics|narcotics|mesh-ancestor
101406333|NCT00103805|Levodopa|levodopa|mesh-list
101748856|NCT00713726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101748857|NCT00713726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748858|NCT00713726|Analgesics|analgesics|mesh-ancestor
101748859|NCT00713726|Sensory System Agents|sensory system agents|mesh-ancestor
101748860|NCT00713726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101748861|NCT00713726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101748862|NCT00713726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101748863|NCT00713726|Anesthetics, General|anesthetics, general|mesh-ancestor
101748864|NCT00713726|Anesthetics|anesthetics|mesh-ancestor
101748865|NCT00800553|Donepezil|donepezil|mesh-list
101748866|NCT00800553|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101748867|NCT00800553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101748868|NCT00800553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748869|NCT00800553|Cholinergic Agents|cholinergic agents|mesh-ancestor
101561952|NCT03906136|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101561953|NCT03906136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101561955|NCT03875573|Durvalumab|durvalumab|mesh-list
101561956|NCT03875573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101561957|NCT03875573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561958|NCT03800524|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
101748870|NCT00800553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101748871|NCT00800553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748872|NCT00800553|Nootropic Agents|nootropic agents|mesh-ancestor
101748873|NCT00793767|Epoetin Alfa|epoetin alfa|mesh-list
101748874|NCT00793767|Hematinics|hematinics|mesh-ancestor
101748875|NCT00796029|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101748876|NCT00796029|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101748877|NCT00796029|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101748878|NCT00796029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101748879|NCT00796029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748880|NCT00796029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101748881|NCT00796029|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101748882|NCT00796029|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101748883|NCT00796029|Serotonin Agents|serotonin agents|mesh-ancestor
101748884|NCT00796029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101748885|NCT00796029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748886|NCT00796029|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101748887|NCT00796029|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101748888|NCT00796029|Dopamine Agents|dopamine agents|mesh-ancestor
101748889|NCT00793845|Cyclophosphamide|cyclophosphamide|mesh-list
101748890|NCT00793845|Melphalan|melphalan|mesh-list
101748891|NCT00793845|Thiotepa|thiotepa|mesh-list
101748892|NCT00793845|Carboplatin|carboplatin|mesh-list
101748893|NCT00793845|Etoposide|etoposide|mesh-list
101748894|NCT00793845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101748896|NCT00793845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748897|NCT00793845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101748898|NCT00793845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101748899|NCT00793845|Alkylating Agents|alkylating agents|mesh-ancestor
101748900|NCT00793845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748913|NCT00800709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748914|NCT00800709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101748915|NCT00800709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101748916|NCT00793923|Dexamethasone|dexamethasone|mesh-list
101748917|NCT00793923|Ranibizumab|ranibizumab|mesh-list
101748918|NCT00793923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101748919|NCT00793923|Antiemetics|antiemetics|mesh-ancestor
101748920|NCT00793923|Autonomic Agents|autonomic agents|mesh-ancestor
101748921|NCT00793923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101748922|NCT00793923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748923|NCT00793923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101748924|NCT00793923|Glucocorticoids|glucocorticoids|mesh-ancestor
101748925|NCT00793923|Hormones|hormones|mesh-ancestor
101748926|NCT00793923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101748927|NCT00793923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101748928|NCT00793923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101748929|NCT00793923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101748930|NCT00793923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101748931|NCT00793923|Growth Substances|growth substances|mesh-ancestor
101748932|NCT00793923|Growth Inhibitors|growth inhibitors|mesh-ancestor
101748933|NCT01247324|Interferons|interferons|mesh-list
101748934|NCT01247324|Interferon-beta|interferon-beta|mesh-list
101748935|NCT01247324|Interferon beta-1a|interferon beta-1a|mesh-list
101748936|NCT01247324|Ocrelizumab|ocrelizumab|mesh-list
101748937|NCT01247324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101748938|NCT01247324|Antiviral Agents|antiviral agents|mesh-ancestor
101748939|NCT01247324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101748940|NCT01247324|Immunologic Factors|immunologic factors|mesh-ancestor
101748941|NCT01247324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748942|NCT01247324|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101748943|NCT00772577|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101748944|NCT00772577|Ramipril|ramipril|mesh-list
101748945|NCT00772577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101748946|NCT00772577|Diuretics|diuretics|mesh-ancestor
101748947|NCT00772577|Natriuretic Agents|natriuretic agents|mesh-ancestor
101561960|NCT03800524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101561961|NCT03800524|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101561962|NCT03800524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101561963|NCT03782207|Atezolizumab|atezolizumab|mesh-list
101561964|NCT03782207|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101410341|NCT00426010|Caffeine|caffeine|mesh-list
101748948|NCT00772577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748949|NCT00772577|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101748950|NCT00772577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101748951|NCT00772577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748952|NCT00772577|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101748953|NCT00772577|Protease Inhibitors|protease inhibitors|mesh-ancestor
101748954|NCT00772577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101748955|NCT02345850|Cyclophosphamide|cyclophosphamide|mesh-list
101748956|NCT02345850|Methotrexate|methotrexate|mesh-list
101748957|NCT02345850|Tacrolimus|tacrolimus|mesh-list
101748958|NCT02345850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101748959|NCT02345850|Immunologic Factors|immunologic factors|mesh-ancestor
101748960|NCT02345850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748961|NCT02345850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101748962|NCT02345850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101748963|NCT02345850|Alkylating Agents|alkylating agents|mesh-ancestor
101748965|NCT02345850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101748966|NCT02345850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101748967|NCT02345850|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101748968|NCT02345850|Abortifacient Agents|abortifacient agents|mesh-ancestor
101748969|NCT02345850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101748970|NCT02345850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101748971|NCT02345850|Antimetabolites|antimetabolites|mesh-ancestor
101748972|NCT02345850|Dermatologic Agents|dermatologic agents|mesh-ancestor
101748973|NCT02345850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101748974|NCT02345850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101748975|NCT02345850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101748976|NCT02345850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101748977|NCT00800787|Immunoglobulins|immunoglobulins|mesh-list
101748978|NCT00800787|Immunologic Factors|immunologic factors|mesh-ancestor
101748979|NCT00800787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748980|NCT04073550|Topotecan|topotecan|mesh-list
101748981|NCT04073550|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101748982|NCT04073550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101748983|NCT04073550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101748984|NCT04073550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748985|NCT04073550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101748986|NCT02576600|Remifentanil|remifentanil|mesh-list
101748987|NCT02576600|Propofol|propofol|mesh-list
101748988|NCT02576600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101405194|NCT00098852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101748989|NCT02576600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101748990|NCT02576600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748991|NCT02576600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101748992|NCT02576600|Anesthetics, General|anesthetics, general|mesh-ancestor
101748993|NCT02576600|Anesthetics|anesthetics|mesh-ancestor
101748994|NCT02576600|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101748995|NCT02576600|Narcotics|narcotics|mesh-ancestor
101748996|NCT02576600|Analgesics|analgesics|mesh-ancestor
101748997|NCT02576600|Sensory System Agents|sensory system agents|mesh-ancestor
101748998|NCT02576600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101748999|NCT02863770|Pancrelipase|pancrelipase|mesh-list
101749000|NCT02863770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101749001|NCT00796185|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101749002|NCT00796185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101749003|NCT00796185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101749004|NCT00796185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101406467|NCT00137085|Ketamine|ketamine|mesh-list
101749005|NCT00796185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749006|NCT00796185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101749007|NCT00796185|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101749008|NCT00796185|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101749010|NCT00796185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101561965|NCT03782207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561966|NCT03782207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101561968|NCT03760523|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
101561969|NCT03760523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101561970|NCT03760523|Alkylating Agents|alkylating agents|mesh-ancestor
101561971|NCT03760523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561972|NCT03760523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561973|NCT03712943|Nivolumab|nivolumab|mesh-list
101561974|NCT03712943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101561975|NCT03712943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101749011|NCT00796185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749012|NCT00796185|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101749013|NCT00796185|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101749014|NCT00796185|Dopamine Agents|dopamine agents|mesh-ancestor
101749015|NCT00660309|Irbesartan|irbesartan|mesh-list
101749016|NCT00660309|Captopril|captopril|mesh-list
101749017|NCT00660309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101749018|NCT00660309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101749019|NCT00660309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101749020|NCT00660309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749021|NCT00660309|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101749022|NCT00660309|Protease Inhibitors|protease inhibitors|mesh-ancestor
101749023|NCT00660309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101749024|NCT04046133|Pembrolizumab|pembrolizumab|mesh-list
101749025|NCT04046133|Capecitabine|capecitabine|mesh-list
101749026|NCT04046133|Mitomycins|mitomycins|mesh-list
101749027|NCT04046133|Mitomycin|mitomycin|mesh-list
101749028|NCT04046133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101749029|NCT04046133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101749030|NCT04046133|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101749031|NCT04046133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749032|NCT04046133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101749033|NCT04046133|Antimetabolites|antimetabolites|mesh-ancestor
101749034|NCT04046133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101749035|NCT04046133|Alkylating Agents|alkylating agents|mesh-ancestor
101749036|NCT04046133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101749042|NCT02573714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749044|NCT02573714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101749045|NCT02573714|Anesthetics, General|anesthetics, general|mesh-ancestor
101749046|NCT02573714|Anesthetics|anesthetics|mesh-ancestor
101749047|NCT02573714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101749048|NCT02573714|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101749049|NCT02573714|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101749050|NCT02573714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101749051|NCT02573714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749052|NCT00794235|Sorafenib|sorafenib|mesh-list
101749053|NCT00794235|Dacarbazine|dacarbazine|mesh-list
101749054|NCT00794235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101749055|NCT00794235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101749056|NCT00794235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101749057|NCT00794235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749058|NCT00794235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101749059|NCT00794235|Alkylating Agents|alkylating agents|mesh-ancestor
101749060|NCT00800943|Alemtuzumab|alemtuzumab|mesh-list
101749061|NCT00800943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101749062|NCT00800943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101749063|NCT02575664|Buprenorphine|buprenorphine|mesh-list
101749064|NCT02575664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101749065|NCT02575664|Narcotics|narcotics|mesh-ancestor
101561976|NCT03712943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101561977|NCT03712943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561978|NCT03695744|Dexamethasone|dexamethasone|mesh-list
101561979|NCT03695744|Bortezomib|bortezomib|mesh-list
101561980|NCT03695744|Daratumumab|daratumumab|mesh-list
101561981|NCT03695744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101561982|NCT03695744|Antiemetics|antiemetics|mesh-ancestor
101561983|NCT03695744|Autonomic Agents|autonomic agents|mesh-ancestor
101561984|NCT03695744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101561985|NCT03695744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561986|NCT03695744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101561987|NCT03695744|Glucocorticoids|glucocorticoids|mesh-ancestor
101561988|NCT03695744|Hormones|hormones|mesh-ancestor
101561989|NCT03695744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101561990|NCT03695744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101561991|NCT03695744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101749066|NCT02575664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101749067|NCT02575664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749068|NCT02575664|Analgesics|analgesics|mesh-ancestor
101749069|NCT02575664|Sensory System Agents|sensory system agents|mesh-ancestor
101749070|NCT02575664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101749071|NCT02575664|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101749072|NCT00796497|Ondansetron|ondansetron|mesh-list
101749073|NCT00796497|Antiemetics|antiemetics|mesh-ancestor
101749074|NCT00796497|Autonomic Agents|autonomic agents|mesh-ancestor
101749075|NCT00796497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101749076|NCT00796497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749077|NCT00796497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101749078|NCT00796497|Antipruritics|antipruritics|mesh-ancestor
101749079|NCT00796497|Dermatologic Agents|dermatologic agents|mesh-ancestor
101749080|NCT00796497|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101749081|NCT00796497|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101405233|NCT01057147|Rebamipide|rebamipide|mesh-list
101749082|NCT00796497|Serotonin Agents|serotonin agents|mesh-ancestor
101749083|NCT00796497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101749084|NCT00796497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749085|NCT00801177|Necitumumab|necitumumab|mesh-list
101749086|NCT00801177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101749087|NCT00801177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101749088|NCT00801177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101749089|NCT00801177|Immunologic Factors|immunologic factors|mesh-ancestor
101749090|NCT00801177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749091|NCT00581100|Etanercept|etanercept|mesh-list
101749092|NCT00581100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101749093|NCT00581100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101749094|NCT00581100|Analgesics|analgesics|mesh-ancestor
101749095|NCT00581100|Sensory System Agents|sensory system agents|mesh-ancestor
101749096|NCT00581100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101749097|NCT00581100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749098|NCT00581100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101749099|NCT00581100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101749100|NCT00581100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101749101|NCT00581100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101749102|NCT00581100|Immunologic Factors|immunologic factors|mesh-ancestor
101749103|NCT00579098|Atorvastatin|atorvastatin|mesh-list
101749104|NCT00579098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101749105|NCT00579098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101749106|NCT00579098|Antimetabolites|antimetabolites|mesh-ancestor
101749112|NCT00772109|Immunologic Factors|immunologic factors|mesh-ancestor
101749113|NCT00772109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101561992|NCT03690869|Cemiplimab|cemiplimab|mesh-list
101561993|NCT03690869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101561994|NCT03690869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101561995|NCT03637764|Atezolizumab|atezolizumab|mesh-list
101561996|NCT03637764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101561997|NCT03637764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101561998|NCT03637764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101561999|NCT03637764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101749115|NCT00801255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101749116|NCT00801255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101749117|NCT00794625|Valproic Acid|valproic acid|mesh-list
101749118|NCT00794625|Risperidone|risperidone|mesh-list
101749119|NCT00794625|Dextroamphetamine|dextroamphetamine|mesh-list
101749120|NCT00794625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101749121|NCT00794625|Serotonin Agents|serotonin agents|mesh-ancestor
101749122|NCT00794625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101749123|NCT00794625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749124|NCT00794625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749125|NCT00794625|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101749126|NCT00794625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101749127|NCT00794625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101749128|NCT00794625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101749129|NCT00794625|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101749130|NCT00794625|Dopamine Agents|dopamine agents|mesh-ancestor
101749131|NCT00794625|Anticonvulsants|anticonvulsants|mesh-ancestor
101749132|NCT00794625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101749133|NCT00794625|GABA Agents|gaba agents|mesh-ancestor
101749134|NCT00794625|Antimanic Agents|antimanic agents|mesh-ancestor
101749135|NCT00794625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101749136|NCT00794625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101405273|NCT00434317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749137|NCT00794625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101749138|NCT00794625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101749139|NCT02577432|Fentanyl|fentanyl|mesh-list
101749140|NCT02577432|Bupivacaine|bupivacaine|mesh-list
101749141|NCT02577432|Anesthetics, Local|anesthetics, local|mesh-ancestor
101749142|NCT02577432|Anesthetics|anesthetics|mesh-ancestor
101749143|NCT02577432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101749144|NCT02577432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749145|NCT02577432|Sensory System Agents|sensory system agents|mesh-ancestor
101749146|NCT02577432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101749147|NCT02577432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101749148|NCT02577432|Narcotics|narcotics|mesh-ancestor
101749149|NCT02577432|Analgesics|analgesics|mesh-ancestor
101749150|NCT02577432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101749151|NCT02577432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101749152|NCT02577432|Anesthetics, General|anesthetics, general|mesh-ancestor
101749153|NCT00794703|Itraconazole|itraconazole|mesh-list
101749154|NCT00794703|Micafungin|micafungin|mesh-list
101749155|NCT00794703|Antifungal Agents|antifungal agents|mesh-ancestor
101749156|NCT00794703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101749157|NCT00794703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101749158|NCT00794703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101749159|NCT00794703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101749160|NCT00794703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749161|NCT00794703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101749162|NCT00794703|Hormone Antagonists|hormone antagonists|mesh-ancestor
101749163|NCT00794703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101749164|NCT00794703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749165|NCT00794703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101749166|NCT00772031|Topiramate|topiramate|mesh-list
101749167|NCT00772031|Propranolol|propranolol|mesh-list
101749168|NCT00772031|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101749169|NCT00772031|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101749170|NCT00772031|Adrenergic Agents|adrenergic agents|mesh-ancestor
101749171|NCT00772031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101749172|NCT00772031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562000|NCT03611595|Tretinoin|tretinoin|mesh-list
101562001|NCT03611595|Isotretinoin|isotretinoin|mesh-list
101562002|NCT03611595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101562003|NCT03611595|Keratolytic Agents|keratolytic agents|mesh-ancestor
101562004|NCT03611595|Dermatologic Agents|dermatologic agents|mesh-ancestor
101562005|NCT03481569|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101749173|NCT00772031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749174|NCT00772031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101749175|NCT00772031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101749176|NCT00772031|Vasodilator Agents|vasodilator agents|mesh-ancestor
101749193|NCT00801411|Antimitotic Agents|antimitotic agents|mesh-ancestor
101749194|NCT00801411|Mitosis Modulators|mitosis modulators|mesh-ancestor
101749195|NCT00801411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101749196|NCT00801411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101749197|NCT00801411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101749198|NCT00801411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101749200|NCT04330820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101749201|NCT00794859|Sorafenib|sorafenib|mesh-list
101749202|NCT00794859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101749203|NCT00794859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101749204|NCT00794859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101749205|NCT00794859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749206|NCT04940013|Misoprostol|misoprostol|mesh-list
101749207|NCT04940013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101749208|NCT04940013|Abortifacient Agents|abortifacient agents|mesh-ancestor
101749209|NCT04940013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101749210|NCT04940013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749211|NCT04940013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101749212|NCT04940013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101749213|NCT04940013|Oxytocics|oxytocics|mesh-ancestor
101749214|NCT00771953|Docetaxel|docetaxel|mesh-list
101749215|NCT00771953|Pemetrexed|pemetrexed|mesh-list
101749216|NCT00771953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101749217|NCT00771953|Tubulin Modulators|tubulin modulators|mesh-ancestor
101749218|NCT00771953|Antimitotic Agents|antimitotic agents|mesh-ancestor
101749219|NCT00771953|Mitosis Modulators|mitosis modulators|mesh-ancestor
101749220|NCT00771953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749221|NCT00771953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101749222|NCT00771953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101749223|NCT00771953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101749224|NCT00714584|Naltrexone|naltrexone|mesh-list
101749225|NCT00714584|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101749226|NCT00714584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101749227|NCT00714584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749228|NCT00714584|Sensory System Agents|sensory system agents|mesh-ancestor
101749229|NCT00714584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101749230|NCT00621244|Panobinostat|panobinostat|mesh-list
101749231|NCT00621244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101749232|NCT00621244|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101749233|NCT00621244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101749234|NCT00621244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749235|NCT00916409|Temozolomide|temozolomide|mesh-list
101749236|NCT00916409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101749237|NCT00916409|Alkylating Agents|alkylating agents|mesh-ancestor
101749239|NCT00916409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101749241|NCT00714740|Anticonvulsants|anticonvulsants|mesh-ancestor
101749242|NCT00714740|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101749243|NCT00714740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101749244|NCT00714740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749245|NCT00714740|Diuretics|diuretics|mesh-ancestor
101749246|NCT00714740|Natriuretic Agents|natriuretic agents|mesh-ancestor
101749247|NCT00714740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749248|NCT00659529|Sildenafil Citrate|sildenafil citrate|mesh-list
101749249|NCT00659529|Vasodilator Agents|vasodilator agents|mesh-ancestor
101749250|NCT00659529|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101749251|NCT00659529|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101749252|NCT00659529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101749253|NCT00659529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749254|NCT00659529|Urological Agents|urological agents|mesh-ancestor
101749255|NCT02575508|Fluorouracil|fluorouracil|mesh-list
101562006|NCT03481569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101562007|NCT03442556|Carboplatin|carboplatin|mesh-list
101562008|NCT03442556|Docetaxel|docetaxel|mesh-list
101562009|NCT03442556|Rucaparib|rucaparib|mesh-list
101562010|NCT03442556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101562011|NCT03442556|Tubulin Modulators|tubulin modulators|mesh-ancestor
101562012|NCT03442556|Antimitotic Agents|antimitotic agents|mesh-ancestor
101562013|NCT03442556|Mitosis Modulators|mitosis modulators|mesh-ancestor
101405379|NCT00099554|Immunologic Factors|immunologic factors|mesh-ancestor
101562014|NCT03442556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562015|NCT03442556|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101562016|NCT03442556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101562017|NCT03401853|Rituximab|rituximab|mesh-list
101749256|NCT02575508|Oxaliplatin|oxaliplatin|mesh-list
101749257|NCT02575508|Irinotecan|irinotecan|mesh-list
101749258|NCT02575508|Camptothecin|camptothecin|mesh-list
101749259|NCT02575508|Infigratinib|infigratinib|mesh-list
101749260|NCT02575508|Antimetabolites|antimetabolites|mesh-ancestor
101749261|NCT02575508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749262|NCT02575508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101749263|NCT02575508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101749264|NCT02575508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101749265|NCT02575508|Immunologic Factors|immunologic factors|mesh-ancestor
101749266|NCT02575508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749267|NCT02575508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101749268|NCT02575508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101749269|NCT02575508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101749270|NCT02575508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101749272|NCT00795015|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101749273|NCT00795015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101749274|NCT00795015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749275|NCT00796887|Niacin|niacin|mesh-list
101749276|NCT00796887|Niacinamide|niacinamide|mesh-list
101749277|NCT00796887|Nicotinic Acids|nicotinic acids|mesh-list
101749278|NCT00796887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101749279|NCT00796887|Antimetabolites|antimetabolites|mesh-ancestor
101749280|NCT00796887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749281|NCT00796887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101749282|NCT00796887|Vasodilator Agents|vasodilator agents|mesh-ancestor
101749283|NCT00796887|Vitamin B Complex|vitamin b complex|mesh-ancestor
101749284|NCT00796887|Vitamins|vitamins|mesh-ancestor
101749285|NCT00796887|Micronutrients|micronutrients|mesh-ancestor
101528484|NCT04824911|Analgesics|analgesics|mesh-ancestor
101749286|NCT00796887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749287|NCT00578942|Alemtuzumab|alemtuzumab|mesh-list
101749288|NCT00578942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101749289|NCT00578942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101749290|NCT00843934|Epirubicin|epirubicin|mesh-list
101749291|NCT00843934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101749292|NCT00843934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101749293|NCT00843934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101749294|NCT00843934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101405551|NCT04728659|Hormones|hormones|mesh-ancestor
101749295|NCT00843934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101749296|NCT00843934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749297|NCT00805701|Dutasteride|dutasteride|mesh-list
101749298|NCT00805701|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101749299|NCT00805701|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101749300|NCT00805701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101749301|NCT00805701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749302|NCT00805701|Hormone Antagonists|hormone antagonists|mesh-ancestor
101749303|NCT00805701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101749304|NCT00805701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749305|NCT04042948|Acetaminophen|acetaminophen|mesh-list
101749306|NCT04042948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101406768|NCT01054144|Glucocorticoids|glucocorticoids|mesh-ancestor
101749307|NCT04042948|Analgesics|analgesics|mesh-ancestor
101749308|NCT04042948|Sensory System Agents|sensory system agents|mesh-ancestor
101562018|NCT03401853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101562020|NCT03401853|Obinutuzumab|obinutuzumab|mesh-list
101562021|NCT03401853|Antibodies|antibodies|mesh-list
101562022|NCT03401853|Immunoglobulins|immunoglobulins|mesh-list
101562023|NCT03401853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101562024|NCT03401853|Immunologic Factors|immunologic factors|mesh-ancestor
101562025|NCT03401853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562026|NCT03401853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101562027|NCT03401853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101562028|NCT03401853|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101562046|NCT03281369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101562047|NCT03281369|Immunologic Factors|immunologic factors|mesh-ancestor
101562048|NCT03281369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562049|NCT03281369|Antidotes|antidotes|mesh-ancestor
101562050|NCT03281369|Protective Agents|protective agents|mesh-ancestor
101562051|NCT03281369|Vitamin B Complex|vitamin b complex|mesh-ancestor
101562052|NCT03281369|Vitamins|vitamins|mesh-ancestor
101528718|NCT04626063|Acetaminophen|acetaminophen|mesh-list
101562053|NCT03281369|Micronutrients|micronutrients|mesh-ancestor
101562054|NCT03281369|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101562055|NCT03281369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101749309|NCT04042948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101749310|NCT04042948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749322|NCT00765245|Growth Inhibitors|growth inhibitors|mesh-ancestor
101749324|NCT00801879|Calcium|calcium|mesh-list
101749325|NCT00801879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101749326|NCT00801879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749327|NCT00801879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101749328|NCT00801879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101749329|NCT00801879|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101749330|NCT00801879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101749331|NCT00801879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749332|NCT00718484|Doxorubicin|doxorubicin|mesh-list
101749333|NCT00718484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101749334|NCT00718484|Isophosphamide mustard|isophosphamide mustard|mesh-list
101528837|NCT02903888|Levonorgestrel|levonorgestrel|mesh-list
101749336|NCT00718484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101749337|NCT00718484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101749338|NCT00718484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101749339|NCT00718484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101749340|NCT00718484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528969|NCT02902640|Sympathomimetics|sympathomimetics|mesh-ancestor
101749341|NCT00718484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749342|NCT00718484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101749343|NCT00718484|Alkylating Agents|alkylating agents|mesh-ancestor
101749344|NCT00841126|Iron|iron|mesh-list
101749345|NCT00841126|Trace Elements|trace elements|mesh-ancestor
101749346|NCT00841126|Micronutrients|micronutrients|mesh-ancestor
101749347|NCT00841126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749348|NCT00805857|Tipranavir|tipranavir|mesh-list
101749349|NCT00805857|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101749350|NCT00805857|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101749351|NCT00805857|Antiviral Agents|antiviral agents|mesh-ancestor
101749352|NCT00805857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101749353|NCT00801957|Hydrocortisone|hydrocortisone|mesh-list
101749354|NCT00801957|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101749355|NCT00801957|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101749356|NCT00801957|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101562056|NCT03281369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101562057|NCT03281369|Incretins|incretins|mesh-ancestor
101562058|NCT03281369|Hormones|hormones|mesh-ancestor
101562059|NCT03281369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101562060|NCT03281369|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101562061|NCT03281369|Protease Inhibitors|protease inhibitors|mesh-ancestor
101562062|NCT03281369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101562064|NCT03222076|Ipilimumab|ipilimumab|mesh-list
101562065|NCT03222076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101410417|NCT01059526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101749357|NCT00801957|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
101749358|NCT00801957|Tacrolimus|tacrolimus|mesh-list
101749359|NCT00801957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101749360|NCT00801957|Immunologic Factors|immunologic factors|mesh-ancestor
101749361|NCT00801957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749362|NCT00801957|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101749363|NCT00801957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101749364|NCT00801957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749365|NCT00801957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101749366|NCT00801957|Dermatologic Agents|dermatologic agents|mesh-ancestor
101749367|NCT00836134|Bupivacaine|bupivacaine|mesh-list
101749368|NCT00836134|Anesthetics, Local|anesthetics, local|mesh-list
101749369|NCT00836134|Anesthetics|anesthetics|mesh-list
101749370|NCT00836134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101749371|NCT00836134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749372|NCT00836134|Sensory System Agents|sensory system agents|mesh-ancestor
101749373|NCT00836134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101749374|NCT00782795|Pioglitazone|pioglitazone|mesh-list
101749375|NCT00782795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101749376|NCT00782795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749391|NCT02573558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749392|NCT02573558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101749393|NCT02573558|Anesthetics, General|anesthetics, general|mesh-ancestor
101749394|NCT02573558|Anesthetics|anesthetics|mesh-ancestor
101749396|NCT00656799|Rocuronium|rocuronium|mesh-list
101749397|NCT00656799|Anticonvulsants|anticonvulsants|mesh-ancestor
101749398|NCT00656799|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101405789|NCT00135681|Nedocromil|nedocromil|mesh-list
101749399|NCT00656799|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101749400|NCT00656799|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101749401|NCT00656799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101749402|NCT00656799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749403|NCT00764699|Mecasermin|mecasermin|mesh-list
101749404|NCT00764699|Growth Substances|growth substances|mesh-ancestor
101749405|NCT00764699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749406|NCT00844012|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101749407|NCT00844012|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101749408|NCT00844012|Estradiol|estradiol|mesh-list
101749409|NCT00844012|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101749410|NCT00844012|Estrogens|estrogens|mesh-ancestor
101749411|NCT00844012|Hormones|hormones|mesh-ancestor
101749412|NCT00844012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101749413|NCT00844012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749414|NCT00844012|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101749415|NCT00844012|Contraceptive Agents|contraceptive agents|mesh-ancestor
101749416|NCT00844012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101749417|NCT00844012|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101749418|NCT02574962|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101749419|NCT02574962|Hormones|hormones|mesh-ancestor
101749420|NCT02574962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101405859|NCT00102167|GABA Agents|gaba agents|mesh-ancestor
101749421|NCT02574962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749422|NCT00802035|Baclofen|baclofen|mesh-list
101749423|NCT00802035|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101749424|NCT00802035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749425|NCT00802035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101562066|NCT03222076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101562067|NCT03222076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101562068|NCT03222076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562069|NCT03215706|Paclitaxel|paclitaxel|mesh-list
101562070|NCT03215706|Carboplatin|carboplatin|mesh-list
101562071|NCT03215706|Nivolumab|nivolumab|mesh-list
101562072|NCT03215706|Pemetrexed|pemetrexed|mesh-list
101562073|NCT03215706|Ipilimumab|ipilimumab|mesh-list
101562074|NCT03215706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101562075|NCT03215706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101562076|NCT03215706|Tubulin Modulators|tubulin modulators|mesh-ancestor
101749426|NCT00802035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101749427|NCT00802035|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101749428|NCT00802035|GABA Agonists|gaba agonists|mesh-ancestor
101749429|NCT00802035|GABA Agents|gaba agents|mesh-ancestor
101749430|NCT00802035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101749431|NCT00802035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749432|NCT00836212|Efavirenz|efavirenz|mesh-list
101749433|NCT00836212|Lopinavir|lopinavir|mesh-list
101749434|NCT00836212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101749435|NCT00836212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101749436|NCT00836212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101749437|NCT00836212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749443|NCT00836212|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101749444|NCT00836212|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101749445|NCT00836212|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101749446|NCT00836212|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101749447|NCT00836212|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101406020|NCT00102713|GABA Agents|gaba agents|mesh-ancestor
101749448|NCT00836212|Protease Inhibitors|protease inhibitors|mesh-ancestor
101749449|NCT00836212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101749450|NCT00836212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101749451|NCT00836212|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101749452|NCT00782717|Prednisolone|prednisolone|mesh-list
101749453|NCT00782717|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101749454|NCT00782717|Methylprednisolone|methylprednisolone|mesh-list
101749455|NCT00782717|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101406918|NCT00435292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101749456|NCT00782717|Prednisolone acetate|prednisolone acetate|mesh-list
101749457|NCT00782717|Nepafenac|nepafenac|mesh-list
101749458|NCT00782717|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101406083|NCT00136266|Vitamin D|vitamin d|mesh-list
101749459|NCT00782717|Prednisolone phosphate|prednisolone phosphate|mesh-list
101749460|NCT00782717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101749461|NCT00782717|Glucocorticoids|glucocorticoids|mesh-ancestor
101749462|NCT00782717|Hormones|hormones|mesh-ancestor
101749463|NCT00782717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101749464|NCT00782717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749465|NCT00782717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101749466|NCT00782717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101749467|NCT00782717|Antiemetics|antiemetics|mesh-ancestor
101749468|NCT00782717|Autonomic Agents|autonomic agents|mesh-ancestor
101749469|NCT00782717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101749470|NCT00782717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101749471|NCT00782717|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101749472|NCT00782717|Protective Agents|protective agents|mesh-ancestor
101749473|NCT00782717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101749474|NCT00782717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101749475|NCT00782717|Analgesics|analgesics|mesh-ancestor
101749476|NCT00782717|Sensory System Agents|sensory system agents|mesh-ancestor
101749477|NCT00782717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101749478|NCT00656175|Raltegravir Potassium|raltegravir potassium|mesh-list
101749479|NCT00656175|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101749480|NCT00656175|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101749481|NCT00656175|Antiviral Agents|antiviral agents|mesh-ancestor
101749482|NCT00656175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101749483|NCT00656175|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101562078|NCT03215706|Mitosis Modulators|mitosis modulators|mesh-ancestor
101562079|NCT03215706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562080|NCT03215706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101562081|NCT03215706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101562082|NCT03215706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101562083|NCT03215706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101562084|NCT03215706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101562102|NCT03141177|Nivolumab|nivolumab|mesh-list
101562103|NCT03141177|Ipilimumab|ipilimumab|mesh-list
101562104|NCT03141177|Sunitinib|sunitinib|mesh-list
101524064|NCT02910206|Sufentanil|sufentanil|mesh-list
101562105|NCT03141177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101562106|NCT03141177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101562107|NCT03141177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101562108|NCT03141177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562109|NCT03141177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101749484|NCT00656175|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101749485|NCT00656175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101749486|NCT00656175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749487|NCT02601677|Fluoxetine|fluoxetine|mesh-list
101749488|NCT02601677|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101749489|NCT02601677|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101749490|NCT02601677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101749491|NCT02601677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749492|NCT02601677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101749493|NCT02601677|Serotonin Agents|serotonin agents|mesh-ancestor
101749494|NCT02601677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749495|NCT02601677|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101749496|NCT02601677|Antidepressive Agents|antidepressive agents|mesh-ancestor
101749497|NCT02601677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101749498|NCT02601677|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101749499|NCT02601677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101749500|NCT02601677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101749501|NCT00620776|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101749502|NCT00620776|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101749503|NCT00620776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101749522|NCT00841516|Immunomodulating Agents|immunomodulating agents|mesh-list
101749523|NCT00841516|Immunologic Factors|immunologic factors|mesh-ancestor
101749524|NCT00841516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749525|NCT00841594|Nitroglycerin|nitroglycerin|mesh-list
101749526|NCT00841594|Vasodilator Agents|vasodilator agents|mesh-ancestor
101749527|NCT04068974|Apatinib|apatinib|mesh-list
101749528|NCT04068974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101749529|NCT04068974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101749530|NCT04068974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101749531|NCT04068974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749532|NCT00836368|Vitamin E|vitamin e|mesh-list
101749533|NCT00836368|Tocopherols|tocopherols|mesh-list
101749534|NCT00836368|Tocotrienols|tocotrienols|mesh-list
101749535|NCT00836368|alpha-Tocopherol|alpha-tocopherol|mesh-list
101749536|NCT00836368|gamma-Tocopherol|gamma-tocopherol|mesh-list
101749537|NCT00836368|Vitamins|vitamins|mesh-ancestor
101749538|NCT00836368|Micronutrients|micronutrients|mesh-ancestor
101749539|NCT00836368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749540|NCT00836368|Antioxidants|antioxidants|mesh-ancestor
101562110|NCT03141177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101562111|NCT03141177|Growth Substances|growth substances|mesh-ancestor
101562112|NCT03141177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562113|NCT03141177|Growth Inhibitors|growth inhibitors|mesh-ancestor
101562114|NCT03141177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101562115|NCT03141177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101562116|NCT02936843|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
101562117|NCT02936843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101562118|NCT02936843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101562119|NCT02936843|Analgesics|analgesics|mesh-ancestor
101562120|NCT02936843|Sensory System Agents|sensory system agents|mesh-ancestor
101562121|NCT02936843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101562122|NCT02936843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562123|NCT02936843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101562124|NCT02936843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101749541|NCT00836368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749542|NCT00836368|Protective Agents|protective agents|mesh-ancestor
101749543|NCT00718796|Coenzyme Q10|coenzyme q10|mesh-list
101749544|NCT00718796|Ubiquinone|ubiquinone|mesh-list
101749545|NCT00718796|Atorvastatin|atorvastatin|mesh-list
101749546|NCT00718796|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101749547|NCT00718796|Simvastatin|simvastatin|mesh-list
101749548|NCT00718796|Pravastatin|pravastatin|mesh-list
101749549|NCT00718796|Lovastatin|lovastatin|mesh-list
101749550|NCT00718796|L 647318|l 647318|mesh-list
101749551|NCT00718796|Dihydromevinolin|dihydromevinolin|mesh-list
101749552|NCT00718796|Anticholesteremic Agents|anticholesteremic agents|mesh-list
101749553|NCT00718796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101749554|NCT00718796|Antimetabolites|antimetabolites|mesh-ancestor
101749555|NCT00718796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749556|NCT00718796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101749557|NCT00718796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101749558|NCT00718796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101749560|NCT00718796|Micronutrients|micronutrients|mesh-ancestor
101749561|NCT00718796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749562|NCT00844168|Sorafenib|sorafenib|mesh-list
101749563|NCT00844168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101749564|NCT00844168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101749575|NCT00764465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749577|NCT00764465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101749578|NCT00764465|Antiviral Agents|antiviral agents|mesh-ancestor
101749579|NCT00764465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101529959|NCT04679597|Oxaliplatin|oxaliplatin|mesh-list
101749580|NCT00764465|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101749581|NCT00764465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101749582|NCT00764465|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101749583|NCT00764465|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101749584|NCT00764465|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101749585|NCT00655863|Pioglitazone|pioglitazone|mesh-list
101749586|NCT00655863|Alogliptin|alogliptin|mesh-list
101749587|NCT00655863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101749588|NCT00655863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749589|NCT00655863|Incretins|incretins|mesh-ancestor
101749590|NCT00655863|Hormones|hormones|mesh-ancestor
101749591|NCT00655863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101530051|NCT02187302|Sunitinib|sunitinib|mesh-list
101749592|NCT00655863|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101749593|NCT00655863|Protease Inhibitors|protease inhibitors|mesh-ancestor
101749594|NCT00655863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101749595|NCT00655863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749596|NCT00718952|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101562126|NCT02811861|Everolimus|everolimus|mesh-list
101562127|NCT02811861|Sunitinib|sunitinib|mesh-list
101562128|NCT02811861|Lenvatinib|lenvatinib|mesh-list
101562129|NCT02811861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101562130|NCT02811861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101562131|NCT02811861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101749597|NCT00718952|Vasodilator Agents|vasodilator agents|mesh-ancestor
101749598|NCT00718952|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101749599|NCT00718952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101749600|NCT00718952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101749601|NCT00718952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749602|NCT00718952|Urological Agents|urological agents|mesh-ancestor
101749603|NCT00781937|Liraglutide|liraglutide|mesh-list
101749604|NCT00781937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101749605|NCT00781937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749606|NCT00781937|Incretins|incretins|mesh-ancestor
101749607|NCT00781937|Hormones|hormones|mesh-ancestor
101749608|NCT00781937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101749609|NCT00802581|Anesthetics|anesthetics|mesh-list
101749610|NCT00802581|Anesthetics, Local|anesthetics, local|mesh-list
101749611|NCT00802581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101749612|NCT00802581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749613|NCT00802581|Sensory System Agents|sensory system agents|mesh-ancestor
101749614|NCT00802581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101749615|NCT00719108|Insulin|insulin|mesh-list
101530494|NCT04629885|Oxytocin|oxytocin|mesh-list
101749616|NCT00719108|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101749617|NCT00719108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101749618|NCT00719108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749619|NCT00842140|Metformin|metformin|mesh-list
101749620|NCT00842140|Spironolactone|spironolactone|mesh-list
101749621|NCT00842140|Contraceptive Agents|contraceptive agents|mesh-list
101749622|NCT00842140|Contraceptives, Oral|contraceptives, oral|mesh-list
101749623|NCT00842140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101749624|NCT00842140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749625|NCT00842140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101749626|NCT00842140|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101749627|NCT00842140|Hormone Antagonists|hormone antagonists|mesh-ancestor
101749628|NCT00842140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101749635|NCT00806169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101749636|NCT00806169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101749637|NCT00806169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101749638|NCT00806169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101749639|NCT00806169|Growth Substances|growth substances|mesh-ancestor
101749640|NCT00806169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749641|NCT00806169|Growth Inhibitors|growth inhibitors|mesh-ancestor
101749642|NCT00806169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101749643|NCT00806169|Glucocorticoids|glucocorticoids|mesh-ancestor
101749644|NCT00806169|Hormones|hormones|mesh-ancestor
101749645|NCT00806169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101749646|NCT00844324|Candesartan|candesartan|mesh-list
101749647|NCT00844324|Candesartan cilexetil|candesartan cilexetil|mesh-list
101749648|NCT00844324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101749649|NCT00844324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101749650|NCT00844324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101530747|NCT01780844|Glucocorticoids|glucocorticoids|mesh-ancestor
101749651|NCT00844324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749652|NCT00802815|Etanercept|etanercept|mesh-list
101749653|NCT00802815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101749654|NCT00802815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101749655|NCT00802815|Analgesics|analgesics|mesh-ancestor
101749656|NCT00802815|Sensory System Agents|sensory system agents|mesh-ancestor
101749657|NCT00802815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101749658|NCT00802815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749659|NCT00802815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101749660|NCT00802815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101749661|NCT00802815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101749662|NCT00802815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101749663|NCT00802815|Immunologic Factors|immunologic factors|mesh-ancestor
101562132|NCT02811861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562133|NCT02811861|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101562134|NCT02811861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101562135|NCT02811861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101562136|NCT02811861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101530847|NCT04608669|Acetaminophen|acetaminophen|mesh-list
101562137|NCT02811861|Immunologic Factors|immunologic factors|mesh-ancestor
101562138|NCT02811861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410470|NCT00444574|Dopamine Agents|dopamine agents|mesh-ancestor
101749664|NCT04100759|Sildenafil Citrate|sildenafil citrate|mesh-list
101749665|NCT04100759|Vasodilator Agents|vasodilator agents|mesh-ancestor
101749666|NCT04100759|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101749667|NCT04100759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101749668|NCT04100759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101749669|NCT04100759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749670|NCT04100759|Urological Agents|urological agents|mesh-ancestor
101749671|NCT00836914|Idelalisib|idelalisib|mesh-list
101749672|NCT00836914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101749673|NCT00836914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101749674|NCT00836914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749675|NCT00844402|Atorvastatin|atorvastatin|mesh-list
101530900|NCT01858883|Paclitaxel|paclitaxel|mesh-list
101749676|NCT00844402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101749677|NCT00844402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101749678|NCT00844402|Antimetabolites|antimetabolites|mesh-ancestor
101749679|NCT00844402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749680|NCT00844402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101407145|NCT00437359|Toremifene|toremifene|mesh-list
101749681|NCT00844402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101749682|NCT00844402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101749683|NCT00806247|Tapentadol|tapentadol|mesh-list
101749684|NCT00806247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101749685|NCT00806247|Narcotics|narcotics|mesh-ancestor
101749686|NCT00806247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101749687|NCT00806247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749688|NCT00806247|Analgesics|analgesics|mesh-ancestor
101749689|NCT00806247|Sensory System Agents|sensory system agents|mesh-ancestor
101749690|NCT00806247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101749691|NCT00806247|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101749692|NCT00806247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101749693|NCT00806247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101406553|NCT00134550|Antimetabolites|antimetabolites|mesh-ancestor
101749694|NCT00806247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749695|NCT00806247|Adrenergic Agents|adrenergic agents|mesh-ancestor
101749715|NCT00659373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101749716|NCT00659373|Hormone Antagonists|hormone antagonists|mesh-ancestor
101749717|NCT00659373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101749718|NCT00659373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749719|NCT00659373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101749720|NCT00659373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101749721|NCT00659373|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101749722|NCT00659373|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101749723|NCT00659373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101749724|NCT00659373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101749725|NCT00659373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101749726|NCT00659373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101749727|NCT00659373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531399|NCT04606017|Antacids|antacids|mesh-ancestor
101749728|NCT00659373|Luteolytic Agents|luteolytic agents|mesh-ancestor
101749729|NCT00659373|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101749730|NCT00659373|Contraceptive Agents|contraceptive agents|mesh-ancestor
101749731|NCT00659373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101749732|NCT00659373|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101749733|NCT00842452|Topotecan|topotecan|mesh-list
101749734|NCT00842452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101749735|NCT00842452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101749736|NCT00842452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101562139|NCT02811861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101562140|NCT02811861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101562141|NCT02811861|Growth Substances|growth substances|mesh-ancestor
101562142|NCT02811861|Growth Inhibitors|growth inhibitors|mesh-ancestor
101562143|NCT02744612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101562144|NCT02744612|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101562145|NCT02744612|Antibodies|antibodies|mesh-list
101562146|NCT02744612|Immunoglobulins|immunoglobulins|mesh-list
101562147|NCT02744612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101749737|NCT00842452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749738|NCT00842452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101749739|NCT02552745|Parecoxib|parecoxib|mesh-list
101749740|NCT02552745|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101531666|NCT00566592|Ethanol|ethanol|mesh-list
101749741|NCT02552745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101749742|NCT02552745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101749743|NCT02552745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749744|NCT02552745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101749745|NCT02552745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101749746|NCT02552745|Analgesics|analgesics|mesh-ancestor
101749747|NCT02552745|Sensory System Agents|sensory system agents|mesh-ancestor
101749748|NCT02552745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101749749|NCT02552745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501164|NCT00483158|Finafloxacin|finafloxacin|mesh-list
101749764|NCT02547844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101749765|NCT02547844|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101749766|NCT02547844|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101749767|NCT02547844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101749768|NCT02547844|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101749769|NCT00439777|Enoxaparin|enoxaparin|mesh-list
101749770|NCT00439777|Rivaroxaban|rivaroxaban|mesh-list
101749771|NCT00439777|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101749772|NCT00439777|Antithrombins|antithrombins|mesh-ancestor
101749773|NCT00439777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101749775|NCT00439777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101749776|NCT00439777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749777|NCT00439777|Anticoagulants|anticoagulants|mesh-ancestor
101749778|NCT00439777|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101749779|NCT00439777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101749780|NCT00842686|Bevacizumab|bevacizumab|mesh-list
101749781|NCT00842686|Capecitabine|capecitabine|mesh-list
101749782|NCT00842686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101749783|NCT00842686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101749784|NCT00842686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101749785|NCT00842686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101749786|NCT00842686|Growth Substances|growth substances|mesh-ancestor
101749787|NCT00842686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749788|NCT00842686|Growth Inhibitors|growth inhibitors|mesh-ancestor
101749789|NCT00842686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101749790|NCT00842686|Antimetabolites|antimetabolites|mesh-ancestor
101749791|NCT00842686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749792|NCT04045821|Plerixafor|plerixafor|mesh-list
101749793|NCT04045821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101749794|NCT04045821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101749795|NCT04045821|Antiviral Agents|antiviral agents|mesh-ancestor
101749796|NCT04045821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101749797|NCT00803439|Clobetasol|clobetasol|mesh-list
101749798|NCT00803439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101749799|NCT00803439|Glucocorticoids|glucocorticoids|mesh-ancestor
101749800|NCT00803439|Hormones|hormones|mesh-ancestor
101749801|NCT00803439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101406718|NCT00134979|Autonomic Agents|autonomic agents|mesh-ancestor
101749802|NCT00803439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749803|NCT00806481|Sevelamer|sevelamer|mesh-list
101749804|NCT00806481|Chelating Agents|chelating agents|mesh-ancestor
101749805|NCT00806481|Sequestering Agents|sequestering agents|mesh-ancestor
101749806|NCT00806481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749807|NCT00709436|Ketamine|ketamine|mesh-list
101562148|NCT02744612|Immunoconjugates|immunoconjugates|mesh-list
101562149|NCT02744612|Immunologic Factors|immunologic factors|mesh-ancestor
101562150|NCT02744612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562151|NCT02744612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101562152|NCT02744612|Immunotoxins|immunotoxins|mesh-ancestor
101562153|NCT02700451|Acetaminophen|acetaminophen|mesh-list
101562154|NCT02700451|Ketorolac|ketorolac|mesh-list
101562155|NCT02700451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101562156|NCT02700451|Analgesics|analgesics|mesh-ancestor
101562157|NCT02700451|Sensory System Agents|sensory system agents|mesh-ancestor
101562158|NCT02700451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101749808|NCT00709436|Analgesics|analgesics|mesh-ancestor
101749809|NCT00709436|Sensory System Agents|sensory system agents|mesh-ancestor
101749810|NCT00709436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101749811|NCT00709436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749812|NCT00709436|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101749813|NCT00709436|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101749817|NCT00709436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101749818|NCT00709436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101532459|NCT00637234|Oxcarbazepine|oxcarbazepine|mesh-list
101749819|NCT00709436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101749820|NCT00709436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749821|NCT00844792|Vitamin D|vitamin d|mesh-list
101749822|NCT00844792|Cholecalciferol|cholecalciferol|mesh-list
101749823|NCT00844792|Vitamins|vitamins|mesh-list
101749824|NCT00844792|Vitamin E|vitamin e|mesh-list
101749825|NCT00844792|Selenium|selenium|mesh-list
101749826|NCT00844792|Lycopene|lycopene|mesh-list
101749827|NCT00844792|Micronutrients|micronutrients|mesh-ancestor
101749828|NCT00844792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407290|NCT00438607|Purinergic Agents|purinergic agents|mesh-ancestor
101749829|NCT00844792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101749830|NCT00844792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101749831|NCT00844792|Antioxidants|antioxidants|mesh-ancestor
101749832|NCT00844792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749833|NCT00844792|Protective Agents|protective agents|mesh-ancestor
101749834|NCT00844792|Trace Elements|trace elements|mesh-ancestor
101749835|NCT00844792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101532686|NCT05035316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101749836|NCT00844792|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101749837|NCT00844792|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101749838|NCT00844792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101749839|NCT00719420|Amoxicillin|amoxicillin|mesh-list
101749840|NCT00719420|Metronidazole|metronidazole|mesh-list
101749841|NCT00719420|Clarithromycin|clarithromycin|mesh-list
101749842|NCT00719420|Omeprazole|omeprazole|mesh-list
101749843|NCT00719420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101749844|NCT00719420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101749845|NCT00719420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101749846|NCT00719420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101749847|NCT00719420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101210069|NCT01449448|Ketorolac|ketorolac|mesh-list
101749848|NCT00719420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101749849|NCT00719420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101406839|NCT00105950|Lapatinib|lapatinib|mesh-list
101749850|NCT00719420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101749851|NCT00719420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749852|NCT00719420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101749853|NCT00719420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101532900|NCT00563069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101749854|NCT00719420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101749855|NCT00803829|Sulfalene|sulfalene|mesh-list
101749856|NCT00803829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101749857|NCT00803829|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101749858|NCT00803829|Antimalarials|antimalarials|mesh-ancestor
101749859|NCT00803829|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101749860|NCT00803829|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101749861|NCT00716612|Ubiquinone|ubiquinone|mesh-list
101749862|NCT00716612|Coenzyme Q10|coenzyme q10|mesh-list
101749863|NCT00716612|Micronutrients|micronutrients|mesh-ancestor
101749864|NCT00716612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749865|NCT00716612|Vitamins|vitamins|mesh-ancestor
101562159|NCT02700451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562160|NCT02700451|Antipyretics|antipyretics|mesh-ancestor
101562161|NCT02700451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101562162|NCT02700451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101562163|NCT02700451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101562164|NCT02700451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101562165|NCT02700451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101562166|NCT02700451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562167|NCT02697344|Acetic Acid|acetic acid|mesh-list
101562168|NCT02697344|Dexamethasone|dexamethasone|mesh-list
101562169|NCT02697344|Dexamethasone acetate|dexamethasone acetate|mesh-list
101562170|NCT02697344|Lenalidomide|lenalidomide|mesh-list
101562171|NCT02697344|Retinol acetate|retinol acetate|mesh-list
101562172|NCT02697344|Gossypol acetic acid|gossypol acetic acid|mesh-list
101562173|NCT02697344|Gossypol|gossypol|mesh-list
101749866|NCT00842920|Simvastatin|simvastatin|mesh-list
101533229|NCT01150123|Immunologic Factors|immunologic factors|mesh-ancestor
101749867|NCT00842920|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101749868|NCT00842920|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101749869|NCT00842920|Antimetabolites|antimetabolites|mesh-ancestor
101749870|NCT00842920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749871|NCT00842920|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101533327|NCT00575523|Atropine|atropine|mesh-list
101749872|NCT00842920|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101749873|NCT00842920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101749874|NCT00842998|Trastuzumab|trastuzumab|mesh-list
101749875|NCT00842998|Lapatinib|lapatinib|mesh-list
101749876|NCT00842998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101749877|NCT00842998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101749878|NCT00842998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101749879|NCT00842998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101749880|NCT00842998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749881|NCT00716846|Atorvastatin|atorvastatin|mesh-list
101749882|NCT00716846|Simvastatin|simvastatin|mesh-list
101749883|NCT00716846|Pitavastatin|pitavastatin|mesh-list
101749884|NCT00716846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101749885|NCT00716846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101749886|NCT00716846|Antimetabolites|antimetabolites|mesh-ancestor
101749908|NCT00430027|Capecitabine|capecitabine|mesh-list
101749909|NCT00430027|Oxaliplatin|oxaliplatin|mesh-list
101749910|NCT00430027|Cetuximab|cetuximab|mesh-list
101749911|NCT00430027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101749912|NCT00430027|Antimetabolites|antimetabolites|mesh-ancestor
101749913|NCT00430027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749914|NCT00430027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101749915|NCT00430027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101749916|NCT04766229|Gabapentin|gabapentin|mesh-list
101749917|NCT04766229|Citalopram|citalopram|mesh-list
101749918|NCT04766229|Analgesics|analgesics|mesh-ancestor
101749919|NCT04766229|Sensory System Agents|sensory system agents|mesh-ancestor
101749920|NCT04766229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101749921|NCT04766229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749922|NCT04766229|Anticonvulsants|anticonvulsants|mesh-ancestor
101749923|NCT04766229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101749924|NCT04766229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101749925|NCT04766229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101749926|NCT04766229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101533689|NCT04596488|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101749927|NCT04766229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101749928|NCT04766229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101749929|NCT04766229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101749930|NCT04766229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749931|NCT04766229|Antimanic Agents|antimanic agents|mesh-ancestor
101749932|NCT04766229|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101562175|NCT02697344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101562176|NCT02697344|Antiemetics|antiemetics|mesh-ancestor
101562177|NCT02697344|Autonomic Agents|autonomic agents|mesh-ancestor
101562178|NCT02697344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101524124|NCT02910050|Androgen Antagonists|androgen antagonists|mesh-ancestor
101562179|NCT02697344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562180|NCT02697344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101562181|NCT02697344|Glucocorticoids|glucocorticoids|mesh-ancestor
101562182|NCT02697344|Hormones|hormones|mesh-ancestor
101410509|NCT00444886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410510|NCT00444886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101749933|NCT04766229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101749934|NCT04766229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101749958|NCT00803907|Interferon Inducers|interferon inducers|mesh-ancestor
101749959|NCT00843154|Candesartan|candesartan|mesh-list
101749960|NCT00843154|Candesartan cilexetil|candesartan cilexetil|mesh-list
101749961|NCT00843154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101749962|NCT00843154|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101749963|NCT00843154|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101749964|NCT00843154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749965|NCT00429793|Sirolimus|sirolimus|mesh-list
101749966|NCT00429793|Temsirolimus|temsirolimus|mesh-list
101749967|NCT00429793|MTOR Inhibitors|mtor inhibitors|mesh-list
101749968|NCT00429793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101749969|NCT00429793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101749970|NCT00429793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749971|NCT00429793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101749972|NCT00429793|Immunologic Factors|immunologic factors|mesh-ancestor
101749973|NCT00429793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749974|NCT00429793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101749975|NCT00429793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101749976|NCT00429793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101749977|NCT00429793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101749979|NCT00806871|Methylprednisolone|methylprednisolone|mesh-list
101749980|NCT00806871|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101749981|NCT00806871|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101749982|NCT00806871|Prednisolone|prednisolone|mesh-list
101749983|NCT00806871|Prednisolone acetate|prednisolone acetate|mesh-list
101749984|NCT00806871|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101749985|NCT00806871|Prednisolone phosphate|prednisolone phosphate|mesh-list
101749986|NCT00806871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101750003|NCT00798213|Immunoconjugates|immunoconjugates|mesh-ancestor
101750004|NCT00798213|Immunologic Factors|immunologic factors|mesh-ancestor
101750005|NCT00798213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750006|NCT04069208|Cytarabine|cytarabine|mesh-list
101750007|NCT04069208|Idarubicin|idarubicin|mesh-list
101750008|NCT04069208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101750009|NCT04069208|Antimetabolites|antimetabolites|mesh-ancestor
101750010|NCT04069208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750011|NCT04069208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750012|NCT04069208|Antiviral Agents|antiviral agents|mesh-ancestor
101750013|NCT04069208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101750014|NCT04069208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101750015|NCT04069208|Immunologic Factors|immunologic factors|mesh-ancestor
101750016|NCT04069208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750017|NCT04069208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101750018|NCT04069208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101750019|NCT04069208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101534235|NCT04586465|Carboplatin|carboplatin|mesh-list
101750020|NCT04069208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101750021|NCT00845104|Bevacizumab|bevacizumab|mesh-list
101750022|NCT00845104|Rituximab|rituximab|mesh-list
101750023|NCT00845104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101750024|NCT00845104|Fludarabine|fludarabine|mesh-list
101750025|NCT00845104|Fludarabine phosphate|fludarabine phosphate|mesh-list
101562183|NCT02697344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101562184|NCT02697344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101562186|NCT02697344|Immunologic Factors|immunologic factors|mesh-ancestor
101562187|NCT02697344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101562188|NCT02697344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101562189|NCT02697344|Growth Substances|growth substances|mesh-ancestor
101562190|NCT02697344|Growth Inhibitors|growth inhibitors|mesh-ancestor
101562191|NCT02697344|Protease Inhibitors|protease inhibitors|mesh-ancestor
101562192|NCT02697344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101562193|NCT02697344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562194|NCT02697344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101562195|NCT02697344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101562196|NCT02697344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101562197|NCT02697344|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101562198|NCT02697344|Protective Agents|protective agents|mesh-ancestor
101562199|NCT02697344|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101562200|NCT02697344|Contraceptive Agents|contraceptive agents|mesh-ancestor
101562201|NCT02697344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101562202|NCT02697344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101562203|NCT02697344|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101562204|NCT02697344|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
101562205|NCT02697344|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
101562206|NCT02667418|Vancomycin|vancomycin|mesh-list
101562207|NCT02667418|Fidaxomicin|fidaxomicin|mesh-list
101562208|NCT02667418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101562209|NCT02667418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101562210|NCT02623426|Dexamethasone|dexamethasone|mesh-list
101562211|NCT02623426|Methotrexate|methotrexate|mesh-list
101562212|NCT02623426|Ranibizumab|ranibizumab|mesh-list
101562213|NCT02623426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101562214|NCT02623426|Antiemetics|antiemetics|mesh-ancestor
101562215|NCT02623426|Autonomic Agents|autonomic agents|mesh-ancestor
101562216|NCT02623426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101750026|NCT00845104|Antibodies|antibodies|mesh-list
101750027|NCT00845104|Immunoglobulins|immunoglobulins|mesh-list
101750028|NCT00845104|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101750029|NCT00845104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750030|NCT00845104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101750031|NCT00845104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101750032|NCT00845104|Growth Substances|growth substances|mesh-ancestor
101750033|NCT00845104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562217|NCT02623426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562218|NCT02623426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101562219|NCT02623426|Glucocorticoids|glucocorticoids|mesh-ancestor
101562221|NCT02623426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101562222|NCT02623426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101750034|NCT00845104|Growth Inhibitors|growth inhibitors|mesh-ancestor
101750035|NCT00845104|Immunologic Factors|immunologic factors|mesh-ancestor
101750036|NCT00845104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101750037|NCT00845104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101750038|NCT00845104|Antimetabolites|antimetabolites|mesh-ancestor
101750039|NCT00845104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750040|NCT00845104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101750041|NCT00763451|Metformin|metformin|mesh-list
101750042|NCT00763451|Lixisenatide|lixisenatide|mesh-list
101750043|NCT00763451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101750044|NCT00763451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750045|NCT00762762|Triclosan|triclosan|mesh-list
101750054|NCT00762762|Antimetabolites|antimetabolites|mesh-ancestor
101750055|NCT00762762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750056|NCT00762762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101750057|NCT00424489|Methylprednisolone|methylprednisolone|mesh-list
101750058|NCT00424489|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101750059|NCT00424489|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101750060|NCT00424489|Prednisolone|prednisolone|mesh-list
101750061|NCT00424489|Prednisolone acetate|prednisolone acetate|mesh-list
101750062|NCT00424489|Cyclophosphamide|cyclophosphamide|mesh-list
101750063|NCT00424489|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101750064|NCT00424489|Prednisolone phosphate|prednisolone phosphate|mesh-list
101750065|NCT00424489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101750066|NCT00424489|Immunologic Factors|immunologic factors|mesh-ancestor
101750067|NCT00424489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750068|NCT00424489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101750069|NCT00424489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101750070|NCT00424489|Alkylating Agents|alkylating agents|mesh-ancestor
101750071|NCT00424489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750072|NCT00424489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750073|NCT00424489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101750074|NCT00424489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101750076|NCT00424489|Autonomic Agents|autonomic agents|mesh-ancestor
101750077|NCT00424489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101750078|NCT00424489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101750079|NCT00424489|Glucocorticoids|glucocorticoids|mesh-ancestor
101750080|NCT00424489|Hormones|hormones|mesh-ancestor
101750081|NCT00424489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101750082|NCT00424489|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101750083|NCT00424489|Protective Agents|protective agents|mesh-ancestor
101750084|NCT00424489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101750085|NCT00578864|Cyclophosphamide|cyclophosphamide|mesh-list
101750086|NCT00578864|Doxorubicin|doxorubicin|mesh-list
101750087|NCT00578864|Etoposide|etoposide|mesh-list
101750088|NCT00578864|Etoposide phosphate|etoposide phosphate|mesh-list
101750089|NCT00578864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101750090|NCT00578864|Immunologic Factors|immunologic factors|mesh-ancestor
101750091|NCT00578864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750092|NCT00578864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101750093|NCT00578864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101750094|NCT00578864|Alkylating Agents|alkylating agents|mesh-ancestor
101750095|NCT00578864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750096|NCT00578864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750097|NCT00578864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101750098|NCT00578864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101750099|NCT00578864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101750100|NCT00578864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101750101|NCT00578864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101750102|NCT00578864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101750103|NCT01034683|Leucovorin|leucovorin|mesh-list
101750104|NCT01034683|Antidotes|antidotes|mesh-ancestor
101562223|NCT02623426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101562224|NCT02623426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101562225|NCT02623426|Abortifacient Agents|abortifacient agents|mesh-ancestor
101562226|NCT02623426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101562227|NCT02623426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101562228|NCT02623426|Antimetabolites|antimetabolites|mesh-ancestor
101750105|NCT01034683|Protective Agents|protective agents|mesh-ancestor
101750106|NCT01034683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750107|NCT01034683|Vitamin B Complex|vitamin b complex|mesh-ancestor
101750108|NCT01034683|Vitamins|vitamins|mesh-ancestor
101750109|NCT01034683|Micronutrients|micronutrients|mesh-ancestor
101750110|NCT00717470|Mycophenolic Acid|mycophenolic acid|mesh-list
101750111|NCT00717470|Prednisone|prednisone|mesh-list
101750112|NCT00717470|Methylprednisolone|methylprednisolone|mesh-list
101750113|NCT00717470|Tacrolimus|tacrolimus|mesh-list
101750114|NCT00717470|Basiliximab|basiliximab|mesh-list
101750115|NCT00717470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101750125|NCT00717470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101750126|NCT00717470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750127|NCT00717470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101750128|NCT00717470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101750129|NCT00717470|Antitubercular Agents|antitubercular agents|mesh-ancestor
101750130|NCT00717470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101750131|NCT00717470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101750132|NCT00717470|Antiemetics|antiemetics|mesh-ancestor
101750133|NCT00717470|Autonomic Agents|autonomic agents|mesh-ancestor
101750134|NCT00717470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101750135|NCT00717470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101750136|NCT00717470|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101750137|NCT00717470|Protective Agents|protective agents|mesh-ancestor
101750138|NCT00631566|Mupirocin|mupirocin|mesh-list
101750139|NCT00631566|Triclosan|triclosan|mesh-list
101750140|NCT00631566|Hexachlorophene|hexachlorophene|mesh-list
101750141|NCT00631566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101750142|NCT00631566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101750143|NCT00631566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101750144|NCT00631566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101750145|NCT00631566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750146|NCT00631566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101750147|NCT00631566|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101750148|NCT00631566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101750149|NCT00631566|Antimetabolites|antimetabolites|mesh-ancestor
101750150|NCT00631566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101750151|NCT00722852|Ketoprofen|ketoprofen|mesh-list
101750152|NCT00722852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101750153|NCT00722852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101750154|NCT00722852|Analgesics|analgesics|mesh-ancestor
101750155|NCT00722852|Sensory System Agents|sensory system agents|mesh-ancestor
101750156|NCT00722852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101750157|NCT00722852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750158|NCT00722852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101750159|NCT00722852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101750160|NCT00722852|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101750161|NCT00722852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101750162|NCT00722852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750163|NCT05657444|Tenecteplase|tenecteplase|mesh-list
101750164|NCT05657444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101750165|NCT05657444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101750166|NCT05657444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750167|NCT01410942|Methylphenidate|methylphenidate|mesh-list
101750168|NCT01410942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101750169|NCT01410942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750170|NCT01410942|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101750171|NCT01410942|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101750172|NCT01410942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101750173|NCT01410942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750174|NCT01410942|Dopamine Agents|dopamine agents|mesh-ancestor
101750175|NCT01410942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101750176|NCT04833426|Testosterone|testosterone|mesh-list
101562229|NCT02623426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562231|NCT02623426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101562232|NCT02623426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101562233|NCT02623426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101562234|NCT02623426|Immunologic Factors|immunologic factors|mesh-ancestor
101562235|NCT02623426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101562236|NCT02623426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101562237|NCT02623426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101562238|NCT02623426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101562239|NCT02623426|Growth Substances|growth substances|mesh-ancestor
101750177|NCT04833426|Androgens|androgens|mesh-ancestor
101750178|NCT04833426|Hormones|hormones|mesh-ancestor
101451741|NCT00203099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750191|NCT00763139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750192|NCT01366092|Interleukin-2|interleukin-2|mesh-list
101750193|NCT01366092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750194|NCT01366092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101750195|NCT01366092|Analgesics|analgesics|mesh-ancestor
101750196|NCT01366092|Sensory System Agents|sensory system agents|mesh-ancestor
101750197|NCT01366092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101750198|NCT01366092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750199|NCT00781859|Plasminogen|plasminogen|mesh-list
101750200|NCT00781859|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101750201|NCT00781859|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101750202|NCT00781859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407683|NCT00441181|Travoprost|travoprost|mesh-list
101750203|NCT01344252|Lidocaine|lidocaine|mesh-list
101750204|NCT01344252|Anesthetics, Local|anesthetics, local|mesh-ancestor
101750205|NCT01344252|Anesthetics|anesthetics|mesh-ancestor
101750206|NCT01344252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101750207|NCT01344252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750208|NCT01344252|Sensory System Agents|sensory system agents|mesh-ancestor
101750209|NCT01344252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101750210|NCT01344252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101750211|NCT01344252|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101750212|NCT01344252|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101750213|NCT01344252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101750214|NCT01344252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750215|NCT04101383|Insulin|insulin|mesh-list
101750217|NCT04101383|Insulin Glargine|insulin glargine|mesh-list
101750218|NCT04101383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101750219|NCT04101383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750220|NCT02576808|Loratadine|loratadine|mesh-list
101750221|NCT02576808|Antipruritics|antipruritics|mesh-ancestor
101750222|NCT02576808|Dermatologic Agents|dermatologic agents|mesh-ancestor
101750223|NCT02576808|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101750224|NCT02576808|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101750225|NCT02576808|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101750226|NCT02576808|Histamine Antagonists|histamine antagonists|mesh-ancestor
101750227|NCT02576808|Histamine Agents|histamine agents|mesh-ancestor
101750228|NCT02576808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101750229|NCT02576808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750230|NCT02576808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750231|NCT00580788|Parathyroid Hormone|parathyroid hormone|mesh-list
101750232|NCT00580788|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
101750233|NCT00580788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750234|NCT00580788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101750235|NCT04073160|Durvalumab|durvalumab|mesh-list
101750236|NCT04073160|Tremelimumab|tremelimumab|mesh-list
101750237|NCT04073160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101750238|NCT04073160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750239|NCT00417079|Prednisone|prednisone|mesh-list
101750240|NCT00417079|Mitoxantrone|mitoxantrone|mesh-list
101750253|NCT00417079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101562240|NCT02623426|Growth Inhibitors|growth inhibitors|mesh-ancestor
101562241|NCT02580058|Doxorubicin|doxorubicin|mesh-list
101562242|NCT02580058|Avelumab|avelumab|mesh-list
101562243|NCT02580058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101562244|NCT02580058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101562245|NCT02580058|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101562246|NCT02580058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101562247|NCT02580058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101562248|NCT02580058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562249|NCT02580058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101562250|NCT02539394|Methylprednisolone|methylprednisolone|mesh-list
101750254|NCT00417079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750255|NCT02578914|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101750256|NCT02578914|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101750257|NCT00429169|Bupropion|bupropion|mesh-list
101750258|NCT00429169|Paroxetine|paroxetine|mesh-list
101750259|NCT00429169|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101750260|NCT00429169|Antidepressive Agents|antidepressive agents|mesh-ancestor
101750261|NCT00429169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101750262|NCT00429169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101750263|NCT00429169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101750264|NCT00429169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101750265|NCT00429169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750266|NCT00429169|Dopamine Agents|dopamine agents|mesh-ancestor
101750267|NCT00429169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101750268|NCT00429169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750269|NCT00429169|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101750270|NCT00429169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101750271|NCT00429169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101750272|NCT00429169|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101750273|NCT00429169|Serotonin Agents|serotonin agents|mesh-ancestor
101750274|NCT01037491|Aspirin|aspirin|mesh-list
101750275|NCT01037491|Rabeprazole|rabeprazole|mesh-list
101750276|NCT01037491|Clopidogrel|clopidogrel|mesh-list
101750277|NCT01037491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101750278|NCT01037491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101750279|NCT01037491|Analgesics|analgesics|mesh-ancestor
101750280|NCT01037491|Sensory System Agents|sensory system agents|mesh-ancestor
101750281|NCT01037491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101750282|NCT01037491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750283|NCT01037491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101750284|NCT01037491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101750285|NCT01037491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101750286|NCT01037491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101750287|NCT01037491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263504|NCT01762332|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101750288|NCT01037491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101750289|NCT01037491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101750290|NCT01037491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101750291|NCT01037491|Antipyretics|antipyretics|mesh-ancestor
101750292|NCT01037491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101750293|NCT01037491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101750294|NCT01037491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101750295|NCT01037491|Purinergic Agents|purinergic agents|mesh-ancestor
101750296|NCT01037491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101750297|NCT01037491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101750298|NCT01037491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101750299|NCT01037491|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101750303|NCT02576340|Bromides|bromides|mesh-list
101750304|NCT02576340|Anticonvulsants|anticonvulsants|mesh-ancestor
101750305|NCT02576340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101750306|NCT02576340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101562251|NCT02539394|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101562252|NCT02539394|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101562253|NCT02539394|Prednisolone|prednisolone|mesh-list
101562254|NCT02539394|Prednisolone acetate|prednisolone acetate|mesh-list
101562255|NCT02539394|Hemostatics|hemostatics|mesh-list
101562256|NCT02539394|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101524197|NCT01216072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101534481|NCT01145755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101562257|NCT02539394|Prednisolone phosphate|prednisolone phosphate|mesh-list
101562258|NCT02539394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101562259|NCT02539394|Antiemetics|antiemetics|mesh-ancestor
101750307|NCT02576340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750308|NCT02576340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101750309|NCT02576340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750310|NCT02576340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101750311|NCT02576340|Parasympatholytics|parasympatholytics|mesh-ancestor
101750312|NCT02576340|Autonomic Agents|autonomic agents|mesh-ancestor
101750313|NCT02576340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101750314|NCT02576340|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101750315|NCT02576340|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101750316|NCT02576340|Cholinergic Agents|cholinergic agents|mesh-ancestor
101750317|NCT02576340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101750318|NCT02578602|Edetic Acid|edetic acid|mesh-list
101750319|NCT02578602|Pentetic Acid|pentetic acid|mesh-list
101750320|NCT02578602|Antidotes|antidotes|mesh-ancestor
101750321|NCT02578602|Protective Agents|protective agents|mesh-ancestor
101750322|NCT02578602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750323|NCT02578602|Chelating Agents|chelating agents|mesh-ancestor
101750324|NCT02578602|Sequestering Agents|sequestering agents|mesh-ancestor
101750325|NCT02578602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750326|NCT02578602|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101750327|NCT02578602|Anticoagulants|anticoagulants|mesh-ancestor
101750328|NCT02578602|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101750329|NCT00128856|Paclitaxel|paclitaxel|mesh-list
101750330|NCT00128856|Gemcitabine|gemcitabine|mesh-list
101750331|NCT00128856|Doxorubicin|doxorubicin|mesh-list
101750332|NCT00128856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101750333|NCT00128856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750334|NCT00128856|Tubulin Modulators|tubulin modulators|mesh-ancestor
101750335|NCT00128856|Antimitotic Agents|antimitotic agents|mesh-ancestor
101750336|NCT00128856|Mitosis Modulators|mitosis modulators|mesh-ancestor
101750337|NCT00128856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750338|NCT00128856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101750339|NCT00128856|Antimetabolites|antimetabolites|mesh-ancestor
101750340|NCT00128856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101750341|NCT00128856|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101750342|NCT00128856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101750343|NCT00128856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101750344|NCT00128778|Doxorubicin|doxorubicin|mesh-list
101750345|NCT00128778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101750346|NCT00128778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101750347|NCT00128778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750348|NCT00128778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101750349|NCT00128778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101750350|NCT00128778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101750351|NCT00128778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750352|NCT00709488|Talaporfin|talaporfin|mesh-list
101750353|NCT00709488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750355|NCT00709488|Dermatologic Agents|dermatologic agents|mesh-ancestor
101750356|NCT00714246|Carboplatin|carboplatin|mesh-list
101750357|NCT00714246|Docetaxel|docetaxel|mesh-list
101750358|NCT00714246|Bortezomib|bortezomib|mesh-list
101750359|NCT00714246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750360|NCT00714246|Tubulin Modulators|tubulin modulators|mesh-ancestor
101750361|NCT00714246|Antimitotic Agents|antimitotic agents|mesh-ancestor
101750362|NCT00714246|Mitosis Modulators|mitosis modulators|mesh-ancestor
101407119|NCT00436930|Sargramostim|sargramostim|mesh-list
101750363|NCT00714246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750364|NCT00416455|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101562260|NCT02539394|Autonomic Agents|autonomic agents|mesh-ancestor
101562261|NCT02539394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101562262|NCT02539394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562263|NCT02539394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101562264|NCT02539394|Glucocorticoids|glucocorticoids|mesh-ancestor
101562265|NCT02539394|Hormones|hormones|mesh-ancestor
101562266|NCT02539394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101410595|NCT00445861|Docetaxel|docetaxel|mesh-list
101750365|NCT00416455|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101750366|NCT00416455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750367|NCT00415909|Imatinib Mesylate|imatinib mesylate|mesh-list
101750368|NCT00415909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750369|NCT00415909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101750370|NCT00415909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101750371|NCT00415909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750372|NCT00709644|Folic Acid|folic acid|mesh-list
101750373|NCT00709644|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101750374|NCT00709644|Norgestimate|norgestimate|mesh-list
101750375|NCT00709644|Estradiol|estradiol|mesh-list
101750389|NCT00709644|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101750390|NCT00709644|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101750391|NCT00415597|Naltrexone|naltrexone|mesh-list
101750392|NCT00415597|Morphine|morphine|mesh-list
101750393|NCT00415597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101750394|NCT00415597|Narcotics|narcotics|mesh-ancestor
101750395|NCT00415597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101750396|NCT00415597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750397|NCT00415597|Analgesics|analgesics|mesh-ancestor
101750398|NCT00415597|Sensory System Agents|sensory system agents|mesh-ancestor
101750399|NCT00415597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101750400|NCT00415597|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101750401|NCT00415597|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101750402|NCT00714480|Thymoglobulin|thymoglobulin|mesh-list
101750403|NCT00714480|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101750404|NCT00714480|Immunologic Factors|immunologic factors|mesh-ancestor
101750405|NCT00714480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750406|NCT00714480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101750407|NCT00714558|Fentanyl|fentanyl|mesh-list
101750408|NCT00714558|Naltrexone|naltrexone|mesh-list
101750409|NCT00714558|Naloxone|naloxone|mesh-list
101750410|NCT00714558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101750411|NCT00714558|Narcotics|narcotics|mesh-ancestor
101750412|NCT00714558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101750413|NCT00714558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750414|NCT00714558|Analgesics|analgesics|mesh-ancestor
101750415|NCT00714558|Sensory System Agents|sensory system agents|mesh-ancestor
101750416|NCT00714558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101750417|NCT00714558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101750418|NCT00714558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101750419|NCT00714558|Anesthetics, General|anesthetics, general|mesh-ancestor
101750420|NCT00714558|Anesthetics|anesthetics|mesh-ancestor
101750421|NCT00714558|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101750422|NCT00714558|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101750423|NCT02575638|Camptothecin|camptothecin|mesh-list
101750424|NCT02575638|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101750425|NCT02575638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750426|NCT02575638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101750427|NCT02575638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101750428|NCT02575638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101750429|NCT02575638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750430|NCT02573610|Levofloxacin|levofloxacin|mesh-list
101750431|NCT02573610|Ofloxacin|ofloxacin|mesh-list
101750432|NCT02573610|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101750433|NCT02573610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101750434|NCT02573610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101750435|NCT02573610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101750436|NCT02573610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101750437|NCT02573610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101750438|NCT02573610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562267|NCT02539394|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101562268|NCT02539394|Protective Agents|protective agents|mesh-ancestor
101562269|NCT02539394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101562270|NCT02539394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750439|NCT02573610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750455|NCT02574468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750456|NCT02574468|Protease Inhibitors|protease inhibitors|mesh-ancestor
101750457|NCT02574468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101750458|NCT02574468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750459|NCT00710268|Bevacizumab|bevacizumab|mesh-list
101750460|NCT00710268|Olaparib|olaparib|mesh-list
101750461|NCT00710268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101750462|NCT00710268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750463|NCT00710268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101750464|NCT00710268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101750465|NCT00710268|Growth Substances|growth substances|mesh-ancestor
101750466|NCT00710268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750467|NCT00710268|Growth Inhibitors|growth inhibitors|mesh-ancestor
101750468|NCT00710268|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101750469|NCT00710268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101750470|NCT00710268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750471|NCT02575248|Dienogest|dienogest|mesh-list
101750472|NCT02575248|Clomiphene|clomiphene|mesh-list
101750473|NCT02575248|Enclomiphene|enclomiphene|mesh-list
101750474|NCT02575248|Zuclomiphene|zuclomiphene|mesh-list
101750475|NCT02575248|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101750476|NCT02575248|Hormone Antagonists|hormone antagonists|mesh-ancestor
101750477|NCT02575248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101750478|NCT02575248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750479|NCT02575248|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101750480|NCT02575248|Fertility Agents|fertility agents|mesh-ancestor
101750481|NCT02575248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101750482|NCT02575248|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101750483|NCT02575248|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101750484|NCT02575248|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101750485|NCT02575248|Contraceptive Agents|contraceptive agents|mesh-ancestor
101750486|NCT02575248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101750487|NCT02575248|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101750488|NCT02575248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101750489|NCT02575248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101750490|NCT02575248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101750491|NCT02575248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750492|NCT02575170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101750493|NCT00710736|Fluorouracil|fluorouracil|mesh-list
101750494|NCT00710736|Capecitabine|capecitabine|mesh-list
101750495|NCT00710736|Antimetabolites|antimetabolites|mesh-ancestor
101750496|NCT00710736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750497|NCT00710736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101750498|NCT00710736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750500|NCT00710736|Immunologic Factors|immunologic factors|mesh-ancestor
101750501|NCT00710736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750502|NCT00620542|Atorvastatin|atorvastatin|mesh-list
101750503|NCT00620542|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101750504|NCT00620542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101750505|NCT00620542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101750506|NCT00620542|Antimetabolites|antimetabolites|mesh-ancestor
101750507|NCT00620542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750508|NCT00620542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101750509|NCT00620542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101750510|NCT00620542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101750511|NCT04070742|Minocycline|minocycline|mesh-list
101750513|NCT04070742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101750514|NCT00851344|Cetirizine|cetirizine|mesh-list
101750515|NCT00851344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101750516|NCT00851344|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101750517|NCT00851344|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101750518|NCT00851344|Histamine Antagonists|histamine antagonists|mesh-ancestor
101750519|NCT00851344|Histamine Agents|histamine agents|mesh-ancestor
101750520|NCT00851344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101562271|NCT02539394|Coagulants|coagulants|mesh-ancestor
101562272|NCT02530437|Paclitaxel|paclitaxel|mesh-list
101562273|NCT02530437|Carboplatin|carboplatin|mesh-list
101562274|NCT02530437|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101562275|NCT02530437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101562276|NCT02530437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101562277|NCT02530437|Tubulin Modulators|tubulin modulators|mesh-ancestor
101562278|NCT02530437|Antimitotic Agents|antimitotic agents|mesh-ancestor
101562279|NCT02530437|Mitosis Modulators|mitosis modulators|mesh-ancestor
101562280|NCT02530437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562281|NCT02412670|Cisplatin|cisplatin|mesh-list
101562282|NCT02412670|Carboplatin|carboplatin|mesh-list
101410601|NCT00445861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410602|NCT00445861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101410603|NCT00445900|Thalidomide|thalidomide|mesh-list
101410604|NCT00445900|Prednisone|prednisone|mesh-list
101410605|NCT00445900|Cyclophosphamide|cyclophosphamide|mesh-list
101410606|NCT00445900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101750521|NCT00851344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750522|NCT00851344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750523|NCT04523922|Oxytocin|oxytocin|mesh-list
101750524|NCT04523922|Oxytocics|oxytocics|mesh-ancestor
101750525|NCT04523922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101750526|NCT04523922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750527|NCT00711204|Donepezil|donepezil|mesh-list
101750528|NCT00711204|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101750529|NCT00711204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101750530|NCT00711204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750531|NCT00711204|Cholinergic Agents|cholinergic agents|mesh-ancestor
101750532|NCT00711204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101750533|NCT00711204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750534|NCT00711204|Nootropic Agents|nootropic agents|mesh-ancestor
101750535|NCT05810792|Interleukin-2|interleukin-2|mesh-list
101750536|NCT05810792|Histamine|histamine|mesh-list
101750537|NCT05810792|Histamine phosphate|histamine phosphate|mesh-list
101750538|NCT05810792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750539|NCT05810792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101750540|NCT05810792|Analgesics|analgesics|mesh-ancestor
101750541|NCT05810792|Sensory System Agents|sensory system agents|mesh-ancestor
101750542|NCT05810792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101750543|NCT05810792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750544|NCT05810792|Histamine Agonists|histamine agonists|mesh-ancestor
101750545|NCT05810792|Histamine Agents|histamine agents|mesh-ancestor
101750546|NCT05810792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101750547|NCT05810792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750548|NCT05810571|Morphine|morphine|mesh-list
101750549|NCT05810571|Remifentanil|remifentanil|mesh-list
101750550|NCT05810571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101750551|NCT05810571|Narcotics|narcotics|mesh-ancestor
101750552|NCT05810571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101750553|NCT05810571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750554|NCT05810571|Analgesics|analgesics|mesh-ancestor
101750555|NCT05810571|Sensory System Agents|sensory system agents|mesh-ancestor
101750556|NCT05810571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101750557|NCT05810558|Glycine|glycine|mesh-list
101750558|NCT05810558|Glycine Agents|glycine agents|mesh-ancestor
101750559|NCT05810558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101750560|NCT05810558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562283|NCT02412670|Gemcitabine|gemcitabine|mesh-list
101562284|NCT02412670|Doxorubicin|doxorubicin|mesh-list
101562285|NCT02412670|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101562286|NCT02412670|Methotrexate|methotrexate|mesh-list
101562287|NCT02412670|Vinblastine|vinblastine|mesh-list
101562288|NCT02412670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101562289|NCT02412670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101750561|NCT05810558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750562|NCT05810389|Fluorides|fluorides|mesh-list
101750563|NCT05810389|Cariostatic Agents|cariostatic agents|mesh-ancestor
101750564|NCT05810389|Protective Agents|protective agents|mesh-ancestor
101750565|NCT05810389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750566|NCT05809986|Ofatumumab|ofatumumab|mesh-list
101750567|NCT05809986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750568|NCT05809869|Durvalumab|durvalumab|mesh-list
101750569|NCT05809869|Tremelimumab|tremelimumab|mesh-list
101750570|NCT05809869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101750571|NCT05809869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750572|NCT05809843|Pancrelipase|pancrelipase|mesh-list
101750573|NCT05809843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101750574|NCT05809804|Esketamine|esketamine|mesh-list
101501956|NCT01241487|Amlodipine|amlodipine|mesh-list
101750590|NCT05809609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750592|NCT05809518|Propofol|propofol|mesh-list
101750593|NCT05809518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101750594|NCT05809518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101750595|NCT05809518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750596|NCT05809518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101750597|NCT05809518|Analgesics|analgesics|mesh-ancestor
101750598|NCT05809518|Sensory System Agents|sensory system agents|mesh-ancestor
101750599|NCT05809518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101750600|NCT05809518|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101750601|NCT05809518|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101750602|NCT05809518|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101750603|NCT05809518|Adrenergic Agents|adrenergic agents|mesh-ancestor
101750604|NCT05809518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101750605|NCT05809518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750606|NCT05809518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101750607|NCT05809518|Anesthetics, General|anesthetics, general|mesh-ancestor
101750608|NCT05809518|Anesthetics|anesthetics|mesh-ancestor
101750609|NCT05809414|Amantadine|amantadine|mesh-list
101750610|NCT05809414|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101750611|NCT05809414|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101750612|NCT05809414|Antiviral Agents|antiviral agents|mesh-ancestor
101750613|NCT05809414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101750614|NCT05809414|Dopamine Agents|dopamine agents|mesh-ancestor
101750615|NCT05809414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101750616|NCT05809414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750617|NCT05809414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750618|NCT05809414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101750619|NCT05809414|Analgesics|analgesics|mesh-ancestor
101750620|NCT05809414|Sensory System Agents|sensory system agents|mesh-ancestor
101750621|NCT05809414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101750622|NCT05809336|Pembrolizumab|pembrolizumab|mesh-list
101750623|NCT05809336|Atezolizumab|atezolizumab|mesh-list
101750624|NCT05809336|Tislelizumab|tislelizumab|mesh-list
101750625|NCT05809336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101750626|NCT05809336|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101750627|NCT05809336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101750628|NCT05809336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750629|NCT05809336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750630|NCT05809336|Immunologic Factors|immunologic factors|mesh-ancestor
101750631|NCT05809336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750632|NCT05809271|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
101750633|NCT05809271|Hallucinogens|hallucinogens|mesh-ancestor
101502028|NCT01302067|Fesoterodine|fesoterodine|mesh-list
101750669|NCT05764876|Linezolid|linezolid|mesh-list
101750670|NCT05764876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101750671|NCT05764876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101451742|NCT00203099|Protective Agents|protective agents|mesh-ancestor
101750679|NCT05737576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562290|NCT02412670|Antimetabolites|antimetabolites|mesh-ancestor
101562291|NCT02412670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562292|NCT02412670|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101562293|NCT02412670|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101562294|NCT02412670|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101750680|NCT05720988|Azacitidine|azacitidine|mesh-list
101750681|NCT05720988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101750682|NCT05720988|Antimetabolites|antimetabolites|mesh-ancestor
101750683|NCT05720988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750684|NCT05720988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750685|NCT05720988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101750686|NCT05716763|Tramadol|tramadol|mesh-list
101750687|NCT05716763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101750688|NCT05716763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101750689|NCT05716763|Narcotics|narcotics|mesh-ancestor
101750690|NCT05716763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101750691|NCT05716763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750692|NCT05716763|Analgesics|analgesics|mesh-ancestor
101750693|NCT05716763|Sensory System Agents|sensory system agents|mesh-ancestor
101750694|NCT05716763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101750695|NCT05716503|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101750696|NCT05716503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101750697|NCT05716009|Gemtuzumab|gemtuzumab|mesh-list
101750698|NCT05716009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101750699|NCT05716009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750700|NCT05716009|Immunotoxins|immunotoxins|mesh-ancestor
101750701|NCT05716009|Immunoconjugates|immunoconjugates|mesh-ancestor
101750702|NCT05716009|Immunologic Factors|immunologic factors|mesh-ancestor
101750703|NCT05716009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750704|NCT05696938|Niacinamide|niacinamide|mesh-list
101750706|NCT05696938|Nicotinic Acids|nicotinic acids|mesh-list
101750707|NCT05696938|Vitamin B Complex|vitamin b complex|mesh-ancestor
101750708|NCT05696938|Vitamins|vitamins|mesh-ancestor
101750709|NCT05696938|Micronutrients|micronutrients|mesh-ancestor
101750710|NCT05696938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750711|NCT05696938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101750712|NCT05696938|Antimetabolites|antimetabolites|mesh-ancestor
101750713|NCT05696938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750714|NCT05696938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101750715|NCT05696938|Vasodilator Agents|vasodilator agents|mesh-ancestor
101750716|NCT05695508|Dexamethasone|dexamethasone|mesh-list
101750717|NCT05695508|Lenalidomide|lenalidomide|mesh-list
101750718|NCT05695508|Bortezomib|bortezomib|mesh-list
101750719|NCT05695508|Daratumumab|daratumumab|mesh-list
101750720|NCT05695508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101750721|NCT05695508|Antiemetics|antiemetics|mesh-ancestor
101750722|NCT05695508|Autonomic Agents|autonomic agents|mesh-ancestor
101750723|NCT05695508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101750724|NCT05695508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750725|NCT05695508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101750726|NCT05695508|Glucocorticoids|glucocorticoids|mesh-ancestor
101750727|NCT05695508|Hormones|hormones|mesh-ancestor
101750728|NCT05695508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101408176|NCT00444184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101750729|NCT05695508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101750730|NCT05695508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750731|NCT05695508|Immunologic Factors|immunologic factors|mesh-ancestor
101750732|NCT05695508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101750733|NCT05695508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101750735|NCT05695508|Growth Inhibitors|growth inhibitors|mesh-ancestor
101750736|NCT05679908|Oxytocin|oxytocin|mesh-list
101750737|NCT05679908|Oxytocics|oxytocics|mesh-ancestor
101750738|NCT05679908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101750739|NCT05679908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750740|NCT05648435|Lithium Carbonate|lithium carbonate|mesh-list
101750741|NCT05648435|Antidepressive Agents|antidepressive agents|mesh-ancestor
101750775|NCT05624138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101750776|NCT05610800|Exenatide|exenatide|mesh-list
101750777|NCT05610800|Nicotine|nicotine|mesh-list
101750778|NCT05610800|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101750779|NCT05610800|Autonomic Agents|autonomic agents|mesh-ancestor
101750780|NCT05610800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101562295|NCT02412670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101562296|NCT02412670|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101562297|NCT02412670|Abortifacient Agents|abortifacient agents|mesh-ancestor
101562298|NCT02412670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101562299|NCT02412670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562300|NCT02412670|Dermatologic Agents|dermatologic agents|mesh-ancestor
101562301|NCT02412670|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101562302|NCT02412670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101562303|NCT02412670|Immunologic Factors|immunologic factors|mesh-ancestor
101410627|NCT00115479|Insulin|insulin|mesh-list
101750781|NCT05610800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750782|NCT05610800|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101750783|NCT05610800|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101750784|NCT05610800|Cholinergic Agents|cholinergic agents|mesh-ancestor
101750785|NCT05610800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101451743|NCT00203099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750802|NCT05594745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101750803|NCT05568953|Vaccines|vaccines|mesh-list
101750804|NCT05568953|Immunologic Factors|immunologic factors|mesh-ancestor
101750805|NCT05568953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750806|NCT05556200|Apatinib|apatinib|mesh-list
101750807|NCT05556200|Antibodies|antibodies|mesh-list
101750808|NCT05556200|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101407138|NCT00106496|Tacrolimus|tacrolimus|mesh-list
101750809|NCT05556200|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101750810|NCT05556200|Immunologic Factors|immunologic factors|mesh-ancestor
101750811|NCT05556200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750812|NCT05556200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750813|NCT05556200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101750814|NCT05556200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101750815|NCT05556200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750817|NCT05532215|Oxytocin|oxytocin|mesh-list
101750818|NCT05532215|Oxytocics|oxytocics|mesh-ancestor
101750819|NCT05532215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101750820|NCT05532215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750821|NCT05532215|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101750822|NCT05532215|Abortifacient Agents|abortifacient agents|mesh-ancestor
101750823|NCT05532215|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101750824|NCT05532215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101750825|NCT05516654|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101750826|NCT05516654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101750827|NCT05505552|Vitamin K|vitamin k|mesh-list
101750828|NCT05505552|Vitamin K 1|vitamin k 1|mesh-list
101750829|NCT05505552|Vitamins|vitamins|mesh-ancestor
101750830|NCT05505552|Micronutrients|micronutrients|mesh-ancestor
101750831|NCT05505552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750832|NCT05505552|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101750833|NCT05505552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101750834|NCT05505552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750835|NCT05505552|Hemostatics|hemostatics|mesh-ancestor
101750836|NCT05505552|Coagulants|coagulants|mesh-ancestor
101750837|NCT05471947|Glycolic acid|glycolic acid|mesh-list
101750838|NCT05471947|Keratolytic Agents|keratolytic agents|mesh-ancestor
101750839|NCT05471947|Dermatologic Agents|dermatologic agents|mesh-ancestor
101750840|NCT05463601|Tamoxifen|tamoxifen|mesh-list
101750841|NCT05463601|Letrozole|letrozole|mesh-list
101750842|NCT05463601|Fulvestrant|fulvestrant|mesh-list
101750843|NCT05463601|Exemestane|exemestane|mesh-list
101750844|NCT05463601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750845|NCT05463601|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101750846|NCT05463601|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101750847|NCT05463601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101750848|NCT05463601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750849|NCT05463601|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101750880|NCT05366764|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101750882|NCT05366764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101750883|NCT05366764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750884|NCT05366764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101562304|NCT02412670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101562305|NCT02412670|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101562306|NCT02412670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101562307|NCT02412670|Tubulin Modulators|tubulin modulators|mesh-ancestor
101562308|NCT02412670|Antimitotic Agents|antimitotic agents|mesh-ancestor
101562309|NCT02412670|Mitosis Modulators|mitosis modulators|mesh-ancestor
101562310|NCT01889199|Flutamide|flutamide|mesh-list
101750885|NCT05366764|Respiratory System Agents|respiratory system agents|mesh-ancestor
101750886|NCT05366764|Tocolytic Agents|tocolytic agents|mesh-ancestor
101750887|NCT05366764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101750888|NCT05366764|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101750889|NCT05366764|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101750890|NCT05366764|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101750891|NCT05366764|Adrenergic Agents|adrenergic agents|mesh-ancestor
101750892|NCT05366764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101750900|NCT05366166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750901|NCT05366166|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101750902|NCT05366166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101750903|NCT05359835|Edetic Acid|edetic acid|mesh-list
101750905|NCT05359835|Pentetic Acid|pentetic acid|mesh-list
101750906|NCT05359835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101750907|NCT05359835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750908|NCT05359835|Antidotes|antidotes|mesh-ancestor
101750909|NCT05359835|Protective Agents|protective agents|mesh-ancestor
101750910|NCT05359835|Chelating Agents|chelating agents|mesh-ancestor
101750911|NCT05359835|Sequestering Agents|sequestering agents|mesh-ancestor
101750912|NCT05359835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750913|NCT05359835|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101750914|NCT05359835|Anticoagulants|anticoagulants|mesh-ancestor
101750915|NCT05359835|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101750916|NCT05355051|Pembrolizumab|pembrolizumab|mesh-list
101750917|NCT05355051|Azacitidine|azacitidine|mesh-list
101750918|NCT05355051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101750919|NCT05355051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750920|NCT05355051|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101750921|NCT05355051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750922|NCT05355051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101750923|NCT05355051|Antimetabolites|antimetabolites|mesh-ancestor
101750924|NCT05355051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101750925|NCT05335148|Colchicine|colchicine|mesh-list
101750926|NCT05335148|Gout Suppressants|gout suppressants|mesh-ancestor
101750927|NCT05335148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101750928|NCT05335148|Tubulin Modulators|tubulin modulators|mesh-ancestor
101750929|NCT05335148|Antimitotic Agents|antimitotic agents|mesh-ancestor
101750930|NCT05335148|Mitosis Modulators|mitosis modulators|mesh-ancestor
101750931|NCT05335148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750932|NCT05335148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750933|NCT05314933|Deoxyglucose|deoxyglucose|mesh-list
101750934|NCT05314933|Antimetabolites|antimetabolites|mesh-ancestor
101750935|NCT05314933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750936|NCT05314933|Antiviral Agents|antiviral agents|mesh-ancestor
101750937|NCT05314933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101750938|NCT05303844|Tislelizumab|tislelizumab|mesh-list
101750939|NCT05303844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101750940|NCT05303844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750941|NCT05260606|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101750942|NCT05260606|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101750943|NCT05260606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750944|NCT05236946|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101750945|NCT05236946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101750946|NCT05236946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101750947|NCT05236946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750948|NCT05222932|Avelumab|avelumab|mesh-list
101750949|NCT05222932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101750950|NCT05222932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750951|NCT05216419|Cholecalciferol|cholecalciferol|mesh-list
101750952|NCT05216419|Vitamin D|vitamin d|mesh-list
101562312|NCT01889199|Hormone Antagonists|hormone antagonists|mesh-ancestor
101562313|NCT01889199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101562314|NCT01889199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562315|NCT01889199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101562316|NCT01889199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101562317|NCT01737502|Sirolimus|sirolimus|mesh-list
101562318|NCT01737502|Auranofin|auranofin|mesh-list
101562319|NCT01737502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101562320|NCT01737502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101562321|NCT01737502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101562322|NCT01737502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750953|NCT05216419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101750954|NCT05216419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750955|NCT05216419|Vitamins|vitamins|mesh-ancestor
101750956|NCT05216419|Micronutrients|micronutrients|mesh-ancestor
101750957|NCT05216419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101750958|NCT05117034|Morphine|morphine|mesh-list
101750959|NCT05117034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101750960|NCT05117034|Narcotics|narcotics|mesh-ancestor
101750961|NCT05117034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101750984|NCT05080946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101750986|NCT05080946|Sensory System Agents|sensory system agents|mesh-ancestor
101750987|NCT05080946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101750988|NCT05080946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750989|NCT05080946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101750990|NCT05080946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101750991|NCT05080946|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101750992|NCT05080946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101750993|NCT05080946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750994|NCT05080946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101750995|NCT05080946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101750996|NCT05080946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101750997|NCT05080946|Antipyretics|antipyretics|mesh-ancestor
101750998|NCT05068752|Sorafenib|sorafenib|mesh-list
101750999|NCT05068752|Vemurafenib|vemurafenib|mesh-list
101751000|NCT05068752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751001|NCT05068752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101751002|NCT05068752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101751003|NCT05068752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751004|NCT05052879|Tadalafil|tadalafil|mesh-list
101751005|NCT05052879|Vasodilator Agents|vasodilator agents|mesh-ancestor
101751006|NCT05052879|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101751007|NCT05052879|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101751008|NCT05052879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101751009|NCT05052879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502399|NCT00491114|Gemcitabine|gemcitabine|mesh-list
101751021|NCT05049707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101751022|NCT05049707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751023|NCT05049707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101751025|NCT05049707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101751026|NCT05043805|Dextromethorphan|dextromethorphan|mesh-list
101751027|NCT05043805|Antitussive Agents|antitussive agents|mesh-ancestor
101751028|NCT05043805|Respiratory System Agents|respiratory system agents|mesh-ancestor
101751029|NCT05043805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101751030|NCT05043805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101751031|NCT05043805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101751032|NCT05043805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751033|NCT05043805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562323|NCT01737502|Antifungal Agents|antifungal agents|mesh-ancestor
101562324|NCT01737502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101562325|NCT01737502|Immunologic Factors|immunologic factors|mesh-ancestor
101562326|NCT01737502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562327|NCT01737502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101562328|NCT01666080|Fludarabine|fludarabine|mesh-list
101562330|NCT01666080|Levetiracetam|levetiracetam|mesh-list
101562331|NCT01666080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101524274|NCT00555984|Remifentanil|remifentanil|mesh-list
101562332|NCT01666080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410652|NCT00446017|Mydriatics|mydriatics|mesh-ancestor
101410653|NCT00446017|Sympathomimetics|sympathomimetics|mesh-ancestor
101751034|NCT05042687|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
101408472|NCT00452881|Gemcitabine|gemcitabine|mesh-list
101211245|NCT05537766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101751036|NCT05042687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751037|NCT05036109|Aspirin|aspirin|mesh-list
101751038|NCT05036109|Vitamin D|vitamin d|mesh-list
101751039|NCT05036109|Vitamins|vitamins|mesh-ancestor
101751040|NCT05036109|Micronutrients|micronutrients|mesh-ancestor
101751041|NCT05036109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751042|NCT05036109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101751043|NCT05036109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101751044|NCT05036109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101751045|NCT05036109|Analgesics|analgesics|mesh-ancestor
101751046|NCT05036109|Sensory System Agents|sensory system agents|mesh-ancestor
101751047|NCT05036109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101751048|NCT05036109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101751049|NCT05036109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101751050|NCT05036109|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101751051|NCT05036109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101751052|NCT05036109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751053|NCT05036109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101751054|NCT05036109|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101751055|NCT05036109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101751056|NCT05036109|Antipyretics|antipyretics|mesh-ancestor
101751057|NCT05033483|Ferrous fumarate|ferrous fumarate|mesh-list
101751058|NCT05033483|Trace Elements|trace elements|mesh-ancestor
101751059|NCT05033483|Micronutrients|micronutrients|mesh-ancestor
101751060|NCT05033483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751061|NCT04999969|Paclitaxel|paclitaxel|mesh-list
101751062|NCT04999969|Gemcitabine|gemcitabine|mesh-list
101751063|NCT04999969|Durvalumab|durvalumab|mesh-list
101751064|NCT04999969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101751065|NCT04999969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751066|NCT04999969|Tubulin Modulators|tubulin modulators|mesh-ancestor
101751067|NCT04999969|Antimitotic Agents|antimitotic agents|mesh-ancestor
101751068|NCT04999969|Mitosis Modulators|mitosis modulators|mesh-ancestor
101751069|NCT04999969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751070|NCT04999969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101751071|NCT04999969|Antimetabolites|antimetabolites|mesh-ancestor
101751093|NCT04977830|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101751094|NCT04977830|Anesthetics, General|anesthetics, general|mesh-ancestor
101751096|NCT04977830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101751097|NCT04977830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751098|NCT04929600|Amlodipine|amlodipine|mesh-list
101751099|NCT04929600|Valsartan|valsartan|mesh-list
101751100|NCT04929600|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101751101|NCT04929600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101751102|NCT04929600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101751103|NCT04929600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101751104|NCT04929600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562333|NCT01666080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101562334|NCT01666080|Immunologic Factors|immunologic factors|mesh-ancestor
101562335|NCT01666080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562336|NCT01666080|Alkylating Agents|alkylating agents|mesh-ancestor
101751105|NCT04929600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101751106|NCT04929600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751107|NCT04929600|Vasodilator Agents|vasodilator agents|mesh-ancestor
101751108|NCT04929600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101751109|NCT04929600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101751111|NCT04925648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751112|NCT04925648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101751113|NCT04925648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101751114|NCT04925648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751115|NCT04904536|Atorvastatin|atorvastatin|mesh-list
101751116|NCT04904536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101751117|NCT04904536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101751118|NCT04904536|Antimetabolites|antimetabolites|mesh-ancestor
101751119|NCT04904536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751120|NCT04904536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101751121|NCT04904536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101751122|NCT04904536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101751138|NCT04848337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101751139|NCT04848337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751140|NCT04848337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101751141|NCT04848337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101751142|NCT04824417|Itraconazole|itraconazole|mesh-list
101751143|NCT04824417|Voriconazole|voriconazole|mesh-list
101751144|NCT04824417|Antifungal Agents|antifungal agents|mesh-ancestor
101751145|NCT04824417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101751146|NCT04824417|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101751147|NCT04824417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101751148|NCT04824417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101751149|NCT04824417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751150|NCT04824417|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101751151|NCT04824417|Hormone Antagonists|hormone antagonists|mesh-ancestor
101751152|NCT04824417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101751153|NCT04824417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751154|NCT04824417|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101751155|NCT04727996|Tislelizumab|tislelizumab|mesh-list
101751156|NCT04727996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101751157|NCT04727996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751158|NCT04720781|Esomeprazole|esomeprazole|mesh-list
101751159|NCT04720781|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101751160|NCT04720781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101751161|NCT04720781|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101751162|NCT04720781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101751163|NCT04720781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751165|NCT04692623|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101751166|NCT04692623|Moxifloxacin|moxifloxacin|mesh-list
101751167|NCT04692623|Gemifloxacin|gemifloxacin|mesh-list
101751168|NCT04692623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101751169|NCT04692623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751170|NCT04692623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101751171|NCT04692623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101751172|NCT04692623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101751173|NCT04692623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101751174|NCT04692623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101751175|NCT04692623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751176|NCT04692623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751177|NCT04690608|Triamcinolone|triamcinolone|mesh-list
101751178|NCT04690608|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101502559|NCT05642689|Trace Elements|trace elements|mesh-ancestor
101751184|NCT04690608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101751185|NCT04690608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751186|NCT04690608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101751187|NCT04690608|Immunologic Factors|immunologic factors|mesh-ancestor
101562337|NCT01666080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101562338|NCT01666080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101562339|NCT01666080|Anticonvulsants|anticonvulsants|mesh-ancestor
101562340|NCT01666080|Nootropic Agents|nootropic agents|mesh-ancestor
101562341|NCT01358877|Paclitaxel|paclitaxel|mesh-list
101562342|NCT01358877|Docetaxel|docetaxel|mesh-list
101562343|NCT01358877|Cyclophosphamide|cyclophosphamide|mesh-list
101562344|NCT01358877|Carboplatin|carboplatin|mesh-list
101562345|NCT01358877|Doxorubicin|doxorubicin|mesh-list
101562346|NCT01358877|Fluorouracil|fluorouracil|mesh-list
101562347|NCT01358877|Trastuzumab|trastuzumab|mesh-list
101562348|NCT01358877|Epirubicin|epirubicin|mesh-list
101562349|NCT01358877|Pertuzumab|pertuzumab|mesh-list
101410674|NCT00446212|Propofol|propofol|mesh-list
101751188|NCT04690608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101751189|NCT04690608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751191|NCT04684238|Isoflurane|isoflurane|mesh-list
101751192|NCT04684238|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101751193|NCT04684238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101751194|NCT04684238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101751195|NCT04684238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751196|NCT04684238|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101751197|NCT04684238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101751198|NCT04684238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101751199|NCT04684238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101751200|NCT04684238|Anesthetics, General|anesthetics, general|mesh-ancestor
101751201|NCT04684238|Anesthetics|anesthetics|mesh-ancestor
101751202|NCT04684238|GABA Modulators|gaba modulators|mesh-ancestor
101751203|NCT04684238|GABA Agents|gaba agents|mesh-ancestor
101751204|NCT04684238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101751205|NCT04684238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751206|NCT04684238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101751207|NCT04586348|Iodine|iodine|mesh-list
101751208|NCT04586348|Cadexomer iodine|cadexomer iodine|mesh-list
101751209|NCT04586348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101751210|NCT04586348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101751211|NCT04586348|Trace Elements|trace elements|mesh-ancestor
101751212|NCT04586348|Micronutrients|micronutrients|mesh-ancestor
101751213|NCT04586348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751214|NCT04577001|Letrozole|letrozole|mesh-list
101751215|NCT04577001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751216|NCT04577001|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101751217|NCT04577001|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101751218|NCT04577001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101751219|NCT04577001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751220|NCT04577001|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101751221|NCT04577001|Hormone Antagonists|hormone antagonists|mesh-ancestor
101751222|NCT04577001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101751223|NCT04577001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751224|NCT04576078|Nefopam|nefopam|mesh-list
101751225|NCT04576078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101751226|NCT04576078|Analgesics|analgesics|mesh-ancestor
101751227|NCT04576078|Sensory System Agents|sensory system agents|mesh-ancestor
101751228|NCT04576078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101751229|NCT04576078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751230|NCT04561557|Cyclophosphamide|cyclophosphamide|mesh-list
101751231|NCT04561557|Fludarabine|fludarabine|mesh-list
101751232|NCT04561557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101751233|NCT04561557|Immunologic Factors|immunologic factors|mesh-ancestor
101751234|NCT04561557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751235|NCT04561557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101751236|NCT04561557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101751237|NCT04561557|Alkylating Agents|alkylating agents|mesh-ancestor
101751238|NCT04561557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751239|NCT04561557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751240|NCT04561557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101751241|NCT04561375|Fentanyl|fentanyl|mesh-list
101562350|NCT01358877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101562351|NCT01358877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101562352|NCT01358877|Tubulin Modulators|tubulin modulators|mesh-ancestor
101562353|NCT01358877|Antimitotic Agents|antimitotic agents|mesh-ancestor
101562354|NCT01358877|Mitosis Modulators|mitosis modulators|mesh-ancestor
101562355|NCT01358877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562356|NCT01358877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101562357|NCT01358877|Immunologic Factors|immunologic factors|mesh-ancestor
101562358|NCT01358877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562359|NCT01358877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101562360|NCT01358877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101562361|NCT01358877|Alkylating Agents|alkylating agents|mesh-ancestor
101562362|NCT01358877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101562363|NCT01358877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101562364|NCT01358877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101562365|NCT01358877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101562366|NCT01358877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101562367|NCT01358877|Antimetabolites|antimetabolites|mesh-ancestor
101562368|NCT01358877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101562369|NCT01358877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101562370|NCT01084252|Dexamethasone|dexamethasone|mesh-list
101562371|NCT01084252|Dexamethasone acetate|dexamethasone acetate|mesh-list
101562372|NCT01084252|BB 1101|bb 1101|mesh-list
101562373|NCT01084252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101410678|NCT00446212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410681|NCT00446212|Anesthetics|anesthetics|mesh-ancestor
101751242|NCT04561375|Sufentanil|sufentanil|mesh-list
101751243|NCT04561375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101751244|NCT04561375|Narcotics|narcotics|mesh-ancestor
101751245|NCT04561375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101751246|NCT04561375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751247|NCT04561375|Analgesics|analgesics|mesh-ancestor
101751248|NCT04561375|Sensory System Agents|sensory system agents|mesh-ancestor
101751249|NCT04561375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101751250|NCT04561375|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101751252|NCT04561375|Anesthetics, General|anesthetics, general|mesh-ancestor
101751253|NCT04561375|Anesthetics|anesthetics|mesh-ancestor
101751255|NCT04560127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751256|NCT04560127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101751257|NCT04560127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101751258|NCT04560127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751260|NCT04536532|Antiviral Agents|antiviral agents|mesh-ancestor
101751261|NCT04536532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101751262|NCT04509115|Analgesics, Opioid|analgesics, opioid|mesh-list
101751263|NCT04509115|Narcotics|narcotics|mesh-ancestor
101751264|NCT04509115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101751265|NCT04509115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751266|NCT04509115|Analgesics|analgesics|mesh-ancestor
101562374|NCT01084252|Antiemetics|antiemetics|mesh-ancestor
101562375|NCT01084252|Autonomic Agents|autonomic agents|mesh-ancestor
101562376|NCT01084252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101562377|NCT01084252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751267|NCT04509115|Sensory System Agents|sensory system agents|mesh-ancestor
101751268|NCT04509115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101751270|NCT04508634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101751271|NCT04508634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751272|NCT04489771|Belzutifan|belzutifan|mesh-list
101751273|NCT04489771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751274|NCT04480502|Ipilimumab|ipilimumab|mesh-list
101751275|NCT04480502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101751276|NCT04480502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751277|NCT04480502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101751278|NCT04480502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751279|NCT04447092|Leucovorin|leucovorin|mesh-list
101751280|NCT04447092|Paclitaxel|paclitaxel|mesh-list
101751281|NCT04447092|Gemcitabine|gemcitabine|mesh-list
101751282|NCT04447092|Pembrolizumab|pembrolizumab|mesh-list
101751283|NCT04447092|Oxaliplatin|oxaliplatin|mesh-list
101751284|NCT04447092|Irinotecan|irinotecan|mesh-list
101751285|NCT04447092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101751286|NCT04447092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751287|NCT04447092|Tubulin Modulators|tubulin modulators|mesh-ancestor
101751288|NCT04447092|Antimitotic Agents|antimitotic agents|mesh-ancestor
101751289|NCT04447092|Mitosis Modulators|mitosis modulators|mesh-ancestor
101751290|NCT04447092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751291|NCT04447092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101751292|NCT04447092|Antimetabolites|antimetabolites|mesh-ancestor
101751293|NCT04447092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101751294|NCT04447092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101751295|NCT04447092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101751296|NCT04447092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101751297|NCT04447092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101751298|NCT04447092|Antidotes|antidotes|mesh-ancestor
101751299|NCT04447092|Protective Agents|protective agents|mesh-ancestor
101751300|NCT04447092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751301|NCT04447092|Vitamin B Complex|vitamin b complex|mesh-ancestor
101751302|NCT04447092|Vitamins|vitamins|mesh-ancestor
101751303|NCT04447092|Micronutrients|micronutrients|mesh-ancestor
101751304|NCT04398524|Cemiplimab|cemiplimab|mesh-list
101751305|NCT04398524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101751306|NCT04398524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751307|NCT04371224|Leucovorin|leucovorin|mesh-list
101751308|NCT04371224|Fluorouracil|fluorouracil|mesh-list
101751309|NCT04371224|Capecitabine|capecitabine|mesh-list
101751310|NCT04371224|Irinotecan|irinotecan|mesh-list
101751311|NCT04371224|Antimetabolites|antimetabolites|mesh-ancestor
101751312|NCT04371224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751313|NCT04371224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101751314|NCT04371224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751315|NCT04371224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101751316|NCT04371224|Immunologic Factors|immunologic factors|mesh-ancestor
101751317|NCT04371224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751318|NCT04371224|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101751319|NCT04371224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101751320|NCT04371224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101751321|NCT04371224|Antidotes|antidotes|mesh-ancestor
101751322|NCT04371224|Protective Agents|protective agents|mesh-ancestor
101751323|NCT04371224|Vitamin B Complex|vitamin b complex|mesh-ancestor
101751324|NCT04371224|Vitamins|vitamins|mesh-ancestor
101751325|NCT04371224|Micronutrients|micronutrients|mesh-ancestor
101751326|NCT04306900|Paclitaxel|paclitaxel|mesh-list
101751327|NCT04306900|Docetaxel|docetaxel|mesh-list
101751328|NCT04306900|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101751329|NCT04306900|Gemcitabine|gemcitabine|mesh-list
101751336|NCT04306900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751339|NCT04306900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101751340|NCT04306900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101751341|NCT04288687|Niraparib|niraparib|mesh-list
101751342|NCT04288687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101751343|NCT04288687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101751344|NCT04288687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562378|NCT01084252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101562379|NCT01084252|Glucocorticoids|glucocorticoids|mesh-ancestor
101562380|NCT01084252|Hormones|hormones|mesh-ancestor
101562381|NCT01084252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101562382|NCT01084252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101562383|NCT01084252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101562384|NCT01084252|Protease Inhibitors|protease inhibitors|mesh-ancestor
101562385|NCT01084252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101410706|NCT00115518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101751345|NCT04288687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751346|NCT04231708|Hydrocortisone|hydrocortisone|mesh-list
101751347|NCT04231708|Yohimbine|yohimbine|mesh-list
101534503|NCT00568217|Analgesics|analgesics|mesh-ancestor
101751348|NCT04231708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101751349|NCT04231708|Mydriatics|mydriatics|mesh-ancestor
101751350|NCT04231708|Autonomic Agents|autonomic agents|mesh-ancestor
101751351|NCT04231708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101751352|NCT04231708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751353|NCT04231708|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101751354|NCT04231708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101751355|NCT04231708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101751356|NCT04231708|Adrenergic Agents|adrenergic agents|mesh-ancestor
101751357|NCT04231708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101751358|NCT04231708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751359|NCT04231708|Urological Agents|urological agents|mesh-ancestor
101751360|NCT04218786|Colchicine|colchicine|mesh-list
101751361|NCT04218786|Gout Suppressants|gout suppressants|mesh-ancestor
101751362|NCT04218786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101751363|NCT04218786|Tubulin Modulators|tubulin modulators|mesh-ancestor
101751364|NCT04218786|Antimitotic Agents|antimitotic agents|mesh-ancestor
101751365|NCT04218786|Mitosis Modulators|mitosis modulators|mesh-ancestor
101751366|NCT04218786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751367|NCT04218786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751368|NCT04216524|Cytarabine|cytarabine|mesh-list
101751369|NCT04216524|Dexamethasone|dexamethasone|mesh-list
101751370|NCT04216524|Dexamethasone acetate|dexamethasone acetate|mesh-list
101751371|NCT04216524|Prednisone|prednisone|mesh-list
101751372|NCT04216524|Methylprednisolone|methylprednisolone|mesh-list
101751373|NCT04216524|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101751374|NCT04216524|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101751375|NCT04216524|Prednisolone|prednisolone|mesh-list
101751376|NCT04216524|Prednisolone acetate|prednisolone acetate|mesh-list
101751377|NCT04216524|Cortisone|cortisone|mesh-list
101751378|NCT04216524|Cyclophosphamide|cyclophosphamide|mesh-list
101751379|NCT04216524|Rituximab|rituximab|mesh-list
101751380|NCT04216524|Doxorubicin|doxorubicin|mesh-list
101751381|NCT04216524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101751382|NCT04216524|Methotrexate|methotrexate|mesh-list
101751383|NCT04216524|Vincristine|vincristine|mesh-list
101751384|NCT04216524|Daunorubicin|daunorubicin|mesh-list
101751385|NCT04216524|Venetoclax|venetoclax|mesh-list
101751386|NCT04216524|Mercaptopurine|mercaptopurine|mesh-list
101751387|NCT04216524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101751388|NCT04216524|Antibodies|antibodies|mesh-list
101751389|NCT04216524|Immunoglobulins|immunoglobulins|mesh-list
101751390|NCT04216524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101751391|NCT04216524|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101751392|NCT04216524|Prednisolone phosphate|prednisolone phosphate|mesh-list
101751393|NCT04216524|BB 1101|bb 1101|mesh-list
101751394|NCT04216524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101751395|NCT04216524|Immunologic Factors|immunologic factors|mesh-ancestor
101751396|NCT04216524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751397|NCT04216524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101751398|NCT04216524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101751399|NCT04216524|Alkylating Agents|alkylating agents|mesh-ancestor
101502761|NCT00487422|Serotonin Agents|serotonin agents|mesh-ancestor
101751415|NCT04216524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101751416|NCT04216524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101751417|NCT04216524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101751418|NCT04216524|Abortifacient Agents|abortifacient agents|mesh-ancestor
101562386|NCT01084252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562388|NCT00992238|Parasympatholytics|parasympatholytics|mesh-ancestor
101562389|NCT00992238|Autonomic Agents|autonomic agents|mesh-ancestor
101562390|NCT00992238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101562391|NCT00992238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562392|NCT00992238|Urological Agents|urological agents|mesh-ancestor
101562393|NCT00858897|Insulin|insulin|mesh-list
101562394|NCT00858897|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101751419|NCT04216524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101751420|NCT04216524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101751421|NCT04216524|Antimetabolites|antimetabolites|mesh-ancestor
101751422|NCT04216524|Dermatologic Agents|dermatologic agents|mesh-ancestor
101751423|NCT04216524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101751424|NCT04216524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101751425|NCT04216524|Antiviral Agents|antiviral agents|mesh-ancestor
101751426|NCT04216524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101751427|NCT04216524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101751428|NCT04216524|Tubulin Modulators|tubulin modulators|mesh-ancestor
101751429|NCT04216524|Antimitotic Agents|antimitotic agents|mesh-ancestor
101751430|NCT04216524|Mitosis Modulators|mitosis modulators|mesh-ancestor
101751431|NCT04216524|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101751432|NCT04216524|Protective Agents|protective agents|mesh-ancestor
101751433|NCT04202692|Magnesium trisilicate|magnesium trisilicate|mesh-list
101751434|NCT04202692|Hyaluronic Acid|hyaluronic acid|mesh-list
101751435|NCT04202692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101751436|NCT04202692|Immunologic Factors|immunologic factors|mesh-ancestor
101751437|NCT04202692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751438|NCT04202692|Viscosupplements|viscosupplements|mesh-ancestor
101751439|NCT04202692|Protective Agents|protective agents|mesh-ancestor
101751440|NCT04202692|Antacids|antacids|mesh-ancestor
101751441|NCT04202692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751442|NCT04202692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101751443|NCT04177758|Vitamin D|vitamin d|mesh-list
101751444|NCT04177758|Vitamins|vitamins|mesh-ancestor
101751445|NCT04177758|Micronutrients|micronutrients|mesh-ancestor
101751446|NCT04177758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751447|NCT04177758|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101751448|NCT04168112|Dexamethasone|dexamethasone|mesh-list
101751449|NCT04168112|Prednisolone|prednisolone|mesh-list
101751450|NCT04168112|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101751451|NCT04168112|Methylprednisolone|methylprednisolone|mesh-list
101751452|NCT04168112|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101751453|NCT04168112|Prednisolone acetate|prednisolone acetate|mesh-list
101751454|NCT04168112|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101751455|NCT04168112|Prednisolone phosphate|prednisolone phosphate|mesh-list
101751456|NCT04168112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101751457|NCT04168112|Antiemetics|antiemetics|mesh-ancestor
101751458|NCT04168112|Autonomic Agents|autonomic agents|mesh-ancestor
101751459|NCT04168112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101751471|NCT04150458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101751472|NCT04150458|Antimetabolites|antimetabolites|mesh-ancestor
101751473|NCT04150458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751474|NCT04150458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101751475|NCT04150458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101751476|NCT04150458|Nootropic Agents|nootropic agents|mesh-ancestor
101751477|NCT04147208|Ritonavir|ritonavir|mesh-list
101751478|NCT04147208|Entecavir|entecavir|mesh-list
101751479|NCT04147208|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101751480|NCT04147208|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101751481|NCT04147208|Protease Inhibitors|protease inhibitors|mesh-ancestor
101751482|NCT04147208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101751483|NCT04147208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751484|NCT04147208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101751485|NCT04147208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101751486|NCT04147208|Antiviral Agents|antiviral agents|mesh-ancestor
101751487|NCT04147208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101211691|NCT05083949|Metformin|metformin|mesh-list
101562395|NCT00858897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101562396|NCT00858897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562397|NCT05940909|Amlodipine|amlodipine|mesh-list
101562398|NCT05940909|Perindopril|perindopril|mesh-list
101562399|NCT05940909|Indapamide|indapamide|mesh-list
101562400|NCT05940909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101562401|NCT05940909|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101562402|NCT05940909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101410724|NCT05589753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101751488|NCT04147208|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101751489|NCT04147208|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101751499|NCT04008706|Acalabrutinib|acalabrutinib|mesh-list
101751500|NCT04008706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751501|NCT04003103|Islatravir|islatravir|mesh-list
101751502|NCT04003103|Antiviral Agents|antiviral agents|mesh-ancestor
101751503|NCT04003103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101751504|NCT04003103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101751505|NCT04003103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751506|NCT04003103|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101751507|NCT04003103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101751508|NCT04003103|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101751509|NCT03999216|Diuretics|diuretics|mesh-list
101751510|NCT03999216|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
101751511|NCT03999216|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
101751512|NCT03999216|Natriuretic Agents|natriuretic agents|mesh-ancestor
101751513|NCT03999216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751514|NCT03999216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101751515|NCT03999216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751516|NCT03978611|Ipilimumab|ipilimumab|mesh-list
101751517|NCT03978611|Relatlimab|relatlimab|mesh-list
101751518|NCT03978611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101751519|NCT03978611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751520|NCT03978611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101751521|NCT03978611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502895|NCT00487734|Hormones|hormones|mesh-ancestor
101751528|NCT03945448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101751529|NCT03945448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101751530|NCT03945448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751531|NCT03945448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101751532|NCT03945448|Hormone Antagonists|hormone antagonists|mesh-ancestor
101751533|NCT03945448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101751534|NCT03945448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751535|NCT03945448|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101751536|NCT03945448|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101751538|NCT03945448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101751539|NCT03945448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101751540|NCT03945448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101751541|NCT03941873|Tislelizumab|tislelizumab|mesh-list
101751542|NCT03941873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101751543|NCT03941873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751544|NCT03941587|Aflibercept|aflibercept|mesh-list
101751545|NCT03941587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101751546|NCT03941587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101751547|NCT03941587|Growth Substances|growth substances|mesh-ancestor
101751548|NCT03941587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751549|NCT03941587|Growth Inhibitors|growth inhibitors|mesh-ancestor
101751550|NCT03941587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751551|NCT03917420|Tenofovir|tenofovir|mesh-list
101751552|NCT03917420|Emtricitabine|emtricitabine|mesh-list
101751553|NCT03917420|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101751554|NCT03917420|Antiviral Agents|antiviral agents|mesh-ancestor
101751555|NCT03917420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101751556|NCT03917420|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101751557|NCT03917420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101562403|NCT05940909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562404|NCT05940909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101562405|NCT05940909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562406|NCT05940909|Vasodilator Agents|vasodilator agents|mesh-ancestor
101562407|NCT05940909|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101562408|NCT05940909|Protease Inhibitors|protease inhibitors|mesh-ancestor
101562409|NCT05940909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101562410|NCT05940909|Diuretics|diuretics|mesh-ancestor
101562411|NCT05940909|Natriuretic Agents|natriuretic agents|mesh-ancestor
101562412|NCT05940909|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101562413|NCT05940896|Disitamab vedotin|disitamab vedotin|mesh-list
101562414|NCT05940896|Immunoconjugates|immunoconjugates|mesh-ancestor
101562415|NCT05940896|Immunologic Factors|immunologic factors|mesh-ancestor
101562416|NCT05940896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562417|NCT05940701|Listerine|listerine|mesh-list
101562418|NCT05940701|Sodium Fluoride|sodium fluoride|mesh-list
101562419|NCT05940701|Cariostatic Agents|cariostatic agents|mesh-ancestor
101562420|NCT05940701|Protective Agents|protective agents|mesh-ancestor
101751558|NCT03917420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101751559|NCT03917420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751560|NCT03917420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101751561|NCT03917420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101408993|NCT00456898|Serotonin Agents|serotonin agents|mesh-ancestor
101751562|NCT03913195|Ibalizumab|ibalizumab|mesh-list
101751563|NCT03913195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101751564|NCT03913195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101751565|NCT03913195|Antiviral Agents|antiviral agents|mesh-ancestor
101751566|NCT03913195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101751567|NCT03884556|Paclitaxel|paclitaxel|mesh-list
101751568|NCT03884556|Gemcitabine|gemcitabine|mesh-list
101751569|NCT03884556|Pembrolizumab|pembrolizumab|mesh-list
101751570|NCT03884556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101751571|NCT03884556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751572|NCT03884556|Tubulin Modulators|tubulin modulators|mesh-ancestor
101751573|NCT03884556|Antimitotic Agents|antimitotic agents|mesh-ancestor
101751574|NCT03884556|Mitosis Modulators|mitosis modulators|mesh-ancestor
101751575|NCT03884556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751576|NCT03884556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101751577|NCT03884556|Antimetabolites|antimetabolites|mesh-ancestor
101751578|NCT03884556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101751579|NCT03884556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101751580|NCT03720119|Lidocaine|lidocaine|mesh-list
101751581|NCT03720119|Anesthetics, Local|anesthetics, local|mesh-ancestor
101751582|NCT03720119|Anesthetics|anesthetics|mesh-ancestor
101751583|NCT03720119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101751584|NCT03720119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751585|NCT03720119|Sensory System Agents|sensory system agents|mesh-ancestor
101751586|NCT03720119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101751587|NCT03720119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101751588|NCT03720119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101751606|NCT03669718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751608|NCT03644966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101751609|NCT03642990|Niacinamide|niacinamide|mesh-list
101751610|NCT03642990|Niacin|niacin|mesh-list
101751611|NCT03642990|Nicotinic Acids|nicotinic acids|mesh-list
101751612|NCT03642990|Vitamin B Complex|vitamin b complex|mesh-ancestor
101751613|NCT03642990|Vitamins|vitamins|mesh-ancestor
101751614|NCT03642990|Micronutrients|micronutrients|mesh-ancestor
101562421|NCT05940701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562422|NCT05940701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101562423|NCT05940701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101562424|NCT05940649|Norepinephrine|norepinephrine|mesh-list
101562425|NCT05940649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101562426|NCT05940649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101562427|NCT05940649|Adrenergic Agents|adrenergic agents|mesh-ancestor
101562428|NCT05940649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101562429|NCT05940649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410748|NCT00446680|Diuretics|diuretics|mesh-ancestor
101751615|NCT03642990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751616|NCT03642990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101751617|NCT03642990|Antimetabolites|antimetabolites|mesh-ancestor
101751618|NCT03642990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751619|NCT03642990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101751620|NCT03642990|Vasodilator Agents|vasodilator agents|mesh-ancestor
101751621|NCT03582475|Cisplatin|cisplatin|mesh-list
101751622|NCT03582475|Carboplatin|carboplatin|mesh-list
101751623|NCT03582475|Docetaxel|docetaxel|mesh-list
101751624|NCT03582475|Pembrolizumab|pembrolizumab|mesh-list
101751625|NCT03582475|Etoposide|etoposide|mesh-list
101751626|NCT03582475|Etoposide phosphate|etoposide phosphate|mesh-list
101751627|NCT03582475|Podophyllotoxin|podophyllotoxin|mesh-list
101751628|NCT03582475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751629|NCT03582475|Tubulin Modulators|tubulin modulators|mesh-ancestor
101751630|NCT03582475|Antimitotic Agents|antimitotic agents|mesh-ancestor
101751631|NCT03582475|Mitosis Modulators|mitosis modulators|mesh-ancestor
101751632|NCT03582475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751633|NCT03582475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101751634|NCT03582475|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101751635|NCT03582475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101751636|NCT03582475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101751637|NCT03582475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101751638|NCT03582475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101751639|NCT03582475|Keratolytic Agents|keratolytic agents|mesh-ancestor
101751640|NCT03582475|Dermatologic Agents|dermatologic agents|mesh-ancestor
101751643|NCT03579784|Olaparib|olaparib|mesh-list
101751644|NCT03579784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101751645|NCT03579784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751646|NCT03579784|Tubulin Modulators|tubulin modulators|mesh-ancestor
101751647|NCT03579784|Antimitotic Agents|antimitotic agents|mesh-ancestor
101751648|NCT03579784|Mitosis Modulators|mitosis modulators|mesh-ancestor
101751649|NCT03579784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751650|NCT03579784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101751655|NCT03564678|Vitamins|vitamins|mesh-ancestor
101751656|NCT03564678|Micronutrients|micronutrients|mesh-ancestor
101751657|NCT03564678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751658|NCT03564678|Hematinics|hematinics|mesh-ancestor
101751659|NCT03553563|Esomeprazole|esomeprazole|mesh-list
101751660|NCT03553563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101751661|NCT03553563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101751662|NCT03553563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101751663|NCT03553563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101751664|NCT03553563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751665|NCT03542760|Methylene Blue|methylene blue|mesh-list
101751666|NCT03542760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101751667|NCT03542760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751668|NCT03530397|Paclitaxel|paclitaxel|mesh-list
101751669|NCT03530397|Carboplatin|carboplatin|mesh-list
101751670|NCT03530397|Pembrolizumab|pembrolizumab|mesh-list
101751671|NCT03530397|Pemetrexed|pemetrexed|mesh-list
101751672|NCT03530397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101751673|NCT03530397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751674|NCT03530397|Tubulin Modulators|tubulin modulators|mesh-ancestor
101751675|NCT03530397|Antimitotic Agents|antimitotic agents|mesh-ancestor
101751676|NCT03530397|Mitosis Modulators|mitosis modulators|mesh-ancestor
101562430|NCT05940649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562431|NCT05940649|Sympathomimetics|sympathomimetics|mesh-ancestor
101562432|NCT05940649|Autonomic Agents|autonomic agents|mesh-ancestor
101562433|NCT05940649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101751677|NCT03530397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751678|NCT03530397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101751679|NCT03530397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101751680|NCT03530397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101751681|NCT03530397|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101751682|NCT03530397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101751683|NCT03515304|Evolocumab|evolocumab|mesh-list
101751684|NCT03515304|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101751685|NCT03515304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101751686|NCT03515304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101751687|NCT03515304|Antimetabolites|antimetabolites|mesh-ancestor
101751688|NCT03515304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751689|NCT03515304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101751690|NCT03515304|Protease Inhibitors|protease inhibitors|mesh-ancestor
101751691|NCT03515304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101751692|NCT03515304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101751693|NCT03477292|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101751694|NCT03477292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101751695|NCT03465540|Dexamethasone|dexamethasone|mesh-list
101751696|NCT03465540|Azacitidine|azacitidine|mesh-list
101751697|NCT03465540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101751698|NCT03465540|Antiemetics|antiemetics|mesh-ancestor
101751699|NCT03465540|Autonomic Agents|autonomic agents|mesh-ancestor
101751700|NCT03465540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101751701|NCT03465540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751702|NCT03465540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101751703|NCT03465540|Glucocorticoids|glucocorticoids|mesh-ancestor
101751704|NCT03465540|Hormones|hormones|mesh-ancestor
101751705|NCT03465540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101751706|NCT03465540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101751707|NCT03465540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751708|NCT03465540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101751709|NCT03465540|Antimetabolites|antimetabolites|mesh-ancestor
101751710|NCT03465540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751711|NCT03465540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101751712|NCT03368547|Edetic Acid|edetic acid|mesh-list
101751713|NCT03368547|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101751714|NCT03368547|Chelating Agents|chelating agents|mesh-ancestor
101751715|NCT03368547|Sequestering Agents|sequestering agents|mesh-ancestor
101751716|NCT03368547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751717|NCT03368547|Anticoagulants|anticoagulants|mesh-ancestor
101751718|NCT03368547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101751719|NCT03368547|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101751720|NCT03217227|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
101751721|NCT03217227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751722|NCT03217227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101451744|NCT00203099|Antidotes|antidotes|mesh-ancestor
101751766|NCT03048877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751767|NCT03048877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101751768|NCT03048877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101751769|NCT03048877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751770|NCT02951351|Proxymetacaine|proxymetacaine|mesh-list
101751771|NCT02951351|Anesthetics, Local|anesthetics, local|mesh-ancestor
101751772|NCT02951351|Anesthetics|anesthetics|mesh-ancestor
101751773|NCT02951351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101751774|NCT02951351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751775|NCT02951351|Sensory System Agents|sensory system agents|mesh-ancestor
101751776|NCT02951351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101751777|NCT02940925|Cisplatin|cisplatin|mesh-list
101751778|NCT02940925|Fluorouracil|fluorouracil|mesh-list
101751779|NCT02940925|Capecitabine|capecitabine|mesh-list
101751780|NCT02940925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751781|NCT02940925|Antimetabolites|antimetabolites|mesh-ancestor
101751782|NCT02940925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751783|NCT02940925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101751784|NCT02940925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101751785|NCT02940925|Immunologic Factors|immunologic factors|mesh-ancestor
101562434|NCT05940649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101562435|NCT05940545|Ribavirin|ribavirin|mesh-list
101562436|NCT05940545|Favipiravir|favipiravir|mesh-list
101562437|NCT05940545|Antimetabolites|antimetabolites|mesh-ancestor
101562438|NCT05940545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562439|NCT05940545|Antiviral Agents|antiviral agents|mesh-ancestor
101562440|NCT05940545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101562441|NCT05940441|Capecitabine|capecitabine|mesh-list
101751786|NCT02940925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751787|NCT02915705|Vitamin D|vitamin d|mesh-list
101751788|NCT02915705|Vitamins|vitamins|mesh-ancestor
101751789|NCT02915705|Micronutrients|micronutrients|mesh-ancestor
101751790|NCT02915705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751801|NCT02891278|Immunologic Factors|immunologic factors|mesh-ancestor
101751802|NCT02891278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751803|NCT02891278|Antidepressive Agents|antidepressive agents|mesh-ancestor
101751804|NCT02891278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101751805|NCT02891278|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101751806|NCT02891278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101751807|NCT02891278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101751808|NCT02891278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101751809|NCT02891278|Serotonin Agents|serotonin agents|mesh-ancestor
101751810|NCT02807181|Cisplatin|cisplatin|mesh-list
101751811|NCT02807181|Gemcitabine|gemcitabine|mesh-list
101751812|NCT02807181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751813|NCT02807181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101751814|NCT02807181|Antimetabolites|antimetabolites|mesh-ancestor
101751815|NCT02807181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751816|NCT02454543|Androgens|androgens|mesh-list
101751817|NCT02454543|Hormones|hormones|mesh-ancestor
101751818|NCT02454543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101751819|NCT02454543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751820|NCT02384512|Rasagiline|rasagiline|mesh-list
101751821|NCT02384512|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101751822|NCT02384512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101751823|NCT02384512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751824|NCT02384512|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101751825|NCT02384512|Protective Agents|protective agents|mesh-ancestor
101751826|NCT02384512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751827|NCT02366494|Docetaxel|docetaxel|mesh-list
101751828|NCT02366494|Leuprolide|leuprolide|mesh-list
101751829|NCT02366494|Goserelin|goserelin|mesh-list
101751830|NCT02366494|Bicalutamide|bicalutamide|mesh-list
101751831|NCT02366494|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101751832|NCT02366494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751833|NCT02366494|Tubulin Modulators|tubulin modulators|mesh-ancestor
101751834|NCT02366494|Antimitotic Agents|antimitotic agents|mesh-ancestor
101751835|NCT02366494|Mitosis Modulators|mitosis modulators|mesh-ancestor
101751836|NCT02366494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751837|NCT02366494|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101751838|NCT02366494|Fertility Agents|fertility agents|mesh-ancestor
101751839|NCT02366494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101751840|NCT02366494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751841|NCT02366494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101751842|NCT02366494|Androgen Antagonists|androgen antagonists|mesh-ancestor
101751843|NCT02366494|Hormone Antagonists|hormone antagonists|mesh-ancestor
101751844|NCT02366494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101751845|NCT02366494|Luteolytic Agents|luteolytic agents|mesh-ancestor
101751846|NCT02366494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101751847|NCT02366494|Contraceptive Agents|contraceptive agents|mesh-ancestor
101751848|NCT02366494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101751849|NCT02157610|Nicotine|nicotine|mesh-list
101751850|NCT02157610|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101751851|NCT02157610|Autonomic Agents|autonomic agents|mesh-ancestor
101751852|NCT02157610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101751853|NCT02157610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751854|NCT02157610|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101751855|NCT02157610|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101562442|NCT05940441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101562443|NCT05940441|Antimetabolites|antimetabolites|mesh-ancestor
101562444|NCT05940441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562445|NCT05940441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101562446|NCT05940376|Insulin, Short-Acting|insulin, short-acting|mesh-list
101562447|NCT05940376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101751887|NCT02078869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101751888|NCT02078869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751889|NCT01946815|Atorvastatin|atorvastatin|mesh-list
101751890|NCT01946815|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101751891|NCT01946815|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101751892|NCT01946815|Antimetabolites|antimetabolites|mesh-ancestor
101751893|NCT01946815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751894|NCT01946815|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101751895|NCT01946815|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101751896|NCT01946815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101751897|NCT01937156|Granisetron|granisetron|mesh-list
101751898|NCT01937156|Antiemetics|antiemetics|mesh-ancestor
101751899|NCT01937156|Autonomic Agents|autonomic agents|mesh-ancestor
101751900|NCT01937156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101751901|NCT01937156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751902|NCT01937156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101751903|NCT01937156|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101751904|NCT01937156|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101751905|NCT01937156|Serotonin Agents|serotonin agents|mesh-ancestor
101751917|NCT01718873|Capecitabine|capecitabine|mesh-list
101751918|NCT01718873|Oxaliplatin|oxaliplatin|mesh-list
101751919|NCT01718873|Levoleucovorin|levoleucovorin|mesh-list
101751920|NCT01718873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101751921|NCT01718873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751922|NCT01718873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101751923|NCT01718873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101751924|NCT01718873|Growth Substances|growth substances|mesh-ancestor
101751925|NCT01718873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751926|NCT01718873|Growth Inhibitors|growth inhibitors|mesh-ancestor
101751927|NCT01718873|Antimetabolites|antimetabolites|mesh-ancestor
101751928|NCT01718873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751929|NCT01718873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101751930|NCT01718873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101751931|NCT01718873|Immunologic Factors|immunologic factors|mesh-ancestor
101751932|NCT01718873|Antidotes|antidotes|mesh-ancestor
101751933|NCT01718873|Protective Agents|protective agents|mesh-ancestor
101751934|NCT01718873|Vitamin B Complex|vitamin b complex|mesh-ancestor
101751936|NCT01718873|Micronutrients|micronutrients|mesh-ancestor
101751937|NCT01718873|Hematinics|hematinics|mesh-ancestor
101751938|NCT01612351|Paclitaxel|paclitaxel|mesh-list
101751939|NCT01612351|Cisplatin|cisplatin|mesh-list
101751941|NCT01612351|Lapatinib|lapatinib|mesh-list
101751942|NCT01612351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101751943|NCT01612351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751944|NCT01612351|Tubulin Modulators|tubulin modulators|mesh-ancestor
101751945|NCT01612351|Antimitotic Agents|antimitotic agents|mesh-ancestor
101751946|NCT01612351|Mitosis Modulators|mitosis modulators|mesh-ancestor
101751947|NCT01612351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751948|NCT01612351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101751949|NCT01612351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101751950|NCT01424566|Nabiximols|nabiximols|mesh-list
101751951|NCT01424566|Analgesics|analgesics|mesh-ancestor
101751952|NCT01424566|Sensory System Agents|sensory system agents|mesh-ancestor
101751953|NCT01424566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101751954|NCT01424566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751955|NCT01367561|Naloxone|naloxone|mesh-list
101751956|NCT01367561|Methylnaltrexone|methylnaltrexone|mesh-list
101751957|NCT01367561|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101751958|NCT01367561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751959|NCT01367561|Sensory System Agents|sensory system agents|mesh-ancestor
101751960|NCT01367561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101751961|NCT01361607|Nabiximols|nabiximols|mesh-list
101751962|NCT01361607|Analgesics|analgesics|mesh-ancestor
101562448|NCT05940376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562449|NCT05940324|Naltrexone|naltrexone|mesh-list
101562450|NCT05940324|Ketamine|ketamine|mesh-list
101562451|NCT05940324|Analgesics|analgesics|mesh-ancestor
101562452|NCT05940324|Sensory System Agents|sensory system agents|mesh-ancestor
101562453|NCT05940324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101410774|NCT00446836|Tubulin Modulators|tubulin modulators|mesh-ancestor
101751963|NCT01361607|Sensory System Agents|sensory system agents|mesh-ancestor
101751964|NCT01361607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101751965|NCT01361607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751966|NCT01337089|Nabiximols|nabiximols|mesh-list
101751967|NCT01337089|Analgesics|analgesics|mesh-ancestor
101751968|NCT01337089|Sensory System Agents|sensory system agents|mesh-ancestor
101751969|NCT01337089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101751970|NCT01337089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751971|NCT01297400|Sulfadiazine|sulfadiazine|mesh-list
101751972|NCT01297400|Silver Sulfadiazine|silver sulfadiazine|mesh-list
101751981|NCT01276587|Cholecalciferol|cholecalciferol|mesh-list
101751982|NCT01276587|Vitamins|vitamins|mesh-list
101751983|NCT01276587|Micronutrients|micronutrients|mesh-ancestor
101751984|NCT01276587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751985|NCT01276587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101751986|NCT01276587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101751987|NCT01217580|Ropivacaine|ropivacaine|mesh-list
101751988|NCT01217580|Anesthetics, Local|anesthetics, local|mesh-ancestor
101751989|NCT01217580|Anesthetics|anesthetics|mesh-ancestor
101751990|NCT01217580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101751991|NCT01217580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751992|NCT01217580|Sensory System Agents|sensory system agents|mesh-ancestor
101751993|NCT01217580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101751994|NCT00802646|Epinephrine|epinephrine|mesh-list
101751995|NCT00802646|Fentanyl|fentanyl|mesh-list
101751996|NCT00802646|Bupivacaine|bupivacaine|mesh-list
101751997|NCT00802646|Anesthetics, Local|anesthetics, local|mesh-ancestor
101751998|NCT00802646|Anesthetics|anesthetics|mesh-ancestor
101751999|NCT00802646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101752000|NCT00802646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752001|NCT00802646|Sensory System Agents|sensory system agents|mesh-ancestor
101752002|NCT00802646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101752003|NCT00802646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101752004|NCT00802646|Narcotics|narcotics|mesh-ancestor
101752005|NCT00802646|Analgesics|analgesics|mesh-ancestor
101752006|NCT00802646|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101752007|NCT00802646|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101752008|NCT00802646|Anesthetics, General|anesthetics, general|mesh-ancestor
101752009|NCT00802646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101752010|NCT00802646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101752011|NCT00802646|Adrenergic Agents|adrenergic agents|mesh-ancestor
101752012|NCT00802646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101752013|NCT00802646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752014|NCT00802646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101752015|NCT00802646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101752016|NCT00802646|Autonomic Agents|autonomic agents|mesh-ancestor
101752017|NCT00802646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101752018|NCT00802646|Respiratory System Agents|respiratory system agents|mesh-ancestor
101752019|NCT00802646|Mydriatics|mydriatics|mesh-ancestor
101752020|NCT00802646|Sympathomimetics|sympathomimetics|mesh-ancestor
101752021|NCT00802646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101752022|NCT00473707|Oxytocin|oxytocin|mesh-list
101752023|NCT00473707|Oxytocics|oxytocics|mesh-ancestor
101752024|NCT00473707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101752025|NCT00473707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752026|NCT00233675|Tiagabine|tiagabine|mesh-list
101752027|NCT00233675|Anticonvulsants|anticonvulsants|mesh-ancestor
101752028|NCT00233675|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
101752029|NCT00233675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101752030|NCT00233675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101752031|NCT00233675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752032|NCT00233675|GABA Agents|gaba agents|mesh-ancestor
101407174|NCT00437554|Immunologic Factors|immunologic factors|mesh-ancestor
101752033|NCT00233675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101752034|NCT00233675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562454|NCT05940324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562455|NCT05940324|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101562457|NCT05940324|Anesthetics, General|anesthetics, general|mesh-ancestor
101562458|NCT05940324|Anesthetics|anesthetics|mesh-ancestor
101562459|NCT05940324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101562460|NCT05940324|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101562461|NCT05940324|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101562462|NCT05940324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101562463|NCT05940324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752035|NCT00202774|Fluorouracil|fluorouracil|mesh-list
101752036|NCT00202774|Capecitabine|capecitabine|mesh-list
101752037|NCT00202774|Oxaliplatin|oxaliplatin|mesh-list
101752038|NCT00202774|Antimetabolites|antimetabolites|mesh-ancestor
101752039|NCT00202774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752040|NCT00202774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101752041|NCT00202774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101752042|NCT00202774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101752059|NCT00845338|Darifenacin|darifenacin|mesh-list
101752060|NCT00845338|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101752061|NCT00845338|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101752062|NCT00845338|Cholinergic Agents|cholinergic agents|mesh-ancestor
101752063|NCT00845338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101752064|NCT00845338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752065|NCT00845338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752066|NCT00845338|Urological Agents|urological agents|mesh-ancestor
101752067|NCT00923962|Adenosine|adenosine|mesh-list
101752068|NCT00923962|Glucagon|glucagon|mesh-list
101752069|NCT00923962|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101752070|NCT00923962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101752071|NCT00923962|Hormones|hormones|mesh-ancestor
101752072|NCT00923962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101752073|NCT00923962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752074|NCT00923962|Incretins|incretins|mesh-ancestor
101752075|NCT00923962|Analgesics|analgesics|mesh-ancestor
101752076|NCT00923962|Sensory System Agents|sensory system agents|mesh-ancestor
101752077|NCT00923962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101752078|NCT00923962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101752079|NCT00923962|Vasodilator Agents|vasodilator agents|mesh-ancestor
101752080|NCT00923962|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101752081|NCT00923962|Purinergic Agonists|purinergic agonists|mesh-ancestor
101752082|NCT00923962|Purinergic Agents|purinergic agents|mesh-ancestor
101752083|NCT00923962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101752084|NCT00923962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752085|NCT02575092|Folic Acid|folic acid|mesh-list
101752086|NCT02575092|Enalapril|enalapril|mesh-list
101752087|NCT02575092|Enalaprilat|enalaprilat|mesh-list
101752088|NCT02575092|Maleic acid|maleic acid|mesh-list
101752089|NCT02575092|Hematinics|hematinics|mesh-ancestor
101752090|NCT02575092|Vitamin B Complex|vitamin b complex|mesh-ancestor
101752091|NCT02575092|Vitamins|vitamins|mesh-ancestor
101752092|NCT02575092|Micronutrients|micronutrients|mesh-ancestor
101752093|NCT02575092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752094|NCT02575092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101752095|NCT02575092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752096|NCT02575092|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101752097|NCT02575092|Protease Inhibitors|protease inhibitors|mesh-ancestor
101752098|NCT02575092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101752099|NCT04097470|Decitabine|decitabine|mesh-list
101752100|NCT04097470|Midostaurin|midostaurin|mesh-list
101752101|NCT04097470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101752110|NCT04041934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101752111|NCT00851734|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101752112|NCT00851734|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101752113|NCT00845572|Risperidone|risperidone|mesh-list
101562464|NCT05940324|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101562465|NCT05940324|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101562466|NCT05940285|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
101562467|NCT05940285|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101562468|NCT05940285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562469|NCT05940233|Letrozole|letrozole|mesh-list
101562470|NCT05940233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101562471|NCT05940233|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101562472|NCT05940233|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101562473|NCT05940233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101562474|NCT05940233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562475|NCT05940233|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101562476|NCT05940233|Hormone Antagonists|hormone antagonists|mesh-ancestor
101562477|NCT05940233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101752114|NCT00845572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101752115|NCT00845572|Serotonin Agents|serotonin agents|mesh-ancestor
101752116|NCT00845572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101752117|NCT00845572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752118|NCT00845572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752119|NCT00845572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101752120|NCT00845572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101752121|NCT00845572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101752122|NCT00845572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101752123|NCT00845572|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101752124|NCT00845572|Dopamine Agents|dopamine agents|mesh-ancestor
101752125|NCT00711906|Pyrimethamine|pyrimethamine|mesh-list
101752126|NCT00711906|Sulfadoxine|sulfadoxine|mesh-list
101752127|NCT00711906|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101752128|NCT00711906|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101752129|NCT00711906|Antimalarials|antimalarials|mesh-ancestor
101752130|NCT00711906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101752131|NCT00711906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101752132|NCT00711906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101752133|NCT00711906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101752134|NCT00711906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101752135|NCT00711906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752136|NCT00711906|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101752137|NCT00711906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101752138|NCT04502550|Propofol|propofol|mesh-list
101752139|NCT04502550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101752140|NCT04502550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101752141|NCT04502550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752142|NCT04502550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101752143|NCT04502550|Anesthetics, General|anesthetics, general|mesh-ancestor
101752144|NCT04502550|Anesthetics|anesthetics|mesh-ancestor
101752145|NCT04227184|Trospium chloride|trospium chloride|mesh-list
101752146|NCT04227184|Parasympatholytics|parasympatholytics|mesh-ancestor
101752147|NCT04227184|Autonomic Agents|autonomic agents|mesh-ancestor
101752148|NCT04227184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101752149|NCT04227184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752150|NCT04227184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101752151|NCT04227184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101752152|NCT04227184|Cholinergic Agents|cholinergic agents|mesh-ancestor
101752153|NCT04227184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101752154|NCT04227184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752155|NCT04227184|Urological Agents|urological agents|mesh-ancestor
101752156|NCT04018950|Durlobactam|durlobactam|mesh-list
101752157|NCT04018950|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101752158|NCT04018950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101562478|NCT05940233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562480|NCT05940064|Zanubrutinib|zanubrutinib|mesh-list
101562481|NCT05940064|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
101562482|NCT05940064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101562483|NCT05940064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101562484|NCT05940064|Immunologic Factors|immunologic factors|mesh-ancestor
101562485|NCT05940064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562486|NCT05940064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101562487|NCT05940064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101562488|NCT05940064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101562489|NCT05940064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752159|NCT04018950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752160|NCT04018950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101752161|NCT04018950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101752162|NCT02545972|Tacrolimus|tacrolimus|mesh-list
101752163|NCT02545972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101212351|NCT04277637|Obinutuzumab|obinutuzumab|mesh-list
101752164|NCT02545972|Immunologic Factors|immunologic factors|mesh-ancestor
101752165|NCT02545972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752166|NCT02545972|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101752185|NCT02573064|Tigecycline|tigecycline|mesh-list
101752186|NCT02573064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101752187|NCT02573064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101752188|NCT02573064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101752189|NCT02573064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101752190|NCT02573064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752191|NCT00845884|Bevacizumab|bevacizumab|mesh-list
101752192|NCT00845884|Cisplatin|cisplatin|mesh-list
101752193|NCT00845884|Docetaxel|docetaxel|mesh-list
101752194|NCT00845884|Capecitabine|capecitabine|mesh-list
101752195|NCT00845884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101752196|NCT00845884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101752197|NCT00845884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101752198|NCT00845884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101752199|NCT00845884|Growth Substances|growth substances|mesh-ancestor
101752200|NCT00845884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752201|NCT00845884|Growth Inhibitors|growth inhibitors|mesh-ancestor
101752202|NCT00845884|Tubulin Modulators|tubulin modulators|mesh-ancestor
101752203|NCT00845884|Antimitotic Agents|antimitotic agents|mesh-ancestor
101752204|NCT00845884|Mitosis Modulators|mitosis modulators|mesh-ancestor
101752205|NCT00845884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752206|NCT00845884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101752207|NCT00845884|Antimetabolites|antimetabolites|mesh-ancestor
101752208|NCT00923806|Aldesleukin|aldesleukin|mesh-list
101752209|NCT00923806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101752210|NCT00923806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101752211|NCT00923806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101752212|NCT00923806|Antiviral Agents|antiviral agents|mesh-ancestor
101752213|NCT00923806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101752214|NCT00848068|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101752215|NCT00848068|Lubricant Eye Drops|lubricant eye drops|mesh-list
101752216|NCT00848068|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101752217|NCT00718536|Raltegravir Potassium|raltegravir potassium|mesh-list
101752218|NCT00718536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101752219|NCT00718536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101752220|NCT00718536|Antiviral Agents|antiviral agents|mesh-ancestor
101752221|NCT00718536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101752222|NCT00718536|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101752223|NCT00718536|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101752234|NCT00712140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101752235|NCT02545738|Liraglutide|liraglutide|mesh-list
101752236|NCT02545738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101212423|NCT04169347|Leucovorin|leucovorin|mesh-list
101562490|NCT05940064|Immunoconjugates|immunoconjugates|mesh-ancestor
101562491|NCT05940051|Rituximab|rituximab|mesh-list
101562492|NCT05940051|Zanubrutinib|zanubrutinib|mesh-list
101562493|NCT05940051|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
101562494|NCT05940051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101562495|NCT05940051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101562496|NCT05940051|Immunologic Factors|immunologic factors|mesh-ancestor
101562497|NCT05940051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562498|NCT05940051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101562499|NCT05940051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101752237|NCT02545738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752239|NCT02545738|Hormones|hormones|mesh-ancestor
101752240|NCT02545738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101752241|NCT00848302|Nitric Oxide|nitric oxide|mesh-list
101752242|NCT00848302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101752243|NCT00848302|Autonomic Agents|autonomic agents|mesh-ancestor
101752244|NCT00848302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101752245|NCT00848302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752246|NCT00848302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101752247|NCT00848302|Respiratory System Agents|respiratory system agents|mesh-ancestor
101752248|NCT00848302|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101752249|NCT00848302|Antioxidants|antioxidants|mesh-ancestor
101752250|NCT00848302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752251|NCT00848302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101752252|NCT00848302|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101752253|NCT00848302|Vasodilator Agents|vasodilator agents|mesh-ancestor
101752255|NCT00848302|Protective Agents|protective agents|mesh-ancestor
101752256|NCT02572596|Cyclophosphamide|cyclophosphamide|mesh-list
101752257|NCT02572596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101752258|NCT02572596|Immunologic Factors|immunologic factors|mesh-ancestor
101752259|NCT02572596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752260|NCT02572596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101752261|NCT02572596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101752262|NCT02572596|Alkylating Agents|alkylating agents|mesh-ancestor
101752263|NCT02572596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752264|NCT02572596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101752265|NCT02572596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101752266|NCT00712374|Pyrimethamine|pyrimethamine|mesh-list
101752267|NCT00712374|Sulfadoxine|sulfadoxine|mesh-list
101752268|NCT00712374|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101752269|NCT00712374|Amodiaquine|amodiaquine|mesh-list
101752270|NCT00712374|Antimalarials|antimalarials|mesh-ancestor
101752271|NCT00712374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101752272|NCT00712374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101752273|NCT00712374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101752274|NCT00712374|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101752275|NCT00712374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101752276|NCT00712374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752277|NCT00712374|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101752278|NCT02573220|Leucovorin|leucovorin|mesh-list
101752279|NCT02573220|Fluorouracil|fluorouracil|mesh-list
101752280|NCT02573220|Irinotecan|irinotecan|mesh-list
101752281|NCT02573220|Cetuximab|cetuximab|mesh-list
101752282|NCT02573220|Camptothecin|camptothecin|mesh-list
101752283|NCT02573220|Calcium|calcium|mesh-list
101752284|NCT02573220|Levoleucovorin|levoleucovorin|mesh-list
101752285|NCT02573220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101752286|NCT02573220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752287|NCT02573220|Antimetabolites|antimetabolites|mesh-ancestor
101752288|NCT02573220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752290|NCT02573220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101752291|NCT02573220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101752293|NCT02573220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101752294|NCT02573220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101752295|NCT02573220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101752296|NCT02573220|Antidotes|antidotes|mesh-ancestor
101562500|NCT05940051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101562501|NCT05940051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562502|NCT05940051|Immunoconjugates|immunoconjugates|mesh-ancestor
101562503|NCT05939882|Atropine|atropine|mesh-list
101562504|NCT05939882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101562505|NCT05939882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101562506|NCT05939882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101562507|NCT05939882|Autonomic Agents|autonomic agents|mesh-ancestor
101562508|NCT05939882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101562509|NCT05939882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562510|NCT05939882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101410825|NCT00115635|Docetaxel|docetaxel|mesh-list
101752297|NCT02573220|Protective Agents|protective agents|mesh-ancestor
101752298|NCT02573220|Vitamin B Complex|vitamin b complex|mesh-ancestor
101752299|NCT02573220|Vitamins|vitamins|mesh-ancestor
101752300|NCT02573220|Micronutrients|micronutrients|mesh-ancestor
101752301|NCT02573220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101752302|NCT02573220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101752303|NCT00712452|Cyclophosphamide|cyclophosphamide|mesh-list
101752304|NCT00712452|Vinblastine|vinblastine|mesh-list
101752305|NCT00712452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101752306|NCT00712452|Immunologic Factors|immunologic factors|mesh-ancestor
101752307|NCT00712452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752308|NCT00712452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101752309|NCT00712452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101752310|NCT00712452|Alkylating Agents|alkylating agents|mesh-ancestor
101752311|NCT00712452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752312|NCT00712452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101752313|NCT00712452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101752314|NCT00712452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101752315|NCT00712452|Tubulin Modulators|tubulin modulators|mesh-ancestor
101752316|NCT00712452|Antimitotic Agents|antimitotic agents|mesh-ancestor
101752317|NCT00712452|Mitosis Modulators|mitosis modulators|mesh-ancestor
101752318|NCT00618982|Sorafenib|sorafenib|mesh-list
101752319|NCT00618982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101752320|NCT00618982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101752321|NCT00618982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101752322|NCT00618982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752323|NCT02544880|Tadalafil|tadalafil|mesh-list
101752324|NCT02544880|Vaccines|vaccines|mesh-list
101752325|NCT02544880|Immunologic Factors|immunologic factors|mesh-ancestor
101752326|NCT02544880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752328|NCT02544880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101752329|NCT02544880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101752330|NCT02544880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101752331|NCT02544880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752332|NCT02544880|Urological Agents|urological agents|mesh-ancestor
101752333|NCT00856570|Warfarin|warfarin|mesh-list
101752334|NCT00856570|Mirabegron|mirabegron|mesh-list
101752335|NCT00856570|Anticoagulants|anticoagulants|mesh-ancestor
101752336|NCT00856570|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101752337|NCT00856570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101752338|NCT00856570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101752339|NCT00856570|Adrenergic Agents|adrenergic agents|mesh-ancestor
101752340|NCT00856570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101752341|NCT00856570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752342|NCT00856570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752343|NCT00856570|Urological Agents|urological agents|mesh-ancestor
101752344|NCT04068870|Contraceptive Agents|contraceptive agents|mesh-list
101752345|NCT04068870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101752346|NCT04068870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752347|NCT00856804|Ribavirin|ribavirin|mesh-list
101752348|NCT00856804|Thalidomide|thalidomide|mesh-list
101752349|NCT00856804|Antimetabolites|antimetabolites|mesh-ancestor
101562512|NCT05939882|Mydriatics|mydriatics|mesh-ancestor
101562513|NCT05939882|Parasympatholytics|parasympatholytics|mesh-ancestor
101562514|NCT05939882|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101562515|NCT05939882|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101562516|NCT05939882|Cholinergic Agents|cholinergic agents|mesh-ancestor
101562517|NCT05939882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101562518|NCT05939882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562519|NCT05939817|Triamcinolone|triamcinolone|mesh-list
101562520|NCT05939817|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101562521|NCT05939817|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101410842|NCT00447577|Tobramycin|tobramycin|mesh-list
101752350|NCT00856804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752351|NCT00856804|Antiviral Agents|antiviral agents|mesh-ancestor
101752352|NCT00856804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101752353|NCT00856804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101752354|NCT00856804|Immunologic Factors|immunologic factors|mesh-ancestor
101752355|NCT00856804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752356|NCT00856804|Leprostatic Agents|leprostatic agents|mesh-ancestor
101752357|NCT00856804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101752358|NCT00856804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101752359|NCT00856804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101752360|NCT00856804|Growth Substances|growth substances|mesh-ancestor
101752361|NCT00856804|Growth Inhibitors|growth inhibitors|mesh-ancestor
101752362|NCT00856804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101752363|NCT00856882|Caseins|caseins|mesh-list
101752375|NCT00712686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101752376|NCT00712686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101752377|NCT00712686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101752378|NCT00712686|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101752379|NCT00712686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101752380|NCT00712686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101752381|NCT00712686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752382|NCT00712686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101752383|NCT00712686|Serotonin Agents|serotonin agents|mesh-ancestor
101752384|NCT00712686|Antidepressive Agents|antidepressive agents|mesh-ancestor
101752385|NCT00712686|Dopamine Agonists|dopamine agonists|mesh-ancestor
101752386|NCT00712686|Dopamine Agents|dopamine agents|mesh-ancestor
101752387|NCT00712686|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101752388|NCT00712686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101752389|NCT00712686|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101752390|NCT00712686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101752391|NCT00712686|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101752392|NCT00712686|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101752393|NCT04041856|Povidone-Iodine|povidone-iodine|mesh-list
101752395|NCT04041856|Plasma Substitutes|plasma substitutes|mesh-ancestor
101752396|NCT04041856|Blood Substitutes|blood substitutes|mesh-ancestor
101752397|NCT04041856|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101752398|NCT04041856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101409819|NCT00351130|Valsartan|valsartan|mesh-list
101752399|NCT00856960|Losartan|losartan|mesh-list
101752400|NCT00856960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101752401|NCT00856960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101752402|NCT00856960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101752403|NCT00856960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101752404|NCT00856960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752406|NCT00712764|Analgesics|analgesics|mesh-ancestor
101752407|NCT00712764|Sensory System Agents|sensory system agents|mesh-ancestor
101752408|NCT00712764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101752409|NCT00712764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752410|NCT00712764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101752411|NCT00712764|Vasodilator Agents|vasodilator agents|mesh-ancestor
101562522|NCT05939817|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101562523|NCT05939817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101562524|NCT05939817|Glucocorticoids|glucocorticoids|mesh-ancestor
101562525|NCT05939817|Hormones|hormones|mesh-ancestor
101562526|NCT05939817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101562527|NCT05939817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562528|NCT05939817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101562529|NCT05939817|Immunologic Factors|immunologic factors|mesh-ancestor
101562530|NCT05939817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101752412|NCT00712764|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101752413|NCT00712764|Purinergic Agonists|purinergic agonists|mesh-ancestor
101752414|NCT00712764|Purinergic Agents|purinergic agents|mesh-ancestor
101752415|NCT00712764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101752416|NCT00712764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752417|NCT00848458|Azelaic acid|azelaic acid|mesh-list
101752418|NCT00848458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101752419|NCT00848458|Dermatologic Agents|dermatologic agents|mesh-ancestor
101752420|NCT00578786|Ambrisentan|ambrisentan|mesh-list
101752421|NCT00578786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101752422|NCT00424255|Lapatinib|lapatinib|mesh-list
101752423|NCT00424255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101752424|NCT00424255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101752425|NCT00424255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101752426|NCT00424255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752431|NCT00848692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101752432|NCT00848692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101752433|NCT00848692|Immunologic Factors|immunologic factors|mesh-ancestor
101752434|NCT00848692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752435|NCT00848692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101752436|NCT00848770|Norepinephrine|norepinephrine|mesh-list
101752437|NCT00848770|Esmolol|esmolol|mesh-list
101752438|NCT00848770|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101752439|NCT00848770|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101752440|NCT00848770|Adrenergic Agents|adrenergic agents|mesh-ancestor
101752441|NCT00848770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101752442|NCT00848770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752443|NCT00848770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752444|NCT00848770|Sympathomimetics|sympathomimetics|mesh-ancestor
101752445|NCT00848770|Autonomic Agents|autonomic agents|mesh-ancestor
101752446|NCT00848770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101752447|NCT00848770|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101752448|NCT00848770|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101752449|NCT00848770|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101752450|NCT00848770|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101752451|NCT00717704|Dasatinib|dasatinib|mesh-list
101752452|NCT00717704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101752453|NCT00717704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101752454|NCT00717704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101752455|NCT00717704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752456|NCT00620074|Voriconazole|voriconazole|mesh-list
101752457|NCT00620074|Anidulafungin|anidulafungin|mesh-list
101752458|NCT00620074|Antifungal Agents|antifungal agents|mesh-ancestor
101752459|NCT00620074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101752460|NCT00620074|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101752461|NCT00620074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101752462|NCT00620074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101752463|NCT00620074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752464|NCT00620074|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101752465|NCT00620074|Hormone Antagonists|hormone antagonists|mesh-ancestor
101752466|NCT00620074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101752467|NCT00620074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752468|NCT00620074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101752469|NCT02571296|Progesterone|progesterone|mesh-list
101752470|NCT02571296|Progestins|progestins|mesh-ancestor
101752471|NCT02571296|Hormones|hormones|mesh-ancestor
101562531|NCT05939817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562532|NCT05939765|Antipsychotic Agents|antipsychotic agents|mesh-list
101562533|NCT05939765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101562534|NCT05939765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101562535|NCT05939765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562536|NCT05939765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101562537|NCT05939726|Vitamins|vitamins|mesh-list
101562538|NCT05939726|Vitamin E|vitamin e|mesh-list
101562539|NCT05939726|Tocopherols|tocopherols|mesh-list
101562540|NCT05939726|Tocotrienols|tocotrienols|mesh-list
101562541|NCT05939726|alpha-Tocopherol|alpha-tocopherol|mesh-list
101562542|NCT05939726|Carbamide Peroxide|carbamide peroxide|mesh-list
101562543|NCT05939726|Micronutrients|micronutrients|mesh-ancestor
101562544|NCT05939726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752472|NCT02571296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101752473|NCT02571296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752475|NCT00857038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101752476|NCT00857038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101752477|NCT00857038|Antimalarials|antimalarials|mesh-ancestor
101752478|NCT00857038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101752479|NCT00857038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101752480|NCT00857116|Albendazole|albendazole|mesh-list
101752481|NCT00857116|Anthelmintics|anthelmintics|mesh-ancestor
101752482|NCT00857116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101752483|NCT00857116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101752484|NCT00857116|Anticestodal Agents|anticestodal agents|mesh-ancestor
101752485|NCT00857116|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101752486|NCT00857116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101752487|NCT00857116|Tubulin Modulators|tubulin modulators|mesh-ancestor
101752488|NCT00857116|Antimitotic Agents|antimitotic agents|mesh-ancestor
101752489|NCT00857116|Mitosis Modulators|mitosis modulators|mesh-ancestor
101752490|NCT00857116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752491|NCT00857116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101752492|NCT00717782|Botulinum Toxins|botulinum toxins|mesh-list
101752493|NCT00717782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101752494|NCT00717782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101752495|NCT00717782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752496|NCT00717782|Cholinergic Agents|cholinergic agents|mesh-ancestor
101752497|NCT00717782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101503820|NCT00498251|Ipratropium|ipratropium|mesh-list
101752519|NCT00857428|Analgesics|analgesics|mesh-ancestor
101752520|NCT00857428|Sensory System Agents|sensory system agents|mesh-ancestor
101752521|NCT00857428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101752522|NCT00857428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101752523|NCT04018768|Acetaminophen|acetaminophen|mesh-list
101752525|NCT04018768|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
101752526|NCT04018768|Oxycodone|oxycodone|mesh-list
101752527|NCT04018768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101752528|NCT04018768|Analgesics|analgesics|mesh-ancestor
101752529|NCT04018768|Sensory System Agents|sensory system agents|mesh-ancestor
101752530|NCT04018768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101752531|NCT04018768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752532|NCT04018768|Antipyretics|antipyretics|mesh-ancestor
101752533|NCT04018768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101752534|NCT04018768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101752535|NCT04018768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101752536|NCT04018768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101752537|NCT04018768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101752538|NCT04018768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752539|NCT04018768|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101752541|NCT04018768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101752542|NCT00848848|Vaccines|vaccines|mesh-list
101562545|NCT05939726|Antioxidants|antioxidants|mesh-ancestor
101562546|NCT05939726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562547|NCT05939726|Protective Agents|protective agents|mesh-ancestor
101562548|NCT05939726|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101562549|NCT05939726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101562551|NCT05939648|Immunologic Factors|immunologic factors|mesh-ancestor
101562552|NCT05939648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562553|NCT05939284|Cetrorelix|cetrorelix|mesh-list
101562554|NCT05939284|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101562555|NCT05939284|Fertility Agents|fertility agents|mesh-ancestor
101562556|NCT05939284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101562557|NCT05939284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562558|NCT05939284|Hormone Antagonists|hormone antagonists|mesh-ancestor
101752543|NCT00848848|Immunologic Factors|immunologic factors|mesh-ancestor
101752544|NCT00848848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752545|NCT02573922|Oxycodone|oxycodone|mesh-list
101752546|NCT02573922|Naloxone|naloxone|mesh-list
101752547|NCT02573922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101752548|NCT02573922|Narcotics|narcotics|mesh-ancestor
101752549|NCT02573922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101409986|NCT00112346|Cetuximab|cetuximab|mesh-list
101752550|NCT02573922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752551|NCT02573922|Analgesics|analgesics|mesh-ancestor
101752552|NCT02573922|Sensory System Agents|sensory system agents|mesh-ancestor
101503893|NCT05149287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101752569|NCT00720512|Leucovorin|leucovorin|mesh-list
101752570|NCT00720512|Bevacizumab|bevacizumab|mesh-list
101752571|NCT00720512|Fluorouracil|fluorouracil|mesh-list
101752572|NCT00720512|Oxaliplatin|oxaliplatin|mesh-list
101752573|NCT00720512|Irinotecan|irinotecan|mesh-list
101752574|NCT00720512|Calcium|calcium|mesh-list
101752575|NCT00720512|Levoleucovorin|levoleucovorin|mesh-list
101752576|NCT00720512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101752577|NCT00720512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101752578|NCT00720512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101752579|NCT00720512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101752580|NCT00720512|Growth Substances|growth substances|mesh-ancestor
101752581|NCT00720512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752582|NCT00720512|Growth Inhibitors|growth inhibitors|mesh-ancestor
101752583|NCT00720512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101752584|NCT00720512|Antimetabolites|antimetabolites|mesh-ancestor
101752585|NCT00720512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752586|NCT00720512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101752587|NCT00720512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101752588|NCT00720512|Immunologic Factors|immunologic factors|mesh-ancestor
101752589|NCT00720512|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101752590|NCT00720512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101752591|NCT00720512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101752592|NCT00720512|Antidotes|antidotes|mesh-ancestor
101752593|NCT00720512|Protective Agents|protective agents|mesh-ancestor
101752594|NCT00720512|Vitamin B Complex|vitamin b complex|mesh-ancestor
101752595|NCT00720512|Vitamins|vitamins|mesh-ancestor
101752596|NCT00720512|Micronutrients|micronutrients|mesh-ancestor
101752597|NCT04069286|Amoxicillin|amoxicillin|mesh-list
101752598|NCT04069286|Omeprazole|omeprazole|mesh-list
101752599|NCT04069286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101752600|NCT04069286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101752601|NCT04069286|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101752602|NCT04069286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101752603|NCT04069286|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101752604|NCT04069286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101752605|NCT04069286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562559|NCT05939284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101562560|NCT05939180|Cytarabine|cytarabine|mesh-list
101562561|NCT05939180|Azacitidine|azacitidine|mesh-list
101562562|NCT05939180|Daunorubicin|daunorubicin|mesh-list
101562563|NCT05939180|Venetoclax|venetoclax|mesh-list
101562564|NCT05939180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101562565|NCT05939180|Antimetabolites|antimetabolites|mesh-ancestor
101562566|NCT05939180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410882|NCT00447928|Nitroglycerin|nitroglycerin|mesh-list
101752606|NCT00713622|Zonisamide|zonisamide|mesh-list
101752607|NCT00713622|Valproic Acid|valproic acid|mesh-list
101752608|NCT00713622|Anticonvulsants|anticonvulsants|mesh-ancestor
101752609|NCT00713622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101752610|NCT00713622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752612|NCT00713622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101503950|NCT05145543|Anesthetics|anesthetics|mesh-ancestor
101752616|NCT00713622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101752617|NCT00713622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101752618|NCT00713622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101752619|NCT00713622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101752620|NCT00713622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101752622|NCT00718172|Antimetabolites|antimetabolites|mesh-ancestor
101752623|NCT00718172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752624|NCT00718172|Antiviral Agents|antiviral agents|mesh-ancestor
101752625|NCT00718172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101752626|NCT00720018|Sumatriptan|sumatriptan|mesh-list
101752627|NCT00720018|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101752628|NCT00720018|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101752629|NCT00720018|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101752630|NCT00720018|Serotonin Agents|serotonin agents|mesh-ancestor
101752631|NCT00720018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101752632|NCT00720018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752633|NCT00720018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752634|NCT03992456|Trifluridine|trifluridine|mesh-list
101752635|NCT03992456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101752636|NCT03992456|Panitumumab|panitumumab|mesh-list
101752637|NCT03992456|Antibodies|antibodies|mesh-list
101752638|NCT03992456|Immunoglobulins|immunoglobulins|mesh-list
101752639|NCT03992456|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101752640|NCT03992456|Immunologic Factors|immunologic factors|mesh-ancestor
101752641|NCT03992456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752642|NCT03992456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101752643|NCT03992456|Antimetabolites|antimetabolites|mesh-ancestor
101752644|NCT03992456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752645|NCT03992456|Antiviral Agents|antiviral agents|mesh-ancestor
101752646|NCT03992456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101752647|NCT00618826|Paclitaxel|paclitaxel|mesh-list
101752648|NCT00618826|Gemcitabine|gemcitabine|mesh-list
101752649|NCT00618826|Bevacizumab|bevacizumab|mesh-list
101752650|NCT00618826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101752651|NCT00618826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101752652|NCT00618826|Tubulin Modulators|tubulin modulators|mesh-ancestor
101752653|NCT00618826|Antimitotic Agents|antimitotic agents|mesh-ancestor
101752654|NCT00618826|Mitosis Modulators|mitosis modulators|mesh-ancestor
101752655|NCT00618826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752656|NCT00618826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101752657|NCT00618826|Antimetabolites|antimetabolites|mesh-ancestor
101752658|NCT00618826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101752659|NCT00618826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101752660|NCT00618826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101752661|NCT00618826|Growth Substances|growth substances|mesh-ancestor
101752662|NCT00618826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752663|NCT00618826|Growth Inhibitors|growth inhibitors|mesh-ancestor
101752664|NCT00720174|Doxorubicin|doxorubicin|mesh-list
101752665|NCT00720174|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101562567|NCT05939180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101562569|NCT05939180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101562570|NCT05939180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101562571|NCT05939180|Immunologic Factors|immunologic factors|mesh-ancestor
101562572|NCT05939180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562573|NCT05939180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101562574|NCT05939180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101562575|NCT05939180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101562576|NCT05939180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101562577|NCT05939076|Sotalol|sotalol|mesh-list
101562578|NCT05939076|Flecainide|flecainide|mesh-list
101752666|NCT00720174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101752667|NCT00720174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101752668|NCT00720174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101752669|NCT00720174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101752670|NCT00720174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101752671|NCT00720174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101752672|NCT00720174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752673|NCT00720174|Immunologic Factors|immunologic factors|mesh-ancestor
101752674|NCT00720174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752675|NCT00722930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101752676|NCT00722930|Immunologic Factors|immunologic factors|mesh-ancestor
101752677|NCT00722930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752678|NCT03834740|Everolimus|everolimus|mesh-list
101752679|NCT03834740|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101752680|NCT03834740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101752681|NCT03834740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101752682|NCT03834740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752683|NCT03834740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101752688|NCT00849082|Cyproterone Acetate|cyproterone acetate|mesh-list
101752689|NCT00849082|Cyproterone|cyproterone|mesh-list
101752690|NCT00849082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101752691|NCT00849082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101752692|NCT00849082|Androgen Antagonists|androgen antagonists|mesh-ancestor
101752693|NCT00849082|Hormone Antagonists|hormone antagonists|mesh-ancestor
101752694|NCT00849082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101752695|NCT00849082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752696|NCT00849082|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101752697|NCT00849082|Contraceptive Agents|contraceptive agents|mesh-ancestor
101752698|NCT00849082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101410125|NCT00352651|Pregabalin|pregabalin|mesh-list
101752699|NCT00849160|Darunavir|darunavir|mesh-list
101752700|NCT00849160|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101752702|NCT00849160|Protease Inhibitors|protease inhibitors|mesh-ancestor
101752703|NCT00849160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101752704|NCT00849160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752705|NCT00849160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101752706|NCT00849160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101752707|NCT00849160|Antiviral Agents|antiviral agents|mesh-ancestor
101752708|NCT00849160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101752709|NCT00720590|Ritonavir|ritonavir|mesh-list
101752710|NCT00720590|Lopinavir|lopinavir|mesh-list
101752711|NCT00720590|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101752712|NCT00720590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101752713|NCT00720590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101752714|NCT00720590|Protease Inhibitors|protease inhibitors|mesh-ancestor
101752715|NCT00720590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101752716|NCT00720590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752717|NCT00720590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101752718|NCT00720590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101752719|NCT00720590|Antiviral Agents|antiviral agents|mesh-ancestor
101752720|NCT00720590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101752721|NCT00720590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101562580|NCT05939076|Propafenone|propafenone|mesh-list
101562581|NCT05939076|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101562582|NCT05939076|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101562583|NCT05939076|Adrenergic Agents|adrenergic agents|mesh-ancestor
101562584|NCT05939076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101562585|NCT05939076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562586|NCT05939076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410903|NCT00401856|Eplerenone|eplerenone|mesh-list
101752722|NCT00720590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101752723|NCT00718406|Metoprolol|metoprolol|mesh-list
101752724|NCT00718406|Morphine|morphine|mesh-list
101752725|NCT00718406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101752726|NCT00718406|Narcotics|narcotics|mesh-ancestor
101752727|NCT00718406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101752728|NCT00718406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752729|NCT00718406|Analgesics|analgesics|mesh-ancestor
101752730|NCT00718406|Sensory System Agents|sensory system agents|mesh-ancestor
101752731|NCT00718406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101752732|NCT00718406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101752733|NCT00718406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101752734|NCT00718406|Sympatholytics|sympatholytics|mesh-ancestor
101752735|NCT00718406|Autonomic Agents|autonomic agents|mesh-ancestor
101752736|NCT00718406|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101752737|NCT00718406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101752738|NCT00718406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101752739|NCT00718406|Adrenergic Agents|adrenergic agents|mesh-ancestor
101752740|NCT00718406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101752741|NCT00718406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752742|NCT00849238|Mycophenolic Acid|mycophenolic acid|mesh-list
101752743|NCT00849238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101752744|NCT00849238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101752745|NCT00849238|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101752746|NCT00849238|Antitubercular Agents|antitubercular agents|mesh-ancestor
101752747|NCT00849238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101752748|NCT00849238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101752749|NCT00849238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101752750|NCT00849238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752751|NCT00720408|Mycophenolic Acid|mycophenolic acid|mesh-list
101752752|NCT00720408|Tacrolimus|tacrolimus|mesh-list
101752753|NCT00720408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101752754|NCT00720408|Immunologic Factors|immunologic factors|mesh-ancestor
101752755|NCT00720408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752759|NCT00720408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101752761|NCT00720408|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101752762|NCT00720408|Antitubercular Agents|antitubercular agents|mesh-ancestor
101752763|NCT00720408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101752764|NCT00720408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101752765|NCT00849316|Insulin Aspart|insulin aspart|mesh-list
101752766|NCT00849316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101752767|NCT00849316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752768|NCT00852670|Ponesimod|ponesimod|mesh-list
101752769|NCT00852670|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101752770|NCT00852670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752771|NCT00852670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101752772|NCT00852670|Immunologic Factors|immunologic factors|mesh-ancestor
101752773|NCT00852670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752774|NCT00717210|Temozolomide|temozolomide|mesh-list
101752775|NCT00717210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101752776|NCT00717210|Alkylating Agents|alkylating agents|mesh-ancestor
101752777|NCT00717210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752778|NCT00717210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101752779|NCT00723086|Docetaxel|docetaxel|mesh-list
101752780|NCT00723086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101752781|NCT00723086|Tubulin Modulators|tubulin modulators|mesh-ancestor
101752782|NCT00723086|Antimitotic Agents|antimitotic agents|mesh-ancestor
101562587|NCT05939076|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101562588|NCT05939076|Sympatholytics|sympatholytics|mesh-ancestor
101562589|NCT05939076|Autonomic Agents|autonomic agents|mesh-ancestor
101562590|NCT05939076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101562591|NCT05939076|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101562592|NCT05939076|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101562593|NCT05939076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101562594|NCT05939037|Zanubrutinib|zanubrutinib|mesh-list
101562595|NCT05939037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101562596|NCT05939037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101562597|NCT05939037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101562598|NCT05939037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562599|NCT05938972|Omalizumab|omalizumab|mesh-list
101562600|NCT05938972|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101562601|NCT05938972|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101562602|NCT05938972|Respiratory System Agents|respiratory system agents|mesh-ancestor
101562603|NCT05938959|Ropivacaine|ropivacaine|mesh-list
101562604|NCT05938959|Anesthetics, Local|anesthetics, local|mesh-ancestor
101562605|NCT05938959|Anesthetics|anesthetics|mesh-ancestor
101562606|NCT05938959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101562607|NCT05938959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562608|NCT05938959|Sensory System Agents|sensory system agents|mesh-ancestor
101562609|NCT05938959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101562610|NCT05938907|Mitogens|mitogens|mesh-list
101562611|NCT05938907|Mitosis Modulators|mitosis modulators|mesh-ancestor
101562612|NCT05938907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562613|NCT05938530|Sirolimus|sirolimus|mesh-list
101752783|NCT00723086|Mitosis Modulators|mitosis modulators|mesh-ancestor
101752784|NCT00723086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752785|NCT04018378|Varenicline|varenicline|mesh-list
101752786|NCT04018378|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101752787|NCT04018378|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101752788|NCT04018378|Cholinergic Agents|cholinergic agents|mesh-ancestor
101752789|NCT04018378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101752790|NCT04018378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752791|NCT04018378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752792|NCT00849550|Bevacizumab|bevacizumab|mesh-list
101752793|NCT00849550|Capecitabine|capecitabine|mesh-list
101752794|NCT00849550|Oxaliplatin|oxaliplatin|mesh-list
101752795|NCT00849550|Everolimus|everolimus|mesh-list
101752796|NCT00849550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101752797|NCT00849550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101752798|NCT00849550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101752799|NCT00849550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101752800|NCT00849550|Growth Substances|growth substances|mesh-ancestor
101752801|NCT00849550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752802|NCT00849550|Growth Inhibitors|growth inhibitors|mesh-ancestor
101752803|NCT00849550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101562614|NCT05938530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101562615|NCT05938530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101562616|NCT05938530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101562617|NCT05938530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101562618|NCT05938530|Antifungal Agents|antifungal agents|mesh-ancestor
101562619|NCT05938530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101562620|NCT05938530|Immunologic Factors|immunologic factors|mesh-ancestor
101562621|NCT05938530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752805|NCT00849550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752806|NCT00849550|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101752807|NCT00849550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101752808|NCT00849550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101752809|NCT00849550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101752810|NCT00849550|Immunologic Factors|immunologic factors|mesh-ancestor
101752811|NCT03816488|Metformin|metformin|mesh-list
101752812|NCT03816488|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
101752813|NCT03816488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101752814|NCT03816488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752815|NCT03816488|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101752816|NCT03816488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101752817|NCT03816488|Analgesics|analgesics|mesh-ancestor
101752818|NCT03816488|Sensory System Agents|sensory system agents|mesh-ancestor
101752819|NCT03816488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101752820|NCT03816488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101752821|NCT03816488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101752822|NCT00858676|Acarbose|acarbose|mesh-list
101752823|NCT00858676|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101752824|NCT00858676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101752825|NCT00858676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752840|NCT00723164|Sensory System Agents|sensory system agents|mesh-ancestor
101752841|NCT00723164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101752842|NCT00723164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101752843|NCT00723164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101752844|NCT00723164|Anesthetics, General|anesthetics, general|mesh-ancestor
101752845|NCT00723164|Anesthetics|anesthetics|mesh-ancestor
101752846|NCT00723164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101752847|NCT00723164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101752848|NCT00723164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101410262|NCT00353743|Antimalarials|antimalarials|mesh-ancestor
101752849|NCT00723164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101752851|NCT00723164|GABA Agents|gaba agents|mesh-ancestor
101752852|NCT00723164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101752853|NCT00723164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752854|NCT00723242|Ribavirin|ribavirin|mesh-list
101752855|NCT00723242|Antimetabolites|antimetabolites|mesh-ancestor
101752856|NCT00723242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752857|NCT00723242|Antiviral Agents|antiviral agents|mesh-ancestor
101752858|NCT00723242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101752859|NCT02545426|Dialysis Solutions|dialysis solutions|mesh-list
101752860|NCT02545426|Calcium|calcium|mesh-list
101752861|NCT02545426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101752862|NCT02545426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752863|NCT02545426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101752864|NCT00720824|Anesthetics|anesthetics|mesh-list
101752865|NCT00720824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
101752866|NCT00720824|Anesthetics, Local|anesthetics, local|mesh-list
101752867|NCT00720824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101752868|NCT00720824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752869|NCT00720824|Sensory System Agents|sensory system agents|mesh-ancestor
101752870|NCT00720824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101752871|NCT05373134|Pentoxifylline|pentoxifylline|mesh-list
101752872|NCT05373134|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101752873|NCT05373134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101752874|NCT05373134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752875|NCT05373134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101752876|NCT05373134|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101562623|NCT05937282|Dexmedetomidine|dexmedetomidine|mesh-list
101562624|NCT05937282|Propofol|propofol|mesh-list
101562625|NCT05937282|Anesthetics, Local|anesthetics, local|mesh-ancestor
101562626|NCT05937282|Anesthetics|anesthetics|mesh-ancestor
101562627|NCT05937282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101562628|NCT05937282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562629|NCT05937282|Sensory System Agents|sensory system agents|mesh-ancestor
101410947|NCT05553678|Anesthetics|anesthetics|mesh-ancestor
101752877|NCT05373134|Protective Agents|protective agents|mesh-ancestor
101752878|NCT05373134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752879|NCT05373134|Vasodilator Agents|vasodilator agents|mesh-ancestor
101752880|NCT05373134|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101752881|NCT05373134|Antioxidants|antioxidants|mesh-ancestor
101752882|NCT00723320|Atorvastatin|atorvastatin|mesh-list
101752883|NCT00723320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101752884|NCT00723320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101752885|NCT00723320|Antimetabolites|antimetabolites|mesh-ancestor
101752886|NCT00723320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752887|NCT00723320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101752903|NCT00720564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752904|NCT00720564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101752905|NCT00714090|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101752907|NCT00714090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101752908|NCT00714090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101752909|NCT00714090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752910|NCT00714090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101752911|NCT00714090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752912|NCT00714090|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101752913|NCT00714090|Antidepressive Agents|antidepressive agents|mesh-ancestor
101752914|NCT00714090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101752915|NCT04067024|Anesthetics|anesthetics|mesh-list
101752916|NCT04067024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101752917|NCT04067024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752918|NCT00618748|Olanzapine|olanzapine|mesh-list
101752919|NCT00618748|Antiemetics|antiemetics|mesh-ancestor
101752920|NCT00618748|Autonomic Agents|autonomic agents|mesh-ancestor
101752921|NCT00618748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101752922|NCT00618748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752924|NCT00618748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101752925|NCT00618748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101752926|NCT00618748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101752927|NCT00618748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101752928|NCT00618748|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101752929|NCT00618748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101752930|NCT00618748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101752931|NCT00618748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752932|NCT00618748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101752933|NCT00618748|Serotonin Agents|serotonin agents|mesh-ancestor
101752934|NCT04067102|Paclitaxel|paclitaxel|mesh-list
101752935|NCT04067102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101752936|NCT04067102|Cyclophosphamide|cyclophosphamide|mesh-list
101752937|NCT04067102|Carboplatin|carboplatin|mesh-list
101752938|NCT04067102|Epirubicin|epirubicin|mesh-list
101752939|NCT04067102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101752940|NCT04067102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101752941|NCT04067102|Tubulin Modulators|tubulin modulators|mesh-ancestor
101752942|NCT04067102|Antimitotic Agents|antimitotic agents|mesh-ancestor
101752943|NCT04067102|Mitosis Modulators|mitosis modulators|mesh-ancestor
101752944|NCT04067102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752945|NCT04067102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101752946|NCT04067102|Immunologic Factors|immunologic factors|mesh-ancestor
101752958|NCT05659290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101752959|NCT05659290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101752960|NCT05659290|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101752961|NCT05659290|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101562630|NCT05937282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101562631|NCT05937282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101562632|NCT05937282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101562633|NCT05937282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101562634|NCT05937282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101562635|NCT05937282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752962|NCT05659290|Growth Substances|growth substances|mesh-ancestor
101752963|NCT05659290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752964|NCT05659290|Growth Inhibitors|growth inhibitors|mesh-ancestor
101752965|NCT05659290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101752966|NCT05659290|Antimetabolites|antimetabolites|mesh-ancestor
101752967|NCT05659290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752968|NCT00717678|Mycophenolic Acid|mycophenolic acid|mesh-list
101752969|NCT00717678|Tacrolimus|tacrolimus|mesh-list
101752970|NCT00717678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101752971|NCT00717678|Immunologic Factors|immunologic factors|mesh-ancestor
101752972|NCT00717678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752973|NCT00717678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101752974|NCT00717678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101752975|NCT00717678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752976|NCT00717678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101752977|NCT00717678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101752978|NCT00717678|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101752979|NCT00717678|Antitubercular Agents|antitubercular agents|mesh-ancestor
101752980|NCT00717678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101752981|NCT00717678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101752983|NCT00859534|Dermatologic Agents|dermatologic agents|mesh-ancestor
101752984|NCT02571842|Prednisolone|prednisolone|mesh-list
101752985|NCT02571842|Rituximab|rituximab|mesh-list
101752986|NCT02571842|Enalapril|enalapril|mesh-list
101752987|NCT02571842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101752988|NCT02571842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101752989|NCT02571842|Immunologic Factors|immunologic factors|mesh-ancestor
101752990|NCT02571842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752991|NCT02571842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101752992|NCT02571842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101752993|NCT02571842|Glucocorticoids|glucocorticoids|mesh-ancestor
101752994|NCT02571842|Hormones|hormones|mesh-ancestor
101752995|NCT02571842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101752996|NCT02571842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101752997|NCT02571842|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101752998|NCT02571842|Protease Inhibitors|protease inhibitors|mesh-ancestor
101752999|NCT02571842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101753000|NCT02571842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753001|NCT02571842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101753002|NCT02546284|Lenzilumab|lenzilumab|mesh-list
101753003|NCT02546284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101753004|NCT00721448|Ticagrelor|ticagrelor|mesh-list
101753005|NCT00721448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101753006|NCT00721448|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101753007|NCT00721448|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101753008|NCT00721448|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101753009|NCT00721448|Purinergic Agents|purinergic agents|mesh-ancestor
101753010|NCT00721448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101753029|NCT04961528|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101753030|NCT00721032|Amiodarone|amiodarone|mesh-list
101753031|NCT00721032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101753032|NCT00721032|Vasodilator Agents|vasodilator agents|mesh-ancestor
101753033|NCT00721032|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101753034|NCT00721032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101753035|NCT00721032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753036|NCT00721032|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101753037|NCT00721032|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101753038|NCT00721032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101753039|NCT00721032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101562636|NCT05937282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101562637|NCT05937282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101562638|NCT05937282|Analgesics|analgesics|mesh-ancestor
101562639|NCT05937282|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101562640|NCT05937282|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101562641|NCT05937282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101562642|NCT05937282|Adrenergic Agents|adrenergic agents|mesh-ancestor
101562643|NCT05937282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101562644|NCT05937282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101562645|NCT05937282|Anesthetics, General|anesthetics, general|mesh-ancestor
101562646|NCT05936268|Colchicine|colchicine|mesh-list
101562647|NCT05936268|Gout Suppressants|gout suppressants|mesh-ancestor
101562648|NCT05936268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101562649|NCT05936268|Tubulin Modulators|tubulin modulators|mesh-ancestor
101562650|NCT05936268|Antimitotic Agents|antimitotic agents|mesh-ancestor
101562651|NCT05936268|Mitosis Modulators|mitosis modulators|mesh-ancestor
101562652|NCT05936268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753040|NCT00721032|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101753041|NCT00721032|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101753042|NCT00721032|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101753043|NCT00723866|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101753044|NCT00723866|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101753045|NCT00723866|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101753046|NCT00723866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101753047|NCT00723866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753048|NCT00723866|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101753049|NCT00723866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101213239|NCT02419495|Leucovorin|leucovorin|mesh-list
101753050|NCT00723866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753051|NCT00723866|Cholinergic Agents|cholinergic agents|mesh-ancestor
101753052|NCT00723866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101753053|NCT00853294|Chlorpheniramine|chlorpheniramine|mesh-list
101753054|NCT00853294|Hydrocodone|hydrocodone|mesh-list
101753055|NCT00853294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753056|NCT00853294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101753057|NCT00853294|Narcotics|narcotics|mesh-ancestor
101753058|NCT00853294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101753059|NCT00853294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753060|NCT00853294|Analgesics|analgesics|mesh-ancestor
101753061|NCT00853294|Sensory System Agents|sensory system agents|mesh-ancestor
101753062|NCT00853294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101753063|NCT00853294|Antitussive Agents|antitussive agents|mesh-ancestor
101753064|NCT00853294|Respiratory System Agents|respiratory system agents|mesh-ancestor
101753084|NCT00658359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101753085|NCT00658359|Immunologic Factors|immunologic factors|mesh-ancestor
101753086|NCT00658359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753087|NCT00658359|Antifungal Agents|antifungal agents|mesh-ancestor
101753088|NCT00658359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101753089|NCT00658359|Dermatologic Agents|dermatologic agents|mesh-ancestor
101753090|NCT00658359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101753091|NCT00658359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101753092|NCT00658359|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101753093|NCT00658359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101753095|NCT00853450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101753096|NCT00853450|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101562653|NCT05936268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101562655|NCT05935787|Niacinamide|niacinamide|mesh-list
101562656|NCT05935787|Niacin|niacin|mesh-list
101562657|NCT05935787|Nicotinic Acids|nicotinic acids|mesh-list
101562658|NCT05935787|Vitamin B Complex|vitamin b complex|mesh-ancestor
101562659|NCT05935787|Vitamins|vitamins|mesh-ancestor
101753097|NCT00853450|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101753098|NCT00853450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101753099|NCT00853450|Purinergic Agents|purinergic agents|mesh-ancestor
101753100|NCT00853450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101753101|NCT00853450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753102|NCT00853450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753103|NCT04066790|Paclitaxel|paclitaxel|mesh-list
101753104|NCT04066790|Trastuzumab|trastuzumab|mesh-list
101753105|NCT04066790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101753106|NCT04066790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101753107|NCT04066790|Tubulin Modulators|tubulin modulators|mesh-ancestor
101753108|NCT04066790|Antimitotic Agents|antimitotic agents|mesh-ancestor
101753109|NCT04066790|Mitosis Modulators|mitosis modulators|mesh-ancestor
101753110|NCT04066790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753111|NCT04066790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101753142|NCT00724022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101753143|NCT00724022|Immunologic Factors|immunologic factors|mesh-ancestor
101753144|NCT00724022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753145|NCT00724022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101753146|NCT00724022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101753147|NCT00724022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753148|NCT00724022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101753149|NCT00724022|Glucocorticoids|glucocorticoids|mesh-ancestor
101753151|NCT00724022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101753152|NCT00724022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101753153|NCT00724022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101753154|NCT00724022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101753155|NCT00724022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101753156|NCT00724022|Antitubercular Agents|antitubercular agents|mesh-ancestor
101753157|NCT00724022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101753158|NCT00724022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101753159|NCT00721344|Moxifloxacin|moxifloxacin|mesh-list
101753160|NCT00721344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101753161|NCT00721344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101753162|NCT00721344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101753163|NCT00721344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101753164|NCT00721344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101753165|NCT00721344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753166|NCT00721344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101753167|NCT00717990|Bevacizumab|bevacizumab|mesh-list
101753168|NCT00717990|Capecitabine|capecitabine|mesh-list
101753169|NCT00717990|Irinotecan|irinotecan|mesh-list
101753170|NCT00717990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101753171|NCT00717990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101753172|NCT00717990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101753173|NCT00717990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101753174|NCT00717990|Growth Substances|growth substances|mesh-ancestor
101753175|NCT00717990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753176|NCT00717990|Growth Inhibitors|growth inhibitors|mesh-ancestor
101753177|NCT00717990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101753178|NCT00717990|Antimetabolites|antimetabolites|mesh-ancestor
101753179|NCT00717990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753180|NCT00717990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101753181|NCT00717990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101753182|NCT00717990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101753183|NCT02572986|Permethrin|permethrin|mesh-list
101753184|NCT02572986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101753185|NCT02572986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753186|NCT00853684|Capecitabine|capecitabine|mesh-list
101753187|NCT00853684|Endostar protein|endostar protein|mesh-list
101753188|NCT00853684|Endostatins|endostatins|mesh-list
101753189|NCT00853684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101562660|NCT05935787|Micronutrients|micronutrients|mesh-ancestor
101562661|NCT05935787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562662|NCT05935787|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101562663|NCT05935787|Dermatologic Agents|dermatologic agents|mesh-ancestor
101562664|NCT05935787|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101562665|NCT05935787|Antimetabolites|antimetabolites|mesh-ancestor
101753190|NCT00853684|Antimetabolites|antimetabolites|mesh-ancestor
101753191|NCT00853684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753192|NCT00853684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101753193|NCT00853684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101753194|NCT00853684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101753195|NCT00853684|Growth Substances|growth substances|mesh-ancestor
101407222|NCT00438139|Hallucinogens|hallucinogens|mesh-ancestor
101753196|NCT00853684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753197|NCT00853684|Growth Inhibitors|growth inhibitors|mesh-ancestor
101753202|NCT00723060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753203|NCT00723060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101753205|NCT00723060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753206|NCT02571140|Teriparatide|teriparatide|mesh-list
101753207|NCT02571140|Parathyroid Hormone|parathyroid hormone|mesh-list
101753208|NCT02571140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101753209|NCT02571140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753210|NCT02571140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101753211|NCT00723216|Enoxaparin|enoxaparin|mesh-list
101753212|NCT00723216|Anticoagulants|anticoagulants|mesh-ancestor
101753213|NCT00723216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101753214|NCT00723216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101753215|NCT00723216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753216|NCT00724178|Vitamin D|vitamin d|mesh-list
101753217|NCT00724178|Cholecalciferol|cholecalciferol|mesh-list
101753218|NCT00724178|Calcium Carbonate|calcium carbonate|mesh-list
101753219|NCT00724178|Calcium|calcium|mesh-list
101753220|NCT00724178|Vitamins|vitamins|mesh-ancestor
101753221|NCT00724178|Micronutrients|micronutrients|mesh-ancestor
101753222|NCT00724178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753223|NCT00724178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101753224|NCT00724178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101753225|NCT00724178|Antacids|antacids|mesh-ancestor
101753226|NCT00724178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753227|NCT00724178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101753228|NCT02546050|Metformin|metformin|mesh-list
101753229|NCT02546050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101753230|NCT02546050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753231|NCT04800224|Propolis|propolis|mesh-list
101753232|NCT04800224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101753233|NCT00718146|Vaccines|vaccines|mesh-list
101753234|NCT00718146|Immunologic Factors|immunologic factors|mesh-ancestor
101753235|NCT00718146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753236|NCT00860626|Interferons|interferons|mesh-list
101753237|NCT00860626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101753238|NCT00860626|Antiviral Agents|antiviral agents|mesh-ancestor
101753239|NCT00860626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101753240|NCT00724256|Ceftibuten|ceftibuten|mesh-list
101753241|NCT00724256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101753242|NCT00724256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101753243|NCT04742660|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
101753244|NCT04742660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101753245|NCT01005914|Cytarabine|cytarabine|mesh-list
101753246|NCT01005914|Dexamethasone|dexamethasone|mesh-list
101753247|NCT01005914|Methylprednisolone|methylprednisolone|mesh-list
101753248|NCT01005914|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101753249|NCT01005914|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101753250|NCT01005914|Cyclophosphamide|cyclophosphamide|mesh-list
101753251|NCT01005914|Doxorubicin|doxorubicin|mesh-list
101753252|NCT01005914|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101753253|NCT01005914|Methotrexate|methotrexate|mesh-list
101753254|NCT01005914|Vincristine|vincristine|mesh-list
101753255|NCT01005914|Imatinib Mesylate|imatinib mesylate|mesh-list
101753256|NCT01005914|Asparaginase|asparaginase|mesh-list
101753257|NCT01005914|Pegaspargase|pegaspargase|mesh-list
101753258|NCT01005914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101753259|NCT01005914|Immunologic Factors|immunologic factors|mesh-ancestor
101753266|NCT01005914|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101753267|NCT01005914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101562666|NCT05935787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562667|NCT05935787|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101562668|NCT05935787|Vasodilator Agents|vasodilator agents|mesh-ancestor
101562669|NCT05933642|Aminophylline|aminophylline|mesh-list
101562670|NCT05933642|Furosemide|furosemide|mesh-list
101562671|NCT05933642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101562672|NCT05933642|Autonomic Agents|autonomic agents|mesh-ancestor
101562673|NCT05933642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101753268|NCT01005914|Antiemetics|antiemetics|mesh-ancestor
101753269|NCT01005914|Autonomic Agents|autonomic agents|mesh-ancestor
101753270|NCT01005914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101753271|NCT01005914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101753272|NCT01005914|Glucocorticoids|glucocorticoids|mesh-ancestor
101753274|NCT01005914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101753275|NCT01005914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101753276|NCT01005914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101753277|NCT01005914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101753278|NCT01005914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101753279|NCT01005914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101753280|NCT01005914|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101753281|NCT01005914|Abortifacient Agents|abortifacient agents|mesh-ancestor
101753282|NCT01005914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101753283|NCT01005914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101753284|NCT01005914|Antimetabolites|antimetabolites|mesh-ancestor
101753285|NCT01005914|Dermatologic Agents|dermatologic agents|mesh-ancestor
101753286|NCT01005914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101753287|NCT01005914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101753288|NCT01005914|Antiviral Agents|antiviral agents|mesh-ancestor
101753289|NCT01005914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101753290|NCT01005914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101753291|NCT01005914|Tubulin Modulators|tubulin modulators|mesh-ancestor
101753292|NCT01005914|Antimitotic Agents|antimitotic agents|mesh-ancestor
101753293|NCT01005914|Mitosis Modulators|mitosis modulators|mesh-ancestor
101753294|NCT01005914|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101753295|NCT01005914|Protective Agents|protective agents|mesh-ancestor
101753296|NCT01005914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101753298|NCT00854230|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101753299|NCT00854230|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101753300|NCT00854230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753301|NCT00854230|Sensory System Agents|sensory system agents|mesh-ancestor
101753302|NCT00854230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101753303|NCT00861016|Metoprolol|metoprolol|mesh-list
101753304|NCT00861016|Felodipine|felodipine|mesh-list
101753305|NCT00861016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101753306|NCT00861016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101753307|NCT00861016|Sympatholytics|sympatholytics|mesh-ancestor
101753308|NCT00861016|Autonomic Agents|autonomic agents|mesh-ancestor
101753309|NCT00861016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101753310|NCT00861016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753311|NCT00861016|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101753312|NCT00861016|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101753313|NCT00861016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101753314|NCT00861016|Adrenergic Agents|adrenergic agents|mesh-ancestor
101753315|NCT00861016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101753316|NCT00861016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753317|NCT00861016|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101753318|NCT00861016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101753319|NCT00861016|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101753320|NCT00861016|Vasodilator Agents|vasodilator agents|mesh-ancestor
101753321|NCT00721916|Leucovorin|leucovorin|mesh-list
101753322|NCT00721916|Oxaliplatin|oxaliplatin|mesh-list
101753323|NCT00721916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101753324|NCT00721916|Antidotes|antidotes|mesh-ancestor
101753325|NCT00721916|Protective Agents|protective agents|mesh-ancestor
101753326|NCT00721916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753327|NCT00721916|Vitamin B Complex|vitamin b complex|mesh-ancestor
101753338|NCT00861250|Glucocorticoids|glucocorticoids|mesh-ancestor
101562674|NCT05933642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562675|NCT05933642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101562676|NCT05933642|Respiratory System Agents|respiratory system agents|mesh-ancestor
101562677|NCT05933642|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101562678|NCT05933642|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101562679|NCT05933642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101562680|NCT05933642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562681|NCT05933642|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101562682|NCT05933642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101562683|NCT05933642|Purinergic Agents|purinergic agents|mesh-ancestor
101753339|NCT00861250|Hormones|hormones|mesh-ancestor
101753340|NCT00861250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101753341|NCT00861250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101753342|NCT00861250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101753343|NCT00722150|Artesunate|artesunate|mesh-list
101753344|NCT00722150|Antimalarials|antimalarials|mesh-ancestor
101753345|NCT00722150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101753346|NCT00722150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101753347|NCT00722150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101753348|NCT00722150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101753349|NCT00722150|Antiviral Agents|antiviral agents|mesh-ancestor
101753350|NCT00722150|Schistosomicides|schistosomicides|mesh-ancestor
101753351|NCT00722150|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101753352|NCT00722150|Anthelmintics|anthelmintics|mesh-ancestor
101753353|NCT00861094|Leucovorin|leucovorin|mesh-list
101753354|NCT00861094|Folic Acid|folic acid|mesh-list
101753355|NCT00861094|Fluorouracil|fluorouracil|mesh-list
101753356|NCT00861094|Oxaliplatin|oxaliplatin|mesh-list
101753357|NCT00861094|Levoleucovorin|levoleucovorin|mesh-list
101753358|NCT00861094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101753359|NCT00861094|Antimetabolites|antimetabolites|mesh-ancestor
101753360|NCT00861094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753361|NCT00861094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101753362|NCT00861094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101753363|NCT00861094|Immunologic Factors|immunologic factors|mesh-ancestor
101753364|NCT00861094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753365|NCT00861094|Antidotes|antidotes|mesh-ancestor
101753366|NCT00861094|Protective Agents|protective agents|mesh-ancestor
101753367|NCT00861094|Vitamin B Complex|vitamin b complex|mesh-ancestor
101753368|NCT00861094|Vitamins|vitamins|mesh-ancestor
101753369|NCT00861094|Micronutrients|micronutrients|mesh-ancestor
101753370|NCT00861094|Hematinics|hematinics|mesh-ancestor
101753371|NCT00807261|Gemcitabine|gemcitabine|mesh-list
101753372|NCT00807261|Docetaxel|docetaxel|mesh-list
101753373|NCT00807261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101753374|NCT00807261|Antimetabolites|antimetabolites|mesh-ancestor
101753375|NCT00807261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753376|NCT00807261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101753377|NCT00807261|Tubulin Modulators|tubulin modulators|mesh-ancestor
101753378|NCT00807261|Antimitotic Agents|antimitotic agents|mesh-ancestor
101753379|NCT00807261|Mitosis Modulators|mitosis modulators|mesh-ancestor
101753380|NCT04019106|Budesonide|budesonide|mesh-list
101753381|NCT04019106|Pulmonary Surfactants|pulmonary surfactants|mesh-list
101753382|NCT04019106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101753383|NCT04019106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101753384|NCT04019106|Autonomic Agents|autonomic agents|mesh-ancestor
101753385|NCT04019106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101753386|NCT04019106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753387|NCT04019106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101753388|NCT04019106|Respiratory System Agents|respiratory system agents|mesh-ancestor
101753389|NCT04019106|Glucocorticoids|glucocorticoids|mesh-ancestor
101753390|NCT04019106|Hormones|hormones|mesh-ancestor
101753391|NCT04019106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101753392|NCT02571608|Metformin|metformin|mesh-list
101753393|NCT02571608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101753394|NCT02571608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562684|NCT05933642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101562685|NCT05933642|Protective Agents|protective agents|mesh-ancestor
101562686|NCT05933642|Diuretics|diuretics|mesh-ancestor
101562687|NCT05933642|Natriuretic Agents|natriuretic agents|mesh-ancestor
101562688|NCT05933642|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101562689|NCT05933642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101562691|NCT05932251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101562692|NCT05932251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562693|NCT05928520|Lidocaine|lidocaine|mesh-list
101562694|NCT05928520|Tramadol|tramadol|mesh-list
101562695|NCT05928520|Anesthetics, Local|anesthetics, local|mesh-ancestor
101562696|NCT05928520|Anesthetics|anesthetics|mesh-ancestor
101753395|NCT00865072|Metformin|metformin|mesh-list
101753396|NCT00865072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101753397|NCT00865072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753401|NCT00804297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101753402|NCT00861328|Oxaliplatin|oxaliplatin|mesh-list
101753403|NCT00861328|Irinotecan|irinotecan|mesh-list
101753404|NCT00861328|Camptothecin|camptothecin|mesh-list
101753405|NCT00861328|ON 01910|on 01910|mesh-list
101753407|NCT00861328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101753408|NCT00861328|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101753409|NCT00861328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101753410|NCT00861328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101753411|NCT00861328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753412|NCT00861328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101753413|NCT00861328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101753414|NCT00861328|Glycine Agents|glycine agents|mesh-ancestor
101753415|NCT00861328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101753416|NCT00861328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753417|NCT00861406|Interferons|interferons|mesh-list
101753418|NCT00861406|Interferon-alpha|interferon-alpha|mesh-list
101753419|NCT00861406|Interferon alpha-2|interferon alpha-2|mesh-list
101753420|NCT00861406|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101753421|NCT00861406|Vaccines|vaccines|mesh-list
101753422|NCT00861406|Immunologic Factors|immunologic factors|mesh-ancestor
101753423|NCT00861406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753424|NCT00861406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101753425|NCT00861406|Antiviral Agents|antiviral agents|mesh-ancestor
101753426|NCT00861406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101753427|NCT04261790|Ocrelizumab|ocrelizumab|mesh-list
101753428|NCT04261790|Immunologic Factors|immunologic factors|mesh-ancestor
101753429|NCT04261790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753430|NCT00865384|Mirtazapine|mirtazapine|mesh-list
101753431|NCT00865384|Antidepressive Agents|antidepressive agents|mesh-ancestor
101753432|NCT00865384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101753433|NCT00865384|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101753434|NCT00865384|Histamine Antagonists|histamine antagonists|mesh-ancestor
101753435|NCT00865384|Histamine Agents|histamine agents|mesh-ancestor
101753436|NCT00865384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101753437|NCT00865384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753438|NCT00865384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753439|NCT00865384|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101753440|NCT00865384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101753441|NCT00865384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101753442|NCT00865384|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101753443|NCT00865384|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101753444|NCT00865384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101753445|NCT00865384|Adrenergic Agents|adrenergic agents|mesh-ancestor
101753446|NCT00865384|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101753447|NCT00865384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101753448|NCT00865384|Serotonin Agents|serotonin agents|mesh-ancestor
101753449|NCT00865384|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101753450|NCT00724724|Aspirin|aspirin|mesh-list
101562697|NCT05928520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101562698|NCT05928520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562699|NCT05928520|Sensory System Agents|sensory system agents|mesh-ancestor
101562700|NCT05928520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101562701|NCT05928520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101562702|NCT05928520|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101562703|NCT05928520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101562704|NCT05928520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101562705|NCT05928520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562706|NCT05928520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101562707|NCT05928520|Narcotics|narcotics|mesh-ancestor
101562708|NCT05928520|Analgesics|analgesics|mesh-ancestor
101562709|NCT05928390|Pasireotide|pasireotide|mesh-list
101562710|NCT05928390|Hormones|hormones|mesh-ancestor
101524653|NCT04322123|Azithromycin|azithromycin|mesh-list
101562711|NCT05928390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101562712|NCT05928390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562713|NCT05923411|Rabeprazole|rabeprazole|mesh-list
101562714|NCT05923411|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101411021|NCT00449020|Docetaxel|docetaxel|mesh-list
101753451|NCT00724724|3-n-butylphthalide|3-n-butylphthalide|mesh-list
101753452|NCT00724724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101753453|NCT00724724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101753454|NCT00724724|Analgesics|analgesics|mesh-ancestor
101753455|NCT00724724|Sensory System Agents|sensory system agents|mesh-ancestor
101753456|NCT00724724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101753457|NCT00724724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753458|NCT00724724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101753459|NCT00724724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101753460|NCT00724724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101753461|NCT00724724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101753462|NCT00724724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753463|NCT00724724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101753464|NCT00724724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101753465|NCT00724724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101753466|NCT00724724|Antipyretics|antipyretics|mesh-ancestor
101753467|NCT00724724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101753468|NCT00724724|Protective Agents|protective agents|mesh-ancestor
101753469|NCT00865462|Bupropion|bupropion|mesh-list
101753470|NCT00865462|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101753471|NCT00865462|Antidepressive Agents|antidepressive agents|mesh-ancestor
101753475|NCT00865462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101753476|NCT00865462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753478|NCT00865462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101213672|NCT01456507|Naltrexone|naltrexone|mesh-list
101753479|NCT00865462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753480|NCT00865462|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101753481|NCT00865462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101753482|NCT00865462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101753484|NCT04130204|Gout Suppressants|gout suppressants|mesh-ancestor
101753485|NCT04130204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101753486|NCT04130204|Tubulin Modulators|tubulin modulators|mesh-ancestor
101753487|NCT04130204|Antimitotic Agents|antimitotic agents|mesh-ancestor
101753488|NCT04130204|Mitosis Modulators|mitosis modulators|mesh-ancestor
101562715|NCT05923411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101562716|NCT05923411|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101562717|NCT05923411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101562718|NCT05923411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562719|NCT05923190|Pembrolizumab|pembrolizumab|mesh-list
101562720|NCT05923190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101562721|NCT05923190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101562722|NCT05923190|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101562723|NCT05923190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753489|NCT04130204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753490|NCT04130204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101753492|NCT00723918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101753493|NCT00723918|Narcotics|narcotics|mesh-ancestor
101753494|NCT00723918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101753495|NCT00723918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753496|NCT00723918|Analgesics|analgesics|mesh-ancestor
101753497|NCT00723918|Sensory System Agents|sensory system agents|mesh-ancestor
101753498|NCT00723918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101753499|NCT00723918|Antitussive Agents|antitussive agents|mesh-ancestor
101753500|NCT00723918|Respiratory System Agents|respiratory system agents|mesh-ancestor
101753501|NCT00865540|Prednisolone|prednisolone|mesh-list
101753502|NCT00865540|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101753503|NCT00865540|Methylprednisolone|methylprednisolone|mesh-list
101753504|NCT00865540|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101753505|NCT00865540|Prednisolone acetate|prednisolone acetate|mesh-list
101753506|NCT00865540|Ketorolac|ketorolac|mesh-list
101753507|NCT00865540|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101753508|NCT00865540|Nepafenac|nepafenac|mesh-list
101753509|NCT00865540|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101753510|NCT00865540|Prednisolone phosphate|prednisolone phosphate|mesh-list
101753511|NCT00865540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101753512|NCT00865540|Glucocorticoids|glucocorticoids|mesh-ancestor
101753513|NCT00865540|Hormones|hormones|mesh-ancestor
101753514|NCT00865540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101753515|NCT00865540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753516|NCT00865540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101753517|NCT00865540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101753518|NCT00865540|Antiemetics|antiemetics|mesh-ancestor
101753519|NCT00865540|Autonomic Agents|autonomic agents|mesh-ancestor
101753520|NCT00865540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101753521|NCT00865540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101753522|NCT00865540|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101753523|NCT00865540|Protective Agents|protective agents|mesh-ancestor
101753524|NCT00865540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101753525|NCT00865540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101410935|NCT00114686|GABA Agents|gaba agents|mesh-ancestor
101753526|NCT00865540|Analgesics|analgesics|mesh-ancestor
101753527|NCT00865540|Sensory System Agents|sensory system agents|mesh-ancestor
101753528|NCT00865540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101753529|NCT00865540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101753530|NCT00865540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101753531|NCT00865540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753532|NCT00865618|Eplerenone|eplerenone|mesh-list
101753533|NCT00865618|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101753534|NCT00865618|Hormone Antagonists|hormone antagonists|mesh-ancestor
101753535|NCT00865618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101753536|NCT00865618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753537|NCT00865618|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101753538|NCT00865618|Diuretics|diuretics|mesh-ancestor
101753539|NCT00865618|Natriuretic Agents|natriuretic agents|mesh-ancestor
101753540|NCT00865618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101753541|NCT00655629|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101753557|NCT00865696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101562724|NCT05919173|Dexmedetomidine|dexmedetomidine|mesh-list
101562726|NCT05919173|Anesthetics, Local|anesthetics, local|mesh-ancestor
101562727|NCT05919173|Anesthetics|anesthetics|mesh-ancestor
101562728|NCT05919173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101562729|NCT05919173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562730|NCT05919173|Sensory System Agents|sensory system agents|mesh-ancestor
101562731|NCT05919173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101562732|NCT05919173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101562733|NCT05919173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101562734|NCT05919173|Analgesics|analgesics|mesh-ancestor
101411052|NCT00449137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411053|NCT00449137|Antimetabolites|antimetabolites|mesh-ancestor
101753558|NCT00865696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101753559|NCT00865696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101753560|NCT00865696|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101753561|NCT00865696|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101753562|NCT00865696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101753563|NCT00865696|Adrenergic Agents|adrenergic agents|mesh-ancestor
101753564|NCT00865696|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101753565|NCT00865696|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101753566|NCT00865696|Serotonin Agents|serotonin agents|mesh-ancestor
101753567|NCT00865696|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101753569|NCT00724802|Antifungal Agents|antifungal agents|mesh-ancestor
101753570|NCT00724802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101753571|NCT02545114|Tolvaptan|tolvaptan|mesh-list
101753572|NCT02545114|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101753573|NCT02545114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753574|NCT02545114|Natriuretic Agents|natriuretic agents|mesh-ancestor
101753575|NCT02545114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753576|NCT00724880|Clopidogrel|clopidogrel|mesh-list
101753577|NCT00724880|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101753578|NCT00724880|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101753579|NCT00724880|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101753580|NCT00724880|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101753581|NCT00724880|Purinergic Agents|purinergic agents|mesh-ancestor
101753582|NCT00724880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101753583|NCT00724880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753584|NCT00724880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753585|NCT00724074|Bupivacaine|bupivacaine|mesh-list
101753586|NCT00724074|Anesthetics, Local|anesthetics, local|mesh-ancestor
101753587|NCT00724074|Anesthetics|anesthetics|mesh-ancestor
101753588|NCT00724074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101753589|NCT00724074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753590|NCT00724074|Sensory System Agents|sensory system agents|mesh-ancestor
101753591|NCT00724074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101753592|NCT00854776|Lansoprazole|lansoprazole|mesh-list
101753593|NCT00854776|Dexlansoprazole|dexlansoprazole|mesh-list
101753594|NCT00854776|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101753595|NCT00854776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101753596|NCT00854776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101753597|NCT00854776|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101753598|NCT00854776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101753599|NCT00854776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753623|NCT00724230|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101753624|NCT00724230|Interferon-alpha|interferon-alpha|mesh-list
101753625|NCT00724230|Antimetabolites|antimetabolites|mesh-ancestor
101753626|NCT00724230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753627|NCT00724230|Antiviral Agents|antiviral agents|mesh-ancestor
101753628|NCT00724230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101562735|NCT05919173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101562736|NCT05919173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101562737|NCT05919173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101562738|NCT05919173|Adrenergic Agents|adrenergic agents|mesh-ancestor
101562739|NCT05919173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101562740|NCT05919173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562741|NCT05911776|Dexmedetomidine|dexmedetomidine|mesh-list
101562742|NCT05911776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101753629|NCT00724230|Immunologic Factors|immunologic factors|mesh-ancestor
101753630|NCT00724230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753631|NCT00725036|Insulin|insulin|mesh-list
101753632|NCT00725036|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101753633|NCT00725036|Insulin Aspart|insulin aspart|mesh-list
101753634|NCT00725036|Isophane Insulin, Human|isophane insulin, human|mesh-list
101753635|NCT00725036|Insulin, Isophane|insulin, isophane|mesh-list
101753636|NCT00725036|Isophane insulin, beef|isophane insulin, beef|mesh-list
101753637|NCT00725036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101753638|NCT00725036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753639|NCT00724386|Paclitaxel|paclitaxel|mesh-list
101753640|NCT00724386|Vinorelbine|vinorelbine|mesh-list
101753641|NCT00724386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101753642|NCT00724386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101753643|NCT00724386|Tubulin Modulators|tubulin modulators|mesh-ancestor
101753644|NCT00724386|Antimitotic Agents|antimitotic agents|mesh-ancestor
101753645|NCT00724386|Mitosis Modulators|mitosis modulators|mesh-ancestor
101753646|NCT00724386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753647|NCT00865852|Metformin|metformin|mesh-list
101753648|NCT00865852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101753649|NCT00865852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753650|NCT00725114|Tetrodotoxin|tetrodotoxin|mesh-list
101753651|NCT00725114|Anesthetics, Local|anesthetics, local|mesh-ancestor
101753652|NCT00725114|Anesthetics|anesthetics|mesh-ancestor
101753653|NCT00725114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101753654|NCT00725114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753656|NCT00725114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101753657|NCT00725114|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101753658|NCT00725114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101753659|NCT00725114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753661|NCT00724542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101753662|NCT00724542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753663|NCT00724542|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101753664|NCT00724542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101753665|NCT00724542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753666|NCT00724620|Ribavirin|ribavirin|mesh-list
101753667|NCT00724620|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101753668|NCT00724620|Antimetabolites|antimetabolites|mesh-ancestor
101753669|NCT00724620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753670|NCT00724620|Antiviral Agents|antiviral agents|mesh-ancestor
101753671|NCT00724620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101753672|NCT00866008|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101411092|NCT00115115|Dopamine|dopamine|mesh-list
101753673|NCT00866008|Ganirelix|ganirelix|mesh-list
101753674|NCT00866008|Luteolytic Agents|luteolytic agents|mesh-ancestor
101753675|NCT00866008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101753676|NCT00866008|Contraceptive Agents|contraceptive agents|mesh-ancestor
101753677|NCT00866008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101753678|NCT00866008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753679|NCT00866008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101753680|NCT00866008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101753681|NCT00866008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101753682|NCT00866008|Hormone Antagonists|hormone antagonists|mesh-ancestor
101753683|NCT00866008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101753684|NCT02571426|Propofol|propofol|mesh-list
101753685|NCT02571426|Sevoflurane|sevoflurane|mesh-list
101753686|NCT02571426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101753687|NCT02571426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101562743|NCT05911776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101562744|NCT05911776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562745|NCT05911776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101562746|NCT05911776|Analgesics|analgesics|mesh-ancestor
101562747|NCT05911776|Sensory System Agents|sensory system agents|mesh-ancestor
101562748|NCT05911776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101411073|NCT00449410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101753688|NCT02571426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753689|NCT02571426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101753690|NCT02571426|Anesthetics, General|anesthetics, general|mesh-ancestor
101753691|NCT02571426|Anesthetics|anesthetics|mesh-ancestor
101753692|NCT02571426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101753693|NCT02571426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101753694|NCT03491540|Gentamicins|gentamicins|mesh-list
101753695|NCT03491540|Ornidazole|ornidazole|mesh-list
101753696|NCT03491540|Sennosides|sennosides|mesh-list
101753697|NCT03491540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101753698|NCT03491540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101753699|NCT03491540|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101753700|NCT03491540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101753701|NCT03491540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753703|NCT03491540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101753704|NCT03491540|Amebicides|amebicides|mesh-ancestor
101753705|NCT03491540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101753706|NCT03491540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101753707|NCT03491540|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
101753708|NCT00854932|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101753709|NCT00854932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101753710|NCT00578292|Cyclophosphamide|cyclophosphamide|mesh-list
101753711|NCT00578292|Busulfan|busulfan|mesh-list
101753712|NCT00578292|Fludarabine|fludarabine|mesh-list
101753713|NCT00578292|Alemtuzumab|alemtuzumab|mesh-list
101753714|NCT00578292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101753715|NCT00578292|Immunologic Factors|immunologic factors|mesh-ancestor
101753716|NCT00578292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753717|NCT00578292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101753718|NCT00578292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101753719|NCT00578292|Alkylating Agents|alkylating agents|mesh-ancestor
101753720|NCT00578292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753721|NCT00578292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101753722|NCT00578292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101753723|NCT00578292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101753724|NCT00861874|Sirolimus|sirolimus|mesh-list
101753725|NCT00861874|Decitabine|decitabine|mesh-list
101753726|NCT00861874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101753727|NCT00861874|Antimetabolites|antimetabolites|mesh-ancestor
101753728|NCT00861874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753732|NCT00861874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101753733|NCT00861874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101753734|NCT00861874|Antifungal Agents|antifungal agents|mesh-ancestor
101753735|NCT00861874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101753736|NCT00861874|Immunologic Factors|immunologic factors|mesh-ancestor
101753737|NCT00861874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753738|NCT05372874|Antiviral Agents|antiviral agents|mesh-list
101753739|NCT05372874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101753740|NCT04067856|Dexamethasone|dexamethasone|mesh-list
101753741|NCT04067856|Bevacizumab|bevacizumab|mesh-list
101753742|NCT04067856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101753743|NCT04067856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101753744|NCT04067856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101753745|NCT04067856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101753746|NCT04067856|Growth Substances|growth substances|mesh-ancestor
101753747|NCT04067856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411160|NCT00449839|Insulin Aspart|insulin aspart|mesh-list
101753748|NCT04067856|Growth Inhibitors|growth inhibitors|mesh-ancestor
101753749|NCT04067856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101753750|NCT04067856|Antiemetics|antiemetics|mesh-ancestor
101753751|NCT04067856|Autonomic Agents|autonomic agents|mesh-ancestor
101753752|NCT04067856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101562749|NCT05911776|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101562750|NCT05911776|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101562751|NCT05911776|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101562752|NCT05911776|Adrenergic Agents|adrenergic agents|mesh-ancestor
101562753|NCT05911776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101562754|NCT05911776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753753|NCT04067856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101753754|NCT04067856|Glucocorticoids|glucocorticoids|mesh-ancestor
101753755|NCT04067856|Hormones|hormones|mesh-ancestor
101753756|NCT04067856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101753757|NCT04067856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101753758|NCT04042714|Trifluridine|trifluridine|mesh-list
101753759|NCT04042714|Antimetabolites|antimetabolites|mesh-ancestor
101753760|NCT04042714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753761|NCT04042714|Antiviral Agents|antiviral agents|mesh-ancestor
101753762|NCT04042714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101753763|NCT03401918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101753764|NCT03401918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101753765|NCT00725348|R 115866|r 115866|mesh-list
101753766|NCT00725348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101753767|NCT00725348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101753768|NCT00725348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753769|NCT00577772|Rifaximin|rifaximin|mesh-list
101753770|NCT00577772|Lactulose|lactulose|mesh-list
101753771|NCT00577772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101753772|NCT00577772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101753773|NCT00577772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101753775|NCT00578136|Anesthetics, Local|anesthetics, local|mesh-ancestor
101753776|NCT00578136|Anesthetics|anesthetics|mesh-ancestor
101753777|NCT00578136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101753778|NCT00578136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753779|NCT00578136|Sensory System Agents|sensory system agents|mesh-ancestor
101753780|NCT00578136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101753781|NCT00861952|Mineral Oil|mineral oil|mesh-list
101753782|NCT00861952|Emollients|emollients|mesh-ancestor
101753783|NCT00861952|Dermatologic Agents|dermatologic agents|mesh-ancestor
101753784|NCT00655551|Lacosamide|lacosamide|mesh-list
101753785|NCT00655551|Anticonvulsants|anticonvulsants|mesh-ancestor
101753786|NCT00655551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101753787|NCT00655551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101753788|NCT00655551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101753789|NCT00655551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753790|NCT00855088|Ritonavir|ritonavir|mesh-list
101753791|NCT00855088|Darunavir|darunavir|mesh-list
101753792|NCT00855088|Etravirine|etravirine|mesh-list
101753793|NCT00855088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101753794|NCT00855088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101753795|NCT00855088|Protease Inhibitors|protease inhibitors|mesh-ancestor
101753796|NCT00855088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101753797|NCT00855088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753798|NCT00855088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101753799|NCT00855088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101753800|NCT00855088|Antiviral Agents|antiviral agents|mesh-ancestor
101753801|NCT00855088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101753808|NCT02553603|Tesamorelin|tesamorelin|mesh-list
101753809|NCT02553603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101753810|NCT02553603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753811|NCT02553603|Growth Substances|growth substances|mesh-ancestor
101753812|NCT00804531|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101753813|NCT00804531|Methylprednisolone|methylprednisolone|mesh-list
101753814|NCT00804531|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101753815|NCT00804531|Prednisolone|prednisolone|mesh-list
101753816|NCT00804531|Prednisolone acetate|prednisolone acetate|mesh-list
101753817|NCT00804531|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101753818|NCT00804531|Prednisolone phosphate|prednisolone phosphate|mesh-list
101753819|NCT00804531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101753820|NCT00804531|Antiemetics|antiemetics|mesh-ancestor
101753821|NCT00804531|Autonomic Agents|autonomic agents|mesh-ancestor
101562755|NCT05908747|Paclitaxel|paclitaxel|mesh-list
101562756|NCT05908747|Gemcitabine|gemcitabine|mesh-list
101562757|NCT05908747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101562758|NCT05908747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101562759|NCT05908747|Tubulin Modulators|tubulin modulators|mesh-ancestor
101562760|NCT05908747|Antimitotic Agents|antimitotic agents|mesh-ancestor
101562761|NCT05908747|Mitosis Modulators|mitosis modulators|mesh-ancestor
101411085|NCT00449449|Sensory System Agents|sensory system agents|mesh-ancestor
101753822|NCT00804531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101753823|NCT00804531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753824|NCT00804531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101753825|NCT00804531|Glucocorticoids|glucocorticoids|mesh-ancestor
101753827|NCT00804531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101753828|NCT00804531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101753829|NCT00804531|Protective Agents|protective agents|mesh-ancestor
101753830|NCT00804531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101753831|NCT00804531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101753832|NCT00866866|Acetylcysteine|acetylcysteine|mesh-list
101753833|NCT00866866|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101753834|NCT00866866|Antiviral Agents|antiviral agents|mesh-ancestor
101753835|NCT00866866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101753836|NCT00866866|Expectorants|expectorants|mesh-ancestor
101753837|NCT00866866|Respiratory System Agents|respiratory system agents|mesh-ancestor
101753838|NCT00866866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101753839|NCT00866866|Antioxidants|antioxidants|mesh-ancestor
101753840|NCT00866866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753841|NCT00866866|Protective Agents|protective agents|mesh-ancestor
101753842|NCT00866866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753843|NCT00866866|Antidotes|antidotes|mesh-ancestor
101753844|NCT00312728|Bevacizumab|bevacizumab|mesh-list
101753845|NCT00312728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101753846|NCT00312728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101753847|NCT00312728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101753848|NCT00312728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101753849|NCT00312728|Growth Substances|growth substances|mesh-ancestor
101753850|NCT00312728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753851|NCT00312728|Growth Inhibitors|growth inhibitors|mesh-ancestor
101753852|NCT00804921|Bevacizumab|bevacizumab|mesh-list
101753853|NCT00804921|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101753854|NCT00804921|Acetazolamide|acetazolamide|mesh-list
101753855|NCT00804921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101753856|NCT00804921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101753857|NCT00804921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101753858|NCT00804921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101753859|NCT00804921|Growth Substances|growth substances|mesh-ancestor
101753860|NCT00804921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753861|NCT00804921|Growth Inhibitors|growth inhibitors|mesh-ancestor
101753862|NCT00804921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101753863|NCT00804921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101753864|NCT00804921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101753865|NCT00804921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101753866|NCT00804921|Adrenergic Agents|adrenergic agents|mesh-ancestor
101753867|NCT00804921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101753868|NCT00804921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753869|NCT00804921|Anticonvulsants|anticonvulsants|mesh-ancestor
101753883|NCT00866944|Immunologic Factors|immunologic factors|mesh-ancestor
101753884|NCT00866944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753886|NCT00866944|Protective Agents|protective agents|mesh-ancestor
101753887|NCT00866944|Vitamin B Complex|vitamin b complex|mesh-ancestor
101753888|NCT00866944|Vitamins|vitamins|mesh-ancestor
101753889|NCT00866944|Micronutrients|micronutrients|mesh-ancestor
101753890|NCT00577824|Exenatide|exenatide|mesh-list
101753891|NCT00577824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101753892|NCT00577824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753893|NCT00577824|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101753894|NCT00577824|Incretins|incretins|mesh-ancestor
101753895|NCT00577824|Hormones|hormones|mesh-ancestor
101753896|NCT00577824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101562762|NCT05908747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562763|NCT05908747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101562764|NCT05908747|Antimetabolites|antimetabolites|mesh-ancestor
101562765|NCT05906511|Dronabinol|dronabinol|mesh-list
101562766|NCT05906511|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101562767|NCT05906511|Hallucinogens|hallucinogens|mesh-ancestor
101411093|NCT00115115|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101753897|NCT02632448|Gemcitabine|gemcitabine|mesh-list
101753898|NCT02632448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101753899|NCT02632448|Antimetabolites|antimetabolites|mesh-ancestor
101753900|NCT02632448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411317|NCT03274024|Mitomycins|mitomycins|mesh-list
101753901|NCT02632448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101753902|NCT04046289|Calcium, Dietary|calcium, dietary|mesh-list
101753903|NCT04046289|Calcium Carbonate|calcium carbonate|mesh-list
101753904|NCT04046289|Calcium|calcium|mesh-list
101753905|NCT04046289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101753906|NCT04046289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753907|NCT04046289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101753908|NCT04046289|Antacids|antacids|mesh-ancestor
101753909|NCT04046289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753910|NCT04046289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101753911|NCT00807807|Folic Acid|folic acid|mesh-list
101753912|NCT00807807|Vitamin B Complex|vitamin b complex|mesh-list
101753913|NCT00807807|Hematinics|hematinics|mesh-ancestor
101753914|NCT00807807|Vitamins|vitamins|mesh-ancestor
101753915|NCT00807807|Micronutrients|micronutrients|mesh-ancestor
101753916|NCT00807807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753917|NCT03011814|Lenalidomide|lenalidomide|mesh-list
101753918|NCT03011814|Durvalumab|durvalumab|mesh-list
101753919|NCT03011814|Immunoglobulins|immunoglobulins|mesh-list
101753920|NCT03011814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101753921|NCT03011814|Immunoglobulin G|immunoglobulin g|mesh-list
101753922|NCT03011814|Immunologic Factors|immunologic factors|mesh-ancestor
101753923|NCT03011814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753924|NCT03011814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101753925|NCT03011814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101753926|NCT03011814|Growth Substances|growth substances|mesh-ancestor
101753927|NCT03011814|Growth Inhibitors|growth inhibitors|mesh-ancestor
101753928|NCT03011814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101753929|NCT03011814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101753930|NCT00870298|Trimethoprim|trimethoprim|mesh-list
101753931|NCT00870298|Sulfamethoxazole|sulfamethoxazole|mesh-list
101753932|NCT00870298|Warfarin|warfarin|mesh-list
101753933|NCT00870298|Anticoagulants|anticoagulants|mesh-ancestor
101753934|NCT00870298|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101753935|NCT00870298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101753939|NCT00870298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101753940|NCT00870298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101753941|NCT00870298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753942|NCT00870298|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101753943|NCT00870298|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101753944|NCT00870298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101753945|NCT00805155|Mometasone Furoate|mometasone furoate|mesh-list
101753946|NCT00805155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101753947|NCT00805155|Dermatologic Agents|dermatologic agents|mesh-ancestor
101753948|NCT00805155|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101753949|NCT00807963|Zoledronic Acid|zoledronic acid|mesh-list
101753950|NCT00807963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101753951|NCT00807963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753953|NCT00730418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101753954|NCT00730418|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101753955|NCT00730418|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101753956|NCT00730418|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101753957|NCT00730418|Adrenergic Agents|adrenergic agents|mesh-ancestor
101753958|NCT00730418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101753959|NCT00730418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753960|NCT00730418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753961|NCT00805233|Bromfenac|bromfenac|mesh-list
101562768|NCT05906511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562769|NCT05906511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101562770|NCT05906511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101562772|NCT05906511|Sensory System Agents|sensory system agents|mesh-ancestor
101562773|NCT05906511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101562774|NCT05906511|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101411098|NCT00115115|Dopamine Agents|dopamine agents|mesh-ancestor
101753962|NCT00805233|Ranibizumab|ranibizumab|mesh-list
101753963|NCT00805233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101753964|NCT00805233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101753965|NCT00805233|Growth Substances|growth substances|mesh-ancestor
101753966|NCT00805233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753967|NCT00805233|Growth Inhibitors|growth inhibitors|mesh-ancestor
101753968|NCT00805233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101753969|NCT00805233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101753970|NCT00805233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101753971|NCT00805233|Analgesics|analgesics|mesh-ancestor
101753972|NCT00805233|Sensory System Agents|sensory system agents|mesh-ancestor
101753973|NCT00805233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101753974|NCT00805233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101753975|NCT00805233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101753976|NCT02569502|Enfuvirtide|enfuvirtide|mesh-list
101753977|NCT02569502|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101753978|NCT02569502|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101753979|NCT02569502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753980|NCT02569502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101753981|NCT02569502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101753982|NCT02569502|Antiviral Agents|antiviral agents|mesh-ancestor
101753983|NCT02569502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101753984|NCT00725400|Cetuximab|cetuximab|mesh-list
101753985|NCT00725400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101753986|NCT00725400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101753987|NCT00798915|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
101753988|NCT00798915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101753989|NCT00798915|Incretins|incretins|mesh-ancestor
101753990|NCT00798915|Hormones|hormones|mesh-ancestor
101753991|NCT00798915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101753992|NCT00798915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753993|NCT00798993|Cholecalciferol|cholecalciferol|mesh-list
101753994|NCT00798993|Vitamin D|vitamin d|mesh-list
101753995|NCT00798993|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
101753996|NCT00798993|Calcifediol|calcifediol|mesh-list
101753997|NCT00798993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101753998|NCT00798993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753999|NCT00798993|Vitamins|vitamins|mesh-ancestor
101754000|NCT00798993|Micronutrients|micronutrients|mesh-ancestor
101754001|NCT00798993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101754002|NCT00862108|Methylphenidate|methylphenidate|mesh-list
101754003|NCT00862108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101754004|NCT00862108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754005|NCT00862108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101754006|NCT00862108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101754021|NCT00862264|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101754022|NCT00862264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101754023|NCT00862264|Adrenergic Agents|adrenergic agents|mesh-ancestor
101754024|NCT00862264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101754025|NCT00862264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754026|NCT00862264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101754027|NCT00862264|Glucocorticoids|glucocorticoids|mesh-ancestor
101754028|NCT00862264|Hormones|hormones|mesh-ancestor
101754029|NCT00862264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101754030|NCT00862264|Anesthetics|anesthetics|mesh-ancestor
101754031|NCT00862264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101754032|NCT00730574|Vitamins|vitamins|mesh-list
101754033|NCT00730574|Folic Acid|folic acid|mesh-list
101754034|NCT00730574|Vitamin B 12|vitamin b 12|mesh-list
101562775|NCT05906511|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101754036|NCT00730574|Vitamin B Complex|vitamin b complex|mesh-list
101754037|NCT00730574|Micronutrients|micronutrients|mesh-ancestor
101754038|NCT00730574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754039|NCT00730574|Hematinics|hematinics|mesh-ancestor
101754040|NCT00870532|Sorafenib|sorafenib|mesh-list
101754041|NCT00870532|Vinorelbine|vinorelbine|mesh-list
101754042|NCT00870532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101754043|NCT00870532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101754044|NCT00870532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101754045|NCT00870532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754046|NCT00870532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101754047|NCT00870532|Tubulin Modulators|tubulin modulators|mesh-ancestor
101754048|NCT00870532|Antimitotic Agents|antimitotic agents|mesh-ancestor
101754049|NCT00870532|Mitosis Modulators|mitosis modulators|mesh-ancestor
101754050|NCT00725478|Piribedil|piribedil|mesh-list
101754051|NCT00725478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101754052|NCT00725478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101754053|NCT00725478|Dopamine Agonists|dopamine agonists|mesh-ancestor
101754054|NCT00725478|Dopamine Agents|dopamine agents|mesh-ancestor
101754055|NCT00725478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101754056|NCT00725478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754057|NCT00725478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754058|NCT01951274|Serlopitant|serlopitant|mesh-list
101754059|NCT01951274|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101754060|NCT01951274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101754061|NCT01951274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754062|NCT01951274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754063|NCT03355794|Everolimus|everolimus|mesh-list
101754064|NCT03355794|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101754065|NCT03355794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101754066|NCT03355794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528681|NCT00561990|Nimotuzumab|nimotuzumab|mesh-list
101754075|NCT01487174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101754076|NCT01487174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754077|NCT00725634|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101754078|NCT00725634|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101754079|NCT00725634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101754080|NCT00725634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101754081|NCT00725634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101754082|NCT00725634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754083|NCT00725634|Immunologic Factors|immunologic factors|mesh-ancestor
101754084|NCT00725634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754085|NCT00617344|Vaccines|vaccines|mesh-list
101754086|NCT00617344|Immunologic Factors|immunologic factors|mesh-ancestor
101754087|NCT00617344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754088|NCT00862342|Bevacizumab|bevacizumab|mesh-list
101754089|NCT00862342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101754090|NCT00862342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101754091|NCT00862342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101754092|NCT00862342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101754093|NCT00862342|Growth Substances|growth substances|mesh-ancestor
101754094|NCT00862342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754095|NCT00862342|Growth Inhibitors|growth inhibitors|mesh-ancestor
101754096|NCT00732212|Hemostatics|hemostatics|mesh-list
101754097|NCT00732212|Coagulants|coagulants|mesh-ancestor
101754098|NCT02544724|Interleukin-12|interleukin-12|mesh-list
101754099|NCT02544724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101754100|NCT02544724|Immunologic Factors|immunologic factors|mesh-ancestor
101754101|NCT02544724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754102|NCT02544724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101754103|NCT02544724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101754104|NCT02544724|Growth Substances|growth substances|mesh-ancestor
101754105|NCT02544724|Growth Inhibitors|growth inhibitors|mesh-ancestor
101754106|NCT02544724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101754107|NCT00862420|Ticlopidine|ticlopidine|mesh-list
101754108|NCT00862420|Clopidogrel|clopidogrel|mesh-list
101754109|NCT00862420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101754110|NCT00862420|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101754111|NCT00862420|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101754112|NCT00862420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101754113|NCT00862420|Purinergic Agents|purinergic agents|mesh-ancestor
101754114|NCT00862420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101562777|NCT05906511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562778|NCT05906511|Hormones|hormones|mesh-ancestor
101562779|NCT05906511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101562780|NCT05904808|Metolazone|metolazone|mesh-list
101562781|NCT05904808|Furosemide|furosemide|mesh-list
101562782|NCT05904808|Acetazolamide|acetazolamide|mesh-list
101562783|NCT05904808|Magnesium citrate|magnesium citrate|mesh-list
101562784|NCT05904808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562785|NCT05904808|Diuretics|diuretics|mesh-ancestor
101562787|NCT05904808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562788|NCT05904808|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101411108|NCT00115830|Antimetabolites|antimetabolites|mesh-ancestor
101754115|NCT00862420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754116|NCT00862420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754117|NCT00862420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101754118|NCT00862420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101754119|NCT00862420|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101754120|NCT00862420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101754121|NCT00862420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101754122|NCT00321698|Docetaxel|docetaxel|mesh-list
101754123|NCT00321698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101754124|NCT00321698|Tubulin Modulators|tubulin modulators|mesh-ancestor
101754125|NCT00321698|Antimitotic Agents|antimitotic agents|mesh-ancestor
101754126|NCT00321698|Mitosis Modulators|mitosis modulators|mesh-ancestor
101411549|NCT03273595|Paclitaxel|paclitaxel|mesh-list
101754127|NCT00321698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754128|NCT02569970|Fluoxetine|fluoxetine|mesh-list
101754129|NCT02569970|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101528738|NCT02905526|Contraceptive Agents|contraceptive agents|mesh-list
101754137|NCT02569970|Antidepressive Agents|antidepressive agents|mesh-ancestor
101754138|NCT02569970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101754139|NCT02569970|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101754140|NCT02569970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101754141|NCT02569970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101754142|NCT00725790|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101754143|NCT00725790|Vasodilator Agents|vasodilator agents|mesh-ancestor
101754144|NCT00725790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101754145|NCT00725790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101754146|NCT00725790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101754147|NCT00725790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754148|NCT00725790|Urological Agents|urological agents|mesh-ancestor
101754149|NCT00731276|Irinotecan|irinotecan|mesh-list
101754150|NCT00731276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101754151|NCT00731276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101754152|NCT00731276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101754153|NCT00731276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754154|NCT00731276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101754156|NCT00725946|Cadexomer iodine|cadexomer iodine|mesh-list
101754157|NCT00725946|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101754158|NCT00725946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101754159|NCT00725946|Trace Elements|trace elements|mesh-ancestor
101754160|NCT00725946|Micronutrients|micronutrients|mesh-ancestor
101754161|NCT00725946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754162|NCT02569346|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
101754163|NCT02569346|Lamivudine|lamivudine|mesh-list
101754164|NCT02569346|Abacavir|abacavir|mesh-list
101754165|NCT02569346|Dolutegravir|dolutegravir|mesh-list
101754166|NCT02569346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101754167|NCT02569346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101754168|NCT02569346|Antiviral Agents|antiviral agents|mesh-ancestor
101562789|NCT05904808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101562790|NCT05904808|Anticonvulsants|anticonvulsants|mesh-ancestor
101562791|NCT05904808|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101562792|NCT05904808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101562793|NCT05904808|Cathartics|cathartics|mesh-ancestor
101411119|NCT00449527|Budesonide|budesonide|mesh-list
101754169|NCT02569346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101754170|NCT02569346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101754171|NCT02569346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101754172|NCT02569346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101754173|NCT02569346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754174|NCT02569346|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101754175|NCT02569346|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101754176|NCT00726804|Adalimumab|adalimumab|mesh-list
101754177|NCT00726804|Etanercept|etanercept|mesh-list
101754178|NCT00726804|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101754179|NCT00726804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101754180|NCT00726804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101754181|NCT00726804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101754182|NCT00726804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101754183|NCT00726804|Analgesics|analgesics|mesh-ancestor
101754184|NCT00726804|Sensory System Agents|sensory system agents|mesh-ancestor
101754185|NCT00726804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101754186|NCT00726804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754187|NCT00726804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101754188|NCT00726804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101754189|NCT00726804|Immunologic Factors|immunologic factors|mesh-ancestor
101754190|NCT00726960|Buprenorphine|buprenorphine|mesh-list
101754191|NCT00726960|Aprepitant|aprepitant|mesh-list
101754192|NCT00726960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101754193|NCT00726960|Narcotics|narcotics|mesh-ancestor
101754194|NCT00726960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101528799|NCT04653792|Anticonvulsants|anticonvulsants|mesh-ancestor
101754216|NCT00726258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101754217|NCT00726258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754218|NCT00726258|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101754219|NCT00726258|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101754220|NCT00726258|Anesthetics, General|anesthetics, general|mesh-ancestor
101754221|NCT00726258|Anesthetics|anesthetics|mesh-ancestor
101754222|NCT00726258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101754223|NCT00726258|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101754224|NCT00726258|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101754225|NCT00726258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101754226|NCT00726258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193641|NCT01721616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101754228|NCT02950766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101754229|NCT02950766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101754230|NCT02950766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101754231|NCT02950766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754232|NCT02569814|Amlodipine|amlodipine|mesh-list
101754233|NCT02569814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101754234|NCT02569814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101754235|NCT02569814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101754236|NCT02569814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101754237|NCT02569814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754238|NCT02569814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101754239|NCT02569814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754240|NCT02569814|Vasodilator Agents|vasodilator agents|mesh-ancestor
101754241|NCT02569814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101754242|NCT02569814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101754243|NCT02569814|Antimetabolites|antimetabolites|mesh-ancestor
101754244|NCT02569814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101754245|NCT02569814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101754266|NCT00726726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101754267|NCT00726726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101754268|NCT00726726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101754269|NCT00726726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101754270|NCT00726726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101562794|NCT05904808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101562795|NCT05904808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101562796|NCT05904808|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101562797|NCT05888350|Beclomethasone|beclomethasone|mesh-list
101562798|NCT05888350|Formoterol Fumarate|formoterol fumarate|mesh-list
101562799|NCT05888350|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101562800|NCT05888350|Autonomic Agents|autonomic agents|mesh-ancestor
101562801|NCT05888350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101562802|NCT05888350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562803|NCT05888350|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101411126|NCT00449527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101754271|NCT00726726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101754272|NCT00726726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101754273|NCT00726726|Anesthetics, General|anesthetics, general|mesh-ancestor
101754274|NCT00726726|Anesthetics|anesthetics|mesh-ancestor
101754275|NCT00726726|GABA Modulators|gaba modulators|mesh-ancestor
101754276|NCT00726726|GABA Agents|gaba agents|mesh-ancestor
101754277|NCT00726726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101754278|NCT00726726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754279|NCT00726726|Anticoagulants|anticoagulants|mesh-ancestor
101754280|NCT00726726|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101754281|NCT00726726|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101754282|NCT00726726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101754283|NCT00726726|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101754284|NCT00726726|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101754285|NCT00726726|Purinergic Agents|purinergic agents|mesh-ancestor
101754286|NCT00726726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101754287|NCT00726726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101754288|NCT00726726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101754289|NCT00726726|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101754290|NCT00726726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101754291|NCT00726726|Hemostatics|hemostatics|mesh-ancestor
101754292|NCT00726726|Coagulants|coagulants|mesh-ancestor
101754293|NCT00726726|Antitussive Agents|antitussive agents|mesh-ancestor
101754294|NCT00726726|Respiratory System Agents|respiratory system agents|mesh-ancestor
101754295|NCT00726726|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101754296|NCT00726726|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101754297|NCT00726726|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101754298|NCT00654381|Inositol|inositol|mesh-list
101754299|NCT00654381|Linagliptin|linagliptin|mesh-list
101754300|NCT00654381|Voglibose|voglibose|mesh-list
101754301|NCT00654381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101754302|NCT00654381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754303|NCT00654381|Incretins|incretins|mesh-ancestor
101754304|NCT00654381|Hormones|hormones|mesh-ancestor
101754305|NCT00654381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101754306|NCT00654381|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101754318|NCT04018482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101754319|NCT04018482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101754320|NCT00805311|Aspirin|aspirin|mesh-list
101754321|NCT00805311|Losartan|losartan|mesh-list
101754322|NCT00805311|Amlodipine|amlodipine|mesh-list
101754323|NCT00805311|Atorvastatin|atorvastatin|mesh-list
101754324|NCT00805311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101754325|NCT00805311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101754326|NCT00805311|Analgesics|analgesics|mesh-ancestor
101754327|NCT00805311|Sensory System Agents|sensory system agents|mesh-ancestor
101754328|NCT00805311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101754329|NCT00805311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754330|NCT00805311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101754331|NCT00805311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101754332|NCT00805311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101754333|NCT00805311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101754334|NCT00805311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754335|NCT00805311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101562804|NCT05888350|Respiratory System Agents|respiratory system agents|mesh-ancestor
101562805|NCT05888350|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101562806|NCT05888350|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101562807|NCT05888350|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101562808|NCT05888350|Adrenergic Agents|adrenergic agents|mesh-ancestor
101562809|NCT05888350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101562810|NCT05888350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562811|NCT05888350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101562812|NCT05888350|Glucocorticoids|glucocorticoids|mesh-ancestor
101562813|NCT05888350|Hormones|hormones|mesh-ancestor
101411134|NCT00449527|Adrenergic Agents|adrenergic agents|mesh-ancestor
101754336|NCT00805311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101754337|NCT00805311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101754338|NCT00805311|Antipyretics|antipyretics|mesh-ancestor
101754339|NCT00805311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101754340|NCT00805311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101754341|NCT00805311|Antimetabolites|antimetabolites|mesh-ancestor
101754342|NCT00805311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101754343|NCT00805311|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101754344|NCT00805311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101754345|NCT00805311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101754346|NCT00805311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101754347|NCT00805311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101754348|NCT00805311|Vasodilator Agents|vasodilator agents|mesh-ancestor
101754349|NCT00805311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101754350|NCT00805311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101754351|NCT00805311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101754352|NCT00732290|Fluoxetine|fluoxetine|mesh-list
101754353|NCT00732290|Clopidogrel|clopidogrel|mesh-list
101754354|NCT00732290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101754355|NCT00732290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101754356|NCT00732290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101754357|NCT00732290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101754358|NCT00732290|Purinergic Agents|purinergic agents|mesh-ancestor
101754359|NCT00732290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101754360|NCT00732290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754361|NCT00732290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754362|NCT00732290|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101754363|NCT00732290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101754364|NCT00732290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101754365|NCT00732290|Serotonin Agents|serotonin agents|mesh-ancestor
101754366|NCT00732290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101754367|NCT00732290|Antidepressive Agents|antidepressive agents|mesh-ancestor
101754368|NCT00732290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101754369|NCT00732290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101754387|NCT00732446|Hormones|hormones|mesh-ancestor
101754388|NCT00732446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101754389|NCT00732446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101754390|NCT00732446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101754391|NCT00732446|Protease Inhibitors|protease inhibitors|mesh-ancestor
101754392|NCT00732446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101754393|NCT00732446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754394|NCT00732446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101754395|NCT00732446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101754396|NCT00732446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101754397|NCT00732446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101754398|NCT00732446|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101754399|NCT00732446|Contraceptive Agents|contraceptive agents|mesh-ancestor
101754400|NCT00732446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101754401|NCT00732446|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101562814|NCT05888350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101562819|NCT05881083|Nicotine|nicotine|mesh-list
101562820|NCT05881083|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101562821|NCT05881083|Autonomic Agents|autonomic agents|mesh-ancestor
101562822|NCT05881083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101562823|NCT05881083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562824|NCT05881083|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101562825|NCT05881083|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101562826|NCT05881083|Cholinergic Agents|cholinergic agents|mesh-ancestor
101562827|NCT05881083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101562828|NCT05881083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562829|NCT05875961|MF59 oil emulsion|mf59 oil emulsion|mesh-list
101562830|NCT05875961|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101562835|NCT05870683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101562836|NCT05870683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101562837|NCT05870683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101411145|NCT00449683|Urological Agents|urological agents|mesh-ancestor
101754402|NCT00732446|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101754403|NCT00732446|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101754404|NCT00732524|Glipizide|glipizide|mesh-list
101754405|NCT00732524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101754406|NCT00732524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754407|NCT00657267|Temozolomide|temozolomide|mesh-list
101754408|NCT00657267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101754409|NCT00657267|Alkylating Agents|alkylating agents|mesh-ancestor
101754410|NCT00657267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754411|NCT00657267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101754412|NCT00733850|Gemcitabine|gemcitabine|mesh-list
101754413|NCT00733850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101754414|NCT00733850|Antimetabolites|antimetabolites|mesh-ancestor
101754415|NCT00733850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754416|NCT00733850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101754417|NCT00727766|Clofarabine|clofarabine|mesh-list
101754418|NCT00727766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101754419|NCT00727766|Antimetabolites|antimetabolites|mesh-ancestor
101754420|NCT00727766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754421|NCT00727766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101754422|NCT00799071|Posaconazole|posaconazole|mesh-list
101754423|NCT00799071|Antifungal Agents|antifungal agents|mesh-ancestor
101754424|NCT00799071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101754425|NCT00799071|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101754426|NCT00799071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101754427|NCT00799071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101754445|NCT00799149|Gabapentin|gabapentin|mesh-list
101754446|NCT00799149|Analgesics|analgesics|mesh-ancestor
101754447|NCT00799149|Sensory System Agents|sensory system agents|mesh-ancestor
101754448|NCT00799149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101754449|NCT00799149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754450|NCT00799149|Anticonvulsants|anticonvulsants|mesh-ancestor
101754451|NCT00799149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101754452|NCT00799149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101754453|NCT00799149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101754454|NCT00799149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101562838|NCT05870683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101562839|NCT05870683|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101562840|NCT05870683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101562841|NCT05870683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562846|NCT05860400|Immunosuppressive Agents|immunosuppressive agents|mesh-list
101562847|NCT05860400|Immunologic Factors|immunologic factors|mesh-ancestor
101562848|NCT05860400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754455|NCT00799149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101754456|NCT00799149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101754457|NCT00799149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101754458|NCT00799149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754459|NCT00799149|Antimanic Agents|antimanic agents|mesh-ancestor
101754460|NCT00799149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101754461|NCT00799149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101754462|NCT00799149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101754463|NCT00799149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101754464|NCT00799149|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101754465|NCT00799149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101754466|NCT00799149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101754467|NCT00732914|Sorafenib|sorafenib|mesh-list
101754468|NCT00732914|Sunitinib|sunitinib|mesh-list
101754469|NCT00732914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101754470|NCT00732914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101754471|NCT00732914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101754472|NCT00732914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754473|NCT00732914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101754474|NCT00732914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101754475|NCT00732914|Growth Substances|growth substances|mesh-ancestor
101754476|NCT00732914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754477|NCT00732914|Growth Inhibitors|growth inhibitors|mesh-ancestor
101754478|NCT00808275|Calcium, Dietary|calcium, dietary|mesh-list
101754479|NCT00808275|Calcium|calcium|mesh-list
101754480|NCT00808275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101754481|NCT00808275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754482|NCT00808275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101754483|NCT00809289|Moxifloxacin|moxifloxacin|mesh-list
101754493|NCT00728000|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101754494|NCT00728000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101754495|NCT00728000|Antimetabolites|antimetabolites|mesh-ancestor
101754496|NCT00728000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754497|NCT00728000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101754498|NCT00728000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101754499|NCT00728000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101754500|NCT04065230|Tenofovir|tenofovir|mesh-list
101754501|NCT04065230|Antiviral Agents|antiviral agents|mesh-ancestor
101754502|NCT04065230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101754503|NCT04065230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101754504|NCT04065230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101754505|NCT04065230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101754506|NCT04065230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754507|NCT04065230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101754508|NCT04065230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101754509|NCT00728078|Thalidomide|thalidomide|mesh-list
101754510|NCT00728078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101754511|NCT00728078|Immunologic Factors|immunologic factors|mesh-ancestor
101754512|NCT00728078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754513|NCT00728078|Leprostatic Agents|leprostatic agents|mesh-ancestor
101754514|NCT00728078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101754515|NCT00728078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101754516|NCT00728078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101754517|NCT00728078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101754518|NCT00728078|Growth Substances|growth substances|mesh-ancestor
101754519|NCT00728078|Growth Inhibitors|growth inhibitors|mesh-ancestor
101754520|NCT00728078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101754521|NCT04066088|Guanfacine|guanfacine|mesh-list
101562850|NCT05854784|Dermatologic Agents|dermatologic agents|mesh-ancestor
101562851|NCT05847452|Benralizumab|benralizumab|mesh-list
101562852|NCT05847452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101562853|NCT05847452|Respiratory System Agents|respiratory system agents|mesh-ancestor
101562854|NCT05833776|Fentanyl|fentanyl|mesh-list
101562855|NCT05833776|Bupivacaine|bupivacaine|mesh-list
101562856|NCT05833776|Anesthetics, Local|anesthetics, local|mesh-ancestor
101562857|NCT05833776|Anesthetics|anesthetics|mesh-ancestor
101562858|NCT05833776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101754522|NCT04066088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101754523|NCT04066088|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101754524|NCT04066088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101754525|NCT04066088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101754526|NCT04066088|Adrenergic Agents|adrenergic agents|mesh-ancestor
101754527|NCT04066088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101754528|NCT04066088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754529|NCT04066088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754530|NCT00733148|Insulin|insulin|mesh-list
101754531|NCT00733148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101754532|NCT00733148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754533|NCT00730392|Etanercept|etanercept|mesh-list
101754534|NCT00730392|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101754535|NCT00730392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101754536|NCT00730392|Analgesics|analgesics|mesh-ancestor
101754537|NCT00730392|Sensory System Agents|sensory system agents|mesh-ancestor
101754538|NCT00730392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101754539|NCT00730392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754540|NCT00730392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101754541|NCT00730392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101754542|NCT00730392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101754543|NCT00730392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101754544|NCT00730392|Immunologic Factors|immunologic factors|mesh-ancestor
101754545|NCT01528046|Metformin|metformin|mesh-list
101754546|NCT01528046|Irinotecan|irinotecan|mesh-list
101754547|NCT01528046|Camptothecin|camptothecin|mesh-list
101754548|NCT01528046|Vincristine|vincristine|mesh-list
101754549|NCT01528046|Temozolomide|temozolomide|mesh-list
101754550|NCT01528046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101754557|NCT01528046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101754559|NCT01528046|Antimitotic Agents|antimitotic agents|mesh-ancestor
101754560|NCT01528046|Mitosis Modulators|mitosis modulators|mesh-ancestor
101754561|NCT01528046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101754562|NCT01528046|Alkylating Agents|alkylating agents|mesh-ancestor
101754563|NCT00652899|Aldesleukin|aldesleukin|mesh-list
101754564|NCT00652899|Cyclophosphamide|cyclophosphamide|mesh-list
101754565|NCT00652899|Fludarabine|fludarabine|mesh-list
101754566|NCT00652899|Fludarabine phosphate|fludarabine phosphate|mesh-list
101754567|NCT00652899|Interleukin-2|interleukin-2|mesh-list
101754568|NCT00652899|Allopurinol|allopurinol|mesh-list
101754569|NCT00652899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101754570|NCT00652899|Immunologic Factors|immunologic factors|mesh-ancestor
101754571|NCT00652899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754572|NCT00652899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101411999|NCT00465283|Donepezil|donepezil|mesh-list
101754573|NCT00652899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101754574|NCT00652899|Alkylating Agents|alkylating agents|mesh-ancestor
101754575|NCT00652899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754576|NCT00652899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101754577|NCT00652899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101754578|NCT00652899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101754579|NCT00652899|Antimetabolites|antimetabolites|mesh-ancestor
101754580|NCT00652899|Antiviral Agents|antiviral agents|mesh-ancestor
101754581|NCT00652899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101754582|NCT00652899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101754583|NCT00652899|Analgesics|analgesics|mesh-ancestor
101754584|NCT00652899|Sensory System Agents|sensory system agents|mesh-ancestor
101754585|NCT00652899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101754586|NCT00652899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101754587|NCT00652899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101562859|NCT05833776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562860|NCT05833776|Sensory System Agents|sensory system agents|mesh-ancestor
101562861|NCT05833776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101562862|NCT05833776|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101562863|NCT05833776|Narcotics|narcotics|mesh-ancestor
101562864|NCT05833776|Analgesics|analgesics|mesh-ancestor
101562865|NCT05833776|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101562866|NCT05833776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101754588|NCT00652899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101754589|NCT00652899|Gout Suppressants|gout suppressants|mesh-ancestor
101754590|NCT00652899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101754591|NCT00652899|Antioxidants|antioxidants|mesh-ancestor
101754592|NCT00652899|Protective Agents|protective agents|mesh-ancestor
101754593|NCT04066452|Immunoglobulins|immunoglobulins|mesh-list
101754594|NCT04066452|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101754595|NCT04066452|Antibodies|antibodies|mesh-list
101754596|NCT04066452|Immunologic Factors|immunologic factors|mesh-ancestor
101754597|NCT04066452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754598|NCT00728520|Azacitidine|azacitidine|mesh-list
101754599|NCT00728520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101754600|NCT00728520|Antimetabolites|antimetabolites|mesh-ancestor
101754601|NCT00728520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754602|NCT00728520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101754603|NCT00728520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101754604|NCT04065308|Daratumumab|daratumumab|mesh-list
101754605|NCT04065308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101754606|NCT00733538|Zoledronic Acid|zoledronic acid|mesh-list
101754607|NCT00733538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101754608|NCT00733538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754609|NCT00728156|Clopidogrel|clopidogrel|mesh-list
101754610|NCT00728156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101754611|NCT00728156|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101754612|NCT00728156|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101754613|NCT00728156|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101754614|NCT00728156|Purinergic Agents|purinergic agents|mesh-ancestor
101754615|NCT00728156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101754616|NCT00728156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754617|NCT00728156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754645|NCT00733616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101754646|NCT00733616|Tubulin Modulators|tubulin modulators|mesh-ancestor
101754647|NCT00733616|Antimitotic Agents|antimitotic agents|mesh-ancestor
101754648|NCT00733616|Mitosis Modulators|mitosis modulators|mesh-ancestor
101412063|NCT00465439|Autonomic Agents|autonomic agents|mesh-ancestor
101754649|NCT00733616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754650|NCT00733616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101754651|NCT00733616|Antimetabolites|antimetabolites|mesh-ancestor
101754652|NCT00728832|Morphine|morphine|mesh-list
101754653|NCT00728832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101754654|NCT00728832|Narcotics|narcotics|mesh-ancestor
101754655|NCT00728832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101754656|NCT00728832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754657|NCT00728832|Analgesics|analgesics|mesh-ancestor
101754658|NCT00728832|Sensory System Agents|sensory system agents|mesh-ancestor
101754659|NCT00728832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101754660|NCT03924804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101754661|NCT00728312|Aripiprazole|aripiprazole|mesh-list
101754662|NCT00728312|Antidepressive Agents|antidepressive agents|mesh-ancestor
101754663|NCT00728312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101754664|NCT00728312|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101754665|NCT00728312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101529283|NCT02900417|Incretins|incretins|mesh-ancestor
101754671|NCT00728312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754673|NCT00728312|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101754674|NCT00728312|Serotonin Agents|serotonin agents|mesh-ancestor
101754675|NCT00728312|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101754676|NCT00728312|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101754677|NCT00728312|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101562867|NCT05833776|Anesthetics, General|anesthetics, general|mesh-ancestor
101562868|NCT05823441|Oxytocin|oxytocin|mesh-list
101562869|NCT05823441|Oxytocics|oxytocics|mesh-ancestor
101562870|NCT05823441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101562871|NCT05823441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562872|NCT05821309|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101562873|NCT05821309|Glycerol|glycerol|mesh-list
101562874|NCT05821309|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101562875|NCT05821309|Protective Agents|protective agents|mesh-ancestor
101754678|NCT00728312|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101754679|NCT00728546|Isoniazid|isoniazid|mesh-list
101754680|NCT00728546|Antitubercular Agents|antitubercular agents|mesh-ancestor
101754681|NCT00728546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101754682|NCT00728546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101754683|NCT00728546|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101754684|NCT00728546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101754685|NCT00728546|Antimetabolites|antimetabolites|mesh-ancestor
101754686|NCT00728546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754687|NCT00728546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101754688|NCT00617890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101754689|NCT00617890|Immunologic Factors|immunologic factors|mesh-ancestor
101754690|NCT00617890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754691|NCT00728780|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101754692|NCT00728780|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101754693|NCT00728780|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101754694|NCT00728780|Antimetabolites|antimetabolites|mesh-ancestor
101754695|NCT00728780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754696|NCT00728780|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101754697|NCT00728780|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101754698|NCT00728780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101754699|NCT04066296|Bupivacaine|bupivacaine|mesh-list
101754700|NCT04066296|Anesthetics, Local|anesthetics, local|mesh-list
101754701|NCT04066296|Anesthetics|anesthetics|mesh-list
101754702|NCT04066296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101754703|NCT04066296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754704|NCT04066296|Sensory System Agents|sensory system agents|mesh-ancestor
101754705|NCT04066296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101754706|NCT02341014|Lenalidomide|lenalidomide|mesh-list
101754707|NCT02341014|Romidepsin|romidepsin|mesh-list
101754708|NCT02341014|Immunologic Factors|immunologic factors|mesh-ancestor
101754709|NCT02341014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754710|NCT02341014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101754711|NCT02341014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101754712|NCT02341014|Growth Substances|growth substances|mesh-ancestor
101754713|NCT02341014|Growth Inhibitors|growth inhibitors|mesh-ancestor
101754714|NCT02341014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101754715|NCT02341014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101754716|NCT02341014|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101754717|NCT02341014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101754718|NCT02341014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754719|NCT00868426|Budesonide|budesonide|mesh-list
101754720|NCT00868426|Formoterol Fumarate|formoterol fumarate|mesh-list
101754721|NCT00868426|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101754722|NCT00868426|Charcoal|charcoal|mesh-list
101754723|NCT00868426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101754724|NCT00868426|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101754725|NCT00868426|Autonomic Agents|autonomic agents|mesh-ancestor
101754726|NCT00868426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101754727|NCT00868426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754728|NCT00868426|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101754729|NCT00868426|Respiratory System Agents|respiratory system agents|mesh-ancestor
101754731|NCT00868426|Hormones|hormones|mesh-ancestor
101754732|NCT00868426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101529327|NCT00562770|Valacyclovir|valacyclovir|mesh-list
101754747|NCT00868738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754748|NCT00868738|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101754749|NCT00868816|Oxaliplatin|oxaliplatin|mesh-list
101562876|NCT05821309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562878|NCT05821309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101562879|NCT05816616|Xenon|xenon|mesh-list
101562880|NCT05816616|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101562881|NCT05816616|Anesthetics, General|anesthetics, general|mesh-ancestor
101562882|NCT05816616|Anesthetics|anesthetics|mesh-ancestor
101562883|NCT05816616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101562884|NCT05816616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562885|NCT05792319|Copper|copper|mesh-list
101562886|NCT05792319|Trace Elements|trace elements|mesh-ancestor
101562887|NCT05792319|Micronutrients|micronutrients|mesh-ancestor
101754750|NCT00868816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101754751|NCT02569866|Cephalexin|cephalexin|mesh-list
101754752|NCT02569866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101754753|NCT02569866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101754754|NCT00868894|Latanoprost|latanoprost|mesh-list
101754755|NCT00868894|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101754756|NCT00868894|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101754757|NCT00730938|Cefuroxime|cefuroxime|mesh-list
101754758|NCT00730938|Cefuroxime axetil|cefuroxime axetil|mesh-list
101754759|NCT00730938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101754760|NCT00730938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101754761|NCT00712010|Caseins|caseins|mesh-list
101754762|NCT00712010|Chelating Agents|chelating agents|mesh-ancestor
101754763|NCT00712010|Sequestering Agents|sequestering agents|mesh-ancestor
101754764|NCT00712010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754765|NCT00731016|Zoledronic Acid|zoledronic acid|mesh-list
101754766|NCT00731016|Pravastatin|pravastatin|mesh-list
101754767|NCT00731016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101754768|NCT00731016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754769|NCT00731016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101754770|NCT00731016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101754771|NCT00731016|Antimetabolites|antimetabolites|mesh-ancestor
101754772|NCT00731016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754773|NCT00731016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101754774|NCT00731016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101194136|NCT03400020|Vitamins|vitamins|mesh-ancestor
101754775|NCT00731016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101754776|NCT00799539|Prednisone|prednisone|mesh-list
101754777|NCT00799539|Bortezomib|bortezomib|mesh-list
101754778|NCT00799539|Melphalan|melphalan|mesh-list
101754779|NCT00799539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101754780|NCT00799539|Glucocorticoids|glucocorticoids|mesh-ancestor
101754781|NCT00799539|Hormones|hormones|mesh-ancestor
101754782|NCT00799539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101754783|NCT00799539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754784|NCT00799539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101754785|NCT00799539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101754786|NCT00799539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101754787|NCT00799539|Alkylating Agents|alkylating agents|mesh-ancestor
101754788|NCT00799539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754789|NCT00799539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101754790|NCT00799539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101754791|NCT00799539|Immunologic Factors|immunologic factors|mesh-ancestor
101754792|NCT00731172|Glatiramer Acetate|glatiramer acetate|mesh-list
101754793|NCT00731172|(T,G)-A-L|(t,g)-a-l|mesh-list
101754794|NCT00731172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101754795|NCT00731172|Immunologic Factors|immunologic factors|mesh-ancestor
101754803|NCT00738842|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101754804|NCT00738842|Purinergic Agents|purinergic agents|mesh-ancestor
101754805|NCT00738842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101754806|NCT00738842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754807|NCT00738842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754809|NCT00809913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101754810|NCT00809913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101562888|NCT05792319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562889|NCT05760261|Midazolam|midazolam|mesh-list
101562890|NCT05760261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101562891|NCT05760261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101562892|NCT05760261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101562893|NCT05760261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562894|NCT05760261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101562895|NCT05760261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101562896|NCT05760261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101562897|NCT05760261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101754811|NCT00809913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101754812|NCT00809913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101754813|NCT00809913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101754814|NCT00809913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754815|NCT00809913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101754816|NCT00809913|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101754817|NCT00809913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101754818|NCT00729222|Rolofylline|rolofylline|mesh-list
101754819|NCT00729222|Diuretics|diuretics|mesh-ancestor
101754820|NCT00729222|Natriuretic Agents|natriuretic agents|mesh-ancestor
101754821|NCT00729222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754823|NCT00808743|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101754824|NCT00808743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101754825|NCT00808743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101754826|NCT00808743|Analgesics|analgesics|mesh-ancestor
101754827|NCT00808743|Sensory System Agents|sensory system agents|mesh-ancestor
101754828|NCT00808743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101754829|NCT00808743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754830|NCT00808743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101754831|NCT00808743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101754832|NCT00808743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101754833|NCT00808743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101754834|NCT00808743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101754835|NCT00808743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754836|NCT00808743|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101754837|NCT00808743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101754838|NCT00869596|Fluticasone|fluticasone|mesh-list
101754839|NCT00869596|Xhance|xhance|mesh-list
101754840|NCT00869596|Albuterol|albuterol|mesh-list
101754841|NCT00869596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101754842|NCT00869596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101754843|NCT00869596|Autonomic Agents|autonomic agents|mesh-ancestor
101754844|NCT00869596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101754845|NCT00869596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754846|NCT00869596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101754847|NCT00869596|Respiratory System Agents|respiratory system agents|mesh-ancestor
101754848|NCT00869596|Dermatologic Agents|dermatologic agents|mesh-ancestor
101754849|NCT00869596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101754850|NCT00869596|Tocolytic Agents|tocolytic agents|mesh-ancestor
101754851|NCT00869596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101754852|NCT00869596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101754853|NCT00869596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101754854|NCT00869596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101754855|NCT00869596|Adrenergic Agents|adrenergic agents|mesh-ancestor
101754856|NCT00869596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101754857|NCT00869596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754858|NCT03743376|UB-421|ub-421|mesh-list
101754859|NCT03743376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101754860|NCT03743376|Antiviral Agents|antiviral agents|mesh-ancestor
101754861|NCT03743376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101754862|NCT00734864|Anticonvulsants|anticonvulsants|mesh-list
101754863|NCT03728478|Etanercept|etanercept|mesh-list
101754864|NCT03728478|Methotrexate|methotrexate|mesh-list
101754872|NCT03728478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101562898|NCT05760261|Anesthetics, General|anesthetics, general|mesh-ancestor
101562899|NCT05760261|Anesthetics|anesthetics|mesh-ancestor
101562900|NCT05760261|GABA Modulators|gaba modulators|mesh-ancestor
101562901|NCT05760261|GABA Agents|gaba agents|mesh-ancestor
101562902|NCT05760261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101562903|NCT05760261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562904|NCT05746377|Metoclopramide|metoclopramide|mesh-list
101754873|NCT03728478|Dermatologic Agents|dermatologic agents|mesh-ancestor
101754874|NCT03728478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101754875|NCT03728478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101754876|NCT03728478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101754877|NCT03728478|Immunologic Factors|immunologic factors|mesh-ancestor
101754878|NCT03728478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101754879|NCT03728478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101754880|NCT03728478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101754881|NCT03728478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101754882|NCT03728478|Analgesics|analgesics|mesh-ancestor
101754883|NCT03728478|Sensory System Agents|sensory system agents|mesh-ancestor
101754884|NCT03728478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101754885|NCT03728478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101754886|NCT03728478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101754887|NCT00653523|Simvastatin|simvastatin|mesh-list
101754888|NCT00653523|Ezetimibe|ezetimibe|mesh-list
101754889|NCT00653523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101754890|NCT00653523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101754891|NCT00653523|Antimetabolites|antimetabolites|mesh-ancestor
101754892|NCT00653523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754893|NCT00653523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101754894|NCT00653523|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101754895|NCT00653523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101754896|NCT00808977|Mesalamine|mesalamine|mesh-list
101754897|NCT00808977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101754898|NCT00808977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101754899|NCT00808977|Analgesics|analgesics|mesh-ancestor
101754900|NCT00808977|Sensory System Agents|sensory system agents|mesh-ancestor
101754901|NCT00808977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101754902|NCT00808977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754903|NCT00808977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101754904|NCT00808977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101754905|NCT00735020|Vaccines|vaccines|mesh-list
101754906|NCT00735020|Immunologic Factors|immunologic factors|mesh-ancestor
101754907|NCT00735020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754908|NCT04065906|Methylphenidate|methylphenidate|mesh-list
101754909|NCT04065906|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101754910|NCT04065906|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101754911|NCT04065906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754912|NCT04065906|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101754913|NCT04065906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101754914|NCT04065906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101754915|NCT04065906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754916|NCT04065906|Dopamine Agents|dopamine agents|mesh-ancestor
101754917|NCT04065906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101754918|NCT04065906|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101754919|NCT04065906|Adrenergic Agents|adrenergic agents|mesh-ancestor
101754920|NCT00739388|Azacitidine|azacitidine|mesh-list
101754921|NCT00739388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101754922|NCT00739388|Antimetabolites|antimetabolites|mesh-ancestor
101754923|NCT00739388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754924|NCT00739388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101754925|NCT00739388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101754926|NCT00862888|Sildenafil Citrate|sildenafil citrate|mesh-list
101754927|NCT00862888|Vasodilator Agents|vasodilator agents|mesh-ancestor
101529519|NCT04618107|Anesthetics|anesthetics|mesh-list
101263583|NCT01762657|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101754951|NCT02569320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754952|NCT02569320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101754953|NCT02569320|Glucocorticoids|glucocorticoids|mesh-ancestor
101754954|NCT02569320|Hormones|hormones|mesh-ancestor
101562906|NCT05746377|Autonomic Agents|autonomic agents|mesh-ancestor
101562907|NCT05746377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101562908|NCT05746377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562909|NCT05746377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101562910|NCT05746377|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101562911|NCT05746377|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101754955|NCT02569320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101754956|NCT02569320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101754957|NCT02569320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101754958|NCT02569320|Protease Inhibitors|protease inhibitors|mesh-ancestor
101754959|NCT02569320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101754960|NCT02569320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754961|NCT02569320|Immunologic Factors|immunologic factors|mesh-ancestor
101754962|NCT02569320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101754963|NCT02569320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101754964|NCT02569320|Growth Substances|growth substances|mesh-ancestor
101754965|NCT02569320|Growth Inhibitors|growth inhibitors|mesh-ancestor
101754966|NCT02569320|Dermatologic Agents|dermatologic agents|mesh-ancestor
101754967|NCT00739466|Alendronate|alendronate|mesh-list
101754968|NCT00739466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101754969|NCT00739466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754970|NCT00869908|Insulin|insulin|mesh-list
101754971|NCT00869908|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101754972|NCT00869908|Insulin Aspart|insulin aspart|mesh-list
101754973|NCT00869908|Insulin, Long-Acting|insulin, long-acting|mesh-list
101754974|NCT00869908|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101754975|NCT00869908|Insulin Detemir|insulin detemir|mesh-list
101754976|NCT00869908|Biphasic Insulins|biphasic insulins|mesh-list
101754977|NCT00869908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101754978|NCT00869908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754979|NCT00739622|Rilpivirine|rilpivirine|mesh-list
101754980|NCT00739622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101754992|NCT00731562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101754993|NCT00731562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754994|NCT00731562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754995|NCT00870142|Amlodipine|amlodipine|mesh-list
101754996|NCT00870142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101754997|NCT00870142|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101754998|NCT00870142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101754999|NCT00870142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755000|NCT00870142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101755001|NCT00870142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755002|NCT00870142|Vasodilator Agents|vasodilator agents|mesh-ancestor
101755003|NCT00870220|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101755004|NCT00870220|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101755005|NCT00870220|Estradiol|estradiol|mesh-list
101755006|NCT00870220|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101755007|NCT00870220|Estrogens|estrogens|mesh-ancestor
101755008|NCT00870220|Hormones|hormones|mesh-ancestor
101755009|NCT00870220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101755010|NCT00870220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755011|NCT00870220|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101755012|NCT00870220|Contraceptive Agents|contraceptive agents|mesh-ancestor
101755013|NCT00870220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101755014|NCT00870220|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101755015|NCT00729768|Cyclosporine|cyclosporine|mesh-list
101755016|NCT00729768|Mycophenolic Acid|mycophenolic acid|mesh-list
101755017|NCT00729768|Cyclosporins|cyclosporins|mesh-list
101755018|NCT00729768|Basiliximab|basiliximab|mesh-list
101755019|NCT00729768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101755020|NCT00729768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755021|NCT00729768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101755022|NCT00729768|Immunologic Factors|immunologic factors|mesh-ancestor
101215221|NCT01472510|Ranibizumab|ranibizumab|mesh-list
101755023|NCT00729768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562912|NCT05746377|Dopamine Agents|dopamine agents|mesh-ancestor
101562913|NCT05746377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101562914|NCT05746377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562915|NCT05725798|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101562916|NCT05725798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101562917|NCT05725798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562918|NCT05725798|Incretins|incretins|mesh-ancestor
101562919|NCT05725798|Hormones|hormones|mesh-ancestor
101411231|NCT00450853|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101411233|NCT00450853|Serotonin Agents|serotonin agents|mesh-ancestor
101755025|NCT00729768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101755026|NCT00729768|Dermatologic Agents|dermatologic agents|mesh-ancestor
101755027|NCT00729768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101755028|NCT00729768|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101755029|NCT00729768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101755030|NCT00729768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101755031|NCT00729768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101755032|NCT00729768|Antitubercular Agents|antitubercular agents|mesh-ancestor
101755033|NCT00729768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101755034|NCT00871156|Chloroquine|chloroquine|mesh-list
101755035|NCT00871156|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
101755036|NCT00871156|Tafenoquine|tafenoquine|mesh-list
101755037|NCT00871156|Amebicides|amebicides|mesh-ancestor
101755038|NCT00871156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101755039|NCT00871156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101755040|NCT00871156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101755041|NCT00871156|Antimalarials|antimalarials|mesh-ancestor
101755042|NCT00871156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101755043|NCT00871156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101529637|NCT05349383|Antineoplastic Agents|antineoplastic agents|mesh-list
101755062|NCT00734526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755063|NCT00734526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101755064|NCT00734526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101755065|NCT00734526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101755066|NCT00729404|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101755067|NCT00729404|Gestodene|gestodene|mesh-list
101755068|NCT00729404|Femovan|femovan|mesh-list
101755069|NCT00729404|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101755070|NCT00729404|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101755071|NCT00729404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101755072|NCT00729404|Contraceptive Agents|contraceptive agents|mesh-ancestor
101755073|NCT00729404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101755074|NCT00729404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755075|NCT00729404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101755076|NCT00729404|Estrogens|estrogens|mesh-ancestor
101755077|NCT00729404|Hormones|hormones|mesh-ancestor
101755078|NCT00729404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101755079|NCT00729404|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101755080|NCT00729404|Progestins|progestins|mesh-ancestor
101755081|NCT00729404|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101755082|NCT00731952|Bortezomib|bortezomib|mesh-list
101755083|NCT00731952|Vorinostat|vorinostat|mesh-list
101755084|NCT00731952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101755085|NCT00731952|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101755086|NCT00731952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101755087|NCT00731952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755088|NCT04065932|Deucravacitinib|deucravacitinib|mesh-list
101755089|NCT04065932|Famotidine|famotidine|mesh-list
101755090|NCT04065932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101755091|NCT04065932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101755092|NCT04065932|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101755093|NCT04065932|Histamine Antagonists|histamine antagonists|mesh-ancestor
101755094|NCT04065932|Histamine Agents|histamine agents|mesh-ancestor
101755095|NCT04065932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101755096|NCT04065932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755097|NCT04065932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562920|NCT05725798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101562921|NCT05725798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101562922|NCT05725798|Protease Inhibitors|protease inhibitors|mesh-ancestor
101562923|NCT05725798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101562924|NCT05725798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562925|NCT05708859|Tirzepatide|tirzepatide|mesh-list
101562926|NCT05708859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101562927|NCT05708859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562928|NCT05708859|Incretins|incretins|mesh-ancestor
101562929|NCT05708859|Hormones|hormones|mesh-ancestor
101411240|NCT00450892|Tubulin Modulators|tubulin modulators|mesh-ancestor
101755098|NCT04065932|Dermatologic Agents|dermatologic agents|mesh-ancestor
101755099|NCT04065932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101755100|NCT04065932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101755101|NCT00740090|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101755102|NCT00740090|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101755103|NCT00740090|Immunologic Factors|immunologic factors|mesh-ancestor
101755104|NCT00740090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755116|NCT00738660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101755117|NCT00740168|Bevacizumab|bevacizumab|mesh-list
101755118|NCT00740168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101755119|NCT00740168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101755120|NCT00740168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101755121|NCT00740168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101755122|NCT00740168|Growth Substances|growth substances|mesh-ancestor
101755123|NCT00740168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755124|NCT00740168|Growth Inhibitors|growth inhibitors|mesh-ancestor
101755125|NCT05225974|Liraglutide|liraglutide|mesh-list
101755126|NCT05225974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101755127|NCT05225974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755128|NCT05225974|Incretins|incretins|mesh-ancestor
101755129|NCT05225974|Hormones|hormones|mesh-ancestor
101755130|NCT05225974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101755131|NCT00729638|Lenalidomide|lenalidomide|mesh-list
101755132|NCT00729638|Everolimus|everolimus|mesh-list
101755133|NCT00729638|Immunologic Factors|immunologic factors|mesh-ancestor
101755134|NCT00729638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755135|NCT00729638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101755136|NCT00729638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101755137|NCT00729638|Growth Substances|growth substances|mesh-ancestor
101755138|NCT00729638|Growth Inhibitors|growth inhibitors|mesh-ancestor
101755139|NCT00729638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101755140|NCT00729638|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101755141|NCT00729638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101755142|NCT00729638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101755143|NCT00729638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755144|NCT00729638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101755145|NCT00734682|Irinotecan|irinotecan|mesh-list
101755146|NCT00734682|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101755147|NCT00734682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101755148|NCT00734682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101755149|NCT00734682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755150|NCT00734682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101755151|NCT00732108|Topiramate|topiramate|mesh-list
101755152|NCT00732108|Lactulose|lactulose|mesh-list
101755153|NCT00732108|Anticonvulsants|anticonvulsants|mesh-ancestor
101755154|NCT00732108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101755155|NCT00732108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755156|NCT00732108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101755157|NCT00876616|Mycophenolic Acid|mycophenolic acid|mesh-list
101755158|NCT00876616|Cyclophosphamide|cyclophosphamide|mesh-list
101755159|NCT00876616|Tacrolimus|tacrolimus|mesh-list
101407297|NCT00106847|Dermatologic Agents|dermatologic agents|mesh-ancestor
101755160|NCT00876616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101755161|NCT00876616|Immunologic Factors|immunologic factors|mesh-ancestor
101755162|NCT00876616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562930|NCT05708859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101562931|NCT05699252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
101562932|NCT05699252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101562933|NCT05699252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562935|NCT05655949|Gemcitabine|gemcitabine|mesh-list
101562936|NCT05655949|Durvalumab|durvalumab|mesh-list
101524880|NCT04659057|Lidocaine|lidocaine|mesh-list
101755163|NCT00876616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101755164|NCT00876616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101755165|NCT00876616|Alkylating Agents|alkylating agents|mesh-ancestor
101755166|NCT00876616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755167|NCT00876616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101755180|NCT00729794|Methylprednisolone|methylprednisolone|mesh-list
101755181|NCT00729794|Hydrocortisone|hydrocortisone|mesh-list
101755182|NCT00729794|Vasopressins|vasopressins|mesh-list
101755183|NCT00729794|Epinephrine|epinephrine|mesh-list
101755184|NCT00729794|Racepinephrine|racepinephrine|mesh-list
101755185|NCT00729794|Epinephryl borate|epinephryl borate|mesh-list
101755186|NCT00729794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101755187|NCT00729794|Antiemetics|antiemetics|mesh-ancestor
101755188|NCT00729794|Autonomic Agents|autonomic agents|mesh-ancestor
101755189|NCT00729794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101755190|NCT00729794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755191|NCT00729794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101755192|NCT00729794|Glucocorticoids|glucocorticoids|mesh-ancestor
101755193|NCT00729794|Hormones|hormones|mesh-ancestor
101755194|NCT00729794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101755195|NCT00729794|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101755196|NCT00729794|Protective Agents|protective agents|mesh-ancestor
101755197|NCT00729794|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101755198|NCT00729794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101755199|NCT00729794|Adrenergic Agents|adrenergic agents|mesh-ancestor
101755200|NCT00729794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101755201|NCT00729794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755202|NCT00729794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101755203|NCT00729794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101755204|NCT00729794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101755205|NCT00729794|Respiratory System Agents|respiratory system agents|mesh-ancestor
101755206|NCT00729794|Mydriatics|mydriatics|mesh-ancestor
101755207|NCT00729794|Sympathomimetics|sympathomimetics|mesh-ancestor
101755208|NCT00729794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101755209|NCT00729794|Hemostatics|hemostatics|mesh-ancestor
101755210|NCT00729794|Coagulants|coagulants|mesh-ancestor
101755211|NCT00729794|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101755212|NCT00729794|Natriuretic Agents|natriuretic agents|mesh-ancestor
101755213|NCT00871546|Bortezomib|bortezomib|mesh-list
101755214|NCT00871546|Alemtuzumab|alemtuzumab|mesh-list
101755215|NCT00871546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101755216|NCT00871546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101755217|NCT03778294|Temozolomide|temozolomide|mesh-list
101755218|NCT03778294|Levodopa|levodopa|mesh-list
101755219|NCT03778294|Fluorides|fluorides|mesh-list
101755220|NCT03778294|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101755221|NCT03778294|Alkylating Agents|alkylating agents|mesh-ancestor
101755222|NCT03778294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755223|NCT03778294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101755224|NCT03778294|Cariostatic Agents|cariostatic agents|mesh-ancestor
101755225|NCT03778294|Protective Agents|protective agents|mesh-ancestor
101755226|NCT03778294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755227|NCT03778294|Dopamine Agents|dopamine agents|mesh-ancestor
101755228|NCT03778294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101755229|NCT03778294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101755230|NCT03778294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101755231|NCT00732186|Ipilimumab|ipilimumab|mesh-list
101755232|NCT00732186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101755233|NCT00732186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101755249|NCT00876772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101755250|NCT00876772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101562937|NCT05655949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101562938|NCT05655949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101562940|NCT05655949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562941|NCT05655949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101562942|NCT05646719|Phentolamine|phentolamine|mesh-list
101562943|NCT05646719|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101562944|NCT05646719|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101562945|NCT05646719|Pilocarpine|pilocarpine|mesh-list
101755251|NCT00876772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101755252|NCT00876772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101755253|NCT00876772|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101755254|NCT00876772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101755255|NCT00876772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101755256|NCT00876772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755257|NCT00876772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101755258|NCT00876772|Serotonin Agents|serotonin agents|mesh-ancestor
101755259|NCT00729950|Ipilimumab|ipilimumab|mesh-list
101755260|NCT00729950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101755261|NCT00729950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101755262|NCT00729950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101755263|NCT00729950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755264|NCT00616018|Acetaminophen|acetaminophen|mesh-list
101755265|NCT00616018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101755266|NCT00616018|Analgesics|analgesics|mesh-ancestor
101755267|NCT00616018|Sensory System Agents|sensory system agents|mesh-ancestor
101755268|NCT00616018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101755269|NCT00616018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755270|NCT00616018|Antipyretics|antipyretics|mesh-ancestor
101755271|NCT00740948|Rituximab|rituximab|mesh-list
101755272|NCT00740948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101755273|NCT00740948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101755274|NCT00740948|Immunologic Factors|immunologic factors|mesh-ancestor
101755275|NCT00740948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755276|NCT00740948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101755277|NCT00876850|Linezolid|linezolid|mesh-list
101755278|NCT00876850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101755279|NCT00876850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101755280|NCT00876850|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101755281|NCT00876850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101755282|NCT00876850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755283|NCT00734916|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101755284|NCT00734916|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101755285|NCT00734916|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101755286|NCT00734916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101755287|NCT05157412|Doxycycline|doxycycline|mesh-list
101755288|NCT05157412|Prednisolone|prednisolone|mesh-list
101755289|NCT05157412|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101755290|NCT05157412|Methylprednisolone|methylprednisolone|mesh-list
101755291|NCT05157412|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101755292|NCT05157412|Prednisolone acetate|prednisolone acetate|mesh-list
101755293|NCT05157412|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101263614|NCT01762787|Hormones|hormones|mesh-ancestor
101755307|NCT05157412|Protective Agents|protective agents|mesh-ancestor
101755308|NCT05157412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101755309|NCT05157412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101755310|NCT05157412|Antimalarials|antimalarials|mesh-ancestor
101755311|NCT05157412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101755312|NCT05157412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101755313|NCT00732420|Topotecan|topotecan|mesh-list
101755314|NCT00732420|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101755315|NCT00732420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101755316|NCT00732420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101755317|NCT00732420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755318|NCT00732420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101562946|NCT05646719|Miotics|miotics|mesh-ancestor
101562947|NCT05646719|Autonomic Agents|autonomic agents|mesh-ancestor
101562948|NCT05646719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101562949|NCT05646719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562950|NCT05646719|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101562951|NCT05646719|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101562952|NCT05646719|Cholinergic Agents|cholinergic agents|mesh-ancestor
101562953|NCT05646719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101755319|NCT00735228|Pancrelipase|pancrelipase|mesh-list
101755320|NCT00735228|Pancreatin|pancreatin|mesh-list
101755321|NCT00735228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101755322|NCT00739128|Vaccines|vaccines|mesh-list
101755323|NCT00739128|Immunologic Factors|immunologic factors|mesh-ancestor
101755324|NCT00739128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755325|NCT00863668|Tenofovir|tenofovir|mesh-list
101755326|NCT00863668|Emtricitabine|emtricitabine|mesh-list
101755327|NCT00863668|Efavirenz|efavirenz|mesh-list
101755328|NCT00863668|Raltegravir Potassium|raltegravir potassium|mesh-list
101755329|NCT00863668|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101755330|NCT00863668|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
101755331|NCT00863668|Integrase Inhibitors|integrase inhibitors|mesh-list
101755332|NCT00863668|Antiviral Agents|antiviral agents|mesh-ancestor
101755333|NCT00863668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101755334|NCT00863668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101755335|NCT00863668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101755336|NCT00863668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755337|NCT00863668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101755338|NCT00863668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101755339|NCT00863668|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101755340|NCT00863668|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101755341|NCT00863668|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101755342|NCT00863668|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101755343|NCT00863668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101755344|NCT00863668|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101755345|NCT00863668|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101755346|NCT00872248|Anesthetics|anesthetics|mesh-list
101755347|NCT00872248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101755348|NCT00872248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755349|NCT00732576|Vitamin K 2|vitamin k 2|mesh-list
101755350|NCT00732576|Vitamin K|vitamin k|mesh-list
101755351|NCT00732576|Menaquinone 7|menaquinone 7|mesh-list
101755352|NCT00732576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101755353|NCT00732576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101755354|NCT00732576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755355|NCT00732576|Hemostatics|hemostatics|mesh-ancestor
101755356|NCT00732576|Coagulants|coagulants|mesh-ancestor
101755372|NCT00732810|Antimetabolites|antimetabolites|mesh-ancestor
101755373|NCT00732810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755374|NCT00732810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101755375|NCT00732810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101755376|NCT00732810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101755377|NCT00732888|Calcium Carbonate|calcium carbonate|mesh-list
101755379|NCT00732888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101755380|NCT00732888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755381|NCT00732888|Antacids|antacids|mesh-ancestor
101755382|NCT00732888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755383|NCT00732888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101755384|NCT00732966|Losartan|losartan|mesh-list
101755385|NCT00732966|Valsartan|valsartan|mesh-list
101755386|NCT00732966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101755387|NCT00732966|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101755388|NCT00732966|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101755389|NCT00732966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755390|NCT00732966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101755391|NCT00735852|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101755392|NCT00735852|Luteolytic Agents|luteolytic agents|mesh-ancestor
101755393|NCT00735852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101562954|NCT05646719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755394|NCT00735852|Contraceptive Agents|contraceptive agents|mesh-ancestor
101755395|NCT00735852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101755396|NCT00735852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755397|NCT00735852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101755398|NCT00735852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101755399|NCT00735852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101412821|NCT00479206|Artesunate|artesunate|mesh-list
101755401|NCT00424021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101755402|NCT00735930|Lenalidomide|lenalidomide|mesh-list
101755403|NCT00735930|Alvocidib|alvocidib|mesh-list
101755404|NCT00735930|Immunologic Factors|immunologic factors|mesh-ancestor
101755405|NCT00735930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755406|NCT00735930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101755407|NCT00735930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101755408|NCT00735930|Growth Substances|growth substances|mesh-ancestor
101755409|NCT00735930|Growth Inhibitors|growth inhibitors|mesh-ancestor
101755410|NCT00735930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101755411|NCT00735930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101755412|NCT00735930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101755413|NCT00735930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755414|NCT00617734|Cetuximab|cetuximab|mesh-list
101755440|NCT00415519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755441|NCT00415519|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101755442|NCT00415519|Protective Agents|protective agents|mesh-ancestor
101755443|NCT00415519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755446|NCT02568176|Esketamine|esketamine|mesh-list
101755447|NCT02568176|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101755448|NCT02568176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101755449|NCT02568176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101755450|NCT02568176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755451|NCT02568176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101755452|NCT02568176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101755453|NCT02568176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101755454|NCT02568176|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101755455|NCT02568176|Anesthetics, General|anesthetics, general|mesh-ancestor
101755456|NCT02568176|Anesthetics|anesthetics|mesh-ancestor
101755457|NCT02568176|GABA Modulators|gaba modulators|mesh-ancestor
101755458|NCT02568176|GABA Agents|gaba agents|mesh-ancestor
101755459|NCT02568176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101755460|NCT02568176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755461|NCT02568176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101755462|NCT02568176|Antidepressive Agents|antidepressive agents|mesh-ancestor
101412887|NCT00119210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101755475|NCT00423943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101755476|NCT00423943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755477|NCT00423943|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101755478|NCT00423943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101755479|NCT00423943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101755480|NCT00423943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755481|NCT00736346|Paroxetine|paroxetine|mesh-list
101755482|NCT00736346|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101755483|NCT00736346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101755484|NCT00736346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101755485|NCT00736346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755486|NCT00736346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101755487|NCT00736346|Serotonin Agents|serotonin agents|mesh-ancestor
101755488|NCT00736346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755489|NCT00736346|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101755490|NCT00736346|Antidepressive Agents|antidepressive agents|mesh-ancestor
101755491|NCT00736346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101755492|NCT00736346|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101755493|NCT00736346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101755494|NCT00736346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101755495|NCT00864058|Gabapentin|gabapentin|mesh-list
101755496|NCT00864058|Analgesics|analgesics|mesh-ancestor
101755497|NCT00864058|Sensory System Agents|sensory system agents|mesh-ancestor
101755498|NCT00864058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101755499|NCT00864058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755500|NCT00864058|Anticonvulsants|anticonvulsants|mesh-ancestor
101562955|NCT05646719|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101562956|NCT05646719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101562957|NCT05646719|Adrenergic Agents|adrenergic agents|mesh-ancestor
101562958|NCT05646719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101562959|NCT05645406|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101562960|NCT05645406|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101562961|NCT05645406|Estradiol|estradiol|mesh-list
101562962|NCT05645406|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101562963|NCT05645406|Estrogens|estrogens|mesh-ancestor
101562964|NCT05645406|Hormones|hormones|mesh-ancestor
101562965|NCT05645406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101755501|NCT00864058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101755502|NCT00864058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101755503|NCT00864058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101755504|NCT00864058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101755505|NCT00864058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101755506|NCT00864058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101755507|NCT00864058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101755508|NCT00864058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755509|NCT00864058|Antimanic Agents|antimanic agents|mesh-ancestor
101755510|NCT00864136|Levonorgestrel|levonorgestrel|mesh-list
101755511|NCT00864136|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101755512|NCT00864136|Contraceptive Agents|contraceptive agents|mesh-ancestor
101755513|NCT00864136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101755514|NCT00864136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755515|NCT00864136|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101755516|NCT00864136|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101755517|NCT00864136|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101755518|NCT00864214|Hormones|hormones|mesh-list
101755519|NCT00864214|Estradiol|estradiol|mesh-list
101530114|NCT00563862|Fluorouracil|fluorouracil|mesh-list
101755545|NCT01324063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101755546|NCT01324063|Antimetabolites|antimetabolites|mesh-ancestor
101755547|NCT01324063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755548|NCT01324063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101755549|NCT01324063|Antiviral Agents|antiviral agents|mesh-ancestor
101755550|NCT01324063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101755551|NCT01324063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101755552|NCT01324063|Immunologic Factors|immunologic factors|mesh-ancestor
101755553|NCT01324063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755554|NCT01324063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101755555|NCT01324063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101755556|NCT01324063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101755557|NCT01324063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101755558|NCT00864448|Ramipril|ramipril|mesh-list
101755559|NCT00864448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101755560|NCT00864448|Protease Inhibitors|protease inhibitors|mesh-ancestor
101755561|NCT00864448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101755562|NCT00864448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755563|NCT00864448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101755564|NCT00406315|Ziprasidone|ziprasidone|mesh-list
101755565|NCT00406315|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101755566|NCT00406315|Serotonin Agents|serotonin agents|mesh-ancestor
101755567|NCT00406315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101755568|NCT00406315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755569|NCT00406315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755581|NCT00872716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101755582|NCT00872716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755584|NCT00864526|Oxycodone|oxycodone|mesh-list
101755585|NCT00864526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101755586|NCT00864526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101755587|NCT00864526|Analgesics|analgesics|mesh-ancestor
101755588|NCT00864526|Sensory System Agents|sensory system agents|mesh-ancestor
101562966|NCT05645406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562967|NCT05645406|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101562968|NCT05645406|Contraceptive Agents|contraceptive agents|mesh-ancestor
101562969|NCT05645406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101755589|NCT00864526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101755590|NCT00864526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755591|NCT00864526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101755592|NCT00864526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101755593|NCT00864526|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101755594|NCT00864526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101755595|NCT00864526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755596|NCT00864526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101755597|NCT00864526|Narcotics|narcotics|mesh-ancestor
101755598|NCT00864526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101755599|NCT00864604|Nabumetone|nabumetone|mesh-list
101755600|NCT00864604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101755601|NCT00864604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101755602|NCT00864604|Analgesics|analgesics|mesh-ancestor
101755603|NCT00864604|Sensory System Agents|sensory system agents|mesh-ancestor
101755604|NCT00864604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101755605|NCT00864604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755606|NCT00864604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101755607|NCT00864604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101755608|NCT00864604|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101755609|NCT00864604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101755610|NCT00864604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101755611|NCT00864604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755612|NCT04064138|Anesthetics|anesthetics|mesh-list
101755613|NCT04064138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101755614|NCT04064138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755615|NCT01323751|Ricolinostat|ricolinostat|mesh-list
101755616|NCT01323751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101755617|NCT01323751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101755618|NCT01323751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101755619|NCT01323751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755620|NCT00711594|Afatinib|afatinib|mesh-list
101755621|NCT00711594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101755622|NCT00711594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101755623|NCT00711594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101755624|NCT00711594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755626|NCT00864760|Analgesics|analgesics|mesh-ancestor
101755627|NCT00864760|Sensory System Agents|sensory system agents|mesh-ancestor
101755628|NCT00864760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101755629|NCT00864760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755630|NCT00864760|Anticonvulsants|anticonvulsants|mesh-ancestor
101755631|NCT00864760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101755632|NCT00864760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101530226|NCT02032277|Antimitotic Agents|antimitotic agents|mesh-ancestor
101755658|NCT00736814|Mitosis Modulators|mitosis modulators|mesh-ancestor
101755659|NCT00736814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101755660|NCT04063904|Misoprostol|misoprostol|mesh-list
101755661|NCT04063904|Mifepristone|mifepristone|mesh-list
101755662|NCT04063904|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101755663|NCT04063904|Abortifacient Agents|abortifacient agents|mesh-ancestor
101755664|NCT04063904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101755665|NCT04063904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755666|NCT04063904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101755667|NCT04063904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101755668|NCT04063904|Oxytocics|oxytocics|mesh-ancestor
101755669|NCT04063904|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101755670|NCT04063904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101755671|NCT04063904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101755672|NCT04063904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101755673|NCT04063904|Contraceptive Agents|contraceptive agents|mesh-ancestor
101755674|NCT04063904|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101755675|NCT04063904|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101755676|NCT04063904|Hormone Antagonists|hormone antagonists|mesh-ancestor
101562970|NCT05645406|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101562972|NCT05645393|Hormones|hormones|mesh-ancestor
101562973|NCT05645393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101562974|NCT05645393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562975|NCT05625594|Cyclophosphamide|cyclophosphamide|mesh-list
101562976|NCT05625594|Fludarabine|fludarabine|mesh-list
101562977|NCT05625594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101562978|NCT05625594|Immunologic Factors|immunologic factors|mesh-ancestor
101562979|NCT05625594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755677|NCT04063904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101755678|NCT04063904|Luteolytic Agents|luteolytic agents|mesh-ancestor
101755679|NCT04063904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101755680|NCT04063904|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101755693|NCT00711516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755696|NCT00864838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101407320|NCT00438841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101755697|NCT00864838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101755698|NCT00864838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101755699|NCT00864838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101755700|NCT00864838|Adrenergic Agents|adrenergic agents|mesh-ancestor
101755701|NCT00864838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101755702|NCT00864838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755703|NCT00864838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755704|NCT00864838|Anticonvulsants|anticonvulsants|mesh-ancestor
101755705|NCT00864838|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101755706|NCT00864838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101755707|NCT00864838|Diuretics|diuretics|mesh-ancestor
101755708|NCT00864838|Natriuretic Agents|natriuretic agents|mesh-ancestor
101755709|NCT04039516|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
101755710|NCT04039516|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101755711|NCT04039516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755712|NCT00615550|Progesterone|progesterone|mesh-list
101755713|NCT00615550|Progestins|progestins|mesh-ancestor
101755714|NCT00615550|Hormones|hormones|mesh-ancestor
101755715|NCT00615550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101755716|NCT00615550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755717|NCT00186888|Cyclophosphamide|cyclophosphamide|mesh-list
101755718|NCT00186888|Carboplatin|carboplatin|mesh-list
101755719|NCT00186888|Doxorubicin|doxorubicin|mesh-list
101755720|NCT00186888|Etoposide|etoposide|mesh-list
101755721|NCT00186888|Etoposide phosphate|etoposide phosphate|mesh-list
101755722|NCT00186888|Vincristine|vincristine|mesh-list
101755723|NCT00186888|Topotecan|topotecan|mesh-list
101755724|NCT00186888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101755725|NCT00186888|Immunologic Factors|immunologic factors|mesh-ancestor
101755726|NCT00186888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755727|NCT00186888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101755728|NCT00186888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101755729|NCT00186888|Alkylating Agents|alkylating agents|mesh-ancestor
101755730|NCT00186888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755731|NCT00186888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101755732|NCT00186888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101755733|NCT00186888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101755734|NCT00186888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101755735|NCT00186888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101755736|NCT00186888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101755737|NCT00186888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101755738|NCT00186888|Tubulin Modulators|tubulin modulators|mesh-ancestor
101755739|NCT00186888|Antimitotic Agents|antimitotic agents|mesh-ancestor
101755740|NCT00186888|Mitosis Modulators|mitosis modulators|mesh-ancestor
101530356|NCT01165138|Xhance|xhance|mesh-list
101755752|NCT00739830|Megestrol Acetate|megestrol acetate|mesh-list
101755753|NCT00739830|Medroxyprogesterone|medroxyprogesterone|mesh-list
101755754|NCT00739830|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101755755|NCT00739830|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101562980|NCT05625594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101562981|NCT05625594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101562982|NCT05625594|Alkylating Agents|alkylating agents|mesh-ancestor
101755756|NCT00739830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101755757|NCT00739830|Contraceptive Agents|contraceptive agents|mesh-ancestor
101755758|NCT00739830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101755759|NCT00739830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755760|NCT00739830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101755761|NCT00739830|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101755762|NCT00739830|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101755763|NCT00739830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101755764|NCT00739830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101755765|NCT00739830|Appetite Stimulants|appetite stimulants|mesh-ancestor
101755766|NCT00739830|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101755767|NCT00739830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101755768|NCT00739830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101755769|NCT00739830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101755770|NCT00739830|Antifungal Agents|antifungal agents|mesh-ancestor
101755771|NCT00739830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101755772|NCT00739830|Immunologic Factors|immunologic factors|mesh-ancestor
101755774|NCT00577382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101755775|NCT00577382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101755776|NCT00577382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101755777|NCT00577382|Growth Substances|growth substances|mesh-ancestor
101755778|NCT00577382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755779|NCT00577382|Growth Inhibitors|growth inhibitors|mesh-ancestor
101755780|NCT00577382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101755781|NCT00577382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101755782|NCT00577382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755783|NCT00733434|Alprostadil|alprostadil|mesh-list
101755784|NCT00733434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101755785|NCT00733434|Vasodilator Agents|vasodilator agents|mesh-ancestor
101755786|NCT00733434|Urological Agents|urological agents|mesh-ancestor
101755787|NCT00736320|Vincristine|vincristine|mesh-list
101755788|NCT00736320|Doxorubicin|doxorubicin|mesh-list
101755789|NCT00736320|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101755790|NCT00736320|Dacarbazine|dacarbazine|mesh-list
101755791|NCT00736320|Bleomycin|bleomycin|mesh-list
101755792|NCT00736320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101755793|NCT00736320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101755794|NCT00736320|Tubulin Modulators|tubulin modulators|mesh-ancestor
101755795|NCT00736320|Antimitotic Agents|antimitotic agents|mesh-ancestor
101755796|NCT00736320|Mitosis Modulators|mitosis modulators|mesh-ancestor
101755797|NCT00736320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755798|NCT00736320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101755799|NCT00736320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101755800|NCT00736320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101755801|NCT00736320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101755802|NCT00736320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101755803|NCT00736320|Alkylating Agents|alkylating agents|mesh-ancestor
101755804|NCT04065282|Capecitabine|capecitabine|mesh-list
101755805|NCT04065282|Oxaliplatin|oxaliplatin|mesh-list
101755814|NCT00873262|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101755816|NCT00873262|Progesterone|progesterone|mesh-list
101755817|NCT00873262|Estrogens|estrogens|mesh-ancestor
101755818|NCT00873262|Hormones|hormones|mesh-ancestor
101755819|NCT00873262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101755820|NCT00873262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755821|NCT00873262|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101755822|NCT00873262|Contraceptive Agents|contraceptive agents|mesh-ancestor
101755823|NCT00873262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101755824|NCT00873262|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101755825|NCT00873262|Progestins|progestins|mesh-ancestor
101755826|NCT00739986|Semapimod|semapimod|mesh-list
101755827|NCT00739986|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101755828|NCT00739986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101755829|NCT00739986|Analgesics|analgesics|mesh-ancestor
101755830|NCT00739986|Sensory System Agents|sensory system agents|mesh-ancestor
101755831|NCT00739986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101755832|NCT00739986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562983|NCT05625594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562984|NCT05625594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101562985|NCT05625594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101562986|NCT05618301|Natalizumab|natalizumab|mesh-list
101562987|NCT05618301|Immunologic Factors|immunologic factors|mesh-ancestor
101562988|NCT05618301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562989|NCT05617625|Fludarabine|fludarabine|mesh-list
101562990|NCT05617625|Melphalan|melphalan|mesh-list
101562991|NCT05617625|Busulfan|busulfan|mesh-list
101562992|NCT05617625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101411303|NCT00458731|Cediranib|cediranib|mesh-list
101755833|NCT00739986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101755834|NCT00739986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101755835|NCT00739986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101755836|NCT00739986|Immunologic Factors|immunologic factors|mesh-ancestor
101755837|NCT00736970|Sirolimus|sirolimus|mesh-list
101755838|NCT00736970|Trastuzumab|trastuzumab|mesh-list
101755839|NCT00736970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101755840|NCT00736970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101755841|NCT00736970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101755842|NCT00736970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101755843|NCT00736970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101413334|NCT00482716|Iron|iron|mesh-list
101755844|NCT00736970|Antifungal Agents|antifungal agents|mesh-ancestor
101755845|NCT00736970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101755846|NCT00736970|Immunologic Factors|immunologic factors|mesh-ancestor
101755847|NCT00736970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755849|NCT00873340|Interferon beta-1b|interferon beta-1b|mesh-list
101755850|NCT00873340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101755851|NCT00873340|Antiviral Agents|antiviral agents|mesh-ancestor
101755852|NCT00873340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101755853|NCT00873340|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101755854|NCT00873340|Immunologic Factors|immunologic factors|mesh-ancestor
101755855|NCT00873340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755856|NCT00740064|Lamivudine|lamivudine|mesh-list
101755857|NCT00740064|Abacavir|abacavir|mesh-list
101755858|NCT00740064|Raltegravir Potassium|raltegravir potassium|mesh-list
101755859|NCT00740064|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101755860|NCT00740064|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101755861|NCT00740064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101755862|NCT00740064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755863|NCT00740064|Antiviral Agents|antiviral agents|mesh-ancestor
101755864|NCT00740064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101755865|NCT00740064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101755866|NCT00740064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101755867|NCT00740064|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101755868|NCT00740064|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101755869|NCT00614926|Modafinil|modafinil|mesh-list
101755870|NCT00614926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101755871|NCT00614926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755872|NCT00614926|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101530464|NCT01164475|Lenograstim|lenograstim|mesh-list
101755885|NCT00879892|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101755886|NCT00879892|Anesthetics, General|anesthetics, general|mesh-ancestor
101755888|NCT00879892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101755889|NCT00879892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755890|NCT00740142|Lactulose|lactulose|mesh-list
101755891|NCT00740142|N-Methylaspartate|n-methylaspartate|mesh-list
101755892|NCT00740142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101755893|NCT00740142|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
101755894|NCT00740142|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101755895|NCT00740142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101755896|NCT00740142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755897|NCT00740142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755898|NCT00873652|Vaccines|vaccines|mesh-list
101755899|NCT00873652|Immunologic Factors|immunologic factors|mesh-ancestor
101755900|NCT00873652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562993|NCT05617625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101562994|NCT05617625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101562995|NCT05617625|Immunologic Factors|immunologic factors|mesh-ancestor
101562996|NCT05617625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101562997|NCT05617625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101562998|NCT05617625|Alkylating Agents|alkylating agents|mesh-ancestor
101562999|NCT05617625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101563000|NCT05612074|Nitric Oxide|nitric oxide|mesh-list
101563001|NCT05612074|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101563002|NCT05612074|Autonomic Agents|autonomic agents|mesh-ancestor
101563003|NCT05612074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101563004|NCT05612074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563005|NCT05612074|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101563006|NCT05612074|Respiratory System Agents|respiratory system agents|mesh-ancestor
101563007|NCT05612074|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101563008|NCT05612074|Antioxidants|antioxidants|mesh-ancestor
101563009|NCT05612074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563010|NCT05612074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101563011|NCT05612074|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101563036|NCT05581589|Camptothecin|camptothecin|mesh-list
101563038|NCT05581589|Immunoconjugates|immunoconjugates|mesh-list
101563039|NCT05581589|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
101563040|NCT05581589|Immunologic Factors|immunologic factors|mesh-ancestor
101563041|NCT05581589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563042|NCT05581589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101563043|NCT05581589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563044|NCT05581589|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101755901|NCT00423319|Enoxaparin|enoxaparin|mesh-list
101755902|NCT00423319|Enoxaparin sodium|enoxaparin sodium|mesh-list
101755903|NCT00423319|Apixaban|apixaban|mesh-list
101755904|NCT00423319|Anticoagulants|anticoagulants|mesh-ancestor
101755905|NCT00423319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101755906|NCT00423319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101755907|NCT00423319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755908|NCT00423319|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101755909|NCT00423319|Antithrombins|antithrombins|mesh-ancestor
101755910|NCT00423319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101755911|NCT00423319|Protease Inhibitors|protease inhibitors|mesh-ancestor
101755912|NCT00423319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101755913|NCT05224492|Sulforaphane|sulforaphane|mesh-list
101755914|NCT05224492|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101563045|NCT05581589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101563046|NCT05581589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101563047|NCT05581589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563048|NCT05565105|Cyclophosphamide|cyclophosphamide|mesh-list
101563049|NCT05565105|Melphalan|melphalan|mesh-list
101563050|NCT05565105|Busulfan|busulfan|mesh-list
101563051|NCT05565105|Thiotepa|thiotepa|mesh-list
101563052|NCT05565105|Fludarabine|fludarabine|mesh-list
101563053|NCT05565105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101411345|NCT00115583|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101755915|NCT05224492|Protective Agents|protective agents|mesh-ancestor
101755916|NCT05224492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755917|NCT05224492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101755918|NCT00733668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101755919|NCT00733668|Antidepressive Agents|antidepressive agents|mesh-ancestor
101755920|NCT00733668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101755921|NCT00733668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101755922|NCT00733668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101755923|NCT00733668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101755924|NCT00733668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755926|NCT04039126|Cadexomer iodine|cadexomer iodine|mesh-list
101755927|NCT04039126|Povidone-Iodine|povidone-iodine|mesh-list
101755928|NCT04039126|Tetracycline|tetracycline|mesh-list
101755929|NCT04039126|Povidone|povidone|mesh-list
101755930|NCT04039126|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101755931|NCT04039126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101755932|NCT04039126|Trace Elements|trace elements|mesh-ancestor
101755933|NCT04039126|Micronutrients|micronutrients|mesh-ancestor
101755934|NCT04039126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755935|NCT04039126|Plasma Substitutes|plasma substitutes|mesh-ancestor
101755936|NCT04039126|Blood Substitutes|blood substitutes|mesh-ancestor
101755937|NCT04039126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101530530|NCT04629846|Antimitotic Agents|antimitotic agents|mesh-ancestor
101755955|NCT04064190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101755956|NCT04064190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101755957|NCT04064190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101755958|NCT04064190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101755959|NCT04064190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755961|NCT00873886|Antiviral Agents|antiviral agents|mesh-ancestor
101755962|NCT00873886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101755963|NCT00873886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101755964|NCT00873886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755965|NCT00880282|Sirolimus|sirolimus|mesh-list
101755966|NCT00880282|Temsirolimus|temsirolimus|mesh-list
101755967|NCT00880282|MTOR Inhibitors|mtor inhibitors|mesh-list
101755968|NCT00880282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101755969|NCT00880282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101755970|NCT00880282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101755971|NCT00880282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755972|NCT00880282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101755973|NCT00880282|Immunologic Factors|immunologic factors|mesh-ancestor
101755974|NCT00880282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755975|NCT00880282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101755976|NCT00880282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101755977|NCT00880282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101755978|NCT00880282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101755979|NCT00880282|Antifungal Agents|antifungal agents|mesh-ancestor
101755980|NCT00879268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101755981|NCT00874042|Gemcitabine|gemcitabine|mesh-list
101755982|NCT00874042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101755983|NCT00874042|Antimetabolites|antimetabolites|mesh-ancestor
101755984|NCT00874042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755985|NCT00874042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101755986|NCT00736866|Acetylcysteine|acetylcysteine|mesh-list
101755987|NCT00736866|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101755988|NCT00736866|Antiviral Agents|antiviral agents|mesh-ancestor
101755989|NCT00736866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101563054|NCT05565105|Immunologic Factors|immunologic factors|mesh-ancestor
101563055|NCT05565105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563056|NCT05565105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101563057|NCT05565105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101563058|NCT05565105|Alkylating Agents|alkylating agents|mesh-ancestor
101563059|NCT05565105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411356|NCT00115622|Dermatologic Agents|dermatologic agents|mesh-ancestor
101755990|NCT00736866|Expectorants|expectorants|mesh-ancestor
101755991|NCT00736866|Respiratory System Agents|respiratory system agents|mesh-ancestor
101755992|NCT00736866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101755993|NCT00736866|Antioxidants|antioxidants|mesh-ancestor
101755994|NCT00736866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755995|NCT00736866|Protective Agents|protective agents|mesh-ancestor
101755996|NCT00736866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756028|NCT00713544|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
101756031|NCT00713544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101756033|NCT00713544|Sensory System Agents|sensory system agents|mesh-ancestor
101756034|NCT00713544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101756035|NCT00713544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756036|NCT00713544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101756037|NCT00713544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101530653|NCT04609254|Ibuprofen|ibuprofen|mesh-list
101756048|NCT00737126|Hematinics|hematinics|mesh-ancestor
101756049|NCT00737126|Vitamin B Complex|vitamin b complex|mesh-ancestor
101756051|NCT00737126|Micronutrients|micronutrients|mesh-ancestor
101756052|NCT00737126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756053|NCT04063046|Anesthetics|anesthetics|mesh-list
101756054|NCT04063046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101756055|NCT04063046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756056|NCT05529056|Atropine|atropine|mesh-list
101756057|NCT05529056|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101756058|NCT05529056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101756059|NCT05529056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101756060|NCT05529056|Autonomic Agents|autonomic agents|mesh-ancestor
101756061|NCT05529056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101756062|NCT05529056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756063|NCT05529056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101756064|NCT05529056|Respiratory System Agents|respiratory system agents|mesh-ancestor
101756065|NCT05529056|Mydriatics|mydriatics|mesh-ancestor
101756066|NCT05529056|Parasympatholytics|parasympatholytics|mesh-ancestor
101756067|NCT05529056|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101756068|NCT05529056|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101413487|NCT00483964|Olanzapine|olanzapine|mesh-list
101756069|NCT05529056|Cholinergic Agents|cholinergic agents|mesh-ancestor
101756070|NCT05529056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101756071|NCT05529056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756072|NCT00740922|Becaplermin|becaplermin|mesh-list
101756073|NCT00740922|Anticoagulants|anticoagulants|mesh-ancestor
101756074|NCT00740922|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
101756075|NCT00740922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101756076|NCT00740922|Growth Substances|growth substances|mesh-ancestor
101756077|NCT00740922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756078|NCT05523440|Bevacizumab|bevacizumab|mesh-list
101756079|NCT05523440|Niraparib|niraparib|mesh-list
101756080|NCT05523440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101756081|NCT05523440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101756082|NCT05523440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101756083|NCT05523440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101756084|NCT05523440|Growth Substances|growth substances|mesh-ancestor
101756085|NCT05523440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756086|NCT05523440|Growth Inhibitors|growth inhibitors|mesh-ancestor
101756087|NCT05523440|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101756088|NCT05523440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101756089|NCT05523440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756090|NCT00741078|Amlodipine|amlodipine|mesh-list
101563060|NCT05565105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563061|NCT05565105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101563084|NCT05556512|Tirzepatide|tirzepatide|mesh-list
101563085|NCT05556512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101563086|NCT05556512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563087|NCT05556512|Incretins|incretins|mesh-ancestor
101563088|NCT05556512|Hormones|hormones|mesh-ancestor
101756091|NCT00741078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101756092|NCT00741078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101756093|NCT00741078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101756094|NCT00741078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756095|NCT00741078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101756096|NCT00741078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756097|NCT00741078|Vasodilator Agents|vasodilator agents|mesh-ancestor
101756098|NCT02568800|Cefepime|cefepime|mesh-list
101756099|NCT02568800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101756100|NCT02568800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101756101|NCT00741234|Azacitidine|azacitidine|mesh-list
101756112|NCT00713258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101756113|NCT00713258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101756114|NCT00710034|Nicotine|nicotine|mesh-list
101756115|NCT00710034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101756116|NCT00710034|Autonomic Agents|autonomic agents|mesh-ancestor
101756117|NCT00710034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101756118|NCT00710034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756119|NCT00710034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101756120|NCT00710034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101756121|NCT00710034|Cholinergic Agents|cholinergic agents|mesh-ancestor
101756122|NCT00710034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101756123|NCT00710034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756124|NCT02567942|Propofol|propofol|mesh-list
101756125|NCT02567942|Sevoflurane|sevoflurane|mesh-list
101756126|NCT02567942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101756127|NCT02567942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101756128|NCT02567942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756129|NCT02567942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101756130|NCT02567942|Anesthetics, General|anesthetics, general|mesh-ancestor
101756131|NCT02567942|Anesthetics|anesthetics|mesh-ancestor
101756132|NCT02567942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101756133|NCT02567942|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101756134|NCT00414973|Teriparatide|teriparatide|mesh-list
101756135|NCT00414973|Calcitonin|calcitonin|mesh-list
101756136|NCT00414973|Salmon calcitonin|salmon calcitonin|mesh-list
101756137|NCT00414973|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
101756138|NCT00414973|Katacalcin|katacalcin|mesh-list
101756139|NCT00414973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101756140|NCT00414973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756141|NCT00414973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101756142|NCT00414973|Vasodilator Agents|vasodilator agents|mesh-ancestor
101756143|NCT00423085|Rivastigmine|rivastigmine|mesh-list
101413559|NCT00484237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101756144|NCT00423085|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101756145|NCT00423085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101756146|NCT00423085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756147|NCT00423085|Cholinergic Agents|cholinergic agents|mesh-ancestor
101756148|NCT00423085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101756149|NCT00423085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756150|NCT00423085|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101756151|NCT00423085|Protective Agents|protective agents|mesh-ancestor
101756152|NCT00414661|Tofacitinib|tofacitinib|mesh-list
101756153|NCT00414661|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101756154|NCT00414661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101756155|NCT00414661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101756156|NCT00414661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756157|NCT01608451|Cholecalciferol|cholecalciferol|mesh-list
101756159|NCT01608451|Progesterone|progesterone|mesh-list
101756160|NCT01608451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101756161|NCT01608451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756162|NCT01608451|Vitamins|vitamins|mesh-ancestor
101563089|NCT05556512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101563090|NCT05554367|Palbociclib|palbociclib|mesh-list
101563091|NCT05554367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563092|NCT05554367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101563093|NCT05554367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101563094|NCT05554367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756163|NCT01608451|Micronutrients|micronutrients|mesh-ancestor
101756164|NCT01608451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101756181|NCT00708708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101756182|NCT00708708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101756183|NCT00708708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101756184|NCT00708708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101756185|NCT00708708|Immunologic Factors|immunologic factors|mesh-ancestor
101756188|NCT00404755|Escitalopram|escitalopram|mesh-list
101756189|NCT00404755|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101756190|NCT00404755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101756191|NCT00404755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101756192|NCT00404755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756193|NCT00404755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101756194|NCT00404755|Serotonin Agents|serotonin agents|mesh-ancestor
101756195|NCT00404755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756196|NCT00404755|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101756197|NCT00404755|Antidepressive Agents|antidepressive agents|mesh-ancestor
101756198|NCT00404755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101756199|NCT00404755|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101756200|NCT00404755|Dopamine Agents|dopamine agents|mesh-ancestor
101756201|NCT00404755|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101756202|NCT00404755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101756203|NCT00404755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101756204|NCT00404755|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101756205|NCT00404755|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101756206|NCT00404755|Adrenergic Agents|adrenergic agents|mesh-ancestor
101756207|NCT03904381|Fluorouracil|fluorouracil|mesh-list
101756208|NCT03904381|Antimetabolites|antimetabolites|mesh-ancestor
101756209|NCT03904381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756210|NCT03904381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101756211|NCT03904381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101756212|NCT03904381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101756213|NCT03904381|Immunologic Factors|immunologic factors|mesh-ancestor
101756214|NCT03904381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756215|NCT00737256|Aripiprazole|aripiprazole|mesh-list
101756216|NCT00737256|Perphenazine|perphenazine|mesh-list
101756217|NCT00737256|Antidepressive Agents|antidepressive agents|mesh-ancestor
101756219|NCT00737256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101756220|NCT00737256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101756221|NCT00737256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101756222|NCT00737256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756223|NCT00737256|Dopamine Agonists|dopamine agonists|mesh-ancestor
101756232|NCT00737256|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101756233|NCT00737256|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101756234|NCT00614614|Vaccines|vaccines|mesh-list
101756235|NCT00614614|Immunologic Factors|immunologic factors|mesh-ancestor
101756236|NCT00614614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756237|NCT00713310|Mesalamine|mesalamine|mesh-list
101756238|NCT00713310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101756239|NCT00713310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101756240|NCT00713310|Analgesics|analgesics|mesh-ancestor
101756241|NCT00713310|Sensory System Agents|sensory system agents|mesh-ancestor
101756242|NCT00713310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101756243|NCT00713310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756244|NCT00713310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101756245|NCT00713310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101756246|NCT05740488|Hormones|hormones|mesh-list
101756247|NCT05740488|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101756248|NCT05740488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101563095|NCT05549778|Polaprezinc|polaprezinc|mesh-list
101563096|NCT05549778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101563097|NCT05549778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101563098|NCT05513924|Fluorouracil|fluorouracil|mesh-list
101563099|NCT05513924|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101563100|NCT05513924|Latanoprost|latanoprost|mesh-list
101563101|NCT05513924|Antimetabolites|antimetabolites|mesh-ancestor
101411376|NCT00401804|Dexamethasone|dexamethasone|mesh-list
101756249|NCT05740488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756250|NCT05742126|Heparin|heparin|mesh-list
101756251|NCT05742126|Calcium heparin|calcium heparin|mesh-list
101756252|NCT05742126|Anticoagulants|anticoagulants|mesh-ancestor
101756253|NCT05742126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101756254|NCT05742126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101756255|NCT05742126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756256|NCT00882856|Bisoprolol|bisoprolol|mesh-list
101756257|NCT00882856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101756258|NCT00882856|Sympatholytics|sympatholytics|mesh-ancestor
101756259|NCT00882856|Autonomic Agents|autonomic agents|mesh-ancestor
101756260|NCT00882856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101756261|NCT00882856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756262|NCT00882856|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101756263|NCT00882856|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101756264|NCT00882856|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101756265|NCT00882856|Adrenergic Agents|adrenergic agents|mesh-ancestor
101756266|NCT00882856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101756267|NCT00882856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756268|NCT00880672|Dutasteride|dutasteride|mesh-list
101756269|NCT00880672|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101756270|NCT00880672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101756271|NCT00880672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101756272|NCT00880672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756273|NCT00880672|Hormone Antagonists|hormone antagonists|mesh-ancestor
101756274|NCT00880672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101756275|NCT00880672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756276|NCT00737724|Efavirenz|efavirenz|mesh-list
101756277|NCT00737724|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101756278|NCT00737724|Isoniazid|isoniazid|mesh-list
101756279|NCT00737724|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101756280|NCT00737724|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101756281|NCT00737724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101756282|NCT00737724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756283|NCT00737724|Antiviral Agents|antiviral agents|mesh-ancestor
101756284|NCT00737724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101756285|NCT00737724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101756286|NCT00737724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101756312|NCT00712920|Respiratory System Agents|respiratory system agents|mesh-ancestor
101756313|NCT00712920|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101756314|NCT00712920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101756315|NCT00712920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756316|NCT00712920|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101756317|NCT00712920|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101756318|NCT00712920|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101756319|NCT00712920|Histamine Antagonists|histamine antagonists|mesh-ancestor
101756320|NCT00712920|Histamine Agents|histamine agents|mesh-ancestor
101756321|NCT00712920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101756323|NCT00874744|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101756324|NCT00874744|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101756325|NCT00874744|Bevacizumab|bevacizumab|mesh-list
101756326|NCT00874744|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101756327|NCT00874744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101756328|NCT00874744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101756329|NCT00874744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101756330|NCT00874744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101756331|NCT00874744|Growth Substances|growth substances|mesh-ancestor
101756332|NCT00874744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563102|NCT05513924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563103|NCT05513924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101563104|NCT05513924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563105|NCT05513924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101563106|NCT05513924|Immunologic Factors|immunologic factors|mesh-ancestor
101563107|NCT05513924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563108|NCT05513924|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101563110|NCT05505630|Dexmedetomidine|dexmedetomidine|mesh-list
101756333|NCT00874744|Growth Inhibitors|growth inhibitors|mesh-ancestor
101756337|NCT00874744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101756339|NCT00874744|Immunologic Factors|immunologic factors|mesh-ancestor
101756340|NCT00874744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101756341|NCT00874744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756342|NCT05736744|Magnesium Sulfate|magnesium sulfate|mesh-list
101756343|NCT05736744|Bromides|bromides|mesh-list
101756344|NCT05736744|Rocuronium|rocuronium|mesh-list
101756345|NCT05736744|Atracurium|atracurium|mesh-list
101756346|NCT05736744|Cisatracurium|cisatracurium|mesh-list
101756347|NCT05736744|Anticonvulsants|anticonvulsants|mesh-ancestor
101756348|NCT05736744|Analgesics|analgesics|mesh-ancestor
101756349|NCT05736744|Sensory System Agents|sensory system agents|mesh-ancestor
101756350|NCT05736744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101756351|NCT05736744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756352|NCT05736744|Anesthetics|anesthetics|mesh-ancestor
101756353|NCT05736744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101756354|NCT05736744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101756355|NCT05736744|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101756356|NCT05736744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101756357|NCT05736744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756358|NCT05736744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101756359|NCT05736744|Tocolytic Agents|tocolytic agents|mesh-ancestor
101756360|NCT05736744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101407388|NCT00439504|Cholinergic Agents|cholinergic agents|mesh-ancestor
101756361|NCT05736744|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101756362|NCT05736744|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101756363|NCT05736744|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101756364|NCT05736744|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101756365|NCT05736744|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101756366|NCT05736744|Cholinergic Agents|cholinergic agents|mesh-ancestor
101756367|NCT05736744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101756368|NCT00920868|Bevacizumab|bevacizumab|mesh-list
101756369|NCT00920868|Capecitabine|capecitabine|mesh-list
101756370|NCT00920868|Oxaliplatin|oxaliplatin|mesh-list
101756371|NCT00920868|Dasatinib|dasatinib|mesh-list
101756372|NCT00920868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101756373|NCT00920868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101756374|NCT00920868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101756375|NCT00920868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101756376|NCT00920868|Growth Substances|growth substances|mesh-ancestor
101756377|NCT00920868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756378|NCT00920868|Growth Inhibitors|growth inhibitors|mesh-ancestor
101756379|NCT00920868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101756380|NCT00920868|Antimetabolites|antimetabolites|mesh-ancestor
101756381|NCT00920868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756382|NCT00920868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101756383|NCT00920868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101756384|NCT05741814|Propofol|propofol|mesh-list
101756385|NCT05741814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101756386|NCT05741814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101756387|NCT05741814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756388|NCT05741814|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101756390|NCT05741814|Anesthetics|anesthetics|mesh-ancestor
101756391|NCT04721626|Chlorhexidine|chlorhexidine|mesh-list
101756392|NCT04721626|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101756393|NCT04721626|Povidone-Iodine|povidone-iodine|mesh-list
101756394|NCT04721626|Tetracycline|tetracycline|mesh-list
101756395|NCT04721626|Doxycycline|doxycycline|mesh-list
101756396|NCT04721626|Povidone|povidone|mesh-list
101563112|NCT05505630|Anesthetics, Dissociative|anesthetics, dissociative|mesh-list
101563113|NCT05505630|Anesthetics|anesthetics|mesh-list
101563114|NCT05505630|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101563115|NCT05505630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101563116|NCT05505630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563117|NCT05505630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101563118|NCT05505630|Analgesics|analgesics|mesh-ancestor
101411388|NCT00401804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101756397|NCT04721626|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101756398|NCT04721626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101756399|NCT04721626|Disinfectants|disinfectants|mesh-ancestor
101756400|NCT04721626|Dermatologic Agents|dermatologic agents|mesh-ancestor
101756401|NCT04721626|Plasma Substitutes|plasma substitutes|mesh-ancestor
101756402|NCT04721626|Blood Substitutes|blood substitutes|mesh-ancestor
101756403|NCT04721626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101756404|NCT04721626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101756405|NCT04721626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101756406|NCT04721626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756407|NCT04721626|Antimalarials|antimalarials|mesh-ancestor
101756435|NCT00874978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756436|NCT00874978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101756437|NCT00874978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101756438|NCT00874978|Growth Substances|growth substances|mesh-ancestor
101756439|NCT00874978|Growth Inhibitors|growth inhibitors|mesh-ancestor
101756440|NCT00874978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101756442|NCT00737880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101756443|NCT05728632|Nebivolol|nebivolol|mesh-list
101756444|NCT05728632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101756445|NCT05728632|Vasodilator Agents|vasodilator agents|mesh-ancestor
101756446|NCT05728632|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101756447|NCT05728632|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101756448|NCT05728632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101756449|NCT05728632|Adrenergic Agents|adrenergic agents|mesh-ancestor
101756450|NCT05728632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101756451|NCT05728632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756452|NCT05728632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756453|NCT00612586|Leucovorin|leucovorin|mesh-list
101756477|NCT00614380|Telmisartan|telmisartan|mesh-list
101756478|NCT00614380|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
101756479|NCT00614380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101195208|NCT05334472|Ofatumumab|ofatumumab|mesh-list
101756480|NCT00614380|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101756481|NCT00614380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101756482|NCT00614380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756483|NCT00614380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101756484|NCT00614380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756485|NCT00614380|Vasodilator Agents|vasodilator agents|mesh-ancestor
101756486|NCT00614380|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101756487|NCT00614380|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101756489|NCT00738192|Sufentanil|sufentanil|mesh-list
101756490|NCT00738192|Dsuvia|dsuvia|mesh-list
101756491|NCT00738192|Butorphanol|butorphanol|mesh-list
101756492|NCT00738192|Citric Acid|citric acid|mesh-list
101756493|NCT00738192|Sodium Citrate|sodium citrate|mesh-list
101756494|NCT00738192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101756495|NCT00738192|Narcotics|narcotics|mesh-ancestor
101756496|NCT00738192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101756497|NCT00738192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756498|NCT00738192|Analgesics|analgesics|mesh-ancestor
101756499|NCT00738192|Sensory System Agents|sensory system agents|mesh-ancestor
101756500|NCT00738192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101756501|NCT00738192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101756502|NCT00738192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101756503|NCT00738192|Anesthetics, General|anesthetics, general|mesh-ancestor
101756504|NCT00738192|Anesthetics|anesthetics|mesh-ancestor
101756505|NCT00738192|Anticoagulants|anticoagulants|mesh-ancestor
101756506|NCT00738192|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101563119|NCT05505630|Sensory System Agents|sensory system agents|mesh-ancestor
101563120|NCT05505630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101563121|NCT05505630|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101563122|NCT05505630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101563124|NCT05505630|Adrenergic Agents|adrenergic agents|mesh-ancestor
101563125|NCT05505630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101563126|NCT05505630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563127|NCT05505630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101563128|NCT05505630|Anesthetics, General|anesthetics, general|mesh-ancestor
101563129|NCT05505630|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101563130|NCT05505630|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101756507|NCT00738192|Chelating Agents|chelating agents|mesh-ancestor
101756508|NCT00738192|Sequestering Agents|sequestering agents|mesh-ancestor
101451745|NCT00203099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101756522|NCT05500170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756523|NCT05500170|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101756524|NCT05500170|Vasodilator Agents|vasodilator agents|mesh-ancestor
101756525|NCT00884104|Solifenacin Succinate|solifenacin succinate|mesh-list
101756526|NCT00884104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101756527|NCT00884104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101756528|NCT00884104|Cholinergic Agents|cholinergic agents|mesh-ancestor
101756529|NCT00884104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101756530|NCT00884104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756531|NCT00884104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756532|NCT00884104|Urological Agents|urological agents|mesh-ancestor
101756533|NCT04140214|Carbocysteine|carbocysteine|mesh-list
101756534|NCT04140214|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101756535|NCT04140214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101756536|NCT04140214|Expectorants|expectorants|mesh-ancestor
101756537|NCT04140214|Respiratory System Agents|respiratory system agents|mesh-ancestor
101756538|NCT00612508|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101756539|NCT00612508|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101756540|NCT00612508|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101756541|NCT00612508|Etonogestrel|etonogestrel|mesh-list
101756542|NCT00612508|Desogestrel|desogestrel|mesh-list
101756543|NCT00612508|NuvaRing|nuvaring|mesh-list
101756544|NCT00612508|Estradiol|estradiol|mesh-list
101756545|NCT00612508|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101756546|NCT00612508|Estrogens|estrogens|mesh-ancestor
101756547|NCT00612508|Hormones|hormones|mesh-ancestor
101756548|NCT00612508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101756549|NCT00612508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756550|NCT00612508|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101756551|NCT00612508|Contraceptive Agents|contraceptive agents|mesh-ancestor
101756552|NCT00612508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101756553|NCT00612508|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101756554|NCT00612508|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101756555|NCT00612508|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101756556|NCT00612508|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101756557|NCT00612508|Progestins|progestins|mesh-ancestor
101756558|NCT00881218|Regadenoson|regadenoson|mesh-list
101756559|NCT00881218|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
101756560|NCT00881218|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101756561|NCT00881218|Purinergic Agonists|purinergic agonists|mesh-ancestor
101756562|NCT00881218|Purinergic Agents|purinergic agents|mesh-ancestor
101756563|NCT00881218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101756564|NCT00881218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756565|NCT00881218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756566|NCT00613834|Lidocaine|lidocaine|mesh-list
101756567|NCT00613834|Anesthetics, Local|anesthetics, local|mesh-ancestor
101756568|NCT00613834|Anesthetics|anesthetics|mesh-ancestor
101563131|NCT05505630|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101563132|NCT05505630|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101563133|NCT05505630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101563134|NCT05505630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101563135|NCT05505630|GABA Modulators|gaba modulators|mesh-ancestor
101563136|NCT05505630|GABA Agents|gaba agents|mesh-ancestor
101563137|NCT05473715|Aflibercept|aflibercept|mesh-list
101563138|NCT05473715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101563139|NCT05473715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101563140|NCT05473715|Growth Substances|growth substances|mesh-ancestor
101563141|NCT05473715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563142|NCT05473715|Growth Inhibitors|growth inhibitors|mesh-ancestor
101756569|NCT00613834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101756570|NCT00613834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756571|NCT00613834|Sensory System Agents|sensory system agents|mesh-ancestor
101756572|NCT00613834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101756578|NCT00875368|Maraviroc|maraviroc|mesh-list
101756579|NCT00875368|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101756580|NCT00875368|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101756581|NCT00875368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756582|NCT00875368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101756583|NCT00875368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101756584|NCT00875368|Antiviral Agents|antiviral agents|mesh-ancestor
101756585|NCT00875368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101756586|NCT00875368|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101756587|NCT03912298|Analgesics, Opioid|analgesics, opioid|mesh-list
101756588|NCT03912298|Narcotics|narcotics|mesh-ancestor
101756589|NCT03912298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101756590|NCT03912298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756591|NCT03912298|Analgesics|analgesics|mesh-ancestor
101756592|NCT03912298|Sensory System Agents|sensory system agents|mesh-ancestor
101756593|NCT03912298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101756594|NCT02543710|Taxane|taxane|mesh-list
101756595|NCT02543710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101756596|NCT00884260|Levonorgestrel|levonorgestrel|mesh-list
101756597|NCT00884260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101756598|NCT00884260|Contraceptive Agents|contraceptive agents|mesh-ancestor
101756599|NCT00884260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101756600|NCT00884260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756601|NCT00884260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101756602|NCT00884260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101756603|NCT00884260|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101756604|NCT00881296|Carboplatin|carboplatin|mesh-list
101756605|NCT00881296|Gemcitabine|gemcitabine|mesh-list
101756606|NCT00881296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101756607|NCT00881296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101756608|NCT00881296|Antimetabolites|antimetabolites|mesh-ancestor
101263647|NCT01762891|Rofecoxib|rofecoxib|mesh-list
101756609|NCT00881296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756610|NCT00613366|Misoprostol|misoprostol|mesh-list
101756611|NCT00613366|Magnesium Oxide|magnesium oxide|mesh-list
101756612|NCT00613366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101756613|NCT00613366|Abortifacient Agents|abortifacient agents|mesh-ancestor
101756614|NCT00613366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101756615|NCT00613366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756616|NCT00613366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101756617|NCT00613366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101756618|NCT00613366|Oxytocics|oxytocics|mesh-ancestor
101756619|NCT00613366|Antacids|antacids|mesh-ancestor
101756620|NCT00613366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756621|NCT00612352|Ethanol|ethanol|mesh-list
101756622|NCT00612352|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101756623|NCT00612352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101756624|NCT00612352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101563143|NCT05473715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563144|NCT05444777|Ketamine|ketamine|mesh-list
101563145|NCT05444777|Analgesics|analgesics|mesh-ancestor
101563146|NCT05444777|Sensory System Agents|sensory system agents|mesh-ancestor
101563147|NCT05444777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101563148|NCT05444777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563149|NCT05444777|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101563150|NCT05444777|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101756625|NCT00612352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756626|NCT00884416|Sorafenib|sorafenib|mesh-list
101756627|NCT00884416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101756628|NCT00884416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101756629|NCT00884416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101756630|NCT00884416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756631|NCT00884494|Insulin|insulin|mesh-list
101756632|NCT00884494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101756633|NCT00884494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756634|NCT00881686|Adenosine|adenosine|mesh-list
101756635|NCT00881686|Analgesics|analgesics|mesh-ancestor
101756636|NCT00881686|Sensory System Agents|sensory system agents|mesh-ancestor
101756637|NCT00881686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101756638|NCT00881686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756639|NCT00881686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101756640|NCT00881686|Vasodilator Agents|vasodilator agents|mesh-ancestor
101756641|NCT00881686|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101756643|NCT00881686|Purinergic Agents|purinergic agents|mesh-ancestor
101756644|NCT00881686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101756645|NCT00881686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756646|NCT00885508|Lenalidomide|lenalidomide|mesh-list
101756647|NCT00885508|Immunologic Factors|immunologic factors|mesh-ancestor
101756648|NCT00885508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756649|NCT00885508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101756650|NCT00885508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101756651|NCT00885508|Growth Substances|growth substances|mesh-ancestor
101756652|NCT00885508|Growth Inhibitors|growth inhibitors|mesh-ancestor
101756653|NCT00885508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101756654|NCT02543086|Piperaquine|piperaquine|mesh-list
101756655|NCT02543086|Antimalarials|antimalarials|mesh-ancestor
101756656|NCT02543086|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101756657|NCT02543086|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101756658|NCT02543086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101756659|NCT00885586|Gabapentin|gabapentin|mesh-list
101756660|NCT00885586|Analgesics|analgesics|mesh-ancestor
101756661|NCT00885586|Sensory System Agents|sensory system agents|mesh-ancestor
101756662|NCT00885586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101756663|NCT00885586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756664|NCT00885586|Anticonvulsants|anticonvulsants|mesh-ancestor
101756665|NCT00885586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101756666|NCT00885586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101756667|NCT00885586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101756669|NCT00885586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101756670|NCT00885586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101756671|NCT00885586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101756672|NCT00885586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756673|NCT00885586|Antimanic Agents|antimanic agents|mesh-ancestor
101756674|NCT02542930|Thymalfasin|thymalfasin|mesh-list
101756675|NCT02542930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101756676|NCT02542930|Immunologic Factors|immunologic factors|mesh-ancestor
101756677|NCT02542930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756678|NCT00881764|Anesthetics|anesthetics|mesh-list
101756679|NCT00881764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101756680|NCT00881764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756681|NCT04038034|Coenzyme Q10|coenzyme q10|mesh-list
101756682|NCT04038034|Vitamins|vitamins|mesh-ancestor
101756683|NCT04038034|Micronutrients|micronutrients|mesh-ancestor
101756685|NCT04037878|Tramadol|tramadol|mesh-list
101756686|NCT04037878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101756687|NCT04037878|Narcotics|narcotics|mesh-ancestor
101563151|NCT05444777|Anesthetics, General|anesthetics, general|mesh-ancestor
101563152|NCT05444777|Anesthetics|anesthetics|mesh-ancestor
101563153|NCT05444777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101563154|NCT05444777|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101563155|NCT05444777|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101563156|NCT05444777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101563157|NCT05444777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756688|NCT04037878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101756689|NCT04037878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756690|NCT04037878|Analgesics|analgesics|mesh-ancestor
101756691|NCT04037878|Sensory System Agents|sensory system agents|mesh-ancestor
101756692|NCT04037878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101756693|NCT02542852|Ritonavir|ritonavir|mesh-list
101756694|NCT02542852|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101756695|NCT02542852|Dolutegravir|dolutegravir|mesh-list
101756696|NCT02542852|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101756697|NCT02542852|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101756698|NCT02542852|Protease Inhibitors|protease inhibitors|mesh-ancestor
101756699|NCT02542852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101756700|NCT02542852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756701|NCT02542852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101756702|NCT02542852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101756703|NCT02542852|Antiviral Agents|antiviral agents|mesh-ancestor
101756704|NCT02542852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101756705|NCT02542852|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101756706|NCT02542852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101756707|NCT02542852|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101756708|NCT02542852|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101756709|NCT00651261|Cytarabine|cytarabine|mesh-list
101756710|NCT00651261|Dexamethasone|dexamethasone|mesh-list
101756711|NCT00651261|Dexamethasone acetate|dexamethasone acetate|mesh-list
101756712|NCT00651261|Daunorubicin|daunorubicin|mesh-list
101756713|NCT00651261|Midostaurin|midostaurin|mesh-list
101756714|NCT00651261|BB 1101|bb 1101|mesh-list
101756715|NCT00651261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101756716|NCT00651261|Antiemetics|antiemetics|mesh-ancestor
101756717|NCT00651261|Autonomic Agents|autonomic agents|mesh-ancestor
101756718|NCT00651261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101756719|NCT00651261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756736|NCT00651261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101756737|NCT00651261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101756738|NCT00651261|Protease Inhibitors|protease inhibitors|mesh-ancestor
101756740|NCT00885820|Methylprednisolone|methylprednisolone|mesh-list
101756741|NCT00885820|Tacrolimus|tacrolimus|mesh-list
101756742|NCT00885820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101756743|NCT00885820|Glucocorticoids|glucocorticoids|mesh-ancestor
101756744|NCT00885820|Hormones|hormones|mesh-ancestor
101756745|NCT00885820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101756746|NCT00885820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756747|NCT00885820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101756748|NCT00885820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101756749|NCT00885820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101756750|NCT00885820|Immunologic Factors|immunologic factors|mesh-ancestor
101756751|NCT00885820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101756752|NCT00885820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101756753|NCT00885820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756754|NCT00885820|Antiemetics|antiemetics|mesh-ancestor
101756755|NCT00885820|Autonomic Agents|autonomic agents|mesh-ancestor
101756756|NCT00885820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101756757|NCT00885820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101756758|NCT00885820|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101756759|NCT00885820|Protective Agents|protective agents|mesh-ancestor
101756761|NCT02567838|Anesthetics, Local|anesthetics, local|mesh-ancestor
101756762|NCT02567838|Anesthetics|anesthetics|mesh-ancestor
101756763|NCT02567838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101756764|NCT02567838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756765|NCT02567838|Sensory System Agents|sensory system agents|mesh-ancestor
101756766|NCT02567838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101563158|NCT05433961|Xenon|xenon|mesh-list
101563159|NCT05433961|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101563160|NCT05433961|Anesthetics, General|anesthetics, general|mesh-ancestor
101563161|NCT05433961|Anesthetics|anesthetics|mesh-ancestor
101563162|NCT05433961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101525100|NCT03813875|Analgesics|analgesics|mesh-ancestor
101563163|NCT05433961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563164|NCT05410821|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
101756767|NCT02567838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101756768|NCT02567838|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101756769|NCT02567838|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101756770|NCT02567838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101756771|NCT02567838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756772|NCT00651183|Pramipexole|pramipexole|mesh-list
101756773|NCT00651183|Antioxidants|antioxidants|mesh-ancestor
101756774|NCT00651183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756775|NCT00651183|Protective Agents|protective agents|mesh-ancestor
101756776|NCT00651183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756783|NCT00810381|Isosorbide|isosorbide|mesh-list
101756784|NCT00810381|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
101756785|NCT00810381|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
101756786|NCT00810381|Nitroglycerin|nitroglycerin|mesh-list
101756787|NCT00810381|Vasodilator Agents|vasodilator agents|mesh-ancestor
101756788|NCT00810381|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101756789|NCT00810381|Diuretics|diuretics|mesh-ancestor
101756790|NCT00810381|Natriuretic Agents|natriuretic agents|mesh-ancestor
101756791|NCT00810381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756792|NCT00810381|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101756793|NCT00810381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756794|NCT00810381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101756795|NCT00800319|ALKS-33|alks-33|mesh-list
101756796|NCT00800319|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101756797|NCT00800319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756798|NCT00800319|Sensory System Agents|sensory system agents|mesh-ancestor
101756799|NCT00800319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101756800|NCT00813501|Immunosuppressive Agents|immunosuppressive agents|mesh-list
101756801|NCT00813501|Immunologic Factors|immunologic factors|mesh-ancestor
101756802|NCT00813501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756803|NCT00800475|Gemfibrozil|gemfibrozil|mesh-list
101756804|NCT00800475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101756805|NCT00800475|Antimetabolites|antimetabolites|mesh-ancestor
101756806|NCT00800475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756807|NCT00800475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101756808|NCT00800475|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101756809|NCT00800475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101756810|NCT00800475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101756811|NCT00810849|Prednisolone|prednisolone|mesh-list
101756812|NCT00810849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101756813|NCT00810849|Glucocorticoids|glucocorticoids|mesh-ancestor
101756814|NCT00810849|Hormones|hormones|mesh-ancestor
101756815|NCT00810849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101414244|NCT00489892|Modafinil|modafinil|mesh-list
101756816|NCT00810849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756817|NCT00810849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101756818|NCT00810849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101756819|NCT00811005|5-Methoxypsoralen|5-methoxypsoralen|mesh-list
101756820|NCT00811005|Methoxsalen|methoxsalen|mesh-list
101756821|NCT00811005|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101756822|NCT00811005|Dermatologic Agents|dermatologic agents|mesh-ancestor
101756823|NCT00811005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101756825|NCT00813735|Eszopiclone|eszopiclone|mesh-list
101756826|NCT00813735|Citalopram|citalopram|mesh-list
101756827|NCT00813735|Escitalopram|escitalopram|mesh-list
101756828|NCT00813735|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101756829|NCT00813735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101756830|NCT00813735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101563166|NCT05410821|Sequestering Agents|sequestering agents|mesh-ancestor
101563167|NCT05410821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563168|NCT05410418|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
101563169|NCT05410418|Immunoconjugates|immunoconjugates|mesh-ancestor
101563170|NCT05410418|Immunologic Factors|immunologic factors|mesh-ancestor
101563171|NCT05410418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563172|NCT05402293|Lidocaine|lidocaine|mesh-list
101563173|NCT05402293|Anesthetics, Local|anesthetics, local|mesh-ancestor
101563174|NCT05402293|Anesthetics|anesthetics|mesh-ancestor
101756831|NCT00813735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217029|NCT01485185|Gabapentin|gabapentin|mesh-list
101756832|NCT00813735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101756833|NCT00813735|Serotonin Agents|serotonin agents|mesh-ancestor
101756834|NCT00813735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534579|NCT04582097|Ramipril|ramipril|mesh-list
101756835|NCT00813735|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101756836|NCT00813735|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101756837|NCT00813735|Parasympatholytics|parasympatholytics|mesh-ancestor
101756838|NCT00813735|Autonomic Agents|autonomic agents|mesh-ancestor
101756839|NCT00813735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101756840|NCT00813735|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101756841|NCT00813735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101756842|NCT00813735|Cholinergic Agents|cholinergic agents|mesh-ancestor
101756843|NCT00813735|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101756844|NCT00813735|Antidepressive Agents|antidepressive agents|mesh-ancestor
101756845|NCT00813735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101756846|NCT00813735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101756872|NCT00813891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101756873|NCT00813891|Growth Substances|growth substances|mesh-ancestor
101756874|NCT00813891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756875|NCT00813891|Growth Inhibitors|growth inhibitors|mesh-ancestor
101756876|NCT00813891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101756877|NCT00817557|Loteprednol Etabonate|loteprednol etabonate|mesh-list
101756878|NCT00817557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101756879|NCT00611026|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101756880|NCT00611026|Fesoterodine|fesoterodine|mesh-list
101756881|NCT00611026|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101756882|NCT00611026|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101756883|NCT00611026|Cholinergic Agents|cholinergic agents|mesh-ancestor
101756884|NCT00611026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101756885|NCT00611026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756886|NCT00611026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756887|NCT00611026|Urological Agents|urological agents|mesh-ancestor
101756888|NCT02552589|Fluorides|fluorides|mesh-list
101756889|NCT02552589|Fluorophosphate|fluorophosphate|mesh-list
101756890|NCT02552589|Cariostatic Agents|cariostatic agents|mesh-ancestor
101756891|NCT02552589|Protective Agents|protective agents|mesh-ancestor
101756892|NCT02552589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756893|NCT00811239|Antivenins|antivenins|mesh-list
101756894|NCT00811239|Immunologic Factors|immunologic factors|mesh-ancestor
101756895|NCT00811239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756896|NCT00814047|Yohimbine|yohimbine|mesh-list
101756897|NCT00814047|Mydriatics|mydriatics|mesh-ancestor
101756913|NCT00814125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756914|NCT00814125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101756915|NCT00814125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101756916|NCT00814125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101756917|NCT00814125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101756918|NCT00814125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101756919|NCT00814125|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101756920|NCT00814125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101756921|NCT00814125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101756922|NCT00814125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756923|NCT00817713|Ivermectin|ivermectin|mesh-list
101756924|NCT00817713|Albendazole|albendazole|mesh-list
101756925|NCT00817713|Praziquantel|praziquantel|mesh-list
101411451|NCT00460369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101563175|NCT05402293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101563176|NCT05402293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563177|NCT05402293|Sensory System Agents|sensory system agents|mesh-ancestor
101563178|NCT05402293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101563179|NCT05402293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101563180|NCT05402293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101563181|NCT05402293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101563182|NCT05402293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101563183|NCT05402293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563184|NCT05355168|Nimotuzumab|nimotuzumab|mesh-list
101563185|NCT05355168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101563186|NCT05355168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563187|NCT05348356|Nirogacestat|nirogacestat|mesh-list
101411453|NCT00460369|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101756926|NCT00817713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101756927|NCT00817713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101756928|NCT00817713|Anthelmintics|anthelmintics|mesh-ancestor
101756929|NCT00817713|Anticestodal Agents|anticestodal agents|mesh-ancestor
101756930|NCT00817713|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101756931|NCT00817713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101756932|NCT00817713|Tubulin Modulators|tubulin modulators|mesh-ancestor
101756933|NCT00817713|Antimitotic Agents|antimitotic agents|mesh-ancestor
101756934|NCT00817713|Mitosis Modulators|mitosis modulators|mesh-ancestor
101756935|NCT00817713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756936|NCT00817713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101756937|NCT00422383|Rituximab|rituximab|mesh-list
101756938|NCT00422383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101756939|NCT00422383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101756940|NCT00422383|Immunologic Factors|immunologic factors|mesh-ancestor
101756941|NCT00422383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756942|NCT00422383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101756943|NCT00814281|Montelukast|montelukast|mesh-list
101756944|NCT00814281|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101756945|NCT00814281|Respiratory System Agents|respiratory system agents|mesh-ancestor
101756946|NCT00814281|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101756947|NCT00814281|Hormone Antagonists|hormone antagonists|mesh-ancestor
101756948|NCT00814281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101756949|NCT00814281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756950|NCT00814281|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101756951|NCT00814281|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101756952|NCT00814281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756953|NCT00814359|Benzydamine|benzydamine|mesh-list
101756954|NCT00814359|Sucralfate|sucralfate|mesh-list
101756973|NCT00422227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756974|NCT00422227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101756975|NCT00422227|Antimetabolites|antimetabolites|mesh-ancestor
101756976|NCT00422227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756977|NCT00422227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101756978|NCT00422227|Dermatologic Agents|dermatologic agents|mesh-ancestor
101756979|NCT00422227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101756980|NCT00422227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101756981|NCT00422227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101756982|NCT00422227|Immunologic Factors|immunologic factors|mesh-ancestor
101756983|NCT00422227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101756984|NCT00422227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101563188|NCT05348356|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101563189|NCT05348356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101563190|NCT05348356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563191|NCT05330130|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101563192|NCT05330130|Hormones|hormones|mesh-ancestor
101563193|NCT05330130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101563194|NCT05330130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563195|NCT05323981|Pertuzumab|pertuzumab|mesh-list
101563196|NCT05323981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101756985|NCT00422227|Antimalarials|antimalarials|mesh-ancestor
101756986|NCT00422227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101756987|NCT00422227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101756988|NCT00422227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101756989|NCT00422227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101756990|NCT00422227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101756991|NCT00422227|Analgesics|analgesics|mesh-ancestor
101756992|NCT00422227|Sensory System Agents|sensory system agents|mesh-ancestor
101756993|NCT00422227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101756994|NCT00422227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101756995|NCT00422227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101756996|NCT00811785|Copper|copper|mesh-list
101756997|NCT00811785|Trace Elements|trace elements|mesh-ancestor
101756998|NCT00811785|Micronutrients|micronutrients|mesh-ancestor
101756999|NCT00811785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757000|NCT00814515|Cyclosporine|cyclosporine|mesh-list
101757001|NCT00814515|Cyclosporins|cyclosporins|mesh-list
101757002|NCT00814515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101757003|NCT00814515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757004|NCT00814515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101757005|NCT00814515|Immunologic Factors|immunologic factors|mesh-ancestor
101757006|NCT00814515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757007|NCT00814515|Antifungal Agents|antifungal agents|mesh-ancestor
101757008|NCT00814515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101757009|NCT00814515|Dermatologic Agents|dermatologic agents|mesh-ancestor
101757010|NCT00814515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101757011|NCT00814515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101757012|NCT00814593|Carmustine|carmustine|mesh-list
101757013|NCT00814593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101757014|NCT00814593|Alkylating Agents|alkylating agents|mesh-ancestor
101451746|NCT00203099|Immunologic Factors|immunologic factors|mesh-ancestor
101757026|NCT00421993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757027|NCT00421993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101757028|NCT00421993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101757030|NCT00884884|Aripiprazole|aripiprazole|mesh-list
101757031|NCT00884884|Antidepressive Agents|antidepressive agents|mesh-ancestor
101757032|NCT00884884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101757033|NCT00884884|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101757034|NCT00884884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101757035|NCT00884884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101757036|NCT00884884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757037|NCT00884884|Dopamine Agonists|dopamine agonists|mesh-ancestor
101757038|NCT00884884|Dopamine Agents|dopamine agents|mesh-ancestor
101757039|NCT00884884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101757040|NCT00884884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757041|NCT00884884|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101757042|NCT00884884|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101757043|NCT00884884|Serotonin Agents|serotonin agents|mesh-ancestor
101757044|NCT00884884|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101757046|NCT00884884|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101757047|NCT00884884|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101757048|NCT00884884|Anticonvulsants|anticonvulsants|mesh-ancestor
101757049|NCT00884884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101757050|NCT01037725|Oxazolidinones|oxazolidinones|mesh-list
101757051|NCT01037725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101563197|NCT05323981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563198|NCT05317364|Estradiol|estradiol|mesh-list
101563199|NCT05317364|Estrogens|estrogens|mesh-ancestor
101563200|NCT05317364|Hormones|hormones|mesh-ancestor
101563201|NCT05317364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101563202|NCT05317364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563203|NCT05313243|Pembrolizumab|pembrolizumab|mesh-list
101563204|NCT05313243|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101757052|NCT01037725|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101757053|NCT01037725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101757054|NCT01037725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757055|NCT02551029|Capsaicin|capsaicin|mesh-list
101757056|NCT02551029|Antipruritics|antipruritics|mesh-ancestor
101757057|NCT02551029|Dermatologic Agents|dermatologic agents|mesh-ancestor
101757058|NCT02551029|Sensory System Agents|sensory system agents|mesh-ancestor
101757059|NCT02551029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101757060|NCT02551029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757061|NCT00812019|Vaccines|vaccines|mesh-list
101757062|NCT00812019|MF59 oil emulsion|mf59 oil emulsion|mesh-list
101757063|NCT00812019|Immunologic Factors|immunologic factors|mesh-ancestor
101757064|NCT00812019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757065|NCT00812019|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101757066|NCT00413959|Dexamethasone|dexamethasone|mesh-list
101757067|NCT00413959|Cyclophosphamide|cyclophosphamide|mesh-list
101757068|NCT00413959|Rituximab|rituximab|mesh-list
101757069|NCT00413959|Bortezomib|bortezomib|mesh-list
101757070|NCT00413959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101757071|NCT00413959|Immunologic Factors|immunologic factors|mesh-ancestor
101757072|NCT00413959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757073|NCT00413959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101757074|NCT00413959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101757075|NCT00413959|Alkylating Agents|alkylating agents|mesh-ancestor
101757076|NCT00413959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757077|NCT00413959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101531644|NCT01157182|Norethindrone|norethindrone|mesh-list
101757091|NCT00814905|Clindamycin phosphate|clindamycin phosphate|mesh-list
101757092|NCT00814905|Gentamicins|gentamicins|mesh-list
101757093|NCT00814905|Ampicillin|ampicillin|mesh-list
101757094|NCT00814905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101757095|NCT00814905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101757096|NCT00814905|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101757097|NCT00814905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101757098|NCT00814905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757099|NCT00611884|Insulin|insulin|mesh-list
101757100|NCT00611884|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101757101|NCT00611884|Metformin|metformin|mesh-list
101757102|NCT00611884|Insulin Glargine|insulin glargine|mesh-list
101757103|NCT00611884|Insulin, Long-Acting|insulin, long-acting|mesh-list
101757104|NCT00611884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101757105|NCT00611884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757106|NCT00611806|Folic Acid|folic acid|mesh-list
101757107|NCT00611806|Vitamin B 12|vitamin b 12|mesh-list
101757108|NCT00611806|Hematinics|hematinics|mesh-ancestor
101757109|NCT00611806|Vitamin B Complex|vitamin b complex|mesh-ancestor
101757110|NCT00611806|Vitamins|vitamins|mesh-ancestor
101757111|NCT00611806|Micronutrients|micronutrients|mesh-ancestor
101757112|NCT00611806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757113|NCT00413413|Amlodipine|amlodipine|mesh-list
101757114|NCT00413413|Valsartan|valsartan|mesh-list
101757115|NCT00413413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101757116|NCT00413413|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101757117|NCT00413413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101757118|NCT00413413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757119|NCT00413413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101757120|NCT00413413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757121|NCT00413413|Vasodilator Agents|vasodilator agents|mesh-ancestor
101757122|NCT00413413|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101757123|NCT00413413|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101563205|NCT05313243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101563206|NCT05313243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563207|NCT05313243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101563208|NCT05313243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563209|NCT05313243|Immunotoxins|immunotoxins|mesh-ancestor
101563210|NCT05313243|Immunoconjugates|immunoconjugates|mesh-ancestor
101563211|NCT05313243|Immunologic Factors|immunologic factors|mesh-ancestor
101563212|NCT05313243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757124|NCT00886132|Sunitinib|sunitinib|mesh-list
101757125|NCT00886132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101757126|NCT00886132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101757127|NCT00886132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101757128|NCT00886132|Growth Substances|growth substances|mesh-ancestor
101757129|NCT00886132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757130|NCT00886132|Growth Inhibitors|growth inhibitors|mesh-ancestor
101757131|NCT00886132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101217354|NCT01486602|Paclitaxel|paclitaxel|mesh-list
101757133|NCT00886132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757134|NCT01040455|Lansoprazole|lansoprazole|mesh-list
101757135|NCT01040455|Dexlansoprazole|dexlansoprazole|mesh-list
101757136|NCT01040455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101757137|NCT01040455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101757138|NCT01040455|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101757139|NCT01040455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101757140|NCT01040455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757159|NCT00610714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101757160|NCT00610714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101757161|NCT00610714|Tubulin Modulators|tubulin modulators|mesh-ancestor
101757162|NCT00610714|Antimitotic Agents|antimitotic agents|mesh-ancestor
101757163|NCT00610714|Mitosis Modulators|mitosis modulators|mesh-ancestor
101757164|NCT00610714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757165|NCT00610714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101757166|NCT00403585|Adefovir|adefovir|mesh-list
101757167|NCT00403585|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101757168|NCT00403585|Antiviral Agents|antiviral agents|mesh-ancestor
101757169|NCT00403585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101757170|NCT00403585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101757171|NCT00403585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101757172|NCT00403585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101757173|NCT00403585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757174|NCT00645411|Vaccines|vaccines|mesh-list
101757175|NCT00645411|Immunologic Factors|immunologic factors|mesh-ancestor
101757176|NCT00645411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757177|NCT00403273|Botulinum Toxins|botulinum toxins|mesh-list
101757178|NCT00403273|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101757179|NCT00403273|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101757180|NCT00403273|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101757181|NCT00403273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101757182|NCT00403273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757183|NCT00403273|Cholinergic Agents|cholinergic agents|mesh-ancestor
101757184|NCT00403273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101757185|NCT00403273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757186|NCT00403273|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101757187|NCT00403273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101757188|NCT00885274|Magnesium Oxide|magnesium oxide|mesh-list
101757189|NCT00885274|Citric Acid|citric acid|mesh-list
101757190|NCT00885274|Antacids|antacids|mesh-ancestor
101757191|NCT00885274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757192|NCT00885274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101757193|NCT00885274|Anticoagulants|anticoagulants|mesh-ancestor
101757194|NCT00885274|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101757195|NCT00885274|Chelating Agents|chelating agents|mesh-ancestor
101757196|NCT00885274|Sequestering Agents|sequestering agents|mesh-ancestor
101757197|NCT00402727|Amoxicillin|amoxicillin|mesh-list
101757198|NCT00402727|Moxifloxacin|moxifloxacin|mesh-list
101757216|NCT00402727|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101563213|NCT05313009|Sotorasib|sotorasib|mesh-list
101563214|NCT05313009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101563215|NCT05313009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563216|NCT05313009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101563217|NCT05313009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563218|NCT05311475|Mometasone Furoate|mometasone furoate|mesh-list
101563219|NCT05311475|Azelastine|azelastine|mesh-list
101563220|NCT05311475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101563221|NCT05311475|Dermatologic Agents|dermatologic agents|mesh-ancestor
101563222|NCT05311475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101757217|NCT00402727|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101757218|NCT00402727|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101757219|NCT00402727|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101757220|NCT00923494|Ropivacaine|ropivacaine|mesh-list
101757221|NCT00923494|Anesthetics, Local|anesthetics, local|mesh-ancestor
101757222|NCT00923494|Anesthetics|anesthetics|mesh-ancestor
101757223|NCT00923494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101757224|NCT00923494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757225|NCT00923494|Sensory System Agents|sensory system agents|mesh-ancestor
101757226|NCT00923494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101757227|NCT00888784|Propranolol|propranolol|mesh-list
101757228|NCT00888784|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101757229|NCT00888784|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101757230|NCT00888784|Adrenergic Agents|adrenergic agents|mesh-ancestor
101757231|NCT00888784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101757232|NCT00888784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757233|NCT00888784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757234|NCT00888784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101757235|NCT00888784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101757236|NCT00888784|Vasodilator Agents|vasodilator agents|mesh-ancestor
101757237|NCT00886678|Carboplatin|carboplatin|mesh-list
101757238|NCT00886678|Pemetrexed|pemetrexed|mesh-list
101757239|NCT00886678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101757240|NCT00886678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101757241|NCT00886678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757242|NCT00886678|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101757243|NCT00886678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101757244|NCT00402337|Linaclotide|linaclotide|mesh-list
101757245|NCT00402337|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
101757246|NCT00402337|Enzyme Activators|enzyme activators|mesh-ancestor
101757247|NCT00402337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757248|NCT00402337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101757249|NCT00888862|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101757250|NCT00888862|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101757251|NCT00888862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101757252|NCT00888862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101531822|NCT04627181|Vitamin B Complex|vitamin b complex|mesh-ancestor
101757261|NCT00886990|Protease Inhibitors|protease inhibitors|mesh-ancestor
101757262|NCT00886990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101757263|NCT00886990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757264|NCT00886990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101757265|NCT00886990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101757266|NCT00886990|Antiviral Agents|antiviral agents|mesh-ancestor
101757267|NCT00886990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101757268|NCT00886990|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101414680|NCT00493480|Antioxidants|antioxidants|mesh-ancestor
101757269|NCT00886990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101757270|NCT00650091|Acetylcysteine|acetylcysteine|mesh-list
101757271|NCT00650091|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101757272|NCT00650091|Antiviral Agents|antiviral agents|mesh-ancestor
101757273|NCT00650091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101757274|NCT00650091|Expectorants|expectorants|mesh-ancestor
101757275|NCT00650091|Respiratory System Agents|respiratory system agents|mesh-ancestor
101757276|NCT00650091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101757277|NCT00650091|Antioxidants|antioxidants|mesh-ancestor
101563223|NCT05311475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101563224|NCT05311475|Autonomic Agents|autonomic agents|mesh-ancestor
101563225|NCT05311475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101563226|NCT05311475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411502|NCT00460954|Levodopa|levodopa|mesh-list
101757278|NCT00650091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757279|NCT00650091|Protective Agents|protective agents|mesh-ancestor
101757280|NCT00650091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757281|NCT00650091|Antidotes|antidotes|mesh-ancestor
101757282|NCT00889018|Carboplatin|carboplatin|mesh-list
101757283|NCT00889018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101757284|NCT00889096|Propranolol|propranolol|mesh-list
101757285|NCT00889096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101757286|NCT00889096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101757287|NCT00889096|Adrenergic Agents|adrenergic agents|mesh-ancestor
101757288|NCT00889096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101757289|NCT00889096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757290|NCT00889096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757291|NCT00889096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101757292|NCT00889096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101757293|NCT00889096|Vasodilator Agents|vasodilator agents|mesh-ancestor
101757294|NCT00818103|Interferons|interferons|mesh-list
101757295|NCT00818103|Atorvastatin|atorvastatin|mesh-list
101757296|NCT00818103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101757297|NCT00818103|Antiviral Agents|antiviral agents|mesh-ancestor
101757298|NCT00818103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101757299|NCT00818103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101757300|NCT00818103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101757301|NCT00818103|Antimetabolites|antimetabolites|mesh-ancestor
101757302|NCT00818103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757303|NCT00818103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101757304|NCT00818103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101757305|NCT00818103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101757306|NCT00642369|Haloperidol|haloperidol|mesh-list
101757307|NCT00642369|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101757308|NCT00642369|Haloperidol decanoate|haloperidol decanoate|mesh-list
101757309|NCT00642369|Antidepressive Agents|antidepressive agents|mesh-ancestor
101757310|NCT00642369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101757311|NCT00642369|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101757312|NCT00642369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101757313|NCT00642369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101757314|NCT00642369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757315|NCT00642369|Antiemetics|antiemetics|mesh-ancestor
101757316|NCT00642369|Autonomic Agents|autonomic agents|mesh-ancestor
101757317|NCT00642369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101531881|NCT04626089|Metformin|metformin|mesh-list
101757330|NCT01154335|Immunologic Factors|immunologic factors|mesh-ancestor
101757331|NCT01154335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757332|NCT01154335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101757333|NCT00889642|Lidocaine|lidocaine|mesh-list
101757334|NCT00889642|Epinephrine|epinephrine|mesh-list
101757335|NCT00889642|Racepinephrine|racepinephrine|mesh-list
101757336|NCT00889642|Epinephryl borate|epinephryl borate|mesh-list
101757337|NCT00889642|Anesthetics, Local|anesthetics, local|mesh-ancestor
101757338|NCT00889642|Anesthetics|anesthetics|mesh-ancestor
101757339|NCT00889642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101757340|NCT00889642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757341|NCT00889642|Sensory System Agents|sensory system agents|mesh-ancestor
101757342|NCT00889642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101757343|NCT00889642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101757344|NCT00889642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101757345|NCT00889642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101757346|NCT00889642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101757347|NCT00889642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757348|NCT00889642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101757349|NCT00889642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101217556|NCT01488136|Diazoxide|diazoxide|mesh-list
101757350|NCT00889642|Adrenergic Agents|adrenergic agents|mesh-ancestor
101757351|NCT00889642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101757352|NCT00889642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101757353|NCT00889642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101563227|NCT05311475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101563228|NCT05311475|Respiratory System Agents|respiratory system agents|mesh-ancestor
101563229|NCT05311475|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101563231|NCT05311475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563232|NCT05311475|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101563233|NCT05311475|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101563234|NCT05311475|Histamine Antagonists|histamine antagonists|mesh-ancestor
101563235|NCT05311475|Histamine Agents|histamine agents|mesh-ancestor
101757354|NCT00889642|Autonomic Agents|autonomic agents|mesh-ancestor
101757355|NCT00889642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101757356|NCT00889642|Respiratory System Agents|respiratory system agents|mesh-ancestor
101757357|NCT00889642|Mydriatics|mydriatics|mesh-ancestor
101757358|NCT00889642|Sympathomimetics|sympathomimetics|mesh-ancestor
101757359|NCT00889642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101757360|NCT02541526|Mirtazapine|mirtazapine|mesh-list
101757361|NCT02541526|Antidepressive Agents|antidepressive agents|mesh-ancestor
101757362|NCT02541526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101757363|NCT02541526|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101757364|NCT02541526|Histamine Antagonists|histamine antagonists|mesh-ancestor
101757365|NCT02541526|Histamine Agents|histamine agents|mesh-ancestor
101757366|NCT02541526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101757367|NCT02541526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757368|NCT02541526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757369|NCT02541526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101757370|NCT02541526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101757371|NCT02541526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101757372|NCT02541526|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101757373|NCT02541526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101757374|NCT02541526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101757375|NCT02541526|Adrenergic Agents|adrenergic agents|mesh-ancestor
101757376|NCT02541526|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101757377|NCT02541526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101757378|NCT02541526|Serotonin Agents|serotonin agents|mesh-ancestor
101757388|NCT01037959|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101757389|NCT01037959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101757391|NCT01038037|Vinorelbine|vinorelbine|mesh-list
101757392|NCT01038037|Panitumumab|panitumumab|mesh-list
101757393|NCT01038037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101757394|NCT01038037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101757395|NCT01038037|Tubulin Modulators|tubulin modulators|mesh-ancestor
101757396|NCT01038037|Antimitotic Agents|antimitotic agents|mesh-ancestor
101757397|NCT01038037|Mitosis Modulators|mitosis modulators|mesh-ancestor
101757398|NCT01038037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757399|NCT01038037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101757400|NCT00645099|Olanzapine|olanzapine|mesh-list
101757401|NCT00645099|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101757402|NCT00645099|Antiemetics|antiemetics|mesh-ancestor
101757403|NCT00645099|Autonomic Agents|autonomic agents|mesh-ancestor
101757404|NCT00645099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101757405|NCT00645099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757406|NCT00645099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101757407|NCT00645099|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101757408|NCT00645099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101757409|NCT00645099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101407431|NCT00107354|Antimetabolites|antimetabolites|mesh-ancestor
101757410|NCT00645099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101757411|NCT00645099|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101757412|NCT00645099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101757413|NCT00645099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101757414|NCT00645099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757415|NCT00645099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101757416|NCT00645099|Serotonin Agents|serotonin agents|mesh-ancestor
101757417|NCT00645099|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101563236|NCT05311475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101563237|NCT05311176|Paclitaxel|paclitaxel|mesh-list
101563238|NCT05311176|Pembrolizumab|pembrolizumab|mesh-list
101563239|NCT05311176|Ramucirumab|ramucirumab|mesh-list
101563240|NCT05311176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101563241|NCT05311176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563242|NCT05311176|Tubulin Modulators|tubulin modulators|mesh-ancestor
101757418|NCT00645099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101757419|NCT00645099|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101757420|NCT00645099|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101757421|NCT00645099|Dopamine Agents|dopamine agents|mesh-ancestor
101757422|NCT04401982|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101757423|NCT04401982|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101757424|NCT01038349|Methotrexate|methotrexate|mesh-list
101757425|NCT01038349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101757426|NCT01038349|Abortifacient Agents|abortifacient agents|mesh-ancestor
101757427|NCT01038349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101757428|NCT01038349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757429|NCT01038349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101757430|NCT01038349|Antimetabolites|antimetabolites|mesh-ancestor
101757431|NCT01038349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757432|NCT01038349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101757433|NCT01038349|Dermatologic Agents|dermatologic agents|mesh-ancestor
101757434|NCT01038349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101757435|NCT01038349|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101757436|NCT01038349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101757437|NCT01038349|Immunologic Factors|immunologic factors|mesh-ancestor
101757438|NCT01038349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101757439|NCT01038349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101757440|NCT00887770|Moxifloxacin|moxifloxacin|mesh-list
101532006|NCT00567177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757452|NCT00887770|Antiviral Agents|antiviral agents|mesh-ancestor
101757454|NCT01038505|Mycophenolic Acid|mycophenolic acid|mesh-list
101757455|NCT01038505|Tacrolimus|tacrolimus|mesh-list
101757456|NCT01038505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101757457|NCT01038505|Immunologic Factors|immunologic factors|mesh-ancestor
101757458|NCT01038505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757459|NCT01038505|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101757460|NCT01038505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101757461|NCT01038505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757462|NCT01038505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101757463|NCT01038505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101757464|NCT01038505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101757465|NCT01038505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101757466|NCT01038505|Antifungal Agents|antifungal agents|mesh-ancestor
101757467|NCT01038505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101757468|NCT01038505|Antitubercular Agents|antitubercular agents|mesh-ancestor
101757469|NCT01038583|Aspirin|aspirin|mesh-list
101757470|NCT01038583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101757471|NCT01038583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101757472|NCT01038583|Analgesics|analgesics|mesh-ancestor
101757473|NCT01038583|Sensory System Agents|sensory system agents|mesh-ancestor
101757474|NCT01038583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101757475|NCT01038583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757476|NCT01038583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101757477|NCT01038583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101757478|NCT01038583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101757479|NCT01038583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101757480|NCT01038583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757481|NCT01038583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101757482|NCT01038583|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101757483|NCT01038583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101757484|NCT01038583|Antipyretics|antipyretics|mesh-ancestor
101757485|NCT02551107|Nitric Oxide|nitric oxide|mesh-list
101757486|NCT02551107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101757487|NCT02551107|Autonomic Agents|autonomic agents|mesh-ancestor
101757488|NCT02551107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101757489|NCT02551107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757490|NCT02551107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101563243|NCT05311176|Antimitotic Agents|antimitotic agents|mesh-ancestor
101563244|NCT05311176|Mitosis Modulators|mitosis modulators|mesh-ancestor
101563245|NCT05311176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563246|NCT05311176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101563247|NCT05311176|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101563249|NCT05302817|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101563250|NCT05302817|Anesthetics, General|anesthetics, general|mesh-ancestor
101563251|NCT05302817|Anesthetics|anesthetics|mesh-ancestor
101411518|NCT00461149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101757491|NCT02551107|Respiratory System Agents|respiratory system agents|mesh-ancestor
101757492|NCT02551107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101757493|NCT02551107|Antioxidants|antioxidants|mesh-ancestor
101757494|NCT02551107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757495|NCT02551107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101757496|NCT02551107|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101757497|NCT02551107|Vasodilator Agents|vasodilator agents|mesh-ancestor
101757498|NCT02551107|Gasotransmitters|gasotransmitters|mesh-ancestor
101757499|NCT02551107|Protective Agents|protective agents|mesh-ancestor
101757500|NCT01038661|Docetaxel|docetaxel|mesh-list
101757515|NCT00420511|Hormones|hormones|mesh-ancestor
101757516|NCT00420511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101757517|NCT00420511|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101757518|NCT00420511|Protease Inhibitors|protease inhibitors|mesh-ancestor
101757519|NCT00420511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101757520|NCT00420511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757521|NCT01038895|Ramipril|ramipril|mesh-list
101757522|NCT01038895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101757523|NCT01038895|Protease Inhibitors|protease inhibitors|mesh-ancestor
101757524|NCT01038895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101757525|NCT01038895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757526|NCT01038895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101757527|NCT00420199|Abatacept|abatacept|mesh-list
101757528|NCT00420199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101757529|NCT00420199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757530|NCT00420199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101757531|NCT00420199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101757532|NCT00420199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101757533|NCT00420199|Immunologic Factors|immunologic factors|mesh-ancestor
101757534|NCT00420199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757535|NCT00420199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101757536|NCT00649389|Amlodipine|amlodipine|mesh-list
101757537|NCT00649389|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101757538|NCT00649389|Olmesartan|olmesartan|mesh-list
101757539|NCT00649389|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101757540|NCT00649389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101757541|NCT00649389|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101757542|NCT00649389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101757543|NCT00649389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757544|NCT00649389|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101757545|NCT00649389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757546|NCT00649389|Vasodilator Agents|vasodilator agents|mesh-ancestor
101757547|NCT00649389|Diuretics|diuretics|mesh-ancestor
101757548|NCT00649389|Natriuretic Agents|natriuretic agents|mesh-ancestor
101757549|NCT00649389|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101757550|NCT00649389|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101757551|NCT00649389|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101757552|NCT00402103|Amlodipine|amlodipine|mesh-list
101757553|NCT00402103|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101757554|NCT00402103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101757555|NCT00402103|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101757556|NCT00402103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101563252|NCT05302817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101563253|NCT05302817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563255|NCT05289492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101563256|NCT05289492|Antiemetics|antiemetics|mesh-ancestor
101563257|NCT05289492|Autonomic Agents|autonomic agents|mesh-ancestor
101563258|NCT05289492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101757557|NCT00402103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757558|NCT00402103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101757576|NCT00815373|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101757577|NCT00815373|Adrenergic Agents|adrenergic agents|mesh-ancestor
101757578|NCT00815373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101757579|NCT00815373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757580|NCT00815373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101757581|NCT00815373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101757582|NCT00815373|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101757583|NCT00815373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101757584|NCT00815373|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101757585|NCT00641667|Fentanyl|fentanyl|mesh-list
101757586|NCT00641667|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101757587|NCT00641667|Narcotics|narcotics|mesh-ancestor
101757588|NCT00641667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101757589|NCT00641667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757590|NCT00641667|Analgesics|analgesics|mesh-ancestor
101757591|NCT00641667|Sensory System Agents|sensory system agents|mesh-ancestor
101757592|NCT00641667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101757593|NCT00641667|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101757594|NCT00641667|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101757595|NCT00641667|Anesthetics, General|anesthetics, general|mesh-ancestor
101757596|NCT00641667|Anesthetics|anesthetics|mesh-ancestor
101757597|NCT00704184|Interferons|interferons|mesh-list
101757598|NCT00704184|Ribavirin|ribavirin|mesh-list
101757599|NCT00704184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101757600|NCT00704184|Antiviral Agents|antiviral agents|mesh-ancestor
101757601|NCT00704184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101757602|NCT00704184|Antimetabolites|antimetabolites|mesh-ancestor
101757603|NCT00704184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757604|NCT00641043|Pioglitazone|pioglitazone|mesh-list
101757605|NCT00641043|Linagliptin|linagliptin|mesh-list
101757606|NCT00641043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101757607|NCT00641043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757608|NCT00641043|Incretins|incretins|mesh-ancestor
101757609|NCT00641043|Hormones|hormones|mesh-ancestor
101757610|NCT00641043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101757611|NCT00641043|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101757612|NCT00641043|Protease Inhibitors|protease inhibitors|mesh-ancestor
101757613|NCT00641043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101757614|NCT00641043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757615|NCT02567916|Propofol|propofol|mesh-list
101757616|NCT02567916|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101757617|NCT02567916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101757626|NCT00609622|Sunitinib|sunitinib|mesh-list
101757627|NCT00609622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101757628|NCT00609622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101757629|NCT00609622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101757630|NCT00609622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101757631|NCT00609622|Growth Substances|growth substances|mesh-ancestor
101757632|NCT00609622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757633|NCT00609622|Growth Inhibitors|growth inhibitors|mesh-ancestor
101757634|NCT00609622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101757635|NCT00609622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101757636|NCT00609622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415049|NCT00497107|Antidotes|antidotes|mesh-ancestor
101757637|NCT00818415|Naproxen|naproxen|mesh-list
101263663|NCT01762995|Calcium Carbonate|calcium carbonate|mesh-list
101757638|NCT00818415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101757639|NCT00818415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101757641|NCT00818415|Sensory System Agents|sensory system agents|mesh-ancestor
101407435|NCT00107354|Immunologic Factors|immunologic factors|mesh-ancestor
101563259|NCT05289492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563260|NCT05289492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101563261|NCT05289492|Glucocorticoids|glucocorticoids|mesh-ancestor
101563262|NCT05289492|Hormones|hormones|mesh-ancestor
101563263|NCT05289492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101563264|NCT05289492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101563265|NCT05289492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563266|NCT05274048|Trastuzumab|trastuzumab|mesh-list
101563267|NCT05274048|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
101563268|NCT05274048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101563269|NCT05274048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101757642|NCT00818415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101757643|NCT00818415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757644|NCT00818415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101757645|NCT00818415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101757646|NCT00818415|Gout Suppressants|gout suppressants|mesh-ancestor
101757647|NCT00818415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101757648|NCT00818415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101757649|NCT00818415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757650|NCT00815841|Methylphenidate|methylphenidate|mesh-list
101757651|NCT00815841|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101757652|NCT00815841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757653|NCT00815841|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101757654|NCT00815841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101757655|NCT00815841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101757656|NCT00815841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757657|NCT00815841|Dopamine Agents|dopamine agents|mesh-ancestor
101757658|NCT00815841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101757659|NCT03897192|Bevacizumab|bevacizumab|mesh-list
101757660|NCT03897192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101757661|NCT03897192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101757662|NCT03897192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101757663|NCT03897192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101757664|NCT03897192|Growth Substances|growth substances|mesh-ancestor
101757665|NCT03897192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757666|NCT03897192|Growth Inhibitors|growth inhibitors|mesh-ancestor
101757667|NCT02567214|Glycopyrrolate|glycopyrrolate|mesh-list
101757668|NCT02567214|Tiotropium Bromide|tiotropium bromide|mesh-list
101757669|NCT02567214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101757670|NCT02567214|Autonomic Agents|autonomic agents|mesh-ancestor
101757671|NCT02567214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101757672|NCT02567214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757673|NCT02567214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101757674|NCT02567214|Respiratory System Agents|respiratory system agents|mesh-ancestor
101757675|NCT02567214|Parasympatholytics|parasympatholytics|mesh-ancestor
101757676|NCT02567214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101757677|NCT02567214|Cholinergic Agents|cholinergic agents|mesh-ancestor
101757678|NCT02567214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101757679|NCT02567214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757680|NCT02567214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101757681|NCT02567214|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101757698|NCT02566824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101757699|NCT02566824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757700|NCT02566824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101757701|NCT02566824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101757702|NCT02566824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101757703|NCT02566824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757704|NCT02566824|Dopamine Agents|dopamine agents|mesh-ancestor
101757705|NCT02566824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101757706|NCT02566824|Sympathomimetics|sympathomimetics|mesh-ancestor
101757707|NCT02566824|Autonomic Agents|autonomic agents|mesh-ancestor
101563270|NCT05274048|Immunoconjugates|immunoconjugates|mesh-ancestor
101563271|NCT05274048|Immunologic Factors|immunologic factors|mesh-ancestor
101563272|NCT05274048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563273|NCT05261399|Carboplatin|carboplatin|mesh-list
101563274|NCT05261399|Pemetrexed|pemetrexed|mesh-list
101563275|NCT05261399|Osimertinib|osimertinib|mesh-list
101563276|NCT05261399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563277|NCT05261399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101563278|NCT05261399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563279|NCT05261399|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101563280|NCT05261399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101563281|NCT05261399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101563282|NCT05260528|Cytarabine|cytarabine|mesh-list
101563283|NCT05260528|Idarubicin|idarubicin|mesh-list
101563284|NCT05260528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101563285|NCT05260528|Antimetabolites|antimetabolites|mesh-ancestor
101563286|NCT05260528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563287|NCT05260528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101411552|NCT03273595|Epirubicin|epirubicin|mesh-list
101757708|NCT02566824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101757709|NCT02566824|Adrenergic Agents|adrenergic agents|mesh-ancestor
101415127|NCT00127868|Selenium|selenium|mesh-list
101757710|NCT02566824|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101757711|NCT00890188|Thalidomide|thalidomide|mesh-list
101757712|NCT00890188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101757713|NCT00890188|Immunologic Factors|immunologic factors|mesh-ancestor
101757714|NCT00890188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757715|NCT00890188|Leprostatic Agents|leprostatic agents|mesh-ancestor
101757716|NCT00890188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101757717|NCT00890188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101757718|NCT00890188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101757719|NCT00890188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101757720|NCT00890188|Growth Substances|growth substances|mesh-ancestor
101757721|NCT00890188|Growth Inhibitors|growth inhibitors|mesh-ancestor
101757722|NCT00890188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101757723|NCT05388942|Nitrous Oxide|nitrous oxide|mesh-list
101757724|NCT05388942|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101757725|NCT05388942|Anesthetics, General|anesthetics, general|mesh-ancestor
101757726|NCT05388942|Anesthetics|anesthetics|mesh-ancestor
101757727|NCT05388942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101757728|NCT05388942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757729|NCT05388942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101757730|NCT05388942|Analgesics|analgesics|mesh-ancestor
101757731|NCT05388942|Sensory System Agents|sensory system agents|mesh-ancestor
101757732|NCT05388942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101757733|NCT04037566|Cyclophosphamide|cyclophosphamide|mesh-list
101757734|NCT04037566|Fludarabine|fludarabine|mesh-list
101757735|NCT04037566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101757736|NCT04037566|Immunologic Factors|immunologic factors|mesh-ancestor
101757737|NCT04037566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757738|NCT04037566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101757739|NCT04037566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101757740|NCT04037566|Alkylating Agents|alkylating agents|mesh-ancestor
101757759|NCT00610168|Vaccines|vaccines|mesh-list
101757760|NCT00610168|Immunologic Factors|immunologic factors|mesh-ancestor
101757761|NCT00610168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757762|NCT00921102|Atropine|atropine|mesh-list
101757763|NCT00921102|Morphine|morphine|mesh-list
101757764|NCT00921102|Bupivacaine|bupivacaine|mesh-list
101563288|NCT05260528|Antiviral Agents|antiviral agents|mesh-ancestor
101563289|NCT05260528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101563290|NCT05260528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101563291|NCT05260528|Immunologic Factors|immunologic factors|mesh-ancestor
101411565|NCT03273595|Alkylating Agents|alkylating agents|mesh-ancestor
101757765|NCT00921102|Anesthetics, Local|anesthetics, local|mesh-list
101757766|NCT00921102|Anesthetics|anesthetics|mesh-list
101757767|NCT00921102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101757768|NCT00921102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757769|NCT00921102|Sensory System Agents|sensory system agents|mesh-ancestor
101757770|NCT00921102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101757771|NCT00921102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101757772|NCT00921102|Narcotics|narcotics|mesh-ancestor
101757773|NCT00921102|Analgesics|analgesics|mesh-ancestor
101757774|NCT00921102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101757775|NCT00921102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101757776|NCT00921102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101757777|NCT00921102|Autonomic Agents|autonomic agents|mesh-ancestor
101757778|NCT00921102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101757779|NCT00921102|Respiratory System Agents|respiratory system agents|mesh-ancestor
101757780|NCT00921102|Mydriatics|mydriatics|mesh-ancestor
101757781|NCT00921102|Parasympatholytics|parasympatholytics|mesh-ancestor
101757782|NCT00921102|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101757783|NCT00921102|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101757784|NCT00921102|Cholinergic Agents|cholinergic agents|mesh-ancestor
101218000|NCT01490047|Etanercept|etanercept|mesh-list
101757785|NCT00921102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101757786|NCT00921102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757787|NCT00890500|Sirolimus|sirolimus|mesh-list
101757788|NCT00890500|Fludarabine|fludarabine|mesh-list
101757789|NCT00890500|Melphalan|melphalan|mesh-list
101757790|NCT00890500|Tacrolimus|tacrolimus|mesh-list
101757791|NCT00890500|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101757792|NCT00890500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101757793|NCT00890500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757794|NCT00890500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101757795|NCT00890500|Immunologic Factors|immunologic factors|mesh-ancestor
101757796|NCT00890500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757797|NCT00890500|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101757798|NCT00890500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101532370|NCT00562523|Sorafenib|sorafenib|mesh-list
101757808|NCT04061772|Etoposide|etoposide|mesh-list
101757809|NCT04061772|Bortezomib|bortezomib|mesh-list
101757810|NCT04061772|Epirubicin|epirubicin|mesh-list
101757811|NCT04061772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101757812|NCT04061772|Immunologic Factors|immunologic factors|mesh-ancestor
101757813|NCT04061772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757814|NCT04061772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101757815|NCT04061772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101757816|NCT04061772|Alkylating Agents|alkylating agents|mesh-ancestor
101757817|NCT04061772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757818|NCT04061772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101757819|NCT04061772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101757820|NCT04061772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101757821|NCT04061772|Glucocorticoids|glucocorticoids|mesh-ancestor
101757822|NCT04061772|Hormones|hormones|mesh-ancestor
101757823|NCT04061772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101757824|NCT04061772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101757825|NCT04061772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101757826|NCT04061772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101757827|NCT04061772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101757828|NCT04061772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101757829|NCT04061772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101757830|NCT00644787|Fentanyl|fentanyl|mesh-list
101757831|NCT00644787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101757832|NCT00644787|Narcotics|narcotics|mesh-ancestor
101757833|NCT00644787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101757834|NCT00644787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757835|NCT00644787|Analgesics|analgesics|mesh-ancestor
101757836|NCT00644787|Sensory System Agents|sensory system agents|mesh-ancestor
101757837|NCT00644787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101757838|NCT00644787|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101563292|NCT05260528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563293|NCT05260528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101563294|NCT05260528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101563295|NCT05260528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101563296|NCT05260528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101563297|NCT05255666|Pembrolizumab|pembrolizumab|mesh-list
101563298|NCT05255666|Irinotecan|irinotecan|mesh-list
101563299|NCT05255666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101563300|NCT05255666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563301|NCT05255666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101563302|NCT05255666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563303|NCT05255666|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101563304|NCT05255666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101563305|NCT05255666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101563306|NCT05255146|Nitrous Oxide|nitrous oxide|mesh-list
101563307|NCT05255146|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101563308|NCT05255146|Anesthetics, General|anesthetics, general|mesh-ancestor
101563309|NCT05255146|Anesthetics|anesthetics|mesh-ancestor
101757839|NCT00644787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101757840|NCT00644787|Anesthetics, General|anesthetics, general|mesh-ancestor
101757841|NCT00644787|Anesthetics|anesthetics|mesh-ancestor
101757842|NCT00821301|Fluphenazine|fluphenazine|mesh-list
101757843|NCT00821301|Fluphenazine depot|fluphenazine depot|mesh-list
101757844|NCT00821301|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
101757845|NCT00821301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101757846|NCT00821301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101757847|NCT00821301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101757848|NCT00821301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757849|NCT00821301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101757850|NCT00821301|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101757851|NCT00821301|Dopamine Agents|dopamine agents|mesh-ancestor
101757852|NCT00821301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101757853|NCT00821301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757854|NCT00699348|Epoetin Alfa|epoetin alfa|mesh-list
101757855|NCT00699348|Hematinics|hematinics|mesh-ancestor
101757856|NCT00643851|Metformin|metformin|mesh-list
101757857|NCT00643851|Dapagliflozin|dapagliflozin|mesh-list
101757858|NCT00643851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101757859|NCT00643851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757860|NCT00643851|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101757861|NCT00643851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415307|NCT00498901|Letrozole|letrozole|mesh-list
101757862|NCT00821457|Mitogens|mitogens|mesh-list
101757863|NCT00821457|Mitosis Modulators|mitosis modulators|mesh-ancestor
101757864|NCT00821457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757883|NCT00821535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757885|NCT00821535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101757886|NCT00821535|Antiviral Agents|antiviral agents|mesh-ancestor
101757887|NCT00821535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101757888|NCT00821535|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101757889|NCT04062006|Aldesleukin|aldesleukin|mesh-list
101757890|NCT04062006|Interleukin-2|interleukin-2|mesh-list
101757891|NCT04062006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101757892|NCT04062006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101757893|NCT04062006|Analgesics|analgesics|mesh-ancestor
101757894|NCT04062006|Sensory System Agents|sensory system agents|mesh-ancestor
101757895|NCT04062006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101563310|NCT05255146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101563311|NCT05255146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563312|NCT05255146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101563313|NCT05255146|Analgesics|analgesics|mesh-ancestor
101563314|NCT05255146|Sensory System Agents|sensory system agents|mesh-ancestor
101563315|NCT05255146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101563316|NCT05254743|Pirtobrutinib|pirtobrutinib|mesh-list
101563317|NCT05254743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101563318|NCT05254743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101411585|NCT04728308|Bupivacaine|bupivacaine|mesh-list
101757896|NCT04062006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757897|NCT04062006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101757898|NCT04062006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101757899|NCT04062006|Antiviral Agents|antiviral agents|mesh-ancestor
101757900|NCT04062006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101757901|NCT04872582|Bevacizumab|bevacizumab|mesh-list
101757902|NCT04872582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101757903|NCT04872582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101757904|NCT04872582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101757905|NCT04872582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101757906|NCT04872582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101757907|NCT04872582|Growth Substances|growth substances|mesh-ancestor
101757908|NCT04872582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757909|NCT04872582|Growth Inhibitors|growth inhibitors|mesh-ancestor
101757910|NCT04872582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757911|NCT04061538|Zinc|zinc|mesh-list
101757912|NCT04061538|Zinc Sulfate|zinc sulfate|mesh-list
101757913|NCT04061538|Trace Elements|trace elements|mesh-ancestor
101757914|NCT04061538|Micronutrients|micronutrients|mesh-ancestor
101757915|NCT04061538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757916|NCT04061538|Astringents|astringents|mesh-ancestor
101757917|NCT04061538|Dermatologic Agents|dermatologic agents|mesh-ancestor
101757918|NCT04351620|Hydroxychloroquine|hydroxychloroquine|mesh-list
101757919|NCT04351620|Antimalarials|antimalarials|mesh-ancestor
101757938|NCT00627393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101757940|NCT00627393|Autonomic Agents|autonomic agents|mesh-ancestor
101757941|NCT00627393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101757942|NCT00627393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757943|NCT00627393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101757944|NCT00627393|Glucocorticoids|glucocorticoids|mesh-ancestor
101757946|NCT00627393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101757947|NCT00627393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101757948|NCT00627393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101757949|NCT00577122|Cyclophosphamide|cyclophosphamide|mesh-list
101757950|NCT00577122|Methotrexate|methotrexate|mesh-list
101757951|NCT00577122|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101757952|NCT00577122|Medroxyprogesterone|medroxyprogesterone|mesh-list
101757953|NCT00577122|Progesterone|progesterone|mesh-list
101757954|NCT00577122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101757955|NCT00577122|Immunologic Factors|immunologic factors|mesh-ancestor
101757956|NCT00577122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757957|NCT00577122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101757958|NCT00577122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101757959|NCT00577122|Alkylating Agents|alkylating agents|mesh-ancestor
101757960|NCT00577122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757961|NCT00577122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101757962|NCT00577122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101757963|NCT00577122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101757964|NCT00577122|Abortifacient Agents|abortifacient agents|mesh-ancestor
101757965|NCT00577122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101757966|NCT00577122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101757967|NCT00577122|Antimetabolites|antimetabolites|mesh-ancestor
101757968|NCT00577122|Dermatologic Agents|dermatologic agents|mesh-ancestor
101757969|NCT00577122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101757970|NCT00577122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101563319|NCT05254743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563321|NCT05198609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563323|NCT05198609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101563324|NCT05198609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563325|NCT05191004|Fulvestrant|fulvestrant|mesh-list
101563326|NCT05191004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101563327|NCT05191004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563328|NCT05191004|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101563329|NCT05191004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101563330|NCT05191004|Hormone Antagonists|hormone antagonists|mesh-ancestor
101411595|NCT00461422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757971|NCT00577122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101757972|NCT00577122|Progestins|progestins|mesh-ancestor
101757973|NCT00577122|Hormones|hormones|mesh-ancestor
101757974|NCT00577122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101757975|NCT00577122|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101757976|NCT00577122|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101532538|NCT00568503|Bromides|bromides|mesh-list
101757990|NCT00822081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101757991|NCT00822081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101757993|NCT00822081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101757994|NCT00822081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757995|NCT00822081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101757996|NCT00822081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101757997|NCT00822081|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101757998|NCT00822081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101757999|NCT00822081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101758000|NCT00822081|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101758001|NCT00696774|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101758002|NCT00696774|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101758003|NCT00696774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101758004|NCT00696774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101758005|NCT00696774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758006|NCT00696774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101758007|NCT00696774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758008|NCT00696774|Analgesics|analgesics|mesh-ancestor
101758009|NCT00696774|Sensory System Agents|sensory system agents|mesh-ancestor
101415423|NCT00127985|Antiemetics|antiemetics|mesh-ancestor
101758010|NCT00696774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101758011|NCT00696774|Antidepressive Agents|antidepressive agents|mesh-ancestor
101758012|NCT00696774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101758013|NCT00696774|Dopamine Agents|dopamine agents|mesh-ancestor
101758014|NCT00608842|Deoxycholic Acid|deoxycholic acid|mesh-list
101758015|NCT00608842|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101758016|NCT00608842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101758017|NCT00626925|Topiramate|topiramate|mesh-list
101758018|NCT00626925|Anticonvulsants|anticonvulsants|mesh-ancestor
101758019|NCT00626925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101758020|NCT00626925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758021|NCT00816543|Docetaxel|docetaxel|mesh-list
101758022|NCT00816543|Oxaliplatin|oxaliplatin|mesh-list
101758023|NCT00816543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101758024|NCT00816543|Tubulin Modulators|tubulin modulators|mesh-ancestor
101758025|NCT00816543|Antimitotic Agents|antimitotic agents|mesh-ancestor
101758026|NCT00816543|Mitosis Modulators|mitosis modulators|mesh-ancestor
101758027|NCT00816543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758028|NCT00698646|Valsartan|valsartan|mesh-list
101758029|NCT00698646|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101758030|NCT00698646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101758031|NCT00698646|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101563331|NCT05191004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101563332|NCT05191004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563333|NCT05185089|Maleic acid|maleic acid|mesh-list
101563334|NCT05185089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101563335|NCT05185089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563336|NCT05157672|Letrozole|letrozole|mesh-list
101563337|NCT05157672|Nicotine|nicotine|mesh-list
101563338|NCT05157672|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101563339|NCT05157672|Autonomic Agents|autonomic agents|mesh-ancestor
101563340|NCT05157672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101563341|NCT05157672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758032|NCT00698646|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101758033|NCT00698646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758034|NCT00698646|Diuretics|diuretics|mesh-ancestor
101758045|NCT02565888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101758046|NCT02565888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758047|NCT02565888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101758048|NCT02565888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101758049|NCT02565888|Antiviral Agents|antiviral agents|mesh-ancestor
101758050|NCT02565888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101758051|NCT02565888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101758052|NCT02565888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101758053|NCT00609466|Morphine|morphine|mesh-list
101758054|NCT00609466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101758055|NCT00609466|Narcotics|narcotics|mesh-ancestor
101758056|NCT00609466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101758057|NCT00609466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758058|NCT00609466|Analgesics|analgesics|mesh-ancestor
101758059|NCT00609466|Sensory System Agents|sensory system agents|mesh-ancestor
101758060|NCT00609466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101758061|NCT00822315|Efavirenz|efavirenz|mesh-list
101758062|NCT00822315|Raltegravir Potassium|raltegravir potassium|mesh-list
101758063|NCT00822315|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101758064|NCT00822315|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101758065|NCT00822315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101758066|NCT00822315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758067|NCT00822315|Antiviral Agents|antiviral agents|mesh-ancestor
101758068|NCT00822315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101758069|NCT00822315|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101758070|NCT00822315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101758071|NCT00822315|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101758072|NCT00822315|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101758073|NCT00822315|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101758074|NCT00822315|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101758075|NCT00822315|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101758076|NCT00822315|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101758077|NCT00822315|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101758078|NCT00822315|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101218299|NCT01491321|Loxoprofen|loxoprofen|mesh-list
101758079|NCT00696696|Gemcitabine|gemcitabine|mesh-list
101758080|NCT00696696|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101758081|NCT00696696|Sorafenib|sorafenib|mesh-list
101758082|NCT00696696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101758083|NCT00696696|Antimetabolites|antimetabolites|mesh-ancestor
101758084|NCT00696696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758085|NCT00696696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101758086|NCT00696696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101758087|NCT00696696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101758089|NCT00822393|Treosulfan|treosulfan|mesh-list
101758090|NCT00822393|Alkylating Agents|alkylating agents|mesh-ancestor
101758091|NCT00822393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563342|NCT05157672|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101563343|NCT05157672|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101563344|NCT05157672|Cholinergic Agents|cholinergic agents|mesh-ancestor
101563345|NCT05157672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101563346|NCT05157672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563347|NCT05157672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563348|NCT05157672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101563349|NCT05157672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101411620|NCT00461578|Antiviral Agents|antiviral agents|mesh-ancestor
101758092|NCT00822393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101758093|NCT00822393|Immunologic Factors|immunologic factors|mesh-ancestor
101758094|NCT00822393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758095|NCT00822393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101758096|NCT00822393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101758097|NCT00822393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101758098|NCT00819195|Glatiramer Acetate|glatiramer acetate|mesh-list
101758099|NCT00819195|(T,G)-A-L|(t,g)-a-l|mesh-list
101758114|NCT00892918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758115|NCT00892918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101758116|NCT02551185|Citarinostat|citarinostat|mesh-list
101758117|NCT02551185|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101758118|NCT02551185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101758119|NCT02551185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758120|NCT00892996|Dexamethasone|dexamethasone|mesh-list
101758121|NCT00892996|Dexamethasone acetate|dexamethasone acetate|mesh-list
101758122|NCT00892996|BB 1101|bb 1101|mesh-list
101758123|NCT00892996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101758124|NCT00892996|Antiemetics|antiemetics|mesh-ancestor
101758125|NCT00892996|Autonomic Agents|autonomic agents|mesh-ancestor
101758126|NCT00892996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101758127|NCT00892996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758128|NCT00892996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101758129|NCT00892996|Glucocorticoids|glucocorticoids|mesh-ancestor
101758130|NCT00892996|Hormones|hormones|mesh-ancestor
101758131|NCT00892996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101758132|NCT00892996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101758133|NCT00892996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101758134|NCT00892996|Protease Inhibitors|protease inhibitors|mesh-ancestor
101758135|NCT00892996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101758136|NCT00892996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758137|NCT00891670|Aspirin|aspirin|mesh-list
101758138|NCT00891670|Cilostazol|cilostazol|mesh-list
101758139|NCT00891670|Clopidogrel|clopidogrel|mesh-list
101758140|NCT00891670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101758141|NCT00891670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101758142|NCT00891670|Analgesics|analgesics|mesh-ancestor
101758143|NCT00891670|Sensory System Agents|sensory system agents|mesh-ancestor
101758144|NCT00891670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101758145|NCT00891670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758146|NCT00891670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101758147|NCT00891670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101758148|NCT00891670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101758149|NCT00891670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101758150|NCT00891670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758151|NCT00891670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101758152|NCT00891670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101758153|NCT00891670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101758154|NCT00891670|Antipyretics|antipyretics|mesh-ancestor
101758155|NCT00891670|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101758156|NCT00891670|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101758157|NCT00891670|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101758158|NCT00891670|Purinergic Agents|purinergic agents|mesh-ancestor
101758159|NCT00891670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101758160|NCT00891670|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101758171|NCT00699192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101563350|NCT05157672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101563351|NCT05157672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101563352|NCT05157672|Hormone Antagonists|hormone antagonists|mesh-ancestor
101563353|NCT05157672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101563355|NCT05111145|Elexacaftor|elexacaftor|mesh-list
101563356|NCT05111145|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101563357|NCT05111145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101563358|NCT05111145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758172|NCT00699192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101758173|NCT00699192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101758174|NCT00699192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758175|NCT00699192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101758176|NCT00699192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758177|NCT00699192|Vasodilator Agents|vasodilator agents|mesh-ancestor
101534588|NCT04575675|Dapagliflozin|dapagliflozin|mesh-list
101758178|NCT00699192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101758179|NCT00699192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101758180|NCT00921180|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101758181|NCT00921180|Interferon-alpha|interferon-alpha|mesh-list
101758182|NCT00921180|Entecavir|entecavir|mesh-list
101758183|NCT00921180|Antiviral Agents|antiviral agents|mesh-ancestor
101758184|NCT00921180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101758185|NCT00921180|Immunologic Factors|immunologic factors|mesh-ancestor
101758186|NCT00921180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758187|NCT04671810|Eculizumab|eculizumab|mesh-list
101758188|NCT04671810|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101758189|NCT04671810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101758190|NCT04671810|Immunologic Factors|immunologic factors|mesh-ancestor
101758191|NCT04671810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758192|NCT00893542|Mycophenolic Acid|mycophenolic acid|mesh-list
101758193|NCT00893542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101758194|NCT00893542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101758195|NCT00893542|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101758196|NCT00893542|Antitubercular Agents|antitubercular agents|mesh-ancestor
101758197|NCT00893542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101758198|NCT00893542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101758199|NCT00893542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101758200|NCT00893542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758201|NCT00401245|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101758202|NCT00401245|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101758203|NCT00401245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101758204|NCT00401245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101758205|NCT00401245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758206|NCT00401245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101758207|NCT00401245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758208|NCT00401245|Antidepressive Agents|antidepressive agents|mesh-ancestor
101758209|NCT00401245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101758210|NCT04661280|Donepezil|donepezil|mesh-list
101758211|NCT04661280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101758212|NCT04661280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101758213|NCT04661280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758214|NCT04661280|Cholinergic Agents|cholinergic agents|mesh-ancestor
101758215|NCT04661280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101758216|NCT04661280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758217|NCT04661280|Nootropic Agents|nootropic agents|mesh-ancestor
101758218|NCT00696384|Antihypertensive Agents|antihypertensive agents|mesh-list
101758219|NCT00696384|Chlorthalidone|chlorthalidone|mesh-list
101758220|NCT00696384|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
101758221|NCT00696384|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101758222|NCT00696384|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101758223|NCT00696384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563360|NCT05090033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563361|NCT05060432|Pembrolizumab|pembrolizumab|mesh-list
101563362|NCT05060432|Dostarlimab|dostarlimab|mesh-list
101563363|NCT05060432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101563364|NCT05060432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563365|NCT05060432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101563366|NCT05060432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563367|NCT05023980|Rituximab|rituximab|mesh-list
101563368|NCT05023980|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101563369|NCT05023980|Pirtobrutinib|pirtobrutinib|mesh-list
101411639|NCT00116064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101758238|NCT01041625|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101758240|NCT01041625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101758241|NCT01041625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758242|NCT02566356|Oxytocin|oxytocin|mesh-list
101758243|NCT02566356|Oxytocics|oxytocics|mesh-ancestor
101758244|NCT02566356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101758245|NCT02566356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758246|NCT00892450|Oxybutynin|oxybutynin|mesh-list
101758247|NCT00892450|Darifenacin|darifenacin|mesh-list
101758248|NCT00892450|Parasympatholytics|parasympatholytics|mesh-ancestor
101758249|NCT00892450|Autonomic Agents|autonomic agents|mesh-ancestor
101758250|NCT00892450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101758251|NCT00892450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758252|NCT00892450|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101758253|NCT00892450|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101758254|NCT00892450|Cholinergic Agents|cholinergic agents|mesh-ancestor
101758255|NCT00892450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101758256|NCT00892450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758257|NCT00892450|Urological Agents|urological agents|mesh-ancestor
101758258|NCT01566565|Theophylline|theophylline|mesh-list
101758259|NCT01566565|Bambuterol|bambuterol|mesh-list
101758260|NCT01566565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101758261|NCT01566565|Autonomic Agents|autonomic agents|mesh-ancestor
101758262|NCT01566565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101758263|NCT01566565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758264|NCT01566565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101758265|NCT01566565|Respiratory System Agents|respiratory system agents|mesh-ancestor
101758266|NCT01566565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101758267|NCT01566565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101758268|NCT01566565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758269|NCT01566565|Vasodilator Agents|vasodilator agents|mesh-ancestor
101758270|NCT01566565|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101758271|NCT01566565|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101758272|NCT01566565|Purinergic Agents|purinergic agents|mesh-ancestor
101758273|NCT01566565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101758274|NCT01039363|Cytarabine|cytarabine|mesh-list
101758275|NCT01039363|Vorinostat|vorinostat|mesh-list
101758276|NCT01039363|Idarubicin|idarubicin|mesh-list
101758277|NCT01039363|Gemtuzumab|gemtuzumab|mesh-list
101758278|NCT01039363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101758279|NCT01039363|Antimetabolites|antimetabolites|mesh-ancestor
101758280|NCT01039363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758281|NCT01039363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101758282|NCT01039363|Antiviral Agents|antiviral agents|mesh-ancestor
101758283|NCT01039363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101758296|NCT01039441|Anesthetics, Local|anesthetics, local|mesh-ancestor
101758297|NCT01039441|Anesthetics|anesthetics|mesh-ancestor
101218543|NCT01493388|Insulin|insulin|mesh-list
101758298|NCT01039441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101758299|NCT01039441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758300|NCT01039441|Sensory System Agents|sensory system agents|mesh-ancestor
101758301|NCT01039441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101758302|NCT01034917|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101563370|NCT05023980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101563371|NCT05023980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563372|NCT05023980|Immunologic Factors|immunologic factors|mesh-ancestor
101563373|NCT05023980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563374|NCT05023980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101563375|NCT05023980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101563376|NCT05023980|Alkylating Agents|alkylating agents|mesh-ancestor
101563377|NCT05023980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563378|NCT05023980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101563379|NCT05023980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101563380|NCT05007522|Ketotifen|ketotifen|mesh-list
101411650|NCT04728035|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101758304|NCT01034917|Antiviral Agents|antiviral agents|mesh-ancestor
101758305|NCT01034917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101758306|NCT01034917|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101758307|NCT01034917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101415722|NCT00502099|Antimetabolites|antimetabolites|mesh-ancestor
101758308|NCT01034917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101758309|NCT01034917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758310|NCT00816699|Anesthetics|anesthetics|mesh-list
101758311|NCT00816699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101758312|NCT00816699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758313|NCT00822549|Morphine|morphine|mesh-list
101758314|NCT00822549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101758315|NCT00822549|Narcotics|narcotics|mesh-ancestor
101758316|NCT00822549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101758317|NCT00822549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758318|NCT00822549|Analgesics|analgesics|mesh-ancestor
101758319|NCT00822549|Sensory System Agents|sensory system agents|mesh-ancestor
101758320|NCT00822549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101758321|NCT00819351|Asparaginase|asparaginase|mesh-list
101758322|NCT00819351|Pegaspargase|pegaspargase|mesh-list
101758323|NCT00819351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101758324|NCT00699998|Aspirin|aspirin|mesh-list
101758325|NCT00699998|Clopidogrel|clopidogrel|mesh-list
101758326|NCT00699998|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101758327|NCT00699998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101758328|NCT00699998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101758329|NCT00699998|Analgesics|analgesics|mesh-ancestor
101758330|NCT00699998|Sensory System Agents|sensory system agents|mesh-ancestor
101758331|NCT00699998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101758332|NCT00699998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758333|NCT00699998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101758334|NCT00699998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101758335|NCT00699998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101758336|NCT00699998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101758337|NCT00699998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758338|NCT00699998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101758339|NCT00699998|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101758340|NCT00699998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101758341|NCT00699998|Antipyretics|antipyretics|mesh-ancestor
101758342|NCT00699998|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101758343|NCT00699998|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101758344|NCT00699998|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101758345|NCT00699998|Purinergic Agents|purinergic agents|mesh-ancestor
101758363|NCT00816855|Antimitotic Agents|antimitotic agents|mesh-ancestor
101758364|NCT00816855|Mitosis Modulators|mitosis modulators|mesh-ancestor
101758365|NCT00816855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758366|NCT00816855|Antimetabolites|antimetabolites|mesh-ancestor
101758367|NCT00816855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101758368|NCT00816855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101563381|NCT05007522|Indomethacin|indomethacin|mesh-list
101563382|NCT05007522|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101563383|NCT05007522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101563384|NCT05007522|Analgesics|analgesics|mesh-ancestor
101563385|NCT05007522|Sensory System Agents|sensory system agents|mesh-ancestor
101563386|NCT05007522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101563387|NCT05007522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563388|NCT05007522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101563389|NCT05007522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101758369|NCT00816855|Immunologic Factors|immunologic factors|mesh-ancestor
101758370|NCT00816855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758372|NCT00822783|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101758373|NCT00822783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101758374|NCT00822783|Respiratory System Agents|respiratory system agents|mesh-ancestor
101758375|NCT00634647|Prednisone|prednisone|mesh-list
101758376|NCT00634647|Satraplatin|satraplatin|mesh-list
101758377|NCT00634647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101758378|NCT00634647|Glucocorticoids|glucocorticoids|mesh-ancestor
101758379|NCT00634647|Hormones|hormones|mesh-ancestor
101758380|NCT00634647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101758381|NCT00634647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758382|NCT00634647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101758383|NCT00634647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101758384|NCT00576732|Risperidone|risperidone|mesh-list
101758385|NCT00576732|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101758386|NCT00576732|Serotonin Agents|serotonin agents|mesh-ancestor
101758387|NCT00576732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101758388|NCT00576732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758389|NCT00576732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758390|NCT00576732|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101758391|NCT00576732|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101758392|NCT00576732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101758393|NCT00576732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101758394|NCT00576732|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101758395|NCT00576732|Dopamine Agents|dopamine agents|mesh-ancestor
101758396|NCT00817011|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101758397|NCT00817011|Mirtazapine|mirtazapine|mesh-list
101758398|NCT00817011|Trazodone|trazodone|mesh-list
101758399|NCT00817011|Bupropion|bupropion|mesh-list
101758400|NCT00817011|Fluoxetine|fluoxetine|mesh-list
101758401|NCT00817011|Paroxetine|paroxetine|mesh-list
101758402|NCT00817011|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101758403|NCT00817011|Citalopram|citalopram|mesh-list
101758404|NCT00817011|Sertraline|sertraline|mesh-list
101758405|NCT00817011|Nortriptyline|nortriptyline|mesh-list
101532968|NCT00571116|Disulfiram|disulfiram|mesh-list
101758420|NCT00817011|Analgesics|analgesics|mesh-ancestor
101758421|NCT00817011|Sensory System Agents|sensory system agents|mesh-ancestor
101758422|NCT00817011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101758423|NCT00817011|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101758424|NCT00817011|Serotonin Agents|serotonin agents|mesh-ancestor
101758425|NCT00817011|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101758426|NCT00817011|Histamine Antagonists|histamine antagonists|mesh-ancestor
101758427|NCT00817011|Histamine Agents|histamine agents|mesh-ancestor
101758428|NCT00817011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101758429|NCT00817011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101758430|NCT00817011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101758431|NCT00817011|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101758432|NCT00817011|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101758433|NCT00817011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101758434|NCT00817011|Adrenergic Agents|adrenergic agents|mesh-ancestor
101758435|NCT00817011|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101758436|NCT00817011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101758437|NCT00817011|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101758438|NCT00817011|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101758439|NCT00817011|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101758440|NCT00697788|Dexmedetomidine|dexmedetomidine|mesh-list
101758441|NCT00697788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101563390|NCT05007522|Gout Suppressants|gout suppressants|mesh-ancestor
101563391|NCT05007522|Tocolytic Agents|tocolytic agents|mesh-ancestor
101563392|NCT05007522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101563393|NCT05007522|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101563394|NCT05007522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101563395|NCT05007522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563397|NCT05007522|Dermatologic Agents|dermatologic agents|mesh-ancestor
101411669|NCT00461968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101758442|NCT00697788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101758443|NCT00697788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758444|NCT00697788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101758445|NCT00697788|Analgesics|analgesics|mesh-ancestor
101758446|NCT00697788|Sensory System Agents|sensory system agents|mesh-ancestor
101758447|NCT00697788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101758448|NCT00697788|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101758449|NCT00697788|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101758450|NCT00697788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101758451|NCT00697788|Adrenergic Agents|adrenergic agents|mesh-ancestor
101758452|NCT00697788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101758453|NCT00697788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415873|NCT00503542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101758454|NCT00400153|Ipratropium|ipratropium|mesh-list
101758455|NCT00400153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101758456|NCT00400153|Autonomic Agents|autonomic agents|mesh-ancestor
101758457|NCT00400153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101758458|NCT00400153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533018|NCT04613609|Nicotine|nicotine|mesh-list
101758476|NCT00817245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101758477|NCT00817245|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101758478|NCT00817245|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101758479|NCT00817245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101758480|NCT00817245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101758481|NCT00817245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101758482|NCT00817245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101758483|NCT00817245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758484|NCT02550483|Beta Carotene|beta carotene|mesh-list
101758485|NCT02550483|Lycopene|lycopene|mesh-list
101758486|NCT02550483|Carotenoids|carotenoids|mesh-list
101758487|NCT02550483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101758488|NCT02550483|Antioxidants|antioxidants|mesh-ancestor
101758489|NCT02550483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758490|NCT02550483|Protective Agents|protective agents|mesh-ancestor
101758491|NCT02550483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758492|NCT02550483|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101758493|NCT02550483|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101758494|NCT02550483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101758495|NCT02550483|Provitamins|provitamins|mesh-ancestor
101758496|NCT02550483|Vitamins|vitamins|mesh-ancestor
101758497|NCT02550483|Micronutrients|micronutrients|mesh-ancestor
101758498|NCT04608318|Venetoclax|venetoclax|mesh-list
101758499|NCT04608318|Obinutuzumab|obinutuzumab|mesh-list
101758500|NCT04608318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101758501|NCT04608318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101758502|NCT04063358|Ranibizumab|ranibizumab|mesh-list
101758503|NCT04063358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101758504|NCT04063358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101758505|NCT04063358|Growth Substances|growth substances|mesh-ancestor
101758506|NCT04063358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758507|NCT04063358|Growth Inhibitors|growth inhibitors|mesh-ancestor
101758508|NCT04063358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101758509|NCT00631917|Ramipril|ramipril|mesh-list
101758510|NCT00631917|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101758511|NCT00631917|Protease Inhibitors|protease inhibitors|mesh-ancestor
101758512|NCT00631917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101758513|NCT00631917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758514|NCT00631917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101758515|NCT00419341|Immunoglobulins|immunoglobulins|mesh-list
101563398|NCT05007522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101563399|NCT05007522|Histamine Antagonists|histamine antagonists|mesh-ancestor
101563400|NCT05007522|Histamine Agents|histamine agents|mesh-ancestor
101563401|NCT05007522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101758516|NCT00419341|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101758517|NCT00419341|Antibodies|antibodies|mesh-list
101758518|NCT00419341|Immunologic Factors|immunologic factors|mesh-ancestor
101758519|NCT00419341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758520|NCT00694122|Insulin Glargine|insulin glargine|mesh-list
101758521|NCT00694122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101758539|NCT01034995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758540|NCT01034995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101758541|NCT01034995|Serotonin Agents|serotonin agents|mesh-ancestor
101758542|NCT01034995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758543|NCT00921414|Rituximab|rituximab|mesh-list
101758544|NCT00921414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101758545|NCT00921414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101758546|NCT00921414|Immunologic Factors|immunologic factors|mesh-ancestor
101758547|NCT00921414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758548|NCT00921414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101758549|NCT04060914|Clopidogrel|clopidogrel|mesh-list
101758550|NCT04060914|Ticagrelor|ticagrelor|mesh-list
101758551|NCT04060914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101758552|NCT04060914|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101758553|NCT04060914|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101758554|NCT04060914|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101758555|NCT04060914|Purinergic Agents|purinergic agents|mesh-ancestor
101758556|NCT04060914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101758557|NCT04060914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758558|NCT04060914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758559|NCT03894696|Antiviral Agents|antiviral agents|mesh-list
101758560|NCT03894696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101758561|NCT00399763|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101758562|NCT00399763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101407472|NCT00107393|Capecitabine|capecitabine|mesh-list
101758563|NCT00399763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101758564|NCT00399763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101758565|NCT00399763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758566|NCT00399763|Adrenergic Agents|adrenergic agents|mesh-ancestor
101758567|NCT00399763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101758568|NCT00399763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758569|NCT05324904|Vitamin D|vitamin d|mesh-list
101758570|NCT05324904|Acyclovir|acyclovir|mesh-list
101758571|NCT05324904|Vitamins|vitamins|mesh-ancestor
101758572|NCT05324904|Micronutrients|micronutrients|mesh-ancestor
101758573|NCT05324904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758574|NCT05324904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101758575|NCT05324904|Antiviral Agents|antiviral agents|mesh-ancestor
101758576|NCT05324904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101533143|NCT00568347|Xhance|xhance|mesh-list
101758599|NCT00399529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101758600|NCT00399529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101758601|NCT00399529|Alkylating Agents|alkylating agents|mesh-ancestor
101758602|NCT00399529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758603|NCT00399529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101758604|NCT00399529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101758605|NCT00399529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101758606|NCT00712712|Acetaminophen|acetaminophen|mesh-list
101758608|NCT00712712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101758609|NCT00712712|Narcotics|narcotics|mesh-ancestor
101758610|NCT00712712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101758611|NCT00712712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758612|NCT00712712|Analgesics|analgesics|mesh-ancestor
101758613|NCT00712712|Sensory System Agents|sensory system agents|mesh-ancestor
101758614|NCT00712712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101758615|NCT00712712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101758616|NCT00712712|Antipyretics|antipyretics|mesh-ancestor
101758617|NCT00411151|Sunitinib|sunitinib|mesh-list
101758618|NCT00411151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101758619|NCT00411151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101758620|NCT00411151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101758621|NCT00411151|Growth Substances|growth substances|mesh-ancestor
101563402|NCT05007522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101563403|NCT05003349|Salicylic Acid|salicylic acid|mesh-list
101563404|NCT05003349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101563405|NCT05003349|Antifungal Agents|antifungal agents|mesh-ancestor
101563406|NCT05003349|Keratolytic Agents|keratolytic agents|mesh-ancestor
101563407|NCT05003349|Dermatologic Agents|dermatologic agents|mesh-ancestor
101563408|NCT04952779|Insulin|insulin|mesh-list
101563409|NCT04952779|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101563410|NCT04952779|Liraglutide|liraglutide|mesh-list
101563411|NCT04952779|Insulin, Long-Acting|insulin, long-acting|mesh-list
101563412|NCT04952779|Xultophy|xultophy|mesh-list
101563413|NCT04952779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101563414|NCT04952779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563415|NCT04952779|Incretins|incretins|mesh-ancestor
101563416|NCT04952779|Hormones|hormones|mesh-ancestor
101563417|NCT04952779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101758622|NCT00411151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758623|NCT00411151|Growth Inhibitors|growth inhibitors|mesh-ancestor
101758624|NCT00411151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101758625|NCT00411151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101758626|NCT00411151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758627|NCT00607048|Paclitaxel|paclitaxel|mesh-list
101758646|NCT04035850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101758647|NCT04035850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101758648|NCT04035850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758649|NCT04035850|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101758650|NCT04035850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101758651|NCT04035850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101758652|NCT04035850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758653|NCT04035850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101758654|NCT04035850|Serotonin Agents|serotonin agents|mesh-ancestor
101758655|NCT04035850|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101758656|NCT04035850|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101758657|NCT04035850|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101758658|NCT04035850|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101758659|NCT00699608|Zopiclone|zopiclone|mesh-list
101758660|NCT00699608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101758661|NCT00699608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101758662|NCT00699608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758663|NCT00895570|Modafinil|modafinil|mesh-list
101758664|NCT00895570|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101758665|NCT00895570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758666|NCT00895570|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101758667|NCT00895570|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101758668|NCT00895570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101758669|NCT00895570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758670|NCT00895648|Pemetrexed|pemetrexed|mesh-list
101758671|NCT00895648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101758672|NCT00895648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101758673|NCT00895648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758674|NCT00895648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101758675|NCT00895648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101758676|NCT00893854|Triamcinolone|triamcinolone|mesh-list
101758677|NCT00893854|Diclofenac|diclofenac|mesh-list
101758678|NCT00893854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101758679|NCT00893854|Glucocorticoids|glucocorticoids|mesh-ancestor
101758680|NCT00893854|Hormones|hormones|mesh-ancestor
101758681|NCT00893854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101563419|NCT04941573|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101563420|NCT04941573|Anesthetics, General|anesthetics, general|mesh-ancestor
101563422|NCT04941573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101563423|NCT04941573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563424|NCT04926948|Immunomodulating Agents|immunomodulating agents|mesh-list
101563425|NCT04926948|Immunologic Factors|immunologic factors|mesh-ancestor
101563426|NCT04926948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563427|NCT04900623|Paclitaxel|paclitaxel|mesh-list
101563428|NCT04900623|Cisplatin|cisplatin|mesh-list
101563429|NCT04900623|Carboplatin|carboplatin|mesh-list
101758682|NCT00893854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758695|NCT00895804|Adrenergic Agents|adrenergic agents|mesh-ancestor
101758696|NCT00895804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101758697|NCT00895804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758698|NCT00895804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758699|NCT00895804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101758700|NCT00895804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101758701|NCT00895804|Serotonin Agents|serotonin agents|mesh-ancestor
101758702|NCT00895804|Vasodilator Agents|vasodilator agents|mesh-ancestor
101758703|NCT00895882|Interferons|interferons|mesh-list
101758704|NCT00895882|Ribavirin|ribavirin|mesh-list
101758705|NCT00895882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101758706|NCT00895882|Antiviral Agents|antiviral agents|mesh-ancestor
101758707|NCT00895882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101758708|NCT00895882|Antimetabolites|antimetabolites|mesh-ancestor
101758709|NCT00895882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758710|NCT00706706|Sunitinib|sunitinib|mesh-list
101758711|NCT00706706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101758712|NCT00706706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101758713|NCT00706706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101758714|NCT00706706|Growth Substances|growth substances|mesh-ancestor
101758715|NCT00706706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758716|NCT00706706|Growth Inhibitors|growth inhibitors|mesh-ancestor
101758717|NCT00706706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101758718|NCT00706706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101758719|NCT00706706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758720|NCT00894010|Carbamazepine|carbamazepine|mesh-list
101758721|NCT00894010|Levetiracetam|levetiracetam|mesh-list
101758722|NCT00894010|Anticonvulsants|anticonvulsants|mesh-ancestor
101758723|NCT00894010|Nootropic Agents|nootropic agents|mesh-ancestor
101758724|NCT00894010|Antimanic Agents|antimanic agents|mesh-ancestor
101758725|NCT00894010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101758726|NCT00894010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101758727|NCT00894010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758728|NCT00894010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101758729|NCT00894010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101758730|NCT00894010|Analgesics|analgesics|mesh-ancestor
101758731|NCT00894010|Sensory System Agents|sensory system agents|mesh-ancestor
101758732|NCT00894010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101758733|NCT00894010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101758734|NCT00894010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101758735|NCT00894010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758737|NCT00894010|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101758738|NCT00895960|Temozolomide|temozolomide|mesh-list
101758739|NCT00895960|Dasatinib|dasatinib|mesh-list
101758740|NCT00895960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101758741|NCT00895960|Alkylating Agents|alkylating agents|mesh-ancestor
101758742|NCT00895960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758743|NCT00895960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101758744|NCT00895960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101758745|NCT00895960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101758758|NCT03818178|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101758760|NCT00921128|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101758761|NCT00921128|GABA Agonists|gaba agonists|mesh-ancestor
101563430|NCT04900623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101563431|NCT04900623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563433|NCT04900623|Antimitotic Agents|antimitotic agents|mesh-ancestor
101563434|NCT04900623|Mitosis Modulators|mitosis modulators|mesh-ancestor
101563435|NCT04900623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563436|NCT04899050|Cannabidiol|cannabidiol|mesh-list
101563437|NCT04899050|Anticonvulsants|anticonvulsants|mesh-ancestor
101563438|NCT04876781|Tofacitinib|tofacitinib|mesh-list
101563439|NCT04876781|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101563440|NCT04876781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101563441|NCT04876781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101563442|NCT04876781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758762|NCT00921128|GABA Agents|gaba agents|mesh-ancestor
101758763|NCT00921128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101758764|NCT00921128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758765|NCT00921128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758766|NCT05508776|Moxifloxacin|moxifloxacin|mesh-list
101758767|NCT05508776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101758768|NCT05508776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101758769|NCT05508776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101758770|NCT05508776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101758771|NCT05508776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101758772|NCT05508776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758773|NCT05508776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101758774|NCT00896428|Gallopamil|gallopamil|mesh-list
101758775|NCT00896428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101758776|NCT00896428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101758777|NCT00896428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758778|NCT00896428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101758779|NCT00896428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758780|NCT02962050|Capsaicin|capsaicin|mesh-list
101758781|NCT02962050|Antipruritics|antipruritics|mesh-ancestor
101758782|NCT02962050|Dermatologic Agents|dermatologic agents|mesh-ancestor
101758783|NCT02962050|Sensory System Agents|sensory system agents|mesh-ancestor
101758784|NCT02962050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101758785|NCT02962050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758786|NCT04486716|Ofatumumab|ofatumumab|mesh-list
101758787|NCT04486716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101758788|NCT00410605|Dexamethasone|dexamethasone|mesh-list
101758789|NCT00410605|Bevacizumab|bevacizumab|mesh-list
101758790|NCT00410605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101758791|NCT00410605|Lenalidomide|lenalidomide|mesh-list
101758792|NCT00410605|Antibodies|antibodies|mesh-list
101758793|NCT00410605|Immunoglobulins|immunoglobulins|mesh-list
101758794|NCT00410605|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101758795|NCT00410605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101758796|NCT00410605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101758797|NCT00410605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101758798|NCT00410605|Growth Substances|growth substances|mesh-ancestor
101758799|NCT00410605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758800|NCT00410605|Growth Inhibitors|growth inhibitors|mesh-ancestor
101758801|NCT00410605|Immunologic Factors|immunologic factors|mesh-ancestor
101758802|NCT00410605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101758803|NCT00410605|Antiemetics|antiemetics|mesh-ancestor
101758804|NCT00410605|Autonomic Agents|autonomic agents|mesh-ancestor
101758805|NCT00410605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101533373|NCT00575640|Hydralazine|hydralazine|mesh-list
101758817|NCT00742638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101758818|NCT00742638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758819|NCT00742638|Anticonvulsants|anticonvulsants|mesh-ancestor
101563454|NCT04818216|Niacinamide|niacinamide|mesh-list
101563455|NCT04818216|Niacin|niacin|mesh-list
101563456|NCT04818216|Nicotinic Acids|nicotinic acids|mesh-list
101563457|NCT04818216|Vitamin B Complex|vitamin b complex|mesh-ancestor
101758820|NCT00742638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101758821|NCT00742638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758822|NCT00742638|GABA Agents|gaba agents|mesh-ancestor
101758823|NCT00742638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101758824|NCT00742638|Antimanic Agents|antimanic agents|mesh-ancestor
101758826|NCT00418717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101758827|NCT00418717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101758828|NCT00418717|Analgesics|analgesics|mesh-ancestor
101758829|NCT00418717|Sensory System Agents|sensory system agents|mesh-ancestor
101758830|NCT00418717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101758831|NCT00418717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758832|NCT00418717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101758833|NCT00418717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101758834|NCT00418717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101758835|NCT00418717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101758836|NCT00418717|Immunologic Factors|immunologic factors|mesh-ancestor
101758838|NCT00572572|Antiemetics|antiemetics|mesh-ancestor
101758839|NCT00572572|Autonomic Agents|autonomic agents|mesh-ancestor
101758840|NCT00572572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101758841|NCT00572572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758842|NCT00572572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101758843|NCT00572572|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101758844|NCT00572572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101758845|NCT00572572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758846|NCT00897130|Azacitidine|azacitidine|mesh-list
101758847|NCT00897130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101758848|NCT00897130|Antimetabolites|antimetabolites|mesh-ancestor
101758849|NCT00897130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758850|NCT00897130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101758851|NCT00897130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101758852|NCT00398047|Mitogens|mitogens|mesh-list
101758853|NCT00398047|Mitosis Modulators|mitosis modulators|mesh-ancestor
101758854|NCT00398047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758855|NCT00631371|Interferons|interferons|mesh-list
101758856|NCT00631371|Interferon-alpha|interferon-alpha|mesh-list
101758857|NCT00631371|Sirolimus|sirolimus|mesh-list
101758858|NCT00631371|Bevacizumab|bevacizumab|mesh-list
101758859|NCT00631371|Temsirolimus|temsirolimus|mesh-list
101758860|NCT00631371|MTOR Inhibitors|mtor inhibitors|mesh-list
101758861|NCT00631371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101758862|NCT00631371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101758863|NCT00631371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101758864|NCT00631371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101758865|NCT00631371|Growth Substances|growth substances|mesh-ancestor
101758866|NCT00631371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758867|NCT00631371|Growth Inhibitors|growth inhibitors|mesh-ancestor
101758868|NCT00631371|Antiviral Agents|antiviral agents|mesh-ancestor
101758869|NCT00631371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101758870|NCT00631371|Immunologic Factors|immunologic factors|mesh-ancestor
101758898|NCT04016740|Adrenergic Agents|adrenergic agents|mesh-ancestor
101758899|NCT04016740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101758900|NCT04016740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758901|NCT04016740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101758902|NCT04016740|Anesthetics, General|anesthetics, general|mesh-ancestor
101758903|NCT04016740|Anesthetics|anesthetics|mesh-ancestor
101758904|NCT04016740|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101758905|NCT04016740|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101758906|NCT04016740|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101563458|NCT04818216|Vitamins|vitamins|mesh-ancestor
101525401|NCT04678791|Cisplatin|cisplatin|mesh-list
101563459|NCT04818216|Micronutrients|micronutrients|mesh-ancestor
101563460|NCT04818216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563461|NCT04818216|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101563462|NCT04818216|Antimetabolites|antimetabolites|mesh-ancestor
101197122|NCT01389557|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101563463|NCT04818216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563465|NCT04818216|Vasodilator Agents|vasodilator agents|mesh-ancestor
101758907|NCT04016740|Anesthetics, Local|anesthetics, local|mesh-ancestor
101758908|NCT04016740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101758909|NCT04016740|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101758910|NCT04016740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101758911|NCT04016740|Narcotics|narcotics|mesh-ancestor
101758912|NCT04016740|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101758913|NCT04016740|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101758914|NCT04016740|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101758915|NCT02540512|Acetaminophen|acetaminophen|mesh-list
101758916|NCT02540512|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
101758917|NCT02540512|Hydrocodone|hydrocodone|mesh-list
101758918|NCT02540512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101758919|NCT02540512|Analgesics|analgesics|mesh-ancestor
101758932|NCT00897520|Interferons|interferons|mesh-list
101758933|NCT00897520|Interferon-alpha|interferon-alpha|mesh-list
101758934|NCT00897520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101758935|NCT00897520|Antiviral Agents|antiviral agents|mesh-ancestor
101758936|NCT00897520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101758937|NCT00897520|Immunologic Factors|immunologic factors|mesh-ancestor
101758938|NCT00897520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758939|NCT00894634|Brompheniramine|brompheniramine|mesh-list
101758940|NCT00894634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758941|NCT00894634|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101758942|NCT00894634|Histamine Antagonists|histamine antagonists|mesh-ancestor
101758943|NCT00894634|Histamine Agents|histamine agents|mesh-ancestor
101758944|NCT00894634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101758945|NCT00894634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758946|NCT00894634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101758947|NCT00894712|Sulforaphane|sulforaphane|mesh-list
101758948|NCT00894712|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101758949|NCT00894712|Protective Agents|protective agents|mesh-ancestor
101758950|NCT00894712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758951|NCT00894712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101758952|NCT00823641|Infliximab|infliximab|mesh-list
101758953|NCT00823641|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101758954|NCT00823641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101758955|NCT00823641|Dermatologic Agents|dermatologic agents|mesh-ancestor
101758956|NCT00823641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101758957|NCT00823641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101758958|NCT00823875|Cilostazol|cilostazol|mesh-list
101758959|NCT00823875|Probucol|probucol|mesh-list
101758960|NCT00823875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101758961|NCT00823875|Autonomic Agents|autonomic agents|mesh-ancestor
101758962|NCT00823875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101758963|NCT00823875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758964|NCT00823875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101758965|NCT00823875|Respiratory System Agents|respiratory system agents|mesh-ancestor
101758966|NCT00823875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101758967|NCT00823875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101758968|NCT00823875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758969|NCT00823875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101758970|NCT00823875|Vasodilator Agents|vasodilator agents|mesh-ancestor
101758971|NCT00823875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101758972|NCT00823875|Protective Agents|protective agents|mesh-ancestor
101758973|NCT00823875|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101758974|NCT00823875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101758975|NCT00823875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101758976|NCT00823875|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101758977|NCT00823875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101758978|NCT00823875|Antimetabolites|antimetabolites|mesh-ancestor
101758979|NCT00823875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101563466|NCT04808622|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
101563467|NCT04808622|Antioxidants|antioxidants|mesh-ancestor
101563468|NCT04808622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563469|NCT04808622|Protective Agents|protective agents|mesh-ancestor
101563470|NCT04808622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563471|NCT04808622|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101411742|NCT00405015|Rosiglitazone|rosiglitazone|mesh-list
101758980|NCT00823875|Antioxidants|antioxidants|mesh-ancestor
101758981|NCT00397189|Melatonin|melatonin|mesh-list
101758982|NCT00397189|Antioxidants|antioxidants|mesh-ancestor
101451747|NCT00203099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101758995|NCT04044651|Lenvatinib|lenvatinib|mesh-list
101758996|NCT04044651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101758997|NCT04044651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101758998|NCT04044651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101758999|NCT04044651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759000|NCT04044651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101759001|NCT04044651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101759002|NCT00606034|Insulin|insulin|mesh-list
101759003|NCT00606034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101759004|NCT00606034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759005|NCT00819975|Caseins|caseins|mesh-list
101759006|NCT00819975|Chelating Agents|chelating agents|mesh-ancestor
101759007|NCT00819975|Sequestering Agents|sequestering agents|mesh-ancestor
101759008|NCT00819975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759009|NCT04044417|Curcumin|curcumin|mesh-list
101759010|NCT04044417|Simvastatin|simvastatin|mesh-list
101759011|NCT04044417|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101759012|NCT04044417|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101759013|NCT04044417|Antimetabolites|antimetabolites|mesh-ancestor
101759014|NCT04044417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759015|NCT04044417|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101759016|NCT04044417|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101759017|NCT04044417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101759018|NCT04044417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101759019|NCT04044417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101759020|NCT04044417|Analgesics|analgesics|mesh-ancestor
101759021|NCT04044417|Sensory System Agents|sensory system agents|mesh-ancestor
101759022|NCT04044417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101759023|NCT04044417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759024|NCT04044417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101759025|NCT04044417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101759026|NCT04044417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101759027|NCT00397033|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101759028|NCT00397033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101759029|NCT00397033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101759030|NCT00397033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101759031|NCT00397033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759032|NCT00397033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101759033|NCT00397033|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101759034|NCT00397033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101759036|NCT00397033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101759037|NCT00397033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759038|NCT00397033|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101759039|NCT00397033|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101759040|NCT00397033|Dopamine Agents|dopamine agents|mesh-ancestor
101759041|NCT00820053|Epirubicin|epirubicin|mesh-list
101759042|NCT00820053|Ethiodized Oil|ethiodized oil|mesh-list
101759043|NCT00820053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101759044|NCT00820053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101759045|NCT00820053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101759046|NCT00820053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101759055|NCT00572728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101759056|NCT00572728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101759058|NCT00699374|Sorafenib|sorafenib|mesh-list
101759059|NCT00699374|Sunitinib|sunitinib|mesh-list
101759060|NCT00699374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101759061|NCT00699374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101563472|NCT04808622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563474|NCT04798339|Hematinics|hematinics|mesh-ancestor
101563475|NCT04783675|Rituximab|rituximab|mesh-list
101563476|NCT04783675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101563477|NCT04783675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563478|NCT04783675|Immunologic Factors|immunologic factors|mesh-ancestor
101563479|NCT04783675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563480|NCT04783675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101563481|NCT04695080|Cladribine|cladribine|mesh-list
101563482|NCT04695080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101759062|NCT00699374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101759063|NCT00699374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759064|NCT00699374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101759065|NCT00699374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101759066|NCT00699374|Growth Substances|growth substances|mesh-ancestor
101759067|NCT00699374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759068|NCT00699374|Growth Inhibitors|growth inhibitors|mesh-ancestor
101759069|NCT00898534|Chrysarobin|chrysarobin|mesh-list
101759070|NCT00898534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101759071|NCT00898534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101759072|NCT00898534|Analgesics|analgesics|mesh-ancestor
101759073|NCT00898534|Sensory System Agents|sensory system agents|mesh-ancestor
101759074|NCT00898534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101759075|NCT00898534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759076|NCT00898534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101759077|NCT00898534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101759078|NCT00606892|Nicotine|nicotine|mesh-list
101759079|NCT00606892|Varenicline|varenicline|mesh-list
101759080|NCT00606892|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101759081|NCT00606892|Autonomic Agents|autonomic agents|mesh-ancestor
101759082|NCT00606892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101759083|NCT00606892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759084|NCT00606892|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101759085|NCT00606892|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101759086|NCT00606892|Cholinergic Agents|cholinergic agents|mesh-ancestor
101759087|NCT00606892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101759088|NCT00606892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759089|NCT00894946|Ethiodized Oil|ethiodized oil|mesh-list
101759090|NCT00894946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101759091|NCT01042561|Vitamin D|vitamin d|mesh-list
101759092|NCT01042561|Ergocalciferols|ergocalciferols|mesh-list
101759093|NCT01042561|Cholecalciferol|cholecalciferol|mesh-list
101759094|NCT01042561|Vitamins|vitamins|mesh-list
101759095|NCT01042561|Micronutrients|micronutrients|mesh-ancestor
101759096|NCT01042561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759097|NCT01042561|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101759098|NCT01042561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101759099|NCT01035853|Colistin|colistin|mesh-list
101759100|NCT01035853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101759101|NCT01035853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101759102|NCT01042717|Plerixafor|plerixafor|mesh-list
101759103|NCT01042717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101759104|NCT01042717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101759105|NCT01042717|Antiviral Agents|antiviral agents|mesh-ancestor
101759106|NCT01042717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101759107|NCT03648385|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101759108|NCT03648385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101759109|NCT03648385|Immunologic Factors|immunologic factors|mesh-ancestor
101759110|NCT03648385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759111|NCT00898846|Tegafur|tegafur|mesh-list
101759112|NCT00898846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101759113|NCT00898846|Antimetabolites|antimetabolites|mesh-ancestor
101533657|NCT00577161|Vidarabine|vidarabine|mesh-list
101759139|NCT02550717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101759140|NCT02550717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101759142|NCT02550717|Sensory System Agents|sensory system agents|mesh-ancestor
101563483|NCT04695080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101563484|NCT04695080|Immunologic Factors|immunologic factors|mesh-ancestor
101563485|NCT04695080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411758|NCT00462787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101759143|NCT02550717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101759144|NCT02550717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759145|NCT02550717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101759146|NCT02550717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101759147|NCT02550717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101759148|NCT02550717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101759149|NCT02550717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759150|NCT02550717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101759151|NCT02550717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101759152|NCT02550717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101759153|NCT02550717|Antipyretics|antipyretics|mesh-ancestor
101759154|NCT02550717|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101759155|NCT02550717|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101759156|NCT02550717|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101759157|NCT02550717|Purinergic Agents|purinergic agents|mesh-ancestor
101759158|NCT02550717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101759159|NCT02550249|Nivolumab|nivolumab|mesh-list
101759175|NCT00824811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101759176|NCT00824811|Dermatologic Agents|dermatologic agents|mesh-ancestor
101759177|NCT00824811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101759178|NCT00824811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101759179|NCT00824811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101759180|NCT00824811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101759181|NCT00824811|Glucocorticoids|glucocorticoids|mesh-ancestor
101759183|NCT00824811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101759184|NCT00824811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101759185|NCT00606580|Paromomycin|paromomycin|mesh-list
101759186|NCT00606580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101759187|NCT00606580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101759188|NCT00606580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101759189|NCT00606580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101759190|NCT02550327|Paclitaxel|paclitaxel|mesh-list
101759191|NCT02550327|Gemcitabine|gemcitabine|mesh-list
101759192|NCT02550327|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101759193|NCT02550327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101759194|NCT02550327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101759195|NCT02550327|Tubulin Modulators|tubulin modulators|mesh-ancestor
101759196|NCT02550327|Antimitotic Agents|antimitotic agents|mesh-ancestor
101759197|NCT02550327|Mitosis Modulators|mitosis modulators|mesh-ancestor
101759198|NCT02550327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759199|NCT02550327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101759200|NCT02550327|Antimetabolites|antimetabolites|mesh-ancestor
101759201|NCT02550327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101759202|NCT00825045|Risperidone|risperidone|mesh-list
101759203|NCT00825045|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101759204|NCT00825045|Serotonin Agents|serotonin agents|mesh-ancestor
101759205|NCT00825045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101416624|NCT00130754|Thymoglobulin|thymoglobulin|mesh-list
101759206|NCT00825045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759207|NCT00825045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759208|NCT00825045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101759209|NCT00825045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101759210|NCT00825045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101759211|NCT00825045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101759212|NCT00825045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101759214|NCT00606502|Vitamins|vitamins|mesh-list
101759215|NCT00606502|Folic Acid|folic acid|mesh-list
101759216|NCT00606502|Vitamin B 12|vitamin b 12|mesh-list
101759217|NCT00606502|Vitamin B Complex|vitamin b complex|mesh-list
101759218|NCT00606502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101759219|NCT00606502|10-deazaaminopterin|10-deazaaminopterin|mesh-list
101759229|NCT00825123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101563493|NCT04591353|Lidocaine|lidocaine|mesh-list
101563494|NCT04591353|Anesthetics, Local|anesthetics, local|mesh-ancestor
101563495|NCT04591353|Anesthetics|anesthetics|mesh-ancestor
101563496|NCT04591353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101563497|NCT04591353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563498|NCT04591353|Sensory System Agents|sensory system agents|mesh-ancestor
101563499|NCT04591353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101563500|NCT04591353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101563501|NCT04591353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101563502|NCT04591353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101563503|NCT04591353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101759230|NCT00825123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101759231|NCT00825123|Sympatholytics|sympatholytics|mesh-ancestor
101759232|NCT00825123|Autonomic Agents|autonomic agents|mesh-ancestor
101759233|NCT00825123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101759234|NCT00825123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759235|NCT00825123|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101759236|NCT00825123|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101759237|NCT00825123|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101759238|NCT00825123|Adrenergic Agents|adrenergic agents|mesh-ancestor
101759239|NCT00825123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101759240|NCT00825123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759241|NCT00826839|Leuprolide|leuprolide|mesh-list
101759242|NCT00826839|Contraceptive Agents|contraceptive agents|mesh-list
101759243|NCT00826839|Contraceptives, Oral|contraceptives, oral|mesh-list
101759244|NCT00826839|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
101759245|NCT00826839|Ganirelix|ganirelix|mesh-list
101759246|NCT00826839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101759247|NCT00826839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759248|NCT00826839|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101759249|NCT00826839|Fertility Agents|fertility agents|mesh-ancestor
101759250|NCT00826839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101759251|NCT00826839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101759252|NCT00826839|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101759253|NCT00826839|Hormone Antagonists|hormone antagonists|mesh-ancestor
101759254|NCT00826839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101759255|NCT04017988|Ethanol|ethanol|mesh-list
101759256|NCT04017988|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101759257|NCT04017988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101759258|NCT04017988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101759259|NCT04017988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759260|NCT00825201|Paclitaxel|paclitaxel|mesh-list
101759261|NCT00825201|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101759262|NCT00825201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101759263|NCT00825201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101759264|NCT00825201|Tubulin Modulators|tubulin modulators|mesh-ancestor
101759265|NCT00825201|Antimitotic Agents|antimitotic agents|mesh-ancestor
101759266|NCT00825201|Mitosis Modulators|mitosis modulators|mesh-ancestor
101759267|NCT00825201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759268|NCT00820911|Cyclosporine|cyclosporine|mesh-list
101759269|NCT00820911|Everolimus|everolimus|mesh-list
101759270|NCT00820911|Cyclosporins|cyclosporins|mesh-list
101759271|NCT00820911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101759272|NCT00820911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759273|NCT00820911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101759274|NCT00820911|Immunologic Factors|immunologic factors|mesh-ancestor
101759275|NCT00820911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759276|NCT00820911|Antifungal Agents|antifungal agents|mesh-ancestor
101759277|NCT00820911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101759278|NCT00820911|Dermatologic Agents|dermatologic agents|mesh-ancestor
101759279|NCT00820911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101563504|NCT04591353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563506|NCT04540211|Atezolizumab|atezolizumab|mesh-list
101563507|NCT04540211|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101563508|NCT04540211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101563509|NCT04540211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563510|NCT04540211|Tubulin Modulators|tubulin modulators|mesh-ancestor
101563511|NCT04540211|Antimitotic Agents|antimitotic agents|mesh-ancestor
101563512|NCT04540211|Mitosis Modulators|mitosis modulators|mesh-ancestor
101563513|NCT04540211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563514|NCT04540211|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101563515|NCT04540211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101563516|NCT04540211|Immunologic Factors|immunologic factors|mesh-ancestor
101563517|NCT04540211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416701|NCT00131027|Antimetabolites|antimetabolites|mesh-ancestor
101759280|NCT00820911|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101759281|NCT00820911|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101759282|NCT00820911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101759283|NCT00820911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101759284|NCT00605722|Bevacizumab|bevacizumab|mesh-list
101759292|NCT00605722|Growth Inhibitors|growth inhibitors|mesh-ancestor
101759293|NCT00605722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101759294|NCT00605722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101759295|NCT00605722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759296|NCT00882076|Etoposide|etoposide|mesh-list
101759297|NCT00882076|Mitoxantrone|mitoxantrone|mesh-list
101759298|NCT00882076|Etoposide phosphate|etoposide phosphate|mesh-list
101759299|NCT00882076|Clofarabine|clofarabine|mesh-list
101759300|NCT00882076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101759301|NCT00882076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101759302|NCT00882076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101759303|NCT00882076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101759304|NCT00882076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101759305|NCT00882076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759306|NCT00882076|Analgesics|analgesics|mesh-ancestor
101759307|NCT00882076|Sensory System Agents|sensory system agents|mesh-ancestor
101759308|NCT00882076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101759309|NCT00882076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759310|NCT00882076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101759311|NCT00882076|Antimetabolites|antimetabolites|mesh-ancestor
101759312|NCT00827151|Estrogens|estrogens|mesh-list
101759313|NCT00827151|Hormones|hormones|mesh-ancestor
101759314|NCT00827151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101759315|NCT00827151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759316|NCT00882154|Cefdinir|cefdinir|mesh-list
101759317|NCT00882154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101759318|NCT00882154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101759319|NCT00825591|Melatonin|melatonin|mesh-list
101759320|NCT00825591|Antioxidants|antioxidants|mesh-ancestor
101759321|NCT00825591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759322|NCT00825591|Protective Agents|protective agents|mesh-ancestor
101759323|NCT00825591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759324|NCT00825591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101759325|NCT00882232|Hyaluronic Acid|hyaluronic acid|mesh-list
101759326|NCT00882232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101759327|NCT00882232|Immunologic Factors|immunologic factors|mesh-ancestor
101759328|NCT00882232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759329|NCT00882232|Viscosupplements|viscosupplements|mesh-ancestor
101759330|NCT00882232|Protective Agents|protective agents|mesh-ancestor
101759331|NCT00900172|Paclitaxel|paclitaxel|mesh-list
101759332|NCT00900172|Bevacizumab|bevacizumab|mesh-list
101563518|NCT04505774|Dapagliflozin|dapagliflozin|mesh-list
101563519|NCT04505774|Empagliflozin|empagliflozin|mesh-list
101563520|NCT04505774|Canagliflozin|canagliflozin|mesh-list
101563521|NCT04505774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
101563522|NCT04505774|Ertugliflozin|ertugliflozin|mesh-list
101563523|NCT04505774|Heparin|heparin|mesh-list
101563524|NCT04505774|Calcium heparin|calcium heparin|mesh-list
101563525|NCT04505774|Enoxaparin|enoxaparin|mesh-list
101563526|NCT04505774|Dalteparin|dalteparin|mesh-list
101563527|NCT04505774|Tinzaparin|tinzaparin|mesh-list
101563528|NCT04505774|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101563529|NCT04505774|Enoxaparin sodium|enoxaparin sodium|mesh-list
101563530|NCT04505774|Clopidogrel|clopidogrel|mesh-list
101563531|NCT04505774|Ticagrelor|ticagrelor|mesh-list
101563532|NCT04505774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101563533|NCT04505774|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101563534|NCT04505774|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101563535|NCT04505774|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101563536|NCT04505774|Purinergic Agents|purinergic agents|mesh-ancestor
101563537|NCT04505774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101525477|NCT00557232|Bevacizumab|bevacizumab|mesh-list
101563538|NCT04505774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563539|NCT04505774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563540|NCT04505774|Anticoagulants|anticoagulants|mesh-ancestor
101563541|NCT04505774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101759333|NCT00900172|Carboplatin|carboplatin|mesh-list
101759334|NCT00900172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101759335|NCT00900172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101759336|NCT00900172|Tubulin Modulators|tubulin modulators|mesh-ancestor
101759337|NCT00900172|Antimitotic Agents|antimitotic agents|mesh-ancestor
101759338|NCT00900172|Mitosis Modulators|mitosis modulators|mesh-ancestor
101759339|NCT00900172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759340|NCT00900172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101759341|NCT00900172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101759342|NCT00900172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101759343|NCT00900172|Growth Substances|growth substances|mesh-ancestor
101759344|NCT00900172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759345|NCT00900172|Growth Inhibitors|growth inhibitors|mesh-ancestor
101759346|NCT00605566|Cyclophosphamide|cyclophosphamide|mesh-list
101759347|NCT00605566|Sorafenib|sorafenib|mesh-list
101759348|NCT00605566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101759349|NCT00605566|Immunologic Factors|immunologic factors|mesh-ancestor
101759350|NCT00605566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759351|NCT00605566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101533886|NCT00578760|Aspirin|aspirin|mesh-list
101759364|NCT00882388|Analgesics|analgesics|mesh-ancestor
101759365|NCT00882388|Sensory System Agents|sensory system agents|mesh-ancestor
101759366|NCT00882388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101759367|NCT00882388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759368|NCT00882388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101759369|NCT00882388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101759370|NCT00882388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101759371|NCT00882388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101759372|NCT00882388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563542|NCT04505774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101563543|NCT04505774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101563544|NCT04499950|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
101563545|NCT04499950|Naltrexone|naltrexone|mesh-list
101563546|NCT04499950|Bupropion|bupropion|mesh-list
101563547|NCT04499950|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101563548|NCT04499950|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101563549|NCT04499950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563550|NCT04499950|Sensory System Agents|sensory system agents|mesh-ancestor
101563551|NCT04499950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101563552|NCT04499950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101563553|NCT04499950|Antidepressive Agents|antidepressive agents|mesh-ancestor
101563554|NCT04499950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101563555|NCT04499950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101563556|NCT04499950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101563557|NCT04499950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101759373|NCT00882388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101759374|NCT00882388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101759375|NCT00882388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101759376|NCT00882388|Antipyretics|antipyretics|mesh-ancestor
101759377|NCT00882388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101759378|NCT00882388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101759379|NCT00882388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101759380|NCT00882388|Purinergic Agents|purinergic agents|mesh-ancestor
101759381|NCT00882388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101759382|NCT00882388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101759383|NCT00396877|Clopidogrel|clopidogrel|mesh-list
101759384|NCT00396877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101759385|NCT00396877|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101759386|NCT00396877|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101759387|NCT00396877|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101759388|NCT00396877|Purinergic Agents|purinergic agents|mesh-ancestor
101759389|NCT00396877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101759390|NCT00396877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759391|NCT00396877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759392|NCT00124891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
101759393|NCT00882466|Epoetin Alfa|epoetin alfa|mesh-list
101759394|NCT00882466|Hematinics|hematinics|mesh-ancestor
101759395|NCT00901498|BMS 708163|bms 708163|mesh-list
101759396|NCT00901498|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101759397|NCT00901498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101759398|NCT00901498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759399|NCT00628251|Doxorubicin|doxorubicin|mesh-list
101759400|NCT00628251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101759401|NCT00628251|Olaparib|olaparib|mesh-list
101759402|NCT00628251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101759403|NCT00628251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101759404|NCT00628251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101759405|NCT00628251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101759406|NCT00628251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101759407|NCT00628251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759408|NCT00628251|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101759409|NCT01036399|Lenalidomide|lenalidomide|mesh-list
101759410|NCT01036399|Immunologic Factors|immunologic factors|mesh-ancestor
101759428|NCT00625131|Cholinergic Agents|cholinergic agents|mesh-ancestor
101759429|NCT00625131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101563558|NCT04499950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563560|NCT04499950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101563561|NCT04499950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101563562|NCT04499950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101563563|NCT04499950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101563564|NCT04499950|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101563565|NCT04444492|Ranibizumab|ranibizumab|mesh-list
101563566|NCT04444492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101563567|NCT04444492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101563568|NCT04444492|Growth Substances|growth substances|mesh-ancestor
101563569|NCT04444492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563570|NCT04444492|Growth Inhibitors|growth inhibitors|mesh-ancestor
101563571|NCT04444492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563572|NCT04402385|Aspirin|aspirin|mesh-list
101563573|NCT04402385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101563574|NCT04402385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101563575|NCT04402385|Analgesics|analgesics|mesh-ancestor
101563576|NCT04402385|Sensory System Agents|sensory system agents|mesh-ancestor
101563577|NCT04402385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101563578|NCT04402385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759430|NCT00625131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759431|NCT00625131|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101759432|NCT00625131|Antidepressive Agents|antidepressive agents|mesh-ancestor
101759433|NCT00625131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101759434|NCT00625131|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101759435|NCT00625131|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101759436|NCT00625131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101759437|NCT00625131|Dopamine Agents|dopamine agents|mesh-ancestor
101759438|NCT00625131|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101759439|NCT00625131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101759440|NCT00625131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101759441|NCT00901732|Calcium|calcium|mesh-list
101759442|NCT00901732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101759443|NCT00901732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759444|NCT00882700|Cefdinir|cefdinir|mesh-list
101759445|NCT00882700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101759446|NCT00882700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101759447|NCT00408499|Cetuximab|cetuximab|mesh-list
101759448|NCT00408499|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101759449|NCT00408499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101759450|NCT00408499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101759451|NCT00408499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101759452|NCT00408499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101759453|NCT00408499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759454|NCT00837369|Regadenoson|regadenoson|mesh-list
101759455|NCT00837369|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
101759456|NCT00837369|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101759457|NCT00837369|Purinergic Agonists|purinergic agonists|mesh-ancestor
101759458|NCT00837369|Purinergic Agents|purinergic agents|mesh-ancestor
101759459|NCT00837369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101759460|NCT00837369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563579|NCT04402385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101563580|NCT04402385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101563581|NCT04402385|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101563582|NCT04402385|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101563583|NCT04402385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563584|NCT04402385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101563585|NCT04402385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101563586|NCT04402385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101563587|NCT04402385|Antipyretics|antipyretics|mesh-ancestor
101563588|NCT04396730|Cannabidiol|cannabidiol|mesh-list
101563589|NCT04396730|Contraceptive Agents|contraceptive agents|mesh-list
101563590|NCT04396730|Contraceptives, Oral|contraceptives, oral|mesh-list
101563591|NCT04396730|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
101563592|NCT04396730|Anticonvulsants|anticonvulsants|mesh-ancestor
101563593|NCT04396730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101563594|NCT04396730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563595|NCT04396730|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101563596|NCT04385368|Durvalumab|durvalumab|mesh-list
101563597|NCT04385368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101563598|NCT04385368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563599|NCT04378868|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101563600|NCT04378868|Metronidazole|metronidazole|mesh-list
101563601|NCT04378868|Cefuroxime|cefuroxime|mesh-list
101563602|NCT04378868|Cefuroxime axetil|cefuroxime axetil|mesh-list
101563603|NCT04378868|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101563604|NCT04378868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101563605|NCT04378868|Antitubercular Agents|antitubercular agents|mesh-ancestor
101563606|NCT04378868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101563607|NCT04378868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101563608|NCT04300556|Farletuzumab|farletuzumab|mesh-list
101759461|NCT00837369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759462|NCT00900874|Albuterol|albuterol|mesh-list
101759463|NCT00900874|Formoterol Fumarate|formoterol fumarate|mesh-list
101759464|NCT00900874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101759465|NCT00900874|Autonomic Agents|autonomic agents|mesh-ancestor
101759466|NCT00900874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101759475|NCT00900874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759477|NCT00900874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101759478|NCT02539810|Antihypertensive Agents|antihypertensive agents|mesh-list
101759479|NCT00901888|Nitroprusside|nitroprusside|mesh-list
101759480|NCT00901888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101759481|NCT00901888|Vasodilator Agents|vasodilator agents|mesh-ancestor
101759482|NCT00901888|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101759483|NCT00901888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759484|NCT00908362|Fluticasone|fluticasone|mesh-list
101759485|NCT00908362|Xhance|xhance|mesh-list
101563609|NCT04300556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563611|NCT04251585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101563612|NCT04251585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563613|NCT04218357|Probenecid|probenecid|mesh-list
101563614|NCT04218357|Uricosuric Agents|uricosuric agents|mesh-ancestor
101563615|NCT04218357|Gout Suppressants|gout suppressants|mesh-ancestor
101563616|NCT04218357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101563617|NCT04166877|Magnesium Sulfate|magnesium sulfate|mesh-list
101563618|NCT04166877|Analgesics|analgesics|mesh-ancestor
101563619|NCT04166877|Sensory System Agents|sensory system agents|mesh-ancestor
101563620|NCT04166877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101563621|NCT04166877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563622|NCT04166877|Anesthetics|anesthetics|mesh-ancestor
101563623|NCT04166877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101563624|NCT04166877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101563625|NCT04166877|Anticonvulsants|anticonvulsants|mesh-ancestor
101563626|NCT04166877|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101411878|NCT00463957|Urological Agents|urological agents|mesh-ancestor
101759486|NCT00908362|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101759487|NCT00908362|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101759488|NCT00908362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101759489|NCT00908362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101759490|NCT00908362|Autonomic Agents|autonomic agents|mesh-ancestor
101759491|NCT00908362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101759492|NCT00908362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759493|NCT00908362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101759494|NCT00908362|Respiratory System Agents|respiratory system agents|mesh-ancestor
101759495|NCT00908362|Dermatologic Agents|dermatologic agents|mesh-ancestor
101759496|NCT00908362|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101759497|NCT00908362|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101759498|NCT00908362|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101759499|NCT00908362|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101759500|NCT00908362|Adrenergic Agents|adrenergic agents|mesh-ancestor
101759501|NCT00908362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101759502|NCT00908362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759503|NCT00908362|Glucocorticoids|glucocorticoids|mesh-ancestor
101759504|NCT00908362|Hormones|hormones|mesh-ancestor
101759505|NCT00908362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101759506|NCT00908362|Sympathomimetics|sympathomimetics|mesh-ancestor
101759507|NCT02549469|Naproxen|naproxen|mesh-list
101759508|NCT02549469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101759509|NCT02549469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101759510|NCT02549469|Analgesics|analgesics|mesh-ancestor
101759511|NCT02549469|Sensory System Agents|sensory system agents|mesh-ancestor
101759512|NCT02549469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101759513|NCT02549469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759514|NCT02549469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101759515|NCT02549469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101759516|NCT02549469|Gout Suppressants|gout suppressants|mesh-ancestor
101759517|NCT02549469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101759518|NCT02549469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101759519|NCT02549469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759520|NCT02548533|Lidocaine|lidocaine|mesh-list
101759521|NCT02548533|Epinephrine|epinephrine|mesh-list
101759522|NCT02548533|Prilocaine|prilocaine|mesh-list
101759523|NCT02548533|Carticaine|carticaine|mesh-list
101563627|NCT04166877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101563628|NCT04166877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563629|NCT04166877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101563630|NCT04166877|Tocolytic Agents|tocolytic agents|mesh-ancestor
101563631|NCT04166877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101563632|NCT04164979|Pembrolizumab|pembrolizumab|mesh-list
101563633|NCT04164979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101759524|NCT02548533|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
101759525|NCT02548533|Anesthetics, Local|anesthetics, local|mesh-ancestor
101759526|NCT02548533|Anesthetics|anesthetics|mesh-ancestor
101759527|NCT02548533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101759528|NCT02548533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759529|NCT02548533|Sensory System Agents|sensory system agents|mesh-ancestor
101759530|NCT02548533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101759531|NCT02548533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101759532|NCT02548533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101759533|NCT02548533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101759543|NCT02548533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101759544|NCT02548533|Respiratory System Agents|respiratory system agents|mesh-ancestor
101759545|NCT02548533|Mydriatics|mydriatics|mesh-ancestor
101759546|NCT02548533|Sympathomimetics|sympathomimetics|mesh-ancestor
101759547|NCT02548533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101759548|NCT02548533|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
101759550|NCT02549391|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101759551|NCT02549391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759552|NCT02549391|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101759553|NCT02549391|Hormone Antagonists|hormone antagonists|mesh-ancestor
101759554|NCT02549391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101759555|NCT02538172|Valganciclovir|valganciclovir|mesh-list
101759556|NCT02538172|Antiviral Agents|antiviral agents|mesh-ancestor
101759557|NCT02538172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101759558|NCT00837837|Chlorpheniramine|chlorpheniramine|mesh-list
101759559|NCT00837837|Antipruritics|antipruritics|mesh-ancestor
101759560|NCT00837837|Dermatologic Agents|dermatologic agents|mesh-ancestor
101759561|NCT00837837|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101759562|NCT00837837|Histamine Antagonists|histamine antagonists|mesh-ancestor
101759563|NCT00837837|Histamine Agents|histamine agents|mesh-ancestor
101759564|NCT00837837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101759565|NCT00837837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759566|NCT00837837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759567|NCT00837837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101759568|NCT00908674|Cyproterone Acetate|cyproterone acetate|mesh-list
101759569|NCT00908674|Cyproterone|cyproterone|mesh-list
101759570|NCT00908674|Androgen Antagonists|androgen antagonists|mesh-ancestor
101759571|NCT00908674|Hormone Antagonists|hormone antagonists|mesh-ancestor
101759572|NCT00908674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101759573|NCT00908674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759574|NCT00908674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101759575|NCT00908674|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101759576|NCT00908674|Contraceptive Agents|contraceptive agents|mesh-ancestor
101759577|NCT00908674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101759578|NCT00621777|Varenicline|varenicline|mesh-list
101759579|NCT00621777|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101759580|NCT00621777|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101759581|NCT00621777|Cholinergic Agents|cholinergic agents|mesh-ancestor
101759582|NCT00621777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101759583|NCT00621777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759584|NCT00621777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759586|NCT02538718|Sympathomimetics|sympathomimetics|mesh-ancestor
101759587|NCT02538718|Autonomic Agents|autonomic agents|mesh-ancestor
101759588|NCT02538718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101759589|NCT02538718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759590|NCT02538718|Tocolytic Agents|tocolytic agents|mesh-ancestor
101759591|NCT02538718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101759592|NCT02538718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101563634|NCT04164979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563635|NCT04164979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101563636|NCT04164979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563637|NCT04135846|Doxazosin|doxazosin|mesh-list
101563638|NCT04135846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101563639|NCT04135846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101563640|NCT04135846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101563641|NCT04135846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101563642|NCT04135846|Adrenergic Agents|adrenergic agents|mesh-ancestor
101563643|NCT04135846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101563644|NCT04135846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563645|NCT04135846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563646|NCT04117893|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101563647|NCT04117893|Hyaluronic Acid|hyaluronic acid|mesh-list
101563648|NCT04117893|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101759593|NCT02538718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101759594|NCT02538718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101759595|NCT02538718|Adrenergic Agents|adrenergic agents|mesh-ancestor
101759596|NCT02538718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101759597|NCT02538718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759598|NCT00902512|Sildenafil Citrate|sildenafil citrate|mesh-list
101759615|NCT00827307|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101759617|NCT00837915|Pseudoephedrine|pseudoephedrine|mesh-list
101759618|NCT00837915|Ephedrine|ephedrine|mesh-list
101759619|NCT00837915|Antipruritics|antipruritics|mesh-ancestor
101759621|NCT00837915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101759622|NCT00837915|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101759623|NCT00837915|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101759624|NCT00837915|Histamine Antagonists|histamine antagonists|mesh-ancestor
101759625|NCT00837915|Histamine Agents|histamine agents|mesh-ancestor
101759626|NCT00837915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101759627|NCT00837915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759628|NCT00837915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759629|NCT00837915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101759630|NCT00837915|Autonomic Agents|autonomic agents|mesh-ancestor
101759631|NCT00837915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101759632|NCT00837915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101759633|NCT00837915|Respiratory System Agents|respiratory system agents|mesh-ancestor
101759634|NCT00837915|Nasal Decongestants|nasal decongestants|mesh-ancestor
101759635|NCT00837915|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101759636|NCT00837915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101759637|NCT00837915|Sympathomimetics|sympathomimetics|mesh-ancestor
101759638|NCT00837915|Adrenergic Agents|adrenergic agents|mesh-ancestor
101759639|NCT00908986|Rituximab|rituximab|mesh-list
101759640|NCT00908986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101759641|NCT00908986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101759642|NCT00908986|Immunologic Factors|immunologic factors|mesh-ancestor
101759643|NCT00908986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759644|NCT00908986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101759645|NCT00909142|Clodronic Acid|clodronic acid|mesh-list
101759646|NCT00909142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101759647|NCT00909142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759648|NCT00838071|Immunoglobulins|immunoglobulins|mesh-list
101759649|NCT00838071|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101759651|NCT00838071|Immunologic Factors|immunologic factors|mesh-ancestor
101759652|NCT00838071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759653|NCT02547519|Insulin|insulin|mesh-list
101563649|NCT04117893|Immunologic Factors|immunologic factors|mesh-ancestor
101563650|NCT04117893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563651|NCT04117893|Viscosupplements|viscosupplements|mesh-ancestor
101563652|NCT04117893|Protective Agents|protective agents|mesh-ancestor
101563653|NCT04117893|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101563654|NCT04117893|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101563655|NCT04117893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101563656|NCT04117893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563657|NCT04117893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101563658|NCT04117893|Analgesics|analgesics|mesh-ancestor
101563659|NCT04117893|Sensory System Agents|sensory system agents|mesh-ancestor
101563660|NCT04117893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101563661|NCT04117893|Antidepressive Agents|antidepressive agents|mesh-ancestor
101563662|NCT04117893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101563663|NCT04117893|Dopamine Agents|dopamine agents|mesh-ancestor
101563664|NCT04111458|Trametinib|trametinib|mesh-list
101563665|NCT04111458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101759654|NCT02547519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101759655|NCT02547519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759656|NCT00909454|Vitamin D|vitamin d|mesh-list
101759657|NCT00909454|Ergocalciferols|ergocalciferols|mesh-list
101759670|NCT04035070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101759671|NCT04035070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101759672|NCT04035070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101759673|NCT04035070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101759674|NCT04035070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759675|NCT04035070|Disinfectants|disinfectants|mesh-ancestor
101759676|NCT04035070|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101759677|NCT00408421|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101759678|NCT00408421|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101759679|NCT00408421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101759680|NCT00408421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101759681|NCT00408421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759682|NCT00408421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101759683|NCT00408421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759684|NCT00408421|Analgesics|analgesics|mesh-ancestor
101759685|NCT00408421|Sensory System Agents|sensory system agents|mesh-ancestor
101759686|NCT00408421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101759687|NCT00408421|Antidepressive Agents|antidepressive agents|mesh-ancestor
101759688|NCT00408421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101759689|NCT00408421|Dopamine Agents|dopamine agents|mesh-ancestor
101759690|NCT00604786|Omalizumab|omalizumab|mesh-list
101759691|NCT00604786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101759692|NCT00604786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101759693|NCT00604786|Respiratory System Agents|respiratory system agents|mesh-ancestor
101759694|NCT01042873|Dobutamine|dobutamine|mesh-list
101759695|NCT01042873|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101759696|NCT01042873|Sympathomimetics|sympathomimetics|mesh-ancestor
101759697|NCT01042873|Autonomic Agents|autonomic agents|mesh-ancestor
101759698|NCT01042873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101759699|NCT01042873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759700|NCT01042873|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101759701|NCT01042873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101759702|NCT01042873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101759703|NCT01042873|Adrenergic Agents|adrenergic agents|mesh-ancestor
101759704|NCT01042873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101563666|NCT04111458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101563667|NCT04111458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101563668|NCT04111458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563669|NCT04098003|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101563670|NCT04098003|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101563671|NCT04098003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101563672|NCT04098003|Antimetabolites|antimetabolites|mesh-ancestor
101563673|NCT04098003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563674|NCT04098003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101563675|NCT04098003|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101759705|NCT01042873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759706|NCT01042873|Protective Agents|protective agents|mesh-ancestor
101759707|NCT01042951|Vaccines|vaccines|mesh-list
101759708|NCT01042951|Immunologic Factors|immunologic factors|mesh-ancestor
101759709|NCT01042951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759710|NCT01037023|Topotecan|topotecan|mesh-list
101759711|NCT01037023|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101759712|NCT01037023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101759713|NCT01037023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101759714|NCT01037023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759715|NCT01037023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101759716|NCT00604708|Vaccines|vaccines|mesh-list
101759717|NCT00604708|Immunologic Factors|immunologic factors|mesh-ancestor
101759718|NCT00604708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759719|NCT00909688|BLI-489|bli-489|mesh-list
101759720|NCT00909688|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101759740|NCT04034836|Sensory System Agents|sensory system agents|mesh-ancestor
101759741|NCT04034836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101759742|NCT04034836|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101759743|NCT04034836|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101759744|NCT04034836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101759745|NCT04034836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759746|NCT04034836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101759747|NCT04034836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101759748|NCT04034836|Analgesics|analgesics|mesh-ancestor
101759749|NCT04034836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101759750|NCT04034836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101759751|NCT00407797|Pregabalin|pregabalin|mesh-list
101759752|NCT00407797|Analgesics|analgesics|mesh-ancestor
101759753|NCT00407797|Sensory System Agents|sensory system agents|mesh-ancestor
101759754|NCT00407797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101759755|NCT00407797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759756|NCT00407797|Anticonvulsants|anticonvulsants|mesh-ancestor
101759757|NCT00407797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101759758|NCT00407797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101759759|NCT00407797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759760|NCT00407797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101759761|NCT00407797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101759762|NCT00407797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101759763|NCT00407797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101759764|NCT00407797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101759765|NCT00903292|Pemetrexed|pemetrexed|mesh-list
101759766|NCT00903292|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101759767|NCT00903292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101759768|NCT00903292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101759769|NCT00903292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759770|NCT00903292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101759771|NCT00903292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101759772|NCT00903292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101759774|NCT00903838|Antioxidants|antioxidants|mesh-ancestor
101759775|NCT00903838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563676|NCT04098003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101563677|NCT04049851|Ivermectin|ivermectin|mesh-list
101563678|NCT04049851|Moxidectin|moxidectin|mesh-list
101563679|NCT04049851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101563680|NCT04049851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101563681|NCT04049851|Anthelmintics|anthelmintics|mesh-ancestor
101563682|NCT04049851|Antinematodal Agents|antinematodal agents|mesh-ancestor
101563683|NCT04002115|Mycophenolic Acid|mycophenolic acid|mesh-list
101563684|NCT04002115|Cyclophosphamide|cyclophosphamide|mesh-list
101563685|NCT04002115|Busulfan|busulfan|mesh-list
101525629|NCT00538421|Propofol|propofol|mesh-list
101563686|NCT04002115|Fludarabine|fludarabine|mesh-list
101563687|NCT04002115|Clofarabine|clofarabine|mesh-list
101563688|NCT04002115|Tacrolimus|tacrolimus|mesh-list
101563689|NCT04002115|Lenograstim|lenograstim|mesh-list
101563690|NCT04002115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101563691|NCT04002115|Immunologic Factors|immunologic factors|mesh-ancestor
101563692|NCT04002115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563693|NCT04002115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101759776|NCT00903838|Protective Agents|protective agents|mesh-ancestor
101759792|NCT00924586|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101759793|NCT00924586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101759794|NCT00924586|Adrenergic Agents|adrenergic agents|mesh-ancestor
101759795|NCT00924586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101759796|NCT00924586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759797|NCT00924586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759798|NCT00924586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101759800|NCT00903994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101759801|NCT00903994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101759802|NCT00903994|Analgesics|analgesics|mesh-ancestor
101759803|NCT00903994|Sensory System Agents|sensory system agents|mesh-ancestor
101759804|NCT00903994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101759805|NCT00903994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759806|NCT00903994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101759807|NCT00903994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101759808|NCT00903994|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101759809|NCT00903994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101759810|NCT00903994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759811|NCT00924742|Tazobactam|tazobactam|mesh-list
101759812|NCT00924742|Piperacillin|piperacillin|mesh-list
101759813|NCT00924742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101759814|NCT00924742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101759815|NCT00924742|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101759816|NCT00924742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101759817|NCT00924742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759818|NCT00407563|Paclitaxel|paclitaxel|mesh-list
101759819|NCT00407563|Bevacizumab|bevacizumab|mesh-list
101759820|NCT00407563|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101759821|NCT00407563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101759822|NCT00407563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101759823|NCT00407563|Tubulin Modulators|tubulin modulators|mesh-ancestor
101759824|NCT00407563|Antimitotic Agents|antimitotic agents|mesh-ancestor
101759825|NCT00407563|Mitosis Modulators|mitosis modulators|mesh-ancestor
101759826|NCT00407563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759827|NCT00407563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101759828|NCT00407563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101759829|NCT00407563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101759830|NCT00407563|Growth Substances|growth substances|mesh-ancestor
101759831|NCT00407563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759832|NCT00407563|Growth Inhibitors|growth inhibitors|mesh-ancestor
101563694|NCT04002115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101563695|NCT04002115|Alkylating Agents|alkylating agents|mesh-ancestor
101563696|NCT04002115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563697|NCT04002115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563698|NCT04002115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101563699|NCT04002115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101563700|NCT04002115|Antimetabolites|antimetabolites|mesh-ancestor
101563701|NCT04002115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101563702|NCT04002115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101563703|NCT04002115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101563704|NCT04002115|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101563705|NCT04002115|Antitubercular Agents|antitubercular agents|mesh-ancestor
101563706|NCT04002115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101563707|NCT04002115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101563708|NCT04002115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101563709|NCT03970954|Interleukin-2|interleukin-2|mesh-list
101563710|NCT03970954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101759833|NCT00906724|Insulin|insulin|mesh-list
101759834|NCT00906724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101759835|NCT00906724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759836|NCT01037101|Cycloserine|cycloserine|mesh-list
101759845|NCT00904306|Picolinic acid|picolinic acid|mesh-list
101759846|NCT00904306|Trace Elements|trace elements|mesh-ancestor
101759847|NCT00904306|Micronutrients|micronutrients|mesh-ancestor
101759848|NCT00904306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759849|NCT00904306|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101759850|NCT00904306|Chelating Agents|chelating agents|mesh-ancestor
101759851|NCT00904306|Sequestering Agents|sequestering agents|mesh-ancestor
101759852|NCT00904306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759853|NCT00623103|Rivastigmine|rivastigmine|mesh-list
101759854|NCT00623103|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101759855|NCT00623103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101759856|NCT00623103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759857|NCT00623103|Cholinergic Agents|cholinergic agents|mesh-ancestor
101759858|NCT00623103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101759859|NCT00623103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759860|NCT00623103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101759861|NCT00623103|Protective Agents|protective agents|mesh-ancestor
101759863|NCT01043341|Immunologic Factors|immunologic factors|mesh-ancestor
101759864|NCT01043341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759865|NCT01043419|Xenon|xenon|mesh-list
101759866|NCT01043419|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101759867|NCT01043419|Anesthetics, General|anesthetics, general|mesh-ancestor
101759868|NCT01043419|Anesthetics|anesthetics|mesh-ancestor
101759869|NCT01043419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101759870|NCT01043419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759871|NCT01037335|Morphine|morphine|mesh-list
101759872|NCT01037335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101759873|NCT01037335|Narcotics|narcotics|mesh-ancestor
101759874|NCT01037335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101759875|NCT01037335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759876|NCT01037335|Analgesics|analgesics|mesh-ancestor
101759877|NCT01037335|Sensory System Agents|sensory system agents|mesh-ancestor
101759878|NCT01037335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101759879|NCT04015492|Factor VIII|factor viii|mesh-list
101759880|NCT04015492|BAX 855|bax 855|mesh-list
101759881|NCT04015492|Coagulants|coagulants|mesh-ancestor
101759882|NCT00904462|Lidocaine|lidocaine|mesh-list
101759883|NCT00904462|Anesthetics, Local|anesthetics, local|mesh-ancestor
101563711|NCT03970954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101563713|NCT03970954|Sensory System Agents|sensory system agents|mesh-ancestor
101563714|NCT03970954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101563715|NCT03970954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563716|NCT03963375|Cladribine|cladribine|mesh-list
101563717|NCT03963375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101759884|NCT00904462|Anesthetics|anesthetics|mesh-ancestor
101759885|NCT00904462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101759886|NCT00904462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759887|NCT00904462|Sensory System Agents|sensory system agents|mesh-ancestor
101759888|NCT00904462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101759889|NCT00904462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101759890|NCT00904462|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101759891|NCT00904462|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101759892|NCT00904462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101759893|NCT00904462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759894|NCT00396565|Olanzapine|olanzapine|mesh-list
101759895|NCT00396565|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101759896|NCT00396565|Antiemetics|antiemetics|mesh-ancestor
101759897|NCT00396565|Autonomic Agents|autonomic agents|mesh-ancestor
101759898|NCT00396565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101759899|NCT00396565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759900|NCT00396565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101759901|NCT00396565|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101759902|NCT00396565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101759903|NCT00396565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101759904|NCT00396565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101759905|NCT00396565|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101759933|NCT00906880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101759934|NCT00906880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101759935|NCT00906880|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
101759936|NCT00906880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101759937|NCT00906880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759938|NCT00904852|Bevacizumab|bevacizumab|mesh-list
101759939|NCT00904852|Temozolomide|temozolomide|mesh-list
101759940|NCT00904852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101759941|NCT00904852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101759942|NCT00904852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101759943|NCT00904852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101759944|NCT00904852|Growth Substances|growth substances|mesh-ancestor
101759945|NCT00904852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759946|NCT00904852|Growth Inhibitors|growth inhibitors|mesh-ancestor
101759947|NCT00904852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101759948|NCT00904852|Alkylating Agents|alkylating agents|mesh-ancestor
101759949|NCT00904852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759966|NCT00394771|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101759968|NCT00396409|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101759969|NCT00396409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101759970|NCT00396409|Respiratory System Agents|respiratory system agents|mesh-ancestor
101759971|NCT04060836|Factor VIII|factor viii|mesh-list
101759972|NCT04060836|Coagulants|coagulants|mesh-ancestor
101759973|NCT00693420|Bimatoprost|bimatoprost|mesh-list
101759974|NCT00693420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101759975|NCT00693420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101759976|NCT04034524|Insulin|insulin|mesh-list
101759977|NCT04034524|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101759978|NCT04034524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101759979|NCT04034524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759980|NCT00925912|Bupivacaine|bupivacaine|mesh-list
101759981|NCT00925912|Anesthetics, Local|anesthetics, local|mesh-ancestor
101759982|NCT00925912|Anesthetics|anesthetics|mesh-ancestor
101759983|NCT00925912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101759984|NCT00925912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759985|NCT00925912|Sensory System Agents|sensory system agents|mesh-ancestor
101759986|NCT00925912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101759987|NCT00695136|Donepezil|donepezil|mesh-list
101563718|NCT03963375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101563719|NCT03963375|Immunologic Factors|immunologic factors|mesh-ancestor
101563720|NCT03963375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563721|NCT03810105|Durvalumab|durvalumab|mesh-list
101563722|NCT03810105|Olaparib|olaparib|mesh-list
101563723|NCT03810105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101563724|NCT03810105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563725|NCT03810105|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101563726|NCT03810105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101411990|NCT00465244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101759988|NCT00695136|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101759989|NCT00695136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101759990|NCT00695136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759991|NCT00695136|Cholinergic Agents|cholinergic agents|mesh-ancestor
101759992|NCT00695136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101759993|NCT00695136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759994|NCT00695136|Nootropic Agents|nootropic agents|mesh-ancestor
101759995|NCT00921570|Amlodipine|amlodipine|mesh-list
101759996|NCT00921570|Valsartan|valsartan|mesh-list
101759997|NCT00921570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101759998|NCT00921570|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101759999|NCT00921570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101760000|NCT00921570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760001|NCT00921570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101760002|NCT00921570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760003|NCT00921570|Vasodilator Agents|vasodilator agents|mesh-ancestor
101760004|NCT00921570|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101760005|NCT00921570|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101760006|NCT02710890|Lacosamide|lacosamide|mesh-list
101760007|NCT02710890|Anticonvulsants|anticonvulsants|mesh-ancestor
101760008|NCT02710890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101760009|NCT02710890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101417443|NCT00141414|Anticonvulsants|anticonvulsants|mesh-ancestor
101760020|NCT00926302|Levetiracetam|levetiracetam|mesh-list
101760021|NCT00926302|Anticonvulsants|anticonvulsants|mesh-ancestor
101760022|NCT00926302|Nootropic Agents|nootropic agents|mesh-ancestor
101760023|NCT00907036|Cyclosporine|cyclosporine|mesh-list
101760024|NCT00907036|Fludarabine|fludarabine|mesh-list
101760025|NCT00907036|Fludarabine phosphate|fludarabine phosphate|mesh-list
101760027|NCT00907036|Alemtuzumab|alemtuzumab|mesh-list
101760028|NCT00907036|Cyclosporins|cyclosporins|mesh-list
101760029|NCT00907036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101760030|NCT00907036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101760031|NCT00907036|Antimetabolites|antimetabolites|mesh-ancestor
101760032|NCT00907036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760033|NCT00907036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101760034|NCT00907036|Immunologic Factors|immunologic factors|mesh-ancestor
101760035|NCT00907036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760036|NCT00907036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101760037|NCT00907036|Antifungal Agents|antifungal agents|mesh-ancestor
101760038|NCT00907036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101760039|NCT00907036|Dermatologic Agents|dermatologic agents|mesh-ancestor
101760040|NCT00907036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101760041|NCT00907036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101760042|NCT00907036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101760043|NCT00907036|Alkylating Agents|alkylating agents|mesh-ancestor
101760044|NCT00907036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101760045|NCT00907036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101760046|NCT00926614|Pioglitazone|pioglitazone|mesh-list
101760047|NCT00926614|Atorvastatin|atorvastatin|mesh-list
101760048|NCT00926614|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101760049|NCT00926614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101760050|NCT00926614|Antimetabolites|antimetabolites|mesh-ancestor
101760051|NCT00926614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760052|NCT00926614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101563727|NCT03810105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563728|NCT03798691|Vaccines|vaccines|mesh-list
101563729|NCT03798691|Immunologic Factors|immunologic factors|mesh-ancestor
101563730|NCT03798691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563731|NCT03785210|Vancomycin|vancomycin|mesh-list
101563732|NCT03785210|Nivolumab|nivolumab|mesh-list
101563733|NCT03785210|Tadalafil|tadalafil|mesh-list
101563734|NCT03785210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101563735|NCT03785210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563736|NCT03785210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101760053|NCT00926614|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101760054|NCT00926614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101760055|NCT00926614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101760056|NCT00926614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760057|NCT00907114|Ketorolac|ketorolac|mesh-list
101760058|NCT00907114|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101760059|NCT00907114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101760060|NCT00907114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101760062|NCT00907114|Sensory System Agents|sensory system agents|mesh-ancestor
101760063|NCT00907114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101760064|NCT00907114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760065|NCT00907114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101760066|NCT00907114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101760067|NCT00907114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101760068|NCT00907114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101760069|NCT00907114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760070|NCT02564094|Epoetin Alfa|epoetin alfa|mesh-list
101760071|NCT02564094|Hematinics|hematinics|mesh-ancestor
101760072|NCT00745914|Pioglitazone|pioglitazone|mesh-list
101760073|NCT00745914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101760074|NCT00745914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760075|NCT00746070|Spironolactone|spironolactone|mesh-list
101760095|NCT00927550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101760096|NCT00927550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760099|NCT00926926|Autonomic Agents|autonomic agents|mesh-ancestor
101760100|NCT00926926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101760101|NCT00926926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760102|NCT00926926|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101760103|NCT00926926|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101760104|NCT00926926|Cholinergic Agents|cholinergic agents|mesh-ancestor
101760105|NCT00926926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101760106|NCT00926926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760107|NCT00926926|Urological Agents|urological agents|mesh-ancestor
101760108|NCT00396253|Tenecteplase|tenecteplase|mesh-list
101760109|NCT00396253|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101760110|NCT00396253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101760111|NCT00396253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760112|NCT00927004|Etoricoxib|etoricoxib|mesh-list
101760113|NCT00927004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101760114|NCT00927004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101760115|NCT00927004|Analgesics|analgesics|mesh-ancestor
101760116|NCT00927004|Sensory System Agents|sensory system agents|mesh-ancestor
101760117|NCT00927004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101760118|NCT00927004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760119|NCT00927004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101760120|NCT00927004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101760121|NCT00927004|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101760122|NCT00927004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101760123|NCT00927004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101760124|NCT00927004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760125|NCT00931450|Sunitinib|sunitinib|mesh-list
101760126|NCT00931450|Exemestane|exemestane|mesh-list
101760127|NCT00931450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101760128|NCT00931450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101412011|NCT03272425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101563737|NCT03785210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563738|NCT03785210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101563739|NCT03785210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101563740|NCT03785210|Vasodilator Agents|vasodilator agents|mesh-ancestor
101563741|NCT03785210|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101563742|NCT03785210|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101563743|NCT03785210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101563744|NCT03785210|Urological Agents|urological agents|mesh-ancestor
101563745|NCT03757689|Pembrolizumab|pembrolizumab|mesh-list
101563746|NCT03757689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101760129|NCT00931450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101760130|NCT00931450|Growth Substances|growth substances|mesh-ancestor
101760140|NCT00931450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101760143|NCT00928330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101760144|NCT00928330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101760145|NCT00928330|Immunotoxins|immunotoxins|mesh-ancestor
101760146|NCT00928330|Immunoconjugates|immunoconjugates|mesh-ancestor
101760147|NCT00928330|Immunologic Factors|immunologic factors|mesh-ancestor
101760148|NCT00928330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760149|NCT00928330|Tubulin Modulators|tubulin modulators|mesh-ancestor
101760150|NCT00928330|Antimitotic Agents|antimitotic agents|mesh-ancestor
101760151|NCT00928330|Mitosis Modulators|mitosis modulators|mesh-ancestor
101760152|NCT00928330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760153|NCT00928798|Sirolimus|sirolimus|mesh-list
101760154|NCT00928798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101760155|NCT00928798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101760156|NCT00928798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101760157|NCT00928798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101760158|NCT00928798|Antifungal Agents|antifungal agents|mesh-ancestor
101760159|NCT00928798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101760160|NCT00928798|Immunologic Factors|immunologic factors|mesh-ancestor
101760161|NCT00928798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760162|NCT00931840|Irinotecan|irinotecan|mesh-list
101760163|NCT00931840|Cetuximab|cetuximab|mesh-list
101760164|NCT00931840|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101760165|NCT00931840|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101760166|NCT00931840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101760167|NCT00931840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760168|NCT00931840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101417600|NCT00134693|Prednisolone|prednisolone|mesh-list
101760169|NCT00931840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101760170|NCT04034368|Tenofovir|tenofovir|mesh-list
101760171|NCT04034368|Antiviral Agents|antiviral agents|mesh-ancestor
101760172|NCT04034368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101760173|NCT04034368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101760174|NCT04034368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101760175|NCT04034368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101760176|NCT04034368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760177|NCT04034368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101760178|NCT04034368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101760179|NCT00907270|Cholecalciferol|cholecalciferol|mesh-list
101760180|NCT00907270|Vitamin D|vitamin d|mesh-list
101760181|NCT00907270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101760182|NCT00907270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760183|NCT00907270|Vitamins|vitamins|mesh-ancestor
101760184|NCT00907270|Micronutrients|micronutrients|mesh-ancestor
101760185|NCT00907270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101760186|NCT00375505|Zoledronic Acid|zoledronic acid|mesh-list
101760187|NCT00375505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101760188|NCT00375505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760189|NCT00928876|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101563747|NCT03757689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563748|NCT03757689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101563749|NCT03757689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563750|NCT03750968|Carotenoids|carotenoids|mesh-list
101563751|NCT03750968|Antioxidants|antioxidants|mesh-ancestor
101563752|NCT03750968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563753|NCT03750968|Protective Agents|protective agents|mesh-ancestor
101563754|NCT03750968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563755|NCT03735979|Argatroban|argatroban|mesh-list
101563756|NCT03735979|Eptifibatide|eptifibatide|mesh-list
101563757|NCT03735979|Antithrombins|antithrombins|mesh-ancestor
101563758|NCT03735979|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101563759|NCT03735979|Protease Inhibitors|protease inhibitors|mesh-ancestor
101563760|NCT03735979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101563761|NCT03735979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563762|NCT03735979|Anticoagulants|anticoagulants|mesh-ancestor
101563769|NCT03722498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563770|NCT03722498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101563771|NCT03722498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101760190|NCT00928876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101760191|NCT00907504|Cisplatin|cisplatin|mesh-list
101760192|NCT00907504|Gemcitabine|gemcitabine|mesh-list
101760193|NCT00907504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101760212|NCT00932542|Prilocaine|prilocaine|mesh-list
101760213|NCT00932542|Anesthetics, Local|anesthetics, local|mesh-ancestor
101760214|NCT00932542|Anesthetics|anesthetics|mesh-ancestor
101760215|NCT00932542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101760216|NCT00932542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760217|NCT00932542|Sensory System Agents|sensory system agents|mesh-ancestor
101760218|NCT00932542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101760219|NCT00932542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101760220|NCT00932542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101760221|NCT00932542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101760222|NCT00932542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101760223|NCT00932542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760224|NCT00375427|Zoledronic Acid|zoledronic acid|mesh-list
101760225|NCT00375427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101760226|NCT00375427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760227|NCT04014634|Methylprednisolone|methylprednisolone|mesh-list
101760228|NCT04014634|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101760229|NCT04014634|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101760230|NCT04014634|Prednisolone|prednisolone|mesh-list
101760231|NCT04014634|Prednisolone acetate|prednisolone acetate|mesh-list
101760232|NCT04014634|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101760233|NCT04014634|Prednisolone phosphate|prednisolone phosphate|mesh-list
101760234|NCT04014634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101760235|NCT04014634|Antiemetics|antiemetics|mesh-ancestor
101760236|NCT04014634|Autonomic Agents|autonomic agents|mesh-ancestor
101760237|NCT04014634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101760238|NCT04014634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760239|NCT04014634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101760240|NCT04014634|Glucocorticoids|glucocorticoids|mesh-ancestor
101760241|NCT04014634|Hormones|hormones|mesh-ancestor
101760242|NCT04014634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101563772|NCT03722498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101563773|NCT03722498|Immunologic Factors|immunologic factors|mesh-ancestor
101563774|NCT03722498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563776|NCT03722498|Protective Agents|protective agents|mesh-ancestor
101563777|NCT03722498|Vitamin B Complex|vitamin b complex|mesh-ancestor
101563779|NCT03722498|Micronutrients|micronutrients|mesh-ancestor
101563780|NCT03722498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101563781|NCT03722498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101563782|NCT03710824|Nintedanib|nintedanib|mesh-list
101563783|NCT03710824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563784|NCT03710824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101412042|NCT00465439|Lidocaine|lidocaine|mesh-list
101760243|NCT04014634|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101760244|NCT04014634|Protective Agents|protective agents|mesh-ancestor
101760245|NCT04014634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101760246|NCT04014634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101760247|NCT01043575|Rifampin|rifampin|mesh-list
101760248|NCT01043575|Rifapentine|rifapentine|mesh-list
101760249|NCT01043575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101760261|NCT01043575|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101760262|NCT01043575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101760264|NCT01045837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101760265|NCT01045837|Glucocorticoids|glucocorticoids|mesh-ancestor
101760266|NCT01045837|Hormones|hormones|mesh-ancestor
101760267|NCT01045837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101760268|NCT01045837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760269|NCT01045837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101760270|NCT01045837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101760271|NCT00567268|Gabapentin|gabapentin|mesh-list
101760272|NCT00567268|Analgesics|analgesics|mesh-ancestor
101760273|NCT00567268|Sensory System Agents|sensory system agents|mesh-ancestor
101760274|NCT00567268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101760275|NCT00567268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760276|NCT00567268|Anticonvulsants|anticonvulsants|mesh-ancestor
101220512|NCT01503788|Anesthetics|anesthetics|mesh-ancestor
101760277|NCT00567268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101760278|NCT00567268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101760279|NCT00567268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101760280|NCT00567268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101760281|NCT00567268|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101760282|NCT00567268|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101760283|NCT00567268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101760284|NCT00567268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760285|NCT00567268|Antimanic Agents|antimanic agents|mesh-ancestor
101760286|NCT00907894|Telbivudine|telbivudine|mesh-list
101760287|NCT00907894|Antiviral Agents|antiviral agents|mesh-ancestor
101760288|NCT00907894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101760289|NCT00907894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101760290|NCT00907894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101760291|NCT00907894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760292|NCT04014556|Aflibercept|aflibercept|mesh-list
101760293|NCT04014556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101760294|NCT04014556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101760295|NCT04014556|Growth Substances|growth substances|mesh-ancestor
101760296|NCT04014556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760297|NCT04014556|Growth Inhibitors|growth inhibitors|mesh-ancestor
101760298|NCT04014556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101760299|NCT00929812|Glucagon|glucagon|mesh-list
101760300|NCT00929812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101760301|NCT00929812|Hormones|hormones|mesh-ancestor
101760302|NCT00929812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101760303|NCT00929812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760304|NCT00907972|Vitamin D|vitamin d|mesh-list
101563785|NCT03710824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101563786|NCT03710824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563788|NCT03648892|Fallypride|fallypride|mesh-list
101563789|NCT03648892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101563790|NCT03648892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101563791|NCT03648892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101563792|NCT03648892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563793|NCT03648892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101563794|NCT03648892|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101760305|NCT00907972|Ergocalciferols|ergocalciferols|mesh-list
101760306|NCT00907972|Cholecalciferol|cholecalciferol|mesh-list
101760307|NCT00907972|Vitamins|vitamins|mesh-list
101760308|NCT00907972|Micronutrients|micronutrients|mesh-ancestor
101760309|NCT00907972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760332|NCT00933790|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101760333|NCT00933790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101760334|NCT00933790|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101760335|NCT00933790|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101760336|NCT00933790|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101760337|NCT00933790|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101760338|NCT00566254|Zonisamide|zonisamide|mesh-list
101760339|NCT00566254|Anticonvulsants|anticonvulsants|mesh-ancestor
101760340|NCT00566254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101760341|NCT00566254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101760342|NCT00566254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760343|NCT00566254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101760344|NCT00566254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760345|NCT00930202|Conivaptan|conivaptan|mesh-list
101760346|NCT00930202|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101760347|NCT00930202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760348|NCT00930202|Natriuretic Agents|natriuretic agents|mesh-ancestor
101760349|NCT00930202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760350|NCT00393367|Prednisone|prednisone|mesh-list
101760351|NCT00393367|Methylprednisolone|methylprednisolone|mesh-list
101760352|NCT00393367|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101760353|NCT00393367|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101760354|NCT00393367|Prednisolone|prednisolone|mesh-list
101760355|NCT00393367|Prednisolone acetate|prednisolone acetate|mesh-list
101760356|NCT00393367|Budesonide|budesonide|mesh-list
101760357|NCT00393367|Bromides|bromides|mesh-list
101760358|NCT00393367|Albuterol|albuterol|mesh-list
101760359|NCT00393367|Ipratropium|ipratropium|mesh-list
101760372|NCT00393367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101760373|NCT00393367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101760375|NCT00393367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101760376|NCT00393367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101760377|NCT00393367|Respiratory System Agents|respiratory system agents|mesh-ancestor
101760378|NCT00393367|Anticonvulsants|anticonvulsants|mesh-ancestor
101760379|NCT00393367|Tocolytic Agents|tocolytic agents|mesh-ancestor
101760380|NCT00393367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101760381|NCT00393367|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101760382|NCT00393367|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101760383|NCT00393367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101760384|NCT00393367|Adrenergic Agents|adrenergic agents|mesh-ancestor
101760385|NCT00393367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101760386|NCT00393367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760387|NCT00393367|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101760388|NCT00393367|Cholinergic Agents|cholinergic agents|mesh-ancestor
101760389|NCT00395629|Deferasirox|deferasirox|mesh-list
101760390|NCT00395629|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101760391|NCT00395629|Chelating Agents|chelating agents|mesh-ancestor
101760392|NCT00395629|Sequestering Agents|sequestering agents|mesh-ancestor
101760393|NCT00395629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760394|NCT00392665|Sulindac|sulindac|mesh-list
101760395|NCT00392665|Bevacizumab|bevacizumab|mesh-list
101563796|NCT03648892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101563797|NCT03648892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563798|NCT03648892|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101563799|NCT03637543|Nivolumab|nivolumab|mesh-list
101563800|NCT03637543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101563801|NCT03637543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563802|NCT03637543|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101563803|NCT03637543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563804|NCT03626831|Evolocumab|evolocumab|mesh-list
101563805|NCT03626831|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101760396|NCT00392665|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101760397|NCT00392665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101760398|NCT00392665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101760399|NCT00392665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101760400|NCT00392665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101760401|NCT00392665|Growth Substances|growth substances|mesh-ancestor
101760402|NCT00392665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760403|NCT00392665|Growth Inhibitors|growth inhibitors|mesh-ancestor
101760404|NCT00392665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101760405|NCT00392665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101760406|NCT00392665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760407|NCT00392665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101760408|NCT00392665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101760409|NCT00392665|Analgesics|analgesics|mesh-ancestor
101760410|NCT00392665|Sensory System Agents|sensory system agents|mesh-ancestor
101760411|NCT00392665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101760412|NCT00392665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101760413|NCT00392665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101760414|NCT00392665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101760415|NCT01043965|Metformin|metformin|mesh-list
101760416|NCT01043965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101760417|NCT01043965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760418|NCT00622869|Everolimus|everolimus|mesh-list
101760419|NCT00622869|Tacrolimus|tacrolimus|mesh-list
101760420|NCT00622869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101760421|NCT00622869|Immunologic Factors|immunologic factors|mesh-ancestor
101760440|NCT00366457|Antimetabolites|antimetabolites|mesh-ancestor
101760441|NCT00366457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760442|NCT00366457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101760443|NCT00366457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101760444|NCT00624819|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101760445|NCT00624819|Immunologic Factors|immunologic factors|mesh-ancestor
101760446|NCT00624819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760447|NCT01049347|Amitriptyline|amitriptyline|mesh-list
101760448|NCT01049347|Paroxetine|paroxetine|mesh-list
101760449|NCT01049347|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101760450|NCT01049347|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101760451|NCT01049347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101760452|NCT01049347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760453|NCT01049347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101760454|NCT01049347|Serotonin Agents|serotonin agents|mesh-ancestor
101760455|NCT01049347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760456|NCT01049347|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101760457|NCT01049347|Antidepressive Agents|antidepressive agents|mesh-ancestor
101760458|NCT01049347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101760459|NCT01049347|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101760460|NCT01049347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101760461|NCT01049347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101760462|NCT01049347|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101760463|NCT01049347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101563806|NCT03626831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101563807|NCT03626831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101563808|NCT03626831|Antimetabolites|antimetabolites|mesh-ancestor
101563809|NCT03626831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563810|NCT03626831|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101563811|NCT03626831|Protease Inhibitors|protease inhibitors|mesh-ancestor
101563812|NCT03626831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101563813|NCT03626831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101563815|NCT03619213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101563816|NCT03619213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563817|NCT03619213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101563818|NCT03619213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563819|NCT03595059|Paclitaxel|paclitaxel|mesh-list
101563820|NCT03595059|Docetaxel|docetaxel|mesh-list
101760465|NCT01049347|Sensory System Agents|sensory system agents|mesh-ancestor
101760466|NCT01049347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101760467|NCT01049347|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101760468|NCT01049347|Adrenergic Agents|adrenergic agents|mesh-ancestor
101760469|NCT01049425|Cyclophosphamide|cyclophosphamide|mesh-list
101760470|NCT01049425|Docetaxel|docetaxel|mesh-list
101760471|NCT01049425|Epirubicin|epirubicin|mesh-list
101760472|NCT01049425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101760473|NCT01049425|Immunologic Factors|immunologic factors|mesh-ancestor
101760474|NCT01049425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760475|NCT01049425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101760476|NCT01049425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101760508|NCT00838305|Antidepressive Agents|antidepressive agents|mesh-ancestor
101760509|NCT00838305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101760510|NCT00622713|Rivastigmine|rivastigmine|mesh-list
101760511|NCT00622713|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101760512|NCT00622713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101760513|NCT00622713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760514|NCT00622713|Cholinergic Agents|cholinergic agents|mesh-ancestor
101760515|NCT00622713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101760548|NCT00391807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101760549|NCT00391807|Contraceptive Agents|contraceptive agents|mesh-ancestor
101760550|NCT00391807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101760551|NCT00391807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101760552|NCT00391807|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101760553|NCT00391807|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101760554|NCT00391807|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101760556|NCT00624585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101760557|NCT00624585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101760558|NCT00624585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101760573|NCT00831597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760575|NCT00622635|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101760576|NCT00622635|Autonomic Agents|autonomic agents|mesh-ancestor
101760577|NCT00622635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101760578|NCT00622635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760579|NCT00622635|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101760580|NCT00622635|Respiratory System Agents|respiratory system agents|mesh-ancestor
101760581|NCT00622635|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101760582|NCT00622635|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101760583|NCT00622635|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101760584|NCT00622635|Adrenergic Agents|adrenergic agents|mesh-ancestor
101760585|NCT00622635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101760586|NCT00622635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563821|NCT03595059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101563822|NCT03595059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563823|NCT03595059|Tubulin Modulators|tubulin modulators|mesh-ancestor
101563824|NCT03595059|Antimitotic Agents|antimitotic agents|mesh-ancestor
101563825|NCT03595059|Mitosis Modulators|mitosis modulators|mesh-ancestor
101563826|NCT03595059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563827|NCT03570892|Tisagenlecleucel|tisagenlecleucel|mesh-list
101412087|NCT00473551|Immunologic Factors|immunologic factors|mesh-ancestor
101760587|NCT00391027|Insulin|insulin|mesh-list
101760588|NCT00391027|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101760589|NCT00391027|Insulin Glargine|insulin glargine|mesh-list
101760590|NCT00391027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101760591|NCT00391027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760592|NCT00622401|Interleukin-12|interleukin-12|mesh-list
101760593|NCT00622401|Vaccines|vaccines|mesh-list
101760594|NCT00622401|Immunologic Factors|immunologic factors|mesh-ancestor
101760595|NCT00622401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760596|NCT00622401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101760597|NCT00622401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101760598|NCT00622401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101760599|NCT00622401|Growth Substances|growth substances|mesh-ancestor
101760600|NCT00622401|Growth Inhibitors|growth inhibitors|mesh-ancestor
101760601|NCT00622401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101760602|NCT04018365|Empagliflozin|empagliflozin|mesh-list
101760603|NCT04018365|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101760604|NCT04018365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760605|NCT04018365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101760606|NCT04018365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760607|NCT00828087|Cobalt|cobalt|mesh-list
101760608|NCT00828087|Chromium|chromium|mesh-list
101760609|NCT00828087|Everolimus|everolimus|mesh-list
101760610|NCT00828087|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101760611|NCT00828087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101760613|NCT00828087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760614|NCT00828087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101760615|NCT00828087|Immunologic Factors|immunologic factors|mesh-ancestor
101760616|NCT00828087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760617|NCT00828087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101760649|NCT02549001|Antifungal Agents|antifungal agents|mesh-ancestor
101760650|NCT02549001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101760652|NCT00621543|Levonorgestrel|levonorgestrel|mesh-list
101760653|NCT00621543|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101760654|NCT00621543|Contraceptive Agents|contraceptive agents|mesh-ancestor
101760655|NCT00621543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101760656|NCT00621543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760657|NCT00621543|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101760658|NCT00621543|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101760659|NCT00621543|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101760660|NCT00621543|Trace Elements|trace elements|mesh-ancestor
101760661|NCT00621543|Micronutrients|micronutrients|mesh-ancestor
101760662|NCT00623805|Bevacizumab|bevacizumab|mesh-list
101760663|NCT00623805|Capecitabine|capecitabine|mesh-list
101760664|NCT00623805|Oxaliplatin|oxaliplatin|mesh-list
101760665|NCT00623805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101451748|NCT00203099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101760686|NCT02548923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101760687|NCT02548923|Adrenergic Agents|adrenergic agents|mesh-ancestor
101760688|NCT02548923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101760689|NCT02548923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760690|NCT02548923|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101760691|NCT02548923|Anesthetics, General|anesthetics, general|mesh-ancestor
101760692|NCT02548923|Anesthetics|anesthetics|mesh-ancestor
101760693|NCT00832221|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101760694|NCT00832221|Raclopride|raclopride|mesh-list
101760695|NCT00832221|Antidepressive Agents|antidepressive agents|mesh-ancestor
101760696|NCT00832221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101760697|NCT00832221|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101760698|NCT00832221|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101412093|NCT00473551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563828|NCT03570892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101563829|NCT03570892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563835|NCT03445949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
101563836|NCT03342690|Eplerenone|eplerenone|mesh-list
101563837|NCT03342690|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101563838|NCT03342690|Hormone Antagonists|hormone antagonists|mesh-ancestor
101563839|NCT03342690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101563840|NCT03342690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760699|NCT00832221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101760700|NCT00832221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760701|NCT00832221|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101760702|NCT00832221|Dopamine Agents|dopamine agents|mesh-ancestor
101760703|NCT00832221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101760704|NCT00832221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760705|NCT00839397|Paroxetine|paroxetine|mesh-list
101760706|NCT00839397|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101760707|NCT00839397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101760708|NCT00839397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101760709|NCT00839397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760710|NCT00839397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101760711|NCT00839397|Serotonin Agents|serotonin agents|mesh-ancestor
101760712|NCT00839397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760713|NCT00839397|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101760714|NCT00839397|Antidepressive Agents|antidepressive agents|mesh-ancestor
101760715|NCT00839397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101760716|NCT00839397|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101451749|NCT00226200|Omalizumab|omalizumab|mesh-list
101760735|NCT00621309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101760736|NCT00621309|Leprostatic Agents|leprostatic agents|mesh-ancestor
101760737|NCT00621309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101760738|NCT00621309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101760739|NCT00621309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760740|NCT00621309|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101760741|NCT00621309|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101760742|NCT00621309|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101760743|NCT00621309|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101760744|NCT00621309|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101760745|NCT00621309|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101760746|NCT00621309|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101760747|NCT00621309|Protective Agents|protective agents|mesh-ancestor
101760748|NCT00621309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760749|NCT00621309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101760750|NCT00839553|Minocycline|minocycline|mesh-list
101760751|NCT00839553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101760752|NCT00839553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101760753|NCT00832689|Gemcitabine|gemcitabine|mesh-list
101760754|NCT00832689|Irinotecan|irinotecan|mesh-list
101760755|NCT00832689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101760756|NCT00832689|Antimetabolites|antimetabolites|mesh-ancestor
101760757|NCT00832689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760758|NCT00832689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101760759|NCT00832689|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101760760|NCT00832689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101760761|NCT00832689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101760762|NCT00567190|Docetaxel|docetaxel|mesh-list
101760763|NCT00567190|Trastuzumab|trastuzumab|mesh-list
101760764|NCT00567190|Pertuzumab|pertuzumab|mesh-list
101760765|NCT00567190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101760766|NCT00567190|Tubulin Modulators|tubulin modulators|mesh-ancestor
101760767|NCT00567190|Antimitotic Agents|antimitotic agents|mesh-ancestor
101760768|NCT00567190|Mitosis Modulators|mitosis modulators|mesh-ancestor
101563841|NCT03342690|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101563842|NCT03342690|Diuretics|diuretics|mesh-ancestor
101563843|NCT03342690|Natriuretic Agents|natriuretic agents|mesh-ancestor
101563844|NCT03342690|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101563845|NCT03333616|Nivolumab|nivolumab|mesh-list
101563846|NCT03333616|Ipilimumab|ipilimumab|mesh-list
101563847|NCT03333616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101563848|NCT03333616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563849|NCT03333616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101563850|NCT03333616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563851|NCT03262662|Varenicline|varenicline|mesh-list
101760769|NCT00567190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760770|NCT00567190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101760771|NCT00922389|Lenograstim|lenograstim|mesh-list
101760772|NCT00922389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101760773|NCT00922389|Immunologic Factors|immunologic factors|mesh-ancestor
101760774|NCT00922389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760775|NCT00691938|Decitabine|decitabine|mesh-list
101760776|NCT00691938|Panobinostat|panobinostat|mesh-list
101760794|NCT00365365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101760795|NCT00365365|Alkylating Agents|alkylating agents|mesh-ancestor
101760796|NCT00365365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760797|NCT00365365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101760798|NCT00365365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101760799|NCT00365365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101760800|NCT00365365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101760801|NCT00365365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101760802|NCT00365365|Growth Substances|growth substances|mesh-ancestor
101760803|NCT00365365|Growth Inhibitors|growth inhibitors|mesh-ancestor
101760804|NCT00365365|Tubulin Modulators|tubulin modulators|mesh-ancestor
101760805|NCT00365365|Antimitotic Agents|antimitotic agents|mesh-ancestor
101760806|NCT00365365|Mitosis Modulators|mitosis modulators|mesh-ancestor
101760807|NCT00365365|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101760808|NCT00365365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101760809|NCT00365365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101760810|NCT00365365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101760812|NCT01046461|Aprepitant|aprepitant|mesh-list
101760813|NCT01046461|Ramosetron|ramosetron|mesh-list
101760814|NCT01046461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101760815|NCT01046461|Antiemetics|antiemetics|mesh-ancestor
101760816|NCT01046461|Autonomic Agents|autonomic agents|mesh-ancestor
101760817|NCT01046461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101760818|NCT01046461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760819|NCT01046461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101760820|NCT01046461|Glucocorticoids|glucocorticoids|mesh-ancestor
101760821|NCT01046461|Hormones|hormones|mesh-ancestor
101760822|NCT01046461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101760823|NCT01046461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101760824|NCT01046461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101760825|NCT01046461|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101760826|NCT01046461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101760827|NCT01046461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760828|NCT01046461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101760829|NCT01046461|Serotonin Agents|serotonin agents|mesh-ancestor
101760830|NCT00623727|Factor VIII|factor viii|mesh-list
101760831|NCT00623727|Coagulants|coagulants|mesh-ancestor
101760832|NCT01046539|Buprenorphine|buprenorphine|mesh-list
101760833|NCT01046539|ALKS-33|alks-33|mesh-list
101760834|NCT01046539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101418270|NCT00153543|Vaccines|vaccines|mesh-list
101760855|NCT00828789|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101760856|NCT00828789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101760857|NCT00828789|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101563852|NCT03262662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101563853|NCT03262662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101563854|NCT03262662|Cholinergic Agents|cholinergic agents|mesh-ancestor
101563855|NCT03262662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101563856|NCT03262662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563857|NCT03262662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563858|NCT03257267|Cemiplimab|cemiplimab|mesh-list
101563859|NCT03257267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101412110|NCT00473980|Indomethacin|indomethacin|mesh-list
101760858|NCT00828789|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101760859|NCT00828789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101760860|NCT00828789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101760862|NCT00930358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101760863|NCT00930358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760864|NCT00372775|Sunitinib|sunitinib|mesh-list
101760865|NCT00372775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101760866|NCT00372775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101760867|NCT00372775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101760868|NCT00372775|Growth Substances|growth substances|mesh-ancestor
101760869|NCT00372775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760870|NCT00372775|Growth Inhibitors|growth inhibitors|mesh-ancestor
101760871|NCT00372775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101760872|NCT00372775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101760873|NCT00372775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760874|NCT00936676|Rasagiline|rasagiline|mesh-list
101760875|NCT00936676|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101760876|NCT00936676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101760877|NCT00936676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760878|NCT00936676|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101760879|NCT00936676|Protective Agents|protective agents|mesh-ancestor
101760880|NCT00936676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760881|NCT00839787|Morphine|morphine|mesh-list
101760882|NCT00839787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101760883|NCT00839787|Narcotics|narcotics|mesh-ancestor
101760884|NCT00839787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101760885|NCT00839787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760886|NCT00839787|Analgesics|analgesics|mesh-ancestor
101760887|NCT00839787|Sensory System Agents|sensory system agents|mesh-ancestor
101760888|NCT00839787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101760889|NCT00934258|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101760900|NCT00372697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101760901|NCT00372697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101760903|NCT00934414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101760904|NCT00934414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760905|NCT00930514|Rituximab|rituximab|mesh-list
101760906|NCT00930514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101760907|NCT00930514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101760908|NCT00930514|Immunologic Factors|immunologic factors|mesh-ancestor
101760909|NCT00930514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760910|NCT00930514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101760911|NCT00936988|Cinacalcet|cinacalcet|mesh-list
101760912|NCT00936988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101760913|NCT00936988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760914|NCT00936988|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101760915|NCT00936988|Hormone Antagonists|hormone antagonists|mesh-ancestor
101760916|NCT00936988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101760917|NCT00934492|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101760918|NCT00934492|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101760919|NCT00934492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101760920|NCT00934492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101760921|NCT00934492|Antimalarials|antimalarials|mesh-ancestor
101760922|NCT00934492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101563860|NCT03257267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563861|NCT03191149|Osimertinib|osimertinib|mesh-list
101563862|NCT03191149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563863|NCT03191149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101563864|NCT03191149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101563865|NCT03191149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563866|NCT03190668|Cefazolin|cefazolin|mesh-list
101563867|NCT03190668|Dialysis Solutions|dialysis solutions|mesh-list
101563868|NCT03190668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101563869|NCT03190668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101412119|NCT00473980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101760923|NCT00934492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101760924|NCT00934570|Metformin|metformin|mesh-list
101760925|NCT00934570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101760926|NCT00934570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760927|NCT00930670|Esomeprazole|esomeprazole|mesh-list
101760928|NCT00930670|Omeprazole|omeprazole|mesh-list
101760929|NCT00930670|Pantoprazole|pantoprazole|mesh-list
101760930|NCT00930670|Ranitidine|ranitidine|mesh-list
101760931|NCT00930670|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
101760932|NCT00930670|Atorvastatin|atorvastatin|mesh-list
101760933|NCT00930670|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101760934|NCT00930670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101760935|NCT00930670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101760937|NCT00930670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760938|NCT00930670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101760939|NCT00930670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101760940|NCT00930670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101760941|NCT00930670|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101760942|NCT00930670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101760943|NCT00930670|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101760944|NCT00930670|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101760945|NCT00930670|Histamine Antagonists|histamine antagonists|mesh-ancestor
101760946|NCT00930670|Histamine Agents|histamine agents|mesh-ancestor
101760947|NCT00930670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101760948|NCT00930670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760949|NCT00937144|Sildenafil Citrate|sildenafil citrate|mesh-list
101760950|NCT00937144|Vasodilator Agents|vasodilator agents|mesh-ancestor
101760951|NCT00937144|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101760952|NCT00937144|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101760953|NCT00937144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101760954|NCT00937144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760964|NCT00937300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101760966|NCT00937300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760967|NCT00937300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101760968|NCT00937300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101760969|NCT00937300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101760970|NCT00937300|Antimetabolites|antimetabolites|mesh-ancestor
101760971|NCT00937300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101760972|NCT00937300|Analgesics|analgesics|mesh-ancestor
101760973|NCT00937300|Sensory System Agents|sensory system agents|mesh-ancestor
101760974|NCT00937300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101760975|NCT02226276|Copper|copper|mesh-list
101760976|NCT02226276|Trastuzumab|trastuzumab|mesh-list
101760977|NCT02226276|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101760978|NCT02226276|Maytansine|maytansine|mesh-list
101760979|NCT02226276|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101760980|NCT02226276|Immunoconjugates|immunoconjugates|mesh-list
101760981|NCT02226276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101760982|NCT02226276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101760983|NCT02226276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760984|NCT02226276|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101760985|NCT02226276|Trace Elements|trace elements|mesh-ancestor
101760986|NCT02226276|Micronutrients|micronutrients|mesh-ancestor
101760987|NCT02226276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563870|NCT03190668|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101563871|NCT03162653|Allopurinol|allopurinol|mesh-list
101563872|NCT03162653|Mannitol|mannitol|mesh-list
101563873|NCT03162653|Antimetabolites|antimetabolites|mesh-ancestor
101563874|NCT03162653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563875|NCT03162653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101563876|NCT03162653|Gout Suppressants|gout suppressants|mesh-ancestor
101563877|NCT03162653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101563878|NCT03162653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101563879|NCT03162653|Antioxidants|antioxidants|mesh-ancestor
101563880|NCT03162653|Protective Agents|protective agents|mesh-ancestor
101760988|NCT02226276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101760989|NCT02226276|Tubulin Modulators|tubulin modulators|mesh-ancestor
101760990|NCT02226276|Antimitotic Agents|antimitotic agents|mesh-ancestor
101760991|NCT02226276|Mitosis Modulators|mitosis modulators|mesh-ancestor
101760992|NCT02226276|Immunotoxins|immunotoxins|mesh-ancestor
101760993|NCT02226276|Immunologic Factors|immunologic factors|mesh-ancestor
101760994|NCT00935116|Etoricoxib|etoricoxib|mesh-list
101760995|NCT00935116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101760996|NCT00935116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101760997|NCT00935116|Analgesics|analgesics|mesh-ancestor
101760998|NCT00935116|Sensory System Agents|sensory system agents|mesh-ancestor
101760999|NCT00935116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101761000|NCT00935116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761001|NCT00935116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101761002|NCT00935116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101761003|NCT00935116|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101761004|NCT00935116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101761005|NCT00935116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101761006|NCT00935116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761007|NCT00931138|Cytarabine|cytarabine|mesh-list
101761008|NCT00931138|Daunorubicin|daunorubicin|mesh-list
101761010|NCT00931138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101761011|NCT00931138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101761012|NCT00931138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101761014|NCT00931138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761015|NCT00931138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101761016|NCT00931138|Antimetabolites|antimetabolites|mesh-ancestor
101761017|NCT00931138|Antiviral Agents|antiviral agents|mesh-ancestor
101761018|NCT00931138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101761019|NCT00931138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101761020|NCT00931138|Immunologic Factors|immunologic factors|mesh-ancestor
101761021|NCT00931138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761022|NCT00935194|Oseltamivir|oseltamivir|mesh-list
101761023|NCT00935194|Antiviral Agents|antiviral agents|mesh-ancestor
101761043|NCT00574275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101761044|NCT00574275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101761045|NCT00574275|Growth Substances|growth substances|mesh-ancestor
101761046|NCT00574275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761047|NCT00574275|Growth Inhibitors|growth inhibitors|mesh-ancestor
101761048|NCT01742832|Citalopram|citalopram|mesh-list
101761049|NCT01742832|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
101761050|NCT01742832|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101761051|NCT01742832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101761052|NCT01742832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101761053|NCT01742832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761054|NCT01742832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101761055|NCT01742832|Serotonin Agents|serotonin agents|mesh-ancestor
101761056|NCT01742832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761057|NCT01742832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101761058|NCT01742832|Antidepressive Agents|antidepressive agents|mesh-ancestor
101761059|NCT01742832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101761060|NCT01742832|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101761061|NCT01742832|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101563881|NCT03162653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563882|NCT03162653|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101563884|NCT03162653|Natriuretic Agents|natriuretic agents|mesh-ancestor
101563885|NCT03064035|Thrombin|thrombin|mesh-list
101563886|NCT03064035|Hemostatics|hemostatics|mesh-ancestor
101563887|NCT03064035|Coagulants|coagulants|mesh-ancestor
101563888|NCT03008278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101563889|NCT03008278|Olaparib|olaparib|mesh-list
101412139|NCT00474136|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101761062|NCT00833079|Tacrolimus|tacrolimus|mesh-list
101761063|NCT00833079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101761064|NCT00833079|Immunologic Factors|immunologic factors|mesh-ancestor
101761065|NCT00833079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761066|NCT00833079|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101761068|NCT00833079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761069|NCT00935506|Aspirin|aspirin|mesh-list
101761070|NCT00935506|Clopidogrel|clopidogrel|mesh-list
101761071|NCT00935506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101761072|NCT00935506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101761073|NCT00935506|Analgesics|analgesics|mesh-ancestor
101761074|NCT00935506|Sensory System Agents|sensory system agents|mesh-ancestor
101761075|NCT00935506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101761076|NCT00935506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761077|NCT00935506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101761078|NCT00935506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101761079|NCT00935506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101761099|NCT00833157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101761100|NCT00833157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101761101|NCT00833157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101761102|NCT00833157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761103|NCT00833235|Lubricant Eye Drops|lubricant eye drops|mesh-list
101761104|NCT00833235|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101761105|NCT00833235|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101761106|NCT04285671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101761107|NCT04285671|Trastuzumab|trastuzumab|mesh-list
101761108|NCT04285671|Necitumumab|necitumumab|mesh-list
101761109|NCT04285671|Osimertinib|osimertinib|mesh-list
101761110|NCT04285671|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
101761111|NCT04285671|Antibodies|antibodies|mesh-list
101761112|NCT04285671|Immunoglobulins|immunoglobulins|mesh-list
101761113|NCT04285671|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101761114|NCT04285671|Immunologic Factors|immunologic factors|mesh-ancestor
101761115|NCT04285671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761116|NCT04285671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101761117|NCT04285671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761118|NCT04285671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101761119|NCT04285671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101761120|NCT00931372|Lixisenatide|lixisenatide|mesh-list
101761121|NCT00931372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101761122|NCT00931372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761123|NCT00829257|Fluticasone|fluticasone|mesh-list
101761124|NCT00829257|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101761125|NCT00829257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101761126|NCT00829257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101761127|NCT00829257|Autonomic Agents|autonomic agents|mesh-ancestor
101761128|NCT00829257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101761129|NCT00829257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761130|NCT00829257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101761131|NCT00829257|Respiratory System Agents|respiratory system agents|mesh-ancestor
101761132|NCT00829257|Dermatologic Agents|dermatologic agents|mesh-ancestor
101761142|NCT03978832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761143|NCT03978832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761144|NCT03978832|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101761145|NCT03978832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101563891|NCT03008278|Ramucirumab|ramucirumab|mesh-list
101563892|NCT03008278|Antibodies|antibodies|mesh-list
101563893|NCT03008278|Immunoglobulins|immunoglobulins|mesh-list
101563894|NCT03008278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101563895|NCT03008278|Lexatumumab|lexatumumab|mesh-list
101563896|NCT03008278|Immunologic Factors|immunologic factors|mesh-ancestor
101563897|NCT03008278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563898|NCT03008278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563899|NCT03008278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101761146|NCT03978832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101761147|NCT03978832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101761148|NCT03978832|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101761149|NCT03978832|Dopamine Agents|dopamine agents|mesh-ancestor
101761150|NCT00840333|Levofloxacin|levofloxacin|mesh-list
101761151|NCT00840333|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101761152|NCT00840333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101761153|NCT00840333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101761154|NCT00840333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101761155|NCT00840333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101761156|NCT00840333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101761157|NCT00840333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761158|NCT00840333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101761159|NCT00840333|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101761160|NCT00840333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101761161|NCT00840489|Ribavirin|ribavirin|mesh-list
101761162|NCT00840489|Colchicine|colchicine|mesh-list
101761163|NCT00840489|Antimetabolites|antimetabolites|mesh-ancestor
101761164|NCT00840489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761165|NCT00840489|Antiviral Agents|antiviral agents|mesh-ancestor
101761166|NCT00840489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101761167|NCT00840489|Gout Suppressants|gout suppressants|mesh-ancestor
101761168|NCT00840489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101761169|NCT00840489|Tubulin Modulators|tubulin modulators|mesh-ancestor
101761170|NCT00840489|Antimitotic Agents|antimitotic agents|mesh-ancestor
101761171|NCT00840489|Mitosis Modulators|mitosis modulators|mesh-ancestor
101761172|NCT00840489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101761173|NCT00743496|Antibodies|antibodies|mesh-list
101761174|NCT00743496|Immunologic Factors|immunologic factors|mesh-ancestor
101761175|NCT00743496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761176|NCT00829569|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101761177|NCT00829569|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101761178|NCT00829569|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101761179|NCT00829569|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101761180|NCT00840645|Mirabegron|mirabegron|mesh-list
101761181|NCT00840645|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101761182|NCT00840645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101761183|NCT00840645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101761184|NCT00840645|Adrenergic Agents|adrenergic agents|mesh-ancestor
101761185|NCT00840645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101761186|NCT00840645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761187|NCT00840645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761188|NCT00840645|Urological Agents|urological agents|mesh-ancestor
101761189|NCT00566722|Adalimumab|adalimumab|mesh-list
101761190|NCT00566722|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101761191|NCT00566722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101761192|NCT00566722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101761193|NCT00691704|Prednisone|prednisone|mesh-list
101761194|NCT00691704|Lenalidomide|lenalidomide|mesh-list
101761195|NCT00691704|Bortezomib|bortezomib|mesh-list
101761196|NCT00691704|Melphalan|melphalan|mesh-list
101761197|NCT00691704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101761198|NCT00691704|Glucocorticoids|glucocorticoids|mesh-ancestor
101761199|NCT00691704|Hormones|hormones|mesh-ancestor
101451750|NCT00226200|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101761212|NCT00691704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101761213|NCT00691704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101761214|NCT00829647|Lenalidomide|lenalidomide|mesh-list
101563900|NCT03008278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563901|NCT02991456|Ondansetron|ondansetron|mesh-list
101563902|NCT02991456|Rolapitant|rolapitant|mesh-list
101563903|NCT02991456|Antiemetics|antiemetics|mesh-ancestor
101563904|NCT02991456|Autonomic Agents|autonomic agents|mesh-ancestor
101563905|NCT02991456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101563906|NCT02991456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563907|NCT02991456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101563908|NCT02991456|Antipruritics|antipruritics|mesh-ancestor
101563909|NCT02991456|Dermatologic Agents|dermatologic agents|mesh-ancestor
101563910|NCT02991456|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101761215|NCT00829647|Dasatinib|dasatinib|mesh-list
101761216|NCT00829647|Immunologic Factors|immunologic factors|mesh-ancestor
101761217|NCT00829647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761218|NCT00829647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101761219|NCT00829647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101761220|NCT00829647|Growth Substances|growth substances|mesh-ancestor
101761221|NCT00829647|Growth Inhibitors|growth inhibitors|mesh-ancestor
101761222|NCT00829647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101761223|NCT00829647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101761224|NCT00829647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101761225|NCT00829647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761226|NCT00939328|Rituximab|rituximab|mesh-list
101761227|NCT00939328|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101761228|NCT00939328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101761229|NCT00939328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101761230|NCT00939328|Immunologic Factors|immunologic factors|mesh-ancestor
101761231|NCT00939328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761232|NCT00939328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101761233|NCT00939328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101761234|NCT00939328|Alkylating Agents|alkylating agents|mesh-ancestor
101761235|NCT00939328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761236|NCT00829881|Betahistine|betahistine|mesh-list
101761237|NCT00829881|Vasodilator Agents|vasodilator agents|mesh-ancestor
101761238|NCT00829881|Histamine Agonists|histamine agonists|mesh-ancestor
101761239|NCT00829881|Histamine Agents|histamine agents|mesh-ancestor
101761240|NCT00829881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101761241|NCT00829881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761242|NCT00829881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761243|NCT04014244|Triamcinolone|triamcinolone|mesh-list
101761244|NCT04014244|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101761245|NCT04014244|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101761246|NCT04014244|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101761247|NCT04014244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101761248|NCT04014244|Glucocorticoids|glucocorticoids|mesh-ancestor
101761249|NCT04014244|Hormones|hormones|mesh-ancestor
101761250|NCT04014244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101761251|NCT04014244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761252|NCT04014244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101761253|NCT04014244|Immunologic Factors|immunologic factors|mesh-ancestor
101761254|NCT04014244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101761255|NCT04014244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761256|NCT02548611|Clopidogrel|clopidogrel|mesh-list
101761257|NCT02548611|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101761258|NCT02548611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101761273|NCT00937924|Anesthetics|anesthetics|mesh-ancestor
101761274|NCT00937924|Sensory System Agents|sensory system agents|mesh-ancestor
101761275|NCT00937924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101761276|NCT00937924|Antiemetics|antiemetics|mesh-ancestor
101761277|NCT00937924|Autonomic Agents|autonomic agents|mesh-ancestor
101761278|NCT00937924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101761279|NCT00937924|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101761280|NCT00937924|Histamine Antagonists|histamine antagonists|mesh-ancestor
101563911|NCT02991456|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101563912|NCT02991456|Serotonin Agents|serotonin agents|mesh-ancestor
101563913|NCT02991456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101563914|NCT02991456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563915|NCT02991456|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101563916|NCT02867384|Obinutuzumab|obinutuzumab|mesh-list
101563917|NCT02867384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101412175|NCT00117182|Hormones|hormones|mesh-ancestor
101761281|NCT00937924|Histamine Agents|histamine agents|mesh-ancestor
101761282|NCT00937924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101761283|NCT00937924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761284|NCT00937924|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101761285|NCT00937924|Antipruritics|antipruritics|mesh-ancestor
101761286|NCT00937924|Dermatologic Agents|dermatologic agents|mesh-ancestor
101761289|NCT00743886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761290|NCT00830193|Acetylcysteine|acetylcysteine|mesh-list
101761291|NCT00830193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101761292|NCT00830193|Antiviral Agents|antiviral agents|mesh-ancestor
101761293|NCT00830193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101761294|NCT00830193|Expectorants|expectorants|mesh-ancestor
101761295|NCT00830193|Respiratory System Agents|respiratory system agents|mesh-ancestor
101761296|NCT00830193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101761297|NCT00830193|Antioxidants|antioxidants|mesh-ancestor
101761298|NCT00830193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761299|NCT00830193|Protective Agents|protective agents|mesh-ancestor
101761301|NCT00830193|Antidotes|antidotes|mesh-ancestor
101761302|NCT00938158|rGLP-1 protein|rglp-1 protein|mesh-list
101761303|NCT00938158|Incretins|incretins|mesh-ancestor
101761304|NCT00938158|Hormones|hormones|mesh-ancestor
101761305|NCT00938158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101761306|NCT00938158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761307|NCT00840957|Infliximab|infliximab|mesh-list
101761308|NCT00840957|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101761309|NCT00840957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101761310|NCT00840957|Dermatologic Agents|dermatologic agents|mesh-ancestor
101761311|NCT00840957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101761312|NCT00840957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101761313|NCT00743964|Capecitabine|capecitabine|mesh-list
101761314|NCT00743964|Epirubicin|epirubicin|mesh-list
101761315|NCT00743964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101761316|NCT00743964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101761317|NCT00743964|Antimetabolites|antimetabolites|mesh-ancestor
101761318|NCT00743964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761319|NCT00743964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101761334|NCT00830349|Dopamine Agents|dopamine agents|mesh-ancestor
101761335|NCT00841113|Goserelin|goserelin|mesh-list
101761336|NCT00841113|Bicalutamide|bicalutamide|mesh-list
101761337|NCT00841113|Abarelix|abarelix|mesh-list
101761338|NCT00841113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101761339|NCT00841113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101761340|NCT00841113|Androgen Antagonists|androgen antagonists|mesh-ancestor
101761341|NCT00841113|Hormone Antagonists|hormone antagonists|mesh-ancestor
101761342|NCT00841113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101761343|NCT00841113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761344|NCT00830505|Fluticasone|fluticasone|mesh-list
101761345|NCT00830505|Xhance|xhance|mesh-list
101761346|NCT00830505|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101761347|NCT00830505|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101761348|NCT00830505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101761349|NCT00830505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101761350|NCT00830505|Autonomic Agents|autonomic agents|mesh-ancestor
101761351|NCT00830505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101761352|NCT00830505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761353|NCT00830505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101761354|NCT00830505|Respiratory System Agents|respiratory system agents|mesh-ancestor
101761355|NCT00830505|Dermatologic Agents|dermatologic agents|mesh-ancestor
101761356|NCT00830505|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101563918|NCT02867384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563919|NCT02842827|Tretinoin|tretinoin|mesh-list
101563920|NCT02842827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563921|NCT02842827|Keratolytic Agents|keratolytic agents|mesh-ancestor
101563922|NCT02842827|Dermatologic Agents|dermatologic agents|mesh-ancestor
101563923|NCT02823821|Dialysis Solutions|dialysis solutions|mesh-list
101563924|NCT02823821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101563925|NCT02503774|Durvalumab|durvalumab|mesh-list
101761357|NCT00830505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101761358|NCT00830505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101418786|NCT00139568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101761359|NCT00830505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101761360|NCT00830505|Adrenergic Agents|adrenergic agents|mesh-ancestor
101761361|NCT00830505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101761362|NCT00830505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761363|NCT00830505|Glucocorticoids|glucocorticoids|mesh-ancestor
101761364|NCT00830505|Hormones|hormones|mesh-ancestor
101761365|NCT00830505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101761366|NCT00830505|Sympathomimetics|sympathomimetics|mesh-ancestor
101761367|NCT00566020|Lamotrigine|lamotrigine|mesh-list
101761368|NCT00566020|Anticonvulsants|anticonvulsants|mesh-ancestor
101761369|NCT00566020|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101761370|NCT00566020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101761371|NCT00566020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761372|NCT00566020|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101761373|NCT00566020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761374|NCT00566020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101761375|NCT00566020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101761376|NCT00566020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101761377|NCT00566020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101761378|NCT00566020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101761388|NCT02563782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101761389|NCT02563782|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101761390|NCT02563782|Antitubercular Agents|antitubercular agents|mesh-ancestor
101761391|NCT02563782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101761392|NCT02563782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101761393|NCT00841191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101761395|NCT00841191|Antibodies|antibodies|mesh-list
101761396|NCT00841191|Immunoglobulins|immunoglobulins|mesh-list
101761397|NCT00841191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101761398|NCT00841191|Immunologic Factors|immunologic factors|mesh-ancestor
101761399|NCT00841191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761400|NCT00841191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101761401|NCT00843453|Vitamin B 12|vitamin b 12|mesh-list
101761402|NCT00843453|Hydroxocobalamin|hydroxocobalamin|mesh-list
101761403|NCT00843453|Vitamin B Complex|vitamin b complex|mesh-ancestor
101761404|NCT00843453|Vitamins|vitamins|mesh-ancestor
101761405|NCT00843453|Micronutrients|micronutrients|mesh-ancestor
101761406|NCT00843453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761407|NCT00843453|Hematinics|hematinics|mesh-ancestor
101761408|NCT00921726|Oseltamivir|oseltamivir|mesh-list
101761409|NCT00921726|Zanamivir|zanamivir|mesh-list
101761410|NCT00921726|Antiviral Agents|antiviral agents|mesh-ancestor
101761411|NCT00921726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101761412|NCT00921726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101761413|NCT00921726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761414|NCT00938236|Cyclosporine|cyclosporine|mesh-list
101761415|NCT00938236|Cyclosporins|cyclosporins|mesh-list
101761416|NCT00938236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101761417|NCT00938236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761418|NCT00938236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101761419|NCT00938236|Immunologic Factors|immunologic factors|mesh-ancestor
101761420|NCT00938236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761421|NCT00938236|Antifungal Agents|antifungal agents|mesh-ancestor
101761422|NCT00938236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101761423|NCT00938236|Dermatologic Agents|dermatologic agents|mesh-ancestor
101761424|NCT00938236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101761425|NCT00938236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101761426|NCT00741780|Plerixafor|plerixafor|mesh-list
101761427|NCT00741780|Lenograstim|lenograstim|mesh-list
101563926|NCT02503774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101563927|NCT02503774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563928|NCT02477826|Paclitaxel|paclitaxel|mesh-list
101563929|NCT02477826|Carboplatin|carboplatin|mesh-list
101563930|NCT02477826|Gemcitabine|gemcitabine|mesh-list
101563931|NCT02477826|Nivolumab|nivolumab|mesh-list
101563932|NCT02477826|Pemetrexed|pemetrexed|mesh-list
101563933|NCT02477826|Ipilimumab|ipilimumab|mesh-list
101412182|NCT00117182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101761428|NCT00741780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101761429|NCT00741780|Immunologic Factors|immunologic factors|mesh-ancestor
101761430|NCT00741780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761431|NCT00741780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101761432|NCT00741780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101761433|NCT00741780|Antiviral Agents|antiviral agents|mesh-ancestor
101761434|NCT00741780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101761435|NCT00936442|Anastrozole|anastrozole|mesh-list
101761436|NCT00936442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101761437|NCT00936442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101761438|NCT00936442|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101761439|NCT00936442|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101761440|NCT00936442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101761441|NCT00936442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761442|NCT00936442|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101761443|NCT00936442|Hormone Antagonists|hormone antagonists|mesh-ancestor
101761444|NCT00936442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101761445|NCT00936442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761458|NCT04043325|Immunologic Factors|immunologic factors|mesh-ancestor
101761459|NCT04043325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761460|NCT00936520|Lifitegrast|lifitegrast|mesh-list
101761461|NCT00936520|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101761462|NCT00936520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101761463|NCT00835029|Clotrimazole|clotrimazole|mesh-list
101761464|NCT00835029|Miconazole|miconazole|mesh-list
101761465|NCT00835029|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101761466|NCT00835029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101761467|NCT00835029|Antifungal Agents|antifungal agents|mesh-ancestor
101761468|NCT00835029|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101761469|NCT00835029|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101761470|NCT00835029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101761471|NCT00835029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761472|NCT00835029|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101761473|NCT00835029|Hormone Antagonists|hormone antagonists|mesh-ancestor
101761474|NCT00835029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101761475|NCT00835029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761476|NCT00835029|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101761477|NCT00835029|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101761478|NCT00835107|Ziprasidone|ziprasidone|mesh-list
101761479|NCT00835107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101761480|NCT00835107|Serotonin Agents|serotonin agents|mesh-ancestor
101761481|NCT00835107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101761482|NCT00835107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761483|NCT00835107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761484|NCT00835107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101761485|NCT00835107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101761486|NCT00835107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101761487|NCT00835107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101761488|NCT00835107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101761489|NCT00835107|Dopamine Agents|dopamine agents|mesh-ancestor
101761490|NCT00690612|Candesartan|candesartan|mesh-list
101761491|NCT00690612|Candesartan cilexetil|candesartan cilexetil|mesh-list
101761492|NCT00690612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101761493|NCT00690612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101761494|NCT00690612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101761495|NCT00690612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761496|NCT00742014|Sildenafil Citrate|sildenafil citrate|mesh-list
101761497|NCT00742014|Vasodilator Agents|vasodilator agents|mesh-ancestor
101563934|NCT02477826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101563935|NCT02477826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563936|NCT02477826|Tubulin Modulators|tubulin modulators|mesh-ancestor
101563937|NCT02477826|Antimitotic Agents|antimitotic agents|mesh-ancestor
101563938|NCT02477826|Mitosis Modulators|mitosis modulators|mesh-ancestor
101563939|NCT02477826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563940|NCT02477826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101563941|NCT02477826|Antimetabolites|antimetabolites|mesh-ancestor
101563942|NCT02477826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101563943|NCT02477826|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101563944|NCT02477826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101563945|NCT02477826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101563946|NCT02477826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101563947|NCT02432274|Etoposide|etoposide|mesh-list
101563948|NCT02432274|Etoposide phosphate|etoposide phosphate|mesh-list
101563949|NCT02432274|Lenvatinib|lenvatinib|mesh-list
101563950|NCT02432274|Ifosfamide|ifosfamide|mesh-list
101563951|NCT02432274|Isophosphamide mustard|isophosphamide mustard|mesh-list
101563952|NCT02432274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101563953|NCT02432274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101761498|NCT00742014|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101761499|NCT00742014|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101761500|NCT00742014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101761501|NCT00742014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761502|NCT00742014|Urological Agents|urological agents|mesh-ancestor
101761503|NCT00742092|Miglustat|miglustat|mesh-list
101761504|NCT00742092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101761505|NCT00742092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761506|NCT00742092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101761507|NCT00742092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101761526|NCT00742248|Respiratory System Agents|respiratory system agents|mesh-ancestor
101761527|NCT00742248|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101761529|NCT00742248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101761530|NCT00742248|Adrenergic Agents|adrenergic agents|mesh-ancestor
101761531|NCT00742248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101761532|NCT00742248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761533|NCT04249167|Paclitaxel|paclitaxel|mesh-list
101761534|NCT04249167|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101761535|NCT04249167|Atezolizumab|atezolizumab|mesh-list
101761536|NCT04249167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101761537|NCT04249167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101761538|NCT04249167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101761539|NCT04249167|Tubulin Modulators|tubulin modulators|mesh-ancestor
101761540|NCT04249167|Antimitotic Agents|antimitotic agents|mesh-ancestor
101761541|NCT04249167|Mitosis Modulators|mitosis modulators|mesh-ancestor
101761542|NCT04249167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761543|NCT04249167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101761544|NCT04249167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101761545|NCT04249167|Immunologic Factors|immunologic factors|mesh-ancestor
101761546|NCT04249167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761547|NCT00621153|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101761548|NCT00621153|Candesartan|candesartan|mesh-list
101761549|NCT00621153|Candesartan cilexetil|candesartan cilexetil|mesh-list
101563954|NCT02432274|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101563955|NCT02432274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101563956|NCT02432274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101563957|NCT02432274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563958|NCT02432274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101563959|NCT02432274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101563960|NCT02432274|Alkylating Agents|alkylating agents|mesh-ancestor
101563961|NCT02393859|Dexamethasone|dexamethasone|mesh-list
101563962|NCT02393859|Methotrexate|methotrexate|mesh-list
101563963|NCT02393859|Daunorubicin|daunorubicin|mesh-list
101563964|NCT02393859|Asparaginase|asparaginase|mesh-list
101563965|NCT02393859|Ifosfamide|ifosfamide|mesh-list
101563966|NCT02393859|Blinatumomab|blinatumomab|mesh-list
101761550|NCT00621153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101761551|NCT00621153|Diuretics|diuretics|mesh-ancestor
101761552|NCT00621153|Natriuretic Agents|natriuretic agents|mesh-ancestor
101761553|NCT00621153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761554|NCT00621153|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101761555|NCT00621153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101761556|NCT00621153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761557|NCT00621153|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101761558|NCT00621153|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101761559|NCT00574119|Spironolactone|spironolactone|mesh-list
101761560|NCT00574119|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101761561|NCT00574119|Hormone Antagonists|hormone antagonists|mesh-ancestor
101761562|NCT00574119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101761563|NCT00574119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761592|NCT00844233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101761594|NCT00841893|Alkylating Agents|alkylating agents|mesh-ancestor
101761595|NCT00841893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761596|NCT00841893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101761597|NCT00841893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101761598|NCT00844311|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101761599|NCT00844311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101761600|NCT00844311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761602|NCT00840801|Immunologic Factors|immunologic factors|mesh-ancestor
101761603|NCT00840801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761604|NCT02547597|Atenolol|atenolol|mesh-list
101761605|NCT02547597|Carvedilol|carvedilol|mesh-list
101761606|NCT02547597|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101761607|NCT02547597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101761608|NCT02547597|Adrenergic Agents|adrenergic agents|mesh-ancestor
101761609|NCT02547597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101761625|NCT02547597|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101761626|NCT00842127|Methylphenidate|methylphenidate|mesh-list
101761627|NCT00842127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101761628|NCT00842127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761629|NCT00842127|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101761630|NCT00842127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101761631|NCT00842127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101761632|NCT00842127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761633|NCT00842127|Dopamine Agents|dopamine agents|mesh-ancestor
101761634|NCT00842127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101761636|NCT00835965|Dexamethasone acetate|dexamethasone acetate|mesh-list
101761637|NCT00835965|Aprepitant|aprepitant|mesh-list
101761638|NCT00835965|Fosaprepitant|fosaprepitant|mesh-list
101761639|NCT00835965|BB 1101|bb 1101|mesh-list
101761640|NCT00835965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101761641|NCT00835965|Antiemetics|antiemetics|mesh-ancestor
101761642|NCT00835965|Autonomic Agents|autonomic agents|mesh-ancestor
101761643|NCT00835965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101563967|NCT02393859|Pegaspargase|pegaspargase|mesh-list
101563968|NCT02393859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101563969|NCT02393859|Antiemetics|antiemetics|mesh-ancestor
101563970|NCT02393859|Autonomic Agents|autonomic agents|mesh-ancestor
101563971|NCT02393859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101563972|NCT02393859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101563973|NCT02393859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101563974|NCT02393859|Glucocorticoids|glucocorticoids|mesh-ancestor
101563975|NCT02393859|Hormones|hormones|mesh-ancestor
101761644|NCT00835965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761645|NCT00835965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101761646|NCT00835965|Glucocorticoids|glucocorticoids|mesh-ancestor
101761647|NCT00835965|Hormones|hormones|mesh-ancestor
101761648|NCT00835965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101761649|NCT00835965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101761650|NCT00835965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101761651|NCT00835965|Protease Inhibitors|protease inhibitors|mesh-ancestor
101761652|NCT00835965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101761653|NCT00835965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761654|NCT00835965|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101761655|NCT00835965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101419086|NCT00154791|Gemcitabine|gemcitabine|mesh-list
101761656|NCT02567786|Plasma-lyte 148|plasma-lyte 148|mesh-list
101761657|NCT02567786|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101761658|NCT02567786|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101761659|NCT05667740|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101761660|NCT05667740|Immunologic Factors|immunologic factors|mesh-ancestor
101761661|NCT05667740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761663|NCT00842205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101761664|NCT00842205|Antiviral Agents|antiviral agents|mesh-ancestor
101761665|NCT00842205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101761666|NCT00738296|Simvastatin|simvastatin|mesh-list
101761676|NCT00836043|Alemtuzumab|alemtuzumab|mesh-list
101761677|NCT00836043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101761678|NCT00836043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101761679|NCT02567396|Talazoparib|talazoparib|mesh-list
101761680|NCT02567396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101761681|NCT02567396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101761682|NCT02567396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761683|NCT02567396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101761684|NCT00738452|Antibodies|antibodies|mesh-list
101761685|NCT00738452|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101761686|NCT00738452|Immunologic Factors|immunologic factors|mesh-ancestor
101761687|NCT00738452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761688|NCT05667428|Leuprolide|leuprolide|mesh-list
101761689|NCT05667428|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101761690|NCT05667428|Fertility Agents|fertility agents|mesh-ancestor
101761691|NCT05667428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101761692|NCT05667428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761693|NCT05667428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101761694|NCT05667428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101761695|NCT05664542|Dexmedetomidine|dexmedetomidine|mesh-list
101761696|NCT05664542|Ropivacaine|ropivacaine|mesh-list
101761697|NCT05664542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101761698|NCT05664542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101761699|NCT05664542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761700|NCT05664542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101761701|NCT05664542|Analgesics|analgesics|mesh-ancestor
101761702|NCT05664542|Sensory System Agents|sensory system agents|mesh-ancestor
101761703|NCT05664542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101761704|NCT05664542|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101761705|NCT05664542|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101761706|NCT05664542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101761707|NCT05664542|Adrenergic Agents|adrenergic agents|mesh-ancestor
101761708|NCT05664542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101761709|NCT05664542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563976|NCT02393859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101563977|NCT02393859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101563978|NCT02393859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101563979|NCT02393859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101563980|NCT02393859|Abortifacient Agents|abortifacient agents|mesh-ancestor
101563981|NCT02393859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101563982|NCT02393859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101563983|NCT02393859|Antimetabolites|antimetabolites|mesh-ancestor
101761710|NCT05664542|Anesthetics, Local|anesthetics, local|mesh-ancestor
101761711|NCT05664542|Anesthetics|anesthetics|mesh-ancestor
101761712|NCT00562978|Cyclophosphamide|cyclophosphamide|mesh-list
101761714|NCT00562978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101761715|NCT00562978|Immunologic Factors|immunologic factors|mesh-ancestor
101761716|NCT00562978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761717|NCT00562978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101761718|NCT00562978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101761719|NCT00562978|Alkylating Agents|alkylating agents|mesh-ancestor
101761720|NCT00562978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761721|NCT00562978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101761722|NCT00562978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101761723|NCT00562978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101761724|NCT00562978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101761725|NCT00562978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101761726|NCT00562978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101761727|NCT00842595|Prednisone|prednisone|mesh-list
101761728|NCT00842595|Rituximab|rituximab|mesh-list
101761729|NCT00842595|Vinorelbine|vinorelbine|mesh-list
101761730|NCT00842595|Ifosfamide|ifosfamide|mesh-list
101761731|NCT00842595|Mitoxantrone|mitoxantrone|mesh-list
101761732|NCT00842595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101761745|NCT00842595|Mitosis Modulators|mitosis modulators|mesh-ancestor
101761746|NCT00842595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761747|NCT00842595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101761748|NCT00842595|Alkylating Agents|alkylating agents|mesh-ancestor
101761749|NCT00842595|Analgesics|analgesics|mesh-ancestor
101761750|NCT00842595|Sensory System Agents|sensory system agents|mesh-ancestor
101761751|NCT00842595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101761752|NCT00842595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101761753|NCT00842595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101761754|NCT00842595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101761755|NCT00938626|Antibodies|antibodies|mesh-list
101761756|NCT00938626|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101761757|NCT00938626|Immunologic Factors|immunologic factors|mesh-ancestor
101761758|NCT00938626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761759|NCT00836199|Vaccines|vaccines|mesh-list
101761760|NCT00836199|Immunologic Factors|immunologic factors|mesh-ancestor
101761761|NCT00836199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761762|NCT04013386|Dexamethasone|dexamethasone|mesh-list
101761763|NCT04013386|Dexamethasone acetate|dexamethasone acetate|mesh-list
101761764|NCT04013386|Aprepitant|aprepitant|mesh-list
101761765|NCT04013386|Mirtazapine|mirtazapine|mesh-list
101761766|NCT04013386|BB 1101|bb 1101|mesh-list
101761767|NCT04013386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101761768|NCT04013386|Antiemetics|antiemetics|mesh-ancestor
101761769|NCT04013386|Autonomic Agents|autonomic agents|mesh-ancestor
101761770|NCT04013386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101761771|NCT04013386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761772|NCT04013386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101761773|NCT04013386|Glucocorticoids|glucocorticoids|mesh-ancestor
101761774|NCT04013386|Hormones|hormones|mesh-ancestor
101761775|NCT04013386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101761776|NCT04013386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101761777|NCT04013386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101761778|NCT04013386|Protease Inhibitors|protease inhibitors|mesh-ancestor
101761779|NCT04013386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101761780|NCT04013386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563984|NCT02393859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101563985|NCT02393859|Dermatologic Agents|dermatologic agents|mesh-ancestor
101563986|NCT02393859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101563987|NCT02393859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101563988|NCT02393859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101563989|NCT02393859|Immunologic Factors|immunologic factors|mesh-ancestor
101563990|NCT02393859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101563991|NCT02393859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101525936|NCT00540800|Docetaxel|docetaxel|mesh-list
101563992|NCT02393859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101563993|NCT02393859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101563994|NCT02393859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101563995|NCT02393859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101563996|NCT02393859|Alkylating Agents|alkylating agents|mesh-ancestor
101563998|NCT02392429|Alovudine|alovudine|mesh-list
101563999|NCT02392429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101564000|NCT02392429|Antimetabolites|antimetabolites|mesh-ancestor
101564001|NCT02392429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564002|NCT02392429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101564003|NCT02392429|Antiviral Agents|antiviral agents|mesh-ancestor
101761781|NCT04013386|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101761782|NCT04013386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101761783|NCT04013386|Antidepressive Agents|antidepressive agents|mesh-ancestor
101761784|NCT04013386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101761785|NCT04013386|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101761786|NCT04013386|Histamine Antagonists|histamine antagonists|mesh-ancestor
101761787|NCT04013386|Histamine Agents|histamine agents|mesh-ancestor
101761788|NCT04013386|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101761789|NCT04013386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101761790|NCT04013386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101761791|NCT04013386|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101761792|NCT04013386|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101761793|NCT04013386|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101761794|NCT04013386|Adrenergic Agents|adrenergic agents|mesh-ancestor
101761795|NCT04013386|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101761808|NCT00842907|Tretinoin|tretinoin|mesh-list
101761809|NCT00842907|Isotretinoin|isotretinoin|mesh-list
101761810|NCT00842907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101761811|NCT00842907|Keratolytic Agents|keratolytic agents|mesh-ancestor
101761812|NCT00842907|Dermatologic Agents|dermatologic agents|mesh-ancestor
101761813|NCT00620373|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
101761814|NCT00620373|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101761815|NCT00620373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761816|NCT00940654|Acetaminophen|acetaminophen|mesh-list
101761817|NCT00940654|Antipyretics|antipyretics|mesh-list
101761818|NCT00940654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101761819|NCT00940654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101761820|NCT00940654|Analgesics|analgesics|mesh-ancestor
101761821|NCT00940654|Sensory System Agents|sensory system agents|mesh-ancestor
101761822|NCT00940654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101761823|NCT00940654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761824|NCT00843063|Pantoprazole|pantoprazole|mesh-list
101761825|NCT00843063|Famotidine|famotidine|mesh-list
101761826|NCT00843063|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101564004|NCT02392429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101564005|NCT02392429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101564006|NCT02392429|Immunologic Factors|immunologic factors|mesh-ancestor
101564007|NCT02392429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564008|NCT02379416|Paclitaxel|paclitaxel|mesh-list
101564009|NCT02379416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101564010|NCT02379416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101564011|NCT02379416|Tubulin Modulators|tubulin modulators|mesh-ancestor
101564012|NCT02379416|Antimitotic Agents|antimitotic agents|mesh-ancestor
101564013|NCT02379416|Mitosis Modulators|mitosis modulators|mesh-ancestor
101412262|NCT00117299|Vatalanib|vatalanib|mesh-list
101761827|NCT00843063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101761828|NCT00843063|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101761829|NCT00843063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101761830|NCT00843063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761831|NCT00843063|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101761832|NCT00843063|Histamine Antagonists|histamine antagonists|mesh-ancestor
101761833|NCT00843063|Histamine Agents|histamine agents|mesh-ancestor
101761834|NCT00843063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101761835|NCT00843063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761836|NCT04013464|Escitalopram|escitalopram|mesh-list
101761837|NCT04013464|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101761838|NCT04013464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101761839|NCT04013464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101761840|NCT04013464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761841|NCT04013464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101761842|NCT04013464|Serotonin Agents|serotonin agents|mesh-ancestor
101761843|NCT04013464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761844|NCT04012918|Capecitabine|capecitabine|mesh-list
101761845|NCT04012918|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101761846|NCT04012918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101761847|NCT04012918|Antimetabolites|antimetabolites|mesh-ancestor
101761848|NCT04012918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761849|NCT04012918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101761850|NCT04012918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101761851|NCT04012918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101761852|NCT04012918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101761853|NCT04012918|Hormone Antagonists|hormone antagonists|mesh-ancestor
101761854|NCT04012918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101761855|NCT04012918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761856|NCT00939718|Vitamin B 12|vitamin b 12|mesh-list
101761873|NCT00845559|Exenatide|exenatide|mesh-list
101761874|NCT00845559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101761875|NCT00845559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761876|NCT00845559|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101761877|NCT00845559|Incretins|incretins|mesh-ancestor
101761878|NCT00845559|Hormones|hormones|mesh-ancestor
101761879|NCT00845559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101761880|NCT00836823|Alfuzosin|alfuzosin|mesh-list
101761881|NCT00836823|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101761882|NCT00836823|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101761883|NCT00836823|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101761884|NCT00836823|Adrenergic Agents|adrenergic agents|mesh-ancestor
101761885|NCT00836823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101761886|NCT00836823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761887|NCT00836823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761888|NCT00836823|Urological Agents|urological agents|mesh-ancestor
101761889|NCT02567240|Carbon Monoxide|carbon monoxide|mesh-list
101761890|NCT02567240|Antimetabolites|antimetabolites|mesh-ancestor
101761891|NCT02567240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761892|NCT02567240|Gasotransmitters|gasotransmitters|mesh-ancestor
101761893|NCT02567240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101564014|NCT02379416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564016|NCT02197234|Simvastatin|simvastatin|mesh-list
101564017|NCT02197234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101564018|NCT02197234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101564019|NCT02197234|Antimetabolites|antimetabolites|mesh-ancestor
101564020|NCT02197234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564021|NCT02197234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101412271|NCT00117000|Androgens|androgens|mesh-ancestor
101761894|NCT02567240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761895|NCT05107778|Entecavir|entecavir|mesh-list
101761896|NCT05107778|Antiviral Agents|antiviral agents|mesh-ancestor
101761897|NCT05107778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101761898|NCT00372619|Cytarabine|cytarabine|mesh-list
101761899|NCT00372619|Methotrexate|methotrexate|mesh-list
101761900|NCT00372619|Clofarabine|clofarabine|mesh-list
101761901|NCT00372619|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101761902|NCT00372619|Abortifacient Agents|abortifacient agents|mesh-ancestor
101761903|NCT00372619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101761904|NCT00372619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761905|NCT00372619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101761906|NCT00372619|Antimetabolites|antimetabolites|mesh-ancestor
101761907|NCT00372619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761908|NCT00372619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101761909|NCT00372619|Dermatologic Agents|dermatologic agents|mesh-ancestor
101761910|NCT00372619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101761911|NCT00372619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101761912|NCT00372619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101761913|NCT00372619|Immunologic Factors|immunologic factors|mesh-ancestor
101761914|NCT00372619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101761925|NCT00851175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101761926|NCT00851175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101761927|NCT00851175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101761928|NCT00851175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761929|NCT00851175|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101761930|NCT00851175|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101761931|NCT00851175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101761932|NCT00851175|Purinergic Agents|purinergic agents|mesh-ancestor
101761933|NCT00851175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101761934|NCT02566226|Morphine|morphine|mesh-list
101761935|NCT02566226|Bupivacaine|bupivacaine|mesh-list
101761936|NCT02566226|Anesthetics, Local|anesthetics, local|mesh-ancestor
101761937|NCT02566226|Anesthetics|anesthetics|mesh-ancestor
101761938|NCT02566226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101761939|NCT02566226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761940|NCT02566226|Sensory System Agents|sensory system agents|mesh-ancestor
101761941|NCT02566226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101761942|NCT02566226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101761943|NCT02566226|Narcotics|narcotics|mesh-ancestor
101761944|NCT02566226|Analgesics|analgesics|mesh-ancestor
101761945|NCT00837135|Vaccines|vaccines|mesh-list
101761946|NCT00837135|Immunologic Factors|immunologic factors|mesh-ancestor
101761947|NCT00837135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761948|NCT00562588|Dipyridamole|dipyridamole|mesh-list
101761949|NCT00562588|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
101761950|NCT00562588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101761951|NCT00562588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101761952|NCT00562588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761953|NCT00562588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101761954|NCT00562588|Vasodilator Agents|vasodilator agents|mesh-ancestor
101761955|NCT04263038|Rivaroxaban|rivaroxaban|mesh-list
101761956|NCT04263038|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101761957|NCT04263038|Antithrombins|antithrombins|mesh-ancestor
101761958|NCT04263038|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101761959|NCT04263038|Protease Inhibitors|protease inhibitors|mesh-ancestor
101564022|NCT02197234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101564023|NCT02197234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101564024|NCT02197234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101564025|NCT02197234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101564026|NCT02096588|Cyclophosphamide|cyclophosphamide|mesh-list
101761960|NCT04263038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101761961|NCT04263038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761962|NCT04263038|Anticoagulants|anticoagulants|mesh-ancestor
101761963|NCT02546349|Fluticasone|fluticasone|mesh-list
101761964|NCT02546349|Tiotropium Bromide|tiotropium bromide|mesh-list
101761965|NCT02546349|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101761966|NCT02546349|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101761967|NCT02546349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101761968|NCT02546349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101761969|NCT02546349|Autonomic Agents|autonomic agents|mesh-ancestor
101761970|NCT02546349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101761971|NCT02546349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761972|NCT02546349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101761973|NCT02546349|Respiratory System Agents|respiratory system agents|mesh-ancestor
101761974|NCT02546349|Dermatologic Agents|dermatologic agents|mesh-ancestor
101761975|NCT02546349|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101761976|NCT02546349|Parasympatholytics|parasympatholytics|mesh-ancestor
101761977|NCT02546349|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101761978|NCT02546349|Cholinergic Agents|cholinergic agents|mesh-ancestor
101761994|NCT00372385|Interferon-alpha|interferon-alpha|mesh-list
101761995|NCT00372385|Interferon alpha-2|interferon alpha-2|mesh-list
101761996|NCT00372385|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101761997|NCT00372385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101761998|NCT00372385|Antiviral Agents|antiviral agents|mesh-ancestor
101761999|NCT00372385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101762000|NCT00372385|Antimetabolites|antimetabolites|mesh-ancestor
101762001|NCT00372385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762002|NCT00372385|Immunologic Factors|immunologic factors|mesh-ancestor
101762003|NCT00372385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762004|NCT03830281|Insulin|insulin|mesh-list
101762005|NCT03830281|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101762006|NCT03830281|Insulin Lispro|insulin lispro|mesh-list
101762007|NCT03830281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101762008|NCT03830281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762009|NCT00563368|Topiramate|topiramate|mesh-list
101762010|NCT00563368|Phentermine|phentermine|mesh-list
101762011|NCT00563368|Anticonvulsants|anticonvulsants|mesh-ancestor
101762012|NCT00563368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101407587|NCT00440245|Respiratory System Agents|respiratory system agents|mesh-ancestor
101762013|NCT00563368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762014|NCT00563368|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101762015|NCT00563368|Appetite Depressants|appetite depressants|mesh-ancestor
101762016|NCT00563368|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101762017|NCT00563368|Sympathomimetics|sympathomimetics|mesh-ancestor
101762018|NCT00563368|Autonomic Agents|autonomic agents|mesh-ancestor
101762019|NCT00563368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101762020|NCT00563368|Adrenergic Agents|adrenergic agents|mesh-ancestor
101762021|NCT00563368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101762022|NCT00563368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762023|NCT00390013|Gabapentin|gabapentin|mesh-list
101762024|NCT00390013|Analgesics|analgesics|mesh-ancestor
101762025|NCT00390013|Sensory System Agents|sensory system agents|mesh-ancestor
101762026|NCT00390013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101762027|NCT00390013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762028|NCT00390013|Anticonvulsants|anticonvulsants|mesh-ancestor
101762029|NCT00390013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101762030|NCT00390013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101762031|NCT00390013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101762032|NCT00390013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101762033|NCT00390013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101762035|NCT00390013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101762036|NCT00390013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762037|NCT00390013|Antimanic Agents|antimanic agents|mesh-ancestor
101762038|NCT00562120|Fexofenadine|fexofenadine|mesh-list
101762039|NCT00562120|Terfenadine|terfenadine|mesh-list
101762040|NCT00562120|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101564027|NCT02096588|Doxorubicin|doxorubicin|mesh-list
101564028|NCT02096588|Simvastatin|simvastatin|mesh-list
101564029|NCT02096588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101564030|NCT02096588|Immunologic Factors|immunologic factors|mesh-ancestor
101564031|NCT02096588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564032|NCT02096588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101564033|NCT02096588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101762065|NCT00621855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101762066|NCT00621855|Protease Inhibitors|protease inhibitors|mesh-ancestor
101762067|NCT00621855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101762068|NCT00621855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762069|NCT00621855|Anticoagulants|anticoagulants|mesh-ancestor
101762071|NCT00851565|Antibodies|antibodies|mesh-list
101762072|NCT00851565|Immunologic Factors|immunologic factors|mesh-ancestor
101762073|NCT00851565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762074|NCT00851565|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101762075|NCT00851565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101762076|NCT00851565|Dermatologic Agents|dermatologic agents|mesh-ancestor
101762077|NCT00851565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101762078|NCT00851565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101762079|NCT00561574|Mirtazapine|mirtazapine|mesh-list
101762080|NCT00561574|Antidepressive Agents|antidepressive agents|mesh-ancestor
101762081|NCT00561574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101762082|NCT00561574|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101762083|NCT00561574|Histamine Antagonists|histamine antagonists|mesh-ancestor
101762084|NCT00561574|Histamine Agents|histamine agents|mesh-ancestor
101762085|NCT00561574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101762086|NCT00561574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762087|NCT00561574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762088|NCT00561574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101762089|NCT00561574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101762124|NCT02563704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101762126|NCT02563704|Sensory System Agents|sensory system agents|mesh-ancestor
101762127|NCT00848523|Panobinostat|panobinostat|mesh-list
101762128|NCT00848523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101762129|NCT00848523|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101762130|NCT00848523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101762131|NCT00848523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762149|NCT00742404|Glucocorticoids|glucocorticoids|mesh-ancestor
101762150|NCT00742404|Hormones|hormones|mesh-ancestor
101762151|NCT00742404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101762152|NCT00742404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101762153|NCT00742404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101762154|NCT00742404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101762155|NCT00742404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101762156|NCT00742404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101762157|NCT00742404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101762158|NCT00742404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762159|NCT00744666|Prednisolone|prednisolone|mesh-list
101762160|NCT00744666|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101762161|NCT00744666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101762162|NCT00744666|Glucocorticoids|glucocorticoids|mesh-ancestor
101762163|NCT00744666|Hormones|hormones|mesh-ancestor
101762164|NCT00744666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101762165|NCT00744666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762166|NCT00744666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101762167|NCT00744666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101762168|NCT00744666|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101762169|NCT04013620|Abatacept|abatacept|mesh-list
101762170|NCT04013620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101762171|NCT04013620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762172|NCT04013620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101762173|NCT04013620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101762174|NCT04013620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101762175|NCT04013620|Immunologic Factors|immunologic factors|mesh-ancestor
101564034|NCT02096588|Alkylating Agents|alkylating agents|mesh-ancestor
101564035|NCT02096588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564036|NCT02096588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101564037|NCT02096588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101564038|NCT02096588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101564039|NCT02096588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101564040|NCT02096588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101564041|NCT02096588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101564042|NCT02096588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101564043|NCT02096588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101564044|NCT02096588|Antimetabolites|antimetabolites|mesh-ancestor
101564045|NCT02096588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101564046|NCT02096588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101564047|NCT02022982|Palbociclib|palbociclib|mesh-list
101564048|NCT02022982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101564049|NCT02022982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101564050|NCT02022982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101564051|NCT02022982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564052|NCT01622335|Nitrous Oxide|nitrous oxide|mesh-list
101564053|NCT01622335|Anesthetics|anesthetics|mesh-ancestor
101762176|NCT04013620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762177|NCT04013620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101762178|NCT00749112|Rituximab|rituximab|mesh-list
101762179|NCT00749112|Alemtuzumab|alemtuzumab|mesh-list
101762180|NCT00749112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101762182|NCT00749112|Immunologic Factors|immunologic factors|mesh-ancestor
101762183|NCT00749112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762184|NCT00749112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101762185|NCT00848679|Lidocaine|lidocaine|mesh-list
101762186|NCT00848679|Anesthetics, Local|anesthetics, local|mesh-ancestor
101762187|NCT00848679|Anesthetics|anesthetics|mesh-ancestor
101762188|NCT00848679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101762189|NCT00848679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762190|NCT00848679|Sensory System Agents|sensory system agents|mesh-ancestor
101762191|NCT00848679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101762204|NCT04012606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762205|NCT02545959|Methylprednisolone|methylprednisolone|mesh-list
101762206|NCT02545959|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101762207|NCT02545959|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101762208|NCT02545959|Prednisolone|prednisolone|mesh-list
101762209|NCT02545959|Prednisolone acetate|prednisolone acetate|mesh-list
101762210|NCT02545959|Rituximab|rituximab|mesh-list
101762211|NCT02545959|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101762212|NCT02545959|Prednisolone phosphate|prednisolone phosphate|mesh-list
101762213|NCT02545959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101762214|NCT02545959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101762215|NCT02545959|Immunologic Factors|immunologic factors|mesh-ancestor
101762216|NCT02545959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762217|NCT02545959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101762218|NCT02545959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101762219|NCT02545959|Antiemetics|antiemetics|mesh-ancestor
101762220|NCT02545959|Autonomic Agents|autonomic agents|mesh-ancestor
101762221|NCT02545959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101762222|NCT02545959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101564054|NCT01622335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101564055|NCT01622335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564057|NCT01622335|Anesthetics, General|anesthetics, general|mesh-ancestor
101564058|NCT01622335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101564059|NCT01622335|Analgesics|analgesics|mesh-ancestor
101564060|NCT01622335|Sensory System Agents|sensory system agents|mesh-ancestor
101564061|NCT01622335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101564062|NCT01359592|Prednisone|prednisone|mesh-list
101564063|NCT01359592|Cyclophosphamide|cyclophosphamide|mesh-list
101762223|NCT02545959|Glucocorticoids|glucocorticoids|mesh-ancestor
101762224|NCT02545959|Hormones|hormones|mesh-ancestor
101762225|NCT02545959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101762226|NCT02545959|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101762227|NCT02545959|Protective Agents|protective agents|mesh-ancestor
101762228|NCT02545959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101762229|NCT00744900|Pemetrexed|pemetrexed|mesh-list
101762230|NCT00744900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101762231|NCT00744900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101762232|NCT00744900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762233|NCT00744900|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101762234|NCT00744900|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101762235|NCT00727090|Conivaptan|conivaptan|mesh-list
101762236|NCT00727090|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101762237|NCT00727090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762238|NCT00727090|Natriuretic Agents|natriuretic agents|mesh-ancestor
101762239|NCT00727090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762240|NCT00689052|Pramipexole|pramipexole|mesh-list
101762241|NCT00689052|Antioxidants|antioxidants|mesh-ancestor
101762242|NCT00689052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762243|NCT00689052|Protective Agents|protective agents|mesh-ancestor
101762244|NCT00689052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762245|NCT00689052|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101762246|NCT00689052|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101762247|NCT00689052|Dopamine Agonists|dopamine agonists|mesh-ancestor
101762248|NCT00689052|Dopamine Agents|dopamine agents|mesh-ancestor
101762249|NCT00689052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101762250|NCT04012450|Anesthetics|anesthetics|mesh-list
101762251|NCT04012450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101762261|NCT02565212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101762263|NCT02565212|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101762264|NCT02565212|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101762265|NCT02565212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762266|NCT00747708|Lenograstim|lenograstim|mesh-list
101762267|NCT00747708|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101762268|NCT00747708|Immunologic Factors|immunologic factors|mesh-ancestor
101762269|NCT00747708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762270|NCT05602064|Acetaminophen|acetaminophen|mesh-list
101762271|NCT05602064|Ibuprofen|ibuprofen|mesh-list
101762272|NCT05602064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101762273|NCT05602064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101762274|NCT05602064|Analgesics|analgesics|mesh-ancestor
101762275|NCT05602064|Sensory System Agents|sensory system agents|mesh-ancestor
101762276|NCT05602064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101762277|NCT05602064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762278|NCT05602064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101762279|NCT05602064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101762280|NCT05602064|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101762281|NCT05602064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101762282|NCT05602064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762283|NCT05602064|Antipyretics|antipyretics|mesh-ancestor
101762284|NCT00560950|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101564064|NCT01359592|Rituximab|rituximab|mesh-list
101564065|NCT01359592|Doxorubicin|doxorubicin|mesh-list
101526003|NCT04659525|Protease Inhibitors|protease inhibitors|mesh-ancestor
101564066|NCT01359592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101564067|NCT01359592|Vincristine|vincristine|mesh-list
101564068|NCT01359592|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101564069|NCT01359592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101564070|NCT01359592|Immunologic Factors|immunologic factors|mesh-ancestor
101564071|NCT01359592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564072|NCT01359592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101412320|NCT02964195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101762285|NCT00560950|Immunologic Factors|immunologic factors|mesh-ancestor
101762286|NCT00560950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762287|NCT02562144|Lidocaine|lidocaine|mesh-list
101762288|NCT02562144|Anesthetics, Local|anesthetics, local|mesh-ancestor
101762289|NCT02562144|Anesthetics|anesthetics|mesh-ancestor
101762290|NCT02562144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101762291|NCT02562144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762292|NCT02562144|Sensory System Agents|sensory system agents|mesh-ancestor
101762293|NCT02562144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101762294|NCT02562144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101762295|NCT02562144|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101762296|NCT02562144|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101762297|NCT02562144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101762298|NCT02562144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762299|NCT02562300|Misoprostol|misoprostol|mesh-list
101762300|NCT02562300|Oxytocin|oxytocin|mesh-list
101762301|NCT02562300|Oxytocics|oxytocics|mesh-ancestor
101762302|NCT02562300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101762303|NCT02562300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762304|NCT02562300|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101762305|NCT02562300|Abortifacient Agents|abortifacient agents|mesh-ancestor
101762306|NCT02562300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101762307|NCT02562300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101762308|NCT00945178|Naproxen|naproxen|mesh-list
101762309|NCT00945178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101762310|NCT00945178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101762311|NCT00945178|Analgesics|analgesics|mesh-ancestor
101762312|NCT00945178|Sensory System Agents|sensory system agents|mesh-ancestor
101762313|NCT00945178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101762314|NCT00945178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762315|NCT00945178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101762340|NCT00923676|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101762341|NCT00923676|Antimetabolites|antimetabolites|mesh-ancestor
101762342|NCT00923676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762343|NCT00923676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101762344|NCT00923676|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101762345|NCT00923676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101762346|NCT00921284|Dexmedetomidine|dexmedetomidine|mesh-list
101762347|NCT00921284|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101762348|NCT00921284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101762349|NCT00921284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762350|NCT00921284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101762351|NCT00921284|Analgesics|analgesics|mesh-ancestor
101762352|NCT00921284|Sensory System Agents|sensory system agents|mesh-ancestor
101762353|NCT00921284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101762354|NCT00921284|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101762355|NCT00921284|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101762356|NCT00921284|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101762357|NCT00921284|Adrenergic Agents|adrenergic agents|mesh-ancestor
101762358|NCT00921284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101762359|NCT00921284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762360|NCT00749502|Niraparib|niraparib|mesh-list
101762361|NCT00749502|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101564073|NCT01359592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101564074|NCT01359592|Alkylating Agents|alkylating agents|mesh-ancestor
101564075|NCT01359592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564076|NCT01359592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101564077|NCT01359592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101412331|NCT00475462|Adrenergic Agents|adrenergic agents|mesh-ancestor
101762362|NCT00749502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101762363|NCT00749502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762364|NCT00749502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101762385|NCT00749814|Melatonin|melatonin|mesh-list
101762386|NCT00749814|Antioxidants|antioxidants|mesh-ancestor
101762387|NCT00749814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762388|NCT00749814|Protective Agents|protective agents|mesh-ancestor
101762389|NCT00749814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762390|NCT00749814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101762391|NCT00748176|Anesthetics|anesthetics|mesh-list
101762392|NCT00748176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101762393|NCT00748176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762394|NCT00619359|Dexamethasone|dexamethasone|mesh-list
101762395|NCT00619359|Dexamethasone acetate|dexamethasone acetate|mesh-list
101762396|NCT00619359|Ondansetron|ondansetron|mesh-list
101762397|NCT00619359|Aprepitant|aprepitant|mesh-list
101762398|NCT00619359|Fosaprepitant|fosaprepitant|mesh-list
101762399|NCT00619359|BB 1101|bb 1101|mesh-list
101762400|NCT00619359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101762401|NCT00619359|Antiemetics|antiemetics|mesh-ancestor
101762402|NCT00619359|Autonomic Agents|autonomic agents|mesh-ancestor
101762403|NCT00619359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101762404|NCT00619359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762405|NCT00619359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101762406|NCT00619359|Glucocorticoids|glucocorticoids|mesh-ancestor
101762407|NCT00619359|Hormones|hormones|mesh-ancestor
101762408|NCT00619359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101762409|NCT00619359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101762410|NCT00619359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101762411|NCT00619359|Protease Inhibitors|protease inhibitors|mesh-ancestor
101762412|NCT00619359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101762413|NCT00619359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762414|NCT00619359|Antipruritics|antipruritics|mesh-ancestor
101762415|NCT00619359|Dermatologic Agents|dermatologic agents|mesh-ancestor
101762416|NCT00619359|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101762417|NCT00619359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101762418|NCT00619359|Serotonin Agents|serotonin agents|mesh-ancestor
101762419|NCT00619359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101762420|NCT00619359|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101762421|NCT00848991|Dexmedetomidine|dexmedetomidine|mesh-list
101762432|NCT00848991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101762433|NCT00848991|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101762434|NCT00848991|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101762435|NCT00848991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101762436|NCT00848991|Adrenergic Agents|adrenergic agents|mesh-ancestor
101762437|NCT00848991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101762438|NCT00848991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762439|NCT00950794|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101762440|NCT00950794|Tulobuterol|tulobuterol|mesh-list
101762441|NCT00950794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101762442|NCT00950794|Autonomic Agents|autonomic agents|mesh-ancestor
101762443|NCT00950794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101762444|NCT00950794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762445|NCT00950794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101762446|NCT00950794|Respiratory System Agents|respiratory system agents|mesh-ancestor
101762447|NCT00950794|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101762448|NCT00950794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101762449|NCT00950794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101762450|NCT00950794|Adrenergic Agents|adrenergic agents|mesh-ancestor
101762451|NCT00950794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101564078|NCT01359592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101564079|NCT01359592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101564080|NCT01359592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101564081|NCT01359592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101564082|NCT01359592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101564083|NCT01359592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101564084|NCT01359592|Glucocorticoids|glucocorticoids|mesh-ancestor
101564085|NCT01359592|Hormones|hormones|mesh-ancestor
101412335|NCT00475618|Fluorides, Topical|fluorides, topical|mesh-list
101412336|NCT00475618|Cariostatic Agents|cariostatic agents|mesh-ancestor
101762452|NCT00950794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762453|NCT00852189|Folic Acid|folic acid|mesh-list
101762454|NCT00852189|Vitamin B Complex|vitamin b complex|mesh-list
101762455|NCT00852189|Vinca Alkaloids|vinca alkaloids|mesh-list
101762456|NCT00852189|Hematinics|hematinics|mesh-ancestor
101762457|NCT00852189|Vitamins|vitamins|mesh-ancestor
101762458|NCT00852189|Micronutrients|micronutrients|mesh-ancestor
101762459|NCT00852189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762460|NCT00852189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101762461|NCT00852189|Tubulin Modulators|tubulin modulators|mesh-ancestor
101762462|NCT00852189|Antimitotic Agents|antimitotic agents|mesh-ancestor
101762463|NCT00852189|Mitosis Modulators|mitosis modulators|mesh-ancestor
101762464|NCT00852189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762465|NCT00951106|Pyrimethamine|pyrimethamine|mesh-list
101762466|NCT00951106|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101762467|NCT00951106|Antimalarials|antimalarials|mesh-ancestor
101762468|NCT00951106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101762469|NCT00951106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101762470|NCT00951106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101762471|NCT00951106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101762472|NCT00951106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101762473|NCT00951106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762474|NCT00372229|Valganciclovir|valganciclovir|mesh-list
101762475|NCT00372229|Ganciclovir|ganciclovir|mesh-list
101762476|NCT00372229|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101762477|NCT00372229|Antiviral Agents|antiviral agents|mesh-ancestor
101762478|NCT00372229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101762479|NCT00372229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101762480|NCT00372229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101762481|NCT00372229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762482|NCT05301010|Docetaxel|docetaxel|mesh-list
101762483|NCT05301010|Trastuzumab|trastuzumab|mesh-list
101762484|NCT05301010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101762485|NCT05301010|Tubulin Modulators|tubulin modulators|mesh-ancestor
101762486|NCT05301010|Antimitotic Agents|antimitotic agents|mesh-ancestor
101762487|NCT05301010|Mitosis Modulators|mitosis modulators|mesh-ancestor
101762506|NCT04012294|Allopurinol|allopurinol|mesh-list
101762507|NCT04012294|Antimetabolites|antimetabolites|mesh-ancestor
101762508|NCT04012294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762509|NCT04012294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101762510|NCT04012294|Gout Suppressants|gout suppressants|mesh-ancestor
101762511|NCT04012294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101762512|NCT04012294|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101762513|NCT04012294|Antioxidants|antioxidants|mesh-ancestor
101762514|NCT04012294|Protective Agents|protective agents|mesh-ancestor
101762515|NCT04012294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762516|NCT00849459|Interleukin-12|interleukin-12|mesh-list
101762517|NCT00849459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101762518|NCT00849459|Immunologic Factors|immunologic factors|mesh-ancestor
101762519|NCT00849459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762520|NCT00849459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101762521|NCT00849459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101762522|NCT00849459|Growth Substances|growth substances|mesh-ancestor
101762523|NCT00849459|Growth Inhibitors|growth inhibitors|mesh-ancestor
101762524|NCT00849459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101762525|NCT00852345|Clofazimine|clofazimine|mesh-list
101762526|NCT00852345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101564086|NCT01359592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101564087|NCT01359592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101564088|NCT01359592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101564090|NCT01359592|Antimitotic Agents|antimitotic agents|mesh-ancestor
101564091|NCT01359592|Mitosis Modulators|mitosis modulators|mesh-ancestor
101564092|NCT01359592|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101564093|NCT01331018|Plerixafor|plerixafor|mesh-list
101564094|NCT01331018|Prednisone|prednisone|mesh-list
101564095|NCT01331018|Methylprednisolone|methylprednisolone|mesh-list
101412343|NCT00475696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101762527|NCT00852345|Leprostatic Agents|leprostatic agents|mesh-ancestor
101762528|NCT00852345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101762529|NCT00852345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101762530|NCT00852423|Artesunate|artesunate|mesh-list
101762531|NCT00852423|Lumefantrine|lumefantrine|mesh-list
101762532|NCT00852423|Artemether|artemether|mesh-list
101762533|NCT00852423|Piperaquine|piperaquine|mesh-list
101762534|NCT00852423|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101762535|NCT00852423|Amodiaquine|amodiaquine|mesh-list
101762536|NCT00852423|Artenimol|artenimol|mesh-list
101762537|NCT00852423|Mefloquine|mefloquine|mesh-list
101762538|NCT00852423|Antimalarials|antimalarials|mesh-ancestor
101762549|NCT00941824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101762550|NCT00941824|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101762551|NCT00941824|Antitubercular Agents|antitubercular agents|mesh-ancestor
101762552|NCT00941824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101762553|NCT00941824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101762554|NCT00941824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101762555|NCT00941824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762556|NCT00849537|Triamcinolone|triamcinolone|mesh-list
101762557|NCT00849537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101762558|NCT00849537|Glucocorticoids|glucocorticoids|mesh-ancestor
101534599|NCT04575675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101762560|NCT00849537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101762561|NCT00849537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762562|NCT01049815|Calcium Carbonate|calcium carbonate|mesh-list
101762563|NCT01049815|Calcium|calcium|mesh-list
101762564|NCT01049815|Sevelamer|sevelamer|mesh-list
101762565|NCT01049815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101762566|NCT01049815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762567|NCT01049815|Antacids|antacids|mesh-ancestor
101762568|NCT01049815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762569|NCT01049815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101762570|NCT01049815|Chelating Agents|chelating agents|mesh-ancestor
101762571|NCT01049815|Sequestering Agents|sequestering agents|mesh-ancestor
101762572|NCT00849615|Leucovorin|leucovorin|mesh-list
101762573|NCT00849615|Folic Acid|folic acid|mesh-list
101762574|NCT00849615|Docetaxel|docetaxel|mesh-list
101762575|NCT00849615|Fluorouracil|fluorouracil|mesh-list
101762576|NCT00849615|Oxaliplatin|oxaliplatin|mesh-list
101762577|NCT00849615|Levoleucovorin|levoleucovorin|mesh-list
101762578|NCT00849615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101762579|NCT00849615|Tubulin Modulators|tubulin modulators|mesh-ancestor
101762580|NCT00849615|Antimitotic Agents|antimitotic agents|mesh-ancestor
101762581|NCT00849615|Mitosis Modulators|mitosis modulators|mesh-ancestor
101762582|NCT00849615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762583|NCT00849615|Antimetabolites|antimetabolites|mesh-ancestor
101762584|NCT00849615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101762585|NCT00849615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101762586|NCT00849615|Immunologic Factors|immunologic factors|mesh-ancestor
101762587|NCT00849615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762588|NCT00849615|Antidotes|antidotes|mesh-ancestor
101762589|NCT00849615|Protective Agents|protective agents|mesh-ancestor
101762590|NCT00849615|Vitamin B Complex|vitamin b complex|mesh-ancestor
101762591|NCT00849615|Vitamins|vitamins|mesh-ancestor
101762592|NCT00849615|Micronutrients|micronutrients|mesh-ancestor
101762593|NCT00849615|Hematinics|hematinics|mesh-ancestor
101762594|NCT00946036|Sertraline|sertraline|mesh-list
101564096|NCT01331018|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101564097|NCT01331018|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101564098|NCT01331018|Prednisolone|prednisolone|mesh-list
101564099|NCT01331018|Prednisolone acetate|prednisolone acetate|mesh-list
101564100|NCT01331018|Cortisone|cortisone|mesh-list
101564101|NCT01331018|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101564102|NCT01331018|Prednisolone phosphate|prednisolone phosphate|mesh-list
101564103|NCT01331018|Lenograstim|lenograstim|mesh-list
101564104|NCT01331018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101564105|NCT01331018|Glucocorticoids|glucocorticoids|mesh-ancestor
101564106|NCT01331018|Hormones|hormones|mesh-ancestor
101564107|NCT01331018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101564108|NCT01331018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564109|NCT01331018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101564110|NCT01331018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101564111|NCT01331018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101564112|NCT01331018|Immunologic Factors|immunologic factors|mesh-ancestor
101564113|NCT01331018|Antiemetics|antiemetics|mesh-ancestor
101564114|NCT01331018|Autonomic Agents|autonomic agents|mesh-ancestor
101412353|NCT00475696|Dopamine Agents|dopamine agents|mesh-ancestor
101762595|NCT00946036|Antidepressive Agents|antidepressive agents|mesh-ancestor
101762596|NCT00946036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101762597|NCT00946036|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101762598|NCT00946036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101762599|NCT00946036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101762600|NCT00946036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762601|NCT00946036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101762602|NCT00946036|Serotonin Agents|serotonin agents|mesh-ancestor
101762603|NCT00946036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762604|NCT00688740|Cyclophosphamide|cyclophosphamide|mesh-list
101762605|NCT00688740|Docetaxel|docetaxel|mesh-list
101762606|NCT00688740|Doxorubicin|doxorubicin|mesh-list
101762617|NCT00688740|Tubulin Modulators|tubulin modulators|mesh-ancestor
101762618|NCT00688740|Antimitotic Agents|antimitotic agents|mesh-ancestor
101762619|NCT00688740|Mitosis Modulators|mitosis modulators|mesh-ancestor
101762620|NCT00688740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101762621|NCT00688740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101762622|NCT00688740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101762623|NCT00688740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101762624|NCT00688740|Antimetabolites|antimetabolites|mesh-ancestor
101762625|NCT00688740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101762627|NCT05323058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101762628|NCT01046773|Cholecalciferol|cholecalciferol|mesh-list
101762629|NCT01046773|Vitamin D|vitamin d|mesh-list
101762630|NCT01046773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101762631|NCT01046773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762632|NCT01046773|Vitamins|vitamins|mesh-ancestor
101762633|NCT01046773|Micronutrients|micronutrients|mesh-ancestor
101762634|NCT01046773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101762635|NCT00850005|Immunoglobulins|immunoglobulins|mesh-list
101762636|NCT00850005|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101762637|NCT00850005|Antibodies|antibodies|mesh-list
101762638|NCT00850005|gamma-Globulins|gamma-globulins|mesh-list
101762639|NCT00850005|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101762640|NCT00850005|Immunologic Factors|immunologic factors|mesh-ancestor
101762641|NCT00850005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762642|NCT00852579|Azithromycin|azithromycin|mesh-list
101564115|NCT01331018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101564116|NCT01331018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101564117|NCT01331018|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101564118|NCT01331018|Protective Agents|protective agents|mesh-ancestor
101564119|NCT01331018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101564120|NCT01331018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101564121|NCT01331018|Antiviral Agents|antiviral agents|mesh-ancestor
101564122|NCT01331018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101564123|NCT00840853|Acetaminophen|acetaminophen|mesh-list
101564124|NCT00840853|Diphenhydramine|diphenhydramine|mesh-list
101762643|NCT00852579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101762644|NCT00852579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101762645|NCT00942136|Dolutegravir|dolutegravir|mesh-list
101762646|NCT00942136|Omeprazole|omeprazole|mesh-list
101762647|NCT00942136|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101762648|NCT00942136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101762649|NCT00942136|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101762650|NCT00942136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101762651|NCT00942136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762652|NCT00942136|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101762653|NCT00942136|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101762654|NCT00942136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101762655|NCT00942136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101762656|NCT00942136|Antiviral Agents|antiviral agents|mesh-ancestor
101762657|NCT00942136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101762658|NCT05300932|Cyclophosphamide|cyclophosphamide|mesh-list
101762659|NCT05300932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101762660|NCT05300932|Immunologic Factors|immunologic factors|mesh-ancestor
101762661|NCT05300932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762662|NCT05300932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101762663|NCT05300932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101762664|NCT05300932|Alkylating Agents|alkylating agents|mesh-ancestor
101762665|NCT05300932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762666|NCT05300932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101762667|NCT05300932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101762668|NCT00942214|Natalizumab|natalizumab|mesh-list
101762669|NCT00942214|Immunologic Factors|immunologic factors|mesh-ancestor
101762670|NCT00942214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762671|NCT00850161|Insulin|insulin|mesh-list
101762687|NCT00686790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101762689|NCT00686790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762690|NCT00856089|Retapamulin|retapamulin|mesh-list
101762691|NCT00856089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101762692|NCT00856089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101762693|NCT00686712|Insulin|insulin|mesh-list
101762694|NCT00686712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101762695|NCT00686712|Insulin Glargine|insulin glargine|mesh-list
101762696|NCT00686712|Insulin, Isophane|insulin, isophane|mesh-list
101762697|NCT00686712|Isophane Insulin, Human|isophane insulin, human|mesh-list
101762698|NCT00686712|Isophane insulin, beef|isophane insulin, beef|mesh-list
101762699|NCT00686712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101762700|NCT00686712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762701|NCT00748644|Rituximab|rituximab|mesh-list
101762702|NCT00748644|Azathioprine|azathioprine|mesh-list
101762703|NCT00748644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101762704|NCT00748644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101762705|NCT00748644|Immunologic Factors|immunologic factors|mesh-ancestor
101407599|NCT00142779|Fluoxetine|fluoxetine|mesh-list
101762706|NCT00748644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762707|NCT00748644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101762708|NCT00748644|Antimetabolites|antimetabolites|mesh-ancestor
101762709|NCT00748644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762710|NCT00748644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101762711|NCT00748644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101762712|NCT00686634|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101762713|NCT00686634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101762714|NCT00686634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762715|NCT00686634|Incretins|incretins|mesh-ancestor
101564125|NCT00840853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101564126|NCT00840853|Analgesics|analgesics|mesh-ancestor
101564127|NCT00840853|Sensory System Agents|sensory system agents|mesh-ancestor
101564128|NCT00840853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101564129|NCT00840853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564130|NCT00840853|Antipyretics|antipyretics|mesh-ancestor
101564131|NCT00840853|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101564132|NCT00840853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101564133|NCT00840853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101564134|NCT00840853|Anesthetics, Local|anesthetics, local|mesh-ancestor
101762716|NCT00686634|Hormones|hormones|mesh-ancestor
101762717|NCT00686634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101762718|NCT00686634|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101762719|NCT00686634|Protease Inhibitors|protease inhibitors|mesh-ancestor
101762720|NCT00686634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101762721|NCT00686634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762722|NCT00856401|Parathyroid Hormone|parathyroid hormone|mesh-list
101762723|NCT00856401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762724|NCT00856401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101762725|NCT00560404|Epoetin Alfa|epoetin alfa|mesh-list
101762726|NCT00560404|Hematinics|hematinics|mesh-ancestor
101762727|NCT00942526|Nystatin|nystatin|mesh-list
101762728|NCT00942526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101762729|NCT00942526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101762730|NCT00942526|Antifungal Agents|antifungal agents|mesh-ancestor
101762731|NCT00942526|Ionophores|ionophores|mesh-ancestor
101762745|NCT00946504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762747|NCT00619983|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101762748|NCT00619983|Donepezil|donepezil|mesh-list
101762749|NCT00619983|Analgesics|analgesics|mesh-ancestor
101762750|NCT00619983|Sensory System Agents|sensory system agents|mesh-ancestor
101762751|NCT00619983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101762752|NCT00619983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762753|NCT00619983|Anticonvulsants|anticonvulsants|mesh-ancestor
101762754|NCT00619983|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101762755|NCT00619983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101762756|NCT00619983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101762757|NCT00619983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101762758|NCT00619983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101762759|NCT00619983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101762760|NCT00619983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101762761|NCT00619983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762762|NCT00619983|Antimanic Agents|antimanic agents|mesh-ancestor
101762763|NCT00619983|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101762764|NCT00619983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101762765|NCT00619983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101762766|NCT00619983|Antidepressive Agents|antidepressive agents|mesh-ancestor
101762767|NCT00619983|Dopamine Agents|dopamine agents|mesh-ancestor
101762768|NCT00619983|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101762769|NCT00619983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101762770|NCT00619983|Cholinergic Agents|cholinergic agents|mesh-ancestor
101762771|NCT00619983|Nootropic Agents|nootropic agents|mesh-ancestor
101762772|NCT00942682|Sorafenib|sorafenib|mesh-list
101762773|NCT00942682|Everolimus|everolimus|mesh-list
101762774|NCT00942682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101762775|NCT00942682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101762776|NCT00942682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101762777|NCT00942682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762778|NCT00942682|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101762779|NCT00942682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101762780|NCT00942682|Immunologic Factors|immunologic factors|mesh-ancestor
101762781|NCT00942682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762782|NCT00853983|Saracatinib|saracatinib|mesh-list
101762783|NCT00853983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101564135|NCT00840853|Anesthetics|anesthetics|mesh-ancestor
101564136|NCT00840853|Antiemetics|antiemetics|mesh-ancestor
101564137|NCT00840853|Autonomic Agents|autonomic agents|mesh-ancestor
101564138|NCT00840853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101564139|NCT00840853|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101564140|NCT00840853|Histamine Antagonists|histamine antagonists|mesh-ancestor
101564141|NCT00840853|Histamine Agents|histamine agents|mesh-ancestor
101564142|NCT00840853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101564143|NCT00840853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564144|NCT00840853|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101412389|NCT00475930|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101762784|NCT00853983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101762785|NCT00853983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762786|NCT00750048|Acetaminophen|acetaminophen|mesh-list
101420207|NCT00155883|Vitamins|vitamins|mesh-ancestor
101762788|NCT00750048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101762789|NCT00750048|Analgesics|analgesics|mesh-ancestor
101762790|NCT00750048|Sensory System Agents|sensory system agents|mesh-ancestor
101762791|NCT00750048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101762792|NCT00750048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762808|NCT05279872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101762809|NCT05279872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762810|NCT00854139|Cyclosporine|cyclosporine|mesh-list
101762811|NCT00854139|Cyclophosphamide|cyclophosphamide|mesh-list
101762812|NCT00854139|Cyclosporins|cyclosporins|mesh-list
101762813|NCT00854139|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101762814|NCT00854139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101762815|NCT00854139|Immunologic Factors|immunologic factors|mesh-ancestor
101762816|NCT00854139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762817|NCT00854139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101762818|NCT00854139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101762819|NCT00854139|Alkylating Agents|alkylating agents|mesh-ancestor
101762820|NCT00854139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762821|NCT00854139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101762822|NCT00854139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101762823|NCT00854139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101762824|NCT00854139|Antifungal Agents|antifungal agents|mesh-ancestor
101762825|NCT00854139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101762826|NCT00854139|Dermatologic Agents|dermatologic agents|mesh-ancestor
101762827|NCT00854139|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101762828|NCT00755820|Cycloserine|cycloserine|mesh-list
101762829|NCT00755820|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101762830|NCT00755820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101762831|NCT00755820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101762832|NCT00755820|Antitubercular Agents|antitubercular agents|mesh-ancestor
101762833|NCT00755820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101762834|NCT00755820|Antimetabolites|antimetabolites|mesh-ancestor
101762835|NCT00755820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762836|NCT00752154|Curcumin|curcumin|mesh-list
101762837|NCT00752154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101762838|NCT00752154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101762839|NCT00752154|Analgesics|analgesics|mesh-ancestor
101762840|NCT00752154|Sensory System Agents|sensory system agents|mesh-ancestor
101762841|NCT00752154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101762842|NCT00752154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762843|NCT00752154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101762844|NCT00752154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101762845|NCT00752154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101762846|NCT00752154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101762847|NCT00752154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762848|NCT00943228|Mycophenolic Acid|mycophenolic acid|mesh-list
101762849|NCT00943228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101762850|NCT00943228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101762851|NCT00943228|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101564146|NCT00697073|Antioxidants|antioxidants|mesh-ancestor
101564147|NCT00697073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564148|NCT00697073|Protective Agents|protective agents|mesh-ancestor
101564149|NCT00697073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564150|NCT00656331|Amlodipine|amlodipine|mesh-list
101564151|NCT00656331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101564152|NCT00656331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101564153|NCT00656331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101564154|NCT00656331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564155|NCT00656331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101564156|NCT00656331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564157|NCT00656331|Vasodilator Agents|vasodilator agents|mesh-ancestor
101564158|NCT00653432|Hyaluronic Acid|hyaluronic acid|mesh-list
101564159|NCT00653432|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101564160|NCT00653432|Immunologic Factors|immunologic factors|mesh-ancestor
101564161|NCT00653432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564162|NCT00653432|Viscosupplements|viscosupplements|mesh-ancestor
101564163|NCT00653432|Protective Agents|protective agents|mesh-ancestor
101762852|NCT00943228|Antitubercular Agents|antitubercular agents|mesh-ancestor
101762856|NCT00943228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762858|NCT00755898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101762859|NCT00755898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101762860|NCT00755898|Antiviral Agents|antiviral agents|mesh-ancestor
101420272|NCT00506623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101762861|NCT00755898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101762863|NCT00755898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101762864|NCT00755898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762865|NCT00755898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762866|NCT00755898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101762867|NCT00755898|Analgesics|analgesics|mesh-ancestor
101762868|NCT00755898|Sensory System Agents|sensory system agents|mesh-ancestor
101762869|NCT00755898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101762870|NCT00750126|Fludarabine|fludarabine|mesh-list
101762871|NCT00750126|Busulfan|busulfan|mesh-list
101762872|NCT00750126|Thymoglobulin|thymoglobulin|mesh-list
101762873|NCT00750126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101762874|NCT00750126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762875|NCT00750126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101762876|NCT00750126|Immunologic Factors|immunologic factors|mesh-ancestor
101762877|NCT00750126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762878|NCT00750126|Alkylating Agents|alkylating agents|mesh-ancestor
101762879|NCT00750126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101762880|NCT00750126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101762881|NCT00755976|Sulindac|sulindac|mesh-list
101762882|NCT00755976|Epirubicin|epirubicin|mesh-list
101762883|NCT00755976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101762884|NCT00755976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101762885|NCT00755976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101762886|NCT00755976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101762887|NCT00755976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101762888|NCT00755976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762889|NCT00755976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101762890|NCT00755976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101564164|NCT00537680|Ubiquinone|ubiquinone|mesh-list
101564165|NCT00537680|Idebenone|idebenone|mesh-list
101564166|NCT00537680|Antioxidants|antioxidants|mesh-ancestor
101564167|NCT00537680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564168|NCT00537680|Protective Agents|protective agents|mesh-ancestor
101564169|NCT00537680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762891|NCT00755976|Analgesics|analgesics|mesh-ancestor
101762892|NCT00755976|Sensory System Agents|sensory system agents|mesh-ancestor
101762893|NCT00755976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101762894|NCT00755976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762895|NCT00755976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101762896|NCT00755976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101762897|NCT00755976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101762898|NCT00752310|Darunavir|darunavir|mesh-list
101762899|NCT00752310|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101762900|NCT00752310|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101762901|NCT00752310|Protease Inhibitors|protease inhibitors|mesh-ancestor
101762902|NCT00752310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101762903|NCT00752310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762904|NCT00752310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101762905|NCT00752310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101762906|NCT00752310|Antiviral Agents|antiviral agents|mesh-ancestor
101762907|NCT00752310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101762908|NCT00943462|Temozolomide|temozolomide|mesh-list
101762909|NCT00943462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101762910|NCT00943462|Alkylating Agents|alkylating agents|mesh-ancestor
101762911|NCT00943462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762912|NCT00943462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101762913|NCT02560974|Capecitabine|capecitabine|mesh-list
101762914|NCT02560974|Oxaliplatin|oxaliplatin|mesh-list
101762915|NCT02560974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101762916|NCT02560974|Antimetabolites|antimetabolites|mesh-ancestor
101762917|NCT02560974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762918|NCT02560974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101762919|NCT00854451|Amoxicillin|amoxicillin|mesh-list
101762920|NCT00854451|Omeprazole|omeprazole|mesh-list
101762921|NCT00854451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101762922|NCT00854451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101762923|NCT00854451|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101762930|NCT00854529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101762931|NCT00854529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101762932|NCT00854529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101762933|NCT00854529|Growth Substances|growth substances|mesh-ancestor
101762934|NCT00854529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762936|NCT00952432|Carbamazepine|carbamazepine|mesh-list
101762937|NCT00952432|Anticonvulsants|anticonvulsants|mesh-ancestor
101762938|NCT00952432|Antimanic Agents|antimanic agents|mesh-ancestor
101762939|NCT00952432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101762940|NCT00952432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101762941|NCT00952432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762942|NCT00952432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101762943|NCT00952432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101762944|NCT00952432|Analgesics|analgesics|mesh-ancestor
101762945|NCT00952432|Sensory System Agents|sensory system agents|mesh-ancestor
101762946|NCT00952432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101762947|NCT00952432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101762948|NCT00952432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101762949|NCT00952432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762950|NCT00952432|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101762951|NCT00952432|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101762952|NCT00861315|Amikacin|amikacin|mesh-list
101762953|NCT00861315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101762954|NCT00861315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101762955|NCT00943540|Lamivudine|lamivudine|mesh-list
101762956|NCT00943540|Emtricitabine|emtricitabine|mesh-list
101762957|NCT00943540|Raltegravir Potassium|raltegravir potassium|mesh-list
101762958|NCT00943540|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101762959|NCT00943540|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101762960|NCT00943540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101564170|NCT00537680|Micronutrients|micronutrients|mesh-ancestor
101564171|NCT00516724|Paclitaxel|paclitaxel|mesh-list
101564172|NCT00516724|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101564173|NCT00516724|Carboplatin|carboplatin|mesh-list
101564174|NCT00516724|Olaparib|olaparib|mesh-list
101564175|NCT00516724|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
101564176|NCT00516724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101564177|NCT00516724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101564178|NCT00516724|Tubulin Modulators|tubulin modulators|mesh-ancestor
101564179|NCT00516724|Antimitotic Agents|antimitotic agents|mesh-ancestor
101412429|NCT00476359|Lopinavir|lopinavir|mesh-list
101762961|NCT00943540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101762962|NCT00943540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762963|NCT00943540|Antiviral Agents|antiviral agents|mesh-ancestor
101762964|NCT00943540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101762965|NCT00943540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101762966|NCT00943540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101762967|NCT00943540|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101762968|NCT00943540|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101762969|NCT00943540|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101762970|NCT00943540|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101762971|NCT00943540|Protease Inhibitors|protease inhibitors|mesh-ancestor
101762972|NCT00861627|Paclitaxel|paclitaxel|mesh-list
101762973|NCT00861627|Carboplatin|carboplatin|mesh-list
101762974|NCT00861627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101762975|NCT00861627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101762976|NCT00861627|Tubulin Modulators|tubulin modulators|mesh-ancestor
101762977|NCT00861627|Antimitotic Agents|antimitotic agents|mesh-ancestor
101762978|NCT00861627|Mitosis Modulators|mitosis modulators|mesh-ancestor
101762979|NCT00861627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762980|NCT00943930|Dronabinol|dronabinol|mesh-list
101762981|NCT00943930|Amphetamine|amphetamine|mesh-list
101762982|NCT00943930|Dextroamphetamine|dextroamphetamine|mesh-list
101762983|NCT00943930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101762984|NCT00943930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762985|NCT00943930|Sympathomimetics|sympathomimetics|mesh-ancestor
101762986|NCT00943930|Autonomic Agents|autonomic agents|mesh-ancestor
101762987|NCT00943930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101762988|NCT00943930|Dopamine Agents|dopamine agents|mesh-ancestor
101762989|NCT00943930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101762990|NCT00943930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762991|NCT00943930|Adrenergic Agents|adrenergic agents|mesh-ancestor
101762992|NCT00943930|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101762993|NCT00943930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101762994|NCT00943930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101762998|NCT00943930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101763000|NCT00943930|Sensory System Agents|sensory system agents|mesh-ancestor
101763001|NCT00943930|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101763002|NCT00943930|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101763003|NCT00943930|Hormones|hormones|mesh-ancestor
101763004|NCT00943930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101763005|NCT00854763|Olmesartan|olmesartan|mesh-list
101763006|NCT00854763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101763007|NCT00854763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101763008|NCT00854763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101763009|NCT00854763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763010|NCT00854841|Imatinib Mesylate|imatinib mesylate|mesh-list
101763011|NCT00854841|Dasatinib|dasatinib|mesh-list
101763012|NCT00854841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101763013|NCT00854841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101763014|NCT00854841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101763015|NCT00854841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763016|NCT00854919|Antipsychotic Agents|antipsychotic agents|mesh-list
101763017|NCT00854919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101564180|NCT00516724|Mitosis Modulators|mitosis modulators|mesh-ancestor
101564181|NCT00516724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564182|NCT00516724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101564183|NCT00446043|Adapalene|adapalene|mesh-list
101564184|NCT00446043|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
101564185|NCT00446043|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101564186|NCT00446043|Dermatologic Agents|dermatologic agents|mesh-ancestor
101564187|NCT00446043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101564188|NCT00446043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101564189|NCT00446043|Analgesics|analgesics|mesh-ancestor
101564190|NCT00446043|Sensory System Agents|sensory system agents|mesh-ancestor
101763018|NCT00854919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101763019|NCT00854919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763020|NCT00854919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101763021|NCT00861783|Oxaliplatin|oxaliplatin|mesh-list
101763022|NCT00861783|Irinotecan|irinotecan|mesh-list
101763023|NCT00861783|Camptothecin|camptothecin|mesh-list
101763024|NCT00861783|ON 01910|on 01910|mesh-list
101763025|NCT00861783|Glycine|glycine|mesh-list
101763026|NCT00861783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101763027|NCT00861783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101763028|NCT00861783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101763029|NCT00861783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101763030|NCT00861783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763031|NCT00861783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101763032|NCT00861783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101763033|NCT00861783|Glycine Agents|glycine agents|mesh-ancestor
101763034|NCT00861783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101763035|NCT00861783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763036|NCT00947128|Ondansetron|ondansetron|mesh-list
101763037|NCT00947128|Antiemetics|antiemetics|mesh-ancestor
101763038|NCT00947128|Autonomic Agents|autonomic agents|mesh-ancestor
101763039|NCT00947128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101763040|NCT00947128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763041|NCT00947128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101763042|NCT00947128|Antipruritics|antipruritics|mesh-ancestor
101763043|NCT00947128|Dermatologic Agents|dermatologic agents|mesh-ancestor
101763044|NCT00947128|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101763045|NCT00947128|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101763046|NCT00947128|Serotonin Agents|serotonin agents|mesh-ancestor
101763047|NCT00947128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101763048|NCT00947128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763049|NCT00861861|Atorvastatin|atorvastatin|mesh-list
101763050|NCT00861861|Pitavastatin|pitavastatin|mesh-list
101763051|NCT00861861|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101763052|NCT00861861|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101763053|NCT00861861|Antimetabolites|antimetabolites|mesh-ancestor
101763054|NCT00861861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763055|NCT00861861|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101763056|NCT00861861|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101763057|NCT00861861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101763058|NCT00686166|Capecitabine|capecitabine|mesh-list
101763059|NCT00686166|Oxaliplatin|oxaliplatin|mesh-list
101763060|NCT00686166|Cetuximab|cetuximab|mesh-list
101763061|NCT00686166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101763062|NCT00686166|Antimetabolites|antimetabolites|mesh-ancestor
101763063|NCT00686166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763064|NCT00686166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101763065|NCT00686166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101763066|NCT04280536|Trifluridine|trifluridine|mesh-list
101763067|NCT04280536|Antimetabolites|antimetabolites|mesh-ancestor
101763080|NCT00944242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763082|NCT00363649|Interferon-alpha|interferon-alpha|mesh-list
101763083|NCT00363649|Sargramostim|sargramostim|mesh-list
101763085|NCT00363649|Antiviral Agents|antiviral agents|mesh-ancestor
101564191|NCT00446043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101564192|NCT00446043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564193|NCT00446043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101564194|NCT00446043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101564195|NCT00400725|Clobetasol|clobetasol|mesh-list
101564196|NCT00400725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101564197|NCT00400725|Glucocorticoids|glucocorticoids|mesh-ancestor
101564198|NCT00400725|Hormones|hormones|mesh-ancestor
101564199|NCT00400725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101564200|NCT00400725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564201|NCT00099437|Fulvestrant|fulvestrant|mesh-list
101564202|NCT00099437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101412443|NCT00117117|Hematinics|hematinics|mesh-ancestor
101763086|NCT00363649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101763087|NCT00363649|Immunologic Factors|immunologic factors|mesh-ancestor
101763088|NCT00363649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763089|NCT00855153|Cycloserine|cycloserine|mesh-list
101763090|NCT00855153|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101763091|NCT00855153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101763092|NCT00855153|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101763093|NCT00855153|Antitubercular Agents|antitubercular agents|mesh-ancestor
101763094|NCT00855153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101763095|NCT00855153|Antimetabolites|antimetabolites|mesh-ancestor
101763096|NCT00855153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763097|NCT00952978|Omeprazole|omeprazole|mesh-list
101763098|NCT00952978|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101763099|NCT00952978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101763100|NCT00952978|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101763101|NCT00952978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101763102|NCT00952978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763103|NCT00861939|Bupropion|bupropion|mesh-list
101763104|NCT00861939|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101763105|NCT00861939|Antidepressive Agents|antidepressive agents|mesh-ancestor
101763106|NCT00861939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101763107|NCT00861939|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101763108|NCT00861939|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101763109|NCT00861939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101763110|NCT00861939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763111|NCT00861939|Dopamine Agents|dopamine agents|mesh-ancestor
101763112|NCT00861939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101763113|NCT00861939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763114|NCT00861939|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101763115|NCT00861939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101763116|NCT00861939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101763117|NCT00953134|Folic Acid|folic acid|mesh-list
101763118|NCT00953134|Micronutrients|micronutrients|mesh-list
101763119|NCT00953134|Ferrous fumarate|ferrous fumarate|mesh-list
101763120|NCT00953134|Trace Elements|trace elements|mesh-list
101763121|NCT00953134|Hematinics|hematinics|mesh-ancestor
101763122|NCT00953134|Vitamin B Complex|vitamin b complex|mesh-ancestor
101763123|NCT00953134|Vitamins|vitamins|mesh-ancestor
101763124|NCT00953134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763125|NCT00944398|Vitamins|vitamins|mesh-list
101763126|NCT00944398|Zinc|zinc|mesh-list
101763127|NCT00944398|Vitamin B Complex|vitamin b complex|mesh-list
101763128|NCT00944398|Zinc Sulfate|zinc sulfate|mesh-list
101763129|NCT00944398|Micronutrients|micronutrients|mesh-ancestor
101763130|NCT00944398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763138|NCT00947596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101763139|NCT00947596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101763140|NCT00947596|Autonomic Agents|autonomic agents|mesh-ancestor
101763141|NCT00947596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101763142|NCT00947596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564203|NCT00099437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101564204|NCT00099437|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101564205|NCT00099437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101564206|NCT00099437|Hormone Antagonists|hormone antagonists|mesh-ancestor
101564207|NCT00099437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101564208|NCT00099437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564209|NCT00018044|Clofazimine|clofazimine|mesh-list
101564210|NCT00018044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101412456|NCT00117494|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101763143|NCT00947596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101763144|NCT00947596|Respiratory System Agents|respiratory system agents|mesh-ancestor
101763145|NCT00947596|Mydriatics|mydriatics|mesh-ancestor
101763146|NCT00947596|Parasympatholytics|parasympatholytics|mesh-ancestor
101263739|NCT01763463|Sympathomimetics|sympathomimetics|mesh-ancestor
101763147|NCT00947596|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101763148|NCT00947596|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101763149|NCT00947596|Cholinergic Agents|cholinergic agents|mesh-ancestor
101763150|NCT00947596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101763151|NCT00947596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763152|NCT00865059|Gabapentin|gabapentin|mesh-list
101763153|NCT00865059|Analgesics|analgesics|mesh-ancestor
101763154|NCT00865059|Sensory System Agents|sensory system agents|mesh-ancestor
101763155|NCT00865059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101763156|NCT00865059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763157|NCT00865059|Anticonvulsants|anticonvulsants|mesh-ancestor
101763158|NCT00865059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101763159|NCT00865059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101420589|NCT05594849|Budesonide|budesonide|mesh-list
101763160|NCT00865059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101763161|NCT00865059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101763162|NCT00865059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101763163|NCT00865059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101763164|NCT00865059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101763165|NCT00865059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763166|NCT00865059|Antimanic Agents|antimanic agents|mesh-ancestor
101763167|NCT00865137|Tacrolimus|tacrolimus|mesh-list
101763168|NCT00865137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101763169|NCT00865137|Immunologic Factors|immunologic factors|mesh-ancestor
101763170|NCT00865137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763171|NCT00865137|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101763172|NCT00865137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101763173|NCT00865137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763174|NCT00862095|Topiramate|topiramate|mesh-list
101763175|NCT00862095|Propranolol|propranolol|mesh-list
101763176|NCT00862095|Amitriptyline|amitriptyline|mesh-list
101763177|NCT00862095|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101763178|NCT00862095|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101763179|NCT00862095|Adrenergic Agents|adrenergic agents|mesh-ancestor
101763180|NCT00862095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101763181|NCT00862095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763182|NCT00862095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763183|NCT00862095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101763184|NCT00862095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101763185|NCT00862095|Vasodilator Agents|vasodilator agents|mesh-ancestor
101763186|NCT00862095|Anticonvulsants|anticonvulsants|mesh-ancestor
101763187|NCT00862095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101763188|NCT00862095|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101763189|NCT00862095|Antidepressive Agents|antidepressive agents|mesh-ancestor
101763190|NCT00862095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101763191|NCT00862095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101763192|NCT00862095|Analgesics|analgesics|mesh-ancestor
101763193|NCT00862095|Sensory System Agents|sensory system agents|mesh-ancestor
101763194|NCT00862095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101763195|NCT00862095|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101763196|NCT00862095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101564211|NCT00018044|Leprostatic Agents|leprostatic agents|mesh-ancestor
101564212|NCT00018044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101564213|NCT00018044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101564214|NCT00932113|Folic Acid|folic acid|mesh-list
101564215|NCT00932113|Adalimumab|adalimumab|mesh-list
101564216|NCT00932113|Methotrexate|methotrexate|mesh-list
101564217|NCT00932113|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101564218|NCT00932113|Abortifacient Agents|abortifacient agents|mesh-ancestor
101564219|NCT00932113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101564220|NCT00932113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564221|NCT00932113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101412468|NCT00117611|Omalizumab|omalizumab|mesh-list
101763197|NCT00862095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101763198|NCT04054128|Heparin|heparin|mesh-list
101763206|NCT00865215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101763207|NCT00865215|Adrenergic Agents|adrenergic agents|mesh-ancestor
101763208|NCT00865215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101763209|NCT00865215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763210|NCT00865215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763211|NCT00865215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101763212|NCT00865215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101763213|NCT00865215|Vasodilator Agents|vasodilator agents|mesh-ancestor
101763214|NCT00865371|Bupropion|bupropion|mesh-list
101763215|NCT00865371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101763216|NCT00865371|Antidepressive Agents|antidepressive agents|mesh-ancestor
101763217|NCT00865371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101763218|NCT00865371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101763219|NCT00865371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101763220|NCT00865371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101763221|NCT00865371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763223|NCT00865371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101763224|NCT00865371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763225|NCT00865371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101763226|NCT00865371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101763227|NCT00865371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101763228|NCT00865449|Spironolactone|spironolactone|mesh-list
101763229|NCT00865449|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101763230|NCT00865449|Hormone Antagonists|hormone antagonists|mesh-ancestor
101763231|NCT00865449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101420661|NCT02276677|Oxytocin|oxytocin|mesh-list
101763232|NCT00865449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763233|NCT00865449|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101763234|NCT00865449|Diuretics|diuretics|mesh-ancestor
101763235|NCT00865449|Natriuretic Agents|natriuretic agents|mesh-ancestor
101763236|NCT00858195|Indomethacin|indomethacin|mesh-list
101763237|NCT00858195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101763238|NCT00858195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101763239|NCT00858195|Analgesics|analgesics|mesh-ancestor
101763240|NCT00858195|Sensory System Agents|sensory system agents|mesh-ancestor
101763241|NCT00858195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101763242|NCT00858195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763243|NCT00858195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101763244|NCT00858195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101763245|NCT00858195|Gout Suppressants|gout suppressants|mesh-ancestor
101763246|NCT00858195|Tocolytic Agents|tocolytic agents|mesh-ancestor
101763247|NCT00858195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101763248|NCT00858195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101763249|NCT00858195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101763250|NCT00858195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763251|NCT00618813|Cyclophosphamide|cyclophosphamide|mesh-list
101763252|NCT00618813|Ifosfamide|ifosfamide|mesh-list
101763253|NCT00618813|Doxorubicin|doxorubicin|mesh-list
101564223|NCT00932113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564224|NCT00932113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101564225|NCT00932113|Dermatologic Agents|dermatologic agents|mesh-ancestor
101564226|NCT00932113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101564227|NCT00932113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101564228|NCT00932113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101564229|NCT00932113|Immunologic Factors|immunologic factors|mesh-ancestor
101564230|NCT00932113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101763254|NCT00618813|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101763255|NCT00618813|Etoposide|etoposide|mesh-list
101763256|NCT00618813|Vincristine|vincristine|mesh-list
101763257|NCT00618813|Etoposide phosphate|etoposide phosphate|mesh-list
101763258|NCT00618813|Topotecan|topotecan|mesh-list
101763259|NCT00618813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101763260|NCT00618813|Immunologic Factors|immunologic factors|mesh-ancestor
101763261|NCT00618813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763262|NCT00618813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101763263|NCT00618813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101763264|NCT00618813|Alkylating Agents|alkylating agents|mesh-ancestor
101763265|NCT00618813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763276|NCT00618813|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101763277|NCT00554788|Cyclophosphamide|cyclophosphamide|mesh-list
101763278|NCT00554788|Thiotepa|thiotepa|mesh-list
101763279|NCT00554788|Cisplatin|cisplatin|mesh-list
101763280|NCT00554788|Carboplatin|carboplatin|mesh-list
101763281|NCT00554788|Etoposide|etoposide|mesh-list
101763282|NCT00554788|Vincristine|vincristine|mesh-list
101763283|NCT00554788|Etoposide phosphate|etoposide phosphate|mesh-list
101763284|NCT00554788|Podophyllotoxin|podophyllotoxin|mesh-list
101763285|NCT00554788|Lenograstim|lenograstim|mesh-list
101763286|NCT00554788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101763287|NCT00554788|Immunologic Factors|immunologic factors|mesh-ancestor
101763288|NCT00554788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763289|NCT00554788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101763290|NCT00554788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101763291|NCT00554788|Alkylating Agents|alkylating agents|mesh-ancestor
101763292|NCT00554788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763293|NCT00554788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101763294|NCT00554788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101763295|NCT00554788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101763296|NCT00554788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101763297|NCT00554788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101763298|NCT00554788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101763299|NCT00554788|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101763300|NCT00554788|Tubulin Modulators|tubulin modulators|mesh-ancestor
101763301|NCT00554788|Antimitotic Agents|antimitotic agents|mesh-ancestor
101763302|NCT00554788|Mitosis Modulators|mitosis modulators|mesh-ancestor
101763303|NCT00554788|Keratolytic Agents|keratolytic agents|mesh-ancestor
101763304|NCT00554788|Dermatologic Agents|dermatologic agents|mesh-ancestor
101763305|NCT00685698|Nemonoxacin|nemonoxacin|mesh-list
101763306|NCT00685698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101763307|NCT00685698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101763308|NCT00858429|Capecitabine|capecitabine|mesh-list
101763309|NCT00858429|Doxifluridine|doxifluridine|mesh-list
101763310|NCT00858429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101763311|NCT00858429|Antimetabolites|antimetabolites|mesh-ancestor
101763312|NCT00858429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763313|NCT00858429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101763314|NCT00858429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101763315|NCT00858429|Immunologic Factors|immunologic factors|mesh-ancestor
101763316|NCT00858429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763317|NCT00858429|Appetite Stimulants|appetite stimulants|mesh-ancestor
101763318|NCT00858429|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101763319|NCT02566928|Chlorhexidine|chlorhexidine|mesh-list
101763320|NCT02566928|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101763322|NCT02566928|Mupirocin|mupirocin|mesh-list
101763323|NCT02566928|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101564231|NCT00932113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101564232|NCT00932113|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101564233|NCT00932113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101564234|NCT00932113|Hematinics|hematinics|mesh-ancestor
101564235|NCT00932113|Vitamin B Complex|vitamin b complex|mesh-ancestor
101564236|NCT00932113|Vitamins|vitamins|mesh-ancestor
101564237|NCT00932113|Micronutrients|micronutrients|mesh-ancestor
101564238|NCT00931801|Tenofovir|tenofovir|mesh-list
101763324|NCT02566928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101763325|NCT02566928|Disinfectants|disinfectants|mesh-ancestor
101763326|NCT02566928|Dermatologic Agents|dermatologic agents|mesh-ancestor
101763327|NCT02566928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101763328|NCT02566928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101763329|NCT02566928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101763330|NCT02566928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763331|NCT00865605|Clobetasol|clobetasol|mesh-list
101763332|NCT00865605|Halobetasol|halobetasol|mesh-list
101763333|NCT00865605|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101763344|NCT00956644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763345|NCT00956644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101763346|NCT00956644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763348|NCT00956644|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101763349|NCT00956644|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101763350|NCT00858663|Everolimus|everolimus|mesh-list
101763351|NCT00858663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101763352|NCT00858663|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101763353|NCT00858663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101763354|NCT00858663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101763355|NCT00858663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763356|NCT00858663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101763357|NCT00858663|Immunologic Factors|immunologic factors|mesh-ancestor
101763358|NCT00858663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763359|NCT02544789|Clofarabine|clofarabine|mesh-list
101763360|NCT02544789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101763361|NCT02544789|Antimetabolites|antimetabolites|mesh-ancestor
101763362|NCT02544789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763363|NCT02544789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101763364|NCT02565836|Thrombin|thrombin|mesh-list
101763365|NCT02565836|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
101763366|NCT02565836|Hemostatics|hemostatics|mesh-ancestor
101763367|NCT02565836|Coagulants|coagulants|mesh-ancestor
101763368|NCT00865761|Alprazolam|alprazolam|mesh-list
101763369|NCT00865761|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101763370|NCT00865761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101763371|NCT00865761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763372|NCT00865761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101763373|NCT00865761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101763374|NCT00865761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101763375|NCT00865761|GABA Modulators|gaba modulators|mesh-ancestor
101763376|NCT00865761|GABA Agents|gaba agents|mesh-ancestor
101763377|NCT00865761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101763378|NCT00865761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763379|NCT00865839|Metformin|metformin|mesh-list
101763380|NCT00865839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101763381|NCT00865839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763382|NCT00865917|Metoprolol|metoprolol|mesh-list
101763383|NCT00865917|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101763384|NCT00865917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101763385|NCT00865917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101763386|NCT00865917|Sympatholytics|sympatholytics|mesh-ancestor
101763387|NCT00865917|Autonomic Agents|autonomic agents|mesh-ancestor
101763388|NCT00865917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101763389|NCT00865917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763390|NCT00865917|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101763391|NCT00865917|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101763392|NCT00865917|Adrenergic Agents|adrenergic agents|mesh-ancestor
101763393|NCT00865917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101564240|NCT00931801|Raltegravir Potassium|raltegravir potassium|mesh-list
101564241|NCT00931801|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101564242|NCT00931801|Antiviral Agents|antiviral agents|mesh-ancestor
101564243|NCT00931801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101564244|NCT00931801|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101564245|NCT00931801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101763394|NCT00865917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763395|NCT00696410|Zinc|zinc|mesh-list
101763396|NCT00696410|Trace Elements|trace elements|mesh-ancestor
101763397|NCT00696410|Micronutrients|micronutrients|mesh-ancestor
101763412|NCT00866073|Antimetabolites|antimetabolites|mesh-ancestor
101763413|NCT00866073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763414|NCT00866073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101763415|NCT00866073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101763416|NCT00752466|Topiramate|topiramate|mesh-list
101763417|NCT00752466|Flunarizine|flunarizine|mesh-list
101763418|NCT00752466|Anticonvulsants|anticonvulsants|mesh-ancestor
101763419|NCT00752466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101763420|NCT00752466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763421|NCT00752466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101763422|NCT00752466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101763423|NCT00752466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763424|NCT00752466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101763425|NCT00752466|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101763426|NCT00752466|Histamine Antagonists|histamine antagonists|mesh-ancestor
101763427|NCT00752466|Histamine Agents|histamine agents|mesh-ancestor
101763428|NCT00752466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101763429|NCT00752466|Vasodilator Agents|vasodilator agents|mesh-ancestor
101763430|NCT00957190|Timolol|timolol|mesh-list
101763431|NCT00957190|Dorzolamide|dorzolamide|mesh-list
101763432|NCT00957190|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101763433|NCT00957190|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101763434|NCT00957190|Adrenergic Agents|adrenergic agents|mesh-ancestor
101763435|NCT00957190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101763436|NCT00957190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763437|NCT00957190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763438|NCT00957190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101763439|NCT00957190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101763440|NCT00957190|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101763441|NCT00957190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101763442|NCT00866229|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101763443|NCT00866229|Simvastatin|simvastatin|mesh-list
101763444|NCT00866229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101763445|NCT00866229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101763446|NCT00866229|Antimetabolites|antimetabolites|mesh-ancestor
101763447|NCT00866229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763448|NCT00866229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101763449|NCT00866229|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101763450|NCT00866229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101763451|NCT00953914|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
101763452|NCT00953914|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101763453|NCT00953914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101763454|NCT00953914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763455|NCT00953914|Cholinergic Agents|cholinergic agents|mesh-ancestor
101763456|NCT00953914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101763457|NCT00953914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763475|NCT00957346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763476|NCT00957346|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101763477|NCT00957346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101763478|NCT00957346|Oxytocics|oxytocics|mesh-ancestor
101763479|NCT00957346|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101763480|NCT00957346|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101763481|NCT00957346|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101763482|NCT00957346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101763483|NCT00957346|Contraceptive Agents|contraceptive agents|mesh-ancestor
101564246|NCT00931801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101564247|NCT00931801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564248|NCT00931801|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101564249|NCT00931801|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101564250|NCT00931801|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101564251|NCT00931801|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101564252|NCT00931801|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101564253|NCT00931801|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101412502|NCT02273947|BMS-955176|bms-955176|mesh-list
101763484|NCT00957346|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101763485|NCT00957346|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101763486|NCT00957346|Hormone Antagonists|hormone antagonists|mesh-ancestor
101763487|NCT00957346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101763488|NCT00957346|Luteolytic Agents|luteolytic agents|mesh-ancestor
101763489|NCT00957346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101763490|NCT00957346|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101763491|NCT00752544|Simeprevir|simeprevir|mesh-list
101763492|NCT00752544|Antiviral Agents|antiviral agents|mesh-ancestor
101763493|NCT00752544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101763494|NCT00752544|Protease Inhibitors|protease inhibitors|mesh-ancestor
101763495|NCT00752544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101763496|NCT00752544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763497|NCT00751062|Timolol|timolol|mesh-list
101763498|NCT00751062|Latanoprost|latanoprost|mesh-list
101763499|NCT00751062|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101763500|NCT00751062|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101763501|NCT00751062|Adrenergic Agents|adrenergic agents|mesh-ancestor
101763502|NCT00751062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101763503|NCT00751062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763504|NCT00751062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763505|NCT00751062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101763506|NCT00751062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101763507|NCT00751062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101763508|NCT00751062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101763509|NCT04030052|Factor VIII|factor viii|mesh-list
101763510|NCT04030052|Coagulants|coagulants|mesh-ancestor
101763511|NCT00751374|Gentamicins|gentamicins|mesh-list
101763512|NCT00751374|Mupirocin|mupirocin|mesh-list
101763513|NCT00751374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101763514|NCT00751374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101763531|NCT00363415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101763532|NCT00757380|Diminazene aceturate|diminazene aceturate|mesh-list
101763533|NCT00757380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101763534|NCT00757380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101763535|NCT00757380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101763536|NCT00757380|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101763538|NCT00752934|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101763539|NCT00752934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763540|NCT00752934|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101763541|NCT00752934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101763542|NCT00752934|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101763543|NCT00752934|GABA Agonists|gaba agonists|mesh-ancestor
101763544|NCT00752934|GABA Agents|gaba agents|mesh-ancestor
101763545|NCT00752934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101763546|NCT00752934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763547|NCT00696020|Bromides|bromides|mesh-list
101763548|NCT00696020|Tiotropium Bromide|tiotropium bromide|mesh-list
101763549|NCT00696020|Olodaterol|olodaterol|mesh-list
101763550|NCT00696020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101763551|NCT00696020|Autonomic Agents|autonomic agents|mesh-ancestor
101763552|NCT00696020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101763553|NCT00696020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763554|NCT00696020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101763555|NCT00696020|Respiratory System Agents|respiratory system agents|mesh-ancestor
101763556|NCT00696020|Parasympatholytics|parasympatholytics|mesh-ancestor
101763557|NCT00696020|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101564254|NCT00931801|Protease Inhibitors|protease inhibitors|mesh-ancestor
101564255|NCT00931723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101564256|NCT00931723|Antidepressive Agents|antidepressive agents|mesh-ancestor
101564257|NCT00931723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101564258|NCT00931723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101564259|NCT00931723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101564260|NCT00931723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101412507|NCT05367336|Fentanyl|fentanyl|mesh-list
101763558|NCT00696020|Cholinergic Agents|cholinergic agents|mesh-ancestor
101763559|NCT00696020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101763560|NCT00696020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763561|NCT00696020|Anticonvulsants|anticonvulsants|mesh-ancestor
101763562|NCT00576576|Atorvastatin|atorvastatin|mesh-list
101763563|NCT00576576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101763564|NCT00576576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101763565|NCT00576576|Antimetabolites|antimetabolites|mesh-ancestor
101763566|NCT00576576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763567|NCT00576576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101763568|NCT00576576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101763569|NCT00576576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101763570|NCT00751764|Moxidectin|moxidectin|mesh-list
101763571|NCT00751764|Anthelmintics|anthelmintics|mesh-ancestor
101763572|NCT00751764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101763573|NCT00751764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101763574|NCT00751764|Antinematodal Agents|antinematodal agents|mesh-ancestor
101763575|NCT00757458|Propofol|propofol|mesh-list
101763580|NCT00757458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763581|NCT00757458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101763582|NCT00757458|Anesthetics, General|anesthetics, general|mesh-ancestor
101763584|NCT00757458|Anticoagulants|anticoagulants|mesh-ancestor
101763585|NCT00757458|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101763586|NCT00757458|Chelating Agents|chelating agents|mesh-ancestor
101763587|NCT00757458|Sequestering Agents|sequestering agents|mesh-ancestor
101763588|NCT00757458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763589|NCT00757458|Antidotes|antidotes|mesh-ancestor
101763590|NCT00757458|Protective Agents|protective agents|mesh-ancestor
101763591|NCT00757458|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101763592|NCT00923247|Bortezomib|bortezomib|mesh-list
101763593|NCT00923247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101763594|NCT02866136|Carboplatin|carboplatin|mesh-list
101763595|NCT02866136|Etoposide|etoposide|mesh-list
101763596|NCT02866136|Etoposide phosphate|etoposide phosphate|mesh-list
101763597|NCT02866136|Melphalan|melphalan|mesh-list
101763598|NCT02866136|Vincristine|vincristine|mesh-list
101763599|NCT02866136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101763600|NCT02866136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101763601|NCT02866136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101763602|NCT02866136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101763603|NCT02866136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101763604|NCT02866136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763605|NCT02866136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101763606|NCT02866136|Alkylating Agents|alkylating agents|mesh-ancestor
101763607|NCT02866136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101763608|NCT02866136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101763609|NCT02866136|Immunologic Factors|immunologic factors|mesh-ancestor
101763610|NCT02866136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763612|NCT02866136|Antimitotic Agents|antimitotic agents|mesh-ancestor
101763613|NCT02866136|Mitosis Modulators|mitosis modulators|mesh-ancestor
101763614|NCT00757692|Bicalutamide|bicalutamide|mesh-list
101763615|NCT00757692|Androgen Antagonists|androgen antagonists|mesh-ancestor
101763616|NCT00757692|Hormone Antagonists|hormone antagonists|mesh-ancestor
101763617|NCT00757692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101763618|NCT00757692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763619|NCT00757692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101763620|NCT00753168|Timolol|timolol|mesh-list
101763621|NCT00753168|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101763622|NCT00753168|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101763623|NCT00753168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564261|NCT00931723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564262|NCT05025397|Propofol|propofol|mesh-list
101564263|NCT05025397|Sevoflurane|sevoflurane|mesh-list
101564264|NCT05025397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101564265|NCT05025397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101564266|NCT05025397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564267|NCT05025397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101564268|NCT05025397|Anesthetics, General|anesthetics, general|mesh-ancestor
101763624|NCT00753168|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101763625|NCT00753168|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101763626|NCT00753168|Adrenergic Agents|adrenergic agents|mesh-ancestor
101763627|NCT00753168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101763628|NCT00753168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763629|NCT00753168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101763630|NCT00753168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101763631|NCT02565602|Vitamin D|vitamin d|mesh-list
101763632|NCT02565602|Cholecalciferol|cholecalciferol|mesh-list
101763633|NCT02565602|Vitamins|vitamins|mesh-ancestor
101763634|NCT02565602|Micronutrients|micronutrients|mesh-ancestor
101763635|NCT02565602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763636|NCT02565602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101763637|NCT02565602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101763638|NCT00866463|Sildenafil Citrate|sildenafil citrate|mesh-list
101763639|NCT00866463|Vasodilator Agents|vasodilator agents|mesh-ancestor
101763640|NCT00866463|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101763641|NCT00866463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101763642|NCT00866463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101763643|NCT00866463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763644|NCT00866463|Urological Agents|urological agents|mesh-ancestor
101763645|NCT00695864|Ondansetron|ondansetron|mesh-list
101763646|NCT00695864|Antiemetics|antiemetics|mesh-ancestor
101763647|NCT00695864|Autonomic Agents|autonomic agents|mesh-ancestor
101763648|NCT00695864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101763655|NCT00695864|Serotonin Agents|serotonin agents|mesh-ancestor
101763656|NCT00695864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101763657|NCT00695864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763658|NCT00684996|Bevacizumab|bevacizumab|mesh-list
101763659|NCT00684996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101763660|NCT00684996|Antibodies|antibodies|mesh-list
101763661|NCT00684996|Immunoglobulins|immunoglobulins|mesh-list
101763662|NCT00684996|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101763663|NCT00684996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101763664|NCT00684996|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101763665|NCT00684996|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101763666|NCT00684996|Growth Substances|growth substances|mesh-ancestor
101763667|NCT00684996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763668|NCT00684996|Growth Inhibitors|growth inhibitors|mesh-ancestor
101763669|NCT00684996|Immunologic Factors|immunologic factors|mesh-ancestor
101763670|NCT05325008|Immunoglobulins|immunoglobulins|mesh-list
101763671|NCT05325008|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101763672|NCT05325008|Antibodies|antibodies|mesh-list
101763673|NCT05325008|gamma-Globulins|gamma-globulins|mesh-list
101763674|NCT05325008|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101763675|NCT05325008|Immunologic Factors|immunologic factors|mesh-ancestor
101763676|NCT05325008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763677|NCT00684762|Cilostazol|cilostazol|mesh-list
101763678|NCT00684762|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101763679|NCT00684762|Autonomic Agents|autonomic agents|mesh-ancestor
101763680|NCT00684762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101763681|NCT00684762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763682|NCT00684762|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101763683|NCT00684762|Respiratory System Agents|respiratory system agents|mesh-ancestor
101763684|NCT00684762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101763685|NCT00684762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101763686|NCT00684762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763687|NCT00684762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101763688|NCT00684762|Vasodilator Agents|vasodilator agents|mesh-ancestor
101763689|NCT00684762|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101564269|NCT05025397|Anesthetics|anesthetics|mesh-ancestor
101564270|NCT05025397|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101564271|NCT05025397|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101564272|NCT00608803|Doxorubicin|doxorubicin|mesh-list
101564273|NCT00608803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101412523|NCT00476515|Immunologic Factors|immunologic factors|mesh-ancestor
101763690|NCT00684762|Protective Agents|protective agents|mesh-ancestor
101763691|NCT00684762|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101763692|NCT00684762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101763693|NCT00684762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101763694|NCT00753246|Nimotuzumab|nimotuzumab|mesh-list
101763695|NCT00753246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101763696|NCT00753246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101763697|NCT00695786|Rituximab|rituximab|mesh-list
101763698|NCT00695786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101763699|NCT00695786|Lenalidomide|lenalidomide|mesh-list
101763700|NCT00695786|Antibodies|antibodies|mesh-list
101763701|NCT00695786|Immunoglobulins|immunoglobulins|mesh-list
101763702|NCT00695786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101763703|NCT00695786|Immunologic Factors|immunologic factors|mesh-ancestor
101763704|NCT00695786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763705|NCT00695786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101763706|NCT00695786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101763707|NCT00695786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101763708|NCT00695786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101763709|NCT00695786|Growth Substances|growth substances|mesh-ancestor
101763710|NCT00695786|Growth Inhibitors|growth inhibitors|mesh-ancestor
101763711|NCT00753324|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101763712|NCT00753324|Antiviral Agents|antiviral agents|mesh-ancestor
101763713|NCT00753324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101763714|NCT02561520|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101763715|NCT02561520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101763716|NCT00387127|Lapatinib|lapatinib|mesh-list
101763717|NCT00387127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101763718|NCT00387127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101763737|NCT00753402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101763738|NCT00753402|Adrenergic Agents|adrenergic agents|mesh-ancestor
101763739|NCT00753402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101763740|NCT00753402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763741|NCT00753402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763742|NCT00753402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101763743|NCT00753402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101763744|NCT00753402|Autonomic Agents|autonomic agents|mesh-ancestor
101763745|NCT00753402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101763746|NCT00753402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101763747|NCT00753402|Respiratory System Agents|respiratory system agents|mesh-ancestor
101763748|NCT00753402|Mydriatics|mydriatics|mesh-ancestor
101763749|NCT00753402|Sympathomimetics|sympathomimetics|mesh-ancestor
101763750|NCT00753402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101763751|NCT05434884|Salicylic Acid|salicylic acid|mesh-list
101763752|NCT05434884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101763753|NCT05434884|Antifungal Agents|antifungal agents|mesh-ancestor
101763754|NCT05434884|Keratolytic Agents|keratolytic agents|mesh-ancestor
101763755|NCT05434884|Dermatologic Agents|dermatologic agents|mesh-ancestor
101763756|NCT00758004|Atorvastatin|atorvastatin|mesh-list
101763757|NCT00758004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101763758|NCT00758004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101763759|NCT00758004|Antimetabolites|antimetabolites|mesh-ancestor
101763760|NCT00758004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763761|NCT00758004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101763762|NCT00758004|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101763764|NCT02656706|Nivolumab|nivolumab|mesh-list
101763765|NCT02656706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101763766|NCT02656706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101763767|NCT02656706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101763768|NCT02656706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763769|NCT04049916|Artesunate|artesunate|mesh-list
101763770|NCT04049916|Primaquine|primaquine|mesh-list
101763771|NCT04049916|Piperaquine|piperaquine|mesh-list
101763772|NCT04049916|Artenimol|artenimol|mesh-list
101763773|NCT04049916|Pyronaridine|pyronaridine|mesh-list
101763774|NCT04049916|Antimalarials|antimalarials|mesh-ancestor
101564274|NCT00608803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101564275|NCT00608803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101564276|NCT00608803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101564278|NCT00608803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564279|NCT00931255|Sirolimus|sirolimus|mesh-list
101564280|NCT00931255|Tacrolimus|tacrolimus|mesh-list
101564281|NCT00931255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101763781|NCT04049916|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101763782|NCT04049916|Anthelmintics|anthelmintics|mesh-ancestor
101763783|NCT00753558|Gentamicins|gentamicins|mesh-list
101763784|NCT00753558|Polymyxins|polymyxins|mesh-list
101763785|NCT00753558|Colistin|colistin|mesh-list
101763786|NCT00753558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101763787|NCT00753558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101763788|NCT00753558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101763789|NCT00753558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101763790|NCT00753558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763791|NCT00753792|Methylprednisolone|methylprednisolone|mesh-list
101763792|NCT00753792|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101763793|NCT00753792|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101763794|NCT00753792|Prednisolone|prednisolone|mesh-list
101763795|NCT00753792|Prednisolone acetate|prednisolone acetate|mesh-list
101763796|NCT00753792|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101763797|NCT00753792|Prednisolone phosphate|prednisolone phosphate|mesh-list
101763798|NCT00753792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101763799|NCT00753792|Antiemetics|antiemetics|mesh-ancestor
101763800|NCT00753792|Autonomic Agents|autonomic agents|mesh-ancestor
101763801|NCT00753792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101763802|NCT00753792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763803|NCT00753792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101763804|NCT00753792|Glucocorticoids|glucocorticoids|mesh-ancestor
101763805|NCT00753792|Hormones|hormones|mesh-ancestor
101763806|NCT00753792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101763807|NCT00753792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101763808|NCT00753792|Protective Agents|protective agents|mesh-ancestor
101763809|NCT00753792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101763810|NCT00753792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101763811|NCT00575094|Tigecycline|tigecycline|mesh-list
101763812|NCT00575094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101763813|NCT00575094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101763814|NCT00575094|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101763815|NCT00575094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101763816|NCT00575094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763817|NCT00553696|Sunitinib|sunitinib|mesh-list
101763818|NCT00553696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101763819|NCT00553696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101763820|NCT00553696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101763821|NCT00553696|Growth Substances|growth substances|mesh-ancestor
101763822|NCT00553696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763823|NCT00553696|Growth Inhibitors|growth inhibitors|mesh-ancestor
101763824|NCT00553696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101763825|NCT00553696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101763826|NCT00553696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763827|NCT05430126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-list
101763828|NCT05430126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101763829|NCT05430126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763830|NCT00958204|Fluoxetine|fluoxetine|mesh-list
101763831|NCT00958204|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101763832|NCT00958204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101763833|NCT00958204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101763834|NCT00958204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421271|NCT00470041|Lamivudine|lamivudine|mesh-list
101763835|NCT00958204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101763836|NCT00958204|Serotonin Agents|serotonin agents|mesh-ancestor
101763837|NCT00958204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564282|NCT00931255|Immunologic Factors|immunologic factors|mesh-ancestor
101564283|NCT00931255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564284|NCT00931255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101564285|NCT00931255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101564286|NCT00931255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564287|NCT00931255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101763838|NCT00958204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101763839|NCT00958204|Antidepressive Agents|antidepressive agents|mesh-ancestor
101763840|NCT00958204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101763841|NCT00958204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101763846|NCT00617409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101763847|NCT00617409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101763848|NCT00617409|Tubulin Modulators|tubulin modulators|mesh-ancestor
101763849|NCT00617409|Antimitotic Agents|antimitotic agents|mesh-ancestor
101763850|NCT00617409|Mitosis Modulators|mitosis modulators|mesh-ancestor
101763851|NCT00617409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763852|NCT00617409|Keratolytic Agents|keratolytic agents|mesh-ancestor
101763853|NCT00617409|Dermatologic Agents|dermatologic agents|mesh-ancestor
101763854|NCT00695318|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
101763855|NCT00695318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101763856|NCT00695318|Glucocorticoids|glucocorticoids|mesh-ancestor
101763858|NCT00695318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101763859|NCT00695318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763860|NCT00754104|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101763861|NCT00754104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101763862|NCT00754104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101763863|NCT00754104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101763864|NCT00754104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763865|NCT00386425|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
101763866|NCT00386425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101763867|NCT03529448|Temozolomide|temozolomide|mesh-list
101763868|NCT03529448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101763869|NCT03529448|Alkylating Agents|alkylating agents|mesh-ancestor
101763870|NCT03529448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763871|NCT03529448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101763872|NCT05396898|Tacrolimus|tacrolimus|mesh-list
101763873|NCT05396898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101763874|NCT05396898|Immunologic Factors|immunologic factors|mesh-ancestor
101763875|NCT05396898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763876|NCT05396898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101763877|NCT05396898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101763878|NCT05396898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763879|NCT00694304|Vortioxetine|vortioxetine|mesh-list
101763880|NCT00694304|Antidepressive Agents|antidepressive agents|mesh-ancestor
101763881|NCT00694304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101763882|NCT00694304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101763883|NCT00694304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101763884|NCT00694304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101763885|NCT00694304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763886|NCT00694304|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101763887|NCT00694304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101763888|NCT00694304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101763889|NCT00694304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763890|NCT00694304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101763892|NCT00694304|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101763893|NCT00694304|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101763894|NCT00694304|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101763895|NCT00694304|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101763896|NCT00866853|Simeprevir|simeprevir|mesh-list
101763897|NCT00866853|Antiviral Agents|antiviral agents|mesh-ancestor
101763898|NCT00866853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101763899|NCT00866853|Protease Inhibitors|protease inhibitors|mesh-ancestor
101763900|NCT00866853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101564288|NCT00931255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101564289|NCT00931255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101564290|NCT00931255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101564291|NCT00931255|Antifungal Agents|antifungal agents|mesh-ancestor
101564292|NCT00609193|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101564293|NCT00609193|Antidepressive Agents|antidepressive agents|mesh-ancestor
101564294|NCT00609193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101564295|NCT00609193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101564296|NCT00609193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101412543|NCT00117273|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101763901|NCT00866853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763902|NCT04685876|Bupivacaine|bupivacaine|mesh-list
101763903|NCT04685876|Anesthetics, Local|anesthetics, local|mesh-ancestor
101763904|NCT04685876|Anesthetics|anesthetics|mesh-ancestor
101763905|NCT04685876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101763906|NCT04685876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763907|NCT04685876|Sensory System Agents|sensory system agents|mesh-ancestor
101763908|NCT04685876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101763910|NCT00682890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101763911|NCT00682890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763912|NCT02565368|Metformin|metformin|mesh-list
101763925|NCT00921804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763926|NCT00921804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763927|NCT00921804|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101763928|NCT00921804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101763929|NCT00921804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101763930|NCT00921804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101763931|NCT00921804|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101763932|NCT00921804|Dopamine Agents|dopamine agents|mesh-ancestor
101763934|NCT00859911|Trace Elements|trace elements|mesh-list
101763935|NCT00859911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763936|NCT00698516|Bevacizumab|bevacizumab|mesh-list
101763937|NCT00698516|Topotecan|topotecan|mesh-list
101763938|NCT00698516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101763939|NCT00698516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101763940|NCT00698516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101763941|NCT00698516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101763942|NCT00698516|Growth Substances|growth substances|mesh-ancestor
101763943|NCT00698516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763944|NCT00698516|Growth Inhibitors|growth inhibitors|mesh-ancestor
101763945|NCT00698516|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101763946|NCT00698516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101763947|NCT00698516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101763948|NCT00698516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763949|NCT00679302|Trimethoprim|trimethoprim|mesh-list
101763950|NCT00679302|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101763951|NCT00679302|Sulfamethoxazole|sulfamethoxazole|mesh-list
101763952|NCT00679302|Simethicone|simethicone|mesh-list
101763953|NCT00679302|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101763954|NCT00679302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101763955|NCT00679302|Antimalarials|antimalarials|mesh-ancestor
101763956|NCT00679302|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101763957|NCT00679302|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101763958|NCT00679302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101763959|NCT00679302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101763960|NCT00679302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763961|NCT00679302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101763962|NCT00679302|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101763963|NCT00679302|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101763964|NCT00679302|Antifoaming Agents|antifoaming agents|mesh-ancestor
101763965|NCT00679302|Emollients|emollients|mesh-ancestor
101763966|NCT00679302|Dermatologic Agents|dermatologic agents|mesh-ancestor
101763967|NCT00679302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101763968|NCT04011124|Rifampin|rifampin|mesh-list
101763969|NCT04011124|Fluzoparib|fluzoparib|mesh-list
101564297|NCT00609193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101564298|NCT00609193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564299|NCT00930553|Alemtuzumab|alemtuzumab|mesh-list
101564300|NCT00930553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101763970|NCT04011124|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101763971|NCT04011124|Antitubercular Agents|antitubercular agents|mesh-ancestor
101763972|NCT04011124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101763973|NCT04011124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101763974|NCT04011124|Leprostatic Agents|leprostatic agents|mesh-ancestor
101763975|NCT04011124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101763976|NCT04011124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101763984|NCT04011124|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101763985|NCT04011124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101763986|NCT00862875|Insulin|insulin|mesh-list
101763987|NCT00862875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101763988|NCT00862875|Insulin Detemir|insulin detemir|mesh-list
101763989|NCT00862875|Insulin, Long-Acting|insulin, long-acting|mesh-list
101763990|NCT00862875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101763991|NCT00862875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763992|NCT02544165|Caffeine|caffeine|mesh-list
101763993|NCT02544165|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101763994|NCT02544165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763995|NCT02544165|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101763996|NCT02544165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101763997|NCT02544165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763998|NCT02544165|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101763999|NCT02544165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101764000|NCT02544165|Purinergic Agents|purinergic agents|mesh-ancestor
101764001|NCT02544165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101764002|NCT05343156|Dexamethasone|dexamethasone|mesh-list
101764003|NCT05343156|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101764004|NCT05343156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101764005|NCT05343156|Antiemetics|antiemetics|mesh-ancestor
101764006|NCT05343156|Autonomic Agents|autonomic agents|mesh-ancestor
101764007|NCT05343156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101764008|NCT05343156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764009|NCT05343156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101764010|NCT05343156|Glucocorticoids|glucocorticoids|mesh-ancestor
101764011|NCT05343156|Hormones|hormones|mesh-ancestor
101764012|NCT05343156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101764013|NCT05343156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101764014|NCT05343156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101764015|NCT05343156|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101764016|NCT00955162|Buprenorphine|buprenorphine|mesh-list
101764017|NCT00955162|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101764018|NCT00955162|Naloxone|naloxone|mesh-list
101764019|NCT00955162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101764020|NCT00955162|Narcotics|narcotics|mesh-ancestor
101764021|NCT00955162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101764022|NCT00955162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764023|NCT00955162|Analgesics|analgesics|mesh-ancestor
101764024|NCT00955162|Sensory System Agents|sensory system agents|mesh-ancestor
101764025|NCT00955162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101764026|NCT00955162|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101764027|NCT00949546|Etanercept|etanercept|mesh-list
101407638|NCT00142896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101764028|NCT00949546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101764029|NCT00949546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101764030|NCT00949546|Analgesics|analgesics|mesh-ancestor
101764031|NCT00949546|Sensory System Agents|sensory system agents|mesh-ancestor
101764032|NCT00949546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101764033|NCT00949546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764034|NCT00949546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101764035|NCT00949546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101764036|NCT00949546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101764037|NCT00949546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101764038|NCT00949546|Immunologic Factors|immunologic factors|mesh-ancestor
101764039|NCT00949624|Docetaxel|docetaxel|mesh-list
101764040|NCT00949624|Axitinib|axitinib|mesh-list
101764041|NCT00949624|Crenolanib|crenolanib|mesh-list
101764042|NCT00949624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101764047|NCT00949624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101564301|NCT00930553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101564302|NCT04262089|Pembrolizumab|pembrolizumab|mesh-list
101564303|NCT04262089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101564304|NCT04262089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101564305|NCT04262089|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101564306|NCT04262089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412562|NCT00117728|Nevirapine|nevirapine|mesh-list
101764048|NCT00949624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101764049|NCT04019379|Calcium, Dietary|calcium, dietary|mesh-list
101764050|NCT04019379|Calcium|calcium|mesh-list
101764051|NCT04019379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101764052|NCT04019379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764053|NCT04019379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101764054|NCT05351788|Carboplatin|carboplatin|mesh-list
101764055|NCT05351788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101764056|NCT04005339|Leucovorin|leucovorin|mesh-list
101764057|NCT04005339|Fluorouracil|fluorouracil|mesh-list
101421488|NCT00149565|Antiviral Agents|antiviral agents|mesh-ancestor
101764058|NCT04005339|Irinotecan|irinotecan|mesh-list
101764059|NCT04005339|Antimetabolites|antimetabolites|mesh-ancestor
101764060|NCT04005339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764061|NCT04005339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101764062|NCT04005339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101764063|NCT04005339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101764064|NCT04005339|Immunologic Factors|immunologic factors|mesh-ancestor
101764065|NCT04005339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764066|NCT04005339|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101764067|NCT04005339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101764068|NCT04005339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101764070|NCT04005339|Protective Agents|protective agents|mesh-ancestor
101764071|NCT04005339|Vitamin B Complex|vitamin b complex|mesh-ancestor
101764072|NCT04005339|Vitamins|vitamins|mesh-ancestor
101764073|NCT04005339|Micronutrients|micronutrients|mesh-ancestor
101764074|NCT00949780|Chloral Hydrate|chloral hydrate|mesh-list
101764075|NCT00949780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101764076|NCT00949780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101764077|NCT00949780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764078|NCT02544243|Gemcitabine|gemcitabine|mesh-list
101764079|NCT02544243|Vinorelbine|vinorelbine|mesh-list
101764080|NCT02544243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101764081|NCT02544243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101764082|NCT02544243|Antimetabolites|antimetabolites|mesh-ancestor
101764083|NCT02544243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764084|NCT02544243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101764085|NCT02544243|Tubulin Modulators|tubulin modulators|mesh-ancestor
101764086|NCT02544243|Antimitotic Agents|antimitotic agents|mesh-ancestor
101764087|NCT02544243|Mitosis Modulators|mitosis modulators|mesh-ancestor
101764088|NCT04011670|Caffeine|caffeine|mesh-list
101764089|NCT04011670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101764090|NCT04011670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764091|NCT04011670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101764092|NCT04011670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101764093|NCT04011670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764094|NCT04011670|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101764095|NCT04011670|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101764096|NCT04011670|Purinergic Agents|purinergic agents|mesh-ancestor
101764097|NCT04011670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101764098|NCT01581073|Darbepoetin alfa|darbepoetin alfa|mesh-list
101764099|NCT01581073|Hematinics|hematinics|mesh-ancestor
101764100|NCT00742820|Calcium, Dietary|calcium, dietary|mesh-list
101764101|NCT00742820|Calcium|calcium|mesh-list
101764102|NCT00742820|Calcium acetate|calcium acetate|mesh-list
101764103|NCT00742820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101764104|NCT00742820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764105|NCT00742820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101764106|NCT00742820|Chelating Agents|chelating agents|mesh-ancestor
101764107|NCT00742820|Sequestering Agents|sequestering agents|mesh-ancestor
101764108|NCT00742820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564307|NCT00609817|Dexamethasone|dexamethasone|mesh-list
101564308|NCT00609817|Bortezomib|bortezomib|mesh-list
101564309|NCT00609817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101564310|NCT00609817|Antiemetics|antiemetics|mesh-ancestor
101564311|NCT00609817|Autonomic Agents|autonomic agents|mesh-ancestor
101564312|NCT00609817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101564313|NCT00609817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564314|NCT00609817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101564315|NCT00609817|Glucocorticoids|glucocorticoids|mesh-ancestor
101564317|NCT00609817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101412565|NCT00117728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101764109|NCT01324843|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
101764110|NCT01324843|Anesthetics, Local|anesthetics, local|mesh-ancestor
101764111|NCT01324843|Anesthetics|anesthetics|mesh-ancestor
101764112|NCT01324843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101764113|NCT01324843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764120|NCT00742976|Isophane Insulin, Human|isophane insulin, human|mesh-list
101764121|NCT00742976|Insulin, Isophane|insulin, isophane|mesh-list
101764122|NCT00742976|Isophane insulin, beef|isophane insulin, beef|mesh-list
101764123|NCT00742976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101764124|NCT00742976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764126|NCT00571662|Mycophenolic Acid|mycophenolic acid|mesh-list
101764127|NCT00571662|Pentostatin|pentostatin|mesh-list
101764128|NCT00571662|Cyclosporins|cyclosporins|mesh-list
101764129|NCT00571662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101764130|NCT00571662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764131|NCT00571662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101764132|NCT00571662|Immunologic Factors|immunologic factors|mesh-ancestor
101764133|NCT00571662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764134|NCT00571662|Antifungal Agents|antifungal agents|mesh-ancestor
101764135|NCT00571662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101764136|NCT00571662|Dermatologic Agents|dermatologic agents|mesh-ancestor
101764137|NCT00571662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101764138|NCT00571662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101764139|NCT00571662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101764140|NCT00571662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101764141|NCT00571662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101764142|NCT00571662|Antitubercular Agents|antitubercular agents|mesh-ancestor
101764143|NCT00571662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101764144|NCT00571662|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
101764145|NCT00955240|Fluorouracil|fluorouracil|mesh-list
101764146|NCT00955240|Cetuximab|cetuximab|mesh-list
101764147|NCT00955240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101764148|NCT00955240|Antimetabolites|antimetabolites|mesh-ancestor
101764149|NCT00955240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764150|NCT00955240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101764151|NCT00955240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101764152|NCT00955240|Immunologic Factors|immunologic factors|mesh-ancestor
101764153|NCT00955240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764154|NCT00955240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101764155|NCT03387085|Leucovorin|leucovorin|mesh-list
101764156|NCT03387085|Paclitaxel|paclitaxel|mesh-list
101764157|NCT03387085|Cyclophosphamide|cyclophosphamide|mesh-list
101764158|NCT03387085|Bevacizumab|bevacizumab|mesh-list
101764159|NCT03387085|Fluorouracil|fluorouracil|mesh-list
101764160|NCT03387085|Capecitabine|capecitabine|mesh-list
101764161|NCT03387085|Avelumab|avelumab|mesh-list
101764162|NCT03387085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101764163|NCT03387085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101764164|NCT03387085|Tubulin Modulators|tubulin modulators|mesh-ancestor
101764165|NCT03387085|Antimitotic Agents|antimitotic agents|mesh-ancestor
101764166|NCT03387085|Mitosis Modulators|mitosis modulators|mesh-ancestor
101764167|NCT03387085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764168|NCT03387085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101764169|NCT03387085|Immunologic Factors|immunologic factors|mesh-ancestor
101564318|NCT00609817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101564319|NCT00609817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101564320|NCT00929695|Prednisone|prednisone|mesh-list
101564321|NCT00929695|Methylprednisolone|methylprednisolone|mesh-list
101564322|NCT00929695|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101564323|NCT00929695|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101564324|NCT00929695|Prednisolone|prednisolone|mesh-list
101564325|NCT00929695|Prednisolone acetate|prednisolone acetate|mesh-list
101564326|NCT00929695|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101564327|NCT00929695|Prednisolone phosphate|prednisolone phosphate|mesh-list
101564328|NCT00929695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101412579|NCT03277066|Diclofenac|diclofenac|mesh-list
101764170|NCT03387085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764171|NCT03387085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101764172|NCT03387085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101764173|NCT03387085|Alkylating Agents|alkylating agents|mesh-ancestor
101764174|NCT03387085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101764175|NCT03387085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101764176|NCT03387085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101764177|NCT03387085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101764178|NCT03387085|Growth Substances|growth substances|mesh-ancestor
101764179|NCT03387085|Growth Inhibitors|growth inhibitors|mesh-ancestor
101764180|NCT03387085|Antimetabolites|antimetabolites|mesh-ancestor
101764181|NCT03387085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101764182|NCT03387085|Antidotes|antidotes|mesh-ancestor
101764183|NCT03387085|Protective Agents|protective agents|mesh-ancestor
101764205|NCT00860223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764206|NCT00860223|Protective Agents|protective agents|mesh-ancestor
101764207|NCT00860223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764208|NCT00698204|Celecoxib|celecoxib|mesh-list
101764209|NCT00698204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101764210|NCT00698204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101764211|NCT00698204|Analgesics|analgesics|mesh-ancestor
101764212|NCT00698204|Sensory System Agents|sensory system agents|mesh-ancestor
101764213|NCT00698204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101764214|NCT00698204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764215|NCT00698204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101764216|NCT00698204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101764217|NCT00698204|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101764218|NCT00698204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101764219|NCT00698204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101764220|NCT00698204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764221|NCT00549718|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
101764222|NCT00549718|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101764223|NCT00549718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101764224|NCT00549718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101764225|NCT00549718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764226|NCT00549718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101764227|NCT00549718|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101764228|NCT00549718|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101764229|NCT00549718|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101764230|NCT00549718|Adrenergic Agents|adrenergic agents|mesh-ancestor
101764231|NCT00549718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101764232|NCT00549718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764233|NCT00549718|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101764234|NCT00549718|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101764235|NCT00549718|Serotonin Agents|serotonin agents|mesh-ancestor
101764236|NCT00549718|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101764237|NCT00549718|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101764262|NCT00371761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101764263|NCT00371761|Antiviral Agents|antiviral agents|mesh-ancestor
101564329|NCT00929695|Glucocorticoids|glucocorticoids|mesh-ancestor
101564330|NCT00929695|Hormones|hormones|mesh-ancestor
101564331|NCT00929695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101564332|NCT00929695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564333|NCT00929695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101564334|NCT00929695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101564335|NCT00929695|Antiemetics|antiemetics|mesh-ancestor
101564336|NCT00929695|Autonomic Agents|autonomic agents|mesh-ancestor
101564337|NCT00929695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101764264|NCT00371761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101764265|NCT00371761|Immunologic Factors|immunologic factors|mesh-ancestor
101764266|NCT00371761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764267|NCT00371761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101764268|NCT00371761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101764269|NCT00371761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101764270|NCT00371761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764271|NCT00754962|Protriptyline|protriptyline|mesh-list
101764272|NCT00754962|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101764273|NCT00754962|Antidepressive Agents|antidepressive agents|mesh-ancestor
101764274|NCT00754962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101764275|NCT00754962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101764276|NCT00754962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101764277|NCT00754962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101764278|NCT00754962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764279|NCT00754962|Adrenergic Agents|adrenergic agents|mesh-ancestor
101764280|NCT00754962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101764281|NCT00754962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764282|NCT00868023|Formoterol Fumarate|formoterol fumarate|mesh-list
101764283|NCT00868023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101764284|NCT00868023|Autonomic Agents|autonomic agents|mesh-ancestor
101764285|NCT00868023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101764286|NCT00868023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764287|NCT00868023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101764288|NCT00868023|Respiratory System Agents|respiratory system agents|mesh-ancestor
101764289|NCT00868023|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101764294|NCT00868023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764295|NCT05300386|Escitalopram|escitalopram|mesh-list
101764296|NCT05300386|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101764297|NCT05300386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101764298|NCT05300386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101764299|NCT05300386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764300|NCT05300386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101764301|NCT05300386|Serotonin Agents|serotonin agents|mesh-ancestor
101764302|NCT05300386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764303|NCT00863499|Methylphenidate|methylphenidate|mesh-list
101764304|NCT00863499|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101764305|NCT00863499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764306|NCT00863499|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101764307|NCT00863499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101764308|NCT00863499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101764309|NCT00863499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764310|NCT00863499|Dopamine Agents|dopamine agents|mesh-ancestor
101764311|NCT00863499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101764312|NCT00755118|Leucovorin|leucovorin|mesh-list
101764313|NCT00755118|Bevacizumab|bevacizumab|mesh-list
101764314|NCT00755118|Cetuximab|cetuximab|mesh-list
101764315|NCT00755118|Fluorouracil|fluorouracil|mesh-list
101764316|NCT00755118|Oxaliplatin|oxaliplatin|mesh-list
101764317|NCT00755118|Irinotecan|irinotecan|mesh-list
101764318|NCT00755118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101764319|NCT00755118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101764320|NCT00755118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101564338|NCT00929695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101564339|NCT00929695|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101564340|NCT00929695|Protective Agents|protective agents|mesh-ancestor
101564341|NCT00609895|Insulin Glargine|insulin glargine|mesh-list
101564342|NCT00609895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101564343|NCT00609895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564344|NCT04261465|Paclitaxel|paclitaxel|mesh-list
101564345|NCT04261465|Carboplatin|carboplatin|mesh-list
101564346|NCT04261465|Olaparib|olaparib|mesh-list
101201074|NCT01402245|Vaccines|vaccines|mesh-list
101564347|NCT04261465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101564348|NCT04261465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101564349|NCT04261465|Tubulin Modulators|tubulin modulators|mesh-ancestor
101564350|NCT04261465|Antimitotic Agents|antimitotic agents|mesh-ancestor
101764321|NCT00755118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101764322|NCT00755118|Growth Substances|growth substances|mesh-ancestor
101764323|NCT00755118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764324|NCT00755118|Growth Inhibitors|growth inhibitors|mesh-ancestor
101764325|NCT00755118|Antimetabolites|antimetabolites|mesh-ancestor
101764326|NCT00755118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764327|NCT00755118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101764328|NCT00755118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101764329|NCT00755118|Immunologic Factors|immunologic factors|mesh-ancestor
101764330|NCT00755118|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101764331|NCT00755118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101764332|NCT00755118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101764333|NCT00755118|Antidotes|antidotes|mesh-ancestor
101764334|NCT00755118|Protective Agents|protective agents|mesh-ancestor
101764335|NCT00755118|Vitamin B Complex|vitamin b complex|mesh-ancestor
101764336|NCT00755118|Vitamins|vitamins|mesh-ancestor
101764337|NCT00755118|Micronutrients|micronutrients|mesh-ancestor
101764338|NCT00755352|Pravastatin|pravastatin|mesh-list
101764339|NCT00755352|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
101764340|NCT00755352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101764341|NCT00755352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101764342|NCT00755352|Antimetabolites|antimetabolites|mesh-ancestor
101764343|NCT00755352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764344|NCT00755352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101764345|NCT00755352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101764346|NCT00755352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101764347|NCT00549640|Methylphenidate|methylphenidate|mesh-list
101764348|NCT00549640|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101764349|NCT00549640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764350|NCT00549640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101764351|NCT00549640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101764352|NCT00549640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101764353|NCT00549640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764354|NCT00549640|Dopamine Agents|dopamine agents|mesh-ancestor
101764355|NCT00549640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101764356|NCT04444804|Rivaroxaban|rivaroxaban|mesh-list
101421786|NCT00405080|Casopitant|casopitant|mesh-list
101764358|NCT04444804|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101764359|NCT04444804|Antithrombins|antithrombins|mesh-ancestor
101764366|NCT00863577|Anticoagulants|anticoagulants|mesh-ancestor
101764367|NCT00868413|Cyclophosphamide|cyclophosphamide|mesh-list
101764368|NCT00868413|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101764369|NCT00868413|Rituximab|rituximab|mesh-list
101764370|NCT00868413|Fludarabine|fludarabine|mesh-list
101764371|NCT00868413|Navitoclax|navitoclax|mesh-list
101764372|NCT00868413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101764373|NCT00868413|Immunologic Factors|immunologic factors|mesh-ancestor
101764374|NCT00868413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764375|NCT00868413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101764376|NCT00868413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101764377|NCT00868413|Alkylating Agents|alkylating agents|mesh-ancestor
101564351|NCT04261465|Mitosis Modulators|mitosis modulators|mesh-ancestor
101564352|NCT04261465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564353|NCT04261465|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101564354|NCT04261465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101564355|NCT04260607|Ketamine|ketamine|mesh-list
101564356|NCT04260607|Analgesics|analgesics|mesh-ancestor
101564357|NCT04260607|Sensory System Agents|sensory system agents|mesh-ancestor
101564358|NCT04260607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101764378|NCT00868413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764379|NCT00868413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101764380|NCT00868413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101764381|NCT00868413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101764382|NCT03897348|Lacosamide|lacosamide|mesh-list
101764383|NCT03897348|Anticonvulsants|anticonvulsants|mesh-ancestor
101764384|NCT03897348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101764385|NCT03897348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101764386|NCT03897348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101764387|NCT03897348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764388|NCT04010578|Vitamin D|vitamin d|mesh-list
101764389|NCT04010578|Cholecalciferol|cholecalciferol|mesh-list
101764390|NCT04010578|Vitamins|vitamins|mesh-ancestor
101764391|NCT04010578|Micronutrients|micronutrients|mesh-ancestor
101764392|NCT04010578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764393|NCT04010578|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101764394|NCT04010578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101764395|NCT00868491|Cisplatin|cisplatin|mesh-list
101764396|NCT00868491|Docetaxel|docetaxel|mesh-list
101764397|NCT00868491|Fluorouracil|fluorouracil|mesh-list
101764398|NCT00868491|Cetuximab|cetuximab|mesh-list
101764399|NCT00868491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101764400|NCT00868491|Tubulin Modulators|tubulin modulators|mesh-ancestor
101764401|NCT00868491|Antimitotic Agents|antimitotic agents|mesh-ancestor
101764402|NCT00868491|Mitosis Modulators|mitosis modulators|mesh-ancestor
101764403|NCT00868491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764404|NCT00868491|Antimetabolites|antimetabolites|mesh-ancestor
101764405|NCT00868491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101764406|NCT00868491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101764407|NCT00868491|Immunologic Factors|immunologic factors|mesh-ancestor
101764408|NCT00868491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764409|NCT00868491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101764410|NCT00955630|Ranibizumab|ranibizumab|mesh-list
101764411|NCT00955630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101764412|NCT00955630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101764413|NCT00955630|Growth Substances|growth substances|mesh-ancestor
101764414|NCT00955630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764415|NCT00955630|Growth Inhibitors|growth inhibitors|mesh-ancestor
101764416|NCT00955630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101764417|NCT00868569|Leucovorin|leucovorin|mesh-list
101764418|NCT00868569|Fluorouracil|fluorouracil|mesh-list
101764419|NCT00868569|Oxaliplatin|oxaliplatin|mesh-list
101764420|NCT00868569|Antimetabolites|antimetabolites|mesh-ancestor
101764421|NCT00868569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764422|NCT00868569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101764423|NCT00868569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101764424|NCT00868569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101764425|NCT00868569|Immunologic Factors|immunologic factors|mesh-ancestor
101764426|NCT00868569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764427|NCT00868569|Antidotes|antidotes|mesh-ancestor
101764428|NCT00868569|Protective Agents|protective agents|mesh-ancestor
101764429|NCT00868569|Vitamin B Complex|vitamin b complex|mesh-ancestor
101764430|NCT00868569|Vitamins|vitamins|mesh-ancestor
101764446|NCT00549562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101764447|NCT00549562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764448|NCT00549562|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101764449|NCT00549562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101764450|NCT00549562|Dopamine Agents|dopamine agents|mesh-ancestor
101764452|NCT00860925|Analgesics|analgesics|mesh-ancestor
101564359|NCT04260607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564360|NCT04260607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101564361|NCT04260607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101564362|NCT04260607|Anesthetics, General|anesthetics, general|mesh-ancestor
101564364|NCT04260607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101564365|NCT04260607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101564366|NCT04260607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101564367|NCT04260607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101564368|NCT04260607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564370|NCT00927355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101764453|NCT00860925|Sensory System Agents|sensory system agents|mesh-ancestor
101764454|NCT00860925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101764455|NCT00860925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764456|NCT00860925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101764457|NCT00860925|Sympatholytics|sympatholytics|mesh-ancestor
101764458|NCT00860925|Autonomic Agents|autonomic agents|mesh-ancestor
101764459|NCT00860925|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101764460|NCT00860925|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101764461|NCT00860925|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101764462|NCT00860925|Adrenergic Agents|adrenergic agents|mesh-ancestor
101764463|NCT00860925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101764464|NCT00860925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764465|NCT04237012|Dexamethasone|dexamethasone|mesh-list
101764466|NCT04237012|Lubricant Eye Drops|lubricant eye drops|mesh-list
101764467|NCT04237012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101764468|NCT04237012|Antiemetics|antiemetics|mesh-ancestor
101764469|NCT04237012|Autonomic Agents|autonomic agents|mesh-ancestor
101764470|NCT04237012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101764471|NCT04237012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764472|NCT04237012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101764473|NCT04237012|Glucocorticoids|glucocorticoids|mesh-ancestor
101764474|NCT04237012|Hormones|hormones|mesh-ancestor
101764475|NCT04237012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101764476|NCT04237012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101764477|NCT04237012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101764478|NCT04237012|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101764479|NCT04237012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101764480|NCT00863889|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101764481|NCT00863889|Methylprednisolone|methylprednisolone|mesh-list
101764482|NCT00863889|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101764483|NCT00863889|Prednisolone|prednisolone|mesh-list
101764484|NCT00863889|Prednisolone acetate|prednisolone acetate|mesh-list
101764485|NCT00863889|Lidocaine|lidocaine|mesh-list
101764486|NCT00863889|Bupivacaine|bupivacaine|mesh-list
101764487|NCT00863889|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101764488|NCT00863889|Prednisolone phosphate|prednisolone phosphate|mesh-list
101764489|NCT00863889|Anesthetics, Local|anesthetics, local|mesh-ancestor
101764490|NCT00863889|Anesthetics|anesthetics|mesh-ancestor
101764496|NCT00863889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101764497|NCT00863889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101764498|NCT00863889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101764499|NCT00863889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764500|NCT00863889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101764501|NCT00863889|Antiemetics|antiemetics|mesh-ancestor
101764502|NCT00863889|Autonomic Agents|autonomic agents|mesh-ancestor
101764503|NCT00863889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101764504|NCT00863889|Glucocorticoids|glucocorticoids|mesh-ancestor
101764505|NCT00863889|Hormones|hormones|mesh-ancestor
101764506|NCT00863889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101764507|NCT00863889|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101764508|NCT00863889|Protective Agents|protective agents|mesh-ancestor
101564371|NCT00927355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564373|NCT00923845|Cyclophosphamide|cyclophosphamide|mesh-list
101564374|NCT00923845|Pentostatin|pentostatin|mesh-list
101564375|NCT00923845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101564376|NCT00923845|Immunologic Factors|immunologic factors|mesh-ancestor
101564377|NCT00923845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764509|NCT00863889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101764510|NCT00863889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101764511|NCT00677352|Sertraline|sertraline|mesh-list
101764512|NCT00677352|Paroxetine|paroxetine|mesh-list
101764513|NCT00677352|Antidepressive Agents|antidepressive agents|mesh-ancestor
101764514|NCT00677352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101764515|NCT00677352|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101764516|NCT00677352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101764517|NCT00677352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101764518|NCT00677352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764519|NCT00677352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101764520|NCT00677352|Serotonin Agents|serotonin agents|mesh-ancestor
101764521|NCT00677352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764522|NCT00677352|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101764523|NCT00677352|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101764524|NCT00677352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101764525|NCT00677352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101764526|NCT00864045|Olanzapine|olanzapine|mesh-list
101764527|NCT00864045|Sertindole|sertindole|mesh-list
101764528|NCT00864045|Antiemetics|antiemetics|mesh-ancestor
101764529|NCT00864045|Autonomic Agents|autonomic agents|mesh-ancestor
101764530|NCT00864045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101764531|NCT00864045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764532|NCT00864045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101764533|NCT00864045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101764534|NCT00864045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101764535|NCT00864045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101764536|NCT00864045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101764537|NCT00864045|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101764538|NCT00864045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101764539|NCT00864045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101764540|NCT00864045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764541|NCT00864045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101764542|NCT00864045|Serotonin Agents|serotonin agents|mesh-ancestor
101764543|NCT00755508|Gabapentin|gabapentin|mesh-list
101764544|NCT00755508|Analgesics|analgesics|mesh-ancestor
101764545|NCT00755508|Sensory System Agents|sensory system agents|mesh-ancestor
101764546|NCT00755508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101764547|NCT00755508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764548|NCT00755508|Anticonvulsants|anticonvulsants|mesh-ancestor
101764549|NCT00755508|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101764550|NCT00755508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101764551|NCT00755508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101764552|NCT00755508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101764553|NCT00755508|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101764554|NCT00755508|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101764555|NCT00755508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101764556|NCT00755508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764557|NCT00755508|Antimanic Agents|antimanic agents|mesh-ancestor
101764562|NCT03680352|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101764563|NCT03680352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101764564|NCT03680352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764566|NCT00864201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101764567|NCT00864201|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101764568|NCT00864201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764569|NCT00864279|Cetirizine|cetirizine|mesh-list
101764570|NCT00864279|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101764571|NCT00864279|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101764572|NCT00864279|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101564379|NCT00923845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101564380|NCT00923845|Alkylating Agents|alkylating agents|mesh-ancestor
101564381|NCT00923845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564382|NCT00923845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101564383|NCT00923845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101564384|NCT00923845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101564385|NCT00923845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101564386|NCT00923845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101564387|NCT00923845|Antifungal Agents|antifungal agents|mesh-ancestor
101564388|NCT00923845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101564389|NCT00923845|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
101564390|NCT05052541|Dronabinol|dronabinol|mesh-list
101564391|NCT05052541|Hallucinogens|hallucinogens|mesh-ancestor
101412633|NCT03271021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101764573|NCT00864279|Histamine Antagonists|histamine antagonists|mesh-ancestor
101764574|NCT00864279|Histamine Agents|histamine agents|mesh-ancestor
101764575|NCT00864279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101764576|NCT00864279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764577|NCT00864279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764578|NCT02559648|Denosumab|denosumab|mesh-list
101764579|NCT02559648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101764580|NCT02559648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764581|NCT00864357|Ibuprofen|ibuprofen|mesh-list
101764582|NCT00864357|Oxycodone|oxycodone|mesh-list
101764583|NCT00864357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101764584|NCT00864357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101764585|NCT00864357|Analgesics|analgesics|mesh-ancestor
101764586|NCT00864357|Sensory System Agents|sensory system agents|mesh-ancestor
101764587|NCT00864357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101764588|NCT00864357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764589|NCT00864357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101764590|NCT00864357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101764591|NCT00864357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101764592|NCT00864357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101764593|NCT00864357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764594|NCT00864357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101764595|NCT00864357|Narcotics|narcotics|mesh-ancestor
101764596|NCT00864357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101764597|NCT00864435|Carvedilol|carvedilol|mesh-list
101764598|NCT00864435|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101764599|NCT00864435|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101764600|NCT00864435|Adrenergic Agents|adrenergic agents|mesh-ancestor
101764601|NCT00864435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101764602|NCT00864435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764603|NCT00864435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764604|NCT00864435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101764605|NCT00864435|Antioxidants|antioxidants|mesh-ancestor
101764606|NCT00864435|Protective Agents|protective agents|mesh-ancestor
101764607|NCT00864435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101764608|NCT00864435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101764609|NCT00864435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101764610|NCT00864435|Vasodilator Agents|vasodilator agents|mesh-ancestor
101764611|NCT00864435|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101764612|NCT00864435|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101764613|NCT00755664|Vitamins|vitamins|mesh-list
101764614|NCT00755664|Vitamin B Complex|vitamin b complex|mesh-list
101764615|NCT00755664|Micronutrients|micronutrients|mesh-ancestor
101564392|NCT05052541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564393|NCT05052541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101564394|NCT05052541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101564396|NCT05052541|Sensory System Agents|sensory system agents|mesh-ancestor
101564397|NCT05052541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101564398|NCT05052541|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101564399|NCT05052541|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101564400|NCT05052541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101412648|NCT00476983|Ritonavir|ritonavir|mesh-list
101764616|NCT00755664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764617|NCT00956098|Oltipraz|oltipraz|mesh-list
101764618|NCT00956098|Antiviral Agents|antiviral agents|mesh-ancestor
101764619|NCT00956098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101764620|NCT00956098|Schistosomicides|schistosomicides|mesh-ancestor
101764621|NCT00956098|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101764622|NCT00956098|Anthelmintics|anthelmintics|mesh-ancestor
101764623|NCT00956098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101764624|NCT00956098|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101764625|NCT00956098|Protective Agents|protective agents|mesh-ancestor
101764626|NCT00956098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764627|NCT00956098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101764628|NCT00956098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101764629|NCT00956098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101764645|NCT05350384|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101764646|NCT05350384|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101764647|NCT05350384|Prednisolone|prednisolone|mesh-list
101764648|NCT05350384|Prednisolone acetate|prednisolone acetate|mesh-list
101764649|NCT05350384|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101764650|NCT05350384|Prednisolone phosphate|prednisolone phosphate|mesh-list
101764651|NCT05350384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101764652|NCT05350384|Antiemetics|antiemetics|mesh-ancestor
101764653|NCT05350384|Autonomic Agents|autonomic agents|mesh-ancestor
101422101|NCT00150228|Varenicline|varenicline|mesh-list
101764654|NCT05350384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101764655|NCT05350384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764656|NCT05350384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101764657|NCT05350384|Glucocorticoids|glucocorticoids|mesh-ancestor
101764658|NCT05350384|Hormones|hormones|mesh-ancestor
101764659|NCT05350384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101764660|NCT05350384|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101764661|NCT05350384|Protective Agents|protective agents|mesh-ancestor
101764662|NCT05350384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101764663|NCT05350384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101764664|NCT00870441|Valacyclovir|valacyclovir|mesh-list
101764665|NCT00870441|Antiviral Agents|antiviral agents|mesh-ancestor
101764666|NCT00870441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101764667|NCT04079452|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
101764668|NCT04079452|Antiviral Agents|antiviral agents|mesh-ancestor
101764669|NCT04079452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101764670|NCT04079452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101764671|NCT04079452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101764672|NCT04079452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101764673|NCT04079452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764674|NCT04079452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101764675|NCT04079452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101764676|NCT00864669|Metformin|metformin|mesh-list
101764677|NCT00864669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101764678|NCT00864669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764679|NCT00864747|Propranolol|propranolol|mesh-list
101764680|NCT00864747|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101764681|NCT00864747|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101764682|NCT00864747|Adrenergic Agents|adrenergic agents|mesh-ancestor
101764683|NCT00864747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101764684|NCT00864747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564401|NCT05052541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564402|NCT05052541|Hormones|hormones|mesh-ancestor
101564403|NCT05052541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101564404|NCT04260685|Lidocaine|lidocaine|mesh-list
101564405|NCT04260685|Esmolol|esmolol|mesh-list
101564406|NCT04260685|Anesthetics, Local|anesthetics, local|mesh-ancestor
101764685|NCT00864747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764686|NCT00864747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101764687|NCT00864747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101764702|NCT02559102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101764703|NCT02559102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101764704|NCT02559102|Adrenergic Agents|adrenergic agents|mesh-ancestor
101764705|NCT02559102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101764706|NCT02559102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764707|NCT02559102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101764708|NCT02559102|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101764709|NCT02559102|Anesthetics, General|anesthetics, general|mesh-ancestor
101764710|NCT05348668|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101764711|NCT05348668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764712|NCT05348668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101764713|NCT05348668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101764714|NCT00864825|Allopurinol|allopurinol|mesh-list
101764715|NCT00864825|Antimetabolites|antimetabolites|mesh-ancestor
101764716|NCT00864825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764717|NCT00864825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101764718|NCT00864825|Gout Suppressants|gout suppressants|mesh-ancestor
101764719|NCT00864825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101764720|NCT00864825|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101764721|NCT00864825|Antioxidants|antioxidants|mesh-ancestor
101764722|NCT00864825|Protective Agents|protective agents|mesh-ancestor
101764723|NCT00864825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764724|NCT00956176|Cidofovir|cidofovir|mesh-list
101764725|NCT00956176|Antiviral Agents|antiviral agents|mesh-ancestor
101764726|NCT00956176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101764727|NCT00956176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101764728|NCT00956176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764729|NCT00864981|Bupropion|bupropion|mesh-list
101764730|NCT00864981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101764731|NCT00864981|Antidepressive Agents|antidepressive agents|mesh-ancestor
101764732|NCT00864981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101764733|NCT00864981|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101764734|NCT00864981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101764735|NCT00864981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101764736|NCT00864981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764737|NCT00864981|Dopamine Agents|dopamine agents|mesh-ancestor
101764738|NCT00864981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101764739|NCT00864981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764740|NCT00864981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101764741|NCT00864981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101764742|NCT00864981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101764743|NCT00371683|Enoxaparin|enoxaparin|mesh-list
101764744|NCT00371683|Apixaban|apixaban|mesh-list
101764745|NCT00371683|Anticoagulants|anticoagulants|mesh-ancestor
101764746|NCT00371683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101764747|NCT00371683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101764767|NCT00876135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101764768|NCT00876135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764769|NCT04039815|Ascorbic Acid|ascorbic acid|mesh-list
101764770|NCT04039815|Thiamine|thiamine|mesh-list
101764771|NCT04039815|Hydrocortisone|hydrocortisone|mesh-list
101764772|NCT04039815|Vitamins|vitamins|mesh-ancestor
101764773|NCT04039815|Micronutrients|micronutrients|mesh-ancestor
101764774|NCT04039815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764775|NCT04039815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101764776|NCT04039815|Vitamin B Complex|vitamin b complex|mesh-ancestor
101764777|NCT04039815|Antioxidants|antioxidants|mesh-ancestor
101764778|NCT04039815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764779|NCT04039815|Protective Agents|protective agents|mesh-ancestor
101564408|NCT04260685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101564409|NCT04260685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564410|NCT04260685|Sensory System Agents|sensory system agents|mesh-ancestor
101564411|NCT04260685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101564412|NCT04260685|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101564413|NCT04260685|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101564414|NCT04260685|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101564415|NCT04260685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101564416|NCT04260685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564417|NCT04260685|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101564418|NCT04260685|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101564419|NCT04260685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101564420|NCT04260685|Adrenergic Agents|adrenergic agents|mesh-ancestor
101412664|NCT00477061|Morphine|morphine|mesh-list
101764780|NCT00870987|Vaccines|vaccines|mesh-list
101764781|NCT00870987|Immunologic Factors|immunologic factors|mesh-ancestor
101764782|NCT00870987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764783|NCT00962026|Rilonacept|rilonacept|mesh-list
101764784|NCT00962026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101764785|NCT00616239|Salicylic Acid|salicylic acid|mesh-list
101764786|NCT00616239|Salicylates|salicylates|mesh-list
101764787|NCT00616239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101764788|NCT00616239|Antifungal Agents|antifungal agents|mesh-ancestor
101764789|NCT00616239|Keratolytic Agents|keratolytic agents|mesh-ancestor
101764790|NCT00616239|Dermatologic Agents|dermatologic agents|mesh-ancestor
101764791|NCT00616239|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101764792|NCT00616239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101764793|NCT00616239|Analgesics|analgesics|mesh-ancestor
101764794|NCT00616239|Sensory System Agents|sensory system agents|mesh-ancestor
101764795|NCT00616239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101764796|NCT00616239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764797|NCT00616239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101764798|NCT00616239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101764799|NCT00616239|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101764800|NCT00616239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101764801|NCT00616239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764802|NCT00547534|Rituximab|rituximab|mesh-list
101764803|NCT00547534|Bortezomib|bortezomib|mesh-list
101764804|NCT00547534|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101764809|NCT00547534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101764810|NCT00547534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101764811|NCT00547534|Alkylating Agents|alkylating agents|mesh-ancestor
101764812|NCT00547534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764814|NCT00871455|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101764815|NCT00871455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764816|NCT00871455|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101764817|NCT00871455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101764818|NCT00871455|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101764819|NCT00871455|GABA Agonists|gaba agonists|mesh-ancestor
101764820|NCT00871455|GABA Agents|gaba agents|mesh-ancestor
101764821|NCT00871455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101764822|NCT00871455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764823|NCT00871533|Interferon-alpha|interferon-alpha|mesh-list
101764824|NCT00871533|Interferon alpha-2|interferon alpha-2|mesh-list
101764825|NCT00871533|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
101764826|NCT00871533|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101764827|NCT00871533|Antiviral Agents|antiviral agents|mesh-ancestor
101564421|NCT04260685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101564422|NCT05052151|Dialysis Solutions|dialysis solutions|mesh-list
101564423|NCT05052151|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101564424|NCT05013463|Hydroxychloroquine|hydroxychloroquine|mesh-list
101564425|NCT05013463|Indapamide|indapamide|mesh-list
101564426|NCT05013463|Antimalarials|antimalarials|mesh-ancestor
101564427|NCT05013463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101764828|NCT00871533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101764829|NCT00871533|Immunologic Factors|immunologic factors|mesh-ancestor
101764830|NCT00871533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764831|NCT00871533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101764832|NCT00877149|Telbivudine|telbivudine|mesh-list
101764833|NCT00877149|Antiviral Agents|antiviral agents|mesh-ancestor
101764834|NCT00877149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101764835|NCT00877149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101764836|NCT00877149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101764837|NCT00877149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764838|NCT00877227|Leucovorin|leucovorin|mesh-list
101764839|NCT00877227|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
101764840|NCT00877227|Levoleucovorin|levoleucovorin|mesh-list
101764841|NCT00877227|Antidotes|antidotes|mesh-ancestor
101764842|NCT00877227|Protective Agents|protective agents|mesh-ancestor
101764843|NCT00877227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764844|NCT00877227|Vitamin B Complex|vitamin b complex|mesh-ancestor
101764845|NCT00877227|Vitamins|vitamins|mesh-ancestor
101764846|NCT00877227|Micronutrients|micronutrients|mesh-ancestor
101764847|NCT00871767|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
101764848|NCT00871767|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101764849|NCT00871767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764850|NCT00871767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101764851|NCT00871767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101764852|NCT00871767|Antiviral Agents|antiviral agents|mesh-ancestor
101764853|NCT00871767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101764854|NCT00384397|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101764855|NCT00384397|Immunologic Factors|immunologic factors|mesh-ancestor
101764856|NCT00384397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764857|NCT05119894|Brexpiprazole|brexpiprazole|mesh-list
101764858|NCT05119894|Serotonin Agents|serotonin agents|mesh-ancestor
101764859|NCT05119894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101764860|NCT05119894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764861|NCT05119894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764862|NCT05119894|Dopamine Agonists|dopamine agonists|mesh-ancestor
101764863|NCT05119894|Dopamine Agents|dopamine agents|mesh-ancestor
101764864|NCT00877539|Fluticasone|fluticasone|mesh-list
101764866|NCT00877539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101764867|NCT00877539|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101764868|NCT00877539|Autonomic Agents|autonomic agents|mesh-ancestor
101764869|NCT00877539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101764870|NCT00877539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764871|NCT00877539|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101764872|NCT00877539|Respiratory System Agents|respiratory system agents|mesh-ancestor
101764873|NCT00877539|Dermatologic Agents|dermatologic agents|mesh-ancestor
101764878|NCT00872235|Diuretics|diuretics|mesh-ancestor
101764879|NCT00872235|Natriuretic Agents|natriuretic agents|mesh-ancestor
101764880|NCT00872235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764881|NCT00872235|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101764882|NCT00872235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101764883|NCT00872235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764884|NCT00872235|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101764885|NCT00872235|Protease Inhibitors|protease inhibitors|mesh-ancestor
101764886|NCT00872235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101764887|NCT00872469|Tranexamic Acid|tranexamic acid|mesh-list
101764888|NCT00872469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101764889|NCT00872469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101764890|NCT00872469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764891|NCT00872469|Hemostatics|hemostatics|mesh-ancestor
101764892|NCT00872469|Coagulants|coagulants|mesh-ancestor
101564428|NCT05013463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101564429|NCT05013463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101564430|NCT05013463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101564431|NCT05013463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564432|NCT05013463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101564433|NCT05013463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101564434|NCT05013463|Diuretics|diuretics|mesh-ancestor
101564435|NCT05013463|Natriuretic Agents|natriuretic agents|mesh-ancestor
101564436|NCT05013463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564437|NCT05013463|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101564438|NCT05013463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101564439|NCT00922987|Pregabalin|pregabalin|mesh-list
101564440|NCT00922987|Analgesics|analgesics|mesh-ancestor
101412680|NCT00477373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101412682|NCT00477373|Antimanic Agents|antimanic agents|mesh-ancestor
101764893|NCT00872625|Cyclophosphamide|cyclophosphamide|mesh-list
101764894|NCT00872625|Docetaxel|docetaxel|mesh-list
101764895|NCT00872625|Fluorouracil|fluorouracil|mesh-list
101764896|NCT00872625|Epirubicin|epirubicin|mesh-list
101764897|NCT00872625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101764898|NCT00872625|Immunologic Factors|immunologic factors|mesh-ancestor
101764899|NCT00872625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764900|NCT00872625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101263771|NCT01763658|Antiemetics|antiemetics|mesh-ancestor
101764901|NCT00872625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101764902|NCT00872625|Alkylating Agents|alkylating agents|mesh-ancestor
101764903|NCT00872625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764904|NCT00872625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101201547|NCT01404689|Analgesics|analgesics|mesh-ancestor
101764905|NCT00872625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101764906|NCT00872625|Tubulin Modulators|tubulin modulators|mesh-ancestor
101764907|NCT00872625|Antimitotic Agents|antimitotic agents|mesh-ancestor
101764908|NCT00872625|Mitosis Modulators|mitosis modulators|mesh-ancestor
101764910|NCT00872625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101764911|NCT00872625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101764912|NCT00872625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101764913|NCT00872625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101764914|NCT00872625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101764915|NCT00872781|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101764916|NCT00872781|Quinapril|quinapril|mesh-list
101764917|NCT00872781|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101764918|NCT00872781|Diuretics|diuretics|mesh-ancestor
101764919|NCT00872781|Natriuretic Agents|natriuretic agents|mesh-ancestor
101764920|NCT00872781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764921|NCT00872781|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101764922|NCT00872781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101764923|NCT00872781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764924|NCT00872781|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101764925|NCT00872781|Protease Inhibitors|protease inhibitors|mesh-ancestor
101764926|NCT00872781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101764927|NCT00384085|Insulin|insulin|mesh-list
101764928|NCT00384085|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101764929|NCT00384085|Insulin Glargine|insulin glargine|mesh-list
101764930|NCT00384085|Insulin glulisine|insulin glulisine|mesh-list
101764931|NCT00384085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101764932|NCT00384085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764933|NCT00361231|Bevacizumab|bevacizumab|mesh-list
101764934|NCT00361231|Gemcitabine|gemcitabine|mesh-list
101764935|NCT00361231|Oxaliplatin|oxaliplatin|mesh-list
101764936|NCT00361231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101764937|NCT00361231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101764938|NCT00361231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101564441|NCT00922987|Sensory System Agents|sensory system agents|mesh-ancestor
101564442|NCT00922987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101564443|NCT00922987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564445|NCT00922987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101564446|NCT00922987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101564447|NCT00922987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564448|NCT00922987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101564449|NCT00922987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101564450|NCT00922987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101564451|NCT00922987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101564452|NCT00922987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101564454|NCT00610909|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101412694|NCT00477763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101764939|NCT00361231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101764940|NCT00361231|Growth Substances|growth substances|mesh-ancestor
101764941|NCT00361231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764942|NCT00361231|Growth Inhibitors|growth inhibitors|mesh-ancestor
101764943|NCT00361231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101764944|NCT00361231|Antimetabolites|antimetabolites|mesh-ancestor
101764945|NCT00361231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764961|NCT00676650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764963|NCT01045369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101764964|NCT01045369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101764965|NCT01045369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101764966|NCT01045369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764967|NCT01045369|Antiviral Agents|antiviral agents|mesh-ancestor
101764968|NCT01045369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101764969|NCT00615459|Tiotropium Bromide|tiotropium bromide|mesh-list
101764970|NCT00615459|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101764971|NCT00615459|Autonomic Agents|autonomic agents|mesh-ancestor
101764972|NCT00615459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101764973|NCT00615459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764975|NCT00615459|Respiratory System Agents|respiratory system agents|mesh-ancestor
101764976|NCT00615459|Parasympatholytics|parasympatholytics|mesh-ancestor
101764977|NCT00615459|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101764978|NCT00615459|Cholinergic Agents|cholinergic agents|mesh-ancestor
101764979|NCT00615459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101764980|NCT00615459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764981|NCT03839511|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101764982|NCT03839511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764984|NCT00383149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101764985|NCT00383149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101764986|NCT00878631|Dextrans|dextrans|mesh-list
101764987|NCT00878631|Anticoagulants|anticoagulants|mesh-ancestor
101764988|NCT00878631|Plasma Substitutes|plasma substitutes|mesh-ancestor
101764989|NCT00878631|Blood Substitutes|blood substitutes|mesh-ancestor
101764990|NCT00382993|Naproxen|naproxen|mesh-list
101764991|NCT00382993|Sumatriptan|sumatriptan|mesh-list
101764992|NCT00382993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101764993|NCT00382993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101764994|NCT00382993|Analgesics|analgesics|mesh-ancestor
101764995|NCT00382993|Sensory System Agents|sensory system agents|mesh-ancestor
101764996|NCT00382993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101764997|NCT00382993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564455|NCT00610909|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101564456|NCT00610909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101564457|NCT00610909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564458|NCT00610909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101564459|NCT00610909|Serotonin Agents|serotonin agents|mesh-ancestor
101564460|NCT00610909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564461|NCT00610909|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101564462|NCT00610909|Antidepressive Agents|antidepressive agents|mesh-ancestor
101564463|NCT00610909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101564464|NCT00610909|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101564465|NCT00610909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101564466|NCT00610909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101564468|NCT00927901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101564469|NCT00927901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564470|NCT04255771|Cisplatin|cisplatin|mesh-list
101564471|NCT04255771|Gemcitabine|gemcitabine|mesh-list
101564472|NCT04255771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101564473|NCT04255771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101564474|NCT04255771|Antimetabolites|antimetabolites|mesh-ancestor
101564475|NCT04255771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564476|NCT01218204|Atorvastatin|atorvastatin|mesh-list
101564477|NCT01218204|Ezetimibe|ezetimibe|mesh-list
101564478|NCT01218204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101564479|NCT01218204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101564480|NCT01218204|Antimetabolites|antimetabolites|mesh-ancestor
101564481|NCT01218204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564482|NCT01218204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101564483|NCT01218204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101564484|NCT01218204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101764998|NCT00382993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101764999|NCT00382993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101765000|NCT00382993|Gout Suppressants|gout suppressants|mesh-ancestor
101765001|NCT00382993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101765002|NCT00382993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101765003|NCT00382993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765004|NCT00382993|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101765005|NCT00382993|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101765017|NCT00760968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101765018|NCT00760968|Dermatologic Agents|dermatologic agents|mesh-ancestor
101765019|NCT00760968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101765020|NCT00760968|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101564485|NCT00926575|Beclomethasone|beclomethasone|mesh-list
101564486|NCT00926575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101564487|NCT00926575|Glucocorticoids|glucocorticoids|mesh-ancestor
101564488|NCT00926575|Hormones|hormones|mesh-ancestor
101407668|NCT00440869|Acetylcysteine|acetylcysteine|mesh-list
101564489|NCT00926575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101564490|NCT00926575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564491|NCT00926575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101564492|NCT00926575|Respiratory System Agents|respiratory system agents|mesh-ancestor
101564493|NCT05456412|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
101564494|NCT05456412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101564495|NCT05456412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101564496|NCT05456412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564497|NCT01217892|Metformin|metformin|mesh-list
101564498|NCT01217892|Dapagliflozin|dapagliflozin|mesh-list
101564499|NCT01217892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101564500|NCT01217892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765021|NCT00760968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101765022|NCT00760968|Immunologic Factors|immunologic factors|mesh-ancestor
101765023|NCT00760968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101765024|NCT00760968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101765025|NCT00369967|Contraceptive Agents|contraceptive agents|mesh-list
101765026|NCT00369967|NuvaRing|nuvaring|mesh-list
101765027|NCT00369967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101765028|NCT00369967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422462|NCT00165633|Vitamin K 2|vitamin k 2|mesh-list
101765029|NCT00369967|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101765031|NCT00878865|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101765032|NCT00878865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101765033|NCT00878865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765034|NCT00878865|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101765035|NCT00878865|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101765036|NCT00878865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101765037|NCT00878865|GABA Modulators|gaba modulators|mesh-ancestor
101765038|NCT00878865|GABA Agents|gaba agents|mesh-ancestor
101765039|NCT00878865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101765040|NCT00878865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765041|NCT00873483|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101765042|NCT00873483|Gestodene|gestodene|mesh-list
101765043|NCT00873483|Femovan|femovan|mesh-list
101765044|NCT00873483|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101765045|NCT00873483|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101765046|NCT00873483|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101765047|NCT00873483|Contraceptive Agents|contraceptive agents|mesh-ancestor
101765049|NCT00873483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765050|NCT00873483|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101765051|NCT00873483|Estrogens|estrogens|mesh-ancestor
101765052|NCT00873483|Hormones|hormones|mesh-ancestor
101765053|NCT00873483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101765054|NCT00873483|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101765055|NCT00873483|Progestins|progestins|mesh-ancestor
101765056|NCT00873483|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101765057|NCT01050517|Ivermectin|ivermectin|mesh-list
101765058|NCT01050517|Albendazole|albendazole|mesh-list
101765059|NCT01050517|Praziquantel|praziquantel|mesh-list
101765060|NCT01050517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101765061|NCT01050517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101765062|NCT01050517|Anthelmintics|anthelmintics|mesh-ancestor
101765063|NCT01050517|Anticestodal Agents|anticestodal agents|mesh-ancestor
101765064|NCT01050517|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101765065|NCT01050517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101564501|NCT01217892|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101564502|NCT01217892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564503|NCT01217814|Leucovorin|leucovorin|mesh-list
101564504|NCT01217814|Folic Acid|folic acid|mesh-list
101564505|NCT01217814|Golimumab|golimumab|mesh-list
101564506|NCT01217814|Methotrexate|methotrexate|mesh-list
101564507|NCT01217814|Levoleucovorin|levoleucovorin|mesh-list
101564508|NCT01217814|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101564509|NCT01217814|Abortifacient Agents|abortifacient agents|mesh-ancestor
101564510|NCT01217814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101564511|NCT01217814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564512|NCT01217814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101564513|NCT01217814|Antimetabolites|antimetabolites|mesh-ancestor
101564514|NCT01217814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564515|NCT01217814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101564516|NCT01217814|Dermatologic Agents|dermatologic agents|mesh-ancestor
101564517|NCT01217814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101412754|NCT00117468|Progestins|progestins|mesh-ancestor
101765066|NCT01050517|Tubulin Modulators|tubulin modulators|mesh-ancestor
101765067|NCT01050517|Antimitotic Agents|antimitotic agents|mesh-ancestor
101765068|NCT01050517|Mitosis Modulators|mitosis modulators|mesh-ancestor
101765069|NCT01050517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765070|NCT01050517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101765074|NCT02534467|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101765075|NCT02534467|Hormone Antagonists|hormone antagonists|mesh-ancestor
101765076|NCT02534467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101765077|NCT02534467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765078|NCT02534467|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101765079|NCT02534467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101765080|NCT02534467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765081|NCT01050595|Naltrexone|naltrexone|mesh-list
101765082|NCT01050595|Bromides|bromides|mesh-list
101765083|NCT01050595|Methylnaltrexone|methylnaltrexone|mesh-list
101765084|NCT01050595|Anticonvulsants|anticonvulsants|mesh-ancestor
101765085|NCT01050595|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101765086|NCT01050595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765087|NCT01050595|Sensory System Agents|sensory system agents|mesh-ancestor
101765088|NCT01050595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101765089|NCT01050595|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101765090|NCT00878943|Sildenafil Citrate|sildenafil citrate|mesh-list
101765091|NCT00878943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765092|NCT00878943|Vasodilator Agents|vasodilator agents|mesh-ancestor
101765093|NCT00878943|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101765094|NCT00878943|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101765095|NCT00878943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101765096|NCT00878943|Urological Agents|urological agents|mesh-ancestor
101765097|NCT00873639|Insulin|insulin|mesh-list
101765098|NCT00873639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101765099|NCT00873639|Insulin Aspart|insulin aspart|mesh-list
101765100|NCT00873639|Insulin Detemir|insulin detemir|mesh-list
101765101|NCT00873639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101765102|NCT00873639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765103|NCT00879021|Pregabalin|pregabalin|mesh-list
101765104|NCT00879021|Analgesics|analgesics|mesh-ancestor
101765105|NCT00879021|Sensory System Agents|sensory system agents|mesh-ancestor
101765106|NCT00879021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101765107|NCT00879021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564518|NCT01217814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101564519|NCT01217814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101564520|NCT01217814|Immunologic Factors|immunologic factors|mesh-ancestor
101564521|NCT01217814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101564522|NCT01217814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101564523|NCT01217814|Antidotes|antidotes|mesh-ancestor
101564524|NCT01217814|Protective Agents|protective agents|mesh-ancestor
101564525|NCT01217814|Vitamin B Complex|vitamin b complex|mesh-ancestor
101564526|NCT01217814|Vitamins|vitamins|mesh-ancestor
101564527|NCT01217814|Micronutrients|micronutrients|mesh-ancestor
101564528|NCT01217814|Hematinics|hematinics|mesh-ancestor
101564529|NCT01217814|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101564530|NCT01217814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101564531|NCT01217190|Ondansetron|ondansetron|mesh-list
101564532|NCT01217190|Antiemetics|antiemetics|mesh-ancestor
101564533|NCT01217190|Autonomic Agents|autonomic agents|mesh-ancestor
101564534|NCT01217190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101765108|NCT00879021|Anticonvulsants|anticonvulsants|mesh-ancestor
101765109|NCT00879021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101765110|NCT00879021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101765111|NCT00879021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765112|NCT00879021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101765113|NCT00879021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101765114|NCT00879021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101765115|NCT00879021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101765116|NCT00879021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101765118|NCT00879099|Paroxetine|paroxetine|mesh-list
101765119|NCT00879099|Maleic acid|maleic acid|mesh-list
101765120|NCT00879099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101765121|NCT00879099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263785|NCT01763710|Paclitaxel|paclitaxel|mesh-list
101765123|NCT00879099|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101765124|NCT00879099|Adrenergic Agents|adrenergic agents|mesh-ancestor
101765125|NCT00879099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101765126|NCT00879099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765127|NCT00879099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101765128|NCT00879099|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101765129|NCT00879099|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101765130|NCT00879099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101765131|NCT00879099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101765132|NCT00879099|Serotonin Agents|serotonin agents|mesh-ancestor
101765133|NCT00879099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101765134|NCT00879099|Antidepressive Agents|antidepressive agents|mesh-ancestor
101765135|NCT00879099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101765136|NCT00879099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101765137|NCT00879099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101765138|NCT00369655|Aflibercept|aflibercept|mesh-list
101765139|NCT00369655|Endothelial Growth Factors|endothelial growth factors|mesh-list
101765140|NCT00369655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101765141|NCT00369655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101765142|NCT00369655|Growth Substances|growth substances|mesh-ancestor
101765148|NCT00879177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101765149|NCT00879177|Cholinergic Agents|cholinergic agents|mesh-ancestor
101765150|NCT00879177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101765151|NCT00879177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765152|NCT00879177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765153|NCT00676338|Metformin|metformin|mesh-list
101765154|NCT00676338|Pioglitazone|pioglitazone|mesh-list
101765155|NCT00676338|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101564535|NCT01217190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564536|NCT01217190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101564537|NCT01217190|Antipruritics|antipruritics|mesh-ancestor
101564538|NCT01217190|Dermatologic Agents|dermatologic agents|mesh-ancestor
101564539|NCT01217190|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101564540|NCT01217190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101564541|NCT01217190|Serotonin Agents|serotonin agents|mesh-ancestor
101412785|NCT00478699|Antimetabolites|antimetabolites|mesh-ancestor
101765156|NCT00676338|Exenatide|exenatide|mesh-list
101765157|NCT00676338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101765158|NCT00676338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765159|NCT00676338|Incretins|incretins|mesh-ancestor
101765160|NCT00676338|Hormones|hormones|mesh-ancestor
101765161|NCT00676338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101765162|NCT00676338|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101765163|NCT00676338|Protease Inhibitors|protease inhibitors|mesh-ancestor
101765164|NCT00676338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101765165|NCT00676338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765166|NCT00676338|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101765167|NCT02534623|Fentanyl|fentanyl|mesh-list
101765168|NCT02534623|Bupivacaine|bupivacaine|mesh-list
101765169|NCT02534623|Anesthetics|anesthetics|mesh-list
101765170|NCT02534623|Propofol|propofol|mesh-list
101765171|NCT02534623|Sevoflurane|sevoflurane|mesh-list
101765172|NCT02534623|Anesthetics, Local|anesthetics, local|mesh-ancestor
101765173|NCT02534623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101765174|NCT02534623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765175|NCT02534623|Sensory System Agents|sensory system agents|mesh-ancestor
101765176|NCT02534623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101765177|NCT02534623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101765178|NCT02534623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101765179|NCT02534623|Anesthetics, General|anesthetics, general|mesh-ancestor
101765180|NCT02534623|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101765181|NCT02534623|Narcotics|narcotics|mesh-ancestor
101765182|NCT02534623|Analgesics|analgesics|mesh-ancestor
101765183|NCT02534623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101765184|NCT02534623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101765185|NCT02534623|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101765186|NCT00873795|Aripiprazole|aripiprazole|mesh-list
101765187|NCT00873795|Sertraline|sertraline|mesh-list
101765188|NCT00873795|Antidepressive Agents|antidepressive agents|mesh-ancestor
101765189|NCT00873795|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101765190|NCT00873795|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101765191|NCT00873795|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101765192|NCT00873795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101765193|NCT00873795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765194|NCT00873795|Dopamine Agonists|dopamine agonists|mesh-ancestor
101765195|NCT00873795|Dopamine Agents|dopamine agents|mesh-ancestor
101765196|NCT00873795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101765198|NCT00873795|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101765199|NCT00873795|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101765200|NCT00873795|Serotonin Agents|serotonin agents|mesh-ancestor
101765201|NCT00873795|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101765202|NCT00873795|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101765203|NCT00873795|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101765204|NCT00873795|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101765205|NCT00873795|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101765206|NCT00873795|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101765207|NCT00873795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101765208|NCT00873951|Caseins|caseins|mesh-list
101765209|NCT00873951|Chelating Agents|chelating agents|mesh-ancestor
101765210|NCT00873951|Sequestering Agents|sequestering agents|mesh-ancestor
101765211|NCT00873951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765212|NCT00874107|Paclitaxel|paclitaxel|mesh-list
101765213|NCT00874107|Bevacizumab|bevacizumab|mesh-list
101765214|NCT00874107|Carboplatin|carboplatin|mesh-list
101765215|NCT00874107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101765228|NCT00761358|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101564543|NCT01217190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564544|NCT01136733|Everolimus|everolimus|mesh-list
101564545|NCT01136733|Lenvatinib|lenvatinib|mesh-list
101564546|NCT01136733|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101765229|NCT00761358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101765230|NCT00761358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765231|NCT00761358|Cholinergic Agents|cholinergic agents|mesh-ancestor
101765232|NCT00761358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101765233|NCT00761358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765234|NCT00761358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101765235|NCT00879723|Vitamins|vitamins|mesh-list
101765236|NCT00879723|Micronutrients|micronutrients|mesh-ancestor
101765237|NCT00879723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765238|NCT00874419|Carboplatin|carboplatin|mesh-list
101765239|NCT00874419|Gemcitabine|gemcitabine|mesh-list
101765240|NCT00874419|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101765241|NCT00874419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101765242|NCT00874419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101765243|NCT00874419|Antimetabolites|antimetabolites|mesh-ancestor
101765244|NCT00874419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765245|NCT00874419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101765246|NCT00874419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101765247|NCT00381043|Acamprosate|acamprosate|mesh-list
101765248|NCT00381043|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101765249|NCT01050985|Sirolimus|sirolimus|mesh-list
101765250|NCT01050985|Capecitabine|capecitabine|mesh-list
101765251|NCT01050985|Temsirolimus|temsirolimus|mesh-list
101765252|NCT01050985|MTOR Inhibitors|mtor inhibitors|mesh-list
101765253|NCT01050985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101765254|NCT01050985|Antimetabolites|antimetabolites|mesh-ancestor
101765255|NCT01050985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765257|NCT01050985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101765258|NCT01050985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101765259|NCT01050985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101765260|NCT01050985|Immunologic Factors|immunologic factors|mesh-ancestor
101765261|NCT01050985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765262|NCT01050985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101765263|NCT01050985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101765264|NCT01050985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101765265|NCT01050985|Antifungal Agents|antifungal agents|mesh-ancestor
101765266|NCT00614991|Ritonavir|ritonavir|mesh-list
101765267|NCT00614991|Fosamprenavir|fosamprenavir|mesh-list
101765268|NCT00614991|Raltegravir Potassium|raltegravir potassium|mesh-list
101765269|NCT00614991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101765270|NCT00614991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101765271|NCT00614991|Protease Inhibitors|protease inhibitors|mesh-ancestor
101765273|NCT00614991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765274|NCT00614991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101765275|NCT00614991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101765276|NCT00614991|Antiviral Agents|antiviral agents|mesh-ancestor
101765277|NCT00614991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101765278|NCT00614991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101765279|NCT00614991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101765287|NCT00874575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765288|NCT00874575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101765289|NCT00874575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101765290|NCT00874653|Levonorgestrel|levonorgestrel|mesh-list
101765291|NCT00874653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101765292|NCT00874653|Contraceptive Agents|contraceptive agents|mesh-ancestor
101765293|NCT00874653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101765294|NCT00874653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765295|NCT00874653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101765296|NCT00874653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101765297|NCT00874653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101765298|NCT00369577|Loxapine|loxapine|mesh-list
101765299|NCT00369577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101765300|NCT00369577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101564547|NCT01136733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101564548|NCT01136733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101564549|NCT01136733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564550|NCT01136733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101564551|NCT01136733|Immunologic Factors|immunologic factors|mesh-ancestor
101564552|NCT01136733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564553|NCT01136733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101564554|NCT05178693|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
101564555|NCT05178693|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
101564556|NCT05178693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101765301|NCT00369577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101765302|NCT00369577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765303|NCT00369577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101765304|NCT00369577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101765305|NCT00369577|Dopamine Agents|dopamine agents|mesh-ancestor
101765306|NCT00369577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101765307|NCT00369577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765308|NCT00879957|Heparin|heparin|mesh-list
101765309|NCT00879957|Calcium heparin|calcium heparin|mesh-list
101765310|NCT00879957|Anticoagulants|anticoagulants|mesh-ancestor
101765311|NCT00879957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101765312|NCT00879957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101765313|NCT00879957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765314|NCT00874809|Insulin|insulin|mesh-list
101765315|NCT00874809|Insulin, Short-Acting|insulin, short-acting|mesh-list
101765316|NCT00874809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101765317|NCT00874809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765318|NCT00875355|Temozolomide|temozolomide|mesh-list
101765319|NCT00875355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101765320|NCT00875355|Alkylating Agents|alkylating agents|mesh-ancestor
101765321|NCT00875355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765322|NCT00875355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101765323|NCT00678288|Interferons|interferons|mesh-list
101765324|NCT00678288|Sorafenib|sorafenib|mesh-list
101765325|NCT00678288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101765326|NCT00678288|Antiviral Agents|antiviral agents|mesh-ancestor
101765327|NCT00678288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101765328|NCT00678288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101765329|NCT00678288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101765330|NCT00678288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765331|NCT00880815|Rituximab|rituximab|mesh-list
101765332|NCT00880815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101765333|NCT00880815|Methotrexate|methotrexate|mesh-list
101765334|NCT00880815|Fludarabine|fludarabine|mesh-list
101765335|NCT00880815|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101765336|NCT00880815|Antibodies|antibodies|mesh-list
101765337|NCT00880815|Immunoglobulins|immunoglobulins|mesh-list
101765338|NCT00880815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101765339|NCT00880815|Lenograstim|lenograstim|mesh-list
101765340|NCT00880815|Tacrolimus|tacrolimus|mesh-list
101765341|NCT00880815|Thymoglobulin|thymoglobulin|mesh-list
101765342|NCT00880815|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101765343|NCT00880815|Immunologic Factors|immunologic factors|mesh-ancestor
101765344|NCT00880815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765345|NCT00880815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101765346|NCT00880815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101765347|NCT00880815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101765348|NCT00880815|Abortifacient Agents|abortifacient agents|mesh-ancestor
101765349|NCT00880815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101765350|NCT00880815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101765358|NCT00880815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101765359|NCT00880815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101765360|NCT00880815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101765361|NCT00880815|Alkylating Agents|alkylating agents|mesh-ancestor
101564558|NCT05178693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564559|NCT05178693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101564560|NCT05178693|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101564561|NCT01136655|Budesonide|budesonide|mesh-list
101564562|NCT01136655|Formoterol Fumarate|formoterol fumarate|mesh-list
101564563|NCT01136655|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101564564|NCT01136655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101564565|NCT01136655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101564566|NCT01136655|Autonomic Agents|autonomic agents|mesh-ancestor
101564567|NCT01136655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101564568|NCT01136655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564569|NCT01136655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101564570|NCT01136655|Respiratory System Agents|respiratory system agents|mesh-ancestor
101564571|NCT01136655|Glucocorticoids|glucocorticoids|mesh-ancestor
101564572|NCT01136655|Hormones|hormones|mesh-ancestor
101564573|NCT01136655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101564574|NCT01136655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101564575|NCT01136655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101564576|NCT01136655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101564577|NCT01136655|Adrenergic Agents|adrenergic agents|mesh-ancestor
101564578|NCT01136655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101412807|NCT00478855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101765362|NCT00369343|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101765363|NCT00369343|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101765364|NCT00369343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101765365|NCT00369343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101765366|NCT00369343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765367|NCT00369343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101765368|NCT00369343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765369|NCT00369343|Antidepressive Agents|antidepressive agents|mesh-ancestor
101765370|NCT00369343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101765371|NCT00881049|Imatinib Mesylate|imatinib mesylate|mesh-list
101765372|NCT00881049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101765373|NCT00881049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101765374|NCT00881049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101765375|NCT00881049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765376|NCT00881127|Cetirizine|cetirizine|mesh-list
101765377|NCT00881127|Pseudoephedrine|pseudoephedrine|mesh-list
101765378|NCT00881127|Ephedrine|ephedrine|mesh-list
101765379|NCT00881127|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101765380|NCT00881127|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101765381|NCT00881127|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101765382|NCT00881127|Histamine Antagonists|histamine antagonists|mesh-ancestor
101765383|NCT00881127|Histamine Agents|histamine agents|mesh-ancestor
101765384|NCT00881127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101765385|NCT00881127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765386|NCT00881127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564579|NCT01136655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564580|NCT01135017|Dronedarone|dronedarone|mesh-list
101564581|NCT01135017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101564582|NCT01134705|Beclomethasone|beclomethasone|mesh-list
101564583|NCT01134705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101564584|NCT01134705|Glucocorticoids|glucocorticoids|mesh-ancestor
101564585|NCT01134705|Hormones|hormones|mesh-ancestor
101564586|NCT01134705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101564587|NCT01134705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526525|NCT05823870|Metformin|metformin|mesh-list
101412831|NCT00119132|Artesunate|artesunate|mesh-list
101412832|NCT00119132|Pyrimethamine|pyrimethamine|mesh-list
101765387|NCT00881127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101765388|NCT00881127|Autonomic Agents|autonomic agents|mesh-ancestor
101765389|NCT00881127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101765390|NCT00881127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101765391|NCT00881127|Respiratory System Agents|respiratory system agents|mesh-ancestor
101765392|NCT00881127|Nasal Decongestants|nasal decongestants|mesh-ancestor
101765393|NCT00881127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101765394|NCT00881127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101765395|NCT00881127|Sympathomimetics|sympathomimetics|mesh-ancestor
101765396|NCT00881127|Adrenergic Agents|adrenergic agents|mesh-ancestor
101765397|NCT00369265|Lansoprazole|lansoprazole|mesh-list
101765398|NCT00369265|Dexlansoprazole|dexlansoprazole|mesh-list
101765399|NCT00369265|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101765400|NCT00369265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101765401|NCT00369265|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101765402|NCT00369265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101765403|NCT00369265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765404|NCT00875745|Sorafenib|sorafenib|mesh-list
101765405|NCT00875745|Vorinostat|vorinostat|mesh-list
101765406|NCT00875745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101765407|NCT00875745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101765408|NCT00875745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101765409|NCT00875745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765410|NCT00875745|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101765411|NCT00368875|Paclitaxel|paclitaxel|mesh-list
101765412|NCT00368875|Bevacizumab|bevacizumab|mesh-list
101765413|NCT00368875|Vorinostat|vorinostat|mesh-list
101765414|NCT00368875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101765415|NCT00368875|Antibodies|antibodies|mesh-list
101765416|NCT00368875|Immunoglobulins|immunoglobulins|mesh-list
101765417|NCT00368875|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101765423|NCT00368875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765424|NCT00368875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101765425|NCT00368875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101765426|NCT00368875|Growth Substances|growth substances|mesh-ancestor
101765427|NCT00368875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765428|NCT00368875|Growth Inhibitors|growth inhibitors|mesh-ancestor
101765429|NCT00368875|Immunologic Factors|immunologic factors|mesh-ancestor
101765430|NCT00368875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101765431|NCT00368875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101765432|NCT00614055|Insulin|insulin|mesh-list
101765433|NCT00614055|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101765434|NCT00614055|Metformin|metformin|mesh-list
101765435|NCT00614055|Insulin Glargine|insulin glargine|mesh-list
101765436|NCT00614055|Insulin Aspart|insulin aspart|mesh-list
101765437|NCT00614055|Insulin, Long-Acting|insulin, long-acting|mesh-list
101765438|NCT00614055|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101765439|NCT00614055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101765440|NCT00614055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765441|NCT00613821|Lidocaine|lidocaine|mesh-list
101765442|NCT00613821|Anesthetics, Local|anesthetics, local|mesh-ancestor
101765443|NCT00613821|Anesthetics|anesthetics|mesh-ancestor
101765444|NCT00613821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101564588|NCT01134705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101564589|NCT01134705|Respiratory System Agents|respiratory system agents|mesh-ancestor
101564591|NCT01134627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101564592|NCT01134627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101564594|NCT01134393|Telmisartan|telmisartan|mesh-list
101564595|NCT01134393|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
101564596|NCT01134393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101564597|NCT01134393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101564598|NCT01134393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101765445|NCT00613821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765446|NCT00613821|Sensory System Agents|sensory system agents|mesh-ancestor
101765447|NCT00613821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101765448|NCT00613821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101765449|NCT00613821|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101765450|NCT00613821|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101765451|NCT00613821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101765452|NCT00613821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765453|NCT00882765|Genistein|genistein|mesh-list
101765454|NCT00882765|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101765455|NCT00882765|Protective Agents|protective agents|mesh-ancestor
101765456|NCT00882765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765457|NCT00882765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101765458|NCT00882765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101765459|NCT00882765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101765460|NCT00882765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765461|NCT00882765|Phytoestrogens|phytoestrogens|mesh-ancestor
101765462|NCT00882765|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101765463|NCT00882765|Estrogens|estrogens|mesh-ancestor
101765464|NCT00882765|Hormones|hormones|mesh-ancestor
101765465|NCT00882765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101765466|NCT00548548|Bevacizumab|bevacizumab|mesh-list
101765467|NCT00548548|Fluorouracil|fluorouracil|mesh-list
101765468|NCT00548548|Capecitabine|capecitabine|mesh-list
101765469|NCT00548548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101765470|NCT00548548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101765471|NCT00548548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101765472|NCT00548548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101765473|NCT00548548|Growth Substances|growth substances|mesh-ancestor
101765474|NCT00548548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765475|NCT00548548|Growth Inhibitors|growth inhibitors|mesh-ancestor
101765476|NCT00548548|Antimetabolites|antimetabolites|mesh-ancestor
101765477|NCT00548548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765478|NCT00548548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101765479|NCT00548548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101765480|NCT00548548|Immunologic Factors|immunologic factors|mesh-ancestor
101765481|NCT00613509|Interferons|interferons|mesh-list
101765482|NCT00613509|Interferon-alpha|interferon-alpha|mesh-list
101765483|NCT00613509|Vaccines|vaccines|mesh-list
101765484|NCT00613509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101765485|NCT00613509|Antiviral Agents|antiviral agents|mesh-ancestor
101765486|NCT00613509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101765487|NCT00613509|Immunologic Factors|immunologic factors|mesh-ancestor
101765496|NCT00881595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101765498|NCT00883155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101765499|NCT00883155|Antidepressive Agents|antidepressive agents|mesh-ancestor
101765500|NCT00883155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101765501|NCT00883155|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101765502|NCT00883155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101765503|NCT00883155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101765504|NCT00883155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765505|NCT00883155|Dopamine Agents|dopamine agents|mesh-ancestor
101765506|NCT00883155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101564599|NCT01134393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564600|NCT01134393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101564602|NCT01134393|Vasodilator Agents|vasodilator agents|mesh-ancestor
101564603|NCT01134393|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101564604|NCT01134393|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101564605|NCT05331469|Insulin|insulin|mesh-list
101564606|NCT05331469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101564607|NCT05331469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564608|NCT00922441|Valsartan|valsartan|mesh-list
101564609|NCT00922441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101564610|NCT00922441|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101765507|NCT00883155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765508|NCT00883155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101765509|NCT00883155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101765510|NCT00883155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101765511|NCT00881673|Dexamethasone|dexamethasone|mesh-list
101765512|NCT00881673|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101765513|NCT00881673|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101765514|NCT00881673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101765515|NCT00881673|Antiemetics|antiemetics|mesh-ancestor
101765516|NCT00881673|Autonomic Agents|autonomic agents|mesh-ancestor
101765517|NCT00881673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101765518|NCT00881673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765519|NCT00881673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101765520|NCT00881673|Glucocorticoids|glucocorticoids|mesh-ancestor
101765521|NCT00881673|Hormones|hormones|mesh-ancestor
101765522|NCT00881673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101765523|NCT00881673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101765524|NCT00881673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101765525|NCT04638465|Cisplatin|cisplatin|mesh-list
101765526|NCT04638465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101765527|NCT00881907|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101765528|NCT00881907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101765529|NCT00881907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101765530|NCT00881907|Antitubercular Agents|antitubercular agents|mesh-ancestor
101765531|NCT04487925|Hormones|hormones|mesh-list
101765532|NCT04487925|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101765533|NCT04487925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101765534|NCT04487925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765535|NCT00547300|Metoprolol|metoprolol|mesh-list
101765536|NCT00547300|Nebivolol|nebivolol|mesh-list
101765537|NCT00547300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101765538|NCT00547300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101765539|NCT00547300|Sympatholytics|sympatholytics|mesh-ancestor
101765540|NCT00547300|Autonomic Agents|autonomic agents|mesh-ancestor
101765541|NCT00547300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101765542|NCT00547300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765543|NCT00547300|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101765544|NCT00547300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101765545|NCT00547300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101765546|NCT00547300|Adrenergic Agents|adrenergic agents|mesh-ancestor
101765547|NCT00547300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101765548|NCT00547300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765549|NCT00547300|Vasodilator Agents|vasodilator agents|mesh-ancestor
101765550|NCT00547300|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101765551|NCT00547300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101765555|NCT00612807|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101765556|NCT00612807|Sertraline|sertraline|mesh-list
101765557|NCT00612807|Nortriptyline|nortriptyline|mesh-list
101564611|NCT00922441|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101564612|NCT00922441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564614|NCT01217112|Anticonvulsants|anticonvulsants|mesh-ancestor
101564615|NCT01216332|Vaccines|vaccines|mesh-list
101564616|NCT01216332|Immunologic Factors|immunologic factors|mesh-ancestor
101564617|NCT01216332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765558|NCT00612807|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101765559|NCT00612807|Antidepressive Agents|antidepressive agents|mesh-ancestor
101765560|NCT00612807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101765561|NCT00612807|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101765562|NCT00612807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101263793|NCT01763749|Clopidogrel|clopidogrel|mesh-list
101765564|NCT00612807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765565|NCT00612807|Dopamine Agents|dopamine agents|mesh-ancestor
101765566|NCT00612807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101765567|NCT00612807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765568|NCT00612807|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101765569|NCT00612807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101765570|NCT00612807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101765571|NCT00612807|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101765572|NCT00612807|Serotonin Agents|serotonin agents|mesh-ancestor
101765573|NCT00612807|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101765574|NCT00612807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101765575|NCT00612807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101765576|NCT00612807|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101765577|NCT00612807|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101765578|NCT00612807|Adrenergic Agents|adrenergic agents|mesh-ancestor
101765579|NCT00612807|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101765580|NCT00612807|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101765581|NCT00958750|Minoxidil|minoxidil|mesh-list
101765582|NCT00958750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101765583|NCT00958750|Vasodilator Agents|vasodilator agents|mesh-ancestor
101765584|NCT00958906|Infliximab|infliximab|mesh-list
101765585|NCT00958906|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101765586|NCT00958906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101765587|NCT00958906|Dermatologic Agents|dermatologic agents|mesh-ancestor
101765588|NCT00958906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101765589|NCT00958906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101765590|NCT00959062|Clonidine|clonidine|mesh-list
101765591|NCT00959062|Analgesics|analgesics|mesh-ancestor
101765592|NCT00959062|Sensory System Agents|sensory system agents|mesh-ancestor
101765593|NCT00959062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101765594|NCT00959062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765595|NCT00959062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101765596|NCT00959062|Sympatholytics|sympatholytics|mesh-ancestor
101765597|NCT00959062|Autonomic Agents|autonomic agents|mesh-ancestor
101765598|NCT00959062|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101765599|NCT00959062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101765600|NCT00959062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101765601|NCT00959062|Adrenergic Agents|adrenergic agents|mesh-ancestor
101765602|NCT00959062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101765603|NCT00959062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765604|NCT04038411|Etoposide|etoposide|mesh-list
101765605|NCT04038411|Lenalidomide|lenalidomide|mesh-list
101765606|NCT04038411|Antibodies|antibodies|mesh-list
101765607|NCT04038411|Immunologic Factors|immunologic factors|mesh-ancestor
101765608|NCT04038411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765609|NCT04038411|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101765610|NCT04038411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101765611|NCT04038411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101765612|NCT04038411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101765613|NCT04038411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101765614|NCT04038411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765615|NCT04038411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101765616|NCT04038411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101765617|NCT04038411|Growth Substances|growth substances|mesh-ancestor
101564618|NCT00922207|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101564619|NCT00922207|Entecavir|entecavir|mesh-list
101564620|NCT00922207|Adefovir|adefovir|mesh-list
101564621|NCT00922207|Antiviral Agents|antiviral agents|mesh-ancestor
101564622|NCT00922207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101564623|NCT00922207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101564624|NCT00922207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101564625|NCT00922207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101564626|NCT00922207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564627|NCT01134315|Calcitriol|calcitriol|mesh-list
101564628|NCT01134315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101564629|NCT01134315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412879|NCT00479479|Vitamins|vitamins|mesh-ancestor
101765618|NCT04038411|Growth Inhibitors|growth inhibitors|mesh-ancestor
101765619|NCT00882375|Nicotine|nicotine|mesh-list
101765620|NCT00882375|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101765621|NCT00882375|Autonomic Agents|autonomic agents|mesh-ancestor
101765622|NCT00882375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101765623|NCT00882375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765624|NCT00882375|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101765628|NCT00882375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765630|NCT00882453|Interferon-beta|interferon-beta|mesh-list
101765631|NCT00882453|Interferon beta-1b|interferon beta-1b|mesh-list
101765632|NCT00882453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101765633|NCT00882453|Antiviral Agents|antiviral agents|mesh-ancestor
101765634|NCT00882453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101765635|NCT00882453|Immunologic Factors|immunologic factors|mesh-ancestor
101765636|NCT00882453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765637|NCT00882453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101765638|NCT00882531|Isotretinoin|isotretinoin|mesh-list
101765639|NCT00882531|Dermatologic Agents|dermatologic agents|mesh-ancestor
101765640|NCT00963274|Bortezomib|bortezomib|mesh-list
101765641|NCT00963274|Romidepsin|romidepsin|mesh-list
101765642|NCT00963274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101765643|NCT00963274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101765644|NCT00963274|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101765645|NCT00963274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101765646|NCT00963274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765647|NCT00882609|Fluorides|fluorides|mesh-list
101765648|NCT00882609|Cariostatic Agents|cariostatic agents|mesh-ancestor
101765649|NCT00882609|Protective Agents|protective agents|mesh-ancestor
101765650|NCT00882609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765651|NCT00883623|Lenalidomide|lenalidomide|mesh-list
101765652|NCT00883623|Immunologic Factors|immunologic factors|mesh-ancestor
101765653|NCT00883623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765654|NCT00883623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101765655|NCT00883623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101765656|NCT00883623|Growth Substances|growth substances|mesh-ancestor
101765657|NCT00883623|Growth Inhibitors|growth inhibitors|mesh-ancestor
101765658|NCT00883623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101765659|NCT00959218|Dronabinol|dronabinol|mesh-list
101765660|NCT00959218|Hallucinogens|hallucinogens|mesh-ancestor
101765661|NCT00959218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765662|NCT00959218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101765663|NCT00959218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101765664|NCT00959218|Analgesics|analgesics|mesh-ancestor
101765665|NCT00959218|Sensory System Agents|sensory system agents|mesh-ancestor
101765666|NCT00959218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101765667|NCT00959218|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101202381|NCT01409408|Amlodipine|amlodipine|mesh-list
101765668|NCT00959218|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101765669|NCT00959218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101765670|NCT00959218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765671|NCT00959218|Hormones|hormones|mesh-ancestor
101564630|NCT01134315|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101564631|NCT01134315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101564632|NCT01134315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564633|NCT01134315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101564634|NCT01134315|Vitamins|vitamins|mesh-ancestor
101765672|NCT00959218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101765673|NCT00678210|Tofacitinib|tofacitinib|mesh-list
101765674|NCT00678210|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101765675|NCT00678210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101765676|NCT00678210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101765677|NCT00678210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765678|NCT00611715|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101765679|NCT00611715|Letrozole|letrozole|mesh-list
101765680|NCT00611715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101765681|NCT00611715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101765682|NCT00611715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101765683|NCT00611715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765684|NCT00611715|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101765685|NCT00611715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101765686|NCT00611715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101765687|NCT00611715|Hormone Antagonists|hormone antagonists|mesh-ancestor
101765688|NCT00611715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101765689|NCT00611715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765690|NCT04722718|Paclitaxel|paclitaxel|mesh-list
101765691|NCT04722718|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101765692|NCT04722718|Carboplatin|carboplatin|mesh-list
101765693|NCT04722718|Apatinib|apatinib|mesh-list
101765694|NCT04722718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101765695|NCT04722718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101765696|NCT04722718|Tubulin Modulators|tubulin modulators|mesh-ancestor
101765715|NCT00761670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101765716|NCT00761670|Antidepressive Agents|antidepressive agents|mesh-ancestor
101765717|NCT00963664|Interferons|interferons|mesh-list
101765718|NCT00963664|Interferon-alpha|interferon-alpha|mesh-list
101765719|NCT00963664|Interferon alpha-2|interferon alpha-2|mesh-list
101765720|NCT00963664|Lovastatin|lovastatin|mesh-list
101765721|NCT00963664|L 647318|l 647318|mesh-list
101765722|NCT00963664|Dihydromevinolin|dihydromevinolin|mesh-list
101765723|NCT00963664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101765724|NCT00963664|Antiviral Agents|antiviral agents|mesh-ancestor
101765725|NCT00963664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101765726|NCT00963664|Immunologic Factors|immunologic factors|mesh-ancestor
101765727|NCT00963664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765728|NCT00963664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101765729|NCT00963664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101765730|NCT00963664|Antimetabolites|antimetabolites|mesh-ancestor
101765731|NCT00963664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765732|NCT00963664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101765733|NCT00963664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101765734|NCT00963664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101765735|NCT00611559|PENTA|penta|mesh-list
101765736|NCT00611559|Anticoagulants|anticoagulants|mesh-ancestor
101765737|NCT00611559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101765738|NCT00611559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101765739|NCT00611559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765740|NCT00761904|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101765741|NCT00761904|Simvastatin|simvastatin|mesh-list
101765742|NCT00761904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101765743|NCT00761904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101765744|NCT00761904|Antimetabolites|antimetabolites|mesh-ancestor
101765745|NCT00761904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765746|NCT00761904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101765747|NCT00761904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101765748|NCT00761904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101765749|NCT00761904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101765750|NCT00761904|Diuretics|diuretics|mesh-ancestor
101765751|NCT00761904|Natriuretic Agents|natriuretic agents|mesh-ancestor
101765752|NCT00761904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564635|NCT01134315|Micronutrients|micronutrients|mesh-ancestor
101564636|NCT01134315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101564637|NCT01216176|Anastrozole|anastrozole|mesh-list
101564638|NCT01216176|Saracatinib|saracatinib|mesh-list
101564639|NCT01216176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101564640|NCT01216176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101564641|NCT01216176|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101564642|NCT01216176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101564643|NCT01216176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101564644|NCT01216176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412892|NCT00119210|Dopamine Agents|dopamine agents|mesh-ancestor
101765765|NCT00963976|Adrenergic Agents|adrenergic agents|mesh-ancestor
101765766|NCT00963976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101765767|NCT00963976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765768|NCT00963976|Sympathomimetics|sympathomimetics|mesh-ancestor
101765769|NCT00963976|Autonomic Agents|autonomic agents|mesh-ancestor
101765770|NCT00963976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101765771|NCT00963976|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101765772|NCT00963976|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101765773|NCT00963976|Vasodilator Agents|vasodilator agents|mesh-ancestor
101765775|NCT02558868|Irinotecan|irinotecan|mesh-list
101765776|NCT02558868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101765777|NCT02558868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101765778|NCT02558868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101765779|NCT02558868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101765780|NCT02558868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765781|NCT00611247|Temozolomide|temozolomide|mesh-list
101765782|NCT00611247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101765783|NCT00611247|Alkylating Agents|alkylating agents|mesh-ancestor
101765784|NCT00611247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765785|NCT00611247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101765786|NCT00883935|Ritonavir|ritonavir|mesh-list
101765787|NCT00883935|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101765788|NCT00883935|Dolutegravir|dolutegravir|mesh-list
101765789|NCT00883935|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101765790|NCT00883935|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101765791|NCT00883935|Protease Inhibitors|protease inhibitors|mesh-ancestor
101765792|NCT00883935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101765793|NCT00883935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765794|NCT00883935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101765795|NCT00883935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101765796|NCT00883935|Antiviral Agents|antiviral agents|mesh-ancestor
101765797|NCT00883935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101765798|NCT00883935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101765799|NCT00883935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101765800|NCT00883935|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101765801|NCT00883935|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101765802|NCT00675948|Nabiximols|nabiximols|mesh-list
101765803|NCT00675948|Analgesics|analgesics|mesh-ancestor
101765804|NCT00675948|Sensory System Agents|sensory system agents|mesh-ancestor
101765805|NCT00675948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101765806|NCT00675948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765807|NCT00885885|Panitumumab|panitumumab|mesh-list
101765808|NCT00885885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101765809|NCT00885885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101765810|NCT00610935|Peramivir|peramivir|mesh-list
101765811|NCT00610935|Antiviral Agents|antiviral agents|mesh-ancestor
101765812|NCT00610935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101765813|NCT00610935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101765814|NCT00610935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765825|NCT00762060|Anesthetics, Local|anesthetics, local|mesh-list
101765826|NCT00762060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101765827|NCT00762060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765828|NCT00762060|Sensory System Agents|sensory system agents|mesh-ancestor
101564645|NCT01216176|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101564646|NCT01216176|Hormone Antagonists|hormone antagonists|mesh-ancestor
101564647|NCT01216176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101564648|NCT01216176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564649|NCT01133847|Guanfacine|guanfacine|mesh-list
101564650|NCT01133847|Methylphenidate|methylphenidate|mesh-list
101564651|NCT01133847|Amphetamine|amphetamine|mesh-list
101564652|NCT01133847|Adderall|adderall|mesh-list
101564653|NCT01133847|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101765829|NCT00762060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101202524|NCT01410708|Dasatinib|dasatinib|mesh-list
101765830|NCT00610857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101765832|NCT00610857|Immunoglobulins|immunoglobulins|mesh-list
101765833|NCT00610857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101765834|NCT00610857|Immunologic Factors|immunologic factors|mesh-ancestor
101765835|NCT00610857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765836|NCT00610857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101765837|NCT00672984|Moxifloxacin|moxifloxacin|mesh-list
101765838|NCT00672984|Guanfacine|guanfacine|mesh-list
101765839|NCT00672984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101765840|NCT00672984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101765841|NCT00672984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101765842|NCT00672984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101765843|NCT00672984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101765844|NCT00672984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765845|NCT00672984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101765846|NCT00672984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765847|NCT00672984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101765848|NCT00672984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101765849|NCT00672984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101765850|NCT00672984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101765851|NCT00672984|Adrenergic Agents|adrenergic agents|mesh-ancestor
101765852|NCT00672984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101765853|NCT02543697|Epinephrine|epinephrine|mesh-list
101765854|NCT02543697|Racepinephrine|racepinephrine|mesh-list
101765855|NCT02543697|Epinephryl borate|epinephryl borate|mesh-list
101765856|NCT02543697|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101765857|NCT02543697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101765858|NCT02543697|Adrenergic Agents|adrenergic agents|mesh-ancestor
101765859|NCT02543697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101765860|NCT02543697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765861|NCT02543697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765862|NCT02543697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101765863|NCT02543697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101765864|NCT02543697|Autonomic Agents|autonomic agents|mesh-ancestor
101765865|NCT02543697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101765866|NCT02543697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101765867|NCT02543697|Respiratory System Agents|respiratory system agents|mesh-ancestor
101765868|NCT02543697|Mydriatics|mydriatics|mesh-ancestor
101765869|NCT02543697|Sympathomimetics|sympathomimetics|mesh-ancestor
101765870|NCT02543697|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101765871|NCT00886275|Midazolam|midazolam|mesh-list
101765872|NCT00886275|Dexmedetomidine|dexmedetomidine|mesh-list
101765873|NCT00886275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101765874|NCT00886275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101765875|NCT00886275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765876|NCT00886275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101765877|NCT00886275|Analgesics|analgesics|mesh-ancestor
101765878|NCT00886275|Sensory System Agents|sensory system agents|mesh-ancestor
101765879|NCT00886275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101765884|NCT00886275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101765885|NCT00886275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765886|NCT00886275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101765887|NCT00886275|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101765888|NCT00886275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101765889|NCT00886275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101765890|NCT00886275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101564654|NCT01133847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101564655|NCT01133847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564656|NCT01133847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101564657|NCT01133847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101412910|NCT00479908|Sildenafil Citrate|sildenafil citrate|mesh-list
101765891|NCT00886275|Anesthetics, General|anesthetics, general|mesh-ancestor
101765892|NCT00886275|Anesthetics|anesthetics|mesh-ancestor
101765893|NCT00886275|GABA Modulators|gaba modulators|mesh-ancestor
101765894|NCT00886275|GABA Agents|gaba agents|mesh-ancestor
101765895|NCT04017897|Pembrolizumab|pembrolizumab|mesh-list
101765896|NCT04017897|Nivolumab|nivolumab|mesh-list
101765897|NCT04017897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101765898|NCT04017897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101765899|NCT04017897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101765900|NCT04017897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765901|NCT02542137|Thymalfasin|thymalfasin|mesh-list
101765902|NCT02542137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101765903|NCT02542137|Immunologic Factors|immunologic factors|mesh-ancestor
101765904|NCT02542137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765905|NCT00886509|Lenograstim|lenograstim|mesh-list
101765906|NCT00886509|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101765907|NCT00886509|Immunologic Factors|immunologic factors|mesh-ancestor
101765908|NCT00886509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765909|NCT02543385|Ketamine|ketamine|mesh-list
101765910|NCT02543385|Esketamine|esketamine|mesh-list
101765911|NCT02543385|Analgesics|analgesics|mesh-ancestor
101765912|NCT02543385|Sensory System Agents|sensory system agents|mesh-ancestor
101765913|NCT02543385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101765914|NCT02543385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765915|NCT02543385|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101765916|NCT02543385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101765917|NCT02543385|Anesthetics, General|anesthetics, general|mesh-ancestor
101765918|NCT02543385|Anesthetics|anesthetics|mesh-ancestor
101765919|NCT02543385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101765920|NCT02543385|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101765921|NCT02543385|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101765922|NCT02543385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101765923|NCT02543385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765924|NCT02543385|Antidepressive Agents|antidepressive agents|mesh-ancestor
101765925|NCT02543385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101765926|NCT00884481|Natalizumab|natalizumab|mesh-list
101765927|NCT00884481|Immunologic Factors|immunologic factors|mesh-ancestor
101765928|NCT00884481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423364|NCT05731596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101765929|NCT02543229|Ranibizumab|ranibizumab|mesh-list
101765930|NCT02543229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101765931|NCT02543229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101765932|NCT02543229|Growth Substances|growth substances|mesh-ancestor
101765933|NCT02543229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765934|NCT02543229|Growth Inhibitors|growth inhibitors|mesh-ancestor
101765935|NCT02543229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101765936|NCT02543073|Glucocorticoids|glucocorticoids|mesh-list
101765938|NCT02543073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101765939|NCT02543073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765940|NCT00546364|Docetaxel|docetaxel|mesh-list
101765941|NCT00546364|Capecitabine|capecitabine|mesh-list
101765942|NCT00546364|Epothilones|epothilones|mesh-list
101765943|NCT00546364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101765944|NCT00546364|Tubulin Modulators|tubulin modulators|mesh-ancestor
101765945|NCT00546364|Antimitotic Agents|antimitotic agents|mesh-ancestor
101765946|NCT00546364|Mitosis Modulators|mitosis modulators|mesh-ancestor
101765947|NCT00546364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765948|NCT00546364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101765949|NCT00546364|Antimetabolites|antimetabolites|mesh-ancestor
101765950|NCT00887211|Sirolimus|sirolimus|mesh-list
101765951|NCT00887211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101765962|NCT00887367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101765963|NCT00887367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765965|NCT00964288|Anesthetics, Local|anesthetics, local|mesh-ancestor
101765966|NCT00964288|Anesthetics|anesthetics|mesh-ancestor
101564658|NCT01133847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101564659|NCT01133847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564660|NCT01133847|Dopamine Agents|dopamine agents|mesh-ancestor
101564661|NCT01133847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101564662|NCT01133847|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101564663|NCT01133847|Adrenergic Agents|adrenergic agents|mesh-ancestor
101564664|NCT01133847|Sympathomimetics|sympathomimetics|mesh-ancestor
101765967|NCT00964288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101765968|NCT00964288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765969|NCT00964288|Sensory System Agents|sensory system agents|mesh-ancestor
101765970|NCT00964288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101765971|NCT00964288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101765972|NCT00964288|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101765973|NCT00964288|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101765974|NCT00964288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101765975|NCT00964288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765976|NCT05955040|Labetalol|labetalol|mesh-list
101765977|NCT05955040|Nifedipine|nifedipine|mesh-list
101765978|NCT05955040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101765979|NCT05955040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101765980|NCT05955040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765981|NCT05955040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101765982|NCT05955040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765983|NCT05955040|Vasodilator Agents|vasodilator agents|mesh-ancestor
101765984|NCT05955040|Tocolytic Agents|tocolytic agents|mesh-ancestor
101765985|NCT05955040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101765986|NCT05955040|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101765987|NCT05955040|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101765988|NCT05955040|Adrenergic Agents|adrenergic agents|mesh-ancestor
101765989|NCT05955040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101765990|NCT05955040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101765991|NCT05955040|Sympathomimetics|sympathomimetics|mesh-ancestor
101765992|NCT05955040|Autonomic Agents|autonomic agents|mesh-ancestor
101765993|NCT05955040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101765994|NCT05955040|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101765995|NCT05955040|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101765996|NCT05955001|Tadalafil|tadalafil|mesh-list
101765997|NCT05955001|Vasodilator Agents|vasodilator agents|mesh-ancestor
101765998|NCT05955001|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101765999|NCT05955001|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101766000|NCT05955001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101766001|NCT05955001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766002|NCT05955001|Urological Agents|urological agents|mesh-ancestor
101766003|NCT05954910|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
101766005|NCT05954910|Immunologic Factors|immunologic factors|mesh-ancestor
101766006|NCT05954910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766007|NCT05954897|Lenvatinib|lenvatinib|mesh-list
101766008|NCT05954897|Tislelizumab|tislelizumab|mesh-list
101766009|NCT05954897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101766010|NCT05954897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101766011|NCT05954897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101766012|NCT05954897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766013|NCT05954897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101766014|NCT05954806|Antivenins|antivenins|mesh-list
101766015|NCT05954806|Immunologic Factors|immunologic factors|mesh-ancestor
101766019|NCT05954624|Digoxin|digoxin|mesh-list
101766020|NCT05954624|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101766021|NCT05954624|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101766022|NCT05954624|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101766023|NCT05954624|Antimetabolites|antimetabolites|mesh-ancestor
101766024|NCT05954624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766025|NCT05954624|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101766026|NCT05954624|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101766027|NCT05954624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101766028|NCT05954624|Antifungal Agents|antifungal agents|mesh-ancestor
101564665|NCT01133847|Autonomic Agents|autonomic agents|mesh-ancestor
101564666|NCT01133847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101564667|NCT01133847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101564668|NCT01133847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101564669|NCT01133847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101564670|NCT01133847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101564671|NCT01133379|Fluorides|fluorides|mesh-list
101564672|NCT01133379|Cariostatic Agents|cariostatic agents|mesh-ancestor
101564673|NCT01133379|Protective Agents|protective agents|mesh-ancestor
101766029|NCT05954624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101766030|NCT05954624|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101766031|NCT05954624|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101766032|NCT05954624|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101766033|NCT05954624|Hormone Antagonists|hormone antagonists|mesh-ancestor
101766034|NCT05954624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101766035|NCT05954624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766036|NCT05954624|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101766037|NCT05954624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101766038|NCT05954624|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101766039|NCT05954624|Protective Agents|protective agents|mesh-ancestor
101766040|NCT05954624|Uricosuric Agents|uricosuric agents|mesh-ancestor
101766041|NCT05954624|Gout Suppressants|gout suppressants|mesh-ancestor
101766042|NCT05954624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101766043|NCT05954143|Pertuzumab|pertuzumab|mesh-list
101766044|NCT05954143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101766045|NCT05954143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101766046|NCT05954078|Leucovorin|leucovorin|mesh-list
101766047|NCT05954078|Fluorouracil|fluorouracil|mesh-list
101766048|NCT05954078|Oxaliplatin|oxaliplatin|mesh-list
101766049|NCT05954078|Irinotecan|irinotecan|mesh-list
101766050|NCT05954078|Levoleucovorin|levoleucovorin|mesh-list
101766051|NCT05954078|Antimetabolites|antimetabolites|mesh-ancestor
101766052|NCT05954078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766053|NCT05954078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101766054|NCT05954078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101766055|NCT05954078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101766056|NCT05954078|Immunologic Factors|immunologic factors|mesh-ancestor
101766057|NCT05954078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766058|NCT05954078|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101766059|NCT05954078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101766060|NCT05954078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101766061|NCT05954078|Antidotes|antidotes|mesh-ancestor
101766062|NCT05954078|Protective Agents|protective agents|mesh-ancestor
101766063|NCT05954078|Vitamin B Complex|vitamin b complex|mesh-ancestor
101766064|NCT05954078|Vitamins|vitamins|mesh-ancestor
101766065|NCT05954078|Micronutrients|micronutrients|mesh-ancestor
101766066|NCT05953909|Paclitaxel|paclitaxel|mesh-list
101766067|NCT05953909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101766068|NCT05953909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101766069|NCT05953909|Tubulin Modulators|tubulin modulators|mesh-ancestor
101766070|NCT05953909|Antimitotic Agents|antimitotic agents|mesh-ancestor
101766071|NCT05953909|Mitosis Modulators|mitosis modulators|mesh-ancestor
101766072|NCT05953909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766073|NCT05953896|Hyaluronic Acid|hyaluronic acid|mesh-list
101766074|NCT05953896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101766075|NCT05953896|Immunologic Factors|immunologic factors|mesh-ancestor
101766076|NCT05953896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766077|NCT05953896|Viscosupplements|viscosupplements|mesh-ancestor
101263802|NCT01763788|Gemcitabine|gemcitabine|mesh-list
101766078|NCT05953896|Protective Agents|protective agents|mesh-ancestor
101766079|NCT05953714|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
101766080|NCT05953714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101766081|NCT05953675|Ethanol|ethanol|mesh-list
101766082|NCT05953675|Heparin|heparin|mesh-list
101766083|NCT05953675|Anticoagulants|anticoagulants|mesh-ancestor
101766084|NCT05953675|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101766085|NCT05953675|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101766086|NCT05953675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564674|NCT01133379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564675|NCT04253353|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101564676|NCT04253353|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101564677|NCT04253353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101564678|NCT04253353|Antimetabolites|antimetabolites|mesh-ancestor
101564679|NCT04253353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564680|NCT04253353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101766087|NCT05953675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101766088|NCT05953675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101766117|NCT05953350|Antimalarials|antimalarials|mesh-ancestor
101766118|NCT05953350|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101766119|NCT05953350|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101766120|NCT05953350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101766121|NCT05953350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101766122|NCT05953350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766123|NCT05953350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101766124|NCT05953350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101766125|NCT05953350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101766126|NCT05950802|Cyclophosphamide|cyclophosphamide|mesh-list
101766127|NCT05950802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101766128|NCT05950802|Immunologic Factors|immunologic factors|mesh-ancestor
101766129|NCT05950802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766130|NCT05950802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101766131|NCT05950802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101766132|NCT05950802|Alkylating Agents|alkylating agents|mesh-ancestor
101766133|NCT05950802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766145|NCT05938608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101766146|NCT05928312|Oxaliplatin|oxaliplatin|mesh-list
101766147|NCT05928312|Irinotecan|irinotecan|mesh-list
101766148|NCT05928312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101766149|NCT05928312|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101766150|NCT05928312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101766151|NCT05928312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101766152|NCT05928312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766153|NCT05921760|Nivolumab|nivolumab|mesh-list
101766154|NCT05921760|Ipilimumab|ipilimumab|mesh-list
101766155|NCT05921760|Ivosidenib|ivosidenib|mesh-list
101766156|NCT05921760|Glycine|glycine|mesh-list
101766157|NCT05921760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101766158|NCT05921760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101766159|NCT05921760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101766160|NCT05921760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766161|NCT05921760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101766162|NCT05921760|Glycine Agents|glycine agents|mesh-ancestor
101766163|NCT05921760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101766164|NCT05921760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766165|NCT05919147|Pioglitazone|pioglitazone|mesh-list
101766166|NCT05919147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101766167|NCT05919147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766168|NCT05919030|Paclitaxel|paclitaxel|mesh-list
101766169|NCT05919030|Tislelizumab|tislelizumab|mesh-list
101766170|NCT05919030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101766171|NCT05919030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101766172|NCT05919030|Tubulin Modulators|tubulin modulators|mesh-ancestor
101766173|NCT05919030|Antimitotic Agents|antimitotic agents|mesh-ancestor
101766174|NCT05919030|Mitosis Modulators|mitosis modulators|mesh-ancestor
101766175|NCT05919030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766176|NCT05919030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101766177|NCT05917509|Rilpivirine|rilpivirine|mesh-list
101766178|NCT05917509|Cabotegravir|cabotegravir|mesh-list
101766179|NCT05917509|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101766180|NCT05917509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101766181|NCT05917509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101766182|NCT05917509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766183|NCT05917509|Antiviral Agents|antiviral agents|mesh-ancestor
101766184|NCT05917509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101766185|NCT05917509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101564681|NCT04253353|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101564682|NCT04253353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101564683|NCT05154669|Nicotine|nicotine|mesh-list
101564684|NCT05154669|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101564685|NCT05154669|Autonomic Agents|autonomic agents|mesh-ancestor
101564686|NCT05154669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101564687|NCT05154669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412937|NCT00480142|Oxycodone|oxycodone|mesh-list
101766186|NCT05917509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101766187|NCT05917509|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101766188|NCT05917509|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101766189|NCT05895201|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101766190|NCT05895201|Cyclophosphamide|cyclophosphamide|mesh-list
101766191|NCT05895201|Bortezomib|bortezomib|mesh-list
101766192|NCT05895201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101766193|NCT05895201|Immunologic Factors|immunologic factors|mesh-ancestor
101766194|NCT05895201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766195|NCT05895201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101766196|NCT05895201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101766197|NCT05895201|Alkylating Agents|alkylating agents|mesh-ancestor
101766198|NCT05895201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766199|NCT05895201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101766200|NCT05895201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101766201|NCT05895201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101766202|NCT05895201|Incretins|incretins|mesh-ancestor
101766203|NCT05895201|Hormones|hormones|mesh-ancestor
101766204|NCT05895201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101766205|NCT05895201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101766206|NCT05895201|Protease Inhibitors|protease inhibitors|mesh-ancestor
101766207|NCT05895201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101766208|NCT05890027|Phenylephrine|phenylephrine|mesh-list
101766209|NCT05890027|Oxymetazoline|oxymetazoline|mesh-list
101766219|NCT05890027|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101766220|NCT05890027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101766221|NCT05890027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101766222|NCT05890027|Adrenergic Agents|adrenergic agents|mesh-ancestor
101766223|NCT05890027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101766224|NCT05890027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766225|NCT05890027|Protective Agents|protective agents|mesh-ancestor
101766226|NCT05870956|Nintedanib|nintedanib|mesh-list
101766227|NCT05870956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101766228|NCT05870956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101766229|NCT05870956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101766230|NCT05870956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766231|NCT05866354|Tisotumab vedotin|tisotumab vedotin|mesh-list
101766232|NCT05866354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101766233|NCT05866354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101766234|NCT05864209|Bisphenol A|bisphenol a|mesh-list
101766235|NCT05864209|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101766236|NCT05864209|Estrogens|estrogens|mesh-ancestor
101766237|NCT05864209|Hormones|hormones|mesh-ancestor
101766238|NCT05864209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101766239|NCT05864209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766240|NCT05864209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101766241|NCT05864209|Antioxidants|antioxidants|mesh-ancestor
101766242|NCT05864209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766243|NCT05864209|Protective Agents|protective agents|mesh-ancestor
101766244|NCT05852769|Flurbiprofen|flurbiprofen|mesh-list
101766245|NCT05852769|Digoxin|digoxin|mesh-list
101766246|NCT05852769|Midazolam|midazolam|mesh-list
101766247|NCT05852769|Caffeine|caffeine|mesh-list
101766248|NCT05852769|Omeprazole|omeprazole|mesh-list
101766249|NCT05852769|Pravastatin|pravastatin|mesh-list
101766250|NCT05852769|Montelukast|montelukast|mesh-list
101766251|NCT05852769|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101766252|NCT05852769|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101766253|NCT05852769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101766254|NCT05852769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564689|NCT05154669|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101564690|NCT05154669|Cholinergic Agents|cholinergic agents|mesh-ancestor
101564691|NCT05154669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101564692|NCT05154669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564693|NCT00637455|Fexofenadine|fexofenadine|mesh-list
101564694|NCT00637455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101564695|NCT00637455|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101564696|NCT00637455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101564697|NCT00637455|Histamine Antagonists|histamine antagonists|mesh-ancestor
101564698|NCT00637455|Histamine Agents|histamine agents|mesh-ancestor
101564699|NCT00637455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101564700|NCT00637455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766255|NCT05852769|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101766256|NCT05852769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101766257|NCT05852769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101766258|NCT05852769|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101766259|NCT05852769|Anesthetics, General|anesthetics, general|mesh-ancestor
101766260|NCT05852769|Anesthetics|anesthetics|mesh-ancestor
101766261|NCT05852769|GABA Modulators|gaba modulators|mesh-ancestor
101766262|NCT05852769|GABA Agents|gaba agents|mesh-ancestor
101766263|NCT05852769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101766264|NCT05852769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766265|NCT05852769|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101766266|NCT05852769|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101766267|NCT05852769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101766268|NCT05852769|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101766269|NCT05852769|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101766270|NCT05852769|Purinergic Agents|purinergic agents|mesh-ancestor
101766271|NCT05852769|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101766272|NCT05852769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101766273|NCT05852769|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101766274|NCT05852769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101766275|NCT05852769|Respiratory System Agents|respiratory system agents|mesh-ancestor
101766276|NCT05852769|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101766295|NCT05852769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101766296|NCT05852769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101766298|NCT05848765|Cyclophosphamide|cyclophosphamide|mesh-list
101766299|NCT05848765|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101766300|NCT05848765|Rituximab|rituximab|mesh-list
101766301|NCT05848765|Doxorubicin|doxorubicin|mesh-list
101766302|NCT05848765|Vincristine|vincristine|mesh-list
101766303|NCT05848765|Lenalidomide|lenalidomide|mesh-list
101766304|NCT05848765|Obinutuzumab|obinutuzumab|mesh-list
101766305|NCT05848765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101766306|NCT05848765|Immunologic Factors|immunologic factors|mesh-ancestor
101766307|NCT05848765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766308|NCT05848765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101766309|NCT05848765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101766310|NCT05848765|Alkylating Agents|alkylating agents|mesh-ancestor
101766311|NCT05848765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202915|NCT01413620|Antioxidants|antioxidants|mesh-ancestor
101766312|NCT05848765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101766313|NCT05848765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101766314|NCT05848765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101766315|NCT05848765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101766316|NCT05848765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101766317|NCT05848765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101766318|NCT05848765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101766319|NCT05848765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101766320|NCT05848765|Glucocorticoids|glucocorticoids|mesh-ancestor
101766321|NCT05848765|Hormones|hormones|mesh-ancestor
101766322|NCT05848765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101766323|NCT05848765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101564701|NCT00637455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564702|NCT00919711|Denosumab|denosumab|mesh-list
101564703|NCT00919711|Risedronic Acid|risedronic acid|mesh-list
101564704|NCT00919711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101564705|NCT00919711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766324|NCT05848765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101766325|NCT05848765|Tubulin Modulators|tubulin modulators|mesh-ancestor
101766326|NCT05848765|Antimitotic Agents|antimitotic agents|mesh-ancestor
101766327|NCT05848765|Mitosis Modulators|mitosis modulators|mesh-ancestor
101766328|NCT05848765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101766329|NCT05848765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101766330|NCT05848765|Growth Substances|growth substances|mesh-ancestor
101766344|NCT05836753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101766345|NCT05836753|Dermatologic Agents|dermatologic agents|mesh-ancestor
101766346|NCT05827211|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101766347|NCT05827211|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101766348|NCT05827211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101766349|NCT05827211|Antitubercular Agents|antitubercular agents|mesh-ancestor
101766350|NCT05822063|Lidocaine|lidocaine|mesh-list
101766351|NCT05822063|Anesthetics, Local|anesthetics, local|mesh-ancestor
101766352|NCT05822063|Anesthetics|anesthetics|mesh-ancestor
101766353|NCT05822063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101766354|NCT05822063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766355|NCT05822063|Sensory System Agents|sensory system agents|mesh-ancestor
101766356|NCT05822063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101766357|NCT05822063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101766358|NCT05822063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101766359|NCT05822063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101766360|NCT05822063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101766361|NCT05822063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766362|NCT05820503|Anesthetics|anesthetics|mesh-list
101766363|NCT05820503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101766364|NCT05820503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766365|NCT05817097|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
101766366|NCT05817097|Protease Inhibitors|protease inhibitors|mesh-ancestor
101766367|NCT05817097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101766368|NCT05817097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766369|NCT05817097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101766370|NCT05817097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766371|NCT05814354|Paclitaxel|paclitaxel|mesh-list
101766372|NCT05814354|Gemcitabine|gemcitabine|mesh-list
101766373|NCT05814354|Capecitabine|capecitabine|mesh-list
101766374|NCT05814354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101766375|NCT05814354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101766376|NCT05814354|Tubulin Modulators|tubulin modulators|mesh-ancestor
101766377|NCT05814354|Antimitotic Agents|antimitotic agents|mesh-ancestor
101766378|NCT05814354|Mitosis Modulators|mitosis modulators|mesh-ancestor
101766379|NCT05814354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766380|NCT05814354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101766381|NCT05814354|Antimetabolites|antimetabolites|mesh-ancestor
101766383|NCT05794659|Carboplatin|carboplatin|mesh-list
101766384|NCT05794659|Molgramostim|molgramostim|mesh-list
101766385|NCT05794659|Sargramostim|sargramostim|mesh-list
101766386|NCT05794659|Immunologic Factors|immunologic factors|mesh-ancestor
101766387|NCT05794659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766388|NCT05794659|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101766389|NCT05794659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101766390|NCT05794659|Tubulin Modulators|tubulin modulators|mesh-ancestor
101766391|NCT05794659|Antimitotic Agents|antimitotic agents|mesh-ancestor
101766392|NCT05794659|Mitosis Modulators|mitosis modulators|mesh-ancestor
101451751|NCT00226200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101766398|NCT05791565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101766399|NCT05791565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766400|NCT05791565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101766401|NCT05791565|Respiratory System Agents|respiratory system agents|mesh-ancestor
101766402|NCT05791565|Tocolytic Agents|tocolytic agents|mesh-ancestor
101766403|NCT05791565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101766404|NCT05791565|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101766405|NCT05791565|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101564706|NCT00919711|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101564707|NCT00919711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101564708|NCT00919711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564709|NCT00919711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101564710|NCT01131585|Ranibizumab|ranibizumab|mesh-list
101564711|NCT01131585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101564712|NCT01131585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101564713|NCT01131585|Growth Substances|growth substances|mesh-ancestor
101766406|NCT05791565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101766407|NCT05791565|Adrenergic Agents|adrenergic agents|mesh-ancestor
101766408|NCT05791565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101766409|NCT05791565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766410|NCT05791565|Anesthetics|anesthetics|mesh-ancestor
101766411|NCT05791565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101766412|NCT05776927|Fluticasone|fluticasone|mesh-list
101766414|NCT05776927|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101766415|NCT05776927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101766416|NCT05776927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101766417|NCT05776927|Autonomic Agents|autonomic agents|mesh-ancestor
101766418|NCT05776927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101766419|NCT05776927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766420|NCT05776927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101766421|NCT05776927|Respiratory System Agents|respiratory system agents|mesh-ancestor
101766422|NCT05776927|Dermatologic Agents|dermatologic agents|mesh-ancestor
101766423|NCT05776927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101766424|NCT05776927|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101766425|NCT05776927|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101766426|NCT05776927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101766427|NCT05776927|Adrenergic Agents|adrenergic agents|mesh-ancestor
101766428|NCT05776927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101766429|NCT05776927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766442|NCT05771584|Sargramostim|sargramostim|mesh-list
101766443|NCT05771584|Immunologic Factors|immunologic factors|mesh-ancestor
101766444|NCT05771584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766445|NCT05761041|Listerine|listerine|mesh-list
101766446|NCT05761041|Fluorides|fluorides|mesh-list
101766447|NCT05761041|Sodium Fluoride|sodium fluoride|mesh-list
101766448|NCT05761041|Fluorides, Topical|fluorides, topical|mesh-list
101766449|NCT05761041|Cariostatic Agents|cariostatic agents|mesh-ancestor
101766450|NCT05761041|Protective Agents|protective agents|mesh-ancestor
101766451|NCT05761041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766452|NCT05761041|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101766453|NCT05761041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101766454|NCT05753436|Curcumin|curcumin|mesh-list
101766455|NCT05753436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101766456|NCT05753436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101766457|NCT05753436|Analgesics|analgesics|mesh-ancestor
101766458|NCT05753436|Sensory System Agents|sensory system agents|mesh-ancestor
101766459|NCT05753436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101766460|NCT05753436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766461|NCT05753436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101766462|NCT05753436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101766463|NCT05753436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101766464|NCT05753436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101766465|NCT05753436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766466|NCT05750966|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101766468|NCT05750966|Gentamicins|gentamicins|mesh-list
101766469|NCT05750966|Ceftriaxone|ceftriaxone|mesh-list
101766470|NCT05750966|Cefuroxime|cefuroxime|mesh-list
101766471|NCT05750966|Cefuroxime axetil|cefuroxime axetil|mesh-list
101766472|NCT05750966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101766473|NCT05750966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101766474|NCT05750966|Antitubercular Agents|antitubercular agents|mesh-ancestor
101766475|NCT05750966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101766476|NCT05750966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101766491|NCT05660746|Dermatologic Agents|dermatologic agents|mesh-ancestor
101564714|NCT01131585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564715|NCT01131585|Growth Inhibitors|growth inhibitors|mesh-ancestor
101564716|NCT01131585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101564717|NCT01131507|Pancrelipase|pancrelipase|mesh-list
101564718|NCT01131507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101564719|NCT00919633|Interferons|interferons|mesh-list
101564720|NCT00919633|Ribavirin|ribavirin|mesh-list
101564721|NCT00919633|Interferon-alpha|interferon-alpha|mesh-list
101564722|NCT00919633|Interferon alpha-2|interferon alpha-2|mesh-list
101564723|NCT00919633|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101564724|NCT00919633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564725|NCT00919633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101564726|NCT00919633|Antiviral Agents|antiviral agents|mesh-ancestor
101564727|NCT00919633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101564728|NCT00919633|Antimetabolites|antimetabolites|mesh-ancestor
101564729|NCT00919633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564730|NCT00919633|Immunologic Factors|immunologic factors|mesh-ancestor
101564731|NCT00926029|Listerine|listerine|mesh-list
101564732|NCT00926029|Triclosan|triclosan|mesh-list
101564733|NCT00926029|Fluorides|fluorides|mesh-list
101564734|NCT00926029|Sodium Fluoride|sodium fluoride|mesh-list
101564735|NCT00926029|Cariostatic Agents|cariostatic agents|mesh-ancestor
101412967|NCT00480298|Methylprednisolone|methylprednisolone|mesh-list
101412968|NCT00480298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101412969|NCT00480298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101766492|NCT05660746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101766493|NCT05660746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101766494|NCT05658380|Atropine|atropine|mesh-list
101766495|NCT05658380|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101766496|NCT05658380|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101766497|NCT05658380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101766498|NCT05658380|Autonomic Agents|autonomic agents|mesh-ancestor
101766499|NCT05658380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101766500|NCT05658380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766501|NCT05658380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101766502|NCT05658380|Respiratory System Agents|respiratory system agents|mesh-ancestor
101766503|NCT05658380|Mydriatics|mydriatics|mesh-ancestor
101766504|NCT05658380|Parasympatholytics|parasympatholytics|mesh-ancestor
101766505|NCT05658380|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101766506|NCT05658380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101766507|NCT05658380|Cholinergic Agents|cholinergic agents|mesh-ancestor
101766508|NCT05658380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101766509|NCT05658380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766510|NCT05610319|Faricimab|faricimab|mesh-list
101766511|NCT05610319|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101766512|NCT05610319|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101766513|NCT05610319|Growth Substances|growth substances|mesh-ancestor
101766514|NCT05610319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766515|NCT05610319|Growth Inhibitors|growth inhibitors|mesh-ancestor
101766516|NCT05610319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101766517|NCT05551104|Labetalol|labetalol|mesh-list
101766518|NCT05551104|Nifedipine|nifedipine|mesh-list
101766519|NCT05551104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101766520|NCT05551104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101564736|NCT00926029|Protective Agents|protective agents|mesh-ancestor
101564737|NCT00926029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564738|NCT00926029|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101564739|NCT00926029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101564740|NCT00926029|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101564741|NCT00926029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101564742|NCT00926029|Antimetabolites|antimetabolites|mesh-ancestor
101412988|NCT00480376|Ofloxacin|ofloxacin|mesh-list
101766521|NCT05551104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766522|NCT05551104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101766526|NCT05551104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101766527|NCT05551104|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101766528|NCT05551104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101766529|NCT05551104|Adrenergic Agents|adrenergic agents|mesh-ancestor
101766530|NCT05551104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101407702|NCT00441415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101766531|NCT05551104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101766533|NCT05551104|Autonomic Agents|autonomic agents|mesh-ancestor
101766534|NCT05551104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101766535|NCT05551104|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101766557|NCT05494762|Tislelizumab|tislelizumab|mesh-list
101766558|NCT05494762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101766559|NCT05494762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101766560|NCT05473273|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101766561|NCT05473273|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101766562|NCT05473273|Estradiol|estradiol|mesh-list
101766563|NCT05473273|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101766564|NCT05473273|Progesterone|progesterone|mesh-list
101766565|NCT05473273|Estrogens|estrogens|mesh-ancestor
101766566|NCT05473273|Hormones|hormones|mesh-ancestor
101766567|NCT05473273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101766568|NCT05473273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766569|NCT05473273|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101766570|NCT05473273|Contraceptive Agents|contraceptive agents|mesh-ancestor
101766571|NCT05473273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101766572|NCT05473273|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101766573|NCT05473273|Progestins|progestins|mesh-ancestor
101766574|NCT05464680|Dimercaprol|dimercaprol|mesh-list
101766575|NCT05464680|Chelating Agents|chelating agents|mesh-ancestor
101766576|NCT05464680|Sequestering Agents|sequestering agents|mesh-ancestor
101766577|NCT05464680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766607|NCT05389813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766608|NCT05389813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101766609|NCT05389813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101766610|NCT05389813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101766611|NCT05389813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101766612|NCT05389813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101766613|NCT05389813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101766614|NCT05389813|Narcotics|narcotics|mesh-ancestor
101766615|NCT05387811|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
101766616|NCT05387811|Diuretics|diuretics|mesh-list
101766617|NCT05387811|Natriuretic Agents|natriuretic agents|mesh-ancestor
101766618|NCT05387811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766619|NCT05374512|Paclitaxel|paclitaxel|mesh-list
101766620|NCT05374512|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101766621|NCT05374512|Carboplatin|carboplatin|mesh-list
101766622|NCT05374512|Capecitabine|capecitabine|mesh-list
101766623|NCT05374512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101766624|NCT05374512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101766625|NCT05374512|Tubulin Modulators|tubulin modulators|mesh-ancestor
101766626|NCT05374512|Antimitotic Agents|antimitotic agents|mesh-ancestor
101766627|NCT05374512|Mitosis Modulators|mitosis modulators|mesh-ancestor
101766628|NCT05374512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766629|NCT05374512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101766630|NCT05374512|Antimetabolites|antimetabolites|mesh-ancestor
101766631|NCT05341167|Phenylephrine|phenylephrine|mesh-list
101766632|NCT05341167|Oxymetazoline|oxymetazoline|mesh-list
101564743|NCT00926029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564744|NCT00926029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101564745|NCT04254835|Chlorhexidine, thymol drug combination|chlorhexidine, thymol drug combination|mesh-list
101564746|NCT04254835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101564747|NCT04254835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101564748|NCT04254913|Edaravone|edaravone|mesh-list
101564749|NCT04254913|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101564750|NCT04254913|Antioxidants|antioxidants|mesh-ancestor
101564751|NCT04254913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564752|NCT04254913|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101564753|NCT04254913|Protective Agents|protective agents|mesh-ancestor
101766633|NCT05341167|Norepinephrine|norepinephrine|mesh-list
101766634|NCT05341167|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101766635|NCT05341167|Mydriatics|mydriatics|mesh-ancestor
101766636|NCT05341167|Autonomic Agents|autonomic agents|mesh-ancestor
101766637|NCT05341167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101766638|NCT05341167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766639|NCT05341167|Sympathomimetics|sympathomimetics|mesh-ancestor
101766640|NCT05341167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101766641|NCT05341167|Nasal Decongestants|nasal decongestants|mesh-ancestor
101766642|NCT05341167|Respiratory System Agents|respiratory system agents|mesh-ancestor
101766643|NCT05341167|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101766644|NCT05341167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101203191|NCT01415778|Bicalutamide|bicalutamide|mesh-list
101766645|NCT05341167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101766646|NCT05341167|Adrenergic Agents|adrenergic agents|mesh-ancestor
101766647|NCT05341167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101766648|NCT05341167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766649|NCT05341167|Protective Agents|protective agents|mesh-ancestor
101766650|NCT05312970|Polidocanol|polidocanol|mesh-list
101766651|NCT05312970|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
101766652|NCT05312970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101766653|NCT05308979|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101766654|NCT05308979|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101766655|NCT05308979|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101766656|NCT05308979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101766657|NCT05308979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766658|NCT05308979|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101766659|NCT05308979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101766660|NCT05308979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766661|NCT05308979|Cholinergic Agents|cholinergic agents|mesh-ancestor
101766662|NCT05308979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101766663|NCT05293132|Ubiquinone|ubiquinone|mesh-list
101766664|NCT05293132|Coenzyme Q10|coenzyme q10|mesh-list
101766665|NCT05293132|Montelukast|montelukast|mesh-list
101766667|NCT05293132|Respiratory System Agents|respiratory system agents|mesh-ancestor
101766668|NCT05293132|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101766670|NCT05293132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101766671|NCT05293132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263810|NCT01764087|Tirbanibulin|tirbanibulin|mesh-list
101766672|NCT05293132|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101766673|NCT05293132|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101766674|NCT05293132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766675|NCT05293132|Micronutrients|micronutrients|mesh-ancestor
101766676|NCT05293132|Vitamins|vitamins|mesh-ancestor
101766677|NCT05288361|Acetylcholine|acetylcholine|mesh-list
101766678|NCT05288361|Vasodilator Agents|vasodilator agents|mesh-ancestor
101766679|NCT05288361|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101766680|NCT05288361|Cholinergic Agents|cholinergic agents|mesh-ancestor
101424124|NCT03815019|Megestrol|megestrol|mesh-list
101766681|NCT05288361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101766682|NCT05288361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766683|NCT05288361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766685|NCT05288283|Anticonvulsants|anticonvulsants|mesh-ancestor
101564754|NCT04254913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564755|NCT01130493|Levodopa|levodopa|mesh-list
101564756|NCT01130493|Carbidopa|carbidopa|mesh-list
101564757|NCT01130493|Entacapone|entacapone|mesh-list
101564758|NCT01130493|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101564759|NCT01130493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101564760|NCT01130493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101564761|NCT01130493|Dopamine Agents|dopamine agents|mesh-ancestor
101564762|NCT01130493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101564763|NCT01130493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564764|NCT01130493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564765|NCT01130493|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101564766|NCT01130493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101413006|NCT00117702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101766686|NCT05257590|Nivolumab|nivolumab|mesh-list
101766687|NCT05257590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101766688|NCT05257590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101766689|NCT05257590|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101766690|NCT05257590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766691|NCT05239169|Capecitabine|capecitabine|mesh-list
101766692|NCT05239169|Durvalumab|durvalumab|mesh-list
101766693|NCT05239169|Tremelimumab|tremelimumab|mesh-list
101534612|NCT04575675|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101766694|NCT05239169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101766695|NCT05239169|Antimetabolites|antimetabolites|mesh-ancestor
101766696|NCT05239169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766697|NCT05239169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101766698|NCT05239169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101766699|NCT05231980|Thioctic Acid|thioctic acid|mesh-list
101766700|NCT05231980|Pentoxifylline|pentoxifylline|mesh-list
101766701|NCT05231980|Clomiphene|clomiphene|mesh-list
101766702|NCT05231980|Enclomiphene|enclomiphene|mesh-list
101766703|NCT05231980|Zuclomiphene|zuclomiphene|mesh-list
101766704|NCT05231980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766705|NCT05231980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101766706|NCT05231980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101766707|NCT05231980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101766708|NCT05231980|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101766709|NCT05231980|Protective Agents|protective agents|mesh-ancestor
101766710|NCT05231980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766711|NCT05231980|Vasodilator Agents|vasodilator agents|mesh-ancestor
101766712|NCT05231980|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101766713|NCT05231980|Antioxidants|antioxidants|mesh-ancestor
101766714|NCT05231980|Vitamin B Complex|vitamin b complex|mesh-ancestor
101766715|NCT05231980|Vitamins|vitamins|mesh-ancestor
101766716|NCT05231980|Micronutrients|micronutrients|mesh-ancestor
101766717|NCT05231980|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101766718|NCT05231980|Hormone Antagonists|hormone antagonists|mesh-ancestor
101766719|NCT05231980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101766720|NCT05231980|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101766721|NCT05231980|Fertility Agents|fertility agents|mesh-ancestor
101766722|NCT05231980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101766723|NCT05231980|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101766724|NCT05231980|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101766725|NCT05215158|Dexmedetomidine|dexmedetomidine|mesh-list
101766726|NCT05215158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101766727|NCT05215158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101766728|NCT05215158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766729|NCT05215158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101766730|NCT05215158|Analgesics|analgesics|mesh-ancestor
101766731|NCT05215158|Sensory System Agents|sensory system agents|mesh-ancestor
101766732|NCT05215158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101564767|NCT01130493|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101564768|NCT01130493|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101564769|NCT01130493|Immunologic Factors|immunologic factors|mesh-ancestor
101564770|NCT01130493|Dopamine Agonists|dopamine agonists|mesh-ancestor
101564771|NCT01130337|Capecitabine|capecitabine|mesh-list
101564772|NCT01130337|Oxaliplatin|oxaliplatin|mesh-list
101564773|NCT01130337|Trastuzumab|trastuzumab|mesh-list
101564774|NCT01130337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101766733|NCT05215158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101766734|NCT05215158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101766735|NCT05215158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101766736|NCT05215158|Adrenergic Agents|adrenergic agents|mesh-ancestor
101766737|NCT05215158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101766744|NCT05179876|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101766745|NCT05179876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101766746|NCT05179876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766747|NCT05179876|Urological Agents|urological agents|mesh-ancestor
101766748|NCT05179876|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101766749|NCT05179876|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101766750|NCT05179876|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
101766751|NCT05179876|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101766752|NCT05171062|Pembrolizumab|pembrolizumab|mesh-list
101766753|NCT05171062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101766754|NCT05171062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424193|NCT03216187|Pregabalin|pregabalin|mesh-list
101766755|NCT05171062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101766756|NCT05171062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766757|NCT05169554|Amoxicillin|amoxicillin|mesh-list
101766758|NCT05169554|Clarithromycin|clarithromycin|mesh-list
101766759|NCT05169554|Rifampin|rifampin|mesh-list
101766760|NCT05169554|Clavulanic Acid|clavulanic acid|mesh-list
101766761|NCT05169554|Clavulanic Acids|clavulanic acids|mesh-list
101534623|NCT00568412|Sensory System Agents|sensory system agents|mesh-ancestor
101766762|NCT05169554|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101766763|NCT05169554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101766764|NCT05169554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101766765|NCT05169554|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101766766|NCT05169554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101766767|NCT05169554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766768|NCT05169554|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101766769|NCT05169554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101766770|NCT05169554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101766771|NCT05169554|Antitubercular Agents|antitubercular agents|mesh-ancestor
101766772|NCT05169554|Leprostatic Agents|leprostatic agents|mesh-ancestor
101766773|NCT05169554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101766774|NCT05169554|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101766775|NCT05169554|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101766776|NCT05169554|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101766777|NCT05169554|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101766778|NCT05169554|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101766779|NCT05169554|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101766780|NCT05169554|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101766781|NCT05148962|Vaccines|vaccines|mesh-list
101766782|NCT05148962|Immunologic Factors|immunologic factors|mesh-ancestor
101766783|NCT05148962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766784|NCT05140941|Sofosbuvir|sofosbuvir|mesh-list
101766785|NCT05140941|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
101766786|NCT05140941|Velpatasvir|velpatasvir|mesh-list
101766787|NCT05140941|Antiviral Agents|antiviral agents|mesh-ancestor
101766788|NCT05140941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101766789|NCT05083182|Ustekinumab|ustekinumab|mesh-list
101766790|NCT05083182|Dermatologic Agents|dermatologic agents|mesh-ancestor
101766791|NCT05068440|Zanubrutinib|zanubrutinib|mesh-list
101766792|NCT05068440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101766793|NCT05068440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101766794|NCT05068440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101564776|NCT01130337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564777|NCT01130337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101564778|NCT01130337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101564779|NCT04901689|Leronlimab|leronlimab|mesh-list
101564780|NCT04901689|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101564781|NCT04901689|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101564782|NCT04901689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564783|NCT04901689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101564784|NCT04901689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101564785|NCT04901689|Antiviral Agents|antiviral agents|mesh-ancestor
101564786|NCT04901689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101564787|NCT04252963|Streptokinase|streptokinase|mesh-list
101564788|NCT04252963|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101564789|NCT04252963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101564790|NCT04252963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564791|NCT04258657|Paclitaxel|paclitaxel|mesh-list
101564792|NCT04258657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101564793|NCT04258657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101766795|NCT05068440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766796|NCT05050305|Dexamethasone|dexamethasone|mesh-list
101766797|NCT05050305|Pomalidomide|pomalidomide|mesh-list
101766798|NCT05050305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101766799|NCT05050305|Antiemetics|antiemetics|mesh-ancestor
101766800|NCT05050305|Autonomic Agents|autonomic agents|mesh-ancestor
101766801|NCT05050305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101766802|NCT05050305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766803|NCT05050305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101766804|NCT05050305|Glucocorticoids|glucocorticoids|mesh-ancestor
101766805|NCT05050305|Hormones|hormones|mesh-ancestor
101766807|NCT05050305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101766808|NCT05050305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101766809|NCT05050305|Immunologic Factors|immunologic factors|mesh-ancestor
101766810|NCT05050305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101766811|NCT05050305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101766812|NCT05050305|Growth Substances|growth substances|mesh-ancestor
101766813|NCT05050305|Growth Inhibitors|growth inhibitors|mesh-ancestor
101766814|NCT05020327|Amoxicillin|amoxicillin|mesh-list
101766815|NCT05020327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101766816|NCT05020327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101766818|NCT05016310|Ergocalciferols|ergocalciferols|mesh-list
101766819|NCT05016310|Cholecalciferol|cholecalciferol|mesh-list
101766820|NCT05016310|Vitamins|vitamins|mesh-list
101766821|NCT05016310|Micronutrients|micronutrients|mesh-ancestor
101766822|NCT05016310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766823|NCT05016310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101766824|NCT05016310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101766825|NCT04981951|Dexmedetomidine|dexmedetomidine|mesh-list
101766826|NCT04981951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101766827|NCT04981951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101766828|NCT04981951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766829|NCT04981951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101766830|NCT04981951|Analgesics|analgesics|mesh-ancestor
101766831|NCT04981951|Sensory System Agents|sensory system agents|mesh-ancestor
101766832|NCT04981951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101564794|NCT04258657|Tubulin Modulators|tubulin modulators|mesh-ancestor
101564795|NCT04258657|Antimitotic Agents|antimitotic agents|mesh-ancestor
101564796|NCT04258657|Mitosis Modulators|mitosis modulators|mesh-ancestor
101564797|NCT04258657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564798|NCT01130103|Paroxetine|paroxetine|mesh-list
101564799|NCT01130103|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101564800|NCT01130103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101564801|NCT01130103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101564802|NCT01130103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766833|NCT04981951|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101766834|NCT04981951|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101766835|NCT04981951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101766836|NCT04981951|Adrenergic Agents|adrenergic agents|mesh-ancestor
101766837|NCT04981951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101766838|NCT04981951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766839|NCT04947527|Fluorides|fluorides|mesh-list
101766840|NCT04947527|Fluorides, Topical|fluorides, topical|mesh-list
101766841|NCT04947527|Cariostatic Agents|cariostatic agents|mesh-ancestor
101766842|NCT04947527|Protective Agents|protective agents|mesh-ancestor
101766843|NCT04947527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766844|NCT04939935|Metformin|metformin|mesh-list
101766845|NCT04939935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101766846|NCT04939935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766847|NCT04910815|Rifaximin|rifaximin|mesh-list
101766848|NCT04910815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101766849|NCT04910815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101766850|NCT04910815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101766851|NCT04907214|Empagliflozin|empagliflozin|mesh-list
101766852|NCT04907214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101766853|NCT04907214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766854|NCT04907214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101766855|NCT04907214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766856|NCT04907032|Mirabegron|mirabegron|mesh-list
101766857|NCT04907032|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101766858|NCT04907032|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101766859|NCT04907032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101766860|NCT04907032|Adrenergic Agents|adrenergic agents|mesh-ancestor
101766861|NCT04907032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101766862|NCT04907032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766863|NCT04907032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766864|NCT04907032|Urological Agents|urological agents|mesh-ancestor
101766865|NCT04891289|Dexamethasone|dexamethasone|mesh-list
101766866|NCT04891289|Gemcitabine|gemcitabine|mesh-list
101766867|NCT04891289|Oxaliplatin|oxaliplatin|mesh-list
101766868|NCT04891289|Floxuridine|floxuridine|mesh-list
101766869|NCT04891289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101766870|NCT04891289|Antiemetics|antiemetics|mesh-ancestor
101766871|NCT04891289|Autonomic Agents|autonomic agents|mesh-ancestor
101766872|NCT04891289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101766873|NCT04891289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766874|NCT04891289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101766875|NCT04891289|Glucocorticoids|glucocorticoids|mesh-ancestor
101766876|NCT04891289|Hormones|hormones|mesh-ancestor
101766877|NCT04891289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101407705|NCT02964728|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101766878|NCT04891289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101766879|NCT04891289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101766890|NCT04879368|Tubulin Modulators|tubulin modulators|mesh-ancestor
101766891|NCT04879368|Antimitotic Agents|antimitotic agents|mesh-ancestor
101766892|NCT04879368|Mitosis Modulators|mitosis modulators|mesh-ancestor
101766893|NCT04879368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766894|NCT04879368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101766895|NCT04879368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101766896|NCT04879368|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101564803|NCT01130103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101564804|NCT01130103|Serotonin Agents|serotonin agents|mesh-ancestor
101413056|NCT00480844|Risperidone|risperidone|mesh-list
101766897|NCT04879368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101766898|NCT04879368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101766899|NCT04879368|Antimetabolites|antimetabolites|mesh-ancestor
101766900|NCT04879368|Antiviral Agents|antiviral agents|mesh-ancestor
101766901|NCT04879368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101766902|NCT04877990|Deucravacitinib|deucravacitinib|mesh-list
101766903|NCT04877990|Dermatologic Agents|dermatologic agents|mesh-ancestor
101766904|NCT04877990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101766905|NCT04877990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101766906|NCT04877990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766908|NCT04861051|Analgesics|analgesics|mesh-ancestor
101766909|NCT04861051|Sensory System Agents|sensory system agents|mesh-ancestor
101766910|NCT04861051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101766911|NCT04861051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766912|NCT04861051|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101766913|NCT04861051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101766914|NCT04861051|Anesthetics, General|anesthetics, general|mesh-ancestor
101766915|NCT04861051|Anesthetics|anesthetics|mesh-ancestor
101766916|NCT04861051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101766917|NCT04861051|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101766918|NCT04861051|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101766919|NCT04861051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101766920|NCT04861051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766921|NCT04834375|Dexamethasone|dexamethasone|mesh-list
101766922|NCT04834375|Dexamethasone acetate|dexamethasone acetate|mesh-list
101766924|NCT04834375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101766925|NCT04834375|Antiemetics|antiemetics|mesh-ancestor
101766926|NCT04834375|Autonomic Agents|autonomic agents|mesh-ancestor
101766927|NCT04834375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101766928|NCT04834375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766929|NCT04834375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101766930|NCT04834375|Glucocorticoids|glucocorticoids|mesh-ancestor
101766931|NCT04834375|Hormones|hormones|mesh-ancestor
101766932|NCT04834375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101766933|NCT04834375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101766934|NCT04834375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101766935|NCT04834375|Protease Inhibitors|protease inhibitors|mesh-ancestor
101766936|NCT04834375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101766937|NCT04834375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766938|NCT04788745|Trimetazidine|trimetazidine|mesh-list
101766939|NCT04788745|Vasodilator Agents|vasodilator agents|mesh-ancestor
101766940|NCT04712903|Carboplatin|carboplatin|mesh-list
101766941|NCT04712903|Etoposide|etoposide|mesh-list
101766942|NCT04712903|Durvalumab|durvalumab|mesh-list
101766943|NCT04712903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101766944|NCT04712903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101766945|NCT04712903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101766973|NCT04657666|Sensory System Agents|sensory system agents|mesh-ancestor
101766974|NCT04657666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101766975|NCT04657666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766976|NCT04646967|Acetaminophen|acetaminophen|mesh-list
101766977|NCT04646967|Ibuprofen|ibuprofen|mesh-list
101766978|NCT04646967|Ketorolac|ketorolac|mesh-list
101766979|NCT04646967|Bupivacaine|bupivacaine|mesh-list
101766980|NCT04646967|Sevoflurane|sevoflurane|mesh-list
101766981|NCT04646967|Anesthetics, Local|anesthetics, local|mesh-ancestor
101766982|NCT04646967|Anesthetics|anesthetics|mesh-ancestor
101766983|NCT04646967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101766984|NCT04646967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766985|NCT04646967|Sensory System Agents|sensory system agents|mesh-ancestor
101766986|NCT04646967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101766987|NCT04646967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101766988|NCT04646967|Analgesics|analgesics|mesh-ancestor
101766989|NCT04646967|Antipyretics|antipyretics|mesh-ancestor
101766990|NCT04646967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101766991|NCT04646967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101766992|NCT04646967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101766996|NCT04646967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101766997|NCT04646967|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101766998|NCT04646967|Anesthetics, General|anesthetics, general|mesh-ancestor
101767014|NCT04551521|Atezolizumab|atezolizumab|mesh-list
101767015|NCT04551521|Pertuzumab|pertuzumab|mesh-list
101767016|NCT04551521|Vemurafenib|vemurafenib|mesh-list
101767017|NCT04551521|Ipatasertib|ipatasertib|mesh-list
101767018|NCT04551521|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101767019|NCT04551521|Inavolisib|inavolisib|mesh-list
101767020|NCT04551521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101767021|NCT04551521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767022|NCT04551521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101767023|NCT04551521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767024|NCT04551521|Immunologic Factors|immunologic factors|mesh-ancestor
101767025|NCT04551521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767026|NCT04551521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101767027|NCT04551521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101767028|NCT04551521|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
101767029|NCT04539249|Magnesium Sulfate|magnesium sulfate|mesh-list
101767030|NCT04539249|Pentazocine|pentazocine|mesh-list
101767031|NCT04539249|Analgesics|analgesics|mesh-ancestor
101767032|NCT04539249|Sensory System Agents|sensory system agents|mesh-ancestor
101767033|NCT04539249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101767034|NCT04539249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767035|NCT04539249|Anesthetics|anesthetics|mesh-ancestor
101767036|NCT04539249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101767037|NCT04539249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101767038|NCT04539249|Anticonvulsants|anticonvulsants|mesh-ancestor
101767039|NCT04539249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101767040|NCT04539249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101304292|NCT02012088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101767041|NCT04539249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767043|NCT04539249|Tocolytic Agents|tocolytic agents|mesh-ancestor
101767044|NCT04539249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101767045|NCT04539249|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101767046|NCT04539249|Narcotics|narcotics|mesh-ancestor
101767047|NCT04539249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101767048|NCT04539249|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101767049|NCT04538664|Carboplatin|carboplatin|mesh-list
101767050|NCT04538664|Pemetrexed|pemetrexed|mesh-list
101767051|NCT04538664|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
101767052|NCT04538664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767053|NCT04538664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101767054|NCT04538664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767055|NCT04538664|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101767056|NCT04538664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101767057|NCT04538664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101767058|NCT04538378|Durvalumab|durvalumab|mesh-list
101767059|NCT04538378|Olaparib|olaparib|mesh-list
101564810|NCT01130103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101564811|NCT01130103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101564813|NCT04254523|Bupivacaine|bupivacaine|mesh-list
101564814|NCT04254523|Anesthetics, Local|anesthetics, local|mesh-ancestor
101564815|NCT04254523|Anesthetics|anesthetics|mesh-ancestor
101564816|NCT04254523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101564817|NCT04254523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564818|NCT04254523|Sensory System Agents|sensory system agents|mesh-ancestor
101767060|NCT04538378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101767061|NCT04538378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767062|NCT04538378|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101767063|NCT04538378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101767081|NCT04492891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101767082|NCT04449198|Resveratrol|resveratrol|mesh-list
101767083|NCT04449198|Antioxidants|antioxidants|mesh-ancestor
101767084|NCT04449198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767085|NCT04449198|Protective Agents|protective agents|mesh-ancestor
101767086|NCT04449198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767087|NCT04449198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101767088|NCT04449198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101767089|NCT04305327|Ustekinumab|ustekinumab|mesh-list
101767090|NCT04305327|Brodalumab|brodalumab|mesh-list
101767091|NCT04305327|Dermatologic Agents|dermatologic agents|mesh-ancestor
101767092|NCT04271189|Metformin|metformin|mesh-list
101767093|NCT04271189|Pioglitazone|pioglitazone|mesh-list
101767094|NCT04271189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101767095|NCT04271189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101767096|NCT04271189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767097|NCT04271189|Incretins|incretins|mesh-ancestor
101767098|NCT04271189|Hormones|hormones|mesh-ancestor
101767099|NCT04271189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101767100|NCT04271189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101767101|NCT04271189|Protease Inhibitors|protease inhibitors|mesh-ancestor
101767102|NCT04271189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101767103|NCT04271189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767104|NCT04221945|Cisplatin|cisplatin|mesh-list
101767105|NCT04221945|Pembrolizumab|pembrolizumab|mesh-list
101767106|NCT04221945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767107|NCT04221945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101767108|NCT04221945|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101767109|NCT04221945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767110|NCT04199325|Uric Acid|uric acid|mesh-list
101767111|NCT04199325|Antioxidants|antioxidants|mesh-ancestor
101767112|NCT04199325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767113|NCT04199325|Protective Agents|protective agents|mesh-ancestor
101767114|NCT04199325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767115|NCT04189133|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101767116|NCT04189133|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101767117|NCT04189133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767118|NCT04166396|Resveratrol|resveratrol|mesh-list
101767119|NCT04166396|Antioxidants|antioxidants|mesh-ancestor
101767120|NCT04166396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767129|NCT04160494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767130|NCT04160494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101424565|NCT00518479|Amlodipine|amlodipine|mesh-list
101767132|NCT04160494|Immunologic Factors|immunologic factors|mesh-ancestor
101767133|NCT04160494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767134|NCT04157725|Clomiphene|clomiphene|mesh-list
101767135|NCT04157725|Enclomiphene|enclomiphene|mesh-list
101767136|NCT04157725|Zuclomiphene|zuclomiphene|mesh-list
101767137|NCT04157725|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101767138|NCT04157725|Hormone Antagonists|hormone antagonists|mesh-ancestor
101767139|NCT04157725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101767140|NCT04157725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564819|NCT04254523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101564820|NCT04254523|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101564821|NCT04254523|Narcotics|narcotics|mesh-ancestor
101564822|NCT04254523|Analgesics|analgesics|mesh-ancestor
101564823|NCT00625209|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
101564824|NCT00625209|Hydrocortisone|hydrocortisone|mesh-list
101564825|NCT00625209|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101564826|NCT00625209|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101564827|NCT00625209|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101564828|NCT00625209|Fludrocortisone|fludrocortisone|mesh-list
101564829|NCT00625209|Protein C|protein c|mesh-list
101564830|NCT00625209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101564831|NCT00625209|Anticoagulants|anticoagulants|mesh-ancestor
101564832|NCT00625209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101564833|NCT00625209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101413073|NCT00480883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101767141|NCT04157725|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101767142|NCT04157725|Fertility Agents|fertility agents|mesh-ancestor
101767143|NCT04157725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101767144|NCT04157725|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101767145|NCT04157725|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101767146|NCT04145518|Naproxen|naproxen|mesh-list
101767147|NCT04145518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101767148|NCT04145518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101767149|NCT04145518|Analgesics|analgesics|mesh-ancestor
101767150|NCT04145518|Sensory System Agents|sensory system agents|mesh-ancestor
101767151|NCT04145518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101767152|NCT04145518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767153|NCT04145518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101767154|NCT04145518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101767155|NCT04145518|Gout Suppressants|gout suppressants|mesh-ancestor
101767156|NCT04145518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101767157|NCT04145518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101767158|NCT04145518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767159|NCT04140903|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101767160|NCT04140903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101767161|NCT04140903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101767162|NCT04140903|Antitubercular Agents|antitubercular agents|mesh-ancestor
101767163|NCT04101721|Aflibercept|aflibercept|mesh-list
101767164|NCT04101721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101767165|NCT04101721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101767166|NCT04101721|Growth Substances|growth substances|mesh-ancestor
101767167|NCT04101721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767168|NCT04101721|Growth Inhibitors|growth inhibitors|mesh-ancestor
101767169|NCT04101721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767170|NCT04100135|Clopidogrel|clopidogrel|mesh-list
101767171|NCT04100135|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101767172|NCT04100135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101767173|NCT04100135|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101767174|NCT04100135|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101767175|NCT04100135|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101767176|NCT04100135|Purinergic Agents|purinergic agents|mesh-ancestor
101767177|NCT04100135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101767178|NCT04100135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767179|NCT04100135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767180|NCT04055012|Metformin|metformin|mesh-list
101767181|NCT04055012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101767182|NCT04055012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767183|NCT04044690|Immunoglobulins|immunoglobulins|mesh-list
101564834|NCT00625209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564836|NCT04254601|Erythromycin|erythromycin|mesh-list
101564837|NCT04254601|Erythromycin Estolate|erythromycin estolate|mesh-list
101564838|NCT04254601|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101564839|NCT04254601|Erythromycin stearate|erythromycin stearate|mesh-list
101564840|NCT04254601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101564841|NCT04254601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101564842|NCT04254601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101564843|NCT04254601|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101767184|NCT04044690|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101767188|NCT04044690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767189|NCT04042831|Olaparib|olaparib|mesh-list
101767190|NCT04042831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
101767191|NCT04042831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101767192|NCT04042831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767193|NCT04042831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767194|NCT04009668|Adalimumab|adalimumab|mesh-list
101767195|NCT04009668|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101767196|NCT04009668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101767197|NCT04009668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101767198|NCT03968640|Coenzyme Q10|coenzyme q10|mesh-list
101767199|NCT03968640|Vitamins|vitamins|mesh-ancestor
101767200|NCT03968640|Micronutrients|micronutrients|mesh-ancestor
101767201|NCT03968640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767202|NCT03948074|Dronabinol|dronabinol|mesh-list
101767203|NCT03948074|Cannabidiol|cannabidiol|mesh-list
101767204|NCT03948074|Anticonvulsants|anticonvulsants|mesh-ancestor
101767205|NCT03948074|Hallucinogens|hallucinogens|mesh-ancestor
101767206|NCT03948074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767207|NCT03948074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101767208|NCT03948074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101767210|NCT03948074|Sensory System Agents|sensory system agents|mesh-ancestor
101767211|NCT03948074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101767212|NCT03948074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101767213|NCT03948074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101767214|NCT03948074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101767215|NCT03948074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767216|NCT03948074|Hormones|hormones|mesh-ancestor
101767217|NCT03948074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101767218|NCT03942328|Bevacizumab|bevacizumab|mesh-list
101767219|NCT03942328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101767220|NCT03942328|Atezolizumab|atezolizumab|mesh-list
101767221|NCT03942328|Vaccines|vaccines|mesh-list
101767222|NCT03942328|Antibodies|antibodies|mesh-list
101767223|NCT03942328|Immunoglobulins|immunoglobulins|mesh-list
101767224|NCT03942328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101767225|NCT03942328|Immunoglobulin G|immunoglobulin g|mesh-list
101767226|NCT03942328|Endothelial Growth Factors|endothelial growth factors|mesh-list
101767227|NCT03942328|Immunologic Factors|immunologic factors|mesh-ancestor
101767228|NCT03942328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767229|NCT03942328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767230|NCT03942328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101767231|NCT03942328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101767232|NCT03942328|Growth Substances|growth substances|mesh-ancestor
101767233|NCT03942328|Growth Inhibitors|growth inhibitors|mesh-ancestor
101767234|NCT03942328|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101767235|NCT03942328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767236|NCT03939104|Artesunate|artesunate|mesh-list
101767237|NCT03939104|Lumefantrine|lumefantrine|mesh-list
101767238|NCT03939104|Artemether|artemether|mesh-list
101767239|NCT03939104|Piperaquine|piperaquine|mesh-list
101767240|NCT03939104|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101767241|NCT03939104|Amodiaquine|amodiaquine|mesh-list
101767242|NCT03939104|Mefloquine|mefloquine|mesh-list
101767243|NCT03939104|Antimalarials|antimalarials|mesh-ancestor
101564844|NCT04254601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101564845|NCT04254601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564846|NCT01129557|Valsartan|valsartan|mesh-list
101564847|NCT01129557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101564848|NCT01129557|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101564849|NCT01129557|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101564850|NCT01129557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564851|NCT04254679|Analgesics, Opioid|analgesics, opioid|mesh-list
101564852|NCT04254679|Analgesics|analgesics|mesh-list
101564853|NCT04254679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
101564854|NCT04254679|Narcotics|narcotics|mesh-ancestor
101564855|NCT04254679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101564856|NCT04254679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767244|NCT03939104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101767245|NCT03939104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101767246|NCT03939104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101767247|NCT03939104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767248|NCT03939104|Antiviral Agents|antiviral agents|mesh-ancestor
101767249|NCT03939104|Schistosomicides|schistosomicides|mesh-ancestor
101767250|NCT03939104|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101767251|NCT03939104|Anthelmintics|anthelmintics|mesh-ancestor
101767252|NCT03932318|Azacitidine|azacitidine|mesh-list
101767253|NCT03932318|Venetoclax|venetoclax|mesh-list
101767254|NCT03932318|Lintuzumab|lintuzumab|mesh-list
101767255|NCT03932318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101767256|NCT03932318|Antimetabolites|antimetabolites|mesh-ancestor
101767257|NCT03932318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767258|NCT03932318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767259|NCT03932318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101767260|NCT03932318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101767261|NCT03923725|Artesunate|artesunate|mesh-list
101767265|NCT03923725|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101767266|NCT03923725|Amodiaquine|amodiaquine|mesh-list
101767267|NCT03923725|Mefloquine|mefloquine|mesh-list
101767268|NCT03923725|Antimalarials|antimalarials|mesh-ancestor
101767269|NCT03923725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101767270|NCT03923725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101767271|NCT03923725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101767272|NCT03923725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767273|NCT03923725|Antiviral Agents|antiviral agents|mesh-ancestor
101767274|NCT03923725|Schistosomicides|schistosomicides|mesh-ancestor
101767275|NCT03923725|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101767276|NCT03923725|Anthelmintics|anthelmintics|mesh-ancestor
101767277|NCT03864926|Tacrolimus|tacrolimus|mesh-list
101767278|NCT03864926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101767279|NCT03864926|Immunologic Factors|immunologic factors|mesh-ancestor
101767280|NCT03864926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767281|NCT03864926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101767282|NCT03864926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101767283|NCT03864926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767284|NCT03836261|Venetoclax|venetoclax|mesh-list
101767285|NCT03836261|Obinutuzumab|obinutuzumab|mesh-list
101767286|NCT03836261|Acalabrutinib|acalabrutinib|mesh-list
101767287|NCT03836261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767288|NCT03836261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101767289|NCT03809533|Sofosbuvir|sofosbuvir|mesh-list
101767290|NCT03809533|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
101767291|NCT03809533|Velpatasvir|velpatasvir|mesh-list
101767292|NCT03809533|Antiviral Agents|antiviral agents|mesh-ancestor
101767293|NCT03809533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101767294|NCT03745326|Aldesleukin|aldesleukin|mesh-list
101767295|NCT03745326|Cyclophosphamide|cyclophosphamide|mesh-list
101767296|NCT03745326|Fludarabine|fludarabine|mesh-list
101767297|NCT03745326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101564857|NCT04254679|Sensory System Agents|sensory system agents|mesh-ancestor
101564858|NCT04254679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101564859|NCT01129011|Naproxen|naproxen|mesh-list
101564860|NCT01129011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101564861|NCT01129011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101564862|NCT01129011|Analgesics|analgesics|mesh-ancestor
101564863|NCT01129011|Sensory System Agents|sensory system agents|mesh-ancestor
101564864|NCT01129011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101564865|NCT01129011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564866|NCT01129011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101564867|NCT01129011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101564868|NCT01129011|Gout Suppressants|gout suppressants|mesh-ancestor
101564869|NCT01129011|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101564870|NCT01129011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101413109|NCT01240096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101767298|NCT03745326|Immunologic Factors|immunologic factors|mesh-ancestor
101767299|NCT03745326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767300|NCT03745326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101767301|NCT03745326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101767302|NCT03745326|Alkylating Agents|alkylating agents|mesh-ancestor
101767303|NCT03745326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767304|NCT03745326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767305|NCT03745326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101767306|NCT03745326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101767307|NCT03745326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101767308|NCT03745326|Antiviral Agents|antiviral agents|mesh-ancestor
101767309|NCT03745326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101767310|NCT03718234|Hydrocortisone|hydrocortisone|mesh-list
101767311|NCT03718234|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101767312|NCT03718234|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101767313|NCT03718234|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101767314|NCT03718234|Glucocorticoids|glucocorticoids|mesh-list
101767315|NCT03718234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101767316|NCT03718234|Hormones|hormones|mesh-ancestor
101767317|NCT03718234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101767318|NCT03718234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767319|NCT03643107|Prednisolone|prednisolone|mesh-list
101767320|NCT03643107|Irofulven|irofulven|mesh-list
101767321|NCT03643107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101767322|NCT03643107|Glucocorticoids|glucocorticoids|mesh-ancestor
101767323|NCT03643107|Hormones|hormones|mesh-ancestor
101767324|NCT03643107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101767325|NCT03643107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767326|NCT03643107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101767327|NCT03643107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767328|NCT03643107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101767329|NCT03643107|Alkylating Agents|alkylating agents|mesh-ancestor
101767330|NCT03643107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767331|NCT03623243|Siponimod|siponimod|mesh-list
101767332|NCT03623243|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101767333|NCT03623243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767334|NCT03623243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101767335|NCT03623243|Immunologic Factors|immunologic factors|mesh-ancestor
101767341|NCT03619707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767342|NCT03597568|Resveratrol|resveratrol|mesh-list
101767343|NCT03597568|Antioxidants|antioxidants|mesh-ancestor
101767344|NCT03597568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767345|NCT03597568|Protective Agents|protective agents|mesh-ancestor
101203852|NCT01420094|Aspirin|aspirin|mesh-list
101564871|NCT01129011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564872|NCT04252885|Ritonavir|ritonavir|mesh-list
101564873|NCT04252885|Lopinavir|lopinavir|mesh-list
101564874|NCT04252885|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101564875|NCT04252885|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101564876|NCT04252885|Protease Inhibitors|protease inhibitors|mesh-ancestor
101564877|NCT04252885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101564878|NCT04252885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767346|NCT03597568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767347|NCT03597568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101767348|NCT03597568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101767349|NCT03593408|Fentanyl|fentanyl|mesh-list
101767350|NCT03593408|Midazolam|midazolam|mesh-list
101767351|NCT03593408|Dexmedetomidine|dexmedetomidine|mesh-list
101767352|NCT03593408|Morphine|morphine|mesh-list
101767353|NCT03593408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101767354|NCT03593408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101767355|NCT03593408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767356|NCT03593408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101767357|NCT03593408|Analgesics|analgesics|mesh-ancestor
101767358|NCT03593408|Sensory System Agents|sensory system agents|mesh-ancestor
101767359|NCT03593408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101767360|NCT03593408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101424793|NCT00151827|Losartan|losartan|mesh-list
101767361|NCT03593408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101767362|NCT03593408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101767363|NCT03593408|Adrenergic Agents|adrenergic agents|mesh-ancestor
101767364|NCT03593408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101767365|NCT03593408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767366|NCT03593408|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101767367|NCT03593408|Narcotics|narcotics|mesh-ancestor
101767368|NCT03593408|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101767369|NCT03593408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101767370|NCT03593408|Anesthetics, General|anesthetics, general|mesh-ancestor
101767371|NCT03593408|Anesthetics|anesthetics|mesh-ancestor
101767372|NCT03593408|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101767373|NCT03593408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101767374|NCT03593408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101767375|NCT03593408|GABA Modulators|gaba modulators|mesh-ancestor
101767376|NCT03593408|GABA Agents|gaba agents|mesh-ancestor
101767377|NCT03581240|Eflornithine|eflornithine|mesh-list
101767378|NCT03581240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767379|NCT03581240|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101767380|NCT03581240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101767381|NCT03581240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101767382|NCT03581240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101767383|NCT03581240|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
101767384|NCT03581240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101767385|NCT03581240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767387|NCT03572582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101767388|NCT03572582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767389|NCT03572582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101767390|NCT03572582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767391|NCT03562832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
101767392|NCT03562832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101767393|NCT03562832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767394|NCT03562832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767395|NCT03432871|Niacinamide|niacinamide|mesh-list
101767396|NCT03432871|Niacin|niacin|mesh-list
101767397|NCT03432871|Nicotinic Acids|nicotinic acids|mesh-list
101767398|NCT03432871|Vitamin B Complex|vitamin b complex|mesh-ancestor
101767399|NCT03432871|Vitamins|vitamins|mesh-ancestor
101767400|NCT03432871|Micronutrients|micronutrients|mesh-ancestor
101767401|NCT03432871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767402|NCT03432871|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101767403|NCT03432871|Antimetabolites|antimetabolites|mesh-ancestor
101203930|NCT01420575|Olanzapine|olanzapine|mesh-list
101767404|NCT03432871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564879|NCT04252885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101564880|NCT04252885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101564881|NCT04252885|Antiviral Agents|antiviral agents|mesh-ancestor
101564882|NCT04252885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101564883|NCT04252885|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101564884|NCT04252885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101564886|NCT04962841|Amlodipine|amlodipine|mesh-list
101564887|NCT04962841|Ramipril|ramipril|mesh-list
101564888|NCT04962841|Nebivolol|nebivolol|mesh-list
101564889|NCT04962841|Rivastigmine|rivastigmine|mesh-list
101564890|NCT04962841|Sertraline|sertraline|mesh-list
101564891|NCT04962841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101564892|NCT04962841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564893|NCT04962841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101564894|NCT04962841|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101564895|NCT04962841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101564896|NCT04962841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564897|NCT04962841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101564898|NCT04962841|Vasodilator Agents|vasodilator agents|mesh-ancestor
101564899|NCT04962841|Antidepressive Agents|antidepressive agents|mesh-ancestor
101564900|NCT04962841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101564901|NCT04962841|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101564902|NCT04962841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101564903|NCT04962841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101564904|NCT04962841|Serotonin Agents|serotonin agents|mesh-ancestor
101564905|NCT04962841|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101413131|NCT01240252|Insulin|insulin|mesh-list
101767405|NCT03432871|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101767406|NCT03432871|Vasodilator Agents|vasodilator agents|mesh-ancestor
101767414|NCT03399318|Antipyretics|antipyretics|mesh-ancestor
101767415|NCT03399318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101767416|NCT03399318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101767417|NCT03399318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101767418|NCT03399318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101767419|NCT03399318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101767420|NCT03399318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767421|NCT03389139|Anesthetics|anesthetics|mesh-list
101767422|NCT03389139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101767423|NCT03389139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767424|NCT03382938|Dexmedetomidine|dexmedetomidine|mesh-list
101767425|NCT03382938|Ropivacaine|ropivacaine|mesh-list
101767426|NCT03382938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101767427|NCT03382938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101767428|NCT03382938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767429|NCT03382938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101767430|NCT03382938|Analgesics|analgesics|mesh-ancestor
101767431|NCT03382938|Sensory System Agents|sensory system agents|mesh-ancestor
101564906|NCT04962841|Protease Inhibitors|protease inhibitors|mesh-ancestor
101564907|NCT04962841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101564908|NCT04962841|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101564909|NCT04962841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101564910|NCT04962841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101564911|NCT04962841|Adrenergic Agents|adrenergic agents|mesh-ancestor
101564912|NCT04962841|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101564913|NCT04962841|Cholinergic Agents|cholinergic agents|mesh-ancestor
101564914|NCT04962841|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101564915|NCT04962841|Protective Agents|protective agents|mesh-ancestor
101564917|NCT00919867|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101564918|NCT00919867|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101564919|NCT00919867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564920|NCT00919867|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101564921|NCT00919867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101564922|NCT00919867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101413158|NCT01240408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101767432|NCT03382938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101424872|NCT04694365|Fluzoparib|fluzoparib|mesh-list
101767433|NCT03382938|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101767434|NCT03382938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101767435|NCT03382938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101767436|NCT03382938|Adrenergic Agents|adrenergic agents|mesh-ancestor
101767437|NCT03382938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101767438|NCT03382938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767439|NCT03382938|Anesthetics, Local|anesthetics, local|mesh-ancestor
101767441|NCT03380468|Pemetrexed|pemetrexed|mesh-list
101767442|NCT03380468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767443|NCT03380468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101767444|NCT03380468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767445|NCT03380468|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101767446|NCT03380468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101767447|NCT03279952|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
101767448|NCT03279952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767449|NCT03258853|Pancrelipase|pancrelipase|mesh-list
101767450|NCT03258853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101767451|NCT03246347|Docetaxel|docetaxel|mesh-list
101767452|NCT03246347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767453|NCT03246347|Tubulin Modulators|tubulin modulators|mesh-ancestor
101767454|NCT03246347|Antimitotic Agents|antimitotic agents|mesh-ancestor
101767455|NCT03246347|Mitosis Modulators|mitosis modulators|mesh-ancestor
101767456|NCT03246347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767457|NCT03236155|Analgesics, Opioid|analgesics, opioid|mesh-list
101767458|NCT03236155|Narcotics|narcotics|mesh-ancestor
101767459|NCT03236155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101767460|NCT03236155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767461|NCT03236155|Analgesics|analgesics|mesh-ancestor
101767462|NCT03236155|Sensory System Agents|sensory system agents|mesh-ancestor
101767463|NCT03236155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101767464|NCT03177122|Inositol|inositol|mesh-list
101767465|NCT03177122|Vitamin B Complex|vitamin b complex|mesh-ancestor
101767466|NCT03177122|Vitamins|vitamins|mesh-ancestor
101767467|NCT03177122|Micronutrients|micronutrients|mesh-ancestor
101767468|NCT03177122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767469|NCT03169166|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101767470|NCT03169166|Luteolytic Agents|luteolytic agents|mesh-ancestor
101564923|NCT00919867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564924|NCT00919867|Dopamine Agents|dopamine agents|mesh-ancestor
101564925|NCT00919867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101564926|NCT00919867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101564927|NCT00919867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101564928|NCT00919867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101564929|NCT00919867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101564930|NCT00919867|Adrenergic Agents|adrenergic agents|mesh-ancestor
101564931|NCT04252261|Sulforaphane|sulforaphane|mesh-list
101564932|NCT04252261|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101564933|NCT04252261|Protective Agents|protective agents|mesh-ancestor
101564934|NCT04252261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564935|NCT04252261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101564936|NCT04251871|Interferons|interferons|mesh-list
101564937|NCT04251871|Ritonavir|ritonavir|mesh-list
101564938|NCT04251871|Lopinavir|lopinavir|mesh-list
101564939|NCT04251871|Interferon-alpha|interferon-alpha|mesh-list
101564940|NCT04251871|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
101564941|NCT04251871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101564942|NCT04251871|Antiviral Agents|antiviral agents|mesh-ancestor
101564943|NCT04251871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101413187|NCT00481312|Anesthetics|anesthetics|mesh-ancestor
101767471|NCT03169166|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101767472|NCT03169166|Contraceptive Agents|contraceptive agents|mesh-ancestor
101767473|NCT03169166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101767474|NCT03169166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767478|NCT03165994|Paclitaxel|paclitaxel|mesh-list
101767479|NCT03165994|Carboplatin|carboplatin|mesh-list
101767480|NCT03165994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101767481|NCT03165994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767482|NCT03165994|Tubulin Modulators|tubulin modulators|mesh-ancestor
101767483|NCT03165994|Antimitotic Agents|antimitotic agents|mesh-ancestor
101767484|NCT03165994|Mitosis Modulators|mitosis modulators|mesh-ancestor
101767485|NCT03165994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767486|NCT03089606|Pembrolizumab|pembrolizumab|mesh-list
101767487|NCT03089606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101767488|NCT03089606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767489|NCT03089606|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101767490|NCT03089606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767491|NCT03071406|Nivolumab|nivolumab|mesh-list
101767492|NCT03071406|Ipilimumab|ipilimumab|mesh-list
101767493|NCT03071406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101767494|NCT03071406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767495|NCT03071406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101767496|NCT03071406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767497|NCT03032172|Risdiplam|risdiplam|mesh-list
101767498|NCT03032172|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101767499|NCT03032172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101767500|NCT03032172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767501|NCT03006848|Avelumab|avelumab|mesh-list
101767502|NCT03006848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101767503|NCT03006848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767504|NCT02981069|Dapagliflozin|dapagliflozin|mesh-list
101767505|NCT02981069|Exenatide|exenatide|mesh-list
101564944|NCT04251871|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101564945|NCT04251871|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101564946|NCT04251871|Protease Inhibitors|protease inhibitors|mesh-ancestor
101564947|NCT04251871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101564948|NCT04251871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564949|NCT04251871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101564950|NCT04251871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101564951|NCT04251871|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101564952|NCT04251871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101767506|NCT02981069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101767507|NCT02981069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767508|NCT02981069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101767509|NCT02981069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767510|NCT02981069|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101767511|NCT02981069|Incretins|incretins|mesh-ancestor
101767512|NCT02981069|Hormones|hormones|mesh-ancestor
101767513|NCT02981069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101767514|NCT02980991|Pemetrexed|pemetrexed|mesh-list
101767515|NCT02980991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767516|NCT02980991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101767517|NCT02980991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767518|NCT02980991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101767519|NCT02980991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101767520|NCT02942355|Palbociclib|palbociclib|mesh-list
101767521|NCT02942355|Anastrozole|anastrozole|mesh-list
101767522|NCT02942355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767523|NCT02942355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101767524|NCT02942355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101767525|NCT02942355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767526|NCT02942355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101767527|NCT02942355|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101767528|NCT02942355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101767529|NCT02942355|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101767530|NCT02942355|Hormone Antagonists|hormone antagonists|mesh-ancestor
101767531|NCT02942355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101767532|NCT02942355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767533|NCT02923128|Sufentanil|sufentanil|mesh-list
101767534|NCT02923128|Dexmedetomidine|dexmedetomidine|mesh-list
101767535|NCT02923128|Dsuvia|dsuvia|mesh-list
101767536|NCT02923128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101767537|NCT02923128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101767538|NCT02923128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767539|NCT02923128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101767540|NCT02923128|Analgesics|analgesics|mesh-ancestor
101767541|NCT02923128|Sensory System Agents|sensory system agents|mesh-ancestor
101767542|NCT02923128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101767543|NCT02923128|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101767548|NCT02923128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767550|NCT02923128|Narcotics|narcotics|mesh-ancestor
101767551|NCT02923128|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101767552|NCT02923128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101767553|NCT02923128|Anesthetics, General|anesthetics, general|mesh-ancestor
101767554|NCT02923128|Anesthetics|anesthetics|mesh-ancestor
101767555|NCT02839642|Rivastigmine|rivastigmine|mesh-list
101767556|NCT02839642|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101767557|NCT02839642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101767558|NCT02839642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767559|NCT02839642|Cholinergic Agents|cholinergic agents|mesh-ancestor
101767560|NCT02839642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101767561|NCT02839642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767562|NCT02839642|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101767563|NCT02839642|Protective Agents|protective agents|mesh-ancestor
101564954|NCT04251871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564955|NCT01128621|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101564956|NCT01128621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101564957|NCT01128621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564958|NCT01128621|Incretins|incretins|mesh-ancestor
101564959|NCT01128621|Hormones|hormones|mesh-ancestor
101767564|NCT02830724|Aldesleukin|aldesleukin|mesh-list
101767565|NCT02830724|Cyclophosphamide|cyclophosphamide|mesh-list
101767566|NCT02830724|Fludarabine|fludarabine|mesh-list
101767567|NCT02830724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101767568|NCT02830724|Immunologic Factors|immunologic factors|mesh-ancestor
101767569|NCT02830724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767570|NCT02830724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101767571|NCT02830724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101767572|NCT02830724|Alkylating Agents|alkylating agents|mesh-ancestor
101767573|NCT02830724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767574|NCT02830724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767575|NCT02830724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101767576|NCT02830724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101767577|NCT02830724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101767578|NCT02830724|Antiviral Agents|antiviral agents|mesh-ancestor
101767579|NCT02830724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101767580|NCT02828358|Calcium, Dietary|calcium, dietary|mesh-list
101767581|NCT02828358|Leucovorin|leucovorin|mesh-list
101767582|NCT02828358|Folic Acid|folic acid|mesh-list
101767583|NCT02828358|Cytarabine|cytarabine|mesh-list
101767584|NCT02828358|Dexamethasone|dexamethasone|mesh-list
101767585|NCT02828358|Dexamethasone acetate|dexamethasone acetate|mesh-list
101767586|NCT02828358|Prednisolone|prednisolone|mesh-list
101767587|NCT02828358|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101767588|NCT02828358|Methylprednisolone|methylprednisolone|mesh-list
101767589|NCT02828358|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101767590|NCT02828358|Prednisolone acetate|prednisolone acetate|mesh-list
101767591|NCT02828358|Hydrocortisone|hydrocortisone|mesh-list
101767592|NCT02828358|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101767593|NCT02828358|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101767594|NCT02828358|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101767595|NCT02828358|Cortisone|cortisone|mesh-list
101767596|NCT02828358|Cyclophosphamide|cyclophosphamide|mesh-list
101767597|NCT02828358|Methotrexate|methotrexate|mesh-list
101767598|NCT02828358|Vincristine|vincristine|mesh-list
101767599|NCT02828358|Azacitidine|azacitidine|mesh-list
101767600|NCT02828358|Daunorubicin|daunorubicin|mesh-list
101767601|NCT02828358|Asparaginase|asparaginase|mesh-list
101767602|NCT02828358|Mercaptopurine|mercaptopurine|mesh-list
101767603|NCT02828358|Pegaspargase|pegaspargase|mesh-list
101767605|NCT02828358|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101767606|NCT02828358|Prednisolone phosphate|prednisolone phosphate|mesh-list
101767607|NCT02828358|BB 1101|bb 1101|mesh-list
101767608|NCT02828358|Calcium|calcium|mesh-list
101767609|NCT02828358|2-Aminopurine|2-aminopurine|mesh-list
101767610|NCT02828358|Levoleucovorin|levoleucovorin|mesh-list
101767611|NCT02828358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101767612|NCT02828358|Immunologic Factors|immunologic factors|mesh-ancestor
101767613|NCT02828358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767614|NCT02828358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101767615|NCT02828358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101767616|NCT02828358|Alkylating Agents|alkylating agents|mesh-ancestor
101767617|NCT02828358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767618|NCT02828358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767623|NCT02828358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101767625|NCT02828358|Glucocorticoids|glucocorticoids|mesh-ancestor
101767626|NCT02828358|Hormones|hormones|mesh-ancestor
101767627|NCT02828358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101767628|NCT02828358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101767629|NCT02828358|Protease Inhibitors|protease inhibitors|mesh-ancestor
101767630|NCT02828358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101767631|NCT02828358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101767632|NCT02828358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101767633|NCT02828358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101767634|NCT02828358|Abortifacient Agents|abortifacient agents|mesh-ancestor
101564960|NCT01128621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101564961|NCT01128621|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101564963|NCT01128621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101564964|NCT01128621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564966|NCT00918463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101564967|NCT00918463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101564968|NCT00918463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101564969|NCT00918463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564970|NCT05330065|Bevacizumab|bevacizumab|mesh-list
101767635|NCT02828358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101767636|NCT02828358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101767637|NCT02828358|Antimetabolites|antimetabolites|mesh-ancestor
101767638|NCT02828358|Dermatologic Agents|dermatologic agents|mesh-ancestor
101767639|NCT02828358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101767640|NCT02828358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101767641|NCT02828358|Antiviral Agents|antiviral agents|mesh-ancestor
101767642|NCT02828358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101767643|NCT02828358|Antidotes|antidotes|mesh-ancestor
101767644|NCT02828358|Protective Agents|protective agents|mesh-ancestor
101767645|NCT02828358|Vitamin B Complex|vitamin b complex|mesh-ancestor
101767646|NCT02828358|Vitamins|vitamins|mesh-ancestor
101767647|NCT02828358|Micronutrients|micronutrients|mesh-ancestor
101767648|NCT02828358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101767649|NCT02828358|Tubulin Modulators|tubulin modulators|mesh-ancestor
101767650|NCT02828358|Antimitotic Agents|antimitotic agents|mesh-ancestor
101767651|NCT02828358|Mitosis Modulators|mitosis modulators|mesh-ancestor
101767652|NCT02828358|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101767653|NCT02828358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101767654|NCT02828358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101767655|NCT02828358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101767656|NCT02828358|Hematinics|hematinics|mesh-ancestor
101767657|NCT02810444|Immunoglobulins|immunoglobulins|mesh-list
101767658|NCT02810444|gamma-Globulins|gamma-globulins|mesh-list
101767659|NCT02810444|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101767660|NCT02810444|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101767661|NCT02810444|Immunologic Factors|immunologic factors|mesh-ancestor
101767662|NCT02810444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767663|NCT02612311|Obinutuzumab|obinutuzumab|mesh-list
101767664|NCT02612311|Chlorambucil|chlorambucil|mesh-list
101767665|NCT02612311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101767666|NCT02612311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767667|NCT02612311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101767668|NCT02612311|Alkylating Agents|alkylating agents|mesh-ancestor
101767669|NCT02612311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767670|NCT02607319|Bemiparin|bemiparin|mesh-list
101767671|NCT02607319|Anticoagulants|anticoagulants|mesh-ancestor
101767672|NCT02581085|Tocotrienols|tocotrienols|mesh-list
101767673|NCT02581085|Vitamin E|vitamin e|mesh-list
101767674|NCT02581085|Tocopherols|tocopherols|mesh-list
101767675|NCT02581085|Antioxidants|antioxidants|mesh-ancestor
101767676|NCT02581085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767677|NCT02581085|Protective Agents|protective agents|mesh-ancestor
101767678|NCT02581085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767679|NCT02581085|Vitamins|vitamins|mesh-ancestor
101767680|NCT02581085|Micronutrients|micronutrients|mesh-ancestor
101767681|NCT02575963|Cytarabine|cytarabine|mesh-list
101767682|NCT02575963|Lintuzumab|lintuzumab|mesh-list
101767683|NCT02575963|Furosemide|furosemide|mesh-list
101767684|NCT02575963|Spironolactone|spironolactone|mesh-list
101767685|NCT02575963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101767686|NCT02575963|Antimetabolites|antimetabolites|mesh-ancestor
101767687|NCT02575963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564971|NCT05330065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101564972|NCT05330065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101564973|NCT05330065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101564974|NCT05330065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101564975|NCT05330065|Growth Substances|growth substances|mesh-ancestor
101564976|NCT05330065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564977|NCT05330065|Growth Inhibitors|growth inhibitors|mesh-ancestor
101564978|NCT01128543|Vinorelbine|vinorelbine|mesh-list
101564979|NCT01128543|Lapatinib|lapatinib|mesh-list
101564980|NCT01128543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101564981|NCT01128543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101413226|NCT00481819|Prednisolone|prednisolone|mesh-list
101767688|NCT02575963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767689|NCT02575963|Antiviral Agents|antiviral agents|mesh-ancestor
101767690|NCT02575963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101767691|NCT02575963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101767700|NCT02575963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101767702|NCT02575963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101767703|NCT02546661|Durvalumab|durvalumab|mesh-list
101767704|NCT02546661|Olaparib|olaparib|mesh-list
101767705|NCT02546661|Adavosertib|adavosertib|mesh-list
101767706|NCT02546661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101767707|NCT02546661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767708|NCT02546661|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101767709|NCT02546661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101767710|NCT02546661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767711|NCT02507284|SRX246|srx246|mesh-list
101767712|NCT02507284|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101767713|NCT02507284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767714|NCT02507284|Natriuretic Agents|natriuretic agents|mesh-ancestor
101767715|NCT02507284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767716|NCT02501096|Pembrolizumab|pembrolizumab|mesh-list
101767717|NCT02501096|Lenvatinib|lenvatinib|mesh-list
101767718|NCT02501096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101767719|NCT02501096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767720|NCT02501096|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101767721|NCT02501096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767722|NCT02501096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101767723|NCT02501096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101767724|NCT02494986|Rilpivirine|rilpivirine|mesh-list
101767725|NCT02494986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101767726|NCT02494986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101767727|NCT02494986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101767728|NCT02494986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767729|NCT02494986|Antiviral Agents|antiviral agents|mesh-ancestor
101767730|NCT02494986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101767731|NCT02494986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101767732|NCT02494986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101767733|NCT02432248|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101767734|NCT02432248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101767735|NCT02432248|Immunologic Factors|immunologic factors|mesh-ancestor
101767736|NCT02432248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767737|NCT02364089|Epinephrine|epinephrine|mesh-list
101767738|NCT02364089|Racepinephrine|racepinephrine|mesh-list
101767739|NCT02364089|Epinephryl borate|epinephryl borate|mesh-list
101767740|NCT02364089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101767741|NCT02364089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101767742|NCT02364089|Adrenergic Agents|adrenergic agents|mesh-ancestor
101767743|NCT02364089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101767744|NCT02364089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767745|NCT02364089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564982|NCT01128543|Tubulin Modulators|tubulin modulators|mesh-ancestor
101564983|NCT01128543|Antimitotic Agents|antimitotic agents|mesh-ancestor
101564984|NCT01128543|Mitosis Modulators|mitosis modulators|mesh-ancestor
101564985|NCT01128543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101564986|NCT01128543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101564987|NCT01128543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101564988|NCT01128387|Panitumumab|panitumumab|mesh-list
101564989|NCT01128387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101767746|NCT02364089|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101767747|NCT02364089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101767748|NCT02364089|Autonomic Agents|autonomic agents|mesh-ancestor
101767749|NCT02364089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101767750|NCT02364089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101767751|NCT02364089|Respiratory System Agents|respiratory system agents|mesh-ancestor
101767753|NCT02364089|Sympathomimetics|sympathomimetics|mesh-ancestor
101767754|NCT02364089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101767757|NCT02193425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767758|NCT02122562|Ketamine|ketamine|mesh-list
101767759|NCT02122562|Analgesics|analgesics|mesh-ancestor
101767760|NCT02122562|Sensory System Agents|sensory system agents|mesh-ancestor
101767761|NCT02122562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101767762|NCT02122562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767763|NCT02122562|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101767764|NCT02122562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101767765|NCT02122562|Anesthetics, General|anesthetics, general|mesh-ancestor
101767766|NCT02122562|Anesthetics|anesthetics|mesh-ancestor
101767767|NCT02122562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101767768|NCT02122562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101767769|NCT02122562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101767770|NCT02122562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101767771|NCT02122562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767772|NCT02115724|Vitamins|vitamins|mesh-list
101767773|NCT02115724|Vitamin E|vitamin e|mesh-list
101767774|NCT02115724|Thioctic Acid|thioctic acid|mesh-list
101767775|NCT02115724|Nitroglycerin|nitroglycerin|mesh-list
101767776|NCT02115724|Antioxidants|antioxidants|mesh-list
101767777|NCT02115724|Micronutrients|micronutrients|mesh-ancestor
101767778|NCT02115724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767779|NCT02115724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767780|NCT02115724|Protective Agents|protective agents|mesh-ancestor
101767781|NCT02115724|Vitamin B Complex|vitamin b complex|mesh-ancestor
101767782|NCT02115724|Vasodilator Agents|vasodilator agents|mesh-ancestor
101767783|NCT02036372|Insulin|insulin|mesh-list
101767784|NCT02036372|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101767785|NCT02036372|Liraglutide|liraglutide|mesh-list
101767786|NCT02036372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101767787|NCT02036372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767788|NCT02036372|Incretins|incretins|mesh-ancestor
101767789|NCT02036372|Hormones|hormones|mesh-ancestor
101767790|NCT02036372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101767791|NCT01991977|Temozolomide|temozolomide|mesh-list
101767792|NCT01991977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101767793|NCT01991977|Alkylating Agents|alkylating agents|mesh-ancestor
101767794|NCT01991977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767795|NCT01991977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767796|NCT01633541|Carboplatin|carboplatin|mesh-list
101767797|NCT01633541|Docetaxel|docetaxel|mesh-list
101767798|NCT01633541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767799|NCT01633541|Tubulin Modulators|tubulin modulators|mesh-ancestor
101767800|NCT01633541|Antimitotic Agents|antimitotic agents|mesh-ancestor
101767801|NCT01633541|Mitosis Modulators|mitosis modulators|mesh-ancestor
101767802|NCT01633541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767803|NCT01399372|Cytarabine|cytarabine|mesh-list
101767804|NCT01399372|Rituximab|rituximab|mesh-list
101767805|NCT01399372|Methotrexate|methotrexate|mesh-list
101767806|NCT01399372|Vincristine|vincristine|mesh-list
101767807|NCT01399372|Procarbazine|procarbazine|mesh-list
101564990|NCT01128387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101564991|NCT01214850|Vaccines|vaccines|mesh-list
101564992|NCT01214850|Immunologic Factors|immunologic factors|mesh-ancestor
101564993|NCT01214850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564994|NCT01128153|Saxagliptin|saxagliptin|mesh-list
101564995|NCT01128153|Incretins|incretins|mesh-ancestor
101564996|NCT01128153|Hormones|hormones|mesh-ancestor
101767808|NCT01399372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101767809|NCT01399372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767810|NCT01399372|Immunologic Factors|immunologic factors|mesh-ancestor
101767811|NCT01399372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767812|NCT01399372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101767813|NCT01399372|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101767814|NCT01399372|Abortifacient Agents|abortifacient agents|mesh-ancestor
101767815|NCT01399372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101767816|NCT01399372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101767817|NCT01399372|Antimetabolites|antimetabolites|mesh-ancestor
101767818|NCT01399372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767819|NCT01399372|Dermatologic Agents|dermatologic agents|mesh-ancestor
101767820|NCT01399372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101767821|NCT01399372|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101767822|NCT01399372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101767823|NCT01399372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101767824|NCT01399372|Antiviral Agents|antiviral agents|mesh-ancestor
101767825|NCT01399372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101767826|NCT01399372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101767827|NCT01399372|Tubulin Modulators|tubulin modulators|mesh-ancestor
101767828|NCT01399372|Antimitotic Agents|antimitotic agents|mesh-ancestor
101767841|NCT01244399|Vitamin B Complex|vitamin b complex|mesh-ancestor
101767843|NCT01244399|Micronutrients|micronutrients|mesh-ancestor
101767844|NCT01244399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767845|NCT01063517|Paclitaxel|paclitaxel|mesh-list
101767846|NCT01063517|Olaparib|olaparib|mesh-list
101767847|NCT01063517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101767848|NCT01063517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767849|NCT01063517|Tubulin Modulators|tubulin modulators|mesh-ancestor
101767850|NCT01063517|Antimitotic Agents|antimitotic agents|mesh-ancestor
101767851|NCT01063517|Mitosis Modulators|mitosis modulators|mesh-ancestor
101767852|NCT01063517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767853|NCT01063517|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101767854|NCT01063517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101767855|NCT00920621|Vitamin D|vitamin d|mesh-list
101767856|NCT00920621|Ergocalciferols|ergocalciferols|mesh-list
101767857|NCT00920621|Cholecalciferol|cholecalciferol|mesh-list
101767858|NCT00920621|Vitamins|vitamins|mesh-list
101767859|NCT00920621|Micronutrients|micronutrients|mesh-ancestor
101767860|NCT00920621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767861|NCT00920621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101767862|NCT00920621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101767874|NCT00964756|Ganciclovir|ganciclovir|mesh-list
101767875|NCT00964756|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101767876|NCT00964756|Antiviral Agents|antiviral agents|mesh-ancestor
101767877|NCT00964756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101767878|NCT00964756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101767879|NCT00964756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101767880|NCT00964756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767881|NCT00964834|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101767882|NCT00964834|Doxycycline|doxycycline|mesh-list
101767883|NCT00964834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101564997|NCT01128153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101564998|NCT01128153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101564999|NCT01128153|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101565000|NCT01128153|Protease Inhibitors|protease inhibitors|mesh-ancestor
101565001|NCT01128153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101565002|NCT01128153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565003|NCT01128153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101565004|NCT00925015|Irinotecan|irinotecan|mesh-list
101767884|NCT00964834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101767885|NCT00964834|Antitubercular Agents|antitubercular agents|mesh-ancestor
101767886|NCT00964834|Antimalarials|antimalarials|mesh-ancestor
101767887|NCT00964834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101767888|NCT00964834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101767889|NCT00612105|Ezogabine|ezogabine|mesh-list
101767890|NCT00612105|Anticonvulsants|anticonvulsants|mesh-ancestor
101767891|NCT00612105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101767892|NCT00612105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767893|NCT04017741|Methylprednisolone|methylprednisolone|mesh-list
101767894|NCT04017741|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101767903|NCT04017741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101767904|NCT04017741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767905|NCT04017741|Sensory System Agents|sensory system agents|mesh-ancestor
101767906|NCT04017741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101767907|NCT04017741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101767908|NCT04017741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101767909|NCT04017741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101767910|NCT04017741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101767911|NCT04017741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767912|NCT04017741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101767913|NCT04017741|Antiemetics|antiemetics|mesh-ancestor
101767914|NCT04017741|Autonomic Agents|autonomic agents|mesh-ancestor
101767915|NCT04017741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101767916|NCT04017741|Glucocorticoids|glucocorticoids|mesh-ancestor
101828258|NCT05853367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767918|NCT04017741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101767919|NCT04017741|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101767920|NCT04017741|Protective Agents|protective agents|mesh-ancestor
101767921|NCT04017741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101767922|NCT04017741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767924|NCT00546052|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101767925|NCT00546052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101767926|NCT00546052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101767927|NCT00546052|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101767928|NCT00546052|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101767929|NCT00546052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767930|NCT00546052|Diuretics|diuretics|mesh-ancestor
101767931|NCT00546052|Natriuretic Agents|natriuretic agents|mesh-ancestor
101767932|NCT00546052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767933|NCT00546052|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101767934|NCT00546052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101767935|NCT00887601|Donepezil|donepezil|mesh-list
101767936|NCT00887601|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101767937|NCT00887601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101767938|NCT00887601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767939|NCT00887601|Cholinergic Agents|cholinergic agents|mesh-ancestor
101767940|NCT00887601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101767941|NCT00887601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767942|NCT00887601|Nootropic Agents|nootropic agents|mesh-ancestor
101767943|NCT02542839|Botulinum Toxins|botulinum toxins|mesh-list
101767944|NCT02542839|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101767945|NCT02542839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101767946|NCT02542839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565005|NCT00925015|Cetuximab|cetuximab|mesh-list
101565006|NCT00925015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101565007|NCT00925015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101565008|NCT00925015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101565009|NCT00925015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101565010|NCT00925015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565011|NCT00925015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101565012|NCT00925015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101565013|NCT00925015|Immunologic Factors|immunologic factors|mesh-ancestor
101565014|NCT00925015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565015|NCT01127763|Carboplatin|carboplatin|mesh-list
101565016|NCT01127763|Everolimus|everolimus|mesh-list
101413263|NCT00481975|Hormones|hormones|mesh-ancestor
101767947|NCT02542839|Cholinergic Agents|cholinergic agents|mesh-ancestor
101767948|NCT02542839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101767949|NCT02542839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767950|NCT00887757|Gemcitabine|gemcitabine|mesh-list
101767951|NCT00887757|Navitoclax|navitoclax|mesh-list
101767952|NCT00887757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101767953|NCT00887757|Antimetabolites|antimetabolites|mesh-ancestor
101767954|NCT00887757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767955|NCT00887757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767956|NCT00965224|Immunomodulating Agents|immunomodulating agents|mesh-list
101767957|NCT00965224|Immunologic Factors|immunologic factors|mesh-ancestor
101767958|NCT00965224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767959|NCT04392921|Amiodarone|amiodarone|mesh-list
101767960|NCT04392921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101767961|NCT04392921|Vasodilator Agents|vasodilator agents|mesh-ancestor
101767962|NCT04392921|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101767965|NCT04392921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101767966|NCT04392921|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101767967|NCT04392921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101767968|NCT04392921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101767969|NCT04392921|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101767970|NCT04392921|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101767971|NCT04392921|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101767973|NCT00673920|Ocrelizumab|ocrelizumab|mesh-list
101767974|NCT00673920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101407752|NCT00142974|Tegaserod|tegaserod|mesh-list
101767975|NCT00673920|Abortifacient Agents|abortifacient agents|mesh-ancestor
101767976|NCT00673920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101767977|NCT00673920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767978|NCT00673920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101767979|NCT00673920|Antimetabolites|antimetabolites|mesh-ancestor
101767980|NCT00673920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767981|NCT00673920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767982|NCT00673920|Dermatologic Agents|dermatologic agents|mesh-ancestor
101767983|NCT00673920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101767984|NCT00673920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101767985|NCT00673920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101767986|NCT00673920|Immunologic Factors|immunologic factors|mesh-ancestor
101767987|NCT00673920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101767988|NCT00673920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101767989|NCT00959686|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101767990|NCT00959686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101767991|NCT00959686|Alkylating Agents|alkylating agents|mesh-ancestor
101767992|NCT00959686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767993|NCT00959686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767994|NCT00379795|Ranibizumab|ranibizumab|mesh-list
101767995|NCT00379795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101767996|NCT00379795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101565017|NCT01127763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101565018|NCT01127763|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101565019|NCT01127763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101565020|NCT01127763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101565021|NCT01127763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565022|NCT01127763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101565023|NCT01127763|Immunologic Factors|immunologic factors|mesh-ancestor
101565024|NCT01127763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767997|NCT00379795|Growth Substances|growth substances|mesh-ancestor
101767998|NCT00379795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767999|NCT00379795|Growth Inhibitors|growth inhibitors|mesh-ancestor
101768000|NCT00379795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101768002|NCT04588948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101768003|NCT04588948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101768004|NCT04588948|Growth Substances|growth substances|mesh-ancestor
101768005|NCT04588948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768006|NCT04588948|Growth Inhibitors|growth inhibitors|mesh-ancestor
101768007|NCT04588948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101768008|NCT00765024|Ivermectin|ivermectin|mesh-list
101768009|NCT00765024|Albendazole|albendazole|mesh-list
101768010|NCT00765024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101768011|NCT00765024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101768012|NCT00765024|Anthelmintics|anthelmintics|mesh-ancestor
101768013|NCT00765024|Anticestodal Agents|anticestodal agents|mesh-ancestor
101768014|NCT00765024|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101768015|NCT00765024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101768016|NCT00765024|Tubulin Modulators|tubulin modulators|mesh-ancestor
101768017|NCT00765024|Antimitotic Agents|antimitotic agents|mesh-ancestor
101768018|NCT00765024|Mitosis Modulators|mitosis modulators|mesh-ancestor
101768019|NCT00765024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768020|NCT00765024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101768021|NCT02557932|Bismuth|bismuth|mesh-list
101768022|NCT02557932|Antacids|antacids|mesh-ancestor
101768023|NCT02557932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768024|NCT02557932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101768025|NCT00960232|Cholecalciferol|cholecalciferol|mesh-list
101768026|NCT00960232|Vitamin D|vitamin d|mesh-list
101768027|NCT00960232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101768028|NCT00960232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768029|NCT00960232|Vitamins|vitamins|mesh-ancestor
101768030|NCT00960232|Micronutrients|micronutrients|mesh-ancestor
101768038|NCT04577014|Tubulin Modulators|tubulin modulators|mesh-ancestor
101768039|NCT04577014|Antimitotic Agents|antimitotic agents|mesh-ancestor
101768040|NCT04577014|Mitosis Modulators|mitosis modulators|mesh-ancestor
101768041|NCT05282550|Trazodone|trazodone|mesh-list
101768042|NCT05282550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101768043|NCT05282550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101768044|NCT05282550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101768045|NCT05282550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768046|NCT05282550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101768047|NCT05282550|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101768048|NCT05282550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101828268|NCT05839119|Gemcitabine|gemcitabine|mesh-list
101768049|NCT05282550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101768050|NCT05282550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768051|NCT05282550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101768052|NCT05282550|Serotonin Agents|serotonin agents|mesh-ancestor
101768053|NCT05282550|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101768054|NCT05282550|Antidepressive Agents|antidepressive agents|mesh-ancestor
101768055|NCT00960310|Bicalutamide|bicalutamide|mesh-list
101768056|NCT00960310|Androgen Antagonists|androgen antagonists|mesh-ancestor
101768057|NCT00960310|Hormone Antagonists|hormone antagonists|mesh-ancestor
101768058|NCT00960310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101768059|NCT00960310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768060|NCT00960310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101768061|NCT00610155|Pregabalin|pregabalin|mesh-list
101565025|NCT01127607|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101565026|NCT01127607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101565027|NCT01127607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565028|NCT01127607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101565029|NCT01127607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101565030|NCT01127607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101768063|NCT00610155|Analgesics|analgesics|mesh-ancestor
101768064|NCT00610155|Sensory System Agents|sensory system agents|mesh-ancestor
101768065|NCT00610155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101768066|NCT00610155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768067|NCT00610155|Anticonvulsants|anticonvulsants|mesh-ancestor
101768068|NCT00610155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101768069|NCT00610155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101768070|NCT00610155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768071|NCT00610155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101768072|NCT00610155|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101768073|NCT00610155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101768074|NCT00610155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101768075|NCT00610155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101768076|NCT00610155|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101768077|NCT00610155|Narcotics|narcotics|mesh-ancestor
101768078|NCT00759018|Remestemcel-l|remestemcel-l|mesh-list
101768079|NCT00759018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101768080|NCT00759018|Antiviral Agents|antiviral agents|mesh-ancestor
101768081|NCT00759018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101768082|NCT00960544|Capecitabine|capecitabine|mesh-list
101768083|NCT00960544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101768084|NCT00960544|Antimetabolites|antimetabolites|mesh-ancestor
101768085|NCT00960544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768086|NCT00960544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101768087|NCT04488952|Anesthetics|anesthetics|mesh-list
101768088|NCT04488952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101768089|NCT04488952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768090|NCT00888303|Dexamethasone|dexamethasone|mesh-list
101768091|NCT00888303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101768092|NCT00888303|Antiemetics|antiemetics|mesh-ancestor
101768093|NCT00888303|Autonomic Agents|autonomic agents|mesh-ancestor
101768094|NCT00888303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101768095|NCT00888303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768099|NCT00888303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101768100|NCT00888303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101768101|NCT00888303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101768103|NCT00967642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101768104|NCT00967642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768105|NCT00674700|Immunomodulating Agents|immunomodulating agents|mesh-list
101768106|NCT00674700|Immunologic Factors|immunologic factors|mesh-list
101768107|NCT00674700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768108|NCT00762918|Vitamin D|vitamin d|mesh-list
101768109|NCT00762918|Cholecalciferol|cholecalciferol|mesh-list
101768110|NCT00762918|Vitamins|vitamins|mesh-ancestor
101768111|NCT00762918|Micronutrients|micronutrients|mesh-ancestor
101768112|NCT00762918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768113|NCT00762918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101768114|NCT00762918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101768115|NCT00546910|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101768116|NCT00546910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101768117|NCT00546910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101768118|NCT00546910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101768119|NCT00546910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768120|NCT00546910|Adrenergic Agents|adrenergic agents|mesh-ancestor
101768121|NCT00546910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101768122|NCT00546910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768123|NCT00759720|Glyburide|glyburide|mesh-list
101768124|NCT00759720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101565031|NCT01127607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565032|NCT01127607|Dopamine Agents|dopamine agents|mesh-ancestor
101565033|NCT01127607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101565034|NCT00924781|Epoetin Alfa|epoetin alfa|mesh-list
101565035|NCT00924781|Hematinics|hematinics|mesh-ancestor
101565036|NCT01127451|Denileukin diftitox|denileukin diftitox|mesh-list
101565037|NCT01127451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101565038|NCT01214616|Vinorelbine|vinorelbine|mesh-list
101565039|NCT01214616|Afatinib|afatinib|mesh-list
101768125|NCT00759720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768126|NCT00379639|Gemcitabine|gemcitabine|mesh-list
101768127|NCT00379639|Romidepsin|romidepsin|mesh-list
101768128|NCT00379639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101768129|NCT00379639|Antimetabolites|antimetabolites|mesh-ancestor
101768130|NCT00379639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768131|NCT00379639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101768132|NCT00379639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101768133|NCT00379639|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101768134|NCT00379639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101768135|NCT00609765|Dexamethasone|dexamethasone|mesh-list
101768136|NCT00609765|Bevacizumab|bevacizumab|mesh-list
101768137|NCT00609765|Doxorubicin|doxorubicin|mesh-list
101768138|NCT00609765|Fluorouracil|fluorouracil|mesh-list
101768139|NCT00609765|Streptozocin|streptozocin|mesh-list
101768140|NCT00609765|Ondansetron|ondansetron|mesh-list
101768141|NCT00609765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101768142|NCT00609765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101768143|NCT00609765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101768144|NCT00609765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101768145|NCT00609765|Growth Substances|growth substances|mesh-ancestor
101768146|NCT00609765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768147|NCT00609765|Growth Inhibitors|growth inhibitors|mesh-ancestor
101768148|NCT00609765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101768149|NCT00609765|Antiemetics|antiemetics|mesh-ancestor
101768150|NCT00609765|Autonomic Agents|autonomic agents|mesh-ancestor
101768151|NCT00609765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101768152|NCT00609765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101768153|NCT00609765|Glucocorticoids|glucocorticoids|mesh-ancestor
101768154|NCT00609765|Hormones|hormones|mesh-ancestor
101768155|NCT00609765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101768156|NCT00609765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101768157|NCT00609765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101768158|NCT00609765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101768159|NCT00609765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101768160|NCT00609765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101768161|NCT00609765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768162|NCT00609765|Antimetabolites|antimetabolites|mesh-ancestor
101768163|NCT00609765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101768164|NCT00609765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101768165|NCT00609765|Immunologic Factors|immunologic factors|mesh-ancestor
101768166|NCT00609765|Antipruritics|antipruritics|mesh-ancestor
101768167|NCT00609765|Dermatologic Agents|dermatologic agents|mesh-ancestor
101768174|NCT01051219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101768175|NCT01051219|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101768176|NCT01051219|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101768177|NCT01051219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768178|NCT00961324|Insulin|insulin|mesh-list
101768179|NCT00961324|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101768180|NCT00961324|Insulin Glargine|insulin glargine|mesh-list
101768181|NCT00961324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101768182|NCT00961324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768183|NCT00766350|Amitriptyline|amitriptyline|mesh-list
101768184|NCT00766350|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101768185|NCT00766350|Antidepressive Agents|antidepressive agents|mesh-ancestor
101768186|NCT00766350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101768187|NCT00766350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101425605|NCT03539627|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
101768188|NCT00766350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101565040|NCT01214616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101565041|NCT01214616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101565042|NCT01214616|Tubulin Modulators|tubulin modulators|mesh-ancestor
101565043|NCT01214616|Antimitotic Agents|antimitotic agents|mesh-ancestor
101565044|NCT01214616|Mitosis Modulators|mitosis modulators|mesh-ancestor
101565045|NCT01214616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565046|NCT01214616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101565047|NCT01214616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101565048|NCT01213836|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101565049|NCT01213836|Antidepressive Agents|antidepressive agents|mesh-ancestor
101565050|NCT01213836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101565051|NCT01213836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101565052|NCT01213836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101565053|NCT01213836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101565054|NCT01213836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565055|NCT01213524|Nicotine|nicotine|mesh-list
101565056|NCT01213524|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101768189|NCT00766350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101768190|NCT00766350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768191|NCT00766350|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101768192|NCT00766350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101768193|NCT00766350|Analgesics|analgesics|mesh-ancestor
101768194|NCT00766350|Sensory System Agents|sensory system agents|mesh-ancestor
101768195|NCT00766350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101768196|NCT00766350|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101768197|NCT00766350|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101768198|NCT00766350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101768199|NCT00766350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768200|NCT00766350|Adrenergic Agents|adrenergic agents|mesh-ancestor
101768201|NCT00766350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101768202|NCT00889161|Curcumin|curcumin|mesh-list
101768203|NCT00889161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101768204|NCT00889161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101768205|NCT00889161|Analgesics|analgesics|mesh-ancestor
101768206|NCT00889161|Sensory System Agents|sensory system agents|mesh-ancestor
101768207|NCT00889161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101768208|NCT00889161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768209|NCT00889161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101768210|NCT00889161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101768211|NCT00889161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101768212|NCT00889161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101768213|NCT00889161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768214|NCT03992755|Treprostinil|treprostinil|mesh-list
101768215|NCT03992755|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101768216|NCT01563328|Dolutegravir|dolutegravir|mesh-list
101768217|NCT01563328|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101768218|NCT01563328|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101768219|NCT01563328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101768220|NCT01563328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768221|NCT01563328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101768222|NCT01563328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101768223|NCT01563328|Antiviral Agents|antiviral agents|mesh-ancestor
101768224|NCT01563328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101768225|NCT00760032|Ciprofloxacin|ciprofloxacin|mesh-list
101768226|NCT00760032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101768227|NCT00760032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101565057|NCT01213524|Autonomic Agents|autonomic agents|mesh-ancestor
101565058|NCT01213524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101565059|NCT01213524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565060|NCT01213524|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101565061|NCT01213524|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101565062|NCT01213524|Cholinergic Agents|cholinergic agents|mesh-ancestor
101565063|NCT01213524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101565064|NCT01213524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565066|NCT01212588|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101565067|NCT01212588|Abortifacient Agents|abortifacient agents|mesh-ancestor
101565068|NCT01212588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101565069|NCT01212588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565070|NCT01212588|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101565071|NCT01212588|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101565072|NCT01212588|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101565073|NCT01212588|Contraceptive Agents|contraceptive agents|mesh-ancestor
101768228|NCT00760032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101768229|NCT00760032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101768230|NCT00760032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101768231|NCT00760032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768232|NCT00760032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101768233|NCT00760032|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101768234|NCT00760032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101768245|NCT00961480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768247|NCT00766662|Sulfadoxine|sulfadoxine|mesh-list
101768248|NCT00766662|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101768249|NCT00766662|Antimalarials|antimalarials|mesh-ancestor
101768250|NCT00766662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101768251|NCT00766662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101768252|NCT00766662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101768253|NCT00766662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101768254|NCT00766662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101768255|NCT00766662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768256|NCT00766662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101768257|NCT00965926|Mirabegron|mirabegron|mesh-list
101768258|NCT00965926|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101768259|NCT00965926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101768260|NCT00965926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101768261|NCT00965926|Adrenergic Agents|adrenergic agents|mesh-ancestor
101768262|NCT00965926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101768263|NCT00965926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768264|NCT00965926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768265|NCT00965926|Urological Agents|urological agents|mesh-ancestor
101768267|NCT00966004|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101768268|NCT00966004|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101768269|NCT00966004|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101768270|NCT00966004|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101768271|NCT00966004|Adrenergic Agents|adrenergic agents|mesh-ancestor
101768272|NCT00966004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101768273|NCT00966004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768274|NCT00966004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768275|NCT00966004|Urological Agents|urological agents|mesh-ancestor
101768276|NCT00966004|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101768277|NCT00966004|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101768278|NCT00966004|Cholinergic Agents|cholinergic agents|mesh-ancestor
101565074|NCT01212588|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101565075|NCT01212588|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101565076|NCT01212588|Hormone Antagonists|hormone antagonists|mesh-ancestor
101565077|NCT01212588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101565078|NCT01212588|Luteolytic Agents|luteolytic agents|mesh-ancestor
101565079|NCT01212588|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101768279|NCT00966082|Propranolol|propranolol|mesh-list
101768280|NCT00966082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101768281|NCT00966082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101768282|NCT00966082|Adrenergic Agents|adrenergic agents|mesh-ancestor
101768283|NCT00966082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101768284|NCT00966082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768285|NCT00966082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768286|NCT00966082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101768287|NCT00966082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101768288|NCT00966082|Vasodilator Agents|vasodilator agents|mesh-ancestor
101768289|NCT00889629|Vitamin D|vitamin d|mesh-list
101768290|NCT00889629|Cholecalciferol|cholecalciferol|mesh-list
101768291|NCT00889629|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
101768292|NCT00889629|Ergocalciferols|ergocalciferols|mesh-list
101768293|NCT00889629|Vitamins|vitamins|mesh-ancestor
101768294|NCT00889629|Micronutrients|micronutrients|mesh-ancestor
101768295|NCT00889629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768296|NCT00889629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101768297|NCT00889629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101768298|NCT00966160|Ritonavir|ritonavir|mesh-list
101768299|NCT00966160|Lopinavir|lopinavir|mesh-list
101768305|NCT00966160|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101768306|NCT00966160|Protease Inhibitors|protease inhibitors|mesh-ancestor
101768307|NCT00966160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101768308|NCT00966160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768309|NCT00966160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101768310|NCT00966160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101768311|NCT00966160|Antiviral Agents|antiviral agents|mesh-ancestor
101768312|NCT00966160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101768313|NCT00966160|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101768314|NCT00966160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101768315|NCT00966160|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101768316|NCT00966160|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101768317|NCT00966160|Antimetabolites|antimetabolites|mesh-ancestor
101768318|NCT00966160|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101768319|NCT00966160|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101768320|NCT00966160|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101768321|NCT00966160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101768322|NCT00966160|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101768323|NCT00766818|Lopinavir|lopinavir|mesh-list
101768324|NCT00766818|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101768325|NCT00766818|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101768326|NCT00766818|Protease Inhibitors|protease inhibitors|mesh-ancestor
101768327|NCT00766818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101768328|NCT00766818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768329|NCT00766818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101768330|NCT00766818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101768331|NCT00766818|Antiviral Agents|antiviral agents|mesh-ancestor
101768332|NCT00766818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101768333|NCT00766818|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101425762|NCT02946970|Analgesics|analgesics|mesh-ancestor
101768334|NCT00766818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101768336|NCT00966316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101768337|NCT00966316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101768338|NCT00966316|Analgesics|analgesics|mesh-ancestor
101768339|NCT00966316|Sensory System Agents|sensory system agents|mesh-ancestor
101768340|NCT00966316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101768341|NCT00966316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768342|NCT00966316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101768343|NCT00966316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101565080|NCT01212588|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101565081|NCT00918385|Dasatinib|dasatinib|mesh-list
101565082|NCT00918385|Nilutamide|nilutamide|mesh-list
101565083|NCT00918385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101565084|NCT00918385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101565085|NCT00918385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101565086|NCT00918385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565087|NCT00918385|Androgen Antagonists|androgen antagonists|mesh-ancestor
101565088|NCT00918385|Hormone Antagonists|hormone antagonists|mesh-ancestor
101565089|NCT00918385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101565090|NCT00918385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565091|NCT00637819|Leflunomide|leflunomide|mesh-list
101565092|NCT00637819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101413330|NCT00120302|Immunologic Factors|immunologic factors|mesh-ancestor
101768344|NCT00966316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101768345|NCT00966316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101768346|NCT00966316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768347|NCT00966316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101768348|NCT00966316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101768349|NCT00966316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101768350|NCT00966316|Antipyretics|antipyretics|mesh-ancestor
101768351|NCT00892827|Rituximab|rituximab|mesh-list
101768352|NCT00892827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101768353|NCT00892827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101768354|NCT00892827|Immunologic Factors|immunologic factors|mesh-ancestor
101768355|NCT00892827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768356|NCT00892827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101768357|NCT00766896|Aspirin|aspirin|mesh-list
101768358|NCT00766896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101768359|NCT00766896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101768360|NCT00766896|Analgesics|analgesics|mesh-ancestor
101768361|NCT00766896|Sensory System Agents|sensory system agents|mesh-ancestor
101768362|NCT00766896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101768363|NCT00766896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768364|NCT00766896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101768365|NCT00766896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101768366|NCT00766896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101768367|NCT00766896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101768368|NCT00766896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768376|NCT00763620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768378|NCT00973804|Tacrolimus|tacrolimus|mesh-list
101768379|NCT00973804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101768380|NCT00973804|Immunologic Factors|immunologic factors|mesh-ancestor
101768381|NCT00973804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768382|NCT00973804|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101768383|NCT00973804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101768384|NCT00973804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768385|NCT00973804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101768386|NCT00973804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101768387|NCT00973804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101768388|NCT00973804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101768389|NCT00973804|Antifungal Agents|antifungal agents|mesh-ancestor
101768390|NCT04018131|Cimetidine|cimetidine|mesh-list
101768391|NCT04018131|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101768392|NCT04018131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101768393|NCT04018131|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101768394|NCT04018131|Histamine Antagonists|histamine antagonists|mesh-ancestor
101768395|NCT04018131|Histamine Agents|histamine agents|mesh-ancestor
101768396|NCT04018131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101565093|NCT00637819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565094|NCT00637819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101565095|NCT00637819|Immunologic Factors|immunologic factors|mesh-ancestor
101565096|NCT00637819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565097|NCT00631501|Doxycycline|doxycycline|mesh-list
101565098|NCT00631501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101565099|NCT00631501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101565100|NCT00631501|Antimalarials|antimalarials|mesh-ancestor
101565101|NCT00631501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101565102|NCT00631501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101565103|NCT04746547|Dolutegravir|dolutegravir|mesh-list
101565104|NCT04746547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101565105|NCT04746547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101565106|NCT04746547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101565107|NCT04746547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565109|NCT04746547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101565110|NCT04746547|Antiviral Agents|antiviral agents|mesh-ancestor
101565111|NCT04746547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101565112|NCT04782037|Calcium|calcium|mesh-list
101565113|NCT04782037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101565114|NCT04782037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565115|NCT00924469|Prednisone|prednisone|mesh-list
101565116|NCT00924469|Leuprolide|leuprolide|mesh-list
101413353|NCT00120380|Iloprost|iloprost|mesh-list
101768397|NCT04018131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768398|NCT04018131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768399|NCT04018131|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101768400|NCT04018131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101768401|NCT04018131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101768402|NCT00973882|Carboplatin|carboplatin|mesh-list
101768403|NCT00973882|Etoposide|etoposide|mesh-list
101768404|NCT00973882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101768405|NCT00973882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101768406|NCT00973882|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101768407|NCT00973882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101768408|NCT00973882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101768409|NCT00973882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768410|NCT02558088|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101768411|NCT02558088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101768412|NCT02558088|Autonomic Agents|autonomic agents|mesh-ancestor
101768413|NCT02558088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101768414|NCT02558088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768415|NCT02558088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101768416|NCT02558088|Respiratory System Agents|respiratory system agents|mesh-ancestor
101768417|NCT02558088|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101768418|NCT02558088|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101768419|NCT02558088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101768420|NCT02558088|Adrenergic Agents|adrenergic agents|mesh-ancestor
101768421|NCT02558088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101565117|NCT00924469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101565118|NCT00924469|Glucocorticoids|glucocorticoids|mesh-ancestor
101565119|NCT00924469|Hormones|hormones|mesh-ancestor
101565120|NCT00924469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101565121|NCT00924469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565122|NCT00924469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101768422|NCT02558088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768423|NCT05279482|Methylprednisolone|methylprednisolone|mesh-list
101768424|NCT05279482|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101768425|NCT05279482|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101768426|NCT05279482|Prednisolone|prednisolone|mesh-list
101768427|NCT05279482|Prednisolone acetate|prednisolone acetate|mesh-list
101768428|NCT05279482|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101768429|NCT05279482|Prednisolone phosphate|prednisolone phosphate|mesh-list
101768430|NCT05279482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101768431|NCT05279482|Antiemetics|antiemetics|mesh-ancestor
101768432|NCT05279482|Autonomic Agents|autonomic agents|mesh-ancestor
101768433|NCT05279482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101768434|NCT05279482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768435|NCT05279482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101768442|NCT05279482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101768443|NCT00890175|Loxapine|loxapine|mesh-list
101768444|NCT00890175|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101768445|NCT00890175|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101768446|NCT00890175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101768447|NCT00890175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768448|NCT00890175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101768449|NCT00890175|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101768450|NCT00890175|Dopamine Agents|dopamine agents|mesh-ancestor
101768451|NCT00890175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101768452|NCT00890175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768453|NCT00966472|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101768454|NCT00966472|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101768455|NCT00966472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101768456|NCT00966472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101768457|NCT00966472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101768458|NCT00966472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768459|NCT00966472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101768460|NCT00966472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101768461|NCT00966472|Antimetabolites|antimetabolites|mesh-ancestor
101768462|NCT00966472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101768463|NCT00966472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101768464|NCT00890253|Mycophenolic Acid|mycophenolic acid|mesh-list
101768465|NCT00890253|Prednisone|prednisone|mesh-list
101768466|NCT00890253|Prednisolone|prednisolone|mesh-list
101768467|NCT00890253|Everolimus|everolimus|mesh-list
101768468|NCT00890253|Basiliximab|basiliximab|mesh-list
101768469|NCT00890253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101768470|NCT00890253|Glucocorticoids|glucocorticoids|mesh-ancestor
101768471|NCT00890253|Hormones|hormones|mesh-ancestor
101768472|NCT00890253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101768473|NCT00890253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768474|NCT00890253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101768475|NCT00890253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101768476|NCT00890253|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101768477|NCT00890253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101768478|NCT00890253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101768479|NCT00890253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768480|NCT00890253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101768481|NCT00890253|Immunologic Factors|immunologic factors|mesh-ancestor
101768483|NCT00890253|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101768484|NCT00890253|Antitubercular Agents|antitubercular agents|mesh-ancestor
101768485|NCT00890253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101768486|NCT00890253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101768487|NCT00674154|Vitamin D|vitamin d|mesh-list
101768489|NCT00674154|Vitamins|vitamins|mesh-ancestor
101768490|NCT00674154|Micronutrients|micronutrients|mesh-ancestor
101319357|NCT04733326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101768491|NCT00674154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565123|NCT00924469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101565124|NCT00924469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101565125|NCT00924469|Fertility Agents|fertility agents|mesh-ancestor
101565126|NCT00924469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101565127|NCT00631579|Rasburicase|rasburicase|mesh-list
101565128|NCT00631579|Gout Suppressants|gout suppressants|mesh-ancestor
101565129|NCT00631579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101565130|NCT04256473|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101768492|NCT00674154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101768493|NCT00674154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101768494|NCT00967954|Hormones|hormones|mesh-list
101768495|NCT00967954|Androgen Antagonists|androgen antagonists|mesh-list
101768496|NCT00967954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101768497|NCT00967954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768498|NCT00967954|Hormone Antagonists|hormone antagonists|mesh-ancestor
101768499|NCT00767286|Cobalt|cobalt|mesh-list
101768500|NCT00767286|Goserelin|goserelin|mesh-list
101768501|NCT00767286|Flutamide|flutamide|mesh-list
101768502|NCT00767286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101768503|NCT00767286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101768504|NCT00767286|Trace Elements|trace elements|mesh-ancestor
101768505|NCT00767286|Micronutrients|micronutrients|mesh-ancestor
101768506|NCT00767286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768512|NCT00968110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101768513|NCT00968110|Respiratory System Agents|respiratory system agents|mesh-ancestor
101768514|NCT00608517|Methylprednisolone|methylprednisolone|mesh-list
101768515|NCT00608517|Cyclophosphamide|cyclophosphamide|mesh-list
101768516|NCT00608517|Fludarabine|fludarabine|mesh-list
101768517|NCT00608517|Fludarabine phosphate|fludarabine phosphate|mesh-list
101768518|NCT00608517|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101768519|NCT00608517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101768520|NCT00608517|Immunologic Factors|immunologic factors|mesh-ancestor
101768521|NCT00608517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768522|NCT00608517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101768523|NCT00608517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101768524|NCT00608517|Alkylating Agents|alkylating agents|mesh-ancestor
101768525|NCT00608517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768526|NCT00608517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101768527|NCT00608517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101768528|NCT00608517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101768529|NCT00608517|Antimetabolites|antimetabolites|mesh-ancestor
101768530|NCT00608517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101768531|NCT00608517|Antiemetics|antiemetics|mesh-ancestor
101768532|NCT00608517|Autonomic Agents|autonomic agents|mesh-ancestor
101768533|NCT00608517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101768534|NCT00608517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101768535|NCT00608517|Glucocorticoids|glucocorticoids|mesh-ancestor
101768536|NCT00608517|Hormones|hormones|mesh-ancestor
101768537|NCT00608517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101768538|NCT00608517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101768539|NCT00608517|Protective Agents|protective agents|mesh-ancestor
101768540|NCT00966706|Gemcitabine|gemcitabine|mesh-list
101768541|NCT00966706|Docetaxel|docetaxel|mesh-list
101768542|NCT00966706|Capecitabine|capecitabine|mesh-list
101768543|NCT00966706|Epirubicin|epirubicin|mesh-list
101768544|NCT00966706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101768545|NCT00966706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101768546|NCT00966706|Antimetabolites|antimetabolites|mesh-ancestor
101768547|NCT00966706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768548|NCT00966706|Tubulin Modulators|tubulin modulators|mesh-ancestor
101768549|NCT00966706|Antimitotic Agents|antimitotic agents|mesh-ancestor
101768550|NCT00966706|Mitosis Modulators|mitosis modulators|mesh-ancestor
101768551|NCT00966706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101768552|NCT00966706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101768553|NCT00966706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101768554|NCT00966706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101768555|NCT00893061|Tamoxifen|tamoxifen|mesh-list
101768556|NCT00893061|Letrozole|letrozole|mesh-list
101768557|NCT00893061|Anastrozole|anastrozole|mesh-list
101768558|NCT00893061|Exemestane|exemestane|mesh-list
101565132|NCT04256473|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101565133|NCT04256473|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101565134|NCT04256473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565135|NCT00916357|Insulin|insulin|mesh-list
101413383|NCT05176470|Cyclophosphamide|cyclophosphamide|mesh-list
101768559|NCT00893061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768560|NCT00893061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101768561|NCT00893061|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101768562|NCT00893061|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101768563|NCT00893061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101768564|NCT00893061|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101768565|NCT00893061|Hormone Antagonists|hormone antagonists|mesh-ancestor
101768566|NCT00893061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101768567|NCT00893061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768568|NCT00893061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101768569|NCT00893061|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101768570|NCT00893061|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101768571|NCT00893061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101768572|NCT00974272|Exenatide|exenatide|mesh-list
101768573|NCT00974272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101768574|NCT00974272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768575|NCT00974272|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101768576|NCT00974272|Incretins|incretins|mesh-ancestor
101768577|NCT00974272|Hormones|hormones|mesh-ancestor
101768583|NCT00974584|Paclitaxel|paclitaxel|mesh-list
101768584|NCT00974584|Bevacizumab|bevacizumab|mesh-list
101768585|NCT00974584|Carboplatin|carboplatin|mesh-list
101768586|NCT00974584|Pemetrexed|pemetrexed|mesh-list
101768587|NCT00974584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101768588|NCT00974584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101768589|NCT00974584|Tubulin Modulators|tubulin modulators|mesh-ancestor
101768590|NCT00974584|Antimitotic Agents|antimitotic agents|mesh-ancestor
101768591|NCT00974584|Mitosis Modulators|mitosis modulators|mesh-ancestor
101768592|NCT00974584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768593|NCT00974584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101768594|NCT00974584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101768595|NCT00974584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101768596|NCT00974584|Growth Substances|growth substances|mesh-ancestor
101768597|NCT00974584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768598|NCT00974584|Growth Inhibitors|growth inhibitors|mesh-ancestor
101768599|NCT00974584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101768600|NCT00974584|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101768601|NCT00974584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101768602|NCT00608205|Fluorouracil|fluorouracil|mesh-list
101768603|NCT00608205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101768604|NCT00608205|Antimetabolites|antimetabolites|mesh-ancestor
101768605|NCT00608205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768606|NCT00608205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101768607|NCT00608205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101768608|NCT00608205|Immunologic Factors|immunologic factors|mesh-ancestor
101768609|NCT00608205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768610|NCT00974740|Atorvastatin|atorvastatin|mesh-list
101768611|NCT00974740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101768612|NCT00974740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101768613|NCT00974740|Antimetabolites|antimetabolites|mesh-ancestor
101768614|NCT00974740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768615|NCT00974740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101768616|NCT00974740|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101768617|NCT00974740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101768618|NCT00967096|Rifaximin|rifaximin|mesh-list
101768619|NCT00967096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101319380|NCT00387179|Melatonin|melatonin|mesh-list
101768620|NCT00967096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101768621|NCT00967096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101768622|NCT05227300|Lidocaine|lidocaine|mesh-list
101768623|NCT05227300|Epinephrine|epinephrine|mesh-list
101768624|NCT05227300|Anesthetics, Local|anesthetics, local|mesh-ancestor
101768625|NCT05227300|Anesthetics|anesthetics|mesh-ancestor
101768626|NCT05227300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101565136|NCT00916357|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101565137|NCT00916357|Insulin Lispro|insulin lispro|mesh-list
101565138|NCT00916357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101565139|NCT00916357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565140|NCT00916279|Paclitaxel|paclitaxel|mesh-list
101565141|NCT00916279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101413387|NCT05176470|Immunologic Factors|immunologic factors|mesh-ancestor
101768627|NCT05227300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768628|NCT05227300|Sensory System Agents|sensory system agents|mesh-ancestor
101768629|NCT05227300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101768630|NCT05227300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101768631|NCT05227300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101426077|NCT00527449|Carboplatin|carboplatin|mesh-list
101768632|NCT05227300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101768633|NCT05227300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101768634|NCT05227300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768635|NCT05227300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101768636|NCT05227300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101768637|NCT05227300|Adrenergic Agents|adrenergic agents|mesh-ancestor
101768638|NCT05227300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101768639|NCT05227300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101768640|NCT05227300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101768641|NCT05227300|Autonomic Agents|autonomic agents|mesh-ancestor
101768642|NCT05227300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101768643|NCT05227300|Respiratory System Agents|respiratory system agents|mesh-ancestor
101768644|NCT05227300|Mydriatics|mydriatics|mesh-ancestor
101768645|NCT05227300|Sympathomimetics|sympathomimetics|mesh-ancestor
101768654|NCT00890565|Antiemetics|antiemetics|mesh-ancestor
101768655|NCT00890565|Autonomic Agents|autonomic agents|mesh-ancestor
101768656|NCT00890565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101768657|NCT00890565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768658|NCT00890565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101768659|NCT00890565|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101768660|NCT00890565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101768661|NCT00890565|Serotonin Agents|serotonin agents|mesh-ancestor
101768662|NCT00890565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101768663|NCT00890565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768664|NCT00890643|Prazosin|prazosin|mesh-list
101768665|NCT00890643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101768666|NCT00890643|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101768667|NCT00890643|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101768668|NCT00890643|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101768669|NCT00890643|Adrenergic Agents|adrenergic agents|mesh-ancestor
101768670|NCT00890643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101768671|NCT00890643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768672|NCT00890643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768673|NCT00893217|Interferons|interferons|mesh-list
101768674|NCT00893217|Interferon-beta|interferon-beta|mesh-list
101768675|NCT00893217|Interferon beta-1b|interferon beta-1b|mesh-list
101768676|NCT00893217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101768677|NCT00893217|Antiviral Agents|antiviral agents|mesh-ancestor
101768678|NCT00893217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101768679|NCT00893217|Immunologic Factors|immunologic factors|mesh-ancestor
101768680|NCT00893217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768681|NCT00893217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101319393|NCT05640726|Leucovorin|leucovorin|mesh-list
101768682|NCT00767598|Sildenafil Citrate|sildenafil citrate|mesh-list
101768683|NCT00767598|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101768684|NCT00767598|Udenafil|udenafil|mesh-list
101768685|NCT00767598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
101768686|NCT00767598|Vasodilator Agents|vasodilator agents|mesh-ancestor
101768687|NCT00767598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101768688|NCT00767598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101768689|NCT00767598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768690|NCT00767598|Urological Agents|urological agents|mesh-ancestor
101768691|NCT00670800|Metformin|metformin|mesh-list
101768692|NCT00670800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101768693|NCT00670800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768694|NCT00764166|Docetaxel|docetaxel|mesh-list
101565142|NCT00916279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101565143|NCT00916279|Tubulin Modulators|tubulin modulators|mesh-ancestor
101565144|NCT00916279|Antimitotic Agents|antimitotic agents|mesh-ancestor
101565145|NCT00916279|Mitosis Modulators|mitosis modulators|mesh-ancestor
101413393|NCT05176470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101768695|NCT00764166|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101768696|NCT00764166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101768697|NCT00764166|Tubulin Modulators|tubulin modulators|mesh-ancestor
101768698|NCT00764166|Antimitotic Agents|antimitotic agents|mesh-ancestor
101768699|NCT00764166|Mitosis Modulators|mitosis modulators|mesh-ancestor
101768700|NCT00764166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768701|NCT00764166|Hormones|hormones|mesh-ancestor
101768702|NCT00764166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101768703|NCT00764166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426128|NCT00527761|Alkylating Agents|alkylating agents|mesh-ancestor
101768704|NCT00770406|Botulinum Toxins|botulinum toxins|mesh-list
101768705|NCT00770406|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101768706|NCT00770406|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101768707|NCT00770406|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101768709|NCT00770406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768710|NCT00770406|Cholinergic Agents|cholinergic agents|mesh-ancestor
101768711|NCT00770406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101768712|NCT00770406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768721|NCT00767754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101768722|NCT00767754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101768723|NCT00767754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768724|NCT00767754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101768726|NCT00767754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768727|NCT00767754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101768728|NCT00767754|Antidepressive Agents|antidepressive agents|mesh-ancestor
101768729|NCT00767754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101768730|NCT00767754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101768731|NCT00767754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101768732|NCT00767754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101768733|NCT00764244|Triamcinolone|triamcinolone|mesh-list
101768734|NCT00764244|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101768735|NCT00764244|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101768736|NCT00764244|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101768737|NCT00764244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101768738|NCT00764244|Glucocorticoids|glucocorticoids|mesh-ancestor
101768739|NCT00764244|Hormones|hormones|mesh-ancestor
101768740|NCT00764244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101768741|NCT00764244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768742|NCT00764244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101768743|NCT00764244|Immunologic Factors|immunologic factors|mesh-ancestor
101768744|NCT00764244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101768745|NCT00764244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768746|NCT00770640|Insulin|insulin|mesh-list
101768747|NCT00770640|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101768748|NCT00770640|Pioglitazone|pioglitazone|mesh-list
101768749|NCT00770640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101768750|NCT00770640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768751|NCT00770718|Thrombin|thrombin|mesh-list
101768752|NCT00770718|Hemostatics|hemostatics|mesh-ancestor
101768753|NCT00770718|Coagulants|coagulants|mesh-ancestor
101768754|NCT00770796|Atorvastatin|atorvastatin|mesh-list
101768755|NCT00770796|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101768756|NCT00770796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101768757|NCT00770796|Antimetabolites|antimetabolites|mesh-ancestor
101768758|NCT00770796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768759|NCT00770796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101768760|NCT00770796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101768761|NCT00770796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101768762|NCT00545740|Mesalamine|mesalamine|mesh-list
101768763|NCT00545740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101768764|NCT00545740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101768765|NCT00545740|Analgesics|analgesics|mesh-ancestor
101768766|NCT00545740|Sensory System Agents|sensory system agents|mesh-ancestor
101565146|NCT00916279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565147|NCT01209078|Linezolid|linezolid|mesh-list
101565148|NCT01209078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101565149|NCT01209078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101565150|NCT01209078|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101565151|NCT01209078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101565152|NCT01209078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565153|NCT04318158|Fentanyl|fentanyl|mesh-list
101768767|NCT00545740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101768768|NCT00545740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768769|NCT00545740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101768770|NCT00545740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101768771|NCT05208190|Clozapine|clozapine|mesh-list
101768772|NCT05208190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101768773|NCT05208190|Serotonin Agents|serotonin agents|mesh-ancestor
101768774|NCT05208190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101768775|NCT05208190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768776|NCT05208190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768777|NCT05208190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101768778|NCT05208190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101768784|NCT00609609|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101768785|NCT00609609|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101768787|NCT00609609|Prednisolone acetate|prednisolone acetate|mesh-list
101768788|NCT00609609|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101768789|NCT00609609|Prednisolone phosphate|prednisolone phosphate|mesh-list
101768790|NCT00609609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101768791|NCT00609609|Antiemetics|antiemetics|mesh-ancestor
101768792|NCT00609609|Autonomic Agents|autonomic agents|mesh-ancestor
101768793|NCT00609609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101768794|NCT00609609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768795|NCT00609609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101768796|NCT00609609|Glucocorticoids|glucocorticoids|mesh-ancestor
101768798|NCT00609609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101768799|NCT00609609|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101768800|NCT00609609|Protective Agents|protective agents|mesh-ancestor
101768801|NCT00609609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101768802|NCT00609609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101768803|NCT00673452|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101768804|NCT00673452|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101768805|NCT00673452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101768806|NCT00673452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101319412|NCT05640726|Antidotes|antidotes|mesh-ancestor
101768807|NCT00673452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768808|NCT00673452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101768809|NCT00673452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768810|NCT00673452|Analgesics|analgesics|mesh-ancestor
101768811|NCT00673452|Sensory System Agents|sensory system agents|mesh-ancestor
101768812|NCT00673452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101768813|NCT00673452|Antidepressive Agents|antidepressive agents|mesh-ancestor
101768814|NCT00673452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101768815|NCT00673452|Dopamine Agents|dopamine agents|mesh-ancestor
101768816|NCT00967174|Nicotine|nicotine|mesh-list
101768817|NCT00967174|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101768818|NCT00967174|Autonomic Agents|autonomic agents|mesh-ancestor
101768819|NCT00967174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101768820|NCT00967174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768821|NCT00967174|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101768822|NCT00967174|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101768823|NCT00967174|Cholinergic Agents|cholinergic agents|mesh-ancestor
101768824|NCT00967174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101768825|NCT00967174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768826|NCT00967252|Atorvastatin|atorvastatin|mesh-list
101768827|NCT00967252|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101768828|NCT00967252|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101768829|NCT00967252|Antimetabolites|antimetabolites|mesh-ancestor
101565154|NCT04318158|Dexmedetomidine|dexmedetomidine|mesh-list
101565156|NCT04318158|Anesthetics, Local|anesthetics, local|mesh-ancestor
101565157|NCT04318158|Anesthetics|anesthetics|mesh-ancestor
101565158|NCT04318158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101565159|NCT04318158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565160|NCT04318158|Sensory System Agents|sensory system agents|mesh-ancestor
101565161|NCT04318158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101565162|NCT04318158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101565163|NCT04318158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101565164|NCT04318158|Analgesics|analgesics|mesh-ancestor
101565165|NCT04318158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101565166|NCT04318158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101565167|NCT04318158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101565168|NCT04318158|Adrenergic Agents|adrenergic agents|mesh-ancestor
101565169|NCT04318158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101413406|NCT00483067|Antimetabolites|antimetabolites|mesh-ancestor
101768830|NCT00967252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768831|NCT00967252|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101768832|NCT00967252|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101768833|NCT00967252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101768834|NCT00890955|Cyclophosphamide|cyclophosphamide|mesh-list
101768835|NCT00890955|Amrubicin|amrubicin|mesh-list
101768836|NCT00890955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101768837|NCT00890955|Immunologic Factors|immunologic factors|mesh-ancestor
101768838|NCT00890955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768839|NCT00890955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101768840|NCT00890955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101768841|NCT00890955|Alkylating Agents|alkylating agents|mesh-ancestor
101768842|NCT00890955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768843|NCT00890955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101768844|NCT00890955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101768845|NCT00975052|Metformin|metformin|mesh-list
101768846|NCT00975052|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101768851|NCT00975052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101768854|NCT00975052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101768855|NCT00975052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768856|NCT00891033|Bortezomib|bortezomib|mesh-list
101768857|NCT00891033|Panobinostat|panobinostat|mesh-list
101768858|NCT00891033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101768859|NCT00891033|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101768860|NCT00891033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101828270|NCT05839119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101768861|NCT00891033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768862|NCT00770952|Pioglitazone|pioglitazone|mesh-list
101768863|NCT00770952|Glimepiride|glimepiride|mesh-list
101768864|NCT00770952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101768865|NCT00770952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768866|NCT00770952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101768867|NCT00770952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101768868|NCT00770952|Immunologic Factors|immunologic factors|mesh-ancestor
101768869|NCT00764556|Insulin|insulin|mesh-list
101768870|NCT00764556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101768871|NCT00764556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768872|NCT00968578|Methylprednisolone|methylprednisolone|mesh-list
101768873|NCT00968578|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101768874|NCT00968578|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101768875|NCT00968578|Prednisolone|prednisolone|mesh-list
101768876|NCT00968578|Prednisolone acetate|prednisolone acetate|mesh-list
101565170|NCT04318158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565171|NCT04318158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101565172|NCT04318158|Narcotics|narcotics|mesh-ancestor
101565173|NCT04318158|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101565174|NCT04318158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101565175|NCT04318158|Anesthetics, General|anesthetics, general|mesh-ancestor
101565176|NCT01207596|Hydromorphone|hydromorphone|mesh-list
101565177|NCT01207596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101565178|NCT01207596|Narcotics|narcotics|mesh-ancestor
101413422|NCT00483106|Dopamine Agents|dopamine agents|mesh-ancestor
101768877|NCT00968578|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101768878|NCT00968578|Prednisolone phosphate|prednisolone phosphate|mesh-list
101768879|NCT00968578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101768880|NCT00968578|Antiemetics|antiemetics|mesh-ancestor
101768881|NCT00968578|Autonomic Agents|autonomic agents|mesh-ancestor
101768882|NCT00968578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101768883|NCT00968578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768884|NCT00968578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101768885|NCT00968578|Glucocorticoids|glucocorticoids|mesh-ancestor
101768886|NCT00968578|Hormones|hormones|mesh-ancestor
101768887|NCT00968578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101768888|NCT00968578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101768889|NCT00968578|Protective Agents|protective agents|mesh-ancestor
101768890|NCT00968578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101768891|NCT00968578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101768892|NCT00893373|Sorafenib|sorafenib|mesh-list
101768893|NCT00893373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101768894|NCT00893373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101768895|NCT00893373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101768896|NCT00893373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768897|NCT00891267|Amlodipine|amlodipine|mesh-list
101768898|NCT00891267|Olmesartan|olmesartan|mesh-list
101768899|NCT00891267|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101768900|NCT00891267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101768901|NCT00891267|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101768902|NCT00891267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101768903|NCT00891267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768904|NCT00891267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101768905|NCT00891267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768906|NCT00891267|Vasodilator Agents|vasodilator agents|mesh-ancestor
101768907|NCT00891267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101768908|NCT00891267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101768909|NCT00545584|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101768910|NCT00545584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101768911|NCT00545584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768912|NCT00545584|Incretins|incretins|mesh-ancestor
101768913|NCT00545584|Hormones|hormones|mesh-ancestor
101768914|NCT00545584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101768915|NCT00545584|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101768916|NCT00545584|Protease Inhibitors|protease inhibitors|mesh-ancestor
101768922|NCT00378703|Sorafenib|sorafenib|mesh-list
101768923|NCT00378703|Temsirolimus|temsirolimus|mesh-list
101768924|NCT00378703|MTOR Inhibitors|mtor inhibitors|mesh-list
101768925|NCT00378703|Endothelial Growth Factors|endothelial growth factors|mesh-list
101768928|NCT00378703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101768929|NCT00378703|Immunoglobulin G|immunoglobulin g|mesh-list
101768930|NCT00378703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101768931|NCT00378703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101768932|NCT00378703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101768933|NCT00378703|Growth Substances|growth substances|mesh-ancestor
101768934|NCT00378703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768935|NCT00378703|Growth Inhibitors|growth inhibitors|mesh-ancestor
101768936|NCT00378703|Immunologic Factors|immunologic factors|mesh-ancestor
101768937|NCT00378703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101768938|NCT00378703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101565179|NCT01207596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101565180|NCT01207596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565182|NCT01207596|Sensory System Agents|sensory system agents|mesh-ancestor
101565183|NCT01207596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101565184|NCT00915343|Hydrocortisone|hydrocortisone|mesh-list
101565185|NCT00915343|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101565186|NCT00915343|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101565187|NCT00915343|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101565188|NCT00915343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101565189|NCT04203043|Pycnogenols|pycnogenols|mesh-list
101565190|NCT04203043|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101565191|NCT04203043|Immunologic Factors|immunologic factors|mesh-ancestor
101565192|NCT04203043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565193|NCT04203043|Antioxidants|antioxidants|mesh-ancestor
101565194|NCT04203043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565195|NCT04203043|Protective Agents|protective agents|mesh-ancestor
101565196|NCT04203043|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101768939|NCT00378703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768940|NCT00378703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101768941|NCT00378703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101768942|NCT00378703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101768943|NCT00378703|Antifungal Agents|antifungal agents|mesh-ancestor
101768944|NCT00378703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101768945|NCT00893451|Vitamin D|vitamin d|mesh-list
101768946|NCT00893451|Cholecalciferol|cholecalciferol|mesh-list
101768947|NCT00893451|Vitamins|vitamins|mesh-ancestor
101768948|NCT00893451|Micronutrients|micronutrients|mesh-ancestor
101768949|NCT00893451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768950|NCT00893451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101768951|NCT00893451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101768952|NCT00967408|Escitalopram|escitalopram|mesh-list
101768953|NCT00967408|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101768954|NCT00967408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101768955|NCT00967408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101768956|NCT00967408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768957|NCT00967408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101768958|NCT00967408|Serotonin Agents|serotonin agents|mesh-ancestor
101768959|NCT00967408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768960|NCT00891423|Meropenem|meropenem|mesh-list
101768961|NCT00891423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101768962|NCT00891423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101768963|NCT04035382|Misoprostol|misoprostol|mesh-list
101768964|NCT04035382|Oxytocin|oxytocin|mesh-list
101768965|NCT04035382|Oxytocics|oxytocics|mesh-ancestor
101768966|NCT04035382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101768967|NCT04035382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768968|NCT04035382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101768969|NCT04035382|Abortifacient Agents|abortifacient agents|mesh-ancestor
101768970|NCT04035382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101768971|NCT04035382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101768972|NCT02541045|Metadoxine|metadoxine|mesh-list
101768973|NCT02541045|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101768974|NCT00891579|Pemetrexed|pemetrexed|mesh-list
101768975|NCT00891579|Gefitinib|gefitinib|mesh-list
101768976|NCT00891579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101565197|NCT04435015|Camostat|camostat|mesh-list
101565198|NCT04435015|Protease Inhibitors|protease inhibitors|mesh-ancestor
101565199|NCT04435015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101565200|NCT04435015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768977|NCT00891579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101768978|NCT00891579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768979|NCT00891579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101768980|NCT00891579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101768981|NCT00891579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101768982|NCT00968734|Cholecalciferol|cholecalciferol|mesh-list
101768983|NCT00968734|Vitamin D|vitamin d|mesh-list
101768984|NCT00968734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101768985|NCT00968734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768986|NCT00968734|Vitamins|vitamins|mesh-ancestor
101768987|NCT00968734|Micronutrients|micronutrients|mesh-ancestor
101768988|NCT00968734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101768989|NCT03620643|Fulvestrant|fulvestrant|mesh-list
101769003|NCT04008316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101769004|NCT04008316|Tubulin Modulators|tubulin modulators|mesh-ancestor
101769005|NCT04008316|Antimitotic Agents|antimitotic agents|mesh-ancestor
101769006|NCT04008316|Mitosis Modulators|mitosis modulators|mesh-ancestor
101769007|NCT04008316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769008|NCT04008316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101769009|NCT00893607|Methoxamine|methoxamine|mesh-list
101769010|NCT00893607|Sympathomimetics|sympathomimetics|mesh-ancestor
101769011|NCT00893607|Autonomic Agents|autonomic agents|mesh-ancestor
101769012|NCT00893607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101769013|NCT00893607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769014|NCT00893607|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101769015|NCT00893607|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101769016|NCT00893607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101769017|NCT00893607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101769018|NCT00893607|Adrenergic Agents|adrenergic agents|mesh-ancestor
101769019|NCT00893607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101769020|NCT00893607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769021|NCT00969046|Epothilone B|epothilone b|mesh-list
101769022|NCT00969046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101769023|NCT00969046|Tubulin Modulators|tubulin modulators|mesh-ancestor
101769024|NCT00969046|Antimitotic Agents|antimitotic agents|mesh-ancestor
101769025|NCT00969046|Mitosis Modulators|mitosis modulators|mesh-ancestor
101769026|NCT00969046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769027|NCT05008354|Pyridoxine|pyridoxine|mesh-list
101769028|NCT05008354|Vitamin B Complex|vitamin b complex|mesh-ancestor
101769029|NCT05008354|Vitamins|vitamins|mesh-ancestor
101769030|NCT05008354|Micronutrients|micronutrients|mesh-ancestor
101769031|NCT05008354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769032|NCT00975754|Budesonide|budesonide|mesh-list
101769033|NCT00975754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101769034|NCT00975754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101769035|NCT00975754|Autonomic Agents|autonomic agents|mesh-ancestor
101769036|NCT00975754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101319469|NCT03958513|Bupivacaine|bupivacaine|mesh-list
101769037|NCT00975754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769038|NCT00975754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101769039|NCT00975754|Respiratory System Agents|respiratory system agents|mesh-ancestor
101769040|NCT00975754|Glucocorticoids|glucocorticoids|mesh-ancestor
101769041|NCT00975754|Hormones|hormones|mesh-ancestor
101769042|NCT00975754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101769043|NCT01045681|Dexamethasone|dexamethasone|mesh-list
101769044|NCT01045681|Dexamethasone acetate|dexamethasone acetate|mesh-list
101769045|NCT01045681|Bortezomib|bortezomib|mesh-list
101769046|NCT01045681|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101769047|NCT01045681|BB 1101|bb 1101|mesh-list
101769048|NCT01045681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101769049|NCT01045681|Antiemetics|antiemetics|mesh-ancestor
101769050|NCT01045681|Autonomic Agents|autonomic agents|mesh-ancestor
101769056|NCT01045681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101769057|NCT01045681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101769058|NCT01045681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101769059|NCT01045681|Protease Inhibitors|protease inhibitors|mesh-ancestor
101565201|NCT04435015|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101565202|NCT04435015|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101565203|NCT00631813|Prucalopride|prucalopride|mesh-list
101565204|NCT00631813|Laxatives|laxatives|mesh-ancestor
101565205|NCT00631813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101565206|NCT00631813|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101565207|NCT00631813|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101565208|NCT00631813|Serotonin Agents|serotonin agents|mesh-ancestor
101565209|NCT00631813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101565210|NCT00631813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769060|NCT01045681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101769061|NCT01045681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769062|NCT01045681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101769063|NCT01045681|Alkylating Agents|alkylating agents|mesh-ancestor
101769064|NCT00975910|Lidocaine|lidocaine|mesh-list
101769065|NCT00975910|Anesthetics, Local|anesthetics, local|mesh-ancestor
101769066|NCT00975910|Anesthetics|anesthetics|mesh-ancestor
101769067|NCT00975910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101769068|NCT00975910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769069|NCT00975910|Sensory System Agents|sensory system agents|mesh-ancestor
101769070|NCT00975910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101769071|NCT00975910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101769072|NCT00975910|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101263877|NCT01763424|Antimetabolites|antimetabolites|mesh-ancestor
101769073|NCT00975910|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101769074|NCT00975910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101769075|NCT00975910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769076|NCT03617913|Cisplatin|cisplatin|mesh-list
101769077|NCT03617913|Fluorouracil|fluorouracil|mesh-list
101769078|NCT03617913|Mitomycins|mitomycins|mesh-list
101769079|NCT03617913|Mitomycin|mitomycin|mesh-list
101769080|NCT03617913|Avelumab|avelumab|mesh-list
101769081|NCT03617913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101769082|NCT03617913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101769083|NCT03617913|Antimetabolites|antimetabolites|mesh-ancestor
101769084|NCT03617913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769085|NCT03617913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101769086|NCT03617913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101769087|NCT03617913|Immunologic Factors|immunologic factors|mesh-ancestor
101769088|NCT03617913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769089|NCT03617913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101769090|NCT03617913|Alkylating Agents|alkylating agents|mesh-ancestor
101769091|NCT03617913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101769092|NCT03617913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101769093|NCT03617913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101769094|NCT00975988|Lapatinib|lapatinib|mesh-list
101769095|NCT00975988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101769096|NCT00975988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101769097|NCT00975988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101769098|NCT00975988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769099|NCT00976066|Naltrexone|naltrexone|mesh-list
101769100|NCT00976066|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101769101|NCT00976066|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101769102|NCT00976066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769103|NCT00976066|Sensory System Agents|sensory system agents|mesh-ancestor
101769104|NCT00976066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101769105|NCT00969592|Insulin|insulin|mesh-list
101769106|NCT00969592|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101769107|NCT00969592|Insulin Aspart|insulin aspart|mesh-list
101769108|NCT00969592|Insulin, Long-Acting|insulin, long-acting|mesh-list
101769109|NCT00969592|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101769110|NCT00969592|Insulin glulisine|insulin glulisine|mesh-list
101769111|NCT00969592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101769112|NCT00969592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565211|NCT00631813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565213|NCT04404049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101565214|NCT04404049|Antiviral Agents|antiviral agents|mesh-ancestor
101565215|NCT04404049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101565216|NCT04911517|Capecitabine|capecitabine|mesh-list
101565217|NCT04911517|Antibodies|antibodies|mesh-list
101565218|NCT04911517|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101565219|NCT04911517|Immunologic Factors|immunologic factors|mesh-ancestor
101565220|NCT04911517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565221|NCT04911517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101565222|NCT04911517|Antimetabolites|antimetabolites|mesh-ancestor
101565223|NCT04911517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769113|NCT00368641|Icodextrin|icodextrin|mesh-list
101769114|NCT00368641|Dialysis Solutions|dialysis solutions|mesh-ancestor
101769115|NCT00368641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101769116|NCT00976222|Ranibizumab|ranibizumab|mesh-list
101769117|NCT00976222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101769118|NCT00976222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101769119|NCT00976222|Growth Substances|growth substances|mesh-ancestor
101769122|NCT00976222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101769123|NCT00976300|Cyclosporine|cyclosporine|mesh-list
101769124|NCT00976300|Cyclophosphamide|cyclophosphamide|mesh-list
101769125|NCT00976300|Cyclosporins|cyclosporins|mesh-list
101769126|NCT00976300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101769127|NCT00976300|Immunologic Factors|immunologic factors|mesh-ancestor
101769128|NCT00976300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769129|NCT00976300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101769130|NCT00976300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101769131|NCT00976300|Alkylating Agents|alkylating agents|mesh-ancestor
101769132|NCT00976300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769133|NCT00976300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101769134|NCT00976300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101769135|NCT00976300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101769136|NCT00976300|Antifungal Agents|antifungal agents|mesh-ancestor
101769137|NCT00976300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101769138|NCT00976300|Dermatologic Agents|dermatologic agents|mesh-ancestor
101769139|NCT00976300|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101769140|NCT00979966|Sirolimus|sirolimus|mesh-list
101769141|NCT00979966|Sunitinib|sunitinib|mesh-list
101769142|NCT00979966|Temsirolimus|temsirolimus|mesh-list
101769143|NCT00979966|MTOR Inhibitors|mtor inhibitors|mesh-list
101769144|NCT00979966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101769145|NCT00979966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101769146|NCT00979966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101769147|NCT00979966|Growth Substances|growth substances|mesh-ancestor
101769148|NCT00979966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769149|NCT00979966|Growth Inhibitors|growth inhibitors|mesh-ancestor
101769150|NCT00979966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101769151|NCT00979966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101769152|NCT00979966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769153|NCT00979966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101769154|NCT00979966|Immunologic Factors|immunologic factors|mesh-ancestor
101769155|NCT00979966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101769156|NCT00979966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101769157|NCT00979966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101769158|NCT00979966|Antifungal Agents|antifungal agents|mesh-ancestor
101769159|NCT00969904|Acetylcysteine|acetylcysteine|mesh-list
101769160|NCT00969904|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101769161|NCT00969904|Antiviral Agents|antiviral agents|mesh-ancestor
101769162|NCT00969904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101769163|NCT00969904|Expectorants|expectorants|mesh-ancestor
101769164|NCT00969904|Respiratory System Agents|respiratory system agents|mesh-ancestor
101769165|NCT00969904|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101769166|NCT00969904|Antioxidants|antioxidants|mesh-ancestor
101565224|NCT04911517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101565225|NCT00637897|Paclitaxel|paclitaxel|mesh-list
101565226|NCT00637897|Docetaxel|docetaxel|mesh-list
101565227|NCT00637897|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101565228|NCT00637897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101565229|NCT00637897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101565230|NCT00637897|Tubulin Modulators|tubulin modulators|mesh-ancestor
101565231|NCT00637897|Antimitotic Agents|antimitotic agents|mesh-ancestor
101565232|NCT00637897|Mitosis Modulators|mitosis modulators|mesh-ancestor
101565233|NCT00637897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565234|NCT03992443|Reteplase|reteplase|mesh-list
101413471|NCT00405171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769167|NCT00969904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769168|NCT00969904|Protective Agents|protective agents|mesh-ancestor
101769169|NCT00969904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769170|NCT00969904|Antidotes|antidotes|mesh-ancestor
101769171|NCT00976690|Mesalamine|mesalamine|mesh-list
101769172|NCT00976690|Azathioprine|azathioprine|mesh-list
101769173|NCT00976690|Antimetabolites|antimetabolites|mesh-ancestor
101769174|NCT00976690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769175|NCT00976690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101769176|NCT00976690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101769177|NCT00976690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101769178|NCT00976690|Immunologic Factors|immunologic factors|mesh-ancestor
101769179|NCT00976690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769180|NCT00976690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101769181|NCT00976690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101769182|NCT00976690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101769183|NCT00976690|Analgesics|analgesics|mesh-ancestor
101769184|NCT00976690|Sensory System Agents|sensory system agents|mesh-ancestor
101769185|NCT00976690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101769186|NCT00976690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101769187|NCT00976768|Fluorouracil|fluorouracil|mesh-list
101769188|NCT00976768|Oxaliplatin|oxaliplatin|mesh-list
101769189|NCT00976768|Antimetabolites|antimetabolites|mesh-ancestor
101769190|NCT00976768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769191|NCT00976768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101769192|NCT00976768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101769193|NCT00976768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101769197|NCT00608985|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101769198|NCT00608985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101769199|NCT00608985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101769200|NCT00608985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769201|NCT00608985|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101769202|NCT00608985|GABA Agonists|gaba agonists|mesh-ancestor
101769203|NCT00608985|GABA Agents|gaba agents|mesh-ancestor
101769204|NCT00608985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101769205|NCT00608985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769206|NCT00969982|Misoprostol|misoprostol|mesh-list
101769207|NCT00969982|Mifepristone|mifepristone|mesh-list
101769208|NCT00969982|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101769209|NCT00969982|Abortifacient Agents|abortifacient agents|mesh-ancestor
101769210|NCT00969982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101769211|NCT00969982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769212|NCT00969982|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101769213|NCT00969982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101769214|NCT00969982|Oxytocics|oxytocics|mesh-ancestor
101769215|NCT00969982|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101769216|NCT00969982|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101769217|NCT00969982|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101769218|NCT00969982|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101769219|NCT00969982|Contraceptive Agents|contraceptive agents|mesh-ancestor
101565235|NCT03992443|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101565236|NCT03992443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101565237|NCT03992443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565238|NCT04329949|Paclitaxel|paclitaxel|mesh-list
101565239|NCT04329949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101565240|NCT04329949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101769220|NCT00969982|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101769221|NCT00969982|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101769222|NCT00969982|Hormone Antagonists|hormone antagonists|mesh-ancestor
101769223|NCT00969982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101769224|NCT00969982|Luteolytic Agents|luteolytic agents|mesh-ancestor
101769225|NCT00969982|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101769226|NCT00969982|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101769227|NCT00970138|Apatinib|apatinib|mesh-list
101769228|NCT00970138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101769229|NCT00970138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101769230|NCT00970138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101769231|NCT00970138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769232|NCT00892125|Carbamazepine|carbamazepine|mesh-list
101769233|NCT00892125|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101769234|NCT00892125|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101769235|NCT00892125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101769236|NCT00892125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101769237|NCT00892125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769238|NCT00892125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101769239|NCT00892125|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101769240|NCT00892125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101769241|NCT00892125|Serotonin Agents|serotonin agents|mesh-ancestor
101769242|NCT00892125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101769243|NCT00892125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769244|NCT00892125|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101769245|NCT00892125|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101769246|NCT00892125|Dopamine Agents|dopamine agents|mesh-ancestor
101769247|NCT00892125|Anticonvulsants|anticonvulsants|mesh-ancestor
101769248|NCT00892125|Antimanic Agents|antimanic agents|mesh-ancestor
101769249|NCT00892125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101769250|NCT00892125|Analgesics|analgesics|mesh-ancestor
101769251|NCT00892125|Sensory System Agents|sensory system agents|mesh-ancestor
101769252|NCT00892125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101769253|NCT00892125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101769254|NCT00892125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101769255|NCT00892125|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101769256|NCT00892125|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101769257|NCT00980356|Vildagliptin|vildagliptin|mesh-list
101769258|NCT00980356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101769259|NCT00980356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769260|NCT00980356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101769261|NCT00980356|Protease Inhibitors|protease inhibitors|mesh-ancestor
101769262|NCT00980356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101769263|NCT00980356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769289|NCT00378079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101769290|NCT00378079|Antitussive Agents|antitussive agents|mesh-ancestor
101769291|NCT00378079|Respiratory System Agents|respiratory system agents|mesh-ancestor
101769292|NCT00970450|Acetaminophen|acetaminophen|mesh-list
101769293|NCT00970450|Tropisetron|tropisetron|mesh-list
101769294|NCT00970450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101769295|NCT00970450|Analgesics|analgesics|mesh-ancestor
101769296|NCT00970450|Sensory System Agents|sensory system agents|mesh-ancestor
101769297|NCT00970450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101769298|NCT00970450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769299|NCT00970450|Antipyretics|antipyretics|mesh-ancestor
101769300|NCT00970450|Antiemetics|antiemetics|mesh-ancestor
101769301|NCT00970450|Autonomic Agents|autonomic agents|mesh-ancestor
101769302|NCT00970450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101769303|NCT00970450|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101769304|NCT00970450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101769305|NCT00970450|Serotonin Agents|serotonin agents|mesh-ancestor
101426728|NCT00145847|Naltrexone|naltrexone|mesh-list
101565241|NCT04329949|Tubulin Modulators|tubulin modulators|mesh-ancestor
101565242|NCT04329949|Antimitotic Agents|antimitotic agents|mesh-ancestor
101565243|NCT04329949|Mitosis Modulators|mitosis modulators|mesh-ancestor
101565244|NCT04329949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565246|NCT04597099|Estradiol|estradiol|mesh-list
101565247|NCT04597099|Progesterone|progesterone|mesh-list
101565248|NCT04597099|Estrogens|estrogens|mesh-ancestor
101565249|NCT04597099|Hormones|hormones|mesh-ancestor
101565250|NCT04597099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101565251|NCT04597099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565252|NCT04597099|Progestins|progestins|mesh-ancestor
101565253|NCT04597099|Androgen Antagonists|androgen antagonists|mesh-ancestor
101565254|NCT04597099|Hormone Antagonists|hormone antagonists|mesh-ancestor
101413489|NCT00483964|Autonomic Agents|autonomic agents|mesh-ancestor
101769306|NCT00970450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101769307|NCT00970450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769308|NCT00970528|Acarbose|acarbose|mesh-list
101769309|NCT00970528|Voglibose|voglibose|mesh-list
101769310|NCT00970528|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101769311|NCT00970528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101769312|NCT00970528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769313|NCT00970528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101769327|NCT00978172|Artesunate|artesunate|mesh-list
101769328|NCT00978172|Mefloquine|mefloquine|mesh-list
101769329|NCT00978172|Antimalarials|antimalarials|mesh-ancestor
101769330|NCT00978172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101769331|NCT00978172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101769332|NCT00978172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101769333|NCT00978172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101769334|NCT00978172|Antiviral Agents|antiviral agents|mesh-ancestor
101769335|NCT00978172|Schistosomicides|schistosomicides|mesh-ancestor
101769336|NCT00978172|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101769337|NCT00978172|Anthelmintics|anthelmintics|mesh-ancestor
101769338|NCT03923530|Eplerenone|eplerenone|mesh-list
101769339|NCT03923530|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101769340|NCT03923530|Hormone Antagonists|hormone antagonists|mesh-ancestor
101769341|NCT03923530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101769342|NCT03923530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769343|NCT03923530|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101769344|NCT03923530|Diuretics|diuretics|mesh-ancestor
101769345|NCT03923530|Natriuretic Agents|natriuretic agents|mesh-ancestor
101769346|NCT03923530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101769347|NCT00608907|Rifampin|rifampin|mesh-list
101769348|NCT00608907|Dexamethasone|dexamethasone|mesh-list
101769349|NCT00608907|Dexamethasone acetate|dexamethasone acetate|mesh-list
101769350|NCT00608907|Bortezomib|bortezomib|mesh-list
101769351|NCT00608907|BB 1101|bb 1101|mesh-list
101769352|NCT00608907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101769353|NCT00608907|Antiemetics|antiemetics|mesh-ancestor
101769354|NCT00608907|Autonomic Agents|autonomic agents|mesh-ancestor
101769355|NCT00608907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101769356|NCT00608907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769357|NCT00608907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101769358|NCT00608907|Glucocorticoids|glucocorticoids|mesh-ancestor
101769359|NCT00608907|Hormones|hormones|mesh-ancestor
101769360|NCT00608907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101769361|NCT00608907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101769362|NCT00608907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101769363|NCT00608907|Protease Inhibitors|protease inhibitors|mesh-ancestor
101769364|NCT00608907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101769365|NCT00608907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565255|NCT04597099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101565256|NCT04597099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101565258|NCT04816513|Dermatologic Agents|dermatologic agents|mesh-ancestor
101565259|NCT04203511|Paclitaxel|paclitaxel|mesh-list
101565260|NCT04203511|Etoposide|etoposide|mesh-list
101565261|NCT04203511|Carboplatin|carboplatin|mesh-list
101565262|NCT04203511|Pemetrexed|pemetrexed|mesh-list
101769366|NCT00608907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101769367|NCT00608907|Antitubercular Agents|antitubercular agents|mesh-ancestor
101769368|NCT00608907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101769369|NCT00608907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101769370|NCT00608907|Leprostatic Agents|leprostatic agents|mesh-ancestor
101769371|NCT00608907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101769372|NCT00608907|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101769373|NCT00608907|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101769374|NCT00608907|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101769377|NCT00608907|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101426801|NCT00145925|Gliclazide|gliclazide|mesh-list
101769380|NCT00970996|Interferon alpha-2|interferon alpha-2|mesh-list
101769381|NCT00970996|Paclitaxel|paclitaxel|mesh-list
101769382|NCT00970996|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101769383|NCT00970996|Cisplatin|cisplatin|mesh-list
101769384|NCT00970996|Temozolomide|temozolomide|mesh-list
101769385|NCT00970996|Interleukin-2|interleukin-2|mesh-list
101769386|NCT00970996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101769387|NCT00970996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101769388|NCT00970996|Tubulin Modulators|tubulin modulators|mesh-ancestor
101769389|NCT00970996|Antimitotic Agents|antimitotic agents|mesh-ancestor
101769390|NCT00970996|Mitosis Modulators|mitosis modulators|mesh-ancestor
101769391|NCT00970996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769392|NCT00970996|Antiviral Agents|antiviral agents|mesh-ancestor
101769393|NCT00970996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101769394|NCT00970996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101769395|NCT00970996|Alkylating Agents|alkylating agents|mesh-ancestor
101769396|NCT00970996|Immunologic Factors|immunologic factors|mesh-ancestor
101828271|NCT05839119|Antimetabolites|antimetabolites|mesh-ancestor
101769397|NCT00970996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769398|NCT00970996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101769399|NCT00970996|Analgesics|analgesics|mesh-ancestor
101769400|NCT00970996|Sensory System Agents|sensory system agents|mesh-ancestor
101769401|NCT00970996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101769402|NCT00869193|Grape Seed Extract|grape seed extract|mesh-list
101769403|NCT00869193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101769404|NCT00869193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101769405|NCT00869193|Antioxidants|antioxidants|mesh-ancestor
101769406|NCT00869193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769407|NCT00869193|Protective Agents|protective agents|mesh-ancestor
101769408|NCT00869193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769409|NCT04009018|Anesthetics|anesthetics|mesh-list
101769410|NCT04009018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101769411|NCT04009018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769412|NCT00869271|Leucovorin|leucovorin|mesh-list
101769413|NCT00869271|Fluorouracil|fluorouracil|mesh-list
101769414|NCT00869271|Oxaliplatin|oxaliplatin|mesh-list
101769415|NCT00869271|Antimetabolites|antimetabolites|mesh-ancestor
101769416|NCT00869271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769417|NCT00869271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101769418|NCT00869271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101769419|NCT00869271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101769420|NCT00869271|Immunologic Factors|immunologic factors|mesh-ancestor
101769421|NCT00869271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769422|NCT00869271|Antidotes|antidotes|mesh-ancestor
101769423|NCT00869271|Protective Agents|protective agents|mesh-ancestor
101769424|NCT00869271|Vitamin B Complex|vitamin b complex|mesh-ancestor
101769425|NCT00869271|Vitamins|vitamins|mesh-ancestor
101769426|NCT00869271|Micronutrients|micronutrients|mesh-ancestor
101769427|NCT00971074|Hylan|hylan|mesh-list
101769428|NCT00971074|Viscosupplements|viscosupplements|mesh-ancestor
101769429|NCT00971074|Protective Agents|protective agents|mesh-ancestor
101769430|NCT00971074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769431|NCT00971152|Menotropins|menotropins|mesh-list
101565263|NCT04203511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101565264|NCT04203511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101565265|NCT04203511|Tubulin Modulators|tubulin modulators|mesh-ancestor
101565266|NCT04203511|Antimitotic Agents|antimitotic agents|mesh-ancestor
101565267|NCT04203511|Mitosis Modulators|mitosis modulators|mesh-ancestor
101565268|NCT04203511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565269|NCT04203511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101565270|NCT04203511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101565271|NCT04203511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101565272|NCT04203511|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101413506|NCT00484003|Analgesics|analgesics|mesh-ancestor
101769432|NCT00971152|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101769433|NCT00971152|Fertility Agents|fertility agents|mesh-ancestor
101769434|NCT00971152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101769435|NCT00971152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769436|NCT00893919|Mycophenolic Acid|mycophenolic acid|mesh-list
101769437|NCT00893919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101769438|NCT00893919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101769439|NCT00893919|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101769440|NCT00893919|Antitubercular Agents|antitubercular agents|mesh-ancestor
101769441|NCT00893919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101769442|NCT00893919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101769443|NCT00893919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101769444|NCT00893919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769445|NCT00978328|Oxycodone|oxycodone|mesh-list
101319569|NCT05637567|Antipyretics|antipyretics|mesh-ancestor
101769446|NCT00978328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101769447|NCT00978328|Narcotics|narcotics|mesh-ancestor
101769448|NCT00978328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101769457|NCT01051531|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101769458|NCT01051531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101769459|NCT01051531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101769460|NCT01051531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769461|NCT01051531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101769462|NCT01051531|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101769463|NCT01051531|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101769464|NCT01051531|Serotonin Agents|serotonin agents|mesh-ancestor
101769465|NCT01051531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101769466|NCT01051531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769467|NCT01051531|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101769468|NCT01051531|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101769469|NCT01051531|Dopamine Agents|dopamine agents|mesh-ancestor
101769470|NCT03992911|Carboplatin|carboplatin|mesh-list
101769471|NCT03992911|Etoposide|etoposide|mesh-list
101769472|NCT03992911|Etoposide phosphate|etoposide phosphate|mesh-list
101769473|NCT03992911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101769474|NCT03992911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101769475|NCT03992911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101769476|NCT03992911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101769477|NCT03992911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101769478|NCT03992911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769479|NCT00545272|Formoterol Fumarate|formoterol fumarate|mesh-list
101769480|NCT00545272|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101769481|NCT00545272|Autonomic Agents|autonomic agents|mesh-ancestor
101769482|NCT00545272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101769483|NCT00545272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769484|NCT00545272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101769485|NCT00545272|Respiratory System Agents|respiratory system agents|mesh-ancestor
101769486|NCT00545272|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101769487|NCT00545272|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101769488|NCT00545272|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101769489|NCT00545272|Adrenergic Agents|adrenergic agents|mesh-ancestor
101769490|NCT00545272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101565273|NCT04203511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101565274|NCT03690037|Tranexamic Acid|tranexamic acid|mesh-list
101565275|NCT03690037|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101565276|NCT03690037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101565277|NCT03690037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565278|NCT03690037|Hemostatics|hemostatics|mesh-ancestor
101565279|NCT03690037|Coagulants|coagulants|mesh-ancestor
101565280|NCT00910273|Etanercept|etanercept|mesh-list
101769491|NCT00545272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769492|NCT00377455|Bosentan|bosentan|mesh-list
101769493|NCT00377455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101769494|NCT00377455|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101769495|NCT00377455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769496|NCT00895557|Varenicline|varenicline|mesh-list
101769497|NCT00895557|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101769498|NCT00895557|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101769499|NCT00895557|Cholinergic Agents|cholinergic agents|mesh-ancestor
101769500|NCT00895557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101769501|NCT00895557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769502|NCT00895557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769503|NCT00869973|Dexamethasone|dexamethasone|mesh-list
101769504|NCT00869973|Aprepitant|aprepitant|mesh-list
101769505|NCT00869973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101769506|NCT00869973|Antiemetics|antiemetics|mesh-ancestor
101769507|NCT00869973|Autonomic Agents|autonomic agents|mesh-ancestor
101769508|NCT00869973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101769509|NCT00869973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769510|NCT00869973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101769511|NCT00869973|Glucocorticoids|glucocorticoids|mesh-ancestor
101769512|NCT00869973|Hormones|hormones|mesh-ancestor
101769519|NCT04008784|Triamcinolone|triamcinolone|mesh-list
101769520|NCT04008784|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101769521|NCT04008784|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101769522|NCT04008784|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101769523|NCT04008784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101769524|NCT04008784|Glucocorticoids|glucocorticoids|mesh-ancestor
101769525|NCT04008784|Hormones|hormones|mesh-ancestor
101769526|NCT04008784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101769527|NCT04008784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769528|NCT04008784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101426954|NCT02276989|Analgesics|analgesics|mesh-ancestor
101769529|NCT04008784|Immunologic Factors|immunologic factors|mesh-ancestor
101769530|NCT04008784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101769531|NCT04008784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769532|NCT01051687|Botulinum Toxins|botulinum toxins|mesh-list
101769533|NCT01051687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101769534|NCT01051687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101769535|NCT01051687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101769536|NCT01051687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101769537|NCT01051687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769538|NCT01051687|Cholinergic Agents|cholinergic agents|mesh-ancestor
101769539|NCT01051687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101769540|NCT01051687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769541|NCT01051687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101769542|NCT01051687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101769543|NCT00978718|Selenium|selenium|mesh-list
101769544|NCT00978718|Antioxidants|antioxidants|mesh-ancestor
101769545|NCT00978718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769546|NCT00978718|Protective Agents|protective agents|mesh-ancestor
101769547|NCT00978718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769548|NCT00978718|Trace Elements|trace elements|mesh-ancestor
101769549|NCT00978718|Micronutrients|micronutrients|mesh-ancestor
101769550|NCT00895713|Immunoglobulins|immunoglobulins|mesh-list
101769551|NCT00895713|Antibodies|antibodies|mesh-list
101769552|NCT00895713|gamma-Globulins|gamma-globulins|mesh-list
101769553|NCT00895713|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101769554|NCT00895713|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101565281|NCT00910273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101565282|NCT00910273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101565283|NCT00910273|Analgesics|analgesics|mesh-ancestor
101565284|NCT00910273|Sensory System Agents|sensory system agents|mesh-ancestor
101502558|NCT05642689|Iron|iron|mesh-list
101769555|NCT00895713|Immunologic Factors|immunologic factors|mesh-ancestor
101769556|NCT00895713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769557|NCT01051765|Irinotecan|irinotecan|mesh-list
101769558|NCT01051765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101769559|NCT01051765|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101769560|NCT01051765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101769561|NCT01051765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101769562|NCT01051765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769563|NCT00978796|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101769564|NCT00978796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101769565|NCT00978796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769566|NCT00978796|Incretins|incretins|mesh-ancestor
101769567|NCT00978796|Hormones|hormones|mesh-ancestor
101769568|NCT00978796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101769569|NCT00978796|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101769570|NCT00978796|Protease Inhibitors|protease inhibitors|mesh-ancestor
101769571|NCT00978796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101769572|NCT00978796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769573|NCT00894231|Levocetirizine|levocetirizine|mesh-list
101769574|NCT00894231|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101769575|NCT00894231|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101769576|NCT00894231|Histamine Antagonists|histamine antagonists|mesh-ancestor
101769579|NCT00894231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769580|NCT00894231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769581|NCT00377299|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
101769582|NCT00377299|Nootropic Agents|nootropic agents|mesh-ancestor
101769583|NCT03472365|Capecitabine|capecitabine|mesh-list
101769584|NCT03472365|Oxaliplatin|oxaliplatin|mesh-list
101769585|NCT03472365|Apatinib|apatinib|mesh-list
101769586|NCT03472365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101769587|NCT03472365|Antimetabolites|antimetabolites|mesh-ancestor
101769588|NCT03472365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769589|NCT03472365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101769590|NCT03472365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101769591|NCT03472365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101769593|NCT00894621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101769594|NCT00894621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101769595|NCT00894621|Adrenergic Agents|adrenergic agents|mesh-ancestor
101769596|NCT00894621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101769597|NCT00894621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769598|NCT00894621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769599|NCT00894621|Sympathomimetics|sympathomimetics|mesh-ancestor
101769600|NCT00894621|Autonomic Agents|autonomic agents|mesh-ancestor
101769601|NCT00894621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101427021|NCT00174876|Serotonin Agents|serotonin agents|mesh-ancestor
101769602|NCT00894621|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101769603|NCT00376675|Methylphenidate|methylphenidate|mesh-list
101769604|NCT00376675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101769605|NCT00376675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769606|NCT00376675|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101769607|NCT00376675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101769608|NCT00376675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101769609|NCT00376675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769610|NCT00376675|Dopamine Agents|dopamine agents|mesh-ancestor
101769611|NCT00376675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101769612|NCT00979186|Hemostatics|hemostatics|mesh-list
101769613|NCT00979186|Coagulants|coagulants|mesh-ancestor
101769614|NCT05178628|Paclitaxel|paclitaxel|mesh-list
101769615|NCT05178628|Gemcitabine|gemcitabine|mesh-list
101769616|NCT05178628|Tinzaparin|tinzaparin|mesh-list
101769617|NCT05178628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101769618|NCT05178628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101769619|NCT05178628|Tubulin Modulators|tubulin modulators|mesh-ancestor
101769620|NCT05178628|Antimitotic Agents|antimitotic agents|mesh-ancestor
101769621|NCT05178628|Mitosis Modulators|mitosis modulators|mesh-ancestor
101565285|NCT00910273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101565286|NCT00910273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565287|NCT00910273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101565289|NCT00910273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101565290|NCT00910273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101565292|NCT00910039|Sunitinib|sunitinib|mesh-list
101565293|NCT00910039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101565294|NCT00910039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101565295|NCT00910039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101565296|NCT00910039|Growth Substances|growth substances|mesh-ancestor
101565297|NCT00910039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565298|NCT00910039|Growth Inhibitors|growth inhibitors|mesh-ancestor
101565299|NCT00910039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101565300|NCT00910039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101565301|NCT00910039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769622|NCT05178628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769623|NCT05178628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101769624|NCT05178628|Antimetabolites|antimetabolites|mesh-ancestor
101769625|NCT05178628|Anticoagulants|anticoagulants|mesh-ancestor
101769626|NCT05178628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101769627|NCT05178628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101769628|NCT00896571|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101769629|NCT00896571|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101769630|NCT00896571|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101769631|NCT00896571|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101769632|NCT00896571|Contraceptive Agents|contraceptive agents|mesh-ancestor
101769633|NCT00896571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101769634|NCT00896571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769635|NCT00896571|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101769636|NCT00896571|Estrogens|estrogens|mesh-ancestor
101769637|NCT00896571|Hormones|hormones|mesh-ancestor
101769638|NCT00896571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101769639|NCT00896727|Antibodies|antibodies|mesh-list
101769640|NCT00896727|Immunologic Factors|immunologic factors|mesh-ancestor
101769641|NCT00896727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769642|NCT00981838|Rituximab|rituximab|mesh-list
101769643|NCT00981838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101769644|NCT00981838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101769645|NCT00981838|Immunologic Factors|immunologic factors|mesh-ancestor
101769646|NCT00981838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769647|NCT00981838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101769648|NCT02533765|Olaparib|olaparib|mesh-list
101769649|NCT02533765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101769659|NCT00367237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101769660|NCT00367237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769661|NCT00367237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101769662|NCT00367237|Antimetabolites|antimetabolites|mesh-ancestor
101769663|NCT00367237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769664|NCT00367237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101769665|NCT00367237|Dermatologic Agents|dermatologic agents|mesh-ancestor
101769666|NCT00367237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101769667|NCT00367237|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101769668|NCT00367237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101769669|NCT00367237|Immunologic Factors|immunologic factors|mesh-ancestor
101769670|NCT00367237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101769671|NCT00367237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101565302|NCT00909181|Mandelic Acids|mandelic acids|mesh-list
101565304|NCT00909181|Parasympatholytics|parasympatholytics|mesh-ancestor
101565305|NCT00909181|Autonomic Agents|autonomic agents|mesh-ancestor
101565306|NCT00909181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101565307|NCT00909181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565308|NCT00909181|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101565309|NCT00909181|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101565310|NCT00909181|Cholinergic Agents|cholinergic agents|mesh-ancestor
101565311|NCT00909181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101769672|NCT00367237|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101769673|NCT00367237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101769674|NCT00367237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101769675|NCT00901407|Lamotrigine|lamotrigine|mesh-list
101427102|NCT00175032|Aspirin|aspirin|mesh-list
101769676|NCT00901407|Paroxetine|paroxetine|mesh-list
101769677|NCT00901407|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101769678|NCT00901407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101769679|NCT00901407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101769680|NCT00901407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769681|NCT00901407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101769682|NCT00901407|Serotonin Agents|serotonin agents|mesh-ancestor
101769683|NCT00901407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769684|NCT00901407|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101769685|NCT00901407|Antidepressive Agents|antidepressive agents|mesh-ancestor
101769686|NCT00901407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101769687|NCT00901407|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101769688|NCT00901407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101769689|NCT00901407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101769690|NCT00901407|Anticonvulsants|anticonvulsants|mesh-ancestor
101769691|NCT00901407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101769692|NCT00901407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101769693|NCT00901407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101769694|NCT00901407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101769695|NCT00901407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101769696|NCT00901407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101769697|NCT00984724|Nicotine|nicotine|mesh-list
101769698|NCT00984724|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101769699|NCT00984724|Autonomic Agents|autonomic agents|mesh-ancestor
101769700|NCT00984724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101769701|NCT00984724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769702|NCT00984724|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101769703|NCT00984724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101769704|NCT00984724|Cholinergic Agents|cholinergic agents|mesh-ancestor
101769705|NCT00984724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101769706|NCT00984724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769707|NCT00901719|Nitroprusside|nitroprusside|mesh-list
101769708|NCT00901719|Acetylcholine|acetylcholine|mesh-list
101769709|NCT00901719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101769710|NCT00901719|Vasodilator Agents|vasodilator agents|mesh-ancestor
101769711|NCT00901719|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101769712|NCT00901719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769719|NCT00972712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101769720|NCT02539641|Hormones|hormones|mesh-list
101769721|NCT02539641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101769722|NCT02539641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769723|NCT00544882|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101769724|NCT00544882|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101769725|NCT00544882|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101769726|NCT00544882|Desogestrel|desogestrel|mesh-list
101769727|NCT00544882|Oviol|oviol|mesh-list
101769728|NCT00544882|Estradiol|estradiol|mesh-list
101769729|NCT00544882|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101769730|NCT00544882|Estrogens|estrogens|mesh-ancestor
101769731|NCT00544882|Hormones|hormones|mesh-ancestor
101565312|NCT00909181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565313|NCT00909181|Urological Agents|urological agents|mesh-ancestor
101565314|NCT00909181|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101565315|NCT00909181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101565316|NCT05579665|Hyaluronic Acid|hyaluronic acid|mesh-list
101565317|NCT05579665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101565318|NCT05579665|Immunologic Factors|immunologic factors|mesh-ancestor
101769732|NCT00544882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101769733|NCT00544882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769734|NCT00544882|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101769735|NCT00544882|Contraceptive Agents|contraceptive agents|mesh-ancestor
101769736|NCT00544882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101769737|NCT00544882|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101769738|NCT00544882|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101769739|NCT00544882|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101769740|NCT00544882|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101769741|NCT00544882|Progestins|progestins|mesh-ancestor
101769742|NCT00544882|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101769743|NCT04035603|Cycloserine|cycloserine|mesh-list
101769744|NCT04035603|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101769745|NCT04035603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101769746|NCT04035603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101769747|NCT04035603|Antitubercular Agents|antitubercular agents|mesh-ancestor
101769748|NCT04035603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101769749|NCT04035603|Antimetabolites|antimetabolites|mesh-ancestor
101427169|NCT02944045|Antiemetics|antiemetics|mesh-ancestor
101769750|NCT04035603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769751|NCT00606801|Galantamine|galantamine|mesh-list
101769752|NCT00606801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101769753|NCT00606801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101769754|NCT00606801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769755|NCT00606801|Cholinergic Agents|cholinergic agents|mesh-ancestor
101769756|NCT00606801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101769757|NCT00606801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769758|NCT00606801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101769759|NCT00606801|Autonomic Agents|autonomic agents|mesh-ancestor
101769760|NCT00606801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101769761|NCT00606801|Nootropic Agents|nootropic agents|mesh-ancestor
101769762|NCT00972790|Bupivacaine|bupivacaine|mesh-list
101769763|NCT00972790|Anesthetics, Local|anesthetics, local|mesh-ancestor
101769764|NCT00972790|Anesthetics|anesthetics|mesh-ancestor
101769765|NCT00972790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101769766|NCT00972790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769767|NCT00972790|Sensory System Agents|sensory system agents|mesh-ancestor
101769768|NCT00972790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101769769|NCT00901875|Buprenorphine|buprenorphine|mesh-list
101769770|NCT00901875|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101769772|NCT00901875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101769773|NCT00901875|Narcotics|narcotics|mesh-ancestor
101769774|NCT00901875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101769775|NCT00901875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769776|NCT00901875|Analgesics|analgesics|mesh-ancestor
101769777|NCT00901875|Sensory System Agents|sensory system agents|mesh-ancestor
101769778|NCT00901875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101769779|NCT00901875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101769780|NCT00972946|Dextrans|dextrans|mesh-list
101769781|NCT00972946|Anticoagulants|anticoagulants|mesh-ancestor
101769782|NCT00972946|Plasma Substitutes|plasma substitutes|mesh-ancestor
101769783|NCT00972946|Blood Substitutes|blood substitutes|mesh-ancestor
101769789|NCT00606177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101769790|NCT00606177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769792|NCT00606177|Dopamine Agents|dopamine agents|mesh-ancestor
101769793|NCT00606177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101769794|NCT00606177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769795|NCT00606177|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101769796|NCT00606177|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101565319|NCT05579665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565320|NCT05579665|Viscosupplements|viscosupplements|mesh-ancestor
101565321|NCT05579665|Protective Agents|protective agents|mesh-ancestor
101565322|NCT01286987|Talazoparib|talazoparib|mesh-list
101565323|NCT01286987|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101565324|NCT01286987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101565325|NCT01286987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769797|NCT00606177|Serotonin Agents|serotonin agents|mesh-ancestor
101769798|NCT00606177|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101769799|NCT00606177|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101769800|NCT00606177|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101769801|NCT00606177|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101769802|NCT00985270|Rifampin|rifampin|mesh-list
101769803|NCT00985270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101769804|NCT00985270|Antitubercular Agents|antitubercular agents|mesh-ancestor
101769805|NCT00985270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101769806|NCT00985270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101769807|NCT00985270|Leprostatic Agents|leprostatic agents|mesh-ancestor
101769808|NCT00985270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101769809|NCT00985270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101769810|NCT00985270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769811|NCT00985270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101769812|NCT00985270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101769813|NCT00985270|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101769814|NCT00985270|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101769815|NCT00985270|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101769816|NCT00985270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101769818|NCT00359281|Dextromethorphan|dextromethorphan|mesh-list
101769819|NCT00359281|Atorvastatin|atorvastatin|mesh-list
101769820|NCT00359281|Simvastatin|simvastatin|mesh-list
101769821|NCT00359281|Ezetimibe|ezetimibe|mesh-list
101769822|NCT00359281|Fenofibrate|fenofibrate|mesh-list
101769823|NCT00359281|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101769824|NCT00359281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101769825|NCT00359281|Antimetabolites|antimetabolites|mesh-ancestor
101769826|NCT00359281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769827|NCT00359281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101769828|NCT00359281|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101769829|NCT00359281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101769830|NCT00359281|Vasodilator Agents|vasodilator agents|mesh-ancestor
101769831|NCT00359281|Vitamin B Complex|vitamin b complex|mesh-ancestor
101769832|NCT00359281|Vitamins|vitamins|mesh-ancestor
101769833|NCT00359281|Micronutrients|micronutrients|mesh-ancestor
101769834|NCT00359281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769835|NCT00359281|Antitussive Agents|antitussive agents|mesh-ancestor
101769836|NCT00359281|Respiratory System Agents|respiratory system agents|mesh-ancestor
101769837|NCT00359281|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101769838|NCT00359281|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101769839|NCT00359281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101769840|NCT00902031|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
101769841|NCT00902031|Sennosides|sennosides|mesh-list
101769842|NCT00902031|Senna Extract|senna extract|mesh-list
101769843|NCT00902031|Antidiarrheals|antidiarrheals|mesh-ancestor
101769844|NCT00902031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101769845|NCT00902031|Laxatives|laxatives|mesh-ancestor
101769846|NCT00902031|Cathartics|cathartics|mesh-ancestor
101769847|NCT00985348|Levetiracetam|levetiracetam|mesh-list
101769848|NCT00985348|Anticonvulsants|anticonvulsants|mesh-ancestor
101769849|NCT00985348|Nootropic Agents|nootropic agents|mesh-ancestor
101769850|NCT00973336|Vitamin D|vitamin d|mesh-list
101769851|NCT00973336|Calcium|calcium|mesh-list
101769852|NCT00973336|Vitamins|vitamins|mesh-ancestor
101769853|NCT00973336|Micronutrients|micronutrients|mesh-ancestor
101769854|NCT00973336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769855|NCT00973336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101769864|NCT00902187|Urological Agents|urological agents|mesh-ancestor
101769866|NCT01052311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101769867|NCT01052311|Antimetabolites|antimetabolites|mesh-ancestor
101769868|NCT01052311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565326|NCT01286987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101565327|NCT01286753|Vemurafenib|vemurafenib|mesh-list
101565328|NCT01286753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101565329|NCT01286753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101565330|NCT01286753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101565331|NCT01286753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565332|NCT01284959|Risperidone|risperidone|mesh-list
101565333|NCT01284959|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101413568|NCT00484432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101769869|NCT01052311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101769870|NCT01052311|Vasodilator Agents|vasodilator agents|mesh-ancestor
101769871|NCT01052311|Vitamin B Complex|vitamin b complex|mesh-ancestor
101769872|NCT01052311|Vitamins|vitamins|mesh-ancestor
101769873|NCT01052311|Micronutrients|micronutrients|mesh-ancestor
101769874|NCT01052311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769875|NCT00988078|Metformin|metformin|mesh-list
101769876|NCT00988078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101769877|NCT00988078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769878|NCT00895089|Moxifloxacin|moxifloxacin|mesh-list
101769879|NCT00895089|Ceftriaxone|ceftriaxone|mesh-list
101769880|NCT00895089|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101769881|NCT00895089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101769882|NCT00895089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101769883|NCT00895089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101769884|NCT00895089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101769885|NCT00895089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101769886|NCT00895089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769887|NCT00895089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101769888|NCT00895089|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101769889|NCT00895089|Contraceptive Agents|contraceptive agents|mesh-ancestor
101769890|NCT00895089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101769891|NCT00895089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769892|NCT00895089|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101769893|NCT00895089|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101769894|NCT00895089|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101769895|NCT00982540|Caspofungin|caspofungin|mesh-list
101769896|NCT00982540|Antifungal Agents|antifungal agents|mesh-list
101769897|NCT00982540|Clotrimazole|clotrimazole|mesh-list
101769898|NCT00982540|Miconazole|miconazole|mesh-list
101769899|NCT00982540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101769900|NCT00982540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101769901|NCT00982540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769902|NCT00982540|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101769903|NCT00982540|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101769904|NCT00982540|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101769905|NCT00982540|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101769906|NCT00982540|Hormone Antagonists|hormone antagonists|mesh-ancestor
101769907|NCT00982540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101769908|NCT00982540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769909|NCT00982540|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101769910|NCT00982540|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101769911|NCT04674358|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101769912|NCT04674358|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101769913|NCT00366535|Neurotropin|neurotropin|mesh-list
101769914|NCT00366535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101769915|NCT00366535|Immunologic Factors|immunologic factors|mesh-ancestor
101769916|NCT00366535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769917|NCT00366535|Analgesics|analgesics|mesh-ancestor
101769918|NCT00366535|Sensory System Agents|sensory system agents|mesh-ancestor
101769919|NCT00366535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101769920|NCT00366535|Anticonvulsants|anticonvulsants|mesh-ancestor
101769933|NCT00982618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769935|NCT00982618|Narcotics|narcotics|mesh-ancestor
101769936|NCT00982618|Analgesics|analgesics|mesh-ancestor
101769937|NCT00895167|Curcumin|curcumin|mesh-list
101565334|NCT01284959|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101565335|NCT01284959|Serotonin Agents|serotonin agents|mesh-ancestor
101565336|NCT01284959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101565337|NCT01284959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565338|NCT01284959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565339|NCT01284959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101565340|NCT01284959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101565341|NCT01284959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101565342|NCT01284959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101565343|NCT01284959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101769938|NCT00895167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101769939|NCT00895167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101769940|NCT00895167|Analgesics|analgesics|mesh-ancestor
101769941|NCT00895167|Sensory System Agents|sensory system agents|mesh-ancestor
101769942|NCT00895167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101769943|NCT00895167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769944|NCT00895167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101769945|NCT00895167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101769946|NCT00895167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101769947|NCT00895167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101769948|NCT00895167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769949|NCT00902421|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
101769950|NCT00902421|Serotonin|serotonin|mesh-list
101769951|NCT00902421|Muscarinic Antagonists|muscarinic antagonists|mesh-list
101769952|NCT00902421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101769953|NCT00902421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101263887|NCT01764555|Acetaminophen|acetaminophen|mesh-list
101769954|NCT00902421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769955|NCT00902421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101769956|NCT00902421|Serotonin Agents|serotonin agents|mesh-ancestor
101769957|NCT00902421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769958|NCT00902421|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101769959|NCT00902421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101769960|NCT00902421|Cholinergic Agents|cholinergic agents|mesh-ancestor
101769961|NCT00985660|Nisoldipine|nisoldipine|mesh-list
101769962|NCT00985660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101769963|NCT00985660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101769964|NCT00985660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101769965|NCT00985660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769966|NCT00985660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101769967|NCT00985660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769968|NCT00985660|Vasodilator Agents|vasodilator agents|mesh-ancestor
101769969|NCT00350545|Cyclosporine|cyclosporine|mesh-list
101769970|NCT00350545|Prednisone|prednisone|mesh-list
101769971|NCT00350545|Rituximab|rituximab|mesh-list
101769972|NCT00350545|Tacrolimus|tacrolimus|mesh-list
101769973|NCT00350545|Cyclosporins|cyclosporins|mesh-list
101769974|NCT00350545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101427395|NCT00169728|Vaccines|vaccines|mesh-list
101769975|NCT00350545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101769976|NCT00350545|Immunologic Factors|immunologic factors|mesh-ancestor
101769977|NCT00350545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769978|NCT00350545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101769979|NCT00350545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101769980|NCT00350545|Glucocorticoids|glucocorticoids|mesh-ancestor
101769984|NCT00350545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101769985|NCT00350545|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101769986|NCT00350545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101769987|NCT00350545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769988|NCT00350545|Antifungal Agents|antifungal agents|mesh-ancestor
101769989|NCT00350545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101769990|NCT00350545|Dermatologic Agents|dermatologic agents|mesh-ancestor
101769991|NCT04006054|Midazolam|midazolam|mesh-list
101769992|NCT04006054|Dexmedetomidine|dexmedetomidine|mesh-list
101565344|NCT01284959|Dopamine Agents|dopamine agents|mesh-ancestor
101565345|NCT01284959|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101565346|NCT01284959|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101565347|NCT01283009|Methylprednisolone|methylprednisolone|mesh-list
101565348|NCT01283009|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101565349|NCT01283009|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101565350|NCT01283009|Prednisolone|prednisolone|mesh-list
101769993|NCT04006054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101769994|NCT04006054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101769995|NCT04006054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769996|NCT04006054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101769997|NCT04006054|Analgesics|analgesics|mesh-ancestor
101769998|NCT04006054|Sensory System Agents|sensory system agents|mesh-ancestor
101769999|NCT04006054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101770000|NCT04006054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101770001|NCT04006054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101770002|NCT04006054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101770003|NCT04006054|Adrenergic Agents|adrenergic agents|mesh-ancestor
101770004|NCT04006054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101770005|NCT04006054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770006|NCT04006054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101770007|NCT04006054|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101770008|NCT04006054|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101770009|NCT04006054|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101770010|NCT04006054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101770011|NCT04006054|Anesthetics, General|anesthetics, general|mesh-ancestor
101770012|NCT04006054|Anesthetics|anesthetics|mesh-ancestor
101770013|NCT04006054|GABA Modulators|gaba modulators|mesh-ancestor
101770014|NCT04006054|GABA Agents|gaba agents|mesh-ancestor
101770015|NCT00897975|Red yeast rice|red yeast rice|mesh-list
101770016|NCT00897975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101770017|NCT00897975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101770018|NCT00897975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101770019|NCT00897975|Antimetabolites|antimetabolites|mesh-ancestor
101770020|NCT00897975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770021|NCT00897975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101770022|NCT00897975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101770023|NCT01052389|Haloperidol|haloperidol|mesh-list
101770024|NCT01052389|Olanzapine|olanzapine|mesh-list
101770025|NCT01052389|Aripiprazole|aripiprazole|mesh-list
101770026|NCT01052389|Haloperidol decanoate|haloperidol decanoate|mesh-list
101770027|NCT01052389|Antiemetics|antiemetics|mesh-ancestor
101770028|NCT01052389|Autonomic Agents|autonomic agents|mesh-ancestor
101770029|NCT01052389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101770030|NCT01052389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770031|NCT01052389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101770032|NCT01052389|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101770033|NCT01052389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101770034|NCT01052389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101770035|NCT01052389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101770036|NCT01052389|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101770037|NCT01052389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101770038|NCT01052389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101770039|NCT01052389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770040|NCT01052389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101770041|NCT01052389|Serotonin Agents|serotonin agents|mesh-ancestor
101770042|NCT01052389|Antidepressive Agents|antidepressive agents|mesh-ancestor
101770043|NCT01052389|Dopamine Agonists|dopamine agonists|mesh-ancestor
101770044|NCT01052389|Dopamine Agents|dopamine agents|mesh-ancestor
101770045|NCT01052389|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101770046|NCT01052389|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101770047|NCT01052389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101770048|NCT01052389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101770049|NCT01052389|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101770050|NCT01052389|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101770066|NCT00349921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101565351|NCT01283009|Prednisolone acetate|prednisolone acetate|mesh-list
101565352|NCT01283009|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101565353|NCT01283009|Prednisolone phosphate|prednisolone phosphate|mesh-list
101565354|NCT01283009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101565355|NCT01283009|Antiemetics|antiemetics|mesh-ancestor
101565356|NCT01283009|Autonomic Agents|autonomic agents|mesh-ancestor
101770067|NCT00349921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101770069|NCT00349921|Adrenergic Agents|adrenergic agents|mesh-ancestor
101770070|NCT00349921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101770071|NCT00349921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770072|NCT00349921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101770073|NCT00349921|Vasodilator Agents|vasodilator agents|mesh-ancestor
101770074|NCT00349921|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101770075|NCT00349921|Purinergic Agonists|purinergic agonists|mesh-ancestor
101770076|NCT00349921|Purinergic Agents|purinergic agents|mesh-ancestor
101770077|NCT00902655|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101770078|NCT00902655|Hemostatics|hemostatics|mesh-ancestor
101770079|NCT00902655|Coagulants|coagulants|mesh-ancestor
101770080|NCT00902655|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101770081|NCT00902655|Natriuretic Agents|natriuretic agents|mesh-ancestor
101770082|NCT00902655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770083|NCT01052623|Clonidine|clonidine|mesh-list
101770084|NCT01052623|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101319683|NCT03151369|Morphine|morphine|mesh-list
101770085|NCT01052623|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101770086|NCT01052623|Estradiol|estradiol|mesh-list
101770087|NCT01052623|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101770088|NCT01052623|Hormones|hormones|mesh-ancestor
101770089|NCT01052623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101770090|NCT01052623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770091|NCT01052623|Estrogens|estrogens|mesh-ancestor
101770092|NCT01052623|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101770093|NCT01052623|Contraceptive Agents|contraceptive agents|mesh-ancestor
101770094|NCT01052623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101770095|NCT01052623|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101770096|NCT01052623|Analgesics|analgesics|mesh-ancestor
101770097|NCT01052623|Sensory System Agents|sensory system agents|mesh-ancestor
101770098|NCT01052623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101770099|NCT01052623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101770100|NCT01052623|Sympatholytics|sympatholytics|mesh-ancestor
101770101|NCT01052623|Autonomic Agents|autonomic agents|mesh-ancestor
101770102|NCT01052623|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101770103|NCT01052623|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101770104|NCT01052623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101770105|NCT01052623|Adrenergic Agents|adrenergic agents|mesh-ancestor
101770106|NCT01052623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101770107|NCT01052623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770108|NCT00902811|Artesunate|artesunate|mesh-list
101770109|NCT00902811|Amodiaquine|amodiaquine|mesh-list
101770110|NCT00902811|Antimalarials|antimalarials|mesh-ancestor
101770111|NCT00902811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101770112|NCT00902811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101770120|NCT00898287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101427541|NCT02931136|Huperzine A|huperzine a|mesh-list
101770122|NCT00898287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770123|NCT00898287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101770124|NCT04034823|Docetaxel|docetaxel|mesh-list
101770125|NCT04034823|Trastuzumab|trastuzumab|mesh-list
101770127|NCT04034823|Tubulin Modulators|tubulin modulators|mesh-ancestor
101770128|NCT04034823|Antimitotic Agents|antimitotic agents|mesh-ancestor
101770129|NCT04034823|Mitosis Modulators|mitosis modulators|mesh-ancestor
101770130|NCT04034823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770131|NCT04034823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101770132|NCT00606021|Pemetrexed|pemetrexed|mesh-list
101770133|NCT00606021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101770134|NCT00606021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101770135|NCT00606021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770136|NCT00606021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101770137|NCT00606021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101770138|NCT00337675|Montelukast|montelukast|mesh-list
101770139|NCT00337675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101565357|NCT01283009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101565358|NCT01283009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565359|NCT01283009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101565360|NCT01283009|Glucocorticoids|glucocorticoids|mesh-ancestor
101565361|NCT01283009|Hormones|hormones|mesh-ancestor
101565362|NCT01283009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101565363|NCT01283009|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101770140|NCT00337675|Respiratory System Agents|respiratory system agents|mesh-ancestor
101770141|NCT00337675|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101770142|NCT00337675|Hormone Antagonists|hormone antagonists|mesh-ancestor
101770143|NCT00337675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101770144|NCT00337675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770145|NCT00337675|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101770146|NCT00337675|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101770147|NCT00337675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770148|NCT00902967|Atorvastatin|atorvastatin|mesh-list
101770149|NCT00902967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101770150|NCT00902967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101770151|NCT00902967|Antimetabolites|antimetabolites|mesh-ancestor
101770152|NCT00902967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770153|NCT00902967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101770154|NCT00902967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101770155|NCT00902967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101770156|NCT00903045|Propiverine|propiverine|mesh-list
101770157|NCT00903045|Parasympatholytics|parasympatholytics|mesh-ancestor
101770158|NCT00903045|Autonomic Agents|autonomic agents|mesh-ancestor
101770159|NCT00903045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101770160|NCT00903045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770161|NCT00903045|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101770162|NCT00903045|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101770163|NCT00903045|Cholinergic Agents|cholinergic agents|mesh-ancestor
101770164|NCT00903045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101770165|NCT00903045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770166|NCT00903045|Urological Agents|urological agents|mesh-ancestor
101770167|NCT00337285|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101770168|NCT00337285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101770169|NCT00337285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770170|NCT00337285|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101770171|NCT00337285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101770172|NCT00337285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101770173|NCT00337285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770174|NCT00337285|Dopamine Agents|dopamine agents|mesh-ancestor
101770175|NCT00337285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101770176|NCT04035525|Coenzyme Q10|coenzyme q10|mesh-list
101770177|NCT04035525|Ubiquinone|ubiquinone|mesh-list
101770178|NCT04035525|Vitamins|vitamins|mesh-ancestor
101770194|NCT00905931|Lycopene|lycopene|mesh-list
101770195|NCT00905931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101770196|NCT00905931|Antioxidants|antioxidants|mesh-ancestor
101770197|NCT00905931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770198|NCT00905931|Protective Agents|protective agents|mesh-ancestor
101770199|NCT00905931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770200|NCT00905931|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101770201|NCT00905931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101770202|NCT00905931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101770204|NCT04035135|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101770205|NCT04035135|Antibodies|antibodies|mesh-list
101770206|NCT04035135|gamma-Globulins|gamma-globulins|mesh-list
101770207|NCT04035135|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101770208|NCT04035135|Immunologic Factors|immunologic factors|mesh-ancestor
101770209|NCT04035135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770210|NCT00903279|Retapamulin|retapamulin|mesh-list
101770211|NCT00903279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101770212|NCT00903279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101770213|NCT02539017|Immunomodulating Agents|immunomodulating agents|mesh-list
101565364|NCT01283009|Protective Agents|protective agents|mesh-ancestor
101565365|NCT01283009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101565366|NCT01283009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101565367|NCT01282463|Docetaxel|docetaxel|mesh-list
101565368|NCT01282463|Ramucirumab|ramucirumab|mesh-list
101565369|NCT01282463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101565370|NCT01282463|Tubulin Modulators|tubulin modulators|mesh-ancestor
101565371|NCT01282463|Antimitotic Agents|antimitotic agents|mesh-ancestor
101565372|NCT01282463|Mitosis Modulators|mitosis modulators|mesh-ancestor
101565373|NCT01282463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770214|NCT02539017|Immunologic Factors|immunologic factors|mesh-ancestor
101770215|NCT02539017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770216|NCT00605865|Sertraline|sertraline|mesh-list
101770217|NCT00605865|Antidepressive Agents|antidepressive agents|mesh-ancestor
101770218|NCT00605865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101770219|NCT00605865|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101770220|NCT00605865|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101770221|NCT00605865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101770222|NCT00605865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770223|NCT00605865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101770224|NCT00605865|Serotonin Agents|serotonin agents|mesh-ancestor
101770225|NCT00605865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770226|NCT00922467|Esmolol|esmolol|mesh-list
101770227|NCT00922467|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101770228|NCT00922467|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101770229|NCT00922467|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101770230|NCT00922467|Adrenergic Agents|adrenergic agents|mesh-ancestor
101770231|NCT00922467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101770232|NCT00922467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770233|NCT00922467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770234|NCT00903747|Moxifloxacin|moxifloxacin|mesh-list
101770235|NCT00903747|Prucalopride|prucalopride|mesh-list
101770236|NCT00903747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101770255|NCT00903825|Lidocaine|lidocaine|mesh-list
101770256|NCT00903825|Anesthetics, Local|anesthetics, local|mesh-list
101770257|NCT00903825|Anesthetics|anesthetics|mesh-list
101770258|NCT00903825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101770259|NCT00903825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770260|NCT00903825|Sensory System Agents|sensory system agents|mesh-ancestor
101770261|NCT00903825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101770262|NCT00903825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101770263|NCT00903825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101770264|NCT00903825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101770265|NCT00903825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101770266|NCT00903825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770267|NCT00904059|Asunaprevir|asunaprevir|mesh-list
101770268|NCT00904059|Protease Inhibitors|protease inhibitors|mesh-ancestor
101427695|NCT00148265|Hormones|hormones|mesh-ancestor
101770269|NCT00904059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101770270|NCT00904059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770271|NCT00337207|Bevacizumab|bevacizumab|mesh-list
101770272|NCT00337207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101770273|NCT00337207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101770274|NCT00337207|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101770275|NCT00337207|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101770276|NCT00337207|Growth Substances|growth substances|mesh-ancestor
101770277|NCT00337207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770278|NCT00337207|Growth Inhibitors|growth inhibitors|mesh-ancestor
101770279|NCT01055743|Fluorouracil|fluorouracil|mesh-list
101770280|NCT01055743|Antimetabolites|antimetabolites|mesh-ancestor
101770281|NCT01055743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770282|NCT01055743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101770283|NCT01055743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101565375|NCT01281917|Bortezomib|bortezomib|mesh-list
101565376|NCT01281917|Temsirolimus|temsirolimus|mesh-list
101565377|NCT01281917|MTOR Inhibitors|mtor inhibitors|mesh-list
101565378|NCT01281917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101565379|NCT01281917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101565380|NCT01281917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101565381|NCT01281917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565382|NCT01281917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101565383|NCT01281917|Immunologic Factors|immunologic factors|mesh-ancestor
101770284|NCT01055743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101770285|NCT01055743|Immunologic Factors|immunologic factors|mesh-ancestor
101770286|NCT01055743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770287|NCT00604695|Tenecteplase|tenecteplase|mesh-list
101770297|NCT01055821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770299|NCT00904293|Anticoagulants|anticoagulants|mesh-ancestor
101770300|NCT00904449|Oxymorphone|oxymorphone|mesh-list
101770301|NCT00904449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101770302|NCT00904449|Narcotics|narcotics|mesh-ancestor
101770303|NCT00904449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101770304|NCT00904449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770305|NCT00904449|Analgesics|analgesics|mesh-ancestor
101770306|NCT00904449|Sensory System Agents|sensory system agents|mesh-ancestor
101770307|NCT00904449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101770308|NCT00904449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101770309|NCT00348595|Lenalidomide|lenalidomide|mesh-list
101770310|NCT00348595|Immunologic Factors|immunologic factors|mesh-ancestor
101770311|NCT00348595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770312|NCT00348595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101770313|NCT00348595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101770314|NCT00348595|Growth Substances|growth substances|mesh-ancestor
101770315|NCT00348595|Growth Inhibitors|growth inhibitors|mesh-ancestor
101770316|NCT00348595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101770317|NCT02538939|Sodium thiosulfate|sodium thiosulfate|mesh-list
101770318|NCT02538939|Antidotes|antidotes|mesh-ancestor
101770319|NCT02538939|Protective Agents|protective agents|mesh-ancestor
101770320|NCT02538939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770321|NCT02538939|Antioxidants|antioxidants|mesh-ancestor
101770322|NCT02538939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770323|NCT02538939|Antitubercular Agents|antitubercular agents|mesh-ancestor
101770324|NCT02538939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101770325|NCT02538939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101770326|NCT02538939|Chelating Agents|chelating agents|mesh-ancestor
101770327|NCT02538939|Sequestering Agents|sequestering agents|mesh-ancestor
101770328|NCT00904605|Celecoxib|celecoxib|mesh-list
101770329|NCT00904605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101770330|NCT00904605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101770331|NCT00904605|Analgesics|analgesics|mesh-ancestor
101770332|NCT00904605|Sensory System Agents|sensory system agents|mesh-ancestor
101770333|NCT00904605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101770334|NCT00904605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770335|NCT00904605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101770336|NCT00904605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101770337|NCT00904605|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101770338|NCT00904605|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101770339|NCT00904605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101770340|NCT00904605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770341|NCT00905073|Cyclosporine|cyclosporine|mesh-list
101770342|NCT00905073|Methotrexate|methotrexate|mesh-list
101770343|NCT00905073|Cyclosporins|cyclosporins|mesh-list
101770344|NCT00905073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101770345|NCT00905073|Abortifacient Agents|abortifacient agents|mesh-ancestor
101770346|NCT00905073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101770347|NCT00905073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770348|NCT00905073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101770349|NCT00905073|Antimetabolites|antimetabolites|mesh-ancestor
101565384|NCT01281917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565385|NCT01281917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101565386|NCT01281917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101565387|NCT01281917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101565388|NCT01281917|Antifungal Agents|antifungal agents|mesh-ancestor
101770350|NCT00905073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770351|NCT00905073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101770352|NCT00905073|Dermatologic Agents|dermatologic agents|mesh-ancestor
101770353|NCT00905073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101770361|NCT00905073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101770363|NCT00905229|Vitamin K|vitamin k|mesh-list
101770364|NCT00905229|Vitamin K 1|vitamin k 1|mesh-list
101770365|NCT00905229|Micronutrients|micronutrients|mesh-ancestor
101770366|NCT00905229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770367|NCT00905229|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101770368|NCT00905229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101770369|NCT00905229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770370|NCT00905229|Hemostatics|hemostatics|mesh-ancestor
101770371|NCT00905229|Coagulants|coagulants|mesh-ancestor
101770372|NCT00905541|Simvastatin|simvastatin|mesh-list
101770373|NCT00905541|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101770374|NCT00905541|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101770375|NCT00905541|Antimetabolites|antimetabolites|mesh-ancestor
101770376|NCT00905541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770377|NCT00905541|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101263893|NCT01764555|Antipyretics|antipyretics|mesh-ancestor
101770378|NCT00905541|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101770379|NCT00905541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101770380|NCT00348283|Adalimumab|adalimumab|mesh-list
101770381|NCT00348283|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101770382|NCT00348283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101770383|NCT00348283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101770384|NCT00336895|Mycophenolic Acid|mycophenolic acid|mesh-list
101770385|NCT00336895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101770386|NCT00336895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101770387|NCT00336895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101770388|NCT00336895|Antitubercular Agents|antitubercular agents|mesh-ancestor
101770389|NCT00336895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101770390|NCT00336895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101770391|NCT00336895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101770392|NCT00336895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770393|NCT00336583|Cytarabine|cytarabine|mesh-list
101770394|NCT00336583|Methylprednisolone|methylprednisolone|mesh-list
101770395|NCT00336583|Oxaliplatin|oxaliplatin|mesh-list
101770396|NCT00336583|Etoposide|etoposide|mesh-list
101770397|NCT00336583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101770398|NCT00336583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101770399|NCT00336583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101770400|NCT00336583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101770401|NCT00336583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101770402|NCT00336583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770403|NCT00336583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101770404|NCT00336583|Antimetabolites|antimetabolites|mesh-ancestor
101770405|NCT00336583|Antiviral Agents|antiviral agents|mesh-ancestor
101770406|NCT00336583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101770407|NCT00336583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101770408|NCT00336583|Immunologic Factors|immunologic factors|mesh-ancestor
101770409|NCT00336583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770410|NCT00336583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101770411|NCT00336583|Antiemetics|antiemetics|mesh-ancestor
101770412|NCT00336583|Autonomic Agents|autonomic agents|mesh-ancestor
101770413|NCT00336583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101770414|NCT00336583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101770415|NCT00336583|Glucocorticoids|glucocorticoids|mesh-ancestor
101770416|NCT00336583|Hormones|hormones|mesh-ancestor
101770417|NCT00336583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101770418|NCT00336583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101770419|NCT00336583|Protective Agents|protective agents|mesh-ancestor
101770420|NCT00336505|Clarithromycin|clarithromycin|mesh-list
101770421|NCT00336505|Cethromycin|cethromycin|mesh-list
101565390|NCT01281839|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101565391|NCT01281839|Simeprevir|simeprevir|mesh-list
101565392|NCT01281839|Antimetabolites|antimetabolites|mesh-ancestor
101565393|NCT01281839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565394|NCT01281839|Antiviral Agents|antiviral agents|mesh-ancestor
101565395|NCT01281839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101565396|NCT01281839|Protease Inhibitors|protease inhibitors|mesh-ancestor
101565397|NCT01281839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101565398|NCT01280981|Tranexamic Acid|tranexamic acid|mesh-list
101413631|NCT00120809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770426|NCT00336505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770427|NCT00336505|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101770428|NCT00336505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101770429|NCT00357877|Chlorhexidine|chlorhexidine|mesh-list
101770430|NCT00357877|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101770431|NCT00357877|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101770432|NCT00357877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101770433|NCT00357877|Disinfectants|disinfectants|mesh-ancestor
101770434|NCT00357877|Dermatologic Agents|dermatologic agents|mesh-ancestor
101770436|NCT03987529|Sevoflurane|sevoflurane|mesh-list
101770437|NCT03987529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101770438|NCT03987529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101770439|NCT03987529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770440|NCT03987529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101770441|NCT03987529|Anesthetics, General|anesthetics, general|mesh-ancestor
101770442|NCT03987529|Anesthetics|anesthetics|mesh-ancestor
101770443|NCT03987529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101770444|NCT03987529|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101770445|NCT00335959|Capecitabine|capecitabine|mesh-list
101770446|NCT00335959|Oxaliplatin|oxaliplatin|mesh-list
101770447|NCT00335959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101770448|NCT00335959|Antimetabolites|antimetabolites|mesh-ancestor
101770449|NCT00335959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770450|NCT00335959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101770451|NCT01053169|Thrombin|thrombin|mesh-list
101770452|NCT01053169|Hemostatics|hemostatics|mesh-ancestor
101770453|NCT01053169|Coagulants|coagulants|mesh-ancestor
101770454|NCT01059331|Pregabalin|pregabalin|mesh-list
101770455|NCT01059331|Analgesics|analgesics|mesh-ancestor
101770456|NCT01059331|Sensory System Agents|sensory system agents|mesh-ancestor
101770457|NCT01059331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101770458|NCT01059331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770459|NCT01059331|Anticonvulsants|anticonvulsants|mesh-ancestor
101770460|NCT01059331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101770461|NCT01059331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101770462|NCT01059331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770463|NCT01059331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101770464|NCT01059331|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101770465|NCT01059331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101770466|NCT01059331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101770467|NCT01059331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101770468|NCT01059955|Dexamethasone|dexamethasone|mesh-list
101770469|NCT01059955|Dexamethasone acetate|dexamethasone acetate|mesh-list
101770470|NCT01059955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101770471|NCT01059955|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101770472|NCT01059955|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101770473|NCT01059955|BB 1101|bb 1101|mesh-list
101770474|NCT01059955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101770475|NCT01059955|Antiemetics|antiemetics|mesh-ancestor
101770476|NCT01059955|Autonomic Agents|autonomic agents|mesh-ancestor
101770477|NCT01059955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101770478|NCT01059955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770479|NCT01059955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101770480|NCT01059955|Glucocorticoids|glucocorticoids|mesh-ancestor
101565399|NCT01280981|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101565400|NCT01280981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101565401|NCT01280981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565402|NCT01280981|Hemostatics|hemostatics|mesh-ancestor
101565403|NCT01280981|Coagulants|coagulants|mesh-ancestor
101565404|NCT02889653|Anticoagulants|anticoagulants|mesh-list
101565405|NCT01280591|Naproxen|naproxen|mesh-list
101565406|NCT01280591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101565407|NCT01280591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101565408|NCT01280591|Analgesics|analgesics|mesh-ancestor
101565409|NCT01280591|Sensory System Agents|sensory system agents|mesh-ancestor
101527359|NCT01941641|Capecitabine|capecitabine|mesh-list
101565410|NCT01280591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101565411|NCT01280591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565412|NCT01280591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101565413|NCT01280591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101565414|NCT01280591|Gout Suppressants|gout suppressants|mesh-ancestor
101565415|NCT01280591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101565416|NCT01280591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101565417|NCT01280591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565418|NCT04323761|Remdesivir|remdesivir|mesh-list
101565419|NCT04323761|Antimetabolites|antimetabolites|mesh-ancestor
101565420|NCT04323761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770481|NCT01059955|Hormones|hormones|mesh-ancestor
101770482|NCT01059955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101770483|NCT01059955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101770484|NCT01059955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101770485|NCT01059955|Protease Inhibitors|protease inhibitors|mesh-ancestor
101770486|NCT01059955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101770487|NCT01059955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770488|NCT01060189|Tranexamic Acid|tranexamic acid|mesh-list
101770489|NCT01060189|Urinastatin|urinastatin|mesh-list
101770490|NCT01060189|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101770491|NCT01060189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101770492|NCT01060189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770493|NCT01060189|Hemostatics|hemostatics|mesh-ancestor
101770502|NCT01060267|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101770503|NCT01060267|Erythromycin stearate|erythromycin stearate|mesh-list
101770504|NCT01060267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101770505|NCT01060267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101770506|NCT01060267|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101770507|NCT01060267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101770508|NCT01060267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770509|NCT01060423|Irinotecan|irinotecan|mesh-list
101770510|NCT01060423|Cetuximab|cetuximab|mesh-list
101770511|NCT01060423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101770512|NCT01060423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101770513|NCT01060423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101770514|NCT01060423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770515|NCT01060423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101770516|NCT01060423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101565421|NCT04323761|Antiviral Agents|antiviral agents|mesh-ancestor
101565422|NCT04323761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101565423|NCT05566223|Aldesleukin|aldesleukin|mesh-list
101565424|NCT05566223|Cyclophosphamide|cyclophosphamide|mesh-list
101565425|NCT05566223|Pembrolizumab|pembrolizumab|mesh-list
101565426|NCT05566223|Fludarabine|fludarabine|mesh-list
101565427|NCT05566223|Interleukin-2|interleukin-2|mesh-list
101565428|NCT05566223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101565429|NCT05566223|Immunologic Factors|immunologic factors|mesh-ancestor
101565430|NCT05566223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565431|NCT05566223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101565432|NCT05566223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101565433|NCT05566223|Alkylating Agents|alkylating agents|mesh-ancestor
101565434|NCT05566223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565435|NCT05566223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101565436|NCT05566223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101565437|NCT05566223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101565438|NCT05566223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101565439|NCT05566223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101565441|NCT05566223|Sensory System Agents|sensory system agents|mesh-ancestor
101565442|NCT05566223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101413663|NCT05062356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101770517|NCT01060501|Leucovorin|leucovorin|mesh-list
101770518|NCT01060501|Folic Acid|folic acid|mesh-list
101770519|NCT01060501|Interferons|interferons|mesh-list
101770520|NCT01060501|Interferon-alpha|interferon-alpha|mesh-list
101770521|NCT01060501|Levoleucovorin|levoleucovorin|mesh-list
101770522|NCT01060501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101770523|NCT01060501|Antiviral Agents|antiviral agents|mesh-ancestor
101770524|NCT01060501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101770525|NCT01060501|Immunologic Factors|immunologic factors|mesh-ancestor
101770526|NCT01060501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770527|NCT01060501|Antidotes|antidotes|mesh-ancestor
101770528|NCT01060501|Protective Agents|protective agents|mesh-ancestor
101770529|NCT01060501|Vitamin B Complex|vitamin b complex|mesh-ancestor
101770530|NCT01060501|Vitamins|vitamins|mesh-ancestor
101770531|NCT01060501|Micronutrients|micronutrients|mesh-ancestor
101770532|NCT01060501|Hematinics|hematinics|mesh-ancestor
101770533|NCT00671658|Cytarabine|cytarabine|mesh-list
101770534|NCT00671658|Dexamethasone|dexamethasone|mesh-list
101770535|NCT00671658|Methylprednisolone|methylprednisolone|mesh-list
101770536|NCT00671658|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101770537|NCT00671658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101770538|NCT00671658|Prednisolone|prednisolone|mesh-list
101770539|NCT00671658|Prednisolone acetate|prednisolone acetate|mesh-list
101770540|NCT00671658|Cyclophosphamide|cyclophosphamide|mesh-list
101770541|NCT00671658|Rituximab|rituximab|mesh-list
101770542|NCT00671658|Doxorubicin|doxorubicin|mesh-list
101770543|NCT00671658|Methotrexate|methotrexate|mesh-list
101770544|NCT00671658|Vincristine|vincristine|mesh-list
101770545|NCT00671658|Asparaginase|asparaginase|mesh-list
101770546|NCT00671658|Pegaspargase|pegaspargase|mesh-list
101770547|NCT00671658|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101770548|NCT00671658|Prednisolone phosphate|prednisolone phosphate|mesh-list
101770549|NCT00671658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101770550|NCT00671658|Immunologic Factors|immunologic factors|mesh-ancestor
101770551|NCT00671658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770552|NCT00671658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101565443|NCT05566223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101565444|NCT05566223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101565445|NCT05566223|Antiviral Agents|antiviral agents|mesh-ancestor
101565446|NCT05566223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101565447|NCT01271933|Pregabalin|pregabalin|mesh-list
101565448|NCT01271933|Analgesics|analgesics|mesh-ancestor
101565449|NCT01271933|Sensory System Agents|sensory system agents|mesh-ancestor
101565450|NCT01271933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101565451|NCT01271933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565452|NCT01271933|Anticonvulsants|anticonvulsants|mesh-ancestor
101770553|NCT00671658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101770554|NCT00671658|Alkylating Agents|alkylating agents|mesh-ancestor
101770555|NCT00671658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770556|NCT00671658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101770557|NCT00671658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101770558|NCT00671658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101770559|NCT00671658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101770560|NCT00671658|Antiemetics|antiemetics|mesh-ancestor
101770561|NCT00671658|Autonomic Agents|autonomic agents|mesh-ancestor
101770562|NCT00671658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101770563|NCT00671658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101770564|NCT00671658|Glucocorticoids|glucocorticoids|mesh-ancestor
101770569|NCT00671658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101770570|NCT00671658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101427996|NCT00149084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101770571|NCT00671658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101770572|NCT00671658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101770573|NCT00671658|Abortifacient Agents|abortifacient agents|mesh-ancestor
101770574|NCT00671658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101770575|NCT00671658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101770576|NCT00671658|Antimetabolites|antimetabolites|mesh-ancestor
101770577|NCT00671658|Dermatologic Agents|dermatologic agents|mesh-ancestor
101770578|NCT00671658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101770579|NCT00671658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101770580|NCT00671658|Antiviral Agents|antiviral agents|mesh-ancestor
101770581|NCT00671658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101770582|NCT00671658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101770583|NCT00671658|Tubulin Modulators|tubulin modulators|mesh-ancestor
101770584|NCT00671658|Antimitotic Agents|antimitotic agents|mesh-ancestor
101770585|NCT00671658|Mitosis Modulators|mitosis modulators|mesh-ancestor
101770586|NCT00671658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101770587|NCT00671658|Protective Agents|protective agents|mesh-ancestor
101770588|NCT00764712|Insulin|insulin|mesh-list
101770589|NCT00764712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101770590|NCT00764712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770591|NCT00768456|Ropivacaine|ropivacaine|mesh-list
101770592|NCT00768456|Anesthetics, Local|anesthetics, local|mesh-ancestor
101770593|NCT00768456|Anesthetics|anesthetics|mesh-ancestor
101770594|NCT00768456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101770595|NCT00768456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770596|NCT00768456|Sensory System Agents|sensory system agents|mesh-ancestor
101770597|NCT00768456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101770598|NCT00768612|Risperidone|risperidone|mesh-list
101770599|NCT00768612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101770600|NCT00768612|Serotonin Agents|serotonin agents|mesh-ancestor
101770601|NCT00768612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101770602|NCT00768612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770603|NCT00768612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770604|NCT00768612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101770605|NCT00768612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101770606|NCT00768612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101770607|NCT00768612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101770608|NCT00768612|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101770609|NCT00768612|Dopamine Agents|dopamine agents|mesh-ancestor
101770610|NCT00604383|Ruboxistaurin|ruboxistaurin|mesh-list
101565453|NCT01271933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101565454|NCT01271933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101565455|NCT01271933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565456|NCT01271933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101565457|NCT01271933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101565458|NCT01271933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101565459|NCT01271933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101565460|NCT01271933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101565461|NCT01269125|Leuprolide|leuprolide|mesh-list
101565462|NCT01269125|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101413700|NCT01241500|ON 01910|on 01910|mesh-list
101770611|NCT00604383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101770612|NCT00604383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770613|NCT04048200|Fentanyl|fentanyl|mesh-list
101770614|NCT04048200|Dexmedetomidine|dexmedetomidine|mesh-list
101770615|NCT04048200|Ketamine|ketamine|mesh-list
101770616|NCT04048200|Analgesics, Opioid|analgesics, opioid|mesh-list
101770617|NCT04048200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101770618|NCT04048200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101770619|NCT04048200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770620|NCT04048200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101770621|NCT04048200|Analgesics|analgesics|mesh-ancestor
101770622|NCT04048200|Sensory System Agents|sensory system agents|mesh-ancestor
101770623|NCT04048200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101770624|NCT04048200|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101770625|NCT04048200|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101770626|NCT04048200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101770627|NCT04048200|Adrenergic Agents|adrenergic agents|mesh-ancestor
101770628|NCT04048200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101770629|NCT04048200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770630|NCT04048200|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101770631|NCT04048200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101770632|NCT04048200|Anesthetics, General|anesthetics, general|mesh-ancestor
101770633|NCT04048200|Anesthetics|anesthetics|mesh-ancestor
101770637|NCT04048200|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101770638|NCT04034589|Fulvestrant|fulvestrant|mesh-list
101770639|NCT04034589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101770640|NCT04034589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101770641|NCT04034589|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101770642|NCT04034589|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101770643|NCT04034589|Hormone Antagonists|hormone antagonists|mesh-ancestor
101770644|NCT04034589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101770645|NCT04034589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428088|NCT00170820|Everolimus|everolimus|mesh-list
101770646|NCT00988312|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
101770647|NCT00988312|Immunologic Factors|immunologic factors|mesh-ancestor
101770648|NCT00988312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770649|NCT00906867|Methacholine Chloride|methacholine chloride|mesh-list
101770651|NCT00906867|Autonomic Agents|autonomic agents|mesh-ancestor
101770652|NCT00906867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101770653|NCT00906867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770654|NCT00906867|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101770655|NCT00906867|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
101770656|NCT00906867|Respiratory System Agents|respiratory system agents|mesh-ancestor
101770657|NCT00906867|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101770658|NCT00906867|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101770659|NCT00906867|Cholinergic Agents|cholinergic agents|mesh-ancestor
101770660|NCT00906867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101770661|NCT00906867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770662|NCT00768690|Ketoconazole|ketoconazole|mesh-list
101770663|NCT00768690|Antifungal Agents|antifungal agents|mesh-ancestor
101770664|NCT00768690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101565463|NCT01269125|Fertility Agents|fertility agents|mesh-ancestor
101565464|NCT01269125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101565465|NCT01269125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565466|NCT01269125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101565467|NCT01269125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101565468|NCT01268891|Rasagiline|rasagiline|mesh-list
101565469|NCT01268891|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101565470|NCT01268891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101413703|NCT01241500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101770665|NCT00768690|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101770666|NCT00768690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101770667|NCT00768690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101770668|NCT00768690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770669|NCT00768690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101770670|NCT00768690|Hormone Antagonists|hormone antagonists|mesh-ancestor
101770671|NCT00768690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101770672|NCT00768690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770673|NCT00768690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101770674|NCT00768768|Terbinafine|terbinafine|mesh-list
101770675|NCT00768768|Antifungal Agents|antifungal agents|mesh-ancestor
101770676|NCT00768768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101770677|NCT00768768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101770678|NCT00768768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770679|NCT00775086|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101770680|NCT00775086|Norelgestromin|norelgestromin|mesh-list
101770681|NCT00775086|Contraceptive Agents|contraceptive agents|mesh-list
101770682|NCT00775086|Estradiol|estradiol|mesh-list
101770683|NCT00775086|Estrogens|estrogens|mesh-ancestor
101770684|NCT00775086|Hormones|hormones|mesh-ancestor
101770685|NCT00775086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101770686|NCT00775086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770687|NCT00775086|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101770688|NCT00775086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101770689|NCT00775086|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101770690|NCT00775086|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101770691|NCT00775086|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101770692|NCT02557854|Doxorubicin|doxorubicin|mesh-list
101770693|NCT02557854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101770694|NCT02557854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101770695|NCT02557854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101770696|NCT02557854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101770697|NCT02557854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101770698|NCT02557854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101770699|NCT02557854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770700|NCT02557386|Levobupivacaine|levobupivacaine|mesh-list
101770701|NCT02557386|Anesthetics, Local|anesthetics, local|mesh-ancestor
101770702|NCT02557386|Anesthetics|anesthetics|mesh-ancestor
101770703|NCT02557386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101770709|NCT00986050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101770710|NCT00986050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101770711|NCT00986050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101770712|NCT00986050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101770713|NCT00986050|Antifungal Agents|antifungal agents|mesh-ancestor
101770714|NCT00986050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101770715|NCT00986050|Immunologic Factors|immunologic factors|mesh-ancestor
101770716|NCT00986050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770717|NCT00986050|Anticoagulants|anticoagulants|mesh-ancestor
101770718|NCT00986050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101770720|NCT00986128|Anticonvulsants|anticonvulsants|mesh-ancestor
101770721|NCT00986128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101770722|NCT00986128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770723|NCT00771342|Nitric Oxide|nitric oxide|mesh-list
101770724|NCT00771342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101770725|NCT00771342|Autonomic Agents|autonomic agents|mesh-ancestor
101770726|NCT00771342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101565471|NCT01268891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565472|NCT01268891|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101565473|NCT01268891|Protective Agents|protective agents|mesh-ancestor
101565474|NCT01268891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565475|NCT04323527|Chloroquine|chloroquine|mesh-list
101565476|NCT04323527|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
101565477|NCT04323527|Amebicides|amebicides|mesh-ancestor
101565478|NCT04323527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101565479|NCT04323527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101565480|NCT04323527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101565481|NCT04323527|Antimalarials|antimalarials|mesh-ancestor
101413713|NCT05058612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101770727|NCT00771342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770728|NCT00771342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101770729|NCT00771342|Respiratory System Agents|respiratory system agents|mesh-ancestor
101770730|NCT00771342|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101770731|NCT00771342|Antioxidants|antioxidants|mesh-ancestor
101770732|NCT00771342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770733|NCT00771342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101770734|NCT00771342|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101770735|NCT00771342|Vasodilator Agents|vasodilator agents|mesh-ancestor
101770736|NCT00771342|Gasotransmitters|gasotransmitters|mesh-ancestor
101770737|NCT00771342|Protective Agents|protective agents|mesh-ancestor
101770738|NCT00775164|Metformin|metformin|mesh-list
101770739|NCT00775164|Pioglitazone|pioglitazone|mesh-list
101770740|NCT00775164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101770741|NCT00775164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770742|NCT00771420|Mavrilimumab|mavrilimumab|mesh-list
101770743|NCT00771420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101770744|NCT00771420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101770745|NCT00771420|Immunologic Factors|immunologic factors|mesh-ancestor
101770746|NCT00771420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770747|NCT04767256|Dexamethasone|dexamethasone|mesh-list
101770748|NCT04767256|Dexmedetomidine|dexmedetomidine|mesh-list
101770749|NCT04767256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101770750|NCT04767256|Antiemetics|antiemetics|mesh-ancestor
101770751|NCT04767256|Autonomic Agents|autonomic agents|mesh-ancestor
101770752|NCT04767256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101770753|NCT04767256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770754|NCT04767256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101770755|NCT04767256|Glucocorticoids|glucocorticoids|mesh-ancestor
101770756|NCT04767256|Hormones|hormones|mesh-ancestor
101770757|NCT04767256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101770758|NCT04767256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101770759|NCT04767256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101770760|NCT04767256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101770761|NCT04767256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101770762|NCT04767256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101770763|NCT04767256|Analgesics|analgesics|mesh-ancestor
101770764|NCT04767256|Sensory System Agents|sensory system agents|mesh-ancestor
101770765|NCT04767256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101770766|NCT04767256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101770767|NCT04767256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101770768|NCT04767256|Adrenergic Agents|adrenergic agents|mesh-ancestor
101770769|NCT04767256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101770770|NCT04767256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770771|NCT00771498|Lopinavir|lopinavir|mesh-list
101770772|NCT00771498|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101770773|NCT00771498|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101770774|NCT00771498|Protease Inhibitors|protease inhibitors|mesh-ancestor
101770787|NCT00986284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770788|NCT00988780|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101770789|NCT00988780|Efavirenz|efavirenz|mesh-list
101565482|NCT04323527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101565483|NCT04323527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101565484|NCT04323527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101565486|NCT04323527|Sensory System Agents|sensory system agents|mesh-ancestor
101565487|NCT04323527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101565488|NCT04323527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770791|NCT00988780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101770792|NCT00988780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101770793|NCT00988780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101770794|NCT00988780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770795|NCT00988780|Antiviral Agents|antiviral agents|mesh-ancestor
101770796|NCT00988780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101770797|NCT00988780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101770798|NCT00988780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101770799|NCT00988780|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101770800|NCT00988780|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101770801|NCT00988780|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101770802|NCT00988780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101770803|NCT00988780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101770804|NCT00988780|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101770805|NCT00988780|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101770806|NCT00988780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101770807|NCT00988780|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101770808|NCT00775242|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101770809|NCT00775242|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101770810|NCT00775242|Estradiol|estradiol|mesh-list
101770811|NCT00775242|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101770812|NCT00775242|Estrogens|estrogens|mesh-list
101770813|NCT00775242|Progesterone|progesterone|mesh-list
101770814|NCT00775242|Progestins|progestins|mesh-list
101770815|NCT00775242|Hormones|hormones|mesh-ancestor
101770816|NCT00775242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101770817|NCT00775242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770818|NCT00775242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101770819|NCT00775242|Contraceptive Agents|contraceptive agents|mesh-ancestor
101770820|NCT00775242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101770821|NCT00775242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101770823|NCT00986518|Immunologic Factors|immunologic factors|mesh-ancestor
101770824|NCT00986518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770825|NCT00769158|Topiramate|topiramate|mesh-list
101770826|NCT00769158|Naltrexone|naltrexone|mesh-list
101770827|NCT00769158|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101770828|NCT00769158|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101770829|NCT00769158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770830|NCT00769158|Sensory System Agents|sensory system agents|mesh-ancestor
101770831|NCT00769158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101770832|NCT00769158|Anticonvulsants|anticonvulsants|mesh-ancestor
101770833|NCT00769158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101770834|NCT00983164|Antioxidants|antioxidants|mesh-list
101770835|NCT00983164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770841|NCT00333775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101770842|NCT00333775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101770843|NCT00333775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101770844|NCT00333775|Growth Substances|growth substances|mesh-ancestor
101770845|NCT00333775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770846|NCT00333775|Growth Inhibitors|growth inhibitors|mesh-ancestor
101770847|NCT00333775|Tubulin Modulators|tubulin modulators|mesh-ancestor
101770848|NCT00333775|Antimitotic Agents|antimitotic agents|mesh-ancestor
101770849|NCT00333775|Mitosis Modulators|mitosis modulators|mesh-ancestor
101770850|NCT00333775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770851|NCT03860428|Acetaminophen|acetaminophen|mesh-list
101770852|NCT03860428|Ibuprofen|ibuprofen|mesh-list
101770853|NCT03860428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
101770854|NCT03860428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101565489|NCT04323527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101565491|NCT04323527|Antinematodal Agents|antinematodal agents|mesh-ancestor
101565492|NCT04323527|Anthelmintics|anthelmintics|mesh-ancestor
101565493|NCT02889497|Vaccines|vaccines|mesh-list
101413727|NCT01241422|Montelukast|montelukast|mesh-list
101770855|NCT03860428|Analgesics|analgesics|mesh-ancestor
101770856|NCT03860428|Sensory System Agents|sensory system agents|mesh-ancestor
101770857|NCT03860428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101319845|NCT02866006|Topotecan|topotecan|mesh-list
101770858|NCT03860428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770859|NCT03860428|Antipyretics|antipyretics|mesh-ancestor
101770860|NCT03860428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101770861|NCT03860428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101770862|NCT03860428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101770863|NCT03860428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101770864|NCT03860428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770865|NCT00771888|Lanreotide|lanreotide|mesh-list
101770866|NCT00771888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101770867|NCT00605475|Metformin|metformin|mesh-list
101770868|NCT00605475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101770869|NCT00605475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770870|NCT00986596|Vitamin D|vitamin d|mesh-list
101770871|NCT00986596|Cholecalciferol|cholecalciferol|mesh-list
101770872|NCT00986596|Vitamins|vitamins|mesh-ancestor
101770873|NCT00986596|Micronutrients|micronutrients|mesh-ancestor
101770874|NCT00986596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770875|NCT00986596|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101770876|NCT00986596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101770877|NCT00769470|Carboplatin|carboplatin|mesh-list
101770878|NCT00769470|Docetaxel|docetaxel|mesh-list
101770879|NCT00769470|Trastuzumab|trastuzumab|mesh-list
101770880|NCT00769470|Lapatinib|lapatinib|mesh-list
101770881|NCT00769470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101770882|NCT00769470|Tubulin Modulators|tubulin modulators|mesh-ancestor
101770883|NCT00769470|Antimitotic Agents|antimitotic agents|mesh-ancestor
101770884|NCT00769470|Mitosis Modulators|mitosis modulators|mesh-ancestor
101770885|NCT00769470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770886|NCT00769470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101770887|NCT00769470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101770888|NCT00769470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101770889|NCT00605319|Fesoterodine|fesoterodine|mesh-list
101770890|NCT00605319|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101770891|NCT00605319|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101770892|NCT00605319|Cholinergic Agents|cholinergic agents|mesh-ancestor
101770893|NCT00605319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101770894|NCT00605319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770895|NCT00605319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770896|NCT00605319|Urological Agents|urological agents|mesh-ancestor
101770898|NCT00983320|Antidepressive Agents|antidepressive agents|mesh-ancestor
101770899|NCT00983320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101770900|NCT00983320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101770901|NCT00983320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101770902|NCT00983320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101770903|NCT00983320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770904|NCT00908661|Cellulose, Oxidized|cellulose, oxidized|mesh-list
101770905|NCT00908661|Hemostatics|hemostatics|mesh-ancestor
101770906|NCT00908661|Coagulants|coagulants|mesh-ancestor
101770907|NCT00983398|Sodium thiosulfate|sodium thiosulfate|mesh-list
101770908|NCT00983398|Carboplatin|carboplatin|mesh-list
101770915|NCT00983398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101770916|NCT00983398|Alkylating Agents|alkylating agents|mesh-ancestor
101770917|NCT00983398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770918|NCT00983398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101770919|NCT00983398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101770920|NCT00983398|Immunologic Factors|immunologic factors|mesh-ancestor
101770921|NCT00983398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770922|NCT00983398|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101770923|NCT00983398|Diuretics|diuretics|mesh-ancestor
101770924|NCT00983398|Natriuretic Agents|natriuretic agents|mesh-ancestor
101770925|NCT00983398|Protective Agents|protective agents|mesh-ancestor
101770926|NCT00983398|Antioxidants|antioxidants|mesh-ancestor
101770927|NCT00983398|Antitubercular Agents|antitubercular agents|mesh-ancestor
101565494|NCT02889497|Immunologic Factors|immunologic factors|mesh-ancestor
101565495|NCT02889497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565496|NCT01266317|Rituximab|rituximab|mesh-list
101565497|NCT01266317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101565498|NCT01266317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101565499|NCT01266317|Immunologic Factors|immunologic factors|mesh-ancestor
101770928|NCT00983398|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101770929|NCT00983398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101770930|NCT00983398|Chelating Agents|chelating agents|mesh-ancestor
101770931|NCT00983398|Sequestering Agents|sequestering agents|mesh-ancestor
101770932|NCT00333229|Zoledronic Acid|zoledronic acid|mesh-list
101770933|NCT00333229|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101770934|NCT00333229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770935|NCT00769548|Goserelin|goserelin|mesh-list
101770936|NCT00769548|Flutamide|flutamide|mesh-list
101770937|NCT00769548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101770938|NCT00769548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101770939|NCT00769548|Androgen Antagonists|androgen antagonists|mesh-ancestor
101770940|NCT00769548|Hormone Antagonists|hormone antagonists|mesh-ancestor
101770941|NCT00769548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101770942|NCT00769548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770943|NCT05277675|Bevacizumab|bevacizumab|mesh-list
101770944|NCT05277675|Tislelizumab|tislelizumab|mesh-list
101770945|NCT05277675|Lenvatinib|lenvatinib|mesh-list
101770946|NCT05277675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101770947|NCT05277675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101770948|NCT05277675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101770949|NCT05277675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101770950|NCT05277675|Growth Substances|growth substances|mesh-ancestor
101770951|NCT05277675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770952|NCT05277675|Growth Inhibitors|growth inhibitors|mesh-ancestor
101770953|NCT05277675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101770954|NCT05277675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101770955|NCT05277675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770956|NCT03984409|Potassium Citrate|potassium citrate|mesh-list
101770957|NCT03984409|Diuretics|diuretics|mesh-ancestor
101770958|NCT03984409|Natriuretic Agents|natriuretic agents|mesh-ancestor
101770959|NCT03984409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770960|NCT03984409|Expectorants|expectorants|mesh-ancestor
101770961|NCT03984409|Respiratory System Agents|respiratory system agents|mesh-ancestor
101770962|NCT00983554|Anastrozole|anastrozole|mesh-list
101770963|NCT00983554|Testosterone|testosterone|mesh-list
101770964|NCT00983554|Dutasteride|dutasteride|mesh-list
101770965|NCT00983554|Androgens|androgens|mesh-ancestor
101770966|NCT00983554|Hormones|hormones|mesh-ancestor
101770967|NCT00983554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101770968|NCT00983554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770969|NCT00983554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101770970|NCT00983554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101770971|NCT00983554|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101770972|NCT00983554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101770973|NCT00983554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101770974|NCT00983554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770975|NCT00983554|Hormone Antagonists|hormone antagonists|mesh-ancestor
101770976|NCT00983554|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101770977|NCT00983554|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101770979|NCT05004987|Citalopram|citalopram|mesh-list
101770980|NCT05004987|Escitalopram|escitalopram|mesh-list
101770986|NCT05004987|Serotonin Agents|serotonin agents|mesh-ancestor
101770987|NCT05004987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770988|NCT05004987|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101770989|NCT05004987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101770990|NCT05004987|Parasympatholytics|parasympatholytics|mesh-ancestor
101770991|NCT05004987|Autonomic Agents|autonomic agents|mesh-ancestor
101770992|NCT05004987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101770993|NCT05004987|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101770994|NCT05004987|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101770995|NCT05004987|Cholinergic Agents|cholinergic agents|mesh-ancestor
101565500|NCT01266317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565501|NCT01266317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101565503|NCT01266161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101565504|NCT01266161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101565505|NCT01266161|Analgesics|analgesics|mesh-ancestor
101565506|NCT01266161|Sensory System Agents|sensory system agents|mesh-ancestor
101565507|NCT01266161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101565508|NCT01266161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565509|NCT01266161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101565510|NCT01266161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101565511|NCT01266161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101565512|NCT01266161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101565513|NCT01266161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565514|NCT01265849|Indomethacin|indomethacin|mesh-list
101565515|NCT01265849|Cyclophosphamide|cyclophosphamide|mesh-list
101565516|NCT01265849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101565517|NCT01265849|Immunologic Factors|immunologic factors|mesh-ancestor
101565518|NCT01265849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565519|NCT01265849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101770996|NCT05004987|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101770997|NCT05004987|Antidepressive Agents|antidepressive agents|mesh-ancestor
101770998|NCT05004987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101428437|NCT05781516|Glucocorticoids|glucocorticoids|mesh-ancestor
101770999|NCT00908817|Chlorhexidine|chlorhexidine|mesh-list
101771000|NCT00908817|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101771001|NCT00908817|Triamcinolone|triamcinolone|mesh-list
101771002|NCT00908817|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101771003|NCT00908817|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101771004|NCT00908817|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101771005|NCT00908817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101771006|NCT00908817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101771007|NCT00908817|Disinfectants|disinfectants|mesh-ancestor
101771008|NCT00908817|Dermatologic Agents|dermatologic agents|mesh-ancestor
101771009|NCT00908817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101771010|NCT00908817|Glucocorticoids|glucocorticoids|mesh-ancestor
101771011|NCT00908817|Hormones|hormones|mesh-ancestor
101771012|NCT00908817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101771013|NCT00908817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771014|NCT00908817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101771015|NCT00908817|Immunologic Factors|immunologic factors|mesh-ancestor
101771016|NCT00908817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101771017|NCT00908817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771018|NCT00332839|Cyclosporine|cyclosporine|mesh-list
101771019|NCT00332839|Mycophenolic Acid|mycophenolic acid|mesh-list
101771020|NCT00332839|Everolimus|everolimus|mesh-list
101771021|NCT00332839|Tacrolimus|tacrolimus|mesh-list
101771022|NCT00332839|Cyclosporins|cyclosporins|mesh-list
101771023|NCT00332839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101771024|NCT00332839|Immunologic Factors|immunologic factors|mesh-ancestor
101771025|NCT00332839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771026|NCT00332839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101771027|NCT00332839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101771028|NCT00332839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771029|NCT00332839|Antifungal Agents|antifungal agents|mesh-ancestor
101771030|NCT00332839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101565520|NCT01265849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101565521|NCT01265849|Alkylating Agents|alkylating agents|mesh-ancestor
101319894|NCT02122081|Methotrexate|methotrexate|mesh-list
101565522|NCT01265849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565523|NCT01265849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101565524|NCT01265849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101565525|NCT01265849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101565526|NCT01265849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101565527|NCT01265849|Analgesics|analgesics|mesh-ancestor
101565528|NCT01265849|Sensory System Agents|sensory system agents|mesh-ancestor
101565529|NCT01265849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101565530|NCT01265849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101565531|NCT01265849|Gout Suppressants|gout suppressants|mesh-ancestor
101565532|NCT01265849|Tocolytic Agents|tocolytic agents|mesh-ancestor
101565533|NCT01265849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101565534|NCT01265849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101565535|NCT01265849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101565536|NCT01265615|Cholecalciferol|cholecalciferol|mesh-list
101771031|NCT00332839|Dermatologic Agents|dermatologic agents|mesh-ancestor
101771032|NCT00332839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101771033|NCT00332839|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101771034|NCT00332839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101771035|NCT00332839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101771036|NCT00332839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101771037|NCT00332839|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101771038|NCT00332839|Antitubercular Agents|antitubercular agents|mesh-ancestor
101771039|NCT00332839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101771040|NCT00927147|Cetuximab|cetuximab|mesh-list
101771041|NCT00927147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101771042|NCT00927147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101771043|NCT05712616|Strontium ranelate|strontium ranelate|mesh-list
101771044|NCT05712616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101771045|NCT05712616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771046|NCT00927225|Ropivacaine|ropivacaine|mesh-list
101771047|NCT00927225|Anesthetics, Local|anesthetics, local|mesh-ancestor
101771048|NCT00927225|Anesthetics|anesthetics|mesh-ancestor
101771055|NCT00357097|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101771056|NCT00357097|Dopamine Agonists|dopamine agonists|mesh-ancestor
101771057|NCT00357097|Dopamine Agents|dopamine agents|mesh-ancestor
101771058|NCT00357097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101771059|NCT00357097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771060|NCT00357097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771061|NCT00983788|Bezafibrate|bezafibrate|mesh-list
101771062|NCT00983788|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101771063|NCT00983788|Antimetabolites|antimetabolites|mesh-ancestor
101771064|NCT00983788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771065|NCT00983788|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101771066|NCT00983944|Prednisone|prednisone|mesh-list
101771067|NCT00983944|Cyclophosphamide|cyclophosphamide|mesh-list
101771068|NCT00983944|Rituximab|rituximab|mesh-list
101771069|NCT00983944|Doxorubicin|doxorubicin|mesh-list
101771070|NCT00983944|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101771071|NCT00983944|Etoposide|etoposide|mesh-list
101771072|NCT00983944|Vincristine|vincristine|mesh-list
101771073|NCT00983944|Bleomycin|bleomycin|mesh-list
101771074|NCT00983944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101771075|NCT00983944|Immunologic Factors|immunologic factors|mesh-ancestor
101771076|NCT00983944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771077|NCT00983944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101771078|NCT00983944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101565537|NCT01265615|Vitamin D|vitamin d|mesh-list
101565538|NCT01265615|Calcitriol|calcitriol|mesh-list
101565539|NCT01265615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101565540|NCT01265615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565541|NCT01265615|Vitamins|vitamins|mesh-ancestor
101565542|NCT01265615|Micronutrients|micronutrients|mesh-ancestor
101565543|NCT01265615|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101565544|NCT01265615|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101565545|NCT01265615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101319909|NCT02122081|Abortifacient Agents|abortifacient agents|mesh-ancestor
101565546|NCT01265615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771079|NCT00983944|Alkylating Agents|alkylating agents|mesh-ancestor
101771080|NCT00983944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771081|NCT00983944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101771082|NCT00983944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101771083|NCT00983944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101771084|NCT00983944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101771085|NCT00983944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101771086|NCT00983944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101771087|NCT00983944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101771088|NCT00983944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101771089|NCT00983944|Glucocorticoids|glucocorticoids|mesh-ancestor
101771090|NCT00983944|Hormones|hormones|mesh-ancestor
101771091|NCT00983944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101771092|NCT00983944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101771093|NCT00983944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101771094|NCT00983944|Tubulin Modulators|tubulin modulators|mesh-ancestor
101771095|NCT00983944|Antimitotic Agents|antimitotic agents|mesh-ancestor
101771096|NCT00983944|Mitosis Modulators|mitosis modulators|mesh-ancestor
101771097|NCT00927537|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101771098|NCT00927537|Telmisartan|telmisartan|mesh-list
101771099|NCT00927537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101771100|NCT00927537|Diuretics|diuretics|mesh-ancestor
101771101|NCT00927537|Natriuretic Agents|natriuretic agents|mesh-ancestor
101771102|NCT00927537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771103|NCT00927537|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101771104|NCT00927537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101771105|NCT00927537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771106|NCT00927537|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101771107|NCT00927537|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101771108|NCT02538003|Delpazolid|delpazolid|mesh-list
101771109|NCT02538003|Oxazolidinones|oxazolidinones|mesh-list
101771110|NCT02538003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101771111|NCT02538003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101771112|NCT02538003|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101771113|NCT02538003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101771114|NCT02538003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771115|NCT00909129|Interferons|interferons|mesh-list
101771116|NCT00909129|Ribavirin|ribavirin|mesh-list
101771117|NCT00909129|Interferon-alpha|interferon-alpha|mesh-list
101771126|NCT01053325|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101771128|NCT01053325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101771129|NCT01053325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101771130|NCT01053325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101771131|NCT01053325|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101771132|NCT01053325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101771133|NCT01053403|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
101771134|NCT01053403|Hallucinogens|hallucinogens|mesh-ancestor
101771135|NCT01053403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771136|NCT01053403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101771137|NCT01053403|Serotonin Agents|serotonin agents|mesh-ancestor
101771138|NCT01053403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101771139|NCT01053403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771140|NCT01053403|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101565547|NCT01265615|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101565548|NCT01264679|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
101565549|NCT01264679|Hematinics|hematinics|mesh-ancestor
101565550|NCT01264679|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101565551|NCT01264679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101565552|NCT05542667|Fluorides|fluorides|mesh-list
101565553|NCT05542667|Fluorides, Topical|fluorides, topical|mesh-list
101565554|NCT05542667|Cariostatic Agents|cariostatic agents|mesh-ancestor
101565555|NCT05542667|Protective Agents|protective agents|mesh-ancestor
101771141|NCT01053403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101771142|NCT01053403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101771143|NCT01053403|Adrenergic Agents|adrenergic agents|mesh-ancestor
101771144|NCT00927615|Abciximab|abciximab|mesh-list
101771145|NCT00927615|Anticoagulants|anticoagulants|mesh-ancestor
101771146|NCT00927615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101771147|NCT03990103|Paclitaxel|paclitaxel|mesh-list
101771148|NCT03990103|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101771149|NCT03990103|Bevacizumab|bevacizumab|mesh-list
101771150|NCT03990103|Oxaliplatin|oxaliplatin|mesh-list
101771151|NCT03990103|Tegafur|tegafur|mesh-list
101771152|NCT03990103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101771153|NCT03990103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101771154|NCT03990103|Tubulin Modulators|tubulin modulators|mesh-ancestor
101771155|NCT03990103|Antimitotic Agents|antimitotic agents|mesh-ancestor
101771156|NCT03990103|Mitosis Modulators|mitosis modulators|mesh-ancestor
101771157|NCT03990103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771158|NCT03990103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101771159|NCT03990103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101771160|NCT03990103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101771161|NCT03990103|Growth Substances|growth substances|mesh-ancestor
101771162|NCT03990103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771163|NCT03990103|Growth Inhibitors|growth inhibitors|mesh-ancestor
101771164|NCT03990103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101771165|NCT03990103|Antimetabolites|antimetabolites|mesh-ancestor
101771166|NCT00927693|Calcium|calcium|mesh-list
101771167|NCT00927693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101771168|NCT00927693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771169|NCT00987220|Donepezil|donepezil|mesh-list
101771170|NCT00987220|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101771171|NCT00987220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101771172|NCT00987220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771173|NCT00987220|Cholinergic Agents|cholinergic agents|mesh-ancestor
101771174|NCT00987220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101771175|NCT00987220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771176|NCT00987220|Nootropic Agents|nootropic agents|mesh-ancestor
101771177|NCT01581151|Dexamethasone|dexamethasone|mesh-list
101771178|NCT01581151|Ranibizumab|ranibizumab|mesh-list
101771179|NCT01581151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101771180|NCT01581151|Antiemetics|antiemetics|mesh-ancestor
101771181|NCT01581151|Autonomic Agents|autonomic agents|mesh-ancestor
101771182|NCT01581151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101771184|NCT01581151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101771185|NCT01581151|Glucocorticoids|glucocorticoids|mesh-ancestor
101771187|NCT01581151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101771188|NCT01581151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101771189|NCT01581151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101771190|NCT01581151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101771191|NCT01581151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101771192|NCT01581151|Growth Substances|growth substances|mesh-ancestor
101771193|NCT01581151|Growth Inhibitors|growth inhibitors|mesh-ancestor
101771194|NCT01053481|Vitamin D|vitamin d|mesh-list
101771195|NCT01053481|Vitamins|vitamins|mesh-ancestor
101771196|NCT01053481|Micronutrients|micronutrients|mesh-ancestor
101771197|NCT01053481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771198|NCT01053481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101771199|NCT00927771|Azelaic acid|azelaic acid|mesh-list
101771200|NCT00927771|Hydroquinone|hydroquinone|mesh-list
101771201|NCT00927771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101565556|NCT05542667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565557|NCT01263509|Inositol|inositol|mesh-list
101565558|NCT01263509|Alogliptin|alogliptin|mesh-list
101565559|NCT01263509|Voglibose|voglibose|mesh-list
101565560|NCT01263509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101565561|NCT01263509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565562|NCT01263509|Incretins|incretins|mesh-ancestor
101565563|NCT01263509|Hormones|hormones|mesh-ancestor
101565564|NCT01263509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101565565|NCT01263509|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101565566|NCT01263509|Protease Inhibitors|protease inhibitors|mesh-ancestor
101565567|NCT01263509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101771202|NCT00927771|Dermatologic Agents|dermatologic agents|mesh-ancestor
101771203|NCT00927771|Antioxidants|antioxidants|mesh-ancestor
101771204|NCT00927771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771205|NCT00927771|Protective Agents|protective agents|mesh-ancestor
101771206|NCT00927771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771207|NCT00927771|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101771208|NCT01053559|Certolizumab Pegol|certolizumab pegol|mesh-list
101771209|NCT01053559|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101771210|NCT01053559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101771211|NCT01053559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101771212|NCT01053559|Immunologic Factors|immunologic factors|mesh-ancestor
101771213|NCT01053559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771214|NCT01053559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101771215|NCT01053637|Acetaminophen|acetaminophen|mesh-list
101771216|NCT01053637|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
101771217|NCT01053637|Hydrocodone|hydrocodone|mesh-list
101771218|NCT01053637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101771219|NCT01053637|Analgesics|analgesics|mesh-ancestor
101771220|NCT01053637|Sensory System Agents|sensory system agents|mesh-ancestor
101771221|NCT01053637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101771222|NCT01053637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771223|NCT01053637|Antipyretics|antipyretics|mesh-ancestor
101771224|NCT01053637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101771225|NCT01053637|Narcotics|narcotics|mesh-ancestor
101771226|NCT01053637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101771227|NCT01053637|Antitussive Agents|antitussive agents|mesh-ancestor
101771228|NCT01053637|Respiratory System Agents|respiratory system agents|mesh-ancestor
101771229|NCT01053637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101771230|NCT01053637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101771231|NCT01053637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101771232|NCT00928161|Dexlansoprazole|dexlansoprazole|mesh-list
101771233|NCT00928161|Lansoprazole|lansoprazole|mesh-list
101319953|NCT01807429|Midazolam|midazolam|mesh-list
101771234|NCT00928161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101771235|NCT00928161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101771236|NCT00928161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101771237|NCT00928161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101771238|NCT00928161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771239|NCT00909519|Naproxen|naproxen|mesh-list
101771240|NCT00909519|Furosemide|furosemide|mesh-list
101771241|NCT00909519|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
101771242|NCT00909519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101771243|NCT00909519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101771244|NCT00909519|Analgesics|analgesics|mesh-ancestor
101771245|NCT00909519|Sensory System Agents|sensory system agents|mesh-ancestor
101771246|NCT00909519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101771247|NCT00909519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771248|NCT00909519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101771249|NCT00909519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101771250|NCT00909519|Gout Suppressants|gout suppressants|mesh-ancestor
101771251|NCT00909519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101771252|NCT00909519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101565568|NCT01263509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565569|NCT01263509|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101565570|NCT01263509|Vitamin B Complex|vitamin b complex|mesh-ancestor
101565571|NCT01263509|Vitamins|vitamins|mesh-ancestor
101565572|NCT01263509|Micronutrients|micronutrients|mesh-ancestor
101771253|NCT00909519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771254|NCT00909519|Diuretics|diuretics|mesh-ancestor
101771255|NCT00909519|Natriuretic Agents|natriuretic agents|mesh-ancestor
101451752|NCT00226200|Respiratory System Agents|respiratory system agents|mesh-ancestor
101771265|NCT00355615|Antimetabolites|antimetabolites|mesh-ancestor
101771266|NCT00355615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771267|NCT00355615|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101771268|NCT00355615|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101771269|NCT00355615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101771270|NCT00907179|Pemetrexed|pemetrexed|mesh-list
101771271|NCT00907179|Panobinostat|panobinostat|mesh-list
101771272|NCT00907179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101771273|NCT00907179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101771274|NCT00907179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771275|NCT00907179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101771276|NCT00907179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101771277|NCT00907179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101771278|NCT00347269|Psychotropic Drugs|psychotropic drugs|mesh-list
101771279|NCT00544648|Paclitaxel|paclitaxel|mesh-list
101771280|NCT00544648|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101771281|NCT00544648|Carboplatin|carboplatin|mesh-list
101771282|NCT00544648|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101771283|NCT00544648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101771284|NCT00544648|Tubulin Modulators|tubulin modulators|mesh-ancestor
101771285|NCT00544648|Antimitotic Agents|antimitotic agents|mesh-ancestor
101771286|NCT00544648|Mitosis Modulators|mitosis modulators|mesh-ancestor
101771287|NCT00544648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771288|NCT01053871|Fentanyl|fentanyl|mesh-list
101771289|NCT01053871|Midazolam|midazolam|mesh-list
101771290|NCT01053871|Propofol|propofol|mesh-list
101771291|NCT01053871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101771292|NCT01053871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101771293|NCT01053871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771294|NCT01053871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101771295|NCT01053871|Anesthetics, General|anesthetics, general|mesh-ancestor
101771296|NCT01053871|Anesthetics|anesthetics|mesh-ancestor
101771297|NCT01053871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101771298|NCT01053871|Narcotics|narcotics|mesh-ancestor
101771299|NCT01053871|Analgesics|analgesics|mesh-ancestor
101771300|NCT01053871|Sensory System Agents|sensory system agents|mesh-ancestor
101428738|NCT04923841|Atropine|atropine|mesh-list
101771301|NCT01053871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101771302|NCT01053871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101771303|NCT01053871|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101771304|NCT01053871|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101771305|NCT01053871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101771306|NCT01053871|GABA Modulators|gaba modulators|mesh-ancestor
101771307|NCT01053871|GABA Agents|gaba agents|mesh-ancestor
101771308|NCT01053871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101771309|NCT01053871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771310|NCT01053949|Thalidomide|thalidomide|mesh-list
101771311|NCT01053949|Pomalidomide|pomalidomide|mesh-list
101771312|NCT01053949|Immunologic Factors|immunologic factors|mesh-ancestor
101771313|NCT01053949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771314|NCT01053949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101771315|NCT01053949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101771316|NCT01053949|Growth Substances|growth substances|mesh-ancestor
101771317|NCT01053949|Growth Inhibitors|growth inhibitors|mesh-ancestor
101771318|NCT01053949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101771319|NCT01053949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101771320|NCT01053949|Leprostatic Agents|leprostatic agents|mesh-ancestor
101771328|NCT00987376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101771329|NCT00987376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101771330|NCT00987376|Nootropic Agents|nootropic agents|mesh-ancestor
101771331|NCT00987454|Epoetin Alfa|epoetin alfa|mesh-list
101771332|NCT00987454|Hematinics|hematinics|mesh-ancestor
101565573|NCT01263197|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
101565574|NCT01263197|Propranolol|propranolol|mesh-list
101565575|NCT01263197|Albuterol|albuterol|mesh-list
101565576|NCT01263197|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101565577|NCT01263197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101565578|NCT01263197|Adrenergic Agents|adrenergic agents|mesh-ancestor
101565579|NCT01263197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101565580|NCT01263197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565581|NCT01263197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565582|NCT01263197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101565583|NCT01263197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101565584|NCT01263197|Vasodilator Agents|vasodilator agents|mesh-ancestor
101771333|NCT04005664|Phenylephrine|phenylephrine|mesh-list
101771334|NCT04005664|Oxymetazoline|oxymetazoline|mesh-list
101771335|NCT04005664|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101771336|NCT04005664|Mydriatics|mydriatics|mesh-ancestor
101771337|NCT04005664|Autonomic Agents|autonomic agents|mesh-ancestor
101771338|NCT04005664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101771339|NCT04005664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771340|NCT04005664|Sympathomimetics|sympathomimetics|mesh-ancestor
101771341|NCT04005664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101771342|NCT04005664|Nasal Decongestants|nasal decongestants|mesh-ancestor
101771343|NCT04005664|Respiratory System Agents|respiratory system agents|mesh-ancestor
101771344|NCT04005664|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101771345|NCT04005664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101771346|NCT04005664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101771347|NCT04005664|Adrenergic Agents|adrenergic agents|mesh-ancestor
101771348|NCT04005664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101771349|NCT04005664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771350|NCT04005664|Protective Agents|protective agents|mesh-ancestor
101771351|NCT00330967|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101771352|NCT00330967|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101771353|NCT00330967|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101771354|NCT00330967|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101771355|NCT00924573|Metformin|metformin|mesh-list
101771356|NCT00924573|Glimepiride|glimepiride|mesh-list
101771357|NCT00924573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101771358|NCT00924573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771359|NCT00924573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101771360|NCT00924573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101771361|NCT00924573|Immunologic Factors|immunologic factors|mesh-ancestor
101771362|NCT01054027|Phenylephrine|phenylephrine|mesh-list
101771363|NCT01054027|Oxymetazoline|oxymetazoline|mesh-list
101771364|NCT01054027|Cyclopentolate|cyclopentolate|mesh-list
101771365|NCT01054027|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101771366|NCT01054027|Mydriatics|mydriatics|mesh-ancestor
101771367|NCT01054027|Autonomic Agents|autonomic agents|mesh-ancestor
101771368|NCT01054027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101771369|NCT01054027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771370|NCT01054027|Sympathomimetics|sympathomimetics|mesh-ancestor
101771371|NCT01054027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101771372|NCT01054027|Nasal Decongestants|nasal decongestants|mesh-ancestor
101771373|NCT01054027|Respiratory System Agents|respiratory system agents|mesh-ancestor
101771374|NCT01054027|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101771375|NCT01054027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101771376|NCT01054027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101771377|NCT01054027|Adrenergic Agents|adrenergic agents|mesh-ancestor
101771378|NCT01054027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101771379|NCT01054027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771380|NCT01054027|Protective Agents|protective agents|mesh-ancestor
101771381|NCT01054027|Parasympatholytics|parasympatholytics|mesh-ancestor
101771382|NCT01054027|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101771383|NCT01054027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101771384|NCT01054027|Cholinergic Agents|cholinergic agents|mesh-ancestor
101565585|NCT01263197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101565586|NCT01263197|Autonomic Agents|autonomic agents|mesh-ancestor
101565587|NCT01263197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101565588|NCT01263197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101565589|NCT01263197|Respiratory System Agents|respiratory system agents|mesh-ancestor
101565590|NCT01263197|Tocolytic Agents|tocolytic agents|mesh-ancestor
101565591|NCT01263197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101565592|NCT01263197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101565593|NCT01263197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101565594|NCT01263197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101565595|NCT01263197|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101771386|NCT01054105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101771387|NCT01054105|Vasodilator Agents|vasodilator agents|mesh-ancestor
101771388|NCT00330343|Naloxone|naloxone|mesh-list
101771389|NCT00330343|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101771390|NCT00330343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771391|NCT00330343|Sensory System Agents|sensory system agents|mesh-ancestor
101263925|NCT01764867|Fluoxetine|fluoxetine|mesh-list
101771416|NCT04005430|Protease Inhibitors|protease inhibitors|mesh-ancestor
101771417|NCT04005430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101771418|NCT04005430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771419|NCT00330187|Bupropion|bupropion|mesh-list
101771420|NCT00330187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101771421|NCT00330187|Antidepressive Agents|antidepressive agents|mesh-ancestor
101771422|NCT00330187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101771423|NCT00330187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101771424|NCT00330187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101771425|NCT00330187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101771426|NCT00330187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771427|NCT00330187|Dopamine Agents|dopamine agents|mesh-ancestor
101771428|NCT00330187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101771429|NCT00330187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771430|NCT00330187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101771431|NCT00330187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101771432|NCT00330187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101771433|NCT00987844|Prucalopride|prucalopride|mesh-list
101771434|NCT00987844|Laxatives|laxatives|mesh-ancestor
101771435|NCT00987844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101771436|NCT00987844|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101771437|NCT00987844|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101771438|NCT00987844|Serotonin Agents|serotonin agents|mesh-ancestor
101771439|NCT00987844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101771444|NCT03986905|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101771445|NCT03986905|Antiemetics|antiemetics|mesh-ancestor
101771446|NCT03986905|Autonomic Agents|autonomic agents|mesh-ancestor
101771447|NCT03986905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101771448|NCT03986905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771449|NCT03986905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101771450|NCT03986905|Mydriatics|mydriatics|mesh-ancestor
101771451|NCT03986905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101771452|NCT03986905|Cholinergic Agents|cholinergic agents|mesh-ancestor
101771453|NCT03986905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101771454|NCT03986905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771455|NCT03986905|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101771456|NCT03986905|Parasympatholytics|parasympatholytics|mesh-ancestor
101771457|NCT00329797|Vitamin D|vitamin d|mesh-list
101771458|NCT00329797|Zoledronic Acid|zoledronic acid|mesh-list
101771459|NCT00329797|Calcium|calcium|mesh-list
101771460|NCT00329797|Vitamins|vitamins|mesh-ancestor
101771461|NCT00329797|Micronutrients|micronutrients|mesh-ancestor
101771462|NCT00329797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771463|NCT00329797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101565596|NCT01263197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101565597|NCT01263197|Disinfectants|disinfectants|mesh-ancestor
101565598|NCT01263119|Warfarin|warfarin|mesh-list
101565599|NCT01263119|Anticoagulants|anticoagulants|mesh-ancestor
101565600|NCT01262651|Nabiximols|nabiximols|mesh-list
101565601|NCT01262651|Analgesics|analgesics|mesh-ancestor
101565602|NCT01262651|Sensory System Agents|sensory system agents|mesh-ancestor
101565603|NCT01262651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101413819|NCT00485875|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101771464|NCT00329797|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101771465|NCT00541450|Metformin|metformin|mesh-list
101771466|NCT00541450|Pioglitazone|pioglitazone|mesh-list
101771467|NCT00541450|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101771468|NCT00541450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101771469|NCT00541450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771470|NCT00541450|Incretins|incretins|mesh-ancestor
101771471|NCT00541450|Hormones|hormones|mesh-ancestor
101771472|NCT00541450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101771473|NCT00541450|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101771474|NCT00541450|Protease Inhibitors|protease inhibitors|mesh-ancestor
101320102|NCT01805908|Pertuzumab|pertuzumab|mesh-list
101771475|NCT00541450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101771476|NCT00541450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771477|NCT01056679|Doxorubicin|doxorubicin|mesh-list
101771478|NCT01056679|Lenalidomide|lenalidomide|mesh-list
101771479|NCT01056679|Vinblastine|vinblastine|mesh-list
101771480|NCT01056679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101771481|NCT01056679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101771482|NCT01056679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101771483|NCT01056679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101771484|NCT01056679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101771485|NCT01056679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771486|NCT01056679|Immunologic Factors|immunologic factors|mesh-ancestor
101771487|NCT01056679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771488|NCT01056679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101771489|NCT01056679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101771491|NCT01056679|Growth Inhibitors|growth inhibitors|mesh-ancestor
101771492|NCT01056679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101771493|NCT01056679|Tubulin Modulators|tubulin modulators|mesh-ancestor
101771494|NCT01056679|Antimitotic Agents|antimitotic agents|mesh-ancestor
101771495|NCT01056679|Mitosis Modulators|mitosis modulators|mesh-ancestor
101771496|NCT04769362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101771497|NCT04769362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101771498|NCT04769362|Adrenergic Agents|adrenergic agents|mesh-ancestor
101771499|NCT04769362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101771500|NCT04769362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771501|NCT04769362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771502|NCT03983551|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
101771503|NCT03983551|Protease Inhibitors|protease inhibitors|mesh-ancestor
101771504|NCT03983551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101771505|NCT03983551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771506|NCT03983551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101771507|NCT03983551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771508|NCT05709574|Tadalafil|tadalafil|mesh-list
101771509|NCT05709574|Vasodilator Agents|vasodilator agents|mesh-ancestor
101451770|NCT00203177|Rasagiline|rasagiline|mesh-list
101771514|NCT05709574|Urological Agents|urological agents|mesh-ancestor
101771516|NCT04690504|Antioxidants|antioxidants|mesh-ancestor
101771517|NCT04690504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771518|NCT04690504|Protective Agents|protective agents|mesh-ancestor
101771519|NCT04690504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771520|NCT04690504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101771521|NCT00540124|Tadalafil|tadalafil|mesh-list
101771522|NCT00540124|Tamsulosin|tamsulosin|mesh-list
101771523|NCT00540124|Vasodilator Agents|vasodilator agents|mesh-ancestor
101771524|NCT00540124|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101771525|NCT00540124|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101771526|NCT00540124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101428967|NCT04232657|Denosumab|denosumab|mesh-list
101565604|NCT01262651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565605|NCT01261793|Epratuzumab|epratuzumab|mesh-list
101565606|NCT01261793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101565607|NCT01261793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101565608|NCT04321967|Nitroglycerin|nitroglycerin|mesh-list
101565609|NCT04321967|Vasodilator Agents|vasodilator agents|mesh-ancestor
101565610|NCT04321655|Ibuprofen|ibuprofen|mesh-list
101565611|NCT04321655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101771527|NCT00540124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771528|NCT00540124|Urological Agents|urological agents|mesh-ancestor
101771529|NCT00540124|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101771530|NCT00540124|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101771531|NCT00540124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101771532|NCT00540124|Adrenergic Agents|adrenergic agents|mesh-ancestor
101771533|NCT00540124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101771534|NCT00540124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771535|NCT00540046|Copper|copper|mesh-list
101771536|NCT00540046|Trace Elements|trace elements|mesh-ancestor
101771537|NCT00540046|Micronutrients|micronutrients|mesh-ancestor
101771538|NCT00540046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771539|NCT04613830|Tramadol|tramadol|mesh-list
101771540|NCT04613830|Bupivacaine|bupivacaine|mesh-list
101771541|NCT04613830|Anesthetics, Local|anesthetics, local|mesh-ancestor
101771542|NCT04613830|Anesthetics|anesthetics|mesh-ancestor
101771543|NCT04613830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101771544|NCT04613830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771545|NCT04613830|Sensory System Agents|sensory system agents|mesh-ancestor
101771546|NCT04613830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101771547|NCT04613830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101771548|NCT04613830|Narcotics|narcotics|mesh-ancestor
101771549|NCT04613830|Analgesics|analgesics|mesh-ancestor
101771550|NCT00689936|Thalidomide|thalidomide|mesh-list
101771551|NCT00689936|Dexamethasone|dexamethasone|mesh-list
101771552|NCT00689936|Dexamethasone acetate|dexamethasone acetate|mesh-list
101771553|NCT00689936|Prednisone|prednisone|mesh-list
101771554|NCT00689936|Lenalidomide|lenalidomide|mesh-list
101771555|NCT00689936|Melphalan|melphalan|mesh-list
101771556|NCT00689936|BB 1101|bb 1101|mesh-list
101771557|NCT00689936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101771558|NCT00689936|Antiemetics|antiemetics|mesh-ancestor
101771559|NCT00689936|Autonomic Agents|autonomic agents|mesh-ancestor
101771560|NCT00689936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101771561|NCT00689936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771562|NCT00689936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101771563|NCT00689936|Glucocorticoids|glucocorticoids|mesh-ancestor
101771564|NCT00689936|Hormones|hormones|mesh-ancestor
101263928|NCT01764867|Sertraline|sertraline|mesh-list
101771565|NCT00689936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101771566|NCT00689936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101771568|NCT00689936|Protease Inhibitors|protease inhibitors|mesh-ancestor
101771569|NCT00689936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101771570|NCT00689936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771571|NCT00689936|Immunologic Factors|immunologic factors|mesh-ancestor
101771572|NCT00689936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101771573|NCT00689936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101771574|NCT00689936|Growth Substances|growth substances|mesh-ancestor
101771575|NCT00689936|Growth Inhibitors|growth inhibitors|mesh-ancestor
101771576|NCT00689936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101771577|NCT00689936|Alkylating Agents|alkylating agents|mesh-ancestor
101771578|NCT00689936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101771579|NCT00689936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101771580|NCT00689936|Leprostatic Agents|leprostatic agents|mesh-ancestor
101771587|NCT01563718|Sensory System Agents|sensory system agents|mesh-ancestor
101771588|NCT01563718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101771589|NCT05473234|Amoxicillin|amoxicillin|mesh-list
101771590|NCT05473234|Azithromycin|azithromycin|mesh-list
101771591|NCT05473234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101771592|NCT05473234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101771593|NCT04500418|Cenicriviroc|cenicriviroc|mesh-list
101771594|NCT04500418|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101565612|NCT04321655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101565614|NCT04321655|Sensory System Agents|sensory system agents|mesh-ancestor
101565615|NCT04321655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101565616|NCT04321655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565617|NCT04321655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101565618|NCT04321655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101565619|NCT04321655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101565620|NCT04321655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101565621|NCT04321655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565622|NCT05529251|Carboplatin|carboplatin|mesh-list
101565623|NCT05529251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101565624|NCT01261325|Brivaracetam|brivaracetam|mesh-list
101771595|NCT04500418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771596|NCT04500418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101771597|NCT04500418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101771598|NCT04500418|Antiviral Agents|antiviral agents|mesh-ancestor
101771599|NCT04500418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101771600|NCT00671034|Cytarabine|cytarabine|mesh-list
101771601|NCT00671034|Dexamethasone|dexamethasone|mesh-list
101429046|NCT03954327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101771602|NCT00671034|Dexamethasone acetate|dexamethasone acetate|mesh-list
101771603|NCT00671034|Prednisone|prednisone|mesh-list
101771604|NCT00671034|Cortisone|cortisone|mesh-list
101771605|NCT00671034|Cyclophosphamide|cyclophosphamide|mesh-list
101771606|NCT00671034|Doxorubicin|doxorubicin|mesh-list
101771607|NCT00671034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101771608|NCT00671034|Methotrexate|methotrexate|mesh-list
101771609|NCT00671034|Vincristine|vincristine|mesh-list
101771610|NCT00671034|Daunorubicin|daunorubicin|mesh-list
101771611|NCT00671034|Asparaginase|asparaginase|mesh-list
101771612|NCT00671034|Mercaptopurine|mercaptopurine|mesh-list
101771613|NCT00671034|Pegaspargase|pegaspargase|mesh-list
101771614|NCT00671034|Thioguanine|thioguanine|mesh-list
101771615|NCT00671034|BB 1101|bb 1101|mesh-list
101771616|NCT00671034|2-Aminopurine|2-aminopurine|mesh-list
101771617|NCT00671034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101771618|NCT00671034|Immunologic Factors|immunologic factors|mesh-ancestor
101771619|NCT00671034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771620|NCT00671034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101771621|NCT00671034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101771622|NCT00671034|Alkylating Agents|alkylating agents|mesh-ancestor
101771623|NCT00671034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771624|NCT00671034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101771625|NCT00671034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101771626|NCT00671034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101771627|NCT00671034|Antiemetics|antiemetics|mesh-ancestor
101771628|NCT00671034|Autonomic Agents|autonomic agents|mesh-ancestor
101771629|NCT00671034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101771630|NCT00671034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101771631|NCT00671034|Glucocorticoids|glucocorticoids|mesh-ancestor
101771632|NCT00671034|Hormones|hormones|mesh-ancestor
101771633|NCT00671034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101771634|NCT00671034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101771635|NCT00671034|Protease Inhibitors|protease inhibitors|mesh-ancestor
101771636|NCT00671034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101771637|NCT00671034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101771638|NCT00671034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101771639|NCT00671034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101771640|NCT00671034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101771642|NCT00671034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101771643|NCT00671034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101771644|NCT00671034|Antimetabolites|antimetabolites|mesh-ancestor
101771645|NCT00671034|Dermatologic Agents|dermatologic agents|mesh-ancestor
101771646|NCT00671034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101565625|NCT01261325|Anticonvulsants|anticonvulsants|mesh-list
101565627|NCT01260467|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101565628|NCT01260467|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101565629|NCT01260467|Dopamine Agents|dopamine agents|mesh-ancestor
101565630|NCT01260467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101565631|NCT01260467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565632|NCT01260467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565633|NCT01260467|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101565634|NCT01260467|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101771647|NCT00671034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101771648|NCT00671034|Antiviral Agents|antiviral agents|mesh-ancestor
101771649|NCT00671034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101771650|NCT00671034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101771651|NCT00671034|Tubulin Modulators|tubulin modulators|mesh-ancestor
101771652|NCT00671034|Antimitotic Agents|antimitotic agents|mesh-ancestor
101771653|NCT00671034|Mitosis Modulators|mitosis modulators|mesh-ancestor
101771663|NCT04425070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771664|NCT04425070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101771665|NCT04425070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101771666|NCT04425070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101771667|NCT04425070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101771668|NCT04425070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101771669|NCT04425070|Alkylating Agents|alkylating agents|mesh-ancestor
101771670|NCT04425070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101771671|NCT00743678|Cetuximab|cetuximab|mesh-list
101771672|NCT00743678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101771673|NCT00743678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101771674|NCT02679508|Lansoprazole|lansoprazole|mesh-list
101771675|NCT02679508|Dexlansoprazole|dexlansoprazole|mesh-list
101429115|NCT03460353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101771676|NCT02679508|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101771677|NCT02679508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101771678|NCT02679508|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101771679|NCT02679508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101771680|NCT02679508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771681|NCT00775632|Cyclosporine|cyclosporine|mesh-list
101771682|NCT00775632|Methotrexate|methotrexate|mesh-list
101771683|NCT00775632|Alemtuzumab|alemtuzumab|mesh-list
101771684|NCT00775632|Cyclosporins|cyclosporins|mesh-list
101771685|NCT00775632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101771686|NCT00775632|Abortifacient Agents|abortifacient agents|mesh-ancestor
101771687|NCT00775632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101771688|NCT00775632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771689|NCT00775632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101771690|NCT00775632|Antimetabolites|antimetabolites|mesh-ancestor
101771691|NCT00775632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771692|NCT00775632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101771693|NCT00775632|Dermatologic Agents|dermatologic agents|mesh-ancestor
101771694|NCT00775632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101771695|NCT00775632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101771696|NCT00775632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101771697|NCT00775632|Immunologic Factors|immunologic factors|mesh-ancestor
101771698|NCT00775632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101771699|NCT00775632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101771700|NCT00775632|Antifungal Agents|antifungal agents|mesh-ancestor
101771701|NCT00775632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101771702|NCT00775632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101771703|NCT00775632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101771704|NCT04047654|Anticoagulants|anticoagulants|mesh-list
101771705|NCT00772356|Insulin|insulin|mesh-list
101771706|NCT00772356|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101771707|NCT00772356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101565635|NCT01260311|Fesoterodine|fesoterodine|mesh-list
101527576|NCT00545675|Valproic Acid|valproic acid|mesh-list
101565636|NCT01260311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101565637|NCT01260311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101565638|NCT01260311|Cholinergic Agents|cholinergic agents|mesh-ancestor
101565639|NCT01260311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101565640|NCT01260311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565641|NCT01260311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565642|NCT01260311|Urological Agents|urological agents|mesh-ancestor
101565643|NCT00623987|Warfarin|warfarin|mesh-list
101565644|NCT00623987|Anticoagulants|anticoagulants|mesh-ancestor
101565645|NCT01259375|Amrubicin|amrubicin|mesh-list
101771708|NCT00772356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771709|NCT04394182|Ritonavir|ritonavir|mesh-list
101771710|NCT04394182|Lopinavir|lopinavir|mesh-list
101771711|NCT04394182|Azithromycin|azithromycin|mesh-list
101771712|NCT04394182|Hydroxychloroquine|hydroxychloroquine|mesh-list
101771713|NCT04394182|Tazobactam|tazobactam|mesh-list
101771714|NCT04394182|Piperacillin|piperacillin|mesh-list
101771715|NCT04394182|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101771716|NCT04394182|Heparin|heparin|mesh-list
101771717|NCT04394182|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101771719|NCT04394182|Dalteparin|dalteparin|mesh-list
101771720|NCT04394182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101771721|NCT04394182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101771722|NCT04394182|Protease Inhibitors|protease inhibitors|mesh-ancestor
101771723|NCT04394182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101771738|NCT04394182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101771739|NCT04394182|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101771740|NCT05386576|Venetoclax|venetoclax|mesh-list
101771741|NCT05386576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101771742|NCT05325580|Magnesium Sulfate|magnesium sulfate|mesh-list
101771743|NCT05325580|Analgesics|analgesics|mesh-ancestor
101771744|NCT05325580|Sensory System Agents|sensory system agents|mesh-ancestor
101771745|NCT05325580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101771746|NCT05325580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771747|NCT05325580|Anesthetics|anesthetics|mesh-ancestor
101771748|NCT05325580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101771749|NCT05325580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101771750|NCT05325580|Anticonvulsants|anticonvulsants|mesh-ancestor
101771751|NCT05325580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101771752|NCT05325580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101771753|NCT05325580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771754|NCT05325580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101771755|NCT05325580|Tocolytic Agents|tocolytic agents|mesh-ancestor
101771756|NCT05325580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101771757|NCT00539734|Ranibizumab|ranibizumab|mesh-list
101771758|NCT00539734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101771759|NCT00539734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101771761|NCT00539734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771762|NCT00539734|Growth Inhibitors|growth inhibitors|mesh-ancestor
101771763|NCT00539734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101771764|NCT04004572|Pegaspargase|pegaspargase|mesh-list
101771765|NCT04004572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101771766|NCT04050436|Cemiplimab|cemiplimab|mesh-list
101771767|NCT04050436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101771768|NCT04050436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101771769|NCT01093976|Dronabinol|dronabinol|mesh-list
101771770|NCT01093976|Hallucinogens|hallucinogens|mesh-ancestor
101771771|NCT01093976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771772|NCT01093976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101771773|NCT01093976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101771774|NCT01093976|Analgesics|analgesics|mesh-ancestor
101771775|NCT01093976|Sensory System Agents|sensory system agents|mesh-ancestor
101771776|NCT01093976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101771777|NCT01093976|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101565646|NCT01259375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101565648|NCT05536037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101565649|NCT05536037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565650|NCT00624143|Voriconazole|voriconazole|mesh-list
101565651|NCT00624143|Amphotericin B|amphotericin b|mesh-list
101565652|NCT00624143|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101565653|NCT00624143|Antifungal Agents|antifungal agents|mesh-ancestor
101565654|NCT00624143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101565655|NCT00624143|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101565656|NCT00624143|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101565657|NCT00624143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101565658|NCT00624143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413867|NCT00486343|Hormone Antagonists|hormone antagonists|mesh-ancestor
101771778|NCT01093976|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101771779|NCT01093976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101771780|NCT01093976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771781|NCT01093976|Hormones|hormones|mesh-ancestor
101771782|NCT01093976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101771783|NCT00329719|Sirolimus|sirolimus|mesh-list
101771784|NCT00329719|Sorafenib|sorafenib|mesh-list
101771788|NCT00329719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101771789|NCT00329719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101771790|NCT00329719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771791|NCT00329719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101771792|NCT00329719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101771793|NCT00329719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101771794|NCT00329719|Antifungal Agents|antifungal agents|mesh-ancestor
101771795|NCT00329719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101771796|NCT00329719|Immunologic Factors|immunologic factors|mesh-ancestor
101771797|NCT00329719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771799|NCT04008628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101771800|NCT04008628|Anesthetics, General|anesthetics, general|mesh-ancestor
101771801|NCT04008628|Anesthetics|anesthetics|mesh-ancestor
101771802|NCT04008628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101771803|NCT04008628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771804|NCT04008628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101771805|NCT04008628|Analgesics|analgesics|mesh-ancestor
101771806|NCT04008628|Sensory System Agents|sensory system agents|mesh-ancestor
101771807|NCT04008628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101771808|NCT00743834|Fluvoxamine|fluvoxamine|mesh-list
101771809|NCT00743834|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101771810|NCT00743834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101771811|NCT00743834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101771812|NCT00743834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771813|NCT00743834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101771814|NCT00743834|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101771815|NCT00743834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101771816|NCT00743834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101771817|NCT00743834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771818|NCT00743834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101771819|NCT00743834|Serotonin Agents|serotonin agents|mesh-ancestor
101771820|NCT00743834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101771821|NCT00743834|Antidepressive Agents|antidepressive agents|mesh-ancestor
101771822|NCT00743834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101771823|NCT00743834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101771824|NCT00743834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101565660|NCT00624143|Hormone Antagonists|hormone antagonists|mesh-ancestor
101565661|NCT00624143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101565662|NCT00624143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565663|NCT00624143|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101565664|NCT00624143|Amebicides|amebicides|mesh-ancestor
101565665|NCT00624143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101565666|NCT00624143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101565667|NCT00624143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101565668|NCT05241275|Xenon|xenon|mesh-list
101565669|NCT05241275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101771825|NCT00743834|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101771826|NCT00743912|Rifaximin|rifaximin|mesh-list
101771827|NCT00743912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101771828|NCT00743912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101771829|NCT00743912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101771830|NCT04060472|Paclitaxel|paclitaxel|mesh-list
101771831|NCT04060472|Oxaliplatin|oxaliplatin|mesh-list
101429262|NCT02406209|Prednisolone|prednisolone|mesh-list
101771832|NCT04060472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101771833|NCT04060472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101771834|NCT04060472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101771835|NCT04060472|Tubulin Modulators|tubulin modulators|mesh-ancestor
101771836|NCT04060472|Antimitotic Agents|antimitotic agents|mesh-ancestor
101771837|NCT04060472|Mitosis Modulators|mitosis modulators|mesh-ancestor
101771838|NCT04060472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771839|NCT00329641|Paclitaxel|paclitaxel|mesh-list
101771840|NCT00329641|Carboplatin|carboplatin|mesh-list
101771841|NCT00329641|Sorafenib|sorafenib|mesh-list
101771842|NCT00329641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101771843|NCT00329641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101771844|NCT00329641|Tubulin Modulators|tubulin modulators|mesh-ancestor
101771845|NCT00329641|Antimitotic Agents|antimitotic agents|mesh-ancestor
101771846|NCT00329641|Mitosis Modulators|mitosis modulators|mesh-ancestor
101771847|NCT00329641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771848|NCT00329641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101771849|NCT00329641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101771850|NCT02533219|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
101771851|NCT02533219|Dopamine Agents|dopamine agents|mesh-ancestor
101771852|NCT02533219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101771853|NCT02533219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771854|NCT02533219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771872|NCT01056835|Epoprostenol|epoprostenol|mesh-list
101771873|NCT01056835|Tezosentan|tezosentan|mesh-list
101771874|NCT01056835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101771875|NCT01056835|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101771876|NCT01056835|Vasodilator Agents|vasodilator agents|mesh-ancestor
101771877|NCT03986515|Apatinib|apatinib|mesh-list
101771878|NCT03986515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101771879|NCT03986515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101771880|NCT03986515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101771881|NCT03986515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771882|NCT00567489|Icodextrin|icodextrin|mesh-list
101771883|NCT00567489|Dialysis Solutions|dialysis solutions|mesh-ancestor
101771884|NCT00567489|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101771885|NCT02538393|Sorafenib|sorafenib|mesh-list
101771886|NCT02538393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101771887|NCT02538393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101771888|NCT02538393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101771889|NCT02538393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771890|NCT00924963|Lidocaine|lidocaine|mesh-list
101771891|NCT00924963|Anesthetics, Local|anesthetics, local|mesh-ancestor
101771892|NCT00924963|Anesthetics|anesthetics|mesh-ancestor
101771893|NCT00924963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101565670|NCT05241275|Anesthetics, General|anesthetics, general|mesh-ancestor
101565671|NCT05241275|Anesthetics|anesthetics|mesh-ancestor
101565672|NCT05241275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101565673|NCT05241275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565674|NCT04005287|Pirenzepine|pirenzepine|mesh-list
101565675|NCT04005287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101771894|NCT00924963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771895|NCT00924963|Sensory System Agents|sensory system agents|mesh-ancestor
101771896|NCT00924963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101771897|NCT00924963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101771898|NCT00924963|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101771899|NCT00924963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101771900|NCT00924963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101771901|NCT00924963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771902|NCT00669864|Metformin|metformin|mesh-list
101771903|NCT00669864|Insulin Aspart|insulin aspart|mesh-list
101771904|NCT00669864|Biphasic Insulins|biphasic insulins|mesh-list
101771905|NCT00669864|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101771906|NCT00669864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101771907|NCT00669864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771908|NCT00770172|Lenograstim|lenograstim|mesh-list
101771909|NCT00770172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101771910|NCT00770172|Immunologic Factors|immunologic factors|mesh-ancestor
101771911|NCT00770172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771912|NCT00776022|Cetirizine|cetirizine|mesh-list
101771913|NCT00776022|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101771914|NCT00776022|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101534988|NCT02883556|Pembrolizumab|pembrolizumab|mesh-list
101771917|NCT00776022|Histamine Agents|histamine agents|mesh-ancestor
101771918|NCT00776022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101771919|NCT00776022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771920|NCT00776022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771921|NCT00772902|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101771922|NCT00772902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101771923|NCT00772902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101771924|NCT00772902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101771925|NCT00772902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771926|NCT00772902|Antiviral Agents|antiviral agents|mesh-ancestor
101771927|NCT00772902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101771928|NCT00772902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101771929|NCT00772902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101771930|NCT00779220|Methotrexate|methotrexate|mesh-list
101771931|NCT00779220|Ocrelizumab|ocrelizumab|mesh-list
101771932|NCT00779220|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101771933|NCT00779220|Abortifacient Agents|abortifacient agents|mesh-ancestor
101771934|NCT00779220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101771935|NCT00779220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771936|NCT00779220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101771937|NCT00779220|Antimetabolites|antimetabolites|mesh-ancestor
101771938|NCT00779220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771939|NCT00779220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101771940|NCT00779220|Dermatologic Agents|dermatologic agents|mesh-ancestor
101771941|NCT00779220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101771942|NCT00779220|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101771943|NCT00779220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101771944|NCT00779220|Immunologic Factors|immunologic factors|mesh-ancestor
101771945|NCT00779220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101771946|NCT00779220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101771948|NCT00779376|Antimetabolites|antimetabolites|mesh-ancestor
101771949|NCT00779376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771950|NCT00779376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101771951|NCT00779376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101771952|NCT00779376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101771953|NCT00779376|Antiviral Agents|antiviral agents|mesh-ancestor
101771954|NCT00779376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101771955|NCT00779376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101565676|NCT04005287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101565677|NCT04005287|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101565678|NCT04005287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101565679|NCT04005287|Cholinergic Agents|cholinergic agents|mesh-ancestor
101565680|NCT04005287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101565681|NCT04005287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771956|NCT00779376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101771958|NCT00779454|Capecitabine|capecitabine|mesh-list
101771959|NCT00779454|Oxaliplatin|oxaliplatin|mesh-list
101771960|NCT00779454|Panitumumab|panitumumab|mesh-list
101771961|NCT00779454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101771962|NCT00779454|Antimetabolites|antimetabolites|mesh-ancestor
101771963|NCT00779454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771964|NCT00779454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101771965|NCT00779454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101771966|NCT00773058|Hydrocortisone|hydrocortisone|mesh-list
101771967|NCT00773058|Glucocorticoids|glucocorticoids|mesh-list
101771968|NCT00773058|Hormones|hormones|mesh-ancestor
101771969|NCT00773058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101771970|NCT00773058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771971|NCT00773058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101771972|NCT00776334|Fosinopril|fosinopril|mesh-list
101771973|NCT00776334|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101771974|NCT00776334|Protease Inhibitors|protease inhibitors|mesh-ancestor
101771975|NCT00776334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101771976|NCT00776334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771977|NCT00776334|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101771978|NCT00668148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101771979|NCT00668148|Immunologic Factors|immunologic factors|mesh-ancestor
101771980|NCT00668148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771981|NCT00667992|Budesonide|budesonide|mesh-list
101771982|NCT00667992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101771983|NCT00667992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101771984|NCT00667992|Autonomic Agents|autonomic agents|mesh-ancestor
101771985|NCT00667992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101771986|NCT00667992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772015|NCT00776724|Docetaxel|docetaxel|mesh-list
101772016|NCT00776724|Epirubicin|epirubicin|mesh-list
101772017|NCT00776724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101772018|NCT00776724|Tubulin Modulators|tubulin modulators|mesh-ancestor
101772019|NCT00776724|Antimitotic Agents|antimitotic agents|mesh-ancestor
101772020|NCT00776724|Mitosis Modulators|mitosis modulators|mesh-ancestor
101772021|NCT00776724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772022|NCT00776724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101772023|NCT00776724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101772024|NCT00776724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101772025|NCT00776724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101772026|NCT00776802|Dexamethasone|dexamethasone|mesh-list
101772027|NCT00776802|Etoposide|etoposide|mesh-list
101772028|NCT00776802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101772029|NCT00776802|Antiemetics|antiemetics|mesh-ancestor
101772030|NCT00776802|Autonomic Agents|autonomic agents|mesh-ancestor
101772031|NCT00776802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101772055|NCT00774072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101772056|NCT00780780|Triamcinolone|triamcinolone|mesh-list
101772057|NCT00780780|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101772058|NCT00780780|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101772060|NCT00780780|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101772061|NCT00780780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101772062|NCT00780780|Glucocorticoids|glucocorticoids|mesh-ancestor
101772063|NCT00780780|Hormones|hormones|mesh-ancestor
101772064|NCT00780780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101772065|NCT00780780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772066|NCT00780780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101772067|NCT00780780|Immunologic Factors|immunologic factors|mesh-ancestor
101772068|NCT00780780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101772069|NCT00780780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772070|NCT00780780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101565682|NCT04005287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565683|NCT04320173|Lidocaine|lidocaine|mesh-list
101565684|NCT04320173|Anesthetics, Local|anesthetics, local|mesh-ancestor
101565685|NCT04320173|Anesthetics|anesthetics|mesh-ancestor
101565686|NCT04320173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101772071|NCT00780780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101772072|NCT00780780|Analgesics|analgesics|mesh-ancestor
101772073|NCT00780780|Sensory System Agents|sensory system agents|mesh-ancestor
101772074|NCT00780780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101772075|NCT00780780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101772076|NCT00780858|Ganirelix|ganirelix|mesh-list
101772077|NCT00780858|Hormone Antagonists|hormone antagonists|mesh-ancestor
101772090|NCT00669396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101772091|NCT00669396|Trace Elements|trace elements|mesh-ancestor
101772092|NCT00669396|Micronutrients|micronutrients|mesh-ancestor
101772093|NCT00774462|Rituximab|rituximab|mesh-list
101772094|NCT00774462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101772095|NCT00774462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101772096|NCT00774462|Immunologic Factors|immunologic factors|mesh-ancestor
101772097|NCT00774462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772098|NCT00774462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101772099|NCT00669318|Rituximab|rituximab|mesh-list
101772100|NCT00669318|Alemtuzumab|alemtuzumab|mesh-list
101772101|NCT00669318|Pentostatin|pentostatin|mesh-list
101772102|NCT00669318|Sargramostim|sargramostim|mesh-list
101772103|NCT00669318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101772104|NCT00669318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101772105|NCT00669318|Immunologic Factors|immunologic factors|mesh-ancestor
101320206|NCT01465906|Anticonvulsants|anticonvulsants|mesh-ancestor
101772106|NCT00669318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772107|NCT00669318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101772108|NCT00669318|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
101772109|NCT00669318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101772110|NCT00669318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772111|NCT00774540|Ketorolac|ketorolac|mesh-list
101772112|NCT00774540|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101772113|NCT00774540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101772114|NCT00774540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101772115|NCT00774540|Analgesics|analgesics|mesh-ancestor
101772116|NCT00774540|Sensory System Agents|sensory system agents|mesh-ancestor
101772117|NCT00774540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101772118|NCT00774540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772119|NCT00774540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101772120|NCT00774540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101772121|NCT00774540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101772122|NCT00774540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101772123|NCT00774540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772124|NCT00669240|Varenicline|varenicline|mesh-list
101772125|NCT00669240|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101772126|NCT00669240|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101772127|NCT00669240|Cholinergic Agents|cholinergic agents|mesh-ancestor
101772128|NCT00669240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101772129|NCT00669240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772130|NCT00669240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772131|NCT00669162|Docetaxel|docetaxel|mesh-list
101772132|NCT00669162|Leuprolide|leuprolide|mesh-list
101772133|NCT00669162|Goserelin|goserelin|mesh-list
101772134|NCT00669162|Bicalutamide|bicalutamide|mesh-list
101772135|NCT00669162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101772136|NCT00669162|Tubulin Modulators|tubulin modulators|mesh-ancestor
101772137|NCT00669162|Antimitotic Agents|antimitotic agents|mesh-ancestor
101772138|NCT00669162|Mitosis Modulators|mitosis modulators|mesh-ancestor
101772139|NCT00669162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772141|NCT00669162|Fertility Agents|fertility agents|mesh-ancestor
101772142|NCT00669162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101772143|NCT00669162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772144|NCT00669162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101772145|NCT00669162|Androgen Antagonists|androgen antagonists|mesh-ancestor
101772146|NCT00669162|Hormone Antagonists|hormone antagonists|mesh-ancestor
101772147|NCT00669162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101772148|NCT00774696|Clarithromycin|clarithromycin|mesh-list
101565687|NCT04320173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565688|NCT04320173|Sensory System Agents|sensory system agents|mesh-ancestor
101565689|NCT04320173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101565690|NCT04320173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101565691|NCT04320173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101565692|NCT04320173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101413907|NCT00486694|Artesunate|artesunate|mesh-list
101772149|NCT00774696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101772150|NCT00774696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101772151|NCT00774696|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101772152|NCT00774696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101772153|NCT00774696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772154|NCT00774696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101772155|NCT00774696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101772156|NCT02556060|Lamotrigine|lamotrigine|mesh-list
101772157|NCT02556060|Anticonvulsants|anticonvulsants|mesh-ancestor
101772158|NCT02556060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101772159|NCT02556060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101772160|NCT02556060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772161|NCT02556060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101772162|NCT02556060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772163|NCT02556060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101772164|NCT02556060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101772165|NCT02556060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101772166|NCT02556060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101772167|NCT02556060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101772168|NCT00400946|Leucovorin|leucovorin|mesh-list
101772169|NCT00400946|Cytarabine|cytarabine|mesh-list
101772170|NCT00400946|Dexamethasone|dexamethasone|mesh-list
101772171|NCT00400946|Methylprednisolone|methylprednisolone|mesh-list
101772172|NCT00400946|Prednisolone|prednisolone|mesh-list
101772173|NCT00400946|Hydrocortisone|hydrocortisone|mesh-list
101772174|NCT00400946|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101772175|NCT00400946|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101772176|NCT00400946|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101772177|NCT00400946|Cyclophosphamide|cyclophosphamide|mesh-list
101772178|NCT00400946|Doxorubicin|doxorubicin|mesh-list
101772179|NCT00400946|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101772180|NCT00400946|Methotrexate|methotrexate|mesh-list
101772181|NCT00400946|Etoposide|etoposide|mesh-list
101772182|NCT00400946|Vincristine|vincristine|mesh-list
101772183|NCT00400946|Asparaginase|asparaginase|mesh-list
101772184|NCT00400946|Mercaptopurine|mercaptopurine|mesh-list
101772185|NCT00400946|Pegaspargase|pegaspargase|mesh-list
101772186|NCT00400946|Dexrazoxane|dexrazoxane|mesh-list
101772187|NCT00400946|Razoxane|razoxane|mesh-list
101772188|NCT00400946|Levoleucovorin|levoleucovorin|mesh-list
101772189|NCT00400946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101772190|NCT00400946|Immunologic Factors|immunologic factors|mesh-ancestor
101772191|NCT00400946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772192|NCT00400946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101772193|NCT00400946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101772194|NCT00400946|Alkylating Agents|alkylating agents|mesh-ancestor
101772195|NCT00400946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772196|NCT00400946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101772197|NCT00400946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101772198|NCT00400946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101772199|NCT00400946|Antiemetics|antiemetics|mesh-ancestor
101772200|NCT00400946|Autonomic Agents|autonomic agents|mesh-ancestor
101772201|NCT00400946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101772202|NCT00400946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101772203|NCT00400946|Glucocorticoids|glucocorticoids|mesh-ancestor
101772204|NCT00400946|Hormones|hormones|mesh-ancestor
101772205|NCT00400946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101772206|NCT00400946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101772207|NCT00400946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101772208|NCT00400946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101772209|NCT00400946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101772210|NCT00400946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101565694|NCT04320173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565695|NCT04321733|Amoxicillin|amoxicillin|mesh-list
101772211|NCT00400946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101772212|NCT00400946|Abortifacient Agents|abortifacient agents|mesh-ancestor
101772213|NCT00400946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101772214|NCT00400946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101772221|NCT00400946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101772222|NCT00400946|Antidotes|antidotes|mesh-ancestor
101772223|NCT00400946|Protective Agents|protective agents|mesh-ancestor
101772224|NCT00400946|Vitamin B Complex|vitamin b complex|mesh-ancestor
101772225|NCT00400946|Vitamins|vitamins|mesh-ancestor
101772226|NCT00400946|Micronutrients|micronutrients|mesh-ancestor
101772227|NCT00400946|Tubulin Modulators|tubulin modulators|mesh-ancestor
101772228|NCT00400946|Antimitotic Agents|antimitotic agents|mesh-ancestor
101772229|NCT00400946|Mitosis Modulators|mitosis modulators|mesh-ancestor
101772230|NCT00400946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101772231|NCT00400946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101772232|NCT00354770|Acetylcysteine|acetylcysteine|mesh-list
101772233|NCT00354770|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101772234|NCT00354770|Antiviral Agents|antiviral agents|mesh-ancestor
101772235|NCT00354770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101772236|NCT00354770|Expectorants|expectorants|mesh-ancestor
101772237|NCT00354770|Respiratory System Agents|respiratory system agents|mesh-ancestor
101320227|NCT01465438|Adalimumab|adalimumab|mesh-list
101772238|NCT00354770|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101772239|NCT00354770|Antioxidants|antioxidants|mesh-ancestor
101772240|NCT00354770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772241|NCT00354770|Protective Agents|protective agents|mesh-ancestor
101772242|NCT00354770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772243|NCT00354770|Antidotes|antidotes|mesh-ancestor
101772244|NCT00744224|Exenatide|exenatide|mesh-list
101772245|NCT00744224|Prednisolone|prednisolone|mesh-list
101772246|NCT00744224|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101772247|NCT00744224|Methylprednisolone|methylprednisolone|mesh-list
101772248|NCT00744224|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101772249|NCT00744224|Prednisolone acetate|prednisolone acetate|mesh-list
101772250|NCT00744224|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101772251|NCT00744224|Prednisolone phosphate|prednisolone phosphate|mesh-list
101772252|NCT00744224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101772253|NCT00744224|Glucocorticoids|glucocorticoids|mesh-ancestor
101772254|NCT00744224|Hormones|hormones|mesh-ancestor
101772255|NCT00744224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101772256|NCT00744224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772257|NCT00744224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101772258|NCT00744224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101772259|NCT00744224|Antiemetics|antiemetics|mesh-ancestor
101772260|NCT00744224|Autonomic Agents|autonomic agents|mesh-ancestor
101772261|NCT00744224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101772262|NCT00744224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101772263|NCT00744224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101772264|NCT00744224|Protective Agents|protective agents|mesh-ancestor
101772265|NCT00744224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101772266|NCT00744224|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101772267|NCT00744224|Incretins|incretins|mesh-ancestor
101772268|NCT00744302|Dialysis Solutions|dialysis solutions|mesh-list
101772269|NCT00744302|Calcium|calcium|mesh-list
101772270|NCT00744302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101772271|NCT00744302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772272|NCT00744302|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101772273|NCT00666588|Cytarabine|cytarabine|mesh-list
101772274|NCT00666588|Etoposide|etoposide|mesh-list
101772275|NCT00666588|Idarubicin|idarubicin|mesh-list
101772276|NCT00666588|Etoposide phosphate|etoposide phosphate|mesh-list
101772277|NCT00666588|Bortezomib|bortezomib|mesh-list
101772278|NCT00666588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101772279|NCT00666588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101772280|NCT00666588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101429710|NCT00150449|Analgesics|analgesics|mesh-ancestor
101772281|NCT00666588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101772282|NCT00666588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101772283|NCT00666588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772284|NCT00666588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101772285|NCT00666588|Antimetabolites|antimetabolites|mesh-ancestor
101772289|NCT00666588|Immunologic Factors|immunologic factors|mesh-ancestor
101565696|NCT04321733|Clavulanic Acid|clavulanic acid|mesh-list
101565697|NCT04321733|Clavulanic Acids|clavulanic acids|mesh-list
101565698|NCT04321733|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101565699|NCT04321733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101565700|NCT04321733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101772290|NCT00666588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772291|NCT00666588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101772292|NCT00689390|Ribavirin|ribavirin|mesh-list
101772293|NCT00689390|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101772294|NCT00689390|Antimetabolites|antimetabolites|mesh-ancestor
101772295|NCT00689390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772296|NCT00689390|Antiviral Agents|antiviral agents|mesh-ancestor
101772297|NCT00689390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101772298|NCT00567879|Trastuzumab|trastuzumab|mesh-list
101772299|NCT00567879|Panobinostat|panobinostat|mesh-list
101772300|NCT00567879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101772301|NCT00567879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101772302|NCT00567879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101772303|NCT00567879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101772304|NCT00567879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772305|NCT00781404|Adenosine|adenosine|mesh-list
101772306|NCT00781404|Analgesics|analgesics|mesh-ancestor
101772307|NCT00781404|Sensory System Agents|sensory system agents|mesh-ancestor
101772308|NCT00781404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101772309|NCT00781404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772310|NCT00781404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101772311|NCT00781404|Vasodilator Agents|vasodilator agents|mesh-ancestor
101772312|NCT00781404|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101772313|NCT00781404|Purinergic Agonists|purinergic agonists|mesh-ancestor
101772314|NCT00781404|Purinergic Agents|purinergic agents|mesh-ancestor
101772315|NCT00781404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101772316|NCT00781404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772317|NCT00777504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
101772318|NCT00777504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101772319|NCT00777504|Growth Substances|growth substances|mesh-ancestor
101772320|NCT00777504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772321|NCT00777504|Growth Inhibitors|growth inhibitors|mesh-ancestor
101772322|NCT00777504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101772323|NCT00781482|Zolpidem|zolpidem|mesh-list
101772324|NCT00781482|Eszopiclone|eszopiclone|mesh-list
101772325|NCT00781482|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101772326|NCT00781482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101772327|NCT00781482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101772328|NCT00781482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772329|NCT00781482|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101772330|NCT00781482|GABA Agonists|gaba agonists|mesh-ancestor
101772331|NCT00781482|GABA Agents|gaba agents|mesh-ancestor
101772332|NCT00781482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101772333|NCT00781482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772334|NCT00603915|Carboplatin|carboplatin|mesh-list
101772335|NCT00603915|Gemcitabine|gemcitabine|mesh-list
101772336|NCT00603915|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101772337|NCT00603915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101772338|NCT00603915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101772339|NCT00603915|Antimetabolites|antimetabolites|mesh-ancestor
101772340|NCT00603915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772341|NCT00603915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101772342|NCT00603915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101772343|NCT00929487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101772344|NCT00925977|Insulin|insulin|mesh-list
101772345|NCT00925977|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101772346|NCT00925977|Insulin Glargine|insulin glargine|mesh-list
101772347|NCT00925977|Insulin glulisine|insulin glulisine|mesh-list
101772348|NCT00925977|Isophane Insulin, Human|isophane insulin, human|mesh-list
101772349|NCT00925977|Insulin, Isophane|insulin, isophane|mesh-list
101772350|NCT00925977|Isophane insulin, beef|isophane insulin, beef|mesh-list
101772351|NCT00925977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101772352|NCT00925977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772353|NCT00926055|Simvastatin|simvastatin|mesh-list
101772354|NCT00926055|Ezetimibe|ezetimibe|mesh-list
101429787|NCT00150527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101565701|NCT04321733|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101565702|NCT04321733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101565703|NCT04321733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565704|NCT02029001|Everolimus|everolimus|mesh-list
101565705|NCT02029001|Sorafenib|sorafenib|mesh-list
101565706|NCT02029001|Durvalumab|durvalumab|mesh-list
101565707|NCT02029001|Olaparib|olaparib|mesh-list
101527652|NCT00560118|Fotemustine|fotemustine|mesh-list
101565708|NCT02029001|Lapatinib|lapatinib|mesh-list
101772355|NCT00926055|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
101772356|NCT00926055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101772357|NCT00926055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101772386|NCT00690794|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101772387|NCT00690794|Latanoprost|latanoprost|mesh-list
101772388|NCT00690794|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101772389|NCT00690794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101772390|NCT00666276|Linezolid|linezolid|mesh-list
101772391|NCT00666276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101772392|NCT00666276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101772393|NCT00666276|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101772394|NCT00666276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101772395|NCT00666276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772396|NCT00567255|Naltrexone|naltrexone|mesh-list
101772397|NCT00567255|Bupropion|bupropion|mesh-list
101772398|NCT00567255|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101772399|NCT00567255|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101772400|NCT00567255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772401|NCT00567255|Sensory System Agents|sensory system agents|mesh-ancestor
101772402|NCT00567255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101772403|NCT00567255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101772404|NCT00567255|Antidepressive Agents|antidepressive agents|mesh-ancestor
101772412|NCT00567255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101772413|NCT00567255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101772414|NCT00567255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101772415|NCT00746174|Rosiglitazone|rosiglitazone|mesh-list
101772416|NCT00746174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101772417|NCT00746174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772418|NCT00784446|Bevacizumab|bevacizumab|mesh-list
101772419|NCT00784446|Capecitabine|capecitabine|mesh-list
101772420|NCT00784446|Oxaliplatin|oxaliplatin|mesh-list
101772421|NCT00784446|Imatinib Mesylate|imatinib mesylate|mesh-list
101772422|NCT00784446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101772423|NCT00784446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101772424|NCT00784446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101772425|NCT00784446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101772426|NCT00784446|Growth Substances|growth substances|mesh-ancestor
101772427|NCT00784446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772428|NCT00784446|Growth Inhibitors|growth inhibitors|mesh-ancestor
101772429|NCT00784446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101772430|NCT00784446|Antimetabolites|antimetabolites|mesh-ancestor
101429856|NCT00164112|Azithromycin|azithromycin|mesh-list
101772431|NCT00784446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772432|NCT00784446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101772433|NCT00784446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101772434|NCT00744536|Lenalidomide|lenalidomide|mesh-list
101772435|NCT00744536|Melphalan|melphalan|mesh-list
101772436|NCT00744536|Immunologic Factors|immunologic factors|mesh-ancestor
101772437|NCT00744536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772438|NCT00744536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101772439|NCT00744536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101772440|NCT00744536|Growth Substances|growth substances|mesh-ancestor
101772441|NCT00744536|Growth Inhibitors|growth inhibitors|mesh-ancestor
101772442|NCT00744536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101772443|NCT00744536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101772444|NCT00744536|Alkylating Agents|alkylating agents|mesh-ancestor
101772445|NCT00744536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772446|NCT00744536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101772447|NCT00744536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101565709|NCT02029001|Tremelimumab|tremelimumab|mesh-list
101565710|NCT02029001|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101565711|NCT02029001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101565713|NCT02029001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565714|NCT02029001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101565715|NCT02029001|Immunologic Factors|immunologic factors|mesh-ancestor
101565716|NCT02029001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565717|NCT02029001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101565718|NCT02029001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101772448|NCT00929799|Hormones|hormones|mesh-list
101772449|NCT00929799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101772450|NCT00929799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772451|NCT00777738|Bortezomib|bortezomib|mesh-list
101772452|NCT00777738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101772453|NCT00744770|Rilpivirine|rilpivirine|mesh-list
101772454|NCT00744770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101772455|NCT00744770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101772456|NCT00744770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101772457|NCT00744770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772458|NCT00744770|Antiviral Agents|antiviral agents|mesh-ancestor
101772459|NCT00744770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101772460|NCT00744770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101772461|NCT00744770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101772462|NCT00784680|Tamoxifen|tamoxifen|mesh-list
101772463|NCT00784680|Anastrozole|anastrozole|mesh-list
101772464|NCT00784680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101772465|NCT00784680|Hormone Antagonists|hormone antagonists|mesh-ancestor
101772466|NCT00784680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101772467|NCT00784680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772468|NCT00784680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101772469|NCT00784680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101772474|NCT00784680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101772475|NCT00784680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101772476|NCT00784680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772477|NCT00908271|Dapagliflozin|dapagliflozin|mesh-list
101772478|NCT00908271|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101772479|NCT00908271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772480|NCT00908271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101772481|NCT00908271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772482|NCT02556840|Insulin|insulin|mesh-list
101772483|NCT02556840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101772484|NCT02556840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772485|NCT00929877|Ketoprofen|ketoprofen|mesh-list
101772486|NCT00929877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101772487|NCT00929877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101772488|NCT00929877|Analgesics|analgesics|mesh-ancestor
101772489|NCT00929877|Sensory System Agents|sensory system agents|mesh-ancestor
101772490|NCT00929877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101772491|NCT00929877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772492|NCT00929877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101772493|NCT00929877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101772494|NCT00929877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101772495|NCT00929877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101772496|NCT00929877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772497|NCT00741884|Varenicline|varenicline|mesh-list
101772498|NCT00741884|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101772499|NCT00741884|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101772500|NCT00741884|Cholinergic Agents|cholinergic agents|mesh-ancestor
101772501|NCT00741884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101772502|NCT00741884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772503|NCT00741884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772504|NCT00931437|Vitamin K|vitamin k|mesh-list
101772506|NCT00931437|Micronutrients|micronutrients|mesh-ancestor
101565719|NCT02029001|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101565720|NCT01613495|Octreotide|octreotide|mesh-list
101565721|NCT01613495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101565722|NCT01613495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101565723|NCT01613495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101565724|NCT01321073|Treprostinil|treprostinil|mesh-list
101772507|NCT00931437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772508|NCT00931437|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101772509|NCT00931437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101772510|NCT00931437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772511|NCT00931437|Hemostatics|hemostatics|mesh-ancestor
101772512|NCT00931437|Coagulants|coagulants|mesh-ancestor
101772513|NCT00742040|Captopril|captopril|mesh-list
101772514|NCT00742040|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101772515|NCT00742040|Protease Inhibitors|protease inhibitors|mesh-ancestor
101772516|NCT00742040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101772517|NCT00742040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772518|NCT00742040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101772519|NCT00926757|Entecavir|entecavir|mesh-list
101772520|NCT00926757|Antiviral Agents|antiviral agents|mesh-ancestor
101772521|NCT00926757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101772522|NCT00782106|Immunoglobulins|immunoglobulins|mesh-list
101772523|NCT00782106|Antibodies|antibodies|mesh-list
101772524|NCT00782106|gamma-Globulins|gamma-globulins|mesh-list
101772525|NCT00782106|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101772526|NCT00782106|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101772527|NCT00782106|Immunoglobulin G|immunoglobulin g|mesh-list
101772528|NCT00782106|Immunologic Factors|immunologic factors|mesh-ancestor
101772529|NCT00782106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772530|NCT00929955|Ondansetron|ondansetron|mesh-list
101772531|NCT00929955|Simvastatin|simvastatin|mesh-list
101772532|NCT00929955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101772533|NCT00929955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101772534|NCT00929955|Antimetabolites|antimetabolites|mesh-ancestor
101772535|NCT00929955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772536|NCT00929955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101772537|NCT00929955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101772538|NCT00929955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101772539|NCT00929955|Antiemetics|antiemetics|mesh-ancestor
101772550|NCT00784914|Sirolimus|sirolimus|mesh-list
101772551|NCT00784914|Temsirolimus|temsirolimus|mesh-list
101772552|NCT00784914|MTOR Inhibitors|mtor inhibitors|mesh-list
101772553|NCT00784914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101772554|NCT00784914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101772555|NCT00784914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772556|NCT00784914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101772557|NCT00784914|Immunologic Factors|immunologic factors|mesh-ancestor
101772558|NCT00784914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772559|NCT00784914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101772560|NCT00784914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101772561|NCT00784914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101772562|NCT00784914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101772563|NCT00784914|Antifungal Agents|antifungal agents|mesh-ancestor
101772564|NCT00745004|Ondansetron|ondansetron|mesh-list
101772565|NCT00745004|Antiemetics|antiemetics|mesh-ancestor
101772566|NCT00745004|Autonomic Agents|autonomic agents|mesh-ancestor
101772567|NCT00745004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101772568|NCT00745004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772569|NCT00745004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101772570|NCT00745004|Antipruritics|antipruritics|mesh-ancestor
101772571|NCT00745004|Dermatologic Agents|dermatologic agents|mesh-ancestor
101772572|NCT00745004|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101772573|NCT00745004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101772574|NCT00745004|Serotonin Agents|serotonin agents|mesh-ancestor
101772575|NCT00745004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101772576|NCT00745004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430002|NCT00151034|Mitosis Modulators|mitosis modulators|mesh-ancestor
101772577|NCT05450978|Lamotrigine|lamotrigine|mesh-list
101565725|NCT01321073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101565726|NCT00694733|Anastrozole|anastrozole|mesh-list
101565727|NCT00694733|Leuprolide|leuprolide|mesh-list
101565728|NCT00694733|Methyltestosterone|methyltestosterone|mesh-list
101565729|NCT00694733|Estradiol|estradiol|mesh-list
101565730|NCT00694733|Estrogens|estrogens|mesh-list
101565731|NCT00694733|Testosterone|testosterone|mesh-list
101565732|NCT00694733|Testosterone undecanoate|testosterone undecanoate|mesh-list
101565733|NCT00694733|Testosterone enanthate|testosterone enanthate|mesh-list
101772578|NCT05450978|Levetiracetam|levetiracetam|mesh-list
101772579|NCT05450978|Anticonvulsants|anticonvulsants|mesh-list
101772580|NCT05450978|Nootropic Agents|nootropic agents|mesh-ancestor
101772581|NCT05450978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101772582|NCT05450978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101772583|NCT05450978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772584|NCT05450978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101772585|NCT05450978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772586|NCT05450978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101772587|NCT05450978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101772588|NCT05450978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101772589|NCT05450978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101772590|NCT05450978|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101772591|NCT04060550|Omalizumab|omalizumab|mesh-list
101772592|NCT04060550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101772593|NCT04060550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101772594|NCT04060550|Respiratory System Agents|respiratory system agents|mesh-ancestor
101772595|NCT00921674|Ivermectin|ivermectin|mesh-list
101772596|NCT00921674|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101772597|NCT00921674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101772598|NCT00667446|Leuprolide|leuprolide|mesh-list
101772599|NCT00667446|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101772600|NCT00667446|Fertility Agents|fertility agents|mesh-ancestor
101772601|NCT00667446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101263940|NCT01764867|Autonomic Agents|autonomic agents|mesh-ancestor
101772602|NCT00667446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772619|NCT00778050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101772620|NCT00746486|Budesonide|budesonide|mesh-list
101772621|NCT00746486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101772622|NCT00746486|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101772623|NCT00746486|Autonomic Agents|autonomic agents|mesh-ancestor
101772624|NCT00746486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101772625|NCT00746486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772626|NCT00746486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101772627|NCT00746486|Respiratory System Agents|respiratory system agents|mesh-ancestor
101772628|NCT00746486|Glucocorticoids|glucocorticoids|mesh-ancestor
101772629|NCT00746486|Hormones|hormones|mesh-ancestor
101772630|NCT00746486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101772631|NCT00778128|Gemcitabine|gemcitabine|mesh-list
101772632|NCT00778128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101772633|NCT00778128|Antimetabolites|antimetabolites|mesh-ancestor
101772634|NCT00778128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772635|NCT00778128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101772636|NCT00778284|Amoxicillin|amoxicillin|mesh-list
101772637|NCT00778284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101772638|NCT00778284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101772639|NCT00749138|Tamoxifen|tamoxifen|mesh-list
101772640|NCT00749138|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101772641|NCT00749138|Hormone Antagonists|hormone antagonists|mesh-ancestor
101772642|NCT00749138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101772643|NCT00749138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772644|NCT00749138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101772645|NCT00749138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101772646|NCT00749138|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101772647|NCT00749138|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101772648|NCT00749138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101772649|NCT02563340|Rituximab|rituximab|mesh-list
101772650|NCT02563340|Bortezomib|bortezomib|mesh-list
101772651|NCT02563340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101565734|NCT00694733|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101565735|NCT00694733|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101565736|NCT00694733|Hormones|hormones|mesh-ancestor
101565737|NCT00694733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101565738|NCT00694733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565740|NCT00694733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101565741|NCT00694733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101565742|NCT00694733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101413950|NCT01242046|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101772652|NCT02563340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101772653|NCT02563340|Immunologic Factors|immunologic factors|mesh-ancestor
101772654|NCT02563340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772655|NCT02563340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101772657|NCT00782652|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101772658|NCT00782652|Autonomic Agents|autonomic agents|mesh-ancestor
101772659|NCT00782652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101772660|NCT00782652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772672|NCT00785382|Analgesics|analgesics|mesh-ancestor
101772673|NCT00785382|Sensory System Agents|sensory system agents|mesh-ancestor
101772674|NCT00785382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101772675|NCT00785382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772676|NCT00785382|Anticonvulsants|anticonvulsants|mesh-ancestor
101772677|NCT00785382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101772678|NCT00785382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101772679|NCT00785382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772680|NCT00785382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101772681|NCT00785382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101772682|NCT00785382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101772683|NCT00785382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101772684|NCT00785382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101772685|NCT00667368|Metronidazole|metronidazole|mesh-list
101772686|NCT00667368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101772687|NCT00667368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101772688|NCT00667368|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101772689|NCT00667368|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101772690|NCT00785460|Benphothiamine|benphothiamine|mesh-list
101772691|NCT00785460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101772692|NCT00785460|Immunologic Factors|immunologic factors|mesh-ancestor
101772693|NCT00785460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772694|NCT00785460|Chelating Agents|chelating agents|mesh-ancestor
101772695|NCT00785460|Sequestering Agents|sequestering agents|mesh-ancestor
101772696|NCT00785460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772697|NCT00567567|Vitamin A|vitamin a|mesh-list
101772698|NCT00567567|Cyclophosphamide|cyclophosphamide|mesh-list
101772699|NCT00567567|Melphalan|melphalan|mesh-list
101772700|NCT00567567|Mechlorethamine|mechlorethamine|mesh-list
101772701|NCT00567567|Thiotepa|thiotepa|mesh-list
101772702|NCT00567567|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
101772703|NCT00567567|Cisplatin|cisplatin|mesh-list
101772704|NCT00567567|Carboplatin|carboplatin|mesh-list
101772705|NCT00567567|Doxorubicin|doxorubicin|mesh-list
101772706|NCT00567567|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101772707|NCT00567567|Etoposide|etoposide|mesh-list
101772708|NCT00567567|Vincristine|vincristine|mesh-list
101772709|NCT00567567|Etoposide phosphate|etoposide phosphate|mesh-list
101772710|NCT00567567|Topotecan|topotecan|mesh-list
101772711|NCT00567567|Tretinoin|tretinoin|mesh-list
101772712|NCT00567567|Podophyllotoxin|podophyllotoxin|mesh-list
101772713|NCT00567567|Isotretinoin|isotretinoin|mesh-list
101772714|NCT00567567|Lenograstim|lenograstim|mesh-list
101772715|NCT00567567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101772716|NCT00567567|Immunologic Factors|immunologic factors|mesh-ancestor
101772717|NCT00567567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772718|NCT00567567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101772719|NCT00567567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101772720|NCT00567567|Alkylating Agents|alkylating agents|mesh-ancestor
101772721|NCT00567567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565743|NCT00694733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101565744|NCT00694733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565745|NCT00694733|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101565746|NCT00694733|Hormone Antagonists|hormone antagonists|mesh-ancestor
101565747|NCT00694733|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101565748|NCT00694733|Fertility Agents|fertility agents|mesh-ancestor
101565749|NCT00694733|Androgens|androgens|mesh-ancestor
101565750|NCT00694733|Anabolic Agents|anabolic agents|mesh-ancestor
101772722|NCT00567567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101772723|NCT00567567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101772724|NCT00567567|Vitamins|vitamins|mesh-ancestor
101772725|NCT00567567|Micronutrients|micronutrients|mesh-ancestor
101772726|NCT00567567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101772727|NCT00567567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101772735|NCT00567567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101772737|NCT00567567|Dermatologic Agents|dermatologic agents|mesh-ancestor
101772738|NCT00666198|Sildenafil Citrate|sildenafil citrate|mesh-list
101772739|NCT00666198|Vasodilator Agents|vasodilator agents|mesh-ancestor
101772740|NCT00666198|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101772741|NCT00666198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101772742|NCT00666198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101772743|NCT00666198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772744|NCT00666198|Urological Agents|urological agents|mesh-ancestor
101772745|NCT00778596|Prednisolone|prednisolone|mesh-list
101772746|NCT00778596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101772747|NCT00778596|Glucocorticoids|glucocorticoids|mesh-ancestor
101772748|NCT00778596|Hormones|hormones|mesh-ancestor
101772749|NCT00778596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101772750|NCT00778596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772751|NCT00778596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101772752|NCT00778596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101772753|NCT00778674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101772755|NCT00778674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101772756|NCT00778674|Diuretics|diuretics|mesh-ancestor
101772757|NCT00778674|Natriuretic Agents|natriuretic agents|mesh-ancestor
101772758|NCT00778674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772759|NCT00778674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101772760|NCT00778674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101772761|NCT00778674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772762|NCT00778674|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101772763|NCT00778674|Protease Inhibitors|protease inhibitors|mesh-ancestor
101772764|NCT00778674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101772765|NCT00778752|Lenalidomide|lenalidomide|mesh-list
101772766|NCT00778752|Immunologic Factors|immunologic factors|mesh-ancestor
101772767|NCT00778752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772768|NCT00778752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101772769|NCT00778752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101772770|NCT00778752|Growth Substances|growth substances|mesh-ancestor
101772771|NCT00778752|Growth Inhibitors|growth inhibitors|mesh-ancestor
101772772|NCT00778752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101772773|NCT00926835|Lamotrigine|lamotrigine|mesh-list
101772774|NCT00926835|Dexetimide|dexetimide|mesh-list
101772775|NCT00926835|Aripiprazole|aripiprazole|mesh-list
101772776|NCT00926835|Mirtazapine|mirtazapine|mesh-list
101772777|NCT00926835|Citalopram|citalopram|mesh-list
101772778|NCT00926835|Bupropion|bupropion|mesh-list
101772779|NCT00926835|Paroxetine|paroxetine|mesh-list
101772780|NCT00926835|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101772781|NCT00926835|Escitalopram|escitalopram|mesh-list
101772782|NCT00926835|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101772783|NCT00926835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101772784|NCT00926835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101772785|NCT00926835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772786|NCT00926835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101772787|NCT00926835|Serotonin Agents|serotonin agents|mesh-ancestor
101772788|NCT00926835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772789|NCT00926835|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101772790|NCT00926835|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101565751|NCT01259297|Amlodipine|amlodipine|mesh-list
101565752|NCT01259297|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101565753|NCT01259297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101565754|NCT01259297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101565755|NCT01259297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101772791|NCT00926835|Parasympatholytics|parasympatholytics|mesh-ancestor
101772792|NCT00926835|Autonomic Agents|autonomic agents|mesh-ancestor
101772793|NCT00926835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101772794|NCT00926835|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101772795|NCT00926835|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101772796|NCT00926835|Cholinergic Agents|cholinergic agents|mesh-ancestor
101772808|NCT00926835|Dopamine Agonists|dopamine agonists|mesh-ancestor
101772809|NCT00926835|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101772810|NCT00926835|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101772811|NCT00926835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101772812|NCT00926835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101320378|NCT00847678|Amphotericin B|amphotericin b|mesh-list
101772813|NCT00926835|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101772814|NCT00926835|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101772815|NCT00926835|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101772816|NCT00926835|Anticonvulsants|anticonvulsants|mesh-ancestor
101772817|NCT00926835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101772818|NCT00926835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101772819|NCT00926835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101772820|NCT00926835|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101772821|NCT00926835|Histamine Antagonists|histamine antagonists|mesh-ancestor
101772822|NCT00926835|Histamine Agents|histamine agents|mesh-ancestor
101772823|NCT00926835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101772824|NCT00926835|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101772825|NCT00926835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101772826|NCT00926835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101772827|NCT00926835|Adrenergic Agents|adrenergic agents|mesh-ancestor
101772828|NCT00926835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101772829|NCT00930033|Sunitinib|sunitinib|mesh-list
101772830|NCT00930033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101772831|NCT00930033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101772832|NCT00930033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101772833|NCT00930033|Growth Substances|growth substances|mesh-ancestor
101772834|NCT00930033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772835|NCT00930033|Growth Inhibitors|growth inhibitors|mesh-ancestor
101772836|NCT00930033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101772837|NCT00930033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101772838|NCT00930033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772839|NCT00664560|Celecoxib|celecoxib|mesh-list
101772840|NCT00664560|Antacids|antacids|mesh-list
101772841|NCT00664560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101772842|NCT00664560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101772843|NCT00664560|Analgesics|analgesics|mesh-ancestor
101772844|NCT00664560|Sensory System Agents|sensory system agents|mesh-ancestor
101772845|NCT00664560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101772846|NCT00664560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772847|NCT00664560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101772848|NCT00664560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101772849|NCT00664560|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101772850|NCT00664560|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101772851|NCT00664560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101772852|NCT00664560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772853|NCT00664560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101772854|NCT00783042|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101772855|NCT00783042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101772856|NCT00783042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101772857|NCT00783042|Antimetabolites|antimetabolites|mesh-ancestor
101772863|NCT00688688|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101772864|NCT00688688|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101772865|NCT00688688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101772866|NCT00688688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101772867|NCT00688688|Adrenergic Agents|adrenergic agents|mesh-ancestor
101772868|NCT00688688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101772869|NCT00688688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565756|NCT01259297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565757|NCT01259297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101565758|NCT01259297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565760|NCT01259297|Diuretics|diuretics|mesh-ancestor
101565761|NCT01259297|Natriuretic Agents|natriuretic agents|mesh-ancestor
101565762|NCT01259297|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101565763|NCT01126437|Tiotropium Bromide|tiotropium bromide|mesh-list
101565764|NCT01126437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101772870|NCT00688688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772871|NCT00688688|Urological Agents|urological agents|mesh-ancestor
101772872|NCT00688688|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101320387|NCT00847678|Antifungal Agents|antifungal agents|mesh-ancestor
101772873|NCT00688688|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101772874|NCT00688688|Cholinergic Agents|cholinergic agents|mesh-ancestor
101772875|NCT00930189|Triamcinolone|triamcinolone|mesh-list
101772876|NCT00930189|Ranibizumab|ranibizumab|mesh-list
101772877|NCT00930189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101772878|NCT00930189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101772879|NCT00930189|Growth Substances|growth substances|mesh-ancestor
101772880|NCT00930189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772881|NCT00930189|Growth Inhibitors|growth inhibitors|mesh-ancestor
101772882|NCT00930189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101772883|NCT00930189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101772884|NCT00930189|Glucocorticoids|glucocorticoids|mesh-ancestor
101772885|NCT00930189|Hormones|hormones|mesh-ancestor
101772886|NCT00930189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101772887|NCT00936819|Plasma-lyte 148|plasma-lyte 148|mesh-list
101772888|NCT00936819|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101772889|NCT00936819|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101772890|NCT00931827|Levonorgestrel|levonorgestrel|mesh-list
101772891|NCT00931827|Etonogestrel|etonogestrel|mesh-list
101772892|NCT00931827|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101772893|NCT00931827|Contraceptive Agents|contraceptive agents|mesh-ancestor
101772894|NCT00931827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101772895|NCT00931827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772896|NCT00931827|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101772897|NCT00931827|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101772898|NCT00931827|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101772899|NCT00778908|Cisplatin|cisplatin|mesh-list
101772900|NCT00778908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101772901|NCT02561468|Nefopam|nefopam|mesh-list
101772902|NCT02561468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101772903|NCT02561468|Analgesics|analgesics|mesh-ancestor
101772904|NCT02561468|Sensory System Agents|sensory system agents|mesh-ancestor
101772905|NCT02561468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101772906|NCT02561468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772907|NCT02555748|Sunitinib|sunitinib|mesh-list
101772908|NCT02555748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101772909|NCT02555748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101772910|NCT02555748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101772911|NCT02555748|Growth Substances|growth substances|mesh-ancestor
101772912|NCT02555748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772913|NCT02555748|Growth Inhibitors|growth inhibitors|mesh-ancestor
101772914|NCT02555748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101772915|NCT02555748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101772916|NCT02555748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772917|NCT00930345|Sunitinib|sunitinib|mesh-list
101772918|NCT00930345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101772919|NCT00930345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101772920|NCT00930345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101772921|NCT00930345|Growth Substances|growth substances|mesh-ancestor
101772922|NCT00930345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772923|NCT00930345|Growth Inhibitors|growth inhibitors|mesh-ancestor
101772924|NCT00930345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101772925|NCT00930345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101565765|NCT01126437|Autonomic Agents|autonomic agents|mesh-ancestor
101565766|NCT01126437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101320398|NCT00847483|Bimatoprost|bimatoprost|mesh-list
101565767|NCT01126437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565768|NCT01126437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101565769|NCT01126437|Respiratory System Agents|respiratory system agents|mesh-ancestor
101565770|NCT01126437|Parasympatholytics|parasympatholytics|mesh-ancestor
101565771|NCT01126437|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101565772|NCT01126437|Cholinergic Agents|cholinergic agents|mesh-ancestor
101772926|NCT00930345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772932|NCT00746720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101772934|NCT00746720|Sensory System Agents|sensory system agents|mesh-ancestor
101772935|NCT00746720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101772936|NCT00746720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772937|NCT00746720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101772938|NCT00746720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101772939|NCT00746720|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101772940|NCT00746720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101772941|NCT00746720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101772942|NCT00746720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772943|NCT00686972|Glucagon|glucagon|mesh-list
101772944|NCT00686972|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101772945|NCT00686972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101772946|NCT00686972|Hormones|hormones|mesh-ancestor
101772947|NCT00686972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101772948|NCT00686972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772949|NCT00686972|Incretins|incretins|mesh-ancestor
101772950|NCT00665652|Lenalidomide|lenalidomide|mesh-list
101772951|NCT00665652|Immunologic Factors|immunologic factors|mesh-ancestor
101772952|NCT00665652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772953|NCT00665652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101772954|NCT00665652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101772955|NCT00665652|Growth Substances|growth substances|mesh-ancestor
101772956|NCT00665652|Growth Inhibitors|growth inhibitors|mesh-ancestor
101772957|NCT00665652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101772958|NCT00752024|Hemostatics|hemostatics|mesh-list
101772959|NCT00752024|Coagulants|coagulants|mesh-ancestor
101772960|NCT00937677|Natalizumab|natalizumab|mesh-list
101772961|NCT00937677|Immunologic Factors|immunologic factors|mesh-ancestor
101772962|NCT00937677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772963|NCT00786240|Fesoterodine|fesoterodine|mesh-list
101772964|NCT00786240|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101772965|NCT00786240|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101772966|NCT00786240|Cholinergic Agents|cholinergic agents|mesh-ancestor
101772967|NCT00786240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101772968|NCT00786240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772969|NCT00786240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772970|NCT00786240|Urological Agents|urological agents|mesh-ancestor
101772971|NCT04498923|Dexamethasone|dexamethasone|mesh-list
101772972|NCT04498923|Epinephrine|epinephrine|mesh-list
101772973|NCT04498923|Bupivacaine|bupivacaine|mesh-list
101772975|NCT04498923|Antiemetics|antiemetics|mesh-ancestor
101772976|NCT04498923|Autonomic Agents|autonomic agents|mesh-ancestor
101772977|NCT04498923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101772978|NCT04498923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772979|NCT04498923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101772980|NCT04498923|Glucocorticoids|glucocorticoids|mesh-ancestor
101772981|NCT04498923|Hormones|hormones|mesh-ancestor
101320419|NCT00847366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101772982|NCT04498923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101772983|NCT04498923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101772984|NCT04498923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101772985|NCT04498923|Anesthetics, Local|anesthetics, local|mesh-ancestor
101772986|NCT04498923|Anesthetics|anesthetics|mesh-ancestor
101772987|NCT04498923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101772988|NCT04498923|Sensory System Agents|sensory system agents|mesh-ancestor
101772989|NCT04498923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101772990|NCT04498923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101413989|NCT00487591|Simvastatin|simvastatin|mesh-list
101565773|NCT01126437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101565774|NCT01126437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565775|NCT01258595|Vaccines|vaccines|mesh-list
101565776|NCT01258595|Immunologic Factors|immunologic factors|mesh-ancestor
101565777|NCT01258595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565778|NCT01257737|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
101565779|NCT01257737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101565780|NCT01126359|Lidocaine|lidocaine|mesh-list
101772991|NCT04498923|Adrenergic Agents|adrenergic agents|mesh-ancestor
101772992|NCT04498923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101772993|NCT04498923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772994|NCT04498923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101772995|NCT04498923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101772996|NCT04498923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101772997|NCT04498923|Respiratory System Agents|respiratory system agents|mesh-ancestor
101772998|NCT04498923|Mydriatics|mydriatics|mesh-ancestor
101773013|NCT00932217|Lenograstim|lenograstim|mesh-list
101773014|NCT00932217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101773015|NCT00932217|Immunologic Factors|immunologic factors|mesh-ancestor
101773016|NCT00932217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773017|NCT00786318|Ziprasidone|ziprasidone|mesh-list
101773018|NCT00786318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101773019|NCT00786318|Serotonin Agents|serotonin agents|mesh-ancestor
101773020|NCT00786318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101773021|NCT00786318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773022|NCT00786318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773023|NCT00786318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101773024|NCT00786318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101773025|NCT00786318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101773026|NCT00786318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101773027|NCT00786318|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101430452|NCT04687111|Valsartan|valsartan|mesh-list
101773028|NCT00786318|Dopamine Agents|dopamine agents|mesh-ancestor
101773029|NCT00566631|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101773030|NCT00566631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101773031|NCT00566631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101773032|NCT00566631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101773033|NCT00566631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773034|NCT00566631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101773035|NCT00566631|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101773036|NCT00566631|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101773037|NCT00566631|Serotonin Agents|serotonin agents|mesh-ancestor
101773038|NCT00566631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101773039|NCT00566631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773040|NCT00566631|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101773041|NCT00566631|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101773042|NCT00566631|Dopamine Agents|dopamine agents|mesh-ancestor
101773043|NCT00937911|Darexaban|darexaban|mesh-list
101773044|NCT00937911|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101773045|NCT00937911|Antithrombins|antithrombins|mesh-ancestor
101773046|NCT00937911|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101773047|NCT00937911|Protease Inhibitors|protease inhibitors|mesh-ancestor
101773048|NCT00937911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101773049|NCT00937911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773050|NCT00937911|Anticoagulants|anticoagulants|mesh-ancestor
101773051|NCT00930891|Bevacizumab|bevacizumab|mesh-list
101773052|NCT00930891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101773053|NCT00930891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101773054|NCT00930891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101773055|NCT00930891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101773056|NCT00930891|Growth Substances|growth substances|mesh-ancestor
101773057|NCT00930891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773058|NCT00930891|Growth Inhibitors|growth inhibitors|mesh-ancestor
101773059|NCT00938379|Insect Repellents|insect repellents|mesh-list
101773071|NCT00932529|Risperidone|risperidone|mesh-list
101565781|NCT01126359|Anesthetics, Local|anesthetics, local|mesh-ancestor
101565782|NCT01126359|Anesthetics|anesthetics|mesh-ancestor
101565783|NCT01126359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101565784|NCT01126359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527724|NCT00560274|Ribavirin|ribavirin|mesh-list
101565785|NCT01126359|Sensory System Agents|sensory system agents|mesh-ancestor
101565786|NCT01126359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101565787|NCT01126359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101565788|NCT01126359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101565789|NCT01126359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101565790|NCT01126359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101413996|NCT00487591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101773072|NCT00932529|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101773073|NCT00932529|Ziprasidone|ziprasidone|mesh-list
101773074|NCT00932529|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101773075|NCT00932529|Serotonin Agents|serotonin agents|mesh-ancestor
101773076|NCT00932529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101773077|NCT00932529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773078|NCT00932529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773079|NCT00932529|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101773080|NCT00932529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101773081|NCT00932529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101773082|NCT00932529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101773083|NCT00932529|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101773084|NCT00932529|Dopamine Agents|dopamine agents|mesh-ancestor
101773085|NCT00932529|Antiemetics|antiemetics|mesh-ancestor
101773086|NCT00932529|Autonomic Agents|autonomic agents|mesh-ancestor
101773087|NCT00932529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101773088|NCT00932529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101773089|NCT00932529|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101773090|NCT00932529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101773091|NCT00932529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101773092|NCT00932529|Antidepressive Agents|antidepressive agents|mesh-ancestor
101773094|NCT00783744|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101773095|NCT00783744|Metformin|metformin|mesh-list
101773096|NCT00783744|Insulin Glargine|insulin glargine|mesh-list
101773097|NCT00783744|Glimepiride|glimepiride|mesh-list
101773098|NCT00783744|Isophane Insulin, Human|isophane insulin, human|mesh-list
101773099|NCT00783744|Insulin, Isophane|insulin, isophane|mesh-list
101773100|NCT00783744|Isophane insulin, beef|isophane insulin, beef|mesh-list
101773101|NCT00783744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101773102|NCT00783744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773103|NCT00783744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101773104|NCT00783744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101773105|NCT00783744|Immunologic Factors|immunologic factors|mesh-ancestor
101773106|NCT00932607|Immunomodulating Agents|immunomodulating agents|mesh-list
101773108|NCT00932607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773109|NCT00932685|Midazolam|midazolam|mesh-list
101773110|NCT00932685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101773111|NCT00932685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101773112|NCT00932685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101773113|NCT00932685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773114|NCT00932685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101773115|NCT00932685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101773116|NCT00932685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101773117|NCT00932685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101773118|NCT00932685|Anesthetics, General|anesthetics, general|mesh-ancestor
101773119|NCT00932685|Anesthetics|anesthetics|mesh-ancestor
101773120|NCT00932685|GABA Modulators|gaba modulators|mesh-ancestor
101773121|NCT00932685|GABA Agents|gaba agents|mesh-ancestor
101773122|NCT00932685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101773123|NCT00932685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773124|NCT00931125|Ranibizumab|ranibizumab|mesh-list
101565791|NCT01126359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565792|NCT00637533|Botulinum Toxins|botulinum toxins|mesh-list
101565793|NCT00637533|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101565794|NCT00637533|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101565795|NCT00637533|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101565796|NCT00637533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101565797|NCT00637533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565798|NCT00637533|Cholinergic Agents|cholinergic agents|mesh-ancestor
101414008|NCT00488137|Serotonin Agents|serotonin agents|mesh-ancestor
101773125|NCT00931125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101773150|NCT00783900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101773151|NCT00783900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101773152|NCT00783900|Adrenergic Agents|adrenergic agents|mesh-ancestor
101773153|NCT00783900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101773154|NCT00783900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773155|NCT00938613|Budesonide|budesonide|mesh-list
101773156|NCT00938613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101773157|NCT00938613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101773158|NCT00938613|Autonomic Agents|autonomic agents|mesh-ancestor
101773159|NCT00938613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101773160|NCT00938613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773161|NCT00938613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101773162|NCT00938613|Respiratory System Agents|respiratory system agents|mesh-ancestor
101773163|NCT00938613|Glucocorticoids|glucocorticoids|mesh-ancestor
101773164|NCT00938613|Hormones|hormones|mesh-ancestor
101773165|NCT00938613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101773166|NCT00786552|Paclitaxel|paclitaxel|mesh-list
101773167|NCT00786552|Pemetrexed|pemetrexed|mesh-list
101773168|NCT00786552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101773169|NCT00786552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101773170|NCT00786552|Tubulin Modulators|tubulin modulators|mesh-ancestor
101773171|NCT00786552|Antimitotic Agents|antimitotic agents|mesh-ancestor
101773172|NCT00786552|Mitosis Modulators|mitosis modulators|mesh-ancestor
101773173|NCT00786552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773174|NCT00786552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101773215|NCT00570492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101773216|NCT00570492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773217|NCT00570492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101773218|NCT00570492|Respiratory System Agents|respiratory system agents|mesh-ancestor
101773219|NCT00570492|Dermatologic Agents|dermatologic agents|mesh-ancestor
101320484|NCT03940586|Antiviral Agents|antiviral agents|mesh-ancestor
101773220|NCT00570492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101773221|NCT00931281|Ritonavir|ritonavir|mesh-list
101773222|NCT00931281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101773223|NCT00931281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101773224|NCT00931281|Protease Inhibitors|protease inhibitors|mesh-ancestor
101773225|NCT00931281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101773226|NCT00931281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773227|NCT00931281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101773228|NCT00931281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101773229|NCT00931281|Antiviral Agents|antiviral agents|mesh-ancestor
101773230|NCT00931281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101773231|NCT00931281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101773232|NCT00931281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101773233|NCT04014855|Lactoferrin|lactoferrin|mesh-list
101773234|NCT04014855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101773235|NCT00571922|Acamprosate|acamprosate|mesh-list
101773236|NCT00571922|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101773237|NCT00933231|Mycophenolic Acid|mycophenolic acid|mesh-list
101773238|NCT00933231|Prednisone|prednisone|mesh-list
101773239|NCT00933231|Methylprednisolone|methylprednisolone|mesh-list
101773240|NCT00933231|Ramipril|ramipril|mesh-list
101773241|NCT00933231|Irbesartan|irbesartan|mesh-list
101773242|NCT00933231|Tacrolimus|tacrolimus|mesh-list
101773243|NCT00933231|Basiliximab|basiliximab|mesh-list
101773244|NCT00933231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101565800|NCT00637533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565801|NCT00637533|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101565802|NCT00637533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101565803|NCT01125813|Factor VIII|factor viii|mesh-list
101565804|NCT01125813|Coagulants|coagulants|mesh-ancestor
101565805|NCT04311645|Charcoal|charcoal|mesh-list
101565806|NCT04311645|Antidotes|antidotes|mesh-ancestor
101773245|NCT00933231|Glucocorticoids|glucocorticoids|mesh-ancestor
101773246|NCT00933231|Hormones|hormones|mesh-ancestor
101773247|NCT00933231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101773248|NCT00933231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773249|NCT00933231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101773250|NCT00933231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101773251|NCT00933231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101773252|NCT00933231|Immunologic Factors|immunologic factors|mesh-ancestor
101773253|NCT00933231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101773254|NCT00933231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101773255|NCT00933231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773256|NCT00933231|Antiemetics|antiemetics|mesh-ancestor
101773257|NCT00933231|Autonomic Agents|autonomic agents|mesh-ancestor
101773258|NCT00933231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101773259|NCT00933231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101773260|NCT00933231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101773261|NCT00933231|Protective Agents|protective agents|mesh-ancestor
101773262|NCT00933231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101773263|NCT00933231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101773264|NCT00933231|Antitubercular Agents|antitubercular agents|mesh-ancestor
101773265|NCT00933231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101773266|NCT00933231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101773267|NCT00933231|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101773268|NCT00933231|Protease Inhibitors|protease inhibitors|mesh-ancestor
101773269|NCT00933231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101773270|NCT00933231|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101773271|NCT00933231|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101773272|NCT03489525|Antibodies|antibodies|mesh-list
101773273|NCT03489525|Immunoglobulins|immunoglobulins|mesh-list
101773274|NCT03489525|Immunoconjugates|immunoconjugates|mesh-list
101773275|NCT03489525|Immunologic Factors|immunologic factors|mesh-ancestor
101773276|NCT03489525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773277|NCT00752180|Insulin|insulin|mesh-list
101773278|NCT00752180|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101773279|NCT00752180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101773280|NCT00752180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773281|NCT00784290|Orantinib|orantinib|mesh-list
101773282|NCT00784290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101773285|NCT00752414|Levofloxacin|levofloxacin|mesh-list
101773286|NCT00752414|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101773287|NCT00752414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101773288|NCT00752414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101773289|NCT00752414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101773290|NCT00752414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101773291|NCT00752414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101773292|NCT00752414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773293|NCT00752414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101773294|NCT00752414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101773295|NCT00752414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101773296|NCT04059224|Trametinib|trametinib|mesh-list
101773297|NCT04059224|Dabrafenib|dabrafenib|mesh-list
101773298|NCT04059224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101773299|NCT04059224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101773300|NCT04059224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101773301|NCT04059224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773302|NCT00686894|Infliximab|infliximab|mesh-list
101773303|NCT00686894|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101773304|NCT00686894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101773305|NCT00686894|Dermatologic Agents|dermatologic agents|mesh-ancestor
101773306|NCT00686894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101565807|NCT04311645|Protective Agents|protective agents|mesh-ancestor
101565808|NCT04311645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565810|NCT01257581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101565811|NCT01257581|Hormone Antagonists|hormone antagonists|mesh-ancestor
101565812|NCT01257581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101565813|NCT01257581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565814|NCT01257581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101565815|NCT01257581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101773307|NCT00686894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101773308|NCT00328627|Pioglitazone|pioglitazone|mesh-list
101773309|NCT00328627|Alogliptin|alogliptin|mesh-list
101773310|NCT00328627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101773311|NCT00328627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773312|NCT00328627|Incretins|incretins|mesh-ancestor
101773313|NCT00328627|Hormones|hormones|mesh-ancestor
101773314|NCT00328627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101773315|NCT00328627|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101773316|NCT00328627|Protease Inhibitors|protease inhibitors|mesh-ancestor
101773317|NCT00328627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101773318|NCT00328627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773319|NCT03977727|Insulin Aspart|insulin aspart|mesh-list
101773320|NCT03977727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101773321|NCT03977727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773322|NCT00663858|Cetrorelix|cetrorelix|mesh-list
101773323|NCT00663858|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101773324|NCT00663858|Fertility Agents|fertility agents|mesh-ancestor
101320508|NCT00846859|Varenicline|varenicline|mesh-list
101773325|NCT00663858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101773326|NCT00663858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773327|NCT00663858|Hormone Antagonists|hormone antagonists|mesh-ancestor
101773328|NCT00663858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101773329|NCT05223400|Clindamycin|clindamycin|mesh-list
101773330|NCT05223400|Clindamycin palmitate|clindamycin palmitate|mesh-list
101773331|NCT05223400|Clindamycin phosphate|clindamycin phosphate|mesh-list
101773332|NCT05223400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101773333|NCT05223400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101773334|NCT05223400|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101773335|NCT05223400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101773336|NCT05223400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773337|NCT00790608|Nitric Oxide|nitric oxide|mesh-list
101773338|NCT00790608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101773339|NCT00790608|Autonomic Agents|autonomic agents|mesh-ancestor
101773340|NCT00790608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101773341|NCT00790608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773342|NCT00790608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101773343|NCT00790608|Respiratory System Agents|respiratory system agents|mesh-ancestor
101773344|NCT00790608|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101773345|NCT00790608|Antioxidants|antioxidants|mesh-ancestor
101263949|NCT01764867|Dopamine Agents|dopamine agents|mesh-ancestor
101773346|NCT00790608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773347|NCT00790608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101773348|NCT00790608|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101773349|NCT00790608|Vasodilator Agents|vasodilator agents|mesh-ancestor
101773350|NCT00790608|Gasotransmitters|gasotransmitters|mesh-ancestor
101773351|NCT00790608|Protective Agents|protective agents|mesh-ancestor
101773352|NCT00749450|Fluorouracil|fluorouracil|mesh-list
101773353|NCT00749450|Capecitabine|capecitabine|mesh-list
101773360|NCT00749450|Immunologic Factors|immunologic factors|mesh-ancestor
101773361|NCT00749450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773363|NCT00795444|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101773364|NCT00795444|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101773365|NCT00795444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773366|NCT00795444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101773367|NCT00795444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101565816|NCT01257581|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101565817|NCT01257581|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101565818|NCT01257581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101565820|NCT00995566|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101565821|NCT00995566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565822|NCT01257425|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101565823|NCT01257425|Luteolytic Agents|luteolytic agents|mesh-ancestor
101565824|NCT01257425|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101565825|NCT01257425|Contraceptive Agents|contraceptive agents|mesh-ancestor
101773368|NCT00795444|Antiviral Agents|antiviral agents|mesh-ancestor
101773369|NCT00795444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101773370|NCT00795444|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101773371|NCT02561936|Rilpivirine|rilpivirine|mesh-list
101773372|NCT02561936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101773373|NCT02561936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101773374|NCT02561936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101773375|NCT02561936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773376|NCT02561936|Antiviral Agents|antiviral agents|mesh-ancestor
101773377|NCT02561936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101773378|NCT02561936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101773379|NCT02561936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101773381|NCT00752648|Antiviral Agents|antiviral agents|mesh-ancestor
101773382|NCT00752648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101773383|NCT00752648|Protease Inhibitors|protease inhibitors|mesh-ancestor
101320532|NCT00846703|Hormones|hormones|mesh-ancestor
101773384|NCT00752648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101773385|NCT00752648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773386|NCT00790920|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
101773387|NCT00790920|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101773388|NCT00790920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101773389|NCT00790920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773390|NCT00752882|Ceftazidime|ceftazidime|mesh-list
101773391|NCT00752882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101773392|NCT00752882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101773393|NCT01060735|Vitamin D|vitamin d|mesh-list
101773394|NCT01060735|Vitamins|vitamins|mesh-ancestor
101773395|NCT01060735|Micronutrients|micronutrients|mesh-ancestor
101773396|NCT01060735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773397|NCT01060735|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101773398|NCT02555358|Docetaxel|docetaxel|mesh-list
101773399|NCT02555358|Capecitabine|capecitabine|mesh-list
101773400|NCT02555358|Oxaliplatin|oxaliplatin|mesh-list
101773401|NCT02555358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101773402|NCT02555358|Tubulin Modulators|tubulin modulators|mesh-ancestor
101773403|NCT02555358|Antimitotic Agents|antimitotic agents|mesh-ancestor
101773404|NCT02555358|Mitosis Modulators|mitosis modulators|mesh-ancestor
101773405|NCT02555358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773406|NCT02555358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101773407|NCT02555358|Antimetabolites|antimetabolites|mesh-ancestor
101773408|NCT00683774|Diazoxide|diazoxide|mesh-list
101773409|NCT00683774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101773410|NCT00683774|Vasodilator Agents|vasodilator agents|mesh-ancestor
101773411|NCT00787410|Gefitinib|gefitinib|mesh-list
101773412|NCT00787410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101773413|NCT00787410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101773414|NCT00787410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101773415|NCT00787410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773416|NCT03989557|Aspirin|aspirin|mesh-list
101773417|NCT03989557|Clopidogrel|clopidogrel|mesh-list
101773418|NCT03989557|Ticagrelor|ticagrelor|mesh-list
101263951|NCT01764867|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101773419|NCT03989557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101773420|NCT03989557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101565826|NCT01257425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101565827|NCT01257425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565828|NCT01257425|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101565829|NCT01257425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101565830|NCT01257425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101773421|NCT03989557|Analgesics|analgesics|mesh-ancestor
101773441|NCT00790998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101773442|NCT00790998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101773443|NCT00790998|Anthelmintics|anthelmintics|mesh-ancestor
101773444|NCT00790998|Antinematodal Agents|antinematodal agents|mesh-ancestor
101773445|NCT02555046|Anesthetics|anesthetics|mesh-list
101773446|NCT02555046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101773447|NCT02555046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773448|NCT00354679|Bevacizumab|bevacizumab|mesh-list
101773450|NCT00354679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101773451|NCT00354679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101773452|NCT00354679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101773453|NCT00354679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101773454|NCT00354679|Growth Substances|growth substances|mesh-ancestor
101773455|NCT00354679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773456|NCT00354679|Growth Inhibitors|growth inhibitors|mesh-ancestor
101773457|NCT00354679|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101773458|NCT00354679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101773459|NCT00354679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101773460|NCT00354679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773461|NCT00540514|Paclitaxel|paclitaxel|mesh-list
101773462|NCT00540514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101773463|NCT00540514|Carboplatin|carboplatin|mesh-list
101773464|NCT00540514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101773465|NCT00540514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101773466|NCT00540514|Tubulin Modulators|tubulin modulators|mesh-ancestor
101773467|NCT00540514|Antimitotic Agents|antimitotic agents|mesh-ancestor
101773468|NCT00540514|Mitosis Modulators|mitosis modulators|mesh-ancestor
101773469|NCT00540514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773470|NCT00663702|Abatacept|abatacept|mesh-list
101773471|NCT00663702|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101773472|NCT00663702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773473|NCT00663702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101773474|NCT00663702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101773475|NCT00663702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101773476|NCT00663702|Immunologic Factors|immunologic factors|mesh-ancestor
101773481|NCT02022592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101773482|NCT02022592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101773483|NCT02022592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101773484|NCT02022592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773485|NCT02022592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101773486|NCT02022592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101773487|NCT02022592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101773488|NCT02022592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101773489|NCT02022592|Anesthetics, General|anesthetics, general|mesh-ancestor
101773490|NCT02022592|Anesthetics|anesthetics|mesh-ancestor
101773491|NCT02022592|GABA Modulators|gaba modulators|mesh-ancestor
101773492|NCT02022592|GABA Agents|gaba agents|mesh-ancestor
101773493|NCT02022592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101773494|NCT02022592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773495|NCT00683618|Atorvastatin|atorvastatin|mesh-list
101773496|NCT00683618|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101773497|NCT00683618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101773498|NCT00683618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101773499|NCT00683618|Antimetabolites|antimetabolites|mesh-ancestor
101773500|NCT00683618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773501|NCT00683618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101773502|NCT00683618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101773503|NCT00683618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101773504|NCT00795678|Paclitaxel|paclitaxel|mesh-list
101773505|NCT00795678|Vinorelbine|vinorelbine|mesh-list
101773506|NCT00795678|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101773507|NCT00795678|Cyclophosphamide|cyclophosphamide|mesh-list
101565832|NCT00995488|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101565833|NCT00995488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101565834|NCT00995488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101565835|NCT00995488|Tubulin Modulators|tubulin modulators|mesh-ancestor
101565836|NCT00995488|Antimitotic Agents|antimitotic agents|mesh-ancestor
101565837|NCT00995488|Mitosis Modulators|mitosis modulators|mesh-ancestor
101565838|NCT00995488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565839|NCT04293172|Ticagrelor|ticagrelor|mesh-list
101565840|NCT04293172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101565841|NCT04293172|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101565842|NCT04293172|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101565843|NCT04293172|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101565844|NCT04293172|Purinergic Agents|purinergic agents|mesh-ancestor
101565845|NCT04293172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101565846|NCT04293172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773508|NCT00795678|Gemcitabine|gemcitabine|mesh-list
101773509|NCT00795678|Doxorubicin|doxorubicin|mesh-list
101773510|NCT00795678|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101773511|NCT00795678|Capecitabine|capecitabine|mesh-list
101773512|NCT00795678|Trastuzumab|trastuzumab|mesh-list
101773513|NCT00795678|Lapatinib|lapatinib|mesh-list
101773514|NCT00795678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101773515|NCT00795678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101773516|NCT00795678|Tubulin Modulators|tubulin modulators|mesh-ancestor
101773517|NCT00795678|Antimitotic Agents|antimitotic agents|mesh-ancestor
101773518|NCT00795678|Mitosis Modulators|mitosis modulators|mesh-ancestor
101773519|NCT00795678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773520|NCT00795678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101773521|NCT00795678|Immunologic Factors|immunologic factors|mesh-ancestor
101773522|NCT00795678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773523|NCT00795678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101773524|NCT00795678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101773525|NCT00795678|Alkylating Agents|alkylating agents|mesh-ancestor
101773526|NCT00795678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101773527|NCT00795678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101773528|NCT00795678|Antimetabolites|antimetabolites|mesh-ancestor
101773529|NCT00795678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101773530|NCT00795678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101773531|NCT00795678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101773532|NCT00795678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101773533|NCT00795678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101773534|NCT00795678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101773535|NCT00753038|Paclitaxel|paclitaxel|mesh-list
101773536|NCT00753038|Carboplatin|carboplatin|mesh-list
101773537|NCT00753038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101773538|NCT00753038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101773539|NCT00753038|Tubulin Modulators|tubulin modulators|mesh-ancestor
101773540|NCT00753038|Antimitotic Agents|antimitotic agents|mesh-ancestor
101773541|NCT00753038|Mitosis Modulators|mitosis modulators|mesh-ancestor
101773542|NCT00753038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773543|NCT00795756|Cytarabine|cytarabine|mesh-list
101773544|NCT00795756|Methotrexate|methotrexate|mesh-list
101773545|NCT00795756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101773546|NCT00795756|Abortifacient Agents|abortifacient agents|mesh-ancestor
101773547|NCT00795756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101773548|NCT00795756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565847|NCT04293172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565849|NCT01256879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101773549|NCT00795756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101263954|NCT01764867|Analgesics|analgesics|mesh-ancestor
101773559|NCT00795756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101773560|NCT00795756|Antiviral Agents|antiviral agents|mesh-ancestor
101773561|NCT00795756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101773562|NCT04058522|Triamcinolone|triamcinolone|mesh-list
101773563|NCT04058522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101773564|NCT04058522|Glucocorticoids|glucocorticoids|mesh-ancestor
101773565|NCT04058522|Hormones|hormones|mesh-ancestor
101773566|NCT04058522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101320568|NCT00846508|Cisplatin|cisplatin|mesh-list
101773567|NCT04058522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773568|NCT00791232|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101773569|NCT00791232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101773570|NCT00791232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101773571|NCT00791232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101773572|NCT00791232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773573|NCT00791232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101773574|NCT00791232|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101773575|NCT00791232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101773576|NCT00791232|Serotonin Agents|serotonin agents|mesh-ancestor
101773577|NCT00791232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101773578|NCT00791232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773579|NCT00791232|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101773580|NCT00791232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101773581|NCT00791232|Dopamine Agents|dopamine agents|mesh-ancestor
101773582|NCT01563952|Sirolimus|sirolimus|mesh-list
101773583|NCT01563952|Umirolimus|umirolimus|mesh-list
101773584|NCT01563952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101773585|NCT01563952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101773586|NCT01563952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101773587|NCT01563952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101773588|NCT01563952|Antifungal Agents|antifungal agents|mesh-ancestor
101773589|NCT01563952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101773590|NCT01563952|Immunologic Factors|immunologic factors|mesh-ancestor
101773591|NCT01563952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773592|NCT01563952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101773593|NCT00795912|Atorvastatin|atorvastatin|mesh-list
101773594|NCT00795912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101773595|NCT00795912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101773596|NCT00795912|Antimetabolites|antimetabolites|mesh-ancestor
101773597|NCT00795912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773598|NCT00795912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101773599|NCT00795912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101773600|NCT00795912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101773601|NCT00788034|Vortioxetine|vortioxetine|mesh-list
101773602|NCT00788034|Antidepressive Agents|antidepressive agents|mesh-ancestor
101773603|NCT00788034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101773604|NCT00788034|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101773605|NCT00788034|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101773606|NCT00788034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101773607|NCT00788034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773608|NCT00788034|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101773609|NCT00788034|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101773610|NCT00788034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101773611|NCT00788034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773612|NCT00788034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101773613|NCT00788034|Serotonin Agents|serotonin agents|mesh-ancestor
101773620|NCT04004884|Contraceptive Agents|contraceptive agents|mesh-ancestor
101263965|NCT01764867|Adrenergic Agents|adrenergic agents|mesh-ancestor
101773621|NCT04004884|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101773622|NCT04004884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773623|NCT04004884|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101773624|NCT00688064|Doxycycline|doxycycline|mesh-list
101773625|NCT00688064|Adapalene|adapalene|mesh-list
101773626|NCT00688064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101773627|NCT00688064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101773628|NCT00688064|Antimalarials|antimalarials|mesh-ancestor
101773629|NCT00688064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101773630|NCT00688064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101565850|NCT01256879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101565851|NCT01256879|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101565852|NCT01256879|Histamine Antagonists|histamine antagonists|mesh-ancestor
101565853|NCT01256879|Histamine Agents|histamine agents|mesh-ancestor
101565854|NCT01256879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101565855|NCT01256879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565856|NCT01256879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773631|NCT00688064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101773632|NCT00688064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101773634|NCT00688064|Sensory System Agents|sensory system agents|mesh-ancestor
101773635|NCT00688064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101773636|NCT00688064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773637|NCT00688064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101773638|NCT00688064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101773639|NCT00688064|Dermatologic Agents|dermatologic agents|mesh-ancestor
101773641|NCT00788112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101773642|NCT00788112|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101773643|NCT00788112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101773644|NCT00788112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773645|NCT03112174|Venetoclax|venetoclax|mesh-list
101773646|NCT03112174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101773647|NCT00749918|Vitamin D|vitamin d|mesh-list
101773648|NCT00749918|Cholecalciferol|cholecalciferol|mesh-list
101773649|NCT00749918|Vitamins|vitamins|mesh-ancestor
101773650|NCT00749918|Micronutrients|micronutrients|mesh-ancestor
101773651|NCT00749918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773652|NCT00749918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101773653|NCT00749918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101773654|NCT04058132|Sildenafil Citrate|sildenafil citrate|mesh-list
101773655|NCT04058132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773656|NCT04058132|Vasodilator Agents|vasodilator agents|mesh-ancestor
101773657|NCT04058132|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101773658|NCT04058132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101773659|NCT04058132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101773660|NCT04058132|Urological Agents|urological agents|mesh-ancestor
101773661|NCT00791544|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101773662|NCT00791544|Sorafenib|sorafenib|mesh-list
101773663|NCT00791544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101773664|NCT00791544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101773665|NCT00791544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101773666|NCT00791544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773667|NCT05171686|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101773668|NCT05171686|Chlorthalidone|chlorthalidone|mesh-list
101773669|NCT05171686|Torsemide|torsemide|mesh-list
101773670|NCT05171686|Furosemide|furosemide|mesh-list
101773671|NCT05171686|Bumetanide|bumetanide|mesh-list
101773672|NCT05171686|Diuretics|diuretics|mesh-list
101773673|NCT05171686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101773674|NCT05171686|Natriuretic Agents|natriuretic agents|mesh-ancestor
101773675|NCT05171686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773676|NCT05171686|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101773677|NCT05171686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101773678|NCT05171686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773679|NCT05171686|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101773680|NCT00990028|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101773681|NCT00990028|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101773689|NCT00663234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101773690|NCT00663234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101773691|NCT00663234|Antimetabolites|antimetabolites|mesh-ancestor
101773692|NCT00663234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773693|NCT00663234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101773694|NCT00663234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101773695|NCT00663234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101773696|NCT00683384|Etanercept|etanercept|mesh-list
101565857|NCT01256879|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101565858|NCT01256879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101565859|NCT01256879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101565860|NCT02869672|Vaccines|vaccines|mesh-list
101565861|NCT02869672|Immunologic Factors|immunologic factors|mesh-ancestor
101565862|NCT02869672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565863|NCT01125189|Interferons|interferons|mesh-list
101565864|NCT01125189|Ribavirin|ribavirin|mesh-list
101565865|NCT01125189|Interferon-alpha|interferon-alpha|mesh-list
101565866|NCT01125189|Interferon alpha-2|interferon alpha-2|mesh-list
101773697|NCT00683384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101773698|NCT00683384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101773699|NCT00683384|Analgesics|analgesics|mesh-ancestor
101773700|NCT00683384|Sensory System Agents|sensory system agents|mesh-ancestor
101773701|NCT00683384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101773702|NCT00683384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773703|NCT00683384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101773704|NCT00683384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101773705|NCT00683384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101773706|NCT00683384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101773707|NCT00683384|Immunologic Factors|immunologic factors|mesh-ancestor
101773708|NCT00753740|Camptothecin|camptothecin|mesh-list
101773709|NCT00753740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101773710|NCT00753740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101773711|NCT00753740|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101773712|NCT00753740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101773713|NCT00753740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101773714|NCT00753740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773715|NCT00326911|Bevacizumab|bevacizumab|mesh-list
101773716|NCT00326911|Cetuximab|cetuximab|mesh-list
101773717|NCT00326911|Gemcitabine|gemcitabine|mesh-list
101773718|NCT00326911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101773719|NCT00326911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101773720|NCT00326911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101773721|NCT00326911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101773722|NCT00326911|Growth Substances|growth substances|mesh-ancestor
101773723|NCT00326911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773724|NCT00326911|Growth Inhibitors|growth inhibitors|mesh-ancestor
101773725|NCT00326911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101773726|NCT00326911|Antimetabolites|antimetabolites|mesh-ancestor
101773727|NCT00326911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773728|NCT00791622|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101773729|NCT00791622|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101773730|NCT00791622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101773731|NCT00791622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101773732|NCT00791622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773733|NCT00791622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101773734|NCT00791622|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101773735|NCT00791622|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101773736|NCT00791622|Serotonin Agents|serotonin agents|mesh-ancestor
101773737|NCT00791622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101773738|NCT00791622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773739|NCT00791622|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101773740|NCT00791622|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101773741|NCT00791622|Dopamine Agents|dopamine agents|mesh-ancestor
101773742|NCT00747110|Budesonide|budesonide|mesh-list
101773743|NCT00747110|Mesalamine|mesalamine|mesh-list
101773744|NCT00747110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101773745|NCT00747110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101773746|NCT00747110|Autonomic Agents|autonomic agents|mesh-ancestor
101773747|NCT00747110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101773758|NCT00747110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101773759|NCT00796458|Docetaxel|docetaxel|mesh-list
101773760|NCT00796458|Hormones|hormones|mesh-list
101773761|NCT00796458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101773762|NCT00796458|Tubulin Modulators|tubulin modulators|mesh-ancestor
101565868|NCT01125189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101565869|NCT01125189|Antiviral Agents|antiviral agents|mesh-ancestor
101565870|NCT01125189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101565871|NCT01125189|Antimetabolites|antimetabolites|mesh-ancestor
101565872|NCT01125189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565873|NCT01125189|Immunologic Factors|immunologic factors|mesh-ancestor
101565874|NCT01125189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565875|NCT01256567|Docetaxel|docetaxel|mesh-list
101565876|NCT01256567|Ramucirumab|ramucirumab|mesh-list
101565877|NCT01256567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101565878|NCT01256567|Tubulin Modulators|tubulin modulators|mesh-ancestor
101565879|NCT01256567|Antimitotic Agents|antimitotic agents|mesh-ancestor
101565880|NCT01256567|Mitosis Modulators|mitosis modulators|mesh-ancestor
101565881|NCT01256567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565882|NCT00996736|Voriconazole|voriconazole|mesh-list
101565883|NCT00996736|Natamycin|natamycin|mesh-list
101503109|NCT04513860|Cenobamate|cenobamate|mesh-list
101414082|NCT00145236|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101773763|NCT00796458|Antimitotic Agents|antimitotic agents|mesh-ancestor
101773764|NCT00796458|Mitosis Modulators|mitosis modulators|mesh-ancestor
101773765|NCT00796458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773766|NCT00796458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101773767|NCT00796458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773769|NCT04046016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101773770|NCT04046016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101773771|NCT04046016|Tubulin Modulators|tubulin modulators|mesh-ancestor
101773772|NCT04046016|Antimitotic Agents|antimitotic agents|mesh-ancestor
101773773|NCT04046016|Mitosis Modulators|mitosis modulators|mesh-ancestor
101773774|NCT04046016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773775|NCT01057615|Ascorbic Acid|ascorbic acid|mesh-list
101773776|NCT01057615|Vitamins|vitamins|mesh-ancestor
101773777|NCT01057615|Micronutrients|micronutrients|mesh-ancestor
101773778|NCT01057615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773779|NCT01057615|Antioxidants|antioxidants|mesh-ancestor
101431192|NCT02932774|Cetirizine|cetirizine|mesh-list
101773780|NCT01057615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773781|NCT01057615|Protective Agents|protective agents|mesh-ancestor
101773782|NCT00788424|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
101773783|NCT00788424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101773784|NCT00788424|Immunologic Factors|immunologic factors|mesh-ancestor
101773785|NCT00788424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773786|NCT00788424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101773787|NCT00788424|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101773788|NCT00788424|Protective Agents|protective agents|mesh-ancestor
101773789|NCT00788424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101773790|NCT00788424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101773791|NCT00788424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101773792|NCT00788424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773793|NCT00788424|Antiviral Agents|antiviral agents|mesh-ancestor
101773794|NCT00788424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101773795|NCT00791856|Methyltestosterone|methyltestosterone|mesh-list
101773796|NCT00791856|Testosterone|testosterone|mesh-list
101773797|NCT00791856|Testosterone undecanoate|testosterone undecanoate|mesh-list
101773798|NCT00791856|Testosterone enanthate|testosterone enanthate|mesh-list
101773799|NCT00791856|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101565884|NCT00996736|Antifungal Agents|antifungal agents|mesh-ancestor
101565885|NCT00996736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101565886|NCT00996736|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101565887|NCT00996736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101565888|NCT00996736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101565889|NCT00996736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565890|NCT00996736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101565891|NCT00996736|Hormone Antagonists|hormone antagonists|mesh-ancestor
101565892|NCT00996736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101565893|NCT00996736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565894|NCT00996736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101565895|NCT00996736|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101565896|NCT00996736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101565897|NCT00996658|Linagliptin|linagliptin|mesh-list
101565898|NCT00996658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101565899|NCT00996658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565900|NCT00996658|Incretins|incretins|mesh-ancestor
101565901|NCT00996658|Hormones|hormones|mesh-ancestor
101414097|NCT00488995|Tremelimumab|tremelimumab|mesh-list
101773800|NCT00791856|Androgens|androgens|mesh-ancestor
101773801|NCT00791856|Hormones|hormones|mesh-ancestor
101773802|NCT00791856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101773803|NCT00791856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773804|NCT00791856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101773805|NCT00791856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101773806|NCT00791856|Anabolic Agents|anabolic agents|mesh-ancestor
101773807|NCT00796692|Heparin|heparin|mesh-list
101773808|NCT00796692|Calcium heparin|calcium heparin|mesh-list
101773809|NCT00796692|Nadroparin|nadroparin|mesh-list
101773810|NCT00796692|Anticoagulants|anticoagulants|mesh-ancestor
101773811|NCT00796692|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101773819|NCT00788580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101773820|NCT00788580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101773821|NCT00788580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773822|NCT00788580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101773823|NCT00788580|Immunologic Factors|immunologic factors|mesh-ancestor
101773824|NCT00788580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773825|NCT00788580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101773826|NCT00788580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101773827|NCT00788580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101773828|NCT00788580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101773829|NCT00788580|Antifungal Agents|antifungal agents|mesh-ancestor
101773831|NCT00792012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101773832|NCT00792012|Alkylating Agents|alkylating agents|mesh-ancestor
101773833|NCT00792012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773834|NCT00792012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101773835|NCT00990418|Fentanyl|fentanyl|mesh-list
101773836|NCT00990418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101773837|NCT00990418|Narcotics|narcotics|mesh-ancestor
101773838|NCT00990418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101773839|NCT00990418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773840|NCT00990418|Analgesics|analgesics|mesh-ancestor
101773841|NCT00990418|Sensory System Agents|sensory system agents|mesh-ancestor
101773842|NCT00990418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101565902|NCT00996658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101565903|NCT00996658|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101565904|NCT00996658|Protease Inhibitors|protease inhibitors|mesh-ancestor
101565905|NCT00996658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101565906|NCT00996658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565908|NCT04310631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101565909|NCT04310631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101565910|NCT04310631|Growth Substances|growth substances|mesh-ancestor
101565911|NCT04310631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565912|NCT04310631|Growth Inhibitors|growth inhibitors|mesh-ancestor
101320646|NCT00277108|Escitalopram|escitalopram|mesh-list
101565913|NCT04310631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101565914|NCT01256411|Amlodipine|amlodipine|mesh-list
101773843|NCT00990418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101773844|NCT00990418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101773845|NCT00990418|Anesthetics, General|anesthetics, general|mesh-ancestor
101773846|NCT00990418|Anesthetics|anesthetics|mesh-ancestor
101773847|NCT02562950|Midazolam|midazolam|mesh-list
101773848|NCT02562950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101773849|NCT02562950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101773850|NCT02562950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101773851|NCT02562950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773852|NCT02562950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101773853|NCT02562950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101773854|NCT02562950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101773855|NCT02562950|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101773856|NCT02562950|Anesthetics, General|anesthetics, general|mesh-ancestor
101773857|NCT02562950|Anesthetics|anesthetics|mesh-ancestor
101773858|NCT02562950|GABA Modulators|gaba modulators|mesh-ancestor
101773859|NCT02562950|GABA Agents|gaba agents|mesh-ancestor
101773860|NCT02562950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101773861|NCT02562950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773862|NCT00792168|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101773863|NCT00792168|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101773864|NCT00792168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101773865|NCT00792168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101773866|NCT00792168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773867|NCT00792168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101773868|NCT00792168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773869|NCT00792168|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101773870|NCT00792168|Antidepressive Agents|antidepressive agents|mesh-ancestor
101773871|NCT00792168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101773872|NCT00687440|Docetaxel|docetaxel|mesh-list
101773873|NCT00687440|Doxorubicin|doxorubicin|mesh-list
101773874|NCT00687440|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101773875|NCT00687440|Trastuzumab|trastuzumab|mesh-list
101773876|NCT00687440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101773877|NCT00687440|Tubulin Modulators|tubulin modulators|mesh-ancestor
101773878|NCT00687440|Antimitotic Agents|antimitotic agents|mesh-ancestor
101773890|NCT02554734|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101773891|NCT02554734|Dopamine Agents|dopamine agents|mesh-ancestor
101773892|NCT02554734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101773893|NCT02554734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773894|NCT02554734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773895|NCT02554734|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101773896|NCT02554734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101773897|NCT02554734|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101773898|NCT00990496|Cyclophosphamide|cyclophosphamide|mesh-list
101773899|NCT00990496|Fludarabine|fludarabine|mesh-list
101565916|NCT01256411|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101565917|NCT01256411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101565918|NCT01256411|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101414131|NCT00145314|Leucovorin|leucovorin|mesh-list
101773900|NCT00990496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101773901|NCT00990496|Immunologic Factors|immunologic factors|mesh-ancestor
101773902|NCT00990496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773903|NCT00990496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101773904|NCT00990496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101773905|NCT00990496|Alkylating Agents|alkylating agents|mesh-ancestor
101773906|NCT00990496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773907|NCT00990496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101773908|NCT00990496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101773909|NCT00754910|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
101773910|NCT00754910|Trioxsalen|trioxsalen|mesh-list
101773911|NCT00754910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101773912|NCT00754910|Dermatologic Agents|dermatologic agents|mesh-ancestor
101773913|NCT00754910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101773914|NCT00755066|Fluticasone|fluticasone|mesh-list
101773915|NCT00755066|Xhance|xhance|mesh-list
101773916|NCT00755066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101773917|NCT00755066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101773918|NCT00755066|Autonomic Agents|autonomic agents|mesh-ancestor
101773919|NCT00755066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101773920|NCT00755066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773921|NCT00755066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101773922|NCT00755066|Respiratory System Agents|respiratory system agents|mesh-ancestor
101773923|NCT00755066|Dermatologic Agents|dermatologic agents|mesh-ancestor
101773924|NCT00755066|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101773925|NCT00990574|Anesthetics|anesthetics|mesh-list
101773926|NCT00990574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101773927|NCT00990574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431347|NCT02924857|Paclitaxel|paclitaxel|mesh-list
101773928|NCT00659490|Naproxen|naproxen|mesh-list
101773929|NCT00659490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101773930|NCT00659490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101773931|NCT00659490|Analgesics|analgesics|mesh-ancestor
101773932|NCT00659490|Sensory System Agents|sensory system agents|mesh-ancestor
101773933|NCT00659490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101773934|NCT00659490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773935|NCT00659490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101773936|NCT00659490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101773937|NCT00659490|Gout Suppressants|gout suppressants|mesh-ancestor
101773938|NCT00659490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101773939|NCT00659490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101773940|NCT00659490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773941|NCT00792246|Voriconazole|voriconazole|mesh-list
101773951|NCT00792246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773952|NCT00792246|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101773954|NCT00539500|Etoposide|etoposide|mesh-list
101773955|NCT00539500|Melphalan|melphalan|mesh-list
101773956|NCT00539500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101773957|NCT00539500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101773958|NCT00539500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101773959|NCT00539500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101773960|NCT00539500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101773961|NCT00539500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773962|NCT00539500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101773963|NCT00539500|Alkylating Agents|alkylating agents|mesh-ancestor
101773964|NCT00539500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101773965|NCT00539500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101773966|NCT00539500|Immunologic Factors|immunologic factors|mesh-ancestor
101773967|NCT00539500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773968|NCT00662532|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101773969|NCT00662532|Minocycline|minocycline|mesh-list
101773970|NCT00662532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101773971|NCT00792324|Efavirenz|efavirenz|mesh-list
101773972|NCT00792324|Etravirine|etravirine|mesh-list
101773973|NCT00792324|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101565919|NCT01256411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101565920|NCT01256411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565921|NCT01256411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101565922|NCT01256411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565923|NCT01256411|Vasodilator Agents|vasodilator agents|mesh-ancestor
101565924|NCT01256411|Diuretics|diuretics|mesh-ancestor
101565925|NCT01256411|Natriuretic Agents|natriuretic agents|mesh-ancestor
101565926|NCT01256411|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101565927|NCT01256411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101565928|NCT00996580|Levonorgestrel|levonorgestrel|mesh-list
101527874|NCT00560586|Glucocorticoids|glucocorticoids|mesh-ancestor
101414135|NCT00145314|Cetuximab|cetuximab|mesh-list
101414136|NCT00145314|Levoleucovorin|levoleucovorin|mesh-list
101773974|NCT00792324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101773975|NCT00792324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101773976|NCT00792324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773977|NCT00792324|Antiviral Agents|antiviral agents|mesh-ancestor
101773978|NCT00792324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101773979|NCT00792324|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101773980|NCT00792324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101263979|NCT01765010|Cholecalciferol|cholecalciferol|mesh-list
101773982|NCT00792324|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101773983|NCT00792324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101773984|NCT00792324|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101773985|NCT00990808|Atorvastatin|atorvastatin|mesh-list
101773986|NCT00990808|Anacetrapib|anacetrapib|mesh-list
101773987|NCT00990808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101773988|NCT00990808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101773989|NCT00990808|Antimetabolites|antimetabolites|mesh-ancestor
101773990|NCT00990808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773991|NCT00990808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101773992|NCT00990808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101773993|NCT00990808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101773994|NCT00797160|Propofol|propofol|mesh-list
101773995|NCT00797160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101773996|NCT00797160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101773997|NCT00797160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773998|NCT00797160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101773999|NCT00797160|Anesthetics, General|anesthetics, general|mesh-ancestor
101774000|NCT00797160|Anesthetics|anesthetics|mesh-ancestor
101774001|NCT00682448|Metformin|metformin|mesh-list
101774002|NCT00682448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101774003|NCT00682448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774009|NCT04003792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101774010|NCT04003792|Growth Substances|growth substances|mesh-ancestor
101774011|NCT04003792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774012|NCT04003792|Growth Inhibitors|growth inhibitors|mesh-ancestor
101774013|NCT00990886|Oxybutynin|oxybutynin|mesh-list
101774014|NCT00990886|Parasympatholytics|parasympatholytics|mesh-ancestor
101774015|NCT00990886|Autonomic Agents|autonomic agents|mesh-ancestor
101774016|NCT00990886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101774017|NCT00990886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774018|NCT00990886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101774019|NCT00990886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101774020|NCT00990886|Cholinergic Agents|cholinergic agents|mesh-ancestor
101774021|NCT00990886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101774022|NCT00990886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774023|NCT00990886|Urological Agents|urological agents|mesh-ancestor
101774024|NCT00797394|Saw palmetto extract|saw palmetto extract|mesh-list
101774025|NCT00797394|Urological Agents|urological agents|mesh-ancestor
101565929|NCT00996580|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101565931|NCT00996580|Estrogens|estrogens|mesh-ancestor
101565932|NCT00996580|Hormones|hormones|mesh-ancestor
101565933|NCT00996580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101565934|NCT00996580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565935|NCT00996580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101565936|NCT00996580|Contraceptive Agents|contraceptive agents|mesh-ancestor
101565937|NCT00996580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101414147|NCT00145314|Vitamin B Complex|vitamin b complex|mesh-ancestor
101774026|NCT00681824|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101774027|NCT00681824|Thrombin|thrombin|mesh-list
101774028|NCT00681824|Aprotinin|aprotinin|mesh-list
101774029|NCT00681824|Hemostatics|hemostatics|mesh-ancestor
101774030|NCT00681824|Coagulants|coagulants|mesh-ancestor
101774031|NCT00681824|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101774032|NCT00681824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101774033|NCT00681824|Protease Inhibitors|protease inhibitors|mesh-ancestor
101774034|NCT00681824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101774035|NCT00681824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774036|NCT00797472|Bleomycin|bleomycin|mesh-list
101774037|NCT00797472|Dacarbazine|dacarbazine|mesh-list
101774038|NCT00797472|Vinblastine|vinblastine|mesh-list
101774039|NCT00797472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101774040|NCT00797472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101774041|NCT00797472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774042|NCT00797472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101774043|NCT00797472|Alkylating Agents|alkylating agents|mesh-ancestor
101774044|NCT00797472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101774045|NCT00797472|Tubulin Modulators|tubulin modulators|mesh-ancestor
101774046|NCT00797472|Antimitotic Agents|antimitotic agents|mesh-ancestor
101774047|NCT00797472|Mitosis Modulators|mitosis modulators|mesh-ancestor
101774048|NCT00681668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101774049|NCT00681668|Antidepressive Agents|antidepressive agents|mesh-ancestor
101774050|NCT00681668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101774051|NCT00681668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101774052|NCT00681668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101774053|NCT00681668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101774054|NCT00681668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774055|NCT00539188|Acetylcysteine|acetylcysteine|mesh-list
101774056|NCT00539188|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101774057|NCT00539188|Antiviral Agents|antiviral agents|mesh-ancestor
101774058|NCT00539188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101774059|NCT00539188|Expectorants|expectorants|mesh-ancestor
101774060|NCT00539188|Respiratory System Agents|respiratory system agents|mesh-ancestor
101774061|NCT00539188|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101774062|NCT00539188|Antioxidants|antioxidants|mesh-ancestor
101774063|NCT00539188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774064|NCT00539188|Protective Agents|protective agents|mesh-ancestor
101774065|NCT00539188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774066|NCT00539188|Antidotes|antidotes|mesh-ancestor
101774067|NCT00681590|Vitamin D|vitamin d|mesh-list
101774068|NCT00681590|Ergocalciferols|ergocalciferols|mesh-list
101774069|NCT00681590|Cholecalciferol|cholecalciferol|mesh-list
101774070|NCT00681590|Vitamins|vitamins|mesh-list
101774071|NCT00681590|Micronutrients|micronutrients|mesh-ancestor
101774072|NCT00681590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774073|NCT00681590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101774074|NCT00681590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101774075|NCT05359432|Empagliflozin|empagliflozin|mesh-list
101774076|NCT05359432|Vildagliptin|vildagliptin|mesh-list
101774093|NCT00755534|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101774094|NCT00755534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101774095|NCT00755534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101774096|NCT00755534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101774097|NCT00326599|Carboplatin|carboplatin|mesh-list
101774098|NCT00326599|Gemcitabine|gemcitabine|mesh-list
101774099|NCT00326599|Cediranib|cediranib|mesh-list
101774100|NCT00326599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101565939|NCT00996580|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101565940|NCT00996580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101565941|NCT00996580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101565942|NCT01124175|Losartan|losartan|mesh-list
101565943|NCT01124175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101565944|NCT01124175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101565945|NCT01124175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101565946|NCT01124175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101565947|NCT01124175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565948|NCT01256177|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101565949|NCT01256177|Antidepressive Agents|antidepressive agents|mesh-ancestor
101565950|NCT01256177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101565951|NCT01256177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101565952|NCT01256177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101565953|NCT01256177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101565954|NCT01256177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565956|NCT02882451|Bromides|bromides|mesh-list
101565957|NCT02882451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414156|NCT00489229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101774101|NCT00326599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101774102|NCT00326599|Antimetabolites|antimetabolites|mesh-ancestor
101774103|NCT00326599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774104|NCT00326599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101774105|NCT00326599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101774106|NCT05004688|BCG Vaccine|bcg vaccine|mesh-list
101774107|NCT05004688|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101774108|NCT05004688|Immunologic Factors|immunologic factors|mesh-ancestor
101774109|NCT05004688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774110|NCT00750386|Paclitaxel|paclitaxel|mesh-list
101774111|NCT00750386|Carboplatin|carboplatin|mesh-list
101774112|NCT00750386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101774113|NCT00750386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101774114|NCT00750386|Tubulin Modulators|tubulin modulators|mesh-ancestor
101774115|NCT00750386|Antimitotic Agents|antimitotic agents|mesh-ancestor
101774116|NCT00750386|Mitosis Modulators|mitosis modulators|mesh-ancestor
101774117|NCT00750386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774118|NCT00539032|Vaccines|vaccines|mesh-list
101774119|NCT00539032|Immunologic Factors|immunologic factors|mesh-ancestor
101774120|NCT00539032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774122|NCT00685802|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101774123|NCT00685802|Autonomic Agents|autonomic agents|mesh-ancestor
101774124|NCT00685802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101774125|NCT00685802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774126|NCT00685802|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101774127|NCT00685802|Respiratory System Agents|respiratory system agents|mesh-ancestor
101774128|NCT00685802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101774129|NCT00685802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101774130|NCT00685802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774131|NCT00685802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101774132|NCT00685802|Vasodilator Agents|vasodilator agents|mesh-ancestor
101774133|NCT00685802|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101774134|NCT00685802|Protective Agents|protective agents|mesh-ancestor
101565958|NCT02882451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565959|NCT02882451|Anticonvulsants|anticonvulsants|mesh-ancestor
101565960|NCT02882451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101565961|NCT02882451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101565962|NCT02882451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101565963|NCT02882451|Parasympatholytics|parasympatholytics|mesh-ancestor
101565964|NCT02882451|Autonomic Agents|autonomic agents|mesh-ancestor
101565965|NCT02882451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101565966|NCT00999544|Oxycodone|oxycodone|mesh-list
101565967|NCT00999544|Aprepitant|aprepitant|mesh-list
101565968|NCT00999544|Fosaprepitant|fosaprepitant|mesh-list
101565969|NCT00999544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101565970|NCT00999544|Narcotics|narcotics|mesh-ancestor
101565971|NCT00999544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101565972|NCT00999544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101565973|NCT00999544|Analgesics|analgesics|mesh-ancestor
101565974|NCT00999544|Sensory System Agents|sensory system agents|mesh-ancestor
101565975|NCT00999544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101565976|NCT00999544|Antiemetics|antiemetics|mesh-ancestor
101774135|NCT00685802|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101774141|NCT01054651|Praziquantel|praziquantel|mesh-list
101774142|NCT01054651|Antimalarials|antimalarials|mesh-ancestor
101774143|NCT01054651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101774144|NCT01054651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101774145|NCT01054651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101774146|NCT01054651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101774147|NCT01054651|Antiviral Agents|antiviral agents|mesh-ancestor
101774148|NCT01054651|Schistosomicides|schistosomicides|mesh-ancestor
101774149|NCT01054651|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101774150|NCT01054651|Anthelmintics|anthelmintics|mesh-ancestor
101774151|NCT01054651|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101774152|NCT01054651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101774153|NCT01054651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431587|NCT02921269|Antibodies|antibodies|mesh-list
101774154|NCT01054651|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101774155|NCT00792714|Mannitol|mannitol|mesh-list
101774156|NCT00792714|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101774157|NCT00792714|Diuretics|diuretics|mesh-ancestor
101774158|NCT00792714|Natriuretic Agents|natriuretic agents|mesh-ancestor
101774159|NCT00792714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774160|NCT04961554|Anesthetics|anesthetics|mesh-list
101774161|NCT04961554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101774162|NCT04961554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774163|NCT00354601|Docetaxel|docetaxel|mesh-list
101774164|NCT00354601|Capecitabine|capecitabine|mesh-list
101774165|NCT00354601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101774166|NCT00354601|Tubulin Modulators|tubulin modulators|mesh-ancestor
101774167|NCT00354601|Antimitotic Agents|antimitotic agents|mesh-ancestor
101774168|NCT00354601|Mitosis Modulators|mitosis modulators|mesh-ancestor
101774169|NCT00354601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774170|NCT00354601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101774171|NCT00354601|Antimetabolites|antimetabolites|mesh-ancestor
101774172|NCT01563640|Permethrin|permethrin|mesh-list
101774173|NCT01563640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101774174|NCT01563640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774175|NCT00750620|Mirabegron|mirabegron|mesh-list
101774176|NCT00750620|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101565977|NCT00999544|Autonomic Agents|autonomic agents|mesh-ancestor
101565978|NCT00999544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101565979|NCT00999544|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101565980|NCT00999544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101565981|NCT00999544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565982|NCT02869984|Ramosetron|ramosetron|mesh-list
101565983|NCT02869984|Antiemetics|antiemetics|mesh-ancestor
101565984|NCT02869984|Autonomic Agents|autonomic agents|mesh-ancestor
101565985|NCT02869984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101565986|NCT02869984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414195|NCT00489658|Nifurtimox|nifurtimox|mesh-list
101774177|NCT00750620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101774178|NCT00750620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101774179|NCT00750620|Adrenergic Agents|adrenergic agents|mesh-ancestor
101774180|NCT00750620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101774181|NCT00750620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774182|NCT00750620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774183|NCT00750620|Urological Agents|urological agents|mesh-ancestor
101774185|NCT03827473|Prednisone|prednisone|mesh-list
101774186|NCT03827473|Cortisone|cortisone|mesh-list
101774187|NCT03827473|Docetaxel|docetaxel|mesh-list
101774188|NCT03827473|Abiraterone Acetate|abiraterone acetate|mesh-list
101774189|NCT03827473|Methyltestosterone|methyltestosterone|mesh-list
101774190|NCT03827473|Hormones|hormones|mesh-list
101774191|NCT03827473|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101774192|NCT03827473|Androgens|androgens|mesh-list
101774193|NCT03827473|Androgen Antagonists|androgen antagonists|mesh-list
101774194|NCT03827473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101774195|NCT03827473|Tubulin Modulators|tubulin modulators|mesh-ancestor
101774196|NCT03827473|Antimitotic Agents|antimitotic agents|mesh-ancestor
101774197|NCT03827473|Mitosis Modulators|mitosis modulators|mesh-ancestor
101774198|NCT03827473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774199|NCT03827473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101774200|NCT03827473|Glucocorticoids|glucocorticoids|mesh-ancestor
101774201|NCT03827473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101774202|NCT03827473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774203|NCT03827473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101774204|NCT03827473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101774205|NCT03827473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101774206|NCT03827473|Hormone Antagonists|hormone antagonists|mesh-ancestor
101774207|NCT03827473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101774208|NCT03827473|Antioxidants|antioxidants|mesh-ancestor
101774209|NCT03827473|Protective Agents|protective agents|mesh-ancestor
101774243|NCT00800748|Ribavirin|ribavirin|mesh-list
101774244|NCT00800748|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101774245|NCT00800748|Antimetabolites|antimetabolites|mesh-ancestor
101774246|NCT00800748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774247|NCT00800748|Antiviral Agents|antiviral agents|mesh-ancestor
101774248|NCT00800748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101774249|NCT00798252|Paclitaxel|paclitaxel|mesh-list
101774250|NCT00798252|Docetaxel|docetaxel|mesh-list
101774251|NCT00798252|Doxorubicin|doxorubicin|mesh-list
101774252|NCT00798252|Capecitabine|capecitabine|mesh-list
101774258|NCT00798252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774260|NCT00798252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101774261|NCT00798252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101774262|NCT00798252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101774263|NCT00798252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101774264|NCT00798252|Antimetabolites|antimetabolites|mesh-ancestor
101774265|NCT00748046|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
101774266|NCT00748046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101774267|NCT00326209|Mesalamine|mesalamine|mesh-list
101774268|NCT00326209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101774269|NCT00326209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101774270|NCT00326209|Analgesics|analgesics|mesh-ancestor
101774271|NCT00326209|Sensory System Agents|sensory system agents|mesh-ancestor
101565987|NCT02869984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101565988|NCT02869984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101565989|NCT02869984|Serotonin Agents|serotonin agents|mesh-ancestor
101565990|NCT02869984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101565991|NCT02869984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565992|NCT01124097|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
101565993|NCT01124097|Anticonvulsants|anticonvulsants|mesh-ancestor
101565994|NCT01124097|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101565995|NCT01124097|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101565996|NCT01124097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101565997|NCT01124097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101565998|NCT01123395|Colchicine|colchicine|mesh-list
101565999|NCT01123395|Gout Suppressants|gout suppressants|mesh-ancestor
101566000|NCT01123395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101566001|NCT01123395|Tubulin Modulators|tubulin modulators|mesh-ancestor
101566002|NCT01123395|Antimitotic Agents|antimitotic agents|mesh-ancestor
101566003|NCT01123395|Mitosis Modulators|mitosis modulators|mesh-ancestor
101774272|NCT00326209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101774273|NCT00326209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774274|NCT00326209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101774275|NCT00326209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101774276|NCT00537940|Pregabalin|pregabalin|mesh-list
101774277|NCT00537940|Gabapentin|gabapentin|mesh-list
101774278|NCT00537940|Analgesics|analgesics|mesh-ancestor
101774279|NCT00537940|Sensory System Agents|sensory system agents|mesh-ancestor
101774280|NCT00537940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101774281|NCT00537940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774282|NCT00537940|Anticonvulsants|anticonvulsants|mesh-ancestor
101774283|NCT00537940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101774284|NCT00537940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101774285|NCT00537940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774286|NCT00537940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101774287|NCT00537940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101774288|NCT00537940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101774289|NCT00537940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101774290|NCT00537940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101774291|NCT00537940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101774292|NCT00537940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101774293|NCT00537940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101774294|NCT00537940|Antimanic Agents|antimanic agents|mesh-ancestor
101774295|NCT00661362|Metformin|metformin|mesh-list
101774296|NCT00661362|Saxagliptin|saxagliptin|mesh-list
101774297|NCT00661362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101774298|NCT00661362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774299|NCT00661362|Incretins|incretins|mesh-ancestor
101774300|NCT00661362|Hormones|hormones|mesh-ancestor
101774301|NCT00661362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101774302|NCT00661362|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101774303|NCT00661362|Protease Inhibitors|protease inhibitors|mesh-ancestor
101774304|NCT00661362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101774305|NCT00661362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774306|NCT00748202|Complement C1s|complement c1s|mesh-list
101774307|NCT00748202|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
101774308|NCT00748202|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
101774309|NCT00748202|Immunologic Factors|immunologic factors|mesh-ancestor
101774310|NCT00748202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566004|NCT01123395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566005|NCT01123395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566006|NCT01255787|Vortioxetine|vortioxetine|mesh-list
101566007|NCT01255787|Antidepressive Agents|antidepressive agents|mesh-ancestor
101566008|NCT01255787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101566009|NCT01255787|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101414223|NCT00489775|Paroxetine|paroxetine|mesh-list
101774311|NCT00748202|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101774312|NCT00748202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101774313|NCT00325897|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101774314|NCT00325897|Azithromycin|azithromycin|mesh-list
101774315|NCT00325897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101774316|NCT00800826|Dexmedetomidine|dexmedetomidine|mesh-list
101774317|NCT00800826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101774318|NCT00800826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101774319|NCT00800826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774320|NCT00800826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101774325|NCT00800826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101774327|NCT00800826|Adrenergic Agents|adrenergic agents|mesh-ancestor
101774328|NCT00800826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101774329|NCT00800826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774330|NCT03989089|Pembrolizumab|pembrolizumab|mesh-list
101774331|NCT03989089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101774332|NCT03989089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101774333|NCT03989089|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101774334|NCT03989089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774335|NCT00793338|Sildenafil Citrate|sildenafil citrate|mesh-list
101774336|NCT00793338|Vasodilator Agents|vasodilator agents|mesh-ancestor
101774337|NCT00793338|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101774338|NCT00793338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101774339|NCT00793338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101774340|NCT00793338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774341|NCT00793338|Urological Agents|urological agents|mesh-ancestor
101774342|NCT05406856|Cisplatin|cisplatin|mesh-list
101774343|NCT05406856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101774344|NCT00344773|Gefitinib|gefitinib|mesh-list
101774345|NCT00344773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101774346|NCT00344773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101774347|NCT00344773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101774348|NCT00344773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774349|NCT02554344|Curcumin|curcumin|mesh-list
101774350|NCT02554344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101774351|NCT02554344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101774352|NCT02554344|Analgesics|analgesics|mesh-ancestor
101774353|NCT02554344|Sensory System Agents|sensory system agents|mesh-ancestor
101774354|NCT02554344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101774355|NCT02554344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774356|NCT02554344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101774357|NCT02554344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101774358|NCT02554344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101774359|NCT02554344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101774360|NCT02554344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774361|NCT01055041|Budesonide|budesonide|mesh-list
101774362|NCT01055041|Doxofylline|doxofylline|mesh-list
101774363|NCT01055041|Montelukast|montelukast|mesh-list
101774364|NCT01055041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101774365|NCT01055041|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101774366|NCT01055041|Autonomic Agents|autonomic agents|mesh-ancestor
101774367|NCT01055041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101774368|NCT01055041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774369|NCT01055041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101774370|NCT01055041|Respiratory System Agents|respiratory system agents|mesh-ancestor
101774371|NCT01055041|Glucocorticoids|glucocorticoids|mesh-ancestor
101774372|NCT01055041|Hormones|hormones|mesh-ancestor
101774373|NCT01055041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101774374|NCT01055041|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101774375|NCT01055041|Hormone Antagonists|hormone antagonists|mesh-ancestor
101566010|NCT01255787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101566011|NCT01255787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101566012|NCT01255787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566013|NCT01255787|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101566014|NCT01255787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101566015|NCT01255787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101774376|NCT01055041|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101774377|NCT01055041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101774378|NCT01055041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774379|NCT01055041|Antitussive Agents|antitussive agents|mesh-ancestor
101774380|NCT01055041|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101774381|NCT01055041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101774382|NCT00325819|Acetaminophen|acetaminophen|mesh-list
101774383|NCT00325819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101774384|NCT00325819|Analgesics|analgesics|mesh-ancestor
101774385|NCT00325819|Sensory System Agents|sensory system agents|mesh-ancestor
101774386|NCT00325819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101774387|NCT00325819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774388|NCT00325819|Antipyretics|antipyretics|mesh-ancestor
101774389|NCT00748358|Sunitinib|sunitinib|mesh-list
101774390|NCT00748358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101774391|NCT00748358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101774395|NCT00748358|Growth Inhibitors|growth inhibitors|mesh-ancestor
101774396|NCT00748358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101774397|NCT00748358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101774398|NCT00748358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774400|NCT00748436|Vasodilator Agents|vasodilator agents|mesh-ancestor
101774401|NCT00748436|Histamine Agonists|histamine agonists|mesh-ancestor
101774402|NCT00748436|Histamine Agents|histamine agents|mesh-ancestor
101774403|NCT00748436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101774404|NCT00748436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320744|NCT00276757|Antidotes|antidotes|mesh-ancestor
101774405|NCT00748436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774406|NCT00756860|Sevelamer|sevelamer|mesh-list
101774407|NCT00756860|Chelating Agents|chelating agents|mesh-ancestor
101774408|NCT00756860|Sequestering Agents|sequestering agents|mesh-ancestor
101774409|NCT00756860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774410|NCT00757016|Triamcinolone|triamcinolone|mesh-list
101774411|NCT00757016|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101774412|NCT00757016|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101774413|NCT00757016|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101774414|NCT00757016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101774415|NCT00757016|Glucocorticoids|glucocorticoids|mesh-ancestor
101774416|NCT00757016|Hormones|hormones|mesh-ancestor
101774417|NCT00757016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101774418|NCT00757016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774419|NCT00757016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101774420|NCT00757016|Immunologic Factors|immunologic factors|mesh-ancestor
101774421|NCT00757016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101774422|NCT00757016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774423|NCT00687362|Infliximab|infliximab|mesh-list
101774424|NCT00687362|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101774425|NCT00687362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101774426|NCT00687362|Dermatologic Agents|dermatologic agents|mesh-ancestor
101774427|NCT00687362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101774428|NCT00687362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101774429|NCT00757250|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
101774430|NCT00757250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101774431|NCT00757250|Vasodilator Agents|vasodilator agents|mesh-ancestor
101774432|NCT00751478|Naltrexone|naltrexone|mesh-list
101774433|NCT00751478|Morphine|morphine|mesh-list
101774434|NCT00751478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101774435|NCT00751478|Narcotics|narcotics|mesh-ancestor
101774436|NCT00751478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101774437|NCT00751478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774438|NCT00751478|Analgesics|analgesics|mesh-ancestor
101774439|NCT00751478|Sensory System Agents|sensory system agents|mesh-ancestor
101566016|NCT01255787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566017|NCT01255787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101566018|NCT01255787|Serotonin Agents|serotonin agents|mesh-ancestor
101566019|NCT01255787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101566020|NCT01255787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101566021|NCT01255787|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101774440|NCT00751478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101774441|NCT00751478|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101774442|NCT00751478|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101774443|NCT00751556|Naproxen|naproxen|mesh-list
101774444|NCT00751556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101774445|NCT00751556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101774446|NCT00751556|Analgesics|analgesics|mesh-ancestor
101774447|NCT00751556|Sensory System Agents|sensory system agents|mesh-ancestor
101774448|NCT00751556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101774449|NCT00751556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774450|NCT00751556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101774451|NCT00751556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101774452|NCT00751556|Gout Suppressants|gout suppressants|mesh-ancestor
101774453|NCT00751556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101774454|NCT00751556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101774455|NCT00751556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774456|NCT00685334|Olanzapine|olanzapine|mesh-list
101774457|NCT00685334|Aripiprazole|aripiprazole|mesh-list
101774458|NCT00685334|Antiemetics|antiemetics|mesh-ancestor
101774459|NCT00685334|Autonomic Agents|autonomic agents|mesh-ancestor
101774460|NCT00685334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101774461|NCT00685334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774462|NCT00685334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101774463|NCT00685334|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101774468|NCT00685334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101774469|NCT00685334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101774470|NCT00685334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774471|NCT00685334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101774473|NCT00685334|Antidepressive Agents|antidepressive agents|mesh-ancestor
101774474|NCT00685334|Dopamine Agonists|dopamine agonists|mesh-ancestor
101774475|NCT00685334|Dopamine Agents|dopamine agents|mesh-ancestor
101774476|NCT00685334|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101774477|NCT00685334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101774478|NCT00685334|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101774479|NCT00685334|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101774480|NCT00685334|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101774481|NCT00685334|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101774483|NCT00801294|Afatinib|afatinib|mesh-list
101774484|NCT00801294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101774485|NCT00801294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101774486|NCT00801294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101774487|NCT00801294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774488|NCT04013919|Insulin|insulin|mesh-list
101774489|NCT04013919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101774490|NCT04013919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101774491|NCT04013919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774492|NCT00344461|Tenofovir|tenofovir|mesh-list
101774493|NCT00344461|Nevirapine|nevirapine|mesh-list
101774494|NCT00344461|Antiviral Agents|antiviral agents|mesh-ancestor
101774495|NCT00344461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101774496|NCT00344461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101774497|NCT00344461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101774498|NCT00344461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101774499|NCT00344461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774500|NCT00344461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101774501|NCT00344461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101774502|NCT00344461|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101774503|NCT00344461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101774504|NCT00685178|Topiramate|topiramate|mesh-list
101774505|NCT00685178|Anticonvulsants|anticonvulsants|mesh-ancestor
101566022|NCT01255787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101566024|NCT04540835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101566025|NCT04540835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538225|NCT04562103|Autonomic Agents|autonomic agents|mesh-ancestor
101774506|NCT00685178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101774507|NCT00685178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774508|NCT00537394|Raltegravir Potassium|raltegravir potassium|mesh-list
101774509|NCT00537394|Maraviroc|maraviroc|mesh-list
101774510|NCT00537394|Darunavir|darunavir|mesh-list
101774511|NCT00537394|Tipranavir|tipranavir|mesh-list
101774512|NCT00537394|Enfuvirtide|enfuvirtide|mesh-list
101774513|NCT00537394|Etravirine|etravirine|mesh-list
101774514|NCT00537394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101774515|NCT00537394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101774516|NCT00537394|Antiviral Agents|antiviral agents|mesh-ancestor
101774517|NCT00537394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101774518|NCT00537394|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101774519|NCT00537394|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101774520|NCT00537394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101774521|NCT00537394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774522|NCT00537394|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101774523|NCT00537394|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101774524|NCT00537394|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101774525|NCT00537394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101774526|NCT00537394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101774527|NCT00537394|Protease Inhibitors|protease inhibitors|mesh-ancestor
101774528|NCT00537394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101774529|NCT00537394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101774530|NCT00933309|Metformin|metformin|mesh-list
101774531|NCT00933309|Rosiglitazone|rosiglitazone|mesh-list
101774532|NCT00933309|Exemestane|exemestane|mesh-list
101774533|NCT00933309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101774534|NCT00933309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774535|NCT00933309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101774545|NCT00352885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101774546|NCT00352885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101774547|NCT00352885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774548|NCT00352885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101774549|NCT00352885|Serotonin Agents|serotonin agents|mesh-ancestor
101774550|NCT00352885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774551|NCT00933387|Paclitaxel|paclitaxel|mesh-list
101774552|NCT00933387|Cetuximab|cetuximab|mesh-list
101774553|NCT00933387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101774554|NCT00933387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101774555|NCT00933387|Tubulin Modulators|tubulin modulators|mesh-ancestor
101774556|NCT00933387|Antimitotic Agents|antimitotic agents|mesh-ancestor
101774557|NCT00933387|Mitosis Modulators|mitosis modulators|mesh-ancestor
101774558|NCT00933387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774559|NCT00933387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101774560|NCT00660660|Esomeprazole|esomeprazole|mesh-list
101774561|NCT00660660|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101774562|NCT00660660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101774563|NCT00660660|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101774564|NCT00660660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101774565|NCT00660660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774566|NCT02560766|Gabapentin|gabapentin|mesh-list
101774567|NCT02560766|Analgesics|analgesics|mesh-ancestor
101774568|NCT02560766|Sensory System Agents|sensory system agents|mesh-ancestor
101774569|NCT02560766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101774570|NCT02560766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774571|NCT02560766|Anticonvulsants|anticonvulsants|mesh-ancestor
101774572|NCT02560766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101774573|NCT02560766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101774574|NCT02560766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101774575|NCT02560766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101774576|NCT02560766|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101774577|NCT02560766|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101774578|NCT02560766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101774579|NCT02560766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566027|NCT01255163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101566028|NCT01255163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566029|NCT01255163|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101566031|NCT01255163|Hormones|hormones|mesh-ancestor
101566032|NCT01255163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101566033|NCT01123083|Muromonab-CD3|muromonab-cd3|mesh-list
101566034|NCT01123083|Immunologic Factors|immunologic factors|mesh-ancestor
101774580|NCT02560766|Antimanic Agents|antimanic agents|mesh-ancestor
101774581|NCT00933465|Loperamide|loperamide|mesh-list
101774582|NCT00933465|Antidiarrheals|antidiarrheals|mesh-list
101774583|NCT00933465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101774584|NCT00757874|Clobetasol|clobetasol|mesh-list
101774585|NCT00757874|Tacrolimus|tacrolimus|mesh-list
101774586|NCT00757874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101774587|NCT00757874|Immunologic Factors|immunologic factors|mesh-ancestor
101774588|NCT00757874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774589|NCT00757874|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101774590|NCT00757874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101774591|NCT00757874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774592|NCT00757874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101774593|NCT00757874|Glucocorticoids|glucocorticoids|mesh-ancestor
101774594|NCT00757874|Hormones|hormones|mesh-ancestor
101774595|NCT00757874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101774596|NCT00344305|Vaccines|vaccines|mesh-list
101774597|NCT00344305|Immunologic Factors|immunologic factors|mesh-ancestor
101774598|NCT00344305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774599|NCT00933777|Everolimus|everolimus|mesh-list
101774600|NCT00933777|Sorafenib|sorafenib|mesh-list
101774601|NCT00933777|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101774613|NCT00801450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101774614|NCT00801450|Glucocorticoids|glucocorticoids|mesh-ancestor
101774615|NCT00801450|Hormones|hormones|mesh-ancestor
101774616|NCT00801450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101774617|NCT00801450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774618|NCT00801450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101774619|NCT00801450|Immunologic Factors|immunologic factors|mesh-ancestor
101774620|NCT00801450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101774621|NCT00801450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774622|NCT00660816|Docetaxel|docetaxel|mesh-list
101774623|NCT00660816|Pemetrexed|pemetrexed|mesh-list
101774624|NCT00660816|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101774625|NCT00660816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101774626|NCT00660816|Tubulin Modulators|tubulin modulators|mesh-ancestor
101774627|NCT00660816|Antimitotic Agents|antimitotic agents|mesh-ancestor
101774628|NCT00660816|Mitosis Modulators|mitosis modulators|mesh-ancestor
101774629|NCT00660816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774630|NCT00660816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101774631|NCT00660816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101774632|NCT00660816|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101774633|NCT00660816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101774634|NCT00801528|Diclofenac|diclofenac|mesh-list
101774635|NCT00801528|Ropivacaine|ropivacaine|mesh-list
101774636|NCT00801528|Anesthetics, Local|anesthetics, local|mesh-ancestor
101774637|NCT00801528|Anesthetics|anesthetics|mesh-ancestor
101774638|NCT00801528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101774639|NCT00801528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774640|NCT00801528|Sensory System Agents|sensory system agents|mesh-ancestor
101774641|NCT00801528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101774642|NCT00801528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101774643|NCT00801528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101774644|NCT00801528|Analgesics|analgesics|mesh-ancestor
101774645|NCT00801528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101774646|NCT00801528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101774647|NCT00801528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101774648|NCT00801528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101774649|NCT00801528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774650|NCT01060891|Colistin|colistin|mesh-list
101774651|NCT01060891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101774652|NCT01060891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101774653|NCT04003402|Ethanol|ethanol|mesh-list
101566035|NCT01123083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566036|NCT01123083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101566037|NCT02870062|Chlorhexidine|chlorhexidine|mesh-list
101566038|NCT02870062|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101566039|NCT02870062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101566040|NCT02870062|Disinfectants|disinfectants|mesh-ancestor
101566041|NCT01254305|Milnacipran|milnacipran|mesh-list
101566042|NCT01254305|Sertraline|sertraline|mesh-list
101566043|NCT01254305|Fluoxetine|fluoxetine|mesh-list
101414251|NCT00490087|Levonorgestrel|levonorgestrel|mesh-list
101774654|NCT04003402|ASP8062|asp8062|mesh-list
101774655|NCT04003402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101774656|NCT04003402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101774657|NCT04003402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101774658|NCT04003402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774659|NCT04003402|Analgesics|analgesics|mesh-ancestor
101774660|NCT04003402|Sensory System Agents|sensory system agents|mesh-ancestor
101774661|NCT04003402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101774662|NCT04003402|GABA Modulators|gaba modulators|mesh-ancestor
101774663|NCT04003402|GABA Agents|gaba agents|mesh-ancestor
101774668|NCT00576056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101774669|NCT00576056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101774670|NCT00576056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774671|NCT05360602|Thioctic Acid|thioctic acid|mesh-list
101774672|NCT05360602|Antioxidants|antioxidants|mesh-ancestor
101774673|NCT05360602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774674|NCT05360602|Protective Agents|protective agents|mesh-ancestor
101774675|NCT05360602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774676|NCT05360602|Vitamin B Complex|vitamin b complex|mesh-ancestor
101774677|NCT05360602|Vitamins|vitamins|mesh-ancestor
101774678|NCT05360602|Micronutrients|micronutrients|mesh-ancestor
101432094|NCT04686448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774679|NCT00991744|Cytarabine|cytarabine|mesh-list
101774680|NCT00991744|Cortisone|cortisone|mesh-list
101774681|NCT00991744|Prednisolone|prednisolone|mesh-list
101774682|NCT00991744|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101774683|NCT00991744|Methylprednisolone|methylprednisolone|mesh-list
101774684|NCT00991744|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101774685|NCT00991744|Prednisolone acetate|prednisolone acetate|mesh-list
101774686|NCT00991744|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101774687|NCT00991744|Prednisolone phosphate|prednisolone phosphate|mesh-list
101774688|NCT00991744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101774689|NCT00991744|Antimetabolites|antimetabolites|mesh-ancestor
101774690|NCT00991744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774691|NCT00991744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101774692|NCT00991744|Antiviral Agents|antiviral agents|mesh-ancestor
101774693|NCT00991744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101774694|NCT00991744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101774695|NCT00991744|Immunologic Factors|immunologic factors|mesh-ancestor
101774696|NCT00991744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774697|NCT00991744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101774698|NCT00991744|Glucocorticoids|glucocorticoids|mesh-ancestor
101774699|NCT00991744|Hormones|hormones|mesh-ancestor
101774700|NCT00991744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101774701|NCT00991744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101774702|NCT00991744|Antiemetics|antiemetics|mesh-ancestor
101774703|NCT00991744|Autonomic Agents|autonomic agents|mesh-ancestor
101774704|NCT00991744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101774705|NCT00991744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101774706|NCT00991744|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101774707|NCT00991744|Protective Agents|protective agents|mesh-ancestor
101774708|NCT00798876|Vitamin E|vitamin e|mesh-list
101774709|NCT00798876|Vitamins|vitamins|mesh-ancestor
101774710|NCT00798876|Micronutrients|micronutrients|mesh-ancestor
101774711|NCT00798876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774712|NCT00798876|Antioxidants|antioxidants|mesh-ancestor
101774713|NCT00798876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774714|NCT00798876|Protective Agents|protective agents|mesh-ancestor
101774715|NCT00989404|Zanamivir|zanamivir|mesh-list
101566044|NCT01254305|Paroxetine|paroxetine|mesh-list
101566045|NCT01254305|Citalopram|citalopram|mesh-list
101566046|NCT01254305|Levomilnacipran|levomilnacipran|mesh-list
101566047|NCT01254305|Antidepressive Agents|antidepressive agents|mesh-ancestor
101566048|NCT01254305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101566049|NCT01254305|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101566050|NCT01254305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101566051|NCT01254305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101566052|NCT01254305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566053|NCT01254305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101566054|NCT01254305|Serotonin Agents|serotonin agents|mesh-ancestor
101414258|NCT00490087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101774716|NCT00989404|Antiviral Agents|antiviral agents|mesh-ancestor
101774717|NCT00989404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101774718|NCT00989404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101774719|NCT00989404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774720|NCT00758030|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101774721|NCT00758030|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101774722|NCT00758030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101774723|NCT00758030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101774724|NCT00758030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774725|NCT00758030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101774726|NCT00758030|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101774727|NCT00758030|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101774728|NCT00758030|Serotonin Agents|serotonin agents|mesh-ancestor
101774729|NCT00758030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101774730|NCT00758030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774731|NCT00758030|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101774732|NCT00758030|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101774733|NCT00758030|Dopamine Agents|dopamine agents|mesh-ancestor
101774747|NCT00798954|Paclitaxel|paclitaxel|mesh-list
101774748|NCT00798954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101774749|NCT00798954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101774750|NCT00798954|Tubulin Modulators|tubulin modulators|mesh-ancestor
101774751|NCT00798954|Antimitotic Agents|antimitotic agents|mesh-ancestor
101774752|NCT00798954|Mitosis Modulators|mitosis modulators|mesh-ancestor
101774753|NCT00798954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774754|NCT00798954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101432167|NCT02569645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101774755|NCT00798954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101774756|NCT00798954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101774757|NCT00798954|Antifungal Agents|antifungal agents|mesh-ancestor
101774758|NCT00798954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101774759|NCT00798954|Immunologic Factors|immunologic factors|mesh-ancestor
101774760|NCT00798954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774761|NCT00934011|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101774762|NCT00934011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101774763|NCT00934011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101774764|NCT00934011|Antitubercular Agents|antitubercular agents|mesh-ancestor
101774765|NCT00934167|Heparin|heparin|mesh-list
101774766|NCT00934167|Calcium heparin|calcium heparin|mesh-list
101774767|NCT00934167|Anticoagulants|anticoagulants|mesh-ancestor
101774768|NCT00934167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101774769|NCT00934167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101774770|NCT00934167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774771|NCT00801606|Zinc|zinc|mesh-list
101774772|NCT00801606|Trace Elements|trace elements|mesh-list
101774773|NCT00801606|Micronutrients|micronutrients|mesh-list
101774774|NCT00801606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774775|NCT00934245|Vaccines|vaccines|mesh-list
101774776|NCT00934245|Immunologic Factors|immunologic factors|mesh-ancestor
101774777|NCT00934245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774778|NCT02560688|Clopidogrel|clopidogrel|mesh-list
101566055|NCT01254305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566056|NCT01254305|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101566057|NCT01254305|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101566058|NCT01254305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101566059|NCT01254305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101774779|NCT02560688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101774780|NCT02560688|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101774781|NCT02560688|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101774782|NCT02560688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101774783|NCT02560688|Purinergic Agents|purinergic agents|mesh-ancestor
101774784|NCT02560688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101774785|NCT02560688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774786|NCT02560688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774787|NCT00939549|Cyclophosphamide|cyclophosphamide|mesh-list
101774788|NCT00939549|Glatiramer Acetate|glatiramer acetate|mesh-list
101774790|NCT00939549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101774791|NCT00939549|Immunologic Factors|immunologic factors|mesh-ancestor
101774792|NCT00939549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774793|NCT00939549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101774794|NCT00939549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101774799|NCT00939549|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101774800|NCT00934323|Metformin|metformin|mesh-list
101774801|NCT00934323|Glimepiride|glimepiride|mesh-list
101774802|NCT00934323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101774803|NCT00934323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774804|NCT00934323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101774805|NCT00934323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101774806|NCT00934323|Immunologic Factors|immunologic factors|mesh-ancestor
101774807|NCT00575666|Insulin|insulin|mesh-list
101774808|NCT00575666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101774809|NCT00575666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774810|NCT00934479|Lubiprostone|lubiprostone|mesh-list
101774811|NCT00934479|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101774812|NCT00934479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101774813|NCT00934479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774814|NCT00658632|Esomeprazole|esomeprazole|mesh-list
101774815|NCT00658632|Rabeprazole|rabeprazole|mesh-list
101774816|NCT00658632|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101774817|NCT00658632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101774818|NCT00658632|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101774819|NCT00658632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101774820|NCT00658632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774821|NCT00677534|Vitamin D|vitamin d|mesh-list
101774822|NCT00677534|Cholecalciferol|cholecalciferol|mesh-list
101774823|NCT00677534|Ergocalciferols|ergocalciferols|mesh-list
101774824|NCT00677534|Vitamins|vitamins|mesh-ancestor
101774825|NCT00677534|Micronutrients|micronutrients|mesh-ancestor
101774826|NCT00677534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774827|NCT00677534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101774828|NCT00677534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101774829|NCT00989716|Antihypertensive Agents|antihypertensive agents|mesh-list
101774830|NCT00989716|Nitroglycerin|nitroglycerin|mesh-list
101432242|NCT05470972|Ethanol|ethanol|mesh-list
101774831|NCT00989716|Vasodilator Agents|vasodilator agents|mesh-ancestor
101774832|NCT00660348|Morphine|morphine|mesh-list
101774833|NCT00660348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101774834|NCT00660348|Narcotics|narcotics|mesh-ancestor
101774835|NCT00660348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101774836|NCT00660348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774837|NCT00660348|Analgesics|analgesics|mesh-ancestor
101774838|NCT00660348|Sensory System Agents|sensory system agents|mesh-ancestor
101774839|NCT00660348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101774840|NCT03734198|Daratumumab|daratumumab|mesh-list
101774841|NCT03734198|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101774842|NCT03734198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101774843|NCT03734198|Immunologic Factors|immunologic factors|mesh-ancestor
101774844|NCT03734198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774845|NCT01564108|Ranibizumab|ranibizumab|mesh-list
101566060|NCT01254305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101566061|NCT01254305|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101566062|NCT01254305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101566063|NCT01254305|Analgesics|analgesics|mesh-ancestor
101566064|NCT01254305|Sensory System Agents|sensory system agents|mesh-ancestor
101566065|NCT01122927|Aripiprazole|aripiprazole|mesh-list
101774846|NCT01564108|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101774847|NCT01564108|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101774848|NCT01564108|Growth Substances|growth substances|mesh-ancestor
101774849|NCT01564108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774850|NCT01564108|Growth Inhibitors|growth inhibitors|mesh-ancestor
101774851|NCT01564108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101774852|NCT00801918|Cyclophosphamide|cyclophosphamide|mesh-list
101774853|NCT00801918|Ifosfamide|ifosfamide|mesh-list
101774854|NCT00801918|Etoposide|etoposide|mesh-list
101774855|NCT00801918|Denileukin diftitox|denileukin diftitox|mesh-list
101774856|NCT00801918|Interleukin-2|interleukin-2|mesh-list
101774857|NCT00801918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101774858|NCT00801918|Immunologic Factors|immunologic factors|mesh-ancestor
101774859|NCT00801918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774860|NCT00801918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101774861|NCT00801918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101774862|NCT00801918|Alkylating Agents|alkylating agents|mesh-ancestor
101774863|NCT00801918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774864|NCT00801918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101774865|NCT00801918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101774873|NCT00801918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101774875|NCT00799188|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101774876|NCT00799188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101774877|NCT00799188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101774878|NCT00799188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774879|NCT00799188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101774880|NCT00799188|Immunologic Factors|immunologic factors|mesh-ancestor
101774881|NCT00799188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774882|NCT00799188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101774883|NCT00571688|Risperidone|risperidone|mesh-list
101774884|NCT00571688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101774885|NCT00571688|Serotonin Agents|serotonin agents|mesh-ancestor
101774886|NCT00571688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101774887|NCT00571688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774888|NCT00571688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774889|NCT00571688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101774890|NCT00571688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101774891|NCT00571688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101774892|NCT00571688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101774893|NCT00571688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101774894|NCT00571688|Dopamine Agents|dopamine agents|mesh-ancestor
101774895|NCT00799656|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
101774896|NCT00799656|Enzyme Activators|enzyme activators|mesh-ancestor
101774897|NCT00799656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774898|NCT05408104|Tolvaptan|tolvaptan|mesh-list
101774899|NCT05408104|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101774900|NCT05408104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774901|NCT05408104|Natriuretic Agents|natriuretic agents|mesh-ancestor
101774902|NCT05408104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774903|NCT00343291|Paclitaxel|paclitaxel|mesh-list
101774904|NCT00343291|Bevacizumab|bevacizumab|mesh-list
101774905|NCT00343291|Carboplatin|carboplatin|mesh-list
101774907|NCT00343291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101774908|NCT00343291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101774909|NCT00343291|Tubulin Modulators|tubulin modulators|mesh-ancestor
101774910|NCT00343291|Antimitotic Agents|antimitotic agents|mesh-ancestor
101774911|NCT00343291|Mitosis Modulators|mitosis modulators|mesh-ancestor
101774912|NCT00343291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774913|NCT00343291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101566067|NCT01122927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101566068|NCT01122927|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101566069|NCT01122927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101566070|NCT01122927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101566071|NCT01122927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566072|NCT01122927|Dopamine Agonists|dopamine agonists|mesh-ancestor
101566073|NCT01122927|Dopamine Agents|dopamine agents|mesh-ancestor
101566074|NCT01122927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101566075|NCT01122927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528018|NCT00550199|Panobinostat|panobinostat|mesh-list
101566076|NCT01122927|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101566077|NCT01122927|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101774914|NCT00343291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101774915|NCT00343291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101774916|NCT00343291|Growth Substances|growth substances|mesh-ancestor
101774917|NCT00343291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774918|NCT00343291|Growth Inhibitors|growth inhibitors|mesh-ancestor
101774920|NCT05407870|Etomidate|etomidate|mesh-list
101774921|NCT05407870|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101774922|NCT05407870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101774923|NCT05407870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774924|NCT05407870|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101774925|NCT05407870|Anesthetics, General|anesthetics, general|mesh-ancestor
101774926|NCT05407870|Anesthetics|anesthetics|mesh-ancestor
101774927|NCT03988231|Enoxaparin|enoxaparin|mesh-list
101774928|NCT03988231|Anticoagulants|anticoagulants|mesh-ancestor
101774929|NCT03988231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101774930|NCT03988231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101774931|NCT03988231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774932|NCT00658788|Calcitriol|calcitriol|mesh-list
101774933|NCT00658788|Clobetasol|clobetasol|mesh-list
101774938|NCT00658788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774939|NCT00658788|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101774940|NCT00658788|Vitamins|vitamins|mesh-ancestor
101774941|NCT00658788|Micronutrients|micronutrients|mesh-ancestor
101774942|NCT00658788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101774943|NCT00658788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101774944|NCT00658788|Glucocorticoids|glucocorticoids|mesh-ancestor
101774945|NCT00658788|Hormones|hormones|mesh-ancestor
101774946|NCT00658788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101774947|NCT01060969|Acetazolamide|acetazolamide|mesh-list
101774948|NCT01060969|Tadalafil|tadalafil|mesh-list
101774949|NCT01060969|Vasodilator Agents|vasodilator agents|mesh-ancestor
101774950|NCT01060969|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101774951|NCT01060969|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101774952|NCT01060969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101774953|NCT01060969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774954|NCT01060969|Urological Agents|urological agents|mesh-ancestor
101774955|NCT01060969|Anticonvulsants|anticonvulsants|mesh-ancestor
101774956|NCT01060969|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101774957|NCT01060969|Diuretics|diuretics|mesh-ancestor
101774958|NCT01060969|Natriuretic Agents|natriuretic agents|mesh-ancestor
101774959|NCT01060969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774960|NCT05407246|Hemay005|hemay005|mesh-list
101774961|NCT05407246|Dermatologic Agents|dermatologic agents|mesh-ancestor
101774962|NCT05407246|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101774963|NCT05407246|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101774964|NCT05407246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101774965|NCT05407246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774966|NCT00799890|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
101774967|NCT00799890|Antioxidants|antioxidants|mesh-ancestor
101566078|NCT01122927|Serotonin Agents|serotonin agents|mesh-ancestor
101566079|NCT01122927|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101566080|NCT01122927|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101566081|NCT01122927|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101566082|NCT01122927|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101566083|NCT01254227|Deferasirox|deferasirox|mesh-list
101566084|NCT01254227|Deferoxamine|deferoxamine|mesh-list
101566085|NCT01254227|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101774968|NCT00799890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774969|NCT00799890|Protective Agents|protective agents|mesh-ancestor
101774970|NCT00799890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774971|NCT00799890|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101774972|NCT00799890|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101774973|NCT00799890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101774974|NCT00799890|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101774975|NCT00799968|Fibrinolytic Agents|fibrinolytic agents|mesh-list
101774976|NCT00799968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101774977|NCT00799968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774978|NCT05590312|Anesthetics|anesthetics|mesh-list
101774979|NCT05590312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101774980|NCT05590312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774981|NCT00802230|Terbutaline|terbutaline|mesh-list
101774982|NCT00802230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101774983|NCT00802230|Autonomic Agents|autonomic agents|mesh-ancestor
101774984|NCT00802230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101264026|NCT01765374|Rituximab|rituximab|mesh-list
101774985|NCT00802230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774986|NCT00802230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101774987|NCT00802230|Respiratory System Agents|respiratory system agents|mesh-ancestor
101774989|NCT00802230|Tocolytic Agents|tocolytic agents|mesh-ancestor
101774990|NCT00802230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101774991|NCT00802230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101774992|NCT00802230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101774993|NCT00802230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101774994|NCT00802230|Adrenergic Agents|adrenergic agents|mesh-ancestor
101774995|NCT00802230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101774996|NCT00802230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774997|NCT00802308|Morphine|morphine|mesh-list
101774998|NCT00802308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101774999|NCT00802308|Narcotics|narcotics|mesh-ancestor
101775000|NCT00802308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101775001|NCT00802308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775004|NCT00802308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101775006|NCT00562965|Prednisone|prednisone|mesh-list
101775007|NCT00562965|Prednisolone|prednisolone|mesh-list
101775008|NCT00562965|Cyclophosphamide|cyclophosphamide|mesh-list
101775009|NCT00562965|Rituximab|rituximab|mesh-list
101775010|NCT00562965|Fludarabine|fludarabine|mesh-list
101775011|NCT00562965|Vincristine|vincristine|mesh-list
101775012|NCT00562965|Mitoxantrone|mitoxantrone|mesh-list
101775013|NCT00562965|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
101775014|NCT00562965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101775015|NCT00562965|Immunologic Factors|immunologic factors|mesh-ancestor
101775016|NCT00562965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775017|NCT00562965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101775018|NCT00562965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101775019|NCT00562965|Alkylating Agents|alkylating agents|mesh-ancestor
101775020|NCT00562965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775021|NCT00562965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101775022|NCT00562965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101775023|NCT00562965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101775024|NCT00562965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101775025|NCT00562965|Antiemetics|antiemetics|mesh-ancestor
101775026|NCT00562965|Autonomic Agents|autonomic agents|mesh-ancestor
101320873|NCT00276055|Bevacizumab|bevacizumab|mesh-list
101775027|NCT00562965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101775028|NCT00562965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101775029|NCT00562965|Glucocorticoids|glucocorticoids|mesh-ancestor
101566086|NCT01254227|Chelating Agents|chelating agents|mesh-ancestor
101566087|NCT01254227|Sequestering Agents|sequestering agents|mesh-ancestor
101566088|NCT01254227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566089|NCT01254227|Siderophores|siderophores|mesh-ancestor
101566090|NCT04311255|Anesthetics|anesthetics|mesh-list
101566091|NCT04311255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101566092|NCT04311255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566093|NCT01122381|Ethosuximide|ethosuximide|mesh-list
101566094|NCT01122381|Anticonvulsants|anticonvulsants|mesh-ancestor
101566096|NCT00996034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566097|NCT00996034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101566098|NCT00996034|Autonomic Agents|autonomic agents|mesh-ancestor
101566099|NCT00996034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101566100|NCT00996034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101566101|NCT00996034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101566102|NCT00996034|Cholinergic Agents|cholinergic agents|mesh-ancestor
101775030|NCT00562965|Hormones|hormones|mesh-ancestor
101775031|NCT00562965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101775032|NCT00562965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101775033|NCT00562965|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101775034|NCT00562965|Tubulin Modulators|tubulin modulators|mesh-ancestor
101775035|NCT00562965|Antimitotic Agents|antimitotic agents|mesh-ancestor
101775036|NCT00562965|Mitosis Modulators|mitosis modulators|mesh-ancestor
101775037|NCT00562965|Analgesics|analgesics|mesh-ancestor
101775038|NCT00562965|Sensory System Agents|sensory system agents|mesh-ancestor
101775039|NCT00562965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101775040|NCT00562965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101775041|NCT00562965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775042|NCT00562965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101775043|NCT00562965|Immunotoxins|immunotoxins|mesh-ancestor
101775044|NCT00562965|Immunoconjugates|immunoconjugates|mesh-ancestor
101775045|NCT05406934|Infliximab|infliximab|mesh-list
101775046|NCT05406934|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101775047|NCT05406934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101775048|NCT05406934|Dermatologic Agents|dermatologic agents|mesh-ancestor
101775049|NCT05406934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101775050|NCT05406934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101775051|NCT00794898|Infliximab|infliximab|mesh-list
101775052|NCT00794898|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101775053|NCT00794898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101775054|NCT00794898|Dermatologic Agents|dermatologic agents|mesh-ancestor
101775055|NCT00794898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101775056|NCT00794898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101775057|NCT00800280|Cimetidine|cimetidine|mesh-list
101775058|NCT00800280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101775059|NCT00800280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101775060|NCT00800280|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101775061|NCT00800280|Histamine Antagonists|histamine antagonists|mesh-ancestor
101775062|NCT00800280|Histamine Agents|histamine agents|mesh-ancestor
101775063|NCT00800280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101775064|NCT00800280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775065|NCT00800280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775066|NCT00800280|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101775067|NCT00800280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101775068|NCT00800280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775070|NCT00800358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101775071|NCT00800358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775072|NCT00800358|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101775073|NCT00800358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101566103|NCT00996034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101566104|NCT00996034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566106|NCT01121991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101566107|NCT01121991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566109|NCT04292236|Perilla seed oil|perilla seed oil|mesh-list
101566110|NCT04292236|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101566111|NCT04292236|Protective Agents|protective agents|mesh-ancestor
101566112|NCT04292236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566113|NCT04292236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566114|NCT01121913|Trazodone|trazodone|mesh-list
101566115|NCT01121913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101775074|NCT00800358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775075|NCT00800358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101775076|NCT00800358|Vitamins|vitamins|mesh-ancestor
101775078|NCT00800358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101775079|NCT00934713|Montelukast|montelukast|mesh-list
101775080|NCT00934713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101775081|NCT00934713|Respiratory System Agents|respiratory system agents|mesh-ancestor
101775082|NCT00934713|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101775083|NCT00934713|Hormone Antagonists|hormone antagonists|mesh-ancestor
101775084|NCT00934713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101775085|NCT00934713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775086|NCT00934713|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101775087|NCT00934713|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101775088|NCT00934713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775089|NCT01057849|Olanzapine|olanzapine|mesh-list
101775090|NCT01057849|Risperidone|risperidone|mesh-list
101775091|NCT01057849|Aripiprazole|aripiprazole|mesh-list
101775092|NCT01057849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101775093|NCT01057849|Serotonin Agents|serotonin agents|mesh-ancestor
101775094|NCT01057849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101775095|NCT01057849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775096|NCT01057849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775097|NCT01057849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101775098|NCT01057849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101775099|NCT01057849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101775100|NCT01057849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101775101|NCT01057849|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101775102|NCT01057849|Dopamine Agents|dopamine agents|mesh-ancestor
101775103|NCT01057849|Antiemetics|antiemetics|mesh-ancestor
101775104|NCT01057849|Autonomic Agents|autonomic agents|mesh-ancestor
101775105|NCT01057849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101775106|NCT01057849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101775107|NCT01057849|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101775108|NCT01057849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101775109|NCT01057849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101775110|NCT01057849|Antidepressive Agents|antidepressive agents|mesh-ancestor
101775111|NCT01057849|Dopamine Agonists|dopamine agonists|mesh-ancestor
101775112|NCT01057849|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101775113|NCT01057849|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101775114|NCT01057849|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101775115|NCT01057849|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101775116|NCT00794976|Dexamethasone|dexamethasone|mesh-list
101775117|NCT00794976|Dexamethasone acetate|dexamethasone acetate|mesh-list
101775118|NCT00794976|BB 1101|bb 1101|mesh-list
101775119|NCT00794976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101775120|NCT00794976|Antiemetics|antiemetics|mesh-ancestor
101775121|NCT00794976|Autonomic Agents|autonomic agents|mesh-ancestor
101775122|NCT00794976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101566116|NCT01121913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101566117|NCT01121913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101566118|NCT01121913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566119|NCT01121913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101775123|NCT00794976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320900|NCT00275665|Valganciclovir|valganciclovir|mesh-list
101775124|NCT00794976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101775125|NCT00794976|Glucocorticoids|glucocorticoids|mesh-ancestor
101775126|NCT00794976|Hormones|hormones|mesh-ancestor
101775127|NCT00794976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101775128|NCT00794976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101775129|NCT00794976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101775130|NCT00794976|Protease Inhibitors|protease inhibitors|mesh-ancestor
101775131|NCT00794976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775132|NCT00794976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775133|NCT00939939|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101775135|NCT00939939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101775136|NCT00939939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775137|NCT00939939|Incretins|incretins|mesh-ancestor
101775138|NCT00939939|Hormones|hormones|mesh-ancestor
101775139|NCT00939939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101775140|NCT00939939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101775141|NCT00939939|Protease Inhibitors|protease inhibitors|mesh-ancestor
101775142|NCT00939939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775143|NCT00939939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775144|NCT00939939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101775145|NCT00939939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101775146|NCT00939939|Immunologic Factors|immunologic factors|mesh-ancestor
101775147|NCT00537082|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101775148|NCT00537082|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101451771|NCT00203177|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101775170|NCT00324961|Adefovir|adefovir|mesh-list
101775171|NCT00324961|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101775172|NCT00324961|Antiviral Agents|antiviral agents|mesh-ancestor
101775173|NCT00324961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101775174|NCT00324961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101775175|NCT00324961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101775176|NCT00324961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775177|NCT00324961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775178|NCT00935415|Montelukast|montelukast|mesh-list
101775179|NCT00935415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101775180|NCT00935415|Respiratory System Agents|respiratory system agents|mesh-ancestor
101775181|NCT00935415|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101775182|NCT00935415|Hormone Antagonists|hormone antagonists|mesh-ancestor
101775183|NCT00935415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101775184|NCT00935415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775185|NCT00935415|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101775186|NCT00935415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101775187|NCT00935415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775188|NCT00935571|Remifentanil|remifentanil|mesh-list
101775189|NCT00935571|Propofol|propofol|mesh-list
101775190|NCT00935571|Sevoflurane|sevoflurane|mesh-list
101775191|NCT00935571|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101775192|NCT00935571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101775193|NCT00935571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775194|NCT00935571|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101320915|NCT00275548|Ribavirin|ribavirin|mesh-list
101775195|NCT00935571|Anesthetics, General|anesthetics, general|mesh-ancestor
101775196|NCT00935571|Anesthetics|anesthetics|mesh-ancestor
101775197|NCT00935571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101775198|NCT00935571|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101775199|NCT00935571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101775201|NCT00935571|Analgesics|analgesics|mesh-ancestor
101775206|NCT00324649|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101775207|NCT00324649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101775208|NCT00324649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101775209|NCT00324649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775210|NCT00324649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775211|NCT00324649|Antiviral Agents|antiviral agents|mesh-ancestor
101566121|NCT01121913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101566122|NCT01121913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101566123|NCT01121913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566124|NCT01121913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101566125|NCT01121913|Serotonin Agents|serotonin agents|mesh-ancestor
101566126|NCT01121913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101566127|NCT01121913|Antidepressive Agents|antidepressive agents|mesh-ancestor
101566128|NCT04310943|Paclitaxel|paclitaxel|mesh-list
101566129|NCT04310943|Tislelizumab|tislelizumab|mesh-list
101566130|NCT04310943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101566131|NCT04310943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566132|NCT04310943|Tubulin Modulators|tubulin modulators|mesh-ancestor
101566133|NCT04310943|Antimitotic Agents|antimitotic agents|mesh-ancestor
101566134|NCT04310943|Mitosis Modulators|mitosis modulators|mesh-ancestor
101566135|NCT04310943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566136|NCT04310943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101566137|NCT02868814|Pregabalin|pregabalin|mesh-list
101566138|NCT02868814|Analgesics|analgesics|mesh-ancestor
101566139|NCT02868814|Sensory System Agents|sensory system agents|mesh-ancestor
101566140|NCT02868814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101566141|NCT02868814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566142|NCT02868814|Anticonvulsants|anticonvulsants|mesh-ancestor
101566143|NCT02868814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101566144|NCT02868814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101566145|NCT02868814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566146|NCT02868814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101566147|NCT02868814|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101528093|NCT04633746|Growth Inhibitors|growth inhibitors|mesh-ancestor
101775212|NCT00324649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101775213|NCT00324649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101775214|NCT00324649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101775215|NCT00324649|Antimetabolites|antimetabolites|mesh-ancestor
101775217|NCT03743259|Antidotes|antidotes|mesh-ancestor
101775218|NCT03743259|Protective Agents|protective agents|mesh-ancestor
101775219|NCT03743259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775220|NCT03983239|Efavirenz|efavirenz|mesh-list
101775221|NCT03983239|Rifampin|rifampin|mesh-list
101775222|NCT03983239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101775223|NCT03983239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101775224|NCT03983239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775225|NCT03983239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775226|NCT03983239|Antiviral Agents|antiviral agents|mesh-ancestor
101566148|NCT02868814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101566149|NCT02868814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101566150|NCT02868814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101566151|NCT04292314|Hydroxyurea|hydroxyurea|mesh-list
101566152|NCT04292314|Deferoxamine|deferoxamine|mesh-list
101566153|NCT04292314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101775227|NCT03983239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101775228|NCT03983239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101775229|NCT03983239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101775230|NCT03983239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101775231|NCT03983239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101775232|NCT03983239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101775233|NCT03983239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101775234|NCT03983239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101775235|NCT03983239|Antitubercular Agents|antitubercular agents|mesh-ancestor
101775236|NCT03983239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101775237|NCT03983239|Leprostatic Agents|leprostatic agents|mesh-ancestor
101775238|NCT03983239|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101775239|NCT03983239|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101775240|NCT03983239|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101775241|NCT00935805|Insulin|insulin|mesh-list
101775242|NCT00935805|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101775243|NCT00935805|Metformin|metformin|mesh-list
101775244|NCT00935805|Insulin, Isophane|insulin, isophane|mesh-list
101775245|NCT00935805|Isophane Insulin, Human|isophane insulin, human|mesh-list
101775246|NCT00935805|Isophane insulin, beef|isophane insulin, beef|mesh-list
101775247|NCT00935805|Glyburide|glyburide|mesh-list
101775248|NCT00935805|Propranolol|propranolol|mesh-list
101775249|NCT00935805|Amlodipine|amlodipine|mesh-list
101775250|NCT00935805|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101775251|NCT00935805|Captopril|captopril|mesh-list
101775252|NCT00935805|Diuretics|diuretics|mesh-list
101775253|NCT00935805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101775254|NCT00935805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775255|NCT00935805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101775256|NCT00935805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101775257|NCT00935805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101775258|NCT00935805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775259|NCT00935805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101775260|NCT00935805|Vasodilator Agents|vasodilator agents|mesh-ancestor
101775261|NCT00935805|Natriuretic Agents|natriuretic agents|mesh-ancestor
101775262|NCT00935805|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101775263|NCT00935805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101775264|NCT00935805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101775265|NCT00935805|Adrenergic Agents|adrenergic agents|mesh-ancestor
101775266|NCT00935805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101775267|NCT00935805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101775268|NCT00935805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101775269|NCT00935805|Protease Inhibitors|protease inhibitors|mesh-ancestor
101775270|NCT00935805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775271|NCT00935961|Docetaxel|docetaxel|mesh-list
101775272|NCT00935961|Everolimus|everolimus|mesh-list
101575070|NCT01027845|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101575071|NCT01027845|Immunologic Factors|immunologic factors|mesh-ancestor
101575072|NCT01027845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575073|NCT04221919|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101575074|NCT04221919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101575075|NCT04221919|Adrenergic Agents|adrenergic agents|mesh-ancestor
101575076|NCT04221919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101575077|NCT04221919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575078|NCT04221919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575079|NCT04299633|Calcium|calcium|mesh-list
101575080|NCT04299633|Sevelamer|sevelamer|mesh-list
101575081|NCT04299633|Calcium acetate|calcium acetate|mesh-list
101575082|NCT04299633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101575083|NCT04299633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575084|NCT04299633|Chelating Agents|chelating agents|mesh-ancestor
101575085|NCT04299633|Sequestering Agents|sequestering agents|mesh-ancestor
101575086|NCT04299633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566154|NCT04292314|Antisickling Agents|antisickling agents|mesh-ancestor
101566155|NCT04292314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101566156|NCT04292314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320946|NCT02979977|Cetuximab|cetuximab|mesh-list
101566157|NCT04292314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101566158|NCT04292314|Siderophores|siderophores|mesh-ancestor
101566159|NCT04292314|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101566160|NCT04292314|Chelating Agents|chelating agents|mesh-ancestor
101566161|NCT04292314|Sequestering Agents|sequestering agents|mesh-ancestor
101566162|NCT01121757|Lenalidomide|lenalidomide|mesh-list
101566163|NCT01121757|Azacitidine|azacitidine|mesh-list
101566164|NCT01121757|Immunologic Factors|immunologic factors|mesh-ancestor
101566165|NCT01121757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566166|NCT01121757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101566167|NCT01121757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101566168|NCT01121757|Growth Substances|growth substances|mesh-ancestor
101566169|NCT01121757|Growth Inhibitors|growth inhibitors|mesh-ancestor
101566170|NCT01121757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566171|NCT01121757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101566172|NCT01121757|Antimetabolites|antimetabolites|mesh-ancestor
101414363|NCT00490789|Antifungal Agents|antifungal agents|mesh-ancestor
101575087|NCT02695459|Everolimus|everolimus|mesh-list
101575088|NCT02695459|Cisplatin|cisplatin|mesh-list
101575089|NCT02695459|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101575090|NCT02695459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101575091|NCT02695459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101575092|NCT02695459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575093|NCT02695459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101575094|NCT02695459|Immunologic Factors|immunologic factors|mesh-ancestor
101575095|NCT02695459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575096|NCT02695459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101575097|NCT04288713|Eculizumab|eculizumab|mesh-list
101575098|NCT04288713|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101575099|NCT04288713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101575100|NCT04288713|Immunologic Factors|immunologic factors|mesh-ancestor
101575101|NCT04288713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575102|NCT05112991|Lenvatinib|lenvatinib|mesh-list
101575103|NCT05112991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101575104|NCT05112991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101575105|NCT05112991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101575106|NCT05112991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575107|NCT01030341|Insulin|insulin|mesh-list
101575108|NCT01030341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101575109|NCT01030341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101575110|NCT01030341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575111|NCT02750293|Cholecalciferol|cholecalciferol|mesh-list
101575112|NCT02750293|Vitamin D|vitamin d|mesh-list
101575113|NCT02750293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101575114|NCT02750293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575115|NCT02750293|Vitamins|vitamins|mesh-ancestor
101575116|NCT02750293|Micronutrients|micronutrients|mesh-ancestor
101232013|NCT01557257|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101575117|NCT02750293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101575118|NCT04217785|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101575119|NCT04217785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101575121|NCT01026831|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101575122|NCT01026831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101575123|NCT01026831|Adrenergic Agents|adrenergic agents|mesh-ancestor
101566173|NCT01121757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566174|NCT01121757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101566175|NCT04319471|Capecitabine|capecitabine|mesh-list
101566176|NCT04319471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101566177|NCT04319471|Antimetabolites|antimetabolites|mesh-ancestor
101566178|NCT04319471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566179|NCT04319471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566180|NCT02882217|Histamine|histamine|mesh-list
101566181|NCT02882217|Glutarimide|glutarimide|mesh-list
101566182|NCT02882217|Histamine Agonists|histamine agonists|mesh-ancestor
101566183|NCT02882217|Histamine Agents|histamine agents|mesh-ancestor
101566184|NCT02882217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101566185|NCT02882217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414381|NCT00122330|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101575124|NCT01026831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101575125|NCT01026831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575126|NCT01026831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575127|NCT01026831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101575128|NCT01026831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101575129|NCT02750137|Tetracaine|tetracaine|mesh-list
101575133|NCT02750137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575135|NCT02750137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101575137|NCT02760043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101575138|NCT02760043|Antiemetics|antiemetics|mesh-ancestor
101575139|NCT02760043|Autonomic Agents|autonomic agents|mesh-ancestor
101575140|NCT02760043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101575141|NCT02760043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575142|NCT02760043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101575143|NCT02760043|Glucocorticoids|glucocorticoids|mesh-ancestor
101575144|NCT02760043|Hormones|hormones|mesh-ancestor
101575145|NCT02760043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101575146|NCT02760043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101575147|NCT02760043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101575148|NCT02750059|Tenofovir|tenofovir|mesh-list
101575149|NCT02750059|Lamivudine|lamivudine|mesh-list
101575150|NCT02750059|Efavirenz|efavirenz|mesh-list
101575151|NCT02750059|Telmisartan|telmisartan|mesh-list
101575152|NCT02750059|Antiviral Agents|antiviral agents|mesh-ancestor
101575153|NCT02750059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101575154|NCT02750059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101575155|NCT02750059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101575156|NCT02750059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101575157|NCT02750059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575158|NCT02750059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101575159|NCT02750059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101575160|NCT02750059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101575161|NCT02750059|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101575162|NCT02750059|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101575163|NCT02750059|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101575164|NCT02750059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101575165|NCT02750059|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101575166|NCT02750059|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101575167|NCT02750059|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101575168|NCT02750059|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101575169|NCT02749825|Goserelin|goserelin|mesh-list
101575170|NCT02749825|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101575171|NCT02749825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101566186|NCT02882217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566187|NCT02882217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101566188|NCT02882217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101566189|NCT01253135|Petrolatum|petrolatum|mesh-list
101566190|NCT01253135|Emollients|emollients|mesh-ancestor
101566191|NCT01253135|Dermatologic Agents|dermatologic agents|mesh-ancestor
101566192|NCT00993616|Carboplatin|carboplatin|mesh-list
101566193|NCT00993616|Belinostat|belinostat|mesh-list
101566194|NCT00993616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566195|NCT00993616|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101566196|NCT00993616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101566197|NCT00993616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566198|NCT01120899|Minocycline|minocycline|mesh-list
101566199|NCT01120899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101414399|NCT00122486|Tenofovir|tenofovir|mesh-list
101575172|NCT02749825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101575173|NCT02749825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101575174|NCT02749825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575175|NCT02749825|Luteolytic Agents|luteolytic agents|mesh-ancestor
101575176|NCT02749825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101575177|NCT02749825|Contraceptive Agents|contraceptive agents|mesh-ancestor
101575178|NCT02749825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101575179|NCT02759107|Dulaglutide|dulaglutide|mesh-list
101575180|NCT02759107|Tirzepatide|tirzepatide|mesh-list
101575181|NCT02759107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101575182|NCT02759107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575183|NCT02759107|Incretins|incretins|mesh-ancestor
101575184|NCT02759107|Hormones|hormones|mesh-ancestor
101575185|NCT02759107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101575186|NCT02758873|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101575187|NCT02758873|Montelukast|montelukast|mesh-list
101575188|NCT02758873|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101575189|NCT02758873|Autonomic Agents|autonomic agents|mesh-ancestor
101575190|NCT02758873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101575191|NCT02758873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575192|NCT02758873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101575193|NCT02758873|Respiratory System Agents|respiratory system agents|mesh-ancestor
101575194|NCT02758873|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101575195|NCT02758873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101575196|NCT02758873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101575197|NCT02758873|Adrenergic Agents|adrenergic agents|mesh-ancestor
101575198|NCT02758873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101575199|NCT02758873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575200|NCT02758873|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101575231|NCT04359979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101575232|NCT04359979|Adrenergic Agents|adrenergic agents|mesh-ancestor
101575233|NCT04359979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101575234|NCT04359979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575235|NCT04359979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575236|NCT04359979|Urological Agents|urological agents|mesh-ancestor
101575238|NCT04180813|Acarbose|acarbose|mesh-list
101575239|NCT04180813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101451772|NCT00203177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101575245|NCT04180813|Protease Inhibitors|protease inhibitors|mesh-ancestor
101575246|NCT04180813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101575247|NCT04180813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575248|NCT04180813|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101575249|NCT04116775|Pembrolizumab|pembrolizumab|mesh-list
101575250|NCT04116775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101575251|NCT04116775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101575252|NCT04116775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101566200|NCT01120899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101566201|NCT01120275|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
101566202|NCT01120275|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101566203|NCT01120275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101566204|NCT01120275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566205|NCT00991510|Mycophenolic Acid|mycophenolic acid|mesh-list
101575253|NCT04116775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575254|NCT03913741|Tisotumab vedotin|tisotumab vedotin|mesh-list
101575255|NCT03913741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101575256|NCT03913741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101575257|NCT02749123|Lidocaine|lidocaine|mesh-list
101575258|NCT02749123|Menthol|menthol|mesh-list
101575259|NCT02749123|Anesthetics, Local|anesthetics, local|mesh-ancestor
101575260|NCT02749123|Anesthetics|anesthetics|mesh-ancestor
101575261|NCT02749123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101575262|NCT02749123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575263|NCT02749123|Sensory System Agents|sensory system agents|mesh-ancestor
101575264|NCT02749123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101575265|NCT02749123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101575266|NCT02749123|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101575267|NCT02749123|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101575268|NCT02749123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101575269|NCT02749123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575270|NCT02749123|Antipruritics|antipruritics|mesh-ancestor
101575271|NCT02749123|Dermatologic Agents|dermatologic agents|mesh-ancestor
101575272|NCT00635557|Carboplatin|carboplatin|mesh-list
101575273|NCT00635557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101575274|NCT02748265|Epoprostenol|epoprostenol|mesh-list
101575275|NCT02748265|Phenylephrine|phenylephrine|mesh-list
101575276|NCT02748265|Oxymetazoline|oxymetazoline|mesh-list
101575277|NCT02748265|Tezosentan|tezosentan|mesh-list
101575278|NCT02748265|Propofol|propofol|mesh-list
101575279|NCT02748265|Sevoflurane|sevoflurane|mesh-list
101575280|NCT02748265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101575281|NCT02748265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101575282|NCT02748265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575283|NCT02748265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101575284|NCT02748265|Anesthetics, General|anesthetics, general|mesh-ancestor
101575285|NCT02748265|Anesthetics|anesthetics|mesh-ancestor
101575286|NCT02748265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101575287|NCT02748265|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101575288|NCT02748265|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101575289|NCT02748265|Mydriatics|mydriatics|mesh-ancestor
101575290|NCT02748265|Autonomic Agents|autonomic agents|mesh-ancestor
101575291|NCT02748265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101575292|NCT02748265|Sympathomimetics|sympathomimetics|mesh-ancestor
101575293|NCT02748265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101575294|NCT02748265|Nasal Decongestants|nasal decongestants|mesh-ancestor
101575295|NCT02748265|Respiratory System Agents|respiratory system agents|mesh-ancestor
101575296|NCT02748265|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101575297|NCT02748265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101575298|NCT02748265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101575299|NCT02748265|Adrenergic Agents|adrenergic agents|mesh-ancestor
101575300|NCT02748265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101575301|NCT02748265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575302|NCT02748265|Protective Agents|protective agents|mesh-ancestor
101575303|NCT02748265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101575304|NCT02748265|Vasodilator Agents|vasodilator agents|mesh-ancestor
101575305|NCT01015833|Doxorubicin|doxorubicin|mesh-list
101575306|NCT01015833|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101575307|NCT01015833|Sorafenib|sorafenib|mesh-list
101575308|NCT01015833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101575309|NCT01015833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101575324|NCT02695381|Anesthetics|anesthetics|mesh-ancestor
101575325|NCT02695381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101575326|NCT02695381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566206|NCT00991510|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101566207|NCT00991510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566208|NCT00991510|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101566209|NCT00991510|Antitubercular Agents|antitubercular agents|mesh-ancestor
101566210|NCT00991510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101566211|NCT00991510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101566212|NCT00991510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101575327|NCT02695381|Sensory System Agents|sensory system agents|mesh-ancestor
101575328|NCT02695381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101575329|NCT02695381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101575330|NCT02695381|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101575331|NCT02695381|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101575332|NCT02695381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101575333|NCT02695381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575334|NCT02695381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101575335|NCT02695381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101575336|NCT02695381|Analgesics|analgesics|mesh-ancestor
101575337|NCT02695381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101575338|NCT02695381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101575339|NCT02695381|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101232234|NCT01558713|Fentanyl|fentanyl|mesh-list
101575340|NCT02695381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101575341|NCT02695381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101575342|NCT02746783|Vaccines|vaccines|mesh-list
101575343|NCT02746783|Immunologic Factors|immunologic factors|mesh-ancestor
101575344|NCT02746783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575345|NCT02747953|Afatinib|afatinib|mesh-list
101575346|NCT02747953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101575347|NCT02747953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101575348|NCT02747953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101575349|NCT02747953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575350|NCT02735239|Leucovorin|leucovorin|mesh-list
101575352|NCT02735239|Docetaxel|docetaxel|mesh-list
101575353|NCT02735239|Carboplatin|carboplatin|mesh-list
101575354|NCT02735239|Fluorouracil|fluorouracil|mesh-list
101575355|NCT02735239|Capecitabine|capecitabine|mesh-list
101575356|NCT02735239|Oxaliplatin|oxaliplatin|mesh-list
101575357|NCT02735239|Durvalumab|durvalumab|mesh-list
101575358|NCT02735239|Tremelimumab|tremelimumab|mesh-list
101575359|NCT02735239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101575360|NCT02735239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101575361|NCT02735239|Tubulin Modulators|tubulin modulators|mesh-ancestor
101575362|NCT02735239|Antimitotic Agents|antimitotic agents|mesh-ancestor
101575363|NCT02735239|Mitosis Modulators|mitosis modulators|mesh-ancestor
101575364|NCT02735239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575365|NCT02735239|Antimetabolites|antimetabolites|mesh-ancestor
101575366|NCT02735239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101575367|NCT02735239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101575368|NCT02735239|Immunologic Factors|immunologic factors|mesh-ancestor
101575369|NCT02735239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575370|NCT02735239|Antidotes|antidotes|mesh-ancestor
101575375|NCT02735239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101575376|NCT02655523|Dexamethasone|dexamethasone|mesh-list
101575377|NCT02655523|Triamcinolone|triamcinolone|mesh-list
101575378|NCT02655523|Bupivacaine|bupivacaine|mesh-list
101575379|NCT02655523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101575380|NCT02655523|Antiemetics|antiemetics|mesh-ancestor
101575381|NCT02655523|Autonomic Agents|autonomic agents|mesh-ancestor
101575382|NCT02655523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101575383|NCT02655523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575384|NCT02655523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101575385|NCT02655523|Glucocorticoids|glucocorticoids|mesh-ancestor
101575386|NCT02655523|Hormones|hormones|mesh-ancestor
101575387|NCT02655523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101575388|NCT02655523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101575389|NCT02655523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101575390|NCT02655523|Anesthetics, Local|anesthetics, local|mesh-ancestor
101575391|NCT02655523|Anesthetics|anesthetics|mesh-ancestor
101566213|NCT00991510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566214|NCT01119963|Castor Oil|castor oil|mesh-list
101566215|NCT01119963|Progesterone|progesterone|mesh-list
101566216|NCT01119963|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
101566217|NCT01119963|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
101566218|NCT01119963|Progestins|progestins|mesh-ancestor
101566219|NCT01119963|Hormones|hormones|mesh-ancestor
101575392|NCT02655523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101575393|NCT02655523|Sensory System Agents|sensory system agents|mesh-ancestor
101575394|NCT02644291|Mebendazole|mebendazole|mesh-list
101575395|NCT02644291|Piperazine|piperazine|mesh-list
101575396|NCT02644291|Piperazine citrate|piperazine citrate|mesh-list
101575397|NCT02644291|DMP 777|dmp 777|mesh-list
101575398|NCT02644291|Antinematodal Agents|antinematodal agents|mesh-ancestor
101575399|NCT02644291|Anthelmintics|anthelmintics|mesh-ancestor
101575400|NCT02644291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101575401|NCT02644291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101575402|NCT02644291|Tubulin Modulators|tubulin modulators|mesh-ancestor
101575403|NCT02644291|Antimitotic Agents|antimitotic agents|mesh-ancestor
101575404|NCT02644291|Mitosis Modulators|mitosis modulators|mesh-ancestor
101575405|NCT02644291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575406|NCT02644291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101575407|NCT02644291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101575408|NCT01015677|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101575409|NCT01015677|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101575410|NCT01015677|Estradiol|estradiol|mesh-list
101575411|NCT01015677|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101575412|NCT01015677|Estrogens|estrogens|mesh-ancestor
101575413|NCT01015677|Hormones|hormones|mesh-ancestor
101575414|NCT01015677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101575415|NCT01015677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575416|NCT01015677|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101575417|NCT01015677|Contraceptive Agents|contraceptive agents|mesh-ancestor
101575418|NCT01015677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101575419|NCT01015677|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101575420|NCT02281981|Curcumin|curcumin|mesh-list
101575421|NCT02281981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101575422|NCT02281981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101575423|NCT02281981|Analgesics|analgesics|mesh-ancestor
101575424|NCT02281981|Sensory System Agents|sensory system agents|mesh-ancestor
101575425|NCT02281981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101575426|NCT02281981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575427|NCT02281981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101575428|NCT02281981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101575429|NCT02281981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101575430|NCT02281981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101575431|NCT02281981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575432|NCT04297839|Heparin|heparin|mesh-list
101575433|NCT04297839|Calcium heparin|calcium heparin|mesh-list
101575434|NCT04297839|Citric Acid|citric acid|mesh-list
101575435|NCT04297839|Sodium Citrate|sodium citrate|mesh-list
101575436|NCT04297839|Anticoagulants|anticoagulants|mesh-ancestor
101575437|NCT04297839|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101575438|NCT04297839|Chelating Agents|chelating agents|mesh-ancestor
101575439|NCT04297839|Sequestering Agents|sequestering agents|mesh-ancestor
101575440|NCT04297839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575441|NCT04297839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101575442|NCT04297839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101575443|NCT02751151|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101575444|NCT02751151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101575450|NCT04216459|Micronutrients|micronutrients|mesh-ancestor
101575451|NCT04216459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575452|NCT04216459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101575453|NCT04216459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101575454|NCT04216459|Vitamin B Complex|vitamin b complex|mesh-ancestor
101575456|NCT04216771|Idarubicin|idarubicin|mesh-list
101575457|NCT04216771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101575458|NCT04216771|Antimetabolites|antimetabolites|mesh-ancestor
101575459|NCT04216771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575460|NCT04216771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566220|NCT01119963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101566221|NCT01119963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566222|NCT01119963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101566223|NCT01119963|Hormone Antagonists|hormone antagonists|mesh-ancestor
101566224|NCT01119963|Cathartics|cathartics|mesh-ancestor
101566225|NCT01119963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101566226|NCT01252667|Cyclosporine|cyclosporine|mesh-list
101566227|NCT01252667|Mycophenolic Acid|mycophenolic acid|mesh-list
101566228|NCT01252667|Clofarabine|clofarabine|mesh-list
101539237|NCT00556127|Hormones|hormones|mesh-ancestor
101575461|NCT04216771|Antiviral Agents|antiviral agents|mesh-ancestor
101575462|NCT04216771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101575463|NCT04216771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101575464|NCT04216771|Immunologic Factors|immunologic factors|mesh-ancestor
101575465|NCT04216771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575466|NCT04216771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101575467|NCT04216771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101575468|NCT04216771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101575469|NCT04216771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101321001|NCT00390000|Pemetrexed|pemetrexed|mesh-list
101575470|NCT00636259|Bicalutamide|bicalutamide|mesh-list
101575471|NCT00636259|Androgen Antagonists|androgen antagonists|mesh-ancestor
101575472|NCT00636259|Hormone Antagonists|hormone antagonists|mesh-ancestor
101575473|NCT00636259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101575474|NCT00636259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575475|NCT00636259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101575476|NCT02736019|Celecoxib|celecoxib|mesh-list
101575477|NCT02736019|Tramadol|tramadol|mesh-list
101575478|NCT02736019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101575479|NCT02736019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101575480|NCT02736019|Analgesics|analgesics|mesh-ancestor
101575481|NCT02736019|Sensory System Agents|sensory system agents|mesh-ancestor
101575482|NCT02736019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101575483|NCT02736019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575484|NCT02736019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101575485|NCT02736019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101575486|NCT02736019|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101575487|NCT02736019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101575488|NCT02736019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101575489|NCT02736019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575490|NCT02736019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101575491|NCT02736019|Narcotics|narcotics|mesh-ancestor
101575492|NCT02736019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101575493|NCT04284397|Aspirin|aspirin|mesh-list
101575494|NCT04284397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101575495|NCT04284397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101575496|NCT04284397|Analgesics|analgesics|mesh-ancestor
101575497|NCT04284397|Sensory System Agents|sensory system agents|mesh-ancestor
101575498|NCT04284397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101575499|NCT04284397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575500|NCT04284397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101575501|NCT04284397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101264042|NCT01765556|Vemurafenib|vemurafenib|mesh-list
101575502|NCT04284397|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101575503|NCT04284397|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101575504|NCT04284397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575505|NCT04284397|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101575506|NCT04284397|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101575507|NCT04284397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101575508|NCT04284397|Antipyretics|antipyretics|mesh-ancestor
101575509|NCT05595889|Irinotecan|irinotecan|mesh-list
101575510|NCT05595889|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101575511|NCT05595889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101575512|NCT05595889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101575513|NCT05595889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575514|NCT05595889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566229|NCT01252667|Cyclosporins|cyclosporins|mesh-list
101566230|NCT01252667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101566231|NCT01252667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566232|NCT01252667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101566233|NCT01252667|Immunologic Factors|immunologic factors|mesh-ancestor
101566234|NCT01252667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566235|NCT01252667|Antifungal Agents|antifungal agents|mesh-ancestor
101575532|NCT02740933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101575533|NCT02740933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101575534|NCT02739685|Everolimus|everolimus|mesh-list
101575535|NCT02739685|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101575536|NCT02739685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101575537|NCT02739685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101575538|NCT02739685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575539|NCT02739685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101575540|NCT02739685|Immunologic Factors|immunologic factors|mesh-ancestor
101575541|NCT02739685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575542|NCT02739685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101575543|NCT02735317|Vitamin B 12|vitamin b 12|mesh-list
101575544|NCT02735317|Hydroxocobalamin|hydroxocobalamin|mesh-list
101575545|NCT02735317|Gentamicins|gentamicins|mesh-list
101575546|NCT02735317|Dexamethasone|dexamethasone|mesh-list
101575547|NCT02735317|Procaine|procaine|mesh-list
101575548|NCT02735317|Vitamins|vitamins|mesh-ancestor
101575549|NCT02735317|Micronutrients|micronutrients|mesh-ancestor
101575550|NCT02735317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575551|NCT02735317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101575552|NCT02735317|Antiemetics|antiemetics|mesh-ancestor
101575553|NCT02735317|Autonomic Agents|autonomic agents|mesh-ancestor
101575554|NCT02735317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101575555|NCT02735317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101575556|NCT02735317|Glucocorticoids|glucocorticoids|mesh-ancestor
101575557|NCT02735317|Hormones|hormones|mesh-ancestor
101575558|NCT02735317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101575559|NCT02735317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101575560|NCT02735317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101575561|NCT02735317|Vitamin B Complex|vitamin b complex|mesh-ancestor
101575562|NCT02735317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101575563|NCT02735317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101575564|NCT02735317|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101575565|NCT02735317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101575566|NCT02735317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575567|NCT02735317|Hematinics|hematinics|mesh-ancestor
101575568|NCT02735317|Anesthetics, Local|anesthetics, local|mesh-ancestor
101575569|NCT02735317|Anesthetics|anesthetics|mesh-ancestor
101575570|NCT02735317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101575571|NCT02735317|Sensory System Agents|sensory system agents|mesh-ancestor
101575572|NCT02739529|genexol-PM|genexol-pm|mesh-list
101575573|NCT02739529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101575574|NCT02739529|Tubulin Modulators|tubulin modulators|mesh-ancestor
101575575|NCT02739529|Antimitotic Agents|antimitotic agents|mesh-ancestor
101575584|NCT05544721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101575585|NCT02738983|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101575586|NCT02738983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101575587|NCT02738983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101575588|NCT02738983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101575589|NCT02738983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575590|NCT02739061|Fluvoxamine|fluvoxamine|mesh-list
101575592|NCT02739061|Antidepressive Agents|antidepressive agents|mesh-ancestor
101575593|NCT02739061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101575594|NCT02739061|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101575595|NCT02739061|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101575596|NCT02739061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101575597|NCT02739061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575598|NCT02739061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101575599|NCT02739061|Serotonin Agents|serotonin agents|mesh-ancestor
101575600|NCT02739061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575601|NCT02739061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101566236|NCT01252667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101566237|NCT01252667|Dermatologic Agents|dermatologic agents|mesh-ancestor
101566238|NCT01252667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101566239|NCT01252667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101566240|NCT01252667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101566241|NCT01252667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566242|NCT01252667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101566243|NCT01252667|Antitubercular Agents|antitubercular agents|mesh-ancestor
101414447|NCT00491998|Entacapone|entacapone|mesh-list
101575602|NCT02739061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101575603|NCT02739061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101575604|NCT02739061|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101575605|NCT02739061|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101575606|NCT02739061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101575607|NCT02739061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101575608|NCT02739061|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101575609|NCT02745925|Ibuprofen|ibuprofen|mesh-list
101575610|NCT02745925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101575611|NCT02745925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101575612|NCT02745925|Analgesics|analgesics|mesh-ancestor
101575613|NCT02745925|Sensory System Agents|sensory system agents|mesh-ancestor
101575614|NCT02745925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101575615|NCT02745925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575616|NCT02745925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101575617|NCT02745925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101575618|NCT02745925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101575619|NCT02745925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101575620|NCT02745925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575621|NCT04374253|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101575622|NCT04374253|Immunologic Factors|immunologic factors|mesh-ancestor
101575623|NCT04374253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575624|NCT02738905|Rifaximin|rifaximin|mesh-list
101575625|NCT02738905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101575626|NCT02738905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101575627|NCT02738905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101575628|NCT02745691|Gefitinib|gefitinib|mesh-list
101575629|NCT02745691|Crizotinib|crizotinib|mesh-list
101575630|NCT02745691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101575631|NCT02745691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101575632|NCT02745691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101575633|NCT02745691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575634|NCT02745769|Ramucirumab|ramucirumab|mesh-list
101575635|NCT02745769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101575636|NCT02734069|Carboplatin|carboplatin|mesh-list
101575637|NCT02734069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101575638|NCT02737813|Bupivacaine|bupivacaine|mesh-list
101575639|NCT02737813|Anesthetics, Local|anesthetics, local|mesh-ancestor
101575640|NCT02737813|Anesthetics|anesthetics|mesh-ancestor
101575644|NCT02737813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101575645|NCT00636415|Morphine|morphine|mesh-list
101575646|NCT00636415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101575647|NCT00636415|Narcotics|narcotics|mesh-ancestor
101575648|NCT00636415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101575649|NCT00636415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575650|NCT00636415|Analgesics|analgesics|mesh-ancestor
101575651|NCT00636415|Sensory System Agents|sensory system agents|mesh-ancestor
101575652|NCT00636415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101575653|NCT02733835|Remifentanil|remifentanil|mesh-list
101575654|NCT02733835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101575655|NCT02733835|Narcotics|narcotics|mesh-ancestor
101575656|NCT02733835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101575657|NCT02733835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575658|NCT02733835|Analgesics|analgesics|mesh-ancestor
101575659|NCT02733835|Sensory System Agents|sensory system agents|mesh-ancestor
101575660|NCT02733835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101575661|NCT02737423|Vitamin D|vitamin d|mesh-list
101575662|NCT02737423|Cholecalciferol|cholecalciferol|mesh-list
101566244|NCT01252667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101566245|NCT01252667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101566246|NCT01252667|Antimetabolites|antimetabolites|mesh-ancestor
101566248|NCT02868580|Abacavir|abacavir|mesh-list
101566249|NCT02868580|Dolutegravir|dolutegravir|mesh-list
101566250|NCT02868580|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
101566251|NCT02868580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101566252|NCT02868580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101566253|NCT02868580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101566254|NCT02868580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566255|NCT02868580|Antiviral Agents|antiviral agents|mesh-ancestor
101566256|NCT02868580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101566257|NCT02868580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101566258|NCT02868580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101566259|NCT02868580|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101566260|NCT02868580|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101414452|NCT00491998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575663|NCT02737423|Vitamins|vitamins|mesh-ancestor
101575664|NCT02737423|Micronutrients|micronutrients|mesh-ancestor
101575665|NCT02737423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575666|NCT02737423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101575667|NCT02737423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101575668|NCT02733679|Metformin|metformin|mesh-list
101575669|NCT02733679|Pioglitazone|pioglitazone|mesh-list
101575670|NCT02733679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101575671|NCT02733679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575672|NCT03289741|Octreotide|octreotide|mesh-list
101575673|NCT03289741|Lanreotide|lanreotide|mesh-list
101575674|NCT03289741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101575675|NCT03289741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101575676|NCT03289741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101575677|NCT05629429|Olaparib|olaparib|mesh-list
101575678|NCT05629429|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101575679|NCT05629429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101575680|NCT05629429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575681|NCT05629429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101575682|NCT02744131|Metformin|metformin|mesh-list
101575683|NCT02744131|Cyproterone Acetate|cyproterone acetate|mesh-list
101575684|NCT02744131|Contraceptive Agents|contraceptive agents|mesh-list
101575685|NCT02744131|Contraceptives, Oral|contraceptives, oral|mesh-list
101575686|NCT02744131|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
101575687|NCT02744131|Estradiol|estradiol|mesh-list
101575688|NCT02744131|Cyproterone|cyproterone|mesh-list
101575689|NCT02744131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101575690|NCT02744131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575691|NCT02744131|Estrogens|estrogens|mesh-ancestor
101575692|NCT02744131|Hormones|hormones|mesh-ancestor
101575693|NCT02744131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101575694|NCT02744131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101575695|NCT02744131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101575696|NCT02744131|Androgen Antagonists|androgen antagonists|mesh-ancestor
101575697|NCT02744131|Hormone Antagonists|hormone antagonists|mesh-ancestor
101575698|NCT02744131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101575699|NCT02744131|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101575700|NCT03326791|Aspirin|aspirin|mesh-list
101566261|NCT02881749|Mechlorethamine|mechlorethamine|mesh-list
101566262|NCT02881749|Alkylating Agents|alkylating agents|mesh-ancestor
101566263|NCT02881749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566264|NCT02881749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101566265|NCT02881749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566266|NCT01119105|Vancomycin|vancomycin|mesh-list
101566267|NCT01119105|Lefamulin|lefamulin|mesh-list
101566268|NCT01119105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101566269|NCT01119105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101566270|NCT01118949|Lacosamide|lacosamide|mesh-list
101566271|NCT01118949|Anticonvulsants|anticonvulsants|mesh-ancestor
101414469|NCT00492388|Sensory System Agents|sensory system agents|mesh-ancestor
101575701|NCT03326791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101575702|NCT03326791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101575703|NCT03326791|Analgesics|analgesics|mesh-ancestor
101575704|NCT03326791|Sensory System Agents|sensory system agents|mesh-ancestor
101575705|NCT03326791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101575706|NCT03326791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575707|NCT03326791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101575708|NCT03326791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101575709|NCT03326791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101575710|NCT03326791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101575711|NCT03326791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575712|NCT03326791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101575713|NCT03326791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101575730|NCT02743663|Respiratory System Agents|respiratory system agents|mesh-ancestor
101575731|NCT02743663|Tocolytic Agents|tocolytic agents|mesh-ancestor
101575732|NCT02743663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101575733|NCT02743663|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101575734|NCT02743663|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101575735|NCT02743663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101575736|NCT02743663|Adrenergic Agents|adrenergic agents|mesh-ancestor
101575737|NCT02743663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101575738|NCT02743663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575739|NCT02733445|Dasatinib|dasatinib|mesh-list
101575740|NCT02733445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101575741|NCT02733445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101575742|NCT02733445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101575743|NCT02733445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575744|NCT02731105|Clindamycin|clindamycin|mesh-list
101575745|NCT02731105|Clindamycin palmitate|clindamycin palmitate|mesh-list
101575746|NCT02731105|Clindamycin phosphate|clindamycin phosphate|mesh-list
101575747|NCT02731105|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
101575748|NCT02731105|Tretinoin|tretinoin|mesh-list
101575749|NCT02731105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101575750|NCT02731105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101575751|NCT02731105|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101575752|NCT02731105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101575753|NCT02731105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575754|NCT02731105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101575755|NCT02731105|Keratolytic Agents|keratolytic agents|mesh-ancestor
101575756|NCT02731105|Dermatologic Agents|dermatologic agents|mesh-ancestor
101575757|NCT02731105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101575758|NCT02731105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101575759|NCT02731105|Analgesics|analgesics|mesh-ancestor
101575760|NCT02731105|Sensory System Agents|sensory system agents|mesh-ancestor
101575761|NCT02731105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101575762|NCT02731105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575763|NCT02731105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101575764|NCT02731105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101575765|NCT02743429|Dinutuximab|dinutuximab|mesh-list
101575766|NCT02743429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101575767|NCT02730949|Folic Acid|folic acid|mesh-list
101566272|NCT01118949|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101566273|NCT01118949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101566274|NCT01118949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101566275|NCT01118949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575768|NCT02730949|Inositol|inositol|mesh-list
101575769|NCT02730949|Hematinics|hematinics|mesh-ancestor
101575770|NCT02730949|Vitamin B Complex|vitamin b complex|mesh-ancestor
101575771|NCT02730949|Vitamins|vitamins|mesh-ancestor
101575772|NCT02730949|Micronutrients|micronutrients|mesh-ancestor
101575773|NCT02730949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575778|NCT04205929|Sensory System Agents|sensory system agents|mesh-ancestor
101575779|NCT04205929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101575780|NCT04205929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575781|NCT04205929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101575782|NCT04205929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101575783|NCT04205929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101575784|NCT04205929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101575785|NCT04205929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575787|NCT03259867|Tirapazamine|tirapazamine|mesh-list
101575788|NCT03259867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101575789|NCT03259867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101575790|NCT03259867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101575791|NCT03259867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575792|NCT00636493|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
101321049|NCT02453984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101321050|NCT02453984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101575793|NCT00636493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101575794|NCT00636493|Glucocorticoids|glucocorticoids|mesh-ancestor
101232680|NCT04410406|Filaricides|filaricides|mesh-ancestor
101575795|NCT00636493|Hormones|hormones|mesh-ancestor
101575796|NCT00636493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101575797|NCT00636493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575799|NCT02730481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101575800|NCT02730481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101575801|NCT02730481|Tubulin Modulators|tubulin modulators|mesh-ancestor
101575802|NCT02730481|Antimitotic Agents|antimitotic agents|mesh-ancestor
101575803|NCT02730481|Mitosis Modulators|mitosis modulators|mesh-ancestor
101575804|NCT02730481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575805|NCT02730091|Letrozole|letrozole|mesh-list
101575806|NCT02730091|Vinorelbine|vinorelbine|mesh-list
101575807|NCT02730091|Anastrozole|anastrozole|mesh-list
101575808|NCT02730091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101575809|NCT02730091|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101575810|NCT02730091|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101575811|NCT02730091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101575812|NCT02730091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575813|NCT02730091|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101575814|NCT02730091|Hormone Antagonists|hormone antagonists|mesh-ancestor
101575815|NCT02730091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101575816|NCT02730091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575817|NCT02730091|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101575818|NCT02730091|Tubulin Modulators|tubulin modulators|mesh-ancestor
101575819|NCT02730091|Antimitotic Agents|antimitotic agents|mesh-ancestor
101575820|NCT02730091|Mitosis Modulators|mitosis modulators|mesh-ancestor
101575821|NCT02730091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101575822|NCT02742805|Vitamin D|vitamin d|mesh-list
101575823|NCT02742805|Ergocalciferols|ergocalciferols|mesh-list
101575824|NCT02742805|Cholecalciferol|cholecalciferol|mesh-list
101575825|NCT02742805|Vitamins|vitamins|mesh-list
101575826|NCT02742805|Omalizumab|omalizumab|mesh-list
101575827|NCT02742805|Micronutrients|micronutrients|mesh-ancestor
101575828|NCT02742805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575829|NCT02742805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101575830|NCT02742805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101575831|NCT02742805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101575832|NCT02742805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101575833|NCT02742805|Respiratory System Agents|respiratory system agents|mesh-ancestor
101575834|NCT02690389|Flumazenil|flumazenil|mesh-list
101575835|NCT02690389|Antidotes|antidotes|mesh-ancestor
101575836|NCT02690389|Protective Agents|protective agents|mesh-ancestor
101566277|NCT01252355|Interferon-beta|interferon-beta|mesh-list
101566278|NCT01252355|Teriflunomide|teriflunomide|mesh-list
101566279|NCT01252355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566280|NCT01252355|Antiviral Agents|antiviral agents|mesh-ancestor
101566281|NCT01252355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101566282|NCT01252355|Immunologic Factors|immunologic factors|mesh-ancestor
101566283|NCT01252355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566284|NCT01252355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101566285|NCT01252355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101566286|NCT01252355|Analgesics|analgesics|mesh-ancestor
101566287|NCT01252355|Sensory System Agents|sensory system agents|mesh-ancestor
101566288|NCT01252355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101566289|NCT01252355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101566290|NCT01252355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101566291|NCT01252355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101566292|NCT01118325|Clopidogrel|clopidogrel|mesh-list
101566293|NCT01118325|Ticagrelor|ticagrelor|mesh-list
101566294|NCT01118325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101566295|NCT01118325|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101566296|NCT01118325|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101566297|NCT01118325|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101566298|NCT01118325|Purinergic Agents|purinergic agents|mesh-ancestor
101566299|NCT01118325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101566300|NCT01118325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566301|NCT01118325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566302|NCT01117857|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101566303|NCT01117857|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101414486|NCT00492427|Epoetin Alfa|epoetin alfa|mesh-list
101575837|NCT02690389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575838|NCT02690389|GABA Modulators|gaba modulators|mesh-ancestor
101575839|NCT02690389|GABA Agents|gaba agents|mesh-ancestor
101575840|NCT02690389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101575841|NCT02690389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575842|NCT02732197|Thiopental|thiopental|mesh-list
101575843|NCT02732197|Anticonvulsants|anticonvulsants|mesh-ancestor
101575847|NCT02732197|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101575848|NCT02732197|Anesthetics, General|anesthetics, general|mesh-ancestor
101575849|NCT02732197|Anesthetics|anesthetics|mesh-ancestor
101575850|NCT02732197|GABA Modulators|gaba modulators|mesh-ancestor
101575851|NCT02732197|GABA Agents|gaba agents|mesh-ancestor
101575852|NCT02732197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101575853|NCT02732197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575854|NCT02729935|Parecoxib|parecoxib|mesh-list
101575855|NCT02729935|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101575856|NCT02729935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101566304|NCT01117857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101566305|NCT01117857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101566306|NCT01117857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566307|NCT01117857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101566308|NCT01117857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566309|NCT01117857|Analgesics|analgesics|mesh-ancestor
101566310|NCT01117857|Sensory System Agents|sensory system agents|mesh-ancestor
101566311|NCT01117857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101566312|NCT01117857|Antidepressive Agents|antidepressive agents|mesh-ancestor
101575857|NCT02729935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101575858|NCT02729935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575859|NCT02729935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101575860|NCT02729935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101575861|NCT02729935|Analgesics|analgesics|mesh-ancestor
101575862|NCT02729935|Sensory System Agents|sensory system agents|mesh-ancestor
101575863|NCT02729935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101575864|NCT02729935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575865|NCT02729935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101575866|NCT02729935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101575867|NCT02729467|Itraconazole|itraconazole|mesh-list
101575868|NCT02729467|Rifampin|rifampin|mesh-list
101575869|NCT02729467|Antifungal Agents|antifungal agents|mesh-ancestor
101575870|NCT02729467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101575871|NCT02729467|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101575872|NCT02729467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101575873|NCT02729467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101575874|NCT02729467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575875|NCT02729467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101575876|NCT02729467|Hormone Antagonists|hormone antagonists|mesh-ancestor
101321070|NCT04574245|Immunomodulating Agents|immunomodulating agents|mesh-list
101575877|NCT02729467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101575878|NCT02729467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575879|NCT02729467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101575880|NCT02729467|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101575881|NCT02729467|Antitubercular Agents|antitubercular agents|mesh-ancestor
101575882|NCT02729467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101575883|NCT02729467|Leprostatic Agents|leprostatic agents|mesh-ancestor
101575884|NCT02729467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101575885|NCT02729467|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101575886|NCT02729467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101575887|NCT02729467|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101575888|NCT02729467|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101575889|NCT02729467|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101575890|NCT02729467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101575891|NCT02727205|Rotigotine|rotigotine|mesh-list
101575892|NCT02727205|Dopamine Agonists|dopamine agonists|mesh-ancestor
101575893|NCT02727205|Dopamine Agents|dopamine agents|mesh-ancestor
101575894|NCT02727205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101575895|NCT02727205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575896|NCT02727205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575897|NCT02721433|Denosumab|denosumab|mesh-list
101575898|NCT02721433|Zoledronic Acid|zoledronic acid|mesh-list
101575899|NCT02721433|Pamidronate|pamidronate|mesh-list
101575900|NCT02721433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101575901|NCT02721433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575902|NCT02721043|Lenalidomide|lenalidomide|mesh-list
101575903|NCT02721043|Vaccines|vaccines|mesh-list
101575904|NCT02721043|Poly ICLC|poly iclc|mesh-list
101575905|NCT02721043|Immunologic Factors|immunologic factors|mesh-ancestor
101575906|NCT02721043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575907|NCT02721043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101575908|NCT02721043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101575909|NCT02721043|Growth Substances|growth substances|mesh-ancestor
101566313|NCT01117857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101566314|NCT01117857|Dopamine Agents|dopamine agents|mesh-ancestor
101566315|NCT00991276|Pregabalin|pregabalin|mesh-list
101566316|NCT00991276|Pramipexole|pramipexole|mesh-list
101566317|NCT00991276|Analgesics|analgesics|mesh-ancestor
101566318|NCT00991276|Sensory System Agents|sensory system agents|mesh-ancestor
101566319|NCT00991276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101566320|NCT00991276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566321|NCT00991276|Anticonvulsants|anticonvulsants|mesh-ancestor
101575910|NCT02721043|Growth Inhibitors|growth inhibitors|mesh-ancestor
101575911|NCT02721043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101575912|NCT02721043|Interferon Inducers|interferon inducers|mesh-ancestor
101575913|NCT02728843|Deferiprone|deferiprone|mesh-list
101575922|NCT02726503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575924|NCT02720965|Anesthetics, Local|anesthetics, local|mesh-list
101575925|NCT02720965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101575926|NCT02720965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575927|NCT02720965|Sensory System Agents|sensory system agents|mesh-ancestor
101575928|NCT02720965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101575929|NCT02726737|Lidocaine|lidocaine|mesh-list
101575930|NCT02726737|Anesthetics, Local|anesthetics, local|mesh-ancestor
101575931|NCT02726737|Anesthetics|anesthetics|mesh-ancestor
101575932|NCT02726737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101575933|NCT02726737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575934|NCT02726737|Sensory System Agents|sensory system agents|mesh-ancestor
101575935|NCT02726737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101575936|NCT02726737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101575937|NCT02726737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101575938|NCT02726737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101575939|NCT02726737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101575940|NCT02726737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575941|NCT02720575|Vitamin D|vitamin d|mesh-list
101575942|NCT02720575|Vitamins|vitamins|mesh-ancestor
101232829|NCT03280511|Oxaliplatin|oxaliplatin|mesh-list
101575943|NCT02720575|Micronutrients|micronutrients|mesh-ancestor
101575944|NCT02720575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575945|NCT02720575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101575946|NCT02720341|Armin|armin|mesh-list
101575947|NCT02720341|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101575948|NCT02720341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101575949|NCT02720341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575950|NCT02720341|Cholinergic Agents|cholinergic agents|mesh-ancestor
101575951|NCT02720341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101575952|NCT02720341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575953|NCT02728453|Empagliflozin|empagliflozin|mesh-list
101575954|NCT02728453|Glimepiride|glimepiride|mesh-list
101575955|NCT02728453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101575956|NCT02728453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575957|NCT02728453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101575958|NCT02728453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575959|NCT02728453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101575960|NCT02728453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101575961|NCT02728453|Immunologic Factors|immunologic factors|mesh-ancestor
101575962|NCT02728687|Mannitol|mannitol|mesh-list
101575963|NCT02728687|Menthol|menthol|mesh-list
101575964|NCT02728687|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101575965|NCT02728687|Diuretics|diuretics|mesh-ancestor
101575966|NCT02728687|Natriuretic Agents|natriuretic agents|mesh-ancestor
101575967|NCT02728687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575968|NCT02728687|Antipruritics|antipruritics|mesh-ancestor
101575969|NCT02728687|Dermatologic Agents|dermatologic agents|mesh-ancestor
101575970|NCT02726269|Ofloxacin|ofloxacin|mesh-list
101575971|NCT02726269|Levofloxacin|levofloxacin|mesh-list
101575972|NCT02726269|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101575973|NCT02726269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101575974|NCT02726269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101575975|NCT02726269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101575976|NCT02726269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101566322|NCT00991276|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101566323|NCT00991276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101566324|NCT00991276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566325|NCT00991276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101566326|NCT00991276|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101566327|NCT00991276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101566328|NCT00991276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101566329|NCT00991276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101566330|NCT00991276|Antioxidants|antioxidants|mesh-ancestor
101566331|NCT00991276|Protective Agents|protective agents|mesh-ancestor
101575977|NCT02726269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101575978|NCT02726269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575984|NCT02694289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575985|NCT02719795|Ropivacaine|ropivacaine|mesh-list
101575986|NCT02719795|Anesthetics, Local|anesthetics, local|mesh-ancestor
101575987|NCT02719795|Anesthetics|anesthetics|mesh-ancestor
101575988|NCT02719795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101575989|NCT02719795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575990|NCT02719795|Sensory System Agents|sensory system agents|mesh-ancestor
101575991|NCT02719795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101575992|NCT02726347|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101575993|NCT02726347|Immunologic Factors|immunologic factors|mesh-ancestor
101575994|NCT02726347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575995|NCT02726035|Naltrexone|naltrexone|mesh-list
101575996|NCT02726035|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101575997|NCT02726035|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101575998|NCT02726035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575999|NCT02726035|Sensory System Agents|sensory system agents|mesh-ancestor
101576000|NCT02726035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101576001|NCT02719405|Caseins|caseins|mesh-list
101576002|NCT02719405|Chelating Agents|chelating agents|mesh-ancestor
101576003|NCT02719405|Sequestering Agents|sequestering agents|mesh-ancestor
101576004|NCT02719405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576005|NCT02725255|Albendazole|albendazole|mesh-list
101576006|NCT02725255|Anthelmintics|anthelmintics|mesh-ancestor
101576007|NCT02725255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101576008|NCT02725255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101576009|NCT02725255|Anticestodal Agents|anticestodal agents|mesh-ancestor
101576010|NCT02725255|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101576011|NCT02725255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101576012|NCT02725255|Tubulin Modulators|tubulin modulators|mesh-ancestor
101576013|NCT02725255|Antimitotic Agents|antimitotic agents|mesh-ancestor
101576014|NCT02725255|Mitosis Modulators|mitosis modulators|mesh-ancestor
101576015|NCT02725255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576016|NCT02725255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101576017|NCT02719015|Pembrolizumab|pembrolizumab|mesh-list
101576018|NCT02719015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101576019|NCT02719015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101576020|NCT02719015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101576021|NCT02719015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576022|NCT02725489|Durvalumab|durvalumab|mesh-list
101576023|NCT02725489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101576024|NCT02725489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101576025|NCT02718547|Timolol|timolol|mesh-list
101576026|NCT02718547|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101576027|NCT02718547|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101576028|NCT02718547|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
101576029|NCT02718547|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101576030|NCT02718547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576031|NCT02718547|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101576032|NCT02718547|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101576033|NCT02718547|Adrenergic Agents|adrenergic agents|mesh-ancestor
101566332|NCT00991276|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101566333|NCT00991276|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101566334|NCT00991276|Dopamine Agonists|dopamine agonists|mesh-ancestor
101566335|NCT00991276|Dopamine Agents|dopamine agents|mesh-ancestor
101566336|NCT00991276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101566337|NCT02869126|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
101566338|NCT02869126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101566339|NCT02869126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566340|NCT00990652|Temozolomide|temozolomide|mesh-list
101566341|NCT00990652|Bortezomib|bortezomib|mesh-list
101566342|NCT00990652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101566343|NCT00990652|Alkylating Agents|alkylating agents|mesh-ancestor
101566344|NCT00990652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566345|NCT00990652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566346|NCT02867878|Adenosine|adenosine|mesh-list
101566347|NCT02867878|Analgesics|analgesics|mesh-ancestor
101414543|NCT00402350|Anesthetics|anesthetics|mesh-ancestor
101414551|NCT02274454|Oxytocin|oxytocin|mesh-list
101576034|NCT02718547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101576035|NCT02718547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576036|NCT02718547|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101576037|NCT02718547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101576038|NCT02718547|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101576039|NCT02718547|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101576040|NCT02718547|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101576041|NCT02725099|Ticagrelor|ticagrelor|mesh-list
101576042|NCT02725099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101576043|NCT02725099|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101576044|NCT02725099|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101576045|NCT02725099|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101576046|NCT02725099|Purinergic Agents|purinergic agents|mesh-ancestor
101576053|NCT01225211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576055|NCT02685709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101576056|NCT02685709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101576057|NCT02685709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101576058|NCT02265367|Milnacipran|milnacipran|mesh-list
101576059|NCT02265367|Levomilnacipran|levomilnacipran|mesh-list
101576060|NCT02265367|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101576061|NCT02265367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101576062|NCT02265367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101576063|NCT02265367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576064|NCT02265367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101576065|NCT02265367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576066|NCT02265367|Antidepressive Agents|antidepressive agents|mesh-ancestor
101576067|NCT02265367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101576068|NCT02265367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101576069|NCT02265367|Analgesics|analgesics|mesh-ancestor
101576070|NCT02265367|Sensory System Agents|sensory system agents|mesh-ancestor
101576071|NCT02265367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101576072|NCT02718469|Vaccines|vaccines|mesh-list
101576073|NCT02718469|Immunologic Factors|immunologic factors|mesh-ancestor
101576074|NCT02718469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576075|NCT02716285|Peppermint oil|peppermint oil|mesh-list
101576076|NCT02716285|Antiemetics|antiemetics|mesh-ancestor
101576077|NCT02716285|Autonomic Agents|autonomic agents|mesh-ancestor
101576078|NCT02716285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101566348|NCT02867878|Sensory System Agents|sensory system agents|mesh-ancestor
101566349|NCT02867878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101566350|NCT02867878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566351|NCT02867878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101566352|NCT02867878|Vasodilator Agents|vasodilator agents|mesh-ancestor
101566353|NCT02867878|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101566354|NCT02867878|Purinergic Agonists|purinergic agonists|mesh-ancestor
101566355|NCT02867878|Purinergic Agents|purinergic agents|mesh-ancestor
101566356|NCT02867878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101321152|NCT04729465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101566357|NCT02867878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566359|NCT01207440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566360|NCT01207440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101566361|NCT01207440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101566362|NCT01207440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566363|NCT00990184|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
101566364|NCT00990184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101566365|NCT00990184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101566366|NCT00990184|Antimetabolites|antimetabolites|mesh-ancestor
101576079|NCT02716285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576080|NCT02716285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101576081|NCT02716285|Parasympatholytics|parasympatholytics|mesh-ancestor
101576082|NCT01224821|Tositumomab I-131|tositumomab i-131|mesh-list
101576083|NCT01224821|Antibodies|antibodies|mesh-list
101576084|NCT01224821|Immunologic Factors|immunologic factors|mesh-ancestor
101576085|NCT01224821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576086|NCT01224821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101576087|NCT02684851|Fibrinolytic Agents|fibrinolytic agents|mesh-list
101576088|NCT02684851|Tranexamic Acid|tranexamic acid|mesh-list
101576089|NCT02684851|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
101576090|NCT02684851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101576091|NCT02684851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576092|NCT02684851|Hemostatics|hemostatics|mesh-ancestor
101576093|NCT02684851|Coagulants|coagulants|mesh-ancestor
101576094|NCT01224431|Lidocaine|lidocaine|mesh-list
101576095|NCT01224431|Anesthetics, Local|anesthetics, local|mesh-ancestor
101576096|NCT01224431|Anesthetics|anesthetics|mesh-ancestor
101576097|NCT01224431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101576098|NCT01224431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576099|NCT01224431|Sensory System Agents|sensory system agents|mesh-ancestor
101576100|NCT01224431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101576101|NCT01224431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101576102|NCT01224431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101576103|NCT01224431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101576104|NCT01224431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101576105|NCT01224431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576106|NCT02716129|Morphine|morphine|mesh-list
101576107|NCT02716129|Nalbuphine|nalbuphine|mesh-list
101576108|NCT02716129|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101576109|NCT02716129|Narcotics|narcotics|mesh-ancestor
101576110|NCT02716129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101576111|NCT02716129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576112|NCT02716129|Analgesics|analgesics|mesh-ancestor
101576113|NCT02716129|Sensory System Agents|sensory system agents|mesh-ancestor
101576124|NCT02718079|Antiviral Agents|antiviral agents|mesh-ancestor
101566367|NCT00990184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566368|NCT00990184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101566369|NCT00990106|Prazosin|prazosin|mesh-list
101223237|NCT01517321|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101566370|NCT00990106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101566371|NCT00990106|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101566372|NCT00990106|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101566373|NCT00990106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101566374|NCT00990106|Adrenergic Agents|adrenergic agents|mesh-ancestor
101566375|NCT00990106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101566376|NCT00990106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566377|NCT00990106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566378|NCT02867566|Rituximab|rituximab|mesh-list
101566379|NCT02867566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101566380|NCT02867566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566381|NCT02867566|Immunologic Factors|immunologic factors|mesh-ancestor
101566382|NCT02867566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566383|NCT02867566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101566384|NCT02867722|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101414585|NCT00126542|Antibodies|antibodies|mesh-list
101576125|NCT02718079|Expectorants|expectorants|mesh-ancestor
101576126|NCT02718079|Respiratory System Agents|respiratory system agents|mesh-ancestor
101576127|NCT02718079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101576128|NCT02718079|Antioxidants|antioxidants|mesh-ancestor
101576129|NCT02718079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576130|NCT02718079|Protective Agents|protective agents|mesh-ancestor
101576131|NCT02718079|Antidotes|antidotes|mesh-ancestor
101576132|NCT02717923|Capecitabine|capecitabine|mesh-list
101576133|NCT02717923|Cetuximab|cetuximab|mesh-list
101576134|NCT02717923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101576135|NCT02717923|Antimetabolites|antimetabolites|mesh-ancestor
101576136|NCT02717923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576137|NCT02717923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101576138|NCT02717923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101576139|NCT02724163|Cytarabine|cytarabine|mesh-list
101576140|NCT02724163|Cyclophosphamide|cyclophosphamide|mesh-list
101576141|NCT02724163|Busulfan|busulfan|mesh-list
101576142|NCT02724163|Fludarabine|fludarabine|mesh-list
101576143|NCT02724163|Daunorubicin|daunorubicin|mesh-list
101576144|NCT02724163|Mitoxantrone|mitoxantrone|mesh-list
101576145|NCT02724163|Gemtuzumab|gemtuzumab|mesh-list
101576146|NCT02724163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101576147|NCT02724163|Immunologic Factors|immunologic factors|mesh-ancestor
101576148|NCT02724163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576149|NCT02724163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101576150|NCT02724163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101576151|NCT02724163|Alkylating Agents|alkylating agents|mesh-ancestor
101576152|NCT02724163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576153|NCT02724163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101576154|NCT02724163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101576155|NCT02724163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101576156|NCT02724163|Antimetabolites|antimetabolites|mesh-ancestor
101576157|NCT02724163|Antiviral Agents|antiviral agents|mesh-ancestor
101576158|NCT02724163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101576159|NCT02724163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101566385|NCT02867722|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101566386|NCT02867722|Dermatologic Agents|dermatologic agents|mesh-ancestor
101566387|NCT02867800|Acetaminophen|acetaminophen|mesh-list
101566388|NCT02867800|Diphenhydramine|diphenhydramine|mesh-list
101566389|NCT02867800|Promethazine|promethazine|mesh-list
101566390|NCT02867800|Cyclosporine|cyclosporine|mesh-list
101566391|NCT02867800|Sirolimus|sirolimus|mesh-list
101566392|NCT02867800|Mycophenolic Acid|mycophenolic acid|mesh-list
101566393|NCT02867800|Methylprednisolone|methylprednisolone|mesh-list
101566394|NCT02867800|Methotrexate|methotrexate|mesh-list
101566395|NCT02867800|Fludarabine|fludarabine|mesh-list
101566396|NCT02867800|Melphalan|melphalan|mesh-list
101566397|NCT02867800|Alemtuzumab|alemtuzumab|mesh-list
101566398|NCT02867800|Abatacept|abatacept|mesh-list
101566399|NCT02867800|Thiotepa|thiotepa|mesh-list
101566400|NCT02867800|Meperidine|meperidine|mesh-list
101566401|NCT02867800|Tacrolimus|tacrolimus|mesh-list
101566402|NCT02867800|Cyclosporins|cyclosporins|mesh-list
101576160|NCT02724163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101576161|NCT02724163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101576162|NCT02724163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101576163|NCT02724163|Analgesics|analgesics|mesh-ancestor
101576164|NCT02724163|Sensory System Agents|sensory system agents|mesh-ancestor
101576165|NCT02724163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101233054|NCT01565239|Thrombin|thrombin|mesh-list
101576166|NCT02724163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101576167|NCT02724163|Immunotoxins|immunotoxins|mesh-ancestor
101576169|NCT02723461|Oxytocin|oxytocin|mesh-list
101576170|NCT02723461|Oxytocics|oxytocics|mesh-ancestor
101576171|NCT02723461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101576172|NCT02723461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576173|NCT02715193|Volagidemab|volagidemab|mesh-list
101576174|NCT02715193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101576175|NCT02715193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576176|NCT01223027|Sorafenib|sorafenib|mesh-list
101576177|NCT01223027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101576178|NCT01223027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101576179|NCT01223027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101576180|NCT01223027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576181|NCT02714959|Aldesleukin|aldesleukin|mesh-list
101576182|NCT02714959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101576217|NCT02723383|Baclofen|baclofen|mesh-list
101576218|NCT02723383|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101576219|NCT02723383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576220|NCT02723383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101576221|NCT02723383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101576222|NCT02723383|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101576223|NCT02723383|GABA Agonists|gaba agonists|mesh-ancestor
101576224|NCT02723383|GABA Agents|gaba agents|mesh-ancestor
101576230|NCT05269537|Oxytocin|oxytocin|mesh-list
101576231|NCT05269537|Anesthetics, Local|anesthetics, local|mesh-ancestor
101576232|NCT05269537|Anesthetics|anesthetics|mesh-ancestor
101576233|NCT05269537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101576234|NCT05269537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576235|NCT05269537|Sensory System Agents|sensory system agents|mesh-ancestor
101576236|NCT05269537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101576237|NCT05269537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101576238|NCT05269537|Narcotics|narcotics|mesh-ancestor
101576239|NCT05269537|Analgesics|analgesics|mesh-ancestor
101576240|NCT05269537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101233139|NCT01568684|Citalopram|citalopram|mesh-list
101576241|NCT05269537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101576242|NCT05269537|Anesthetics, General|anesthetics, general|mesh-ancestor
101576243|NCT05269537|Oxytocics|oxytocics|mesh-ancestor
101576244|NCT05269537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101576245|NCT05269537|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101576246|NCT05269537|Sympathomimetics|sympathomimetics|mesh-ancestor
101566404|NCT02867800|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101566405|NCT02867800|Abortifacient Agents|abortifacient agents|mesh-ancestor
101566406|NCT02867800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101566407|NCT02867800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566408|NCT02867800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101566409|NCT02867800|Antimetabolites|antimetabolites|mesh-ancestor
101566410|NCT02867800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566411|NCT02867800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566412|NCT02867800|Dermatologic Agents|dermatologic agents|mesh-ancestor
101566413|NCT02867800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101566414|NCT02867800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101566415|NCT02867800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101566416|NCT02867800|Immunologic Factors|immunologic factors|mesh-ancestor
101566417|NCT02867800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101566418|NCT02867800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101566419|NCT02867800|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101566420|NCT02867800|Antifungal Agents|antifungal agents|mesh-ancestor
101566421|NCT02867800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101566422|NCT02867800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101566423|NCT02867800|Analgesics|analgesics|mesh-ancestor
101566424|NCT02867800|Sensory System Agents|sensory system agents|mesh-ancestor
101576247|NCT05269537|Autonomic Agents|autonomic agents|mesh-ancestor
101576248|NCT05269537|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101576249|NCT05269537|Adrenergic Agents|adrenergic agents|mesh-ancestor
101576250|NCT05269537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101321194|NCT02966665|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101576251|NCT05269537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576252|NCT01222715|Sirolimus|sirolimus|mesh-list
101576253|NCT01222715|Cyclophosphamide|cyclophosphamide|mesh-list
101576254|NCT01222715|Bevacizumab|bevacizumab|mesh-list
101576255|NCT01222715|Temsirolimus|temsirolimus|mesh-list
101576256|NCT01222715|Vinorelbine|vinorelbine|mesh-list
101576257|NCT01222715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101576258|NCT01222715|MTOR Inhibitors|mtor inhibitors|mesh-list
101576259|NCT01222715|Antibodies|antibodies|mesh-list
101576260|NCT01222715|Immunoglobulins|immunoglobulins|mesh-list
101576261|NCT01222715|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101576262|NCT01222715|Immunoglobulin G|immunoglobulin g|mesh-list
101576263|NCT01222715|Endothelial Growth Factors|endothelial growth factors|mesh-list
101576264|NCT01222715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101576265|NCT01222715|Immunologic Factors|immunologic factors|mesh-ancestor
101576266|NCT01222715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576267|NCT01222715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101576268|NCT01222715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101576269|NCT01222715|Alkylating Agents|alkylating agents|mesh-ancestor
101576270|NCT01222715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576271|NCT01222715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101576272|NCT01222715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101576273|NCT01222715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101576274|NCT01222715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101576275|NCT01222715|Growth Substances|growth substances|mesh-ancestor
101576276|NCT01222715|Growth Inhibitors|growth inhibitors|mesh-ancestor
101576277|NCT01222715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101576278|NCT01222715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101566425|NCT02867800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101566426|NCT02867800|Antipyretics|antipyretics|mesh-ancestor
101566427|NCT02867800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101566428|NCT02867800|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101566429|NCT02867800|Antitubercular Agents|antitubercular agents|mesh-ancestor
101566430|NCT02867800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101566431|NCT02867800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101566432|NCT02867800|Antiemetics|antiemetics|mesh-ancestor
101566433|NCT02867800|Autonomic Agents|autonomic agents|mesh-ancestor
101566434|NCT02867800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101566435|NCT02867800|Glucocorticoids|glucocorticoids|mesh-ancestor
101566436|NCT02867800|Hormones|hormones|mesh-ancestor
101566437|NCT02867800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101566438|NCT02867800|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101566439|NCT02867800|Protective Agents|protective agents|mesh-ancestor
101566440|NCT02867800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101566441|NCT02867800|Alkylating Agents|alkylating agents|mesh-ancestor
101566442|NCT02867800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101566443|NCT02867800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101566444|NCT02867800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101414636|NCT00126698|Trimethoprim|trimethoprim|mesh-list
101576279|NCT01222715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101576280|NCT01222715|Antifungal Agents|antifungal agents|mesh-ancestor
101576281|NCT01222715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101576282|NCT01222715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101576283|NCT01222715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101576284|NCT01222715|Tubulin Modulators|tubulin modulators|mesh-ancestor
101576285|NCT01222715|Antimitotic Agents|antimitotic agents|mesh-ancestor
101576286|NCT01222715|Mitosis Modulators|mitosis modulators|mesh-ancestor
101576287|NCT02723071|Ocrelizumab|ocrelizumab|mesh-list
101576288|NCT02723071|Immunologic Factors|immunologic factors|mesh-ancestor
101576289|NCT02723071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576290|NCT02722759|Chrysarobin|chrysarobin|mesh-list
101576291|NCT02722759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101576292|NCT02722759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101576293|NCT02722759|Analgesics|analgesics|mesh-ancestor
101576294|NCT02722759|Sensory System Agents|sensory system agents|mesh-ancestor
101576295|NCT02722759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101576296|NCT02722759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576300|NCT02722447|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101576301|NCT02722447|Antithrombins|antithrombins|mesh-ancestor
101576302|NCT02722447|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101576303|NCT02722447|Protease Inhibitors|protease inhibitors|mesh-ancestor
101576304|NCT02722447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101576305|NCT02722447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576306|NCT02722447|Anticoagulants|anticoagulants|mesh-ancestor
101576308|NCT01222403|MF59 oil emulsion|mf59 oil emulsion|mesh-list
101576309|NCT01222403|Immunologic Factors|immunologic factors|mesh-ancestor
101576310|NCT01222403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576311|NCT01222403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101576312|NCT02722369|Hydroxychloroquine|hydroxychloroquine|mesh-list
101576313|NCT02722369|Carboplatin|carboplatin|mesh-list
101576314|NCT02722369|Gemcitabine|gemcitabine|mesh-list
101576316|NCT02722369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101576317|NCT02722369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101566445|NCT02867800|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101566446|NCT02867800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101566447|NCT02867800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101566449|NCT02867800|Anesthetics|anesthetics|mesh-ancestor
101566450|NCT02867800|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101566451|NCT02867800|Histamine Antagonists|histamine antagonists|mesh-ancestor
101566452|NCT02867800|Histamine Agents|histamine agents|mesh-ancestor
101566453|NCT02867800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101566454|NCT02867800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101566455|NCT02867800|Antipruritics|antipruritics|mesh-ancestor
101566456|NCT02867800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101566457|NCT02867800|Narcotics|narcotics|mesh-ancestor
101566458|NCT02867800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101566459|NCT00629200|Interferons|interferons|mesh-list
101566460|NCT00629200|Interferon-alpha|interferon-alpha|mesh-list
101566461|NCT00629200|Interferon alpha-2|interferon alpha-2|mesh-list
101566462|NCT00629200|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
101566463|NCT00629200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566464|NCT00629200|Antiviral Agents|antiviral agents|mesh-ancestor
101566465|NCT00629200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101566466|NCT00629200|Immunologic Factors|immunologic factors|mesh-ancestor
101566467|NCT00629200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566468|NCT00629200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101566469|NCT00629200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101566470|NCT00629200|Schistosomicides|schistosomicides|mesh-ancestor
101566471|NCT00629200|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101576318|NCT02722369|Antimetabolites|antimetabolites|mesh-ancestor
101576319|NCT02722369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576320|NCT02722369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101576321|NCT02722369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101576322|NCT02722369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101576323|NCT02722369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101576324|NCT02722369|Antimalarials|antimalarials|mesh-ancestor
101576325|NCT02722369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101576326|NCT02722369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101576327|NCT02722369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101576328|NCT02722369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101576329|NCT01222247|Betamethasone|betamethasone|mesh-list
101576330|NCT01222247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101576331|NCT01222247|Glucocorticoids|glucocorticoids|mesh-ancestor
101576332|NCT01222247|Hormones|hormones|mesh-ancestor
101576333|NCT01222247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101576334|NCT01222247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576335|NCT01222247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101576336|NCT01222247|Respiratory System Agents|respiratory system agents|mesh-ancestor
101576337|NCT01014975|Fibrinolysin|fibrinolysin|mesh-list
101576338|NCT01014975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101576339|NCT01014975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101576340|NCT01014975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576341|NCT03982537|Acetylcysteine|acetylcysteine|mesh-list
101576342|NCT03982537|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101566473|NCT02867176|Ketorolac|ketorolac|mesh-list
101566474|NCT02867176|Gabapentin|gabapentin|mesh-list
101566475|NCT02867176|Analgesics|analgesics|mesh-ancestor
101566476|NCT02867176|Sensory System Agents|sensory system agents|mesh-ancestor
101566477|NCT02867176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101566478|NCT02867176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566479|NCT02867176|Anticonvulsants|anticonvulsants|mesh-ancestor
101566480|NCT02867176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101576343|NCT03982537|Antiviral Agents|antiviral agents|mesh-ancestor
101576344|NCT03982537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101576345|NCT03982537|Expectorants|expectorants|mesh-ancestor
101576346|NCT03982537|Respiratory System Agents|respiratory system agents|mesh-ancestor
101576347|NCT03982537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101576348|NCT03982537|Antioxidants|antioxidants|mesh-ancestor
101576349|NCT03982537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576350|NCT03982537|Protective Agents|protective agents|mesh-ancestor
101576351|NCT03982537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576352|NCT03982537|Antidotes|antidotes|mesh-ancestor
101576353|NCT05260593|Vitamins|vitamins|mesh-list
101576354|NCT05260593|Hydroxocobalamin|hydroxocobalamin|mesh-list
101576355|NCT05260593|Vitamin B 12|vitamin b 12|mesh-list
101576356|NCT05260593|Vitamin B Complex|vitamin b complex|mesh-list
101576357|NCT05260593|Micronutrients|micronutrients|mesh-ancestor
101576358|NCT05260593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576359|NCT05260593|Hematinics|hematinics|mesh-ancestor
101576360|NCT02713477|Insulin|insulin|mesh-list
101576361|NCT02713477|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101576362|NCT02713477|Insulin Glargine|insulin glargine|mesh-list
101576363|NCT02713477|Lixisenatide|lixisenatide|mesh-list
101576364|NCT02713477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101576365|NCT02713477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576366|NCT01014585|Milnacipran|milnacipran|mesh-list
101576367|NCT01014585|Levomilnacipran|levomilnacipran|mesh-list
101576368|NCT01014585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101576369|NCT01014585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101576370|NCT01014585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101576371|NCT01014585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576386|NCT00611143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101576388|NCT02712619|Metformin|metformin|mesh-list
101576389|NCT02712619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101576390|NCT02712619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576391|NCT01220609|Epothilones|epothilones|mesh-list
101576392|NCT01220609|Tubulin Modulators|tubulin modulators|mesh-ancestor
101576393|NCT01220609|Antimitotic Agents|antimitotic agents|mesh-ancestor
101576394|NCT01220609|Mitosis Modulators|mitosis modulators|mesh-ancestor
101576395|NCT01220609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576396|NCT01220609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101576397|NCT02713087|Phenylephrine|phenylephrine|mesh-list
101576398|NCT02713087|Oxymetazoline|oxymetazoline|mesh-list
101576400|NCT02713087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101576401|NCT02713087|Mydriatics|mydriatics|mesh-ancestor
101576402|NCT02713087|Autonomic Agents|autonomic agents|mesh-ancestor
101576403|NCT02713087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101576404|NCT02713087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576405|NCT02713087|Sympathomimetics|sympathomimetics|mesh-ancestor
101576406|NCT02713087|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101576407|NCT02713087|Nasal Decongestants|nasal decongestants|mesh-ancestor
101576408|NCT02713087|Respiratory System Agents|respiratory system agents|mesh-ancestor
101576409|NCT02713087|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101576410|NCT02713087|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101576411|NCT02713087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101576412|NCT02713087|Adrenergic Agents|adrenergic agents|mesh-ancestor
101576413|NCT02713087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101576414|NCT02713087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576415|NCT02713087|Protective Agents|protective agents|mesh-ancestor
101576416|NCT02713087|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101576417|NCT02722603|Gabapentin|gabapentin|mesh-list
101576418|NCT02722603|Tramadol|tramadol|mesh-list
101566481|NCT02867176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101566482|NCT02867176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101566483|NCT02867176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101566484|NCT02867176|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101566485|NCT02867176|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101566486|NCT02867176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101566487|NCT02867176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566488|NCT02867176|Antimanic Agents|antimanic agents|mesh-ancestor
101321324|NCT00006050|Immunologic Factors|immunologic factors|mesh-ancestor
101566489|NCT02867176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101566490|NCT02867176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101566491|NCT02867176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101566492|NCT02867176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101566493|NCT02867176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101566494|NCT02867176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101566495|NCT00982228|Insulin|insulin|mesh-list
101566496|NCT00982228|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101566497|NCT00982228|Insulin Glargine|insulin glargine|mesh-list
101566498|NCT00982228|Insulin Aspart|insulin aspart|mesh-list
101566499|NCT00982228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101566500|NCT00982228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566501|NCT02867956|Etoposide|etoposide|mesh-list
101566502|NCT02867956|Apatinib|apatinib|mesh-list
101566503|NCT02867956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101566504|NCT02867956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566505|NCT02867956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101566506|NCT02867956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101576419|NCT02722603|Analgesics|analgesics|mesh-ancestor
101576420|NCT02722603|Sensory System Agents|sensory system agents|mesh-ancestor
101576421|NCT02722603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101321379|NCT00084097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101576422|NCT02722603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576423|NCT02722603|Anticonvulsants|anticonvulsants|mesh-ancestor
101576424|NCT02722603|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101576425|NCT02722603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101576426|NCT02722603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101576427|NCT02722603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101576428|NCT02722603|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101576429|NCT02722603|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101576430|NCT02722603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101576431|NCT02722603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576432|NCT02722603|Antimanic Agents|antimanic agents|mesh-ancestor
101576440|NCT02712697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576441|NCT02712697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101576442|NCT02712697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101576443|NCT01220297|Mycophenolic Acid|mycophenolic acid|mesh-list
101576444|NCT01220297|Sirolimus|sirolimus|mesh-list
101576445|NCT01220297|Cyclophosphamide|cyclophosphamide|mesh-list
101576446|NCT01220297|Carmustine|carmustine|mesh-list
101576447|NCT01220297|Etoposide|etoposide|mesh-list
101576448|NCT01220297|Etoposide phosphate|etoposide phosphate|mesh-list
101576449|NCT01220297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101566507|NCT02867956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101566508|NCT02867956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566509|NCT02867956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101566510|NCT04291066|Acetylcysteine|acetylcysteine|mesh-list
101566511|NCT04291066|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101566512|NCT04291066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566513|NCT04291066|Antiviral Agents|antiviral agents|mesh-ancestor
101566514|NCT04291066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101566515|NCT04291066|Expectorants|expectorants|mesh-ancestor
101566516|NCT04291066|Respiratory System Agents|respiratory system agents|mesh-ancestor
101566517|NCT04291066|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101576450|NCT01220297|Immunologic Factors|immunologic factors|mesh-ancestor
101576451|NCT01220297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576452|NCT01220297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101576453|NCT01220297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101576454|NCT01220297|Alkylating Agents|alkylating agents|mesh-ancestor
101576455|NCT01220297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576456|NCT01220297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101576457|NCT01220297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101576458|NCT01220297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101576459|NCT01220297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101576460|NCT01220297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101576461|NCT01220297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101576462|NCT01220297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101576463|NCT01220297|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101576465|NCT01220297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101576466|NCT01220297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101576467|NCT01220297|Antifungal Agents|antifungal agents|mesh-ancestor
101576468|NCT02712775|Minocycline|minocycline|mesh-list
101576469|NCT02712775|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101321492|NCT00084721|Celecoxib|celecoxib|mesh-list
101576470|NCT02712775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101576471|NCT04318847|Ondansetron|ondansetron|mesh-list
101576472|NCT04318847|Antiemetics|antiemetics|mesh-ancestor
101576473|NCT04318847|Autonomic Agents|autonomic agents|mesh-ancestor
101576474|NCT04318847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101576475|NCT04318847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576476|NCT04318847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101576477|NCT04318847|Antipruritics|antipruritics|mesh-ancestor
101576478|NCT04318847|Dermatologic Agents|dermatologic agents|mesh-ancestor
101576479|NCT04318847|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101576480|NCT04318847|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101576481|NCT04318847|Serotonin Agents|serotonin agents|mesh-ancestor
101576482|NCT04318847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101576483|NCT04318847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576485|NCT02721511|Diuretics|diuretics|mesh-ancestor
101576486|NCT02721511|Natriuretic Agents|natriuretic agents|mesh-ancestor
101576487|NCT02721511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576488|NCT02721511|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101576489|NCT02721511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101576490|NCT02721511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576491|NCT02712307|Penicillins|penicillins|mesh-list
101576492|NCT02712307|Penicillin V|penicillin v|mesh-list
101576493|NCT02712307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101576494|NCT02712307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101576495|NCT02708251|Lidocaine|lidocaine|mesh-list
101576496|NCT02708251|Nitroglycerin|nitroglycerin|mesh-list
101576497|NCT02708251|Anesthetics, Local|anesthetics, local|mesh-ancestor
101576498|NCT02708251|Anesthetics|anesthetics|mesh-ancestor
101576499|NCT02708251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101576500|NCT02708251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576501|NCT02708251|Sensory System Agents|sensory system agents|mesh-ancestor
101576502|NCT02708251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101576503|NCT02708251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101566518|NCT04291066|Antioxidants|antioxidants|mesh-ancestor
101566519|NCT04291066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566520|NCT04291066|Protective Agents|protective agents|mesh-ancestor
101566521|NCT04291066|Antidotes|antidotes|mesh-ancestor
101566522|NCT01260350|Sofosbuvir|sofosbuvir|mesh-list
101566523|NCT01260350|Antiviral Agents|antiviral agents|mesh-ancestor
101566524|NCT01260350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101566525|NCT01260194|Trastuzumab|trastuzumab|mesh-list
101566526|NCT01260194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101576517|NCT00612625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101576518|NCT00612625|Hormones|hormones|mesh-ancestor
101576519|NCT00612625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101576520|NCT00612625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576521|NCT00612625|Incretins|incretins|mesh-ancestor
101576522|NCT02711917|Propofol|propofol|mesh-list
101576523|NCT02711917|Etomidate|etomidate|mesh-list
101576524|NCT02711917|Rocuronium|rocuronium|mesh-list
101576525|NCT02711917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101576526|NCT02711917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101576527|NCT02711917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576528|NCT02711917|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101576529|NCT02711917|Anesthetics, General|anesthetics, general|mesh-ancestor
101576530|NCT02711917|Anesthetics|anesthetics|mesh-ancestor
101576531|NCT02711917|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101576532|NCT02711917|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101576533|NCT02711917|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101576534|NCT02711917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101576535|NCT02711449|Methylprednisolone|methylprednisolone|mesh-list
101576536|NCT02711449|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101576537|NCT02711449|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101576538|NCT02711449|Prednisolone|prednisolone|mesh-list
101576539|NCT02711449|Prednisolone acetate|prednisolone acetate|mesh-list
101576540|NCT02711449|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101576541|NCT02711449|Prednisolone phosphate|prednisolone phosphate|mesh-list
101576542|NCT02711449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101576543|NCT02711449|Antiemetics|antiemetics|mesh-ancestor
101576544|NCT02711449|Autonomic Agents|autonomic agents|mesh-ancestor
101576545|NCT02711449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101576546|NCT02711449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576547|NCT02711449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101576548|NCT02711449|Glucocorticoids|glucocorticoids|mesh-ancestor
101576549|NCT02711449|Hormones|hormones|mesh-ancestor
101576550|NCT02711449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101576551|NCT02711449|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101576552|NCT02711449|Protective Agents|protective agents|mesh-ancestor
101576553|NCT02711449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101576554|NCT02711449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101576555|NCT00612079|Sertindole|sertindole|mesh-list
101576556|NCT00612079|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101576557|NCT00612079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101576558|NCT00612079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101321726|NCT00086086|Hematinics|hematinics|mesh-ancestor
101576559|NCT00612079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576560|NCT00612079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101576561|NCT00940498|Gedatolisib|gedatolisib|mesh-list
101576562|NCT00940498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101576563|NCT00940498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101576582|NCT02707393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576584|NCT02707393|Immunologic Factors|immunologic factors|mesh-ancestor
101576585|NCT02707393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576586|NCT02707393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101576587|NCT02707393|Antifungal Agents|antifungal agents|mesh-ancestor
101576588|NCT02707393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101576589|NCT02707393|Dermatologic Agents|dermatologic agents|mesh-ancestor
101576590|NCT02707393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101576591|NCT02707393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101576592|NCT02707393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101576593|NCT02707393|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101566527|NCT01260194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566528|NCT00629278|Tamoxifen|tamoxifen|mesh-list
101566529|NCT00629278|Docetaxel|docetaxel|mesh-list
101566530|NCT00629278|Cyclophosphamide|cyclophosphamide|mesh-list
101566531|NCT00629278|Doxorubicin|doxorubicin|mesh-list
101566532|NCT00629278|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101576594|NCT02707393|Antitubercular Agents|antitubercular agents|mesh-ancestor
101576595|NCT02707393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101576596|NCT02707393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101576597|NCT02707393|Alkylating Agents|alkylating agents|mesh-ancestor
101576598|NCT02707393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101576599|NCT00940342|Rituximab|rituximab|mesh-list
101576600|NCT00940342|Molgramostim|molgramostim|mesh-list
101576601|NCT00940342|Sargramostim|sargramostim|mesh-list
101576602|NCT00940342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101576603|NCT00940342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101576604|NCT00940342|Immunologic Factors|immunologic factors|mesh-ancestor
101576605|NCT00940342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576606|NCT00940342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101576607|NCT00936910|Amphotericin B|amphotericin b|mesh-list
101576608|NCT00936910|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101576609|NCT00936910|Amebicides|amebicides|mesh-ancestor
101576610|NCT00936910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101576611|NCT00936910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101576612|NCT00936910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101576613|NCT00936910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101576614|NCT00936910|Antifungal Agents|antifungal agents|mesh-ancestor
101576615|NCT02707315|Gemcitabine|gemcitabine|mesh-list
101576616|NCT02707315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101576617|NCT02707315|Antimetabolites|antimetabolites|mesh-ancestor
101576618|NCT02707315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576619|NCT02707315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101576620|NCT00604942|Domperidone|domperidone|mesh-list
101576621|NCT00604942|Esomeprazole|esomeprazole|mesh-list
101576637|NCT02711683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101576638|NCT02711683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576639|NCT02711683|Cholinergic Agents|cholinergic agents|mesh-ancestor
101576640|NCT02711683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101576641|NCT02711683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576642|NCT02711683|Nootropic Agents|nootropic agents|mesh-ancestor
101576643|NCT02711683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101576644|NCT02711683|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101576645|NCT02711683|Protective Agents|protective agents|mesh-ancestor
101576646|NCT05079061|Misoprostol|misoprostol|mesh-list
101576647|NCT05079061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101576648|NCT05079061|Abortifacient Agents|abortifacient agents|mesh-ancestor
101576649|NCT05079061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101576650|NCT05079061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576651|NCT05079061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101576652|NCT05079061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101576653|NCT05079061|Oxytocics|oxytocics|mesh-ancestor
101576654|NCT00605020|Insulin|insulin|mesh-list
101576655|NCT00605020|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101576656|NCT00605020|Insulin Aspart|insulin aspart|mesh-list
101576657|NCT00605020|Insulin, Long-Acting|insulin, long-acting|mesh-list
101576658|NCT00605020|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101576659|NCT00605020|Insulin Detemir|insulin detemir|mesh-list
101576660|NCT00605020|Biphasic Insulins|biphasic insulins|mesh-list
101321882|NCT00087217|Paclitaxel|paclitaxel|mesh-list
101576661|NCT00605020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101576662|NCT00605020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576663|NCT02707081|Lidocaine|lidocaine|mesh-list
101576664|NCT02707081|Anesthetics, Local|anesthetics, local|mesh-ancestor
101576665|NCT02707081|Anesthetics|anesthetics|mesh-ancestor
101576666|NCT02707081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101576667|NCT02707081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576668|NCT02707081|Sensory System Agents|sensory system agents|mesh-ancestor
101576669|NCT02707081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101576670|NCT02707081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101576671|NCT02707081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101576672|NCT02707081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101576673|NCT02707081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101566533|NCT00629278|Fluorouracil|fluorouracil|mesh-list
101566534|NCT00629278|Trastuzumab|trastuzumab|mesh-list
101566535|NCT00629278|Epirubicin|epirubicin|mesh-list
101566536|NCT00629278|Hormones|hormones|mesh-list
101566537|NCT00629278|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101566538|NCT00629278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566539|NCT00629278|Tubulin Modulators|tubulin modulators|mesh-ancestor
101566540|NCT00629278|Antimitotic Agents|antimitotic agents|mesh-ancestor
101576674|NCT02707081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576675|NCT00605098|Ritonavir|ritonavir|mesh-list
101576676|NCT00605098|Lopinavir|lopinavir|mesh-list
101576677|NCT00605098|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101576678|NCT00605098|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101576679|NCT00605098|Protease Inhibitors|protease inhibitors|mesh-ancestor
101576680|NCT00605098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101576681|NCT00605098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576686|NCT00605098|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101576687|NCT00605098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101576688|NCT02711215|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101576689|NCT02711215|Mirtazapine|mirtazapine|mesh-list
101576691|NCT02711215|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101576692|NCT02711215|Escitalopram|escitalopram|mesh-list
101576693|NCT02711215|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101576694|NCT02711215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101576695|NCT02711215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101576696|NCT02711215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576697|NCT02711215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101576698|NCT02711215|Serotonin Agents|serotonin agents|mesh-ancestor
101576699|NCT02711215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576700|NCT02711215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101233568|NCT01572285|Dexamethasone|dexamethasone|mesh-list
101576701|NCT02711215|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101576702|NCT02711215|Antidepressive Agents|antidepressive agents|mesh-ancestor
101576703|NCT02711215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101576704|NCT02711215|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101576705|NCT02711215|Analgesics|analgesics|mesh-ancestor
101576706|NCT02711215|Sensory System Agents|sensory system agents|mesh-ancestor
101576707|NCT02711215|Dopamine Agents|dopamine agents|mesh-ancestor
101576708|NCT02711215|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101576709|NCT02711215|Histamine Antagonists|histamine antagonists|mesh-ancestor
101576710|NCT02711215|Histamine Agents|histamine agents|mesh-ancestor
101576711|NCT02711215|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101576712|NCT02711215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101576713|NCT02711215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101576714|NCT02711215|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101576715|NCT02711215|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101576716|NCT02711215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101576717|NCT02711215|Adrenergic Agents|adrenergic agents|mesh-ancestor
101576718|NCT02711215|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101576719|NCT02711215|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101576720|NCT02711215|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101576721|NCT00603772|Tretinoin|tretinoin|mesh-list
101576722|NCT00603772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101576723|NCT00603772|Keratolytic Agents|keratolytic agents|mesh-ancestor
101576724|NCT00603772|Dermatologic Agents|dermatologic agents|mesh-ancestor
101576725|NCT02706769|Acetaminophen|acetaminophen|mesh-list
101576726|NCT02706769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101576727|NCT02706769|Analgesics|analgesics|mesh-ancestor
101576728|NCT02706769|Sensory System Agents|sensory system agents|mesh-ancestor
101576729|NCT02706769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101576730|NCT02706769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576731|NCT02706769|Antipyretics|antipyretics|mesh-ancestor
101576732|NCT05044117|Capecitabine|capecitabine|mesh-list
101576733|NCT05044117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101576734|NCT05044117|Antimetabolites|antimetabolites|mesh-ancestor
101576735|NCT05044117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576736|NCT05044117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566542|NCT00629278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566543|NCT00629278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101566544|NCT00629278|Immunologic Factors|immunologic factors|mesh-ancestor
101566545|NCT00629278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566546|NCT00629278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101414744|NCT00494338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101576737|NCT03961165|Scopolamine|scopolamine|mesh-list
101576738|NCT03961165|Bromides|bromides|mesh-list
101576739|NCT03961165|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101576740|NCT03961165|Anticonvulsants|anticonvulsants|mesh-ancestor
101576741|NCT03961165|Parasympatholytics|parasympatholytics|mesh-ancestor
101576742|NCT03961165|Autonomic Agents|autonomic agents|mesh-ancestor
101576743|NCT03961165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101576744|NCT03961165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576745|NCT03961165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101576746|NCT03961165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101576747|NCT03961165|Cholinergic Agents|cholinergic agents|mesh-ancestor
101576748|NCT03961165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101576749|NCT03961165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576750|NCT03961165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101576751|NCT03961165|Antiemetics|antiemetics|mesh-ancestor
101576759|NCT02706535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101576760|NCT02706535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101576761|NCT02706535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576762|NCT02706535|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101576763|NCT02706535|Hormone Antagonists|hormone antagonists|mesh-ancestor
101576764|NCT02706535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101576765|NCT02706535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576766|NCT02706535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101576767|NCT02706535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101576768|NCT02706535|Antitubercular Agents|antitubercular agents|mesh-ancestor
101576769|NCT02706535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101576770|NCT02706535|Leprostatic Agents|leprostatic agents|mesh-ancestor
101576771|NCT02706535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101576772|NCT02706535|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101576773|NCT02706535|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101576774|NCT02706535|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101576775|NCT02706535|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101576776|NCT02706535|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101576777|NCT02706535|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101576778|NCT02711059|Parathyroid Hormone|parathyroid hormone|mesh-list
101576779|NCT02711059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101576780|NCT02711059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576782|NCT00612157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101576783|NCT00612157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101576784|NCT00612157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576785|NCT00936598|Zolpidem|zolpidem|mesh-list
101576786|NCT00936598|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101576787|NCT00936598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101576788|NCT00936598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101576789|NCT00936598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576790|NCT00936598|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101576791|NCT00936598|GABA Agonists|gaba agonists|mesh-ancestor
101576792|NCT00936598|GABA Agents|gaba agents|mesh-ancestor
101576793|NCT00936598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101576794|NCT00936598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576795|NCT01025817|Mycophenolic Acid|mycophenolic acid|mesh-list
101576796|NCT01025817|Everolimus|everolimus|mesh-list
101576797|NCT01025817|Tacrolimus|tacrolimus|mesh-list
101576798|NCT01025817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101576799|NCT01025817|Immunologic Factors|immunologic factors|mesh-ancestor
101576800|NCT01025817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576801|NCT01025817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101576802|NCT01025817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101566547|NCT00629278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101566548|NCT00629278|Alkylating Agents|alkylating agents|mesh-ancestor
101566549|NCT00629278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101566550|NCT00629278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101566551|NCT00629278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101566552|NCT00629278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101566553|NCT00629278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101576803|NCT01025817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576804|NCT01025817|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101576805|NCT01025817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101576806|NCT01025817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101576807|NCT01025817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101576808|NCT01025817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101322186|NCT00088933|Vaccines|vaccines|mesh-list
101576809|NCT01025817|Antitubercular Agents|antitubercular agents|mesh-ancestor
101576810|NCT01025817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101576811|NCT01025817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101576812|NCT00636883|Gemcitabine|gemcitabine|mesh-list
101576813|NCT00636883|Oxaliplatin|oxaliplatin|mesh-list
101576814|NCT00636883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101576815|NCT00636883|Antimetabolites|antimetabolites|mesh-ancestor
101576816|NCT00636883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576817|NCT00636883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101576818|NCT00605410|Bromides|bromides|mesh-list
101576824|NCT00605410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576825|NCT00605410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101576826|NCT00605410|Respiratory System Agents|respiratory system agents|mesh-ancestor
101576827|NCT00605410|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101576828|NCT00605410|Cholinergic Agents|cholinergic agents|mesh-ancestor
101576829|NCT00605410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101576830|NCT00605410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576831|NCT04300881|Eplerenone|eplerenone|mesh-list
101576832|NCT04300881|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101576833|NCT04300881|Hormone Antagonists|hormone antagonists|mesh-ancestor
101576834|NCT04300881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101576835|NCT04300881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576836|NCT04300881|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101576837|NCT04300881|Diuretics|diuretics|mesh-ancestor
101576838|NCT04300881|Natriuretic Agents|natriuretic agents|mesh-ancestor
101322238|NCT00089167|Antiemetics|antiemetics|mesh-ancestor
101576839|NCT04300881|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101576840|NCT03873493|Venetoclax|venetoclax|mesh-list
101576841|NCT03873493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101576842|NCT00611689|Imatinib Mesylate|imatinib mesylate|mesh-list
101576843|NCT00611689|Vatalanib|vatalanib|mesh-list
101576844|NCT00611689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101576845|NCT00611689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101576846|NCT00611689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101576847|NCT00611689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576848|NCT05264077|Midazolam|midazolam|mesh-list
101576849|NCT05264077|Dexmedetomidine|dexmedetomidine|mesh-list
101576850|NCT05264077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101576851|NCT05264077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101576852|NCT05264077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576853|NCT05264077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101576854|NCT05264077|Analgesics|analgesics|mesh-ancestor
101576855|NCT05264077|Sensory System Agents|sensory system agents|mesh-ancestor
101576856|NCT05264077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101576857|NCT05264077|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101576858|NCT05264077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101576859|NCT05264077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101576860|NCT05264077|Adrenergic Agents|adrenergic agents|mesh-ancestor
101576861|NCT05264077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101576862|NCT05264077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576863|NCT05264077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101576864|NCT05264077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101576865|NCT05264077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101576866|NCT05264077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101566554|NCT00629278|Antimetabolites|antimetabolites|mesh-ancestor
101566555|NCT00629278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101566556|NCT00629278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101566557|NCT00629278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101566558|NCT00629278|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101566559|NCT00629278|Hormone Antagonists|hormone antagonists|mesh-ancestor
101566560|NCT00629278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101566561|NCT00629278|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101566562|NCT00629278|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101566563|NCT00629278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101576867|NCT05264077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101576868|NCT05264077|Anesthetics, General|anesthetics, general|mesh-ancestor
101576869|NCT05264077|Anesthetics|anesthetics|mesh-ancestor
101576870|NCT05264077|GABA Modulators|gaba modulators|mesh-ancestor
101576871|NCT05264077|GABA Agents|gaba agents|mesh-ancestor
101576872|NCT00612859|Levetiracetam|levetiracetam|mesh-list
101576873|NCT00612859|Anticonvulsants|anticonvulsants|mesh-ancestor
101576874|NCT00612859|Nootropic Agents|nootropic agents|mesh-ancestor
101576875|NCT03872401|Evolocumab|evolocumab|mesh-list
101576876|NCT03872401|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101576877|NCT03872401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101576878|NCT03872401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101576879|NCT03872401|Antimetabolites|antimetabolites|mesh-ancestor
101576880|NCT03872401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576881|NCT03872401|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101576882|NCT03872401|Protease Inhibitors|protease inhibitors|mesh-ancestor
101576883|NCT03872401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101576884|NCT03872401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101576885|NCT01010217|Mycophenolic Acid|mycophenolic acid|mesh-list
101576886|NCT01010217|Cyclophosphamide|cyclophosphamide|mesh-list
101576887|NCT01010217|Melphalan|melphalan|mesh-list
101576888|NCT01010217|Thiotepa|thiotepa|mesh-list
101576889|NCT01010217|Rituximab|rituximab|mesh-list
101576890|NCT01010217|Fludarabine|fludarabine|mesh-list
101576891|NCT01010217|Fludarabine phosphate|fludarabine phosphate|mesh-list
101576902|NCT01010217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101576903|NCT01010217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101576904|NCT01010217|Antimetabolites|antimetabolites|mesh-ancestor
101576905|NCT01010217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101576906|NCT01010217|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101576907|NCT01010217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101576908|NCT01010217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101576909|NCT01010217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101576910|NCT01010217|Antitubercular Agents|antitubercular agents|mesh-ancestor
101576911|NCT01010217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101576912|NCT00604006|Spironolactone|spironolactone|mesh-list
101576913|NCT00604006|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101576914|NCT00604006|Hormone Antagonists|hormone antagonists|mesh-ancestor
101576915|NCT00604006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101576916|NCT00604006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576917|NCT00604006|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101576918|NCT00604006|Diuretics|diuretics|mesh-ancestor
101576919|NCT00604006|Natriuretic Agents|natriuretic agents|mesh-ancestor
101576920|NCT00604084|Ivermectin|ivermectin|mesh-list
101576921|NCT00604084|Permethrin|permethrin|mesh-list
101576922|NCT00604084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101576923|NCT00604084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101576924|NCT00604084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101576925|NCT00604084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576926|NCT05379478|Antibodies|antibodies|mesh-list
101576927|NCT05379478|Immunologic Factors|immunologic factors|mesh-ancestor
101576928|NCT05379478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576929|NCT04267042|Budesonide|budesonide|mesh-list
101576930|NCT04267042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101576931|NCT04267042|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101566564|NCT00629278|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101566565|NCT04207112|Moxifloxacin|moxifloxacin|mesh-list
101566567|NCT04207112|Bedaquiline|bedaquiline|mesh-list
101566568|NCT04207112|Clofazimine|clofazimine|mesh-list
101566569|NCT04207112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101566570|NCT04207112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101566571|NCT04207112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101414767|NCT00146016|Dopamine Agents|dopamine agents|mesh-ancestor
101576932|NCT04267042|Autonomic Agents|autonomic agents|mesh-ancestor
101576933|NCT04267042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101576934|NCT04267042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576935|NCT04267042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101576936|NCT04267042|Respiratory System Agents|respiratory system agents|mesh-ancestor
101576937|NCT04267042|Glucocorticoids|glucocorticoids|mesh-ancestor
101576938|NCT04267042|Hormones|hormones|mesh-ancestor
101576939|NCT04267042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101576940|NCT01217957|Dexamethasone|dexamethasone|mesh-list
101576941|NCT01217957|Lenalidomide|lenalidomide|mesh-list
101576942|NCT01217957|Ixazomib|ixazomib|mesh-list
101576943|NCT01217957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101576944|NCT01217957|Antiemetics|antiemetics|mesh-ancestor
101576945|NCT01217957|Autonomic Agents|autonomic agents|mesh-ancestor
101576946|NCT01217957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101576947|NCT01217957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576948|NCT01217957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101576949|NCT01217957|Glucocorticoids|glucocorticoids|mesh-ancestor
101576950|NCT01217957|Hormones|hormones|mesh-ancestor
101576951|NCT01217957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101576952|NCT01217957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101576953|NCT01217957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101576954|NCT01217957|Immunologic Factors|immunologic factors|mesh-ancestor
101576955|NCT01217957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101576970|NCT01217801|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101576971|NCT01217801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101576972|NCT01217801|Serotonin Agents|serotonin agents|mesh-ancestor
101576973|NCT01217801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101576974|NCT01217801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576975|NCT00935818|Bupropion|bupropion|mesh-list
101576976|NCT00935818|Varenicline|varenicline|mesh-list
101576977|NCT00935818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101576978|NCT00935818|Antidepressive Agents|antidepressive agents|mesh-ancestor
101576979|NCT00935818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101576980|NCT00935818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101264069|NCT01765738|Leprostatic Agents|leprostatic agents|mesh-ancestor
101576981|NCT00935818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101322589|NCT00006203|Naltrexone|naltrexone|mesh-list
101576982|NCT00935818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101576983|NCT00935818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576984|NCT00935818|Dopamine Agents|dopamine agents|mesh-ancestor
101576985|NCT00935818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101576986|NCT00935818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576987|NCT00935818|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101576988|NCT00935818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101576989|NCT00935818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101576990|NCT00935818|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101576991|NCT00935818|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101576992|NCT00935818|Cholinergic Agents|cholinergic agents|mesh-ancestor
101576993|NCT02709265|Amikacin|amikacin|mesh-list
101576994|NCT02709265|Fosfomycin|fosfomycin|mesh-list
101576995|NCT02709265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101576996|NCT02709265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101576997|NCT00611845|Aprotinin|aprotinin|mesh-list
101576998|NCT00611845|Hemostatics|hemostatics|mesh-ancestor
101576999|NCT00611845|Coagulants|coagulants|mesh-ancestor
101577000|NCT00611845|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101577001|NCT00611845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101577002|NCT00611845|Protease Inhibitors|protease inhibitors|mesh-ancestor
101577003|NCT00611845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101566572|NCT04207112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101566573|NCT04207112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101566574|NCT04207112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577004|NCT00611845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577005|NCT01216163|Acetaminophen|acetaminophen|mesh-list
101577006|NCT01216163|Ibuprofen|ibuprofen|mesh-list
101577007|NCT01216163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101577008|NCT01216163|Analgesics|analgesics|mesh-ancestor
101577009|NCT01216163|Sensory System Agents|sensory system agents|mesh-ancestor
101577010|NCT01216163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101577011|NCT01216163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577012|NCT01216163|Antipyretics|antipyretics|mesh-ancestor
101577013|NCT01216163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101577014|NCT01216163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101577015|NCT01216163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101577036|NCT00612469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101577037|NCT00612469|Disinfectants|disinfectants|mesh-ancestor
101577038|NCT00612469|Dermatologic Agents|dermatologic agents|mesh-ancestor
101577039|NCT00612469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101577040|NCT00933244|Vitamin D|vitamin d|mesh-list
101577041|NCT00933244|Ergocalciferols|ergocalciferols|mesh-list
101577042|NCT00933244|Cholecalciferol|cholecalciferol|mesh-list
101577043|NCT00933244|Vitamins|vitamins|mesh-list
101577044|NCT00933244|Micronutrients|micronutrients|mesh-ancestor
101577045|NCT00933244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577046|NCT00933244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101577047|NCT00933244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101577048|NCT02709187|Candesartan|candesartan|mesh-list
101577049|NCT02709187|Candesartan cilexetil|candesartan cilexetil|mesh-list
101577050|NCT02709187|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101577051|NCT02709187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101577052|NCT02709187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101577053|NCT02709187|Antimetabolites|antimetabolites|mesh-ancestor
101577054|NCT02709187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577055|NCT02709187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101577056|NCT02709187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101577057|NCT02709187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101577058|NCT02709187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101577059|NCT02709187|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101577060|NCT02709187|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101577061|NCT00930046|Ropivacaine|ropivacaine|mesh-list
101577062|NCT00930046|Anesthetics, Local|anesthetics, local|mesh-ancestor
101577063|NCT00930046|Anesthetics|anesthetics|mesh-ancestor
101577064|NCT00930046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101577065|NCT00930046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577066|NCT00930046|Sensory System Agents|sensory system agents|mesh-ancestor
101577067|NCT00930046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101577068|NCT05244031|Analgesics, Opioid|analgesics, opioid|mesh-list
101577069|NCT05244031|Narcotics|narcotics|mesh-ancestor
101577070|NCT05244031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101577071|NCT05244031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577072|NCT05244031|Analgesics|analgesics|mesh-ancestor
101577083|NCT04712071|Anesthetics|anesthetics|mesh-ancestor
101577084|NCT04712071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101577085|NCT04712071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101577086|NCT04712071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101577087|NCT04712071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101577088|NCT04712071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577089|NCT05151328|Plecanatide|plecanatide|mesh-list
101577090|NCT05151328|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
101577091|NCT05151328|Enzyme Activators|enzyme activators|mesh-ancestor
101577092|NCT05151328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577093|NCT05151328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101577094|NCT00609388|Tacrolimus|tacrolimus|mesh-list
101577095|NCT00609388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101577096|NCT00609388|Immunologic Factors|immunologic factors|mesh-ancestor
101577097|NCT00609388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577098|NCT00609388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101577099|NCT00609388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101566575|NCT04207112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566576|NCT04207112|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101566577|NCT04207112|Antitubercular Agents|antitubercular agents|mesh-ancestor
101566578|NCT04207112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101566579|NCT04207112|Leprostatic Agents|leprostatic agents|mesh-ancestor
101566580|NCT01259492|Methylphenidate|methylphenidate|mesh-list
101566581|NCT01259492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101566582|NCT01259492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577100|NCT00609388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577101|NCT02709031|Cicletanine|cicletanine|mesh-list
101577102|NCT02709031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101577103|NCT02709031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101577104|NCT02709031|Diuretics|diuretics|mesh-ancestor
101577105|NCT02709031|Natriuretic Agents|natriuretic agents|mesh-ancestor
101577106|NCT02709031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577107|NCT05225545|Iron|iron|mesh-list
101577108|NCT05225545|Trace Elements|trace elements|mesh-ancestor
101577109|NCT05225545|Micronutrients|micronutrients|mesh-ancestor
101577110|NCT05225545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577111|NCT05378932|Melatonin|melatonin|mesh-list
101577112|NCT05378932|Antioxidants|antioxidants|mesh-ancestor
101577113|NCT05378932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577114|NCT05378932|Protective Agents|protective agents|mesh-ancestor
101577115|NCT05378932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577116|NCT05378932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101577117|NCT00612547|Artesunate|artesunate|mesh-list
101577118|NCT00612547|Amodiaquine|amodiaquine|mesh-list
101577119|NCT00612547|Antimalarials|antimalarials|mesh-ancestor
101577120|NCT00612547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101577121|NCT00612547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101577122|NCT00612547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101577123|NCT00612547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101577124|NCT00612547|Antiviral Agents|antiviral agents|mesh-ancestor
101577125|NCT00612547|Schistosomicides|schistosomicides|mesh-ancestor
101577126|NCT00612547|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101577127|NCT00612547|Anthelmintics|anthelmintics|mesh-ancestor
101577128|NCT00606268|Micafungin|micafungin|mesh-list
101577129|NCT00606268|Antifungal Agents|antifungal agents|mesh-ancestor
101577130|NCT00606268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101577132|NCT05342857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101577133|NCT05342857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101577134|NCT05342857|Growth Substances|growth substances|mesh-ancestor
101577135|NCT05342857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577136|NCT05342857|Growth Inhibitors|growth inhibitors|mesh-ancestor
101577137|NCT05342857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101577138|NCT04264624|Erythritol|erythritol|mesh-list
101577149|NCT01215851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101577150|NCT01215851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577151|NCT01215851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101577152|NCT01215851|Antitubercular Agents|antitubercular agents|mesh-ancestor
101577153|NCT00613093|Temozolomide|temozolomide|mesh-list
101577154|NCT00613093|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
101322759|NCT00093184|Anticoagulants|anticoagulants|mesh-list
101577155|NCT00613093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101577156|NCT00613093|Alkylating Agents|alkylating agents|mesh-ancestor
101577157|NCT00613093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577158|NCT00613093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101577159|NCT00613093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101577160|NCT00607750|Mecamylamine|mecamylamine|mesh-list
101577161|NCT00607750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101577162|NCT00607750|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
101577163|NCT00607750|Autonomic Agents|autonomic agents|mesh-ancestor
101577164|NCT00607750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101577165|NCT00607750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577166|NCT00607750|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101577167|NCT00607750|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101577168|NCT00607750|Cholinergic Agents|cholinergic agents|mesh-ancestor
101577169|NCT00607750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101577170|NCT00607750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566583|NCT01259492|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101566584|NCT01259492|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101566585|NCT01259492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101566586|NCT01259492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566587|NCT01259492|Dopamine Agents|dopamine agents|mesh-ancestor
101566588|NCT01259492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101577172|NCT00609544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101577174|NCT04908475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101577175|NCT04908475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101577176|NCT04908475|Analgesics|analgesics|mesh-ancestor
101577177|NCT04908475|Sensory System Agents|sensory system agents|mesh-ancestor
101577178|NCT04908475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101577179|NCT04908475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577180|NCT04908475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101577181|NCT04908475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101577182|NCT04908475|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101577183|NCT04908475|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101577184|NCT04908475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101577185|NCT04908475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577186|NCT03513211|Hydroxychloroquine|hydroxychloroquine|mesh-list
101322803|NCT00093418|Tipifarnib|tipifarnib|mesh-list
101577187|NCT03513211|Itraconazole|itraconazole|mesh-list
101577188|NCT03513211|Antimalarials|antimalarials|mesh-ancestor
101577189|NCT03513211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101577190|NCT03513211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101577191|NCT03513211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101577192|NCT03513211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101577193|NCT03513211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577194|NCT03513211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101577195|NCT03513211|Antifungal Agents|antifungal agents|mesh-ancestor
101577196|NCT03513211|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101577197|NCT03513211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101577198|NCT03513211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101577199|NCT03513211|Hormone Antagonists|hormone antagonists|mesh-ancestor
101577200|NCT03513211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101577201|NCT03513211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577202|NCT03513211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101577207|NCT04611139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577208|NCT04570501|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
101577209|NCT04570501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101577210|NCT04570501|Vasodilator Agents|vasodilator agents|mesh-ancestor
101577211|NCT05198791|Eplerenone|eplerenone|mesh-list
101577212|NCT05198791|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101577213|NCT05198791|Hormone Antagonists|hormone antagonists|mesh-ancestor
101577214|NCT05198791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101577215|NCT05198791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577216|NCT05198791|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101577217|NCT05198791|Diuretics|diuretics|mesh-ancestor
101577218|NCT05198791|Natriuretic Agents|natriuretic agents|mesh-ancestor
101577219|NCT05198791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101577220|NCT01010061|Rituximab|rituximab|mesh-list
101577221|NCT01010061|Obinutuzumab|obinutuzumab|mesh-list
101577222|NCT01010061|Chlorambucil|chlorambucil|mesh-list
101577223|NCT01010061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101577224|NCT01010061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101577225|NCT01010061|Immunologic Factors|immunologic factors|mesh-ancestor
101577226|NCT01010061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234094|NCT01576419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101577227|NCT01010061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101577228|NCT01010061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101577229|NCT01010061|Alkylating Agents|alkylating agents|mesh-ancestor
101577230|NCT01010061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577231|NCT00607984|Melphalan|melphalan|mesh-list
101577232|NCT00607984|Thiotepa|thiotepa|mesh-list
101577233|NCT00607984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101577234|NCT00607984|Alkylating Agents|alkylating agents|mesh-ancestor
101566589|NCT00624026|Memantine|memantine|mesh-list
101566590|NCT00624026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101566591|NCT00624026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101566592|NCT00624026|Dopamine Agents|dopamine agents|mesh-ancestor
101566593|NCT00624026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101566594|NCT00624026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566595|NCT00624026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566596|NCT00624026|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101566597|NCT00624026|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101566598|NCT05512910|Minocycline|minocycline|mesh-list
101577235|NCT00607984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577236|NCT00607984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101577237|NCT00607984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101577238|NCT00607984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101577239|NCT00607984|Immunologic Factors|immunologic factors|mesh-ancestor
101322884|NCT00006239|Tretinoin|tretinoin|mesh-list
101577240|NCT00607984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577241|NCT00929734|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101577242|NCT00929734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
101577243|NCT00929734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101577244|NCT00929734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101577245|NCT00929734|Antimetabolites|antimetabolites|mesh-ancestor
101577246|NCT00929734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577247|NCT00929734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101577248|NCT00929734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101577249|NCT00609856|Insulin Glargine|insulin glargine|mesh-list
101577250|NCT00609856|Pioglitazone|pioglitazone|mesh-list
101577251|NCT00609856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101577252|NCT00609856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577253|NCT04527757|Anesthetics|anesthetics|mesh-list
101577254|NCT04527757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101577255|NCT04527757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577256|NCT00613249|Dapivirine|dapivirine|mesh-list
101577257|NCT00613249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101577258|NCT00613249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101577259|NCT00613249|Antiviral Agents|antiviral agents|mesh-ancestor
101577260|NCT00613249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101577261|NCT00613561|Fludarabine|fludarabine|mesh-list
101577262|NCT00613561|Busulfan|busulfan|mesh-list
101577263|NCT00613561|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101577264|NCT00613561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101577265|NCT00613561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577266|NCT00613561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101577267|NCT00613561|Immunologic Factors|immunologic factors|mesh-ancestor
101577268|NCT00613561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577269|NCT00613561|Alkylating Agents|alkylating agents|mesh-ancestor
101577270|NCT00613561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101577271|NCT00613561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101577272|NCT01009983|Paclitaxel|paclitaxel|mesh-list
101577273|NCT01009983|Carboplatin|carboplatin|mesh-list
101577274|NCT01009983|Panitumumab|panitumumab|mesh-list
101577281|NCT01009983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101577282|NCT04297215|Anti-Infective Agents|anti-infective agents|mesh-list
101577283|NCT04297215|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101577284|NCT04297215|Chitosan|chitosan|mesh-list
101577285|NCT04297215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101577286|NCT04297215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101577287|NCT04297215|Antimetabolites|antimetabolites|mesh-ancestor
101577288|NCT04297215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577289|NCT04297215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101577290|NCT04297215|Chelating Agents|chelating agents|mesh-ancestor
101577291|NCT04297215|Sequestering Agents|sequestering agents|mesh-ancestor
101577292|NCT04297215|Hemostatics|hemostatics|mesh-ancestor
101577293|NCT04297215|Coagulants|coagulants|mesh-ancestor
101577294|NCT02873091|Sufentanil|sufentanil|mesh-list
101577295|NCT02873091|Ropivacaine|ropivacaine|mesh-list
101577296|NCT02873091|Anesthetics, Local|anesthetics, local|mesh-ancestor
101566599|NCT05512910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101566600|NCT05512910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101566601|NCT02888990|Dasatinib|dasatinib|mesh-list
101566602|NCT02888990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566603|NCT02888990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101566604|NCT02888990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101566605|NCT02888990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566606|NCT05101928|Prednisone|prednisone|mesh-list
101566607|NCT05101928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101566608|NCT05101928|Glucocorticoids|glucocorticoids|mesh-ancestor
101566609|NCT05101928|Hormones|hormones|mesh-ancestor
101566610|NCT05101928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101566611|NCT05101928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566612|NCT05101928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101566613|NCT05101928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101414802|NCT01244269|Dopamine Agents|dopamine agents|mesh-ancestor
101577297|NCT02873091|Anesthetics|anesthetics|mesh-ancestor
101577298|NCT02873091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101577299|NCT02873091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577300|NCT02873091|Sensory System Agents|sensory system agents|mesh-ancestor
101577301|NCT02873091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101577302|NCT02873091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101577304|NCT02873091|Analgesics|analgesics|mesh-ancestor
101577305|NCT02873091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101577306|NCT02873091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101577307|NCT02873091|Anesthetics, General|anesthetics, general|mesh-ancestor
101577308|NCT04298775|Morphine|morphine|mesh-list
101577309|NCT04298775|Anesthetics|anesthetics|mesh-list
101577310|NCT04298775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101577311|NCT04298775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577312|NCT04298775|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101577313|NCT04298775|Narcotics|narcotics|mesh-ancestor
101577314|NCT04298775|Analgesics|analgesics|mesh-ancestor
101577315|NCT04298775|Sensory System Agents|sensory system agents|mesh-ancestor
101577316|NCT04298775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101577317|NCT01215227|Rasagiline|rasagiline|mesh-list
101577318|NCT01215227|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101577319|NCT01215227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101577320|NCT01215227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577321|NCT01215227|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101577322|NCT01215227|Protective Agents|protective agents|mesh-ancestor
101577323|NCT01215227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577324|NCT01009515|Paclitaxel|paclitaxel|mesh-list
101577325|NCT01009515|Carboplatin|carboplatin|mesh-list
101577326|NCT01009515|Temozolomide|temozolomide|mesh-list
101577327|NCT01009515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101577328|NCT01009515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101577329|NCT01009515|Tubulin Modulators|tubulin modulators|mesh-ancestor
101577330|NCT01009515|Antimitotic Agents|antimitotic agents|mesh-ancestor
101577331|NCT01009515|Mitosis Modulators|mitosis modulators|mesh-ancestor
101577332|NCT01009515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577333|NCT01009515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101577334|NCT01009515|Alkylating Agents|alkylating agents|mesh-ancestor
101577335|NCT04550481|Lisinopril|lisinopril|mesh-list
101577336|NCT04550481|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101577337|NCT04550481|Protease Inhibitors|protease inhibitors|mesh-ancestor
101577338|NCT04550481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101577339|NCT04550481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577340|NCT04550481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101566615|NCT04654052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101566616|NCT04654052|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101566617|NCT04654052|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101566618|NCT04654052|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101566619|NCT04654052|Purinergic Agents|purinergic agents|mesh-ancestor
101566620|NCT04654052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101566621|NCT04654052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566622|NCT04654052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566623|NCT05625308|Folic Acid|folic acid|mesh-list
101566624|NCT05625308|Vitamin B 12|vitamin b 12|mesh-list
101566625|NCT05625308|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
101566626|NCT05625308|Hyaluronic Acid|hyaluronic acid|mesh-list
101566627|NCT05625308|Vitamins|vitamins|mesh-ancestor
101566628|NCT05625308|Micronutrients|micronutrients|mesh-ancestor
101566629|NCT05625308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566630|NCT05625308|Hematinics|hematinics|mesh-ancestor
101566631|NCT05625308|Vitamin B Complex|vitamin b complex|mesh-ancestor
101577341|NCT04550481|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101577342|NCT04550481|Protective Agents|protective agents|mesh-ancestor
101577343|NCT04550481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577344|NCT01214915|Anagrelide|anagrelide|mesh-list
101577345|NCT01214915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101577346|NCT01214915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101577350|NCT01009203|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101577351|NCT01009203|Temsirolimus|temsirolimus|mesh-list
101577352|NCT01009203|MTOR Inhibitors|mtor inhibitors|mesh-list
101577353|NCT01009203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101577354|NCT01009203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101577355|NCT01009203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101577356|NCT01009203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577357|NCT01009203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101577358|NCT01009203|Immunologic Factors|immunologic factors|mesh-ancestor
101577359|NCT01009203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577360|NCT01009203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101577361|NCT01009203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101577362|NCT01009203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101577363|NCT01009203|Antifungal Agents|antifungal agents|mesh-ancestor
101577364|NCT01009047|Aripiprazole|aripiprazole|mesh-list
101577365|NCT01009047|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101577366|NCT01009047|Antidepressive Agents|antidepressive agents|mesh-ancestor
101577367|NCT01009047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101577368|NCT01009047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101577369|NCT01009047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101577370|NCT01009047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101577371|NCT01009047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577372|NCT01009047|Dopamine Agonists|dopamine agonists|mesh-ancestor
101577373|NCT01009047|Dopamine Agents|dopamine agents|mesh-ancestor
101577374|NCT01009047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101577375|NCT01009047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234242|NCT01577459|Tedizolid phosphate|tedizolid phosphate|mesh-list
101577376|NCT01009047|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101577377|NCT01009047|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101577378|NCT01009047|Serotonin Agents|serotonin agents|mesh-ancestor
101577379|NCT01009047|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101577380|NCT01009047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101566632|NCT05625308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101566633|NCT05625308|Immunologic Factors|immunologic factors|mesh-ancestor
101566634|NCT05625308|Viscosupplements|viscosupplements|mesh-ancestor
101566635|NCT05625308|Protective Agents|protective agents|mesh-ancestor
101566636|NCT05625308|Antioxidants|antioxidants|mesh-ancestor
101566637|NCT05625308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566638|NCT05625308|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101566639|NCT05625308|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101566640|NCT05625308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566641|NCT05625308|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101566642|NCT04291664|Prednisone|prednisone|mesh-list
101566643|NCT04291664|Abiraterone Acetate|abiraterone acetate|mesh-list
101566644|NCT04291664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101566645|NCT04291664|Glucocorticoids|glucocorticoids|mesh-ancestor
101566646|NCT04291664|Hormones|hormones|mesh-ancestor
101566647|NCT04291664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101566648|NCT04291664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577381|NCT01009047|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101577382|NCT01009047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101577383|NCT04205097|Neostigmine|neostigmine|mesh-list
101577384|NCT04205097|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101577385|NCT04205097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101577386|NCT04205097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577387|NCT04205097|Cholinergic Agents|cholinergic agents|mesh-ancestor
101577388|NCT04205097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101577389|NCT04205097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577390|NCT04205097|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101577391|NCT04205097|Autonomic Agents|autonomic agents|mesh-ancestor
101577392|NCT04205097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101577394|NCT04205565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101577395|NCT04205565|Nootropic Agents|nootropic agents|mesh-ancestor
101577396|NCT01025193|Belimumab|belimumab|mesh-list
101577397|NCT01025193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101577398|NCT01025193|Immunologic Factors|immunologic factors|mesh-ancestor
101577399|NCT01025193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577400|NCT01008423|Budesonide|budesonide|mesh-list
101577401|NCT01008423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101577402|NCT01008423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101577403|NCT01008423|Autonomic Agents|autonomic agents|mesh-ancestor
101577404|NCT01008423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101577405|NCT01008423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577406|NCT01008423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101577407|NCT01008423|Respiratory System Agents|respiratory system agents|mesh-ancestor
101577408|NCT01008423|Glucocorticoids|glucocorticoids|mesh-ancestor
101577409|NCT01008423|Hormones|hormones|mesh-ancestor
101577410|NCT01008423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101577411|NCT04735861|Bevacizumab|bevacizumab|mesh-list
101577412|NCT04735861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101577413|NCT04735861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101577414|NCT04735861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101577415|NCT04735861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101577416|NCT04735861|Growth Substances|growth substances|mesh-ancestor
101577417|NCT04735861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577453|NCT03369301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577454|NCT05345119|Sirolimus|sirolimus|mesh-list
101577455|NCT05345119|Methylprednisolone|methylprednisolone|mesh-list
101577456|NCT05345119|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101577457|NCT05345119|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101577458|NCT05345119|Prednisolone|prednisolone|mesh-list
101566649|NCT04291664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101566650|NCT04291664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566651|NCT04291664|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101566652|NCT04291664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101566653|NCT04291664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566654|NCT04291664|Hormone Antagonists|hormone antagonists|mesh-ancestor
101566655|NCT04291664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101577459|NCT05345119|Prednisolone acetate|prednisolone acetate|mesh-list
101323257|NCT00096148|Immunoglobulins|immunoglobulins|mesh-list
101577460|NCT05345119|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101577461|NCT05345119|Prednisolone phosphate|prednisolone phosphate|mesh-list
101577462|NCT05345119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101577463|NCT05345119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101577465|NCT05345119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101577466|NCT05345119|Antifungal Agents|antifungal agents|mesh-ancestor
101577467|NCT05345119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101577468|NCT05345119|Immunologic Factors|immunologic factors|mesh-ancestor
101577469|NCT05345119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577470|NCT05345119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101577471|NCT05345119|Antiemetics|antiemetics|mesh-ancestor
101577472|NCT05345119|Autonomic Agents|autonomic agents|mesh-ancestor
101577473|NCT05345119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101577474|NCT05345119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101577475|NCT05345119|Glucocorticoids|glucocorticoids|mesh-ancestor
101577476|NCT05345119|Hormones|hormones|mesh-ancestor
101577477|NCT05345119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101577478|NCT05345119|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101577479|NCT05345119|Protective Agents|protective agents|mesh-ancestor
101577480|NCT05345119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101577481|NCT03529123|Insulin|insulin|mesh-list
101577482|NCT03529123|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101577483|NCT03529123|Metformin|metformin|mesh-list
101577484|NCT03529123|Insulin Glargine|insulin glargine|mesh-list
101577485|NCT03529123|Insulin glulisine|insulin glulisine|mesh-list
101577486|NCT03529123|Lixisenatide|lixisenatide|mesh-list
101577487|NCT03529123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101577488|NCT03529123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577489|NCT04074187|Methylprednisolone|methylprednisolone|mesh-list
101577490|NCT04074187|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101577491|NCT04074187|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101577492|NCT04074187|Prednisolone|prednisolone|mesh-list
101577493|NCT04074187|Prednisolone acetate|prednisolone acetate|mesh-list
101577494|NCT04074187|Rituximab|rituximab|mesh-list
101577495|NCT04074187|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101577496|NCT04074187|Prednisolone phosphate|prednisolone phosphate|mesh-list
101577497|NCT04074187|Immunosuppressive Agents|immunosuppressive agents|mesh-list
101577498|NCT04074187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101577499|NCT04074187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101577500|NCT04074187|Immunologic Factors|immunologic factors|mesh-ancestor
101577501|NCT04074187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577502|NCT04074187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101577503|NCT04074187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101577504|NCT04074187|Antiemetics|antiemetics|mesh-ancestor
101577505|NCT04074187|Autonomic Agents|autonomic agents|mesh-ancestor
101577506|NCT04074187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101577507|NCT04074187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101577508|NCT04074187|Glucocorticoids|glucocorticoids|mesh-ancestor
101577509|NCT04074187|Hormones|hormones|mesh-ancestor
101577510|NCT04074187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101577511|NCT04074187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101577512|NCT04074187|Protective Agents|protective agents|mesh-ancestor
101577513|NCT04074187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101577514|NCT03128905|Prednisone|prednisone|mesh-list
101577515|NCT03128905|Colchicine|colchicine|mesh-list
101577516|NCT03128905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101577517|NCT03128905|Glucocorticoids|glucocorticoids|mesh-ancestor
101577518|NCT03128905|Hormones|hormones|mesh-ancestor
101577519|NCT03128905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101577520|NCT03128905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577521|NCT03128905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101566656|NCT04187469|Moxifloxacin|moxifloxacin|mesh-list
101566657|NCT04187469|Rifampin|rifampin|mesh-list
101566658|NCT04187469|Isoniazid|isoniazid|mesh-list
101566659|NCT04187469|Pyrazinamide|pyrazinamide|mesh-list
101566660|NCT04187469|Ethambutol|ethambutol|mesh-list
101566661|NCT04187469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101566662|NCT04187469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101566663|NCT04187469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101566664|NCT04187469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101566665|NCT04187469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101577522|NCT03128905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101577523|NCT03128905|Gout Suppressants|gout suppressants|mesh-ancestor
101577524|NCT03128905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101577525|NCT03128905|Tubulin Modulators|tubulin modulators|mesh-ancestor
101577526|NCT03128905|Antimitotic Agents|antimitotic agents|mesh-ancestor
101577527|NCT03128905|Mitosis Modulators|mitosis modulators|mesh-ancestor
101577528|NCT03128905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577529|NCT02430181|Interferons|interferons|mesh-list
101577530|NCT02430181|Ritonavir|ritonavir|mesh-list
101577531|NCT02430181|Interferon-alpha|interferon-alpha|mesh-list
101577532|NCT02430181|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101577533|NCT02430181|Lonafarnib|lonafarnib|mesh-list
101577534|NCT02430181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101577535|NCT02430181|Antiviral Agents|antiviral agents|mesh-ancestor
101577536|NCT02430181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101577537|NCT02430181|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101577538|NCT02430181|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101577539|NCT02430181|Protease Inhibitors|protease inhibitors|mesh-ancestor
101577540|NCT02430181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101577564|NCT03909451|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101577565|NCT03909451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577566|NCT03909451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101577567|NCT03909451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577568|NCT03463135|Immunomodulating Agents|immunomodulating agents|mesh-list
101577569|NCT03463135|Immunologic Factors|immunologic factors|mesh-ancestor
101577570|NCT03463135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577571|NCT03596125|Acetylcysteine|acetylcysteine|mesh-list
101577572|NCT03596125|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101577573|NCT03596125|Antiviral Agents|antiviral agents|mesh-ancestor
101577574|NCT03596125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101577575|NCT03596125|Expectorants|expectorants|mesh-ancestor
101577576|NCT03596125|Respiratory System Agents|respiratory system agents|mesh-ancestor
101577577|NCT03596125|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101577578|NCT03596125|Antioxidants|antioxidants|mesh-ancestor
101577579|NCT03596125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577580|NCT03596125|Protective Agents|protective agents|mesh-ancestor
101577581|NCT03596125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577582|NCT03596125|Antidotes|antidotes|mesh-ancestor
101577584|NCT02118727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101577585|NCT02118727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101577586|NCT02118727|Dopamine Agents|dopamine agents|mesh-ancestor
101577587|NCT02118727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101577592|NCT05343637|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101577593|NCT05343637|Vasodilator Agents|vasodilator agents|mesh-ancestor
101577594|NCT05343637|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101577595|NCT05343637|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101577596|NCT05343637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101577597|NCT05343637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577598|NCT05343637|Urological Agents|urological agents|mesh-ancestor
101577599|NCT03776227|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
101577600|NCT03776227|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101577601|NCT03776227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577602|NCT03776227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101577603|NCT03776227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577604|NCT00614809|Gefitinib|gefitinib|mesh-list
101577605|NCT00614809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566666|NCT04187469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566667|NCT04187469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566668|NCT04187469|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101566669|NCT04187469|Antitubercular Agents|antitubercular agents|mesh-ancestor
101566670|NCT04187469|Leprostatic Agents|leprostatic agents|mesh-ancestor
101566671|NCT04187469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101566672|NCT04187469|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101566673|NCT04187469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101414863|NCT01244659|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101577606|NCT00614809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101577607|NCT00614809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101577608|NCT00614809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577609|NCT02964013|Carboplatin|carboplatin|mesh-list
101577610|NCT02964013|Pembrolizumab|pembrolizumab|mesh-list
101577611|NCT02964013|Etoposide|etoposide|mesh-list
101577612|NCT02964013|Pemetrexed|pemetrexed|mesh-list
101577613|NCT02964013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101577614|NCT02964013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101577615|NCT02964013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101577616|NCT02964013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577617|NCT02964013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101577618|NCT02964013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101577619|NCT02964013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101577620|NCT02964013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101577621|NCT02964013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101577622|NCT02964013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101577623|NCT02699437|Antibodies|antibodies|mesh-list
101577624|NCT02699437|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
101577625|NCT02699437|Immunologic Factors|immunologic factors|mesh-ancestor
101577626|NCT02699437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577627|NCT01211483|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101577628|NCT01211483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101577629|NCT01211483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101577630|NCT01211483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101577631|NCT01211483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577632|NCT00615823|Atorvastatin|atorvastatin|mesh-list
101577633|NCT00615823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101577634|NCT00615823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101577635|NCT00615823|Antimetabolites|antimetabolites|mesh-ancestor
101577636|NCT00615823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577637|NCT00615823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101577638|NCT00615823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101577639|NCT00615823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101577640|NCT02699281|Palmidrol|palmidrol|mesh-list
101577641|NCT02699281|Analgesics|analgesics|mesh-ancestor
101577642|NCT02699281|Sensory System Agents|sensory system agents|mesh-ancestor
101323554|NCT00006347|Antibodies|antibodies|mesh-list
101577643|NCT02699281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101577644|NCT02699281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577645|NCT02699281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101577646|NCT02699281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101577647|NCT02699281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101577648|NCT02699281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101577649|NCT02699281|Antiviral Agents|antiviral agents|mesh-ancestor
101577650|NCT02699281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101577651|NCT02699281|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101577652|NCT02699281|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101577663|NCT02704507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101577664|NCT02704507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577665|NCT02704507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101577666|NCT02704507|Keratolytic Agents|keratolytic agents|mesh-ancestor
101577667|NCT02704507|Dermatologic Agents|dermatologic agents|mesh-ancestor
101566674|NCT04187469|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101566675|NCT04187469|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101566676|NCT04187469|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101566677|NCT04187469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101566678|NCT04187469|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101566679|NCT04187469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101566680|NCT04187469|Antimetabolites|antimetabolites|mesh-ancestor
101577668|NCT01210001|Empagliflozin|empagliflozin|mesh-list
101577669|NCT01210001|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101323598|NCT00099502|Immunologic Factors|immunologic factors|mesh-ancestor
101577670|NCT01210001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577671|NCT01210001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101577672|NCT01210001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577673|NCT00624455|Gabapentin|gabapentin|mesh-list
101577674|NCT00624455|Analgesics|analgesics|mesh-ancestor
101577675|NCT00624455|Sensory System Agents|sensory system agents|mesh-ancestor
101234544|NCT01578824|Miotics|miotics|mesh-ancestor
101577676|NCT00624455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101577677|NCT00624455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577678|NCT00624455|Anticonvulsants|anticonvulsants|mesh-ancestor
101577679|NCT00624455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101577680|NCT00624455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101577681|NCT00624455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101577682|NCT00624455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101577683|NCT00624455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101577684|NCT00624455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101577685|NCT00624455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101323646|NCT00400621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101577686|NCT00624455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577687|NCT00624455|Antimanic Agents|antimanic agents|mesh-ancestor
101577688|NCT01127659|Testosterone|testosterone|mesh-list
101577689|NCT01127659|Androgens|androgens|mesh-ancestor
101577691|NCT01127659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101577692|NCT01127659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577693|NCT02698969|Atropine|atropine|mesh-list
101577694|NCT02698969|Fentanyl|fentanyl|mesh-list
101577695|NCT02698969|Propofol|propofol|mesh-list
101577696|NCT02698969|Sevoflurane|sevoflurane|mesh-list
101577697|NCT02698969|Rocuronium|rocuronium|mesh-list
101577698|NCT02698969|Neostigmine|neostigmine|mesh-list
101577699|NCT02698969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101577700|NCT02698969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101577701|NCT02698969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577702|NCT02698969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101577703|NCT02698969|Anesthetics, General|anesthetics, general|mesh-ancestor
101577704|NCT02698969|Anesthetics|anesthetics|mesh-ancestor
101577705|NCT02698969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101577706|NCT02698969|Narcotics|narcotics|mesh-ancestor
101577707|NCT02698969|Analgesics|analgesics|mesh-ancestor
101577708|NCT02698969|Sensory System Agents|sensory system agents|mesh-ancestor
101577709|NCT02698969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101577710|NCT02698969|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101577711|NCT02698969|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101577712|NCT02698969|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101577713|NCT02698969|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101577714|NCT02698969|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101577715|NCT02698969|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101577716|NCT02698969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101577717|NCT02698969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101577718|NCT02698969|Autonomic Agents|autonomic agents|mesh-ancestor
101577724|NCT02698969|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101577725|NCT02698969|Cholinergic Agents|cholinergic agents|mesh-ancestor
101577726|NCT02698969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101577727|NCT02698969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577728|NCT02698969|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101577729|NCT02698969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101577730|NCT02698969|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101577731|NCT00848731|Nitric Oxide|nitric oxide|mesh-list
101577732|NCT00848731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101566681|NCT04187469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101566682|NCT01116687|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
101566683|NCT01116687|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101566684|NCT01116687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101566685|NCT01116687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566686|NCT02867020|Prednisone|prednisone|mesh-list
101566687|NCT02867020|Goserelin|goserelin|mesh-list
101566688|NCT02867020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101566689|NCT02867020|Glucocorticoids|glucocorticoids|mesh-ancestor
101566690|NCT02867020|Hormones|hormones|mesh-ancestor
101577733|NCT00848731|Autonomic Agents|autonomic agents|mesh-ancestor
101577734|NCT00848731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101577735|NCT00848731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577736|NCT00848731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101577737|NCT00848731|Respiratory System Agents|respiratory system agents|mesh-ancestor
101577738|NCT00848731|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101577739|NCT00848731|Antioxidants|antioxidants|mesh-ancestor
101577740|NCT00848731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577741|NCT00848731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101577742|NCT00848731|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101577743|NCT00848731|Vasodilator Agents|vasodilator agents|mesh-ancestor
101577744|NCT00848731|Gasotransmitters|gasotransmitters|mesh-ancestor
101577745|NCT00848731|Protective Agents|protective agents|mesh-ancestor
101577746|NCT01209143|Rosiglitazone|rosiglitazone|mesh-list
101577747|NCT01209143|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101577748|NCT01209143|Norethindrone|norethindrone|mesh-list
101577749|NCT01209143|Norethindrone Acetate|norethindrone acetate|mesh-list
101577750|NCT01209143|Estradiol|estradiol|mesh-list
101577751|NCT01209143|Estrogens|estrogens|mesh-ancestor
101577752|NCT01209143|Hormones|hormones|mesh-ancestor
101577753|NCT01209143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101577754|NCT01209143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577755|NCT01209143|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101577756|NCT01209143|Contraceptive Agents|contraceptive agents|mesh-ancestor
101577757|NCT01209143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101577758|NCT01209143|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101577759|NCT01209143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101323817|NCT00100594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101577760|NCT01209143|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101577761|NCT01209143|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101577762|NCT01209143|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101577763|NCT00454285|Amoxicillin|amoxicillin|mesh-list
101577764|NCT00454285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101577765|NCT00454285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101577766|NCT00614965|Irinotecan|irinotecan|mesh-list
101577767|NCT00614965|Pemetrexed|pemetrexed|mesh-list
101577768|NCT00614965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101577769|NCT00614965|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101577770|NCT00614965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101577771|NCT00614965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101577772|NCT00614965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577773|NCT00614965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101577774|NCT00614965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101577775|NCT00405613|Aspirin|aspirin|mesh-list
101577776|NCT00405613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101577777|NCT00405613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101577778|NCT00405613|Analgesics|analgesics|mesh-ancestor
101323850|NCT00006377|Carboplatin|carboplatin|mesh-list
101577779|NCT00405613|Sensory System Agents|sensory system agents|mesh-ancestor
101577780|NCT00405613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101577781|NCT00405613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577782|NCT00405613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101577783|NCT00405613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101577784|NCT00405613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101577785|NCT00405613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101566691|NCT02867020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101566692|NCT02867020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566693|NCT02867020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101566694|NCT02867020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566695|NCT03817502|Cariprazine|cariprazine|mesh-list
101566696|NCT03817502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101566697|NCT03817502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101566698|NCT03817502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101566699|NCT03817502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566700|NCT03817502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101566701|NCT04319978|Dexamethasone|dexamethasone|mesh-list
101566702|NCT04319978|Dexamethasone acetate|dexamethasone acetate|mesh-list
101566703|NCT04319978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101566704|NCT04319978|Antiemetics|antiemetics|mesh-ancestor
101566705|NCT04319978|Autonomic Agents|autonomic agents|mesh-ancestor
101566706|NCT04319978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101566707|NCT04319978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414895|NCT00495352|Bupropion|bupropion|mesh-list
101577786|NCT00405613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577787|NCT00405613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101577788|NCT00405613|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101577808|NCT02703571|Trametinib|trametinib|mesh-list
101577809|NCT02703571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101577810|NCT02703571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101577811|NCT02703571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101577812|NCT02703571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577813|NCT02703415|Tramadol|tramadol|mesh-list
101577814|NCT02703415|Bupivacaine|bupivacaine|mesh-list
101577815|NCT02703415|Anesthetics, Local|anesthetics, local|mesh-ancestor
101577816|NCT02703415|Anesthetics|anesthetics|mesh-ancestor
101577817|NCT02703415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101577818|NCT02703415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577819|NCT02703415|Sensory System Agents|sensory system agents|mesh-ancestor
101577820|NCT02703415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101577821|NCT02703415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101577822|NCT02703415|Narcotics|narcotics|mesh-ancestor
101577823|NCT02703415|Analgesics|analgesics|mesh-ancestor
101577824|NCT02703181|Diketopiperazines|diketopiperazines|mesh-list
101577825|NCT02703181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101577826|NCT02703181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101577827|NCT04215835|Letrozole|letrozole|mesh-list
101577828|NCT04215835|Misoprostol|misoprostol|mesh-list
101577829|NCT04215835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101577830|NCT04215835|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101577831|NCT04215835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101577832|NCT04215835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101577833|NCT04215835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577834|NCT04215835|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101577835|NCT04215835|Hormone Antagonists|hormone antagonists|mesh-ancestor
101577836|NCT04215835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101577837|NCT04215835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577838|NCT04215835|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101577839|NCT04215835|Abortifacient Agents|abortifacient agents|mesh-ancestor
101577840|NCT04215835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101577841|NCT04215835|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101577842|NCT04215835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101566708|NCT04319978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101566709|NCT04319978|Glucocorticoids|glucocorticoids|mesh-ancestor
101566710|NCT04319978|Hormones|hormones|mesh-ancestor
101566711|NCT04319978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101566712|NCT04319978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101566713|NCT04319978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566714|NCT01114737|Verapamil|verapamil|mesh-list
101541518|NCT04550702|Mirabegron|mirabegron|mesh-list
101577843|NCT04215835|Oxytocics|oxytocics|mesh-ancestor
101577844|NCT01208207|Naproxen|naproxen|mesh-list
101577852|NCT01208207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101577853|NCT01208207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101577854|NCT01208207|Gout Suppressants|gout suppressants|mesh-ancestor
101577855|NCT01208207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101577856|NCT01208207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101577857|NCT01208207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577858|NCT01208207|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101577859|NCT05420285|Dapagliflozin|dapagliflozin|mesh-list
101577860|NCT05420285|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101577861|NCT05420285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577862|NCT05420285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101577863|NCT05420285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577864|NCT01012713|Calcitriol|calcitriol|mesh-list
101577865|NCT01012713|Clobetasol|clobetasol|mesh-list
101577866|NCT01012713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101577867|NCT01012713|Glucocorticoids|glucocorticoids|mesh-ancestor
101577868|NCT01012713|Hormones|hormones|mesh-ancestor
101775273|NCT00935961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101577869|NCT01012713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101577870|NCT01012713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577871|NCT01012713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101577872|NCT01012713|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101577873|NCT01012713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101577874|NCT01012713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577875|NCT01012713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101577877|NCT01012713|Micronutrients|micronutrients|mesh-ancestor
101577878|NCT01012713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101577879|NCT02698813|Hyaluronic Acid|hyaluronic acid|mesh-list
101577880|NCT02698813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101577881|NCT02698813|Immunologic Factors|immunologic factors|mesh-ancestor
101577882|NCT02698813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577883|NCT02698813|Viscosupplements|viscosupplements|mesh-ancestor
101577884|NCT02698813|Protective Agents|protective agents|mesh-ancestor
101577885|NCT02702323|Apatinib|apatinib|mesh-list
101577886|NCT02702323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101577887|NCT02702323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101577888|NCT02702323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101577889|NCT02702323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577890|NCT01007253|Fluticasone|fluticasone|mesh-list
101577891|NCT01007253|Xhance|xhance|mesh-list
101577892|NCT01007253|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
101577893|NCT01007253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101577894|NCT01007253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101577895|NCT01007253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101577896|NCT01007253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101577897|NCT01007253|Autonomic Agents|autonomic agents|mesh-ancestor
101577898|NCT01007253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101324055|NCT00101569|Serotonin Agents|serotonin agents|mesh-ancestor
101577899|NCT01007253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577900|NCT01007253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101577901|NCT01007253|Respiratory System Agents|respiratory system agents|mesh-ancestor
101577902|NCT01007253|Dermatologic Agents|dermatologic agents|mesh-ancestor
101577903|NCT01007253|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101577904|NCT01007253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101577905|NCT01007253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101577906|NCT01007253|Analgesics|analgesics|mesh-ancestor
101577907|NCT01007253|Sensory System Agents|sensory system agents|mesh-ancestor
101577908|NCT01007253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101566715|NCT01114737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101566716|NCT01114737|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101566717|NCT01114737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101566718|NCT01114737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566719|NCT01114737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101566720|NCT01114737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566721|NCT01114737|Vasodilator Agents|vasodilator agents|mesh-ancestor
101566722|NCT00624182|Gemcitabine|gemcitabine|mesh-list
101577909|NCT01007253|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101577910|NCT01007253|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101577917|NCT02691949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101577918|NCT02691949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101577919|NCT02691949|Antitubercular Agents|antitubercular agents|mesh-ancestor
101577920|NCT02691949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101577921|NCT02691949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101577922|NCT02691949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101577923|NCT02691949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577924|NCT01006707|Ondansetron|ondansetron|mesh-list
101577925|NCT01006707|Antiemetics|antiemetics|mesh-ancestor
101577926|NCT01006707|Autonomic Agents|autonomic agents|mesh-ancestor
101577927|NCT01006707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101577928|NCT01006707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577929|NCT01006707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101577930|NCT01006707|Antipruritics|antipruritics|mesh-ancestor
101577931|NCT01006707|Dermatologic Agents|dermatologic agents|mesh-ancestor
101577932|NCT01006707|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101577933|NCT01006707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101577934|NCT01006707|Serotonin Agents|serotonin agents|mesh-ancestor
101577935|NCT01006707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101577936|NCT01006707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577937|NCT01006629|Palivizumab|palivizumab|mesh-list
101577938|NCT01006629|Antiviral Agents|antiviral agents|mesh-ancestor
101577939|NCT01006629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101577940|NCT04214977|Anesthetics|anesthetics|mesh-list
101577941|NCT04214977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101577942|NCT04214977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577943|NCT02701933|Ketamine|ketamine|mesh-list
101577944|NCT02701933|Analgesics|analgesics|mesh-ancestor
101577945|NCT02701933|Sensory System Agents|sensory system agents|mesh-ancestor
101577946|NCT02701933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101577947|NCT02701933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577948|NCT02701933|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101577949|NCT02701933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101577950|NCT02701933|Anesthetics, General|anesthetics, general|mesh-ancestor
101577951|NCT02701933|Anesthetics|anesthetics|mesh-ancestor
101577952|NCT02701933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101577953|NCT02701933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101577954|NCT02701933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101577955|NCT02701933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101577956|NCT02701933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577957|NCT04295967|Formaldehyde|formaldehyde|mesh-list
101577958|NCT04295967|Disinfectants|disinfectants|mesh-ancestor
101577959|NCT04295967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101577960|NCT01012323|Immunoglobulins|immunoglobulins|mesh-list
101577961|NCT01012323|Immunologic Factors|immunologic factors|mesh-ancestor
101577962|NCT01012323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577963|NCT02871765|Warfarin|warfarin|mesh-list
101577964|NCT02871765|Anticoagulants|anticoagulants|mesh-ancestor
101577965|NCT02549209|Paclitaxel|paclitaxel|mesh-list
101577966|NCT02549209|Carboplatin|carboplatin|mesh-list
101577967|NCT02549209|Pembrolizumab|pembrolizumab|mesh-list
101577968|NCT02549209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101577969|NCT02549209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101577970|NCT02549209|Tubulin Modulators|tubulin modulators|mesh-ancestor
101577971|NCT02549209|Antimitotic Agents|antimitotic agents|mesh-ancestor
101566723|NCT00624182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101566724|NCT00624182|Antimetabolites|antimetabolites|mesh-ancestor
101566725|NCT00624182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566726|NCT00624182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566728|NCT00625677|Immunologic Factors|immunologic factors|mesh-ancestor
101414929|NCT00405405|Growth Substances|growth substances|mesh-ancestor
101577972|NCT02549209|Mitosis Modulators|mitosis modulators|mesh-ancestor
101577973|NCT02549209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577974|NCT02549209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101577975|NCT02549209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101577976|NCT02698267|Itraconazole|itraconazole|mesh-list
101577977|NCT02698267|Antifungal Agents|antifungal agents|mesh-ancestor
101577978|NCT02698267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101577979|NCT02698267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101577987|NCT02698267|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101577989|NCT01011465|Oxytocics|oxytocics|mesh-ancestor
101577990|NCT01011465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101577991|NCT01011465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577992|NCT02494141|Curcumin|curcumin|mesh-list
101577993|NCT02494141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101577994|NCT02494141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101577995|NCT02494141|Analgesics|analgesics|mesh-ancestor
101577996|NCT02494141|Sensory System Agents|sensory system agents|mesh-ancestor
101577997|NCT02494141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101577998|NCT02494141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577999|NCT02494141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101578000|NCT02494141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101578001|NCT02494141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101578002|NCT02494141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101578003|NCT02494141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578004|NCT01011309|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
101578005|NCT01011309|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101578006|NCT01011309|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101578007|NCT01011309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101578008|NCT01011309|Schistosomicides|schistosomicides|mesh-ancestor
101578009|NCT01011309|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101578010|NCT01011309|Anthelmintics|anthelmintics|mesh-ancestor
101578011|NCT04214821|Moxifloxacin|moxifloxacin|mesh-list
101578012|NCT04214821|Levofloxacin|levofloxacin|mesh-list
101578013|NCT04214821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101578014|NCT04214821|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101578015|NCT04214821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101578016|NCT04214821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101578017|NCT04214821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101578018|NCT04214821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101578019|NCT04214821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101578020|NCT04214821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578021|NCT04214821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101578022|NCT04214821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101578023|NCT04214821|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101578024|NCT04214821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101578025|NCT00616213|Lenograstim|lenograstim|mesh-list
101578026|NCT00616213|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101578027|NCT00616213|Immunologic Factors|immunologic factors|mesh-ancestor
101578028|NCT00616213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578030|NCT00615667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101578031|NCT00615667|Immunologic Factors|immunologic factors|mesh-ancestor
101578032|NCT00615667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578033|NCT00615667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101578034|NCT00615667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101578035|NCT00615667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578036|NCT02697955|Epinephrine|epinephrine|mesh-list
101578037|NCT02697955|Bupivacaine|bupivacaine|mesh-list
101578038|NCT02697955|Anesthetics, Local|anesthetics, local|mesh-ancestor
101578039|NCT02697955|Anesthetics|anesthetics|mesh-ancestor
101578040|NCT02697955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101566729|NCT00625677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566730|NCT00979576|Pemetrexed|pemetrexed|mesh-list
101566731|NCT00979576|Nintedanib|nintedanib|mesh-list
101566732|NCT00979576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566733|NCT00979576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101566734|NCT00979576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566735|NCT00979576|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101566736|NCT00979576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101566737|NCT00979576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101566738|NCT02867332|Cyclophosphamide|cyclophosphamide|mesh-list
101566739|NCT02867332|Interleukin-2|interleukin-2|mesh-list
101414938|NCT00495898|Sirolimus|sirolimus|mesh-list
101578041|NCT02697955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578042|NCT02697955|Sensory System Agents|sensory system agents|mesh-ancestor
101578043|NCT02697955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101578044|NCT02697955|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101578045|NCT02697955|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101578055|NCT02697955|Sympathomimetics|sympathomimetics|mesh-ancestor
101578056|NCT02697955|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101578057|NCT04294329|Bupivacaine|bupivacaine|mesh-list
101578058|NCT04294329|Anesthetics, Local|anesthetics, local|mesh-ancestor
101578059|NCT04294329|Anesthetics|anesthetics|mesh-ancestor
101578060|NCT04294329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101578061|NCT04294329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578062|NCT04294329|Sensory System Agents|sensory system agents|mesh-ancestor
101578063|NCT04294329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101578065|NCT02701309|Protoporphyrin IX|protoporphyrin ix|mesh-list
101578066|NCT02701309|Zinc protoporphyrin|zinc protoporphyrin|mesh-list
101578067|NCT02701309|Trace Elements|trace elements|mesh-ancestor
101578068|NCT02701309|Micronutrients|micronutrients|mesh-ancestor
101578069|NCT02701309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578070|NCT02701309|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101578071|NCT02701309|Dermatologic Agents|dermatologic agents|mesh-ancestor
101578072|NCT02701309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101578073|NCT02701309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578074|NCT03250507|Bupivacaine|bupivacaine|mesh-list
101578075|NCT03250507|Anesthetics, Local|anesthetics, local|mesh-ancestor
101578076|NCT03250507|Anesthetics|anesthetics|mesh-ancestor
101578077|NCT03250507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101578078|NCT03250507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578079|NCT03250507|Sensory System Agents|sensory system agents|mesh-ancestor
101578080|NCT03250507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101578081|NCT00997893|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101578082|NCT00997893|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101578083|NCT00997893|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101578084|NCT00997893|Medroxyprogesterone|medroxyprogesterone|mesh-list
101578085|NCT00997893|Estradiol|estradiol|mesh-list
101578086|NCT00997893|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101578087|NCT00997893|Estrogens|estrogens|mesh-list
101578088|NCT00997893|Phytoestrogens|phytoestrogens|mesh-list
101578089|NCT00997893|Hormones|hormones|mesh-ancestor
101578090|NCT00997893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101578091|NCT00997893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578092|NCT00997893|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101578093|NCT00997893|Contraceptive Agents|contraceptive agents|mesh-ancestor
101578094|NCT00997893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101578095|NCT00997893|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101578096|NCT00997893|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101578097|NCT00997893|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101578098|NCT00997893|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101578099|NCT00997893|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101578100|NCT00997893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101578101|NCT00997893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566740|NCT02867332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101566741|NCT02867332|Immunologic Factors|immunologic factors|mesh-ancestor
101566742|NCT02867332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566743|NCT02867332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101566744|NCT02867332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101566745|NCT02867332|Alkylating Agents|alkylating agents|mesh-ancestor
101566746|NCT02867332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578102|NCT00997893|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101578103|NCT02697877|Regadenoson|regadenoson|mesh-list
101578104|NCT02697877|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
101578105|NCT02697877|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101578106|NCT02697877|Purinergic Agonists|purinergic agonists|mesh-ancestor
101578107|NCT02697877|Purinergic Agents|purinergic agents|mesh-ancestor
101578108|NCT02697877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101578109|NCT02697877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221737|NCT01509209|Sympathomimetics|sympathomimetics|mesh-ancestor
101578118|NCT04214665|Micronutrients|micronutrients|mesh-ancestor
101578119|NCT02870673|Triamcinolone|triamcinolone|mesh-list
101578120|NCT02870673|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101578121|NCT02870673|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101578122|NCT02870673|Lidocaine|lidocaine|mesh-list
101578123|NCT02870673|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101578124|NCT02870673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101578125|NCT02870673|Glucocorticoids|glucocorticoids|mesh-ancestor
101578126|NCT02870673|Hormones|hormones|mesh-ancestor
101578127|NCT02870673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101578128|NCT02870673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578129|NCT02870673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101578130|NCT02870673|Immunologic Factors|immunologic factors|mesh-ancestor
101578131|NCT02870673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101578132|NCT02870673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578133|NCT02870673|Anesthetics, Local|anesthetics, local|mesh-ancestor
101578134|NCT02870673|Anesthetics|anesthetics|mesh-ancestor
101578135|NCT02870673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101578136|NCT02870673|Sensory System Agents|sensory system agents|mesh-ancestor
101578137|NCT02870673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101578138|NCT02870673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101578139|NCT02870673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101578140|NCT02870673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101578141|NCT02870673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101578142|NCT00615745|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101578143|NCT00615745|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101578144|NCT00615745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101578145|NCT00615745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101578146|NCT00615745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578147|NCT00615745|Antiviral Agents|antiviral agents|mesh-ancestor
101578148|NCT00615745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101578149|NCT00615745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101578150|NCT00615745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101578151|NCT05324839|Botulinum Toxins|botulinum toxins|mesh-list
101578152|NCT05324839|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101578153|NCT05324839|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101578154|NCT05324839|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101578155|NCT05324839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101578156|NCT05324839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578157|NCT05324839|Cholinergic Agents|cholinergic agents|mesh-ancestor
101578158|NCT05324839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101578159|NCT05324839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264086|NCT01765829|Olanzapine|olanzapine|mesh-list
101578160|NCT05324839|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101578161|NCT05324839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101578162|NCT02700685|Methylphenidate|methylphenidate|mesh-list
101578164|NCT02700685|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101578165|NCT02700685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566747|NCT02867332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566748|NCT02867332|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101566749|NCT02867332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101566750|NCT02867332|Analgesics|analgesics|mesh-ancestor
101566751|NCT02867332|Sensory System Agents|sensory system agents|mesh-ancestor
101566752|NCT02867332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101566753|NCT02702180|Molgramostim|molgramostim|mesh-list
101566754|NCT02702180|Sargramostim|sargramostim|mesh-list
101566755|NCT02702180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566756|NCT02702180|Immunologic Factors|immunologic factors|mesh-ancestor
101566757|NCT02702180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566758|NCT00980980|Chlorhexidine|chlorhexidine|mesh-list
101566759|NCT00980980|Mupirocin|mupirocin|mesh-list
101414950|NCT00127478|Atrasentan|atrasentan|mesh-list
101578166|NCT02700685|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101578167|NCT02700685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101578168|NCT02700685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101578169|NCT02700685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578170|NCT02700685|Dopamine Agents|dopamine agents|mesh-ancestor
101578171|NCT02700685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101578172|NCT02700685|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101578173|NCT02700685|Immunologic Factors|immunologic factors|mesh-ancestor
101578181|NCT02700763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578183|NCT03151681|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101578184|NCT03151681|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101578185|NCT03151681|Adrenergic Agents|adrenergic agents|mesh-ancestor
101578186|NCT03151681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101578187|NCT03151681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578188|NCT03151681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578189|NCT03151681|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101578190|NCT03151681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101578191|NCT03151681|Vasodilator Agents|vasodilator agents|mesh-ancestor
101578192|NCT04215445|Empagliflozin|empagliflozin|mesh-list
101578193|NCT04215445|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101578194|NCT04215445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578195|NCT04215445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101578196|NCT04215445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578197|NCT00951457|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101578198|NCT00951457|Alemtuzumab|alemtuzumab|mesh-list
101578199|NCT00951457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101578200|NCT00951457|Alkylating Agents|alkylating agents|mesh-ancestor
101578201|NCT00951457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578202|NCT00951457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101578203|NCT00951457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101578204|NCT02691871|Docetaxel|docetaxel|mesh-list
101578205|NCT02691871|Apatinib|apatinib|mesh-list
101578206|NCT02691871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101578207|NCT02691871|Tubulin Modulators|tubulin modulators|mesh-ancestor
101578208|NCT02691871|Antimitotic Agents|antimitotic agents|mesh-ancestor
101578209|NCT02691871|Mitosis Modulators|mitosis modulators|mesh-ancestor
101578210|NCT02691871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578211|NCT02691871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101578212|NCT02691871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101578213|NCT02700217|Remifentanil|remifentanil|mesh-list
101578214|NCT02700217|Heroin|heroin|mesh-list
101578215|NCT02700217|Bupivacaine|bupivacaine|mesh-list
101578216|NCT02700217|Propofol|propofol|mesh-list
101578217|NCT02700217|Anesthetics, Local|anesthetics, local|mesh-ancestor
101578218|NCT02700217|Anesthetics|anesthetics|mesh-ancestor
101578219|NCT02700217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101578220|NCT02700217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578221|NCT02700217|Sensory System Agents|sensory system agents|mesh-ancestor
101566760|NCT00980980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101566761|NCT00980980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101566762|NCT00980980|Disinfectants|disinfectants|mesh-ancestor
101566763|NCT00980980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101566764|NCT00980980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101566765|NCT00980980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101578222|NCT02700217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101578223|NCT02700217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101578224|NCT02700217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101578225|NCT02700217|Anesthetics, General|anesthetics, general|mesh-ancestor
101578226|NCT02700217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101578228|NCT02700217|Analgesics|analgesics|mesh-ancestor
101578229|NCT02699827|Magnesium Sulfate|magnesium sulfate|mesh-list
101578230|NCT02699827|Levobupivacaine|levobupivacaine|mesh-list
101578231|NCT02699827|Analgesics|analgesics|mesh-ancestor
101578232|NCT02699827|Sensory System Agents|sensory system agents|mesh-ancestor
101578233|NCT02699827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101264089|NCT01765829|Risperidone|risperidone|mesh-list
101578234|NCT02699827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578236|NCT02699827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101578237|NCT02699827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101578238|NCT02699827|Anticonvulsants|anticonvulsants|mesh-ancestor
101578239|NCT02699827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101578240|NCT02699827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101578241|NCT02699827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578247|NCT02705989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101578249|NCT02705989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578250|NCT02706067|Orlistat|orlistat|mesh-list
101578251|NCT02706067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101578252|NCT02706067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578253|NCT02706067|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101578254|NCT02706067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101578255|NCT02939287|Olanzapine|olanzapine|mesh-list
101578256|NCT02939287|Aprepitant|aprepitant|mesh-list
101578257|NCT02939287|Fosaprepitant|fosaprepitant|mesh-list
101578258|NCT02939287|Antiemetics|antiemetics|mesh-ancestor
101578259|NCT02939287|Autonomic Agents|autonomic agents|mesh-ancestor
101578260|NCT02939287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101578261|NCT02939287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578262|NCT02939287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101578263|NCT02939287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101578264|NCT02939287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101578265|NCT02939287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101578266|NCT02939287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101578267|NCT02939287|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101578268|NCT02939287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101578269|NCT02939287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101235139|NCT01591122|Hormone Antagonists|hormone antagonists|mesh-ancestor
101578270|NCT02939287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578271|NCT02939287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101578272|NCT02939287|Serotonin Agents|serotonin agents|mesh-ancestor
101578273|NCT02939287|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101578274|NCT05323201|Cyclophosphamide|cyclophosphamide|mesh-list
101578275|NCT05323201|Fludarabine|fludarabine|mesh-list
101578276|NCT05323201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101578277|NCT05323201|Immunologic Factors|immunologic factors|mesh-ancestor
101578278|NCT05323201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578279|NCT05323201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101578280|NCT05323201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101578281|NCT05323201|Alkylating Agents|alkylating agents|mesh-ancestor
101578282|NCT05323201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578283|NCT05323201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101578284|NCT05323201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101578285|NCT01208051|Lenalidomide|lenalidomide|mesh-list
101578286|NCT01208051|Cediranib|cediranib|mesh-list
101578287|NCT01208051|Maleic acid|maleic acid|mesh-list
101578288|NCT01208051|Immunologic Factors|immunologic factors|mesh-ancestor
101578289|NCT01208051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566766|NCT00980980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566767|NCT04116502|Interferons|interferons|mesh-list
101566768|NCT04116502|Interferon-alpha|interferon-alpha|mesh-list
101566769|NCT04116502|Interferon alpha-2|interferon alpha-2|mesh-list
101566770|NCT04116502|Hydroxyurea|hydroxyurea|mesh-list
101566771|NCT04116502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566772|NCT04116502|Antiviral Agents|antiviral agents|mesh-ancestor
101566773|NCT04116502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101566774|NCT04116502|Immunologic Factors|immunologic factors|mesh-ancestor
101578290|NCT01208051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101578291|NCT01208051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101578292|NCT01208051|Growth Substances|growth substances|mesh-ancestor
101578293|NCT01208051|Growth Inhibitors|growth inhibitors|mesh-ancestor
101578294|NCT01208051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101578295|NCT01208051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101578296|NCT01208051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578297|NCT01208051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101578298|NCT05322889|Telmisartan|telmisartan|mesh-list
101578299|NCT05322889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101578300|NCT05322889|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101578301|NCT05322889|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101578302|NCT05322889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578303|NCT00616915|Bupropion|bupropion|mesh-list
101578304|NCT00616915|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101578305|NCT00616915|Antidepressive Agents|antidepressive agents|mesh-ancestor
101578306|NCT00616915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101578307|NCT00616915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101578308|NCT00616915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101578325|NCT05410223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578326|NCT05410223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101578327|NCT05410223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101578328|NCT05410223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101578329|NCT05410223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101578330|NCT05410223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578331|NCT05410223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101578332|NCT05410223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101578334|NCT05410223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101578335|NCT05410223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101578336|NCT05410223|Antacids|antacids|mesh-ancestor
101578337|NCT05410223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101578338|NCT05410223|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101324164|NCT00102700|Beta-lapachone|beta-lapachone|mesh-list
101578339|NCT05410223|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101578340|NCT05410223|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
101578341|NCT05410223|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101578342|NCT01206101|Liraglutide|liraglutide|mesh-list
101578343|NCT01206101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101578344|NCT01206101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578345|NCT01206101|Incretins|incretins|mesh-ancestor
101578346|NCT01206101|Hormones|hormones|mesh-ancestor
101578347|NCT01206101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101578348|NCT00997503|Aspirin|aspirin|mesh-list
101578349|NCT00997503|Paclitaxel|paclitaxel|mesh-list
101578350|NCT00997503|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101578351|NCT00997503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101578352|NCT00997503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101578353|NCT00997503|Tubulin Modulators|tubulin modulators|mesh-ancestor
101578354|NCT00997503|Antimitotic Agents|antimitotic agents|mesh-ancestor
101578355|NCT00997503|Mitosis Modulators|mitosis modulators|mesh-ancestor
101578356|NCT00997503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578357|NCT00997503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101578358|NCT00997503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101578359|NCT00997503|Analgesics|analgesics|mesh-ancestor
101578360|NCT00997503|Sensory System Agents|sensory system agents|mesh-ancestor
101578361|NCT00997503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101566775|NCT04116502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566776|NCT04116502|Antisickling Agents|antisickling agents|mesh-ancestor
101566777|NCT04116502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101566778|NCT04116502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566779|NCT04116502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101566780|NCT04290442|Ropivacaine|ropivacaine|mesh-list
101566781|NCT04290442|Anesthetics, Local|anesthetics, local|mesh-ancestor
101566782|NCT04290442|Anesthetics|anesthetics|mesh-ancestor
101566783|NCT04290442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101566784|NCT04290442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566785|NCT04290442|Sensory System Agents|sensory system agents|mesh-ancestor
101566786|NCT04290442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101566787|NCT02866786|Metformin|metformin|mesh-list
101566788|NCT02866786|Cyproterone Acetate|cyproterone acetate|mesh-list
101566789|NCT02866786|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101566790|NCT02866786|Estradiol|estradiol|mesh-list
101566791|NCT02866786|Cyproterone|cyproterone|mesh-list
101566792|NCT02866786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101414974|NCT00496444|GABA Agents|gaba agents|mesh-ancestor
101578362|NCT00997503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578363|NCT00997503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101578364|NCT00997503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101578365|NCT00997503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101578366|NCT00997503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101578373|NCT02705053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578375|NCT01204775|Saxagliptin|saxagliptin|mesh-list
101578376|NCT01204775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101578377|NCT01204775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578378|NCT01204775|Incretins|incretins|mesh-ancestor
101578379|NCT01204775|Hormones|hormones|mesh-ancestor
101578380|NCT01204775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101578381|NCT01204775|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101578382|NCT01204775|Protease Inhibitors|protease inhibitors|mesh-ancestor
101578383|NCT01204775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101578384|NCT01204775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578385|NCT02844907|Dexamethasone|dexamethasone|mesh-list
101578386|NCT02844907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101578387|NCT02844907|Antiemetics|antiemetics|mesh-ancestor
101578388|NCT02844907|Autonomic Agents|autonomic agents|mesh-ancestor
101578389|NCT02844907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101578390|NCT02844907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578391|NCT02844907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101578392|NCT02844907|Glucocorticoids|glucocorticoids|mesh-ancestor
101578393|NCT02844907|Hormones|hormones|mesh-ancestor
101578394|NCT02844907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101578395|NCT02844907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101578396|NCT02844907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101578397|NCT00628719|Amphotericin B|amphotericin b|mesh-list
101578398|NCT00628719|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101578399|NCT00628719|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
101578400|NCT00628719|Deoxycholic Acid|deoxycholic acid|mesh-list
101578401|NCT00628719|Amebicides|amebicides|mesh-ancestor
101578402|NCT00628719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101578403|NCT00628719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101578404|NCT00628719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101578405|NCT00628719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101566793|NCT02866786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566794|NCT02866786|Estrogens|estrogens|mesh-ancestor
101566796|NCT02866786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101566797|NCT02866786|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101566798|NCT02866786|Contraceptive Agents|contraceptive agents|mesh-ancestor
101566799|NCT02866786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101566800|NCT02866786|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101566801|NCT02866786|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101566802|NCT02866786|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101566803|NCT02866786|Androgen Antagonists|androgen antagonists|mesh-ancestor
101578406|NCT00628719|Antifungal Agents|antifungal agents|mesh-ancestor
101578407|NCT00628719|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101578408|NCT00628719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101578409|NCT00616993|Difluprednate|difluprednate|mesh-list
101578410|NCT00616993|Glucocorticoids|glucocorticoids|mesh-ancestor
101578411|NCT00616993|Hormones|hormones|mesh-ancestor
101578412|NCT00616993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101578413|NCT00616993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578414|NCT02870361|Insulin|insulin|mesh-list
101578415|NCT02870361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101578416|NCT02870361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578417|NCT00616681|Oxcarbazepine|oxcarbazepine|mesh-list
101578418|NCT00616681|Anticonvulsants|anticonvulsants|mesh-ancestor
101235290|NCT01592162|Anesthetics|anesthetics|mesh-ancestor
101578419|NCT00616681|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101578420|NCT00616681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101578421|NCT00616681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101578422|NCT00616681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578423|NCT00616681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101578424|NCT00616681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101578425|NCT00997035|Voriconazole|voriconazole|mesh-list
101578426|NCT00997035|Antifungal Agents|antifungal agents|mesh-ancestor
101578427|NCT00997035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101578428|NCT00997035|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101578429|NCT00997035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101578430|NCT00997035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101578431|NCT00997035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578432|NCT00997035|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101578433|NCT00997035|Hormone Antagonists|hormone antagonists|mesh-ancestor
101578443|NCT01204697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578445|NCT01204697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101578446|NCT01203917|Gefitinib|gefitinib|mesh-list
101578447|NCT01203917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324194|NCT00102856|Rivastigmine|rivastigmine|mesh-list
101578448|NCT01203917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101578449|NCT01203917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101578450|NCT01203917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578451|NCT04213495|Anesthetics|anesthetics|mesh-list
101578452|NCT04213495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101578453|NCT04213495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578454|NCT04318223|Palbociclib|palbociclib|mesh-list
101578455|NCT04318223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101578456|NCT04318223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101578457|NCT04318223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101578458|NCT04318223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578459|NCT01202903|Omalizumab|omalizumab|mesh-list
101578460|NCT01202903|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101578461|NCT01202903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101578462|NCT01202903|Respiratory System Agents|respiratory system agents|mesh-ancestor
101578463|NCT00618631|Carfentanil|carfentanil|mesh-list
101578464|NCT00618631|Nicotine|nicotine|mesh-list
101566804|NCT02866786|Hormone Antagonists|hormone antagonists|mesh-ancestor
101566805|NCT02866786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566806|NCT02866786|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101566807|NCT00979654|Sifalimumab|sifalimumab|mesh-list
101566808|NCT00979654|Immunologic Factors|immunologic factors|mesh-ancestor
101566809|NCT00979654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566810|NCT00978562|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
101578465|NCT00618631|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101578466|NCT00618631|Autonomic Agents|autonomic agents|mesh-ancestor
101578467|NCT00618631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101578468|NCT00618631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578469|NCT00618631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101578470|NCT00618631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101578471|NCT00618631|Cholinergic Agents|cholinergic agents|mesh-ancestor
101578472|NCT00618631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101578473|NCT00618631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578474|NCT00618631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101578475|NCT00618631|Narcotics|narcotics|mesh-ancestor
101578476|NCT00618631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101578477|NCT00618631|Analgesics|analgesics|mesh-ancestor
101578478|NCT00618631|Sensory System Agents|sensory system agents|mesh-ancestor
101578479|NCT04213573|Fluorides|fluorides|mesh-list
101578480|NCT04213573|Cariostatic Agents|cariostatic agents|mesh-ancestor
101578481|NCT04213573|Protective Agents|protective agents|mesh-ancestor
101578482|NCT04213573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578483|NCT00620269|Irinotecan|irinotecan|mesh-list
101578484|NCT00620269|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101578485|NCT00620269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101578486|NCT00620269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101578487|NCT00620269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101578488|NCT00620269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101578489|NCT00620269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578490|NCT00620269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101578491|NCT04212403|Levofloxacin|levofloxacin|mesh-list
101578492|NCT04212403|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101578493|NCT04212403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101578494|NCT04212403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101578495|NCT04212403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101578496|NCT04212403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101578497|NCT04212403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101578507|NCT00637117|Immunologic Factors|immunologic factors|mesh-ancestor
101578508|NCT00637117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578509|NCT02052193|Vemurafenib|vemurafenib|mesh-list
101578510|NCT02052193|Dabrafenib|dabrafenib|mesh-list
101578511|NCT02052193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101578512|NCT02052193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101578513|NCT02052193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101578514|NCT02052193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578515|NCT00617695|Zolmitriptan|zolmitriptan|mesh-list
101578516|NCT00617695|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101578517|NCT00617695|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101578518|NCT00617695|Serotonin Agents|serotonin agents|mesh-ancestor
101578519|NCT00617695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101578520|NCT00617695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578521|NCT00617695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578522|NCT00619021|Gemcitabine|gemcitabine|mesh-list
101775274|NCT00935961|Tubulin Modulators|tubulin modulators|mesh-ancestor
101578523|NCT00619021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101578524|NCT00619021|Antimetabolites|antimetabolites|mesh-ancestor
101578525|NCT00619021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578526|NCT00619021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101578527|NCT00620347|Sunitinib|sunitinib|mesh-list
101578528|NCT00620347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101578529|NCT00620347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101578530|NCT00620347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101578531|NCT00620347|Growth Substances|growth substances|mesh-ancestor
101578532|NCT00620347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566812|NCT00978562|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101566813|NCT00978562|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101566814|NCT04289974|Fulvestrant|fulvestrant|mesh-list
101566815|NCT04289974|Palbociclib|palbociclib|mesh-list
101566816|NCT04289974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101566817|NCT04289974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566818|NCT04289974|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101566819|NCT04289974|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101566820|NCT04289974|Hormone Antagonists|hormone antagonists|mesh-ancestor
101566821|NCT04289974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101566822|NCT04289974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566823|NCT04289974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101578533|NCT00620347|Growth Inhibitors|growth inhibitors|mesh-ancestor
101578534|NCT00620347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101578535|NCT00620347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101578536|NCT00620347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578537|NCT04213105|Denosumab|denosumab|mesh-list
101578538|NCT04213105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101578539|NCT04213105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578540|NCT01887301|Nabiximols|nabiximols|mesh-list
101578541|NCT01887301|Analgesics|analgesics|mesh-ancestor
101578542|NCT01887301|Sensory System Agents|sensory system agents|mesh-ancestor
101578543|NCT01887301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101578544|NCT01887301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578545|NCT00996801|Vitamin D|vitamin d|mesh-list
101578546|NCT00996801|Cholecalciferol|cholecalciferol|mesh-list
101578547|NCT00996801|Alendronate|alendronate|mesh-list
101578548|NCT00996801|Calcium Carbonate|calcium carbonate|mesh-list
101578549|NCT00996801|Calcium|calcium|mesh-list
101578550|NCT00996801|Vitamins|vitamins|mesh-ancestor
101578551|NCT00996801|Micronutrients|micronutrients|mesh-ancestor
101578552|NCT00996801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578553|NCT00996801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101578554|NCT00996801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101578555|NCT00996801|Antacids|antacids|mesh-ancestor
101578556|NCT00996801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578557|NCT00996801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101578558|NCT00619333|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101578559|NCT00619333|Hormones|hormones|mesh-ancestor
101578560|NCT00619333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101578567|NCT04924621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101578568|NCT04924621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101578569|NCT04924621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578570|NCT04924621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101578571|NCT04924621|Anesthetics, General|anesthetics, general|mesh-ancestor
101578572|NCT04924621|Anesthetics|anesthetics|mesh-ancestor
101578573|NCT04924621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101578574|NCT04924621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101578575|NCT04924621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101578576|NCT04924621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101578577|NCT04924621|GABA Modulators|gaba modulators|mesh-ancestor
101578578|NCT04924621|GABA Agents|gaba agents|mesh-ancestor
101578579|NCT04924621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101578580|NCT04924621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578581|NCT04924621|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101578582|NCT04924621|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101578583|NCT04924621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101578584|NCT04924621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101578585|NCT04924621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101578586|NCT04924621|Narcotics|narcotics|mesh-ancestor
101415026|NCT04665765|Immunologic Factors|immunologic factors|mesh-ancestor
101566824|NCT04289974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101566825|NCT04289974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566827|NCT02865616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101566828|NCT02865616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101566830|NCT02865460|Micronutrients|micronutrients|mesh-ancestor
101566831|NCT02865460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566832|NCT02865460|Vitamins|vitamins|mesh-ancestor
101566833|NCT01206816|Afatinib|afatinib|mesh-list
101566834|NCT01206816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566835|NCT01206816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101578587|NCT04924621|Analgesics|analgesics|mesh-ancestor
101578588|NCT04924621|Sensory System Agents|sensory system agents|mesh-ancestor
101578589|NCT04924621|Anesthetics, Local|anesthetics, local|mesh-ancestor
101578590|NCT02213497|Paclitaxel|paclitaxel|mesh-list
101578591|NCT02213497|Carboplatin|carboplatin|mesh-list
101578592|NCT02213497|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101578593|NCT02213497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101578594|NCT02213497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101578595|NCT02213497|Tubulin Modulators|tubulin modulators|mesh-ancestor
101578596|NCT02213497|Antimitotic Agents|antimitotic agents|mesh-ancestor
101578597|NCT02213497|Mitosis Modulators|mitosis modulators|mesh-ancestor
101578598|NCT02213497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578599|NCT02213497|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101578600|NCT00618163|Meloxicam|meloxicam|mesh-list
101578601|NCT00618163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101578602|NCT00618163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101578603|NCT00618163|Analgesics|analgesics|mesh-ancestor
101578604|NCT00618163|Sensory System Agents|sensory system agents|mesh-ancestor
101578605|NCT00618163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101578606|NCT00618163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578607|NCT00618163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101578608|NCT00618163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101578609|NCT00618163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101578610|NCT00618163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101578611|NCT00618163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101578612|NCT00618163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578613|NCT00618241|Raltegravir Potassium|raltegravir potassium|mesh-list
101578614|NCT00618241|Lamotrigine|lamotrigine|mesh-list
101578615|NCT00618241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101578616|NCT00618241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101578617|NCT00618241|Antiviral Agents|antiviral agents|mesh-ancestor
101578618|NCT00618241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101578619|NCT00618241|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101578620|NCT00618241|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101578621|NCT00618241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101578622|NCT00618241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578623|NCT00618241|Anticonvulsants|anticonvulsants|mesh-ancestor
101578624|NCT00618241|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101578625|NCT00618241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101578626|NCT00618241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101578627|NCT00618241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578628|NCT00618241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101578629|NCT00618241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101578630|NCT00618241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101578631|NCT00618241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101578635|NCT00618397|Sensory System Agents|sensory system agents|mesh-ancestor
101578636|NCT00618397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101578637|NCT00618397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578638|NCT00618397|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101578639|NCT00618397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101578641|NCT00618397|Anesthetics|anesthetics|mesh-ancestor
101566836|NCT01206816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101566837|NCT01206816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566838|NCT01259102|Buprenorphine|buprenorphine|mesh-list
101566839|NCT01259102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101566840|NCT01259102|Narcotics|narcotics|mesh-ancestor
101578642|NCT00618397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101578643|NCT00618397|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101578644|NCT00618397|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101578645|NCT00618397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101578646|NCT00618397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578648|NCT04211545|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101578649|NCT04211545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101578650|NCT04211545|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101578651|NCT04211545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101578652|NCT04211545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578653|NCT00620581|Paroxetine|paroxetine|mesh-list
101578654|NCT00620581|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101578655|NCT00620581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101578656|NCT00620581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101578657|NCT00620581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578658|NCT00620581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101578659|NCT00620581|Serotonin Agents|serotonin agents|mesh-ancestor
101578660|NCT00620581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578661|NCT00620581|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101578662|NCT00620581|Antidepressive Agents|antidepressive agents|mesh-ancestor
101578663|NCT00620581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101578664|NCT00620581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101578665|NCT00620581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101578666|NCT00620581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101578667|NCT01000311|Vaccines|vaccines|mesh-list
101578668|NCT01000311|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101578669|NCT01000311|Immunologic Factors|immunologic factors|mesh-ancestor
101578670|NCT01000311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578671|NCT04209439|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
101578672|NCT04209439|Bupivacaine|bupivacaine|mesh-list
101578673|NCT04209439|Anesthetics, Local|anesthetics, local|mesh-ancestor
101578674|NCT04209439|Anesthetics|anesthetics|mesh-ancestor
101578675|NCT04209439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101578676|NCT04209439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578677|NCT04209439|Sensory System Agents|sensory system agents|mesh-ancestor
101578678|NCT04209439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101578679|NCT04209439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101578680|NCT04209439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101578681|NCT04209439|Analgesics|analgesics|mesh-ancestor
101324241|NCT00103051|Gemcitabine|gemcitabine|mesh-list
101578682|NCT04209439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101578683|NCT04209439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101578684|NCT05228041|Benralizumab|benralizumab|mesh-list
101578685|NCT05228041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101578686|NCT05228041|Respiratory System Agents|respiratory system agents|mesh-ancestor
101578687|NCT01003899|Afatinib|afatinib|mesh-list
101578688|NCT01003899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101578689|NCT01003899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101578690|NCT01003899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101578691|NCT01003899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578692|NCT04160377|Fluvoxamine|fluvoxamine|mesh-list
101578693|NCT04160377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101578694|NCT04160377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578695|NCT04160377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101578696|NCT04160377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101578697|NCT04160377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101578698|NCT04160377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578699|NCT04160377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101578700|NCT04160377|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101578701|NCT04160377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101578720|NCT00999921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578721|NCT00999921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101566841|NCT01259102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101566842|NCT01259102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566843|NCT01259102|Analgesics|analgesics|mesh-ancestor
101566844|NCT01259102|Sensory System Agents|sensory system agents|mesh-ancestor
101566845|NCT01259102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101566846|NCT01259102|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101566847|NCT00978250|Tetrahydrouridine|tetrahydrouridine|mesh-list
101578722|NCT00999921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101578723|NCT00999921|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101578724|NCT00999921|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101578725|NCT00999921|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101578726|NCT00999921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101578727|NCT00999921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101578729|NCT00999921|Sensory System Agents|sensory system agents|mesh-ancestor
101578730|NCT00999921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101578731|NCT00999921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101578732|NCT00999921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101578733|NCT00999921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101578734|NCT00999921|Antimetabolites|antimetabolites|mesh-ancestor
101578735|NCT00999921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775275|NCT00935961|Antimitotic Agents|antimitotic agents|mesh-ancestor
101578736|NCT00999921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101578737|NCT00999921|Dermatologic Agents|dermatologic agents|mesh-ancestor
101578738|NCT02869347|Complement C1s|complement c1s|mesh-list
101578739|NCT02869347|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
101578740|NCT02869347|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
101578741|NCT02869347|Immunologic Factors|immunologic factors|mesh-ancestor
101578742|NCT02869347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578743|NCT02869347|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101578744|NCT02869347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101578745|NCT00621673|Factor VIII|factor viii|mesh-list
101578746|NCT00621673|Coagulants|coagulants|mesh-ancestor
101578747|NCT01002573|Acetaminophen|acetaminophen|mesh-list
101578748|NCT01002573|Ibuprofen|ibuprofen|mesh-list
101578749|NCT01002573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101578750|NCT01002573|Analgesics|analgesics|mesh-ancestor
101578751|NCT01002573|Sensory System Agents|sensory system agents|mesh-ancestor
101578752|NCT01002573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101324254|NCT02697474|Vaccines|vaccines|mesh-list
101578753|NCT01002573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578759|NCT01002573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101578760|NCT01002573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578761|NCT00620893|Lubricant Eye Drops|lubricant eye drops|mesh-list
101578762|NCT00620893|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101578763|NCT00620893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101578764|NCT04293549|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101578765|NCT04293549|Mitogens|mitogens|mesh-list
101578766|NCT04293549|Mitosis Modulators|mitosis modulators|mesh-ancestor
101578767|NCT04293549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578768|NCT04293549|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101578769|NCT00996333|Gemcitabine|gemcitabine|mesh-list
101578770|NCT00996333|Capecitabine|capecitabine|mesh-list
101578771|NCT00996333|Docetaxel|docetaxel|mesh-list
101578772|NCT00996333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101578773|NCT00996333|Antimetabolites|antimetabolites|mesh-ancestor
101578774|NCT00996333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578775|NCT00996333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101578776|NCT00996333|Tubulin Modulators|tubulin modulators|mesh-ancestor
101578777|NCT00996333|Antimitotic Agents|antimitotic agents|mesh-ancestor
101578778|NCT00996333|Mitosis Modulators|mitosis modulators|mesh-ancestor
101578779|NCT00621907|Levobupivacaine|levobupivacaine|mesh-list
101578780|NCT00621907|Anesthetics, Local|anesthetics, local|mesh-ancestor
101578781|NCT00621907|Anesthetics|anesthetics|mesh-ancestor
101578782|NCT00621907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101578783|NCT00621907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578784|NCT00621907|Sensory System Agents|sensory system agents|mesh-ancestor
101578785|NCT00621907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101578786|NCT01349101|Mycophenolic Acid|mycophenolic acid|mesh-list
101578787|NCT01349101|Cyclophosphamide|cyclophosphamide|mesh-list
101566849|NCT00978250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566850|NCT01259024|Chlorotrianisene|chlorotrianisene|mesh-list
101566851|NCT01259024|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101566852|NCT01259024|Estrogens|estrogens|mesh-ancestor
101566853|NCT01259024|Hormones|hormones|mesh-ancestor
101566854|NCT01259024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101566855|NCT01259024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566856|NCT01259024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101235686|NCT01594229|Rituximab|rituximab|mesh-list
101578789|NCT01349101|Fludarabine|fludarabine|mesh-list
101578790|NCT01349101|Fludarabine phosphate|fludarabine phosphate|mesh-list
101578791|NCT01349101|Tacrolimus|tacrolimus|mesh-list
101578792|NCT01349101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101578793|NCT01349101|Immunologic Factors|immunologic factors|mesh-ancestor
101578794|NCT01349101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578795|NCT01349101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101578796|NCT01349101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101578797|NCT01349101|Alkylating Agents|alkylating agents|mesh-ancestor
101578798|NCT01349101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578799|NCT01349101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101578800|NCT01349101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101578801|NCT01349101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101578802|NCT01349101|Antimetabolites|antimetabolites|mesh-ancestor
101578803|NCT01349101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101578804|NCT01349101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101578805|NCT01349101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101578806|NCT01349101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101578807|NCT01349101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101578808|NCT01349101|Antitubercular Agents|antitubercular agents|mesh-ancestor
101578809|NCT01349101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101578810|NCT00620971|Bevacizumab|bevacizumab|mesh-list
101578811|NCT00620971|Cisplatin|cisplatin|mesh-list
101578813|NCT00620971|Docetaxel|docetaxel|mesh-list
101578814|NCT00620971|Vinorelbine|vinorelbine|mesh-list
101578815|NCT00620971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101578816|NCT00620971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101578817|NCT00620971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101578818|NCT00620971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101578819|NCT00620971|Growth Substances|growth substances|mesh-ancestor
101578820|NCT00620971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578821|NCT00620971|Growth Inhibitors|growth inhibitors|mesh-ancestor
101578822|NCT00620971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101578823|NCT00620971|Antimetabolites|antimetabolites|mesh-ancestor
101578824|NCT00620971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578825|NCT00620971|Tubulin Modulators|tubulin modulators|mesh-ancestor
101578831|NCT04223661|Daratumumab|daratumumab|mesh-list
101578832|NCT04223661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101578833|NCT04223661|Antiemetics|antiemetics|mesh-ancestor
101578834|NCT04223661|Autonomic Agents|autonomic agents|mesh-ancestor
101578835|NCT04223661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101578836|NCT04223661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578837|NCT04223661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101578838|NCT04223661|Glucocorticoids|glucocorticoids|mesh-ancestor
101578839|NCT04223661|Hormones|hormones|mesh-ancestor
101578840|NCT04223661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101578841|NCT04223661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101578842|NCT04223661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101578843|NCT04223661|Immunologic Factors|immunologic factors|mesh-ancestor
101578844|NCT04223661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101578845|NCT04223661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101578846|NCT04223661|Growth Substances|growth substances|mesh-ancestor
101578847|NCT04223661|Growth Inhibitors|growth inhibitors|mesh-ancestor
101578848|NCT00622141|Saquinavir|saquinavir|mesh-list
101578849|NCT00622141|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101578850|NCT00622141|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101566857|NCT01259024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566858|NCT04319900|Chloroquine|chloroquine|mesh-list
101566859|NCT04319900|Favipiravir|favipiravir|mesh-list
101566860|NCT04319900|Amebicides|amebicides|mesh-ancestor
101566861|NCT04319900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101566862|NCT04319900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101566863|NCT04319900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101566864|NCT04319900|Antimalarials|antimalarials|mesh-ancestor
101566865|NCT04319900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101578851|NCT00622141|Protease Inhibitors|protease inhibitors|mesh-ancestor
101578852|NCT00622141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101578853|NCT00622141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578854|NCT00622141|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101578855|NCT00622141|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101578856|NCT00622141|Antiviral Agents|antiviral agents|mesh-ancestor
101578857|NCT00622141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101578858|NCT00622141|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101578859|NCT00622141|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101578860|NCT04210765|Clomiphene|clomiphene|mesh-list
101578861|NCT04210765|Enclomiphene|enclomiphene|mesh-list
101235750|NCT01594619|Diltiazem|diltiazem|mesh-list
101578862|NCT04210765|Zuclomiphene|zuclomiphene|mesh-list
101578863|NCT04210765|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101578864|NCT04210765|Hormone Antagonists|hormone antagonists|mesh-ancestor
101578865|NCT04210765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101578866|NCT04210765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578867|NCT04210765|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101578868|NCT04210765|Fertility Agents|fertility agents|mesh-ancestor
101578869|NCT04210765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101578870|NCT04210765|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101578871|NCT04210765|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101578872|NCT00621283|Secretin|secretin|mesh-list
101578873|NCT00621283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101578874|NCT00621283|Hormones|hormones|mesh-ancestor
101578875|NCT00621283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101324275|NCT00103519|Hormones|hormones|mesh-ancestor
101578876|NCT00621283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578877|NCT00995709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101578878|NCT00995709|Immunologic Factors|immunologic factors|mesh-ancestor
101578879|NCT00995709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578880|NCT05662189|Exenatide|exenatide|mesh-list
101578881|NCT05662189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101578882|NCT05662189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578883|NCT05662189|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101578884|NCT05662189|Incretins|incretins|mesh-ancestor
101578885|NCT05662189|Hormones|hormones|mesh-ancestor
101578886|NCT05662189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101578887|NCT00629031|Paromomycin|paromomycin|mesh-list
101578888|NCT00629031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101578889|NCT00629031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101578890|NCT00629031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101578891|NCT00629031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101578892|NCT00621361|Etoposide|etoposide|mesh-list
101578893|NCT00621361|Cediranib|cediranib|mesh-list
101578894|NCT00621361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101578895|NCT00621361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101578908|NCT04208581|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101578910|NCT04208581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101578911|NCT04208581|Autonomic Agents|autonomic agents|mesh-ancestor
101578912|NCT04208581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101578913|NCT04208581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578914|NCT04208581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101578915|NCT04208581|Respiratory System Agents|respiratory system agents|mesh-ancestor
101578916|NCT04208581|Dermatologic Agents|dermatologic agents|mesh-ancestor
101578917|NCT04208581|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101578918|NCT04208581|Glucocorticoids|glucocorticoids|mesh-ancestor
101578919|NCT04208581|Hormones|hormones|mesh-ancestor
101578920|NCT04208581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101566866|NCT04319900|Antiviral Agents|antiviral agents|mesh-ancestor
101566867|NCT01257698|Timolol|timolol|mesh-list
101566868|NCT01257698|Dorzolamide|dorzolamide|mesh-list
101566869|NCT01257698|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101566870|NCT01257698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101566871|NCT01257698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101566872|NCT01257698|Adrenergic Agents|adrenergic agents|mesh-ancestor
101566873|NCT01257698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101578921|NCT04208581|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101578922|NCT04208581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101578923|NCT04208581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101578924|NCT04208581|Adrenergic Agents|adrenergic agents|mesh-ancestor
101578925|NCT04208581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101578926|NCT04208581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578927|NCT04208581|Parasympatholytics|parasympatholytics|mesh-ancestor
101578928|NCT04208581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101578929|NCT04208581|Cholinergic Agents|cholinergic agents|mesh-ancestor
101578930|NCT04208581|Anticonvulsants|anticonvulsants|mesh-ancestor
101578931|NCT05368675|Buprenorphine|buprenorphine|mesh-list
101578932|NCT05368675|Methadone|methadone|mesh-list
101578933|NCT05368675|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101578934|NCT05368675|Naloxone|naloxone|mesh-list
101578935|NCT05368675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101578936|NCT05368675|Narcotics|narcotics|mesh-ancestor
101578937|NCT05368675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101578938|NCT05368675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578939|NCT05368675|Analgesics|analgesics|mesh-ancestor
101578951|NCT05368051|Antibodies|antibodies|mesh-list
101578952|NCT05368051|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101578953|NCT05368051|Immunologic Factors|immunologic factors|mesh-ancestor
101578954|NCT05368051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578955|NCT05368051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101578956|NCT05368051|Antimetabolites|antimetabolites|mesh-ancestor
101578957|NCT05368051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578958|NCT05368051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101578959|NCT02641873|Leucovorin|leucovorin|mesh-list
101578960|NCT02641873|Bevacizumab|bevacizumab|mesh-list
101578961|NCT02641873|Irinotecan|irinotecan|mesh-list
101578962|NCT02641873|Levoleucovorin|levoleucovorin|mesh-list
101578963|NCT02641873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101578964|NCT02641873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101578965|NCT02641873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101578966|NCT02641873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101578967|NCT02641873|Growth Substances|growth substances|mesh-ancestor
101578968|NCT02641873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578969|NCT02641873|Growth Inhibitors|growth inhibitors|mesh-ancestor
101578970|NCT02641873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101578987|NCT05240391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101578988|NCT05240391|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101578989|NCT05240391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101578990|NCT05240391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101578991|NCT05240391|Adrenergic Agents|adrenergic agents|mesh-ancestor
101578992|NCT05240391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101578993|NCT05240391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578994|NCT00628953|Esomeprazole|esomeprazole|mesh-list
101578995|NCT00628953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101578996|NCT00628953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101578997|NCT00628953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101578998|NCT00628953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101578999|NCT00628953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579000|NCT04294953|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101579001|NCT04294953|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101579002|NCT04294953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101579003|NCT04294953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101579004|NCT04294953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579005|NCT04294953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101579006|NCT04294953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579007|NCT04294953|Analgesics|analgesics|mesh-ancestor
101566874|NCT01257698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566875|NCT01257698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566876|NCT01257698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101566877|NCT01257698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101566878|NCT01257698|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101566879|NCT01257698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101566880|NCT01257698|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101415072|NCT04599894|Pregabalin|pregabalin|mesh-list
101579008|NCT04294953|Sensory System Agents|sensory system agents|mesh-ancestor
101579009|NCT04294953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101579010|NCT04294953|Antidepressive Agents|antidepressive agents|mesh-ancestor
101579011|NCT04294953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101579012|NCT04294953|Dopamine Agents|dopamine agents|mesh-ancestor
101235891|NCT01595633|Tenofovir|tenofovir|mesh-list
101579013|NCT02869815|Methylene Blue|methylene blue|mesh-list
101579014|NCT02869815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101579015|NCT02869815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579016|NCT04293081|Maleic acid|maleic acid|mesh-list
101579017|NCT04293081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101579018|NCT04293081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579019|NCT04205643|Infliximab|infliximab|mesh-list
101579020|NCT04205643|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101579021|NCT04205643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101579022|NCT04205643|Dermatologic Agents|dermatologic agents|mesh-ancestor
101579023|NCT04205643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101324305|NCT00103792|Mycophenolic Acid|mycophenolic acid|mesh-list
101579024|NCT04205643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101579025|NCT02868801|Pregabalin|pregabalin|mesh-list
101579026|NCT02868801|Analgesics|analgesics|mesh-ancestor
101579027|NCT02868801|Sensory System Agents|sensory system agents|mesh-ancestor
101579028|NCT02868801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101579029|NCT02868801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579055|NCT01002339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101579056|NCT01002339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101579057|NCT01002339|Glucocorticoids|glucocorticoids|mesh-ancestor
101579058|NCT01002339|Hormones|hormones|mesh-ancestor
101579059|NCT01002339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101579060|NCT01002339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101579061|NCT01002339|Antifungal Agents|antifungal agents|mesh-ancestor
101579062|NCT01002339|Dermatologic Agents|dermatologic agents|mesh-ancestor
101579063|NCT01002339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101579064|NCT01002105|Baclofen|baclofen|mesh-list
101579065|NCT01002105|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101579066|NCT01002105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579067|NCT01002105|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101579068|NCT01002105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101579069|NCT01002105|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101579070|NCT01002105|GABA Agonists|gaba agonists|mesh-ancestor
101579071|NCT01002105|GABA Agents|gaba agents|mesh-ancestor
101579072|NCT01002105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101579073|NCT01002105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579074|NCT02605993|Ravulizumab|ravulizumab|mesh-list
101579075|NCT02605993|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101579076|NCT02605993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101579077|NCT02605993|Immunologic Factors|immunologic factors|mesh-ancestor
101579078|NCT02605993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579096|NCT02471911|Rituximab|rituximab|mesh-list
101579097|NCT02471911|Carboplatin|carboplatin|mesh-list
101579098|NCT02471911|Etoposide|etoposide|mesh-list
101579099|NCT02471911|Ifosfamide|ifosfamide|mesh-list
101579100|NCT02471911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101579101|NCT02471911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101579102|NCT02471911|Immunologic Factors|immunologic factors|mesh-ancestor
101579103|NCT02471911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579104|NCT02471911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101579105|NCT02471911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101579106|NCT02471911|Antiemetics|antiemetics|mesh-ancestor
101579107|NCT02471911|Autonomic Agents|autonomic agents|mesh-ancestor
101579108|NCT02471911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101566881|NCT01257542|Dextromethorphan|dextromethorphan|mesh-list
101566882|NCT01257542|Antitussive Agents|antitussive agents|mesh-ancestor
101566883|NCT01257542|Respiratory System Agents|respiratory system agents|mesh-ancestor
101566884|NCT01257542|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101566885|NCT01257542|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101566886|NCT01257542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101566887|NCT01257542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579109|NCT02471911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101579110|NCT02471911|Glucocorticoids|glucocorticoids|mesh-ancestor
101579111|NCT02471911|Hormones|hormones|mesh-ancestor
101579112|NCT02471911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101579113|NCT02471911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101579114|NCT02471911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101579115|NCT02471911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101579116|NCT02471911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101579117|NCT02471911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775276|NCT00935961|Mitosis Modulators|mitosis modulators|mesh-ancestor
101324312|NCT00103792|Alkylating Agents|alkylating agents|mesh-ancestor
101579118|NCT02471911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579119|NCT02471911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101579120|NCT02471911|Alkylating Agents|alkylating agents|mesh-ancestor
101579121|NCT00622375|Mesalamine|mesalamine|mesh-list
101579122|NCT00622375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101579123|NCT00622375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101579124|NCT00622375|Analgesics|analgesics|mesh-ancestor
101579125|NCT00622375|Sensory System Agents|sensory system agents|mesh-ancestor
101579126|NCT00622375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101579127|NCT00622375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579128|NCT00622375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101579129|NCT00622375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101579130|NCT02691325|Charcoal|charcoal|mesh-list
101579131|NCT02691325|Nemiralisib|nemiralisib|mesh-list
101579132|NCT02691325|Antidotes|antidotes|mesh-ancestor
101579133|NCT02691325|Protective Agents|protective agents|mesh-ancestor
101579134|NCT02691325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579135|NCT02691325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101579136|NCT02691325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101579137|NCT02691325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579138|NCT01678027|Clarithromycin|clarithromycin|mesh-list
101579149|NCT02697331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101579150|NCT02697331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579151|NCT04278625|Acetaminophen|acetaminophen|mesh-list
101579152|NCT04278625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101579153|NCT04278625|Analgesics|analgesics|mesh-ancestor
101579154|NCT04278625|Sensory System Agents|sensory system agents|mesh-ancestor
101579155|NCT04278625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101579156|NCT04278625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579157|NCT04278625|Antipyretics|antipyretics|mesh-ancestor
101579158|NCT02689141|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101579159|NCT02689141|Ofatumumab|ofatumumab|mesh-list
101579160|NCT02689141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101579161|NCT02689141|Alkylating Agents|alkylating agents|mesh-ancestor
101579162|NCT02689141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579163|NCT02689141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101579164|NCT00622687|Iloprost|iloprost|mesh-list
101579165|NCT00622687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101579166|NCT00622687|Vasodilator Agents|vasodilator agents|mesh-ancestor
101579168|NCT02691403|Levobupivacaine|levobupivacaine|mesh-list
101579169|NCT02691403|Anesthetics, Local|anesthetics, local|mesh-ancestor
101579170|NCT02691403|Anesthetics|anesthetics|mesh-ancestor
101579171|NCT02691403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101579172|NCT02691403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579173|NCT02691403|Sensory System Agents|sensory system agents|mesh-ancestor
101579174|NCT02691403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101579175|NCT00995007|Carboplatin|carboplatin|mesh-list
101579176|NCT00995007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101579177|NCT00909883|Botulinum Toxins|botulinum toxins|mesh-list
101566888|NCT01257542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566889|NCT01257230|Tiotropium Bromide|tiotropium bromide|mesh-list
101566890|NCT01257230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101566891|NCT01257230|Autonomic Agents|autonomic agents|mesh-ancestor
101566892|NCT01257230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101566893|NCT01257230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566894|NCT01257230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101566895|NCT01257230|Respiratory System Agents|respiratory system agents|mesh-ancestor
101566896|NCT01257230|Parasympatholytics|parasympatholytics|mesh-ancestor
101579178|NCT00909883|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101579179|NCT00909883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101579180|NCT00909883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579181|NCT00909883|Cholinergic Agents|cholinergic agents|mesh-ancestor
101579182|NCT00909883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101579183|NCT00909883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579184|NCT00639925|Gemcitabine|gemcitabine|mesh-list
101579185|NCT00639925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101579186|NCT00639925|Antimetabolites|antimetabolites|mesh-ancestor
101579187|NCT00639925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579188|NCT00639925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101579189|NCT00994461|Celecoxib|celecoxib|mesh-list
101579190|NCT00994461|Loxoprofen|loxoprofen|mesh-list
101579191|NCT00994461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101579192|NCT00994461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101579193|NCT00994461|Analgesics|analgesics|mesh-ancestor
101579194|NCT00994461|Sensory System Agents|sensory system agents|mesh-ancestor
101579195|NCT00994461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101579196|NCT00994461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579197|NCT00994461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101579198|NCT00994461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101579199|NCT00994461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101579200|NCT00994461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101579201|NCT00994461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101579202|NCT00994461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579232|NCT01202279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101579233|NCT01202279|Respiratory System Agents|respiratory system agents|mesh-ancestor
101579234|NCT01202279|Nasal Decongestants|nasal decongestants|mesh-ancestor
101579235|NCT01202279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101579236|NCT01202279|Sympathomimetics|sympathomimetics|mesh-ancestor
101236119|NCT01596517|Ribavirin|ribavirin|mesh-list
101579237|NCT01202279|Adrenergic Agents|adrenergic agents|mesh-ancestor
101579238|NCT01202279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101579239|NCT01202279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579240|NCT01202279|Expectorants|expectorants|mesh-ancestor
101579241|NCT01202279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101579242|NCT01202279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101579243|NCT01202279|Appetite Depressants|appetite depressants|mesh-ancestor
101579244|NCT01202279|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101579251|NCT03877315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101579252|NCT03877315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579253|NCT03877315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579254|NCT03877315|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101579255|NCT03877315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101579256|NCT03877315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101579258|NCT02687347|Methadone|methadone|mesh-list
101579259|NCT02687347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101579260|NCT02687347|Narcotics|narcotics|mesh-ancestor
101579261|NCT02687347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101579262|NCT02687347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579263|NCT02687347|Analgesics|analgesics|mesh-ancestor
101579264|NCT02687347|Sensory System Agents|sensory system agents|mesh-ancestor
101579265|NCT02687347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101579266|NCT02687347|Antitussive Agents|antitussive agents|mesh-ancestor
101579267|NCT02687347|Respiratory System Agents|respiratory system agents|mesh-ancestor
101579268|NCT02687425|Pioglitazone|pioglitazone|mesh-list
101566897|NCT01257230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101566898|NCT01257230|Cholinergic Agents|cholinergic agents|mesh-ancestor
101566899|NCT01257230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101566900|NCT01257230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566901|NCT01256684|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101566902|NCT01256684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101566903|NCT01256684|Immunologic Factors|immunologic factors|mesh-ancestor
101566904|NCT01256684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566905|NCT01204710|Prednisone|prednisone|mesh-list
101566906|NCT01204710|Mitoxantrone|mitoxantrone|mesh-list
101566907|NCT01204710|Olaratumab|olaratumab|mesh-list
101415096|NCT04726982|Diuretics|diuretics|mesh-ancestor
101579269|NCT02687425|Imatinib Mesylate|imatinib mesylate|mesh-list
101579270|NCT02687425|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101579271|NCT02687425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101579272|NCT02687425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579273|NCT02687425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101579274|NCT02687425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101579275|NCT02687425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101579276|NCT02687425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579277|NCT02687269|Ranolazine|ranolazine|mesh-list
101579278|NCT02687269|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101579279|NCT02687269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101579280|NCT02687269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579281|NCT02689297|Chlorine dioxide|chlorine dioxide|mesh-list
101579282|NCT02689297|Dental Disinfectants|dental disinfectants|mesh-ancestor
101579283|NCT02689297|Disinfectants|disinfectants|mesh-ancestor
101579284|NCT02689297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101579285|NCT04185805|Fexuprazan|fexuprazan|mesh-list
101579286|NCT04185805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101579287|NCT01201811|Azacitidine|azacitidine|mesh-list
101579288|NCT01201811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101579289|NCT01201811|Antimetabolites|antimetabolites|mesh-ancestor
101579290|NCT01201811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579291|NCT01201811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101579292|NCT01201811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101579293|NCT04186897|Salicylic Acid|salicylic acid|mesh-list
101579294|NCT04186897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101579295|NCT04186897|Antifungal Agents|antifungal agents|mesh-ancestor
101579296|NCT04186897|Keratolytic Agents|keratolytic agents|mesh-ancestor
101579297|NCT04186897|Dermatologic Agents|dermatologic agents|mesh-ancestor
101579298|NCT05392127|Vitamin K|vitamin k|mesh-list
101579299|NCT05392127|Vitamin K 1|vitamin k 1|mesh-list
101579300|NCT05392127|Repaglinide|repaglinide|mesh-list
101579301|NCT05392127|Midazolam|midazolam|mesh-list
101579302|NCT05392127|Omeprazole|omeprazole|mesh-list
101579303|NCT05392127|Warfarin|warfarin|mesh-list
101579304|NCT05392127|Vitamins|vitamins|mesh-ancestor
101579305|NCT05392127|Micronutrients|micronutrients|mesh-ancestor
101579306|NCT05392127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579307|NCT05392127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101579308|NCT05392127|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101579309|NCT05392127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101579310|NCT05392127|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101579311|NCT05392127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101579312|NCT05392127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101579313|NCT05392127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101579314|NCT05392127|Anesthetics, General|anesthetics, general|mesh-ancestor
101579316|NCT05392127|GABA Modulators|gaba modulators|mesh-ancestor
101579317|NCT05392127|GABA Agents|gaba agents|mesh-ancestor
101579326|NCT05392127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101579327|NCT05392127|Hemostatics|hemostatics|mesh-ancestor
101579328|NCT05392127|Coagulants|coagulants|mesh-ancestor
101579329|NCT05392127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101579330|NCT05378399|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101579331|NCT05378399|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
101566908|NCT01204710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101566909|NCT01204710|Glucocorticoids|glucocorticoids|mesh-ancestor
101566910|NCT01204710|Hormones|hormones|mesh-ancestor
101566911|NCT01204710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101566912|NCT01204710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566913|NCT01204710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101579332|NCT05378399|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101579333|NCT05378399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101579334|NCT05378399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101579335|NCT05378399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579336|NCT05378399|Antiviral Agents|antiviral agents|mesh-ancestor
101579337|NCT05378399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101579338|NCT05378399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101579339|NCT05378399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101579340|NCT04379011|Brivaracetam|brivaracetam|mesh-list
101579341|NCT04379011|Anticonvulsants|anticonvulsants|mesh-ancestor
101579342|NCT02685163|Antioxidants|antioxidants|mesh-list
101579343|NCT02685163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579344|NCT02685163|Protective Agents|protective agents|mesh-ancestor
101579345|NCT02685163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579346|NCT00640003|Baclofen|baclofen|mesh-list
101579347|NCT00640003|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101579348|NCT00640003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579349|NCT00640003|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101579350|NCT00640003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101579351|NCT00640003|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101579352|NCT00640003|GABA Agonists|gaba agonists|mesh-ancestor
101579353|NCT00640003|GABA Agents|gaba agents|mesh-ancestor
101579354|NCT00640003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101579355|NCT00640003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579356|NCT01201343|Interferons|interferons|mesh-list
101579357|NCT01201343|Interferon-beta|interferon-beta|mesh-list
101579358|NCT01201343|Interferon beta-1a|interferon beta-1a|mesh-list
101579359|NCT01201343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101579360|NCT01201343|Antiviral Agents|antiviral agents|mesh-ancestor
101579361|NCT01201343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101579362|NCT01201343|Immunologic Factors|immunologic factors|mesh-ancestor
101579363|NCT01201343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579364|NCT01201343|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101579365|NCT04185649|Capecitabine|capecitabine|mesh-list
101579366|NCT04185649|Lapatinib|lapatinib|mesh-list
101579367|NCT04185649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101579368|NCT04185649|Antimetabolites|antimetabolites|mesh-ancestor
101579369|NCT04185649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579370|NCT04185649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101579371|NCT04185649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101579372|NCT04185649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101579373|NCT01201265|Bevacizumab|bevacizumab|mesh-list
101579374|NCT01201265|Carboplatin|carboplatin|mesh-list
101579375|NCT01201265|Gemcitabine|gemcitabine|mesh-list
101579376|NCT01201265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101579377|NCT01201265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101579378|NCT01201265|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101579379|NCT01201265|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101579380|NCT01201265|Growth Substances|growth substances|mesh-ancestor
101579381|NCT01201265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579382|NCT01201265|Growth Inhibitors|growth inhibitors|mesh-ancestor
101579383|NCT01201265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101579398|NCT01200485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579399|NCT01200485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101579400|NCT01200485|Gout Suppressants|gout suppressants|mesh-ancestor
101579401|NCT01200485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101579402|NCT01200485|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101579403|NCT01200485|Antioxidants|antioxidants|mesh-ancestor
101579404|NCT01200485|Protective Agents|protective agents|mesh-ancestor
101579405|NCT01200485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579406|NCT02688907|Adavosertib|adavosertib|mesh-list
101579407|NCT02688907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101566914|NCT01204710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566915|NCT01204710|Analgesics|analgesics|mesh-ancestor
101566916|NCT01204710|Sensory System Agents|sensory system agents|mesh-ancestor
101566917|NCT01204710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101566918|NCT01204710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101566919|NCT01204710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101579408|NCT02688907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579409|NCT02686645|Metronidazole|metronidazole|mesh-list
101579411|NCT02686645|Loperamide|loperamide|mesh-list
101579412|NCT02686645|Antidiarrheals|antidiarrheals|mesh-list
101579413|NCT02686645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101579414|NCT02686645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101579415|NCT02686645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101579416|NCT02686645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101579417|NCT02686645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101579418|NCT04318067|Melatonin|melatonin|mesh-list
101579419|NCT04318067|Antioxidants|antioxidants|mesh-ancestor
101579420|NCT04318067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579421|NCT04318067|Protective Agents|protective agents|mesh-ancestor
101579422|NCT04318067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579423|NCT04318067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101579424|NCT01200407|Amlodipine|amlodipine|mesh-list
101579425|NCT01200407|Olmesartan|olmesartan|mesh-list
101579426|NCT01200407|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101579427|NCT01200407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101579428|NCT01200407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101579429|NCT01200407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101579430|NCT01200407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579431|NCT01200407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101579432|NCT01200407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579433|NCT01200407|Vasodilator Agents|vasodilator agents|mesh-ancestor
101579434|NCT01200407|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101579435|NCT01200407|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101579436|NCT02685085|Misoprostol|misoprostol|mesh-list
101579437|NCT02685085|Dinoprostone|dinoprostone|mesh-list
101579438|NCT02685085|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101579439|NCT02685085|Abortifacient Agents|abortifacient agents|mesh-ancestor
101579440|NCT02685085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101579441|NCT02685085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579442|NCT02685085|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101579443|NCT02685085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101579444|NCT02685085|Oxytocics|oxytocics|mesh-ancestor
101579445|NCT02688595|Anesthetics|anesthetics|mesh-list
101579454|NCT01200329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101579455|NCT01200329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101579456|NCT01200329|Alkylating Agents|alkylating agents|mesh-ancestor
101579457|NCT01200329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101579458|NCT01200329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101579459|NCT01200329|Immunologic Factors|immunologic factors|mesh-ancestor
101579460|NCT01200329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579461|NCT01199939|Ritonavir|ritonavir|mesh-list
101236349|NCT01597310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101579462|NCT01199939|Darunavir|darunavir|mesh-list
101579463|NCT01199939|Etravirine|etravirine|mesh-list
101579464|NCT01199939|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101579465|NCT01199939|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101579466|NCT01199939|Protease Inhibitors|protease inhibitors|mesh-ancestor
101579467|NCT01199939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101579468|NCT01199939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579469|NCT01199939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101579470|NCT01199939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101579471|NCT01199939|Antiviral Agents|antiviral agents|mesh-ancestor
101579472|NCT01199939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101579473|NCT01199939|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101579474|NCT01199939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101579475|NCT01199939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101579476|NCT01199939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101579477|NCT02688361|Acetylcysteine|acetylcysteine|mesh-list
101566921|NCT01204710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566922|NCT01256450|Buprenorphine|buprenorphine|mesh-list
101566923|NCT01256450|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101566924|NCT01256450|Narcotics|narcotics|mesh-ancestor
101566925|NCT01256450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101566926|NCT01256450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566927|NCT01256450|Analgesics|analgesics|mesh-ancestor
101566928|NCT01256450|Sensory System Agents|sensory system agents|mesh-ancestor
101566929|NCT01256450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101566930|NCT01256450|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101566931|NCT01204398|Amlodipine|amlodipine|mesh-list
101579478|NCT02688361|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101579479|NCT02688361|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101579480|NCT02688361|Antiviral Agents|antiviral agents|mesh-ancestor
101579481|NCT02688361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101579483|NCT02688361|Respiratory System Agents|respiratory system agents|mesh-ancestor
101579484|NCT02688361|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101579485|NCT02688361|Antioxidants|antioxidants|mesh-ancestor
101579486|NCT02688361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579487|NCT02688361|Protective Agents|protective agents|mesh-ancestor
101579488|NCT02688361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579489|NCT02688361|Antidotes|antidotes|mesh-ancestor
101579490|NCT01199861|Vaccines|vaccines|mesh-list
101579491|NCT01199861|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101579492|NCT01199861|Immunologic Factors|immunologic factors|mesh-ancestor
101579493|NCT01199861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579494|NCT01199861|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101579495|NCT01199861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579496|NCT01199861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101579497|NCT03196219|Anti-Infective Agents|anti-infective agents|mesh-list
101579498|NCT03196219|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101579499|NCT00640081|Leucovorin|leucovorin|mesh-list
101579500|NCT00640081|Fluorouracil|fluorouracil|mesh-list
101579501|NCT00640081|Capecitabine|capecitabine|mesh-list
101579502|NCT00640081|Oxaliplatin|oxaliplatin|mesh-list
101579503|NCT00640081|Cetuximab|cetuximab|mesh-list
101579504|NCT00640081|Calcium|calcium|mesh-list
101579505|NCT00640081|Levoleucovorin|levoleucovorin|mesh-list
101579506|NCT00640081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101579507|NCT00640081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579508|NCT00640081|Antimetabolites|antimetabolites|mesh-ancestor
101579509|NCT00640081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579510|NCT00640081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101579511|NCT00640081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101579512|NCT00640081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101579513|NCT00640081|Immunologic Factors|immunologic factors|mesh-ancestor
101579519|NCT00640081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101579520|NCT01199705|Immunoglobulins|immunoglobulins|mesh-list
101579522|NCT01199705|gamma-Globulins|gamma-globulins|mesh-list
101579523|NCT01199705|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101579524|NCT01199705|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101579525|NCT01199705|Immunologic Factors|immunologic factors|mesh-ancestor
101579526|NCT01199705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579527|NCT02688127|Tranexamic Acid|tranexamic acid|mesh-list
101579528|NCT02688127|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101579529|NCT02688127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101579530|NCT02688127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579531|NCT02688127|Hemostatics|hemostatics|mesh-ancestor
101579532|NCT02688127|Coagulants|coagulants|mesh-ancestor
101579533|NCT04184947|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
101579534|NCT04184947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579535|NCT04184947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101566933|NCT01204398|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
101566934|NCT01204398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101566935|NCT01204398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101566936|NCT01204398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101566937|NCT01204398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566938|NCT01204398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101566939|NCT01204398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566940|NCT01204398|Vasodilator Agents|vasodilator agents|mesh-ancestor
101566941|NCT01204398|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101415128|NCT00127868|Ketoconazole|ketoconazole|mesh-list
101579536|NCT04184947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579537|NCT00638833|Memantine|memantine|mesh-list
101579538|NCT00638833|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101579539|NCT00638833|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101579540|NCT00638833|Dopamine Agents|dopamine agents|mesh-ancestor
101236424|NCT01597700|Ezetimibe|ezetimibe|mesh-list
101579541|NCT00638833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101579542|NCT00638833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579543|NCT00638833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579544|NCT00638833|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101579545|NCT00638833|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101579546|NCT01198145|Sulfasalazine|sulfasalazine|mesh-list
101579547|NCT01198145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101579548|NCT01198145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101579549|NCT01198145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101579550|NCT01198145|Analgesics|analgesics|mesh-ancestor
101579551|NCT01198145|Sensory System Agents|sensory system agents|mesh-ancestor
101264127|NCT01765829|GABA Antagonists|gaba antagonists|mesh-ancestor
101579552|NCT01198145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101579553|NCT01198145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579554|NCT01198145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101579555|NCT01198145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101579556|NCT01198145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101579557|NCT01179048|Liraglutide|liraglutide|mesh-list
101579558|NCT01179048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101579559|NCT01179048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579560|NCT01179048|Incretins|incretins|mesh-ancestor
101579561|NCT01179048|Hormones|hormones|mesh-ancestor
101579562|NCT01179048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101579563|NCT00603265|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101579564|NCT00603265|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101579565|NCT00603265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101579566|NCT00603265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101579567|NCT00603265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579568|NCT00603265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101579569|NCT00603265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579570|NCT00603265|Analgesics|analgesics|mesh-ancestor
101579571|NCT00603265|Sensory System Agents|sensory system agents|mesh-ancestor
101579572|NCT00603265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101579573|NCT00603265|Antidepressive Agents|antidepressive agents|mesh-ancestor
101579574|NCT00603265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101579575|NCT00603265|Dopamine Agents|dopamine agents|mesh-ancestor
101579576|NCT02686177|Metformin|metformin|mesh-list
101579577|NCT02686177|Liraglutide|liraglutide|mesh-list
101579578|NCT02686177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101579579|NCT02686177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579580|NCT02686177|Incretins|incretins|mesh-ancestor
101579581|NCT02686177|Hormones|hormones|mesh-ancestor
101579595|NCT02686021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566942|NCT01204398|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101566943|NCT01111851|Dexamethasone|dexamethasone|mesh-list
101566944|NCT01111851|Dexamethasone acetate|dexamethasone acetate|mesh-list
101566945|NCT01111851|Ondansetron|ondansetron|mesh-list
101566946|NCT01111851|Aprepitant|aprepitant|mesh-list
101566947|NCT01111851|Fosaprepitant|fosaprepitant|mesh-list
101566948|NCT01111851|BB 1101|bb 1101|mesh-list
101566949|NCT01111851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101566950|NCT01111851|Antiemetics|antiemetics|mesh-ancestor
101566951|NCT01111851|Autonomic Agents|autonomic agents|mesh-ancestor
101566952|NCT01111851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101566953|NCT01111851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566954|NCT01111851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101579597|NCT01158534|Interferons|interferons|mesh-list
101579598|NCT01158534|Interferon-alpha|interferon-alpha|mesh-list
101579599|NCT01158534|Interferon alpha-2|interferon alpha-2|mesh-list
101579600|NCT01158534|Celecoxib|celecoxib|mesh-list
101579601|NCT01158534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101579602|NCT01158534|Antiviral Agents|antiviral agents|mesh-ancestor
101579603|NCT01158534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101579604|NCT01158534|Immunologic Factors|immunologic factors|mesh-ancestor
101579605|NCT01158534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579606|NCT01158534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101579607|NCT01158534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101579608|NCT01158534|Analgesics|analgesics|mesh-ancestor
101579609|NCT01158534|Sensory System Agents|sensory system agents|mesh-ancestor
101579610|NCT01158534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101264131|NCT01765842|Rituximab|rituximab|mesh-list
101579611|NCT01158534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101579612|NCT01158534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101579613|NCT01158534|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101579614|NCT01158534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101579615|NCT01158534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101579616|NCT01158534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579617|NCT02687971|Miltefosine|miltefosine|mesh-list
101579618|NCT02687971|Antifungal Agents|antifungal agents|mesh-ancestor
101579619|NCT02687971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101579620|NCT02687971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101579621|NCT02687971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101579622|NCT02687971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101579624|NCT05272878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101579625|NCT05272878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101579626|NCT05272878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101579627|NCT05272878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579628|NCT02683213|Fluoxetine|fluoxetine|mesh-list
101579629|NCT02683213|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101579630|NCT02683213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101579631|NCT02683213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101579632|NCT02683213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579633|NCT02683213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101579634|NCT02683213|Serotonin Agents|serotonin agents|mesh-ancestor
101579635|NCT02683213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579636|NCT02683213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101579637|NCT02683213|Antidepressive Agents|antidepressive agents|mesh-ancestor
101579638|NCT02683213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101579639|NCT02683213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101579658|NCT00639691|Respiratory System Agents|respiratory system agents|mesh-ancestor
101579659|NCT02684071|Cyclophosphamide|cyclophosphamide|mesh-list
101579660|NCT02684071|Methotrexate|methotrexate|mesh-list
101579661|NCT02684071|Topotecan|topotecan|mesh-list
101579662|NCT02684071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101579663|NCT02684071|Immunologic Factors|immunologic factors|mesh-ancestor
101579664|NCT02684071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566955|NCT01111851|Glucocorticoids|glucocorticoids|mesh-ancestor
101566956|NCT01111851|Hormones|hormones|mesh-ancestor
101566957|NCT01111851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101566958|NCT01111851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101566959|NCT01111851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101566960|NCT01111851|Protease Inhibitors|protease inhibitors|mesh-ancestor
101566961|NCT01111851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101566962|NCT01111851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566963|NCT01111851|Antipruritics|antipruritics|mesh-ancestor
101566964|NCT01111851|Dermatologic Agents|dermatologic agents|mesh-ancestor
101566965|NCT01111851|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101566966|NCT01111851|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101415155|NCT00497614|Adalimumab|adalimumab|mesh-list
101579665|NCT02684071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101579666|NCT02684071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101579667|NCT02684071|Alkylating Agents|alkylating agents|mesh-ancestor
101579668|NCT02684071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579669|NCT02684071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101264146|NCT01765946|Metformin|metformin|mesh-list
101579670|NCT02684071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101579671|NCT02684071|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101579672|NCT02684071|Abortifacient Agents|abortifacient agents|mesh-ancestor
101579673|NCT02684071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101579674|NCT02684071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101579676|NCT02684071|Dermatologic Agents|dermatologic agents|mesh-ancestor
101579677|NCT02684071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101579678|NCT02684071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101579679|NCT02684071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101579680|NCT02684071|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101579681|NCT02684071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101579682|NCT00640861|Vaccines|vaccines|mesh-list
101579683|NCT00640861|Sargramostim|sargramostim|mesh-list
101579684|NCT00640861|Freund's Adjuvant|freund's adjuvant|mesh-list
101579685|NCT00640861|Immunologic Factors|immunologic factors|mesh-ancestor
101579686|NCT00640861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236587|NCT01598402|Amoxicillin|amoxicillin|mesh-list
101579687|NCT00640861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101579688|NCT00602797|Paclitaxel|paclitaxel|mesh-list
101579689|NCT00602797|Vinorelbine|vinorelbine|mesh-list
101579690|NCT00602797|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101579691|NCT00602797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101579692|NCT00602797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101579693|NCT00602797|Tubulin Modulators|tubulin modulators|mesh-ancestor
101579694|NCT00602797|Antimitotic Agents|antimitotic agents|mesh-ancestor
101579719|NCT02940769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579720|NCT02940769|Adrenergic Agents|adrenergic agents|mesh-ancestor
101579721|NCT02940769|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101579722|NCT02940769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101579723|NCT02940769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101579724|NCT02940769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101579725|NCT04315584|Deoxyglucose|deoxyglucose|mesh-list
101579726|NCT04315584|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101579727|NCT04315584|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
101579728|NCT04315584|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101579729|NCT04315584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579730|NCT04315584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579731|NCT04315584|Antimetabolites|antimetabolites|mesh-ancestor
101579732|NCT04315584|Antiviral Agents|antiviral agents|mesh-ancestor
101579733|NCT04315584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101579734|NCT04315584|Dopamine Agents|dopamine agents|mesh-ancestor
101579735|NCT04315584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101566967|NCT01111851|Serotonin Agents|serotonin agents|mesh-ancestor
101566968|NCT01111851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101566969|NCT01111851|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101566970|NCT01256294|Tacrolimus|tacrolimus|mesh-list
101566971|NCT01256294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101566972|NCT01256294|Immunologic Factors|immunologic factors|mesh-ancestor
101566973|NCT01256294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566974|NCT01256294|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101566976|NCT01256294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566977|NCT01256060|Oxytocin|oxytocin|mesh-list
101566978|NCT01256060|Oxytocics|oxytocics|mesh-ancestor
101566979|NCT01256060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101566980|NCT01256060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543151|NCT04535804|Aspirin|aspirin|mesh-list
101579736|NCT02683291|Mycophenolic Acid|mycophenolic acid|mesh-list
101579737|NCT02683291|Sirolimus|sirolimus|mesh-list
101579738|NCT02683291|Prednisone|prednisone|mesh-list
101579739|NCT02683291|Tacrolimus|tacrolimus|mesh-list
101579740|NCT02683291|Thymoglobulin|thymoglobulin|mesh-list
101579741|NCT02683291|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101579742|NCT02683291|Basiliximab|basiliximab|mesh-list
101579743|NCT02683291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101579744|NCT02683291|Glucocorticoids|glucocorticoids|mesh-ancestor
101579745|NCT02683291|Hormones|hormones|mesh-ancestor
101579757|NCT02683291|Antitubercular Agents|antitubercular agents|mesh-ancestor
101579758|NCT02683291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101579759|NCT02683291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101579760|NCT02683291|Antifungal Agents|antifungal agents|mesh-ancestor
101579761|NCT02685397|Leuprolide|leuprolide|mesh-list
101236663|NCT01598883|Heparin|heparin|mesh-list
101579762|NCT02685397|Goserelin|goserelin|mesh-list
101579763|NCT02685397|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101579764|NCT02685397|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101579765|NCT02685397|Fertility Agents|fertility agents|mesh-ancestor
101579766|NCT02685397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101579767|NCT02685397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579768|NCT02685397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101579769|NCT02685397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101579770|NCT02685397|Luteolytic Agents|luteolytic agents|mesh-ancestor
101579771|NCT02685397|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101579772|NCT02685397|Contraceptive Agents|contraceptive agents|mesh-ancestor
101579773|NCT02685397|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101579774|NCT02683837|Remifentanil|remifentanil|mesh-list
101579775|NCT02683837|Sevoflurane|sevoflurane|mesh-list
101579776|NCT02683837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101579777|NCT02683837|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101579778|NCT02683837|Anesthetics, General|anesthetics, general|mesh-ancestor
101579779|NCT02683837|Anesthetics|anesthetics|mesh-ancestor
101579780|NCT02683837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101579781|NCT02683837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579782|NCT02683837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101579783|NCT02683837|Narcotics|narcotics|mesh-ancestor
101579784|NCT02683837|Analgesics|analgesics|mesh-ancestor
101579785|NCT02683837|Sensory System Agents|sensory system agents|mesh-ancestor
101579786|NCT02683837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101579787|NCT02680951|Cytarabine|cytarabine|mesh-list
101579788|NCT02680951|Fludarabine|fludarabine|mesh-list
101579789|NCT02680951|Dasatinib|dasatinib|mesh-list
101579790|NCT02680951|Idarubicin|idarubicin|mesh-list
101579791|NCT02680951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101579792|NCT02680951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101579793|NCT02680951|Antimetabolites|antimetabolites|mesh-ancestor
101579794|NCT02680951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579795|NCT02680951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101579796|NCT02680951|Immunologic Factors|immunologic factors|mesh-ancestor
101566981|NCT01255904|Dexmedetomidine|dexmedetomidine|mesh-list
101566982|NCT01255904|Chloral Hydrate|chloral hydrate|mesh-list
101566983|NCT01255904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101566984|NCT01255904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101566985|NCT01255904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101566986|NCT01255904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101566987|NCT01255904|Analgesics|analgesics|mesh-ancestor
101566988|NCT01255904|Sensory System Agents|sensory system agents|mesh-ancestor
101566989|NCT01255904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101566990|NCT01255904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101566991|NCT01255904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101566992|NCT01255904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101566993|NCT01255904|Adrenergic Agents|adrenergic agents|mesh-ancestor
101566994|NCT01255904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101415177|NCT00127907|Hemostatics|hemostatics|mesh-ancestor
101579797|NCT02680951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579798|NCT02680951|Antiviral Agents|antiviral agents|mesh-ancestor
101579799|NCT02680951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101579800|NCT02680951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101579801|NCT02680951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101579802|NCT02680951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101579803|NCT02680951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101264164|NCT01766089|Analgesics|analgesics|mesh-ancestor
101579804|NCT02680951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101579806|NCT02680717|Calcipotriene|calcipotriene|mesh-list
101579807|NCT02680717|Tacrolimus|tacrolimus|mesh-list
101579808|NCT02680717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101579834|NCT02683759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101579835|NCT02683759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579837|NCT02683759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101579838|NCT02683759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101579839|NCT02683759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101579840|NCT02683759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579841|NCT04292691|Ropivacaine|ropivacaine|mesh-list
101579842|NCT04292691|Anesthetics, Local|anesthetics, local|mesh-ancestor
101579843|NCT04292691|Anesthetics|anesthetics|mesh-ancestor
101579844|NCT04292691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101579845|NCT04292691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579846|NCT04292691|Sensory System Agents|sensory system agents|mesh-ancestor
101579847|NCT04292691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101579848|NCT00990249|Busulfan|busulfan|mesh-list
101579849|NCT00990249|Clofarabine|clofarabine|mesh-list
101579850|NCT00990249|Thymoglobulin|thymoglobulin|mesh-list
101579851|NCT00990249|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101579852|NCT00990249|Alkylating Agents|alkylating agents|mesh-ancestor
101579853|NCT00990249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579854|NCT00990249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101579855|NCT00990249|Immunologic Factors|immunologic factors|mesh-ancestor
101579856|NCT00990249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579883|NCT00640939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101579884|NCT00640939|Analgesics|analgesics|mesh-ancestor
101579885|NCT00640939|Sensory System Agents|sensory system agents|mesh-ancestor
101579886|NCT00640939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101579887|NCT00640939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579888|NCT00640939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101579889|NCT00640939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101579890|NCT00640939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101579891|NCT00640939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101579892|NCT00640939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579894|NCT05663749|Topiramate|topiramate|mesh-list
101566995|NCT01255904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101566996|NCT01255670|Metronidazole|metronidazole|mesh-list
101566997|NCT01255670|Penicillins|penicillins|mesh-list
101566998|NCT01255670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101566999|NCT01255670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101567000|NCT01255670|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101567001|NCT01255670|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101567002|NCT01203930|Rituximab|rituximab|mesh-list
101567003|NCT01203930|Idelalisib|idelalisib|mesh-list
101504237|NCT05146713|Eusol|eusol|mesh-list
101567004|NCT01203930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101567005|NCT01203930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101567006|NCT01203930|Immunologic Factors|immunologic factors|mesh-ancestor
101567007|NCT01203930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567008|NCT01203930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101579895|NCT05663749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101579896|NCT05663749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579897|NCT05663749|Anticonvulsants|anticonvulsants|mesh-ancestor
101579898|NCT02867553|Rituximab|rituximab|mesh-list
101579899|NCT02867553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101579900|NCT02867553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101579901|NCT02867553|Immunologic Factors|immunologic factors|mesh-ancestor
101579907|NCT00642577|Leucovorin|leucovorin|mesh-list
101579908|NCT00642577|Bevacizumab|bevacizumab|mesh-list
101579909|NCT00642577|Fluorouracil|fluorouracil|mesh-list
101579910|NCT00642577|Irinotecan|irinotecan|mesh-list
101579911|NCT00642577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101579912|NCT00642577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101579913|NCT00642577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101579914|NCT00642577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101579915|NCT00642577|Growth Substances|growth substances|mesh-ancestor
101579916|NCT00642577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579917|NCT00642577|Growth Inhibitors|growth inhibitors|mesh-ancestor
101579918|NCT00642577|Antimetabolites|antimetabolites|mesh-ancestor
101579919|NCT00642577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579920|NCT00642577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101579921|NCT00642577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101579922|NCT00642577|Immunologic Factors|immunologic factors|mesh-ancestor
101579923|NCT00642577|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101579924|NCT00642577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101579925|NCT00642577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101579927|NCT00642577|Protective Agents|protective agents|mesh-ancestor
101579928|NCT00642577|Vitamin B Complex|vitamin b complex|mesh-ancestor
101579929|NCT00642577|Vitamins|vitamins|mesh-ancestor
101579930|NCT00642577|Micronutrients|micronutrients|mesh-ancestor
101579931|NCT02682121|Metformin|metformin|mesh-list
101579932|NCT02682121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101579933|NCT02682121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579934|NCT02683603|Imipenem|imipenem|mesh-list
101579935|NCT02683603|Colistin|colistin|mesh-list
101579936|NCT02683603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101579937|NCT02683603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101579938|NCT00641095|Cyclophosphamide|cyclophosphamide|mesh-list
101579939|NCT00641095|Rituximab|rituximab|mesh-list
101579940|NCT00641095|Fludarabine|fludarabine|mesh-list
101579941|NCT00641095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101579942|NCT00641095|Immunologic Factors|immunologic factors|mesh-ancestor
101579943|NCT00641095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579944|NCT00641095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101579945|NCT00641095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101579946|NCT00641095|Alkylating Agents|alkylating agents|mesh-ancestor
101579947|NCT00641095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579948|NCT00641095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101567009|NCT01203930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101567010|NCT01203930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567011|NCT01254890|Azacitidine|azacitidine|mesh-list
101567012|NCT01254890|Sorafenib|sorafenib|mesh-list
101567013|NCT01254890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101567014|NCT01254890|Antimetabolites|antimetabolites|mesh-ancestor
101415206|NCT00498004|Antidepressive Agents|antidepressive agents|mesh-ancestor
101579949|NCT00641095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101579950|NCT00641095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101579951|NCT01196975|Vaccines|vaccines|mesh-list
101579952|NCT01196975|Immunologic Factors|immunologic factors|mesh-ancestor
101579953|NCT01196975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579954|NCT00992589|Rabeprazole|rabeprazole|mesh-list
101579955|NCT00992589|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101579956|NCT00992589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101579957|NCT00992589|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101579958|NCT00992589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101579959|NCT00992589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579960|NCT01196741|Paclitaxel|paclitaxel|mesh-list
101579961|NCT01196741|Saracatinib|saracatinib|mesh-list
101579962|NCT01196741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101579963|NCT01196741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101579964|NCT01196741|Tubulin Modulators|tubulin modulators|mesh-ancestor
101579965|NCT01196741|Antimitotic Agents|antimitotic agents|mesh-ancestor
101579966|NCT01196741|Mitosis Modulators|mitosis modulators|mesh-ancestor
101579967|NCT01196741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579968|NCT01196741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101579969|NCT00629187|Temozolomide|temozolomide|mesh-list
101579970|NCT00629187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101579971|NCT00629187|Alkylating Agents|alkylating agents|mesh-ancestor
101579972|NCT00629187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579973|NCT00629187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101579977|NCT00983385|Tapentadol|tapentadol|mesh-list
101579978|NCT00983385|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101579979|NCT00983385|Narcotics|narcotics|mesh-ancestor
101579980|NCT00983385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101579981|NCT00983385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579982|NCT00983385|Analgesics|analgesics|mesh-ancestor
101579983|NCT00983385|Sensory System Agents|sensory system agents|mesh-ancestor
101579984|NCT00983385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101579985|NCT00983385|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101579986|NCT00983385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101579987|NCT00983385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101579988|NCT00983385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579989|NCT00983385|Adrenergic Agents|adrenergic agents|mesh-ancestor
101579990|NCT00983385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101579991|NCT00992511|Vaccines|vaccines|mesh-list
101579992|NCT00992511|Immunologic Factors|immunologic factors|mesh-ancestor
101579993|NCT00992511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579994|NCT02869035|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101579995|NCT02869035|Escitalopram|escitalopram|mesh-list
101579996|NCT02869035|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101579997|NCT02869035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101579998|NCT02869035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101579999|NCT02869035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580000|NCT02869035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101580001|NCT02869035|Serotonin Agents|serotonin agents|mesh-ancestor
101580002|NCT02869035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580003|NCT02869035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101580004|NCT02869035|Antidepressive Agents|antidepressive agents|mesh-ancestor
101580005|NCT02869035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101580006|NCT02869035|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101580007|NCT02869035|Analgesics|analgesics|mesh-ancestor
101580008|NCT02869035|Sensory System Agents|sensory system agents|mesh-ancestor
101580009|NCT02869035|Dopamine Agents|dopamine agents|mesh-ancestor
101580010|NCT04290819|Caffeine|caffeine|mesh-list
101580011|NCT04290819|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101567015|NCT01254890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567016|NCT01254890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101567017|NCT01254890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101567018|NCT01254890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101567019|NCT01203852|Metoprolol|metoprolol|mesh-list
101580012|NCT04290819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580013|NCT04290819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101580014|NCT04290819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101580015|NCT04290819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580016|NCT04290819|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101580017|NCT04290819|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101580018|NCT04290819|Purinergic Agents|purinergic agents|mesh-ancestor
101580019|NCT04290819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101580020|NCT01196429|Sirolimus|sirolimus|mesh-list
101580021|NCT01196429|Paclitaxel|paclitaxel|mesh-list
101580022|NCT01196429|Docetaxel|docetaxel|mesh-list
101580023|NCT01196429|Carboplatin|carboplatin|mesh-list
101580024|NCT01196429|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101580025|NCT01196429|Temsirolimus|temsirolimus|mesh-list
101580026|NCT01196429|MTOR Inhibitors|mtor inhibitors|mesh-list
101580027|NCT01196429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101580028|NCT01196429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101580029|NCT01196429|Tubulin Modulators|tubulin modulators|mesh-ancestor
101580030|NCT01196429|Antimitotic Agents|antimitotic agents|mesh-ancestor
101580031|NCT01196429|Mitosis Modulators|mitosis modulators|mesh-ancestor
101580032|NCT01196429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580033|NCT01196429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101580034|NCT01196429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101580035|NCT01196429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101580036|NCT01196429|Antifungal Agents|antifungal agents|mesh-ancestor
101580037|NCT01196429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101580038|NCT01196429|Immunologic Factors|immunologic factors|mesh-ancestor
101580039|NCT01196429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580040|NCT01196429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101580041|NCT01196429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101580042|NCT01157364|Bimatoprost|bimatoprost|mesh-list
101580043|NCT01157364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101580044|NCT01195415|Gemcitabine|gemcitabine|mesh-list
101580052|NCT01195103|Fospropofol|fospropofol|mesh-list
101580053|NCT01195103|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101580054|NCT01195103|Narcotics|narcotics|mesh-ancestor
101580055|NCT01195103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101580056|NCT01195103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580057|NCT01195103|Analgesics|analgesics|mesh-ancestor
101580058|NCT01195103|Sensory System Agents|sensory system agents|mesh-ancestor
101580059|NCT01195103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101580060|NCT01195103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101580061|NCT01195103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101580062|NCT01195103|Anesthetics, General|anesthetics, general|mesh-ancestor
101580063|NCT01195103|Anesthetics|anesthetics|mesh-ancestor
101580064|NCT01195103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101580065|NCT01195103|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101580066|NCT01195103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101580067|NCT01195103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101580068|NCT01195103|GABA Modulators|gaba modulators|mesh-ancestor
101580069|NCT01195103|GABA Agents|gaba agents|mesh-ancestor
101580070|NCT01195103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101580071|NCT01195103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580072|NCT01194869|Paclitaxel|paclitaxel|mesh-list
101580073|NCT01194869|Cisplatin|cisplatin|mesh-list
101580074|NCT01194869|Sorafenib|sorafenib|mesh-list
101580075|NCT01194869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101580076|NCT01194869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101580077|NCT01194869|Tubulin Modulators|tubulin modulators|mesh-ancestor
101580078|NCT01194869|Antimitotic Agents|antimitotic agents|mesh-ancestor
101580079|NCT01194869|Mitosis Modulators|mitosis modulators|mesh-ancestor
101580080|NCT01194869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580081|NCT01194869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101580082|NCT01194869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101580083|NCT01177800|Infliximab|infliximab|mesh-list
101580084|NCT01177800|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101580085|NCT01177800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101567020|NCT01203852|Chlorthalidone|chlorthalidone|mesh-list
101567021|NCT01203852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101567022|NCT01203852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101567023|NCT01203852|Sympatholytics|sympatholytics|mesh-ancestor
101567024|NCT01203852|Autonomic Agents|autonomic agents|mesh-ancestor
101567025|NCT01203852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101567026|NCT01203852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415217|NCT00146523|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101580086|NCT01177800|Dermatologic Agents|dermatologic agents|mesh-ancestor
101580087|NCT01177800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101580088|NCT01177800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101580089|NCT01177722|Vaccines|vaccines|mesh-list
101580090|NCT01177722|Immunologic Factors|immunologic factors|mesh-ancestor
101580091|NCT01177722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580092|NCT02884986|Etoricoxib|etoricoxib|mesh-list
101580093|NCT02884986|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101580094|NCT02884986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101580095|NCT02884986|Analgesics|analgesics|mesh-ancestor
101580096|NCT02884986|Sensory System Agents|sensory system agents|mesh-ancestor
101580097|NCT02884986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101580098|NCT02884986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580099|NCT02884986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101580100|NCT02884986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101580101|NCT02884986|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101580102|NCT02884986|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101580103|NCT02884986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101580104|NCT02884986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580106|NCT04124562|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101580107|NCT04124562|Anesthetics, General|anesthetics, general|mesh-ancestor
101580108|NCT04124562|Anesthetics|anesthetics|mesh-ancestor
101580109|NCT04124562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101580110|NCT04124562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580111|NCT04124562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101580112|NCT04124562|Analgesics|analgesics|mesh-ancestor
101580113|NCT04124562|Sensory System Agents|sensory system agents|mesh-ancestor
101580114|NCT04124562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101580115|NCT01177410|Mesalamine|mesalamine|mesh-list
101580119|NCT01177410|Sensory System Agents|sensory system agents|mesh-ancestor
101580120|NCT01177410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101580121|NCT01177410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580122|NCT01177410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101580123|NCT01177410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101580125|NCT02884596|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
101580126|NCT02884596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101580127|NCT02884596|Serotonin Agents|serotonin agents|mesh-ancestor
101580128|NCT02884596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101580129|NCT02884596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580130|NCT02884596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580131|NCT02884596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101580132|NCT02884596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101580133|NCT04205916|Moxifloxacin|moxifloxacin|mesh-list
101580134|NCT04205916|Dexamethasone|dexamethasone|mesh-list
101580135|NCT04205916|Ketorolac|ketorolac|mesh-list
101580136|NCT04205916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101580137|NCT04205916|Antiemetics|antiemetics|mesh-ancestor
101580138|NCT04205916|Autonomic Agents|autonomic agents|mesh-ancestor
101580139|NCT04205916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101580140|NCT04205916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580141|NCT04205916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101580142|NCT04205916|Glucocorticoids|glucocorticoids|mesh-ancestor
101580143|NCT04205916|Hormones|hormones|mesh-ancestor
101580144|NCT04205916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101580145|NCT04205916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101580146|NCT04205916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101580147|NCT04205916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101580148|NCT04205916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101567027|NCT01203852|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101567028|NCT01203852|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101567029|NCT01203852|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101567030|NCT01203852|Adrenergic Agents|adrenergic agents|mesh-ancestor
101567031|NCT01203852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101567032|NCT01203852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567033|NCT01203852|Diuretics|diuretics|mesh-ancestor
101567034|NCT01203852|Natriuretic Agents|natriuretic agents|mesh-ancestor
101415224|NCT00402623|Antioxidants|antioxidants|mesh-ancestor
101580149|NCT04205916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101580150|NCT04205916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101580151|NCT04205916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101580152|NCT04205916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580153|NCT04205916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101580154|NCT04205916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101580155|NCT04205916|Analgesics|analgesics|mesh-ancestor
101580156|NCT04205916|Sensory System Agents|sensory system agents|mesh-ancestor
101580157|NCT04205916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101580158|NCT04205916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101580159|NCT01176240|Mannitol|mannitol|mesh-list
101580160|NCT01176240|Droxidopa|droxidopa|mesh-list
101580161|NCT01176240|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101580162|NCT01176240|Diuretics|diuretics|mesh-ancestor
101580163|NCT01176240|Natriuretic Agents|natriuretic agents|mesh-ancestor
101580164|NCT01176240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580165|NCT01176240|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101580166|NCT01176240|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101580167|NCT01149096|Lenograstim|lenograstim|mesh-list
101580168|NCT01149096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101580169|NCT01149096|Immunologic Factors|immunologic factors|mesh-ancestor
101580170|NCT01149096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580171|NCT02867397|Oxaliplatin|oxaliplatin|mesh-list
101580172|NCT02867397|Epirubicin|epirubicin|mesh-list
101580173|NCT02867397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101580174|NCT02867397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101580175|NCT02867397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101580177|NCT02867397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101580178|NCT02867397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580179|NCT01175382|Tamsulosin|tamsulosin|mesh-list
101580180|NCT01175382|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101580181|NCT01175382|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101580182|NCT01175382|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101580183|NCT01175382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101580184|NCT01175382|Adrenergic Agents|adrenergic agents|mesh-ancestor
101580185|NCT01175382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101580186|NCT01175382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580187|NCT01175382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580218|NCT01193153|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101580219|NCT01193153|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101580221|NCT01193153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101580222|NCT01193153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580223|NCT01193153|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101580224|NCT01193153|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101580225|NCT01193153|Dopamine Agents|dopamine agents|mesh-ancestor
101580226|NCT02867007|Mogamulizumab|mogamulizumab|mesh-list
101580227|NCT02867007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101580228|NCT04289883|Calcium|calcium|mesh-list
101580229|NCT04289883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101580230|NCT04289883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580231|NCT02865369|Asunaprevir|asunaprevir|mesh-list
101580232|NCT02865369|Protease Inhibitors|protease inhibitors|mesh-ancestor
101580235|NCT01192295|Oxycodone|oxycodone|mesh-list
101580236|NCT01192295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101580237|NCT01192295|Narcotics|narcotics|mesh-ancestor
101580238|NCT01192295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101567035|NCT01203852|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101567036|NCT01203852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101567037|NCT01203072|Edoxaban|edoxaban|mesh-list
101567038|NCT01203072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101567039|NCT01203072|Antithrombins|antithrombins|mesh-ancestor
101567040|NCT01203072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101567041|NCT01203072|Protease Inhibitors|protease inhibitors|mesh-ancestor
101567042|NCT01203072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101567043|NCT01203072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567044|NCT01203072|Anticoagulants|anticoagulants|mesh-ancestor
101567045|NCT01105377|Azacitidine|azacitidine|mesh-list
101567046|NCT01105377|Entinostat|entinostat|mesh-list
101415238|NCT00498316|Mycophenolic Acid|mycophenolic acid|mesh-list
101580239|NCT01192295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580240|NCT01192295|Analgesics|analgesics|mesh-ancestor
101580241|NCT01192295|Sensory System Agents|sensory system agents|mesh-ancestor
101580242|NCT01192295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101580243|NCT04289103|Inolimomab|inolimomab|mesh-list
101580244|NCT04289103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101580245|NCT04289103|Immunologic Factors|immunologic factors|mesh-ancestor
101580246|NCT04289103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580247|NCT01154166|Ropinirole|ropinirole|mesh-list
101580248|NCT01154166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101580249|NCT01154166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101580250|NCT01154166|Dopamine Agonists|dopamine agonists|mesh-ancestor
101580251|NCT01154166|Dopamine Agents|dopamine agents|mesh-ancestor
101580252|NCT01154166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101580253|NCT01154166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580254|NCT01154166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580255|NCT04290195|Aflibercept|aflibercept|mesh-list
101580256|NCT04290195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101580257|NCT04290195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101580258|NCT04290195|Growth Substances|growth substances|mesh-ancestor
101580259|NCT04290195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580260|NCT04290195|Growth Inhibitors|growth inhibitors|mesh-ancestor
101580261|NCT04290195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101580262|NCT05656703|Anesthetics|anesthetics|mesh-list
101580263|NCT05656703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101580264|NCT05656703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580265|NCT05656079|Cyclophosphamide|cyclophosphamide|mesh-list
101580266|NCT05656079|Docetaxel|docetaxel|mesh-list
101580267|NCT05656079|Doxorubicin|doxorubicin|mesh-list
101580268|NCT05656079|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101580269|NCT05656079|Trastuzumab|trastuzumab|mesh-list
101580270|NCT05656079|Epirubicin|epirubicin|mesh-list
101580271|NCT05656079|Pertuzumab|pertuzumab|mesh-list
101580272|NCT05656079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101580273|NCT05656079|Immunologic Factors|immunologic factors|mesh-ancestor
101580274|NCT05656079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580275|NCT05656079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101580276|NCT05656079|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101580277|NCT05656079|Alkylating Agents|alkylating agents|mesh-ancestor
101580278|NCT05656079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580279|NCT05656079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101580280|NCT05656079|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101580281|NCT05656079|Tubulin Modulators|tubulin modulators|mesh-ancestor
101580282|NCT05656079|Antimitotic Agents|antimitotic agents|mesh-ancestor
101580283|NCT05656079|Mitosis Modulators|mitosis modulators|mesh-ancestor
101580284|NCT05656079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101580285|NCT05656079|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101580286|NCT05656079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101580287|NCT05656079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101580288|NCT05656079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101580289|NCT01181921|Galantamine|galantamine|mesh-list
101567047|NCT01105377|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
101567048|NCT01105377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101567049|NCT01105377|Antimetabolites|antimetabolites|mesh-ancestor
101567050|NCT01105377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567051|NCT01105377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101415246|NCT00498316|Tacrolimus|tacrolimus|mesh-list
101580290|NCT01181921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101580291|NCT01181921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101580292|NCT01181921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580293|NCT01181921|Cholinergic Agents|cholinergic agents|mesh-ancestor
101580294|NCT01181921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101580295|NCT01181921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580296|NCT01181921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101580297|NCT01181921|Autonomic Agents|autonomic agents|mesh-ancestor
101580298|NCT01181921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101580299|NCT01181921|Nootropic Agents|nootropic agents|mesh-ancestor
101580301|NCT00932698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101580302|NCT00932698|Protease Inhibitors|protease inhibitors|mesh-ancestor
101580303|NCT00932698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101580304|NCT00932698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580305|NCT00978627|Insulin|insulin|mesh-list
101580306|NCT00978627|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101580307|NCT00978627|Insulin Aspart|insulin aspart|mesh-list
101580319|NCT01181609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580320|NCT01181609|Growth Inhibitors|growth inhibitors|mesh-ancestor
101580321|NCT04261426|Immunoglobulins|immunoglobulins|mesh-list
101580322|NCT04261426|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101580323|NCT04261426|Antibodies|antibodies|mesh-list
101580324|NCT04261426|gamma-Globulins|gamma-globulins|mesh-list
101580325|NCT04261426|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101580326|NCT04261426|Immunologic Factors|immunologic factors|mesh-ancestor
101580327|NCT04261426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580328|NCT04264078|Fludarabine|fludarabine|mesh-list
101580329|NCT04264078|Cyclophosphamide|cyclophosphamide|mesh-list
101580330|NCT04264078|Melphalan|melphalan|mesh-list
101580331|NCT04264078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101580332|NCT04264078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580333|NCT04264078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101580334|NCT04264078|Immunologic Factors|immunologic factors|mesh-ancestor
101580335|NCT04264078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580336|NCT04264078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101580337|NCT04264078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101580338|NCT04264078|Alkylating Agents|alkylating agents|mesh-ancestor
101580339|NCT04264078|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101580340|NCT01153698|Dabigatran|dabigatran|mesh-list
101580341|NCT01153698|Antithrombins|antithrombins|mesh-ancestor
101580342|NCT01153698|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101580343|NCT01153698|Protease Inhibitors|protease inhibitors|mesh-ancestor
101580344|NCT01153698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101580345|NCT01153698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580346|NCT01153698|Anticoagulants|anticoagulants|mesh-ancestor
101580347|NCT00608218|Ciclesonide|ciclesonide|mesh-list
101580348|NCT00608218|Glucocorticoids|glucocorticoids|mesh-ancestor
101580349|NCT00608218|Hormones|hormones|mesh-ancestor
101580350|NCT00608218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101580351|NCT00608218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580352|NCT00608218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101580353|NCT02884050|Topiramate|topiramate|mesh-list
101580354|NCT02884050|Anticonvulsants|anticonvulsants|mesh-ancestor
101580355|NCT02884050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101580356|NCT02884050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580357|NCT00609934|Sorafenib|sorafenib|mesh-list
101580358|NCT00609934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101580359|NCT00609934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101580360|NCT00609934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101580361|NCT00609934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580362|NCT01147926|Prucalopride|prucalopride|mesh-list
101580363|NCT01147926|Laxatives|laxatives|mesh-ancestor
101580364|NCT01147926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101580365|NCT01147926|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101567053|NCT01105065|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101567054|NCT01105065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101325090|NCT00109408|Abortifacient Agents|abortifacient agents|mesh-ancestor
101567055|NCT01105065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101567056|NCT01105065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101567057|NCT01105065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101567058|NCT01105065|Adrenergic Agents|adrenergic agents|mesh-ancestor
101567059|NCT01105065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101567060|NCT01105065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415252|NCT00498316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101543742|NCT01641224|Pinaverium|pinaverium|mesh-list
101580366|NCT01147926|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101580367|NCT01147926|Serotonin Agents|serotonin agents|mesh-ancestor
101580368|NCT01147926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101580369|NCT01147926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580370|NCT01147926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580402|NCT00608374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580403|NCT00608374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101580404|NCT00608374|Immunologic Factors|immunologic factors|mesh-ancestor
101580405|NCT00608374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580406|NCT00608374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101580407|NCT00608374|Alkylating Agents|alkylating agents|mesh-ancestor
101580408|NCT00625014|Haloperidol|haloperidol|mesh-list
101580409|NCT00625014|Haloperidol decanoate|haloperidol decanoate|mesh-list
101580410|NCT00625014|Antiemetics|antiemetics|mesh-ancestor
101580411|NCT00625014|Autonomic Agents|autonomic agents|mesh-ancestor
101580412|NCT00625014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101580413|NCT00625014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580414|NCT00625014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101580415|NCT00625014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101580416|NCT00625014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101580417|NCT00625014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101580426|NCT01147848|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101580427|NCT01147848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101580428|NCT01147848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101580429|NCT01147848|Autonomic Agents|autonomic agents|mesh-ancestor
101580430|NCT01147848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101580431|NCT01147848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580432|NCT01147848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101580433|NCT01147848|Respiratory System Agents|respiratory system agents|mesh-ancestor
101580434|NCT01147848|Dermatologic Agents|dermatologic agents|mesh-ancestor
101580435|NCT01147848|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101580436|NCT01147848|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101580437|NCT01147848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101580438|NCT01147848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101580439|NCT01147848|Adrenergic Agents|adrenergic agents|mesh-ancestor
101580440|NCT01147848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101580441|NCT01147848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580442|NCT04261270|Ritonavir|ritonavir|mesh-list
101580443|NCT04261270|Oseltamivir|oseltamivir|mesh-list
101237334|NCT03258281|Evolocumab|evolocumab|mesh-list
101580444|NCT04261270|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101580445|NCT04261270|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101580446|NCT04261270|Protease Inhibitors|protease inhibitors|mesh-ancestor
101580447|NCT04261270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101580448|NCT04261270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580449|NCT04261270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101580450|NCT04261270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101580451|NCT04261270|Antiviral Agents|antiviral agents|mesh-ancestor
101580452|NCT04261270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101580453|NCT04261270|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101580454|NCT04261270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101567062|NCT01111539|Aripiprazole|aripiprazole|mesh-list
101567063|NCT01111539|Escitalopram|escitalopram|mesh-list
101567064|NCT01111539|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101567065|NCT01111539|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101567066|NCT01111539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101567067|NCT01111539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580455|NCT01152996|Vortioxetine|vortioxetine|mesh-list
101580456|NCT01152996|Antidepressive Agents|antidepressive agents|mesh-ancestor
101580457|NCT01152996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101580458|NCT01152996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101580459|NCT01152996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101580460|NCT01152996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101580461|NCT01152996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580462|NCT01152996|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101580463|NCT01152996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101580464|NCT01152996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101325245|NCT00110734|Sensory System Agents|sensory system agents|mesh-ancestor
101580465|NCT01152996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580466|NCT01152996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101580467|NCT01152996|Serotonin Agents|serotonin agents|mesh-ancestor
101580468|NCT01152996|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101580469|NCT01152996|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101580470|NCT01152996|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101580471|NCT01152996|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101580472|NCT00624936|Azacitidine|azacitidine|mesh-list
101580473|NCT00624936|Bortezomib|bortezomib|mesh-list
101580474|NCT00624936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101580475|NCT00624936|Antimetabolites|antimetabolites|mesh-ancestor
101580476|NCT00624936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580477|NCT00624936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101580478|NCT00624936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101580479|NCT00979953|Oxycodone|oxycodone|mesh-list
101580480|NCT00979953|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101580481|NCT00979953|Narcotics|narcotics|mesh-ancestor
101580482|NCT00979953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101580491|NCT01181531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580492|NCT01181531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101580493|NCT01181531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101580494|NCT01181531|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101325300|NCT00111124|Etanercept|etanercept|mesh-list
101580495|NCT01181531|Hormone Antagonists|hormone antagonists|mesh-ancestor
101580496|NCT01181531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101580497|NCT01152450|Tiotropium Bromide|tiotropium bromide|mesh-list
101580498|NCT01152450|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101580499|NCT01152450|Autonomic Agents|autonomic agents|mesh-ancestor
101580500|NCT01152450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101580501|NCT01152450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580502|NCT01152450|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101580503|NCT01152450|Respiratory System Agents|respiratory system agents|mesh-ancestor
101580504|NCT01152450|Parasympatholytics|parasympatholytics|mesh-ancestor
101580505|NCT01152450|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101580506|NCT01152450|Cholinergic Agents|cholinergic agents|mesh-ancestor
101580507|NCT01152450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101580508|NCT01152450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580510|NCT00610246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101580511|NCT00610246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101580512|NCT00610246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101580513|NCT00610246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580514|NCT01181141|Enoxaparin|enoxaparin|mesh-list
101580515|NCT01181141|Enoxaparin sodium|enoxaparin sodium|mesh-list
101580516|NCT01181141|Edoxaban|edoxaban|mesh-list
101580517|NCT01181141|Anticoagulants|anticoagulants|mesh-ancestor
101580518|NCT01181141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101325348|NCT00111436|Etanercept|etanercept|mesh-list
101580519|NCT01181141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101567068|NCT01111539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101567070|NCT01111539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567071|NCT01111539|Antidepressive Agents|antidepressive agents|mesh-ancestor
101567072|NCT01111539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101567073|NCT01111539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101567074|NCT01111539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101567075|NCT01111539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101567076|NCT01111539|Dopamine Agonists|dopamine agonists|mesh-ancestor
101567077|NCT01111539|Dopamine Agents|dopamine agents|mesh-ancestor
101567078|NCT01111539|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101415268|NCT01245166|Metformin|metformin|mesh-list
101580520|NCT01181141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580521|NCT01181141|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101580522|NCT01181141|Antithrombins|antithrombins|mesh-ancestor
101580523|NCT01181141|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101580524|NCT01181141|Protease Inhibitors|protease inhibitors|mesh-ancestor
101580525|NCT01181141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101580526|NCT00606814|Docetaxel|docetaxel|mesh-list
101580527|NCT00606814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101580528|NCT00606814|Tubulin Modulators|tubulin modulators|mesh-ancestor
101580529|NCT00606814|Antimitotic Agents|antimitotic agents|mesh-ancestor
101580530|NCT00606814|Mitosis Modulators|mitosis modulators|mesh-ancestor
101580531|NCT00606814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580532|NCT01173120|Abatacept|abatacept|mesh-list
101580533|NCT01173120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101580534|NCT01173120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580535|NCT01173120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101580536|NCT01173120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101580537|NCT01173120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101580538|NCT01173120|Immunologic Factors|immunologic factors|mesh-ancestor
101580539|NCT01173120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580540|NCT01173120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101580541|NCT00977379|Capecitabine|capecitabine|mesh-list
101580542|NCT00977379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101580543|NCT00977379|Antimetabolites|antimetabolites|mesh-ancestor
101580544|NCT00977379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580545|NCT00977379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101580546|NCT04263844|Midazolam|midazolam|mesh-list
101580547|NCT04263844|Dexmedetomidine|dexmedetomidine|mesh-list
101580548|NCT04263844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101580549|NCT04263844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101580550|NCT04263844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580551|NCT04263844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101580552|NCT04263844|Analgesics|analgesics|mesh-ancestor
101580553|NCT04263844|Sensory System Agents|sensory system agents|mesh-ancestor
101580554|NCT04263844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101580555|NCT04263844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101580556|NCT04263844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101580557|NCT04263844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101580558|NCT04263844|Adrenergic Agents|adrenergic agents|mesh-ancestor
101580559|NCT04263844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101580571|NCT00610324|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101580572|NCT00610324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101580573|NCT00610324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101580574|NCT00610324|Disinfectants|disinfectants|mesh-ancestor
101580575|NCT00610324|Dermatologic Agents|dermatologic agents|mesh-ancestor
101580576|NCT02884128|Leucovorin|leucovorin|mesh-list
101580577|NCT02884128|Fluorouracil|fluorouracil|mesh-list
101580578|NCT02884128|Irinotecan|irinotecan|mesh-list
101580579|NCT02884128|Antimetabolites|antimetabolites|mesh-ancestor
101580580|NCT02884128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580581|NCT02884128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101567079|NCT01111539|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101567080|NCT01111539|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101567081|NCT01111539|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101567082|NCT01111539|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101580582|NCT02884128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101580583|NCT02884128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101580584|NCT02884128|Immunologic Factors|immunologic factors|mesh-ancestor
101580585|NCT02884128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580586|NCT02884128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101580587|NCT02884128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101580588|NCT02884128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101580589|NCT02884128|Antidotes|antidotes|mesh-ancestor
101580590|NCT02884128|Protective Agents|protective agents|mesh-ancestor
101580591|NCT02884128|Vitamin B Complex|vitamin b complex|mesh-ancestor
101580592|NCT02884128|Vitamins|vitamins|mesh-ancestor
101580593|NCT02884128|Micronutrients|micronutrients|mesh-ancestor
101580594|NCT00629343|Azacitidine|azacitidine|mesh-list
101580595|NCT00629343|Temozolomide|temozolomide|mesh-list
101580596|NCT00629343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101580597|NCT00629343|Antimetabolites|antimetabolites|mesh-ancestor
101580598|NCT00629343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580599|NCT00629343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101580600|NCT00629343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101580601|NCT00629343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101580602|NCT00629343|Alkylating Agents|alkylating agents|mesh-ancestor
101580603|NCT01180049|Sirolimus|sirolimus|mesh-list
101580604|NCT01180049|Temsirolimus|temsirolimus|mesh-list
101580605|NCT01180049|MTOR Inhibitors|mtor inhibitors|mesh-list
101580606|NCT01180049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101580607|NCT01180049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101580608|NCT01180049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580609|NCT01180049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101580610|NCT01180049|Immunologic Factors|immunologic factors|mesh-ancestor
101580611|NCT01180049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580612|NCT01180049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101580613|NCT01180049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101580614|NCT01180049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101580615|NCT01180049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101580616|NCT01180049|Antifungal Agents|antifungal agents|mesh-ancestor
101580617|NCT01147458|Naproxen|naproxen|mesh-list
101580618|NCT01147458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101580619|NCT01147458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101580620|NCT01147458|Analgesics|analgesics|mesh-ancestor
101580621|NCT01147458|Sensory System Agents|sensory system agents|mesh-ancestor
101580622|NCT01147458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101580623|NCT01147458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580624|NCT01147458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101580625|NCT01147458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101580626|NCT01147458|Gout Suppressants|gout suppressants|mesh-ancestor
101580641|NCT01172808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101580642|NCT01172808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580643|NCT01172808|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101580644|NCT01172808|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101580645|NCT01172808|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101580646|NCT01172808|Adrenergic Agents|adrenergic agents|mesh-ancestor
101580647|NCT04315194|Clarithromycin|clarithromycin|mesh-list
101580648|NCT04315194|Oseltamivir|oseltamivir|mesh-list
101580649|NCT04315194|Naproxen|naproxen|mesh-list
101580650|NCT04315194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101580651|NCT04315194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101580652|NCT04315194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101580653|NCT04315194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101580654|NCT04315194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580655|NCT04315194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101580656|NCT04315194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101325521|NCT00007592|Furosemide|furosemide|mesh-list
101580657|NCT04315194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101580658|NCT04315194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101580659|NCT04315194|Analgesics|analgesics|mesh-ancestor
101580660|NCT04315194|Sensory System Agents|sensory system agents|mesh-ancestor
101580661|NCT04315194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101567083|NCT01111539|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101567084|NCT02880345|Pembrolizumab|pembrolizumab|mesh-list
101567085|NCT02880345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101567086|NCT02880345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101567087|NCT02880345|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101567088|NCT02880345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567089|NCT02879955|Acarbose|acarbose|mesh-list
101567090|NCT02879955|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101567091|NCT02879955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101567092|NCT02879955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567093|NCT02879955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101567094|NCT02879955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580662|NCT04315194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580663|NCT04315194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101580664|NCT04315194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101580665|NCT04315194|Gout Suppressants|gout suppressants|mesh-ancestor
101580666|NCT04315194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101580667|NCT04315194|Antiviral Agents|antiviral agents|mesh-ancestor
101580668|NCT04066491|Gemcitabine|gemcitabine|mesh-list
101580669|NCT04066491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101580670|NCT04066491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101580671|NCT04066491|Antimetabolites|antimetabolites|mesh-ancestor
101580672|NCT04066491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580673|NCT01149486|Losartan|losartan|mesh-list
101580674|NCT01149486|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101580675|NCT01149486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101580676|NCT01149486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101580677|NCT01149486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101580678|NCT01149486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101580679|NCT01149486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580680|NCT01149486|Diuretics|diuretics|mesh-ancestor
101580681|NCT01149486|Natriuretic Agents|natriuretic agents|mesh-ancestor
101580682|NCT01149486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580683|NCT01149486|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101580684|NCT01149486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101580685|NCT00601705|Fluorouracil|fluorouracil|mesh-list
101580686|NCT00601705|Oxaliplatin|oxaliplatin|mesh-list
101580687|NCT00601705|Epirubicin|epirubicin|mesh-list
101580694|NCT00601705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580695|NCT00601705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101580696|NCT00601705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101580697|NCT00601705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101580698|NCT00601705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101580700|NCT00641173|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101580701|NCT00641173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101580702|NCT00641173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101580703|NCT00641173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580704|NCT00641173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101580705|NCT00641173|Serotonin Agents|serotonin agents|mesh-ancestor
101580706|NCT00641173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580707|NCT00641173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101580708|NCT00641173|Antidepressive Agents|antidepressive agents|mesh-ancestor
101580709|NCT00641173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101580710|NCT00641173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101580711|NCT00641173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101580712|NCT00641173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101580713|NCT00929110|Glycopyrrolate|glycopyrrolate|mesh-list
101580714|NCT00929110|Bromides|bromides|mesh-list
101580715|NCT00929110|Tiotropium Bromide|tiotropium bromide|mesh-list
101580716|NCT00929110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101567095|NCT02880033|Deferiprone|deferiprone|mesh-list
101567096|NCT02880033|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101567097|NCT02880033|Chelating Agents|chelating agents|mesh-ancestor
101567098|NCT02880033|Sequestering Agents|sequestering agents|mesh-ancestor
101567099|NCT02880033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567100|NCT00625911|Ketamine|ketamine|mesh-list
101580717|NCT00929110|Autonomic Agents|autonomic agents|mesh-ancestor
101580718|NCT00929110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101580719|NCT00929110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580720|NCT00929110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101580721|NCT00929110|Respiratory System Agents|respiratory system agents|mesh-ancestor
101580722|NCT00929110|Parasympatholytics|parasympatholytics|mesh-ancestor
101580723|NCT00929110|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101580724|NCT00929110|Cholinergic Agents|cholinergic agents|mesh-ancestor
101580725|NCT00929110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101580726|NCT00929110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580727|NCT00929110|Anticonvulsants|anticonvulsants|mesh-ancestor
101580728|NCT00929110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101580729|NCT00929110|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101580730|NCT00922519|Listerine|listerine|mesh-list
101580731|NCT00922519|Fluorides|fluorides|mesh-list
101580732|NCT00922519|Sodium Fluoride|sodium fluoride|mesh-list
101580733|NCT00922519|Cariostatic Agents|cariostatic agents|mesh-ancestor
101580734|NCT00922519|Protective Agents|protective agents|mesh-ancestor
101580735|NCT00922519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580736|NCT00922519|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101580737|NCT00922519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101580738|NCT00640549|Atorvastatin|atorvastatin|mesh-list
101580739|NCT00640549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101580740|NCT00640549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101580741|NCT00640549|Antimetabolites|antimetabolites|mesh-ancestor
101237629|NCT03841110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101580742|NCT00640549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580743|NCT00640549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101580744|NCT00640549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101580745|NCT00640549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101580746|NCT02683369|Iron|iron|mesh-list
101580747|NCT02683369|Trace Elements|trace elements|mesh-ancestor
101580748|NCT02683369|Micronutrients|micronutrients|mesh-ancestor
101580749|NCT02683369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580750|NCT01147068|Hemagglutinins|hemagglutinins|mesh-list
101580751|NCT01147068|Agglutinins|agglutinins|mesh-ancestor
101580752|NCT01147068|Immunologic Factors|immunologic factors|mesh-ancestor
101580753|NCT01147068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580754|NCT01147068|Coagulants|coagulants|mesh-ancestor
101580767|NCT00640627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580769|NCT02681887|Antioxidants|antioxidants|mesh-ancestor
101580770|NCT02681887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580771|NCT02681887|Protective Agents|protective agents|mesh-ancestor
101580772|NCT02681887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580773|NCT02681887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101580774|NCT01134042|Fluticasone|fluticasone|mesh-list
101580776|NCT01134042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101580777|NCT01134042|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101580778|NCT01134042|Autonomic Agents|autonomic agents|mesh-ancestor
101580779|NCT01134042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101580780|NCT01134042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580781|NCT01134042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101580782|NCT01134042|Respiratory System Agents|respiratory system agents|mesh-ancestor
101580783|NCT01134042|Dermatologic Agents|dermatologic agents|mesh-ancestor
101580784|NCT01134042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101580785|NCT01179347|Tiotropium Bromide|tiotropium bromide|mesh-list
101580786|NCT01179347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101580787|NCT01179347|Autonomic Agents|autonomic agents|mesh-ancestor
101580788|NCT01179347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101580789|NCT01179347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580790|NCT01179347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101580791|NCT01179347|Respiratory System Agents|respiratory system agents|mesh-ancestor
101580792|NCT01179347|Parasympatholytics|parasympatholytics|mesh-ancestor
101580793|NCT01179347|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101567101|NCT00625911|Morphine|morphine|mesh-list
101567102|NCT00625911|Analgesics|analgesics|mesh-ancestor
101567103|NCT00625911|Sensory System Agents|sensory system agents|mesh-ancestor
101567104|NCT00625911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101567105|NCT00625911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567106|NCT00625911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101567107|NCT00625911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101567108|NCT00625911|Anesthetics, General|anesthetics, general|mesh-ancestor
101580794|NCT01179347|Cholinergic Agents|cholinergic agents|mesh-ancestor
101580795|NCT01179347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101580796|NCT01179347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580797|NCT01146288|Furosemide|furosemide|mesh-list
101580798|NCT01146288|Acetazolamide|acetazolamide|mesh-list
101580799|NCT01146288|Diuretics|diuretics|mesh-ancestor
101580800|NCT01146288|Natriuretic Agents|natriuretic agents|mesh-ancestor
101580801|NCT01146288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580802|NCT01146288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101580803|NCT01146288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101580804|NCT01146288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580805|NCT01146288|Anticonvulsants|anticonvulsants|mesh-ancestor
101580806|NCT01146288|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101580807|NCT01146288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101580808|NCT01146054|Gemcitabine|gemcitabine|mesh-list
101580809|NCT01146054|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101580810|NCT01146054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101580811|NCT01146054|Antimetabolites|antimetabolites|mesh-ancestor
101580812|NCT01146054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580813|NCT01146054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101580814|NCT01146054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101580815|NCT00640705|Diclofenac|diclofenac|mesh-list
101580826|NCT00640705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580827|NCT01145898|Timolol|timolol|mesh-list
101580828|NCT01145898|Dorzolamide|dorzolamide|mesh-list
101580829|NCT01145898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101580830|NCT01145898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101580831|NCT01145898|Adrenergic Agents|adrenergic agents|mesh-ancestor
101580832|NCT01145898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101580833|NCT01145898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325751|NCT00113698|Protease Inhibitors|protease inhibitors|mesh-ancestor
101580834|NCT01145898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580835|NCT01145898|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101580836|NCT01145898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101580837|NCT01145898|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101580838|NCT01145898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101580839|NCT02681653|Atorvastatin|atorvastatin|mesh-list
101580840|NCT02681653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101580841|NCT02681653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101580842|NCT02681653|Antimetabolites|antimetabolites|mesh-ancestor
101580843|NCT02681653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580844|NCT02681653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101580845|NCT02681653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101580846|NCT02681653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101580847|NCT04315116|Loperamide|loperamide|mesh-list
101580848|NCT04315116|Antidiarrheals|antidiarrheals|mesh-list
101580849|NCT04315116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101580850|NCT02883114|Itraconazole|itraconazole|mesh-list
101580851|NCT02883114|Antifungal Agents|antifungal agents|mesh-ancestor
101580852|NCT02883114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101580853|NCT02883114|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101580854|NCT02883114|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101580855|NCT02883114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101580856|NCT02883114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580857|NCT02883114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101580858|NCT02883114|Hormone Antagonists|hormone antagonists|mesh-ancestor
101580859|NCT02883114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101567109|NCT00625911|Anesthetics|anesthetics|mesh-ancestor
101567110|NCT00625911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101567111|NCT00625911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101567112|NCT00625911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101567113|NCT00625911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101567114|NCT00625911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567115|NCT00625911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101567116|NCT00625911|Narcotics|narcotics|mesh-ancestor
101580860|NCT02883114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580861|NCT02883114|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101580862|NCT04183387|Simvastatin|simvastatin|mesh-list
101580863|NCT04183387|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101580864|NCT04183387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101580865|NCT04183387|Antimetabolites|antimetabolites|mesh-ancestor
101580866|NCT04183387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580867|NCT04183387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101580868|NCT04183387|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101580869|NCT04183387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101580870|NCT00625092|Leucovorin|leucovorin|mesh-list
101580871|NCT00625092|Fluorouracil|fluorouracil|mesh-list
101580872|NCT00625092|Oxaliplatin|oxaliplatin|mesh-list
101580873|NCT00625092|Calcium|calcium|mesh-list
101580874|NCT00625092|Levoleucovorin|levoleucovorin|mesh-list
101580875|NCT00625092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101580876|NCT00625092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580877|NCT00625092|Antimetabolites|antimetabolites|mesh-ancestor
101580878|NCT00625092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580895|NCT00931918|Immunologic Factors|immunologic factors|mesh-ancestor
101580896|NCT00931918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325813|NCT00113815|Anticonvulsants|anticonvulsants|mesh-ancestor
101580897|NCT00931918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101580898|NCT00931918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101580899|NCT00931918|Alkylating Agents|alkylating agents|mesh-ancestor
101580900|NCT00931918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580901|NCT00931918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101580902|NCT00931918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101580903|NCT00931918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101580904|NCT00931918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101580905|NCT00931918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101580906|NCT00931918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101580907|NCT00931918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101580908|NCT00931918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101580909|NCT00931918|Glucocorticoids|glucocorticoids|mesh-ancestor
101580910|NCT00931918|Hormones|hormones|mesh-ancestor
101580911|NCT00931918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101580912|NCT00931918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101580913|NCT00931918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101580914|NCT00931918|Tubulin Modulators|tubulin modulators|mesh-ancestor
101580915|NCT00931918|Antimitotic Agents|antimitotic agents|mesh-ancestor
101580916|NCT00931918|Mitosis Modulators|mitosis modulators|mesh-ancestor
101580917|NCT04183075|Vitamins|vitamins|mesh-list
101580918|NCT04183075|Ascorbic Acid|ascorbic acid|mesh-list
101580919|NCT04183075|Micronutrients|micronutrients|mesh-ancestor
101580920|NCT04183075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580921|NCT04183075|Antioxidants|antioxidants|mesh-ancestor
101325875|NCT00114400|Pyridoxine|pyridoxine|mesh-list
101580922|NCT04183075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580923|NCT04183075|Protective Agents|protective agents|mesh-ancestor
101580924|NCT02679001|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
101580925|NCT02679001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101580926|NCT02678221|Aspirin|aspirin|mesh-list
101580927|NCT02678221|Sildenafil Citrate|sildenafil citrate|mesh-list
101580928|NCT02678221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101580929|NCT02678221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101580930|NCT02678221|Analgesics|analgesics|mesh-ancestor
101580931|NCT02678221|Sensory System Agents|sensory system agents|mesh-ancestor
101580932|NCT02678221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101567117|NCT01111149|Bupropion|bupropion|mesh-list
101567118|NCT01111149|Varenicline|varenicline|mesh-list
101567119|NCT01111149|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101567120|NCT01111149|Antidepressive Agents|antidepressive agents|mesh-ancestor
101567121|NCT01111149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101567122|NCT01111149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101567123|NCT01111149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101567124|NCT01111149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101567125|NCT01111149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567126|NCT01111149|Dopamine Agents|dopamine agents|mesh-ancestor
101567127|NCT01111149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101567128|NCT01111149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580933|NCT02678221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580934|NCT02678221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101580935|NCT02678221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101580936|NCT02678221|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101580937|NCT02678221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101580938|NCT02678221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580939|NCT02678221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101580940|NCT02678221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101580944|NCT02678221|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101580945|NCT02678221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101580946|NCT02678221|Urological Agents|urological agents|mesh-ancestor
101580947|NCT00641329|Clonidine|clonidine|mesh-list
101325985|NCT00115024|Estradiol|estradiol|mesh-list
101580948|NCT00641329|Analgesics|analgesics|mesh-ancestor
101580949|NCT00641329|Sensory System Agents|sensory system agents|mesh-ancestor
101580950|NCT00641329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101580951|NCT00641329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580952|NCT00641329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101580953|NCT00641329|Sympatholytics|sympatholytics|mesh-ancestor
101580954|NCT00641329|Autonomic Agents|autonomic agents|mesh-ancestor
101580955|NCT00641329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101580956|NCT00641329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101580957|NCT00641329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101580958|NCT00641329|Adrenergic Agents|adrenergic agents|mesh-ancestor
101580959|NCT00641329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101580960|NCT00641329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580961|NCT01179191|Naltrexone|naltrexone|mesh-list
101580962|NCT01179191|Morphine|morphine|mesh-list
101580963|NCT01179191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101580964|NCT01179191|Narcotics|narcotics|mesh-ancestor
101580965|NCT01179191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101580966|NCT01179191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580967|NCT01179191|Analgesics|analgesics|mesh-ancestor
101237856|NCT02938442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101580968|NCT01179191|Sensory System Agents|sensory system agents|mesh-ancestor
101580969|NCT01179191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101580970|NCT01179191|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101580971|NCT01179191|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101580972|NCT00642421|Octreotide|octreotide|mesh-list
101580973|NCT00642421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101580974|NCT00642421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101580975|NCT00642421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101580976|NCT00642187|Budesonide|budesonide|mesh-list
101580977|NCT00642187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101580978|NCT00642187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101580979|NCT00642187|Autonomic Agents|autonomic agents|mesh-ancestor
101580980|NCT00642187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101580981|NCT00642187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580982|NCT00642187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101580983|NCT00642187|Respiratory System Agents|respiratory system agents|mesh-ancestor
101580984|NCT00642187|Glucocorticoids|glucocorticoids|mesh-ancestor
101567129|NCT01111149|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101567130|NCT01111149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101567131|NCT01111149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101326048|NCT00115219|Analgesics|analgesics|mesh-ancestor
101567132|NCT01111149|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101567133|NCT01111149|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101567134|NCT01111149|Cholinergic Agents|cholinergic agents|mesh-ancestor
101567135|NCT01254656|Efavirenz|efavirenz|mesh-list
101567136|NCT01254656|Etravirine|etravirine|mesh-list
101567137|NCT01254656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101567138|NCT01254656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101567139|NCT01254656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101567140|NCT01254656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567141|NCT01254656|Antiviral Agents|antiviral agents|mesh-ancestor
101567142|NCT01254656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101567143|NCT01254656|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101567144|NCT01254656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101580985|NCT00642187|Hormones|hormones|mesh-ancestor
101580986|NCT00642187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101580987|NCT05663125|Temozolomide|temozolomide|mesh-list
101580988|NCT05663125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101580989|NCT05663125|Alkylating Agents|alkylating agents|mesh-ancestor
101580990|NCT05663125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580991|NCT05663125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101580992|NCT01132482|Sildenafil Citrate|sildenafil citrate|mesh-list
101580993|NCT01132482|Vasodilator Agents|vasodilator agents|mesh-ancestor
101580994|NCT01132482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101580995|NCT01132482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101580996|NCT01132482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101580997|NCT01132482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580998|NCT01132482|Urological Agents|urological agents|mesh-ancestor
101580999|NCT02678767|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
101581000|NCT02678767|Hematinics|hematinics|mesh-ancestor
101581001|NCT02678767|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101581002|NCT02678767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101581003|NCT00931762|Panobinostat|panobinostat|mesh-list
101326086|NCT00115492|Xhance|xhance|mesh-list
101581004|NCT00931762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101581005|NCT00931762|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101581006|NCT00931762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101581007|NCT00931762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581008|NCT00641407|Insulin|insulin|mesh-list
101581009|NCT00641407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101581010|NCT00641407|Insulin Glargine|insulin glargine|mesh-list
101581011|NCT00641407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101581012|NCT00641407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581036|NCT01145508|Metronidazole|metronidazole|mesh-list
101581037|NCT01145508|Prednisone|prednisone|mesh-list
101581038|NCT01145508|Cortisone|cortisone|mesh-list
101581039|NCT01145508|Docetaxel|docetaxel|mesh-list
101581040|NCT01145508|Vaccines|vaccines|mesh-list
101581041|NCT01145508|Immunologic Factors|immunologic factors|mesh-ancestor
101581042|NCT01145508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581043|NCT01145508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101581044|NCT01145508|Tubulin Modulators|tubulin modulators|mesh-ancestor
101581045|NCT01145508|Antimitotic Agents|antimitotic agents|mesh-ancestor
101581046|NCT01145508|Mitosis Modulators|mitosis modulators|mesh-ancestor
101581047|NCT01145508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581048|NCT01145508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101581049|NCT01145508|Glucocorticoids|glucocorticoids|mesh-ancestor
101567145|NCT01254656|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101567146|NCT01254656|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101567147|NCT01254656|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101567148|NCT01254656|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101581051|NCT01145508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101581052|NCT01145508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101581053|NCT01145508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101581054|NCT01145508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101581055|NCT01145508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101581056|NCT01145508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101581057|NCT00931528|Tadalafil|tadalafil|mesh-list
101581058|NCT00931528|Vasodilator Agents|vasodilator agents|mesh-ancestor
101581059|NCT00931528|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101581060|NCT00931528|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101581061|NCT00931528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101581062|NCT00931528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581063|NCT00931528|Urological Agents|urological agents|mesh-ancestor
101581064|NCT04181749|Aspirin|aspirin|mesh-list
101581065|NCT04181749|Atorvastatin|atorvastatin|mesh-list
101581071|NCT04181749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581072|NCT04181749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101581073|NCT04181749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101581074|NCT04181749|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101581075|NCT04181749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101581076|NCT04181749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581077|NCT04181749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101581078|NCT04181749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101581079|NCT04181749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101581080|NCT04181749|Antipyretics|antipyretics|mesh-ancestor
101581081|NCT04181749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101581082|NCT04181749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101581083|NCT04181749|Antimetabolites|antimetabolites|mesh-ancestor
101581084|NCT04181749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101581085|NCT04181749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101581086|NCT04312152|Vitamins|vitamins|mesh-list
101581087|NCT04312152|Vitamin E|vitamin e|mesh-list
101581088|NCT04312152|Tocopherols|tocopherols|mesh-list
101581089|NCT04312152|Folic Acid|folic acid|mesh-list
101581090|NCT04312152|Vitamin B Complex|vitamin b complex|mesh-list
101581091|NCT04312152|Micronutrients|micronutrients|mesh-ancestor
101581092|NCT04312152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581093|NCT04312152|Antioxidants|antioxidants|mesh-ancestor
101581094|NCT04312152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581095|NCT04312152|Protective Agents|protective agents|mesh-ancestor
101581096|NCT04312152|Hematinics|hematinics|mesh-ancestor
101581097|NCT00975195|Fluticasone|fluticasone|mesh-list
101581098|NCT00975195|Xhance|xhance|mesh-list
101581099|NCT00975195|Tiotropium Bromide|tiotropium bromide|mesh-list
101581100|NCT00975195|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101581101|NCT00975195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101581102|NCT00975195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101581103|NCT00975195|Autonomic Agents|autonomic agents|mesh-ancestor
101581104|NCT00975195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101581105|NCT00975195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581106|NCT00975195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101581107|NCT00975195|Respiratory System Agents|respiratory system agents|mesh-ancestor
101581108|NCT00975195|Dermatologic Agents|dermatologic agents|mesh-ancestor
101581109|NCT00975195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101581110|NCT00975195|Parasympatholytics|parasympatholytics|mesh-ancestor
101581111|NCT00975195|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101581112|NCT00975195|Cholinergic Agents|cholinergic agents|mesh-ancestor
101581113|NCT00975195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101581114|NCT00975195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581115|NCT00975195|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101581116|NCT00975195|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101581117|NCT00975195|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101581118|NCT00975195|Adrenergic Agents|adrenergic agents|mesh-ancestor
101581119|NCT00642499|Dronabinol|dronabinol|mesh-list
101581120|NCT00642499|Hallucinogens|hallucinogens|mesh-ancestor
101567151|NCT01254344|Ertapenem|ertapenem|mesh-list
101567152|NCT01254344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101567153|NCT01254344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101567154|NCT01254344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101567155|NCT01254344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101567156|NCT05051007|Lidocaine|lidocaine|mesh-list
101567157|NCT05051007|Fentanyl|fentanyl|mesh-list
101567158|NCT05051007|Anesthetics, Local|anesthetics, local|mesh-ancestor
101567159|NCT05051007|Anesthetics|anesthetics|mesh-ancestor
101567160|NCT05051007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101581121|NCT00642499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581122|NCT00642499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101581123|NCT00642499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101581124|NCT00642499|Analgesics|analgesics|mesh-ancestor
101581125|NCT00642499|Sensory System Agents|sensory system agents|mesh-ancestor
101581126|NCT00642499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101581127|NCT00642499|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101581128|NCT00642499|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101581129|NCT00642499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101581130|NCT00642499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581131|NCT00642499|Hormones|hormones|mesh-ancestor
101581132|NCT00642499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101581133|NCT00644215|Mitomycins|mitomycins|mesh-list
101581134|NCT00644215|Mitomycin|mitomycin|mesh-list
101581135|NCT00644215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101581136|NCT00644215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101581140|NCT00644215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101581142|NCT01145352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101581143|NCT01145352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101581144|NCT01145352|Analgesics|analgesics|mesh-ancestor
101581145|NCT01145352|Sensory System Agents|sensory system agents|mesh-ancestor
101581146|NCT01145352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101581147|NCT01145352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581148|NCT01145352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101581149|NCT01145352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101581150|NCT01145352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101581151|NCT01145352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101581152|NCT01145352|Immunologic Factors|immunologic factors|mesh-ancestor
101581153|NCT01178099|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101581154|NCT01178099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101581155|NCT02673463|Spironolactone|spironolactone|mesh-list
101581156|NCT02673463|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101326324|NCT00116623|Tocolytic Agents|tocolytic agents|mesh-ancestor
101581157|NCT02673463|Hormone Antagonists|hormone antagonists|mesh-ancestor
101581158|NCT02673463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101581159|NCT02673463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581160|NCT02673463|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101581161|NCT02673463|Diuretics|diuretics|mesh-ancestor
101581162|NCT02673463|Natriuretic Agents|natriuretic agents|mesh-ancestor
101581163|NCT01169532|Vorinostat|vorinostat|mesh-list
101581164|NCT01169532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101581165|NCT01169532|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101581166|NCT01169532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101581167|NCT01169532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581168|NCT02537353|Epinephrine|epinephrine|mesh-list
101581169|NCT02537353|Racepinephrine|racepinephrine|mesh-list
101581170|NCT02537353|Epinephryl borate|epinephryl borate|mesh-list
101581171|NCT02537353|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101581172|NCT02537353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101581173|NCT02537353|Adrenergic Agents|adrenergic agents|mesh-ancestor
101581174|NCT02537353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101581175|NCT02537353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581176|NCT02537353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581177|NCT02537353|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101581178|NCT02537353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101581179|NCT02537353|Autonomic Agents|autonomic agents|mesh-ancestor
101567161|NCT05051007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567162|NCT05051007|Sensory System Agents|sensory system agents|mesh-ancestor
101567163|NCT05051007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101567164|NCT05051007|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101567165|NCT05051007|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101567166|NCT05051007|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101567167|NCT05051007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101567168|NCT05051007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567169|NCT05051007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101581180|NCT02537353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101581181|NCT02537353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101581182|NCT02537353|Respiratory System Agents|respiratory system agents|mesh-ancestor
101581183|NCT02537353|Mydriatics|mydriatics|mesh-ancestor
101581184|NCT02537353|Sympathomimetics|sympathomimetics|mesh-ancestor
101581185|NCT02537353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101581186|NCT00643357|Nitrous Oxide|nitrous oxide|mesh-list
101581187|NCT00643357|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101581188|NCT00643357|Anesthetics, General|anesthetics, general|mesh-ancestor
101581189|NCT00643357|Anesthetics|anesthetics|mesh-ancestor
101581190|NCT00643357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101581191|NCT00643357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581192|NCT00643357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101581193|NCT00643357|Analgesics|analgesics|mesh-ancestor
101581194|NCT00643357|Sensory System Agents|sensory system agents|mesh-ancestor
101581195|NCT00643357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101581196|NCT01177943|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101581197|NCT01177943|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101581198|NCT01177943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101581199|NCT01177943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101581200|NCT01177943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581201|NCT01177943|Adrenergic Agents|adrenergic agents|mesh-ancestor
101581202|NCT01177943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101581203|NCT01177943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581204|NCT04178785|Remifentanil|remifentanil|mesh-list
101581205|NCT04178785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101581206|NCT04178785|Narcotics|narcotics|mesh-ancestor
101581215|NCT00928486|Antiemetics|antiemetics|mesh-ancestor
101581216|NCT00928486|Autonomic Agents|autonomic agents|mesh-ancestor
101581217|NCT00928486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101581218|NCT00928486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581219|NCT00928486|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101581220|NCT00928486|Glucocorticoids|glucocorticoids|mesh-ancestor
101581221|NCT00928486|Hormones|hormones|mesh-ancestor
101581222|NCT00928486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101581223|NCT00928486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101581224|NCT00928486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101581225|NCT00928486|Immunologic Factors|immunologic factors|mesh-ancestor
101581226|NCT00928486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101581227|NCT00928486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101326417|NCT00117130|Hematinics|hematinics|mesh-ancestor
101581228|NCT00928486|Growth Substances|growth substances|mesh-ancestor
101581229|NCT00928486|Growth Inhibitors|growth inhibitors|mesh-ancestor
101581230|NCT03867357|Goserelin|goserelin|mesh-list
101581231|NCT03867357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101581232|NCT03867357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101581233|NCT05655221|Mitogens|mitogens|mesh-list
101581234|NCT05655221|Mitosis Modulators|mitosis modulators|mesh-ancestor
101581235|NCT05655221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581236|NCT00610792|Doxorubicin|doxorubicin|mesh-list
101581237|NCT00610792|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101581238|NCT00610792|Bortezomib|bortezomib|mesh-list
101581239|NCT00610792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101581240|NCT00610792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101581241|NCT00610792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101581242|NCT00610792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101567170|NCT05051007|Narcotics|narcotics|mesh-ancestor
101567171|NCT05051007|Analgesics|analgesics|mesh-ancestor
101567172|NCT05051007|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101567173|NCT05051007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101567174|NCT05051007|Anesthetics, General|anesthetics, general|mesh-ancestor
101326456|NCT00117520|Caffeine|caffeine|mesh-list
101567175|NCT01102803|Cycloserine|cycloserine|mesh-list
101567176|NCT01102803|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101567177|NCT01102803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101567178|NCT01102803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101581243|NCT00610792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101581244|NCT00610792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581245|NCT00610870|Atorvastatin|atorvastatin|mesh-list
101581246|NCT00610870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101581247|NCT00610870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101581248|NCT00610870|Antimetabolites|antimetabolites|mesh-ancestor
101581249|NCT00610870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581250|NCT00610870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101581251|NCT00610870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101581252|NCT00610870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101581253|NCT01168596|Rasagiline|rasagiline|mesh-list
101581254|NCT01168596|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101581255|NCT01168596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101581256|NCT01168596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581257|NCT01168596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101581258|NCT01168596|Protective Agents|protective agents|mesh-ancestor
101581259|NCT01168596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581260|NCT02675647|Heparin|heparin|mesh-list
101581261|NCT02675647|Protamines|protamines|mesh-list
101581262|NCT02675647|Anticoagulants|anticoagulants|mesh-ancestor
101581263|NCT02675647|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101581264|NCT02675647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101581265|NCT02675647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581266|NCT02675647|Heparin Antagonists|heparin antagonists|mesh-ancestor
101581267|NCT02675647|Coagulants|coagulants|mesh-ancestor
101238159|NCT02727803|Antimetabolites|antimetabolites|mesh-ancestor
101581268|NCT05370898|Calcium Carbonate|calcium carbonate|mesh-list
101581269|NCT05370898|Antacids|antacids|mesh-ancestor
101581270|NCT05370898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581271|NCT05370898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101581272|NCT00610948|Leucovorin|leucovorin|mesh-list
101581273|NCT00610948|Fluorouracil|fluorouracil|mesh-list
101581280|NCT00610948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581282|NCT00610948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581283|NCT00610948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101581284|NCT00610948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101581285|NCT00610948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101581286|NCT00610948|Immunologic Factors|immunologic factors|mesh-ancestor
101581287|NCT00610948|Antidotes|antidotes|mesh-ancestor
101581288|NCT00610948|Protective Agents|protective agents|mesh-ancestor
101581289|NCT00610948|Vitamin B Complex|vitamin b complex|mesh-ancestor
101581290|NCT00610948|Vitamins|vitamins|mesh-ancestor
101581291|NCT00610948|Micronutrients|micronutrients|mesh-ancestor
101581292|NCT00610948|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101581293|NCT00610948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101581294|NCT00610948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101581295|NCT00610948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101581296|NCT02675413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101581297|NCT02675413|Dermatologic Agents|dermatologic agents|mesh-ancestor
101581298|NCT02675413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101581299|NCT02675413|Immunologic Factors|immunologic factors|mesh-ancestor
101581300|NCT02675413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581301|NCT00928408|Cinacalcet|cinacalcet|mesh-list
101581302|NCT00928408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101581303|NCT00928408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581304|NCT00928408|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101581305|NCT00928408|Hormone Antagonists|hormone antagonists|mesh-ancestor
101581306|NCT00928408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101567179|NCT01102803|Antitubercular Agents|antitubercular agents|mesh-ancestor
101567180|NCT01102803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101567182|NCT01102803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567183|NCT01109979|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101567184|NCT01109979|Drospirenone|drospirenone|mesh-list
101567185|NCT01109979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101415385|NCT00499018|Hormones|hormones|mesh-ancestor
101581307|NCT00928252|Fluorides|fluorides|mesh-list
101581308|NCT00928252|Cariostatic Agents|cariostatic agents|mesh-ancestor
101581309|NCT00928252|Protective Agents|protective agents|mesh-ancestor
101581310|NCT00928252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581311|NCT02673229|Bacitracin|bacitracin|mesh-list
101581312|NCT02673229|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101581313|NCT02673229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101581314|NCT02673229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101581315|NCT00644293|Azithromycin|azithromycin|mesh-list
101581316|NCT00644293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101581317|NCT00644293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101581318|NCT00930982|Ciprofloxacin|ciprofloxacin|mesh-list
101581319|NCT00930982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101581320|NCT00930982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101581321|NCT00930982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101581322|NCT00930982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101581323|NCT00930982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101581324|NCT00930982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581325|NCT00930982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101581326|NCT00930982|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101581327|NCT00930982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101581328|NCT01176773|Hyaluronic Acid|hyaluronic acid|mesh-list
101581329|NCT01176773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101581330|NCT01176773|Immunologic Factors|immunologic factors|mesh-ancestor
101581331|NCT01176773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581332|NCT01176773|Viscosupplements|viscosupplements|mesh-ancestor
101581333|NCT01176773|Protective Agents|protective agents|mesh-ancestor
101581334|NCT02887625|Insulin|insulin|mesh-list
101581335|NCT02887625|Insulin Glargine|insulin glargine|mesh-list
101581336|NCT02887625|Pioglitazone|pioglitazone|mesh-list
101581337|NCT02887625|Insulin Aspart|insulin aspart|mesh-list
101581338|NCT02887625|Exenatide|exenatide|mesh-list
101581339|NCT02887625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101581340|NCT02887625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326689|NCT00119002|Hormones|hormones|mesh-ancestor
101581341|NCT02887625|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101581342|NCT02887625|Incretins|incretins|mesh-ancestor
101581343|NCT02887625|Hormones|hormones|mesh-ancestor
101581344|NCT02887625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101581345|NCT02886377|Antibodies|antibodies|mesh-list
101581369|NCT00928018|Cyclosporins|cyclosporins|mesh-list
101581370|NCT00928018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101581371|NCT00928018|Abortifacient Agents|abortifacient agents|mesh-ancestor
101581372|NCT00928018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101581373|NCT00928018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581374|NCT00928018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101581375|NCT00928018|Antimetabolites|antimetabolites|mesh-ancestor
101581376|NCT00928018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581377|NCT00928018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101581378|NCT00928018|Dermatologic Agents|dermatologic agents|mesh-ancestor
101581379|NCT00928018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101581380|NCT00928018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101581381|NCT00928018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101581382|NCT00928018|Immunologic Factors|immunologic factors|mesh-ancestor
101581383|NCT00928018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101326721|NCT00119431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101581384|NCT00928018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101581385|NCT00928018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101581386|NCT00928018|Antifungal Agents|antifungal agents|mesh-ancestor
101581387|NCT00928018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101581388|NCT00928018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101581389|NCT00928018|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101567186|NCT01109979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101567187|NCT01109979|Medroxyprogesterone|medroxyprogesterone|mesh-list
101567188|NCT01109979|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
101567189|NCT01109979|Estradiol|estradiol|mesh-list
101567190|NCT01109979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101567191|NCT01109979|Estrogens|estrogens|mesh-ancestor
101567192|NCT01109979|Hormones|hormones|mesh-ancestor
101567193|NCT01109979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101567194|NCT01109979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567195|NCT01109979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101567196|NCT01109979|Contraceptive Agents|contraceptive agents|mesh-ancestor
101567197|NCT01109979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101567198|NCT01109979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101581390|NCT00928018|Antitubercular Agents|antitubercular agents|mesh-ancestor
101581391|NCT00928018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101581392|NCT02672839|Betadex|betadex|mesh-list
101581393|NCT02672839|Sequestering Agents|sequestering agents|mesh-ancestor
101581394|NCT02672839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581395|NCT00609154|Glucagon|glucagon|mesh-list
101581396|NCT00609154|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101581397|NCT00609154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101581398|NCT00609154|Hormones|hormones|mesh-ancestor
101581401|NCT00609154|Incretins|incretins|mesh-ancestor
101581402|NCT00910117|Nimotuzumab|nimotuzumab|mesh-list
101581403|NCT00910117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101581404|NCT00910117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101581405|NCT00927862|Warfarin|warfarin|mesh-list
101581406|NCT00927862|Anticoagulants|anticoagulants|mesh-ancestor
101581407|NCT02672527|Dexamethasone|dexamethasone|mesh-list
101581408|NCT02672527|Trabectedin|trabectedin|mesh-list
101581409|NCT02672527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101581410|NCT02672527|Antiemetics|antiemetics|mesh-ancestor
101581411|NCT02672527|Autonomic Agents|autonomic agents|mesh-ancestor
101326788|NCT00402181|Hormones|hormones|mesh-ancestor
101581412|NCT02672527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101581413|NCT02672527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581414|NCT02672527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101581415|NCT02672527|Glucocorticoids|glucocorticoids|mesh-ancestor
101581416|NCT02672527|Hormones|hormones|mesh-ancestor
101581417|NCT02672527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101581418|NCT02672527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101581419|NCT02672527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101581420|NCT02672527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101581421|NCT02672527|Alkylating Agents|alkylating agents|mesh-ancestor
101581422|NCT02672527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581423|NCT00976989|Docetaxel|docetaxel|mesh-list
101581424|NCT00976989|Trastuzumab|trastuzumab|mesh-list
101581425|NCT00976989|Pertuzumab|pertuzumab|mesh-list
101581426|NCT00976989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101581427|NCT00976989|Tubulin Modulators|tubulin modulators|mesh-ancestor
101581428|NCT00976989|Antimitotic Agents|antimitotic agents|mesh-ancestor
101581429|NCT00976989|Mitosis Modulators|mitosis modulators|mesh-ancestor
101581430|NCT00976989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581431|NCT00976989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101581432|NCT05449171|Vitamin D|vitamin d|mesh-list
101581433|NCT05449171|Vitamins|vitamins|mesh-list
101581434|NCT05449171|Thioctic Acid|thioctic acid|mesh-list
101581435|NCT05449171|Vitamin B 6|vitamin b 6|mesh-list
101581436|NCT05449171|Pyridoxal|pyridoxal|mesh-list
101581437|NCT05449171|Pyridoxine|pyridoxine|mesh-list
101581438|NCT05449171|Hyaluronic Acid|hyaluronic acid|mesh-list
101581439|NCT05449171|Micronutrients|micronutrients|mesh-ancestor
101581440|NCT05449171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581441|NCT05449171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101567199|NCT01109979|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101567200|NCT01109979|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101567201|NCT01109979|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101567202|NCT01109979|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101567203|NCT01109979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101567204|NCT01109979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101567205|NCT01109979|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101567206|NCT01109979|Hormone Antagonists|hormone antagonists|mesh-ancestor
101581442|NCT05449171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101581443|NCT05449171|Immunologic Factors|immunologic factors|mesh-ancestor
101581445|NCT05449171|Protective Agents|protective agents|mesh-ancestor
101581446|NCT05449171|Vitamin B Complex|vitamin b complex|mesh-ancestor
101581447|NCT05449171|Antioxidants|antioxidants|mesh-ancestor
101581448|NCT05449171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581449|NCT02675023|Adalimumab|adalimumab|mesh-list
101581450|NCT02675023|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101581451|NCT02675023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101581452|NCT02675023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101581453|NCT00644371|Rituximab|rituximab|mesh-list
101581454|NCT00644371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101581455|NCT00644371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101581456|NCT00644371|Immunologic Factors|immunologic factors|mesh-ancestor
101581457|NCT00644371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581458|NCT00644371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101581459|NCT02864199|Ribavirin|ribavirin|mesh-list
101581460|NCT02864199|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101581461|NCT02864199|Antimetabolites|antimetabolites|mesh-ancestor
101581462|NCT02864199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581463|NCT02864199|Antiviral Agents|antiviral agents|mesh-ancestor
101581464|NCT02864199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101581465|NCT05911126|Celecoxib|celecoxib|mesh-list
101581466|NCT05911126|Scopolamine|scopolamine|mesh-list
101581467|NCT05911126|Bromides|bromides|mesh-list
101581468|NCT05911126|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101581469|NCT05911126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101581470|NCT05911126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101581471|NCT05911126|Analgesics|analgesics|mesh-ancestor
101581472|NCT05911126|Sensory System Agents|sensory system agents|mesh-ancestor
101581473|NCT05911126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101581485|NCT05911126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101581486|NCT05911126|Mydriatics|mydriatics|mesh-ancestor
101581487|NCT05911126|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101581488|NCT05911126|Cholinergic Agents|cholinergic agents|mesh-ancestor
101581489|NCT05911126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101581490|NCT05911126|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101581491|NCT05911126|Parasympatholytics|parasympatholytics|mesh-ancestor
101581492|NCT05908526|Suvorexant|suvorexant|mesh-list
101581493|NCT05908526|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101581494|NCT05908526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101581495|NCT05908526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101581496|NCT05908526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581497|NCT05908526|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
101581498|NCT05908526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101581499|NCT05908526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581500|NCT05908513|Acetylcysteine|acetylcysteine|mesh-list
101581501|NCT05908513|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101581502|NCT05908513|Antiviral Agents|antiviral agents|mesh-ancestor
101581503|NCT05908513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101581504|NCT05908513|Expectorants|expectorants|mesh-ancestor
101581505|NCT05908513|Respiratory System Agents|respiratory system agents|mesh-ancestor
101581506|NCT05908513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101581507|NCT05908513|Antioxidants|antioxidants|mesh-ancestor
101581508|NCT05908513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581509|NCT05908513|Protective Agents|protective agents|mesh-ancestor
101581510|NCT05908513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567207|NCT01109979|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101567208|NCT01109979|Diuretics|diuretics|mesh-ancestor
101567209|NCT01109979|Natriuretic Agents|natriuretic agents|mesh-ancestor
101567210|NCT01102491|Ramosetron|ramosetron|mesh-list
101567211|NCT01102491|Antiemetics|antiemetics|mesh-ancestor
101567212|NCT01102491|Autonomic Agents|autonomic agents|mesh-ancestor
101567213|NCT01102491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101567214|NCT01102491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101567215|NCT01102491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101567216|NCT01102491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101567217|NCT01102491|Serotonin Agents|serotonin agents|mesh-ancestor
101567218|NCT01102491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101567219|NCT01102491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101567220|NCT01108809|Telmisartan|telmisartan|mesh-list
101567221|NCT01108809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101415409|NCT00127985|Prednisolone|prednisolone|mesh-list
101581511|NCT05908513|Antidotes|antidotes|mesh-ancestor
101581512|NCT05908305|Epinephrine|epinephrine|mesh-list
101581513|NCT05908305|Racepinephrine|racepinephrine|mesh-list
101581514|NCT05908305|Anesthetics|anesthetics|mesh-list
101581515|NCT05908305|Mepivacaine|mepivacaine|mesh-list
101581516|NCT05908305|Carticaine|carticaine|mesh-list
101581517|NCT05908305|Epinephryl borate|epinephryl borate|mesh-list
101581518|NCT05908305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101581519|NCT05908305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581520|NCT05908305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101581521|NCT05908305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101581522|NCT05908305|Adrenergic Agents|adrenergic agents|mesh-ancestor
101581523|NCT05908305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101581524|NCT05908305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581525|NCT05908305|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101581526|NCT05908305|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101581527|NCT05908305|Autonomic Agents|autonomic agents|mesh-ancestor
101581528|NCT05908305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101581529|NCT05908305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101581530|NCT05908305|Respiratory System Agents|respiratory system agents|mesh-ancestor
101581531|NCT05908305|Mydriatics|mydriatics|mesh-ancestor
101581532|NCT05908305|Sympathomimetics|sympathomimetics|mesh-ancestor
101581533|NCT05908305|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101581534|NCT05908305|Anesthetics, Local|anesthetics, local|mesh-ancestor
101581535|NCT05908305|Sensory System Agents|sensory system agents|mesh-ancestor
101581536|NCT02672995|Bevacizumab|bevacizumab|mesh-list
101581537|NCT02672995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101581562|NCT05907902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101581563|NCT05907902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101581565|NCT05907733|Mitogens|mitogens|mesh-list
101581566|NCT05907733|Mitosis Modulators|mitosis modulators|mesh-ancestor
101581567|NCT05907733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581568|NCT05907499|Decitabine|decitabine|mesh-list
101581569|NCT05907499|Epoetin Alfa|epoetin alfa|mesh-list
101581570|NCT05907499|Lenograstim|lenograstim|mesh-list
101581571|NCT05907499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101581572|NCT05907499|Antimetabolites|antimetabolites|mesh-ancestor
101581573|NCT05907499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581574|NCT05907499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101581575|NCT05907499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101581576|NCT05907499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101581577|NCT05907499|Immunologic Factors|immunologic factors|mesh-ancestor
101581578|NCT05907499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581579|NCT05907499|Hematinics|hematinics|mesh-ancestor
101581580|NCT05907486|Cytarabine|cytarabine|mesh-list
101581581|NCT05907486|Acetylcysteine|acetylcysteine|mesh-list
101567222|NCT01108809|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101567223|NCT01108809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101616710|NCT04107103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101616711|NCT04107103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101616712|NCT04107103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101415424|NCT00127985|Autonomic Agents|autonomic agents|mesh-ancestor
101581582|NCT05907486|Cyclophosphamide|cyclophosphamide|mesh-list
101581583|NCT05907486|Busulfan|busulfan|mesh-list
101581584|NCT05907486|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101581585|NCT05907486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101581586|NCT05907486|Immunologic Factors|immunologic factors|mesh-ancestor
101581587|NCT05907486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581588|NCT05907486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101581589|NCT05907486|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101581590|NCT05907486|Alkylating Agents|alkylating agents|mesh-ancestor
101581591|NCT05907486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581592|NCT05907486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101581593|NCT05907486|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101581594|NCT05907486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101581595|NCT05907486|Antimetabolites|antimetabolites|mesh-ancestor
101581596|NCT05907486|Antiviral Agents|antiviral agents|mesh-ancestor
101581597|NCT05907486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101581616|NCT05906615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101581617|NCT05906615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101581618|NCT05906615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581619|NCT05906576|Infliximab|infliximab|mesh-list
101581620|NCT05906576|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101581621|NCT05906576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101581622|NCT05906576|Dermatologic Agents|dermatologic agents|mesh-ancestor
101581623|NCT05906576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101581624|NCT05906576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101581625|NCT05906563|Metformin|metformin|mesh-list
101581626|NCT05906563|Melatonin|melatonin|mesh-list
101581627|NCT05906563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101581628|NCT05906563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581629|NCT05906563|Antioxidants|antioxidants|mesh-ancestor
101581630|NCT05906563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581631|NCT05906563|Protective Agents|protective agents|mesh-ancestor
101581632|NCT05906563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101581633|NCT05906524|Bevacizumab|bevacizumab|mesh-list
101581634|NCT05906524|Tislelizumab|tislelizumab|mesh-list
101327075|NCT00122473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101581635|NCT05906524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101581636|NCT05906524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101581637|NCT05906524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101581638|NCT05906524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101581639|NCT05906524|Growth Substances|growth substances|mesh-ancestor
101581640|NCT05906524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581641|NCT05906524|Growth Inhibitors|growth inhibitors|mesh-ancestor
101581642|NCT05906498|Vitamin E|vitamin e|mesh-list
101581643|NCT05906498|Acetylcysteine|acetylcysteine|mesh-list
101581644|NCT05906498|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101581645|NCT05906498|Vitamins|vitamins|mesh-ancestor
101581646|NCT05906498|Micronutrients|micronutrients|mesh-ancestor
101581647|NCT05906498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581648|NCT05906498|Antioxidants|antioxidants|mesh-ancestor
101581649|NCT05906498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581650|NCT05906498|Protective Agents|protective agents|mesh-ancestor
101581651|NCT05906498|Antiviral Agents|antiviral agents|mesh-ancestor
101238534|NCT01608958|Oxytocin|oxytocin|mesh-list
101581652|NCT05906498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101581653|NCT05906498|Expectorants|expectorants|mesh-ancestor
101581654|NCT05906498|Respiratory System Agents|respiratory system agents|mesh-ancestor
101581655|NCT05906498|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101581659|NCT05901961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101581660|NCT05901961|Trace Elements|trace elements|mesh-ancestor
101581661|NCT05901961|Micronutrients|micronutrients|mesh-ancestor
101581662|NCT05901961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581663|NCT05901961|Dermatologic Agents|dermatologic agents|mesh-ancestor
101581664|NCT05901961|Sunscreening Agents|sunscreening agents|mesh-ancestor
101581665|NCT05901961|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101616713|NCT04107103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616715|NCT04107103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101616716|NCT04107103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101616717|NCT02617810|Midazolam|midazolam|mesh-list
101616719|NCT02617810|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101616720|NCT02617810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101616721|NCT02617810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101581666|NCT05901961|Protective Agents|protective agents|mesh-ancestor
101581668|NCT05892510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101581669|NCT05892510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101581670|NCT05892510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581671|NCT05886972|Propofol|propofol|mesh-list
101581672|NCT05886972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101581673|NCT05886972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101581674|NCT05886972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581675|NCT05886972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101581676|NCT05886972|Anesthetics, General|anesthetics, general|mesh-ancestor
101581677|NCT05886972|Anesthetics|anesthetics|mesh-ancestor
101581678|NCT05879835|Heparin|heparin|mesh-list
101581679|NCT05879835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101581680|NCT05879835|Anticoagulants|anticoagulants|mesh-ancestor
101581681|NCT05879835|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101581682|NCT05879835|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101581683|NCT05879835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581684|NCT05874401|Topotecan|topotecan|mesh-list
101581685|NCT05874401|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101581686|NCT05874401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101581687|NCT05874401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101581688|NCT05874401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581689|NCT05874401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101581690|NCT05858957|Magnesium Sulfate|magnesium sulfate|mesh-list
101327180|NCT00129142|Toremifene|toremifene|mesh-list
101581691|NCT05858957|Analgesics|analgesics|mesh-ancestor
101581692|NCT05858957|Sensory System Agents|sensory system agents|mesh-ancestor
101581693|NCT05858957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101581694|NCT05858957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581695|NCT05858957|Anesthetics|anesthetics|mesh-ancestor
101581696|NCT05858957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101581697|NCT05858957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101581698|NCT05858957|Anticonvulsants|anticonvulsants|mesh-ancestor
101581699|NCT05858957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101581700|NCT05858957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101581701|NCT05858957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581702|NCT05858957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101581703|NCT05858957|Tocolytic Agents|tocolytic agents|mesh-ancestor
101581704|NCT05858957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101581705|NCT05760807|Oxytocin|oxytocin|mesh-list
101581706|NCT05760807|Oxytocics|oxytocics|mesh-ancestor
101581707|NCT05760807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101581708|NCT05760807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581709|NCT05754996|Nifuroxazide|nifuroxazide|mesh-list
101581710|NCT05754996|Lactulose|lactulose|mesh-list
101581711|NCT05754996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101581712|NCT05754996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101581713|NCT05746442|Nicotine|nicotine|mesh-list
101581714|NCT05746442|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101581715|NCT05746442|Autonomic Agents|autonomic agents|mesh-ancestor
101581716|NCT05746442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101581717|NCT05746442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581718|NCT05746442|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101581719|NCT05746442|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101581720|NCT05746442|Cholinergic Agents|cholinergic agents|mesh-ancestor
101581721|NCT05746442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101264212|NCT01766375|Antimetabolites|antimetabolites|mesh-ancestor
101581722|NCT05746442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581723|NCT05736874|Fluticasone|fluticasone|mesh-list
101581724|NCT05736874|Xhance|xhance|mesh-list
101616722|NCT02617810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616723|NCT02617810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101616724|NCT02617810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101616725|NCT02617810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101616726|NCT02617810|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101616727|NCT02617810|Anesthetics, General|anesthetics, general|mesh-ancestor
101616728|NCT02617810|Anesthetics|anesthetics|mesh-ancestor
101581725|NCT05736874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101581726|NCT05736874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101581727|NCT05736874|Autonomic Agents|autonomic agents|mesh-ancestor
101581728|NCT05736874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101581735|NCT05730036|Pomalidomide|pomalidomide|mesh-list
101581736|NCT05730036|Elotuzumab|elotuzumab|mesh-list
101581737|NCT05730036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101581738|NCT05730036|Antiemetics|antiemetics|mesh-ancestor
101581739|NCT05730036|Autonomic Agents|autonomic agents|mesh-ancestor
101581740|NCT05730036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101581741|NCT05730036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581742|NCT05730036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101581743|NCT05730036|Glucocorticoids|glucocorticoids|mesh-ancestor
101581744|NCT05730036|Hormones|hormones|mesh-ancestor
101581745|NCT05730036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101581746|NCT05730036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101581747|NCT05730036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101581748|NCT05730036|Immunologic Factors|immunologic factors|mesh-ancestor
101581749|NCT05730036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101581750|NCT05730036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101581751|NCT05730036|Growth Substances|growth substances|mesh-ancestor
101581752|NCT05730036|Growth Inhibitors|growth inhibitors|mesh-ancestor
101581753|NCT05699655|Oxaliplatin|oxaliplatin|mesh-list
101581754|NCT05699655|Apatinib|apatinib|mesh-list
101581755|NCT05699655|Tislelizumab|tislelizumab|mesh-list
101581756|NCT05699655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101581757|NCT05699655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101581758|NCT05699655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101581759|NCT05699655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581760|NCT05699655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101581761|NCT05687500|Glyburide|glyburide|mesh-list
101581762|NCT05687500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101327324|NCT00394537|Labetalol|labetalol|mesh-list
101581763|NCT05687500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581764|NCT05681611|Rocuronium|rocuronium|mesh-list
101581765|NCT05681611|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101581766|NCT05681611|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101581767|NCT05681611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101581768|NCT05681611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101581769|NCT05681611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581770|NCT05675163|Vitamin K|vitamin k|mesh-list
101581771|NCT05675163|Vitamin K 2|vitamin k 2|mesh-list
101581772|NCT05675163|Vitamins|vitamins|mesh-ancestor
101581773|NCT05675163|Micronutrients|micronutrients|mesh-ancestor
101581774|NCT05675163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581775|NCT05675163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101581776|NCT05675163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101581777|NCT05675163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581778|NCT05675163|Hemostatics|hemostatics|mesh-ancestor
101581779|NCT05675163|Coagulants|coagulants|mesh-ancestor
101581780|NCT05656170|Bupivacaine|bupivacaine|mesh-list
101581781|NCT05656170|Anesthetics, Local|anesthetics, local|mesh-ancestor
101581782|NCT05656170|Anesthetics|anesthetics|mesh-ancestor
101581783|NCT05656170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101581784|NCT05656170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581785|NCT05656170|Sensory System Agents|sensory system agents|mesh-ancestor
101581786|NCT05656170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101581787|NCT05596786|Rituximab|rituximab|mesh-list
101581788|NCT05596786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101581789|NCT05596786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101581790|NCT05596786|Immunologic Factors|immunologic factors|mesh-ancestor
101581791|NCT05596786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616731|NCT02617810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101266548|NCT01782950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101616732|NCT02617810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616733|NCT02617810|Anticoagulants|anticoagulants|mesh-ancestor
101616734|NCT00898443|Anesthetics|anesthetics|mesh-list
101616735|NCT00898443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101266850|NCT01785108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101581792|NCT05596786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101581793|NCT05582707|Pioglitazone|pioglitazone|mesh-list
101581794|NCT05582707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101581795|NCT05582707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581796|NCT05564611|Omalizumab|omalizumab|mesh-list
101581797|NCT05564611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101581798|NCT05564611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101581799|NCT05564611|Respiratory System Agents|respiratory system agents|mesh-ancestor
101581800|NCT05559164|Atorvastatin|atorvastatin|mesh-list
101535825|NCT00193479|Glucocorticoids|glucocorticoids|mesh-ancestor
101581803|NCT05559164|Antimetabolites|antimetabolites|mesh-ancestor
101581804|NCT05559164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238694|NCT01611415|Furosemide|furosemide|mesh-list
101581805|NCT05559164|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101581806|NCT05559164|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101581808|NCT05558098|Dapagliflozin|dapagliflozin|mesh-list
101581809|NCT05558098|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101581810|NCT05558098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581811|NCT05558098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101581812|NCT05558098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581813|NCT05558007|Tadalafil|tadalafil|mesh-list
101581814|NCT05558007|Vasodilator Agents|vasodilator agents|mesh-ancestor
101581815|NCT05558007|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101581816|NCT05558007|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101581817|NCT05558007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101581818|NCT05558007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581819|NCT05558007|Urological Agents|urological agents|mesh-ancestor
101581820|NCT05553704|Metformin|metformin|mesh-list
101581821|NCT05553704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101581822|NCT05553704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581823|NCT05553405|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101581824|NCT05553405|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101581825|NCT05553405|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101581826|NCT05553405|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101581827|NCT05536349|Valacyclovir|valacyclovir|mesh-list
101581828|NCT05536349|Venetoclax|venetoclax|mesh-list
101581829|NCT05536349|Obinutuzumab|obinutuzumab|mesh-list
101581830|NCT05536349|Allopurinol|allopurinol|mesh-list
101581831|NCT05536349|Pirtobrutinib|pirtobrutinib|mesh-list
101581832|NCT05536349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101581833|NCT05536349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101581834|NCT05536349|Antimetabolites|antimetabolites|mesh-ancestor
101581835|NCT05536349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581836|NCT05536349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101581837|NCT05536349|Gout Suppressants|gout suppressants|mesh-ancestor
101581838|NCT05536349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101581839|NCT05536349|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101581840|NCT05536349|Antioxidants|antioxidants|mesh-ancestor
101581841|NCT05536349|Protective Agents|protective agents|mesh-ancestor
101327542|NCT00019435|Immunologic Factors|immunologic factors|mesh-ancestor
101581842|NCT05536349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581843|NCT05536349|Antiviral Agents|antiviral agents|mesh-ancestor
101581844|NCT05536349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101581845|NCT05536349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101581846|NCT05518903|FAPI-46|fapi-46|mesh-list
101581847|NCT05518903|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101581848|NCT05518903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581849|NCT05517642|Vaccines|vaccines|mesh-list
101581850|NCT05517642|Immunologic Factors|immunologic factors|mesh-ancestor
101581851|NCT05517642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581852|NCT05514132|Durvalumab|durvalumab|mesh-list
101266925|NCT01785641|Ciprofloxacin|ciprofloxacin|mesh-list
101616736|NCT00898443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616737|NCT02614612|Prednisone|prednisone|mesh-list
101616738|NCT02614612|Methylprednisolone|methylprednisolone|mesh-list
101267078|NCT01786382|Midazolam|midazolam|mesh-list
101616739|NCT02614612|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101616740|NCT02614612|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101581853|NCT05514132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101581854|NCT05514132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101581855|NCT05514132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101581856|NCT05514132|Immunologic Factors|immunologic factors|mesh-ancestor
101581857|NCT05514132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581858|NCT05487261|Valsartan|valsartan|mesh-list
101581859|NCT05487261|Enalapril|enalapril|mesh-list
101581860|NCT05487261|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101581861|NCT05487261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101581862|NCT05487261|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101581863|NCT05487261|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101581864|NCT05487261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581865|NCT05487261|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101581866|NCT05487261|Protease Inhibitors|protease inhibitors|mesh-ancestor
101581867|NCT05487261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101581868|NCT05479240|Capecitabine|capecitabine|mesh-list
101581869|NCT05479240|Oxaliplatin|oxaliplatin|mesh-list
101581870|NCT05479240|Tislelizumab|tislelizumab|mesh-list
101581871|NCT05479240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101581872|NCT05479240|Antimetabolites|antimetabolites|mesh-ancestor
101581885|NCT05461573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101581886|NCT05461573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581887|NCT05461573|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101581889|NCT05461573|Natriuretic Agents|natriuretic agents|mesh-ancestor
101581890|NCT05457972|Estradiol|estradiol|mesh-list
101581891|NCT05457972|Estrogens|estrogens|mesh-ancestor
101581892|NCT05457972|Hormones|hormones|mesh-ancestor
101327655|NCT00019864|Vitamins|vitamins|mesh-ancestor
101581893|NCT05457972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101581894|NCT05457972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581895|NCT05442684|Vaccines|vaccines|mesh-list
101581896|NCT05442684|Immunologic Factors|immunologic factors|mesh-ancestor
101581897|NCT05442684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581898|NCT05380388|Vaccines|vaccines|mesh-list
101581899|NCT05380388|Immunologic Factors|immunologic factors|mesh-ancestor
101581900|NCT05380388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581901|NCT05369819|Midazolam|midazolam|mesh-list
101581902|NCT05369819|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101581903|NCT05369819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101581904|NCT05369819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101581905|NCT05369819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581906|NCT05369819|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101581907|NCT05369819|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101581908|NCT05369819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101581909|NCT05369819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101581910|NCT05369819|Anesthetics, General|anesthetics, general|mesh-ancestor
101581911|NCT05369819|Anesthetics|anesthetics|mesh-ancestor
101581912|NCT05369819|GABA Modulators|gaba modulators|mesh-ancestor
101581913|NCT05369819|GABA Agents|gaba agents|mesh-ancestor
101581914|NCT05369819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101327713|NCT00020332|Alvocidib|alvocidib|mesh-list
101581915|NCT05369819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581916|NCT05332444|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101581917|NCT05332444|Amoxicillin|amoxicillin|mesh-list
101581918|NCT05332444|Metronidazole|metronidazole|mesh-list
101581919|NCT05332444|Clarithromycin|clarithromycin|mesh-list
101581920|NCT05332444|Levofloxacin|levofloxacin|mesh-list
101581921|NCT05332444|Tetracycline|tetracycline|mesh-list
101581922|NCT05332444|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101581923|NCT05332444|Rabeprazole|rabeprazole|mesh-list
101581924|NCT05332444|Bismuth|bismuth|mesh-list
101581925|NCT05332444|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101581926|NCT05332444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101581927|NCT05332444|Antitubercular Agents|antitubercular agents|mesh-ancestor
101581928|NCT05332444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101415457|NCT01245361|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101581929|NCT05332444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101581930|NCT05332444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101581931|NCT05332444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101581932|NCT05332444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581933|NCT05332444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101581950|NCT05290740|Sympathomimetics|sympathomimetics|mesh-ancestor
101581951|NCT05290740|Autonomic Agents|autonomic agents|mesh-ancestor
101581952|NCT05290740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101581953|NCT05290740|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101581954|NCT05260684|Trametinib|trametinib|mesh-list
101581955|NCT05260684|Vemurafenib|vemurafenib|mesh-list
101581956|NCT05260684|Dabrafenib|dabrafenib|mesh-list
101581957|NCT05260684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101581958|NCT05260684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101581959|NCT05260684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101581960|NCT05260684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581961|NCT05234554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101581962|NCT05234554|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101581963|NCT05212311|Chitosan|chitosan|mesh-list
101581964|NCT05212311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101581965|NCT05212311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101581966|NCT05212311|Antimetabolites|antimetabolites|mesh-ancestor
101581967|NCT05212311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581968|NCT05212311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101581969|NCT05212311|Chelating Agents|chelating agents|mesh-ancestor
101581970|NCT05212311|Sequestering Agents|sequestering agents|mesh-ancestor
101581971|NCT05212311|Hemostatics|hemostatics|mesh-ancestor
101581972|NCT05212311|Coagulants|coagulants|mesh-ancestor
101581973|NCT05208242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101581974|NCT05159752|Afamelanotide|afamelanotide|mesh-list
101581975|NCT05159752|Dermatologic Agents|dermatologic agents|mesh-ancestor
101581976|NCT05095116|Fluticasone|fluticasone|mesh-list
101581977|NCT05095116|Xhance|xhance|mesh-list
101581978|NCT05095116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101581979|NCT05095116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101581980|NCT05095116|Autonomic Agents|autonomic agents|mesh-ancestor
101581981|NCT05095116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101581982|NCT05095116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581983|NCT05095116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101581984|NCT05095116|Respiratory System Agents|respiratory system agents|mesh-ancestor
101581985|NCT05095116|Dermatologic Agents|dermatologic agents|mesh-ancestor
101581986|NCT05095116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101581987|NCT05093322|Gemcitabine|gemcitabine|mesh-list
101581988|NCT05093322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101581989|NCT05093322|Antimetabolites|antimetabolites|mesh-ancestor
101581990|NCT05093322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581991|NCT05093322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101581992|NCT05074355|Azacitidine|azacitidine|mesh-list
101581993|NCT05074355|Venetoclax|venetoclax|mesh-list
101581994|NCT05074355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101581995|NCT05074355|Antimetabolites|antimetabolites|mesh-ancestor
101267736|NCT01796522|Nifedipine|nifedipine|mesh-list
101616750|NCT02614612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101775288|NCT00803556|Paclitaxel|paclitaxel|mesh-list
101616751|NCT02614612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101616752|NCT02614612|Antiemetics|antiemetics|mesh-ancestor
101616753|NCT02614612|Autonomic Agents|autonomic agents|mesh-ancestor
101616754|NCT02614612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101616755|NCT02614612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101545178|NCT01689194|genexol-PM|genexol-pm|mesh-list
101582020|NCT05006417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101582021|NCT05006417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101582022|NCT05006417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101582024|NCT05006417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101582025|NCT05006417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101582026|NCT05006417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582027|NCT05006417|Cholinergic Agents|cholinergic agents|mesh-ancestor
101582028|NCT05006417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101582029|NCT05001152|Ozanimod|ozanimod|mesh-list
101238911|NCT01612975|Naproxen|naproxen|mesh-list
101582030|NCT05001152|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101582031|NCT05001152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582032|NCT05001152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101582033|NCT05001152|Immunologic Factors|immunologic factors|mesh-ancestor
101582034|NCT05001152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582035|NCT04930653|Mogamulizumab|mogamulizumab|mesh-list
101582036|NCT04930653|Immunoglobulins|immunoglobulins|mesh-list
101582037|NCT04930653|Immunoglobulin G|immunoglobulin g|mesh-list
101582038|NCT04930653|Immunologic Factors|immunologic factors|mesh-ancestor
101582039|NCT04930653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582040|NCT04930653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582041|NCT04918173|Antithrombin III|antithrombin iii|mesh-list
101582042|NCT04918173|Antithrombins|antithrombins|mesh-ancestor
101582043|NCT04918173|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101582044|NCT04918173|Protease Inhibitors|protease inhibitors|mesh-ancestor
101582045|NCT04918173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101582046|NCT04918173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582047|NCT04918173|Anticoagulants|anticoagulants|mesh-ancestor
101582048|NCT04889079|Contraceptive Agents|contraceptive agents|mesh-list
101582049|NCT04889079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101582050|NCT04889079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582051|NCT04880434|Cyclophosphamide|cyclophosphamide|mesh-list
101582052|NCT04880434|Fludarabine|fludarabine|mesh-list
101582053|NCT04880434|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
101582054|NCT04880434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101582055|NCT04880434|Immunologic Factors|immunologic factors|mesh-ancestor
101582056|NCT04880434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582072|NCT04839549|Glucocorticoids|glucocorticoids|mesh-ancestor
101582073|NCT04839549|Hormones|hormones|mesh-ancestor
101582074|NCT04839549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101582075|NCT04839549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101582076|NCT04794569|Tinzaparin|tinzaparin|mesh-list
101582077|NCT04794569|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101582078|NCT04794569|Dalteparin|dalteparin|mesh-list
101582079|NCT04794569|Rivaroxaban|rivaroxaban|mesh-list
101582080|NCT04794569|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101582081|NCT04794569|Antithrombins|antithrombins|mesh-ancestor
101582082|NCT04794569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101582083|NCT04794569|Protease Inhibitors|protease inhibitors|mesh-ancestor
101582084|NCT04794569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101582085|NCT04794569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616756|NCT02614612|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101616757|NCT02614612|Protective Agents|protective agents|mesh-ancestor
101616758|NCT00900159|Eszopiclone|eszopiclone|mesh-list
101327989|NCT00021385|Growth Substances|growth substances|mesh-ancestor
101616759|NCT00900159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101268473|NCT01804985|Imatinib Mesylate|imatinib mesylate|mesh-list
101616760|NCT00900159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101775289|NCT00803556|Trastuzumab|trastuzumab|mesh-list
101616761|NCT00900159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616763|NCT01689909|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101582086|NCT04794569|Anticoagulants|anticoagulants|mesh-ancestor
101582087|NCT04794569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101582088|NCT04794569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101582089|NCT04787042|Pembrolizumab|pembrolizumab|mesh-list
101582090|NCT04787042|Obinutuzumab|obinutuzumab|mesh-list
101582091|NCT04787042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101582092|NCT04787042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582093|NCT04787042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101582094|NCT04787042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582105|NCT04661358|Fenofibrate|fenofibrate|mesh-list
101582106|NCT04661358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101582107|NCT04661358|Antimetabolites|antimetabolites|mesh-ancestor
101582108|NCT04661358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582109|NCT04661358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101582111|NCT04630808|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101582112|NCT04630808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101582118|NCT04624178|Nivolumab|nivolumab|mesh-list
101582119|NCT04624178|Rucaparib|rucaparib|mesh-list
101582120|NCT04624178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101582121|NCT04624178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582122|NCT04624178|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101582123|NCT04624178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582124|NCT04624178|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101582136|NCT04563338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101582137|NCT04563338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101582138|NCT04563338|Growth Substances|growth substances|mesh-ancestor
101582139|NCT04563338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582140|NCT04563338|Growth Inhibitors|growth inhibitors|mesh-ancestor
101582141|NCT04563338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101582142|NCT04563338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582143|NCT04524910|Aflibercept|aflibercept|mesh-list
101582144|NCT04524910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101582145|NCT04524910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101582146|NCT04524910|Growth Substances|growth substances|mesh-ancestor
101582147|NCT04524910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582148|NCT04524910|Growth Inhibitors|growth inhibitors|mesh-ancestor
101582149|NCT04524910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582150|NCT04410653|Afatinib|afatinib|mesh-list
101582151|NCT04410653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582152|NCT04410653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101582153|NCT04410653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101582154|NCT04410653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582155|NCT04377087|Olaparib|olaparib|mesh-list
101582156|NCT04377087|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101582157|NCT04377087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101582158|NCT04377087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582159|NCT04377087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582160|NCT04341779|Tenofovir|tenofovir|mesh-list
101582161|NCT04341779|Antiviral Agents|antiviral agents|mesh-ancestor
101582162|NCT04341779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101582163|NCT04341779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101582164|NCT04341779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101582165|NCT04341779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101582166|NCT04341779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616764|NCT01689909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101616765|NCT01689909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101616766|NCT01689909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616767|NCT01689909|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101582167|NCT04341779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101582168|NCT04341779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101328148|NCT00022126|Antiemetics|antiemetics|mesh-ancestor
101582170|NCT04205838|Cyclophosphamide|cyclophosphamide|mesh-list
101582171|NCT04205838|Fludarabine|fludarabine|mesh-list
101582172|NCT04205838|Fludarabine phosphate|fludarabine phosphate|mesh-list
101582173|NCT04205838|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
101582174|NCT04205838|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101582175|NCT04205838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101582176|NCT04205838|Immunologic Factors|immunologic factors|mesh-ancestor
101582177|NCT04205838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582178|NCT04205838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101582179|NCT04205838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101239054|NCT01613807|Insulin, Long-Acting|insulin, long-acting|mesh-list
101582180|NCT04205838|Alkylating Agents|alkylating agents|mesh-ancestor
101582181|NCT04205838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582182|NCT04205838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582183|NCT04205838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101582184|NCT04205838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101582185|NCT04205838|Antimetabolites|antimetabolites|mesh-ancestor
101582186|NCT04205838|Antiviral Agents|antiviral agents|mesh-ancestor
101582187|NCT04205838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101582211|NCT04170543|Dapagliflozin|dapagliflozin|mesh-list
101582212|NCT04170543|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101582213|NCT04170543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582214|NCT04170543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101582215|NCT04170543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582216|NCT04163016|Certolizumab Pegol|certolizumab pegol|mesh-list
101582217|NCT04163016|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101582218|NCT04163016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101582219|NCT04163016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101582220|NCT04163016|Immunologic Factors|immunologic factors|mesh-ancestor
101582221|NCT04163016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582222|NCT04163016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101582223|NCT04147013|Celecoxib|celecoxib|mesh-list
101582224|NCT04147013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101582225|NCT04147013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101582226|NCT04147013|Analgesics|analgesics|mesh-ancestor
101582227|NCT04147013|Sensory System Agents|sensory system agents|mesh-ancestor
101582228|NCT04147013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101582229|NCT04147013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582230|NCT04147013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101582231|NCT04147013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101582232|NCT04147013|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101582233|NCT04147013|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101582234|NCT04147013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101582235|NCT04147013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582236|NCT04086485|Olaparib|olaparib|mesh-list
101582237|NCT04086485|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101582239|NCT04086485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582240|NCT04086485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582241|NCT04084717|Crizotinib|crizotinib|mesh-list
101616768|NCT01689909|GABA Agonists|gaba agonists|mesh-ancestor
101616769|NCT01689909|GABA Agents|gaba agents|mesh-ancestor
101269300|NCT01813513|Protease Inhibitors|protease inhibitors|mesh-ancestor
101616770|NCT01689909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101269374|NCT01813656|Aripiprazole|aripiprazole|mesh-list
101269445|NCT01814085|Serotonin Agents|serotonin agents|mesh-ancestor
101616771|NCT01689909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616772|NCT00854308|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101616773|NCT00854308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101616774|NCT00854308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101616775|NCT00854308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101616776|NCT00854308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269890|NCT01816789|Fertility Agents|fertility agents|mesh-ancestor
101269965|NCT01817322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101415491|NCT00499525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101582242|NCT04084717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582243|NCT04084717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101582244|NCT04084717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101582245|NCT04084717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582246|NCT04042701|Pembrolizumab|pembrolizumab|mesh-list
101582247|NCT04042701|Trastuzumab|trastuzumab|mesh-list
101582248|NCT04042701|Camptothecin|camptothecin|mesh-list
101582267|NCT04016389|Mitosis Modulators|mitosis modulators|mesh-ancestor
101582268|NCT04016389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582269|NCT03991819|Pembrolizumab|pembrolizumab|mesh-list
101582270|NCT03991819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101582271|NCT03991819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582272|NCT03991819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101582273|NCT03991819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582274|NCT03919552|Cisplatin|cisplatin|mesh-list
101582275|NCT03919552|Carboplatin|carboplatin|mesh-list
101582276|NCT03919552|Docetaxel|docetaxel|mesh-list
101582277|NCT03919552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582278|NCT03919552|Tubulin Modulators|tubulin modulators|mesh-ancestor
101582279|NCT03919552|Antimitotic Agents|antimitotic agents|mesh-ancestor
101582280|NCT03919552|Mitosis Modulators|mitosis modulators|mesh-ancestor
101582281|NCT03919552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582282|NCT03901469|Talazoparib|talazoparib|mesh-list
101582283|NCT03901469|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101582284|NCT03901469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101582285|NCT03901469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582286|NCT03901469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582287|NCT03897998|Naloxone|naloxone|mesh-list
101582288|NCT03897998|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101582289|NCT03897998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582290|NCT03897998|Sensory System Agents|sensory system agents|mesh-ancestor
101582291|NCT03897998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101582292|NCT03853707|Paclitaxel|paclitaxel|mesh-list
101582293|NCT03853707|Carboplatin|carboplatin|mesh-list
101582294|NCT03853707|Capecitabine|capecitabine|mesh-list
101582295|NCT03853707|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101582296|NCT03853707|Atezolizumab|atezolizumab|mesh-list
101582297|NCT03853707|Ipatasertib|ipatasertib|mesh-list
101582298|NCT03853707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101582299|NCT03853707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101582300|NCT03853707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582301|NCT03853707|Tubulin Modulators|tubulin modulators|mesh-ancestor
101582302|NCT03853707|Antimitotic Agents|antimitotic agents|mesh-ancestor
101582303|NCT03853707|Mitosis Modulators|mitosis modulators|mesh-ancestor
101270040|NCT01817803|Hormone Antagonists|hormone antagonists|mesh-ancestor
101775290|NCT00803556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101616778|NCT00592852|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101270256|NCT01819610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101616779|NCT00592852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101616780|NCT00592852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101270551|NCT01821274|Vasodilator Agents|vasodilator agents|mesh-ancestor
101775291|NCT00803556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101616781|NCT00592852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582305|NCT03853707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101582307|NCT03853707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101582308|NCT03853707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101582309|NCT03853707|Immunologic Factors|immunologic factors|mesh-ancestor
101582310|NCT03853707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582311|NCT03853707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101582312|NCT03853707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101582314|NCT03836209|Daunorubicin|daunorubicin|mesh-list
101582315|NCT03836209|Midostaurin|midostaurin|mesh-list
101582316|NCT03836209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101582317|NCT03836209|Antimetabolites|antimetabolites|mesh-ancestor
101582318|NCT03836209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582319|NCT03836209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582320|NCT03836209|Antiviral Agents|antiviral agents|mesh-ancestor
101582321|NCT03836209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101582322|NCT03836209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101328485|NCT00000173|Donepezil|donepezil|mesh-list
101582323|NCT03836209|Immunologic Factors|immunologic factors|mesh-ancestor
101582324|NCT03836209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582325|NCT03836209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101582326|NCT03836209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101582327|NCT03836209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101582328|NCT03836209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101582329|NCT03836209|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101582330|NCT03824808|Lidocaine|lidocaine|mesh-list
101582331|NCT03824808|Anesthetics, Local|anesthetics, local|mesh-ancestor
101582332|NCT03824808|Anesthetics|anesthetics|mesh-ancestor
101582333|NCT03824808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101582334|NCT03824808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582335|NCT03824808|Sensory System Agents|sensory system agents|mesh-ancestor
101582336|NCT03824808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101582337|NCT03824808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101582338|NCT03824808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101582339|NCT03824808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101582340|NCT03824808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101582341|NCT03824808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582342|NCT03822962|Acetaminophen|acetaminophen|mesh-list
101582343|NCT03822962|Ibuprofen|ibuprofen|mesh-list
101582344|NCT03822962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101582345|NCT03822962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101582346|NCT03822962|Analgesics|analgesics|mesh-ancestor
101582347|NCT03822962|Sensory System Agents|sensory system agents|mesh-ancestor
101582348|NCT03822962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101582349|NCT03822962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582350|NCT03822962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101582351|NCT03822962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101582352|NCT03822962|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101582353|NCT03822962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101582354|NCT03822962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582355|NCT03822962|Antipyretics|antipyretics|mesh-ancestor
101582356|NCT03758950|Mometasone Furoate|mometasone furoate|mesh-list
101582357|NCT03758950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101582358|NCT03758950|Dermatologic Agents|dermatologic agents|mesh-ancestor
101582359|NCT03758950|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101270845|NCT01823393|Heparin|heparin|mesh-list
101616784|NCT00592852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775292|NCT00803556|Tubulin Modulators|tubulin modulators|mesh-ancestor
101775293|NCT00803556|Antimitotic Agents|antimitotic agents|mesh-ancestor
101775294|NCT00803556|Mitosis Modulators|mitosis modulators|mesh-ancestor
101616785|NCT00592852|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101616786|NCT00592852|Antidepressive Agents|antidepressive agents|mesh-ancestor
101271598|NCT01829178|Antioxidants|antioxidants|mesh-ancestor
101582360|NCT03749460|Nivolumab|nivolumab|mesh-list
101582361|NCT03749460|Ipilimumab|ipilimumab|mesh-list
101582362|NCT03749460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101582363|NCT03749460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582364|NCT03749460|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101582365|NCT03749460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582366|NCT03725007|Upadacitinib|upadacitinib|mesh-list
101582367|NCT03725007|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101582368|NCT03725007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101582369|NCT03725007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101582370|NCT03725007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582371|NCT03725007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101582372|NCT03712098|Liraglutide|liraglutide|mesh-list
101582373|NCT03712098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101582374|NCT03712098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582375|NCT03712098|Incretins|incretins|mesh-ancestor
101582382|NCT03711279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582384|NCT03703297|Tremelimumab|tremelimumab|mesh-list
101582385|NCT03703297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101582386|NCT03703297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582387|NCT03641456|Dexamethasone|dexamethasone|mesh-list
101582388|NCT03641456|Dexamethasone acetate|dexamethasone acetate|mesh-list
101582389|NCT03641456|Lenalidomide|lenalidomide|mesh-list
101582390|NCT03641456|Bortezomib|bortezomib|mesh-list
101582391|NCT03641456|BB 1101|bb 1101|mesh-list
101582392|NCT03641456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101582393|NCT03641456|Antiemetics|antiemetics|mesh-ancestor
101582394|NCT03641456|Autonomic Agents|autonomic agents|mesh-ancestor
101582395|NCT03641456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101582396|NCT03641456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239279|NCT01613729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101582397|NCT03641456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101582398|NCT03641456|Glucocorticoids|glucocorticoids|mesh-ancestor
101582399|NCT03641456|Hormones|hormones|mesh-ancestor
101582400|NCT03641456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101328636|NCT00000221|Buprenorphine|buprenorphine|mesh-list
101582401|NCT03641456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101582402|NCT03641456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582403|NCT03641456|Protease Inhibitors|protease inhibitors|mesh-ancestor
101582404|NCT03641456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101582405|NCT03641456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582406|NCT03641456|Immunologic Factors|immunologic factors|mesh-ancestor
101582407|NCT03641456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101582408|NCT03641456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101582409|NCT03641456|Growth Substances|growth substances|mesh-ancestor
101582410|NCT03641456|Growth Inhibitors|growth inhibitors|mesh-ancestor
101582411|NCT03582176|Ketotifen|ketotifen|mesh-list
101582412|NCT03582176|Antipruritics|antipruritics|mesh-ancestor
101582413|NCT03582176|Dermatologic Agents|dermatologic agents|mesh-ancestor
101582414|NCT03582176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101582415|NCT03582176|Histamine Antagonists|histamine antagonists|mesh-ancestor
101582416|NCT03582176|Histamine Agents|histamine agents|mesh-ancestor
101582417|NCT03582176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101582418|NCT03582176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582419|NCT03582176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582420|NCT03582176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101582421|NCT03493152|Everolimus|everolimus|mesh-list
101582422|NCT03493152|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101582423|NCT03493152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101582424|NCT03493152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101582425|NCT03493152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271667|NCT01829841|Growth Inhibitors|growth inhibitors|mesh-ancestor
101616788|NCT00592852|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101271810|NCT01835197|Abrocitinib|abrocitinib|mesh-list
101616789|NCT00592852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101616791|NCT00895245|Dexamethasone|dexamethasone|mesh-list
101616792|NCT00895245|Palonosetron|palonosetron|mesh-list
101616793|NCT00895245|Fosaprepitant|fosaprepitant|mesh-list
101545566|NCT01332318|Gabapentin|gabapentin|mesh-list
101582426|NCT03493152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101582427|NCT03493152|Immunologic Factors|immunologic factors|mesh-ancestor
101582428|NCT03493152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582429|NCT03493152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582430|NCT03492671|Paclitaxel|paclitaxel|mesh-list
101582431|NCT03492671|Gemcitabine|gemcitabine|mesh-list
101582432|NCT03492671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101582433|NCT03492671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582434|NCT03492671|Tubulin Modulators|tubulin modulators|mesh-ancestor
101582435|NCT03492671|Antimitotic Agents|antimitotic agents|mesh-ancestor
101582436|NCT03492671|Mitosis Modulators|mitosis modulators|mesh-ancestor
101582437|NCT03492671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582438|NCT03492671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101582439|NCT03492671|Antimetabolites|antimetabolites|mesh-ancestor
101582440|NCT03486301|Pembrolizumab|pembrolizumab|mesh-list
101582441|NCT03486301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101328739|NCT00024154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101582442|NCT03486301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582443|NCT03486301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101582455|NCT04218851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101582456|NCT04218851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101582457|NCT04218851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582459|NCT04218851|Hormone Antagonists|hormone antagonists|mesh-ancestor
101582460|NCT04218851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101582461|NCT04218851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582462|NCT03355300|Cannabidiol|cannabidiol|mesh-list
101582463|NCT03355300|Anticonvulsants|anticonvulsants|mesh-ancestor
101582464|NCT03255434|Oxaliplatin|oxaliplatin|mesh-list
101582465|NCT03255434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582466|NCT03199040|Durvalumab|durvalumab|mesh-list
101582467|NCT03199040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101582468|NCT03199040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582469|NCT03173924|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101582470|NCT03173924|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101582471|NCT03173924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582472|NCT03087903|Grape Seed Extract|grape seed extract|mesh-list
101582473|NCT03087903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101239360|NCT01615393|Ribavirin|ribavirin|mesh-list
101582474|NCT03087903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582475|NCT03087903|Antioxidants|antioxidants|mesh-ancestor
101582476|NCT03087903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582477|NCT03087903|Protective Agents|protective agents|mesh-ancestor
101582478|NCT03087903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582479|NCT03074045|Drospirenone|drospirenone|mesh-list
101582480|NCT03074045|Levonorgestrel|levonorgestrel|mesh-list
101582481|NCT03074045|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101582482|NCT03074045|Estradiol|estradiol|mesh-list
101582483|NCT03074045|Estrogens|estrogens|mesh-ancestor
101582484|NCT03074045|Hormones|hormones|mesh-ancestor
101582485|NCT03074045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101582486|NCT03074045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582487|NCT03074045|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101582488|NCT03074045|Contraceptive Agents|contraceptive agents|mesh-ancestor
101582489|NCT03074045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101582490|NCT03074045|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101582491|NCT03074045|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101582492|NCT03074045|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101582493|NCT03074045|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101616795|NCT00895245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101616796|NCT00895245|Antiemetics|antiemetics|mesh-ancestor
101272339|NCT01843075|Hormones|hormones|mesh-ancestor
101616797|NCT00895245|Autonomic Agents|autonomic agents|mesh-ancestor
101616798|NCT00895245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101272567|NCT01844141|Ethanol|ethanol|mesh-list
101616799|NCT00895245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272850|NCT01845675|Growth Inhibitors|growth inhibitors|mesh-ancestor
101582494|NCT03074045|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101582495|NCT03074045|Hormone Antagonists|hormone antagonists|mesh-ancestor
101582496|NCT03074045|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101582497|NCT03074045|Diuretics|diuretics|mesh-ancestor
101582498|NCT03074045|Natriuretic Agents|natriuretic agents|mesh-ancestor
101582499|NCT02948543|Mitomycins|mitomycins|mesh-list
101582500|NCT02948543|Mitomycin|mitomycin|mesh-list
101582501|NCT02948543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101582502|NCT02948543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582503|NCT02948543|Alkylating Agents|alkylating agents|mesh-ancestor
101582504|NCT02948543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582505|NCT02948543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101582506|NCT02948543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101582520|NCT02901041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101328913|NCT00025090|Mitomycins|mitomycins|mesh-list
101582521|NCT02901041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582522|NCT02840227|Anesthetics|anesthetics|mesh-list
101582523|NCT02840227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101582524|NCT02840227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582525|NCT02705508|Gemcitabine|gemcitabine|mesh-list
101582526|NCT02705508|Etoposide|etoposide|mesh-list
101582527|NCT02705508|Etoposide phosphate|etoposide phosphate|mesh-list
101582528|NCT02705508|Pegaspargase|pegaspargase|mesh-list
101582529|NCT02705508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101582530|NCT02705508|Antimetabolites|antimetabolites|mesh-ancestor
101582531|NCT02705508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582532|NCT02705508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582533|NCT02705508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101582534|NCT02705508|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101582535|NCT02705508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101582536|NCT02705508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101582547|NCT02636322|Prednisone|prednisone|mesh-list
101582548|NCT02636322|Cortisone|cortisone|mesh-list
101582549|NCT02636322|Cyclophosphamide|cyclophosphamide|mesh-list
101582550|NCT02636322|Rituximab|rituximab|mesh-list
101582551|NCT02636322|Doxorubicin|doxorubicin|mesh-list
101582552|NCT02636322|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101582553|NCT02636322|Etoposide|etoposide|mesh-list
101582554|NCT02636322|Vincristine|vincristine|mesh-list
101582555|NCT02636322|Lenalidomide|lenalidomide|mesh-list
101582556|NCT02636322|Etoposide phosphate|etoposide phosphate|mesh-list
101582557|NCT02636322|Podophyllotoxin|podophyllotoxin|mesh-list
101582558|NCT02636322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101582559|NCT02636322|Antibodies|antibodies|mesh-list
101582560|NCT02636322|Immunoglobulins|immunoglobulins|mesh-list
101582561|NCT02636322|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101582562|NCT02636322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101582563|NCT02636322|Immunologic Factors|immunologic factors|mesh-ancestor
101582564|NCT02636322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582565|NCT02636322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101582566|NCT02636322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101582567|NCT02636322|Alkylating Agents|alkylating agents|mesh-ancestor
101582568|NCT02636322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582569|NCT02636322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582570|NCT02636322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101582571|NCT02636322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101582572|NCT02636322|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101582573|NCT02636322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101582574|NCT02636322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101582575|NCT02636322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101582576|NCT02636322|Glucocorticoids|glucocorticoids|mesh-ancestor
101582577|NCT02636322|Hormones|hormones|mesh-ancestor
101582578|NCT02636322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101616800|NCT00895245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101616801|NCT00895245|Glucocorticoids|glucocorticoids|mesh-ancestor
101616803|NCT00895245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101616804|NCT00895245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101273301|NCT01849211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101616806|NCT00895245|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101616807|NCT00895245|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101616808|NCT00895245|Serotonin Agents|serotonin agents|mesh-ancestor
101616809|NCT00895245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101415538|NCT00500188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101415541|NCT04710914|Midazolam|midazolam|mesh-list
101582590|NCT02547987|Carboplatin|carboplatin|mesh-list
101582591|NCT02547987|Docetaxel|docetaxel|mesh-list
101582592|NCT02547987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582593|NCT02547987|Tubulin Modulators|tubulin modulators|mesh-ancestor
101582594|NCT02547987|Antimitotic Agents|antimitotic agents|mesh-ancestor
101582595|NCT02547987|Mitosis Modulators|mitosis modulators|mesh-ancestor
101582596|NCT02547987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582597|NCT02530489|Paclitaxel|paclitaxel|mesh-list
101582598|NCT02530489|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101582599|NCT02530489|Atezolizumab|atezolizumab|mesh-list
101582600|NCT02530489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101582601|NCT02530489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101582602|NCT02530489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582603|NCT02530489|Tubulin Modulators|tubulin modulators|mesh-ancestor
101582604|NCT02530489|Antimitotic Agents|antimitotic agents|mesh-ancestor
101582605|NCT02530489|Mitosis Modulators|mitosis modulators|mesh-ancestor
101582606|NCT02530489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582607|NCT02530489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101582608|NCT02530489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101582609|NCT02530489|Immunologic Factors|immunologic factors|mesh-ancestor
101582610|NCT02530489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582611|NCT02523040|Lenalidomide|lenalidomide|mesh-list
101582612|NCT02523040|Immunologic Factors|immunologic factors|mesh-ancestor
101582613|NCT02523040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582614|NCT02523040|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101582615|NCT02523040|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101582616|NCT02523040|Growth Substances|growth substances|mesh-ancestor
101582617|NCT02523040|Growth Inhibitors|growth inhibitors|mesh-ancestor
101582618|NCT02523040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582619|NCT02396043|Cytarabine|cytarabine|mesh-list
101582620|NCT02396043|Dexamethasone|dexamethasone|mesh-list
101582621|NCT02396043|Prednisone|prednisone|mesh-list
101582622|NCT02396043|Cyclophosphamide|cyclophosphamide|mesh-list
101582623|NCT02396043|Methotrexate|methotrexate|mesh-list
101582624|NCT02396043|Vincristine|vincristine|mesh-list
101582625|NCT02396043|Mercaptopurine|mercaptopurine|mesh-list
101582626|NCT02396043|Pegaspargase|pegaspargase|mesh-list
101582627|NCT02396043|Asparaginase|asparaginase|mesh-list
101582628|NCT02396043|Pirarubicin|pirarubicin|mesh-list
101582629|NCT02396043|Doxorubicin|doxorubicin|mesh-list
101582630|NCT02396043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101582631|NCT02396043|Immunologic Factors|immunologic factors|mesh-ancestor
101582632|NCT02396043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582633|NCT02396043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101582634|NCT02396043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101582635|NCT02396043|Alkylating Agents|alkylating agents|mesh-ancestor
101582636|NCT02396043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582637|NCT02396043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582638|NCT02396043|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101582639|NCT02396043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101582640|NCT02396043|Antiemetics|antiemetics|mesh-ancestor
101582641|NCT02396043|Autonomic Agents|autonomic agents|mesh-ancestor
101582642|NCT02396043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101582643|NCT02396043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101582644|NCT02396043|Glucocorticoids|glucocorticoids|mesh-ancestor
101616810|NCT00895245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616811|NCT00895245|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101616812|NCT03172377|Adalimumab|adalimumab|mesh-list
101616813|NCT03172377|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101616814|NCT03172377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101616815|NCT03172377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101616816|NCT02617654|Liraglutide|liraglutide|mesh-list
101274121|NCT01855321|Vitamin D|vitamin d|mesh-list
101616818|NCT02617654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616819|NCT02617654|Incretins|incretins|mesh-ancestor
101582647|NCT02396043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101582648|NCT02396043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101582649|NCT02396043|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101582650|NCT02396043|Abortifacient Agents|abortifacient agents|mesh-ancestor
101582651|NCT02396043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101582652|NCT02396043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101582653|NCT02396043|Antimetabolites|antimetabolites|mesh-ancestor
101582654|NCT02396043|Dermatologic Agents|dermatologic agents|mesh-ancestor
101582655|NCT02396043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101582656|NCT02396043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101582657|NCT02396043|Antiviral Agents|antiviral agents|mesh-ancestor
101582658|NCT02396043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101582659|NCT02396043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101582660|NCT02396043|Tubulin Modulators|tubulin modulators|mesh-ancestor
101582661|NCT02396043|Antimitotic Agents|antimitotic agents|mesh-ancestor
101582662|NCT02396043|Mitosis Modulators|mitosis modulators|mesh-ancestor
101582663|NCT02396043|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101582664|NCT02396043|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101582665|NCT02396043|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101582666|NCT02232191|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101582667|NCT02232191|Immunologic Factors|immunologic factors|mesh-ancestor
101582668|NCT02232191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582669|NCT02181413|Ixazomib|ixazomib|mesh-list
101582670|NCT02181413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582671|NCT02181413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582672|NCT02181413|Protease Inhibitors|protease inhibitors|mesh-ancestor
101582673|NCT02181413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101582674|NCT02151981|Osimertinib|osimertinib|mesh-list
101582675|NCT02151981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582676|NCT02151981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101582677|NCT02151981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101582678|NCT02151981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582680|NCT02097134|Mechlorethamine|mechlorethamine|mesh-list
101582681|NCT02097134|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
101582682|NCT02097134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101582683|NCT02097134|Alkylating Agents|alkylating agents|mesh-ancestor
101329136|NCT00025519|Growth Substances|growth substances|mesh-ancestor
101582684|NCT02097134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582685|NCT02097134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582686|NCT02097134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101582687|NCT02097134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101582688|NCT02097134|Immunologic Factors|immunologic factors|mesh-ancestor
101582689|NCT02097134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582690|NCT01525966|Paclitaxel|paclitaxel|mesh-list
101582691|NCT01525966|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101582692|NCT01525966|Carboplatin|carboplatin|mesh-list
101582693|NCT01525966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101582694|NCT01525966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582695|NCT01525966|Tubulin Modulators|tubulin modulators|mesh-ancestor
101582696|NCT01525966|Antimitotic Agents|antimitotic agents|mesh-ancestor
101582697|NCT01525966|Mitosis Modulators|mitosis modulators|mesh-ancestor
101582698|NCT01525966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582699|NCT01273610|Trastuzumab|trastuzumab|mesh-list
101582700|NCT01273610|Lapatinib|lapatinib|mesh-list
101239578|NCT01616927|Lanreotide|lanreotide|mesh-list
101582753|NCT00999804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582754|NCT00999804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101582755|NCT00544830|Leuprolide|leuprolide|mesh-list
101582756|NCT00544830|Goserelin|goserelin|mesh-list
101274559|NCT01857596|Trazodone|trazodone|mesh-list
101616830|NCT00700024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616831|NCT00700024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101616832|NCT00700024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101616834|NCT00697450|Insulin Detemir|insulin detemir|mesh-list
101274785|NCT01858207|Doxorubicin|doxorubicin|mesh-list
101274864|NCT01858623|Losartan|losartan|mesh-list
101616835|NCT00697450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101616836|NCT00697450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275013|NCT01859728|Cisplatin|cisplatin|mesh-list
101616839|NCT00796003|Antimetabolites|antimetabolites|mesh-ancestor
101616840|NCT00796003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616841|NCT00796003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101275374|NCT01862263|Vildagliptin|vildagliptin|mesh-list
101616843|NCT04110535|Midazolam|midazolam|mesh-list
101616844|NCT04110535|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101582757|NCT00544830|Bicalutamide|bicalutamide|mesh-list
101582758|NCT00544830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101582759|NCT00544830|Fertility Agents|fertility agents|mesh-ancestor
101582760|NCT00544830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101582761|NCT00544830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582762|NCT00544830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101582763|NCT00544830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582764|NCT00544830|Androgen Antagonists|androgen antagonists|mesh-ancestor
101582765|NCT00544830|Hormone Antagonists|hormone antagonists|mesh-ancestor
101582766|NCT00544830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101582767|NCT00130221|Chlorhexidine|chlorhexidine|mesh-list
101582768|NCT00130221|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101582769|NCT00130221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101582770|NCT00130221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101582771|NCT00130221|Disinfectants|disinfectants|mesh-ancestor
101582772|NCT00130221|Dermatologic Agents|dermatologic agents|mesh-ancestor
101582773|NCT00077129|Paclitaxel|paclitaxel|mesh-list
101582774|NCT00077129|Carboplatin|carboplatin|mesh-list
101582775|NCT00077129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101582776|NCT00077129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582777|NCT00077129|Tubulin Modulators|tubulin modulators|mesh-ancestor
101582778|NCT00077129|Antimitotic Agents|antimitotic agents|mesh-ancestor
101582779|NCT00077129|Mitosis Modulators|mitosis modulators|mesh-ancestor
101582780|NCT00077129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582781|NCT00052884|Melphalan|melphalan|mesh-list
101582782|NCT00052884|Amifostine|amifostine|mesh-list
101582783|NCT00052884|Immunologic Factors|immunologic factors|mesh-ancestor
101582784|NCT00052884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582798|NCT00040807|Mitosis Modulators|mitosis modulators|mesh-ancestor
101582799|NCT00040807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329218|NCT00025675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101582800|NCT00040807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101582801|NCT00040807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101582802|NCT00040807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101582803|NCT00028678|Dalteparin|dalteparin|mesh-list
101582804|NCT00028678|Tinzaparin|tinzaparin|mesh-list
101582805|NCT00028678|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101582806|NCT00028678|Anticoagulants|anticoagulants|mesh-ancestor
101582807|NCT00028678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101582808|NCT00028678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101582809|NCT00028678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582810|NCT00004223|Gemcitabine|gemcitabine|mesh-list
101582811|NCT00004223|Docetaxel|docetaxel|mesh-list
101582812|NCT00004223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101582813|NCT00004223|Antimetabolites|antimetabolites|mesh-ancestor
101616845|NCT04110535|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101616846|NCT04110535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101275739|NCT01864265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101616847|NCT04110535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616848|NCT04110535|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101616849|NCT04110535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101616850|NCT04110535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101616851|NCT04110535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101276165|NCT01868113|Xhance|xhance|mesh-list
101616852|NCT04110535|Anesthetics, General|anesthetics, general|mesh-ancestor
101582814|NCT00004223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582815|NCT00004223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582816|NCT00004223|Tubulin Modulators|tubulin modulators|mesh-ancestor
101582817|NCT00004223|Antimitotic Agents|antimitotic agents|mesh-ancestor
101582818|NCT00004223|Mitosis Modulators|mitosis modulators|mesh-ancestor
101582819|NCT00003764|Cyclophosphamide|cyclophosphamide|mesh-list
101582820|NCT00003764|Fludarabine|fludarabine|mesh-list
101582821|NCT00003764|Fludarabine phosphate|fludarabine phosphate|mesh-list
101582822|NCT00003764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101582823|NCT00003764|Immunologic Factors|immunologic factors|mesh-ancestor
101582824|NCT00003764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329269|NCT00026143|Growth Substances|growth substances|mesh-ancestor
101582826|NCT00003764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101582827|NCT00003764|Alkylating Agents|alkylating agents|mesh-ancestor
101582828|NCT00003764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582829|NCT00003764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582830|NCT00003764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101582831|NCT00003764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101582832|NCT00003764|Antimetabolites|antimetabolites|mesh-ancestor
101582833|NCT00003601|Tretinoin|tretinoin|mesh-list
101582834|NCT00003601|Fenretinide|fenretinide|mesh-list
101582835|NCT00003601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582836|NCT00003601|Keratolytic Agents|keratolytic agents|mesh-ancestor
101582837|NCT00003601|Dermatologic Agents|dermatologic agents|mesh-ancestor
101582838|NCT00003601|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101582839|NCT00003601|Protective Agents|protective agents|mesh-ancestor
101582840|NCT00003601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582841|NCT00003266|Methylphenidate|methylphenidate|mesh-list
101582842|NCT00003266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101582843|NCT00003266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582844|NCT00003266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101582845|NCT00003266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101582846|NCT00003266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101582851|NCT00003236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101239731|NCT01617707|Midazolam|midazolam|mesh-list
101582852|NCT00003236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101582853|NCT00003236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582854|NCT00003057|Octreotide|octreotide|mesh-list
101582855|NCT00003057|Loperamide|loperamide|mesh-list
101582856|NCT00003057|Antidiarrheals|antidiarrheals|mesh-list
101582857|NCT00003057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101582858|NCT00003057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101582859|NCT00003057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582860|NCT00002922|Paclitaxel|paclitaxel|mesh-list
101582861|NCT00002922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101582862|NCT00002922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582863|NCT00002922|Tubulin Modulators|tubulin modulators|mesh-ancestor
101582864|NCT00002922|Antimitotic Agents|antimitotic agents|mesh-ancestor
101582865|NCT00002922|Mitosis Modulators|mitosis modulators|mesh-ancestor
101582866|NCT00002922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582867|NCT00002514|Leucovorin|leucovorin|mesh-list
101582868|NCT00002514|Cytarabine|cytarabine|mesh-list
101582869|NCT00002514|Dexamethasone|dexamethasone|mesh-list
101582870|NCT00002514|Prednisone|prednisone|mesh-list
101582871|NCT00002514|Cyclophosphamide|cyclophosphamide|mesh-list
101582872|NCT00002514|Methotrexate|methotrexate|mesh-list
101582873|NCT00002514|Etoposide|etoposide|mesh-list
101582874|NCT00002514|Vincristine|vincristine|mesh-list
101616854|NCT04110535|GABA Modulators|gaba modulators|mesh-ancestor
101616855|NCT04110535|GABA Agents|gaba agents|mesh-ancestor
101616856|NCT04110535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101616857|NCT04110535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616858|NCT04025203|Ibuprofen|ibuprofen|mesh-list
101616859|NCT04025203|Ibuprofen arginine|ibuprofen arginine|mesh-list
101616861|NCT04025203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101616862|NCT04025203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101616863|NCT04025203|Analgesics|analgesics|mesh-ancestor
101276554|NCT01870440|Dexamethasone|dexamethasone|mesh-list
101276777|NCT01871701|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101616864|NCT04025203|Sensory System Agents|sensory system agents|mesh-ancestor
101616865|NCT04025203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101276856|NCT01871922|Mydriatics|mydriatics|mesh-ancestor
101616866|NCT04025203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616867|NCT04025203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101616868|NCT04025203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101616869|NCT04025203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101277074|NCT01872871|Analgesics|analgesics|mesh-ancestor
101616871|NCT04025203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616872|NCT04025203|Anticonvulsants|anticonvulsants|mesh-ancestor
101616873|NCT04025203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101616874|NCT04025203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101415594|NCT01245946|Adapalene|adapalene|mesh-list
101415595|NCT01245946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101582875|NCT00002514|Imatinib Mesylate|imatinib mesylate|mesh-list
101582876|NCT00002514|Daunorubicin|daunorubicin|mesh-list
101582877|NCT00002514|Asparaginase|asparaginase|mesh-list
101582878|NCT00002514|Mercaptopurine|mercaptopurine|mesh-list
101582879|NCT00002514|Thioguanine|thioguanine|mesh-list
101582880|NCT00002514|Sargramostim|sargramostim|mesh-list
101582881|NCT00002514|Levoleucovorin|levoleucovorin|mesh-list
101582882|NCT00002514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101582883|NCT00002514|Immunologic Factors|immunologic factors|mesh-ancestor
101582884|NCT00002514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582885|NCT00002514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101582886|NCT00002514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101582887|NCT00002514|Alkylating Agents|alkylating agents|mesh-ancestor
101329415|NCT00000428|Adrenergic Agents|adrenergic agents|mesh-ancestor
101582888|NCT00002514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582889|NCT00002514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582890|NCT00002514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101582891|NCT00002514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101582892|NCT00002514|Antiemetics|antiemetics|mesh-ancestor
101582893|NCT00002514|Autonomic Agents|autonomic agents|mesh-ancestor
101582894|NCT00002514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101582895|NCT00002514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101582896|NCT00002514|Glucocorticoids|glucocorticoids|mesh-ancestor
101582897|NCT00002514|Hormones|hormones|mesh-ancestor
101582898|NCT00002514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101582899|NCT00002514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101582900|NCT00002514|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101582901|NCT00002514|Abortifacient Agents|abortifacient agents|mesh-ancestor
101616875|NCT04025203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101277523|NCT05528718|Midazolam|midazolam|mesh-list
101616876|NCT04025203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101277666|NCT05302999|Antimanic Agents|antimanic agents|mesh-ancestor
101616877|NCT04025203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101616878|NCT04025203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101616879|NCT04025203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101582902|NCT00002514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101582903|NCT00002514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101582904|NCT00002514|Antimetabolites|antimetabolites|mesh-ancestor
101582905|NCT00002514|Dermatologic Agents|dermatologic agents|mesh-ancestor
101582906|NCT00002514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101582907|NCT00002514|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101582908|NCT00002514|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101329460|NCT00027547|Cytarabine|cytarabine|mesh-list
101582909|NCT00002514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101582910|NCT00002514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101582911|NCT00002514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101582912|NCT00002514|Antiviral Agents|antiviral agents|mesh-ancestor
101582913|NCT00002514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101582914|NCT00002514|Antidotes|antidotes|mesh-ancestor
101582915|NCT00002514|Protective Agents|protective agents|mesh-ancestor
101582916|NCT00002514|Vitamin B Complex|vitamin b complex|mesh-ancestor
101582917|NCT00002514|Vitamins|vitamins|mesh-ancestor
101582918|NCT00002514|Micronutrients|micronutrients|mesh-ancestor
101582919|NCT00002514|Tubulin Modulators|tubulin modulators|mesh-ancestor
101582920|NCT00002514|Antimitotic Agents|antimitotic agents|mesh-ancestor
101582933|NCT00927472|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101582934|NCT00927472|Cholinergic Agents|cholinergic agents|mesh-ancestor
101582935|NCT00927472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101582936|NCT00927472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582938|NCT00642655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101582939|NCT00642655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582940|NCT00642655|Immunologic Factors|immunologic factors|mesh-ancestor
101582941|NCT00642655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582942|NCT00642655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101582943|NCT00642733|Gemcitabine|gemcitabine|mesh-list
101582944|NCT00642733|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101582945|NCT00642733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101582946|NCT00642733|Antimetabolites|antimetabolites|mesh-ancestor
101582947|NCT00642733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582948|NCT00642733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582949|NCT00642733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101582950|NCT00642733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101582951|NCT00927394|Valsartan|valsartan|mesh-list
101582952|NCT00927394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101582953|NCT00927394|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101582954|NCT00927394|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101582955|NCT00927394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582956|NCT00643825|Temozolomide|temozolomide|mesh-list
101582957|NCT00643825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101582958|NCT00643825|Alkylating Agents|alkylating agents|mesh-ancestor
101582959|NCT00643825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582960|NCT00643825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582961|NCT04178863|Timolol|timolol|mesh-list
101582962|NCT04178863|Latanoprost|latanoprost|mesh-list
101582963|NCT04178863|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101582964|NCT04178863|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101582965|NCT04178863|Adrenergic Agents|adrenergic agents|mesh-ancestor
101582966|NCT04178863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101582967|NCT04178863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582968|NCT04178863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582969|NCT04178863|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101582970|NCT04178863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101582971|NCT04178863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101582972|NCT04178863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101582973|NCT04264858|Immunoglobulins|immunoglobulins|mesh-list
101582974|NCT04264858|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101616880|NCT04025203|Antimanic Agents|antimanic agents|mesh-ancestor
101616881|NCT02843607|Immunomodulating Agents|immunomodulating agents|mesh-list
101616883|NCT02843607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277953|NCT04717362|Hormones|hormones|mesh-ancestor
101616884|NCT02843685|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
101278029|NCT04255160|Estradiol|estradiol|mesh-list
101616885|NCT02843685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101582975|NCT04264858|Antibodies|antibodies|mesh-list
101582976|NCT04264858|gamma-Globulins|gamma-globulins|mesh-list
101582977|NCT04264858|Immunologic Factors|immunologic factors|mesh-ancestor
101582978|NCT04264858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582979|NCT00976911|Paclitaxel|paclitaxel|mesh-list
101582980|NCT00976911|Bevacizumab|bevacizumab|mesh-list
101582981|NCT00976911|Doxorubicin|doxorubicin|mesh-list
101582982|NCT00976911|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101583000|NCT00976911|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101583001|NCT05336968|Triamcinolone|triamcinolone|mesh-list
101583002|NCT05336968|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101583003|NCT05336968|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101583004|NCT05336968|Ketorolac|ketorolac|mesh-list
101583005|NCT05336968|Ropivacaine|ropivacaine|mesh-list
101583006|NCT05336968|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101583008|NCT05336968|Anesthetics|anesthetics|mesh-ancestor
101583009|NCT05336968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101583010|NCT05336968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583011|NCT05336968|Sensory System Agents|sensory system agents|mesh-ancestor
101583012|NCT05336968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101583013|NCT05336968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101583014|NCT05336968|Glucocorticoids|glucocorticoids|mesh-ancestor
101583015|NCT05336968|Hormones|hormones|mesh-ancestor
101583016|NCT05336968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101583017|NCT05336968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101583018|NCT05336968|Immunologic Factors|immunologic factors|mesh-ancestor
101583019|NCT05336968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101583020|NCT05336968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583021|NCT05336968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101583022|NCT05336968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101583023|NCT05336968|Analgesics|analgesics|mesh-ancestor
101583024|NCT05336968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101583025|NCT05336968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101583026|NCT02674555|Naquotinib|naquotinib|mesh-list
101583027|NCT02674555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101583028|NCT02674555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101583029|NCT02674555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101583030|NCT02674555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583031|NCT00934648|Rituximab|rituximab|mesh-list
101583032|NCT00934648|Methotrexate|methotrexate|mesh-list
101583033|NCT00934648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101583034|NCT00934648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101583035|NCT00934648|Immunologic Factors|immunologic factors|mesh-ancestor
101583036|NCT00934648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583037|NCT00934648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101583038|NCT00934648|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101583039|NCT00934648|Abortifacient Agents|abortifacient agents|mesh-ancestor
101583061|NCT00644449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101583062|NCT00644449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583063|NCT00644449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101583064|NCT00644449|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101583065|NCT00644449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101583067|NCT04287777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101583068|NCT04287777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101583069|NCT04287777|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101583070|NCT04287777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101583071|NCT04287777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583072|NCT04180657|Protein C|protein c|mesh-list
101583073|NCT04180657|Anticoagulants|anticoagulants|mesh-ancestor
101583074|NCT04180657|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101583075|NCT04180657|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101583076|NCT04180657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616886|NCT00915577|Interferons|interferons|mesh-list
101616887|NCT00915577|Interferon-beta|interferon-beta|mesh-list
101616888|NCT00915577|Interferon beta-1a|interferon beta-1a|mesh-list
101616889|NCT00915577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101616890|NCT00915577|Antiviral Agents|antiviral agents|mesh-ancestor
101616891|NCT00915577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101616892|NCT00915577|Immunologic Factors|immunologic factors|mesh-ancestor
101329715|NCT00027976|Celecoxib|celecoxib|mesh-list
101415631|NCT01246180|Analgesics|analgesics|mesh-ancestor
101583077|NCT00927082|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101583078|NCT00927082|Antiviral Agents|antiviral agents|mesh-ancestor
101583079|NCT00927082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101583080|NCT02674243|Povidone-Iodine|povidone-iodine|mesh-list
101583081|NCT02674243|Povidone|povidone|mesh-list
101583082|NCT02674243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101583083|NCT02674243|Plasma Substitutes|plasma substitutes|mesh-ancestor
101583084|NCT02674243|Blood Substitutes|blood substitutes|mesh-ancestor
101583085|NCT02674243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101583086|NCT02674243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101583087|NCT04256200|Dienogest|dienogest|mesh-list
101583088|NCT04256200|Contraceptive Agents|contraceptive agents|mesh-list
101583089|NCT04256200|Contraceptives, Oral|contraceptives, oral|mesh-list
101583090|NCT04256200|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
101583091|NCT04256200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101583092|NCT04256200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583093|NCT04256200|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101583106|NCT00976677|Carboplatin|carboplatin|mesh-list
101583107|NCT00976677|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101583108|NCT00976677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101583110|NCT00976677|Immunoglobulins|immunoglobulins|mesh-list
101583111|NCT00976677|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101583112|NCT00976677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101583113|NCT00976677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101583114|NCT00976677|Tubulin Modulators|tubulin modulators|mesh-ancestor
101583115|NCT00976677|Antimitotic Agents|antimitotic agents|mesh-ancestor
101583116|NCT00976677|Mitosis Modulators|mitosis modulators|mesh-ancestor
101329768|NCT00012090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101583117|NCT00976677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583118|NCT00976677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101583119|NCT00976677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101583120|NCT00976677|Growth Substances|growth substances|mesh-ancestor
101583121|NCT00976677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583122|NCT00976677|Growth Inhibitors|growth inhibitors|mesh-ancestor
101583123|NCT00976677|Immunologic Factors|immunologic factors|mesh-ancestor
101583124|NCT00976677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101583125|NCT00976677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101583126|NCT00642967|Epoetin Alfa|epoetin alfa|mesh-list
101583127|NCT00642967|Hematinics|hematinics|mesh-ancestor
101583128|NCT02865993|Povidone-Iodine|povidone-iodine|mesh-list
101583129|NCT02865993|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101583130|NCT02865993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101583131|NCT04287543|Melatonin|melatonin|mesh-list
101583132|NCT04287543|Antioxidants|antioxidants|mesh-ancestor
101583133|NCT04287543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583134|NCT04287543|Protective Agents|protective agents|mesh-ancestor
101583135|NCT04287543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583136|NCT04287543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101583137|NCT04287387|Pioglitazone|pioglitazone|mesh-list
101583138|NCT04287387|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101583139|NCT04287387|Dapagliflozin|dapagliflozin|mesh-list
101583140|NCT04287387|Metformin|metformin|mesh-list
101583141|NCT04287387|Glimepiride|glimepiride|mesh-list
101583142|NCT04287387|Acarbose|acarbose|mesh-list
101583143|NCT04287387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101583144|NCT04287387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583145|NCT04287387|Incretins|incretins|mesh-ancestor
101583146|NCT04287387|Hormones|hormones|mesh-ancestor
101583147|NCT04287387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101583148|NCT04287387|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101583149|NCT04287387|Protease Inhibitors|protease inhibitors|mesh-ancestor
101583150|NCT04287387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101240016|NCT01619176|Leflunomide|leflunomide|mesh-list
101583151|NCT04287387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616893|NCT00915577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616894|NCT00915577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101616895|NCT00899847|Acetaminophen|acetaminophen|mesh-list
101616896|NCT00899847|Diphenhydramine|diphenhydramine|mesh-list
101616897|NCT00899847|Promethazine|promethazine|mesh-list
101616898|NCT00899847|Cyclosporine|cyclosporine|mesh-list
101616899|NCT00899847|Mycophenolic Acid|mycophenolic acid|mesh-list
101616900|NCT00899847|Hydrocortisone|hydrocortisone|mesh-list
101278850|NCT01874730|Anesthetics|anesthetics|mesh-list
101616901|NCT00899847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101616902|NCT00899847|Cyclophosphamide|cyclophosphamide|mesh-list
101616904|NCT00899847|Mechlorethamine|mechlorethamine|mesh-list
101616906|NCT00899847|Thymoglobulin|thymoglobulin|mesh-list
101616907|NCT00899847|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101415638|NCT01246180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101329869|NCT00028405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101583152|NCT04287387|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101583153|NCT04287387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101583154|NCT04287387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101583164|NCT02865681|Letrozole|letrozole|mesh-list
101583165|NCT02865681|Clomiphene|clomiphene|mesh-list
101583166|NCT02865681|Enclomiphene|enclomiphene|mesh-list
101583167|NCT02865681|Zuclomiphene|zuclomiphene|mesh-list
101583168|NCT02865681|Menotropins|menotropins|mesh-list
101583169|NCT02865681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583170|NCT02865681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101583171|NCT02865681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101583172|NCT02865681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101583173|NCT02865681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101583174|NCT02865681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101583175|NCT02865681|Hormone Antagonists|hormone antagonists|mesh-ancestor
101583176|NCT02865681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101583177|NCT02865681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583178|NCT02865681|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101583179|NCT02865681|Fertility Agents|fertility agents|mesh-ancestor
101583180|NCT02865681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101583181|NCT02865681|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101583182|NCT02865681|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101583183|NCT00644137|Pregabalin|pregabalin|mesh-list
101583184|NCT00644137|Analgesics|analgesics|mesh-ancestor
101583185|NCT00644137|Sensory System Agents|sensory system agents|mesh-ancestor
101583186|NCT00644137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101583187|NCT00644137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583188|NCT00644137|Anticonvulsants|anticonvulsants|mesh-ancestor
101583189|NCT00644137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101583190|NCT00644137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101583191|NCT00644137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583192|NCT00644137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101583193|NCT00644137|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101583194|NCT00644137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101583195|NCT00644137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101583197|NCT00910195|Acetaminophen|acetaminophen|mesh-list
101583198|NCT00910195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101583199|NCT00910195|Analgesics|analgesics|mesh-ancestor
101583200|NCT00910195|Sensory System Agents|sensory system agents|mesh-ancestor
101583201|NCT00910195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101583202|NCT00910195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583203|NCT00910195|Antipyretics|antipyretics|mesh-ancestor
101583204|NCT04176367|Nicergoline|nicergoline|mesh-list
101583205|NCT04176367|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101583206|NCT04176367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101583207|NCT04176367|Adrenergic Agents|adrenergic agents|mesh-ancestor
101583208|NCT04176367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101616908|NCT00899847|Lenograstim|lenograstim|mesh-list
101616909|NCT00899847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101616910|NCT00899847|Immunologic Factors|immunologic factors|mesh-ancestor
101616911|NCT00899847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616912|NCT00899847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101616913|NCT00899847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101616914|NCT00899847|Alkylating Agents|alkylating agents|mesh-ancestor
101775296|NCT00803556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101775297|NCT00936195|Ritonavir|ritonavir|mesh-list
101775299|NCT00936195|Tenofovir|tenofovir|mesh-list
101616915|NCT00899847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279277|NCT01878357|Artenimol|artenimol|mesh-list
101616916|NCT00899847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101616917|NCT00899847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101616919|NCT00899847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101616920|NCT00899847|Antifungal Agents|antifungal agents|mesh-ancestor
101279444|NCT01879514|Prednisone|prednisone|mesh-list
101616921|NCT00899847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101279507|NCT01880216|Enoxaparin|enoxaparin|mesh-list
101616922|NCT00899847|Dermatologic Agents|dermatologic agents|mesh-ancestor
101616923|NCT00899847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101616924|NCT00899847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101616925|NCT00899847|Analgesics|analgesics|mesh-ancestor
101616926|NCT00899847|Sensory System Agents|sensory system agents|mesh-ancestor
101616927|NCT00899847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101616928|NCT00899847|Antipyretics|antipyretics|mesh-ancestor
101279802|NCT01883102|Capsaicin|capsaicin|mesh-list
101583209|NCT04176367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583210|NCT04176367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583211|NCT04176367|Vasodilator Agents|vasodilator agents|mesh-ancestor
101583212|NCT04176367|Nootropic Agents|nootropic agents|mesh-ancestor
101583213|NCT04259476|Ketamine|ketamine|mesh-list
101583214|NCT04259476|Analgesics|analgesics|mesh-ancestor
101583215|NCT04259476|Sensory System Agents|sensory system agents|mesh-ancestor
101583216|NCT04259476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101583217|NCT04259476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583218|NCT04259476|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101583219|NCT04259476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101583220|NCT04259476|Anesthetics, General|anesthetics, general|mesh-ancestor
101583227|NCT05319574|Tislelizumab|tislelizumab|mesh-list
101583228|NCT05319574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101583229|NCT05319574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101583231|NCT00970281|Antiemetics|antiemetics|mesh-ancestor
101583232|NCT00970281|Autonomic Agents|autonomic agents|mesh-ancestor
101583233|NCT00970281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101583234|NCT00970281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583235|NCT00970281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101583236|NCT00970281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101583237|NCT00970281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101583238|NCT00970281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101583239|NCT00970281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101616929|NCT00899847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101616930|NCT00899847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101616931|NCT00899847|Antitubercular Agents|antitubercular agents|mesh-ancestor
101280317|NCT01886443|Vitamin E|vitamin e|mesh-list
101616933|NCT00899847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101583240|NCT00970281|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101583241|NCT00970281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101583242|NCT00970281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101583243|NCT00970281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583244|NCT00970281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101583245|NCT00970281|Serotonin Agents|serotonin agents|mesh-ancestor
101583246|NCT00607438|Paclitaxel|paclitaxel|mesh-list
101583247|NCT00607438|Sorafenib|sorafenib|mesh-list
101583248|NCT00607438|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101583249|NCT00607438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101583250|NCT00607438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101583251|NCT00607438|Tubulin Modulators|tubulin modulators|mesh-ancestor
101583252|NCT00607438|Antimitotic Agents|antimitotic agents|mesh-ancestor
101583253|NCT00607438|Mitosis Modulators|mitosis modulators|mesh-ancestor
101583254|NCT00607438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583255|NCT00607438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101583256|NCT00607438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101583257|NCT00976209|Phenylephrine|phenylephrine|mesh-list
101583258|NCT00976209|Oxymetazoline|oxymetazoline|mesh-list
101583259|NCT00976209|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101583260|NCT00976209|Mydriatics|mydriatics|mesh-ancestor
101583261|NCT00976209|Autonomic Agents|autonomic agents|mesh-ancestor
101583262|NCT00976209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101583263|NCT00976209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583264|NCT00976209|Sympathomimetics|sympathomimetics|mesh-ancestor
101583265|NCT00976209|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101583266|NCT00976209|Nasal Decongestants|nasal decongestants|mesh-ancestor
101583267|NCT00976209|Respiratory System Agents|respiratory system agents|mesh-ancestor
101583268|NCT00976209|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101583269|NCT00976209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101583270|NCT00976209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101583271|NCT00976209|Adrenergic Agents|adrenergic agents|mesh-ancestor
101583272|NCT00976209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101583273|NCT00976209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583274|NCT00976209|Protective Agents|protective agents|mesh-ancestor
101583275|NCT03746301|Rivaroxaban|rivaroxaban|mesh-list
101583276|NCT03746301|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101583277|NCT03746301|Antithrombins|antithrombins|mesh-ancestor
101583278|NCT03746301|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101583279|NCT03746301|Protease Inhibitors|protease inhibitors|mesh-ancestor
101583280|NCT03746301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101329998|NCT00028756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101583281|NCT03746301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583282|NCT03746301|Anticoagulants|anticoagulants|mesh-ancestor
101583283|NCT00925990|Ribavirin|ribavirin|mesh-list
101583284|NCT00925990|Antimetabolites|antimetabolites|mesh-ancestor
101583285|NCT00925990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583286|NCT00925990|Antiviral Agents|antiviral agents|mesh-ancestor
101583287|NCT00925990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101583288|NCT02670655|Lidocaine|lidocaine|mesh-list
101583289|NCT02670655|Prilocaine|prilocaine|mesh-list
101583302|NCT02670655|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
101583305|NCT01131078|Irinotecan|irinotecan|mesh-list
101583306|NCT01131078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101583307|NCT01131078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101583308|NCT01131078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101583309|NCT01131078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101583310|NCT01131078|Growth Substances|growth substances|mesh-ancestor
101583311|NCT01131078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583312|NCT01131078|Growth Inhibitors|growth inhibitors|mesh-ancestor
101583313|NCT01131078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101583314|NCT01131078|Antimetabolites|antimetabolites|mesh-ancestor
101583315|NCT01131078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583316|NCT01131078|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101583317|NCT01131078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101583318|NCT01131078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101616934|NCT00899847|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101616935|NCT00899847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101616936|NCT00899847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101616937|NCT00899847|Anesthetics, Local|anesthetics, local|mesh-ancestor
101616938|NCT00899847|Anesthetics|anesthetics|mesh-ancestor
101616939|NCT00899847|Antiemetics|antiemetics|mesh-ancestor
101616940|NCT00899847|Autonomic Agents|autonomic agents|mesh-ancestor
101616941|NCT00899847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101616942|NCT00899847|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101616943|NCT00899847|Histamine Antagonists|histamine antagonists|mesh-ancestor
101583319|NCT03709017|Ponatinib|ponatinib|mesh-list
101583320|NCT03709017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101583321|NCT03709017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101583322|NCT03709017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101583323|NCT03709017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583324|NCT03695445|Norepinephrine|norepinephrine|mesh-list
101583325|NCT03695445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101583326|NCT03695445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101583327|NCT03695445|Adrenergic Agents|adrenergic agents|mesh-ancestor
101583328|NCT03695445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101583329|NCT03695445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583330|NCT03695445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583331|NCT03695445|Sympathomimetics|sympathomimetics|mesh-ancestor
101583332|NCT03695445|Autonomic Agents|autonomic agents|mesh-ancestor
101583333|NCT03695445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101583334|NCT03695445|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101583335|NCT04177303|Metformin|metformin|mesh-list
101583336|NCT04177303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101583337|NCT04177303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583338|NCT01167426|Glatiramer Acetate|glatiramer acetate|mesh-list
101583339|NCT01167426|(T,G)-A-L|(t,g)-a-l|mesh-list
101583340|NCT01167426|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101583341|NCT01167426|Immunologic Factors|immunologic factors|mesh-ancestor
101583342|NCT01167426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583343|NCT01167426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101583344|NCT01167426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101583345|NCT02862873|Ondansetron|ondansetron|mesh-list
101583346|NCT02862873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583347|NCT02862873|Antiemetics|antiemetics|mesh-ancestor
101583348|NCT02862873|Autonomic Agents|autonomic agents|mesh-ancestor
101330018|NCT00012324|Nolatrexed|nolatrexed|mesh-list
101583349|NCT02862873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101583350|NCT02862873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101583356|NCT02862873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101583357|NCT02862873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583358|NCT03814005|Paclitaxel|paclitaxel|mesh-list
101583359|NCT03814005|Docetaxel|docetaxel|mesh-list
101583360|NCT03814005|Carboplatin|carboplatin|mesh-list
101583361|NCT03814005|Azacitidine|azacitidine|mesh-list
101583362|NCT03814005|Pevonedistat|pevonedistat|mesh-list
101583363|NCT03814005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101583364|NCT03814005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101583365|NCT03814005|Tubulin Modulators|tubulin modulators|mesh-ancestor
101583366|NCT03814005|Antimitotic Agents|antimitotic agents|mesh-ancestor
101583367|NCT03814005|Mitosis Modulators|mitosis modulators|mesh-ancestor
101583368|NCT03814005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583369|NCT03814005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101583370|NCT03814005|Antimetabolites|antimetabolites|mesh-ancestor
101583371|NCT03814005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101583372|NCT03449901|Gemcitabine|gemcitabine|mesh-list
101583373|NCT03449901|Docetaxel|docetaxel|mesh-list
101583374|NCT03449901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101583375|NCT03449901|Antimetabolites|antimetabolites|mesh-ancestor
101583376|NCT03449901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583377|NCT03449901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101583378|NCT03449901|Tubulin Modulators|tubulin modulators|mesh-ancestor
101616944|NCT00899847|Histamine Agents|histamine agents|mesh-ancestor
101616945|NCT00899847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101616946|NCT00899847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101616947|NCT00899847|Antipruritics|antipruritics|mesh-ancestor
101280910|NCT01889290|Methylnaltrexone|methylnaltrexone|mesh-list
101775301|NCT00936195|Emtricitabine|emtricitabine|mesh-list
101281128|NCT01895049|Tacrolimus|tacrolimus|mesh-list
101281275|NCT01900301|Scopolamine|scopolamine|mesh-list
101415690|NCT00147264|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101583379|NCT03449901|Antimitotic Agents|antimitotic agents|mesh-ancestor
101583380|NCT03449901|Mitosis Modulators|mitosis modulators|mesh-ancestor
101583381|NCT04016233|Tenofovir|tenofovir|mesh-list
101583382|NCT04016233|Antiviral Agents|antiviral agents|mesh-ancestor
101583383|NCT04016233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101583384|NCT04016233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101583385|NCT04016233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101583386|NCT04016233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101583387|NCT04016233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583388|NCT04016233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101583389|NCT04016233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101583390|NCT04033471|Midazolam|midazolam|mesh-list
101583391|NCT04033471|Morphine|morphine|mesh-list
101583392|NCT04033471|Bupivacaine|bupivacaine|mesh-list
101583393|NCT04033471|Anesthetics, Local|anesthetics, local|mesh-ancestor
101583394|NCT04033471|Anesthetics|anesthetics|mesh-ancestor
101583395|NCT04033471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101583396|NCT04033471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583397|NCT04033471|Sensory System Agents|sensory system agents|mesh-ancestor
101583398|NCT04033471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101583399|NCT04033471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101583400|NCT04033471|Narcotics|narcotics|mesh-ancestor
101583401|NCT04033471|Analgesics|analgesics|mesh-ancestor
101583402|NCT04033471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101583403|NCT04033471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101583404|NCT04033471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101583405|NCT04033471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101583406|NCT04033471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101583407|NCT04033471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101583408|NCT04033471|Anesthetics, General|anesthetics, general|mesh-ancestor
101583409|NCT04033471|GABA Modulators|gaba modulators|mesh-ancestor
101583410|NCT04033471|GABA Agents|gaba agents|mesh-ancestor
101583411|NCT04033471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101583412|NCT04033471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583413|NCT00910351|Ciprofloxacin|ciprofloxacin|mesh-list
101583414|NCT00910351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101583415|NCT00910351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101583416|NCT00910351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101583417|NCT00910351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101583418|NCT00910351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101583419|NCT00910351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583420|NCT00910351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101583421|NCT00910351|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101583434|NCT02668159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101583435|NCT02668159|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101583437|NCT02670109|Busulfan|busulfan|mesh-list
101583438|NCT02670109|Carmustine|carmustine|mesh-list
101583439|NCT02670109|Carboplatin|carboplatin|mesh-list
101583440|NCT02670109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101583441|NCT02670109|Immunologic Factors|immunologic factors|mesh-ancestor
101583442|NCT02670109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583443|NCT02670109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101583444|NCT02670109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101583445|NCT02670109|Alkylating Agents|alkylating agents|mesh-ancestor
101583446|NCT02670109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583447|NCT02670109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101583448|NCT02670109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101583449|NCT00922636|Methylphenidate|methylphenidate|mesh-list
101616950|NCT00899847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101281357|NCT01900639|Aspirin|aspirin|mesh-list
101273983|NCT01854489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101281441|NCT01901003|Lorazepam|lorazepam|mesh-list
101616951|NCT00899847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101616952|NCT00899847|Protective Agents|protective agents|mesh-ancestor
101616953|NCT00899847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101415698|NCT00147303|Sarpogrelate|sarpogrelate|mesh-list
101583450|NCT00922636|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101583451|NCT00922636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583452|NCT00922636|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101583453|NCT00922636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101583454|NCT00922636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101583455|NCT00922636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583456|NCT00922636|Dopamine Agents|dopamine agents|mesh-ancestor
101583457|NCT00922636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101583458|NCT02667925|Cisplatin|cisplatin|mesh-list
101583459|NCT02667925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101583460|NCT02669719|Carboplatin|carboplatin|mesh-list
101583461|NCT02669719|Pemetrexed|pemetrexed|mesh-list
101583462|NCT02669719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101583463|NCT02669719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101583464|NCT02669719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583465|NCT02669719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101583466|NCT02669719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101583467|NCT00644761|Adefovir|adefovir|mesh-list
101583468|NCT00644761|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101583469|NCT00644761|Antiviral Agents|antiviral agents|mesh-ancestor
101583470|NCT00644761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101583471|NCT00644761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101583472|NCT00644761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101583473|NCT00644761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101583474|NCT00644761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583475|NCT00645073|Levofloxacin|levofloxacin|mesh-list
101583476|NCT00645073|Cefdinir|cefdinir|mesh-list
101583477|NCT00645073|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101583478|NCT00645073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101583479|NCT00645073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101583480|NCT00645073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101583481|NCT00645073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101583482|NCT00645073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101583483|NCT00645073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583484|NCT00645073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101583503|NCT01175135|Serotonin Agents|serotonin agents|mesh-ancestor
101583504|NCT01175135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101583505|NCT01175135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583506|NCT01175135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583507|NCT01175135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101583508|NCT01175135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101583509|NCT01175135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101583510|NCT01175135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101583511|NCT01175135|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101583512|NCT01175135|Dopamine Agents|dopamine agents|mesh-ancestor
101583514|NCT02669641|Lipotropic Agents|lipotropic agents|mesh-ancestor
101583515|NCT02669641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101583516|NCT02669641|Antimetabolites|antimetabolites|mesh-ancestor
101583517|NCT02669641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583518|NCT02669641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101583519|NCT02669641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101583520|NCT02669641|Nootropic Agents|nootropic agents|mesh-ancestor
101583521|NCT00922480|Losartan|losartan|mesh-list
101583522|NCT00922480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101583523|NCT00922480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101583524|NCT00922480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101583525|NCT00922480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101616954|NCT04106791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
101616955|NCT00529113|Gemcitabine|gemcitabine|mesh-list
101281643|NCT01902225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101616956|NCT00529113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101616957|NCT00529113|Antimetabolites|antimetabolites|mesh-ancestor
101281792|NCT01903070|Protease Inhibitors|protease inhibitors|mesh-ancestor
101281936|NCT01904253|Topotecan|topotecan|mesh-list
101616958|NCT00529113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282083|NCT01905150|Leucovorin|leucovorin|mesh-list
101415705|NCT00147303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101583526|NCT00922480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583527|NCT04963036|Anesthetics|anesthetics|mesh-list
101240394|NCT01621386|Prednisone|prednisone|mesh-list
101583528|NCT04963036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101583529|NCT04963036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583530|NCT00973479|Golimumab|golimumab|mesh-list
101583531|NCT00973479|Methotrexate|methotrexate|mesh-list
101583532|NCT00973479|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101583533|NCT00973479|Abortifacient Agents|abortifacient agents|mesh-ancestor
101583534|NCT00973479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101583535|NCT00973479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583536|NCT00973479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101583537|NCT00973479|Antimetabolites|antimetabolites|mesh-ancestor
101583538|NCT00973479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330047|NCT00028834|Bevacizumab|bevacizumab|mesh-list
101583539|NCT00973479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101583548|NCT00973479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101583549|NCT01174043|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101583550|NCT01174043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101583551|NCT01174043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101583552|NCT01174043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101583553|NCT01174043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583554|NCT04315493|Maleic acid|maleic acid|mesh-list
101583555|NCT04315493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101583556|NCT04315493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583557|NCT04173871|Snake venom protein C activator|snake venom protein c activator|mesh-list
101583558|NCT04173871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101583559|NCT04173871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101583560|NCT04173871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583561|NCT02862483|Tadalafil|tadalafil|mesh-list
101583562|NCT02862483|Tamsulosin|tamsulosin|mesh-list
101583563|NCT02862483|Vasodilator Agents|vasodilator agents|mesh-ancestor
101583564|NCT02862483|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101583565|NCT02862483|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101583566|NCT02862483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101583567|NCT02862483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583568|NCT02862483|Urological Agents|urological agents|mesh-ancestor
101583569|NCT02862483|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101583570|NCT02862483|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101583571|NCT02862483|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101583572|NCT02862483|Adrenergic Agents|adrenergic agents|mesh-ancestor
101583573|NCT02862483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101583574|NCT02862483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583575|NCT02667535|Isosorbide|isosorbide|mesh-list
101583576|NCT02667535|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
101583577|NCT02667535|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
101583578|NCT02667535|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101583579|NCT02667535|Diuretics|diuretics|mesh-ancestor
101583580|NCT02667535|Natriuretic Agents|natriuretic agents|mesh-ancestor
101583581|NCT02667535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583582|NCT02667535|Vasodilator Agents|vasodilator agents|mesh-ancestor
101583583|NCT02667535|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101583584|NCT02667535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583585|NCT04286841|Immunomodulating Agents|immunomodulating agents|mesh-list
101583586|NCT04286841|Immunologic Factors|immunologic factors|mesh-ancestor
101282160|NCT01905696|Expectorants|expectorants|mesh-ancestor
101616959|NCT00529113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101616960|NCT04106557|Gaboxadol|gaboxadol|mesh-list
101616961|NCT04106557|Analgesics|analgesics|mesh-ancestor
101282407|NCT01907594|Nicotine|nicotine|mesh-list
101616962|NCT04106557|Sensory System Agents|sensory system agents|mesh-ancestor
101282467|NCT01907984|Diclofenac|diclofenac|mesh-list
101616963|NCT04106557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101616964|NCT04106557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616966|NCT04106557|GABA Agonists|gaba agonists|mesh-ancestor
101616967|NCT04106557|GABA Agents|gaba agents|mesh-ancestor
101616968|NCT04106557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101282834|NCT01910415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101282908|NCT01910766|Vitamins|vitamins|mesh-ancestor
101415714|NCT00502099|Ribavirin|ribavirin|mesh-list
101583587|NCT04286841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583588|NCT00645151|Atorvastatin|atorvastatin|mesh-list
101583589|NCT00645151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101583590|NCT00645151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101583591|NCT00645151|Antimetabolites|antimetabolites|mesh-ancestor
101583592|NCT00645151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583593|NCT00645151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101583594|NCT00645151|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101583595|NCT00645151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101583596|NCT00645229|Ziprasidone|ziprasidone|mesh-list
101583597|NCT00645229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101583598|NCT00645229|Serotonin Agents|serotonin agents|mesh-ancestor
101583599|NCT00645229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101583600|NCT00645229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583601|NCT00645229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583602|NCT00645229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101583603|NCT00645229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101583604|NCT00645229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101583629|NCT00645307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101583630|NCT00645307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101583631|NCT00645307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101583632|NCT00645307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583633|NCT00645307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101583634|NCT00645307|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101583635|NCT00645307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101583636|NCT00645307|Serotonin Agents|serotonin agents|mesh-ancestor
101583637|NCT00645307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101583638|NCT00645307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583639|NCT00645307|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101583640|NCT00645307|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101583641|NCT00645307|Dopamine Agents|dopamine agents|mesh-ancestor
101583643|NCT02668861|Budesonide|budesonide|mesh-list
101583644|NCT02668861|Vitamins|vitamins|mesh-ancestor
101583645|NCT02668861|Micronutrients|micronutrients|mesh-ancestor
101583646|NCT02668861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583647|NCT02668861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101583648|NCT02668861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101583649|NCT02668861|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101583650|NCT02668861|Autonomic Agents|autonomic agents|mesh-ancestor
101583651|NCT02668861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101583652|NCT02668861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101583653|NCT02668861|Respiratory System Agents|respiratory system agents|mesh-ancestor
101583663|NCT00968253|Prednisolone acetate|prednisolone acetate|mesh-list
101583665|NCT00968253|Doxorubicin|doxorubicin|mesh-list
101583666|NCT00968253|Methotrexate|methotrexate|mesh-list
101583667|NCT00968253|Vincristine|vincristine|mesh-list
101583668|NCT00968253|Everolimus|everolimus|mesh-list
101583669|NCT00968253|Lenograstim|lenograstim|mesh-list
101616969|NCT04106557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616970|NCT04117750|Cholecalciferol|cholecalciferol|mesh-list
101616972|NCT04117750|Calcium Carbonate|calcium carbonate|mesh-list
101616973|NCT04117750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101616974|NCT04117750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616975|NCT04117750|Vitamins|vitamins|mesh-ancestor
101616976|NCT04117750|Micronutrients|micronutrients|mesh-ancestor
101616977|NCT04117750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101616978|NCT04117750|Antacids|antacids|mesh-ancestor
101283201|NCT01912586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101283348|NCT01913444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101283423|NCT01914042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101283501|NCT01914692|Somatostatin|somatostatin|mesh-list
101616979|NCT04117750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616980|NCT04117750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101616981|NCT04131322|Adalimumab|adalimumab|mesh-list
101616982|NCT04131322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101616983|NCT04131322|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101616984|NCT04131322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101616985|NCT04131322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101616987|NCT02840175|Etanercept|etanercept|mesh-list
101616988|NCT02840175|Abatacept|abatacept|mesh-list
101616989|NCT02840175|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101284088|NCT01918098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101284162|NCT01918384|Arbekacin|arbekacin|mesh-list
101616990|NCT02840175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101284236|NCT01918865|Metformin|metformin|mesh-list
101616991|NCT02840175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101284463|NCT01921374|Estrogens|estrogens|mesh-ancestor
101284539|NCT01927640|Cocaine|cocaine|mesh-list
101415727|NCT00502138|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
101583670|NCT00968253|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101583671|NCT00968253|Prednisolone phosphate|prednisolone phosphate|mesh-list
101583672|NCT00968253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101583673|NCT00968253|Immunologic Factors|immunologic factors|mesh-ancestor
101583674|NCT00968253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583675|NCT00968253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101583676|NCT00968253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101583677|NCT00968253|Alkylating Agents|alkylating agents|mesh-ancestor
101583678|NCT00968253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583679|NCT00968253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101583680|NCT00968253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101583681|NCT00968253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101583682|NCT00968253|Antiemetics|antiemetics|mesh-ancestor
101583683|NCT00968253|Autonomic Agents|autonomic agents|mesh-ancestor
101583684|NCT00968253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101583685|NCT00968253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101284614|NCT01930292|Mitosis Modulators|mitosis modulators|mesh-ancestor
101616992|NCT02840175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101616993|NCT02840175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101616994|NCT02840175|Analgesics|analgesics|mesh-ancestor
101616995|NCT02840175|Sensory System Agents|sensory system agents|mesh-ancestor
101616996|NCT02840175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101284908|NCT01931683|Analgesics|analgesics|mesh-ancestor
101616997|NCT02840175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616998|NCT02840175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101616999|NCT02840175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101617000|NCT02840175|Immunologic Factors|immunologic factors|mesh-ancestor
101285207|NCT01933997|Pyridoxine|pyridoxine|mesh-list
101285299|NCT01934569|Antimetabolites|antimetabolites|mesh-ancestor
101617001|NCT02840175|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101285357|NCT01934933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101285446|NCT01935505|Bupropion|bupropion|mesh-list
101285504|NCT01935557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101617002|NCT02840175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617003|NCT02840175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101617004|NCT02840175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101617006|NCT02603497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101617007|NCT02603497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617008|NCT02603497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101617009|NCT02603497|Immunologic Factors|immunologic factors|mesh-ancestor
101583686|NCT00968253|Glucocorticoids|glucocorticoids|mesh-ancestor
101583687|NCT00968253|Hormones|hormones|mesh-ancestor
101583688|NCT00968253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101583689|NCT00968253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101583690|NCT00968253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101583691|NCT00968253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101583692|NCT00968253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101583693|NCT00968253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101583694|NCT00968253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101583695|NCT00968253|Abortifacient Agents|abortifacient agents|mesh-ancestor
101583696|NCT00968253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101583697|NCT00968253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101583698|NCT00968253|Antimetabolites|antimetabolites|mesh-ancestor
101583699|NCT00968253|Dermatologic Agents|dermatologic agents|mesh-ancestor
101583700|NCT00968253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101583701|NCT00968253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101583702|NCT00968253|Antiviral Agents|antiviral agents|mesh-ancestor
101583703|NCT00968253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101583704|NCT00968253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101583705|NCT00968253|Tubulin Modulators|tubulin modulators|mesh-ancestor
101583706|NCT00968253|Antimitotic Agents|antimitotic agents|mesh-ancestor
101583707|NCT00968253|Mitosis Modulators|mitosis modulators|mesh-ancestor
101583708|NCT00968253|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101583709|NCT00968253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101583710|NCT00968253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101583711|NCT00968253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101617011|NCT02840409|Bevacizumab|bevacizumab|mesh-list
101617012|NCT02840409|Vinblastine|vinblastine|mesh-list
101617013|NCT02840409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101617014|NCT02840409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101617015|NCT02840409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101617016|NCT02840409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101583712|NCT00968253|Protective Agents|protective agents|mesh-ancestor
101583713|NCT00646009|Fluticasone|fluticasone|mesh-list
101583714|NCT00646009|Budesonide|budesonide|mesh-list
101583715|NCT00646009|Albuterol|albuterol|mesh-list
101583716|NCT00646009|Formoterol Fumarate|formoterol fumarate|mesh-list
101583717|NCT00646009|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101583718|NCT00646009|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101583719|NCT00646009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101583720|NCT00646009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101583721|NCT00646009|Autonomic Agents|autonomic agents|mesh-ancestor
101583732|NCT00646009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101583733|NCT00646009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101583734|NCT00646009|Adrenergic Agents|adrenergic agents|mesh-ancestor
101583735|NCT00646009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101583736|NCT00646009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583737|NCT00646009|Tocolytic Agents|tocolytic agents|mesh-ancestor
101583738|NCT00646009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101583739|NCT00646009|Sympathomimetics|sympathomimetics|mesh-ancestor
101583740|NCT00646087|Ketamine|ketamine|mesh-list
101583741|NCT00646087|Analgesics|analgesics|mesh-ancestor
101583742|NCT00646087|Sensory System Agents|sensory system agents|mesh-ancestor
101583743|NCT00646087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101583744|NCT00646087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583745|NCT00646087|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101583746|NCT00646087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101583747|NCT00646087|Anesthetics, General|anesthetics, general|mesh-ancestor
101583748|NCT00646087|Anesthetics|anesthetics|mesh-ancestor
101583749|NCT00646087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101583750|NCT00646087|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101583751|NCT00646087|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101583752|NCT00646087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101583753|NCT00646087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583754|NCT04255576|Vitamin D|vitamin d|mesh-list
101583755|NCT04255576|Calcium|calcium|mesh-list
101583756|NCT04255576|Vitamins|vitamins|mesh-ancestor
101583757|NCT04255576|Micronutrients|micronutrients|mesh-ancestor
101583758|NCT04255576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583759|NCT04255576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101583760|NCT04255576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101583761|NCT04255498|Etanercept|etanercept|mesh-list
101583762|NCT04255498|Mifepristone|mifepristone|mesh-list
101583763|NCT04255498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101583764|NCT04255498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101583765|NCT04255498|Analgesics|analgesics|mesh-ancestor
101583766|NCT04255498|Sensory System Agents|sensory system agents|mesh-ancestor
101583767|NCT04255498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101583768|NCT04255498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583769|NCT04255498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101583770|NCT04255498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101583771|NCT04255498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101583772|NCT04255498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101583773|NCT04255498|Immunologic Factors|immunologic factors|mesh-ancestor
101583774|NCT04255498|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101583775|NCT04255498|Abortifacient Agents|abortifacient agents|mesh-ancestor
101583776|NCT04255498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101583777|NCT04255498|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101583778|NCT04255498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101583779|NCT04255498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101583780|NCT04255498|Contraceptive Agents|contraceptive agents|mesh-ancestor
101583781|NCT04255498|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101583782|NCT04255498|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101617017|NCT02840409|Growth Substances|growth substances|mesh-ancestor
101617018|NCT02840409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617019|NCT02840409|Growth Inhibitors|growth inhibitors|mesh-ancestor
101617020|NCT02840409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101617021|NCT02840409|Tubulin Modulators|tubulin modulators|mesh-ancestor
101285862|NCT01937728|Interferons|interferons|mesh-list
101617022|NCT02840409|Antimitotic Agents|antimitotic agents|mesh-ancestor
101617023|NCT02840409|Mitosis Modulators|mitosis modulators|mesh-ancestor
101286166|NCT01939483|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101583783|NCT04255498|Hormone Antagonists|hormone antagonists|mesh-ancestor
101583795|NCT02666209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583796|NCT02666209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101583797|NCT02666209|Glucocorticoids|glucocorticoids|mesh-ancestor
101583798|NCT02666209|Hormones|hormones|mesh-ancestor
101583799|NCT02666209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101583800|NCT02666209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101583801|NCT02666209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101583802|NCT02666209|Immunologic Factors|immunologic factors|mesh-ancestor
101583803|NCT02666209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101583804|NCT02666209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101583805|NCT02666209|Growth Substances|growth substances|mesh-ancestor
101583806|NCT02666209|Growth Inhibitors|growth inhibitors|mesh-ancestor
101583807|NCT00964743|Cytarabine|cytarabine|mesh-list
101583808|NCT00964743|Sorafenib|sorafenib|mesh-list
101583809|NCT00964743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101583810|NCT00964743|Antimetabolites|antimetabolites|mesh-ancestor
101583811|NCT00964743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583812|NCT00964743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101583813|NCT00964743|Antiviral Agents|antiviral agents|mesh-ancestor
101583814|NCT00964743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101583815|NCT00964743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101583816|NCT00964743|Immunologic Factors|immunologic factors|mesh-ancestor
101583817|NCT00964743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583818|NCT00964743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101583819|NCT00964743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101583820|NCT02862327|Dexamethasone|dexamethasone|mesh-list
101583821|NCT02862327|Dexamethasone acetate|dexamethasone acetate|mesh-list
101583822|NCT02862327|Ropivacaine|ropivacaine|mesh-list
101583823|NCT02862327|BB 1101|bb 1101|mesh-list
101583824|NCT02862327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101583825|NCT02862327|Antiemetics|antiemetics|mesh-ancestor
101583826|NCT02862327|Autonomic Agents|autonomic agents|mesh-ancestor
101583827|NCT02862327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101240689|NCT01623362|Protective Agents|protective agents|mesh-ancestor
101583828|NCT02862327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583829|NCT02862327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101583830|NCT02862327|Glucocorticoids|glucocorticoids|mesh-ancestor
101583831|NCT02862327|Hormones|hormones|mesh-ancestor
101583832|NCT02862327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101583833|NCT02862327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101583834|NCT02862327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101583835|NCT02862327|Protease Inhibitors|protease inhibitors|mesh-ancestor
101583836|NCT02862327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101583837|NCT02862327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583838|NCT02862327|Anesthetics, Local|anesthetics, local|mesh-ancestor
101583839|NCT02862327|Anesthetics|anesthetics|mesh-ancestor
101583840|NCT02862327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101583841|NCT02862327|Sensory System Agents|sensory system agents|mesh-ancestor
101583842|NCT04945720|Durvalumab|durvalumab|mesh-list
101583843|NCT04945720|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101583844|NCT04945720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101583845|NCT04945720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101583846|NCT04945720|Immunologic Factors|immunologic factors|mesh-ancestor
101583847|NCT04945720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583884|NCT00646711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101617024|NCT02840409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617025|NCT02839941|Mycophenolic Acid|mycophenolic acid|mesh-list
101617026|NCT02839941|Tacrolimus|tacrolimus|mesh-list
101617027|NCT02839941|Glucocorticoids|glucocorticoids|mesh-list
101617028|NCT02839941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101617029|NCT02839941|Immunologic Factors|immunologic factors|mesh-ancestor
101617030|NCT02839941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617031|NCT02839941|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101617032|NCT02839941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101286982|NCT01944215|Purinergic Agents|purinergic agents|mesh-ancestor
101617033|NCT02839941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287206|NCT05410093|Antioxidants|antioxidants|mesh-ancestor
101617034|NCT02839941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101287283|NCT04773392|Hormones|hormones|mesh-ancestor
101617037|NCT02839941|Antitubercular Agents|antitubercular agents|mesh-ancestor
101617038|NCT02839941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101617039|NCT02839941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101617040|NCT02839941|Hormones|hormones|mesh-ancestor
101287797|NCT03581370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101617041|NCT02839941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101617042|NCT02842983|Esmolol|esmolol|mesh-list
101617043|NCT02842983|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101287947|NCT00712322|Darifenacin|darifenacin|mesh-list
101617044|NCT02842983|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101617045|NCT02842983|Adrenergic Agents|adrenergic agents|mesh-ancestor
101288173|NCT04641234|Aflibercept|aflibercept|mesh-list
101617046|NCT02842983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101288398|NCT02238496|Immunologic Factors|immunologic factors|mesh-ancestor
101617047|NCT02842983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583885|NCT00646711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583915|NCT00918736|Viscosupplements|viscosupplements|mesh-ancestor
101583916|NCT00918736|Protective Agents|protective agents|mesh-ancestor
101583917|NCT02666053|Fostemsavir|fostemsavir|mesh-list
101583918|NCT02666053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101583919|NCT02666053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101583920|NCT02666053|Antiviral Agents|antiviral agents|mesh-ancestor
101583921|NCT02666053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101583922|NCT02666053|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101583923|NCT02666053|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101583924|NCT02666053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583925|NCT04257838|Meropenem|meropenem|mesh-list
101583926|NCT04257838|Tazobactam|tazobactam|mesh-list
101583927|NCT04257838|Piperacillin|piperacillin|mesh-list
101583928|NCT04257838|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101583929|NCT04257838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101583930|NCT04257838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101583936|NCT01172639|Methotrexate|methotrexate|mesh-list
101288547|NCT01946399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101288625|NCT01946984|Diclofenac|diclofenac|mesh-list
101617048|NCT02842983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617049|NCT02842983|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101617050|NCT02839785|Ibuprofen|ibuprofen|mesh-list
101288844|NCT01948336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101617051|NCT02839785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101583937|NCT01172639|Leflunomide|leflunomide|mesh-list
101583938|NCT01172639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101583939|NCT01172639|Glucocorticoids|glucocorticoids|mesh-ancestor
101583940|NCT01172639|Hormones|hormones|mesh-ancestor
101583941|NCT01172639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101583942|NCT01172639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583943|NCT01172639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101583944|NCT01172639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101583945|NCT01172639|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101583946|NCT01172639|Abortifacient Agents|abortifacient agents|mesh-ancestor
101583947|NCT01172639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101583948|NCT01172639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101583949|NCT01172639|Antimetabolites|antimetabolites|mesh-ancestor
101583950|NCT01172639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583951|NCT01172639|Dermatologic Agents|dermatologic agents|mesh-ancestor
101583952|NCT01172639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101583953|NCT01172639|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101583954|NCT01172639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101583955|NCT01172639|Immunologic Factors|immunologic factors|mesh-ancestor
101583956|NCT01172639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101583957|NCT01172639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101583958|NCT01172639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101583959|NCT01172639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101583960|NCT01172639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101583961|NCT01172639|Analgesics|analgesics|mesh-ancestor
101583962|NCT01172639|Sensory System Agents|sensory system agents|mesh-ancestor
101583963|NCT01172639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101583964|NCT01172639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101583965|NCT01225562|Ticagrelor|ticagrelor|mesh-list
101583966|NCT01225562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101583967|NCT01225562|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101583968|NCT01225562|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101583969|NCT01225562|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101583970|NCT01225562|Purinergic Agents|purinergic agents|mesh-ancestor
101583971|NCT01225562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101583972|NCT01225562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583973|NCT01225562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583974|NCT00925288|Vaccines|vaccines|mesh-list
101240855|NCT01624246|Avibactam|avibactam|mesh-list
101583975|NCT00925288|Immunologic Factors|immunologic factors|mesh-ancestor
101583976|NCT00925288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583977|NCT01143714|Petrolatum|petrolatum|mesh-list
101583978|NCT01143714|Emollients|emollients|mesh-ancestor
101583979|NCT01143714|Dermatologic Agents|dermatologic agents|mesh-ancestor
101583980|NCT04920682|Iodine|iodine|mesh-list
101583981|NCT04920682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101583982|NCT04920682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101583983|NCT04920682|Trace Elements|trace elements|mesh-ancestor
101583984|NCT04920682|Micronutrients|micronutrients|mesh-ancestor
101583985|NCT04920682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583986|NCT04174339|Apatinib|apatinib|mesh-list
101583987|NCT04174339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101583988|NCT04174339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101583989|NCT04174339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101583990|NCT04174339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583991|NCT00972543|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101583992|NCT00972543|Immunologic Factors|immunologic factors|mesh-ancestor
101583993|NCT00972543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583994|NCT00925132|Temozolomide|temozolomide|mesh-list
101583995|NCT00925132|Decitabine|decitabine|mesh-list
101583996|NCT00925132|Panobinostat|panobinostat|mesh-list
101617052|NCT02839785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101617053|NCT02839785|Analgesics|analgesics|mesh-ancestor
101617054|NCT02839785|Sensory System Agents|sensory system agents|mesh-ancestor
101617055|NCT02839785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101289292|NCT01951209|Rifaximin|rifaximin|mesh-list
101617056|NCT02839785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617057|NCT02839785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101617058|NCT02839785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101617059|NCT02839785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101617060|NCT02839785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101289360|NCT01951560|Valproic Acid|valproic acid|mesh-list
101617061|NCT02839785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617062|NCT02843061|Rituximab|rituximab|mesh-list
101415831|NCT00503152|Valsartan|valsartan|mesh-list
101583997|NCT00925132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101583998|NCT00925132|Alkylating Agents|alkylating agents|mesh-ancestor
101264243|NCT01766518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101584022|NCT00646945|Anesthetics|anesthetics|mesh-ancestor
101584023|NCT00646945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101584024|NCT00646945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584025|NCT00646945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101584026|NCT00646945|Analgesics|analgesics|mesh-ancestor
101584027|NCT00646945|Sensory System Agents|sensory system agents|mesh-ancestor
101584028|NCT00646945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101584029|NCT00629889|Pregabalin|pregabalin|mesh-list
101584030|NCT00629889|Levetiracetam|levetiracetam|mesh-list
101584031|NCT00629889|Analgesics|analgesics|mesh-ancestor
101584032|NCT00629889|Sensory System Agents|sensory system agents|mesh-ancestor
101584033|NCT00629889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101584034|NCT00629889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584035|NCT00629889|Anticonvulsants|anticonvulsants|mesh-ancestor
101584036|NCT00629889|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101584037|NCT00629889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101584038|NCT00629889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584039|NCT00629889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101584040|NCT00629889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101584041|NCT00629889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101584042|NCT00629889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101584043|NCT00629889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101584044|NCT00629889|Nootropic Agents|nootropic agents|mesh-ancestor
101584045|NCT03381261|Botulinum Toxins|botulinum toxins|mesh-list
101584046|NCT03381261|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101584047|NCT03381261|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101584048|NCT03381261|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101584049|NCT03381261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101584062|NCT02861859|Olanzapine|olanzapine|mesh-list
101584063|NCT02861859|Antiemetics|antiemetics|mesh-ancestor
101584064|NCT02861859|Autonomic Agents|autonomic agents|mesh-ancestor
101584065|NCT02861859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101330169|NCT00029497|Adrenergic Agents|adrenergic agents|mesh-ancestor
101584066|NCT02861859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584067|NCT02861859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101584068|NCT02861859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101584069|NCT02861859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101584070|NCT02861859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101584071|NCT02861859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101584072|NCT02861859|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101584073|NCT02861859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101584074|NCT02861859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101584075|NCT02861859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584076|NCT02861859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101584077|NCT02861859|Serotonin Agents|serotonin agents|mesh-ancestor
101617063|NCT02843061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101617064|NCT02843061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101617065|NCT02843061|Immunologic Factors|immunologic factors|mesh-ancestor
101617066|NCT02843061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617067|NCT02843061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101617068|NCT02839239|Vitamin D|vitamin d|mesh-list
101617069|NCT02839239|Ergocalciferols|ergocalciferols|mesh-list
101617070|NCT02839239|Cholecalciferol|cholecalciferol|mesh-list
101617071|NCT02839239|Vitamins|vitamins|mesh-list
101584078|NCT00647023|Metformin|metformin|mesh-list
101584079|NCT00647023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101584080|NCT00647023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584081|NCT00924898|Tenofovir|tenofovir|mesh-list
101584082|NCT00924898|Emtricitabine|emtricitabine|mesh-list
101584083|NCT00924898|Efavirenz|efavirenz|mesh-list
101584084|NCT00924898|Antiviral Agents|antiviral agents|mesh-ancestor
101584085|NCT00924898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101584086|NCT00924898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101584087|NCT00924898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101584088|NCT00924898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101584089|NCT00924898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584090|NCT00924898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101584091|NCT00924898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101584092|NCT00924898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101584093|NCT00924898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101584094|NCT00924898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101584095|NCT00924898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101584096|NCT00924898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101584097|NCT00924898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101584098|NCT01167192|Carboplatin|carboplatin|mesh-list
101584099|NCT01167192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101584100|NCT00646321|Budesonide|budesonide|mesh-list
101584101|NCT00646321|Formoterol Fumarate|formoterol fumarate|mesh-list
101584102|NCT00646321|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101584103|NCT00646321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101584104|NCT00646321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101584105|NCT00646321|Autonomic Agents|autonomic agents|mesh-ancestor
101584106|NCT00646321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101584107|NCT00646321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584108|NCT00646321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101584109|NCT00646321|Respiratory System Agents|respiratory system agents|mesh-ancestor
101584125|NCT01166958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584126|NCT01166958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101584127|NCT01166958|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101584128|NCT01166958|Hormone Antagonists|hormone antagonists|mesh-ancestor
101584129|NCT01166958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101330181|NCT00000494|Tocolytic Agents|tocolytic agents|mesh-ancestor
101584130|NCT01166958|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101584131|NCT01166958|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101584132|NCT01170221|Linezolid|linezolid|mesh-list
101584133|NCT01170221|Tedizolid phosphate|tedizolid phosphate|mesh-list
101584134|NCT01170221|Tedizolid|tedizolid|mesh-list
101584135|NCT01170221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101584136|NCT01170221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101584137|NCT01170221|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101584138|NCT01170221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101584139|NCT01170221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584140|NCT04254640|Cytarabine|cytarabine|mesh-list
101584141|NCT04254640|Cladribine|cladribine|mesh-list
101584142|NCT04254640|Aclarubicin|aclarubicin|mesh-list
101584143|NCT04254640|Lenograstim|lenograstim|mesh-list
101584144|NCT04254640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101584145|NCT04254640|Antimetabolites|antimetabolites|mesh-ancestor
101584146|NCT04254640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584147|NCT04254640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101584148|NCT04254640|Antiviral Agents|antiviral agents|mesh-ancestor
101584149|NCT04254640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101617073|NCT02839239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617074|NCT02839239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101617075|NCT02839239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101617076|NCT02837835|Ceftazidime|ceftazidime|mesh-list
101617077|NCT02837835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101289938|NCT05786040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101617078|NCT02837835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101617079|NCT02839161|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101617080|NCT02839161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101617081|NCT02839161|Immunologic Factors|immunologic factors|mesh-ancestor
101415855|NCT00503503|Etanercept|etanercept|mesh-list
101584150|NCT04254640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101584151|NCT04254640|Immunologic Factors|immunologic factors|mesh-ancestor
101584152|NCT04254640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584153|NCT04254640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101584154|NCT04254640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101584155|NCT04254640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101584156|NCT04254640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101584157|NCT04254640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101584158|NCT01166646|Clobetasol|clobetasol|mesh-list
101584159|NCT01166646|Halobetasol|halobetasol|mesh-list
101584160|NCT01166646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101584161|NCT01166646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101584162|NCT01166646|Glucocorticoids|glucocorticoids|mesh-ancestor
101584163|NCT01166646|Hormones|hormones|mesh-ancestor
101584164|NCT01166646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101584165|NCT01166646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584186|NCT00924820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101584187|NCT00924820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101584188|NCT00924820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101584189|NCT00924820|Growth Substances|growth substances|mesh-ancestor
101584190|NCT00924820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584191|NCT00924820|Growth Inhibitors|growth inhibitors|mesh-ancestor
101584192|NCT01225172|Letrozole|letrozole|mesh-list
101584193|NCT01225172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101584194|NCT01225172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101584195|NCT01225172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101584196|NCT01225172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101584197|NCT01225172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584198|NCT01225172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101584199|NCT01225172|Hormone Antagonists|hormone antagonists|mesh-ancestor
101584200|NCT01225172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101584201|NCT01225172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584202|NCT02665039|Carboplatin|carboplatin|mesh-list
101584203|NCT02665039|Gemcitabine|gemcitabine|mesh-list
101584204|NCT02665039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330194|NCT00012519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101584205|NCT02665039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101584206|NCT02665039|Antimetabolites|antimetabolites|mesh-ancestor
101584207|NCT02665039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584208|NCT00647491|Adalimumab|adalimumab|mesh-list
101584209|NCT00647491|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101584210|NCT00647491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101584211|NCT00647491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101584212|NCT04252456|Leucovorin|leucovorin|mesh-list
101584213|NCT04252456|Folic Acid|folic acid|mesh-list
101584214|NCT04252456|Fluorouracil|fluorouracil|mesh-list
101584215|NCT04252456|Aflibercept|aflibercept|mesh-list
101584216|NCT04252456|Levoleucovorin|levoleucovorin|mesh-list
101584217|NCT04252456|Antimetabolites|antimetabolites|mesh-ancestor
101584218|NCT04252456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584236|NCT02665351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101617082|NCT02839161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617083|NCT02839161|Antacids|antacids|mesh-ancestor
101617084|NCT02839161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617085|NCT02839161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101617086|NCT04249713|Brodalumab|brodalumab|mesh-list
101617087|NCT04249713|Dermatologic Agents|dermatologic agents|mesh-ancestor
101617088|NCT00610506|Dexetimide|dexetimide|mesh-list
101617089|NCT00610506|Citalopram|citalopram|mesh-list
101617090|NCT00610506|Escitalopram|escitalopram|mesh-list
101584237|NCT02665351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101584238|NCT02665351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584239|NCT01222520|Amlodipine|amlodipine|mesh-list
101584240|NCT01222520|Telmisartan|telmisartan|mesh-list
101584241|NCT01222520|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
101584242|NCT01222520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101584243|NCT01222520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101584244|NCT01222520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101584245|NCT01222520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584246|NCT01222520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101584247|NCT01222520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584248|NCT01222520|Vasodilator Agents|vasodilator agents|mesh-ancestor
101584249|NCT01222520|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101584250|NCT01222520|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101584251|NCT01221350|Thioctic Acid|thioctic acid|mesh-list
101584252|NCT01221350|Antioxidants|antioxidants|mesh-ancestor
101584253|NCT01221350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584254|NCT01221350|Protective Agents|protective agents|mesh-ancestor
101584255|NCT01221350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584256|NCT01221350|Vitamin B Complex|vitamin b complex|mesh-ancestor
101584257|NCT01221350|Vitamins|vitamins|mesh-ancestor
101584258|NCT01221350|Micronutrients|micronutrients|mesh-ancestor
101584259|NCT00647647|Terbinafine|terbinafine|mesh-list
101584260|NCT00647647|Antifungal Agents|antifungal agents|mesh-ancestor
101584261|NCT00647647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101584262|NCT00647647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101584263|NCT00647647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584264|NCT01221272|Ranolazine|ranolazine|mesh-list
101584265|NCT01221272|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101584266|NCT01221272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101584267|NCT01221272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584268|NCT01220414|Naltrexone|naltrexone|mesh-list
101584269|NCT01220414|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101584270|NCT01220414|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101584271|NCT01220414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584272|NCT01220414|Sensory System Agents|sensory system agents|mesh-ancestor
101584273|NCT01220414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101584275|NCT01128894|rGLP-1 protein|rglp-1 protein|mesh-list
101584276|NCT01128894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101584277|NCT01128894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584278|NCT01128894|Incretins|incretins|mesh-ancestor
101584279|NCT01128894|Hormones|hormones|mesh-ancestor
101584307|NCT01143090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101584308|NCT01143090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584309|NCT01143090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101584310|NCT01143090|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101584311|NCT01143090|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101584312|NCT01143090|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101584313|NCT01143090|Adrenergic Agents|adrenergic agents|mesh-ancestor
101584314|NCT01143090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101584315|NCT01143090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584316|NCT01143090|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101584317|NCT01143090|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101584318|NCT01143090|Serotonin Agents|serotonin agents|mesh-ancestor
101584319|NCT01143090|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101584320|NCT01143090|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101584321|NCT01143090|Dopamine Agents|dopamine agents|mesh-ancestor
101617091|NCT00610506|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101617092|NCT00610506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101617093|NCT00610506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101617094|NCT00610506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617095|NCT00610506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101617096|NCT00610506|Serotonin Agents|serotonin agents|mesh-ancestor
101617097|NCT00610506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617098|NCT00610506|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101617099|NCT00610506|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101584341|NCT01218308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584342|NCT02887976|Methylprednisolone|methylprednisolone|mesh-list
101584343|NCT02887976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101584344|NCT02887976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101584345|NCT02887976|Prednisolone|prednisolone|mesh-list
101584346|NCT02887976|Prednisolone acetate|prednisolone acetate|mesh-list
101584347|NCT02887976|Abiraterone Acetate|abiraterone acetate|mesh-list
101584348|NCT02887976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101584349|NCT02887976|Prednisolone phosphate|prednisolone phosphate|mesh-list
101584350|NCT02887976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101584351|NCT02887976|Antiemetics|antiemetics|mesh-ancestor
101584352|NCT02887976|Autonomic Agents|autonomic agents|mesh-ancestor
101584353|NCT02887976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101584354|NCT02887976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584355|NCT02887976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101264259|NCT01766609|Hormones|hormones|mesh-ancestor
101584356|NCT02887976|Glucocorticoids|glucocorticoids|mesh-ancestor
101584357|NCT02887976|Hormones|hormones|mesh-ancestor
101584358|NCT02887976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101584359|NCT02887976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101584360|NCT02887976|Protective Agents|protective agents|mesh-ancestor
101584361|NCT02887976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101584362|NCT02887976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101584363|NCT02887976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101584364|NCT02887976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101584365|NCT02887976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584366|NCT02887976|Hormone Antagonists|hormone antagonists|mesh-ancestor
101584367|NCT02887976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101584368|NCT01165320|Caspofungin|caspofungin|mesh-list
101584369|NCT01165320|Antifungal Agents|antifungal agents|mesh-ancestor
101584370|NCT01165320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101584371|NCT01165320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330208|NCT00029770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101584372|NCT01165320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584373|NCT01217606|Timolol|timolol|mesh-list
101584378|NCT01217606|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101584379|NCT01217606|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101584380|NCT01217606|Adrenergic Agents|adrenergic agents|mesh-ancestor
101584381|NCT01217606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101584382|NCT01217606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584383|NCT01217606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584384|NCT01217606|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101584385|NCT01217606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101584386|NCT01217606|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101584387|NCT01217606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101584388|NCT01217606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101584389|NCT01128114|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101584390|NCT01128114|Antidepressive Agents|antidepressive agents|mesh-ancestor
101584391|NCT01128114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101584392|NCT01128114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101584393|NCT01128114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101584394|NCT01128114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101584395|NCT01128114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584396|NCT01217060|Dexamethasone|dexamethasone|mesh-list
101584397|NCT01217060|Docetaxel|docetaxel|mesh-list
101290441|NCT04006210|Carbidopa|carbidopa|mesh-list
101617100|NCT00610506|Parasympatholytics|parasympatholytics|mesh-ancestor
101617101|NCT00610506|Autonomic Agents|autonomic agents|mesh-ancestor
101617102|NCT00610506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101617103|NCT00610506|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101617104|NCT00610506|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101617105|NCT00610506|Cholinergic Agents|cholinergic agents|mesh-ancestor
101415883|NCT00503542|Hormone Antagonists|hormone antagonists|mesh-ancestor
101584398|NCT01217060|Fluorouracil|fluorouracil|mesh-list
101584399|NCT01217060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101584400|NCT01217060|Antiemetics|antiemetics|mesh-ancestor
101584401|NCT01217060|Autonomic Agents|autonomic agents|mesh-ancestor
101584402|NCT01217060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101584403|NCT01217060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584404|NCT01217060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101584405|NCT01217060|Glucocorticoids|glucocorticoids|mesh-ancestor
101584406|NCT01217060|Hormones|hormones|mesh-ancestor
101584407|NCT01217060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101584408|NCT01217060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101584409|NCT01217060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101584410|NCT01217060|Tubulin Modulators|tubulin modulators|mesh-ancestor
101584411|NCT01217060|Antimitotic Agents|antimitotic agents|mesh-ancestor
101584412|NCT01217060|Mitosis Modulators|mitosis modulators|mesh-ancestor
101584413|NCT01217060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584414|NCT01217060|Antimetabolites|antimetabolites|mesh-ancestor
101584415|NCT01217060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101584416|NCT01217060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101584417|NCT01217060|Immunologic Factors|immunologic factors|mesh-ancestor
101584418|NCT01170065|Nintedanib|nintedanib|mesh-list
101584419|NCT01170065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101584420|NCT01170065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101584421|NCT01170065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101584422|NCT01170065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584423|NCT02885922|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101584424|NCT02885922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584426|NCT00966693|Dexamethasone|dexamethasone|mesh-list
101584427|NCT00966693|Dexamethasone acetate|dexamethasone acetate|mesh-list
101584428|NCT00966693|Lenalidomide|lenalidomide|mesh-list
101584429|NCT00966693|Ichthammol|ichthammol|mesh-list
101584430|NCT00966693|BB 1101|bb 1101|mesh-list
101584432|NCT00966693|Antiemetics|antiemetics|mesh-ancestor
101584433|NCT00966693|Autonomic Agents|autonomic agents|mesh-ancestor
101584434|NCT00966693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101584435|NCT00966693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584436|NCT00966693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101584437|NCT00966693|Glucocorticoids|glucocorticoids|mesh-ancestor
101584438|NCT00966693|Hormones|hormones|mesh-ancestor
101584439|NCT00966693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101584440|NCT00966693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101584441|NCT00966693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101584442|NCT00966693|Immunologic Factors|immunologic factors|mesh-ancestor
101584443|NCT00966693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101584444|NCT00966693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101584445|NCT00966693|Growth Substances|growth substances|mesh-ancestor
101584446|NCT00966693|Growth Inhibitors|growth inhibitors|mesh-ancestor
101584447|NCT00966693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101584483|NCT02664493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101584484|NCT02664493|Antiemetics|antiemetics|mesh-ancestor
101584485|NCT02664493|Autonomic Agents|autonomic agents|mesh-ancestor
101584486|NCT02664493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101584487|NCT02664493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584488|NCT02664493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101584489|NCT02664493|Glucocorticoids|glucocorticoids|mesh-ancestor
101584491|NCT02664493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101584492|NCT02664493|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101584493|NCT02664493|Protective Agents|protective agents|mesh-ancestor
101584494|NCT02664493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101584495|NCT02664493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101617106|NCT00610506|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101617107|NCT00610506|Antidepressive Agents|antidepressive agents|mesh-ancestor
101617108|NCT00610506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101617109|NCT04260828|Aspirin|aspirin|mesh-list
101617110|NCT04260828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101617111|NCT04260828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101617112|NCT04260828|Analgesics|analgesics|mesh-ancestor
101617113|NCT04260828|Sensory System Agents|sensory system agents|mesh-ancestor
101617114|NCT04260828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101617115|NCT04260828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617116|NCT04260828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101617117|NCT04260828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101617118|NCT04260828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101617119|NCT04260828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101617120|NCT04260828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617121|NCT04260828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101617122|NCT04260828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101617123|NCT04260828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101617124|NCT04260828|Antipyretics|antipyretics|mesh-ancestor
101617125|NCT00928746|Bromides|bromides|mesh-list
101617126|NCT00928746|Ipratropium|ipratropium|mesh-list
101617127|NCT00928746|Anticonvulsants|anticonvulsants|mesh-ancestor
101617128|NCT00928746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101617129|NCT00928746|Autonomic Agents|autonomic agents|mesh-ancestor
101617130|NCT00928746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101617131|NCT00928746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584496|NCT00963807|Deoxyglucose|deoxyglucose|mesh-list
101584497|NCT00963807|Alovudine|alovudine|mesh-list
101584498|NCT00963807|Dideoxynucleosides|dideoxynucleosides|mesh-list
101584499|NCT00963807|Cisplatin|cisplatin|mesh-list
101584500|NCT00963807|Docetaxel|docetaxel|mesh-list
101584501|NCT00963807|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101584502|NCT00963807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101584503|NCT00963807|Tubulin Modulators|tubulin modulators|mesh-ancestor
101584504|NCT00963807|Antimitotic Agents|antimitotic agents|mesh-ancestor
101584505|NCT00963807|Mitosis Modulators|mitosis modulators|mesh-ancestor
101584507|NCT00963807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101584508|NCT00963807|Antimetabolites|antimetabolites|mesh-ancestor
101584509|NCT00963807|Antiviral Agents|antiviral agents|mesh-ancestor
101584510|NCT00963807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101584511|NCT00963807|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101584512|NCT00963807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101584513|NCT00963807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101584514|NCT01142466|Interferons|interferons|mesh-list
101584515|NCT01142466|Interferon-beta|interferon-beta|mesh-list
101584516|NCT01142466|Interferon beta-1a|interferon beta-1a|mesh-list
101584517|NCT01142466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101584518|NCT01142466|Antiviral Agents|antiviral agents|mesh-ancestor
101584519|NCT01142466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101584520|NCT01142466|Immunologic Factors|immunologic factors|mesh-ancestor
101584521|NCT01142466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617132|NCT00928746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101617133|NCT00928746|Respiratory System Agents|respiratory system agents|mesh-ancestor
101617134|NCT00928746|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101617135|NCT00928746|Cholinergic Agents|cholinergic agents|mesh-ancestor
101290588|NCT03337087|Vitamins|vitamins|mesh-ancestor
101617136|NCT00928746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101290709|NCT02866747|Durvalumab|durvalumab|mesh-list
101617137|NCT00928746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617138|NCT04468815|Esomeprazole|esomeprazole|mesh-list
101617139|NCT04468815|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101290861|NCT02106572|Viscum album peptide|viscum album peptide|mesh-list
101617140|NCT04468815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101617141|NCT04468815|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101617142|NCT04468815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101584522|NCT01142466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101584523|NCT00648505|Metformin|metformin|mesh-list
101584524|NCT00648505|Glipizide|glipizide|mesh-list
101584525|NCT00648505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101584526|NCT00648505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584527|NCT01215734|Vaccines|vaccines|mesh-list
101584528|NCT01215734|Immunologic Factors|immunologic factors|mesh-ancestor
101584529|NCT01215734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584530|NCT04172311|Levetiracetam|levetiracetam|mesh-list
101584531|NCT04172311|Anticonvulsants|anticonvulsants|mesh-ancestor
101584532|NCT04172311|Nootropic Agents|nootropic agents|mesh-ancestor
101584533|NCT02863185|Atorvastatin|atorvastatin|mesh-list
101584534|NCT02863185|Pitavastatin|pitavastatin|mesh-list
101584535|NCT02863185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101584536|NCT02863185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101584537|NCT02863185|Antimetabolites|antimetabolites|mesh-ancestor
101584538|NCT02863185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584539|NCT02863185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101584540|NCT02863185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101584541|NCT02863185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101584542|NCT00647881|Paroxetine|paroxetine|mesh-list
101584543|NCT00647881|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101584544|NCT00647881|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101584545|NCT00647881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101584546|NCT00647881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584547|NCT00647881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101584548|NCT00647881|Serotonin Agents|serotonin agents|mesh-ancestor
101584549|NCT00647881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584550|NCT00647881|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101584551|NCT00647881|Antidepressive Agents|antidepressive agents|mesh-ancestor
101330268|NCT00000500|Aspirin|aspirin|mesh-list
101584552|NCT00647881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101584553|NCT00647881|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101584554|NCT00647881|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101584555|NCT00647881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101584556|NCT04174261|Clopidogrel|clopidogrel|mesh-list
101584565|NCT04174261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584566|NCT00971997|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
101584568|NCT00971997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584569|NCT00910741|Gemcitabine|gemcitabine|mesh-list
101584570|NCT00910741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101584571|NCT00910741|Antimetabolites|antimetabolites|mesh-ancestor
101584572|NCT00910741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584573|NCT00910741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101584574|NCT00647959|Doxycycline|doxycycline|mesh-list
101584575|NCT00647959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101584576|NCT00647959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101584577|NCT00647959|Antimalarials|antimalarials|mesh-ancestor
101291156|NCT01953835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101291230|NCT01954043|Rifampin|rifampin|mesh-list
101617143|NCT04468815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291471|NCT01955421|Gefitinib|gefitinib|mesh-list
101617145|NCT00610584|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101617146|NCT00610584|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101291537|NCT01955759|Sympatholytics|sympatholytics|mesh-ancestor
101291671|NCT01956981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291744|NCT01957436|Mitosis Modulators|mitosis modulators|mesh-ancestor
101617147|NCT00610584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101617148|NCT00610584|Histamine Antagonists|histamine antagonists|mesh-ancestor
101584578|NCT00647959|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101584579|NCT00647959|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101584580|NCT03602235|Ascorbic Acid|ascorbic acid|mesh-list
101584581|NCT03602235|Melphalan|melphalan|mesh-list
101584582|NCT03602235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101584583|NCT03602235|Alkylating Agents|alkylating agents|mesh-ancestor
101584584|NCT03602235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584585|NCT03602235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101584586|NCT03602235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101584587|NCT03602235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101584588|NCT03602235|Immunologic Factors|immunologic factors|mesh-ancestor
101584589|NCT03602235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584590|NCT03602235|Antioxidants|antioxidants|mesh-ancestor
101584591|NCT03602235|Protective Agents|protective agents|mesh-ancestor
101584592|NCT03602235|Vitamins|vitamins|mesh-ancestor
101584593|NCT03602235|Micronutrients|micronutrients|mesh-ancestor
101584594|NCT00648583|Ondansetron|ondansetron|mesh-list
101584595|NCT00648583|Antiemetics|antiemetics|mesh-ancestor
101584596|NCT00648583|Autonomic Agents|autonomic agents|mesh-ancestor
101584597|NCT00648583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101584598|NCT00648583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584599|NCT00648583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101584600|NCT00648583|Antipruritics|antipruritics|mesh-ancestor
101584601|NCT00648583|Dermatologic Agents|dermatologic agents|mesh-ancestor
101584602|NCT00648583|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101584603|NCT00648583|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101584604|NCT00648583|Serotonin Agents|serotonin agents|mesh-ancestor
101584605|NCT00648583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101584606|NCT00648583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584607|NCT03809481|Danaparoid|danaparoid|mesh-list
101584608|NCT03809481|Argatroban|argatroban|mesh-list
101584609|NCT03809481|Antithrombins|antithrombins|mesh-ancestor
101584610|NCT03809481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101584611|NCT03809481|Protease Inhibitors|protease inhibitors|mesh-ancestor
101584612|NCT03809481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101584613|NCT03809481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584614|NCT03809481|Anticoagulants|anticoagulants|mesh-ancestor
101584615|NCT03809481|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101584616|NCT03809481|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101584617|NCT03809481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101584618|NCT00649129|Oxybutynin|oxybutynin|mesh-list
101584619|NCT00649129|Parasympatholytics|parasympatholytics|mesh-ancestor
101584620|NCT00649129|Autonomic Agents|autonomic agents|mesh-ancestor
101584621|NCT00649129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101584627|NCT00649129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584628|NCT00649129|Urological Agents|urological agents|mesh-ancestor
101584629|NCT01127646|Methylphenidate|methylphenidate|mesh-list
101584630|NCT01127646|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101584631|NCT01127646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101584632|NCT01127646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584633|NCT01127646|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101584634|NCT01127646|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101584635|NCT01127646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101617149|NCT00610584|Histamine Agents|histamine agents|mesh-ancestor
101291966|NCT01959152|Imidacloprid|imidacloprid|mesh-list
101617150|NCT00610584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101584636|NCT01127646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584637|NCT01127646|Dopamine Agents|dopamine agents|mesh-ancestor
101584638|NCT01127646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101584639|NCT01127646|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101584640|NCT01127646|Adrenergic Agents|adrenergic agents|mesh-ancestor
101584641|NCT02660047|Liraglutide|liraglutide|mesh-list
101584642|NCT02660047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101584643|NCT02660047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584644|NCT02660047|Incretins|incretins|mesh-ancestor
101584645|NCT02660047|Hormones|hormones|mesh-ancestor
101584646|NCT02660047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101584647|NCT00648661|Dexetimide|dexetimide|mesh-list
101584648|NCT00648661|Citalopram|citalopram|mesh-list
101584649|NCT00648661|Escitalopram|escitalopram|mesh-list
101584655|NCT00648661|Serotonin Agents|serotonin agents|mesh-ancestor
101584656|NCT00648661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584657|NCT00648661|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101584658|NCT00648661|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101584659|NCT00648661|Parasympatholytics|parasympatholytics|mesh-ancestor
101584660|NCT00648661|Autonomic Agents|autonomic agents|mesh-ancestor
101584661|NCT00648661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101584662|NCT00648661|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101584663|NCT00648661|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101584664|NCT00648661|Cholinergic Agents|cholinergic agents|mesh-ancestor
101584665|NCT00648661|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101584666|NCT00648661|Antidepressive Agents|antidepressive agents|mesh-ancestor
101584667|NCT00648661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101330287|NCT00395902|Cinacalcet|cinacalcet|mesh-list
101584668|NCT05367414|Tea Tree Oil|tea tree oil|mesh-list
101584669|NCT05367414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101584670|NCT05367414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101584671|NCT04171687|Clopidogrel|clopidogrel|mesh-list
101584672|NCT04171687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101584673|NCT04171687|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101584674|NCT04171687|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101584675|NCT04171687|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101584676|NCT04171687|Purinergic Agents|purinergic agents|mesh-ancestor
101584677|NCT04171687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101584678|NCT04171687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584679|NCT04171687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584680|NCT00648817|Tenofovir|tenofovir|mesh-list
101584681|NCT00648817|Antiviral Agents|antiviral agents|mesh-ancestor
101584682|NCT00648817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101584683|NCT00648817|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101584684|NCT00648817|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101584685|NCT00648817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101584686|NCT00648817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584687|NCT00648817|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101584688|NCT00648817|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101584695|NCT02663323|Sirolimus|sirolimus|mesh-list
101584696|NCT02663323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101584697|NCT02663323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101584698|NCT02663323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101584699|NCT02663323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101584700|NCT02663323|Antifungal Agents|antifungal agents|mesh-ancestor
101584701|NCT02663323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101584706|NCT01215188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584707|NCT04285281|Gabapentin|gabapentin|mesh-list
101584708|NCT04285281|Analgesics|analgesics|mesh-ancestor
101584709|NCT04285281|Sensory System Agents|sensory system agents|mesh-ancestor
101584710|NCT04285281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101584711|NCT04285281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584712|NCT04285281|Anticonvulsants|anticonvulsants|mesh-ancestor
101584713|NCT04285281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101584714|NCT04285281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101584715|NCT04285281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101584716|NCT04285281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101584717|NCT04285281|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101584718|NCT04285281|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101584719|NCT04285281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101292037|NCT01959477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101617151|NCT00610584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617152|NCT00610584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617153|NCT00894543|Escitalopram|escitalopram|mesh-list
101617154|NCT00894543|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101617155|NCT00894543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101292333|NCT01962363|Protective Agents|protective agents|mesh-ancestor
101617156|NCT00894543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101617157|NCT00894543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292481|NCT01963754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101617159|NCT00894543|Serotonin Agents|serotonin agents|mesh-ancestor
101617160|NCT00894543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617161|NCT00922272|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101292779|NCT01965041|Growth Substances|growth substances|mesh-ancestor
101617162|NCT00922272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101584720|NCT04285281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584721|NCT04285281|Antimanic Agents|antimanic agents|mesh-ancestor
101241600|NCT01629628|Adalimumab|adalimumab|mesh-list
101584722|NCT02659657|Interleukin-2|interleukin-2|mesh-list
101584723|NCT02659657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101584724|NCT02659657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101584725|NCT02659657|Analgesics|analgesics|mesh-ancestor
101584726|NCT02659657|Sensory System Agents|sensory system agents|mesh-ancestor
101330308|NCT00030004|Midazolam|midazolam|mesh-list
101584727|NCT02659657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101584728|NCT02659657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584729|NCT02659891|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101584730|NCT02659891|Immunologic Factors|immunologic factors|mesh-ancestor
101584731|NCT02659891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584732|NCT05438498|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
101584733|NCT05438498|Antiviral Agents|antiviral agents|mesh-ancestor
101584734|NCT05438498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101584736|NCT00648193|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101584737|NCT00648193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101584738|NCT00648193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101584739|NCT00648193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584740|NCT00648193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101584741|NCT00648193|Serotonin Agents|serotonin agents|mesh-ancestor
101584742|NCT00648193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584743|NCT00648193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101584744|NCT00648193|Antidepressive Agents|antidepressive agents|mesh-ancestor
101584745|NCT00648193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101584746|NCT00648193|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101584747|NCT00648193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101584748|NCT00648193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101584750|NCT01215032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101584751|NCT01215032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584752|NCT02663089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101584753|NCT02664103|Cyclophosphamide|cyclophosphamide|mesh-list
101584754|NCT02664103|Capecitabine|capecitabine|mesh-list
101584755|NCT02664103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101584756|NCT02664103|Immunologic Factors|immunologic factors|mesh-ancestor
101584757|NCT02664103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584758|NCT02664103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101584759|NCT02664103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101584760|NCT02664103|Alkylating Agents|alkylating agents|mesh-ancestor
101617163|NCT00922272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617164|NCT00922272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101292999|NCT01966575|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101293074|NCT01967095|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101617165|NCT00922272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101293151|NCT01967524|Ropivacaine|ropivacaine|mesh-list
101617166|NCT00922272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101617167|NCT00922272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617168|NCT00922272|Dopamine Agents|dopamine agents|mesh-ancestor
101617169|NCT00922272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101584761|NCT02664103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584762|NCT02664103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101584763|NCT02664103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101584764|NCT02664103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101584765|NCT02664103|Antimetabolites|antimetabolites|mesh-ancestor
101584766|NCT02662855|Favipiravir|favipiravir|mesh-list
101584767|NCT02662855|Antiviral Agents|antiviral agents|mesh-ancestor
101584768|NCT02662855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101584769|NCT00648271|Metoprolol|metoprolol|mesh-list
101584770|NCT00648271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101584779|NCT00648271|Adrenergic Agents|adrenergic agents|mesh-ancestor
101584780|NCT00648271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101584781|NCT00648271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584782|NCT00648349|Rabeprazole|rabeprazole|mesh-list
101584783|NCT00648349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101584784|NCT00648349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101584785|NCT00648349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101584786|NCT00648349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101584787|NCT00648349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584788|NCT00649207|Veliparib|veliparib|mesh-list
101584789|NCT00649207|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101584790|NCT00649207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101584791|NCT00649207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584792|NCT00649207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101584793|NCT00920686|Sumatriptan|sumatriptan|mesh-list
101584794|NCT00920686|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101584795|NCT00920686|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101584796|NCT00920686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101584797|NCT00920686|Serotonin Agents|serotonin agents|mesh-ancestor
101584798|NCT00920686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101584799|NCT00920686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584800|NCT00920686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584801|NCT00648427|Paroxetine|paroxetine|mesh-list
101584802|NCT00648427|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101584803|NCT00648427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101584804|NCT00648427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101584805|NCT00648427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584806|NCT00648427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101584807|NCT00648427|Serotonin Agents|serotonin agents|mesh-ancestor
101584808|NCT00648427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584809|NCT00648427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101584810|NCT00648427|Antidepressive Agents|antidepressive agents|mesh-ancestor
101584811|NCT00648427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101584812|NCT00648427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101584813|NCT00648427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101584814|NCT00648427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101584815|NCT04170751|Vasopressins|vasopressins|mesh-list
101584816|NCT04170751|Arginine Vasopressin|arginine vasopressin|mesh-list
101584817|NCT04170751|Norepinephrine|norepinephrine|mesh-list
101584818|NCT04170751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101617170|NCT00853372|Sunitinib|sunitinib|mesh-list
101617171|NCT00853372|Trebananib|trebananib|mesh-list
101617172|NCT00853372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
101617173|NCT00853372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101617174|NCT00853372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101617175|NCT00853372|Growth Substances|growth substances|mesh-ancestor
101293588|NCT01970072|Midazolam|midazolam|mesh-list
101617176|NCT00853372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617177|NCT00853372|Growth Inhibitors|growth inhibitors|mesh-ancestor
101617178|NCT00853372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101617179|NCT00853372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101293881|NCT01972490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101617180|NCT00853372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617181|NCT02836977|Tegafur|tegafur|mesh-list
101294102|NCT01974024|Methylprednisolone|methylprednisolone|mesh-list
101294175|NCT01974518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101617182|NCT02836977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101617183|NCT02836977|Antimetabolites|antimetabolites|mesh-ancestor
101584819|NCT04170751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101584820|NCT04170751|Adrenergic Agents|adrenergic agents|mesh-ancestor
101584821|NCT04170751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101584822|NCT04170751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584823|NCT04170751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584824|NCT04170751|Sympathomimetics|sympathomimetics|mesh-ancestor
101584825|NCT04170751|Autonomic Agents|autonomic agents|mesh-ancestor
101584826|NCT04170751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101584827|NCT04170751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101584828|NCT04170751|Hemostatics|hemostatics|mesh-ancestor
101584829|NCT04170751|Coagulants|coagulants|mesh-ancestor
101584830|NCT04170751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101584831|NCT04170751|Natriuretic Agents|natriuretic agents|mesh-ancestor
101584832|NCT02659033|Ceftriaxone|ceftriaxone|mesh-list
101584833|NCT02659033|Cephalosporins|cephalosporins|mesh-list
101584834|NCT02659033|Cefotaxime|cefotaxime|mesh-list
101584835|NCT02659033|Cefoxitin|cefoxitin|mesh-list
101584841|NCT00648973|Diphenhydramine|diphenhydramine|mesh-list
101584842|NCT00648973|Promethazine|promethazine|mesh-list
101584843|NCT00648973|Pseudoephedrine|pseudoephedrine|mesh-list
101584844|NCT00648973|Ephedrine|ephedrine|mesh-list
101584845|NCT00648973|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101584846|NCT00648973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101584847|NCT00648973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101584848|NCT00648973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584849|NCT00648973|Anesthetics, Local|anesthetics, local|mesh-ancestor
101584850|NCT00648973|Anesthetics|anesthetics|mesh-ancestor
101584851|NCT00648973|Sensory System Agents|sensory system agents|mesh-ancestor
101584852|NCT00648973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101584853|NCT00648973|Antiemetics|antiemetics|mesh-ancestor
101584854|NCT00648973|Autonomic Agents|autonomic agents|mesh-ancestor
101584855|NCT00648973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101584856|NCT00648973|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101584857|NCT00648973|Histamine Antagonists|histamine antagonists|mesh-ancestor
101584858|NCT00648973|Histamine Agents|histamine agents|mesh-ancestor
101584859|NCT00648973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101584860|NCT00648973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584861|NCT00648973|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101584862|NCT00648973|Antipruritics|antipruritics|mesh-ancestor
101584863|NCT00648973|Dermatologic Agents|dermatologic agents|mesh-ancestor
101584864|NCT00648973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101584865|NCT00648973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101584866|NCT00648973|Respiratory System Agents|respiratory system agents|mesh-ancestor
101617184|NCT02836977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617185|NCT02836977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101617187|NCT04988256|Prednisone|prednisone|mesh-list
101617188|NCT04988256|Methylprednisolone|methylprednisolone|mesh-list
101617189|NCT04988256|Cyclosporins|cyclosporins|mesh-list
101617190|NCT04988256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101617191|NCT04988256|Glucocorticoids|glucocorticoids|mesh-ancestor
101617192|NCT04988256|Hormones|hormones|mesh-ancestor
101294545|NCT01977417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101294618|NCT01978405|Vitamin B Complex|vitamin b complex|mesh-ancestor
101617193|NCT04988256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101617194|NCT04988256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584867|NCT00648973|Nasal Decongestants|nasal decongestants|mesh-ancestor
101584868|NCT00648973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101584869|NCT00648973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101584871|NCT00648973|Adrenergic Agents|adrenergic agents|mesh-ancestor
101584872|NCT02662309|Atezolizumab|atezolizumab|mesh-list
101584873|NCT02662309|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101584874|NCT02662309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584875|NCT02662309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101584876|NCT02662309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101584877|NCT04032691|Clonidine|clonidine|mesh-list
101584878|NCT04032691|Analgesics|analgesics|mesh-ancestor
101584879|NCT04032691|Sensory System Agents|sensory system agents|mesh-ancestor
101584880|NCT04032691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101584881|NCT04032691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584882|NCT04032691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101584883|NCT04032691|Sympatholytics|sympatholytics|mesh-ancestor
101584884|NCT04032691|Autonomic Agents|autonomic agents|mesh-ancestor
101584885|NCT04032691|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101584886|NCT04032691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101584887|NCT04032691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101584888|NCT04032691|Adrenergic Agents|adrenergic agents|mesh-ancestor
101584889|NCT04032691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101584890|NCT04032691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584891|NCT02658799|Diclofenac|diclofenac|mesh-list
101584892|NCT02658799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101584893|NCT02658799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101584894|NCT02658799|Analgesics|analgesics|mesh-ancestor
101584895|NCT02658799|Sensory System Agents|sensory system agents|mesh-ancestor
101584896|NCT02658799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101584897|NCT02658799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584898|NCT02658799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101584899|NCT02658799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101584900|NCT02658799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101584901|NCT02658799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101584902|NCT02658799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584903|NCT02655757|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101584904|NCT02655757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101584905|NCT02655757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584906|NCT02655757|Incretins|incretins|mesh-ancestor
101584933|NCT04169269|Rivaroxaban|rivaroxaban|mesh-list
101584934|NCT04169269|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101584935|NCT04169269|Antithrombins|antithrombins|mesh-ancestor
101584936|NCT04169269|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101584937|NCT04169269|Protease Inhibitors|protease inhibitors|mesh-ancestor
101584938|NCT04169269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101584939|NCT04169269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584940|NCT04169269|Anticoagulants|anticoagulants|mesh-ancestor
101584941|NCT04169269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101584942|NCT04169269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101584944|NCT02661373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101241806|NCT01631136|Pemetrexed|pemetrexed|mesh-list
101617195|NCT04988256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101617196|NCT04988256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101617197|NCT04988256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101617198|NCT04988256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617199|NCT04988256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101617200|NCT04988256|Immunologic Factors|immunologic factors|mesh-ancestor
101584945|NCT02661373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101584946|NCT02661373|Antiviral Agents|antiviral agents|mesh-ancestor
101584947|NCT02661373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101584948|NCT02661373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101584949|NCT02661373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101584950|NCT02661373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101584951|NCT02661373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584952|NCT00649051|Metolazone|metolazone|mesh-list
101584953|NCT00649051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101584954|NCT00649051|Diuretics|diuretics|mesh-ancestor
101584964|NCT04168879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584965|NCT04168879|Sensory System Agents|sensory system agents|mesh-ancestor
101584966|NCT04168879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101584967|NCT00649987|Albuterol|albuterol|mesh-list
101584968|NCT00649987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101584969|NCT00649987|Autonomic Agents|autonomic agents|mesh-ancestor
101584970|NCT00649987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101584971|NCT00649987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584972|NCT00649987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101584973|NCT00649987|Respiratory System Agents|respiratory system agents|mesh-ancestor
101584974|NCT00649987|Tocolytic Agents|tocolytic agents|mesh-ancestor
101584975|NCT00649987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101584976|NCT00649987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101584977|NCT00649987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101584978|NCT00649987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101584979|NCT00649987|Adrenergic Agents|adrenergic agents|mesh-ancestor
101584980|NCT00649987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101584981|NCT00649987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584982|NCT01142232|Lenalidomide|lenalidomide|mesh-list
101584983|NCT01142232|Melphalan|melphalan|mesh-list
101584984|NCT01142232|Immunologic Factors|immunologic factors|mesh-ancestor
101584985|NCT01142232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584986|NCT01142232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101584987|NCT01142232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101584988|NCT01142232|Growth Substances|growth substances|mesh-ancestor
101584989|NCT01142232|Growth Inhibitors|growth inhibitors|mesh-ancestor
101584990|NCT01142232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101584991|NCT01142232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101584992|NCT01142232|Alkylating Agents|alkylating agents|mesh-ancestor
101584993|NCT01142232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584994|NCT01142232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101584995|NCT01142232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101584996|NCT02536807|Hyaluronic Acid|hyaluronic acid|mesh-list
101584997|NCT02536807|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101584998|NCT02536807|Immunologic Factors|immunologic factors|mesh-ancestor
101584999|NCT02536807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585000|NCT02536807|Viscosupplements|viscosupplements|mesh-ancestor
101585001|NCT02536807|Protective Agents|protective agents|mesh-ancestor
101585002|NCT02536495|Docetaxel|docetaxel|mesh-list
101585003|NCT02536495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101585004|NCT02536495|Tubulin Modulators|tubulin modulators|mesh-ancestor
101585005|NCT02536495|Antimitotic Agents|antimitotic agents|mesh-ancestor
101585006|NCT02536495|Mitosis Modulators|mitosis modulators|mesh-ancestor
101585007|NCT02536495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585008|NCT02536417|Melatonin|melatonin|mesh-list
101585009|NCT02536417|Antioxidants|antioxidants|mesh-ancestor
101264281|NCT01766843|Sympathomimetics|sympathomimetics|mesh-ancestor
101585010|NCT02536417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585011|NCT02536417|Protective Agents|protective agents|mesh-ancestor
101585012|NCT02536417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585013|NCT02536417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101617201|NCT04988256|Antifungal Agents|antifungal agents|mesh-ancestor
101294830|NCT01980277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101617202|NCT04988256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101617204|NCT04988256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101617205|NCT04988256|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101295145|NCT01982799|Ibuprofen|ibuprofen|mesh-list
101617206|NCT04988256|Antiemetics|antiemetics|mesh-ancestor
101617207|NCT04988256|Autonomic Agents|autonomic agents|mesh-ancestor
101295358|NCT01984073|Nicotinic Acids|nicotinic acids|mesh-list
101617208|NCT04988256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101617209|NCT04988256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101295514|NCT01985152|Choline|choline|mesh-list
101617210|NCT04988256|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101295598|NCT01985724|Antimetabolites|antimetabolites|mesh-ancestor
101617211|NCT04988256|Protective Agents|protective agents|mesh-ancestor
101617212|NCT00848536|Travoprost|travoprost|mesh-list
101295661|NCT01985854|Propofol|propofol|mesh-list
101585014|NCT01140906|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101585016|NCT01140906|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101585017|NCT01140906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101241910|NCT01631513|Tapentadol|tapentadol|mesh-list
101585028|NCT01140906|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101585029|NCT01140906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101585030|NCT01140906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101585031|NCT01140906|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101585032|NCT01140906|Serotonin Agents|serotonin agents|mesh-ancestor
101585033|NCT01140906|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101585034|NCT01140906|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101585035|NCT01140906|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101585036|NCT01140906|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101585038|NCT00650065|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101585039|NCT00650065|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101585040|NCT00650065|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101585041|NCT00650065|Histamine Antagonists|histamine antagonists|mesh-ancestor
101585042|NCT00650065|Histamine Agents|histamine agents|mesh-ancestor
101585043|NCT00650065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101585044|NCT00650065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585045|NCT00650065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585046|NCT04170439|Chromium|chromium|mesh-list
101585047|NCT04170439|Metformin|metformin|mesh-list
101585048|NCT04170439|Citric Acid|citric acid|mesh-list
101585049|NCT04170439|Sodium Citrate|sodium citrate|mesh-list
101585050|NCT04170439|Clomiphene|clomiphene|mesh-list
101585051|NCT04170439|Enclomiphene|enclomiphene|mesh-list
101585052|NCT04170439|Zuclomiphene|zuclomiphene|mesh-list
101585053|NCT04170439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101585054|NCT04170439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585055|NCT04170439|Anticoagulants|anticoagulants|mesh-ancestor
101585056|NCT04170439|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101585057|NCT04170439|Chelating Agents|chelating agents|mesh-ancestor
101585058|NCT04170439|Sequestering Agents|sequestering agents|mesh-ancestor
101585059|NCT04170439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585060|NCT04170439|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101585061|NCT04170439|Hormone Antagonists|hormone antagonists|mesh-ancestor
101585062|NCT04170439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101585063|NCT04170439|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101585064|NCT04170439|Fertility Agents|fertility agents|mesh-ancestor
101585065|NCT04170439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101330405|NCT00000527|Aspirin|aspirin|mesh-list
101585066|NCT04170439|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101585067|NCT04170439|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101585068|NCT04170439|Trace Elements|trace elements|mesh-ancestor
101295742|NCT01986322|Vaccines|vaccines|mesh-list
101295811|NCT01986673|Sildenafil Citrate|sildenafil citrate|mesh-list
101295880|NCT01987076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101617213|NCT00848536|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101617215|NCT00848536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101617216|NCT00922116|Epoetin Alfa|epoetin alfa|mesh-list
101617217|NCT00922116|Hematinics|hematinics|mesh-ancestor
101296394|NCT01991275|Morphine|morphine|mesh-list
101617219|NCT04260516|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101617220|NCT04260516|Antiviral Agents|antiviral agents|mesh-ancestor
101617221|NCT04260516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101617222|NCT04260516|Expectorants|expectorants|mesh-ancestor
101617223|NCT04260516|Respiratory System Agents|respiratory system agents|mesh-ancestor
101296692|NCT01993589|Antipyretics|antipyretics|mesh-ancestor
101617224|NCT04260516|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101617225|NCT04260516|Antioxidants|antioxidants|mesh-ancestor
101296838|NCT01994967|Bupivacaine|bupivacaine|mesh-list
101416016|NCT00147771|Imiquimod|imiquimod|mesh-list
101585069|NCT04170439|Micronutrients|micronutrients|mesh-ancestor
101585070|NCT00649363|Ondansetron|ondansetron|mesh-list
101585071|NCT00649363|Antiemetics|antiemetics|mesh-ancestor
101585072|NCT00649363|Autonomic Agents|autonomic agents|mesh-ancestor
101585073|NCT00649363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101585074|NCT00649363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585075|NCT00649363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101585076|NCT00649363|Antipruritics|antipruritics|mesh-ancestor
101585077|NCT00649363|Dermatologic Agents|dermatologic agents|mesh-ancestor
101585078|NCT00649363|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101585079|NCT00649363|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101585080|NCT00649363|Serotonin Agents|serotonin agents|mesh-ancestor
101585081|NCT00649363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101585100|NCT04168723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585101|NCT04168723|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101585102|NCT04168723|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101585103|NCT04168723|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101585104|NCT00649441|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101585106|NCT00649441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101585107|NCT00649441|Diuretics|diuretics|mesh-ancestor
101585108|NCT00649441|Natriuretic Agents|natriuretic agents|mesh-ancestor
101585109|NCT00649441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585110|NCT00649441|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101585111|NCT00649441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101585112|NCT00649441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585113|NCT00649441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101585114|NCT00649441|Protease Inhibitors|protease inhibitors|mesh-ancestor
101585115|NCT00649441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101585116|NCT02654665|Liraglutide|liraglutide|mesh-list
101585117|NCT02654665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101585118|NCT02654665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585119|NCT02654665|Incretins|incretins|mesh-ancestor
101585120|NCT02654665|Hormones|hormones|mesh-ancestor
101585121|NCT02654665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101585122|NCT02658721|Diclofenac|diclofenac|mesh-list
101585123|NCT02658721|Lidocaine|lidocaine|mesh-list
101585124|NCT02658721|Atropine|atropine|mesh-list
101585125|NCT02658721|Ephedrine|ephedrine|mesh-list
101585126|NCT02658721|Fentanyl|fentanyl|mesh-list
101585127|NCT02658721|Midazolam|midazolam|mesh-list
101585128|NCT02658721|Tramadol|tramadol|mesh-list
101585129|NCT02658721|Ondansetron|ondansetron|mesh-list
101585130|NCT02658721|Anesthetics, Local|anesthetics, local|mesh-ancestor
101585131|NCT02658721|Anesthetics|anesthetics|mesh-ancestor
101585132|NCT02658721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101585133|NCT02658721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617226|NCT04260516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617227|NCT04260516|Protective Agents|protective agents|mesh-ancestor
101617228|NCT04260516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617229|NCT04260516|Antidotes|antidotes|mesh-ancestor
101297064|NCT01996384|Lidocaine|lidocaine|mesh-list
101617230|NCT00921024|Ceftazidime|ceftazidime|mesh-list
101297141|NCT01996501|Olanzapine|olanzapine|mesh-list
101617231|NCT00921024|Ceftolozane|ceftolozane|mesh-list
101617232|NCT00921024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101617233|NCT00921024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101297354|NCT01998113|Metformin|metformin|mesh-list
101297436|NCT01998503|Hormones|hormones|mesh-ancestor
101585134|NCT02658721|Sensory System Agents|sensory system agents|mesh-ancestor
101585140|NCT02658721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585141|NCT02658721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101585142|NCT02658721|Narcotics|narcotics|mesh-ancestor
101585143|NCT02658721|Analgesics|analgesics|mesh-ancestor
101585144|NCT02658721|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101585145|NCT02658721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101585146|NCT02658721|Anesthetics, General|anesthetics, general|mesh-ancestor
101585147|NCT02658721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101585148|NCT02658721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101585149|NCT02658721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101585150|NCT02658721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101585151|NCT02658721|GABA Modulators|gaba modulators|mesh-ancestor
101585152|NCT02658721|GABA Agents|gaba agents|mesh-ancestor
101585153|NCT02658721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101585154|NCT02658721|Antiemetics|antiemetics|mesh-ancestor
101585155|NCT02658721|Autonomic Agents|autonomic agents|mesh-ancestor
101585156|NCT02658721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101585157|NCT02658721|Antipruritics|antipruritics|mesh-ancestor
101585158|NCT02658721|Dermatologic Agents|dermatologic agents|mesh-ancestor
101585159|NCT02658721|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101585160|NCT02658721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101585161|NCT02658721|Serotonin Agents|serotonin agents|mesh-ancestor
101585162|NCT02658721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101585163|NCT02658721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101585164|NCT02658721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101585165|NCT02658721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101585166|NCT02658721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101585167|NCT02658721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101585168|NCT02658721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101585169|NCT02658721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101585170|NCT02658721|Respiratory System Agents|respiratory system agents|mesh-ancestor
101585171|NCT02658721|Mydriatics|mydriatics|mesh-ancestor
101585172|NCT02658721|Parasympatholytics|parasympatholytics|mesh-ancestor
101585173|NCT02658721|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101585174|NCT02658721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101585175|NCT02658721|Cholinergic Agents|cholinergic agents|mesh-ancestor
101585176|NCT02658721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101585177|NCT02658721|Sympathomimetics|sympathomimetics|mesh-ancestor
101585178|NCT02658721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101585179|NCT02658721|Adrenergic Agents|adrenergic agents|mesh-ancestor
101585180|NCT00629967|Interferons|interferons|mesh-list
101585181|NCT00629967|Ribavirin|ribavirin|mesh-list
101585182|NCT00629967|Interferon-alpha|interferon-alpha|mesh-list
101585183|NCT00629967|Interferon alpha-2|interferon alpha-2|mesh-list
101585184|NCT00629967|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101585185|NCT00629967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101585186|NCT00629967|Antiviral Agents|antiviral agents|mesh-ancestor
101585187|NCT00629967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101585188|NCT00629967|Antimetabolites|antimetabolites|mesh-ancestor
101585189|NCT00629967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585190|NCT00629967|Immunologic Factors|immunologic factors|mesh-ancestor
101585191|NCT00629967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585192|NCT02654587|Docetaxel|docetaxel|mesh-list
101585193|NCT02654587|Pemetrexed|pemetrexed|mesh-list
101585194|NCT02654587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101617235|NCT00928668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101617236|NCT00928668|Autonomic Agents|autonomic agents|mesh-ancestor
101297506|NCT01998776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101617237|NCT00928668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101297801|NCT02001272|Tubulin Modulators|tubulin modulators|mesh-ancestor
101297878|NCT02001584|GABA Agonists|gaba agonists|mesh-ancestor
101297950|NCT02001974|Tubulin Modulators|tubulin modulators|mesh-ancestor
101298028|NCT02002260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101617238|NCT00928668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617239|NCT00928668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101298327|NCT02004574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101617240|NCT00928668|Respiratory System Agents|respiratory system agents|mesh-ancestor
101617241|NCT00700960|Insulin Detemir|insulin detemir|mesh-list
101617242|NCT00700960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101617243|NCT00700960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617244|NCT00700492|Progesterone|progesterone|mesh-list
101617245|NCT00700492|Progestins|progestins|mesh-ancestor
101617247|NCT00700492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101585195|NCT02654587|Tubulin Modulators|tubulin modulators|mesh-ancestor
101585196|NCT02654587|Antimitotic Agents|antimitotic agents|mesh-ancestor
101585197|NCT02654587|Mitosis Modulators|mitosis modulators|mesh-ancestor
101585198|NCT02654587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585199|NCT02654587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101585200|NCT02654587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101585201|NCT02654587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101585202|NCT01122264|Sildenafil Citrate|sildenafil citrate|mesh-list
101585203|NCT01122264|Tadalafil|tadalafil|mesh-list
101585204|NCT01122264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585205|NCT01122264|Vasodilator Agents|vasodilator agents|mesh-ancestor
101585217|NCT03288675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101585218|NCT03288675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101585219|NCT00920218|Vaccines|vaccines|mesh-list
101585220|NCT00920218|Immunologic Factors|immunologic factors|mesh-ancestor
101585221|NCT00920218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585222|NCT00649519|Amlodipine|amlodipine|mesh-list
101585223|NCT00649519|Benazepril|benazepril|mesh-list
101585224|NCT00649519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101585225|NCT00649519|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101585226|NCT00649519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101585227|NCT00649519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585228|NCT00649519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101585229|NCT00649519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585230|NCT00649519|Vasodilator Agents|vasodilator agents|mesh-ancestor
101585231|NCT00649519|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101585232|NCT00649519|Protease Inhibitors|protease inhibitors|mesh-ancestor
101585233|NCT00649519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101585234|NCT00629811|Mitogens|mitogens|mesh-list
101585235|NCT00629811|Mitosis Modulators|mitosis modulators|mesh-ancestor
101585236|NCT00629811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585237|NCT02652091|Interferons|interferons|mesh-list
101585238|NCT02652091|Interferon-beta|interferon-beta|mesh-list
101585239|NCT02652091|Interferon beta-1b|interferon beta-1b|mesh-list
101585240|NCT02652091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101585241|NCT02652091|Antiviral Agents|antiviral agents|mesh-ancestor
101585242|NCT02652091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101298669|NCT05970263|Budesonide|budesonide|mesh-list
101617248|NCT00700492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617249|NCT00700648|Insulin Aspart|insulin aspart|mesh-list
101617250|NCT00700648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101617251|NCT00700648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617252|NCT00703300|Bortezomib|bortezomib|mesh-list
101274292|NCT01856127|Serotonin Agents|serotonin agents|mesh-ancestor
101617253|NCT00703300|Decitabine|decitabine|mesh-list
101617254|NCT00703300|Azacitidine|azacitidine|mesh-list
101617255|NCT00703300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101617256|NCT00703300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101617257|NCT00703300|Antimetabolites|antimetabolites|mesh-ancestor
101617258|NCT00703300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617259|NCT00703300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101617260|NCT00703378|Docetaxel|docetaxel|mesh-list
101617261|NCT00703378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101617262|NCT00703378|Tubulin Modulators|tubulin modulators|mesh-ancestor
101617263|NCT00703378|Antimitotic Agents|antimitotic agents|mesh-ancestor
101299057|NCT05951387|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101299058|NCT05944926|Fluoxetine|fluoxetine|mesh-list
101299059|NCT05944926|Antidepressive Agents|antidepressive agents|mesh-list
101299072|NCT05940220|Acetazolamide|acetazolamide|mesh-list
101617264|NCT00703378|Mitosis Modulators|mitosis modulators|mesh-ancestor
101617265|NCT00703378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617266|NCT00852202|Cariprazine|cariprazine|mesh-list
101617267|NCT00852202|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101617268|NCT00852202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101617269|NCT00852202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101617270|NCT00852202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617271|NCT00852202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101617272|NCT01074008|Ritonavir|ritonavir|mesh-list
101617273|NCT01074008|Ribavirin|ribavirin|mesh-list
101617274|NCT01074008|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101585243|NCT02652091|Immunologic Factors|immunologic factors|mesh-ancestor
101585244|NCT02652091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585245|NCT02652091|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101585246|NCT00625560|Lamivudine|lamivudine|mesh-list
101585247|NCT00625560|Entecavir|entecavir|mesh-list
101585248|NCT00625560|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101585249|NCT00625560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101585250|NCT00625560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101585251|NCT00625560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585252|NCT00625560|Antiviral Agents|antiviral agents|mesh-ancestor
101585253|NCT00625560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101585254|NCT00625560|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101585255|NCT00625560|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101585256|NCT00650455|Naproxen|naproxen|mesh-list
101617276|NCT01074008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101299142|NCT05917340|Rifampin|rifampin|mesh-list
101617277|NCT01074008|Protease Inhibitors|protease inhibitors|mesh-ancestor
101617278|NCT01074008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101617279|NCT01074008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617280|NCT01074008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101617281|NCT01074008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101617282|NCT01074008|Antiviral Agents|antiviral agents|mesh-ancestor
101299220|NCT05882214|Niacinamide|niacinamide|mesh-list
101617283|NCT01074008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101617284|NCT01074008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101617285|NCT01074008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101299420|NCT05741502|Olanzapine|olanzapine|mesh-list
101617287|NCT02613052|Propofol|propofol|mesh-list
101299567|NCT05651594|Leucovorin|leucovorin|mesh-list
101299644|NCT05584657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101617288|NCT02613052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101299793|NCT05469893|Dexamethasone|dexamethasone|mesh-list
101416091|NCT01248442|Vitamins|vitamins|mesh-ancestor
101585257|NCT00650455|Valdecoxib|valdecoxib|mesh-list
101585258|NCT00650455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101585259|NCT00650455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101585260|NCT00650455|Analgesics|analgesics|mesh-ancestor
101585261|NCT00650455|Sensory System Agents|sensory system agents|mesh-ancestor
101585262|NCT00650455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101585263|NCT00650455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585264|NCT00650455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101585265|NCT00650455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101585266|NCT00650455|Gout Suppressants|gout suppressants|mesh-ancestor
101585267|NCT00650455|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101585268|NCT00650455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101585272|NCT02654041|Antithyroid Agents|antithyroid agents|mesh-ancestor
101585273|NCT02654041|Hormone Antagonists|hormone antagonists|mesh-ancestor
101585274|NCT02654041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101585275|NCT02654041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585276|NCT02658409|Vaccines|vaccines|mesh-list
101585277|NCT02658409|Immunologic Factors|immunologic factors|mesh-ancestor
101585278|NCT02658409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585279|NCT01121562|Sunitinib|sunitinib|mesh-list
101585280|NCT01121562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101585281|NCT01121562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101585282|NCT01121562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101585283|NCT01121562|Growth Substances|growth substances|mesh-ancestor
101585284|NCT01121562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585285|NCT01121562|Growth Inhibitors|growth inhibitors|mesh-ancestor
101585286|NCT01121562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101585287|NCT01121562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101585288|NCT01121562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585289|NCT02658253|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101585290|NCT02658253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101585291|NCT02658253|Immunologic Factors|immunologic factors|mesh-ancestor
101585292|NCT02658253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585293|NCT02658253|Antacids|antacids|mesh-ancestor
101585294|NCT02658253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585295|NCT02658253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101585296|NCT02651623|Moxifloxacin|moxifloxacin|mesh-list
101617289|NCT02613052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101617290|NCT02613052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617291|NCT02613052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101617292|NCT02613052|Anesthetics, General|anesthetics, general|mesh-ancestor
101617293|NCT02613052|Anesthetics|anesthetics|mesh-ancestor
101617294|NCT01073930|Bisacodyl|bisacodyl|mesh-list
101617295|NCT01073930|Picosulfate sodium|picosulfate sodium|mesh-list
101617296|NCT01073930|Cathartics|cathartics|mesh-ancestor
101300027|NCT05260021|Tirzepatide|tirzepatide|mesh-list
101416108|NCT01249339|Cholinergic Agents|cholinergic agents|mesh-ancestor
101585297|NCT02651623|Sertraline|sertraline|mesh-list
101585298|NCT02651623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101585299|NCT02651623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101585300|NCT02651623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101264292|NCT01767025|Oxytocin|oxytocin|mesh-list
101585301|NCT02651623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101585302|NCT02651623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101585303|NCT02651623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585304|NCT02651623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101585305|NCT02651623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585306|NCT02651623|Antidepressive Agents|antidepressive agents|mesh-ancestor
101585307|NCT02651623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101585308|NCT02651623|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101585309|NCT02651623|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101585310|NCT02651623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101585311|NCT02651623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101585313|NCT01121484|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101585314|NCT01121484|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101585315|NCT01121484|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101585316|NCT01121484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101585317|NCT01121484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585318|NCT01121484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101585319|NCT01121484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585320|NCT01121484|Antidepressive Agents|antidepressive agents|mesh-ancestor
101585321|NCT01121484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101585322|NCT00650221|Pravastatin|pravastatin|mesh-list
101585323|NCT00650221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101585324|NCT00650221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101585325|NCT00650221|Antimetabolites|antimetabolites|mesh-ancestor
101585326|NCT00650221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585327|NCT00650221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101585328|NCT00650221|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101585329|NCT00650221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101585330|NCT01169675|Pemetrexed|pemetrexed|mesh-list
101585331|NCT01169675|Afatinib|afatinib|mesh-list
101585332|NCT01169675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101585333|NCT01169675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101585334|NCT01169675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585335|NCT01169675|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101585336|NCT01169675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101585344|NCT02881866|Furosemide|furosemide|mesh-list
101585345|NCT02881866|Diuretics|diuretics|mesh-ancestor
101585346|NCT02881866|Natriuretic Agents|natriuretic agents|mesh-ancestor
101585347|NCT02881866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585348|NCT02881866|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101585349|NCT02881866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101585350|NCT02881866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585351|NCT00924664|Tanezumab|tanezumab|mesh-list
101585352|NCT00924664|Analgesics|analgesics|mesh-ancestor
101585353|NCT00924664|Sensory System Agents|sensory system agents|mesh-ancestor
101585354|NCT00924664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101585355|NCT00924664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585356|NCT02653651|Lidocaine|lidocaine|mesh-list
101585357|NCT02653651|Ketamine|ketamine|mesh-list
101300090|NCT05139017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300166|NCT05038735|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101300240|NCT04999449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101617297|NCT01073930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101617298|NCT01073930|Laxatives|laxatives|mesh-ancestor
101617299|NCT01073618|Voriconazole|voriconazole|mesh-list
101300391|NCT04840602|Venetoclax|venetoclax|mesh-list
101617300|NCT01073618|Antifungal Agents|antifungal agents|mesh-ancestor
101617301|NCT01073618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101617302|NCT01073618|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101617303|NCT01073618|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101617304|NCT01073618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101617305|NCT01073618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585358|NCT02653651|Anesthetics, Local|anesthetics, local|mesh-ancestor
101585359|NCT02653651|Anesthetics|anesthetics|mesh-ancestor
101585360|NCT02653651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101585361|NCT02653651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585362|NCT02653651|Sensory System Agents|sensory system agents|mesh-ancestor
101585363|NCT02653651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101585364|NCT02653651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101585365|NCT02653651|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101585366|NCT02653651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101585367|NCT02653651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101585368|NCT02653651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585369|NCT02653651|Analgesics|analgesics|mesh-ancestor
101585370|NCT02653651|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101585371|NCT02653651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101585372|NCT02653651|Anesthetics, General|anesthetics, general|mesh-ancestor
101585373|NCT02653651|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101585374|NCT02653651|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101585375|NCT02653651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101585376|NCT02651311|Ibuprofen|ibuprofen|mesh-list
101585377|NCT02651311|Fentanyl|fentanyl|mesh-list
101585378|NCT02651311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101585379|NCT02651311|Narcotics|narcotics|mesh-ancestor
101585380|NCT02651311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101585381|NCT02651311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585382|NCT02651311|Analgesics|analgesics|mesh-ancestor
101585383|NCT02651311|Sensory System Agents|sensory system agents|mesh-ancestor
101585384|NCT02651311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101585385|NCT02651311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101585386|NCT02651311|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101585387|NCT02651311|Anesthetics, General|anesthetics, general|mesh-ancestor
101585388|NCT02651311|Anesthetics|anesthetics|mesh-ancestor
101585389|NCT02651311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101585390|NCT02651311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101585391|NCT02651311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101585392|NCT02651311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101585393|NCT02651311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101585394|NCT02651311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101585395|NCT02651311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585396|NCT02653261|Tranexamic Acid|tranexamic acid|mesh-list
101585397|NCT02653261|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101585398|NCT02653261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101585399|NCT02653261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585400|NCT02653261|Hemostatics|hemostatics|mesh-ancestor
101585401|NCT02653261|Coagulants|coagulants|mesh-ancestor
101585402|NCT02653339|Loratadine|loratadine|mesh-list
101585403|NCT02653339|Antipruritics|antipruritics|mesh-ancestor
101585404|NCT02653339|Dermatologic Agents|dermatologic agents|mesh-ancestor
101585411|NCT02653339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617306|NCT01073618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101617307|NCT01073618|Hormone Antagonists|hormone antagonists|mesh-ancestor
101617308|NCT01073618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101617309|NCT01073618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617310|NCT01073618|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101617311|NCT00789373|Pemetrexed|pemetrexed|mesh-list
101617312|NCT00789373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101617313|NCT00789373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101617314|NCT00789373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617315|NCT00789373|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101617316|NCT00789373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101617317|NCT00851890|Interferons|interferons|mesh-list
101617318|NCT00851890|Ribavirin|ribavirin|mesh-list
101330513|NCT00031018|Donepezil|donepezil|mesh-list
101617319|NCT00851890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101585412|NCT02653339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585413|NCT00649597|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101585414|NCT00649597|Benazepril|benazepril|mesh-list
101585415|NCT00649597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101585416|NCT00649597|Diuretics|diuretics|mesh-ancestor
101585417|NCT00649597|Natriuretic Agents|natriuretic agents|mesh-ancestor
101585418|NCT00649597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585419|NCT00649597|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101585420|NCT00649597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101585421|NCT00649597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585422|NCT00649597|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101585423|NCT00649597|Protease Inhibitors|protease inhibitors|mesh-ancestor
101585424|NCT00649597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101585425|NCT02653027|Ivacaftor|ivacaftor|mesh-list
101585426|NCT02653027|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101585427|NCT02653027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101585428|NCT02653027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585429|NCT02652793|Lamivudine|lamivudine|mesh-list
101585430|NCT02652793|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101585431|NCT02652793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101585432|NCT02652793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101585433|NCT02652793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101585434|NCT02652793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585435|NCT02652793|Antiviral Agents|antiviral agents|mesh-ancestor
101585436|NCT02652793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101585437|NCT02652793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101585438|NCT02652793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101585439|NCT02652793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101585440|NCT02652793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101585441|NCT02652793|Protease Inhibitors|protease inhibitors|mesh-ancestor
101585442|NCT00650611|Ziprasidone|ziprasidone|mesh-list
101585443|NCT00650611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101585445|NCT00650611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101585446|NCT00650611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585447|NCT00650611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585448|NCT00650611|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101585449|NCT00650611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101585450|NCT00650611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101585451|NCT00650611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101585452|NCT00650611|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101585453|NCT00650611|Dopamine Agents|dopamine agents|mesh-ancestor
101585454|NCT00600067|Topiramate|topiramate|mesh-list
101585455|NCT00600067|Phentermine|phentermine|mesh-list
101585456|NCT00600067|Anticonvulsants|anticonvulsants|mesh-ancestor
101585457|NCT00600067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101617320|NCT00851890|Antiviral Agents|antiviral agents|mesh-ancestor
101617321|NCT00851890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101617322|NCT00851890|Antimetabolites|antimetabolites|mesh-ancestor
101617323|NCT00851890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617324|NCT00592072|Decanoic acid|decanoic acid|mesh-list
101617325|NCT00592072|Antifungal Agents|antifungal agents|mesh-ancestor
101300612|NCT04651166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300613|NCT04651166|Hemostatics|hemostatics|mesh-ancestor
101300614|NCT04651166|Coagulants|coagulants|mesh-ancestor
101300616|NCT04642547|Gefitinib|gefitinib|mesh-list
101300617|NCT04642547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300618|NCT04642547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101300619|NCT04642547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101416143|NCT00504205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585458|NCT00600067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585459|NCT00600067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101585460|NCT00600067|Appetite Depressants|appetite depressants|mesh-ancestor
101585461|NCT00600067|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101585462|NCT00600067|Sympathomimetics|sympathomimetics|mesh-ancestor
101585463|NCT00600067|Autonomic Agents|autonomic agents|mesh-ancestor
101585464|NCT00600067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101585465|NCT00600067|Adrenergic Agents|adrenergic agents|mesh-ancestor
101585466|NCT00600067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101585467|NCT00600067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585468|NCT02650609|Methylprednisolone|methylprednisolone|mesh-list
101585469|NCT02650609|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101585470|NCT02650609|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101585472|NCT02650609|Prednisolone acetate|prednisolone acetate|mesh-list
101585473|NCT02650609|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101585474|NCT02650609|Prednisolone phosphate|prednisolone phosphate|mesh-list
101585495|NCT02652871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101585496|NCT02652871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101585497|NCT02652871|Immunologic Factors|immunologic factors|mesh-ancestor
101585498|NCT02652871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585499|NCT02652871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101585500|NCT02652871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101585501|NCT02652871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101585502|NCT02652871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101585503|NCT00650299|Alprazolam|alprazolam|mesh-list
101585504|NCT00650299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101585505|NCT00650299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101585506|NCT00650299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585507|NCT00650299|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101585508|NCT00650299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101585509|NCT00650299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101585510|NCT00650299|GABA Modulators|gaba modulators|mesh-ancestor
101585511|NCT00650299|GABA Agents|gaba agents|mesh-ancestor
101585512|NCT00650299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101585513|NCT00650299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585514|NCT04168099|Cefotaxime|cefotaxime|mesh-list
101585515|NCT04168099|Cefoxitin|cefoxitin|mesh-list
101585516|NCT04168099|Gemifloxacin|gemifloxacin|mesh-list
101585517|NCT04168099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101585518|NCT04168099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101585519|NCT04168099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101585520|NCT04168099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101585521|NCT04168099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101585522|NCT04168099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585523|NCT04168099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101585524|NCT04283877|Methylphenidate|methylphenidate|mesh-list
101300620|NCT04642547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300630|NCT04622007|Pembrolizumab|pembrolizumab|mesh-list
101617326|NCT00592072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101617327|NCT00626288|Mesalamine|mesalamine|mesh-list
101617328|NCT00626288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101617329|NCT00626288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101617330|NCT00626288|Analgesics|analgesics|mesh-ancestor
101617331|NCT00626288|Sensory System Agents|sensory system agents|mesh-ancestor
101617332|NCT00626288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101617333|NCT00626288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617334|NCT00626288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101617335|NCT00626288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101617336|NCT00792571|Epoprostenol|epoprostenol|mesh-list
101617337|NCT00792571|Beraprost|beraprost|mesh-list
101416157|NCT01249690|Antiemetics|antiemetics|mesh-ancestor
101585525|NCT04283877|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101585526|NCT04283877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585527|NCT04283877|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101585528|NCT04283877|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101585536|NCT04283331|Propoxycaine|propoxycaine|mesh-list
101585537|NCT04283331|Anesthetics, Local|anesthetics, local|mesh-ancestor
101585538|NCT04283331|Anesthetics|anesthetics|mesh-ancestor
101585539|NCT04283331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101585540|NCT04283331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585541|NCT04283331|Sensory System Agents|sensory system agents|mesh-ancestor
101585542|NCT04283331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101585543|NCT02657473|Tobramycin|tobramycin|mesh-list
101585544|NCT02657473|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101585545|NCT02657473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101585546|NCT02657473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101585547|NCT02652637|Metronidazole|metronidazole|mesh-list
101585548|NCT02652637|Neomycin|neomycin|mesh-list
101585549|NCT02652637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101585550|NCT02652637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101585551|NCT02652637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101585552|NCT02652637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101585553|NCT02652637|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101585554|NCT02652637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101585555|NCT02652637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585556|NCT00649675|Meloxicam|meloxicam|mesh-list
101585557|NCT00649675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101585558|NCT00649675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101585559|NCT00649675|Analgesics|analgesics|mesh-ancestor
101585560|NCT00649675|Sensory System Agents|sensory system agents|mesh-ancestor
101585561|NCT00649675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101585562|NCT00649675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585563|NCT00649675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101585564|NCT00649675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101585565|NCT00649675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101585566|NCT00649675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101585567|NCT00649675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101585568|NCT00649675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585569|NCT02860923|Exenatide|exenatide|mesh-list
101585570|NCT02860923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101585571|NCT02860923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585572|NCT02860923|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101585573|NCT02860923|Incretins|incretins|mesh-ancestor
101585574|NCT02860923|Hormones|hormones|mesh-ancestor
101585575|NCT02860923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101585576|NCT01121406|Paclitaxel|paclitaxel|mesh-list
101585577|NCT01121406|Gemcitabine|gemcitabine|mesh-list
101617338|NCT00792571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101617339|NCT00792571|Vasodilator Agents|vasodilator agents|mesh-ancestor
101617340|NCT00792571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101617341|NCT00794365|Varenicline|varenicline|mesh-list
101617342|NCT00794365|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101617343|NCT00794365|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101617344|NCT00794365|Cholinergic Agents|cholinergic agents|mesh-ancestor
101617345|NCT00794365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101301050|NCT04073615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617346|NCT00794365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617347|NCT00794365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416182|NCT03712826|Ustekinumab|ustekinumab|mesh-list
101585578|NCT01121406|Doxorubicin|doxorubicin|mesh-list
101585579|NCT01121406|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101585580|NCT01121406|Topotecan|topotecan|mesh-list
101585581|NCT01121406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101585582|NCT01121406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101585583|NCT01121406|Tubulin Modulators|tubulin modulators|mesh-ancestor
101330551|NCT00031135|Choline|choline|mesh-list
101585584|NCT01121406|Antimitotic Agents|antimitotic agents|mesh-ancestor
101585585|NCT01121406|Mitosis Modulators|mitosis modulators|mesh-ancestor
101585586|NCT01121406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585587|NCT01121406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101585588|NCT01121406|Antimetabolites|antimetabolites|mesh-ancestor
101585589|NCT01121406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101585590|NCT01121406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101585591|NCT01121406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101585592|NCT01121406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101585593|NCT01121406|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101585594|NCT02652325|Iodine|iodine|mesh-list
101585595|NCT02652325|Cadexomer iodine|cadexomer iodine|mesh-list
101585596|NCT02652325|Povidone-Iodine|povidone-iodine|mesh-list
101585597|NCT02652325|Povidone|povidone|mesh-list
101585598|NCT02652325|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101585605|NCT00960687|Fenofibrate|fenofibrate|mesh-list
101585606|NCT00960687|Fenofibric acid|fenofibric acid|mesh-list
101585607|NCT00960687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101585608|NCT00960687|Antimetabolites|antimetabolites|mesh-ancestor
101585609|NCT00960687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585610|NCT00960687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101585611|NCT00960687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101585612|NCT00920140|Trametinib|trametinib|mesh-list
101585613|NCT00920140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101585614|NCT00920140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101585615|NCT00920140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101585616|NCT00920140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585617|NCT04032847|Pembrolizumab|pembrolizumab|mesh-list
101585618|NCT04032847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101585619|NCT04032847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101585620|NCT04032847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101585621|NCT04032847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585622|NCT01120626|Donepezil|donepezil|mesh-list
101585623|NCT01120626|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101585624|NCT01120626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101585625|NCT01120626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585626|NCT01120626|Cholinergic Agents|cholinergic agents|mesh-ancestor
101585627|NCT01120626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101585628|NCT01120626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585629|NCT01120626|Nootropic Agents|nootropic agents|mesh-ancestor
101585630|NCT00650377|Finasteride|finasteride|mesh-list
101585631|NCT00650377|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101585632|NCT00650377|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101585633|NCT00650377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101301277|NCT03859024|Ibuprofen|ibuprofen|mesh-list
101617351|NCT01067144|Sensory System Agents|sensory system agents|mesh-ancestor
101617352|NCT01067144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101617353|NCT01067144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617354|NCT01067144|Anticonvulsants|anticonvulsants|mesh-ancestor
101617355|NCT01067144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101617356|NCT01067144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101617357|NCT01067144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101617358|NCT01067144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101617359|NCT01067144|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101617360|NCT01067144|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101617361|NCT01067144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101617362|NCT01067144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617363|NCT01067144|Antimanic Agents|antimanic agents|mesh-ancestor
101585634|NCT00650377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585635|NCT00650377|Hormone Antagonists|hormone antagonists|mesh-ancestor
101585636|NCT00650377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101585637|NCT00650377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585638|NCT00650377|Urological Agents|urological agents|mesh-ancestor
101585639|NCT02649751|Roscovitine|roscovitine|mesh-list
101585640|NCT02649751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101585641|NCT02649751|Antiviral Agents|antiviral agents|mesh-ancestor
101585642|NCT02649751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101585643|NCT02649751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101585644|NCT02649751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101585645|NCT02649751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585646|NCT04252300|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101585647|NCT04252300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101585648|NCT04252300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101585649|NCT04252300|Antimetabolites|antimetabolites|mesh-ancestor
101585650|NCT04252300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585651|NCT04252300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101585652|NCT04252300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101585653|NCT04252300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101585654|NCT00924508|Triamcinolone|triamcinolone|mesh-list
101585655|NCT00924508|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101585656|NCT00924508|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101585657|NCT00924508|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101585658|NCT00924508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101585659|NCT00924508|Glucocorticoids|glucocorticoids|mesh-ancestor
101585660|NCT00924508|Hormones|hormones|mesh-ancestor
101585661|NCT00924508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101585662|NCT00924508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585663|NCT00924508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101585664|NCT00924508|Immunologic Factors|immunologic factors|mesh-ancestor
101585665|NCT00924508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101585670|NCT00650923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101585672|NCT00650923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585673|NCT00650923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101585674|NCT00650923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101585675|NCT00650923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101585676|NCT00650923|Growth Substances|growth substances|mesh-ancestor
101617365|NCT01067144|Autonomic Agents|autonomic agents|mesh-ancestor
101617366|NCT01067144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101617367|NCT01067144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101617368|NCT01067144|GABA Modulators|gaba modulators|mesh-ancestor
101617369|NCT01067144|GABA Agents|gaba agents|mesh-ancestor
101617370|NCT01078298|Varenicline|varenicline|mesh-list
101617371|NCT01078298|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101301646|NCT03012971|Dexmedetomidine|dexmedetomidine|mesh-list
101617372|NCT01078298|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101617373|NCT01078298|Cholinergic Agents|cholinergic agents|mesh-ancestor
101617374|NCT01078298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101617375|NCT01078298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617376|NCT01078298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617378|NCT00788593|Pancrelipase|pancrelipase|mesh-list
101416206|NCT00405444|Fentanyl|fentanyl|mesh-list
101585677|NCT00650923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585678|NCT00650923|Growth Inhibitors|growth inhibitors|mesh-ancestor
101585679|NCT00637858|Lycopene|lycopene|mesh-list
101585680|NCT00637858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101585681|NCT00637858|Antioxidants|antioxidants|mesh-ancestor
101585682|NCT00637858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585683|NCT00637858|Protective Agents|protective agents|mesh-ancestor
101585684|NCT00637858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585685|NCT00637858|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101585686|NCT00637858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101585687|NCT00637858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101585688|NCT02657161|Vaccines|vaccines|mesh-list
101585689|NCT02657161|Immunologic Factors|immunologic factors|mesh-ancestor
101585690|NCT02657161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585691|NCT01139580|Calcipotriene|calcipotriene|mesh-list
101585692|NCT01139580|Dermatologic Agents|dermatologic agents|mesh-ancestor
101585693|NCT04686760|Nitroglycerin|nitroglycerin|mesh-list
101585694|NCT04686760|Vasodilator Agents|vasodilator agents|mesh-ancestor
101585695|NCT04312698|Antihypertensive Agents|antihypertensive agents|mesh-list
101585696|NCT04312698|Hypolipidemic Agents|hypolipidemic agents|mesh-list
101585697|NCT04312698|Antimetabolites|antimetabolites|mesh-ancestor
101585698|NCT04312698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585699|NCT04312698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101585700|NCT04251832|Sodium thiosulfate|sodium thiosulfate|mesh-list
101585701|NCT04251832|Antidotes|antidotes|mesh-ancestor
101585702|NCT04251832|Protective Agents|protective agents|mesh-ancestor
101585703|NCT04251832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585704|NCT04251832|Antioxidants|antioxidants|mesh-ancestor
101585705|NCT04251832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585706|NCT04251832|Antitubercular Agents|antitubercular agents|mesh-ancestor
101585707|NCT04251832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101585708|NCT04251832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101585709|NCT04251832|Chelating Agents|chelating agents|mesh-ancestor
101585710|NCT04251832|Sequestering Agents|sequestering agents|mesh-ancestor
101585711|NCT02656771|Metronidazole|metronidazole|mesh-list
101585712|NCT02656771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101585713|NCT02656771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101585714|NCT02656771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101585715|NCT02656771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101585716|NCT00917644|Atorvastatin|atorvastatin|mesh-list
101585717|NCT00917644|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101585718|NCT00917644|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101585719|NCT00917644|Antimetabolites|antimetabolites|mesh-ancestor
101585720|NCT00917644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585721|NCT00917644|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101585722|NCT00917644|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101585723|NCT00917644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101585724|NCT00625170|Haloperidol|haloperidol|mesh-list
101617379|NCT00788593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101617381|NCT04106011|Analgesics|analgesics|mesh-ancestor
101617382|NCT04106011|Sensory System Agents|sensory system agents|mesh-ancestor
101617383|NCT04106011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101302319|NCT01274338|Immunologic Factors|immunologic factors|mesh-ancestor
101617384|NCT04106011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617385|NCT04106011|Anticonvulsants|anticonvulsants|mesh-ancestor
101585725|NCT00625170|Olanzapine|olanzapine|mesh-list
101585726|NCT00625170|Haloperidol decanoate|haloperidol decanoate|mesh-list
101585727|NCT00625170|Antiemetics|antiemetics|mesh-ancestor
101585728|NCT00625170|Autonomic Agents|autonomic agents|mesh-ancestor
101585729|NCT00625170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101585730|NCT00625170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585731|NCT00625170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101585732|NCT00625170|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101585733|NCT00625170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101585734|NCT00625170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101585735|NCT00625170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101585736|NCT00625170|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101585742|NCT00625170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101585743|NCT00625170|Dopamine Agents|dopamine agents|mesh-ancestor
101585744|NCT00625170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101585747|NCT00599755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101585748|NCT00599755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101585749|NCT00599755|Antimetabolites|antimetabolites|mesh-ancestor
101330579|NCT00396058|Dopamine Agents|dopamine agents|mesh-ancestor
101585750|NCT00599755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585751|NCT04251364|Acetazolamide|acetazolamide|mesh-list
101585752|NCT04251364|Atorvastatin|atorvastatin|mesh-list
101585753|NCT04251364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101585754|NCT04251364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101585755|NCT04251364|Antimetabolites|antimetabolites|mesh-ancestor
101585756|NCT04251364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585757|NCT04251364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101585758|NCT04251364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101585759|NCT04251364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101585760|NCT04251364|Anticonvulsants|anticonvulsants|mesh-ancestor
101585761|NCT04251364|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101585762|NCT04251364|Diuretics|diuretics|mesh-ancestor
101585763|NCT04251364|Natriuretic Agents|natriuretic agents|mesh-ancestor
101585764|NCT04251364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585765|NCT04811014|Buprenorphine|buprenorphine|mesh-list
101242637|NCT01636505|Fertility Agents|fertility agents|mesh-ancestor
101585766|NCT04811014|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101585767|NCT04811014|Naloxone|naloxone|mesh-list
101585768|NCT04811014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101585769|NCT04811014|Narcotics|narcotics|mesh-ancestor
101585770|NCT04811014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101585771|NCT04811014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585772|NCT04811014|Analgesics|analgesics|mesh-ancestor
101585773|NCT04811014|Sensory System Agents|sensory system agents|mesh-ancestor
101585774|NCT04811014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101585775|NCT04811014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101585776|NCT02648425|Leucovorin|leucovorin|mesh-list
101585777|NCT02648425|Cisplatin|cisplatin|mesh-list
101585778|NCT02648425|Fluorouracil|fluorouracil|mesh-list
101585779|NCT02648425|Capecitabine|capecitabine|mesh-list
101585780|NCT02648425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101585781|NCT02648425|Antimetabolites|antimetabolites|mesh-ancestor
101585782|NCT02648425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585783|NCT02648425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101585784|NCT02648425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101585785|NCT02648425|Immunologic Factors|immunologic factors|mesh-ancestor
101585786|NCT02648425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585787|NCT02648425|Antidotes|antidotes|mesh-ancestor
101585788|NCT02648425|Protective Agents|protective agents|mesh-ancestor
101585789|NCT02648425|Vitamin B Complex|vitamin b complex|mesh-ancestor
101585790|NCT02648425|Vitamins|vitamins|mesh-ancestor
101585791|NCT02648425|Micronutrients|micronutrients|mesh-ancestor
101585792|NCT02648503|Atropine|atropine|mesh-list
101617386|NCT04106011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101617387|NCT04106011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101302697|NCT02007174|Growth Substances|growth substances|mesh-ancestor
101617388|NCT04106011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101617389|NCT04106011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101617390|NCT04106011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101617391|NCT04106011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101302991|NCT02009007|Sympathomimetics|sympathomimetics|mesh-ancestor
101303073|NCT05777902|Ozanimod|ozanimod|mesh-list
101617392|NCT04106011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101303140|NCT05777122|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101416225|NCT00504283|Sensory System Agents|sensory system agents|mesh-ancestor
101585793|NCT02648503|Rocuronium|rocuronium|mesh-list
101585794|NCT02648503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101585795|NCT02648503|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101585796|NCT02648503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101585797|NCT02648503|Autonomic Agents|autonomic agents|mesh-ancestor
101585798|NCT02648503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101585799|NCT02648503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585800|NCT02648503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101585801|NCT02648503|Respiratory System Agents|respiratory system agents|mesh-ancestor
101585802|NCT02648503|Mydriatics|mydriatics|mesh-ancestor
101585803|NCT02648503|Parasympatholytics|parasympatholytics|mesh-ancestor
101585804|NCT02648503|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101585805|NCT02648503|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101585806|NCT02648503|Cholinergic Agents|cholinergic agents|mesh-ancestor
101585817|NCT05253508|Sensory System Agents|sensory system agents|mesh-ancestor
101585818|NCT05253508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101585819|NCT05253508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101585820|NCT05253508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101585821|NCT05253508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101585822|NCT05253508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101585823|NCT05253508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585826|NCT04524130|Anesthetics, Local|anesthetics, local|mesh-ancestor
101585827|NCT04524130|Anesthetics|anesthetics|mesh-ancestor
101585828|NCT04524130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101585829|NCT04524130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585830|NCT04524130|Sensory System Agents|sensory system agents|mesh-ancestor
101585831|NCT04524130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101585832|NCT04524130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101585833|NCT04524130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101585834|NCT04524130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101585835|NCT04524130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101585836|NCT04524130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585837|NCT04524130|Analgesics|analgesics|mesh-ancestor
101585838|NCT04524130|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101585839|NCT04524130|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101585840|NCT04524130|Anesthetics, General|anesthetics, general|mesh-ancestor
101585841|NCT04524130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101585842|NCT04524130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101585843|NCT04524130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101585844|NCT00649831|Amoxicillin|amoxicillin|mesh-list
101585845|NCT00649831|Azithromycin|azithromycin|mesh-list
101585846|NCT00649831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101585847|NCT00649831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101585848|NCT02648659|Amoxicillin|amoxicillin|mesh-list
101585849|NCT02648659|Metronidazole|metronidazole|mesh-list
101585850|NCT02648659|Clarithromycin|clarithromycin|mesh-list
101585851|NCT02648659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101585852|NCT02648659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101585853|NCT02648659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101585854|NCT02648659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101617393|NCT04106011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617394|NCT04106011|Antimanic Agents|antimanic agents|mesh-ancestor
101617395|NCT02875886|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101303368|NCT04495855|Dienogest|dienogest|mesh-list
101617397|NCT02875886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101303433|NCT04200911|Sirolimus|sirolimus|mesh-list
101617398|NCT02875886|Diuretics|diuretics|mesh-ancestor
101585855|NCT02648659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101585856|NCT02648659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101585857|NCT02648659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585858|NCT02648659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101585859|NCT02648659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101585860|NCT01125930|Tretinoin|tretinoin|mesh-list
101585861|NCT01125930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101585862|NCT01125930|Keratolytic Agents|keratolytic agents|mesh-ancestor
101585863|NCT01125930|Dermatologic Agents|dermatologic agents|mesh-ancestor
101585864|NCT02656615|Abiraterone Acetate|abiraterone acetate|mesh-list
101585865|NCT02656615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101585866|NCT02656615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101585867|NCT02656615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101585868|NCT02656615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585878|NCT00651235|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101585879|NCT00651235|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101585880|NCT00651235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585881|NCT00651235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101330612|NCT00031642|Rituximab|rituximab|mesh-list
101585882|NCT00651235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101585883|NCT00651235|Adrenergic Agents|adrenergic agents|mesh-ancestor
101585884|NCT00651235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101585885|NCT00651235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585886|NCT00651235|Vasodilator Agents|vasodilator agents|mesh-ancestor
101585887|NCT00651235|Sympatholytics|sympatholytics|mesh-ancestor
101585888|NCT00651235|Autonomic Agents|autonomic agents|mesh-ancestor
101585889|NCT00651235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101585890|NCT00651235|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101585891|NCT04806178|BCG Vaccine|bcg vaccine|mesh-list
101585892|NCT04806178|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101585893|NCT04806178|Immunologic Factors|immunologic factors|mesh-ancestor
101585894|NCT04806178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585895|NCT04015219|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101585896|NCT04015219|Lifitegrast|lifitegrast|mesh-list
101585897|NCT04015219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101585898|NCT01137474|Dapagliflozin|dapagliflozin|mesh-list
101585899|NCT01137474|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101585900|NCT01137474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585901|NCT01137474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101585902|NCT01137474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585903|NCT04790188|Nootropic Agents|nootropic agents|mesh-list
101585905|NCT01168973|Ramucirumab|ramucirumab|mesh-list
101585906|NCT01168973|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101585907|NCT01168973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101585908|NCT01168973|Tubulin Modulators|tubulin modulators|mesh-ancestor
101585909|NCT01168973|Antimitotic Agents|antimitotic agents|mesh-ancestor
101585910|NCT01168973|Mitosis Modulators|mitosis modulators|mesh-ancestor
101585911|NCT01168973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585912|NCT01168973|Immunologic Factors|immunologic factors|mesh-ancestor
101585913|NCT01168973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585914|NCT00631618|Sunitinib|sunitinib|mesh-list
101585915|NCT00631618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101585916|NCT00631618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101585917|NCT00631618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101585918|NCT00631618|Growth Substances|growth substances|mesh-ancestor
101585919|NCT00631618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585920|NCT00631618|Growth Inhibitors|growth inhibitors|mesh-ancestor
101585921|NCT00631618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101585922|NCT00631618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101617399|NCT02875886|Natriuretic Agents|natriuretic agents|mesh-ancestor
101617400|NCT02875886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617401|NCT02875886|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101617402|NCT02875886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101617403|NCT02875886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617404|NCT02875886|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
101617405|NCT02875886|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101617406|NCT02875886|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101617407|NCT02875886|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101303958|NCT02009436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101617409|NCT00793819|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101304115|NCT02011126|Imetelstat|imetelstat|mesh-list
101617410|NCT00793819|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101585923|NCT00631618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585924|NCT04431778|Ethosuximide|ethosuximide|mesh-list
101585925|NCT04431778|Anticonvulsants|anticonvulsants|mesh-ancestor
101585926|NCT04669132|Olanzapine|olanzapine|mesh-list
101585927|NCT04669132|Antiemetics|antiemetics|mesh-ancestor
101585928|NCT04669132|Autonomic Agents|autonomic agents|mesh-ancestor
101585929|NCT04669132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101585930|NCT04669132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585931|NCT04669132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101585936|NCT04669132|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101585937|NCT04669132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101585938|NCT04669132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101585939|NCT04669132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585940|NCT04669132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101585941|NCT04669132|Serotonin Agents|serotonin agents|mesh-ancestor
101585942|NCT01168349|Epoetin Alfa|epoetin alfa|mesh-list
101585943|NCT01168349|Hematinics|hematinics|mesh-ancestor
101585945|NCT00915772|Linagliptin|linagliptin|mesh-list
101585946|NCT00915772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101585947|NCT00915772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585948|NCT00915772|Incretins|incretins|mesh-ancestor
101585949|NCT00915772|Hormones|hormones|mesh-ancestor
101585950|NCT00915772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101585951|NCT00915772|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101585952|NCT00915772|Protease Inhibitors|protease inhibitors|mesh-ancestor
101585953|NCT00915772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101585954|NCT00915772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585955|NCT00632086|Aspirin|aspirin|mesh-list
101585956|NCT00632086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101585957|NCT00632086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101585958|NCT00632086|Analgesics|analgesics|mesh-ancestor
101585959|NCT00632086|Sensory System Agents|sensory system agents|mesh-ancestor
101585960|NCT00632086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101585961|NCT00632086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585962|NCT00632086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101585963|NCT00632086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101585964|NCT00632086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101585965|NCT00632086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101585966|NCT00632086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585967|NCT00632086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101585968|NCT00632086|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101617411|NCT00793819|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101617412|NCT00793819|Adrenergic Agents|adrenergic agents|mesh-ancestor
101617413|NCT00793819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101617414|NCT00793819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617415|NCT00793819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617416|NCT00793819|Urological Agents|urological agents|mesh-ancestor
101617417|NCT04109833|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101617418|NCT04109833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101617419|NCT02836665|Dermatologic Agents|dermatologic agents|mesh-list
101617421|NCT02836821|Apatinib|apatinib|mesh-list
101617422|NCT02836821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101617423|NCT02836821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101617424|NCT02836821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101617425|NCT02836821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617426|NCT02836821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101617427|NCT02836821|Antitubercular Agents|antitubercular agents|mesh-ancestor
101617428|NCT02836821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101585969|NCT00632086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101585970|NCT00632086|Antipyretics|antipyretics|mesh-ancestor
101585971|NCT00912964|Mirabegron|mirabegron|mesh-list
101585972|NCT00912964|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101585973|NCT00912964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101585974|NCT00912964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101585975|NCT00912964|Adrenergic Agents|adrenergic agents|mesh-ancestor
101585976|NCT00912964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101585977|NCT00912964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585978|NCT00912964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585979|NCT00912964|Urological Agents|urological agents|mesh-ancestor
101585980|NCT02641639|Fosbretabulin|fosbretabulin|mesh-list
101585981|NCT02641639|Combretastatin|combretastatin|mesh-list
101585982|NCT02641639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101585983|NCT02641639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101585984|NCT02641639|Tubulin Modulators|tubulin modulators|mesh-ancestor
101585985|NCT02641639|Antimitotic Agents|antimitotic agents|mesh-ancestor
101585986|NCT02641639|Mitosis Modulators|mitosis modulators|mesh-ancestor
101585987|NCT02641639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585988|NCT02647567|Caffeine|caffeine|mesh-list
101585989|NCT02647567|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101585990|NCT02647567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585991|NCT02647567|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101585992|NCT02647567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101585993|NCT02647567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585994|NCT02647567|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101585995|NCT02647567|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101585996|NCT02647567|Purinergic Agents|purinergic agents|mesh-ancestor
101585997|NCT02647567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101585998|NCT02647489|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101585999|NCT02647489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101586000|NCT02647489|Immunologic Factors|immunologic factors|mesh-ancestor
101586001|NCT02647489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586008|NCT00910897|Bortezomib|bortezomib|mesh-list
101586009|NCT00910897|BB 1101|bb 1101|mesh-list
101586010|NCT00910897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101586011|NCT00910897|Antiemetics|antiemetics|mesh-ancestor
101586012|NCT00910897|Autonomic Agents|autonomic agents|mesh-ancestor
101617429|NCT02836821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101617430|NCT02836821|Leprostatic Agents|leprostatic agents|mesh-ancestor
101617431|NCT02836821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101617432|NCT02836821|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101617433|NCT02836821|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101617434|NCT02836821|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101617435|NCT02836821|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101617436|NCT02836821|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101617437|NCT02836821|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101617438|NCT02836743|Melatonin|melatonin|mesh-list
101586013|NCT00910897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101586014|NCT00910897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586015|NCT00910897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101586016|NCT00910897|Glucocorticoids|glucocorticoids|mesh-ancestor
101586017|NCT00910897|Hormones|hormones|mesh-ancestor
101264319|NCT01767272|Histamine Agents|histamine agents|mesh-ancestor
101586018|NCT00910897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101586019|NCT00910897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101586020|NCT00910897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101586021|NCT00910897|Protease Inhibitors|protease inhibitors|mesh-ancestor
101586022|NCT00910897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101586023|NCT00910897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586024|NCT00910897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101586025|NCT00910897|Immunologic Factors|immunologic factors|mesh-ancestor
101586026|NCT00910897|Leprostatic Agents|leprostatic agents|mesh-ancestor
101586027|NCT00910897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101586028|NCT00910897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101586029|NCT00910897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101586030|NCT00910897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101586031|NCT00910897|Growth Substances|growth substances|mesh-ancestor
101586032|NCT00910897|Growth Inhibitors|growth inhibitors|mesh-ancestor
101586033|NCT00651547|Budesonide|budesonide|mesh-list
101586034|NCT00651547|Formoterol Fumarate|formoterol fumarate|mesh-list
101586035|NCT00651547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101586036|NCT00651547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101586037|NCT00651547|Autonomic Agents|autonomic agents|mesh-ancestor
101586038|NCT00651547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101586039|NCT00651547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586040|NCT00651547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101586041|NCT00651547|Respiratory System Agents|respiratory system agents|mesh-ancestor
101586042|NCT00651547|Glucocorticoids|glucocorticoids|mesh-ancestor
101586043|NCT00651547|Hormones|hormones|mesh-ancestor
101586044|NCT00651547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101586045|NCT00651547|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101586046|NCT00651547|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101586047|NCT00651547|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101586048|NCT00651547|Adrenergic Agents|adrenergic agents|mesh-ancestor
101586049|NCT00651547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101586050|NCT00651547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586051|NCT00912808|Donepezil|donepezil|mesh-list
101586052|NCT00912808|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101586053|NCT00912808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101586054|NCT00912808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586055|NCT00912808|Cholinergic Agents|cholinergic agents|mesh-ancestor
101586056|NCT00912808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101586057|NCT00912808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586058|NCT00912808|Nootropic Agents|nootropic agents|mesh-ancestor
101586059|NCT02647255|Methylprednisolone|methylprednisolone|mesh-list
101586060|NCT02647255|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101586061|NCT02647255|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101586062|NCT02647255|Prednisolone|prednisolone|mesh-list
101586063|NCT02647255|Prednisolone acetate|prednisolone acetate|mesh-list
101617440|NCT02836743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617441|NCT02836743|Protective Agents|protective agents|mesh-ancestor
101617442|NCT02836743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617443|NCT02836743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101617444|NCT04255368|Choline|choline|mesh-list
101617445|NCT04255368|Lipotropic Agents|lipotropic agents|mesh-ancestor
101617446|NCT04255368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101617447|NCT04255368|Antimetabolites|antimetabolites|mesh-ancestor
101617448|NCT04255368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617449|NCT04255368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101617450|NCT04255368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101617451|NCT04255368|Nootropic Agents|nootropic agents|mesh-ancestor
101617452|NCT00610818|Mitogens|mitogens|mesh-list
101586064|NCT02647255|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101586065|NCT02647255|Prednisolone phosphate|prednisolone phosphate|mesh-list
101586066|NCT02647255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101586067|NCT02647255|Antiemetics|antiemetics|mesh-ancestor
101586068|NCT02647255|Autonomic Agents|autonomic agents|mesh-ancestor
101586069|NCT02647255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101586070|NCT02647255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586084|NCT04329442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101586085|NCT04329442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101586086|NCT04329442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586087|NCT04329442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101586088|NCT04329442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101586089|NCT04414228|Anesthetics|anesthetics|mesh-list
101586090|NCT04414228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101586091|NCT04414228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586092|NCT00960531|Saponin QA-21V1|saponin qa-21v1|mesh-list
101586093|NCT00960531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101586094|NCT00960531|Immunologic Factors|immunologic factors|mesh-ancestor
101586095|NCT00960531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586097|NCT03017833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101586098|NCT03017833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586099|NCT02859909|Immunoglobulins|immunoglobulins|mesh-list
101586100|NCT02859909|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101586101|NCT02859909|Immunologic Factors|immunologic factors|mesh-ancestor
101586102|NCT02859909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586103|NCT00652639|Clonazepam|clonazepam|mesh-list
101586104|NCT00652639|Anticonvulsants|anticonvulsants|mesh-ancestor
101586105|NCT00652639|GABA Modulators|gaba modulators|mesh-ancestor
101586106|NCT00652639|GABA Agents|gaba agents|mesh-ancestor
101586107|NCT00652639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101586108|NCT00652639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586109|NCT00652639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586110|NCT02644915|Edaravone|edaravone|mesh-list
101586111|NCT02644915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101586112|NCT02644915|Antioxidants|antioxidants|mesh-ancestor
101586113|NCT02644915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586114|NCT02644915|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101586115|NCT02644915|Protective Agents|protective agents|mesh-ancestor
101586116|NCT02644915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586117|NCT00651703|Imiquimod|imiquimod|mesh-list
101586118|NCT00651703|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101586119|NCT00651703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101586120|NCT00651703|Immunologic Factors|immunologic factors|mesh-ancestor
101586121|NCT00651703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586122|NCT00651703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101586123|NCT00651703|Interferon Inducers|interferon inducers|mesh-ancestor
101586124|NCT02964585|Canagliflozin|canagliflozin|mesh-list
101617453|NCT00610818|Mitosis Modulators|mitosis modulators|mesh-ancestor
101617454|NCT00610818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617455|NCT00787891|Rabeprazole|rabeprazole|mesh-list
101617456|NCT00787891|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101617457|NCT00787891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101617458|NCT00787891|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101617459|NCT00787891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101617460|NCT00787891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617461|NCT00892437|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101617462|NCT00892437|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101617464|NCT00892437|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101617465|NCT00892437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101617466|NCT00892437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101617467|NCT00892437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617468|NCT00892437|Antiviral Agents|antiviral agents|mesh-ancestor
101617469|NCT00892437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101617470|NCT00892437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101617471|NCT00892437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101617472|NCT00892437|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101617473|NCT00892437|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101416303|NCT04725747|Anesthetics|anesthetics|mesh-ancestor
101586125|NCT02964585|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101586126|NCT02964585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586127|NCT02964585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101586128|NCT02964585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586129|NCT02640703|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101586130|NCT02640703|Immunologic Factors|immunologic factors|mesh-ancestor
101586131|NCT02640703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586132|NCT00651781|Bortezomib|bortezomib|mesh-list
101330677|NCT00031837|Gemcitabine|gemcitabine|mesh-list
101586133|NCT00651781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101586143|NCT00957801|Testosterone undecanoate|testosterone undecanoate|mesh-list
101586145|NCT00957801|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101586146|NCT00957801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101586147|NCT00957801|Antiemetics|antiemetics|mesh-ancestor
101586148|NCT00957801|Autonomic Agents|autonomic agents|mesh-ancestor
101586149|NCT00957801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101586150|NCT00957801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586151|NCT00957801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101586152|NCT00957801|Glucocorticoids|glucocorticoids|mesh-ancestor
101586153|NCT00957801|Hormones|hormones|mesh-ancestor
101586154|NCT00957801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101586155|NCT00957801|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101586156|NCT00957801|Protective Agents|protective agents|mesh-ancestor
101586157|NCT00957801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101586158|NCT00957801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101586159|NCT00957801|Androgens|androgens|mesh-ancestor
101586160|NCT00957801|Anabolic Agents|anabolic agents|mesh-ancestor
101586161|NCT02640469|Chlorhexidine|chlorhexidine|mesh-list
101586162|NCT02640469|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101617474|NCT00892437|Protease Inhibitors|protease inhibitors|mesh-ancestor
101617475|NCT00892437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101617476|NCT00892437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101617477|NCT02838537|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
101586163|NCT02640469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101586164|NCT02640469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101586165|NCT02640469|Disinfectants|disinfectants|mesh-ancestor
101586166|NCT02640469|Dermatologic Agents|dermatologic agents|mesh-ancestor
101586167|NCT02646709|Ketamine|ketamine|mesh-list
101586168|NCT02646709|Rocuronium|rocuronium|mesh-list
101586169|NCT02646709|Analgesics|analgesics|mesh-ancestor
101586170|NCT02646709|Sensory System Agents|sensory system agents|mesh-ancestor
101586171|NCT02646709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101586172|NCT02646709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586173|NCT02646709|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101586174|NCT02646709|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101586175|NCT02646709|Anesthetics, General|anesthetics, general|mesh-ancestor
101586176|NCT02646709|Anesthetics|anesthetics|mesh-ancestor
101586177|NCT02646709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101586178|NCT02646709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101586179|NCT02646709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101586180|NCT02646709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101586181|NCT02646709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586182|NCT02646709|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101586183|NCT02646709|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101586184|NCT02646709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101586185|NCT00651859|Bimatoprost|bimatoprost|mesh-list
101586186|NCT00651859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101586187|NCT00651859|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101586188|NCT00651859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101586189|NCT02640313|Choline|choline|mesh-list
101586190|NCT02640313|Lipotropic Agents|lipotropic agents|mesh-ancestor
101586191|NCT02640313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101586192|NCT02640313|Antimetabolites|antimetabolites|mesh-ancestor
101586193|NCT02640313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586194|NCT02640313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101586195|NCT02640313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101586196|NCT02640313|Nootropic Agents|nootropic agents|mesh-ancestor
101586197|NCT02955823|Dexamethasone|dexamethasone|mesh-list
101586198|NCT02955823|Rituximab|rituximab|mesh-list
101586199|NCT02955823|Lenalidomide|lenalidomide|mesh-list
101586200|NCT02955823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101586212|NCT02955823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101586214|NCT02955823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101586215|NCT02955823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101586216|NCT02955823|Growth Substances|growth substances|mesh-ancestor
101586217|NCT02955823|Growth Inhibitors|growth inhibitors|mesh-ancestor
101586218|NCT02646397|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101586219|NCT02646397|Fosinopril|fosinopril|mesh-list
101586220|NCT02646397|Benidipine|benidipine|mesh-list
101586221|NCT02646397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101586222|NCT02646397|Diuretics|diuretics|mesh-ancestor
101586223|NCT02646397|Natriuretic Agents|natriuretic agents|mesh-ancestor
101586224|NCT02646397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586225|NCT02646397|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101586226|NCT02646397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101586227|NCT02646397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586228|NCT02646397|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101586229|NCT02646397|Protease Inhibitors|protease inhibitors|mesh-ancestor
101586230|NCT02646397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101586231|NCT02646397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101586232|NCT02646397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101586233|NCT02646397|Vasodilator Agents|vasodilator agents|mesh-ancestor
101586234|NCT00652795|Doxycycline|doxycycline|mesh-list
101586235|NCT00652795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101586236|NCT00652795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101586237|NCT00652795|Antimalarials|antimalarials|mesh-ancestor
101586238|NCT00652795|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101586239|NCT00652795|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101617478|NCT02838537|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101617479|NCT02838537|Serotonin Agents|serotonin agents|mesh-ancestor
101617480|NCT02838537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101617481|NCT02838537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617482|NCT02838537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617483|NCT02836509|Acetaminophen|acetaminophen|mesh-list
101617485|NCT02836509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101617486|NCT02836509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101617487|NCT02836509|Analgesics|analgesics|mesh-ancestor
101617488|NCT02836509|Sensory System Agents|sensory system agents|mesh-ancestor
101617489|NCT02836509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101416327|NCT04725942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101586241|NCT00911170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101586242|NCT00911170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101586243|NCT00911170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101586244|NCT00911170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101586245|NCT00911170|Growth Substances|growth substances|mesh-ancestor
101586246|NCT00911170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586247|NCT00911170|Growth Inhibitors|growth inhibitors|mesh-ancestor
101586248|NCT00910975|Interferons|interferons|mesh-list
101586249|NCT00910975|Ribavirin|ribavirin|mesh-list
101586250|NCT00910975|Interferon-alpha|interferon-alpha|mesh-list
101586251|NCT00910975|Interferon alpha-2|interferon alpha-2|mesh-list
101586252|NCT00910975|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101586253|NCT00910975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101586254|NCT00910975|Antiviral Agents|antiviral agents|mesh-ancestor
101586255|NCT00910975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101586256|NCT00910975|Antimetabolites|antimetabolites|mesh-ancestor
101586257|NCT00910975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586258|NCT00910975|Immunologic Factors|immunologic factors|mesh-ancestor
101586259|NCT00910975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586260|NCT01167881|Glimepiride|glimepiride|mesh-list
101586261|NCT01167881|Empagliflozin|empagliflozin|mesh-list
101586262|NCT01167881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101586263|NCT01167881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101586264|NCT01167881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586265|NCT01167881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101586276|NCT02639767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101586277|NCT02639767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101586278|NCT04829344|Carticaine|carticaine|mesh-list
101586279|NCT04829344|Anesthetics, Local|anesthetics, local|mesh-ancestor
101586280|NCT04829344|Anesthetics|anesthetics|mesh-ancestor
101586281|NCT04829344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101586282|NCT04829344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586283|NCT04829344|Sensory System Agents|sensory system agents|mesh-ancestor
101586284|NCT04829344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101586285|NCT00960063|Cyclophosphamide|cyclophosphamide|mesh-list
101586286|NCT00960063|Temozolomide|temozolomide|mesh-list
101586287|NCT00960063|Ifosfamide|ifosfamide|mesh-list
101586288|NCT00960063|Doxorubicin|doxorubicin|mesh-list
101586289|NCT00960063|Irinotecan|irinotecan|mesh-list
101586290|NCT00960063|Etoposide|etoposide|mesh-list
101586291|NCT00960063|Vincristine|vincristine|mesh-list
101586292|NCT00960063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101586293|NCT00960063|Immunologic Factors|immunologic factors|mesh-ancestor
101586294|NCT00960063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586295|NCT00960063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101586296|NCT00960063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101586297|NCT00960063|Alkylating Agents|alkylating agents|mesh-ancestor
101586298|NCT00960063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586299|NCT00960063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101586300|NCT00960063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101586301|NCT00960063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101617490|NCT02836509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617491|NCT02836509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101617492|NCT02836509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101617493|NCT02836509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101617494|NCT02836509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101617495|NCT02836509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617496|NCT02836509|Antipyretics|antipyretics|mesh-ancestor
101617497|NCT05306379|Simvastatin|simvastatin|mesh-list
101617498|NCT05306379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101617499|NCT05306379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101617500|NCT05306379|Antimetabolites|antimetabolites|mesh-ancestor
101586302|NCT00960063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101586303|NCT00960063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101586304|NCT00960063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101586305|NCT00960063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101586306|NCT00960063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101586307|NCT00960063|Tubulin Modulators|tubulin modulators|mesh-ancestor
101586308|NCT00960063|Antimitotic Agents|antimitotic agents|mesh-ancestor
101586309|NCT00960063|Mitosis Modulators|mitosis modulators|mesh-ancestor
101586310|NCT02646319|Sirolimus|sirolimus|mesh-list
101586311|NCT02646319|Temsirolimus|temsirolimus|mesh-list
101586312|NCT02646319|MTOR Inhibitors|mtor inhibitors|mesh-list
101586313|NCT02646319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101586314|NCT02646319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101586315|NCT02646319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101586316|NCT02646319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101586317|NCT02646319|Antifungal Agents|antifungal agents|mesh-ancestor
101586318|NCT02646319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101586319|NCT02646319|Immunologic Factors|immunologic factors|mesh-ancestor
101586320|NCT02646319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586321|NCT02646319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101586322|NCT02646319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101586323|NCT02646319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586324|NCT00653965|Atorvastatin|atorvastatin|mesh-list
101586325|NCT00653965|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101586326|NCT00653965|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101586327|NCT00653965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101586328|NCT00653965|Antimetabolites|antimetabolites|mesh-ancestor
101586329|NCT00653965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586340|NCT00959907|Cholinergic Agents|cholinergic agents|mesh-ancestor
101586341|NCT00959907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101586342|NCT00959907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586343|NCT00959907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101586344|NCT00959907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101586345|NCT00912340|Trastuzumab|trastuzumab|mesh-list
101586346|NCT00912340|Everolimus|everolimus|mesh-list
101586347|NCT00912340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101586348|NCT00912340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101586349|NCT00912340|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101586350|NCT00912340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101586351|NCT00912340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101586352|NCT00912340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586353|NCT00912340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101586354|NCT00912340|Immunologic Factors|immunologic factors|mesh-ancestor
101586355|NCT00912340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586356|NCT01167257|Botulinum Toxins|botulinum toxins|mesh-list
101586357|NCT01167257|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101586358|NCT01167257|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101586359|NCT01167257|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101586360|NCT01167257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101586361|NCT01167257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586362|NCT01167257|Cholinergic Agents|cholinergic agents|mesh-ancestor
101586363|NCT01167257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101586364|NCT01167257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617501|NCT05306379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617502|NCT05306379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101617503|NCT05306379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101617504|NCT05306379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101617505|NCT05304663|Lomustine|lomustine|mesh-list
101617506|NCT05304663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101617507|NCT05304663|Alkylating Agents|alkylating agents|mesh-ancestor
101617508|NCT05304663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617509|NCT05304663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101617510|NCT04109755|Pembrolizumab|pembrolizumab|mesh-list
101617511|NCT04109755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101617512|NCT04109755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101617513|NCT04109755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101416348|NCT03890952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101243253|NCT01638962|Tocolytic Agents|tocolytic agents|mesh-ancestor
101586366|NCT01167257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101586367|NCT01119846|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101586368|NCT01119846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101586369|NCT01119846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586370|NCT01119846|Incretins|incretins|mesh-ancestor
101586371|NCT01119846|Hormones|hormones|mesh-ancestor
101586372|NCT01119846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101586373|NCT01119846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101586374|NCT01119846|Protease Inhibitors|protease inhibitors|mesh-ancestor
101586375|NCT01119846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101586376|NCT01119846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586377|NCT03775525|Capecitabine|capecitabine|mesh-list
101586378|NCT03775525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101586379|NCT03775525|Antimetabolites|antimetabolites|mesh-ancestor
101586380|NCT03775525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586381|NCT03775525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101586382|NCT00654043|Torsemide|torsemide|mesh-list
101586383|NCT00654043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101586384|NCT00654043|Diuretics|diuretics|mesh-ancestor
101586385|NCT00654043|Natriuretic Agents|natriuretic agents|mesh-ancestor
101586386|NCT00654043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586387|NCT00654043|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101586388|NCT00654043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101586389|NCT00654043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330713|NCT00031954|Antimetabolites|antimetabolites|mesh-ancestor
101586391|NCT04167007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101586423|NCT02639533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101586424|NCT02639377|Chlorhexidine|chlorhexidine|mesh-list
101586425|NCT02639377|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101586426|NCT02639377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101586427|NCT02639377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101586428|NCT02639377|Disinfectants|disinfectants|mesh-ancestor
101586429|NCT02639377|Dermatologic Agents|dermatologic agents|mesh-ancestor
101586430|NCT00910000|Carboplatin|carboplatin|mesh-list
101586431|NCT00910000|Gemcitabine|gemcitabine|mesh-list
101586432|NCT00910000|Vorinostat|vorinostat|mesh-list
101586433|NCT00910000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101586437|NCT00910000|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101586439|NCT02885909|Insulin|insulin|mesh-list
101586440|NCT02885909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101586441|NCT02885909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586442|NCT05657171|Cyproterone Acetate|cyproterone acetate|mesh-list
101586443|NCT05657171|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101586444|NCT05657171|Estradiol|estradiol|mesh-list
101586445|NCT05657171|Cyproterone|cyproterone|mesh-list
101617514|NCT04109755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617515|NCT04248309|Progesterone|progesterone|mesh-list
101617516|NCT04248309|Progestins|progestins|mesh-ancestor
101617517|NCT04248309|Hormones|hormones|mesh-ancestor
101617518|NCT04248309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101617519|NCT04248309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617520|NCT00892281|Doxycycline|doxycycline|mesh-list
101617521|NCT00892281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101617522|NCT00892281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101617523|NCT00892281|Antimalarials|antimalarials|mesh-ancestor
101617524|NCT00892281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101617525|NCT00892281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101617526|NCT02836353|Rifaximin|rifaximin|mesh-list
101617527|NCT02836353|Somatostatin|somatostatin|mesh-list
101617528|NCT02836353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101617529|NCT02836353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101617530|NCT02836353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101617531|NCT02836353|Hormones|hormones|mesh-ancestor
101617532|NCT02836353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101617533|NCT02836353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617534|NCT02836431|Dexmedetomidine|dexmedetomidine|mesh-list
101586446|NCT05657171|Estrogens|estrogens|mesh-ancestor
101586447|NCT05657171|Hormones|hormones|mesh-ancestor
101586448|NCT05657171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101586449|NCT05657171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586450|NCT05657171|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101586451|NCT05657171|Contraceptive Agents|contraceptive agents|mesh-ancestor
101586452|NCT05657171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101586453|NCT05657171|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101586454|NCT05657171|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101586455|NCT05657171|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101586456|NCT05657171|Androgen Antagonists|androgen antagonists|mesh-ancestor
101586457|NCT05657171|Hormone Antagonists|hormone antagonists|mesh-ancestor
101586458|NCT05657171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101586459|NCT05657171|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101586460|NCT00652873|Cabergoline|cabergoline|mesh-list
101586461|NCT00652873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101586462|NCT00652873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101586463|NCT00652873|Dopamine Agonists|dopamine agonists|mesh-ancestor
101586464|NCT00652873|Dopamine Agents|dopamine agents|mesh-ancestor
101586465|NCT00652873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101586466|NCT00652873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586467|NCT00652873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586468|NCT00652171|Lamotrigine|lamotrigine|mesh-list
101586469|NCT00652171|Anticonvulsants|anticonvulsants|mesh-ancestor
101586470|NCT00652171|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101586471|NCT00652171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101209081|NCT01443624|Hematinics|hematinics|mesh-ancestor
101586472|NCT00652171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586473|NCT00652171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101586474|NCT00652171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586475|NCT00652171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101586476|NCT00652171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101586477|NCT00652171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101617535|NCT02836431|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101617536|NCT02836431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101617537|NCT02836431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617538|NCT02836431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101617539|NCT02836431|Analgesics|analgesics|mesh-ancestor
101617540|NCT02836431|Sensory System Agents|sensory system agents|mesh-ancestor
101617541|NCT02836431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101617542|NCT02836431|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101617543|NCT02836431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101617544|NCT02836431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101617545|NCT02836431|Adrenergic Agents|adrenergic agents|mesh-ancestor
101617546|NCT02836431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101416384|NCT02824523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101586478|NCT00652171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101586479|NCT00652171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101586480|NCT01119768|Esomeprazole|esomeprazole|mesh-list
101586481|NCT01119768|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101586482|NCT01119768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101586483|NCT01119768|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101586484|NCT01119768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101586485|NCT01119768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586487|NCT01165307|Levonorgestrel|levonorgestrel|mesh-list
101586488|NCT01165307|Contraceptive Agents|contraceptive agents|mesh-list
101586489|NCT01165307|Contraceptives, Oral|contraceptives, oral|mesh-list
101586490|NCT01165307|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
101586491|NCT01165307|Estradiol|estradiol|mesh-list
101586492|NCT01165307|Estrogens|estrogens|mesh-ancestor
101586493|NCT01165307|Hormones|hormones|mesh-ancestor
101586494|NCT01165307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101586495|NCT01165307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586496|NCT01165307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101586497|NCT01165307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101586498|NCT01165307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101586499|NCT01165307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101586500|NCT01165307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101586501|NCT01165307|Analgesics|analgesics|mesh-ancestor
101586502|NCT01165307|Sensory System Agents|sensory system agents|mesh-ancestor
101586518|NCT02639143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101586519|NCT02639143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586520|NCT02639143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586521|NCT02644057|Dobutamine|dobutamine|mesh-list
101586522|NCT02644057|Milrinone|milrinone|mesh-list
101586523|NCT02644057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101586524|NCT02644057|Sympathomimetics|sympathomimetics|mesh-ancestor
101586525|NCT02644057|Autonomic Agents|autonomic agents|mesh-ancestor
101586526|NCT02644057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101586527|NCT02644057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586528|NCT02644057|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101586529|NCT02644057|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101586530|NCT02644057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101264323|NCT01767298|Valsartan|valsartan|mesh-list
101586531|NCT02644057|Adrenergic Agents|adrenergic agents|mesh-ancestor
101586532|NCT02644057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101586533|NCT02644057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586534|NCT02644057|Protective Agents|protective agents|mesh-ancestor
101586535|NCT02644057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101586536|NCT02644057|Vasodilator Agents|vasodilator agents|mesh-ancestor
101586537|NCT02644057|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101586538|NCT02644057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101586539|NCT02644057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101617547|NCT02836431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617549|NCT05326425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101617550|NCT05326425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101274589|NCT01857726|Doxorubicin|doxorubicin|mesh-list
101617551|NCT05326425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617552|NCT00784693|Tanezumab|tanezumab|mesh-list
101617553|NCT00784693|Analgesics|analgesics|mesh-ancestor
101617554|NCT00784693|Sensory System Agents|sensory system agents|mesh-ancestor
101617555|NCT00784693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101617556|NCT00784693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617557|NCT00915811|Fludarabine|fludarabine|mesh-list
101586540|NCT00654277|Ondansetron|ondansetron|mesh-list
101586541|NCT00654277|Antiemetics|antiemetics|mesh-ancestor
101586542|NCT00654277|Autonomic Agents|autonomic agents|mesh-ancestor
101586543|NCT00654277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101586544|NCT00654277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586545|NCT00654277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101586546|NCT00654277|Antipruritics|antipruritics|mesh-ancestor
101586547|NCT00654277|Dermatologic Agents|dermatologic agents|mesh-ancestor
101586548|NCT00654277|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101586549|NCT00654277|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101586550|NCT00654277|Serotonin Agents|serotonin agents|mesh-ancestor
101586551|NCT00654277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101586552|NCT00654277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586553|NCT01124838|Prednisone|prednisone|mesh-list
101586554|NCT01124838|Adalimumab|adalimumab|mesh-list
101586555|NCT01124838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101586556|NCT01124838|Glucocorticoids|glucocorticoids|mesh-ancestor
101586557|NCT01124838|Hormones|hormones|mesh-ancestor
101586558|NCT01124838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101586559|NCT01124838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586564|NCT00630435|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101586565|NCT00630435|Estrogens|estrogens|mesh-ancestor
101586566|NCT00630435|Hormones|hormones|mesh-ancestor
101586567|NCT00630435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101586568|NCT00630435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586569|NCT02858193|Carbocysteine|carbocysteine|mesh-list
101586570|NCT02858193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101586571|NCT02858193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101586572|NCT02858193|Expectorants|expectorants|mesh-ancestor
101586573|NCT02858193|Respiratory System Agents|respiratory system agents|mesh-ancestor
101586574|NCT02581215|Ramucirumab|ramucirumab|mesh-list
101586575|NCT02581215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101586576|NCT04282941|Ibuprofen|ibuprofen|mesh-list
101586577|NCT04282941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101586578|NCT04282941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101586579|NCT04282941|Analgesics|analgesics|mesh-ancestor
101586580|NCT04282941|Sensory System Agents|sensory system agents|mesh-ancestor
101586581|NCT04282941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101586582|NCT04282941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586583|NCT04282941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101586584|NCT04282941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101586585|NCT04282941|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101586586|NCT04282941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101586587|NCT04282941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586589|NCT00910858|Epoetin Alfa|epoetin alfa|mesh-list
101586590|NCT00910858|Immunologic Factors|immunologic factors|mesh-ancestor
101586591|NCT00910858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586592|NCT00910858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101586593|NCT00910858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101586594|NCT00910858|Growth Substances|growth substances|mesh-ancestor
101586595|NCT00910858|Growth Inhibitors|growth inhibitors|mesh-ancestor
101617558|NCT00915811|Busulfan|busulfan|mesh-list
101617559|NCT00915811|Thymoglobulin|thymoglobulin|mesh-list
101617560|NCT00915811|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101617561|NCT00915811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101617562|NCT00915811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617563|NCT00915811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101617564|NCT00915811|Immunologic Factors|immunologic factors|mesh-ancestor
101617565|NCT00915811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617566|NCT00915811|Alkylating Agents|alkylating agents|mesh-ancestor
101617567|NCT00915811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101617568|NCT00915811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101617569|NCT00892047|Aripiprazole|aripiprazole|mesh-list
101617570|NCT00892047|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101617571|NCT00892047|Antidepressive Agents|antidepressive agents|mesh-ancestor
101617572|NCT00892047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101617573|NCT00892047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101617574|NCT00892047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101586596|NCT00910858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101586597|NCT00910858|Hematinics|hematinics|mesh-ancestor
101586598|NCT02567253|Cisplatin|cisplatin|mesh-list
101586599|NCT02567253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101586600|NCT02859285|Estradiol|estradiol|mesh-list
101586601|NCT02859285|Estrogens|estrogens|mesh-ancestor
101586602|NCT02859285|Hormones|hormones|mesh-ancestor
101586603|NCT02859285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101586604|NCT02859285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586605|NCT04260412|Psyllium|psyllium|mesh-list
101586606|NCT04260412|Cathartics|cathartics|mesh-ancestor
101586607|NCT04260412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101586609|NCT03223155|Ipilimumab|ipilimumab|mesh-list
101586610|NCT03223155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101586611|NCT03223155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101586612|NCT03223155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101586613|NCT03223155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586614|NCT04476550|Lenograstim|lenograstim|mesh-list
101586615|NCT04476550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101586616|NCT04476550|Immunologic Factors|immunologic factors|mesh-ancestor
101586617|NCT04476550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586618|NCT00598975|Irinotecan|irinotecan|mesh-list
101586619|NCT00598975|Cetuximab|cetuximab|mesh-list
101586620|NCT00598975|Etirinotecan pegol|etirinotecan pegol|mesh-list
101586621|NCT00598975|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101586622|NCT00598975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101586623|NCT00598975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101586624|NCT00598975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586625|NCT00598975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101586626|NCT00598975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101586627|NCT00598975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101586628|NCT01124604|Tapentadol|tapentadol|mesh-list
101586629|NCT01124604|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101586630|NCT01124604|Narcotics|narcotics|mesh-ancestor
101586631|NCT01124604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101586632|NCT01124604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586633|NCT01124604|Analgesics|analgesics|mesh-ancestor
101586645|NCT00909844|Contraceptive Agents|contraceptive agents|mesh-ancestor
101586646|NCT00909844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101586647|NCT00909844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586648|NCT00909844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101586649|NCT00909844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101617575|NCT00892047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101617576|NCT00892047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617577|NCT00892047|Dopamine Agonists|dopamine agonists|mesh-ancestor
101617578|NCT00892047|Dopamine Agents|dopamine agents|mesh-ancestor
101617579|NCT00892047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101617580|NCT00892047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617581|NCT00892047|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101617582|NCT00892047|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101617583|NCT00892047|Serotonin Agents|serotonin agents|mesh-ancestor
101617584|NCT00892047|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101617585|NCT00892047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101617586|NCT00892047|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101617587|NCT00892047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101617588|NCT00892047|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101617589|NCT00892047|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101617590|NCT00892047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101416431|NCT00139230|Vitamins|vitamins|mesh-ancestor
101586650|NCT00909844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101586651|NCT01124448|TFF1 protein, human|tff1 protein, human|mesh-list
101586652|NCT01124448|Growth Inhibitors|growth inhibitors|mesh-ancestor
101586653|NCT01124448|Growth Substances|growth substances|mesh-ancestor
101586654|NCT01124448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586656|NCT02638909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101586657|NCT02638909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101586658|NCT02638909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101586659|NCT02638909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586660|NCT02643823|Methotrexate|methotrexate|mesh-list
101586661|NCT02643823|Antirheumatic Agents|antirheumatic agents|mesh-list
101586662|NCT02643823|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101586663|NCT02643823|Abortifacient Agents|abortifacient agents|mesh-ancestor
101586664|NCT02643823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101586665|NCT02643823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586666|NCT02643823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101586667|NCT02643823|Antimetabolites|antimetabolites|mesh-ancestor
101586668|NCT02643823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586669|NCT02643823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101586670|NCT02643823|Dermatologic Agents|dermatologic agents|mesh-ancestor
101586671|NCT02643823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101586672|NCT02643823|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101586673|NCT02643823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101586674|NCT02643823|Immunologic Factors|immunologic factors|mesh-ancestor
101586675|NCT02643823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101586676|NCT02638831|Ketorolac|ketorolac|mesh-list
101586677|NCT02638831|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101586678|NCT02638831|Ketoprofen|ketoprofen|mesh-list
101586679|NCT02638831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101586680|NCT02638831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101586681|NCT02638831|Analgesics|analgesics|mesh-ancestor
101586682|NCT02638831|Sensory System Agents|sensory system agents|mesh-ancestor
101586683|NCT02638831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101586684|NCT02638831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586685|NCT02638831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101586686|NCT02638831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101586687|NCT02638831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101617591|NCT00892047|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101617592|NCT02835729|Cytarabine|cytarabine|mesh-list
101617593|NCT02835729|Idarubicin|idarubicin|mesh-list
101617594|NCT02835729|Tryptophan|tryptophan|mesh-list
101617595|NCT02835729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101617596|NCT02835729|Antimetabolites|antimetabolites|mesh-ancestor
101617597|NCT02835729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617598|NCT02835729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101617599|NCT02835729|Antiviral Agents|antiviral agents|mesh-ancestor
101617600|NCT02835729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101617601|NCT02835729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101617602|NCT02835729|Immunologic Factors|immunologic factors|mesh-ancestor
101586688|NCT02638831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101586689|NCT02638831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586690|NCT01136772|Haloperidol|haloperidol|mesh-list
101586691|NCT01136772|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101586692|NCT01136772|Haloperidol decanoate|haloperidol decanoate|mesh-list
101586693|NCT01136772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101586694|NCT01136772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101586699|NCT01136772|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101586700|NCT01136772|Serotonin Agents|serotonin agents|mesh-ancestor
101586701|NCT01136772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101586702|NCT01136772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586703|NCT01136772|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101586704|NCT01136772|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101586705|NCT01136772|Dopamine Agents|dopamine agents|mesh-ancestor
101586706|NCT01136772|Antiemetics|antiemetics|mesh-ancestor
101586707|NCT01136772|Autonomic Agents|autonomic agents|mesh-ancestor
101586708|NCT01136772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101586709|NCT01136772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101586710|NCT01136772|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101586711|NCT00909532|Ivacaftor|ivacaftor|mesh-list
101586712|NCT00909532|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101586713|NCT00909532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101586714|NCT00909532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586715|NCT02756845|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
101586716|NCT02756845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101586717|NCT02756845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101586718|NCT01136382|Budesonide|budesonide|mesh-list
101586719|NCT01136382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101586720|NCT01136382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101586721|NCT01136382|Autonomic Agents|autonomic agents|mesh-ancestor
101586722|NCT01136382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101586723|NCT01136382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586724|NCT01136382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101586725|NCT01136382|Respiratory System Agents|respiratory system agents|mesh-ancestor
101586726|NCT01136382|Glucocorticoids|glucocorticoids|mesh-ancestor
101586727|NCT01136382|Hormones|hormones|mesh-ancestor
101586728|NCT01136382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101586729|NCT03513562|Venetoclax|venetoclax|mesh-list
101586730|NCT03513562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101586731|NCT02731729|Nivolumab|nivolumab|mesh-list
101586732|NCT02731729|Ipilimumab|ipilimumab|mesh-list
101586733|NCT02731729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101586734|NCT02731729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101586735|NCT02731729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101586736|NCT02731729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586737|NCT02645461|Palmidrol|palmidrol|mesh-list
101586738|NCT02645461|Riluzole|riluzole|mesh-list
101586739|NCT02645461|Anticonvulsants|anticonvulsants|mesh-ancestor
101586740|NCT02645461|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101586741|NCT02645461|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101586742|NCT02645461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101330775|NCT00032149|Analgesics|analgesics|mesh-ancestor
101617603|NCT02835729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617604|NCT02835729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101617605|NCT02835729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101617606|NCT02835729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101617607|NCT02835729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101586743|NCT02645461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586744|NCT02645461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586745|NCT02645461|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101586746|NCT02645461|Protective Agents|protective agents|mesh-ancestor
101586747|NCT02645461|Analgesics|analgesics|mesh-ancestor
101586748|NCT02645461|Sensory System Agents|sensory system agents|mesh-ancestor
101586749|NCT02645461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101586750|NCT02645461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101586752|NCT02645461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101586753|NCT02645461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101586754|NCT02645461|Antiviral Agents|antiviral agents|mesh-ancestor
101586755|NCT02645461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101586756|NCT02645461|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101586757|NCT02645461|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101586758|NCT02645461|Hormones|hormones|mesh-ancestor
101586759|NCT02645461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101586760|NCT00654589|Deferasirox|deferasirox|mesh-list
101586761|NCT00654589|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101586762|NCT00654589|Chelating Agents|chelating agents|mesh-ancestor
101586763|NCT00654589|Sequestering Agents|sequestering agents|mesh-ancestor
101586764|NCT00654589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586765|NCT02645227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101586766|NCT02645227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101586767|NCT02645227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101586768|NCT02645227|Antimetabolites|antimetabolites|mesh-ancestor
101586769|NCT02645227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586770|NCT02645227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101586771|NCT02645227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101586772|NCT02645227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101586773|NCT00652483|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101586774|NCT00652483|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101586775|NCT00652483|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101586776|NCT00652483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101586777|NCT00652483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101586778|NCT00652483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101586779|NCT00652483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101586780|NCT00652483|Adrenergic Agents|adrenergic agents|mesh-ancestor
101586781|NCT00652483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101586782|NCT00652483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586783|NCT00652483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586784|NCT01119066|Cyclophosphamide|cyclophosphamide|mesh-list
101586785|NCT01119066|Melphalan|melphalan|mesh-list
101586786|NCT01119066|Busulfan|busulfan|mesh-list
101586787|NCT01119066|Thiotepa|thiotepa|mesh-list
101586788|NCT01119066|Fludarabine|fludarabine|mesh-list
101586789|NCT01119066|Clofarabine|clofarabine|mesh-list
101586790|NCT01119066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101586791|NCT01119066|Immunologic Factors|immunologic factors|mesh-ancestor
101586792|NCT01119066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586793|NCT01119066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101586794|NCT01119066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101586795|NCT01119066|Alkylating Agents|alkylating agents|mesh-ancestor
101586796|NCT01119066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586797|NCT01119066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101586798|NCT01119066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101586799|NCT01119066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101586800|NCT01119066|Antimetabolites|antimetabolites|mesh-ancestor
101586801|NCT00910624|Ribavirin|ribavirin|mesh-list
101586802|NCT00910624|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101586803|NCT00910624|Antimetabolites|antimetabolites|mesh-ancestor
101586804|NCT00910624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586805|NCT00910624|Antiviral Agents|antiviral agents|mesh-ancestor
101586806|NCT00910624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101617608|NCT02835729|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101617609|NCT02835729|Antidepressive Agents|antidepressive agents|mesh-ancestor
101617610|NCT02835729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101617611|NCT02835651|Palmitic Acid|palmitic acid|mesh-list
101617612|NCT02835651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101617613|NCT02835651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617614|NCT00787267|Dasatinib|dasatinib|mesh-list
101617615|NCT00787267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101617616|NCT00787267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101549166|NCT01313559|Everolimus|everolimus|mesh-list
101586807|NCT00654667|Resveratrol|resveratrol|mesh-list
101586808|NCT00654667|Antioxidants|antioxidants|mesh-ancestor
101586809|NCT00654667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586810|NCT00654667|Protective Agents|protective agents|mesh-ancestor
101586811|NCT00654667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586812|NCT00654667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101586813|NCT00654667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101586815|NCT01123980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101586816|NCT01123980|Metformin|metformin|mesh-list
101586817|NCT01123980|Insulin Glargine|insulin glargine|mesh-list
101586818|NCT01123980|Insulin Aspart|insulin aspart|mesh-list
101586819|NCT01123980|Glimepiride|glimepiride|mesh-list
101586820|NCT01123980|Biphasic Insulins|biphasic insulins|mesh-list
101586821|NCT01123980|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101586822|NCT01123980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101586823|NCT01123980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586824|NCT01123980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101586825|NCT01123980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101586827|NCT02859129|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
101586828|NCT02859129|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101586829|NCT02859129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101586830|NCT02859129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101586831|NCT02859129|Antimetabolites|antimetabolites|mesh-ancestor
101586832|NCT02859129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586833|NCT02859129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101586834|NCT02859129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101586835|NCT02859129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101586836|NCT02859129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101586837|NCT04164823|Analgesics|analgesics|mesh-list
101586838|NCT04164823|Sensory System Agents|sensory system agents|mesh-ancestor
101586839|NCT04164823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101586840|NCT04164823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586841|NCT02857959|Penicillins|penicillins|mesh-list
101586845|NCT02857959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101586846|NCT02857959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101586848|NCT02643433|Immunologic Factors|immunologic factors|mesh-ancestor
101586849|NCT02643433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586850|NCT00632476|Ascorbic Acid|ascorbic acid|mesh-list
101586851|NCT00632476|Vitamins|vitamins|mesh-ancestor
101586852|NCT00632476|Micronutrients|micronutrients|mesh-ancestor
101586853|NCT00632476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586854|NCT00632476|Antioxidants|antioxidants|mesh-ancestor
101586855|NCT00632476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586856|NCT00632476|Protective Agents|protective agents|mesh-ancestor
101586857|NCT04164745|Pembrolizumab|pembrolizumab|mesh-list
101586858|NCT04164745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101586859|NCT04164745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101586860|NCT04164745|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101586861|NCT04164745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586862|NCT01198522|Gemcitabine|gemcitabine|mesh-list
101586863|NCT01198522|Antibodies|antibodies|mesh-list
101586864|NCT01198522|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101586865|NCT01198522|Immunologic Factors|immunologic factors|mesh-ancestor
101586866|NCT01198522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586867|NCT01198522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101617617|NCT00787267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101617618|NCT00787267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617619|NCT02838615|Dexamethasone|dexamethasone|mesh-list
101617620|NCT02838615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101617621|NCT02838615|Antiemetics|antiemetics|mesh-ancestor
101617622|NCT02838615|Autonomic Agents|autonomic agents|mesh-ancestor
101586868|NCT01198522|Antimetabolites|antimetabolites|mesh-ancestor
101586869|NCT01198522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586870|NCT01198522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101586871|NCT02638285|Clomiphene|clomiphene|mesh-list
101586872|NCT02638285|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101586873|NCT02638285|Hormone Antagonists|hormone antagonists|mesh-ancestor
101586874|NCT02638285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101586875|NCT02638285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586876|NCT02638285|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101586877|NCT02638285|Fertility Agents|fertility agents|mesh-ancestor
101586878|NCT02638285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101586879|NCT02638285|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101586880|NCT02638285|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101586881|NCT01134250|Paclitaxel|paclitaxel|mesh-list
101243776|NCT01650883|Vitamins|vitamins|mesh-list
101586882|NCT01134250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101586883|NCT01134250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101586884|NCT01134250|Tubulin Modulators|tubulin modulators|mesh-ancestor
101586885|NCT01134250|Antimitotic Agents|antimitotic agents|mesh-ancestor
101586886|NCT01134250|Mitosis Modulators|mitosis modulators|mesh-ancestor
101586887|NCT01134250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586888|NCT01118520|Amlodipine|amlodipine|mesh-list
101586889|NCT01118520|Perindopril|perindopril|mesh-list
101586890|NCT01118520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101586891|NCT01118520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101586892|NCT01118520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101586893|NCT01118520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586894|NCT01118520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101586895|NCT01118520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586896|NCT01118520|Vasodilator Agents|vasodilator agents|mesh-ancestor
101586897|NCT01118520|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101586898|NCT01118520|Protease Inhibitors|protease inhibitors|mesh-ancestor
101586899|NCT01118520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101586901|NCT01135992|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101586902|NCT01135992|Insulin Glargine|insulin glargine|mesh-list
101586903|NCT01135992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101586904|NCT01135992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586905|NCT03734770|Progesterone|progesterone|mesh-list
101586906|NCT03734770|Progestins|progestins|mesh-ancestor
101586907|NCT03734770|Hormones|hormones|mesh-ancestor
101586908|NCT03734770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101586909|NCT03734770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586910|NCT00959049|Vaccines|vaccines|mesh-list
101586911|NCT00959049|Immunologic Factors|immunologic factors|mesh-ancestor
101586912|NCT00959049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586913|NCT00956943|Nicotine|nicotine|mesh-list
101586926|NCT01135914|Growth Substances|growth substances|mesh-ancestor
101586927|NCT01135914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586928|NCT01135914|Growth Inhibitors|growth inhibitors|mesh-ancestor
101586929|NCT01135914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101586931|NCT00907738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101586932|NCT00907738|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101586933|NCT00907738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101586934|NCT00907738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586935|NCT02829723|Spartalizumab|spartalizumab|mesh-list
101586936|NCT02829723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101586937|NCT02829723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586938|NCT02829723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101586939|NCT02829723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101586940|NCT01123356|Lenalidomide|lenalidomide|mesh-list
101586941|NCT01123356|Ofatumumab|ofatumumab|mesh-list
101586942|NCT01123356|Immunologic Factors|immunologic factors|mesh-ancestor
101617623|NCT02838615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101617662|NCT02838225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101617663|NCT02838225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101617664|NCT02838225|Tubulin Modulators|tubulin modulators|mesh-ancestor
101617665|NCT02838225|Antimitotic Agents|antimitotic agents|mesh-ancestor
101617666|NCT02838225|Mitosis Modulators|mitosis modulators|mesh-ancestor
101617667|NCT02838225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101617668|NCT02838225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101586943|NCT01123356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586944|NCT01123356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101586945|NCT01123356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101586946|NCT01123356|Growth Substances|growth substances|mesh-ancestor
101586947|NCT01123356|Growth Inhibitors|growth inhibitors|mesh-ancestor
101586948|NCT01123356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101586949|NCT00630357|Levetiracetam|levetiracetam|mesh-list
101586950|NCT00630357|Anticonvulsants|anticonvulsants|mesh-ancestor
101586951|NCT00630357|Nootropic Agents|nootropic agents|mesh-ancestor
101586952|NCT02858817|Atovaquone|atovaquone|mesh-list
101586953|NCT02858817|Proguanil|proguanil|mesh-list
101586954|NCT02858817|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
101586955|NCT02858817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101586956|NCT02858817|Antimalarials|antimalarials|mesh-ancestor
101586957|NCT02858817|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101586958|NCT02858817|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101586959|NCT02858817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101586960|NCT02858817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586961|NCT02858817|Antimetabolites|antimetabolites|mesh-ancestor
101586962|NCT02883192|Ondansetron|ondansetron|mesh-list
101586963|NCT02883192|Antiemetics|antiemetics|mesh-ancestor
101586964|NCT02883192|Autonomic Agents|autonomic agents|mesh-ancestor
101586965|NCT02883192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101586966|NCT02883192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586967|NCT02883192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101586968|NCT02883192|Antipruritics|antipruritics|mesh-ancestor
101586969|NCT02883192|Dermatologic Agents|dermatologic agents|mesh-ancestor
101586970|NCT02883192|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101586971|NCT02883192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101586972|NCT02883192|Serotonin Agents|serotonin agents|mesh-ancestor
101586973|NCT02883192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101586974|NCT02883192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586991|NCT00632554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101586992|NCT00632554|Antiemetics|antiemetics|mesh-ancestor
101586993|NCT00632554|Autonomic Agents|autonomic agents|mesh-ancestor
101586994|NCT00632554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101586995|NCT00632554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101586996|NCT00632554|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101586997|NCT00632554|Protective Agents|protective agents|mesh-ancestor
101586998|NCT03082209|Bevacizumab|bevacizumab|mesh-list
101586999|NCT03082209|Venetoclax|venetoclax|mesh-list
101587000|NCT03082209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101587001|NCT03082209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101587002|NCT03082209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101587003|NCT03082209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101587004|NCT03082209|Growth Substances|growth substances|mesh-ancestor
101587005|NCT03082209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587006|NCT03082209|Growth Inhibitors|growth inhibitors|mesh-ancestor
101587007|NCT02224144|Vitamin D|vitamin d|mesh-list
101587008|NCT02224144|Cholecalciferol|cholecalciferol|mesh-list
101587009|NCT02224144|Calcitriol|calcitriol|mesh-list
101587010|NCT02224144|Vitamins|vitamins|mesh-ancestor
101587011|NCT02224144|Micronutrients|micronutrients|mesh-ancestor
101587012|NCT02224144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587013|NCT02224144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101587014|NCT02224144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101587015|NCT02224144|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101587016|NCT02224144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101617669|NCT02838225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101617670|NCT02838225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101617672|NCT00928434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101617673|NCT00928434|Fertility Agents|fertility agents|mesh-ancestor
101617674|NCT00928434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101617675|NCT00928434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617676|NCT00928434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101416489|NCT00403442|Bevacizumab|bevacizumab|mesh-list
101587017|NCT02224144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587018|NCT02224144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101587019|NCT05419180|Stiripentol|stiripentol|mesh-list
101587020|NCT05419180|Anticonvulsants|anticonvulsants|mesh-ancestor
101587021|NCT04280289|Cannabidiol|cannabidiol|mesh-list
101587022|NCT04280289|Anticonvulsants|anticonvulsants|mesh-ancestor
101587023|NCT03302728|Lenalidomide|lenalidomide|mesh-list
101587024|NCT03302728|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101587025|NCT03302728|Immunologic Factors|immunologic factors|mesh-ancestor
101587026|NCT03302728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587027|NCT03302728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101587028|NCT03302728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101587029|NCT03302728|Growth Substances|growth substances|mesh-ancestor
101587030|NCT03302728|Growth Inhibitors|growth inhibitors|mesh-ancestor
101587031|NCT03302728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101587032|NCT03302728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101587033|NCT03302728|Immunotoxins|immunotoxins|mesh-ancestor
101587034|NCT03302728|Immunoconjugates|immunoconjugates|mesh-ancestor
101587035|NCT03832972|Estrogens|estrogens|mesh-list
101587036|NCT03832972|Hormones|hormones|mesh-ancestor
101587042|NCT02860299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587043|NCT02860299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101587044|NCT02860299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101587045|NCT02858505|Iron|iron|mesh-list
101587046|NCT02858505|Trace Elements|trace elements|mesh-ancestor
101587047|NCT02858505|Micronutrients|micronutrients|mesh-ancestor
101587048|NCT02858505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587049|NCT01518556|Idarubicin|idarubicin|mesh-list
101587050|NCT01518556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101587051|NCT01518556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101587052|NCT01518556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101587053|NCT01518556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101587054|NCT01518556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101587055|NCT01518556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587057|NCT02994069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101587058|NCT02860221|Epinephrine|epinephrine|mesh-list
101587059|NCT02860221|Tranexamic Acid|tranexamic acid|mesh-list
101587060|NCT02860221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101587061|NCT02860221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101587062|NCT02860221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587063|NCT02860221|Hemostatics|hemostatics|mesh-ancestor
101587064|NCT02860221|Coagulants|coagulants|mesh-ancestor
101587065|NCT02860221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101587066|NCT02860221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101587067|NCT02860221|Adrenergic Agents|adrenergic agents|mesh-ancestor
101587068|NCT02860221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101587069|NCT02860221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587070|NCT02860221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101587071|NCT02860221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101587072|NCT02860221|Autonomic Agents|autonomic agents|mesh-ancestor
101587073|NCT02860221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101587074|NCT02860221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101587075|NCT02860221|Respiratory System Agents|respiratory system agents|mesh-ancestor
101587076|NCT02860221|Mydriatics|mydriatics|mesh-ancestor
101587077|NCT02860221|Sympathomimetics|sympathomimetics|mesh-ancestor
101587078|NCT02860221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101587079|NCT02857569|Nivolumab|nivolumab|mesh-list
101587080|NCT02857569|Ipilimumab|ipilimumab|mesh-list
101587081|NCT02857569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101617677|NCT00928434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101617678|NCT04248621|Goserelin|goserelin|mesh-list
101617679|NCT04248621|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101617680|NCT04248621|Leuprolide|leuprolide|mesh-list
101617681|NCT04248621|Flutamide|flutamide|mesh-list
101617682|NCT04248621|Bicalutamide|bicalutamide|mesh-list
101617683|NCT04248621|Androgens|androgens|mesh-list
101617684|NCT04248621|Androgen Antagonists|androgen antagonists|mesh-list
101617685|NCT04248621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101617686|NCT04248621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101617687|NCT04248621|Hormones|hormones|mesh-ancestor
101617688|NCT04248621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101617689|NCT04248621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617690|NCT04248621|Hormone Antagonists|hormone antagonists|mesh-ancestor
101617691|NCT04248621|Luteolytic Agents|luteolytic agents|mesh-ancestor
101617692|NCT04248621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101617693|NCT04248621|Contraceptive Agents|contraceptive agents|mesh-ancestor
101587082|NCT02857569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101587083|NCT02857569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101587084|NCT02857569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587085|NCT04164355|Tadalafil|tadalafil|mesh-list
101587086|NCT04164355|Vasodilator Agents|vasodilator agents|mesh-ancestor
101587087|NCT04164355|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101587088|NCT04164355|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101587089|NCT04164355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101587090|NCT04164355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587091|NCT04164355|Urological Agents|urological agents|mesh-ancestor
101587092|NCT01605253|Eszopiclone|eszopiclone|mesh-list
101587093|NCT01605253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101587094|NCT01605253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101587095|NCT01605253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587096|NCT00655135|Vedolizumab|vedolizumab|mesh-list
101587097|NCT00655135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101587098|NCT02635867|Calcium, Dietary|calcium, dietary|mesh-list
101587099|NCT02635867|Calcium|calcium|mesh-list
101587100|NCT02635867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101330859|NCT00032890|Celecoxib|celecoxib|mesh-list
101587101|NCT02635867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587102|NCT02635867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101587103|NCT00955305|Paclitaxel|paclitaxel|mesh-list
101587104|NCT00955305|Bevacizumab|bevacizumab|mesh-list
101587105|NCT00955305|Carboplatin|carboplatin|mesh-list
101587106|NCT00955305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101587107|NCT00955305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101587120|NCT00656695|Antifungal Agents|antifungal agents|mesh-ancestor
101587121|NCT00656695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101587122|NCT00656695|Dermatologic Agents|dermatologic agents|mesh-ancestor
101587123|NCT00656695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101264329|NCT01767298|Diuretics|diuretics|mesh-ancestor
101587124|NCT00656695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587125|NCT00656695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101587126|NCT00656695|Immunologic Factors|immunologic factors|mesh-ancestor
101587127|NCT00656695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587128|NCT00656695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101587129|NCT00656695|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101587130|NCT04204083|Hyaluronic Acid|hyaluronic acid|mesh-list
101587131|NCT04204083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101587132|NCT04204083|Immunologic Factors|immunologic factors|mesh-ancestor
101587133|NCT04204083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587134|NCT04204083|Viscosupplements|viscosupplements|mesh-ancestor
101587135|NCT04204083|Protective Agents|protective agents|mesh-ancestor
101617694|NCT04248621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101617695|NCT04248621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101617696|NCT04248621|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101617697|NCT04248621|Fertility Agents|fertility agents|mesh-ancestor
101617698|NCT00784459|Abatacept|abatacept|mesh-list
101617699|NCT00784459|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101617700|NCT00784459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617701|NCT00784459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101617702|NCT00784459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101617703|NCT00784459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101617704|NCT00784459|Immunologic Factors|immunologic factors|mesh-ancestor
101587136|NCT00598585|Sildenafil Citrate|sildenafil citrate|mesh-list
101587137|NCT00598585|Vasodilator Agents|vasodilator agents|mesh-ancestor
101587138|NCT00598585|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101587139|NCT00598585|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101587140|NCT00598585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101587141|NCT00598585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587142|NCT00598585|Urological Agents|urological agents|mesh-ancestor
101587143|NCT02635243|Glucagon|glucagon|mesh-list
101587144|NCT02635243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587145|NCT02635243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101587146|NCT02635243|Hormones|hormones|mesh-ancestor
101587147|NCT02635243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101587148|NCT00953667|Niacin|niacin|mesh-list
101587149|NCT00953667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101587150|NCT00953667|Antimetabolites|antimetabolites|mesh-ancestor
101587151|NCT00953667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587152|NCT00953667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101587153|NCT00953667|Vasodilator Agents|vasodilator agents|mesh-ancestor
101587154|NCT00953667|Vitamin B Complex|vitamin b complex|mesh-ancestor
101587155|NCT00953667|Vitamins|vitamins|mesh-ancestor
101587156|NCT00953667|Micronutrients|micronutrients|mesh-ancestor
101587157|NCT00953667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587158|NCT02857491|Ranibizumab|ranibizumab|mesh-list
101587159|NCT02857491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101587160|NCT02857491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101587161|NCT02857491|Growth Substances|growth substances|mesh-ancestor
101587162|NCT02857491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587163|NCT02857491|Growth Inhibitors|growth inhibitors|mesh-ancestor
101587164|NCT02857491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101587165|NCT00883129|Mycophenolic Acid|mycophenolic acid|mesh-list
101587166|NCT00883129|Cyclophosphamide|cyclophosphamide|mesh-list
101587167|NCT00883129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101587168|NCT00883129|Immunologic Factors|immunologic factors|mesh-ancestor
101587169|NCT00883129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587170|NCT00883129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101587174|NCT00883129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101587175|NCT00883129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101587176|NCT00883129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101587177|NCT00883129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101587178|NCT00883129|Antitubercular Agents|antitubercular agents|mesh-ancestor
101587179|NCT00883129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101587180|NCT00883129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101587181|NCT00883129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101587182|NCT02856867|Leucovorin|leucovorin|mesh-list
101587183|NCT02856867|Fluorouracil|fluorouracil|mesh-list
101587184|NCT02856867|Oxaliplatin|oxaliplatin|mesh-list
101587185|NCT02856867|Nintedanib|nintedanib|mesh-list
101587186|NCT02856867|Antimetabolites|antimetabolites|mesh-ancestor
101587187|NCT02856867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244077|NCT01652378|Lidocaine|lidocaine|mesh-list
101587188|NCT02856867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101587189|NCT02856867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101617705|NCT00784459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617706|NCT00784459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101617708|NCT02835183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101617709|NCT02835183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617711|NCT02602483|Ibuprofen|ibuprofen|mesh-list
101617712|NCT02602483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101617713|NCT02602483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101617714|NCT02602483|Analgesics|analgesics|mesh-ancestor
101617715|NCT02602483|Sensory System Agents|sensory system agents|mesh-ancestor
101617716|NCT02602483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101617717|NCT02602483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617718|NCT02602483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101617719|NCT02602483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101617720|NCT02602483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101617721|NCT02602483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101617722|NCT02602483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617723|NCT02602483|Antioxidants|antioxidants|mesh-ancestor
101617724|NCT02602483|Protective Agents|protective agents|mesh-ancestor
101617725|NCT02602483|Vitamins|vitamins|mesh-ancestor
101587190|NCT02856867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101587191|NCT02856867|Immunologic Factors|immunologic factors|mesh-ancestor
101587192|NCT02856867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587193|NCT02856867|Antidotes|antidotes|mesh-ancestor
101587194|NCT02856867|Protective Agents|protective agents|mesh-ancestor
101587195|NCT02856867|Vitamin B Complex|vitamin b complex|mesh-ancestor
101587196|NCT02856867|Vitamins|vitamins|mesh-ancestor
101587197|NCT02856867|Micronutrients|micronutrients|mesh-ancestor
101587198|NCT02856867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101587199|NCT02856867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101587200|NCT00630513|Ampicillin|ampicillin|mesh-list
101587201|NCT00630513|Ertapenem|ertapenem|mesh-list
101587202|NCT00630513|Sulbactam|sulbactam|mesh-list
101587203|NCT00630513|Sultamicillin|sultamicillin|mesh-list
101587204|NCT00630513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101587205|NCT00630513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101587206|NCT00630513|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101587207|NCT00630513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101587208|NCT00630513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587209|NCT05287360|Apatinib|apatinib|mesh-list
101587210|NCT05287360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101587211|NCT05287360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101587212|NCT05287360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101587213|NCT05287360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587214|NCT00954447|Linagliptin|linagliptin|mesh-list
101587215|NCT00954447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101587216|NCT00954447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587217|NCT00954447|Incretins|incretins|mesh-ancestor
101587218|NCT00954447|Hormones|hormones|mesh-ancestor
101330874|NCT00032929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101587219|NCT00954447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101587220|NCT00954447|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101587221|NCT00954447|Protease Inhibitors|protease inhibitors|mesh-ancestor
101587222|NCT00954447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101587223|NCT00954447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587224|NCT00903760|Decitabine|decitabine|mesh-list
101587225|NCT00903760|Clofarabine|clofarabine|mesh-list
101617726|NCT02602483|Micronutrients|micronutrients|mesh-ancestor
101617727|NCT00784147|Ibalizumab|ibalizumab|mesh-list
101617728|NCT00784147|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101617729|NCT00784147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101617730|NCT00784147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101617731|NCT00784147|Antiviral Agents|antiviral agents|mesh-ancestor
101617732|NCT00784147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101617733|NCT00784147|Immunologic Factors|immunologic factors|mesh-ancestor
101617734|NCT00784147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617735|NCT04260360|Docetaxel|docetaxel|mesh-list
101587226|NCT00903760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101587227|NCT00903760|Antimetabolites|antimetabolites|mesh-ancestor
101587228|NCT00903760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587229|NCT00903760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101587230|NCT00903760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101587231|NCT05273554|Pembrolizumab|pembrolizumab|mesh-list
101587232|NCT05273554|Lenvatinib|lenvatinib|mesh-list
101587233|NCT05273554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101587234|NCT05273554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101587235|NCT05273554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101587236|NCT05273554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587237|NCT05273554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101587238|NCT05273554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101587239|NCT05177614|Micronutrients|micronutrients|mesh-list
101587240|NCT05177614|Trace Elements|trace elements|mesh-list
101587241|NCT05177614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587242|NCT04202536|Tenofovir|tenofovir|mesh-list
101587247|NCT04202536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101587248|NCT04202536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587249|NCT04202536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101587250|NCT04202536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101587251|NCT02794402|Exenatide|exenatide|mesh-list
101587252|NCT02794402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101587253|NCT02794402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587254|NCT02794402|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101587255|NCT02794402|Incretins|incretins|mesh-ancestor
101587256|NCT02794402|Hormones|hormones|mesh-ancestor
101587257|NCT02794402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101587258|NCT00883051|Lasmiditan|lasmiditan|mesh-list
101587259|NCT00883051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101587260|NCT00883051|Serotonin Agents|serotonin agents|mesh-ancestor
101587261|NCT00883051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101587262|NCT00883051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587263|NCT00883051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587264|NCT03395587|Temozolomide|temozolomide|mesh-list
101587265|NCT03395587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101587266|NCT03395587|Alkylating Agents|alkylating agents|mesh-ancestor
101587267|NCT03395587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587268|NCT03395587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101587269|NCT00903682|Efavirenz|efavirenz|mesh-list
101587270|NCT00903682|Etravirine|etravirine|mesh-list
101587271|NCT00903682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101587272|NCT00903682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101587273|NCT00903682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101587274|NCT00903682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587275|NCT00903682|Antiviral Agents|antiviral agents|mesh-ancestor
101587276|NCT00903682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101587277|NCT00903682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101587278|NCT00903682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101587279|NCT00903682|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101587280|NCT00903682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101587281|NCT00903682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101587282|NCT00903682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101587283|NCT00655603|Pancrelipase|pancrelipase|mesh-list
101587284|NCT00655603|Hormones|hormones|mesh-list
101617736|NCT04260360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101617737|NCT04260360|Tubulin Modulators|tubulin modulators|mesh-ancestor
101617738|NCT04260360|Antimitotic Agents|antimitotic agents|mesh-ancestor
101617739|NCT04260360|Mitosis Modulators|mitosis modulators|mesh-ancestor
101617740|NCT04260360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617741|NCT04254822|Carvedilol|carvedilol|mesh-list
101617742|NCT04254822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101617743|NCT04254822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101617744|NCT04254822|Adrenergic Agents|adrenergic agents|mesh-ancestor
101617745|NCT04254822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101617746|NCT04254822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587285|NCT00655603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101587286|NCT00655603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587287|NCT00655603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101587288|NCT02715466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101587289|NCT00655681|Pamidronate|pamidronate|mesh-list
101587290|NCT00655681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101587291|NCT00655681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587292|NCT04221568|Fentanyl|fentanyl|mesh-list
101587293|NCT04221568|Bupivacaine|bupivacaine|mesh-list
101587294|NCT04221568|Levobupivacaine|levobupivacaine|mesh-list
101587295|NCT04221568|Anesthetics, Local|anesthetics, local|mesh-ancestor
101587296|NCT04221568|Anesthetics|anesthetics|mesh-ancestor
101587297|NCT04221568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101587298|NCT04221568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587299|NCT04221568|Sensory System Agents|sensory system agents|mesh-ancestor
101587300|NCT04221568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101587301|NCT04221568|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101587302|NCT04221568|Narcotics|narcotics|mesh-ancestor
101587303|NCT04221568|Analgesics|analgesics|mesh-ancestor
101587304|NCT04221568|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101587305|NCT04221568|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101587306|NCT04221568|Anesthetics, General|anesthetics, general|mesh-ancestor
101587307|NCT01135524|Buprenorphine|buprenorphine|mesh-list
101587308|NCT01135524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101587309|NCT01135524|Narcotics|narcotics|mesh-ancestor
101587310|NCT01135524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101587311|NCT01135524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587312|NCT01135524|Analgesics|analgesics|mesh-ancestor
101587320|NCT00948675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101587321|NCT00948675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101587322|NCT00948675|Tubulin Modulators|tubulin modulators|mesh-ancestor
101587323|NCT00948675|Antimitotic Agents|antimitotic agents|mesh-ancestor
101587324|NCT00948675|Mitosis Modulators|mitosis modulators|mesh-ancestor
101587325|NCT00948675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587326|NCT00948675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101587327|NCT00948675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101587328|NCT00948675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101587329|NCT00948675|Growth Substances|growth substances|mesh-ancestor
101587330|NCT00948675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587331|NCT00948675|Growth Inhibitors|growth inhibitors|mesh-ancestor
101587332|NCT00948675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101587333|NCT00948675|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101587334|NCT00948675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101587335|NCT02642497|Ketamine|ketamine|mesh-list
101587336|NCT02642497|Analgesics|analgesics|mesh-ancestor
101587337|NCT02642497|Sensory System Agents|sensory system agents|mesh-ancestor
101587338|NCT02642497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101587339|NCT02642497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587340|NCT02642497|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101587341|NCT02642497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101587342|NCT02642497|Anesthetics, General|anesthetics, general|mesh-ancestor
101587343|NCT02642497|Anesthetics|anesthetics|mesh-ancestor
101617747|NCT04254822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617748|NCT04254822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101617750|NCT04254822|Protective Agents|protective agents|mesh-ancestor
101617751|NCT04254822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101617752|NCT04254822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101587344|NCT02642497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101587345|NCT02642497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101587346|NCT02642497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101587347|NCT02642497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101587348|NCT02642497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587349|NCT04273581|Thalidomide|thalidomide|mesh-list
101587350|NCT04273581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101587351|NCT04273581|Immunologic Factors|immunologic factors|mesh-ancestor
101587352|NCT04273581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587353|NCT04273581|Leprostatic Agents|leprostatic agents|mesh-ancestor
101587354|NCT04273581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101587355|NCT04273581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101587356|NCT04273581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101587357|NCT04273581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101587358|NCT04273581|Growth Substances|growth substances|mesh-ancestor
101587359|NCT04273581|Growth Inhibitors|growth inhibitors|mesh-ancestor
101587360|NCT04273581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101587361|NCT01110408|Amoxicillin|amoxicillin|mesh-list
101587362|NCT01110408|Clavulanic Acid|clavulanic acid|mesh-list
101587363|NCT01110408|Clavulanic Acids|clavulanic acids|mesh-list
101587364|NCT01110408|Cefepime|cefepime|mesh-list
101587365|NCT01110408|Doripenem|doripenem|mesh-list
101587366|NCT01110408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101587367|NCT01110408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101587368|NCT01110408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101587369|NCT01110408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101587370|NCT01110408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101587371|NCT01110408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587372|NCT00953043|Lubiprostone|lubiprostone|mesh-list
101587373|NCT00953043|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101587374|NCT00953043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101587375|NCT00953043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587376|NCT02850484|Budesonide|budesonide|mesh-list
101587377|NCT02850484|Formoterol Fumarate|formoterol fumarate|mesh-list
101587378|NCT02850484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101587379|NCT02850484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101587380|NCT02850484|Autonomic Agents|autonomic agents|mesh-ancestor
101587381|NCT02850484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101587385|NCT02850484|Glucocorticoids|glucocorticoids|mesh-ancestor
101587386|NCT02850484|Hormones|hormones|mesh-ancestor
101587387|NCT02850484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101587388|NCT02850484|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101587389|NCT02850484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101587390|NCT02850484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101587391|NCT02850484|Adrenergic Agents|adrenergic agents|mesh-ancestor
101587392|NCT02850484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101587393|NCT02850484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587394|NCT01135134|Mometasone Furoate|mometasone furoate|mesh-list
101587395|NCT01135134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101587396|NCT01135134|Dermatologic Agents|dermatologic agents|mesh-ancestor
101587397|NCT01135134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101587398|NCT00948441|Ethanol|ethanol|mesh-list
101587399|NCT00948441|Heparin|heparin|mesh-list
101587400|NCT00948441|Anticoagulants|anticoagulants|mesh-ancestor
101587401|NCT00948441|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101587402|NCT00948441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101587403|NCT00948441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587404|NCT00948441|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101587405|NCT00948441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101587406|NCT00948441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101587407|NCT00948441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587408|NCT02849782|4-Aminopyridine|4-aminopyridine|mesh-list
101617753|NCT04254822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101617754|NCT04254822|Vasodilator Agents|vasodilator agents|mesh-ancestor
101617755|NCT04254822|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101617756|NCT04254822|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101617757|NCT00891813|Ergocalciferols|ergocalciferols|mesh-list
101617758|NCT00891813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101617759|NCT00891813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617761|NCT00891813|Micronutrients|micronutrients|mesh-ancestor
101617762|NCT00891813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101617763|NCT04255056|Cyclophosphamide|cyclophosphamide|mesh-list
101617764|NCT04255056|Epirubicin|epirubicin|mesh-list
101617765|NCT04255056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101617766|NCT04255056|Immunologic Factors|immunologic factors|mesh-ancestor
101587409|NCT02849782|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101587410|NCT02849782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101587411|NCT02849782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587412|NCT00630903|Methoxsalen|methoxsalen|mesh-list
101587413|NCT00630903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101587414|NCT00630903|Dermatologic Agents|dermatologic agents|mesh-ancestor
101587416|NCT02883426|Immunologic Factors|immunologic factors|mesh-ancestor
101587417|NCT02883426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587418|NCT02849314|Immunomodulating Agents|immunomodulating agents|mesh-list
101587419|NCT02849314|Immunologic Factors|immunologic factors|mesh-ancestor
101587420|NCT02849314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587421|NCT02849236|Ropivacaine|ropivacaine|mesh-list
101587422|NCT02849236|Anesthetics, Local|anesthetics, local|mesh-ancestor
101587423|NCT02849236|Anesthetics|anesthetics|mesh-ancestor
101587424|NCT02849236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101587425|NCT02849236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587426|NCT02849236|Sensory System Agents|sensory system agents|mesh-ancestor
101587427|NCT02849236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101587428|NCT02856789|Hemostatics|hemostatics|mesh-list
101587429|NCT02856789|Coagulants|coagulants|mesh-ancestor
101587430|NCT01117350|Metformin|metformin|mesh-list
101587431|NCT01117350|Insulin Glargine|insulin glargine|mesh-list
101587432|NCT01117350|Liraglutide|liraglutide|mesh-list
101587433|NCT01117350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101587434|NCT01117350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587435|NCT01117350|Incretins|incretins|mesh-ancestor
101587436|NCT01117350|Hormones|hormones|mesh-ancestor
101587437|NCT01117350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101587438|NCT00952731|Tamoxifen|tamoxifen|mesh-list
101587439|NCT00952731|Afimoxifene|afimoxifene|mesh-list
101587440|NCT00952731|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101587441|NCT00952731|Hormone Antagonists|hormone antagonists|mesh-ancestor
101587442|NCT00952731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101587443|NCT00952731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587444|NCT00952731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101587445|NCT00952731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101587446|NCT00952731|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101587447|NCT00952731|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101587448|NCT00952731|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101587449|NCT04202224|Acetaminophen|acetaminophen|mesh-list
101587450|NCT04202224|Ibuprofen|ibuprofen|mesh-list
101331772|NCT00014430|Trastuzumab|trastuzumab|mesh-list
101587451|NCT04202224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101587452|NCT04202224|Analgesics|analgesics|mesh-ancestor
101587453|NCT04202224|Sensory System Agents|sensory system agents|mesh-ancestor
101587469|NCT02848612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101587470|NCT02848612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101617767|NCT04255056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617768|NCT04255056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101617769|NCT04255056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101617770|NCT04255056|Alkylating Agents|alkylating agents|mesh-ancestor
101617771|NCT04255056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617772|NCT04255056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101617773|NCT04255056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101587471|NCT02848612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587472|NCT04811404|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
101587473|NCT04811404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101587474|NCT04811404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101587475|NCT04235062|Furosemide|furosemide|mesh-list
101587476|NCT04235062|Calcium|calcium|mesh-list
101587477|NCT04235062|Diuretics|diuretics|mesh-list
101587478|NCT04235062|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
101587479|NCT04235062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101587480|NCT04235062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587481|NCT04235062|Natriuretic Agents|natriuretic agents|mesh-ancestor
101587482|NCT04235062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101587483|NCT04235062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587484|NCT02848768|Sunitinib|sunitinib|mesh-list
101587485|NCT02848768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101587486|NCT02848768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101587487|NCT02848768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101587488|NCT02848768|Growth Substances|growth substances|mesh-ancestor
101587489|NCT02848768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587490|NCT02848768|Growth Inhibitors|growth inhibitors|mesh-ancestor
101587491|NCT02848768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101587492|NCT02848768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101587493|NCT02848768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587494|NCT02848300|Bimatoprost|bimatoprost|mesh-list
101587495|NCT02848300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101587496|NCT00953745|Aripiprazole|aripiprazole|mesh-list
101587497|NCT00953745|Escitalopram|escitalopram|mesh-list
101587498|NCT00953745|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101587499|NCT00953745|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101587500|NCT00953745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101587501|NCT00953745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587502|NCT00953745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101587503|NCT00953745|Serotonin Agents|serotonin agents|mesh-ancestor
101587504|NCT00953745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587505|NCT00953745|Antidepressive Agents|antidepressive agents|mesh-ancestor
101587506|NCT00953745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101587507|NCT00953745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101587508|NCT00953745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101587509|NCT00953745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101587510|NCT00953745|Dopamine Agonists|dopamine agonists|mesh-ancestor
101587518|NCT04202380|Azithromycin|azithromycin|mesh-list
101587519|NCT04202380|Ampicillin|ampicillin|mesh-list
101587520|NCT04202380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101587521|NCT04202380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101587522|NCT02847442|Levodopa|levodopa|mesh-list
101587523|NCT02847442|Opicapone|opicapone|mesh-list
101587524|NCT02847442|Dopa Decarboxylase|dopa decarboxylase|mesh-list
101587525|NCT02847442|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-list
101587526|NCT02847442|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101587527|NCT02847442|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101587528|NCT02847442|Dopamine Agents|dopamine agents|mesh-ancestor
101587529|NCT02847442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101587530|NCT02847442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587531|NCT02847442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587532|NCT02847442|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101587533|NCT02847442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101587534|NCT04736602|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101587535|NCT04736602|Luteolytic Agents|luteolytic agents|mesh-ancestor
101617774|NCT04255056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101617775|NCT04255056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101617776|NCT04255056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101617777|NCT04255056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101617778|NCT00783835|Methylphenidate|methylphenidate|mesh-list
101617779|NCT00783835|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101617780|NCT00783835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617781|NCT00783835|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101549822|NCT04306471|Evolocumab|evolocumab|mesh-list
101587536|NCT04736602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101587537|NCT04736602|Contraceptive Agents|contraceptive agents|mesh-ancestor
101587538|NCT04736602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101587539|NCT04736602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587540|NCT04736602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101587541|NCT04736602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101587542|NCT04736602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101587543|NCT01478698|Plasminogen|plasminogen|mesh-list
101587544|NCT01478698|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101587545|NCT01478698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101587546|NCT01478698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101587547|NCT01478698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587548|NCT01199380|Nicotine|nicotine|mesh-list
101587549|NCT01199380|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101587550|NCT01199380|Autonomic Agents|autonomic agents|mesh-ancestor
101587551|NCT01199380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101587552|NCT01199380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587553|NCT01199380|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101587554|NCT01199380|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101587555|NCT01199380|Cholinergic Agents|cholinergic agents|mesh-ancestor
101587556|NCT01199380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101587557|NCT01199380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587558|NCT02847286|Dapivirine|dapivirine|mesh-list
101587559|NCT02847286|Clotrimazole|clotrimazole|mesh-list
101587560|NCT02847286|Miconazole|miconazole|mesh-list
101587561|NCT02847286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101244485|NCT01654640|Metformin|metformin|mesh-list
101587562|NCT02847286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101587563|NCT02847286|Antiviral Agents|antiviral agents|mesh-ancestor
101587564|NCT02847286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101587565|NCT02847286|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101587567|NCT02847286|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101587568|NCT02847286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101587569|NCT02847286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101587570|NCT02847286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587571|NCT02847286|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101587572|NCT02847286|Hormone Antagonists|hormone antagonists|mesh-ancestor
101587573|NCT02847286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101587574|NCT02847286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587575|NCT02847286|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101587576|NCT02847286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101587588|NCT00433420|Cyclophosphamide|cyclophosphamide|mesh-list
101587589|NCT00433420|Fluorouracil|fluorouracil|mesh-list
101587590|NCT00433420|Epirubicin|epirubicin|mesh-list
101587591|NCT00433420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101587592|NCT00433420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101587593|NCT00433420|Tubulin Modulators|tubulin modulators|mesh-ancestor
101587594|NCT00433420|Antimitotic Agents|antimitotic agents|mesh-ancestor
101587595|NCT00433420|Mitosis Modulators|mitosis modulators|mesh-ancestor
101587596|NCT00433420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587597|NCT00433420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101587598|NCT00433420|Immunologic Factors|immunologic factors|mesh-ancestor
101587599|NCT00433420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587600|NCT00433420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101587601|NCT00433420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101617782|NCT00783835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101617783|NCT00783835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101617784|NCT00783835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617785|NCT00783835|Dopamine Agents|dopamine agents|mesh-ancestor
101617786|NCT00783835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101617787|NCT04254744|Sevoflurane|sevoflurane|mesh-list
101587602|NCT00433420|Alkylating Agents|alkylating agents|mesh-ancestor
101587603|NCT00433420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101587604|NCT00433420|Antimetabolites|antimetabolites|mesh-ancestor
101587605|NCT00433420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101587606|NCT00433420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101587607|NCT00433420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101587608|NCT00433420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101587609|NCT00433420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101587610|NCT04202068|Ceftriaxone|ceftriaxone|mesh-list
101587611|NCT04202068|Sulbactam|sulbactam|mesh-list
101587612|NCT04202068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101587613|NCT04202068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101587614|NCT04202068|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101587615|NCT04202068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101587616|NCT04202068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587617|NCT02850250|Cefuroxime|cefuroxime|mesh-list
101587618|NCT02850250|Cefuroxime axetil|cefuroxime axetil|mesh-list
101587619|NCT02850250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101587620|NCT02850250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101587621|NCT05012644|Palbociclib|palbociclib|mesh-list
101587622|NCT05012644|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101587623|NCT05012644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101587624|NCT05012644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101587625|NCT05012644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101587626|NCT05012644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587627|NCT05012644|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101587628|NCT05012644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101587629|NCT05012644|Hormone Antagonists|hormone antagonists|mesh-ancestor
101587630|NCT05012644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101587631|NCT05012644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587632|NCT02846506|Metformin|metformin|mesh-list
101587633|NCT02846506|Canagliflozin|canagliflozin|mesh-list
101587634|NCT02846506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101587635|NCT02846506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587636|NCT02846506|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101264337|NCT01767363|Adrenergic Agents|adrenergic agents|mesh-ancestor
101587637|NCT02846506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587638|NCT02846428|Cyclophosphamide|cyclophosphamide|mesh-list
101587639|NCT02846428|Docetaxel|docetaxel|mesh-list
101587640|NCT02846428|Fluorouracil|fluorouracil|mesh-list
101587656|NCT02846428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101587657|NCT02846428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101587658|NCT02846428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101587659|NCT02846428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101587660|NCT02846428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101587661|NCT03561376|Petrolatum|petrolatum|mesh-list
101587662|NCT03561376|Zinc Oxide|zinc oxide|mesh-list
101587663|NCT03561376|Emollients|emollients|mesh-ancestor
101587664|NCT03561376|Dermatologic Agents|dermatologic agents|mesh-ancestor
101587665|NCT03561376|Sunscreening Agents|sunscreening agents|mesh-ancestor
101587666|NCT03561376|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101587667|NCT03561376|Protective Agents|protective agents|mesh-ancestor
101587668|NCT03561376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587669|NCT02844712|beta-Lactams|beta-lactams|mesh-list
101587670|NCT02844712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101587671|NCT02844712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101587672|NCT00947349|Interferons|interferons|mesh-list
101587673|NCT00947349|Ribavirin|ribavirin|mesh-list
101587674|NCT00947349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101587675|NCT00947349|Antiviral Agents|antiviral agents|mesh-ancestor
101587676|NCT00947349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101587677|NCT00947349|Antimetabolites|antimetabolites|mesh-ancestor
101587678|NCT00947349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617788|NCT04254744|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101617789|NCT04254744|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101617790|NCT04254744|Anesthetics, General|anesthetics, general|mesh-ancestor
101617791|NCT04254744|Anesthetics|anesthetics|mesh-ancestor
101617792|NCT04254744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101617793|NCT04254744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617794|NCT02831361|Metformin|metformin|mesh-list
101617795|NCT02831361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101617796|NCT02831361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617797|NCT04103905|Antibodies|antibodies|mesh-list
101617798|NCT04103905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101617799|NCT04103905|Immunologic Factors|immunologic factors|mesh-ancestor
101587679|NCT03425812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101587680|NCT03425812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101587681|NCT03425812|Analgesics|analgesics|mesh-ancestor
101587682|NCT03425812|Sensory System Agents|sensory system agents|mesh-ancestor
101587683|NCT03425812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101587684|NCT03425812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587685|NCT03425812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101587686|NCT03425812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101587687|NCT02845804|Everolimus|everolimus|mesh-list
101587688|NCT02845804|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101587689|NCT02845804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101587690|NCT02845804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101587691|NCT02845804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587692|NCT02845804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101587693|NCT02845804|Immunologic Factors|immunologic factors|mesh-ancestor
101587694|NCT02845804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587695|NCT02845804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101587696|NCT02844634|Tenofovir|tenofovir|mesh-list
101587697|NCT02844634|Emtricitabine|emtricitabine|mesh-list
101587698|NCT02844634|Doxycycline|doxycycline|mesh-list
101587699|NCT02844634|Antiviral Agents|antiviral agents|mesh-ancestor
101587700|NCT02844634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101587701|NCT02844634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101587724|NCT02844322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587725|NCT02844322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101587726|NCT02845570|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101587727|NCT02845570|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101587728|NCT02845570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587729|NCT01996605|Oxytocin|oxytocin|mesh-list
101587730|NCT01996605|Oxytocics|oxytocics|mesh-ancestor
101587731|NCT01996605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101587732|NCT01996605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587733|NCT00630981|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101587734|NCT00630981|Escitalopram|escitalopram|mesh-list
101587735|NCT00630981|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101587736|NCT00630981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101587737|NCT00630981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101587738|NCT00630981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587739|NCT00630981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101587740|NCT00630981|Serotonin Agents|serotonin agents|mesh-ancestor
101587741|NCT00630981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587742|NCT00630981|Antidepressive Agents|antidepressive agents|mesh-ancestor
101587743|NCT00630981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101587744|NCT00630981|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101587745|NCT00630981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101587746|NCT00630981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101587747|NCT00952341|Dexamethasone|dexamethasone|mesh-list
101587748|NCT00952341|Dexamethasone acetate|dexamethasone acetate|mesh-list
101587749|NCT00952341|Aprepitant|aprepitant|mesh-list
101587750|NCT00952341|Fosaprepitant|fosaprepitant|mesh-list
101587751|NCT00952341|Granisetron|granisetron|mesh-list
101587752|NCT00952341|BB 1101|bb 1101|mesh-list
101617800|NCT04103905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617801|NCT02831205|Cobalt|cobalt|mesh-list
101617802|NCT02831205|Chromium|chromium|mesh-list
101617803|NCT02831205|Everolimus|everolimus|mesh-list
101617804|NCT02831205|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101617805|NCT02831205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101617806|NCT02831205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101617807|NCT02831205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617808|NCT02831205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101617809|NCT02831205|Immunologic Factors|immunologic factors|mesh-ancestor
101617810|NCT02831205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617811|NCT02831205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101587757|NCT00952341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587758|NCT00952341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101587759|NCT00952341|Glucocorticoids|glucocorticoids|mesh-ancestor
101587760|NCT00952341|Hormones|hormones|mesh-ancestor
101587761|NCT00952341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101587762|NCT00952341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101587763|NCT00952341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101587764|NCT00952341|Protease Inhibitors|protease inhibitors|mesh-ancestor
101587765|NCT00952341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101587766|NCT00952341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587767|NCT00952341|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101587768|NCT00952341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101587769|NCT00952341|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101587770|NCT00952341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101587771|NCT00952341|Serotonin Agents|serotonin agents|mesh-ancestor
101587772|NCT02845024|Doxycycline|doxycycline|mesh-list
101587773|NCT02845024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101587774|NCT02845024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101587775|NCT02845024|Antimalarials|antimalarials|mesh-ancestor
101587776|NCT02845024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101587777|NCT02845024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101587778|NCT02853903|Immunomodulating Agents|immunomodulating agents|mesh-list
101587779|NCT02853903|Immunologic Factors|immunologic factors|mesh-ancestor
101587780|NCT02853903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587781|NCT05242120|Anesthetics|anesthetics|mesh-list
101587782|NCT05242120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101587783|NCT05242120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587784|NCT01909089|Chloroprocaine|chloroprocaine|mesh-list
101587785|NCT01909089|Anesthetics, Local|anesthetics, local|mesh-ancestor
101587786|NCT01909089|Anesthetics|anesthetics|mesh-ancestor
101587787|NCT01909089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101587788|NCT01909089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587789|NCT01909089|Sensory System Agents|sensory system agents|mesh-ancestor
101587790|NCT01909089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101587791|NCT02844790|Insulin|insulin|mesh-list
101587792|NCT02844790|Insulin Aspart|insulin aspart|mesh-list
101587793|NCT02844790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101587794|NCT02844790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587795|NCT02856243|Antiviral Agents|antiviral agents|mesh-list
101587796|NCT02856243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101587797|NCT04410328|Aspirin|aspirin|mesh-list
101587798|NCT04410328|Dipyridamole|dipyridamole|mesh-list
101587799|NCT04410328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101587800|NCT04410328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101587801|NCT04410328|Analgesics|analgesics|mesh-ancestor
101587802|NCT04410328|Sensory System Agents|sensory system agents|mesh-ancestor
101587803|NCT04410328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101587804|NCT04410328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587805|NCT04410328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101587806|NCT04410328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101587807|NCT04410328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101617812|NCT02831205|Trace Elements|trace elements|mesh-ancestor
101617813|NCT02831205|Micronutrients|micronutrients|mesh-ancestor
101617814|NCT00783289|Benralizumab|benralizumab|mesh-list
101617815|NCT00783289|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101617816|NCT00783289|Respiratory System Agents|respiratory system agents|mesh-ancestor
101617817|NCT02828163|Triamcinolone|triamcinolone|mesh-list
101617818|NCT02828163|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101617819|NCT02828163|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101617820|NCT02828163|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101617821|NCT02828163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101617822|NCT02828163|Glucocorticoids|glucocorticoids|mesh-ancestor
101617823|NCT02828163|Hormones|hormones|mesh-ancestor
101617824|NCT02828163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101587808|NCT04410328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101587809|NCT04410328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587810|NCT04410328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101587811|NCT04410328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101587812|NCT04410328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101587813|NCT04410328|Antipyretics|antipyretics|mesh-ancestor
101587814|NCT04410328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101587815|NCT04410328|Vasodilator Agents|vasodilator agents|mesh-ancestor
101587816|NCT02852577|Clonazepam|clonazepam|mesh-list
101587817|NCT02852577|Paroxetine|paroxetine|mesh-list
101587818|NCT02852577|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101587819|NCT02852577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101587820|NCT02852577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101587821|NCT02852577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587822|NCT02852577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101587823|NCT02852577|Serotonin Agents|serotonin agents|mesh-ancestor
101587829|NCT02852577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101587830|NCT02852577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101587831|NCT02852577|Anticonvulsants|anticonvulsants|mesh-ancestor
101587832|NCT02852577|GABA Modulators|gaba modulators|mesh-ancestor
101587833|NCT02852577|GABA Agents|gaba agents|mesh-ancestor
101587834|NCT00902044|Cyclophosphamide|cyclophosphamide|mesh-list
101587835|NCT00902044|Fludarabine|fludarabine|mesh-list
101587836|NCT00902044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101587837|NCT00902044|Immunologic Factors|immunologic factors|mesh-ancestor
101587838|NCT00902044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587839|NCT00902044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101587840|NCT00902044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101587841|NCT00902044|Alkylating Agents|alkylating agents|mesh-ancestor
101587842|NCT00902044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587843|NCT00902044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101587844|NCT00902044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101587845|NCT04201990|Apatinib|apatinib|mesh-list
101587846|NCT04201990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101587847|NCT04201990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101587848|NCT04201990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101587849|NCT04201990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587850|NCT00632866|Hydroxychloroquine|hydroxychloroquine|mesh-list
101587851|NCT00632866|Antimalarials|antimalarials|mesh-ancestor
101587852|NCT00632866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101587853|NCT00632866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101587855|NCT00632866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101587856|NCT00632866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587857|NCT00632866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101587858|NCT00901186|Ranibizumab|ranibizumab|mesh-list
101587859|NCT00901186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101587860|NCT00901186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101587861|NCT00901186|Growth Substances|growth substances|mesh-ancestor
101587862|NCT00901186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617825|NCT02828163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617826|NCT02828163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101617827|NCT02828163|Immunologic Factors|immunologic factors|mesh-ancestor
101617828|NCT02828163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101617829|NCT02828163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587863|NCT00901186|Growth Inhibitors|growth inhibitors|mesh-ancestor
101587864|NCT00901186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101587866|NCT05040880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101587867|NCT05040880|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101587868|NCT05040880|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101587869|NCT05040880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587870|NCT04073290|Rifaximin|rifaximin|mesh-list
101587871|NCT04073290|Lactulose|lactulose|mesh-list
101587872|NCT04073290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101587873|NCT04073290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101587874|NCT04073290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101587875|NCT03763162|Dexamethasone|dexamethasone|mesh-list
101587876|NCT03763162|Dexamethasone acetate|dexamethasone acetate|mesh-list
101587877|NCT03763162|Bortezomib|bortezomib|mesh-list
101587878|NCT03763162|Daratumumab|daratumumab|mesh-list
101587879|NCT03763162|Ixazomib|ixazomib|mesh-list
101587880|NCT03763162|Ichthammol|ichthammol|mesh-list
101587881|NCT03763162|BB 1101|bb 1101|mesh-list
101587882|NCT03763162|Glycine|glycine|mesh-list
101587883|NCT03763162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101587884|NCT03763162|Antiemetics|antiemetics|mesh-ancestor
101587885|NCT03763162|Autonomic Agents|autonomic agents|mesh-ancestor
101587886|NCT03763162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101587887|NCT03763162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587888|NCT03763162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101587889|NCT03763162|Glucocorticoids|glucocorticoids|mesh-ancestor
101587890|NCT03763162|Hormones|hormones|mesh-ancestor
101587891|NCT03763162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101587892|NCT03763162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101587893|NCT03763162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101587894|NCT03763162|Protease Inhibitors|protease inhibitors|mesh-ancestor
101587895|NCT03763162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101587903|NCT03936790|Anesthetics|anesthetics|mesh-ancestor
101587904|NCT03936790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101587905|NCT03936790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587906|NCT03936790|Sensory System Agents|sensory system agents|mesh-ancestor
101587907|NCT03936790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101587908|NCT03936790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101587909|NCT03936790|Narcotics|narcotics|mesh-ancestor
101587910|NCT03936790|Analgesics|analgesics|mesh-ancestor
101587911|NCT03936790|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101587912|NCT03936790|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101587913|NCT03936790|Anesthetics, General|anesthetics, general|mesh-ancestor
101587914|NCT04782700|Prednisone|prednisone|mesh-list
101587915|NCT04782700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101587916|NCT04782700|Glucocorticoids|glucocorticoids|mesh-ancestor
101587917|NCT04782700|Hormones|hormones|mesh-ancestor
101587918|NCT04782700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101587919|NCT04782700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587920|NCT04782700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101587921|NCT04782700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101587922|NCT03711448|Prednisone|prednisone|mesh-list
101587923|NCT03711448|Ustekinumab|ustekinumab|mesh-list
101587924|NCT03711448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101587925|NCT03711448|Glucocorticoids|glucocorticoids|mesh-ancestor
101587926|NCT03711448|Hormones|hormones|mesh-ancestor
101587927|NCT03711448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101587928|NCT03711448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587929|NCT03711448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101587930|NCT03711448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101587931|NCT03711448|Dermatologic Agents|dermatologic agents|mesh-ancestor
101587933|NCT00885703|Amphotericin B|amphotericin b|mesh-list
101587934|NCT00885703|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101587935|NCT00885703|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
101587936|NCT00885703|Deoxycholic Acid|deoxycholic acid|mesh-list
101617830|NCT04107805|Midazolam|midazolam|mesh-list
101617831|NCT04107805|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101617832|NCT04107805|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101617833|NCT04107805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101617834|NCT04107805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617835|NCT04107805|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101617836|NCT04107805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101617837|NCT04107805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101617838|NCT04107805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101617839|NCT04107805|Anesthetics, General|anesthetics, general|mesh-ancestor
101617840|NCT04107805|Anesthetics|anesthetics|mesh-ancestor
101617841|NCT04107805|GABA Modulators|gaba modulators|mesh-ancestor
101617842|NCT04107805|GABA Agents|gaba agents|mesh-ancestor
101617843|NCT04107805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101617844|NCT04107805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617845|NCT02833155|Exemestane|exemestane|mesh-list
101617846|NCT02833155|Entinostat|entinostat|mesh-list
101617847|NCT02833155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101617848|NCT02833155|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101617849|NCT02833155|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101617850|NCT02833155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101617851|NCT02833155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617852|NCT02833155|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101617853|NCT02833155|Hormone Antagonists|hormone antagonists|mesh-ancestor
101416652|NCT00139815|Enoxaparin|enoxaparin|mesh-list
101587937|NCT00885703|Antifungal Agents|antifungal agents|mesh-ancestor
101244826|NCT01656057|Cholecystokinin|cholecystokinin|mesh-list
101587938|NCT00885703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101587939|NCT00885703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101587940|NCT00885703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101587941|NCT00885703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101587942|NCT00885703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587943|NCT00885703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101587944|NCT00885703|Hormone Antagonists|hormone antagonists|mesh-ancestor
101587945|NCT00885703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101587946|NCT00885703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587947|NCT00885703|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101587948|NCT00885703|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101587949|NCT00885703|Amebicides|amebicides|mesh-ancestor
101587950|NCT00885703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101587951|NCT00885703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101587952|NCT00885703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101587953|NCT00885703|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101587954|NCT00885703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101587956|NCT02642419|Rivaroxaban|rivaroxaban|mesh-list
101587957|NCT02642419|Clopidogrel|clopidogrel|mesh-list
101587958|NCT02642419|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101587959|NCT02642419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
101587960|NCT02642419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101587961|NCT02642419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101617854|NCT02833155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101617855|NCT02833155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617856|NCT02833155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101617857|NCT04672460|Talazoparib|talazoparib|mesh-list
101617858|NCT04672460|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101617859|NCT04672460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101617860|NCT04672460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617861|NCT04672460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101617862|NCT00847912|Fluorouracil|fluorouracil|mesh-list
101617863|NCT00847912|Antimetabolites|antimetabolites|mesh-ancestor
101617864|NCT00847912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617865|NCT00847912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101617866|NCT00847912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101617867|NCT00847912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101617868|NCT00847912|Immunologic Factors|immunologic factors|mesh-ancestor
101617869|NCT00847912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617870|NCT00850564|Hormones|hormones|mesh-list
101617871|NCT00850564|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
101617872|NCT00850564|Tesamorelin|tesamorelin|mesh-list
101617873|NCT00850564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101617874|NCT00850564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617875|NCT00850564|Growth Substances|growth substances|mesh-ancestor
101617876|NCT00837148|Sorafenib|sorafenib|mesh-list
101617877|NCT00837148|Dacarbazine|dacarbazine|mesh-list
101587962|NCT02642419|Analgesics|analgesics|mesh-ancestor
101587963|NCT02642419|Sensory System Agents|sensory system agents|mesh-ancestor
101587964|NCT02642419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101587976|NCT02642419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101587977|NCT02642419|Purinergic Agents|purinergic agents|mesh-ancestor
101587978|NCT02642419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101587979|NCT02642419|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101587980|NCT02642419|Antithrombins|antithrombins|mesh-ancestor
101587981|NCT02642419|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101587982|NCT02642419|Protease Inhibitors|protease inhibitors|mesh-ancestor
101587983|NCT02642419|Anticoagulants|anticoagulants|mesh-ancestor
101587984|NCT00901576|Methylphenidate|methylphenidate|mesh-list
101587985|NCT00901576|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101587986|NCT00901576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587987|NCT00901576|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101587988|NCT00901576|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101587989|NCT00901576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101587990|NCT00901576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587991|NCT00901576|Dopamine Agents|dopamine agents|mesh-ancestor
101587992|NCT00901576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101587993|NCT00655837|Rituximab|rituximab|mesh-list
101587994|NCT00655837|Dacetuzumab|dacetuzumab|mesh-list
101587995|NCT00655837|Gemcitabine|gemcitabine|mesh-list
101587996|NCT00655837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101617878|NCT00837148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101617879|NCT00837148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101617880|NCT00837148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101617881|NCT00837148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617882|NCT00837148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101617883|NCT00837148|Alkylating Agents|alkylating agents|mesh-ancestor
101617884|NCT00703690|Fenofibrate|fenofibrate|mesh-list
101617885|NCT00703690|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101617886|NCT00703690|Antimetabolites|antimetabolites|mesh-ancestor
101617887|NCT00703690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617888|NCT00703690|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101617889|NCT05297968|Oseltamivir|oseltamivir|mesh-list
101617890|NCT05297968|Antiviral Agents|antiviral agents|mesh-ancestor
101617891|NCT05297968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101617892|NCT05297968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101617893|NCT05297968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617894|NCT02613130|Fluorides|fluorides|mesh-list
101617895|NCT02613130|Tin Fluorides|tin fluorides|mesh-list
101587997|NCT00655837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101587998|NCT00655837|Immunologic Factors|immunologic factors|mesh-ancestor
101587999|NCT00655837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588000|NCT00655837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101588001|NCT00655837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101588002|NCT00655837|Antimetabolites|antimetabolites|mesh-ancestor
101588003|NCT00655837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588004|NCT00655915|Betamethasone|betamethasone|mesh-list
101588005|NCT00655915|Lidocaine|lidocaine|mesh-list
101588006|NCT00655915|Anesthetics, Local|anesthetics, local|mesh-ancestor
101588007|NCT00655915|Anesthetics|anesthetics|mesh-ancestor
101588008|NCT00655915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101588009|NCT00655915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588010|NCT00655915|Sensory System Agents|sensory system agents|mesh-ancestor
101588011|NCT00655915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101588012|NCT00655915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101588013|NCT00655915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101588014|NCT00655915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101588015|NCT00655915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101588016|NCT00655915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588017|NCT00655915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101588018|NCT00655915|Glucocorticoids|glucocorticoids|mesh-ancestor
101588020|NCT00655915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101588021|NCT00655915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101588022|NCT00655915|Respiratory System Agents|respiratory system agents|mesh-ancestor
101588023|NCT02637193|Moxifloxacin|moxifloxacin|mesh-list
101588024|NCT02637193|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101588025|NCT02637193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101588026|NCT02637193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101588030|NCT02637193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588031|NCT02637193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101588032|NCT02637193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588033|NCT02637193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101588034|NCT02637193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101588035|NCT02637193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101588036|NCT02637193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101617896|NCT02613130|Cariostatic Agents|cariostatic agents|mesh-ancestor
101617897|NCT02613130|Protective Agents|protective agents|mesh-ancestor
101617898|NCT02613130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617899|NCT00849472|Paclitaxel|paclitaxel|mesh-list
101617900|NCT00849472|Cyclophosphamide|cyclophosphamide|mesh-list
101617901|NCT00849472|Doxorubicin|doxorubicin|mesh-list
101617902|NCT00849472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101617903|NCT00849472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101617904|NCT00849472|Tubulin Modulators|tubulin modulators|mesh-ancestor
101617905|NCT00849472|Antimitotic Agents|antimitotic agents|mesh-ancestor
101416711|NCT00139854|Alprazolam|alprazolam|mesh-list
101588037|NCT02637193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101588038|NCT02637193|Antidepressive Agents|antidepressive agents|mesh-ancestor
101588039|NCT02637193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101588041|NCT00656773|Morphine|morphine|mesh-list
101588042|NCT00656773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101588043|NCT00656773|Narcotics|narcotics|mesh-ancestor
101588044|NCT00656773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101588045|NCT00656773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588046|NCT00656773|Analgesics|analgesics|mesh-ancestor
101588047|NCT00656773|Sensory System Agents|sensory system agents|mesh-ancestor
101588048|NCT00656773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101588049|NCT00656773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101588050|NCT00656773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101588051|NCT00656773|Anesthetics, General|anesthetics, general|mesh-ancestor
101588052|NCT00656773|Anesthetics|anesthetics|mesh-ancestor
101588053|NCT00882583|Cisplatin|cisplatin|mesh-list
101588054|NCT00882583|Cetuximab|cetuximab|mesh-list
101588055|NCT00882583|Dasatinib|dasatinib|mesh-list
101588056|NCT00882583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101588057|NCT00882583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101588058|NCT00882583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101588059|NCT00882583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101588060|NCT00882583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588061|NCT04481308|Fentanyl|fentanyl|mesh-list
101588062|NCT04481308|Propofol|propofol|mesh-list
101588063|NCT04481308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101588064|NCT04481308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101588065|NCT04481308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588066|NCT04481308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101588067|NCT04481308|Anesthetics, General|anesthetics, general|mesh-ancestor
101588068|NCT04481308|Anesthetics|anesthetics|mesh-ancestor
101588069|NCT04481308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101588070|NCT04481308|Narcotics|narcotics|mesh-ancestor
101588071|NCT04481308|Analgesics|analgesics|mesh-ancestor
101588072|NCT04481308|Sensory System Agents|sensory system agents|mesh-ancestor
101588073|NCT04481308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101588074|NCT04481308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101588076|NCT02634541|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101588077|NCT02634541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101588078|NCT02634541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101588079|NCT04475848|Midazolam|midazolam|mesh-list
101588080|NCT04475848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101588081|NCT04475848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101588082|NCT04475848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101588083|NCT04475848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244987|NCT01657071|Antipyretics|antipyretics|mesh-ancestor
101588084|NCT04475848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101588085|NCT04475848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101588086|NCT04475848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101588087|NCT04475848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101588088|NCT04475848|Anesthetics, General|anesthetics, general|mesh-ancestor
101588089|NCT04475848|Anesthetics|anesthetics|mesh-ancestor
101588090|NCT04475848|GABA Modulators|gaba modulators|mesh-ancestor
101588091|NCT04475848|GABA Agents|gaba agents|mesh-ancestor
101588092|NCT04475848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101588093|NCT04475848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617906|NCT00849472|Mitosis Modulators|mitosis modulators|mesh-ancestor
101617907|NCT00849472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617908|NCT00849472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101617909|NCT00849472|Immunologic Factors|immunologic factors|mesh-ancestor
101617910|NCT00849472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617911|NCT00849472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101617912|NCT00849472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101617913|NCT00849472|Alkylating Agents|alkylating agents|mesh-ancestor
101617914|NCT00849472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101617915|NCT00849472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101617916|NCT00849472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101617917|NCT00849472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101617918|NCT00849472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101617919|NCT00782509|Olodaterol|olodaterol|mesh-list
101617920|NCT00782509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101617921|NCT00782509|Autonomic Agents|autonomic agents|mesh-ancestor
101617922|NCT00782509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101617923|NCT00782509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617924|NCT00782509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101617925|NCT00782509|Respiratory System Agents|respiratory system agents|mesh-ancestor
101617926|NCT00701428|Losartan|losartan|mesh-list
101617927|NCT00701428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101617928|NCT00701428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101617929|NCT00701428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101617930|NCT00701428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101617931|NCT00701428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617932|NCT00848926|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101617933|NCT00848926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101588094|NCT00599521|Adapalene|adapalene|mesh-list
101588095|NCT00599521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101588096|NCT00599521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101588097|NCT00599521|Analgesics|analgesics|mesh-ancestor
101588098|NCT00599521|Sensory System Agents|sensory system agents|mesh-ancestor
101588113|NCT00653341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101588114|NCT00653341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588115|NCT02642263|Carbetocin|carbetocin|mesh-list
101588116|NCT02642263|Oxytocics|oxytocics|mesh-ancestor
101588117|NCT02642263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101588118|NCT02642263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588119|NCT00779740|Mometasone Furoate|mometasone furoate|mesh-list
101588120|NCT00779740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101588121|NCT00779740|Dermatologic Agents|dermatologic agents|mesh-ancestor
101588122|NCT00779740|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101588123|NCT02636803|Albendazole|albendazole|mesh-list
101588124|NCT02636803|Oxfendazole|oxfendazole|mesh-list
101617934|NCT00848926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101617935|NCT00848926|Immunotoxins|immunotoxins|mesh-ancestor
101617936|NCT00848926|Immunoconjugates|immunoconjugates|mesh-ancestor
101617937|NCT00848926|Immunologic Factors|immunologic factors|mesh-ancestor
101617938|NCT00848926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617939|NCT00706888|Vitamin B 6|vitamin b 6|mesh-list
101617940|NCT00706888|Pyridoxal|pyridoxal|mesh-list
101617941|NCT00706888|Pyridoxine|pyridoxine|mesh-list
101617942|NCT00706888|Vitamins|vitamins|mesh-ancestor
101617943|NCT00706888|Micronutrients|micronutrients|mesh-ancestor
101617944|NCT00706888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617945|NCT00706888|Vitamin B Complex|vitamin b complex|mesh-ancestor
101617946|NCT05019534|Cetuximab|cetuximab|mesh-list
101617947|NCT05019534|Vemurafenib|vemurafenib|mesh-list
101617948|NCT05019534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101416755|NCT00131261|Dexamethasone|dexamethasone|mesh-list
101588125|NCT02636803|Anthelmintics|anthelmintics|mesh-ancestor
101588126|NCT02636803|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101588127|NCT02636803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101588128|NCT02636803|Anticestodal Agents|anticestodal agents|mesh-ancestor
101588129|NCT02636803|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101588130|NCT02636803|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101588131|NCT02636803|Tubulin Modulators|tubulin modulators|mesh-ancestor
101588132|NCT02636803|Antimitotic Agents|antimitotic agents|mesh-ancestor
101588133|NCT02636803|Mitosis Modulators|mitosis modulators|mesh-ancestor
101588134|NCT02636803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588135|NCT02636803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101588136|NCT02636803|Antinematodal Agents|antinematodal agents|mesh-ancestor
101588137|NCT02634463|Olanzapine|olanzapine|mesh-list
101588138|NCT02634463|Risperidone|risperidone|mesh-list
101588139|NCT02634463|Aripiprazole|aripiprazole|mesh-list
101588140|NCT02634463|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101588141|NCT02634463|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101588142|NCT02634463|Serotonin Agents|serotonin agents|mesh-ancestor
101588143|NCT02634463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101588144|NCT02634463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588145|NCT02634463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588146|NCT02634463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101588147|NCT02634463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101588148|NCT02634463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101588149|NCT02634463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101588150|NCT02634463|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101588151|NCT02634463|Dopamine Agents|dopamine agents|mesh-ancestor
101588152|NCT02634463|Antiemetics|antiemetics|mesh-ancestor
101588153|NCT02634463|Autonomic Agents|autonomic agents|mesh-ancestor
101588154|NCT02634463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101588155|NCT02634463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101588156|NCT02634463|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101588157|NCT02634463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101588158|NCT02634463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101588159|NCT02634463|Antidepressive Agents|antidepressive agents|mesh-ancestor
101588160|NCT02634463|Dopamine Agonists|dopamine agonists|mesh-ancestor
101588161|NCT02634463|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101588165|NCT00882115|Sulforaphane|sulforaphane|mesh-list
101588166|NCT00882115|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101588167|NCT00882115|Protective Agents|protective agents|mesh-ancestor
101588168|NCT00882115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588169|NCT00882115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101588170|NCT00653419|Buspirone|buspirone|mesh-list
101588171|NCT00653419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101588172|NCT00653419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101588173|NCT00653419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101588174|NCT00653419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617949|NCT05019534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101617950|NCT05019534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101617951|NCT05019534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101617952|NCT05019534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617953|NCT04254042|Perindopril|perindopril|mesh-list
101617955|NCT04254042|Captopril|captopril|mesh-list
101617956|NCT04254042|Calcium|calcium|mesh-list
101617957|NCT04254042|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101617958|NCT04254042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617959|NCT04254042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101617960|NCT04254042|Protease Inhibitors|protease inhibitors|mesh-ancestor
101617961|NCT04254042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101617962|NCT04254042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617963|NCT04254042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101617964|NCT00918138|Metformin|metformin|mesh-list
101617965|NCT00918138|Saxagliptin|saxagliptin|mesh-list
101617966|NCT00918138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101617967|NCT00918138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617968|NCT00918138|Incretins|incretins|mesh-ancestor
101617969|NCT00918138|Hormones|hormones|mesh-ancestor
101617970|NCT00918138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101617971|NCT00918138|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101617972|NCT00918138|Protease Inhibitors|protease inhibitors|mesh-ancestor
101617973|NCT00918138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101617974|NCT00918138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617975|NCT04253574|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101617976|NCT04253574|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101617977|NCT04253574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617978|NCT00782275|Sirolimus|sirolimus|mesh-list
101617979|NCT00782275|Bevacizumab|bevacizumab|mesh-list
101617980|NCT00782275|Temsirolimus|temsirolimus|mesh-list
101617981|NCT00782275|MTOR Inhibitors|mtor inhibitors|mesh-list
101617982|NCT00782275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101617983|NCT00782275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101617984|NCT00782275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101588175|NCT00653419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101617985|NCT00782275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101617986|NCT00782275|Growth Substances|growth substances|mesh-ancestor
101617987|NCT00782275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101617988|NCT00782275|Growth Inhibitors|growth inhibitors|mesh-ancestor
101588176|NCT00653419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101588177|NCT00653419|Serotonin Agents|serotonin agents|mesh-ancestor
101588178|NCT00653419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101588179|NCT00653419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588180|NCT00884377|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
101588181|NCT00884377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101588182|NCT00884377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101588183|NCT00884377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101588184|NCT00884377|Schistosomicides|schistosomicides|mesh-ancestor
101588185|NCT00884377|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101588186|NCT00884377|Anthelmintics|anthelmintics|mesh-ancestor
101588187|NCT00656929|Vitamin D|vitamin d|mesh-list
101588188|NCT00656929|Cholecalciferol|cholecalciferol|mesh-list
101588189|NCT00656929|Vitamins|vitamins|mesh-ancestor
101588190|NCT00656929|Micronutrients|micronutrients|mesh-ancestor
101588191|NCT00656929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588192|NCT00656929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101588193|NCT00656929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101588194|NCT00884221|Menotropins|menotropins|mesh-list
101588195|NCT00884221|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101588196|NCT00884221|Fertility Agents|fertility agents|mesh-ancestor
101588197|NCT00884221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101588198|NCT00884221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588199|NCT02153632|Amantadine|amantadine|mesh-list
101588200|NCT02153632|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101588201|NCT02153632|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101588202|NCT02153632|Antiviral Agents|antiviral agents|mesh-ancestor
101588203|NCT02153632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101588204|NCT02153632|Dopamine Agents|dopamine agents|mesh-ancestor
101588205|NCT02153632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101588206|NCT02153632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330901|NCT00032968|Analgesics|analgesics|mesh-ancestor
101588207|NCT02153632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588208|NCT02153632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101588209|NCT02153632|Analgesics|analgesics|mesh-ancestor
101588210|NCT02153632|Sensory System Agents|sensory system agents|mesh-ancestor
101588211|NCT02153632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101588212|NCT01934452|Sunitinib|sunitinib|mesh-list
101588213|NCT01934452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101588214|NCT01934452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101588215|NCT01934452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101588216|NCT01934452|Growth Substances|growth substances|mesh-ancestor
101588217|NCT01934452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588218|NCT01934452|Growth Inhibitors|growth inhibitors|mesh-ancestor
101588219|NCT01934452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101588220|NCT01934452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101588221|NCT01934452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588222|NCT03524326|Cetuximab|cetuximab|mesh-list
101588223|NCT03524326|Lenvatinib|lenvatinib|mesh-list
101588224|NCT03524326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101588225|NCT03524326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101588226|NCT03524326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101588227|NCT03524326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101588228|NCT03524326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588229|NCT01236430|Atorvastatin|atorvastatin|mesh-list
101588230|NCT01236430|Ezetimibe|ezetimibe|mesh-list
101588231|NCT01236430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101588232|NCT01236430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101588233|NCT01236430|Antimetabolites|antimetabolites|mesh-ancestor
101588237|NCT01236430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101588238|NCT00726856|Ezetimibe|ezetimibe|mesh-list
101588240|NCT00726856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101588241|NCT00726856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101588242|NCT00726856|Antimetabolites|antimetabolites|mesh-ancestor
101588243|NCT00726856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588244|NCT00726856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101588245|NCT00651274|Ezetimibe|ezetimibe|mesh-list
101588246|NCT00651274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101617989|NCT00782275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101617990|NCT00782275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101617991|NCT00782275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101617992|NCT00782275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101617993|NCT00782275|Immunologic Factors|immunologic factors|mesh-ancestor
101617994|NCT00782275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101617995|NCT00782275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101617996|NCT00782275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101617997|NCT00782275|Antifungal Agents|antifungal agents|mesh-ancestor
101588247|NCT00651274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101588248|NCT00651274|Antimetabolites|antimetabolites|mesh-ancestor
101588249|NCT00651274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588250|NCT00651274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101588251|NCT00212836|Olanzapine|olanzapine|mesh-list
101588252|NCT00212836|Asenapine|asenapine|mesh-list
101588253|NCT00212836|Antiemetics|antiemetics|mesh-ancestor
101588254|NCT00212836|Autonomic Agents|autonomic agents|mesh-ancestor
101588255|NCT00212836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101588256|NCT00212836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588257|NCT00212836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101588258|NCT00212836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101588259|NCT00212836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101588260|NCT00212836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101588261|NCT00212836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101588262|NCT00212836|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101588263|NCT00212836|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101588264|NCT00212836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101588265|NCT00212836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588266|NCT00212836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101588267|NCT00212836|Serotonin Agents|serotonin agents|mesh-ancestor
101588268|NCT00805324|Desloratadine|desloratadine|mesh-list
101588269|NCT00805324|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101588270|NCT00805324|Cholinergic Agents|cholinergic agents|mesh-ancestor
101588271|NCT00805324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101588272|NCT00805324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588273|NCT00805324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588274|NCT00805324|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101588275|NCT00805324|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101588276|NCT00805324|Histamine Antagonists|histamine antagonists|mesh-ancestor
101588277|NCT00805324|Histamine Agents|histamine agents|mesh-ancestor
101588278|NCT00157924|Atorvastatin|atorvastatin|mesh-list
101588279|NCT00157924|Simvastatin|simvastatin|mesh-list
101588280|NCT00157924|Ezetimibe|ezetimibe|mesh-list
101588281|NCT00157924|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101588282|NCT00157924|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101588283|NCT00157924|Antimetabolites|antimetabolites|mesh-ancestor
101588284|NCT00157924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588285|NCT00157924|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101588286|NCT00157924|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101588287|NCT00157924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101588288|NCT00794794|Cetirizine|cetirizine|mesh-list
101588289|NCT00794794|Desloratadine|desloratadine|mesh-list
101588290|NCT00794794|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101588291|NCT00794794|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101588292|NCT00794794|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101588293|NCT00794794|Histamine Antagonists|histamine antagonists|mesh-ancestor
101588294|NCT00794794|Histamine Agents|histamine agents|mesh-ancestor
101588295|NCT00794794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101588296|NCT00794794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588297|NCT00794794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588298|NCT00794794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101588299|NCT00794794|Cholinergic Agents|cholinergic agents|mesh-ancestor
101588300|NCT03612466|Plerixafor|plerixafor|mesh-list
101588301|NCT03612466|Calcium Carbonate|calcium carbonate|mesh-list
101588302|NCT03612466|Calcium|calcium|mesh-list
101617998|NCT00791557|Infliximab|infliximab|mesh-list
101617999|NCT00791557|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101618000|NCT00791557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101618001|NCT00791557|Dermatologic Agents|dermatologic agents|mesh-ancestor
101618002|NCT00791557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101618003|NCT00791557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101618004|NCT00920790|Mogamulizumab|mogamulizumab|mesh-list
101618005|NCT00920790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101618006|NCT05176314|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101618007|NCT05176314|Pirtobrutinib|pirtobrutinib|mesh-list
101618008|NCT05176314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101618009|NCT05176314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101618010|NCT05176314|Antimetabolites|antimetabolites|mesh-ancestor
101618011|NCT05176314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618012|NCT05176314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101336110|NCT00054418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101618013|NCT05176314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101618014|NCT05176314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101618015|NCT05176314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101416816|NCT00140166|Pyridoxine|pyridoxine|mesh-list
101588303|NCT03612466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101588317|NCT00142558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101588318|NCT00142558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101588319|NCT00142558|Analgesics|analgesics|mesh-ancestor
101588320|NCT00142558|Sensory System Agents|sensory system agents|mesh-ancestor
101588321|NCT00142558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101588322|NCT00142558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101588323|NCT00142558|Gout Suppressants|gout suppressants|mesh-ancestor
101588324|NCT00142558|Tocolytic Agents|tocolytic agents|mesh-ancestor
101588325|NCT00142558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101588326|NCT00142558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101588327|NCT00142558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101588328|NCT00142558|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101588329|NCT02842294|Bevacizumab|bevacizumab|mesh-list
101588330|NCT02842294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101588331|NCT02842294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101588332|NCT02842294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101588333|NCT02842294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101588334|NCT02842294|Growth Substances|growth substances|mesh-ancestor
101588335|NCT02842294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588336|NCT02842294|Growth Inhibitors|growth inhibitors|mesh-ancestor
101588337|NCT02841982|Morphine|morphine|mesh-list
101588338|NCT02841982|Ropivacaine|ropivacaine|mesh-list
101588339|NCT02841982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101588340|NCT02841982|Narcotics|narcotics|mesh-ancestor
101588341|NCT02841982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101588342|NCT02841982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588343|NCT02841982|Analgesics|analgesics|mesh-ancestor
101588344|NCT02841982|Sensory System Agents|sensory system agents|mesh-ancestor
101588345|NCT02841982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101588346|NCT02841982|Anesthetics, Local|anesthetics, local|mesh-ancestor
101588347|NCT02841982|Anesthetics|anesthetics|mesh-ancestor
101588348|NCT02843698|Dexmedetomidine|dexmedetomidine|mesh-list
101588349|NCT02843698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101588350|NCT02843698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101588351|NCT02843698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588352|NCT02843698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101588353|NCT02843698|Analgesics|analgesics|mesh-ancestor
101618016|NCT00920556|Bortezomib|bortezomib|mesh-list
101618017|NCT00920556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101618018|NCT00781885|Beraprost|beraprost|mesh-list
101618019|NCT00781885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101618020|NCT00781885|Vasodilator Agents|vasodilator agents|mesh-ancestor
101618021|NCT04901676|Leronlimab|leronlimab|mesh-list
101618022|NCT04901676|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101618023|NCT04901676|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101618024|NCT04901676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618025|NCT04901676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101618026|NCT04901676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101618027|NCT04901676|Antiviral Agents|antiviral agents|mesh-ancestor
101618028|NCT04901676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101618029|NCT04831086|Tocolytic Agents|tocolytic agents|mesh-list
101416835|NCT00131768|Protective Agents|protective agents|mesh-ancestor
101416837|NCT01248949|Paclitaxel|paclitaxel|mesh-list
101588354|NCT02843698|Sensory System Agents|sensory system agents|mesh-ancestor
101588355|NCT02843698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101588356|NCT02843698|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101588357|NCT02843698|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101588358|NCT02843698|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101588359|NCT02843698|Adrenergic Agents|adrenergic agents|mesh-ancestor
101588360|NCT02843698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101588361|NCT02843698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588362|NCT00690898|Lanreotide|lanreotide|mesh-list
101588363|NCT00690898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101588364|NCT02841202|Contraceptive Agents|contraceptive agents|mesh-list
101588365|NCT02841202|Contraceptives, Oral|contraceptives, oral|mesh-list
101588366|NCT02841202|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
101588367|NCT02841202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101588384|NCT01822288|Tibolone|tibolone|mesh-list
101588385|NCT01822288|Medroxyprogesterone|medroxyprogesterone|mesh-list
101588386|NCT01822288|Estradiol|estradiol|mesh-list
101588387|NCT01822288|Estrogens|estrogens|mesh-ancestor
101588388|NCT01822288|Hormones|hormones|mesh-ancestor
101588389|NCT01822288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101588390|NCT01822288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588391|NCT01822288|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101588392|NCT01822288|Contraceptive Agents|contraceptive agents|mesh-ancestor
101588393|NCT01822288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101588394|NCT01822288|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101588395|NCT01822288|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101588396|NCT01822288|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101588397|NCT01822288|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101588398|NCT01822288|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101588399|NCT01822288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101588400|NCT01822288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101588401|NCT01822288|Androgen Antagonists|androgen antagonists|mesh-ancestor
101588402|NCT01822288|Hormone Antagonists|hormone antagonists|mesh-ancestor
101588403|NCT01822288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101588404|NCT01822288|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101588405|NCT01822288|Anabolic Agents|anabolic agents|mesh-ancestor
101588406|NCT01328626|Venetoclax|venetoclax|mesh-list
101588407|NCT01328626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101588408|NCT02840812|Nemonoxacin|nemonoxacin|mesh-list
101588409|NCT02840812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101588410|NCT02840812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101588411|NCT01212770|Thalidomide|thalidomide|mesh-list
101588412|NCT01212770|Apremilast|apremilast|mesh-list
101588413|NCT01212770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101588414|NCT01212770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101618030|NCT04831086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101618031|NCT04831086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618032|NCT02603965|Copper|copper|mesh-list
101618033|NCT02603965|Trace Elements|trace elements|mesh-ancestor
101618034|NCT02603965|Micronutrients|micronutrients|mesh-ancestor
101618035|NCT02603965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618036|NCT00918684|Escitalopram|escitalopram|mesh-list
101618037|NCT00918684|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101588415|NCT01212770|Analgesics|analgesics|mesh-ancestor
101588416|NCT01212770|Sensory System Agents|sensory system agents|mesh-ancestor
101588417|NCT01212770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101588418|NCT01212770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588419|NCT01212770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101588420|NCT01212770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101588421|NCT01212770|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101588422|NCT01212770|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101588423|NCT01212770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101588424|NCT01212770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588425|NCT01212770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101336180|NCT02970097|Analgesics|analgesics|mesh-ancestor
101588431|NCT01212770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101588432|NCT01212770|Growth Substances|growth substances|mesh-ancestor
101588433|NCT01212770|Growth Inhibitors|growth inhibitors|mesh-ancestor
101588434|NCT01212770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101588436|NCT05334316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101588437|NCT05334316|Antiemetics|antiemetics|mesh-ancestor
101588438|NCT05334316|Autonomic Agents|autonomic agents|mesh-ancestor
101588439|NCT05334316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101588440|NCT05334316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588441|NCT05334316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101588442|NCT05334316|Glucocorticoids|glucocorticoids|mesh-ancestor
101588443|NCT05334316|Hormones|hormones|mesh-ancestor
101264356|NCT01767428|Analgesics|analgesics|mesh-ancestor
101588444|NCT05334316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101588445|NCT05334316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101588446|NCT05334316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101588448|NCT00598273|Hematinics|hematinics|mesh-ancestor
101588449|NCT02636491|Insulin|insulin|mesh-list
101588450|NCT02636491|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101588451|NCT02636491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101588452|NCT02636491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588453|NCT00657007|Belimumab|belimumab|mesh-list
101588454|NCT00657007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101588455|NCT00657007|Immunologic Factors|immunologic factors|mesh-ancestor
101588456|NCT00657007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588457|NCT04318652|Methylprednisolone|methylprednisolone|mesh-list
101588458|NCT04318652|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101588459|NCT04318652|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101588460|NCT04318652|Prednisolone|prednisolone|mesh-list
101588461|NCT04318652|Prednisolone acetate|prednisolone acetate|mesh-list
101588462|NCT04318652|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101588463|NCT04318652|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101588464|NCT04318652|Prednisolone phosphate|prednisolone phosphate|mesh-list
101588466|NCT04318652|Antiemetics|antiemetics|mesh-ancestor
101588467|NCT04318652|Autonomic Agents|autonomic agents|mesh-ancestor
101588468|NCT04318652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101588469|NCT04318652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588470|NCT04318652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101588471|NCT04318652|Glucocorticoids|glucocorticoids|mesh-ancestor
101588472|NCT04318652|Hormones|hormones|mesh-ancestor
101456541|NCT00245115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101588473|NCT04318652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101588474|NCT04318652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101588475|NCT04318652|Protective Agents|protective agents|mesh-ancestor
101588476|NCT04318652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101588477|NCT04318652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101588478|NCT04318652|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101588479|NCT02633995|Anesthetics|anesthetics|mesh-list
101588480|NCT02633995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101618038|NCT00918684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101618039|NCT00918684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101618040|NCT00918684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618041|NCT00918684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101618042|NCT00918684|Serotonin Agents|serotonin agents|mesh-ancestor
101528979|NCT02902523|Tenofovir|tenofovir|mesh-list
101618043|NCT00918684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618044|NCT00919854|Ritonavir|ritonavir|mesh-list
101618045|NCT00919854|Darunavir|darunavir|mesh-list
101618046|NCT00919854|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101618047|NCT00919854|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101618048|NCT00919854|Protease Inhibitors|protease inhibitors|mesh-ancestor
101618049|NCT00919854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101618050|NCT00919854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618051|NCT00919854|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101618052|NCT00919854|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101618053|NCT00919854|Antiviral Agents|antiviral agents|mesh-ancestor
101618054|NCT00919854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101618055|NCT00919854|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101588481|NCT02633995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588482|NCT02633683|Gabapentin|gabapentin|mesh-list
101588483|NCT02633683|Analgesics|analgesics|mesh-ancestor
101588484|NCT02633683|Sensory System Agents|sensory system agents|mesh-ancestor
101588485|NCT02633683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101588486|NCT02633683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588487|NCT02633683|Anticonvulsants|anticonvulsants|mesh-ancestor
101588488|NCT02633683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101588489|NCT02633683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101588490|NCT02633683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101588491|NCT02633683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101588492|NCT02633683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101588493|NCT02633683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101588494|NCT02633683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101588495|NCT02633683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588496|NCT02633683|Antimanic Agents|antimanic agents|mesh-ancestor
101588497|NCT01211522|Haloperidol|haloperidol|mesh-list
101588510|NCT01211522|Dopamine Agents|dopamine agents|mesh-ancestor
101588511|NCT01211522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101588512|NCT01211522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588513|NCT01211522|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101588514|NCT01211522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101588515|NCT01211522|Serotonin Agents|serotonin agents|mesh-ancestor
101588516|NCT05404724|Itraconazole|itraconazole|mesh-list
101588517|NCT05404724|Antifungal Agents|antifungal agents|mesh-ancestor
101588518|NCT05404724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101588520|NCT05404724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101588521|NCT05404724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101588522|NCT05404724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588523|NCT05404724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101588524|NCT05404724|Hormone Antagonists|hormone antagonists|mesh-ancestor
101588525|NCT05404724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101588526|NCT05404724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588527|NCT05404724|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101588528|NCT03314935|Leucovorin|leucovorin|mesh-list
101618056|NCT00919854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101618057|NCT04669782|Teriparatide|teriparatide|mesh-list
101618059|NCT04669782|Vitamins|vitamins|mesh-ancestor
101618060|NCT04669782|Micronutrients|micronutrients|mesh-ancestor
101618061|NCT04669782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416878|NCT00140361|Pyrimethamine|pyrimethamine|mesh-list
101588529|NCT03314935|Paclitaxel|paclitaxel|mesh-list
101588530|NCT03314935|Gemcitabine|gemcitabine|mesh-list
101588531|NCT03314935|Fluorouracil|fluorouracil|mesh-list
101588532|NCT03314935|Oxaliplatin|oxaliplatin|mesh-list
101588533|NCT03314935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101588534|NCT03314935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101588535|NCT03314935|Tubulin Modulators|tubulin modulators|mesh-ancestor
101588536|NCT03314935|Antimitotic Agents|antimitotic agents|mesh-ancestor
101588537|NCT03314935|Mitosis Modulators|mitosis modulators|mesh-ancestor
101588538|NCT03314935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588539|NCT03314935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101588540|NCT03314935|Antimetabolites|antimetabolites|mesh-ancestor
101588541|NCT03314935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101588542|NCT03314935|Immunologic Factors|immunologic factors|mesh-ancestor
101588543|NCT03314935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588544|NCT03314935|Antidotes|antidotes|mesh-ancestor
101588545|NCT03314935|Protective Agents|protective agents|mesh-ancestor
101588546|NCT03314935|Vitamin B Complex|vitamin b complex|mesh-ancestor
101588547|NCT03314935|Vitamins|vitamins|mesh-ancestor
101588548|NCT03314935|Micronutrients|micronutrients|mesh-ancestor
101588549|NCT02633761|Misoprostol|misoprostol|mesh-list
101588550|NCT02633761|Mifepristone|mifepristone|mesh-list
101588551|NCT02633761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101588552|NCT02633761|Abortifacient Agents|abortifacient agents|mesh-ancestor
101588553|NCT02633761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101588554|NCT02633761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588555|NCT02633761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101588556|NCT02633761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101588557|NCT02633761|Oxytocics|oxytocics|mesh-ancestor
101588558|NCT02633761|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101588559|NCT02633761|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101588560|NCT02633761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101588561|NCT02633761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101588562|NCT02633761|Contraceptive Agents|contraceptive agents|mesh-ancestor
101588580|NCT02632903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101588581|NCT02632903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588583|NCT00657397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101588584|NCT00657397|Narcotics|narcotics|mesh-ancestor
101588585|NCT00657397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101588586|NCT00657397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588587|NCT00657397|Analgesics|analgesics|mesh-ancestor
101588588|NCT00657397|Sensory System Agents|sensory system agents|mesh-ancestor
101588589|NCT00657397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101588590|NCT00657397|Antitussive Agents|antitussive agents|mesh-ancestor
101588591|NCT00657397|Respiratory System Agents|respiratory system agents|mesh-ancestor
101588593|NCT04160611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101588594|NCT04160611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101588595|NCT04160611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101588596|NCT04160611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588597|NCT04160611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101588598|NCT04160611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101588599|NCT04160611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101588600|NCT04160611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101588601|NCT04160611|Anesthetics, General|anesthetics, general|mesh-ancestor
101588602|NCT04160611|Anesthetics|anesthetics|mesh-ancestor
101588603|NCT04160611|GABA Modulators|gaba modulators|mesh-ancestor
101588604|NCT04160611|GABA Agents|gaba agents|mesh-ancestor
101588605|NCT04160611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101588606|NCT04160611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588607|NCT04161001|Amlodipine|amlodipine|mesh-list
101588608|NCT04161001|Olmesartan|olmesartan|mesh-list
101588609|NCT04161001|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101588610|NCT04161001|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
101588611|NCT04161001|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101618062|NCT04669782|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101618063|NCT04669782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101618064|NCT04669782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618065|NCT04669782|Hemostatics|hemostatics|mesh-ancestor
101618066|NCT04669782|Coagulants|coagulants|mesh-ancestor
101618067|NCT04669782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101618068|NCT04669782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101618069|NCT00891735|Ranibizumab|ranibizumab|mesh-list
101618070|NCT00891735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101618071|NCT00891735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101618072|NCT00891735|Growth Substances|growth substances|mesh-ancestor
101618073|NCT00891735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416894|NCT00131846|Diuretics|diuretics|mesh-list
101588612|NCT04161001|Ezetimibe|ezetimibe|mesh-list
101588613|NCT04161001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101588614|NCT04161001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101588615|NCT04161001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101588616|NCT04161001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588617|NCT04161001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101588629|NCT00881569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101588630|NCT00657163|Fluoxetine|fluoxetine|mesh-list
101588631|NCT00657163|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101588632|NCT00657163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101588633|NCT00657163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101588634|NCT00657163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588635|NCT00657163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101588636|NCT00657163|Serotonin Agents|serotonin agents|mesh-ancestor
101588637|NCT00657163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588638|NCT00657163|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101588639|NCT00657163|Antidepressive Agents|antidepressive agents|mesh-ancestor
101588640|NCT00657163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101588641|NCT00657163|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101588642|NCT00657163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101588643|NCT00657163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101588644|NCT02636101|Betamethasone|betamethasone|mesh-list
101588645|NCT02636101|Betamethasone Valerate|betamethasone valerate|mesh-list
101588646|NCT02636101|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101588647|NCT02636101|Betamethasone benzoate|betamethasone benzoate|mesh-list
101588648|NCT02636101|Calcipotriene|calcipotriene|mesh-list
101588649|NCT02636101|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101588650|NCT02636101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101588651|NCT02636101|Glucocorticoids|glucocorticoids|mesh-ancestor
101588652|NCT02636101|Hormones|hormones|mesh-ancestor
101588653|NCT02636101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101588654|NCT02636101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588655|NCT02636101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101588656|NCT02636101|Respiratory System Agents|respiratory system agents|mesh-ancestor
101588657|NCT02636101|Dermatologic Agents|dermatologic agents|mesh-ancestor
101588658|NCT00657475|Heparin|heparin|mesh-list
101588659|NCT00657475|Calcium heparin|calcium heparin|mesh-list
101588660|NCT00657475|Anticoagulants|anticoagulants|mesh-ancestor
101588661|NCT00657475|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101588662|NCT00657475|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101432694|NCT00189618|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101588663|NCT00657475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588664|NCT00657319|Insulin Aspart|insulin aspart|mesh-list
101588665|NCT00657319|Biphasic Insulins|biphasic insulins|mesh-list
101588666|NCT00657319|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101588667|NCT00657319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101618074|NCT00891735|Growth Inhibitors|growth inhibitors|mesh-ancestor
101618075|NCT00891735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101618076|NCT04252248|Decitabine|decitabine|mesh-list
101618077|NCT04252248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101618078|NCT04252248|Antimetabolites|antimetabolites|mesh-ancestor
101618079|NCT04252248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618080|NCT04252248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101618081|NCT04252248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101618082|NCT04247373|Ropivacaine|ropivacaine|mesh-list
101618083|NCT04247373|Anesthetics, Local|anesthetics, local|mesh-ancestor
101588668|NCT00657319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588669|NCT04159597|Upadacitinib|upadacitinib|mesh-list
101588670|NCT04159597|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101588671|NCT04159597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101588672|NCT04159597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101588673|NCT04159597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588674|NCT04159597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101588675|NCT00661219|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101588676|NCT00661219|Vasodilator Agents|vasodilator agents|mesh-ancestor
101588677|NCT00661219|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101588683|NCT00665743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101588684|NCT00665743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101588685|NCT00665743|Analgesics|analgesics|mesh-ancestor
101588686|NCT00665743|Sensory System Agents|sensory system agents|mesh-ancestor
101588687|NCT00665743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101588688|NCT00665743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588689|NCT00665743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101588690|NCT00665743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101588691|NCT00665743|Gout Suppressants|gout suppressants|mesh-ancestor
101588692|NCT00665743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101588693|NCT00665743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101588694|NCT00665743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588695|NCT00661297|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101588696|NCT00661297|Vasodilator Agents|vasodilator agents|mesh-ancestor
101588697|NCT00661297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101588698|NCT00661297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101588699|NCT00661297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101588700|NCT00661297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588701|NCT00661297|Urological Agents|urological agents|mesh-ancestor
101588702|NCT00879775|Sodium Benzoate|sodium benzoate|mesh-list
101588703|NCT00879775|Caffeine|caffeine|mesh-list
101588704|NCT00879775|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101588705|NCT00879775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588706|NCT00879775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101588707|NCT00879775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101588708|NCT00879775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588709|NCT00879775|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101588710|NCT00879775|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101588711|NCT00879775|Purinergic Agents|purinergic agents|mesh-ancestor
101588712|NCT00879775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101588713|NCT00879775|Antifungal Agents|antifungal agents|mesh-ancestor
101588714|NCT00879775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101588715|NCT00894790|Celecoxib|celecoxib|mesh-list
101588716|NCT00894790|Diclofenac|diclofenac|mesh-list
101588717|NCT00894790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101588718|NCT00894790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101588719|NCT00894790|Analgesics|analgesics|mesh-ancestor
101588720|NCT00894790|Sensory System Agents|sensory system agents|mesh-ancestor
101588721|NCT00894790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101588722|NCT00894790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588723|NCT00894790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101588724|NCT00894790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101588725|NCT00894790|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101588726|NCT00894790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101618085|NCT04247373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101618086|NCT04247373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618087|NCT04247373|Sensory System Agents|sensory system agents|mesh-ancestor
101618088|NCT04247373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101618089|NCT02832999|Liraglutide|liraglutide|mesh-list
101618090|NCT02832999|Vildagliptin|vildagliptin|mesh-list
101618091|NCT02832999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101618092|NCT02832999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618093|NCT02832999|Incretins|incretins|mesh-ancestor
101618094|NCT02832999|Hormones|hormones|mesh-ancestor
101618095|NCT02832999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101588727|NCT00894790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101588728|NCT00894790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588729|NCT00665977|Triamcinolone|triamcinolone|mesh-list
101588730|NCT00665977|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101588731|NCT00665977|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101588732|NCT00665977|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101588733|NCT00665977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101588734|NCT00665977|Glucocorticoids|glucocorticoids|mesh-ancestor
101588735|NCT00665977|Hormones|hormones|mesh-ancestor
101588736|NCT00665977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101588737|NCT00665977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588738|NCT00665977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101588739|NCT00665977|Immunologic Factors|immunologic factors|mesh-ancestor
101588740|NCT00665977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101588741|NCT00665977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588742|NCT00666055|Ritonavir|ritonavir|mesh-list
101588743|NCT00666055|Lopinavir|lopinavir|mesh-list
101588744|NCT00666055|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101588745|NCT00666055|Tenofovir|tenofovir|mesh-list
101588746|NCT00666055|Lamivudine|lamivudine|mesh-list
101588747|NCT00666055|Emtricitabine|emtricitabine|mesh-list
101588748|NCT00666055|Zidovudine|zidovudine|mesh-list
101588753|NCT00666055|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101588754|NCT00666055|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101588755|NCT00666055|Protease Inhibitors|protease inhibitors|mesh-ancestor
101588756|NCT00666055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101588757|NCT00666055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588758|NCT00666055|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101588759|NCT00666055|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101588760|NCT00666055|Antiviral Agents|antiviral agents|mesh-ancestor
101245650|NCT01660386|Glimepiride|glimepiride|mesh-list
101588761|NCT00666055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101588762|NCT00666055|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101588763|NCT00666055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101588764|NCT00666055|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101588765|NCT00666055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101588766|NCT00666055|Antimetabolites|antimetabolites|mesh-ancestor
101588767|NCT00666055|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101588768|NCT00666055|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101588769|NCT00666055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101588770|NCT00666055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101588771|NCT00666055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101588772|NCT00666055|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101588773|NCT00666055|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101588774|NCT00666055|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101588775|NCT00666055|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101588776|NCT00666055|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101588777|NCT00661375|Sorafenib|sorafenib|mesh-list
101588778|NCT00661375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101588779|NCT00661375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101588780|NCT00661375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101618096|NCT02832999|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101618097|NCT02832999|Protease Inhibitors|protease inhibitors|mesh-ancestor
101618098|NCT02832999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101618099|NCT02832999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618100|NCT04245033|Piperaquine|piperaquine|mesh-list
101618101|NCT04245033|Artenimol|artenimol|mesh-list
101618102|NCT04245033|Antimalarials|antimalarials|mesh-ancestor
101618103|NCT04245033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101618104|NCT04245033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101588781|NCT00661375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588782|NCT00911287|Oxymorphone|oxymorphone|mesh-list
101588783|NCT00911287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101588784|NCT00911287|Narcotics|narcotics|mesh-ancestor
101588785|NCT00911287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101588786|NCT00911287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588787|NCT00911287|Analgesics|analgesics|mesh-ancestor
101588788|NCT00911287|Sensory System Agents|sensory system agents|mesh-ancestor
101588789|NCT00911287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101588790|NCT00911287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101588791|NCT04494880|Bupivacaine|bupivacaine|mesh-list
101588792|NCT04494880|Anesthetics, Local|anesthetics, local|mesh-ancestor
101588793|NCT04494880|Anesthetics|anesthetics|mesh-ancestor
101588794|NCT04494880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101588795|NCT04494880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588796|NCT04494880|Sensory System Agents|sensory system agents|mesh-ancestor
101588797|NCT04494880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101588798|NCT02631031|Valsartan|valsartan|mesh-list
101588799|NCT02631031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101588800|NCT02631031|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101588801|NCT02631031|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101588802|NCT02631031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588803|NCT02839408|Azithromycin|azithromycin|mesh-list
101588804|NCT02839408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101588805|NCT02839408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101588806|NCT02837614|Acetaminophen|acetaminophen|mesh-list
101588807|NCT02837614|Amoxicillin|amoxicillin|mesh-list
101588809|NCT02837614|Dexamethasone acetate|dexamethasone acetate|mesh-list
101588810|NCT02837614|BB 1101|bb 1101|mesh-list
101588811|NCT02837614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101588812|NCT02837614|Antiemetics|antiemetics|mesh-ancestor
101588813|NCT02837614|Autonomic Agents|autonomic agents|mesh-ancestor
101588814|NCT02837614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101588815|NCT02837614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588816|NCT02837614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101588817|NCT02837614|Glucocorticoids|glucocorticoids|mesh-ancestor
101588818|NCT02837614|Hormones|hormones|mesh-ancestor
101588819|NCT02837614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101588823|NCT02837614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101588824|NCT02837614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588825|NCT02837614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101588826|NCT02837614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101588827|NCT02837614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101588829|NCT02837614|Sensory System Agents|sensory system agents|mesh-ancestor
101588830|NCT02837614|Antipyretics|antipyretics|mesh-ancestor
101588831|NCT02839486|Vancomycin|vancomycin|mesh-list
101588832|NCT02839486|Cefoxitin|cefoxitin|mesh-list
101588833|NCT02839486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101588834|NCT02839486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101588835|NCT00879229|Ambrisentan|ambrisentan|mesh-list
101588836|NCT00879229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101588837|NCT04249570|Povidone-Iodine|povidone-iodine|mesh-list
101588838|NCT04249570|Povidone|povidone|mesh-list
101588839|NCT04249570|Plasma Substitutes|plasma substitutes|mesh-ancestor
101588840|NCT04249570|Blood Substitutes|blood substitutes|mesh-ancestor
101588841|NCT04249570|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101588842|NCT04249570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101588843|NCT02837770|Diclofenac|diclofenac|mesh-list
101588844|NCT02837770|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101618105|NCT04245033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101618106|NCT00915018|Paclitaxel|paclitaxel|mesh-list
101618107|NCT00915018|Trastuzumab|trastuzumab|mesh-list
101618108|NCT00915018|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101618109|NCT00915018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101618110|NCT00915018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101618111|NCT00915018|Tubulin Modulators|tubulin modulators|mesh-ancestor
101618112|NCT00915018|Antimitotic Agents|antimitotic agents|mesh-ancestor
101416928|NCT00132158|Irinotecan|irinotecan|mesh-list
101588845|NCT02837770|Lubricant Eye Drops|lubricant eye drops|mesh-list
101588846|NCT02837770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101588847|NCT02837770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101588848|NCT02837770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101588849|NCT02837770|Analgesics|analgesics|mesh-ancestor
101588850|NCT02837770|Sensory System Agents|sensory system agents|mesh-ancestor
101588851|NCT02837770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101588852|NCT02837770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588853|NCT02837770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101588854|NCT02837770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101336368|NCT00055978|Celecoxib|celecoxib|mesh-list
101588855|NCT02837770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101588856|NCT02837770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101588857|NCT02837770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588858|NCT00878995|Methyltestosterone|methyltestosterone|mesh-list
101588859|NCT00878995|Testosterone|testosterone|mesh-list
101588860|NCT00878995|Testosterone undecanoate|testosterone undecanoate|mesh-list
101588861|NCT00878995|Testosterone enanthate|testosterone enanthate|mesh-list
101588862|NCT00878995|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101588863|NCT00878995|Androgens|androgens|mesh-ancestor
101588864|NCT00878995|Hormones|hormones|mesh-ancestor
101588865|NCT00878995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101588866|NCT00878995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588867|NCT00878995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101588868|NCT00878995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101588869|NCT00878995|Anabolic Agents|anabolic agents|mesh-ancestor
101588870|NCT02837146|Methotrexate|methotrexate|mesh-list
101588871|NCT02837146|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101588872|NCT02837146|Abortifacient Agents|abortifacient agents|mesh-ancestor
101588873|NCT02837146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101588874|NCT02837146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588875|NCT02837146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101588876|NCT02837146|Antimetabolites|antimetabolites|mesh-ancestor
101588877|NCT02837146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588878|NCT02837146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101588879|NCT02837146|Dermatologic Agents|dermatologic agents|mesh-ancestor
101588880|NCT02837146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101588881|NCT02837146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101588882|NCT02837146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101588883|NCT02837146|Immunologic Factors|immunologic factors|mesh-ancestor
101588884|NCT02837146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101588885|NCT02837146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101588887|NCT00657865|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101588888|NCT00657865|Protease Inhibitors|protease inhibitors|mesh-ancestor
101588889|NCT00657865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101588890|NCT00657865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588891|NCT00657865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101588892|NCT00661765|Varenicline|varenicline|mesh-list
101588909|NCT00657943|Heparin Antagonists|heparin antagonists|mesh-ancestor
101588910|NCT00657943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245791|NCT01661192|Protease Inhibitors|protease inhibitors|mesh-ancestor
101588911|NCT00657943|Coagulants|coagulants|mesh-ancestor
101588912|NCT04249804|Magnesium Sulfate|magnesium sulfate|mesh-list
101588913|NCT04249804|Analgesics|analgesics|mesh-ancestor
101588914|NCT04249804|Sensory System Agents|sensory system agents|mesh-ancestor
101588915|NCT04249804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101588916|NCT04249804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588917|NCT04249804|Anesthetics|anesthetics|mesh-ancestor
101618113|NCT00915018|Mitosis Modulators|mitosis modulators|mesh-ancestor
101618114|NCT00915018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618115|NCT00915018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101618116|NCT04246905|Sulforaphane|sulforaphane|mesh-list
101618117|NCT04246905|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101618118|NCT04246905|Protective Agents|protective agents|mesh-ancestor
101618119|NCT04246905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618120|NCT04246905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101618121|NCT02830347|Amoxicillin|amoxicillin|mesh-list
101618122|NCT02830347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101618123|NCT02830347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101618124|NCT00916578|Capecitabine|capecitabine|mesh-list
101618125|NCT00916578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101618126|NCT00916578|Antimetabolites|antimetabolites|mesh-ancestor
101618127|NCT00916578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618128|NCT00916578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101618129|NCT04675866|Paclitaxel|paclitaxel|mesh-list
101588918|NCT04249804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101588919|NCT04249804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101588920|NCT04249804|Anticonvulsants|anticonvulsants|mesh-ancestor
101588921|NCT04249804|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101588922|NCT04249804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101588923|NCT04249804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588924|NCT04249804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101588925|NCT04249804|Tocolytic Agents|tocolytic agents|mesh-ancestor
101588926|NCT04249804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101588927|NCT02631109|Methylprednisolone|methylprednisolone|mesh-list
101588928|NCT02631109|Doxorubicin|doxorubicin|mesh-list
101588929|NCT02631109|Etoposide|etoposide|mesh-list
101588930|NCT02631109|Pegaspargase|pegaspargase|mesh-list
101588931|NCT02631109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101588932|NCT02631109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101588933|NCT02631109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101588934|NCT02631109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101588935|NCT02631109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101588936|NCT02631109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588937|NCT02631109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101588938|NCT02631109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101588939|NCT02631109|Antiemetics|antiemetics|mesh-ancestor
101588940|NCT02631109|Autonomic Agents|autonomic agents|mesh-ancestor
101588941|NCT02631109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101588942|NCT02631109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588943|NCT02631109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101588944|NCT02631109|Glucocorticoids|glucocorticoids|mesh-ancestor
101588945|NCT02631109|Hormones|hormones|mesh-ancestor
101588946|NCT02631109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101588947|NCT02631109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101588948|NCT02631109|Protective Agents|protective agents|mesh-ancestor
101588949|NCT02630485|Inositol|inositol|mesh-list
101588950|NCT02630485|Letrozole|letrozole|mesh-list
101588951|NCT02630485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101588962|NCT02630485|Micronutrients|micronutrients|mesh-ancestor
101588963|NCT00894556|Sumatriptan|sumatriptan|mesh-list
101588964|NCT00894556|Rizatriptan|rizatriptan|mesh-list
101588965|NCT00894556|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101588966|NCT00894556|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101588967|NCT00894556|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101618130|NCT04675866|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101618131|NCT04675866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101618132|NCT04675866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101618133|NCT04675866|Tubulin Modulators|tubulin modulators|mesh-ancestor
101618134|NCT04675866|Antimitotic Agents|antimitotic agents|mesh-ancestor
101618135|NCT04675866|Mitosis Modulators|mitosis modulators|mesh-ancestor
101618136|NCT04675866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618137|NCT02829879|Listerine|listerine|mesh-list
101618138|NCT02829879|Fluorides|fluorides|mesh-list
101618139|NCT02829879|Sodium Fluoride|sodium fluoride|mesh-list
101588968|NCT00894556|Serotonin Agents|serotonin agents|mesh-ancestor
101588969|NCT00894556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101588970|NCT00894556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588971|NCT00894556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588972|NCT01210352|Oxymorphone|oxymorphone|mesh-list
101588973|NCT01210352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101588974|NCT01210352|Narcotics|narcotics|mesh-ancestor
101588975|NCT01210352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101588976|NCT01210352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588977|NCT01210352|Analgesics|analgesics|mesh-ancestor
101588978|NCT01210352|Sensory System Agents|sensory system agents|mesh-ancestor
101588979|NCT01210352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101588980|NCT01210352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101588981|NCT04250506|Moxifloxacin|moxifloxacin|mesh-list
101588982|NCT04250506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101336386|NCT00056095|Cyclosporine|cyclosporine|mesh-list
101588983|NCT04250506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101588984|NCT04250506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101588985|NCT04250506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101588986|NCT04250506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101588987|NCT04250506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588988|NCT04250506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101588989|NCT00662077|Ibandronic Acid|ibandronic acid|mesh-list
101588990|NCT00662077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101588991|NCT00662077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588993|NCT00658099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101588994|NCT00658099|Insulin Detemir|insulin detemir|mesh-list
101588995|NCT00658099|Isophane Insulin, Human|isophane insulin, human|mesh-list
101588996|NCT00658099|Insulin, Isophane|insulin, isophane|mesh-list
101588997|NCT00658099|Isophane insulin, beef|isophane insulin, beef|mesh-list
101588998|NCT00658099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101588999|NCT00658099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589000|NCT00658177|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101589001|NCT00658177|Vasodilator Agents|vasodilator agents|mesh-ancestor
101589002|NCT00658177|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101589003|NCT00658177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101589004|NCT00658177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101589005|NCT00658177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589006|NCT00658177|Urological Agents|urological agents|mesh-ancestor
101589007|NCT00658255|Budesonide|budesonide|mesh-list
101589008|NCT00658255|Formoterol Fumarate|formoterol fumarate|mesh-list
101589009|NCT00658255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101589010|NCT00658255|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101589011|NCT00658255|Autonomic Agents|autonomic agents|mesh-ancestor
101589012|NCT00658255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101589013|NCT00658255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589014|NCT00658255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101589015|NCT00658255|Respiratory System Agents|respiratory system agents|mesh-ancestor
101589016|NCT00658255|Glucocorticoids|glucocorticoids|mesh-ancestor
101589017|NCT00658255|Hormones|hormones|mesh-ancestor
101589031|NCT02836288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101589032|NCT02836288|Anesthetics, General|anesthetics, general|mesh-ancestor
101589033|NCT02836288|Anesthetics|anesthetics|mesh-ancestor
101589034|NCT02836288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101589035|NCT02836288|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101618141|NCT02829879|Cariostatic Agents|cariostatic agents|mesh-ancestor
101618142|NCT02829879|Protective Agents|protective agents|mesh-ancestor
101618143|NCT02829879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618144|NCT02829879|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101618145|NCT02829879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101618146|NCT05246007|Dexmedetomidine|dexmedetomidine|mesh-list
101618147|NCT05246007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101416959|NCT00140517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101589036|NCT02836288|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101589037|NCT02836288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101589038|NCT02836288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589039|NCT00658645|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101589040|NCT00658645|Antidepressive Agents|antidepressive agents|mesh-ancestor
101589041|NCT00658645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101589042|NCT00658645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101589043|NCT00658645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101589044|NCT00658645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101589045|NCT00658645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589046|NCT01208402|Esmolol|esmolol|mesh-list
101589047|NCT01208402|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101589048|NCT01208402|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101589049|NCT01208402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101589050|NCT01208402|Adrenergic Agents|adrenergic agents|mesh-ancestor
101589051|NCT01208402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101589052|NCT01208402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589053|NCT01208402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589054|NCT01208324|Estrogens|estrogens|mesh-list
101589055|NCT01208324|Hormones|hormones|mesh-ancestor
101589056|NCT01208324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101589057|NCT01208324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589058|NCT02838940|Cefazolin|cefazolin|mesh-list
101589059|NCT02838940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101589060|NCT02838940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101589061|NCT02835742|Sargramostim|sargramostim|mesh-list
101589062|NCT02835742|Immunologic Factors|immunologic factors|mesh-ancestor
101589063|NCT02835742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589064|NCT05326360|Ramosetron|ramosetron|mesh-list
101589065|NCT05326360|Antiemetics|antiemetics|mesh-ancestor
101589066|NCT05326360|Autonomic Agents|autonomic agents|mesh-ancestor
101589067|NCT05326360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101589068|NCT05326360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589069|NCT05326360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101589070|NCT05326360|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101589071|NCT05326360|Serotonin Agents|serotonin agents|mesh-ancestor
101589072|NCT05326360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101589073|NCT05326360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589074|NCT00666601|Tedizolid phosphate|tedizolid phosphate|mesh-list
101589075|NCT00666601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101589092|NCT02838472|Vitamins|vitamins|mesh-ancestor
101589093|NCT02838472|Micronutrients|micronutrients|mesh-ancestor
101589094|NCT02838472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589095|NCT02838472|Antioxidants|antioxidants|mesh-ancestor
101589096|NCT02838472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589097|NCT02838472|Protective Agents|protective agents|mesh-ancestor
101589098|NCT00666991|Paclitaxel|paclitaxel|mesh-list
101589099|NCT00666991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101589100|NCT00666991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101589101|NCT00666991|Tubulin Modulators|tubulin modulators|mesh-ancestor
101589102|NCT00666991|Antimitotic Agents|antimitotic agents|mesh-ancestor
101589103|NCT00666991|Mitosis Modulators|mitosis modulators|mesh-ancestor
101589104|NCT00666991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589105|NCT00667147|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101589107|NCT00667147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101618148|NCT05246007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101618149|NCT05246007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618150|NCT05246007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101618151|NCT05246007|Analgesics|analgesics|mesh-ancestor
101618152|NCT05246007|Sensory System Agents|sensory system agents|mesh-ancestor
101618153|NCT05246007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101618154|NCT05246007|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101618155|NCT05246007|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101618156|NCT05246007|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101618157|NCT05246007|Adrenergic Agents|adrenergic agents|mesh-ancestor
101618158|NCT05246007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101618159|NCT05246007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589108|NCT00667147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101589109|NCT00667147|Tubulin Modulators|tubulin modulators|mesh-ancestor
101589110|NCT00667147|Antimitotic Agents|antimitotic agents|mesh-ancestor
101589111|NCT00667147|Mitosis Modulators|mitosis modulators|mesh-ancestor
101589112|NCT00667147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589113|NCT02835586|Paclitaxel|paclitaxel|mesh-list
101589114|NCT02835586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101589115|NCT02835586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101589116|NCT02835586|Tubulin Modulators|tubulin modulators|mesh-ancestor
101589117|NCT02835586|Antimitotic Agents|antimitotic agents|mesh-ancestor
101589118|NCT02835586|Mitosis Modulators|mitosis modulators|mesh-ancestor
101589119|NCT02835586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589120|NCT00667303|Antibodies|antibodies|mesh-list
101589121|NCT00667303|Immunologic Factors|immunologic factors|mesh-ancestor
101589122|NCT00667303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589123|NCT02838238|Capecitabine|capecitabine|mesh-list
101589124|NCT02838238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101589125|NCT02838238|Antimetabolites|antimetabolites|mesh-ancestor
101589126|NCT02838238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589127|NCT02838238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101589128|NCT00667537|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
101589129|NCT00667537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101589130|NCT00667771|Naltrexone|naltrexone|mesh-list
101589131|NCT00667771|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101589132|NCT00667771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101589133|NCT00667771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589134|NCT00667771|Sensory System Agents|sensory system agents|mesh-ancestor
101246020|NCT01662804|Antibodies|antibodies|mesh-list
101589136|NCT01206764|Everolimus|everolimus|mesh-list
101589137|NCT01206764|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101589138|NCT01206764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101589158|NCT00668005|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101589159|NCT00668005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101589161|NCT00668005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589162|NCT00668005|Urological Agents|urological agents|mesh-ancestor
101589163|NCT00668239|Triamcinolone|triamcinolone|mesh-list
101589164|NCT00668239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101589165|NCT00668239|Glucocorticoids|glucocorticoids|mesh-ancestor
101589166|NCT00668239|Hormones|hormones|mesh-ancestor
101589167|NCT00668239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101589168|NCT00668239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589169|NCT02631499|Epirubicin|epirubicin|mesh-list
101589170|NCT02631499|Ethiodized Oil|ethiodized oil|mesh-list
101589171|NCT02631499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101589172|NCT02631499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101589173|NCT02631499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101589174|NCT02631499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101589175|NCT02631499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101589176|NCT02631499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618160|NCT00914940|Fludarabine|fludarabine|mesh-list
101618161|NCT00914940|Fludarabine phosphate|fludarabine phosphate|mesh-list
101618162|NCT00914940|Thiotepa|thiotepa|mesh-list
101618163|NCT00914940|Tacrolimus|tacrolimus|mesh-list
101618164|NCT00914940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101618165|NCT00914940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101618166|NCT00914940|Antimetabolites|antimetabolites|mesh-ancestor
101618167|NCT00914940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416984|NCT01246999|Vaccines|vaccines|mesh-list
101589178|NCT00662233|Ifosfamide|ifosfamide|mesh-list
101589179|NCT00662233|Doxorubicin|doxorubicin|mesh-list
101589180|NCT00662233|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101589181|NCT00662233|Etoposide|etoposide|mesh-list
101589182|NCT00662233|Vincristine|vincristine|mesh-list
101589183|NCT00662233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101589184|NCT00662233|Immunologic Factors|immunologic factors|mesh-ancestor
101589185|NCT00662233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589186|NCT00662233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101589187|NCT00662233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101589188|NCT00662233|Alkylating Agents|alkylating agents|mesh-ancestor
101589189|NCT00662233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336460|NCT00423709|Fludarabine|fludarabine|mesh-list
101589190|NCT00662233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101589191|NCT00662233|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101589192|NCT00662233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101589201|NCT00658957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101589202|NCT00658957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101589203|NCT00658957|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101589204|NCT00658957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101589205|NCT00658957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589206|NCT00662467|Aspirin|aspirin|mesh-list
101589207|NCT00662467|Warfarin|warfarin|mesh-list
101589208|NCT00662467|Clopidogrel|clopidogrel|mesh-list
101246107|NCT01663558|Imiquimod|imiquimod|mesh-list
101589209|NCT00662467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101589210|NCT00662467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101589211|NCT00662467|Analgesics|analgesics|mesh-ancestor
101589212|NCT00662467|Sensory System Agents|sensory system agents|mesh-ancestor
101589213|NCT00662467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101589214|NCT00662467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589215|NCT00662467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101589216|NCT00662467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101589217|NCT00662467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101589218|NCT00662467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101589219|NCT00662467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589220|NCT00662467|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101589221|NCT00662467|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101589222|NCT00662467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101589223|NCT00662467|Antipyretics|antipyretics|mesh-ancestor
101589224|NCT00662467|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101589225|NCT00662467|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101589226|NCT00662467|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101589227|NCT00662467|Purinergic Agents|purinergic agents|mesh-ancestor
101589228|NCT00662467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101589229|NCT00662467|Anticoagulants|anticoagulants|mesh-ancestor
101589230|NCT00668941|Vitamin D|vitamin d|mesh-list
101589231|NCT00668941|Cholecalciferol|cholecalciferol|mesh-list
101589232|NCT00668941|Alendronate|alendronate|mesh-list
101589233|NCT00668941|Teriparatide|teriparatide|mesh-list
101589234|NCT00668941|Calcium|calcium|mesh-list
101589235|NCT00668941|Vitamins|vitamins|mesh-ancestor
101589236|NCT00668941|Micronutrients|micronutrients|mesh-ancestor
101589237|NCT00668941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589238|NCT00668941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101589239|NCT00668941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101589240|NCT00894322|Exenatide|exenatide|mesh-list
101589241|NCT00894322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101589242|NCT00894322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589243|NCT00894322|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101589244|NCT00894322|Incretins|incretins|mesh-ancestor
101618168|NCT00914940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101618169|NCT00914940|Immunologic Factors|immunologic factors|mesh-ancestor
101618170|NCT00914940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618171|NCT00914940|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101618172|NCT00914940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101618173|NCT00914940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101618174|NCT00914940|Alkylating Agents|alkylating agents|mesh-ancestor
101618175|NCT00914940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101618176|NCT00835978|Axitinib|axitinib|mesh-list
101618177|NCT00835978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416988|NCT00140595|Rituximab|rituximab|mesh-list
101589245|NCT00894322|Hormones|hormones|mesh-ancestor
101589246|NCT00894322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101589247|NCT00633412|Esomeprazole|esomeprazole|mesh-list
101589248|NCT00633412|Ranitidine|ranitidine|mesh-list
101336470|NCT00056797|Interleukin-2|interleukin-2|mesh-list
101589249|NCT00633412|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
101589250|NCT00633412|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101264373|NCT01767545|Dexamethasone|dexamethasone|mesh-list
101589252|NCT00633412|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101589253|NCT00633412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101589254|NCT00633412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589255|NCT00633412|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101589256|NCT00633412|Histamine Antagonists|histamine antagonists|mesh-ancestor
101589257|NCT00633412|Histamine Agents|histamine agents|mesh-ancestor
101589258|NCT00633412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101589259|NCT00633412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589260|NCT04250116|Apixaban|apixaban|mesh-list
101589282|NCT00662779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101589284|NCT00662779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101589286|NCT00662779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101589287|NCT00662779|Respiratory System Agents|respiratory system agents|mesh-ancestor
101589288|NCT00662779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101589289|NCT00662779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101589290|NCT00662779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101589291|NCT00662779|Adrenergic Agents|adrenergic agents|mesh-ancestor
101589292|NCT00662779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101589293|NCT00662779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589294|NCT02630095|Nadroparin|nadroparin|mesh-list
101589295|NCT02630095|Warfarin|warfarin|mesh-list
101589296|NCT02630095|Calcium|calcium|mesh-list
101589297|NCT02630095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101589298|NCT02630095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589299|NCT02630095|Anticoagulants|anticoagulants|mesh-ancestor
101589300|NCT02630095|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101589301|NCT02630095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101589302|NCT02630095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589303|NCT00669487|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101589304|NCT00669487|Lamivudine|lamivudine|mesh-list
101589305|NCT00669487|Stavudine|stavudine|mesh-list
101589306|NCT00669487|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101589307|NCT00669487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101589308|NCT00669487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101589309|NCT00669487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589310|NCT00669487|Antiviral Agents|antiviral agents|mesh-ancestor
101589311|NCT00669487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101589312|NCT00669487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101589318|NCT00669643|Rifampin|rifampin|mesh-list
101589319|NCT00669643|Dapsone|dapsone|mesh-list
101589320|NCT00669643|Clofazimine|clofazimine|mesh-list
101589321|NCT00669643|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101589322|NCT00669643|Antitubercular Agents|antitubercular agents|mesh-ancestor
101589323|NCT00669643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101589324|NCT00669643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101589325|NCT00669643|Leprostatic Agents|leprostatic agents|mesh-ancestor
101589326|NCT00669643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101618178|NCT00835978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101618179|NCT00835978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101618180|NCT00835978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618181|NCT01077518|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101618182|NCT01077518|Ofatumumab|ofatumumab|mesh-list
101618183|NCT01077518|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101618184|NCT01077518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101618185|NCT01077518|Alkylating Agents|alkylating agents|mesh-ancestor
101417004|NCT04696783|Esomeprazole|esomeprazole|mesh-list
101589328|NCT00669643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589329|NCT00669643|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101589330|NCT00669643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101589331|NCT00669643|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101589332|NCT00669643|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101589333|NCT00669643|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101589334|NCT00669643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101589335|NCT00669643|Antimalarials|antimalarials|mesh-ancestor
101330927|NCT00033163|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101589336|NCT00669643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101589337|NCT00669643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101589338|NCT00669643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101589339|NCT00669643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101589340|NCT00669721|Heparin|heparin|mesh-list
101589341|NCT00669721|Calcium heparin|calcium heparin|mesh-list
101589342|NCT00669721|Nadroparin|nadroparin|mesh-list
101589343|NCT00669721|Anticoagulants|anticoagulants|mesh-ancestor
101589344|NCT00669721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101589345|NCT00669721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101589346|NCT00669721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589347|NCT00894166|Bupropion|bupropion|mesh-list
101589348|NCT00894166|Nicotine|nicotine|mesh-list
101589349|NCT00894166|Varenicline|varenicline|mesh-list
101589350|NCT00894166|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101589351|NCT00894166|Autonomic Agents|autonomic agents|mesh-ancestor
101589352|NCT00894166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101589353|NCT00894166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589354|NCT00894166|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101589355|NCT00894166|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101589356|NCT00894166|Cholinergic Agents|cholinergic agents|mesh-ancestor
101589357|NCT00894166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101589358|NCT00894166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589359|NCT00894166|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101589360|NCT00894166|Antidepressive Agents|antidepressive agents|mesh-ancestor
101589361|NCT00894166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101589362|NCT00894166|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101589363|NCT00894166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101589364|NCT00894166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101589366|NCT00894166|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101589367|NCT00894166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101589368|NCT00894166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101589369|NCT00659503|Ciclesonide|ciclesonide|mesh-list
101589370|NCT00659503|Glucocorticoids|glucocorticoids|mesh-ancestor
101589371|NCT00659503|Hormones|hormones|mesh-ancestor
101589372|NCT00659503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101589373|NCT00659503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589374|NCT00659503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101589375|NCT00670345|Tranexamic Acid|tranexamic acid|mesh-list
101589376|NCT00670345|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101589377|NCT00670345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101589378|NCT00670345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589379|NCT00670345|Hemostatics|hemostatics|mesh-ancestor
101589380|NCT00670345|Coagulants|coagulants|mesh-ancestor
101589381|NCT04153981|Insulin Glargine|insulin glargine|mesh-list
101589382|NCT04153981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101589383|NCT04153981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589384|NCT00670423|Sirolimus|sirolimus|mesh-list
101589385|NCT00670423|Bortezomib|bortezomib|mesh-list
101618186|NCT01077518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618187|NCT01077518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101618188|NCT01077518|Immunologic Factors|immunologic factors|mesh-ancestor
101417005|NCT04696783|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101336483|NCT00056836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101589389|NCT00670423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589390|NCT00670423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101589391|NCT00670423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101589392|NCT00670423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589393|NCT00670423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101589394|NCT00670423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101589395|NCT00670423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101589396|NCT00670423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101589397|NCT00670423|Antifungal Agents|antifungal agents|mesh-ancestor
101589399|NCT00659659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101589400|NCT00659659|Respiratory System Agents|respiratory system agents|mesh-ancestor
101589401|NCT00670501|Vitamin D|vitamin d|mesh-list
101589402|NCT00670501|Teriparatide|teriparatide|mesh-list
101589403|NCT00670501|Calcium|calcium|mesh-list
101589404|NCT00670501|Vitamins|vitamins|mesh-ancestor
101589405|NCT00670501|Micronutrients|micronutrients|mesh-ancestor
101589406|NCT00670501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589407|NCT00670501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101589408|NCT00670501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101589409|NCT00663247|Mesalamine|mesalamine|mesh-list
101589410|NCT00663247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101589411|NCT00663247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101589412|NCT00663247|Analgesics|analgesics|mesh-ancestor
101589413|NCT00663247|Sensory System Agents|sensory system agents|mesh-ancestor
101589414|NCT00663247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101589415|NCT00663247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589416|NCT00663247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101589417|NCT00663247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101589418|NCT01163747|Methotrexate|methotrexate|mesh-list
101589419|NCT01163747|Vaccines|vaccines|mesh-list
101589420|NCT01163747|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101589421|NCT01163747|Immunologic Factors|immunologic factors|mesh-ancestor
101589422|NCT01163747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589423|NCT01163747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101589424|NCT01163747|Abortifacient Agents|abortifacient agents|mesh-ancestor
101589425|NCT01163747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101589426|NCT01163747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101589427|NCT01163747|Antimetabolites|antimetabolites|mesh-ancestor
101589428|NCT01163747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589429|NCT01163747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101589430|NCT01163747|Dermatologic Agents|dermatologic agents|mesh-ancestor
101589431|NCT01163747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101589432|NCT01163747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101589433|NCT01163747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101589435|NCT01163747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101589436|NCT00670657|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101589437|NCT00670657|Antifungal Agents|antifungal agents|mesh-ancestor
101589438|NCT00670657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101589439|NCT00670657|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101589440|NCT00670657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101589441|NCT05657015|Simvastatin|simvastatin|mesh-list
101589442|NCT05657015|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101589443|NCT05657015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101589444|NCT05657015|Antimetabolites|antimetabolites|mesh-ancestor
101589445|NCT05657015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589446|NCT05657015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101589447|NCT05657015|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101589448|NCT05657015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101589449|NCT02887313|Leucovorin|leucovorin|mesh-list
101589450|NCT02887313|Fluorouracil|fluorouracil|mesh-list
101589451|NCT02887313|Oxaliplatin|oxaliplatin|mesh-list
101589452|NCT02887313|Antimetabolites|antimetabolites|mesh-ancestor
101336536|NCT00057265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101589453|NCT02887313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589454|NCT02887313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101589455|NCT02887313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101618189|NCT01077518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618190|NCT04203186|Lumefantrine|lumefantrine|mesh-list
101618191|NCT04203186|Artemether|artemether|mesh-list
101618192|NCT04203186|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101618193|NCT04203186|Atovaquone|atovaquone|mesh-list
101618194|NCT04203186|Proguanil|proguanil|mesh-list
101618195|NCT04203186|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
101618196|NCT04203186|Antimalarials|antimalarials|mesh-ancestor
101618197|NCT04203186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101618198|NCT04203186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101618199|NCT04203186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101618200|NCT04203186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101618201|NCT04203186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618202|NCT04203186|Antimetabolites|antimetabolites|mesh-ancestor
101618203|NCT00835120|Pioglitazone|pioglitazone|mesh-list
101417010|NCT00132431|Cinacalcet|cinacalcet|mesh-list
101589456|NCT02887313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101589457|NCT02887313|Immunologic Factors|immunologic factors|mesh-ancestor
101589458|NCT02887313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589459|NCT02887313|Antidotes|antidotes|mesh-ancestor
101589471|NCT01206140|Antifungal Agents|antifungal agents|mesh-ancestor
101589472|NCT01206140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101589473|NCT01206140|Immunologic Factors|immunologic factors|mesh-ancestor
101589474|NCT01206140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589475|NCT01206140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101589476|NCT01206140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101264374|NCT01767545|Bevacizumab|bevacizumab|mesh-list
101589477|NCT01206140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589479|NCT01162421|Methotrexate|methotrexate|mesh-list
101589480|NCT01162421|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101589481|NCT01162421|Abortifacient Agents|abortifacient agents|mesh-ancestor
101589482|NCT01162421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101589483|NCT01162421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589484|NCT01162421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101589485|NCT01162421|Antimetabolites|antimetabolites|mesh-ancestor
101589486|NCT01162421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589487|NCT01162421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101589488|NCT01162421|Dermatologic Agents|dermatologic agents|mesh-ancestor
101589489|NCT01162421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101589490|NCT01162421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101589491|NCT01162421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101589492|NCT01162421|Immunologic Factors|immunologic factors|mesh-ancestor
101589493|NCT01162421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101589494|NCT01162421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101589495|NCT01162421|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101589496|NCT01162421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101589497|NCT02885441|Ketorolac|ketorolac|mesh-list
101589498|NCT02885441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101589499|NCT02885441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101589500|NCT02885441|Analgesics|analgesics|mesh-ancestor
101589501|NCT02885441|Sensory System Agents|sensory system agents|mesh-ancestor
101589502|NCT02885441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101589503|NCT02885441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589504|NCT02885441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101589505|NCT02885441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101589506|NCT02885441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101589507|NCT02885441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101246397|NCT01665586|Analgesics|analgesics|mesh-ancestor
101589508|NCT02885441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589509|NCT02885597|Methotrexate|methotrexate|mesh-list
101618204|NCT00835120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101618205|NCT00835120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618206|NCT00914316|Ranolazine|ranolazine|mesh-list
101618207|NCT00914316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101618208|NCT00914316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101618209|NCT00914316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618210|NCT00701740|Isotretinoin|isotretinoin|mesh-list
101618211|NCT00701740|Terephthalylidene dicamphor sulfonic acid|terephthalylidene dicamphor sulfonic acid|mesh-list
101618212|NCT00701740|Dermatologic Agents|dermatologic agents|mesh-ancestor
101618213|NCT00701740|Sunscreening Agents|sunscreening agents|mesh-ancestor
101618214|NCT00701740|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101618215|NCT00701740|Protective Agents|protective agents|mesh-ancestor
101618216|NCT00701740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618217|NCT04938882|Lidocaine|lidocaine|mesh-list
101417024|NCT00132548|Artesunate|artesunate|mesh-list
101589510|NCT02885597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101589511|NCT02885597|Abortifacient Agents|abortifacient agents|mesh-ancestor
101589512|NCT02885597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101589513|NCT02885597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589514|NCT02885597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101589515|NCT02885597|Antimetabolites|antimetabolites|mesh-ancestor
101589516|NCT02885597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589517|NCT02885597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101589518|NCT02885597|Dermatologic Agents|dermatologic agents|mesh-ancestor
101589519|NCT02885597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101589520|NCT02885597|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101589521|NCT02885597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101589522|NCT02885597|Immunologic Factors|immunologic factors|mesh-ancestor
101589523|NCT02885597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101589529|NCT01188551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101589531|NCT01188551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101589532|NCT01188551|Analgesics|analgesics|mesh-ancestor
101589533|NCT01188551|Sensory System Agents|sensory system agents|mesh-ancestor
101589534|NCT01188551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101589535|NCT01188551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101589536|NCT01188551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101589537|NCT01188551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101589538|NCT01188551|Adrenergic Agents|adrenergic agents|mesh-ancestor
101589539|NCT01188551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101589540|NCT01188551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589541|NCT01188551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101589542|NCT01188551|Narcotics|narcotics|mesh-ancestor
101589543|NCT01188551|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101589544|NCT01188551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101589545|NCT01188551|Anesthetics, General|anesthetics, general|mesh-ancestor
101589546|NCT01188551|Anesthetics|anesthetics|mesh-ancestor
101589547|NCT01188551|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101589548|NCT01188551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101589550|NCT01188551|GABA Modulators|gaba modulators|mesh-ancestor
101589551|NCT01188551|GABA Agents|gaba agents|mesh-ancestor
101589552|NCT01161407|Calcium Carbonate|calcium carbonate|mesh-list
101589553|NCT01161407|Calcium|calcium|mesh-list
101589554|NCT01161407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101589555|NCT01161407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589556|NCT01161407|Antacids|antacids|mesh-ancestor
101589557|NCT01161407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589558|NCT01161407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101589559|NCT01161173|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101589560|NCT01161173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101589561|NCT01161173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101618218|NCT04938882|Ropivacaine|ropivacaine|mesh-list
101618219|NCT04938882|Anesthetics, Local|anesthetics, local|mesh-ancestor
101618220|NCT04938882|Anesthetics|anesthetics|mesh-ancestor
101618221|NCT04938882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101618222|NCT04938882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618223|NCT04938882|Sensory System Agents|sensory system agents|mesh-ancestor
101618224|NCT04938882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101618225|NCT04938882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101618226|NCT04938882|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101618227|NCT04938882|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101275263|NCT01861041|Bupivacaine|bupivacaine|mesh-list
101589562|NCT01161173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101589563|NCT01161173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589564|NCT01159769|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
101589565|NCT01159769|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101589566|NCT01159769|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101589567|NCT01159769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101589568|NCT01159769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101589569|NCT01159769|Analgesics|analgesics|mesh-ancestor
101589570|NCT01159769|Sensory System Agents|sensory system agents|mesh-ancestor
101589571|NCT01159769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101589572|NCT01159769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589573|NCT01159769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101589574|NCT01159769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101589575|NCT01159769|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101589576|NCT01159769|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101589577|NCT01159769|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101589578|NCT01159769|Histamine Antagonists|histamine antagonists|mesh-ancestor
101589579|NCT01159769|Histamine Agents|histamine agents|mesh-ancestor
101589580|NCT01159769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101589581|NCT01159769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589582|NCT01185821|Siponimod|siponimod|mesh-list
101589583|NCT01185821|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101589584|NCT01185821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589585|NCT01185821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101589586|NCT01185821|Immunologic Factors|immunologic factors|mesh-ancestor
101589587|NCT01185821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589588|NCT00893464|Ixazomib|ixazomib|mesh-list
101589589|NCT00893464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101589590|NCT00893464|Protease Inhibitors|protease inhibitors|mesh-ancestor
101589591|NCT00893464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101589592|NCT00893464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589593|NCT00891904|Cetuximab|cetuximab|mesh-list
101589595|NCT00891904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101589597|NCT02834260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101589598|NCT02834260|Antiemetics|antiemetics|mesh-ancestor
101589599|NCT02834260|Autonomic Agents|autonomic agents|mesh-ancestor
101589600|NCT02834260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101589601|NCT02834260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589602|NCT02834260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101589603|NCT02834260|Glucocorticoids|glucocorticoids|mesh-ancestor
101589604|NCT02834260|Hormones|hormones|mesh-ancestor
101589605|NCT02834260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101589606|NCT02834260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101589607|NCT02834260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101589608|NCT01157351|Olanzapine|olanzapine|mesh-list
101589609|NCT01157351|Risperidone|risperidone|mesh-list
101589610|NCT01157351|Aripiprazole|aripiprazole|mesh-list
101589611|NCT01157351|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101589612|NCT01157351|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101589613|NCT01157351|Perphenazine|perphenazine|mesh-list
101589614|NCT01157351|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101589615|NCT01157351|Serotonin Agents|serotonin agents|mesh-ancestor
101618228|NCT04938882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101618229|NCT04938882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618230|NCT00704080|Temozolomide|temozolomide|mesh-list
101618231|NCT00704080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101589616|NCT01157351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101589617|NCT01157351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589618|NCT01157351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589619|NCT01157351|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101589620|NCT01157351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101264376|NCT01767545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101589621|NCT01157351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101589622|NCT01157351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101589623|NCT01157351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101589624|NCT01157351|Dopamine Agents|dopamine agents|mesh-ancestor
101589625|NCT01157351|Antiemetics|antiemetics|mesh-ancestor
101589626|NCT01157351|Autonomic Agents|autonomic agents|mesh-ancestor
101589627|NCT01157351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101589628|NCT01157351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101589629|NCT01157351|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101589630|NCT01157351|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101589631|NCT01157351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101589632|NCT01157351|Antidepressive Agents|antidepressive agents|mesh-ancestor
101589633|NCT01157351|Dopamine Agonists|dopamine agonists|mesh-ancestor
101589634|NCT01157351|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101589635|NCT01157351|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101589636|NCT01157351|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101589637|NCT01157351|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101589638|NCT02831686|Dexamethasone|dexamethasone|mesh-list
101589639|NCT02831686|Ixazomib|ixazomib|mesh-list
101589640|NCT02831686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101589641|NCT02831686|Antiemetics|antiemetics|mesh-ancestor
101589642|NCT02831686|Autonomic Agents|autonomic agents|mesh-ancestor
101589643|NCT02831686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101589644|NCT02831686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589645|NCT02831686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101589646|NCT02831686|Glucocorticoids|glucocorticoids|mesh-ancestor
101589647|NCT02831686|Hormones|hormones|mesh-ancestor
101589648|NCT02831686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101589649|NCT02831686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101589650|NCT02831686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101589651|NCT02831686|Protease Inhibitors|protease inhibitors|mesh-ancestor
101589652|NCT02831686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101589653|NCT02831686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589654|NCT00633490|Apatinib|apatinib|mesh-list
101589655|NCT00633490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101589656|NCT00633490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101589657|NCT00633490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101589658|NCT00633490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589659|NCT02831374|Anesthetics|anesthetics|mesh-list
101589660|NCT02831374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101589661|NCT02831374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589662|NCT02831218|Aspirin|aspirin|mesh-list
101589663|NCT02831218|Clopidogrel|clopidogrel|mesh-list
101589664|NCT02831218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101589673|NCT02831218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101589674|NCT02831218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589675|NCT02831218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101589676|NCT02831218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101589677|NCT02831218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101589678|NCT02831218|Antipyretics|antipyretics|mesh-ancestor
101589679|NCT02831218|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101589680|NCT02831218|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101589681|NCT02831218|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101589682|NCT02831218|Purinergic Agents|purinergic agents|mesh-ancestor
101589683|NCT02831218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101589684|NCT02833480|Fluticasone|fluticasone|mesh-list
101589686|NCT02833480|Formoterol Fumarate|formoterol fumarate|mesh-list
101618232|NCT00704080|Alkylating Agents|alkylating agents|mesh-ancestor
101618233|NCT00704080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618234|NCT00704080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101618236|NCT05253066|Epirubicin|epirubicin|mesh-list
101618237|NCT05253066|Exemestane|exemestane|mesh-list
101618238|NCT05253066|Goserelin|goserelin|mesh-list
101589687|NCT02833480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101589688|NCT02833480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101589689|NCT02833480|Autonomic Agents|autonomic agents|mesh-ancestor
101589690|NCT02833480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101589691|NCT02833480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589692|NCT02833480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101589693|NCT02833480|Respiratory System Agents|respiratory system agents|mesh-ancestor
101589694|NCT02833480|Dermatologic Agents|dermatologic agents|mesh-ancestor
101589695|NCT02833480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101589696|NCT02833480|Glucocorticoids|glucocorticoids|mesh-ancestor
101589697|NCT02833480|Hormones|hormones|mesh-ancestor
101589698|NCT02833480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101589699|NCT02833480|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101589700|NCT02833480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101589701|NCT02833480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101589702|NCT02833480|Adrenergic Agents|adrenergic agents|mesh-ancestor
101589703|NCT02833480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101589704|NCT02833480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589705|NCT04201054|Fluconazole|fluconazole|mesh-list
101589706|NCT04201054|Antifungal Agents|antifungal agents|mesh-ancestor
101589707|NCT04201054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101589708|NCT04201054|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101589709|NCT04201054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101589710|NCT04201054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101589711|NCT04201054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589712|NCT04201054|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101589713|NCT04201054|Hormone Antagonists|hormone antagonists|mesh-ancestor
101589714|NCT04201054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101589715|NCT04201054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589716|NCT04201054|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101589717|NCT04201054|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101589718|NCT01157117|Omalizumab|omalizumab|mesh-list
101589719|NCT01157117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101589720|NCT01157117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101589721|NCT01157117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101589722|NCT01157117|Respiratory System Agents|respiratory system agents|mesh-ancestor
101589723|NCT01157117|Immunologic Factors|immunologic factors|mesh-ancestor
101589724|NCT01157117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589725|NCT00891202|Eliglustat|eliglustat|mesh-list
101589726|NCT00891202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101589727|NCT00891202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589728|NCT02830906|Ondansetron|ondansetron|mesh-list
101589729|NCT02830906|Ramosetron|ramosetron|mesh-list
101589738|NCT02830906|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101589739|NCT02830906|Serotonin Agents|serotonin agents|mesh-ancestor
101589740|NCT02830906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101589741|NCT02830906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589743|NCT02832778|Lamivudine|lamivudine|mesh-list
101589744|NCT02832778|Emtricitabine|emtricitabine|mesh-list
101589745|NCT02832778|Zidovudine|zidovudine|mesh-list
101589746|NCT02832778|Efavirenz|efavirenz|mesh-list
101589747|NCT02832778|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101589748|NCT02832778|Isoniazid|isoniazid|mesh-list
101589749|NCT02832778|Antiviral Agents|antiviral agents|mesh-ancestor
101589750|NCT02832778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101589751|NCT02832778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101589752|NCT02832778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101589753|NCT02832778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101589754|NCT02832778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589755|NCT02832778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101589756|NCT02832778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101589757|NCT02832778|Antimetabolites|antimetabolites|mesh-ancestor
101618239|NCT05253066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101618240|NCT05253066|Tubulin Modulators|tubulin modulators|mesh-ancestor
101618241|NCT05253066|Antimitotic Agents|antimitotic agents|mesh-ancestor
101618242|NCT05253066|Mitosis Modulators|mitosis modulators|mesh-ancestor
101618243|NCT05253066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589758|NCT02832778|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101589759|NCT02832778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101589760|NCT02832778|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101589761|NCT02832778|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101589762|NCT02832778|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101589763|NCT02832778|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101589764|NCT02832778|Antitubercular Agents|antitubercular agents|mesh-ancestor
101589765|NCT02832778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101589766|NCT02832778|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101589767|NCT02832778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101589768|NCT02832778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101589769|NCT01185509|Trastuzumab|trastuzumab|mesh-list
101589770|NCT01185509|Vinorelbine|vinorelbine|mesh-list
101589771|NCT01185509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101589772|NCT01185509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101589773|NCT01185509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101589774|NCT01185509|Tubulin Modulators|tubulin modulators|mesh-ancestor
101589775|NCT01185509|Antimitotic Agents|antimitotic agents|mesh-ancestor
101589776|NCT01185509|Mitosis Modulators|mitosis modulators|mesh-ancestor
101589777|NCT01185509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589778|NCT04247230|Tetracaine|tetracaine|mesh-list
101589779|NCT04247230|Anesthetics, Local|anesthetics, local|mesh-ancestor
101589780|NCT04247230|Anesthetics|anesthetics|mesh-ancestor
101589781|NCT04247230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101589782|NCT04247230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589783|NCT04247230|Sensory System Agents|sensory system agents|mesh-ancestor
101589784|NCT04247230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101589785|NCT02832700|Caseins|caseins|mesh-list
101589786|NCT02832700|Chelating Agents|chelating agents|mesh-ancestor
101589787|NCT02832700|Sequestering Agents|sequestering agents|mesh-ancestor
101589788|NCT02832700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589789|NCT02831842|Bevacizumab|bevacizumab|mesh-list
101589790|NCT02831842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101589791|NCT02831842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101589792|NCT02831842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101589793|NCT02831842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101589794|NCT02831842|Growth Substances|growth substances|mesh-ancestor
101589795|NCT02831842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589796|NCT02831842|Growth Inhibitors|growth inhibitors|mesh-ancestor
101589802|NCT02830126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589804|NCT02828566|Analgesics|analgesics|mesh-ancestor
101589805|NCT02828566|Sensory System Agents|sensory system agents|mesh-ancestor
101589806|NCT02828566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101589807|NCT02828566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589808|NCT02828566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101589809|NCT02828566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101589810|NCT02828566|Anesthetics, General|anesthetics, general|mesh-ancestor
101589812|NCT02828566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101589813|NCT02828566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101589814|NCT02828566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101589815|NCT02828566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101589816|NCT02828566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589817|NCT04245046|Amlodipine|amlodipine|mesh-list
101589818|NCT04245046|Candesartan|candesartan|mesh-list
101589819|NCT04245046|Candesartan cilexetil|candesartan cilexetil|mesh-list
101589820|NCT04245046|Atorvastatin|atorvastatin|mesh-list
101589821|NCT04245046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101589822|NCT04245046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101589823|NCT04245046|Antimetabolites|antimetabolites|mesh-ancestor
101589824|NCT04245046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589825|NCT04245046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101589826|NCT04245046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101618244|NCT05253066|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101618245|NCT05253066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101618246|NCT05253066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101618247|NCT05253066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101618248|NCT05253066|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101618249|NCT05253066|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101618250|NCT05253066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101618251|NCT05253066|Hormone Antagonists|hormone antagonists|mesh-ancestor
101618252|NCT05253066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101618253|NCT05253066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589827|NCT04245046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101589828|NCT04245046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101589829|NCT04245046|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101589830|NCT04245046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101589831|NCT04245046|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101589832|NCT04245046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589833|NCT04245046|Vasodilator Agents|vasodilator agents|mesh-ancestor
101589834|NCT04245046|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101589835|NCT04245046|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101589837|NCT02828176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101589838|NCT02828176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589839|NCT00633568|Cisplatin|cisplatin|mesh-list
101589840|NCT00633568|Docetaxel|docetaxel|mesh-list
101589841|NCT00633568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101589842|NCT00633568|Tubulin Modulators|tubulin modulators|mesh-ancestor
101589843|NCT00633568|Antimitotic Agents|antimitotic agents|mesh-ancestor
101589844|NCT00633568|Mitosis Modulators|mitosis modulators|mesh-ancestor
101589845|NCT00633568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589846|NCT02829346|Tranexamic Acid|tranexamic acid|mesh-list
101589847|NCT02829346|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101589848|NCT02829346|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101589849|NCT02829346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589850|NCT02829346|Hemostatics|hemostatics|mesh-ancestor
101589851|NCT02829346|Coagulants|coagulants|mesh-ancestor
101589852|NCT05210764|Ketamine|ketamine|mesh-list
101589853|NCT05210764|Anesthetics|anesthetics|mesh-list
101589854|NCT05210764|Propofol|propofol|mesh-list
101589855|NCT05210764|Sevoflurane|sevoflurane|mesh-list
101589856|NCT05210764|Esketamine|esketamine|mesh-list
101589857|NCT05210764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101589858|NCT05210764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589859|NCT05210764|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101589860|NCT05210764|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101589861|NCT05210764|Anesthetics, General|anesthetics, general|mesh-ancestor
101589862|NCT05210764|Analgesics|analgesics|mesh-ancestor
101589863|NCT05210764|Sensory System Agents|sensory system agents|mesh-ancestor
101589864|NCT05210764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101589865|NCT05210764|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101589866|NCT05210764|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101589871|NCT05210764|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101589872|NCT05210764|Antidepressive Agents|antidepressive agents|mesh-ancestor
101589873|NCT05210764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101589875|NCT00889720|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101589876|NCT00889720|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101589877|NCT00889720|Cholinergic Agents|cholinergic agents|mesh-ancestor
101589878|NCT00889720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101589879|NCT00889720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589881|NCT01116648|Olaparib|olaparib|mesh-list
101589882|NCT01116648|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
101589883|NCT01116648|Cediranib|cediranib|mesh-list
101589884|NCT01116648|Maleic acid|maleic acid|mesh-list
101589885|NCT01116648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101618254|NCT05253066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101618256|NCT04303598|Lamivudine|lamivudine|mesh-list
101618257|NCT04303598|Efavirenz|efavirenz|mesh-list
101618258|NCT04303598|Antiviral Agents|antiviral agents|mesh-ancestor
101618259|NCT04303598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101618260|NCT04303598|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101618261|NCT04303598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101336707|NCT00392262|Amlodipine|amlodipine|mesh-list
101618262|NCT04303598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101417072|NCT01245673|Growth Substances|growth substances|mesh-ancestor
101589886|NCT01116648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589887|NCT01116648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101589888|NCT01116648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101589889|NCT04243954|Morphine|morphine|mesh-list
101589890|NCT04243954|Hydromorphone|hydromorphone|mesh-list
101589891|NCT04243954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101589892|NCT04243954|Narcotics|narcotics|mesh-ancestor
101589893|NCT04243954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101589894|NCT04243954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589895|NCT04243954|Analgesics|analgesics|mesh-ancestor
101589896|NCT04243954|Sensory System Agents|sensory system agents|mesh-ancestor
101589897|NCT04243954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101589898|NCT02827942|Amoxicillin|amoxicillin|mesh-list
101589899|NCT02827942|Metronidazole|metronidazole|mesh-list
101589900|NCT02827942|Clarithromycin|clarithromycin|mesh-list
101589901|NCT02827942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101589902|NCT02827942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101589903|NCT02827942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101589904|NCT02827942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101589905|NCT02827942|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101589906|NCT02827942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101589907|NCT02827942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589908|NCT02827942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101589909|NCT02827942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101589910|NCT00889252|Ketotifen|ketotifen|mesh-list
101589911|NCT00889252|Antipruritics|antipruritics|mesh-ancestor
101589912|NCT00889252|Dermatologic Agents|dermatologic agents|mesh-ancestor
101589913|NCT00889252|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101589914|NCT00889252|Histamine Antagonists|histamine antagonists|mesh-ancestor
101589915|NCT00889252|Histamine Agents|histamine agents|mesh-ancestor
101589916|NCT00889252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101589917|NCT00889252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589918|NCT00889252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589919|NCT00889252|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101589921|NCT00670813|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101589922|NCT00670813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589923|NCT00670813|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101589924|NCT00670813|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101589925|NCT00670813|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101589926|NCT00670813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589927|NCT01110330|Ketoconazole|ketoconazole|mesh-list
101589928|NCT01110330|Antifungal Agents|antifungal agents|mesh-ancestor
101589929|NCT01110330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101589930|NCT01110330|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101589931|NCT01110330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101589932|NCT01110330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101589933|NCT01110330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589934|NCT01110330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101589935|NCT01110330|Hormone Antagonists|hormone antagonists|mesh-ancestor
101451773|NCT00203177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589942|NCT00663481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589943|NCT00663481|Vitamin B Complex|vitamin b complex|mesh-ancestor
101589945|NCT00663481|Micronutrients|micronutrients|mesh-ancestor
101589946|NCT04308954|Flumazenil|flumazenil|mesh-list
101589947|NCT04308954|Antidotes|antidotes|mesh-ancestor
101618263|NCT04303598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618264|NCT04303598|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101618265|NCT04303598|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101618266|NCT04303598|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101618267|NCT04303598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101589948|NCT04308954|Protective Agents|protective agents|mesh-ancestor
101336741|NCT02969473|Antimetabolites|antimetabolites|mesh-ancestor
101589949|NCT04308954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589950|NCT04308954|GABA Modulators|gaba modulators|mesh-ancestor
101589951|NCT04308954|GABA Agents|gaba agents|mesh-ancestor
101589952|NCT04308954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101589953|NCT04308954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589954|NCT00596947|Mycophenolic Acid|mycophenolic acid|mesh-list
101589956|NCT00596947|Methylprednisolone|methylprednisolone|mesh-list
101589957|NCT00596947|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101589958|NCT00596947|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101589959|NCT00596947|Prednisolone|prednisolone|mesh-list
101589960|NCT00596947|Prednisolone acetate|prednisolone acetate|mesh-list
101589961|NCT00596947|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101589962|NCT00596947|Prednisolone phosphate|prednisolone phosphate|mesh-list
101589963|NCT00596947|Tacrolimus|tacrolimus|mesh-list
101589964|NCT00596947|Thymoglobulin|thymoglobulin|mesh-list
101589965|NCT00596947|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101589966|NCT00596947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101589967|NCT00596947|Glucocorticoids|glucocorticoids|mesh-ancestor
101589968|NCT00596947|Hormones|hormones|mesh-ancestor
101589969|NCT00596947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101589970|NCT00596947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589971|NCT00596947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101589972|NCT00596947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101589973|NCT00596947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101589974|NCT00596947|Immunologic Factors|immunologic factors|mesh-ancestor
101589975|NCT00596947|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101589976|NCT00596947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101589977|NCT00596947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589978|NCT00596947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101589979|NCT00596947|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101589980|NCT00596947|Antitubercular Agents|antitubercular agents|mesh-ancestor
101589981|NCT00596947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101589982|NCT00596947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101589983|NCT00596947|Antiemetics|antiemetics|mesh-ancestor
101589984|NCT00596947|Autonomic Agents|autonomic agents|mesh-ancestor
101589985|NCT00596947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101589986|NCT00596947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101589987|NCT00596947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101589988|NCT00596947|Protective Agents|protective agents|mesh-ancestor
101589989|NCT04155697|Hand Sanitizers|hand sanitizers|mesh-list
101589990|NCT04155697|Ethanol|ethanol|mesh-list
101589991|NCT04155697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101589992|NCT04155697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101589993|NCT04155697|Disinfectants|disinfectants|mesh-ancestor
101589994|NCT04155697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101589995|NCT04155697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589996|NCT00663559|Sunitinib|sunitinib|mesh-list
101589997|NCT00663559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101589998|NCT00663559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101589999|NCT00663559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101590000|NCT00663559|Growth Substances|growth substances|mesh-ancestor
101590001|NCT00663559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590002|NCT00663559|Growth Inhibitors|growth inhibitors|mesh-ancestor
101590003|NCT00663559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101590004|NCT00663559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101590005|NCT00663559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590012|NCT00888940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590013|NCT00888940|Hemostatics|hemostatics|mesh-ancestor
101590014|NCT00888940|Coagulants|coagulants|mesh-ancestor
101590015|NCT00888940|Analgesics|analgesics|mesh-ancestor
101590016|NCT00888940|Sensory System Agents|sensory system agents|mesh-ancestor
101590017|NCT00888940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101590018|NCT00888940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618268|NCT04303598|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101618270|NCT04303598|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101618271|NCT04303598|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101618272|NCT04636086|Cholecalciferol|cholecalciferol|mesh-list
101618273|NCT04636086|Vitamin D|vitamin d|mesh-list
101618274|NCT04636086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101618275|NCT04636086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618276|NCT04636086|Vitamins|vitamins|mesh-ancestor
101618277|NCT04636086|Micronutrients|micronutrients|mesh-ancestor
101590019|NCT00888940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101590020|NCT00888940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101590021|NCT00888940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101590022|NCT00888940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101590023|NCT02826070|Adefovir|adefovir|mesh-list
101590024|NCT02826070|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101590025|NCT02826070|Telbivudine|telbivudine|mesh-list
101590026|NCT02826070|Antiviral Agents|antiviral agents|mesh-ancestor
101590027|NCT02826070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101590028|NCT02826070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101590029|NCT02826070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101590031|NCT02826070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590032|NCT02826226|Bronchodilator Agents|bronchodilator agents|mesh-list
101590033|NCT02826226|Autonomic Agents|autonomic agents|mesh-ancestor
101590034|NCT02826226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101590035|NCT02826226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590036|NCT02826226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101590037|NCT02826226|Respiratory System Agents|respiratory system agents|mesh-ancestor
101590038|NCT00671203|Erythromycin|erythromycin|mesh-list
101590039|NCT00671203|Erythromycin Estolate|erythromycin estolate|mesh-list
101590040|NCT00671203|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101590041|NCT00671203|Erythromycin stearate|erythromycin stearate|mesh-list
101590042|NCT00671203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101590043|NCT00671203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101590044|NCT00671203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101590045|NCT00671203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101590046|NCT00671203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101590047|NCT00671203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590048|NCT04157803|Acetic Acid|acetic acid|mesh-list
101590049|NCT04157803|Retinol acetate|retinol acetate|mesh-list
101590050|NCT04157803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101590051|NCT04157803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101590052|NCT04157803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101590053|NCT04157803|Immunologic Factors|immunologic factors|mesh-ancestor
101590054|NCT04157803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590055|NCT04157803|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101590056|NCT04157803|Protective Agents|protective agents|mesh-ancestor
101590057|NCT04157803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101590058|NCT04157959|Febuxostat|febuxostat|mesh-list
101590059|NCT04157959|Gout Suppressants|gout suppressants|mesh-ancestor
101590060|NCT04157959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101590061|NCT00660283|Temozolomide|temozolomide|mesh-list
101590062|NCT00660283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101590063|NCT00660283|Alkylating Agents|alkylating agents|mesh-ancestor
101590064|NCT00660283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590066|NCT00663949|Captopril|captopril|mesh-list
101590067|NCT00663949|Pentoxifylline|pentoxifylline|mesh-list
101590068|NCT00663949|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101590069|NCT00663949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101590070|NCT00663949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590071|NCT00663949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101590072|NCT00663949|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101590073|NCT00663949|Protective Agents|protective agents|mesh-ancestor
101590074|NCT00663949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618278|NCT04636086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101618280|NCT00827242|Vasodilator Agents|vasodilator agents|mesh-ancestor
101618281|NCT00827242|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101618282|NCT00827242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101618283|NCT00827242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101618284|NCT00827242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618285|NCT00827242|Urological Agents|urological agents|mesh-ancestor
101618286|NCT01077362|Ustekinumab|ustekinumab|mesh-list
101590075|NCT00663949|Vasodilator Agents|vasodilator agents|mesh-ancestor
101590076|NCT00663949|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101590077|NCT00663949|Antioxidants|antioxidants|mesh-ancestor
101590081|NCT00888238|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101590082|NCT00888238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101590083|NCT00888238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590084|NCT00888238|Incretins|incretins|mesh-ancestor
101590085|NCT00888238|Hormones|hormones|mesh-ancestor
101590086|NCT00888238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101590087|NCT00888238|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101590088|NCT00888238|Protease Inhibitors|protease inhibitors|mesh-ancestor
101590089|NCT00888238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101590090|NCT00888238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590091|NCT05660356|Hormones|hormones|mesh-list
101590092|NCT05660356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101590093|NCT05660356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590094|NCT02825914|Caseins|caseins|mesh-list
101590095|NCT02825914|Chelating Agents|chelating agents|mesh-ancestor
101590096|NCT02825914|Sequestering Agents|sequestering agents|mesh-ancestor
101590097|NCT02825914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590098|NCT00671281|Tranexamic Acid|tranexamic acid|mesh-list
101590099|NCT00671281|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101590100|NCT00671281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101247004|NCT01669824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101590101|NCT00671281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590102|NCT00671281|Hemostatics|hemostatics|mesh-ancestor
101590103|NCT00671281|Coagulants|coagulants|mesh-ancestor
101590104|NCT04155229|Acetaminophen|acetaminophen|mesh-list
101590105|NCT04155229|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
101590106|NCT04155229|Oxycodone|oxycodone|mesh-list
101590107|NCT04155229|Hydrocodone|hydrocodone|mesh-list
101590108|NCT04155229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101590109|NCT04155229|Analgesics|analgesics|mesh-ancestor
101590110|NCT04155229|Sensory System Agents|sensory system agents|mesh-ancestor
101590111|NCT04155229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101590112|NCT04155229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590113|NCT04155229|Antipyretics|antipyretics|mesh-ancestor
101590114|NCT04155229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101590115|NCT04155229|Narcotics|narcotics|mesh-ancestor
101590116|NCT04155229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101590117|NCT04155229|Antitussive Agents|antitussive agents|mesh-ancestor
101590118|NCT04155229|Respiratory System Agents|respiratory system agents|mesh-ancestor
101590119|NCT04155229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101590120|NCT04155229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101590121|NCT04155229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101590122|NCT00671359|Tedizolid phosphate|tedizolid phosphate|mesh-list
101590123|NCT00671359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101590124|NCT00671359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101590125|NCT04153201|Hydroxychloroquine|hydroxychloroquine|mesh-list
101590126|NCT04153201|Antimalarials|antimalarials|mesh-list
101590127|NCT04153201|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101590128|NCT04153201|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101590129|NCT04153201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101590130|NCT04153201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101590131|NCT04153201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590132|NCT04153201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101590133|NCT05660278|Caseins|caseins|mesh-list
101618287|NCT01077362|Dermatologic Agents|dermatologic agents|mesh-ancestor
101618288|NCT00846586|Tiotropium Bromide|tiotropium bromide|mesh-list
101618289|NCT00846586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101618290|NCT00846586|Autonomic Agents|autonomic agents|mesh-ancestor
101618291|NCT00846586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101417106|NCT00132821|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101590134|NCT05660278|Chelating Agents|chelating agents|mesh-ancestor
101590135|NCT05660278|Sequestering Agents|sequestering agents|mesh-ancestor
101590136|NCT05660278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590138|NCT04153123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101590139|NCT04153123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101590140|NCT04153123|Adrenergic Agents|adrenergic agents|mesh-ancestor
101590141|NCT04153123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101590142|NCT04153123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590143|NCT04153123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590144|NCT04153123|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101590145|NCT04153123|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101590146|NCT04153123|Autonomic Agents|autonomic agents|mesh-ancestor
101590147|NCT04153123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101590148|NCT04153123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101590157|NCT00671593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590158|NCT00671593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101590159|NCT00671593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101590160|NCT00671593|Disinfectants|disinfectants|mesh-ancestor
101590161|NCT00671593|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
101590162|NCT00671593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101590163|NCT01104870|Treprostinil|treprostinil|mesh-list
101590164|NCT01104870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101590165|NCT02632279|Tryptophan|tryptophan|mesh-list
101590166|NCT02632279|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101590167|NCT02632279|Antidepressive Agents|antidepressive agents|mesh-ancestor
101590168|NCT02632279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101590169|NCT00664417|Vaccines|vaccines|mesh-list
101590170|NCT00664417|Immunologic Factors|immunologic factors|mesh-ancestor
101590171|NCT00664417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590172|NCT04031755|Minocycline|minocycline|mesh-list
101590173|NCT04031755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101590174|NCT04031755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101590175|NCT01104792|Cariprazine|cariprazine|mesh-list
101590176|NCT01104792|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101590177|NCT01104792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101590178|NCT01104792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101590179|NCT01104792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590180|NCT01104792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101590181|NCT01205126|Oxycodone|oxycodone|mesh-list
101590182|NCT01205126|Hydromorphone|hydromorphone|mesh-list
101590183|NCT01205126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101590184|NCT01205126|Narcotics|narcotics|mesh-ancestor
101590185|NCT01205126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101590186|NCT01205126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590187|NCT01205126|Analgesics|analgesics|mesh-ancestor
101590188|NCT01205126|Sensory System Agents|sensory system agents|mesh-ancestor
101590189|NCT01205126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101590190|NCT02629627|Metformin|metformin|mesh-list
101590191|NCT02629627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101590192|NCT02629627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590193|NCT00946647|Azacitidine|azacitidine|mesh-list
101590194|NCT00946647|Panobinostat|panobinostat|mesh-list
101590195|NCT00946647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101590196|NCT00946647|Antimetabolites|antimetabolites|mesh-ancestor
101590197|NCT00946647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590198|NCT00946647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101590199|NCT00946647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101590200|NCT00946647|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101590201|NCT05117736|Valsartan|valsartan|mesh-list
101590202|NCT05117736|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101590203|NCT05117736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101590204|NCT05117736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101590205|NCT05117736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101618292|NCT00846586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618293|NCT00846586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101618294|NCT00846586|Respiratory System Agents|respiratory system agents|mesh-ancestor
101618295|NCT00846586|Parasympatholytics|parasympatholytics|mesh-ancestor
101618296|NCT00846586|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101618297|NCT00846586|Cholinergic Agents|cholinergic agents|mesh-ancestor
101618298|NCT00846586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101618299|NCT00846586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590206|NCT05117736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590207|NCT04157491|Antibodies|antibodies|mesh-list
101590208|NCT04157491|Immunologic Factors|immunologic factors|mesh-ancestor
101590209|NCT04157491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590210|NCT00660751|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101590211|NCT00660751|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101590212|NCT00660751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101590214|NCT00660751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590215|NCT00660751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101590216|NCT00660751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590217|NCT00660751|Analgesics|analgesics|mesh-ancestor
101590218|NCT00660751|Sensory System Agents|sensory system agents|mesh-ancestor
101590219|NCT00660751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101590225|NCT00664963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101590226|NCT00664963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101590227|NCT00664963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101590228|NCT00664963|Antifungal Agents|antifungal agents|mesh-ancestor
101590229|NCT00664963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101590230|NCT00664963|Immunologic Factors|immunologic factors|mesh-ancestor
101590231|NCT00664963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590232|NCT00672295|Paclitaxel|paclitaxel|mesh-list
101590233|NCT00672295|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101590234|NCT00672295|Carboplatin|carboplatin|mesh-list
101590235|NCT00672295|Dasatinib|dasatinib|mesh-list
101590236|NCT00672295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101590237|NCT00672295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101590238|NCT00672295|Tubulin Modulators|tubulin modulators|mesh-ancestor
101590239|NCT00672295|Antimitotic Agents|antimitotic agents|mesh-ancestor
101590240|NCT00672295|Mitosis Modulators|mitosis modulators|mesh-ancestor
101590241|NCT00672295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590242|NCT00672295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101590243|NCT00672295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101590244|NCT00665041|Quinagolide|quinagolide|mesh-list
101590245|NCT00665041|Dopamine Agonists|dopamine agonists|mesh-ancestor
101590246|NCT00665041|Dopamine Agents|dopamine agents|mesh-ancestor
101590247|NCT00665041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101590248|NCT00665041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590249|NCT00665041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590250|NCT04152655|Coenzyme Q10|coenzyme q10|mesh-list
101590251|NCT04152655|Idebenone|idebenone|mesh-list
101590252|NCT04152655|Micronutrients|micronutrients|mesh-ancestor
101590253|NCT04152655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590254|NCT04152655|Vitamins|vitamins|mesh-ancestor
101590255|NCT04152655|Antioxidants|antioxidants|mesh-ancestor
101590256|NCT04152655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590257|NCT04152655|Protective Agents|protective agents|mesh-ancestor
101590258|NCT00665119|Remifentanil|remifentanil|mesh-list
101590259|NCT00665119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101590260|NCT00665119|Narcotics|narcotics|mesh-ancestor
101590261|NCT00665119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101590262|NCT00665119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590263|NCT00665119|Analgesics|analgesics|mesh-ancestor
101590264|NCT00665119|Sensory System Agents|sensory system agents|mesh-ancestor
101590265|NCT00665119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101590266|NCT00887224|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101618301|NCT00785785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101618302|NCT00785785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101618303|NCT00785785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101618304|NCT00785785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618306|NCT00707278|Oxaliplatin|oxaliplatin|mesh-list
101618307|NCT00707278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101590267|NCT00887224|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101590268|NCT00887224|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101590269|NCT00887224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101590270|NCT00887224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590271|NCT00887224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101590272|NCT00887224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590273|NCT00887224|Antidepressive Agents|antidepressive agents|mesh-ancestor
101590274|NCT00887224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101590275|NCT00672763|Calcium, Dietary|calcium, dietary|mesh-list
101590276|NCT00672763|Vitamin D|vitamin d|mesh-list
101590277|NCT00672763|Ergocalciferols|ergocalciferols|mesh-list
101590278|NCT00672763|Cholecalciferol|cholecalciferol|mesh-list
101590279|NCT00672763|Vitamins|vitamins|mesh-list
101590280|NCT00672763|Calcium|calcium|mesh-list
101590281|NCT00672763|Micronutrients|micronutrients|mesh-ancestor
101590282|NCT00672763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590283|NCT00672763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101590284|NCT00672763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101590285|NCT04154449|Insulin|insulin|mesh-list
101590286|NCT04154449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101590288|NCT00661063|Clonidine|clonidine|mesh-list
101590289|NCT00661063|Ketamine|ketamine|mesh-list
101590290|NCT00661063|Analgesics|analgesics|mesh-ancestor
101590291|NCT00661063|Sensory System Agents|sensory system agents|mesh-ancestor
101590292|NCT00661063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101590298|NCT00661063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101590299|NCT00661063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101590300|NCT00661063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101590301|NCT00661063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101590302|NCT00661063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590303|NCT00661063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101590304|NCT00661063|Sympatholytics|sympatholytics|mesh-ancestor
101590305|NCT00661063|Autonomic Agents|autonomic agents|mesh-ancestor
101590306|NCT00661063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101590307|NCT00661063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101590308|NCT00661063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101590309|NCT00661063|Adrenergic Agents|adrenergic agents|mesh-ancestor
101590310|NCT00672919|Pioglitazone|pioglitazone|mesh-list
101590311|NCT00672919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101590312|NCT00672919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590313|NCT01109316|Insulin|insulin|mesh-list
101590314|NCT01109316|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101590315|NCT01109316|Insulin Aspart|insulin aspart|mesh-list
101590316|NCT01109316|Insulin Lispro|insulin lispro|mesh-list
101590317|NCT01109316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101590318|NCT01109316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590319|NCT02825290|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101590320|NCT02825290|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101590321|NCT02825290|Luteolytic Agents|luteolytic agents|mesh-ancestor
101590322|NCT02825290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101590323|NCT02825290|Contraceptive Agents|contraceptive agents|mesh-ancestor
101590324|NCT02825290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101590325|NCT02825290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590326|NCT02825290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101590327|NCT02825290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101590328|NCT02825290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101247230|NCT01678937|Cyclosporine|cyclosporine|mesh-list
101590329|NCT00675961|Naltrexone|naltrexone|mesh-list
101590330|NCT00675961|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101590331|NCT00675961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101590332|NCT00675961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618308|NCT00707278|Antimetabolites|antimetabolites|mesh-ancestor
101618309|NCT00707278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618310|NCT00707278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101618311|NCT01077284|Allopurinol|allopurinol|mesh-list
101618312|NCT01077284|Febuxostat|febuxostat|mesh-list
101618313|NCT01077284|Antimetabolites|antimetabolites|mesh-ancestor
101618314|NCT01077284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618315|NCT01077284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101618316|NCT01077284|Gout Suppressants|gout suppressants|mesh-ancestor
101618317|NCT01077284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101618318|NCT01077284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101417128|NCT01244815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101590333|NCT00675961|Sensory System Agents|sensory system agents|mesh-ancestor
101590334|NCT00675961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101590335|NCT00887068|Azacitidine|azacitidine|mesh-list
101590336|NCT00887068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101590337|NCT00887068|Antimetabolites|antimetabolites|mesh-ancestor
101590338|NCT00887068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590339|NCT00887068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101590340|NCT00887068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101590341|NCT00941031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101590342|NCT00941031|Immunologic Factors|immunologic factors|mesh-ancestor
101590343|NCT00941031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590344|NCT00886834|Misoprostol|misoprostol|mesh-list
101590345|NCT00886834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101590346|NCT00886834|Abortifacient Agents|abortifacient agents|mesh-ancestor
101590347|NCT00886834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101590348|NCT00886834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590349|NCT00886834|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101590350|NCT00886834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101590351|NCT00886834|Oxytocics|oxytocics|mesh-ancestor
101590352|NCT00880009|Letrozole|letrozole|mesh-list
101590353|NCT00880009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101590354|NCT00880009|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101590355|NCT00880009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101590356|NCT00880009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101590357|NCT00880009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590358|NCT00880009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101590359|NCT00880009|Hormone Antagonists|hormone antagonists|mesh-ancestor
101590360|NCT00880009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101590375|NCT01104636|Varenicline|varenicline|mesh-list
101590376|NCT01104636|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101590377|NCT01104636|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101590378|NCT01104636|Cholinergic Agents|cholinergic agents|mesh-ancestor
101590379|NCT01104636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101590380|NCT01104636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590381|NCT01104636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590382|NCT04931602|Vitamin D|vitamin d|mesh-list
101590383|NCT04931602|Vitamins|vitamins|mesh-ancestor
101590384|NCT04931602|Micronutrients|micronutrients|mesh-ancestor
101590385|NCT04931602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590386|NCT04931602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101590387|NCT04157257|Tenofovir|tenofovir|mesh-list
101590388|NCT04157257|Entecavir|entecavir|mesh-list
101590389|NCT04157257|Antiviral Agents|antiviral agents|mesh-ancestor
101590390|NCT04157257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101590391|NCT04157257|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101590392|NCT04157257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101590393|NCT04157257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101590394|NCT04157257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590395|NCT04157257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101590396|NCT04157257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101618319|NCT01077284|Antioxidants|antioxidants|mesh-ancestor
101618320|NCT01077284|Protective Agents|protective agents|mesh-ancestor
101618321|NCT01077284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618322|NCT00704314|Simvastatin|simvastatin|mesh-list
101618323|NCT00704314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101618324|NCT00704314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101618325|NCT00704314|Antimetabolites|antimetabolites|mesh-ancestor
101590397|NCT04152889|Docetaxel|docetaxel|mesh-list
101590398|NCT04152889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101590399|NCT04152889|Tubulin Modulators|tubulin modulators|mesh-ancestor
101590400|NCT04152889|Antimitotic Agents|antimitotic agents|mesh-ancestor
101590401|NCT04152889|Mitosis Modulators|mitosis modulators|mesh-ancestor
101590402|NCT04152889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590403|NCT00602511|Thalidomide|thalidomide|mesh-list
101590404|NCT00602511|Bortezomib|bortezomib|mesh-list
101590405|NCT00602511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101590406|NCT00602511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101590407|NCT00602511|Immunologic Factors|immunologic factors|mesh-ancestor
101590408|NCT00602511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590409|NCT00602511|Leprostatic Agents|leprostatic agents|mesh-ancestor
101590410|NCT00602511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101590411|NCT00602511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101590412|NCT00602511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101590413|NCT00602511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101590414|NCT00602511|Growth Substances|growth substances|mesh-ancestor
101590415|NCT00602511|Growth Inhibitors|growth inhibitors|mesh-ancestor
101590416|NCT02826616|Trimetazidine|trimetazidine|mesh-list
101590417|NCT02826616|Vasodilator Agents|vasodilator agents|mesh-ancestor
101590418|NCT00676117|Loxoprofen|loxoprofen|mesh-list
101590419|NCT00676117|Esomeprazole|esomeprazole|mesh-list
101590434|NCT01104558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101590435|NCT01104558|Sympatholytics|sympatholytics|mesh-ancestor
101590436|NCT01104558|Autonomic Agents|autonomic agents|mesh-ancestor
101590437|NCT01104558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101590438|NCT01104558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590439|NCT01104558|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101590440|NCT01104558|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101590441|NCT01104558|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101590442|NCT01104558|Adrenergic Agents|adrenergic agents|mesh-ancestor
101336864|NCT02968927|Immunologic Factors|immunologic factors|mesh-ancestor
101590443|NCT01104558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101590444|NCT01104558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590445|NCT00602589|Levofloxacin|levofloxacin|mesh-list
101590446|NCT00602589|Ofloxacin|ofloxacin|mesh-list
101590447|NCT00602589|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101590448|NCT00602589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101590449|NCT00602589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101590450|NCT00602589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101590451|NCT00602589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101590452|NCT00602589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101590453|NCT00602589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590454|NCT00602589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101590455|NCT00602589|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101590456|NCT00602589|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101590457|NCT04270071|Nitroglycerin|nitroglycerin|mesh-list
101590458|NCT04270071|Vasodilator Agents|vasodilator agents|mesh-ancestor
101590459|NCT02856087|Remifentanil|remifentanil|mesh-list
101590460|NCT02856087|Naloxone|naloxone|mesh-list
101590461|NCT02856087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101590462|NCT02856087|Narcotics|narcotics|mesh-ancestor
101590463|NCT02856087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101590464|NCT02856087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590465|NCT02856087|Analgesics|analgesics|mesh-ancestor
101590466|NCT02856087|Sensory System Agents|sensory system agents|mesh-ancestor
101590467|NCT02856087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101590468|NCT02856087|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101590469|NCT00676429|Ziprasidone|ziprasidone|mesh-list
101590470|NCT00676429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101590471|NCT00676429|Serotonin Agents|serotonin agents|mesh-ancestor
101590472|NCT00676429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101590473|NCT00676429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618326|NCT00704314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618327|NCT00704314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101618328|NCT00704314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101618330|NCT00704392|XL647|xl647|mesh-list
101618331|NCT00704392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101618332|NCT00704392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101618333|NCT00704392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101417142|NCT00132899|Immunologic Factors|immunologic factors|mesh-ancestor
101590474|NCT00676429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590475|NCT00676429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101590476|NCT00676429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101590477|NCT00676429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101247380|NCT05596227|Fentanyl|fentanyl|mesh-list
101590478|NCT00676429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101590479|NCT00676429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101590486|NCT01204658|Immunologic Factors|immunologic factors|mesh-ancestor
101590487|NCT01204658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590488|NCT00951483|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101590489|NCT00951483|Antidepressive Agents|antidepressive agents|mesh-ancestor
101590490|NCT00951483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101590491|NCT00951483|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101590492|NCT00951483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101590493|NCT00951483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101590494|NCT00951483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590495|NCT01104246|Testosterone|testosterone|mesh-list
101590496|NCT01104246|Androgens|androgens|mesh-ancestor
101590497|NCT01104246|Hormones|hormones|mesh-ancestor
101590498|NCT01104246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101590499|NCT01104246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590500|NCT00676741|Insulin|insulin|mesh-list
101590501|NCT00676741|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101590502|NCT00676741|Insulin Aspart|insulin aspart|mesh-list
101590503|NCT00676741|Insulin, Long-Acting|insulin, long-acting|mesh-list
101590504|NCT00676741|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101590505|NCT00676741|Insulin Detemir|insulin detemir|mesh-list
101264388|NCT01767545|Hormones|hormones|mesh-ancestor
101590507|NCT00676741|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101590508|NCT00676741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101590509|NCT00676741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590510|NCT01103778|Bortezomib|bortezomib|mesh-list
101590511|NCT01103778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101590512|NCT00673621|Albuterol|albuterol|mesh-list
101590513|NCT00673621|Methacholine Chloride|methacholine chloride|mesh-list
101590514|NCT00673621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590515|NCT00673621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101590516|NCT00673621|Autonomic Agents|autonomic agents|mesh-ancestor
101590517|NCT00673621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101590518|NCT00673621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101590519|NCT00673621|Respiratory System Agents|respiratory system agents|mesh-ancestor
101590520|NCT00673621|Tocolytic Agents|tocolytic agents|mesh-ancestor
101590521|NCT00673621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101590522|NCT00673621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101590523|NCT00673621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101590524|NCT00673621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101590525|NCT00673621|Adrenergic Agents|adrenergic agents|mesh-ancestor
101590526|NCT00673621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101590527|NCT00673621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590528|NCT00673621|Miotics|miotics|mesh-ancestor
101590529|NCT00673621|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101590530|NCT00673621|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
101590531|NCT00673621|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101590532|NCT00673621|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101590533|NCT00673621|Cholinergic Agents|cholinergic agents|mesh-ancestor
101590534|NCT02627053|Rivaroxaban|rivaroxaban|mesh-list
101590535|NCT02627053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101618334|NCT00704392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618335|NCT04103125|Hyaluronic Acid|hyaluronic acid|mesh-list
101590536|NCT02627053|Antithrombins|antithrombins|mesh-ancestor
101590537|NCT02627053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101590538|NCT02627053|Protease Inhibitors|protease inhibitors|mesh-ancestor
101590539|NCT02627053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101590540|NCT02627053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590541|NCT02627053|Anticoagulants|anticoagulants|mesh-ancestor
101213539|NCT01042379|Veliparib|veliparib|mesh-list
101590542|NCT00945945|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101590543|NCT00945945|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101590544|NCT00945945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101590545|NCT00945945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101590546|NCT00945945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590547|NCT00945945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101590574|NCT00676819|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101590575|NCT00676819|Insulin Aspart|insulin aspart|mesh-list
101590576|NCT00676819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101590577|NCT00676819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590578|NCT00625794|Nicotine|nicotine|mesh-list
101590579|NCT00625794|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101590580|NCT00625794|Autonomic Agents|autonomic agents|mesh-ancestor
101590581|NCT00625794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101590582|NCT00625794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590583|NCT00625794|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101590584|NCT00625794|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101590585|NCT00625794|Cholinergic Agents|cholinergic agents|mesh-ancestor
101590586|NCT00625794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101590587|NCT00625794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590588|NCT01203098|Enoxaparin|enoxaparin|mesh-list
101590589|NCT01203098|Enoxaparin sodium|enoxaparin sodium|mesh-list
101590590|NCT01203098|Edoxaban|edoxaban|mesh-list
101590591|NCT01203098|Anticoagulants|anticoagulants|mesh-ancestor
101590592|NCT01203098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101590593|NCT01203098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101590594|NCT01203098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590595|NCT01203098|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101590596|NCT01203098|Antithrombins|antithrombins|mesh-ancestor
101590597|NCT01203098|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101590598|NCT01203098|Protease Inhibitors|protease inhibitors|mesh-ancestor
101590599|NCT01203098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101590600|NCT05032794|Bisacodyl|bisacodyl|mesh-list
101590601|NCT05032794|Cathartics|cathartics|mesh-ancestor
101590604|NCT00945555|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101590605|NCT00945555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101590606|NCT01108458|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101590607|NCT01108458|Pertuzumab|pertuzumab|mesh-list
101590608|NCT01108458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101590609|NCT01108458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101590610|NCT01108458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101590611|NCT01108458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590612|NCT01108458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101590613|NCT04318262|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101590614|NCT04318262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101590615|NCT00680485|Ketoconazole|ketoconazole|mesh-list
101590616|NCT00680485|Antifungal Agents|antifungal agents|mesh-ancestor
101590617|NCT00680485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101590618|NCT00680485|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101590619|NCT00680485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101590620|NCT00680485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101590621|NCT00680485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590622|NCT00680485|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101590623|NCT00680485|Hormone Antagonists|hormone antagonists|mesh-ancestor
101590624|NCT00680485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101590625|NCT00680485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590626|NCT00680485|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101590627|NCT00680563|Epoetin Alfa|epoetin alfa|mesh-list
101590628|NCT00680563|Hematinics|hematinics|mesh-ancestor
101590629|NCT01108068|Lithium Carbonate|lithium carbonate|mesh-list
101590630|NCT01108068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590631|NCT01108068|Antidepressive Agents|antidepressive agents|mesh-ancestor
101618336|NCT04103125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101618337|NCT04103125|Immunologic Factors|immunologic factors|mesh-ancestor
101618338|NCT04103125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618339|NCT04103125|Viscosupplements|viscosupplements|mesh-ancestor
101618340|NCT04103125|Protective Agents|protective agents|mesh-ancestor
101618341|NCT00826618|Ranibizumab|ranibizumab|mesh-list
101618342|NCT00826618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101618343|NCT00826618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101618344|NCT00826618|Growth Substances|growth substances|mesh-ancestor
101618345|NCT00826618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618346|NCT00826618|Growth Inhibitors|growth inhibitors|mesh-ancestor
101590632|NCT01108068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101590633|NCT01108068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101590634|NCT01108068|Antimanic Agents|antimanic agents|mesh-ancestor
101590635|NCT01108068|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101590636|NCT01108068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101264391|NCT01767571|Cephalexin|cephalexin|mesh-list
101590637|NCT01108068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590638|NCT00680641|Simvastatin|simvastatin|mesh-list
101590639|NCT00680641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101590640|NCT00680641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101590641|NCT00680641|Antimetabolites|antimetabolites|mesh-ancestor
101590642|NCT00680641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590643|NCT00680641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101590644|NCT00680641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101590645|NCT00680641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101590646|NCT01201850|Bevacizumab|bevacizumab|mesh-list
101590647|NCT01201850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101590648|NCT01201850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101590649|NCT01201850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101590650|NCT01201850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101590651|NCT01201850|Growth Substances|growth substances|mesh-ancestor
101590652|NCT01201850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590653|NCT01201850|Growth Inhibitors|growth inhibitors|mesh-ancestor
101590654|NCT05660122|Fexuprazan|fexuprazan|mesh-list
101590655|NCT05660122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101590656|NCT04980144|Lubricant Eye Drops|lubricant eye drops|mesh-list
101590657|NCT04980144|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101590658|NCT04980144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101590659|NCT02825056|Morphine|morphine|mesh-list
101590660|NCT02825056|Bupivacaine|bupivacaine|mesh-list
101590661|NCT02825056|Anesthetics, Local|anesthetics, local|mesh-ancestor
101590662|NCT02825056|Anesthetics|anesthetics|mesh-ancestor
101590663|NCT02825056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101590664|NCT02825056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590665|NCT02825056|Sensory System Agents|sensory system agents|mesh-ancestor
101590666|NCT02825056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101590667|NCT02825056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101590668|NCT02825056|Narcotics|narcotics|mesh-ancestor
101590669|NCT02825056|Analgesics|analgesics|mesh-ancestor
101590670|NCT02826772|Androgens|androgens|mesh-list
101590671|NCT02826772|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
101590672|NCT02826772|Hormones|hormones|mesh-ancestor
101590673|NCT02826772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101590683|NCT00674011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590684|NCT00674011|Growth Inhibitors|growth inhibitors|mesh-ancestor
101590685|NCT00674089|Vitamin A|vitamin a|mesh-list
101590686|NCT00674089|Vitamins|vitamins|mesh-ancestor
101590687|NCT00674089|Micronutrients|micronutrients|mesh-ancestor
101590688|NCT00674089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590689|NCT01200992|Mitomycins|mitomycins|mesh-list
101590690|NCT01200992|Mitomycin|mitomycin|mesh-list
101590691|NCT01200992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101590692|NCT01200992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101590693|NCT01200992|Alkylating Agents|alkylating agents|mesh-ancestor
101590694|NCT01200992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618347|NCT00826618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101618349|NCT02876822|Cholecalciferol|cholecalciferol|mesh-list
101618350|NCT02876822|Vitamins|vitamins|mesh-ancestor
101618351|NCT02876822|Micronutrients|micronutrients|mesh-ancestor
101618352|NCT02876822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618353|NCT02876822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101618354|NCT02876822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101618355|NCT00826540|Bevacizumab|bevacizumab|mesh-list
101590695|NCT01200992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101590696|NCT01200992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101590697|NCT02824666|Fallypride|fallypride|mesh-list
101590698|NCT02824666|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101590699|NCT02824666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101590700|NCT02824666|Dopamine Agents|dopamine agents|mesh-ancestor
101590701|NCT02824666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101590702|NCT02824666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590703|NCT02824666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247610|NCT05057949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101590704|NCT00674167|Docetaxel|docetaxel|mesh-list
101590705|NCT00674167|Capecitabine|capecitabine|mesh-list
101590706|NCT00674167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101590707|NCT00674167|Tubulin Modulators|tubulin modulators|mesh-ancestor
101590708|NCT00674167|Antimitotic Agents|antimitotic agents|mesh-ancestor
101590709|NCT00674167|Mitosis Modulators|mitosis modulators|mesh-ancestor
101590710|NCT00674167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590711|NCT00674167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101590712|NCT00674167|Antimetabolites|antimetabolites|mesh-ancestor
101590713|NCT00912145|Alprazolam|alprazolam|mesh-list
101590714|NCT00912145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101590715|NCT00912145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101590716|NCT00912145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590717|NCT00912145|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101590718|NCT00912145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101590719|NCT00912145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101590720|NCT00912145|GABA Modulators|gaba modulators|mesh-ancestor
101590721|NCT00912145|GABA Agents|gaba agents|mesh-ancestor
101590722|NCT00912145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101590723|NCT00912145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590724|NCT02824510|Insulin|insulin|mesh-list
101590725|NCT02824510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101590726|NCT02824510|Insulin Aspart|insulin aspart|mesh-list
101590727|NCT02824510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101590728|NCT02824510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590729|NCT00674245|Pantoprazole|pantoprazole|mesh-list
101590730|NCT00674245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101590731|NCT00674245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101590732|NCT00674245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101590733|NCT00674245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101590734|NCT00674245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590735|NCT00878215|Liver Extracts|liver extracts|mesh-list
101590736|NCT00878215|Hematinics|hematinics|mesh-ancestor
101590737|NCT02628847|Sildenafil Citrate|sildenafil citrate|mesh-list
101590738|NCT02628847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590739|NCT02628847|Vasodilator Agents|vasodilator agents|mesh-ancestor
101590748|NCT00677443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590749|NCT00677443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101590750|NCT00674557|Exemestane|exemestane|mesh-list
101590751|NCT00674557|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
101590752|NCT00674557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101590753|NCT00674557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101590754|NCT00674557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101590755|NCT00674557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101590756|NCT00674557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590757|NCT00674557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101590758|NCT00674557|Hormone Antagonists|hormone antagonists|mesh-ancestor
101590759|NCT00674557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101590760|NCT00674557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618356|NCT00826540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101618357|NCT00826540|Sorafenib|sorafenib|mesh-list
101618358|NCT00826540|Antibodies|antibodies|mesh-list
101618359|NCT00826540|Immunoglobulins|immunoglobulins|mesh-list
101618360|NCT00826540|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101618361|NCT00826540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101618362|NCT00826540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101618363|NCT00826540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101618364|NCT00826540|Growth Substances|growth substances|mesh-ancestor
101618365|NCT00826540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417171|NCT00141063|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
101590761|NCT00674557|Chelating Agents|chelating agents|mesh-ancestor
101590762|NCT00674557|Sequestering Agents|sequestering agents|mesh-ancestor
101590763|NCT00674557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101590764|NCT00674557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101590765|NCT00674557|Growth Substances|growth substances|mesh-ancestor
101590766|NCT00674557|Growth Inhibitors|growth inhibitors|mesh-ancestor
101590767|NCT00677521|Acarbose|acarbose|mesh-list
101590768|NCT00677521|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101590769|NCT00677521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101590770|NCT00677521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590771|NCT00677521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101590772|NCT00677521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590773|NCT00674713|Ondansetron|ondansetron|mesh-list
101590774|NCT00674713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101590775|NCT00674713|Antiemetics|antiemetics|mesh-ancestor
101590776|NCT00674713|Autonomic Agents|autonomic agents|mesh-ancestor
101590777|NCT00674713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101247683|NCT04650841|Sensory System Agents|sensory system agents|mesh-ancestor
101590778|NCT00674713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590779|NCT00674713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101590781|NCT00674713|Dermatologic Agents|dermatologic agents|mesh-ancestor
101590782|NCT00674713|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101590783|NCT00674713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101590785|NCT00674713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101590786|NCT00674713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590787|NCT04241380|Heparin|heparin|mesh-list
101590788|NCT04241380|Anticoagulants|anticoagulants|mesh-list
101590789|NCT04241380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101590790|NCT04241380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101590791|NCT04241380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101590792|NCT04241380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590793|NCT02824354|Nalmefene|nalmefene|mesh-list
101590794|NCT02824354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101590795|NCT02824354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590796|NCT02824354|Sensory System Agents|sensory system agents|mesh-ancestor
101590797|NCT02824354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101590798|NCT02823496|Sunscreening Agents|sunscreening agents|mesh-list
101590799|NCT02823496|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101590800|NCT02823496|Protective Agents|protective agents|mesh-ancestor
101590801|NCT02823496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590802|NCT02823496|Dermatologic Agents|dermatologic agents|mesh-ancestor
101590803|NCT00677755|Misoprostol|misoprostol|mesh-list
101590804|NCT00677755|Mifepristone|mifepristone|mesh-list
101590805|NCT00677755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101590806|NCT00677755|Abortifacient Agents|abortifacient agents|mesh-ancestor
101590807|NCT00677755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101590840|NCT02824042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590841|NCT02824042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101590842|NCT02824042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101590843|NCT02824042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101590844|NCT02824042|Tubulin Modulators|tubulin modulators|mesh-ancestor
101590863|NCT04241458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101618366|NCT00826540|Growth Inhibitors|growth inhibitors|mesh-ancestor
101618367|NCT00826540|Immunologic Factors|immunologic factors|mesh-ancestor
101618368|NCT00826540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101618369|NCT00826540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101618370|NCT00826540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618371|NCT04303130|Endostar protein|endostar protein|mesh-list
101618372|NCT04303130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101417179|NCT00141063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101590864|NCT04241458|Anesthetics, General|anesthetics, general|mesh-ancestor
101590865|NCT04241458|Anesthetics|anesthetics|mesh-ancestor
101590866|NCT04241458|GABA Modulators|gaba modulators|mesh-ancestor
101590867|NCT04241458|GABA Agents|gaba agents|mesh-ancestor
101590868|NCT04241458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101590869|NCT04241458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590870|NCT00681343|Alemtuzumab|alemtuzumab|mesh-list
101590871|NCT00681343|Thymoglobulin|thymoglobulin|mesh-list
101590872|NCT00681343|Daclizumab|daclizumab|mesh-list
101590873|NCT00681343|Immunologic Factors|immunologic factors|mesh-ancestor
101590874|NCT00681343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590875|NCT00681343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101590876|NCT00681343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101590877|NCT00681343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101590878|NCT02823808|Glimepiride|glimepiride|mesh-list
101590879|NCT02823808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101590880|NCT02823808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101590881|NCT02823808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590882|NCT02823808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101590883|NCT02823808|Immunologic Factors|immunologic factors|mesh-ancestor
101590884|NCT04151719|Bromides|bromides|mesh-list
101590885|NCT04151719|Methylnaltrexone|methylnaltrexone|mesh-list
101590886|NCT04151719|Anticonvulsants|anticonvulsants|mesh-ancestor
101590887|NCT04151719|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101590888|NCT04151719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590889|NCT04151719|Sensory System Agents|sensory system agents|mesh-ancestor
101590890|NCT04151719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101590891|NCT02822482|Cetuximab|cetuximab|mesh-list
101590892|NCT02822482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101590893|NCT02822482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101590894|NCT00675493|Insulin Aspart|insulin aspart|mesh-list
101590895|NCT00675493|Biphasic Insulins|biphasic insulins|mesh-list
101590896|NCT00675493|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101590897|NCT00675493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101590898|NCT00675493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590899|NCT04240834|Aspirin|aspirin|mesh-list
101590900|NCT04240834|Ticagrelor|ticagrelor|mesh-list
101590901|NCT04240834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101590902|NCT04240834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101590903|NCT04240834|Analgesics|analgesics|mesh-ancestor
101590927|NCT01200758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101590928|NCT01200758|Immunologic Factors|immunologic factors|mesh-ancestor
101590929|NCT01200758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590930|NCT01200758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101590931|NCT01200758|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101590932|NCT01200758|Alkylating Agents|alkylating agents|mesh-ancestor
101590933|NCT01200758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590934|NCT01200758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101590935|NCT01200758|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101590936|NCT01200758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101590937|NCT01200758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101590938|NCT01200758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101590939|NCT01200758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101590940|NCT01200758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101590941|NCT01200758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101590942|NCT01200758|Glucocorticoids|glucocorticoids|mesh-ancestor
101590943|NCT01200758|Hormones|hormones|mesh-ancestor
101590944|NCT01200758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101590945|NCT01200758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101336941|NCT02968693|Vancomycin|vancomycin|mesh-list
101618373|NCT04303130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101618374|NCT04303130|Growth Substances|growth substances|mesh-ancestor
101618375|NCT04303130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618376|NCT04303130|Growth Inhibitors|growth inhibitors|mesh-ancestor
101618377|NCT04303130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101618378|NCT00626600|Oxycodone|oxycodone|mesh-list
101618379|NCT00626600|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101590946|NCT01200758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101590947|NCT01200758|Tubulin Modulators|tubulin modulators|mesh-ancestor
101590948|NCT01200758|Antimitotic Agents|antimitotic agents|mesh-ancestor
101590949|NCT01200758|Mitosis Modulators|mitosis modulators|mesh-ancestor
101590950|NCT02823106|Verapamil|verapamil|mesh-list
101590951|NCT02823106|Choline|choline|mesh-list
101590952|NCT02823106|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
101590953|NCT02823106|Lipotropic Agents|lipotropic agents|mesh-ancestor
101590954|NCT02823106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101590955|NCT02823106|Antimetabolites|antimetabolites|mesh-ancestor
101590973|NCT00876343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101590974|NCT00876343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101590975|NCT00876343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590976|NCT00876343|Dopamine Agonists|dopamine agonists|mesh-ancestor
101590977|NCT00876343|Dopamine Agents|dopamine agents|mesh-ancestor
101590978|NCT00876343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101590979|NCT00876343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590980|NCT00876343|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101590981|NCT00876343|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101590982|NCT00876343|Serotonin Agents|serotonin agents|mesh-ancestor
101590983|NCT00876343|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101590984|NCT00876343|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101590985|NCT00876343|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101590986|NCT00876343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101590987|NCT02627989|Diflucortolone|diflucortolone|mesh-list
101590988|NCT02627989|Diflucortolone valerate|diflucortolone valerate|mesh-list
101590989|NCT02627989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101590990|NCT02627989|Glucocorticoids|glucocorticoids|mesh-ancestor
101590992|NCT02627989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101590993|NCT02627989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590994|NCT00675649|Golimumab|golimumab|mesh-list
101590995|NCT00675649|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101590996|NCT00675649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101590997|NCT00675649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101590998|NCT00675649|Immunologic Factors|immunologic factors|mesh-ancestor
101590999|NCT00675649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591000|NCT01107912|Clopidogrel|clopidogrel|mesh-list
101591001|NCT01107912|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101591002|NCT01107912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101264415|NCT01768039|Vitamins|vitamins|mesh-ancestor
101247906|NCT03518086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101591003|NCT01107912|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101591004|NCT01107912|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101591005|NCT01107912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101591006|NCT01107912|Purinergic Agents|purinergic agents|mesh-ancestor
101591007|NCT01107912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101591008|NCT01107912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591026|NCT00678145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101591027|NCT00678145|Autonomic Agents|autonomic agents|mesh-ancestor
101591028|NCT00678145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101591029|NCT00678145|Respiratory System Agents|respiratory system agents|mesh-ancestor
101591031|NCT00678145|Sympathomimetics|sympathomimetics|mesh-ancestor
101591032|NCT00678145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101591033|NCT00678145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101591034|NCT02879916|Levobupivacaine|levobupivacaine|mesh-list
101591035|NCT02879916|Anesthetics, Local|anesthetics, local|mesh-ancestor
101591036|NCT02879916|Anesthetics|anesthetics|mesh-ancestor
101591037|NCT02879916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101591038|NCT02879916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618380|NCT00626600|Narcotics|narcotics|mesh-ancestor
101618381|NCT00626600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101618382|NCT00626600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618383|NCT00626600|Analgesics|analgesics|mesh-ancestor
101618384|NCT00626600|Sensory System Agents|sensory system agents|mesh-ancestor
101618385|NCT00626600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101618386|NCT00707512|Natalizumab|natalizumab|mesh-list
101417195|NCT01154439|Antimetabolites|antimetabolites|mesh-ancestor
101591039|NCT02879916|Sensory System Agents|sensory system agents|mesh-ancestor
101591040|NCT02879916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101591041|NCT02690506|Pregabalin|pregabalin|mesh-list
101591042|NCT02690506|Analgesics|analgesics|mesh-ancestor
101591043|NCT02690506|Sensory System Agents|sensory system agents|mesh-ancestor
101591044|NCT02690506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101591045|NCT02690506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591046|NCT02690506|Anticonvulsants|anticonvulsants|mesh-ancestor
101591047|NCT02690506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101591048|NCT02690506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101591049|NCT02690506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591050|NCT02690506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101591051|NCT02690506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101591052|NCT02690506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101591053|NCT02690506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101591054|NCT02690506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101591055|NCT04310280|Insulin Glargine|insulin glargine|mesh-list
101591056|NCT04310280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101591057|NCT04310280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591058|NCT04239586|Glyburide|glyburide|mesh-list
101591059|NCT04239586|Glipizide|glipizide|mesh-list
101591060|NCT04239586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101591061|NCT04239586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591062|NCT02628613|Paclitaxel|paclitaxel|mesh-list
101591063|NCT02628613|Vinorelbine|vinorelbine|mesh-list
101591064|NCT02628613|Epirubicin|epirubicin|mesh-list
101591065|NCT02628613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101591066|NCT02628613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101591067|NCT02628613|Tubulin Modulators|tubulin modulators|mesh-ancestor
101591096|NCT02821468|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
101591097|NCT02821468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101591098|NCT02821468|Analgesics|analgesics|mesh-ancestor
101591099|NCT02821468|Sensory System Agents|sensory system agents|mesh-ancestor
101591100|NCT02821468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101591101|NCT02821468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591102|NCT02821468|Antipyretics|antipyretics|mesh-ancestor
101591103|NCT02821468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101591104|NCT02821468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101591105|NCT02821468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591106|NCT02821468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101591107|NCT02821468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101591108|NCT02821468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101591109|NCT04964622|Ibuprofen|ibuprofen|mesh-list
101591110|NCT04964622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101591111|NCT04964622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101591112|NCT04964622|Analgesics|analgesics|mesh-ancestor
101591113|NCT04964622|Sensory System Agents|sensory system agents|mesh-ancestor
101591114|NCT04964622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101591142|NCT02821390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591143|NCT02821390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101591144|NCT02821390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101591146|NCT02821312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101591147|NCT02821312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101591148|NCT02821312|Cholinergic Agents|cholinergic agents|mesh-ancestor
101264419|NCT01767610|Infliximab|infliximab|mesh-list
101591149|NCT02821312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101591150|NCT02821312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591151|NCT02821312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591152|NCT02821156|Nitric Oxide|nitric oxide|mesh-list
101591153|NCT02821156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101618387|NCT00707512|Immunologic Factors|immunologic factors|mesh-ancestor
101618388|NCT00707512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618389|NCT00704548|Simvastatin|simvastatin|mesh-list
101618390|NCT00704548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101618391|NCT00704548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101618392|NCT00704548|Antimetabolites|antimetabolites|mesh-ancestor
101618393|NCT00704548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618394|NCT00704548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101618395|NCT00704548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101618396|NCT00704548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101591155|NCT02821156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101591156|NCT02821156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591157|NCT02821156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101591158|NCT02821156|Respiratory System Agents|respiratory system agents|mesh-ancestor
101591159|NCT02821156|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101591160|NCT02821156|Antioxidants|antioxidants|mesh-ancestor
101591161|NCT02821156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591179|NCT02820688|Sensory System Agents|sensory system agents|mesh-ancestor
101591180|NCT02820688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101591181|NCT02818816|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101591182|NCT02818816|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101591183|NCT02818816|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101591184|NCT02818816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101591185|NCT02818816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101591186|NCT02818816|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101591187|NCT02818816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101591188|NCT02818816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101591189|NCT02818816|Adrenergic Agents|adrenergic agents|mesh-ancestor
101591190|NCT02818816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101591191|NCT02818816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591192|NCT02818816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591193|NCT02818816|Laxatives|laxatives|mesh-ancestor
101591194|NCT02818816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101591195|NCT02820610|Magnesium Sulfate|magnesium sulfate|mesh-list
101591196|NCT02820610|Dexmedetomidine|dexmedetomidine|mesh-list
101591197|NCT02820610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101591198|NCT02820610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101591199|NCT02820610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591200|NCT02820610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101591201|NCT02820610|Analgesics|analgesics|mesh-ancestor
101591202|NCT02820610|Sensory System Agents|sensory system agents|mesh-ancestor
101591203|NCT02820610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101591204|NCT02820610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101591205|NCT02820610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101591206|NCT02820610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101591207|NCT02820610|Adrenergic Agents|adrenergic agents|mesh-ancestor
101591208|NCT02820610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101591209|NCT02820610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591210|NCT02820610|Anesthetics|anesthetics|mesh-ancestor
101591211|NCT02820610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101591212|NCT02820610|Anticonvulsants|anticonvulsants|mesh-ancestor
101591213|NCT02820610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101591214|NCT02820610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101591215|NCT02820610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101591216|NCT02820610|Tocolytic Agents|tocolytic agents|mesh-ancestor
101591217|NCT02820610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101591218|NCT04745728|Prednisone|prednisone|mesh-list
101591219|NCT04745728|Cyclophosphamide|cyclophosphamide|mesh-list
101591220|NCT04745728|Rituximab|rituximab|mesh-list
101591228|NCT04745728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101591229|NCT04745728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101591230|NCT04745728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101591231|NCT04745728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101618397|NCT00592384|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101618398|NCT00592384|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101618399|NCT00592384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101618400|NCT00592384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101618401|NCT00592384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417210|NCT00133172|Prednisone|prednisone|mesh-list
101591232|NCT04745728|Glucocorticoids|glucocorticoids|mesh-ancestor
101591234|NCT04745728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101591235|NCT04745728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101591236|NCT02818660|Cosyntropin|cosyntropin|mesh-list
101591237|NCT02818660|Hormones|hormones|mesh-ancestor
101591238|NCT02818660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101591239|NCT02818660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591240|NCT05659186|Tislelizumab|tislelizumab|mesh-list
101591241|NCT05659186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101591242|NCT05659186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101591243|NCT01107444|Docetaxel|docetaxel|mesh-list
101591244|NCT01107444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101591245|NCT01107444|Tubulin Modulators|tubulin modulators|mesh-ancestor
101591246|NCT01107444|Antimitotic Agents|antimitotic agents|mesh-ancestor
101591247|NCT01107444|Mitosis Modulators|mitosis modulators|mesh-ancestor
101591248|NCT01107444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591249|NCT04238806|Desflurane|desflurane|mesh-list
101591250|NCT04238806|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101591251|NCT04238806|Anesthetics, General|anesthetics, general|mesh-ancestor
101591252|NCT04238806|Anesthetics|anesthetics|mesh-ancestor
101591253|NCT04238806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101591254|NCT04238806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591255|NCT00876187|Naproxen|naproxen|mesh-list
101591256|NCT00876187|Tanezumab|tanezumab|mesh-list
101591257|NCT00876187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101591258|NCT00876187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101591259|NCT00876187|Analgesics|analgesics|mesh-ancestor
101591260|NCT00876187|Sensory System Agents|sensory system agents|mesh-ancestor
101591261|NCT00876187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101591262|NCT00876187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591263|NCT00876187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101591264|NCT00876187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101591265|NCT00876187|Gout Suppressants|gout suppressants|mesh-ancestor
101591266|NCT00876187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101591267|NCT00876187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101591268|NCT00876187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591269|NCT04238884|Voriconazole|voriconazole|mesh-list
101591270|NCT04238884|Antifungal Agents|antifungal agents|mesh-ancestor
101591271|NCT04238884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101591272|NCT04238884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101591273|NCT04238884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101591274|NCT04238884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101591275|NCT04238884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591276|NCT04238884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101591277|NCT04238884|Hormone Antagonists|hormone antagonists|mesh-ancestor
101591278|NCT04238884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101591279|NCT04238884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591280|NCT04238884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101591281|NCT01102374|Vitamin D|vitamin d|mesh-list
101591282|NCT01102374|Ergocalciferols|ergocalciferols|mesh-list
101591283|NCT01102374|Cholecalciferol|cholecalciferol|mesh-list
101591284|NCT01102374|Vitamins|vitamins|mesh-list
101591285|NCT01102374|Micronutrients|micronutrients|mesh-ancestor
101591286|NCT01102374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591287|NCT01102374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101591295|NCT05658640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591297|NCT05658640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101591298|NCT05658640|Alkylating Agents|alkylating agents|mesh-ancestor
101591299|NCT05658640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618402|NCT00592384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101618403|NCT00592384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618404|NCT00592384|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101618405|NCT00592384|Antidepressive Agents|antidepressive agents|mesh-ancestor
101618406|NCT00592384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101618407|NCT00846040|Fallypride|fallypride|mesh-list
101618408|NCT00846040|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101618409|NCT00846040|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101618410|NCT00846040|Dopamine Agents|dopamine agents|mesh-ancestor
101417220|NCT00133172|Immunologic Factors|immunologic factors|mesh-ancestor
101591300|NCT05658640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101591301|NCT05658640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101591302|NCT05658640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101591304|NCT05658640|Autonomic Agents|autonomic agents|mesh-ancestor
101591305|NCT05658640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101591306|NCT05658640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101591307|NCT05658640|Glucocorticoids|glucocorticoids|mesh-ancestor
101591308|NCT05658640|Hormones|hormones|mesh-ancestor
101591309|NCT05658640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101591310|NCT05658640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101591311|NCT05658640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101591312|NCT05658640|Antimetabolites|antimetabolites|mesh-ancestor
101591313|NCT05658640|Antiviral Agents|antiviral agents|mesh-ancestor
101591314|NCT05658640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101591315|NCT05658640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101591316|NCT05658640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101591317|NCT02818270|Acetylcysteine|acetylcysteine|mesh-list
101591318|NCT02818270|Albuterol|albuterol|mesh-list
101591319|NCT02818270|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101591320|NCT02818270|Antiviral Agents|antiviral agents|mesh-ancestor
101591321|NCT02818270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101591322|NCT02818270|Expectorants|expectorants|mesh-ancestor
101591323|NCT02818270|Respiratory System Agents|respiratory system agents|mesh-ancestor
101591324|NCT02818270|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101591325|NCT02818270|Antioxidants|antioxidants|mesh-ancestor
101591326|NCT02818270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591327|NCT02818270|Protective Agents|protective agents|mesh-ancestor
101591328|NCT02818270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591329|NCT02818270|Antidotes|antidotes|mesh-ancestor
101591330|NCT02818270|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101591331|NCT02818270|Autonomic Agents|autonomic agents|mesh-ancestor
101591332|NCT02818270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101591333|NCT02818270|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101591334|NCT02818270|Tocolytic Agents|tocolytic agents|mesh-ancestor
101591335|NCT02818270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101591336|NCT02818270|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101591337|NCT02818270|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101591338|NCT02818270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101591339|NCT02818270|Adrenergic Agents|adrenergic agents|mesh-ancestor
101591340|NCT02818270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101591341|NCT02879760|Pembrolizumab|pembrolizumab|mesh-list
101591342|NCT02879760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101591343|NCT02879760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101591344|NCT02879760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101591345|NCT02879760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591346|NCT02818348|Darunavir|darunavir|mesh-list
101591347|NCT02818348|Cobicistat|cobicistat|mesh-list
101591348|NCT02818348|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
101591349|NCT02818348|Etravirine|etravirine|mesh-list
101591350|NCT02818348|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101591351|NCT02818348|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101591352|NCT02818348|Protease Inhibitors|protease inhibitors|mesh-ancestor
101591353|NCT02818348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101591354|NCT02818348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591355|NCT02818348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101591356|NCT02818348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101618411|NCT00846040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101618412|NCT00846040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618413|NCT00846040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618414|NCT02611336|Tadalafil|tadalafil|mesh-list
101618415|NCT02611336|Vasodilator Agents|vasodilator agents|mesh-ancestor
101618416|NCT02611336|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101591357|NCT02818348|Antiviral Agents|antiviral agents|mesh-ancestor
101591367|NCT00684463|Antiemetics|antiemetics|mesh-ancestor
101591368|NCT00684463|Autonomic Agents|autonomic agents|mesh-ancestor
101591369|NCT00684463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101591370|NCT00684463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591371|NCT00684463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101591372|NCT00684463|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101591373|NCT00684463|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101591374|NCT00684463|Serotonin Agents|serotonin agents|mesh-ancestor
101591375|NCT00684463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101591376|NCT00684463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591377|NCT00678457|Ondansetron|ondansetron|mesh-list
101591379|NCT00678457|Antiemetics|antiemetics|mesh-ancestor
101591380|NCT00678457|Autonomic Agents|autonomic agents|mesh-ancestor
101591381|NCT00678457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101591382|NCT00678457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591383|NCT00678457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101591384|NCT00678457|Antipruritics|antipruritics|mesh-ancestor
101591385|NCT00678457|Dermatologic Agents|dermatologic agents|mesh-ancestor
101591386|NCT00678457|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101591387|NCT00678457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101591388|NCT00678457|Serotonin Agents|serotonin agents|mesh-ancestor
101591389|NCT00678457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101591390|NCT00678457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591391|NCT00678457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101591392|NCT00678457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101591393|NCT00678457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101591394|NCT00678457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101591395|NCT00678457|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101591396|NCT00678457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101591397|NCT00678457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101591398|NCT00678613|Norfloxacin|norfloxacin|mesh-list
101591399|NCT00678613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101591400|NCT00678613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101591401|NCT00678613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101591402|NCT00678613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101591403|NCT00678613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101591404|NCT00678613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591405|NCT00678613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101591406|NCT00678613|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101591407|NCT00678613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101591408|NCT00678769|Sirolimus|sirolimus|mesh-list
101591409|NCT00678769|Temsirolimus|temsirolimus|mesh-list
101591410|NCT00678769|MTOR Inhibitors|mtor inhibitors|mesh-list
101591411|NCT00678769|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101591412|NCT00678769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101591413|NCT00678769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101591414|NCT00678769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101591415|NCT00678769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101591416|NCT00678769|Antifungal Agents|antifungal agents|mesh-ancestor
101591417|NCT00678769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101591418|NCT00678769|Immunologic Factors|immunologic factors|mesh-ancestor
101591419|NCT00678769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591420|NCT00678769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101337071|NCT00061438|Meropenem|meropenem|mesh-list
101591421|NCT00678769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101591446|NCT00684853|Growth Substances|growth substances|mesh-ancestor
101591447|NCT00684853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591448|NCT00684853|Growth Inhibitors|growth inhibitors|mesh-ancestor
101591449|NCT02816476|Daratumumab|daratumumab|mesh-list
101591450|NCT02816476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101591451|NCT04547140|Protease Inhibitors|protease inhibitors|mesh-list
101618417|NCT02611336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101618419|NCT02611336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618420|NCT02611336|Urological Agents|urological agents|mesh-ancestor
101618421|NCT00704704|Thalidomide|thalidomide|mesh-list
101618422|NCT00704704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101618423|NCT00704704|Immunologic Factors|immunologic factors|mesh-ancestor
101417231|NCT00141141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101591452|NCT04547140|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
101591453|NCT04547140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101591454|NCT04547140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591455|NCT04547140|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101591456|NCT04547140|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101591457|NCT00679159|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101591458|NCT00679159|Immunologic Factors|immunologic factors|mesh-ancestor
101591459|NCT00679159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591460|NCT00685009|Hormones|hormones|mesh-list
101591461|NCT00685009|Progesterone|progesterone|mesh-list
101591462|NCT00685009|Estrogens|estrogens|mesh-list
101591463|NCT00685009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101591464|NCT00685009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591465|NCT00685009|Progestins|progestins|mesh-ancestor
101591466|NCT00679237|Metformin|metformin|mesh-list
101591467|NCT00679237|Glimepiride|glimepiride|mesh-list
101591468|NCT00679237|Ezetimibe|ezetimibe|mesh-list
101591469|NCT00679237|Diuretics|diuretics|mesh-list
101591470|NCT00679237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101591476|NCT00679237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101591477|NCT00679237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101591478|NCT00679237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101591479|NCT00679237|Immunologic Factors|immunologic factors|mesh-ancestor
101591480|NCT00679237|Natriuretic Agents|natriuretic agents|mesh-ancestor
101591481|NCT00681733|Pioglitazone|pioglitazone|mesh-list
101591482|NCT00681733|Pentoxifylline|pentoxifylline|mesh-list
101591483|NCT00681733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101591484|NCT00681733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591485|NCT00681733|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101591486|NCT00681733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101591487|NCT00681733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591488|NCT00681733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101591489|NCT00681733|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101591490|NCT00681733|Protective Agents|protective agents|mesh-ancestor
101591491|NCT00681733|Vasodilator Agents|vasodilator agents|mesh-ancestor
101591492|NCT00681733|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101591493|NCT00681733|Antioxidants|antioxidants|mesh-ancestor
101591494|NCT00679315|Alfuzosin|alfuzosin|mesh-list
101591495|NCT00679315|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101591496|NCT00679315|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101591497|NCT00679315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101591498|NCT00679315|Adrenergic Agents|adrenergic agents|mesh-ancestor
101591499|NCT00679315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101591500|NCT00679315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591501|NCT00679315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591502|NCT00679315|Urological Agents|urological agents|mesh-ancestor
101591503|NCT05652400|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101591504|NCT05652400|Antiviral Agents|antiviral agents|mesh-ancestor
101591505|NCT05652400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101591506|NCT01098474|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101591507|NCT01098474|Immunologic Factors|immunologic factors|mesh-ancestor
101591508|NCT01098474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591509|NCT00633802|Risperidone|risperidone|mesh-list
101591510|NCT00633802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101591511|NCT00633802|Serotonin Agents|serotonin agents|mesh-ancestor
101591512|NCT00633802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101591513|NCT00633802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591514|NCT00633802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591515|NCT00633802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101591516|NCT00633802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101591517|NCT00633802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101618424|NCT00704704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618425|NCT00704704|Leprostatic Agents|leprostatic agents|mesh-ancestor
101618426|NCT00704704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101618427|NCT00704704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101618428|NCT00704704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101618429|NCT00704704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101618430|NCT00704704|Growth Substances|growth substances|mesh-ancestor
101618431|NCT00704704|Growth Inhibitors|growth inhibitors|mesh-ancestor
101618432|NCT00704704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101618433|NCT00707824|Nalbuphine|nalbuphine|mesh-list
101618434|NCT00707824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101618435|NCT00707824|Narcotics|narcotics|mesh-ancestor
101618436|NCT00707824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101618437|NCT00707824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618438|NCT00707824|Analgesics|analgesics|mesh-ancestor
101618439|NCT00707824|Sensory System Agents|sensory system agents|mesh-ancestor
101618440|NCT00707824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101618441|NCT00826228|Teriparatide|teriparatide|mesh-list
101618442|NCT00826228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101618443|NCT00826228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618444|NCT00826228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101618445|NCT00791479|Dulaglutide|dulaglutide|mesh-list
101618446|NCT00791479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101618447|NCT00791479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618448|NCT00890097|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101618449|NCT00890097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101618450|NCT02831751|Vaccines|vaccines|mesh-list
101618451|NCT02831751|Immunologic Factors|immunologic factors|mesh-ancestor
101618452|NCT02831751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618453|NCT00913458|Etanercept|etanercept|mesh-list
101618454|NCT00913458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101618455|NCT00913458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101618456|NCT00913458|Analgesics|analgesics|mesh-ancestor
101618457|NCT00913458|Sensory System Agents|sensory system agents|mesh-ancestor
101618458|NCT00913458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101618459|NCT00913458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591518|NCT00633802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101591519|NCT00633802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101618460|NCT00913458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101618461|NCT00913458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101618462|NCT00913458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101618463|NCT00913458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101618464|NCT00913458|Immunologic Factors|immunologic factors|mesh-ancestor
101618465|NCT05208333|Albendazole|albendazole|mesh-list
101618466|NCT05208333|Anthelmintics|anthelmintics|mesh-ancestor
101618467|NCT05208333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101618468|NCT05208333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101618469|NCT05208333|Anticestodal Agents|anticestodal agents|mesh-ancestor
101618470|NCT05208333|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101618471|NCT05208333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101618472|NCT05208333|Tubulin Modulators|tubulin modulators|mesh-ancestor
101618473|NCT05208333|Antimitotic Agents|antimitotic agents|mesh-ancestor
101618474|NCT05208333|Mitosis Modulators|mitosis modulators|mesh-ancestor
101417274|NCT00141258|Analgesics|analgesics|mesh-ancestor
101591520|NCT00633802|Dopamine Agents|dopamine agents|mesh-ancestor
101591521|NCT04460248|Rituximab|rituximab|mesh-list
101591522|NCT04460248|Lenalidomide|lenalidomide|mesh-list
101591523|NCT04460248|Zanubrutinib|zanubrutinib|mesh-list
101591524|NCT04460248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101591525|NCT04460248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101591526|NCT04460248|Immunologic Factors|immunologic factors|mesh-ancestor
101248438|NCT05395052|Analgesics|analgesics|mesh-ancestor
101591527|NCT04460248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591528|NCT04460248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101591529|NCT04460248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101591530|NCT04460248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101591531|NCT04460248|Growth Substances|growth substances|mesh-ancestor
101591532|NCT04460248|Growth Inhibitors|growth inhibitors|mesh-ancestor
101330961|NCT00000620|Carvedilol|carvedilol|mesh-list
101591533|NCT04460248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101591534|NCT04460248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101591535|NCT04460248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591536|NCT05658874|Methenamine|methenamine|mesh-list
101591537|NCT05658874|Methenamine hippurate|methenamine hippurate|mesh-list
101591538|NCT05658874|Methenamine mandelate|methenamine mandelate|mesh-list
101591539|NCT05658874|Gabapentin|gabapentin|mesh-list
101591556|NCT05658874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591558|NCT05658874|Hormones|hormones|mesh-ancestor
101591559|NCT05658874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101591560|NCT05658874|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101591561|NCT05658874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101591562|NCT05658874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101591563|NCT05658874|Adrenergic Agents|adrenergic agents|mesh-ancestor
101591564|NCT05658874|Urological Agents|urological agents|mesh-ancestor
101591565|NCT05658874|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101591566|NCT05658874|Antidepressive Agents|antidepressive agents|mesh-ancestor
101591567|NCT05658874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101591568|NCT05658874|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101591569|NCT05658874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101591570|NCT05658874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101591571|NCT05658874|Parasympatholytics|parasympatholytics|mesh-ancestor
101591572|NCT05658874|Autonomic Agents|autonomic agents|mesh-ancestor
101591573|NCT05658874|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101591574|NCT05658874|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101591575|NCT05658874|Cholinergic Agents|cholinergic agents|mesh-ancestor
101591576|NCT05658874|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101591577|NCT05658874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101591578|NCT05658874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101591579|NCT01106898|Paclitaxel|paclitaxel|mesh-list
101591580|NCT01106898|Cyclophosphamide|cyclophosphamide|mesh-list
101591581|NCT01106898|Trastuzumab|trastuzumab|mesh-list
101618475|NCT05208333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618476|NCT05208333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101618477|NCT04309773|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101618478|NCT04309773|Bezafibrate|bezafibrate|mesh-list
101618479|NCT04309773|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101618480|NCT04309773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101618481|NCT04309773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101618482|NCT04309773|Antimetabolites|antimetabolites|mesh-ancestor
101618483|NCT04309773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591582|NCT01106898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101591583|NCT01106898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101591584|NCT01106898|Tubulin Modulators|tubulin modulators|mesh-ancestor
101591585|NCT01106898|Antimitotic Agents|antimitotic agents|mesh-ancestor
101591586|NCT01106898|Mitosis Modulators|mitosis modulators|mesh-ancestor
101591587|NCT01106898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591588|NCT01106898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101591589|NCT01106898|Immunologic Factors|immunologic factors|mesh-ancestor
101591590|NCT01106898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591591|NCT01106898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101591592|NCT01106898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101591593|NCT01106898|Alkylating Agents|alkylating agents|mesh-ancestor
101591594|NCT01106898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101591595|NCT01106898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101591596|NCT04425538|Infliximab|infliximab|mesh-list
101591597|NCT04425538|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101591619|NCT04139941|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
101591620|NCT04139941|Immunologic Factors|immunologic factors|mesh-ancestor
101591621|NCT04139941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591622|NCT02814994|Respiratory System Agents|respiratory system agents|mesh-list
101591623|NCT00875017|Sevelamer|sevelamer|mesh-list
101591624|NCT00875017|Chelating Agents|chelating agents|mesh-ancestor
101591625|NCT00875017|Sequestering Agents|sequestering agents|mesh-ancestor
101591626|NCT00875017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591627|NCT00679705|Atosiban|atosiban|mesh-list
101591628|NCT00679705|Ritodrine|ritodrine|mesh-list
101591629|NCT00679705|Hormone Antagonists|hormone antagonists|mesh-ancestor
101591630|NCT00679705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101591631|NCT00679705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591632|NCT00679705|Tocolytic Agents|tocolytic agents|mesh-ancestor
101591633|NCT00679705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101591634|NCT00679705|Sympathomimetics|sympathomimetics|mesh-ancestor
101591635|NCT00679705|Autonomic Agents|autonomic agents|mesh-ancestor
101591636|NCT00679705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101591637|NCT00679705|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101591638|NCT00679705|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101591639|NCT00679705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101591640|NCT00679705|Adrenergic Agents|adrenergic agents|mesh-ancestor
101591641|NCT00679705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101591642|NCT00679705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591643|NCT00685633|Bicalutamide|bicalutamide|mesh-list
101591644|NCT00685633|Androgen Antagonists|androgen antagonists|mesh-ancestor
101591645|NCT00685633|Hormone Antagonists|hormone antagonists|mesh-ancestor
101591646|NCT00685633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101591647|NCT00685633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591648|NCT00685633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101591649|NCT04371952|Doxycycline|doxycycline|mesh-list
101591650|NCT04371952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101591651|NCT04371952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101591652|NCT04371952|Antimalarials|antimalarials|mesh-ancestor
101591657|NCT04329832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101591658|NCT04329832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101591659|NCT04329832|Antimalarials|antimalarials|mesh-ancestor
101591660|NCT04329832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101618484|NCT04309773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101618486|NCT02829333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101618487|NCT02829333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618488|NCT05251662|Bevacizumab|bevacizumab|mesh-list
101618489|NCT05251662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101618490|NCT05251662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101618491|NCT05251662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101618492|NCT05251662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101618493|NCT05251662|Growth Substances|growth substances|mesh-ancestor
101591661|NCT04329832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101591662|NCT04329832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101591663|NCT04329832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591664|NCT04329832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101591665|NCT04237246|Tacrolimus|tacrolimus|mesh-list
101591666|NCT04237246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101591667|NCT04237246|Immunologic Factors|immunologic factors|mesh-ancestor
101591668|NCT04237246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591669|NCT04237246|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101591670|NCT04237246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101591671|NCT04237246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591672|NCT00680095|Tavaborole|tavaborole|mesh-list
101591673|NCT00680095|Antifungal Agents|antifungal agents|mesh-ancestor
101591674|NCT00680095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101591675|NCT02814058|Zolpidem|zolpidem|mesh-list
101591676|NCT02814058|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101248604|NCT04614636|Elotuzumab|elotuzumab|mesh-list
101591677|NCT02814058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101591678|NCT02814058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101591679|NCT02814058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591680|NCT02814058|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101591681|NCT02814058|GABA Agonists|gaba agonists|mesh-ancestor
101591682|NCT02814058|GABA Agents|gaba agents|mesh-ancestor
101591683|NCT02814058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101591684|NCT02814058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591685|NCT00680173|Interferons|interferons|mesh-list
101591686|NCT00680173|Ribavirin|ribavirin|mesh-list
101591687|NCT00680173|Interferon-alpha|interferon-alpha|mesh-list
101591688|NCT00680173|Interferon alpha-2|interferon alpha-2|mesh-list
101591689|NCT00680173|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101591690|NCT00680173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101591691|NCT00680173|Antiviral Agents|antiviral agents|mesh-ancestor
101591692|NCT00680173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101591693|NCT00680173|Antimetabolites|antimetabolites|mesh-ancestor
101591694|NCT00680173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591695|NCT00680173|Immunologic Factors|immunologic factors|mesh-ancestor
101591696|NCT00680173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591697|NCT00682279|Topotecan|topotecan|mesh-list
101591698|NCT00682279|Lapatinib|lapatinib|mesh-list
101591699|NCT00682279|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101591700|NCT00682279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101591701|NCT00682279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101591702|NCT00682279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591703|NCT00682279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101591704|NCT00682279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101591705|NCT02811484|Dapagliflozin|dapagliflozin|mesh-list
101591706|NCT02811484|Exenatide|exenatide|mesh-list
101591707|NCT02811484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101591708|NCT02811484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591709|NCT02811484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101591710|NCT02811484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591711|NCT02811484|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101591712|NCT02811484|Incretins|incretins|mesh-ancestor
101591713|NCT02811484|Hormones|hormones|mesh-ancestor
101591714|NCT02811484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101618494|NCT05251662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618496|NCT02829177|Allopurinol|allopurinol|mesh-list
101618497|NCT02829177|Antimetabolites|antimetabolites|mesh-ancestor
101618498|NCT02829177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618499|NCT02829177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101618500|NCT02829177|Gout Suppressants|gout suppressants|mesh-ancestor
101618501|NCT02829177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101618502|NCT02829177|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101618503|NCT02829177|Antioxidants|antioxidants|mesh-ancestor
101618504|NCT02829177|Protective Agents|protective agents|mesh-ancestor
101618505|NCT02829177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618506|NCT05112081|Botulinum Toxins|botulinum toxins|mesh-list
101618507|NCT05112081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101618508|NCT05112081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101618509|NCT05112081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101417306|NCT00141336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101417309|NCT00133406|Vitamin A|vitamin a|mesh-list
101591715|NCT00686179|Moxifloxacin|moxifloxacin|mesh-list
101591716|NCT00686179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101591717|NCT00686179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101591718|NCT00686179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101591719|NCT00686179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101591720|NCT00686179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101591721|NCT00686179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591722|NCT00686179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101591723|NCT00922597|Factor VIII|factor viii|mesh-list
101536353|NCT02277600|Darunavir|darunavir|mesh-list
101591727|NCT00874939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101591728|NCT00874939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591729|NCT00874939|Cholinergic Agents|cholinergic agents|mesh-ancestor
101591730|NCT00874939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101591731|NCT00874939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591732|NCT00874939|Nootropic Agents|nootropic agents|mesh-ancestor
101591733|NCT00634348|Aripiprazole|aripiprazole|mesh-list
101591734|NCT00634348|Ziprasidone|ziprasidone|mesh-list
101591735|NCT00634348|Antidepressive Agents|antidepressive agents|mesh-ancestor
101591736|NCT00634348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101591737|NCT00634348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101591738|NCT00634348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101591739|NCT00634348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101591740|NCT00634348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591741|NCT00634348|Dopamine Agonists|dopamine agonists|mesh-ancestor
101591742|NCT00634348|Dopamine Agents|dopamine agents|mesh-ancestor
101591743|NCT00634348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101591744|NCT00634348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591745|NCT00634348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101591746|NCT00634348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101591747|NCT00634348|Serotonin Agents|serotonin agents|mesh-ancestor
101591748|NCT00634348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101591749|NCT00634348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101591750|NCT00634348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101591751|NCT00634348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101591753|NCT00680329|Travoprost|travoprost|mesh-list
101591754|NCT00680329|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101591755|NCT00680329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101591756|NCT00680329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101591757|NCT00680329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101618510|NCT05112081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101618511|NCT05112081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618512|NCT05112081|Cholinergic Agents|cholinergic agents|mesh-ancestor
101618513|NCT05112081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101618514|NCT05112081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591758|NCT00680329|Adrenergic Agents|adrenergic agents|mesh-ancestor
101591759|NCT00680329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101591760|NCT00680329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591761|NCT00680329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591762|NCT00680329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101591763|NCT00680329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101591764|NCT02811016|Budesonide|budesonide|mesh-list
101591765|NCT02811016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101591766|NCT02811016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101591767|NCT02811016|Autonomic Agents|autonomic agents|mesh-ancestor
101591768|NCT02811016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101591769|NCT02811016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591770|NCT02811016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101591771|NCT02811016|Respiratory System Agents|respiratory system agents|mesh-ancestor
101591772|NCT02811016|Glucocorticoids|glucocorticoids|mesh-ancestor
101591773|NCT02811016|Hormones|hormones|mesh-ancestor
101591774|NCT02811016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101591775|NCT00690313|Moxifloxacin|moxifloxacin|mesh-list
101591776|NCT00690313|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101591777|NCT00690313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101591778|NCT00690313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101591779|NCT00690313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101591780|NCT00690313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101591781|NCT00690313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101591782|NCT00690313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591783|NCT00690313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101591784|NCT00690313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101591785|NCT00690313|Contraceptive Agents|contraceptive agents|mesh-ancestor
101591786|NCT00690313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101591787|NCT00690313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591788|NCT00690313|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101591789|NCT00690313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101591790|NCT00690313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101591791|NCT04237480|Vitamin D|vitamin d|mesh-list
101591792|NCT04237480|Ergocalciferols|ergocalciferols|mesh-list
101591793|NCT04237480|Cholecalciferol|cholecalciferol|mesh-list
101591794|NCT04237480|Vitamins|vitamins|mesh-list
101591795|NCT04237480|Micronutrients|micronutrients|mesh-ancestor
101591796|NCT04237480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591809|NCT02810782|Anticonvulsants|anticonvulsants|mesh-ancestor
101591810|NCT02810782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101591811|NCT02810782|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101591812|NCT02810782|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101591813|NCT02810782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101591814|NCT02810782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591815|NCT02810782|GABA Modulators|gaba modulators|mesh-ancestor
101591816|NCT02810782|GABA Agents|gaba agents|mesh-ancestor
101591817|NCT02810782|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101591818|NCT02810782|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101591819|NCT02810782|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101591820|NCT02810782|Antiemetics|antiemetics|mesh-ancestor
101591821|NCT02810782|Autonomic Agents|autonomic agents|mesh-ancestor
101591822|NCT02810782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101591823|NCT02810782|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101591824|NCT02810782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101591825|NCT02810782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101591826|NCT02810782|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101591827|NCT02810782|Dopamine Agents|dopamine agents|mesh-ancestor
101591828|NCT02810548|Mitogens|mitogens|mesh-list
101591829|NCT02810548|Mitosis Modulators|mitosis modulators|mesh-ancestor
101591830|NCT02810548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591831|NCT01155869|Naltrexone|naltrexone|mesh-list
101591832|NCT01155869|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101618515|NCT05112081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101618516|NCT05112081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101618517|NCT04244097|Bupivacaine|bupivacaine|mesh-list
101618518|NCT04244097|Neostigmine|neostigmine|mesh-list
101618519|NCT04244097|Anesthetics, Local|anesthetics, local|mesh-ancestor
101618520|NCT04244097|Anesthetics|anesthetics|mesh-ancestor
101618521|NCT04244097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101618522|NCT04244097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618523|NCT04244097|Sensory System Agents|sensory system agents|mesh-ancestor
101618524|NCT04244097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101618525|NCT04244097|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101618526|NCT04244097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101417329|NCT00141375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101591833|NCT01155869|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101591834|NCT01155869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591835|NCT01155869|Sensory System Agents|sensory system agents|mesh-ancestor
101591836|NCT01155869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101591837|NCT00687037|Cetylpyridinium|cetylpyridinium|mesh-list
101591838|NCT00687037|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101591839|NCT00687037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101591840|NCT02625415|Vitamins|vitamins|mesh-list
101591841|NCT02625415|Vitamin B 6|vitamin b 6|mesh-list
101591842|NCT02625415|Pyridoxal|pyridoxal|mesh-list
101591843|NCT02625415|Pyridoxine|pyridoxine|mesh-list
101591844|NCT02625415|Vitamin B Complex|vitamin b complex|mesh-list
101591845|NCT02625415|Micronutrients|micronutrients|mesh-ancestor
101591846|NCT02625415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591847|NCT02809768|Itraconazole|itraconazole|mesh-list
101591848|NCT02809768|Fluconazole|fluconazole|mesh-list
101591849|NCT02809768|Rifampin|rifampin|mesh-list
101591850|NCT02809768|Antifungal Agents|antifungal agents|mesh-ancestor
101591851|NCT02809768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101591852|NCT02809768|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101591853|NCT02809768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101591854|NCT02809768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101591855|NCT02809768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591856|NCT02809768|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101591857|NCT02809768|Hormone Antagonists|hormone antagonists|mesh-ancestor
101591858|NCT02809768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101591859|NCT02809768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591860|NCT02809768|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101591869|NCT02809768|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101591870|NCT02809768|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101591871|NCT02809768|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101591872|NCT02809768|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101591873|NCT02809768|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101591874|NCT04237090|Diphenhydramine|diphenhydramine|mesh-list
101591876|NCT04237090|Cetirizine|cetirizine|mesh-list
101591877|NCT04237090|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101591878|NCT04237090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101591879|NCT04237090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101591880|NCT04237090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591881|NCT04237090|Anesthetics, Local|anesthetics, local|mesh-ancestor
101591882|NCT04237090|Anesthetics|anesthetics|mesh-ancestor
101591883|NCT04237090|Sensory System Agents|sensory system agents|mesh-ancestor
101591884|NCT04237090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101591885|NCT04237090|Antiemetics|antiemetics|mesh-ancestor
101591886|NCT04237090|Autonomic Agents|autonomic agents|mesh-ancestor
101591887|NCT04237090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101591888|NCT04237090|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101591889|NCT04237090|Histamine Antagonists|histamine antagonists|mesh-ancestor
101618527|NCT04244097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618528|NCT04244097|Cholinergic Agents|cholinergic agents|mesh-ancestor
101618529|NCT04244097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101618530|NCT04244097|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101618532|NCT00785629|Calcium|calcium|mesh-list
101618533|NCT00785629|Sevelamer|sevelamer|mesh-list
101618534|NCT00785629|Calcium acetate|calcium acetate|mesh-list
101618535|NCT00785629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101591890|NCT04237090|Histamine Agents|histamine agents|mesh-ancestor
101591891|NCT04237090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101591892|NCT04237090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591893|NCT04237090|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101591894|NCT04237090|Antipruritics|antipruritics|mesh-ancestor
101591895|NCT04237090|Dermatologic Agents|dermatologic agents|mesh-ancestor
101591896|NCT04237090|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101591897|NCT00690781|Caseins|caseins|mesh-list
101591898|NCT00690781|Chelating Agents|chelating agents|mesh-ancestor
101591899|NCT00690781|Sequestering Agents|sequestering agents|mesh-ancestor
101591900|NCT00690781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591901|NCT00682825|Anesthetics|anesthetics|mesh-list
101591902|NCT00682825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
101591903|NCT00682825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101591904|NCT00682825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591906|NCT00912379|Chrysarobin|chrysarobin|mesh-list
101591907|NCT00912379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101591908|NCT00912379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101591909|NCT00912379|Analgesics|analgesics|mesh-ancestor
101591910|NCT00912379|Sensory System Agents|sensory system agents|mesh-ancestor
101591911|NCT00912379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101591912|NCT00912379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591913|NCT00912379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101591914|NCT00912379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101591915|NCT02809378|Remifentanil|remifentanil|mesh-list
101591916|NCT02809378|Thiopental|thiopental|mesh-list
101591917|NCT02809378|Palonosetron|palonosetron|mesh-list
101591918|NCT02809378|Propofol|propofol|mesh-list
101591919|NCT02809378|Sevoflurane|sevoflurane|mesh-list
101591920|NCT02809378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101591921|NCT02809378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101591922|NCT02809378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591923|NCT02809378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101591924|NCT02809378|Anesthetics, General|anesthetics, general|mesh-ancestor
101591925|NCT02809378|Anesthetics|anesthetics|mesh-ancestor
101591926|NCT02809378|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101591927|NCT02809378|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101591928|NCT02809378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101591932|NCT02809378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101591933|NCT02809378|Antiemetics|antiemetics|mesh-ancestor
101591934|NCT02809378|Autonomic Agents|autonomic agents|mesh-ancestor
101591935|NCT02809378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101591936|NCT02809378|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101591937|NCT02809378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101591938|NCT02809378|Serotonin Agents|serotonin agents|mesh-ancestor
101591939|NCT02809378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101591940|NCT02809378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591941|NCT02809378|Anticonvulsants|anticonvulsants|mesh-ancestor
101591942|NCT02809378|GABA Modulators|gaba modulators|mesh-ancestor
101591943|NCT02809378|GABA Agents|gaba agents|mesh-ancestor
101591944|NCT00683059|Paclitaxel|paclitaxel|mesh-list
101591945|NCT00683059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101591946|NCT00683059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101591947|NCT00683059|Tubulin Modulators|tubulin modulators|mesh-ancestor
101591948|NCT00683059|Antimitotic Agents|antimitotic agents|mesh-ancestor
101591949|NCT00683059|Mitosis Modulators|mitosis modulators|mesh-ancestor
101591950|NCT00683059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591951|NCT01185353|Methotrexate|methotrexate|mesh-list
101618536|NCT00785629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618537|NCT00785629|Chelating Agents|chelating agents|mesh-ancestor
101618538|NCT00785629|Sequestering Agents|sequestering agents|mesh-ancestor
101618539|NCT00785629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618540|NCT00915733|Aspirin|aspirin|mesh-list
101618541|NCT00915733|Cilostazol|cilostazol|mesh-list
101618542|NCT00915733|Clopidogrel|clopidogrel|mesh-list
101417351|NCT00404391|Antipyretics|antipyretics|mesh-ancestor
101591952|NCT01185353|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101591953|NCT01185353|Abortifacient Agents|abortifacient agents|mesh-ancestor
101591954|NCT01185353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101591955|NCT01185353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591956|NCT01185353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101591957|NCT01185353|Antimetabolites|antimetabolites|mesh-ancestor
101591958|NCT01185353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591959|NCT01185353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101591960|NCT01185353|Dermatologic Agents|dermatologic agents|mesh-ancestor
101591961|NCT01185353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101591962|NCT01185353|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101591963|NCT01185353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101591964|NCT01185353|Immunologic Factors|immunologic factors|mesh-ancestor
101591965|NCT01185353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101591966|NCT01185353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101591967|NCT00683137|Valdecoxib|valdecoxib|mesh-list
101591968|NCT00683137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101591969|NCT00683137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101591970|NCT00683137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101591971|NCT00683137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591972|NCT00683137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101591973|NCT00683137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101591974|NCT00683137|Analgesics|analgesics|mesh-ancestor
101591975|NCT00683137|Sensory System Agents|sensory system agents|mesh-ancestor
101591976|NCT00683137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101591977|NCT00683137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591978|NCT00683137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101591979|NCT00683137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101591980|NCT02809456|Nicorandil|nicorandil|mesh-list
101591981|NCT02809456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101591982|NCT02809456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101591983|NCT02809456|Vasodilator Agents|vasodilator agents|mesh-ancestor
101591984|NCT02809456|Vitamin B Complex|vitamin b complex|mesh-ancestor
101591985|NCT02809456|Vitamins|vitamins|mesh-ancestor
101591986|NCT02809456|Micronutrients|micronutrients|mesh-ancestor
101591987|NCT02809456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591988|NCT05576740|Contraceptive Agents|contraceptive agents|mesh-list
101591989|NCT05576740|Hormones|hormones|mesh-list
101591990|NCT05576740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101591991|NCT05576740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591992|NCT05576740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101591993|NCT04139629|Antibodies|antibodies|mesh-list
101591994|NCT04139629|Immunologic Factors|immunologic factors|mesh-ancestor
101591995|NCT04139629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591996|NCT02813044|Anesthetics|anesthetics|mesh-list
101591997|NCT02813044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101591998|NCT02813044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591999|NCT04236778|Vancomycin|vancomycin|mesh-list
101592000|NCT04236778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101536617|NCT02882893|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101592028|NCT00687817|Mitosis Modulators|mitosis modulators|mesh-ancestor
101592029|NCT00687817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592030|NCT00687817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101592031|NCT02808988|Zoledronic Acid|zoledronic acid|mesh-list
101592032|NCT02808988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101592033|NCT02808988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592034|NCT02625805|Methylphenidate|methylphenidate|mesh-list
101592035|NCT02625805|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101592036|NCT02625805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618543|NCT00915733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101618545|NCT00915733|Analgesics|analgesics|mesh-ancestor
101618546|NCT00915733|Sensory System Agents|sensory system agents|mesh-ancestor
101618547|NCT00915733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101592037|NCT02625805|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101592038|NCT02625805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101592039|NCT02625805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101592040|NCT02625805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592041|NCT02625805|Dopamine Agents|dopamine agents|mesh-ancestor
101592042|NCT02625805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101592043|NCT00688207|Rosiglitazone|rosiglitazone|mesh-list
101592044|NCT00688207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101592045|NCT00688207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592046|NCT02880462|Sulforaphane|sulforaphane|mesh-list
101592047|NCT02880462|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101592056|NCT00688363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101592057|NCT00688363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592058|NCT00688363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101592059|NCT00688363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101592060|NCT02812654|Doxorubicin|doxorubicin|mesh-list
101592061|NCT02812654|Ifosfamide|ifosfamide|mesh-list
101592062|NCT02812654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101592063|NCT02812654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101592064|NCT02812654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101592065|NCT02812654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101592066|NCT02812654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101592067|NCT02812654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592068|NCT02812654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101592069|NCT02812654|Alkylating Agents|alkylating agents|mesh-ancestor
101592070|NCT02809066|Calcium, Dietary|calcium, dietary|mesh-list
101592071|NCT02809066|Calcium|calcium|mesh-list
101330974|NCT00000620|Furosemide|furosemide|mesh-list
101592072|NCT02809066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101592073|NCT02809066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592074|NCT02809066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101592075|NCT01097694|Imatinib Mesylate|imatinib mesylate|mesh-list
101592076|NCT01097694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101592077|NCT01097694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101592078|NCT01097694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101592079|NCT01097694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592080|NCT00688987|Hydrocortisone|hydrocortisone|mesh-list
101592081|NCT00688987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101592082|NCT02808676|Vitamin D|vitamin d|mesh-list
101592083|NCT02808676|Cholecalciferol|cholecalciferol|mesh-list
101592084|NCT02808676|Vitamins|vitamins|mesh-ancestor
101592085|NCT02808676|Micronutrients|micronutrients|mesh-ancestor
101592086|NCT02808676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592087|NCT02808676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101592088|NCT02808676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101592089|NCT00690937|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
101592090|NCT00690937|Sevelamer|sevelamer|mesh-list
101592091|NCT00690937|Chelating Agents|chelating agents|mesh-ancestor
101592092|NCT00690937|Sequestering Agents|sequestering agents|mesh-ancestor
101592093|NCT00690937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592094|NCT00690937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101592095|NCT00690937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101592096|NCT00690937|Antimetabolites|antimetabolites|mesh-ancestor
101592097|NCT00690937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101592098|NCT00689143|Sargramostim|sargramostim|mesh-list
101592099|NCT00689143|Immunologic Factors|immunologic factors|mesh-ancestor
101592100|NCT00689143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592101|NCT00912457|Donepezil|donepezil|mesh-list
101592102|NCT00912457|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101592103|NCT00912457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101592104|NCT00912457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592105|NCT00912457|Cholinergic Agents|cholinergic agents|mesh-ancestor
101592106|NCT00912457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101592107|NCT00912457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592108|NCT00912457|Nootropic Agents|nootropic agents|mesh-ancestor
101618548|NCT00915733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618549|NCT00915733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101618550|NCT00915733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101618551|NCT00915733|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101618552|NCT00915733|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101618553|NCT00915733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592109|NCT04200586|Dapagliflozin|dapagliflozin|mesh-list
101592110|NCT04200586|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101592111|NCT04200586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592112|NCT04200586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101592113|NCT04200586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592118|NCT02625103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592120|NCT02625103|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101592121|NCT02625103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101592122|NCT02625103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101592123|NCT02625103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101592124|NCT02625103|GABA Antagonists|gaba antagonists|mesh-ancestor
101592125|NCT02625103|GABA Agents|gaba agents|mesh-ancestor
101592126|NCT01155479|Rasagiline|rasagiline|mesh-list
101592127|NCT01155479|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101592128|NCT01155479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101592129|NCT01155479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592130|NCT01155479|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101592131|NCT01155479|Protective Agents|protective agents|mesh-ancestor
101592132|NCT01155479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592133|NCT02807272|Tipifarnib|tipifarnib|mesh-list
101592134|NCT02807272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101592135|NCT02807194|Anesthetics|anesthetics|mesh-list
101264474|NCT01768260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101592136|NCT02807194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101592137|NCT02807194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592138|NCT00912535|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101592139|NCT00912535|Antidepressive Agents|antidepressive agents|mesh-ancestor
101592140|NCT00912535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101592141|NCT00912535|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101592142|NCT00912535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101592143|NCT00912535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101592144|NCT00912535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592145|NCT02625727|Hyaluronic Acid|hyaluronic acid|mesh-list
101592146|NCT02625727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101592147|NCT02625727|Immunologic Factors|immunologic factors|mesh-ancestor
101592148|NCT02625727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592149|NCT02625727|Viscosupplements|viscosupplements|mesh-ancestor
101592150|NCT02625727|Protective Agents|protective agents|mesh-ancestor
101592151|NCT02807116|Rifampin|rifampin|mesh-list
101592152|NCT02807116|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101592153|NCT02807116|Antitubercular Agents|antitubercular agents|mesh-ancestor
101592154|NCT02807116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101592155|NCT02807116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101592156|NCT02807116|Leprostatic Agents|leprostatic agents|mesh-ancestor
101592157|NCT02807116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101592158|NCT02807116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101592159|NCT02807116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592160|NCT02807116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101592161|NCT02807116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101592162|NCT02807116|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101592163|NCT02807116|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101592164|NCT02807116|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101592165|NCT02807116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101592166|NCT04313699|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101592167|NCT04313699|Antiviral Agents|antiviral agents|mesh-ancestor
101592168|NCT04313699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101592169|NCT01155167|Lidocaine|lidocaine|mesh-list
101592170|NCT01155167|Nitroglycerin|nitroglycerin|mesh-list
101592171|NCT01155167|Anesthetics, Local|anesthetics, local|mesh-ancestor
101592172|NCT01155167|Anesthetics|anesthetics|mesh-ancestor
101618555|NCT00915733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101618556|NCT00915733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101618557|NCT00915733|Antipyretics|antipyretics|mesh-ancestor
101618558|NCT00915733|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101618559|NCT00915733|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101592173|NCT01155167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101592174|NCT01155167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592175|NCT01155167|Sensory System Agents|sensory system agents|mesh-ancestor
101592176|NCT01155167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101592177|NCT01155167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101592178|NCT01155167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101592179|NCT01155167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101337234|NCT00392340|Doxorubicin|doxorubicin|mesh-list
101592180|NCT01155167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101592181|NCT01155167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592182|NCT01155167|Vasodilator Agents|vasodilator agents|mesh-ancestor
101592183|NCT05238155|Antimetabolites|antimetabolites|mesh-list
101592186|NCT01106586|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101592188|NCT01106586|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101592189|NCT01106586|Protease Inhibitors|protease inhibitors|mesh-ancestor
101592190|NCT01106586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101592191|NCT01106586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592192|NCT01106586|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101592193|NCT01106586|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101592194|NCT01106586|Antiviral Agents|antiviral agents|mesh-ancestor
101592195|NCT01106586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101592196|NCT01106586|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101592197|NCT01106586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101592198|NCT00683995|Fentanyl|fentanyl|mesh-list
101592199|NCT00683995|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101592200|NCT00683995|Narcotics|narcotics|mesh-ancestor
101592201|NCT00683995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101592202|NCT00683995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592203|NCT00683995|Analgesics|analgesics|mesh-ancestor
101592204|NCT00683995|Sensory System Agents|sensory system agents|mesh-ancestor
101592205|NCT00683995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101592206|NCT00683995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101592207|NCT00683995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101592208|NCT00683995|Anesthetics, General|anesthetics, general|mesh-ancestor
101592209|NCT00683995|Anesthetics|anesthetics|mesh-ancestor
101592210|NCT02806882|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
101592211|NCT02806882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101592212|NCT02806882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101592213|NCT02884817|Listerine|listerine|mesh-list
101592214|NCT02884817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101592215|NCT02884817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101592216|NCT02806804|Vaccines|vaccines|mesh-list
101592217|NCT02806804|Immunologic Factors|immunologic factors|mesh-ancestor
101592218|NCT02806804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592219|NCT02879292|Anesthetics|anesthetics|mesh-list
101592220|NCT02879292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101592221|NCT02879292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592222|NCT02806648|Palbociclib|palbociclib|mesh-list
101592223|NCT02806648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101592224|NCT02806648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101592225|NCT02806648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101592226|NCT02806648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592227|NCT00689845|Cytarabine|cytarabine|mesh-list
101592228|NCT00689845|Prednisone|prednisone|mesh-list
101592229|NCT00689845|Prednisolone|prednisolone|mesh-list
101592230|NCT00689845|Cyclophosphamide|cyclophosphamide|mesh-list
101592231|NCT00689845|Ifosfamide|ifosfamide|mesh-list
101592232|NCT00689845|Rituximab|rituximab|mesh-list
101592233|NCT00689845|Doxorubicin|doxorubicin|mesh-list
101592234|NCT00689845|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101592235|NCT00689845|Methotrexate|methotrexate|mesh-list
101592236|NCT00689845|Etoposide|etoposide|mesh-list
101592237|NCT00689845|Vincristine|vincristine|mesh-list
101592238|NCT00689845|Bleomycin|bleomycin|mesh-list
101618560|NCT00915733|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101618561|NCT00915733|Purinergic Agents|purinergic agents|mesh-ancestor
101618562|NCT00915733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101618563|NCT00915733|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101618564|NCT00915733|Autonomic Agents|autonomic agents|mesh-ancestor
101618565|NCT00915733|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101618566|NCT00915733|Respiratory System Agents|respiratory system agents|mesh-ancestor
101618567|NCT00915733|Vasodilator Agents|vasodilator agents|mesh-ancestor
101618568|NCT00915733|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101618569|NCT00915733|Protective Agents|protective agents|mesh-ancestor
101618570|NCT00915733|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101592239|NCT00689845|Etoposide phosphate|etoposide phosphate|mesh-list
101592240|NCT00689845|Vindesine|vindesine|mesh-list
101592241|NCT00689845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101592242|NCT00689845|Immunologic Factors|immunologic factors|mesh-ancestor
101592243|NCT00689845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592244|NCT00689845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101592245|NCT00689845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101592246|NCT00689845|Alkylating Agents|alkylating agents|mesh-ancestor
101592247|NCT00689845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592248|NCT00689845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101592249|NCT00689845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101592250|NCT00689845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101592251|NCT00689845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101592252|NCT00689845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101592253|NCT00689845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101592254|NCT00689845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101592255|NCT00689845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101592256|NCT00689845|Glucocorticoids|glucocorticoids|mesh-ancestor
101592257|NCT00689845|Hormones|hormones|mesh-ancestor
101592261|NCT00689845|Abortifacient Agents|abortifacient agents|mesh-ancestor
101592262|NCT00689845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101592263|NCT00689845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101592264|NCT00689845|Antimetabolites|antimetabolites|mesh-ancestor
101592265|NCT00689845|Dermatologic Agents|dermatologic agents|mesh-ancestor
101592266|NCT00689845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101592267|NCT00689845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101592268|NCT00689845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101592269|NCT00689845|Antiviral Agents|antiviral agents|mesh-ancestor
101592270|NCT00689845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101592271|NCT00689845|Tubulin Modulators|tubulin modulators|mesh-ancestor
101592272|NCT00689845|Antimitotic Agents|antimitotic agents|mesh-ancestor
101592273|NCT00689845|Mitosis Modulators|mitosis modulators|mesh-ancestor
101592274|NCT00624767|Insulin|insulin|mesh-list
101592275|NCT00624767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101592276|NCT00624767|Insulin Aspart|insulin aspart|mesh-list
101592277|NCT00624767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101592278|NCT00624767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592279|NCT02806492|Phenylephrine|phenylephrine|mesh-list
101592280|NCT02806492|Oxymetazoline|oxymetazoline|mesh-list
101592281|NCT02806492|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101592282|NCT02806492|Mydriatics|mydriatics|mesh-ancestor
101592284|NCT02806492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101592285|NCT02806492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592286|NCT02806492|Sympathomimetics|sympathomimetics|mesh-ancestor
101592287|NCT02806492|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101592288|NCT02806492|Nasal Decongestants|nasal decongestants|mesh-ancestor
101592289|NCT02806492|Respiratory System Agents|respiratory system agents|mesh-ancestor
101592290|NCT02806492|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101592291|NCT02806492|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101592292|NCT02806492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101592293|NCT02806492|Adrenergic Agents|adrenergic agents|mesh-ancestor
101592294|NCT02806492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101592295|NCT02806492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592296|NCT02806492|Protective Agents|protective agents|mesh-ancestor
101618571|NCT00915733|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101618573|NCT00913770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101618574|NCT00913770|Narcotics|narcotics|mesh-ancestor
101618575|NCT00913770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101618576|NCT00913770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618577|NCT00913770|Analgesics|analgesics|mesh-ancestor
101618578|NCT00913770|Sensory System Agents|sensory system agents|mesh-ancestor
101618579|NCT00913770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101592297|NCT00691405|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101592298|NCT00691405|Formoterol Fumarate|formoterol fumarate|mesh-list
101592299|NCT00691405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101592300|NCT00691405|Autonomic Agents|autonomic agents|mesh-ancestor
101592301|NCT00691405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101592302|NCT00691405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592303|NCT00691405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101592304|NCT00691405|Respiratory System Agents|respiratory system agents|mesh-ancestor
101592305|NCT00691405|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101592306|NCT00691405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101592307|NCT00691405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101592308|NCT00691405|Adrenergic Agents|adrenergic agents|mesh-ancestor
101592309|NCT00691405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101592310|NCT00691405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592311|NCT01106430|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101592312|NCT01106430|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101592313|NCT01106430|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101592314|NCT01106430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101592315|NCT01106430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101592316|NCT01106430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592317|NCT01106430|Adrenergic Agents|adrenergic agents|mesh-ancestor
101592318|NCT01106430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101592319|NCT01106430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592320|NCT01106430|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101592321|NCT01106430|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101592322|NCT01106430|Dopamine Agents|dopamine agents|mesh-ancestor
101592323|NCT02804776|Gefitinib|gefitinib|mesh-list
101592324|NCT02804776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101592325|NCT02804776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101592326|NCT02804776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101592327|NCT02804776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592334|NCT01154153|Glucocorticoids|glucocorticoids|mesh-ancestor
101592335|NCT01154153|Hormones|hormones|mesh-ancestor
101592336|NCT01154153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101592337|NCT01154153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592338|NCT01154153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101592339|NCT01154153|Immunologic Factors|immunologic factors|mesh-ancestor
101592340|NCT01154153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101592341|NCT01154153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592342|NCT01154153|Antipruritics|antipruritics|mesh-ancestor
101592343|NCT01154153|Dermatologic Agents|dermatologic agents|mesh-ancestor
101592344|NCT01154153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101592345|NCT01154153|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101592347|NCT01154153|Histamine Antagonists|histamine antagonists|mesh-ancestor
101592348|NCT01154153|Histamine Agents|histamine agents|mesh-ancestor
101592349|NCT01154153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101249278|NCT01690767|Lidocaine|lidocaine|mesh-list
101592350|NCT00684229|Anesthetics|anesthetics|mesh-list
101592351|NCT00684229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101592352|NCT00684229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592353|NCT00874237|Moxifloxacin|moxifloxacin|mesh-list
101592354|NCT00874237|Loxapine|loxapine|mesh-list
101592355|NCT00874237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101592356|NCT00874237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101618580|NCT00913770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101618582|NCT00912912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101618583|NCT00912912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101618584|NCT00912912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101618585|NCT00912912|Growth Substances|growth substances|mesh-ancestor
101618586|NCT00912912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618587|NCT00912912|Growth Inhibitors|growth inhibitors|mesh-ancestor
101618588|NCT00912912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101618589|NCT00912912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101417394|NCT00404508|GABA Agents|gaba agents|mesh-ancestor
101592357|NCT00874237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101592358|NCT00874237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101592359|NCT00874237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101592360|NCT00874237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592361|NCT00874237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101592362|NCT00874237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592363|NCT00874237|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101592364|NCT00874237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101592365|NCT00874237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101592366|NCT00874237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101592367|NCT00874237|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101592368|NCT00874237|Dopamine Agents|dopamine agents|mesh-ancestor
101592369|NCT00874237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101592370|NCT02805946|Posaconazole|posaconazole|mesh-list
101592371|NCT02805946|Antifungal Agents|antifungal agents|mesh-ancestor
101592372|NCT02805946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101592373|NCT02805946|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101592374|NCT02805946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101592375|NCT02805946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101592376|NCT02805946|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101592377|NCT02805946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101592378|NCT02805946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101592379|NCT02805946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592380|NCT02805946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101592381|NCT02805946|Hormone Antagonists|hormone antagonists|mesh-ancestor
101592382|NCT02805946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101592383|NCT02805946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592384|NCT02804386|Sofosbuvir|sofosbuvir|mesh-list
101592385|NCT02804386|Antiviral Agents|antiviral agents|mesh-ancestor
101592386|NCT02804386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101592387|NCT02805868|Siltuximab|siltuximab|mesh-list
101592388|NCT02805868|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101592389|NCT02805868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101592390|NCT02805868|Immunologic Factors|immunologic factors|mesh-ancestor
101592391|NCT02805868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592392|NCT00684385|Gefitinib|gefitinib|mesh-list
101592393|NCT00684385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101592394|NCT00684385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101592395|NCT00684385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101592396|NCT00684385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592400|NCT02690038|gamma-Globulins|gamma-globulins|mesh-list
101592401|NCT02690038|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101592402|NCT02690038|Immunologic Factors|immunologic factors|mesh-ancestor
101592403|NCT02690038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592404|NCT00691795|Clonidine|clonidine|mesh-list
101592405|NCT00691795|Fentanyl|fentanyl|mesh-list
101592406|NCT00691795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101592407|NCT00691795|Narcotics|narcotics|mesh-ancestor
101592408|NCT00691795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101592409|NCT00691795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592410|NCT00691795|Analgesics|analgesics|mesh-ancestor
101592411|NCT00691795|Sensory System Agents|sensory system agents|mesh-ancestor
101592412|NCT00691795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101618590|NCT00912912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618591|NCT00913692|Glycine|glycine|mesh-list
101618592|NCT00913692|Glycine Agents|glycine agents|mesh-ancestor
101618593|NCT00913692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101618594|NCT00913692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618595|NCT00913692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618596|NCT00784927|Dexamethasone|dexamethasone|mesh-list
101618597|NCT00784927|Cyclophosphamide|cyclophosphamide|mesh-list
101618598|NCT00784927|Rituximab|rituximab|mesh-list
101618599|NCT00784927|Lenalidomide|lenalidomide|mesh-list
101618600|NCT00784927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101618601|NCT00784927|Immunologic Factors|immunologic factors|mesh-ancestor
101592413|NCT00691795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101592414|NCT00691795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101592415|NCT00691795|Anesthetics, General|anesthetics, general|mesh-ancestor
101592416|NCT00691795|Anesthetics|anesthetics|mesh-ancestor
101592417|NCT00691795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101592418|NCT00691795|Sympatholytics|sympatholytics|mesh-ancestor
101592419|NCT00691795|Autonomic Agents|autonomic agents|mesh-ancestor
101592420|NCT00691795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101592421|NCT00691795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101592422|NCT00691795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101337330|NCT04733625|Vitamin D|vitamin d|mesh-list
101592423|NCT00691795|Adrenergic Agents|adrenergic agents|mesh-ancestor
101592424|NCT00691795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101592425|NCT00691795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592426|NCT02805556|Fostemsavir|fostemsavir|mesh-list
101592427|NCT02805556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101592428|NCT02805556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101592429|NCT02805556|Antiviral Agents|antiviral agents|mesh-ancestor
101592430|NCT02805556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101592431|NCT02805556|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101592432|NCT02805556|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101592433|NCT02805556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592434|NCT04032964|Doxorubicin|doxorubicin|mesh-list
101592435|NCT04032964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101592436|NCT04032964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101592437|NCT04032964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101592438|NCT04032964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101592439|NCT04032964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101592440|NCT04032964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592441|NCT00694291|Sorafenib|sorafenib|mesh-list
101592442|NCT00694291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101592443|NCT00694291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101592444|NCT00694291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101592445|NCT00694291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592446|NCT01153763|Dabrafenib|dabrafenib|mesh-list
101592447|NCT01153763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101592448|NCT01153763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101592449|NCT01153763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101592450|NCT01153763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592451|NCT00691873|Omalizumab|omalizumab|mesh-list
101592452|NCT00691873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101592453|NCT00691873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101592454|NCT00691873|Respiratory System Agents|respiratory system agents|mesh-ancestor
101592455|NCT05538052|Lidocaine|lidocaine|mesh-list
101592456|NCT05538052|Tramadol|tramadol|mesh-list
101592457|NCT05538052|Anesthetics, Local|anesthetics, local|mesh-ancestor
101592458|NCT05538052|Anesthetics|anesthetics|mesh-ancestor
101592459|NCT05538052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101592460|NCT05538052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592461|NCT05538052|Sensory System Agents|sensory system agents|mesh-ancestor
101592462|NCT05538052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101592463|NCT05538052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101618602|NCT00784927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618603|NCT00784927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101618604|NCT00784927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101618605|NCT00784927|Alkylating Agents|alkylating agents|mesh-ancestor
101618606|NCT00784927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618607|NCT00784927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101618608|NCT00784927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101618609|NCT00784927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101618610|NCT00784927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101618611|NCT00784927|Antiemetics|antiemetics|mesh-ancestor
101618612|NCT00784927|Autonomic Agents|autonomic agents|mesh-ancestor
101618613|NCT00784927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101618614|NCT00784927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101618615|NCT00784927|Glucocorticoids|glucocorticoids|mesh-ancestor
101618616|NCT00784927|Hormones|hormones|mesh-ancestor
101618617|NCT00784927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101618618|NCT00784927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101618619|NCT00784927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101618620|NCT00784927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101618621|NCT00784927|Growth Substances|growth substances|mesh-ancestor
101618622|NCT00784927|Growth Inhibitors|growth inhibitors|mesh-ancestor
101618623|NCT00637884|Fexofenadine|fexofenadine|mesh-list
101337332|NCT04733625|Vitamins|vitamins|mesh-ancestor
101618624|NCT00637884|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101618625|NCT00637884|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101618626|NCT00637884|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101618627|NCT00637884|Histamine Antagonists|histamine antagonists|mesh-ancestor
101618628|NCT00637884|Histamine Agents|histamine agents|mesh-ancestor
101618629|NCT00637884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101618630|NCT00637884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618631|NCT00637884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618643|NCT04203342|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101618644|NCT04834206|Docetaxel|docetaxel|mesh-list
101618645|NCT04834206|Fluorouracil|fluorouracil|mesh-list
101618646|NCT04834206|Nedaplatin|nedaplatin|mesh-list
101618647|NCT04834206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101618648|NCT04834206|Tubulin Modulators|tubulin modulators|mesh-ancestor
101618649|NCT04834206|Antimitotic Agents|antimitotic agents|mesh-ancestor
101618650|NCT04834206|Mitosis Modulators|mitosis modulators|mesh-ancestor
101417455|NCT00145002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417456|NCT00141492|Testosterone|testosterone|mesh-list
101417457|NCT00141492|Androgens|androgens|mesh-ancestor
101417458|NCT00141492|Hormones|hormones|mesh-ancestor
101592464|NCT05538052|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101592465|NCT05538052|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101592466|NCT05538052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101592467|NCT05538052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592468|NCT05538052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101592469|NCT05538052|Narcotics|narcotics|mesh-ancestor
101592476|NCT05298475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101592477|NCT05298475|Protease Inhibitors|protease inhibitors|mesh-ancestor
101592478|NCT05298475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101592479|NCT05298475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101592480|NCT00691951|Budesonide|budesonide|mesh-list
101592481|NCT00691951|Formoterol Fumarate|formoterol fumarate|mesh-list
101592482|NCT00691951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101592483|NCT00691951|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101592484|NCT00691951|Autonomic Agents|autonomic agents|mesh-ancestor
101592485|NCT00691951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101592486|NCT00691951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592487|NCT00691951|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101592488|NCT00691951|Respiratory System Agents|respiratory system agents|mesh-ancestor
101592489|NCT00691951|Glucocorticoids|glucocorticoids|mesh-ancestor
101592490|NCT00691951|Hormones|hormones|mesh-ancestor
101592491|NCT00691951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101592492|NCT00691951|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101592494|NCT00691951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101592495|NCT00691951|Adrenergic Agents|adrenergic agents|mesh-ancestor
101592496|NCT00691951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101592497|NCT00691951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592498|NCT04316351|Pemetrexed|pemetrexed|mesh-list
101592499|NCT04316351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101592500|NCT04316351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101592501|NCT04316351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592503|NCT04316351|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101592504|NCT02625337|Pembrolizumab|pembrolizumab|mesh-list
101592505|NCT02625337|Trametinib|trametinib|mesh-list
101592506|NCT02625337|Dabrafenib|dabrafenib|mesh-list
101592507|NCT02625337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101592508|NCT02625337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101592509|NCT02625337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101592510|NCT02625337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592511|NCT02625337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101592512|NCT02625337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101592513|NCT04236310|Trastuzumab|trastuzumab|mesh-list
101592514|NCT04236310|Anastrozole|anastrozole|mesh-list
101592515|NCT04236310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101592516|NCT04236310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337342|NCT00062803|Heparin|heparin|mesh-list
101592517|NCT04236310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101592518|NCT04236310|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101592519|NCT04236310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101592520|NCT04236310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101592521|NCT04236310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592522|NCT04236310|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101592523|NCT04236310|Hormone Antagonists|hormone antagonists|mesh-ancestor
101618651|NCT04834206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618652|NCT04834206|Antimetabolites|antimetabolites|mesh-ancestor
101618653|NCT04834206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101618654|NCT04834206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101618655|NCT04834206|Immunologic Factors|immunologic factors|mesh-ancestor
101618656|NCT04834206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618657|NCT00631722|Haloperidol|haloperidol|mesh-list
101618658|NCT00631722|Haloperidol decanoate|haloperidol decanoate|mesh-list
101618659|NCT00631722|Antiemetics|antiemetics|mesh-ancestor
101618660|NCT00631722|Autonomic Agents|autonomic agents|mesh-ancestor
101417460|NCT00141492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417461|NCT00141531|Apaziquone|apaziquone|mesh-list
101417464|NCT00134069|Cetuximab|cetuximab|mesh-list
101592524|NCT04236310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101592525|NCT04236310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592526|NCT02621515|Nivolumab|nivolumab|mesh-list
101592527|NCT02621515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101592528|NCT02621515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101592529|NCT02621515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101592530|NCT02621515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592531|NCT02803918|Metformin|metformin|mesh-list
101592532|NCT02803918|Lixisenatide|lixisenatide|mesh-list
101592533|NCT02803918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101592534|NCT02803918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592535|NCT02805010|Abatacept|abatacept|mesh-list
101592536|NCT02805010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101592537|NCT02805010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592538|NCT02805010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101592551|NCT00692263|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101592552|NCT00692263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101592553|NCT00692263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101592554|NCT00692263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592555|NCT00692263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101592556|NCT00692263|Serotonin Agents|serotonin agents|mesh-ancestor
101592557|NCT00692263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592558|NCT00692263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101592559|NCT00692263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101592560|NCT00692263|Narcotics|narcotics|mesh-ancestor
101592561|NCT00692263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101592562|NCT00692263|Analgesics|analgesics|mesh-ancestor
101592563|NCT00692263|Sensory System Agents|sensory system agents|mesh-ancestor
101592564|NCT02800486|Cetuximab|cetuximab|mesh-list
101592565|NCT02800486|Mannitol|mannitol|mesh-list
101592566|NCT02800486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101592567|NCT02800486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101592568|NCT02800486|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101592570|NCT02800486|Natriuretic Agents|natriuretic agents|mesh-ancestor
101592571|NCT02800486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592572|NCT00694759|Metformin|metformin|mesh-list
101592573|NCT00694759|Pioglitazone|pioglitazone|mesh-list
101592574|NCT00694759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101592575|NCT00694759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592576|NCT00694837|Nelfinavir|nelfinavir|mesh-list
101592577|NCT00694837|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101337349|NCT00062842|Irinotecan|irinotecan|mesh-list
101592578|NCT00694837|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101592579|NCT00694837|Protease Inhibitors|protease inhibitors|mesh-ancestor
101592580|NCT00694837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101592581|NCT00694837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592582|NCT00694837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101592583|NCT00694837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101592584|NCT00694837|Antiviral Agents|antiviral agents|mesh-ancestor
101592585|NCT00694837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101618661|NCT00631722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101618662|NCT00631722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618663|NCT00631722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101618664|NCT00631722|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101618665|NCT00631722|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101618666|NCT00631722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101618667|NCT00631722|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101618668|NCT00631722|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101618669|NCT00631722|Dopamine Agents|dopamine agents|mesh-ancestor
101618670|NCT00631722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101592586|NCT02800252|Aspirin|aspirin|mesh-list
101592587|NCT02800252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101592588|NCT02800252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101592589|NCT02800252|Analgesics|analgesics|mesh-ancestor
101592590|NCT02800252|Sensory System Agents|sensory system agents|mesh-ancestor
101592591|NCT02800252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101592592|NCT02800252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592593|NCT02800252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101592594|NCT02800252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101592595|NCT02800252|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101592596|NCT02800252|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101592597|NCT02800252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592598|NCT02800252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101592599|NCT02800252|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101592600|NCT02800252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101592601|NCT02800252|Antipyretics|antipyretics|mesh-ancestor
101592602|NCT02621359|Doxycycline|doxycycline|mesh-list
101592603|NCT02621359|Levofloxacin|levofloxacin|mesh-list
101592604|NCT02621359|Nitazoxanide|nitazoxanide|mesh-list
101592605|NCT02621359|Omeprazole|omeprazole|mesh-list
101592611|NCT02621359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101592612|NCT02621359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101592613|NCT02621359|Antimalarials|antimalarials|mesh-ancestor
101592614|NCT02621359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101592615|NCT02621359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101592616|NCT02621359|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101592617|NCT02621359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101592618|NCT02621359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101592619|NCT02621359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101592620|NCT02621359|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101592621|NCT02621359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101592622|NCT01152437|Cetuximab|cetuximab|mesh-list
101592623|NCT01152437|Afatinib|afatinib|mesh-list
101592624|NCT01152437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101592625|NCT01152437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101592626|NCT01152437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101592627|NCT01152437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101592628|NCT01152437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592629|NCT02800174|Clopidogrel|clopidogrel|mesh-list
101592630|NCT02800174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
101592631|NCT02800174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592632|NCT02800174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592633|NCT02800174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101592634|NCT02800174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101592635|NCT02800174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101592636|NCT02800174|Purinergic Agents|purinergic agents|mesh-ancestor
101592637|NCT02800174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101592638|NCT02800330|Esomeprazole|esomeprazole|mesh-list
101592639|NCT02800330|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101592640|NCT02800330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101592641|NCT02800330|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101592642|NCT02800330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101592643|NCT02800330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592644|NCT02799862|Paclitaxel|paclitaxel|mesh-list
101592645|NCT02799862|Carboplatin|carboplatin|mesh-list
101618671|NCT00631722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618673|NCT00845728|Tiotropium Bromide|tiotropium bromide|mesh-list
101618674|NCT00845728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101618675|NCT00845728|Autonomic Agents|autonomic agents|mesh-ancestor
101275709|NCT01864161|Iron|iron|mesh-list
101618676|NCT00845728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101618677|NCT00845728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618678|NCT00845728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101618679|NCT00845728|Respiratory System Agents|respiratory system agents|mesh-ancestor
101592646|NCT02799862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101592647|NCT02799862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101592648|NCT02799862|Tubulin Modulators|tubulin modulators|mesh-ancestor
101592649|NCT02799862|Antimitotic Agents|antimitotic agents|mesh-ancestor
101592650|NCT02799862|Mitosis Modulators|mitosis modulators|mesh-ancestor
101592651|NCT02799862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592652|NCT01151579|Albuterol|albuterol|mesh-list
101592653|NCT01151579|Ipratropium|ipratropium|mesh-list
101592654|NCT01151579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101592655|NCT01151579|Autonomic Agents|autonomic agents|mesh-ancestor
101592656|NCT01151579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101592657|NCT01151579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592658|NCT01151579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101592659|NCT01151579|Respiratory System Agents|respiratory system agents|mesh-ancestor
101592660|NCT01151579|Tocolytic Agents|tocolytic agents|mesh-ancestor
101592661|NCT01151579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101592662|NCT01151579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101592663|NCT01151579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101592664|NCT01151579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101592665|NCT01151579|Adrenergic Agents|adrenergic agents|mesh-ancestor
101592666|NCT01151579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101592667|NCT01151579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592668|NCT01151579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101592669|NCT01151579|Cholinergic Agents|cholinergic agents|mesh-ancestor
101592670|NCT00694915|BCG Vaccine|bcg vaccine|mesh-list
101592671|NCT00694915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101592672|NCT00694915|Immunologic Factors|immunologic factors|mesh-ancestor
101592673|NCT00694915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592677|NCT01097616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101592678|NCT01097616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592680|NCT01097616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101592681|NCT01097616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592682|NCT00695071|Itraconazole|itraconazole|mesh-list
101592683|NCT00695071|Antifungal Agents|antifungal agents|mesh-ancestor
101592684|NCT00695071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101592685|NCT00695071|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101592686|NCT00695071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101592687|NCT00695071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101592688|NCT00695071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592689|NCT00695071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101592690|NCT00695071|Hormone Antagonists|hormone antagonists|mesh-ancestor
101592691|NCT00695071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101592692|NCT00695071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592693|NCT00695071|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101592694|NCT04939428|Molnupiravir|molnupiravir|mesh-list
101592695|NCT04939428|Antiviral Agents|antiviral agents|mesh-ancestor
101592696|NCT04939428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101592697|NCT02803216|Amoxicillin|amoxicillin|mesh-list
101592698|NCT02803216|Clarithromycin|clarithromycin|mesh-list
101592699|NCT02803216|Omeprazole|omeprazole|mesh-list
101592700|NCT02803216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101592701|NCT02803216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101592702|NCT02803216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101618681|NCT00845728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101618682|NCT00845728|Cholinergic Agents|cholinergic agents|mesh-ancestor
101618683|NCT00845728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101618684|NCT00845728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618685|NCT00779467|Fentanyl|fentanyl|mesh-list
101618686|NCT00779467|Bupivacaine|bupivacaine|mesh-list
101618687|NCT00779467|Neostigmine|neostigmine|mesh-list
101618688|NCT00779467|Anesthetics, Local|anesthetics, local|mesh-ancestor
101618689|NCT00779467|Anesthetics|anesthetics|mesh-ancestor
101618690|NCT00779467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101618691|NCT00779467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618692|NCT00779467|Sensory System Agents|sensory system agents|mesh-ancestor
101618693|NCT00779467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101592703|NCT02803216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101592704|NCT02803216|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101592705|NCT02803216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101592706|NCT02803216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592707|NCT02803216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101592708|NCT02803216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101592709|NCT02803216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101592710|NCT02799316|Antibodies|antibodies|mesh-list
101592711|NCT02799316|Immunologic Factors|immunologic factors|mesh-ancestor
101592712|NCT02799316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592713|NCT02620969|Dialysis Solutions|dialysis solutions|mesh-list
101592714|NCT02620969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101592715|NCT02799238|Temozolomide|temozolomide|mesh-list
101592716|NCT02799238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101592717|NCT02799238|Alkylating Agents|alkylating agents|mesh-ancestor
101592718|NCT02799238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592719|NCT02799238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101592720|NCT02620813|Tretinoin|tretinoin|mesh-list
101592721|NCT02620813|Isotretinoin|isotretinoin|mesh-list
101592722|NCT02620813|Dermatologic Agents|dermatologic agents|mesh-ancestor
101592723|NCT02620813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101592724|NCT02620813|Keratolytic Agents|keratolytic agents|mesh-ancestor
101592725|NCT00692731|Caffeine|caffeine|mesh-list
101592726|NCT00692731|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101592727|NCT00692731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592728|NCT00692731|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101592729|NCT00692731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101592730|NCT00692731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592731|NCT00692731|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101592732|NCT00692731|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101592733|NCT00692731|Purinergic Agents|purinergic agents|mesh-ancestor
101592734|NCT00692731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101592735|NCT02624401|Dexmedetomidine|dexmedetomidine|mesh-list
101592736|NCT02624401|Ketamine|ketamine|mesh-list
101592737|NCT02624401|Propofol|propofol|mesh-list
101592738|NCT02624401|Sevoflurane|sevoflurane|mesh-list
101592739|NCT02624401|Esketamine|esketamine|mesh-list
101592740|NCT02624401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101592741|NCT02624401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101592742|NCT02624401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592743|NCT02624401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101592744|NCT02624401|Analgesics|analgesics|mesh-ancestor
101592750|NCT02624401|Adrenergic Agents|adrenergic agents|mesh-ancestor
101592751|NCT02624401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101592752|NCT02624401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592753|NCT02624401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101592754|NCT02624401|Anesthetics, General|anesthetics, general|mesh-ancestor
101618694|NCT00779467|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101618696|NCT00779467|Analgesics|analgesics|mesh-ancestor
101618697|NCT00779467|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101618698|NCT00779467|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101618699|NCT00779467|Anesthetics, General|anesthetics, general|mesh-ancestor
101618700|NCT00779467|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101618701|NCT00779467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101618702|NCT00779467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618703|NCT00779467|Cholinergic Agents|cholinergic agents|mesh-ancestor
101618704|NCT00779467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101618705|NCT00779467|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101592755|NCT02624401|Anesthetics|anesthetics|mesh-ancestor
101592756|NCT02624401|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101592757|NCT02624401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101592758|NCT02624401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101592759|NCT02624401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101592760|NCT02624401|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101592761|NCT02624401|Antidepressive Agents|antidepressive agents|mesh-ancestor
101592762|NCT02624401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101592763|NCT02802748|Letrozole|letrozole|mesh-list
101592764|NCT02802748|Vinorelbine|vinorelbine|mesh-list
101592765|NCT02802748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101592766|NCT02802748|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101592767|NCT02802748|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101592768|NCT02802748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101592769|NCT02802748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592770|NCT02802748|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101592771|NCT02802748|Hormone Antagonists|hormone antagonists|mesh-ancestor
101592772|NCT02802748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101592773|NCT02802748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592774|NCT02802748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101592775|NCT02802748|Tubulin Modulators|tubulin modulators|mesh-ancestor
101592776|NCT02802748|Antimitotic Agents|antimitotic agents|mesh-ancestor
101592777|NCT02802748|Mitosis Modulators|mitosis modulators|mesh-ancestor
101592778|NCT02798068|Methylprednisolone|methylprednisolone|mesh-list
101592779|NCT02798068|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101592780|NCT02798068|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101592781|NCT02798068|Prednisolone|prednisolone|mesh-list
101592782|NCT02798068|Prednisolone acetate|prednisolone acetate|mesh-list
101592783|NCT02798068|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101592784|NCT02798068|Prednisolone phosphate|prednisolone phosphate|mesh-list
101592785|NCT02798068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101592786|NCT02798068|Antiemetics|antiemetics|mesh-ancestor
101592787|NCT02798068|Autonomic Agents|autonomic agents|mesh-ancestor
101592788|NCT02798068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101592789|NCT02798068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592790|NCT02798068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101592791|NCT02798068|Glucocorticoids|glucocorticoids|mesh-ancestor
101592792|NCT02798068|Hormones|hormones|mesh-ancestor
101592793|NCT02798068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101592794|NCT02798068|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101592795|NCT02798068|Protective Agents|protective agents|mesh-ancestor
101592796|NCT02798068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101592797|NCT02798068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101592798|NCT00593827|Epothilones|epothilones|mesh-list
101592799|NCT00593827|Tubulin Modulators|tubulin modulators|mesh-ancestor
101592800|NCT00593827|Antimitotic Agents|antimitotic agents|mesh-ancestor
101592801|NCT00593827|Mitosis Modulators|mitosis modulators|mesh-ancestor
101592802|NCT00593827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592803|NCT00593827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101592804|NCT04135885|Folic Acid|folic acid|mesh-list
101592805|NCT04135885|Hematinics|hematinics|mesh-ancestor
101618706|NCT00779467|Autonomic Agents|autonomic agents|mesh-ancestor
101618707|NCT04559100|Carbon Monoxide|carbon monoxide|mesh-list
101618708|NCT04559100|Antimetabolites|antimetabolites|mesh-ancestor
101330984|NCT00000620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101618709|NCT04559100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618710|NCT04559100|Gasotransmitters|gasotransmitters|mesh-ancestor
101618711|NCT04559100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101618712|NCT04559100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618714|NCT00778921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101592806|NCT04135885|Vitamin B Complex|vitamin b complex|mesh-ancestor
101592807|NCT04135885|Vitamins|vitamins|mesh-ancestor
101592808|NCT04135885|Micronutrients|micronutrients|mesh-ancestor
101592809|NCT04135885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592810|NCT00693043|Lidocaine|lidocaine|mesh-list
101592811|NCT00693043|Anesthetics, Local|anesthetics, local|mesh-ancestor
101592812|NCT00693043|Anesthetics|anesthetics|mesh-ancestor
101592813|NCT00693043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101592817|NCT00693043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101592818|NCT00693043|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101592819|NCT00693043|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101592820|NCT00693043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101592821|NCT00693043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592822|NCT00695929|Simendan|simendan|mesh-list
101592823|NCT00695929|Milrinone|milrinone|mesh-list
101592824|NCT00695929|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101592825|NCT00695929|Vasodilator Agents|vasodilator agents|mesh-ancestor
101592826|NCT00695929|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101592827|NCT00695929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101592828|NCT00695929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101592829|NCT00695929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592830|NCT00695929|Protective Agents|protective agents|mesh-ancestor
101592831|NCT00695929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592832|NCT00695929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101592833|NCT04235296|Mitogens|mitogens|mesh-list
101592834|NCT04235296|Mitosis Modulators|mitosis modulators|mesh-ancestor
101592835|NCT04235296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592836|NCT02620501|Lidocaine|lidocaine|mesh-list
101592837|NCT02620501|Anesthetics, Local|anesthetics, local|mesh-ancestor
101592838|NCT02620501|Anesthetics|anesthetics|mesh-ancestor
101592839|NCT02620501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101592840|NCT02620501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592841|NCT02620501|Sensory System Agents|sensory system agents|mesh-ancestor
101592842|NCT02620501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101592843|NCT02620501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101592844|NCT02620501|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101592845|NCT02620501|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101592846|NCT02620501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101592847|NCT02620501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592849|NCT00693121|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101592850|NCT00693121|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101592851|NCT00693121|Antiviral Agents|antiviral agents|mesh-ancestor
101592852|NCT00693121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101592853|NCT00693121|Dopamine Agents|dopamine agents|mesh-ancestor
101592854|NCT00693121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101592855|NCT00693121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592856|NCT00693121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592857|NCT00693121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101592858|NCT00693121|Analgesics|analgesics|mesh-ancestor
101592859|NCT00693121|Sensory System Agents|sensory system agents|mesh-ancestor
101592860|NCT00693121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101592861|NCT02620423|Leucovorin|leucovorin|mesh-list
101592862|NCT02620423|Gemcitabine|gemcitabine|mesh-list
101592863|NCT02620423|Fluorouracil|fluorouracil|mesh-list
101592864|NCT02620423|Pembrolizumab|pembrolizumab|mesh-list
101592865|NCT02620423|Irinotecan|irinotecan|mesh-list
101592866|NCT02620423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101592867|NCT02620423|Antimetabolites|antimetabolites|mesh-ancestor
101618715|NCT00778921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101618716|NCT00778921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101618717|NCT00778921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618718|NCT00778921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101618719|NCT00778921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618720|NCT00778921|Vasodilator Agents|vasodilator agents|mesh-ancestor
101618721|NCT04173312|Bupivacaine|bupivacaine|mesh-list
101618722|NCT04173312|Anesthetics, Local|anesthetics, local|mesh-ancestor
101618723|NCT04173312|Anesthetics|anesthetics|mesh-ancestor
101618724|NCT04173312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101592868|NCT02620423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592869|NCT02620423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101592870|NCT02620423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101592871|NCT02620423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101592872|NCT02620423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101592873|NCT02620423|Immunologic Factors|immunologic factors|mesh-ancestor
101592874|NCT02620423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592875|NCT02620423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101592876|NCT02620423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101592877|NCT02620423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101592878|NCT02620423|Antidotes|antidotes|mesh-ancestor
101592879|NCT02620423|Protective Agents|protective agents|mesh-ancestor
101592880|NCT02620423|Vitamin B Complex|vitamin b complex|mesh-ancestor
101592881|NCT02620423|Vitamins|vitamins|mesh-ancestor
101592882|NCT02620423|Micronutrients|micronutrients|mesh-ancestor
101592883|NCT00696007|Gemcitabine|gemcitabine|mesh-list
101592884|NCT00696007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101592885|NCT00696007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101592896|NCT02796196|Keratolytic Agents|keratolytic agents|mesh-ancestor
101592897|NCT02796196|Dermatologic Agents|dermatologic agents|mesh-ancestor
101592898|NCT00693199|Amlodipine|amlodipine|mesh-list
101592899|NCT00693199|Prazosin|prazosin|mesh-list
101592900|NCT00693199|Terazosin|terazosin|mesh-list
101592901|NCT00693199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101592902|NCT00693199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101592903|NCT00693199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101592904|NCT00693199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592905|NCT00693199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101592906|NCT00693199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592907|NCT00693199|Vasodilator Agents|vasodilator agents|mesh-ancestor
101592908|NCT00693199|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101592909|NCT00693199|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101592910|NCT00693199|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101592911|NCT00693199|Adrenergic Agents|adrenergic agents|mesh-ancestor
101592912|NCT00693199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101592913|NCT00693199|Urological Agents|urological agents|mesh-ancestor
101592914|NCT02795884|Cisplatin|cisplatin|mesh-list
101592915|NCT02795884|Pemetrexed|pemetrexed|mesh-list
101592916|NCT02795884|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101592917|NCT02795884|Vinorelbine|vinorelbine|mesh-list
101592918|NCT02795884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101592919|NCT02795884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101592920|NCT02795884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592921|NCT02795884|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101592922|NCT02795884|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101592923|NCT02795884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101592924|NCT02795884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101592925|NCT02795884|Tubulin Modulators|tubulin modulators|mesh-ancestor
101592926|NCT02795884|Antimitotic Agents|antimitotic agents|mesh-ancestor
101592927|NCT02795884|Mitosis Modulators|mitosis modulators|mesh-ancestor
101592928|NCT02795572|Vitamin D|vitamin d|mesh-list
101592929|NCT02795572|Vitamins|vitamins|mesh-list
101592930|NCT02795572|Vitamin B 12|vitamin b 12|mesh-list
101592931|NCT02795572|Vitamin B 6|vitamin b 6|mesh-list
101592932|NCT02795572|Pyridoxal|pyridoxal|mesh-list
101618725|NCT04173312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618727|NCT04173312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101618728|NCT00587431|Docetaxel|docetaxel|mesh-list
101618729|NCT00587431|Leuprolide|leuprolide|mesh-list
101618730|NCT00587431|Testosterone|testosterone|mesh-list
101618731|NCT00587431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101618732|NCT00587431|Tubulin Modulators|tubulin modulators|mesh-ancestor
101618733|NCT00587431|Antimitotic Agents|antimitotic agents|mesh-ancestor
101592933|NCT02795572|Pyridoxine|pyridoxine|mesh-list
101592934|NCT02795572|Vitamin B Complex|vitamin b complex|mesh-list
101592935|NCT02795572|Micronutrients|micronutrients|mesh-ancestor
101592936|NCT02795572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592937|NCT02795572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101592938|NCT02801188|Dexmedetomidine|dexmedetomidine|mesh-list
101592939|NCT02801188|Bupivacaine|bupivacaine|mesh-list
101592940|NCT02801188|Anesthetics, Local|anesthetics, local|mesh-ancestor
101592941|NCT02801188|Anesthetics|anesthetics|mesh-ancestor
101592942|NCT02801188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101592943|NCT02801188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592944|NCT02801188|Sensory System Agents|sensory system agents|mesh-ancestor
101592945|NCT02801188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101592946|NCT02801188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101592947|NCT02801188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101592948|NCT02801188|Analgesics|analgesics|mesh-ancestor
101592949|NCT02801188|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101592950|NCT02801188|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101592951|NCT02801188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101592953|NCT02801188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101592957|NCT02801032|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101592959|NCT02801032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101592960|NCT02801032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592961|NCT02801032|Urological Agents|urological agents|mesh-ancestor
101592962|NCT05442190|Hypericin|hypericin|mesh-list
101592963|NCT05442190|Antidepressive Agents|antidepressive agents|mesh-ancestor
101592964|NCT05442190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101592965|NCT05442190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101592966|NCT05442190|Antiviral Agents|antiviral agents|mesh-ancestor
101592967|NCT05442190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101592968|NCT05442190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101592969|NCT05442190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592970|NCT05442190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101592971|NCT05442190|Immunologic Factors|immunologic factors|mesh-ancestor
101592972|NCT05442190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592973|NCT02689960|Prednisone|prednisone|mesh-list
101592974|NCT02689960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101592975|NCT02689960|Glucocorticoids|glucocorticoids|mesh-ancestor
101592976|NCT02689960|Hormones|hormones|mesh-ancestor
101337454|NCT00064207|Gemcitabine|gemcitabine|mesh-list
101592977|NCT02689960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101592978|NCT02689960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592979|NCT02689960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101592980|NCT02689960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101592981|NCT01150097|Everolimus|everolimus|mesh-list
101592982|NCT01150097|Tacrolimus|tacrolimus|mesh-list
101592983|NCT01150097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101592984|NCT01150097|Immunologic Factors|immunologic factors|mesh-ancestor
101592985|NCT01150097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592986|NCT01150097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101592987|NCT01150097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101592988|NCT01150097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592989|NCT01150097|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101592990|NCT01150097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101592991|NCT01150097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101592992|NCT02794948|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101592993|NCT02794948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101592994|NCT02794948|Immunologic Factors|immunologic factors|mesh-ancestor
101592995|NCT02794948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592996|NCT01149863|Plerixafor|plerixafor|mesh-list
101618734|NCT00587431|Mitosis Modulators|mitosis modulators|mesh-ancestor
101618735|NCT00587431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618736|NCT00587431|Androgens|androgens|mesh-ancestor
101618737|NCT00587431|Hormones|hormones|mesh-ancestor
101618738|NCT00587431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101618739|NCT00587431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618740|NCT00587431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101618741|NCT00587431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101618742|NCT00587431|Fertility Agents|fertility agents|mesh-ancestor
101618743|NCT00587431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101618744|NCT00776659|Exemestane|exemestane|mesh-list
101618745|NCT00776659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101618746|NCT00776659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101618747|NCT00776659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101618748|NCT00776659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101417540|NCT00134420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101592997|NCT01149863|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101592998|NCT01149863|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101592999|NCT01149863|Antiviral Agents|antiviral agents|mesh-ancestor
101593000|NCT01149863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101593001|NCT02794792|Metformin|metformin|mesh-list
101593002|NCT02794792|Ipragliflozin|ipragliflozin|mesh-list
101593003|NCT02794792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101593004|NCT02794792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593005|NCT02794792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101593006|NCT02794792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593007|NCT01149473|Losartan|losartan|mesh-list
101593008|NCT01149473|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101593009|NCT01149473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101593010|NCT01149473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101593011|NCT01149473|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101593012|NCT01149473|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101593013|NCT01149473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593014|NCT01149473|Diuretics|diuretics|mesh-ancestor
101593015|NCT01149473|Natriuretic Agents|natriuretic agents|mesh-ancestor
101593016|NCT01149473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593017|NCT01149473|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101593018|NCT01149473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101593019|NCT00872989|Docetaxel|docetaxel|mesh-list
101593020|NCT00872989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101593021|NCT00872989|Tubulin Modulators|tubulin modulators|mesh-ancestor
101593022|NCT00872989|Antimitotic Agents|antimitotic agents|mesh-ancestor
101593023|NCT00872989|Mitosis Modulators|mitosis modulators|mesh-ancestor
101593029|NCT02794714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101593030|NCT02794714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593032|NCT01148771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101593033|NCT01148771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101593034|NCT01148693|Gentamicins|gentamicins|mesh-list
101593035|NCT01148693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101593036|NCT01148693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101593037|NCT01148693|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101593038|NCT01148693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101593039|NCT01148693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593040|NCT00693355|Butyric Acid|butyric acid|mesh-list
101593041|NCT00693355|Histamine Antagonists|histamine antagonists|mesh-ancestor
101593042|NCT00693355|Histamine Agents|histamine agents|mesh-ancestor
101618749|NCT00776659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618750|NCT00776659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101618752|NCT00776659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101618753|NCT00776659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618754|NCT00632268|Leucovorin|leucovorin|mesh-list
101618755|NCT00632268|Everolimus|everolimus|mesh-list
101618756|NCT00632268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101618757|NCT00632268|Antidotes|antidotes|mesh-ancestor
101417556|NCT00141804|Immunologic Factors|immunologic factors|mesh-ancestor
101593043|NCT00693355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101593044|NCT00693355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593045|NCT00693355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593046|NCT00693433|Sirolimus|sirolimus|mesh-list
101593047|NCT00693433|Dexamethasone|dexamethasone|mesh-list
101593048|NCT00693433|Temsirolimus|temsirolimus|mesh-list
101593049|NCT00693433|MTOR Inhibitors|mtor inhibitors|mesh-list
101593050|NCT00693433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101593051|NCT00693433|Antiemetics|antiemetics|mesh-ancestor
101593052|NCT00693433|Autonomic Agents|autonomic agents|mesh-ancestor
101593053|NCT00693433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101593054|NCT00693433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593055|NCT00693433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101593056|NCT00693433|Glucocorticoids|glucocorticoids|mesh-ancestor
101593057|NCT00693433|Hormones|hormones|mesh-ancestor
101593058|NCT00693433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101593059|NCT00693433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101593060|NCT00693433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101593061|NCT00693433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101593062|NCT00693433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101593063|NCT00693433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593064|NCT00693433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101593065|NCT00693433|Immunologic Factors|immunologic factors|mesh-ancestor
101593066|NCT00693433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101593067|NCT00693433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101593068|NCT00693433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101593069|NCT00693433|Antifungal Agents|antifungal agents|mesh-ancestor
101593070|NCT05414422|Ketamine|ketamine|mesh-list
101593071|NCT05414422|Analgesics|analgesics|mesh-ancestor
101593072|NCT05414422|Sensory System Agents|sensory system agents|mesh-ancestor
101593073|NCT05414422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101593074|NCT05414422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593075|NCT05414422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101593076|NCT05414422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101593077|NCT05414422|Anesthetics, General|anesthetics, general|mesh-ancestor
101593078|NCT05414422|Anesthetics|anesthetics|mesh-ancestor
101593079|NCT05414422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101593080|NCT05414422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101593081|NCT05414422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101593082|NCT05414422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101593083|NCT05414422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593084|NCT00872599|Fenofibrate|fenofibrate|mesh-list
101593085|NCT00872599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101593086|NCT00872599|Antimetabolites|antimetabolites|mesh-ancestor
101337512|NCT00064636|Bortezomib|bortezomib|mesh-list
101593087|NCT00872599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593088|NCT00872599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101593089|NCT02623621|Bevacizumab|bevacizumab|mesh-list
101593090|NCT02623621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101593091|NCT02623621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101250012|NCT05294640|Sympathomimetics|sympathomimetics|mesh-ancestor
101593099|NCT00693589|Hydroxocobalamin|hydroxocobalamin|mesh-list
101593100|NCT00693589|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101593101|NCT00693589|Vitamins|vitamins|mesh-ancestor
101593102|NCT00693589|Micronutrients|micronutrients|mesh-ancestor
101593103|NCT00693589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593104|NCT00693589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101618758|NCT00632268|Protective Agents|protective agents|mesh-ancestor
101618759|NCT00632268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618760|NCT00632268|Vitamin B Complex|vitamin b complex|mesh-ancestor
101618761|NCT00632268|Vitamins|vitamins|mesh-ancestor
101618762|NCT00632268|Micronutrients|micronutrients|mesh-ancestor
101618763|NCT00632268|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101618764|NCT00632268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101593105|NCT00693589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101593106|NCT00693589|Antimetabolites|antimetabolites|mesh-ancestor
101593107|NCT00693589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593108|NCT00693589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101593109|NCT00693589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101593110|NCT00693589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101593111|NCT00693589|Hematinics|hematinics|mesh-ancestor
101593112|NCT00693589|Vitamin B Complex|vitamin b complex|mesh-ancestor
101593113|NCT01148537|Moxifloxacin|moxifloxacin|mesh-list
101593114|NCT01148537|Buprenorphine|buprenorphine|mesh-list
101593115|NCT01148537|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101593116|NCT01148537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101593117|NCT01148537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101593118|NCT01148537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101593119|NCT01148537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101593120|NCT01148537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101593121|NCT01148537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593122|NCT01148537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101593123|NCT01148537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101593124|NCT01148537|Contraceptive Agents|contraceptive agents|mesh-ancestor
101593125|NCT01148537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101593126|NCT01148537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593127|NCT01148537|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101593128|NCT01148537|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101593129|NCT01148537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101593130|NCT01148537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101593131|NCT01148537|Narcotics|narcotics|mesh-ancestor
101593132|NCT01148537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101593133|NCT01148537|Analgesics|analgesics|mesh-ancestor
101593134|NCT01148537|Sensory System Agents|sensory system agents|mesh-ancestor
101593135|NCT01148537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101593136|NCT01148537|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101593137|NCT02793544|Mycophenolic Acid|mycophenolic acid|mesh-list
101593138|NCT02793544|Sirolimus|sirolimus|mesh-list
101593139|NCT02793544|Cyclophosphamide|cyclophosphamide|mesh-list
101593140|NCT02793544|Busulfan|busulfan|mesh-list
101593141|NCT02793544|Fludarabine|fludarabine|mesh-list
101593142|NCT02793544|Mesna|mesna|mesh-list
101593143|NCT02793544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101593144|NCT02793544|Immunologic Factors|immunologic factors|mesh-ancestor
101593145|NCT02793544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337546|NCT00065455|Vitamin A|vitamin a|mesh-list
101593146|NCT02793544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101593147|NCT02793544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101593148|NCT02793544|Alkylating Agents|alkylating agents|mesh-ancestor
101593149|NCT02793544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593150|NCT02793544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101593151|NCT02793544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101593152|NCT02793544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101593153|NCT02793544|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101593154|NCT02793544|Antitubercular Agents|antitubercular agents|mesh-ancestor
101593155|NCT02793544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101593156|NCT02793544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101593157|NCT02793544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101593158|NCT02793544|Antifungal Agents|antifungal agents|mesh-ancestor
101593159|NCT02793544|Protective Agents|protective agents|mesh-ancestor
101593160|NCT02793388|Primaquine|primaquine|mesh-list
101593168|NCT02689882|Vitamin B Complex|vitamin b complex|mesh-ancestor
101593169|NCT02689882|Vitamins|vitamins|mesh-ancestor
101593170|NCT02689882|Micronutrients|micronutrients|mesh-ancestor
101593171|NCT02689882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593172|NCT02689882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101593173|NCT02689882|Antimetabolites|antimetabolites|mesh-ancestor
101593174|NCT02689882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618766|NCT00632268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618767|NCT00632268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101618768|NCT00632268|Immunologic Factors|immunologic factors|mesh-ancestor
101618769|NCT04145076|Citalopram|citalopram|mesh-list
101618770|NCT04145076|Tianeptine|tianeptine|mesh-list
101618771|NCT04145076|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101618772|NCT04145076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101618773|NCT04145076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101618774|NCT04145076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618775|NCT04145076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101417579|NCT00152295|Estrogens|estrogens|mesh-ancestor
101593175|NCT02689882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101593176|NCT02689882|Vasodilator Agents|vasodilator agents|mesh-ancestor
101593177|NCT02789644|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101593178|NCT02789644|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101593179|NCT02789644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101593180|NCT04234594|Panitumumab|panitumumab|mesh-list
101593181|NCT04234594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101593182|NCT04234594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101593183|NCT02789488|Fenugreek seed meal|fenugreek seed meal|mesh-list
101593184|NCT02789488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101593185|NCT02789488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593186|NCT04233346|Ponatinib|ponatinib|mesh-list
101593187|NCT04233346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101593188|NCT04233346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101593189|NCT04233346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101593190|NCT04233346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593191|NCT01148459|Vaccines|vaccines|mesh-list
101593192|NCT01148459|Immunologic Factors|immunologic factors|mesh-ancestor
101593193|NCT01148459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593194|NCT03913234|Trastuzumab|trastuzumab|mesh-list
101593195|NCT03913234|Letrozole|letrozole|mesh-list
101593196|NCT03913234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101593197|NCT03913234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101593198|NCT03913234|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101593199|NCT03913234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101593200|NCT03913234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101593201|NCT03913234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593202|NCT03913234|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101593203|NCT03913234|Hormone Antagonists|hormone antagonists|mesh-ancestor
101593204|NCT03913234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101593205|NCT03913234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593206|NCT03854500|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101593207|NCT03854500|Tenecteplase|tenecteplase|mesh-list
101593208|NCT03854500|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101593209|NCT03854500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101593210|NCT03854500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593211|NCT02789332|Paclitaxel|paclitaxel|mesh-list
101593212|NCT02789332|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101593213|NCT02789332|Cyclophosphamide|cyclophosphamide|mesh-list
101593214|NCT02789332|Carboplatin|carboplatin|mesh-list
101593215|NCT02789332|Epirubicin|epirubicin|mesh-list
101593216|NCT02789332|Olaparib|olaparib|mesh-list
101593217|NCT02789332|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101593218|NCT02789332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101593219|NCT02789332|Tubulin Modulators|tubulin modulators|mesh-ancestor
101593220|NCT02789332|Antimitotic Agents|antimitotic agents|mesh-ancestor
101593221|NCT02789332|Mitosis Modulators|mitosis modulators|mesh-ancestor
101593222|NCT02789332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593223|NCT02789332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101593224|NCT02789332|Immunologic Factors|immunologic factors|mesh-ancestor
101618776|NCT04145076|Serotonin Agents|serotonin agents|mesh-ancestor
101618777|NCT04145076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618778|NCT04145076|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101618779|NCT04145076|Antidepressive Agents|antidepressive agents|mesh-ancestor
101618780|NCT04145076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101417583|NCT00152373|Levetiracetam|levetiracetam|mesh-list
101593225|NCT02789332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593226|NCT02789332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101593227|NCT02789332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101593228|NCT02789332|Alkylating Agents|alkylating agents|mesh-ancestor
101593229|NCT02789332|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101593230|NCT02789332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101593238|NCT02792140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593239|NCT02792140|Sensory System Agents|sensory system agents|mesh-ancestor
101593240|NCT02792140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101593242|NCT02791594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101593243|NCT02791594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101593244|NCT02791594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101593245|NCT02791594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593246|NCT04234516|Morphine|morphine|mesh-list
101593247|NCT04234516|Buprenorphine|buprenorphine|mesh-list
101593248|NCT04234516|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101593249|NCT04234516|Naloxone|naloxone|mesh-list
101593250|NCT04234516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101593251|NCT04234516|Narcotics|narcotics|mesh-ancestor
101593252|NCT04234516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101593253|NCT04234516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593254|NCT04234516|Analgesics|analgesics|mesh-ancestor
101593255|NCT04234516|Sensory System Agents|sensory system agents|mesh-ancestor
101593256|NCT04234516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101593257|NCT04234516|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101593258|NCT02789566|Primaquine|primaquine|mesh-list
101593260|NCT02789566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101593261|NCT02789566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101593262|NCT02789566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101593263|NCT00697021|Aspirin|aspirin|mesh-list
101593264|NCT00697021|Clopidogrel|clopidogrel|mesh-list
101593265|NCT00697021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101593266|NCT00697021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101593267|NCT00697021|Analgesics|analgesics|mesh-ancestor
101593268|NCT00697021|Sensory System Agents|sensory system agents|mesh-ancestor
101593269|NCT00697021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101593270|NCT00697021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593271|NCT00697021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101593272|NCT00697021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101593273|NCT00697021|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101593274|NCT00697021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101593275|NCT00697021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593276|NCT00697021|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101593277|NCT00697021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101593278|NCT00697021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101593279|NCT00697021|Antipyretics|antipyretics|mesh-ancestor
101593280|NCT00697021|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101593281|NCT00697021|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101593282|NCT00697021|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101593283|NCT00697021|Purinergic Agents|purinergic agents|mesh-ancestor
101593284|NCT00697021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101593285|NCT02620345|Dydrogesterone|dydrogesterone|mesh-list
101593286|NCT02620345|Progestins|progestins|mesh-ancestor
101593287|NCT02620345|Hormones|hormones|mesh-ancestor
101593288|NCT02620345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101593289|NCT02620345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593290|NCT00696163|Insulin Aspart|insulin aspart|mesh-list
101593291|NCT00696163|Biphasic Insulins|biphasic insulins|mesh-list
101593292|NCT00696163|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101593293|NCT00696163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101593294|NCT00696163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593295|NCT02790580|Cyclophosphamide|cyclophosphamide|mesh-list
101618781|NCT04145076|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101618782|NCT00707902|Chlorhexidine|chlorhexidine|mesh-list
101618783|NCT00707902|Lidocaine|lidocaine|mesh-list
101618784|NCT00707902|Anesthetics, Local|anesthetics, local|mesh-ancestor
101618785|NCT00707902|Anesthetics|anesthetics|mesh-ancestor
101618786|NCT00707902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101618787|NCT00707902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618788|NCT00707902|Sensory System Agents|sensory system agents|mesh-ancestor
101618789|NCT00707902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101618790|NCT00707902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101618791|NCT00707902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101618792|NCT00707902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101618793|NCT00707902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101417591|NCT00141960|Famotidine|famotidine|mesh-list
101593296|NCT02790580|Doxorubicin|doxorubicin|mesh-list
101593297|NCT02790580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101593298|NCT02790580|Sunitinib|sunitinib|mesh-list
101593299|NCT02790580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101593303|NCT02790580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101593304|NCT02790580|Alkylating Agents|alkylating agents|mesh-ancestor
101593305|NCT02790580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593306|NCT02790580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101593307|NCT02790580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101593308|NCT02790580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101593309|NCT02790580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101593310|NCT02790580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101593311|NCT02790580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101593312|NCT02790580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101593313|NCT02790580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101593314|NCT02790580|Growth Substances|growth substances|mesh-ancestor
101593315|NCT02790580|Growth Inhibitors|growth inhibitors|mesh-ancestor
101593316|NCT02790580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101593317|NCT02788864|Piperaquine|piperaquine|mesh-list
101593318|NCT02788864|Antimalarials|antimalarials|mesh-ancestor
101593319|NCT02788864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101593320|NCT02788864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101593321|NCT02788864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101593322|NCT02788786|Chlorhexidine|chlorhexidine|mesh-list
101593323|NCT02788786|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101593324|NCT02788786|Cetylpyridinium|cetylpyridinium|mesh-list
101593325|NCT02788786|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101593326|NCT02788786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101593327|NCT02788786|Disinfectants|disinfectants|mesh-ancestor
101593329|NCT02623465|Insulin Lispro|insulin lispro|mesh-list
101593330|NCT02623465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101593331|NCT02623465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593333|NCT00693979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101593334|NCT00693979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101593336|NCT00693979|Antimitotic Agents|antimitotic agents|mesh-ancestor
101593337|NCT00693979|Mitosis Modulators|mitosis modulators|mesh-ancestor
101593338|NCT00693979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593339|NCT04232800|Riboflavin|riboflavin|mesh-list
101593340|NCT04232800|Vitamins|vitamins|mesh-ancestor
101593341|NCT04232800|Micronutrients|micronutrients|mesh-ancestor
101593342|NCT04232800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593343|NCT04232800|Vitamin B Complex|vitamin b complex|mesh-ancestor
101593344|NCT04232800|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101593345|NCT04232800|Dermatologic Agents|dermatologic agents|mesh-ancestor
101593346|NCT01148225|Adalimumab|adalimumab|mesh-list
101593347|NCT01148225|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101593348|NCT01148225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101593349|NCT01148225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101593350|NCT02788240|Meropenem|meropenem|mesh-list
101618794|NCT00707902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618795|NCT00707902|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101618796|NCT00707902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101618797|NCT00707902|Disinfectants|disinfectants|mesh-ancestor
101618798|NCT00704860|Antidepressive Agents|antidepressive agents|mesh-list
101618799|NCT00704860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101618800|NCT05511337|Citric Acid|citric acid|mesh-list
101618801|NCT05511337|Sodium Citrate|sodium citrate|mesh-list
101593351|NCT02788240|Terlipressin|terlipressin|mesh-list
101593352|NCT02788240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101593353|NCT02788240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101593354|NCT02788240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101593355|NCT02788240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101593356|NCT04134715|Contraceptive Agents|contraceptive agents|mesh-list
101593357|NCT04134715|Contraceptives, Oral|contraceptives, oral|mesh-list
101593358|NCT04134715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101593359|NCT04134715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593360|NCT04134715|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101593361|NCT02884115|Penicillins|penicillins|mesh-list
101593362|NCT02884115|Penicillin G Benzathine|penicillin g benzathine|mesh-list
101593363|NCT02884115|Penicillin G|penicillin g|mesh-list
101593364|NCT02884115|Penicillin G Procaine|penicillin g procaine|mesh-list
101593365|NCT02884115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101593366|NCT02884115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101593367|NCT01190813|Levodopa|levodopa|mesh-list
101593368|NCT01190813|Carbidopa|carbidopa|mesh-list
101593369|NCT01190813|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101593370|NCT01190813|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101593371|NCT01190813|Dopamine Agents|dopamine agents|mesh-ancestor
101593372|NCT01190813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101593373|NCT01190813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593374|NCT01190813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593380|NCT03641326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101593381|NCT03641326|Growth Substances|growth substances|mesh-ancestor
101593382|NCT03641326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593383|NCT03641326|Growth Inhibitors|growth inhibitors|mesh-ancestor
101593384|NCT03641326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101593385|NCT03641326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101593386|NCT03641326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593387|NCT00870727|Aripiprazole|aripiprazole|mesh-list
101593388|NCT00870727|Antidepressive Agents|antidepressive agents|mesh-ancestor
101593389|NCT00870727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101593390|NCT00870727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101593391|NCT00870727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101593392|NCT00870727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101593393|NCT00870727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593394|NCT00870727|Dopamine Agonists|dopamine agonists|mesh-ancestor
101593395|NCT00870727|Dopamine Agents|dopamine agents|mesh-ancestor
101593396|NCT00870727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101593397|NCT00870727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593398|NCT00870727|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101593399|NCT00870727|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101593400|NCT00870727|Serotonin Agents|serotonin agents|mesh-ancestor
101250317|NCT05238506|Lidocaine|lidocaine|mesh-list
101593401|NCT00870727|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101593402|NCT00870727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101593403|NCT00870727|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101593404|NCT00870727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101593406|NCT02787928|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101593407|NCT02787928|Narcotics|narcotics|mesh-ancestor
101593408|NCT02787928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101593409|NCT02787928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593410|NCT02787928|Analgesics|analgesics|mesh-ancestor
101593411|NCT02787928|Sensory System Agents|sensory system agents|mesh-ancestor
101593412|NCT02787928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101593413|NCT02617069|Botulinum Toxins|botulinum toxins|mesh-list
101618802|NCT05511337|Anticoagulants|anticoagulants|mesh-ancestor
101618803|NCT05511337|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101618804|NCT05511337|Chelating Agents|chelating agents|mesh-ancestor
101618805|NCT05511337|Sequestering Agents|sequestering agents|mesh-ancestor
101618806|NCT05511337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618808|NCT00833794|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101618809|NCT00833794|Narcotics|narcotics|mesh-ancestor
101618810|NCT00833794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101618811|NCT00833794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618812|NCT00833794|Analgesics|analgesics|mesh-ancestor
101618813|NCT00833794|Sensory System Agents|sensory system agents|mesh-ancestor
101618814|NCT00833794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101618815|NCT00778375|Cytarabine|cytarabine|mesh-list
101618816|NCT00778375|Decitabine|decitabine|mesh-list
101593414|NCT02617069|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101593415|NCT02617069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101593416|NCT02617069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593417|NCT02617069|Cholinergic Agents|cholinergic agents|mesh-ancestor
101593418|NCT02617069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101593419|NCT02617069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593420|NCT02788552|Vitamins|vitamins|mesh-list
101593421|NCT02788552|Thiamine|thiamine|mesh-list
101593422|NCT02788552|Micronutrients|micronutrients|mesh-ancestor
101593423|NCT02788552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593424|NCT02788552|Vitamin B Complex|vitamin b complex|mesh-ancestor
101593425|NCT01147055|Rifampin|rifampin|mesh-list
101593426|NCT01147055|Crizotinib|crizotinib|mesh-list
101593427|NCT01147055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101593428|NCT01147055|Antitubercular Agents|antitubercular agents|mesh-ancestor
101593429|NCT01147055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101593430|NCT01147055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101593431|NCT01147055|Leprostatic Agents|leprostatic agents|mesh-ancestor
101593432|NCT01147055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101593433|NCT01147055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101593434|NCT01147055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593435|NCT01147055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101593436|NCT01147055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101593437|NCT01147055|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101593438|NCT01147055|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101593439|NCT01147055|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101593440|NCT01147055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101593441|NCT01147055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101593442|NCT01147055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101593462|NCT02616913|Moxifloxacin|moxifloxacin|mesh-list
101593463|NCT02616913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101593464|NCT02616913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101593465|NCT02616913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101593466|NCT02616913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101593467|NCT02616913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101593468|NCT02616913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593469|NCT02616913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101593470|NCT02884037|Rifaximin|rifaximin|mesh-list
101593471|NCT02884037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101593472|NCT02884037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101593473|NCT02884037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101593474|NCT04233502|Melatonin|melatonin|mesh-list
101593475|NCT04233502|Antioxidants|antioxidants|mesh-ancestor
101593476|NCT04233502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593477|NCT04233502|Protective Agents|protective agents|mesh-ancestor
101593478|NCT04233502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618817|NCT00778375|Clofarabine|clofarabine|mesh-list
101618818|NCT00778375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101618819|NCT00778375|Antimetabolites|antimetabolites|mesh-ancestor
101618820|NCT00778375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618821|NCT00778375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101618822|NCT00778375|Antiviral Agents|antiviral agents|mesh-ancestor
101618823|NCT00778375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101618824|NCT00778375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101618825|NCT00778375|Immunologic Factors|immunologic factors|mesh-ancestor
101618826|NCT00778375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593479|NCT04233502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101593480|NCT00696475|Diazoxide|diazoxide|mesh-list
101593481|NCT00696475|Choline|choline|mesh-list
101593482|NCT00696475|Lipotropic Agents|lipotropic agents|mesh-ancestor
101593483|NCT00696475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101593484|NCT00696475|Antimetabolites|antimetabolites|mesh-ancestor
101593485|NCT00696475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593486|NCT00696475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101593487|NCT00696475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101593488|NCT00696475|Nootropic Agents|nootropic agents|mesh-ancestor
101593489|NCT00696475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101593490|NCT00696475|Vasodilator Agents|vasodilator agents|mesh-ancestor
101593491|NCT03628066|Letrozole|letrozole|mesh-list
101593492|NCT03628066|Palbociclib|palbociclib|mesh-list
101593493|NCT03628066|Goserelin|goserelin|mesh-list
101593494|NCT03628066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101593495|NCT03628066|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101593496|NCT03628066|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101593497|NCT03628066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101593498|NCT03628066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593504|NCT03628066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101593505|NCT00625079|Sildenafil Citrate|sildenafil citrate|mesh-list
101593506|NCT00625079|Vasodilator Agents|vasodilator agents|mesh-ancestor
101593507|NCT00625079|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101593508|NCT00625079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101593509|NCT00625079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101593510|NCT00625079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593511|NCT00625079|Urological Agents|urological agents|mesh-ancestor
101593512|NCT02786992|Misoprostol|misoprostol|mesh-list
101593513|NCT02786992|Oxytocin|oxytocin|mesh-list
101593514|NCT02786992|Carbetocin|carbetocin|mesh-list
101593515|NCT02786992|Oxytocics|oxytocics|mesh-ancestor
101593516|NCT02786992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101593517|NCT02786992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593518|NCT02786992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101593519|NCT02786992|Abortifacient Agents|abortifacient agents|mesh-ancestor
101593520|NCT02786992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101593521|NCT02786992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101593522|NCT04232644|Amphetamine|amphetamine|mesh-list
101593523|NCT04232644|Dextroamphetamine|dextroamphetamine|mesh-list
101593524|NCT04232644|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101593525|NCT04232644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593526|NCT04232644|Sympathomimetics|sympathomimetics|mesh-ancestor
101593527|NCT04232644|Autonomic Agents|autonomic agents|mesh-ancestor
101593528|NCT04232644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101593529|NCT04232644|Dopamine Agents|dopamine agents|mesh-ancestor
101593530|NCT04232644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101593531|NCT04232644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593532|NCT04232644|Adrenergic Agents|adrenergic agents|mesh-ancestor
101593533|NCT04232644|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101593534|NCT04232644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101593535|NCT04232644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101593536|NCT04232644|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101593537|NCT03557788|Rifaximin|rifaximin|mesh-list
101593538|NCT03557788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101618828|NCT04102267|Epinephrine|epinephrine|mesh-list
101618829|NCT04102267|Bupivacaine|bupivacaine|mesh-list
101618830|NCT04102267|Anesthetics, Local|anesthetics, local|mesh-ancestor
101618831|NCT04102267|Anesthetics|anesthetics|mesh-ancestor
101618832|NCT04102267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101618833|NCT04102267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593539|NCT03557788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101593540|NCT03557788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101593541|NCT04133155|Paclitaxel|paclitaxel|mesh-list
101593542|NCT04133155|Gemcitabine|gemcitabine|mesh-list
101593543|NCT04133155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101593544|NCT04133155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101593545|NCT04133155|Tubulin Modulators|tubulin modulators|mesh-ancestor
101593546|NCT04133155|Antimitotic Agents|antimitotic agents|mesh-ancestor
101593547|NCT04133155|Mitosis Modulators|mitosis modulators|mesh-ancestor
101593548|NCT04133155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593549|NCT04133155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101593550|NCT04133155|Antimetabolites|antimetabolites|mesh-ancestor
101593551|NCT01190267|Asenapine|asenapine|mesh-list
101593552|NCT01190267|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101593553|NCT01190267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101593554|NCT01190267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101593555|NCT01190267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593556|NCT01190267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101593557|NCT00869089|Apremilast|apremilast|mesh-list
101593558|NCT00869089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101593559|NCT00869089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101593560|NCT00869089|Analgesics|analgesics|mesh-ancestor
101593561|NCT00869089|Sensory System Agents|sensory system agents|mesh-ancestor
101593562|NCT00869089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101593563|NCT00869089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593564|NCT00869089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101593565|NCT00869089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101593566|NCT00869089|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101593567|NCT00869089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101593573|NCT02616367|Anesthetics|anesthetics|mesh-ancestor
101593574|NCT02616367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101593575|NCT02616367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593576|NCT02616367|Sensory System Agents|sensory system agents|mesh-ancestor
101593577|NCT02616367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101593578|NCT04200040|Dacarbazine|dacarbazine|mesh-list
101593579|NCT04200040|Molgramostim|molgramostim|mesh-list
101593580|NCT04200040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101593581|NCT04200040|Alkylating Agents|alkylating agents|mesh-ancestor
101593582|NCT04200040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593583|NCT04200040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101593584|NCT04232722|Sorafenib|sorafenib|mesh-list
101593585|NCT04232722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101593586|NCT04232722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101593587|NCT04232722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101593588|NCT04232722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593589|NCT02622685|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101593590|NCT02622685|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101593591|NCT02622685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101593592|NCT02622607|Zoledronic Acid|zoledronic acid|mesh-list
101593593|NCT02622607|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101593594|NCT02622607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593595|NCT02787226|Bupivacaine|bupivacaine|mesh-list
101593596|NCT02787226|Anesthetics, Local|anesthetics, local|mesh-ancestor
101593597|NCT02787226|Anesthetics|anesthetics|mesh-ancestor
101593598|NCT02787226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101593599|NCT02787226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593600|NCT02787226|Sensory System Agents|sensory system agents|mesh-ancestor
101593601|NCT02787226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101593602|NCT00697567|Vaccines|vaccines|mesh-list
101593603|NCT00697567|Immunologic Factors|immunologic factors|mesh-ancestor
101593604|NCT00697567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593605|NCT02616289|Emollients|emollients|mesh-list
101618835|NCT04102267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101618836|NCT04102267|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101618837|NCT04102267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101618838|NCT04102267|Adrenergic Agents|adrenergic agents|mesh-ancestor
101618839|NCT04102267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101618840|NCT04102267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618841|NCT04102267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101618842|NCT04102267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101618843|NCT04102267|Autonomic Agents|autonomic agents|mesh-ancestor
101618844|NCT04102267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101618845|NCT04102267|Respiratory System Agents|respiratory system agents|mesh-ancestor
101618846|NCT04102267|Mydriatics|mydriatics|mesh-ancestor
101618847|NCT04102267|Sympathomimetics|sympathomimetics|mesh-ancestor
101618848|NCT04102267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101618849|NCT00777829|Zolpidem|zolpidem|mesh-list
101618850|NCT00777829|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101618851|NCT00777829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101618852|NCT00777829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101618853|NCT00777829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618854|NCT00777829|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101618855|NCT00777829|GABA Agonists|gaba agonists|mesh-ancestor
101618856|NCT00777829|GABA Agents|gaba agents|mesh-ancestor
101618857|NCT00777829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101417639|NCT00134810|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101593606|NCT02616289|Dermatologic Agents|dermatologic agents|mesh-ancestor
101593607|NCT03421756|Sirolimus|sirolimus|mesh-list
101593608|NCT03421756|Alemtuzumab|alemtuzumab|mesh-list
101593609|NCT03421756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101593610|NCT03421756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101593611|NCT03421756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101593612|NCT03421756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101593613|NCT03421756|Antifungal Agents|antifungal agents|mesh-ancestor
101593614|NCT03421756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101593615|NCT03421756|Immunologic Factors|immunologic factors|mesh-ancestor
101593616|NCT03421756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593617|NCT03421756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101593618|NCT00870103|Moxifloxacin|moxifloxacin|mesh-list
101593620|NCT00870103|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101593621|NCT00870103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101593622|NCT00870103|Antiemetics|antiemetics|mesh-ancestor
101593623|NCT00870103|Autonomic Agents|autonomic agents|mesh-ancestor
101593624|NCT00870103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101593625|NCT00870103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593626|NCT00870103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101593627|NCT00870103|Glucocorticoids|glucocorticoids|mesh-ancestor
101593629|NCT00870103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101593630|NCT00870103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101593631|NCT00870103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101618858|NCT00777829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618859|NCT00916045|Vidarabine|vidarabine|mesh-list
101618860|NCT00916045|Cyclosporine|cyclosporine|mesh-list
101618861|NCT00916045|Mycophenolic Acid|mycophenolic acid|mesh-list
101618862|NCT00916045|Cyclophosphamide|cyclophosphamide|mesh-list
101618863|NCT00916045|Melphalan|melphalan|mesh-list
101618864|NCT00916045|Busulfan|busulfan|mesh-list
101593632|NCT00870103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101593633|NCT00870103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101593634|NCT00870103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101593635|NCT00870103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101593636|NCT00870103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101593637|NCT00870103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593638|NCT00870103|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101593642|NCT03365752|Anesthetics, General|anesthetics, general|mesh-list
101593643|NCT03365752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101593644|NCT03365752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593645|NCT03365752|Anesthetics, Local|anesthetics, local|mesh-ancestor
101593646|NCT03365752|Sensory System Agents|sensory system agents|mesh-ancestor
101593647|NCT03365752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101593649|NCT02785666|Grazoprevir|grazoprevir|mesh-list
101593650|NCT02785666|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
101593651|NCT02785666|Antimetabolites|antimetabolites|mesh-ancestor
101593652|NCT02785666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593653|NCT02785666|Antiviral Agents|antiviral agents|mesh-ancestor
101593654|NCT02785666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101593655|NCT01145417|Pregabalin|pregabalin|mesh-list
101593656|NCT01145417|Analgesics|analgesics|mesh-ancestor
101593657|NCT01145417|Sensory System Agents|sensory system agents|mesh-ancestor
101593658|NCT01145417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101593659|NCT01145417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593660|NCT01145417|Anticonvulsants|anticonvulsants|mesh-ancestor
101593661|NCT01145417|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101593662|NCT01145417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101593663|NCT01145417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593664|NCT01145417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101593665|NCT01145417|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101593666|NCT01145417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101593667|NCT01145417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101593668|NCT01145417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101593669|NCT04232332|Mitogens|mitogens|mesh-list
101593670|NCT04232332|Mitosis Modulators|mitosis modulators|mesh-ancestor
101593671|NCT04232332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593672|NCT02785276|Ropivacaine|ropivacaine|mesh-list
101593673|NCT02785276|Anesthetics, Local|anesthetics, local|mesh-ancestor
101593674|NCT02785276|Anesthetics|anesthetics|mesh-ancestor
101593675|NCT02785276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101593676|NCT02785276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593677|NCT02785276|Sensory System Agents|sensory system agents|mesh-ancestor
101593678|NCT02785276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101593679|NCT04316039|Temozolomide|temozolomide|mesh-list
101593680|NCT04316039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101593681|NCT04316039|Alkylating Agents|alkylating agents|mesh-ancestor
101593682|NCT04316039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593683|NCT04316039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101593684|NCT00696631|Dronedarone|dronedarone|mesh-list
101593685|NCT00696631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101593686|NCT02615977|Ethanol|ethanol|mesh-list
101593687|NCT02615977|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101593688|NCT02615977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101337658|NCT00066157|Contraceptive Agents|contraceptive agents|mesh-ancestor
101593689|NCT02615977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101593690|NCT02615977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593691|NCT01189487|Ampicillin|ampicillin|mesh-list
101593692|NCT01189487|Sulbactam|sulbactam|mesh-list
101593693|NCT01189487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101593694|NCT01189487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101593695|NCT01189487|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101593696|NCT01189487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101618866|NCT00916045|Fludarabine|fludarabine|mesh-list
101618867|NCT00916045|Fludarabine phosphate|fludarabine phosphate|mesh-list
101618868|NCT00916045|Cyclosporins|cyclosporins|mesh-list
101618869|NCT00916045|Thymoglobulin|thymoglobulin|mesh-list
101618870|NCT00916045|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101618871|NCT00916045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101618872|NCT00916045|Immunologic Factors|immunologic factors|mesh-ancestor
101618873|NCT00916045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618874|NCT00916045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101618875|NCT00916045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101618876|NCT00916045|Alkylating Agents|alkylating agents|mesh-ancestor
101618877|NCT00916045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618878|NCT00916045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101618879|NCT00916045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101618880|NCT00916045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101618881|NCT00916045|Antimetabolites|antimetabolites|mesh-ancestor
101618882|NCT00916045|Antiviral Agents|antiviral agents|mesh-ancestor
101618883|NCT00916045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101618884|NCT00916045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101618885|NCT00916045|Antifungal Agents|antifungal agents|mesh-ancestor
101618886|NCT00916045|Dermatologic Agents|dermatologic agents|mesh-ancestor
101417672|NCT00134888|Naloxone|naloxone|mesh-list
101593697|NCT01189487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593698|NCT02621905|Itraconazole|itraconazole|mesh-list
101593699|NCT02621905|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
101593700|NCT02621905|Antifungal Agents|antifungal agents|mesh-ancestor
101593701|NCT02621905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101593702|NCT02621905|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101593703|NCT02621905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101593704|NCT02621905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101593705|NCT02621905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593706|NCT02621905|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101593707|NCT02621905|Hormone Antagonists|hormone antagonists|mesh-ancestor
101593708|NCT02621905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101593709|NCT02621905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593713|NCT01106352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101593714|NCT01106352|Tubulin Modulators|tubulin modulators|mesh-ancestor
101593715|NCT01106352|Antimitotic Agents|antimitotic agents|mesh-ancestor
101593716|NCT01106352|Mitosis Modulators|mitosis modulators|mesh-ancestor
101593717|NCT01106352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593718|NCT01144403|Cyclophosphamide|cyclophosphamide|mesh-list
101593719|NCT01144403|Rituximab|rituximab|mesh-list
101593720|NCT01144403|Fludarabine|fludarabine|mesh-list
101593721|NCT01144403|Mitoxantrone|mitoxantrone|mesh-list
101593722|NCT01144403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101593723|NCT01144403|Immunologic Factors|immunologic factors|mesh-ancestor
101593724|NCT01144403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593725|NCT01144403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101593726|NCT01144403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101593727|NCT01144403|Alkylating Agents|alkylating agents|mesh-ancestor
101593728|NCT01144403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618887|NCT00916045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101618888|NCT00916045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101618889|NCT00916045|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101618890|NCT00916045|Antitubercular Agents|antitubercular agents|mesh-ancestor
101593729|NCT01144403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101593730|NCT01144403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101593731|NCT01144403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101593732|NCT01144403|Analgesics|analgesics|mesh-ancestor
101593733|NCT01144403|Sensory System Agents|sensory system agents|mesh-ancestor
101593734|NCT01144403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101593735|NCT01144403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101593736|NCT01144403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101593737|NCT01144403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101593738|NCT03071926|Doxorubicin|doxorubicin|mesh-list
101593739|NCT03071926|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101593740|NCT03071926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101593741|NCT03071926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101593742|NCT03071926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101593743|NCT03071926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101593744|NCT03071926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101593745|NCT03071926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593746|NCT02883647|Tenofovir|tenofovir|mesh-list
101593747|NCT02883647|Entecavir|entecavir|mesh-list
101593748|NCT02883647|Antiviral Agents|antiviral agents|mesh-ancestor
101593749|NCT02883647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101593750|NCT02883647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101593751|NCT02883647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101593752|NCT02883647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101593753|NCT02883647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593754|NCT02883647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101593755|NCT02883647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101593756|NCT02621827|Calcifediol|calcifediol|mesh-list
101593757|NCT02621827|Vitamins|vitamins|mesh-ancestor
101593758|NCT02621827|Micronutrients|micronutrients|mesh-ancestor
101593759|NCT02621827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593760|NCT02621827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101593761|NCT01143389|Riboflavin|riboflavin|mesh-list
101593762|NCT01143389|Vitamin B Complex|vitamin b complex|mesh-ancestor
101593763|NCT01143389|Vitamins|vitamins|mesh-ancestor
101593764|NCT01143389|Micronutrients|micronutrients|mesh-ancestor
101593765|NCT01143389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593766|NCT01143389|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101593767|NCT01143389|Dermatologic Agents|dermatologic agents|mesh-ancestor
101593768|NCT00868231|Bromides|bromides|mesh-list
101593769|NCT00868231|Tiotropium Bromide|tiotropium bromide|mesh-list
101593770|NCT00868231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101593771|NCT00868231|Autonomic Agents|autonomic agents|mesh-ancestor
101593772|NCT00868231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101593773|NCT00868231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593774|NCT00868231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101593775|NCT00868231|Respiratory System Agents|respiratory system agents|mesh-ancestor
101593776|NCT00868231|Parasympatholytics|parasympatholytics|mesh-ancestor
101593778|NCT00868231|Cholinergic Agents|cholinergic agents|mesh-ancestor
101593779|NCT00868231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101593780|NCT00868231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593781|NCT00868231|Anticonvulsants|anticonvulsants|mesh-ancestor
101593782|NCT04231864|Durvalumab|durvalumab|mesh-list
101593783|NCT04231864|Immunoglobulins|immunoglobulins|mesh-list
101593784|NCT04231864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101593791|NCT01143077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101593792|NCT01143077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101593793|NCT01143077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101593794|NCT01143077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593795|NCT01143077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101593796|NCT01143077|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101593797|NCT01143077|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101593798|NCT01143077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101593799|NCT01143077|Adrenergic Agents|adrenergic agents|mesh-ancestor
101593800|NCT01143077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101593801|NCT01143077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593802|NCT01143077|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101618891|NCT00916045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101618892|NCT00916123|Prednisone|prednisone|mesh-list
101618893|NCT00916123|Docetaxel|docetaxel|mesh-list
101618894|NCT00916123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101618895|NCT00916123|Tubulin Modulators|tubulin modulators|mesh-ancestor
101618896|NCT00916123|Antimitotic Agents|antimitotic agents|mesh-ancestor
101618897|NCT00916123|Mitosis Modulators|mitosis modulators|mesh-ancestor
101417696|NCT00135005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101593803|NCT01143077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101593804|NCT01143077|Serotonin Agents|serotonin agents|mesh-ancestor
101593805|NCT01143077|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101593806|NCT01143077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101593807|NCT01143077|Dopamine Agents|dopamine agents|mesh-ancestor
101593808|NCT02786446|Naproxen|naproxen|mesh-list
101593809|NCT02786446|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101593810|NCT02786446|Lidocaine|lidocaine|mesh-list
101593811|NCT02786446|Anesthetics, Local|anesthetics, local|mesh-ancestor
101593812|NCT02786446|Anesthetics|anesthetics|mesh-ancestor
101593813|NCT02786446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101593814|NCT02786446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593815|NCT02786446|Sensory System Agents|sensory system agents|mesh-ancestor
101593816|NCT02786446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101593817|NCT02786446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101593818|NCT02786446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101593819|NCT02786446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101593820|NCT02786446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101593821|NCT02786446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593822|NCT02786446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101593823|NCT02786446|Analgesics|analgesics|mesh-ancestor
101593824|NCT02786446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101593825|NCT02786446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101593826|NCT02786446|Gout Suppressants|gout suppressants|mesh-ancestor
101593827|NCT02786446|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101593828|NCT02786446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101593829|NCT02619019|Dexamethasone|dexamethasone|mesh-list
101593830|NCT02619019|Meperidine|meperidine|mesh-list
101593831|NCT02619019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101593832|NCT02619019|Antiemetics|antiemetics|mesh-ancestor
101593833|NCT02619019|Autonomic Agents|autonomic agents|mesh-ancestor
101593834|NCT02619019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101593835|NCT02619019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593836|NCT02619019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101593837|NCT02619019|Glucocorticoids|glucocorticoids|mesh-ancestor
101593838|NCT02619019|Hormones|hormones|mesh-ancestor
101593839|NCT02619019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101593840|NCT02619019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101593841|NCT02619019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101593842|NCT02619019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101593843|NCT02619019|Narcotics|narcotics|mesh-ancestor
101337687|NCT00066274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101593844|NCT02619019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101593845|NCT02619019|Analgesics|analgesics|mesh-ancestor
101593846|NCT02619019|Sensory System Agents|sensory system agents|mesh-ancestor
101593847|NCT02619019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101593848|NCT02957032|Cytarabine|cytarabine|mesh-list
101593849|NCT02957032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101593850|NCT02957032|Antimetabolites|antimetabolites|mesh-ancestor
101593851|NCT02957032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593857|NCT02957032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593858|NCT02947516|Liver Extracts|liver extracts|mesh-list
101593859|NCT02947516|Hematinics|hematinics|mesh-ancestor
101593860|NCT01096446|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101593861|NCT01096446|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
101593862|NCT01096446|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101593863|NCT01096446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101593864|NCT00864721|Sunitinib|sunitinib|mesh-list
101593865|NCT00864721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101593866|NCT00864721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101593867|NCT00864721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101618898|NCT00916123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618899|NCT00916123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101618900|NCT00916123|Glucocorticoids|glucocorticoids|mesh-ancestor
101618901|NCT00916123|Hormones|hormones|mesh-ancestor
101618902|NCT00916123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101618903|NCT00916123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618904|NCT00916123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101618905|NCT00916201|Cannabidiol|cannabidiol|mesh-list
101417707|NCT04725357|Meloxicam|meloxicam|mesh-list
101593868|NCT00864721|Growth Substances|growth substances|mesh-ancestor
101593869|NCT00864721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593870|NCT00864721|Growth Inhibitors|growth inhibitors|mesh-ancestor
101593871|NCT00864721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101593872|NCT00864721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101593873|NCT00864721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593874|NCT05308420|Morphine|morphine|mesh-list
101593875|NCT05308420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101593876|NCT05308420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593877|NCT05308420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101593878|NCT05308420|Narcotics|narcotics|mesh-ancestor
101593879|NCT05308420|Analgesics|analgesics|mesh-ancestor
101593880|NCT05308420|Sensory System Agents|sensory system agents|mesh-ancestor
101593881|NCT05308420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101593882|NCT02897050|Cyclophosphamide|cyclophosphamide|mesh-list
101593883|NCT02897050|Docetaxel|docetaxel|mesh-list
101593884|NCT02897050|Fluorouracil|fluorouracil|mesh-list
101593885|NCT02897050|Capecitabine|capecitabine|mesh-list
101593886|NCT02897050|Epirubicin|epirubicin|mesh-list
101593887|NCT02897050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101593888|NCT02897050|Immunologic Factors|immunologic factors|mesh-ancestor
101593889|NCT02897050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593890|NCT02897050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101593891|NCT02897050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101593892|NCT02897050|Alkylating Agents|alkylating agents|mesh-ancestor
101593893|NCT02897050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593894|NCT02897050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101593895|NCT02897050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101593896|NCT02897050|Tubulin Modulators|tubulin modulators|mesh-ancestor
101593897|NCT02897050|Antimitotic Agents|antimitotic agents|mesh-ancestor
101593898|NCT02897050|Mitosis Modulators|mitosis modulators|mesh-ancestor
101593899|NCT02897050|Antimetabolites|antimetabolites|mesh-ancestor
101593900|NCT02897050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101593901|NCT02897050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101593902|NCT02897050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101593903|NCT02897050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101593904|NCT02897050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101593905|NCT01095666|Metformin|metformin|mesh-list
101593906|NCT01095666|Pioglitazone|pioglitazone|mesh-list
101593907|NCT01095666|Dapagliflozin|dapagliflozin|mesh-list
101593908|NCT01095666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101593909|NCT01095666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593910|NCT01095666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101593911|NCT01095666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593912|NCT01100658|Methylphenidate|methylphenidate|mesh-list
101593913|NCT01100658|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101593914|NCT01100658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593915|NCT01100658|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101593916|NCT01100658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101593917|NCT01100658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101593918|NCT01100658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593919|NCT01100658|Dopamine Agents|dopamine agents|mesh-ancestor
101593920|NCT01100658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101593921|NCT05276908|Bupivacaine|bupivacaine|mesh-list
101593922|NCT05276908|Anesthetics|anesthetics|mesh-list
101593951|NCT05273710|Vitamin B Complex|vitamin b complex|mesh-ancestor
101618906|NCT00916201|Anticonvulsants|anticonvulsants|mesh-ancestor
101618907|NCT00833638|Tadalafil|tadalafil|mesh-list
101618908|NCT00833638|Vasodilator Agents|vasodilator agents|mesh-ancestor
101618909|NCT00833638|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101618910|NCT00833638|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101618911|NCT00833638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101618912|NCT00833638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618913|NCT00833638|Urological Agents|urological agents|mesh-ancestor
101618914|NCT01041404|Fluorouracil|fluorouracil|mesh-list
101618915|NCT01041404|Capecitabine|capecitabine|mesh-list
101618916|NCT01041404|Trastuzumab|trastuzumab|mesh-list
101618917|NCT01041404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101618918|NCT01041404|Antimetabolites|antimetabolites|mesh-ancestor
101593952|NCT05273710|Vitamins|vitamins|mesh-ancestor
101593953|NCT05273710|Micronutrients|micronutrients|mesh-ancestor
101593954|NCT05273710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593955|NCT02784808|Antirheumatic Agents|antirheumatic agents|mesh-list
101593956|NCT02784652|Zoledronic Acid|zoledronic acid|mesh-list
101593957|NCT02784652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101593958|NCT02784652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593959|NCT01100502|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101593960|NCT01100502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101593961|NCT01100502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101593962|NCT01100502|Immunotoxins|immunotoxins|mesh-ancestor
101593963|NCT01100502|Immunoconjugates|immunoconjugates|mesh-ancestor
101593964|NCT01100502|Immunologic Factors|immunologic factors|mesh-ancestor
101593965|NCT01100502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593966|NCT02784340|Dexamethasone|dexamethasone|mesh-list
101593967|NCT02784340|Dexamethasone acetate|dexamethasone acetate|mesh-list
101593968|NCT02784340|Bupivacaine|bupivacaine|mesh-list
101593974|NCT02784340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101593975|NCT02784340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593976|NCT02784340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101593978|NCT02784340|Hormones|hormones|mesh-ancestor
101593979|NCT02784340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101593980|NCT02784340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101593981|NCT02784340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101593982|NCT02784340|Protease Inhibitors|protease inhibitors|mesh-ancestor
101593983|NCT02784340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101593984|NCT02784340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593985|NCT02784340|Anesthetics, Local|anesthetics, local|mesh-ancestor
101593986|NCT02784340|Anesthetics|anesthetics|mesh-ancestor
101593987|NCT02784340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101593988|NCT02784340|Sensory System Agents|sensory system agents|mesh-ancestor
101593989|NCT02878512|Anesthetics|anesthetics|mesh-list
101337726|NCT00066508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101593990|NCT02878512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101593991|NCT02878512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593992|NCT01094886|Rivaroxaban|rivaroxaban|mesh-list
101593993|NCT01094886|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101593994|NCT01094886|Antithrombins|antithrombins|mesh-ancestor
101593995|NCT01094886|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101593996|NCT01094886|Protease Inhibitors|protease inhibitors|mesh-ancestor
101593997|NCT01094886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101593998|NCT01094886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593999|NCT01094886|Anticoagulants|anticoagulants|mesh-ancestor
101594000|NCT01094808|Pregabalin|pregabalin|mesh-list
101250922|NCT04169438|Petrolatum|petrolatum|mesh-list
101594002|NCT01094808|Sensory System Agents|sensory system agents|mesh-ancestor
101594003|NCT01094808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101594004|NCT01094808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594005|NCT01094808|Anticonvulsants|anticonvulsants|mesh-ancestor
101594006|NCT01094808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101594007|NCT01094808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101618919|NCT01041404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618920|NCT01041404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101618921|NCT01041404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101618922|NCT01041404|Immunologic Factors|immunologic factors|mesh-ancestor
101618923|NCT01041404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618924|NCT01041404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101594008|NCT01094808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594009|NCT01094808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101594010|NCT01094808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101594011|NCT01094808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101594012|NCT01094808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101594013|NCT01094808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101594014|NCT00864253|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101594016|NCT00864253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101594017|NCT00864253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101594018|NCT00864253|Alkylating Agents|alkylating agents|mesh-ancestor
101594019|NCT00864253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594020|NCT02782312|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101594021|NCT02782312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101594022|NCT02782312|Autonomic Agents|autonomic agents|mesh-ancestor
101594023|NCT02782312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101594024|NCT02782312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594025|NCT02782312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101594026|NCT02782312|Respiratory System Agents|respiratory system agents|mesh-ancestor
101594027|NCT02782312|Glucocorticoids|glucocorticoids|mesh-ancestor
101594028|NCT02782312|Hormones|hormones|mesh-ancestor
101594029|NCT02782312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101594030|NCT02782312|Sympathomimetics|sympathomimetics|mesh-ancestor
101594031|NCT04229758|Anticoagulants|anticoagulants|mesh-list
101594032|NCT00698425|Citric Acid|citric acid|mesh-list
101594033|NCT00698425|Sodium Citrate|sodium citrate|mesh-list
101594034|NCT00698425|Anticoagulants|anticoagulants|mesh-ancestor
101594035|NCT00698425|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101594036|NCT00698425|Chelating Agents|chelating agents|mesh-ancestor
101594037|NCT00698425|Sequestering Agents|sequestering agents|mesh-ancestor
101594048|NCT05342272|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101594049|NCT04230460|Ethanol|ethanol|mesh-list
101594050|NCT04230460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101594051|NCT04230460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101594052|NCT04230460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101594053|NCT04230460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594054|NCT02783638|Pregabalin|pregabalin|mesh-list
101594055|NCT02783638|Analgesics|analgesics|mesh-ancestor
101594056|NCT02783638|Sensory System Agents|sensory system agents|mesh-ancestor
101594057|NCT02783638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101594058|NCT02783638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594059|NCT02783638|Anticonvulsants|anticonvulsants|mesh-ancestor
101594060|NCT02783638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101594061|NCT02783638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101594062|NCT02783638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594063|NCT02783638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101594064|NCT02783638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101594065|NCT02783638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101594066|NCT02783638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101594067|NCT02783638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101594068|NCT04230070|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101594069|NCT04230070|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101594070|NCT04230070|Levonorgestrel|levonorgestrel|mesh-list
101594071|NCT04230070|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101594072|NCT04230070|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
101594073|NCT04230070|Estradiol|estradiol|mesh-list
101250991|NCT04096066|Lenalidomide|lenalidomide|mesh-list
101594075|NCT04230070|Estrogens|estrogens|mesh-ancestor
101594076|NCT04230070|Hormones|hormones|mesh-ancestor
101618925|NCT00777049|Panobinostat|panobinostat|mesh-list
101618926|NCT00777049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101618927|NCT00777049|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101618928|NCT00777049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101618929|NCT00777049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594077|NCT04230070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101594078|NCT04230070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594079|NCT04230070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101594080|NCT04230070|Contraceptive Agents|contraceptive agents|mesh-ancestor
101594081|NCT04230070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101594082|NCT04230070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101594083|NCT04230070|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101594084|NCT04230070|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101594085|NCT04230070|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101594086|NCT04230070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101594087|NCT02782078|Clindamycin|clindamycin|mesh-list
101594088|NCT02782078|Clindamycin palmitate|clindamycin palmitate|mesh-list
101594089|NCT02782078|Clindamycin phosphate|clindamycin phosphate|mesh-list
101594090|NCT02782078|Rifampin|rifampin|mesh-list
101594091|NCT02782078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101594092|NCT02782078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101594093|NCT02782078|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101594094|NCT02782078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594095|NCT02782078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594096|NCT02782078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101594097|NCT02782078|Antitubercular Agents|antitubercular agents|mesh-ancestor
101594098|NCT02782078|Leprostatic Agents|leprostatic agents|mesh-ancestor
101594099|NCT02782078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101594100|NCT02782078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101594101|NCT02782078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101594109|NCT01293682|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101594110|NCT01293682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101594111|NCT01293682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594112|NCT01293682|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101594114|NCT01293682|Micronutrients|micronutrients|mesh-ancestor
101594115|NCT01293682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101594116|NCT00864097|Diclofenac|diclofenac|mesh-list
101594117|NCT00864097|Tanezumab|tanezumab|mesh-list
101594118|NCT00864097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101594119|NCT00864097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101594120|NCT00864097|Analgesics|analgesics|mesh-ancestor
101594121|NCT00864097|Sensory System Agents|sensory system agents|mesh-ancestor
101594122|NCT00864097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101594123|NCT00864097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594124|NCT00864097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101594125|NCT00864097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101594126|NCT00864097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101594127|NCT00864097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594128|NCT00864097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594130|NCT02782624|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101594131|NCT02782624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594132|NCT02782624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101594133|NCT02782624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594134|NCT02781766|Thrombin|thrombin|mesh-list
101594135|NCT02781766|Hemostatics|hemostatics|mesh-ancestor
101594136|NCT02781766|Coagulants|coagulants|mesh-ancestor
101594137|NCT00887536|Cyclophosphamide|cyclophosphamide|mesh-list
101594138|NCT00887536|Bevacizumab|bevacizumab|mesh-list
101594139|NCT00887536|Docetaxel|docetaxel|mesh-list
101594140|NCT00887536|Doxorubicin|doxorubicin|mesh-list
101594141|NCT00887536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101594142|NCT00887536|Immunologic Factors|immunologic factors|mesh-ancestor
101594143|NCT00887536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594144|NCT00887536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101594145|NCT00887536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101594146|NCT00887536|Alkylating Agents|alkylating agents|mesh-ancestor
101594147|NCT00887536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618931|NCT00774787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101618932|NCT00774787|Immunologic Factors|immunologic factors|mesh-ancestor
101618933|NCT00774787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618934|NCT00774787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101618935|NCT00774787|Interferon Inducers|interferon inducers|mesh-ancestor
101618936|NCT00888927|Mogamulizumab|mogamulizumab|mesh-list
101618937|NCT00888927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101618938|NCT01040780|Gefitinib|gefitinib|mesh-list
101618939|NCT01040780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101417733|NCT00135122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101417734|NCT00135122|Antiemetics|antiemetics|mesh-ancestor
101417735|NCT00135122|Autonomic Agents|autonomic agents|mesh-ancestor
101417736|NCT00135122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101417737|NCT00135122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101417738|NCT00135122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101417739|NCT00135122|Protective Agents|protective agents|mesh-ancestor
101417740|NCT00142350|Fluorouracil|fluorouracil|mesh-list
101417741|NCT00142350|Irinotecan|irinotecan|mesh-list
101594148|NCT00887536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101594149|NCT00887536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101594150|NCT00887536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101594151|NCT00887536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101594152|NCT00887536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101594153|NCT00887536|Growth Substances|growth substances|mesh-ancestor
101594154|NCT00887536|Growth Inhibitors|growth inhibitors|mesh-ancestor
101594155|NCT00887536|Tubulin Modulators|tubulin modulators|mesh-ancestor
101594156|NCT00887536|Antimitotic Agents|antimitotic agents|mesh-ancestor
101594157|NCT00887536|Mitosis Modulators|mitosis modulators|mesh-ancestor
101594158|NCT00887536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101594159|NCT00887536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101594160|NCT00887536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101594161|NCT00887536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594162|NCT02614339|Metformin|metformin|mesh-list
101594163|NCT02614339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101594164|NCT02614339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594165|NCT02618395|Hydrocodone|hydrocodone|mesh-list
101594166|NCT02618395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101594167|NCT02618395|Narcotics|narcotics|mesh-ancestor
101594168|NCT02618395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101594175|NCT01183013|Pioglitazone|pioglitazone|mesh-list
101594176|NCT01183013|Linagliptin|linagliptin|mesh-list
101594177|NCT01183013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101594178|NCT01183013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594179|NCT01183013|Incretins|incretins|mesh-ancestor
101337763|NCT00067015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101594181|NCT01183013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101594182|NCT01183013|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101594183|NCT01183013|Protease Inhibitors|protease inhibitors|mesh-ancestor
101594184|NCT01183013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594185|NCT01183013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618940|NCT01040780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101618941|NCT01040780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101618942|NCT01040780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618944|NCT04303988|Carboplatin|carboplatin|mesh-list
101618945|NCT04303988|Temozolomide|temozolomide|mesh-list
101618946|NCT04303988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101618947|NCT04303988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101618948|NCT04303988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101618949|NCT04303988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101618950|NCT04303988|Growth Substances|growth substances|mesh-ancestor
101618951|NCT04303988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618952|NCT04303988|Growth Inhibitors|growth inhibitors|mesh-ancestor
101417743|NCT00142350|Antimetabolites|antimetabolites|mesh-ancestor
101594186|NCT04229212|Cimetidine|cimetidine|mesh-list
101594187|NCT04229212|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101594188|NCT04229212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101594189|NCT04229212|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101594190|NCT04229212|Histamine Antagonists|histamine antagonists|mesh-ancestor
101594191|NCT04229212|Histamine Agents|histamine agents|mesh-ancestor
101594192|NCT04229212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101594193|NCT04229212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594194|NCT04229212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594195|NCT04229212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101594196|NCT04229212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101594197|NCT04229212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594198|NCT02615041|Meropenem|meropenem|mesh-list
101594199|NCT02615041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101594200|NCT02615041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101594201|NCT04229602|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101594202|NCT04229602|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101594203|NCT04229602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101594204|NCT04229602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101594205|NCT04229602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594206|NCT04229602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101594207|NCT04229602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594208|NCT04229602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101594209|NCT04229602|Antidepressive Agents|antidepressive agents|mesh-ancestor
101594210|NCT04229602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101594211|NCT05298163|Calcitriol|calcitriol|mesh-list
101594212|NCT05298163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101594213|NCT05298163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594214|NCT05298163|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101594215|NCT05298163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101594216|NCT05298163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594217|NCT05298163|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101594218|NCT05298163|Vitamins|vitamins|mesh-ancestor
101594219|NCT05298163|Micronutrients|micronutrients|mesh-ancestor
101594220|NCT05298163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101594222|NCT01141283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101594223|NCT01141283|Narcotics|narcotics|mesh-ancestor
101594224|NCT01141283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101594225|NCT01141283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594226|NCT01141283|Analgesics|analgesics|mesh-ancestor
101594227|NCT01141283|Sensory System Agents|sensory system agents|mesh-ancestor
101594228|NCT01141283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101594229|NCT01141283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101594230|NCT05340946|Anesthetics|anesthetics|mesh-list
101618953|NCT04303988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101618954|NCT04303988|Alkylating Agents|alkylating agents|mesh-ancestor
101337796|NCT00398905|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101618955|NCT04303988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618956|NCT04991493|Tramadol|tramadol|mesh-list
101618957|NCT04991493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101618958|NCT04991493|Narcotics|narcotics|mesh-ancestor
101618959|NCT04991493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101618960|NCT04991493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618961|NCT04991493|Analgesics|analgesics|mesh-ancestor
101618962|NCT04991493|Sensory System Agents|sensory system agents|mesh-ancestor
101618963|NCT04991493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101618964|NCT01059812|Insulin|insulin|mesh-list
101417763|NCT00135434|Ritonavir|ritonavir|mesh-list
101594231|NCT05340946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101594232|NCT05340946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594233|NCT00863707|Regadenoson|regadenoson|mesh-list
101594234|NCT00863707|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
101594243|NCT05340634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101594244|NCT05340634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594245|NCT05340634|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101594246|NCT05367479|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101594247|NCT05367479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101594248|NCT04187807|Melatonin|melatonin|mesh-list
101594249|NCT04187807|Antioxidants|antioxidants|mesh-ancestor
101594250|NCT04187807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594251|NCT04187807|Protective Agents|protective agents|mesh-ancestor
101594252|NCT04187807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594253|NCT04187807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101594254|NCT01094184|Paclitaxel|paclitaxel|mesh-list
101594255|NCT01094184|Docetaxel|docetaxel|mesh-list
101594256|NCT01094184|Bevacizumab|bevacizumab|mesh-list
101594257|NCT01094184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101594258|NCT01094184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101594259|NCT01094184|Tubulin Modulators|tubulin modulators|mesh-ancestor
101594260|NCT01094184|Antimitotic Agents|antimitotic agents|mesh-ancestor
101594261|NCT01094184|Mitosis Modulators|mitosis modulators|mesh-ancestor
101594262|NCT01094184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594263|NCT01094184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101594264|NCT01094184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101594265|NCT01094184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101594266|NCT01094184|Growth Substances|growth substances|mesh-ancestor
101594267|NCT01094184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594268|NCT01094184|Growth Inhibitors|growth inhibitors|mesh-ancestor
101594269|NCT00697879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
101594270|NCT00697879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594271|NCT00697879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594272|NCT01134731|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101594273|NCT01134731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101594274|NCT01134731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594275|NCT01134731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101594276|NCT01134731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101594277|NCT01134731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594278|NCT01134731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101594279|NCT01134731|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101594280|NCT01134731|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101594281|NCT01134731|Serotonin Agents|serotonin agents|mesh-ancestor
101594282|NCT01134731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101594283|NCT01134731|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101594284|NCT01134731|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101618965|NCT01059812|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101618966|NCT01059812|Insulin Aspart|insulin aspart|mesh-list
101618967|NCT01059812|Insulin, Long-Acting|insulin, long-acting|mesh-list
101618968|NCT01059812|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101618969|NCT01059812|Biphasic Insulins|biphasic insulins|mesh-list
101618970|NCT01059812|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101618971|NCT01059812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101594285|NCT01134731|Dopamine Agents|dopamine agents|mesh-ancestor
101594286|NCT04132063|Levetiracetam|levetiracetam|mesh-list
101594287|NCT04132063|Anticonvulsants|anticonvulsants|mesh-ancestor
101594288|NCT04132063|Nootropic Agents|nootropic agents|mesh-ancestor
101594289|NCT02618317|Minocycline|minocycline|mesh-list
101594290|NCT02618317|Heparin|heparin|mesh-list
101594291|NCT02618317|Anticoagulants|anticoagulants|mesh-ancestor
101594292|NCT02618317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251244|NCT05800847|Gabapentin|gabapentin|mesh-list
101594293|NCT02618317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101594294|NCT02618317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101594295|NCT02618317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101594296|NCT02618317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101594298|NCT01140503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101594299|NCT01140503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101594300|NCT01140503|Analgesics|analgesics|mesh-ancestor
101594308|NCT01140503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594309|NCT01140503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594310|NCT02689726|Imiquimod|imiquimod|mesh-list
101594311|NCT02689726|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101594312|NCT02689726|Immunologic Factors|immunologic factors|mesh-ancestor
101594313|NCT02689726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594314|NCT02689726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101594315|NCT02689726|Interferon Inducers|interferon inducers|mesh-ancestor
101594316|NCT00863317|Montelukast|montelukast|mesh-list
101594317|NCT00863317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101594318|NCT00863317|Respiratory System Agents|respiratory system agents|mesh-ancestor
101594319|NCT00863317|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101594320|NCT00863317|Hormone Antagonists|hormone antagonists|mesh-ancestor
101594321|NCT00863317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101594322|NCT00863317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594323|NCT00863317|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101594324|NCT00863317|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101594325|NCT00863317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594326|NCT02744092|Enoxaparin|enoxaparin|mesh-list
101594327|NCT02744092|Dalteparin|dalteparin|mesh-list
101594329|NCT02744092|Warfarin|warfarin|mesh-list
101594330|NCT02744092|Rivaroxaban|rivaroxaban|mesh-list
101594331|NCT02744092|Dabigatran|dabigatran|mesh-list
101594332|NCT02744092|Apixaban|apixaban|mesh-list
101594333|NCT02744092|Edoxaban|edoxaban|mesh-list
101594334|NCT02744092|Fondaparinux|fondaparinux|mesh-list
101594335|NCT02744092|Anticoagulants|anticoagulants|mesh-ancestor
101594336|NCT02744092|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101594337|NCT02744092|Antithrombins|antithrombins|mesh-ancestor
101594338|NCT02744092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101594339|NCT02744092|Protease Inhibitors|protease inhibitors|mesh-ancestor
101594340|NCT02744092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594341|NCT02744092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594342|NCT02744092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101337836|NCT00067561|Alosetron|alosetron|mesh-list
101594343|NCT02744092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101594344|NCT01200368|Vaccines|vaccines|mesh-list
101594345|NCT01200368|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101594346|NCT01200368|Immunologic Factors|immunologic factors|mesh-ancestor
101594347|NCT01200368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594348|NCT04125121|Propofol|propofol|mesh-list
101594349|NCT04125121|Sevoflurane|sevoflurane|mesh-list
101594350|NCT04125121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101594351|NCT04125121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101594352|NCT04125121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594353|NCT04125121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101594354|NCT04125121|Anesthetics, General|anesthetics, general|mesh-ancestor
101618972|NCT01059812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618973|NCT00888615|Paclitaxel|paclitaxel|mesh-list
101618974|NCT00888615|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101618975|NCT00888615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101618976|NCT00888615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101276015|NCT01866644|Acetylcysteine|acetylcysteine|mesh-list
101618977|NCT00888615|Tubulin Modulators|tubulin modulators|mesh-ancestor
101618978|NCT00888615|Antimitotic Agents|antimitotic agents|mesh-ancestor
101618979|NCT00888615|Mitosis Modulators|mitosis modulators|mesh-ancestor
101618980|NCT00888615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618982|NCT00845650|gamma-Globulins|gamma-globulins|mesh-list
101618983|NCT00845650|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101618984|NCT00845650|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101417777|NCT00135473|Insulin|insulin|mesh-list
101594355|NCT04125121|Anesthetics|anesthetics|mesh-ancestor
101594356|NCT04125121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101594357|NCT04125121|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101594358|NCT01079130|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101594359|NCT01079130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101594360|NCT01079130|Autonomic Agents|autonomic agents|mesh-ancestor
101594361|NCT01079130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101594362|NCT01079130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594363|NCT01079130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101251291|NCT05800197|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101594364|NCT01079130|Respiratory System Agents|respiratory system agents|mesh-ancestor
101594365|NCT01079130|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101594366|NCT01079130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101594367|NCT01079130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101594368|NCT01079130|Adrenergic Agents|adrenergic agents|mesh-ancestor
101594403|NCT04302012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101594404|NCT04302012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594405|NCT00869557|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101594406|NCT00869557|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101594407|NCT00869557|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101594408|NCT00869557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101594622|NCT04227652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101594623|NCT04227652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594624|NCT04227652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594625|NCT02883569|Ibuprofen|ibuprofen|mesh-list
101594626|NCT02883569|Aceclofenac|aceclofenac|mesh-list
101594627|NCT02883569|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
101594628|NCT02883569|Tramadol|tramadol|mesh-list
101594629|NCT02883569|Codeine|codeine|mesh-list
101594630|NCT02883569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101594631|NCT02883569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101594632|NCT02883569|Analgesics|analgesics|mesh-ancestor
101594633|NCT02883569|Sensory System Agents|sensory system agents|mesh-ancestor
101594634|NCT02883569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101594635|NCT02883569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594636|NCT02883569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101594637|NCT02883569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101594638|NCT02883569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101594639|NCT02883569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594640|NCT02883569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594641|NCT02883569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101594642|NCT02883569|Narcotics|narcotics|mesh-ancestor
101594674|NCT01197560|Antimetabolites|antimetabolites|mesh-ancestor
101594675|NCT01197560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101618985|NCT00845650|Immunologic Factors|immunologic factors|mesh-ancestor
101618986|NCT00845650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618987|NCT00888381|Vaccines|vaccines|mesh-list
101618988|NCT00888381|Immunologic Factors|immunologic factors|mesh-ancestor
101618989|NCT00888381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618990|NCT00833560|Dexamethasone|dexamethasone|mesh-list
101618991|NCT00833560|Cyclophosphamide|cyclophosphamide|mesh-list
101618992|NCT00833560|Bortezomib|bortezomib|mesh-list
101618993|NCT00833560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101618994|NCT00833560|Immunologic Factors|immunologic factors|mesh-ancestor
101618995|NCT00833560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101618996|NCT00833560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101618997|NCT00833560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101618998|NCT00833560|Alkylating Agents|alkylating agents|mesh-ancestor
101618999|NCT00833560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619000|NCT00833560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101619001|NCT00833560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101619002|NCT00833560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101417788|NCT00135551|Diuretics|diuretics|mesh-list
101594676|NCT01197560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101594677|NCT01197560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101594678|NCT01197560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101594679|NCT01197560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594680|NCT01197560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101594681|NCT01197560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101594682|NCT01197560|Growth Substances|growth substances|mesh-ancestor
101594683|NCT01197560|Growth Inhibitors|growth inhibitors|mesh-ancestor
101594685|NCT04940572|Anticonvulsants|anticonvulsants|mesh-ancestor
101594686|NCT04940572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594687|NCT04940572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594780|NCT01194440|Hormone Antagonists|hormone antagonists|mesh-ancestor
101594959|NCT04193566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101594960|NCT04193566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594961|NCT00869401|Temozolomide|temozolomide|mesh-list
101594996|NCT01075152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594998|NCT01075152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101594999|NCT01075152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101595000|NCT01075152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101595001|NCT01075152|Antimetabolites|antimetabolites|mesh-ancestor
101595112|NCT04269369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101595113|NCT04269369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101595114|NCT04269369|Immunologic Factors|immunologic factors|mesh-ancestor
101595115|NCT04269369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595117|NCT02776540|Clopidogrel|clopidogrel|mesh-list
101595118|NCT02776540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101595119|NCT02776540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101595120|NCT02776540|Analgesics|analgesics|mesh-ancestor
101595121|NCT02776540|Sensory System Agents|sensory system agents|mesh-ancestor
101595122|NCT02776540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101595123|NCT02776540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595124|NCT02776540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101595125|NCT02776540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101595126|NCT02776540|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101619003|NCT00833560|Antiemetics|antiemetics|mesh-ancestor
101619004|NCT00833560|Autonomic Agents|autonomic agents|mesh-ancestor
101619005|NCT00833560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101619012|NCT04242927|Niacin|niacin|mesh-list
101619076|NCT00702130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619077|NCT00702130|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101619078|NCT00702130|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101619145|NCT00822172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619146|NCT00822172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101619147|NCT00822172|Vasodilator Agents|vasodilator agents|mesh-ancestor
101619148|NCT00822172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101619149|NCT00822172|Protective Agents|protective agents|mesh-ancestor
101619150|NCT00822172|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101619151|NCT00822172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101619211|NCT02825199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619212|NCT02825199|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101619213|NCT02825199|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101619214|NCT02825199|Purinergic Agents|purinergic agents|mesh-ancestor
101619215|NCT02825199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101619282|NCT02603575|Methylprednisolone|methylprednisolone|mesh-list
101619283|NCT02603575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101619284|NCT02603575|Antiemetics|antiemetics|mesh-ancestor
101619285|NCT02603575|Autonomic Agents|autonomic agents|mesh-ancestor
101619286|NCT02603575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101619287|NCT02603575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619288|NCT02603575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101619289|NCT02603575|Glucocorticoids|glucocorticoids|mesh-ancestor
101619290|NCT02603575|Hormones|hormones|mesh-ancestor
101619291|NCT02603575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101619292|NCT02603575|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101619293|NCT02603575|Protective Agents|protective agents|mesh-ancestor
101619294|NCT02603575|Antifungal Agents|antifungal agents|mesh-ancestor
101619295|NCT02603575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101619296|NCT02603575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101619297|NCT02603575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619298|NCT02603575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101619299|NCT02601859|Lithium Carbonate|lithium carbonate|mesh-list
101619300|NCT02601859|Antidepressive Agents|antidepressive agents|mesh-ancestor
101619301|NCT02601859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101619335|NCT02822937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101619336|NCT02822937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619337|NCT02822937|Dopamine Agents|dopamine agents|mesh-ancestor
101619338|NCT02822937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101619339|NCT02822937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101619340|NCT02822937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101619341|NCT02822937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101619342|NCT02822937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101619343|NCT02822937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101619344|NCT02822937|GABA Modulators|gaba modulators|mesh-ancestor
101619345|NCT02822937|GABA Agents|gaba agents|mesh-ancestor
101619346|NCT04200885|Dexamethasone|dexamethasone|mesh-list
101619347|NCT04200885|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
101619348|NCT04200885|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101619349|NCT04200885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101619350|NCT04200885|Antiemetics|antiemetics|mesh-ancestor
101619351|NCT04200885|Autonomic Agents|autonomic agents|mesh-ancestor
101619352|NCT04200885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101619353|NCT04200885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619354|NCT04200885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101619355|NCT04200885|Glucocorticoids|glucocorticoids|mesh-ancestor
101619389|NCT02821689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101619390|NCT02821689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101619391|NCT02821533|Cisplatin|cisplatin|mesh-list
101619392|NCT02821533|Antineoplastic Agents|antineoplastic agents|mesh-list
101619394|NCT05659407|Belimumab|belimumab|mesh-list
101619395|NCT05659407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101619396|NCT05659407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101619397|NCT05659407|Immunologic Factors|immunologic factors|mesh-ancestor
101619398|NCT05659407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619399|NCT05659407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101619400|NCT05659407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101619401|NCT00766675|Acetaminophen|acetaminophen|mesh-list
101619402|NCT00766675|Tramadol|tramadol|mesh-list
101619403|NCT00766675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101619404|NCT00766675|Analgesics|analgesics|mesh-ancestor
101619453|NCT02818881|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101619454|NCT02818881|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101619455|NCT02818881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101619457|NCT02818803|Propolis|propolis|mesh-list
101619521|NCT02820051|GABA Modulators|gaba modulators|mesh-ancestor
101619522|NCT02820051|GABA Agents|gaba agents|mesh-ancestor
101619523|NCT02820051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101619524|NCT02820051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101619525|NCT02820051|Narcotics|narcotics|mesh-ancestor
101619526|NCT02820051|Analgesics|analgesics|mesh-ancestor
101619593|NCT02816853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101619594|NCT02816853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619595|NCT02816853|Antiemetics|antiemetics|mesh-ancestor
101619664|NCT02817477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619665|NCT02817477|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101619666|NCT02817477|Narcotics|narcotics|mesh-ancestor
101619667|NCT02819115|Vaccines|vaccines|mesh-list
101619668|NCT02819115|Immunologic Factors|immunologic factors|mesh-ancestor
101619669|NCT02819115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619670|NCT04099069|Anesthetics|anesthetics|mesh-list
101619671|NCT04099069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101619731|NCT00843856|Antitubercular Agents|antitubercular agents|mesh-ancestor
101619732|NCT00843856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101619733|NCT00843856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101619734|NCT04480125|Azacitidine|azacitidine|mesh-list
101619735|NCT04480125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101619736|NCT04480125|Antimetabolites|antimetabolites|mesh-ancestor
101619737|NCT04480125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101619738|NCT04480125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101619739|NCT04480125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101619797|NCT02237508|Autonomic Agents|autonomic agents|mesh-ancestor
101619798|NCT02237508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101619799|NCT02237508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619800|NCT02237508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101619801|NCT02237508|Respiratory System Agents|respiratory system agents|mesh-ancestor
101619866|NCT05642715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101619867|NCT02874326|Octreotide|octreotide|mesh-list
101619868|NCT02874326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101619869|NCT02874326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101619872|NCT02812641|Cisplatin|cisplatin|mesh-list
101619936|NCT05580510|Empagliflozin|empagliflozin|mesh-list
101619937|NCT05580510|Valsartan|valsartan|mesh-list
101620008|NCT02814669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101620009|NCT02814669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101620010|NCT02808741|Olorofim|olorofim|mesh-list
101620017|NCT02807415|Ivacaftor|ivacaftor|mesh-list
101620081|NCT03893175|Sensory System Agents|sensory system agents|mesh-ancestor
101620082|NCT03893175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101620083|NCT03893175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620084|NCT03893175|Antipyretics|antipyretics|mesh-ancestor
101620085|NCT03893175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101620086|NCT03893175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101620087|NCT03893175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101337901|NCT00068029|Octreotide|octreotide|mesh-list
101620088|NCT03893175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101620089|NCT03893175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101620090|NCT03893175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620091|NCT03893175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101620092|NCT03893175|Narcotics|narcotics|mesh-ancestor
101620093|NCT03893175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101620140|NCT00763555|Calcitriol|calcitriol|mesh-list
101620217|NCT05477589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101620218|NCT05477589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101620219|NCT05477589|Antimetabolites|antimetabolites|mesh-ancestor
101620220|NCT00841672|Amlodipine|amlodipine|mesh-list
101620221|NCT00841672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101620222|NCT00841672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101620223|NCT00841672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101620228|NCT05549115|Amoxicillin|amoxicillin|mesh-list
101620292|NCT05472753|Sensory System Agents|sensory system agents|mesh-ancestor
101620293|NCT05472753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101620294|NCT05472753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620295|NCT05472753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101620296|NCT05472753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101620297|NCT05472753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101620300|NCT05472753|Antioxidants|antioxidants|mesh-ancestor
101620367|NCT05511909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101620368|NCT05511909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620369|NCT05511909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101620370|NCT05511909|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101620371|NCT05511909|Sensory System Agents|sensory system agents|mesh-ancestor
101620372|NCT05511909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101620373|NCT05511909|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101620374|NCT05511909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101620375|NCT05511909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101620376|NCT05511909|Adrenergic Agents|adrenergic agents|mesh-ancestor
101620377|NCT00906282|Carboplatin|carboplatin|mesh-list
101620378|NCT00906282|Pemetrexed|pemetrexed|mesh-list
101620428|NCT04235439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101620429|NCT04235439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620431|NCT02640222|Rivaroxaban|rivaroxaban|mesh-list
101620432|NCT02640222|Apixaban|apixaban|mesh-list
101620433|NCT02640222|Dabigatran|dabigatran|mesh-list
101620434|NCT02640222|Vitamins|vitamins|mesh-ancestor
101620435|NCT02640222|Micronutrients|micronutrients|mesh-ancestor
101620436|NCT02640222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101620437|NCT02640222|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101620438|NCT02640222|Antithrombins|antithrombins|mesh-ancestor
101620495|NCT00913588|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101620496|NCT00913588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101620497|NCT00913588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101620500|NCT00913588|Serotonin Agents|serotonin agents|mesh-ancestor
101620565|NCT00769561|Dermatologic Agents|dermatologic agents|mesh-ancestor
101620566|NCT02797041|Bortezomib|bortezomib|mesh-list
101620568|NCT02794779|Oxytocin|oxytocin|mesh-list
101620640|NCT05804591|Analgesics|analgesics|mesh-ancestor
101620641|NCT05804591|Sensory System Agents|sensory system agents|mesh-ancestor
101620712|NCT05803590|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101620713|NCT05803590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101620714|NCT05803590|Disinfectants|disinfectants|mesh-ancestor
101620715|NCT05803135|Tofacitinib|tofacitinib|mesh-list
101620716|NCT05803135|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101620717|NCT05803135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101620718|NCT05803135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101620719|NCT05803135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620786|NCT05802992|Antimitotic Agents|antimitotic agents|mesh-ancestor
101620787|NCT05802992|Mitosis Modulators|mitosis modulators|mesh-ancestor
101620788|NCT05802979|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-list
101620861|NCT05752734|Glucocorticoids|glucocorticoids|mesh-ancestor
101620862|NCT05752734|Hormones|hormones|mesh-ancestor
101620864|NCT05752734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101620940|NCT05616624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101620941|NCT05616624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621042|NCT05365035|Cytarabine|cytarabine|mesh-list
101621043|NCT05365035|Azacitidine|azacitidine|mesh-list
101621044|NCT05365035|Venetoclax|venetoclax|mesh-list
101621045|NCT05365035|Cladribine|cladribine|mesh-list
101621046|NCT05365035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101621047|NCT05365035|Antimetabolites|antimetabolites|mesh-ancestor
101621048|NCT05365035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621049|NCT05365035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621050|NCT05365035|Antiviral Agents|antiviral agents|mesh-ancestor
101621051|NCT05365035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101621052|NCT05365035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101621053|NCT05365035|Immunologic Factors|immunologic factors|mesh-ancestor
101337916|NCT00068302|Immunologic Factors|immunologic factors|mesh-ancestor
101621054|NCT05365035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621055|NCT05365035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101621056|NCT05359861|Bevacizumab|bevacizumab|mesh-list
101621057|NCT05359861|Atezolizumab|atezolizumab|mesh-list
101621058|NCT05359861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101621059|NCT05359861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621060|NCT05359861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101621070|NCT05350085|Midazolam|midazolam|mesh-list
101621118|NCT05226455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621119|NCT05226455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101621120|NCT05169905|Vaccines|vaccines|mesh-list
101621121|NCT05169905|Immunologic Factors|immunologic factors|mesh-ancestor
101621122|NCT05169905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621123|NCT05163223|Pembrolizumab|pembrolizumab|mesh-list
101621124|NCT05163223|Capecitabine|capecitabine|mesh-list
101621125|NCT05163223|Sargramostim|sargramostim|mesh-list
101621134|NCT05101122|Dronabinol|dronabinol|mesh-list
101621186|NCT05061017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621187|NCT05061017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101621188|NCT05061017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101621189|NCT05061017|Alkylating Agents|alkylating agents|mesh-ancestor
101621190|NCT05061017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621191|NCT05061017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621192|NCT05061017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101621193|NCT05061017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101621194|NCT05061017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101621195|NCT05048901|Lanreotide|lanreotide|mesh-list
101621196|NCT05048901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621197|NCT05042973|Empagliflozin|empagliflozin|mesh-list
101621198|NCT05042973|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101621199|NCT05042973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621245|NCT04920617|Alkylating Agents|alkylating agents|mesh-ancestor
101621246|NCT04920617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621247|NCT04920617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621248|NCT04920617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101621315|NCT04527289|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101621316|NCT04527289|Antiviral Agents|antiviral agents|mesh-ancestor
101621317|NCT04527289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101621318|NCT04527289|Dopamine Agents|dopamine agents|mesh-ancestor
101621388|NCT04218565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101621389|NCT04218565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101621390|NCT04218565|Immunologic Factors|immunologic factors|mesh-ancestor
101621391|NCT04218565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621458|NCT03867500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621530|NCT03512262|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
101621531|NCT03512262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101621602|NCT03153280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621604|NCT03098836|Prednisone|prednisone|mesh-list
101621675|NCT02845596|Thymoglobulin|thymoglobulin|mesh-list
101621676|NCT02845596|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101621677|NCT02845596|Immunosuppressive Agents|immunosuppressive agents|mesh-list
101621746|NCT02256865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101621747|NCT02256865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621748|NCT02256865|Anabolic Agents|anabolic agents|mesh-ancestor
101621749|NCT02256865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101621750|NCT02256865|Antifungal Agents|antifungal agents|mesh-ancestor
101621751|NCT02256865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101621818|NCT01439802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621819|NCT01434316|Veliparib|veliparib|mesh-list
101621820|NCT01434316|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101621821|NCT01434316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101621822|NCT01434316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621823|NCT01434316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621824|NCT00646230|Fenretinide|fenretinide|mesh-list
101621825|NCT00646230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621826|NCT00646230|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101621827|NCT00646230|Protective Agents|protective agents|mesh-ancestor
101338079|NCT00070174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101621828|NCT00646230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621829|NCT00544414|Leucovorin|leucovorin|mesh-list
101595127|NCT02776540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101595128|NCT02776540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595423|NCT02768740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101595425|NCT02851095|Canagliflozin|canagliflozin|mesh-list
101595426|NCT02851095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101595427|NCT02851095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595428|NCT02851095|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101595494|NCT04131283|Adrenergic Agents|adrenergic agents|mesh-ancestor
101595495|NCT04131283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101595496|NCT04131283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595497|NCT04131283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595498|NCT04131283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101595499|NCT04131283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101595500|NCT04131283|Autonomic Agents|autonomic agents|mesh-ancestor
101595660|NCT02767024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101595744|NCT05655338|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101595745|NCT05655338|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101595746|NCT01132313|Ribavirin|ribavirin|mesh-list
101595747|NCT01132313|Antimetabolites|antimetabolites|mesh-ancestor
101595748|NCT01132313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595749|NCT01132313|Antiviral Agents|antiviral agents|mesh-ancestor
101595750|NCT01132313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101595751|NCT00422565|Sirolimus|sirolimus|mesh-list
101595752|NCT00422565|Paclitaxel|paclitaxel|mesh-list
101595753|NCT00422565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101595754|NCT00422565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101595845|NCT01130597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595846|NCT01130597|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101595847|NCT01130597|Diuretics|diuretics|mesh-ancestor
101595848|NCT01130597|Natriuretic Agents|natriuretic agents|mesh-ancestor
101595849|NCT00939003|Adalimumab|adalimumab|mesh-list
101595850|NCT00939003|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101595851|NCT00939003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101595852|NCT00939003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101595882|NCT01130051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101595883|NCT00865189|Leucovorin|leucovorin|mesh-list
101595884|NCT00865189|Folic Acid|folic acid|mesh-list
101595885|NCT00865189|Bevacizumab|bevacizumab|mesh-list
101595886|NCT00865189|Fluorouracil|fluorouracil|mesh-list
101595887|NCT00865189|Oxaliplatin|oxaliplatin|mesh-list
101595888|NCT00865189|Levoleucovorin|levoleucovorin|mesh-list
101595889|NCT00865189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101595890|NCT00865189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101595891|NCT00865189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101595892|NCT00865189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101595893|NCT00865189|Growth Substances|growth substances|mesh-ancestor
101595894|NCT00865189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595895|NCT00865189|Growth Inhibitors|growth inhibitors|mesh-ancestor
101595981|NCT00603759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101621830|NCT00544414|Gemcitabine|gemcitabine|mesh-list
101621831|NCT00544414|Docetaxel|docetaxel|mesh-list
101621832|NCT00544414|Fluorouracil|fluorouracil|mesh-list
101621833|NCT00544414|Calcium|calcium|mesh-list
101621834|NCT00544414|Levoleucovorin|levoleucovorin|mesh-list
101621835|NCT00544414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621836|NCT00544414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101621837|NCT00544414|Antimetabolites|antimetabolites|mesh-ancestor
101621838|NCT00544414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595982|NCT00603759|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101595983|NCT00603759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101252943|NCT01555541|Antimetabolites|antimetabolites|mesh-ancestor
101596016|NCT01186796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596017|NCT05383131|Pirfenidone|pirfenidone|mesh-list
101596018|NCT05383131|Nintedanib|nintedanib|mesh-list
101596019|NCT05383131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101596020|NCT05383131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101596021|NCT05383131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101596056|NCT00940017|Antifungal Agents|antifungal agents|mesh-ancestor
101596057|NCT00940017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101596058|NCT00940017|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101596059|NCT00940017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101596060|NCT00940017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101596094|NCT01186328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101596095|NCT01186328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596096|NCT01186328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101596097|NCT01186328|Glucocorticoids|glucocorticoids|mesh-ancestor
101596098|NCT01186328|Hormones|hormones|mesh-ancestor
101596099|NCT01186328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101596100|NCT01186328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596128|NCT00848497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101596129|NCT00848497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596130|NCT00848497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101596131|NCT00848497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101596132|NCT00848497|Anabolic Agents|anabolic agents|mesh-ancestor
101596133|NCT00848497|Vasodilator Agents|vasodilator agents|mesh-ancestor
101596134|NCT00848497|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101596135|NCT00848497|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101596136|NCT00848497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101596137|NCT00848497|Urological Agents|urological agents|mesh-ancestor
101596138|NCT02763592|Lidocaine|lidocaine|mesh-list
101596139|NCT02763592|Anesthetics, Local|anesthetics, local|mesh-ancestor
101596140|NCT02763592|Anesthetics|anesthetics|mesh-ancestor
101596141|NCT02763592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101596142|NCT02763592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596143|NCT02763592|Sensory System Agents|sensory system agents|mesh-ancestor
101596144|NCT02763592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101596145|NCT02763592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101596146|NCT02763592|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101596147|NCT02763592|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101596158|NCT01185782|Fertility Agents, Male|fertility agents, male|mesh-ancestor
101596159|NCT02761174|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101596160|NCT02761174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101596161|NCT02761174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101596162|NCT02761174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101596163|NCT02761174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101596164|NCT02761174|Adrenergic Agents|adrenergic agents|mesh-ancestor
101596165|NCT02761174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101596166|NCT02761174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596167|NCT02761174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596168|NCT02882555|Capsaicin|capsaicin|mesh-list
101596169|NCT02882555|Antipruritics|antipruritics|mesh-ancestor
101596170|NCT02882555|Dermatologic Agents|dermatologic agents|mesh-ancestor
101596171|NCT02882555|Sensory System Agents|sensory system agents|mesh-ancestor
101338140|NCT00070447|Hormones|hormones|mesh-ancestor
101596172|NCT02882555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101621839|NCT00544414|Tubulin Modulators|tubulin modulators|mesh-ancestor
101621840|NCT00544414|Antimitotic Agents|antimitotic agents|mesh-ancestor
101621841|NCT00544414|Mitosis Modulators|mitosis modulators|mesh-ancestor
101621842|NCT00544414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101621843|NCT00544414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621844|NCT00544414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101621845|NCT00544414|Immunologic Factors|immunologic factors|mesh-ancestor
101621846|NCT00544414|Antidotes|antidotes|mesh-ancestor
101621847|NCT00544414|Protective Agents|protective agents|mesh-ancestor
101621848|NCT00544414|Vitamin B Complex|vitamin b complex|mesh-ancestor
101621849|NCT00544414|Vitamins|vitamins|mesh-ancestor
101621850|NCT00544414|Micronutrients|micronutrients|mesh-ancestor
101621851|NCT00816556|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101621852|NCT00816556|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101621853|NCT00816556|Estradiol|estradiol|mesh-list
101621854|NCT00816556|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101621855|NCT00816556|Estrogens|estrogens|mesh-ancestor
101621856|NCT00816556|Hormones|hormones|mesh-ancestor
101621857|NCT00816556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101596173|NCT02882555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596174|NCT00699361|Pantoprazole|pantoprazole|mesh-list
101596175|NCT00699361|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101596176|NCT00699361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101596177|NCT00699361|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101596178|NCT00699361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101596179|NCT00699361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596180|NCT01185704|Cetrorelix|cetrorelix|mesh-list
101596181|NCT01185704|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101596182|NCT01185704|Hormones|hormones|mesh-list
101596183|NCT01185704|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101596184|NCT01185704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101596185|NCT01185704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596186|NCT01185704|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101596187|NCT01185704|Fertility Agents|fertility agents|mesh-ancestor
101596188|NCT01185704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101596189|NCT01185704|Hormone Antagonists|hormone antagonists|mesh-ancestor
101596190|NCT01128959|Carbamazepine|carbamazepine|mesh-list
101596191|NCT01128959|Anticonvulsants|anticonvulsants|mesh-ancestor
101596192|NCT01128959|Antimanic Agents|antimanic agents|mesh-ancestor
101596193|NCT01128959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101596194|NCT01128959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101596195|NCT01128959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596196|NCT01128959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101596197|NCT01128959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101596198|NCT01128959|Analgesics|analgesics|mesh-ancestor
101596199|NCT01128959|Sensory System Agents|sensory system agents|mesh-ancestor
101596200|NCT01128959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101596201|NCT01128959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101596202|NCT01128959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101596203|NCT01128959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596204|NCT01128959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101596205|NCT01128959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101596206|NCT04119739|Ibuprofen|ibuprofen|mesh-list
101596207|NCT04119739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101596208|NCT04119739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101596209|NCT04119739|Analgesics|analgesics|mesh-ancestor
101596293|NCT01181102|Enoxaparin sodium|enoxaparin sodium|mesh-list
101621858|NCT00816556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331019|NCT00000620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101621859|NCT00816556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101621860|NCT00816556|Contraceptive Agents|contraceptive agents|mesh-ancestor
101621861|NCT00816556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101621862|NCT00816556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101621863|NCT04100473|Insulin|insulin|mesh-list
101621864|NCT04100473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101621865|NCT04100473|Insulin Lispro|insulin lispro|mesh-list
101621866|NCT04100473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101420567|NCT05148637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101596294|NCT01181102|Edoxaban|edoxaban|mesh-list
101596295|NCT01181102|Anticoagulants|anticoagulants|mesh-ancestor
101596296|NCT01181102|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101596297|NCT01181102|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101596298|NCT01181102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596299|NCT01181102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101596300|NCT01181102|Antithrombins|antithrombins|mesh-ancestor
101596301|NCT01181102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101596302|NCT01181102|Protease Inhibitors|protease inhibitors|mesh-ancestor
101596303|NCT01181102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101596304|NCT00858637|Bile Acids and Salts|bile acids and salts|mesh-list
101596305|NCT00858637|Simvastatin|simvastatin|mesh-list
101596306|NCT00858637|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101596307|NCT00858637|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101596308|NCT00858637|Antimetabolites|antimetabolites|mesh-ancestor
101596309|NCT00858637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596310|NCT00858637|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101596596|NCT04220398|Hormones|hormones|mesh-list
101596597|NCT04220398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101596598|NCT04220398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596599|NCT04220632|Prednisone|prednisone|mesh-list
101596600|NCT04220632|Methylprednisolone|methylprednisolone|mesh-list
101596601|NCT04220632|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101596602|NCT04220632|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101596688|NCT01135511|Hyaluronic Acid|hyaluronic acid|mesh-list
101596689|NCT01135511|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101596690|NCT01135511|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101596691|NCT01135511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101596692|NCT01135511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101596693|NCT01135511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596694|NCT01135511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101596695|NCT01135511|Immunologic Factors|immunologic factors|mesh-ancestor
101596696|NCT01135511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596697|NCT01135511|Viscosupplements|viscosupplements|mesh-ancestor
101596698|NCT01135511|Protective Agents|protective agents|mesh-ancestor
101596700|NCT02753140|Cetuximab|cetuximab|mesh-list
101596701|NCT02753140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101596702|NCT02753140|Tubulin Modulators|tubulin modulators|mesh-ancestor
101596703|NCT02753140|Antimitotic Agents|antimitotic agents|mesh-ancestor
101596704|NCT02753140|Mitosis Modulators|mitosis modulators|mesh-ancestor
101596705|NCT02753140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596706|NCT02753140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101596708|NCT02753218|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101596709|NCT02753218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101596710|NCT02753218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101596711|NCT02753218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596712|NCT02753218|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101596713|NCT02753218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101596714|NCT02753218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101596715|NCT02753218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101596716|NCT02753218|Anesthetics, General|anesthetics, general|mesh-ancestor
101596717|NCT02753218|Anesthetics|anesthetics|mesh-ancestor
101596718|NCT02753218|GABA Modulators|gaba modulators|mesh-ancestor
101596719|NCT02753218|GABA Agents|gaba agents|mesh-ancestor
101621867|NCT04100473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621868|NCT02796807|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101338164|NCT00070486|Analgesics|analgesics|mesh-ancestor
101621869|NCT02796807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101621870|NCT02796807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621871|NCT00760747|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101621872|NCT00760747|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101621873|NCT00760747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101621874|NCT00760747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101621875|NCT00760747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621876|NCT00760747|Adrenergic Agents|adrenergic agents|mesh-ancestor
101621877|NCT00760747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101621878|NCT00760747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596720|NCT02753218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101596721|NCT02753218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596722|NCT05429554|Vildagliptin|vildagliptin|mesh-list
101596723|NCT05429554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101596771|NCT05318560|Anesthetics, Local|anesthetics, local|mesh-ancestor
101596772|NCT05318560|Anesthetics|anesthetics|mesh-ancestor
101596773|NCT05318560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101596774|NCT05318560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596775|NCT05318560|Sensory System Agents|sensory system agents|mesh-ancestor
101596776|NCT05318560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101596777|NCT05318560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101596778|NCT05318560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101596779|NCT05318560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101596780|NCT05318560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101596781|NCT05318560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596782|NCT04171258|Botulinum Toxins|botulinum toxins|mesh-list
101596783|NCT04171258|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101596784|NCT04171258|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101596785|NCT04171258|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101596786|NCT04171258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101596787|NCT04171258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596788|NCT04171258|Cholinergic Agents|cholinergic agents|mesh-ancestor
101596789|NCT04171258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101596790|NCT04171258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596791|NCT04171258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101596792|NCT04171258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101596793|NCT01086384|Fluticasone|fluticasone|mesh-list
101596794|NCT01086384|Xhance|xhance|mesh-list
101596795|NCT01086384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101596796|NCT01086384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101596797|NCT01086384|Autonomic Agents|autonomic agents|mesh-ancestor
101596798|NCT01086384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101596799|NCT01086384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596800|NCT01086384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101596801|NCT01086384|Respiratory System Agents|respiratory system agents|mesh-ancestor
101596802|NCT01086384|Dermatologic Agents|dermatologic agents|mesh-ancestor
101596803|NCT01086384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101596804|NCT04115644|Triamcinolone|triamcinolone|mesh-list
101596805|NCT04115644|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101596947|NCT02750254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101596948|NCT02750254|Alkylating Agents|alkylating agents|mesh-ancestor
101596949|NCT02750254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596950|NCT02750254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101596951|NCT02750254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101596952|NCT02750254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101621879|NCT00760669|Infliximab|infliximab|mesh-list
101621880|NCT00760669|Methotrexate|methotrexate|mesh-list
101621881|NCT00760669|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101621882|NCT00760669|Abortifacient Agents|abortifacient agents|mesh-ancestor
101338169|NCT00070486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101621883|NCT00760669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101621884|NCT00760669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621885|NCT00760669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101621886|NCT00760669|Antimetabolites|antimetabolites|mesh-ancestor
101420590|NCT05594849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101596953|NCT02750254|Antimetabolites|antimetabolites|mesh-ancestor
101596954|NCT02750254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101596955|NCT02750254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101596956|NCT02750254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101596957|NCT02750254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101596958|NCT02750254|Antiviral Agents|antiviral agents|mesh-ancestor
101596959|NCT02750254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101596960|NCT00941655|Leucovorin|leucovorin|mesh-list
101596961|NCT00941655|Fluorouracil|fluorouracil|mesh-list
101596962|NCT00941655|Oxaliplatin|oxaliplatin|mesh-list
101596963|NCT00941655|Irinotecan|irinotecan|mesh-list
101596964|NCT00941655|Antimetabolites|antimetabolites|mesh-ancestor
101596965|NCT00941655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596966|NCT00941655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101596967|NCT00941655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101596968|NCT00941655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101596969|NCT00941655|Immunologic Factors|immunologic factors|mesh-ancestor
101596970|NCT00941655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597061|NCT01079988|Antifungal Agents|antifungal agents|mesh-ancestor
101597062|NCT01079988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101597063|NCT01079988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101597065|NCT03974152|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101597066|NCT03974152|Autonomic Agents|autonomic agents|mesh-ancestor
101597067|NCT03974152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101597068|NCT03974152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597069|NCT03974152|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101597070|NCT03974152|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101597071|NCT03974152|Cholinergic Agents|cholinergic agents|mesh-ancestor
101597072|NCT03974152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101597073|NCT03974152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597075|NCT02876718|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101597076|NCT02876718|Antithrombins|antithrombins|mesh-ancestor
101597077|NCT02876718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101597078|NCT02876718|Protease Inhibitors|protease inhibitors|mesh-ancestor
101597079|NCT02876718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101597080|NCT02876718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597081|NCT02876718|Anticoagulants|anticoagulants|mesh-ancestor
101597082|NCT03508570|Nivolumab|nivolumab|mesh-list
101597083|NCT03508570|Ipilimumab|ipilimumab|mesh-list
101597084|NCT03508570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101597085|NCT03508570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101597086|NCT03508570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101597117|NCT02875002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597118|NCT02749396|Interferons|interferons|mesh-list
101597119|NCT02749396|Interferon-beta|interferon-beta|mesh-list
101597120|NCT02749396|Interferon beta-1a|interferon beta-1a|mesh-list
101597121|NCT02749396|Interferon beta-1b|interferon beta-1b|mesh-list
101597122|NCT02749396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101597123|NCT02749396|Antiviral Agents|antiviral agents|mesh-ancestor
101597124|NCT02749396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101597125|NCT02749396|Immunologic Factors|immunologic factors|mesh-ancestor
101597126|NCT02749396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597127|NCT02749396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101597128|NCT02749162|Acetaminophen|acetaminophen|mesh-list
101597129|NCT02749162|Dexamethasone|dexamethasone|mesh-list
101597131|NCT02749162|Morphine|morphine|mesh-list
101597132|NCT02749162|Ropivacaine|ropivacaine|mesh-list
101597145|NCT02749162|Anesthetics, Local|anesthetics, local|mesh-ancestor
101597146|NCT02749162|Anesthetics|anesthetics|mesh-ancestor
101621887|NCT00760669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621888|NCT00760669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621889|NCT00760669|Dermatologic Agents|dermatologic agents|mesh-ancestor
101621890|NCT00760669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101621891|NCT00760669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101621892|NCT00760669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101621893|NCT00760669|Immunologic Factors|immunologic factors|mesh-ancestor
101621894|NCT00760669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101621895|NCT00760669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101621896|NCT00760669|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101621897|NCT00760669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101621898|NCT00760669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101597147|NCT02749162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101597148|NCT02749162|Sensory System Agents|sensory system agents|mesh-ancestor
101597149|NCT02749162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101597150|NCT02749162|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101597151|NCT02749162|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101597152|NCT02749162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101597153|NCT02749162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597154|NCT02749162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101597155|NCT02749162|Narcotics|narcotics|mesh-ancestor
101597156|NCT02749162|Analgesics|analgesics|mesh-ancestor
101597157|NCT02749162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101597158|NCT02749162|Antipyretics|antipyretics|mesh-ancestor
101597159|NCT02041234|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101597160|NCT02041234|Liraglutide|liraglutide|mesh-list
101597161|NCT02041234|Empagliflozin|empagliflozin|mesh-list
101597162|NCT02041234|Linagliptin|linagliptin|mesh-list
101597163|NCT02041234|Canagliflozin|canagliflozin|mesh-list
101597164|NCT02041234|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
101597165|NCT02041234|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
101597166|NCT02041234|Orlistat|orlistat|mesh-list
101597167|NCT02041234|Incretins|incretins|mesh-list
101597168|NCT02041234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101597169|NCT02041234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597170|NCT02041234|Hormones|hormones|mesh-ancestor
101597171|NCT02041234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101597172|NCT02041234|Protease Inhibitors|protease inhibitors|mesh-ancestor
101597173|NCT02041234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101597174|NCT02041234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597175|NCT02041234|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101597176|NCT02041234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101597177|NCT02695732|Carvedilol|carvedilol|mesh-list
101597178|NCT02695732|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101597179|NCT02695732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101597180|NCT02695732|Adrenergic Agents|adrenergic agents|mesh-ancestor
101597181|NCT02695732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101597182|NCT02695732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597183|NCT02695732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597184|NCT02695732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101597185|NCT02695732|Antioxidants|antioxidants|mesh-ancestor
101597186|NCT02695732|Protective Agents|protective agents|mesh-ancestor
101597187|NCT02695732|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101597188|NCT02695732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101597189|NCT02695732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101597190|NCT02695732|Vasodilator Agents|vasodilator agents|mesh-ancestor
101597191|NCT02695732|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101597192|NCT02695732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101597193|NCT02751268|Ropivacaine|ropivacaine|mesh-list
101597194|NCT02751268|Anesthetics, Local|anesthetics, local|mesh-ancestor
101597195|NCT02751268|Anesthetics|anesthetics|mesh-ancestor
101621899|NCT02796183|Bevacizumab|bevacizumab|mesh-list
101621900|NCT02796183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101621901|NCT02796183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338213|NCT00071266|Niacin|niacin|mesh-list
101621902|NCT02796183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101621903|NCT02796183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101621904|NCT02796183|Growth Substances|growth substances|mesh-ancestor
101621905|NCT02796183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621906|NCT02796183|Growth Inhibitors|growth inhibitors|mesh-ancestor
101621907|NCT02796105|Ganirelix|ganirelix|mesh-list
101597223|NCT04216888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101597224|NCT04216888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101597225|NCT04216888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101597226|NCT04216888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101597227|NCT04216888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597228|NCT02746744|Rituximab|rituximab|mesh-list
101597229|NCT02746744|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101597230|NCT02746744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101597231|NCT02746744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101597232|NCT02746744|Immunologic Factors|immunologic factors|mesh-ancestor
101597233|NCT02746744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597234|NCT02746744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101597235|NCT02746744|Dermatologic Agents|dermatologic agents|mesh-ancestor
101597236|NCT02746744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101597237|NCT02748304|Aspirin|aspirin|mesh-list
101597238|NCT02748304|Sorafenib|sorafenib|mesh-list
101597239|NCT02748304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101597240|NCT02748304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101597241|NCT02748304|Analgesics|analgesics|mesh-ancestor
101597242|NCT02748304|Sensory System Agents|sensory system agents|mesh-ancestor
101597243|NCT02748304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101597244|NCT02748304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597245|NCT02748304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101597246|NCT02748304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101597247|NCT02748304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101597248|NCT02748304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101597249|NCT02748304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597250|NCT02748304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101597251|NCT02748304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101597252|NCT02748304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101597253|NCT02748304|Antipyretics|antipyretics|mesh-ancestor
101597254|NCT02748304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101597255|NCT02748304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101597256|NCT02746276|Metronidazole|metronidazole|mesh-list
101597257|NCT02746276|Ceftriaxone|ceftriaxone|mesh-list
101597761|NCT00625469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101597762|NCT00625469|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101597763|NCT00625469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597764|NCT05577910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101597765|NCT05577910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101597766|NCT00637481|Atorvastatin|atorvastatin|mesh-list
101597767|NCT00637481|Calcium|calcium|mesh-list
101597768|NCT00637481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101597769|NCT00637481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597770|NCT00637481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101597771|NCT00637481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101597772|NCT00637481|Antimetabolites|antimetabolites|mesh-ancestor
101597773|NCT00637481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597774|NCT00637481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101597775|NCT00637481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101597776|NCT00637481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101597886|NCT02731378|Epoetin Alfa|epoetin alfa|mesh-list
101597887|NCT02731378|Iron-Dextran Complex|iron-dextran complex|mesh-list
101597888|NCT02731378|Trace Elements|trace elements|mesh-ancestor
101597889|NCT02731378|Micronutrients|micronutrients|mesh-ancestor
101597890|NCT02731378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597891|NCT02731378|Hematinics|hematinics|mesh-ancestor
101338216|NCT00071266|Dihydromevinolin|dihydromevinolin|mesh-list
101621909|NCT02796105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101621910|NCT02796105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621911|NCT02795949|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101621912|NCT02795949|Amoxicillin|amoxicillin|mesh-list
101621913|NCT02795949|Ciprofloxacin|ciprofloxacin|mesh-list
101621914|NCT02795949|Meropenem|meropenem|mesh-list
101621915|NCT02795949|Tazobactam|tazobactam|mesh-list
101621916|NCT02795949|Piperacillin|piperacillin|mesh-list
101621917|NCT02795949|Clavulanic Acid|clavulanic acid|mesh-list
101621918|NCT02795949|Imipenem|imipenem|mesh-list
101621919|NCT02795949|Ceftazidime|ceftazidime|mesh-list
101621920|NCT02795949|Ampicillin|ampicillin|mesh-list
101597892|NCT02731378|Anticoagulants|anticoagulants|mesh-ancestor
101597893|NCT02731378|Plasma Substitutes|plasma substitutes|mesh-ancestor
101597894|NCT02731378|Blood Substitutes|blood substitutes|mesh-ancestor
101597895|NCT02731534|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101597896|NCT02731534|Hematinics|hematinics|mesh-ancestor
101597897|NCT02734420|Tolonium Chloride|tolonium chloride|mesh-list
101597898|NCT02734420|Hemostatics|hemostatics|mesh-ancestor
101597899|NCT02734420|Coagulants|coagulants|mesh-ancestor
101597900|NCT02734420|Heparin Antagonists|heparin antagonists|mesh-ancestor
101597901|NCT02734420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597902|NCT00704275|Cyclosporine|cyclosporine|mesh-list
101597903|NCT00704275|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101597904|NCT00704275|Cyclosporins|cyclosporins|mesh-list
101597905|NCT00704275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101597906|NCT00704275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597907|NCT00704275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101597908|NCT00704275|Immunologic Factors|immunologic factors|mesh-ancestor
101597909|NCT00704275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597910|NCT00704275|Antifungal Agents|antifungal agents|mesh-ancestor
101597911|NCT00704275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101597912|NCT00704275|Dermatologic Agents|dermatologic agents|mesh-ancestor
101597913|NCT00704275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101597914|NCT00704275|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101597915|NCT00704275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101597916|NCT00847015|Gemcitabine|gemcitabine|mesh-list
101597917|NCT00847015|Sunitinib|sunitinib|mesh-list
101597918|NCT00847015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101597919|NCT00847015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101597920|NCT00847015|Antimetabolites|antimetabolites|mesh-ancestor
101597921|NCT00847015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597922|NCT00847015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101597923|NCT00847015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101597924|NCT00847015|Growth Substances|growth substances|mesh-ancestor
101597925|NCT00847015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597926|NCT00847015|Growth Inhibitors|growth inhibitors|mesh-ancestor
101597927|NCT00847015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101597938|NCT00627354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101597939|NCT00627354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101597940|NCT00627354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101597941|NCT00627354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101597942|NCT00627354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101597943|NCT00627354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101597944|NCT00627354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597945|NCT00627354|Tubulin Modulators|tubulin modulators|mesh-ancestor
101597946|NCT00627354|Antimitotic Agents|antimitotic agents|mesh-ancestor
101597947|NCT00627354|Mitosis Modulators|mitosis modulators|mesh-ancestor
101597949|NCT00627354|Sensory System Agents|sensory system agents|mesh-ancestor
101597950|NCT00627354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101597951|NCT00704431|Darapladib|darapladib|mesh-list
101597952|NCT00704431|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
101597953|NCT00704431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101597954|NCT00704431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621921|NCT02795949|Ertapenem|ertapenem|mesh-list
101621922|NCT02795949|Cefuroxime|cefuroxime|mesh-list
101621923|NCT02795949|Cefepime|cefepime|mesh-list
101621924|NCT02795949|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101621925|NCT02795949|Lactams|lactams|mesh-list
101621926|NCT02795949|Aztreonam|aztreonam|mesh-list
101621927|NCT02795949|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101254912|NCT01701518|Hormones|hormones|mesh-ancestor
101597955|NCT02734186|Praziquantel|praziquantel|mesh-list
101597956|NCT02734186|Anthelmintics|anthelmintics|mesh-ancestor
101597958|NCT02734186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101597959|NCT00704509|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101597960|NCT00704509|Antidepressive Agents|antidepressive agents|mesh-ancestor
101597961|NCT00704509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101597962|NCT00704509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101597963|NCT00704509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101597964|NCT00704509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101597965|NCT00704509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597966|NCT02733952|Tranexamic Acid|tranexamic acid|mesh-list
101597967|NCT02733952|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101597968|NCT02733952|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101597969|NCT02733952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597970|NCT02733952|Hemostatics|hemostatics|mesh-ancestor
101597971|NCT02733952|Coagulants|coagulants|mesh-ancestor
101597972|NCT02733640|Pantoprazole|pantoprazole|mesh-list
101597973|NCT02733640|Ranitidine|ranitidine|mesh-list
101597974|NCT02733640|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
101597975|NCT02733640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101597976|NCT02733640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101597977|NCT02733640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101597978|NCT02733640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101597979|NCT02733640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597980|NCT02733640|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101597981|NCT02733640|Histamine Antagonists|histamine antagonists|mesh-ancestor
101597982|NCT02733640|Histamine Agents|histamine agents|mesh-ancestor
101597983|NCT02733640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101597984|NCT02733640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597985|NCT02730676|Menthol|menthol|mesh-list
101597986|NCT02730676|Antipruritics|antipruritics|mesh-ancestor
101597987|NCT02730676|Dermatologic Agents|dermatologic agents|mesh-ancestor
101597988|NCT00855595|Metronidazole|metronidazole|mesh-list
101597989|NCT00855595|Doxycycline|doxycycline|mesh-list
101597990|NCT00855595|Azelaic acid|azelaic acid|mesh-list
101597991|NCT00855595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101597992|NCT00855595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101597993|NCT00855595|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101597994|NCT00855595|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101597995|NCT00855595|Antimalarials|antimalarials|mesh-ancestor
101597996|NCT00855595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101598018|NCT02730442|Fluconazole|fluconazole|mesh-list
101598019|NCT02730442|Antifungal Agents|antifungal agents|mesh-list
101598020|NCT02730442|Clotrimazole|clotrimazole|mesh-list
101598021|NCT02730442|Miconazole|miconazole|mesh-list
101598022|NCT02730442|Olorofim|olorofim|mesh-list
101598023|NCT02730442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101598024|NCT02730442|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101598025|NCT02730442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101598026|NCT02730442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101598027|NCT02730442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598028|NCT02730442|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101598029|NCT02730442|Hormone Antagonists|hormone antagonists|mesh-ancestor
101254986|NCT01701921|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101598030|NCT02730442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101598031|NCT02730442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598032|NCT02730442|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101598033|NCT02730442|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101598034|NCT02730442|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101598035|NCT02730442|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101598036|NCT02733874|Betamethasone|betamethasone|mesh-list
101598037|NCT02733874|Clobetasol|clobetasol|mesh-list
101598038|NCT02733874|Calcipotriene|calcipotriene|mesh-list
101598039|NCT02733874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101621928|NCT02795949|beta-Lactams|beta-lactams|mesh-list
101621929|NCT02795949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101621930|NCT02795949|Trimethoprim|trimethoprim|mesh-list
101621931|NCT02795949|Sulfamethoxazole|sulfamethoxazole|mesh-list
101621932|NCT02795949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101621933|NCT02795949|Antitubercular Agents|antitubercular agents|mesh-ancestor
101621934|NCT02795949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101621935|NCT02795949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101621936|NCT02795949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101621937|NCT02795949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621938|NCT02795949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621939|NCT02795949|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101621940|NCT02795949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101621941|NCT02795949|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101621942|NCT02795949|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101621943|NCT02795949|Antimalarials|antimalarials|mesh-ancestor
101621944|NCT02795949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101420644|NCT00148395|Ifosfamide|ifosfamide|mesh-list
101598040|NCT02733874|Glucocorticoids|glucocorticoids|mesh-ancestor
101598041|NCT02733874|Hormones|hormones|mesh-ancestor
101598042|NCT02733874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101598043|NCT02733874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598044|NCT02733874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101598045|NCT02733874|Respiratory System Agents|respiratory system agents|mesh-ancestor
101598046|NCT02733874|Dermatologic Agents|dermatologic agents|mesh-ancestor
101598047|NCT02730364|Acetaminophen|acetaminophen|mesh-list
101598048|NCT02730364|Pheniramine|pheniramine|mesh-list
101598049|NCT02730364|Phenylephrine|phenylephrine|mesh-list
101598050|NCT02730364|Oxymetazoline|oxymetazoline|mesh-list
101598051|NCT02730364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598060|NCT02730364|Mydriatics|mydriatics|mesh-ancestor
101598061|NCT02730364|Autonomic Agents|autonomic agents|mesh-ancestor
101598062|NCT02730364|Sympathomimetics|sympathomimetics|mesh-ancestor
101598063|NCT02730364|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101598064|NCT02730364|Nasal Decongestants|nasal decongestants|mesh-ancestor
101598065|NCT02730364|Respiratory System Agents|respiratory system agents|mesh-ancestor
101598066|NCT02730364|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101598067|NCT02730364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101598068|NCT02730364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101598069|NCT02730364|Adrenergic Agents|adrenergic agents|mesh-ancestor
101598070|NCT02730364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101598071|NCT02730364|Antipruritics|antipruritics|mesh-ancestor
101598072|NCT02730364|Dermatologic Agents|dermatologic agents|mesh-ancestor
101598073|NCT02730364|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101598074|NCT02730364|Histamine Antagonists|histamine antagonists|mesh-ancestor
101598075|NCT02730364|Histamine Agents|histamine agents|mesh-ancestor
101598076|NCT02730364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101598077|NCT01042392|Ramipril|ramipril|mesh-list
101598078|NCT01042392|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101598079|NCT01042392|Protease Inhibitors|protease inhibitors|mesh-ancestor
101598080|NCT01042392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101598081|NCT01042392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598082|NCT01042392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101598083|NCT00704665|Methocarbamol|methocarbamol|mesh-list
101598084|NCT00704665|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101598085|NCT00704665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598086|NCT00704665|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101621945|NCT02795949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101621946|NCT02795949|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101621947|NCT02795949|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101621948|NCT02795949|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101621949|NCT00769483|Gemcitabine|gemcitabine|mesh-list
101621950|NCT00769483|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101621951|NCT00769483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101621952|NCT00769483|Antimetabolites|antimetabolites|mesh-ancestor
101621953|NCT00769483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621954|NCT00769483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101621955|NCT00769483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101420662|NCT02276677|Oxytocics|oxytocics|mesh-ancestor
101598087|NCT00704665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101598088|NCT00913315|Tamsulosin|tamsulosin|mesh-list
101598089|NCT00913315|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101598090|NCT00913315|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101598091|NCT00913315|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101598092|NCT00913315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101598093|NCT00913315|Adrenergic Agents|adrenergic agents|mesh-ancestor
101598094|NCT00913315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101598095|NCT00913315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598096|NCT00913315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598097|NCT00913315|Urological Agents|urological agents|mesh-ancestor
101598098|NCT00913315|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101598099|NCT00913315|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101598100|NCT00913315|Cholinergic Agents|cholinergic agents|mesh-ancestor
101598101|NCT00701857|Pemetrexed|pemetrexed|mesh-list
101598102|NCT00701857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101598103|NCT00701857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101598104|NCT00701857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598105|NCT00701857|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101598106|NCT00701857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101598107|NCT02729662|Tolvaptan|tolvaptan|mesh-list
101598108|NCT02729662|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101598109|NCT02729662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598111|NCT02729662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598112|NCT02733250|Paclitaxel|paclitaxel|mesh-list
101598113|NCT02733250|Pembrolizumab|pembrolizumab|mesh-list
101598114|NCT02733250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101598115|NCT02733250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101598116|NCT02733250|Tubulin Modulators|tubulin modulators|mesh-ancestor
101598117|NCT02733250|Antimitotic Agents|antimitotic agents|mesh-ancestor
101598118|NCT02733250|Mitosis Modulators|mitosis modulators|mesh-ancestor
101598139|NCT01064310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101598140|NCT01064310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101598141|NCT01064310|Growth Substances|growth substances|mesh-ancestor
101598142|NCT01064310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598143|NCT01064310|Growth Inhibitors|growth inhibitors|mesh-ancestor
101598144|NCT01064310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101598145|NCT01064310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101598146|NCT01064310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598147|NCT02726854|Apatinib|apatinib|mesh-list
101598148|NCT02726854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101598149|NCT02726854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101598150|NCT02726854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101598151|NCT02726854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598152|NCT04724928|Immunomodulating Agents|immunomodulating agents|mesh-list
101598153|NCT04724928|Immunologic Factors|immunologic factors|mesh-ancestor
101598154|NCT04724928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598155|NCT02728492|Paclitaxel|paclitaxel|mesh-list
101621956|NCT00769483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101621957|NCT02794389|Acetylcysteine|acetylcysteine|mesh-list
101621958|NCT02794389|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101621959|NCT02794389|Antiviral Agents|antiviral agents|mesh-ancestor
101621960|NCT02794389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101621961|NCT02794389|Expectorants|expectorants|mesh-ancestor
101621962|NCT02794389|Respiratory System Agents|respiratory system agents|mesh-ancestor
101621963|NCT02794389|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101621964|NCT02794389|Antioxidants|antioxidants|mesh-ancestor
101420671|NCT00156858|Busulfan|busulfan|mesh-list
101598156|NCT02728492|Carboplatin|carboplatin|mesh-list
101598157|NCT02728492|Gemcitabine|gemcitabine|mesh-list
101598158|NCT02728492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101598159|NCT02728492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101598160|NCT02728492|Tubulin Modulators|tubulin modulators|mesh-ancestor
101598161|NCT02728492|Antimitotic Agents|antimitotic agents|mesh-ancestor
101598162|NCT02728492|Mitosis Modulators|mitosis modulators|mesh-ancestor
101598163|NCT02728492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598164|NCT02728492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101598165|NCT02728492|Antimetabolites|antimetabolites|mesh-ancestor
101598166|NCT02726308|Dexamethasone|dexamethasone|mesh-list
101598167|NCT02726308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101598168|NCT02726308|Antiemetics|antiemetics|mesh-ancestor
101598169|NCT02726308|Autonomic Agents|autonomic agents|mesh-ancestor
101598170|NCT02726308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101598171|NCT02726308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598177|NCT02726308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101598178|NCT01037244|Udenafil|udenafil|mesh-list
101598179|NCT01037244|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101598180|NCT01037244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101598181|NCT01037244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101255131|NCT01702974|Vitamins|vitamins|mesh-ancestor
101598182|NCT01037244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598183|NCT00627432|Gemcitabine|gemcitabine|mesh-list
101598184|NCT00627432|Oxaliplatin|oxaliplatin|mesh-list
101598185|NCT00627432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101598186|NCT00627432|Antimetabolites|antimetabolites|mesh-ancestor
101598187|NCT00627432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598188|NCT00627432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101598189|NCT02727712|Anesthetics|anesthetics|mesh-list
101598190|NCT02727712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101598191|NCT02727712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598192|NCT01042236|Fesoterodine|fesoterodine|mesh-list
101598193|NCT01042236|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101598194|NCT01042236|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101598195|NCT01042236|Cholinergic Agents|cholinergic agents|mesh-ancestor
101598196|NCT01042236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101598197|NCT01042236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598198|NCT01042236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598199|NCT01042236|Urological Agents|urological agents|mesh-ancestor
101598200|NCT02725918|Pemetrexed|pemetrexed|mesh-list
101598201|NCT02725918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101598202|NCT02725918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101598203|NCT02725918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598204|NCT02725918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101598205|NCT02725918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101598206|NCT00592501|Fluorouracil|fluorouracil|mesh-list
101598207|NCT00592501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101598208|NCT00592501|Antimetabolites|antimetabolites|mesh-ancestor
101598209|NCT00592501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598210|NCT00592501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101598211|NCT00592501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101598212|NCT00592501|Immunologic Factors|immunologic factors|mesh-ancestor
101598213|NCT00592501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598214|NCT01040832|Cetuximab|cetuximab|mesh-list
101598215|NCT01040832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101621965|NCT02794389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621966|NCT02794389|Protective Agents|protective agents|mesh-ancestor
101621967|NCT02794389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621968|NCT02794389|Antidotes|antidotes|mesh-ancestor
101621969|NCT02601703|Tacrolimus|tacrolimus|mesh-list
101621970|NCT02601703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101621971|NCT02601703|Immunologic Factors|immunologic factors|mesh-ancestor
101621972|NCT02601703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621973|NCT02601703|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101621974|NCT02601703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101598216|NCT01040832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101598217|NCT02721238|Plasma-lyte 148|plasma-lyte 148|mesh-list
101598218|NCT02721238|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101598219|NCT02721238|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101598220|NCT04304196|TEMPO|tempo|mesh-list
101598221|NCT04304196|Antioxidants|antioxidants|mesh-ancestor
101598222|NCT04304196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598223|NCT04304196|Protective Agents|protective agents|mesh-ancestor
101598224|NCT04304196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598225|NCT02720770|Hormones|hormones|mesh-list
101598226|NCT02720770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101598227|NCT02720770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598228|NCT02720926|Capecitabine|capecitabine|mesh-list
101598229|NCT02720926|Oxaliplatin|oxaliplatin|mesh-list
101598230|NCT02720926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101598231|NCT02720926|Antimetabolites|antimetabolites|mesh-ancestor
101598232|NCT02720926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598233|NCT02720926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101598234|NCT00854581|Interferons|interferons|mesh-list
101598235|NCT00854581|Interferon-alpha|interferon-alpha|mesh-list
101598236|NCT00854581|Interferon alpha-2|interferon alpha-2|mesh-list
101598237|NCT00854581|Zidovudine|zidovudine|mesh-list
101598238|NCT00854581|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101598239|NCT00854581|Valproic Acid|valproic acid|mesh-list
101598250|NCT00854581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101598251|NCT00854581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101598252|NCT00854581|Anticonvulsants|anticonvulsants|mesh-ancestor
101598253|NCT00854581|GABA Agents|gaba agents|mesh-ancestor
101598254|NCT00854581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101598255|NCT00854581|Antimanic Agents|antimanic agents|mesh-ancestor
101598256|NCT00854581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101598257|NCT00854581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101598258|NCT00854581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101598259|NCT02720458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
101598260|NCT02720458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101598261|NCT02720458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598263|NCT00833911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101598264|NCT00833911|Narcotics|narcotics|mesh-ancestor
101598265|NCT00833911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101598266|NCT00833911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598267|NCT00833911|Analgesics|analgesics|mesh-ancestor
101598268|NCT00833911|Sensory System Agents|sensory system agents|mesh-ancestor
101598269|NCT00833911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101598270|NCT02719756|Metformin|metformin|mesh-list
101598271|NCT02719756|Dapagliflozin|dapagliflozin|mesh-list
101598272|NCT02719756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101598273|NCT02719756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598274|NCT02719756|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101598275|NCT02719756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598276|NCT01125293|Rituximab|rituximab|mesh-list
101598277|NCT01125293|Everolimus|everolimus|mesh-list
101598278|NCT01125293|Bortezomib|bortezomib|mesh-list
101598279|NCT01125293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101598280|NCT01125293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101598281|NCT01125293|Immunologic Factors|immunologic factors|mesh-ancestor
101621975|NCT02601703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621977|NCT04234191|Hydromorphone|hydromorphone|mesh-list
101621978|NCT04234191|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101621979|NCT04234191|Naloxone|naloxone|mesh-list
101621980|NCT04234191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101621981|NCT04234191|Narcotics|narcotics|mesh-ancestor
101598282|NCT01125293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598283|NCT01125293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101598284|NCT01125293|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101598285|NCT01125293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101598286|NCT01125293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101598287|NCT01125293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598288|NCT01125293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101598289|NCT02719834|Acetaminophen|acetaminophen|mesh-list
101598290|NCT02719834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101598291|NCT02719834|Analgesics|analgesics|mesh-ancestor
101598292|NCT02719834|Sensory System Agents|sensory system agents|mesh-ancestor
101598293|NCT02719834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101598294|NCT02719834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598295|NCT02719834|Antipyretics|antipyretics|mesh-ancestor
101598296|NCT02719210|Mannitol|mannitol|mesh-list
101598297|NCT02719210|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101598298|NCT02719210|Diuretics|diuretics|mesh-ancestor
101598299|NCT02719210|Natriuretic Agents|natriuretic agents|mesh-ancestor
101598300|NCT02719210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598301|NCT02719132|Metformin|metformin|mesh-list
101598302|NCT02719132|Dapagliflozin|dapagliflozin|mesh-list
101598303|NCT02719132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101598304|NCT02719132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598305|NCT02719132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101598306|NCT02719132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598307|NCT02718820|Docetaxel|docetaxel|mesh-list
101598312|NCT02718820|Mitosis Modulators|mitosis modulators|mesh-ancestor
101598313|NCT02718820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598314|NCT02718820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101598315|NCT02718820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101598316|NCT02718976|Lidocaine|lidocaine|mesh-list
101598318|NCT02718976|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
101598319|NCT02718976|Anesthetics, Local|anesthetics, local|mesh-ancestor
101598320|NCT02718976|Anesthetics|anesthetics|mesh-ancestor
101598321|NCT02718976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101598322|NCT02718976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598323|NCT02718976|Sensory System Agents|sensory system agents|mesh-ancestor
101598324|NCT02718976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101598325|NCT02718976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101598326|NCT02718976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101598327|NCT02718976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101598328|NCT02718976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101598329|NCT02718976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255299|NCT01704027|Androgens|androgens|mesh-list
101598330|NCT02718976|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101598331|NCT02718976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101598332|NCT02718976|Adrenergic Agents|adrenergic agents|mesh-ancestor
101598333|NCT02718976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101598334|NCT02718976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101598335|NCT02718976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101598336|NCT02718976|Autonomic Agents|autonomic agents|mesh-ancestor
101598337|NCT02718976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101598338|NCT02718976|Respiratory System Agents|respiratory system agents|mesh-ancestor
101598339|NCT02718976|Mydriatics|mydriatics|mesh-ancestor
101598340|NCT02718976|Sympathomimetics|sympathomimetics|mesh-ancestor
101598341|NCT02718976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101598342|NCT02718976|Chelating Agents|chelating agents|mesh-ancestor
101598343|NCT02718976|Sequestering Agents|sequestering agents|mesh-ancestor
101598344|NCT02718742|Paclitaxel|paclitaxel|mesh-list
101598345|NCT02718742|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101598346|NCT02718742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101621982|NCT04234191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101621983|NCT04234191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621984|NCT04234191|Analgesics|analgesics|mesh-ancestor
101621985|NCT04234191|Sensory System Agents|sensory system agents|mesh-ancestor
101621986|NCT04234191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101621987|NCT04234191|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101621988|NCT02801799|Ropivacaine|ropivacaine|mesh-list
101598347|NCT02718742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101598348|NCT02718742|Tubulin Modulators|tubulin modulators|mesh-ancestor
101598349|NCT02718742|Antimitotic Agents|antimitotic agents|mesh-ancestor
101598350|NCT02718742|Mitosis Modulators|mitosis modulators|mesh-ancestor
101598351|NCT02718742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598352|NCT02717884|Cytarabine|cytarabine|mesh-list
101598353|NCT02717884|Tretinoin|tretinoin|mesh-list
101598354|NCT02717884|Tranylcypromine|tranylcypromine|mesh-list
101598355|NCT02717884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101598356|NCT02717884|Antimetabolites|antimetabolites|mesh-ancestor
101598357|NCT02717884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598358|NCT02717884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101598359|NCT02717884|Antiviral Agents|antiviral agents|mesh-ancestor
101598360|NCT02717884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101598361|NCT02717884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101598362|NCT02717884|Immunologic Factors|immunologic factors|mesh-ancestor
101598363|NCT02717884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598364|NCT02717884|Keratolytic Agents|keratolytic agents|mesh-ancestor
101598365|NCT02717884|Dermatologic Agents|dermatologic agents|mesh-ancestor
101598366|NCT02717884|Antidepressive Agents|antidepressive agents|mesh-ancestor
101598367|NCT02717884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101598368|NCT02717884|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101598369|NCT02717884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101598370|NCT02717884|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101598371|NCT02717884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101598372|NCT02717884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101598373|NCT02717572|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101598374|NCT02717572|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101598375|NCT02717572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598376|NCT01121393|Gemcitabine|gemcitabine|mesh-list
101598377|NCT01121393|Afatinib|afatinib|mesh-list
101598378|NCT01121393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101598385|NCT02882477|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101598386|NCT02882477|Acetylcysteine|acetylcysteine|mesh-list
101598387|NCT02882477|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101598388|NCT02882477|Deferiprone|deferiprone|mesh-list
101598389|NCT02882477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101598390|NCT02882477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598391|NCT02882477|Incretins|incretins|mesh-ancestor
101598392|NCT02882477|Hormones|hormones|mesh-ancestor
101598393|NCT02882477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101598394|NCT02882477|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101598395|NCT02882477|Protease Inhibitors|protease inhibitors|mesh-ancestor
101598396|NCT02882477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101598397|NCT02882477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598398|NCT02882477|Antiviral Agents|antiviral agents|mesh-ancestor
101598399|NCT02882477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101598400|NCT02882477|Expectorants|expectorants|mesh-ancestor
101598401|NCT02882477|Respiratory System Agents|respiratory system agents|mesh-ancestor
101598402|NCT02882477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101598403|NCT02882477|Antioxidants|antioxidants|mesh-ancestor
101598404|NCT02882477|Protective Agents|protective agents|mesh-ancestor
101598405|NCT02882477|Antidotes|antidotes|mesh-ancestor
101598406|NCT02882477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101598407|NCT02882477|Chelating Agents|chelating agents|mesh-ancestor
101598408|NCT02882477|Sequestering Agents|sequestering agents|mesh-ancestor
101598409|NCT04163224|Imidacloprid|imidacloprid|mesh-list
101598410|NCT04163224|Cholinergic Agents|cholinergic agents|mesh-ancestor
101598411|NCT04163224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101598412|NCT04163224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598413|NCT04163224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598414|NCT02716792|Ibandronic Acid|ibandronic acid|mesh-list
101621989|NCT02801799|Anesthetics, Local|anesthetics, local|mesh-ancestor
101621990|NCT02801799|Anesthetics|anesthetics|mesh-ancestor
101621991|NCT02801799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101621992|NCT02801799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101621993|NCT02801799|Sensory System Agents|sensory system agents|mesh-ancestor
101621994|NCT02801799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101621995|NCT02690103|Ribavirin|ribavirin|mesh-list
101621996|NCT02690103|Antimetabolites|antimetabolites|mesh-ancestor
101621997|NCT02690103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101621998|NCT02690103|Antiviral Agents|antiviral agents|mesh-ancestor
101621999|NCT02690103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101598415|NCT02716792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101598416|NCT02716792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598417|NCT04964284|Hormones|hormones|mesh-list
101598418|NCT04964284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101598419|NCT04964284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598420|NCT02716090|Adapalene|adapalene|mesh-list
101598421|NCT02716090|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101598422|NCT02716090|Dermatologic Agents|dermatologic agents|mesh-ancestor
101598423|NCT02716090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101598424|NCT02716090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101598425|NCT02716090|Analgesics|analgesics|mesh-ancestor
101598426|NCT02716090|Sensory System Agents|sensory system agents|mesh-ancestor
101598427|NCT02716090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101598428|NCT02716090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598429|NCT02716090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101598430|NCT02716090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101598431|NCT01227616|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
101598432|NCT01227616|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101598433|NCT01227616|Hematinics|hematinics|mesh-ancestor
101598434|NCT01227616|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101598435|NCT01227616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101598436|NCT04189276|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101598437|NCT04189276|Antiviral Agents|antiviral agents|mesh-ancestor
101598438|NCT04189276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101598439|NCT02714998|Methotrexate|methotrexate|mesh-list
101598440|NCT02714998|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101598441|NCT02714998|Abortifacient Agents|abortifacient agents|mesh-ancestor
101598442|NCT02714998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101598443|NCT02714998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598444|NCT02714998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101598445|NCT02714998|Antimetabolites|antimetabolites|mesh-ancestor
101598446|NCT02714998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598447|NCT02714998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101598457|NCT00765310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598459|NCT00765310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598460|NCT00765310|Vitamin B Complex|vitamin b complex|mesh-ancestor
101598461|NCT00765310|Vitamins|vitamins|mesh-ancestor
101598462|NCT00765310|Micronutrients|micronutrients|mesh-ancestor
101598463|NCT02715154|Dexmedetomidine|dexmedetomidine|mesh-list
101598464|NCT02715154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101598465|NCT02715154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101598466|NCT02715154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598467|NCT02715154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101598468|NCT02715154|Analgesics|analgesics|mesh-ancestor
101598469|NCT02715154|Sensory System Agents|sensory system agents|mesh-ancestor
101598470|NCT02715154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101598471|NCT02715154|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101598472|NCT02715154|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101598473|NCT02715154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101598474|NCT02715154|Adrenergic Agents|adrenergic agents|mesh-ancestor
101598475|NCT02715154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101622001|NCT02790099|Bupivacaine|bupivacaine|mesh-list
101622002|NCT02790099|Anesthetics, Local|anesthetics, local|mesh-ancestor
101622003|NCT02790099|Anesthetics|anesthetics|mesh-ancestor
101622004|NCT02790099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101622005|NCT02790099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622006|NCT02790099|Sensory System Agents|sensory system agents|mesh-ancestor
101622007|NCT02790099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101622008|NCT02790099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101622009|NCT02790099|Narcotics|narcotics|mesh-ancestor
101622010|NCT02790099|Analgesics|analgesics|mesh-ancestor
101622011|NCT02790177|Hyaluronic Acid|hyaluronic acid|mesh-list
101622012|NCT02790177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101622013|NCT02790177|Immunologic Factors|immunologic factors|mesh-ancestor
101622014|NCT02790177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622015|NCT02790177|Viscosupplements|viscosupplements|mesh-ancestor
101598476|NCT02715154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598477|NCT02715232|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101598478|NCT02715232|Cyproterone Acetate|cyproterone acetate|mesh-list
101598479|NCT02715232|Lynestrenol|lynestrenol|mesh-list
101598480|NCT02715232|Estradiol|estradiol|mesh-list
101598481|NCT02715232|Testosterone|testosterone|mesh-list
101598483|NCT02715232|Estrogens|estrogens|mesh-ancestor
101598484|NCT02715232|Hormones|hormones|mesh-ancestor
101598485|NCT02715232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101598486|NCT02715232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598487|NCT02715232|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101598488|NCT02715232|Contraceptive Agents|contraceptive agents|mesh-ancestor
101598489|NCT02715232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101598490|NCT02715232|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101598491|NCT02715232|Androgens|androgens|mesh-ancestor
101598492|NCT02715232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101598493|NCT02715232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101598494|NCT02715232|Luteolytic Agents|luteolytic agents|mesh-ancestor
101598495|NCT02715232|Androgen Antagonists|androgen antagonists|mesh-ancestor
101598496|NCT02715232|Hormone Antagonists|hormone antagonists|mesh-ancestor
101598497|NCT02715232|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101598498|NCT02715232|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101598499|NCT02715232|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101598500|NCT02715232|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101598501|NCT02693860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101598502|NCT02693860|Immunologic Factors|immunologic factors|mesh-ancestor
101598503|NCT02693860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598504|NCT02714842|Diclofenac|diclofenac|mesh-list
101598505|NCT02714842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101598506|NCT02714842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101598507|NCT02714842|Analgesics|analgesics|mesh-ancestor
101598508|NCT02714842|Sensory System Agents|sensory system agents|mesh-ancestor
101598509|NCT02714842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101598510|NCT02714842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598511|NCT02714842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101598512|NCT02714842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101598513|NCT02714842|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101598514|NCT02714842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101598518|NCT02714530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101598519|NCT02714530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101598520|NCT02714530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598521|NCT02713750|Contraceptive Agents|contraceptive agents|mesh-list
101598522|NCT02713750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101598523|NCT02713750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622016|NCT02790177|Protective Agents|protective agents|mesh-ancestor
101622017|NCT04100083|Spironolactone|spironolactone|mesh-list
101622018|NCT04100083|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101622019|NCT04100083|Hormone Antagonists|hormone antagonists|mesh-ancestor
101622020|NCT04100083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101622021|NCT04100083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622022|NCT04100083|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101622023|NCT04100083|Diuretics|diuretics|mesh-ancestor
101622024|NCT04100083|Natriuretic Agents|natriuretic agents|mesh-ancestor
101622025|NCT02794155|Insulin|insulin|mesh-list
101598524|NCT04738162|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101598525|NCT04738162|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101598526|NCT04738162|Dermatologic Agents|dermatologic agents|mesh-ancestor
101598527|NCT04000906|Paclitaxel|paclitaxel|mesh-list
101598528|NCT04000906|Cisplatin|cisplatin|mesh-list
101598529|NCT04000906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101598530|NCT04000906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101598531|NCT04000906|Tubulin Modulators|tubulin modulators|mesh-ancestor
101598532|NCT04000906|Antimitotic Agents|antimitotic agents|mesh-ancestor
101598533|NCT04000906|Mitosis Modulators|mitosis modulators|mesh-ancestor
101598534|NCT04000906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598535|NCT00636766|Metformin|metformin|mesh-list
101598536|NCT00636766|Rosiglitazone|rosiglitazone|mesh-list
101598537|NCT00636766|Rimonabant|rimonabant|mesh-list
101598538|NCT00636766|Atorvastatin|atorvastatin|mesh-list
101598539|NCT00636766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101598540|NCT00636766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598541|NCT00636766|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101598542|NCT00636766|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101598543|NCT00636766|Antimetabolites|antimetabolites|mesh-ancestor
101598544|NCT00636766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598545|NCT00636766|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101598546|NCT00636766|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101598547|NCT00636766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101598548|NCT00636766|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101598549|NCT00636766|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
101598550|NCT00636766|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101598551|NCT00636766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101598552|NCT00636766|Hormones|hormones|mesh-ancestor
101598553|NCT00636766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101598554|NCT03998176|Tenofovir|tenofovir|mesh-list
101598555|NCT03998176|Emtricitabine|emtricitabine|mesh-list
101598556|NCT03998176|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
101598557|NCT03998176|Antiviral Agents|antiviral agents|mesh-ancestor
101598558|NCT03998176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101598559|NCT03998176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101598560|NCT03998176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101598561|NCT03998176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101598562|NCT03998176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598563|NCT03998176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101598564|NCT03998176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101598565|NCT02713282|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101598566|NCT02713282|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101598567|NCT02713282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101598568|NCT02713282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101598569|NCT02713282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598570|NCT02713282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101598571|NCT02713282|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101598572|NCT02713282|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101598573|NCT02713282|Serotonin Agents|serotonin agents|mesh-ancestor
101598574|NCT02713282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101598575|NCT02713282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598576|NCT02713282|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101598577|NCT02713282|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101622026|NCT02794155|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101622028|NCT02794155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101622029|NCT02794155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622030|NCT02793843|Dexamethasone|dexamethasone|mesh-list
101622031|NCT02793843|Ondansetron|ondansetron|mesh-list
101622032|NCT02793843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101622033|NCT02793843|Antiemetics|antiemetics|mesh-ancestor
101622034|NCT02793843|Autonomic Agents|autonomic agents|mesh-ancestor
101622035|NCT02793843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101622036|NCT02793843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622037|NCT02793843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101598578|NCT02713282|Dopamine Agents|dopamine agents|mesh-ancestor
101598579|NCT00611416|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
101598581|NCT00611416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101598582|NCT00611416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598583|NCT00611416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101598584|NCT00611416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101598595|NCT00611416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101598597|NCT02712658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101598598|NCT02712658|Autonomic Agents|autonomic agents|mesh-ancestor
101598599|NCT02712658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101598600|NCT02712658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598601|NCT02712658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101598602|NCT02712658|Respiratory System Agents|respiratory system agents|mesh-ancestor
101598603|NCT02712658|Sympathomimetics|sympathomimetics|mesh-ancestor
101598604|NCT02712658|Tocolytic Agents|tocolytic agents|mesh-ancestor
101598605|NCT02712658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101598606|NCT02712658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101598607|NCT02712658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101598608|NCT02712658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101598609|NCT02712658|Adrenergic Agents|adrenergic agents|mesh-ancestor
101598610|NCT02712658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101264662|NCT01768884|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101598611|NCT02712658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598612|NCT00611494|Mycophenolic Acid|mycophenolic acid|mesh-list
101598613|NCT00611494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101598614|NCT00611494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101598615|NCT00611494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101598616|NCT00611494|Antitubercular Agents|antitubercular agents|mesh-ancestor
101598617|NCT00611494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101598618|NCT00611494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101598619|NCT00611494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101598620|NCT00611494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598621|NCT02712502|Amoxicillin|amoxicillin|mesh-list
101598622|NCT02712502|Levofloxacin|levofloxacin|mesh-list
101598623|NCT02712502|Clavulanic Acid|clavulanic acid|mesh-list
101598624|NCT02712502|Clavulanic Acids|clavulanic acids|mesh-list
101598625|NCT02712502|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101598626|NCT02712502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101598627|NCT02712502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101598628|NCT02712502|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101598630|NCT02712502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101598631|NCT02712502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101598632|NCT02712502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598633|NCT02712502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101598634|NCT02712502|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101598635|NCT02712502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101598636|NCT02712502|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101598637|NCT02712346|Ambrisentan|ambrisentan|mesh-list
101598638|NCT02712346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101598639|NCT04617028|Hydroxyurea|hydroxyurea|mesh-list
101622038|NCT02793843|Glucocorticoids|glucocorticoids|mesh-ancestor
101622039|NCT02793843|Hormones|hormones|mesh-ancestor
101622040|NCT02793843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101622041|NCT02793843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101622042|NCT02793843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101622043|NCT02793843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622044|NCT02793843|Antipruritics|antipruritics|mesh-ancestor
101622045|NCT02793843|Dermatologic Agents|dermatologic agents|mesh-ancestor
101622046|NCT02793843|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101420749|NCT05594342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101598640|NCT04617028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101598641|NCT04617028|Antisickling Agents|antisickling agents|mesh-ancestor
101598642|NCT04617028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101598643|NCT04617028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598644|NCT04617028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101598645|NCT02711410|Clopidogrel|clopidogrel|mesh-list
101598646|NCT02711410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101598657|NCT02711176|Esomeprazole|esomeprazole|mesh-list
101598658|NCT02711176|Lansoprazole|lansoprazole|mesh-list
101598659|NCT02711176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101598660|NCT02711176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101598661|NCT02711176|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101598662|NCT02711176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101598663|NCT02711176|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101598664|NCT02711176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101598665|NCT02711176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598666|NCT02711176|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101598667|NCT02711176|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101598668|NCT02711176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101598669|NCT02711176|Alkylating Agents|alkylating agents|mesh-ancestor
101598670|NCT02711176|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
101598671|NCT02711176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101598672|NCT02711176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101598673|NCT00611650|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
101598674|NCT00611650|Antioxidants|antioxidants|mesh-ancestor
101598675|NCT00611650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598676|NCT00611650|Protective Agents|protective agents|mesh-ancestor
101598677|NCT00611650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598678|NCT00611650|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101598679|NCT00611650|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101598680|NCT00611650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101598681|NCT00611650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101598682|NCT02710552|Amlodipine|amlodipine|mesh-list
101598683|NCT02710552|Antihypertensive Agents|antihypertensive agents|mesh-list
101598685|NCT02710552|Indapamide|indapamide|mesh-list
101598686|NCT02710552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101598687|NCT02710552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101598688|NCT02710552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598689|NCT02710552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101598690|NCT02710552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598691|NCT02710552|Vasodilator Agents|vasodilator agents|mesh-ancestor
101598692|NCT02710552|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101598693|NCT02710552|Protease Inhibitors|protease inhibitors|mesh-ancestor
101598694|NCT02710552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101598695|NCT02710552|Diuretics|diuretics|mesh-ancestor
101598696|NCT02710552|Natriuretic Agents|natriuretic agents|mesh-ancestor
101598697|NCT02710552|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101598698|NCT02710396|Paclitaxel|paclitaxel|mesh-list
101598699|NCT02710396|Carboplatin|carboplatin|mesh-list
101598700|NCT02710396|Pembrolizumab|pembrolizumab|mesh-list
101255678|NCT01706510|Ticagrelor|ticagrelor|mesh-list
101598701|NCT02710396|Pemetrexed|pemetrexed|mesh-list
101622047|NCT02793843|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101622049|NCT02793843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101622050|NCT02793687|Emoxypine succinate|emoxypine succinate|mesh-list
101622051|NCT02793687|Antioxidants|antioxidants|mesh-ancestor
101622052|NCT02793687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279094|NCT01876615|Sensory System Agents|sensory system agents|mesh-ancestor
101622053|NCT02793687|Protective Agents|protective agents|mesh-ancestor
101622054|NCT02793687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622055|NCT02793687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101598702|NCT02710396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101598703|NCT02710396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101598704|NCT02710396|Tubulin Modulators|tubulin modulators|mesh-ancestor
101598705|NCT02710396|Antimitotic Agents|antimitotic agents|mesh-ancestor
101598706|NCT02710396|Mitosis Modulators|mitosis modulators|mesh-ancestor
101598707|NCT02710396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598708|NCT02710396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101598709|NCT02710396|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101598710|NCT02710396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101598725|NCT00611728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101598726|NCT00611728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101338533|NCT00072904|Repaglinide|repaglinide|mesh-list
101598727|NCT00611728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101598728|NCT00611728|Growth Substances|growth substances|mesh-ancestor
101598729|NCT00611728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598730|NCT00611728|Growth Inhibitors|growth inhibitors|mesh-ancestor
101598731|NCT00611728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101598732|NCT02709304|Lidocaine|lidocaine|mesh-list
101598733|NCT02709304|Anesthetics, Local|anesthetics, local|mesh-ancestor
101598734|NCT02709304|Anesthetics|anesthetics|mesh-ancestor
101598735|NCT02709304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101598736|NCT02709304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598737|NCT02709304|Sensory System Agents|sensory system agents|mesh-ancestor
101598738|NCT02709304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101598739|NCT02709304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101598740|NCT02709304|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101598741|NCT02709304|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101598742|NCT02709304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101598743|NCT02709304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598744|NCT04189666|Melatonin|melatonin|mesh-list
101598745|NCT04189666|Rivastigmine|rivastigmine|mesh-list
101598746|NCT04189666|Antioxidants|antioxidants|mesh-ancestor
101598747|NCT04189666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598748|NCT04189666|Protective Agents|protective agents|mesh-ancestor
101598749|NCT04189666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598750|NCT04189666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101598751|NCT04189666|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101598752|NCT04189666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101598753|NCT04189666|Cholinergic Agents|cholinergic agents|mesh-ancestor
101598754|NCT04189666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101598755|NCT04189666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101598756|NCT03944512|Pravastatin|pravastatin|mesh-list
101598757|NCT03944512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101598758|NCT03944512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101598759|NCT03944512|Antimetabolites|antimetabolites|mesh-ancestor
101598760|NCT03944512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598761|NCT03944512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101598762|NCT03944512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101598763|NCT03944512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101598764|NCT00937521|Antipyretics|antipyretics|mesh-list
101598765|NCT00937521|Vaccines|vaccines|mesh-list
101598766|NCT00937521|Immunologic Factors|immunologic factors|mesh-ancestor
101598767|NCT00937521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598768|NCT02709382|Tazobactam|tazobactam|mesh-list
101622056|NCT02793687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101622058|NCT02801487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101622059|NCT02793765|Docetaxel|docetaxel|mesh-list
101622060|NCT02793765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101622061|NCT02793765|Tubulin Modulators|tubulin modulators|mesh-ancestor
101622062|NCT02793765|Antimitotic Agents|antimitotic agents|mesh-ancestor
101622063|NCT02793765|Mitosis Modulators|mitosis modulators|mesh-ancestor
101622064|NCT02793765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622065|NCT02793219|Docetaxel|docetaxel|mesh-list
101622066|NCT02793219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101622067|NCT02793219|Tubulin Modulators|tubulin modulators|mesh-ancestor
101622068|NCT02793219|Antimitotic Agents|antimitotic agents|mesh-ancestor
101622069|NCT02793219|Mitosis Modulators|mitosis modulators|mesh-ancestor
101622070|NCT02793219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622071|NCT02801409|Anesthetics|anesthetics|mesh-list
101622072|NCT02801409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101622073|NCT02801409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622074|NCT03787251|Apatinib|apatinib|mesh-list
101622075|NCT03787251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101622076|NCT03787251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101622077|NCT03787251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101420770|NCT00507793|Dermatologic Agents|dermatologic agents|mesh-ancestor
101420771|NCT00507793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101338543|NCT00072943|Antiviral Agents|antiviral agents|mesh-ancestor
101420772|NCT00507793|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101420773|NCT00507793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101420774|NCT00507793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101420775|NCT00507793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101420776|NCT00507832|Hydrocortisone|hydrocortisone|mesh-list
101420777|NCT00507832|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101420778|NCT00507832|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101420779|NCT00507832|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101420780|NCT00507832|Pimecrolimus|pimecrolimus|mesh-list
101420781|NCT00507832|Tacrolimus|tacrolimus|mesh-list
101420782|NCT00507832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101420784|NCT00507832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101622078|NCT03787251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622079|NCT02789865|Metronidazole|metronidazole|mesh-list
101622080|NCT02789865|Levofloxacin|levofloxacin|mesh-list
101622081|NCT02789865|Ertapenem|ertapenem|mesh-list
101622082|NCT02789865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101622083|NCT02789865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101622084|NCT02789865|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101622085|NCT02789865|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101622086|NCT02789865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101622087|NCT02789865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101622088|NCT02789865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101622089|NCT02789865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101622090|NCT02789865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622091|NCT02789865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101622092|NCT02789865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101622093|NCT02789865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101622094|NCT02792673|Hyaluronic Acid|hyaluronic acid|mesh-list
101622095|NCT02792673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101622096|NCT02792673|Immunologic Factors|immunologic factors|mesh-ancestor
101622097|NCT02792673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622098|NCT02792673|Viscosupplements|viscosupplements|mesh-ancestor
101622099|NCT02792673|Protective Agents|protective agents|mesh-ancestor
101622100|NCT00906204|Thymoglobulin|thymoglobulin|mesh-list
101622101|NCT00906204|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101622102|NCT00906204|Immunologic Factors|immunologic factors|mesh-ancestor
101622103|NCT00906204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622104|NCT00906204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101622105|NCT02794077|Cyclophosphamide|cyclophosphamide|mesh-list
101598769|NCT02709382|Cefepime|cefepime|mesh-list
101598770|NCT02709382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101598771|NCT02709382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101598781|NCT00611962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101598782|NCT00611962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101598783|NCT00611962|Tubulin Modulators|tubulin modulators|mesh-ancestor
101598784|NCT00611962|Antimitotic Agents|antimitotic agents|mesh-ancestor
101598785|NCT00611962|Mitosis Modulators|mitosis modulators|mesh-ancestor
101598786|NCT00611962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598787|NCT05380713|Cyclophosphamide|cyclophosphamide|mesh-list
101598788|NCT05380713|Durvalumab|durvalumab|mesh-list
101598789|NCT05380713|Tremelimumab|tremelimumab|mesh-list
101598790|NCT05380713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101598791|NCT05380713|Immunologic Factors|immunologic factors|mesh-ancestor
101598792|NCT05380713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598793|NCT05380713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101598794|NCT05380713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101598795|NCT05380713|Alkylating Agents|alkylating agents|mesh-ancestor
101622106|NCT02794077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101622107|NCT02794077|Immunologic Factors|immunologic factors|mesh-ancestor
101622108|NCT02794077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622110|NCT02794077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101622111|NCT02794077|Alkylating Agents|alkylating agents|mesh-ancestor
101622112|NCT02794077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622113|NCT02794077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101622114|NCT02794077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101622115|NCT02791737|Coal Tar|coal tar|mesh-list
101622116|NCT02791737|Keratolytic Agents|keratolytic agents|mesh-ancestor
101622117|NCT02791737|Dermatologic Agents|dermatologic agents|mesh-ancestor
101622118|NCT02535936|Anesthetics|anesthetics|mesh-list
101420823|NCT05594186|Tranexamic Acid|tranexamic acid|mesh-list
101598796|NCT05380713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598797|NCT05380713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101598798|NCT05380713|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101598799|NCT05380713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101598800|NCT00606099|Adefovir|adefovir|mesh-list
101598801|NCT00606099|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101598802|NCT00606099|Telbivudine|telbivudine|mesh-list
101598803|NCT00606099|Antiviral Agents|antiviral agents|mesh-ancestor
101598804|NCT00606099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101598805|NCT00606099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101598806|NCT00606099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101598807|NCT00606099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101598808|NCT00606099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598809|NCT00935883|Eculizumab|eculizumab|mesh-list
101598810|NCT00935883|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101598811|NCT00935883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101598812|NCT00935883|Immunologic Factors|immunologic factors|mesh-ancestor
101598813|NCT00935883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598814|NCT02708446|Misoprostol|misoprostol|mesh-list
101598815|NCT02708446|Mifepristone|mifepristone|mesh-list
101598816|NCT02708446|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101598817|NCT02708446|Abortifacient Agents|abortifacient agents|mesh-ancestor
101598818|NCT02708446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101598819|NCT02708446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598820|NCT02708446|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101598821|NCT02708446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101598822|NCT02708446|Oxytocics|oxytocics|mesh-ancestor
101598823|NCT02708446|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101598824|NCT02708446|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101598825|NCT02708446|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101598826|NCT02708446|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101598827|NCT02708446|Contraceptive Agents|contraceptive agents|mesh-ancestor
101598828|NCT02708446|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101598829|NCT02708446|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101598830|NCT02708446|Hormone Antagonists|hormone antagonists|mesh-ancestor
101598831|NCT02708446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101598832|NCT02708446|Luteolytic Agents|luteolytic agents|mesh-ancestor
101598833|NCT02708446|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101598834|NCT02708446|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101598835|NCT05378919|Folic Acid|folic acid|mesh-list
101598836|NCT05378919|Leucovorin|leucovorin|mesh-list
101598837|NCT05378919|Fluorouracil|fluorouracil|mesh-list
101598838|NCT05378919|Oxaliplatin|oxaliplatin|mesh-list
101598839|NCT05378919|Levoleucovorin|levoleucovorin|mesh-list
101598856|NCT00607581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101598857|NCT00607581|Immunologic Factors|immunologic factors|mesh-ancestor
101598858|NCT00607581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598859|NCT00607581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101622119|NCT02535936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101622120|NCT02535936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622121|NCT05332470|Lamivudine|lamivudine|mesh-list
101622122|NCT05332470|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101622123|NCT05332470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101622124|NCT05332470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101622125|NCT05332470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622126|NCT05332470|Antiviral Agents|antiviral agents|mesh-ancestor
101622127|NCT05332470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101622128|NCT05332470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101622129|NCT05332470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101598860|NCT00607581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101598861|NCT00607581|Alkylating Agents|alkylating agents|mesh-ancestor
101598862|NCT00607581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598863|NCT00607581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101598864|NCT00607581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101598865|NCT00607581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101598866|NCT00607581|Antiemetics|antiemetics|mesh-ancestor
101598867|NCT00607581|Autonomic Agents|autonomic agents|mesh-ancestor
101598868|NCT00607581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101598869|NCT00607581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101598870|NCT00607581|Glucocorticoids|glucocorticoids|mesh-ancestor
101598871|NCT00607581|Hormones|hormones|mesh-ancestor
101598872|NCT00607581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101598873|NCT00607581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101598874|NCT00607581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101598875|NCT00607581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101598876|NCT00607581|Growth Substances|growth substances|mesh-ancestor
101598877|NCT00607581|Growth Inhibitors|growth inhibitors|mesh-ancestor
101598878|NCT02707900|Vorinostat|vorinostat|mesh-list
101598879|NCT02707900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101598880|NCT02707900|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101598881|NCT02707900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101598882|NCT02707900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598883|NCT05380479|Megestrol|megestrol|mesh-list
101598884|NCT05380479|Megestrol Acetate|megestrol acetate|mesh-list
101598885|NCT05380479|Mirtazapine|mirtazapine|mesh-list
101598886|NCT05380479|Antidepressive Agents|antidepressive agents|mesh-ancestor
101598887|NCT05380479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101598888|NCT05380479|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101598889|NCT05380479|Histamine Antagonists|histamine antagonists|mesh-ancestor
101598890|NCT05380479|Histamine Agents|histamine agents|mesh-ancestor
101598891|NCT05380479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101598892|NCT05380479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598893|NCT05380479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598894|NCT05380479|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101598895|NCT05380479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101598896|NCT05380479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101598897|NCT05380479|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101598898|NCT05380479|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101598899|NCT05380479|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101598907|NCT05380479|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101598909|NCT05380479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101598910|NCT05380479|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101598911|NCT05380479|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101598912|NCT05380479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101598913|NCT05380479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101598914|NCT05380479|Appetite Stimulants|appetite stimulants|mesh-ancestor
101598915|NCT05380479|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101598916|NCT00936975|Listerine|listerine|mesh-list
101598917|NCT00936975|Fluorides|fluorides|mesh-list
101598918|NCT00936975|Sodium Fluoride|sodium fluoride|mesh-list
101622130|NCT02791815|Selexipag|selexipag|mesh-list
101622131|NCT02791815|Midazolam|midazolam|mesh-list
101622132|NCT02791815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101622133|NCT02791815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101622134|NCT02791815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101622135|NCT02791815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622136|NCT02791815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101622137|NCT02791815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101622138|NCT02791815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101622139|NCT02791815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101622140|NCT02791815|Anesthetics, General|anesthetics, general|mesh-ancestor
101622141|NCT02791815|Anesthetics|anesthetics|mesh-ancestor
101622142|NCT02791815|GABA Modulators|gaba modulators|mesh-ancestor
101622143|NCT02791815|GABA Agents|gaba agents|mesh-ancestor
101598919|NCT00936975|Cariostatic Agents|cariostatic agents|mesh-ancestor
101598920|NCT00936975|Protective Agents|protective agents|mesh-ancestor
101598921|NCT00936975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598922|NCT00936975|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101598923|NCT00936975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101598924|NCT02707120|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101598925|NCT02707120|Lubricant Eye Drops|lubricant eye drops|mesh-list
101598926|NCT02707120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101598927|NCT02693470|Ustekinumab|ustekinumab|mesh-list
101598928|NCT02693470|Dermatologic Agents|dermatologic agents|mesh-ancestor
101598929|NCT00936897|Denosumab|denosumab|mesh-list
101598930|NCT00936897|Ibandronic Acid|ibandronic acid|mesh-list
101598931|NCT00936897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101598932|NCT00936897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598933|NCT05265676|Enoxaparin|enoxaparin|mesh-list
101598934|NCT05265676|Enoxaparin sodium|enoxaparin sodium|mesh-list
101598935|NCT05265676|Anticoagulants|anticoagulants|mesh-ancestor
101598936|NCT05265676|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101598937|NCT05265676|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101598938|NCT05265676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598939|NCT00606333|Sirolimus|sirolimus|mesh-list
101598940|NCT00606333|Paclitaxel|paclitaxel|mesh-list
101598941|NCT00606333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101598942|NCT00606333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101598943|NCT00606333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101598944|NCT00606333|Tubulin Modulators|tubulin modulators|mesh-ancestor
101598945|NCT00606333|Antimitotic Agents|antimitotic agents|mesh-ancestor
101598946|NCT00606333|Mitosis Modulators|mitosis modulators|mesh-ancestor
101598947|NCT00606333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598948|NCT00606333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101598949|NCT00606333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101598950|NCT00606333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101598951|NCT00606333|Antifungal Agents|antifungal agents|mesh-ancestor
101598952|NCT00606333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101598953|NCT00606333|Immunologic Factors|immunologic factors|mesh-ancestor
101598954|NCT00606333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598955|NCT05265442|Methadone|methadone|mesh-list
101598956|NCT05265442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101598957|NCT05265442|Narcotics|narcotics|mesh-ancestor
101598958|NCT05265442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101598959|NCT05265442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598960|NCT05265442|Analgesics|analgesics|mesh-ancestor
101598961|NCT05265442|Sensory System Agents|sensory system agents|mesh-ancestor
101598962|NCT05265442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101598963|NCT05265442|Antitussive Agents|antitussive agents|mesh-ancestor
101598964|NCT05265442|Respiratory System Agents|respiratory system agents|mesh-ancestor
101598965|NCT00606411|Topiramate|topiramate|mesh-list
101598966|NCT00606411|Anticonvulsants|anticonvulsants|mesh-ancestor
101598970|NCT00607737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101598971|NCT00607737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598973|NCT01120691|Albuterol|albuterol|mesh-list
101622144|NCT02791815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101622145|NCT02791815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622146|NCT02791815|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101622148|NCT02389374|Lumefantrine|lumefantrine|mesh-list
101622149|NCT02389374|Artemether|artemether|mesh-list
101622150|NCT02389374|Primaquine|primaquine|mesh-list
101622151|NCT02389374|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101622152|NCT02389374|Amebicides|amebicides|mesh-ancestor
101622153|NCT02389374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101622154|NCT02389374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101622155|NCT02389374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101622156|NCT02389374|Antimalarials|antimalarials|mesh-ancestor
101622157|NCT02389374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101622158|NCT02789475|Amlodipine|amlodipine|mesh-list
101420854|NCT02954068|Oxytocin|oxytocin|mesh-list
101598974|NCT01120691|Tiotropium Bromide|tiotropium bromide|mesh-list
101598975|NCT01120691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101598976|NCT01120691|Autonomic Agents|autonomic agents|mesh-ancestor
101598977|NCT01120691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101598978|NCT01120691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598979|NCT01120691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101598980|NCT01120691|Respiratory System Agents|respiratory system agents|mesh-ancestor
101598981|NCT01120691|Parasympatholytics|parasympatholytics|mesh-ancestor
101598982|NCT01120691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101598983|NCT01120691|Cholinergic Agents|cholinergic agents|mesh-ancestor
101598984|NCT01120691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101598985|NCT01120691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598986|NCT01120691|Tocolytic Agents|tocolytic agents|mesh-ancestor
101598987|NCT01120691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101598988|NCT01120691|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101598989|NCT01120691|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101598990|NCT01120691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101598991|NCT01120691|Adrenergic Agents|adrenergic agents|mesh-ancestor
101598992|NCT01120691|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101598993|NCT01120691|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101598994|NCT00612274|Sirolimus|sirolimus|mesh-list
101598995|NCT00612274|Methotrexate|methotrexate|mesh-list
101598996|NCT00612274|Tacrolimus|tacrolimus|mesh-list
101598997|NCT00612274|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101598998|NCT00612274|Abortifacient Agents|abortifacient agents|mesh-ancestor
101598999|NCT00612274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101599000|NCT00612274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599001|NCT00612274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101599002|NCT00612274|Antimetabolites|antimetabolites|mesh-ancestor
101599003|NCT00612274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599004|NCT00612274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101599005|NCT00612274|Dermatologic Agents|dermatologic agents|mesh-ancestor
101599006|NCT00612274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101599007|NCT00612274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101599008|NCT00612274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101599009|NCT00612274|Immunologic Factors|immunologic factors|mesh-ancestor
101599010|NCT00612274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101599011|NCT00612274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101599012|NCT00612274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101599013|NCT00612274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101599014|NCT00612274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101599015|NCT00612274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101599016|NCT00612274|Antifungal Agents|antifungal agents|mesh-ancestor
101599017|NCT05263882|Gemcitabine|gemcitabine|mesh-list
101599018|NCT05263882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101599019|NCT05263882|Antimetabolites|antimetabolites|mesh-ancestor
101622159|NCT02789475|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101622160|NCT02789475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101622161|NCT02789475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101622162|NCT02789475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101622163|NCT02789475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622164|NCT02789475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101622165|NCT02789475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622166|NCT02789475|Vasodilator Agents|vasodilator agents|mesh-ancestor
101622167|NCT02789475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101622168|NCT02789475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101622169|NCT02789475|Antimetabolites|antimetabolites|mesh-ancestor
101420877|NCT00508690|Kanamycin|kanamycin|mesh-list
101599020|NCT05263882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599021|NCT05263882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101599022|NCT02724904|Methotrexate|methotrexate|mesh-list
101599023|NCT02724904|Fludarabine|fludarabine|mesh-list
101599024|NCT02724904|Thiotepa|thiotepa|mesh-list
101599025|NCT02724904|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101599026|NCT02724904|Abortifacient Agents|abortifacient agents|mesh-ancestor
101599027|NCT02724904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101599028|NCT02724904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599029|NCT02724904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101599030|NCT02724904|Antimetabolites|antimetabolites|mesh-ancestor
101338580|NCT00073372|Abciximab|abciximab|mesh-list
101599031|NCT02724904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599032|NCT02724904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101599033|NCT02724904|Dermatologic Agents|dermatologic agents|mesh-ancestor
101599034|NCT02724904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101599035|NCT02724904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101599036|NCT02724904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101599037|NCT02724904|Immunologic Factors|immunologic factors|mesh-ancestor
101599038|NCT02724904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101599041|NCT02724904|Alkylating Agents|alkylating agents|mesh-ancestor
101599042|NCT02724904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101599043|NCT00935493|Guanfacine|guanfacine|mesh-list
101599044|NCT00935493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101599045|NCT00935493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101599046|NCT00935493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101599047|NCT00935493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101599048|NCT00935493|Adrenergic Agents|adrenergic agents|mesh-ancestor
101599049|NCT00935493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101599050|NCT00935493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599051|NCT00935493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599052|NCT05380245|Clarithromycin|clarithromycin|mesh-list
101599053|NCT05380245|Voriconazole|voriconazole|mesh-list
101599054|NCT05380245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101599055|NCT05380245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101599056|NCT05380245|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101599057|NCT05380245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101599058|NCT05380245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599059|NCT05380245|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101599060|NCT05380245|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101599061|NCT05380245|Antifungal Agents|antifungal agents|mesh-ancestor
101599062|NCT05380245|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101599063|NCT05380245|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101599064|NCT05380245|Hormone Antagonists|hormone antagonists|mesh-ancestor
101599065|NCT05380245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101599066|NCT05380245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599067|NCT00935259|Simvastatin|simvastatin|mesh-list
101599068|NCT00935259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101599069|NCT00935259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101622170|NCT02789475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101622171|NCT02789475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101622172|NCT02789475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101622173|NCT04202484|Oxaliplatin|oxaliplatin|mesh-list
101622174|NCT04202484|Tegafur|tegafur|mesh-list
101622175|NCT04202484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101622176|NCT04202484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101622177|NCT04202484|Antimetabolites|antimetabolites|mesh-ancestor
101622178|NCT04202484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622179|NCT03068910|Spironolactone|spironolactone|mesh-list
101622180|NCT03068910|Progesterone|progesterone|mesh-list
101622181|NCT03068910|Progestins|progestins|mesh-ancestor
101599070|NCT00935259|Antimetabolites|antimetabolites|mesh-ancestor
101599071|NCT00935259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599072|NCT00935259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101599073|NCT00935259|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101599074|NCT00935259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101599075|NCT02937766|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
101599076|NCT02937766|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
101599077|NCT02937766|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101599078|NCT02937766|Hormone Antagonists|hormone antagonists|mesh-ancestor
101599079|NCT02937766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101599080|NCT02937766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599081|NCT02937766|Progestins|progestins|mesh-ancestor
101599082|NCT02937766|Hormones|hormones|mesh-ancestor
101599083|NCT00607971|Renzapride|renzapride|mesh-list
101599084|NCT00607971|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101599085|NCT00607971|Serotonin Agents|serotonin agents|mesh-ancestor
101599086|NCT00607971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101599087|NCT00607971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599088|NCT00607971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599089|NCT02724358|Chlorotrianisene|chlorotrianisene|mesh-list
101599090|NCT02724358|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101599091|NCT02724358|Estrogens|estrogens|mesh-ancestor
101599092|NCT02724358|Hormones|hormones|mesh-ancestor
101599093|NCT02724358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101599094|NCT02724358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599095|NCT02724358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101599096|NCT02724358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101599097|NCT02724202|Curcumin|curcumin|mesh-list
101599098|NCT02724202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101599099|NCT02724202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101599100|NCT02724202|Analgesics|analgesics|mesh-ancestor
101599101|NCT02724202|Sensory System Agents|sensory system agents|mesh-ancestor
101599102|NCT02724202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101599103|NCT02724202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599104|NCT02724202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101599105|NCT02724202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101599106|NCT02724202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101599107|NCT02724202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101451776|NCT00203177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599110|NCT00605397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101599112|NCT00625547|Levodopa|levodopa|mesh-list
101599113|NCT00625547|Cabergoline|cabergoline|mesh-list
101599114|NCT00625547|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101599115|NCT00625547|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101599116|NCT00625547|Dopamine Agents|dopamine agents|mesh-ancestor
101599117|NCT00625547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101599118|NCT00625547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599119|NCT00625547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599120|NCT00625547|Dopamine Agonists|dopamine agonists|mesh-ancestor
101599121|NCT05241340|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101622182|NCT03068910|Hormones|hormones|mesh-ancestor
101775303|NCT00936195|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101622183|NCT03068910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101622184|NCT03068910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622185|NCT03068910|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101622186|NCT03068910|Hormone Antagonists|hormone antagonists|mesh-ancestor
101622187|NCT03068910|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101622188|NCT03068910|Diuretics|diuretics|mesh-ancestor
101622189|NCT03068910|Natriuretic Agents|natriuretic agents|mesh-ancestor
101622190|NCT02790957|Plerixafor|plerixafor|mesh-list
101622191|NCT02790957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101622192|NCT02790957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101622193|NCT02790957|Antiviral Agents|antiviral agents|mesh-ancestor
101264671|NCT01768897|Cytarabine|cytarabine|mesh-list
101599122|NCT05241340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599123|NCT05241340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101599125|NCT02724046|Ciprofloxacin|ciprofloxacin|mesh-list
101599126|NCT02724046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101599127|NCT02724046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101599128|NCT02724046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101599129|NCT02724046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101599130|NCT02724046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101599131|NCT02724046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599132|NCT02724046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101599133|NCT02724046|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101599134|NCT02724046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101599135|NCT01124045|Prednisolone|prednisolone|mesh-list
101599136|NCT01124045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101599137|NCT01124045|Methylprednisolone|methylprednisolone|mesh-list
101599138|NCT01124045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101599139|NCT01124045|Prednisolone acetate|prednisolone acetate|mesh-list
101599140|NCT01124045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101599141|NCT01124045|Prednisolone phosphate|prednisolone phosphate|mesh-list
101599142|NCT01124045|Difluprednate|difluprednate|mesh-list
101599143|NCT01124045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101599144|NCT01124045|Glucocorticoids|glucocorticoids|mesh-ancestor
101599145|NCT01124045|Hormones|hormones|mesh-ancestor
101599146|NCT01124045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101599147|NCT01124045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599148|NCT01124045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101599149|NCT01124045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101599150|NCT01124045|Antiemetics|antiemetics|mesh-ancestor
101599151|NCT01124045|Autonomic Agents|autonomic agents|mesh-ancestor
101599152|NCT01124045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101599153|NCT01124045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101599154|NCT01124045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101599155|NCT01124045|Protective Agents|protective agents|mesh-ancestor
101599156|NCT01123889|Lidocaine|lidocaine|mesh-list
101599157|NCT01123889|Ropivacaine|ropivacaine|mesh-list
101599158|NCT01123889|Anesthetics, Local|anesthetics, local|mesh-ancestor
101599159|NCT01123889|Anesthetics|anesthetics|mesh-ancestor
101599160|NCT01123889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101599161|NCT01123889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599162|NCT01123889|Sensory System Agents|sensory system agents|mesh-ancestor
101599163|NCT01123889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101599164|NCT01123889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101599165|NCT01123889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101599166|NCT01123889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101599167|NCT01123889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101599168|NCT01123889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622194|NCT02790957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101622195|NCT00905424|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101622196|NCT00905424|Antidepressive Agents|antidepressive agents|mesh-list
101622197|NCT00905424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101622198|NCT00905424|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101622199|NCT00905424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622200|NCT00905424|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101599169|NCT02723968|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101599170|NCT00606957|Vitamin D|vitamin d|mesh-list
101599171|NCT00606957|Cholecalciferol|cholecalciferol|mesh-list
101599172|NCT00606957|Vitamins|vitamins|mesh-ancestor
101599173|NCT00606957|Micronutrients|micronutrients|mesh-ancestor
101599174|NCT00606957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599175|NCT00606957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101599176|NCT00606957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101599177|NCT00934947|Propranolol|propranolol|mesh-list
101599178|NCT00934947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101599185|NCT00934947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101599186|NCT00934947|Vasodilator Agents|vasodilator agents|mesh-ancestor
101599188|NCT02723578|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101599189|NCT02723578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101599190|NCT02723578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101599191|NCT02723578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599192|NCT02723578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101599193|NCT02723578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101264672|NCT01768897|Mitoxantrone|mitoxantrone|mesh-list
101599194|NCT02723578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101599195|NCT04189198|Bupivacaine|bupivacaine|mesh-list
101599197|NCT04189198|Anesthetics, Local|anesthetics, local|mesh-ancestor
101599198|NCT04189198|Anesthetics|anesthetics|mesh-ancestor
101599199|NCT04189198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101599200|NCT04189198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599201|NCT04189198|Sensory System Agents|sensory system agents|mesh-ancestor
101599202|NCT04189198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101599203|NCT00608361|Dasatinib|dasatinib|mesh-list
101599204|NCT00608361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101599205|NCT00608361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101599206|NCT00608361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101599207|NCT00608361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599208|NCT00934791|Mycophenolic Acid|mycophenolic acid|mesh-list
101599209|NCT00934791|Sirolimus|sirolimus|mesh-list
101599210|NCT00934791|Prednisone|prednisone|mesh-list
101599211|NCT00934791|Tacrolimus|tacrolimus|mesh-list
101599212|NCT00934791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101599213|NCT00934791|Glucocorticoids|glucocorticoids|mesh-ancestor
101599214|NCT00934791|Hormones|hormones|mesh-ancestor
101599215|NCT00934791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101599216|NCT00934791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599217|NCT00934791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101599218|NCT00934791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101599219|NCT00934791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101599220|NCT00934791|Immunologic Factors|immunologic factors|mesh-ancestor
101599221|NCT00934791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101599222|NCT00934791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101599223|NCT00934791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599224|NCT00934791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101599225|NCT00934791|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101599226|NCT00934791|Antitubercular Agents|antitubercular agents|mesh-ancestor
101599227|NCT00934791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101599228|NCT00934791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101599229|NCT00934791|Antifungal Agents|antifungal agents|mesh-ancestor
101599230|NCT00607035|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101599232|NCT00607035|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101599233|NCT00607035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101599234|NCT00607035|Diuretics|diuretics|mesh-ancestor
101599235|NCT00607035|Natriuretic Agents|natriuretic agents|mesh-ancestor
101599236|NCT00607035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599237|NCT00607035|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101622201|NCT00905424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101622202|NCT00905424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101622203|NCT00905424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622204|NCT00905424|Dopamine Agents|dopamine agents|mesh-ancestor
101622205|NCT00905424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101622206|NCT02791035|Ipragliflozin|ipragliflozin|mesh-list
101622207|NCT02791035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101420916|NCT00148746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101420919|NCT00148746|Analgesics|analgesics|mesh-ancestor
101599238|NCT00607035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101599239|NCT00607035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599240|NCT00607035|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101599241|NCT00607035|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101599242|NCT02723266|Tin Fluorides|tin fluorides|mesh-list
101599243|NCT02723266|Cariostatic Agents|cariostatic agents|mesh-ancestor
101599244|NCT02723266|Protective Agents|protective agents|mesh-ancestor
101599245|NCT02723266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599246|NCT02722954|Pembrolizumab|pembrolizumab|mesh-list
101599250|NCT02722954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599252|NCT00625859|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101599253|NCT00625859|Antidepressive Agents|antidepressive agents|mesh-ancestor
101599254|NCT00625859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101599255|NCT00625859|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101599256|NCT00625859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101599257|NCT00625859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101599258|NCT00625859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599259|NCT00625859|Dopamine Agents|dopamine agents|mesh-ancestor
101599260|NCT00625859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101599261|NCT00625859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599262|NCT00625859|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101599263|NCT00625859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101599264|NCT00625859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101599265|NCT02691195|Ropivacaine|ropivacaine|mesh-list
101599266|NCT02691195|Anesthetics, Local|anesthetics, local|mesh-list
101599267|NCT02691195|Anesthetics|anesthetics|mesh-list
101599268|NCT02691195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101599269|NCT02691195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599270|NCT02691195|Sensory System Agents|sensory system agents|mesh-ancestor
101599271|NCT02691195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101599272|NCT03808090|Calcium|calcium|mesh-list
101599273|NCT03808090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101599274|NCT03808090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599275|NCT01111019|Hormones|hormones|mesh-list
101599276|NCT01111019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101599277|NCT01111019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599278|NCT02883400|Spironolactone|spironolactone|mesh-list
101599279|NCT02883400|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101599280|NCT02883400|Hormone Antagonists|hormone antagonists|mesh-ancestor
101599281|NCT02883400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101599282|NCT02883400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599283|NCT02883400|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101599284|NCT02883400|Diuretics|diuretics|mesh-ancestor
101599285|NCT02883400|Natriuretic Agents|natriuretic agents|mesh-ancestor
101599286|NCT01119287|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
101599287|NCT01119287|Dexamethasone|dexamethasone|mesh-list
101599288|NCT01119287|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101599289|NCT01119287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101599290|NCT01119287|Antiemetics|antiemetics|mesh-ancestor
101599291|NCT01119287|Autonomic Agents|autonomic agents|mesh-ancestor
101599292|NCT01119287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101599293|NCT01119287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622208|NCT02791035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622209|NCT02791035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101622210|NCT02791035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622211|NCT03753243|Pembrolizumab|pembrolizumab|mesh-list
101622212|NCT03753243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101622213|NCT03753243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101622214|NCT03753243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101622215|NCT03753243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622216|NCT02339532|Carboplatin|carboplatin|mesh-list
101622217|NCT02339532|Docetaxel|docetaxel|mesh-list
101622218|NCT02339532|Trastuzumab|trastuzumab|mesh-list
101622219|NCT02339532|Pertuzumab|pertuzumab|mesh-list
101622220|NCT02339532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101622221|NCT02339532|Tubulin Modulators|tubulin modulators|mesh-ancestor
101599294|NCT01119287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101599295|NCT01119287|Glucocorticoids|glucocorticoids|mesh-ancestor
101599296|NCT01119287|Hormones|hormones|mesh-ancestor
101599297|NCT01119287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101599298|NCT01119287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101599299|NCT01119287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101599300|NCT01119287|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101599301|NCT01119287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101599302|NCT01119287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101599303|NCT01119287|Analgesics|analgesics|mesh-ancestor
101599304|NCT01119287|Sensory System Agents|sensory system agents|mesh-ancestor
101599305|NCT01119287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101599306|NCT01119287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101599307|NCT01119287|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101599308|NCT01119287|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101599309|NCT01119287|Histamine Antagonists|histamine antagonists|mesh-ancestor
101599310|NCT01119287|Histamine Agents|histamine agents|mesh-ancestor
101599311|NCT01119287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101599312|NCT01119287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599313|NCT01110707|Hormones|hormones|mesh-list
101599314|NCT01110707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101599320|NCT04931368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101599321|NCT04931368|Immunologic Factors|immunologic factors|mesh-ancestor
101599322|NCT04931368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599323|NCT04931368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101599324|NCT04931368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101599325|NCT04931368|Abortifacient Agents|abortifacient agents|mesh-ancestor
101599326|NCT04931368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101599327|NCT04931368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101599328|NCT04931368|Antimetabolites|antimetabolites|mesh-ancestor
101599329|NCT04931368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599330|NCT04931368|Dermatologic Agents|dermatologic agents|mesh-ancestor
101599331|NCT04931368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101599332|NCT04931368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101599333|NCT04931368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101599334|NCT04931368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101599335|NCT01119131|Vitamin D|vitamin d|mesh-list
101599336|NCT01119131|Cholecalciferol|cholecalciferol|mesh-list
101599337|NCT01119131|Calcium|calcium|mesh-list
101599339|NCT01119131|Micronutrients|micronutrients|mesh-ancestor
101599340|NCT01119131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599341|NCT01119131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101599342|NCT01119131|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101599343|NCT00636922|Everolimus|everolimus|mesh-list
101599344|NCT00636922|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101599345|NCT00636922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101622222|NCT02339532|Antimitotic Agents|antimitotic agents|mesh-ancestor
101622223|NCT02339532|Mitosis Modulators|mitosis modulators|mesh-ancestor
101622224|NCT02339532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622225|NCT02339532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101622226|NCT00632580|Ropivacaine|ropivacaine|mesh-list
101622227|NCT00632580|Anesthetics, Local|anesthetics, local|mesh-ancestor
101622228|NCT00632580|Anesthetics|anesthetics|mesh-ancestor
101622229|NCT00632580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101622230|NCT00632580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622231|NCT00632580|Sensory System Agents|sensory system agents|mesh-ancestor
101599346|NCT00636922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101599347|NCT00636922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599348|NCT00636922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101599349|NCT00636922|Immunologic Factors|immunologic factors|mesh-ancestor
101599350|NCT00636922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599351|NCT00636922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101599352|NCT02722096|Lidocaine|lidocaine|mesh-list
101599353|NCT02722096|Ropivacaine|ropivacaine|mesh-list
101599354|NCT02722096|Anesthetics|anesthetics|mesh-list
101599355|NCT02722096|Anesthetics, Local|anesthetics, local|mesh-ancestor
101599356|NCT02722096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101599357|NCT02722096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599358|NCT02722096|Sensory System Agents|sensory system agents|mesh-ancestor
101599359|NCT02722096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101599360|NCT02722096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101599361|NCT02722096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101599362|NCT02722096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101599363|NCT02722096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101599364|NCT02722096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599365|NCT04862962|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101599366|NCT04862962|Ezetimibe|ezetimibe|mesh-list
101599367|NCT04862962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101599368|NCT04862962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101599369|NCT04862962|Antimetabolites|antimetabolites|mesh-ancestor
101599370|NCT04862962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256336|NCT01710670|Anticonvulsants|anticonvulsants|mesh-ancestor
101599371|NCT04862962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101599372|NCT04862962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101599374|NCT01118975|Lapatinib|lapatinib|mesh-list
101599375|NCT01118975|Vorinostat|vorinostat|mesh-list
101599376|NCT01118975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101599377|NCT01118975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101599378|NCT01118975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101599379|NCT01118975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599380|NCT01118975|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101599381|NCT02721940|Zoledronic Acid|zoledronic acid|mesh-list
101599382|NCT02721940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101599383|NCT02721940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599389|NCT02721862|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101599390|NCT02721862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101599391|NCT00612898|Lamivudine|lamivudine|mesh-list
101599392|NCT00612898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101599393|NCT00612898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101599394|NCT00612898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101599395|NCT00612898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599396|NCT00612898|Antiviral Agents|antiviral agents|mesh-ancestor
101599397|NCT00612898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101599398|NCT00612898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101599399|NCT00612898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101599400|NCT01118663|Acetylcysteine|acetylcysteine|mesh-list
101599401|NCT01118663|Edetic Acid|edetic acid|mesh-list
101599402|NCT01118663|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101599403|NCT01118663|Pentetic Acid|pentetic acid|mesh-list
101622232|NCT00632580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101622233|NCT02789397|Rituximab|rituximab|mesh-list
101622234|NCT02789397|Azathioprine|azathioprine|mesh-list
101622235|NCT02789397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101622236|NCT02789397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101622237|NCT02789397|Immunologic Factors|immunologic factors|mesh-ancestor
101622238|NCT02789397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622239|NCT02789397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101622240|NCT02789397|Antimetabolites|antimetabolites|mesh-ancestor
101599404|NCT01118663|Antiviral Agents|antiviral agents|mesh-ancestor
101599405|NCT01118663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101599406|NCT01118663|Expectorants|expectorants|mesh-ancestor
101599407|NCT01118663|Respiratory System Agents|respiratory system agents|mesh-ancestor
101599408|NCT01118663|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101599409|NCT01118663|Antioxidants|antioxidants|mesh-ancestor
101599410|NCT01118663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599411|NCT01118663|Protective Agents|protective agents|mesh-ancestor
101599412|NCT01118663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599414|NCT01118663|Anticoagulants|anticoagulants|mesh-ancestor
101599415|NCT01118663|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101599416|NCT01118663|Chelating Agents|chelating agents|mesh-ancestor
101599417|NCT01118663|Sequestering Agents|sequestering agents|mesh-ancestor
101599418|NCT01118663|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101599419|NCT01118351|Sunitinib|sunitinib|mesh-list
101599420|NCT01118351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101599421|NCT01118351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101599422|NCT01118351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101599423|NCT01118351|Growth Substances|growth substances|mesh-ancestor
101599424|NCT01118351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599425|NCT01118351|Growth Inhibitors|growth inhibitors|mesh-ancestor
101599426|NCT01118351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101599427|NCT01118351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101599428|NCT01118351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599429|NCT01110005|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101599430|NCT02693392|Metformin|metformin|mesh-list
101599431|NCT02693392|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101599432|NCT02693392|Fenugreek seed meal|fenugreek seed meal|mesh-list
101599433|NCT02693392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599434|NCT04175626|Sirolimus|sirolimus|mesh-list
101599435|NCT04175626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101599436|NCT04175626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101599437|NCT04175626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101599438|NCT04175626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101599439|NCT04175626|Antifungal Agents|antifungal agents|mesh-ancestor
101599440|NCT04175626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101599441|NCT04175626|Immunologic Factors|immunologic factors|mesh-ancestor
101599442|NCT04175626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599443|NCT00613054|Imatinib Mesylate|imatinib mesylate|mesh-list
101599444|NCT00613054|Hydroxyurea|hydroxyurea|mesh-list
101599445|NCT00613054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101256418|NCT01711112|Docetaxel|docetaxel|mesh-list
101599446|NCT00613054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101599447|NCT00613054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101599448|NCT00613054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599449|NCT00613054|Antisickling Agents|antisickling agents|mesh-ancestor
101599450|NCT00613054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101599451|NCT00613132|Everolimus|everolimus|mesh-list
101599452|NCT00613132|Imatinib Mesylate|imatinib mesylate|mesh-list
101599453|NCT00613132|Hydroxyurea|hydroxyurea|mesh-list
101599454|NCT00613132|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101599455|NCT00613132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101599475|NCT04558216|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101599476|NCT04558216|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101599477|NCT04558216|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101599478|NCT04558216|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101599480|NCT04120870|Etomidate|etomidate|mesh-list
101599481|NCT04120870|Analgesics|analgesics|mesh-ancestor
101599482|NCT04120870|Sensory System Agents|sensory system agents|mesh-ancestor
101622241|NCT02789397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622242|NCT02789397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101622243|NCT02789397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101622244|NCT00816166|Aspirin|aspirin|mesh-list
101622245|NCT00816166|Clopidogrel|clopidogrel|mesh-list
101622246|NCT00816166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101622247|NCT00816166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101622248|NCT00816166|Analgesics|analgesics|mesh-ancestor
101338673|NCT00074191|Lomustine|lomustine|mesh-list
101622249|NCT00816166|Sensory System Agents|sensory system agents|mesh-ancestor
101622250|NCT00816166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101622251|NCT00816166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622252|NCT00816166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101622253|NCT00816166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101599483|NCT04120870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101599484|NCT04120870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599485|NCT04120870|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101599486|NCT04120870|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101599487|NCT04120870|Anesthetics, General|anesthetics, general|mesh-ancestor
101599488|NCT04120870|Anesthetics|anesthetics|mesh-ancestor
101599489|NCT04120870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101599490|NCT04120870|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101599491|NCT04120870|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101599492|NCT04120870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101599493|NCT04120870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599494|NCT04120870|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101599495|NCT03747562|Gabapentin|gabapentin|mesh-list
101599496|NCT03747562|Analgesics|analgesics|mesh-ancestor
101599497|NCT03747562|Sensory System Agents|sensory system agents|mesh-ancestor
101599498|NCT03747562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101599499|NCT03747562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599500|NCT03747562|Anticonvulsants|anticonvulsants|mesh-ancestor
101599501|NCT03747562|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101599502|NCT03747562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101599503|NCT03747562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101599504|NCT03747562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101599505|NCT03747562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101599506|NCT03747562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101599514|NCT01109849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101599516|NCT01109849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256488|NCT01711489|Mycophenolic Acid|mycophenolic acid|mesh-list
101599517|NCT01109849|Dopamine Agents|dopamine agents|mesh-ancestor
101599518|NCT01109849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101599519|NCT01061736|Folic Acid|folic acid|mesh-list
101599520|NCT01061736|Methotrexate|methotrexate|mesh-list
101599521|NCT01061736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101599522|NCT01061736|Abortifacient Agents|abortifacient agents|mesh-ancestor
101599523|NCT01061736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101599524|NCT01061736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599525|NCT01061736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101599526|NCT01061736|Antimetabolites|antimetabolites|mesh-ancestor
101599527|NCT01061736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599528|NCT01061736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101599529|NCT01061736|Dermatologic Agents|dermatologic agents|mesh-ancestor
101599530|NCT01061736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101599531|NCT01061736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101599532|NCT01061736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101599533|NCT01061736|Immunologic Factors|immunologic factors|mesh-ancestor
101599534|NCT01061736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101599535|NCT01061736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101622254|NCT00816166|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101622255|NCT00816166|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101622256|NCT00816166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622257|NCT00816166|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101622258|NCT00816166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101622259|NCT00816166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101622260|NCT00816166|Antipyretics|antipyretics|mesh-ancestor
101622261|NCT00816166|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101622262|NCT00816166|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101622263|NCT00816166|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101622264|NCT00816166|Purinergic Agents|purinergic agents|mesh-ancestor
101622265|NCT00816166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101622266|NCT02788851|Guanfacine|guanfacine|mesh-list
101599536|NCT01061736|Hematinics|hematinics|mesh-ancestor
101599537|NCT01061736|Vitamin B Complex|vitamin b complex|mesh-ancestor
101599538|NCT01061736|Vitamins|vitamins|mesh-ancestor
101599539|NCT01061736|Micronutrients|micronutrients|mesh-ancestor
101599540|NCT02874378|Dexmedetomidine|dexmedetomidine|mesh-list
101599541|NCT02874378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101599542|NCT02874378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101599543|NCT02874378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599544|NCT02874378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101599545|NCT02874378|Analgesics|analgesics|mesh-ancestor
101599546|NCT02874378|Sensory System Agents|sensory system agents|mesh-ancestor
101599547|NCT02874378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101599548|NCT02874378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101599549|NCT02874378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101599550|NCT02874378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101599551|NCT02874378|Adrenergic Agents|adrenergic agents|mesh-ancestor
101599552|NCT02874378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101599553|NCT02874378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599554|NCT01117181|Methylphenidate|methylphenidate|mesh-list
101599555|NCT01117181|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101599556|NCT01117181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599557|NCT01117181|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101599558|NCT01117181|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101599559|NCT01117181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101599560|NCT01117181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599562|NCT01117181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101599563|NCT02881619|Etodolac|etodolac|mesh-list
101599564|NCT02881619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101599565|NCT02881619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101599566|NCT02881619|Analgesics|analgesics|mesh-ancestor
101599567|NCT02881619|Sensory System Agents|sensory system agents|mesh-ancestor
101599568|NCT02881619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101599569|NCT02881619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599570|NCT02881619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101599572|NCT02881619|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101599573|NCT02881619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101599574|NCT02881619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101599575|NCT02881619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599576|NCT04303806|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101599577|NCT04303806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101599578|NCT04303806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101599579|NCT04303806|Antimetabolites|antimetabolites|mesh-ancestor
101599580|NCT04303806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599581|NCT04303806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101622268|NCT02788851|Amphetamine|amphetamine|mesh-list
101622269|NCT02788851|Adderall|adderall|mesh-list
101622270|NCT02788851|Dextroamphetamine|dextroamphetamine|mesh-list
101622271|NCT02788851|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101622272|NCT02788851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101420985|NCT00466843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101599582|NCT04303806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101599583|NCT04303806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101599584|NCT02882087|Methotrexate|methotrexate|mesh-list
101599585|NCT02882087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101599586|NCT02882087|Abortifacient Agents|abortifacient agents|mesh-ancestor
101599587|NCT02882087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101599588|NCT02882087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599589|NCT02882087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101599591|NCT02882087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599592|NCT02882087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101599593|NCT02882087|Dermatologic Agents|dermatologic agents|mesh-ancestor
101599594|NCT02882087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101599595|NCT02882087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101599596|NCT02882087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101599597|NCT02882087|Immunologic Factors|immunologic factors|mesh-ancestor
101599598|NCT02882087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101599599|NCT02882087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101599600|NCT04303884|Pembrolizumab|pembrolizumab|mesh-list
101599601|NCT04303884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101599602|NCT04303884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101599603|NCT04303884|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101599604|NCT04303884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599605|NCT01040130|Olodaterol|olodaterol|mesh-list
101599606|NCT01040130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101599607|NCT01040130|Autonomic Agents|autonomic agents|mesh-ancestor
101599608|NCT01040130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101599609|NCT01040130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599610|NCT01040130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101599611|NCT01040130|Respiratory System Agents|respiratory system agents|mesh-ancestor
101599612|NCT00932451|Crizotinib|crizotinib|mesh-list
101599613|NCT00932451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101599614|NCT00932451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101599615|NCT00932451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101599616|NCT00932451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599617|NCT05297682|Propofol|propofol|mesh-list
101599618|NCT05297682|Anesthetics|anesthetics|mesh-ancestor
101599619|NCT05297682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101599620|NCT05297682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599621|NCT05297682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101599622|NCT05297682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101599623|NCT05297682|Anesthetics, General|anesthetics, general|mesh-ancestor
101599624|NCT01108055|Paclitaxel|paclitaxel|mesh-list
101599625|NCT01108055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101599627|NCT01108055|Tubulin Modulators|tubulin modulators|mesh-ancestor
101599628|NCT01108055|Antimitotic Agents|antimitotic agents|mesh-ancestor
101599629|NCT01108055|Mitosis Modulators|mitosis modulators|mesh-ancestor
101599630|NCT01108055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599631|NCT00609375|Cefepime|cefepime|mesh-list
101599632|NCT00609375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101599633|NCT00609375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101599634|NCT01107899|Clopidogrel|clopidogrel|mesh-list
101599635|NCT01107899|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101599636|NCT01107899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101599637|NCT01107899|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101599638|NCT01107899|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101599639|NCT01107899|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101599640|NCT01107899|Purinergic Agents|purinergic agents|mesh-ancestor
101599641|NCT01107899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101599642|NCT01107899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599643|NCT01107899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622273|NCT02788851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622274|NCT02788851|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101622275|NCT02788851|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101622276|NCT02788851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101622277|NCT02788851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622278|NCT02788851|Dopamine Agents|dopamine agents|mesh-ancestor
101622279|NCT02788851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101599644|NCT01107743|Amlodipine|amlodipine|mesh-list
101599659|NCT01107743|Vasodilator Agents|vasodilator agents|mesh-ancestor
101599660|NCT01059864|Atorvastatin|atorvastatin|mesh-list
101599661|NCT01059864|Tofacitinib|tofacitinib|mesh-list
101599662|NCT01059864|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101599664|NCT01059864|Antimetabolites|antimetabolites|mesh-ancestor
101599665|NCT01059864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599666|NCT01059864|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101599667|NCT01059864|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101599668|NCT01059864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101599669|NCT01059864|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101599670|NCT01059864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101599671|NCT01035138|N2-((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-L-alaninamide|n2-((2s)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-n1-((7s)-5-methyl-6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-l-alaninamide|mesh-list
101599672|NCT01035138|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101599673|NCT01035138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101599674|NCT01035138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599675|NCT03739840|Padsevonil|padsevonil|mesh-list
101599676|NCT03739840|Anticonvulsants|anticonvulsants|mesh-ancestor
101599677|NCT00613600|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
101599678|NCT00613600|Cathartics|cathartics|mesh-ancestor
101599679|NCT00613600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101599680|NCT04302402|Rifaximin|rifaximin|mesh-list
101599681|NCT04302402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101599682|NCT04302402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101599683|NCT04302402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101599684|NCT03931408|Gentamicins|gentamicins|mesh-list
101599685|NCT03931408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101599686|NCT03931408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101599687|NCT03931408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101599688|NCT03931408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101599689|NCT03931408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599690|NCT03398824|Metformin|metformin|mesh-list
101599691|NCT03398824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101599692|NCT03398824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599693|NCT01033734|Oseltamivir|oseltamivir|mesh-list
101599694|NCT01033734|Antiviral Agents|antiviral agents|mesh-ancestor
101599695|NCT01033734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101599697|NCT01033734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599698|NCT03792256|Cytarabine|cytarabine|mesh-list
101599699|NCT03792256|Prednisone|prednisone|mesh-list
101599700|NCT03792256|Prednisolone|prednisolone|mesh-list
101599701|NCT03792256|Hydrocortisone|hydrocortisone|mesh-list
101599702|NCT03792256|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101599703|NCT03792256|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101599707|NCT03792256|Vincristine|vincristine|mesh-list
101599708|NCT03792256|Palbociclib|palbociclib|mesh-list
101599709|NCT03792256|Pegaspargase|pegaspargase|mesh-list
101599710|NCT03792256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101599711|NCT03792256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101599712|NCT03792256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101599713|NCT03792256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101599714|NCT03792256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101599715|NCT03792256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599716|NCT03792256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101599717|NCT03792256|Glucocorticoids|glucocorticoids|mesh-ancestor
101599719|NCT03792256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101599720|NCT03792256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622281|NCT02788851|Autonomic Agents|autonomic agents|mesh-ancestor
101622282|NCT02788851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101622283|NCT02788851|Adrenergic Agents|adrenergic agents|mesh-ancestor
101622284|NCT02788851|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101622285|NCT02788851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101622286|NCT02788851|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101622287|NCT02788851|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101622288|NCT02788851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101420996|NCT00148863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101599721|NCT03792256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101599722|NCT03792256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101599723|NCT03792256|Abortifacient Agents|abortifacient agents|mesh-ancestor
101599724|NCT03792256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101599725|NCT03792256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101599726|NCT03792256|Antimetabolites|antimetabolites|mesh-ancestor
101599727|NCT03792256|Dermatologic Agents|dermatologic agents|mesh-ancestor
101599728|NCT03792256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101599729|NCT03792256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101599730|NCT03792256|Immunologic Factors|immunologic factors|mesh-ancestor
101599731|NCT03792256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101599732|NCT03792256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101599733|NCT03792256|Antiviral Agents|antiviral agents|mesh-ancestor
101599734|NCT03792256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101256708|NCT01712477|GABA Agents|gaba agents|mesh-ancestor
101599735|NCT03792256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101599736|NCT03792256|Tubulin Modulators|tubulin modulators|mesh-ancestor
101599737|NCT03792256|Antimitotic Agents|antimitotic agents|mesh-ancestor
101599738|NCT03792256|Mitosis Modulators|mitosis modulators|mesh-ancestor
101599739|NCT03792256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101599740|NCT00613288|Testosterone|testosterone|mesh-list
101599741|NCT00613288|Androgens|androgens|mesh-ancestor
101599742|NCT00613288|Hormones|hormones|mesh-ancestor
101599743|NCT00613288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101599744|NCT00613288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599745|NCT03711838|Acetylcysteine|acetylcysteine|mesh-list
101599746|NCT03711838|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101599747|NCT03711838|Antiviral Agents|antiviral agents|mesh-ancestor
101599748|NCT03711838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101599749|NCT03711838|Expectorants|expectorants|mesh-ancestor
101599750|NCT03711838|Respiratory System Agents|respiratory system agents|mesh-ancestor
101599751|NCT03711838|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101599752|NCT03711838|Antioxidants|antioxidants|mesh-ancestor
101599753|NCT03711838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599754|NCT03711838|Protective Agents|protective agents|mesh-ancestor
101599755|NCT03711838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599756|NCT03711838|Antidotes|antidotes|mesh-ancestor
101599757|NCT04275778|Hydroxychloroquine|hydroxychloroquine|mesh-list
101599758|NCT04275778|Antimalarials|antimalarials|mesh-ancestor
101599759|NCT04275778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101599760|NCT04275778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101338760|NCT02972333|Osimertinib|osimertinib|mesh-list
101599761|NCT04275778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101599762|NCT04275778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101599763|NCT04275778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599764|NCT04275778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101599765|NCT01115855|Eplerenone|eplerenone|mesh-list
101599766|NCT01115855|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101599767|NCT01115855|Hormone Antagonists|hormone antagonists|mesh-ancestor
101599768|NCT01115855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101599769|NCT01115855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599770|NCT01115855|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101599771|NCT01115855|Diuretics|diuretics|mesh-ancestor
101599772|NCT01115855|Natriuretic Agents|natriuretic agents|mesh-ancestor
101599773|NCT01115855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101599774|NCT03615508|Phenylephrine|phenylephrine|mesh-list
101622289|NCT02786823|Folic Acid|folic acid|mesh-list
101622290|NCT02786823|Vitamin B 12|vitamin b 12|mesh-list
101622291|NCT02786823|Metformin|metformin|mesh-list
101622292|NCT02786823|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101622293|NCT02786823|Vitamins|vitamins|mesh-ancestor
101622294|NCT02786823|Micronutrients|micronutrients|mesh-ancestor
101622295|NCT02786823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622296|NCT02786823|Hematinics|hematinics|mesh-ancestor
101622297|NCT02786823|Vitamin B Complex|vitamin b complex|mesh-ancestor
101622298|NCT05332314|Ibuprofen|ibuprofen|mesh-list
101622299|NCT05332314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101622300|NCT05332314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101622301|NCT05332314|Analgesics|analgesics|mesh-ancestor
101599775|NCT03615508|Oxymetazoline|oxymetazoline|mesh-list
101599779|NCT03615508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101599780|NCT03615508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599781|NCT03615508|Sympathomimetics|sympathomimetics|mesh-ancestor
101599782|NCT03615508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101599783|NCT03615508|Nasal Decongestants|nasal decongestants|mesh-ancestor
101599784|NCT03615508|Respiratory System Agents|respiratory system agents|mesh-ancestor
101599785|NCT03615508|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101599786|NCT03615508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101599787|NCT03615508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101599788|NCT03615508|Adrenergic Agents|adrenergic agents|mesh-ancestor
101599789|NCT03615508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101599790|NCT03615508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599791|NCT03615508|Protective Agents|protective agents|mesh-ancestor
101599792|NCT02880995|Amisulpride|amisulpride|mesh-list
101599793|NCT02880995|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101599794|NCT02880995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101599795|NCT02880995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101599796|NCT02880995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599797|NCT02880995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101599798|NCT02880995|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101599799|NCT02880995|Dopamine Agents|dopamine agents|mesh-ancestor
101599800|NCT02880995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101599801|NCT02880995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599802|NCT02880995|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101599803|NCT02880995|Antidepressive Agents|antidepressive agents|mesh-ancestor
101599804|NCT03522064|Carboplatin|carboplatin|mesh-list
101599805|NCT03522064|Methyltestosterone|methyltestosterone|mesh-list
101599806|NCT03522064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101599807|NCT03522064|Testosterone|testosterone|mesh-list
101599808|NCT03522064|Testosterone undecanoate|testosterone undecanoate|mesh-list
101599809|NCT03522064|Testosterone enanthate|testosterone enanthate|mesh-list
101599810|NCT03522064|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101599811|NCT03522064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101599813|NCT03522064|Hormones|hormones|mesh-ancestor
101599814|NCT03522064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101599815|NCT03522064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599816|NCT03522064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101599817|NCT03522064|Anabolic Agents|anabolic agents|mesh-ancestor
101599818|NCT04310579|Midazolam|midazolam|mesh-list
101599819|NCT04310579|Oxycodone|oxycodone|mesh-list
101599820|NCT04310579|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101599821|NCT04310579|Paroxetine|paroxetine|mesh-list
101599822|NCT04310579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101599823|NCT04310579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101599824|NCT04310579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101599825|NCT04310579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599826|NCT04310579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101599827|NCT04310579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101599828|NCT04310579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101599829|NCT04310579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101599830|NCT04310579|Anesthetics, General|anesthetics, general|mesh-ancestor
101599831|NCT04310579|Anesthetics|anesthetics|mesh-ancestor
101622302|NCT05332314|Sensory System Agents|sensory system agents|mesh-ancestor
101622303|NCT05332314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101622304|NCT05332314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622305|NCT05332314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101622306|NCT05332314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101622307|NCT05332314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101622308|NCT05332314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101622309|NCT05332314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622310|NCT00815308|Paclitaxel|paclitaxel|mesh-list
101622311|NCT00815308|Cetuximab|cetuximab|mesh-list
101622312|NCT00815308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101622313|NCT00815308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101622314|NCT00815308|Tubulin Modulators|tubulin modulators|mesh-ancestor
101622315|NCT00815308|Antimitotic Agents|antimitotic agents|mesh-ancestor
101421017|NCT00157482|Ezetimibe|ezetimibe|mesh-list
101599832|NCT04310579|GABA Modulators|gaba modulators|mesh-ancestor
101599833|NCT04310579|GABA Agents|gaba agents|mesh-ancestor
101599834|NCT04310579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101599835|NCT04310579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599836|NCT04310579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101599837|NCT04310579|Narcotics|narcotics|mesh-ancestor
101599838|NCT04310579|Analgesics|analgesics|mesh-ancestor
101599839|NCT04310579|Sensory System Agents|sensory system agents|mesh-ancestor
101599840|NCT04310579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101599841|NCT04310579|Antidepressive Agents|antidepressive agents|mesh-ancestor
101599842|NCT04310579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101599843|NCT04310579|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101599844|NCT04310579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101264682|NCT01768897|Analgesics|analgesics|mesh-ancestor
101599845|NCT04310579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101599846|NCT04310579|Serotonin Agents|serotonin agents|mesh-ancestor
101599847|NCT04310579|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101451777|NCT00208143|Risperidone|risperidone|mesh-list
101599849|NCT04310579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101599851|NCT05244538|Remifentanil|remifentanil|mesh-list
101599852|NCT05244538|Propofol|propofol|mesh-list
101599853|NCT05244538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101599854|NCT05244538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101599855|NCT05244538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599856|NCT05244538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101599857|NCT05244538|Anesthetics, General|anesthetics, general|mesh-ancestor
101599858|NCT05244538|Anesthetics|anesthetics|mesh-ancestor
101599859|NCT05244538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101599860|NCT05244538|Narcotics|narcotics|mesh-ancestor
101599861|NCT05244538|Analgesics|analgesics|mesh-ancestor
101599862|NCT05244538|Sensory System Agents|sensory system agents|mesh-ancestor
101599863|NCT05244538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101599864|NCT03638128|Denosumab|denosumab|mesh-list
101599865|NCT03638128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101599866|NCT03638128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599867|NCT03481660|Aflibercept|aflibercept|mesh-list
101599868|NCT03481660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101338783|NCT00074776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101599869|NCT03481660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101599870|NCT03481660|Growth Substances|growth substances|mesh-ancestor
101599871|NCT03481660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599872|NCT03481660|Growth Inhibitors|growth inhibitors|mesh-ancestor
101599873|NCT03481660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101599874|NCT05345236|Aflibercept|aflibercept|mesh-list
101599875|NCT05345236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101599876|NCT05345236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101599877|NCT05345236|Growth Substances|growth substances|mesh-ancestor
101622317|NCT00815308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622318|NCT00815308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101622319|NCT01039376|Ofatumumab|ofatumumab|mesh-list
101622320|NCT01039376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101622321|NCT02610712|Ketamine|ketamine|mesh-list
101599878|NCT05345236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599879|NCT05345236|Growth Inhibitors|growth inhibitors|mesh-ancestor
101599880|NCT05345236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101599881|NCT02692534|Cocaine|cocaine|mesh-list
101599882|NCT02692534|Anesthetics, Local|anesthetics, local|mesh-ancestor
101599883|NCT02692534|Anesthetics|anesthetics|mesh-ancestor
101599884|NCT02692534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101599885|NCT02692534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599886|NCT02692534|Sensory System Agents|sensory system agents|mesh-ancestor
101599887|NCT02692534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101599888|NCT02692534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101599889|NCT02692534|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101599890|NCT02692534|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101599891|NCT02692534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101599892|NCT02692534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599893|NCT02692534|Dopamine Agents|dopamine agents|mesh-ancestor
101599894|NCT02692534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101599895|NCT00614536|Rabeprazole|rabeprazole|mesh-list
101599896|NCT00614536|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101599897|NCT00614536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101599898|NCT00614536|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101599899|NCT00614536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101599900|NCT00614536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599901|NCT04333654|Hydroxychloroquine|hydroxychloroquine|mesh-list
101599902|NCT04333654|Antimalarials|antimalarials|mesh-ancestor
101599903|NCT04333654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101599904|NCT04333654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101599905|NCT04333654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101599906|NCT04333654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101599907|NCT04333654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599908|NCT04333654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101599909|NCT01059630|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101599910|NCT01059630|Obinutuzumab|obinutuzumab|mesh-list
101599911|NCT01059630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101599912|NCT01059630|Alkylating Agents|alkylating agents|mesh-ancestor
101599913|NCT01059630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599914|NCT01059630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101599915|NCT01059630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101599916|NCT04142086|Vaccines|vaccines|mesh-list
101599917|NCT04142086|Immunologic Factors|immunologic factors|mesh-ancestor
101264683|NCT01768897|Sensory System Agents|sensory system agents|mesh-ancestor
101599918|NCT04142086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599919|NCT03664882|Fexofenadine|fexofenadine|mesh-list
101599924|NCT03664882|Histamine Agents|histamine agents|mesh-ancestor
101599925|NCT03664882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101599926|NCT03664882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599927|NCT03664882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599928|NCT03951142|Losartan|losartan|mesh-list
101599929|NCT03951142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101338792|NCT00075010|Decitabine|decitabine|mesh-list
101599930|NCT03951142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101599931|NCT03951142|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101599932|NCT03951142|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101599933|NCT03951142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599934|NCT03903016|Insulin|insulin|mesh-list
101599935|NCT03903016|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101599936|NCT03903016|Insulin Lispro|insulin lispro|mesh-list
101599937|NCT03903016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101599938|NCT03903016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599939|NCT03514732|Melatonin|melatonin|mesh-list
101599940|NCT03514732|Antioxidants|antioxidants|mesh-ancestor
101599941|NCT03514732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599942|NCT03514732|Protective Agents|protective agents|mesh-ancestor
101622322|NCT02610712|Analgesics|analgesics|mesh-ancestor
101622323|NCT02610712|Sensory System Agents|sensory system agents|mesh-ancestor
101622324|NCT02610712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101622325|NCT02610712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622326|NCT02610712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101622327|NCT02610712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101622328|NCT02610712|Anesthetics, General|anesthetics, general|mesh-ancestor
101622329|NCT02610712|Anesthetics|anesthetics|mesh-ancestor
101622330|NCT02610712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101622331|NCT02610712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101622332|NCT02610712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101599943|NCT03514732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599944|NCT03514732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101599945|NCT03800836|Paclitaxel|paclitaxel|mesh-list
101599946|NCT03800836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101599947|NCT03800836|Atezolizumab|atezolizumab|mesh-list
101599948|NCT03800836|Ipatasertib|ipatasertib|mesh-list
101599949|NCT03800836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101599950|NCT03800836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101599951|NCT03800836|Tubulin Modulators|tubulin modulators|mesh-ancestor
101599952|NCT03800836|Antimitotic Agents|antimitotic agents|mesh-ancestor
101599953|NCT03800836|Mitosis Modulators|mitosis modulators|mesh-ancestor
101599954|NCT03800836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599955|NCT03800836|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101599956|NCT03800836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101599957|NCT03800836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101599958|NCT03800836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101599959|NCT01976182|Cyclophosphamide|cyclophosphamide|mesh-list
101256990|NCT01714089|RNS60|rns60|mesh-list
101599961|NCT01976182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101599962|NCT01976182|Immunologic Factors|immunologic factors|mesh-ancestor
101599963|NCT01976182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599964|NCT01976182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101599965|NCT01976182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101599966|NCT01976182|Alkylating Agents|alkylating agents|mesh-ancestor
101599967|NCT01976182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599968|NCT01976182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101599969|NCT01976182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101599970|NCT01976182|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101599971|NCT01976182|Abortifacient Agents|abortifacient agents|mesh-ancestor
101599972|NCT01976182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101599973|NCT01976182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101599974|NCT01976182|Antimetabolites|antimetabolites|mesh-ancestor
101599975|NCT01976182|Dermatologic Agents|dermatologic agents|mesh-ancestor
101599976|NCT01976182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101599977|NCT01976182|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101599978|NCT01976182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101599979|NCT00932373|Trastuzumab|trastuzumab|mesh-list
101599980|NCT00932373|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101338803|NCT00075010|Antimanic Agents|antimanic agents|mesh-ancestor
101599981|NCT00932373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101599982|NCT00932373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101599983|NCT00932373|Immunotoxins|immunotoxins|mesh-ancestor
101599984|NCT00932373|Immunoconjugates|immunoconjugates|mesh-ancestor
101599985|NCT00932373|Immunologic Factors|immunologic factors|mesh-ancestor
101599986|NCT00932373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599987|NCT00932373|Tubulin Modulators|tubulin modulators|mesh-ancestor
101599988|NCT00932373|Antimitotic Agents|antimitotic agents|mesh-ancestor
101599989|NCT00932373|Mitosis Modulators|mitosis modulators|mesh-ancestor
101599996|NCT04265001|Protective Agents|protective agents|mesh-ancestor
101599997|NCT00608595|Celecoxib|celecoxib|mesh-list
101599998|NCT00608595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101599999|NCT00608595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101600000|NCT00608595|Analgesics|analgesics|mesh-ancestor
101622334|NCT02610712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622335|NCT00905034|Dexamethasone|dexamethasone|mesh-list
101622336|NCT00905034|Rituximab|rituximab|mesh-list
101622337|NCT00905034|Methotrexate|methotrexate|mesh-list
101622338|NCT00905034|Vincristine|vincristine|mesh-list
101622339|NCT00905034|Asparaginase|asparaginase|mesh-list
101622340|NCT00905034|Pegaspargase|pegaspargase|mesh-list
101622341|NCT00905034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101622342|NCT00905034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101622343|NCT00905034|Immunologic Factors|immunologic factors|mesh-ancestor
101600001|NCT00608595|Sensory System Agents|sensory system agents|mesh-ancestor
101600002|NCT00608595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101600003|NCT00608595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600004|NCT00608595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101600005|NCT00608595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101600006|NCT00608595|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101600007|NCT00608595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101600008|NCT00608595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101600009|NCT00608595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600010|NCT03761134|Metformin|metformin|mesh-list
101600011|NCT03761134|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
101600012|NCT03761134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101600013|NCT03761134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600014|NCT03761134|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101600015|NCT03761134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600016|NCT01055496|Dexamethasone|dexamethasone|mesh-list
101600017|NCT01055496|Prednisone|prednisone|mesh-list
101600018|NCT01055496|Cyclophosphamide|cyclophosphamide|mesh-list
101600019|NCT01055496|Rituximab|rituximab|mesh-list
101600020|NCT01055496|Gemcitabine|gemcitabine|mesh-list
101600021|NCT01055496|Vincristine|vincristine|mesh-list
101600022|NCT01055496|Cisplatin|cisplatin|mesh-list
101600023|NCT01055496|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
101600024|NCT01055496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101600025|NCT01055496|Immunologic Factors|immunologic factors|mesh-ancestor
101600026|NCT01055496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600027|NCT01055496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101600028|NCT01055496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101600029|NCT01055496|Alkylating Agents|alkylating agents|mesh-ancestor
101600030|NCT01055496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600031|NCT01055496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101600032|NCT01055496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101600033|NCT01055496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101600034|NCT01055496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101600035|NCT01055496|Antiemetics|antiemetics|mesh-ancestor
101600036|NCT01055496|Autonomic Agents|autonomic agents|mesh-ancestor
101600037|NCT01055496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101600038|NCT01055496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101600039|NCT01055496|Glucocorticoids|glucocorticoids|mesh-ancestor
101600040|NCT01055496|Hormones|hormones|mesh-ancestor
101600041|NCT01055496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101600042|NCT01055496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101600043|NCT01055496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101600044|NCT01055496|Antimetabolites|antimetabolites|mesh-ancestor
101600045|NCT01055496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101600046|NCT01055496|Tubulin Modulators|tubulin modulators|mesh-ancestor
101600047|NCT01055496|Antimitotic Agents|antimitotic agents|mesh-ancestor
101600048|NCT01055496|Mitosis Modulators|mitosis modulators|mesh-ancestor
101600049|NCT01055496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101600050|NCT01055496|Immunotoxins|immunotoxins|mesh-ancestor
101600051|NCT01055496|Immunoconjugates|immunoconjugates|mesh-ancestor
101600052|NCT03436498|Insulin|insulin|mesh-list
101600053|NCT03436498|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101600054|NCT03436498|Insulin Aspart|insulin aspart|mesh-list
101622344|NCT00905034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622346|NCT00905034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101622347|NCT00905034|Antiemetics|antiemetics|mesh-ancestor
101622348|NCT00905034|Autonomic Agents|autonomic agents|mesh-ancestor
101622349|NCT00905034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101622350|NCT00905034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101622351|NCT00905034|Glucocorticoids|glucocorticoids|mesh-ancestor
101622352|NCT00905034|Hormones|hormones|mesh-ancestor
101622353|NCT00905034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101622354|NCT00905034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101622355|NCT00905034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101622356|NCT00905034|Abortifacient Agents|abortifacient agents|mesh-ancestor
101622357|NCT00905034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101622358|NCT00905034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101600055|NCT03436498|Insulin, Long-Acting|insulin, long-acting|mesh-list
101600056|NCT03436498|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101600061|NCT03435952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101600062|NCT03435952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101600063|NCT03435952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101600064|NCT03435952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600065|NCT03435952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101600066|NCT03435952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101600067|NCT03435952|Antimalarials|antimalarials|mesh-ancestor
101600068|NCT03435952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101600069|NCT03435952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101600070|NCT00609531|Citalopram|citalopram|mesh-list
101600071|NCT00609531|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101600072|NCT00609531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101600073|NCT00609531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101600074|NCT00609531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600075|NCT00609531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101600076|NCT00609531|Serotonin Agents|serotonin agents|mesh-ancestor
101600077|NCT00609531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600078|NCT00609531|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101600079|NCT00609531|Antidepressive Agents|antidepressive agents|mesh-ancestor
101600080|NCT00609531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101600081|NCT03406000|Insulin Glargine|insulin glargine|mesh-list
101600082|NCT03406000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101600083|NCT03406000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600084|NCT01052844|Gabapentin|gabapentin|mesh-list
101600085|NCT01052844|Analgesics|analgesics|mesh-ancestor
101600086|NCT01052844|Sensory System Agents|sensory system agents|mesh-ancestor
101600087|NCT01052844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101600088|NCT01052844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600089|NCT01052844|Anticonvulsants|anticonvulsants|mesh-ancestor
101338825|NCT00075439|Gefitinib|gefitinib|mesh-list
101600090|NCT01052844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101600091|NCT01052844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101600092|NCT01052844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101600093|NCT01052844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101600094|NCT01052844|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101600095|NCT01052844|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101600096|NCT01052844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101600097|NCT01052844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600098|NCT01052844|Antimanic Agents|antimanic agents|mesh-ancestor
101600099|NCT01049412|Insulin Glargine|insulin glargine|mesh-list
101622359|NCT00905034|Antimetabolites|antimetabolites|mesh-ancestor
101622360|NCT00905034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622361|NCT00905034|Dermatologic Agents|dermatologic agents|mesh-ancestor
101622362|NCT00905034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101622363|NCT00905034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101622364|NCT00905034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101622365|NCT00905034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101600100|NCT01049412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101600101|NCT01049412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600102|NCT02584426|Cefazolin|cefazolin|mesh-list
101600103|NCT02584426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101600104|NCT02584426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101600105|NCT00934089|Latanoprost|latanoprost|mesh-list
101600106|NCT00934089|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101600107|NCT00934089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101600108|NCT01032174|Azithromycin|azithromycin|mesh-list
101600109|NCT01032174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101600110|NCT01032174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101600111|NCT02704780|Misoprostol|misoprostol|mesh-list
101600112|NCT02704780|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101600113|NCT02704780|Abortifacient Agents|abortifacient agents|mesh-ancestor
101600114|NCT02704780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101600115|NCT02704780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600116|NCT02704780|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101600117|NCT02704780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101600118|NCT02704780|Oxytocics|oxytocics|mesh-ancestor
101600119|NCT02704546|Methylphenidate|methylphenidate|mesh-list
101600120|NCT02704546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101600121|NCT02704546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600122|NCT02704546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101600123|NCT02704546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101600124|NCT02704546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101600125|NCT02704546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600126|NCT02704546|Dopamine Agents|dopamine agents|mesh-ancestor
101600133|NCT01032018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101600134|NCT01032018|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101600135|NCT01032018|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101600136|NCT01032018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101600137|NCT01032018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600138|NCT01032018|Dopamine Agents|dopamine agents|mesh-ancestor
101600139|NCT01032018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101600140|NCT01032018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600141|NCT01032018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101600142|NCT01032018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101600143|NCT01032018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101600144|NCT01032018|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101600145|NCT01032018|Serotonin Agents|serotonin agents|mesh-ancestor
101600146|NCT00927069|Adalimumab|adalimumab|mesh-list
101600147|NCT00927069|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101600148|NCT00927069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101600149|NCT00927069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101600150|NCT01031628|Imatinib Mesylate|imatinib mesylate|mesh-list
101600151|NCT01031628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101600152|NCT01031628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101600153|NCT01031628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101600154|NCT01031628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600155|NCT00609843|Ethiodized Oil|ethiodized oil|mesh-list
101600156|NCT00609843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101600157|NCT00608673|Betamethasone|betamethasone|mesh-list
101600158|NCT00608673|Betamethasone Valerate|betamethasone valerate|mesh-list
101600159|NCT00608673|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101600160|NCT00608673|Betamethasone benzoate|betamethasone benzoate|mesh-list
101600161|NCT00608673|Pimecrolimus|pimecrolimus|mesh-list
101600162|NCT00608673|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101600163|NCT00608673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101600164|NCT00608673|Glucocorticoids|glucocorticoids|mesh-ancestor
101600165|NCT00608673|Hormones|hormones|mesh-ancestor
101622366|NCT00905034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101622367|NCT00905034|Tubulin Modulators|tubulin modulators|mesh-ancestor
101622368|NCT00905034|Antimitotic Agents|antimitotic agents|mesh-ancestor
101622369|NCT00905034|Mitosis Modulators|mitosis modulators|mesh-ancestor
101622370|NCT02611804|Diclofenac|diclofenac|mesh-list
101600166|NCT00608673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101600167|NCT00608673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600168|NCT00608673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101600169|NCT00608673|Respiratory System Agents|respiratory system agents|mesh-ancestor
101600170|NCT00608673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101600171|NCT00608673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101600172|NCT00608673|Analgesics|analgesics|mesh-ancestor
101600173|NCT00608673|Sensory System Agents|sensory system agents|mesh-ancestor
101600174|NCT00608673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101600175|NCT00608673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101600176|NCT00608673|Dermatologic Agents|dermatologic agents|mesh-ancestor
101600177|NCT00608673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101600178|NCT00608673|Immunologic Factors|immunologic factors|mesh-ancestor
101600179|NCT00608673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101600180|NCT00608673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101600181|NCT00608673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600191|NCT00637767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101600192|NCT00637767|Immunologic Factors|immunologic factors|mesh-ancestor
101600193|NCT00637767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600194|NCT00637767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101600195|NCT00637767|Alkylating Agents|alkylating agents|mesh-ancestor
101600196|NCT00637767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600197|NCT00637767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101600198|NCT00637767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101600199|NCT00637767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101600208|NCT00609999|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101600209|NCT00609999|Dasatinib|dasatinib|mesh-list
101600210|NCT00609999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101600211|NCT00609999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101600212|NCT00609999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101600215|NCT00627250|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101600216|NCT00627250|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101600218|NCT00627250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101600219|NCT00627250|Dopamine Agents|dopamine agents|mesh-ancestor
101600220|NCT00627250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101600221|NCT00627250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600222|NCT00627250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600223|NCT00627250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101600224|NCT00627250|Analgesics|analgesics|mesh-ancestor
101600225|NCT00627250|Sensory System Agents|sensory system agents|mesh-ancestor
101600226|NCT00627250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101600227|NCT04300374|Anesthetics|anesthetics|mesh-list
101338844|NCT00075595|Leucovorin|leucovorin|mesh-list
101600228|NCT04300374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101600229|NCT04300374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600230|NCT02703376|Prednisone|prednisone|mesh-list
101600231|NCT02703376|Prednisolone|prednisolone|mesh-list
101600232|NCT02703376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101600233|NCT02703376|Glucocorticoids|glucocorticoids|mesh-ancestor
101600234|NCT02703376|Hormones|hormones|mesh-ancestor
101600235|NCT02703376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101600236|NCT02703376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600237|NCT02703376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101600238|NCT02703376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101600239|NCT00610077|Letrozole|letrozole|mesh-list
101600240|NCT00610077|Clomiphene|clomiphene|mesh-list
101600241|NCT00610077|Enclomiphene|enclomiphene|mesh-list
101600242|NCT00610077|Zuclomiphene|zuclomiphene|mesh-list
101600243|NCT00610077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600244|NCT00610077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101600245|NCT00610077|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101600246|NCT00610077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101600247|NCT00610077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101600248|NCT00610077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101600249|NCT00610077|Hormone Antagonists|hormone antagonists|mesh-ancestor
101622371|NCT02611804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101622372|NCT02611804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101622373|NCT02611804|Analgesics|analgesics|mesh-ancestor
101622374|NCT02611804|Sensory System Agents|sensory system agents|mesh-ancestor
101622375|NCT02611804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101622376|NCT02611804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622377|NCT02611804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101622378|NCT02611804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101622379|NCT02611804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101622380|NCT02611804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101622381|NCT02611804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622382|NCT00706186|Sodium Oxybate|sodium oxybate|mesh-list
101622383|NCT00706186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101622384|NCT00706186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101622385|NCT00706186|Anesthetics, General|anesthetics, general|mesh-ancestor
101622386|NCT00706186|Anesthetics|anesthetics|mesh-ancestor
101622387|NCT00706186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101622388|NCT00706186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622389|NCT02611492|Cytarabine|cytarabine|mesh-list
101622390|NCT02611492|Dexamethasone|dexamethasone|mesh-list
101622391|NCT02611492|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101622392|NCT02611492|Methotrexate|methotrexate|mesh-list
101622393|NCT02611492|Vincristine|vincristine|mesh-list
101622394|NCT02611492|Mercaptopurine|mercaptopurine|mesh-list
101622395|NCT02611492|Lenograstim|lenograstim|mesh-list
101622396|NCT02611492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101622397|NCT02611492|Antiemetics|antiemetics|mesh-ancestor
101622398|NCT02611492|Autonomic Agents|autonomic agents|mesh-ancestor
101622399|NCT02611492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101622400|NCT02611492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622401|NCT02611492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101622402|NCT02611492|Glucocorticoids|glucocorticoids|mesh-ancestor
101622403|NCT02611492|Hormones|hormones|mesh-ancestor
101421084|NCT00467506|Antibodies|antibodies|mesh-list
101600250|NCT00610077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101600251|NCT00610077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600252|NCT00610077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101600253|NCT00610077|Fertility Agents|fertility agents|mesh-ancestor
101600254|NCT00610077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101600255|NCT00610077|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101600256|NCT00610077|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101600257|NCT00823576|Ropivacaine|ropivacaine|mesh-list
101622404|NCT02611492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101622405|NCT02611492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101622406|NCT02611492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101622407|NCT02611492|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101622409|NCT02611492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101622410|NCT02611492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101622411|NCT02611492|Antimetabolites|antimetabolites|mesh-ancestor
101622412|NCT02611492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622413|NCT02611492|Dermatologic Agents|dermatologic agents|mesh-ancestor
101622414|NCT02611492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101622415|NCT02611492|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101600258|NCT00823576|Anesthetics, Local|anesthetics, local|mesh-ancestor
101600259|NCT00823576|Anesthetics|anesthetics|mesh-ancestor
101600260|NCT00823576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101600261|NCT00823576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600262|NCT00823576|Sensory System Agents|sensory system agents|mesh-ancestor
101600263|NCT00823576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101600264|NCT01028352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101600265|NCT01028352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101600266|NCT01028352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101600267|NCT01028352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101600268|NCT01028352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600269|NCT01028352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101600270|NCT01028352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600271|NCT01028352|Analgesics|analgesics|mesh-ancestor
101600272|NCT01028352|Sensory System Agents|sensory system agents|mesh-ancestor
101600273|NCT01028352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101600274|NCT01028352|Antidepressive Agents|antidepressive agents|mesh-ancestor
101600275|NCT01028352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101600276|NCT01028352|Dopamine Agents|dopamine agents|mesh-ancestor
101600277|NCT03172780|Diclofenac|diclofenac|mesh-list
101600278|NCT03172780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101600279|NCT03172780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101600280|NCT03172780|Analgesics|analgesics|mesh-ancestor
101600281|NCT03172780|Sensory System Agents|sensory system agents|mesh-ancestor
101600282|NCT03172780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101600283|NCT03172780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451778|NCT00208143|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101600306|NCT00926367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101600308|NCT00926367|Analgesics|analgesics|mesh-ancestor
101600309|NCT00926367|Sensory System Agents|sensory system agents|mesh-ancestor
101600310|NCT00926367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101600311|NCT00926367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600312|NCT00926367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101600313|NCT00926367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101600314|NCT04261023|Abatacept|abatacept|mesh-list
101600315|NCT04261023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101600316|NCT04261023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600317|NCT04261023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101600318|NCT04261023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101600319|NCT04261023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101600320|NCT04261023|Immunologic Factors|immunologic factors|mesh-ancestor
101600321|NCT04261023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600322|NCT04261023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101600323|NCT01114529|Cyclosporine|cyclosporine|mesh-list
101600324|NCT01114529|Everolimus|everolimus|mesh-list
101600325|NCT01114529|Tacrolimus|tacrolimus|mesh-list
101600326|NCT01114529|Cyclosporins|cyclosporins|mesh-list
101600327|NCT01114529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101600328|NCT01114529|Immunologic Factors|immunologic factors|mesh-ancestor
101622416|NCT02611492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101622417|NCT02611492|Immunologic Factors|immunologic factors|mesh-ancestor
101622418|NCT02611492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101622419|NCT02611492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101622420|NCT02611492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101622421|NCT02611492|Tubulin Modulators|tubulin modulators|mesh-ancestor
101622422|NCT02611492|Antimitotic Agents|antimitotic agents|mesh-ancestor
101622423|NCT02611492|Mitosis Modulators|mitosis modulators|mesh-ancestor
101622424|NCT02611492|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101622425|NCT02611492|Antiviral Agents|antiviral agents|mesh-ancestor
101622426|NCT02611492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101622427|NCT00706576|Mitogens|mitogens|mesh-list
101622428|NCT00706576|Enkephalins|enkephalins|mesh-list
101421130|NCT00468364|Insulin|insulin|mesh-list
101600329|NCT01114529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600330|NCT01114529|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101600331|NCT01114529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101600332|NCT01114529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600333|NCT01114529|Antifungal Agents|antifungal agents|mesh-ancestor
101600334|NCT01114529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101600335|NCT01114529|Dermatologic Agents|dermatologic agents|mesh-ancestor
101600336|NCT01114529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101600337|NCT01114529|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101600338|NCT01114529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101600343|NCT00926289|Diuretics|diuretics|mesh-ancestor
101600344|NCT00926289|Natriuretic Agents|natriuretic agents|mesh-ancestor
101600345|NCT00926289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600346|NCT00926289|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101600347|NCT00926289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101600348|NCT00926289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600349|NCT00926289|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101600350|NCT00926289|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101600351|NCT04309643|Levonorgestrel|levonorgestrel|mesh-list
101600352|NCT04309643|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101600353|NCT04309643|Contraceptive Agents|contraceptive agents|mesh-list
101600354|NCT04309643|Contraceptives, Oral|contraceptives, oral|mesh-list
101600355|NCT04309643|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
101600356|NCT04309643|Estradiol|estradiol|mesh-list
101600357|NCT04309643|Estrogens|estrogens|mesh-ancestor
101600358|NCT04309643|Hormones|hormones|mesh-ancestor
101600359|NCT04309643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101600360|NCT04309643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600361|NCT04309643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101600362|NCT04309643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101600363|NCT04309643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101600364|NCT04309643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101600365|NCT04309643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101600366|NCT03188146|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101600367|NCT03188146|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101600368|NCT03188146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101600369|NCT04259073|Pregabalin|pregabalin|mesh-list
101600370|NCT04259073|Analgesics|analgesics|mesh-ancestor
101600371|NCT04259073|Sensory System Agents|sensory system agents|mesh-ancestor
101600372|NCT04259073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101600373|NCT04259073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600374|NCT04259073|Anticonvulsants|anticonvulsants|mesh-ancestor
101600375|NCT04259073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101600376|NCT04259073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101600377|NCT04259073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622429|NCT00706576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622430|NCT00706576|Mitosis Modulators|mitosis modulators|mesh-ancestor
101622431|NCT00706576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622432|NCT00706576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101622434|NCT00828568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101622435|NCT00828568|Immunologic Factors|immunologic factors|mesh-ancestor
101622436|NCT00828568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622437|NCT00828568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101622438|NCT00828568|Interferon Inducers|interferon inducers|mesh-ancestor
101622439|NCT01038752|Suramin|suramin|mesh-list
101622440|NCT01038752|Carboplatin|carboplatin|mesh-list
101622441|NCT01038752|Docetaxel|docetaxel|mesh-list
101600378|NCT04259073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101600379|NCT04259073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101600380|NCT04259073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101600381|NCT04259073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101600382|NCT04259073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101600383|NCT00609063|Atorvastatin|atorvastatin|mesh-list
101600384|NCT00609063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101600385|NCT00609063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101600386|NCT00609063|Antimetabolites|antimetabolites|mesh-ancestor
101600387|NCT00609063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600388|NCT00609063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101600389|NCT00609063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101600390|NCT00609063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101600391|NCT02703064|Fenugreek seed meal|fenugreek seed meal|mesh-list
101600392|NCT02703064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101600393|NCT02703064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600394|NCT01114373|Melatonin|melatonin|mesh-list
101600395|NCT01114373|Antioxidants|antioxidants|mesh-ancestor
101600396|NCT01114373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600397|NCT01114373|Protective Agents|protective agents|mesh-ancestor
101600398|NCT01114373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600399|NCT01114373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101600400|NCT00925899|Melatonin|melatonin|mesh-list
101600401|NCT00925899|Antioxidants|antioxidants|mesh-ancestor
101600402|NCT00925899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600403|NCT00925899|Protective Agents|protective agents|mesh-ancestor
101600404|NCT00925899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600405|NCT00925899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101600406|NCT02601586|Oxycodone|oxycodone|mesh-list
101600407|NCT02601586|Levodopa|levodopa|mesh-list
101600411|NCT02601586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600412|NCT02601586|Analgesics|analgesics|mesh-ancestor
101600413|NCT02601586|Sensory System Agents|sensory system agents|mesh-ancestor
101600414|NCT02601586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101600415|NCT02601586|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101600416|NCT02601586|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101600417|NCT02601586|Dopamine Agents|dopamine agents|mesh-ancestor
101600418|NCT02601586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101600419|NCT02601586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600420|NCT00609141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101600421|NCT00609141|Immunologic Factors|immunologic factors|mesh-ancestor
101600422|NCT00609141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600423|NCT00610389|Immunomodulating Agents|immunomodulating agents|mesh-list
101600424|NCT00610389|Immunologic Factors|immunologic factors|mesh-ancestor
101600425|NCT00610389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600426|NCT01114217|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
101600427|NCT01114217|Hematinics|hematinics|mesh-ancestor
101600428|NCT01114217|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101600429|NCT01114217|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101622442|NCT01038752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101622443|NCT01038752|Tubulin Modulators|tubulin modulators|mesh-ancestor
101622444|NCT01038752|Antimitotic Agents|antimitotic agents|mesh-ancestor
101622445|NCT01038752|Mitosis Modulators|mitosis modulators|mesh-ancestor
101622446|NCT01038752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622447|NCT01038752|Antinematodal Agents|antinematodal agents|mesh-ancestor
101622448|NCT01038752|Anthelmintics|anthelmintics|mesh-ancestor
101622449|NCT01038752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101622450|NCT01038752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101622451|NCT01038752|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101622452|NCT01038752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101622453|NCT00903630|Doxorubicin|doxorubicin|mesh-list
101622454|NCT00903630|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101622455|NCT00903630|Lenalidomide|lenalidomide|mesh-list
101622456|NCT00903630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101421157|NCT00468754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101600430|NCT01030536|Immunotoxin HA22|immunotoxin ha22|mesh-list
101600431|NCT01030536|Immunotoxins|immunotoxins|mesh-ancestor
101600432|NCT01030536|Immunoconjugates|immunoconjugates|mesh-ancestor
101600433|NCT01030536|Immunologic Factors|immunologic factors|mesh-ancestor
101600434|NCT01030536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600435|NCT01030536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101600436|NCT01030458|Amlodipine|amlodipine|mesh-list
101600437|NCT01030458|Valsartan|valsartan|mesh-list
101600438|NCT01030458|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101600439|NCT01030458|Bisoprolol|bisoprolol|mesh-list
101600440|NCT01030458|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101600441|NCT01030458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101600442|NCT01030458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101600443|NCT01030458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600444|NCT01030458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101600445|NCT01030458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600446|NCT01030458|Vasodilator Agents|vasodilator agents|mesh-ancestor
101600447|NCT01030458|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101600448|NCT01030458|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101600449|NCT01030458|Diuretics|diuretics|mesh-ancestor
101600450|NCT01030458|Natriuretic Agents|natriuretic agents|mesh-ancestor
101600451|NCT01030458|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101600452|NCT01030458|Sympatholytics|sympatholytics|mesh-ancestor
101600453|NCT01030458|Autonomic Agents|autonomic agents|mesh-ancestor
101600454|NCT01030458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101600455|NCT01030458|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101600456|NCT01030458|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101600457|NCT01030458|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101600458|NCT01030458|Adrenergic Agents|adrenergic agents|mesh-ancestor
101600459|NCT01030458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101600460|NCT02702674|Propranolol|propranolol|mesh-list
101600461|NCT02702674|Oxytocin|oxytocin|mesh-list
101600462|NCT02702674|Oxytocics|oxytocics|mesh-ancestor
101600463|NCT02702674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101600464|NCT02702674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600465|NCT02702674|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101600466|NCT02702674|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101600467|NCT02702674|Adrenergic Agents|adrenergic agents|mesh-ancestor
101600468|NCT02702674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101600469|NCT02702674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600470|NCT02702674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101600471|NCT02702674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101600472|NCT02702674|Vasodilator Agents|vasodilator agents|mesh-ancestor
101600473|NCT01114139|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
101622458|NCT00903630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101622459|NCT00903630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101622460|NCT00903630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101622461|NCT00903630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622462|NCT00903630|Immunologic Factors|immunologic factors|mesh-ancestor
101622463|NCT00903630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622464|NCT00903630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101622465|NCT00903630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101622466|NCT00903630|Growth Substances|growth substances|mesh-ancestor
101622467|NCT00903630|Growth Inhibitors|growth inhibitors|mesh-ancestor
101600474|NCT01114139|Hematinics|hematinics|mesh-ancestor
101600475|NCT01114139|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101600476|NCT01114139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101600477|NCT01027884|Idebenone|idebenone|mesh-list
101257458|NCT01716637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101600478|NCT01027884|Antioxidants|antioxidants|mesh-ancestor
101600480|NCT01027884|Protective Agents|protective agents|mesh-ancestor
101600481|NCT01027884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600482|NCT02699008|Clopidogrel|clopidogrel|mesh-list
101600483|NCT02699008|Ticagrelor|ticagrelor|mesh-list
101600484|NCT02699008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101600485|NCT02699008|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101600486|NCT02699008|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101600487|NCT02699008|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101600488|NCT02699008|Purinergic Agents|purinergic agents|mesh-ancestor
101600489|NCT02699008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101600490|NCT02699008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600491|NCT02699008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600492|NCT00627666|Leucovorin|leucovorin|mesh-list
101600493|NCT00627666|Methotrexate|methotrexate|mesh-list
101600494|NCT00627666|Fludarabine phosphate|fludarabine phosphate|mesh-list
101600495|NCT00627666|Fludarabine|fludarabine|mesh-list
101600496|NCT00627666|Busulfan|busulfan|mesh-list
101600497|NCT00627666|Calcium|calcium|mesh-list
101600498|NCT00627666|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101600499|NCT00627666|Levoleucovorin|levoleucovorin|mesh-list
101600500|NCT00627666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101600501|NCT00627666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600502|NCT00627666|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101600503|NCT00627666|Abortifacient Agents|abortifacient agents|mesh-ancestor
101600504|NCT00627666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101600505|NCT00627666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101600506|NCT00627666|Antimetabolites|antimetabolites|mesh-ancestor
101600507|NCT00627666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600508|NCT00627666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101600509|NCT00627666|Dermatologic Agents|dermatologic agents|mesh-ancestor
101600510|NCT00627666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101600511|NCT00627666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101600512|NCT00627666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101600513|NCT00627666|Immunologic Factors|immunologic factors|mesh-ancestor
101600514|NCT00627666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101600515|NCT00627666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101600516|NCT00627666|Antidotes|antidotes|mesh-ancestor
101600517|NCT00627666|Protective Agents|protective agents|mesh-ancestor
101600518|NCT00627666|Vitamin B Complex|vitamin b complex|mesh-ancestor
101600519|NCT00627666|Vitamins|vitamins|mesh-ancestor
101600520|NCT00627666|Micronutrients|micronutrients|mesh-ancestor
101600521|NCT00627666|Alkylating Agents|alkylating agents|mesh-ancestor
101600522|NCT00627666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101600523|NCT00627666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101600524|NCT01022580|Pulmonary Surfactants|pulmonary surfactants|mesh-list
101600525|NCT01022580|Calfactant|calfactant|mesh-list
101622468|NCT04302584|Vasopressins|vasopressins|mesh-list
101622469|NCT04302584|Arginine Vasopressin|arginine vasopressin|mesh-list
101622470|NCT04302584|Norepinephrine|norepinephrine|mesh-list
101622471|NCT04302584|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101622472|NCT04302584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101622473|NCT04302584|Adrenergic Agents|adrenergic agents|mesh-ancestor
101622474|NCT04302584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101622475|NCT04302584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622476|NCT04302584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600526|NCT01022580|Respiratory System Agents|respiratory system agents|mesh-ancestor
101600527|NCT02698930|Dexmedetomidine|dexmedetomidine|mesh-list
101600528|NCT02698930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101600529|NCT02698930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101600530|NCT02698930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600531|NCT02698930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101600532|NCT02698930|Analgesics|analgesics|mesh-ancestor
101600533|NCT02698930|Sensory System Agents|sensory system agents|mesh-ancestor
101600534|NCT02698930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101600535|NCT02698930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101600536|NCT02698930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101600537|NCT02698930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101600538|NCT02698930|Adrenergic Agents|adrenergic agents|mesh-ancestor
101600539|NCT02698930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101600540|NCT02698930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600542|NCT01107353|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101600543|NCT01107353|Antidepressive Agents|antidepressive agents|mesh-ancestor
101600544|NCT01107353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101600545|NCT01107353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101600546|NCT01107353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101600547|NCT01107353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101600548|NCT01107353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600549|NCT01107353|Adrenergic Agents|adrenergic agents|mesh-ancestor
101600550|NCT01107353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101600559|NCT02702206|Immunologic Factors|immunologic factors|mesh-ancestor
101600560|NCT02702206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101600561|NCT02702206|Viscosupplements|viscosupplements|mesh-ancestor
101600562|NCT02702206|Protective Agents|protective agents|mesh-ancestor
101600563|NCT04216186|Ubiquinone|ubiquinone|mesh-list
101600564|NCT04216186|Coenzyme Q10|coenzyme q10|mesh-list
101600565|NCT04216186|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101600566|NCT04216186|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101600567|NCT04216186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101600568|NCT04216186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101600569|NCT04216186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600570|NCT04216186|Adrenergic Agents|adrenergic agents|mesh-ancestor
101600571|NCT04216186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101600572|NCT04216186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600573|NCT04216186|Micronutrients|micronutrients|mesh-ancestor
101600574|NCT04216186|Vitamins|vitamins|mesh-ancestor
101600575|NCT01989598|Trametinib|trametinib|mesh-list
101600576|NCT01989598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101600577|NCT01989598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101600578|NCT01989598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101600579|NCT01989598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600580|NCT04214938|Lidocaine|lidocaine|mesh-list
101600581|NCT04214938|Xylometazoline|xylometazoline|mesh-list
101600582|NCT04214938|Anesthetics, Local|anesthetics, local|mesh-ancestor
101600583|NCT04214938|Anesthetics|anesthetics|mesh-ancestor
101600584|NCT04214938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101600585|NCT04214938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600586|NCT04214938|Sensory System Agents|sensory system agents|mesh-ancestor
101600587|NCT04214938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101600588|NCT04214938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101622477|NCT04302584|Sympathomimetics|sympathomimetics|mesh-ancestor
101622478|NCT04302584|Autonomic Agents|autonomic agents|mesh-ancestor
101622479|NCT04302584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101622480|NCT04302584|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101622481|NCT04302584|Hemostatics|hemostatics|mesh-ancestor
101622482|NCT04302584|Coagulants|coagulants|mesh-ancestor
101622483|NCT04302584|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101622484|NCT04302584|Natriuretic Agents|natriuretic agents|mesh-ancestor
101622485|NCT00703144|Tazobactam|tazobactam|mesh-list
101622486|NCT00703144|Piperacillin|piperacillin|mesh-list
101622487|NCT00703144|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101622488|NCT00703144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101622489|NCT00703144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101622490|NCT00703144|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101622491|NCT00703144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101622492|NCT00703144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622493|NCT01054820|Diclofenac|diclofenac|mesh-list
101622494|NCT01054820|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
101622495|NCT01054820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101421197|NCT04697641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101600589|NCT04214938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101600590|NCT04214938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101600591|NCT04214938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101600592|NCT04214938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600593|NCT04214938|Nasal Decongestants|nasal decongestants|mesh-ancestor
101600594|NCT04214938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101600595|NCT04214938|Respiratory System Agents|respiratory system agents|mesh-ancestor
101600596|NCT00615160|Dacarbazine|dacarbazine|mesh-list
101600597|NCT00615160|Vatalanib|vatalanib|mesh-list
101600598|NCT00615160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101600599|NCT00615160|Alkylating Agents|alkylating agents|mesh-ancestor
101600600|NCT00615160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600601|NCT00615160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101600602|NCT00615160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101600603|NCT00615160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101600604|NCT01112267|Acetaminophen|acetaminophen|mesh-list
101600605|NCT01112267|Tramadol|tramadol|mesh-list
101600606|NCT01112267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101600607|NCT01112267|Analgesics|analgesics|mesh-ancestor
101600608|NCT01112267|Sensory System Agents|sensory system agents|mesh-ancestor
101600609|NCT01112267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101600610|NCT01112267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600611|NCT01112267|Antipyretics|antipyretics|mesh-ancestor
101600612|NCT01112267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101600613|NCT01112267|Narcotics|narcotics|mesh-ancestor
101600614|NCT01112267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101600615|NCT00925587|Darbepoetin alfa|darbepoetin alfa|mesh-list
101600616|NCT00925587|Hematinics|hematinics|mesh-ancestor
101600617|NCT02698306|Dexamethasone|dexamethasone|mesh-list
101600618|NCT02698306|Diclofenac|diclofenac|mesh-list
101600626|NCT02698306|Hormones|hormones|mesh-ancestor
101600627|NCT02698306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101600628|NCT02698306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101600629|NCT02698306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101600630|NCT02698306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101600631|NCT02698306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101622496|NCT01054820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101622498|NCT01054820|Sensory System Agents|sensory system agents|mesh-ancestor
101622499|NCT01054820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101622500|NCT01054820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622501|NCT01054820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101622502|NCT01054820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101622503|NCT01054820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101622504|NCT01054820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101622505|NCT01054820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622506|NCT03105843|Methacholine Chloride|methacholine chloride|mesh-list
101600632|NCT02698306|Analgesics|analgesics|mesh-ancestor
101600633|NCT02698306|Sensory System Agents|sensory system agents|mesh-ancestor
101600634|NCT02698306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101600635|NCT02698306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101600636|NCT02698306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101600637|NCT02698306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600638|NCT02698228|Morphine|morphine|mesh-list
101600639|NCT02698228|Bupivacaine|bupivacaine|mesh-list
101600640|NCT02698228|Anesthetics, Local|anesthetics, local|mesh-ancestor
101600641|NCT02698228|Anesthetics|anesthetics|mesh-ancestor
101600642|NCT02698228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101600643|NCT02698228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600644|NCT02698228|Sensory System Agents|sensory system agents|mesh-ancestor
101600645|NCT02698228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101600646|NCT02698228|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101600647|NCT02698228|Narcotics|narcotics|mesh-ancestor
101600648|NCT02698228|Analgesics|analgesics|mesh-ancestor
101600649|NCT02702128|Tranexamic Acid|tranexamic acid|mesh-list
101600650|NCT02702128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101600651|NCT02702128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101600652|NCT02702128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600654|NCT02702128|Coagulants|coagulants|mesh-ancestor
101600655|NCT00610545|Atorvastatin|atorvastatin|mesh-list
101600656|NCT00610545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101600657|NCT00610545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101600658|NCT00610545|Antimetabolites|antimetabolites|mesh-ancestor
101600659|NCT00610545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600660|NCT00610545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101600661|NCT00610545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101600662|NCT00610545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101600663|NCT00193414|Gemcitabine|gemcitabine|mesh-list
101600664|NCT00193414|Pemetrexed|pemetrexed|mesh-list
101600665|NCT00193414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101600666|NCT00193414|Antimetabolites|antimetabolites|mesh-ancestor
101600667|NCT00193414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600668|NCT00193414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101600669|NCT00193414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101600670|NCT00193414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101600671|NCT00193414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101600672|NCT04260711|Interferons|interferons|mesh-list
101600673|NCT04260711|Teriflunomide|teriflunomide|mesh-list
101600674|NCT04260711|Glatiramer Acetate|glatiramer acetate|mesh-list
101600675|NCT04260711|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101600676|NCT04260711|(T,G)-A-L|(t,g)-a-l|mesh-list
101600677|NCT04260711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101600678|NCT04260711|Antiviral Agents|antiviral agents|mesh-ancestor
101600679|NCT04260711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101600680|NCT04260711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101600681|NCT04260711|Immunologic Factors|immunologic factors|mesh-ancestor
101600682|NCT04260711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600683|NCT04260711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101600684|NCT04260711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101600685|NCT04260711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101622508|NCT03105843|Autonomic Agents|autonomic agents|mesh-ancestor
101622509|NCT03105843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101622510|NCT03105843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622511|NCT03105843|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101622512|NCT03105843|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
101622513|NCT03105843|Respiratory System Agents|respiratory system agents|mesh-ancestor
101622514|NCT03105843|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101622515|NCT03105843|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101622516|NCT03105843|Cholinergic Agents|cholinergic agents|mesh-ancestor
101622517|NCT03105843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101622518|NCT03105843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622519|NCT02874248|Drospirenone|drospirenone|mesh-list
101622520|NCT02874248|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101622521|NCT02874248|Hormone Antagonists|hormone antagonists|mesh-ancestor
101622522|NCT02874248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101622523|NCT02874248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622524|NCT02874248|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101622525|NCT02874248|Diuretics|diuretics|mesh-ancestor
101600686|NCT04260711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101600687|NCT04260711|Analgesics|analgesics|mesh-ancestor
101600688|NCT04260711|Sensory System Agents|sensory system agents|mesh-ancestor
101600709|NCT00928707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101600710|NCT00928707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600711|NCT00928707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101600712|NCT00928707|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101600714|NCT04956705|Calcium|calcium|mesh-list
101600715|NCT04956705|Vitamins|vitamins|mesh-ancestor
101600716|NCT04956705|Micronutrients|micronutrients|mesh-ancestor
101600717|NCT04956705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600718|NCT04956705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101600719|NCT04956705|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101600720|NCT02705950|Baclofen|baclofen|mesh-list
101600721|NCT02705950|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101600722|NCT02705950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600723|NCT02705950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101600724|NCT02705950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101264707|NCT01769040|Rifaximin|rifaximin|mesh-list
101600725|NCT02705950|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101600727|NCT02705950|GABA Agents|gaba agents|mesh-ancestor
101600728|NCT02705950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101600729|NCT02705950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600730|NCT04951323|Vaccines|vaccines|mesh-list
101600731|NCT04951323|Immunologic Factors|immunologic factors|mesh-ancestor
101600732|NCT04951323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600733|NCT02705872|Sufentanil|sufentanil|mesh-list
101600735|NCT02705872|Levobupivacaine|levobupivacaine|mesh-list
101600736|NCT02705872|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101600737|NCT02705872|Narcotics|narcotics|mesh-ancestor
101600738|NCT02705872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101600739|NCT02705872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600740|NCT02705872|Analgesics|analgesics|mesh-ancestor
101600741|NCT02705872|Sensory System Agents|sensory system agents|mesh-ancestor
101600742|NCT02705872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101600743|NCT02705872|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101622526|NCT02874248|Natriuretic Agents|natriuretic agents|mesh-ancestor
101622527|NCT02787603|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101622528|NCT02787603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101622529|NCT02004834|Levobupivacaine|levobupivacaine|mesh-list
101622530|NCT02004834|Anesthetics, Local|anesthetics, local|mesh-ancestor
101622531|NCT02004834|Anesthetics|anesthetics|mesh-ancestor
101622532|NCT02004834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101622533|NCT02004834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622534|NCT02004834|Sensory System Agents|sensory system agents|mesh-ancestor
101622535|NCT02004834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101622536|NCT02788305|Misoprostol|misoprostol|mesh-list
101622537|NCT02788305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101622538|NCT02788305|Abortifacient Agents|abortifacient agents|mesh-ancestor
101622539|NCT02788305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101622540|NCT02788305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622541|NCT02788305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101622542|NCT02788305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101622543|NCT02788305|Oxytocics|oxytocics|mesh-ancestor
101622544|NCT05758012|Oxytocin|oxytocin|mesh-list
101622545|NCT05758012|Carbetocin|carbetocin|mesh-list
101622546|NCT05758012|Oxytocics|oxytocics|mesh-ancestor
101622547|NCT05758012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101622548|NCT05758012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622549|NCT02786667|Rotigotine|rotigotine|mesh-list
101600744|NCT02705872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101600752|NCT02701348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101600753|NCT02701348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600754|NCT02701348|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101600755|NCT02701348|Hormone Antagonists|hormone antagonists|mesh-ancestor
101600756|NCT02701348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101600757|NCT02701348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600758|NCT05324800|Turmeric extract|turmeric extract|mesh-list
101600759|NCT05324800|Antioxidants|antioxidants|mesh-ancestor
101600760|NCT05324800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600761|NCT05324800|Protective Agents|protective agents|mesh-ancestor
101600762|NCT05324800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600763|NCT04258371|Dapagliflozin|dapagliflozin|mesh-list
101600764|NCT04258371|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101600765|NCT04258371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600766|NCT04258371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101600767|NCT04258371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600768|NCT00930579|Metformin|metformin|mesh-list
101600769|NCT00930579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101600770|NCT00930579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600771|NCT02700568|Axitinib|axitinib|mesh-list
101600772|NCT02700568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101600773|NCT02700568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101600774|NCT02700568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101600775|NCT02700568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600776|NCT00925353|Lidocaine|lidocaine|mesh-list
101622550|NCT02786667|Dopamine Agonists|dopamine agonists|mesh-ancestor
101622551|NCT02786667|Dopamine Agents|dopamine agents|mesh-ancestor
101622552|NCT02786667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101622553|NCT02786667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622554|NCT02786667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622555|NCT00913276|Propofol|propofol|mesh-list
101622556|NCT00913276|Sevoflurane|sevoflurane|mesh-list
101622557|NCT00913276|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101622558|NCT00913276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101622559|NCT00913276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600777|NCT00925353|Anesthetics, Local|anesthetics, local|mesh-ancestor
101600778|NCT00925353|Anesthetics|anesthetics|mesh-ancestor
101600779|NCT00925353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101600780|NCT00925353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600781|NCT00925353|Sensory System Agents|sensory system agents|mesh-ancestor
101600782|NCT00925353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101600783|NCT00925353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101600784|NCT00925353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101600785|NCT00925353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101600786|NCT00925353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101600787|NCT00925353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600788|NCT02705482|Durvalumab|durvalumab|mesh-list
101600789|NCT02705482|Tremelimumab|tremelimumab|mesh-list
101600790|NCT02705482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101600791|NCT02705482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101600792|NCT02705638|Rituximab|rituximab|mesh-list
101600793|NCT02705638|Lenalidomide|lenalidomide|mesh-list
101600794|NCT02705638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101600795|NCT02705638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101600796|NCT02705638|Immunologic Factors|immunologic factors|mesh-ancestor
101600797|NCT02705638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600798|NCT02705638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101339149|NCT00077818|Enoxaparin|enoxaparin|mesh-list
101600799|NCT02705638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101600800|NCT02705638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101600801|NCT02705638|Growth Substances|growth substances|mesh-ancestor
101600802|NCT02705638|Growth Inhibitors|growth inhibitors|mesh-ancestor
101600803|NCT02691910|Chloroquine|chloroquine|mesh-list
101600804|NCT02691910|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
101600805|NCT02691910|Primaquine|primaquine|mesh-list
101600806|NCT02691910|Amebicides|amebicides|mesh-ancestor
101600807|NCT02691910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101600808|NCT02691910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101600809|NCT02691910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101600810|NCT02691910|Antimalarials|antimalarials|mesh-ancestor
101600811|NCT02691910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101600812|NCT02691910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101600817|NCT02691910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600819|NCT02691910|Filaricides|filaricides|mesh-ancestor
101600820|NCT02691910|Antinematodal Agents|antinematodal agents|mesh-ancestor
101600821|NCT02691910|Anthelmintics|anthelmintics|mesh-ancestor
101600822|NCT02705014|Hormones|hormones|mesh-list
101600823|NCT02705014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101600824|NCT02705014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600825|NCT02704624|Vitamin D|vitamin d|mesh-list
101600826|NCT02704624|Vitamins|vitamins|mesh-ancestor
101600827|NCT02704624|Micronutrients|micronutrients|mesh-ancestor
101600828|NCT02704624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600829|NCT02704624|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101600830|NCT02700022|Prednisone|prednisone|mesh-list
101600831|NCT02700022|Cyclophosphamide|cyclophosphamide|mesh-list
101600832|NCT02700022|Doxorubicin|doxorubicin|mesh-list
101600833|NCT02700022|Etoposide|etoposide|mesh-list
101600834|NCT02700022|Vincristine|vincristine|mesh-list
101600835|NCT02700022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101600836|NCT02700022|Immunologic Factors|immunologic factors|mesh-ancestor
101600837|NCT02700022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622560|NCT00913276|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101622561|NCT00913276|Anesthetics, General|anesthetics, general|mesh-ancestor
101622562|NCT00913276|Anesthetics|anesthetics|mesh-ancestor
101622563|NCT00913276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101622564|NCT00913276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101622565|NCT04302116|Prednisolone|prednisolone|mesh-list
101622566|NCT04302116|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101622567|NCT04302116|Methylprednisolone|methylprednisolone|mesh-list
101622568|NCT04302116|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101622569|NCT04302116|Prednisolone acetate|prednisolone acetate|mesh-list
101622570|NCT04302116|Vigabatrin|vigabatrin|mesh-list
101622571|NCT04302116|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101622572|NCT04302116|Prednisolone phosphate|prednisolone phosphate|mesh-list
101622573|NCT04302116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101622574|NCT04302116|Glucocorticoids|glucocorticoids|mesh-ancestor
101622575|NCT04302116|Hormones|hormones|mesh-ancestor
101622576|NCT04302116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101622577|NCT04302116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622578|NCT04302116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101622579|NCT04302116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101622580|NCT04302116|Antiemetics|antiemetics|mesh-ancestor
101622581|NCT04302116|Autonomic Agents|autonomic agents|mesh-ancestor
101622582|NCT04302116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101622583|NCT04302116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101622584|NCT04302116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101622585|NCT04302116|Protective Agents|protective agents|mesh-ancestor
101622586|NCT04302116|Anticonvulsants|anticonvulsants|mesh-ancestor
101622587|NCT04302116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101622588|NCT04302116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622590|NCT04302116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101622591|NCT05756998|Copper|copper|mesh-list
101600838|NCT02700022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101600839|NCT02700022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101600840|NCT02700022|Alkylating Agents|alkylating agents|mesh-ancestor
101600841|NCT02700022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600842|NCT02700022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101600843|NCT02700022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101600844|NCT02700022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101600845|NCT02700022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101600846|NCT02700022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101600847|NCT02700022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101600848|NCT02700022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101600849|NCT02700022|Glucocorticoids|glucocorticoids|mesh-ancestor
101600850|NCT02700022|Hormones|hormones|mesh-ancestor
101622592|NCT05756998|Trace Elements|trace elements|mesh-ancestor
101622593|NCT05756998|Micronutrients|micronutrients|mesh-ancestor
101622594|NCT05756998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622595|NCT02890212|Selenium|selenium|mesh-list
101622596|NCT02890212|Antioxidants|antioxidants|mesh-ancestor
101622597|NCT02890212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622598|NCT02890212|Protective Agents|protective agents|mesh-ancestor
101622599|NCT02890212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622600|NCT02890212|Trace Elements|trace elements|mesh-ancestor
101622601|NCT02890212|Micronutrients|micronutrients|mesh-ancestor
101421315|NCT00149292|Olanzapine|olanzapine|mesh-list
101600851|NCT02700022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101600852|NCT02700022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101600853|NCT02700022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101600854|NCT02700022|Tubulin Modulators|tubulin modulators|mesh-ancestor
101600855|NCT02700022|Antimitotic Agents|antimitotic agents|mesh-ancestor
101600856|NCT02700022|Mitosis Modulators|mitosis modulators|mesh-ancestor
101600857|NCT02699710|Folic Acid|folic acid|mesh-list
101600858|NCT02699710|Methotrexate|methotrexate|mesh-list
101600859|NCT02699710|Rabeprazole|rabeprazole|mesh-list
101600860|NCT02699710|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101600861|NCT02699710|Abortifacient Agents|abortifacient agents|mesh-ancestor
101600862|NCT02699710|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101600863|NCT02699710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600864|NCT02699710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101600865|NCT02699710|Antimetabolites|antimetabolites|mesh-ancestor
101600866|NCT02699710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600867|NCT02699710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101600868|NCT02699710|Dermatologic Agents|dermatologic agents|mesh-ancestor
101600869|NCT02699710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101600870|NCT02699710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101600871|NCT02699710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101600872|NCT02699710|Immunologic Factors|immunologic factors|mesh-ancestor
101600873|NCT02699710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101600874|NCT02699710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101600875|NCT02699710|Hematinics|hematinics|mesh-ancestor
101600876|NCT02699710|Vitamin B Complex|vitamin b complex|mesh-ancestor
101600878|NCT02699710|Micronutrients|micronutrients|mesh-ancestor
101600879|NCT02699710|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101600880|NCT02699710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101600881|NCT02699710|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101600882|NCT03140488|Oxytocin|oxytocin|mesh-list
101600883|NCT03140488|Oxytocics|oxytocics|mesh-ancestor
101600884|NCT03140488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101600889|NCT00616408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101600890|NCT02691754|Acetaminophen|acetaminophen|mesh-list
101600891|NCT02691754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101600892|NCT02691754|Analgesics|analgesics|mesh-ancestor
101600893|NCT02691754|Sensory System Agents|sensory system agents|mesh-ancestor
101600894|NCT02691754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101600895|NCT02691754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600896|NCT02691754|Antipyretics|antipyretics|mesh-ancestor
101600897|NCT02691676|Plasma-lyte 148|plasma-lyte 148|mesh-list
101600898|NCT02691676|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101600899|NCT02691676|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101600900|NCT05321602|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101600901|NCT05321602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101600902|NCT05321602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101600903|NCT05321602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101600904|NCT05321602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600905|NCT05321602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101600906|NCT05321602|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101600907|NCT05321602|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101600908|NCT05321602|Serotonin Agents|serotonin agents|mesh-ancestor
101600909|NCT05321602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101622602|NCT05387577|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101622603|NCT05387577|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101622604|NCT05387577|Estradiol|estradiol|mesh-list
101622605|NCT05387577|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101622606|NCT05387577|Estrogens|estrogens|mesh-ancestor
101622607|NCT05387577|Hormones|hormones|mesh-ancestor
101622608|NCT05387577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101622609|NCT05387577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622610|NCT05387577|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101622611|NCT05387577|Contraceptive Agents|contraceptive agents|mesh-ancestor
101622612|NCT05387577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101600910|NCT05321602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600911|NCT05321602|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101600912|NCT05321602|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101600913|NCT05321602|Dopamine Agents|dopamine agents|mesh-ancestor
101600914|NCT01106651|Canagliflozin|canagliflozin|mesh-list
101600915|NCT01106651|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101600916|NCT01106651|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101600917|NCT01106651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600918|NCT01106651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600919|NCT00637078|Amlodipine|amlodipine|mesh-list
101600920|NCT00637078|Spironolactone|spironolactone|mesh-list
101600921|NCT00637078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101600922|NCT00637078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101600923|NCT00637078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101600924|NCT00637078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600925|NCT00637078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101600926|NCT00637078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600927|NCT00637078|Vasodilator Agents|vasodilator agents|mesh-ancestor
101600928|NCT00637078|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101600929|NCT00637078|Hormone Antagonists|hormone antagonists|mesh-ancestor
101600930|NCT00637078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101257914|NCT01719185|Appetite Depressants|appetite depressants|mesh-ancestor
101600931|NCT00637078|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101600932|NCT00637078|Diuretics|diuretics|mesh-ancestor
101600933|NCT00637078|Natriuretic Agents|natriuretic agents|mesh-ancestor
101600934|NCT00625781|Insulin|insulin|mesh-list
101600935|NCT00625781|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101600936|NCT00625781|Insulin Aspart|insulin aspart|mesh-list
101600937|NCT00625781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101600938|NCT00625781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600939|NCT01027650|Dexamethasone|dexamethasone|mesh-list
101600940|NCT01027650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101600941|NCT01027650|Antiemetics|antiemetics|mesh-ancestor
101600942|NCT01027650|Autonomic Agents|autonomic agents|mesh-ancestor
101600943|NCT01027650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101600944|NCT01027650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600945|NCT01027650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101600946|NCT01027650|Glucocorticoids|glucocorticoids|mesh-ancestor
101600947|NCT01027650|Hormones|hormones|mesh-ancestor
101600948|NCT01027650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101600949|NCT01027650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101600950|NCT01027650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101600951|NCT00616876|Lactulose|lactulose|mesh-list
101600952|NCT00616876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101600953|NCT01106027|Eculizumab|eculizumab|mesh-list
101600970|NCT02873520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600972|NCT05026203|Ketamine|ketamine|mesh-list
101600973|NCT05026203|Analgesics|analgesics|mesh-ancestor
101600974|NCT05026203|Sensory System Agents|sensory system agents|mesh-ancestor
101600975|NCT05026203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101600976|NCT05026203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622613|NCT05387577|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101622615|NCT03044613|Carboplatin|carboplatin|mesh-list
101622616|NCT03044613|Nivolumab|nivolumab|mesh-list
101622617|NCT03044613|Relatlimab|relatlimab|mesh-list
101622618|NCT03044613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101622619|NCT03044613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101622620|NCT03044613|Tubulin Modulators|tubulin modulators|mesh-ancestor
101622621|NCT03044613|Antimitotic Agents|antimitotic agents|mesh-ancestor
101622622|NCT03044613|Mitosis Modulators|mitosis modulators|mesh-ancestor
101622623|NCT03044613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421327|NCT00149292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101600977|NCT05026203|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101600978|NCT05026203|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101600979|NCT05026203|Anesthetics, General|anesthetics, general|mesh-ancestor
101600980|NCT05026203|Anesthetics|anesthetics|mesh-ancestor
101600981|NCT05026203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101600982|NCT05026203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101600983|NCT05026203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101600984|NCT05026203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101600985|NCT05026203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600986|NCT05026203|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101600987|NCT05026203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101600988|NCT05026203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101600989|NCT05026203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101600990|NCT05026203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101600991|NCT05026203|GABA Modulators|gaba modulators|mesh-ancestor
101600992|NCT05026203|GABA Agents|gaba agents|mesh-ancestor
101600993|NCT01015638|Clindamycin|clindamycin|mesh-list
101600994|NCT01015638|Clindamycin palmitate|clindamycin palmitate|mesh-list
101600995|NCT01015638|Clindamycin phosphate|clindamycin phosphate|mesh-list
101600996|NCT01015638|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101600997|NCT01015638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101600998|NCT01015638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101600999|NCT01015638|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101601000|NCT01015638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101601001|NCT01015638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601002|NCT01015638|Dermatologic Agents|dermatologic agents|mesh-ancestor
101601003|NCT00627744|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101601004|NCT00627744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101601005|NCT00627744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601006|NCT00627744|Incretins|incretins|mesh-ancestor
101601007|NCT00627744|Hormones|hormones|mesh-ancestor
101601008|NCT00627744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101601009|NCT00627744|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101601013|NCT01105091|Epoprostenol|epoprostenol|mesh-list
101601014|NCT01105091|Tezosentan|tezosentan|mesh-list
101601015|NCT01105091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101601016|NCT01105091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101601017|NCT01105091|Vasodilator Agents|vasodilator agents|mesh-ancestor
101601018|NCT00628056|Perhexiline|perhexiline|mesh-list
101601019|NCT00628056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101601020|NCT00628056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101601021|NCT00628056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601022|NCT00628056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101601023|NCT00628056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601024|NCT00628056|Vasodilator Agents|vasodilator agents|mesh-ancestor
101601025|NCT00924729|Moxifloxacin|moxifloxacin|mesh-list
101601026|NCT00924729|Besifloxacin|besifloxacin|mesh-list
101601027|NCT00924729|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101601028|NCT00924729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101601029|NCT00924729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101601030|NCT00924729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101601031|NCT00924729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101622624|NCT03044613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101622625|NCT03044613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101622627|NCT01372254|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101622628|NCT01372254|Autonomic Agents|autonomic agents|mesh-ancestor
101622629|NCT01372254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101622630|NCT01372254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622631|NCT01372254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101622632|NCT01372254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101622633|NCT01372254|Cholinergic Agents|cholinergic agents|mesh-ancestor
101622634|NCT01372254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101622635|NCT01372254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622636|NCT02785653|Sevoflurane|sevoflurane|mesh-list
101421337|NCT05391893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601032|NCT00924729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101601033|NCT00924729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101601034|NCT00924729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601035|NCT00924729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101601036|NCT01099709|Oxycodone|oxycodone|mesh-list
101601037|NCT01099709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101601038|NCT01099709|Narcotics|narcotics|mesh-ancestor
101601039|NCT01099709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101601040|NCT01099709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601041|NCT01099709|Analgesics|analgesics|mesh-ancestor
101601042|NCT01099709|Sensory System Agents|sensory system agents|mesh-ancestor
101601043|NCT01099709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101601044|NCT04907019|Rifampin|rifampin|mesh-list
101601045|NCT04907019|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101601046|NCT04907019|Antitubercular Agents|antitubercular agents|mesh-ancestor
101601047|NCT04907019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101601048|NCT04907019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101601049|NCT04907019|Leprostatic Agents|leprostatic agents|mesh-ancestor
101601050|NCT04907019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101601051|NCT04907019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101601052|NCT04907019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601053|NCT04907019|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101601054|NCT04907019|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101601055|NCT04907019|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101601056|NCT04907019|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101601057|NCT04907019|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101601058|NCT04907019|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101601059|NCT01022424|Tolvaptan|tolvaptan|mesh-list
101601060|NCT01022424|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101601061|NCT01022424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601062|NCT01022424|Natriuretic Agents|natriuretic agents|mesh-ancestor
101601063|NCT01022424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601064|NCT05329857|Metformin|metformin|mesh-list
101601065|NCT05329857|Vildagliptin|vildagliptin|mesh-list
101601066|NCT05329857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101601067|NCT05329857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601068|NCT05329857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101601069|NCT05329857|Protease Inhibitors|protease inhibitors|mesh-ancestor
101601070|NCT05329857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101601071|NCT05329857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601072|NCT01026948|Dinoprostone|dinoprostone|mesh-list
101601073|NCT01026948|Oxytocics|oxytocics|mesh-ancestor
101601074|NCT01026948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101601075|NCT01026948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622638|NCT02785653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101622639|NCT02785653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101622640|NCT02785653|Anesthetics, General|anesthetics, general|mesh-ancestor
101622641|NCT02785653|Anesthetics|anesthetics|mesh-ancestor
101622642|NCT02785653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101622643|NCT02785653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622644|NCT02785653|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101622645|NCT02785653|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101622646|NCT02785653|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101622647|NCT02785653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101622648|NCT02787447|Gefitinib|gefitinib|mesh-list
101622649|NCT02787447|Thymalfasin|thymalfasin|mesh-list
101622650|NCT02787447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101622651|NCT02787447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101622652|NCT02787447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101622653|NCT02787447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622654|NCT02787447|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101622657|NCT00904722|Rituximab|rituximab|mesh-list
101622695|NCT02901717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101622696|NCT02901717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101622698|NCT02849730|Fentanyl|fentanyl|mesh-list
101622767|NCT02689869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101622768|NCT02689869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101622769|NCT02785809|Contraceptive Agents|contraceptive agents|mesh-list
101622770|NCT02785809|Contraceptives, Oral|contraceptives, oral|mesh-list
101622771|NCT02785809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101622772|NCT02785809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622773|NCT02785809|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101622774|NCT00221988|Levetiracetam|levetiracetam|mesh-list
101622775|NCT00221988|Anticonvulsants|anticonvulsants|mesh-ancestor
101622776|NCT00221988|Nootropic Agents|nootropic agents|mesh-ancestor
101622777|NCT02341911|Carboplatin|carboplatin|mesh-list
101622778|NCT02341911|Gemcitabine|gemcitabine|mesh-list
101622779|NCT02341911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101622780|NCT02341911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101622781|NCT02341911|Antimetabolites|antimetabolites|mesh-ancestor
101622782|NCT02341911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622783|NCT02847000|Decitabine|decitabine|mesh-list
101622784|NCT02847000|Tetrahydrouridine|tetrahydrouridine|mesh-list
101622785|NCT02847000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101622786|NCT02847000|Antimetabolites|antimetabolites|mesh-ancestor
101622823|NCT02690922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101622824|NCT02690922|Immunologic Factors|immunologic factors|mesh-ancestor
101622825|NCT02690922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101622826|NCT02690922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101622827|NCT02690922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101622829|NCT02848950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101622830|NCT02848950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622831|NCT04202406|Acetaminophen|acetaminophen|mesh-list
101622832|NCT04202406|Codeine|codeine|mesh-list
101622833|NCT04202406|Caffeine|caffeine|mesh-list
101622834|NCT04202406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101622835|NCT04202406|Analgesics|analgesics|mesh-ancestor
101622836|NCT04202406|Sensory System Agents|sensory system agents|mesh-ancestor
101622837|NCT04202406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101622838|NCT04202406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622839|NCT04202406|Antipyretics|antipyretics|mesh-ancestor
101622840|NCT04202406|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101622841|NCT04202406|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101622842|NCT04202406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101622843|NCT04202406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622844|NCT04202406|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101622845|NCT04202406|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101622846|NCT04202406|Purinergic Agents|purinergic agents|mesh-ancestor
101622847|NCT04202406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101622874|NCT00839800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101622875|NCT00839800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101622876|NCT00839800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101622877|NCT00839800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101622878|NCT00839800|Adrenergic Agents|adrenergic agents|mesh-ancestor
101622879|NCT00839800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101622880|NCT00839800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622881|NCT00867321|Bevacizumab|bevacizumab|mesh-list
101622882|NCT00867321|Sorafenib|sorafenib|mesh-list
101622883|NCT00867321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101622884|NCT00867321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101622885|NCT00867321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101622886|NCT00867321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101622887|NCT00867321|Growth Substances|growth substances|mesh-ancestor
101622888|NCT00867321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622889|NCT00867321|Growth Inhibitors|growth inhibitors|mesh-ancestor
101622933|NCT02601157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101622934|NCT02601157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101622935|NCT02601157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101622936|NCT02601157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101622937|NCT02601157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101622938|NCT02601157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101622939|NCT02601157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622940|NCT02601157|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101622941|NCT02601157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101622942|NCT02601157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101622943|NCT02601157|Antipyretics|antipyretics|mesh-ancestor
101622944|NCT02601157|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101622945|NCT02601157|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101622949|NCT02784717|Rivaroxaban|rivaroxaban|mesh-list
101622992|NCT05282277|Dopamine Agents|dopamine agents|mesh-ancestor
101622993|NCT05282277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101622994|NCT05282277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101622995|NCT00759109|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101622996|NCT00759109|Antiviral Agents|antiviral agents|mesh-ancestor
101622997|NCT00759109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101622998|NCT02848794|Irinotecan|irinotecan|mesh-list
101622999|NCT02848794|Apatinib|apatinib|mesh-list
101623000|NCT02848794|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101623001|NCT02848794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101623022|NCT00638079|Megestrol|megestrol|mesh-list
101623056|NCT04197219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339328|NCT00079105|Analgesics|analgesics|mesh-ancestor
101623057|NCT04197219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101623058|NCT04197219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101623060|NCT04834908|Immunologic Factors|immunologic factors|mesh-ancestor
101623061|NCT04834908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623062|NCT02512497|Fludarabine|fludarabine|mesh-list
101623063|NCT02512497|Fludarabine phosphate|fludarabine phosphate|mesh-list
101623064|NCT02512497|Busulfan|busulfan|mesh-list
101623065|NCT02512497|Romidepsin|romidepsin|mesh-list
101623066|NCT02512497|Thymoglobulin|thymoglobulin|mesh-list
101623067|NCT02512497|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101623068|NCT02512497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101623069|NCT02512497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101623070|NCT02512497|Antimetabolites|antimetabolites|mesh-ancestor
101623071|NCT02512497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623072|NCT02512497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101623073|NCT02512497|Immunologic Factors|immunologic factors|mesh-ancestor
101623116|NCT02601235|Oxymetazoline|oxymetazoline|mesh-list
101623118|NCT02601235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623119|NCT02601235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101623120|NCT02601235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101623121|NCT02601235|Adrenergic Agents|adrenergic agents|mesh-ancestor
101623122|NCT02601235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101623123|NCT02601235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623124|NCT02601235|Sympathomimetics|sympathomimetics|mesh-ancestor
101623125|NCT02601235|Autonomic Agents|autonomic agents|mesh-ancestor
101623182|NCT05242926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623183|NCT02782221|Hormones|hormones|mesh-list
101623184|NCT02782221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101623185|NCT02782221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623186|NCT04231617|Glyburide|glyburide|mesh-list
101623187|NCT04231617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101623188|NCT04231617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623189|NCT00757705|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101623190|NCT00757705|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101623191|NCT00757705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101623192|NCT00757705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101623193|NCT00757705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623194|NCT00757705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101623195|NCT00757705|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101623196|NCT00757705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101623197|NCT00757705|Serotonin Agents|serotonin agents|mesh-ancestor
101623198|NCT00757705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101623199|NCT00757705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623200|NCT00757705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101623201|NCT00757705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101623202|NCT00757705|Dopamine Agents|dopamine agents|mesh-ancestor
101623203|NCT02845908|Leucovorin|leucovorin|mesh-list
101623234|NCT02784561|Immunologic Factors|immunologic factors|mesh-ancestor
101623235|NCT02784561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623237|NCT02784561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101623238|NCT02784561|Alkylating Agents|alkylating agents|mesh-ancestor
101623239|NCT02784561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101623240|NCT02784561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101623241|NCT02784561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101623242|NCT00757627|Etoricoxib|etoricoxib|mesh-list
101623243|NCT00757627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101623244|NCT00757627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101623245|NCT00757627|Analgesics|analgesics|mesh-ancestor
101623246|NCT00757627|Sensory System Agents|sensory system agents|mesh-ancestor
101623247|NCT00757627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101623248|NCT00757627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623249|NCT00757627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101623250|NCT00757627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101623290|NCT02781909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101623291|NCT02781909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101339336|NCT03647124|Growth Substances|growth substances|mesh-ancestor
101623292|NCT02781909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623293|NCT01022996|Everolimus|everolimus|mesh-list
101623294|NCT01022996|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101623295|NCT01022996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101623296|NCT01022996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101623297|NCT01022996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623298|NCT01022996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101623299|NCT01022996|Immunologic Factors|immunologic factors|mesh-ancestor
101623300|NCT01022996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623354|NCT04095169|Immunologic Factors|immunologic factors|mesh-ancestor
101623355|NCT04095169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623356|NCT05241912|Dobutamine|dobutamine|mesh-list
101623357|NCT05241912|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101623358|NCT05241912|Sympathomimetics|sympathomimetics|mesh-ancestor
101623359|NCT05241912|Autonomic Agents|autonomic agents|mesh-ancestor
101623360|NCT05241912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101623361|NCT05241912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623420|NCT05340153|Lumefantrine|lumefantrine|mesh-list
101623422|NCT05340153|Piperaquine|piperaquine|mesh-list
101623423|NCT05340153|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101623424|NCT05340153|Artenimol|artenimol|mesh-list
101623425|NCT05340153|Antimalarials|antimalarials|mesh-ancestor
101623426|NCT05340153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101623427|NCT05340153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101623428|NCT05340153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101623429|NCT05078502|Vitamin D|vitamin d|mesh-list
101623430|NCT05078502|Cholecalciferol|cholecalciferol|mesh-list
101623431|NCT05078502|Vitamins|vitamins|mesh-ancestor
101623432|NCT05078502|Micronutrients|micronutrients|mesh-ancestor
101623485|NCT00902538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101623487|NCT00902538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101623558|NCT05339217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101623559|NCT04793490|Acetaminophen|acetaminophen|mesh-list
101623560|NCT04793490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101623561|NCT04793490|Analgesics|analgesics|mesh-ancestor
101623562|NCT04793490|Sensory System Agents|sensory system agents|mesh-ancestor
101623565|NCT04793490|Antipyretics|antipyretics|mesh-ancestor
101623630|NCT02779569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101623631|NCT02779569|Antimetabolites|antimetabolites|mesh-ancestor
101623632|NCT02779569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623635|NCT04095013|Fentanyl|fentanyl|mesh-list
101623701|NCT04300322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101623702|NCT04300322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623703|NCT01022762|Repaglinide|repaglinide|mesh-list
101623704|NCT01022762|Gliclazide|gliclazide|mesh-list
101623705|NCT01022762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101623706|NCT01022762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623713|NCT00311844|Desloratadine|desloratadine|mesh-list
101623714|NCT00311844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101623715|NCT00311844|Cholinergic Agents|cholinergic agents|mesh-ancestor
101623716|NCT00311844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101623720|NCT00311844|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101623774|NCT02778945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101623775|NCT02778945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101623776|NCT02778945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623777|NCT02721342|Ramipril|ramipril|mesh-list
101623778|NCT02721342|Irbesartan|irbesartan|mesh-list
101623779|NCT02721342|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101623780|NCT02721342|Protease Inhibitors|protease inhibitors|mesh-ancestor
101623781|NCT02721342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101623782|NCT02721342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623783|NCT02721342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101623837|NCT04228263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101623838|NCT04228263|Analgesics|analgesics|mesh-ancestor
101623839|NCT04228263|Sensory System Agents|sensory system agents|mesh-ancestor
101623840|NCT04228263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101623841|NCT04228263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623842|NCT04228263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101623843|NCT04228263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101623844|NCT04228263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101623846|NCT04228263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623903|NCT04092205|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
101623904|NCT04092205|Chelating Agents|chelating agents|mesh-ancestor
101623905|NCT04092205|Sequestering Agents|sequestering agents|mesh-ancestor
101623906|NCT04092205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623907|NCT05117853|Parathyroid Hormone|parathyroid hormone|mesh-list
101623908|NCT05117853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101623909|NCT05117853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623910|NCT01028222|Dacarbazine|dacarbazine|mesh-list
101623911|NCT01028222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101623912|NCT01028222|Alkylating Agents|alkylating agents|mesh-ancestor
101623913|NCT01028222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623914|NCT01028222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101623916|NCT00586495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101623917|NCT00586495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101623918|NCT00586495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101623919|NCT00586495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623921|NCT02776137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101623922|NCT02776137|Tubulin Modulators|tubulin modulators|mesh-ancestor
101623923|NCT02776137|Antimitotic Agents|antimitotic agents|mesh-ancestor
101623924|NCT02776137|Mitosis Modulators|mitosis modulators|mesh-ancestor
101623925|NCT02776137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101623926|NCT01027754|Varenicline|varenicline|mesh-list
101623927|NCT01027754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101623928|NCT01027754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101623950|NCT02776059|Hormones|hormones|mesh-ancestor
101623951|NCT02776059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101623952|NCT02776059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101623953|NCT02776059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101623954|NCT02776059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101623955|NCT00774930|Lanreotide|lanreotide|mesh-list
101623956|NCT00774930|Somatostatin|somatostatin|mesh-list
101623957|NCT00774930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101624016|NCT02771457|Infliximab|infliximab|mesh-list
101624017|NCT02771457|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101624018|NCT02771457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101624019|NCT02771457|Dermatologic Agents|dermatologic agents|mesh-ancestor
101624020|NCT02771457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101624021|NCT02771457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101624022|NCT02843802|Immunomodulating Agents|immunomodulating agents|mesh-list
101624023|NCT02843802|Immunologic Factors|immunologic factors|mesh-ancestor
101624025|NCT02771379|Idebenone|idebenone|mesh-list
101624082|NCT01033448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101624098|NCT04224831|Mitogens|mitogens|mesh-list
101624159|NCT02773797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101624160|NCT02773797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101624231|NCT04224675|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101624232|NCT04224675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101624233|NCT04224675|Adrenergic Agents|adrenergic agents|mesh-ancestor
101624234|NCT04224675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101624235|NCT04224675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624236|NCT04224675|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101624237|NCT04224675|Protease Inhibitors|protease inhibitors|mesh-ancestor
101624238|NCT04224675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101624299|NCT02767401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101624300|NCT02767401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101624301|NCT02767401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101624302|NCT02767401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624303|NCT02767401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101624304|NCT02767401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101624305|NCT02767401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101624306|NCT02767401|Antipyretics|antipyretics|mesh-ancestor
101624307|NCT02767401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101624308|NCT02767401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101624309|NCT02767401|Antimetabolites|antimetabolites|mesh-ancestor
101624361|NCT04224441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101624362|NCT04224441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624363|NCT04224441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101624433|NCT04091971|Anesthetics, General|anesthetics, general|mesh-ancestor
101624434|NCT04091971|Anesthetics|anesthetics|mesh-ancestor
101624435|NCT04091971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101624436|NCT04091971|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101624437|NCT04091971|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101624438|NCT04091971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101624439|NCT04091971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624441|NCT04091815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101624498|NCT00750919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101624499|NCT00750919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101624500|NCT00750919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101624501|NCT00750919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101624507|NCT02761161|Mianserin|mianserin|mesh-list
101624567|NCT04223739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624568|NCT04223739|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101624569|NCT04223739|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101624570|NCT04223739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101624636|NCT02760459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101624637|NCT02760459|Glucocorticoids|glucocorticoids|mesh-ancestor
101624638|NCT02760459|Hormones|hormones|mesh-ancestor
101624641|NCT02760459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101624708|NCT00749203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101624709|NCT00749203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101624710|NCT00749203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101624711|NCT00749203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624717|NCT00749203|GABA Modulators|gaba modulators|mesh-ancestor
101624778|NCT02764281|Dermatologic Agents|dermatologic agents|mesh-ancestor
101624779|NCT02764281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101624780|NCT02764281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101624781|NCT02764281|Immunologic Factors|immunologic factors|mesh-ancestor
101624787|NCT02763969|Interferons|interferons|mesh-list
101624849|NCT04191681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101624850|NCT02757651|Hydrogen Peroxide|hydrogen peroxide|mesh-list
101624851|NCT02757651|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101624852|NCT02757651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101624853|NCT02752503|Nalmefene|nalmefene|mesh-list
101624854|NCT02752503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101624855|NCT02752503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624856|NCT02752503|Sensory System Agents|sensory system agents|mesh-ancestor
101624857|NCT02752503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101624858|NCT04479579|Apixaban|apixaban|mesh-list
101624915|NCT02755857|Itraconazole|itraconazole|mesh-list
101624916|NCT02755857|Antifungal Agents|antifungal agents|mesh-ancestor
101624917|NCT02755857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101624918|NCT02755857|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101624987|NCT04090801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101624988|NCT04090801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101624989|NCT04090801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101624990|NCT04090801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101624991|NCT04090801|Vasodilator Agents|vasodilator agents|mesh-ancestor
101625056|NCT04219995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101625057|NCT04219995|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101625058|NCT04219995|Protective Agents|protective agents|mesh-ancestor
101625059|NCT04219995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101625060|NCT04219995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101625061|NCT04544475|Estrogens|estrogens|mesh-list
101625122|NCT04217265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101625123|NCT04217265|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101625124|NCT04217265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101625126|NCT00635973|Gefitinib|gefitinib|mesh-list
101625193|NCT04218981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101625194|NCT04218981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101625195|NCT04218981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101625197|NCT04218513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101625198|NCT04218513|Antioxidants|antioxidants|mesh-ancestor
101625199|NCT04218513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625200|NCT04218513|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101625201|NCT04218513|Protective Agents|protective agents|mesh-ancestor
101625202|NCT04218513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625204|NCT04218435|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101625205|NCT04218435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101625209|NCT04138875|Rituximab|rituximab|mesh-list
101625255|NCT04217733|Parasympatholytics|parasympatholytics|mesh-ancestor
101625256|NCT04217733|Autonomic Agents|autonomic agents|mesh-ancestor
101625257|NCT04217733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101625258|NCT04217733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625328|NCT02745639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101625329|NCT02745639|Antimetabolites|antimetabolites|mesh-ancestor
101625330|NCT02745639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625331|NCT02745639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101625332|NCT02745717|Cyclosporine|cyclosporine|mesh-list
101282423|NCT01907633|Domperidone|domperidone|mesh-list
101625333|NCT02745717|Cyclosporins|cyclosporins|mesh-list
101625334|NCT02745717|Thymoglobulin|thymoglobulin|mesh-list
101625335|NCT02745717|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101625336|NCT02745717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101625337|NCT02745717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625338|NCT02745717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101625339|NCT02745717|Immunologic Factors|immunologic factors|mesh-ancestor
101625340|NCT02745717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625341|NCT02745717|Antifungal Agents|antifungal agents|mesh-ancestor
101625342|NCT02745717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101625343|NCT02745717|Dermatologic Agents|dermatologic agents|mesh-ancestor
101625384|NCT02741115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101625385|NCT02741115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101625386|NCT02741115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625387|NCT02740803|Listerine|listerine|mesh-list
101625388|NCT02740803|Fluorides|fluorides|mesh-list
101625455|NCT02610556|Tubulin Modulators|tubulin modulators|mesh-ancestor
101625459|NCT02740101|Oxytocin|oxytocin|mesh-list
101625528|NCT02742675|Fertility Agents|fertility agents|mesh-ancestor
101625529|NCT02742675|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101625530|NCT02742675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625531|NCT02742675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101625532|NCT02742675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101625533|NCT02742675|Androgen Antagonists|androgen antagonists|mesh-ancestor
101625534|NCT02742675|Hormone Antagonists|hormone antagonists|mesh-ancestor
101625535|NCT02742675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101625536|NCT02742675|Luteolytic Agents|luteolytic agents|mesh-ancestor
101625537|NCT02742675|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101625591|NCT04016116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101625592|NCT04016116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625593|NCT02736591|Hormones|hormones|mesh-list
101625597|NCT05757466|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101625659|NCT02738073|Coagulants|coagulants|mesh-ancestor
101625660|NCT03967483|Indomethacin|indomethacin|mesh-list
101625661|NCT03967483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101625662|NCT03967483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101625731|NCT00734929|Autonomic Agents|autonomic agents|mesh-ancestor
101625732|NCT00734929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101625733|NCT00734929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625734|NCT00734929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101625735|NCT00734929|Glucocorticoids|glucocorticoids|mesh-ancestor
101625737|NCT00734929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101625799|NCT02737371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101625800|NCT02737371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101625801|NCT02737371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625802|NCT02737371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101625803|NCT02737371|Hormone Antagonists|hormone antagonists|mesh-ancestor
101625804|NCT02737371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101625805|NCT02737371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625806|NCT02737371|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101625861|NCT00734149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101625862|NCT00734149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101625864|NCT00734149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625865|NCT00734149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101625866|NCT00734149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101625867|NCT00734149|Immunologic Factors|immunologic factors|mesh-ancestor
101625869|NCT04089163|Antifungal Agents|antifungal agents|mesh-ancestor
101625870|NCT04089163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101625871|NCT04089163|Antimetabolites|antimetabolites|mesh-ancestor
101625872|NCT04089163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625873|NCT00743197|Aspirin|aspirin|mesh-list
101625874|NCT00743197|Lisinopril|lisinopril|mesh-list
101625875|NCT00743197|Simvastatin|simvastatin|mesh-list
101625876|NCT00743197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101625877|NCT00743197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101625878|NCT00743197|Analgesics|analgesics|mesh-ancestor
101625879|NCT00743197|Sensory System Agents|sensory system agents|mesh-ancestor
101625880|NCT00743197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101625881|NCT00743197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625882|NCT00743197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101625883|NCT00743197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101625884|NCT00743197|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101625885|NCT00743197|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101625886|NCT00743197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101625887|NCT00743197|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101625908|NCT02731287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101625909|NCT02731287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101625910|NCT02735343|Ketamine|ketamine|mesh-list
101625911|NCT02735343|Prochlorperazine|prochlorperazine|mesh-list
101625912|NCT02735343|Analgesics|analgesics|mesh-ancestor
101625913|NCT02735343|Sensory System Agents|sensory system agents|mesh-ancestor
101625914|NCT02735343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101625915|NCT02735343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101625916|NCT02735343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101625917|NCT02735343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101625918|NCT02735343|Anesthetics, General|anesthetics, general|mesh-ancestor
101625919|NCT02735343|Anesthetics|anesthetics|mesh-ancestor
101625920|NCT02735343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101625921|NCT02735343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101625922|NCT02735343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101625923|NCT02735343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101625964|NCT03255915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101625965|NCT03255915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101625966|NCT03255915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626034|NCT02593669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101626035|NCT02593669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626036|NCT02593669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101626037|NCT02593669|Glucocorticoids|glucocorticoids|mesh-ancestor
101626038|NCT02593669|Hormones|hormones|mesh-ancestor
101626039|NCT02593669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101626040|NCT02593669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101626041|NCT02593669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101626042|NCT02729961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101626043|NCT02729961|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101626044|NCT02729961|Ceritinib|ceritinib|mesh-list
101626045|NCT02729961|Antibodies|antibodies|mesh-list
101626046|NCT02729961|Immunoglobulins|immunoglobulins|mesh-list
101626047|NCT02729961|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101626095|NCT04088461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626167|NCT02610088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626168|NCT02610088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101626169|NCT02610088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626170|NCT02734407|Aflibercept|aflibercept|mesh-list
101626171|NCT02734407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101626237|NCT02729103|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
101626238|NCT02729103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101626239|NCT02733705|Fentanyl|fentanyl|mesh-list
101626240|NCT02733705|Propofol|propofol|mesh-list
101626241|NCT02733705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101626242|NCT02733705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101626243|NCT02733705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626244|NCT02733705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101626245|NCT02733705|Anesthetics, General|anesthetics, general|mesh-ancestor
101626246|NCT02733705|Anesthetics|anesthetics|mesh-ancestor
101626247|NCT02733705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101626248|NCT02733705|Narcotics|narcotics|mesh-ancestor
101626249|NCT02733705|Analgesics|analgesics|mesh-ancestor
101626250|NCT02733705|Sensory System Agents|sensory system agents|mesh-ancestor
101626251|NCT02733705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101626252|NCT02733705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101626253|NCT02597257|Lidocaine|lidocaine|mesh-list
101626254|NCT02597257|Anesthetics, Local|anesthetics, local|mesh-ancestor
101626255|NCT02597257|Anesthetics|anesthetics|mesh-ancestor
101626256|NCT02597257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101626265|NCT02596555|Dabigatran|dabigatran|mesh-list
101626292|NCT02728323|Anesthetics, Local|anesthetics, local|mesh-ancestor
101626293|NCT02728323|Anesthetics|anesthetics|mesh-ancestor
101626294|NCT02728323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101626362|NCT05753722|Pembrolizumab|pembrolizumab|mesh-list
101626363|NCT05753722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101626364|NCT05753722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101626367|NCT02727621|Dexmedetomidine|dexmedetomidine|mesh-list
101626436|NCT02726919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626437|NCT00590902|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101626440|NCT00590902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101626507|NCT00590590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101626508|NCT00590590|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101626583|NCT00806416|Micronutrients|micronutrients|mesh-ancestor
101626587|NCT00811252|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101626654|NCT00811174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626655|NCT02723487|Bupivacaine|bupivacaine|mesh-list
101626656|NCT02723487|Anesthetics, Local|anesthetics, local|mesh-ancestor
101626657|NCT02723487|Anesthetics|anesthetics|mesh-ancestor
101626658|NCT02723487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101626659|NCT02723487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626660|NCT02723487|Sensory System Agents|sensory system agents|mesh-ancestor
101626661|NCT02723487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101626662|NCT02717871|Moxifloxacin|moxifloxacin|mesh-list
101626663|NCT02717871|Ciprofloxacin|ciprofloxacin|mesh-list
101626664|NCT02717871|Levofloxacin|levofloxacin|mesh-list
101626665|NCT02717871|Ofloxacin|ofloxacin|mesh-list
101626666|NCT02717871|Gentamicins|gentamicins|mesh-list
101626667|NCT02717871|Cefazolin|cefazolin|mesh-list
101626668|NCT02717871|Tobramycin|tobramycin|mesh-list
101626669|NCT02717871|Gatifloxacin|gatifloxacin|mesh-list
101626670|NCT02717871|Fluoroquinolones|fluoroquinolones|mesh-list
101626671|NCT02717871|Besifloxacin|besifloxacin|mesh-list
101626672|NCT02717871|Prednisolone|prednisolone|mesh-list
101626673|NCT02717871|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101626674|NCT02717871|Methylprednisolone|methylprednisolone|mesh-list
101626675|NCT02717871|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101626711|NCT02717871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101626712|NCT02723253|Raltitrexed|raltitrexed|mesh-list
101626713|NCT02723253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101626714|NCT02723253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101626715|NCT02723253|Antimetabolites|antimetabolites|mesh-ancestor
101626719|NCT00730405|Albaconazole|albaconazole|mesh-list
101626781|NCT04087915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101626782|NCT04087915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101626784|NCT04087915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626785|NCT04087915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101626786|NCT04087915|Protease Inhibitors|protease inhibitors|mesh-ancestor
101626787|NCT04087915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101626789|NCT02715687|Amiodarone|amiodarone|mesh-list
101626849|NCT00730171|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
101626850|NCT00730171|Enzyme Activators|enzyme activators|mesh-ancestor
101626851|NCT00730171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626853|NCT04787835|Anesthetics|anesthetics|mesh-list
101626922|NCT00248703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101626923|NCT00248703|Tubulin Modulators|tubulin modulators|mesh-ancestor
101626924|NCT00248703|Antimitotic Agents|antimitotic agents|mesh-ancestor
101626925|NCT00248703|Mitosis Modulators|mitosis modulators|mesh-ancestor
101626926|NCT00248703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626927|NCT02713893|Econazole|econazole|mesh-list
101626928|NCT02713893|Benzydamine|benzydamine|mesh-list
101626929|NCT02713893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101626930|NCT02713893|Antifungal Agents|antifungal agents|mesh-ancestor
101626931|NCT02713893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101626932|NCT02713893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101626933|NCT02713893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101626934|NCT02713893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101626935|NCT02713893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626936|NCT02713893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101626937|NCT02713893|Hormone Antagonists|hormone antagonists|mesh-ancestor
101626939|NCT02713893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101626977|NCT00729859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101626978|NCT00729859|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101626979|NCT00729859|Hormone Antagonists|hormone antagonists|mesh-ancestor
101626980|NCT00810394|Sorafenib|sorafenib|mesh-list
101626981|NCT00810394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101626982|NCT00810394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101626983|NCT00810394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101626985|NCT00736333|Doxorubicin|doxorubicin|mesh-list
101627042|NCT02609698|Sensory System Agents|sensory system agents|mesh-ancestor
101627114|NCT02712957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101627115|NCT02712957|Analgesics|analgesics|mesh-ancestor
101627116|NCT02712957|Sensory System Agents|sensory system agents|mesh-ancestor
101627117|NCT02712957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101627186|NCT00808210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101627188|NCT00808210|Hormones|hormones|mesh-ancestor
101627189|NCT00808210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101627190|NCT00808210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101627254|NCT00736099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101627255|NCT00736099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627256|NCT04616547|Edetic Acid|edetic acid|mesh-list
101627257|NCT04616547|Pentetic Acid|pentetic acid|mesh-list
101627258|NCT04616547|Antidotes|antidotes|mesh-ancestor
101627323|NCT02776527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101627326|NCT00729157|Deoxyglucose|deoxyglucose|mesh-list
101627399|NCT00726895|Sensory System Agents|sensory system agents|mesh-ancestor
101627400|NCT02593201|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101627401|NCT02593201|Cefazolin|cefazolin|mesh-list
101627402|NCT02593201|Ceftazidime|ceftazidime|mesh-list
101627420|NCT00585325|Lidocaine|lidocaine|mesh-list
101627470|NCT00611793|Growth Substances|growth substances|mesh-ancestor
101627471|NCT00611793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627472|NCT00611793|Growth Inhibitors|growth inhibitors|mesh-ancestor
101627473|NCT00611793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101627474|NCT00611793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101627475|NCT00611793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627476|NCT00611871|Propranolol|propranolol|mesh-list
101627477|NCT00611871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101627478|NCT00611871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101627479|NCT00611871|Adrenergic Agents|adrenergic agents|mesh-ancestor
101627480|NCT00611871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101627481|NCT00611871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627533|NCT00740857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101627534|NCT00740857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101627535|NCT00740857|Analgesics|analgesics|mesh-ancestor
101627536|NCT00740857|Sensory System Agents|sensory system agents|mesh-ancestor
101627537|NCT00740857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101627538|NCT00740857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627539|NCT00740857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101627540|NCT00740857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101627541|NCT00740857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101627542|NCT00740857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101627543|NCT00740857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627544|NCT00808132|Bazedoxifene|bazedoxifene|mesh-list
101627546|NCT00808132|Medroxyprogesterone|medroxyprogesterone|mesh-list
101627592|NCT02607982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627594|NCT02692989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101627668|NCT00585169|Memantine|memantine|mesh-list
101627669|NCT00585169|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101627670|NCT00585169|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101627671|NCT00585169|Dopamine Agents|dopamine agents|mesh-ancestor
101627672|NCT00585169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101627673|NCT00585169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627676|NCT00585169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101627735|NCT02693145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101627736|NCT00717067|Ritonavir|ritonavir|mesh-list
101627737|NCT00717067|Saquinavir|saquinavir|mesh-list
101627738|NCT00717067|Maraviroc|maraviroc|mesh-list
101627753|NCT05731960|Dexamethasone|dexamethasone|mesh-list
101627808|NCT04356339|Antiviral Agents|antiviral agents|mesh-ancestor
101627809|NCT04356339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101627810|NCT04356339|Immunologic Factors|immunologic factors|mesh-ancestor
101627811|NCT04356339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627812|NCT04356339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101627813|NCT03511846|Capsaicin|capsaicin|mesh-list
101627814|NCT03511846|Antipruritics|antipruritics|mesh-ancestor
101627815|NCT03511846|Dermatologic Agents|dermatologic agents|mesh-ancestor
101627816|NCT03511846|Sensory System Agents|sensory system agents|mesh-ancestor
101627817|NCT03511846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101627818|NCT03511846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627819|NCT04331145|Ticagrelor|ticagrelor|mesh-list
101627820|NCT04331145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101627821|NCT04331145|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101627868|NCT04885257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627869|NCT04885257|Dopamine Agents|dopamine agents|mesh-ancestor
101627871|NCT03484923|Spartalizumab|spartalizumab|mesh-list
101284964|NCT01932229|Afatinib|afatinib|mesh-list
101627872|NCT03484923|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101627873|NCT03484923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101627874|NCT03484923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101627875|NCT03484923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101627876|NCT00802360|Menotropins|menotropins|mesh-list
101627932|NCT04028596|Vasodilator Agents|vasodilator agents|mesh-ancestor
101627933|NCT02692599|Vaccines|vaccines|mesh-list
101627934|NCT02692599|Immunologic Factors|immunologic factors|mesh-ancestor
101627935|NCT02692599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101627937|NCT01026038|Immunologic Factors|immunologic factors|mesh-ancestor
101628005|NCT02731612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101628006|NCT02731612|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101628073|NCT00613665|Vaccines|vaccines|mesh-list
101628074|NCT00613665|Immunologic Factors|immunologic factors|mesh-ancestor
101628143|NCT01024946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628144|NCT01024946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101628145|NCT00724867|Belimumab|belimumab|mesh-list
101628146|NCT00724867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101628147|NCT00724867|Immunologic Factors|immunologic factors|mesh-ancestor
101628148|NCT00724867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628214|NCT00614757|Protective Agents|protective agents|mesh-ancestor
101971987|NCT01339754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101971988|NCT01339754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971990|NCT00313768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101971991|NCT00313768|Bevacizumab|bevacizumab|mesh-list
101971992|NCT00313768|Carboplatin|carboplatin|mesh-list
101971993|NCT00313768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101971994|NCT00313768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101971995|NCT00313768|Tubulin Modulators|tubulin modulators|mesh-ancestor
101971996|NCT00313768|Antimitotic Agents|antimitotic agents|mesh-ancestor
101971997|NCT00313768|Mitosis Modulators|mitosis modulators|mesh-ancestor
101972000|NCT00313768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101972050|NCT05184530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972051|NCT05184530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101972052|NCT05184530|Protease Inhibitors|protease inhibitors|mesh-ancestor
101972053|NCT05184530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101972054|NCT05184530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101972055|NCT05184374|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101972056|NCT05184374|Hormones|hormones|mesh-ancestor
101972058|NCT05184374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972114|NCT01340456|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101972115|NCT01340456|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101972116|NCT01340456|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101972186|NCT01340846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101972187|NCT01340846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972188|NCT01340846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101972189|NCT01340846|Hormone Antagonists|hormone antagonists|mesh-ancestor
101972190|NCT01340846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101972191|NCT01340846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972192|NCT01340846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101972193|NCT01340846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101972194|NCT01340846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101972249|NCT02285374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101972250|NCT02285374|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101972251|NCT02285374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101972252|NCT02285374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101972253|NCT02285374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972254|NCT02285374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101972255|NCT02285374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101972314|NCT01315886|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101972315|NCT01315886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101692121|NCT02680808|Antifungal Agents|antifungal agents|mesh-ancestor
101972388|NCT01209715|Dermatologic Agents|dermatologic agents|mesh-ancestor
101972389|NCT01209715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101972390|NCT01209715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101972391|NCT01209715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101972392|NCT01209715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101972393|NCT01209715|Adrenergic Agents|adrenergic agents|mesh-ancestor
101972394|NCT01209715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101972455|NCT03941899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972456|NCT03941899|Sensory System Agents|sensory system agents|mesh-ancestor
101972457|NCT03941899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101972458|NCT00004912|Megestrol|megestrol|mesh-list
101972459|NCT00004912|Megestrol Acetate|megestrol acetate|mesh-list
101972523|NCT01210339|Esomeprazole|esomeprazole|mesh-list
101972524|NCT01210339|Clopidogrel|clopidogrel|mesh-list
101972525|NCT01210339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101972526|NCT01210339|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101972527|NCT01210339|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101972528|NCT01210339|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101972591|NCT01113229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972592|NCT01113229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101972662|NCT00135382|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101972663|NCT03531970|Dexamethasone|dexamethasone|mesh-list
101972665|NCT03531970|Lidocaine|lidocaine|mesh-list
101972734|NCT03152552|Empagliflozin|empagliflozin|mesh-list
101972735|NCT03152552|Licogliflozin|licogliflozin|mesh-list
101972736|NCT03152552|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101972737|NCT03152552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972738|NCT03152552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101972739|NCT03152552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972740|NCT01211275|Cisplatin|cisplatin|mesh-list
101972802|NCT01316978|Sensory System Agents|sensory system agents|mesh-ancestor
101972803|NCT01316978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101972804|NCT01316978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101972805|NCT01316978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101972806|NCT01316978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101972807|NCT01316978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101972808|NCT01316978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101972809|NCT01316978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972810|NCT01317212|Carboplatin|carboplatin|mesh-list
101972812|NCT05250752|Dapagliflozin|dapagliflozin|mesh-list
101972864|NCT05064488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101972865|NCT05064488|Antimetabolites|antimetabolites|mesh-ancestor
101972866|NCT05064488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101972867|NCT05064488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101972868|NCT05064488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101972869|NCT05064488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101972870|NCT05064488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101972934|NCT03528616|Purinergic Agents|purinergic agents|mesh-ancestor
101972935|NCT03528616|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101972936|NCT03528616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101972937|NCT03528616|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101972938|NCT03528616|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101972939|NCT03528616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101972940|NCT03528616|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101972941|NCT03528616|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101972999|NCT01215799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973000|NCT03145064|Zanubrutinib|zanubrutinib|mesh-list
101973001|NCT03145064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101973002|NCT03145064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101973003|NCT03145064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101973004|NCT03145064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973005|NCT03527134|Amantadine|amantadine|mesh-list
101973066|NCT03937687|Purinergic Agents|purinergic agents|mesh-ancestor
101973067|NCT03937687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101973068|NCT05110144|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101973069|NCT05110144|Amitriptyline|amitriptyline|mesh-list
101973070|NCT05110144|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101973071|NCT05110144|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101973072|NCT05110144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101973073|NCT05110144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973132|NCT01216345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101973133|NCT01216345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101973134|NCT01118533|Pyrithione zinc|pyrithione zinc|mesh-list
101973135|NCT01118533|Keratolytic Agents|keratolytic agents|mesh-ancestor
101973140|NCT01212523|Propofol|propofol|mesh-list
101973203|NCT01216579|Diuretics|diuretics|mesh-ancestor
101973204|NCT01216579|Natriuretic Agents|natriuretic agents|mesh-ancestor
101973205|NCT01216579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973206|NCT03528070|Tranilast|tranilast|mesh-list
101973274|NCT01116115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973275|NCT01217203|Lenalidomide|lenalidomide|mesh-list
101973276|NCT01217203|Immunologic Factors|immunologic factors|mesh-ancestor
101973277|NCT01217203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973343|NCT03193684|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101973344|NCT03193684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973415|NCT01122667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101973416|NCT01120561|Trastuzumab|trastuzumab|mesh-list
101973417|NCT01120561|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101973418|NCT01120561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101973419|NCT01120561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101973420|NCT01120561|Immunotoxins|immunotoxins|mesh-ancestor
101973421|NCT01120561|Immunoconjugates|immunoconjugates|mesh-ancestor
101973486|NCT04467892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101973487|NCT04467892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973488|NCT04467892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101973490|NCT04467892|Hormones|hormones|mesh-ancestor
101973558|NCT01345370|Alkylating Agents|alkylating agents|mesh-ancestor
101973559|NCT01345370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973627|NCT04066114|Prednisone|prednisone|mesh-list
101973628|NCT04066114|Methylprednisolone|methylprednisolone|mesh-list
101973629|NCT04066114|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101973630|NCT04066114|Everolimus|everolimus|mesh-list
101973699|NCT01215019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973700|NCT03795428|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
101973701|NCT03795428|Vasodilator Agents|vasodilator agents|mesh-ancestor
101973702|NCT01215331|Insulin|insulin|mesh-list
101973703|NCT01215331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101973704|NCT01215331|Metformin|metformin|mesh-list
101973705|NCT01215331|Glyburide|glyburide|mesh-list
101973706|NCT01215331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101973707|NCT01215331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973708|NCT03526276|Fluorides|fluorides|mesh-list
101973709|NCT03526276|Cariostatic Agents|cariostatic agents|mesh-ancestor
101973716|NCT04466176|Xhance|xhance|mesh-list
101973763|NCT04674020|Sensory System Agents|sensory system agents|mesh-ancestor
101973764|NCT04674020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101973765|NCT04674020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973834|NCT03934411|Tramadol|tramadol|mesh-list
101973835|NCT03934411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101973836|NCT03934411|Narcotics|narcotics|mesh-ancestor
101973837|NCT03934411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101973838|NCT03934411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973839|NCT03934411|Analgesics|analgesics|mesh-ancestor
101973840|NCT03934411|Sensory System Agents|sensory system agents|mesh-ancestor
101973899|NCT03781375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101973900|NCT03781375|Analgesics|analgesics|mesh-ancestor
101973901|NCT03781375|Sensory System Agents|sensory system agents|mesh-ancestor
101339653|NCT00080626|Docetaxel|docetaxel|mesh-list
101973902|NCT03781375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101973903|NCT03781375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101973904|NCT03781375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101973905|NCT01123915|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
101973906|NCT01123915|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101973907|NCT01123915|Protective Agents|protective agents|mesh-ancestor
101973908|NCT01123915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973909|NCT01123915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101973910|NCT01123915|Antioxidants|antioxidants|mesh-ancestor
101973911|NCT01123915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101973912|NCT01218529|Lapatinib|lapatinib|mesh-list
101973913|NCT01218529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101973914|NCT01218529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101973915|NCT01218529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101973917|NCT03938467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
101973955|NCT03931915|Androgen Antagonists|androgen antagonists|mesh-ancestor
101973956|NCT03931915|Hormone Antagonists|hormone antagonists|mesh-ancestor
101973957|NCT03931915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101973958|NCT03932071|Zoledronic Acid|zoledronic acid|mesh-list
101973959|NCT03932071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101973960|NCT03932071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101973961|NCT01124383|Lidocaine|lidocaine|mesh-list
101973962|NCT01124383|Ephedrine|ephedrine|mesh-list
101973963|NCT01124383|Midazolam|midazolam|mesh-list
101973964|NCT01124383|Sufentanil|sufentanil|mesh-list
101973965|NCT01124383|Dsuvia|dsuvia|mesh-list
101973966|NCT01124383|Anesthetics|anesthetics|mesh-list
101973967|NCT01124383|Propofol|propofol|mesh-list
101973968|NCT01124383|Sevoflurane|sevoflurane|mesh-list
101974019|NCT03150056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974020|NCT03150056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101974021|NCT03150056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974023|NCT01329367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974088|NCT01223131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101974089|NCT01223131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974090|NCT01125553|Insulin|insulin|mesh-list
101974091|NCT01125553|Insulin Aspart|insulin aspart|mesh-list
101974092|NCT01125553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101974094|NCT02640664|Ranibizumab|ranibizumab|mesh-list
101974156|NCT03132038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101974158|NCT03132038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101974159|NCT03132038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974227|NCT01220245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101974228|NCT01220245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974229|NCT03931135|Dexamethasone|dexamethasone|mesh-list
101974230|NCT03931135|Morphine|morphine|mesh-list
101974231|NCT03931135|Cyclizine|cyclizine|mesh-list
101974232|NCT03931135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101974233|NCT03931135|Antiemetics|antiemetics|mesh-ancestor
101974234|NCT03931135|Autonomic Agents|autonomic agents|mesh-ancestor
101974235|NCT03931135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101974236|NCT03931135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974237|NCT03931135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101974238|NCT03931135|Glucocorticoids|glucocorticoids|mesh-ancestor
101974239|NCT03931135|Hormones|hormones|mesh-ancestor
101974240|NCT03931135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101974244|NCT03931135|Narcotics|narcotics|mesh-ancestor
101974288|NCT01126177|Interferon beta-1a|interferon beta-1a|mesh-list
101974289|NCT01126177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974290|NCT01126177|Antiviral Agents|antiviral agents|mesh-ancestor
101974291|NCT01126177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101974292|NCT01126177|Immunologic Factors|immunologic factors|mesh-ancestor
101974293|NCT01126177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974294|NCT01126177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101974295|NCT03680092|Cyclophosphamide|cyclophosphamide|mesh-list
101974355|NCT05789342|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101974356|NCT05789342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101974357|NCT05789342|Antifungal Agents|antifungal agents|mesh-ancestor
101974358|NCT05789342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101974359|NCT05789342|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101974360|NCT05789342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101974361|NCT05789342|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101974362|NCT05789342|Hormone Antagonists|hormone antagonists|mesh-ancestor
101974363|NCT05789342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101974364|NCT05789342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974365|NCT05789342|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101974366|NCT05789342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101974369|NCT05789342|Antiviral Agents|antiviral agents|mesh-ancestor
101974412|NCT05789017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101974413|NCT05789017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974414|NCT05789017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101974415|NCT05789017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974416|NCT05789017|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101974417|NCT05789017|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101974418|NCT05789017|Antitubercular Agents|antitubercular agents|mesh-ancestor
101974419|NCT05789017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101974420|NCT05789017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101974421|NCT05789017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101974476|NCT05767086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101974477|NCT05767086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974478|NCT05767086|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101974546|NCT05670561|Anesthetics|anesthetics|mesh-ancestor
101974547|NCT05670561|Antidepressive Agents|antidepressive agents|mesh-ancestor
101974548|NCT05670561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101974549|NCT05635877|Esmolol|esmolol|mesh-list
101974557|NCT05629546|Nivolumab|nivolumab|mesh-list
101974616|NCT05515029|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
101974617|NCT05515029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101974618|NCT05515029|Immunologic Factors|immunologic factors|mesh-ancestor
101974686|NCT05267288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974688|NCT05218629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974689|NCT05218629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101974755|NCT05017272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974757|NCT05017272|Sensory System Agents|sensory system agents|mesh-ancestor
101974758|NCT05017272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101974828|NCT04808245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974829|NCT04808245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101974830|NCT04808245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974831|NCT04808245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101974832|NCT04808245|Immunologic Factors|immunologic factors|mesh-ancestor
101974833|NCT04808245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101974834|NCT04808245|Interferon Inducers|interferon inducers|mesh-ancestor
101974835|NCT04790513|Evolocumab|evolocumab|mesh-list
101974836|NCT04790513|Alirocumab|alirocumab|mesh-list
101974837|NCT04790513|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101974838|NCT04790513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101974839|NCT04790513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101974840|NCT04790513|Antimetabolites|antimetabolites|mesh-ancestor
101974841|NCT04790513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974842|NCT04790513|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101974843|NCT04790513|Protease Inhibitors|protease inhibitors|mesh-ancestor
101974844|NCT04790513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101974846|NCT04777071|Edetic Acid|edetic acid|mesh-list
101974885|NCT04600167|Leprostatic Agents|leprostatic agents|mesh-ancestor
101974886|NCT04560725|Choline|choline|mesh-list
101974887|NCT04560725|Lipotropic Agents|lipotropic agents|mesh-ancestor
101974888|NCT04560725|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101974889|NCT04560725|Antimetabolites|antimetabolites|mesh-ancestor
101974890|NCT04560725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974891|NCT04560725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101974892|NCT04560725|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101974893|NCT04560725|Nootropic Agents|nootropic agents|mesh-ancestor
101974894|NCT04522284|Capecitabine|capecitabine|mesh-list
101974895|NCT04522284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101974896|NCT04522284|Antimetabolites|antimetabolites|mesh-ancestor
101974897|NCT04522284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101974898|NCT04522284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101974899|NCT04489888|Paclitaxel|paclitaxel|mesh-list
101974900|NCT04489888|Carboplatin|carboplatin|mesh-list
101974945|NCT04350463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101974946|NCT04350463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975015|NCT04188548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101975017|NCT04188548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101975018|NCT04188548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101975019|NCT04188548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975020|NCT04188548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101975021|NCT04188548|Immunologic Factors|immunologic factors|mesh-ancestor
101975022|NCT04188548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975080|NCT03988920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975081|NCT03925402|Ertapenem|ertapenem|mesh-list
101975154|NCT03570099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101975155|NCT03570099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975156|NCT03570099|Sensory System Agents|sensory system agents|mesh-ancestor
101975157|NCT03570099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101975158|NCT03529396|Chloroquine|chloroquine|mesh-list
101975159|NCT03529396|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
101975224|NCT03289351|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101975225|NCT03289351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101975226|NCT03289351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101975227|NCT03289351|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101975296|NCT03103152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101975372|NCT02719613|Protease Inhibitors|protease inhibitors|mesh-ancestor
101975373|NCT02719613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101975374|NCT02719613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975375|NCT02719613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101975376|NCT02719613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101975377|NCT02719613|Immunologic Factors|immunologic factors|mesh-ancestor
101975378|NCT02719613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101975379|NCT02719613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101975380|NCT02719613|Growth Substances|growth substances|mesh-ancestor
101975381|NCT02719613|Growth Inhibitors|growth inhibitors|mesh-ancestor
101975436|NCT01087619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101975437|NCT01087619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975508|NCT04481672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975509|NCT04481672|Anesthetics|anesthetics|mesh-ancestor
101975583|NCT02291536|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101975584|NCT02291536|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101975655|NCT01221103|Glucocorticoids|glucocorticoids|mesh-ancestor
101975657|NCT01221103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101975661|NCT01221103|Alkylating Agents|alkylating agents|mesh-ancestor
101975724|NCT01224457|GABA Modulators|gaba modulators|mesh-ancestor
101975725|NCT01224457|GABA Agents|gaba agents|mesh-ancestor
101975800|NCT02289274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101975801|NCT02289274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101975871|NCT02289586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101975872|NCT02289586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101975944|NCT03132688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101975945|NCT03132688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101975946|NCT03132688|Anesthetics, General|anesthetics, general|mesh-ancestor
101975947|NCT03132688|Anesthetics|anesthetics|mesh-ancestor
101976018|NCT02294656|Hormones|hormones|mesh-ancestor
101976019|NCT02294656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101976020|NCT02294656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101976021|NCT02294656|Immunologic Factors|immunologic factors|mesh-ancestor
101976086|NCT03517618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976087|NCT03517618|Antidotes|antidotes|mesh-ancestor
101976088|NCT03517618|Protective Agents|protective agents|mesh-ancestor
101976089|NCT03517618|Vitamin B Complex|vitamin b complex|mesh-ancestor
101976090|NCT03517618|Vitamins|vitamins|mesh-ancestor
101976157|NCT01131247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101976158|NCT01131247|Immunologic Factors|immunologic factors|mesh-ancestor
101976159|NCT01131247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976227|NCT04464694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976228|NCT04464694|Growth Inhibitors|growth inhibitors|mesh-ancestor
101976229|NCT04464694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101976230|NCT01130779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101976233|NCT01130779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101976295|NCT03923881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101976297|NCT02295748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101976301|NCT03923803|Calcitonin|calcitonin|mesh-list
101976367|NCT02730416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101976368|NCT02293330|Levobupivacaine|levobupivacaine|mesh-list
101976369|NCT02293330|Anesthetics, Local|anesthetics, local|mesh-ancestor
101976370|NCT02293330|Anesthetics|anesthetics|mesh-ancestor
101976371|NCT02293330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101976372|NCT02293330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976373|NCT02293330|Sensory System Agents|sensory system agents|mesh-ancestor
101976374|NCT02293330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101976375|NCT01348880|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101976382|NCT03923179|Etoposide|etoposide|mesh-list
101976431|NCT02299882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101976432|NCT02299882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101976433|NCT01355120|Ipilimumab|ipilimumab|mesh-list
101976434|NCT01355120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101976501|NCT03513172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976503|NCT01349270|Immunoglobulins|immunoglobulins|mesh-list
101976504|NCT01349270|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101976505|NCT01349270|Antibodies|antibodies|mesh-list
101976572|NCT02296762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101976573|NCT02296762|Antifungal Agents|antifungal agents|mesh-ancestor
101976577|NCT01132573|Clofarabine|clofarabine|mesh-list
101976643|NCT02294110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101976644|NCT02294110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976645|NCT03512548|Itraconazole|itraconazole|mesh-list
101976657|NCT03515668|Methylphenidate|methylphenidate|mesh-list
101976712|NCT01232023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101976713|NCT01232023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976714|NCT01232023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101976715|NCT01232023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101976788|NCT01356758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101976789|NCT01356758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101976790|NCT01356758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101976791|NCT01356758|Analgesics|analgesics|mesh-ancestor
101976861|NCT01350050|Anesthetics|anesthetics|mesh-ancestor
101976862|NCT01350050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101976863|NCT01350050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101976864|NCT01350050|Sensory System Agents|sensory system agents|mesh-ancestor
101976865|NCT01350050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101976931|NCT03515200|Hydrocortisone|hydrocortisone|mesh-list
101976932|NCT03515200|Doxorubicin|doxorubicin|mesh-list
101976933|NCT03515200|Methotrexate|methotrexate|mesh-list
101977006|NCT03920605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101977007|NCT03920605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101977008|NCT02301208|Nedaplatin|nedaplatin|mesh-list
101977009|NCT02301208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101977017|NCT01229605|Docetaxel|docetaxel|mesh-list
101977078|NCT01230463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101977079|NCT01230463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977148|NCT01229761|Sulfamethoxazole|sulfamethoxazole|mesh-list
101977149|NCT01229761|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101977150|NCT01229761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101977151|NCT01229761|Antimalarials|antimalarials|mesh-ancestor
101977219|NCT01135927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977220|NCT02301910|Tenecteplase|tenecteplase|mesh-list
101977221|NCT02301910|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101977222|NCT02301910|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101977223|NCT02301910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977224|NCT01585753|Maraviroc|maraviroc|mesh-list
101977225|NCT01585753|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101977226|NCT01585753|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101977227|NCT01585753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977228|NCT01585753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101977229|NCT01585753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101977230|NCT01585753|Antiviral Agents|antiviral agents|mesh-ancestor
101977231|NCT01585753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101977232|NCT01585753|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101977233|NCT01136005|Provitamins|provitamins|mesh-list
101977281|NCT03507634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101977282|NCT03507634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101977283|NCT03507634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101977284|NCT03507634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101977285|NCT03507634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101977286|NCT03507634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977349|NCT01133431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101977350|NCT01133431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101977351|NCT01133431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977352|NCT01133431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101977419|NCT01361984|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101977420|NCT01361984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101977421|NCT01361984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101977422|NCT01361984|Adrenergic Agents|adrenergic agents|mesh-ancestor
101977423|NCT01361984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101977424|NCT01361984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977426|NCT01230775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101977427|NCT01230775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101977428|NCT01230775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977430|NCT01136317|Omeprazole|omeprazole|mesh-list
101977485|NCT01233583|Etanercept|etanercept|mesh-list
101977486|NCT01233583|Acitretin|acitretin|mesh-list
101977487|NCT01233583|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101977488|NCT01233583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101977489|NCT01233583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101977490|NCT01233583|Dermatologic Agents|dermatologic agents|mesh-ancestor
101977491|NCT01233583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101977492|NCT01233583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101977493|NCT01233583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101977495|NCT01233583|Sensory System Agents|sensory system agents|mesh-ancestor
101977496|NCT01233583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101977497|NCT01233583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977498|NCT01233583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101574976|NCT02753647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101574977|NCT02753647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101574978|NCT02753647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101574979|NCT02753647|Alkylating Agents|alkylating agents|mesh-ancestor
101574980|NCT02753647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101574989|NCT02753647|Glucocorticoids|glucocorticoids|mesh-ancestor
101977565|NCT01133743|Glucocorticoids|glucocorticoids|mesh-ancestor
101977566|NCT01133743|Hormones|hormones|mesh-ancestor
101977567|NCT01133743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101977568|NCT01133743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101977569|NCT01133743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101977570|NCT01133743|Immunologic Factors|immunologic factors|mesh-ancestor
101977571|NCT01133743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101977572|NCT01133743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101977573|NCT01133743|Growth Substances|growth substances|mesh-ancestor
101977574|NCT01133743|Growth Inhibitors|growth inhibitors|mesh-ancestor
101977575|NCT01133743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101977576|NCT01133743|Leprostatic Agents|leprostatic agents|mesh-ancestor
101977577|NCT01133743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101977578|NCT01133743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101977579|NCT01138423|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101977580|NCT01138423|Moxonidine|moxonidine|mesh-list
101977624|NCT01136941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101977625|NCT01136941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101977626|NCT01136941|Analgesics|analgesics|mesh-ancestor
101977627|NCT01136941|Sensory System Agents|sensory system agents|mesh-ancestor
101977628|NCT01136941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101977630|NCT01136941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101977691|NCT03508804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101977764|NCT03506620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101977765|NCT03506620|Sensory System Agents|sensory system agents|mesh-ancestor
101977766|NCT03506620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101977767|NCT02305030|Opicapone|opicapone|mesh-list
101977835|NCT02313064|CXA-10|cxa-10|mesh-list
101977836|NCT02313064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101977837|NCT05088889|Nivolumab|nivolumab|mesh-list
101977838|NCT05088889|Ipilimumab|ipilimumab|mesh-list
101977839|NCT05088889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101977840|NCT05088889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101977841|NCT05088889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101977842|NCT05088889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977904|NCT01139905|Lopinavir|lopinavir|mesh-list
101977905|NCT01139905|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101977906|NCT01139905|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101977907|NCT01139905|Protease Inhibitors|protease inhibitors|mesh-ancestor
101977908|NCT01139905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101977909|NCT01139905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101977910|NCT01139905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101977911|NCT01139905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101977912|NCT01139905|Antiviral Agents|antiviral agents|mesh-ancestor
101977913|NCT01139905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101977968|NCT02306278|Antimanic Agents|antimanic agents|mesh-ancestor
101977969|NCT01234129|Zoledronic Acid|zoledronic acid|mesh-list
101977973|NCT02313922|Methotrexate|methotrexate|mesh-list
101978044|NCT02314312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101978045|NCT02314312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101978046|NCT02316340|Hydroxychloroquine|hydroxychloroquine|mesh-list
101978047|NCT02316340|Vorinostat|vorinostat|mesh-list
101978048|NCT02316340|Antimalarials|antimalarials|mesh-ancestor
101978049|NCT02316340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101978050|NCT02316340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101978051|NCT02316340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101978052|NCT02316340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101978053|NCT02316340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978054|NCT02316340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101978055|NCT02316340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101978056|NCT02316340|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101978057|NCT01140997|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101978058|NCT01140997|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101978059|NCT01140997|Antiviral Agents|antiviral agents|mesh-ancestor
101978060|NCT01140997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101978061|NCT02310490|Mannitol|mannitol|mesh-list
101978062|NCT02310490|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101978063|NCT02310490|Diuretics|diuretics|mesh-ancestor
101978100|NCT01141153|Acenocoumarol|acenocoumarol|mesh-list
101978101|NCT01141153|Clopidogrel|clopidogrel|mesh-list
101978102|NCT01141153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101978103|NCT01141153|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101978104|NCT01141153|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101978105|NCT01141153|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101978106|NCT01141153|Purinergic Agents|purinergic agents|mesh-ancestor
101978107|NCT01141153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101978108|NCT01141153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697903|NCT00883740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101978109|NCT01141153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978110|NCT01141153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101978111|NCT01141153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101978112|NCT01141153|Analgesics|analgesics|mesh-ancestor
101978113|NCT01141153|Sensory System Agents|sensory system agents|mesh-ancestor
101978114|NCT01141153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101978115|NCT01141153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101978116|NCT01141153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101978117|NCT01141153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101978118|NCT01141153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101978121|NCT01141153|Antipyretics|antipyretics|mesh-ancestor
101978152|NCT03139604|Prednisolone|prednisolone|mesh-list
101978153|NCT03139604|Prednisolone acetate|prednisolone acetate|mesh-list
101978154|NCT03139604|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101978158|NCT03139604|Hormones|hormones|mesh-ancestor
101978224|NCT01362218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978225|NCT01362218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101978226|NCT01362218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101978227|NCT01362218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101978228|NCT01362218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101978229|NCT01362218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101978230|NCT01362218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101978231|NCT01362218|Antipyretics|antipyretics|mesh-ancestor
101978232|NCT01362218|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101978233|NCT01362218|Protease Inhibitors|protease inhibitors|mesh-ancestor
101978234|NCT01362218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101978235|NCT02316964|Aldesleukin|aldesleukin|mesh-list
101978236|NCT02316964|Decitabine|decitabine|mesh-list
101978237|NCT02316964|Azacitidine|azacitidine|mesh-list
101978238|NCT02316964|Interleukin-2|interleukin-2|mesh-list
101978286|NCT01359020|Antipyretics|antipyretics|mesh-ancestor
101978287|NCT01359020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101978288|NCT01359020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101978289|NCT01359020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101978291|NCT01359020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101978356|NCT01141465|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101978357|NCT01141465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101978358|NCT01141465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101978359|NCT01141465|Autonomic Agents|autonomic agents|mesh-ancestor
101978364|NCT01141465|Dermatologic Agents|dermatologic agents|mesh-ancestor
101978426|NCT01238185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101978427|NCT01238185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101978428|NCT01238185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101978429|NCT01238185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101978434|NCT01238185|Antipyretics|antipyretics|mesh-ancestor
101978495|NCT01351298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101978496|NCT01351298|Respiratory System Agents|respiratory system agents|mesh-ancestor
101978566|NCT04175834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978567|NCT04175834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978568|NCT02324998|Olaparib|olaparib|mesh-list
101978569|NCT02324998|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101978570|NCT02324998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101978571|NCT02324998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101978572|NCT02324998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101978573|NCT03500848|Mycophenolic Acid|mycophenolic acid|mesh-list
101978574|NCT03500848|Sirolimus|sirolimus|mesh-list
101978575|NCT03500848|Tacrolimus|tacrolimus|mesh-list
101978576|NCT03500848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101978577|NCT03500848|Immunologic Factors|immunologic factors|mesh-ancestor
101978578|NCT03500848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978579|NCT03500848|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101978580|NCT03500848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101978588|NCT03500848|Antifungal Agents|antifungal agents|mesh-ancestor
101978623|NCT01364012|Growth Inhibitors|growth inhibitors|mesh-ancestor
101978624|NCT02318056|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101978697|NCT02325934|Antiviral Agents|antiviral agents|mesh-ancestor
101978698|NCT02325934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101978770|NCT01352312|Pentostatin|pentostatin|mesh-list
101978771|NCT01352312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101978772|NCT01352312|Alkylating Agents|alkylating agents|mesh-ancestor
101978792|NCT01236859|Gabapentin|gabapentin|mesh-list
101978843|NCT01142011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101978844|NCT01142011|Immunologic Factors|immunologic factors|mesh-ancestor
101978845|NCT01142011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101978846|NCT02319460|Thrombin|thrombin|mesh-list
101978916|NCT03498820|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101978917|NCT03498820|Narcotics|narcotics|mesh-ancestor
101978918|NCT03498820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101978988|NCT03492580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101978989|NCT03492580|Hormones|hormones|mesh-ancestor
101978990|NCT03492580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101978991|NCT03492580|Incretins|incretins|mesh-ancestor
101978992|NCT03492580|Protease Inhibitors|protease inhibitors|mesh-ancestor
101978993|NCT03492580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101978994|NCT01238965|Calcium, Dietary|calcium, dietary|mesh-list
101978995|NCT01238965|Leucovorin|leucovorin|mesh-list
101979058|NCT04356196|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101979133|NCT01237249|Glucocorticoids|glucocorticoids|mesh-ancestor
101979134|NCT01237249|Hormones|hormones|mesh-ancestor
101979139|NCT01237249|Alkylating Agents|alkylating agents|mesh-ancestor
101979206|NCT01732783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101979207|NCT01732783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101979208|NCT04355728|Heparin|heparin|mesh-list
101979209|NCT04355728|Calcium heparin|calcium heparin|mesh-list
101979279|NCT01145209|Cyclophosphamide|cyclophosphamide|mesh-list
101979280|NCT01145209|Fludarabine|fludarabine|mesh-list
101979353|NCT02322346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101979354|NCT01146301|Clopidogrel|clopidogrel|mesh-list
101979355|NCT01146301|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101979424|NCT02322580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101979425|NCT02322580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101979427|NCT02322580|Sensory System Agents|sensory system agents|mesh-ancestor
101979428|NCT02322580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101979494|NCT03496870|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101979495|NCT03496870|Opicapone|opicapone|mesh-list
101979496|NCT03496870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101979565|NCT00943618|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101979566|NCT00943618|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101979567|NCT00943618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101979637|NCT05136040|Anesthetics, Local|anesthetics, local|mesh-ancestor
101979638|NCT05136040|Anesthetics|anesthetics|mesh-ancestor
101979639|NCT05136040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101979640|NCT05136040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979641|NCT05136040|Sensory System Agents|sensory system agents|mesh-ancestor
101979642|NCT05136040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101979643|NCT03496246|Vitamin D|vitamin d|mesh-list
101979644|NCT03496246|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
101979645|NCT03496246|Alfacalcidol|alfacalcidol|mesh-list
101979646|NCT03496246|Calcifediol|calcifediol|mesh-list
101979647|NCT03496246|Calcium|calcium|mesh-list
101979648|NCT03496246|Vitamins|vitamins|mesh-ancestor
101979649|NCT03496246|Micronutrients|micronutrients|mesh-ancestor
101979650|NCT03496246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979651|NCT03496246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101979652|NCT03496246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101979653|NCT02017964|Cyclophosphamide|cyclophosphamide|mesh-list
101979654|NCT02017964|Carboplatin|carboplatin|mesh-list
101979655|NCT02017964|Methotrexate|methotrexate|mesh-list
101979656|NCT02017964|Etoposide|etoposide|mesh-list
101979657|NCT02017964|Vincristine|vincristine|mesh-list
101979658|NCT02017964|Etoposide phosphate|etoposide phosphate|mesh-list
101979659|NCT02017964|Podophyllotoxin|podophyllotoxin|mesh-list
101979660|NCT02017964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101979661|NCT02017964|Immunologic Factors|immunologic factors|mesh-ancestor
101979662|NCT02017964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979663|NCT02017964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101979664|NCT02017964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101979686|NCT05121298|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101979687|NCT05121298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101979688|NCT05121298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101979689|NCT05121298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979690|NCT05121298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101979691|NCT01956110|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101979692|NCT01956110|Hormones|hormones|mesh-ancestor
101979693|NCT01956110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101979694|NCT01956110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979695|NCT03489928|Misoprostol|misoprostol|mesh-list
101979696|NCT03489928|Dinoprostone|dinoprostone|mesh-list
101979697|NCT03489928|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101979698|NCT03489928|Abortifacient Agents|abortifacient agents|mesh-ancestor
101979699|NCT03489928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101979700|NCT03489928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979701|NCT03489928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101979702|NCT03489928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101979703|NCT03489928|Oxytocics|oxytocics|mesh-ancestor
101979704|NCT02323282|Ropivacaine|ropivacaine|mesh-list
101979705|NCT02323282|Anesthetics, Local|anesthetics, local|mesh-ancestor
101979706|NCT02323282|Anesthetics|anesthetics|mesh-ancestor
101979707|NCT02323282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101979708|NCT02323282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101979709|NCT02323282|Sensory System Agents|sensory system agents|mesh-ancestor
101979710|NCT02323282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101979711|NCT01802086|Lidocaine|lidocaine|mesh-list
101979712|NCT01802086|Prilocaine|prilocaine|mesh-list
101979713|NCT01802086|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
101979726|NCT05347316|Colchicine|colchicine|mesh-list
101979731|NCT05347316|Mitosis Modulators|mitosis modulators|mesh-ancestor
101979732|NCT05347316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979805|NCT01372982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101979807|NCT01372982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979808|NCT01372982|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101979809|NCT01372982|Hormone Antagonists|hormone antagonists|mesh-ancestor
101979810|NCT01372982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101979812|NCT02323516|Aspirin|aspirin|mesh-list
101979871|NCT04742140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101979872|NCT04742140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101979940|NCT03116828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101979942|NCT01319942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101979943|NCT01319942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101979944|NCT01319942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101979947|NCT01373138|Ephedrine|ephedrine|mesh-list
101980010|NCT02324296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101980011|NCT02324296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980012|NCT02324296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101980013|NCT02324296|Alkylating Agents|alkylating agents|mesh-ancestor
101980014|NCT03494686|Anesthetics|anesthetics|mesh-list
101980015|NCT03494686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101980016|NCT03494686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339852|NCT00081874|Everolimus|everolimus|mesh-list
101980017|NCT03487198|Brexpiprazole|brexpiprazole|mesh-list
101980018|NCT03487198|Serotonin Agents|serotonin agents|mesh-ancestor
101980019|NCT03487198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101980020|NCT03487198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980021|NCT03487198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980022|NCT03487198|Dopamine Agonists|dopamine agonists|mesh-ancestor
101980023|NCT03487198|Dopamine Agents|dopamine agents|mesh-ancestor
101980024|NCT02565914|Ivacaftor|ivacaftor|mesh-list
101980067|NCT01367756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980068|NCT01367756|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101980069|NCT01367756|Antidepressive Agents|antidepressive agents|mesh-ancestor
101980136|NCT01367912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101980137|NCT03115112|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101980138|NCT03115112|Bexagliflozin|bexagliflozin|mesh-list
101980139|NCT03115112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101980140|NCT03115112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980141|NCT03115112|Incretins|incretins|mesh-ancestor
101980142|NCT03115112|Hormones|hormones|mesh-ancestor
101980143|NCT03115112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101980144|NCT03115112|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101980145|NCT03115112|Protease Inhibitors|protease inhibitors|mesh-ancestor
101980146|NCT03115112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101980147|NCT03115112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980148|NCT01373528|Budesonide|budesonide|mesh-list
101980149|NCT01373528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101980151|NCT01373528|Autonomic Agents|autonomic agents|mesh-ancestor
101980196|NCT03556358|Immunologic Factors|immunologic factors|mesh-ancestor
101980197|NCT03556358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980198|NCT03556358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101980199|NCT03556358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101980200|NCT03556358|Alkylating Agents|alkylating agents|mesh-ancestor
101980201|NCT03556358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101980202|NCT03556358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101980203|NCT03556358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101980204|NCT03556358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101980263|NCT02891798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101980335|NCT05197088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980336|NCT05197088|Urological Agents|urological agents|mesh-ancestor
101980337|NCT01375088|Propolis|propolis|mesh-list
101980338|NCT01375088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101980408|NCT01375322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980409|NCT01375322|Vasodilator Agents|vasodilator agents|mesh-ancestor
101980428|NCT03485404|Vitamins|vitamins|mesh-list
101980481|NCT05194904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101980482|NCT05194904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101980484|NCT05194904|Adrenergic Agents|adrenergic agents|mesh-ancestor
101980485|NCT05194904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101980486|NCT05194904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980487|NCT05194904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101980546|NCT01375556|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101980547|NCT01375556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101980548|NCT01375556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101980616|NCT05105750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980617|NCT05105750|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101980618|NCT05105750|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101980619|NCT05105750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101980620|NCT05105750|Antipyretics|antipyretics|mesh-ancestor
101980621|NCT03485170|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101980622|NCT03485170|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101980623|NCT03485170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980624|NCT05152264|Analgesics|analgesics|mesh-list
101980625|NCT05152264|Sensory System Agents|sensory system agents|mesh-ancestor
101339945|NCT03151863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101980626|NCT05152264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101980627|NCT05152264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980628|NCT05152186|Disinfectants|disinfectants|mesh-list
101980629|NCT05152186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101980630|NCT03485092|Empagliflozin|empagliflozin|mesh-list
101980675|NCT01376258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101980676|NCT01376258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980691|NCT03531840|Olaparib|olaparib|mesh-list
101980747|NCT03109756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101980748|NCT03109756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980818|NCT03552068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101980819|NCT03552068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101980820|NCT03552068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101980821|NCT03552068|Adrenergic Agents|adrenergic agents|mesh-ancestor
101980822|NCT03552068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101980823|NCT03552068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980824|NCT00702988|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101980825|NCT00702988|Hormones|hormones|mesh-ancestor
101980826|NCT00702988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101980883|NCT03480646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101980884|NCT03480646|Glucocorticoids|glucocorticoids|mesh-ancestor
101980886|NCT03480646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101980887|NCT03480646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101980900|NCT03726372|Bromides|bromides|mesh-list
101980954|NCT05759000|Dapagliflozin|dapagliflozin|mesh-list
101980955|NCT05759000|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101980956|NCT05759000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101980957|NCT05759000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101980959|NCT03726216|Dalbavancin|dalbavancin|mesh-list
101981024|NCT04729543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981025|NCT04729543|Anticonvulsants|anticonvulsants|mesh-ancestor
101981026|NCT04729543|GABA Agents|gaba agents|mesh-ancestor
101981027|NCT04729543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101981028|NCT04729543|Antimanic Agents|antimanic agents|mesh-ancestor
101981029|NCT04729543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101981030|NCT04729543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101981031|NCT04729543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101981032|NCT01310712|Oxybutynin|oxybutynin|mesh-list
101981033|NCT01310712|Parasympatholytics|parasympatholytics|mesh-ancestor
101981034|NCT01310712|Autonomic Agents|autonomic agents|mesh-ancestor
101981035|NCT01310712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101981087|NCT05626387|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101981088|NCT05626387|Prednisolone acetate|prednisolone acetate|mesh-list
101981089|NCT05626387|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101981090|NCT05626387|Prednisolone phosphate|prednisolone phosphate|mesh-list
101981091|NCT05626387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101981092|NCT05626387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101981093|NCT05626387|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101981094|NCT05626387|Antitubercular Agents|antitubercular agents|mesh-ancestor
101981095|NCT05626387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101981096|NCT05626387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101981101|NCT05626387|Hormones|hormones|mesh-ancestor
101981150|NCT03493698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101981151|NCT03493698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101981152|NCT03493698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101981159|NCT03493698|Anesthetics|anesthetics|mesh-ancestor
101981222|NCT01253473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101981223|NCT01253473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981224|NCT01253473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101981293|NCT02348203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101981294|NCT03493542|Vaccines|vaccines|mesh-list
101981295|NCT03493542|Immunologic Factors|immunologic factors|mesh-ancestor
101981348|NCT01248871|Dsuvia|dsuvia|mesh-list
101981363|NCT01248871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101981364|NCT01248871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101981436|NCT03907111|Coagulants|coagulants|mesh-ancestor
101981437|NCT03912727|Thioctic Acid|thioctic acid|mesh-list
101981438|NCT03912727|Antioxidants|antioxidants|mesh-ancestor
101981439|NCT03912727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981440|NCT03912727|Protective Agents|protective agents|mesh-ancestor
101981505|NCT03479320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101981506|NCT03479320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101981510|NCT03912415|Paclitaxel|paclitaxel|mesh-list
101981576|NCT01251835|Antitubercular Agents|antitubercular agents|mesh-ancestor
101981577|NCT01251835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101981578|NCT01251835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101981579|NCT01251835|Leprostatic Agents|leprostatic agents|mesh-ancestor
101981580|NCT01251835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101981581|NCT01251835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101981582|NCT01251835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981583|NCT01251835|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101981584|NCT01251835|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101981585|NCT01251835|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101981586|NCT01251835|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101436723|NCT02403505|Immunologic Factors|immunologic factors|mesh-ancestor
101436724|NCT02403505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436726|NCT02401035|Pantoprazole|pantoprazole|mesh-list
101981637|NCT03479086|Topiramate|topiramate|mesh-list
101981638|NCT03479086|Naltrexone|naltrexone|mesh-list
101981639|NCT03479086|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101981640|NCT03479086|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101981641|NCT03479086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981642|NCT03479086|Sensory System Agents|sensory system agents|mesh-ancestor
101981643|NCT03479086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101981700|NCT03574792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101981702|NCT03574792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101981703|NCT03574792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101981772|NCT03478306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101981773|NCT03478306|Protective Agents|protective agents|mesh-ancestor
101981774|NCT03478306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981843|NCT03718884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981844|NCT03718884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101981916|NCT02527993|Pasireotide|pasireotide|mesh-list
101981917|NCT02527993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101981918|NCT02527993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101981919|NCT02527993|Incretins|incretins|mesh-ancestor
101981920|NCT02527993|Hormones|hormones|mesh-ancestor
101981932|NCT04927052|Lidocaine|lidocaine|mesh-list
101981984|NCT03894007|Trastuzumab|trastuzumab|mesh-list
101981985|NCT03894007|Atezolizumab|atezolizumab|mesh-list
101982058|NCT01586299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101982129|NCT04770740|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101982130|NCT04770740|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101982131|NCT04770740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982133|NCT04770740|Coagulants|coagulants|mesh-ancestor
101982134|NCT03896971|Cyclosporine|cyclosporine|mesh-list
101982135|NCT03896971|Cyclosporins|cyclosporins|mesh-list
101982136|NCT03896971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101982137|NCT03896971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982138|NCT03896971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101982139|NCT03896971|Immunologic Factors|immunologic factors|mesh-ancestor
101982140|NCT03896971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982141|NCT03896971|Antifungal Agents|antifungal agents|mesh-ancestor
101982142|NCT03896971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101982143|NCT03896971|Dermatologic Agents|dermatologic agents|mesh-ancestor
101982144|NCT03896971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101574995|NCT02753647|Antimitotic Agents|antimitotic agents|mesh-ancestor
101701954|NCT00874770|Ribavirin|ribavirin|mesh-list
101982145|NCT03896971|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101982146|NCT01258777|Golimumab|golimumab|mesh-list
101982147|NCT01258777|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101982148|NCT01258777|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101982184|NCT03899077|Leuprolide|leuprolide|mesh-list
101982194|NCT03899077|Fertility Agents|fertility agents|mesh-ancestor
101982254|NCT01257451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101982255|NCT01257451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982256|NCT01257529|Pregabalin|pregabalin|mesh-list
101982324|NCT01260103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982325|NCT01260103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101982326|NCT03480750|Carboplatin|carboplatin|mesh-list
101982398|NCT03716622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101982399|NCT03716622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101982400|NCT03716622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101982402|NCT03716622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101982469|NCT03895411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982470|NCT03895411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101982472|NCT03895411|Autonomic Agents|autonomic agents|mesh-ancestor
101982473|NCT03895411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101982474|NCT03895411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101982475|NCT03895411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101982537|NCT03890341|Betadex|betadex|mesh-list
101982538|NCT03890341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101982539|NCT03890341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101982612|NCT01152931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101982613|NCT01152931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101982614|NCT01152931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101982615|NCT01152931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101982616|NCT01152931|Antiviral Agents|antiviral agents|mesh-ancestor
101982617|NCT01152931|Schistosomicides|schistosomicides|mesh-ancestor
101982680|NCT01153243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101982752|NCT01261741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101982753|NCT01261741|Dopamine Agents|dopamine agents|mesh-ancestor
101982754|NCT01261741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101982755|NCT01261741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982756|NCT01261741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982757|NCT01261741|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101982758|NCT01261741|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101982759|NCT01157455|Aspirin|aspirin|mesh-list
101982760|NCT01157455|Everolimus|everolimus|mesh-list
101982761|NCT01157455|Heparin|heparin|mesh-list
101982762|NCT01157455|Bivalirudin|bivalirudin|mesh-list
101982763|NCT01157455|Clopidogrel|clopidogrel|mesh-list
101982765|NCT01157455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101982816|NCT01154959|Rifampin|rifampin|mesh-list
101982817|NCT01154959|Isoniazid|isoniazid|mesh-list
101982818|NCT01154959|Pyrazinamide|pyrazinamide|mesh-list
101982819|NCT01154959|Ethambutol|ethambutol|mesh-list
101982820|NCT01154959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101574998|NCT02872389|Desflurane|desflurane|mesh-list
101982821|NCT01154959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101982882|NCT01155115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982883|NCT01155115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101340013|NCT00083707|Thalidomide|thalidomide|mesh-list
101982884|NCT01155115|Respiratory System Agents|respiratory system agents|mesh-ancestor
101982885|NCT01155115|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101982886|NCT01155115|Antioxidants|antioxidants|mesh-ancestor
101982891|NCT01155115|Gasotransmitters|gasotransmitters|mesh-ancestor
101982950|NCT03880981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101982951|NCT03880981|Analgesics|analgesics|mesh-ancestor
101982952|NCT03880981|Sensory System Agents|sensory system agents|mesh-ancestor
101982953|NCT03880981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101982954|NCT03880981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101982955|NCT03880981|Antipyretics|antipyretics|mesh-ancestor
101982956|NCT03880981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101982957|NCT03880981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101982958|NCT03880981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101982959|NCT03880981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101982960|NCT03880981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101982961|NCT03880981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101982962|NCT03424044|Glucagon|glucagon|mesh-list
101982963|NCT03424044|Pancrelipase|pancrelipase|mesh-list
101982964|NCT03424044|Pancreatin|pancreatin|mesh-list
101982965|NCT03424044|Hormones|hormones|mesh-list
101983009|NCT01589809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983010|NCT01589809|Vitamin B Complex|vitamin b complex|mesh-ancestor
101983011|NCT01589809|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101983081|NCT03879889|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101983082|NCT03879889|Cholinergic Agents|cholinergic agents|mesh-ancestor
101983083|NCT03879889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101983159|NCT00075725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101983160|NCT00075725|Glucocorticoids|glucocorticoids|mesh-ancestor
101983161|NCT00075725|Hormones|hormones|mesh-ancestor
101983162|NCT00075725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101983163|NCT00075725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101983164|NCT00075725|Protease Inhibitors|protease inhibitors|mesh-ancestor
101983165|NCT00075725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101983166|NCT00075725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101983167|NCT00075725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101983226|NCT01266655|GABA Agents|gaba agents|mesh-ancestor
101983227|NCT01266655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101983228|NCT01266655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983229|NCT00075023|Thalidomide|thalidomide|mesh-list
101983230|NCT00075023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101983231|NCT00075023|Immunologic Factors|immunologic factors|mesh-ancestor
101983232|NCT00075023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983233|NCT00075023|Leprostatic Agents|leprostatic agents|mesh-ancestor
101983234|NCT00075023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101983235|NCT00075023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101983236|NCT00075023|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101983237|NCT00075023|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101983238|NCT00075023|Growth Substances|growth substances|mesh-ancestor
101983241|NCT01100801|Cisplatin|cisplatin|mesh-list
101983287|NCT01265017|Estrogens|estrogens|mesh-ancestor
101983288|NCT01265017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101983300|NCT03420300|Antiviral Agents|antiviral agents|mesh-ancestor
101983359|NCT01266811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101983360|NCT01266811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101983361|NCT01266811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101983362|NCT01266811|Protease Inhibitors|protease inhibitors|mesh-ancestor
101983363|NCT01266811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101983364|NCT01266811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983365|NCT01158937|Meropenem|meropenem|mesh-list
101983366|NCT01158937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101983367|NCT01158937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101983414|NCT03419364|Niacin|niacin|mesh-list
101983423|NCT03419364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101983424|NCT03419364|Vasodilator Agents|vasodilator agents|mesh-ancestor
101983425|NCT01265173|Ciprofloxacin|ciprofloxacin|mesh-list
101983499|NCT02954172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101983500|NCT02954172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101983501|NCT02954172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101983502|NCT02954172|Growth Substances|growth substances|mesh-ancestor
101983570|NCT01160731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101983571|NCT01160731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983572|NCT01160731|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101983573|NCT01160965|Ropivacaine|ropivacaine|mesh-list
101983641|NCT01268215|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
101983642|NCT01269307|Ketamine|ketamine|mesh-list
101983643|NCT01269307|Propofol|propofol|mesh-list
101983644|NCT01269307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101983645|NCT01269307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101983709|NCT03877003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983710|NCT03877003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101983711|NCT03877003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101983712|NCT03877003|Nootropic Agents|nootropic agents|mesh-ancestor
101983713|NCT01280149|Substance P|substance p|mesh-list
101983779|NCT05657652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983780|NCT05657652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101983781|NCT05657652|Antiviral Agents|antiviral agents|mesh-ancestor
101983851|NCT01164085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101983852|NCT01164085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101983853|NCT01164085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983854|NCT01271179|Insulin|insulin|mesh-list
101983855|NCT01271179|Allopurinol|allopurinol|mesh-list
101983856|NCT01271179|Adenosine|adenosine|mesh-list
101983919|NCT01268839|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101983920|NCT01268839|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101983922|NCT03403374|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101983923|NCT03403374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101983924|NCT03403374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101983925|NCT03403374|Antimetabolites|antimetabolites|mesh-ancestor
101983926|NCT03403374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983927|NCT03403374|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101983928|NCT03403374|Protease Inhibitors|protease inhibitors|mesh-ancestor
101983929|NCT03403374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101983930|NCT03403374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101983931|NCT01165567|Sarpogrelate|sarpogrelate|mesh-list
101983932|NCT01165567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101983933|NCT01165567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101983934|NCT01165567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983937|NCT01165567|Serotonin Agents|serotonin agents|mesh-ancestor
101983978|NCT01586611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101983979|NCT01586611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101983981|NCT01586611|Protective Agents|protective agents|mesh-ancestor
101983982|NCT01586611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983983|NCT01586611|Vitamin B Complex|vitamin b complex|mesh-ancestor
101983984|NCT01586611|Vitamins|vitamins|mesh-ancestor
101983985|NCT01586611|Micronutrients|micronutrients|mesh-ancestor
101983986|NCT03386448|Scopolamine|scopolamine|mesh-list
101983987|NCT03386448|Naltrexone|naltrexone|mesh-list
101983988|NCT03386448|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101983989|NCT03386448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101983990|NCT03386448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101983991|NCT03386448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101983995|NCT03386448|Antiemetics|antiemetics|mesh-ancestor
101984041|NCT01268995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984042|NCT01268995|Antifungal Agents|antifungal agents|mesh-ancestor
101984043|NCT01268995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101984046|NCT00009737|Leucovorin|leucovorin|mesh-list
101984114|NCT03960671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101984115|NCT03960671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984116|NCT03960671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101984187|NCT01281787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101984188|NCT01281787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984189|NCT01281787|Sympatholytics|sympatholytics|mesh-ancestor
101984190|NCT01281787|Autonomic Agents|autonomic agents|mesh-ancestor
101984257|NCT01166035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984258|NCT01166035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101984259|NCT01166035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101984260|NCT01166035|Growth Substances|growth substances|mesh-ancestor
101984261|NCT01166035|Growth Inhibitors|growth inhibitors|mesh-ancestor
101984262|NCT01166035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101984263|NCT01166035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101984264|NCT01168375|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101984265|NCT01168375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101984266|NCT03869281|Pancrelipase|pancrelipase|mesh-list
101340096|NCT00135499|Prednisone|prednisone|mesh-list
101984267|NCT03869281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101984320|NCT01168531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101984321|NCT01168531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984322|NCT01168531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101984323|NCT01168531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101984324|NCT01168531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101984325|NCT01168531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101984326|NCT01168531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101984327|NCT01170169|Omeprazole|omeprazole|mesh-list
101984328|NCT01170169|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101984329|NCT01170169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101984330|NCT01170169|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101984331|NCT01170169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101984332|NCT01170169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984333|NCT01587313|Hydralazine|hydralazine|mesh-list
101984334|NCT01587313|Isosorbide|isosorbide|mesh-list
101984335|NCT01587313|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
101984336|NCT01587313|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
101984337|NCT01587313|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101984338|NCT01587313|Diuretics|diuretics|mesh-ancestor
101984339|NCT01587313|Natriuretic Agents|natriuretic agents|mesh-ancestor
101984340|NCT01587313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984341|NCT01587313|Vasodilator Agents|vasodilator agents|mesh-ancestor
101984342|NCT01587313|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101984343|NCT01587313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984344|NCT01587313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101984369|NCT01311570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984370|NCT01311570|Analgesics|analgesics|mesh-ancestor
101984385|NCT05542446|Colistin|colistin|mesh-list
101984442|NCT03868111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984443|NCT03868111|Analgesics|analgesics|mesh-ancestor
101984518|NCT00025259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101984519|NCT00025259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101984520|NCT00025259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101984521|NCT00025259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101984589|NCT01284049|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101984590|NCT01284049|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101984591|NCT01284049|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101984592|NCT01284049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101984593|NCT03863977|Dexamethasone|dexamethasone|mesh-list
101984594|NCT03863977|Dexamethasone acetate|dexamethasone acetate|mesh-list
101984595|NCT03863977|Bupivacaine|bupivacaine|mesh-list
101984596|NCT03863977|BB 1101|bb 1101|mesh-list
101984597|NCT03863977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101984598|NCT03863977|Antiemetics|antiemetics|mesh-ancestor
101984599|NCT03863977|Autonomic Agents|autonomic agents|mesh-ancestor
101984600|NCT03863977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101984601|NCT03863977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984602|NCT03863977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101984603|NCT03863977|Glucocorticoids|glucocorticoids|mesh-ancestor
101984604|NCT03863977|Hormones|hormones|mesh-ancestor
101984605|NCT03863977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101984606|NCT03863977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101984607|NCT03863977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101984608|NCT03863977|Protease Inhibitors|protease inhibitors|mesh-ancestor
101984609|NCT03863977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101984610|NCT03863977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984642|NCT01175161|Trace Elements|trace elements|mesh-ancestor
101984643|NCT01175161|Micronutrients|micronutrients|mesh-ancestor
101984644|NCT01175161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984645|NCT01172041|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101984646|NCT01172041|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101984647|NCT01172041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984648|NCT01284205|BCG Vaccine|bcg vaccine|mesh-list
101984649|NCT01284205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101984650|NCT01284205|Immunologic Factors|immunologic factors|mesh-ancestor
101984651|NCT01284205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984652|NCT00024167|Ketoconazole|ketoconazole|mesh-list
101984653|NCT00024167|Dexamethasone|dexamethasone|mesh-list
101984654|NCT00024167|Prednisone|prednisone|mesh-list
101984655|NCT00024167|Estramustine|estramustine|mesh-list
101984656|NCT00024167|Docetaxel|docetaxel|mesh-list
101984657|NCT00024167|Doxorubicin|doxorubicin|mesh-list
101984658|NCT00024167|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101984659|NCT00024167|Vinblastine|vinblastine|mesh-list
101984660|NCT00024167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101984661|NCT00024167|Antiemetics|antiemetics|mesh-ancestor
101984662|NCT00024167|Autonomic Agents|autonomic agents|mesh-ancestor
101984663|NCT00024167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101984664|NCT00024167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984665|NCT00024167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101984666|NCT00024167|Glucocorticoids|glucocorticoids|mesh-ancestor
101984694|NCT00022763|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101984695|NCT00022763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984696|NCT00022763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101984697|NCT00022763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101984698|NCT00022763|Antiviral Agents|antiviral agents|mesh-ancestor
101984699|NCT00022763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101984700|NCT01285141|polysaccharide-K|polysaccharide-k|mesh-list
101984701|NCT01285141|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101704515|NCT00997009|Paclitaxel|paclitaxel|mesh-list
101984760|NCT01285375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101984761|NCT01285375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101984762|NCT01285375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101984763|NCT01285375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984765|NCT05625893|Atezolizumab|atezolizumab|mesh-list
101984766|NCT05625893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101984767|NCT05625893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101984768|NCT05625893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101984769|NCT05625893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101984770|NCT05625893|Growth Substances|growth substances|mesh-ancestor
101984771|NCT05625893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984772|NCT05625893|Growth Inhibitors|growth inhibitors|mesh-ancestor
101984773|NCT05625893|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101984774|NCT05625893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101984775|NCT01178047|Rasagiline|rasagiline|mesh-list
101984776|NCT01178047|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101984816|NCT01288339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101984817|NCT01288339|Immunologic Factors|immunologic factors|mesh-ancestor
101984818|NCT01288339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984820|NCT01288339|Protective Agents|protective agents|mesh-ancestor
101984821|NCT01288339|Vitamin B Complex|vitamin b complex|mesh-ancestor
101984822|NCT01288339|Vitamins|vitamins|mesh-ancestor
101984884|NCT00006305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101984885|NCT00006305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101984886|NCT00006305|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101984956|NCT03865147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101984957|NCT03865147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101984958|NCT03865147|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101984959|NCT03865147|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101984960|NCT03865147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101984961|NCT03865147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985023|NCT04934579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101985024|NCT04934579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101985025|NCT04934579|Antimetabolites|antimetabolites|mesh-ancestor
101985026|NCT04934579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985027|NCT04934579|Dermatologic Agents|dermatologic agents|mesh-ancestor
101985028|NCT04934579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101985029|NCT04934579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101985030|NCT04934579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101985031|NCT04934579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101985032|NCT04934579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101985033|NCT04934579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101985034|NCT04934579|Growth Substances|growth substances|mesh-ancestor
101985035|NCT04934579|Growth Inhibitors|growth inhibitors|mesh-ancestor
101985037|NCT03134131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101985083|NCT03377556|Talazoparib|talazoparib|mesh-list
101985084|NCT03377556|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101985085|NCT03377556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101985086|NCT03377556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985087|NCT03377556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101985152|NCT01174927|Analgesics|analgesics|mesh-ancestor
101704981|NCT01004575|Cobalt|cobalt|mesh-list
101985153|NCT01174927|Sensory System Agents|sensory system agents|mesh-ancestor
101985154|NCT01174927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101985156|NCT03510663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101985157|NCT03510663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101985158|NCT03510663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101985159|NCT03510663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101985160|NCT03510663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101985161|NCT03510663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985162|NCT03510663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101985164|NCT03948737|Vitamin E|vitamin e|mesh-list
101985218|NCT01180933|Micronutrients|micronutrients|mesh-ancestor
101985219|NCT01180933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985290|NCT03500211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101985291|NCT03500211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101985292|NCT03500211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985293|NCT01288885|Ipragliflozin|ipragliflozin|mesh-list
101985294|NCT01288885|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101985295|NCT01288885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985296|NCT01288885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101985297|NCT01288885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985298|NCT04760717|Spironolactone|spironolactone|mesh-list
101985299|NCT04760717|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101705114|NCT01002703|Hormones|hormones|mesh-ancestor
101985300|NCT04760717|Hormone Antagonists|hormone antagonists|mesh-ancestor
101985301|NCT04760717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101985302|NCT04760717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985303|NCT04760717|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101985304|NCT04760717|Diuretics|diuretics|mesh-ancestor
101985305|NCT04760717|Natriuretic Agents|natriuretic agents|mesh-ancestor
101985306|NCT03478683|Budesonide|budesonide|mesh-list
101985307|NCT03478683|Albuterol|albuterol|mesh-list
101340199|NCT00135967|Antiemetics|antiemetics|mesh-ancestor
101985308|NCT03478683|Formoterol Fumarate|formoterol fumarate|mesh-list
101985309|NCT03478683|Tiotropium Bromide|tiotropium bromide|mesh-list
101985310|NCT03478683|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101985311|NCT03478683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101985312|NCT03478683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101985313|NCT03478683|Autonomic Agents|autonomic agents|mesh-ancestor
101985314|NCT03478683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101985315|NCT03478683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985318|NCT03478683|Glucocorticoids|glucocorticoids|mesh-ancestor
101985333|NCT04744883|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101985334|NCT04744883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985335|NCT04744883|Sensory System Agents|sensory system agents|mesh-ancestor
101985336|NCT04744883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101985337|NCT01176799|Cyclophosphamide|cyclophosphamide|mesh-list
101985338|NCT01176799|Doxorubicin|doxorubicin|mesh-list
101985339|NCT01176799|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101985340|NCT01176799|Sunitinib|sunitinib|mesh-list
101985401|NCT01287715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101985403|NCT01287715|Sensory System Agents|sensory system agents|mesh-ancestor
101985404|NCT01287715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101985472|NCT01180075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101985473|NCT01180075|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101985474|NCT01180075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101985475|NCT01180075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101985476|NCT01180075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101985477|NCT01180075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101985538|NCT03390426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101985539|NCT03390426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985611|NCT03368664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101985612|NCT03368664|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101985613|NCT03368664|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101985614|NCT03368664|Histamine Antagonists|histamine antagonists|mesh-ancestor
101985615|NCT03368664|Histamine Agents|histamine agents|mesh-ancestor
101985616|NCT03368664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101985617|NCT03368664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985618|NCT03368664|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101985624|NCT01177579|Copper|copper|mesh-list
101985679|NCT03857581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985680|NCT03857581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101985681|NCT03857581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101985682|NCT03857581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101985684|NCT03857581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101985750|NCT00004031|Immunologic Factors|immunologic factors|mesh-ancestor
101985751|NCT00004031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985752|NCT00004031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101985754|NCT00004031|Alkylating Agents|alkylating agents|mesh-ancestor
101985817|NCT00003875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101985818|NCT00003875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101985819|NCT00003875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101985823|NCT00003875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101985888|NCT01106495|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101985889|NCT01106495|Antimetabolites|antimetabolites|mesh-ancestor
101985890|NCT01106495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101985891|NCT01106495|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101985892|NCT01106495|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101985958|NCT03719157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101985959|NCT03719157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101985960|NCT03719157|Sensory System Agents|sensory system agents|mesh-ancestor
101985961|NCT03719157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101985962|NCT01185223|Valganciclovir|valganciclovir|mesh-list
101985963|NCT01185223|Ganciclovir|ganciclovir|mesh-list
101985964|NCT01185223|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101985965|NCT01185223|Antiviral Agents|antiviral agents|mesh-ancestor
101985970|NCT03852979|Paclitaxel|paclitaxel|mesh-list
101986023|NCT01291069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101986024|NCT01291069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101986025|NCT01291069|Urological Agents|urological agents|mesh-ancestor
101986094|NCT01185847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101986095|NCT01185847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101986097|NCT01185847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986098|NCT01185847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101986099|NCT01185847|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101986100|NCT01185847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101986165|NCT03344172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101986166|NCT03344172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101986236|NCT03948191|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101986237|NCT03948191|Protective Agents|protective agents|mesh-ancestor
101986238|NCT03948191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101986239|NCT03948191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101986240|NCT03948191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101986241|NCT03948191|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101986242|NCT03948191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986245|NCT01292083|Antimetabolites|antimetabolites|mesh-ancestor
101986300|NCT01107509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101986301|NCT01107509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986302|NCT01107509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101986303|NCT01107509|Immunologic Factors|immunologic factors|mesh-ancestor
101986304|NCT01107509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986305|NCT01107509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101986307|NCT01101815|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101986308|NCT01101815|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101986309|NCT01101815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986310|NCT01101815|Sensory System Agents|sensory system agents|mesh-ancestor
101986311|NCT01101815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101986312|NCT01104935|Trastuzumab|trastuzumab|mesh-list
101986313|NCT01104935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101986314|NCT01104935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101986315|NCT01293643|Clindamycin|clindamycin|mesh-list
101986316|NCT01293643|Clindamycin palmitate|clindamycin palmitate|mesh-list
101986317|NCT01293643|Clindamycin phosphate|clindamycin phosphate|mesh-list
101986318|NCT01293643|Amphotericin B|amphotericin b|mesh-list
101986354|NCT03851731|Naloxone|naloxone|mesh-list
101986355|NCT03851731|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101986356|NCT03851731|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101986357|NCT03851731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986358|NCT03851731|Sensory System Agents|sensory system agents|mesh-ancestor
101986359|NCT03851731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101986360|NCT03707652|Vitamins|vitamins|mesh-list
101986361|NCT03707652|Niacinamide|niacinamide|mesh-list
101986362|NCT03707652|Niacin|niacin|mesh-list
101986363|NCT03707652|Nicotinic Acids|nicotinic acids|mesh-list
101986364|NCT03707652|Vitamin B Complex|vitamin b complex|mesh-list
101986365|NCT03707652|Micronutrients|micronutrients|mesh-ancestor
101986366|NCT03707652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986367|NCT03707652|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101986368|NCT03707652|Antimetabolites|antimetabolites|mesh-ancestor
101986369|NCT03707652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986370|NCT03707652|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101986371|NCT03707652|Vasodilator Agents|vasodilator agents|mesh-ancestor
101986372|NCT01588093|Mecasermin|mecasermin|mesh-list
101986373|NCT01588093|Growth Substances|growth substances|mesh-ancestor
101986374|NCT01588093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986375|NCT01186471|Nicotine|nicotine|mesh-list
101986376|NCT01186471|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101986408|NCT03854617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101986409|NCT03854617|Tubulin Modulators|tubulin modulators|mesh-ancestor
101986410|NCT03854617|Antimitotic Agents|antimitotic agents|mesh-ancestor
101986411|NCT03854617|Mitosis Modulators|mitosis modulators|mesh-ancestor
101986412|NCT03854617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986414|NCT01186549|Ephedrine|ephedrine|mesh-list
101986415|NCT01186549|Pseudoephedrine|pseudoephedrine|mesh-list
101986417|NCT01186549|Anesthetics|anesthetics|mesh-ancestor
101986475|NCT01291459|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101986476|NCT01291459|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101986477|NCT01291459|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101986478|NCT01291459|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101986545|NCT05154682|Antipyretics|antipyretics|mesh-ancestor
101986546|NCT05154682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101986547|NCT05154682|Narcotics|narcotics|mesh-ancestor
101986548|NCT05154682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101986616|NCT03853525|Emollients|emollients|mesh-ancestor
101986617|NCT03853525|Dermatologic Agents|dermatologic agents|mesh-ancestor
101986618|NCT03716583|Melatonin|melatonin|mesh-list
101986619|NCT03716583|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
101986690|NCT02529839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101986759|NCT01108133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101986760|NCT01108133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101986762|NCT01108289|Oxytocin|oxytocin|mesh-list
101986831|NCT02938624|Pembrolizumab|pembrolizumab|mesh-list
101986832|NCT02938624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101986833|NCT02938624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101986834|NCT02938624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101986835|NCT02938624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986836|NCT03469804|Pembrolizumab|pembrolizumab|mesh-list
101986837|NCT03469804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101986838|NCT03469804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101986839|NCT03469804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101986840|NCT03469804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986841|NCT03944291|Bupivacaine|bupivacaine|mesh-list
101986842|NCT03944291|Anesthetics, Local|anesthetics, local|mesh-ancestor
101986843|NCT03944291|Anesthetics|anesthetics|mesh-ancestor
101986844|NCT03944291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101986846|NCT03944291|Sensory System Agents|sensory system agents|mesh-ancestor
101986888|NCT01584791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101986889|NCT01584791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101986890|NCT01584791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101986892|NCT01584791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101986959|NCT01147822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101986960|NCT01147822|Growth Inhibitors|growth inhibitors|mesh-ancestor
101986961|NCT01147822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101986962|NCT01147822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101986964|NCT03431337|Amoxicillin|amoxicillin|mesh-list
101987029|NCT05158348|Lidocaine|lidocaine|mesh-list
101987030|NCT05158348|Dexmedetomidine|dexmedetomidine|mesh-list
101987031|NCT05158348|Anesthetics, Local|anesthetics, local|mesh-ancestor
101987032|NCT05158348|Anesthetics|anesthetics|mesh-ancestor
101987033|NCT05158348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101987098|NCT01109615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987099|NCT01109615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101987100|NCT01109615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101987101|NCT01109615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101987166|NCT03480243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101987167|NCT03480243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987168|NCT03480243|Anticonvulsants|anticonvulsants|mesh-ancestor
101987237|NCT01209455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101987238|NCT01209455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101987239|NCT01194115|Metronidazole|metronidazole|mesh-list
101987311|NCT01192243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101987312|NCT01192243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987313|NCT01192243|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101987314|NCT01192243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101987315|NCT01192243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101987317|NCT01209845|Analgesics|analgesics|mesh-ancestor
101987379|NCT05406895|Sensory System Agents|sensory system agents|mesh-ancestor
101987380|NCT05406895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101987381|NCT05406895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101987382|NCT05406895|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101987448|NCT01113047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101987449|NCT01113047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987450|NCT01113047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101987451|NCT01113047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987452|NCT01113047|Vasodilator Agents|vasodilator agents|mesh-ancestor
101987453|NCT01113125|Fusidic Acid|fusidic acid|mesh-list
101987454|NCT01113125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101987455|NCT01113125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101987456|NCT01113125|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101987457|NCT01113125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101987458|NCT01113125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987459|NCT01210391|Caseins|caseins|mesh-list
101987460|NCT01210391|Chelating Agents|chelating agents|mesh-ancestor
101987461|NCT01210391|Sequestering Agents|sequestering agents|mesh-ancestor
101987508|NCT01197157|Nitazoxanide|nitazoxanide|mesh-list
101987509|NCT01197157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101987510|NCT01197157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101987511|NCT01296997|Calcium|calcium|mesh-list
101987512|NCT01296997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101987579|NCT01113671|Antioxidants|antioxidants|mesh-ancestor
101987580|NCT01113671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987650|NCT01208441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987651|NCT01208441|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101987722|NCT03940391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987723|NCT03940391|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101987724|NCT03940391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101987725|NCT03940391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101987794|NCT01110785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987795|NCT01110785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101987866|NCT01196065|Dopamine Agents|dopamine agents|mesh-ancestor
101987867|NCT01196065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101987868|NCT01196065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987869|NCT01196065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987870|NCT01196065|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101987871|NCT01196065|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101987872|NCT05258773|Azasetron|azasetron|mesh-list
101987873|NCT05258773|Antiemetics|antiemetics|mesh-ancestor
101987874|NCT05258773|Autonomic Agents|autonomic agents|mesh-ancestor
101987877|NCT05258773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101987930|NCT01115543|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
101987931|NCT01115543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101987932|NCT01115543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987933|NCT01115543|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101987934|NCT01115543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101987935|NCT01115543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101987936|NCT01115543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101987937|NCT01115543|Vitamins|vitamins|mesh-ancestor
101987938|NCT01115543|Micronutrients|micronutrients|mesh-ancestor
101987939|NCT01115543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101987940|NCT01216007|Propofol|propofol|mesh-list
101987941|NCT01216007|Sevoflurane|sevoflurane|mesh-list
101987942|NCT01216007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101987943|NCT01216007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101987944|NCT01216007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987945|NCT01216007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101987946|NCT01216007|Anesthetics, General|anesthetics, general|mesh-ancestor
101987947|NCT01216007|Anesthetics|anesthetics|mesh-ancestor
101987948|NCT01216007|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101987949|NCT01216007|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101987950|NCT01198249|Losartan|losartan|mesh-list
101987951|NCT01198249|Amlodipine|amlodipine|mesh-list
101987982|NCT01119209|Anesthetics|anesthetics|mesh-ancestor
101987983|NCT01119209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101987984|NCT01119209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101987985|NCT01119209|Sensory System Agents|sensory system agents|mesh-ancestor
101987986|NCT01119209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101988049|NCT05156437|Levofloxacin|levofloxacin|mesh-list
101988050|NCT05156437|Rifampin|rifampin|mesh-list
101988051|NCT05156437|Ceftriaxone|ceftriaxone|mesh-list
101988052|NCT05156437|Linezolid|linezolid|mesh-list
101988123|NCT01118429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988124|NCT01118429|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101988193|NCT01198639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101988194|NCT01116713|Dexamethasone|dexamethasone|mesh-list
101988195|NCT01116713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101988202|NCT01116713|Hormones|hormones|mesh-ancestor
101988265|NCT01199029|Hormones|hormones|mesh-ancestor
101988266|NCT01199029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101988338|NCT01200901|Antidepressive Agents|antidepressive agents|mesh-ancestor
101988339|NCT01200901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101988340|NCT01200901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101988341|NCT01200901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101988342|NCT01200901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101988343|NCT01200901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988344|NCT01212809|Hyaluronic Acid|hyaluronic acid|mesh-list
101988345|NCT01212809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101988346|NCT01212809|Immunologic Factors|immunologic factors|mesh-ancestor
101988347|NCT01212809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988348|NCT01212809|Viscosupplements|viscosupplements|mesh-ancestor
101988349|NCT01212809|Protective Agents|protective agents|mesh-ancestor
101988350|NCT01214993|Dolutegravir|dolutegravir|mesh-list
101988351|NCT01214993|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101988352|NCT01214993|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101988353|NCT01214993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101988399|NCT04961281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101988400|NCT04961281|Adrenergic Agents|adrenergic agents|mesh-ancestor
101988401|NCT04961281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101988403|NCT04961281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101988468|NCT01213121|Antidepressive Agents|antidepressive agents|mesh-ancestor
101988469|NCT01213121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101988470|NCT01213121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101988471|NCT01213121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101988472|NCT01213121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101988473|NCT01213121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988475|NCT01124435|Carboplatin|carboplatin|mesh-list
101988476|NCT01124435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101988479|NCT01124435|Analgesics|analgesics|mesh-ancestor
101988532|NCT03408873|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101988533|NCT03408873|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101988534|NCT03715101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101988535|NCT03715101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101988536|NCT03715101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101988537|NCT03715101|Antimetabolites|antimetabolites|mesh-ancestor
101988538|NCT03715101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988539|NCT03715101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101988541|NCT03715101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101988598|NCT03408483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988599|NCT03408483|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101988600|NCT03408483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101988601|NCT03408483|Autonomic Agents|autonomic agents|mesh-ancestor
101988602|NCT03408483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101988603|NCT03408483|Respiratory System Agents|respiratory system agents|mesh-ancestor
101988604|NCT03408483|Mydriatics|mydriatics|mesh-ancestor
101988605|NCT03408483|Sympathomimetics|sympathomimetics|mesh-ancestor
101988606|NCT03408483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101988607|NCT03408483|Narcotics|narcotics|mesh-ancestor
101988608|NCT03408483|Analgesics|analgesics|mesh-ancestor
101988609|NCT03777917|Hyaluronic Acid|hyaluronic acid|mesh-list
101988610|NCT03777917|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101988611|NCT03777917|Immunologic Factors|immunologic factors|mesh-ancestor
101988612|NCT03777917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988613|NCT03777917|Viscosupplements|viscosupplements|mesh-ancestor
101988614|NCT03777917|Protective Agents|protective agents|mesh-ancestor
101988616|NCT03715023|Antiviral Agents|antiviral agents|mesh-ancestor
101988617|NCT03715023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101988618|NCT03715023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101988619|NCT03715023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988620|NCT03714867|Pregabalin|pregabalin|mesh-list
101988653|NCT01217099|Glucocorticoids|glucocorticoids|mesh-ancestor
101988654|NCT01217099|Hormones|hormones|mesh-ancestor
101988655|NCT01217099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101988656|NCT01217099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101988657|NCT01217099|Protective Agents|protective agents|mesh-ancestor
101988658|NCT01217099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101988659|NCT01217099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101988660|NCT01217099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101988661|NCT01217099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101988662|NCT04305457|Nitric Oxide|nitric oxide|mesh-list
101988663|NCT04305457|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101988664|NCT04305457|Autonomic Agents|autonomic agents|mesh-ancestor
101988665|NCT04305457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101988666|NCT04305457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988667|NCT04305457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101988668|NCT04305457|Respiratory System Agents|respiratory system agents|mesh-ancestor
101988669|NCT04305457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101988670|NCT04305457|Antioxidants|antioxidants|mesh-ancestor
101988709|NCT02529059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101988710|NCT03100058|Licogliflozin|licogliflozin|mesh-list
101988711|NCT03100058|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101988712|NCT03100058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988713|NCT03100058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101988714|NCT03100058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988715|NCT03933761|Pamiparib|pamiparib|mesh-list
101988716|NCT03933761|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101988717|NCT03933761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101988718|NCT03933761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101988719|NCT03933761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101988720|NCT03932123|Vancomycin|vancomycin|mesh-list
101988721|NCT03932123|Meropenem|meropenem|mesh-list
101988768|NCT02735473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101988769|NCT02735473|Nootropic Agents|nootropic agents|mesh-ancestor
101988770|NCT04199767|Insulin|insulin|mesh-list
101988771|NCT04199767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101988772|NCT04199767|Insulin, Isophane|insulin, isophane|mesh-list
101988842|NCT04209686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101988843|NCT04209686|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101988844|NCT04209686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101988845|NCT01125215|Capsaicin|capsaicin|mesh-list
101988846|NCT01125215|Antipruritics|antipruritics|mesh-ancestor
101988847|NCT01125215|Dermatologic Agents|dermatologic agents|mesh-ancestor
101988848|NCT01125215|Sensory System Agents|sensory system agents|mesh-ancestor
101988849|NCT01125215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101988850|NCT01125215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101988851|NCT01217723|Thymoglobulin|thymoglobulin|mesh-list
101988852|NCT01217723|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101988853|NCT01217723|Immunologic Factors|immunologic factors|mesh-ancestor
101988856|NCT05162872|Niraparib|niraparib|mesh-list
101988905|NCT01127477|Plasma Substitutes|plasma substitutes|mesh-ancestor
101988906|NCT01127477|Blood Substitutes|blood substitutes|mesh-ancestor
101988907|NCT05281861|Lithium Carbonate|lithium carbonate|mesh-list
101988908|NCT05281861|Antidepressive Agents|antidepressive agents|mesh-ancestor
101988926|NCT03714555|Copper|copper|mesh-list
101340261|NCT00136747|Memantine|memantine|mesh-list
101988977|NCT02953821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101989049|NCT03931343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989051|NCT03931343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101989052|NCT03931343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101989119|NCT03471988|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101989120|NCT03471988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101989121|NCT03471988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101989122|NCT03471988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989123|NCT03471988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101989124|NCT03471988|Hormone Antagonists|hormone antagonists|mesh-ancestor
101989125|NCT03471988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101989126|NCT03471988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989127|NCT03471988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101989128|NCT03724981|Dulaglutide|dulaglutide|mesh-list
101989129|NCT03724981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101989130|NCT03724981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989177|NCT01217879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101989178|NCT01217879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989179|NCT01218035|Zoledronic Acid|zoledronic acid|mesh-list
101989180|NCT01218035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101989181|NCT01218035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989182|NCT04249310|Tiotropium Bromide|tiotropium bromide|mesh-list
101989183|NCT04249310|Olodaterol|olodaterol|mesh-list
101989184|NCT04249310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101989185|NCT04249310|Autonomic Agents|autonomic agents|mesh-ancestor
101989186|NCT04249310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101989187|NCT04249310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989188|NCT04249310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101989189|NCT04249310|Respiratory System Agents|respiratory system agents|mesh-ancestor
101989190|NCT04249310|Parasympatholytics|parasympatholytics|mesh-ancestor
101989191|NCT04249310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101989192|NCT04249310|Cholinergic Agents|cholinergic agents|mesh-ancestor
101989193|NCT04249310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101989194|NCT04249310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989195|NCT05665075|Cytarabine|cytarabine|mesh-list
101989196|NCT05665075|Cyclophosphamide|cyclophosphamide|mesh-list
101989197|NCT05665075|Fludarabine|fludarabine|mesh-list
101989198|NCT05665075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101989199|NCT05665075|Immunologic Factors|immunologic factors|mesh-ancestor
101989200|NCT05665075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989201|NCT05665075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101989202|NCT05665075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101989213|NCT03714165|Defensins|defensins|mesh-list
101989224|NCT03932825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101989225|NCT03932825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989295|NCT01123265|Dermatologic Agents|dermatologic agents|mesh-ancestor
101989296|NCT01123265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101989297|NCT01123265|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101989298|NCT01123265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101989299|NCT01123265|Immunologic Factors|immunologic factors|mesh-ancestor
101989300|NCT01123265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101989301|NCT01123265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101989302|NCT01204723|Aprepitant|aprepitant|mesh-list
101989303|NCT01204723|Fosaprepitant|fosaprepitant|mesh-list
101989304|NCT01204723|Antiemetics|antiemetics|mesh-ancestor
101989305|NCT01204723|Autonomic Agents|autonomic agents|mesh-ancestor
101989306|NCT01204723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101989307|NCT01204723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989308|NCT01204723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101989309|NCT01204723|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101989310|NCT01204723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101989311|NCT01204723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989352|NCT01220375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989353|NCT01220375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101989354|NCT01220375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101989355|NCT01220375|Antiviral Agents|antiviral agents|mesh-ancestor
101989356|NCT01220375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101989422|NCT01299181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101989423|NCT01299181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101989424|NCT01299181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101989426|NCT03930875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101989427|NCT03930875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101989428|NCT03930875|Analgesics|analgesics|mesh-ancestor
101989429|NCT03930875|Sensory System Agents|sensory system agents|mesh-ancestor
101989430|NCT03930875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101989431|NCT03930875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989432|NCT03930875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101989433|NCT03930875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101989484|NCT04173338|Pemetrexed|pemetrexed|mesh-list
101989485|NCT04173338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101989486|NCT04173338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101989488|NCT04173338|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101989553|NCT01224041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101989554|NCT01224041|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101989555|NCT01224041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101989556|NCT01224041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989699|NCT01218737|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101989700|NCT01218737|Prednisolone phosphate|prednisolone phosphate|mesh-list
101989773|NCT01127009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101989774|NCT01127009|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101989775|NCT01127009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101989776|NCT01127009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101989777|NCT01127009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989844|NCT01225913|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101989845|NCT01225913|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101989912|NCT01297855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101989913|NCT01297855|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101989914|NCT01297855|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101989915|NCT01297855|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101989916|NCT01297855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101989917|NCT02631070|Luspatercept|luspatercept|mesh-list
101989918|NCT02631070|Hematinics|hematinics|mesh-ancestor
101989919|NCT01298011|Paclitaxel|paclitaxel|mesh-list
101989920|NCT01298011|Gemcitabine|gemcitabine|mesh-list
101989921|NCT01298011|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101989922|NCT01298011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101989975|NCT03821623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101989976|NCT03821623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101989977|NCT03821623|Vasodilator Agents|vasodilator agents|mesh-ancestor
101989978|NCT03928145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101989979|NCT03928145|Chlorthalidone|chlorthalidone|mesh-list
101989980|NCT03928145|Amiloride|amiloride|mesh-list
101989982|NCT03928145|Diuretics|diuretics|mesh-ancestor
101990043|NCT04565392|Histamine Agents|histamine agents|mesh-ancestor
101990044|NCT04565392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101990045|NCT04565392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990046|NCT04565392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990047|NCT05654233|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
101990048|NCT05654233|Anticoagulants|anticoagulants|mesh-ancestor
101990049|NCT05654233|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101990050|NCT05654233|Antimetabolites|antimetabolites|mesh-ancestor
101990108|NCT05164198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101990109|NCT05164198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101990110|NCT05164198|Analgesics|analgesics|mesh-ancestor
101990111|NCT05164198|Sensory System Agents|sensory system agents|mesh-ancestor
101990112|NCT05164198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101990113|NCT05164198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990114|NCT05164198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101990115|NCT05164198|Immunologic Factors|immunologic factors|mesh-ancestor
101990116|NCT03740399|Anesthetics|anesthetics|mesh-list
101990119|NCT05160220|Psilocybin|psilocybin|mesh-list
101990174|NCT01226849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101990175|NCT01226849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990211|NCT05555121|Hormones|hormones|mesh-ancestor
101990245|NCT01301599|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
101990246|NCT01301599|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
101990247|NCT01301599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101990248|NCT01301599|Adrenergic Agents|adrenergic agents|mesh-ancestor
101990249|NCT01301599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101990250|NCT01301599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990251|NCT01301599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990252|NCT01301599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101990253|NCT01301599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101990254|NCT01301599|Hormone Antagonists|hormone antagonists|mesh-ancestor
101990271|NCT05533281|Hormones|hormones|mesh-ancestor
101990307|NCT03923231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101990308|NCT03923231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101990309|NCT03923231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101990311|NCT01227239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990312|NCT01301677|Hydrocortisone|hydrocortisone|mesh-list
101990313|NCT01301677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101990314|NCT02618980|Hemostatics|hemostatics|mesh-list
101990315|NCT02618980|Coagulants|coagulants|mesh-ancestor
101990316|NCT02613598|Bortezomib|bortezomib|mesh-list
101990317|NCT02613598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990318|NCT03718429|Rivaroxaban|rivaroxaban|mesh-list
101990319|NCT03718429|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101990320|NCT03718429|Antithrombins|antithrombins|mesh-ancestor
101990321|NCT03718429|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101990322|NCT03718429|Protease Inhibitors|protease inhibitors|mesh-ancestor
101990323|NCT03718429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101990324|NCT03718429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990325|NCT03718429|Anticoagulants|anticoagulants|mesh-ancestor
101990326|NCT01225523|Paclitaxel|paclitaxel|mesh-list
101990327|NCT01225523|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101990328|NCT01225523|Cisplatin|cisplatin|mesh-list
101990329|NCT01225523|Fluorouracil|fluorouracil|mesh-list
101990330|NCT01225523|Capecitabine|capecitabine|mesh-list
101990331|NCT01225523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101990360|NCT03813277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101990361|NCT03813277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101990362|NCT03813277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101990367|NCT03815461|Paclitaxel|paclitaxel|mesh-list
101990431|NCT01560091|Adrenergic Agents|adrenergic agents|mesh-ancestor
101990432|NCT01560091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101990433|NCT01560091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990434|NCT01560091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990435|NCT01560091|Urological Agents|urological agents|mesh-ancestor
101990436|NCT03382041|Carbon Fiber|carbon fiber|mesh-list
101990437|NCT03382041|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101990438|NCT03382041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101990439|NCT03807271|Anesthetics|anesthetics|mesh-list
101990440|NCT03807271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101990441|NCT03807271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990442|NCT03812731|Fentanyl|fentanyl|mesh-list
101990443|NCT03812731|Ropivacaine|ropivacaine|mesh-list
101990444|NCT03812731|Anesthetics, Local|anesthetics, local|mesh-ancestor
101990445|NCT03812731|Anesthetics|anesthetics|mesh-ancestor
101990448|NCT03812731|Sensory System Agents|sensory system agents|mesh-ancestor
101990491|NCT05165914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101990492|NCT05165914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101990564|NCT01131689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101990565|NCT01131689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990566|NCT03401229|Mometasone Furoate|mometasone furoate|mesh-list
101990567|NCT03401229|Benralizumab|benralizumab|mesh-list
101990568|NCT03401229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101990569|NCT03401229|Dermatologic Agents|dermatologic agents|mesh-ancestor
101990570|NCT03401229|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101990571|NCT03401229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101990572|NCT03401229|Respiratory System Agents|respiratory system agents|mesh-ancestor
101990573|NCT05435053|Nivolumab|nivolumab|mesh-list
101990574|NCT05435053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101990575|NCT05435053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990576|NCT05435053|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101990577|NCT05435053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990578|NCT01132391|Nitroglycerin|nitroglycerin|mesh-list
101990579|NCT01132391|Vasodilator Agents|vasodilator agents|mesh-ancestor
101990580|NCT05281081|Morphine|morphine|mesh-list
101990581|NCT05281081|Levobupivacaine|levobupivacaine|mesh-list
101990582|NCT05281081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101990583|NCT05281081|Narcotics|narcotics|mesh-ancestor
101990586|NCT05281081|Analgesics|analgesics|mesh-ancestor
101990615|NCT01227941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101990616|NCT01227941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101990617|NCT01227941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990618|NCT01227941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101990619|NCT03919565|Tenofovir|tenofovir|mesh-list
101990620|NCT03919565|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101990621|NCT03919565|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101990622|NCT03919565|Antiviral Agents|antiviral agents|mesh-ancestor
101990623|NCT03919565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101990624|NCT03919565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101990630|NCT03380091|Vitamin D|vitamin d|mesh-list
101990680|NCT03804541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101990681|NCT03804541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101990682|NCT03804541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990753|NCT04453930|Apatinib|apatinib|mesh-list
101990754|NCT04453930|Antibodies|antibodies|mesh-list
101990755|NCT04453930|Immunologic Factors|immunologic factors|mesh-ancestor
101990756|NCT04453930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101990757|NCT04453930|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101990758|NCT04453930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101990759|NCT04453930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101990760|NCT04453930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990761|NCT04453930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990762|NCT04453930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101990763|NCT03796507|Temozolomide|temozolomide|mesh-list
101990764|NCT03796507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101990765|NCT03796507|Alkylating Agents|alkylating agents|mesh-ancestor
101990766|NCT03796507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990767|NCT03796507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990768|NCT04586062|Plasminogen|plasminogen|mesh-list
101990769|NCT04586062|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101990770|NCT04586062|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101990771|NCT04586062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990772|NCT01132781|Theophylline|theophylline|mesh-list
101990807|NCT01134341|10-deazaaminopterin|10-deazaaminopterin|mesh-list
101990884|NCT04211272|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101990885|NCT04211272|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101990891|NCT05402189|Fentanyl|fentanyl|mesh-list
101990955|NCT03921671|Carboplatin|carboplatin|mesh-list
101990956|NCT03921671|Ramucirumab|ramucirumab|mesh-list
101990957|NCT03921671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101990958|NCT03921671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101990959|NCT03921671|Tubulin Modulators|tubulin modulators|mesh-ancestor
101990960|NCT03921671|Antimitotic Agents|antimitotic agents|mesh-ancestor
101990961|NCT03921671|Mitosis Modulators|mitosis modulators|mesh-ancestor
101990962|NCT03921671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101990963|NCT03921593|Pancrelipase|pancrelipase|mesh-list
101990964|NCT03921593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101990965|NCT03369951|Minocycline|minocycline|mesh-list
101990966|NCT03369951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101990967|NCT03369951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101990968|NCT01131767|Naproxen|naproxen|mesh-list
101990969|NCT01131767|Pseudoephedrine|pseudoephedrine|mesh-list
101990970|NCT01131767|Ephedrine|ephedrine|mesh-list
101990971|NCT01131767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101990972|NCT01131767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101991014|NCT05481489|Parasympatholytics|parasympatholytics|mesh-ancestor
101991015|NCT05481489|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101991016|NCT05481489|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101991087|NCT03368859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991160|NCT01135199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101991161|NCT01135199|Growth Substances|growth substances|mesh-ancestor
101991162|NCT01135199|Growth Inhibitors|growth inhibitors|mesh-ancestor
101991163|NCT01135199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101991164|NCT03917537|Nivolumab|nivolumab|mesh-list
101991165|NCT03917537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101991229|NCT03810391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101991230|NCT03810391|Antitussive Agents|antitussive agents|mesh-ancestor
101991231|NCT03810391|Respiratory System Agents|respiratory system agents|mesh-ancestor
101991305|NCT01304797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991306|NCT01304797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101991307|NCT01304797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101991308|NCT01304797|Alkylating Agents|alkylating agents|mesh-ancestor
101991309|NCT01304797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991310|NCT01304797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101991311|NCT01304797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101991312|NCT01304797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101991368|NCT03920813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991369|NCT03920813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101991370|NCT03920813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101991373|NCT01649947|Bevacizumab|bevacizumab|mesh-list
101991374|NCT01649947|Carboplatin|carboplatin|mesh-list
101991375|NCT01649947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101991376|NCT01649947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101991377|NCT01649947|Tubulin Modulators|tubulin modulators|mesh-ancestor
101991378|NCT01649947|Antimitotic Agents|antimitotic agents|mesh-ancestor
101991379|NCT01649947|Mitosis Modulators|mitosis modulators|mesh-ancestor
101991380|NCT01649947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991431|NCT03707457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101991432|NCT03707457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991433|NCT01568294|Pomalidomide|pomalidomide|mesh-list
101991434|NCT01568294|Immunologic Factors|immunologic factors|mesh-ancestor
101991435|NCT01568294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991436|NCT01568294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101991437|NCT01568294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101991438|NCT01568294|Growth Substances|growth substances|mesh-ancestor
101991439|NCT01568294|Growth Inhibitors|growth inhibitors|mesh-ancestor
101991496|NCT01233245|Antiviral Agents|antiviral agents|mesh-ancestor
101991497|NCT01233245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101991498|NCT01233245|Immunologic Factors|immunologic factors|mesh-ancestor
101991499|NCT01233245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991501|NCT03776812|Paclitaxel|paclitaxel|mesh-list
101991566|NCT01134185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991567|NCT01134185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991568|NCT03829046|Evolocumab|evolocumab|mesh-list
101991569|NCT03829046|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101991570|NCT03829046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101991571|NCT03829046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101991572|NCT03829046|Antimetabolites|antimetabolites|mesh-ancestor
101991573|NCT03829046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991574|NCT03829046|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101991575|NCT03829046|Protease Inhibitors|protease inhibitors|mesh-ancestor
101991576|NCT03829046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101991594|NCT05306704|Vitamins|vitamins|mesh-ancestor
101340314|NCT00393198|Oxytocics|oxytocics|mesh-ancestor
101991630|NCT05278858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101991631|NCT05278858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991632|NCT03792217|Sodium Hypochlorite|sodium hypochlorite|mesh-list
101991633|NCT03792217|Eusol|eusol|mesh-list
101991634|NCT03792217|Disinfectants|disinfectants|mesh-ancestor
101991699|NCT01135433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101991700|NCT01135433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991701|NCT01135433|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101991702|NCT01135433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991703|NCT04745273|Ondansetron|ondansetron|mesh-list
101991704|NCT04745273|Antiemetics|antiemetics|mesh-ancestor
101991769|NCT01140737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101991770|NCT01140737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101991771|NCT01140737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101991772|NCT01140737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991773|NCT05594095|Everolimus|everolimus|mesh-list
101991775|NCT05594095|Goserelin|goserelin|mesh-list
101991840|NCT01138553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101991841|NCT01138553|Contraceptive Agents|contraceptive agents|mesh-ancestor
101991842|NCT01138553|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101991843|NCT01138553|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101991844|NCT01138553|Hormone Antagonists|hormone antagonists|mesh-ancestor
101991845|NCT01138553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101991846|NCT01138553|Luteolytic Agents|luteolytic agents|mesh-ancestor
101991847|NCT01138553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101991848|NCT01138553|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101991904|NCT03446638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101991905|NCT03446638|Immunologic Factors|immunologic factors|mesh-ancestor
101991906|NCT03446638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991907|NCT05401019|Pramipexole|pramipexole|mesh-list
101991908|NCT05401019|Risperidone|risperidone|mesh-list
101991909|NCT05401019|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101991910|NCT05401019|Serotonin Agents|serotonin agents|mesh-ancestor
101991911|NCT05401019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101991912|NCT05401019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101991913|NCT05401019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991929|NCT03788863|Hormones|hormones|mesh-ancestor
101991966|NCT03445780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101991967|NCT03445780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101991968|NCT03445780|Sensory System Agents|sensory system agents|mesh-ancestor
101991969|NCT03445780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101991970|NCT05364099|Triamcinolone|triamcinolone|mesh-list
101991971|NCT05364099|Lidocaine|lidocaine|mesh-list
101991972|NCT05364099|Anesthetics, Local|anesthetics, local|mesh-ancestor
101992036|NCT03791827|Immunologic Factors|immunologic factors|mesh-ancestor
101992037|NCT03791827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992038|NCT03791827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101992046|NCT03791827|Glucocorticoids|glucocorticoids|mesh-ancestor
101992106|NCT01308229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992107|NCT03445078|Selenium|selenium|mesh-list
101992108|NCT03445078|Antioxidants|antioxidants|mesh-ancestor
101992109|NCT03445078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992177|NCT03706755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992178|NCT03706755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992179|NCT03706755|Sympathomimetics|sympathomimetics|mesh-ancestor
101992180|NCT03706755|Autonomic Agents|autonomic agents|mesh-ancestor
101992181|NCT03706755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101992248|NCT01305733|Sympathomimetics|sympathomimetics|mesh-ancestor
101992250|NCT05210153|Sertraline|sertraline|mesh-list
101992320|NCT05280444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101992321|NCT05280444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101992322|NCT05280444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101992393|NCT05283499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
101992394|NCT05283499|Narcotics|narcotics|mesh-ancestor
101992395|NCT05283499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101992397|NCT05283499|Sensory System Agents|sensory system agents|mesh-ancestor
101992464|NCT01233947|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101992536|NCT03788317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101992537|NCT03788317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992538|NCT03788317|Cholinergic Agents|cholinergic agents|mesh-ancestor
101992539|NCT03788317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101992608|NCT05605639|Sensory System Agents|sensory system agents|mesh-ancestor
101992609|NCT05605639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101992611|NCT03790345|Vitamin B 12|vitamin b 12|mesh-list
101992612|NCT03790345|Pyridoxine|pyridoxine|mesh-list
101992613|NCT03790345|Vitamin B 6|vitamin b 6|mesh-list
101992614|NCT03790345|Vitamin B Complex|vitamin b complex|mesh-list
101992615|NCT03790345|Micronutrients|micronutrients|mesh-ancestor
101992616|NCT03790345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992617|NCT05416190|Anticoagulants|anticoagulants|mesh-list
101992618|NCT05416190|Lupus Coagulation Inhibitor|lupus coagulation inhibitor|mesh-list
101992619|NCT05416190|Immunologic Factors|immunologic factors|mesh-ancestor
101992620|NCT05416190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992621|NCT04454788|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101992622|NCT04454788|Tenecteplase|tenecteplase|mesh-list
101992623|NCT04454788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101992624|NCT04454788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101992625|NCT04454788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992626|NCT04862650|Paclitaxel|paclitaxel|mesh-list
101992627|NCT04862650|Carboplatin|carboplatin|mesh-list
101992628|NCT04862650|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101992629|NCT04862650|Cemiplimab|cemiplimab|mesh-list
101992630|NCT04862650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101992631|NCT04862650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101992632|NCT04862650|Tubulin Modulators|tubulin modulators|mesh-ancestor
101992662|NCT01309009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101992663|NCT01309009|Autonomic Agents|autonomic agents|mesh-ancestor
101992664|NCT01309009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101992665|NCT01309009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992666|NCT01309009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101992667|NCT01309009|Respiratory System Agents|respiratory system agents|mesh-ancestor
101992668|NCT03339453|Glucagon|glucagon|mesh-list
101992669|NCT03339453|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101992670|NCT03339453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101992671|NCT03339453|Hormones|hormones|mesh-ancestor
101992672|NCT03339453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101992673|NCT03339453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101992674|NCT03339453|Incretins|incretins|mesh-ancestor
101992675|NCT05418686|Colchicine|colchicine|mesh-list
101992724|NCT05234697|Sensory System Agents|sensory system agents|mesh-ancestor
101992725|NCT05234697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101992726|NCT03490760|Durvalumab|durvalumab|mesh-list
101992727|NCT03490760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101992794|NCT02989402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101992796|NCT02989402|Cholinergic Agents|cholinergic agents|mesh-ancestor
101992866|NCT05694871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101992867|NCT05694871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101992868|NCT05694871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101992869|NCT05694871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101992870|NCT03359850|Niraparib|niraparib|mesh-list
101992936|NCT03130348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101992938|NCT03130348|Protease Inhibitors|protease inhibitors|mesh-ancestor
101993009|NCT05438992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101993010|NCT05438992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993011|NCT05438992|Sensory System Agents|sensory system agents|mesh-ancestor
101993013|NCT05361486|Primaquine|primaquine|mesh-list
101993082|NCT05215431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993083|NCT05215431|Protective Agents|protective agents|mesh-ancestor
101993084|NCT05215431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993086|NCT03706950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101993087|NCT03706950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101993088|NCT03706950|Antiviral Agents|antiviral agents|mesh-ancestor
101993089|NCT03706950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101993150|NCT04394481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101993151|NCT04394481|Adrenergic Agents|adrenergic agents|mesh-ancestor
101993152|NCT04394481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101993153|NCT04394481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993154|NCT04394481|Anesthetics, Local|anesthetics, local|mesh-ancestor
101993155|NCT04394481|Anesthetics|anesthetics|mesh-ancestor
101993156|NCT03782935|Choline|choline|mesh-list
101993157|NCT03782935|Lipotropic Agents|lipotropic agents|mesh-ancestor
101993158|NCT03782935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101993159|NCT03782935|Antimetabolites|antimetabolites|mesh-ancestor
101993161|NCT03782935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101993216|NCT01309789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101340419|NCT00137566|Acetaminophen|acetaminophen|mesh-list
101993217|NCT01309789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101993218|NCT01309789|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101993219|NCT01309789|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101993220|NCT01309789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101993221|NCT01309789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101993222|NCT01309789|Glucocorticoids|glucocorticoids|mesh-ancestor
101993223|NCT01309789|Hormones|hormones|mesh-ancestor
101993224|NCT01309789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101993225|NCT01309789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101993226|NCT01309789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101993277|NCT03781843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993278|NCT03781843|Sensory System Agents|sensory system agents|mesh-ancestor
101993279|NCT03781843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101993280|NCT03781843|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101993345|NCT05598242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101993359|NCT03787069|Lidocaine|lidocaine|mesh-list
101993419|NCT05598086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101993420|NCT05598086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993494|NCT03468010|Mitosis Modulators|mitosis modulators|mesh-ancestor
101993495|NCT03468010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993496|NCT03337152|Chloroquine|chloroquine|mesh-list
101993498|NCT03337152|Amebicides|amebicides|mesh-ancestor
101993499|NCT03337152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101993500|NCT03337152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101993501|NCT03337152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101993502|NCT03337152|Antimalarials|antimalarials|mesh-ancestor
101993503|NCT03337152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101993504|NCT03467620|Cannabidiol|cannabidiol|mesh-list
101993505|NCT03467620|Anticonvulsants|anticonvulsants|mesh-ancestor
101993506|NCT03780205|Methamphetamine|methamphetamine|mesh-list
101993507|NCT03780205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101993508|NCT03780205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993509|NCT03780205|Sympathomimetics|sympathomimetics|mesh-ancestor
101993510|NCT03780205|Autonomic Agents|autonomic agents|mesh-ancestor
101993511|NCT03780205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101993551|NCT02761070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101993552|NCT02761070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101993553|NCT02761070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101993554|NCT02761070|Growth Substances|growth substances|mesh-ancestor
101993560|NCT03090152|Bupivacaine|bupivacaine|mesh-list
101993619|NCT03780361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101993621|NCT05183646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101993622|NCT05183646|Interferon Inducers|interferon inducers|mesh-ancestor
101993693|NCT03780049|Micronutrients|micronutrients|mesh-ancestor
101713495|NCT00866918|Vitamins|vitamins|mesh-list
101993695|NCT04252287|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101993768|NCT05073744|Sensory System Agents|sensory system agents|mesh-ancestor
101993769|NCT05073744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101993770|NCT05681598|Hydroxyurea|hydroxyurea|mesh-list
101993771|NCT05681598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101993777|NCT01312350|Fluorouracil|fluorouracil|mesh-list
101993840|NCT03462940|Antiviral Agents|antiviral agents|mesh-ancestor
101993841|NCT03462940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101993842|NCT03462940|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101993843|NCT03462940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101993844|NCT03011450|Fenofibrate|fenofibrate|mesh-list
101993845|NCT03011450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101713648|NCT00861614|Ipilimumab|ipilimumab|mesh-list
101993846|NCT03011450|Antimetabolites|antimetabolites|mesh-ancestor
101993847|NCT03011450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993906|NCT01383668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101993907|NCT01383668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101993908|NCT01383668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101993909|NCT01383668|Antifungal Agents|antifungal agents|mesh-ancestor
101993910|NCT01383668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101993911|NCT01383668|Immunologic Factors|immunologic factors|mesh-ancestor
101993912|NCT01383668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993913|NCT01383668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101993914|NCT03656068|Nitazoxanide|nitazoxanide|mesh-list
101993915|NCT03656068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101993916|NCT03656068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101993917|NCT01381796|Sumatriptan|sumatriptan|mesh-list
101993918|NCT01381796|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101993919|NCT01381796|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101993920|NCT01381796|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101993921|NCT01381796|Serotonin Agents|serotonin agents|mesh-ancestor
101993922|NCT01381796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101993923|NCT01381796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101993924|NCT01381796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993925|NCT04375228|Rituximab|rituximab|mesh-list
101993926|NCT04375228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101993927|NCT04375228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101993928|NCT04375228|Immunologic Factors|immunologic factors|mesh-ancestor
101993929|NCT04375228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449026|NCT00189995|Haloperidol|haloperidol|mesh-list
101601076|NCT01104779|Cariprazine|cariprazine|mesh-list
101601077|NCT01104779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101601078|NCT01104779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101601079|NCT01104779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101601086|NCT04308161|Miconazole|miconazole|mesh-list
101601087|NCT04308161|Vitamins|vitamins|mesh-ancestor
101601088|NCT04308161|Micronutrients|micronutrients|mesh-ancestor
101601089|NCT04308161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601090|NCT04308161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101601091|NCT04308161|Antifungal Agents|antifungal agents|mesh-ancestor
101601092|NCT04308161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101601093|NCT04308161|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101601094|NCT04308161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101601095|NCT04308161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101601096|NCT04308161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601097|NCT04308161|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101601098|NCT04308161|Hormone Antagonists|hormone antagonists|mesh-ancestor
101601099|NCT04308161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101601100|NCT04308161|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101601101|NCT04308161|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101601102|NCT04939467|Pirfenidone|pirfenidone|mesh-list
101601103|NCT04939467|Nintedanib|nintedanib|mesh-list
101601104|NCT04939467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101601105|NCT04939467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101601106|NCT04939467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101993930|NCT04375228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101993931|NCT02521714|Lenalidomide|lenalidomide|mesh-list
101993932|NCT02521714|Immunologic Factors|immunologic factors|mesh-ancestor
101993933|NCT02521714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993934|NCT02521714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101993935|NCT02521714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101993936|NCT02521714|Growth Substances|growth substances|mesh-ancestor
101993937|NCT02521714|Growth Inhibitors|growth inhibitors|mesh-ancestor
101993939|NCT03768089|Ivacaftor|ivacaftor|mesh-list
101993996|NCT05068037|Autonomic Agents|autonomic agents|mesh-ancestor
101993997|NCT05068037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101993998|NCT05068037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101993999|NCT05068037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101994000|NCT01136759|Tenofovir|tenofovir|mesh-list
101994001|NCT01136759|Antiviral Agents|antiviral agents|mesh-ancestor
101994002|NCT01136759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101994003|NCT01136759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101994004|NCT01136759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101994005|NCT01136759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101994006|NCT01136759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994007|NCT01136759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101994008|NCT01136759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101994009|NCT01141439|Fluticasone|fluticasone|mesh-list
101994010|NCT01141439|Xhance|xhance|mesh-list
101994011|NCT01141439|Beclomethasone|beclomethasone|mesh-list
101994012|NCT01141439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101994013|NCT01141439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101994014|NCT01141439|Autonomic Agents|autonomic agents|mesh-ancestor
101994015|NCT01141439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101994016|NCT01141439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994017|NCT01141439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101994018|NCT01141439|Respiratory System Agents|respiratory system agents|mesh-ancestor
101994019|NCT01141439|Dermatologic Agents|dermatologic agents|mesh-ancestor
101994045|NCT01232777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101994046|NCT01232777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101994047|NCT01232777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101994048|NCT01232777|Growth Substances|growth substances|mesh-ancestor
101994049|NCT01232777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994050|NCT01232777|Growth Inhibitors|growth inhibitors|mesh-ancestor
101994051|NCT03248271|Insulin Lispro|insulin lispro|mesh-list
101994052|NCT03248271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101994053|NCT03248271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994054|NCT04213677|Dapagliflozin|dapagliflozin|mesh-list
101994055|NCT04213677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101994056|NCT04213677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994057|NCT04213677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101994058|NCT04213677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994059|NCT03247036|Fibrinolytic Agents|fibrinolytic agents|mesh-list
101994102|NCT02943993|Anticoagulants|anticoagulants|mesh-ancestor
101994104|NCT02620150|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101994105|NCT02620150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101994106|NCT02620150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101994107|NCT02620150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994108|NCT02620150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101994109|NCT02620150|Serotonin Agents|serotonin agents|mesh-ancestor
101994110|NCT02620150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994111|NCT04098302|Dutasteride|dutasteride|mesh-list
101994166|NCT03443518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101994167|NCT01142843|Propolis|propolis|mesh-list
101994168|NCT01142843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101994169|NCT04330625|Volagidemab|volagidemab|mesh-list
101994239|NCT03441412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101994240|NCT03441412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101994241|NCT03441412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101994242|NCT03441412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101994243|NCT03441412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101994247|NCT03441412|Sympatholytics|sympatholytics|mesh-ancestor
101994308|NCT03532451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101994309|NCT03532451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101994310|NCT03532451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101994383|NCT04678479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101994384|NCT04678479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994385|NCT04678479|GABA Modulators|gaba modulators|mesh-ancestor
101994454|NCT05016076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101994455|NCT05016076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994456|NCT05016076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101994457|NCT05016076|Glucocorticoids|glucocorticoids|mesh-ancestor
101994458|NCT05016076|Hormones|hormones|mesh-ancestor
101994459|NCT05016076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101994460|NCT05016076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101994461|NCT05016076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101994462|NCT03319953|Antipsychotic Agents|antipsychotic agents|mesh-list
101994463|NCT03319953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101994464|NCT03319953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101994516|NCT03319667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101994517|NCT03319667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994592|NCT03110510|Vitamins|vitamins|mesh-ancestor
101994593|NCT03110510|Micronutrients|micronutrients|mesh-ancestor
101994594|NCT01238237|Cetuximab|cetuximab|mesh-list
101994595|NCT01238237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101340455|NCT00137995|Etoposide|etoposide|mesh-list
101994663|NCT04460183|Autonomic Agents|autonomic agents|mesh-ancestor
101994664|NCT04460183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101994665|NCT04460183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994734|NCT01146509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101994735|NCT01146509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994736|NCT01146509|Nootropic Agents|nootropic agents|mesh-ancestor
101994737|NCT03775993|Hormones|hormones|mesh-list
101994739|NCT03775993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101994803|NCT01321021|Promethazine|promethazine|mesh-list
101994805|NCT01321021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101994875|NCT01143545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101994876|NCT01143545|Analgesics|analgesics|mesh-ancestor
101994877|NCT01143545|Sensory System Agents|sensory system agents|mesh-ancestor
101994878|NCT01143545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101994949|NCT01245959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101994950|NCT01245959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101994951|NCT01245959|Immunologic Factors|immunologic factors|mesh-ancestor
101995022|NCT03113123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101995023|NCT03113123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101995024|NCT03113123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101995027|NCT03113123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101995089|NCT01146041|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101995090|NCT01146041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101995092|NCT01146041|Cholinergic Agents|cholinergic agents|mesh-ancestor
101995160|NCT03434704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101995161|NCT02521636|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101995162|NCT02521636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101995163|NCT04779151|Niraparib|niraparib|mesh-list
101995164|NCT04779151|Dostarlimab|dostarlimab|mesh-list
101995229|NCT02521246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995230|NCT02521246|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101995231|NCT02521246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101995301|NCT03770923|Hormone Antagonists|hormone antagonists|mesh-ancestor
101995302|NCT03770923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101995303|NCT03770923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995304|NCT03770923|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101995305|NCT03770923|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101995306|NCT03770923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995368|NCT02944656|Analgesics|analgesics|mesh-ancestor
101995369|NCT02944656|Sensory System Agents|sensory system agents|mesh-ancestor
101995370|NCT02944656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101995438|NCT03746041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101995439|NCT03746041|Growth Substances|growth substances|mesh-ancestor
101995440|NCT03746041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995441|NCT03746041|Growth Inhibitors|growth inhibitors|mesh-ancestor
101995442|NCT03746041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101995443|NCT01236989|Liver Extracts|liver extracts|mesh-list
101995444|NCT01236989|Hematinics|hematinics|mesh-ancestor
101995445|NCT03423472|Vitamin A|vitamin a|mesh-list
101995446|NCT03423472|Vitamins|vitamins|mesh-ancestor
101995447|NCT03423472|Micronutrients|micronutrients|mesh-ancestor
101995448|NCT03423472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995449|NCT01239563|Thymoglobulin|thymoglobulin|mesh-list
101995450|NCT01239563|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101995451|NCT01239563|Basiliximab|basiliximab|mesh-list
101995452|NCT01239563|Immunologic Factors|immunologic factors|mesh-ancestor
101995455|NCT01321255|Aspirin|aspirin|mesh-list
101995500|NCT01883297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101995501|NCT04546581|Remdesivir|remdesivir|mesh-list
101995502|NCT04546581|Immunoglobulins|immunoglobulins|mesh-list
101995503|NCT04546581|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101995504|NCT04546581|Antibodies|antibodies|mesh-list
101995505|NCT04546581|Immunologic Factors|immunologic factors|mesh-ancestor
101995506|NCT04546581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995507|NCT04546581|Antimetabolites|antimetabolites|mesh-ancestor
101995572|NCT02561273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101995573|NCT02561273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101995574|NCT02561273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101995575|NCT02561273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101995576|NCT02561273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101995577|NCT02561273|Glucocorticoids|glucocorticoids|mesh-ancestor
101995579|NCT02561273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101995591|NCT02521012|Vitamin D|vitamin d|mesh-list
101995641|NCT01144091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995642|NCT01144091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101995643|NCT01144091|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101995644|NCT01144091|Protective Agents|protective agents|mesh-ancestor
101995645|NCT01144091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995646|NCT01144091|Vasodilator Agents|vasodilator agents|mesh-ancestor
101995647|NCT01144091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101995711|NCT00458003|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101995712|NCT00458003|Nasal Decongestants|nasal decongestants|mesh-ancestor
101995713|NCT00458003|Respiratory System Agents|respiratory system agents|mesh-ancestor
101995714|NCT00458003|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101995715|NCT00458003|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101995716|NCT00458003|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101995717|NCT00458003|Adrenergic Agents|adrenergic agents|mesh-ancestor
101995718|NCT00458003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101995720|NCT00458003|Protective Agents|protective agents|mesh-ancestor
101995779|NCT03761485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995780|NCT03766867|Vortioxetine|vortioxetine|mesh-list
101995850|NCT03415750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101995851|NCT03415750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101995852|NCT03415750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101995853|NCT03415750|Antitubercular Agents|antitubercular agents|mesh-ancestor
101995854|NCT03415750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101995855|NCT03415750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101995856|NCT01239719|Clemastine|clemastine|mesh-list
101995857|NCT01239719|Dexamethasone|dexamethasone|mesh-list
101995858|NCT01239719|Dexamethasone acetate|dexamethasone acetate|mesh-list
101995859|NCT01239719|BB 1101|bb 1101|mesh-list
101995860|NCT01239719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101995861|NCT01239719|Antiemetics|antiemetics|mesh-ancestor
101995862|NCT01239719|Autonomic Agents|autonomic agents|mesh-ancestor
101995865|NCT01239719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101995913|NCT03426202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995914|NCT01248299|Cisplatin|cisplatin|mesh-list
101995915|NCT01248299|Docetaxel|docetaxel|mesh-list
101995916|NCT01248299|Oxaliplatin|oxaliplatin|mesh-list
101995917|NCT01248299|Fluorouracil|fluorouracil|mesh-list
101995918|NCT01248299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101995919|NCT01248299|Tubulin Modulators|tubulin modulators|mesh-ancestor
101995920|NCT01248299|Antimitotic Agents|antimitotic agents|mesh-ancestor
101995921|NCT01248299|Mitosis Modulators|mitosis modulators|mesh-ancestor
101995922|NCT01248299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101995923|NCT01248299|Antimetabolites|antimetabolites|mesh-ancestor
101995924|NCT01248299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101995925|NCT01248299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101995926|NCT01248299|Immunologic Factors|immunologic factors|mesh-ancestor
101995927|NCT01248299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101995928|NCT01239875|Vaccines|vaccines|mesh-list
101995972|NCT03620838|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
101995973|NCT03620838|Progesterone|progesterone|mesh-list
101995974|NCT03620838|Progestins|progestins|mesh-ancestor
101995975|NCT03620838|Hormones|hormones|mesh-ancestor
101995978|NCT03620838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101996044|NCT02327455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996045|NCT02327455|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101996046|NCT02327455|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101996047|NCT02327455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101996048|NCT02327455|Adrenergic Agents|adrenergic agents|mesh-ancestor
101996049|NCT02327455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101996050|NCT02327455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996051|NCT02327455|Protective Agents|protective agents|mesh-ancestor
101996052|NCT03638076|Ritonavir|ritonavir|mesh-list
101996053|NCT03638076|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101996054|NCT03638076|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101996055|NCT03638076|Protease Inhibitors|protease inhibitors|mesh-ancestor
101996056|NCT03638076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101996057|NCT03638076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996058|NCT03638076|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101996059|NCT03638076|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101996060|NCT03638076|Antiviral Agents|antiviral agents|mesh-ancestor
101996061|NCT03638076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101996062|NCT03638076|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101996063|NCT03638076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101996064|NCT01329731|Olaflur|olaflur|mesh-list
101996065|NCT01329731|Cariostatic Agents|cariostatic agents|mesh-ancestor
101996066|NCT01329731|Protective Agents|protective agents|mesh-ancestor
101996067|NCT01329731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996068|NCT03765697|Lidocaine|lidocaine|mesh-list
101996069|NCT03765697|Anesthetics, Local|anesthetics, local|mesh-ancestor
101996070|NCT03765697|Anesthetics|anesthetics|mesh-ancestor
101996071|NCT03765697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101996072|NCT03765697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996073|NCT03765697|Sensory System Agents|sensory system agents|mesh-ancestor
101996074|NCT03765697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101996075|NCT03765697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101996076|NCT03765697|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101996077|NCT03765697|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101996078|NCT03765697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101996081|NCT03311841|Midazolam|midazolam|mesh-list
101996082|NCT03311841|Dabigatran|dabigatran|mesh-list
101996083|NCT03311841|Atorvastatin|atorvastatin|mesh-list
101996084|NCT03311841|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101996085|NCT03311841|Pitavastatin|pitavastatin|mesh-list
101996086|NCT03311841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101996136|NCT01249937|Hormones|hormones|mesh-ancestor
101996149|NCT02528201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996150|NCT02528201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101996151|NCT02528201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101996152|NCT02528201|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101996219|NCT03764527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101996220|NCT03764527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101996221|NCT03764527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101996222|NCT03764527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101996291|NCT03759067|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101996292|NCT03759067|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101996293|NCT03759067|Purinergic Agents|purinergic agents|mesh-ancestor
101996294|NCT03759067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101996295|NCT03759067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996360|NCT03424876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101996361|NCT03424876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101996362|NCT03424876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101996363|NCT03424876|Growth Substances|growth substances|mesh-ancestor
101996364|NCT03424876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996365|NCT03424876|Growth Inhibitors|growth inhibitors|mesh-ancestor
101996366|NCT03424876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101996367|NCT03424876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101996368|NCT03424876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996369|NCT03476577|Ibuprofen|ibuprofen|mesh-list
101996370|NCT03476577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101996371|NCT03476577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101996372|NCT03476577|Analgesics|analgesics|mesh-ancestor
101996373|NCT03476577|Sensory System Agents|sensory system agents|mesh-ancestor
101996420|NCT03413020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101996421|NCT03413020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101996422|NCT03413020|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101996423|NCT03413020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101996424|NCT03413020|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101996425|NCT03413020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101996426|NCT03413020|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101996427|NCT03413020|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101996428|NCT03413020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101996429|NCT03413020|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101996430|NCT03413020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101996431|NCT03413020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101996432|NCT03413020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101996481|NCT03412552|Analgesics|analgesics|mesh-ancestor
101996482|NCT03412552|Sensory System Agents|sensory system agents|mesh-ancestor
101996483|NCT03412552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101996484|NCT03412552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996485|NCT03412552|Anesthetics|anesthetics|mesh-ancestor
101996486|NCT03412552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101996487|NCT03412552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101996488|NCT03412552|Anticonvulsants|anticonvulsants|mesh-ancestor
101996489|NCT03412552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101996490|NCT03412552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101996491|NCT03412552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996492|NCT03412552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101996493|NCT03412552|Tocolytic Agents|tocolytic agents|mesh-ancestor
101996494|NCT03412552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101996495|NCT03412474|Acetaminophen|acetaminophen|mesh-list
101996496|NCT03412474|Dexmedetomidine|dexmedetomidine|mesh-list
101996497|NCT03412474|Bupivacaine|bupivacaine|mesh-list
101996498|NCT03412474|Anesthetics, Local|anesthetics, local|mesh-ancestor
101996499|NCT03412474|Anesthetics|anesthetics|mesh-ancestor
101996500|NCT03412474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101996501|NCT03412474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996502|NCT03412474|Sensory System Agents|sensory system agents|mesh-ancestor
101996533|NCT04447612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996534|NCT04447612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101996535|NCT03418558|Trastuzumab|trastuzumab|mesh-list
101996536|NCT03418558|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101996537|NCT03418558|Maytansine|maytansine|mesh-list
101996538|NCT03418558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101996600|NCT03410836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101996601|NCT03410836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996603|NCT03410836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101996609|NCT03273153|Pembrolizumab|pembrolizumab|mesh-list
101996669|NCT05215990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996670|NCT03268941|Metoclopramide|metoclopramide|mesh-list
101996671|NCT03268941|Maleic acid|maleic acid|mesh-list
101996672|NCT03268941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101996673|NCT03268941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996674|NCT03268941|Antiemetics|antiemetics|mesh-ancestor
101996675|NCT03268941|Autonomic Agents|autonomic agents|mesh-ancestor
101996676|NCT03268941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101996677|NCT03268941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996678|NCT03268941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101996679|NCT03268941|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101996680|NCT03268941|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101996681|NCT03268941|Dopamine Agents|dopamine agents|mesh-ancestor
101996682|NCT03268941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101996683|NCT05215834|Remifentanil|remifentanil|mesh-list
101996684|NCT05215834|Propofol|propofol|mesh-list
101996685|NCT05215834|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101996686|NCT05215834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101996688|NCT05215834|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101996726|NCT03393988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996727|NCT03393988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101996728|NCT03393988|Narcotics|narcotics|mesh-ancestor
101996729|NCT03393988|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101996730|NCT03393988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101996731|NCT03393988|Anesthetics, General|anesthetics, general|mesh-ancestor
101996732|NCT03393988|Anesthetics|anesthetics|mesh-ancestor
101996733|NCT03393988|Autonomic Agents|autonomic agents|mesh-ancestor
101996734|NCT03410212|Ketorolac|ketorolac|mesh-list
101996735|NCT03410212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101340558|NCT03150732|Nalbuphine|nalbuphine|mesh-list
101996736|NCT03410212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101996737|NCT03410212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101996738|NCT03410212|Analgesics|analgesics|mesh-ancestor
101996739|NCT03410212|Sensory System Agents|sensory system agents|mesh-ancestor
101996740|NCT03410212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101996741|NCT03410212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996742|NCT03410212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101996743|NCT03410212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101996747|NCT03397264|Aflibercept|aflibercept|mesh-list
101996782|NCT05168176|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101996783|NCT05168176|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101996784|NCT05168176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101996785|NCT05168176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996786|NCT05168176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101996787|NCT05168176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101996788|NCT05168176|Antiviral Agents|antiviral agents|mesh-ancestor
101996789|NCT05168176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101996790|NCT04539730|Bupivacaine|bupivacaine|mesh-list
101996791|NCT04539730|Ropivacaine|ropivacaine|mesh-list
101996792|NCT04539730|Anesthetics, Local|anesthetics, local|mesh-ancestor
101996846|NCT01974609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101996847|NCT01974609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996848|NCT01974609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101996849|NCT01974609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101996850|NCT01974609|Antitussive Agents|antitussive agents|mesh-ancestor
101996851|NCT01974609|Respiratory System Agents|respiratory system agents|mesh-ancestor
101996852|NCT02593123|Mycophenolic Acid|mycophenolic acid|mesh-list
101996916|NCT03763669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101996917|NCT03302247|Gemcitabine|gemcitabine|mesh-list
101996918|NCT03302247|Nivolumab|nivolumab|mesh-list
101996919|NCT03302247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101996920|NCT03302247|Antimetabolites|antimetabolites|mesh-ancestor
101996921|NCT03302247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996922|NCT03302247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101996923|NCT03302247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101996924|NCT03302247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101996925|NCT04363840|Aspirin|aspirin|mesh-list
101996980|NCT04631536|Folic Acid|folic acid|mesh-list
101996981|NCT04631536|Vitamin B Complex|vitamin b complex|mesh-list
101996982|NCT04631536|Nicorandil|nicorandil|mesh-list
101996983|NCT04631536|Nebivolol|nebivolol|mesh-list
101996984|NCT04631536|Atorvastatin|atorvastatin|mesh-list
101996985|NCT04631536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101996986|NCT04631536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101996987|NCT04631536|Antimetabolites|antimetabolites|mesh-ancestor
101996988|NCT04631536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101996989|NCT04631536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101996990|NCT04631536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101996993|NCT04631536|Vitamins|vitamins|mesh-ancestor
101997043|NCT03320850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101997044|NCT03320850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997045|NCT03320850|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101997046|NCT03320850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101997047|NCT04447378|PENTA|penta|mesh-list
101997048|NCT04447378|Fondaparinux|fondaparinux|mesh-list
101997049|NCT04447378|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101997050|NCT04447378|Antithrombins|antithrombins|mesh-ancestor
101997051|NCT04447378|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101997052|NCT04447378|Protease Inhibitors|protease inhibitors|mesh-ancestor
101997053|NCT04447378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101997054|NCT04447378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997055|NCT04447378|Anticoagulants|anticoagulants|mesh-ancestor
101997056|NCT04447378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101997105|NCT04656691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101997106|NCT03399448|Cyclophosphamide|cyclophosphamide|mesh-list
101997107|NCT03399448|Fludarabine|fludarabine|mesh-list
101997108|NCT03399448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101997109|NCT03399448|Immunologic Factors|immunologic factors|mesh-ancestor
101997175|NCT04623684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101997176|NCT04623684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997177|NCT04623684|Sympathomimetics|sympathomimetics|mesh-ancestor
101997178|NCT04623684|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101997179|NCT04623684|Nasal Decongestants|nasal decongestants|mesh-ancestor
101997180|NCT04623684|Respiratory System Agents|respiratory system agents|mesh-ancestor
101997181|NCT04623684|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101997183|NCT04623684|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101997240|NCT03511599|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101997247|NCT01140867|Zonisamide|zonisamide|mesh-list
101997310|NCT02774265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997311|NCT02774265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101997312|NCT02774265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101997313|NCT02774265|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101997314|NCT02774265|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101997315|NCT02774265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997316|NCT02774265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101997317|NCT02774265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101997319|NCT02774265|Antipyretics|antipyretics|mesh-ancestor
101997373|NCT01328002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101997374|NCT01328002|Antidepressive Agents|antidepressive agents|mesh-ancestor
101997376|NCT05239078|Anesthetics|anesthetics|mesh-list
101997444|NCT03395002|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101997445|NCT03395002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101997446|NCT03395002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101997447|NCT03395002|Autonomic Agents|autonomic agents|mesh-ancestor
101997448|NCT03395002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101997449|NCT03395002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997450|NCT03395002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101997451|NCT03395002|Respiratory System Agents|respiratory system agents|mesh-ancestor
101997452|NCT03395002|Dermatologic Agents|dermatologic agents|mesh-ancestor
101997453|NCT03395002|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101997454|NCT03395002|Parasympatholytics|parasympatholytics|mesh-ancestor
101997455|NCT03395002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101997456|NCT03395002|Cholinergic Agents|cholinergic agents|mesh-ancestor
101997457|NCT03395002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101997458|NCT03395002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997459|NCT03395002|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101997460|NCT03395002|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101997461|NCT03395002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101997462|NCT03395002|Adrenergic Agents|adrenergic agents|mesh-ancestor
101997463|NCT05238064|Cyclophosphamide|cyclophosphamide|mesh-list
101997464|NCT05238064|Doxorubicin|doxorubicin|mesh-list
101997465|NCT05238064|Vincristine|vincristine|mesh-list
101997466|NCT05238064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101997467|NCT05238064|Immunologic Factors|immunologic factors|mesh-ancestor
101997468|NCT05238064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997485|NCT03390790|Anesthetics|anesthetics|mesh-ancestor
101997493|NCT03390790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101997494|NCT03390790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997495|NCT03697993|Levofloxacin|levofloxacin|mesh-list
101997565|NCT03394222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997566|NCT03394222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101997567|NCT03394222|Respiratory System Agents|respiratory system agents|mesh-ancestor
101997568|NCT03394222|Glucocorticoids|glucocorticoids|mesh-ancestor
101997569|NCT03394222|Hormones|hormones|mesh-ancestor
101997570|NCT03394222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101997571|NCT03398044|Dexamethasone|dexamethasone|mesh-list
101997572|NCT03398044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101997573|NCT03398044|Antiemetics|antiemetics|mesh-ancestor
101997574|NCT03398044|Autonomic Agents|autonomic agents|mesh-ancestor
101997575|NCT03398044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101997576|NCT03398044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997626|NCT01481272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101997627|NCT01481272|Abortifacient Agents|abortifacient agents|mesh-ancestor
101997628|NCT01481272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101997629|NCT01481272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997630|NCT01481272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101997631|NCT01481272|Antimetabolites|antimetabolites|mesh-ancestor
101997632|NCT01481272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101997633|NCT01481272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101997634|NCT01481272|Dermatologic Agents|dermatologic agents|mesh-ancestor
101997635|NCT01481272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101997636|NCT01481272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101997637|NCT01481272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101997638|NCT01481272|Immunologic Factors|immunologic factors|mesh-ancestor
101997639|NCT01481272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101997640|NCT01481272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101997641|NCT01481272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101997642|NCT01481272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101997643|NCT01481272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101997644|NCT01481272|Antiviral Agents|antiviral agents|mesh-ancestor
101997645|NCT01481272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101997646|NCT01481272|Antidotes|antidotes|mesh-ancestor
101997647|NCT01481272|Protective Agents|protective agents|mesh-ancestor
101997648|NCT01481272|Vitamin B Complex|vitamin b complex|mesh-ancestor
101997649|NCT01481272|Vitamins|vitamins|mesh-ancestor
101997650|NCT01481272|Micronutrients|micronutrients|mesh-ancestor
101997651|NCT01481272|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101997652|NCT04478695|Pembrolizumab|pembrolizumab|mesh-list
101997653|NCT04478695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101997654|NCT04478695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101997655|NCT04478695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101997669|NCT04531813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101997670|NCT01380028|Prednisone|prednisone|mesh-list
101997671|NCT01380028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101997672|NCT01380028|Glucocorticoids|glucocorticoids|mesh-ancestor
101997673|NCT01380028|Hormones|hormones|mesh-ancestor
101997674|NCT01380028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101997675|NCT01380028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101997676|NCT01380028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101997677|NCT01380028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101997684|NCT03754543|Iron|iron|mesh-list
101997735|NCT04401384|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101997736|NCT04401384|Histamine Antagonists|histamine antagonists|mesh-ancestor
101997737|NCT04401384|Histamine Agents|histamine agents|mesh-ancestor
101997738|NCT04401384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101997740|NCT04401384|Parasympatholytics|parasympatholytics|mesh-ancestor
101997807|NCT03311724|Tirzepatide|tirzepatide|mesh-list
101997808|NCT03311724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101997810|NCT03311724|Incretins|incretins|mesh-ancestor
101997882|NCT03682224|Epinephrine|epinephrine|mesh-list
101997883|NCT03682224|Bupivacaine|bupivacaine|mesh-list
101997884|NCT03682224|Anesthetics, Local|anesthetics, local|mesh-ancestor
101997903|NCT01383044|Carvedilol|carvedilol|mesh-list
101997952|NCT03708003|Venetoclax|venetoclax|mesh-list
101998027|NCT02890992|Nicotinic Acids|nicotinic acids|mesh-list
101998028|NCT02890992|Niacin|niacin|mesh-list
101998029|NCT02890992|Niacinamide|niacinamide|mesh-list
101998030|NCT02890992|Ezetimibe|ezetimibe|mesh-list
101998031|NCT02890992|Alirocumab|alirocumab|mesh-list
101998032|NCT02890992|Cholestyramine Resin|cholestyramine resin|mesh-list
101998033|NCT02890992|Fenofibrate|fenofibrate|mesh-list
101998034|NCT02890992|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101998035|NCT02890992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101998036|NCT02890992|Antimetabolites|antimetabolites|mesh-ancestor
101998037|NCT02890992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998038|NCT02890992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101998039|NCT02890992|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101998040|NCT02890992|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101998089|NCT01379144|Latanoprost|latanoprost|mesh-list
101998090|NCT01379144|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101998162|NCT05222724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998163|NCT01382342|Rasagiline|rasagiline|mesh-list
101998164|NCT01382342|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101998175|NCT03630614|Nicotine|nicotine|mesh-list
101998235|NCT05762744|Hormones|hormones|mesh-ancestor
101998236|NCT05762744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101998237|NCT02257424|Hydroxychloroquine|hydroxychloroquine|mesh-list
101998238|NCT02257424|Trametinib|trametinib|mesh-list
101998239|NCT02257424|Dabrafenib|dabrafenib|mesh-list
101998240|NCT02257424|Antimalarials|antimalarials|mesh-ancestor
101998241|NCT02257424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101998242|NCT02257424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101998243|NCT02257424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101998244|NCT02257424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101998303|NCT01377974|Miltefosine|miltefosine|mesh-list
101998304|NCT01377974|Meglumine Antimoniate|meglumine antimoniate|mesh-list
101998305|NCT01377974|Antifungal Agents|antifungal agents|mesh-ancestor
101998306|NCT01377974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101998307|NCT01377974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101998308|NCT01377974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101998309|NCT01377974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101998310|NCT03071276|Cytarabine|cytarabine|mesh-list
101998311|NCT03071276|Hydrocortisone|hydrocortisone|mesh-list
101998312|NCT03071276|Methotrexate|methotrexate|mesh-list
101998313|NCT03071276|Fludarabine phosphate|fludarabine phosphate|mesh-list
101998314|NCT03071276|Fludarabine|fludarabine|mesh-list
101998348|NCT03074162|Diclofenac|diclofenac|mesh-list
101998368|NCT05069012|Analgesics|analgesics|mesh-ancestor
101998369|NCT05069012|Sensory System Agents|sensory system agents|mesh-ancestor
101998370|NCT05069012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101998372|NCT04065074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101998373|NCT04065074|Glucocorticoids|glucocorticoids|mesh-ancestor
101998375|NCT04065074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101998376|NCT04065074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998377|NCT04065074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101998378|NCT04065074|Immunologic Factors|immunologic factors|mesh-ancestor
101998379|NCT03920306|Silver Nitrate|silver nitrate|mesh-list
101998380|NCT03920306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101998431|NCT05121714|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101998432|NCT05121714|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101998433|NCT05121714|Purinergic Agents|purinergic agents|mesh-ancestor
101998501|NCT03243630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101998502|NCT03243630|Autonomic Agents|autonomic agents|mesh-ancestor
101998573|NCT05763836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101998574|NCT05763836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101998575|NCT05763836|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101998578|NCT01237535|Progesterone|progesterone|mesh-list
101998646|NCT01147289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101998647|NCT01237769|Vitamin D|vitamin d|mesh-list
101998648|NCT01237769|Ergocalciferols|ergocalciferols|mesh-list
101998649|NCT01237769|Cholecalciferol|cholecalciferol|mesh-list
101998650|NCT01237769|Vitamins|vitamins|mesh-list
101998717|NCT01250561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101998718|NCT05055908|Atezolizumab|atezolizumab|mesh-list
101998719|NCT05055908|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101998723|NCT01147523|Vitamin E|vitamin e|mesh-list
101998790|NCT01125176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101998791|NCT01125176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101998792|NCT01125176|Growth Substances|growth substances|mesh-ancestor
101998793|NCT01125176|Growth Inhibitors|growth inhibitors|mesh-ancestor
101998798|NCT00882050|Exenatide|exenatide|mesh-list
101998862|NCT04707534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101998863|NCT04707534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101998864|NCT04707534|Glucocorticoids|glucocorticoids|mesh-ancestor
101998865|NCT04707534|Hormones|hormones|mesh-ancestor
101998867|NCT04707534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101998932|NCT03903653|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101998933|NCT03903653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101999003|NCT01148147|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101999004|NCT01148147|Purinergic Agonists|purinergic agonists|mesh-ancestor
101999005|NCT01148147|Purinergic Agents|purinergic agents|mesh-ancestor
101999006|NCT01148147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101999007|NCT01148147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999073|NCT04549376|Cadexomer iodine|cadexomer iodine|mesh-list
101999074|NCT04549376|Povidone-Iodine|povidone-iodine|mesh-list
101999075|NCT04549376|Povidone|povidone|mesh-list
101999144|NCT03907163|Sensory System Agents|sensory system agents|mesh-ancestor
101999145|NCT03907163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101999146|NCT03907163|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101999215|NCT03905837|Sensory System Agents|sensory system agents|mesh-ancestor
101999216|NCT03905837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101999217|NCT03905837|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101999218|NCT03905837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101999219|NCT03905837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101999222|NCT03905837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101999283|NCT01255475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101999284|NCT01255475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999286|NCT05208398|Warfarin|warfarin|mesh-list
101999353|NCT05761418|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101999354|NCT05761418|Abortifacient Agents|abortifacient agents|mesh-ancestor
101999355|NCT05761418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101999424|NCT01256021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999498|NCT03898583|Respiratory System Agents|respiratory system agents|mesh-ancestor
101999499|NCT03898583|Dermatologic Agents|dermatologic agents|mesh-ancestor
101999500|NCT03898583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101999501|NCT03898583|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101999502|NCT03898583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101999565|NCT03746119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101999566|NCT03746119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999567|NCT01149005|Insulin|insulin|mesh-list
101999568|NCT01149005|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101999569|NCT01149005|Insulin Lispro|insulin lispro|mesh-list
101999570|NCT01149005|Insulin Aspart|insulin aspart|mesh-list
101999571|NCT01149005|Insulin, Short-Acting|insulin, short-acting|mesh-list
101999572|NCT01149005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101999573|NCT01149005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999574|NCT03903887|Antibodies|antibodies|mesh-list
101999575|NCT03903887|Immunologic Factors|immunologic factors|mesh-ancestor
101999576|NCT03903887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999577|NCT03903419|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101999578|NCT03903419|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101999579|NCT03903419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999580|NCT05122130|Melatonin|melatonin|mesh-list
101999581|NCT05122130|Antioxidants|antioxidants|mesh-ancestor
101999582|NCT05122130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101999583|NCT05122130|Protective Agents|protective agents|mesh-ancestor
101999584|NCT05122130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999621|NCT01256801|Interleukin-2|interleukin-2|mesh-list
101999622|NCT01256801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101999623|NCT01256801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101999624|NCT01256801|Analgesics|analgesics|mesh-ancestor
101999625|NCT01256801|Sensory System Agents|sensory system agents|mesh-ancestor
101999626|NCT01256801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101999627|NCT01256801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101999628|NCT02519738|Silver Nitrate|silver nitrate|mesh-list
101999629|NCT02519738|Triamcinolone|triamcinolone|mesh-list
101999630|NCT02519738|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101999688|NCT03897413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101999689|NCT01258439|Ritonavir|ritonavir|mesh-list
101999690|NCT01258439|Darunavir|darunavir|mesh-list
101999691|NCT01258439|Tenofovir|tenofovir|mesh-list
101999692|NCT01258439|Emtricitabine|emtricitabine|mesh-list
101999693|NCT01258439|Raltegravir Potassium|raltegravir potassium|mesh-list
101999695|NCT01258439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101999756|NCT05211050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101999757|NCT05211050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101999758|NCT05211050|Respiratory System Agents|respiratory system agents|mesh-ancestor
101999759|NCT05211050|Parasympatholytics|parasympatholytics|mesh-ancestor
101999760|NCT05211050|Vasodilator Agents|vasodilator agents|mesh-ancestor
101999761|NCT03892499|Itraconazole|itraconazole|mesh-list
101999822|NCT03892421|Dexamethasone|dexamethasone|mesh-list
101999823|NCT03892421|Rituximab|rituximab|mesh-list
101999824|NCT03892421|Carboplatin|carboplatin|mesh-list
101999896|NCT05667077|Antiviral Agents|antiviral agents|mesh-ancestor
101999897|NCT05667077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101999898|NCT05667077|Dopamine Agents|dopamine agents|mesh-ancestor
101999969|NCT03889145|Telmisartan|telmisartan|mesh-list
101999970|NCT03889145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101999971|NCT03889145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102000041|NCT01251809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000042|NCT01154387|Mycophenolic Acid|mycophenolic acid|mesh-list
102000043|NCT01154387|Tacrolimus|tacrolimus|mesh-list
102000044|NCT01154387|Thymoglobulin|thymoglobulin|mesh-list
102000045|NCT01154387|Antilymphocyte Serum|antilymphocyte serum|mesh-list
102000046|NCT01154387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102000111|NCT03889379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102000112|NCT03889379|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102000113|NCT03889379|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102000114|NCT03889379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102000115|NCT03889379|Adrenergic Agents|adrenergic agents|mesh-ancestor
102000116|NCT03889379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102000117|NCT03889379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000118|NCT01586507|Tramadol|tramadol|mesh-list
102000119|NCT01586507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102000120|NCT01586507|Narcotics|narcotics|mesh-ancestor
102000121|NCT01586507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102000122|NCT01586507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000123|NCT01586507|Analgesics|analgesics|mesh-ancestor
102000124|NCT01586507|Sensory System Agents|sensory system agents|mesh-ancestor
102000144|NCT03885947|Thiotepa|thiotepa|mesh-list
102000171|NCT01261637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102000172|NCT01261637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000173|NCT01261637|Sensory System Agents|sensory system agents|mesh-ancestor
102000174|NCT01261637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102000176|NCT01262183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102000177|NCT01262183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000178|NCT01154933|Exenatide|exenatide|mesh-list
102000179|NCT01154933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102000180|NCT01154933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000181|NCT01154933|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102000182|NCT01154933|Incretins|incretins|mesh-ancestor
102000183|NCT01154933|Hormones|hormones|mesh-ancestor
102000185|NCT01155635|Carvedilol|carvedilol|mesh-list
102000232|NCT01155791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102000233|NCT01155791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000234|NCT01155791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102000235|NCT01157507|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
102000236|NCT01157507|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
102000245|NCT03881423|Bromides|bromides|mesh-list
102000297|NCT03881111|Pembrolizumab|pembrolizumab|mesh-list
102000298|NCT03881111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000371|NCT01157819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000372|NCT01157819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000373|NCT01157819|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102000375|NCT01264367|Interferons|interferons|mesh-list
102000443|NCT01158755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102000444|NCT01158755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000445|NCT01158755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000516|NCT01156961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000517|NCT01156961|Tubulin Modulators|tubulin modulators|mesh-ancestor
102000518|NCT01156961|Antimitotic Agents|antimitotic agents|mesh-ancestor
102000519|NCT01156961|Mitosis Modulators|mitosis modulators|mesh-ancestor
101340650|NCT00139165|Hormones|hormones|mesh-ancestor
101340657|NCT00139243|Docetaxel|docetaxel|mesh-list
102000520|NCT01156961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000521|NCT01156961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102000583|NCT03876899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102000584|NCT03876899|Dermatologic Agents|dermatologic agents|mesh-ancestor
102000585|NCT03241173|Nivolumab|nivolumab|mesh-list
102000586|NCT03241173|Ipilimumab|ipilimumab|mesh-list
102000587|NCT03241173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102000654|NCT03876587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000655|NCT03876587|Tubulin Modulators|tubulin modulators|mesh-ancestor
102000725|NCT01163201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000726|NCT01163201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102000728|NCT03876041|Dexamethasone acetate|dexamethasone acetate|mesh-list
102000729|NCT03876041|Methylprednisolone|methylprednisolone|mesh-list
102000730|NCT03876041|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102000731|NCT03876041|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
102000732|NCT03876041|BB 1101|bb 1101|mesh-list
102000733|NCT03876041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102000734|NCT03876041|Antiemetics|antiemetics|mesh-ancestor
102000735|NCT03876041|Autonomic Agents|autonomic agents|mesh-ancestor
102000736|NCT03876041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102000787|NCT03757715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000788|NCT03757715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102000789|NCT03757715|Glucocorticoids|glucocorticoids|mesh-ancestor
102000857|NCT03879005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000859|NCT03878771|Benzocaine|benzocaine|mesh-list
102000860|NCT03878771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102000861|NCT03878771|Glucocorticoids|glucocorticoids|mesh-ancestor
102000862|NCT03878771|Hormones|hormones|mesh-ancestor
102000863|NCT03878771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102000864|NCT03878771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000865|NCT03878771|Anesthetics, Local|anesthetics, local|mesh-ancestor
102000866|NCT03878771|Anesthetics|anesthetics|mesh-ancestor
102000867|NCT03878771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102000868|NCT03878771|Sensory System Agents|sensory system agents|mesh-ancestor
102000869|NCT03878771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102000870|NCT02959918|Sirolimus|sirolimus|mesh-list
102000871|NCT02959918|Temsirolimus|temsirolimus|mesh-list
102000872|NCT02959918|MTOR Inhibitors|mtor inhibitors|mesh-list
102000873|NCT02959918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102000874|NCT02959918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102000875|NCT02959918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102000876|NCT02959918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000877|NCT02959918|Antifungal Agents|antifungal agents|mesh-ancestor
102000878|NCT02959918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102000879|NCT02959918|Immunologic Factors|immunologic factors|mesh-ancestor
102000880|NCT02959918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000881|NCT02959918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102000882|NCT02959918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102000883|NCT02959918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000884|NCT01266707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
102000885|NCT01266707|Vaccines|vaccines|mesh-list
101601107|NCT04939467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601108|NCT04939467|Analgesics|analgesics|mesh-ancestor
101601109|NCT04939467|Sensory System Agents|sensory system agents|mesh-ancestor
101601110|NCT04939467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101601111|NCT04939467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601112|NCT04939467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101601113|NCT04939467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101601114|NCT04939467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101601115|NCT04939467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101601116|NCT01015560|Antibodies|antibodies|mesh-list
101601117|NCT01015560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101601119|NCT01015560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601120|NCT04253223|Volagidemab|volagidemab|mesh-list
101601121|NCT04253223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101601122|NCT04253223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601123|NCT00918879|Saxagliptin|saxagliptin|mesh-list
101601124|NCT00918879|Incretins|incretins|mesh-ancestor
101601125|NCT00918879|Hormones|hormones|mesh-ancestor
102000886|NCT01266707|Immunologic Factors|immunologic factors|mesh-ancestor
102000887|NCT01266707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000888|NCT01266707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102000889|NCT01266707|Growth Substances|growth substances|mesh-ancestor
101340753|NCT03837977|Leucovorin|leucovorin|mesh-list
102000890|NCT01266707|Growth Inhibitors|growth inhibitors|mesh-ancestor
102000891|NCT01266707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000892|NCT03263442|Thiamine|thiamine|mesh-list
102000893|NCT03263442|Vitamin B Complex|vitamin b complex|mesh-ancestor
102000894|NCT03263442|Vitamins|vitamins|mesh-ancestor
102000895|NCT03263442|Micronutrients|micronutrients|mesh-ancestor
102000896|NCT03263442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000897|NCT01164215|Leucovorin|leucovorin|mesh-list
102000898|NCT01164215|Fluorouracil|fluorouracil|mesh-list
102000899|NCT01164215|Oxaliplatin|oxaliplatin|mesh-list
102000900|NCT01164215|Levoleucovorin|levoleucovorin|mesh-list
102000901|NCT01164215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000902|NCT01164215|Antimetabolites|antimetabolites|mesh-ancestor
102000903|NCT01164215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000904|NCT01164215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102000905|NCT01164215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102000906|NCT01164215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102000907|NCT01164215|Immunologic Factors|immunologic factors|mesh-ancestor
102000908|NCT01164215|Antidotes|antidotes|mesh-ancestor
102000909|NCT01164215|Protective Agents|protective agents|mesh-ancestor
102000910|NCT01164215|Vitamin B Complex|vitamin b complex|mesh-ancestor
102000911|NCT01164215|Vitamins|vitamins|mesh-ancestor
102000912|NCT01164215|Micronutrients|micronutrients|mesh-ancestor
102000913|NCT04245709|Clenbuterol|clenbuterol|mesh-list
102000914|NCT04245709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102000915|NCT04245709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102000933|NCT05305495|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102000934|NCT05305495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000935|NCT05305495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102000936|NCT05305495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000937|NCT03748537|Hydrocortisone|hydrocortisone|mesh-list
102000938|NCT03748537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102000939|NCT02527109|Nifedipine|nifedipine|mesh-list
102000940|NCT02527109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102000941|NCT02527109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102000942|NCT02527109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102000997|NCT01160315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102000998|NCT01160315|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102001069|NCT04222699|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102001070|NCT04222699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102001071|NCT04222699|Disinfectants|disinfectants|mesh-ancestor
102001072|NCT04222699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102001073|NCT04222699|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102001074|NCT04222699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102001076|NCT01269203|Curcumin|curcumin|mesh-list
102001137|NCT01269281|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
102001138|NCT01269281|Serotonin Agents|serotonin agents|mesh-ancestor
102001139|NCT01269281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102001140|NCT01269281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001141|NCT01269281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001142|NCT02778204|Maraviroc|maraviroc|mesh-list
102001205|NCT01269437|Glucocorticoids|glucocorticoids|mesh-ancestor
102001207|NCT01269437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102001208|NCT03909269|Carbon Monoxide|carbon monoxide|mesh-list
102001209|NCT03909269|Antimetabolites|antimetabolites|mesh-ancestor
102001214|NCT00462748|Atorvastatin|atorvastatin|mesh-list
102001274|NCT01269515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001275|NCT01269515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102001276|NCT01269515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102001348|NCT03260868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001349|NCT01165385|Cisplatin|cisplatin|mesh-list
102001350|NCT01165385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102001351|NCT01267487|Heparin|heparin|mesh-list
102001352|NCT01267487|Calcium heparin|calcium heparin|mesh-list
102001353|NCT01267487|Protamines|protamines|mesh-list
102001354|NCT01267487|Anticoagulants|anticoagulants|mesh-ancestor
102001355|NCT01267487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102001419|NCT02526953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102001497|NCT03379558|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102001498|NCT03379558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102001499|NCT03379558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102001500|NCT03379558|Antimetabolites|antimetabolites|mesh-ancestor
102001570|NCT03871517|Sensory System Agents|sensory system agents|mesh-ancestor
102001571|NCT03871517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102001572|NCT03871517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001581|NCT03871517|Antipyretics|antipyretics|mesh-ancestor
102001641|NCT03493126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102001642|NCT03493126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001643|NCT03257358|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
102001644|NCT03257358|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
102001645|NCT03257358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001646|NCT03257358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102001647|NCT03257358|Immunologic Factors|immunologic factors|mesh-ancestor
102001648|NCT03257358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001649|NCT03386656|Tranexamic Acid|tranexamic acid|mesh-list
102001650|NCT03386656|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102001651|NCT03386656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102001652|NCT03386656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001653|NCT03386656|Hemostatics|hemostatics|mesh-ancestor
102001654|NCT03386656|Coagulants|coagulants|mesh-ancestor
102001655|NCT01281527|Paliperidone Palmitate|paliperidone palmitate|mesh-list
102001656|NCT01281527|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102001657|NCT01281527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102001658|NCT01281527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102001695|NCT01283789|Lapatinib|lapatinib|mesh-list
102001696|NCT01283789|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102001697|NCT01283789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102001698|NCT01283789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102001699|NCT01283789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001700|NCT01283789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102001701|NCT01283789|Immunologic Factors|immunologic factors|mesh-ancestor
102001702|NCT01283789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001703|NCT01283789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102001704|NCT03383068|Metformin|metformin|mesh-list
102001705|NCT03383068|Exenatide|exenatide|mesh-list
102001706|NCT03383068|Acarbose|acarbose|mesh-list
102001707|NCT03383068|Orlistat|orlistat|mesh-list
102001708|NCT03383068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102001709|NCT03383068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001710|NCT03383068|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102001711|NCT03383068|Incretins|incretins|mesh-ancestor
102001712|NCT03383068|Hormones|hormones|mesh-ancestor
102001713|NCT03383068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102001714|NCT03383068|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
102001715|NCT03383068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102001716|NCT03383068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001717|NCT03383068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102001718|NCT03378310|Linrodostat|linrodostat|mesh-list
102001719|NCT03378310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102001720|NCT03378310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001721|NCT01283867|Mycophenolic Acid|mycophenolic acid|mesh-list
102001722|NCT01283867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102001723|NCT01283867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102001724|NCT01283867|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102001725|NCT01283867|Antitubercular Agents|antitubercular agents|mesh-ancestor
102001726|NCT01283867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102001727|NCT01283867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102001728|NCT01283867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628288|NCT00720499|Anticonvulsants|anticonvulsants|mesh-ancestor
101601126|NCT00918879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101601127|NCT00918879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601128|NCT00918879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101601129|NCT00918879|Protease Inhibitors|protease inhibitors|mesh-ancestor
101601130|NCT00918879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102001729|NCT01283867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001730|NCT04094298|FX006|fx006|mesh-list
102001731|NCT04094298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102001732|NCT04094298|Glucocorticoids|glucocorticoids|mesh-ancestor
102001733|NCT04094298|Hormones|hormones|mesh-ancestor
102001735|NCT04094298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001800|NCT01274273|Interferon alpha-2|interferon alpha-2|mesh-list
102001801|NCT01274273|Aldesleukin|aldesleukin|mesh-list
102001802|NCT01274273|Bevacizumab|bevacizumab|mesh-list
102001803|NCT01274273|Interleukin-2|interleukin-2|mesh-list
102001804|NCT01274273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102001875|NCT03226275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102001876|NCT03226275|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
102001877|NCT03226275|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102001878|NCT03226275|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102001879|NCT03226275|Adrenergic Agents|adrenergic agents|mesh-ancestor
102001880|NCT03226275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102001881|NCT03382756|Choline|choline|mesh-list
102001882|NCT03382756|Atorvastatin|atorvastatin|mesh-list
102001883|NCT03382756|Fenofibrate|fenofibrate|mesh-list
102001884|NCT03382756|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102001885|NCT03382756|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102001886|NCT03382756|Antimetabolites|antimetabolites|mesh-ancestor
102001888|NCT03382756|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102001934|NCT01275521|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102001935|NCT01275521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102001936|NCT01275521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001937|NCT01275521|Cholinergic Agents|cholinergic agents|mesh-ancestor
102001938|NCT01275521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102001940|NCT01275911|Esmolol|esmolol|mesh-list
102001941|NCT01275911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102001942|NCT01275911|Narcotics|narcotics|mesh-ancestor
102001943|NCT01275911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102001944|NCT01275911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102001945|NCT01275911|Analgesics|analgesics|mesh-ancestor
102001946|NCT01275911|Sensory System Agents|sensory system agents|mesh-ancestor
102001947|NCT01275911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102001995|NCT03745261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102001996|NCT03745261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102001997|NCT03745261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102001998|NCT03745261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102002066|NCT05666765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002067|NCT01127256|Carbamazepine|carbamazepine|mesh-list
102002068|NCT01127256|Zonisamide|zonisamide|mesh-list
102002069|NCT01127256|Anticonvulsants|anticonvulsants|mesh-ancestor
102002070|NCT01127256|Antimanic Agents|antimanic agents|mesh-ancestor
102002071|NCT01127256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102002072|NCT01127256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102002073|NCT01127256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002074|NCT01127256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102002075|NCT01127256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102002076|NCT01127256|Analgesics|analgesics|mesh-ancestor
102002077|NCT01127256|Sensory System Agents|sensory system agents|mesh-ancestor
102002078|NCT01127256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102002079|NCT01127256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102002128|NCT03377608|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
102002129|NCT03377608|Medroxyprogesterone|medroxyprogesterone|mesh-list
102002130|NCT03377608|Antiviral Agents|antiviral agents|mesh-ancestor
102002131|NCT03377608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101331233|NCT00034060|Etanercept|etanercept|mesh-list
102002132|NCT03377608|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102002133|NCT03377608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102002134|NCT03377608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102002135|NCT03377608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002136|NCT03377608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102002137|NCT03377608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102002138|NCT03377608|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102002139|NCT03377608|Contraceptive Agents|contraceptive agents|mesh-ancestor
102002190|NCT01282151|Mitosis Modulators|mitosis modulators|mesh-ancestor
102002191|NCT03377218|Iodine|iodine|mesh-list
102002192|NCT03377218|Selenium|selenium|mesh-list
102002193|NCT03377218|Cadexomer iodine|cadexomer iodine|mesh-list
102002194|NCT03377218|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102002195|NCT03377218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102002196|NCT03377218|Trace Elements|trace elements|mesh-ancestor
102002197|NCT03377218|Micronutrients|micronutrients|mesh-ancestor
102002198|NCT03377218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002199|NCT03377218|Antioxidants|antioxidants|mesh-ancestor
102002200|NCT03377218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002201|NCT03377218|Protective Agents|protective agents|mesh-ancestor
102002202|NCT01168505|Teferrol|teferrol|mesh-list
102002203|NCT01168505|Hematinics|hematinics|mesh-ancestor
102002253|NCT04050865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102002254|NCT04050865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002255|NCT04050865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102002256|NCT04050865|Glucocorticoids|glucocorticoids|mesh-ancestor
102002257|NCT04050865|Hormones|hormones|mesh-ancestor
102002258|NCT04050865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102002259|NCT04050865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102002320|NCT01171859|Antimalarials|antimalarials|mesh-ancestor
102002321|NCT01171859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102002322|NCT01171859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101722109|NCT05424796|Hemostatics|hemostatics|mesh-list
102002323|NCT01171859|Antiviral Agents|antiviral agents|mesh-ancestor
102002324|NCT01171859|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102002326|NCT02652468|Mycophenolic Acid|mycophenolic acid|mesh-list
102002327|NCT02652468|Cyclophosphamide|cyclophosphamide|mesh-list
102002328|NCT02652468|Rituximab|rituximab|mesh-list
102002329|NCT02652468|Fludarabine|fludarabine|mesh-list
102002330|NCT02652468|Fludarabine phosphate|fludarabine phosphate|mesh-list
102002331|NCT02652468|Tacrolimus|tacrolimus|mesh-list
102002332|NCT02652468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102002333|NCT02652468|Immunologic Factors|immunologic factors|mesh-ancestor
102002334|NCT02652468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002335|NCT02652468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102002336|NCT02652468|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102002337|NCT02652468|Alkylating Agents|alkylating agents|mesh-ancestor
102002338|NCT02652468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002351|NCT04673877|Vancomycin|vancomycin|mesh-list
102002377|NCT01279811|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
102002378|NCT01279811|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102002379|NCT01279811|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102002380|NCT01279811|Adrenergic Agents|adrenergic agents|mesh-ancestor
102002381|NCT01279811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102002382|NCT01279811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002444|NCT03744247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002445|NCT03744247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102002446|NCT03744247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102002515|NCT03751631|Phenylephrine|phenylephrine|mesh-list
102002516|NCT03751631|Oxymetazoline|oxymetazoline|mesh-list
102002517|NCT03751631|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102002518|NCT03751631|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102002587|NCT03655717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102002588|NCT03222531|Sofosbuvir|sofosbuvir|mesh-list
102002589|NCT03222531|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102002590|NCT03222531|Velpatasvir|velpatasvir|mesh-list
102002591|NCT03222531|Antiviral Agents|antiviral agents|mesh-ancestor
102002592|NCT03222531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102002593|NCT03867071|Epoetin Alfa|epoetin alfa|mesh-list
102002594|NCT03867071|Hematinics|hematinics|mesh-ancestor
102002595|NCT01284413|Cisplatin|cisplatin|mesh-list
102002596|NCT01284413|Gemcitabine|gemcitabine|mesh-list
102002597|NCT01284413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102002598|NCT01284413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102002599|NCT01284413|Antimetabolites|antimetabolites|mesh-ancestor
102002600|NCT01284413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002601|NCT05152017|Vaccines|vaccines|mesh-list
102002602|NCT05152017|Immunologic Factors|immunologic factors|mesh-ancestor
102002603|NCT05152017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002604|NCT03866993|Paclitaxel|paclitaxel|mesh-list
102002605|NCT03866993|Carboplatin|carboplatin|mesh-list
102002607|NCT03866993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102002654|NCT03187197|Anticoagulants|anticoagulants|mesh-ancestor
102002655|NCT01284647|Geranylgeranylacetone|geranylgeranylacetone|mesh-list
102002656|NCT01284647|Sucralfate|sucralfate|mesh-list
102002657|NCT01284647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102002658|NCT01284647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102002659|NCT01284647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102002660|NCT04000009|Pimavanserin|pimavanserin|mesh-list
102002723|NCT03376594|Histamine Antagonists|histamine antagonists|mesh-ancestor
102002724|NCT03376594|Histamine Agents|histamine agents|mesh-ancestor
102002725|NCT03376594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102002726|NCT03376594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002794|NCT01178021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102002795|NCT01178021|Filaricides|filaricides|mesh-ancestor
102002796|NCT01178021|Antinematodal Agents|antinematodal agents|mesh-ancestor
102002797|NCT01178021|Anthelmintics|anthelmintics|mesh-ancestor
102002867|NCT01175291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102002868|NCT01175291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102002869|NCT01175291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102002870|NCT01175291|Growth Substances|growth substances|mesh-ancestor
102002871|NCT01175291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002872|NCT01175291|Growth Inhibitors|growth inhibitors|mesh-ancestor
102002873|NCT01175291|Antimetabolites|antimetabolites|mesh-ancestor
102002874|NCT01175291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102002875|NCT01175291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102002876|NCT01175291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102002877|NCT01175291|Immunologic Factors|immunologic factors|mesh-ancestor
102002878|NCT01175291|Antidotes|antidotes|mesh-ancestor
102002881|NCT01175291|Vitamins|vitamins|mesh-ancestor
102002931|NCT03381118|Antimetabolites|antimetabolites|mesh-ancestor
102002932|NCT03381118|Antiviral Agents|antiviral agents|mesh-ancestor
102002933|NCT03381118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102002934|NCT03381118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102002935|NCT03381118|Immunologic Factors|immunologic factors|mesh-ancestor
102002936|NCT03381118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002937|NCT03375112|Bupivacaine|bupivacaine|mesh-list
102002938|NCT03375112|Anesthetics, Local|anesthetics, local|mesh-ancestor
102002939|NCT03375112|Anesthetics|anesthetics|mesh-ancestor
102002940|NCT03375112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102002944|NCT02954575|Factor VIII|factor viii|mesh-list
102002997|NCT03374722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102002998|NCT03374722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102002999|NCT03374722|Analgesics|analgesics|mesh-ancestor
102003068|NCT01173809|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102003069|NCT01173809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102003070|NCT03375580|Metformin|metformin|mesh-list
102003071|NCT03375580|Simvastatin|simvastatin|mesh-list
101341284|NCT00143104|Insulin|insulin|mesh-list
102003072|NCT03375580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102003139|NCT03369574|Respiratory System Agents|respiratory system agents|mesh-ancestor
102003140|NCT03278028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102003141|NCT02651740|Rifaximin|rifaximin|mesh-list
102003142|NCT02651740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102003210|NCT04597320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102003211|NCT04597320|Anesthetics, General|anesthetics, general|mesh-ancestor
102003222|NCT03373708|Tamoxifen|tamoxifen|mesh-list
102003284|NCT05181852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003359|NCT01178645|Alkylating Agents|alkylating agents|mesh-ancestor
102003360|NCT01178645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102003361|NCT01285505|Alprazolam|alprazolam|mesh-list
102003434|NCT01287455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003435|NCT01287455|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102003436|NCT01287455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102003437|NCT03865511|Osimertinib|osimertinib|mesh-list
102003438|NCT03865511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102003439|NCT03865511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102003440|NCT03865511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102003441|NCT03865511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003499|NCT05566548|Protective Agents|protective agents|mesh-ancestor
101341374|NCT00143689|Lamivudine|lamivudine|mesh-list
102003500|NCT05566548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003501|NCT02525003|Vitamin D|vitamin d|mesh-list
102003502|NCT02525003|Ergocalciferols|ergocalciferols|mesh-list
102003503|NCT02525003|Cholecalciferol|cholecalciferol|mesh-list
102003570|NCT04523662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102003571|NCT04523662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003644|NCT01176851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102003645|NCT01176851|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
102003646|NCT01176851|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102003647|NCT01176851|Cholinergic Agents|cholinergic agents|mesh-ancestor
102003648|NCT01176851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102003649|NCT01176851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003650|NCT01176851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003651|NCT04526236|Methadone|methadone|mesh-list
102003707|NCT03360760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102003708|NCT03360760|Alkylating Agents|alkylating agents|mesh-ancestor
102003709|NCT01285661|Vitamin K|vitamin k|mesh-list
102003710|NCT01285661|Warfarin|warfarin|mesh-list
102003711|NCT01285661|Anticoagulants|anticoagulants|mesh-list
102003712|NCT01285661|Vitamins|vitamins|mesh-ancestor
102003713|NCT01285661|Micronutrients|micronutrients|mesh-ancestor
102003714|NCT01285661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003715|NCT01285661|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102003775|NCT03860831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102003776|NCT03860831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102003777|NCT03860831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102003847|NCT03680911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102003848|NCT03680911|Protective Agents|protective agents|mesh-ancestor
102003849|NCT03680911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102003850|NCT03680911|Antidotes|antidotes|mesh-ancestor
102003851|NCT03370588|Dexmedetomidine|dexmedetomidine|mesh-list
102003919|NCT01181063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102003920|NCT01181063|Adrenergic Agents|adrenergic agents|mesh-ancestor
102003923|NCT02596997|Brincidofovir|brincidofovir|mesh-list
102003991|NCT01289561|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
102003992|NCT01289561|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102003993|NCT01289561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102003994|NCT01289561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102003995|NCT01289561|Analgesics|analgesics|mesh-ancestor
102003996|NCT01289561|Sensory System Agents|sensory system agents|mesh-ancestor
102003997|NCT03855527|Chlorhexidine|chlorhexidine|mesh-list
102003999|NCT03855527|Cariostatic Agents|cariostatic agents|mesh-ancestor
102004000|NCT03855527|Protective Agents|protective agents|mesh-ancestor
102004001|NCT03855527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004002|NCT03855527|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102004052|NCT02359513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102004053|NCT01184495|Epoetin Alfa|epoetin alfa|mesh-list
102004054|NCT01184495|Hematinics|hematinics|mesh-ancestor
102004126|NCT01185119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102004127|NCT01185119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004128|NCT01185119|Incretins|incretins|mesh-ancestor
102004129|NCT03357640|Contraceptive Agents|contraceptive agents|mesh-list
102004130|NCT03357640|Contraceptives, Oral|contraceptives, oral|mesh-list
102004195|NCT03123718|Dermatologic Agents|dermatologic agents|mesh-ancestor
102004196|NCT03123718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102004197|NCT03123718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102004271|NCT03733327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102004343|NCT03847896|Albuterol|albuterol|mesh-list
102004344|NCT03847896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102004345|NCT03847896|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102004346|NCT03847896|Autonomic Agents|autonomic agents|mesh-ancestor
102004347|NCT03847896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102004348|NCT03847896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004349|NCT03847896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102004350|NCT03847896|Respiratory System Agents|respiratory system agents|mesh-ancestor
102004408|NCT04520230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102004409|NCT04520230|Adrenergic Agents|adrenergic agents|mesh-ancestor
102004410|NCT04520230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102004412|NCT04520230|Parasympatholytics|parasympatholytics|mesh-ancestor
102004480|NCT01291979|Lidocaine|lidocaine|mesh-list
102004481|NCT01291979|Anesthetics, Local|anesthetics, local|mesh-ancestor
102004482|NCT01291979|Anesthetics|anesthetics|mesh-ancestor
102004483|NCT01291979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102004484|NCT01291979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004485|NCT01291979|Sensory System Agents|sensory system agents|mesh-ancestor
102004548|NCT03732235|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102004549|NCT03732235|Estrogens|estrogens|mesh-ancestor
102004550|NCT03732235|Hormones|hormones|mesh-ancestor
102004551|NCT03732235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102004552|NCT03732235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102004553|NCT01289951|Raltegravir Potassium|raltegravir potassium|mesh-list
102004554|NCT01289951|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102004555|NCT01289951|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102004556|NCT01289951|Antiviral Agents|antiviral agents|mesh-ancestor
102004557|NCT01289951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102004558|NCT01289951|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102004559|NCT01289951|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102004560|NCT01289951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102004562|NCT01182077|Midazolam|midazolam|mesh-list
102004611|NCT03356080|Tretinoin|tretinoin|mesh-list
102004690|NCT03204279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004691|NCT02524301|Diprenorphine|diprenorphine|mesh-list
102004692|NCT02524301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102004693|NCT02524301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004694|NCT02524301|Sensory System Agents|sensory system agents|mesh-ancestor
102004762|NCT03856853|Pirfenidone|pirfenidone|mesh-list
102004763|NCT03856853|Analgesics|analgesics|mesh-ancestor
102004764|NCT03856853|Sensory System Agents|sensory system agents|mesh-ancestor
102004765|NCT03856853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102004766|NCT03856853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004834|NCT03732001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004867|NCT05666089|Calcium|calcium|mesh-list
102004907|NCT01291511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004908|NCT01291511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102004909|NCT01292213|Dimercaprol|dimercaprol|mesh-list
102004978|NCT03856697|Maleic acid|maleic acid|mesh-list
102004979|NCT03856697|Abivertinib|abivertinib|mesh-list
102004980|NCT03856697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102004981|NCT03856697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102004982|NCT03856697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102004983|NCT03856697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102004984|NCT03349606|Amphetamine|amphetamine|mesh-list
102004985|NCT03349606|Dextroamphetamine|dextroamphetamine|mesh-list
102004986|NCT03349606|FLB 457|flb 457|mesh-list
102004987|NCT03349606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102004988|NCT03349606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102004989|NCT03349606|Sympathomimetics|sympathomimetics|mesh-ancestor
102004990|NCT03349606|Autonomic Agents|autonomic agents|mesh-ancestor
102005001|NCT02843451|Silymarin|silymarin|mesh-list
102005041|NCT03349216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102005042|NCT03349216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005112|NCT01060579|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102005113|NCT04443946|Sufentanil|sufentanil|mesh-list
102005114|NCT04443946|Propofol|propofol|mesh-list
102005115|NCT04443946|Sevoflurane|sevoflurane|mesh-list
102005183|NCT03851393|Citric Acid|citric acid|mesh-list
102005185|NCT03851393|Anticoagulants|anticoagulants|mesh-ancestor
102005186|NCT03851393|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102005187|NCT03851393|Chelating Agents|chelating agents|mesh-ancestor
102005256|NCT02517814|Vitamin D|vitamin d|mesh-list
102005257|NCT02517814|Vitamins|vitamins|mesh-ancestor
102005258|NCT02517814|Micronutrients|micronutrients|mesh-ancestor
102005259|NCT02517814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005260|NCT02517814|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102005261|NCT05349201|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
102005262|NCT05349201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102005263|NCT05349201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102005264|NCT05303727|Cyclosporine|cyclosporine|mesh-list
102005265|NCT05303727|Mycophenolic Acid|mycophenolic acid|mesh-list
102005325|NCT01581203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102005326|NCT01581203|Antiviral Agents|antiviral agents|mesh-ancestor
102005335|NCT03168555|Cathartics|cathartics|mesh-ancestor
102005397|NCT04663464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102005398|NCT01292993|Metformin|metformin|mesh-list
102005400|NCT01292993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102005404|NCT03849833|Vitamin D|vitamin d|mesh-list
102005467|NCT03234036|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102005468|NCT03234036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102005469|NCT03606109|Tranexamic Acid|tranexamic acid|mesh-list
102005470|NCT03606109|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102005471|NCT03606109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102005472|NCT03606109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005473|NCT03606109|Hemostatics|hemostatics|mesh-ancestor
102005474|NCT03606109|Coagulants|coagulants|mesh-ancestor
101341755|NCT01806948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341756|NCT01806948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101341757|NCT01806948|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101341758|NCT01806948|Serotonin Agents|serotonin agents|mesh-ancestor
101341759|NCT01806948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101341760|NCT01806948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341783|NCT01806792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341785|NCT05228431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101341786|NCT05228431|Antimetabolites|antimetabolites|mesh-ancestor
101341787|NCT05228431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341788|NCT05228431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101341789|NCT05227456|Etonogestrel|etonogestrel|mesh-list
101341790|NCT05227456|Desogestrel|desogestrel|mesh-list
101341791|NCT05227456|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101341792|NCT05227456|Contraceptive Agents|contraceptive agents|mesh-ancestor
101341793|NCT05227456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101341794|NCT05227456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341797|NCT05227456|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102005475|NCT01191359|Immunomodulating Agents|immunomodulating agents|mesh-list
102005476|NCT01191359|Immunologic Factors|immunologic factors|mesh-ancestor
102005478|NCT01293071|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102005530|NCT04506034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102005531|NCT04506034|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102005532|NCT04506034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102005533|NCT04506034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102005535|NCT01294631|Canagliflozin|canagliflozin|mesh-list
102005597|NCT04454424|Anesthetics, General|anesthetics, general|mesh-ancestor
102005598|NCT04454424|Anesthetics|anesthetics|mesh-ancestor
102005599|NCT04454424|GABA Modulators|gaba modulators|mesh-ancestor
102005600|NCT04454424|GABA Agents|gaba agents|mesh-ancestor
102005601|NCT04454424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102005602|NCT04454424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005603|NCT03348046|Infliximab|infliximab|mesh-list
102005604|NCT03348046|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102005605|NCT03348046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102005606|NCT03348046|Dermatologic Agents|dermatologic agents|mesh-ancestor
102005607|NCT03348046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102005608|NCT03348046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102005609|NCT04505644|Lidocaine|lidocaine|mesh-list
102005610|NCT04505644|Anesthetics, Local|anesthetics, local|mesh-ancestor
102005611|NCT04505644|Anesthetics|anesthetics|mesh-ancestor
102005612|NCT04505644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102005657|NCT01296503|Dexamethasone|dexamethasone|mesh-list
102005658|NCT01296503|Dexamethasone acetate|dexamethasone acetate|mesh-list
102005659|NCT01296503|BB 1101|bb 1101|mesh-list
102005660|NCT01296503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102005661|NCT01296503|Antiemetics|antiemetics|mesh-ancestor
102005662|NCT01296503|Autonomic Agents|autonomic agents|mesh-ancestor
102005663|NCT01296503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102005664|NCT01296503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005665|NCT01296503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102005666|NCT01296503|Glucocorticoids|glucocorticoids|mesh-ancestor
102005667|NCT01296503|Hormones|hormones|mesh-ancestor
102005668|NCT01296503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102005720|NCT03122158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005721|NCT02668653|Cytarabine|cytarabine|mesh-list
102005722|NCT02668653|Daunorubicin|daunorubicin|mesh-list
102005792|NCT01194791|Hormones|hormones|mesh-ancestor
102005793|NCT01194791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102005794|NCT01194791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102005799|NCT03351322|Minoxidil|minoxidil|mesh-list
102005864|NCT03193047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102005865|NCT03193047|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102005867|NCT03193047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102005868|NCT03193047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102005869|NCT03193047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102005870|NCT03193047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102005871|NCT04504552|Avelumab|avelumab|mesh-list
102005872|NCT04504552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102005873|NCT04504552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102005931|NCT03346642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
102005932|NCT03346642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102006002|NCT02871297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006003|NCT02871297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102006004|NCT02871297|Serotonin Agents|serotonin agents|mesh-ancestor
102006074|NCT01584557|Natriuretic Agents|natriuretic agents|mesh-ancestor
102006144|NCT04338828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102006145|NCT04338828|Respiratory System Agents|respiratory system agents|mesh-ancestor
102006146|NCT04338828|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102006147|NCT04338828|Antioxidants|antioxidants|mesh-ancestor
102006148|NCT04338828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341945|NCT00393393|Hylan|hylan|mesh-list
102006149|NCT04338828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102006212|NCT01791478|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102006213|NCT01791478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102006282|NCT03844841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102006283|NCT03844841|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102006354|NCT03173456|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102006429|NCT05282771|Dermatologic Agents|dermatologic agents|mesh-ancestor
102006430|NCT05282771|Keratolytic Agents|keratolytic agents|mesh-ancestor
102006431|NCT05282771|Vitamin B Complex|vitamin b complex|mesh-ancestor
102006432|NCT05282771|Vitamins|vitamins|mesh-ancestor
102006433|NCT05282771|Micronutrients|micronutrients|mesh-ancestor
102006501|NCT03844451|Respiratory System Agents|respiratory system agents|mesh-ancestor
102006503|NCT03844451|Sympathomimetics|sympathomimetics|mesh-ancestor
102006504|NCT03844451|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102006505|NCT03346096|Thiotepa|thiotepa|mesh-list
102006506|NCT03346096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102006507|NCT03346096|Alkylating Agents|alkylating agents|mesh-ancestor
102006508|NCT03346096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006509|NCT03346096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102006510|NCT03346096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102006511|NCT03346096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101342065|NCT01806324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102006562|NCT03844763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102006564|NCT01198925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102006566|NCT03844139|Glycerol|glycerol|mesh-list
102006634|NCT02507440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102006635|NCT02507440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102006636|NCT02507440|Anesthetics, General|anesthetics, general|mesh-ancestor
102006637|NCT02507362|Riboflavin|riboflavin|mesh-list
102006638|NCT02507362|Dextrans|dextrans|mesh-list
102006639|NCT02507362|Vitamin B Complex|vitamin b complex|mesh-ancestor
102006640|NCT02507362|Vitamins|vitamins|mesh-ancestor
102006641|NCT02507362|Micronutrients|micronutrients|mesh-ancestor
102006642|NCT02507362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006643|NCT02507362|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102006702|NCT03034356|Anticonvulsants|anticonvulsants|mesh-ancestor
102006703|NCT03034356|Nootropic Agents|nootropic agents|mesh-ancestor
102006704|NCT03003468|Pembrolizumab|pembrolizumab|mesh-list
102006705|NCT03003468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102006706|NCT03003468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102006707|NCT03003468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102006712|NCT03552523|Pancrelipase|pancrelipase|mesh-list
102006769|NCT02892409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006770|NCT02892409|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102006771|NCT02892409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102006772|NCT02892409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102006773|NCT02892409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102006774|NCT02892409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102006775|NCT02892409|Antacids|antacids|mesh-ancestor
102006776|NCT02507128|Liraglutide|liraglutide|mesh-list
102006777|NCT02507128|Glucagon|glucagon|mesh-list
102006778|NCT02507128|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102006779|NCT02507128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102006780|NCT02507128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006781|NCT02507128|Incretins|incretins|mesh-ancestor
102006782|NCT02507128|Hormones|hormones|mesh-ancestor
101828272|NCT05839119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102006783|NCT02507128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102006784|NCT02507128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102006785|NCT03844529|Lidocaine|lidocaine|mesh-list
102006786|NCT03844529|Anesthetics, Local|anesthetics, local|mesh-ancestor
102006787|NCT03844529|Anesthetics|anesthetics|mesh-ancestor
102006788|NCT03844529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102006789|NCT03844529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006790|NCT03844529|Sensory System Agents|sensory system agents|mesh-ancestor
102006821|NCT03727867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102006822|NCT03727867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102006823|NCT02832648|Selenium|selenium|mesh-list
102006896|NCT03164057|Mitosis Modulators|mitosis modulators|mesh-ancestor
102006897|NCT03620526|Iloprost|iloprost|mesh-list
102006898|NCT03620526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102006899|NCT03620526|Vasodilator Agents|vasodilator agents|mesh-ancestor
102006900|NCT04532346|Hydroxychloroquine|hydroxychloroquine|mesh-list
102006969|NCT03597529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102006970|NCT03597529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102006971|NCT03991091|Oxytocin|oxytocin|mesh-list
102006972|NCT03991091|Oxytocics|oxytocics|mesh-ancestor
102006973|NCT03991091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102006974|NCT03991091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726747|NCT00807846|Analgesics|analgesics|mesh-ancestor
102006975|NCT05420454|Paclitaxel|paclitaxel|mesh-list
102006976|NCT05420454|Docetaxel|docetaxel|mesh-list
102006977|NCT05420454|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
102006978|NCT05420454|Cyclophosphamide|cyclophosphamide|mesh-list
102006979|NCT05420454|Carboplatin|carboplatin|mesh-list
102006980|NCT05420454|Trastuzumab|trastuzumab|mesh-list
102006981|NCT05420454|Epirubicin|epirubicin|mesh-list
102007033|NCT01202435|Analgesics|analgesics|mesh-ancestor
102007034|NCT01202435|Sensory System Agents|sensory system agents|mesh-ancestor
102007035|NCT01202435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102007104|NCT03570697|Protease Inhibitors|protease inhibitors|mesh-ancestor
102007105|NCT03570697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102007106|NCT03570697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102007177|NCT03835715|Vortioxetine|vortioxetine|mesh-list
102007178|NCT03835715|Antidepressive Agents|antidepressive agents|mesh-ancestor
102007249|NCT01202825|Protease Inhibitors|protease inhibitors|mesh-ancestor
102007250|NCT01202825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102007251|NCT01202825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007252|NCT02510872|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102007320|NCT02505568|Dermatologic Agents|dermatologic agents|mesh-ancestor
102007321|NCT02505568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102007322|NCT02505568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102007323|NCT05356728|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102007324|NCT05356728|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102007325|NCT05217836|Hepcidins|hepcidins|mesh-list
102007326|NCT05217836|Chrysarobin|chrysarobin|mesh-list
102007327|NCT05217836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102007328|NCT05217836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102007329|NCT05217836|Analgesics|analgesics|mesh-ancestor
102007330|NCT05217836|Sensory System Agents|sensory system agents|mesh-ancestor
102007334|NCT05217836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102007382|NCT01201499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102007383|NCT01201499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007456|NCT03344614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102007530|NCT02501200|Antimetabolites|antimetabolites|mesh-ancestor
102007531|NCT02501200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007532|NCT02501200|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102007533|NCT01205477|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102007534|NCT01205477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102007535|NCT02501278|Cisplatin|cisplatin|mesh-list
102007600|NCT01345682|Methotrexate|methotrexate|mesh-list
102007601|NCT01345682|Afatinib|afatinib|mesh-list
102007603|NCT01345682|Abortifacient Agents|abortifacient agents|mesh-ancestor
102007673|NCT05126264|Sensory System Agents|sensory system agents|mesh-ancestor
102007674|NCT05126264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102007675|NCT05126264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101828273|NCT05815160|Carboplatin|carboplatin|mesh-list
102007745|NCT03545503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102007746|NCT03545503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102007747|NCT03545503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102007748|NCT03545503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007749|NCT03545503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102007813|NCT05705570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102007814|NCT05705570|Alkylating Agents|alkylating agents|mesh-ancestor
102007815|NCT05705570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007884|NCT05199324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102007885|NCT05199324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102007958|NCT01300793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102007959|NCT01300793|Immunologic Factors|immunologic factors|mesh-ancestor
102007960|NCT01300793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102007961|NCT01300793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102007962|NCT01300793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102008027|NCT02496052|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102008028|NCT02496052|Estradiol|estradiol|mesh-list
102008029|NCT02496052|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
102008030|NCT02496052|Dydrogesterone|dydrogesterone|mesh-list
102008031|NCT02496052|Estrogens|estrogens|mesh-ancestor
102008032|NCT02496052|Hormones|hormones|mesh-ancestor
102008097|NCT03841292|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102008098|NCT03841292|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102008099|NCT03841292|Cholinergic Agents|cholinergic agents|mesh-ancestor
102008169|NCT03558997|Immunologic Factors|immunologic factors|mesh-ancestor
102008170|NCT03558997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008171|NCT03814343|Amphotericin B|amphotericin b|mesh-list
102008172|NCT03814343|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102008173|NCT03814343|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
101727952|NCT00590538|Phytoestrogens|phytoestrogens|mesh-ancestor
102008174|NCT03814343|Amebicides|amebicides|mesh-ancestor
102008175|NCT03814343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102008176|NCT03814343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102008177|NCT03814343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102008178|NCT03814343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102008179|NCT03814343|Antifungal Agents|antifungal agents|mesh-ancestor
102008180|NCT03814343|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
102008232|NCT03725995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
102008236|NCT03725995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102008302|NCT03335098|Growth Substances|growth substances|mesh-ancestor
102008377|NCT04443166|Hyaluronic Acid|hyaluronic acid|mesh-list
102008378|NCT04443166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102008379|NCT04443166|Immunologic Factors|immunologic factors|mesh-ancestor
102008380|NCT04443166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008381|NCT04443166|Viscosupplements|viscosupplements|mesh-ancestor
102008382|NCT04443166|Protective Agents|protective agents|mesh-ancestor
102008383|NCT01560221|Buprenorphine|buprenorphine|mesh-list
102008384|NCT01560221|Methadone|methadone|mesh-list
102008385|NCT01560221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102008386|NCT01560221|Narcotics|narcotics|mesh-ancestor
102008387|NCT01560221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102008388|NCT01560221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008389|NCT01560221|Analgesics|analgesics|mesh-ancestor
102008390|NCT01560221|Sensory System Agents|sensory system agents|mesh-ancestor
102008391|NCT01560221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102008440|NCT03339700|Gemcitabine|gemcitabine|mesh-list
102008441|NCT03339700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102008512|NCT02499874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102008513|NCT02499874|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
102008514|NCT02499874|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102008515|NCT02499874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102008516|NCT02499874|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102008517|NCT02492308|Basiliximab|basiliximab|mesh-list
102008518|NCT02492308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102008519|NCT02492308|Immunologic Factors|immunologic factors|mesh-ancestor
102008520|NCT02492308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008521|NCT05865470|Dronabinol|dronabinol|mesh-list
102008522|NCT05865470|Hallucinogens|hallucinogens|mesh-ancestor
102008523|NCT05865470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008524|NCT05865470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102008525|NCT05865470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102008573|NCT05864053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102008574|NCT05864053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008575|NCT05864053|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
102008576|NCT05864053|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102008577|NCT05864053|Anesthetics, General|anesthetics, general|mesh-ancestor
101342554|NCT00009893|Vitamins|vitamins|mesh-ancestor
102008644|NCT05863858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102008645|NCT05863858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102008646|NCT05863858|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102008653|NCT05863845|Cytarabine|cytarabine|mesh-list
102008717|NCT05863416|Dexmedetomidine|dexmedetomidine|mesh-list
102008718|NCT05863416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102008719|NCT05863416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102008720|NCT05863416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008721|NCT05863416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102008723|NCT05863416|Sensory System Agents|sensory system agents|mesh-ancestor
102008724|NCT05863416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102008725|NCT05863416|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
102008726|NCT05863416|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102008727|NCT05863416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102008728|NCT05863416|Adrenergic Agents|adrenergic agents|mesh-ancestor
102008729|NCT05863416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102008730|NCT05863416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008788|NCT05856500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102008789|NCT05849779|Sevoflurane|sevoflurane|mesh-list
102008790|NCT05849779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102008791|NCT05849779|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102008792|NCT05849779|Anesthetics, General|anesthetics, general|mesh-ancestor
102008793|NCT05849779|Anesthetics|anesthetics|mesh-ancestor
102008794|NCT05849779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102008795|NCT05849779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008796|NCT05847517|Metoprolol|metoprolol|mesh-list
102008853|NCT05766345|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102008854|NCT05766345|Immunologic Factors|immunologic factors|mesh-ancestor
102008855|NCT05766345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102008856|NCT05756153|Cetuximab|cetuximab|mesh-list
102008859|NCT05743777|Pembrolizumab|pembrolizumab|mesh-list
102008926|NCT05580003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102008927|NCT05580003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102008998|NCT05422131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009000|NCT05422131|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102009001|NCT05422131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102009002|NCT05422131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102009003|NCT05422131|GABA Antagonists|gaba antagonists|mesh-ancestor
101728767|NCT00787605|Vasodilator Agents|vasodilator agents|mesh-ancestor
102009004|NCT05422131|GABA Agents|gaba agents|mesh-ancestor
102009005|NCT05415228|Edetic Acid|edetic acid|mesh-list
102009006|NCT05415228|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
102009007|NCT05415228|Chelating Agents|chelating agents|mesh-ancestor
102009008|NCT05415228|Sequestering Agents|sequestering agents|mesh-ancestor
102009009|NCT05415228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009010|NCT05415228|Anticoagulants|anticoagulants|mesh-ancestor
102009011|NCT05415228|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102009012|NCT05415228|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102009013|NCT05357079|Tranexamic Acid|tranexamic acid|mesh-list
102009017|NCT05357079|Hemostatics|hemostatics|mesh-ancestor
102009053|NCT05109728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102009054|NCT05109728|Alkylating Agents|alkylating agents|mesh-ancestor
102009055|NCT05109728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009056|NCT05109728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009057|NCT05109728|Chelating Agents|chelating agents|mesh-ancestor
102009122|NCT04967495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009123|NCT04967495|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102009124|NCT04967495|Estrogens|estrogens|mesh-ancestor
102009125|NCT04967495|Hormones|hormones|mesh-ancestor
102009190|NCT04737889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102009191|NCT04737889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102009192|NCT04737889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102009193|NCT04737889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102009259|NCT04616729|Contraceptive Agents|contraceptive agents|mesh-ancestor
102009260|NCT04616729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102009261|NCT04616729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009334|NCT04255134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102009335|NCT04255134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102009336|NCT04255134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009405|NCT04067037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102009406|NCT04067037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009407|NCT04067037|Tubulin Modulators|tubulin modulators|mesh-ancestor
102009473|NCT03491683|Temozolomide|temozolomide|mesh-list
102009474|NCT03491683|Cemiplimab|cemiplimab|mesh-list
102009475|NCT03491683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102009476|NCT03491683|Alkylating Agents|alkylating agents|mesh-ancestor
102009477|NCT03491683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009478|NCT03491683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102009479|NCT03491683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102009480|NCT03351296|Bevacizumab|bevacizumab|mesh-list
102009481|NCT03351296|Capecitabine|capecitabine|mesh-list
102009539|NCT02669173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102009540|NCT02669173|Antimetabolites|antimetabolites|mesh-ancestor
102009541|NCT02669173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009542|NCT02647437|Levetiracetam|levetiracetam|mesh-list
102009612|NCT01808599|Alkylating Agents|alkylating agents|mesh-ancestor
102009613|NCT01808599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009614|NCT00071071|Zanolimumab|zanolimumab|mesh-list
102009615|NCT00071071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102009616|NCT00071071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102009683|NCT03332524|Ibuprofen|ibuprofen|mesh-list
102009684|NCT03332524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102009685|NCT03332524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102009686|NCT03332524|Analgesics|analgesics|mesh-ancestor
102009687|NCT03332524|Sensory System Agents|sensory system agents|mesh-ancestor
102009755|NCT02440230|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
102009756|NCT02440230|Hormone Antagonists|hormone antagonists|mesh-ancestor
102009757|NCT02440230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102009758|NCT02440230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009825|NCT03515941|Immunologic Factors|immunologic factors|mesh-ancestor
102009826|NCT03515941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009827|NCT03515941|Antidotes|antidotes|mesh-ancestor
102009828|NCT03515941|Protective Agents|protective agents|mesh-ancestor
102009829|NCT03515941|Vitamin B Complex|vitamin b complex|mesh-ancestor
102009830|NCT03515941|Vitamins|vitamins|mesh-ancestor
102009831|NCT03515941|Micronutrients|micronutrients|mesh-ancestor
102009832|NCT02492074|Dronabinol|dronabinol|mesh-list
102009833|NCT02492074|Cannabidiol|cannabidiol|mesh-list
102009834|NCT02492074|Anticonvulsants|anticonvulsants|mesh-ancestor
102009835|NCT02492074|Hallucinogens|hallucinogens|mesh-ancestor
102009836|NCT02492074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102009837|NCT02492074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102009838|NCT02492074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102009839|NCT02492074|Analgesics|analgesics|mesh-ancestor
102009840|NCT02492074|Sensory System Agents|sensory system agents|mesh-ancestor
102009841|NCT02492074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102009842|NCT02492074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
102009843|NCT02492074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
102009844|NCT02492074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102009845|NCT02492074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102009846|NCT02492074|Hormones|hormones|mesh-ancestor
102009879|NCT03331432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102009880|NCT03331432|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
102009881|NCT03331432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102009883|NCT03512353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102009952|NCT03510715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102009953|NCT03510715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102009954|NCT03510715|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102010026|NCT03722875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102010027|NCT03722875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102010030|NCT04860713|Ketamine|ketamine|mesh-list
102010098|NCT03796403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102010102|NCT00706654|Aripiprazole|aripiprazole|mesh-list
102010169|NCT01303055|Protease Inhibitors|protease inhibitors|mesh-ancestor
102010170|NCT01303055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102010171|NCT01303055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010174|NCT03636048|Propofol|propofol|mesh-list
102010239|NCT02861183|Viscosupplements|viscosupplements|mesh-ancestor
102010240|NCT02861183|Protective Agents|protective agents|mesh-ancestor
102010241|NCT02498002|Lidocaine|lidocaine|mesh-list
102010311|NCT03164772|Tremelimumab|tremelimumab|mesh-list
102010312|NCT03164772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102010313|NCT03164772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102010384|NCT03050450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102010385|NCT03050450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010386|NCT03799679|Antineoplastic Agents|antineoplastic agents|mesh-list
102010387|NCT03505021|Simendan|simendan|mesh-list
102010388|NCT03505021|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
102010389|NCT03505021|Vasodilator Agents|vasodilator agents|mesh-ancestor
102010390|NCT03505021|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
102010391|NCT03505021|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102010392|NCT03505021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102010396|NCT03793283|Insulin|insulin|mesh-list
102010452|NCT03792971|Avasopasem manganese|avasopasem manganese|mesh-list
102010453|NCT03792971|Antitussive Agents|antitussive agents|mesh-ancestor
102010454|NCT03792971|Respiratory System Agents|respiratory system agents|mesh-ancestor
102010455|NCT03792971|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102010456|NCT03792971|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102010520|NCT02496910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010521|NCT02496910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102010590|NCT03324490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102010664|NCT01489176|Purinergic Agonists|purinergic agonists|mesh-ancestor
102010665|NCT01489176|Purinergic Agents|purinergic agents|mesh-ancestor
102010666|NCT01489176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102010669|NCT03792503|Pemetrexed|pemetrexed|mesh-list
102010735|NCT03328312|Autonomic Agents|autonomic agents|mesh-ancestor
102010736|NCT03328312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102010738|NCT03328312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102010807|NCT02488564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102010808|NCT02488564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102010809|NCT02966873|Acetylcysteine|acetylcysteine|mesh-list
102010810|NCT02966873|N-monoacetylcystine|n-monoacetylcystine|mesh-list
102010811|NCT02966873|Antiviral Agents|antiviral agents|mesh-ancestor
102010812|NCT02966873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102010813|NCT02966873|Expectorants|expectorants|mesh-ancestor
102010814|NCT02966873|Respiratory System Agents|respiratory system agents|mesh-ancestor
102010815|NCT02966873|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102010816|NCT02966873|Antioxidants|antioxidants|mesh-ancestor
101828274|NCT05815160|Etoposide|etoposide|mesh-list
101331435|NCT00034606|Pemetrexed|pemetrexed|mesh-list
102010817|NCT02966873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010818|NCT02966873|Protective Agents|protective agents|mesh-ancestor
102010819|NCT02966873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010820|NCT02966873|Antidotes|antidotes|mesh-ancestor
102010821|NCT03792347|Pembrolizumab|pembrolizumab|mesh-list
102010822|NCT03792347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102010823|NCT03792347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102010824|NCT03792347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102010825|NCT03792347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010826|NCT04697186|Amoxicillin|amoxicillin|mesh-list
102010863|NCT02488486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010864|NCT02488486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102010865|NCT02488486|Anesthetics, General|anesthetics, general|mesh-ancestor
102010935|NCT01334034|Insulin Glargine|insulin glargine|mesh-list
102010936|NCT01334034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102010937|NCT01334034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010939|NCT03050060|Pembrolizumab|pembrolizumab|mesh-list
102010940|NCT03050060|Nivolumab|nivolumab|mesh-list
102010941|NCT03050060|Atezolizumab|atezolizumab|mesh-list
102010942|NCT03050060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102010943|NCT03050060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102010944|NCT03050060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102010945|NCT03050060|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102010946|NCT03050060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010947|NCT03050060|Immunologic Factors|immunologic factors|mesh-ancestor
102010948|NCT03050060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102010957|NCT01334112|Axitinib|axitinib|mesh-list
102010997|NCT05464940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102010998|NCT05464940|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
102011069|NCT03799601|Tubulin Modulators|tubulin modulators|mesh-ancestor
102011070|NCT03799601|Antimitotic Agents|antimitotic agents|mesh-ancestor
102011071|NCT03799601|Mitosis Modulators|mitosis modulators|mesh-ancestor
102011072|NCT03799601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011136|NCT03797729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011137|NCT03797729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102011138|NCT02487940|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
102011139|NCT02487940|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
102011205|NCT02490982|Immunologic Factors|immunologic factors|mesh-ancestor
102011206|NCT03322150|Atropine|atropine|mesh-list
102011207|NCT03322150|Glycopyrrolate|glycopyrrolate|mesh-list
102011208|NCT03322150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102011209|NCT03322150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102011210|NCT03322150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102011280|NCT01305707|Antidepressive Agents|antidepressive agents|mesh-list
102011281|NCT01305707|Escitalopram|escitalopram|mesh-list
102011282|NCT01305707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102011283|NCT01305707|Serotonin Agents|serotonin agents|mesh-ancestor
102011284|NCT01305707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102011285|NCT01305707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011286|NCT01305707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011287|NCT01305707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102011288|NCT01305707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102011289|NCT01305707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102011290|NCT01305707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102011345|NCT03722329|Immunologic Factors|immunologic factors|mesh-ancestor
102011346|NCT03722329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011347|NCT03467971|Metformin|metformin|mesh-list
102011348|NCT03467971|Gliclazide|gliclazide|mesh-list
102011349|NCT03467971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102011350|NCT03467971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011351|NCT03791099|Metronidazole|metronidazole|mesh-list
102011352|NCT03791099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102011353|NCT03791099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102011354|NCT03791099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102011355|NCT03791099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102011408|NCT00908076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011409|NCT01305317|Atorvastatin|atorvastatin|mesh-list
102011410|NCT01305317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102011411|NCT01305317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102011412|NCT01305317|Antimetabolites|antimetabolites|mesh-ancestor
102011413|NCT01305317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011414|NCT01305317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102011415|NCT01305317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102011473|NCT03498313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011474|NCT03498313|Progestins|progestins|mesh-ancestor
102011546|NCT02487316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102011547|NCT02487316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011548|NCT02490436|Cetuximab|cetuximab|mesh-list
102011549|NCT02490436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102011550|NCT02490436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102011551|NCT03318718|Rocuronium|rocuronium|mesh-list
102011552|NCT03318718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011553|NCT03318718|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
102011557|NCT03325348|Labetalol|labetalol|mesh-list
102011612|NCT01334502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102011613|NCT01334502|Glucocorticoids|glucocorticoids|mesh-ancestor
102011698|NCT03789695|Dabigatran|dabigatran|mesh-list
102011761|NCT00400218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102011834|NCT03321292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102011835|NCT03321292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102011836|NCT03321292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011837|NCT03321292|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102011838|NCT03321292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102011839|NCT03321292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102011840|NCT03321292|Antipyretics|antipyretics|mesh-ancestor
102011841|NCT01306721|Fexofenadine|fexofenadine|mesh-list
102011842|NCT01306721|Pseudoephedrine|pseudoephedrine|mesh-list
102011844|NCT01306721|Terfenadine|terfenadine|mesh-list
102011845|NCT01306721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102011847|NCT01306721|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102011897|NCT01335048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102011898|NCT01335048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102011899|NCT01335048|Antimetabolites|antimetabolites|mesh-ancestor
102011967|NCT01335360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102011968|NCT01335360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102011969|NCT01335360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102011970|NCT01335360|Antiviral Agents|antiviral agents|mesh-ancestor
102011971|NCT01335360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102011972|NCT01335360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102011973|NCT01335360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102011974|NCT01335360|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102011975|NCT01335360|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102011976|NCT02489266|Aldesleukin|aldesleukin|mesh-list
102011977|NCT02489266|Cyclophosphamide|cyclophosphamide|mesh-list
102011978|NCT02489266|Fludarabine|fludarabine|mesh-list
102012030|NCT01307189|Parasympatholytics|parasympatholytics|mesh-ancestor
102012105|NCT03160716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012106|NCT03160716|Sensory System Agents|sensory system agents|mesh-ancestor
102012178|NCT01338090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102012179|NCT01338090|Immunologic Factors|immunologic factors|mesh-ancestor
102012180|NCT01338090|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102012181|NCT01307969|Lidocaine|lidocaine|mesh-list
102012182|NCT01307969|Epinephrine|epinephrine|mesh-list
102012183|NCT01307969|Racepinephrine|racepinephrine|mesh-list
102012184|NCT01307969|Ropivacaine|ropivacaine|mesh-list
102012185|NCT01307969|Epinephryl borate|epinephryl borate|mesh-list
102012245|NCT01308047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102012247|NCT03777605|Vasodilator Agents|vasodilator agents|mesh-ancestor
102012248|NCT03777761|Moxifloxacin|moxifloxacin|mesh-list
102012249|NCT03777761|Tucatinib|tucatinib|mesh-list
102012250|NCT03777761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102012251|NCT03777761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102012252|NCT03777761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102012253|NCT03777761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102012254|NCT03777761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102012255|NCT03777761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012256|NCT03777761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102012257|NCT03777761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102012258|NCT01316861|Acarbose|acarbose|mesh-list
102012304|NCT03775655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102012305|NCT03775655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102012306|NCT03775655|Adrenergic Agents|adrenergic agents|mesh-ancestor
102012307|NCT03775655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102012374|NCT01313429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102012375|NCT01313429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102012376|NCT01313429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102012377|NCT01313429|Analgesics|analgesics|mesh-ancestor
102012378|NCT01313429|Sensory System Agents|sensory system agents|mesh-ancestor
102012379|NCT01313429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102012380|NCT01313429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102012381|NCT01313429|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
102012441|NCT01313585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012443|NCT01313585|Respiratory System Agents|respiratory system agents|mesh-ancestor
102012444|NCT01313585|Tocolytic Agents|tocolytic agents|mesh-ancestor
102012445|NCT01313585|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102012446|NCT01313585|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102012447|NCT01313585|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102012448|NCT01313585|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102012449|NCT01313585|Adrenergic Agents|adrenergic agents|mesh-ancestor
102012450|NCT01313585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102012451|NCT01313585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012501|NCT03315364|Antimitotic Agents|antimitotic agents|mesh-ancestor
102012502|NCT03315364|Mitosis Modulators|mitosis modulators|mesh-ancestor
102012503|NCT03315364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012504|NCT03779633|Estradiol|estradiol|mesh-list
102012505|NCT03779633|Estrogens|estrogens|mesh-ancestor
102012572|NCT01265784|Ertapenem|ertapenem|mesh-list
102012573|NCT01265784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102012574|NCT01265784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102012646|NCT03316690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012647|NCT03315052|Mycophenolic Acid|mycophenolic acid|mesh-list
102012648|NCT03315052|Prednisone|prednisone|mesh-list
102012649|NCT03315052|Budesonide|budesonide|mesh-list
102012650|NCT03315052|Tacrolimus|tacrolimus|mesh-list
102012651|NCT03315052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102012652|NCT03315052|Glucocorticoids|glucocorticoids|mesh-ancestor
102012653|NCT03315052|Hormones|hormones|mesh-ancestor
102012654|NCT03315052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102012655|NCT03315052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012656|NCT03315052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102012657|NCT03315052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102012658|NCT03315052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102012659|NCT03315052|Immunologic Factors|immunologic factors|mesh-ancestor
102012660|NCT03315052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102012661|NCT03315052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102012662|NCT03315052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012705|NCT03156504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102012706|NCT03156504|Anesthetics, General|anesthetics, general|mesh-ancestor
102012707|NCT03156504|Anesthetics|anesthetics|mesh-ancestor
102012708|NCT03156504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102012709|NCT03156504|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102012710|NCT03156504|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102012711|NCT03156504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102012712|NCT03156504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012713|NCT01333332|Capecitabine|capecitabine|mesh-list
102012714|NCT01333332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102012715|NCT01333332|Antimetabolites|antimetabolites|mesh-ancestor
102012716|NCT01333332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012717|NCT01333332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102012718|NCT03316534|Aspirin|aspirin|mesh-list
102012719|NCT03316534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102012720|NCT03316534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102012721|NCT03316534|Analgesics|analgesics|mesh-ancestor
102012722|NCT03316534|Sensory System Agents|sensory system agents|mesh-ancestor
102012758|NCT01320449|Epoetin Alfa|epoetin alfa|mesh-list
102012759|NCT01320449|Hematinics|hematinics|mesh-ancestor
102012760|NCT03430063|Ipilimumab|ipilimumab|mesh-list
102012761|NCT03430063|Cemiplimab|cemiplimab|mesh-list
102012762|NCT03430063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102012763|NCT03430063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102012764|NCT03430063|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101343480|NCT00014651|Vapreotide|vapreotide|mesh-list
102012765|NCT03430063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012766|NCT03158220|Vaccines|vaccines|mesh-list
102012824|NCT03774095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012825|NCT03774095|Protective Agents|protective agents|mesh-ancestor
102012826|NCT03774095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102012827|NCT01333410|Mometasone Furoate|mometasone furoate|mesh-list
102012828|NCT01333410|Tacrolimus|tacrolimus|mesh-list
102012829|NCT01333410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102012830|NCT01333410|Immunologic Factors|immunologic factors|mesh-ancestor
102012831|NCT01333410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102012832|NCT01333410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102012833|NCT01333410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102012834|NCT01333410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102012835|NCT01333410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102012836|NCT01333410|Dermatologic Agents|dermatologic agents|mesh-ancestor
102012837|NCT01333410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102012838|NCT02482090|Cyclophosphamide|cyclophosphamide|mesh-list
102012839|NCT02482090|Fludarabine|fludarabine|mesh-list
102012840|NCT02482090|Interleukin-2|interleukin-2|mesh-list
102012841|NCT02482090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102012842|NCT02482090|Immunologic Factors|immunologic factors|mesh-ancestor
102012844|NCT02482090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102012879|NCT03784703|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102012880|NCT03784703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102012881|NCT02724592|Fluorides|fluorides|mesh-list
102012949|NCT01309139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102012951|NCT01309139|Parasympatholytics|parasympatholytics|mesh-ancestor
102013020|NCT02481076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102013028|NCT02481076|Ionophores|ionophores|mesh-ancestor
102013095|NCT02478424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102013096|NCT02478424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102013097|NCT02478424|Antifungal Agents|antifungal agents|mesh-ancestor
102013098|NCT02478424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102013099|NCT02478424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102013100|NCT02478424|Anticonvulsants|anticonvulsants|mesh-ancestor
102013101|NCT03712787|Tilavonemab|tilavonemab|mesh-list
102013102|NCT03712787|Nootropic Agents|nootropic agents|mesh-ancestor
102013103|NCT02478268|Xenon|xenon|mesh-list
102013104|NCT02478268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
102013105|NCT02478268|Anesthetics, General|anesthetics, general|mesh-ancestor
102013106|NCT02478268|Anesthetics|anesthetics|mesh-ancestor
102013107|NCT02478268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102013108|NCT02478268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013109|NCT04053881|Certolizumab Pegol|certolizumab pegol|mesh-list
102013110|NCT04053881|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102013111|NCT04053881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102013153|NCT04998214|Hemostatics|hemostatics|mesh-ancestor
102013154|NCT04998214|Coagulants|coagulants|mesh-ancestor
102013155|NCT01309607|Paclitaxel|paclitaxel|mesh-list
102013156|NCT01309607|Carboplatin|carboplatin|mesh-list
102013157|NCT01309607|Lapatinib|lapatinib|mesh-list
102013225|NCT05708248|Free Radical Scavengers|free radical scavengers|mesh-ancestor
102013226|NCT05708248|Antioxidants|antioxidants|mesh-ancestor
102013227|NCT05685394|Dapagliflozin|dapagliflozin|mesh-list
102013228|NCT05685394|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
102013230|NCT05685394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102013295|NCT01309685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102013296|NCT01309685|Cholinergic Agents|cholinergic agents|mesh-ancestor
102013297|NCT01309685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102013368|NCT03771053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343615|NCT00015548|Olanzapine|olanzapine|mesh-list
102013369|NCT03771053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102013370|NCT03771053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102013371|NCT03771053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102013372|NCT03770663|Cyclophosphamide|cyclophosphamide|mesh-list
102013373|NCT03770663|Azathioprine|azathioprine|mesh-list
102013375|NCT03770663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102013376|NCT03770663|Immunologic Factors|immunologic factors|mesh-ancestor
102013377|NCT03770663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013378|NCT03770663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102013379|NCT03770663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102013380|NCT03770663|Alkylating Agents|alkylating agents|mesh-ancestor
102013381|NCT03770663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013382|NCT03770663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102013424|NCT01321775|Bevacizumab|bevacizumab|mesh-list
101733168|NCT05438277|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102013426|NCT01321775|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102013427|NCT01321775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102013428|NCT01321775|Tubulin Modulators|tubulin modulators|mesh-ancestor
102013429|NCT01321775|Antimitotic Agents|antimitotic agents|mesh-ancestor
102013430|NCT01321775|Mitosis Modulators|mitosis modulators|mesh-ancestor
102013431|NCT01321775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013432|NCT01321775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102013433|NCT01321775|Immunologic Factors|immunologic factors|mesh-ancestor
102013434|NCT01321775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013435|NCT01321775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102013436|NCT01321775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102013437|NCT01321775|Alkylating Agents|alkylating agents|mesh-ancestor
102013484|NCT03763409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102013485|NCT03763409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013486|NCT01322477|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
102013554|NCT03755609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102013555|NCT03755609|Narcotics|narcotics|mesh-ancestor
102013629|NCT03755531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013630|NCT04854707|Menotropins|menotropins|mesh-list
102013631|NCT04854707|Hormones|hormones|mesh-list
102013700|NCT03753581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102013701|NCT03753581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102013702|NCT03753581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102013705|NCT04507763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102013771|NCT02474212|Enoxaparin|enoxaparin|mesh-list
102013772|NCT02474212|Anticoagulants|anticoagulants|mesh-ancestor
102013773|NCT02474212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102013774|NCT02474212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101331606|NCT00000716|Zidovudine|zidovudine|mesh-list
102013775|NCT02474212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013776|NCT05200286|Olorofim|olorofim|mesh-list
102013842|NCT02477488|Antioxidants|antioxidants|mesh-ancestor
102013843|NCT02477488|Protective Agents|protective agents|mesh-ancestor
102013844|NCT02477488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102013845|NCT05163106|Letrozole|letrozole|mesh-list
102013846|NCT05163106|Goserelin|goserelin|mesh-list
102013913|NCT02473198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102013918|NCT03614728|Azacitidine|azacitidine|mesh-list
102013985|NCT04736394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102013986|NCT04736394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013988|NCT01341834|Panobinostat|panobinostat|mesh-list
102013989|NCT01341834|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
102013990|NCT01341834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102013991|NCT01341834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101343709|NCT00015821|Leprostatic Agents|leprostatic agents|mesh-ancestor
102013992|NCT01341834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102013993|NCT01341834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102013994|NCT01341834|Immunologic Factors|immunologic factors|mesh-ancestor
102013995|NCT01341834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014048|NCT03212716|Diltiazem|diltiazem|mesh-list
102014049|NCT03212716|Antiviral Agents|antiviral agents|mesh-ancestor
102014050|NCT03212716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102014051|NCT03212716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102014059|NCT04762836|Cycloserine|cycloserine|mesh-list
102014120|NCT04702776|Hyaluronic Acid|hyaluronic acid|mesh-list
102014121|NCT04702776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102014122|NCT04702776|Immunologic Factors|immunologic factors|mesh-ancestor
102014123|NCT04702776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014126|NCT03310372|Temozolomide|temozolomide|mesh-list
102014193|NCT03685188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102014194|NCT03685188|Narcotics|narcotics|mesh-ancestor
102014195|NCT03685188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102014204|NCT02305654|Paclitaxel|paclitaxel|mesh-list
102014265|NCT03309436|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102014266|NCT03309436|Fertility Agents|fertility agents|mesh-ancestor
101343777|NCT00275106|Autonomic Agents|autonomic agents|mesh-ancestor
102014267|NCT03309436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102014268|NCT03309436|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102014269|NCT03309436|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102014270|NCT05183334|Sildenafil Citrate|sildenafil citrate|mesh-list
102014271|NCT05183334|Tramadol|tramadol|mesh-list
102014272|NCT05183334|Vasodilator Agents|vasodilator agents|mesh-ancestor
102014273|NCT05183334|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102014274|NCT05183334|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102014275|NCT05183334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102014276|NCT05183334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014277|NCT05183334|Urological Agents|urological agents|mesh-ancestor
102014278|NCT05183334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102014279|NCT05183334|Narcotics|narcotics|mesh-ancestor
102014280|NCT05183334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102014281|NCT05183334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014282|NCT05183334|Analgesics|analgesics|mesh-ancestor
102014283|NCT05183334|Sensory System Agents|sensory system agents|mesh-ancestor
102014284|NCT05183334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102014285|NCT03304444|Bupivacaine|bupivacaine|mesh-list
102014286|NCT03304444|Anesthetics, Local|anesthetics, local|mesh-ancestor
102014287|NCT03304444|Anesthetics|anesthetics|mesh-ancestor
102014288|NCT03304444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102014292|NCT03304288|Rituximab|rituximab|mesh-list
102014316|NCT03303976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014317|NCT03313414|Sofosbuvir|sofosbuvir|mesh-list
102014318|NCT03313414|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102014319|NCT03313414|Velpatasvir|velpatasvir|mesh-list
102014320|NCT03313414|Antiviral Agents|antiviral agents|mesh-ancestor
102014321|NCT03313414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102014382|NCT01343628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102014383|NCT01343628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014384|NCT00703924|Paromomycin|paromomycin|mesh-list
102014385|NCT00703924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102014386|NCT00703924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102014387|NCT00703924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102014388|NCT00703924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102014451|NCT03302182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102014452|NCT03302182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102014522|NCT05214066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102014523|NCT02468206|Polidocanol|polidocanol|mesh-list
102014524|NCT02468206|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
102014594|NCT03210688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102014595|NCT03210688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102014597|NCT03210688|Vitamins|vitamins|mesh-ancestor
102014667|NCT03305068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102014668|NCT03305068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102014670|NCT04490590|Etoposide|etoposide|mesh-list
102014739|NCT01347996|Interleukin-2|interleukin-2|mesh-list
102014814|NCT05245006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102014815|NCT01465334|Methylprednisolone|methylprednisolone|mesh-list
102014816|NCT01465334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102014884|NCT02718898|Dermatologic Agents|dermatologic agents|mesh-ancestor
102014885|NCT05726734|Amoxicillin|amoxicillin|mesh-list
102014886|NCT05726734|Metronidazole|metronidazole|mesh-list
102014887|NCT05726734|Potassium Citrate|potassium citrate|mesh-list
102014888|NCT05726734|Esomeprazole|esomeprazole|mesh-list
102014889|NCT05726734|Bismuth|bismuth|mesh-list
102014890|NCT05726734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102014954|NCT01353846|Triptorelin Pamoate|triptorelin pamoate|mesh-list
102014955|NCT01353846|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
102014956|NCT01353846|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
102015028|NCT03143166|Dabigatran|dabigatran|mesh-list
102015029|NCT03143166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102015030|NCT03143166|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102015031|NCT03143166|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102015033|NCT03143166|Antithrombins|antithrombins|mesh-ancestor
102015097|NCT03928158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102015098|NCT03928158|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102015101|NCT05174884|Etonogestrel|etonogestrel|mesh-list
102015167|NCT00702052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102015168|NCT00702052|Immunologic Factors|immunologic factors|mesh-ancestor
102015169|NCT00702052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344061|NCT00016367|Cisplatin|cisplatin|mesh-list
102015170|NCT00702052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102015172|NCT01354470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102015173|NCT01354470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015174|NCT01354470|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
102015175|NCT01354470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102015176|NCT01354470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102015231|NCT01318590|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102015232|NCT01318590|Bupivacaine|bupivacaine|mesh-list
102015233|NCT01318590|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102015234|NCT01318590|Anesthetics, Local|anesthetics, local|mesh-ancestor
102015303|NCT03377790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015305|NCT01347294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102015306|NCT01347294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102015307|NCT02422368|Methylprednisolone|methylprednisolone|mesh-list
102015377|NCT01844856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102015378|NCT01844856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102015447|NCT02463994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102015448|NCT02463994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102015449|NCT04235686|Amphetamine|amphetamine|mesh-list
102015450|NCT04235686|Dextroamphetamine|dextroamphetamine|mesh-list
102015451|NCT04235686|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102015452|NCT04235686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015516|NCT05605834|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102015517|NCT05605834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102015518|NCT00005780|Prednisone|prednisone|mesh-list
102015519|NCT00005780|Cyclophosphamide|cyclophosphamide|mesh-list
102015520|NCT00005780|Doxorubicin|doxorubicin|mesh-list
102015521|NCT00005780|Etoposide|etoposide|mesh-list
102015522|NCT00005780|Vincristine|vincristine|mesh-list
102015585|NCT02465008|Anesthetics, Local|anesthetics, local|mesh-ancestor
102015586|NCT02465008|Anesthetics|anesthetics|mesh-ancestor
102015587|NCT02465008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102015588|NCT02465008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015658|NCT05547256|Immunologic Factors|immunologic factors|mesh-ancestor
101331778|NCT00014430|Antimitotic Agents|antimitotic agents|mesh-ancestor
102015659|NCT05547256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015660|NCT01757782|Sildenafil Citrate|sildenafil citrate|mesh-list
102015661|NCT01757782|Vasodilator Agents|vasodilator agents|mesh-ancestor
102015662|NCT01757782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102015663|NCT01757782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102015664|NCT01757782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102015665|NCT01757782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015723|NCT03129360|Anticonvulsants|anticonvulsants|mesh-ancestor
102015724|NCT03129360|Nootropic Agents|nootropic agents|mesh-ancestor
102015725|NCT01315275|Ranibizumab|ranibizumab|mesh-list
102015726|NCT01315275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102015727|NCT01315275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102015728|NCT01315275|Growth Substances|growth substances|mesh-ancestor
102015729|NCT01315275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102015730|NCT01315275|Growth Inhibitors|growth inhibitors|mesh-ancestor
102015731|NCT01315275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102015732|NCT01319448|Artesunate|artesunate|mesh-list
102015733|NCT01319448|Pyrimethamine|pyrimethamine|mesh-list
102015734|NCT01319448|Sulfadoxine|sulfadoxine|mesh-list
102015736|NCT01319448|Amodiaquine|amodiaquine|mesh-list
102015788|NCT01845441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344260|NCT00017108|Chlorambucil|chlorambucil|mesh-list
102015789|NCT01845441|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102015863|NCT04623099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102015936|NCT02461030|Listerine|listerine|mesh-list
102015937|NCT02461030|Sodium Fluoride|sodium fluoride|mesh-list
102015938|NCT02461030|Cariostatic Agents|cariostatic agents|mesh-ancestor
102016007|NCT02978404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016009|NCT04441918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102016010|NCT04441918|Immunologic Factors|immunologic factors|mesh-ancestor
102016013|NCT01331655|Drospirenone|drospirenone|mesh-list
102016079|NCT00702806|Hormone Antagonists|hormone antagonists|mesh-ancestor
102016080|NCT00702806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102016081|NCT00702806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016082|NCT00702806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102016083|NCT01336803|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102016084|NCT01336803|Hematinics|hematinics|mesh-ancestor
102016085|NCT01336803|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102016086|NCT01336803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102016087|NCT03635931|Mitogens|mitogens|mesh-list
102016088|NCT03635931|Mitosis Modulators|mitosis modulators|mesh-ancestor
102016089|NCT03635931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016090|NCT01331967|Pioglitazone|pioglitazone|mesh-list
102016091|NCT01331967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102016092|NCT01331967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016093|NCT00696878|Progesterone|progesterone|mesh-list
102016094|NCT00696878|Progestins|progestins|mesh-ancestor
102016095|NCT00696878|Hormones|hormones|mesh-ancestor
102016098|NCT04493151|Imipenem|imipenem|mesh-list
102016135|NCT03108274|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102016136|NCT03108274|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
102016137|NCT03108274|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102016138|NCT03108274|Histamine Antagonists|histamine antagonists|mesh-ancestor
102016139|NCT03108274|Histamine Agents|histamine agents|mesh-ancestor
102016141|NCT02278588|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
102016142|NCT02278588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102016143|NCT02278588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016144|NCT02278588|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102016145|NCT02278588|Protective Agents|protective agents|mesh-ancestor
102016146|NCT02278588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016147|NCT03288610|Vasopressins|vasopressins|mesh-list
102016148|NCT03288610|Hemostatics|hemostatics|mesh-ancestor
102016149|NCT03288610|Coagulants|coagulants|mesh-ancestor
102016150|NCT03288610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102016151|NCT03288610|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
102016152|NCT03288610|Natriuretic Agents|natriuretic agents|mesh-ancestor
102016153|NCT03288610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016154|NCT00696800|Progesterone|progesterone|mesh-list
102016155|NCT00696800|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
102016156|NCT00696800|Ganirelix|ganirelix|mesh-list
102016157|NCT00696800|Progestins|progestins|mesh-ancestor
102016158|NCT00696800|Hormones|hormones|mesh-ancestor
102016159|NCT00696800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102016160|NCT00696800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016161|NCT00696800|Hormone Antagonists|hormone antagonists|mesh-ancestor
102016166|NCT03288532|Durvalumab|durvalumab|mesh-list
102016183|NCT00398606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102016185|NCT00398606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102016253|NCT02461888|Glucocorticoids|glucocorticoids|mesh-ancestor
102016255|NCT02461888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102016257|NCT02461888|Protease Inhibitors|protease inhibitors|mesh-ancestor
102016322|NCT00457275|Antimetabolites|antimetabolites|mesh-ancestor
102016323|NCT00457275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016324|NCT00457275|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102016325|NCT03294070|Amlodipine|amlodipine|mesh-list
102016326|NCT03294070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102016327|NCT03294070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102016389|NCT00398541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102016390|NCT00398541|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102016391|NCT00398541|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
102016392|NCT00398541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016393|NCT00398541|Diuretics|diuretics|mesh-ancestor
102016394|NCT00398541|Natriuretic Agents|natriuretic agents|mesh-ancestor
102016395|NCT00398541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016396|NCT00398541|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
102016397|NCT00398541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102016398|NCT03286582|Clobetasol|clobetasol|mesh-list
102016399|NCT03286582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102016400|NCT03286582|Glucocorticoids|glucocorticoids|mesh-ancestor
102016401|NCT03286582|Hormones|hormones|mesh-ancestor
102016402|NCT03286582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102016403|NCT03286582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016404|NCT05202002|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
102016405|NCT05202002|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
102016406|NCT05202002|beta-Endorphin|beta-endorphin|mesh-list
102016407|NCT05202002|Hormones|hormones|mesh-ancestor
102016408|NCT05202002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102016409|NCT05202002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016410|NCT05202002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102016411|NCT05202002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016412|NCT02460640|Morphine|morphine|mesh-list
102016413|NCT02460640|Ropivacaine|ropivacaine|mesh-list
102016414|NCT02460640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102016415|NCT02460640|Narcotics|narcotics|mesh-ancestor
102016434|NCT05120960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016435|NCT03843008|Melatonin|melatonin|mesh-list
102016436|NCT03843008|Antioxidants|antioxidants|mesh-ancestor
102016506|NCT03297502|Tacrolimus|tacrolimus|mesh-list
102016507|NCT03297502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102016508|NCT03297502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102016509|NCT03297502|Analgesics|analgesics|mesh-ancestor
102016510|NCT03297502|Sensory System Agents|sensory system agents|mesh-ancestor
102016511|NCT03297502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102016512|NCT03297502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016513|NCT03297502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102016514|NCT03297502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102016515|NCT03297502|Dermatologic Agents|dermatologic agents|mesh-ancestor
102016516|NCT03297502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102016517|NCT03297502|Immunologic Factors|immunologic factors|mesh-ancestor
102016518|NCT03297502|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102016522|NCT03292744|Alfacalcidol|alfacalcidol|mesh-list
102016569|NCT02616146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102016570|NCT02616146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016571|NCT02616146|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102016639|NCT04891172|gamma-Globulins|gamma-globulins|mesh-list
102016640|NCT04891172|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
102016641|NCT04891172|Immunologic Factors|immunologic factors|mesh-ancestor
102016643|NCT03135249|Alemtuzumab|alemtuzumab|mesh-list
102016710|NCT02459782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102016711|NCT02459782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016712|NCT02884089|Metformin|metformin|mesh-list
102016713|NCT02884089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102016720|NCT00092625|Ezetimibe|ezetimibe|mesh-list
102016781|NCT01338441|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
102016782|NCT01338441|Erythromycin stearate|erythromycin stearate|mesh-list
102016783|NCT01338441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102016784|NCT01338441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102016785|NCT01338441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102016786|NCT01338441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
102016787|NCT01338441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102016849|NCT01338909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102016850|NCT01338909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016852|NCT03282136|Hormones|hormones|mesh-ancestor
102016853|NCT03282136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102016854|NCT03282136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016855|NCT03156621|Alirocumab|alirocumab|mesh-list
102016856|NCT03156621|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
102016857|NCT03156621|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102016858|NCT03156621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102016859|NCT03156621|Antimetabolites|antimetabolites|mesh-ancestor
102016865|NCT03264586|Lidocaine|lidocaine|mesh-list
102016912|NCT01339143|Pioglitazone|pioglitazone|mesh-list
102016913|NCT01339143|Vildagliptin|vildagliptin|mesh-list
102016914|NCT01339143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102016915|NCT01339143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102016916|NCT01339143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
102016917|NCT01339143|Protease Inhibitors|protease inhibitors|mesh-ancestor
102016920|NCT03264430|Ketamine|ketamine|mesh-list
102016980|NCT01340235|Erythromycin|erythromycin|mesh-list
102016981|NCT01340235|Erythromycin Estolate|erythromycin estolate|mesh-list
102016982|NCT01340235|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
102017052|NCT05183997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102017053|NCT05183997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102017054|NCT05183997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017076|NCT01340547|Ifosfamide|ifosfamide|mesh-list
102017122|NCT03276598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
102017123|NCT03276598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102017124|NCT03276598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017125|NCT03276598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102017126|NCT03276598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017128|NCT03276598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102017129|NCT03276598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
102017131|NCT03276598|Diuretics|diuretics|mesh-ancestor
102017185|NCT03267628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102017186|NCT03267628|Narcotics|narcotics|mesh-ancestor
102017187|NCT03267628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102017188|NCT03267628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017189|NCT03267628|Analgesics|analgesics|mesh-ancestor
102017190|NCT03267628|Sensory System Agents|sensory system agents|mesh-ancestor
101344646|NCT00018759|Antidepressive Agents|antidepressive agents|mesh-ancestor
102017191|NCT03267628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102017192|NCT01359696|Gemcitabine|gemcitabine|mesh-list
102017193|NCT01359696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102017194|NCT01359696|Antimetabolites|antimetabolites|mesh-ancestor
102017195|NCT01359696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017196|NCT01359696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102017197|NCT03268018|Calcium|calcium|mesh-list
102017198|NCT03268018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102017246|NCT03273088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102017247|NCT03273088|Immunologic Factors|immunologic factors|mesh-ancestor
102017248|NCT04235634|Alprostadil|alprostadil|mesh-list
102017249|NCT04235634|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102017250|NCT04235634|Vasodilator Agents|vasodilator agents|mesh-ancestor
102017316|NCT01316757|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101737062|NCT00796991|Ipilimumab|ipilimumab|mesh-list
102017317|NCT01316757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102017318|NCT01316757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102017319|NCT01316757|Tubulin Modulators|tubulin modulators|mesh-ancestor
102017320|NCT01316757|Antimitotic Agents|antimitotic agents|mesh-ancestor
102017321|NCT01316757|Mitosis Modulators|mitosis modulators|mesh-ancestor
102017322|NCT01316757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017383|NCT01360086|Antidotes|antidotes|mesh-ancestor
102017384|NCT01360086|Protective Agents|protective agents|mesh-ancestor
102017385|NCT01360086|Vitamin B Complex|vitamin b complex|mesh-ancestor
102017387|NCT01360086|Micronutrients|micronutrients|mesh-ancestor
102017388|NCT01360086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102017389|NCT02458924|Niacin|niacin|mesh-list
102017390|NCT02458924|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
102017391|NCT02458924|Antimetabolites|antimetabolites|mesh-ancestor
102017392|NCT02458924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017393|NCT02458924|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102017394|NCT02458924|Vasodilator Agents|vasodilator agents|mesh-ancestor
101344761|NCT00019383|Aldesleukin|aldesleukin|mesh-list
102017449|NCT02456584|Medroxyprogesterone|medroxyprogesterone|mesh-list
102017450|NCT02456584|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102017451|NCT02456584|Contraceptive Agents|contraceptive agents|mesh-ancestor
102017452|NCT02456584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102017519|NCT04416048|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102017520|NCT04416048|Antithrombins|antithrombins|mesh-ancestor
102017589|NCT01347957|Gasotransmitters|gasotransmitters|mesh-ancestor
102017590|NCT01347957|Protective Agents|protective agents|mesh-ancestor
102017591|NCT04735965|Meperidine|meperidine|mesh-list
102017592|NCT04735965|Dexmedetomidine|dexmedetomidine|mesh-list
102017593|NCT04735965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102017594|NCT04735965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102017668|NCT03259516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017741|NCT02456350|Fludarabine|fludarabine|mesh-list
102017742|NCT02456350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102017743|NCT02456350|Immunologic Factors|immunologic factors|mesh-ancestor
102017744|NCT02456350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017745|NCT02456350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102017746|NCT02456350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102017747|NCT02456350|Alkylating Agents|alkylating agents|mesh-ancestor
102017748|NCT02456350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017749|NCT02456350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102017750|NCT02456350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102017751|NCT01319370|Minoxidil|minoxidil|mesh-list
102017752|NCT01319370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102017753|NCT01319370|Vasodilator Agents|vasodilator agents|mesh-ancestor
102017754|NCT01363752|Mycophenolic Acid|mycophenolic acid|mesh-list
102017755|NCT01363752|Sirolimus|sirolimus|mesh-list
102017756|NCT01363752|Tacrolimus|tacrolimus|mesh-list
102017757|NCT01363752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102017758|NCT01363752|Immunologic Factors|immunologic factors|mesh-ancestor
102017759|NCT01363752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017760|NCT01363752|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102017761|NCT01363752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102017762|NCT01363752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017763|NCT01363752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102017764|NCT01363752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102017765|NCT01363752|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102017766|NCT01363752|Antitubercular Agents|antitubercular agents|mesh-ancestor
102017767|NCT01363752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102017768|NCT01363752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102017769|NCT01363752|Antifungal Agents|antifungal agents|mesh-ancestor
102017770|NCT01368198|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102017771|NCT01368198|Lubricant Eye Drops|lubricant eye drops|mesh-list
102017772|NCT01368198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102017784|NCT01360788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017785|NCT01360788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102017786|NCT01360788|Respiratory System Agents|respiratory system agents|mesh-ancestor
102017787|NCT01360788|Tocolytic Agents|tocolytic agents|mesh-ancestor
102017855|NCT01369290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102017927|NCT03252496|Anesthetics|anesthetics|mesh-ancestor
102017928|NCT03252496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102017929|NCT03252496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102017930|NCT03252496|Sensory System Agents|sensory system agents|mesh-ancestor
102017931|NCT03252496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102017932|NCT03252496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102017933|NCT03252496|Narcotics|narcotics|mesh-ancestor
102017934|NCT03252496|Analgesics|analgesics|mesh-ancestor
102017935|NCT03252496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101344903|NCT05576675|Sufentanil|sufentanil|mesh-list
102017936|NCT03252496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102017937|NCT03252496|Anesthetics, General|anesthetics, general|mesh-ancestor
102017938|NCT03252496|Oxytocics|oxytocics|mesh-ancestor
102017939|NCT03252496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102017940|NCT03252496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102017941|NCT03252496|Sympathomimetics|sympathomimetics|mesh-ancestor
102017942|NCT03252496|Autonomic Agents|autonomic agents|mesh-ancestor
102017943|NCT03252496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102017944|NCT03252496|Adrenergic Agents|adrenergic agents|mesh-ancestor
102017945|NCT03252496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102017946|NCT03252496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017947|NCT03252418|Ascorbic Acid|ascorbic acid|mesh-list
102017948|NCT03252418|Antioxidants|antioxidants|mesh-ancestor
102017949|NCT03252418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017952|NCT03252418|Vitamins|vitamins|mesh-ancestor
102017978|NCT03486964|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
102017979|NCT03486964|Protease Inhibitors|protease inhibitors|mesh-ancestor
102017980|NCT03486964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102017981|NCT03486964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102017982|NCT03486964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102018045|NCT01365000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102018046|NCT01365000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018047|NCT01365000|Sensory System Agents|sensory system agents|mesh-ancestor
102018048|NCT01365000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102018116|NCT01349439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018117|NCT01349439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102018118|NCT01349439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102018119|NCT01349439|Vasodilator Agents|vasodilator agents|mesh-ancestor
101344988|NCT00020787|Cisplatin|cisplatin|mesh-list
102018120|NCT03245554|Propranolol|propranolol|mesh-list
102018121|NCT03245554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102018186|NCT03244774|Tubulin Modulators|tubulin modulators|mesh-ancestor
102018187|NCT03244774|Antimitotic Agents|antimitotic agents|mesh-ancestor
102018259|NCT03244462|Immunologic Factors|immunologic factors|mesh-ancestor
102018260|NCT03244462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102018261|NCT03244462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102018262|NCT03244540|Acetaminophen|acetaminophen|mesh-list
102018263|NCT03244540|Dipyrone|dipyrone|mesh-list
102018264|NCT03244540|Ketoprofen|ketoprofen|mesh-list
102018265|NCT03244540|Bupivacaine|bupivacaine|mesh-list
102018266|NCT03244540|Ropivacaine|ropivacaine|mesh-list
102018267|NCT03244540|Anesthetics, Local|anesthetics, local|mesh-ancestor
102018268|NCT03244540|Anesthetics|anesthetics|mesh-ancestor
102018269|NCT03244540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102018270|NCT03244540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018271|NCT03244540|Sensory System Agents|sensory system agents|mesh-ancestor
102018272|NCT03244540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102018273|NCT03244540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102018274|NCT03244540|Analgesics|analgesics|mesh-ancestor
102018275|NCT03244540|Antipyretics|antipyretics|mesh-ancestor
102018276|NCT03244540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102018315|NCT00832455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018316|NCT00832455|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
102018317|NCT00832455|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102018318|NCT00832455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018319|NCT00687531|Mometasone Furoate|mometasone furoate|mesh-list
101345051|NCT00020943|Antidotes|antidotes|mesh-ancestor
102018320|NCT00687531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102018321|NCT00687531|Dermatologic Agents|dermatologic agents|mesh-ancestor
102018322|NCT00687531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102018323|NCT01350921|Ticagrelor|ticagrelor|mesh-list
102018324|NCT01350921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102018325|NCT01350921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102018326|NCT01350921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102018327|NCT01350921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102018328|NCT01350921|Purinergic Agents|purinergic agents|mesh-ancestor
102018329|NCT01350921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102018330|NCT01350921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018331|NCT01350921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018332|NCT00423579|Simvastatin|simvastatin|mesh-list
102018333|NCT00423579|Ezetimibe|ezetimibe|mesh-list
102018334|NCT00423579|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
102018335|NCT00423579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102018364|NCT01352559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018365|NCT01352559|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
102018366|NCT01352559|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
102018367|NCT01352559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102018369|NCT01352559|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
102018370|NCT01352559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102018371|NCT01352559|Histamine Antagonists|histamine antagonists|mesh-ancestor
102018372|NCT01352559|Histamine Agents|histamine agents|mesh-ancestor
102018373|NCT01352559|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102018374|NCT01352559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102018375|NCT01352559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102018376|NCT01352559|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102018377|NCT01352559|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102018421|NCT03778372|Analgesics|analgesics|mesh-ancestor
102018422|NCT03778372|Sensory System Agents|sensory system agents|mesh-ancestor
102018423|NCT03778372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102018424|NCT03778372|Antitussive Agents|antitussive agents|mesh-ancestor
102018425|NCT03778372|Respiratory System Agents|respiratory system agents|mesh-ancestor
102018427|NCT03246880|Tamsulosin|tamsulosin|mesh-list
102018428|NCT03246880|Vasodilator Agents|vasodilator agents|mesh-ancestor
102018429|NCT03246880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102018430|NCT03246880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102018431|NCT03246880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102018432|NCT03246880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018433|NCT03246880|Urological Agents|urological agents|mesh-ancestor
102018434|NCT03246880|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
102018435|NCT03246880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102018436|NCT03246880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102018437|NCT03246880|Adrenergic Agents|adrenergic agents|mesh-ancestor
102018438|NCT03246880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102018439|NCT03246880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018440|NCT03257722|Pembrolizumab|pembrolizumab|mesh-list
102018441|NCT03257722|Idelalisib|idelalisib|mesh-list
102018442|NCT03257722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102018443|NCT03257722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102018444|NCT03257722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102018445|NCT03257722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018446|NCT03257722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102018447|NCT03268005|Insulin|insulin|mesh-list
102018448|NCT03268005|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102018449|NCT03268005|Metformin|metformin|mesh-list
102018450|NCT03268005|Insulin Aspart|insulin aspart|mesh-list
102018451|NCT03268005|Insulin, Long-Acting|insulin, long-acting|mesh-list
102018464|NCT03239314|Hormones|hormones|mesh-ancestor
102018465|NCT03239314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102018466|NCT03239314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102018467|NCT03239314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102018469|NCT03241888|Megestrol Acetate|megestrol acetate|mesh-list
102018470|NCT03241888|Levonorgestrel|levonorgestrel|mesh-list
102018471|NCT03241888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102018472|NCT03241888|Contraceptive Agents|contraceptive agents|mesh-ancestor
102018473|NCT03241888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102018474|NCT03241888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018475|NCT03241888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102018476|NCT03241888|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102018477|NCT03241888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102018524|NCT01353339|Ofloxacin|ofloxacin|mesh-list
102018525|NCT01353339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102018526|NCT01353339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102018527|NCT01353339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102018528|NCT01353339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102018529|NCT01353339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102018530|NCT01353339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102018531|NCT01353339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018532|NCT01353339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102018533|NCT01353339|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102018535|NCT03239080|Denosumab|denosumab|mesh-list
102018587|NCT03238612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102018588|NCT03238612|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
102018589|NCT03238612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102018659|NCT00700570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102018660|NCT00700570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102018661|NCT00700570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102018663|NCT00700570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018664|NCT00700570|Growth Inhibitors|growth inhibitors|mesh-ancestor
102018665|NCT00700570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
102018666|NCT00700570|Antimetabolites|antimetabolites|mesh-ancestor
102018726|NCT04486690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102018727|NCT04486690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102018728|NCT04486690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102018729|NCT04486690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102018730|NCT04486690|Anesthetics, General|anesthetics, general|mesh-ancestor
102018731|NCT04486690|Anesthetics|anesthetics|mesh-ancestor
102018732|NCT04486690|Analgesics|analgesics|mesh-ancestor
102018733|NCT04486690|Sensory System Agents|sensory system agents|mesh-ancestor
102018734|NCT04486690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102018790|NCT02874924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102018791|NCT02874924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102018865|NCT03254368|ZGN-1061|zgn-1061|mesh-list
102018866|NCT03254368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102018868|NCT03254368|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102018940|NCT04495283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101345304|NCT00022191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102018941|NCT04495283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102018942|NCT04495283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102018943|NCT03634020|Sirolimus|sirolimus|mesh-list
102019011|NCT03123588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102019012|NCT03123588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019013|NCT03123588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102019014|NCT02452918|Oritavancin|oritavancin|mesh-list
102019017|NCT02821026|Mycophenolic Acid|mycophenolic acid|mesh-list
102019081|NCT01562483|Dronabinol|dronabinol|mesh-list
102019082|NCT01562483|Hallucinogens|hallucinogens|mesh-ancestor
102019083|NCT01562483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019084|NCT01562483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102019086|NCT01562483|Analgesics|analgesics|mesh-ancestor
102019153|NCT03222310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102019154|NCT03222310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102019155|NCT03222310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019156|NCT03222310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
102019157|NCT03222310|Hormone Antagonists|hormone antagonists|mesh-ancestor
102019222|NCT04492475|Interferons|interferons|mesh-list
102019223|NCT04492475|Interferon-beta|interferon-beta|mesh-list
102019224|NCT04492475|Interferon beta-1a|interferon beta-1a|mesh-list
102019226|NCT04492475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102019227|NCT04492475|Antiviral Agents|antiviral agents|mesh-ancestor
102019228|NCT04492475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102019229|NCT04492475|Immunologic Factors|immunologic factors|mesh-ancestor
102019230|NCT04492475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019231|NCT04492475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102019232|NCT04492475|Antimetabolites|antimetabolites|mesh-ancestor
102019233|NCT04492475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019234|NCT04936763|Hyaluronic Acid|hyaluronic acid|mesh-list
102019235|NCT04936763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102019236|NCT04936763|Immunologic Factors|immunologic factors|mesh-ancestor
102019237|NCT04936763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019281|NCT03226210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019282|NCT03229954|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
102019284|NCT03220126|Mirikizumab|mirikizumab|mesh-list
102019353|NCT03208426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102019354|NCT03208426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102019355|NCT03208426|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102019425|NCT03224572|Antioxidants|antioxidants|mesh-ancestor
102019426|NCT03224572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019427|NCT03224572|Protective Agents|protective agents|mesh-ancestor
102019428|NCT02452216|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
102019429|NCT02452216|Hematinics|hematinics|mesh-ancestor
102019430|NCT02452216|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
102019432|NCT03207334|Cytarabine|cytarabine|mesh-list
102019496|NCT04401293|Enoxaparin sodium|enoxaparin sodium|mesh-list
102019497|NCT04401293|Anticoagulants|anticoagulants|mesh-ancestor
102019498|NCT04401293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102019499|NCT04401293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102019566|NCT04454567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019568|NCT04454567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102019569|NCT03206554|Ropivacaine|ropivacaine|mesh-list
101739334|NCT02599532|Apixaban|apixaban|mesh-list
102019636|NCT02451748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102019637|NCT02451748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102019705|NCT03208582|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102019706|NCT03208582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019707|NCT03208582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
102019708|NCT03200938|Zinc|zinc|mesh-list
102019709|NCT03200938|Zinc Oxide|zinc oxide|mesh-list
102019710|NCT03200938|Trace Elements|trace elements|mesh-ancestor
102019711|NCT03200938|Micronutrients|micronutrients|mesh-ancestor
102019717|NCT04297241|Isosorbide|isosorbide|mesh-list
101345514|NCT00394992|Capecitabine|capecitabine|mesh-list
102019773|NCT04393493|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
102019774|NCT04393493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102019777|NCT04393493|Hormone Antagonists|hormone antagonists|mesh-ancestor
102019844|NCT03200080|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102019845|NCT03200080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102019846|NCT03200080|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102019915|NCT03204058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102019916|NCT03204058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102019917|NCT03204058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102019918|NCT03204058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102019984|NCT03198676|Poly I-C|poly i-c|mesh-list
102019985|NCT03198676|Antiviral Agents|antiviral agents|mesh-ancestor
102019986|NCT03198676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102019987|NCT03198676|Interferon Inducers|interferon inducers|mesh-ancestor
102019988|NCT03198676|Immunologic Factors|immunologic factors|mesh-ancestor
102019989|NCT03198676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102019990|NCT04484506|Prednisone|prednisone|mesh-list
102019991|NCT04484506|Cyclophosphamide|cyclophosphamide|mesh-list
102020051|NCT03194620|Protease Inhibitors|protease inhibitors|mesh-ancestor
102020052|NCT03194620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102020053|NCT03194620|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
102020054|NCT03194620|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
102020120|NCT04796714|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102020121|NCT04796714|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102020122|NCT04796714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102020123|NCT04796714|Antipyretics|antipyretics|mesh-ancestor
102020124|NCT02445898|Methylprednisolone|methylprednisolone|mesh-list
102020125|NCT02445898|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
102020126|NCT02445898|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
102020127|NCT02445898|Prednisolone|prednisolone|mesh-list
102020128|NCT02445898|Prednisolone acetate|prednisolone acetate|mesh-list
102020129|NCT02445898|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
102020130|NCT02445898|Prednisolone phosphate|prednisolone phosphate|mesh-list
102020131|NCT02445898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102020132|NCT02445898|Antiemetics|antiemetics|mesh-ancestor
102020133|NCT02445898|Autonomic Agents|autonomic agents|mesh-ancestor
102020134|NCT02445898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102020135|NCT02445898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020136|NCT02445898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102020137|NCT02445898|Glucocorticoids|glucocorticoids|mesh-ancestor
102020138|NCT02445898|Hormones|hormones|mesh-ancestor
102020139|NCT02445898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102020140|NCT02445898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102020141|NCT02445898|Protective Agents|protective agents|mesh-ancestor
102020174|NCT00878462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102020175|NCT00878462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102020246|NCT05581940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102020247|NCT05581940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020319|NCT03202186|Hormones|hormones|mesh-ancestor
102020320|NCT03202186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102020321|NCT03202186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020322|NCT03625076|Lidocaine|lidocaine|mesh-list
102020323|NCT03625076|Propofol|propofol|mesh-list
102020324|NCT03625076|Etomidate|etomidate|mesh-list
102020388|NCT02727998|Anesthetics, General|anesthetics, general|mesh-ancestor
102020389|NCT02727998|Anesthetics|anesthetics|mesh-ancestor
102020390|NCT02727998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102020391|NCT02727998|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102020401|NCT02727998|GABA Agents|gaba agents|mesh-ancestor
102020460|NCT04179461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102020461|NCT04179461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102020462|NCT04179461|Adrenergic Agents|adrenergic agents|mesh-ancestor
102020469|NCT04179461|Histamine Agents|histamine agents|mesh-ancestor
102020535|NCT05058404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102020605|NCT05480150|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102020606|NCT05480150|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
102020607|NCT05480150|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102020608|NCT05480150|Dopamine Agents|dopamine agents|mesh-ancestor
102020609|NCT05464628|Atorvastatin|atorvastatin|mesh-list
102020610|NCT05464628|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
102020676|NCT04050488|Dermatologic Agents|dermatologic agents|mesh-ancestor
102020677|NCT02449252|Prednisone|prednisone|mesh-list
102020678|NCT02449252|Cyclophosphamide|cyclophosphamide|mesh-list
102020679|NCT02449252|Doxorubicin|doxorubicin|mesh-list
102020680|NCT02449252|Vincristine|vincristine|mesh-list
102020681|NCT02449252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102020746|NCT03195634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102020747|NCT03195634|Vasodilator Agents|vasodilator agents|mesh-ancestor
102020749|NCT03195634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102020818|NCT03698474|Tocolytic Agents|tocolytic agents|mesh-ancestor
102020819|NCT03698474|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102020820|NCT03698474|Antioxidants|antioxidants|mesh-ancestor
102020821|NCT03698474|Protective Agents|protective agents|mesh-ancestor
102020891|NCT02443714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102020892|NCT02443714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020893|NCT03703310|Veratrum Alkaloids|veratrum alkaloids|mesh-list
102020963|NCT03187912|Micronutrients|micronutrients|mesh-ancestor
101345690|NCT00023868|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102020964|NCT03187912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102020965|NCT03187912|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
102020966|NCT03187912|Dermatologic Agents|dermatologic agents|mesh-ancestor
102020967|NCT02443012|Nepafenac|nepafenac|mesh-list
102021033|NCT02439190|Analgesics|analgesics|mesh-ancestor
102021034|NCT02439190|Sensory System Agents|sensory system agents|mesh-ancestor
102021035|NCT02439190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102021036|NCT02439190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021037|NCT02439190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102021038|NCT02439190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102021039|NCT02439190|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102021040|NCT02439190|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102021041|NCT02439190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021042|NCT02439190|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102021097|NCT03186664|Analgesics|analgesics|mesh-ancestor
102021098|NCT03186664|Sensory System Agents|sensory system agents|mesh-ancestor
102021099|NCT03186664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102021101|NCT02441842|Atenolol|atenolol|mesh-list
102021169|NCT02441530|Analgesics|analgesics|mesh-ancestor
102021170|NCT02441530|Sensory System Agents|sensory system agents|mesh-ancestor
102021171|NCT02441530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102021181|NCT02433184|Etanercept|etanercept|mesh-list
102021240|NCT02432872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102021241|NCT02432872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102021242|NCT02432872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102021243|NCT02436928|Vaccines|vaccines|mesh-list
102021313|NCT02436226|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102021387|NCT05160090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102021388|NCT05160090|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
102021456|NCT03692546|Anesthetics|anesthetics|mesh-ancestor
102021457|NCT03692546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102021458|NCT03692546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021459|NCT03692546|Sensory System Agents|sensory system agents|mesh-ancestor
102021460|NCT03692546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102021525|NCT03718507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102021526|NCT03718507|Respiratory System Agents|respiratory system agents|mesh-ancestor
102021527|NCT03718507|Mydriatics|mydriatics|mesh-ancestor
102021596|NCT03691688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021597|NCT03691688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102021598|NCT03691688|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102021599|NCT03691688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102021600|NCT03691688|Antipyretics|antipyretics|mesh-ancestor
102021603|NCT03691688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102021663|NCT03028142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021665|NCT02800824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102021666|NCT02800824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102021667|NCT02800824|Autonomic Agents|autonomic agents|mesh-ancestor
102021668|NCT02800824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102021669|NCT02800824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021670|NCT02800824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102021671|NCT02800824|Respiratory System Agents|respiratory system agents|mesh-ancestor
102021672|NCT02800824|Glucocorticoids|glucocorticoids|mesh-ancestor
102021673|NCT02800824|Hormones|hormones|mesh-ancestor
102021674|NCT02800824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102021675|NCT03715777|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
102021676|NCT03715777|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
102021677|NCT03715777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102021678|NCT03715777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021679|NCT03715777|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
102021680|NCT03715777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102021717|NCT02429596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021718|NCT02429596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102021727|NCT02429596|Analgesics|analgesics|mesh-ancestor
102021790|NCT04147715|Midazolam|midazolam|mesh-list
102021791|NCT04147715|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102021792|NCT04147715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102021793|NCT04147715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102021794|NCT04147715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021795|NCT04147715|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102021796|NCT04147715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102021797|NCT04147715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102021798|NCT04147715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102021799|NCT04147715|Anesthetics, General|anesthetics, general|mesh-ancestor
102021800|NCT04147715|Anesthetics|anesthetics|mesh-ancestor
102021801|NCT04147715|GABA Modulators|gaba modulators|mesh-ancestor
102021802|NCT04147715|GABA Agents|gaba agents|mesh-ancestor
102021857|NCT02452554|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
102021858|NCT02452554|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
102021859|NCT02452554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102021860|NCT02452554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102021861|NCT02452554|Tubulin Modulators|tubulin modulators|mesh-ancestor
102021862|NCT02452554|Antimitotic Agents|antimitotic agents|mesh-ancestor
102021863|NCT02452554|Mitosis Modulators|mitosis modulators|mesh-ancestor
102021924|NCT04620252|Chelating Agents|chelating agents|mesh-ancestor
102021925|NCT04620252|Sequestering Agents|sequestering agents|mesh-ancestor
102021926|NCT04620252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102021927|NCT04620252|Cariostatic Agents|cariostatic agents|mesh-ancestor
102021928|NCT04620252|Protective Agents|protective agents|mesh-ancestor
102021994|NCT02429050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102021996|NCT02417142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102021997|NCT02417142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102021998|NCT02417142|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
102021999|NCT02417142|Incretins|incretins|mesh-ancestor
102022000|NCT02417142|Hormones|hormones|mesh-ancestor
102022001|NCT02417142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102022002|NCT01374750|Cyclosporine|cyclosporine|mesh-list
102022003|NCT01374750|Sirolimus|sirolimus|mesh-list
102022004|NCT01374750|Tacrolimus|tacrolimus|mesh-list
102022005|NCT01374750|Cyclosporins|cyclosporins|mesh-list
102022006|NCT01374750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102022057|NCT02428972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102022058|NCT02428972|Anesthetics, General|anesthetics, general|mesh-ancestor
102022059|NCT02428972|Anesthetics|anesthetics|mesh-ancestor
102022128|NCT03717415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102022129|NCT03717415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102022130|NCT03717415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102022131|NCT03717415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022132|NCT03689894|Rituximab|rituximab|mesh-list
101345957|NCT00025389|Growth Inhibitors|growth inhibitors|mesh-ancestor
102022133|NCT03689894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102022134|NCT03689894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102022135|NCT03689894|Immunologic Factors|immunologic factors|mesh-ancestor
102022136|NCT03689894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022137|NCT03689894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102022138|NCT04126343|Moxifloxacin|moxifloxacin|mesh-list
102022139|NCT04126343|Padsevonil|padsevonil|mesh-list
102022140|NCT04126343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102022141|NCT04126343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102022142|NCT04126343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102022143|NCT04126343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102022144|NCT04126343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102022145|NCT04126343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022146|NCT04126343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102022147|NCT04126343|Anticonvulsants|anticonvulsants|mesh-ancestor
102022148|NCT04207710|Ethyl Chloride|ethyl chloride|mesh-list
102022149|NCT04207710|Anesthetics, Local|anesthetics, local|mesh-ancestor
102022150|NCT04207710|Anesthetics|anesthetics|mesh-ancestor
102022182|NCT03689114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022183|NCT03689114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102022255|NCT03688568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102022256|NCT03688568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101828275|NCT05815160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102022257|NCT03688568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022258|NCT05192304|Maleic acid|maleic acid|mesh-list
102022259|NCT05192304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102022260|NCT05192304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022261|NCT03693872|Dopamine|dopamine|mesh-list
102022262|NCT03693872|Apomorphine|apomorphine|mesh-list
102022319|NCT03743987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022392|NCT03698630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102022393|NCT03698630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102022394|NCT03698630|Protective Agents|protective agents|mesh-ancestor
102022465|NCT03682718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102022466|NCT03682718|Abortifacient Agents|abortifacient agents|mesh-ancestor
102022538|NCT01375842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022539|NCT01375842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102022540|NCT01375842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102022541|NCT03682367|Gabapentin|gabapentin|mesh-list
102022542|NCT03682367|Analgesics|analgesics|mesh-ancestor
102022543|NCT03682367|Sensory System Agents|sensory system agents|mesh-ancestor
102022605|NCT02877927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022606|NCT02706886|Lumasiran|lumasiran|mesh-list
102022612|NCT02809131|Cephalexin|cephalexin|mesh-list
102022681|NCT01442649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102022682|NCT01442649|Immunologic Factors|immunologic factors|mesh-ancestor
102022684|NCT04995120|Cisplatin|cisplatin|mesh-list
102022685|NCT04995120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102022752|NCT05198856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102022753|NCT05198856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102022754|NCT05198856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102022755|NCT05198856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102022756|NCT05198856|Growth Substances|growth substances|mesh-ancestor
102022757|NCT05198856|Growth Inhibitors|growth inhibitors|mesh-ancestor
102022823|NCT03178396|Protective Agents|protective agents|mesh-ancestor
102022824|NCT03178396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022825|NCT03178396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102022826|NCT03677258|Hyaluronic Acid|hyaluronic acid|mesh-list
102022827|NCT03677258|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102022828|NCT03677258|Immunologic Factors|immunologic factors|mesh-ancestor
102022829|NCT03677258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022830|NCT03677258|Viscosupplements|viscosupplements|mesh-ancestor
102022831|NCT03677258|Protective Agents|protective agents|mesh-ancestor
102022832|NCT01361763|Dabigatran|dabigatran|mesh-list
102022888|NCT04054193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022889|NCT04054193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102022890|NCT04054193|Serotonin Agents|serotonin agents|mesh-ancestor
102022892|NCT03394027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102022958|NCT02424136|Protective Agents|protective agents|mesh-ancestor
102022959|NCT03770676|Selenium|selenium|mesh-list
102022960|NCT03770676|Antioxidants|antioxidants|mesh-ancestor
102022961|NCT03770676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102022962|NCT03770676|Protective Agents|protective agents|mesh-ancestor
102022963|NCT03770676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102022964|NCT03770676|Trace Elements|trace elements|mesh-ancestor
102022965|NCT03770676|Micronutrients|micronutrients|mesh-ancestor
102023024|NCT01355757|Anesthetics|anesthetics|mesh-list
102023025|NCT01355757|Anesthetics, Local|anesthetics, local|mesh-list
102023026|NCT01355757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102023028|NCT01355757|Sensory System Agents|sensory system agents|mesh-ancestor
101346267|NCT00027495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102023029|NCT01355757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102023030|NCT02507505|Anesthetics|anesthetics|mesh-list
102023031|NCT02507505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102023032|NCT02507505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023033|NCT03181360|Tenecteplase|tenecteplase|mesh-list
102023034|NCT03181360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102023035|NCT03181360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102023036|NCT03181360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023037|NCT04275531|Anesthetics|anesthetics|mesh-list
102023038|NCT04275531|Propofol|propofol|mesh-list
102023039|NCT04275531|Sevoflurane|sevoflurane|mesh-list
102023040|NCT04275531|Isoflurane|isoflurane|mesh-list
102023048|NCT03689712|Manganese|manganese|mesh-list
102023087|NCT01362153|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102023088|NCT01362153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102023089|NCT01362153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102023090|NCT01362153|Immunologic Factors|immunologic factors|mesh-ancestor
102023091|NCT01362153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023092|NCT03184324|Esomeprazole|esomeprazole|mesh-list
102023093|NCT03184324|Fexuprazan|fexuprazan|mesh-list
102023094|NCT03184324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102023095|NCT03184324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102023096|NCT03184324|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102023097|NCT03184324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102023098|NCT03184324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023099|NCT02427334|Dienogest|dienogest|mesh-list
102023100|NCT02427334|Fluoxetine|fluoxetine|mesh-list
102023101|NCT02427334|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102023102|NCT02427334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102023103|NCT02427334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102023104|NCT02427334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023105|NCT02427334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102023141|NCT01355991|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102023142|NCT01355991|Cholinergic Agents|cholinergic agents|mesh-ancestor
102023143|NCT01355991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102023144|NCT01355991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023145|NCT01355991|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
102023209|NCT01356225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102023210|NCT01356225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102023211|NCT01356225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023280|NCT03710863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023281|NCT03178084|Lamivudine|lamivudine|mesh-list
102023282|NCT03178084|Zidovudine|zidovudine|mesh-list
102023283|NCT03178084|Efavirenz|efavirenz|mesh-list
102023284|NCT03178084|Maraviroc|maraviroc|mesh-list
102023351|NCT04583592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023352|NCT04583592|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
102023353|NCT04583592|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102023354|NCT04583592|Anticoagulants|anticoagulants|mesh-ancestor
102023355|NCT02418988|Chlorotrianisene|chlorotrianisene|mesh-list
101346453|NCT00392561|Vitamin E|vitamin e|mesh-list
102023356|NCT02418988|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
102023357|NCT02418988|Estrogens|estrogens|mesh-ancestor
102023358|NCT02418988|Hormones|hormones|mesh-ancestor
102023417|NCT02930343|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102023418|NCT02930343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102023420|NCT02930343|Sensory System Agents|sensory system agents|mesh-ancestor
102023487|NCT02422888|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
102023488|NCT02422888|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102023489|NCT02422888|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
102023490|NCT02422888|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
102023491|NCT02422888|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102023492|NCT02422888|Purinergic Agents|purinergic agents|mesh-ancestor
102023493|NCT02422888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102023556|NCT03116776|Protective Agents|protective agents|mesh-ancestor
102023627|NCT01365741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102023628|NCT03361748|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
102023629|NCT03361748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102023630|NCT03361748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102023631|NCT03681548|Doxorubicin|doxorubicin|mesh-list
102023632|NCT03681548|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102023633|NCT03681548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102023693|NCT05188833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102023694|NCT05188833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102023695|NCT02426164|Methylprednisolone|methylprednisolone|mesh-list
102023696|NCT02426164|Epinephrine|epinephrine|mesh-list
102023697|NCT02426164|Morphine|morphine|mesh-list
102023698|NCT02426164|Bupivacaine|bupivacaine|mesh-list
102023699|NCT02426164|Anesthetics, Local|anesthetics, local|mesh-ancestor
102023700|NCT02426164|Anesthetics|anesthetics|mesh-ancestor
102023701|NCT02426164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102023702|NCT02426164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102023703|NCT02426164|Sensory System Agents|sensory system agents|mesh-ancestor
102023704|NCT02426164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102023705|NCT02426164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102023706|NCT02426164|Narcotics|narcotics|mesh-ancestor
102023757|NCT04447287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
102023758|NCT04447287|GABA Modulators|gaba modulators|mesh-ancestor
102023759|NCT04447287|GABA Agents|gaba agents|mesh-ancestor
102023830|NCT02417116|Viscosupplements|viscosupplements|mesh-ancestor
102023831|NCT02417116|Protective Agents|protective agents|mesh-ancestor
102023832|NCT03183310|Chlorpromazine|chlorpromazine|mesh-list
102023833|NCT03183310|Antiemetics|antiemetics|mesh-ancestor
102023902|NCT03106948|Antioxidants|antioxidants|mesh-ancestor
102023903|NCT03106948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102023904|NCT03106948|Protective Agents|protective agents|mesh-ancestor
102023975|NCT02873754|Nicotine|nicotine|mesh-list
102023976|NCT02873754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
102023977|NCT02873754|Autonomic Agents|autonomic agents|mesh-ancestor
102023980|NCT02873754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
102024046|NCT04046939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024052|NCT04046939|Dopamine Agents|dopamine agents|mesh-ancestor
102024114|NCT03176524|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
102024115|NCT03176524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102024116|NCT03176524|Hormones|hormones|mesh-ancestor
102024117|NCT03176524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102024119|NCT03176524|Incretins|incretins|mesh-ancestor
102024185|NCT05189769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102024186|NCT05189769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024187|NCT05189769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102024188|NCT05189769|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
102024189|NCT05189769|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102024191|NCT03672812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102024192|NCT03672812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024193|NCT03672812|Incretins|incretins|mesh-ancestor
102024194|NCT03672812|Hormones|hormones|mesh-ancestor
102024195|NCT03672812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102024196|NCT05417880|Hypoglycemic Agents|hypoglycemic agents|mesh-list
102024197|NCT05417880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024198|NCT05029726|Clonidine|clonidine|mesh-list
102024199|NCT05029726|Epinephrine|epinephrine|mesh-list
102024200|NCT05029726|Bupivacaine|bupivacaine|mesh-list
102024201|NCT05029726|Anesthetics, Local|anesthetics, local|mesh-ancestor
102024202|NCT05029726|Anesthetics|anesthetics|mesh-ancestor
102024203|NCT05029726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102024204|NCT05029726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024205|NCT05029726|Sensory System Agents|sensory system agents|mesh-ancestor
102024206|NCT05029726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102024207|NCT05029726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
102024208|NCT05029726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102024209|NCT05029726|Adrenergic Agents|adrenergic agents|mesh-ancestor
102024210|NCT05029726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102024211|NCT05029726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024212|NCT05029726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
102024213|NCT05029726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
102024214|NCT05029726|Autonomic Agents|autonomic agents|mesh-ancestor
101601131|NCT00918879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601132|NCT00918879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101601133|NCT01026792|Sirolimus|sirolimus|mesh-list
101601134|NCT01026792|Temsirolimus|temsirolimus|mesh-list
101601135|NCT01026792|MTOR Inhibitors|mtor inhibitors|mesh-list
101601136|NCT01026792|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101601137|NCT01026792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101601138|NCT01026792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601139|NCT01026792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101601140|NCT01026792|Immunologic Factors|immunologic factors|mesh-ancestor
101601141|NCT01026792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601142|NCT01026792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101601143|NCT01026792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101601144|NCT01026792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102024215|NCT05029726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102024216|NCT05029726|Respiratory System Agents|respiratory system agents|mesh-ancestor
102024217|NCT05029726|Mydriatics|mydriatics|mesh-ancestor
102024288|NCT01364181|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
102024289|NCT01364181|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102024290|NCT01364181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102024358|NCT02409004|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102024359|NCT02409004|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102024360|NCT03131895|Dexlansoprazole|dexlansoprazole|mesh-list
102024361|NCT03131895|Lansoprazole|lansoprazole|mesh-list
102024362|NCT03131895|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
102024363|NCT03131895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102024364|NCT03131895|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
102024365|NCT03131895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102024366|NCT03131895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102024367|NCT04039919|Padsevonil|padsevonil|mesh-list
102024368|NCT04039919|Anticonvulsants|anticonvulsants|mesh-ancestor
102024369|NCT01367613|Methylnaltrexone|methylnaltrexone|mesh-list
102024370|NCT01367613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101346737|NCT03958721|Capecitabine|capecitabine|mesh-list
102024420|NCT02915978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102024421|NCT02915978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102024422|NCT02915978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102024494|NCT03175666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102024495|NCT03175666|Alkylating Agents|alkylating agents|mesh-ancestor
102024496|NCT03175666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
102024497|NCT03175666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102024564|NCT02403856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102024565|NCT02403856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
102024566|NCT02403856|Protective Agents|protective agents|mesh-ancestor
102024567|NCT02403856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
102024568|NCT02403856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102024635|NCT02407600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102024636|NCT02407600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024637|NCT02407600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102024638|NCT02407600|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102024706|NCT03175042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024707|NCT03175042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102024708|NCT03175042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102024709|NCT03738059|Dexmedetomidine|dexmedetomidine|mesh-list
102024710|NCT03738059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102024777|NCT03169660|Mitogens|mitogens|mesh-list
102024778|NCT03169660|Endothelial Growth Factors|endothelial growth factors|mesh-list
102024851|NCT03169504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102024852|NCT03169504|Respiratory System Agents|respiratory system agents|mesh-ancestor
102024853|NCT03169504|Dermatologic Agents|dermatologic agents|mesh-ancestor
102024854|NCT03169504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
102024855|NCT03169504|Parasympatholytics|parasympatholytics|mesh-ancestor
102024856|NCT03169504|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102024857|NCT03169504|Cholinergic Agents|cholinergic agents|mesh-ancestor
102024919|NCT03679052|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
102024920|NCT03679052|Histamine Antagonists|histamine antagonists|mesh-ancestor
102024921|NCT03679052|Histamine Agents|histamine agents|mesh-ancestor
102024922|NCT03679052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102024923|NCT03679052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102024924|NCT03679052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102024925|NCT03679052|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
102024926|NCT03679052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102024927|NCT03679052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102024928|NCT03679052|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
102024929|NCT03679052|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102024930|NCT03679052|Serotonin Agents|serotonin agents|mesh-ancestor
102024931|NCT03679052|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101744743|NCT00750399|Ranibizumab|ranibizumab|mesh-list
102024982|NCT03172234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102024983|NCT03172234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102024985|NCT03172234|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102025054|NCT03627767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102025055|NCT03627767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102025056|NCT03627767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025127|NCT04456608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102025128|NCT04456608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025129|NCT04456608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102025130|NCT04456608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102025131|NCT04456608|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102025132|NCT04456608|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102025133|NCT04456608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025134|NCT04456608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
102025135|NCT04456608|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102025136|NCT04456608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102025137|NCT04456608|Antipyretics|antipyretics|mesh-ancestor
102025139|NCT04450212|Vitamins|vitamins|mesh-ancestor
102025140|NCT04450212|Micronutrients|micronutrients|mesh-ancestor
102025145|NCT04450212|Hemostatics|hemostatics|mesh-ancestor
102025187|NCT03731429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025188|NCT03602339|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
102025189|NCT03602339|Chelating Agents|chelating agents|mesh-ancestor
102025190|NCT03602339|Sequestering Agents|sequestering agents|mesh-ancestor
102025191|NCT03602339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025192|NCT03653429|Tranexamic Acid|tranexamic acid|mesh-list
102025193|NCT03653429|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
102025194|NCT03653429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102025196|NCT03653429|Hemostatics|hemostatics|mesh-ancestor
102025249|NCT03115762|Growth Substances|growth substances|mesh-ancestor
102025250|NCT03115762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025251|NCT03115762|Growth Inhibitors|growth inhibitors|mesh-ancestor
102025252|NCT03168958|Methadone|methadone|mesh-list
102025253|NCT03168958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102025321|NCT03334903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102025322|NCT03334903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025323|NCT03334903|Anticonvulsants|anticonvulsants|mesh-ancestor
102025324|NCT03334903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
102025390|NCT02694328|Autonomic Agents|autonomic agents|mesh-ancestor
102025391|NCT02694328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102025392|NCT02694328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025393|NCT02694328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102025394|NCT02694328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102025395|NCT02694328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102025396|NCT02694328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102025397|NCT02694328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102025398|NCT02694328|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
102025399|NCT02694328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
102025400|NCT02694328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
102025401|NCT02694328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102025402|NCT02694328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102025434|NCT02399800|Hormones|hormones|mesh-ancestor
102025448|NCT03167164|Leucovorin|leucovorin|mesh-list
102025449|NCT03167164|Paclitaxel|paclitaxel|mesh-list
102025450|NCT03167164|Cyclophosphamide|cyclophosphamide|mesh-list
102025451|NCT03167164|Bevacizumab|bevacizumab|mesh-list
102025452|NCT03167164|Fluorouracil|fluorouracil|mesh-list
102025453|NCT03167164|Capecitabine|capecitabine|mesh-list
102025454|NCT03167164|Avelumab|avelumab|mesh-list
102025519|NCT02394418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
102025520|NCT02394418|Adrenergic Agents|adrenergic agents|mesh-ancestor
102025521|NCT02394418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102025592|NCT02393482|Tibolone|tibolone|mesh-list
102025593|NCT02393482|Calcium Carbonate|calcium carbonate|mesh-list
102025594|NCT02393482|Hormones|hormones|mesh-list
102025665|NCT03345979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025666|NCT03345979|Dopamine Agonists|dopamine agonists|mesh-ancestor
102025667|NCT03345979|Dopamine Agents|dopamine agents|mesh-ancestor
102025672|NCT03345979|Serotonin Agents|serotonin agents|mesh-ancestor
102025738|NCT02392780|Glucocorticoids|glucocorticoids|mesh-ancestor
102025739|NCT02392780|Hormones|hormones|mesh-ancestor
102025813|NCT03734627|Antipyretics|antipyretics|mesh-ancestor
102025814|NCT03734627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102025888|NCT02397382|Respiratory System Agents|respiratory system agents|mesh-ancestor
102025889|NCT02397382|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102025890|NCT02397382|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102025893|NCT02697916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102025957|NCT03359395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102025958|NCT03359395|Analgesics|analgesics|mesh-ancestor
102025959|NCT03359395|Sensory System Agents|sensory system agents|mesh-ancestor
102025960|NCT03359395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102025961|NCT03359395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102025962|NCT03359395|Anesthetics, General|anesthetics, general|mesh-ancestor
102025963|NCT03359395|Anesthetics|anesthetics|mesh-ancestor
102025964|NCT03733691|Lenalidomide|lenalidomide|mesh-list
102025965|NCT03733691|Ixazomib|ixazomib|mesh-list
102025966|NCT03733691|Immunologic Factors|immunologic factors|mesh-ancestor
102025967|NCT03733691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026022|NCT05733676|Sequestering Agents|sequestering agents|mesh-ancestor
101347045|NCT00392912|Androgens|androgens|mesh-ancestor
102026023|NCT05733676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026024|NCT03343639|Serlopitant|serlopitant|mesh-list
102026025|NCT03343639|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102026026|NCT03343639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102026089|NCT03730181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102026090|NCT03730181|Leprostatic Agents|leprostatic agents|mesh-ancestor
102026091|NCT04167462|Deucravacitinib|deucravacitinib|mesh-list
102026092|NCT04167462|Dermatologic Agents|dermatologic agents|mesh-ancestor
102026161|NCT03582215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102026162|NCT03582215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102026163|NCT03582215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
102026164|NCT03582215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102026165|NCT03582215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026166|NCT05175703|Paclitaxel|paclitaxel|mesh-list
102026167|NCT05175703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102026169|NCT05175703|Tubulin Modulators|tubulin modulators|mesh-ancestor
102026227|NCT03631602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102026228|NCT03631602|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
102026229|NCT03631602|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102026230|NCT03631602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102026231|NCT03631602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102026232|NCT03631602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026234|NCT03631602|Hormone Antagonists|hormone antagonists|mesh-ancestor
102026292|NCT05666219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102026370|NCT03338569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102026373|NCT03338569|Protective Agents|protective agents|mesh-ancestor
102026441|NCT03639558|Antipruritics|antipruritics|mesh-ancestor
102026442|NCT03639558|Dermatologic Agents|dermatologic agents|mesh-ancestor
102026515|NCT03635957|Vitamins|vitamins|mesh-ancestor
102026516|NCT03635957|Micronutrients|micronutrients|mesh-ancestor
102026517|NCT05005507|Tenofovir|tenofovir|mesh-list
102026518|NCT05005507|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
102026519|NCT05005507|Antiviral Agents|antiviral agents|mesh-ancestor
102026520|NCT05005507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102026521|NCT05005507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
102026522|NCT05005507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102026523|NCT05005507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102026524|NCT05005507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026525|NCT05005507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
102026526|NCT05005507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
102026527|NCT04739358|Tepotinib|tepotinib|mesh-list
102026528|NCT04739358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102026529|NCT04893343|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
102026530|NCT04893343|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
102026531|NCT04893343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102026532|NCT04893343|Antitubercular Agents|antitubercular agents|mesh-ancestor
102026533|NCT05399641|Ibrexafungerp|ibrexafungerp|mesh-list
102026534|NCT05399641|Antifungal Agents|antifungal agents|mesh-ancestor
102026535|NCT05399641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102026536|NCT05593666|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
102026537|NCT05593666|Antifungal Agents|antifungal agents|mesh-ancestor
102026538|NCT05593666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101332247|NCT00037102|Methotrexate|methotrexate|mesh-list
102026539|NCT05593666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102026540|NCT05593666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102026541|NCT02684344|Tamsulosin|tamsulosin|mesh-list
102026543|NCT02684344|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
102026562|NCT02689804|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
102026563|NCT04353271|Hydroxychloroquine|hydroxychloroquine|mesh-list
102026564|NCT04353271|Antimalarials|antimalarials|mesh-ancestor
102026636|NCT05119075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101746394|NCT00760695|Dronabinol|dronabinol|mesh-list
102026709|NCT02678416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102026710|NCT02678416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102026711|NCT02678416|Antipyretics|antipyretics|mesh-ancestor
102026712|NCT03164668|Menthol|menthol|mesh-list
102026714|NCT03164668|Dermatologic Agents|dermatologic agents|mesh-ancestor
102026715|NCT03164512|Cannabidiol|cannabidiol|mesh-list
102026716|NCT03164512|Anticonvulsants|anticonvulsants|mesh-ancestor
102026717|NCT02680756|Ferric maltol|ferric maltol|mesh-list
102026718|NCT02680756|Hematinics|hematinics|mesh-ancestor
102026719|NCT03631836|Bevacizumab|bevacizumab|mesh-list
102026720|NCT03631836|Antibodies|antibodies|mesh-list
102026777|NCT05597280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102026778|NCT05597280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102026779|NCT05597280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102026780|NCT05597280|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102026781|NCT05597280|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102026844|NCT03163420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102026846|NCT03163420|Analgesics|analgesics|mesh-ancestor
102026915|NCT03163576|Vitamin B Complex|vitamin b complex|mesh-ancestor
102026916|NCT03163576|Vitamins|vitamins|mesh-ancestor
102026917|NCT03163576|Micronutrients|micronutrients|mesh-ancestor
102026991|NCT04546620|Hormones|hormones|mesh-ancestor
102026992|NCT04546620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102026994|NCT04546620|Antiemetics|antiemetics|mesh-ancestor
102027066|NCT02694718|Oxaliplatin|oxaliplatin|mesh-list
102027067|NCT02694718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101347327|NCT03151499|Rifampin|rifampin|mesh-list
102027068|NCT02694718|Antimetabolites|antimetabolites|mesh-ancestor
102027069|NCT02694718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027070|NCT02694718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102027071|NCT05681299|Liraglutide|liraglutide|mesh-list
102027072|NCT05681299|Hormones|hormones|mesh-list
102027073|NCT05681299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102027074|NCT05681299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027075|NCT05681299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102027076|NCT05681299|Incretins|incretins|mesh-ancestor
102027077|NCT03161080|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102027078|NCT03161080|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
102027079|NCT04908787|Paclitaxel|paclitaxel|mesh-list
102027080|NCT04908787|Doxorubicin|doxorubicin|mesh-list
102027081|NCT04908787|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
102027082|NCT04908787|Topotecan|topotecan|mesh-list
102027083|NCT04908787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102027084|NCT04908787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102027085|NCT04908787|Tubulin Modulators|tubulin modulators|mesh-ancestor
102027086|NCT04908787|Antimitotic Agents|antimitotic agents|mesh-ancestor
102027087|NCT04908787|Mitosis Modulators|mitosis modulators|mesh-ancestor
102027088|NCT04908787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027089|NCT04908787|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102027090|NCT04908787|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
102027091|NCT04908787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
102027092|NCT04908787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102027093|NCT04908787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
102027095|NCT04923139|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102027096|NCT04923139|Antithrombins|antithrombins|mesh-ancestor
102027097|NCT04923139|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102027098|NCT04923139|Protease Inhibitors|protease inhibitors|mesh-ancestor
102027099|NCT04923139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101601145|NCT01026792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101601146|NCT01026792|Antifungal Agents|antifungal agents|mesh-ancestor
101601147|NCT01026324|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
101601148|NCT01026324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101601149|NCT01026324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101451779|NCT00208143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101601153|NCT04300686|Immunoglobulins|immunoglobulins|mesh-list
102027100|NCT04923139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027101|NCT04923139|Anticoagulants|anticoagulants|mesh-ancestor
102027102|NCT05681221|Calcium|calcium|mesh-list
102027172|NCT04698187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102027173|NCT04698187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027248|NCT02942407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
102027249|NCT02942407|Antithrombins|antithrombins|mesh-ancestor
102027250|NCT02942407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
102027251|NCT02942407|Protease Inhibitors|protease inhibitors|mesh-ancestor
102027252|NCT02942407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102027253|NCT02942407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027254|NCT02921035|Interferons|interferons|mesh-list
102027255|NCT02921035|Interferon-beta|interferon-beta|mesh-list
102027256|NCT02921035|Interferon beta-1a|interferon beta-1a|mesh-list
102027257|NCT02921035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102027258|NCT02921035|Antiviral Agents|antiviral agents|mesh-ancestor
102027259|NCT02921035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102027260|NCT02921035|Immunologic Factors|immunologic factors|mesh-ancestor
102027261|NCT02921035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027262|NCT02921035|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
102027263|NCT04621981|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
102027265|NCT03667352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
102027266|NCT03667352|Narcotics|narcotics|mesh-ancestor
102027267|NCT03667352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102027268|NCT03667352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027269|NCT03667352|Analgesics|analgesics|mesh-ancestor
102027270|NCT03667352|Sensory System Agents|sensory system agents|mesh-ancestor
102027271|NCT03667352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102027272|NCT03667352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
102027273|NCT03667352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102027274|NCT03667352|Anesthetics, General|anesthetics, general|mesh-ancestor
102027275|NCT03667352|Anesthetics|anesthetics|mesh-ancestor
102027297|NCT02573233|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
102027298|NCT02573233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102027368|NCT03315793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027369|NCT03315793|Analgesics|analgesics|mesh-ancestor
102027441|NCT01380678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027443|NCT01380600|Sargramostim|sargramostim|mesh-list
102027444|NCT01380600|Immunologic Factors|immunologic factors|mesh-ancestor
102027468|NCT02579044|Everolimus|everolimus|mesh-list
102027511|NCT03476551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
102027512|NCT03476551|Diuretics|diuretics|mesh-ancestor
102027513|NCT03476551|Natriuretic Agents|natriuretic agents|mesh-ancestor
102027514|NCT03476551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027518|NCT04702789|Timolol|timolol|mesh-list
102027579|NCT03751163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027580|NCT03751163|Hemostatics|hemostatics|mesh-ancestor
102027581|NCT03751163|Coagulants|coagulants|mesh-ancestor
102027582|NCT03751163|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
102027583|NCT03751163|Protective Agents|protective agents|mesh-ancestor
102027587|NCT03639545|Metformin|metformin|mesh-list
102027649|NCT03110328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102027651|NCT03110328|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102027719|NCT03521141|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
102027720|NCT03521141|Cholinergic Agents|cholinergic agents|mesh-ancestor
102027721|NCT03521141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102027722|NCT03521141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027723|NCT03725267|Melatonin|melatonin|mesh-list
102027724|NCT03725267|Antioxidants|antioxidants|mesh-ancestor
102027725|NCT03725267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027726|NCT03725267|Protective Agents|protective agents|mesh-ancestor
102027727|NCT03725267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102027728|NCT03725267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102027729|NCT02997176|Talazoparib|talazoparib|mesh-list
102027731|NCT02997176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102027780|NCT02999672|Antimitotic Agents|antimitotic agents|mesh-ancestor
102027781|NCT02999672|Mitosis Modulators|mitosis modulators|mesh-ancestor
102027782|NCT02999672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027783|NCT02999672|Immunotoxins|immunotoxins|mesh-ancestor
102027853|NCT04220008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
102027854|NCT04220008|Tacrolimus|tacrolimus|mesh-list
102027855|NCT04220008|Antibodies|antibodies|mesh-list
102027856|NCT04220008|Immunoglobulins|immunoglobulins|mesh-list
102027857|NCT04220008|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
102027925|NCT03662516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102027926|NCT03662516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102027927|NCT03662516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102027928|NCT03728465|Nivolumab|nivolumab|mesh-list
102027929|NCT03728465|Ipilimumab|ipilimumab|mesh-list
102027930|NCT03728465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102027995|NCT02391688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102027996|NCT02391688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102027997|NCT02391688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
102027998|NCT02391688|Anesthetics, General|anesthetics, general|mesh-ancestor
102027999|NCT02391688|Anesthetics|anesthetics|mesh-ancestor
102028000|NCT02391688|GABA Modulators|gaba modulators|mesh-ancestor
102028001|NCT02391688|GABA Agents|gaba agents|mesh-ancestor
102028065|NCT04056650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
102028066|NCT04056650|Purinergic Agents|purinergic agents|mesh-ancestor
102028067|NCT04056650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102028068|NCT04055480|Insulin|insulin|mesh-list
102028069|NCT04055480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
102028070|NCT04055480|Insulin Aspart|insulin aspart|mesh-list
102028071|NCT04055480|Insulin, Short-Acting|insulin, short-acting|mesh-list
102028072|NCT04055480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
102028073|NCT04055480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028074|NCT03158090|Lanreotide|lanreotide|mesh-list
102028132|NCT03304873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102028133|NCT03304873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102028134|NCT04526509|Cyclophosphamide|cyclophosphamide|mesh-list
102028135|NCT04526509|Fludarabine|fludarabine|mesh-list
102028136|NCT04526509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102028198|NCT01068626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
102028199|NCT01068626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
102028271|NCT03657446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102028272|NCT03657446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028273|NCT03657446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102028274|NCT05276323|Hydrocortisone|hydrocortisone|mesh-list
102028342|NCT03657212|GABA Agents|gaba agents|mesh-ancestor
102028343|NCT03657212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101347785|NCT01807286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102028344|NCT03657212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028345|NCT03310411|Sumatriptan|sumatriptan|mesh-list
102028346|NCT03310411|Lasmiditan|lasmiditan|mesh-list
102028347|NCT03310411|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
102028408|NCT03495232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028409|NCT03495232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028410|NCT03495232|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102028411|NCT03495232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102028413|NCT02389582|Enoxaparin|enoxaparin|mesh-list
102028414|NCT02389582|Dabigatran|dabigatran|mesh-list
102028415|NCT02389582|Anticoagulants|anticoagulants|mesh-ancestor
102028416|NCT02389582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102028417|NCT02389582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102028418|NCT02389582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028419|NCT02389582|Antithrombins|antithrombins|mesh-ancestor
102028423|NCT02389426|Bosentan|bosentan|mesh-list
101347812|NCT00034593|Gemcitabine|gemcitabine|mesh-list
102028471|NCT02387086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
102028543|NCT02388490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102028544|NCT02388490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102028616|NCT02386072|Autonomic Agents|autonomic agents|mesh-ancestor
102028617|NCT02386072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102028618|NCT02386072|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
102028619|NCT02386072|Cholinergic Agents|cholinergic agents|mesh-ancestor
102028620|NCT03655730|Psychotropic Drugs|psychotropic drugs|mesh-list
102028621|NCT02381470|Amoxicillin|amoxicillin|mesh-list
102028622|NCT02381470|Rifampin|rifampin|mesh-list
102028623|NCT02381470|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
102028624|NCT02381470|Clavulanic Acids|clavulanic acids|mesh-list
102028625|NCT02381470|Clavulanic Acid|clavulanic acid|mesh-list
102028626|NCT02381470|Cefadroxil|cefadroxil|mesh-list
102028627|NCT02381470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102028628|NCT02381470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101347871|NCT00034710|Capsaicin|capsaicin|mesh-list
102028629|NCT02381470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102028630|NCT02381470|Antitubercular Agents|antitubercular agents|mesh-ancestor
102028631|NCT02381470|Leprostatic Agents|leprostatic agents|mesh-ancestor
102028632|NCT02381470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102028633|NCT02381470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102028634|NCT02381470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102028635|NCT02381470|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
102028636|NCT02381470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
102028637|NCT02381470|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
102028638|NCT02381470|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
102028639|NCT02381470|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
102028640|NCT02381470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
102028663|NCT02381080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102028664|NCT02381080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102028735|NCT02385448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102028737|NCT02385448|Hormone Antagonists|hormone antagonists|mesh-ancestor
102028808|NCT03293485|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
102028809|NCT03309943|Propranolol|propranolol|mesh-list
102028810|NCT03309943|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
102028811|NCT03309943|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
102028819|NCT01732627|Vaccines|vaccines|mesh-list
102028879|NCT04949269|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
102028880|NCT04949269|Histamine Antagonists|histamine antagonists|mesh-ancestor
102028881|NCT04949269|Histamine Agents|histamine agents|mesh-ancestor
102028952|NCT04715230|Haloperidol|haloperidol|mesh-list
102028953|NCT04715230|Haloperidol decanoate|haloperidol decanoate|mesh-list
102029026|NCT03130959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102029028|NCT03130959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102029030|NCT01370031|Charcoal|charcoal|mesh-list
102029095|NCT01370343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029096|NCT01370343|Antifungal Agents|antifungal agents|mesh-ancestor
102029097|NCT01370343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102029165|NCT02373046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029166|NCT04382404|Sofosbuvir|sofosbuvir|mesh-list
102029167|NCT04382404|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
102029168|NCT04382404|Velpatasvir|velpatasvir|mesh-list
102029169|NCT04382404|Antiviral Agents|antiviral agents|mesh-ancestor
102029238|NCT04381936|Dermatologic Agents|dermatologic agents|mesh-ancestor
102029239|NCT04381936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102029240|NCT03124407|Capsaicin|capsaicin|mesh-list
102029310|NCT02370550|Glucocorticoids|glucocorticoids|mesh-ancestor
102029311|NCT02370550|Hormones|hormones|mesh-ancestor
102029312|NCT02370550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102029314|NCT02370550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102029382|NCT03123861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102029383|NCT03123861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102029384|NCT03123861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102029390|NCT01368783|Ritonavir|ritonavir|mesh-list
102029453|NCT01369017|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
102029454|NCT01369017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102029455|NCT01365351|Hormones|hormones|mesh-list
102029456|NCT01365351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102029457|NCT01365351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029458|NCT01372449|Memantine|memantine|mesh-list
102029459|NCT01372449|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
102029518|NCT02369380|Immunologic Factors|immunologic factors|mesh-ancestor
102029519|NCT02369380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029520|NCT02369380|Viscosupplements|viscosupplements|mesh-ancestor
102029521|NCT02369380|Protective Agents|protective agents|mesh-ancestor
102029522|NCT02038816|Azacitidine|azacitidine|mesh-list
102029523|NCT02038816|Deferasirox|deferasirox|mesh-list
102029536|NCT02359162|Prednisone|prednisone|mesh-list
102029589|NCT03654794|Tacrolimus|tacrolimus|mesh-list
102029590|NCT03654794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102029591|NCT03654794|Immunologic Factors|immunologic factors|mesh-ancestor
102029592|NCT03654794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029593|NCT03654794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
102029594|NCT03654794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102029596|NCT03654170|BI 425809|bi 425809|mesh-list
102029660|NCT03634059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102029661|NCT03634059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102029735|NCT03085914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
102029736|NCT03085914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102029810|NCT01382238|Dolutegravir|dolutegravir|mesh-list
102029811|NCT01382238|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
102029812|NCT01382238|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
102029813|NCT01382238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102029884|NCT00735748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102029885|NCT00735748|Analgesics|analgesics|mesh-ancestor
102029886|NCT00735748|Sensory System Agents|sensory system agents|mesh-ancestor
102029887|NCT00735748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102029888|NCT02367196|Rituximab|rituximab|mesh-list
102029889|NCT02367196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102029890|NCT02367196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102029897|NCT03408886|Vancomycin|vancomycin|mesh-list
102029950|NCT00979212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102029951|NCT00979212|Tubulin Modulators|tubulin modulators|mesh-ancestor
102030023|NCT02365948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102030024|NCT02365948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102030025|NCT02365948|Immunologic Factors|immunologic factors|mesh-ancestor
102030095|NCT01377324|Contraceptive Agents|contraceptive agents|mesh-ancestor
102030096|NCT01377324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102030097|NCT01377324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
102030098|NCT02359942|Citric Acid|citric acid|mesh-list
102030099|NCT02359942|Sodium Citrate|sodium citrate|mesh-list
102030100|NCT02359942|Anticoagulants|anticoagulants|mesh-ancestor
102030101|NCT02359942|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
102030102|NCT02359942|Chelating Agents|chelating agents|mesh-ancestor
102030103|NCT02359942|Sequestering Agents|sequestering agents|mesh-ancestor
102030104|NCT02359942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030105|NCT02354560|Erythromycin|erythromycin|mesh-list
102030106|NCT02354560|Erythromycin Estolate|erythromycin estolate|mesh-list
102030107|NCT02354560|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
102030108|NCT02354560|Erythromycin stearate|erythromycin stearate|mesh-list
102030109|NCT02354560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102030110|NCT02354560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102030111|NCT02354560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102030151|NCT02354170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
102030152|NCT02354170|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
102030153|NCT01377246|Octreotide|octreotide|mesh-list
102030154|NCT01377246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102030222|NCT03727607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102030223|NCT03727607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102030224|NCT03727607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030232|NCT03157804|Plerixafor|plerixafor|mesh-list
102030290|NCT02352064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
102030291|NCT02352064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030292|NCT03723941|Etoposide|etoposide|mesh-list
102030293|NCT03723941|Mitotane|mitotane|mesh-list
102030362|NCT01378650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030363|NCT01378650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
102030364|NCT01378650|Respiratory System Agents|respiratory system agents|mesh-ancestor
102030365|NCT01378650|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
102030433|NCT03930186|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102030434|NCT03930186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102030435|NCT03930186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332388|NCT00037804|Irinotecan|irinotecan|mesh-list
102030504|NCT03723395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030505|NCT03723395|Antifungal Agents|antifungal agents|mesh-ancestor
102030506|NCT03723395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102030507|NCT03723395|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
102030508|NCT03723395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
102030569|NCT05764512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030570|NCT02342392|Ranibizumab|ranibizumab|mesh-list
102030571|NCT02342392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102030572|NCT02342392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
102030573|NCT02342392|Growth Substances|growth substances|mesh-ancestor
102030574|NCT02342392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030575|NCT02342392|Growth Inhibitors|growth inhibitors|mesh-ancestor
102030576|NCT02342392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102030577|NCT02342002|Misoprostol|misoprostol|mesh-list
102030578|NCT02342002|Mifepristone|mifepristone|mesh-list
102030579|NCT02342002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
102030580|NCT02342002|Abortifacient Agents|abortifacient agents|mesh-ancestor
102030581|NCT02342002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102030582|NCT02342002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030628|NCT03601806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102030629|NCT03601806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102030630|NCT03601806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
102030703|NCT03785340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102030706|NCT02345590|Eplerenone|eplerenone|mesh-list
102030779|NCT03197064|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
102030780|NCT03197064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102030781|NCT03197064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030852|NCT02344888|Fertility Agents, Female|fertility agents, female|mesh-ancestor
102030853|NCT02344888|Fertility Agents|fertility agents|mesh-ancestor
102030854|NCT02344888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
102030855|NCT02344888|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
102030856|NCT02344888|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
102030857|NCT03497429|Niraparib|niraparib|mesh-list
102030858|NCT03497429|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
102030859|NCT03497429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102030860|NCT03497429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030861|NCT03497429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102030862|NCT03146104|Propofol|propofol|mesh-list
102030863|NCT03146104|Isoflurane|isoflurane|mesh-list
102030864|NCT03146104|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101348261|NCT00036387|Dermatologic Agents|dermatologic agents|mesh-ancestor
102030865|NCT03146104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102030866|NCT03146104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102030911|NCT02340988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102030912|NCT02340988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102030913|NCT03145480|Obinutuzumab|obinutuzumab|mesh-list
102030914|NCT03145480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102030915|NCT03145480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102030916|NCT03726515|Pembrolizumab|pembrolizumab|mesh-list
102030917|NCT03726515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102030918|NCT03726515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102030919|NCT03726515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
102030920|NCT03726515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102030921|NCT05665283|Ensartinib|ensartinib|mesh-list
102030922|NCT05665283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102030923|NCT05665283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
102030924|NCT05665283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102030926|NCT03071094|Nivolumab|nivolumab|mesh-list
102030970|NCT03720665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
102030971|NCT03720665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102031041|NCT03148522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102031043|NCT03148522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031046|NCT03148522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102031112|NCT02339428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031188|NCT02348788|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
102031189|NCT02348788|Amebicides|amebicides|mesh-ancestor
102031190|NCT02348788|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
102031191|NCT02348788|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
102031192|NCT02348788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102031193|NCT02348788|Antimalarials|antimalarials|mesh-ancestor
102031258|NCT02336386|Autonomic Agents|autonomic agents|mesh-ancestor
102031259|NCT02336386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102031329|NCT03722381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031330|NCT03722381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
102031331|NCT03722381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031332|NCT03722381|Vasodilator Agents|vasodilator agents|mesh-ancestor
102031333|NCT04352608|Vaccines|vaccines|mesh-list
102031398|NCT02335684|Autonomic Agents|autonomic agents|mesh-ancestor
102031399|NCT02335684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102031400|NCT02335684|Dopamine Agents|dopamine agents|mesh-ancestor
102031401|NCT02335684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102031408|NCT05198388|Endorphins|endorphins|mesh-list
102031466|NCT02335372|Acetic Acid|acetic acid|mesh-list
102031467|NCT02335372|Proflavine|proflavine|mesh-list
102031468|NCT02335372|Retinol acetate|retinol acetate|mesh-list
102031469|NCT02335372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
102031542|NCT03488225|Tubulin Modulators|tubulin modulators|mesh-ancestor
102031543|NCT03488225|Antimitotic Agents|antimitotic agents|mesh-ancestor
102031544|NCT03488225|Mitosis Modulators|mitosis modulators|mesh-ancestor
102031545|NCT03488225|Hematinics|hematinics|mesh-ancestor
102031546|NCT03488225|Protease Inhibitors|protease inhibitors|mesh-ancestor
102031547|NCT03488225|Immunotoxins|immunotoxins|mesh-ancestor
102031548|NCT03488225|Immunoconjugates|immunoconjugates|mesh-ancestor
102031549|NCT02334904|Risperidone|risperidone|mesh-list
102031550|NCT02334904|Aripiprazole|aripiprazole|mesh-list
102031551|NCT02334904|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
102031552|NCT02334904|Serotonin Agents|serotonin agents|mesh-ancestor
102031553|NCT02334904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102031554|NCT02334904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031555|NCT02334904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102031556|NCT02334904|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
102031557|NCT02334904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
102031558|NCT02334904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102031559|NCT02334904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
102031560|NCT02334904|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
102031561|NCT02334904|Dopamine Agents|dopamine agents|mesh-ancestor
102031562|NCT02334904|Antidepressive Agents|antidepressive agents|mesh-ancestor
102031577|NCT03720041|Ixazomib|ixazomib|mesh-list
102031599|NCT03720041|Glycine Agents|glycine agents|mesh-ancestor
102031600|NCT03720041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102031673|NCT02330380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
102031674|NCT02330380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102031675|NCT02330380|Immunologic Factors|immunologic factors|mesh-ancestor
102031676|NCT02330380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102031677|NCT02330380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
102031678|NCT02330380|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
102031679|NCT02330380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102031680|NCT02330380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
102031681|NCT02330380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
102031682|NCT02330380|Analgesics|analgesics|mesh-ancestor
102031683|NCT02330380|Sensory System Agents|sensory system agents|mesh-ancestor
102031684|NCT02330380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
102031685|NCT02330380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
102031742|NCT04278404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031743|NCT04278404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101348787|NCT00846326|Autonomic Agents|autonomic agents|mesh-ancestor
102031744|NCT04278404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
102031745|NCT04278404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102031812|NCT04278404|GABA Agonists|gaba agonists|mesh-ancestor
102031814|NCT04278404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
102031815|NCT04278404|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
102031816|NCT04278404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
102031817|NCT04278404|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
102031818|NCT04278404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
102031819|NCT04278404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101348915|NCT00276809|Carmustine|carmustine|mesh-list
102031820|NCT04278404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
102031821|NCT04278404|Sympathomimetics|sympathomimetics|mesh-ancestor
102031822|NCT04278404|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
102031826|NCT04278404|Chelating Agents|chelating agents|mesh-ancestor
102031874|NCT02318277|Durvalumab|durvalumab|mesh-list
102031875|NCT02318277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
102031876|NCT02318277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102031877|NCT03143452|Lidocaine|lidocaine|mesh-list
102031878|NCT03143452|Tetracaine|tetracaine|mesh-list
102031879|NCT03143452|Ophthalmic Solutions|ophthalmic solutions|mesh-list
102031881|NCT03143452|Anesthetics|anesthetics|mesh-ancestor
102031941|NCT02974010|Anesthetics|anesthetics|mesh-ancestor
102031942|NCT02974010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
102031943|NCT02974010|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
102031944|NCT02974010|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
102031945|NCT02974010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102031946|NCT02974010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102031947|NCT02974010|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
102031948|NCT02974010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102031949|NCT02974010|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
102031950|NCT02974010|Antitubercular Agents|antitubercular agents|mesh-ancestor
102032005|NCT02329288|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
102032006|NCT02329288|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
102032007|NCT02329288|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
102032008|NCT02329288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
102032009|NCT02329288|Glucocorticoids|glucocorticoids|mesh-ancestor
102032010|NCT02329288|Hormones|hormones|mesh-ancestor
102032011|NCT02329288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
102032012|NCT02329288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032013|NCT02329288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
102032014|NCT02329288|Immunologic Factors|immunologic factors|mesh-ancestor
102032015|NCT02329288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
102032016|NCT02329288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032017|NCT02329054|Favipiravir|favipiravir|mesh-list
102032018|NCT02329054|Antiviral Agents|antiviral agents|mesh-ancestor
102032019|NCT02329054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
102032020|NCT03122457|C 1027|c 1027|mesh-list
102032021|NCT03122457|Benzoyl Peroxide|benzoyl peroxide|mesh-list
102032022|NCT03122457|Dermatologic Agents|dermatologic agents|mesh-ancestor
102032023|NCT03122457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
102032024|NCT03122457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102032025|NCT04407988|Letrozole|letrozole|mesh-list
102032026|NCT04407988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102032027|NCT04407988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101349434|NCT00129233|Amlodipine|amlodipine|mesh-list
102032057|NCT02332954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
102032058|NCT02332954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
102032059|NCT02332954|Serotonin Agents|serotonin agents|mesh-ancestor
102032128|NCT05077462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
102032129|NCT03714113|Antibodies|antibodies|mesh-list
102032130|NCT03714113|Immunologic Factors|immunologic factors|mesh-ancestor
102032204|NCT00069238|Immunologic Factors|immunologic factors|mesh-ancestor
102032205|NCT00069238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
102032206|NCT00069238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
102032207|NCT00069238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
102032275|NCT02328118|Growth Inhibitors|growth inhibitors|mesh-ancestor
102032276|NCT02328118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101735785|NCT03742531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101735786|NCT03742531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735803|NCT00733902|Tanezumab|tanezumab|mesh-list
101735804|NCT00733902|Analgesics|analgesics|mesh-ancestor
101735805|NCT00733902|Sensory System Agents|sensory system agents|mesh-ancestor
101735806|NCT00733902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101735807|NCT00733902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735808|NCT05737355|Red yeast rice|red yeast rice|mesh-list
101735809|NCT05737355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101735810|NCT05737355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101735811|NCT05737355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101735812|NCT05737355|Antimetabolites|antimetabolites|mesh-ancestor
101735816|NCT03540017|Cisplatin|cisplatin|mesh-list
101735865|NCT00786422|Antithrombins|antithrombins|mesh-ancestor
101735866|NCT00786422|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101735867|NCT00786422|Protease Inhibitors|protease inhibitors|mesh-ancestor
101735868|NCT00786422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101735869|NCT00786422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735871|NCT00718887|Entecavir|entecavir|mesh-list
101735933|NCT04085913|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101735934|NCT04085913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101735935|NCT04085913|Adrenergic Agents|adrenergic agents|mesh-ancestor
101735936|NCT04085913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101735937|NCT04085913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101735938|NCT04085913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101735939|NCT04085913|Autonomic Agents|autonomic agents|mesh-ancestor
101735940|NCT04085913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101735941|NCT04085913|Respiratory System Agents|respiratory system agents|mesh-ancestor
101735942|NCT04085913|Mydriatics|mydriatics|mesh-ancestor
101735943|NCT04085913|Sympathomimetics|sympathomimetics|mesh-ancestor
101735944|NCT04085913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101735945|NCT00806195|Vaccines|vaccines|mesh-list
101735946|NCT00806195|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101735950|NCT03462329|Doxycycline|doxycycline|mesh-list
101735995|NCT02607293|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101735996|NCT02607293|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101735997|NCT02607293|Hormones|hormones|mesh-ancestor
101735998|NCT02607293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101735999|NCT02607293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736000|NCT02607371|Rivaroxaban|rivaroxaban|mesh-list
101736001|NCT02607371|Apixaban|apixaban|mesh-list
101393482|NCT03984448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101736002|NCT02607371|Edoxaban|edoxaban|mesh-list
101736003|NCT02607371|Dabigatran|dabigatran|mesh-list
101736005|NCT02607371|Antithrombins|antithrombins|mesh-ancestor
101736006|NCT02607371|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101736007|NCT02607371|Protease Inhibitors|protease inhibitors|mesh-ancestor
101736008|NCT02607371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101736009|NCT02607371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736010|NCT02607371|Anticoagulants|anticoagulants|mesh-ancestor
101736011|NCT04085757|Dinoprostone|dinoprostone|mesh-list
101736012|NCT04085757|Oxytocics|oxytocics|mesh-ancestor
101736053|NCT00589667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101736054|NCT00589667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101736127|NCT00790400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101736128|NCT00790400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736129|NCT00790400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101736130|NCT00790400|Immunologic Factors|immunologic factors|mesh-ancestor
101736131|NCT00790400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736132|NCT00790400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101736195|NCT00785486|Analgesics|analgesics|mesh-ancestor
101736196|NCT00785486|Sensory System Agents|sensory system agents|mesh-ancestor
101736197|NCT00917904|Dapivirine|dapivirine|mesh-list
101736198|NCT00917904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101736199|NCT00917904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101736200|NCT00917904|Antiviral Agents|antiviral agents|mesh-ancestor
101736201|NCT00917904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101736264|NCT04107194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101736265|NCT04107194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101736266|NCT04107194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101736267|NCT04107194|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101736268|NCT04107194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101736335|NCT00776984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101736336|NCT00776984|Autonomic Agents|autonomic agents|mesh-ancestor
101736337|NCT00776984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101736338|NCT00776984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736339|NCT00776984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101736340|NCT00776984|Respiratory System Agents|respiratory system agents|mesh-ancestor
101736341|NCT00776984|Parasympatholytics|parasympatholytics|mesh-ancestor
101736342|NCT00776984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101736343|NCT00776984|Cholinergic Agents|cholinergic agents|mesh-ancestor
101736344|NCT00776984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101736345|NCT00776984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736346|NCT04015557|Acetaminophen|acetaminophen|mesh-list
101736347|NCT04015557|Acetylcysteine|acetylcysteine|mesh-list
101736348|NCT04015557|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101736349|NCT04015557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101736350|NCT04015557|Analgesics|analgesics|mesh-ancestor
101736351|NCT04015557|Sensory System Agents|sensory system agents|mesh-ancestor
101736352|NCT04015557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101736353|NCT04015557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736354|NCT04015557|Antipyretics|antipyretics|mesh-ancestor
101736355|NCT04015557|Antiviral Agents|antiviral agents|mesh-ancestor
101736356|NCT04015557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101736357|NCT04015557|Expectorants|expectorants|mesh-ancestor
101736358|NCT04015557|Respiratory System Agents|respiratory system agents|mesh-ancestor
101736359|NCT04015557|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101736360|NCT04015557|Antioxidants|antioxidants|mesh-ancestor
101736361|NCT04015557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736362|NCT04015557|Protective Agents|protective agents|mesh-ancestor
101736363|NCT04015557|Antidotes|antidotes|mesh-ancestor
101736364|NCT00784784|Zanamivir|zanamivir|mesh-list
101736365|NCT00784784|Antiviral Agents|antiviral agents|mesh-ancestor
101736366|NCT00784784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101736367|NCT00784784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101736379|NCT00800735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101736380|NCT00800735|Antimetabolites|antimetabolites|mesh-ancestor
101736381|NCT00800735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736382|NCT00800735|Immunologic Factors|immunologic factors|mesh-ancestor
101736383|NCT00800735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736384|NCT05324163|Celecoxib|celecoxib|mesh-list
101736385|NCT05324163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101736386|NCT05324163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101736387|NCT05324163|Analgesics|analgesics|mesh-ancestor
101736388|NCT05324163|Sensory System Agents|sensory system agents|mesh-ancestor
101736389|NCT05324163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101736390|NCT05324163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736391|NCT05324163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101736392|NCT05324163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101736393|NCT05324163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101736394|NCT05324163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101736395|NCT05324163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101736396|NCT05324163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736397|NCT00730158|Irinotecan|irinotecan|mesh-list
101736398|NCT00730158|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101736399|NCT00730158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101736400|NCT00730158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101736403|NCT04114643|Thrombin|thrombin|mesh-list
101736430|NCT00784550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101736431|NCT00784550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736432|NCT00784550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101736433|NCT00784550|Respiratory System Agents|respiratory system agents|mesh-ancestor
101736434|NCT00784550|Dermatologic Agents|dermatologic agents|mesh-ancestor
101736435|NCT00784550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101736497|NCT05684913|Hemostatics|hemostatics|mesh-list
101736498|NCT05684913|Coagulants|coagulants|mesh-ancestor
101736499|NCT00585546|Clenbuterol|clenbuterol|mesh-list
101736500|NCT00585546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101736501|NCT00585546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101736502|NCT00585546|Adrenergic Agents|adrenergic agents|mesh-ancestor
101736507|NCT00585546|Autonomic Agents|autonomic agents|mesh-ancestor
101736565|NCT00775190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101736566|NCT00775190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101736567|NCT00775190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101736639|NCT00767000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101736640|NCT00767000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736641|NCT05194449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
101736642|NCT05194449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101736644|NCT00724932|Atropine|atropine|mesh-list
101736710|NCT00766142|Micronutrients|micronutrients|mesh-ancestor
101736787|NCT02593968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101736788|NCT02593968|Antiviral Agents|antiviral agents|mesh-ancestor
101736789|NCT02593968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101736790|NCT02588547|Granisetron|granisetron|mesh-list
101736791|NCT02588547|Antiemetics|antiemetics|mesh-ancestor
101736792|NCT02588547|Autonomic Agents|autonomic agents|mesh-ancestor
101736793|NCT02588547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101736794|NCT02588547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736795|NCT02588547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101736796|NCT02588547|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101736797|NCT02588547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101736798|NCT02588547|Serotonin Agents|serotonin agents|mesh-ancestor
101736799|NCT02588547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101736800|NCT02588547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736850|NCT04082715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101736851|NCT04082715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101736852|NCT04082715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101736853|NCT04082715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101736854|NCT04082715|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101736920|NCT04102124|Fluzoparib|fluzoparib|mesh-list
101736921|NCT04102124|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101736922|NCT04102124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101736923|NCT04102124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736924|NCT04102124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101736925|NCT04082559|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101736926|NCT04082559|Metronidazole|metronidazole|mesh-list
101736953|NCT00765674|Amlodipine|amlodipine|mesh-list
101736985|NCT02587455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101736987|NCT02587455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101736988|NCT02587455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101736989|NCT04099238|Warfarin|warfarin|mesh-list
101736990|NCT04099238|Rivaroxaban|rivaroxaban|mesh-list
101736991|NCT04099238|Dabigatran|dabigatran|mesh-list
101736992|NCT04099238|Apixaban|apixaban|mesh-list
101736993|NCT04099238|Anticoagulants|anticoagulants|mesh-list
101736994|NCT04099238|Edoxaban|edoxaban|mesh-list
101736995|NCT04099238|Acenocoumarol|acenocoumarol|mesh-list
101736996|NCT04099238|Phenindione|phenindione|mesh-list
101736997|NCT04099238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101736998|NCT04099238|Antithrombins|antithrombins|mesh-ancestor
101736999|NCT04099238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101737000|NCT04099238|Protease Inhibitors|protease inhibitors|mesh-ancestor
101737001|NCT04099238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101737002|NCT04099238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737003|NCT04932135|Hormones|hormones|mesh-list
101737004|NCT04932135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101263288|NCT01761149|Remifentanil|remifentanil|mesh-list
101737005|NCT04932135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737007|NCT04101812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101737008|NCT04101812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101737009|NCT04101812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101737010|NCT04101812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101737035|NCT02587533|Protective Agents|protective agents|mesh-ancestor
101737036|NCT04847661|Mefloquine|mefloquine|mesh-list
101737037|NCT04847661|Antimalarials|antimalarials|mesh-ancestor
101737038|NCT04847661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101737039|NCT04847661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101737040|NCT04847661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101737041|NCT00919815|Cyclosporine|cyclosporine|mesh-list
101737105|NCT00799409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101737106|NCT00799409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101737107|NCT00799409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737108|NCT00799409|Dopamine Agents|dopamine agents|mesh-ancestor
101737109|NCT00799409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101737110|NCT00782210|Olodaterol|olodaterol|mesh-list
101737174|NCT02586129|Antimetabolites|antimetabolites|mesh-ancestor
101828276|NCT05815160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101737175|NCT02586129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737176|NCT02586129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101737179|NCT04081077|Moxifloxacin|moxifloxacin|mesh-list
101737248|NCT04101578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737249|NCT04101578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101737250|NCT04101578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101737251|NCT04101578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101737252|NCT04101578|Glucocorticoids|glucocorticoids|mesh-ancestor
101737257|NCT04101578|Abortifacient Agents|abortifacient agents|mesh-ancestor
101737316|NCT00583947|Adrenergic Agents|adrenergic agents|mesh-ancestor
101737319|NCT00772928|Vaccines|vaccines|mesh-list
101737388|NCT00761306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101737389|NCT00761306|Serotonin Agents|serotonin agents|mesh-ancestor
101737390|NCT00761306|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101737391|NCT00761306|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101737392|NCT00761306|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101737393|NCT00761306|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101737394|NCT00772538|Tiotropium Bromide|tiotropium bromide|mesh-list
101737395|NCT00772538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101737396|NCT00772538|Autonomic Agents|autonomic agents|mesh-ancestor
101737397|NCT00772538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101737451|NCT02584335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101737452|NCT02584335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101737453|NCT02584335|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101737454|NCT02584335|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101737455|NCT02584335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101737519|NCT02596269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101737520|NCT02596269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737521|NCT00741039|Vaccines|vaccines|mesh-list
101737522|NCT00741039|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101737523|NCT00741039|Immunologic Factors|immunologic factors|mesh-ancestor
101737524|NCT00741039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737525|NCT02583321|Silver Sulfadiazine|silver sulfadiazine|mesh-list
101737526|NCT02583321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101737527|NCT02583321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101737528|NCT04454229|Penicillins|penicillins|mesh-list
101737529|NCT04454229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101737530|NCT04454229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101737531|NCT04078659|Lidocaine|lidocaine|mesh-list
101737532|NCT04078659|Magnesium Sulfate|magnesium sulfate|mesh-list
101737533|NCT04078659|Fentanyl|fentanyl|mesh-list
101737534|NCT04078659|Propofol|propofol|mesh-list
101737535|NCT04078659|Atracurium|atracurium|mesh-list
101737536|NCT04078659|Anesthetics, Local|anesthetics, local|mesh-ancestor
101737537|NCT04078659|Anesthetics|anesthetics|mesh-ancestor
101737538|NCT04078659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101737539|NCT04078659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737540|NCT04078659|Sensory System Agents|sensory system agents|mesh-ancestor
101737541|NCT04078659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101737542|NCT04078659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101737543|NCT04078659|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101737544|NCT04078659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101737545|NCT04078659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101737567|NCT02583243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101737568|NCT02583243|Narcotics|narcotics|mesh-ancestor
101737569|NCT02583243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101737570|NCT02583243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737571|NCT02583243|Analgesics|analgesics|mesh-ancestor
101737572|NCT02583243|Sensory System Agents|sensory system agents|mesh-ancestor
101737573|NCT02583243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101737574|NCT02583243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101737575|NCT00798707|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101737631|NCT02582307|Antiemetics|antiemetics|mesh-ancestor
101737632|NCT02582307|Autonomic Agents|autonomic agents|mesh-ancestor
101737633|NCT02582307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101737634|NCT02582307|Mydriatics|mydriatics|mesh-ancestor
101737704|NCT04077957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101737705|NCT04077957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101737706|NCT04102670|Hyaluronic Acid|hyaluronic acid|mesh-list
101737707|NCT04102670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737708|NCT04102670|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101737709|NCT04102670|Immunologic Factors|immunologic factors|mesh-ancestor
101737710|NCT04102670|Viscosupplements|viscosupplements|mesh-ancestor
101737774|NCT04113941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101737775|NCT04113941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737777|NCT04113941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101737845|NCT00771914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101737846|NCT00771914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101737847|NCT00771914|Antipyretics|antipyretics|mesh-ancestor
101737848|NCT04307511|Aspirin|aspirin|mesh-list
101737849|NCT04307511|Ticagrelor|ticagrelor|mesh-list
101737850|NCT04307511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101737851|NCT04307511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101737852|NCT04307511|Analgesics|analgesics|mesh-ancestor
101737853|NCT04307511|Sensory System Agents|sensory system agents|mesh-ancestor
101737854|NCT04307511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101737910|NCT00771758|Adrenergic Agents|adrenergic agents|mesh-ancestor
101737911|NCT00771758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101737912|NCT02581371|Cerebrolysin|cerebrolysin|mesh-list
101737913|NCT02581371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101737914|NCT02581371|Protective Agents|protective agents|mesh-ancestor
101737915|NCT02581371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101737916|NCT02581371|Nootropic Agents|nootropic agents|mesh-ancestor
101737917|NCT02688465|Apomorphine|apomorphine|mesh-list
101737918|NCT02688465|Emetics|emetics|mesh-ancestor
101737920|NCT02688465|Autonomic Agents|autonomic agents|mesh-ancestor
101737974|NCT00638781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101737975|NCT00638781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101737977|NCT04115423|Infliximab|infliximab|mesh-list
101737978|NCT04115423|Golimumab|golimumab|mesh-list
101737979|NCT04115423|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
101737980|NCT04115423|Etanercept|etanercept|mesh-list
101737981|NCT04115423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101737982|NCT04115423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101737983|NCT04115423|Dermatologic Agents|dermatologic agents|mesh-ancestor
101349838|NCT05595603|Gentamicins|gentamicins|mesh-list
101737984|NCT04115423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101737985|NCT04115423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101738039|NCT00802529|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101738040|NCT00802529|Protective Agents|protective agents|mesh-ancestor
101738041|NCT00802529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101738042|NCT00802529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738043|NCT00802529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101738044|NCT00802529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101738045|NCT00802529|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101738046|NCT00802529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101738106|NCT05277285|Sodium thiosulfate|sodium thiosulfate|mesh-list
101738107|NCT05277285|Antidotes|antidotes|mesh-ancestor
101738108|NCT05277285|Protective Agents|protective agents|mesh-ancestor
101738109|NCT05277285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738110|NCT05277285|Antioxidants|antioxidants|mesh-ancestor
101738111|NCT05277285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738112|NCT05277285|Antitubercular Agents|antitubercular agents|mesh-ancestor
101738113|NCT05277285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101738114|NCT05277285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101738116|NCT05277285|Sequestering Agents|sequestering agents|mesh-ancestor
101738117|NCT04110665|Acetaminophen|acetaminophen|mesh-list
101738118|NCT04110665|Morphine|morphine|mesh-list
101738119|NCT04110665|Oxycodone|oxycodone|mesh-list
101738120|NCT04110665|Tramadol|tramadol|mesh-list
101738121|NCT04110665|Nefopam|nefopam|mesh-list
101738122|NCT04110665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101738123|NCT04110665|Narcotics|narcotics|mesh-ancestor
101738124|NCT04110665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101738125|NCT04110665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738126|NCT04110665|Analgesics|analgesics|mesh-ancestor
101738127|NCT04110665|Sensory System Agents|sensory system agents|mesh-ancestor
101738128|NCT04110665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101738129|NCT04110665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101738163|NCT02687841|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101738164|NCT02687841|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101738165|NCT02687841|Protective Agents|protective agents|mesh-ancestor
101738166|NCT02687841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738167|NCT02687841|Vasodilator Agents|vasodilator agents|mesh-ancestor
101738168|NCT02687841|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101738169|NCT02687841|Antioxidants|antioxidants|mesh-ancestor
101738170|NCT00778622|Metformin|metformin|mesh-list
101738171|NCT00778622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101738172|NCT00778622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738173|NCT00777920|Ambrisentan|ambrisentan|mesh-list
101738174|NCT00777920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101738175|NCT04236141|Rituximab|rituximab|mesh-list
101738176|NCT04236141|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101738177|NCT04236141|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
101738224|NCT04097288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101738225|NCT04097288|Serotonin Agents|serotonin agents|mesh-ancestor
101738226|NCT04097288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738296|NCT02604719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738297|NCT02604719|Hemostatics|hemostatics|mesh-ancestor
101738298|NCT02604719|Coagulants|coagulants|mesh-ancestor
101738299|NCT02604797|Flurbiprofen|flurbiprofen|mesh-list
101738300|NCT02604797|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
101738301|NCT02604797|Sufentanil|sufentanil|mesh-list
101738302|NCT02604797|Dsuvia|dsuvia|mesh-list
101738303|NCT02604797|Nalbuphine|nalbuphine|mesh-list
101738304|NCT02604797|Ramosetron|ramosetron|mesh-list
101738367|NCT04077255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738376|NCT00770432|Laxatives|laxatives|mesh-ancestor
101738441|NCT00727506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101738442|NCT00727506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738443|NCT00789815|Midazolam|midazolam|mesh-list
101738444|NCT00789815|Propofol|propofol|mesh-list
101738445|NCT00789815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101738508|NCT00721110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738509|NCT00721110|Sensory System Agents|sensory system agents|mesh-ancestor
101738582|NCT00789581|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101738583|NCT00789581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101738584|NCT00789581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101738585|NCT00789581|Tubulin Modulators|tubulin modulators|mesh-ancestor
101738652|NCT03475953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101738653|NCT03475953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101738725|NCT04105985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101738726|NCT04105985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738727|NCT04105985|Sensory System Agents|sensory system agents|mesh-ancestor
101738728|NCT04105985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101738729|NCT04105985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101738730|NCT04105985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101738731|NCT04105985|Adrenergic Agents|adrenergic agents|mesh-ancestor
101738732|NCT04105985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101738733|NCT04105985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738735|NCT04105985|Autonomic Agents|autonomic agents|mesh-ancestor
101738736|NCT04105985|Nasal Decongestants|nasal decongestants|mesh-ancestor
101738737|NCT04105985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101738786|NCT03326193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101738787|NCT03326193|Growth Substances|growth substances|mesh-ancestor
101738788|NCT03326193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738789|NCT03326193|Growth Inhibitors|growth inhibitors|mesh-ancestor
101738790|NCT03326193|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101738791|NCT03326193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101738792|NCT03326193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738794|NCT02517099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101738795|NCT02517099|Beclomethasone|beclomethasone|mesh-list
101738796|NCT02517099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101738803|NCT02517099|Hormones|hormones|mesh-ancestor
101738849|NCT03249831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101738850|NCT03249831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101738851|NCT03249831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101738918|NCT02600780|Allopurinol|allopurinol|mesh-list
101738919|NCT02600780|Febuxostat|febuxostat|mesh-list
101738920|NCT02600780|Antimetabolites|antimetabolites|mesh-ancestor
101738921|NCT02600780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101738922|NCT02600780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101738923|NCT02600780|Gout Suppressants|gout suppressants|mesh-ancestor
101738924|NCT02600780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101738926|NCT02600780|Antioxidants|antioxidants|mesh-ancestor
101738927|NCT02600780|Protective Agents|protective agents|mesh-ancestor
101738928|NCT02600780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738929|NCT00582309|Insulin|insulin|mesh-list
101738930|NCT00582309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101738931|NCT00582309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101738932|NCT00582309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738982|NCT04096742|Keratolytic Agents|keratolytic agents|mesh-ancestor
101738983|NCT04096742|Dermatologic Agents|dermatologic agents|mesh-ancestor
101738984|NCT04085640|Ropivacaine|ropivacaine|mesh-list
101738985|NCT04085640|Anesthetics, Local|anesthetics, local|mesh-ancestor
101738986|NCT04085640|Anesthetics|anesthetics|mesh-ancestor
101738987|NCT04085640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101738988|NCT04085640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101738989|NCT04085640|Sensory System Agents|sensory system agents|mesh-ancestor
101739051|NCT01021735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101739052|NCT01021735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101739053|NCT00442351|Mometasone Furoate|mometasone furoate|mesh-list
101739124|NCT04072497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739125|NCT04072263|Interferons|interferons|mesh-list
101739126|NCT04072263|Interferon-alpha|interferon-alpha|mesh-list
101739127|NCT04072263|Interferon alpha-2|interferon alpha-2|mesh-list
101739128|NCT04072263|Paclitaxel|paclitaxel|mesh-list
101739129|NCT04072263|Carboplatin|carboplatin|mesh-list
101739130|NCT04072263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101739131|NCT04072263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101739132|NCT04072263|Tubulin Modulators|tubulin modulators|mesh-ancestor
101739133|NCT04072263|Antimitotic Agents|antimitotic agents|mesh-ancestor
101739134|NCT04072263|Mitosis Modulators|mitosis modulators|mesh-ancestor
101739135|NCT04072263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739136|NCT04072263|Antiviral Agents|antiviral agents|mesh-ancestor
101739137|NCT04072263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101739138|NCT04072263|Immunologic Factors|immunologic factors|mesh-ancestor
101739140|NCT00441727|Esomeprazole|esomeprazole|mesh-list
101739185|NCT00436345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101739186|NCT00436345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101739187|NCT00436345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739188|NCT00436345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101739189|NCT00436345|Anesthetics, General|anesthetics, general|mesh-ancestor
101739190|NCT00436345|Anesthetics|anesthetics|mesh-ancestor
101739191|NCT00436345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101739192|NCT00436345|Narcotics|narcotics|mesh-ancestor
101739193|NCT00436345|Analgesics|analgesics|mesh-ancestor
101739194|NCT00436345|Sensory System Agents|sensory system agents|mesh-ancestor
101739195|NCT00436345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101739196|NCT00916448|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101739197|NCT00916448|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101739198|NCT00916448|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101739199|NCT00916448|Protease Inhibitors|protease inhibitors|mesh-ancestor
101739200|NCT00916448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101739201|NCT00916448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739202|NCT00916448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101739241|NCT00754442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101739243|NCT00754442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101739244|NCT00754052|Donepezil|donepezil|mesh-list
101739245|NCT00754052|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101739246|NCT00754052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101739247|NCT00754052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739248|NCT00754052|Cholinergic Agents|cholinergic agents|mesh-ancestor
101739249|NCT00754052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101739250|NCT00754052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739251|NCT00754052|Nootropic Agents|nootropic agents|mesh-ancestor
101739252|NCT04095182|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
101739253|NCT04095182|Anticonvulsants|anticonvulsants|mesh-ancestor
101739254|NCT04095182|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101739258|NCT02927067|Valganciclovir|valganciclovir|mesh-list
101739303|NCT00751790|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101739304|NCT00751790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101739305|NCT00751790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101739306|NCT04020536|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101739307|NCT04020536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101739308|NCT00916760|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101739309|NCT00916760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101739310|NCT00916760|Immunologic Factors|immunologic factors|mesh-ancestor
101739311|NCT00916760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739312|NCT00916760|Antacids|antacids|mesh-ancestor
101739313|NCT00916760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739314|NCT00916760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101739315|NCT05442554|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101739316|NCT05442554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101739317|NCT05442554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101739318|NCT05442554|Immunotoxins|immunotoxins|mesh-ancestor
101739319|NCT05442554|Immunoconjugates|immunoconjugates|mesh-ancestor
101739320|NCT05442554|Immunologic Factors|immunologic factors|mesh-ancestor
101739321|NCT05442554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739322|NCT00723450|Lamotrigine|lamotrigine|mesh-list
101739323|NCT00723450|Anticonvulsants|anticonvulsants|mesh-ancestor
101739324|NCT00723450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101739325|NCT00723450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101739326|NCT00723450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739327|NCT00723450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101739328|NCT00723450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739329|NCT00723450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101739330|NCT00723450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101739349|NCT04085094|Cholinergic Agents|cholinergic agents|mesh-ancestor
101739350|NCT04085094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101739351|NCT04085094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739352|NCT00751400|Naproxen|naproxen|mesh-list
101739353|NCT00751400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101739354|NCT00751400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101739355|NCT00751400|Analgesics|analgesics|mesh-ancestor
101739416|NCT02577783|Antiemetics|antiemetics|mesh-ancestor
101739417|NCT02577783|Autonomic Agents|autonomic agents|mesh-ancestor
101739418|NCT02577783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101739419|NCT02577783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739420|NCT02577783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101739421|NCT02577783|Glucocorticoids|glucocorticoids|mesh-ancestor
101739486|NCT02577393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101739487|NCT02577393|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101739489|NCT00753896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101739490|NCT00753896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739491|NCT00753896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101739492|NCT00753896|Incretins|incretins|mesh-ancestor
101739493|NCT00753896|Hormones|hormones|mesh-ancestor
101739494|NCT00753896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101739495|NCT02597114|Insulin|insulin|mesh-list
101739496|NCT02597114|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101739497|NCT02597114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101739498|NCT02597114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739499|NCT00716976|Sodium thiosulfate|sodium thiosulfate|mesh-list
101739500|NCT00716976|Antidotes|antidotes|mesh-ancestor
101739501|NCT00716976|Protective Agents|protective agents|mesh-ancestor
101739502|NCT00716976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739503|NCT00716976|Antioxidants|antioxidants|mesh-ancestor
101739504|NCT00716976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739505|NCT00716976|Antitubercular Agents|antitubercular agents|mesh-ancestor
101739506|NCT00716976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101739507|NCT00716976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101739508|NCT00716976|Chelating Agents|chelating agents|mesh-ancestor
101739509|NCT00716976|Sequestering Agents|sequestering agents|mesh-ancestor
101739510|NCT00743444|Lesogaberan|lesogaberan|mesh-list
101739511|NCT00743444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101739512|NCT00743444|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101739513|NCT00743444|GABA Agonists|gaba agonists|mesh-ancestor
101739514|NCT00743444|GABA Agents|gaba agents|mesh-ancestor
101739515|NCT00743444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101739516|NCT00743444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739532|NCT01760655|Cyclophosphamide|cyclophosphamide|mesh-list
101739533|NCT01760655|Busulfan|busulfan|mesh-list
101739534|NCT01760655|Methyl Methanesulfonate|methyl methanesulfonate|mesh-list
101739535|NCT01760655|Fludarabine|fludarabine|mesh-list
101739536|NCT01760655|Fludarabine phosphate|fludarabine phosphate|mesh-list
101739537|NCT01760655|Tacrolimus|tacrolimus|mesh-list
101739538|NCT01760655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101739539|NCT01760655|Immunologic Factors|immunologic factors|mesh-ancestor
101739540|NCT01760655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739541|NCT01760655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101739542|NCT01760655|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101739543|NCT01760655|Alkylating Agents|alkylating agents|mesh-ancestor
101739544|NCT01760655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739545|NCT01760655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101739546|NCT01760655|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101739547|NCT01760655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101739548|NCT01760655|Antimetabolites|antimetabolites|mesh-ancestor
101739549|NCT01760655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101739550|NCT01760655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101739551|NCT01760655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101349873|NCT05543785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101739552|NCT01760655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101739553|NCT01760655|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101739554|NCT01760655|Antitubercular Agents|antitubercular agents|mesh-ancestor
101739555|NCT01760655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101739556|NCT00743288|Melphalan|melphalan|mesh-list
101739582|NCT00750308|Urological Agents|urological agents|mesh-ancestor
101739583|NCT00750308|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101739584|NCT00750308|Protease Inhibitors|protease inhibitors|mesh-ancestor
101739585|NCT00750308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101739586|NCT05392790|Calcium|calcium|mesh-list
101739587|NCT05392790|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101739588|NCT05392790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739589|NCT02597036|Zansecimab|zansecimab|mesh-list
101739651|NCT02575755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101349887|NCT05427786|Nicorandil|nicorandil|mesh-list
101739652|NCT02575755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101739653|NCT02575755|Antimalarials|antimalarials|mesh-ancestor
101739654|NCT02575755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101739655|NCT02575755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101739656|NCT02575755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101739657|NCT02575755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101739658|NCT02575755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739659|NCT02575755|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101739660|NCT00746798|Vaccines|vaccines|mesh-list
101739661|NCT00746798|Immunologic Factors|immunologic factors|mesh-ancestor
101739662|NCT00746798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739663|NCT00716274|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101739664|NCT00716274|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101739665|NCT00716274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101739666|NCT00716274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101739667|NCT00716274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739668|NCT00716274|Adrenergic Agents|adrenergic agents|mesh-ancestor
101739669|NCT00716274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101739670|NCT00716274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739671|NCT01298193|Phenothiazine|phenothiazine|mesh-list
101739672|NCT01298193|Droperidol|droperidol|mesh-list
101739673|NCT01298193|Haloperidol|haloperidol|mesh-list
101739674|NCT01298193|Aprepitant|aprepitant|mesh-list
101739675|NCT01298193|Metoclopramide|metoclopramide|mesh-list
101739676|NCT01298193|Domperidone|domperidone|mesh-list
101739677|NCT01298193|Alizapride|alizapride|mesh-list
101739678|NCT01298193|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
101739679|NCT01298193|Antiemetics|antiemetics|mesh-ancestor
101739680|NCT01298193|Autonomic Agents|autonomic agents|mesh-ancestor
101739681|NCT01298193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101739682|NCT01298193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739694|NCT01298193|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101739695|NCT01298193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101739764|NCT02575443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101739765|NCT02575443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739766|NCT02596334|Lamivudine|lamivudine|mesh-list
101739767|NCT02596334|Abacavir|abacavir|mesh-list
101739838|NCT00719472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101739839|NCT00719472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101739840|NCT00719472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101739842|NCT00719472|Hormones|hormones|mesh-ancestor
101739843|NCT00719472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101739844|NCT00719472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101739845|NCT00719472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101739846|NCT00719472|Tubulin Modulators|tubulin modulators|mesh-ancestor
101739847|NCT00719472|Antimitotic Agents|antimitotic agents|mesh-ancestor
101739848|NCT00719472|Mitosis Modulators|mitosis modulators|mesh-ancestor
101739849|NCT00719472|Sensory System Agents|sensory system agents|mesh-ancestor
101739850|NCT00719472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101739900|NCT04086186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101739901|NCT00741338|Cyclosporine|cyclosporine|mesh-list
101739902|NCT00741338|Azathioprine|azathioprine|mesh-list
101739903|NCT00741338|Cyclosporins|cyclosporins|mesh-list
101739904|NCT00741338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101739905|NCT00741338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101739906|NCT00741338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101739907|NCT00741338|Immunologic Factors|immunologic factors|mesh-ancestor
101739908|NCT00741338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101739909|NCT00741338|Antifungal Agents|antifungal agents|mesh-ancestor
101739910|NCT00741338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101739911|NCT00741338|Dermatologic Agents|dermatologic agents|mesh-ancestor
101739914|NCT00741338|Antimetabolites|antimetabolites|mesh-ancestor
101739963|NCT00746330|Dermatologic Agents|dermatologic agents|mesh-ancestor
101739964|NCT00746330|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101739965|NCT02590224|Glycine|glycine|mesh-list
101739966|NCT02590224|Glycine Agents|glycine agents|mesh-ancestor
101739967|NCT02590224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101740034|NCT00718770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101740036|NCT04084158|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101740038|NCT04084158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101740108|NCT00918840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101740109|NCT00918528|Mitomycins|mitomycins|mesh-list
101740110|NCT00918528|Mitomycin|mitomycin|mesh-list
101740111|NCT00918528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101740112|NCT00918528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101740113|NCT00918528|Alkylating Agents|alkylating agents|mesh-ancestor
101740114|NCT00918528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740115|NCT00918528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101740116|NCT00918528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101740117|NCT00468481|Drospirenone|drospirenone|mesh-list
101740118|NCT00468481|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101740119|NCT00468481|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
101740120|NCT00468481|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101740121|NCT00468481|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101740122|NCT00468481|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101740123|NCT00468481|Contraceptive Agents|contraceptive agents|mesh-ancestor
101740124|NCT00468481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101740125|NCT00468481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740126|NCT00468481|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101740127|NCT00468481|Estrogens|estrogens|mesh-ancestor
101740128|NCT00468481|Hormones|hormones|mesh-ancestor
101740129|NCT00468481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101740130|NCT00468481|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101740131|NCT00468481|Hormone Antagonists|hormone antagonists|mesh-ancestor
101740132|NCT00468481|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101740133|NCT00468481|Diuretics|diuretics|mesh-ancestor
101740134|NCT00468481|Natriuretic Agents|natriuretic agents|mesh-ancestor
101740135|NCT02574819|Methylnaltrexone|methylnaltrexone|mesh-list
101740136|NCT02574819|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101740137|NCT02574819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740138|NCT02574819|Sensory System Agents|sensory system agents|mesh-ancestor
101740140|NCT00709839|Hydrocortisone|hydrocortisone|mesh-list
101740149|NCT00709917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101740150|NCT00709917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740151|NCT02574741|Aripiprazole|aripiprazole|mesh-list
101740152|NCT02574741|Antidepressive Agents|antidepressive agents|mesh-ancestor
101740218|NCT02591004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740219|NCT02591004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101740220|NCT02591004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740221|NCT02591004|Vasodilator Agents|vasodilator agents|mesh-ancestor
101740222|NCT02591004|Tocolytic Agents|tocolytic agents|mesh-ancestor
101740223|NCT02591004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101740224|NCT05310786|Analgesics, Opioid|analgesics, opioid|mesh-list
101740225|NCT05310786|Narcotics|narcotics|mesh-ancestor
101740226|NCT05310786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101740227|NCT05310786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740228|NCT05310786|Analgesics|analgesics|mesh-ancestor
101740229|NCT05310786|Sensory System Agents|sensory system agents|mesh-ancestor
101740230|NCT05310786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101740232|NCT04085562|Bisoprolol|bisoprolol|mesh-list
101740233|NCT04085562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101740234|NCT04085562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101740235|NCT04085562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101349953|NCT05298696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101740236|NCT04085562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740237|NCT04085562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101740271|NCT02588196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101740272|NCT02588196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101740273|NCT02588196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101740274|NCT02588196|Protease Inhibitors|protease inhibitors|mesh-ancestor
101740275|NCT02588196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101740276|NCT02588196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740277|NCT02588820|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101740278|NCT02588820|Antiviral Agents|antiviral agents|mesh-ancestor
101740279|NCT02588820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101740281|NCT00579345|Immunologic Factors|immunologic factors|mesh-ancestor
101740282|NCT00579345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740283|NCT00715377|Benztropine|benztropine|mesh-list
101740284|NCT00715377|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101740285|NCT00715377|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101740286|NCT00715377|Parasympatholytics|parasympatholytics|mesh-ancestor
101740287|NCT00715377|Autonomic Agents|autonomic agents|mesh-ancestor
101740288|NCT00715377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101740289|NCT00715377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397763|NCT00086099|Amifostine|amifostine|mesh-list
101740290|NCT00715377|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101740291|NCT00715377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101740292|NCT00715377|Cholinergic Agents|cholinergic agents|mesh-ancestor
101740293|NCT00715377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101740294|NCT00715377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740295|NCT00715377|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101740296|NCT00715377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101740297|NCT00715377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101740298|NCT00715377|Dopamine Agents|dopamine agents|mesh-ancestor
101740300|NCT00715455|Calcium heparin|calcium heparin|mesh-list
101740301|NCT00715455|Anticoagulants|anticoagulants|mesh-ancestor
101740302|NCT00715455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101740314|NCT02574663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101740330|NCT02574663|Antidotes|antidotes|mesh-ancestor
101740387|NCT02589288|Anesthetics, Local|anesthetics, local|mesh-ancestor
101740389|NCT02589288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101740390|NCT02589288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740391|NCT02589288|Sensory System Agents|sensory system agents|mesh-ancestor
101740459|NCT04973124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740460|NCT04973124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101740461|NCT04973124|Analgesics|analgesics|mesh-ancestor
101740462|NCT04973124|Sensory System Agents|sensory system agents|mesh-ancestor
101740463|NCT04973124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101740464|NCT04973124|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101740465|NCT04973124|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101740527|NCT00720135|Immunoglobulins|immunoglobulins|mesh-list
101740528|NCT00720135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101740529|NCT00720135|Immunologic Factors|immunologic factors|mesh-ancestor
101740530|NCT00720135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740531|NCT00720135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101740532|NCT00720135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101740533|NCT00720135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101740534|NCT00720135|Analgesics|analgesics|mesh-ancestor
101740535|NCT00720135|Sensory System Agents|sensory system agents|mesh-ancestor
101740536|NCT00720135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101740537|NCT02588118|Propofol|propofol|mesh-list
101740538|NCT02588118|Cisatracurium|cisatracurium|mesh-list
101740539|NCT02588118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101740591|NCT00716547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101740592|NCT00716547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740593|NCT00716547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101740594|NCT00716547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101740666|NCT04828824|Hormones|hormones|mesh-ancestor
101740667|NCT04828824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101398133|NCT00086879|Alkylating Agents|alkylating agents|mesh-ancestor
101740668|NCT04828824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740670|NCT04828824|Contraceptive Agents|contraceptive agents|mesh-ancestor
101740736|NCT00711789|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101740737|NCT00711789|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101740739|NCT00711789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101740740|NCT00711789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740741|NCT00741260|Capecitabine|capecitabine|mesh-list
101740742|NCT00741260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101740743|NCT00741260|Antimetabolites|antimetabolites|mesh-ancestor
101398207|NCT00087074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101740744|NCT00741260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740798|NCT00720915|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101740799|NCT00720915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101740800|NCT00720915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740801|NCT00720915|Hemostatics|hemostatics|mesh-ancestor
101740802|NCT00720915|Coagulants|coagulants|mesh-ancestor
101740803|NCT00712101|Abciximab|abciximab|mesh-list
101740804|NCT00712101|Anticoagulants|anticoagulants|mesh-ancestor
101740805|NCT00712101|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101740806|NCT00712257|Heparin|heparin|mesh-list
101740807|NCT00712257|Anticoagulants|anticoagulants|mesh-ancestor
101740808|NCT00712257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101740809|NCT00712257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101740810|NCT00712257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740811|NCT00740792|Fluticasone|fluticasone|mesh-list
101740812|NCT00740792|Xhance|xhance|mesh-list
101740860|NCT00712491|Temsirolimus|temsirolimus|mesh-list
101740861|NCT00712491|MTOR Inhibitors|mtor inhibitors|mesh-list
101740862|NCT00712491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101740863|NCT00712491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101740864|NCT00712491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101740865|NCT00712491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101740866|NCT00712491|Antifungal Agents|antifungal agents|mesh-ancestor
101740867|NCT00712491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101740868|NCT00712491|Immunologic Factors|immunologic factors|mesh-ancestor
101740869|NCT00712491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101740870|NCT00712491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101740871|NCT00712491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101740872|NCT00712491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740925|NCT00740714|Antioxidants|antioxidants|mesh-ancestor
101740926|NCT00740714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101740927|NCT00740714|Protective Agents|protective agents|mesh-ancestor
101740928|NCT00721773|Valsartan|valsartan|mesh-list
101740929|NCT00721773|Benazepril|benazepril|mesh-list
101740996|NCT02595554|Cisplatin|cisplatin|mesh-list
101741073|NCT05549297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101741074|NCT05549297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101741075|NCT05549297|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101741076|NCT05549297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741077|NCT00915239|Pantoprazole|pantoprazole|mesh-list
101741078|NCT00915239|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101741079|NCT00915239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101741080|NCT00915239|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101741081|NCT00915239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101741082|NCT00915239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741083|NCT00722631|Pioglitazone|pioglitazone|mesh-list
101741084|NCT00722631|Glimepiride|glimepiride|mesh-list
101741085|NCT00722631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101741086|NCT00722631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741087|NCT00722631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101741088|NCT00722631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101741089|NCT00722631|Immunologic Factors|immunologic factors|mesh-ancestor
101741090|NCT02604095|Melatonin|melatonin|mesh-list
101741091|NCT02604095|Antioxidants|antioxidants|mesh-ancestor
101741092|NCT02604095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741093|NCT02604095|Protective Agents|protective agents|mesh-ancestor
101741096|NCT02571543|Ibuprofen|ibuprofen|mesh-list
101741126|NCT04067505|Antithrombins|antithrombins|mesh-ancestor
101741127|NCT04067505|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101741128|NCT04067505|Protease Inhibitors|protease inhibitors|mesh-ancestor
101741129|NCT04067505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101741130|NCT04067505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741131|NCT04067505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101741132|NCT04067505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101741133|NCT00794963|Metformin|metformin|mesh-list
101741134|NCT00794963|Orlistat|orlistat|mesh-list
101741135|NCT00794963|Irbesartan|irbesartan|mesh-list
101741136|NCT00794963|Fenofibrate|fenofibrate|mesh-list
101741137|NCT00794963|Pravastatin|pravastatin|mesh-list
101741138|NCT00794963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101741139|NCT00794963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741189|NCT00739934|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101741190|NCT00739934|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101741191|NCT00739934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101741192|NCT00739934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741193|NCT00739934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101741194|NCT00739934|Hormone Antagonists|hormone antagonists|mesh-ancestor
101741195|NCT00739934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101741196|NCT00739934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741254|NCT00734630|Protease Inhibitors|protease inhibitors|mesh-ancestor
101741255|NCT00734630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101741265|NCT05636514|Decitabine|decitabine|mesh-list
101741327|NCT00435409|Antimetabolites|antimetabolites|mesh-ancestor
101741328|NCT00435409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741329|NCT00435409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101741330|NCT00435409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101741397|NCT00435019|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101741398|NCT00435019|Insulin Aspart|insulin aspart|mesh-list
101741399|NCT00435019|Insulin Detemir|insulin detemir|mesh-list
101741400|NCT00435019|Isophane Insulin, Human|isophane insulin, human|mesh-list
101741401|NCT00435019|Insulin, Isophane|insulin, isophane|mesh-list
101741402|NCT00435019|Isophane insulin, beef|isophane insulin, beef|mesh-list
101741403|NCT00435019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101741404|NCT00435019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741405|NCT00724581|Amiodarone|amiodarone|mesh-list
101741406|NCT00724581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101741407|NCT00724581|Vasodilator Agents|vasodilator agents|mesh-ancestor
101741408|NCT00724581|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101741409|NCT00724581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101741410|NCT00724581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741411|NCT00724581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101741412|NCT00724581|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101741453|NCT00920088|Lopinavir|lopinavir|mesh-list
101741454|NCT00920088|Darunavir|darunavir|mesh-list
101741455|NCT00920088|Flurbiprofen|flurbiprofen|mesh-list
101741456|NCT00920088|Midazolam|midazolam|mesh-list
101741528|NCT04620291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101741530|NCT04620291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101741531|NCT00794417|Pemetrexed|pemetrexed|mesh-list
101741599|NCT04110275|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101741600|NCT04110275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101741601|NCT04110275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101741602|NCT04110275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741603|NCT04250883|Iodine|iodine|mesh-list
101741604|NCT04250883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101741605|NCT04250883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101741667|NCT04066179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741668|NCT04066179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101741669|NCT04066179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101741671|NCT04110119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101741672|NCT04110119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101741673|NCT04110119|Analgesics|analgesics|mesh-ancestor
101741674|NCT04110119|Sensory System Agents|sensory system agents|mesh-ancestor
101741675|NCT04110119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101741676|NCT04110119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741677|NCT04110119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101741678|NCT04110119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101741679|NCT04110119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101741680|NCT04110119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101741681|NCT04110119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741682|NCT00726687|Capecitabine|capecitabine|mesh-list
101741683|NCT00726687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101741688|NCT00727077|Ribavirin|ribavirin|mesh-list
101399184|NCT04840199|Letermovir|letermovir|mesh-list
101741723|NCT04080336|Oxytocics|oxytocics|mesh-ancestor
101741724|NCT00793871|Sunitinib|sunitinib|mesh-list
101741725|NCT00793871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101741726|NCT00793871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101741727|NCT00793871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101741728|NCT00793871|Growth Substances|growth substances|mesh-ancestor
101741729|NCT00793871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741730|NCT00793871|Growth Inhibitors|growth inhibitors|mesh-ancestor
101741731|NCT00793871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101741732|NCT00793871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101741787|NCT00730197|Autonomic Agents|autonomic agents|mesh-ancestor
101741788|NCT00730197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101741789|NCT00730197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101741790|NCT00730197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101741791|NCT00730197|Respiratory System Agents|respiratory system agents|mesh-ancestor
101741792|NCT00730197|Tocolytic Agents|tocolytic agents|mesh-ancestor
101741793|NCT00730197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101741794|NCT00730197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101741795|NCT00730197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101741858|NCT02582736|Dopamine Agonists|dopamine agonists|mesh-ancestor
101741859|NCT02582736|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101741860|NCT02582736|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101741861|NCT02582736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101741862|NCT02582736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101741863|NCT02582736|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101741864|NCT02582736|GABA Antagonists|gaba antagonists|mesh-ancestor
101741865|NCT02582736|GABA Agents|gaba agents|mesh-ancestor
101741866|NCT02582736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101741867|NCT02582736|Adrenergic Agents|adrenergic agents|mesh-ancestor
101741868|NCT02582736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101741869|NCT02582736|Analgesics|analgesics|mesh-ancestor
101741919|NCT00728013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101741920|NCT00728013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101741921|NCT00728013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101741922|NCT00577707|Pemetrexed|pemetrexed|mesh-list
101741923|NCT00577707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101741924|NCT00577707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101741925|NCT00577707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101741927|NCT00577707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101741984|NCT00731289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101741985|NCT00731289|Glucocorticoids|glucocorticoids|mesh-ancestor
101741986|NCT00731289|Hormones|hormones|mesh-ancestor
101741987|NCT00731289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101741988|NCT00731289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350017|NCT05105919|Antipyretics|antipyretics|mesh-ancestor
101741989|NCT00731289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101741990|NCT00731289|Immunologic Factors|immunologic factors|mesh-ancestor
101741991|NCT00731289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101741992|NCT00731289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101741993|NCT00731289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101741994|NCT00731289|Viscosupplements|viscosupplements|mesh-ancestor
101741995|NCT00731289|Protective Agents|protective agents|mesh-ancestor
101741996|NCT00736515|Insulin|insulin|mesh-list
101742044|NCT00736905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101742045|NCT00736983|Ciprofloxacin|ciprofloxacin|mesh-list
101742046|NCT00736983|Adalimumab|adalimumab|mesh-list
101742047|NCT00736983|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101742048|NCT00736983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101742049|NCT00736983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101742050|NCT00736983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101742115|NCT00729495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101742116|NCT00729495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101742189|NCT00732927|Sensory System Agents|sensory system agents|mesh-ancestor
101742190|NCT00732927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101742191|NCT00732927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742192|NCT00732927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101742193|NCT00732927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101742194|NCT00732927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101742195|NCT00732927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101742259|NCT00738621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101742260|NCT00738621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101742261|NCT00738621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101742331|NCT00577629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101742332|NCT00577629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101742333|NCT00577629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101742334|NCT00577629|Antimetabolites|antimetabolites|mesh-ancestor
101742335|NCT00577629|Antiviral Agents|antiviral agents|mesh-ancestor
101742336|NCT00577629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101742337|NCT00733317|Budesonide|budesonide|mesh-list
101742338|NCT00733317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101742339|NCT00733317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101742340|NCT00733317|Autonomic Agents|autonomic agents|mesh-ancestor
101742341|NCT00733317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101742345|NCT00733317|Glucocorticoids|glucocorticoids|mesh-ancestor
101742396|NCT00738777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101742397|NCT00738777|Hormone Antagonists|hormone antagonists|mesh-ancestor
101742398|NCT00738777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101742467|NCT00711477|Naltrexone|naltrexone|mesh-list
101742468|NCT00711477|Bupropion|bupropion|mesh-list
101742469|NCT00711477|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101742481|NCT00711477|Dopamine Agents|dopamine agents|mesh-ancestor
101742538|NCT02583828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101742540|NCT02568111|Interferon-beta|interferon-beta|mesh-list
101742541|NCT02568111|Interferon beta-1a|interferon beta-1a|mesh-list
101742542|NCT02568111|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101742543|NCT02568111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101742544|NCT02568111|Antiviral Agents|antiviral agents|mesh-ancestor
101742545|NCT02568111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101742546|NCT02568111|Immunologic Factors|immunologic factors|mesh-ancestor
101742547|NCT02568111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742548|NCT02568111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101742549|NCT02568111|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101742550|NCT02568111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101742551|NCT02568111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101742552|NCT02568111|Adrenergic Agents|adrenergic agents|mesh-ancestor
101742553|NCT02568111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101742554|NCT02568111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101742557|NCT05711667|Letermovir|letermovir|mesh-list
101742667|NCT02583594|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101742668|NCT02583594|Protective Agents|protective agents|mesh-ancestor
101742738|NCT00784979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101742739|NCT02595242|Prednisone|prednisone|mesh-list
101742740|NCT02595242|Cyclophosphamide|cyclophosphamide|mesh-list
101742741|NCT02595242|Vincristine|vincristine|mesh-list
101742742|NCT02595242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101742810|NCT05224401|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101742811|NCT05224401|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101742812|NCT05224401|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101742813|NCT05224401|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101742814|NCT05224401|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101742882|NCT05526417|Dermatologic Agents|dermatologic agents|mesh-ancestor
101742883|NCT04096170|Lidocaine|lidocaine|mesh-list
101742884|NCT04096170|Anesthetics, Local|anesthetics, local|mesh-ancestor
101742885|NCT04096170|Anesthetics|anesthetics|mesh-ancestor
101742895|NCT00741117|Bilirubin|bilirubin|mesh-list
101742954|NCT00741351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101742955|NCT00741351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101742956|NCT02582190|Colchicine|colchicine|mesh-list
101742957|NCT02582190|Gout Suppressants|gout suppressants|mesh-ancestor
101742958|NCT02582190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101742959|NCT02582190|Tubulin Modulators|tubulin modulators|mesh-ancestor
101742960|NCT02582190|Antimitotic Agents|antimitotic agents|mesh-ancestor
101743021|NCT04255602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101743022|NCT04255602|Purinergic Agents|purinergic agents|mesh-ancestor
101743023|NCT04255602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101743024|NCT04255602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743025|NCT04255602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743092|NCT02567331|Antimetabolites|antimetabolites|mesh-ancestor
101743093|NCT02567331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743094|NCT02567331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101743095|NCT00577005|Levetiracetam|levetiracetam|mesh-list
101743096|NCT00577005|Anticonvulsants|anticonvulsants|mesh-ancestor
101743097|NCT00577005|Nootropic Agents|nootropic agents|mesh-ancestor
101743098|NCT02581566|Dexmedetomidine|dexmedetomidine|mesh-list
101743159|NCT00738374|Alkylating Agents|alkylating agents|mesh-ancestor
101743160|NCT00738374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743162|NCT02581176|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101743163|NCT02581176|Antithrombins|antithrombins|mesh-ancestor
101743164|NCT02581176|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101743165|NCT02581176|Protease Inhibitors|protease inhibitors|mesh-ancestor
101743166|NCT02581176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101743168|NCT02581176|Anticoagulants|anticoagulants|mesh-ancestor
101743229|NCT04137354|Antioxidants|antioxidants|mesh-ancestor
101743231|NCT04137354|Protective Agents|protective agents|mesh-ancestor
101743302|NCT02593448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101743303|NCT02593448|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101743304|NCT02592746|Capecitabine|capecitabine|mesh-list
101743305|NCT02592746|Palbociclib|palbociclib|mesh-list
101743306|NCT02592746|Leuprolide|leuprolide|mesh-list
101743307|NCT02592746|Exemestane|exemestane|mesh-list
101743308|NCT02592746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101743309|NCT02592746|Antimetabolites|antimetabolites|mesh-ancestor
101743310|NCT02592746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743311|NCT02592746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101743367|NCT04075188|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101743368|NCT04075188|Dermatologic Agents|dermatologic agents|mesh-ancestor
101743369|NCT00726986|Etoposide|etoposide|mesh-list
101743370|NCT00726986|Sorafenib|sorafenib|mesh-list
101743375|NCT00726986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101743439|NCT00921531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101743511|NCT00918320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101743512|NCT00918320|Alkylating Agents|alkylating agents|mesh-ancestor
101743513|NCT00918320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743514|NCT00918320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101743515|NCT00918320|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101743516|NCT00918320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101743517|NCT00918320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101743518|NCT00729560|Flutamide|flutamide|mesh-list
101743519|NCT00729560|Androgen Antagonists|androgen antagonists|mesh-ancestor
101743520|NCT00729560|Hormone Antagonists|hormone antagonists|mesh-ancestor
101743521|NCT00729560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101743522|NCT00729560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743572|NCT00698451|Growth Inhibitors|growth inhibitors|mesh-ancestor
101743573|NCT00698451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101743574|NCT00698451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101743575|NCT00698451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101743576|NCT00698451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101743577|NCT00698451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743579|NCT03980925|Nivolumab|nivolumab|mesh-list
101743580|NCT03980925|Etoposide|etoposide|mesh-list
101743581|NCT03980925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101743582|NCT03980925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101743583|NCT03980925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101743584|NCT03980925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743585|NCT03980925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101743633|NCT02565693|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101743634|NCT02565693|Antithrombins|antithrombins|mesh-ancestor
101743635|NCT02565693|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101743636|NCT02565693|Protease Inhibitors|protease inhibitors|mesh-ancestor
101743637|NCT02565693|Anticoagulants|anticoagulants|mesh-ancestor
101743705|NCT02591888|Anesthetics, Local|anesthetics, local|mesh-ancestor
101743706|NCT02591888|Anesthetics|anesthetics|mesh-ancestor
101743707|NCT02591888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101743708|NCT02591888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743709|NCT02591888|Sensory System Agents|sensory system agents|mesh-ancestor
101743710|NCT02591888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101743711|NCT00724958|Infliximab|infliximab|mesh-list
101743712|NCT00724958|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101743713|NCT00724958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101743717|NCT04088006|Hyaluronic Acid|hyaluronic acid|mesh-list
101743771|NCT00695019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101743772|NCT00695019|Immunologic Factors|immunologic factors|mesh-ancestor
101743773|NCT00695019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743774|NCT04019600|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101743775|NCT04019600|Natriuretic Agents|natriuretic agents|mesh-ancestor
101743776|NCT04019600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743777|NCT00742911|Copper|copper|mesh-list
101743778|NCT00742911|Disulfiram|disulfiram|mesh-list
101743779|NCT00742911|Trace Elements|trace elements|mesh-ancestor
101743780|NCT00742911|Micronutrients|micronutrients|mesh-ancestor
101743781|NCT00742911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743782|NCT00742911|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101743783|NCT00742911|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
101743784|NCT00742911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101743834|NCT00776555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101743836|NCT00776555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101743837|NCT00915785|Azacitidine|azacitidine|mesh-list
101743838|NCT00915785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101743901|NCT00746031|Fertility Agents|fertility agents|mesh-ancestor
101743902|NCT00746031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101743903|NCT00746031|Hormone Antagonists|hormone antagonists|mesh-ancestor
101743904|NCT00720122|Insulin|insulin|mesh-list
101743905|NCT00720122|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101743906|NCT00720122|Mitogens|mitogens|mesh-list
101743907|NCT00720122|Mecasermin|mecasermin|mesh-list
101743908|NCT00720122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101743909|NCT00720122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101743910|NCT00720122|Mitosis Modulators|mitosis modulators|mesh-ancestor
101743969|NCT00923637|Pemetrexed|pemetrexed|mesh-list
101743970|NCT00923637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101743971|NCT00923637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101744042|NCT00744549|Trace Elements|trace elements|mesh-ancestor
101744043|NCT00744549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101744044|NCT00744549|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101744045|NCT00744549|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101744046|NCT00744549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101744047|NCT00746655|Cisplatin|cisplatin|mesh-list
101744048|NCT00746655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101744049|NCT00741429|Insulin|insulin|mesh-list
101744050|NCT00741429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101744051|NCT00741429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744110|NCT00719810|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101744111|NCT00719810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101744112|NCT00719810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744113|NCT00719810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101744114|NCT00723710|Interferons|interferons|mesh-list
101744115|NCT00723710|Interferon-alpha|interferon-alpha|mesh-list
101744116|NCT00723710|Interferon alpha-2|interferon alpha-2|mesh-list
101744117|NCT00723710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101744118|NCT00723710|Antiviral Agents|antiviral agents|mesh-ancestor
101744119|NCT00723710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101744120|NCT00723710|Immunologic Factors|immunologic factors|mesh-ancestor
101744121|NCT00723710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744122|NCT00688545|Celecoxib|celecoxib|mesh-list
101744123|NCT00688545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101744124|NCT00688545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101744125|NCT00688545|Analgesics|analgesics|mesh-ancestor
101744126|NCT00688545|Sensory System Agents|sensory system agents|mesh-ancestor
101744127|NCT00688545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101744128|NCT00688545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744129|NCT00688545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101744130|NCT00688545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101744131|NCT00688545|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101744132|NCT00688545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101744133|NCT00688545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101744134|NCT00688545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744135|NCT04060407|Nivolumab|nivolumab|mesh-list
101744162|NCT00741585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744163|NCT00741585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101744164|NCT00741585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744165|NCT00741585|Vasodilator Agents|vasodilator agents|mesh-ancestor
101744166|NCT00741585|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101744167|NCT00741585|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101744168|NCT00741585|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101744169|NCT00741585|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101744170|NCT00741585|Adrenergic Agents|adrenergic agents|mesh-ancestor
101744171|NCT00741585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101744224|NCT00745173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101744225|NCT00745173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744226|NCT04060095|Anesthetics|anesthetics|mesh-list
101744227|NCT04060095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101744228|NCT04060095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744229|NCT00741897|Fexofenadine|fexofenadine|mesh-list
101744230|NCT00741897|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101744231|NCT00741897|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101744232|NCT00741897|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101744233|NCT00741897|Histamine Antagonists|histamine antagonists|mesh-ancestor
101744234|NCT00741897|Histamine Agents|histamine agents|mesh-ancestor
101744235|NCT00741897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101744246|NCT00747279|Insulin|insulin|mesh-list
101744285|NCT00719264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744286|NCT00719264|Growth Inhibitors|growth inhibitors|mesh-ancestor
101744287|NCT00719264|Antiviral Agents|antiviral agents|mesh-ancestor
101744288|NCT00719264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101744289|NCT00719264|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101401745|NCT00127023|Vaccines|vaccines|mesh-list
101744290|NCT00719264|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101744292|NCT00719264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744293|NCT00719264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101744294|NCT00719264|Immunologic Factors|immunologic factors|mesh-ancestor
101744295|NCT00687609|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101744296|NCT00687609|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101744297|NCT00687609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101744346|NCT02562183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101744347|NCT02562183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744348|NCT00723398|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101744349|NCT00723398|Pitavastatin|pitavastatin|mesh-list
101744415|NCT00918476|Contraceptive Agents|contraceptive agents|mesh-list
101744416|NCT00918476|Contraceptives, Oral|contraceptives, oral|mesh-list
101744417|NCT00918476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101744418|NCT00918476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744419|NCT00918476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101744420|NCT00749385|Naproxen|naproxen|mesh-list
101744421|NCT00749385|Esomeprazole|esomeprazole|mesh-list
101744422|NCT00749385|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101744423|NCT00749385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101744424|NCT00749385|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101744425|NCT00749385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101744426|NCT00749385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744427|NCT00749385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101744428|NCT00749385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101744429|NCT00749385|Analgesics|analgesics|mesh-ancestor
101744430|NCT00749385|Sensory System Agents|sensory system agents|mesh-ancestor
101744431|NCT00749385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101401891|NCT00125463|Candesartan|candesartan|mesh-list
101744473|NCT00748059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101744474|NCT00748059|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101744480|NCT00748059|Antiemetics|antiemetics|mesh-ancestor
101744545|NCT00748371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101744546|NCT00748371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101744547|NCT00748371|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101744548|NCT00748371|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101744549|NCT00748371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744550|NCT00748371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101744551|NCT00748371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101744552|NCT00748371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101744553|NCT00748371|Antipyretics|antipyretics|mesh-ancestor
101744611|NCT00687297|Docetaxel|docetaxel|mesh-list
101744612|NCT00687297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101744613|NCT00687297|Tubulin Modulators|tubulin modulators|mesh-ancestor
101744614|NCT00687297|Antimitotic Agents|antimitotic agents|mesh-ancestor
101744615|NCT00687297|Mitosis Modulators|mitosis modulators|mesh-ancestor
101744616|NCT00687297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744617|NCT00684177|Retapamulin|retapamulin|mesh-list
101744618|NCT00684177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101744619|NCT00684177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101744620|NCT00752661|Tramadol|tramadol|mesh-list
101744621|NCT00752661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101744622|NCT00752661|Narcotics|narcotics|mesh-ancestor
101744623|NCT00752661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101744630|NCT00752739|Selenium|selenium|mesh-list
101744676|NCT00755859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101744678|NCT00686517|Ribavirin|ribavirin|mesh-list
101744679|NCT00686517|Interferon-alpha|interferon-alpha|mesh-list
101744680|NCT00686517|Interferon alpha-2|interferon alpha-2|mesh-list
101744681|NCT00686517|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101744682|NCT00686517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101744683|NCT00686517|Antiviral Agents|antiviral agents|mesh-ancestor
101744684|NCT00686517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101744685|NCT00686517|Antimetabolites|antimetabolites|mesh-ancestor
101744686|NCT00686517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744687|NCT00686517|Immunologic Factors|immunologic factors|mesh-ancestor
101744688|NCT00686517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101744689|NCT00571701|Celecoxib|celecoxib|mesh-list
101744690|NCT00571701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101744691|NCT00571701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101744692|NCT00571701|Analgesics|analgesics|mesh-ancestor
101744734|NCT00683787|Antimitotic Agents|antimitotic agents|mesh-ancestor
101744735|NCT00683787|Mitosis Modulators|mitosis modulators|mesh-ancestor
101744736|NCT00683787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744737|NCT02560935|Hydroxyurea|hydroxyurea|mesh-list
101744806|NCT00715676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101744809|NCT00718328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101744875|NCT00790205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101744876|NCT04056039|Colchicine|colchicine|mesh-list
101744877|NCT04056039|Atorvastatin|atorvastatin|mesh-list
101744878|NCT04056039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101744879|NCT04056039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101744880|NCT04056039|Antimetabolites|antimetabolites|mesh-ancestor
101744945|NCT02589782|Leprostatic Agents|leprostatic agents|mesh-ancestor
101744946|NCT00918554|Methotrexate|methotrexate|mesh-list
101744947|NCT00918554|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101744948|NCT00918554|Abortifacient Agents|abortifacient agents|mesh-ancestor
101744962|NCT02590016|Insulin|insulin|mesh-list
101745016|NCT00916253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101745017|NCT00916253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745018|NCT00757029|Norepinephrine|norepinephrine|mesh-list
101745019|NCT00757029|Methylphenidate|methylphenidate|mesh-list
101745086|NCT02561169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101745087|NCT02561169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101745088|NCT02561169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745089|NCT02561169|Antacids|antacids|mesh-ancestor
101745090|NCT02561169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101745163|NCT00784277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745164|NCT00784277|Analgesics|analgesics|mesh-ancestor
101745165|NCT00784277|Sensory System Agents|sensory system agents|mesh-ancestor
101745166|NCT00784277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101745167|NCT00784277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101745168|NCT00784277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101745169|NCT00784277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101745170|NCT00784277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745171|NCT00784277|Adrenergic Agents|adrenergic agents|mesh-ancestor
101745172|NCT00784277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101745173|NCT05113784|Meplazumab|meplazumab|mesh-list
101745174|NCT05113784|Antiviral Agents|antiviral agents|mesh-ancestor
101745175|NCT05113784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101745176|NCT02588534|Etanercept|etanercept|mesh-list
101745177|NCT02588534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101745178|NCT02588534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101745179|NCT02588534|Analgesics|analgesics|mesh-ancestor
101745228|NCT00758199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101745229|NCT00758199|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101745230|NCT00758199|Protective Agents|protective agents|mesh-ancestor
101745231|NCT00758199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101745232|NCT00758199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101745233|NCT00758199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101745295|NCT00680121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745296|NCT00680121|Chelating Agents|chelating agents|mesh-ancestor
101745297|NCT00680121|Sequestering Agents|sequestering agents|mesh-ancestor
101745298|NCT00680121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745300|NCT00754689|Rimonabant|rimonabant|mesh-list
101745301|NCT00754689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101745302|NCT00754689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745303|NCT00754689|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101745304|NCT00754689|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
101745305|NCT00754689|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101745306|NCT00754689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101745307|NCT00754689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745308|NCT00754689|Hormones|hormones|mesh-ancestor
101745310|NCT00767819|Everolimus|everolimus|mesh-list
101745356|NCT05058092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101745358|NCT00682539|Bevacizumab|bevacizumab|mesh-list
101745359|NCT00682539|Ranibizumab|ranibizumab|mesh-list
101745360|NCT00682539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101745361|NCT00682539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101745362|NCT00682539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101745363|NCT00682539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101745364|NCT00682539|Growth Substances|growth substances|mesh-ancestor
101745365|NCT00682539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745366|NCT00682539|Growth Inhibitors|growth inhibitors|mesh-ancestor
101745422|NCT00919880|Mitosis Modulators|mitosis modulators|mesh-ancestor
101745423|NCT00919880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745424|NCT00755313|Cyclophosphamide|cyclophosphamide|mesh-list
101745425|NCT00755313|Carboplatin|carboplatin|mesh-list
101745426|NCT00755313|Docetaxel|docetaxel|mesh-list
101745493|NCT00679029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101745494|NCT00679029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101745495|NCT00679029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101745496|NCT00679029|Growth Substances|growth substances|mesh-ancestor
101745564|NCT02587130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101745565|NCT02587130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101745566|NCT02587130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101745567|NCT02587130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745568|NCT02559141|Dobutamine|dobutamine|mesh-list
101745569|NCT02559141|Norepinephrine|norepinephrine|mesh-list
101745576|NCT02559141|Sympathomimetics|sympathomimetics|mesh-ancestor
101745632|NCT00678561|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101745633|NCT00678561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101745634|NCT00678561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101745635|NCT00678561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101745637|NCT05683340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101745701|NCT02981979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101745702|NCT02981979|Immunologic Factors|immunologic factors|mesh-ancestor
101745703|NCT04049409|Trastuzumab|trastuzumab|mesh-list
101745704|NCT04049409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101745705|NCT04049409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101745706|NCT00920660|Prednisolone|prednisolone|mesh-list
101745707|NCT00920660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101350118|NCT04859296|Hormones|hormones|mesh-ancestor
101745769|NCT00675441|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101745770|NCT00675441|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101745771|NCT00675441|Growth Substances|growth substances|mesh-ancestor
101745772|NCT00675441|Growth Inhibitors|growth inhibitors|mesh-ancestor
101745773|NCT00675441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101745774|NCT02559297|Sevoflurane|sevoflurane|mesh-list
101745775|NCT02559297|Desflurane|desflurane|mesh-list
101745776|NCT02559297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101745777|NCT02559297|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101745778|NCT02559297|Anesthetics, General|anesthetics, general|mesh-ancestor
101745779|NCT02559297|Anesthetics|anesthetics|mesh-ancestor
101745780|NCT02559297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101745781|NCT02559297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745782|NCT02558517|Prednisone|prednisone|mesh-list
101745783|NCT02558517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101745784|NCT02558517|Glucocorticoids|glucocorticoids|mesh-ancestor
101745785|NCT02558517|Hormones|hormones|mesh-ancestor
101745829|NCT00673179|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101745830|NCT00673179|Antimitotic Agents|antimitotic agents|mesh-ancestor
101745831|NCT00673179|Mitosis Modulators|mitosis modulators|mesh-ancestor
101745832|NCT00758433|Capsaicin|capsaicin|mesh-list
101745833|NCT00758433|Antipruritics|antipruritics|mesh-ancestor
101745834|NCT00758433|Dermatologic Agents|dermatologic agents|mesh-ancestor
101745835|NCT00758433|Sensory System Agents|sensory system agents|mesh-ancestor
101745836|NCT00758433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101745837|NCT00758433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101745838|NCT00584012|Docetaxel|docetaxel|mesh-list
101745839|NCT00584012|Lovastatin|lovastatin|mesh-list
101745840|NCT00584012|L 647318|l 647318|mesh-list
101745841|NCT00584012|Dihydromevinolin|dihydromevinolin|mesh-list
101745895|NCT02582996|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101745896|NCT02582996|Purinergic Agents|purinergic agents|mesh-ancestor
101745897|NCT02582996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101745972|NCT00764907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101745973|NCT00764907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101745974|NCT00764907|Antiviral Agents|antiviral agents|mesh-ancestor
101745975|NCT00764907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101745976|NCT00764907|Antidotes|antidotes|mesh-ancestor
101746040|NCT02557971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746041|NCT02557971|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101746042|NCT02557971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101746044|NCT05332730|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101746045|NCT05332730|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101746046|NCT05332730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101746047|NCT05332730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101746048|NCT05332730|Immunologic Factors|immunologic factors|mesh-ancestor
101746107|NCT00762567|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101746108|NCT00762567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101746109|NCT00762567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101746110|NCT00762567|Adrenergic Agents|adrenergic agents|mesh-ancestor
101746111|NCT00762567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101746112|NCT00762567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746113|NCT00762567|Protective Agents|protective agents|mesh-ancestor
101746114|NCT04338620|Paclitaxel|paclitaxel|mesh-list
101746115|NCT04338620|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101746116|NCT04338620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101746117|NCT04338620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101746171|NCT02557737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746172|NCT02557737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101746173|NCT02557737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101746174|NCT00766857|Insulin|insulin|mesh-list
101746175|NCT00766857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101746241|NCT00767559|Anticoagulants|anticoagulants|mesh-ancestor
101746242|NCT00767559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101746243|NCT00767559|Antithrombins|antithrombins|mesh-ancestor
101746244|NCT00767559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101746245|NCT00767559|Protease Inhibitors|protease inhibitors|mesh-ancestor
101746246|NCT00767559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101828277|NCT05815160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101746247|NCT00767559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746248|NCT00767559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101746249|NCT00767559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101746250|NCT00767715|Haloperidol|haloperidol|mesh-list
101746251|NCT00767715|Olanzapine|olanzapine|mesh-list
101746252|NCT00767715|Haloperidol decanoate|haloperidol decanoate|mesh-list
101746253|NCT00767715|Antiemetics|antiemetics|mesh-ancestor
101746254|NCT00767715|Autonomic Agents|autonomic agents|mesh-ancestor
101746257|NCT00767715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101746302|NCT00767871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101746303|NCT00767871|Serotonin Agents|serotonin agents|mesh-ancestor
101746304|NCT00767871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746305|NCT00760149|Rifampin|rifampin|mesh-list
101746310|NCT00760149|Leprostatic Agents|leprostatic agents|mesh-ancestor
101746373|NCT02558361|Sensory System Agents|sensory system agents|mesh-ancestor
101746374|NCT02558361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101746375|NCT02558361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746376|NCT02558361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101746377|NCT02558361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101746378|NCT02558361|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101746379|NCT02558361|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101746380|NCT02558361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101746381|NCT02558361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746382|NCT02558595|Niacinamide|niacinamide|mesh-list
101746383|NCT02558595|Niacin|niacin|mesh-list
101746384|NCT02558595|Nicotinic Acids|nicotinic acids|mesh-list
101746436|NCT00768729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101746437|NCT00768729|Antifungal Agents|antifungal agents|mesh-ancestor
101746438|NCT00768729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101746439|NCT00768729|Immunologic Factors|immunologic factors|mesh-ancestor
101746445|NCT00768963|Ranibizumab|ranibizumab|mesh-list
101746507|NCT00770835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101746508|NCT00770835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746509|NCT00769587|Thalidomide|thalidomide|mesh-list
101746510|NCT00769587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101746511|NCT00769587|Immunologic Factors|immunologic factors|mesh-ancestor
101746512|NCT00769587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746513|NCT00769587|Leprostatic Agents|leprostatic agents|mesh-ancestor
101746514|NCT00769587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101746515|NCT00769587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101746516|NCT00769587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101746517|NCT00769587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101746518|NCT00769587|Growth Substances|growth substances|mesh-ancestor
101746519|NCT00769587|Growth Inhibitors|growth inhibitors|mesh-ancestor
101746520|NCT00769587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101746521|NCT00570921|Everolimus|everolimus|mesh-list
101746565|NCT00771147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746566|NCT04155710|Interleukin-2|interleukin-2|mesh-list
101746567|NCT04155710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101746568|NCT04155710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101746635|NCT00771459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746636|NCT00771459|Sensory System Agents|sensory system agents|mesh-ancestor
101746637|NCT00771459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101746638|NCT00775359|Fenofibrate|fenofibrate|mesh-list
101746705|NCT00775827|Fenofibrate|fenofibrate|mesh-list
101746706|NCT00775827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101746707|NCT00775827|Antimetabolites|antimetabolites|mesh-ancestor
101746708|NCT00775827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746709|NCT00775827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101746774|NCT00776217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746775|NCT04990232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101746776|NCT04990232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101746777|NCT00667875|Naltrexone|naltrexone|mesh-list
101746778|NCT00667875|Aripiprazole|aripiprazole|mesh-list
101746779|NCT00667875|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101746780|NCT00667875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101746781|NCT00667875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101746782|NCT00667875|Sensory System Agents|sensory system agents|mesh-ancestor
101746783|NCT00667875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101746784|NCT00667875|Antidepressive Agents|antidepressive agents|mesh-ancestor
101746785|NCT00667875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101746786|NCT00667875|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101746800|NCT02579642|Ketamine|ketamine|mesh-list
101746833|NCT00772395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101746835|NCT00772395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101746837|NCT00667251|Docetaxel|docetaxel|mesh-list
101746838|NCT00667251|Trastuzumab|trastuzumab|mesh-list
101746839|NCT00667251|Lapatinib|lapatinib|mesh-list
101746840|NCT00667251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101746841|NCT00667251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101746842|NCT00667251|Tubulin Modulators|tubulin modulators|mesh-ancestor
101746843|NCT00667251|Antimitotic Agents|antimitotic agents|mesh-ancestor
101746844|NCT00667251|Mitosis Modulators|mitosis modulators|mesh-ancestor
101746845|NCT00667251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101746846|NCT00667251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101746847|NCT00667251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101746894|NCT00772551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101746895|NCT00772551|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101746969|NCT00467779|Midazolam|midazolam|mesh-list
101746970|NCT00467779|Dextromethorphan|dextromethorphan|mesh-list
101746980|NCT00467779|Anesthetics|anesthetics|mesh-ancestor
101747042|NCT00777543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747043|NCT00777543|Protective Agents|protective agents|mesh-ancestor
101747044|NCT03410654|Tacrolimus|tacrolimus|mesh-list
101747045|NCT03410654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101747046|NCT03410654|Immunologic Factors|immunologic factors|mesh-ancestor
101747047|NCT03410654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747048|NCT03410654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101747109|NCT00441103|Interferon-beta|interferon-beta|mesh-list
101747110|NCT00441103|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101747111|NCT00441103|Immunologic Factors|immunologic factors|mesh-ancestor
101747112|NCT00441103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747113|NCT00441103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101747114|NCT00441103|Antiviral Agents|antiviral agents|mesh-ancestor
101747115|NCT00441103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101747116|NCT01029613|Adalimumab|adalimumab|mesh-list
101747117|NCT01029613|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101747118|NCT01029613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101747119|NCT01029613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101747120|NCT03540212|Sofosbuvir|sofosbuvir|mesh-list
101747121|NCT03540212|Antiviral Agents|antiviral agents|mesh-ancestor
101747173|NCT00433537|Antimitotic Agents|antimitotic agents|mesh-ancestor
101747174|NCT00433537|Mitosis Modulators|mitosis modulators|mesh-ancestor
101747175|NCT00570765|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
101747176|NCT00570765|Cathartics|cathartics|mesh-ancestor
101747177|NCT00570765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101747178|NCT00777699|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101747179|NCT00777699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101747180|NCT00777699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101747181|NCT00777699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101747182|NCT00777699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747183|NCT05118477|Caffeine|caffeine|mesh-list
101747236|NCT00778011|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101747237|NCT00778011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101747311|NCT00666705|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101747312|NCT00666705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101747313|NCT00666705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747314|NCT00666705|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101747315|NCT00666705|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101747316|NCT00666705|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101747317|NCT04047849|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101747318|NCT04047849|Amoxicillin|amoxicillin|mesh-list
101747319|NCT04047849|Azithromycin|azithromycin|mesh-list
101747320|NCT04047849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101747321|NCT00778557|Cefprozil|cefprozil|mesh-list
101747325|NCT00778713|Fosinopril|fosinopril|mesh-list
101747375|NCT00781521|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101747376|NCT00781521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101747377|NCT00781521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101747378|NCT00781521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101747379|NCT00781521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101747380|NCT00781521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101747381|NCT00781521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747382|NCT00781521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101747385|NCT00774501|Anesthetics|anesthetics|mesh-list
101747439|NCT00784797|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101747440|NCT00784797|Hormone Antagonists|hormone antagonists|mesh-ancestor
101747442|NCT00784797|Luteolytic Agents|luteolytic agents|mesh-ancestor
101747510|NCT00785421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101747511|NCT00785421|Antimetabolites|antimetabolites|mesh-ancestor
101747512|NCT00785421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747513|NCT00785421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101747514|NCT00785421|Antidotes|antidotes|mesh-ancestor
101747515|NCT00785421|Protective Agents|protective agents|mesh-ancestor
101747516|NCT00785421|Vitamin B Complex|vitamin b complex|mesh-ancestor
101747517|NCT00785421|Vitamins|vitamins|mesh-ancestor
101747518|NCT00785421|Micronutrients|micronutrients|mesh-ancestor
101747519|NCT00785421|Hematinics|hematinics|mesh-ancestor
101747520|NCT00785421|Anticoagulants|anticoagulants|mesh-ancestor
101747521|NCT00785421|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101747522|NCT00785421|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101747523|NCT00790179|Ropivacaine|ropivacaine|mesh-list
101747524|NCT00790179|Anesthetics, Local|anesthetics, local|mesh-ancestor
101747573|NCT00790881|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101747574|NCT00790881|Antimalarials|antimalarials|mesh-ancestor
101747575|NCT00790881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101747576|NCT00790881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101747577|NCT00790881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101747643|NCT03192332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101747644|NCT03192332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101747645|NCT03192332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747646|NCT02555943|Ritonavir|ritonavir|mesh-list
101747713|NCT01033981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101747714|NCT01033981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747716|NCT02430194|Ritonavir|ritonavir|mesh-list
101747717|NCT02430194|Interferon-alpha|interferon-alpha|mesh-list
101747718|NCT02430194|Interferon alpha-2|interferon alpha-2|mesh-list
101747719|NCT02430194|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101747720|NCT02430194|Lonafarnib|lonafarnib|mesh-list
101747721|NCT02430194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101747722|NCT02430194|Antiviral Agents|antiviral agents|mesh-ancestor
101747723|NCT02430194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101747724|NCT02430194|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101747725|NCT02430194|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101747726|NCT02430194|Protease Inhibitors|protease inhibitors|mesh-ancestor
101747727|NCT02430194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101747728|NCT02430194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747729|NCT02430194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101747730|NCT02430194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101747731|NCT02430194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101747732|NCT02430194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101747739|NCT02400242|Dexamethasone|dexamethasone|mesh-list
101747767|NCT03087656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101747768|NCT03087656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101747778|NCT02580734|Melatonin|melatonin|mesh-list
101747840|NCT03840902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101747841|NCT03840902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101747842|NCT03840902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101747843|NCT03840902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101747844|NCT03835975|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101747845|NCT03835975|Immunologic Factors|immunologic factors|mesh-ancestor
101747906|NCT00580970|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101747907|NCT00580970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101747909|NCT00580970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747910|NCT00580970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101747911|NCT00580970|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101747912|NCT00580970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101747970|NCT00791193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101747971|NCT00791193|Serotonin Agents|serotonin agents|mesh-ancestor
101747972|NCT00791193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101747973|NCT00791193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101747974|NCT00791193|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101747975|NCT00791193|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101748040|NCT02598960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101748041|NCT02598960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101748042|NCT02598960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101748043|NCT02598960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748044|NCT00426361|Vaccines|vaccines|mesh-list
101748045|NCT00426361|Immunologic Factors|immunologic factors|mesh-ancestor
101748046|NCT00426361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748047|NCT00665847|Etravirine|etravirine|mesh-list
101748048|NCT00665847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101748049|NCT00665847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101748050|NCT00665847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101748051|NCT00665847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748052|NCT00665847|Antiviral Agents|antiviral agents|mesh-ancestor
101748053|NCT00665847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101748054|NCT01030393|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101748055|NCT01030393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101748056|NCT01030393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748095|NCT00425503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101748096|NCT00786669|Cefixime|cefixime|mesh-list
101748097|NCT00786669|Cefpodoxime|cefpodoxime|mesh-list
101748098|NCT00786669|Bevacizumab|bevacizumab|mesh-list
101748099|NCT00786669|Irinotecan|irinotecan|mesh-list
101748100|NCT00786669|Vincristine|vincristine|mesh-list
101748101|NCT00786669|Temozolomide|temozolomide|mesh-list
101748102|NCT00786669|Camptothecin|camptothecin|mesh-list
101748103|NCT00786669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101748104|NCT00786669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101332539|NCT00000962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101748105|NCT00786669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101748106|NCT00786669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101405569|NCT04728386|Analgesics|analgesics|mesh-ancestor
101748107|NCT00786669|Growth Substances|growth substances|mesh-ancestor
101748108|NCT00786669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748155|NCT00430573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101748156|NCT00430573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101748157|NCT00430573|Antitubercular Agents|antitubercular agents|mesh-ancestor
101748158|NCT00430573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101748159|NCT00430573|Antimetabolites|antimetabolites|mesh-ancestor
101748160|NCT00430573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748161|NCT00783393|Temozolomide|temozolomide|mesh-list
101748162|NCT00783393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101748163|NCT00783393|Alkylating Agents|alkylating agents|mesh-ancestor
101748164|NCT00783393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748165|NCT00783393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101748166|NCT00783471|Docetaxel|docetaxel|mesh-list
101748167|NCT00783471|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101748168|NCT00783471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101748169|NCT00783471|Tubulin Modulators|tubulin modulators|mesh-ancestor
101748170|NCT00783471|Antimitotic Agents|antimitotic agents|mesh-ancestor
101748213|NCT04895280|Bupivacaine|bupivacaine|mesh-list
101748214|NCT04895280|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101748215|NCT04895280|Anesthetics, Local|anesthetics, local|mesh-ancestor
101748216|NCT04895280|Anesthetics|anesthetics|mesh-ancestor
101748217|NCT04895280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101748218|NCT04895280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748219|NCT04895280|Sensory System Agents|sensory system agents|mesh-ancestor
101748220|NCT04895280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101748221|NCT04895280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101748222|NCT04895280|Glucocorticoids|glucocorticoids|mesh-ancestor
101748223|NCT04895280|Hormones|hormones|mesh-ancestor
101748224|NCT04895280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101748225|NCT04895280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101748226|NCT04895280|Immunologic Factors|immunologic factors|mesh-ancestor
101748227|NCT04895280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101748228|NCT04895280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748229|NCT04895280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101748230|NCT04895280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101748231|NCT04895280|Analgesics|analgesics|mesh-ancestor
101748269|NCT01937468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748270|NCT00663117|Naltrexone|naltrexone|mesh-list
101748271|NCT00663117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101748272|NCT00663117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101748273|NCT00663117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748274|NCT00663117|Sensory System Agents|sensory system agents|mesh-ancestor
101748275|NCT00663117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101748276|NCT04072328|Midazolam|midazolam|mesh-list
101748338|NCT02578550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101748339|NCT02578550|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101748340|NCT02578550|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101748341|NCT02578550|Protease Inhibitors|protease inhibitors|mesh-ancestor
101748342|NCT02578550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101748343|NCT02578550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101748344|NCT00788463|Beclomethasone|beclomethasone|mesh-list
101748345|NCT00788463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101748346|NCT00788463|Glucocorticoids|glucocorticoids|mesh-ancestor
101748348|NCT00788463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101748349|NCT00788463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748400|NCT00788931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101748401|NCT00788931|Tubulin Modulators|tubulin modulators|mesh-ancestor
101748402|NCT00788931|Antimitotic Agents|antimitotic agents|mesh-ancestor
101748403|NCT00788931|Mitosis Modulators|mitosis modulators|mesh-ancestor
101748404|NCT00788931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748405|NCT00788931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101748406|NCT00788931|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101350228|NCT04654689|Antioxidants|antioxidants|mesh-ancestor
101748407|NCT00788931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405869|NCT00102206|Ritonavir|ritonavir|mesh-list
101748408|NCT02577848|Liraglutide|liraglutide|mesh-list
101748409|NCT02577848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101748410|NCT02577848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748411|NCT02577848|Incretins|incretins|mesh-ancestor
101748413|NCT02577848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101748463|NCT00710528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101748464|NCT00710528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101748465|NCT00710528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828146|NCT05926570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101828147|NCT05923996|Botulinum Toxins|botulinum toxins|mesh-list
101748466|NCT00711074|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
101748467|NCT00711074|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101748468|NCT00711074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748469|NCT00711074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101748470|NCT00711074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101748471|NCT00711074|Antiviral Agents|antiviral agents|mesh-ancestor
101748472|NCT00711074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101748473|NCT00711308|Vitamin K|vitamin k|mesh-list
101748474|NCT00711308|Tinzaparin|tinzaparin|mesh-list
101748475|NCT00711308|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101748476|NCT00711308|Dalteparin|dalteparin|mesh-list
101748477|NCT00711308|Acenocoumarol|acenocoumarol|mesh-list
101748478|NCT00711308|Vitamins|vitamins|mesh-ancestor
101748479|NCT00711308|Micronutrients|micronutrients|mesh-ancestor
101748480|NCT00711308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748481|NCT00711308|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101748482|NCT00711308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101748483|NCT00711308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748484|NCT00711308|Hemostatics|hemostatics|mesh-ancestor
101748486|NCT00711308|Anticoagulants|anticoagulants|mesh-ancestor
101748487|NCT00711308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101748488|NCT02601911|Acetaminophen|acetaminophen|mesh-list
101748489|NCT02601911|Ketorolac|ketorolac|mesh-list
101748490|NCT02601911|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101748491|NCT02601911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101748492|NCT02601911|Analgesics|analgesics|mesh-ancestor
101748493|NCT02601911|Sensory System Agents|sensory system agents|mesh-ancestor
101748494|NCT02601911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101748495|NCT02601911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748496|NCT02601911|Antipyretics|antipyretics|mesh-ancestor
101748498|NCT02601911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101748504|NCT00711620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101748505|NCT00711620|Immunologic Factors|immunologic factors|mesh-ancestor
101748506|NCT00711620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748507|NCT02577614|Coagulants|coagulants|mesh-list
101748508|NCT02577614|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
101748509|NCT02577458|Everolimus|everolimus|mesh-list
101748510|NCT02577458|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101748511|NCT02577458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101748512|NCT02577458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101748513|NCT02577458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748514|NCT02577458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101748515|NCT02577458|Immunologic Factors|immunologic factors|mesh-ancestor
101748516|NCT02577458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748564|NCT03070392|Ipilimumab|ipilimumab|mesh-list
101748565|NCT03070392|Dacarbazine|dacarbazine|mesh-list
101748566|NCT03070392|Imidazole|imidazole|mesh-list
101748567|NCT03070392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101748574|NCT00711698|Analgesics, Opioid|analgesics, opioid|mesh-list
101748637|NCT03015792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101748638|NCT03015792|Antiemetics|antiemetics|mesh-ancestor
101748639|NCT03015792|Autonomic Agents|autonomic agents|mesh-ancestor
101748640|NCT03015792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101748641|NCT03015792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101748642|NCT03015792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101748643|NCT03015792|Glucocorticoids|glucocorticoids|mesh-ancestor
101748644|NCT03015792|Hormones|hormones|mesh-ancestor
101748645|NCT03015792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101748646|NCT03015792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101748647|NCT03015792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101748648|NCT03015792|Protease Inhibitors|protease inhibitors|mesh-ancestor
101748649|NCT03015792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101748650|NCT03015792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748651|NCT03015792|Immunologic Factors|immunologic factors|mesh-ancestor
101748652|NCT03015792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101748653|NCT03015792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101748654|NCT03015792|Growth Substances|growth substances|mesh-ancestor
101748655|NCT03015792|Growth Inhibitors|growth inhibitors|mesh-ancestor
101748656|NCT03015792|Dermatologic Agents|dermatologic agents|mesh-ancestor
101748657|NCT00789165|Quinidine|quinidine|mesh-list
101748658|NCT00789165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101748659|NCT00789165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101350320|NCT04499274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350321|NCT04499274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101350322|NCT04499274|Antipruritics|antipruritics|mesh-ancestor
101350323|NCT04499274|Dermatologic Agents|dermatologic agents|mesh-ancestor
101350324|NCT04499274|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101350325|NCT04499274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101350326|NCT04499274|Serotonin Agents|serotonin agents|mesh-ancestor
101350327|NCT04499274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101350329|NCT04488159|Leucovorin|leucovorin|mesh-list
101748660|NCT00789165|Adrenergic Agents|adrenergic agents|mesh-ancestor
101748661|NCT00789165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101748678|NCT00712556|Fluorides|fluorides|mesh-list
101748683|NCT00772967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101748684|NCT00772967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101748685|NCT00772967|Analgesics|analgesics|mesh-ancestor
101748695|NCT00793377|Tamoxifen|tamoxifen|mesh-list
101748756|NCT02577068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101748829|NCT00713336|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101748830|NCT00713336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101748831|NCT00713336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101748901|NCT00793845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101748902|NCT00793845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101748903|NCT00793845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101748904|NCT00793845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101748905|NCT00793845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101748906|NCT00793845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101748907|NCT00800709|Memantine|memantine|mesh-list
101748908|NCT00800709|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101748909|NCT00800709|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101748910|NCT00800709|Dopamine Agents|dopamine agents|mesh-ancestor
101748911|NCT00800709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101748912|NCT00800709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101748964|NCT02345850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749037|NCT04046133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101749038|NCT02573714|Ketamine|ketamine|mesh-list
101749039|NCT02573714|Analgesics|analgesics|mesh-ancestor
101749040|NCT02573714|Sensory System Agents|sensory system agents|mesh-ancestor
101749041|NCT02573714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101749043|NCT02573714|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101749107|NCT00579098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749108|NCT00579098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101749109|NCT00579098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101749110|NCT00579098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101749111|NCT00772109|Vaccines|vaccines|mesh-list
101749177|NCT00772031|Anticonvulsants|anticonvulsants|mesh-ancestor
101749178|NCT00772031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101749179|NCT00801411|Cyclophosphamide|cyclophosphamide|mesh-list
101749180|NCT00801411|Docetaxel|docetaxel|mesh-list
101749181|NCT00801411|Doxorubicin|doxorubicin|mesh-list
101749182|NCT00801411|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101749183|NCT00801411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101749184|NCT00801411|Immunologic Factors|immunologic factors|mesh-ancestor
101749185|NCT00801411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749186|NCT00801411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101749187|NCT00801411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101749188|NCT00801411|Alkylating Agents|alkylating agents|mesh-ancestor
101749189|NCT00801411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749190|NCT00801411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101749191|NCT00801411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101749192|NCT00801411|Tubulin Modulators|tubulin modulators|mesh-ancestor
101749238|NCT00916409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749240|NCT00714740|Acetazolamide|acetazolamide|mesh-list
101749311|NCT04042948|Antipyretics|antipyretics|mesh-ancestor
101749312|NCT00765245|Rituximab|rituximab|mesh-list
101749313|NCT00765245|Lenalidomide|lenalidomide|mesh-list
101749314|NCT00765245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101749315|NCT00765245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101749316|NCT00765245|Immunologic Factors|immunologic factors|mesh-ancestor
101749317|NCT00765245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749318|NCT00765245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101749319|NCT00765245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101749320|NCT00765245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101749321|NCT00765245|Growth Substances|growth substances|mesh-ancestor
101749323|NCT00801879|Mupirocin|mupirocin|mesh-list
101749377|NCT02573558|Dexmedetomidine|dexmedetomidine|mesh-list
101749378|NCT02573558|Propofol|propofol|mesh-list
101749379|NCT02573558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101749380|NCT02573558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101749381|NCT02573558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749382|NCT02573558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101749383|NCT02573558|Analgesics|analgesics|mesh-ancestor
101749384|NCT02573558|Sensory System Agents|sensory system agents|mesh-ancestor
101749385|NCT02573558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101749386|NCT02573558|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101749387|NCT02573558|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101749388|NCT02573558|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101749389|NCT02573558|Adrenergic Agents|adrenergic agents|mesh-ancestor
101749390|NCT02573558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101749438|NCT00836212|Antiviral Agents|antiviral agents|mesh-ancestor
101749439|NCT00836212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101749440|NCT00836212|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101749441|NCT00836212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101749442|NCT00836212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101749504|NCT00620776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101749505|NCT00620776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749506|NCT00620776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101749507|NCT00620776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749508|NCT00620776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101749509|NCT00620776|Antidepressive Agents|antidepressive agents|mesh-ancestor
101749511|NCT05479097|Antihypertensive Agents|antihypertensive agents|mesh-list
101749512|NCT00656019|Vitamin D|vitamin d|mesh-list
101749513|NCT00656019|Calcipotriene|calcipotriene|mesh-list
101749514|NCT00656019|Vitamins|vitamins|mesh-ancestor
101749515|NCT00656019|Micronutrients|micronutrients|mesh-ancestor
101749516|NCT00656019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749517|NCT00656019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101749518|NCT00656019|Dermatologic Agents|dermatologic agents|mesh-ancestor
101749519|NCT00841438|Abciximab|abciximab|mesh-list
101749520|NCT00841438|Anticoagulants|anticoagulants|mesh-ancestor
101749521|NCT00841438|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101749565|NCT00844168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101749566|NCT00844168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749567|NCT02573168|Psychotropic Drugs|psychotropic drugs|mesh-list
101749569|NCT00764465|Fosamprenavir|fosamprenavir|mesh-list
101749570|NCT00764465|Maraviroc|maraviroc|mesh-list
101749571|NCT00764465|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101749572|NCT00764465|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101749573|NCT00764465|Protease Inhibitors|protease inhibitors|mesh-ancestor
101749574|NCT00764465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101749576|NCT00764465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101749630|NCT00842140|Diuretics|diuretics|mesh-ancestor
101749631|NCT00842140|Natriuretic Agents|natriuretic agents|mesh-ancestor
101749632|NCT00842140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101749633|NCT00806169|Triamcinolone|triamcinolone|mesh-list
101749634|NCT00806169|Bevacizumab|bevacizumab|mesh-list
101749696|NCT00806247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101749697|NCT00797745|Ritonavir|ritonavir|mesh-list
101749698|NCT00797745|Ribavirin|ribavirin|mesh-list
101749699|NCT00797745|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101749700|NCT00797745|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101749701|NCT00797745|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101749702|NCT00797745|Protease Inhibitors|protease inhibitors|mesh-ancestor
101749703|NCT00797745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101749704|NCT00797745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749705|NCT00797745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101749706|NCT00797745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101749707|NCT00797745|Antiviral Agents|antiviral agents|mesh-ancestor
101749708|NCT00797745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101749709|NCT00797745|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101749710|NCT00797745|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101749711|NCT00797745|Antimetabolites|antimetabolites|mesh-ancestor
101749712|NCT00659373|Tamoxifen|tamoxifen|mesh-list
101749713|NCT00659373|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101749714|NCT00659373|Exemestane|exemestane|mesh-list
101749750|NCT02552745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101749751|NCT02552745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101749752|NCT02547844|Tenofovir|tenofovir|mesh-list
101749753|NCT02547844|Efavirenz|efavirenz|mesh-list
101749754|NCT02547844|Emtricitabine|emtricitabine|mesh-list
101749756|NCT02547844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101749757|NCT02547844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101749758|NCT02547844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101749759|NCT02547844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101749760|NCT02547844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749761|NCT02547844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101749762|NCT02547844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101749763|NCT02547844|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101749814|NCT00709436|Anesthetics, General|anesthetics, general|mesh-ancestor
101749816|NCT00709436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101749887|NCT00716846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749888|NCT00716846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101749889|NCT00716846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101749891|NCT00620854|Calcitonin|calcitonin|mesh-list
101749892|NCT00620854|Salmon calcitonin|salmon calcitonin|mesh-list
101749893|NCT00620854|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
101749894|NCT00620854|Katacalcin|katacalcin|mesh-list
101749895|NCT00620854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101749896|NCT00620854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749897|NCT00620854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101749898|NCT00620854|Vasodilator Agents|vasodilator agents|mesh-ancestor
101749899|NCT00716924|Clopidogrel|clopidogrel|mesh-list
101749900|NCT00716924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101749901|NCT00716924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101749902|NCT00716924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101407366|NCT00439426|Capecitabine|capecitabine|mesh-list
101749903|NCT00716924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101749904|NCT00716924|Purinergic Agents|purinergic agents|mesh-ancestor
101749905|NCT00716924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101749906|NCT00716924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749907|NCT00716924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749935|NCT04766229|Serotonin Agents|serotonin agents|mesh-ancestor
101749936|NCT04766229|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101749937|NCT04766229|Antidepressive Agents|antidepressive agents|mesh-ancestor
101749938|NCT04068506|Gabapentin|gabapentin|mesh-list
101749939|NCT04068506|Analgesics|analgesics|mesh-ancestor
101749940|NCT04068506|Sensory System Agents|sensory system agents|mesh-ancestor
101749941|NCT04068506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101749942|NCT04068506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749943|NCT04068506|Anticonvulsants|anticonvulsants|mesh-ancestor
101749944|NCT04068506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101749945|NCT04068506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101749946|NCT04068506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101749947|NCT04068506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101749948|NCT04068506|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101749949|NCT04068506|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101749950|NCT04068506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101749951|NCT04068506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101749952|NCT04068506|Antimanic Agents|antimanic agents|mesh-ancestor
101749953|NCT00803907|Imiquimod|imiquimod|mesh-list
101749954|NCT00803907|Immunologic Factors|immunologic factors|mesh-list
101749955|NCT00803907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101749956|NCT00803907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101749957|NCT00803907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101749987|NCT00806871|Antiemetics|antiemetics|mesh-ancestor
101749988|NCT00806871|Autonomic Agents|autonomic agents|mesh-ancestor
101749989|NCT00806871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101749990|NCT00806871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350416|NCT04243629|Pramlintide|pramlintide|mesh-list
101749991|NCT00806871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101749992|NCT00806871|Glucocorticoids|glucocorticoids|mesh-ancestor
101749993|NCT00806871|Hormones|hormones|mesh-ancestor
101263501|NCT01762319|Oxytocics|oxytocics|mesh-ancestor
101749994|NCT00806871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101749995|NCT00806871|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101749996|NCT00806871|Protective Agents|protective agents|mesh-ancestor
101749997|NCT00806871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101749998|NCT00806871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101749999|NCT00798213|Gemtuzumab|gemtuzumab|mesh-list
101750000|NCT00798213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101750001|NCT00798213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750002|NCT00798213|Immunotoxins|immunotoxins|mesh-ancestor
101750046|NCT00762762|Fluorides|fluorides|mesh-list
101750047|NCT00762762|Cariostatic Agents|cariostatic agents|mesh-ancestor
101750048|NCT00762762|Protective Agents|protective agents|mesh-ancestor
101750049|NCT00762762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750050|NCT00762762|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101750051|NCT00762762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101750052|NCT00762762|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101750053|NCT00762762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101750116|NCT00717470|Glucocorticoids|glucocorticoids|mesh-ancestor
101750117|NCT00717470|Hormones|hormones|mesh-ancestor
101750118|NCT00717470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101750119|NCT00717470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750120|NCT00717470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101750121|NCT00717470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750122|NCT00717470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101750123|NCT00717470|Immunologic Factors|immunologic factors|mesh-ancestor
101750124|NCT00717470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101750179|NCT04833426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101750180|NCT04833426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750181|NCT02576964|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101750182|NCT02576964|Capecitabine|capecitabine|mesh-list
101750183|NCT02576964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101750184|NCT02576964|Antimetabolites|antimetabolites|mesh-ancestor
101750185|NCT02576964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750186|NCT02576964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750187|NCT02576964|Antiviral Agents|antiviral agents|mesh-ancestor
101750188|NCT02576964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101750189|NCT00763139|Pioglitazone|pioglitazone|mesh-list
101750190|NCT00763139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101750241|NCT00417079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101750242|NCT00417079|Glucocorticoids|glucocorticoids|mesh-ancestor
101750243|NCT00417079|Hormones|hormones|mesh-ancestor
101750244|NCT00417079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101750245|NCT00417079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750246|NCT00417079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101750247|NCT00417079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750248|NCT00417079|Analgesics|analgesics|mesh-ancestor
101750249|NCT00417079|Sensory System Agents|sensory system agents|mesh-ancestor
101750250|NCT00417079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101750251|NCT00417079|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101750252|NCT00417079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101750301|NCT01033279|Anticoagulants|anticoagulants|mesh-ancestor
101750302|NCT02576340|Octylonium|octylonium|mesh-list
101750376|NCT00709644|Estrogens|estrogens|mesh-ancestor
101750377|NCT00709644|Hormones|hormones|mesh-ancestor
101750378|NCT00709644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101750379|NCT00709644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750380|NCT00709644|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101750381|NCT00709644|Contraceptive Agents|contraceptive agents|mesh-ancestor
101750382|NCT00709644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101750383|NCT00709644|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101750384|NCT00709644|Hematinics|hematinics|mesh-ancestor
101750385|NCT00709644|Vitamin B Complex|vitamin b complex|mesh-ancestor
101750386|NCT00709644|Vitamins|vitamins|mesh-ancestor
101750387|NCT00709644|Micronutrients|micronutrients|mesh-ancestor
101750388|NCT00709644|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101750441|NCT02573610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101750442|NCT02574468|Dexamethasone|dexamethasone|mesh-list
101750443|NCT02574468|Dexamethasone acetate|dexamethasone acetate|mesh-list
101750444|NCT02574468|BB 1101|bb 1101|mesh-list
101750445|NCT02574468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101750446|NCT02574468|Antiemetics|antiemetics|mesh-ancestor
101750447|NCT02574468|Autonomic Agents|autonomic agents|mesh-ancestor
101750448|NCT02574468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101750449|NCT02574468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750450|NCT02574468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101750451|NCT02574468|Glucocorticoids|glucocorticoids|mesh-ancestor
101750452|NCT02574468|Hormones|hormones|mesh-ancestor
101750453|NCT02574468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101750454|NCT02574468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101750499|NCT00710736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101750575|NCT05809804|Antidepressive Agents|antidepressive agents|mesh-ancestor
101750576|NCT05809804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101750577|NCT05809609|Ketamine|ketamine|mesh-list
101750578|NCT05809609|Analgesics|analgesics|mesh-ancestor
101750579|NCT05809609|Sensory System Agents|sensory system agents|mesh-ancestor
101750580|NCT05809609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101750581|NCT05809609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750582|NCT05809609|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101750583|NCT05809609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101750584|NCT05809609|Anesthetics, General|anesthetics, general|mesh-ancestor
101750586|NCT05809609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101750587|NCT05809609|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101750588|NCT05809609|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101750589|NCT05809609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101750591|NCT05809518|Dexmedetomidine|dexmedetomidine|mesh-list
101750634|NCT05809271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750635|NCT05809271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101750636|NCT05809271|Serotonin Agents|serotonin agents|mesh-ancestor
101750637|NCT05809271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101750638|NCT05809271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750639|NCT05809271|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101750640|NCT05809271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101750641|NCT05809271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101750642|NCT05809271|Adrenergic Agents|adrenergic agents|mesh-ancestor
101750643|NCT05809024|Letrozole|letrozole|mesh-list
101750644|NCT05809024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750645|NCT05809024|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101750646|NCT05809024|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101750647|NCT05809024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101750648|NCT05809024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750649|NCT05809024|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101750650|NCT05809024|Hormone Antagonists|hormone antagonists|mesh-ancestor
101750651|NCT05809024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101750652|NCT05809024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750653|NCT05808985|Butyric Acid|butyric acid|mesh-list
101750654|NCT05808985|Histamine Antagonists|histamine antagonists|mesh-ancestor
101750655|NCT05808985|Histamine Agents|histamine agents|mesh-ancestor
101750656|NCT05808985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101750657|NCT05808985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750658|NCT05808985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750659|NCT05808972|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101750660|NCT05808946|Thioctic Acid|thioctic acid|mesh-list
101750661|NCT05808946|Antioxidants|antioxidants|mesh-ancestor
101332557|NCT00396721|Sirolimus|sirolimus|mesh-list
101750662|NCT05808946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750663|NCT05808946|Protective Agents|protective agents|mesh-ancestor
101750664|NCT05808946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750665|NCT05808946|Vitamin B Complex|vitamin b complex|mesh-ancestor
101750667|NCT05808946|Micronutrients|micronutrients|mesh-ancestor
101750668|NCT05764876|Azithromycin|azithromycin|mesh-list
101750672|NCT05764876|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101750673|NCT05764876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101750674|NCT05764876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750675|NCT05737576|Insulin Aspart|insulin aspart|mesh-list
101750676|NCT05737576|Insulin, Long-Acting|insulin, long-acting|mesh-list
101750677|NCT05737576|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101750678|NCT05737576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101750742|NCT05648435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101750743|NCT05648435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101750744|NCT05648435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750745|NCT05648435|Antimanic Agents|antimanic agents|mesh-ancestor
101750746|NCT05648435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101750747|NCT05648435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101750748|NCT05648435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750749|NCT05642767|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101750750|NCT05642767|Cetrimonium|cetrimonium|mesh-list
101750751|NCT05642767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101750752|NCT05642767|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101750753|NCT05624138|Leucovorin|leucovorin|mesh-list
101750754|NCT05624138|Ketotifen|ketotifen|mesh-list
101750755|NCT05624138|Fluorouracil|fluorouracil|mesh-list
101750756|NCT05624138|Oxaliplatin|oxaliplatin|mesh-list
101750757|NCT05624138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750758|NCT05624138|Antimetabolites|antimetabolites|mesh-ancestor
101750759|NCT05624138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750760|NCT05624138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101750761|NCT05624138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750762|NCT05624138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101750763|NCT05624138|Immunologic Factors|immunologic factors|mesh-ancestor
101750764|NCT05624138|Antidotes|antidotes|mesh-ancestor
101750765|NCT05624138|Protective Agents|protective agents|mesh-ancestor
101750766|NCT05624138|Vitamin B Complex|vitamin b complex|mesh-ancestor
101750767|NCT05624138|Vitamins|vitamins|mesh-ancestor
101750768|NCT05624138|Micronutrients|micronutrients|mesh-ancestor
101750769|NCT05624138|Antipruritics|antipruritics|mesh-ancestor
101750770|NCT05624138|Dermatologic Agents|dermatologic agents|mesh-ancestor
101750771|NCT05624138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101750772|NCT05624138|Histamine Antagonists|histamine antagonists|mesh-ancestor
101750773|NCT05624138|Histamine Agents|histamine agents|mesh-ancestor
101750774|NCT05624138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101750786|NCT05610800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750788|NCT05610800|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101750789|NCT05610800|Incretins|incretins|mesh-ancestor
101750790|NCT05610800|Hormones|hormones|mesh-ancestor
101350513|NCT04113109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101750791|NCT05610800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101750792|NCT05605080|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
101750793|NCT05605080|Hemostatics|hemostatics|mesh-ancestor
101750794|NCT05605080|Coagulants|coagulants|mesh-ancestor
101750795|NCT05596383|Vitamin D|vitamin d|mesh-list
101750796|NCT05596383|Vitamins|vitamins|mesh-ancestor
101750797|NCT05596383|Micronutrients|micronutrients|mesh-ancestor
101750798|NCT05596383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750799|NCT05596383|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101750800|NCT05594745|Lifitegrast|lifitegrast|mesh-list
101750801|NCT05594745|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101750850|NCT05463601|Hormone Antagonists|hormone antagonists|mesh-ancestor
101750851|NCT05463601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101750852|NCT05463601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750853|NCT05463601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101750854|NCT05463601|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101750855|NCT05463601|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101750856|NCT05463601|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101750857|NCT05463601|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101750858|NCT05438082|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101750859|NCT05438082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101750861|NCT05408091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101750862|NCT05408091|Immunologic Factors|immunologic factors|mesh-ancestor
101750863|NCT05408091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750864|NCT05395195|Epoetin Alfa|epoetin alfa|mesh-list
101750865|NCT05395195|Hematinics|hematinics|mesh-ancestor
101750866|NCT05391360|Entecavir|entecavir|mesh-list
101750867|NCT05391360|Antiviral Agents|antiviral agents|mesh-ancestor
101750868|NCT05391360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101750869|NCT05372887|Cyclobenzaprine|cyclobenzaprine|mesh-list
101750870|NCT05372887|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101750871|NCT05372887|Antidepressive Agents|antidepressive agents|mesh-ancestor
101750872|NCT05372887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101750873|NCT05372887|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101750874|NCT05372887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750875|NCT05372887|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101750876|NCT05372887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101750877|NCT05372887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101750878|NCT05372887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101750879|NCT05366764|Albuterol|albuterol|mesh-list
101750881|NCT05366764|Autonomic Agents|autonomic agents|mesh-ancestor
101750893|NCT05366764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750895|NCT05366166|Pembrolizumab|pembrolizumab|mesh-list
101750896|NCT05366166|Olaparib|olaparib|mesh-list
101750897|NCT05366166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750898|NCT05366166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101750899|NCT05366166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101750904|NCT05359835|Calcium|calcium|mesh-list
101750962|NCT05117034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101750963|NCT05117034|Analgesics|analgesics|mesh-ancestor
101750964|NCT05117034|Sensory System Agents|sensory system agents|mesh-ancestor
101211177|NCT05593055|Eplerenone|eplerenone|mesh-list
101750965|NCT05117034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101750966|NCT05115838|Islatravir|islatravir|mesh-list
101750967|NCT05115838|Antiviral Agents|antiviral agents|mesh-ancestor
101750968|NCT05115838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101750969|NCT05115838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101750970|NCT05115838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750971|NCT05115838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101750972|NCT05115838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101750973|NCT05115838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101750974|NCT05093920|Doxorubicin|doxorubicin|mesh-list
101750975|NCT05093920|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101750976|NCT05093920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101750977|NCT05093920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101750978|NCT05093920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101750979|NCT05093920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101750980|NCT05093920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101750981|NCT05093920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101750982|NCT05080946|Aspirin|aspirin|mesh-list
101750983|NCT05080946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101750985|NCT05080946|Analgesics|analgesics|mesh-ancestor
101751010|NCT05052879|Urological Agents|urological agents|mesh-ancestor
101751011|NCT05049707|Magnesium Sulfate|magnesium sulfate|mesh-list
101751012|NCT05049707|Analgesics|analgesics|mesh-ancestor
101350598|NCT03596164|Teduglutide|teduglutide|mesh-list
101751013|NCT05049707|Sensory System Agents|sensory system agents|mesh-ancestor
101751014|NCT05049707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101751015|NCT05049707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751016|NCT05049707|Anesthetics|anesthetics|mesh-ancestor
101751017|NCT05049707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101751018|NCT05049707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101751019|NCT05049707|Anticonvulsants|anticonvulsants|mesh-ancestor
101751020|NCT05049707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101751024|NCT05049707|Tocolytic Agents|tocolytic agents|mesh-ancestor
101751072|NCT04999969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101751073|NCT04982913|Oseltamivir|oseltamivir|mesh-list
101751074|NCT04982913|Antiviral Agents|antiviral agents|mesh-ancestor
101751075|NCT04982913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101751076|NCT04982913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101751077|NCT04982913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751078|NCT04981899|Carboplatin|carboplatin|mesh-list
101751079|NCT04981899|Nivolumab|nivolumab|mesh-list
101751080|NCT04981899|Etoposide|etoposide|mesh-list
101751081|NCT04981899|Ifosfamide|ifosfamide|mesh-list
101751082|NCT04981899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751083|NCT04981899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101751084|NCT04981899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101751085|NCT04981899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751086|NCT04981899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101751087|NCT04981899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101751088|NCT04981899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101751089|NCT04981899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101751090|NCT04981899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101751091|NCT04981899|Alkylating Agents|alkylating agents|mesh-ancestor
101751095|NCT04977830|Anesthetics|anesthetics|mesh-ancestor
101751123|NCT04899479|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
101751124|NCT04899479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751125|NCT04899479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101751126|NCT04899479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751127|NCT04852367|Doxorubicin|doxorubicin|mesh-list
101751128|NCT04852367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101751129|NCT04852367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751130|NCT04852367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101751131|NCT04852367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101751132|NCT04852367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101751133|NCT04852367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751134|NCT04848337|Pembrolizumab|pembrolizumab|mesh-list
101751135|NCT04848337|Lenvatinib|lenvatinib|mesh-list
101751136|NCT04848337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101751137|NCT04848337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751179|NCT04690608|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101751180|NCT04690608|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101751181|NCT04690608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101751190|NCT04684238|Midazolam|midazolam|mesh-list
101751251|NCT04561375|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101751254|NCT04560127|Apatinib|apatinib|mesh-list
101751330|NCT04306900|Pembrolizumab|pembrolizumab|mesh-list
101751331|NCT04306900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101751332|NCT04306900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751333|NCT04306900|Tubulin Modulators|tubulin modulators|mesh-ancestor
101751334|NCT04306900|Antimitotic Agents|antimitotic agents|mesh-ancestor
101751335|NCT04306900|Mitosis Modulators|mitosis modulators|mesh-ancestor
101211540|NCT05256797|Apixaban|apixaban|mesh-list
101751337|NCT04306900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101751400|NCT04216524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751401|NCT04216524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751402|NCT04216524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101751403|NCT04216524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101751404|NCT04216524|Antiemetics|antiemetics|mesh-ancestor
101751405|NCT04216524|Autonomic Agents|autonomic agents|mesh-ancestor
101751406|NCT04216524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101350648|NCT03308578|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101751407|NCT04216524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101751408|NCT04216524|Glucocorticoids|glucocorticoids|mesh-ancestor
101751409|NCT04216524|Hormones|hormones|mesh-ancestor
101751410|NCT04216524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101751411|NCT04216524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101751412|NCT04216524|Protease Inhibitors|protease inhibitors|mesh-ancestor
101751413|NCT04216524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101751414|NCT04216524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101751460|NCT04168112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751461|NCT04168112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101751462|NCT04168112|Glucocorticoids|glucocorticoids|mesh-ancestor
101751464|NCT04168112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101751465|NCT04168112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101751466|NCT04168112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751467|NCT04168112|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101751468|NCT04168112|Protective Agents|protective agents|mesh-ancestor
101751469|NCT04150458|Choline|choline|mesh-list
101751470|NCT04150458|Lipotropic Agents|lipotropic agents|mesh-ancestor
101751523|NCT03945448|Amphotericin B|amphotericin b|mesh-list
101751524|NCT03945448|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101751525|NCT03945448|Antifungal Agents|antifungal agents|mesh-ancestor
101751526|NCT03945448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101751527|NCT03945448|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101751537|NCT03945448|Amebicides|amebicides|mesh-ancestor
101751589|NCT03720119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101751590|NCT03720119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101751591|NCT03720119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751592|NCT03713528|Vancomycin|vancomycin|mesh-list
101751593|NCT03713528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101751594|NCT03713528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101751595|NCT03705845|Tocotrienols|tocotrienols|mesh-list
101751596|NCT03705845|Vitamin E|vitamin e|mesh-list
101751597|NCT03705845|Tocopherols|tocopherols|mesh-list
101751598|NCT03705845|Antioxidants|antioxidants|mesh-ancestor
101751599|NCT03705845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751600|NCT03705845|Protective Agents|protective agents|mesh-ancestor
101751601|NCT03705845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751602|NCT03705845|Vitamins|vitamins|mesh-ancestor
101751603|NCT03705845|Micronutrients|micronutrients|mesh-ancestor
101751604|NCT03669718|Cemiplimab|cemiplimab|mesh-list
101751605|NCT03669718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101751607|NCT03644966|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101751651|NCT03579784|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101751652|NCT03579784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101751653|NCT03564678|Folic Acid|folic acid|mesh-list
101751654|NCT03564678|Vitamin B Complex|vitamin b complex|mesh-list
101751723|NCT03217227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751724|NCT03217227|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101751725|NCT03152903|BCG Vaccine|bcg vaccine|mesh-list
101751726|NCT03152903|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101751727|NCT03152903|Immunologic Factors|immunologic factors|mesh-ancestor
101751728|NCT03152903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751729|NCT03152890|Insulin|insulin|mesh-list
101751730|NCT03152890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101751731|NCT03152890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751749|NCT03123029|Venetoclax|venetoclax|mesh-list
101751750|NCT03123029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751751|NCT03117933|Paclitaxel|paclitaxel|mesh-list
101751752|NCT03117933|Olaparib|olaparib|mesh-list
101751753|NCT03117933|Cediranib|cediranib|mesh-list
101751754|NCT03117933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101751755|NCT03117933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751756|NCT03117933|Tubulin Modulators|tubulin modulators|mesh-ancestor
101751757|NCT03117933|Antimitotic Agents|antimitotic agents|mesh-ancestor
101751758|NCT03117933|Mitosis Modulators|mitosis modulators|mesh-ancestor
101350663|NCT03255473|BB 1101|bb 1101|mesh-list
101751759|NCT03117933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751760|NCT03117933|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101751761|NCT03117933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101751762|NCT03117933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101751763|NCT03077243|Cisplatin|cisplatin|mesh-list
101751764|NCT03077243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751765|NCT03048877|Apatinib|apatinib|mesh-list
101751791|NCT02915705|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101751793|NCT02891278|Sertraline|sertraline|mesh-list
101751794|NCT02891278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101751795|NCT02891278|Antimetabolites|antimetabolites|mesh-ancestor
101751796|NCT02891278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751797|NCT02891278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101751798|NCT02891278|Antiviral Agents|antiviral agents|mesh-ancestor
101751799|NCT02891278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101751800|NCT02891278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101751856|NCT02157610|Cholinergic Agents|cholinergic agents|mesh-ancestor
101751857|NCT02157610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101751858|NCT02157610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751859|NCT02138617|Leucovorin|leucovorin|mesh-list
101751860|NCT02138617|Bevacizumab|bevacizumab|mesh-list
101751861|NCT02138617|Fluorouracil|fluorouracil|mesh-list
101751862|NCT02138617|Irinotecan|irinotecan|mesh-list
101751863|NCT02138617|Levoleucovorin|levoleucovorin|mesh-list
101751864|NCT02138617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101751866|NCT02138617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101751867|NCT02138617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101751868|NCT02138617|Growth Substances|growth substances|mesh-ancestor
101751869|NCT02138617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101751871|NCT02138617|Antimetabolites|antimetabolites|mesh-ancestor
101751872|NCT02138617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751873|NCT02138617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101751874|NCT02138617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101751875|NCT02138617|Immunologic Factors|immunologic factors|mesh-ancestor
101751876|NCT02138617|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101751877|NCT02138617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101751878|NCT02138617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101751879|NCT02138617|Antidotes|antidotes|mesh-ancestor
101751880|NCT02138617|Protective Agents|protective agents|mesh-ancestor
101751881|NCT02138617|Vitamin B Complex|vitamin b complex|mesh-ancestor
101751882|NCT02138617|Vitamins|vitamins|mesh-ancestor
101751883|NCT02138617|Micronutrients|micronutrients|mesh-ancestor
101751884|NCT02078869|Progesterone|progesterone|mesh-list
101751885|NCT02078869|Progestins|progestins|mesh-ancestor
101751886|NCT02078869|Hormones|hormones|mesh-ancestor
101751906|NCT01937156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101751907|NCT01937156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751909|NCT01805804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101751910|NCT01805804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101751911|NCT01805804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101751912|NCT01805804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101751913|NCT01718873|Leucovorin|leucovorin|mesh-list
101751914|NCT01718873|Folic Acid|folic acid|mesh-list
101751915|NCT01718873|Bevacizumab|bevacizumab|mesh-list
101751916|NCT01718873|Fluorouracil|fluorouracil|mesh-list
101751935|NCT01718873|Vitamins|vitamins|mesh-ancestor
101751973|NCT01297400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101751974|NCT01297400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101751975|NCT01297400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101751976|NCT01297400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101751977|NCT01297400|Coccidiostats|coccidiostats|mesh-ancestor
101751978|NCT01297400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101751979|NCT01276587|Vitamin D|vitamin d|mesh-list
101751980|NCT01276587|Ergocalciferols|ergocalciferols|mesh-list
101752043|NCT00202774|Immunologic Factors|immunologic factors|mesh-ancestor
101752044|NCT00202774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752046|NCT00114530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101752047|NCT00114530|Immunologic Factors|immunologic factors|mesh-ancestor
101752048|NCT00114530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752049|NCT00114530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101752050|NCT00114530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101752051|NCT00114530|Alkylating Agents|alkylating agents|mesh-ancestor
101752052|NCT00114530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752053|NCT00114530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101752054|NCT00114530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101752055|NCT00107744|Caseins|caseins|mesh-list
101752056|NCT00107744|Chelating Agents|chelating agents|mesh-ancestor
101752057|NCT00107744|Sequestering Agents|sequestering agents|mesh-ancestor
101752058|NCT00107744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752102|NCT04097470|Antimetabolites|antimetabolites|mesh-ancestor
101752103|NCT04097470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752104|NCT04097470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101752105|NCT04097470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101752106|NCT04097470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101752107|NCT04041934|Tryptophan|tryptophan|mesh-list
101752108|NCT04041934|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101752109|NCT04041934|Antidepressive Agents|antidepressive agents|mesh-ancestor
101752167|NCT02545972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101752168|NCT02545972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752170|NCT00852046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101752171|NCT00852046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101752172|NCT00852046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752173|NCT00852046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101752174|NCT00852046|Analgesics|analgesics|mesh-ancestor
101752175|NCT00852046|Sensory System Agents|sensory system agents|mesh-ancestor
101752176|NCT00852046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101752177|NCT00852046|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101752178|NCT00852046|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101752179|NCT00852046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101752180|NCT00852046|Adrenergic Agents|adrenergic agents|mesh-ancestor
101752181|NCT00852046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101752182|NCT00852046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752183|NCT02573064|Vancomycin|vancomycin|mesh-list
101752184|NCT02573064|Colistin|colistin|mesh-list
101752224|NCT00718536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101752225|NCT00718536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752226|NCT00712062|Pemetrexed|pemetrexed|mesh-list
101752227|NCT00712062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101752228|NCT00712062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101752229|NCT00712062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752230|NCT00712062|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101752231|NCT00712062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101752232|NCT00712140|Trastuzumab|trastuzumab|mesh-list
101752233|NCT00712140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101752289|NCT02573220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101752292|NCT02573220|Immunologic Factors|immunologic factors|mesh-ancestor
101752364|NCT00856882|Chelating Agents|chelating agents|mesh-ancestor
101752365|NCT00856882|Sequestering Agents|sequestering agents|mesh-ancestor
101752366|NCT00856882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752367|NCT00712686|Olanzapine|olanzapine|mesh-list
101752368|NCT00712686|Aripiprazole|aripiprazole|mesh-list
101752369|NCT00712686|Antiemetics|antiemetics|mesh-ancestor
101752370|NCT00712686|Autonomic Agents|autonomic agents|mesh-ancestor
101752371|NCT00712686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101752372|NCT00712686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752373|NCT00712686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101752374|NCT00712686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101752394|NCT04041856|Povidone|povidone|mesh-list
101752427|NCT02574156|Insulin|insulin|mesh-list
101752428|NCT02574156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101752429|NCT02574156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752430|NCT00848692|Rituximab|rituximab|mesh-list
101752498|NCT00717782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752499|NCT00717938|Carboplatin|carboplatin|mesh-list
101752500|NCT00717938|Etoposide|etoposide|mesh-list
101752501|NCT00717938|Etoposide phosphate|etoposide phosphate|mesh-list
101752502|NCT00717938|Cisplatin|cisplatin|mesh-list
101752503|NCT00717938|Enoxaparin|enoxaparin|mesh-list
101752504|NCT00717938|Enoxaparin sodium|enoxaparin sodium|mesh-list
101752505|NCT00717938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101752506|NCT00717938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101752507|NCT00717938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101752508|NCT00717938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101752509|NCT00717938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101752510|NCT00717938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752511|NCT00717938|Anticoagulants|anticoagulants|mesh-ancestor
101752512|NCT00717938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101752513|NCT00717938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101752514|NCT00857428|Oxymorphone|oxymorphone|mesh-list
101752515|NCT00857428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101752516|NCT00857428|Narcotics|narcotics|mesh-ancestor
101752517|NCT00857428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101752518|NCT00857428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752524|NCT04018768|Ibuprofen|ibuprofen|mesh-list
101752553|NCT02573922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101752554|NCT02573922|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101752555|NCT00852436|Pregabalin|pregabalin|mesh-list
101752556|NCT00852436|Analgesics|analgesics|mesh-ancestor
101752557|NCT00852436|Sensory System Agents|sensory system agents|mesh-ancestor
101752558|NCT00852436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101752559|NCT00852436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752560|NCT00852436|Anticonvulsants|anticonvulsants|mesh-ancestor
101752561|NCT00852436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101752562|NCT00852436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101752563|NCT00852436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752564|NCT00852436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101752565|NCT00852436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101752566|NCT00852436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101752567|NCT00852436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101752568|NCT00852436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101752613|NCT00713622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752614|NCT00713622|Antimanic Agents|antimanic agents|mesh-ancestor
101752615|NCT00713622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101752621|NCT00718172|Ribavirin|ribavirin|mesh-list
101752684|NCT03834740|Immunologic Factors|immunologic factors|mesh-ancestor
101752685|NCT03834740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752686|NCT03834740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101752687|NCT00849082|Goserelin|goserelin|mesh-list
101752756|NCT00720408|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101752757|NCT00720408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101752758|NCT00720408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752760|NCT00720408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101752826|NCT00858676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101752827|NCT00858676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752828|NCT00858754|Methylnaltrexone|methylnaltrexone|mesh-list
101752829|NCT00858754|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101752830|NCT00858754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752831|NCT00858754|Sensory System Agents|sensory system agents|mesh-ancestor
101752832|NCT00858754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101752833|NCT00723164|Fentanyl|fentanyl|mesh-list
101752834|NCT00723164|Midazolam|midazolam|mesh-list
101752835|NCT00723164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101752836|NCT00723164|Narcotics|narcotics|mesh-ancestor
101752837|NCT00723164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101752838|NCT00723164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752839|NCT00723164|Analgesics|analgesics|mesh-ancestor
101752888|NCT00723320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101752889|NCT00723320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101752890|NCT00578448|Abatacept|abatacept|mesh-list
101752891|NCT00578448|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101752892|NCT00578448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101752893|NCT00578448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101752894|NCT00578448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101752895|NCT00578448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101752896|NCT00578448|Immunologic Factors|immunologic factors|mesh-ancestor
101752897|NCT00578448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752898|NCT00578448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101752899|NCT00720564|Temozolomide|temozolomide|mesh-list
101752900|NCT00720564|Arsenic Trioxide|arsenic trioxide|mesh-list
101752901|NCT00720564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101752902|NCT00720564|Alkylating Agents|alkylating agents|mesh-ancestor
101752947|NCT04067102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101752949|NCT04067102|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101752950|NCT04067102|Alkylating Agents|alkylating agents|mesh-ancestor
101752951|NCT04067102|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101752952|NCT04067102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101752953|NCT04067102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101752954|NCT04067102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101752955|NCT04067102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101752956|NCT05659290|Bevacizumab|bevacizumab|mesh-list
101752957|NCT05659290|Capecitabine|capecitabine|mesh-list
101753011|NCT00721448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753012|NCT00721448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753013|NCT00853216|Oxycodone|oxycodone|mesh-list
101753014|NCT00853216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101753015|NCT00853216|Narcotics|narcotics|mesh-ancestor
101753016|NCT00853216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101753017|NCT00853216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753018|NCT00853216|Analgesics|analgesics|mesh-ancestor
101753019|NCT00853216|Sensory System Agents|sensory system agents|mesh-ancestor
101753020|NCT00853216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101753021|NCT04961528|Terlipressin|terlipressin|mesh-list
101753022|NCT04961528|Tranexamic Acid|tranexamic acid|mesh-list
101753023|NCT04961528|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101753024|NCT04961528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101753025|NCT04961528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753026|NCT04961528|Hemostatics|hemostatics|mesh-ancestor
101753027|NCT04961528|Coagulants|coagulants|mesh-ancestor
101753028|NCT04961528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101753065|NCT00853294|Antipruritics|antipruritics|mesh-ancestor
101753066|NCT00853294|Dermatologic Agents|dermatologic agents|mesh-ancestor
101753067|NCT00853294|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101753068|NCT00853294|Histamine Antagonists|histamine antagonists|mesh-ancestor
101753070|NCT00853294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101753071|NCT00853294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101753072|NCT03246230|BCG Vaccine|bcg vaccine|mesh-list
101753073|NCT03246230|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101753074|NCT03246230|Immunologic Factors|immunologic factors|mesh-ancestor
101753075|NCT03246230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753076|NCT00717834|Formaldehyde|formaldehyde|mesh-list
101753077|NCT00717834|Disinfectants|disinfectants|mesh-ancestor
101753078|NCT00717834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101753079|NCT00658359|Cyclosporine|cyclosporine|mesh-list
101753080|NCT00658359|Cyclosporins|cyclosporins|mesh-list
101753081|NCT00658359|Tofacitinib|tofacitinib|mesh-list
101753082|NCT00658359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101350835|NCT02399085|Growth Substances|growth substances|mesh-ancestor
101350836|NCT02399085|Growth Inhibitors|growth inhibitors|mesh-ancestor
101350837|NCT02399085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350838|NCT02255409|Vaccines|vaccines|mesh-list
101350839|NCT02255409|Immunologic Factors|immunologic factors|mesh-ancestor
101350840|NCT02255409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350841|NCT02213757|Estrogens|estrogens|mesh-list
101350842|NCT02213757|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101350843|NCT02213757|Hormones|hormones|mesh-ancestor
101350854|NCT02102243|Insulin|insulin|mesh-list
101753083|NCT00658359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753094|NCT00853450|Clopidogrel|clopidogrel|mesh-list
101753132|NCT00721604|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
101753133|NCT00721604|Plasma Substitutes|plasma substitutes|mesh-ancestor
101753134|NCT00721604|Blood Substitutes|blood substitutes|mesh-ancestor
101753135|NCT02571192|Volixibat|volixibat|mesh-list
101753136|NCT02571192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101753137|NCT00724022|Mycophenolic Acid|mycophenolic acid|mesh-list
101753138|NCT00724022|Prednisolone|prednisolone|mesh-list
101753139|NCT00724022|Tacrolimus|tacrolimus|mesh-list
101753140|NCT00724022|Thymoglobulin|thymoglobulin|mesh-list
101753141|NCT00724022|Basiliximab|basiliximab|mesh-list
101410561|NCT00113945|Cinacalcet|cinacalcet|mesh-list
101753198|NCT00723060|Escitalopram|escitalopram|mesh-list
101753199|NCT00723060|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101753200|NCT00723060|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101753201|NCT00723060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101753260|NCT01005914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753261|NCT01005914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101753262|NCT01005914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101753263|NCT01005914|Alkylating Agents|alkylating agents|mesh-ancestor
101753264|NCT01005914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753265|NCT01005914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101753273|NCT01005914|Hormones|hormones|mesh-ancestor
101753328|NCT00721916|Vitamins|vitamins|mesh-ancestor
101753329|NCT00721916|Micronutrients|micronutrients|mesh-ancestor
101753330|NCT00861250|Dexamethasone|dexamethasone|mesh-list
101753331|NCT00861250|Bortezomib|bortezomib|mesh-list
101753332|NCT00861250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101753333|NCT00861250|Antiemetics|antiemetics|mesh-ancestor
101753334|NCT00861250|Autonomic Agents|autonomic agents|mesh-ancestor
101753335|NCT00861250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101753336|NCT00861250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753337|NCT00861250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101753398|NCT00804297|Octreotide|octreotide|mesh-list
101753399|NCT00804297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101753400|NCT00804297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101753472|NCT00865462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101753473|NCT00865462|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101753474|NCT00865462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101753477|NCT00865462|Dopamine Agents|dopamine agents|mesh-ancestor
101753543|NCT00655629|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101753544|NCT00655629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101753545|NCT00655629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101753546|NCT00655629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753547|NCT00655629|Urological Agents|urological agents|mesh-ancestor
101753548|NCT00865696|Mirtazapine|mirtazapine|mesh-list
101753549|NCT00865696|Antidepressive Agents|antidepressive agents|mesh-ancestor
101753550|NCT00865696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101753551|NCT00865696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101753552|NCT00865696|Histamine Antagonists|histamine antagonists|mesh-ancestor
101753553|NCT00865696|Histamine Agents|histamine agents|mesh-ancestor
101753554|NCT00865696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101753555|NCT00865696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753556|NCT00865696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753600|NCT00854776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101753601|NCT00854776|Immunologic Factors|immunologic factors|mesh-ancestor
101753602|NCT00854776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101753603|NCT00854776|Antacids|antacids|mesh-ancestor
101753604|NCT00798525|Lepirudin|lepirudin|mesh-list
101753605|NCT00798525|Argatroban|argatroban|mesh-list
101753606|NCT00798525|Antithrombins|antithrombins|mesh-ancestor
101753607|NCT00798525|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101753608|NCT00798525|Protease Inhibitors|protease inhibitors|mesh-ancestor
101753609|NCT00798525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101753610|NCT00798525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753611|NCT00798525|Anticoagulants|anticoagulants|mesh-ancestor
101753612|NCT00798525|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101753613|NCT00798525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101753614|NCT00798525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101753615|NCT00861640|Omeprazole|omeprazole|mesh-list
101753616|NCT00861640|Rabeprazole|rabeprazole|mesh-list
101753617|NCT00861640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101753618|NCT00861640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101753619|NCT00861640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101753620|NCT00861640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101753621|NCT00861640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753622|NCT00724230|Ribavirin|ribavirin|mesh-list
101753655|NCT00725114|Sensory System Agents|sensory system agents|mesh-ancestor
101753660|NCT00724542|Voglibose|voglibose|mesh-list
101753729|NCT00861874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101753730|NCT00861874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101753731|NCT00861874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101753802|NCT00855088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101753803|NCT00855088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101753804|NCT00855088|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101753805|NCT00855088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101753807|NCT02553603|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
101753870|NCT00804921|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101753871|NCT00804921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101753872|NCT00804921|Diuretics|diuretics|mesh-ancestor
101753873|NCT00804921|Natriuretic Agents|natriuretic agents|mesh-ancestor
101753875|NCT00866944|Fluorouracil|fluorouracil|mesh-list
101753876|NCT00866944|Oxaliplatin|oxaliplatin|mesh-list
101753877|NCT00866944|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101753878|NCT00866944|Antimetabolites|antimetabolites|mesh-ancestor
101753879|NCT00866944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101753880|NCT00866944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101753881|NCT00866944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101753882|NCT00866944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101753885|NCT00866944|Antidotes|antidotes|mesh-ancestor
101753936|NCT00870298|Antimalarials|antimalarials|mesh-ancestor
101753937|NCT00870298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101753938|NCT00870298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101753952|NCT00730418|Doxazosin|doxazosin|mesh-list
101754007|NCT00862108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101754008|NCT00862108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754010|NCT00862108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101754011|NCT00862264|Beclomethasone|beclomethasone|mesh-list
101754012|NCT00862264|Norflurane|norflurane|mesh-list
101754013|NCT00862264|Formoterol Fumarate|formoterol fumarate|mesh-list
101754014|NCT00862264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101332606|NCT00000971|Clarithromycin|clarithromycin|mesh-list
101754015|NCT00862264|Autonomic Agents|autonomic agents|mesh-ancestor
101754016|NCT00862264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101754017|NCT00862264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754018|NCT00862264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101754019|NCT00862264|Respiratory System Agents|respiratory system agents|mesh-ancestor
101754020|NCT00862264|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101754067|NCT03355794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754068|NCT03355794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101754069|NCT03355794|Immunologic Factors|immunologic factors|mesh-ancestor
101754070|NCT03355794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754071|NCT03355794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101754072|NCT01487174|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101754073|NCT01487174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101754074|NCT01487174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101754130|NCT02569970|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101754131|NCT02569970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101754132|NCT02569970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754133|NCT02569970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101754134|NCT02569970|Serotonin Agents|serotonin agents|mesh-ancestor
101754135|NCT02569970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754136|NCT02569970|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101754155|NCT00725946|Iodine|iodine|mesh-list
101754195|NCT00726960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754196|NCT00726960|Analgesics|analgesics|mesh-ancestor
101754197|NCT00726960|Sensory System Agents|sensory system agents|mesh-ancestor
101754198|NCT00726960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101754199|NCT00726960|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101411608|NCT05483634|Estrogens|estrogens|mesh-list
101754200|NCT00726960|Antiemetics|antiemetics|mesh-ancestor
101754201|NCT00726960|Autonomic Agents|autonomic agents|mesh-ancestor
101754202|NCT00726960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101754203|NCT00726960|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101754204|NCT00726960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101754205|NCT00726960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754206|NCT00727038|Ranibizumab|ranibizumab|mesh-list
101754207|NCT00727038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101754208|NCT00727038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101754209|NCT00727038|Growth Substances|growth substances|mesh-ancestor
101754210|NCT00727038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754211|NCT00727038|Growth Inhibitors|growth inhibitors|mesh-ancestor
101754212|NCT00727038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101754213|NCT00726258|Ketamine|ketamine|mesh-list
101754214|NCT00726258|Analgesics|analgesics|mesh-ancestor
101754215|NCT00726258|Sensory System Agents|sensory system agents|mesh-ancestor
101754246|NCT02569814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101754248|NCT00726570|Calcium heparin|calcium heparin|mesh-list
101754249|NCT00726570|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101754250|NCT00726570|Tinzaparin|tinzaparin|mesh-list
101754251|NCT00726570|Dalteparin|dalteparin|mesh-list
101754252|NCT00726570|Anticoagulants|anticoagulants|mesh-list
101754253|NCT00726570|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101754254|NCT00726570|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101754255|NCT00726570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754256|NCT00726726|Vitamin K|vitamin k|mesh-list
101754257|NCT00726726|Midazolam|midazolam|mesh-list
101754258|NCT00726726|Dextromethorphan|dextromethorphan|mesh-list
101754259|NCT00726726|Caffeine|caffeine|mesh-list
101754260|NCT00726726|Omeprazole|omeprazole|mesh-list
101754261|NCT00726726|Warfarin|warfarin|mesh-list
101754262|NCT00726726|BMS 708163|bms 708163|mesh-list
101754263|NCT00726726|Vitamins|vitamins|mesh-ancestor
101754264|NCT00726726|Micronutrients|micronutrients|mesh-ancestor
101754265|NCT00726726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754307|NCT00654381|Protease Inhibitors|protease inhibitors|mesh-ancestor
101754308|NCT00654381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101754309|NCT00654381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754310|NCT00654381|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101754311|NCT00654381|Vitamin B Complex|vitamin b complex|mesh-ancestor
101754312|NCT00654381|Vitamins|vitamins|mesh-ancestor
101754313|NCT00654381|Micronutrients|micronutrients|mesh-ancestor
101754314|NCT04018482|Povidone-Iodine|povidone-iodine|mesh-list
101754315|NCT04018482|Povidone|povidone|mesh-list
101754316|NCT04018482|Plasma Substitutes|plasma substitutes|mesh-ancestor
101754317|NCT04018482|Blood Substitutes|blood substitutes|mesh-ancestor
101754370|NCT00732290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101754371|NCT00732290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101754372|NCT02570334|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101754373|NCT02570334|Antiviral Agents|antiviral agents|mesh-ancestor
101754374|NCT02570334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101754375|NCT00732446|Moxifloxacin|moxifloxacin|mesh-list
101754376|NCT00732446|Dexamethasone|dexamethasone|mesh-list
101754377|NCT00732446|Dexamethasone acetate|dexamethasone acetate|mesh-list
101754378|NCT00732446|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101754379|NCT00732446|BB 1101|bb 1101|mesh-list
101754380|NCT00732446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101754381|NCT00732446|Antiemetics|antiemetics|mesh-ancestor
101754382|NCT00732446|Autonomic Agents|autonomic agents|mesh-ancestor
101754383|NCT00732446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101754384|NCT00732446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754385|NCT00732446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101754386|NCT00732446|Glucocorticoids|glucocorticoids|mesh-ancestor
101754428|NCT00799071|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101754429|NCT00799071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101754430|NCT00799071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101754431|NCT00799071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754432|NCT00799071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101754433|NCT00799071|Hormone Antagonists|hormone antagonists|mesh-ancestor
101351022|NCT05771038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754434|NCT00799071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101754435|NCT00799071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754437|NCT00732836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101754438|NCT00732836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101754439|NCT00732836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101754440|NCT00732836|Tubulin Modulators|tubulin modulators|mesh-ancestor
101754441|NCT00732836|Antimitotic Agents|antimitotic agents|mesh-ancestor
101754442|NCT00732836|Mitosis Modulators|mitosis modulators|mesh-ancestor
101754443|NCT00732836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754484|NCT00809289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101754485|NCT00809289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101754486|NCT00809289|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101754487|NCT00809289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101754488|NCT00809289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101754489|NCT00809289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754490|NCT00809289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101754491|NCT00728000|Gemcitabine|gemcitabine|mesh-list
101754492|NCT00728000|Oxaliplatin|oxaliplatin|mesh-list
101754551|NCT01528046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754552|NCT01528046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101754553|NCT01528046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101754554|NCT01528046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101754555|NCT01528046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754556|NCT01528046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101754558|NCT01528046|Tubulin Modulators|tubulin modulators|mesh-ancestor
101754618|NCT02569554|Rabeprazole|rabeprazole|mesh-list
101754619|NCT02569554|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101754620|NCT02569554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101754621|NCT02569554|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101754622|NCT02569554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101754623|NCT02569554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754624|NCT00734318|Fluticasone|fluticasone|mesh-list
101754626|NCT00734318|Formoterol Fumarate|formoterol fumarate|mesh-list
101754627|NCT00734318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101754628|NCT00734318|Autonomic Agents|autonomic agents|mesh-ancestor
101754629|NCT00734318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101754630|NCT00734318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754631|NCT00734318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101754632|NCT00734318|Respiratory System Agents|respiratory system agents|mesh-ancestor
101351051|NCT05769946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101754633|NCT00734318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101754634|NCT00734318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101754635|NCT00734318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101754636|NCT00734318|Adrenergic Agents|adrenergic agents|mesh-ancestor
101754637|NCT00734318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101754638|NCT00734318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754639|NCT00734318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101754640|NCT00734318|Dermatologic Agents|dermatologic agents|mesh-ancestor
101754641|NCT00734318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101754642|NCT00733616|Docetaxel|docetaxel|mesh-list
101754643|NCT00733616|Capecitabine|capecitabine|mesh-list
101754644|NCT00733616|Oxaliplatin|oxaliplatin|mesh-list
101754666|NCT00728312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101754667|NCT00728312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754668|NCT00728312|Dopamine Agonists|dopamine agonists|mesh-ancestor
101754669|NCT00728312|Dopamine Agents|dopamine agents|mesh-ancestor
101754670|NCT00728312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101754672|NCT00728312|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101754733|NCT00868426|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101754734|NCT00868426|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101754735|NCT00868426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101754736|NCT00868426|Adrenergic Agents|adrenergic agents|mesh-ancestor
101754737|NCT00868426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101754738|NCT00868426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754739|NCT00868426|Antidotes|antidotes|mesh-ancestor
101754740|NCT00868426|Protective Agents|protective agents|mesh-ancestor
101754741|NCT03853746|Ocrelizumab|ocrelizumab|mesh-list
101754742|NCT03853746|Immunologic Factors|immunologic factors|mesh-ancestor
101754743|NCT03853746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754744|NCT00868738|Vitamin D|vitamin d|mesh-list
101754745|NCT00868738|Vitamins|vitamins|mesh-ancestor
101754746|NCT00868738|Micronutrients|micronutrients|mesh-ancestor
101754796|NCT00731172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754797|NCT00731172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101754798|NCT00731172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101754800|NCT00738842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101754801|NCT00738842|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101754802|NCT00738842|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101754865|NCT03728478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101754866|NCT03728478|Abortifacient Agents|abortifacient agents|mesh-ancestor
101754867|NCT03728478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101754868|NCT03728478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754869|NCT03728478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101754870|NCT03728478|Antimetabolites|antimetabolites|mesh-ancestor
101754871|NCT03728478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412286|NCT00475189|Norinyl|norinyl|mesh-list
101754928|NCT00862888|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101754929|NCT00862888|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101754930|NCT00862888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101754931|NCT00862888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754932|NCT00862888|Urological Agents|urological agents|mesh-ancestor
101754934|NCT00729170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101754935|NCT00729170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101754936|NCT00862966|Heparin|heparin|mesh-list
101754937|NCT00862966|Anticoagulants|anticoagulants|mesh-ancestor
101754938|NCT00862966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754939|NCT00862966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101754940|NCT00862966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101754941|NCT02569320|Dexamethasone|dexamethasone|mesh-list
101754942|NCT02569320|Dexamethasone acetate|dexamethasone acetate|mesh-list
101754943|NCT02569320|Pomalidomide|pomalidomide|mesh-list
101754944|NCT02569320|Ichthammol|ichthammol|mesh-list
101754945|NCT02569320|BB 1101|bb 1101|mesh-list
101754946|NCT02569320|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
101754947|NCT02569320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101754949|NCT02569320|Autonomic Agents|autonomic agents|mesh-ancestor
101754950|NCT02569320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101754981|NCT00739622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101754982|NCT00739622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101754983|NCT00739622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101754984|NCT00739622|Antiviral Agents|antiviral agents|mesh-ancestor
101754985|NCT00739622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101754986|NCT00739622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101754987|NCT00739622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101754988|NCT00731562|Varenicline|varenicline|mesh-list
101754989|NCT00731562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101754990|NCT00731562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101754991|NCT00731562|Cholinergic Agents|cholinergic agents|mesh-ancestor
101755044|NCT00871156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101755045|NCT00871156|Analgesics|analgesics|mesh-ancestor
101755046|NCT00871156|Sensory System Agents|sensory system agents|mesh-ancestor
101755047|NCT00871156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101755048|NCT00871156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755049|NCT00871156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101755050|NCT00871156|Filaricides|filaricides|mesh-ancestor
101755051|NCT00871156|Antinematodal Agents|antinematodal agents|mesh-ancestor
101755052|NCT00871156|Anthelmintics|anthelmintics|mesh-ancestor
101755054|NCT00734448|Vitamin B Complex|vitamin b complex|mesh-ancestor
101755055|NCT00734448|Vitamins|vitamins|mesh-ancestor
101755056|NCT00734448|Micronutrients|micronutrients|mesh-ancestor
101755057|NCT00734448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755058|NCT00734526|Temozolomide|temozolomide|mesh-list
101755059|NCT00734526|Sorafenib|sorafenib|mesh-list
101755060|NCT00734526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101755061|NCT00734526|Alkylating Agents|alkylating agents|mesh-ancestor
101755105|NCT00740090|Antacids|antacids|mesh-ancestor
101755106|NCT00740090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755107|NCT00740090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101755108|NCT00738660|Telmisartan|telmisartan|mesh-list
101755109|NCT00738660|Ramipril|ramipril|mesh-list
101755110|NCT00738660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101755111|NCT00738660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101755112|NCT00738660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101755113|NCT00738660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755114|NCT00738660|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101755115|NCT00738660|Protease Inhibitors|protease inhibitors|mesh-ancestor
101755168|NCT00876616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101755169|NCT00876616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101755170|NCT00876616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101755171|NCT00876616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101755172|NCT00876616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101755173|NCT00876616|Antitubercular Agents|antitubercular agents|mesh-ancestor
101755174|NCT00876616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101755175|NCT00876616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101755177|NCT05575440|Cariostatic Agents|cariostatic agents|mesh-ancestor
101755178|NCT05575440|Protective Agents|protective agents|mesh-ancestor
101755179|NCT05575440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755234|NCT00732186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101755235|NCT00732186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755236|NCT04039828|Zinc|zinc|mesh-list
101755237|NCT04039828|Zinc Sulfate|zinc sulfate|mesh-list
101755238|NCT04039828|Trace Elements|trace elements|mesh-ancestor
101755239|NCT04039828|Micronutrients|micronutrients|mesh-ancestor
101755240|NCT04039828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755241|NCT04039828|Astringents|astringents|mesh-ancestor
101755242|NCT04039828|Dermatologic Agents|dermatologic agents|mesh-ancestor
101755243|NCT00876772|Olanzapine|olanzapine|mesh-list
101755244|NCT00876772|Antiemetics|antiemetics|mesh-ancestor
101755245|NCT00876772|Autonomic Agents|autonomic agents|mesh-ancestor
101755246|NCT00876772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101755247|NCT00876772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755248|NCT00876772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101755294|NCT05157412|Prednisolone phosphate|prednisolone phosphate|mesh-list
101755295|NCT05157412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101755296|NCT05157412|Glucocorticoids|glucocorticoids|mesh-ancestor
101755298|NCT05157412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101755299|NCT05157412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755300|NCT05157412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101755301|NCT05157412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101755302|NCT05157412|Antiemetics|antiemetics|mesh-ancestor
101755303|NCT05157412|Autonomic Agents|autonomic agents|mesh-ancestor
101755304|NCT05157412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101755305|NCT05157412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101755306|NCT05157412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101755358|NCT00732576|Micronutrients|micronutrients|mesh-ancestor
101755359|NCT00732576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755360|NCT00863902|Cetirizine|cetirizine|mesh-list
101755361|NCT00863902|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101755362|NCT00863902|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101755363|NCT00863902|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101755364|NCT00863902|Histamine Antagonists|histamine antagonists|mesh-ancestor
101755365|NCT00863902|Histamine Agents|histamine agents|mesh-ancestor
101755366|NCT00863902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101755367|NCT00863902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755368|NCT00863902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755369|NCT00732810|Capecitabine|capecitabine|mesh-list
101755370|NCT00732810|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101755371|NCT00732810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101755378|NCT00732888|Calcium|calcium|mesh-list
101755416|NCT00617734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101755417|NCT00617734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101755418|NCT00617734|Immunologic Factors|immunologic factors|mesh-ancestor
101755419|NCT00617734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755420|NCT00577460|Pramipexole|pramipexole|mesh-list
101755421|NCT00577460|Antioxidants|antioxidants|mesh-ancestor
101755422|NCT00577460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755423|NCT00577460|Protective Agents|protective agents|mesh-ancestor
101755424|NCT00577460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755425|NCT00577460|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101755426|NCT00577460|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101755427|NCT00577460|Dopamine Agonists|dopamine agonists|mesh-ancestor
101755428|NCT00577460|Dopamine Agents|dopamine agents|mesh-ancestor
101755429|NCT00577460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101755430|NCT00863980|Telmisartan|telmisartan|mesh-list
101755431|NCT00863980|Candesartan|candesartan|mesh-list
101755432|NCT00863980|Candesartan cilexetil|candesartan cilexetil|mesh-list
101755433|NCT00863980|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101755434|NCT00863980|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101755435|NCT00863980|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101755436|NCT00863980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755437|NCT00415519|Edaravone|edaravone|mesh-list
101755438|NCT00415519|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101755439|NCT00415519|Antioxidants|antioxidants|mesh-ancestor
101263622|NCT01762787|Protective Agents|protective agents|mesh-ancestor
101755445|NCT02568176|Bupropion|bupropion|mesh-list
101755463|NCT02568176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101755464|NCT02568176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101755465|NCT02568176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101755466|NCT02568176|Dopamine Agents|dopamine agents|mesh-ancestor
101755467|NCT02568176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101755468|NCT02568176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101755469|NCT02568176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101755470|NCT00741182|Teriparatide|teriparatide|mesh-list
101755471|NCT00741182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101755472|NCT00741182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755473|NCT00741182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101755474|NCT00423943|Modafinil|modafinil|mesh-list
101755520|NCT00864214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101755521|NCT00864214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755522|NCT00864214|Estrogens|estrogens|mesh-ancestor
101755523|NCT00872482|Nimotuzumab|nimotuzumab|mesh-list
101755524|NCT00872482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101755525|NCT00872482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101755526|NCT00428389|Rivastigmine|rivastigmine|mesh-list
101755527|NCT00428389|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101755528|NCT00428389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101755529|NCT00428389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755530|NCT00428389|Cholinergic Agents|cholinergic agents|mesh-ancestor
101755531|NCT00428389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101755532|NCT00428389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755533|NCT00428389|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101755534|NCT00428389|Protective Agents|protective agents|mesh-ancestor
101755535|NCT00616642|Rosiglitazone|rosiglitazone|mesh-list
101755536|NCT00616642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101755537|NCT00616642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755538|NCT02568488|Metformin|metformin|mesh-list
101755539|NCT02568488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101755540|NCT02568488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755541|NCT01324063|Cytarabine|cytarabine|mesh-list
101755542|NCT01324063|Daunorubicin|daunorubicin|mesh-list
101755543|NCT01324063|Amsacrine|amsacrine|mesh-list
101755544|NCT01324063|Sargramostim|sargramostim|mesh-list
101755570|NCT00406315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101755571|NCT00406315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101755572|NCT00406315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101755573|NCT00406315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101755574|NCT00406315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101755575|NCT00406315|Dopamine Agents|dopamine agents|mesh-ancestor
101755576|NCT00872716|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101755577|NCT00872716|Antidepressive Agents|antidepressive agents|mesh-ancestor
101755578|NCT00872716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101755579|NCT00872716|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101755580|NCT00872716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101755583|NCT00864526|Ibuprofen|ibuprofen|mesh-list
101755633|NCT00864760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101755634|NCT00864760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101755635|NCT00864760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101755636|NCT00864760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101755637|NCT00864760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101755638|NCT00864760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755639|NCT00864760|Antimanic Agents|antimanic agents|mesh-ancestor
101755640|NCT00710762|Nintedanib|nintedanib|mesh-list
101755641|NCT00710762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101755642|NCT00710762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101755643|NCT00710762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101755644|NCT00710762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755645|NCT05137912|Immunomodulating Agents|immunomodulating agents|mesh-list
101755646|NCT05137912|Immunologic Factors|immunologic factors|mesh-ancestor
101755647|NCT05137912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755648|NCT00736814|Carboplatin|carboplatin|mesh-list
101755649|NCT00736814|Gemcitabine|gemcitabine|mesh-list
101755650|NCT00736814|Docetaxel|docetaxel|mesh-list
101755651|NCT00736814|Vinorelbine|vinorelbine|mesh-list
101755652|NCT00736814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101755653|NCT00736814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101755654|NCT00736814|Antimetabolites|antimetabolites|mesh-ancestor
101755655|NCT00736814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755656|NCT00736814|Tubulin Modulators|tubulin modulators|mesh-ancestor
101755657|NCT00736814|Antimitotic Agents|antimitotic agents|mesh-ancestor
101755682|NCT00573430|Candesartan cilexetil|candesartan cilexetil|mesh-list
101755683|NCT00573430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101755684|NCT00573430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101755685|NCT00573430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101755686|NCT00573430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755687|NCT00711516|Modafinil|modafinil|mesh-list
101755688|NCT00711516|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101755689|NCT00711516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755690|NCT00711516|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101755691|NCT00711516|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101755692|NCT00711516|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101755695|NCT00864838|Acetazolamide|acetazolamide|mesh-list
101755741|NCT00186888|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101755742|NCT00736164|Selenium|selenium|mesh-list
101755743|NCT00736164|Antioxidants|antioxidants|mesh-ancestor
101755744|NCT00736164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755745|NCT00736164|Protective Agents|protective agents|mesh-ancestor
101755746|NCT00736164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755747|NCT00736164|Trace Elements|trace elements|mesh-ancestor
101755748|NCT00736164|Micronutrients|micronutrients|mesh-ancestor
101755749|NCT00739830|Sirolimus|sirolimus|mesh-list
101755750|NCT00739830|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101755751|NCT00739830|Megestrol|megestrol|mesh-list
101755773|NCT00577382|Sunitinib|sunitinib|mesh-list
101755806|NCT04065282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101755807|NCT04065282|Antimetabolites|antimetabolites|mesh-ancestor
101755808|NCT04065282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755809|NCT04065282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101755810|NCT00873262|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101755811|NCT00873262|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101755812|NCT00873262|Estropipate|estropipate|mesh-list
101755813|NCT00873262|Estradiol|estradiol|mesh-list
101755815|NCT00873262|Estrone|estrone|mesh-list
101755873|NCT00614926|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101755874|NCT00614926|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101351193|NCT05533684|Analgesics|analgesics|mesh-ancestor
101755875|NCT00614926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755876|NCT00873496|Hydroxychloroquine|hydroxychloroquine|mesh-list
101755877|NCT00873496|Antimalarials|antimalarials|mesh-ancestor
101755878|NCT00873496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101755879|NCT00873496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101755880|NCT00873496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101755881|NCT00873496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101755882|NCT00873496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755883|NCT00873496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101755938|NCT04039126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101755939|NCT04039126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101755940|NCT04039126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755941|NCT00873808|Zoledronic Acid|zoledronic acid|mesh-list
101755942|NCT00873808|Ibandronic Acid|ibandronic acid|mesh-list
101755943|NCT00873808|Clodronic Acid|clodronic acid|mesh-list
101755944|NCT00873808|Tetracycline|tetracycline|mesh-list
101755945|NCT00873808|Demeclocycline|demeclocycline|mesh-list
101755946|NCT00873808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101755947|NCT00873808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101755948|NCT00873808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101755949|NCT00873808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101755950|NCT00873808|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101755951|NCT00873808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101755952|NCT00873808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101755953|NCT04064190|Durvalumab|durvalumab|mesh-list
101755954|NCT04064190|Vactosertib|vactosertib|mesh-list
101755998|NCT00879424|Vitamin D|vitamin d|mesh-list
101755999|NCT00879424|Cholecalciferol|cholecalciferol|mesh-list
101756000|NCT00879424|Vitamins|vitamins|mesh-ancestor
101756001|NCT00879424|Micronutrients|micronutrients|mesh-ancestor
101756002|NCT00879424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756003|NCT00879424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101756004|NCT00879424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101756005|NCT00710684|Donepezil|donepezil|mesh-list
101756006|NCT00710684|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101756007|NCT00710684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101756008|NCT00710684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756009|NCT00710684|Cholinergic Agents|cholinergic agents|mesh-ancestor
101756010|NCT00710684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101756011|NCT00710684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756012|NCT00710684|Nootropic Agents|nootropic agents|mesh-ancestor
101756013|NCT00710606|NuvaRing|nuvaring|mesh-list
101756014|NCT00710606|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101756015|NCT00710606|Desogestrel|desogestrel|mesh-list
101756016|NCT00710606|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101756017|NCT00710606|Contraceptive Agents|contraceptive agents|mesh-ancestor
101756018|NCT00710606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101756019|NCT00710606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756020|NCT00710606|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101756021|NCT00710606|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101756022|NCT00710606|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101756023|NCT00710606|Estrogens|estrogens|mesh-ancestor
101756024|NCT00710606|Hormones|hormones|mesh-ancestor
101756025|NCT00710606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101756026|NCT00710606|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101756027|NCT00710606|Progestins|progestins|mesh-ancestor
101756029|NCT00713544|Etanercept|etanercept|mesh-list
101756030|NCT00713544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101756032|NCT00713544|Analgesics|analgesics|mesh-ancestor
101756038|NCT00713544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101756039|NCT00713544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101756040|NCT00713544|Immunologic Factors|immunologic factors|mesh-ancestor
101756041|NCT00713544|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101756042|NCT00713544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756043|NCT00713544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101756044|NCT00713544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101756045|NCT00713544|Antiviral Agents|antiviral agents|mesh-ancestor
101756046|NCT00713544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101756047|NCT00737126|Folic Acid|folic acid|mesh-list
101756050|NCT00737126|Vitamins|vitamins|mesh-ancestor
101756102|NCT00741234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101756103|NCT00741234|Antimetabolites|antimetabolites|mesh-ancestor
101756104|NCT00741234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756105|NCT00741234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101756106|NCT00741234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101756107|NCT00713258|Alendronate|alendronate|mesh-list
101756108|NCT00713258|Hormones|hormones|mesh-list
101756109|NCT00713258|Parathyroid Hormone|parathyroid hormone|mesh-list
101756110|NCT00713258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101756111|NCT00713258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756166|NCT01608451|Hormones|hormones|mesh-ancestor
101756167|NCT01608451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101756168|NCT00405067|Ezetimibe|ezetimibe|mesh-list
101756169|NCT00405067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101756170|NCT00405067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101756171|NCT00405067|Antimetabolites|antimetabolites|mesh-ancestor
101756172|NCT00405067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756173|NCT00405067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101756174|NCT00708708|Etanercept|etanercept|mesh-list
101756175|NCT00708708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101756176|NCT00708708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101756177|NCT00708708|Analgesics|analgesics|mesh-ancestor
101756178|NCT00708708|Sensory System Agents|sensory system agents|mesh-ancestor
101756179|NCT00708708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101756180|NCT00708708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756187|NCT00404755|Imipramine|imipramine|mesh-list
101756225|NCT00737256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101756226|NCT00737256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756227|NCT00737256|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101756228|NCT00737256|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101756229|NCT00737256|Serotonin Agents|serotonin agents|mesh-ancestor
101756230|NCT00737256|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101756231|NCT00737256|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101756287|NCT00737724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101756288|NCT00737724|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101756289|NCT00737724|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101756290|NCT00737724|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101756291|NCT00737724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101756292|NCT00737724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101756293|NCT00737724|Antitubercular Agents|antitubercular agents|mesh-ancestor
101756294|NCT00737724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101756295|NCT00737724|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101756296|NCT00737724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101756297|NCT00737724|Antimetabolites|antimetabolites|mesh-ancestor
101756298|NCT00737724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101756299|NCT00880828|Acetaminophen|acetaminophen|mesh-list
101756300|NCT00880828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101756301|NCT00880828|Analgesics|analgesics|mesh-ancestor
101756302|NCT00880828|Sensory System Agents|sensory system agents|mesh-ancestor
101756303|NCT00880828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101756304|NCT00880828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756305|NCT00880828|Antipyretics|antipyretics|mesh-ancestor
101756306|NCT00712920|Azelastine|azelastine|mesh-list
101756307|NCT00712920|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101756308|NCT00712920|Autonomic Agents|autonomic agents|mesh-ancestor
101756309|NCT00712920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101756310|NCT00712920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756311|NCT00712920|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101756322|NCT00874744|Triamcinolone|triamcinolone|mesh-list
101756334|NCT00874744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101756335|NCT00874744|Glucocorticoids|glucocorticoids|mesh-ancestor
101756336|NCT00874744|Hormones|hormones|mesh-ancestor
101756338|NCT00874744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101756409|NCT04721626|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101756410|NCT00881140|Mifepristone|mifepristone|mesh-list
101756411|NCT00881140|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101756412|NCT00881140|Abortifacient Agents|abortifacient agents|mesh-ancestor
101756413|NCT00881140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101756414|NCT00881140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756415|NCT00881140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101756416|NCT00881140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101756417|NCT00881140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101351355|NCT04752163|Prednisone|prednisone|mesh-list
101756418|NCT00881140|Contraceptive Agents|contraceptive agents|mesh-ancestor
101756419|NCT00881140|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101756420|NCT00881140|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101756421|NCT00881140|Hormone Antagonists|hormone antagonists|mesh-ancestor
101756422|NCT00881140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101756423|NCT00881140|Luteolytic Agents|luteolytic agents|mesh-ancestor
101756424|NCT00881140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101756425|NCT00881140|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101756426|NCT05733078|Vitamins|vitamins|mesh-list
101756427|NCT05733078|Ascorbic Acid|ascorbic acid|mesh-list
101756428|NCT05733078|Micronutrients|micronutrients|mesh-ancestor
101756429|NCT05733078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756430|NCT05733078|Antioxidants|antioxidants|mesh-ancestor
101756431|NCT05733078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756432|NCT05733078|Protective Agents|protective agents|mesh-ancestor
101756433|NCT00874978|Lenalidomide|lenalidomide|mesh-list
101756434|NCT00874978|Immunologic Factors|immunologic factors|mesh-ancestor
101756441|NCT00737880|Pancrelipase|pancrelipase|mesh-list
101756454|NCT00612586|Bevacizumab|bevacizumab|mesh-list
101756455|NCT00612586|Fluorouracil|fluorouracil|mesh-list
101756456|NCT00612586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101756457|NCT00612586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101756458|NCT00612586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101756459|NCT00612586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101756461|NCT00612586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756462|NCT00612586|Growth Inhibitors|growth inhibitors|mesh-ancestor
101756463|NCT00612586|Antimetabolites|antimetabolites|mesh-ancestor
101756464|NCT00612586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756465|NCT00612586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101756466|NCT00612586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101756467|NCT00612586|Immunologic Factors|immunologic factors|mesh-ancestor
101756468|NCT00612586|Antidotes|antidotes|mesh-ancestor
101756469|NCT00612586|Protective Agents|protective agents|mesh-ancestor
101756470|NCT00612586|Vitamin B Complex|vitamin b complex|mesh-ancestor
101756471|NCT00612586|Vitamins|vitamins|mesh-ancestor
101756472|NCT00612586|Micronutrients|micronutrients|mesh-ancestor
101756473|NCT00883870|Plasma-lyte 148|plasma-lyte 148|mesh-list
101756474|NCT00883870|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101756475|NCT00883870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101756476|NCT00614380|Amlodipine|amlodipine|mesh-list
101756488|NCT00738192|Fentanyl|fentanyl|mesh-list
101756509|NCT00738192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756510|NCT00738192|Antitussive Agents|antitussive agents|mesh-ancestor
101756511|NCT00738192|Respiratory System Agents|respiratory system agents|mesh-ancestor
101756512|NCT00738192|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101756513|NCT05500170|Niacinamide|niacinamide|mesh-list
101756514|NCT05500170|Niacin|niacin|mesh-list
101756515|NCT05500170|Nicotinic Acids|nicotinic acids|mesh-list
101756516|NCT05500170|Vitamins|vitamins|mesh-ancestor
101756517|NCT05500170|Micronutrients|micronutrients|mesh-ancestor
101756518|NCT05500170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756519|NCT05500170|Vitamin B Complex|vitamin b complex|mesh-ancestor
101756520|NCT05500170|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101756521|NCT05500170|Antimetabolites|antimetabolites|mesh-ancestor
101756573|NCT00613834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101756574|NCT00613834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101756575|NCT00613834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101756576|NCT00613834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101756577|NCT00613834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756642|NCT00881686|Purinergic Agonists|purinergic agonists|mesh-ancestor
101756720|NCT00651261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101756721|NCT00651261|Glucocorticoids|glucocorticoids|mesh-ancestor
101756722|NCT00651261|Hormones|hormones|mesh-ancestor
101756723|NCT00651261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101756724|NCT00651261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101756725|NCT00651261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101756726|NCT00651261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101756727|NCT00651261|Antimetabolites|antimetabolites|mesh-ancestor
101756728|NCT00651261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756729|NCT00651261|Antiviral Agents|antiviral agents|mesh-ancestor
101756730|NCT00651261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101756731|NCT00651261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101756732|NCT00651261|Immunologic Factors|immunologic factors|mesh-ancestor
101756733|NCT00651261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101756734|NCT00651261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101756735|NCT00651261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101756739|NCT00885820|Prednisone|prednisone|mesh-list
101756777|NCT00651183|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101756778|NCT00651183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101756779|NCT00651183|Dopamine Agonists|dopamine agonists|mesh-ancestor
101756780|NCT00651183|Dopamine Agents|dopamine agents|mesh-ancestor
101756781|NCT00651183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101756782|NCT00810381|Nitroprusside|nitroprusside|mesh-list
101756847|NCT00813735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101756848|NCT00811083|Succimer|succimer|mesh-list
101756849|NCT00811083|Antidotes|antidotes|mesh-ancestor
101756850|NCT00811083|Protective Agents|protective agents|mesh-ancestor
101756851|NCT00811083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756852|NCT00811083|Chelating Agents|chelating agents|mesh-ancestor
101756853|NCT00811083|Sequestering Agents|sequestering agents|mesh-ancestor
101756854|NCT00811083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756855|NCT00642759|Paclitaxel|paclitaxel|mesh-list
101756856|NCT00642759|Bevacizumab|bevacizumab|mesh-list
101756857|NCT00642759|Carboplatin|carboplatin|mesh-list
101756858|NCT00642759|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101756859|NCT00642759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101756860|NCT00642759|Tubulin Modulators|tubulin modulators|mesh-ancestor
101756861|NCT00642759|Antimitotic Agents|antimitotic agents|mesh-ancestor
101756862|NCT00642759|Mitosis Modulators|mitosis modulators|mesh-ancestor
101756863|NCT00642759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756864|NCT00642759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101756865|NCT00642759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101756866|NCT00642759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101756867|NCT00642759|Growth Substances|growth substances|mesh-ancestor
101756868|NCT00642759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756869|NCT00642759|Growth Inhibitors|growth inhibitors|mesh-ancestor
101756870|NCT00813891|Ranibizumab|ranibizumab|mesh-list
101756871|NCT00813891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101756898|NCT00814047|Autonomic Agents|autonomic agents|mesh-ancestor
101756899|NCT00814047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101756900|NCT00814047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756901|NCT00814047|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101756902|NCT00814047|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101756903|NCT00814047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101756904|NCT00814047|Adrenergic Agents|adrenergic agents|mesh-ancestor
101756905|NCT00814047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101756906|NCT00814047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101756907|NCT00814047|Urological Agents|urological agents|mesh-ancestor
101756908|NCT00814125|Tamoxifen|tamoxifen|mesh-list
101756909|NCT00814125|Anastrozole|anastrozole|mesh-list
101756910|NCT00814125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101756911|NCT00814125|Hormone Antagonists|hormone antagonists|mesh-ancestor
101756912|NCT00814125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101756955|NCT00814359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101756956|NCT00814359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101756957|NCT00814359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101756958|NCT00612040|Insulin|insulin|mesh-list
101756959|NCT00612040|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101756960|NCT00612040|Insulin Glargine|insulin glargine|mesh-list
101756961|NCT00612040|Insulin Aspart|insulin aspart|mesh-list
101756962|NCT00612040|Insulin, Long-Acting|insulin, long-acting|mesh-list
101756963|NCT00612040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101756964|NCT00612040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101756965|NCT00422227|Hydroxychloroquine|hydroxychloroquine|mesh-list
101756966|NCT00422227|Sulfasalazine|sulfasalazine|mesh-list
101756967|NCT00422227|Etanercept|etanercept|mesh-list
101756968|NCT00422227|Methotrexate|methotrexate|mesh-list
101756969|NCT00422227|Leflunomide|leflunomide|mesh-list
101756970|NCT00422227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101756971|NCT00422227|Abortifacient Agents|abortifacient agents|mesh-ancestor
101756972|NCT00422227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101757015|NCT00814593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757016|NCT00814593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101757017|NCT00421993|Adapalene|adapalene|mesh-list
101757018|NCT00421993|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
101757019|NCT00421993|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101757020|NCT00421993|Dermatologic Agents|dermatologic agents|mesh-ancestor
101757021|NCT00421993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101757022|NCT00421993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101757023|NCT00421993|Analgesics|analgesics|mesh-ancestor
101757024|NCT00421993|Sensory System Agents|sensory system agents|mesh-ancestor
101757025|NCT00421993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101757029|NCT00884884|Topiramate|topiramate|mesh-list
101757078|NCT00413959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101757079|NCT00413959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101757080|NCT00413959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101757081|NCT00413959|Antiemetics|antiemetics|mesh-ancestor
101757082|NCT00413959|Autonomic Agents|autonomic agents|mesh-ancestor
101757083|NCT00413959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101757084|NCT00413959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101757085|NCT00413959|Glucocorticoids|glucocorticoids|mesh-ancestor
101757086|NCT00413959|Hormones|hormones|mesh-ancestor
101757087|NCT00413959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101757088|NCT00413959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101757089|NCT00814905|Clindamycin|clindamycin|mesh-list
101757090|NCT00814905|Clindamycin palmitate|clindamycin palmitate|mesh-list
101757141|NCT01041235|Docetaxel|docetaxel|mesh-list
101757142|NCT01041235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101757143|NCT01041235|Tubulin Modulators|tubulin modulators|mesh-ancestor
101757144|NCT01041235|Antimitotic Agents|antimitotic agents|mesh-ancestor
101757145|NCT01041235|Mitosis Modulators|mitosis modulators|mesh-ancestor
101757146|NCT01041235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757147|NCT01041313|Memantine|memantine|mesh-list
101757148|NCT01041313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101757149|NCT01041313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101757150|NCT01041313|Dopamine Agents|dopamine agents|mesh-ancestor
101757151|NCT01041313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101757152|NCT01041313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757153|NCT01041313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757154|NCT01041313|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101757155|NCT01041313|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101757156|NCT00610714|Paclitaxel|paclitaxel|mesh-list
101757157|NCT00610714|Carboplatin|carboplatin|mesh-list
101757158|NCT00610714|Saracatinib|saracatinib|mesh-list
101757199|NCT00402727|Tazobactam|tazobactam|mesh-list
101757200|NCT00402727|Piperacillin|piperacillin|mesh-list
101757201|NCT00402727|Clavulanic Acids|clavulanic acids|mesh-list
101757202|NCT00402727|Clavulanic Acid|clavulanic acid|mesh-list
101757203|NCT00402727|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101757204|NCT00402727|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101757205|NCT00402727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101757206|NCT00402727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101757207|NCT00402727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101757208|NCT00402727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101757209|NCT00402727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101757210|NCT00402727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757211|NCT00402727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101757212|NCT00402727|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101757213|NCT00402727|Contraceptive Agents|contraceptive agents|mesh-ancestor
101757214|NCT00402727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101757215|NCT00402727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757253|NCT00888862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757254|NCT00888862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101757255|NCT00888862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757256|NCT00888862|Antidepressive Agents|antidepressive agents|mesh-ancestor
101757257|NCT00888862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101757258|NCT00886990|Ritonavir|ritonavir|mesh-list
101757259|NCT00886990|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101757260|NCT00886990|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101757318|NCT00642369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101757319|NCT00642369|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101757320|NCT00642369|Dopamine Agents|dopamine agents|mesh-ancestor
101757321|NCT00642369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101757322|NCT00642369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757323|NCT00642369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101757324|NCT01154335|Everolimus|everolimus|mesh-list
101757325|NCT01154335|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101757326|NCT01154335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101757327|NCT01154335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101757328|NCT01154335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757329|NCT01154335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101757379|NCT02541526|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101757380|NCT01037959|Norfloxacin|norfloxacin|mesh-list
101757381|NCT01037959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101757382|NCT01037959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101757383|NCT01037959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101757384|NCT01037959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101757385|NCT01037959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101757386|NCT01037959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757387|NCT01037959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101757390|NCT01038037|Carboplatin|carboplatin|mesh-list
101757441|NCT00887770|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
101757442|NCT00887770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101757443|NCT00887770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101757444|NCT00887770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101757445|NCT00887770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101757446|NCT00887770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101757447|NCT00887770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757448|NCT00887770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101757449|NCT00887770|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101757450|NCT00887770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101757451|NCT00887770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101757501|NCT01038661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101757502|NCT01038661|Tubulin Modulators|tubulin modulators|mesh-ancestor
101757503|NCT01038661|Antimitotic Agents|antimitotic agents|mesh-ancestor
101757504|NCT01038661|Mitosis Modulators|mitosis modulators|mesh-ancestor
101757505|NCT01038661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757506|NCT01038817|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
101757507|NCT01038817|Cariostatic Agents|cariostatic agents|mesh-ancestor
101757508|NCT01038817|Protective Agents|protective agents|mesh-ancestor
101757509|NCT01038817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757511|NCT00420511|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101757512|NCT00420511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101757513|NCT00420511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757514|NCT00420511|Incretins|incretins|mesh-ancestor
101757559|NCT00402103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757560|NCT00402103|Vasodilator Agents|vasodilator agents|mesh-ancestor
101757561|NCT00402103|Diuretics|diuretics|mesh-ancestor
101757562|NCT00402103|Natriuretic Agents|natriuretic agents|mesh-ancestor
101757563|NCT00402103|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101757564|NCT00812175|Sorafenib|sorafenib|mesh-list
101757565|NCT00812175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101757566|NCT00812175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101757567|NCT00812175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101757568|NCT00812175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757569|NCT00815373|Timolol|timolol|mesh-list
101757570|NCT00815373|Dorzolamide|dorzolamide|mesh-list
101757571|NCT00815373|Latanoprost|latanoprost|mesh-list
101757572|NCT00815373|Maleic acid|maleic acid|mesh-list
101757573|NCT00815373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101757574|NCT00815373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757575|NCT00815373|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101757618|NCT02567916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757619|NCT02567916|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101757620|NCT02567916|Anesthetics, General|anesthetics, general|mesh-ancestor
101757621|NCT02567916|Anesthetics|anesthetics|mesh-ancestor
101757622|NCT00402025|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
101757623|NCT00402025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101757624|NCT00402025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101757625|NCT00609622|Bevacizumab|bevacizumab|mesh-list
101757682|NCT00890110|Sunitinib|sunitinib|mesh-list
101757683|NCT00890110|Vaccines|vaccines|mesh-list
101757684|NCT00890110|Immunologic Factors|immunologic factors|mesh-ancestor
101757685|NCT00890110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757686|NCT00890110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101757687|NCT00890110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101757688|NCT00890110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101757689|NCT00890110|Growth Substances|growth substances|mesh-ancestor
101757690|NCT00890110|Growth Inhibitors|growth inhibitors|mesh-ancestor
101757691|NCT00890110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101757692|NCT00890110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101757693|NCT00890110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757694|NCT02566824|Methylphenidate|methylphenidate|mesh-list
101757695|NCT02566824|Amphetamine|amphetamine|mesh-list
101757696|NCT02566824|Adderall|adderall|mesh-list
101757697|NCT02566824|Dextroamphetamine|dextroamphetamine|mesh-list
101757741|NCT04037566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757742|NCT04037566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101757743|NCT04037566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101757744|NCT00888082|Goserelin|goserelin|mesh-list
101757745|NCT00888082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101757746|NCT00888082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101757747|NCT00627705|Acetylcysteine|acetylcysteine|mesh-list
101757748|NCT00627705|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101757749|NCT00627705|Antiviral Agents|antiviral agents|mesh-ancestor
101757750|NCT00627705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101757751|NCT00627705|Expectorants|expectorants|mesh-ancestor
101757752|NCT00627705|Respiratory System Agents|respiratory system agents|mesh-ancestor
101757753|NCT00627705|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101757754|NCT00627705|Antioxidants|antioxidants|mesh-ancestor
101757755|NCT00627705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757756|NCT00627705|Protective Agents|protective agents|mesh-ancestor
101757757|NCT00627705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757758|NCT00627705|Antidotes|antidotes|mesh-ancestor
101757799|NCT00890500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101757800|NCT00890500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101757801|NCT00890500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101757802|NCT00890500|Antifungal Agents|antifungal agents|mesh-ancestor
101757803|NCT00890500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101757804|NCT00890500|Alkylating Agents|alkylating agents|mesh-ancestor
101757805|NCT00890500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101757806|NCT04061772|Prednisone|prednisone|mesh-list
101757807|NCT04061772|Cyclophosphamide|cyclophosphamide|mesh-list
101757865|NCT03667690|Fluconazole|fluconazole|mesh-list
101757866|NCT03667690|Caspofungin|caspofungin|mesh-list
101757867|NCT03667690|Rezafungin|rezafungin|mesh-list
101757868|NCT03667690|Antifungal Agents|antifungal agents|mesh-ancestor
101757869|NCT03667690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101757870|NCT03667690|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101757871|NCT03667690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101757872|NCT03667690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101351777|NCT03589729|Cytarabine|cytarabine|mesh-list
101757873|NCT03667690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757874|NCT03667690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101757875|NCT03667690|Hormone Antagonists|hormone antagonists|mesh-ancestor
101757876|NCT03667690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101757877|NCT03667690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757878|NCT03667690|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101757879|NCT03667690|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101757880|NCT00821535|Maraviroc|maraviroc|mesh-list
101757881|NCT00821535|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101757882|NCT00821535|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101757884|NCT00821535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101757920|NCT04351620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101757921|NCT04351620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101757922|NCT04351620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101757923|NCT04351620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101757924|NCT04351620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757925|NCT04351620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101757926|NCT00888394|Imidacloprid|imidacloprid|mesh-list
101757927|NCT00888394|Cholinergic Agents|cholinergic agents|mesh-ancestor
101757928|NCT00888394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101757929|NCT00888394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757930|NCT00888394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101757931|NCT02541760|Mometasone Furoate|mometasone furoate|mesh-list
101757932|NCT02541760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101757933|NCT02541760|Dermatologic Agents|dermatologic agents|mesh-ancestor
101757934|NCT02541760|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101757935|NCT00627393|Anti-Infective Agents|anti-infective agents|mesh-list
101757936|NCT00627393|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101757937|NCT00627393|Dexamethasone|dexamethasone|mesh-list
101757977|NCT00577122|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101757978|NCT00577122|Contraceptive Agents|contraceptive agents|mesh-ancestor
101757979|NCT00577122|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101757980|NCT00577122|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101757981|NCT00577122|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101757982|NCT00577122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101757983|NCT00822081|Timolol|timolol|mesh-list
101757984|NCT00822081|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101757985|NCT00822081|Dorzolamide|dorzolamide|mesh-list
101757986|NCT00822081|Maleic acid|maleic acid|mesh-list
101757987|NCT00822081|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
101757988|NCT00822081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101757989|NCT00822081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101757992|NCT00822081|Adrenergic Agents|adrenergic agents|mesh-ancestor
101758035|NCT00698646|Natriuretic Agents|natriuretic agents|mesh-ancestor
101758036|NCT00698646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758037|NCT00698646|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101758038|NCT00698646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101758039|NCT02565888|Ritonavir|ritonavir|mesh-list
101758040|NCT02565888|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101758041|NCT02565888|Cobicistat|cobicistat|mesh-list
101758042|NCT02565888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101758043|NCT02565888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101758044|NCT02565888|Protease Inhibitors|protease inhibitors|mesh-ancestor
101758100|NCT00819195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101758101|NCT00819195|Immunologic Factors|immunologic factors|mesh-ancestor
101758102|NCT00819195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758103|NCT00819195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101758104|NCT00819195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101758106|NCT00892918|Gatifloxacin|gatifloxacin|mesh-list
101758107|NCT00892918|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101758108|NCT00892918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101758109|NCT00892918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101758110|NCT00892918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101758111|NCT00892918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101758112|NCT00892918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101758113|NCT00892918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101758161|NCT00891670|Autonomic Agents|autonomic agents|mesh-ancestor
101758162|NCT00891670|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101758163|NCT00891670|Respiratory System Agents|respiratory system agents|mesh-ancestor
101758164|NCT00891670|Vasodilator Agents|vasodilator agents|mesh-ancestor
101758165|NCT00891670|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101758166|NCT00891670|Protective Agents|protective agents|mesh-ancestor
101758167|NCT00891670|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101758168|NCT00891670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101758169|NCT00699192|Amlodipine|amlodipine|mesh-list
101758170|NCT00699192|Valsartan|valsartan|mesh-list
101758224|NCT00696384|Diuretics|diuretics|mesh-ancestor
101758225|NCT00696384|Natriuretic Agents|natriuretic agents|mesh-ancestor
101758226|NCT00696384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758227|NCT00696384|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101758228|NCT00696384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101758229|NCT01041625|Apremilast|apremilast|mesh-list
101758230|NCT01041625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101758231|NCT01041625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101758232|NCT01041625|Analgesics|analgesics|mesh-ancestor
101758233|NCT01041625|Sensory System Agents|sensory system agents|mesh-ancestor
101758234|NCT01041625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101758235|NCT01041625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758236|NCT01041625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101758237|NCT01041625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101758239|NCT01041625|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101758284|NCT01039363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101758285|NCT01039363|Immunologic Factors|immunologic factors|mesh-ancestor
101758286|NCT01039363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758287|NCT01039363|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101758288|NCT01039363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101758289|NCT01039363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101758290|NCT01039363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101758291|NCT01039363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101758292|NCT01039363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101758294|NCT01039363|Immunoconjugates|immunoconjugates|mesh-ancestor
101758295|NCT01039441|Bupivacaine|bupivacaine|mesh-list
101758346|NCT00699998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101758347|NCT00696072|Letrozole|letrozole|mesh-list
101758348|NCT00696072|Dasatinib|dasatinib|mesh-list
101758349|NCT00696072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101758350|NCT00696072|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101758351|NCT00696072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101758352|NCT00696072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101758353|NCT00696072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758354|NCT00696072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101758355|NCT00696072|Hormone Antagonists|hormone antagonists|mesh-ancestor
101758356|NCT00696072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101758357|NCT00696072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758358|NCT00696072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101758359|NCT00816855|Docetaxel|docetaxel|mesh-list
101758360|NCT00816855|Fluorouracil|fluorouracil|mesh-list
101758361|NCT00816855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101758362|NCT00816855|Tubulin Modulators|tubulin modulators|mesh-ancestor
101758406|NCT00817011|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101758407|NCT00817011|Antidepressive Agents|antidepressive agents|mesh-ancestor
101758408|NCT00817011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101758409|NCT00817011|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101758410|NCT00817011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101758411|NCT00817011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101758412|NCT00817011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758413|NCT00817011|Dopamine Agents|dopamine agents|mesh-ancestor
101758414|NCT00817011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101758415|NCT00817011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758416|NCT00817011|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101758417|NCT00817011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101758418|NCT00817011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101758419|NCT00817011|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101758459|NCT00400153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101758460|NCT00400153|Respiratory System Agents|respiratory system agents|mesh-ancestor
101758461|NCT00400153|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101758462|NCT00400153|Cholinergic Agents|cholinergic agents|mesh-ancestor
101758463|NCT00400153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101758464|NCT00400153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758466|NCT04062890|Anticonvulsants|anticonvulsants|mesh-ancestor
101758467|NCT04062890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101758468|NCT04062890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758469|NCT04062890|GABA Agents|gaba agents|mesh-ancestor
101758470|NCT04062890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101758471|NCT04062890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758472|NCT00817245|Amoxicillin|amoxicillin|mesh-list
101758473|NCT00817245|Metronidazole|metronidazole|mesh-list
101758475|NCT00817245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101758522|NCT00694122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758523|NCT03922620|Bupivacaine|bupivacaine|mesh-list
101758524|NCT03922620|Anesthetics, Local|anesthetics, local|mesh-ancestor
101758525|NCT03922620|Anesthetics|anesthetics|mesh-ancestor
101758526|NCT03922620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101758527|NCT03922620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758528|NCT03922620|Sensory System Agents|sensory system agents|mesh-ancestor
101758529|NCT03922620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101758530|NCT00419263|Peramivir|peramivir|mesh-list
101758531|NCT00419263|Antiviral Agents|antiviral agents|mesh-ancestor
101758532|NCT00419263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101758533|NCT00419263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101758534|NCT00419263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758535|NCT01034995|Escitalopram|escitalopram|mesh-list
101758536|NCT01034995|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101758537|NCT01034995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101758538|NCT01034995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101758577|NCT02085265|Telmisartan|telmisartan|mesh-list
101758578|NCT02085265|Perindopril|perindopril|mesh-list
101758579|NCT02085265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101758580|NCT02085265|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101758581|NCT02085265|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101758582|NCT02085265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758583|NCT02085265|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101758584|NCT02085265|Protease Inhibitors|protease inhibitors|mesh-ancestor
101758585|NCT02085265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101758586|NCT00699842|Lenalidomide|lenalidomide|mesh-list
101758587|NCT00699842|Immunologic Factors|immunologic factors|mesh-ancestor
101758588|NCT00699842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758589|NCT00699842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101263674|NCT01762995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101758590|NCT00699842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101758591|NCT00699842|Growth Substances|growth substances|mesh-ancestor
101758592|NCT00699842|Growth Inhibitors|growth inhibitors|mesh-ancestor
101758593|NCT00699842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101758594|NCT00399529|Cyclophosphamide|cyclophosphamide|mesh-list
101758595|NCT00399529|Trastuzumab|trastuzumab|mesh-list
101758596|NCT00399529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101758597|NCT00399529|Immunologic Factors|immunologic factors|mesh-ancestor
101758598|NCT00399529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758628|NCT00607048|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101758629|NCT00607048|Carboplatin|carboplatin|mesh-list
101758630|NCT00607048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101758631|NCT00607048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101758632|NCT00607048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101758633|NCT00607048|Tubulin Modulators|tubulin modulators|mesh-ancestor
101758634|NCT00607048|Antimitotic Agents|antimitotic agents|mesh-ancestor
101758635|NCT00607048|Mitosis Modulators|mitosis modulators|mesh-ancestor
101758636|NCT00607048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758637|NCT00607048|Immunologic Factors|immunologic factors|mesh-ancestor
101758638|NCT00607048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758639|NCT03592576|Venetoclax|venetoclax|mesh-list
101758640|NCT03592576|Navitoclax|navitoclax|mesh-list
101758641|NCT03592576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101758642|NCT04035850|Vortioxetine|vortioxetine|mesh-list
101758643|NCT04035850|Antidepressive Agents|antidepressive agents|mesh-ancestor
101758644|NCT04035850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101758645|NCT04035850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101758683|NCT00893854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101758684|NCT00893854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758685|NCT00893854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101758686|NCT00893854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101758687|NCT00893854|Analgesics|analgesics|mesh-ancestor
101758688|NCT00893854|Sensory System Agents|sensory system agents|mesh-ancestor
101758689|NCT00893854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101758690|NCT00893854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101758691|NCT00893854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101758693|NCT00895804|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101758694|NCT00895804|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101758746|NCT00894088|Mycophenolic Acid|mycophenolic acid|mesh-list
101758747|NCT00894088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101758748|NCT00894088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101758749|NCT00894088|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101758750|NCT00894088|Antitubercular Agents|antitubercular agents|mesh-ancestor
101758751|NCT00894088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101758752|NCT00894088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101758753|NCT00894088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101416170|NCT01249690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101758754|NCT00894088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758755|NCT03818178|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101758756|NCT03818178|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101758757|NCT03818178|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101758806|NCT00410605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101758807|NCT00410605|Glucocorticoids|glucocorticoids|mesh-ancestor
101758808|NCT00410605|Hormones|hormones|mesh-ancestor
101758809|NCT00410605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101758810|NCT00410605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101758811|NCT00742638|Valproic Acid|valproic acid|mesh-list
101758812|NCT00742638|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101758813|NCT00742638|Antidepressive Agents|antidepressive agents|mesh-ancestor
101758814|NCT00742638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101758815|NCT00742638|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101758816|NCT00742638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101758825|NCT00418717|Etanercept|etanercept|mesh-list
101758871|NCT00631371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101758872|NCT00631371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101758873|NCT00631371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758874|NCT00631371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101758875|NCT00631371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101758876|NCT00631371|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101758877|NCT00631371|Antifungal Agents|antifungal agents|mesh-ancestor
101758878|NCT00409747|Minocycline|minocycline|mesh-list
101758879|NCT00409747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101758880|NCT00409747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101758881|NCT04016740|Dexmedetomidine|dexmedetomidine|mesh-list
101758882|NCT04016740|Ketamine|ketamine|mesh-list
101758883|NCT04016740|Remifentanil|remifentanil|mesh-list
101758884|NCT04016740|Propofol|propofol|mesh-list
101758885|NCT04016740|Ropivacaine|ropivacaine|mesh-list
101758886|NCT04016740|Sevoflurane|sevoflurane|mesh-list
101758887|NCT04016740|Rocuronium|rocuronium|mesh-list
101758888|NCT04016740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101758889|NCT04016740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101758890|NCT04016740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758891|NCT04016740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101758892|NCT04016740|Analgesics|analgesics|mesh-ancestor
101758893|NCT04016740|Sensory System Agents|sensory system agents|mesh-ancestor
101758894|NCT04016740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101758895|NCT04016740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101758896|NCT04016740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101758897|NCT04016740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101758920|NCT02540512|Sensory System Agents|sensory system agents|mesh-ancestor
101758921|NCT02540512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101758922|NCT02540512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758923|NCT02540512|Antipyretics|antipyretics|mesh-ancestor
101758924|NCT02540512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101758925|NCT02540512|Narcotics|narcotics|mesh-ancestor
101758926|NCT02540512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101758927|NCT02540512|Antitussive Agents|antitussive agents|mesh-ancestor
101758928|NCT02540512|Respiratory System Agents|respiratory system agents|mesh-ancestor
101758929|NCT02540512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101758930|NCT02540512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101758931|NCT02540512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101758983|NCT00397189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101758984|NCT00397189|Protective Agents|protective agents|mesh-ancestor
101758985|NCT00397189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101758986|NCT00397189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101758987|NCT00824109|Anti-Infective Agents|anti-infective agents|mesh-list
101758988|NCT00824109|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101758989|NCT01035619|Moxidectin|moxidectin|mesh-list
101758990|NCT01035619|Anthelmintics|anthelmintics|mesh-ancestor
101758991|NCT01035619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101758992|NCT01035619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101758993|NCT01035619|Antinematodal Agents|antinematodal agents|mesh-ancestor
101758994|NCT04044651|Nivolumab|nivolumab|mesh-list
101759047|NCT00820053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101759048|NCT00820053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759049|NCT00572728|Alovudine|alovudine|mesh-list
101759050|NCT00572728|Dideoxynucleosides|dideoxynucleosides|mesh-list
101759051|NCT00572728|Antiviral Agents|antiviral agents|mesh-ancestor
101759052|NCT00572728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101759053|NCT00572728|Antimetabolites|antimetabolites|mesh-ancestor
101759054|NCT00572728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759057|NCT00572728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101759114|NCT00898846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759115|NCT00898846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101759116|NCT00826371|Ranibizumab|ranibizumab|mesh-list
101759117|NCT00826371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101759118|NCT00826371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101759119|NCT00826371|Growth Substances|growth substances|mesh-ancestor
101759120|NCT00826371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759121|NCT00826371|Growth Inhibitors|growth inhibitors|mesh-ancestor
101759122|NCT00826371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101759123|NCT02540824|Apatinib|apatinib|mesh-list
101759124|NCT02540824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101759125|NCT02540824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101759126|NCT02540824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101759127|NCT02540824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416546|NCT01731236|Antimetabolites|antimetabolites|mesh-ancestor
101759128|NCT00826527|Solifenacin Succinate|solifenacin succinate|mesh-list
101759129|NCT00826527|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101759130|NCT00826527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101759131|NCT00826527|Cholinergic Agents|cholinergic agents|mesh-ancestor
101759132|NCT00826527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101759133|NCT00826527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759134|NCT00826527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759135|NCT00826527|Urological Agents|urological agents|mesh-ancestor
101759136|NCT02550717|Aspirin|aspirin|mesh-list
101759137|NCT02550717|Anticoagulants|anticoagulants|mesh-list
101759138|NCT02550717|Clopidogrel|clopidogrel|mesh-list
101759141|NCT02550717|Analgesics|analgesics|mesh-ancestor
101759160|NCT02550249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101759161|NCT02550249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101759162|NCT02550249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101759163|NCT02550249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759164|NCT00824811|Fluorometholone|fluorometholone|mesh-list
101759165|NCT00824811|Cyclosporine|cyclosporine|mesh-list
101759166|NCT00824811|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101759167|NCT00824811|Lubricant Eye Drops|lubricant eye drops|mesh-list
101759168|NCT00824811|Cyclosporins|cyclosporins|mesh-list
101759169|NCT00824811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101759170|NCT00824811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759171|NCT00824811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101759172|NCT00824811|Immunologic Factors|immunologic factors|mesh-ancestor
101759173|NCT00824811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759174|NCT00824811|Antifungal Agents|antifungal agents|mesh-ancestor
101759182|NCT00824811|Hormones|hormones|mesh-ancestor
101759220|NCT00606502|Micronutrients|micronutrients|mesh-ancestor
101759221|NCT00606502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759222|NCT00606502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101759223|NCT00606502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101759224|NCT00606502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101759225|NCT00606502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759226|NCT00606502|Hematinics|hematinics|mesh-ancestor
101759227|NCT00606502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101759228|NCT00825123|Metoprolol|metoprolol|mesh-list
101759285|NCT00605722|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101759286|NCT00605722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101759287|NCT00605722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101759288|NCT00605722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101759289|NCT00605722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101759290|NCT00605722|Growth Substances|growth substances|mesh-ancestor
101759291|NCT00605722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759352|NCT00605566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101759353|NCT00605566|Alkylating Agents|alkylating agents|mesh-ancestor
101416769|NCT00131261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101759354|NCT00605566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759355|NCT00605566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101759356|NCT00605566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101759357|NCT00605566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101759358|NCT00605566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101759359|NCT00882388|Aspirin|aspirin|mesh-list
101759360|NCT00882388|Celecoxib|celecoxib|mesh-list
101759361|NCT00882388|Clopidogrel|clopidogrel|mesh-list
101759362|NCT00882388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101759363|NCT00882388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101759411|NCT01036399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759412|NCT01036399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101759413|NCT01036399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101759414|NCT01036399|Growth Substances|growth substances|mesh-ancestor
101759415|NCT01036399|Growth Inhibitors|growth inhibitors|mesh-ancestor
101759416|NCT01036399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101759417|NCT00901654|Vaccines|vaccines|mesh-list
101759418|NCT00901654|Immunologic Factors|immunologic factors|mesh-ancestor
101759419|NCT00901654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759420|NCT00625131|Bupropion|bupropion|mesh-list
101759421|NCT00625131|Nicotine|nicotine|mesh-list
101759422|NCT00625131|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101759423|NCT00625131|Autonomic Agents|autonomic agents|mesh-ancestor
101759424|NCT00625131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101759425|NCT00625131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759426|NCT00625131|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101759427|NCT00625131|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101416861|NCT01248793|Golimumab|golimumab|mesh-list
101759467|NCT00900874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759468|NCT00900874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101759469|NCT00900874|Respiratory System Agents|respiratory system agents|mesh-ancestor
101759470|NCT00900874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101759471|NCT00900874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101759472|NCT00900874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101759474|NCT00900874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101759476|NCT00900874|Tocolytic Agents|tocolytic agents|mesh-ancestor
101759534|NCT02548533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101759535|NCT02548533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759536|NCT02548533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101759537|NCT02548533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101759538|NCT02548533|Adrenergic Agents|adrenergic agents|mesh-ancestor
101759539|NCT02548533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101759540|NCT02548533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101759541|NCT02548533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101759549|NCT02549391|Cinacalcet|cinacalcet|mesh-list
101759599|NCT00902512|Vasodilator Agents|vasodilator agents|mesh-ancestor
101759600|NCT00902512|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101759601|NCT00902512|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101759602|NCT00902512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101759603|NCT00902512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759604|NCT00902512|Urological Agents|urological agents|mesh-ancestor
101759605|NCT00827307|Tamoxifen|tamoxifen|mesh-list
101759606|NCT00827307|Goserelin|goserelin|mesh-list
101759607|NCT00827307|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101759608|NCT00827307|Hormone Antagonists|hormone antagonists|mesh-ancestor
101759609|NCT00827307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101759610|NCT00827307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759611|NCT00827307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101759612|NCT00827307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101759613|NCT00827307|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101759614|NCT00827307|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101759616|NCT00837915|Loratadine|loratadine|mesh-list
101759658|NCT00909454|Cholecalciferol|cholecalciferol|mesh-list
101759660|NCT00909454|Micronutrients|micronutrients|mesh-ancestor
101759661|NCT00909454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759662|NCT00909454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101759663|NCT00909454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101759664|NCT04035070|Clindamycin|clindamycin|mesh-list
101759665|NCT04035070|Clindamycin palmitate|clindamycin palmitate|mesh-list
101759666|NCT04035070|Clindamycin phosphate|clindamycin phosphate|mesh-list
101759667|NCT04035070|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101759668|NCT04035070|Sodium Hypochlorite|sodium hypochlorite|mesh-list
101759669|NCT04035070|Eusol|eusol|mesh-list
101759721|NCT00909688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101759722|NCT00909688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759723|NCT00909688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101759724|NCT00909688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101759726|NCT00903214|Anticonvulsants|anticonvulsants|mesh-ancestor
101759727|NCT00903214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101759728|NCT00903214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101759729|NCT00903214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101759730|NCT00903214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759731|NCT00903214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759732|NCT00903214|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101759733|NCT00903214|Protective Agents|protective agents|mesh-ancestor
101759734|NCT04034836|Parecoxib|parecoxib|mesh-list
101759735|NCT04034836|Ropivacaine|ropivacaine|mesh-list
101759736|NCT04034836|Anesthetics, Local|anesthetics, local|mesh-ancestor
101759737|NCT04034836|Anesthetics|anesthetics|mesh-ancestor
101759738|NCT04034836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101759739|NCT04034836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759777|NCT00903838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759778|NCT00903838|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101759779|NCT00903838|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101759780|NCT00903838|Dopamine Agonists|dopamine agonists|mesh-ancestor
101759781|NCT00903838|Dopamine Agents|dopamine agents|mesh-ancestor
101759782|NCT00903838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101759783|NCT00924430|Simvastatin|simvastatin|mesh-list
101759784|NCT00924430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101759785|NCT00924430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101759786|NCT00924430|Antimetabolites|antimetabolites|mesh-ancestor
101759787|NCT00924430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759788|NCT00924430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101828148|NCT05923996|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101759789|NCT00924430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101759790|NCT00924430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101759791|NCT00924586|Landiolol|landiolol|mesh-list
101759837|NCT01037101|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101759838|NCT01037101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101759839|NCT01037101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101759841|NCT01037101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101759842|NCT01037101|Antimetabolites|antimetabolites|mesh-ancestor
101759843|NCT01037101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759844|NCT00904306|Chromium|chromium|mesh-list
101759862|NCT01043341|Vaccines|vaccines|mesh-list
101759906|NCT00396565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101759907|NCT00396565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101759908|NCT00396565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759909|NCT00396565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101759910|NCT00396565|Serotonin Agents|serotonin agents|mesh-ancestor
101759911|NCT00396565|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101759912|NCT00396565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101759913|NCT00396565|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101759914|NCT00396565|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101759915|NCT00396565|Dopamine Agents|dopamine agents|mesh-ancestor
101759916|NCT00904540|Lidocaine|lidocaine|mesh-list
101759917|NCT00904540|Anesthetics, Local|anesthetics, local|mesh-ancestor
101759918|NCT00904540|Anesthetics|anesthetics|mesh-ancestor
101759919|NCT00904540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101759920|NCT00904540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759921|NCT00904540|Sensory System Agents|sensory system agents|mesh-ancestor
101759922|NCT00904540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101759923|NCT00904540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101759924|NCT00904540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101759925|NCT00904540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101759926|NCT00904540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101759927|NCT00904540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101759928|NCT00906880|Eflornithine|eflornithine|mesh-list
101759929|NCT00906880|Nifurtimox|nifurtimox|mesh-list
101759930|NCT00906880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101759931|NCT00906880|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101759932|NCT00906880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101759950|NCT00394771|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101759951|NCT00394771|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101759952|NCT00394771|Levonorgestrel|levonorgestrel|mesh-list
101759953|NCT00394771|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101759955|NCT00394771|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101759956|NCT00394771|Estrogens|estrogens|mesh-ancestor
101759957|NCT00394771|Hormones|hormones|mesh-ancestor
101759958|NCT00394771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101759959|NCT00394771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101759960|NCT00394771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101759961|NCT00394771|Contraceptive Agents|contraceptive agents|mesh-ancestor
101759962|NCT00394771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101759963|NCT00394771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101759964|NCT00394771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101759965|NCT00394771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101759967|NCT00396409|Omalizumab|omalizumab|mesh-list
101760010|NCT02710890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101760011|NCT02710890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760012|NCT00605176|Imiquimod|imiquimod|mesh-list
101760013|NCT00605176|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101760014|NCT00605176|Immunologic Factors|immunologic factors|mesh-ancestor
101760015|NCT00605176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760016|NCT00605176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101760017|NCT00605176|Interferon Inducers|interferon inducers|mesh-ancestor
101760018|NCT00743028|Navitoclax|navitoclax|mesh-list
101760019|NCT00743028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101760076|NCT00746070|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101760077|NCT00746070|Hormone Antagonists|hormone antagonists|mesh-ancestor
101760078|NCT00746070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101760079|NCT00746070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760080|NCT00746070|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101760081|NCT00746070|Diuretics|diuretics|mesh-ancestor
101760082|NCT00746070|Natriuretic Agents|natriuretic agents|mesh-ancestor
101760083|NCT00396331|Plerixafor|plerixafor|mesh-list
101760084|NCT00396331|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101760085|NCT00396331|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101760086|NCT00396331|Antiviral Agents|antiviral agents|mesh-ancestor
101760087|NCT00396331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101760088|NCT00927550|Lithium Carbonate|lithium carbonate|mesh-list
101760089|NCT00927550|Antidepressive Agents|antidepressive agents|mesh-ancestor
101760090|NCT00927550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101760091|NCT00927550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101760092|NCT00927550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760093|NCT00927550|Antimanic Agents|antimanic agents|mesh-ancestor
101760094|NCT00927550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101760098|NCT00926926|Parasympatholytics|parasympatholytics|mesh-ancestor
101760131|NCT00931450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760132|NCT00931450|Growth Inhibitors|growth inhibitors|mesh-ancestor
101760133|NCT00931450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101263695|NCT01763281|Hormones|hormones|mesh-ancestor
101760134|NCT00931450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101760135|NCT00931450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760136|NCT00931450|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101760137|NCT00931450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101760138|NCT00931450|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101760139|NCT00931450|Hormone Antagonists|hormone antagonists|mesh-ancestor
101760142|NCT00928330|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101760194|NCT00907504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101760195|NCT00907504|Antimetabolites|antimetabolites|mesh-ancestor
101760196|NCT00907504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760197|NCT00932386|Dexmedetomidine|dexmedetomidine|mesh-list
101760198|NCT00932386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101760199|NCT00932386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101760200|NCT00932386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760201|NCT00932386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101760202|NCT00932386|Analgesics|analgesics|mesh-ancestor
101760203|NCT00932386|Sensory System Agents|sensory system agents|mesh-ancestor
101760204|NCT00932386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101760205|NCT00932386|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101760206|NCT00932386|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101760207|NCT00932386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101760208|NCT00932386|Adrenergic Agents|adrenergic agents|mesh-ancestor
101760209|NCT00932386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101760210|NCT00932386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760250|NCT01043575|Antitubercular Agents|antitubercular agents|mesh-ancestor
101760251|NCT01043575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101760252|NCT01043575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101760253|NCT01043575|Leprostatic Agents|leprostatic agents|mesh-ancestor
101760254|NCT01043575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101760255|NCT01043575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101760256|NCT01043575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760257|NCT01043575|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101760258|NCT01043575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101760259|NCT01043575|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101760260|NCT01043575|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101760263|NCT01045837|Prednisolone|prednisolone|mesh-list
101760310|NCT00907972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101760311|NCT00907972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101760312|NCT03799744|Durvalumab|durvalumab|mesh-list
101760313|NCT03799744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101760314|NCT03799744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101760315|NCT00933634|Propafenone|propafenone|mesh-list
101760316|NCT00933634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101760317|NCT00933634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101760318|NCT00933634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101760319|NCT00933634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101760320|NCT00933634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760321|NCT00933790|Rifampin|rifampin|mesh-list
101760322|NCT00933790|Pyrazinamide|pyrazinamide|mesh-list
101760323|NCT00933790|Ethambutol|ethambutol|mesh-list
101760324|NCT00933790|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101760325|NCT00933790|Antitubercular Agents|antitubercular agents|mesh-ancestor
101760326|NCT00933790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101760327|NCT00933790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101760328|NCT00933790|Leprostatic Agents|leprostatic agents|mesh-ancestor
101760329|NCT00933790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101760330|NCT00933790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101760331|NCT00933790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760360|NCT00393367|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101760361|NCT00393367|Prednisolone phosphate|prednisolone phosphate|mesh-list
101760362|NCT00393367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101760363|NCT00393367|Glucocorticoids|glucocorticoids|mesh-ancestor
101760364|NCT00393367|Hormones|hormones|mesh-ancestor
101760365|NCT00393367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101760366|NCT00393367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760367|NCT00393367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101760368|NCT00393367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101760369|NCT00393367|Antiemetics|antiemetics|mesh-ancestor
101760370|NCT00393367|Autonomic Agents|autonomic agents|mesh-ancestor
101760371|NCT00393367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101760374|NCT00393367|Protective Agents|protective agents|mesh-ancestor
101760422|NCT00622869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760423|NCT00622869|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101760424|NCT00622869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101760425|NCT00622869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760426|NCT00622869|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101760427|NCT00622869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101760428|NCT00622869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101760429|NCT00366457|Bevacizumab|bevacizumab|mesh-list
101760430|NCT00366457|Gemcitabine|gemcitabine|mesh-list
101760431|NCT00366457|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101760432|NCT00366457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101760433|NCT00366457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101760434|NCT00366457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101760435|NCT00366457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101760436|NCT00366457|Growth Substances|growth substances|mesh-ancestor
101760437|NCT00366457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760438|NCT00366457|Growth Inhibitors|growth inhibitors|mesh-ancestor
101760439|NCT00366457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101760477|NCT01049425|Alkylating Agents|alkylating agents|mesh-ancestor
101760478|NCT01049425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760479|NCT01049425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101760480|NCT01049425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101760481|NCT01049425|Tubulin Modulators|tubulin modulators|mesh-ancestor
101760482|NCT01049425|Antimitotic Agents|antimitotic agents|mesh-ancestor
101760483|NCT01049425|Mitosis Modulators|mitosis modulators|mesh-ancestor
101760484|NCT01049425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101760485|NCT01049425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101760486|NCT01049425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101760487|NCT01049425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101760489|NCT00838227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101760490|NCT00838227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760491|NCT00838227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101760492|NCT00838227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101760493|NCT00838227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101760494|NCT00838227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760495|NCT00366301|Metformin|metformin|mesh-list
101760496|NCT00366301|Insulin Glargine|insulin glargine|mesh-list
101760497|NCT00366301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101760498|NCT00366301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760499|NCT00838305|Citalopram|citalopram|mesh-list
101760500|NCT00838305|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101760501|NCT00838305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101760502|NCT00838305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101760503|NCT00838305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760504|NCT00838305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101760505|NCT00838305|Serotonin Agents|serotonin agents|mesh-ancestor
101760506|NCT00838305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760507|NCT00838305|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101760516|NCT00622713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760517|NCT00622713|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101760518|NCT00622713|Protective Agents|protective agents|mesh-ancestor
101760519|NCT01046227|Vaccines|vaccines|mesh-list
101760520|NCT01046227|Immunologic Factors|immunologic factors|mesh-ancestor
101760521|NCT01046227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760522|NCT00392197|Aripiprazole|aripiprazole|mesh-list
101760523|NCT00392197|Antidepressive Agents|antidepressive agents|mesh-ancestor
101760524|NCT00392197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101760525|NCT00392197|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101760526|NCT00392197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101760527|NCT00392197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101760528|NCT00392197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760529|NCT00392197|Dopamine Agonists|dopamine agonists|mesh-ancestor
101760530|NCT00392197|Dopamine Agents|dopamine agents|mesh-ancestor
101760531|NCT00392197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101760532|NCT00392197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760533|NCT00392197|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101760534|NCT00392197|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101760535|NCT00392197|Serotonin Agents|serotonin agents|mesh-ancestor
101760536|NCT00392197|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101760537|NCT00392197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101760538|NCT00392197|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101760539|NCT00392197|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101760540|NCT00391807|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101760541|NCT00391807|Norethindrone|norethindrone|mesh-list
101760542|NCT00391807|Norethindrone Acetate|norethindrone acetate|mesh-list
101760544|NCT00391807|Estrogens|estrogens|mesh-ancestor
101760545|NCT00391807|Hormones|hormones|mesh-ancestor
101760546|NCT00391807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101760547|NCT00391807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760555|NCT00624585|Dasatinib|dasatinib|mesh-list
101760559|NCT00624585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760561|NCT01046383|Chelating Agents|chelating agents|mesh-ancestor
101760562|NCT01046383|Sequestering Agents|sequestering agents|mesh-ancestor
101760563|NCT01046383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760564|NCT00831597|Rituximab|rituximab|mesh-list
101760565|NCT00831597|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101760566|NCT00831597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101760567|NCT00831597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101760568|NCT00831597|Immunologic Factors|immunologic factors|mesh-ancestor
101760569|NCT00831597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760570|NCT00831597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101760571|NCT00831597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101760572|NCT00831597|Alkylating Agents|alkylating agents|mesh-ancestor
101760574|NCT00622635|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101760618|NCT00828087|Trace Elements|trace elements|mesh-ancestor
101760619|NCT00828087|Micronutrients|micronutrients|mesh-ancestor
101760620|NCT00839085|Ascorbic Acid|ascorbic acid|mesh-list
101760621|NCT00839085|Grape Seed Extract|grape seed extract|mesh-list
101760622|NCT00839085|Antioxidants|antioxidants|mesh-ancestor
101760623|NCT00839085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760624|NCT00839085|Protective Agents|protective agents|mesh-ancestor
101760625|NCT00839085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760626|NCT00839085|Vitamins|vitamins|mesh-ancestor
101760627|NCT00839085|Micronutrients|micronutrients|mesh-ancestor
101760628|NCT00839085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101760629|NCT00839085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101760630|NCT00839163|Vitamin K|vitamin k|mesh-list
101760631|NCT00839163|Enoxaparin|enoxaparin|mesh-list
101760632|NCT00839163|Rivaroxaban|rivaroxaban|mesh-list
101760633|NCT00839163|Vitamins|vitamins|mesh-ancestor
101760634|NCT00839163|Micronutrients|micronutrients|mesh-ancestor
101760635|NCT00839163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760636|NCT00839163|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101760637|NCT00839163|Antithrombins|antithrombins|mesh-ancestor
101760638|NCT00839163|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101760639|NCT00839163|Protease Inhibitors|protease inhibitors|mesh-ancestor
101760640|NCT00839163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101760641|NCT00839163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760642|NCT00839163|Anticoagulants|anticoagulants|mesh-ancestor
101760643|NCT00839163|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101760644|NCT00839163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101760645|NCT00839163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101760646|NCT00839163|Hemostatics|hemostatics|mesh-ancestor
101760647|NCT00839163|Coagulants|coagulants|mesh-ancestor
101760648|NCT02549001|Amorolfine|amorolfine|mesh-list
101760651|NCT00621543|Copper|copper|mesh-list
101760666|NCT00623805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101760667|NCT00623805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101760668|NCT00623805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101760669|NCT00623805|Growth Substances|growth substances|mesh-ancestor
101760670|NCT00623805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760671|NCT00623805|Growth Inhibitors|growth inhibitors|mesh-ancestor
101760672|NCT00623805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101760673|NCT00623805|Antimetabolites|antimetabolites|mesh-ancestor
101760674|NCT00623805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760675|NCT02548923|Dexmedetomidine|dexmedetomidine|mesh-list
101760677|NCT02548923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101760678|NCT02548923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101760679|NCT02548923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760680|NCT02548923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101760681|NCT02548923|Analgesics|analgesics|mesh-ancestor
101760682|NCT02548923|Sensory System Agents|sensory system agents|mesh-ancestor
101760683|NCT02548923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101760684|NCT02548923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101760685|NCT02548923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101760717|NCT00839397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101760720|NCT00828477|Bromfenac|bromfenac|mesh-list
101760721|NCT00828477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101760722|NCT00828477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101760723|NCT00828477|Analgesics|analgesics|mesh-ancestor
101760724|NCT00828477|Sensory System Agents|sensory system agents|mesh-ancestor
101760725|NCT00828477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101760726|NCT00828477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760727|NCT00828477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101760728|NCT00828477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101760729|NCT00621309|Rifampin|rifampin|mesh-list
101760730|NCT00621309|Rifamycins|rifamycins|mesh-list
101760731|NCT00621309|Sulforaphane|sulforaphane|mesh-list
101760732|NCT00621309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101760733|NCT00621309|Antitubercular Agents|antitubercular agents|mesh-ancestor
101760734|NCT00621309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101760777|NCT00691938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101760778|NCT00691938|Antimetabolites|antimetabolites|mesh-ancestor
101760779|NCT00691938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760780|NCT00691938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101760781|NCT00691938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101760782|NCT00691938|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101760783|NCT00365365|Cyclophosphamide|cyclophosphamide|mesh-list
101760784|NCT00365365|Bevacizumab|bevacizumab|mesh-list
101760785|NCT00365365|Carboplatin|carboplatin|mesh-list
101760786|NCT00365365|Docetaxel|docetaxel|mesh-list
101760787|NCT00365365|Doxorubicin|doxorubicin|mesh-list
101760788|NCT00365365|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101760789|NCT00365365|Trastuzumab|trastuzumab|mesh-list
101760790|NCT00365365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101760791|NCT00365365|Immunologic Factors|immunologic factors|mesh-ancestor
101760792|NCT00365365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760793|NCT00365365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101760811|NCT01046461|Dexamethasone|dexamethasone|mesh-list
101760835|NCT01046539|Narcotics|narcotics|mesh-ancestor
101760836|NCT01046539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101760837|NCT01046539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760838|NCT01046539|Analgesics|analgesics|mesh-ancestor
101760839|NCT01046539|Sensory System Agents|sensory system agents|mesh-ancestor
101760840|NCT01046539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101760841|NCT01046539|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101760842|NCT01044199|Vaccines|vaccines|mesh-list
101760843|NCT01044199|Immunologic Factors|immunologic factors|mesh-ancestor
101760844|NCT01044199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760845|NCT00828789|Tenofovir|tenofovir|mesh-list
101760846|NCT00828789|Efavirenz|efavirenz|mesh-list
101760847|NCT00828789|Antiviral Agents|antiviral agents|mesh-ancestor
101760848|NCT00828789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101760849|NCT00828789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101760850|NCT00828789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101760851|NCT00828789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101760852|NCT00828789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760853|NCT00828789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101760854|NCT00828789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101760890|NCT00934258|Fenofibrate|fenofibrate|mesh-list
101760891|NCT00934258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101760892|NCT00934258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101760893|NCT00934258|Antimetabolites|antimetabolites|mesh-ancestor
101760894|NCT00934258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101760895|NCT00934258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101760896|NCT00934258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101760897|NCT00934258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101760898|NCT00372697|Octreotide|octreotide|mesh-list
101760899|NCT00372697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101760902|NCT00934414|Insulin|insulin|mesh-list
101760955|NCT00937144|Urological Agents|urological agents|mesh-ancestor
101760956|NCT00937300|Cyclophosphamide|cyclophosphamide|mesh-list
101760957|NCT00937300|Fludarabine|fludarabine|mesh-list
101760958|NCT00937300|Fludarabine phosphate|fludarabine phosphate|mesh-list
101760959|NCT00937300|Interleukin-2|interleukin-2|mesh-list
101760960|NCT00937300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101760961|NCT00937300|Immunologic Factors|immunologic factors|mesh-ancestor
101760962|NCT00937300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101760963|NCT00937300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101760965|NCT00937300|Alkylating Agents|alkylating agents|mesh-ancestor
101761024|NCT00935194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101761025|NCT00935194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101761026|NCT00935194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761027|NCT00690378|Imipenem|imipenem|mesh-list
101761028|NCT00690378|Ceftazidime|ceftazidime|mesh-list
101761029|NCT00690378|Avibactam|avibactam|mesh-list
101761030|NCT00690378|Cilastatin|cilastatin|mesh-list
101761031|NCT00690378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101761032|NCT00690378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101761033|NCT00690378|Protease Inhibitors|protease inhibitors|mesh-ancestor
101761034|NCT00690378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101761035|NCT00690378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761036|NCT00690378|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101761037|NCT00574275|Gemcitabine|gemcitabine|mesh-list
101761038|NCT00574275|Aflibercept|aflibercept|mesh-list
101761039|NCT00574275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101761040|NCT00574275|Antimetabolites|antimetabolites|mesh-ancestor
101761041|NCT00574275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761042|NCT00574275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101761080|NCT00935506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101761081|NCT00935506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761082|NCT00935506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101761083|NCT00935506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101761084|NCT00935506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101761085|NCT00935506|Antipyretics|antipyretics|mesh-ancestor
101761086|NCT00935506|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101761087|NCT00935506|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101761088|NCT00935506|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101761089|NCT00935506|Purinergic Agents|purinergic agents|mesh-ancestor
101761090|NCT00935506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101761091|NCT00833157|Ibuprofen|ibuprofen|mesh-list
101761092|NCT00833157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101761093|NCT00833157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101761094|NCT00833157|Analgesics|analgesics|mesh-ancestor
101761095|NCT00833157|Sensory System Agents|sensory system agents|mesh-ancestor
101761096|NCT00833157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101761097|NCT00833157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761098|NCT00833157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101761133|NCT00829257|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101761134|NCT00829257|Glucocorticoids|glucocorticoids|mesh-ancestor
101761135|NCT00829257|Hormones|hormones|mesh-ancestor
101761136|NCT00829257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101761137|NCT00829257|Sympathomimetics|sympathomimetics|mesh-ancestor
101761138|NCT03978832|Risperidone|risperidone|mesh-list
101761139|NCT03978832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101761140|NCT03978832|Serotonin Agents|serotonin agents|mesh-ancestor
101761141|NCT03978832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101761200|NCT00691704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101761201|NCT00691704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761202|NCT00691704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101761203|NCT00691704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101761204|NCT00691704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761205|NCT00691704|Immunologic Factors|immunologic factors|mesh-ancestor
101761206|NCT00691704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101761207|NCT00691704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101761208|NCT00691704|Growth Substances|growth substances|mesh-ancestor
101761209|NCT00691704|Growth Inhibitors|growth inhibitors|mesh-ancestor
101761210|NCT00691704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101761211|NCT00691704|Alkylating Agents|alkylating agents|mesh-ancestor
101761259|NCT02548611|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101761260|NCT02548611|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101761261|NCT02548611|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101761262|NCT02548611|Purinergic Agents|purinergic agents|mesh-ancestor
101761263|NCT02548611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101761264|NCT02548611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761265|NCT02548611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761266|NCT00937924|Diphenhydramine|diphenhydramine|mesh-list
101761267|NCT00937924|Promethazine|promethazine|mesh-list
101761268|NCT00937924|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101761269|NCT00937924|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101828149|NCT05923996|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101761270|NCT00937924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101761271|NCT00937924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761272|NCT00937924|Anesthetics, Local|anesthetics, local|mesh-ancestor
101761287|NCT00743886|Mitogens|mitogens|mesh-list
101761320|NCT00743964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101761321|NCT00743964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101761322|NCT00743964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101761323|NCT00830349|Risperidone|risperidone|mesh-list
101761324|NCT00830349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101761325|NCT00830349|Serotonin Agents|serotonin agents|mesh-ancestor
101761326|NCT00830349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101761327|NCT00830349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761328|NCT00830349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761329|NCT00830349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101761330|NCT00830349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101761331|NCT00830349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101761332|NCT00830349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101761333|NCT00830349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101761380|NCT02563782|Tacrolimus|tacrolimus|mesh-list
101761381|NCT02563782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101761382|NCT02563782|Immunologic Factors|immunologic factors|mesh-ancestor
101761383|NCT02563782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761384|NCT02563782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101761385|NCT02563782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101761386|NCT02563782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761387|NCT02563782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101761394|NCT00841191|Siltuximab|siltuximab|mesh-list
101761447|NCT00744354|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101761448|NCT00744354|Bortezomib|bortezomib|mesh-list
101761449|NCT00744354|Vorinostat|vorinostat|mesh-list
101761450|NCT00744354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101761451|NCT00744354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101761452|NCT00744354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101761453|NCT00744354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101761454|NCT00744354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101761455|NCT00744354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761456|NCT00744354|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101761457|NCT04043325|Antibodies|antibodies|mesh-list
101761508|NCT00742092|Antiviral Agents|antiviral agents|mesh-ancestor
101761509|NCT00742092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101761510|NCT00742092|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101761511|NCT00742092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101761512|NCT00742092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761514|NCT00841581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101761515|NCT00841581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101761516|NCT00841581|Growth Substances|growth substances|mesh-ancestor
101761517|NCT00841581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761518|NCT00841581|Growth Inhibitors|growth inhibitors|mesh-ancestor
101761519|NCT00841581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101761520|NCT00742248|Formoterol Fumarate|formoterol fumarate|mesh-list
101761521|NCT00742248|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101761523|NCT00742248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101761524|NCT00742248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761525|NCT00742248|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101761528|NCT00742248|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101761564|NCT00574119|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101761565|NCT00574119|Diuretics|diuretics|mesh-ancestor
101761566|NCT00574119|Natriuretic Agents|natriuretic agents|mesh-ancestor
101761567|NCT00705614|Infliximab|infliximab|mesh-list
101761568|NCT00705614|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101761569|NCT00705614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101761570|NCT00705614|Dermatologic Agents|dermatologic agents|mesh-ancestor
101761571|NCT00705614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101761572|NCT00705614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101761573|NCT00844155|Oseltamivir|oseltamivir|mesh-list
101761574|NCT00844155|Antiviral Agents|antiviral agents|mesh-ancestor
101761575|NCT00844155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101761576|NCT00844155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101761577|NCT00844155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761578|NCT05669924|Methylphenidate|methylphenidate|mesh-list
101761579|NCT05669924|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101761580|NCT05669924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761581|NCT05669924|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101761582|NCT05669924|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101761583|NCT05669924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101761584|NCT05669924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761585|NCT05669924|Dopamine Agents|dopamine agents|mesh-ancestor
101761586|NCT05669924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101761588|NCT00844233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101761589|NCT00844233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101761590|NCT00844233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101761591|NCT00844233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761593|NCT00841893|Mechlorethamine|mechlorethamine|mesh-list
101761610|NCT02547597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761611|NCT02547597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761612|NCT02547597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101761613|NCT02547597|Antioxidants|antioxidants|mesh-ancestor
101761614|NCT02547597|Protective Agents|protective agents|mesh-ancestor
101761615|NCT02547597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101761616|NCT02547597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101761617|NCT02547597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101761618|NCT02547597|Vasodilator Agents|vasodilator agents|mesh-ancestor
101761619|NCT02547597|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101761620|NCT02547597|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101761621|NCT02547597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101761622|NCT02547597|Sympatholytics|sympatholytics|mesh-ancestor
101761623|NCT02547597|Autonomic Agents|autonomic agents|mesh-ancestor
101761624|NCT02547597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101761635|NCT00835965|Dexamethasone|dexamethasone|mesh-list
101761668|NCT00738296|Pravastatin|pravastatin|mesh-list
101761669|NCT00738296|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101761670|NCT00738296|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101761671|NCT00738296|Antimetabolites|antimetabolites|mesh-ancestor
101761672|NCT00738296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761673|NCT00738296|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101761674|NCT00738296|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101761675|NCT00738296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101761733|NCT00842595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101761734|NCT00842595|Immunologic Factors|immunologic factors|mesh-ancestor
101761735|NCT00842595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761736|NCT00842595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101761738|NCT00842595|Glucocorticoids|glucocorticoids|mesh-ancestor
101761740|NCT00842595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101761741|NCT00842595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101761742|NCT00842595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101761743|NCT00842595|Tubulin Modulators|tubulin modulators|mesh-ancestor
101761744|NCT00842595|Antimitotic Agents|antimitotic agents|mesh-ancestor
101761796|NCT04013386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101761797|NCT04013386|Serotonin Agents|serotonin agents|mesh-ancestor
101761798|NCT04013386|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101761799|NCT00940420|Ribavirin|ribavirin|mesh-list
101761800|NCT00940420|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101761801|NCT00940420|Interferon-alpha|interferon-alpha|mesh-list
101761802|NCT00940420|Antimetabolites|antimetabolites|mesh-ancestor
101761803|NCT00940420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419238|NCT04511416|Metformin|metformin|mesh-list
101761804|NCT00940420|Antiviral Agents|antiviral agents|mesh-ancestor
101761805|NCT00940420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101761806|NCT00940420|Immunologic Factors|immunologic factors|mesh-ancestor
101761807|NCT00940420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761857|NCT00939718|Hydroxocobalamin|hydroxocobalamin|mesh-list
101761859|NCT00939718|Micronutrients|micronutrients|mesh-ancestor
101761860|NCT00939718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761861|NCT00939718|Vitamin B Complex|vitamin b complex|mesh-ancestor
101761862|NCT00939718|Hematinics|hematinics|mesh-ancestor
101761863|NCT00836667|Sertraline|sertraline|mesh-list
101761864|NCT00836667|Antidepressive Agents|antidepressive agents|mesh-ancestor
101761865|NCT00836667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101761866|NCT00836667|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101761867|NCT00836667|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101761868|NCT00836667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101761869|NCT00836667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761870|NCT00836667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101761871|NCT00836667|Serotonin Agents|serotonin agents|mesh-ancestor
101761872|NCT00836667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101761915|NCT00372619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101761916|NCT00372619|Antiviral Agents|antiviral agents|mesh-ancestor
101761917|NCT00372619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101761918|NCT00851175|Caffeine|caffeine|mesh-list
101761919|NCT00851175|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101761920|NCT00851175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101761921|NCT00851175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101761922|NCT00851175|Antimetabolites|antimetabolites|mesh-ancestor
101761923|NCT00851175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761924|NCT00851175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101761979|NCT02546349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101761980|NCT02546349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101761981|NCT02546349|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101761982|NCT02546349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101761983|NCT02546349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101761984|NCT02546349|Adrenergic Agents|adrenergic agents|mesh-ancestor
101761985|NCT02546349|Glucocorticoids|glucocorticoids|mesh-ancestor
101761986|NCT02546349|Hormones|hormones|mesh-ancestor
101761987|NCT02546349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101761988|NCT02546349|Sympathomimetics|sympathomimetics|mesh-ancestor
101761989|NCT00851487|Amoxicillin|amoxicillin|mesh-list
101761990|NCT00851487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101761991|NCT00851487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101761992|NCT00372385|Interferons|interferons|mesh-list
101761993|NCT00372385|Ribavirin|ribavirin|mesh-list
101762041|NCT00562120|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101762042|NCT00562120|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101762043|NCT00562120|Histamine Antagonists|histamine antagonists|mesh-ancestor
101762044|NCT00562120|Histamine Agents|histamine agents|mesh-ancestor
101762045|NCT00562120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101762046|NCT00562120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762047|NCT00562120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762048|NCT00561730|Pantoprazole|pantoprazole|mesh-list
101762049|NCT00561730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101762050|NCT00561730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101762051|NCT00561730|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101762052|NCT00561730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101762053|NCT00561730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762054|NCT00697112|Sirolimus|sirolimus|mesh-list
101762055|NCT00697112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101762056|NCT00697112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101762057|NCT00697112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101762058|NCT00697112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101762059|NCT00697112|Antifungal Agents|antifungal agents|mesh-ancestor
101762060|NCT00697112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101762061|NCT00697112|Immunologic Factors|immunologic factors|mesh-ancestor
101762062|NCT00697112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762063|NCT00621855|Dabigatran|dabigatran|mesh-list
101762064|NCT00621855|Antithrombins|antithrombins|mesh-ancestor
101762070|NCT00851565|Infliximab|infliximab|mesh-list
101762090|NCT00561574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101762091|NCT00561574|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101762092|NCT00561574|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101762093|NCT00561574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101762095|NCT00561574|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101762096|NCT00561574|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101762097|NCT00561574|Serotonin Agents|serotonin agents|mesh-ancestor
101762098|NCT00561574|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101762099|NCT00619827|Immunomodulating Agents|immunomodulating agents|mesh-list
101762100|NCT00619827|Immunologic Factors|immunologic factors|mesh-ancestor
101762101|NCT00619827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762102|NCT00687804|Ranibizumab|ranibizumab|mesh-list
101762103|NCT00687804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101762104|NCT00687804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101762105|NCT00687804|Growth Substances|growth substances|mesh-ancestor
101762107|NCT00687804|Growth Inhibitors|growth inhibitors|mesh-ancestor
101762108|NCT00687804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101762109|NCT02563704|Artesunate|artesunate|mesh-list
101762110|NCT02563704|Quinine|quinine|mesh-list
101762111|NCT02563704|Antimalarials|antimalarials|mesh-ancestor
101762112|NCT02563704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101762113|NCT02563704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101762114|NCT02563704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101762115|NCT02563704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101762116|NCT02563704|Antiviral Agents|antiviral agents|mesh-ancestor
101762117|NCT02563704|Schistosomicides|schistosomicides|mesh-ancestor
101762118|NCT02563704|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101762119|NCT02563704|Anthelmintics|anthelmintics|mesh-ancestor
101762120|NCT02563704|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101762121|NCT02563704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762122|NCT02563704|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101762123|NCT02563704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101762125|NCT02563704|Analgesics|analgesics|mesh-ancestor
101762147|NCT00742404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762148|NCT00742404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101762192|NCT00848679|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101762193|NCT00848679|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101762194|NCT00848679|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101762195|NCT00848679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101762196|NCT00848679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762197|NCT04012606|Carboplatin|carboplatin|mesh-list
101762198|NCT04012606|Etoposide|etoposide|mesh-list
101762199|NCT04012606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101762200|NCT04012606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101762201|NCT04012606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101762202|NCT04012606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101762203|NCT04012606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101762252|NCT04012450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762254|NCT00945022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101352166|NCT00038844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101762255|NCT00945022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762256|NCT02565212|Montelukast|montelukast|mesh-list
101762257|NCT02565212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101762258|NCT02565212|Respiratory System Agents|respiratory system agents|mesh-ancestor
101762259|NCT02565212|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101762260|NCT02565212|Hormone Antagonists|hormone antagonists|mesh-ancestor
101762262|NCT02565212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762316|NCT00945178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101762317|NCT00945178|Gout Suppressants|gout suppressants|mesh-ancestor
101762318|NCT00945178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101762319|NCT00945178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101762320|NCT00945178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762321|NCT00749346|Pemetrexed|pemetrexed|mesh-list
101762322|NCT00749346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101762323|NCT00749346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101762324|NCT00749346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762325|NCT00749346|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101762326|NCT00749346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101762327|NCT02562690|Thrombin|thrombin|mesh-list
101762328|NCT02562690|Hemostatics|hemostatics|mesh-ancestor
101419754|NCT04514731|Tocolytic Agents|tocolytic agents|mesh-ancestor
101762330|NCT00576758|Rituximab|rituximab|mesh-list
101762331|NCT00576758|Obinutuzumab|obinutuzumab|mesh-list
101762332|NCT00576758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101762333|NCT00576758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101762334|NCT00576758|Immunologic Factors|immunologic factors|mesh-ancestor
101762335|NCT00576758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762336|NCT00576758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101762337|NCT00923676|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101762338|NCT00923676|Fenofibrate|fenofibrate|mesh-list
101762339|NCT00923676|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101762367|NCT00560794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101762368|NCT00560794|Immunologic Factors|immunologic factors|mesh-ancestor
101762369|NCT00560794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762370|NCT00749736|Cholecalciferol|cholecalciferol|mesh-list
101762371|NCT00749736|Vitamin D|vitamin d|mesh-list
101762372|NCT00749736|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
101762373|NCT00749736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101762374|NCT00749736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762375|NCT00749736|Vitamins|vitamins|mesh-ancestor
101762376|NCT00749736|Micronutrients|micronutrients|mesh-ancestor
101762377|NCT00749736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101762378|NCT00950404|Sildenafil Citrate|sildenafil citrate|mesh-list
101762379|NCT00950404|Vasodilator Agents|vasodilator agents|mesh-ancestor
101762380|NCT00950404|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101762381|NCT00950404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101762382|NCT00950404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101762383|NCT00950404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762384|NCT00950404|Urological Agents|urological agents|mesh-ancestor
101762423|NCT00848991|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101762424|NCT00848991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101762425|NCT00848991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762426|NCT00848991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101762427|NCT00848991|Anesthetics, General|anesthetics, general|mesh-ancestor
101762428|NCT00848991|Anesthetics|anesthetics|mesh-ancestor
101762429|NCT00848991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101762430|NCT00848991|Analgesics|analgesics|mesh-ancestor
101762431|NCT00848991|Sensory System Agents|sensory system agents|mesh-ancestor
101762488|NCT05301010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762489|NCT05301010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101762490|NCT00855699|Acamprosate|acamprosate|mesh-list
101762491|NCT00855699|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101762492|NCT00855777|Ibuprofen|ibuprofen|mesh-list
101762493|NCT00855777|Etoricoxib|etoricoxib|mesh-list
101762494|NCT00855777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101762495|NCT00855777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101762496|NCT00855777|Analgesics|analgesics|mesh-ancestor
101762497|NCT00855777|Sensory System Agents|sensory system agents|mesh-ancestor
101762498|NCT00855777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101762499|NCT00855777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762500|NCT00855777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101762501|NCT00855777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101762502|NCT00855777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101762503|NCT00855777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101762504|NCT00855777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762505|NCT00855777|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101762539|NCT00852423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101762540|NCT00852423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101762541|NCT00852423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101762542|NCT00852423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101762543|NCT00852423|Antiviral Agents|antiviral agents|mesh-ancestor
101762544|NCT00852423|Schistosomicides|schistosomicides|mesh-ancestor
101762545|NCT00852423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101762546|NCT00852423|Anthelmintics|anthelmintics|mesh-ancestor
101762547|NCT00941824|Mycophenolic Acid|mycophenolic acid|mesh-list
101762548|NCT00941824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101762559|NCT00849537|Hormones|hormones|mesh-ancestor
101762607|NCT00688740|Fluorouracil|fluorouracil|mesh-list
101762608|NCT00688740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101762609|NCT00688740|Immunologic Factors|immunologic factors|mesh-ancestor
101762610|NCT00688740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762611|NCT00688740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101762612|NCT00688740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101762613|NCT00688740|Alkylating Agents|alkylating agents|mesh-ancestor
101762614|NCT00688740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762615|NCT00688740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101762616|NCT00688740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101762626|NCT05323058|Benzydamine|benzydamine|mesh-list
101762673|NCT00850161|Insulin Aspart|insulin aspart|mesh-list
101762674|NCT00850161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101762675|NCT00850161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762676|NCT00951574|Nadroparin|nadroparin|mesh-list
101762677|NCT00951574|Calcium|calcium|mesh-list
101762678|NCT00951574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101762679|NCT00951574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762680|NCT00951574|Anticoagulants|anticoagulants|mesh-ancestor
101762681|NCT00951574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101762682|NCT00951574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101762683|NCT00951574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762684|NCT00686790|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101762685|NCT00686790|Interferon-alpha|interferon-alpha|mesh-list
101762686|NCT00686790|Antiviral Agents|antiviral agents|mesh-ancestor
101762688|NCT00686790|Immunologic Factors|immunologic factors|mesh-ancestor
101762732|NCT00942526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101762733|NCT00942526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762734|NCT03967444|Hyaluronic Acid|hyaluronic acid|mesh-list
101762735|NCT03967444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101762736|NCT03967444|Immunologic Factors|immunologic factors|mesh-ancestor
101762737|NCT03967444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762738|NCT03967444|Viscosupplements|viscosupplements|mesh-ancestor
101352200|NCT00038922|Oprelvekin|oprelvekin|mesh-list
101762739|NCT03967444|Protective Agents|protective agents|mesh-ancestor
101762740|NCT05300854|Anesthetics|anesthetics|mesh-list
101762741|NCT05300854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101762742|NCT05300854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101762743|NCT00946504|Glipizide|glipizide|mesh-list
101762744|NCT00946504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101762746|NCT00619983|Gabapentin|gabapentin|mesh-list
101762794|NCT00750048|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101762795|NCT00942838|Cisplatin|cisplatin|mesh-list
101762796|NCT00942838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101762797|NCT04057014|Amoxicillin|amoxicillin|mesh-list
101762798|NCT04057014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101762799|NCT04057014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101762800|NCT00364351|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101762801|NCT00364351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101762802|NCT00364351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101762803|NCT00364351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101762804|NCT00364351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762805|NCT05279872|Zanubrutinib|zanubrutinib|mesh-list
101762806|NCT05279872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101762807|NCT05279872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101762853|NCT00943228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101762854|NCT00943228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101762855|NCT00943228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101762857|NCT00755898|Amantadine|amantadine|mesh-list
101762924|NCT00854451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101762925|NCT00854451|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101762927|NCT00854451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101762928|NCT00854529|Bevacizumab|bevacizumab|mesh-list
101762929|NCT00854529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101762995|NCT00943930|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101762996|NCT00943930|Hallucinogens|hallucinogens|mesh-ancestor
101762997|NCT00943930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101763068|NCT04280536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763069|NCT04280536|Antiviral Agents|antiviral agents|mesh-ancestor
101763070|NCT04280536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101763071|NCT00944242|Sertraline|sertraline|mesh-list
101763072|NCT00944242|Antidepressive Agents|antidepressive agents|mesh-ancestor
101763073|NCT00944242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101763074|NCT00944242|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101763075|NCT00944242|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101763076|NCT00944242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101763077|NCT00944242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763078|NCT00944242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101763079|NCT00944242|Serotonin Agents|serotonin agents|mesh-ancestor
101763081|NCT00363649|Interferons|interferons|mesh-list
101763131|NCT00944398|Trace Elements|trace elements|mesh-ancestor
101763132|NCT00944398|Astringents|astringents|mesh-ancestor
101763133|NCT00944398|Dermatologic Agents|dermatologic agents|mesh-ancestor
101763134|NCT00855387|Pancrelipase|pancrelipase|mesh-list
101763135|NCT00855387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101763137|NCT00947596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101763199|NCT04054128|Calcium heparin|calcium heparin|mesh-list
101763200|NCT04054128|Anticoagulants|anticoagulants|mesh-ancestor
101763201|NCT04054128|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101763202|NCT04054128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101763203|NCT04054128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763204|NCT00865215|Propranolol|propranolol|mesh-list
101763205|NCT00865215|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101763266|NCT00618813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101763267|NCT00618813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101763268|NCT00618813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101763269|NCT00618813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101763270|NCT00618813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101763271|NCT00618813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101763272|NCT00618813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101763273|NCT00618813|Tubulin Modulators|tubulin modulators|mesh-ancestor
101763274|NCT00618813|Antimitotic Agents|antimitotic agents|mesh-ancestor
101763275|NCT00618813|Mitosis Modulators|mitosis modulators|mesh-ancestor
101763334|NCT00865605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101763335|NCT00865605|Glucocorticoids|glucocorticoids|mesh-ancestor
101763336|NCT00865605|Hormones|hormones|mesh-ancestor
101763337|NCT00865605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101763338|NCT00865605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763339|NCT00956644|Amlodipine|amlodipine|mesh-list
101763340|NCT00956644|Irbesartan|irbesartan|mesh-list
101763341|NCT00956644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101763342|NCT00956644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101763343|NCT00956644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101763347|NCT00956644|Vasodilator Agents|vasodilator agents|mesh-ancestor
101763398|NCT00696410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763399|NCT00683904|Carboplatin|carboplatin|mesh-list
101763400|NCT00683904|Epothilones|epothilones|mesh-list
101763401|NCT00683904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101763402|NCT00683904|Tubulin Modulators|tubulin modulators|mesh-ancestor
101763403|NCT00683904|Antimitotic Agents|antimitotic agents|mesh-ancestor
101763404|NCT00683904|Mitosis Modulators|mitosis modulators|mesh-ancestor
101763405|NCT00683904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763406|NCT00862329|Caseins|caseins|mesh-list
101763407|NCT00862329|Chelating Agents|chelating agents|mesh-ancestor
101763408|NCT00862329|Sequestering Agents|sequestering agents|mesh-ancestor
101763409|NCT00862329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763410|NCT00866073|Decitabine|decitabine|mesh-list
101763411|NCT00866073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101420880|NCT00508690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101763458|NCT00948220|Ribavirin|ribavirin|mesh-list
101763459|NCT00948220|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101763460|NCT00948220|Antimetabolites|antimetabolites|mesh-ancestor
101763461|NCT00948220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763462|NCT00948220|Antiviral Agents|antiviral agents|mesh-ancestor
101763463|NCT00948220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101763464|NCT00756990|Naltrexone|naltrexone|mesh-list
101763465|NCT00756990|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101763466|NCT00756990|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101763467|NCT00756990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763468|NCT00756990|Sensory System Agents|sensory system agents|mesh-ancestor
101763469|NCT00756990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101763470|NCT00957346|Misoprostol|misoprostol|mesh-list
101763471|NCT00957346|Mifepristone|mifepristone|mesh-list
101763472|NCT00957346|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101763473|NCT00957346|Abortifacient Agents|abortifacient agents|mesh-ancestor
101763474|NCT00957346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101763515|NCT00751374|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101763516|NCT00751374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101763517|NCT00751374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763518|NCT00954304|Loperamide|loperamide|mesh-list
101763519|NCT00954304|Antidiarrheals|antidiarrheals|mesh-list
101763520|NCT00954304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101763521|NCT00363415|Carboplatin|carboplatin|mesh-list
101763522|NCT00363415|Etoposide|etoposide|mesh-list
101763523|NCT00363415|Pemetrexed|pemetrexed|mesh-list
101763524|NCT00363415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101763525|NCT00363415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101763526|NCT00363415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101763527|NCT00363415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101763528|NCT00363415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101763529|NCT00363415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763530|NCT00363415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101763576|NCT00757458|Edetic Acid|edetic acid|mesh-list
101763577|NCT00757458|Pentetic Acid|pentetic acid|mesh-list
101763578|NCT00757458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101763579|NCT00757458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101763583|NCT00757458|Anesthetics|anesthetics|mesh-ancestor
101763649|NCT00695864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763650|NCT00695864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101763651|NCT00695864|Antipruritics|antipruritics|mesh-ancestor
101763652|NCT00695864|Dermatologic Agents|dermatologic agents|mesh-ancestor
101763653|NCT00695864|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101763654|NCT00695864|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101763719|NCT00387127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101763720|NCT00387127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763721|NCT00683592|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
101763722|NCT00683592|Antidepressive Agents|antidepressive agents|mesh-ancestor
101763723|NCT00683592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101763724|NCT00683592|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101763725|NCT00683592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101763726|NCT00683592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101763727|NCT00683592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763728|NCT00683592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101763729|NCT00683592|Serotonin Agents|serotonin agents|mesh-ancestor
101763730|NCT00683592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763731|NCT00683592|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101763732|NCT00683592|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101763733|NCT00695396|Epoetin Alfa|epoetin alfa|mesh-list
101763734|NCT00695396|Hematinics|hematinics|mesh-ancestor
101763735|NCT00753402|Epinephrine|epinephrine|mesh-list
101763736|NCT00753402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101763775|NCT04049916|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101763776|NCT04049916|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101763777|NCT04049916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101763778|NCT04049916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101763779|NCT04049916|Antiviral Agents|antiviral agents|mesh-ancestor
101763780|NCT04049916|Schistosomicides|schistosomicides|mesh-ancestor
101763842|NCT00958204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101763843|NCT00958204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101763844|NCT00617409|Paclitaxel|paclitaxel|mesh-list
101763845|NCT00617409|Tretinoin|tretinoin|mesh-list
101763857|NCT00695318|Hormones|hormones|mesh-ancestor
101763913|NCT02565368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101763914|NCT02565368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101763915|NCT03992365|Bisacodyl|bisacodyl|mesh-list
101763916|NCT03992365|Sodium sulfate|sodium sulfate|mesh-list
101763917|NCT03992365|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101763918|NCT03992365|Cathartics|cathartics|mesh-ancestor
101763919|NCT03992365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101763920|NCT03992365|Laxatives|laxatives|mesh-ancestor
101763921|NCT00921804|Risperidone|risperidone|mesh-list
101763922|NCT00921804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101763923|NCT00921804|Serotonin Agents|serotonin agents|mesh-ancestor
101763924|NCT00921804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101763933|NCT00859911|Micronutrients|micronutrients|mesh-list
101763977|NCT04011124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101763978|NCT04011124|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101763979|NCT04011124|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101763980|NCT04011124|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101352598|NCT00039975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101763981|NCT04011124|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101763982|NCT04011124|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101763983|NCT04011124|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101764043|NCT00949624|Tubulin Modulators|tubulin modulators|mesh-ancestor
101764044|NCT00949624|Antimitotic Agents|antimitotic agents|mesh-ancestor
101764045|NCT00949624|Mitosis Modulators|mitosis modulators|mesh-ancestor
101764046|NCT00949624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764114|NCT01324843|Sensory System Agents|sensory system agents|mesh-ancestor
101764115|NCT01324843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101764116|NCT01324843|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
101764118|NCT00742976|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101764119|NCT00742976|Insulin Detemir|insulin detemir|mesh-list
101764125|NCT00571662|Cyclosporine|cyclosporine|mesh-list
101764184|NCT03387085|Vitamin B Complex|vitamin b complex|mesh-ancestor
101764186|NCT03387085|Micronutrients|micronutrients|mesh-ancestor
101764187|NCT00867867|Ferrous fumarate|ferrous fumarate|mesh-list
101764188|NCT00867867|Trace Elements|trace elements|mesh-ancestor
101764189|NCT00867867|Micronutrients|micronutrients|mesh-ancestor
101764190|NCT00867867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764191|NCT00955318|Apomorphine|apomorphine|mesh-list
101764192|NCT00955318|Emetics|emetics|mesh-ancestor
101764193|NCT00955318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764194|NCT00955318|Autonomic Agents|autonomic agents|mesh-ancestor
101764195|NCT00955318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101764196|NCT00955318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101764197|NCT00955318|Dopamine Agonists|dopamine agonists|mesh-ancestor
101764198|NCT00955318|Dopamine Agents|dopamine agents|mesh-ancestor
101764199|NCT00955318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101764200|NCT00955318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764201|NCT00860223|Digoxin|digoxin|mesh-list
101764202|NCT00860223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101764203|NCT00860223|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101764204|NCT00860223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101764238|NCT00549718|Dopamine Agents|dopamine agents|mesh-ancestor
101764239|NCT00863187|Rituximab|rituximab|mesh-list
101764240|NCT00863187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101764241|NCT00863187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101764242|NCT00863187|Immunologic Factors|immunologic factors|mesh-ancestor
101764243|NCT00863187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764244|NCT00863187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101764245|NCT00754884|Calcitonin|calcitonin|mesh-list
101764246|NCT00754884|Salmon calcitonin|salmon calcitonin|mesh-list
101764247|NCT00754884|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
101764248|NCT00754884|Glycerol|glycerol|mesh-list
101764249|NCT00754884|Katacalcin|katacalcin|mesh-list
101764250|NCT00754884|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101764251|NCT00754884|Protective Agents|protective agents|mesh-ancestor
101764252|NCT00754884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764253|NCT00754884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101764254|NCT00754884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101764255|NCT00754884|Vasodilator Agents|vasodilator agents|mesh-ancestor
101764256|NCT00371761|Interferons|interferons|mesh-list
101764257|NCT00371761|Interferon-alpha|interferon-alpha|mesh-list
101764258|NCT00371761|Interferon alpha-2|interferon alpha-2|mesh-list
101764259|NCT00371761|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101764260|NCT00371761|Adefovir|adefovir|mesh-list
101764261|NCT00371761|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101764290|NCT00868023|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101764291|NCT00868023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101764292|NCT00868023|Adrenergic Agents|adrenergic agents|mesh-ancestor
101764293|NCT00868023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101764360|NCT04444804|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101764362|NCT04444804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101352921|NCT00021359|Glucocorticoids|glucocorticoids|mesh-ancestor
101764363|NCT04444804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764364|NCT04444804|Anticoagulants|anticoagulants|mesh-ancestor
101764365|NCT00863577|Bemiparin|bemiparin|mesh-list
101764431|NCT00868569|Micronutrients|micronutrients|mesh-ancestor
101764432|NCT00863733|Acetic Acid|acetic acid|mesh-list
101764433|NCT00863733|Vadimezan|vadimezan|mesh-list
101421863|NCT00405119|Loxtidine|loxtidine|mesh-list
101764434|NCT00863733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101353063|NCT00049296|Thalidomide|thalidomide|mesh-list
101764435|NCT00863733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101764436|NCT00863733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101764437|NCT00549562|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101764438|NCT00549562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101764439|NCT00549562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101353136|NCT00022022|Antimitotic Agents|antimitotic agents|mesh-ancestor
101764440|NCT00549562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101764441|NCT00549562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764442|NCT00549562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101764443|NCT00549562|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101764444|NCT00549562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101764445|NCT00549562|Serotonin Agents|serotonin agents|mesh-ancestor
101764451|NCT00860925|Clonidine|clonidine|mesh-list
101764491|NCT00863889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101764492|NCT00863889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764493|NCT00863889|Sensory System Agents|sensory system agents|mesh-ancestor
101764494|NCT00863889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101764495|NCT00863889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101332851|NCT04680442|Pertuzumab|pertuzumab|mesh-list
101764560|NCT03680352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101764561|NCT03680352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101764565|NCT00864201|Bosentan|bosentan|mesh-list
101764630|NCT00956098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101764631|NCT00956098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764633|NCT00864591|Analgesics|analgesics|mesh-ancestor
101764634|NCT00864591|Sensory System Agents|sensory system agents|mesh-ancestor
101764635|NCT00864591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101353339|NCT00022724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101764636|NCT00864591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764637|NCT00864591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101764638|NCT00864591|Vasodilator Agents|vasodilator agents|mesh-ancestor
101764639|NCT00864591|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101764640|NCT00864591|Purinergic Agonists|purinergic agonists|mesh-ancestor
101764641|NCT00864591|Purinergic Agents|purinergic agents|mesh-ancestor
101764642|NCT00864591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101764643|NCT00864591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101764644|NCT05350384|Methylprednisolone|methylprednisolone|mesh-list
101764688|NCT00864747|Vasodilator Agents|vasodilator agents|mesh-ancestor
101764689|NCT05279716|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101764690|NCT05279716|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101764691|NCT02559102|Dexmedetomidine|dexmedetomidine|mesh-list
101764693|NCT02559102|Sevoflurane|sevoflurane|mesh-list
101764694|NCT02559102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101764695|NCT02559102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764696|NCT02559102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101764697|NCT02559102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101764698|NCT02559102|Analgesics|analgesics|mesh-ancestor
101764699|NCT02559102|Sensory System Agents|sensory system agents|mesh-ancestor
101764700|NCT02559102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101353621|NCT00023738|Alkylating Agents|alkylating agents|mesh-ancestor
101764701|NCT02559102|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101764748|NCT00371683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353711|NCT00024050|Busulfan|busulfan|mesh-list
101764749|NCT00371683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101764750|NCT00371683|Antithrombins|antithrombins|mesh-ancestor
101764751|NCT00371683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101764752|NCT00371683|Protease Inhibitors|protease inhibitors|mesh-ancestor
101764753|NCT00371683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101764754|NCT00876135|Albuterol|albuterol|mesh-list
101764755|NCT00876135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101764756|NCT00876135|Autonomic Agents|autonomic agents|mesh-ancestor
101764757|NCT00876135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101764758|NCT00876135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764759|NCT00876135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101764760|NCT00876135|Respiratory System Agents|respiratory system agents|mesh-ancestor
101764761|NCT00876135|Tocolytic Agents|tocolytic agents|mesh-ancestor
101764762|NCT00876135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101764763|NCT00876135|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101764764|NCT00876135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101764765|NCT00876135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101764766|NCT00876135|Adrenergic Agents|adrenergic agents|mesh-ancestor
101764805|NCT00547534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101764806|NCT00547534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101764807|NCT00547534|Immunologic Factors|immunologic factors|mesh-ancestor
101764808|NCT00547534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764813|NCT00871455|Baclofen|baclofen|mesh-list
101764874|NCT00877539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101764875|NCT00872235|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101764877|NCT00872235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101764947|NCT00676650|Sunitinib|sunitinib|mesh-list
101354037|NCT00052923|Rituximab|rituximab|mesh-list
101764948|NCT00676650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101764949|NCT00676650|Glucocorticoids|glucocorticoids|mesh-ancestor
101764950|NCT00676650|Hormones|hormones|mesh-ancestor
101764951|NCT00676650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101764952|NCT00676650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101764953|NCT00676650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101764954|NCT00676650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101764955|NCT00676650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101764956|NCT00676650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101764957|NCT00676650|Growth Substances|growth substances|mesh-ancestor
101764958|NCT00676650|Growth Inhibitors|growth inhibitors|mesh-ancestor
101764959|NCT00676650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101764960|NCT00676650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101764962|NCT01045369|Etravirine|etravirine|mesh-list
101765006|NCT00382993|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101765007|NCT00382993|Serotonin Agents|serotonin agents|mesh-ancestor
101765008|NCT00382993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101765009|NCT00760968|Methotrexate|methotrexate|mesh-list
101765010|NCT00760968|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101765011|NCT00760968|Abortifacient Agents|abortifacient agents|mesh-ancestor
101765012|NCT00760968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101765013|NCT00760968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765014|NCT00760968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101765015|NCT00760968|Antimetabolites|antimetabolites|mesh-ancestor
101765016|NCT00760968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765071|NCT02534467|Montelukast|montelukast|mesh-list
101765072|NCT02534467|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101765073|NCT02534467|Respiratory System Agents|respiratory system agents|mesh-ancestor
101765143|NCT00369655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765144|NCT00369655|Growth Inhibitors|growth inhibitors|mesh-ancestor
101765145|NCT00369655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101765146|NCT00879177|Varenicline|varenicline|mesh-list
101765147|NCT00879177|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101765216|NCT00874107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101765217|NCT00874107|Tubulin Modulators|tubulin modulators|mesh-ancestor
101765218|NCT00874107|Antimitotic Agents|antimitotic agents|mesh-ancestor
101765219|NCT00874107|Mitosis Modulators|mitosis modulators|mesh-ancestor
101765220|NCT00874107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765221|NCT00874107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101765222|NCT00874107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101765223|NCT00874107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101765224|NCT00874107|Growth Substances|growth substances|mesh-ancestor
101765225|NCT00874107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765226|NCT00874107|Growth Inhibitors|growth inhibitors|mesh-ancestor
101765227|NCT00761358|Z 338|z 338|mesh-list
101765280|NCT00614991|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101765281|NCT00614991|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101765282|NCT00874575|Vitamin D|vitamin d|mesh-list
101765283|NCT00874575|Ergocalciferols|ergocalciferols|mesh-list
101765284|NCT00874575|Cholecalciferol|cholecalciferol|mesh-list
101765285|NCT00874575|Vitamins|vitamins|mesh-list
101765286|NCT00874575|Micronutrients|micronutrients|mesh-ancestor
101765352|NCT00880815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765353|NCT00880815|Dermatologic Agents|dermatologic agents|mesh-ancestor
101765354|NCT00880815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101765355|NCT00880815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101765356|NCT00880815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101765357|NCT00880815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101765418|NCT00368875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101765419|NCT00368875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101765420|NCT00368875|Tubulin Modulators|tubulin modulators|mesh-ancestor
101765421|NCT00368875|Antimitotic Agents|antimitotic agents|mesh-ancestor
101765422|NCT00368875|Mitosis Modulators|mitosis modulators|mesh-ancestor
101765488|NCT00613509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765489|NCT00881517|Immunoglobulins|immunoglobulins|mesh-list
101765490|NCT00881517|Immunologic Factors|immunologic factors|mesh-ancestor
101765491|NCT00881517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765492|NCT00881595|Temozolomide|temozolomide|mesh-list
101333042|NCT00016107|Docetaxel|docetaxel|mesh-list
101765493|NCT00881595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101765494|NCT00881595|Alkylating Agents|alkylating agents|mesh-ancestor
101765495|NCT00881595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765497|NCT00883155|Bupropion|bupropion|mesh-list
101765553|NCT00612807|Tranylcypromine|tranylcypromine|mesh-list
101765554|NCT00612807|Bupropion|bupropion|mesh-list
101765625|NCT00882375|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101765626|NCT00882375|Cholinergic Agents|cholinergic agents|mesh-ancestor
101765627|NCT00882375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101765629|NCT00882453|Interferons|interferons|mesh-list
101765698|NCT04722718|Mitosis Modulators|mitosis modulators|mesh-ancestor
101765699|NCT04722718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765700|NCT04722718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101765701|NCT04722718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101765702|NCT00761670|Risperidone|risperidone|mesh-list
101765703|NCT00761670|Amisulpride|amisulpride|mesh-list
101765704|NCT00761670|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101765705|NCT00761670|Serotonin Agents|serotonin agents|mesh-ancestor
101765706|NCT00761670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101765707|NCT00761670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765708|NCT00761670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765709|NCT00761670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101765710|NCT00761670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101765711|NCT00761670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101765712|NCT00761670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101765713|NCT00761670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101765714|NCT00761670|Dopamine Agents|dopamine agents|mesh-ancestor
101765753|NCT00761904|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101765754|NCT00761904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101765756|NCT00963976|Labetalol|labetalol|mesh-list
101355058|NCT00028730|Thiotepa|thiotepa|mesh-list
101765757|NCT00963976|Hydralazine|hydralazine|mesh-list
101765758|NCT00963976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101765759|NCT00963976|Protease Inhibitors|protease inhibitors|mesh-ancestor
101765760|NCT00963976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101765761|NCT00963976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765762|NCT00963976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101765763|NCT00963976|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101765764|NCT00963976|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101765774|NCT02558868|Oxaliplatin|oxaliplatin|mesh-list
101765815|NCT02303028|Topotecan|topotecan|mesh-list
101765816|NCT02303028|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101765817|NCT02303028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101765818|NCT02303028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101765819|NCT02303028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101765820|NCT02303028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101765821|NCT02287818|Febuxostat|febuxostat|mesh-list
101765822|NCT02287818|Gout Suppressants|gout suppressants|mesh-ancestor
101765823|NCT02287818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101765824|NCT00762060|Anesthetics|anesthetics|mesh-list
101765831|NCT00610857|Antibodies|antibodies|mesh-list
101765880|NCT00886275|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101765881|NCT00886275|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101765882|NCT00886275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101765883|NCT00886275|Adrenergic Agents|adrenergic agents|mesh-ancestor
101765952|NCT00887211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101765953|NCT00887211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101765954|NCT00887211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101765955|NCT00887211|Antifungal Agents|antifungal agents|mesh-ancestor
101765956|NCT00887211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101765957|NCT00887211|Immunologic Factors|immunologic factors|mesh-ancestor
101765958|NCT00887211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101765959|NCT00887367|Ethanol|ethanol|mesh-list
101765960|NCT00887367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101765961|NCT00887367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101765964|NCT00964288|Lidocaine|lidocaine|mesh-list
101766016|NCT05954806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766017|NCT05954624|Itraconazole|itraconazole|mesh-list
101766018|NCT05954624|Probenecid|probenecid|mesh-list
101766089|NCT05953675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101766090|NCT05953675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766091|NCT05953610|Acetazolamide|acetazolamide|mesh-list
101766092|NCT05953610|Eszopiclone|eszopiclone|mesh-list
101766093|NCT05953610|Anticonvulsants|anticonvulsants|mesh-ancestor
101766094|NCT05953610|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101766095|NCT05953610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101766096|NCT05953610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766097|NCT05953610|Diuretics|diuretics|mesh-ancestor
101766098|NCT05953610|Natriuretic Agents|natriuretic agents|mesh-ancestor
101766099|NCT05953610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766100|NCT05953610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101766101|NCT05953610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101766102|NCT05953428|Analgesics, Opioid|analgesics, opioid|mesh-list
101766103|NCT05953428|Anesthetics|anesthetics|mesh-list
101766104|NCT05953428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101766105|NCT05953428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766106|NCT05953428|Narcotics|narcotics|mesh-ancestor
101766107|NCT05953428|Analgesics|analgesics|mesh-ancestor
101766108|NCT05953428|Sensory System Agents|sensory system agents|mesh-ancestor
101766109|NCT05953428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101766110|NCT05953376|Calcium, Dietary|calcium, dietary|mesh-list
101766111|NCT05953376|Calcium|calcium|mesh-list
101766112|NCT05953376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101766113|NCT05953376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766114|NCT05953376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101766115|NCT05953350|Hydroxychloroquine|hydroxychloroquine|mesh-list
101766116|NCT05953350|Palbociclib|palbociclib|mesh-list
101766134|NCT05950802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101766135|NCT05950802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101766141|NCT05938608|Primaquine|primaquine|mesh-list
101766142|NCT05938608|Antimalarials|antimalarials|mesh-ancestor
101766143|NCT05938608|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101766144|NCT05938608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101766210|NCT05890027|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101766211|NCT05890027|Mydriatics|mydriatics|mesh-ancestor
101766212|NCT05890027|Autonomic Agents|autonomic agents|mesh-ancestor
101766213|NCT05890027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101766214|NCT05890027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766215|NCT05890027|Sympathomimetics|sympathomimetics|mesh-ancestor
101766216|NCT05890027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101766217|NCT05890027|Nasal Decongestants|nasal decongestants|mesh-ancestor
101766218|NCT05890027|Respiratory System Agents|respiratory system agents|mesh-ancestor
101766277|NCT05852769|Hormone Antagonists|hormone antagonists|mesh-ancestor
101766278|NCT05852769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101766279|NCT05852769|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101766280|NCT05852769|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101766281|NCT05852769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101766282|NCT05852769|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101766283|NCT05852769|Protective Agents|protective agents|mesh-ancestor
101766284|NCT05852769|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101766285|NCT05852769|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101766286|NCT05852769|Antimetabolites|antimetabolites|mesh-ancestor
101766287|NCT05852769|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101766288|NCT05852769|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101766289|NCT05852769|Analgesics|analgesics|mesh-ancestor
101766290|NCT05852769|Sensory System Agents|sensory system agents|mesh-ancestor
101766291|NCT05852769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101766292|NCT05852769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101766293|NCT05852769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101766294|NCT05852769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101766297|NCT05848765|Prednisone|prednisone|mesh-list
101766331|NCT05848765|Growth Inhibitors|growth inhibitors|mesh-ancestor
101766332|NCT05847348|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101766333|NCT05847348|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101766334|NCT05847348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766335|NCT05843383|Propofol|propofol|mesh-list
101766336|NCT05843383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101766337|NCT05843383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101766338|NCT05843383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766339|NCT05843383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101766340|NCT05843383|Anesthetics, General|anesthetics, general|mesh-ancestor
101766341|NCT05843383|Anesthetics|anesthetics|mesh-ancestor
101766342|NCT05836753|Sarecycline|sarecycline|mesh-list
101766343|NCT05836753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101766393|NCT05794659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766394|NCT05791565|Norflurane|norflurane|mesh-list
101766395|NCT05791565|Albuterol|albuterol|mesh-list
101766396|NCT05791565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101766397|NCT05791565|Autonomic Agents|autonomic agents|mesh-ancestor
101766413|NCT05776927|Xhance|xhance|mesh-list
101766478|NCT05750966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766479|NCT05750966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101766480|NCT05750966|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101766481|NCT05750966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101766482|NCT05750966|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101766483|NCT05679921|Pembrolizumab|pembrolizumab|mesh-list
101766484|NCT05679921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101766485|NCT05679921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101766486|NCT05679921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101766487|NCT05679921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766488|NCT05660746|Infliximab|infliximab|mesh-list
101766489|NCT05660746|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101766490|NCT05660746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101766536|NCT05551104|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101766538|NCT05539872|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101766539|NCT05539872|Insulin Aspart|insulin aspart|mesh-list
101766540|NCT05539872|Insulin, Long-Acting|insulin, long-acting|mesh-list
101766541|NCT05539872|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101766542|NCT05539872|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101766543|NCT05539872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766544|NCT05527418|Dasatinib|dasatinib|mesh-list
101766545|NCT05527418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101766546|NCT05527418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101766547|NCT05527418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101766548|NCT05527418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766549|NCT05512481|Temozolomide|temozolomide|mesh-list
101766550|NCT05512481|Apatinib|apatinib|mesh-list
101766551|NCT05512481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101766552|NCT05512481|Alkylating Agents|alkylating agents|mesh-ancestor
101766553|NCT05512481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766554|NCT05512481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101766555|NCT05512481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101766556|NCT05512481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101766598|NCT05389813|Pregabalin|pregabalin|mesh-list
101766599|NCT05389813|Oxycodone|oxycodone|mesh-list
101766600|NCT05389813|Analgesics|analgesics|mesh-ancestor
101766601|NCT05389813|Sensory System Agents|sensory system agents|mesh-ancestor
101766602|NCT05389813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101766603|NCT05389813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766604|NCT05389813|Anticonvulsants|anticonvulsants|mesh-ancestor
101766605|NCT05389813|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101766606|NCT05389813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101766666|NCT05293132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101766669|NCT05293132|Hormone Antagonists|hormone antagonists|mesh-ancestor
101766738|NCT05215158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766739|NCT05179876|Selexipag|selexipag|mesh-list
101766740|NCT05179876|Tadalafil|tadalafil|mesh-list
101766741|NCT05179876|Macitentan|macitentan|mesh-list
101766742|NCT05179876|Vasodilator Agents|vasodilator agents|mesh-ancestor
101766743|NCT05179876|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101766806|NCT05050305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101766880|NCT04891289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101766881|NCT04891289|Antimetabolites|antimetabolites|mesh-ancestor
101766882|NCT04891289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766883|NCT04879368|Trifluridine|trifluridine|mesh-list
101766884|NCT04879368|Paclitaxel|paclitaxel|mesh-list
101766885|NCT04879368|Docetaxel|docetaxel|mesh-list
101766886|NCT04879368|Nivolumab|nivolumab|mesh-list
101766887|NCT04879368|Irinotecan|irinotecan|mesh-list
101766888|NCT04879368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101766889|NCT04879368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101766923|NCT04834375|BB 1101|bb 1101|mesh-list
101766946|NCT04712903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101766947|NCT04712903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101766948|NCT04712903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766949|NCT04712903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101766950|NCT04710927|Fluorides|fluorides|mesh-list
101766951|NCT04710927|Cariostatic Agents|cariostatic agents|mesh-ancestor
101766952|NCT04710927|Protective Agents|protective agents|mesh-ancestor
101766953|NCT04710927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766954|NCT04694976|Vitamin D|vitamin d|mesh-list
101766955|NCT04694976|Vitamins|vitamins|mesh-ancestor
101766956|NCT04694976|Micronutrients|micronutrients|mesh-ancestor
101766957|NCT04694976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766958|NCT04694976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101766959|NCT04683627|Diclofenac|diclofenac|mesh-list
101766960|NCT04683627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101766961|NCT04683627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101766962|NCT04683627|Analgesics|analgesics|mesh-ancestor
101766963|NCT04683627|Sensory System Agents|sensory system agents|mesh-ancestor
101766964|NCT04683627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101766965|NCT04683627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101766966|NCT04683627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101766967|NCT04683627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101766968|NCT04683627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101766969|NCT04683627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101766970|NCT04683627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101766971|NCT04657666|Nabiximols|nabiximols|mesh-list
101766972|NCT04657666|Analgesics|analgesics|mesh-ancestor
101766993|NCT04646967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101355428|NCT00057642|Serotonin Agents|serotonin agents|mesh-ancestor
101766994|NCT04646967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101766995|NCT04646967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767064|NCT04538378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767065|NCT04523493|Lenvatinib|lenvatinib|mesh-list
101767066|NCT04523493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767067|NCT04523493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101767068|NCT04523493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101767069|NCT04523493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767070|NCT04492891|Cyclosporine|cyclosporine|mesh-list
101767071|NCT04492891|Cyclosporins|cyclosporins|mesh-list
101767072|NCT04492891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101767073|NCT04492891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767074|NCT04492891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101767075|NCT04492891|Immunologic Factors|immunologic factors|mesh-ancestor
101767076|NCT04492891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767077|NCT04492891|Antifungal Agents|antifungal agents|mesh-ancestor
101767078|NCT04492891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101767079|NCT04492891|Dermatologic Agents|dermatologic agents|mesh-ancestor
101767080|NCT04492891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101767121|NCT04166396|Protective Agents|protective agents|mesh-ancestor
101767122|NCT04166396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767123|NCT04166396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101767124|NCT04166396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101767125|NCT04160494|Atezolizumab|atezolizumab|mesh-list
101767126|NCT04160494|D2C7-(scdsFv)-PE38KDEL|d2c7-(scdsfv)-pe38kdel|mesh-list
101767127|NCT04160494|Immunoconjugates|immunoconjugates|mesh-list
101767128|NCT04160494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101767131|NCT04160494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767185|NCT04044690|Antibodies|antibodies|mesh-list
101767186|NCT04044690|Immunoglobulin G|immunoglobulin g|mesh-list
101767187|NCT04044690|Immunologic Factors|immunologic factors|mesh-ancestor
101767262|NCT03923725|Lumefantrine|lumefantrine|mesh-list
101767263|NCT03923725|Artemether|artemether|mesh-list
101767264|NCT03923725|Piperaquine|piperaquine|mesh-list
101767336|NCT03623243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767337|NCT03619707|Progesterone|progesterone|mesh-list
101767338|NCT03619707|Progestins|progestins|mesh-ancestor
101767339|NCT03619707|Hormones|hormones|mesh-ancestor
101767340|NCT03619707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101767407|NCT03399318|Acetaminophen|acetaminophen|mesh-list
101767408|NCT03399318|Ibuprofen|ibuprofen|mesh-list
101767409|NCT03399318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101767410|NCT03399318|Analgesics|analgesics|mesh-ancestor
101767411|NCT03399318|Sensory System Agents|sensory system agents|mesh-ancestor
101767412|NCT03399318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101767413|NCT03399318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767475|NCT03169166|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101767476|NCT03169166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101767477|NCT03169166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101767544|NCT02923128|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101767545|NCT02923128|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101767546|NCT02923128|Adrenergic Agents|adrenergic agents|mesh-ancestor
101767547|NCT02923128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101767549|NCT02923128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101767619|NCT02828358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101767620|NCT02828358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101767621|NCT02828358|Antiemetics|antiemetics|mesh-ancestor
101767622|NCT02828358|Autonomic Agents|autonomic agents|mesh-ancestor
101767624|NCT02828358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101767692|NCT02575963|Immunologic Factors|immunologic factors|mesh-ancestor
101767693|NCT02575963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767694|NCT02575963|Diuretics|diuretics|mesh-ancestor
101767695|NCT02575963|Natriuretic Agents|natriuretic agents|mesh-ancestor
101767696|NCT02575963|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101767697|NCT02575963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101767698|NCT02575963|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101767699|NCT02575963|Hormone Antagonists|hormone antagonists|mesh-ancestor
101767701|NCT02575963|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101767755|NCT02193425|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101767756|NCT02193425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101767829|NCT01399372|Mitosis Modulators|mitosis modulators|mesh-ancestor
101767832|NCT01267604|Antioxidants|antioxidants|mesh-ancestor
101767833|NCT01267604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101767834|NCT01267604|Protective Agents|protective agents|mesh-ancestor
101767835|NCT01267604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101767836|NCT01267604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101767837|NCT01267604|Vitamin B Complex|vitamin b complex|mesh-ancestor
101767838|NCT01267604|Vitamins|vitamins|mesh-ancestor
101767839|NCT01267604|Micronutrients|micronutrients|mesh-ancestor
101767840|NCT01244399|Inositol|inositol|mesh-list
101767842|NCT01244399|Vitamins|vitamins|mesh-ancestor
101767895|NCT04017741|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101767896|NCT04017741|Prednisolone|prednisolone|mesh-list
101767897|NCT04017741|Prednisolone acetate|prednisolone acetate|mesh-list
101767899|NCT04017741|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101767900|NCT04017741|Prednisolone phosphate|prednisolone phosphate|mesh-list
101767901|NCT04017741|Anesthetics, Local|anesthetics, local|mesh-ancestor
101767902|NCT04017741|Anesthetics|anesthetics|mesh-ancestor
101767963|NCT04392921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101767964|NCT04392921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425401|NCT00512824|Calcium|calcium|mesh-list
101767972|NCT00673920|Methotrexate|methotrexate|mesh-list
101768031|NCT00960232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101768032|NCT04577014|Gemcitabine|gemcitabine|mesh-list
101768033|NCT04577014|Docetaxel|docetaxel|mesh-list
101768034|NCT04577014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101768035|NCT04577014|Antimetabolites|antimetabolites|mesh-ancestor
101425463|NCT00167817|Serotonin Agents|serotonin agents|mesh-ancestor
101768036|NCT04577014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768037|NCT04577014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101768096|NCT00888303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101768098|NCT00888303|Hormones|hormones|mesh-ancestor
101768102|NCT00967642|Insulin|insulin|mesh-list
101768168|NCT00609765|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101768169|NCT00609765|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101768170|NCT00609765|Serotonin Agents|serotonin agents|mesh-ancestor
101768171|NCT00609765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101768173|NCT01051219|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101768235|NCT00961480|Metformin|metformin|mesh-list
101768236|NCT00961480|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101768237|NCT00961480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101768238|NCT00961480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768239|NCT00961480|Incretins|incretins|mesh-ancestor
101768240|NCT00961480|Hormones|hormones|mesh-ancestor
101768241|NCT00961480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101768242|NCT00961480|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101768243|NCT00961480|Protease Inhibitors|protease inhibitors|mesh-ancestor
101768244|NCT00961480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101768246|NCT00766662|Pyrimethamine|pyrimethamine|mesh-list
101768300|NCT00966160|Lamivudine|lamivudine|mesh-list
101768301|NCT00966160|Zidovudine|zidovudine|mesh-list
101768302|NCT00966160|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101768303|NCT00966160|Efavirenz|efavirenz|mesh-list
101768304|NCT00966160|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101768369|NCT00766896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101768370|NCT00766896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101768371|NCT00766896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101768372|NCT00766896|Antipyretics|antipyretics|mesh-ancestor
101768373|NCT00763620|Dimercaprol|dimercaprol|mesh-list
101768374|NCT00763620|Chelating Agents|chelating agents|mesh-ancestor
101768375|NCT00763620|Sequestering Agents|sequestering agents|mesh-ancestor
101768377|NCT00973804|Sirolimus|sirolimus|mesh-list
101768436|NCT05279482|Glucocorticoids|glucocorticoids|mesh-ancestor
101768437|NCT05279482|Hormones|hormones|mesh-ancestor
101828150|NCT05923996|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101768438|NCT05279482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101768439|NCT05279482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101768440|NCT05279482|Protective Agents|protective agents|mesh-ancestor
101768441|NCT05279482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101768507|NCT00767286|Androgen Antagonists|androgen antagonists|mesh-ancestor
101768508|NCT00767286|Hormone Antagonists|hormone antagonists|mesh-ancestor
101768509|NCT00767286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101768510|NCT00968110|Omalizumab|omalizumab|mesh-list
101768511|NCT00968110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101768578|NCT00974272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101768580|NCT00974428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101768581|NCT00974428|Immunologic Factors|immunologic factors|mesh-ancestor
101768582|NCT00974428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768646|NCT05227300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101768647|NCT00890487|Hyaluronic Acid|hyaluronic acid|mesh-list
101768648|NCT00890487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101768649|NCT00890487|Immunologic Factors|immunologic factors|mesh-ancestor
101768650|NCT00890487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768651|NCT00890487|Viscosupplements|viscosupplements|mesh-ancestor
101768652|NCT00890487|Protective Agents|protective agents|mesh-ancestor
101768653|NCT00890565|Granisetron|granisetron|mesh-list
101768714|NCT00770406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101768715|NCT02557542|Polidocanol|polidocanol|mesh-list
101768716|NCT02557542|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
101768717|NCT02557542|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
101768718|NCT02557542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101768719|NCT00767754|Paroxetine|paroxetine|mesh-list
101768720|NCT00767754|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101768725|NCT00767754|Serotonin Agents|serotonin agents|mesh-ancestor
101426202|NCT00144755|Darbepoetin alfa|darbepoetin alfa|mesh-list
101768779|NCT05208190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101768780|NCT05208190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101768781|NCT05208190|GABA Antagonists|gaba antagonists|mesh-ancestor
101768782|NCT05208190|GABA Agents|gaba agents|mesh-ancestor
101768783|NCT00609609|Methylprednisolone|methylprednisolone|mesh-list
101768786|NCT00609609|Prednisolone|prednisolone|mesh-list
101768847|NCT00975052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101768848|NCT00975052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768849|NCT00975052|Incretins|incretins|mesh-ancestor
101768850|NCT00975052|Hormones|hormones|mesh-ancestor
101768853|NCT00975052|Protease Inhibitors|protease inhibitors|mesh-ancestor
101768917|NCT00545584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101768918|NCT00545584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101768920|NCT00378703|Bevacizumab|bevacizumab|mesh-list
101768921|NCT00378703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101768990|NCT03620643|Crizotinib|crizotinib|mesh-list
101768991|NCT03620643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101768992|NCT03620643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101768993|NCT03620643|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101768994|NCT03620643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101768995|NCT03620643|Hormone Antagonists|hormone antagonists|mesh-ancestor
101768996|NCT03620643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101768997|NCT03620643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101768998|NCT03620643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101768999|NCT03620643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101769000|NCT03620643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769001|NCT04008316|Colchicine|colchicine|mesh-list
101769002|NCT04008316|Gout Suppressants|gout suppressants|mesh-ancestor
101769051|NCT01045681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101769052|NCT01045681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769053|NCT01045681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101769054|NCT01045681|Glucocorticoids|glucocorticoids|mesh-ancestor
101769055|NCT01045681|Hormones|hormones|mesh-ancestor
101769120|NCT00976222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769121|NCT00976222|Growth Inhibitors|growth inhibitors|mesh-ancestor
101769194|NCT00976768|Immunologic Factors|immunologic factors|mesh-ancestor
101769195|NCT00976768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769196|NCT00608985|Zolpidem|zolpidem|mesh-list
101769264|NCT00368251|Brivaracetam|brivaracetam|mesh-list
101769265|NCT00368251|Anticonvulsants|anticonvulsants|mesh-ancestor
101769266|NCT00893841|Pramipexole|pramipexole|mesh-list
101769267|NCT00893841|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101769268|NCT00893841|Antidepressive Agents|antidepressive agents|mesh-ancestor
101769269|NCT00893841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101769270|NCT00893841|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101769271|NCT00893841|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101769272|NCT00893841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101769273|NCT00893841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769274|NCT00893841|Antioxidants|antioxidants|mesh-ancestor
101769275|NCT00893841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769276|NCT00893841|Protective Agents|protective agents|mesh-ancestor
101769277|NCT00893841|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101769278|NCT00893841|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101769279|NCT00893841|Dopamine Agonists|dopamine agonists|mesh-ancestor
101769280|NCT00893841|Dopamine Agents|dopamine agents|mesh-ancestor
101769281|NCT00893841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101769283|NCT00378079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101769284|NCT00378079|Narcotics|narcotics|mesh-ancestor
101769285|NCT00378079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101769286|NCT00378079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769287|NCT00378079|Analgesics|analgesics|mesh-ancestor
101769288|NCT00378079|Sensory System Agents|sensory system agents|mesh-ancestor
101769314|NCT00970528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769315|NCT00970762|Rocuronium|rocuronium|mesh-list
101769316|NCT00970762|Vecuronium Bromide|vecuronium bromide|mesh-list
101769317|NCT00970762|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101769318|NCT00970762|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101769319|NCT00970762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101769320|NCT00970762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101769321|NCT00970762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769322|NCT00970762|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101769323|NCT00970762|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101769324|NCT00970762|Cholinergic Agents|cholinergic agents|mesh-ancestor
101769325|NCT00970762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101769326|NCT00970762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769375|NCT00608907|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101769376|NCT00608907|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101769379|NCT00970996|Interferon-alpha|interferon-alpha|mesh-list
101769449|NCT00978328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769450|NCT00978328|Analgesics|analgesics|mesh-ancestor
101769451|NCT00978328|Sensory System Agents|sensory system agents|mesh-ancestor
101769452|NCT00978328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101769453|NCT00892359|Anidulafungin|anidulafungin|mesh-list
101769454|NCT00892359|Antifungal Agents|antifungal agents|mesh-ancestor
101426874|NCT02942602|Atorvastatin|atorvastatin|mesh-list
101769455|NCT00892359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101769456|NCT01051531|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101769513|NCT00869973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101769514|NCT00869973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101769515|NCT00869973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101769516|NCT00869973|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101769517|NCT00869973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101769518|NCT00869973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769577|NCT00894231|Histamine Agents|histamine agents|mesh-ancestor
101769578|NCT00894231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101769650|NCT02533765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101769651|NCT02533765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769652|NCT02533765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101769653|NCT04035993|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101769654|NCT04035993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769656|NCT00367237|Methotrexate|methotrexate|mesh-list
101769657|NCT00367237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101769658|NCT00367237|Abortifacient Agents|abortifacient agents|mesh-ancestor
101769713|NCT00901719|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101769714|NCT00901719|Cholinergic Agents|cholinergic agents|mesh-ancestor
101769715|NCT00901719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101769716|NCT00901719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769717|NCT00972712|Bortezomib|bortezomib|mesh-list
101769718|NCT00972712|Tipifarnib|tipifarnib|mesh-list
101769784|NCT00606177|Aripiprazole|aripiprazole|mesh-list
101769785|NCT00606177|Antidepressive Agents|antidepressive agents|mesh-ancestor
101769786|NCT00606177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101769787|NCT00606177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101769788|NCT00606177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101769791|NCT00606177|Dopamine Agonists|dopamine agonists|mesh-ancestor
101769856|NCT00973336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101769858|NCT00902187|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101769859|NCT00902187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101769860|NCT00902187|Cholinergic Agents|cholinergic agents|mesh-ancestor
101769861|NCT00902187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101769862|NCT00902187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101769863|NCT00902187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769865|NCT01052311|Niacin|niacin|mesh-list
101769921|NCT00982618|Lidocaine|lidocaine|mesh-list
101769922|NCT00982618|Morphine|morphine|mesh-list
101769923|NCT00982618|Anesthetics, Local|anesthetics, local|mesh-list
101769924|NCT00982618|Anesthetics|anesthetics|mesh-list
101769925|NCT00982618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101769926|NCT00982618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101769927|NCT00982618|Sensory System Agents|sensory system agents|mesh-ancestor
101769928|NCT00982618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101769929|NCT00982618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101769930|NCT00982618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101769931|NCT00982618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101769932|NCT00982618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101769934|NCT00982618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101769981|NCT00350545|Hormones|hormones|mesh-ancestor
101769982|NCT00350545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101769983|NCT00350545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101770051|NCT01052389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101770052|NCT00895323|Antibodies|antibodies|mesh-list
101770053|NCT00895323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101770054|NCT00895323|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101770055|NCT00895323|Immunologic Factors|immunologic factors|mesh-ancestor
101770056|NCT00895323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770057|NCT00349921|Adenosine|adenosine|mesh-list
101770058|NCT00349921|Clonidine|clonidine|mesh-list
101770059|NCT00349921|Analgesics|analgesics|mesh-ancestor
101770060|NCT00349921|Sensory System Agents|sensory system agents|mesh-ancestor
101770061|NCT00349921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101770062|NCT00349921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770063|NCT00349921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101770064|NCT00349921|Sympatholytics|sympatholytics|mesh-ancestor
101770065|NCT00349921|Autonomic Agents|autonomic agents|mesh-ancestor
101770068|NCT00349921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101770113|NCT00902811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101770114|NCT00902811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101770115|NCT00902811|Antiviral Agents|antiviral agents|mesh-ancestor
101770116|NCT00902811|Schistosomicides|schistosomicides|mesh-ancestor
101770117|NCT00902811|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101770118|NCT00902811|Anthelmintics|anthelmintics|mesh-ancestor
101770119|NCT00898287|Gemcitabine|gemcitabine|mesh-list
101770121|NCT00898287|Antimetabolites|antimetabolites|mesh-ancestor
101770179|NCT04035525|Micronutrients|micronutrients|mesh-ancestor
101770180|NCT04035525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770181|NCT00905853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
101770182|NCT00905853|Amiodarone|amiodarone|mesh-list
101770183|NCT00905853|Vasodilator Agents|vasodilator agents|mesh-ancestor
101770184|NCT00905853|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101770185|NCT00905853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101770186|NCT00905853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770187|NCT00905853|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101770188|NCT00905853|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101770189|NCT00905853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101770190|NCT00905853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101770191|NCT00905853|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101770192|NCT00905853|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101770193|NCT00905853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101770237|NCT00903747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101770238|NCT00903747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101770239|NCT00903747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101770240|NCT00903747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101770241|NCT00903747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770242|NCT00903747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101770243|NCT00903747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770244|NCT00903747|Laxatives|laxatives|mesh-ancestor
101770245|NCT00903747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101770246|NCT00903747|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101770247|NCT00903747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101770248|NCT00903747|Serotonin Agents|serotonin agents|mesh-ancestor
101770249|NCT00903747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101770250|NCT02538627|Trametinib|trametinib|mesh-list
101770251|NCT02538627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101770252|NCT02538627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101770253|NCT02538627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101770254|NCT02538627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770288|NCT00604695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101770289|NCT00604695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101770290|NCT00604695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770292|NCT01055821|Ribavirin|ribavirin|mesh-list
101770293|NCT01055821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101770294|NCT01055821|Antiviral Agents|antiviral agents|mesh-ancestor
101770295|NCT01055821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101770296|NCT01055821|Antimetabolites|antimetabolites|mesh-ancestor
101770298|NCT00904293|Warfarin|warfarin|mesh-list
101770354|NCT00905073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101770355|NCT00905073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101770356|NCT00905073|Immunologic Factors|immunologic factors|mesh-ancestor
101770357|NCT00905073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101770358|NCT00905073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101770359|NCT00905073|Antifungal Agents|antifungal agents|mesh-ancestor
101770360|NCT00905073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101770362|NCT00905229|Vitamins|vitamins|mesh-list
101770423|NCT00336505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101770424|NCT00336505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101770425|NCT00336505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101770495|NCT01060189|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101427928|NCT02927587|Propofol|propofol|mesh-list
101770496|NCT01060189|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101770497|NCT01060189|Protease Inhibitors|protease inhibitors|mesh-ancestor
101770498|NCT01060189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101770499|NCT01060267|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101770500|NCT01060267|Erythromycin|erythromycin|mesh-list
101770501|NCT01060267|Erythromycin Estolate|erythromycin estolate|mesh-list
101770565|NCT00671658|Hormones|hormones|mesh-ancestor
101770566|NCT00671658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101770567|NCT00671658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101770568|NCT00671658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101770634|NCT04048200|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101770635|NCT04048200|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101770636|NCT04048200|Narcotics|narcotics|mesh-ancestor
101770704|NCT02557386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770705|NCT02557386|Sensory System Agents|sensory system agents|mesh-ancestor
101770706|NCT02557386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101770707|NCT00986050|Sirolimus|sirolimus|mesh-list
101770708|NCT00986050|Abciximab|abciximab|mesh-list
101770719|NCT00986128|Topiramate|topiramate|mesh-list
101770775|NCT00771498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101770776|NCT00771498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770777|NCT00771498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101770778|NCT00771498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101770779|NCT00771498|Antiviral Agents|antiviral agents|mesh-ancestor
101770780|NCT00771498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101770781|NCT00771498|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101770782|NCT00771498|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101770784|NCT00986284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101770785|NCT00986284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101770786|NCT00986284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101770836|NCT00983164|Protective Agents|protective agents|mesh-ancestor
101770837|NCT00983164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101770839|NCT00333775|Docetaxel|docetaxel|mesh-list
101770840|NCT00333775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101770910|NCT00983398|Mechlorethamine|mechlorethamine|mesh-list
101770911|NCT00983398|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
101770912|NCT00983398|Mannitol|mannitol|mesh-list
101770913|NCT00983398|Antidotes|antidotes|mesh-list
101770914|NCT00983398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101770981|NCT05004987|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101770982|NCT05004987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101770983|NCT05004987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101770984|NCT05004987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101770985|NCT05004987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101771049|NCT00927225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101771050|NCT00927225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771051|NCT00927225|Sensory System Agents|sensory system agents|mesh-ancestor
101771052|NCT00927225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101771053|NCT00357097|Ropinirole|ropinirole|mesh-list
101771054|NCT00357097|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101771118|NCT00909129|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101771119|NCT00909129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101771120|NCT00909129|Antiviral Agents|antiviral agents|mesh-ancestor
101771121|NCT00909129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101771122|NCT00909129|Antimetabolites|antimetabolites|mesh-ancestor
101771123|NCT00909129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771124|NCT00909129|Immunologic Factors|immunologic factors|mesh-ancestor
101771125|NCT00909129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771127|NCT01053325|Antimalarials|antimalarials|mesh-ancestor
101771183|NCT01581151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771186|NCT01581151|Hormones|hormones|mesh-ancestor
101771256|NCT00909519|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101771257|NCT00909519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101771258|NCT00909519|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101771259|NCT05014815|Tislelizumab|tislelizumab|mesh-list
101771260|NCT05014815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101771261|NCT05014815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101771262|NCT00355615|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101771263|NCT00355615|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101771264|NCT00355615|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101771321|NCT01053949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101771322|NCT01053949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101771323|NCT00987376|Choline|choline|mesh-list
101771324|NCT00987376|Lipotropic Agents|lipotropic agents|mesh-ancestor
101771325|NCT00987376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101771326|NCT00987376|Antimetabolites|antimetabolites|mesh-ancestor
101771327|NCT00987376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771392|NCT00330343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101771394|NCT00987766|Oxaliplatin|oxaliplatin|mesh-list
101771395|NCT00987766|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101771396|NCT00987766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101771397|NCT00987766|Antimetabolites|antimetabolites|mesh-ancestor
101771398|NCT00987766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771399|NCT00987766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101771400|NCT00987766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101771401|NCT00987766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101771402|NCT04005430|Dexamethasone|dexamethasone|mesh-list
101771403|NCT04005430|Dexamethasone acetate|dexamethasone acetate|mesh-list
101771404|NCT04005430|BB 1101|bb 1101|mesh-list
101771405|NCT04005430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101771406|NCT04005430|Antiemetics|antiemetics|mesh-ancestor
101771407|NCT04005430|Autonomic Agents|autonomic agents|mesh-ancestor
101771408|NCT04005430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101771409|NCT04005430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771410|NCT04005430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101771411|NCT04005430|Glucocorticoids|glucocorticoids|mesh-ancestor
101771412|NCT04005430|Hormones|hormones|mesh-ancestor
101771413|NCT04005430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101771414|NCT04005430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101771415|NCT04005430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101771440|NCT00987844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771441|NCT00987844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771442|NCT03986905|Scopolamine|scopolamine|mesh-list
101771443|NCT03986905|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101771510|NCT05709574|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101771511|NCT05709574|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101771512|NCT05709574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101771513|NCT05709574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771515|NCT04690504|Melatonin|melatonin|mesh-list
101771581|NCT00689936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101771582|NCT00689936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101771583|NCT01563718|Naltrexone|naltrexone|mesh-list
101771584|NCT01563718|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101771585|NCT01563718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101771586|NCT01563718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771654|NCT04425070|Carboplatin|carboplatin|mesh-list
101771655|NCT04425070|Gemcitabine|gemcitabine|mesh-list
101771656|NCT04425070|Oxaliplatin|oxaliplatin|mesh-list
101771657|NCT04425070|Etoposide|etoposide|mesh-list
101771658|NCT04425070|Ifosfamide|ifosfamide|mesh-list
101771659|NCT04425070|Tislelizumab|tislelizumab|mesh-list
101771660|NCT04425070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101771661|NCT04425070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101771662|NCT04425070|Antimetabolites|antimetabolites|mesh-ancestor
101771724|NCT04394182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771725|NCT04394182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101771726|NCT04394182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101771727|NCT04394182|Antiviral Agents|antiviral agents|mesh-ancestor
101771728|NCT04394182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101771729|NCT04394182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101771730|NCT04394182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101771731|NCT04394182|Anticoagulants|anticoagulants|mesh-ancestor
101771732|NCT04394182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101771733|NCT04394182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101771734|NCT04394182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101771735|NCT04394182|Antimalarials|antimalarials|mesh-ancestor
101771736|NCT04394182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101771737|NCT04394182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101771786|NCT00329719|MTOR Inhibitors|mtor inhibitors|mesh-list
101771787|NCT00329719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101771798|NCT04008628|Nitrous Oxide|nitrous oxide|mesh-list
101771855|NCT00743990|Camphor|camphor|mesh-list
101771856|NCT00743990|Menthol|menthol|mesh-list
101771857|NCT00743990|Petrolatum|petrolatum|mesh-list
101771858|NCT00743990|Antipruritics|antipruritics|mesh-ancestor
101771859|NCT00743990|Dermatologic Agents|dermatologic agents|mesh-ancestor
101771860|NCT00743990|Emollients|emollients|mesh-ancestor
101771861|NCT00743990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101771862|NCT00743990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101771863|NCT00329407|Topiramate|topiramate|mesh-list
101771864|NCT00329407|Anticonvulsants|anticonvulsants|mesh-ancestor
101771865|NCT00329407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101771866|NCT00329407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771867|NCT01056757|Ribavirin|ribavirin|mesh-list
101771868|NCT01056757|Antimetabolites|antimetabolites|mesh-ancestor
101771869|NCT01056757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101771870|NCT01056757|Antiviral Agents|antiviral agents|mesh-ancestor
101771871|NCT01056757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101771915|NCT00776022|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101771916|NCT00776022|Histamine Antagonists|histamine antagonists|mesh-ancestor
101771987|NCT00667992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101771988|NCT00667992|Respiratory System Agents|respiratory system agents|mesh-ancestor
101771989|NCT00667992|Glucocorticoids|glucocorticoids|mesh-ancestor
101771990|NCT00667992|Hormones|hormones|mesh-ancestor
101771991|NCT00667992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101771992|NCT00776490|Glimepiride|glimepiride|mesh-list
101771993|NCT00776490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101771994|NCT00776490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101771995|NCT00776490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101771996|NCT00776490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101771997|NCT00776490|Immunologic Factors|immunologic factors|mesh-ancestor
101771998|NCT00776568|Antihypertensive Agents|antihypertensive agents|mesh-list
101771999|NCT00779922|Lenalidomide|lenalidomide|mesh-list
101772000|NCT00779922|Immunologic Factors|immunologic factors|mesh-ancestor
101772001|NCT00779922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772002|NCT00779922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101772003|NCT00779922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101772004|NCT00779922|Growth Substances|growth substances|mesh-ancestor
101772005|NCT00779922|Growth Inhibitors|growth inhibitors|mesh-ancestor
101772006|NCT00779922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101772007|NCT00776646|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101772008|NCT00776646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101772009|NCT00776646|Diuretics|diuretics|mesh-ancestor
101772010|NCT00776646|Natriuretic Agents|natriuretic agents|mesh-ancestor
101772011|NCT00776646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772012|NCT00776646|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101772013|NCT00776646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101772014|NCT00776646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772032|NCT00776802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772033|NCT00776802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101772034|NCT00776802|Glucocorticoids|glucocorticoids|mesh-ancestor
101772036|NCT00776802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101772037|NCT00776802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101772038|NCT00776802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101772039|NCT00776802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101772040|NCT00776802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101772041|NCT00776802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101772042|NCT00776802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101772043|NCT00776802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772044|NCT00773916|Methylphenidate|methylphenidate|mesh-list
101772045|NCT00773916|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101772046|NCT00773916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772047|NCT00773916|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101772048|NCT00773916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101772049|NCT00773916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101772050|NCT00773916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772051|NCT00773916|Dopamine Agents|dopamine agents|mesh-ancestor
101772052|NCT00773916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101772053|NCT00774072|Tobramycin|tobramycin|mesh-list
101772054|NCT00774072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101429488|NCT00405977|Anticonvulsants|anticonvulsants|mesh-ancestor
101772078|NCT00780858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101772079|NCT00780858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772080|NCT00777114|Bortezomib|bortezomib|mesh-list
101772081|NCT00777114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101772082|NCT00669396|Copper|copper|mesh-list
101772083|NCT00669396|Levonorgestrel|levonorgestrel|mesh-list
101772084|NCT00669396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101772085|NCT00669396|Contraceptive Agents|contraceptive agents|mesh-ancestor
101772086|NCT00669396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101772087|NCT00669396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772088|NCT00669396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101772089|NCT00669396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101772140|NCT00669162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101772215|NCT00400946|Antimetabolites|antimetabolites|mesh-ancestor
101772216|NCT00400946|Dermatologic Agents|dermatologic agents|mesh-ancestor
101772217|NCT00400946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101772218|NCT00400946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101772219|NCT00400946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101772220|NCT00400946|Antiviral Agents|antiviral agents|mesh-ancestor
101772286|NCT00666588|Antiviral Agents|antiviral agents|mesh-ancestor
101772287|NCT00666588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101772288|NCT00666588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101772358|NCT00926055|Antimetabolites|antimetabolites|mesh-ancestor
101772359|NCT00926055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772360|NCT00926055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101772361|NCT00926055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101772362|NCT00926055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101772363|NCT04034199|Zoledronic Acid|zoledronic acid|mesh-list
101772365|NCT04034199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101772366|NCT04034199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772367|NCT02538237|Ibuprofen|ibuprofen|mesh-list
101772368|NCT02538237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101772369|NCT02538237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101772370|NCT02538237|Analgesics|analgesics|mesh-ancestor
101772371|NCT02538237|Sensory System Agents|sensory system agents|mesh-ancestor
101772372|NCT02538237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101772373|NCT02538237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772374|NCT02538237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101772375|NCT02538237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101772376|NCT02538237|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101772377|NCT02538237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101772378|NCT02538237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772379|NCT00691028|Infliximab|infliximab|mesh-list
101772380|NCT00691028|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101772381|NCT00691028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101772382|NCT00691028|Dermatologic Agents|dermatologic agents|mesh-ancestor
101772383|NCT00691028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101772384|NCT00691028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101772385|NCT00690794|Travoprost|travoprost|mesh-list
101772405|NCT00567255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101772406|NCT00567255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101772407|NCT00567255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101772408|NCT00567255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101772409|NCT00567255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772410|NCT00567255|Dopamine Agents|dopamine agents|mesh-ancestor
101772411|NCT00567255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101355570|NCT00030914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101772470|NCT00784680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101772471|NCT00784680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101772472|NCT00784680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101772473|NCT00784680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101772540|NCT00929955|Autonomic Agents|autonomic agents|mesh-ancestor
101772541|NCT00929955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101772542|NCT00929955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772543|NCT00929955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101772544|NCT00929955|Antipruritics|antipruritics|mesh-ancestor
101772545|NCT00929955|Dermatologic Agents|dermatologic agents|mesh-ancestor
101772546|NCT00929955|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101772547|NCT00929955|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101772548|NCT00929955|Serotonin Agents|serotonin agents|mesh-ancestor
101772549|NCT00929955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101772603|NCT00667446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101772604|NCT00667446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101772605|NCT00777972|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101772606|NCT00777972|Fosinopril|fosinopril|mesh-list
101772607|NCT00777972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101772608|NCT00777972|Diuretics|diuretics|mesh-ancestor
101772609|NCT00777972|Natriuretic Agents|natriuretic agents|mesh-ancestor
101772610|NCT00777972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772611|NCT00777972|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101772612|NCT00777972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101772613|NCT00777972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772614|NCT00777972|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101772615|NCT00777972|Protease Inhibitors|protease inhibitors|mesh-ancestor
101772616|NCT00777972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101772617|NCT00778050|Amoxicillin|amoxicillin|mesh-list
101772618|NCT00778050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101772661|NCT00782652|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101772662|NCT00782652|Respiratory System Agents|respiratory system agents|mesh-ancestor
101772663|NCT00782652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101772664|NCT00782652|Antioxidants|antioxidants|mesh-ancestor
101772665|NCT00782652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772666|NCT00782652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101772667|NCT00782652|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101772668|NCT00782652|Vasodilator Agents|vasodilator agents|mesh-ancestor
101772669|NCT00782652|Gasotransmitters|gasotransmitters|mesh-ancestor
101772670|NCT00782652|Protective Agents|protective agents|mesh-ancestor
101772671|NCT00785382|Pregabalin|pregabalin|mesh-list
101772728|NCT00567567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101772729|NCT00567567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101772730|NCT00567567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101772731|NCT00567567|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101772733|NCT00567567|Antimitotic Agents|antimitotic agents|mesh-ancestor
101772734|NCT00567567|Mitosis Modulators|mitosis modulators|mesh-ancestor
101772736|NCT00567567|Keratolytic Agents|keratolytic agents|mesh-ancestor
101772797|NCT00926835|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101772798|NCT00926835|Antidepressive Agents|antidepressive agents|mesh-ancestor
101772799|NCT00926835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101772800|NCT00926835|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101772801|NCT00926835|Dopamine Agents|dopamine agents|mesh-ancestor
101772802|NCT00926835|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101772803|NCT00926835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101772804|NCT00926835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101772805|NCT00926835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101772806|NCT00926835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101772807|NCT00926835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101772858|NCT00783042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101772859|NCT00783042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101772860|NCT00783042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101772861|NCT00783042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101772862|NCT00688688|Mirabegron|mirabegron|mesh-list
101772927|NCT02562326|Insulin Lispro|insulin lispro|mesh-list
101772928|NCT02562326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101772929|NCT02562326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101772930|NCT00746720|Etoricoxib|etoricoxib|mesh-list
101772931|NCT00746720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101772999|NCT04498923|Sympathomimetics|sympathomimetics|mesh-ancestor
101773000|NCT04498923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101773001|NCT00779064|Rivaroxaban|rivaroxaban|mesh-list
101773002|NCT00779064|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101773003|NCT00779064|Antithrombins|antithrombins|mesh-ancestor
101773004|NCT00779064|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101773005|NCT00779064|Protease Inhibitors|protease inhibitors|mesh-ancestor
101773006|NCT00779064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101773007|NCT00779064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773008|NCT00779064|Anticoagulants|anticoagulants|mesh-ancestor
101773009|NCT04046874|Analgesics|analgesics|mesh-list
101773010|NCT04046874|Sensory System Agents|sensory system agents|mesh-ancestor
101773011|NCT04046874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101773012|NCT04046874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773060|NCT00938379|Protective Agents|protective agents|mesh-ancestor
101773061|NCT00938379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773062|NCT00661830|Gemcitabine|gemcitabine|mesh-list
101773063|NCT00661830|Sorafenib|sorafenib|mesh-list
101773064|NCT00661830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101773065|NCT00661830|Antimetabolites|antimetabolites|mesh-ancestor
101773066|NCT00661830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773067|NCT00661830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101773068|NCT00661830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101773069|NCT00661830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101773070|NCT00932529|Olanzapine|olanzapine|mesh-list
101773093|NCT00783744|Insulin|insulin|mesh-list
101773126|NCT00931125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101773127|NCT00931125|Growth Substances|growth substances|mesh-ancestor
101773128|NCT00931125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773129|NCT00931125|Growth Inhibitors|growth inhibitors|mesh-ancestor
101773130|NCT00931125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101773131|NCT00932763|Amlodipine|amlodipine|mesh-list
101773132|NCT00932763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101773133|NCT00932763|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101773134|NCT00932763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101773135|NCT00932763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773136|NCT00932763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101773137|NCT00932763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773138|NCT00932763|Vasodilator Agents|vasodilator agents|mesh-ancestor
101773139|NCT00786396|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101773140|NCT00786396|Antiviral Agents|antiviral agents|mesh-ancestor
101773141|NCT00786396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101773142|NCT00783900|Metoprolol|metoprolol|mesh-list
101773143|NCT00783900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101773144|NCT00783900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101773145|NCT00783900|Sympatholytics|sympatholytics|mesh-ancestor
101773146|NCT00783900|Autonomic Agents|autonomic agents|mesh-ancestor
101773147|NCT00783900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101773148|NCT00783900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773149|NCT00783900|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101773175|NCT00786552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101773176|NCT00786552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101773177|NCT04047186|Nivolumab|nivolumab|mesh-list
101773178|NCT04047186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101773179|NCT04047186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101773180|NCT04047186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101773181|NCT04047186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773183|NCT00931203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101773184|NCT00931203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101773185|NCT00931203|Analgesics|analgesics|mesh-ancestor
101355585|NCT00058149|Gemcitabine|gemcitabine|mesh-list
101773186|NCT00931203|Sensory System Agents|sensory system agents|mesh-ancestor
101773187|NCT00931203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101773188|NCT00931203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773189|NCT00931203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101773190|NCT00931203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101773191|NCT00931203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101773192|NCT00931203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101773193|NCT00931203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101773194|NCT00931203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773195|NCT00565773|Sirolimus|sirolimus|mesh-list
101773196|NCT00565773|Alemtuzumab|alemtuzumab|mesh-list
101773197|NCT00565773|Abatacept|abatacept|mesh-list
101773198|NCT00565773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101773199|NCT00565773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101773200|NCT00565773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101773201|NCT00565773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101773202|NCT00565773|Antifungal Agents|antifungal agents|mesh-ancestor
101773203|NCT00565773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101773204|NCT00565773|Immunologic Factors|immunologic factors|mesh-ancestor
101773205|NCT00565773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773206|NCT00565773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773207|NCT00565773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101773208|NCT00565773|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101773209|NCT00565773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101643056|NCT00753883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101643058|NCT00720382|Azelastine|azelastine|mesh-list
101643059|NCT00720382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101773210|NCT00570492|Fluticasone|fluticasone|mesh-list
101773211|NCT00570492|Xhance|xhance|mesh-list
101773212|NCT00570492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101773213|NCT00570492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101773214|NCT00570492|Autonomic Agents|autonomic agents|mesh-ancestor
101773283|NCT00784290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101773284|NCT00784290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773354|NCT00749450|Oxaliplatin|oxaliplatin|mesh-list
101773355|NCT00749450|Antimetabolites|antimetabolites|mesh-ancestor
101773356|NCT00749450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773357|NCT00749450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101773358|NCT00749450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101773359|NCT00749450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101773362|NCT00795444|Maraviroc|maraviroc|mesh-list
101773422|NCT03989557|Sensory System Agents|sensory system agents|mesh-ancestor
101773423|NCT03989557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101773424|NCT03989557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773425|NCT03989557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101773426|NCT03989557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101773427|NCT03989557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101773428|NCT03989557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101773429|NCT03989557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773430|NCT03989557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101773431|NCT03989557|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101773432|NCT03989557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101773433|NCT03989557|Antipyretics|antipyretics|mesh-ancestor
101773434|NCT03989557|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101773435|NCT03989557|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101773436|NCT03989557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101773437|NCT03989557|Purinergic Agents|purinergic agents|mesh-ancestor
101773438|NCT03989557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101773440|NCT00790998|Moxidectin|moxidectin|mesh-list
101773477|NCT00663702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773478|NCT00663702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101773479|NCT02022592|Midazolam|midazolam|mesh-list
101773480|NCT02022592|Lormetazepam|lormetazepam|mesh-list
101773550|NCT00795756|Antimetabolites|antimetabolites|mesh-ancestor
101773551|NCT00795756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355594|NCT00058227|Alvocidib|alvocidib|mesh-list
101773552|NCT00795756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101773553|NCT00795756|Dermatologic Agents|dermatologic agents|mesh-ancestor
101773554|NCT00795756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101773555|NCT00795756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101773556|NCT00795756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101773557|NCT00795756|Immunologic Factors|immunologic factors|mesh-ancestor
101773558|NCT00795756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101773614|NCT00788034|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101773615|NCT00788034|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101773616|NCT00788034|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101773617|NCT00788034|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101773618|NCT04004884|Ulipristal acetate|ulipristal acetate|mesh-list
101773619|NCT04004884|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101773683|NCT00990028|Antimetabolites|antimetabolites|mesh-ancestor
101773684|NCT00990028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773685|NCT00990028|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101773686|NCT00990028|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101773687|NCT00990028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101773688|NCT00663234|Atorvastatin|atorvastatin|mesh-list
101773748|NCT00747110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101773749|NCT00747110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101773750|NCT00747110|Respiratory System Agents|respiratory system agents|mesh-ancestor
101773751|NCT00747110|Glucocorticoids|glucocorticoids|mesh-ancestor
101773752|NCT00747110|Hormones|hormones|mesh-ancestor
101773753|NCT00747110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101773754|NCT00747110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101773755|NCT00747110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101773756|NCT00747110|Analgesics|analgesics|mesh-ancestor
101773757|NCT00747110|Sensory System Agents|sensory system agents|mesh-ancestor
101773812|NCT00796692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101773813|NCT00796692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773814|NCT00540436|Ambrisentan|ambrisentan|mesh-list
101773815|NCT00540436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101773816|NCT00788580|Sirolimus|sirolimus|mesh-list
101773817|NCT00788580|Temsirolimus|temsirolimus|mesh-list
101773818|NCT00788580|MTOR Inhibitors|mtor inhibitors|mesh-list
101773830|NCT00792012|Temozolomide|temozolomide|mesh-list
101773880|NCT00687440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773881|NCT00687440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101773882|NCT00687440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101773883|NCT00687440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101773884|NCT00687440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101773885|NCT00687440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101773886|NCT02554734|Levodopa|levodopa|mesh-list
101773887|NCT02554734|Carbidopa|carbidopa|mesh-list
101773888|NCT02554734|Entacapone|entacapone|mesh-list
101773889|NCT02554734|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101773942|NCT00792246|Antifungal Agents|antifungal agents|mesh-ancestor
101773943|NCT00792246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101773944|NCT00792246|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101773945|NCT00792246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101773946|NCT00792246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101773947|NCT00792246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101773948|NCT00792246|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101773949|NCT00792246|Hormone Antagonists|hormone antagonists|mesh-ancestor
101773950|NCT00792246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101773953|NCT00539500|Carboplatin|carboplatin|mesh-list
101774004|NCT04003792|Bevacizumab|bevacizumab|mesh-list
101774005|NCT04003792|Oxaliplatin|oxaliplatin|mesh-list
101774006|NCT04003792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101774007|NCT04003792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101774008|NCT04003792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101774077|NCT05359432|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101774078|NCT05359432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774079|NCT05359432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101774080|NCT05359432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774081|NCT05359432|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101774082|NCT05359432|Protease Inhibitors|protease inhibitors|mesh-ancestor
101774083|NCT05359432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101774084|NCT00755456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101774085|NCT00755534|Capecitabine|capecitabine|mesh-list
101774086|NCT00755534|Oxaliplatin|oxaliplatin|mesh-list
101774087|NCT00755534|Irinotecan|irinotecan|mesh-list
101774088|NCT00755534|Cetuximab|cetuximab|mesh-list
101774089|NCT00755534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101774090|NCT00755534|Antimetabolites|antimetabolites|mesh-ancestor
101774091|NCT00755534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774092|NCT00755534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101774136|NCT00685802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101774137|NCT00685802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101774138|NCT01054651|Artesunate|artesunate|mesh-list
101774139|NCT01054651|Pyrimethamine|pyrimethamine|mesh-list
101774140|NCT01054651|Sulfalene|sulfalene|mesh-list
101774211|NCT03827473|Micronutrients|micronutrients|mesh-ancestor
101774212|NCT03827473|Estrogens|estrogens|mesh-ancestor
101774213|NCT03827473|Anabolic Agents|anabolic agents|mesh-ancestor
101774214|NCT00800592|Sildenafil Citrate|sildenafil citrate|mesh-list
101774215|NCT00800592|Vasodilator Agents|vasodilator agents|mesh-ancestor
101774216|NCT00800592|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101774217|NCT00800592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101774218|NCT00800592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101774219|NCT00800592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774220|NCT00800592|Urological Agents|urological agents|mesh-ancestor
101774221|NCT00797784|Etanercept|etanercept|mesh-list
101774222|NCT00797784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101774223|NCT00797784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101774224|NCT00797784|Analgesics|analgesics|mesh-ancestor
101774225|NCT00797784|Sensory System Agents|sensory system agents|mesh-ancestor
101774226|NCT00797784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101774227|NCT00797784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774228|NCT00797784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101774229|NCT00797784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101774230|NCT00797784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101431641|NCT00180921|Imatinib Mesylate|imatinib mesylate|mesh-list
101774231|NCT00797784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101774232|NCT00797784|Immunologic Factors|immunologic factors|mesh-ancestor
101774233|NCT00747968|Exenatide|exenatide|mesh-list
101774234|NCT00747968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101774235|NCT00747968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774236|NCT00747968|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101774237|NCT00747968|Incretins|incretins|mesh-ancestor
101774238|NCT00747968|Hormones|hormones|mesh-ancestor
101774239|NCT00747968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101774240|NCT00755924|Acetic Acid|acetic acid|mesh-list
101774241|NCT00755924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101774242|NCT00755924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101774253|NCT00798252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101774254|NCT00798252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101774255|NCT00798252|Tubulin Modulators|tubulin modulators|mesh-ancestor
101774256|NCT00798252|Antimitotic Agents|antimitotic agents|mesh-ancestor
101774257|NCT00798252|Mitosis Modulators|mitosis modulators|mesh-ancestor
101774259|NCT00798252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101774321|NCT00800826|Analgesics|analgesics|mesh-ancestor
101774322|NCT00800826|Sensory System Agents|sensory system agents|mesh-ancestor
101774323|NCT00800826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101774324|NCT00800826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101774392|NCT00748358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101774393|NCT00748358|Growth Substances|growth substances|mesh-ancestor
101774394|NCT00748358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774399|NCT00748436|Betahistine|betahistine|mesh-list
101774464|NCT00685334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101774465|NCT00685334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101774466|NCT00685334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101774467|NCT00685334|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101774482|NCT00801294|Nintedanib|nintedanib|mesh-list
101774536|NCT00933309|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101774537|NCT00933309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101774538|NCT00933309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101774539|NCT00933309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774540|NCT00933309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101774541|NCT00933309|Hormone Antagonists|hormone antagonists|mesh-ancestor
101774542|NCT00933309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101774544|NCT00352885|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101774602|NCT00933777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101774603|NCT00933777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101774604|NCT00933777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774605|NCT00933777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101432022|NCT00409227|Alfuzosin|alfuzosin|mesh-list
101774606|NCT00933777|Immunologic Factors|immunologic factors|mesh-ancestor
101774607|NCT00933777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774608|NCT00933777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101774609|NCT00801450|Triamcinolone|triamcinolone|mesh-list
101774610|NCT00801450|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101774611|NCT00801450|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101774612|NCT00801450|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101774664|NCT04003402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101774665|NCT04003402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774666|NCT00576056|Sorafenib|sorafenib|mesh-list
101774667|NCT00576056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101774734|NCT00991822|Timolol|timolol|mesh-list
101774735|NCT00991822|Dorzolamide|dorzolamide|mesh-list
101774736|NCT00991822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101774737|NCT00991822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101774738|NCT00991822|Adrenergic Agents|adrenergic agents|mesh-ancestor
101774739|NCT00991822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101774740|NCT00991822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774741|NCT00991822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774742|NCT00991822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101774743|NCT00991822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101774744|NCT00991822|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101774745|NCT00991822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101774746|NCT00798954|Sirolimus|sirolimus|mesh-list
101774795|NCT00939549|Alkylating Agents|alkylating agents|mesh-ancestor
101774796|NCT00939549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101774797|NCT00939549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101774798|NCT00939549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101774866|NCT00801918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101774867|NCT00801918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101774868|NCT00801918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101774869|NCT00801918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101774870|NCT00801918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101774871|NCT00801918|Analgesics|analgesics|mesh-ancestor
101774872|NCT00801918|Sensory System Agents|sensory system agents|mesh-ancestor
101774874|NCT00799188|Everolimus|everolimus|mesh-list
101774934|NCT00658788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101774935|NCT00658788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101774936|NCT00658788|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101774937|NCT00658788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101775002|NCT00802308|Analgesics|analgesics|mesh-ancestor
101775003|NCT00802308|Sensory System Agents|sensory system agents|mesh-ancestor
101775005|NCT00562965|Dexamethasone|dexamethasone|mesh-list
101775077|NCT00800358|Micronutrients|micronutrients|mesh-ancestor
101775149|NCT00537082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775150|NCT00537082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101775151|NCT00537082|Immunologic Factors|immunologic factors|mesh-ancestor
101775152|NCT00537082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775154|NCT00805662|Oxytocics|oxytocics|mesh-ancestor
101775155|NCT00805662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101775156|NCT00805662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775157|NCT04978012|Fluzoparib|fluzoparib|mesh-list
101775158|NCT04978012|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101775159|NCT04978012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775160|NCT04978012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775161|NCT04978012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101775162|NCT00803166|Clobetasol|clobetasol|mesh-list
101775163|NCT00803166|Halobetasol|halobetasol|mesh-list
101775164|NCT00803166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101775165|NCT00803166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101775166|NCT00803166|Glucocorticoids|glucocorticoids|mesh-ancestor
101775167|NCT00803166|Hormones|hormones|mesh-ancestor
101775168|NCT00803166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101775169|NCT00803166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775202|NCT00935571|Sensory System Agents|sensory system agents|mesh-ancestor
101432623|NCT00157235|Anticonvulsants|anticonvulsants|mesh-ancestor
101775203|NCT00935571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101775205|NCT00324649|Zidovudine|zidovudine|mesh-list
101775216|NCT03743259|Charcoal|charcoal|mesh-list
101575063|NCT02750917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575065|NCT02750995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101575066|NCT02750995|Antimetabolites|antimetabolites|mesh-ancestor
101575067|NCT02750995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575068|NCT02750995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101575069|NCT02750995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101575130|NCT02750137|Anesthetics, Local|anesthetics, local|mesh-ancestor
101575131|NCT02750137|Anesthetics|anesthetics|mesh-ancestor
101575132|NCT02750137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101575134|NCT02750137|Sensory System Agents|sensory system agents|mesh-ancestor
101575201|NCT02758873|Hormone Antagonists|hormone antagonists|mesh-ancestor
101575202|NCT02758873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101575203|NCT02758873|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101575204|NCT02758873|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101575206|NCT02749747|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101575207|NCT02749747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101575208|NCT02749747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101575209|NCT02749747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575210|NCT02749747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101575211|NCT02749747|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101575212|NCT02749747|Dopamine Agents|dopamine agents|mesh-ancestor
101575213|NCT02749747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101575214|NCT02749747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575215|NCT02749747|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101575216|NCT02749747|Antidepressive Agents|antidepressive agents|mesh-ancestor
101575217|NCT02749591|Botulinum Toxins|botulinum toxins|mesh-list
101575218|NCT02749591|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101575219|NCT02749591|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101575220|NCT02749591|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101575221|NCT02749591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101575222|NCT02749591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575223|NCT02749591|Cholinergic Agents|cholinergic agents|mesh-ancestor
101575224|NCT02749591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101575225|NCT02749591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575226|NCT02749591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101575227|NCT02749591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101575228|NCT04359979|Tamsulosin|tamsulosin|mesh-list
101575229|NCT04359979|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101575230|NCT04359979|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101575237|NCT04180813|Linagliptin|linagliptin|mesh-list
101575240|NCT04180813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575241|NCT04180813|Incretins|incretins|mesh-ancestor
101575242|NCT04180813|Hormones|hormones|mesh-ancestor
101575243|NCT04180813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101575244|NCT04180813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101575310|NCT01015833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101575311|NCT01015833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101575313|NCT01015833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575314|NCT01015833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101575315|NCT03523273|Liraglutide|liraglutide|mesh-list
101575316|NCT03523273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101575317|NCT03523273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575318|NCT03523273|Incretins|incretins|mesh-ancestor
101575319|NCT03523273|Hormones|hormones|mesh-ancestor
101575320|NCT03523273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101575321|NCT02695381|Etodolac|etodolac|mesh-list
101575322|NCT02695381|Lidocaine|lidocaine|mesh-list
101575323|NCT02695381|Anesthetics, Local|anesthetics, local|mesh-ancestor
101575371|NCT02735239|Protective Agents|protective agents|mesh-ancestor
101575372|NCT02735239|Vitamin B Complex|vitamin b complex|mesh-ancestor
101575373|NCT02735239|Vitamins|vitamins|mesh-ancestor
101575374|NCT02735239|Micronutrients|micronutrients|mesh-ancestor
101575445|NCT02751151|Dermatologic Agents|dermatologic agents|mesh-ancestor
101575446|NCT04216459|Cholecalciferol|cholecalciferol|mesh-list
101575447|NCT04216459|Vitamin D|vitamin d|mesh-list
101575448|NCT04216459|Thiamine|thiamine|mesh-list
101575449|NCT04216459|Vitamins|vitamins|mesh-ancestor
101575455|NCT04216771|Cytarabine|cytarabine|mesh-list
101575515|NCT02735395|Amoxicillin|amoxicillin|mesh-list
101575516|NCT02735395|Metronidazole|metronidazole|mesh-list
101575517|NCT02735395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101575518|NCT02735395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101575519|NCT02735395|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101575520|NCT02735395|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101575521|NCT02741947|Levodopa|levodopa|mesh-list
101575522|NCT02741947|Benserazide|benserazide|mesh-list
101575523|NCT02741947|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
101575524|NCT02741947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101575525|NCT02741947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101575526|NCT02741947|Dopamine Agents|dopamine agents|mesh-ancestor
101575527|NCT02741947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101575528|NCT02741947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575529|NCT02741947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575530|NCT02741947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101575531|NCT02740933|Demeclocycline|demeclocycline|mesh-list
101575576|NCT02739529|Mitosis Modulators|mitosis modulators|mesh-ancestor
101575577|NCT02739529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575578|NCT05544721|Ropivacaine|ropivacaine|mesh-list
101575579|NCT05544721|Anesthetics, Local|anesthetics, local|mesh-ancestor
101575580|NCT05544721|Anesthetics|anesthetics|mesh-ancestor
101575581|NCT05544721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101575582|NCT05544721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575583|NCT05544721|Sensory System Agents|sensory system agents|mesh-ancestor
101575591|NCT02739061|Sertraline|sertraline|mesh-list
101575641|NCT02737813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101575642|NCT02737813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575643|NCT02737813|Sensory System Agents|sensory system agents|mesh-ancestor
101575714|NCT03326791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101575715|NCT03326791|Antipyretics|antipyretics|mesh-ancestor
101575716|NCT02743975|Bevacizumab|bevacizumab|mesh-list
101575717|NCT02743975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101575718|NCT02743975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101575719|NCT02743975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101575720|NCT02743975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101575721|NCT02743975|Growth Substances|growth substances|mesh-ancestor
101575722|NCT02743975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575723|NCT02743975|Growth Inhibitors|growth inhibitors|mesh-ancestor
101575724|NCT02743663|Albuterol|albuterol|mesh-list
101575725|NCT02743663|Bronchodilator Agents|bronchodilator agents|mesh-list
101575726|NCT02743663|Autonomic Agents|autonomic agents|mesh-ancestor
101575727|NCT02743663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101575728|NCT02743663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575729|NCT02743663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101575774|NCT04205929|Curcumin|curcumin|mesh-list
101575775|NCT04205929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101575776|NCT04205929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101575777|NCT04205929|Analgesics|analgesics|mesh-ancestor
101575786|NCT03259867|Nivolumab|nivolumab|mesh-list
101575844|NCT02732197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101575845|NCT02732197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101575846|NCT02732197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101575914|NCT02728843|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101575915|NCT02728843|Chelating Agents|chelating agents|mesh-ancestor
101575916|NCT02728843|Sequestering Agents|sequestering agents|mesh-ancestor
101575917|NCT02728843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101575918|NCT02726503|Lenvatinib|lenvatinib|mesh-list
101575919|NCT02726503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101575920|NCT02726503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101575921|NCT02726503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101575923|NCT02720965|Anesthetics|anesthetics|mesh-list
101575979|NCT02726269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101575980|NCT02726269|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101575981|NCT02726269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101575982|NCT02694289|Metformin|metformin|mesh-list
101575983|NCT02694289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101576047|NCT02725099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101576048|NCT02725099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576049|NCT02725099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576050|NCT01225211|Ivacaftor|ivacaftor|mesh-list
101576051|NCT01225211|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101576052|NCT01225211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101576054|NCT02685709|Octreotide|octreotide|mesh-list
101576114|NCT02716129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101576115|NCT02718079|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101576116|NCT02718079|Acetylcysteine|acetylcysteine|mesh-list
101576117|NCT02718079|Mannitol|mannitol|mesh-list
101576118|NCT02718079|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101576119|NCT02718079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101576120|NCT02718079|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101576121|NCT02718079|Diuretics|diuretics|mesh-ancestor
101576122|NCT02718079|Natriuretic Agents|natriuretic agents|mesh-ancestor
101576123|NCT02718079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576183|NCT02714959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101576184|NCT02714959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101576185|NCT02714959|Antiviral Agents|antiviral agents|mesh-ancestor
101576186|NCT02714959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101576187|NCT02714725|Dexmedetomidine|dexmedetomidine|mesh-list
101576188|NCT02714725|Propofol|propofol|mesh-list
101576189|NCT02714725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101576190|NCT02714725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101576191|NCT02714725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576192|NCT02714725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101576193|NCT02714725|Analgesics|analgesics|mesh-ancestor
101576194|NCT02714725|Sensory System Agents|sensory system agents|mesh-ancestor
101576195|NCT02714725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101576196|NCT02714725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101576197|NCT02714725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101576198|NCT02714725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101576199|NCT02714725|Adrenergic Agents|adrenergic agents|mesh-ancestor
101576200|NCT02714725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101576201|NCT02714725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576202|NCT02714725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101576203|NCT02714725|Anesthetics, General|anesthetics, general|mesh-ancestor
101576204|NCT02714725|Anesthetics|anesthetics|mesh-ancestor
101576205|NCT01015287|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101576206|NCT01015287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101576207|NCT02714179|Acetaminophen|acetaminophen|mesh-list
101576208|NCT02714179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101576209|NCT02714179|Analgesics|analgesics|mesh-ancestor
101576210|NCT02714179|Sensory System Agents|sensory system agents|mesh-ancestor
101576211|NCT02714179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101576212|NCT02714179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576213|NCT02714179|Antipyretics|antipyretics|mesh-ancestor
101576214|NCT01015131|Alovudine|alovudine|mesh-list
101576215|NCT01015131|Antiviral Agents|antiviral agents|mesh-ancestor
101576216|NCT01015131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101576226|NCT02723383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576227|NCT05269537|Ephedrine|ephedrine|mesh-list
101576228|NCT05269537|Fentanyl|fentanyl|mesh-list
101576229|NCT05269537|Bupivacaine|bupivacaine|mesh-list
101576297|NCT02722759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101576298|NCT02722759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101576299|NCT02722447|Rivaroxaban|rivaroxaban|mesh-list
101576307|NCT01222403|Vaccines|vaccines|mesh-list
101576372|NCT01014585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101576373|NCT01014585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576374|NCT01014585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101576375|NCT01014585|Analgesics|analgesics|mesh-ancestor
101576376|NCT01014585|Sensory System Agents|sensory system agents|mesh-ancestor
101576377|NCT01014585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101576378|NCT01014585|Antidepressive Agents|antidepressive agents|mesh-ancestor
101576379|NCT01014585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101576380|NCT00611143|Atorvastatin|atorvastatin|mesh-list
101576381|NCT00611143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101576382|NCT00611143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101576383|NCT00611143|Antimetabolites|antimetabolites|mesh-ancestor
101576384|NCT00611143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576385|NCT00611143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101576387|NCT00611143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101576433|NCT02722603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101576434|NCT02722603|Narcotics|narcotics|mesh-ancestor
101576435|NCT02712697|Prednisone|prednisone|mesh-list
101576436|NCT02712697|Hormones|hormones|mesh-list
101576437|NCT02712697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101576438|NCT02712697|Glucocorticoids|glucocorticoids|mesh-ancestor
101576439|NCT02712697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101576504|NCT02708251|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101576505|NCT02708251|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101576506|NCT02708251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101576507|NCT02708251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576508|NCT02708251|Vasodilator Agents|vasodilator agents|mesh-ancestor
101576510|NCT02708173|Immunologic Factors|immunologic factors|mesh-ancestor
101576511|NCT02708173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576512|NCT00611611|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101576513|NCT00611611|Immunologic Factors|immunologic factors|mesh-ancestor
101576514|NCT00611611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576515|NCT00612625|Glucagon|glucagon|mesh-list
101576516|NCT00612625|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101576564|NCT00940498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576566|NCT03820531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101576567|NCT02850718|Sildenafil Citrate|sildenafil citrate|mesh-list
101576568|NCT02850718|Vasodilator Agents|vasodilator agents|mesh-ancestor
101576569|NCT02850718|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101576570|NCT02850718|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101576571|NCT02850718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101576572|NCT02850718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576573|NCT02850718|Urological Agents|urological agents|mesh-ancestor
101576574|NCT02707393|Cyclosporine|cyclosporine|mesh-list
101576575|NCT02707393|Mycophenolic Acid|mycophenolic acid|mesh-list
101576576|NCT02707393|Fludarabine|fludarabine|mesh-list
101576577|NCT02707393|Melphalan|melphalan|mesh-list
101576578|NCT02707393|Thiotepa|thiotepa|mesh-list
101576579|NCT02707393|Cyclosporins|cyclosporins|mesh-list
101576580|NCT02707393|Thymoglobulin|thymoglobulin|mesh-list
101576581|NCT02707393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101576583|NCT02707393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101576622|NCT00604942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101576623|NCT00604942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101576624|NCT00604942|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101576625|NCT00604942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101576626|NCT00604942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576627|NCT00604942|Antiemetics|antiemetics|mesh-ancestor
101576628|NCT00604942|Autonomic Agents|autonomic agents|mesh-ancestor
101576629|NCT00604942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101576630|NCT00604942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576631|NCT00604942|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101576632|NCT00604942|Dopamine Agents|dopamine agents|mesh-ancestor
101576633|NCT00604942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101576634|NCT02711683|3-n-butylphthalide|3-n-butylphthalide|mesh-list
101576635|NCT02711683|Donepezil|donepezil|mesh-list
101576636|NCT02711683|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101576682|NCT00605098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101576683|NCT00605098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101576684|NCT00605098|Antiviral Agents|antiviral agents|mesh-ancestor
101576685|NCT00605098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101576752|NCT03961165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101576753|NCT03961165|Mydriatics|mydriatics|mesh-ancestor
101576754|NCT02706535|Itraconazole|itraconazole|mesh-list
101576756|NCT02706535|Antifungal Agents|antifungal agents|mesh-ancestor
101576757|NCT02706535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101576758|NCT02706535|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101576819|NCT00605410|Ipratropium|ipratropium|mesh-list
101576820|NCT00605410|Anticonvulsants|anticonvulsants|mesh-ancestor
101576821|NCT00605410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101576822|NCT00605410|Autonomic Agents|autonomic agents|mesh-ancestor
101576823|NCT00605410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101576892|NCT01010217|Tacrolimus|tacrolimus|mesh-list
101576893|NCT01010217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101576894|NCT01010217|Immunologic Factors|immunologic factors|mesh-ancestor
101576895|NCT01010217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576896|NCT01010217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101576897|NCT01010217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101576898|NCT01010217|Alkylating Agents|alkylating agents|mesh-ancestor
101576899|NCT01010217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576900|NCT01010217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101576901|NCT01010217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101576956|NCT01217957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101576957|NCT01217957|Growth Substances|growth substances|mesh-ancestor
101576958|NCT01217957|Growth Inhibitors|growth inhibitors|mesh-ancestor
101576959|NCT01217957|Protease Inhibitors|protease inhibitors|mesh-ancestor
101576960|NCT01217957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101576961|NCT01217957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101576962|NCT01217801|Ondansetron|ondansetron|mesh-list
101576963|NCT01217801|Antiemetics|antiemetics|mesh-ancestor
101576964|NCT01217801|Autonomic Agents|autonomic agents|mesh-ancestor
101576965|NCT01217801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101576966|NCT01217801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101576967|NCT01217801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101576968|NCT01217801|Antipruritics|antipruritics|mesh-ancestor
101576969|NCT01217801|Dermatologic Agents|dermatologic agents|mesh-ancestor
101577016|NCT01216163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101577017|NCT01216163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101577018|NCT01216163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577019|NCT05260255|Vitamin D|vitamin d|mesh-list
101577020|NCT05260255|Ergocalciferols|ergocalciferols|mesh-list
101577021|NCT05260255|Vitamins|vitamins|mesh-ancestor
101577022|NCT05260255|Micronutrients|micronutrients|mesh-ancestor
101577023|NCT05260255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577024|NCT05260255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101577025|NCT05260255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101577026|NCT00612469|Chlorhexidine|chlorhexidine|mesh-list
101577027|NCT00612469|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101577028|NCT00612469|Listerine|listerine|mesh-list
101577029|NCT00612469|Vancomycin|vancomycin|mesh-list
101577030|NCT00612469|Fluorides|fluorides|mesh-list
101577031|NCT00612469|Sodium Fluoride|sodium fluoride|mesh-list
101577032|NCT00612469|Cariostatic Agents|cariostatic agents|mesh-ancestor
101577033|NCT00612469|Protective Agents|protective agents|mesh-ancestor
101577034|NCT00612469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577035|NCT00612469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101577073|NCT05244031|Sensory System Agents|sensory system agents|mesh-ancestor
101577074|NCT05244031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101577075|NCT04712071|Ketamine|ketamine|mesh-list
101233943|NCT01575301|Exenatide|exenatide|mesh-list
101577076|NCT04712071|Analgesics|analgesics|mesh-ancestor
101577077|NCT04712071|Sensory System Agents|sensory system agents|mesh-ancestor
101577078|NCT04712071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101577079|NCT04712071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577080|NCT04712071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101577081|NCT04712071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101577082|NCT04712071|Anesthetics, General|anesthetics, general|mesh-ancestor
101577139|NCT04264624|Vasodilator Agents|vasodilator agents|mesh-ancestor
101577140|NCT04188691|Vaccines|vaccines|mesh-list
101577141|NCT04188691|Immunologic Factors|immunologic factors|mesh-ancestor
101577142|NCT04188691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577143|NCT01215851|Moxifloxacin|moxifloxacin|mesh-list
101577144|NCT01215851|Pyrazinamide|pyrazinamide|mesh-list
101577145|NCT01215851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101577146|NCT01215851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101577147|NCT01215851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101577148|NCT01215851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101577171|NCT00609544|Rilonacept|rilonacept|mesh-list
101577203|NCT04611139|Pembrolizumab|pembrolizumab|mesh-list
101577205|NCT04611139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101577206|NCT04611139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101577275|NCT01009983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101577276|NCT01009983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101577278|NCT01009983|Antimitotic Agents|antimitotic agents|mesh-ancestor
101577279|NCT01009983|Mitosis Modulators|mitosis modulators|mesh-ancestor
101577280|NCT01009983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577347|NCT01214915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577348|NCT01214915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101577419|NCT03685747|Vancomycin|vancomycin|mesh-list
101577420|NCT03685747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101577421|NCT03685747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101577422|NCT03586687|Triamcinolone|triamcinolone|mesh-list
101577423|NCT03586687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101577424|NCT03586687|Glucocorticoids|glucocorticoids|mesh-ancestor
101577425|NCT03586687|Hormones|hormones|mesh-ancestor
101577426|NCT03586687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101577427|NCT03586687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577428|NCT01212185|Oxytocin|oxytocin|mesh-list
101577429|NCT01212185|Oxytocics|oxytocics|mesh-ancestor
101577430|NCT01212185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101577431|NCT01212185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577432|NCT00613717|Vitamin D|vitamin d|mesh-list
101577433|NCT00613717|Vitamins|vitamins|mesh-list
101577434|NCT00613717|Folic Acid|folic acid|mesh-list
101577435|NCT00613717|Vitamin A|vitamin a|mesh-list
101577436|NCT00613717|Iron|iron|mesh-list
101577437|NCT00613717|Vitamin B Complex|vitamin b complex|mesh-list
101577438|NCT00613717|Retinol palmitate|retinol palmitate|mesh-list
101577439|NCT00613717|Micronutrients|micronutrients|mesh-ancestor
101577440|NCT00613717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577441|NCT00613717|Trace Elements|trace elements|mesh-ancestor
101577442|NCT00613717|Hematinics|hematinics|mesh-ancestor
101577443|NCT00613717|Antioxidants|antioxidants|mesh-ancestor
101577444|NCT00613717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577445|NCT00613717|Protective Agents|protective agents|mesh-ancestor
101577446|NCT00613717|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101577447|NCT00613717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101577448|NCT00613717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101577449|NCT03369301|Immunoglobulins|immunoglobulins|mesh-list
101577450|NCT03369301|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101577451|NCT03369301|Antibodies|antibodies|mesh-list
101577452|NCT03369301|Immunologic Factors|immunologic factors|mesh-ancestor
101577464|NCT05345119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101577541|NCT02430181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577543|NCT02430181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101577544|NCT02430181|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101577545|NCT02430181|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101577546|NCT02430181|Immunologic Factors|immunologic factors|mesh-ancestor
101577547|NCT02430181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577548|NCT00614653|Bevacizumab|bevacizumab|mesh-list
101577549|NCT00614653|Capecitabine|capecitabine|mesh-list
101577550|NCT00614653|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101577551|NCT00614653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101577552|NCT00614653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101577553|NCT00614653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101577554|NCT00614653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101577555|NCT00614653|Growth Substances|growth substances|mesh-ancestor
101577556|NCT00614653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577557|NCT00614653|Growth Inhibitors|growth inhibitors|mesh-ancestor
101577558|NCT00614653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101577559|NCT00614653|Antimetabolites|antimetabolites|mesh-ancestor
101577560|NCT00614653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577561|NCT00614653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101577562|NCT00614653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101577563|NCT03909451|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
101577588|NCT02118727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577589|NCT02118727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577590|NCT02118727|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101577591|NCT02118727|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101577653|NCT02699281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101577654|NCT02699281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577655|NCT02699281|Hormones|hormones|mesh-ancestor
101577656|NCT02699281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101577657|NCT02704507|Triamcinolone|triamcinolone|mesh-list
101577658|NCT02704507|Tretinoin|tretinoin|mesh-list
101577659|NCT02704507|Emollients|emollients|mesh-list
101577660|NCT02704507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101577661|NCT02704507|Glucocorticoids|glucocorticoids|mesh-ancestor
101577662|NCT02704507|Hormones|hormones|mesh-ancestor
101577720|NCT02698969|Respiratory System Agents|respiratory system agents|mesh-ancestor
101577721|NCT02698969|Mydriatics|mydriatics|mesh-ancestor
101577722|NCT02698969|Parasympatholytics|parasympatholytics|mesh-ancestor
101577723|NCT02698969|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101577789|NCT00405613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101577790|NCT00405613|Antipyretics|antipyretics|mesh-ancestor
101577791|NCT02703961|Cisplatin|cisplatin|mesh-list
101577792|NCT02703961|Docetaxel|docetaxel|mesh-list
101577793|NCT02703961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101577794|NCT02703961|Tubulin Modulators|tubulin modulators|mesh-ancestor
101577795|NCT02703961|Antimitotic Agents|antimitotic agents|mesh-ancestor
101577796|NCT02703961|Mitosis Modulators|mitosis modulators|mesh-ancestor
101577797|NCT02703961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577798|NCT02703649|Letrozole|letrozole|mesh-list
101577799|NCT02703649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101577800|NCT02703649|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101577801|NCT02703649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101577802|NCT02703649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101577803|NCT02703649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577804|NCT02703649|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101577805|NCT02703649|Hormone Antagonists|hormone antagonists|mesh-ancestor
101577806|NCT02703649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101577807|NCT02703649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577845|NCT01208207|Etoricoxib|etoricoxib|mesh-list
101577846|NCT01208207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101577847|NCT01208207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101577848|NCT01208207|Analgesics|analgesics|mesh-ancestor
101577849|NCT01208207|Sensory System Agents|sensory system agents|mesh-ancestor
101577850|NCT01208207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101577851|NCT01208207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101577911|NCT01007253|Histamine Antagonists|histamine antagonists|mesh-ancestor
101577913|NCT01007253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101577914|NCT01007253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577915|NCT02691949|Mycophenolic Acid|mycophenolic acid|mesh-list
101577916|NCT02691949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101577980|NCT02698267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101577981|NCT02698267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101577982|NCT02698267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101577983|NCT02698267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101577984|NCT02698267|Hormone Antagonists|hormone antagonists|mesh-ancestor
101577985|NCT02698267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101577986|NCT02698267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578046|NCT02697955|Adrenergic Agents|adrenergic agents|mesh-ancestor
101578047|NCT02697955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101578048|NCT02697955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234918|NCT01588873|NuvaRing|nuvaring|mesh-list
101578049|NCT02697955|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101578050|NCT02697955|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101578051|NCT02697955|Autonomic Agents|autonomic agents|mesh-ancestor
101578052|NCT02697955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101578053|NCT02697955|Respiratory System Agents|respiratory system agents|mesh-ancestor
101578054|NCT02697955|Mydriatics|mydriatics|mesh-ancestor
101578110|NCT02697877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578112|NCT04214665|Antioxidants|antioxidants|mesh-ancestor
101578113|NCT04214665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578114|NCT04214665|Protective Agents|protective agents|mesh-ancestor
101578115|NCT04214665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578116|NCT04214665|Vitamin B Complex|vitamin b complex|mesh-ancestor
101578117|NCT04214665|Vitamins|vitamins|mesh-ancestor
101578175|NCT02700685|Protective Agents|protective agents|mesh-ancestor
101578176|NCT02700685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101578177|NCT02700763|Dabrafenib|dabrafenib|mesh-list
101578178|NCT02700763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101578179|NCT02700763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101578180|NCT02700763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101578182|NCT03151681|Propranolol|propranolol|mesh-list
101578242|NCT02699827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101578243|NCT02699827|Tocolytic Agents|tocolytic agents|mesh-ancestor
101578244|NCT02699827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101578245|NCT02699827|Anesthetics, Local|anesthetics, local|mesh-ancestor
101578246|NCT02705989|Branebrutinib|branebrutinib|mesh-list
101578248|NCT02705989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101578309|NCT00616915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101578310|NCT00616915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578311|NCT00616915|Dopamine Agents|dopamine agents|mesh-ancestor
101578312|NCT00616915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101578313|NCT00616915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578314|NCT00616915|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101578315|NCT00616915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101578316|NCT00616915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101578317|NCT05410223|Amoxicillin|amoxicillin|mesh-list
101578318|NCT05410223|Clarithromycin|clarithromycin|mesh-list
101578319|NCT05410223|Doxycycline|doxycycline|mesh-list
101578320|NCT05410223|Furazolidone|furazolidone|mesh-list
101578321|NCT05410223|Bismuth|bismuth|mesh-list
101578322|NCT05410223|Antibodies|antibodies|mesh-list
101578323|NCT05410223|Immunoglobulins|immunoglobulins|mesh-list
101578324|NCT05410223|Immunologic Factors|immunologic factors|mesh-ancestor
101578333|NCT05410223|Antimalarials|antimalarials|mesh-ancestor
101578367|NCT00997503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101578368|NCT00997503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101578369|NCT00997503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101578370|NCT00997503|Antipyretics|antipyretics|mesh-ancestor
101578371|NCT02705053|Insulin|insulin|mesh-list
101578372|NCT02705053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101578374|NCT01204775|Metformin|metformin|mesh-list
101578434|NCT00997035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101578435|NCT00997035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578436|NCT00997035|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101578437|NCT01204697|Docetaxel|docetaxel|mesh-list
101578438|NCT01204697|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101578439|NCT01204697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101578440|NCT01204697|Tubulin Modulators|tubulin modulators|mesh-ancestor
101578441|NCT01204697|Antimitotic Agents|antimitotic agents|mesh-ancestor
101578442|NCT01204697|Mitosis Modulators|mitosis modulators|mesh-ancestor
101578444|NCT01204697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101578498|NCT04212403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578499|NCT04212403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101578500|NCT04212403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101578501|NCT04212403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101578502|NCT00637117|Interferons|interferons|mesh-list
101578503|NCT00637117|Interferon-alpha|interferon-alpha|mesh-list
101578504|NCT00637117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101578505|NCT00637117|Antiviral Agents|antiviral agents|mesh-ancestor
101578506|NCT00637117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101578561|NCT00619333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101578562|NCT04924621|Midazolam|midazolam|mesh-list
101578563|NCT04924621|Sufentanil|sufentanil|mesh-list
101578564|NCT04924621|Propofol|propofol|mesh-list
101578565|NCT04924621|Tetracaine|tetracaine|mesh-list
101578566|NCT04924621|Rocuronium|rocuronium|mesh-list
101578632|NCT00618241|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101578633|NCT00618397|Ketamine|ketamine|mesh-list
101578634|NCT00618397|Analgesics|analgesics|mesh-ancestor
101578640|NCT00618397|Anesthetics, General|anesthetics, general|mesh-ancestor
101578702|NCT04160377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101578703|NCT04160377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101578704|NCT04160377|Serotonin Agents|serotonin agents|mesh-ancestor
101578705|NCT04160377|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101578706|NCT04160377|Antidepressive Agents|antidepressive agents|mesh-ancestor
101578707|NCT04160377|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101578708|NCT04160377|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101578709|NCT04160377|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101578710|NCT01000155|Vorinostat|vorinostat|mesh-list
101578711|NCT01000155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101578712|NCT01000155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101578713|NCT01000155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101578714|NCT01000155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578715|NCT00999921|Tamoxifen|tamoxifen|mesh-list
101578716|NCT00999921|Evening primrose oil|evening primrose oil|mesh-list
101578717|NCT00999921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101578718|NCT00999921|Hormone Antagonists|hormone antagonists|mesh-ancestor
101578719|NCT00999921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101578728|NCT00999921|Analgesics|analgesics|mesh-ancestor
101578755|NCT01002573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101578756|NCT01002573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101578757|NCT01002573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101578758|NCT01002573|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101578826|NCT00620971|Antimitotic Agents|antimitotic agents|mesh-ancestor
101578827|NCT00620971|Mitosis Modulators|mitosis modulators|mesh-ancestor
101578828|NCT00620971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101578829|NCT04223661|Dexamethasone|dexamethasone|mesh-list
101578830|NCT04223661|Lenalidomide|lenalidomide|mesh-list
101578896|NCT00621361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101578897|NCT00621361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101578898|NCT00621361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101578899|NCT00621361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578900|NCT00621361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101578901|NCT04208581|Fluticasone|fluticasone|mesh-list
101578902|NCT04208581|Xhance|xhance|mesh-list
101578903|NCT04208581|Budesonide|budesonide|mesh-list
101578904|NCT04208581|Bromides|bromides|mesh-list
101578905|NCT04208581|Formoterol Fumarate|formoterol fumarate|mesh-list
101578906|NCT04208581|Tiotropium Bromide|tiotropium bromide|mesh-list
101578907|NCT04208581|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101578909|NCT04208581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101578971|NCT02641873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101578972|NCT02641873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101578973|NCT02641873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101578974|NCT02641873|Antidotes|antidotes|mesh-ancestor
101578975|NCT02641873|Protective Agents|protective agents|mesh-ancestor
101578976|NCT02641873|Vitamin B Complex|vitamin b complex|mesh-ancestor
101578977|NCT02641873|Vitamins|vitamins|mesh-ancestor
101578978|NCT02641873|Micronutrients|micronutrients|mesh-ancestor
101578979|NCT00998985|Grazoprevir|grazoprevir|mesh-list
101578980|NCT00998985|Antiviral Agents|antiviral agents|mesh-ancestor
101578981|NCT00998985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101578982|NCT05240391|Midodrine|midodrine|mesh-list
101578983|NCT05240391|Sympathomimetics|sympathomimetics|mesh-ancestor
101578984|NCT05240391|Autonomic Agents|autonomic agents|mesh-ancestor
101578985|NCT05240391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101578986|NCT05240391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579030|NCT02868801|Anticonvulsants|anticonvulsants|mesh-ancestor
101579031|NCT02868801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101579032|NCT02868801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101579033|NCT02868801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579034|NCT02868801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101579035|NCT02868801|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101579036|NCT02868801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101579037|NCT02868801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101579038|NCT02868801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101579039|NCT01002339|Mycophenolic Acid|mycophenolic acid|mesh-list
101579040|NCT01002339|Cyclosporine|cyclosporine|mesh-list
101579041|NCT01002339|Prednisone|prednisone|mesh-list
101579042|NCT01002339|Tacrolimus|tacrolimus|mesh-list
101579043|NCT01002339|Basiliximab|basiliximab|mesh-list
101579044|NCT01002339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101579045|NCT01002339|Immunologic Factors|immunologic factors|mesh-ancestor
101579046|NCT01002339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579047|NCT01002339|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101579048|NCT01002339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101579049|NCT01002339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579050|NCT01002339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101579051|NCT01002339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101579052|NCT01002339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101579053|NCT01002339|Antitubercular Agents|antitubercular agents|mesh-ancestor
101579054|NCT01002339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101579079|NCT00995085|Pyridoxine|pyridoxine|mesh-list
101579080|NCT00995085|Metadoxine|metadoxine|mesh-list
101579081|NCT00995085|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101579082|NCT00995085|Vitamin B Complex|vitamin b complex|mesh-ancestor
101579083|NCT00995085|Vitamins|vitamins|mesh-ancestor
101579084|NCT00995085|Micronutrients|micronutrients|mesh-ancestor
101579085|NCT00995085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579086|NCT00603733|Mesalamine|mesalamine|mesh-list
101579087|NCT00603733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101579088|NCT00603733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101579089|NCT00603733|Analgesics|analgesics|mesh-ancestor
101579090|NCT00603733|Sensory System Agents|sensory system agents|mesh-ancestor
101579091|NCT00603733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101579092|NCT00603733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579093|NCT00603733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101579094|NCT00603733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101579095|NCT02471911|Dexamethasone|dexamethasone|mesh-list
101579139|NCT01678027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101579140|NCT01678027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101579141|NCT01678027|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101579142|NCT01678027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101579143|NCT01678027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579144|NCT01678027|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101579145|NCT01678027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101579147|NCT02697331|Progestins|progestins|mesh-ancestor
101579148|NCT02697331|Hormones|hormones|mesh-ancestor
101579203|NCT00993915|Atorvastatin|atorvastatin|mesh-list
101579204|NCT00993915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101579205|NCT00993915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101579206|NCT00993915|Antimetabolites|antimetabolites|mesh-ancestor
101579207|NCT00993915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579208|NCT00993915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101579209|NCT00993915|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101579210|NCT00993915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101579211|NCT01202591|Fulvestrant|fulvestrant|mesh-list
101579212|NCT01202591|Exemestane|exemestane|mesh-list
101579213|NCT01202591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101579214|NCT01202591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101579215|NCT01202591|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101579216|NCT01202591|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101579217|NCT01202591|Hormone Antagonists|hormone antagonists|mesh-ancestor
101579218|NCT01202591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101579219|NCT01202591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579220|NCT01202591|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101579221|NCT01202591|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101579222|NCT01202591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101579223|NCT01202591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579224|NCT01202279|Phenylpropanolamine|phenylpropanolamine|mesh-list
101579225|NCT01202279|Pseudoephedrine|pseudoephedrine|mesh-list
101579226|NCT01202279|Guaifenesin|guaifenesin|mesh-list
101579227|NCT01202279|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
101579228|NCT01202279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101579229|NCT01202279|Autonomic Agents|autonomic agents|mesh-ancestor
101579230|NCT01202279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101579231|NCT01202279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579245|NCT03877315|Cimetidine|cimetidine|mesh-list
101579246|NCT03877315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101579247|NCT03877315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101579248|NCT03877315|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101579249|NCT03877315|Histamine Antagonists|histamine antagonists|mesh-ancestor
101579250|NCT03877315|Histamine Agents|histamine agents|mesh-ancestor
101579257|NCT02687347|Morphine|morphine|mesh-list
101579318|NCT05392127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101579319|NCT05392127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579320|NCT05392127|Anticoagulants|anticoagulants|mesh-ancestor
101579321|NCT05392127|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101579322|NCT05392127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101355773|NCT00031499|Azithromycin|azithromycin|mesh-list
101579323|NCT05392127|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101579324|NCT05392127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101579325|NCT05392127|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101579384|NCT01201265|Antimetabolites|antimetabolites|mesh-ancestor
101579385|NCT01201265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579386|NCT04246801|Clobetasol|clobetasol|mesh-list
101579387|NCT04246801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101579388|NCT04246801|Glucocorticoids|glucocorticoids|mesh-ancestor
101579389|NCT04246801|Hormones|hormones|mesh-ancestor
101236324|NCT01597206|Cobalt|cobalt|mesh-list
101579390|NCT04246801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101579391|NCT04246801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579392|NCT00638677|Sorbitol|sorbitol|mesh-list
101579393|NCT00638677|Cathartics|cathartics|mesh-ancestor
101579394|NCT00638677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101579395|NCT01200485|Allopurinol|allopurinol|mesh-list
101579396|NCT01200485|Rasburicase|rasburicase|mesh-list
101579397|NCT01200485|Antimetabolites|antimetabolites|mesh-ancestor
101579446|NCT02688595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101579447|NCT02688595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579448|NCT01200329|Gemcitabine|gemcitabine|mesh-list
101579450|NCT01200329|Busulfan|busulfan|mesh-list
101579451|NCT01200329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101579452|NCT01200329|Antimetabolites|antimetabolites|mesh-ancestor
101579453|NCT01200329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579515|NCT00640081|Protective Agents|protective agents|mesh-ancestor
101579516|NCT00640081|Vitamin B Complex|vitamin b complex|mesh-ancestor
101579517|NCT00640081|Vitamins|vitamins|mesh-ancestor
101579518|NCT00640081|Micronutrients|micronutrients|mesh-ancestor
101579521|NCT01199705|Antibodies|antibodies|mesh-list
101579582|NCT02686177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101579583|NCT02686021|Dipyrone|dipyrone|mesh-list
101579584|NCT02686021|Ibuprofen|ibuprofen|mesh-list
101579585|NCT02686021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101579586|NCT02686021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101579587|NCT02686021|Analgesics|analgesics|mesh-ancestor
101579588|NCT02686021|Sensory System Agents|sensory system agents|mesh-ancestor
101579589|NCT02686021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101579590|NCT02686021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579591|NCT02686021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101579592|NCT02686021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101579593|NCT02686021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101579594|NCT02686021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101579596|NCT02686021|Antipyretics|antipyretics|mesh-ancestor
101579640|NCT02683213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101579641|NCT02683213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101579642|NCT04185103|Valsartan|valsartan|mesh-list
101579643|NCT04185103|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101579644|NCT04185103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101579645|NCT04185103|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101579646|NCT04185103|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101579647|NCT04185103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579648|NCT04033939|Propofol|propofol|mesh-list
101579649|NCT04033939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101579650|NCT04033939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101579651|NCT04033939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579652|NCT04033939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101579653|NCT04033939|Anesthetics, General|anesthetics, general|mesh-ancestor
101579654|NCT04033939|Anesthetics|anesthetics|mesh-ancestor
101579655|NCT00639691|Omalizumab|omalizumab|mesh-list
101579656|NCT00639691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101579657|NCT00639691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101579695|NCT00602797|Mitosis Modulators|mitosis modulators|mesh-ancestor
101579696|NCT00602797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579697|NCT01158222|Sunitinib|sunitinib|mesh-list
101579698|NCT01158222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101579699|NCT01158222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101579700|NCT01158222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101579701|NCT01158222|Growth Substances|growth substances|mesh-ancestor
101579702|NCT01158222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579703|NCT01158222|Growth Inhibitors|growth inhibitors|mesh-ancestor
101579704|NCT01158222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101579705|NCT01158222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101579706|NCT01158222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579707|NCT02684305|Oxytocin|oxytocin|mesh-list
101579708|NCT02684305|Oxytocics|oxytocics|mesh-ancestor
101579709|NCT02684305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101579710|NCT02684305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579711|NCT02940769|Methamphetamine|methamphetamine|mesh-list
101579712|NCT02940769|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101579713|NCT02940769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579714|NCT02940769|Sympathomimetics|sympathomimetics|mesh-ancestor
101579715|NCT02940769|Autonomic Agents|autonomic agents|mesh-ancestor
101579716|NCT02940769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101579717|NCT02940769|Dopamine Agents|dopamine agents|mesh-ancestor
101579718|NCT02940769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101579746|NCT02683291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101579747|NCT02683291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579748|NCT02683291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101579749|NCT02683291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101579750|NCT02683291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101579751|NCT02683291|Immunologic Factors|immunologic factors|mesh-ancestor
101579752|NCT02683291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101579753|NCT02683291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101579754|NCT02683291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579755|NCT02683291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101579756|NCT02683291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101579809|NCT02680717|Immunologic Factors|immunologic factors|mesh-ancestor
101579810|NCT02680717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579811|NCT02680717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101579812|NCT02680717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101579813|NCT02680717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579814|NCT02680717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101579815|NCT02680717|Glucocorticoids|glucocorticoids|mesh-ancestor
101579816|NCT02680717|Hormones|hormones|mesh-ancestor
101579817|NCT02680717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101579818|NCT02680717|Dermatologic Agents|dermatologic agents|mesh-ancestor
101579819|NCT02680795|Belinostat|belinostat|mesh-list
101579820|NCT02680795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101579821|NCT02680795|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101579822|NCT02680795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101579823|NCT02680795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579824|NCT00640237|Calcifediol|calcifediol|mesh-list
101579825|NCT00640237|Vitamins|vitamins|mesh-ancestor
101579826|NCT00640237|Micronutrients|micronutrients|mesh-ancestor
101579827|NCT00640237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579828|NCT00640237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101579829|NCT02683759|Curcumin|curcumin|mesh-list
101579830|NCT02683759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101579831|NCT02683759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101579832|NCT02683759|Analgesics|analgesics|mesh-ancestor
101579833|NCT02683759|Sensory System Agents|sensory system agents|mesh-ancestor
101579836|NCT02683759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101579857|NCT00990249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101579858|NCT00990249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101579859|NCT00990249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101579860|NCT00990249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101579861|NCT00990249|Antimetabolites|antimetabolites|mesh-ancestor
101579863|NCT02846545|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101579864|NCT02846545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101579865|NCT02846545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101579866|NCT02846545|Immunologic Factors|immunologic factors|mesh-ancestor
101579867|NCT02846545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579868|NCT04291755|Pembrolizumab|pembrolizumab|mesh-list
101579869|NCT04291755|Nivolumab|nivolumab|mesh-list
101579870|NCT04291755|Ipilimumab|ipilimumab|mesh-list
101579871|NCT04291755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101579872|NCT04291755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101579873|NCT04291755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101579874|NCT04291755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579875|NCT04292769|Decitabine|decitabine|mesh-list
101264173|NCT01766089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101579876|NCT04292769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101579877|NCT04292769|Antimetabolites|antimetabolites|mesh-ancestor
101579878|NCT04292769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101579879|NCT04292769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101579880|NCT04292769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101579881|NCT00640939|Diclofenac|diclofenac|mesh-list
101579882|NCT00640939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101579893|NCT05663749|Metformin|metformin|mesh-list
101579902|NCT02867553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579903|NCT02867553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101579904|NCT00909961|Zoledronic Acid|zoledronic acid|mesh-list
101579905|NCT00909961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101579906|NCT00909961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101579974|NCT04291287|Fibrinolytic Agents|fibrinolytic agents|mesh-list
101579975|NCT04291287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101579976|NCT04291287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580045|NCT01195415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101580046|NCT01195415|Antimetabolites|antimetabolites|mesh-ancestor
101580047|NCT01195415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580048|NCT01195415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101580050|NCT01195103|Midazolam|midazolam|mesh-list
101580051|NCT01195103|Propofol|propofol|mesh-list
101580116|NCT01177410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101580117|NCT01177410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101580118|NCT01177410|Analgesics|analgesics|mesh-ancestor
101580124|NCT02884596|Serotonin|serotonin|mesh-list
101580188|NCT01175382|Urological Agents|urological agents|mesh-ancestor
101580189|NCT01175382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101580190|NCT01175382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101580191|NCT01175382|Cholinergic Agents|cholinergic agents|mesh-ancestor
101580192|NCT01194245|Insulin|insulin|mesh-list
101580193|NCT01194245|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101580194|NCT01194245|Insulin Glargine|insulin glargine|mesh-list
101580195|NCT01194245|Insulin Aspart|insulin aspart|mesh-list
101580196|NCT01194245|Insulin Lispro|insulin lispro|mesh-list
101580197|NCT01194245|Insulin glulisine|insulin glulisine|mesh-list
101580198|NCT01194245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101580199|NCT01194245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580200|NCT00979407|Vaccines|vaccines|mesh-list
101580201|NCT00979407|Immunologic Factors|immunologic factors|mesh-ancestor
101580202|NCT00979407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580203|NCT04290429|Teduglutide|teduglutide|mesh-list
101580204|NCT04290429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101580205|NCT04290429|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101580206|NCT04290429|Protective Agents|protective agents|mesh-ancestor
101580207|NCT04290429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580208|NCT00975975|Basiliximab|basiliximab|mesh-list
101580209|NCT00975975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101580210|NCT00975975|Immunologic Factors|immunologic factors|mesh-ancestor
101580211|NCT00975975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580212|NCT01193153|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101580213|NCT01193153|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101580214|NCT01193153|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101580215|NCT01193153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101237110|NCT04643574|Analgesics|analgesics|mesh-ancestor
101580216|NCT01193153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580217|NCT01193153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101580220|NCT01193153|Serotonin Agents|serotonin agents|mesh-ancestor
101580233|NCT02865369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101580234|NCT02865369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580308|NCT00978627|Insulin, Long-Acting|insulin, long-acting|mesh-list
101580309|NCT00978627|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101580310|NCT00978627|Insulin Detemir|insulin detemir|mesh-list
101580311|NCT00978627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101580312|NCT00978627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580313|NCT01181609|Bevacizumab|bevacizumab|mesh-list
101580314|NCT01181609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101580315|NCT01181609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101580316|NCT01181609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101580317|NCT01181609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101580318|NCT01181609|Growth Substances|growth substances|mesh-ancestor
101580371|NCT05115136|Diphenhydramine|diphenhydramine|mesh-list
101580372|NCT05115136|Promethazine|promethazine|mesh-list
101580373|NCT05115136|Doxepin|doxepin|mesh-list
101580374|NCT05115136|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101580375|NCT05115136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101580376|NCT05115136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101580377|NCT05115136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580378|NCT05115136|Anesthetics, Local|anesthetics, local|mesh-ancestor
101580379|NCT05115136|Anesthetics|anesthetics|mesh-ancestor
101580380|NCT05115136|Sensory System Agents|sensory system agents|mesh-ancestor
101580381|NCT05115136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101580382|NCT05115136|Antiemetics|antiemetics|mesh-ancestor
101580383|NCT05115136|Autonomic Agents|autonomic agents|mesh-ancestor
101580384|NCT05115136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101580385|NCT05115136|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101580386|NCT05115136|Histamine Antagonists|histamine antagonists|mesh-ancestor
101580387|NCT05115136|Histamine Agents|histamine agents|mesh-ancestor
101580388|NCT05115136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101580389|NCT05115136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580390|NCT05115136|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101580391|NCT05115136|Antipruritics|antipruritics|mesh-ancestor
101580392|NCT05115136|Dermatologic Agents|dermatologic agents|mesh-ancestor
101580393|NCT05115136|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101580394|NCT05115136|Antidepressive Agents|antidepressive agents|mesh-ancestor
101580395|NCT05115136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101580396|NCT00608374|Fludarabine|fludarabine|mesh-list
101580397|NCT00608374|Fludarabine phosphate|fludarabine phosphate|mesh-list
101580398|NCT00608374|Chlorambucil|chlorambucil|mesh-list
101580400|NCT00608374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101580401|NCT00608374|Antimetabolites|antimetabolites|mesh-ancestor
101580419|NCT00625014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101580420|NCT00625014|Dopamine Agents|dopamine agents|mesh-ancestor
101580421|NCT00625014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101580422|NCT00625014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580423|NCT00625014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101580424|NCT01147848|Fluticasone|fluticasone|mesh-list
101580425|NCT01147848|Xhance|xhance|mesh-list
101580483|NCT00979953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580485|NCT00979953|Sensory System Agents|sensory system agents|mesh-ancestor
101580486|NCT00979953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101580487|NCT01181531|Vitamin D|vitamin d|mesh-list
101643060|NCT00720382|Dermatologic Agents|dermatologic agents|mesh-ancestor
101643061|NCT00720382|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101643062|NCT00720382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101643063|NCT00720382|Autonomic Agents|autonomic agents|mesh-ancestor
101643064|NCT00720382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101643065|NCT00720382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643066|NCT00720382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101643067|NCT00720382|Respiratory System Agents|respiratory system agents|mesh-ancestor
101643068|NCT00720382|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101643069|NCT00720382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101643070|NCT00720382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643071|NCT00720382|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101643072|NCT00720382|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101643073|NCT00720382|Histamine Antagonists|histamine antagonists|mesh-ancestor
101643074|NCT00720382|Histamine Agents|histamine agents|mesh-ancestor
101643075|NCT00720382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101643076|NCT00754039|Fenofibrate|fenofibrate|mesh-list
101643077|NCT00754039|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
101643078|NCT00754039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101643079|NCT00754039|Antimetabolites|antimetabolites|mesh-ancestor
101643080|NCT00754039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643081|NCT00754039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101643082|NCT00754039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101643083|NCT02560909|Vaccines|vaccines|mesh-list
101643084|NCT02560909|Immunologic Factors|immunologic factors|mesh-ancestor
101643085|NCT02560909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643086|NCT02592226|Anesthetics|anesthetics|mesh-list
101643087|NCT02592226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101643088|NCT02592226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643089|NCT00756301|Lidocaine|lidocaine|mesh-list
101643090|NCT00756301|Anesthetics, Local|anesthetics, local|mesh-ancestor
101643091|NCT00756301|Anesthetics|anesthetics|mesh-ancestor
101643092|NCT00756301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101643093|NCT00756301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643094|NCT00756301|Sensory System Agents|sensory system agents|mesh-ancestor
101643095|NCT00756301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101643096|NCT00756301|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101643097|NCT00756301|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101643098|NCT00756301|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101643099|NCT00756301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101643100|NCT00756301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643101|NCT00756691|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
101643102|NCT00756691|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101643103|NCT00756691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643104|NCT00720226|Losartan|losartan|mesh-list
101643105|NCT00720226|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101643106|NCT00720226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101643107|NCT00720226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101643108|NCT00720226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101643109|NCT00720226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643110|NCT00725920|Topiramate|topiramate|mesh-list
101643111|NCT00725920|Anticonvulsants|anticonvulsants|mesh-ancestor
101643112|NCT00725920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101643113|NCT00725920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643114|NCT00725842|Ribavirin|ribavirin|mesh-list
101643115|NCT00725842|Interferon alpha-2|interferon alpha-2|mesh-list
101643116|NCT00725842|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101643117|NCT00725842|Antimetabolites|antimetabolites|mesh-ancestor
101643118|NCT00725842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643119|NCT00725842|Antiviral Agents|antiviral agents|mesh-ancestor
101643120|NCT00725842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101643121|NCT00725842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101643122|NCT04051723|Dexamethasone|dexamethasone|mesh-list
101643123|NCT04051723|Ropivacaine|ropivacaine|mesh-list
101580488|NCT01181531|Cinacalcet|cinacalcet|mesh-list
101580489|NCT01181531|Vitamins|vitamins|mesh-ancestor
101580490|NCT01181531|Micronutrients|micronutrients|mesh-ancestor
101580509|NCT00610246|Sorafenib|sorafenib|mesh-list
101580560|NCT04263844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355826|NCT00031655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101580561|NCT04263844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101580562|NCT04263844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101580563|NCT04263844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101580564|NCT04263844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101580565|NCT04263844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101580566|NCT04263844|Anesthetics, General|anesthetics, general|mesh-ancestor
101580567|NCT04263844|Anesthetics|anesthetics|mesh-ancestor
101580568|NCT04263844|GABA Modulators|gaba modulators|mesh-ancestor
101580569|NCT04263844|GABA Agents|gaba agents|mesh-ancestor
101580570|NCT00610324|Chlorhexidine|chlorhexidine|mesh-list
101580627|NCT01147458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101580628|NCT01147458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101580629|NCT01147458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580631|NCT01172808|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101580632|NCT01172808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101580633|NCT01172808|Autonomic Agents|autonomic agents|mesh-ancestor
101580634|NCT01172808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101580635|NCT01172808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580636|NCT01172808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101580637|NCT01172808|Respiratory System Agents|respiratory system agents|mesh-ancestor
101580638|NCT01172808|Parasympatholytics|parasympatholytics|mesh-ancestor
101580639|NCT01172808|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101580640|NCT01172808|Cholinergic Agents|cholinergic agents|mesh-ancestor
101580688|NCT00601705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101580689|NCT00601705|Antimetabolites|antimetabolites|mesh-ancestor
101580690|NCT00601705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101580691|NCT00601705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101580692|NCT00601705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101580693|NCT00601705|Immunologic Factors|immunologic factors|mesh-ancestor
101580699|NCT00641173|Paroxetine|paroxetine|mesh-list
101580755|NCT00640627|Celecoxib|celecoxib|mesh-list
101580756|NCT00640627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101580757|NCT00640627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101580758|NCT00640627|Analgesics|analgesics|mesh-ancestor
101580759|NCT00640627|Sensory System Agents|sensory system agents|mesh-ancestor
101580760|NCT00640627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101580761|NCT00640627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580762|NCT00640627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101580763|NCT00640627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101580764|NCT00640627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101580765|NCT00640627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101580766|NCT00640627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101580768|NCT02681887|Melatonin|melatonin|mesh-list
101580816|NCT00640705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101580818|NCT00640705|Analgesics|analgesics|mesh-ancestor
101580819|NCT00640705|Sensory System Agents|sensory system agents|mesh-ancestor
101580820|NCT00640705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101580821|NCT00640705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101580822|NCT00640705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101580823|NCT00640705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101580824|NCT00640705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101580825|NCT00640705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101580879|NCT00625092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101580880|NCT00625092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101580881|NCT00625092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101580882|NCT00625092|Immunologic Factors|immunologic factors|mesh-ancestor
101580883|NCT00625092|Antidotes|antidotes|mesh-ancestor
101580884|NCT00625092|Protective Agents|protective agents|mesh-ancestor
101580885|NCT00625092|Vitamin B Complex|vitamin b complex|mesh-ancestor
101580887|NCT00625092|Micronutrients|micronutrients|mesh-ancestor
101580888|NCT00931918|Prednisone|prednisone|mesh-list
101580889|NCT00931918|Cyclophosphamide|cyclophosphamide|mesh-list
101580890|NCT00931918|Rituximab|rituximab|mesh-list
101580891|NCT00931918|Doxorubicin|doxorubicin|mesh-list
101580892|NCT00931918|Vincristine|vincristine|mesh-list
101580893|NCT00931918|Bortezomib|bortezomib|mesh-list
101580894|NCT00931918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101580941|NCT02678221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101580942|NCT02678221|Antipyretics|antipyretics|mesh-ancestor
101580943|NCT02678221|Vasodilator Agents|vasodilator agents|mesh-ancestor
101581014|NCT02677597|Cisplatin|cisplatin|mesh-list
101581015|NCT02677597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101581016|NCT02677597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101581017|NCT02677597|Tubulin Modulators|tubulin modulators|mesh-ancestor
101581018|NCT02677597|Antimitotic Agents|antimitotic agents|mesh-ancestor
101581019|NCT02677597|Mitosis Modulators|mitosis modulators|mesh-ancestor
101581020|NCT02677597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581021|NCT01132326|Droxidopa|droxidopa|mesh-list
101581022|NCT01132326|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101581023|NCT01132326|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101581024|NCT02681263|Temocillin|temocillin|mesh-list
101581025|NCT02681263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101581026|NCT02681263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101581027|NCT02677519|Methylphenidate|methylphenidate|mesh-list
101581028|NCT02677519|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101581029|NCT02677519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581030|NCT02677519|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101581031|NCT02677519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101581032|NCT02677519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101581033|NCT02677519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581034|NCT02677519|Dopamine Agents|dopamine agents|mesh-ancestor
101581035|NCT02677519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101581066|NCT04181749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101581067|NCT04181749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101581068|NCT04181749|Analgesics|analgesics|mesh-ancestor
101581069|NCT04181749|Sensory System Agents|sensory system agents|mesh-ancestor
101581070|NCT04181749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101581137|NCT00644215|Alkylating Agents|alkylating agents|mesh-ancestor
101581138|NCT00644215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581139|NCT00644215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101581141|NCT01145352|Etanercept|etanercept|mesh-list
101581207|NCT04178785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101581208|NCT04178785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581210|NCT04178785|Sensory System Agents|sensory system agents|mesh-ancestor
101581211|NCT04178785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101581212|NCT00928486|Dexamethasone|dexamethasone|mesh-list
101581213|NCT00928486|Lenalidomide|lenalidomide|mesh-list
101581214|NCT00928486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101581274|NCT00610948|Oxaliplatin|oxaliplatin|mesh-list
101581275|NCT00610948|Everolimus|everolimus|mesh-list
101581276|NCT00610948|Panitumumab|panitumumab|mesh-list
101581277|NCT00610948|Calcium|calcium|mesh-list
101581278|NCT00610948|Levoleucovorin|levoleucovorin|mesh-list
101581279|NCT00610948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101581281|NCT00610948|Antimetabolites|antimetabolites|mesh-ancestor
101581346|NCT02886377|Immunologic Factors|immunologic factors|mesh-ancestor
101581347|NCT02886377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581349|NCT02675335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101581350|NCT02675335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581351|NCT02675335|Incretins|incretins|mesh-ancestor
101581352|NCT02675335|Hormones|hormones|mesh-ancestor
101581353|NCT02675335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101581354|NCT02675335|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101581355|NCT02675335|Protease Inhibitors|protease inhibitors|mesh-ancestor
101581356|NCT02675335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101581357|NCT02675335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581358|NCT02675101|Sucrose polyester|sucrose polyester|mesh-list
101581359|NCT02675101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101581360|NCT02675101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101581361|NCT02675101|Antimetabolites|antimetabolites|mesh-ancestor
101581362|NCT02675101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581363|NCT02675101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101581364|NCT00928018|Cyclosporine|cyclosporine|mesh-list
101581365|NCT00928018|Sirolimus|sirolimus|mesh-list
101581366|NCT00928018|Mycophenolic Acid|mycophenolic acid|mesh-list
101581367|NCT00928018|Methotrexate|methotrexate|mesh-list
101581368|NCT00928018|Tacrolimus|tacrolimus|mesh-list
101581399|NCT00609154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101581400|NCT00609154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581474|NCT05911126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581475|NCT05911126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101581476|NCT05911126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101581477|NCT05911126|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101581478|NCT05911126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101581479|NCT05911126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101581480|NCT05911126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581481|NCT05911126|Anticonvulsants|anticonvulsants|mesh-ancestor
101581482|NCT05911126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101581484|NCT05911126|Autonomic Agents|autonomic agents|mesh-ancestor
101581538|NCT02672995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101581539|NCT02672995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101581540|NCT02672995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101581541|NCT02672995|Growth Substances|growth substances|mesh-ancestor
101581542|NCT02672995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581543|NCT02672995|Growth Inhibitors|growth inhibitors|mesh-ancestor
101581549|NCT05907902|Aspirin|aspirin|mesh-list
101581550|NCT05907902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101581551|NCT05907902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101581552|NCT05907902|Analgesics|analgesics|mesh-ancestor
101581553|NCT05907902|Sensory System Agents|sensory system agents|mesh-ancestor
101581554|NCT05907902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101581555|NCT05907902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581556|NCT05907902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101581557|NCT05907902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101581558|NCT05907902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101581559|NCT05907902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101581560|NCT05907902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581561|NCT05907902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101581564|NCT05907902|Antipyretics|antipyretics|mesh-ancestor
101581599|NCT05907486|Respiratory System Agents|respiratory system agents|mesh-ancestor
101581600|NCT05907486|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101581601|NCT05907486|Antioxidants|antioxidants|mesh-ancestor
101581602|NCT05907486|Protective Agents|protective agents|mesh-ancestor
101581603|NCT05907486|Antidotes|antidotes|mesh-ancestor
101581604|NCT05906992|Ocrelizumab|ocrelizumab|mesh-list
101581605|NCT05906992|Immunologic Factors|immunologic factors|mesh-ancestor
101581606|NCT05906992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581607|NCT05906615|Lidocaine|lidocaine|mesh-list
101581608|NCT05906615|Anesthetics, Local|anesthetics, local|mesh-ancestor
101581609|NCT05906615|Anesthetics|anesthetics|mesh-ancestor
101581610|NCT05906615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101581611|NCT05906615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581612|NCT05906615|Sensory System Agents|sensory system agents|mesh-ancestor
101581613|NCT05906615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101581614|NCT05906615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101581615|NCT05906615|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101581656|NCT05906498|Antidotes|antidotes|mesh-ancestor
101581657|NCT05901961|Zinc|zinc|mesh-list
101581658|NCT05901961|Zinc Oxide|zinc oxide|mesh-list
101581667|NCT05892510|Tenecteplase|tenecteplase|mesh-list
101581729|NCT05736874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101581730|NCT05736874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101581731|NCT05736874|Respiratory System Agents|respiratory system agents|mesh-ancestor
101581733|NCT05736874|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101581734|NCT05730036|Dexamethasone|dexamethasone|mesh-list
101581801|NCT05559164|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101581802|NCT05559164|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101581873|NCT05479240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581874|NCT05479240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101581875|NCT05479240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101581877|NCT05465941|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101581878|NCT05465941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101581879|NCT05465941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101581880|NCT05465941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581881|NCT05465941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101581882|NCT05461573|Drospirenone|drospirenone|mesh-list
101581883|NCT05461573|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101581884|NCT05461573|Hormone Antagonists|hormone antagonists|mesh-ancestor
101581888|NCT05461573|Diuretics|diuretics|mesh-ancestor
101581935|NCT05332444|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101581936|NCT05332444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101581937|NCT05332444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101581938|NCT05332444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101581939|NCT05332444|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101581940|NCT05332444|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101581941|NCT05332444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101581942|NCT05332444|Antacids|antacids|mesh-ancestor
101581943|NCT05290740|Norepinephrine|norepinephrine|mesh-list
101581944|NCT05290740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101581945|NCT05290740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101581946|NCT05290740|Adrenergic Agents|adrenergic agents|mesh-ancestor
101581948|NCT05290740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101581949|NCT05290740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582057|NCT04880434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101582058|NCT04880434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101582059|NCT04880434|Alkylating Agents|alkylating agents|mesh-ancestor
101582060|NCT04880434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582061|NCT04880434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582062|NCT04880434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101582063|NCT04880434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101582064|NCT04840394|Pembrolizumab|pembrolizumab|mesh-list
101582065|NCT04840394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101582066|NCT04840394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582067|NCT04840394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101582068|NCT04840394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582069|NCT04839549|Fluorometholone|fluorometholone|mesh-list
101582070|NCT04839549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101582071|NCT04839549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582125|NCT04624178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101582126|NCT04619004|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
101582127|NCT04619004|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101582128|NCT04619004|Immunologic Factors|immunologic factors|mesh-ancestor
101582129|NCT04619004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582130|NCT04619004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101582131|NCT04619004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582132|NCT04563338|Bevacizumab|bevacizumab|mesh-list
101582133|NCT04563338|Atezolizumab|atezolizumab|mesh-list
101582134|NCT04563338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101582135|NCT04563338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582193|NCT04196530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582249|NCT04042701|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
101582250|NCT04042701|Immunoconjugates|immunoconjugates|mesh-list
101582251|NCT04042701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101582252|NCT04042701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582253|NCT04042701|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101582254|NCT04042701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582255|NCT04042701|Immunologic Factors|immunologic factors|mesh-ancestor
101582256|NCT04042701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582257|NCT04042701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101582258|NCT04042701|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101582259|NCT04042701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101582260|NCT04042701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101582262|NCT04016389|Carboplatin|carboplatin|mesh-list
101582263|NCT04016389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101582264|NCT04016389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582265|NCT04016389|Tubulin Modulators|tubulin modulators|mesh-ancestor
101582266|NCT04016389|Antimitotic Agents|antimitotic agents|mesh-ancestor
101582304|NCT03853707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582306|NCT03853707|Antimetabolites|antimetabolites|mesh-ancestor
101582377|NCT03712098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101582378|NCT03711279|Apatinib|apatinib|mesh-list
101582379|NCT03711279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582380|NCT03711279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101582381|NCT03711279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101582383|NCT03703297|Durvalumab|durvalumab|mesh-list
101582444|NCT03486301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582445|NCT03391479|Avelumab|avelumab|mesh-list
101582446|NCT03391479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101582447|NCT03391479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582448|NCT04218851|Posaconazole|posaconazole|mesh-list
101582449|NCT04218851|Antifungal Agents|antifungal agents|mesh-ancestor
101582450|NCT04218851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101582451|NCT04218851|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101582452|NCT04218851|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101582453|NCT04218851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101582454|NCT04218851|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101582507|NCT02901184|Spironolactone|spironolactone|mesh-list
101582508|NCT02901184|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101582509|NCT02901184|Hormone Antagonists|hormone antagonists|mesh-ancestor
101582510|NCT02901184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101582511|NCT02901184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582512|NCT02901184|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101582513|NCT02901184|Diuretics|diuretics|mesh-ancestor
101582514|NCT02901184|Natriuretic Agents|natriuretic agents|mesh-ancestor
101582515|NCT02901041|Zonisamide|zonisamide|mesh-list
101582516|NCT02901041|Anticonvulsants|anticonvulsants|mesh-ancestor
101582517|NCT02901041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101582518|NCT02901041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101582519|NCT02901041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582580|NCT02636322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101582581|NCT02636322|Tubulin Modulators|tubulin modulators|mesh-ancestor
101582582|NCT02636322|Antimitotic Agents|antimitotic agents|mesh-ancestor
101582583|NCT02636322|Mitosis Modulators|mitosis modulators|mesh-ancestor
101582584|NCT02636322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101582585|NCT02636322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101582586|NCT02636322|Growth Substances|growth substances|mesh-ancestor
101582587|NCT02636322|Growth Inhibitors|growth inhibitors|mesh-ancestor
101582588|NCT02636322|Keratolytic Agents|keratolytic agents|mesh-ancestor
101582589|NCT02636322|Dermatologic Agents|dermatologic agents|mesh-ancestor
101582645|NCT02396043|Hormones|hormones|mesh-ancestor
101582646|NCT02396043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101582785|NCT00052884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101582787|NCT00052884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582788|NCT00052884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582789|NCT00052884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101582790|NCT00052884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101582791|NCT00052884|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101582792|NCT00052884|Protective Agents|protective agents|mesh-ancestor
101582793|NCT00040807|Docetaxel|docetaxel|mesh-list
101582794|NCT00040807|Irinotecan|irinotecan|mesh-list
101582795|NCT00040807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582796|NCT00040807|Tubulin Modulators|tubulin modulators|mesh-ancestor
101582797|NCT00040807|Antimitotic Agents|antimitotic agents|mesh-ancestor
101582847|NCT00003266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582849|NCT00003266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101582850|NCT00003236|ISIS 5132|isis 5132|mesh-list
101582922|NCT00002514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101582923|NCT00002514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101582924|NCT00607282|Udenafil|udenafil|mesh-list
101582925|NCT00607282|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101582926|NCT00607282|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101582927|NCT00607282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101582928|NCT00607282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582929|NCT00927472|Permethrin|permethrin|mesh-list
101582930|NCT00927472|Malathion|malathion|mesh-list
101582931|NCT00927472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101582932|NCT00927472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582937|NCT00642655|Rituximab|rituximab|mesh-list
101582983|NCT00976911|Topotecan|topotecan|mesh-list
101582984|NCT00976911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101582985|NCT00976911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101582986|NCT00976911|Tubulin Modulators|tubulin modulators|mesh-ancestor
101582987|NCT00976911|Antimitotic Agents|antimitotic agents|mesh-ancestor
101582988|NCT00976911|Mitosis Modulators|mitosis modulators|mesh-ancestor
101582989|NCT00976911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101582990|NCT00976911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101582991|NCT00976911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101582992|NCT00976911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101582993|NCT00976911|Growth Substances|growth substances|mesh-ancestor
101582994|NCT00976911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101582995|NCT00976911|Growth Inhibitors|growth inhibitors|mesh-ancestor
101582996|NCT00976911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101582997|NCT00976911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101582998|NCT00976911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101582999|NCT00976911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101583040|NCT00934648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101583041|NCT00934648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101583042|NCT00934648|Antimetabolites|antimetabolites|mesh-ancestor
101583043|NCT00934648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583044|NCT00934648|Dermatologic Agents|dermatologic agents|mesh-ancestor
101583045|NCT00934648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101583046|NCT00934648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101583047|NCT00934648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101583048|NCT00934648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101583049|NCT01175213|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101583051|NCT01175213|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101583052|NCT01175213|Immunologic Factors|immunologic factors|mesh-ancestor
101583053|NCT01175213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583054|NCT00644449|Azithromycin|azithromycin|mesh-list
101583055|NCT00644449|Levofloxacin|levofloxacin|mesh-list
101583056|NCT00644449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101583057|NCT00644449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101583058|NCT00644449|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101583059|NCT00644449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101583060|NCT00644449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101583066|NCT04287777|Mupirocin|mupirocin|mesh-list
101583094|NCT04256200|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101583095|NCT04256200|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101583096|NCT04256200|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101583097|NCT04256200|Hormone Antagonists|hormone antagonists|mesh-ancestor
101583098|NCT04256200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101583099|NCT04256200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101583100|NCT04256200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101583101|NCT02676739|Adderall|adderall|mesh-list
101583102|NCT02676739|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101583103|NCT02676739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583104|NCT00976677|Paclitaxel|paclitaxel|mesh-list
101583105|NCT00976677|Bevacizumab|bevacizumab|mesh-list
101583109|NCT00976677|Antibodies|antibodies|mesh-list
101583155|NCT04287387|Immunologic Factors|immunologic factors|mesh-ancestor
101583156|NCT04287387|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101583157|NCT00644605|Sildenafil Citrate|sildenafil citrate|mesh-list
101583158|NCT00644605|Vasodilator Agents|vasodilator agents|mesh-ancestor
101583159|NCT00644605|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101583160|NCT00644605|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101583161|NCT00644605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101583162|NCT00644605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583163|NCT00644605|Urological Agents|urological agents|mesh-ancestor
101583222|NCT04259476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101583223|NCT04259476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101583224|NCT04259476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101583225|NCT04259476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101583226|NCT04259476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583290|NCT02670655|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
101583291|NCT02670655|Anesthetics, Local|anesthetics, local|mesh-ancestor
101583292|NCT02670655|Anesthetics|anesthetics|mesh-ancestor
101583293|NCT02670655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101583294|NCT02670655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583295|NCT02670655|Sensory System Agents|sensory system agents|mesh-ancestor
101583296|NCT02670655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101583297|NCT02670655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101583298|NCT02670655|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101583299|NCT02670655|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101583300|NCT02670655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101583301|NCT02670655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583304|NCT01131078|Capecitabine|capecitabine|mesh-list
101583351|NCT02862873|Antipruritics|antipruritics|mesh-ancestor
101583352|NCT02862873|Dermatologic Agents|dermatologic agents|mesh-ancestor
101583353|NCT02862873|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101583354|NCT02862873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101583355|NCT02862873|Serotonin Agents|serotonin agents|mesh-ancestor
101583422|NCT00910351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101583423|NCT04175587|Tretinoin|tretinoin|mesh-list
101583424|NCT04175587|Arsenic Trioxide|arsenic trioxide|mesh-list
101583425|NCT04175587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101583426|NCT04175587|Keratolytic Agents|keratolytic agents|mesh-ancestor
101583427|NCT04175587|Dermatologic Agents|dermatologic agents|mesh-ancestor
101583428|NCT02668159|Vitamin D|vitamin d|mesh-list
101583429|NCT02668159|Ergocalciferols|ergocalciferols|mesh-list
101583430|NCT02668159|Cholecalciferol|cholecalciferol|mesh-list
101583431|NCT02668159|Vitamins|vitamins|mesh-list
101583432|NCT02668159|Micronutrients|micronutrients|mesh-ancestor
101583433|NCT02668159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583436|NCT02670109|Cyclophosphamide|cyclophosphamide|mesh-list
101583485|NCT00645073|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101583486|NCT00645073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101583488|NCT04259008|Trace Elements|trace elements|mesh-ancestor
101583489|NCT04259008|Micronutrients|micronutrients|mesh-ancestor
101583490|NCT04259008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583491|NCT04258930|Calcium|calcium|mesh-list
101583492|NCT04258930|Calcium acetate|calcium acetate|mesh-list
101583493|NCT04258930|Aluminum sulfate|aluminum sulfate|mesh-list
101583494|NCT04258930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101583495|NCT04258930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583496|NCT04258930|Chelating Agents|chelating agents|mesh-ancestor
101583497|NCT04258930|Sequestering Agents|sequestering agents|mesh-ancestor
101583498|NCT04258930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583499|NCT04258930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101583500|NCT04258930|Immunologic Factors|immunologic factors|mesh-ancestor
101583501|NCT01175135|Risperidone|risperidone|mesh-list
101583502|NCT01175135|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101583513|NCT02669641|Choline|choline|mesh-list
101583540|NCT00973479|Dermatologic Agents|dermatologic agents|mesh-ancestor
101583541|NCT00973479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101583542|NCT00973479|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101583543|NCT00973479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101583544|NCT00973479|Immunologic Factors|immunologic factors|mesh-ancestor
101583545|NCT00973479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101355898|NCT00031889|Bicalutamide|bicalutamide|mesh-list
101583546|NCT00973479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101583547|NCT00973479|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101583605|NCT00645229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101583606|NCT00645229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101583607|NCT00645229|Dopamine Agents|dopamine agents|mesh-ancestor
101583608|NCT01172873|Cycloserine|cycloserine|mesh-list
101583609|NCT01172873|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101583610|NCT01172873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101583611|NCT01172873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101583612|NCT01172873|Antitubercular Agents|antitubercular agents|mesh-ancestor
101583613|NCT01172873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101583614|NCT01172873|Antimetabolites|antimetabolites|mesh-ancestor
101583615|NCT01172873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583616|NCT02886299|Simvastatin|simvastatin|mesh-list
101583617|NCT02886299|Fenofibrate|fenofibrate|mesh-list
101583618|NCT02886299|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101583619|NCT02886299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101583620|NCT02886299|Antimetabolites|antimetabolites|mesh-ancestor
101583621|NCT02886299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583622|NCT02886299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101583623|NCT02886299|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101583624|NCT02886299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101583625|NCT00925600|Denosumab|denosumab|mesh-list
101583626|NCT00925600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101583627|NCT00925600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583628|NCT00645307|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101583642|NCT02668861|Vitamin D|vitamin d|mesh-list
101583654|NCT02668861|Glucocorticoids|glucocorticoids|mesh-ancestor
101583655|NCT02668861|Hormones|hormones|mesh-ancestor
101583656|NCT02668861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101583657|NCT00968253|Cytarabine|cytarabine|mesh-list
101583658|NCT00968253|Dexamethasone|dexamethasone|mesh-list
101583659|NCT00968253|Methylprednisolone|methylprednisolone|mesh-list
101583660|NCT00968253|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101583661|NCT00968253|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101583662|NCT00968253|Prednisolone|prednisolone|mesh-list
101583664|NCT00968253|Cyclophosphamide|cyclophosphamide|mesh-list
101583722|NCT00646009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101583723|NCT00646009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583724|NCT00646009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101583725|NCT00646009|Respiratory System Agents|respiratory system agents|mesh-ancestor
101583726|NCT00646009|Dermatologic Agents|dermatologic agents|mesh-ancestor
101583727|NCT00646009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101583728|NCT00646009|Glucocorticoids|glucocorticoids|mesh-ancestor
101583729|NCT00646009|Hormones|hormones|mesh-ancestor
101583730|NCT00646009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101583731|NCT00646009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101583784|NCT04255498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101583785|NCT04255498|Luteolytic Agents|luteolytic agents|mesh-ancestor
101583786|NCT04255498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101583787|NCT04255498|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101583788|NCT02666209|Dexamethasone|dexamethasone|mesh-list
101583789|NCT02666209|Lenalidomide|lenalidomide|mesh-list
101583790|NCT02666209|Bortezomib|bortezomib|mesh-list
101583791|NCT02666209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101583792|NCT02666209|Antiemetics|antiemetics|mesh-ancestor
101583793|NCT02666209|Autonomic Agents|autonomic agents|mesh-ancestor
101583794|NCT02666209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101583848|NCT02666365|Cefazolin|cefazolin|mesh-list
101583849|NCT02666365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101583850|NCT02666365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101583851|NCT02666443|Dexamethasone|dexamethasone|mesh-list
101583852|NCT02666443|Dexamethasone acetate|dexamethasone acetate|mesh-list
101583853|NCT02666443|BB 1101|bb 1101|mesh-list
101583854|NCT02666443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101583855|NCT02666443|Antiemetics|antiemetics|mesh-ancestor
101583856|NCT02666443|Autonomic Agents|autonomic agents|mesh-ancestor
101583857|NCT02666443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101583858|NCT02666443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583859|NCT02666443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101583860|NCT02666443|Glucocorticoids|glucocorticoids|mesh-ancestor
101583861|NCT02666443|Hormones|hormones|mesh-ancestor
101583862|NCT02666443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101583863|NCT02666443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101583864|NCT02666443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101583865|NCT02666443|Protease Inhibitors|protease inhibitors|mesh-ancestor
101583866|NCT02666443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101583867|NCT02666443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583868|NCT01130532|Tadalafil|tadalafil|mesh-list
101583869|NCT01130532|Vasodilator Agents|vasodilator agents|mesh-ancestor
101583870|NCT01130532|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101583871|NCT01130532|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101583872|NCT01130532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101583873|NCT01130532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583874|NCT01130532|Urological Agents|urological agents|mesh-ancestor
101583875|NCT04258306|Resveratrol|resveratrol|mesh-list
101583876|NCT04258306|Antioxidants|antioxidants|mesh-ancestor
101583877|NCT04258306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583878|NCT04258306|Protective Agents|protective agents|mesh-ancestor
101583879|NCT04258306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583880|NCT04258306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101583881|NCT04258306|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101583882|NCT00646711|Valproic Acid|valproic acid|mesh-list
101583883|NCT00646711|Anticonvulsants|anticonvulsants|mesh-ancestor
101583886|NCT00646711|GABA Agents|gaba agents|mesh-ancestor
101583887|NCT00646711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101583888|NCT00646711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583889|NCT00646711|Antimanic Agents|antimanic agents|mesh-ancestor
101583890|NCT00646711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101583891|NCT00646711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101583892|NCT00646711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101583893|NCT00972777|Besifloxacin|besifloxacin|mesh-list
101583894|NCT00972777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101583895|NCT00972777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101583896|NCT00972777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101583897|NCT00972777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101583898|NCT00972777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101583899|NCT00972777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240780|NCT01624025|Docetaxel|docetaxel|mesh-list
101583900|NCT00972777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101583901|NCT04254874|Interferons|interferons|mesh-list
101583902|NCT04254874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101583903|NCT04254874|Antiviral Agents|antiviral agents|mesh-ancestor
101583904|NCT04254874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101583905|NCT02667223|Bococizumab|bococizumab|mesh-list
101583906|NCT02667223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101583907|NCT02667223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101583908|NCT02667223|Antimetabolites|antimetabolites|mesh-ancestor
101583909|NCT02667223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583910|NCT02667223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101583911|NCT00918736|Hyaluronic Acid|hyaluronic acid|mesh-list
101583912|NCT00918736|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101583913|NCT00918736|Immunologic Factors|immunologic factors|mesh-ancestor
101583914|NCT00918736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101583931|NCT04257838|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101583932|NCT04257838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101583933|NCT04257838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101583934|NCT01172639|Sulfasalazine|sulfasalazine|mesh-list
101583935|NCT01172639|Prednisone|prednisone|mesh-list
101583999|NCT00925132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584000|NCT00925132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355917|NCT00031967|Protective Agents|protective agents|mesh-ancestor
101584001|NCT00925132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101584002|NCT00925132|Antimetabolites|antimetabolites|mesh-ancestor
101584003|NCT00925132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101584004|NCT00925132|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101584005|NCT02862015|Gemcitabine|gemcitabine|mesh-list
101584007|NCT02862015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101584008|NCT02862015|Antimetabolites|antimetabolites|mesh-ancestor
101584009|NCT02862015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584010|NCT02862015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101584011|NCT01143402|Temozolomide|temozolomide|mesh-list
101584012|NCT01143402|Dacarbazine|dacarbazine|mesh-list
101584013|NCT01143402|Imidazole|imidazole|mesh-list
101584014|NCT01143402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101584015|NCT01143402|Alkylating Agents|alkylating agents|mesh-ancestor
101584016|NCT01143402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584017|NCT01143402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101584018|NCT01143402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101584019|NCT00646945|Nitrous Oxide|nitrous oxide|mesh-list
101584020|NCT00646945|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101584021|NCT00646945|Anesthetics, General|anesthetics, general|mesh-ancestor
101584050|NCT03381261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584052|NCT03381261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101584053|NCT03381261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584054|NCT03381261|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101584055|NCT03381261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101584056|NCT00630045|Capecitabine|capecitabine|mesh-list
101584057|NCT00630045|Oxaliplatin|oxaliplatin|mesh-list
101584058|NCT00630045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101584059|NCT00630045|Antimetabolites|antimetabolites|mesh-ancestor
101584060|NCT00630045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584061|NCT00630045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101584110|NCT00646321|Glucocorticoids|glucocorticoids|mesh-ancestor
101584111|NCT00646321|Hormones|hormones|mesh-ancestor
101584112|NCT00646321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101584113|NCT00646321|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101584114|NCT00646321|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101584115|NCT00646321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101584116|NCT00646321|Adrenergic Agents|adrenergic agents|mesh-ancestor
101584117|NCT00646321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101584118|NCT00646321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584119|NCT00647101|Latanoprost|latanoprost|mesh-list
101584120|NCT00647101|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101584121|NCT00647101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101584122|NCT01166958|Teriparatide|teriparatide|mesh-list
101584123|NCT01166958|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101240989|NCT01625520|Hormones|hormones|mesh-ancestor
101584124|NCT01166958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101584166|NCT01129284|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101584167|NCT01129284|Hormones|hormones|mesh-ancestor
101584168|NCT01129284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101584169|NCT01129284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584170|NCT00647257|Losartan|losartan|mesh-list
101584171|NCT00647257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101584172|NCT00647257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101584173|NCT00647257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101584174|NCT00647257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101584175|NCT00647257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584176|NCT01166178|Vitamin D|vitamin d|mesh-list
101584177|NCT01166178|Zoledronic Acid|zoledronic acid|mesh-list
101584178|NCT01166178|Calcium|calcium|mesh-list
101584179|NCT01166178|Vitamins|vitamins|mesh-ancestor
101584180|NCT01166178|Micronutrients|micronutrients|mesh-ancestor
101584181|NCT01166178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584182|NCT01166178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101584183|NCT01166178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101584184|NCT00924820|Bevacizumab|bevacizumab|mesh-list
101584185|NCT00924820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101584219|NCT04252456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101584220|NCT04252456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101584221|NCT04252456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101584222|NCT04252456|Immunologic Factors|immunologic factors|mesh-ancestor
101584223|NCT04252456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584224|NCT04252456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101584225|NCT04252456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101584226|NCT04252456|Growth Substances|growth substances|mesh-ancestor
101584227|NCT04252456|Growth Inhibitors|growth inhibitors|mesh-ancestor
101584229|NCT04252456|Protective Agents|protective agents|mesh-ancestor
101584230|NCT04252456|Vitamin B Complex|vitamin b complex|mesh-ancestor
101584231|NCT04252456|Vitamins|vitamins|mesh-ancestor
101584232|NCT04252456|Micronutrients|micronutrients|mesh-ancestor
101584233|NCT04252456|Hematinics|hematinics|mesh-ancestor
101584234|NCT02665351|Peramivir|peramivir|mesh-list
101584235|NCT02665351|Antiviral Agents|antiviral agents|mesh-ancestor
101584280|NCT01128894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101584281|NCT01220180|Pregabalin|pregabalin|mesh-list
101584282|NCT01220180|Analgesics|analgesics|mesh-ancestor
101584283|NCT01220180|Sensory System Agents|sensory system agents|mesh-ancestor
101584284|NCT01220180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101584285|NCT01220180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584286|NCT01220180|Anticonvulsants|anticonvulsants|mesh-ancestor
101584287|NCT01220180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101584288|NCT01220180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101584289|NCT01220180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264254|NCT01766609|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101584290|NCT01220180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101584291|NCT01220180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101584292|NCT01220180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101584293|NCT01220180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101584294|NCT01220180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101584295|NCT01220024|Bupivacaine|bupivacaine|mesh-list
101584296|NCT01220024|Anesthetics, Local|anesthetics, local|mesh-ancestor
101584297|NCT01220024|Anesthetics|anesthetics|mesh-ancestor
101584298|NCT01220024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101584299|NCT01220024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584300|NCT01220024|Sensory System Agents|sensory system agents|mesh-ancestor
101584301|NCT01220024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101584302|NCT00625248|Anticoagulants|anticoagulants|mesh-list
101584303|NCT00625248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
101584304|NCT01143090|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
101584305|NCT01143090|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101584306|NCT01143090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101584323|NCT05125146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101584324|NCT05125146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101584325|NCT05125146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101584326|NCT05125146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584327|NCT05125146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101584328|NCT05125146|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101584329|NCT05125146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101584330|NCT05125146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101584331|NCT05125146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584332|NCT05125146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101584333|NCT05125146|Serotonin Agents|serotonin agents|mesh-ancestor
101584334|NCT05125146|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101584335|NCT05125146|Antidepressive Agents|antidepressive agents|mesh-ancestor
101584336|NCT01165554|Flutemetamol|flutemetamol|mesh-list
101584337|NCT01165554|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101584338|NCT01165554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584339|NCT01218308|Vaccines|vaccines|mesh-list
101584340|NCT01218308|Immunologic Factors|immunologic factors|mesh-ancestor
101584374|NCT01217606|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101584375|NCT01217606|Bimatoprost|bimatoprost|mesh-list
101584376|NCT01217606|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101584377|NCT01217606|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101584448|NCT00966693|Leprostatic Agents|leprostatic agents|mesh-ancestor
101584449|NCT00966693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101355931|NCT00059826|Antiviral Agents|antiviral agents|mesh-ancestor
101584450|NCT00966693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101584451|NCT00966693|Protease Inhibitors|protease inhibitors|mesh-ancestor
101584452|NCT00966693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101584453|NCT00966693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584454|NCT00966693|Dermatologic Agents|dermatologic agents|mesh-ancestor
101584455|NCT01215968|Dulaglutide|dulaglutide|mesh-list
101584456|NCT01215968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101584457|NCT01215968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584458|NCT02663713|Clopidogrel|clopidogrel|mesh-list
101584459|NCT02663713|Ticagrelor|ticagrelor|mesh-list
101584460|NCT02663713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101584461|NCT02663713|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101584462|NCT02663713|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101584463|NCT02663713|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101584464|NCT02663713|Purinergic Agents|purinergic agents|mesh-ancestor
101584465|NCT02663713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101584466|NCT02663713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584467|NCT02663713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584468|NCT02664649|Apixaban|apixaban|mesh-list
101584469|NCT02664649|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
101584470|NCT02664649|Anticoagulants|anticoagulants|mesh-list
101584471|NCT02664649|Antithrombins|antithrombins|mesh-ancestor
101584472|NCT02664649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101584473|NCT02664649|Protease Inhibitors|protease inhibitors|mesh-ancestor
101584474|NCT02664649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101584475|NCT02664649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584476|NCT02664493|Methylprednisolone|methylprednisolone|mesh-list
101584477|NCT02664493|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101584478|NCT02664493|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101584479|NCT02664493|Prednisolone|prednisolone|mesh-list
101584480|NCT02664493|Prednisolone acetate|prednisolone acetate|mesh-list
101643124|NCT04051723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101643125|NCT04051723|Antiemetics|antiemetics|mesh-ancestor
101643126|NCT04051723|Autonomic Agents|autonomic agents|mesh-ancestor
101643127|NCT04051723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101643128|NCT04051723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643129|NCT04051723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101584481|NCT02664493|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101584482|NCT02664493|Prednisolone phosphate|prednisolone phosphate|mesh-list
101584490|NCT02664493|Hormones|hormones|mesh-ancestor
101584557|NCT04174261|Ticagrelor|ticagrelor|mesh-list
101584558|NCT04174261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101584559|NCT04174261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101584560|NCT04174261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101584561|NCT04174261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101584562|NCT04174261|Purinergic Agents|purinergic agents|mesh-ancestor
101584563|NCT04174261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101584564|NCT04174261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584567|NCT00971997|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101584622|NCT00649129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584623|NCT00649129|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101584624|NCT00649129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101584625|NCT00649129|Cholinergic Agents|cholinergic agents|mesh-ancestor
101584626|NCT00649129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101584702|NCT02663323|Immunologic Factors|immunologic factors|mesh-ancestor
101584703|NCT02663323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584704|NCT01215188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101584705|NCT01215188|Immunologic Factors|immunologic factors|mesh-ancestor
101584771|NCT00648271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101584772|NCT00648271|Sympatholytics|sympatholytics|mesh-ancestor
101584773|NCT00648271|Autonomic Agents|autonomic agents|mesh-ancestor
101584774|NCT00648271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101584775|NCT00648271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584776|NCT00648271|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101584777|NCT00648271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101584778|NCT00648271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101584836|NCT02659033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101584837|NCT02659033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101584838|NCT04170595|Trastuzumab|trastuzumab|mesh-list
101584839|NCT04170595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101584840|NCT04170595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101584907|NCT02655757|Hormones|hormones|mesh-ancestor
101584908|NCT02655757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101584909|NCT02655757|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101584910|NCT02655757|Protease Inhibitors|protease inhibitors|mesh-ancestor
101584911|NCT02655757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101584912|NCT02655757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584913|NCT01214720|Bevacizumab|bevacizumab|mesh-list
101584914|NCT01214720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101584915|NCT01214720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101584916|NCT01214720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101584917|NCT01214720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101584918|NCT01214720|Growth Substances|growth substances|mesh-ancestor
101584919|NCT01214720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584920|NCT01214720|Growth Inhibitors|growth inhibitors|mesh-ancestor
101584921|NCT02655913|Ascorbic Acid|ascorbic acid|mesh-list
101584922|NCT02655913|Vitamins|vitamins|mesh-ancestor
101584923|NCT02655913|Micronutrients|micronutrients|mesh-ancestor
101584924|NCT02655913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584925|NCT02655913|Antioxidants|antioxidants|mesh-ancestor
101584926|NCT02655913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584927|NCT02655913|Protective Agents|protective agents|mesh-ancestor
101584928|NCT00649285|Nitrofurantoin|nitrofurantoin|mesh-list
101584929|NCT00649285|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101584930|NCT00649285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101584931|NCT00649285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101584932|NCT04169269|Enoxaparin|enoxaparin|mesh-list
101584955|NCT00649051|Natriuretic Agents|natriuretic agents|mesh-ancestor
101584956|NCT00649051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101584957|NCT00649051|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101584958|NCT00649051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101584959|NCT00649051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101584960|NCT04168879|Bupivacaine|bupivacaine|mesh-list
101584961|NCT04168879|Anesthetics, Local|anesthetics, local|mesh-ancestor
101584962|NCT04168879|Anesthetics|anesthetics|mesh-ancestor
101584963|NCT04168879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101585018|NCT01140906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101585019|NCT01140906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585020|NCT01140906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101585021|NCT01140906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585022|NCT01140906|Analgesics|analgesics|mesh-ancestor
101585023|NCT01140906|Sensory System Agents|sensory system agents|mesh-ancestor
101585024|NCT01140906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101585025|NCT01140906|Antidepressive Agents|antidepressive agents|mesh-ancestor
101585026|NCT01140906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101585027|NCT01140906|Dopamine Agents|dopamine agents|mesh-ancestor
101585082|NCT00649363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585084|NCT02654743|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101585085|NCT02654743|Protective Agents|protective agents|mesh-ancestor
101585086|NCT02654743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585087|NCT02654743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101585088|NCT04168723|Moxifloxacin|moxifloxacin|mesh-list
101585089|NCT04168723|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101585090|NCT04168723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101585091|NCT04168723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101241957|NCT01631838|Tocotrienols|tocotrienols|mesh-list
101585092|NCT04168723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101585093|NCT04168723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101585094|NCT04168723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101585095|NCT04168723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585096|NCT04168723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101585097|NCT04168723|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101585098|NCT04168723|Contraceptive Agents|contraceptive agents|mesh-ancestor
101585099|NCT04168723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101585105|NCT00649441|Quinapril|quinapril|mesh-list
101585135|NCT02658721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101585136|NCT02658721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101585137|NCT02658721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101585138|NCT02658721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101585139|NCT02658721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101585206|NCT01122264|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101585207|NCT01122264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101585208|NCT01122264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101585209|NCT01122264|Urological Agents|urological agents|mesh-ancestor
101585210|NCT03288675|Serotonin|serotonin|mesh-list
101585211|NCT03288675|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
101585212|NCT03288675|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101585213|NCT03288675|Serotonin Agents|serotonin agents|mesh-ancestor
101585214|NCT03288675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101585215|NCT03288675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585216|NCT03288675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585269|NCT00650455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585270|NCT00650455|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101585337|NCT01169675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101585338|NCT00650533|Glimepiride|glimepiride|mesh-list
101585339|NCT00650533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101585340|NCT00650533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101585341|NCT00650533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585342|NCT00650533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101585343|NCT00650533|Immunologic Factors|immunologic factors|mesh-ancestor
101585405|NCT02653339|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101585406|NCT02653339|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101585407|NCT02653339|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101585408|NCT02653339|Histamine Antagonists|histamine antagonists|mesh-ancestor
101585409|NCT02653339|Histamine Agents|histamine agents|mesh-ancestor
101585410|NCT02653339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101585475|NCT02650609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101585476|NCT02650609|Antiemetics|antiemetics|mesh-ancestor
101585477|NCT02650609|Autonomic Agents|autonomic agents|mesh-ancestor
101585478|NCT02650609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101585479|NCT02650609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585480|NCT02650609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101585481|NCT02650609|Glucocorticoids|glucocorticoids|mesh-ancestor
101585482|NCT02650609|Hormones|hormones|mesh-ancestor
101585483|NCT02650609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101585484|NCT02650609|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101585485|NCT02650609|Protective Agents|protective agents|mesh-ancestor
101585486|NCT02650609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101585487|NCT02650609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101585488|NCT02652871|Cytarabine|cytarabine|mesh-list
101585489|NCT02652871|Idarubicin|idarubicin|mesh-list
101585490|NCT02652871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101585491|NCT02652871|Antimetabolites|antimetabolites|mesh-ancestor
101585492|NCT02652871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585493|NCT02652871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101585494|NCT02652871|Antiviral Agents|antiviral agents|mesh-ancestor
101585529|NCT04283877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101585530|NCT04283877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585531|NCT04283877|Dopamine Agents|dopamine agents|mesh-ancestor
101585532|NCT04283877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101585534|NCT04283487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101585535|NCT04283331|Proxymetacaine|proxymetacaine|mesh-list
101585599|NCT02652325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101585600|NCT02652325|Trace Elements|trace elements|mesh-ancestor
101585601|NCT02652325|Micronutrients|micronutrients|mesh-ancestor
101585602|NCT02652325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585603|NCT02652325|Plasma Substitutes|plasma substitutes|mesh-ancestor
101585604|NCT02652325|Blood Substitutes|blood substitutes|mesh-ancestor
101355957|NCT00032084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101585666|NCT00924508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585667|NCT00650923|Temozolomide|temozolomide|mesh-list
101585668|NCT00650923|Aflibercept|aflibercept|mesh-list
101585669|NCT00650923|Endothelial Growth Factors|endothelial growth factors|mesh-list
101585671|NCT00650923|Alkylating Agents|alkylating agents|mesh-ancestor
101585737|NCT00625170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101585738|NCT00625170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101585739|NCT00625170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585740|NCT00625170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101585741|NCT00625170|Serotonin Agents|serotonin agents|mesh-ancestor
101585746|NCT00599755|Gemcitabine|gemcitabine|mesh-list
101585807|NCT02648503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101585808|NCT02648503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101585809|NCT02648503|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101585810|NCT02648503|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101585811|NCT02648503|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101585813|NCT05253508|Anesthetics, Local|anesthetics, local|mesh-ancestor
101585814|NCT05253508|Anesthetics|anesthetics|mesh-ancestor
101585815|NCT05253508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101585816|NCT05253508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585825|NCT04524130|Ketamine|ketamine|mesh-list
101585869|NCT02656615|Hormone Antagonists|hormone antagonists|mesh-ancestor
101585870|NCT02656615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101264303|NCT01767259|Valsartan|valsartan|mesh-list
101585871|NCT02656615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101585872|NCT02656615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101585873|NCT00651235|Losartan|losartan|mesh-list
101585874|NCT00651235|Propranolol|propranolol|mesh-list
101585875|NCT00651235|Atenolol|atenolol|mesh-list
101585876|NCT00651235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101585877|NCT00651235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101585904|NCT01168973|Docetaxel|docetaxel|mesh-list
101585932|NCT04669132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101585933|NCT04669132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101585934|NCT04669132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101585935|NCT04669132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101586003|NCT02647489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586004|NCT02647489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101586005|NCT00910897|Thalidomide|thalidomide|mesh-list
101586006|NCT00910897|Dexamethasone|dexamethasone|mesh-list
101586007|NCT00910897|Dexamethasone acetate|dexamethasone acetate|mesh-list
101586071|NCT02647255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101586072|NCT02647255|Glucocorticoids|glucocorticoids|mesh-ancestor
101586073|NCT02647255|Hormones|hormones|mesh-ancestor
101586074|NCT02647255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101586075|NCT02647255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101586076|NCT02647255|Protective Agents|protective agents|mesh-ancestor
101586077|NCT02647255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101586078|NCT02647255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101586079|NCT04329442|Tenofovir|tenofovir|mesh-list
101586080|NCT04329442|Emtricitabine|emtricitabine|mesh-list
101586081|NCT04329442|Antiviral Agents|antiviral agents|mesh-ancestor
101586082|NCT04329442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101586083|NCT04329442|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101586134|NCT00957801|Methylprednisolone|methylprednisolone|mesh-list
101586135|NCT00957801|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101586136|NCT00957801|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101586137|NCT00957801|Prednisolone|prednisolone|mesh-list
101586138|NCT00957801|Prednisolone acetate|prednisolone acetate|mesh-list
101586139|NCT00957801|Methyltestosterone|methyltestosterone|mesh-list
101243022|NCT01637844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101586140|NCT00957801|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101586141|NCT00957801|Prednisolone phosphate|prednisolone phosphate|mesh-list
101586144|NCT00957801|Testosterone enanthate|testosterone enanthate|mesh-list
101586201|NCT02955823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101586202|NCT02955823|Immunologic Factors|immunologic factors|mesh-ancestor
101586203|NCT02955823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586204|NCT02955823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101586205|NCT02955823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101586206|NCT02955823|Antiemetics|antiemetics|mesh-ancestor
101586207|NCT02955823|Autonomic Agents|autonomic agents|mesh-ancestor
101586208|NCT02955823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101586209|NCT02955823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101586210|NCT02955823|Glucocorticoids|glucocorticoids|mesh-ancestor
101586211|NCT02955823|Hormones|hormones|mesh-ancestor
101586213|NCT02955823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101586266|NCT01167881|Immunologic Factors|immunologic factors|mesh-ancestor
101586267|NCT01167881|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101586268|NCT01167881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586269|NCT02646085|Carbon-11 methionine|carbon-11 methionine|mesh-list
101586270|NCT02646085|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101586271|NCT02646085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586272|NCT02639767|Pemetrexed|pemetrexed|mesh-list
101586273|NCT02639767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101586274|NCT02639767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101586275|NCT02639767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586330|NCT00653965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101586331|NCT00653965|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101586332|NCT00653965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101586333|NCT00959907|Botulinum Toxins|botulinum toxins|mesh-list
101586334|NCT00959907|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101586335|NCT00959907|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101586336|NCT00959907|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
101586337|NCT00959907|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101586338|NCT00959907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101586339|NCT00959907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586392|NCT04167007|Antimetabolites|antimetabolites|mesh-ancestor
101586393|NCT04167007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586394|NCT04167007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101586395|NCT01167023|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101586396|NCT01167023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101586397|NCT00654121|Insulin|insulin|mesh-list
101586398|NCT00654121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101586399|NCT00654121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101586400|NCT00654121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586401|NCT01166945|Amoxicillin|amoxicillin|mesh-list
101586402|NCT01166945|Clavulanic Acid|clavulanic acid|mesh-list
101586403|NCT01166945|Clavulanic Acids|clavulanic acids|mesh-list
101586404|NCT01166945|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101586405|NCT01166945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101586406|NCT01166945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101586407|NCT01166945|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101586408|NCT01166945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101586409|NCT01166945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586410|NCT02639533|Pregabalin|pregabalin|mesh-list
101586411|NCT02639533|Analgesics|analgesics|mesh-ancestor
101586412|NCT02639533|Sensory System Agents|sensory system agents|mesh-ancestor
101586413|NCT02639533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101586414|NCT02639533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586415|NCT02639533|Anticonvulsants|anticonvulsants|mesh-ancestor
101586416|NCT02639533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101586417|NCT02639533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101586418|NCT02639533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586419|NCT02639533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101586420|NCT02639533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101586421|NCT02639533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101586422|NCT02639533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101586434|NCT00910000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101586436|NCT00910000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243324|NCT01639521|Gemcitabine|gemcitabine|mesh-list
101586438|NCT00910000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101586503|NCT01165307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101586504|NCT01165307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101586505|NCT01165307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101586506|NCT01165307|Gout Suppressants|gout suppressants|mesh-ancestor
101586507|NCT01165307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101586508|NCT01165307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101586509|NCT01165307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586510|NCT01165307|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101586512|NCT02639143|Ticagrelor|ticagrelor|mesh-list
101586513|NCT02639143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101586514|NCT02639143|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101586515|NCT02639143|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101586516|NCT02639143|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101586517|NCT02639143|Purinergic Agents|purinergic agents|mesh-ancestor
101586560|NCT01124838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101586561|NCT01124838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101586562|NCT01124838|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101586563|NCT01124838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101586634|NCT01124604|Sensory System Agents|sensory system agents|mesh-ancestor
101586635|NCT01124604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101586636|NCT01124604|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101586637|NCT01124604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101586638|NCT01124604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101586639|NCT01124604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586640|NCT01124604|Adrenergic Agents|adrenergic agents|mesh-ancestor
101586641|NCT01124604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101586642|NCT00909844|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101586643|NCT00909844|Luteolytic Agents|luteolytic agents|mesh-ancestor
101586644|NCT00909844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101586655|NCT02638909|Ceritinib|ceritinib|mesh-list
101586695|NCT01136772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101586696|NCT01136772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586697|NCT01136772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101586698|NCT01136772|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101586843|NCT02857959|Penicillin G Benzathine|penicillin g benzathine|mesh-list
101586844|NCT02857959|Penicillin G Procaine|penicillin g procaine|mesh-list
101586847|NCT02643433|Vaccines|vaccines|mesh-list
101586915|NCT00956943|Autonomic Agents|autonomic agents|mesh-ancestor
101586916|NCT00956943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101586917|NCT00956943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586918|NCT00956943|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101586919|NCT00956943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101586920|NCT00956943|Cholinergic Agents|cholinergic agents|mesh-ancestor
101586921|NCT00956943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101586922|NCT00956943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101586923|NCT01135914|Ranibizumab|ranibizumab|mesh-list
101586924|NCT01135914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101586925|NCT01135914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101586930|NCT00907738|Vorinostat|vorinostat|mesh-list
101586975|NCT03116529|Immunomodulating Agents|immunomodulating agents|mesh-list
101586976|NCT03116529|Immunologic Factors|immunologic factors|mesh-ancestor
101586977|NCT03116529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586978|NCT00632554|Prednisolone|prednisolone|mesh-list
101586979|NCT00632554|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101586980|NCT00632554|Methylprednisolone|methylprednisolone|mesh-list
101586981|NCT00632554|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101586982|NCT00632554|Prednisolone acetate|prednisolone acetate|mesh-list
101586983|NCT00632554|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101586984|NCT00632554|Prednisolone phosphate|prednisolone phosphate|mesh-list
101586985|NCT00632554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101586986|NCT00632554|Glucocorticoids|glucocorticoids|mesh-ancestor
101586988|NCT00632554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101586989|NCT00632554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101586990|NCT00632554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101587037|NCT03832972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101587038|NCT03832972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587039|NCT02860299|Heparin|heparin|mesh-list
101587040|NCT02860299|Calcium heparin|calcium heparin|mesh-list
101587041|NCT02860299|Anticoagulants|anticoagulants|mesh-ancestor
101587108|NCT00955305|Tubulin Modulators|tubulin modulators|mesh-ancestor
101587109|NCT00955305|Antimitotic Agents|antimitotic agents|mesh-ancestor
101587110|NCT00955305|Mitosis Modulators|mitosis modulators|mesh-ancestor
101587111|NCT00955305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587112|NCT00955305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101587113|NCT00955305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101587114|NCT00955305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101587115|NCT00955305|Growth Substances|growth substances|mesh-ancestor
101587116|NCT00955305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587117|NCT00955305|Growth Inhibitors|growth inhibitors|mesh-ancestor
101587171|NCT00883129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101587172|NCT00883129|Alkylating Agents|alkylating agents|mesh-ancestor
101587173|NCT00883129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587243|NCT04202536|Antiviral Agents|antiviral agents|mesh-ancestor
101587244|NCT04202536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101587245|NCT04202536|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101587246|NCT04202536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101587313|NCT01135524|Sensory System Agents|sensory system agents|mesh-ancestor
101587314|NCT01135524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101587315|NCT01135524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101587317|NCT00948675|Bevacizumab|bevacizumab|mesh-list
101587318|NCT00948675|Carboplatin|carboplatin|mesh-list
101587319|NCT00948675|Pemetrexed|pemetrexed|mesh-list
101587382|NCT02850484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587383|NCT02850484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101587384|NCT02850484|Respiratory System Agents|respiratory system agents|mesh-ancestor
101587454|NCT04202224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101587455|NCT04202224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587456|NCT04202224|Antipyretics|antipyretics|mesh-ancestor
101587457|NCT04202224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101587458|NCT04202224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101587459|NCT04202224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101587460|NCT04202224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101587461|NCT04202224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101587462|NCT04202224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587463|NCT00947427|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101587464|NCT00947427|Immunologic Factors|immunologic factors|mesh-ancestor
101587465|NCT00947427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587466|NCT02848612|Heparin|heparin|mesh-list
101587467|NCT02848612|Calcium heparin|calcium heparin|mesh-list
101587468|NCT02848612|Anticoagulants|anticoagulants|mesh-ancestor
101587511|NCT00953745|Dopamine Agents|dopamine agents|mesh-ancestor
101587512|NCT00953745|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101587513|NCT00953745|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101587514|NCT00953745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101587515|NCT00953745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101587516|NCT00953745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101587517|NCT00953745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101587578|NCT00902668|L 647318|l 647318|mesh-list
101587579|NCT00902668|Dihydromevinolin|dihydromevinolin|mesh-list
101587580|NCT00902668|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101587581|NCT00902668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101587582|NCT00902668|Antimetabolites|antimetabolites|mesh-ancestor
101587583|NCT00902668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587584|NCT00902668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101587585|NCT00902668|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101587586|NCT00902668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101587587|NCT00433420|Paclitaxel|paclitaxel|mesh-list
101587642|NCT02846428|Epirubicin|epirubicin|mesh-list
101587643|NCT02846428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101587644|NCT02846428|Immunologic Factors|immunologic factors|mesh-ancestor
101587645|NCT02846428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587646|NCT02846428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101587647|NCT02846428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101587648|NCT02846428|Alkylating Agents|alkylating agents|mesh-ancestor
101587649|NCT02846428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587650|NCT02846428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101587651|NCT02846428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101587652|NCT02846428|Tubulin Modulators|tubulin modulators|mesh-ancestor
101587653|NCT02846428|Antimitotic Agents|antimitotic agents|mesh-ancestor
101587654|NCT02846428|Mitosis Modulators|mitosis modulators|mesh-ancestor
101587655|NCT02846428|Antimetabolites|antimetabolites|mesh-ancestor
101587703|NCT02844634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101587704|NCT02844634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587705|NCT02844634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101587706|NCT02844634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101587707|NCT02844634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101587708|NCT02844634|Antimalarials|antimalarials|mesh-ancestor
101244602|NCT01655199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101587709|NCT02844634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101587710|NCT02844634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101587711|NCT02845648|Cholinergic Antagonists|cholinergic antagonists|mesh-list
101587712|NCT02845648|Cholinergic Agents|cholinergic agents|mesh-ancestor
101587713|NCT02845648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101587714|NCT02845648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587715|NCT02845648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587717|NCT00952419|Immunologic Factors|immunologic factors|mesh-ancestor
101587718|NCT00952419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587719|NCT02844322|Rituximab|rituximab|mesh-list
101587720|NCT02844322|Bortezomib|bortezomib|mesh-list
101587721|NCT02844322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101587722|NCT02844322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101587723|NCT02844322|Immunologic Factors|immunologic factors|mesh-ancestor
101587753|NCT00952341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101587754|NCT00952341|Antiemetics|antiemetics|mesh-ancestor
101587755|NCT00952341|Autonomic Agents|autonomic agents|mesh-ancestor
101587756|NCT00952341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101587824|NCT02852577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587825|NCT02852577|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101587826|NCT02852577|Antidepressive Agents|antidepressive agents|mesh-ancestor
101587827|NCT02852577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101587828|NCT02852577|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101587896|NCT03763162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587898|NCT03763162|Glycine Agents|glycine agents|mesh-ancestor
101587899|NCT03763162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101587900|NCT03936790|Fentanyl|fentanyl|mesh-list
101587901|NCT03936790|Ropivacaine|ropivacaine|mesh-list
101587902|NCT03936790|Anesthetics, Local|anesthetics, local|mesh-ancestor
101587965|NCT02642419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101587967|NCT02642419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101587968|NCT02642419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101587969|NCT02642419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101587970|NCT02642419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101587971|NCT02642419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101587972|NCT02642419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101587973|NCT02642419|Antipyretics|antipyretics|mesh-ancestor
101587974|NCT02642419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101587975|NCT02642419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101588027|NCT02637193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101355994|NCT00032162|Carboplatin|carboplatin|mesh-list
101588028|NCT02637193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101588040|NCT00656773|Sufentanil|sufentanil|mesh-list
101588099|NCT00599521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101588100|NCT00599521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588101|NCT00599521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101588102|NCT00599521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101588103|NCT00599521|Dermatologic Agents|dermatologic agents|mesh-ancestor
101588104|NCT04201678|Anesthetics|anesthetics|mesh-list
101588105|NCT04201678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101588106|NCT04201678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588108|NCT00653341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101588109|NCT00653341|Insulin Glargine|insulin glargine|mesh-list
101588110|NCT00653341|Isophane Insulin, Human|isophane insulin, human|mesh-list
101588111|NCT00653341|Insulin, Isophane|insulin, isophane|mesh-list
101588112|NCT00653341|Isophane insulin, beef|isophane insulin, beef|mesh-list
101588162|NCT02634463|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101588163|NCT02634463|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101588164|NCT02634463|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101588234|NCT01236430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245124|NCT01657812|Analgesics|analgesics|mesh-ancestor
101588235|NCT01236430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101588236|NCT01236430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101588305|NCT03612466|Antacids|antacids|mesh-ancestor
101588306|NCT03612466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588307|NCT03612466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101588308|NCT03612466|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101588309|NCT03612466|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101588310|NCT03612466|Antiviral Agents|antiviral agents|mesh-ancestor
101588311|NCT03612466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101588312|NCT00142558|Indomethacin|indomethacin|mesh-list
101588313|NCT00142558|Etoricoxib|etoricoxib|mesh-list
101588314|NCT00142558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588316|NCT00142558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101588368|NCT02841202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588369|NCT02841202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101588370|NCT00895414|Doxorubicin|doxorubicin|mesh-list
101588371|NCT00895414|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101588372|NCT00895414|Enalapril|enalapril|mesh-list
101588373|NCT00895414|Enalaprilat|enalaprilat|mesh-list
101588374|NCT00895414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101588375|NCT00895414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101588376|NCT00895414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101588377|NCT00895414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101588378|NCT00895414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101588379|NCT00895414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588380|NCT00895414|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101588381|NCT00895414|Protease Inhibitors|protease inhibitors|mesh-ancestor
101588382|NCT00895414|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101588383|NCT01822288|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101588426|NCT01212770|Immunologic Factors|immunologic factors|mesh-ancestor
101588427|NCT01212770|Leprostatic Agents|leprostatic agents|mesh-ancestor
101588428|NCT01212770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101588429|NCT01212770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101588430|NCT01212770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101588435|NCT05334316|Dexamethasone|dexamethasone|mesh-list
101356003|NCT00032279|Visilizumab|visilizumab|mesh-list
101588498|NCT01211522|Haloperidol decanoate|haloperidol decanoate|mesh-list
101588499|NCT01211522|Ziprasidone|ziprasidone|mesh-list
101588500|NCT01211522|Antiemetics|antiemetics|mesh-ancestor
101588501|NCT01211522|Autonomic Agents|autonomic agents|mesh-ancestor
101588502|NCT01211522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101588503|NCT01211522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588504|NCT01211522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101588505|NCT01211522|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101588506|NCT01211522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101588507|NCT01211522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101588508|NCT01211522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101588509|NCT01211522|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101588563|NCT02633761|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101588564|NCT02633761|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101588565|NCT02633761|Hormone Antagonists|hormone antagonists|mesh-ancestor
101588566|NCT02633761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101588567|NCT02633761|Luteolytic Agents|luteolytic agents|mesh-ancestor
101588568|NCT02633761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101588569|NCT02633761|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101588570|NCT02633839|Carbidopa|carbidopa|mesh-list
101588571|NCT02633839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101588572|NCT02633839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101588573|NCT02633839|Dopamine Agents|dopamine agents|mesh-ancestor
101588574|NCT02633839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101588575|NCT02633839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588576|NCT02633839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588577|NCT02633839|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101588578|NCT02633839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101588579|NCT02632903|Zoledronic Acid|zoledronic acid|mesh-list
101588582|NCT00657397|Methadone|methadone|mesh-list
101588618|NCT04161001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588619|NCT04161001|Vasodilator Agents|vasodilator agents|mesh-ancestor
101588620|NCT04161001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101588621|NCT04161001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101588622|NCT04161001|Antimetabolites|antimetabolites|mesh-ancestor
101588623|NCT04161001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101588624|NCT04161001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101588625|NCT04161001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101588626|NCT04161001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101588627|NCT04161001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101588628|NCT00881569|Efatutazone|efatutazone|mesh-list
101588678|NCT00661219|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101588679|NCT00661219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101588680|NCT00661219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588681|NCT00661219|Urological Agents|urological agents|mesh-ancestor
101588749|NCT00666055|Raltegravir Potassium|raltegravir potassium|mesh-list
101588750|NCT00666055|Maraviroc|maraviroc|mesh-list
101588751|NCT00666055|Efavirenz|efavirenz|mesh-list
101588752|NCT00666055|Etravirine|etravirine|mesh-list
101588820|NCT02837614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101588821|NCT02837614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101588822|NCT02837614|Protease Inhibitors|protease inhibitors|mesh-ancestor
101588893|NCT00661765|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101588894|NCT00661765|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101588895|NCT00661765|Cholinergic Agents|cholinergic agents|mesh-ancestor
101588896|NCT00661765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101588897|NCT00661765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588898|NCT00661765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588899|NCT00657943|Insulin|insulin|mesh-list
101588900|NCT00657943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101588901|NCT00657943|Metformin|metformin|mesh-list
101588902|NCT00657943|Insulin Aspart|insulin aspart|mesh-list
101588903|NCT00657943|Insulin, Long-Acting|insulin, long-acting|mesh-list
101588904|NCT00657943|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101588905|NCT00657943|Insulin Detemir|insulin detemir|mesh-list
101588906|NCT00657943|Protamines|protamines|mesh-list
101588907|NCT00657943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101588908|NCT00657943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588952|NCT02630485|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101588953|NCT02630485|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101588954|NCT02630485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101588955|NCT02630485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101588956|NCT02630485|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101588957|NCT02630485|Hormone Antagonists|hormone antagonists|mesh-ancestor
101588958|NCT02630485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101588959|NCT02630485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101588960|NCT02630485|Vitamin B Complex|vitamin b complex|mesh-ancestor
101589018|NCT00658255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101589019|NCT00658255|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101589020|NCT00658255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101589021|NCT00658255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101589022|NCT00658255|Adrenergic Agents|adrenergic agents|mesh-ancestor
101589023|NCT00658255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101589024|NCT00658255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589025|NCT02836288|Ketamine|ketamine|mesh-list
101589026|NCT02836288|Analgesics|analgesics|mesh-ancestor
101589027|NCT02836288|Sensory System Agents|sensory system agents|mesh-ancestor
101589028|NCT02836288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101589029|NCT02836288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589030|NCT02836288|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101589076|NCT00666601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101589077|NCT01207388|Blinatumomab|blinatumomab|mesh-list
101589078|NCT01207388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101589079|NCT02835664|Niacinamide|niacinamide|mesh-list
101589080|NCT02835664|Niacin|niacin|mesh-list
101589081|NCT02835664|Nicotinic Acids|nicotinic acids|mesh-list
101589082|NCT02835664|Vitamin B Complex|vitamin b complex|mesh-ancestor
101589083|NCT02835664|Vitamins|vitamins|mesh-ancestor
101589084|NCT02835664|Micronutrients|micronutrients|mesh-ancestor
101589085|NCT02835664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589086|NCT02835664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101589087|NCT02835664|Antimetabolites|antimetabolites|mesh-ancestor
101589088|NCT02835664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589089|NCT02835664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101589090|NCT02835664|Vasodilator Agents|vasodilator agents|mesh-ancestor
101589091|NCT02838472|Ascorbic Acid|ascorbic acid|mesh-list
101589139|NCT01206764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101589140|NCT01206764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589141|NCT01206764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101589142|NCT01206764|Immunologic Factors|immunologic factors|mesh-ancestor
101589143|NCT01206764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589144|NCT01206764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101589145|NCT00667927|Cyclophosphamide|cyclophosphamide|mesh-list
101589147|NCT00667927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101589148|NCT00667927|Immunologic Factors|immunologic factors|mesh-ancestor
101589149|NCT00667927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589150|NCT00667927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101589151|NCT00667927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101589152|NCT00667927|Alkylating Agents|alkylating agents|mesh-ancestor
101589153|NCT00667927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589154|NCT00667927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101589155|NCT00667927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101589156|NCT00668005|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101589157|NCT00668005|Vasodilator Agents|vasodilator agents|mesh-ancestor
101589160|NCT00668005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101589193|NCT00662233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101589194|NCT00662233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101589195|NCT00662233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101589196|NCT00662233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101589197|NCT00662233|Tubulin Modulators|tubulin modulators|mesh-ancestor
101589198|NCT00662233|Antimitotic Agents|antimitotic agents|mesh-ancestor
101589199|NCT00662233|Mitosis Modulators|mitosis modulators|mesh-ancestor
101589200|NCT00658957|Gentamicins|gentamicins|mesh-list
101589262|NCT04250116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101589263|NCT04250116|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101589264|NCT04250116|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101589265|NCT04250116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101589266|NCT04250116|Purinergic Agents|purinergic agents|mesh-ancestor
101589267|NCT04250116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101589268|NCT04250116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589269|NCT04250116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589270|NCT04250116|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101589271|NCT04250116|Antithrombins|antithrombins|mesh-ancestor
101589272|NCT04250116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101589273|NCT04250116|Protease Inhibitors|protease inhibitors|mesh-ancestor
101589274|NCT04250116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101589275|NCT04250116|Anticoagulants|anticoagulants|mesh-ancestor
101589276|NCT00659113|Tegafur|tegafur|mesh-list
101589277|NCT00659113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101589278|NCT00659113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101589279|NCT00659113|Antimetabolites|antimetabolites|mesh-ancestor
101589280|NCT00659113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589281|NCT00662779|Formoterol Fumarate|formoterol fumarate|mesh-list
101589283|NCT00662779|Autonomic Agents|autonomic agents|mesh-ancestor
101589313|NCT00669487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101589315|NCT00669565|Bavituximab|bavituximab|mesh-list
101589316|NCT00669565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101589317|NCT00669565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101589386|NCT00670423|Tacrolimus|tacrolimus|mesh-list
101589387|NCT00670423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101589388|NCT00670423|Immunologic Factors|immunologic factors|mesh-ancestor
101589461|NCT02887313|Vitamin B Complex|vitamin b complex|mesh-ancestor
101589462|NCT02887313|Vitamins|vitamins|mesh-ancestor
101589463|NCT02887313|Micronutrients|micronutrients|mesh-ancestor
101589464|NCT01206140|Sirolimus|sirolimus|mesh-list
101589465|NCT01206140|Temsirolimus|temsirolimus|mesh-list
101589466|NCT01206140|MTOR Inhibitors|mtor inhibitors|mesh-list
101589467|NCT01206140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101589468|NCT01206140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101589469|NCT01206140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101589470|NCT01206140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101589524|NCT02885597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101589526|NCT01188551|Midazolam|midazolam|mesh-list
101589527|NCT01188551|Dexmedetomidine|dexmedetomidine|mesh-list
101589528|NCT01188551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101589530|NCT01188551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589594|NCT00891904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101589596|NCT02834260|Dexamethasone|dexamethasone|mesh-list
101589665|NCT02831218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101589666|NCT02831218|Analgesics|analgesics|mesh-ancestor
101589667|NCT02831218|Sensory System Agents|sensory system agents|mesh-ancestor
101589668|NCT02831218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101589669|NCT02831218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589670|NCT02831218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101589671|NCT02831218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101589672|NCT02831218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101589685|NCT02833480|Budesonide|budesonide|mesh-list
101589730|NCT02830906|Antiemetics|antiemetics|mesh-ancestor
101589731|NCT02830906|Autonomic Agents|autonomic agents|mesh-ancestor
101589732|NCT02830906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101589733|NCT02830906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589734|NCT02830906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101589735|NCT02830906|Antipruritics|antipruritics|mesh-ancestor
101589736|NCT02830906|Dermatologic Agents|dermatologic agents|mesh-ancestor
101589737|NCT02830906|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101589797|NCT02830048|Glyburide|glyburide|mesh-list
101589798|NCT02830048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101589799|NCT02830048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589800|NCT02830126|Anesthetics|anesthetics|mesh-list
101356045|NCT00060372|Ipilimumab|ipilimumab|mesh-list
101589801|NCT02830126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101589803|NCT02828566|Ketamine|ketamine|mesh-list
101589867|NCT05210764|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101589868|NCT05210764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101589869|NCT05210764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101589870|NCT05210764|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101589874|NCT00889720|Varenicline|varenicline|mesh-list
101589936|NCT01110330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101589937|NCT01110330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101589938|NCT01110330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101589939|NCT00663481|Leucovorin|leucovorin|mesh-list
101589940|NCT00663481|Antidotes|antidotes|mesh-ancestor
101589941|NCT00663481|Protective Agents|protective agents|mesh-ancestor
101589944|NCT00663481|Vitamins|vitamins|mesh-ancestor
101590006|NCT04158349|Oxaliplatin|oxaliplatin|mesh-list
101590007|NCT04158349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101590008|NCT00888940|Ecallantide|ecallantide|mesh-list
101590009|NCT00888940|Tranexamic Acid|tranexamic acid|mesh-list
101590010|NCT00888940|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101590011|NCT00888940|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101590078|NCT00663949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101590079|NCT00663949|Protease Inhibitors|protease inhibitors|mesh-ancestor
101590080|NCT00663949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101590149|NCT04153123|Respiratory System Agents|respiratory system agents|mesh-ancestor
101590150|NCT04153123|Mydriatics|mydriatics|mesh-ancestor
101590151|NCT04153123|Sympathomimetics|sympathomimetics|mesh-ancestor
101590152|NCT04153123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101590154|NCT00671593|Glycerol|glycerol|mesh-list
101590155|NCT00671593|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101590156|NCT00671593|Protective Agents|protective agents|mesh-ancestor
101590220|NCT00660751|Antidepressive Agents|antidepressive agents|mesh-ancestor
101590221|NCT00660751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101590222|NCT00660751|Dopamine Agents|dopamine agents|mesh-ancestor
101590223|NCT00664963|Sirolimus|sirolimus|mesh-list
101590224|NCT00664963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101590293|NCT00661063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590294|NCT00661063|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101590295|NCT00661063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101590296|NCT00661063|Anesthetics, General|anesthetics, general|mesh-ancestor
101590297|NCT00661063|Anesthetics|anesthetics|mesh-ancestor
101590361|NCT00880009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590362|NCT00676039|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101590363|NCT00676039|Citalopram|citalopram|mesh-list
101590364|NCT00676039|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101590365|NCT00676039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101590366|NCT00676039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101590367|NCT00676039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590368|NCT00676039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101590369|NCT00676039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590370|NCT00676039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101590371|NCT00676039|Antidepressive Agents|antidepressive agents|mesh-ancestor
101590372|NCT00676039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101590373|NCT00676039|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101590374|NCT00676039|Serotonin Agents|serotonin agents|mesh-ancestor
101590420|NCT00676117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101590421|NCT00676117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101590422|NCT00676117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101590423|NCT00676117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101590424|NCT00676117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590425|NCT00676117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101590426|NCT00676117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101590427|NCT00676117|Analgesics|analgesics|mesh-ancestor
101356054|NCT00060411|Leucovorin|leucovorin|mesh-list
101590428|NCT00676117|Sensory System Agents|sensory system agents|mesh-ancestor
101590429|NCT00676117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101590430|NCT00676117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590431|NCT00676117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101590432|NCT00676117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101590480|NCT00676429|Dopamine Agents|dopamine agents|mesh-ancestor
101590481|NCT02629315|Formaldehyde|formaldehyde|mesh-list
101590482|NCT02629315|Disinfectants|disinfectants|mesh-ancestor
101590483|NCT02629315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101590484|NCT01204658|Vaccines|vaccines|mesh-list
101590485|NCT01204658|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101590548|NCT00945945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590549|NCT00945945|Analgesics|analgesics|mesh-ancestor
101590550|NCT00945945|Sensory System Agents|sensory system agents|mesh-ancestor
101590551|NCT00945945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101590552|NCT00945945|Antidepressive Agents|antidepressive agents|mesh-ancestor
101590553|NCT00945945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101590554|NCT00945945|Dopamine Agents|dopamine agents|mesh-ancestor
101590556|NCT01112982|Febuxostat|febuxostat|mesh-list
101590557|NCT01112982|Gout Suppressants|gout suppressants|mesh-ancestor
101590558|NCT01112982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101590559|NCT01112982|Tubulin Modulators|tubulin modulators|mesh-ancestor
101590560|NCT01112982|Antimitotic Agents|antimitotic agents|mesh-ancestor
101590561|NCT01112982|Mitosis Modulators|mitosis modulators|mesh-ancestor
101590562|NCT01112982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590563|NCT01112982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101590564|NCT01203878|Imiquimod|imiquimod|mesh-list
101590565|NCT01203878|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101590566|NCT01203878|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101590567|NCT01203878|Immunologic Factors|immunologic factors|mesh-ancestor
101590568|NCT01203878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590569|NCT01203878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101590570|NCT01203878|Interferon Inducers|interferon inducers|mesh-ancestor
101590571|NCT01203878|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101590572|NCT01203878|Dermatologic Agents|dermatologic agents|mesh-ancestor
101590573|NCT00676819|Insulin|insulin|mesh-list
101590602|NCT05032794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101590674|NCT02826772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590675|NCT02826772|Androgen Antagonists|androgen antagonists|mesh-ancestor
101590676|NCT02826772|Hormone Antagonists|hormone antagonists|mesh-ancestor
101590677|NCT00674011|Bevacizumab|bevacizumab|mesh-list
101590678|NCT00674011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101590679|NCT00674011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101590680|NCT00674011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101590681|NCT00674011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101590682|NCT00674011|Growth Substances|growth substances|mesh-ancestor
101590740|NCT02628847|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101590741|NCT02628847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101590742|NCT02628847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101590743|NCT02628847|Urological Agents|urological agents|mesh-ancestor
101590744|NCT00677443|Capecitabine|capecitabine|mesh-list
101590745|NCT00677443|Oxaliplatin|oxaliplatin|mesh-list
101590746|NCT00677443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101590747|NCT00677443|Antimetabolites|antimetabolites|mesh-ancestor
101590808|NCT00677755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590810|NCT00677755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101590811|NCT00677755|Oxytocics|oxytocics|mesh-ancestor
101590812|NCT00677755|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101590813|NCT00677755|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101590814|NCT00677755|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101590815|NCT00677755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101590816|NCT00677755|Contraceptive Agents|contraceptive agents|mesh-ancestor
101590817|NCT00677755|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101590818|NCT00677755|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101590819|NCT00677755|Hormone Antagonists|hormone antagonists|mesh-ancestor
101590820|NCT00677755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101590821|NCT00677755|Luteolytic Agents|luteolytic agents|mesh-ancestor
101590822|NCT00677755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101590823|NCT00677755|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101590824|NCT00674947|huB3F6-SPDB-DM4 immunoconjugate|hub3f6-spdb-dm4 immunoconjugate|mesh-list
101590825|NCT00674947|Immunoconjugates|immunoconjugates|mesh-ancestor
101590826|NCT00674947|Immunologic Factors|immunologic factors|mesh-ancestor
101590827|NCT00674947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590828|NCT02824042|Itraconazole|itraconazole|mesh-list
101590829|NCT02824042|Maytansine|maytansine|mesh-list
101590830|NCT02824042|Anetumab ravtansine|anetumab ravtansine|mesh-list
101590831|NCT02824042|Antifungal Agents|antifungal agents|mesh-ancestor
101590832|NCT02824042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101590833|NCT02824042|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101590834|NCT02824042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101590835|NCT02824042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101590836|NCT02824042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590837|NCT02824042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101590838|NCT02824042|Hormone Antagonists|hormone antagonists|mesh-ancestor
101590839|NCT02824042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101590845|NCT02824042|Antimitotic Agents|antimitotic agents|mesh-ancestor
101590846|NCT02824042|Mitosis Modulators|mitosis modulators|mesh-ancestor
101590847|NCT02824042|Immunoconjugates|immunoconjugates|mesh-ancestor
101590848|NCT02824042|Immunologic Factors|immunologic factors|mesh-ancestor
101590849|NCT00675181|Melatonin|melatonin|mesh-list
101590850|NCT00675181|Antioxidants|antioxidants|mesh-ancestor
101590851|NCT00675181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590852|NCT00675181|Protective Agents|protective agents|mesh-ancestor
101590853|NCT00675181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590854|NCT00675181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101590855|NCT04241458|Midazolam|midazolam|mesh-list
101590856|NCT04241458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101590857|NCT04241458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101590858|NCT04241458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101590859|NCT04241458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590860|NCT04241458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101590861|NCT04241458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101590862|NCT04241458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101590904|NCT04240834|Sensory System Agents|sensory system agents|mesh-ancestor
101590905|NCT04240834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101590906|NCT04240834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590907|NCT04240834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101590908|NCT04240834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101590909|NCT04240834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101590910|NCT04240834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101590911|NCT04240834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590912|NCT04240834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101590913|NCT04240834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101590914|NCT04240834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101590915|NCT04240834|Antipyretics|antipyretics|mesh-ancestor
101590916|NCT04240834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101590917|NCT04240834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101590918|NCT04240834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101590919|NCT04240834|Purinergic Agents|purinergic agents|mesh-ancestor
101590920|NCT04240834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101590921|NCT01200758|Prednisone|prednisone|mesh-list
101590922|NCT01200758|Prednisolone|prednisolone|mesh-list
101590923|NCT01200758|Cyclophosphamide|cyclophosphamide|mesh-list
101590924|NCT01200758|Rituximab|rituximab|mesh-list
101590925|NCT01200758|Doxorubicin|doxorubicin|mesh-list
101590926|NCT01200758|Vincristine|vincristine|mesh-list
101590956|NCT02823106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101590957|NCT02823106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101590958|NCT02823106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101590959|NCT02823106|Nootropic Agents|nootropic agents|mesh-ancestor
101590960|NCT02823106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101590961|NCT02823106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101590962|NCT02823106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101590963|NCT02823106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101590964|NCT02823106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101590965|NCT02823106|Vasodilator Agents|vasodilator agents|mesh-ancestor
101590966|NCT02821858|Odalasvir|odalasvir|mesh-list
101590967|NCT02821858|Antiviral Agents|antiviral agents|mesh-ancestor
101590968|NCT02821858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101590969|NCT00876343|Aripiprazole|aripiprazole|mesh-list
101590970|NCT00876343|Antidepressive Agents|antidepressive agents|mesh-ancestor
101590971|NCT00876343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101590972|NCT00876343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101590991|NCT02627989|Hormones|hormones|mesh-ancestor
101591009|NCT01107912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591010|NCT00678145|Epinephrine|epinephrine|mesh-list
101591011|NCT00678145|Morphine|morphine|mesh-list
101591012|NCT00678145|Naloxone|naloxone|mesh-list
101591013|NCT00678145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591014|NCT00678145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101591015|NCT00678145|Narcotics|narcotics|mesh-ancestor
101591016|NCT00678145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101591017|NCT00678145|Analgesics|analgesics|mesh-ancestor
101591018|NCT00678145|Sensory System Agents|sensory system agents|mesh-ancestor
101591019|NCT00678145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101591020|NCT00678145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101591021|NCT00678145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101591022|NCT00678145|Adrenergic Agents|adrenergic agents|mesh-ancestor
101591023|NCT00678145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101591024|NCT00678145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591025|NCT00678145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101591030|NCT00678145|Mydriatics|mydriatics|mesh-ancestor
101591068|NCT02628613|Antimitotic Agents|antimitotic agents|mesh-ancestor
101591069|NCT02628613|Mitosis Modulators|mitosis modulators|mesh-ancestor
101591070|NCT02628613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591071|NCT02628613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101591072|NCT02628613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101591073|NCT02628613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101591074|NCT02628613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101591075|NCT01100034|Etanercept|etanercept|mesh-list
101591076|NCT01100034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101591077|NCT01100034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101591079|NCT01100034|Sensory System Agents|sensory system agents|mesh-ancestor
101591080|NCT01100034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101591081|NCT01100034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591082|NCT01100034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101591083|NCT01100034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101591084|NCT01100034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101591085|NCT01100034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101591086|NCT01100034|Immunologic Factors|immunologic factors|mesh-ancestor
101591087|NCT04148833|Paclitaxel|paclitaxel|mesh-list
101591088|NCT04148833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101591089|NCT04148833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101591090|NCT04148833|Tubulin Modulators|tubulin modulators|mesh-ancestor
101591091|NCT04148833|Antimitotic Agents|antimitotic agents|mesh-ancestor
101591092|NCT04148833|Mitosis Modulators|mitosis modulators|mesh-ancestor
101591093|NCT04148833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591094|NCT02821546|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101591095|NCT02821468|Acetaminophen|acetaminophen|mesh-list
101591115|NCT04964622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591116|NCT04964622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101591117|NCT04964622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101591118|NCT04964622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101591119|NCT04964622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101591120|NCT04964622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591121|NCT04769050|Docetaxel|docetaxel|mesh-list
101591122|NCT04769050|Capecitabine|capecitabine|mesh-list
101591123|NCT04769050|Trastuzumab|trastuzumab|mesh-list
101591124|NCT04769050|Pertuzumab|pertuzumab|mesh-list
101591125|NCT04769050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101591126|NCT04769050|Tubulin Modulators|tubulin modulators|mesh-ancestor
101591127|NCT04769050|Antimitotic Agents|antimitotic agents|mesh-ancestor
101591128|NCT04769050|Mitosis Modulators|mitosis modulators|mesh-ancestor
101591129|NCT04769050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591130|NCT04769050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101591131|NCT04769050|Antimetabolites|antimetabolites|mesh-ancestor
101591132|NCT04769050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101591133|NCT02821390|Nepafenac|nepafenac|mesh-list
101591134|NCT02821390|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101591135|NCT02821390|Lubricant Eye Drops|lubricant eye drops|mesh-list
101591136|NCT02821390|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101591137|NCT02821390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101591138|NCT02821390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101591139|NCT02821390|Analgesics|analgesics|mesh-ancestor
101591140|NCT02821390|Sensory System Agents|sensory system agents|mesh-ancestor
101591141|NCT02821390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101591145|NCT02821312|DA-8010|da-8010|mesh-list
101591162|NCT02821156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101591163|NCT02821156|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101591164|NCT02821156|Vasodilator Agents|vasodilator agents|mesh-ancestor
101591165|NCT02821156|Gasotransmitters|gasotransmitters|mesh-ancestor
101591166|NCT02821156|Protective Agents|protective agents|mesh-ancestor
101591168|NCT02820922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101591169|NCT02820922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591170|NCT00633958|Alovudine|alovudine|mesh-list
101591171|NCT00633958|Antiviral Agents|antiviral agents|mesh-ancestor
101591172|NCT00633958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101591173|NCT02820688|Bupivacaine|bupivacaine|mesh-list
101591174|NCT02820688|Prilocaine|prilocaine|mesh-list
101591175|NCT02820688|Anesthetics, Local|anesthetics, local|mesh-ancestor
101591176|NCT02820688|Anesthetics|anesthetics|mesh-ancestor
101591177|NCT02820688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101591178|NCT02820688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591222|NCT04745728|Immunologic Factors|immunologic factors|mesh-ancestor
101591223|NCT04745728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591225|NCT04745728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101591226|NCT04745728|Alkylating Agents|alkylating agents|mesh-ancestor
101591227|NCT04745728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591233|NCT04745728|Hormones|hormones|mesh-ancestor
101591288|NCT01102374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101591289|NCT05658640|Cytarabine|cytarabine|mesh-list
101591290|NCT05658640|Dexamethasone|dexamethasone|mesh-list
101591291|NCT05658640|Cyclophosphamide|cyclophosphamide|mesh-list
101591292|NCT05658640|Trametinib|trametinib|mesh-list
101591293|NCT05658640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101591294|NCT05658640|Immunologic Factors|immunologic factors|mesh-ancestor
101591296|NCT05658640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101591358|NCT02818348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101591359|NCT02818348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101591360|NCT02818348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101591361|NCT02818348|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101591362|NCT02818348|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101591363|NCT00634192|Tobramycin|tobramycin|mesh-list
101591364|NCT00634192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101591365|NCT00634192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101591366|NCT00684463|Palonosetron|palonosetron|mesh-list
101591422|NCT00678769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591423|NCT04146883|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101591424|NCT04146883|Cephalexin|cephalexin|mesh-list
101591425|NCT04146883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101591426|NCT02817256|Vitamins|vitamins|mesh-list
101591427|NCT02817256|Micronutrients|micronutrients|mesh-ancestor
101591428|NCT02817256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591429|NCT02817100|Itraconazole|itraconazole|mesh-list
101591430|NCT02817100|Antifungal Agents|antifungal agents|mesh-ancestor
101591431|NCT02817100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101591432|NCT02817100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101591433|NCT02817100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101591434|NCT02817100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101591435|NCT02817100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591436|NCT02817100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101591437|NCT02817100|Hormone Antagonists|hormone antagonists|mesh-ancestor
101591438|NCT02817100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101591439|NCT02817100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591440|NCT02817100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101591441|NCT00684853|Bevacizumab|bevacizumab|mesh-list
101591442|NCT00684853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101591443|NCT00684853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101591444|NCT00684853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101591445|NCT00684853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101591471|NCT00679237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591472|NCT00679237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101591473|NCT00679237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101591474|NCT00679237|Antimetabolites|antimetabolites|mesh-ancestor
101591475|NCT00679237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591540|NCT05658874|Amitriptyline|amitriptyline|mesh-list
101591541|NCT05658874|Mirabegron|mirabegron|mesh-list
101591542|NCT05658874|Oxybutynin|oxybutynin|mesh-list
101591543|NCT05658874|Estrogens|estrogens|mesh-list
101591544|NCT05658874|Analgesics|analgesics|mesh-ancestor
101591545|NCT05658874|Sensory System Agents|sensory system agents|mesh-ancestor
101591546|NCT05658874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101591547|NCT05658874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591548|NCT05658874|Anticonvulsants|anticonvulsants|mesh-ancestor
101591549|NCT05658874|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101591550|NCT05658874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101591551|NCT05658874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101591552|NCT05658874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101591553|NCT05658874|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101591554|NCT05658874|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101591555|NCT05658874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101591557|NCT05658874|Antimanic Agents|antimanic agents|mesh-ancestor
101591598|NCT04425538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101591599|NCT04425538|Dermatologic Agents|dermatologic agents|mesh-ancestor
101591600|NCT04425538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101591601|NCT04425538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101591603|NCT02627521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101591604|NCT02627521|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101591605|NCT02627521|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101591606|NCT02627521|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101591608|NCT02627521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101591609|NCT02627521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591610|NCT02627521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591611|NCT00681967|Gefitinib|gefitinib|mesh-list
101591612|NCT00681967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101591613|NCT00681967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101591614|NCT00681967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101591615|NCT00681967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101591616|NCT04239118|Hemostatics|hemostatics|mesh-list
101591617|NCT04239118|Coagulants|coagulants|mesh-ancestor
101591618|NCT04139941|Antibodies|antibodies|mesh-list
101591653|NCT04371952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101591654|NCT04371952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101591656|NCT04329832|Hydroxychloroquine|hydroxychloroquine|mesh-list
101591725|NCT00874939|Donepezil|donepezil|mesh-list
101591726|NCT00874939|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101591797|NCT04237480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101591798|NCT04237480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101591800|NCT02810782|Phenobarbital|phenobarbital|mesh-list
101591801|NCT02810782|Chlorpromazine|chlorpromazine|mesh-list
101591802|NCT02810782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101591803|NCT02810782|Narcotics|narcotics|mesh-ancestor
101591804|NCT02810782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101591805|NCT02810782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101591806|NCT02810782|Analgesics|analgesics|mesh-ancestor
101591807|NCT02810782|Sensory System Agents|sensory system agents|mesh-ancestor
101591808|NCT02810782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101591861|NCT02809768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101591862|NCT02809768|Antitubercular Agents|antitubercular agents|mesh-ancestor
101591863|NCT02809768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101591864|NCT02809768|Leprostatic Agents|leprostatic agents|mesh-ancestor
101591865|NCT02809768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101591866|NCT02809768|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101591867|NCT02809768|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101591868|NCT02809768|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101591929|NCT02809378|Narcotics|narcotics|mesh-ancestor
101591930|NCT02809378|Analgesics|analgesics|mesh-ancestor
101591931|NCT02809378|Sensory System Agents|sensory system agents|mesh-ancestor
101592002|NCT02812888|Propranolol|propranolol|mesh-list
101592003|NCT02812888|Methimazole|methimazole|mesh-list
101592004|NCT02812888|Propylthiouracil|propylthiouracil|mesh-list
101592005|NCT02812888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101592006|NCT02812888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101592007|NCT02812888|Adrenergic Agents|adrenergic agents|mesh-ancestor
101592008|NCT02812888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101592009|NCT02812888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592010|NCT02812888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592011|NCT02812888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101592012|NCT02812888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101592013|NCT02812888|Vasodilator Agents|vasodilator agents|mesh-ancestor
101592014|NCT02812888|Antithyroid Agents|antithyroid agents|mesh-ancestor
101592015|NCT02812888|Hormone Antagonists|hormone antagonists|mesh-ancestor
101592016|NCT02812888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101592017|NCT02812888|Antimetabolites|antimetabolites|mesh-ancestor
101592018|NCT00687661|Diphosphonates|diphosphonates|mesh-list
101592019|NCT00687661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101592020|NCT00687661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592021|NCT00687817|Paclitaxel|paclitaxel|mesh-list
101592022|NCT00687817|Carboplatin|carboplatin|mesh-list
101592023|NCT00687817|Bavituximab|bavituximab|mesh-list
101592024|NCT00687817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101592025|NCT00687817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101592026|NCT00687817|Tubulin Modulators|tubulin modulators|mesh-ancestor
101592027|NCT00687817|Antimitotic Agents|antimitotic agents|mesh-ancestor
101592048|NCT02880462|Protective Agents|protective agents|mesh-ancestor
101592049|NCT02880462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592050|NCT02880462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101592051|NCT00688363|Chrysarobin|chrysarobin|mesh-list
101592052|NCT00688363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101592053|NCT00688363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101592054|NCT00688363|Analgesics|analgesics|mesh-ancestor
101592055|NCT00688363|Sensory System Agents|sensory system agents|mesh-ancestor
101592115|NCT02625103|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101592116|NCT02625103|Serotonin Agents|serotonin agents|mesh-ancestor
101592117|NCT02625103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101592119|NCT02625103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101828151|NCT05923996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101592184|NCT05238155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592187|NCT01106586|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101592258|NCT00689845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101592259|NCT00689845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101592260|NCT00689845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101592328|NCT01154153|Loratadine|loratadine|mesh-list
101592329|NCT01154153|Triamcinolone|triamcinolone|mesh-list
101592330|NCT01154153|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101592331|NCT01154153|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101592332|NCT01154153|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101592333|NCT01154153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101592397|NCT02690038|Immunoglobulins|immunoglobulins|mesh-list
101592398|NCT02690038|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101592399|NCT02690038|Antibodies|antibodies|mesh-list
101592471|NCT05298475|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
101592472|NCT05298475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101592473|NCT05298475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101592474|NCT05298475|Antimetabolites|antimetabolites|mesh-ancestor
101592475|NCT05298475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592539|NCT02805010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101592540|NCT02805010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101592541|NCT02805010|Immunologic Factors|immunologic factors|mesh-ancestor
101592542|NCT02805010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592543|NCT02805010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101592544|NCT02800408|Beta-Cryptoxanthin|beta-cryptoxanthin|mesh-list
101592545|NCT02800408|Provitamins|provitamins|mesh-ancestor
101592546|NCT02800408|Vitamins|vitamins|mesh-ancestor
101592547|NCT02800408|Micronutrients|micronutrients|mesh-ancestor
101592548|NCT02800408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592549|NCT00692263|Tramadol|tramadol|mesh-list
101592550|NCT00692263|Escitalopram|escitalopram|mesh-list
101592606|NCT02621359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101592607|NCT02621359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101592608|NCT02621359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101592609|NCT02621359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101592610|NCT02621359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592674|NCT01097616|Suvorexant|suvorexant|mesh-list
101592675|NCT01097616|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101592676|NCT01097616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101592679|NCT01097616|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
101592745|NCT02624401|Sensory System Agents|sensory system agents|mesh-ancestor
101592746|NCT02624401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101592747|NCT02624401|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101592748|NCT02624401|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101592749|NCT02624401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101592814|NCT00693043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592815|NCT00693043|Sensory System Agents|sensory system agents|mesh-ancestor
101592816|NCT00693043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101592887|NCT00696007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592888|NCT02624089|Ropivacaine|ropivacaine|mesh-list
101592889|NCT02624089|Anesthetics, Local|anesthetics, local|mesh-ancestor
101592890|NCT02624089|Anesthetics|anesthetics|mesh-ancestor
101592891|NCT02624089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101592892|NCT02624089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101592893|NCT02624089|Sensory System Agents|sensory system agents|mesh-ancestor
101592894|NCT02624089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101592895|NCT02796196|Coal Tar|coal tar|mesh-list
101592954|NCT02801188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101592955|NCT02801032|Tadalafil|tadalafil|mesh-list
101592956|NCT02801032|Vasodilator Agents|vasodilator agents|mesh-ancestor
101592958|NCT02801032|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101593024|NCT00872989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593025|NCT02794714|Rocuronium|rocuronium|mesh-list
101593026|NCT02794714|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101593027|NCT02794714|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101593028|NCT02794714|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101593031|NCT01148771|Ertapenem|ertapenem|mesh-list
101593092|NCT02623621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101593093|NCT02623621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101593094|NCT02623621|Growth Substances|growth substances|mesh-ancestor
101593095|NCT02623621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593096|NCT02623621|Growth Inhibitors|growth inhibitors|mesh-ancestor
101593097|NCT00693589|Folic Acid|folic acid|mesh-list
101593098|NCT00693589|Vitamin B 12|vitamin b 12|mesh-list
101593161|NCT02793388|Antimalarials|antimalarials|mesh-ancestor
101593162|NCT02793388|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101593163|NCT02793388|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101593164|NCT02793388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101593165|NCT02689882|Niacinamide|niacinamide|mesh-list
101593167|NCT02689882|Nicotinic Acids|nicotinic acids|mesh-list
101593231|NCT02789332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101593232|NCT02789332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101593233|NCT02789332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101593234|NCT02789332|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101593235|NCT02792140|Naltrexone|naltrexone|mesh-list
101593236|NCT02792140|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101593237|NCT02792140|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101593241|NCT02791594|Pembrolizumab|pembrolizumab|mesh-list
101593300|NCT02790580|Immunologic Factors|immunologic factors|mesh-ancestor
101593301|NCT02790580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593302|NCT02790580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101593332|NCT00693979|Paclitaxel|paclitaxel|mesh-list
101593375|NCT01190813|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101593376|NCT01190813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101593377|NCT03641326|Sunitinib|sunitinib|mesh-list
101593378|NCT03641326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101593379|NCT03641326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101593443|NCT02623231|Escitalopram|escitalopram|mesh-list
101593444|NCT02623231|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101593445|NCT02623231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101593446|NCT02623231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101593447|NCT02623231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593448|NCT02623231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101593449|NCT02623231|Serotonin Agents|serotonin agents|mesh-ancestor
101593450|NCT02623231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593451|NCT02623153|Docetaxel|docetaxel|mesh-list
101593452|NCT02623153|Capecitabine|capecitabine|mesh-list
101593453|NCT02623153|Oxaliplatin|oxaliplatin|mesh-list
101593454|NCT02623153|Tegafur|tegafur|mesh-list
101593455|NCT02623153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101593456|NCT02623153|Tubulin Modulators|tubulin modulators|mesh-ancestor
101593457|NCT02623153|Antimitotic Agents|antimitotic agents|mesh-ancestor
101593458|NCT02623153|Mitosis Modulators|mitosis modulators|mesh-ancestor
101593459|NCT02623153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593460|NCT02623153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101593461|NCT02623153|Antimetabolites|antimetabolites|mesh-ancestor
101593499|NCT03628066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101593500|NCT03628066|Hormone Antagonists|hormone antagonists|mesh-ancestor
101593501|NCT03628066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101593502|NCT03628066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593503|NCT03628066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101593568|NCT00869089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101593569|NCT00869089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593570|NCT02616367|Bupivacaine|bupivacaine|mesh-list
101593571|NCT02616367|Ropivacaine|ropivacaine|mesh-list
101593572|NCT02616367|Anesthetics, Local|anesthetics, local|mesh-ancestor
101593639|NCT03365752|Anesthetics|anesthetics|mesh-list
101593640|NCT03365752|Mepivacaine|mepivacaine|mesh-list
101593641|NCT03365752|Chloroprocaine|chloroprocaine|mesh-list
101593710|NCT02621905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101593712|NCT01106352|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
101593785|NCT04231864|Immunoglobulin G|immunoglobulin g|mesh-list
101593786|NCT04231864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101593787|NCT04231864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356140|NCT00060645|Sirolimus|sirolimus|mesh-list
101593788|NCT04231864|Immunologic Factors|immunologic factors|mesh-ancestor
101593789|NCT04231864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593790|NCT01143077|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
101593853|NCT02957032|Antiviral Agents|antiviral agents|mesh-ancestor
101593854|NCT02957032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101593855|NCT02957032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101593856|NCT02957032|Immunologic Factors|immunologic factors|mesh-ancestor
101593923|NCT05276908|Anesthetics, Local|anesthetics, local|mesh-ancestor
101593924|NCT05276908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101593925|NCT05276908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593926|NCT05276908|Sensory System Agents|sensory system agents|mesh-ancestor
101593927|NCT05276908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101593928|NCT02785978|Levodopa|levodopa|mesh-list
101593929|NCT02785978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101593930|NCT02785978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101593931|NCT02785978|Dopamine Agents|dopamine agents|mesh-ancestor
101593932|NCT02785978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101593933|NCT02785978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593934|NCT02785978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593935|NCT02786212|Dexmedetomidine|dexmedetomidine|mesh-list
101593936|NCT02786212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101593937|NCT02786212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101593938|NCT02786212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101593939|NCT02786212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101593940|NCT02786212|Analgesics|analgesics|mesh-ancestor
101593941|NCT02786212|Sensory System Agents|sensory system agents|mesh-ancestor
101593942|NCT02786212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101593943|NCT02786212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101593944|NCT02786212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101593945|NCT02786212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101593946|NCT02786212|Adrenergic Agents|adrenergic agents|mesh-ancestor
101593947|NCT02786212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101593948|NCT02786212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101593949|NCT05273710|Folic Acid|folic acid|mesh-list
101593950|NCT05273710|Hematinics|hematinics|mesh-ancestor
101593969|NCT02784340|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101593970|NCT02784340|BB 1101|bb 1101|mesh-list
101593971|NCT02784340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101593972|NCT02784340|Antiemetics|antiemetics|mesh-ancestor
101593973|NCT02784340|Autonomic Agents|autonomic agents|mesh-ancestor
101593977|NCT02784340|Glucocorticoids|glucocorticoids|mesh-ancestor
101594038|NCT00698425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594040|NCT05342272|Muramidase|muramidase|mesh-list
101594041|NCT05342272|Betaine|betaine|mesh-list
101594042|NCT05342272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101594043|NCT05342272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101594044|NCT05342272|Lipotropic Agents|lipotropic agents|mesh-ancestor
101594045|NCT05342272|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101594046|NCT05342272|Antimetabolites|antimetabolites|mesh-ancestor
101594047|NCT05342272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594102|NCT02782078|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101594103|NCT02782078|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101594104|NCT02782078|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101594105|NCT02782078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101594106|NCT01293682|Calcitriol|calcitriol|mesh-list
101594107|NCT01293682|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101594108|NCT01293682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594113|NCT01293682|Vitamins|vitamins|mesh-ancestor
101594169|NCT02618395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594170|NCT02618395|Analgesics|analgesics|mesh-ancestor
101594171|NCT02618395|Sensory System Agents|sensory system agents|mesh-ancestor
101594172|NCT02618395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101594173|NCT02618395|Antitussive Agents|antitussive agents|mesh-ancestor
101594174|NCT02618395|Respiratory System Agents|respiratory system agents|mesh-ancestor
101594180|NCT01183013|Hormones|hormones|mesh-ancestor
101594235|NCT00863707|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101594236|NCT00863707|Purinergic Agonists|purinergic agonists|mesh-ancestor
101594237|NCT00863707|Purinergic Agents|purinergic agents|mesh-ancestor
101594238|NCT00863707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101594239|NCT00863707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594240|NCT00863707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594241|NCT05340634|Contraceptive Agents|contraceptive agents|mesh-list
101594242|NCT05340634|Contraceptives, Oral|contraceptives, oral|mesh-list
101594301|NCT01140503|Sensory System Agents|sensory system agents|mesh-ancestor
101594302|NCT01140503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101594303|NCT01140503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594304|NCT01140503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101594305|NCT01140503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101594306|NCT01140503|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101594307|NCT01140503|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101594369|NCT01079130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101594370|NCT01079130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594371|NCT01078974|Dexamethasone|dexamethasone|mesh-list
101594372|NCT01078974|Rituximab|rituximab|mesh-list
101594373|NCT01078974|Pomalidomide|pomalidomide|mesh-list
101594374|NCT01078974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101594375|NCT01078974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101594376|NCT01078974|Immunologic Factors|immunologic factors|mesh-ancestor
101594377|NCT01078974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594378|NCT01078974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101594379|NCT01078974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101594380|NCT01078974|Antiemetics|antiemetics|mesh-ancestor
101594381|NCT01078974|Autonomic Agents|autonomic agents|mesh-ancestor
101594382|NCT01078974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101594383|NCT01078974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101594384|NCT01078974|Glucocorticoids|glucocorticoids|mesh-ancestor
101594385|NCT01078974|Hormones|hormones|mesh-ancestor
101594386|NCT01078974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101594387|NCT01078974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101594388|NCT01078974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101594389|NCT01078974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101594390|NCT01078974|Growth Substances|growth substances|mesh-ancestor
101594391|NCT01078974|Growth Inhibitors|growth inhibitors|mesh-ancestor
101594392|NCT04307082|Ibrexafungerp|ibrexafungerp|mesh-list
101594393|NCT04307082|Antifungal Agents|antifungal agents|mesh-ancestor
101594394|NCT04307082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101594395|NCT02878200|Piperaquine|piperaquine|mesh-list
101594396|NCT02878200|Artenimol|artenimol|mesh-list
101594397|NCT02878200|Antimalarials|antimalarials|mesh-ancestor
101594398|NCT02878200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101594399|NCT02878200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101594400|NCT02878200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101594401|NCT04302012|Mydriatics|mydriatics|mesh-list
101594402|NCT04302012|Autonomic Agents|autonomic agents|mesh-ancestor
101643130|NCT04051723|Glucocorticoids|glucocorticoids|mesh-ancestor
101594409|NCT00869557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594410|NCT00869557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594411|NCT00869557|Antiviral Agents|antiviral agents|mesh-ancestor
101594412|NCT00869557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101594413|NCT00869557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101594414|NCT00869557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101594415|NCT02781064|Atorvastatin|atorvastatin|mesh-list
101594416|NCT02781064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101594417|NCT02781064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101594418|NCT02781064|Antimetabolites|antimetabolites|mesh-ancestor
101594419|NCT02781064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594420|NCT02781064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101594421|NCT02781064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101594423|NCT04205682|Cannabidiol|cannabidiol|mesh-list
101594424|NCT04205682|Anticonvulsants|anticonvulsants|mesh-ancestor
101594425|NCT01134263|Vaccines|vaccines|mesh-list
101594426|NCT01134263|Immunologic Factors|immunologic factors|mesh-ancestor
101594427|NCT01134263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594428|NCT01199822|Olaratumab|olaratumab|mesh-list
101594429|NCT01199822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101594430|NCT01096056|Vaccines|vaccines|mesh-list
101594431|NCT01096056|Immunologic Factors|immunologic factors|mesh-ancestor
101594432|NCT01096056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594433|NCT00866359|Apremilast|apremilast|mesh-list
101594434|NCT00866359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101594435|NCT00866359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101594436|NCT00866359|Analgesics|analgesics|mesh-ancestor
101537241|NCT01083576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101643131|NCT04051723|Hormones|hormones|mesh-ancestor
101643132|NCT04051723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101643133|NCT04051723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101643134|NCT04051723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101643135|NCT04051723|Anesthetics, Local|anesthetics, local|mesh-ancestor
101643136|NCT04051723|Anesthetics|anesthetics|mesh-ancestor
101643137|NCT04051723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101643138|NCT04051723|Sensory System Agents|sensory system agents|mesh-ancestor
101643139|NCT00918424|Oxcarbazepine|oxcarbazepine|mesh-list
101643140|NCT00918424|Anticonvulsants|anticonvulsants|mesh-ancestor
101643141|NCT00918424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101643142|NCT00918424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101643143|NCT00918424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101643144|NCT00918424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643145|NCT00918424|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101643146|NCT00918424|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101643147|NCT00756847|Paclitaxel|paclitaxel|mesh-list
101643148|NCT00756847|Carboplatin|carboplatin|mesh-list
101643149|NCT00756847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101594437|NCT00866359|Sensory System Agents|sensory system agents|mesh-ancestor
101594438|NCT00866359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101594439|NCT00866359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594440|NCT00866359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101594441|NCT00866359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101594442|NCT00866359|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101594443|NCT00866359|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101594444|NCT00866359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594445|NCT00866359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594446|NCT01199198|Tolvaptan|tolvaptan|mesh-list
101594447|NCT01199198|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101594448|NCT01199198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594449|NCT01199198|Natriuretic Agents|natriuretic agents|mesh-ancestor
101594450|NCT01199198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594451|NCT05089708|Trifarotene|trifarotene|mesh-list
101594452|NCT05089708|Dermatologic Agents|dermatologic agents|mesh-ancestor
101594453|NCT01095978|Clarithromycin|clarithromycin|mesh-list
101594454|NCT01095978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101643150|NCT00756847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101643151|NCT00756847|Tubulin Modulators|tubulin modulators|mesh-ancestor
101643152|NCT00756847|Antimitotic Agents|antimitotic agents|mesh-ancestor
101643153|NCT00756847|Mitosis Modulators|mitosis modulators|mesh-ancestor
101643154|NCT00756847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643155|NCT04051567|Aspirin|aspirin|mesh-list
101643156|NCT04051567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101643157|NCT04051567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101643158|NCT04051567|Analgesics|analgesics|mesh-ancestor
101643159|NCT04051567|Sensory System Agents|sensory system agents|mesh-ancestor
101643160|NCT04051567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101643161|NCT04051567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643162|NCT04051567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101643163|NCT04051567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101643164|NCT04051567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101643165|NCT04051567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101643166|NCT04051567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643167|NCT04051567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101643168|NCT04051567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101643169|NCT04051567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101643170|NCT04051567|Antipyretics|antipyretics|mesh-ancestor
101643171|NCT00757081|Deoxycholic Acid|deoxycholic acid|mesh-list
101643172|NCT00757081|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101643173|NCT00757081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101643174|NCT00757315|Triamcinolone|triamcinolone|mesh-list
101643175|NCT00757315|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101643176|NCT00757315|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101643177|NCT00757315|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101643178|NCT00757315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101643179|NCT00757315|Glucocorticoids|glucocorticoids|mesh-ancestor
101643180|NCT00757315|Hormones|hormones|mesh-ancestor
101643181|NCT00757315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101643182|NCT00757315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643183|NCT00757315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101643185|NCT00757315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101643186|NCT00757315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594455|NCT01095978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101594456|NCT01095978|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101594457|NCT01095978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594458|NCT01095978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594459|NCT01095978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101594460|NCT01095978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101594461|NCT01134107|Insulin|insulin|mesh-list
101594462|NCT01134107|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101594463|NCT01134107|Insulin Aspart|insulin aspart|mesh-list
101594464|NCT01134107|Insulin Lispro|insulin lispro|mesh-list
101594465|NCT01134107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101594466|NCT01134107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594467|NCT01198574|Vitamins|vitamins|mesh-list
101594468|NCT01198574|Folic Acid|folic acid|mesh-list
101594469|NCT01198574|Vitamin A|vitamin a|mesh-list
101594470|NCT01198574|Iron|iron|mesh-list
101594471|NCT01198574|Retinol palmitate|retinol palmitate|mesh-list
101594472|NCT01198574|Micronutrients|micronutrients|mesh-ancestor
101594473|NCT01198574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594474|NCT01198574|Trace Elements|trace elements|mesh-ancestor
101594475|NCT01198574|Hematinics|hematinics|mesh-ancestor
101594476|NCT01198574|Vitamin B Complex|vitamin b complex|mesh-ancestor
101594477|NCT01198574|Antioxidants|antioxidants|mesh-ancestor
101594478|NCT01198574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594479|NCT01198574|Protective Agents|protective agents|mesh-ancestor
101594480|NCT01198574|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101643187|NCT00757393|Calcium, Dietary|calcium, dietary|mesh-list
101643188|NCT00757393|Vitamin D|vitamin d|mesh-list
101300262|NCT04989283|Mitosis Modulators|mitosis modulators|mesh-ancestor
101643190|NCT00757393|Cholecalciferol|cholecalciferol|mesh-list
101643191|NCT00757393|Vitamins|vitamins|mesh-list
101643192|NCT00757393|Calcium|calcium|mesh-list
101643193|NCT00757393|Micronutrients|micronutrients|mesh-ancestor
101643194|NCT00757393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643195|NCT00757393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101643196|NCT00757393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101643197|NCT00754351|Bevacizumab|bevacizumab|mesh-list
101643198|NCT00754351|Gemcitabine|gemcitabine|mesh-list
101643199|NCT00754351|Docetaxel|docetaxel|mesh-list
101643200|NCT00754351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101643201|NCT00754351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101643202|NCT00754351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101643203|NCT00754351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101643204|NCT00754351|Growth Substances|growth substances|mesh-ancestor
101643205|NCT00754351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643206|NCT00754351|Growth Inhibitors|growth inhibitors|mesh-ancestor
101643207|NCT00754351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101643208|NCT00754351|Antimetabolites|antimetabolites|mesh-ancestor
101643209|NCT00754351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643210|NCT00754351|Tubulin Modulators|tubulin modulators|mesh-ancestor
101643211|NCT00754351|Antimitotic Agents|antimitotic agents|mesh-ancestor
101643212|NCT00754351|Mitosis Modulators|mitosis modulators|mesh-ancestor
101643213|NCT00754429|Losartan|losartan|mesh-list
101594481|NCT01198574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101594482|NCT02580994|Carboplatin|carboplatin|mesh-list
101594483|NCT02580994|Pembrolizumab|pembrolizumab|mesh-list
101594484|NCT02580994|Etoposide|etoposide|mesh-list
101594485|NCT02580994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101594486|NCT02580994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101594487|NCT02580994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101594488|NCT02580994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594489|NCT02580994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101594490|NCT02580994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101594491|NCT02580994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101594492|NCT02580994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594493|NCT01198028|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101594494|NCT01198028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101594495|NCT01198028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101594496|NCT01198028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594497|NCT01198028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594499|NCT01092780|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101594500|NCT01092780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594501|NCT01092780|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101594502|NCT01092780|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101594503|NCT01092780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101594504|NCT01092780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594505|NCT05338606|Bimatoprost|bimatoprost|mesh-list
101643214|NCT00754429|Amlodipine|amlodipine|mesh-list
101643215|NCT00754429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101643216|NCT00754429|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101643217|NCT00754429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101643218|NCT00754429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643219|NCT00754429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101643220|NCT00754429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643221|NCT00754429|Vasodilator Agents|vasodilator agents|mesh-ancestor
101643222|NCT00754429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101643223|NCT00754429|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101643224|NCT00754429|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101643225|NCT00754507|Atorvastatin|atorvastatin|mesh-list
101643226|NCT00754507|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
101643227|NCT00754507|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101643228|NCT00754507|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101643229|NCT00754507|Antimetabolites|antimetabolites|mesh-ancestor
101643230|NCT00754507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643231|NCT00754507|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101643232|NCT00754507|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101643233|NCT00754507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101643234|NCT00725608|Buprenorphine|buprenorphine|mesh-list
101594506|NCT05338606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101594507|NCT01092702|Varenicline|varenicline|mesh-list
101594508|NCT01092702|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101594509|NCT01092702|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101594510|NCT01092702|Cholinergic Agents|cholinergic agents|mesh-ancestor
101594511|NCT01092702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101594512|NCT01092702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594513|NCT01092702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594514|NCT01092546|Flutemetamol|flutemetamol|mesh-list
101594515|NCT01092546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101594516|NCT01092546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594517|NCT02779348|Warfarin|warfarin|mesh-list
101594518|NCT02779348|Anticoagulants|anticoagulants|mesh-ancestor
101594520|NCT02779582|Progestins|progestins|mesh-ancestor
101594521|NCT02779582|Hormones|hormones|mesh-ancestor
101594522|NCT02779582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101594523|NCT02779582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594524|NCT00634894|Letrozole|letrozole|mesh-list
101594525|NCT00634894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101594526|NCT00634894|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101594527|NCT00634894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101594528|NCT00634894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594529|NCT00634894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594530|NCT00634894|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101594531|NCT00634894|Hormone Antagonists|hormone antagonists|mesh-ancestor
101594532|NCT00634894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101594533|NCT00634894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643235|NCT00725608|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101643236|NCT00725608|Naloxone|naloxone|mesh-list
101643237|NCT00725608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101643238|NCT00725608|Narcotics|narcotics|mesh-ancestor
101643239|NCT00725608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101643240|NCT00725608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643241|NCT00725608|Analgesics|analgesics|mesh-ancestor
101643242|NCT00725608|Sensory System Agents|sensory system agents|mesh-ancestor
101643243|NCT00725608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101643244|NCT00725608|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101643245|NCT00725452|Infliximab|infliximab|mesh-list
101643246|NCT00725452|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101643247|NCT00725452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101643248|NCT00725452|Dermatologic Agents|dermatologic agents|mesh-ancestor
101643249|NCT00725452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101643250|NCT00725452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101643251|NCT00725296|Infliximab|infliximab|mesh-list
101643252|NCT00725296|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101643253|NCT00725296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101594534|NCT02779270|Sunscreening Agents|sunscreening agents|mesh-list
101594535|NCT02779270|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101594536|NCT02779270|Protective Agents|protective agents|mesh-ancestor
101594537|NCT02779270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594538|NCT02779270|Dermatologic Agents|dermatologic agents|mesh-ancestor
101594539|NCT01078662|Olaparib|olaparib|mesh-list
101594540|NCT01078662|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101594541|NCT01078662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594542|NCT01078662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594543|NCT01078662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101594544|NCT04227886|Capecitabine|capecitabine|mesh-list
101594545|NCT04227886|Irinotecan|irinotecan|mesh-list
101594546|NCT04227886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101594547|NCT04227886|Antimetabolites|antimetabolites|mesh-ancestor
101594548|NCT04227886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594549|NCT04227886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101594550|NCT04227886|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101594551|NCT04227886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101594552|NCT04227886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594553|NCT02200978|Cytarabine|cytarabine|mesh-list
101594554|NCT02200978|Methotrexate|methotrexate|mesh-list
101594555|NCT02200978|Mercaptopurine|mercaptopurine|mesh-list
101594556|NCT02200978|Mitoxantrone|mitoxantrone|mesh-list
101594557|NCT02200978|Tretinoin|tretinoin|mesh-list
101643254|NCT00725296|Dermatologic Agents|dermatologic agents|mesh-ancestor
101643255|NCT00725296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101643257|NCT00585052|Paclitaxel|paclitaxel|mesh-list
101643258|NCT00585052|Lovastatin|lovastatin|mesh-list
101643259|NCT00585052|L 647318|l 647318|mesh-list
101643260|NCT00585052|Dihydromevinolin|dihydromevinolin|mesh-list
101643261|NCT00585052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101643262|NCT00585052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101643263|NCT00585052|Tubulin Modulators|tubulin modulators|mesh-ancestor
101643264|NCT00585052|Antimitotic Agents|antimitotic agents|mesh-ancestor
101643265|NCT00585052|Mitosis Modulators|mitosis modulators|mesh-ancestor
101643266|NCT00585052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643267|NCT00585052|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101643268|NCT00585052|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101643269|NCT00585052|Antimetabolites|antimetabolites|mesh-ancestor
101643270|NCT00585052|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101643271|NCT00585052|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101643272|NCT00585052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101643273|NCT00724282|Eszopiclone|eszopiclone|mesh-list
101643274|NCT00724282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101643275|NCT00724282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101643276|NCT00724282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643277|NCT04086238|Decitabine|decitabine|mesh-list
101643278|NCT04086238|Tetrahydrouridine|tetrahydrouridine|mesh-list
101643279|NCT04086238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101643280|NCT04086238|Antimetabolites|antimetabolites|mesh-ancestor
101643281|NCT04086238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594559|NCT02200978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101594560|NCT02200978|Abortifacient Agents|abortifacient agents|mesh-ancestor
101594561|NCT02200978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101594562|NCT02200978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594563|NCT02200978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101594564|NCT02200978|Antimetabolites|antimetabolites|mesh-ancestor
101594565|NCT02200978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594566|NCT02200978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101594567|NCT02200978|Dermatologic Agents|dermatologic agents|mesh-ancestor
101594568|NCT02200978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594569|NCT02200978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101594570|NCT02200978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101594572|NCT02200978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101594573|NCT02200978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101594574|NCT02200978|Antiviral Agents|antiviral agents|mesh-ancestor
101594575|NCT02200978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101594576|NCT02200978|Analgesics|analgesics|mesh-ancestor
101594577|NCT02200978|Sensory System Agents|sensory system agents|mesh-ancestor
101594578|NCT02200978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101594579|NCT02200978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101594580|NCT02200978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101594581|NCT02200978|Keratolytic Agents|keratolytic agents|mesh-ancestor
101594582|NCT02779192|Ebselen|ebselen|mesh-list
101594583|NCT02779192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101594584|NCT02779192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101594585|NCT02779192|Analgesics|analgesics|mesh-ancestor
101594586|NCT02779192|Sensory System Agents|sensory system agents|mesh-ancestor
101594587|NCT02779192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101594588|NCT02779192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594589|NCT02779192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101594590|NCT02779192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101594591|NCT02779192|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101251516|NCT05371886|Anesthetics, General|anesthetics, general|mesh-ancestor
101594593|NCT02779192|Antioxidants|antioxidants|mesh-ancestor
101594594|NCT02779192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643282|NCT04086238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101594595|NCT02779192|Protective Agents|protective agents|mesh-ancestor
101594596|NCT02779192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101594597|NCT02779192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594598|NCT02779192|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101594599|NCT05020210|Sivelestat|sivelestat|mesh-list
101594600|NCT05020210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101594601|NCT05020210|Protease Inhibitors|protease inhibitors|mesh-ancestor
101594602|NCT05020210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594603|NCT05020210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594604|NCT04227808|Lenvatinib|lenvatinib|mesh-list
101594605|NCT04227808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101594606|NCT04227808|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101594607|NCT04227808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594608|NCT04227808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594609|NCT01091454|Cisplatin|cisplatin|mesh-list
101594610|NCT01091454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101594611|NCT01140347|Ramucirumab|ramucirumab|mesh-list
101594612|NCT01140347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101594613|NCT04227652|Ibuprofen|ibuprofen|mesh-list
101594614|NCT04227652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101594615|NCT04227652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101594616|NCT04227652|Analgesics|analgesics|mesh-ancestor
101594617|NCT04227652|Sensory System Agents|sensory system agents|mesh-ancestor
101594618|NCT04227652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101594619|NCT04227652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594620|NCT04227652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101594621|NCT04227652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101594643|NCT02883569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101594644|NCT02883569|Antitussive Agents|antitussive agents|mesh-ancestor
101594645|NCT02883569|Respiratory System Agents|respiratory system agents|mesh-ancestor
101594647|NCT02883023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101594648|NCT02883023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101594649|NCT02778958|Acetaminophen|acetaminophen|mesh-list
101594650|NCT02778958|Ibuprofen|ibuprofen|mesh-list
101594651|NCT02778958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101594652|NCT02778958|Analgesics|analgesics|mesh-ancestor
101594653|NCT02778958|Sensory System Agents|sensory system agents|mesh-ancestor
101594654|NCT02778958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101594655|NCT02778958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594656|NCT02778958|Antipyretics|antipyretics|mesh-ancestor
101594657|NCT02778958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101594658|NCT02778958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101594659|NCT02778958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101594660|NCT02778958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101594661|NCT02778958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594662|NCT02778958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594663|NCT01197560|Rituximab|rituximab|mesh-list
101594664|NCT01197560|Gemcitabine|gemcitabine|mesh-list
101594665|NCT01197560|Oxaliplatin|oxaliplatin|mesh-list
101594666|NCT01197560|Etoposide|etoposide|mesh-list
101594667|NCT01197560|Lenalidomide|lenalidomide|mesh-list
101594668|NCT01197560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101594669|NCT01197560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101594670|NCT01197560|Immunologic Factors|immunologic factors|mesh-ancestor
101594671|NCT01197560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594672|NCT01197560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101594673|NCT01197560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101594688|NCT04940572|GABA Agents|gaba agents|mesh-ancestor
101594689|NCT04940572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101594690|NCT04940572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594691|NCT04940572|Antimanic Agents|antimanic agents|mesh-ancestor
101594692|NCT04940572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101594693|NCT04940572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101594694|NCT04940572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101594695|NCT01196078|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101594696|NCT01196078|Vinorelbine|vinorelbine|mesh-list
101594697|NCT01196078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101594698|NCT01196078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101594699|NCT01196078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594700|NCT01196078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594701|NCT01196078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101594702|NCT01196078|Tubulin Modulators|tubulin modulators|mesh-ancestor
101594703|NCT01196078|Antimitotic Agents|antimitotic agents|mesh-ancestor
101594704|NCT01196078|Mitosis Modulators|mitosis modulators|mesh-ancestor
101594705|NCT05314660|Fluorides|fluorides|mesh-list
101594706|NCT05314660|Cariostatic Agents|cariostatic agents|mesh-ancestor
101594707|NCT05314660|Protective Agents|protective agents|mesh-ancestor
101594708|NCT05314660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594709|NCT04920292|Oxfendazole|oxfendazole|mesh-list
101594710|NCT04920292|Anthelmintics|anthelmintics|mesh-ancestor
101594711|NCT04920292|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101594712|NCT04920292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101594713|NCT04920292|Antinematodal Agents|antinematodal agents|mesh-ancestor
101594714|NCT04317872|Dexamethasone|dexamethasone|mesh-list
101594715|NCT04317872|Dexamethasone acetate|dexamethasone acetate|mesh-list
101594716|NCT04317872|BB 1101|bb 1101|mesh-list
101594717|NCT04317872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101594718|NCT04317872|Antiemetics|antiemetics|mesh-ancestor
101594719|NCT04317872|Autonomic Agents|autonomic agents|mesh-ancestor
101594720|NCT04317872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101594721|NCT04317872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594722|NCT04317872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101643283|NCT04086238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101643284|NCT00724126|Rifaximin|rifaximin|mesh-list
101643285|NCT00724126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101643286|NCT00724126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101643287|NCT00724126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101643288|NCT00723892|Ribavirin|ribavirin|mesh-list
101643289|NCT00723892|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101643290|NCT00723892|Interferon-alpha|interferon-alpha|mesh-list
101594723|NCT04317872|Glucocorticoids|glucocorticoids|mesh-ancestor
101594725|NCT04317872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101594726|NCT04317872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101594727|NCT04317872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101594728|NCT04317872|Protease Inhibitors|protease inhibitors|mesh-ancestor
101594729|NCT04317872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594730|NCT04317872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594731|NCT01132547|Cyproheptadine|cyproheptadine|mesh-list
101594732|NCT01132547|Antipruritics|antipruritics|mesh-ancestor
101594733|NCT01132547|Dermatologic Agents|dermatologic agents|mesh-ancestor
101594734|NCT01132547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101594735|NCT01132547|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101594736|NCT01132547|Histamine Antagonists|histamine antagonists|mesh-ancestor
101594737|NCT01132547|Histamine Agents|histamine agents|mesh-ancestor
101594738|NCT01132547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101594739|NCT01132547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594740|NCT01132547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594741|NCT01132547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101251687|NCT04835506|Infliximab|infliximab|mesh-list
101594742|NCT01132547|Serotonin Agents|serotonin agents|mesh-ancestor
101594743|NCT01132547|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101643291|NCT00723892|Antimetabolites|antimetabolites|mesh-ancestor
101643292|NCT00723892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643293|NCT00723892|Antiviral Agents|antiviral agents|mesh-ancestor
101643294|NCT00723892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101643295|NCT00723892|Immunologic Factors|immunologic factors|mesh-ancestor
101643296|NCT00723892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643297|NCT04086940|Esmolol|esmolol|mesh-list
101643298|NCT04086940|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101643299|NCT04086940|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101643300|NCT04086940|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101643301|NCT04086940|Adrenergic Agents|adrenergic agents|mesh-ancestor
101643302|NCT04086940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101643303|NCT04086940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643304|NCT04086940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643305|NCT02590900|Acetaminophen|acetaminophen|mesh-list
101643306|NCT02590900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101643307|NCT02590900|Analgesics|analgesics|mesh-ancestor
101643308|NCT02590900|Sensory System Agents|sensory system agents|mesh-ancestor
101643309|NCT02590900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101643310|NCT02590900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643311|NCT02590900|Antipyretics|antipyretics|mesh-ancestor
101643312|NCT02591914|Bevacizumab|bevacizumab|mesh-list
101643313|NCT02591914|Ranibizumab|ranibizumab|mesh-list
101643314|NCT02591914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101643315|NCT02591914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101643316|NCT02591914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101643317|NCT02591914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101643318|NCT02591914|Growth Substances|growth substances|mesh-ancestor
101643319|NCT02591914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643320|NCT02591914|Growth Inhibitors|growth inhibitors|mesh-ancestor
101594744|NCT01194830|Linagliptin|linagliptin|mesh-list
101594745|NCT01194830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101594746|NCT01194830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356215|NCT00033098|Metyrapone|metyrapone|mesh-list
101594747|NCT01194830|Incretins|incretins|mesh-ancestor
101594748|NCT01194830|Hormones|hormones|mesh-ancestor
101594749|NCT01194830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101594750|NCT01194830|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101594751|NCT01194830|Protease Inhibitors|protease inhibitors|mesh-ancestor
101594752|NCT01194830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594753|NCT01194830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594754|NCT02778178|Clonidine|clonidine|mesh-list
101594755|NCT02778178|Ropivacaine|ropivacaine|mesh-list
101594756|NCT02778178|Anesthetics, Local|anesthetics, local|mesh-ancestor
101594757|NCT02778178|Anesthetics|anesthetics|mesh-ancestor
101594758|NCT02778178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101594759|NCT02778178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594760|NCT02778178|Sensory System Agents|sensory system agents|mesh-ancestor
101594761|NCT02778178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101594762|NCT02778178|Analgesics|analgesics|mesh-ancestor
101594763|NCT02778178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101594764|NCT02778178|Sympatholytics|sympatholytics|mesh-ancestor
101594765|NCT02778178|Autonomic Agents|autonomic agents|mesh-ancestor
101594766|NCT02778178|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101594767|NCT02778178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101594768|NCT02778178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101594769|NCT02778178|Adrenergic Agents|adrenergic agents|mesh-ancestor
101594770|NCT02778178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101594771|NCT02778178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594772|NCT01194440|Zoledronic Acid|zoledronic acid|mesh-list
101594773|NCT01194440|Letrozole|letrozole|mesh-list
101594774|NCT01194440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101594775|NCT01194440|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101594776|NCT01194440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101594777|NCT01194440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594778|NCT01194440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594779|NCT01194440|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101594781|NCT01194440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101594782|NCT01194440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594783|NCT01194440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101594785|NCT04823052|Gaboxadol|gaboxadol|mesh-list
101594786|NCT04823052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101594787|NCT04823052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101594788|NCT04823052|Analgesics|analgesics|mesh-ancestor
101594789|NCT04823052|Sensory System Agents|sensory system agents|mesh-ancestor
101594790|NCT04823052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101594791|NCT04823052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594792|NCT04823052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101594793|NCT04823052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101594794|NCT04823052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101594795|NCT04823052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101594796|NCT04823052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594797|NCT04823052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594798|NCT04823052|Anticonvulsants|anticonvulsants|mesh-ancestor
101594799|NCT04823052|GABA Agonists|gaba agonists|mesh-ancestor
101594800|NCT04823052|GABA Agents|gaba agents|mesh-ancestor
101594801|NCT04823052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101594802|NCT00951015|Efavirenz|efavirenz|mesh-list
101594803|NCT00951015|Dolutegravir|dolutegravir|mesh-list
101594804|NCT00951015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101594805|NCT00951015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101594806|NCT00951015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101643321|NCT00723190|Clonidine|clonidine|mesh-list
101643322|NCT00723190|Analgesics|analgesics|mesh-ancestor
101643323|NCT00723190|Sensory System Agents|sensory system agents|mesh-ancestor
101643324|NCT00723190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101643325|NCT00723190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643326|NCT00723190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101643327|NCT00723190|Sympatholytics|sympatholytics|mesh-ancestor
101643328|NCT00723190|Autonomic Agents|autonomic agents|mesh-ancestor
101643329|NCT00723190|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101221669|NCT01508858|Incretins|incretins|mesh-ancestor
101643330|NCT00723190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101643332|NCT00723190|Adrenergic Agents|adrenergic agents|mesh-ancestor
101643333|NCT00723190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101643334|NCT00723190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643335|NCT00722800|Drospirenone|drospirenone|mesh-list
101643336|NCT00722800|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101643337|NCT00722800|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
101643338|NCT00722800|Estradiol|estradiol|mesh-list
101300416|NCT04839627|Hormones|hormones|mesh-ancestor
101643339|NCT00722800|Estrogens|estrogens|mesh-ancestor
101643340|NCT00722800|Hormones|hormones|mesh-ancestor
101594807|NCT00951015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594808|NCT00951015|Antiviral Agents|antiviral agents|mesh-ancestor
101594809|NCT00951015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101594810|NCT00951015|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101594811|NCT00951015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101594812|NCT00951015|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101594813|NCT00951015|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101594814|NCT00951015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101594815|NCT00951015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101594816|NCT00951015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101594817|NCT00951015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101594818|NCT00951015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101594819|NCT00951015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101594820|NCT02777866|Bupivacaine|bupivacaine|mesh-list
101594821|NCT02777866|Anesthetics, Local|anesthetics, local|mesh-ancestor
101594822|NCT02777866|Anesthetics|anesthetics|mesh-ancestor
101594823|NCT02777866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101594824|NCT02777866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594825|NCT02777866|Sensory System Agents|sensory system agents|mesh-ancestor
101594826|NCT02777866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101594827|NCT00626262|Esomeprazole|esomeprazole|mesh-list
101594828|NCT00626262|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101594829|NCT00626262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101594830|NCT00626262|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101594831|NCT00626262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594832|NCT00626262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594833|NCT02876796|Firsocostat|firsocostat|mesh-list
101594834|NCT02876796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594835|NCT02876796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594836|NCT01193660|Epoetin Alfa|epoetin alfa|mesh-list
101594837|NCT01193660|Hematinics|hematinics|mesh-ancestor
101594839|NCT02777788|Vinorelbine|vinorelbine|mesh-list
101594840|NCT02777788|Docetaxel|docetaxel|mesh-list
101594841|NCT02777788|Carboplatin|carboplatin|mesh-list
101594842|NCT02777788|Gemcitabine|gemcitabine|mesh-list
101594843|NCT02777788|Pemetrexed|pemetrexed|mesh-list
101594844|NCT02777788|Cisplatin|cisplatin|mesh-list
101594845|NCT02777788|Nedaplatin|nedaplatin|mesh-list
101594846|NCT02777788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101594847|NCT02777788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101594848|NCT02777788|Tubulin Modulators|tubulin modulators|mesh-ancestor
101594849|NCT02777788|Antimitotic Agents|antimitotic agents|mesh-ancestor
101594850|NCT02777788|Mitosis Modulators|mitosis modulators|mesh-ancestor
101594851|NCT02777788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594852|NCT02777788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101594853|NCT02777788|Antimetabolites|antimetabolites|mesh-ancestor
101594854|NCT02777788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594855|NCT02777788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101594856|NCT02777788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101594857|NCT01076166|Clarithromycin|clarithromycin|mesh-list
101594858|NCT01076166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101594859|NCT01076166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101594860|NCT01076166|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101594861|NCT01076166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594862|NCT01076166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594863|NCT01076166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101594864|NCT01076166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101594866|NCT02777710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101594867|NCT02777710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101643341|NCT00722800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101643342|NCT00722800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643343|NCT00722800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101643344|NCT00722800|Contraceptive Agents|contraceptive agents|mesh-ancestor
101643345|NCT00722800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101643346|NCT00722800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101643347|NCT00722800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101643348|NCT00722800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101643349|NCT00722800|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101643350|NCT00722800|Hormone Antagonists|hormone antagonists|mesh-ancestor
101643351|NCT00722800|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101643352|NCT00722800|Diuretics|diuretics|mesh-ancestor
101643353|NCT00722800|Natriuretic Agents|natriuretic agents|mesh-ancestor
101643354|NCT00741598|Galantamine|galantamine|mesh-list
101643355|NCT00741598|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101643356|NCT00741598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101643357|NCT00741598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643358|NCT00741598|Cholinergic Agents|cholinergic agents|mesh-ancestor
101643359|NCT00741598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101643360|NCT00741598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643361|NCT00741598|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101643362|NCT00741598|Autonomic Agents|autonomic agents|mesh-ancestor
101643363|NCT00741598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101643364|NCT00741598|Nootropic Agents|nootropic agents|mesh-ancestor
101643365|NCT03947632|Chrysarobin|chrysarobin|mesh-list
101643366|NCT03947632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101643367|NCT03947632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101594868|NCT01193582|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101594869|NCT01193582|Immunologic Factors|immunologic factors|mesh-ancestor
101594870|NCT01193582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594872|NCT00602901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101594873|NCT00602901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101594874|NCT00602901|Analgesics|analgesics|mesh-ancestor
101594875|NCT00602901|Sensory System Agents|sensory system agents|mesh-ancestor
101594876|NCT00602901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101594877|NCT00602901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594878|NCT00602901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101594879|NCT00602901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101594880|NCT00602901|Gout Suppressants|gout suppressants|mesh-ancestor
101594881|NCT00602901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101594882|NCT00602901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594883|NCT00602901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594884|NCT01076088|Metformin|metformin|mesh-list
101594885|NCT01076088|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101594886|NCT01076088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101251822|NCT04461535|beta-Endorphin|beta-endorphin|mesh-list
101594887|NCT01076088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594888|NCT01076088|Incretins|incretins|mesh-ancestor
101594889|NCT01076088|Hormones|hormones|mesh-ancestor
101594890|NCT01076088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101594891|NCT01076088|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101594892|NCT01076088|Protease Inhibitors|protease inhibitors|mesh-ancestor
101594893|NCT01076088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594894|NCT01076088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594895|NCT02777320|Acetaminophen|acetaminophen|mesh-list
101594896|NCT02777320|Ibuprofen|ibuprofen|mesh-list
101594897|NCT02777320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101594898|NCT02777320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101643368|NCT03947632|Analgesics|analgesics|mesh-ancestor
101643369|NCT03947632|Sensory System Agents|sensory system agents|mesh-ancestor
101643370|NCT03947632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101643371|NCT03947632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643372|NCT03947632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101643373|NCT03947632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101643374|NCT04085770|Alfacalcidol|alfacalcidol|mesh-list
101643375|NCT04085770|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
101643376|NCT04085770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101594900|NCT02777320|Sensory System Agents|sensory system agents|mesh-ancestor
101594901|NCT02777320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101594902|NCT02777320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594903|NCT02777320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101594904|NCT02777320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101594905|NCT02777320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101594906|NCT02777320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594907|NCT02777320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594908|NCT02777320|Antipyretics|antipyretics|mesh-ancestor
101594909|NCT01193348|Eculizumab|eculizumab|mesh-list
101594910|NCT01193348|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101594911|NCT01193348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101594912|NCT01193348|Immunologic Factors|immunologic factors|mesh-ancestor
101594913|NCT01193348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594914|NCT00945321|Aprepitant|aprepitant|mesh-list
101594915|NCT00945321|Fosaprepitant|fosaprepitant|mesh-list
101594916|NCT00945321|Antiemetics|antiemetics|mesh-ancestor
101594917|NCT00945321|Autonomic Agents|autonomic agents|mesh-ancestor
101594918|NCT00945321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101594919|NCT00945321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594920|NCT00945321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101594921|NCT00945321|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101594922|NCT00945321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101594923|NCT00945321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594924|NCT02776228|Brotizolam|brotizolam|mesh-list
101643377|NCT04085770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643378|NCT04085770|Vitamins|vitamins|mesh-ancestor
101643379|NCT04085770|Micronutrients|micronutrients|mesh-ancestor
101643380|NCT00741286|Aspirin|aspirin|mesh-list
101643381|NCT00741286|Cilostazol|cilostazol|mesh-list
101643382|NCT00741286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101643383|NCT00741286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101643384|NCT00741286|Analgesics|analgesics|mesh-ancestor
101643385|NCT00741286|Sensory System Agents|sensory system agents|mesh-ancestor
101643386|NCT00741286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101643387|NCT00741286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643388|NCT00741286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101643389|NCT00741286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101643390|NCT00741286|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101643391|NCT00741286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101643392|NCT00741286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643393|NCT00741286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101643394|NCT00741286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101643395|NCT00741286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101643396|NCT00741286|Antipyretics|antipyretics|mesh-ancestor
101643397|NCT00741286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101594925|NCT02776228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101594926|NCT02776228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101594927|NCT02776228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594928|NCT05382728|Osimertinib|osimertinib|mesh-list
101594929|NCT05382728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356256|NCT00060996|Treprostinil|treprostinil|mesh-list
101594930|NCT05382728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101594931|NCT05382728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594932|NCT05382728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594933|NCT01192178|Fluticasone|fluticasone|mesh-list
101594934|NCT01192178|Xhance|xhance|mesh-list
101594935|NCT01192178|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101594936|NCT01192178|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101594937|NCT01192178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101594938|NCT01192178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101594940|NCT01192178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101594941|NCT01192178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594942|NCT01192178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101594943|NCT01192178|Respiratory System Agents|respiratory system agents|mesh-ancestor
101594944|NCT01192178|Dermatologic Agents|dermatologic agents|mesh-ancestor
101594945|NCT01192178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101594946|NCT01192178|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101594947|NCT01192178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101594948|NCT01192178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101594949|NCT01192178|Adrenergic Agents|adrenergic agents|mesh-ancestor
101594950|NCT01192178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101594951|NCT01192178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594952|NCT01192178|Glucocorticoids|glucocorticoids|mesh-ancestor
101594953|NCT01192178|Hormones|hormones|mesh-ancestor
101594954|NCT01192178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101594955|NCT01192178|Sympathomimetics|sympathomimetics|mesh-ancestor
101594956|NCT04193566|Dapagliflozin|dapagliflozin|mesh-list
101594957|NCT04193566|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101594958|NCT04193566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594962|NCT00869401|Dasatinib|dasatinib|mesh-list
101594963|NCT00869401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101594964|NCT00869401|Alkylating Agents|alkylating agents|mesh-ancestor
101594965|NCT00869401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594966|NCT00869401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101594967|NCT00869401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101594968|NCT00869401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594969|NCT01076010|Sorafenib|sorafenib|mesh-list
101594970|NCT01076010|Tivozanib|tivozanib|mesh-list
101594971|NCT01076010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101594972|NCT01076010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101594973|NCT01076010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594974|NCT01076010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594975|NCT04225780|Ganciclovir|ganciclovir|mesh-list
101594976|NCT04225780|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101594977|NCT04225780|Antiviral Agents|antiviral agents|mesh-ancestor
101594978|NCT04225780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101594979|NCT04225780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101594980|NCT04225780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594981|NCT04225780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594982|NCT04045171|Tacrolimus|tacrolimus|mesh-list
101594983|NCT04045171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101594984|NCT04045171|Immunologic Factors|immunologic factors|mesh-ancestor
101594985|NCT04045171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101594986|NCT04045171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101594987|NCT04045171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594988|NCT04045171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101594989|NCT01075152|Lamivudine|lamivudine|mesh-list
101594990|NCT01075152|Zidovudine|zidovudine|mesh-list
101594991|NCT01075152|Efavirenz|efavirenz|mesh-list
101594992|NCT01075152|Stavudine|stavudine|mesh-list
101594993|NCT01075152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101594994|NCT01075152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101594995|NCT01075152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101594997|NCT01075152|Antiviral Agents|antiviral agents|mesh-ancestor
101595002|NCT01075152|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101595003|NCT01075152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101595004|NCT01075152|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101595005|NCT01075152|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101595006|NCT01075152|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101595007|NCT01075152|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101595008|NCT04134637|Bupivacaine|bupivacaine|mesh-list
101595009|NCT04134637|Anesthetics, Local|anesthetics, local|mesh-ancestor
101595010|NCT04134637|Anesthetics|anesthetics|mesh-ancestor
101595011|NCT04134637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101595012|NCT04134637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595013|NCT04134637|Sensory System Agents|sensory system agents|mesh-ancestor
101595014|NCT04134637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101595015|NCT02617849|Paclitaxel|paclitaxel|mesh-list
101595016|NCT02617849|Carboplatin|carboplatin|mesh-list
101595017|NCT02617849|Pembrolizumab|pembrolizumab|mesh-list
101595018|NCT02617849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101595019|NCT02617849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101595020|NCT02617849|Tubulin Modulators|tubulin modulators|mesh-ancestor
101595021|NCT02617849|Antimitotic Agents|antimitotic agents|mesh-ancestor
101595022|NCT02617849|Mitosis Modulators|mitosis modulators|mesh-ancestor
101595023|NCT02617849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595024|NCT02617849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101595025|NCT02617849|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101595026|NCT00950859|Dolutegravir|dolutegravir|mesh-list
101595027|NCT00950859|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101595028|NCT00950859|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101643398|NCT00741286|Autonomic Agents|autonomic agents|mesh-ancestor
101643399|NCT00741286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101643400|NCT00741286|Respiratory System Agents|respiratory system agents|mesh-ancestor
101643401|NCT00741286|Vasodilator Agents|vasodilator agents|mesh-ancestor
101643402|NCT00741286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101643403|NCT00741286|Protective Agents|protective agents|mesh-ancestor
101643404|NCT00741286|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101643405|NCT00741286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101643406|NCT05040334|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101643407|NCT05040334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101643408|NCT00716092|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101643409|NCT00716092|Linagliptin|linagliptin|mesh-list
101643410|NCT00716092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101643411|NCT00716092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643412|NCT00716092|Incretins|incretins|mesh-ancestor
101643414|NCT00716092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101643415|NCT00716092|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101595029|NCT00950859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101595030|NCT00950859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595031|NCT00950859|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101595032|NCT00950859|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101595033|NCT00950859|Antiviral Agents|antiviral agents|mesh-ancestor
101595034|NCT00950859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101595035|NCT02775292|Aldesleukin|aldesleukin|mesh-list
101595036|NCT02775292|Cyclophosphamide|cyclophosphamide|mesh-list
101595037|NCT02775292|Nivolumab|nivolumab|mesh-list
101595038|NCT02775292|Fludarabine|fludarabine|mesh-list
101595039|NCT02775292|Fludarabine phosphate|fludarabine phosphate|mesh-list
101595040|NCT02775292|Interleukin-2|interleukin-2|mesh-list
101595042|NCT02775292|Immunologic Factors|immunologic factors|mesh-ancestor
101595043|NCT02775292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595044|NCT02775292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101595045|NCT02775292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101595046|NCT02775292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101595047|NCT02775292|Alkylating Agents|alkylating agents|mesh-ancestor
101595048|NCT02775292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595049|NCT02775292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101595050|NCT02775292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101595051|NCT02775292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101595052|NCT02775292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101595053|NCT02775292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101595054|NCT02775292|Antimetabolites|antimetabolites|mesh-ancestor
101595055|NCT02775292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101595056|NCT02775292|Analgesics|analgesics|mesh-ancestor
101595057|NCT02775292|Sensory System Agents|sensory system agents|mesh-ancestor
101595058|NCT02775292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101595059|NCT02775292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101356270|NCT00061074|Nicotine|nicotine|mesh-list
101643416|NCT00716092|Protease Inhibitors|protease inhibitors|mesh-ancestor
101643417|NCT00716092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101643418|NCT00716092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643419|NCT02590510|Methotrexate|methotrexate|mesh-list
101643420|NCT02590510|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101643421|NCT02590510|Abortifacient Agents|abortifacient agents|mesh-ancestor
101643422|NCT02590510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101643423|NCT02590510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643424|NCT02590510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101643425|NCT02590510|Antimetabolites|antimetabolites|mesh-ancestor
101643426|NCT02590510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643427|NCT02590510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101643428|NCT02590510|Dermatologic Agents|dermatologic agents|mesh-ancestor
101643429|NCT02590510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101595060|NCT02775292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101595061|NCT02775292|Antiviral Agents|antiviral agents|mesh-ancestor
101595062|NCT02775292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101595063|NCT00862849|Insulin|insulin|mesh-list
101595064|NCT00862849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101595065|NCT00862849|Insulin Lispro|insulin lispro|mesh-list
101595066|NCT00862849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101595067|NCT00862849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595068|NCT01090050|Naproxen|naproxen|mesh-list
101595069|NCT01090050|Sumatriptan|sumatriptan|mesh-list
101595070|NCT01090050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101595071|NCT01090050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101595072|NCT01090050|Analgesics|analgesics|mesh-ancestor
101595073|NCT01090050|Sensory System Agents|sensory system agents|mesh-ancestor
101595074|NCT01090050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101595075|NCT01090050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595076|NCT01090050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101595077|NCT01090050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101595078|NCT01090050|Gout Suppressants|gout suppressants|mesh-ancestor
101595079|NCT01090050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101595080|NCT01090050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101595081|NCT01090050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595082|NCT01090050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101595083|NCT01090050|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101643430|NCT02590510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101643431|NCT02590510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101643432|NCT02590510|Immunologic Factors|immunologic factors|mesh-ancestor
101643433|NCT02590510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101643434|NCT02590510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101643435|NCT00919204|Axitinib|axitinib|mesh-list
101643436|NCT00919204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101643437|NCT00919204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101643438|NCT00919204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101643439|NCT00919204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643440|NCT00715624|Metformin|metformin|mesh-list
101643441|NCT00715624|Lixisenatide|lixisenatide|mesh-list
101643442|NCT00715624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101643443|NCT00715624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643444|NCT00919282|Leucovorin|leucovorin|mesh-list
101643445|NCT00919282|Folic Acid|folic acid|mesh-list
101643446|NCT00919282|Gemcitabine|gemcitabine|mesh-list
101643447|NCT00919282|Levoleucovorin|levoleucovorin|mesh-list
101643448|NCT00919282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101643449|NCT00919282|Antimetabolites|antimetabolites|mesh-ancestor
101643450|NCT00919282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643451|NCT00919282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101643452|NCT00919282|Antidotes|antidotes|mesh-ancestor
101643453|NCT00919282|Protective Agents|protective agents|mesh-ancestor
101643454|NCT00919282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643455|NCT00919282|Vitamin B Complex|vitamin b complex|mesh-ancestor
101643456|NCT00919282|Vitamins|vitamins|mesh-ancestor
101595084|NCT01090050|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101595086|NCT01090050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101595088|NCT02775370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356281|NCT00033332|Pamidronate|pamidronate|mesh-list
101595089|NCT02775370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101595090|NCT02775370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101595091|NCT02775370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595092|NCT04225468|Analgesics, Opioid|analgesics, opioid|mesh-list
101595093|NCT04225468|Narcotics|narcotics|mesh-ancestor
101595094|NCT04225468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101595095|NCT04225468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595096|NCT04225468|Analgesics|analgesics|mesh-ancestor
101595097|NCT04225468|Sensory System Agents|sensory system agents|mesh-ancestor
101595098|NCT04225468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101595099|NCT02855307|Insulin|insulin|mesh-list
101595100|NCT02855307|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101595101|NCT02855307|Hormones|hormones|mesh-list
101595102|NCT02855307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101595103|NCT02855307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595104|NCT02855307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101595105|NCT01077960|Hormones|hormones|mesh-list
101595106|NCT01077960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101595107|NCT01077960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595108|NCT04269369|Fluorouracil|fluorouracil|mesh-list
101595109|NCT04269369|Antimetabolites|antimetabolites|mesh-ancestor
101595110|NCT04269369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595111|NCT04269369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101595116|NCT02776540|Aspirin|aspirin|mesh-list
101595129|NCT02776540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101595130|NCT02776540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101595131|NCT02776540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101595133|NCT02776540|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101595134|NCT02776540|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101595135|NCT02776540|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101595136|NCT02776540|Purinergic Agents|purinergic agents|mesh-ancestor
101595137|NCT02776540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101595138|NCT00944697|Oxycodone|oxycodone|mesh-list
101595139|NCT00944697|Naloxone|naloxone|mesh-list
101595140|NCT00944697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101595141|NCT00944697|Narcotics|narcotics|mesh-ancestor
101595142|NCT00944697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101595143|NCT00944697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595144|NCT00944697|Analgesics|analgesics|mesh-ancestor
101595145|NCT00944697|Sensory System Agents|sensory system agents|mesh-ancestor
101595146|NCT00944697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101595147|NCT00944697|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101595148|NCT02878122|Carboplatin|carboplatin|mesh-list
101595149|NCT02878122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101595150|NCT04807348|Metformin|metformin|mesh-list
101595151|NCT04807348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101595152|NCT04807348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595153|NCT04224922|Paclitaxel|paclitaxel|mesh-list
101595154|NCT04224922|Cyclophosphamide|cyclophosphamide|mesh-list
101595155|NCT04224922|Epirubicin|epirubicin|mesh-list
101595157|NCT04224922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101595158|NCT04224922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101595159|NCT04224922|Tubulin Modulators|tubulin modulators|mesh-ancestor
101595160|NCT04224922|Antimitotic Agents|antimitotic agents|mesh-ancestor
101595161|NCT04224922|Mitosis Modulators|mitosis modulators|mesh-ancestor
101595162|NCT04224922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643457|NCT00919282|Micronutrients|micronutrients|mesh-ancestor
101643458|NCT00919282|Hematinics|hematinics|mesh-ancestor
101643459|NCT05414305|Lidocaine|lidocaine|mesh-list
101643460|NCT05414305|Heparin|heparin|mesh-list
101643461|NCT05414305|Anesthetics, Local|anesthetics, local|mesh-ancestor
101643462|NCT05414305|Anesthetics|anesthetics|mesh-ancestor
101356291|NCT00033332|Hormones|hormones|mesh-ancestor
101643463|NCT05414305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101643464|NCT05414305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643465|NCT05414305|Sensory System Agents|sensory system agents|mesh-ancestor
101643466|NCT05414305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101643467|NCT05414305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101595163|NCT04224922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101595164|NCT04224922|Immunologic Factors|immunologic factors|mesh-ancestor
101595165|NCT04224922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595166|NCT04224922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101595167|NCT04224922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101595168|NCT04224922|Alkylating Agents|alkylating agents|mesh-ancestor
101595169|NCT04224922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101595170|NCT04224922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101595171|NCT04224922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101595172|NCT04224922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101595173|NCT04224922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101595174|NCT02877888|Fluorides|fluorides|mesh-list
101595175|NCT02877888|Fluorides, Topical|fluorides, topical|mesh-list
101595176|NCT02877888|Cariostatic Agents|cariostatic agents|mesh-ancestor
101595177|NCT02877888|Protective Agents|protective agents|mesh-ancestor
101595178|NCT02877888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595179|NCT02772640|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101595180|NCT02772640|Ezetimibe|ezetimibe|mesh-list
101595181|NCT02772640|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101595182|NCT02772640|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101595183|NCT02772640|Antimetabolites|antimetabolites|mesh-ancestor
101595184|NCT02772640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595185|NCT02772640|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101595186|NCT02772640|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101643468|NCT05414305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101643469|NCT05414305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101643470|NCT05414305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101643471|NCT05414305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643472|NCT05414305|Anticoagulants|anticoagulants|mesh-ancestor
101643473|NCT05414305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101643474|NCT05414305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101643475|NCT00757549|Cetuximab|cetuximab|mesh-list
101643476|NCT00757549|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101643477|NCT00757549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101643478|NCT00757549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101643479|NCT00757549|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101643480|NCT00757549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643481|NCT00576199|Bevacizumab|bevacizumab|mesh-list
101643482|NCT00576199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101643483|NCT00576199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101643484|NCT00576199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101643485|NCT00576199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101643486|NCT00576199|Growth Substances|growth substances|mesh-ancestor
101643487|NCT00576199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643488|NCT00576199|Growth Inhibitors|growth inhibitors|mesh-ancestor
101300561|NCT04734080|Analgesics|analgesics|mesh-ancestor
101643489|NCT00754819|Colchicine|colchicine|mesh-list
101643490|NCT00754819|Gout Suppressants|gout suppressants|mesh-ancestor
101643491|NCT00754819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101595188|NCT02772718|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101595189|NCT02772718|Immunologic Factors|immunologic factors|mesh-ancestor
101595190|NCT02772718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595191|NCT00866281|Midostaurin|midostaurin|mesh-list
101595192|NCT00866281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101595193|NCT00866281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101595194|NCT00866281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101595195|NCT00866281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595196|NCT04121611|Aspirin|aspirin|mesh-list
101595197|NCT04121611|Heparin|heparin|mesh-list
101595198|NCT04121611|Calcium heparin|calcium heparin|mesh-list
101595199|NCT04121611|Anticoagulants|anticoagulants|mesh-ancestor
101595200|NCT04121611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101595201|NCT04121611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101595202|NCT04121611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595203|NCT04121611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101595204|NCT04121611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101595205|NCT04121611|Analgesics|analgesics|mesh-ancestor
101595206|NCT04121611|Sensory System Agents|sensory system agents|mesh-ancestor
101595207|NCT04121611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101595208|NCT04121611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595209|NCT04121611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101595210|NCT04121611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101643492|NCT00754819|Tubulin Modulators|tubulin modulators|mesh-ancestor
101643493|NCT00754819|Antimitotic Agents|antimitotic agents|mesh-ancestor
101643494|NCT00754819|Mitosis Modulators|mitosis modulators|mesh-ancestor
101643495|NCT00754819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643496|NCT00754819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101643497|NCT05684692|Siltuximab|siltuximab|mesh-list
101643498|NCT05684692|Erenumab|erenumab|mesh-list
101643499|NCT05684692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101643500|NCT05684692|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
101643501|NCT05684692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643502|NCT05684692|Analgesics|analgesics|mesh-ancestor
101643503|NCT05684692|Sensory System Agents|sensory system agents|mesh-ancestor
101643504|NCT05684692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101643505|NCT05684692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643506|NCT05684692|Immunologic Factors|immunologic factors|mesh-ancestor
101643507|NCT05684692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101643508|NCT02589652|Interferons|interferons|mesh-list
101643509|NCT02589652|Interferon-alpha|interferon-alpha|mesh-list
101643510|NCT02589652|Interferon alpha-2|interferon alpha-2|mesh-list
101643511|NCT02589652|Entecavir|entecavir|mesh-list
101643512|NCT02589652|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101643513|NCT02589652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101643514|NCT02589652|Antiviral Agents|antiviral agents|mesh-ancestor
101643515|NCT02589652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101643516|NCT02589652|Immunologic Factors|immunologic factors|mesh-ancestor
101643517|NCT02589652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643518|NCT00679627|Galantamine|galantamine|mesh-list
101595211|NCT04121611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101595212|NCT04121611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101595213|NCT04121611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101595214|NCT04121611|Antipyretics|antipyretics|mesh-ancestor
101595215|NCT02771860|Denosumab|denosumab|mesh-list
101595216|NCT02771860|Calcium|calcium|mesh-list
101595217|NCT02771860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101595218|NCT02771860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595219|NCT02771860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101595220|NCT02771782|Vaccines|vaccines|mesh-list
101595221|NCT02771782|BCG Vaccine|bcg vaccine|mesh-list
101595222|NCT02771782|Immunologic Factors|immunologic factors|mesh-ancestor
101595223|NCT02771782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595224|NCT02771782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101595225|NCT02771392|Tetracaine|tetracaine|mesh-list
101595226|NCT02771392|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101595227|NCT02771392|Anesthetics, Local|anesthetics, local|mesh-ancestor
101595228|NCT02771392|Anesthetics|anesthetics|mesh-ancestor
101595229|NCT02771392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101595230|NCT02771392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595232|NCT02771392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101595233|NCT02771704|Iodine|iodine|mesh-list
101595234|NCT02771704|Chlorhexidine|chlorhexidine|mesh-list
101595235|NCT02771704|Fluorides|fluorides|mesh-list
101595236|NCT02771704|Cariostatic Agents|cariostatic agents|mesh-ancestor
101595237|NCT02771704|Protective Agents|protective agents|mesh-ancestor
101595238|NCT02771704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595239|NCT02771704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101595240|NCT02771704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101356305|NCT00033410|Paclitaxel|paclitaxel|mesh-list
101595241|NCT02771704|Disinfectants|disinfectants|mesh-ancestor
101595242|NCT02771704|Trace Elements|trace elements|mesh-ancestor
101595243|NCT02771704|Micronutrients|micronutrients|mesh-ancestor
101643519|NCT00679627|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101643520|NCT00679627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101643521|NCT00679627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643522|NCT00679627|Cholinergic Agents|cholinergic agents|mesh-ancestor
101643523|NCT00679627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101643524|NCT00679627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643525|NCT00679627|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101643526|NCT00679627|Autonomic Agents|autonomic agents|mesh-ancestor
101643527|NCT00679627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101643528|NCT00679627|Nootropic Agents|nootropic agents|mesh-ancestor
101643529|NCT00714688|Methylphenidate|methylphenidate|mesh-list
101643530|NCT00714688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101643531|NCT00714688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595244|NCT02771314|Osimertinib|osimertinib|mesh-list
101595245|NCT02771314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101595246|NCT02771314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101595247|NCT02771314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101595248|NCT02771314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595249|NCT02771158|Midodrine|midodrine|mesh-list
101595250|NCT02771158|Sympathomimetics|sympathomimetics|mesh-ancestor
101595251|NCT02771158|Autonomic Agents|autonomic agents|mesh-ancestor
101595252|NCT02771158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101595253|NCT02771158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595254|NCT02771158|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101595255|NCT02771158|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101595256|NCT02771158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101595257|NCT02771158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101595258|NCT02771158|Adrenergic Agents|adrenergic agents|mesh-ancestor
101595259|NCT02771158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101595260|NCT02771158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595261|NCT02770690|Lidocaine|lidocaine|mesh-list
101595262|NCT02770690|Ethyl Chloride|ethyl chloride|mesh-list
101595263|NCT02770690|Anesthetics, Local|anesthetics, local|mesh-ancestor
101595264|NCT02770690|Anesthetics|anesthetics|mesh-ancestor
101595265|NCT02770690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101595266|NCT02770690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595267|NCT02770690|Sensory System Agents|sensory system agents|mesh-ancestor
101595268|NCT02770690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101595269|NCT02770690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101595270|NCT02770690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101643532|NCT00714688|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101643533|NCT00714688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101643534|NCT00714688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101643535|NCT00714688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643537|NCT00714688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101643538|NCT05165212|Amoxicillin|amoxicillin|mesh-list
101643539|NCT05165212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101643540|NCT05165212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101643541|NCT04051099|Dexmedetomidine|dexmedetomidine|mesh-list
101643542|NCT04051099|Bupivacaine|bupivacaine|mesh-list
101643543|NCT04051099|Propofol|propofol|mesh-list
101643544|NCT04051099|Anesthetics, Local|anesthetics, local|mesh-ancestor
101643545|NCT04051099|Anesthetics|anesthetics|mesh-ancestor
101643546|NCT04051099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101643547|NCT04051099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643548|NCT04051099|Sensory System Agents|sensory system agents|mesh-ancestor
101643549|NCT04051099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101595271|NCT02770690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101595272|NCT02770690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101595273|NCT02770690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595275|NCT02770378|Itraconazole|itraconazole|mesh-list
101595276|NCT02770378|Minocycline|minocycline|mesh-list
101595277|NCT02770378|Celecoxib|celecoxib|mesh-list
101595278|NCT02770378|Temozolomide|temozolomide|mesh-list
101595279|NCT02770378|Auranofin|auranofin|mesh-list
101595280|NCT02770378|Captopril|captopril|mesh-list
101595281|NCT02770378|Disulfiram|disulfiram|mesh-list
101595282|NCT02770378|Aprepitant|aprepitant|mesh-list
101595283|NCT02770378|Sertraline|sertraline|mesh-list
101595284|NCT02770378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101595285|NCT02770378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101595286|NCT02770378|Protease Inhibitors|protease inhibitors|mesh-ancestor
101595287|NCT02770378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101595288|NCT02770378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595289|NCT02770378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101595290|NCT02770378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101595291|NCT02770378|Antiviral Agents|antiviral agents|mesh-ancestor
101595292|NCT02770378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101595293|NCT02770378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101595294|NCT02770378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101595295|NCT02770378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101595296|NCT02770378|Alkylating Agents|alkylating agents|mesh-ancestor
101595297|NCT02770378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101595298|NCT02770378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101643550|NCT04051099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101643551|NCT04051099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101643552|NCT04051099|Analgesics|analgesics|mesh-ancestor
101643553|NCT04051099|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101643554|NCT04051099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101643555|NCT04051099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101643556|NCT04051099|Adrenergic Agents|adrenergic agents|mesh-ancestor
101643557|NCT04051099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101643558|NCT04051099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643559|NCT04051099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101643560|NCT04051099|Anesthetics, General|anesthetics, general|mesh-ancestor
101643561|NCT01031069|Vaccines|vaccines|mesh-list
101643562|NCT01031069|Immunologic Factors|immunologic factors|mesh-ancestor
101643563|NCT01031069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643564|NCT04084912|Dexamethasone|dexamethasone|mesh-list
101643565|NCT04084912|Dexamethasone acetate|dexamethasone acetate|mesh-list
101643566|NCT04084912|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101643567|NCT04084912|BB 1101|bb 1101|mesh-list
101643568|NCT04084912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101643569|NCT04084912|Antiemetics|antiemetics|mesh-ancestor
101643570|NCT04084912|Autonomic Agents|autonomic agents|mesh-ancestor
101595299|NCT02770378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101595301|NCT02770378|Sensory System Agents|sensory system agents|mesh-ancestor
101595302|NCT02770378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101595303|NCT02770378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595304|NCT02770378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101595305|NCT02770378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101595306|NCT02770378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101595307|NCT02770378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101595308|NCT02770378|Antifungal Agents|antifungal agents|mesh-ancestor
101595309|NCT02770378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101595310|NCT02770378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101595311|NCT02770378|Hormone Antagonists|hormone antagonists|mesh-ancestor
101595312|NCT02770378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101595313|NCT02770378|Antidepressive Agents|antidepressive agents|mesh-ancestor
101595314|NCT02770378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101595315|NCT02770378|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101595316|NCT02770378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101595317|NCT02770378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101595318|NCT02770378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101595319|NCT02770378|Serotonin Agents|serotonin agents|mesh-ancestor
101595320|NCT02770378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101595321|NCT02770378|Antiemetics|antiemetics|mesh-ancestor
101595322|NCT02770378|Autonomic Agents|autonomic agents|mesh-ancestor
101643571|NCT04084912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101643572|NCT04084912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643573|NCT04084912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101643574|NCT04084912|Glucocorticoids|glucocorticoids|mesh-ancestor
101643575|NCT04084912|Hormones|hormones|mesh-ancestor
101643576|NCT04084912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101643577|NCT04084912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101643578|NCT04084912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101643579|NCT04084912|Protease Inhibitors|protease inhibitors|mesh-ancestor
101643580|NCT04084912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101643581|NCT04084912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643582|NCT00755053|Clotrimazole|clotrimazole|mesh-list
101643583|NCT00755053|Miconazole|miconazole|mesh-list
101643584|NCT00755053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101643585|NCT00755053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101643586|NCT00755053|Antifungal Agents|antifungal agents|mesh-ancestor
101643587|NCT00755053|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101643588|NCT00755053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101643589|NCT00755053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101643590|NCT00755053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643591|NCT00755053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101643592|NCT00755053|Hormone Antagonists|hormone antagonists|mesh-ancestor
101643593|NCT00755053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101595323|NCT02770378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101595324|NCT02770378|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101595325|NCT02770378|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101595326|NCT02770378|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
101595327|NCT02770378|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101595328|NCT02770378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101595329|NCT02770222|Rifampin|rifampin|mesh-list
101595330|NCT02770222|Selexipag|selexipag|mesh-list
101595331|NCT02770222|Gemfibrozil|gemfibrozil|mesh-list
101595332|NCT02770222|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101595333|NCT02770222|Antitubercular Agents|antitubercular agents|mesh-ancestor
101595334|NCT02770222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101595335|NCT02770222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101595336|NCT02770222|Leprostatic Agents|leprostatic agents|mesh-ancestor
101595337|NCT02770222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101595338|NCT02770222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101595339|NCT02770222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595340|NCT02770222|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101595341|NCT02770222|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101595342|NCT02770222|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101595343|NCT02770222|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101595344|NCT02770222|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101595345|NCT02770222|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101595347|NCT02770222|Antimetabolites|antimetabolites|mesh-ancestor
101595348|NCT02770222|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101595349|NCT02770222|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101595350|NCT02770222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101595351|NCT02770222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101595352|NCT00943917|Exenatide|exenatide|mesh-list
101595353|NCT00943917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101643594|NCT00755053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643595|NCT00755053|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101643596|NCT00755053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101643597|NCT00755209|Tranexamic Acid|tranexamic acid|mesh-list
101643598|NCT00755209|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101643599|NCT00755209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101643600|NCT00755209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643601|NCT00755209|Hemostatics|hemostatics|mesh-ancestor
101643602|NCT00755209|Coagulants|coagulants|mesh-ancestor
101595354|NCT00943917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595355|NCT00943917|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101595356|NCT00943917|Incretins|incretins|mesh-ancestor
101595357|NCT00943917|Hormones|hormones|mesh-ancestor
101595358|NCT00943917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101595359|NCT02876250|Cyclosporine|cyclosporine|mesh-list
101595360|NCT02876250|Cyclosporins|cyclosporins|mesh-list
101595361|NCT02876250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101595362|NCT02876250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595363|NCT02876250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101595364|NCT02876250|Immunologic Factors|immunologic factors|mesh-ancestor
101595365|NCT02876250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595366|NCT02876250|Antifungal Agents|antifungal agents|mesh-ancestor
101595367|NCT02876250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101595368|NCT02876250|Dermatologic Agents|dermatologic agents|mesh-ancestor
101595369|NCT02876250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101595370|NCT02876250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101595371|NCT02769910|Capsaicin|capsaicin|mesh-list
101595372|NCT02769910|Antipruritics|antipruritics|mesh-ancestor
101595373|NCT02769910|Dermatologic Agents|dermatologic agents|mesh-ancestor
101595374|NCT02769910|Sensory System Agents|sensory system agents|mesh-ancestor
101595375|NCT02769910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101595376|NCT02769910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643603|NCT02589340|Buspirone|buspirone|mesh-list
101643604|NCT02589340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101643605|NCT02589340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101643606|NCT02589340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101643607|NCT02589340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643608|NCT02589340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101643609|NCT02589340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101643610|NCT02589340|Serotonin Agents|serotonin agents|mesh-ancestor
101643611|NCT02589340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101643612|NCT02589340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643613|NCT00682435|Hydromorphone|hydromorphone|mesh-list
101643614|NCT00682435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101643615|NCT00682435|Narcotics|narcotics|mesh-ancestor
101643616|NCT00682435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101643617|NCT00682435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643618|NCT00682435|Analgesics|analgesics|mesh-ancestor
101643619|NCT00682435|Sensory System Agents|sensory system agents|mesh-ancestor
101643620|NCT00682435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101643621|NCT05340205|Misoprostol|misoprostol|mesh-list
101643622|NCT05340205|Tranexamic Acid|tranexamic acid|mesh-list
101643623|NCT05340205|Oxytocin|oxytocin|mesh-list
101643624|NCT05340205|Oxytocics|oxytocics|mesh-ancestor
101643625|NCT05340205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101643626|NCT05340205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643627|NCT05340205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101643628|NCT05340205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101643629|NCT05340205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643630|NCT05340205|Hemostatics|hemostatics|mesh-ancestor
101643631|NCT05340205|Coagulants|coagulants|mesh-ancestor
101595377|NCT02876484|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
101595378|NCT02876484|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
101595379|NCT02876484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101595380|NCT02876484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101595381|NCT02876484|Antimetabolites|antimetabolites|mesh-ancestor
101595382|NCT02876484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595383|NCT02876484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101595384|NCT02876484|Cathartics|cathartics|mesh-ancestor
101595385|NCT02876484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101595386|NCT02876094|Celecoxib|celecoxib|mesh-list
101595387|NCT02876094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101595388|NCT02876094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101595389|NCT02876094|Analgesics|analgesics|mesh-ancestor
101643632|NCT05340205|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101643633|NCT05340205|Abortifacient Agents|abortifacient agents|mesh-ancestor
101643634|NCT05340205|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101643635|NCT05340205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101643636|NCT00713830|Metformin|metformin|mesh-list
101643637|NCT00713830|Lixisenatide|lixisenatide|mesh-list
101643638|NCT00713830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101643639|NCT00713830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643640|NCT00755521|Etoricoxib|etoricoxib|mesh-list
101643641|NCT00755521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101643643|NCT00755521|Analgesics|analgesics|mesh-ancestor
101643644|NCT00755521|Sensory System Agents|sensory system agents|mesh-ancestor
101643645|NCT00755521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101643646|NCT00755521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643647|NCT00755521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101643648|NCT00755521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101643649|NCT00755521|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101643650|NCT00755521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101643651|NCT00755521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101643652|NCT00755521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643653|NCT00681187|Lanreotide|lanreotide|mesh-list
101643654|NCT00681187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101643655|NCT00681109|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101643656|NCT00681109|Lubricant Eye Drops|lubricant eye drops|mesh-list
101643657|NCT00681109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101643658|NCT00681109|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101643659|NCT00681109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101643660|NCT00680407|Silymarin|silymarin|mesh-list
101643661|NCT00680407|Antioxidants|antioxidants|mesh-ancestor
101643662|NCT00680407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643663|NCT00680407|Protective Agents|protective agents|mesh-ancestor
101643664|NCT00680407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643665|NCT02560519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101643666|NCT04007809|Glucagon|glucagon|mesh-list
101643667|NCT04007809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101643668|NCT04007809|Hormones|hormones|mesh-ancestor
101643669|NCT04007809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101643670|NCT04007809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643671|NCT04083664|Hepcidins|hepcidins|mesh-list
101643672|NCT04083664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101643673|NCT05202730|Anesthetics|anesthetics|mesh-list
101643674|NCT05202730|Anesthetics, Local|anesthetics, local|mesh-list
101643675|NCT05202730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101643676|NCT05202730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643677|NCT05202730|Sensory System Agents|sensory system agents|mesh-ancestor
101643678|NCT05202730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101643679|NCT00677365|Levofloxacin|levofloxacin|mesh-list
101643680|NCT00677365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101595390|NCT02876094|Sensory System Agents|sensory system agents|mesh-ancestor
101595391|NCT02876094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101595392|NCT02876094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595393|NCT02876094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101595394|NCT02876094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101595395|NCT02876094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101595396|NCT02876094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101595397|NCT02876094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101595398|NCT02876094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595399|NCT00603135|Levetiracetam|levetiracetam|mesh-list
101595400|NCT00603135|Anticonvulsants|anticonvulsants|mesh-ancestor
101595401|NCT00603135|Nootropic Agents|nootropic agents|mesh-ancestor
101595402|NCT02769286|Osimertinib|osimertinib|mesh-list
101595403|NCT02769286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101595404|NCT02769286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101595405|NCT02769286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101595406|NCT02769286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595407|NCT02855073|Hyaluronic Acid|hyaluronic acid|mesh-list
101595408|NCT02855073|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101595409|NCT02855073|Immunologic Factors|immunologic factors|mesh-ancestor
101595410|NCT02855073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595411|NCT02855073|Viscosupplements|viscosupplements|mesh-ancestor
101595412|NCT02855073|Protective Agents|protective agents|mesh-ancestor
101595413|NCT02769130|Losartan|losartan|mesh-list
101595414|NCT02769130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101595415|NCT02769130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101252345|NCT03782142|Tenofovir|tenofovir|mesh-list
101595416|NCT02769130|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101595417|NCT02769130|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101595418|NCT02769130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595420|NCT02768740|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101595421|NCT02768740|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101595422|NCT02768740|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101595424|NCT02851095|Metformin|metformin|mesh-list
101356339|NCT00033566|S 3304|s 3304|mesh-list
101595429|NCT02851095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595430|NCT00580047|Calcium, Dietary|calcium, dietary|mesh-list
101595432|NCT00580047|Zoledronic Acid|zoledronic acid|mesh-list
101595433|NCT00580047|Alendronate|alendronate|mesh-list
101595434|NCT00580047|Calcium Carbonate|calcium carbonate|mesh-list
101595435|NCT00580047|Calcium|calcium|mesh-list
101595436|NCT00580047|Vitamins|vitamins|mesh-ancestor
101595437|NCT00580047|Micronutrients|micronutrients|mesh-ancestor
101595438|NCT00580047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595439|NCT00580047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101595440|NCT00580047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101595441|NCT00580047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595442|NCT00580047|Antacids|antacids|mesh-ancestor
101595443|NCT00580047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101595444|NCT01074450|Pramipexole|pramipexole|mesh-list
101595445|NCT01074450|Antioxidants|antioxidants|mesh-ancestor
101595446|NCT01074450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595447|NCT01074450|Protective Agents|protective agents|mesh-ancestor
101595448|NCT01074450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595449|NCT01074450|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101595450|NCT01074450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101595451|NCT01074450|Dopamine Agonists|dopamine agonists|mesh-ancestor
101595452|NCT01074450|Dopamine Agents|dopamine agents|mesh-ancestor
101595453|NCT01074450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101595454|NCT02768116|Sirolimus|sirolimus|mesh-list
101595455|NCT02768116|Temsirolimus|temsirolimus|mesh-list
101595456|NCT02768116|MTOR Inhibitors|mtor inhibitors|mesh-list
101595457|NCT02768116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101595458|NCT02768116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101595459|NCT02768116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101595460|NCT02768116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101595461|NCT02768116|Antifungal Agents|antifungal agents|mesh-ancestor
101595462|NCT02768116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101643681|NCT00677365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101643682|NCT00677365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101643683|NCT00677365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101643684|NCT00677365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101643685|NCT00677365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101643686|NCT00677365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643687|NCT00677365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101643688|NCT00677365|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101595463|NCT02768116|Immunologic Factors|immunologic factors|mesh-ancestor
101595464|NCT02768116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595465|NCT02768116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101595466|NCT02768116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101595467|NCT02768116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595468|NCT00635284|Sirolimus|sirolimus|mesh-list
101595469|NCT00635284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101595470|NCT00635284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101595471|NCT00635284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101595472|NCT00635284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101595473|NCT00635284|Antifungal Agents|antifungal agents|mesh-ancestor
101595474|NCT00635284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101595475|NCT00635284|Immunologic Factors|immunologic factors|mesh-ancestor
101595476|NCT00635284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595477|NCT04131595|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
101595478|NCT04131595|Antiviral Agents|antiviral agents|mesh-ancestor
101595479|NCT04131595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101595480|NCT00699049|Solifenacin Succinate|solifenacin succinate|mesh-list
101595481|NCT00699049|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
101595482|NCT00699049|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101595483|NCT00699049|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101595484|NCT00699049|Cholinergic Agents|cholinergic agents|mesh-ancestor
101595485|NCT00699049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101595486|NCT00699049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595487|NCT00699049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595488|NCT00699049|Urological Agents|urological agents|mesh-ancestor
101252446|NCT03673826|Hormones|hormones|mesh-ancestor
101595489|NCT00699049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101595490|NCT00699049|Adrenergic Agents|adrenergic agents|mesh-ancestor
101595491|NCT04131283|Epinephrine|epinephrine|mesh-list
101595492|NCT04131283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101595493|NCT04131283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101595501|NCT04131283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101595502|NCT04131283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101595503|NCT04131283|Respiratory System Agents|respiratory system agents|mesh-ancestor
101595504|NCT04131283|Mydriatics|mydriatics|mesh-ancestor
101595505|NCT04131283|Sympathomimetics|sympathomimetics|mesh-ancestor
101595506|NCT04131283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101595507|NCT00943761|Interferons|interferons|mesh-list
101595508|NCT00943761|Ribavirin|ribavirin|mesh-list
101595509|NCT00943761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101595510|NCT00943761|Antiviral Agents|antiviral agents|mesh-ancestor
101595511|NCT00943761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101595512|NCT00943761|Antimetabolites|antimetabolites|mesh-ancestor
101595513|NCT00943761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595514|NCT02617771|Vitamin D|vitamin d|mesh-list
101595515|NCT02617771|Cholecalciferol|cholecalciferol|mesh-list
101595516|NCT02617771|Vitamins|vitamins|mesh-ancestor
101595517|NCT02617771|Micronutrients|micronutrients|mesh-ancestor
101595518|NCT02617771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643689|NCT00677365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101643691|NCT05039944|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101643692|NCT05039944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101643693|NCT05039944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101643694|NCT05039944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643695|NCT05039944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101643696|NCT05038462|Lactoferrin|lactoferrin|mesh-list
101643697|NCT05038462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101643698|NCT03719131|Rituximab|rituximab|mesh-list
101643699|NCT03719131|Nivolumab|nivolumab|mesh-list
101643700|NCT03719131|Ipilimumab|ipilimumab|mesh-list
101643701|NCT03719131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101643702|NCT03719131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101643703|NCT03719131|Immunologic Factors|immunologic factors|mesh-ancestor
101643704|NCT03719131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643705|NCT03719131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101643706|NCT03719131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101643707|NCT03719131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643708|NCT05190094|Letrozole|letrozole|mesh-list
101643709|NCT05190094|Palbociclib|palbociclib|mesh-list
101643710|NCT05190094|Anastrozole|anastrozole|mesh-list
101643711|NCT05190094|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101643712|NCT05190094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101643713|NCT05190094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101643714|NCT05190094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101643715|NCT05190094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643716|NCT05190094|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101643717|NCT05190094|Hormone Antagonists|hormone antagonists|mesh-ancestor
101643718|NCT05190094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101643719|NCT05190094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643720|NCT05190094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101643721|NCT05190094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101643722|NCT00680017|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101643723|NCT00680017|Fenofibric acid|fenofibric acid|mesh-list
101643724|NCT00680017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101643725|NCT00680017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101643726|NCT00680017|Antimetabolites|antimetabolites|mesh-ancestor
101643727|NCT00680017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643728|NCT00680017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101643729|NCT00680017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101595519|NCT02617771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101595520|NCT02617771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101595521|NCT02696590|Vitamin D|vitamin d|mesh-list
101595522|NCT02696590|Cholecalciferol|cholecalciferol|mesh-list
101595524|NCT02696590|Micronutrients|micronutrients|mesh-ancestor
101595525|NCT02696590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595526|NCT02696590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101595527|NCT02696590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101595528|NCT02617459|Betaxolol|betaxolol|mesh-list
101595529|NCT02617459|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101595530|NCT02617459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101595531|NCT02617459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101595532|NCT02617459|Sympatholytics|sympatholytics|mesh-ancestor
101595533|NCT02617459|Autonomic Agents|autonomic agents|mesh-ancestor
101595534|NCT02617459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101595535|NCT02617459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595536|NCT02617459|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101595537|NCT02617459|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101595538|NCT02617459|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101595539|NCT02617459|Adrenergic Agents|adrenergic agents|mesh-ancestor
101595540|NCT02617459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101595541|NCT02617459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595542|NCT02854995|Triamcinolone|triamcinolone|mesh-list
101595543|NCT02854995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101595544|NCT02854995|Glucocorticoids|glucocorticoids|mesh-ancestor
101595545|NCT02854995|Hormones|hormones|mesh-ancestor
101643730|NCT00680017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101643731|NCT00676663|Exemestane|exemestane|mesh-list
101643732|NCT00676663|Entinostat|entinostat|mesh-list
101643733|NCT00676663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101643734|NCT00676663|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101643735|NCT00676663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101643736|NCT00676663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101643737|NCT00676663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643738|NCT00676663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101643739|NCT00676663|Hormone Antagonists|hormone antagonists|mesh-ancestor
101643740|NCT00676663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101643741|NCT00676663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643742|NCT00676663|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101643743|NCT02560207|Cefotaxime|cefotaxime|mesh-list
101643744|NCT02560207|Cefoxitin|cefoxitin|mesh-list
101643745|NCT02560207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101643746|NCT02560207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101643747|NCT00678691|Modafinil|modafinil|mesh-list
101643748|NCT00678691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101643749|NCT00678691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643750|NCT00678691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101643751|NCT00678691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101595546|NCT02854995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101595547|NCT02854995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595548|NCT02696512|Thioctic Acid|thioctic acid|mesh-list
101595549|NCT02696512|Minocycline|minocycline|mesh-list
101595550|NCT02696512|Lamotrigine|lamotrigine|mesh-list
101595551|NCT02696512|Flumazenil|flumazenil|mesh-list
101595552|NCT02696512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101595553|NCT02696512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101595554|NCT02696512|Anticonvulsants|anticonvulsants|mesh-ancestor
101595555|NCT02696512|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101595556|NCT02696512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101595557|NCT02696512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595558|NCT02696512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101595559|NCT02696512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595560|NCT02696512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101595561|NCT02696512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101595562|NCT02696512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101595563|NCT02696512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101595564|NCT02696512|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101595566|NCT02696512|Protective Agents|protective agents|mesh-ancestor
101595567|NCT02696512|Vitamin B Complex|vitamin b complex|mesh-ancestor
101595568|NCT02696512|Vitamins|vitamins|mesh-ancestor
101595569|NCT02696512|Micronutrients|micronutrients|mesh-ancestor
101595570|NCT02696512|Antidotes|antidotes|mesh-ancestor
101595571|NCT02696512|GABA Modulators|gaba modulators|mesh-ancestor
101595572|NCT02696512|GABA Agents|gaba agents|mesh-ancestor
101595573|NCT02696512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101595574|NCT00949533|Oseltamivir|oseltamivir|mesh-list
101595575|NCT00949533|Antiviral Agents|antiviral agents|mesh-ancestor
101595576|NCT00949533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101595577|NCT00949533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101595578|NCT00949533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595579|NCT02767258|Lubricant Eye Drops|lubricant eye drops|mesh-list
101595580|NCT02767258|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101595581|NCT02767258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101643752|NCT00678691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101643753|NCT00678691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643754|NCT05003752|Goserelin|goserelin|mesh-list
101643755|NCT05003752|Androgens|androgens|mesh-list
101643756|NCT05003752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101595582|NCT02854761|Vitamin D|vitamin d|mesh-list
101595583|NCT02854761|Vitamins|vitamins|mesh-ancestor
101595584|NCT02854761|Micronutrients|micronutrients|mesh-ancestor
101595585|NCT02854761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595586|NCT02854761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101595587|NCT00866047|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101595588|NCT00866047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101595589|NCT00866047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101595590|NCT00866047|Immunotoxins|immunotoxins|mesh-ancestor
101595591|NCT00866047|Immunoconjugates|immunoconjugates|mesh-ancestor
101595592|NCT00866047|Immunologic Factors|immunologic factors|mesh-ancestor
101595593|NCT00866047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595594|NCT01706692|Cyclosporine|cyclosporine|mesh-list
101595595|NCT01706692|Adalimumab|adalimumab|mesh-list
101595596|NCT01706692|Infliximab|infliximab|mesh-list
101595597|NCT01706692|Etanercept|etanercept|mesh-list
101595598|NCT01706692|Methotrexate|methotrexate|mesh-list
101595599|NCT01706692|Ustekinumab|ustekinumab|mesh-list
101595600|NCT01706692|Cyclosporins|cyclosporins|mesh-list
101595601|NCT01706692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101595602|NCT01706692|Abortifacient Agents|abortifacient agents|mesh-ancestor
101595603|NCT01706692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101595604|NCT01706692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595605|NCT01706692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101643757|NCT05003752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101643758|NCT05003752|Hormones|hormones|mesh-ancestor
101643759|NCT05003752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101643760|NCT05003752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643761|NCT04997980|Amiodarone|amiodarone|mesh-list
101643762|NCT04997980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101643763|NCT04997980|Vasodilator Agents|vasodilator agents|mesh-ancestor
101643764|NCT04997980|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101643765|NCT04997980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101643766|NCT04997980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643767|NCT04997980|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101643768|NCT04997980|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101643769|NCT04997980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101643770|NCT04997980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101643771|NCT04997980|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101643772|NCT04997980|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101643773|NCT04997980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101643774|NCT05101798|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101643775|NCT05101798|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101643776|NCT05101798|Dermatologic Agents|dermatologic agents|mesh-ancestor
101643777|NCT05683912|Aflibercept|aflibercept|mesh-list
101643778|NCT05683912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101643779|NCT05683912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101643780|NCT05683912|Growth Substances|growth substances|mesh-ancestor
101643781|NCT05683912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643782|NCT05683912|Growth Inhibitors|growth inhibitors|mesh-ancestor
101643783|NCT05683912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101595606|NCT01706692|Antimetabolites|antimetabolites|mesh-ancestor
101333208|NCT00016380|Ondansetron|ondansetron|mesh-list
101595607|NCT01706692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595608|NCT01706692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101595609|NCT01706692|Dermatologic Agents|dermatologic agents|mesh-ancestor
101595610|NCT01706692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101595611|NCT01706692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101595612|NCT01706692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101595613|NCT01706692|Immunologic Factors|immunologic factors|mesh-ancestor
101595614|NCT01706692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101595615|NCT01706692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101595616|NCT01706692|Antifungal Agents|antifungal agents|mesh-ancestor
101595617|NCT01706692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101595618|NCT01706692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101595619|NCT01706692|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101595620|NCT01706692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101595621|NCT01706692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101595622|NCT01706692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101643784|NCT00679939|Metformin|metformin|mesh-list
101643785|NCT00679939|Rosiglitazone|rosiglitazone|mesh-list
101643786|NCT00679939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101643787|NCT00679939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643789|NCT04082260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101643790|NCT04082260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101643791|NCT02587390|Simvastatin|simvastatin|mesh-list
101643792|NCT02587390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101643793|NCT02587390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101643794|NCT02587390|Antimetabolites|antimetabolites|mesh-ancestor
101643795|NCT02587390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643796|NCT02587390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101643797|NCT02587390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101643798|NCT02587390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101643800|NCT00760981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101643801|NCT00760981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101643802|NCT00760981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101643803|NCT00760981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643804|NCT02588716|Terlipressin|terlipressin|mesh-list
101643805|NCT02588716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101643806|NCT02588716|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101643807|NCT00673933|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101643808|NCT00673933|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
101643809|NCT00673933|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101643810|NCT00673933|Dermatologic Agents|dermatologic agents|mesh-ancestor
101643811|NCT00761449|Lenalidomide|lenalidomide|mesh-list
101643812|NCT00761449|Immunologic Factors|immunologic factors|mesh-ancestor
101643813|NCT00761449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643814|NCT00761449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101643815|NCT00761449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101643816|NCT00761449|Growth Substances|growth substances|mesh-ancestor
101643817|NCT00761449|Growth Inhibitors|growth inhibitors|mesh-ancestor
101643818|NCT00761449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101643819|NCT04968106|Doxorubicin|doxorubicin|mesh-list
101643820|NCT04968106|Ifosfamide|ifosfamide|mesh-list
101643821|NCT04968106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101643822|NCT04968106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101643823|NCT04968106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101643824|NCT04968106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101643825|NCT04968106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101595623|NCT01706692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101595624|NCT01706692|Analgesics|analgesics|mesh-ancestor
101595625|NCT01706692|Sensory System Agents|sensory system agents|mesh-ancestor
101595626|NCT01706692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101595628|NCT00869323|Bortezomib|bortezomib|mesh-list
101595629|NCT00869323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101595630|NCT00869323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101595631|NCT00869323|Immunologic Factors|immunologic factors|mesh-ancestor
101595632|NCT00869323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595633|NCT00869323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101595634|NCT02767102|Melatonin|melatonin|mesh-list
101595635|NCT02767102|Antioxidants|antioxidants|mesh-ancestor
101595636|NCT02767102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595637|NCT02767102|Protective Agents|protective agents|mesh-ancestor
101595638|NCT02767102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595639|NCT02767102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101595640|NCT02774902|Clarithromycin|clarithromycin|mesh-list
101595641|NCT02774902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101595642|NCT02774902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101595643|NCT02774902|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101595645|NCT02774902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595646|NCT02774902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101595647|NCT02774902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101595648|NCT02767024|Nitroprusside|nitroprusside|mesh-list
101595649|NCT02767024|Dobutamine|dobutamine|mesh-list
101595650|NCT02767024|Furosemide|furosemide|mesh-list
101595651|NCT02767024|Diuretics|diuretics|mesh-ancestor
101595652|NCT02767024|Natriuretic Agents|natriuretic agents|mesh-ancestor
101595653|NCT02767024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595654|NCT02767024|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101595655|NCT02767024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101595656|NCT02767024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595657|NCT02767024|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101595658|NCT02767024|Sympathomimetics|sympathomimetics|mesh-ancestor
101595659|NCT02767024|Autonomic Agents|autonomic agents|mesh-ancestor
101595661|NCT02767024|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101595662|NCT02767024|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101595663|NCT02767024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101595664|NCT02767024|Adrenergic Agents|adrenergic agents|mesh-ancestor
101595665|NCT02767024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101595666|NCT02767024|Protective Agents|protective agents|mesh-ancestor
101595667|NCT02767024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101595668|NCT02767024|Vasodilator Agents|vasodilator agents|mesh-ancestor
101595669|NCT02767024|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101595670|NCT02774200|Apatinib|apatinib|mesh-list
101595671|NCT02774200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101595672|NCT02774200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101595673|NCT02774200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101595674|NCT02774200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595675|NCT02766634|Lenograstim|lenograstim|mesh-list
101595676|NCT02766634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101595677|NCT02766634|Immunologic Factors|immunologic factors|mesh-ancestor
101595678|NCT02766634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595679|NCT02774044|Beractant|beractant|mesh-list
101595680|NCT02774044|Goat lung surfactant extract|goat lung surfactant extract|mesh-list
101595681|NCT02774044|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
101595682|NCT02774044|Respiratory System Agents|respiratory system agents|mesh-ancestor
101595683|NCT02766556|Dexmedetomidine|dexmedetomidine|mesh-list
101595684|NCT02766556|Ropivacaine|ropivacaine|mesh-list
101595685|NCT02766556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101595686|NCT02766556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101595687|NCT02766556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595688|NCT02766556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101595689|NCT02766556|Analgesics|analgesics|mesh-ancestor
101595690|NCT02766556|Sensory System Agents|sensory system agents|mesh-ancestor
101643826|NCT04968106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643827|NCT04968106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101643828|NCT04968106|Alkylating Agents|alkylating agents|mesh-ancestor
101643829|NCT00919438|Diuretics|diuretics|mesh-list
101643830|NCT00919438|Natriuretic Agents|natriuretic agents|mesh-ancestor
101643831|NCT00919438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643832|NCT04082182|Immunomodulating Agents|immunomodulating agents|mesh-list
101643833|NCT04082182|Immunologic Factors|immunologic factors|mesh-ancestor
101643834|NCT04082182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643836|NCT00571519|Pioglitazone|pioglitazone|mesh-list
101643837|NCT00571519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101643838|NCT00571519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643839|NCT02588404|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101643840|NCT02588404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101643841|NCT02588404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101595691|NCT02766556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101595692|NCT02766556|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101595693|NCT02766556|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101595694|NCT02766556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101595695|NCT02766556|Adrenergic Agents|adrenergic agents|mesh-ancestor
101595696|NCT02766556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101595697|NCT02766556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595698|NCT02766556|Anesthetics, Local|anesthetics, local|mesh-ancestor
101595699|NCT02766556|Anesthetics|anesthetics|mesh-ancestor
101595700|NCT01191944|Pramipexole|pramipexole|mesh-list
101595701|NCT01191944|Antioxidants|antioxidants|mesh-ancestor
101595702|NCT01191944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595703|NCT01191944|Protective Agents|protective agents|mesh-ancestor
101595704|NCT01191944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595705|NCT01191944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101595706|NCT01191944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101595707|NCT01191944|Dopamine Agonists|dopamine agonists|mesh-ancestor
101595708|NCT01191944|Dopamine Agents|dopamine agents|mesh-ancestor
101595709|NCT01191944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101595710|NCT00940875|Gemcitabine|gemcitabine|mesh-list
101595711|NCT00940875|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101643842|NCT02588404|Luteolytic Agents|luteolytic agents|mesh-ancestor
101643843|NCT02588404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101643844|NCT02588404|Contraceptive Agents|contraceptive agents|mesh-ancestor
101643845|NCT02588404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101643846|NCT02588404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643847|NCT02588404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101643848|NCT04935034|Vitamin D|vitamin d|mesh-list
101643849|NCT04935034|Vitamins|vitamins|mesh-ancestor
101643850|NCT04935034|Micronutrients|micronutrients|mesh-ancestor
101643851|NCT04935034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643852|NCT04935034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101643853|NCT04807816|Gemcitabine|gemcitabine|mesh-list
101643854|NCT04807816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101643855|NCT04807816|Antimetabolites|antimetabolites|mesh-ancestor
101643856|NCT04807816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643857|NCT04807816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101643858|NCT00762151|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101643859|NCT00762151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101643860|NCT00921973|Vaccines|vaccines|mesh-list
101643861|NCT00921973|Immunologic Factors|immunologic factors|mesh-ancestor
101643862|NCT00921973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643863|NCT00676195|Acetylcysteine|acetylcysteine|mesh-list
101643864|NCT00676195|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101643865|NCT00676195|Antiviral Agents|antiviral agents|mesh-ancestor
101643866|NCT00676195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101643867|NCT00676195|Expectorants|expectorants|mesh-ancestor
101643868|NCT00676195|Respiratory System Agents|respiratory system agents|mesh-ancestor
101643869|NCT00676195|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101643870|NCT00676195|Antioxidants|antioxidants|mesh-ancestor
101643871|NCT00676195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643872|NCT00676195|Protective Agents|protective agents|mesh-ancestor
101643873|NCT00676195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643874|NCT00676195|Antidotes|antidotes|mesh-ancestor
101595712|NCT00940875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101595713|NCT00940875|Antimetabolites|antimetabolites|mesh-ancestor
101595714|NCT00940875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595715|NCT00940875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252646|NCT03242772|Adrenergic Agents|adrenergic agents|mesh-ancestor
101595716|NCT00940875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101595717|NCT00940875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101595719|NCT02766322|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101356395|NCT00033683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101595720|NCT02766322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101595721|NCT02766322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101595722|NCT02766322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595724|NCT05655728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101595725|NCT05655728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595726|NCT00940485|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101595727|NCT00940485|Entecavir|entecavir|mesh-list
101595728|NCT00940485|Antiviral Agents|antiviral agents|mesh-ancestor
101595729|NCT00940485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101595730|NCT04317248|Cyclophosphamide|cyclophosphamide|mesh-list
101595731|NCT04317248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101595732|NCT04317248|Immunologic Factors|immunologic factors|mesh-ancestor
101595733|NCT04317248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595734|NCT04317248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101595735|NCT04317248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101595736|NCT04317248|Alkylating Agents|alkylating agents|mesh-ancestor
101595737|NCT04317248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595738|NCT04317248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101595739|NCT04317248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101595740|NCT05655338|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101595741|NCT05655338|Amoxicillin|amoxicillin|mesh-list
101595742|NCT05655338|Metronidazole|metronidazole|mesh-list
101595743|NCT05655338|Anti-Infective Agents|anti-infective agents|mesh-list
101595755|NCT00422565|Tubulin Modulators|tubulin modulators|mesh-ancestor
101595756|NCT00422565|Antimitotic Agents|antimitotic agents|mesh-ancestor
101595757|NCT00422565|Mitosis Modulators|mitosis modulators|mesh-ancestor
101595758|NCT00422565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595759|NCT00422565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101595760|NCT00422565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101595761|NCT00422565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101595762|NCT00422565|Antifungal Agents|antifungal agents|mesh-ancestor
101595763|NCT00422565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101595764|NCT00422565|Immunologic Factors|immunologic factors|mesh-ancestor
101595765|NCT00422565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595766|NCT04316936|Dexamethasone|dexamethasone|mesh-list
101595767|NCT04316936|Prednisolone|prednisolone|mesh-list
101595768|NCT04316936|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101595769|NCT04316936|Methylprednisolone|methylprednisolone|mesh-list
101595770|NCT04316936|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101595771|NCT04316936|Prednisolone acetate|prednisolone acetate|mesh-list
101595772|NCT04316936|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101595773|NCT04316936|Prednisolone phosphate|prednisolone phosphate|mesh-list
101595774|NCT04316936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101595775|NCT04316936|Antiemetics|antiemetics|mesh-ancestor
101595776|NCT04316936|Autonomic Agents|autonomic agents|mesh-ancestor
101595777|NCT04316936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101595778|NCT04316936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595779|NCT04316936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101595780|NCT04316936|Glucocorticoids|glucocorticoids|mesh-ancestor
101595781|NCT04316936|Hormones|hormones|mesh-ancestor
101595782|NCT04316936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101643875|NCT02558959|Capecitabine|capecitabine|mesh-list
101643877|NCT02558959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101643878|NCT02558959|Antimetabolites|antimetabolites|mesh-ancestor
101643879|NCT02558959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643880|NCT02558959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101643881|NCT02558959|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101643882|NCT02558959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101643883|NCT02558959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101643884|NCT04049539|Cytarabine|cytarabine|mesh-list
101643885|NCT04049539|Daunorubicin|daunorubicin|mesh-list
101643886|NCT04049539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101643887|NCT04049539|Antimetabolites|antimetabolites|mesh-ancestor
101643888|NCT04049539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643889|NCT04049539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101643890|NCT04049539|Antiviral Agents|antiviral agents|mesh-ancestor
101643891|NCT04049539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101356403|NCT00061308|Topotecan|topotecan|mesh-list
101643892|NCT04049539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101643893|NCT04049539|Immunologic Factors|immunologic factors|mesh-ancestor
101595783|NCT04316936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101595785|NCT04316936|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101595786|NCT04316936|Protective Agents|protective agents|mesh-ancestor
101595787|NCT00861757|Tadalafil|tadalafil|mesh-list
101595788|NCT00861757|Tamsulosin|tamsulosin|mesh-list
101595789|NCT00861757|Vasodilator Agents|vasodilator agents|mesh-ancestor
101595790|NCT00861757|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101595791|NCT00861757|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101595792|NCT00861757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101595793|NCT00861757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595794|NCT00861757|Urological Agents|urological agents|mesh-ancestor
101595795|NCT00861757|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101595796|NCT00861757|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101595797|NCT00861757|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101595798|NCT00861757|Adrenergic Agents|adrenergic agents|mesh-ancestor
101595799|NCT00861757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101595800|NCT00861757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595801|NCT02762812|Infliximab|infliximab|mesh-list
101595802|NCT02762812|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101595803|NCT02762812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101595804|NCT02762812|Dermatologic Agents|dermatologic agents|mesh-ancestor
101595805|NCT02762812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101595806|NCT02762812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101595807|NCT02762890|Iodine|iodine|mesh-list
101595808|NCT02762890|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101595809|NCT02762890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101595810|NCT02762890|Trace Elements|trace elements|mesh-ancestor
101595811|NCT02762890|Micronutrients|micronutrients|mesh-ancestor
101595812|NCT02762890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643894|NCT04049539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643895|NCT04049539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101643896|NCT04049539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101643897|NCT04049539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101643898|NCT04049539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101643899|NCT04082962|Dexamethasone|dexamethasone|mesh-list
101643900|NCT04082962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101643901|NCT04082962|Antiemetics|antiemetics|mesh-ancestor
101643902|NCT04082962|Autonomic Agents|autonomic agents|mesh-ancestor
101643903|NCT04082962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101643904|NCT04082962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643905|NCT04082962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101643906|NCT04082962|Glucocorticoids|glucocorticoids|mesh-ancestor
101643907|NCT04082962|Hormones|hormones|mesh-ancestor
101643908|NCT04082962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101595813|NCT02613715|Ethanol|ethanol|mesh-list
101595814|NCT02613715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101595815|NCT02613715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101595816|NCT02613715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101595817|NCT02613715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595818|NCT02762656|Lidocaine|lidocaine|mesh-list
101595819|NCT02762656|Anesthetics, Local|anesthetics, local|mesh-ancestor
101595820|NCT02762656|Anesthetics|anesthetics|mesh-ancestor
101595821|NCT02762656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101595822|NCT02762656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595823|NCT02762656|Sensory System Agents|sensory system agents|mesh-ancestor
101595824|NCT02762656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101595825|NCT02762656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101595826|NCT02762656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101595827|NCT02762656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101595828|NCT02762656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101595829|NCT02762656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595830|NCT00637325|Trastuzumab|trastuzumab|mesh-list
101595831|NCT00637325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101595832|NCT00637325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101595833|NCT02762344|Heparin|heparin|mesh-list
101595834|NCT02762344|Anticoagulants|anticoagulants|mesh-ancestor
101595835|NCT02762344|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101595836|NCT02762344|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101595837|NCT02762344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595838|NCT04663282|Insulin|insulin|mesh-list
101595839|NCT04663282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101595840|NCT04663282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595841|NCT01130597|Spironolactone|spironolactone|mesh-list
101595842|NCT01130597|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101595843|NCT01130597|Hormone Antagonists|hormone antagonists|mesh-ancestor
101595844|NCT01130597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101595853|NCT01188668|Aripiprazole|aripiprazole|mesh-list
101595854|NCT01188668|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101595855|NCT01188668|Antidepressive Agents|antidepressive agents|mesh-ancestor
101595856|NCT01188668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101595857|NCT01188668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101595858|NCT01188668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101595859|NCT01188668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101595860|NCT01188668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595861|NCT01188668|Dopamine Agonists|dopamine agonists|mesh-ancestor
101595862|NCT01188668|Dopamine Agents|dopamine agents|mesh-ancestor
101595863|NCT01188668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101595864|NCT01188668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595865|NCT01188668|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101595866|NCT01188668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101595867|NCT01188668|Serotonin Agents|serotonin agents|mesh-ancestor
101595868|NCT01188668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101595869|NCT01188668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101595870|NCT01188668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101595871|NCT01188668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101595872|NCT01188668|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101595873|NCT01188668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101595874|NCT01188668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101595875|NCT01130051|Colchicine|colchicine|mesh-list
101595876|NCT01130051|Gout Suppressants|gout suppressants|mesh-ancestor
101595877|NCT01130051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101595878|NCT01130051|Tubulin Modulators|tubulin modulators|mesh-ancestor
101595879|NCT01130051|Antimitotic Agents|antimitotic agents|mesh-ancestor
101595880|NCT01130051|Mitosis Modulators|mitosis modulators|mesh-ancestor
101595881|NCT01130051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595896|NCT00865189|Antimetabolites|antimetabolites|mesh-ancestor
101595897|NCT00865189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595898|NCT00865189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101595899|NCT00865189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101595900|NCT00865189|Immunologic Factors|immunologic factors|mesh-ancestor
101595901|NCT00865189|Antidotes|antidotes|mesh-ancestor
101595902|NCT00865189|Protective Agents|protective agents|mesh-ancestor
101595903|NCT00865189|Vitamin B Complex|vitamin b complex|mesh-ancestor
101595904|NCT00865189|Vitamins|vitamins|mesh-ancestor
101595905|NCT00865189|Micronutrients|micronutrients|mesh-ancestor
101595906|NCT00865189|Hematinics|hematinics|mesh-ancestor
101595907|NCT05362292|Mirabegron|mirabegron|mesh-list
101595908|NCT05362292|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101595909|NCT05362292|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101595910|NCT05362292|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101595911|NCT05362292|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101595912|NCT05362292|Adrenergic Agents|adrenergic agents|mesh-ancestor
101595913|NCT05362292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101595914|NCT05362292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595915|NCT05362292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595916|NCT05362292|Urological Agents|urological agents|mesh-ancestor
101595917|NCT05362292|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101595918|NCT05362292|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101595919|NCT05362292|Cholinergic Agents|cholinergic agents|mesh-ancestor
101595920|NCT00698269|Insulin|insulin|mesh-list
101356439|NCT00061542|Betaxolol|betaxolol|mesh-list
101643909|NCT04082962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101643910|NCT04082962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101643911|NCT02471833|Telmisartan|telmisartan|mesh-list
101643912|NCT02471833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101643913|NCT02471833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101643914|NCT02471833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101643915|NCT02471833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643916|NCT04895410|Dexamethasone|dexamethasone|mesh-list
101643917|NCT04895410|Daratumumab|daratumumab|mesh-list
101643918|NCT04895410|Pomalidomide|pomalidomide|mesh-list
101643919|NCT04895410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101643920|NCT04895410|Antiemetics|antiemetics|mesh-ancestor
101643921|NCT04895410|Autonomic Agents|autonomic agents|mesh-ancestor
101643922|NCT04895410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101643923|NCT04895410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643924|NCT04895410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101643925|NCT04895410|Glucocorticoids|glucocorticoids|mesh-ancestor
101643926|NCT04895410|Hormones|hormones|mesh-ancestor
101643927|NCT04895410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101643928|NCT04895410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101643929|NCT04895410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101643930|NCT04895410|Immunologic Factors|immunologic factors|mesh-ancestor
101643931|NCT04895410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101643932|NCT04895410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101595922|NCT00698269|Insulin Aspart|insulin aspart|mesh-list
101595923|NCT00698269|Insulin, Long-Acting|insulin, long-acting|mesh-list
101595924|NCT00698269|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101595925|NCT00698269|Insulin Detemir|insulin detemir|mesh-list
101595926|NCT00698269|Biphasic Insulins|biphasic insulins|mesh-list
101595927|NCT00698269|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101595928|NCT00698269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101595929|NCT00698269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595930|NCT01182194|Drospirenone|drospirenone|mesh-list
101595931|NCT01182194|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101595932|NCT01182194|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101595933|NCT01182194|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101595934|NCT01182194|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
101595935|NCT01182194|Estradiol|estradiol|mesh-list
101595936|NCT01182194|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101595937|NCT01182194|Estrogens|estrogens|mesh-ancestor
101595938|NCT01182194|Hormones|hormones|mesh-ancestor
101595939|NCT01182194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101595940|NCT01182194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595941|NCT01182194|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101595942|NCT01182194|Contraceptive Agents|contraceptive agents|mesh-ancestor
101595943|NCT01182194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101595944|NCT01182194|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101643934|NCT04895410|Growth Inhibitors|growth inhibitors|mesh-ancestor
101643935|NCT00675025|Donepezil|donepezil|mesh-list
101643936|NCT00675025|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101643937|NCT00675025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101643938|NCT00675025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643939|NCT00675025|Cholinergic Agents|cholinergic agents|mesh-ancestor
101643940|NCT00675025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101643941|NCT00675025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643942|NCT00675025|Nootropic Agents|nootropic agents|mesh-ancestor
101643943|NCT00758407|Methylphenidate|methylphenidate|mesh-list
101643944|NCT00758407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101643945|NCT00758407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643946|NCT00758407|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101643947|NCT00758407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101643948|NCT00758407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101643949|NCT00758407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643950|NCT00758407|Dopamine Agents|dopamine agents|mesh-ancestor
101643951|NCT00758407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101643952|NCT00759421|Olanzapine|olanzapine|mesh-list
101643953|NCT00759421|Sertindole|sertindole|mesh-list
101643954|NCT00759421|Antiemetics|antiemetics|mesh-ancestor
101643955|NCT00759421|Autonomic Agents|autonomic agents|mesh-ancestor
101643956|NCT00759421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101643957|NCT00759421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595945|NCT01182194|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101595946|NCT01182194|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101595947|NCT01182194|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101595948|NCT01182194|Hormone Antagonists|hormone antagonists|mesh-ancestor
101595949|NCT01182194|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101595950|NCT01182194|Diuretics|diuretics|mesh-ancestor
101595951|NCT01182194|Natriuretic Agents|natriuretic agents|mesh-ancestor
101595952|NCT01181726|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101595953|NCT01181726|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101595954|NCT01181726|Norethindrone|norethindrone|mesh-list
101595955|NCT01181726|Norethindrone Acetate|norethindrone acetate|mesh-list
101595956|NCT01181726|Estradiol|estradiol|mesh-list
101595957|NCT01181726|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101595958|NCT01181726|Estrogens|estrogens|mesh-ancestor
101595959|NCT01181726|Hormones|hormones|mesh-ancestor
101595960|NCT01181726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101595961|NCT01181726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595962|NCT01181726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101595963|NCT01181726|Contraceptive Agents|contraceptive agents|mesh-ancestor
101595964|NCT01181726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101595965|NCT01181726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101595966|NCT01181726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101595967|NCT01181726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101595968|NCT01181726|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101595969|NCT01137071|Antibodies|antibodies|mesh-list
101595970|NCT01137071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101595971|NCT01137071|Immunologic Factors|immunologic factors|mesh-ancestor
101595972|NCT01137071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595974|NCT00603759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101595975|NCT00603759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101595976|NCT00603759|Analgesics|analgesics|mesh-ancestor
101595977|NCT00603759|Sensory System Agents|sensory system agents|mesh-ancestor
101595978|NCT00603759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101595979|NCT00603759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595980|NCT00603759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101595984|NCT00603759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101595985|NCT00603759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595986|NCT04130815|Furosemide|furosemide|mesh-list
101595987|NCT04130815|Diuretics|diuretics|mesh-ancestor
101595988|NCT04130815|Natriuretic Agents|natriuretic agents|mesh-ancestor
101595989|NCT04130815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595990|NCT04130815|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101595991|NCT04130815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101595992|NCT04130815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101595993|NCT04256265|Risdiplam|risdiplam|mesh-list
101595994|NCT04256265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101595995|NCT04256265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101595996|NCT04256265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101595997|NCT04312061|Tramadol|tramadol|mesh-list
101595998|NCT04312061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101595999|NCT04312061|Narcotics|narcotics|mesh-ancestor
101596000|NCT04312061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101596001|NCT04312061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596002|NCT04312061|Analgesics|analgesics|mesh-ancestor
101596003|NCT04312061|Sensory System Agents|sensory system agents|mesh-ancestor
101596004|NCT04312061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101596005|NCT00860743|Antioxidants|antioxidants|mesh-list
101596006|NCT00860743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596007|NCT00860743|Protective Agents|protective agents|mesh-ancestor
101596008|NCT00860743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596009|NCT01186796|Fulvestrant|fulvestrant|mesh-list
101596010|NCT01186796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101596011|NCT01186796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101596012|NCT01186796|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101596013|NCT01186796|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101596014|NCT01186796|Hormone Antagonists|hormone antagonists|mesh-ancestor
101596015|NCT01186796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101596022|NCT05383131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596023|NCT05383131|Analgesics|analgesics|mesh-ancestor
101596024|NCT05383131|Sensory System Agents|sensory system agents|mesh-ancestor
101596025|NCT05383131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101596026|NCT05383131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596027|NCT05383131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101596028|NCT05383131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101596029|NCT05383131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101596030|NCT05383131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101596031|NCT02761486|Aspirin|aspirin|mesh-list
101596032|NCT02761486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101596033|NCT02761486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101596034|NCT02761486|Analgesics|analgesics|mesh-ancestor
101596035|NCT02761486|Sensory System Agents|sensory system agents|mesh-ancestor
101596036|NCT02761486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101596037|NCT02761486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596038|NCT02761486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101596039|NCT02761486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101596040|NCT02761486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101596041|NCT02761486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101596042|NCT02761486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596043|NCT02761486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101596044|NCT02761486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101596045|NCT02761486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101596046|NCT02761486|Antipyretics|antipyretics|mesh-ancestor
101596047|NCT02882789|Delpazolid|delpazolid|mesh-list
101596048|NCT02882789|Oxazolidinones|oxazolidinones|mesh-list
101596049|NCT02882789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101596050|NCT02882789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101596051|NCT02882789|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101596052|NCT02882789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101596053|NCT02882789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596054|NCT00940017|Voriconazole|voriconazole|mesh-list
101596055|NCT00940017|Anidulafungin|anidulafungin|mesh-list
101596061|NCT00940017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596062|NCT00940017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101596064|NCT00940017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101596065|NCT00940017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596066|NCT00940017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101596067|NCT01129583|Botulinum Toxins|botulinum toxins|mesh-list
101596068|NCT01129583|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101596069|NCT01129583|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101596070|NCT01129583|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101596071|NCT01129583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101596072|NCT01129583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596073|NCT01129583|Cholinergic Agents|cholinergic agents|mesh-ancestor
101596074|NCT01129583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101596075|NCT01129583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596076|NCT01129583|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101596077|NCT01129583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101596078|NCT01186328|Cytarabine|cytarabine|mesh-list
101596079|NCT01186328|Prednisone|prednisone|mesh-list
101596080|NCT01186328|Hydrocortisone|hydrocortisone|mesh-list
101596081|NCT01186328|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101596082|NCT01186328|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101596083|NCT01186328|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101596084|NCT01186328|Cortisone|cortisone|mesh-list
101596085|NCT01186328|Doxorubicin|doxorubicin|mesh-list
101596086|NCT01186328|Methotrexate|methotrexate|mesh-list
101596087|NCT01186328|Vincristine|vincristine|mesh-list
101596088|NCT01186328|Asparaginase|asparaginase|mesh-list
101596089|NCT01186328|Pegaspargase|pegaspargase|mesh-list
101596090|NCT01186328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101596091|NCT01186328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101596092|NCT01186328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101596093|NCT01186328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101596101|NCT01186328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101596102|NCT01186328|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101596103|NCT01186328|Abortifacient Agents|abortifacient agents|mesh-ancestor
101596104|NCT01186328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101596105|NCT01186328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101596106|NCT01186328|Antimetabolites|antimetabolites|mesh-ancestor
101596107|NCT01186328|Dermatologic Agents|dermatologic agents|mesh-ancestor
101596108|NCT01186328|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101596109|NCT01186328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101596110|NCT01186328|Immunologic Factors|immunologic factors|mesh-ancestor
101596111|NCT01186328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101596112|NCT01186328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101596113|NCT01186328|Antiviral Agents|antiviral agents|mesh-ancestor
101596114|NCT01186328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101596115|NCT01186328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101596116|NCT01186328|Tubulin Modulators|tubulin modulators|mesh-ancestor
101596117|NCT01186328|Antimitotic Agents|antimitotic agents|mesh-ancestor
101596118|NCT01186328|Mitosis Modulators|mitosis modulators|mesh-ancestor
101596119|NCT00848497|Methyltestosterone|methyltestosterone|mesh-list
101596120|NCT00848497|Sildenafil Citrate|sildenafil citrate|mesh-list
101596121|NCT00848497|Testosterone|testosterone|mesh-list
101596122|NCT00848497|Testosterone undecanoate|testosterone undecanoate|mesh-list
101596123|NCT00848497|Testosterone enanthate|testosterone enanthate|mesh-list
101596124|NCT00848497|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101596125|NCT00848497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596126|NCT00848497|Androgens|androgens|mesh-ancestor
101596127|NCT00848497|Hormones|hormones|mesh-ancestor
101596148|NCT02763592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101596149|NCT02763592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596150|NCT01185782|Gonadotropins, Pituitary|gonadotropins, pituitary|mesh-list
101596152|NCT01185782|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101596153|NCT01185782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101596154|NCT01185782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596155|NCT01185782|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101596156|NCT01185782|Fertility Agents|fertility agents|mesh-ancestor
101596157|NCT01185782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101596210|NCT04119739|Sensory System Agents|sensory system agents|mesh-ancestor
101596211|NCT04119739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101596212|NCT04119739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596213|NCT04119739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101596214|NCT04119739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101596215|NCT04119739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101596216|NCT04119739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101596217|NCT04119739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596218|NCT00859573|Modafinil|modafinil|mesh-list
101596219|NCT00859573|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101596220|NCT00859573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596221|NCT00859573|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101596222|NCT00859573|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101596223|NCT00859573|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101596224|NCT00859573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596225|NCT02758444|Micronutrients|micronutrients|mesh-list
101596226|NCT02758444|Trace Elements|trace elements|mesh-list
101596227|NCT02758444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596228|NCT01185548|Tolbutamide|tolbutamide|mesh-list
101596229|NCT01185548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101596230|NCT01185548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596231|NCT01128569|Fluticasone|fluticasone|mesh-list
101596232|NCT01128569|Xhance|xhance|mesh-list
101596233|NCT01128569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101596234|NCT01128569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101596235|NCT01128569|Autonomic Agents|autonomic agents|mesh-ancestor
101596236|NCT01128569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101643958|NCT00759421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101643959|NCT00759421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101643960|NCT00759421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101643961|NCT00759421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101643962|NCT00759421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101643963|NCT00759421|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101643964|NCT00759421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101643965|NCT00759421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101643966|NCT00759421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643967|NCT00759421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101643968|NCT00759421|Serotonin Agents|serotonin agents|mesh-ancestor
101643969|NCT00762775|Vitamin D|vitamin d|mesh-list
101643970|NCT00762775|Calcium|calcium|mesh-list
101643971|NCT00762775|Vitamins|vitamins|mesh-ancestor
101643972|NCT00762775|Micronutrients|micronutrients|mesh-ancestor
101643973|NCT00762775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643974|NCT00762775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101596237|NCT01128569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596238|NCT01128569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101596239|NCT01128569|Respiratory System Agents|respiratory system agents|mesh-ancestor
101596240|NCT01128569|Dermatologic Agents|dermatologic agents|mesh-ancestor
101596241|NCT01128569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101596243|NCT04582942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101596244|NCT02883179|Lidocaine|lidocaine|mesh-list
101596245|NCT02883179|Prilocaine|prilocaine|mesh-list
101596246|NCT02883179|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
101596247|NCT02883179|Anesthetics, Local|anesthetics, local|mesh-ancestor
101596248|NCT02883179|Anesthetics|anesthetics|mesh-ancestor
101596249|NCT02883179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101596250|NCT02883179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596251|NCT02883179|Sensory System Agents|sensory system agents|mesh-ancestor
101596252|NCT02883179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101596253|NCT02883179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101596254|NCT02883179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101596255|NCT02883179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101596256|NCT02883179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101596257|NCT02883179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596258|NCT02883179|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
101596259|NCT02758366|Doxorubicin|doxorubicin|mesh-list
101596260|NCT02758366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101596261|NCT02758366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101596262|NCT02758366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101596263|NCT02758366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101596264|NCT02758366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101643975|NCT00762775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101643976|NCT00763165|Triclosan|triclosan|mesh-list
101643977|NCT00763165|Fluorides|fluorides|mesh-list
101643978|NCT00763165|Cariostatic Agents|cariostatic agents|mesh-ancestor
101643979|NCT00763165|Protective Agents|protective agents|mesh-ancestor
101643980|NCT00763165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643981|NCT00763165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101643982|NCT00763165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101643983|NCT00763165|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101643984|NCT00763165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101643985|NCT00763165|Antimetabolites|antimetabolites|mesh-ancestor
101828278|NCT05815160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101643986|NCT00763165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643987|NCT00763165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101643988|NCT04049227|Letrozole|letrozole|mesh-list
101643989|NCT04049227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101643990|NCT04049227|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101643991|NCT04049227|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101643992|NCT04049227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101646175|NCT02582476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101596265|NCT02758366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596267|NCT00637403|Megestrol Acetate|megestrol acetate|mesh-list
101596268|NCT00637403|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101596269|NCT00637403|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101596270|NCT00637403|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101596271|NCT00637403|Contraceptive Agents|contraceptive agents|mesh-ancestor
101596272|NCT00637403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101596273|NCT00637403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596274|NCT00637403|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101596275|NCT00637403|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101596276|NCT00637403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101596277|NCT00637403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101596278|NCT00637403|Appetite Stimulants|appetite stimulants|mesh-ancestor
101596279|NCT00637403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101596281|NCT01185080|Analgesics|analgesics|mesh-ancestor
101596282|NCT01185080|Sensory System Agents|sensory system agents|mesh-ancestor
101596283|NCT01185080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101596284|NCT01185080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596285|NCT01185080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101596286|NCT01185080|Vasodilator Agents|vasodilator agents|mesh-ancestor
101596287|NCT01185080|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101596288|NCT01185080|Purinergic Agonists|purinergic agonists|mesh-ancestor
101596289|NCT01185080|Purinergic Agents|purinergic agents|mesh-ancestor
101596290|NCT01185080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101596291|NCT01185080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596292|NCT01181102|Enoxaparin|enoxaparin|mesh-list
101596311|NCT00858637|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101596312|NCT00858637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101596313|NCT00858637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101596314|NCT02760316|Prednisolone|prednisolone|mesh-list
101596315|NCT02760316|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101596316|NCT02760316|Methylprednisolone|methylprednisolone|mesh-list
101596317|NCT02760316|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101596318|NCT02760316|Prednisolone acetate|prednisolone acetate|mesh-list
101596319|NCT02760316|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101596320|NCT02760316|Prednisolone phosphate|prednisolone phosphate|mesh-list
101596321|NCT02760316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101596322|NCT02760316|Glucocorticoids|glucocorticoids|mesh-ancestor
101596323|NCT02760316|Hormones|hormones|mesh-ancestor
101596324|NCT02760316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101596325|NCT02760316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596326|NCT02760316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101596327|NCT02760316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101596328|NCT02760316|Antiemetics|antiemetics|mesh-ancestor
101596329|NCT02760316|Autonomic Agents|autonomic agents|mesh-ancestor
101596330|NCT02760316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101596331|NCT02760316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101596332|NCT02760316|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101596333|NCT02760316|Protective Agents|protective agents|mesh-ancestor
101596334|NCT00858403|Dasatinib|dasatinib|mesh-list
101596335|NCT00858403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101596336|NCT00858403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101596337|NCT00858403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101596338|NCT00858403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643993|NCT04049227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643994|NCT04049227|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101643995|NCT04049227|Hormone Antagonists|hormone antagonists|mesh-ancestor
101828279|NCT05815160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101643996|NCT04049227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101643997|NCT04049227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643998|NCT00759733|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101643999|NCT00759733|Natriuretic Agents|natriuretic agents|mesh-ancestor
101644000|NCT00759733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644001|NCT00760045|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101644002|NCT00760045|Hyaluronic Acid|hyaluronic acid|mesh-list
101644003|NCT00760045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101644004|NCT00760045|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101644005|NCT00760045|Immunologic Factors|immunologic factors|mesh-ancestor
101644006|NCT00760045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644007|NCT00760045|Viscosupplements|viscosupplements|mesh-ancestor
101596339|NCT02760472|SMOFlipid|smoflipid|mesh-list
101596340|NCT02760472|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101596341|NCT02760472|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101596342|NCT02760472|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101596343|NCT00858247|Vitamin D|vitamin d|mesh-list
101596344|NCT00858247|Cholecalciferol|cholecalciferol|mesh-list
101596345|NCT00858247|Vitamins|vitamins|mesh-ancestor
101596346|NCT00858247|Micronutrients|micronutrients|mesh-ancestor
101596347|NCT00858247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596348|NCT00858247|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101596349|NCT00858247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101596350|NCT04222348|Metformin|metformin|mesh-list
101596351|NCT04222348|Insulin Detemir|insulin detemir|mesh-list
101596352|NCT04222348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101596353|NCT04222348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596354|NCT04222114|Catumaxomab|catumaxomab|mesh-list
101596355|NCT04222114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101596356|NCT00838435|Verapamil|verapamil|mesh-list
101596357|NCT00838435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101596358|NCT00838435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101596359|NCT00838435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101596360|NCT00838435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596361|NCT00838435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101596362|NCT00838435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596363|NCT00838435|Vasodilator Agents|vasodilator agents|mesh-ancestor
101596364|NCT02757508|Vitamins|vitamins|mesh-list
101596365|NCT02757508|Micronutrients|micronutrients|mesh-ancestor
101596366|NCT02757508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596367|NCT04568902|Histamine Antagonists|histamine antagonists|mesh-list
101644008|NCT00760045|Protective Agents|protective agents|mesh-ancestor
101644010|NCT00678379|Clonidine|clonidine|mesh-list
101644011|NCT00678379|Bupivacaine|bupivacaine|mesh-list
101301087|NCT04042558|Growth Substances|growth substances|mesh-ancestor
101644012|NCT00678379|Anesthetics, Local|anesthetics, local|mesh-ancestor
101644013|NCT00678379|Anesthetics|anesthetics|mesh-ancestor
101644014|NCT00678379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101644015|NCT00678379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644016|NCT00678379|Sensory System Agents|sensory system agents|mesh-ancestor
101644017|NCT00678379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101644018|NCT00678379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101644019|NCT00678379|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101644020|NCT00678379|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101644021|NCT00678379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101644022|NCT00678379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596369|NCT04568902|Histamine Agents|histamine agents|mesh-ancestor
101596370|NCT04568902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101596371|NCT04568902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596372|NCT04568902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596373|NCT02757196|Methylprednisolone|methylprednisolone|mesh-list
101596374|NCT02757196|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101596375|NCT02757196|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101596376|NCT02757196|Prednisolone|prednisolone|mesh-list
101596377|NCT02757196|Prednisolone acetate|prednisolone acetate|mesh-list
101596378|NCT02757196|Rituximab|rituximab|mesh-list
101596379|NCT02757196|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101356499|NCT00034463|Micronutrients|micronutrients|mesh-ancestor
101596380|NCT02757196|Prednisolone phosphate|prednisolone phosphate|mesh-list
101596381|NCT02757196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101596382|NCT02757196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101596383|NCT02757196|Immunologic Factors|immunologic factors|mesh-ancestor
101596384|NCT02757196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596385|NCT02757196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101596386|NCT02757196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101596387|NCT02757196|Antiemetics|antiemetics|mesh-ancestor
101596388|NCT02757196|Autonomic Agents|autonomic agents|mesh-ancestor
101596389|NCT02757196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101596390|NCT02757196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101596391|NCT02757196|Glucocorticoids|glucocorticoids|mesh-ancestor
101596393|NCT02757196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101596394|NCT02757196|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101596395|NCT02757196|Protective Agents|protective agents|mesh-ancestor
101596396|NCT02757196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101596397|NCT04403698|Alendronate|alendronate|mesh-list
101596398|NCT04403698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101596399|NCT04403698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644023|NCT00678379|Analgesics|analgesics|mesh-ancestor
101644024|NCT00678379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101644025|NCT00678379|Sympatholytics|sympatholytics|mesh-ancestor
101644026|NCT00678379|Autonomic Agents|autonomic agents|mesh-ancestor
101644027|NCT00678379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101644028|NCT00678379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101644029|NCT00678379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101644030|NCT00678379|Adrenergic Agents|adrenergic agents|mesh-ancestor
101644031|NCT00678379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101644032|NCT00760279|Azithromycin|azithromycin|mesh-list
101644033|NCT00760279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101644034|NCT00760279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101596401|NCT02759926|Denatonium|denatonium|mesh-list
101596402|NCT02759926|Antimalarials|antimalarials|mesh-ancestor
101596403|NCT02759926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101596404|NCT02759926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101596405|NCT02759926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101596406|NCT02759926|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101596407|NCT02759926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596408|NCT02759926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101596409|NCT02759926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101596410|NCT02759926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101596411|NCT02759926|Analgesics|analgesics|mesh-ancestor
101596412|NCT02759926|Sensory System Agents|sensory system agents|mesh-ancestor
101596413|NCT02759926|Aversive Agents|aversive agents|mesh-ancestor
101596414|NCT02759926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596415|NCT02759926|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
101596416|NCT04221256|Escitalopram|escitalopram|mesh-list
101596417|NCT04221256|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101596418|NCT04221256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101596419|NCT04221256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101596420|NCT04221256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596421|NCT04221256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101596422|NCT04221256|Serotonin Agents|serotonin agents|mesh-ancestor
101596423|NCT04221256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596424|NCT00838201|Denosumab|denosumab|mesh-list
101596425|NCT00838201|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101596426|NCT00838201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596427|NCT00837967|Terbutaline|terbutaline|mesh-list
101596428|NCT00837967|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101596429|NCT00837967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101644035|NCT00674323|Ranibizumab|ranibizumab|mesh-list
101644036|NCT00674323|Verteporfin|verteporfin|mesh-list
101644037|NCT00674323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101644038|NCT00674323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101644039|NCT00674323|Growth Substances|growth substances|mesh-ancestor
101644040|NCT00674323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644041|NCT00674323|Growth Inhibitors|growth inhibitors|mesh-ancestor
101644042|NCT00674323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101644043|NCT00674323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101644044|NCT00674323|Dermatologic Agents|dermatologic agents|mesh-ancestor
101644045|NCT00763633|Vitamins|vitamins|mesh-list
101644046|NCT00763633|Vitamin B 6|vitamin b 6|mesh-list
101644047|NCT00763633|Pyridoxal|pyridoxal|mesh-list
101644048|NCT00763633|Pyridoxine|pyridoxine|mesh-list
101596430|NCT00837967|Respiratory System Agents|respiratory system agents|mesh-ancestor
101596431|NCT00837967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101596432|NCT00837967|Autonomic Agents|autonomic agents|mesh-ancestor
101596433|NCT00837967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101596434|NCT00837967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596435|NCT00837967|Sympathomimetics|sympathomimetics|mesh-ancestor
101596436|NCT00837967|Tocolytic Agents|tocolytic agents|mesh-ancestor
101596437|NCT00837967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101596438|NCT00837967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101596439|NCT00837967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101596440|NCT00837967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101596441|NCT00837967|Adrenergic Agents|adrenergic agents|mesh-ancestor
101596442|NCT00837967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101596443|NCT00837967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644049|NCT00763633|Vitamin B Complex|vitamin b complex|mesh-list
101644050|NCT00763633|Micronutrients|micronutrients|mesh-ancestor
101644051|NCT00763633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644052|NCT00763789|Remifentanil|remifentanil|mesh-list
101644053|NCT00763789|Anesthetics|anesthetics|mesh-list
101644054|NCT00763789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101644055|NCT00763789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644056|NCT00763789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101644057|NCT00763789|Narcotics|narcotics|mesh-ancestor
101644058|NCT00763789|Analgesics|analgesics|mesh-ancestor
101644059|NCT00763789|Sensory System Agents|sensory system agents|mesh-ancestor
101644060|NCT00763789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101644062|NCT04115956|Melphalan|melphalan|mesh-list
101644063|NCT04115956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101644064|NCT04115956|Antiemetics|antiemetics|mesh-ancestor
101644065|NCT04115956|Autonomic Agents|autonomic agents|mesh-ancestor
101644066|NCT04115956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101644067|NCT04115956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644068|NCT04115956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101644069|NCT04115956|Glucocorticoids|glucocorticoids|mesh-ancestor
101644070|NCT04115956|Hormones|hormones|mesh-ancestor
101644071|NCT04115956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101644072|NCT04115956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101644073|NCT04115956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101644074|NCT04115956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101644075|NCT04115956|Alkylating Agents|alkylating agents|mesh-ancestor
101644076|NCT04115956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644077|NCT04115956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101644078|NCT04115956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101644079|NCT04115956|Immunologic Factors|immunologic factors|mesh-ancestor
101644080|NCT04081480|Valacyclovir|valacyclovir|mesh-list
101644081|NCT04081480|Antiviral Agents|antiviral agents|mesh-ancestor
101644082|NCT04081480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101644083|NCT00678301|Vaccines|vaccines|mesh-list
101644084|NCT00678301|Immunologic Factors|immunologic factors|mesh-ancestor
101644085|NCT00678301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644086|NCT02586454|Morphine|morphine|mesh-list
101644087|NCT02586454|Ropivacaine|ropivacaine|mesh-list
101644088|NCT02586454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101644089|NCT02586454|Narcotics|narcotics|mesh-ancestor
101644090|NCT02586454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101644091|NCT02586454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644093|NCT02586454|Sensory System Agents|sensory system agents|mesh-ancestor
101644094|NCT02586454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101644095|NCT02586454|Anesthetics, Local|anesthetics, local|mesh-ancestor
101644096|NCT02586454|Anesthetics|anesthetics|mesh-ancestor
101596444|NCT02759614|Bevacizumab|bevacizumab|mesh-list
101596445|NCT02759614|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101596446|NCT02759614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101596447|NCT02759614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101596448|NCT02759614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101596449|NCT02759614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101596450|NCT02759614|Growth Substances|growth substances|mesh-ancestor
101596451|NCT02759614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596452|NCT02759614|Growth Inhibitors|growth inhibitors|mesh-ancestor
101596453|NCT02759614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101596454|NCT02759614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101596455|NCT02759614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596456|NCT02757040|Arsenic Trioxide|arsenic trioxide|mesh-list
101596457|NCT02757040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101596458|NCT02759224|Irsogladine|irsogladine|mesh-list
101596459|NCT02759224|Lafutidine|lafutidine|mesh-list
101596460|NCT02759224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596461|NCT02759224|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101596462|NCT02759224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101644097|NCT00939770|Crizotinib|crizotinib|mesh-list
101644098|NCT00939770|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101644099|NCT00939770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101644100|NCT00939770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101644101|NCT00939770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101644102|NCT00939770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644103|NCT02558569|Levobupivacaine|levobupivacaine|mesh-list
101644104|NCT02558569|Anesthetics, Local|anesthetics, local|mesh-ancestor
101644105|NCT02558569|Anesthetics|anesthetics|mesh-ancestor
101356675|NCT00062127|Growth Substances|growth substances|mesh-ancestor
101644106|NCT02558569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101644107|NCT02558569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644108|NCT02558569|Sensory System Agents|sensory system agents|mesh-ancestor
101644109|NCT02558569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101644110|NCT00939692|Topiramate|topiramate|mesh-list
101644111|NCT00939692|Anticonvulsants|anticonvulsants|mesh-ancestor
101644112|NCT00939692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101644113|NCT00939692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644114|NCT00920608|Methotrexate|methotrexate|mesh-list
101644115|NCT00920608|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101644116|NCT00920608|Abortifacient Agents|abortifacient agents|mesh-ancestor
101644117|NCT00920608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101644118|NCT00920608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644119|NCT00920608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101644120|NCT00920608|Antimetabolites|antimetabolites|mesh-ancestor
101644121|NCT00920608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644122|NCT00920608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101644123|NCT00920608|Dermatologic Agents|dermatologic agents|mesh-ancestor
101644124|NCT00920608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101644125|NCT00920608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101644126|NCT00920608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101644127|NCT00920608|Immunologic Factors|immunologic factors|mesh-ancestor
101644128|NCT00920608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101644129|NCT00920608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101644130|NCT04674514|Dexamethasone|dexamethasone|mesh-list
101644131|NCT04674514|Lenalidomide|lenalidomide|mesh-list
101644132|NCT04674514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101596463|NCT02759224|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101596464|NCT02759224|Histamine Antagonists|histamine antagonists|mesh-ancestor
101596466|NCT02759224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101596467|NCT02759224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596468|NCT02759224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101596469|NCT02759224|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101596470|NCT02759224|Protective Agents|protective agents|mesh-ancestor
101596471|NCT02759224|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101596472|NCT02756728|Melphalan|melphalan|mesh-list
101596473|NCT02756728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101596474|NCT02756728|Alkylating Agents|alkylating agents|mesh-ancestor
101596475|NCT02756728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596476|NCT02756728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101596477|NCT02756728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101596478|NCT02756728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101596479|NCT02756728|Immunologic Factors|immunologic factors|mesh-ancestor
101596480|NCT02756728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596481|NCT04586920|Itraconazole|itraconazole|mesh-list
101644133|NCT04674514|Antiemetics|antiemetics|mesh-ancestor
101644134|NCT04674514|Autonomic Agents|autonomic agents|mesh-ancestor
101644135|NCT04674514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101644136|NCT04674514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535550|NCT04674137|Histamine|histamine|mesh-list
101644137|NCT04674514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101644139|NCT04674514|Hormones|hormones|mesh-ancestor
101644140|NCT04674514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101356788|NCT00035204|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101644141|NCT04674514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101644142|NCT04674514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101644143|NCT04674514|Immunologic Factors|immunologic factors|mesh-ancestor
101644144|NCT04674514|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101644145|NCT04674514|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101644146|NCT04674514|Growth Substances|growth substances|mesh-ancestor
101644147|NCT04674514|Growth Inhibitors|growth inhibitors|mesh-ancestor
101644148|NCT04081012|Acetylcysteine|acetylcysteine|mesh-list
101644149|NCT04081012|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101644150|NCT04081012|Antiviral Agents|antiviral agents|mesh-ancestor
101644151|NCT04081012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101644152|NCT04081012|Expectorants|expectorants|mesh-ancestor
101644153|NCT04081012|Respiratory System Agents|respiratory system agents|mesh-ancestor
101644154|NCT04081012|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101644155|NCT04081012|Antioxidants|antioxidants|mesh-ancestor
101644156|NCT04081012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644157|NCT04081012|Protective Agents|protective agents|mesh-ancestor
101644158|NCT04081012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644159|NCT04081012|Antidotes|antidotes|mesh-ancestor
101644160|NCT04551040|Terazosin|terazosin|mesh-list
101644161|NCT04551040|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101644162|NCT04551040|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101644163|NCT04551040|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101644164|NCT04551040|Adrenergic Agents|adrenergic agents|mesh-ancestor
101644165|NCT04551040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101644166|NCT04551040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644167|NCT04551040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644168|NCT04551040|Urological Agents|urological agents|mesh-ancestor
101596483|NCT04586920|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101596484|NCT04586920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101596485|NCT04586920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101596486|NCT04586920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596487|NCT04586920|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101596488|NCT04586920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101596489|NCT04586920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101596490|NCT04586920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101596491|NCT04586920|Anesthetics, General|anesthetics, general|mesh-ancestor
101596492|NCT04586920|Anesthetics|anesthetics|mesh-ancestor
101596493|NCT04586920|GABA Modulators|gaba modulators|mesh-ancestor
101596494|NCT04586920|GABA Agents|gaba agents|mesh-ancestor
101596495|NCT04586920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101644169|NCT00942968|Dalteparin|dalteparin|mesh-list
101644170|NCT00942968|Tinzaparin|tinzaparin|mesh-list
101644171|NCT00942968|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101644172|NCT00942968|Anticoagulants|anticoagulants|mesh-ancestor
101644173|NCT00942968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101644174|NCT00942968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101644175|NCT00942968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644176|NCT00942734|Everolimus|everolimus|mesh-list
101644177|NCT00942734|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101644178|NCT00942734|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101644179|NCT00942734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101644180|NCT00942734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101644181|NCT00942734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644182|NCT00942734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101644183|NCT00942734|Immunologic Factors|immunologic factors|mesh-ancestor
101644184|NCT00942734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644185|NCT00942734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101644186|NCT02586142|Botulinum Toxins|botulinum toxins|mesh-list
101644187|NCT02586142|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101644188|NCT02586142|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101644189|NCT02586142|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101644190|NCT02586142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101644191|NCT02586142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644192|NCT02586142|Cholinergic Agents|cholinergic agents|mesh-ancestor
101644193|NCT02586142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101644194|NCT02586142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644195|NCT02586142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101644196|NCT02586142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101644197|NCT00919984|Paclitaxel|paclitaxel|mesh-list
101644198|NCT00919984|Carboplatin|carboplatin|mesh-list
101644199|NCT00919984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101644200|NCT00919984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101644201|NCT00919984|Tubulin Modulators|tubulin modulators|mesh-ancestor
101644202|NCT00919984|Antimitotic Agents|antimitotic agents|mesh-ancestor
101644203|NCT00919984|Mitosis Modulators|mitosis modulators|mesh-ancestor
101644204|NCT00919984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644205|NCT00942422|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
101644206|NCT00942422|Antioxidants|antioxidants|mesh-ancestor
101644207|NCT00942422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644208|NCT00942422|Protective Agents|protective agents|mesh-ancestor
101644209|NCT00942422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644210|NCT00942422|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101644211|NCT00942422|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101644212|NCT00942422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101644213|NCT00942422|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101644214|NCT05380934|Methotrexate|methotrexate|mesh-list
101644215|NCT05380934|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101596496|NCT04586920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596497|NCT04586920|Antifungal Agents|antifungal agents|mesh-ancestor
101596498|NCT04586920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101596499|NCT04586920|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101596500|NCT04586920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101596501|NCT04586920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101596502|NCT04586920|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101596503|NCT04586920|Hormone Antagonists|hormone antagonists|mesh-ancestor
101596504|NCT04586920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101596505|NCT04586920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101596506|NCT02758990|Vitamin D|vitamin d|mesh-list
101596507|NCT02758990|Cholecalciferol|cholecalciferol|mesh-list
101596508|NCT02758990|Vitamins|vitamins|mesh-list
101596509|NCT02758990|Ascorbic Acid|ascorbic acid|mesh-list
101596510|NCT02758990|Vitamin E|vitamin e|mesh-list
101644216|NCT05380934|Abortifacient Agents|abortifacient agents|mesh-ancestor
101644217|NCT05380934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101644218|NCT05380934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644219|NCT05380934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101644220|NCT05380934|Antimetabolites|antimetabolites|mesh-ancestor
101644221|NCT05380934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644222|NCT05380934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101644223|NCT05380934|Dermatologic Agents|dermatologic agents|mesh-ancestor
101644224|NCT05380934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101644225|NCT05380934|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101644226|NCT05380934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101644227|NCT05380934|Immunologic Factors|immunologic factors|mesh-ancestor
101644228|NCT05380934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101356971|NCT00063453|Vitamins|vitamins|mesh-list
101644229|NCT05380934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101644230|NCT00603824|PENTA|penta|mesh-list
101644231|NCT00603824|Lepirudin|lepirudin|mesh-list
101644232|NCT00603824|Fondaparinux|fondaparinux|mesh-list
101644233|NCT00603824|Argatroban|argatroban|mesh-list
101644234|NCT00603824|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101644235|NCT00603824|Antithrombins|antithrombins|mesh-ancestor
101644236|NCT00603824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101644237|NCT00603824|Protease Inhibitors|protease inhibitors|mesh-ancestor
101644238|NCT00603824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101644239|NCT00603824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644241|NCT00603824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101644242|NCT00603824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101644243|NCT00603824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101644244|NCT00677833|Azithromycin|azithromycin|mesh-list
101644245|NCT00677833|Chloroquine|chloroquine|mesh-list
101644246|NCT00677833|Lumefantrine|lumefantrine|mesh-list
101644247|NCT00677833|Artemether|artemether|mesh-list
101644248|NCT00677833|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101644249|NCT00677833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101644250|NCT00677833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101644251|NCT00677833|Amebicides|amebicides|mesh-ancestor
101644252|NCT00677833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101644253|NCT00677833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101644254|NCT00677833|Antimalarials|antimalarials|mesh-ancestor
101644255|NCT00677833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101644256|NCT05086874|3-n-butylphthalide|3-n-butylphthalide|mesh-list
101644257|NCT05086874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101644258|NCT05086874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101644259|NCT05086874|Protective Agents|protective agents|mesh-ancestor
101644260|NCT05086874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644261|NCT02585674|Insulin Glargine|insulin glargine|mesh-list
101644262|NCT02585674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101596512|NCT02758990|Vitamin A|vitamin a|mesh-list
101596513|NCT02758990|Niacinamide|niacinamide|mesh-list
101596514|NCT02758990|Niacin|niacin|mesh-list
101596515|NCT02758990|Nicotinic Acids|nicotinic acids|mesh-list
101596516|NCT02758990|Pyridoxine|pyridoxine|mesh-list
101596517|NCT02758990|Pyridoxal|pyridoxal|mesh-list
101596518|NCT02758990|Vitamin B 6|vitamin b 6|mesh-list
101596519|NCT02758990|Caffeine|caffeine|mesh-list
101596520|NCT02758990|Micronutrients|micronutrients|mesh-ancestor
101596521|NCT02758990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596522|NCT02758990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101596523|NCT02758990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101596524|NCT02758990|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101596525|NCT02758990|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101644263|NCT02585674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644264|NCT00942266|Calcium, Dietary|calcium, dietary|mesh-list
101644265|NCT00942266|Leucovorin|leucovorin|mesh-list
101644266|NCT00942266|Fluorouracil|fluorouracil|mesh-list
101644267|NCT00942266|Vorinostat|vorinostat|mesh-list
101644268|NCT00942266|Calcium|calcium|mesh-list
101644269|NCT00942266|Levoleucovorin|levoleucovorin|mesh-list
101644270|NCT00942266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101644271|NCT00942266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644272|NCT00942266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101644273|NCT00942266|Antimetabolites|antimetabolites|mesh-ancestor
101644274|NCT00942266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644275|NCT00942266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101644276|NCT00942266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101644277|NCT00942266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101644278|NCT00942266|Immunologic Factors|immunologic factors|mesh-ancestor
101644279|NCT00942266|Antidotes|antidotes|mesh-ancestor
101644280|NCT00942266|Protective Agents|protective agents|mesh-ancestor
101644281|NCT00942266|Vitamin B Complex|vitamin b complex|mesh-ancestor
101644282|NCT00942266|Vitamins|vitamins|mesh-ancestor
101644283|NCT00942266|Micronutrients|micronutrients|mesh-ancestor
101644284|NCT00942266|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101644285|NCT00942266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101644286|NCT05382182|Androgens|androgens|mesh-list
101644287|NCT05382182|Hormones|hormones|mesh-ancestor
101644288|NCT05382182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101644289|NCT05382182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644291|NCT04079374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101644292|NCT04079374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101644293|NCT04079374|Analgesics|analgesics|mesh-ancestor
101644294|NCT04079374|Sensory System Agents|sensory system agents|mesh-ancestor
101644295|NCT04079374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101644296|NCT04079374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644297|NCT04079374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101644298|NCT04079374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101644299|NCT04079374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101644300|NCT04079374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101644301|NCT04079374|Immunologic Factors|immunologic factors|mesh-ancestor
101644302|NCT00673231|Dapagliflozin|dapagliflozin|mesh-list
101644303|NCT00673231|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101644304|NCT00673231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644305|NCT00673231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101644306|NCT00673231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644307|NCT02583958|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101644308|NCT02583958|Laxatives|laxatives|mesh-ancestor
101644309|NCT02583958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101644310|NCT00604058|Vaccines|vaccines|mesh-list
101644311|NCT00604058|Immunologic Factors|immunologic factors|mesh-ancestor
101644312|NCT00604058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596526|NCT02758990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101596527|NCT02758990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596528|NCT02758990|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101596529|NCT02758990|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101596530|NCT02758990|Purinergic Agents|purinergic agents|mesh-ancestor
101596531|NCT02758990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101596532|NCT02758990|Antioxidants|antioxidants|mesh-ancestor
101596533|NCT02758990|Protective Agents|protective agents|mesh-ancestor
101596534|NCT02758990|Vitamin B Complex|vitamin b complex|mesh-ancestor
101596535|NCT02758990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101253493|NCT01943825|Vaccines|vaccines|mesh-list
101596536|NCT02758990|Antimetabolites|antimetabolites|mesh-ancestor
101596537|NCT02758990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101596538|NCT02758990|Vasodilator Agents|vasodilator agents|mesh-ancestor
101596539|NCT02756104|Vitamin D|vitamin d|mesh-list
101596540|NCT02756104|Vitamins|vitamins|mesh-ancestor
101357089|NCT02967432|Emollients|emollients|mesh-ancestor
101596541|NCT02756104|Micronutrients|micronutrients|mesh-ancestor
101596542|NCT02756104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596543|NCT02756104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101596544|NCT02756026|Micronutrients|micronutrients|mesh-list
101596545|NCT02756026|Trace Elements|trace elements|mesh-list
101596546|NCT02756026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596547|NCT02755714|Bromides|bromides|mesh-list
101596548|NCT02755714|Ipratropium|ipratropium|mesh-list
101596549|NCT02755714|Anticonvulsants|anticonvulsants|mesh-ancestor
101596550|NCT02755714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101596551|NCT02755714|Autonomic Agents|autonomic agents|mesh-ancestor
101596552|NCT02755714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101596553|NCT02755714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596554|NCT02755714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101596555|NCT02755714|Respiratory System Agents|respiratory system agents|mesh-ancestor
101596556|NCT02755714|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101596557|NCT02755714|Cholinergic Agents|cholinergic agents|mesh-ancestor
101596558|NCT02755714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101596559|NCT02755714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596560|NCT02758522|Insulin|insulin|mesh-list
101596561|NCT02758522|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101644313|NCT02852798|Docetaxel|docetaxel|mesh-list
101301392|NCT03679949|Oxycodone|oxycodone|mesh-list
101644314|NCT02852798|Apatinib|apatinib|mesh-list
101644315|NCT02852798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101596562|NCT02758522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101596563|NCT02758522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596564|NCT00942357|Paclitaxel|paclitaxel|mesh-list
101596565|NCT00942357|Cisplatin|cisplatin|mesh-list
101596566|NCT00942357|Carboplatin|carboplatin|mesh-list
101357149|NCT00037115|Antiemetics|antiemetics|mesh-ancestor
101596567|NCT00942357|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101596568|NCT00942357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101596569|NCT00942357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101596570|NCT00942357|Tubulin Modulators|tubulin modulators|mesh-ancestor
101596571|NCT00942357|Antimitotic Agents|antimitotic agents|mesh-ancestor
101596572|NCT00942357|Mitosis Modulators|mitosis modulators|mesh-ancestor
101596573|NCT00942357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596574|NCT02752828|Insulin|insulin|mesh-list
101596575|NCT02752828|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101596576|NCT02752828|Insulin Glargine|insulin glargine|mesh-list
101596577|NCT02752828|Lixisenatide|lixisenatide|mesh-list
101596578|NCT02752828|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101596579|NCT02752828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596580|NCT02753062|Rituximab|rituximab|mesh-list
101596581|NCT02753062|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101596582|NCT02753062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101596583|NCT02753062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101596584|NCT02753062|Immunologic Factors|immunologic factors|mesh-ancestor
101596585|NCT02753062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596586|NCT02753062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101596587|NCT02753062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101596588|NCT02753062|Alkylating Agents|alkylating agents|mesh-ancestor
101596589|NCT02753062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596590|NCT02752204|Rituximab|rituximab|mesh-list
101596591|NCT02752204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101596592|NCT02752204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101596593|NCT02752204|Immunologic Factors|immunologic factors|mesh-ancestor
101596594|NCT02752204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596595|NCT02752204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101596603|NCT04220632|Prednisolone|prednisolone|mesh-list
101596604|NCT04220632|Prednisolone acetate|prednisolone acetate|mesh-list
101596605|NCT04220632|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101596606|NCT04220632|Prednisolone phosphate|prednisolone phosphate|mesh-list
101596607|NCT04220632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101596608|NCT04220632|Glucocorticoids|glucocorticoids|mesh-ancestor
101596609|NCT04220632|Hormones|hormones|mesh-ancestor
101596610|NCT04220632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101596611|NCT04220632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596612|NCT04220632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101253552|NCT01828840|Respiratory System Agents|respiratory system agents|mesh-ancestor
101596613|NCT04220632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101596614|NCT04220632|Antiemetics|antiemetics|mesh-ancestor
101596615|NCT04220632|Autonomic Agents|autonomic agents|mesh-ancestor
101644316|NCT02852798|Tubulin Modulators|tubulin modulators|mesh-ancestor
101644317|NCT02852798|Antimitotic Agents|antimitotic agents|mesh-ancestor
101644318|NCT02852798|Mitosis Modulators|mitosis modulators|mesh-ancestor
101644319|NCT02852798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644320|NCT02852798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101644321|NCT02852798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101644322|NCT02586610|Pembrolizumab|pembrolizumab|mesh-list
101644323|NCT02586610|Capecitabine|capecitabine|mesh-list
101644324|NCT02586610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101644325|NCT02586610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101644326|NCT02586610|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101644327|NCT02586610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357209|NCT00037544|Factor VIII|factor viii|mesh-list
101644328|NCT02586610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101644329|NCT02586610|Antimetabolites|antimetabolites|mesh-ancestor
101644330|NCT00604682|Apremilast|apremilast|mesh-list
101644331|NCT00604682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101644332|NCT00604682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101644333|NCT00604682|Analgesics|analgesics|mesh-ancestor
101644334|NCT00604682|Sensory System Agents|sensory system agents|mesh-ancestor
101644335|NCT00604682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101644336|NCT00604682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644337|NCT00604682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101644338|NCT00604682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101644339|NCT00604682|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101644340|NCT00604682|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101644341|NCT00604682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101644342|NCT00604682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644343|NCT00672841|Antifungal Agents|antifungal agents|mesh-list
101644344|NCT00672841|Clotrimazole|clotrimazole|mesh-list
101644345|NCT00672841|Miconazole|miconazole|mesh-list
101644346|NCT00672841|Anidulafungin|anidulafungin|mesh-list
101644347|NCT00672841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101644348|NCT00672841|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101644349|NCT00672841|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101644350|NCT00672841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101644351|NCT00672841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101644352|NCT00672841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644353|NCT00672841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101357278|NCT00065169|Celecoxib|celecoxib|mesh-list
101644354|NCT00672841|Hormone Antagonists|hormone antagonists|mesh-ancestor
101644355|NCT00672841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101644356|NCT00672841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644357|NCT00672841|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101644358|NCT00672841|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101644359|NCT00920296|Cabotegravir|cabotegravir|mesh-list
101644360|NCT00920296|Etravirine|etravirine|mesh-list
101596616|NCT04220632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101596617|NCT04220632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101596618|NCT04220632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101596619|NCT04220632|Protective Agents|protective agents|mesh-ancestor
101596620|NCT00939627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101596622|NCT00939627|Sorafenib|sorafenib|mesh-list
101596623|NCT00939627|Antibodies|antibodies|mesh-list
101596624|NCT00939627|Immunoglobulins|immunoglobulins|mesh-list
101596625|NCT00939627|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101596626|NCT00939627|Immunologic Factors|immunologic factors|mesh-ancestor
101596627|NCT00939627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596628|NCT00939627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101596629|NCT00939627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101596630|NCT00939627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101596631|NCT00939627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596632|NCT05382741|Durvalumab|durvalumab|mesh-list
101596633|NCT05382741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101596634|NCT05382741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101596635|NCT04220476|Letrozole|letrozole|mesh-list
101596636|NCT04220476|Palbociclib|palbociclib|mesh-list
101596637|NCT04220476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101596638|NCT04220476|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101596639|NCT04220476|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101596640|NCT04220476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101596641|NCT04220476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596642|NCT04220476|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101596643|NCT04220476|Hormone Antagonists|hormone antagonists|mesh-ancestor
101596644|NCT04220476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101596645|NCT04220476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644361|NCT00920296|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101644362|NCT00920296|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101644363|NCT00920296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101644364|NCT00920296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644365|NCT00920296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101644366|NCT00920296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101644367|NCT00920296|Antiviral Agents|antiviral agents|mesh-ancestor
101644368|NCT00920296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101644369|NCT00920296|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101644370|NCT00920296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101644372|NCT04080388|Natriuretic Agents|natriuretic agents|mesh-ancestor
101644373|NCT04080388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644374|NCT00765115|N2-((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-L-alaninamide|n2-((2s)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-n1-((7s)-5-methyl-6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-l-alaninamide|mesh-list
101596646|NCT04220476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101596647|NCT02695810|Metformin|metformin|mesh-list
101596648|NCT02695810|Dapagliflozin|dapagliflozin|mesh-list
101596649|NCT02695810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101596650|NCT02695810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596651|NCT02695810|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101596652|NCT02695810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596653|NCT02753764|Prednisone|prednisone|mesh-list
101596654|NCT02753764|AZD7624|azd7624|mesh-list
101596655|NCT02753764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101596656|NCT02753764|Glucocorticoids|glucocorticoids|mesh-ancestor
101596657|NCT02753764|Hormones|hormones|mesh-ancestor
101596658|NCT02753764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101596659|NCT02753764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596660|NCT02753764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101596661|NCT02753764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101596662|NCT02753764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101596663|NCT02753764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101596664|NCT02753764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596665|NCT02695654|Clonidine|clonidine|mesh-list
101596666|NCT02695654|Levobupivacaine|levobupivacaine|mesh-list
101596667|NCT02695654|Analgesics|analgesics|mesh-ancestor
101596668|NCT02695654|Sensory System Agents|sensory system agents|mesh-ancestor
101644375|NCT00765115|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101644376|NCT00765115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101644377|NCT00765115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644378|NCT04080622|Selenium|selenium|mesh-list
101644379|NCT04080622|Antioxidants|antioxidants|mesh-ancestor
101644380|NCT04080622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644381|NCT04080622|Protective Agents|protective agents|mesh-ancestor
101644382|NCT04080622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644383|NCT04080622|Trace Elements|trace elements|mesh-ancestor
101644384|NCT04080622|Micronutrients|micronutrients|mesh-ancestor
101644385|NCT04079140|Dinoprostone|dinoprostone|mesh-list
101644386|NCT04079140|Oxytocics|oxytocics|mesh-ancestor
101644387|NCT04079140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101644388|NCT04079140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644390|NCT00673465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101644391|NCT00673465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333279|NCT01140516|Trimethoprim|trimethoprim|mesh-list
101644392|NCT00764413|Methylprednisolone|methylprednisolone|mesh-list
101644393|NCT00764413|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101644394|NCT00764413|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101644395|NCT00764413|Prednisolone|prednisolone|mesh-list
101644396|NCT00764413|Prednisolone acetate|prednisolone acetate|mesh-list
101644397|NCT00764413|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101644398|NCT00764413|Prednisolone phosphate|prednisolone phosphate|mesh-list
101644399|NCT00764413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101644400|NCT00764413|Antiemetics|antiemetics|mesh-ancestor
101644401|NCT00764413|Autonomic Agents|autonomic agents|mesh-ancestor
101644402|NCT00764413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101596669|NCT02695654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101596670|NCT02695654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596671|NCT02695654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101596672|NCT02695654|Sympatholytics|sympatholytics|mesh-ancestor
101596673|NCT02695654|Autonomic Agents|autonomic agents|mesh-ancestor
101596674|NCT02695654|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101596675|NCT02695654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101596676|NCT02695654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101596677|NCT02695654|Adrenergic Agents|adrenergic agents|mesh-ancestor
101596678|NCT02695654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101596679|NCT02695654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596680|NCT02695654|Anesthetics, Local|anesthetics, local|mesh-ancestor
101596681|NCT02695654|Anesthetics|anesthetics|mesh-ancestor
101596682|NCT02695654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101596683|NCT02696122|Anesthetics|anesthetics|mesh-list
101596684|NCT02696122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101596685|NCT02696122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596686|NCT01135511|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101596687|NCT01135511|Tofacitinib|tofacitinib|mesh-list
101596724|NCT05429554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596725|NCT05429554|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101596726|NCT05429554|Protease Inhibitors|protease inhibitors|mesh-ancestor
101596727|NCT05429554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101596728|NCT05429554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596729|NCT05429086|Propofol|propofol|mesh-list
101596730|NCT05429086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101596731|NCT05429086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101596732|NCT05429086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596733|NCT05429086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101596734|NCT05429086|Anesthetics, General|anesthetics, general|mesh-ancestor
101596735|NCT05429086|Anesthetics|anesthetics|mesh-ancestor
101596736|NCT00638248|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
101596737|NCT00638248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101596738|NCT00638248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101596739|NCT00638248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596740|NCT05422144|Anti-Infective Agents|anti-infective agents|mesh-list
101596741|NCT05422144|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101644403|NCT00764413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644404|NCT00764413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101644405|NCT00764413|Glucocorticoids|glucocorticoids|mesh-ancestor
101644406|NCT00764413|Hormones|hormones|mesh-ancestor
101644407|NCT00764413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101644408|NCT00764413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101644409|NCT00764413|Protective Agents|protective agents|mesh-ancestor
101644410|NCT00764413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101644411|NCT00764413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101644412|NCT00941798|Mometasone Furoate|mometasone furoate|mesh-list
101644413|NCT00941798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101644414|NCT00941798|Dermatologic Agents|dermatologic agents|mesh-ancestor
101644415|NCT00941798|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101644416|NCT00583102|Cytarabine|cytarabine|mesh-list
101644417|NCT00583102|Lovastatin|lovastatin|mesh-list
101644418|NCT00583102|L 647318|l 647318|mesh-list
101644419|NCT00583102|Dihydromevinolin|dihydromevinolin|mesh-list
101644420|NCT00583102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101644421|NCT00583102|Antimetabolites|antimetabolites|mesh-ancestor
101644422|NCT00583102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644423|NCT00583102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101644424|NCT00583102|Antiviral Agents|antiviral agents|mesh-ancestor
101644425|NCT00583102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101644426|NCT00583102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101644427|NCT00583102|Immunologic Factors|immunologic factors|mesh-ancestor
101644428|NCT00583102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644429|NCT00583102|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101644430|NCT00583102|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101644431|NCT00583102|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101644432|NCT00583102|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101644433|NCT00583102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101596754|NCT01184846|Immunoglobulins|immunoglobulins|mesh-list
101596755|NCT01184846|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101596756|NCT01184846|Antibodies|antibodies|mesh-list
101596757|NCT01184846|Immunologic Factors|immunologic factors|mesh-ancestor
101333292|NCT02347111|Flecainide|flecainide|mesh-list
101596758|NCT01184846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596759|NCT01191086|Topiramate|topiramate|mesh-list
101596760|NCT01191086|Anticonvulsants|anticonvulsants|mesh-ancestor
101596761|NCT01191086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101596762|NCT01191086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596763|NCT01076400|Topotecan|topotecan|mesh-list
101596764|NCT01076400|Adavosertib|adavosertib|mesh-list
101596765|NCT01076400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101596766|NCT01076400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101596767|NCT01076400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101596768|NCT01076400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101596769|NCT01076400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596806|NCT04115644|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101596807|NCT04115644|Ketorolac|ketorolac|mesh-list
101596808|NCT04115644|Bupivacaine|bupivacaine|mesh-list
101596809|NCT04115644|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101596810|NCT04115644|Anesthetics, Local|anesthetics, local|mesh-ancestor
101596811|NCT04115644|Anesthetics|anesthetics|mesh-ancestor
101596812|NCT04115644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101596813|NCT04115644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596814|NCT04115644|Sensory System Agents|sensory system agents|mesh-ancestor
101596815|NCT04115644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101596816|NCT04115644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101596817|NCT04115644|Glucocorticoids|glucocorticoids|mesh-ancestor
101596818|NCT04115644|Hormones|hormones|mesh-ancestor
101357704|NCT00070434|Leucovorin|leucovorin|mesh-list
101596819|NCT04115644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101596820|NCT04115644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101596821|NCT04115644|Immunologic Factors|immunologic factors|mesh-ancestor
101596822|NCT04115644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101596823|NCT04115644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596824|NCT04115644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101596825|NCT04115644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101596826|NCT04115644|Analgesics|analgesics|mesh-ancestor
101596827|NCT04115644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101644434|NCT02585440|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
101644435|NCT02585440|Antiviral Agents|antiviral agents|mesh-ancestor
101644436|NCT02585440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101644437|NCT02585440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101644438|NCT02585440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101644439|NCT00605930|Niacinamide|niacinamide|mesh-list
101644440|NCT00605930|Niacin|niacin|mesh-list
101644441|NCT00605930|Nicotinic Acids|nicotinic acids|mesh-list
101644442|NCT00605930|Vitamin B Complex|vitamin b complex|mesh-ancestor
101644443|NCT00605930|Vitamins|vitamins|mesh-ancestor
101644444|NCT00605930|Micronutrients|micronutrients|mesh-ancestor
101644445|NCT00605930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644446|NCT00605930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101644447|NCT00605930|Antimetabolites|antimetabolites|mesh-ancestor
101644448|NCT00605930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644449|NCT00605930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101644450|NCT00605930|Vasodilator Agents|vasodilator agents|mesh-ancestor
101644451|NCT04699630|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
101644452|NCT04699630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101644453|NCT04699630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101644454|NCT00602186|Prazosin|prazosin|mesh-list
101644455|NCT00602186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101644456|NCT00602186|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101644457|NCT00602186|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101644458|NCT00602186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101644459|NCT00602186|Adrenergic Agents|adrenergic agents|mesh-ancestor
101644460|NCT00602186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101644461|NCT00602186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644462|NCT00602186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301541|NCT03284502|Cetuximab|cetuximab|mesh-list
101596829|NCT00635986|Fentanyl|fentanyl|mesh-list
101596830|NCT00635986|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101596831|NCT00635986|Narcotics|narcotics|mesh-ancestor
101596832|NCT00635986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101596833|NCT00635986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596834|NCT00635986|Analgesics|analgesics|mesh-ancestor
101596835|NCT00635986|Sensory System Agents|sensory system agents|mesh-ancestor
101596836|NCT00635986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101596837|NCT00635986|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101253782|NCT00531232|Clofarabine|clofarabine|mesh-list
101596838|NCT00635986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101596839|NCT00635986|Anesthetics, General|anesthetics, general|mesh-ancestor
101596840|NCT00635986|Anesthetics|anesthetics|mesh-ancestor
101596841|NCT04799626|Levofloxacin|levofloxacin|mesh-list
101596842|NCT04799626|Meropenem|meropenem|mesh-list
101596843|NCT04799626|Tazobactam|tazobactam|mesh-list
101596844|NCT04799626|Piperacillin|piperacillin|mesh-list
101644463|NCT04204304|Isotretinoin|isotretinoin|mesh-list
101644464|NCT04204304|Dermatologic Agents|dermatologic agents|mesh-ancestor
101644465|NCT05380778|Anesthetics|anesthetics|mesh-list
101644466|NCT05380778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101644467|NCT05380778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644468|NCT02852720|Anesthetics|anesthetics|mesh-list
101644469|NCT02852720|Levobupivacaine|levobupivacaine|mesh-list
101644470|NCT02852720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101644471|NCT02852720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644472|NCT02852720|Anesthetics, Local|anesthetics, local|mesh-ancestor
101644473|NCT02852720|Sensory System Agents|sensory system agents|mesh-ancestor
101644474|NCT02852720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101644475|NCT05857631|Cisplatin|cisplatin|mesh-list
101644476|NCT05857631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101644477|NCT05857306|Olvanil|olvanil|mesh-list
101644478|NCT05857306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101644479|NCT05857306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101644480|NCT05857306|Analgesics|analgesics|mesh-ancestor
101644481|NCT05857306|Sensory System Agents|sensory system agents|mesh-ancestor
101644482|NCT05857306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101644483|NCT05857306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644484|NCT05857306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101644485|NCT05857306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101644486|NCT05857267|Timolol|timolol|mesh-list
101644487|NCT05857267|Dorzolamide|dorzolamide|mesh-list
101644488|NCT05857267|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101644489|NCT05857267|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101644490|NCT05857267|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101644491|NCT05857267|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101644492|NCT05857267|Adrenergic Agents|adrenergic agents|mesh-ancestor
101644493|NCT05857267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101644494|NCT05857267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644495|NCT05857267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644496|NCT05857267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101644497|NCT05857267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101644498|NCT05857267|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101644499|NCT05857267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101644500|NCT05857202|Analgesics, Opioid|analgesics, opioid|mesh-list
101644501|NCT05857202|Analgesics|analgesics|mesh-list
101644502|NCT05857202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
101644503|NCT05857202|Narcotics|narcotics|mesh-ancestor
101644504|NCT05857202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101644505|NCT05857202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596845|NCT04799626|Tigecycline|tigecycline|mesh-list
101596846|NCT04799626|Biapenem|biapenem|mesh-list
101596847|NCT04799626|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101596848|NCT04799626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101596849|NCT04799626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101596850|NCT04799626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101596851|NCT04799626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101596852|NCT04799626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101596853|NCT04799626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596854|NCT04799626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101596855|NCT04799626|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101596856|NCT04799626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101644506|NCT05857202|Sensory System Agents|sensory system agents|mesh-ancestor
101644507|NCT05857202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101644508|NCT05857085|Empagliflozin|empagliflozin|mesh-list
101644509|NCT05857085|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101644510|NCT05857085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644511|NCT05857085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101644512|NCT05857085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644514|NCT05857059|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101644515|NCT05857059|Abortifacient Agents|abortifacient agents|mesh-ancestor
101644516|NCT05857059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101644517|NCT05857059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644518|NCT05857059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101644519|NCT05857059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101644520|NCT05857059|Oxytocics|oxytocics|mesh-ancestor
101644521|NCT05857046|Melatonin|melatonin|mesh-list
101644522|NCT05857046|Antioxidants|antioxidants|mesh-ancestor
101644523|NCT05857046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644524|NCT05857046|Protective Agents|protective agents|mesh-ancestor
101644525|NCT05857046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644526|NCT05857046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101644527|NCT05856994|Tacrolimus|tacrolimus|mesh-list
101644528|NCT05856994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101644529|NCT05856994|Immunologic Factors|immunologic factors|mesh-ancestor
101644530|NCT05856994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644531|NCT05856994|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101644532|NCT05856994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101644533|NCT05856994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644534|NCT05856630|Goserelin|goserelin|mesh-list
101644535|NCT05856630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101644536|NCT05856630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101644537|NCT05856578|Canagliflozin|canagliflozin|mesh-list
101644538|NCT05856578|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101644539|NCT05856578|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101644540|NCT05856578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644541|NCT05856578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644542|NCT05856396|Vaccines|vaccines|mesh-list
101644543|NCT05856396|Immunologic Factors|immunologic factors|mesh-ancestor
101644544|NCT05856396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644545|NCT05856383|Vinorelbine|vinorelbine|mesh-list
101644546|NCT05856383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101644547|NCT05856383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101644548|NCT05856383|Tubulin Modulators|tubulin modulators|mesh-ancestor
101357991|NCT00067509|Progesterone|progesterone|mesh-list
101644549|NCT05856383|Antimitotic Agents|antimitotic agents|mesh-ancestor
101644550|NCT05856383|Mitosis Modulators|mitosis modulators|mesh-ancestor
101644551|NCT05856383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644552|NCT05856084|Vaccines|vaccines|mesh-list
101644553|NCT05856084|Immunologic Factors|immunologic factors|mesh-ancestor
101644554|NCT05856084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596857|NCT04799626|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101596858|NCT04799626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101596860|NCT00636064|Valdecoxib|valdecoxib|mesh-list
101596861|NCT00636064|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101596862|NCT00636064|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101596863|NCT00636064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101596864|NCT00636064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596865|NCT00636064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101596866|NCT00636064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101596867|NCT00636064|Analgesics|analgesics|mesh-ancestor
101596868|NCT00636064|Sensory System Agents|sensory system agents|mesh-ancestor
101596869|NCT00636064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101596870|NCT00636064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596871|NCT00636064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101644555|NCT05852132|Temazepam|temazepam|mesh-list
101644556|NCT05852132|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101644557|NCT05852132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101644558|NCT05852132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644559|NCT05852132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101644560|NCT05852132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101644561|NCT05852132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101644562|NCT05852132|GABA Modulators|gaba modulators|mesh-ancestor
101644563|NCT05852132|GABA Agents|gaba agents|mesh-ancestor
101644564|NCT05852132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101644565|NCT05852132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644566|NCT05851313|Vitamin D|vitamin d|mesh-list
101644567|NCT05851313|Vitamins|vitamins|mesh-ancestor
101644568|NCT05851313|Micronutrients|micronutrients|mesh-ancestor
101644569|NCT05851313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644570|NCT05851313|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101644571|NCT05850611|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101644573|NCT05850611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101644574|NCT05850611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644575|NCT05850611|Hemostatics|hemostatics|mesh-ancestor
101644576|NCT05850611|Coagulants|coagulants|mesh-ancestor
101644577|NCT05844813|Doxorubicin|doxorubicin|mesh-list
101644578|NCT05844813|Ifosfamide|ifosfamide|mesh-list
101644579|NCT05844813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101644580|NCT05844813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101644581|NCT05844813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101644582|NCT05844813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101644583|NCT05844813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101644584|NCT05844813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644585|NCT05844813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101644586|NCT05844813|Alkylating Agents|alkylating agents|mesh-ancestor
101644587|NCT05812417|DA-8010|da-8010|mesh-list
101644588|NCT05812417|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101644589|NCT05812417|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101644590|NCT05812417|Cholinergic Agents|cholinergic agents|mesh-ancestor
101644591|NCT05812417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101644592|NCT05812417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644593|NCT05812417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644594|NCT05790681|Insulin|insulin|mesh-list
101644595|NCT05790681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101644596|NCT05790681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644597|NCT05766540|Metformin|metformin|mesh-list
101644598|NCT05766540|Aripiprazole|aripiprazole|mesh-list
101644599|NCT05766540|Clozapine|clozapine|mesh-list
101644600|NCT05766540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101596872|NCT00636064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101596873|NCT02751034|Lidocaine|lidocaine|mesh-list
101596874|NCT02751034|Anesthetics, Local|anesthetics, local|mesh-ancestor
101596875|NCT02751034|Anesthetics|anesthetics|mesh-ancestor
101596876|NCT02751034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101596877|NCT02751034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596878|NCT02751034|Sensory System Agents|sensory system agents|mesh-ancestor
101596879|NCT02751034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101596880|NCT02751034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101596881|NCT02751034|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101596882|NCT02751034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101596883|NCT02751034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101596884|NCT02751034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596885|NCT04217668|Isosorbide|isosorbide|mesh-list
101596886|NCT04217668|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
101596887|NCT04217668|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
101644601|NCT05766540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644602|NCT05766540|Antidepressive Agents|antidepressive agents|mesh-ancestor
101644603|NCT05766540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101644604|NCT05766540|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101644605|NCT05766540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101644606|NCT05766540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101644607|NCT05766540|Dopamine Agonists|dopamine agonists|mesh-ancestor
101644608|NCT05766540|Dopamine Agents|dopamine agents|mesh-ancestor
101644609|NCT05766540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101644610|NCT05766540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644611|NCT05766540|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101644612|NCT05766540|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101301695|NCT02953509|Antimetabolites|antimetabolites|mesh-ancestor
101644613|NCT05766540|Serotonin Agents|serotonin agents|mesh-ancestor
101644614|NCT05766540|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101644615|NCT05766540|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101644616|NCT05766540|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101644617|NCT05766540|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101644618|NCT05766540|GABA Antagonists|gaba antagonists|mesh-ancestor
101644619|NCT05766540|GABA Agents|gaba agents|mesh-ancestor
101644620|NCT05765084|Pemetrexed|pemetrexed|mesh-list
101644621|NCT05765084|Atezolizumab|atezolizumab|mesh-list
101644622|NCT05765084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101644623|NCT05765084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101644624|NCT05765084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644625|NCT05765084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101644626|NCT05765084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101644627|NCT05765084|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101644628|NCT05765084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101644629|NCT05746806|Androgens|androgens|mesh-list
101644630|NCT05746806|Hormones|hormones|mesh-ancestor
101644631|NCT05746806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101644632|NCT05746806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644633|NCT05741229|Nitroglycerin|nitroglycerin|mesh-list
101644634|NCT05741229|Vasodilator Agents|vasodilator agents|mesh-ancestor
101644635|NCT05733715|Pembrolizumab|pembrolizumab|mesh-list
101644636|NCT05733715|Lenvatinib|lenvatinib|mesh-list
101644637|NCT05733715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101644638|NCT05733715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101644639|NCT05733715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101644640|NCT05733715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596888|NCT04217668|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101596890|NCT04217668|Natriuretic Agents|natriuretic agents|mesh-ancestor
101596891|NCT04217668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596892|NCT04217668|Vasodilator Agents|vasodilator agents|mesh-ancestor
101596893|NCT04217668|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101596894|NCT04217668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596895|NCT01127165|Zonisamide|zonisamide|mesh-list
101596896|NCT01127165|Anticonvulsants|anticonvulsants|mesh-ancestor
101596897|NCT01127165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101596898|NCT01127165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101358024|NCT00071253|Serotonin Agents|serotonin agents|mesh-ancestor
101596899|NCT01127165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596900|NCT01127165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101596901|NCT01127165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596902|NCT04335292|Pemetrexed|pemetrexed|mesh-list
101596903|NCT04335292|Osimertinib|osimertinib|mesh-list
101596904|NCT04335292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101596905|NCT04335292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101596906|NCT04335292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596907|NCT04335292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101596908|NCT04335292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101596909|NCT04335292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101596910|NCT04278508|Progesterone|progesterone|mesh-list
101596911|NCT04278508|Progestins|progestins|mesh-ancestor
101596912|NCT04278508|Hormones|hormones|mesh-ancestor
101596913|NCT04278508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101596914|NCT04278508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596915|NCT05382351|Tenofovir|tenofovir|mesh-list
101596916|NCT05382351|Entecavir|entecavir|mesh-list
101596917|NCT05382351|Antiviral Agents|antiviral agents|mesh-ancestor
101596918|NCT05382351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101596919|NCT05382351|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101644641|NCT05733715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101644642|NCT05733715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101644643|NCT05721755|Paclitaxel|paclitaxel|mesh-list
101644644|NCT05721755|Cisplatin|cisplatin|mesh-list
101644645|NCT05721755|Carboplatin|carboplatin|mesh-list
101644646|NCT05721755|Pembrolizumab|pembrolizumab|mesh-list
101644647|NCT05721755|Fluorouracil|fluorouracil|mesh-list
101644648|NCT05721755|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101644649|NCT05721755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101644650|NCT05721755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101644651|NCT05721755|Tubulin Modulators|tubulin modulators|mesh-ancestor
101596920|NCT05382351|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101596921|NCT05382351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101596922|NCT05382351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596923|NCT05382351|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101596924|NCT05382351|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101596925|NCT04218760|Isosorbide|isosorbide|mesh-list
101596926|NCT04218760|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
101596927|NCT04218760|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
101596928|NCT04218760|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101596929|NCT04218760|Diuretics|diuretics|mesh-ancestor
101596930|NCT04218760|Natriuretic Agents|natriuretic agents|mesh-ancestor
101596931|NCT04218760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596932|NCT04218760|Vasodilator Agents|vasodilator agents|mesh-ancestor
101596933|NCT04218760|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101596934|NCT04218760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596935|NCT02750254|Plerixafor|plerixafor|mesh-list
101596936|NCT02750254|Cyclophosphamide|cyclophosphamide|mesh-list
101596937|NCT02750254|Melphalan|melphalan|mesh-list
101596938|NCT02750254|Busulfan|busulfan|mesh-list
101596939|NCT02750254|Fludarabine|fludarabine|mesh-list
101596940|NCT02750254|Fludarabine phosphate|fludarabine phosphate|mesh-list
101596941|NCT02750254|Azacitidine|azacitidine|mesh-list
101596942|NCT02750254|Lenograstim|lenograstim|mesh-list
101596943|NCT02750254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101596944|NCT02750254|Immunologic Factors|immunologic factors|mesh-ancestor
101596945|NCT02750254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596946|NCT02750254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101596971|NCT00941655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101596972|NCT00941655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101596973|NCT00941655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101596974|NCT00941655|Antidotes|antidotes|mesh-ancestor
101596975|NCT00941655|Protective Agents|protective agents|mesh-ancestor
101596976|NCT00941655|Vitamin B Complex|vitamin b complex|mesh-ancestor
101596977|NCT00941655|Vitamins|vitamins|mesh-ancestor
101596978|NCT00941655|Micronutrients|micronutrients|mesh-ancestor
101596979|NCT00605787|1-(carboxymethylthio)tetradecane|1-(carboxymethylthio)tetradecane|mesh-list
101596980|NCT00605787|Antioxidants|antioxidants|mesh-ancestor
101596981|NCT00605787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333310|NCT00001280|Itraconazole|itraconazole|mesh-list
101596982|NCT00605787|Protective Agents|protective agents|mesh-ancestor
101596983|NCT00605787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101596984|NCT00605787|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101596985|NCT00936117|Posaconazole|posaconazole|mesh-list
101596986|NCT00936117|Antifungal Agents|antifungal agents|mesh-ancestor
101596987|NCT00936117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101253933|NCT01695109|Liraglutide|liraglutide|mesh-list
101596988|NCT00936117|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101596989|NCT00936117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101596990|NCT00936117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101596991|NCT00936117|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101596992|NCT00936117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101596993|NCT00936117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101596994|NCT00936117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101596995|NCT00936117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101596996|NCT00936117|Hormone Antagonists|hormone antagonists|mesh-ancestor
101596997|NCT00936117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101596998|NCT00936117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597000|NCT04267653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101597001|NCT04088500|Nivolumab|nivolumab|mesh-list
101597002|NCT04088500|Ipilimumab|ipilimumab|mesh-list
101644652|NCT05721755|Antimitotic Agents|antimitotic agents|mesh-ancestor
101644653|NCT05721755|Mitosis Modulators|mitosis modulators|mesh-ancestor
101644654|NCT05721755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644655|NCT05721755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101644656|NCT05721755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101644657|NCT05721755|Antimetabolites|antimetabolites|mesh-ancestor
101597003|NCT04088500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101597004|NCT04088500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101597005|NCT04088500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101597006|NCT04088500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597007|NCT01082874|Clonidine|clonidine|mesh-list
101597008|NCT01082874|Analgesics|analgesics|mesh-ancestor
101597009|NCT01082874|Sensory System Agents|sensory system agents|mesh-ancestor
101597010|NCT01082874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101597011|NCT01082874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597012|NCT01082874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597013|NCT01082874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101597014|NCT01082874|Sympatholytics|sympatholytics|mesh-ancestor
101644658|NCT05721755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101644659|NCT05721755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101644660|NCT05721755|Immunologic Factors|immunologic factors|mesh-ancestor
101644661|NCT05721755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644662|NCT05700422|Varenicline|varenicline|mesh-list
101644663|NCT05700422|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101644664|NCT05700422|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101644665|NCT05700422|Cholinergic Agents|cholinergic agents|mesh-ancestor
101644666|NCT05700422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101644667|NCT05700422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644668|NCT05700422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644670|NCT05678647|Trace Elements|trace elements|mesh-ancestor
101644671|NCT05678647|Micronutrients|micronutrients|mesh-ancestor
101644672|NCT05678647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644673|NCT05639907|Ethanol|ethanol|mesh-list
101644674|NCT05639907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101644675|NCT05639907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101644676|NCT05639907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101644677|NCT05639907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644678|NCT05625334|Aspirin|aspirin|mesh-list
101644679|NCT05625334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101644680|NCT05625334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101644681|NCT05625334|Analgesics|analgesics|mesh-ancestor
101644682|NCT05625334|Sensory System Agents|sensory system agents|mesh-ancestor
101644683|NCT05625334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101644684|NCT05625334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644685|NCT05625334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101644686|NCT05625334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101644687|NCT05625334|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101644688|NCT05625334|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101644689|NCT05625334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644690|NCT05625334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101644691|NCT05625334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101644692|NCT05625334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101644693|NCT05625334|Antipyretics|antipyretics|mesh-ancestor
101644694|NCT05615636|Lenalidomide|lenalidomide|mesh-list
101644695|NCT05615636|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
101644696|NCT05615636|Immunologic Factors|immunologic factors|mesh-ancestor
101644697|NCT05615636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644698|NCT05615636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101644699|NCT05615636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101644700|NCT05615636|Growth Substances|growth substances|mesh-ancestor
101644701|NCT05615636|Growth Inhibitors|growth inhibitors|mesh-ancestor
101644702|NCT05615636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101644703|NCT05615636|Immunoconjugates|immunoconjugates|mesh-ancestor
101644704|NCT05614115|Empagliflozin|empagliflozin|mesh-list
101644705|NCT05614115|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101644706|NCT05614115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597015|NCT01082874|Autonomic Agents|autonomic agents|mesh-ancestor
101597016|NCT01082874|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101597017|NCT01082874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101597018|NCT01082874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101597019|NCT01082874|Adrenergic Agents|adrenergic agents|mesh-ancestor
101597020|NCT01082874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101597021|NCT00607503|Terbutaline|terbutaline|mesh-list
101597022|NCT00607503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101597023|NCT00607503|Autonomic Agents|autonomic agents|mesh-ancestor
101597024|NCT00607503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101597025|NCT00607503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597026|NCT00607503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101597027|NCT00607503|Respiratory System Agents|respiratory system agents|mesh-ancestor
101597028|NCT00607503|Sympathomimetics|sympathomimetics|mesh-ancestor
101597029|NCT00607503|Tocolytic Agents|tocolytic agents|mesh-ancestor
101597030|NCT00607503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101597031|NCT00607503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101597032|NCT00607503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101597033|NCT00607503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101597034|NCT00607503|Adrenergic Agents|adrenergic agents|mesh-ancestor
101597035|NCT00607503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101597036|NCT00607503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644707|NCT05614115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101644708|NCT05614115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644709|NCT05604794|Ketamine|ketamine|mesh-list
101644710|NCT05604794|Analgesics|analgesics|mesh-ancestor
101644711|NCT05604794|Sensory System Agents|sensory system agents|mesh-ancestor
101358061|NCT00071331|Tolvaptan|tolvaptan|mesh-list
101644712|NCT05604794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101644713|NCT05604794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644714|NCT05604794|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101644715|NCT05604794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101644716|NCT05604794|Anesthetics, General|anesthetics, general|mesh-ancestor
101644717|NCT05604794|Anesthetics|anesthetics|mesh-ancestor
101644718|NCT05604794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101644719|NCT05604794|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101644720|NCT05604794|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101644721|NCT05604794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101644722|NCT05604794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644723|NCT05589688|Acyclovir|acyclovir|mesh-list
101644724|NCT05589688|Antiviral Agents|antiviral agents|mesh-ancestor
101644725|NCT05589688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101644726|NCT05564598|Valganciclovir|valganciclovir|mesh-list
101644727|NCT05564598|Ganciclovir|ganciclovir|mesh-list
101644728|NCT05564598|Antiviral Agents|antiviral agents|mesh-list
101644729|NCT05564598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101644730|NCT05551936|Rituximab|rituximab|mesh-list
101644731|NCT05551936|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101644732|NCT05551936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101644733|NCT05551936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101644734|NCT05551936|Immunologic Factors|immunologic factors|mesh-ancestor
101644735|NCT05551936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644736|NCT05551936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101597037|NCT04217512|Pantoprazole|pantoprazole|mesh-list
101597038|NCT04217512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101597039|NCT04217512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101597040|NCT04217512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101597041|NCT04217512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101597042|NCT04217512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597043|NCT01079988|Cyclosporine|cyclosporine|mesh-list
101597044|NCT01079988|Methotrexate|methotrexate|mesh-list
101597045|NCT01079988|Cyclosporins|cyclosporins|mesh-list
101597046|NCT01079988|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101597047|NCT01079988|Abortifacient Agents|abortifacient agents|mesh-ancestor
101597048|NCT01079988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101597049|NCT01079988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597050|NCT01079988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101597051|NCT01079988|Antimetabolites|antimetabolites|mesh-ancestor
101597052|NCT01079988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597053|NCT01079988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101597054|NCT01079988|Dermatologic Agents|dermatologic agents|mesh-ancestor
101597055|NCT01079988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101597056|NCT01079988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101597057|NCT01079988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101597058|NCT01079988|Immunologic Factors|immunologic factors|mesh-ancestor
101597059|NCT01079988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101597060|NCT01079988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101597064|NCT03974152|Nicotine|nicotine|mesh-list
101597087|NCT03508570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597088|NCT01074216|Vitamin D|vitamin d|mesh-list
101597089|NCT01074216|Ergocalciferols|ergocalciferols|mesh-list
101597090|NCT01074216|Cholecalciferol|cholecalciferol|mesh-list
101597091|NCT01074216|Vitamins|vitamins|mesh-list
101597092|NCT01074216|Micronutrients|micronutrients|mesh-ancestor
101597093|NCT01074216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597094|NCT01074216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101597095|NCT01074216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101597096|NCT00636142|Infliximab|infliximab|mesh-list
101597097|NCT00636142|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101597098|NCT00636142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101597099|NCT00636142|Dermatologic Agents|dermatologic agents|mesh-ancestor
101597100|NCT00636142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101597101|NCT00636142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101597102|NCT02499562|Entecavir|entecavir|mesh-list
101597103|NCT02499562|Antiviral Agents|antiviral agents|mesh-ancestor
101597104|NCT02499562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101597105|NCT04304430|Dapagliflozin|dapagliflozin|mesh-list
101597106|NCT04304430|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
101597107|NCT04304430|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101597108|NCT04304430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597109|NCT04304430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101597110|NCT04304430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597111|NCT04304430|Protease Inhibitors|protease inhibitors|mesh-ancestor
101597112|NCT04304430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101597113|NCT02875002|Belinostat|belinostat|mesh-list
101597114|NCT02875002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101597115|NCT02875002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101597116|NCT02875002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101597130|NCT02749162|Lidocaine|lidocaine|mesh-list
101597134|NCT02749162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101597135|NCT02749162|Antiemetics|antiemetics|mesh-ancestor
101597136|NCT02749162|Autonomic Agents|autonomic agents|mesh-ancestor
101254085|NCT01696552|Cimetidine|cimetidine|mesh-list
101597137|NCT02749162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101597138|NCT02749162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597139|NCT02749162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101597140|NCT02749162|Glucocorticoids|glucocorticoids|mesh-ancestor
101597141|NCT02749162|Hormones|hormones|mesh-ancestor
101597142|NCT02749162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101597143|NCT02749162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101597196|NCT02751268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101597197|NCT02751268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597198|NCT02751268|Sensory System Agents|sensory system agents|mesh-ancestor
101597199|NCT02751268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101597200|NCT02748772|Thalidomide|thalidomide|mesh-list
101597201|NCT02748772|Endostar protein|endostar protein|mesh-list
101597202|NCT02748772|Endostatins|endostatins|mesh-list
101644737|NCT05551936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101644738|NCT05551936|Alkylating Agents|alkylating agents|mesh-ancestor
101644739|NCT05551936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644740|NCT05542134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
101644741|NCT05419089|Cisplatin|cisplatin|mesh-list
101644742|NCT05419089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101644743|NCT05366829|Tislelizumab|tislelizumab|mesh-list
101644744|NCT05366829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101644745|NCT05366829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101644746|NCT05305248|Dexmedetomidine|dexmedetomidine|mesh-list
101644747|NCT05305248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101644748|NCT05305248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101644749|NCT05305248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644750|NCT05305248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101644751|NCT05305248|Analgesics|analgesics|mesh-ancestor
101644752|NCT05305248|Sensory System Agents|sensory system agents|mesh-ancestor
101644753|NCT05305248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101644754|NCT05305248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101644755|NCT05305248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101644756|NCT05305248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101644757|NCT05305248|Adrenergic Agents|adrenergic agents|mesh-ancestor
101644758|NCT05305248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101644759|NCT05305248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644760|NCT05286996|Anesthetics|anesthetics|mesh-list
101644761|NCT05286996|Anesthetics, Local|anesthetics, local|mesh-list
101644762|NCT05286996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101644763|NCT05286996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644764|NCT05286996|Sensory System Agents|sensory system agents|mesh-ancestor
101644765|NCT05286996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101644767|NCT05248984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101644768|NCT05248984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101644769|NCT05248984|Analgesics|analgesics|mesh-ancestor
101644770|NCT05248984|Sensory System Agents|sensory system agents|mesh-ancestor
101358093|NCT02599324|Docetaxel|docetaxel|mesh-list
101644771|NCT05248984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101644772|NCT05248984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644773|NCT05248984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101644774|NCT05248984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101644775|NCT05248984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101644776|NCT05248984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101644777|NCT05248984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644778|NCT05210166|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
101644779|NCT05210166|Antioxidants|antioxidants|mesh-ancestor
101644780|NCT05210166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644781|NCT05210166|Protective Agents|protective agents|mesh-ancestor
101644782|NCT05210166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644783|NCT05210166|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101644784|NCT05210166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101644785|NCT05169593|Adalimumab|adalimumab|mesh-list
101644786|NCT05169593|Infliximab|infliximab|mesh-list
101644787|NCT05169593|Ustekinumab|ustekinumab|mesh-list
101644788|NCT05169593|Vedolizumab|vedolizumab|mesh-list
101644789|NCT05169593|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101644790|NCT05169593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101644791|NCT05169593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101644792|NCT05169593|Dermatologic Agents|dermatologic agents|mesh-ancestor
101644793|NCT05169593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101644794|NCT05158153|Furosemide|furosemide|mesh-list
101644795|NCT05158153|Diuretics|diuretics|mesh-ancestor
101597203|NCT02748772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101597204|NCT02748772|Immunologic Factors|immunologic factors|mesh-ancestor
101597205|NCT02748772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597206|NCT02748772|Leprostatic Agents|leprostatic agents|mesh-ancestor
101597207|NCT02748772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101597208|NCT02748772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101597209|NCT02748772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101597210|NCT02748772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101597211|NCT02748772|Growth Substances|growth substances|mesh-ancestor
101597212|NCT02748772|Growth Inhibitors|growth inhibitors|mesh-ancestor
101254157|NCT01697020|Mercaptopurine|mercaptopurine|mesh-list
101597213|NCT02748772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101597214|NCT04216888|Ketamine|ketamine|mesh-list
101597216|NCT04216888|Sensory System Agents|sensory system agents|mesh-ancestor
101597217|NCT04216888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101597218|NCT04216888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597219|NCT04216888|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101597220|NCT04216888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101597221|NCT04216888|Anesthetics, General|anesthetics, general|mesh-ancestor
101597222|NCT04216888|Anesthetics|anesthetics|mesh-ancestor
101597258|NCT02746276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101597259|NCT02746276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101597260|NCT02746276|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101597261|NCT02746276|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101597262|NCT02745886|Metformin|metformin|mesh-list
101597263|NCT02745886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101597264|NCT02745886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597265|NCT02742142|Fluorides|fluorides|mesh-list
101597266|NCT02742142|Cariostatic Agents|cariostatic agents|mesh-ancestor
101597267|NCT02742142|Protective Agents|protective agents|mesh-ancestor
101597268|NCT02742142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597269|NCT00636298|Bevacizumab|bevacizumab|mesh-list
101597270|NCT00636298|Cetuximab|cetuximab|mesh-list
101597271|NCT00636298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101597272|NCT00636298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101597273|NCT00636298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101597274|NCT00636298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101597275|NCT00636298|Growth Substances|growth substances|mesh-ancestor
101358105|NCT02599324|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101597276|NCT00636298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597277|NCT00636298|Growth Inhibitors|growth inhibitors|mesh-ancestor
101597278|NCT02744716|Aspirin|aspirin|mesh-list
101597279|NCT02744716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101644796|NCT05158153|Natriuretic Agents|natriuretic agents|mesh-ancestor
101644797|NCT05158153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644798|NCT05158153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101644799|NCT05158153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101644800|NCT05158153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644801|NCT05148234|Decitabine|decitabine|mesh-list
101644802|NCT05148234|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
101644803|NCT05148234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101644804|NCT05148234|Antimetabolites|antimetabolites|mesh-ancestor
101644805|NCT05148234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644806|NCT05148234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101644807|NCT05148234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101644808|NCT05147558|Pembrolizumab|pembrolizumab|mesh-list
101644809|NCT05147558|Lenvatinib|lenvatinib|mesh-list
101644810|NCT05147558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101644811|NCT05147558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101644812|NCT05147558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101644813|NCT05147558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644814|NCT05147558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101644815|NCT05147558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101644816|NCT05110001|Chlorhexidine|chlorhexidine|mesh-list
101644817|NCT05110001|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101644818|NCT05110001|Natamycin|natamycin|mesh-list
101644819|NCT05110001|Moxifloxacin|moxifloxacin|mesh-list
101644820|NCT05110001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101644821|NCT05110001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101644822|NCT05110001|Disinfectants|disinfectants|mesh-ancestor
101644823|NCT05110001|Dermatologic Agents|dermatologic agents|mesh-ancestor
101644824|NCT05110001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101644825|NCT05110001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101644826|NCT05110001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101597280|NCT02744716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101597281|NCT02744716|Analgesics|analgesics|mesh-ancestor
101597282|NCT02744716|Sensory System Agents|sensory system agents|mesh-ancestor
101597283|NCT02744716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101597284|NCT02744716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597285|NCT02744716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101597286|NCT02744716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101597287|NCT02744716|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101597288|NCT02744716|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101597289|NCT02744716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597290|NCT02744716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101597291|NCT02744716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101597292|NCT02744716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101597293|NCT02744716|Antipyretics|antipyretics|mesh-ancestor
101597294|NCT02744872|Felodipine|felodipine|mesh-list
101597295|NCT02744872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101597296|NCT02744872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101597297|NCT02744872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101597298|NCT02744872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101597299|NCT02744872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597300|NCT02744872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101597301|NCT02744872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597302|NCT02744872|Vasodilator Agents|vasodilator agents|mesh-ancestor
101597303|NCT02744638|Metronidazole|metronidazole|mesh-list
101597304|NCT02744638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101597305|NCT02744638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101597306|NCT02744638|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101597307|NCT02744638|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101597308|NCT02740894|Gefitinib|gefitinib|mesh-list
101597309|NCT02740894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101597310|NCT02740894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101597311|NCT02740894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101597312|NCT02740894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597313|NCT00857389|Cyclophosphamide|cyclophosphamide|mesh-list
101597314|NCT00857389|Busulfan|busulfan|mesh-list
101597315|NCT00857389|Thiotepa|thiotepa|mesh-list
101644827|NCT05110001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101597316|NCT00857389|Methotrexate|methotrexate|mesh-list
101597317|NCT00857389|Clofarabine|clofarabine|mesh-list
101597318|NCT00857389|Tacrolimus|tacrolimus|mesh-list
101597319|NCT00857389|Thymoglobulin|thymoglobulin|mesh-list
101597320|NCT00857389|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101597321|NCT00857389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101597322|NCT00857389|Immunologic Factors|immunologic factors|mesh-ancestor
101597323|NCT00857389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597324|NCT00857389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101597325|NCT00857389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101597326|NCT00857389|Alkylating Agents|alkylating agents|mesh-ancestor
101597327|NCT00857389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597328|NCT00857389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101597329|NCT00857389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101597330|NCT00857389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101597331|NCT00857389|Abortifacient Agents|abortifacient agents|mesh-ancestor
101597332|NCT00857389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101597333|NCT00857389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101597334|NCT00857389|Antimetabolites|antimetabolites|mesh-ancestor
101597335|NCT00857389|Dermatologic Agents|dermatologic agents|mesh-ancestor
101644828|NCT05110001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644829|NCT05110001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101644830|NCT05110001|Antifungal Agents|antifungal agents|mesh-ancestor
101644831|NCT05098366|Furosemide|furosemide|mesh-list
101644832|NCT05098366|Diuretics|diuretics|mesh-ancestor
101644833|NCT05098366|Natriuretic Agents|natriuretic agents|mesh-ancestor
101644834|NCT05098366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644835|NCT05098366|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101644836|NCT05098366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101644837|NCT05098366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644838|NCT05082480|Hyaluronic Acid|hyaluronic acid|mesh-list
101644839|NCT05082480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101644840|NCT05082480|Immunologic Factors|immunologic factors|mesh-ancestor
101644841|NCT05082480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644842|NCT05082480|Viscosupplements|viscosupplements|mesh-ancestor
101644843|NCT05082480|Protective Agents|protective agents|mesh-ancestor
101644845|NCT05073250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101644846|NCT05073250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101644847|NCT05073250|Immunologic Factors|immunologic factors|mesh-ancestor
101644848|NCT05073250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644849|NCT05073250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101644850|NCT05041270|Dexmedetomidine|dexmedetomidine|mesh-list
101644851|NCT05041270|Nalbuphine|nalbuphine|mesh-list
101644852|NCT05041270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101644853|NCT05041270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101644854|NCT05041270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644855|NCT05041270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101644856|NCT05041270|Analgesics|analgesics|mesh-ancestor
101644857|NCT05041270|Sensory System Agents|sensory system agents|mesh-ancestor
101644858|NCT05041270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101644859|NCT05041270|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101644860|NCT05041270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101597336|NCT00857389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101597337|NCT00857389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101597338|NCT00857389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101597339|NCT00857389|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101597340|NCT02744482|Risedronic Acid|risedronic acid|mesh-list
101597341|NCT02744482|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101597342|NCT02744482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101597343|NCT02744482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597344|NCT02744482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101597345|NCT02744482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597346|NCT02744482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101597347|NCT01071798|Rituximab|rituximab|mesh-list
101597348|NCT01071798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101644861|NCT05041270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101644862|NCT05041270|Adrenergic Agents|adrenergic agents|mesh-ancestor
101644863|NCT05041270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101644864|NCT05041270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644865|NCT05041270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101644866|NCT05041270|Narcotics|narcotics|mesh-ancestor
101644867|NCT05039736|Nivolumab|nivolumab|mesh-list
101644868|NCT05039736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101644869|NCT05039736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101644870|NCT05039736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101644871|NCT05039736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644872|NCT05010590|Denosumab|denosumab|mesh-list
101644873|NCT05010590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101644874|NCT05010590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644875|NCT04983940|Methyltestosterone|methyltestosterone|mesh-list
101644876|NCT04983940|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101644877|NCT04983940|Testosterone|testosterone|mesh-list
101644878|NCT04983940|Testosterone undecanoate|testosterone undecanoate|mesh-list
101644879|NCT04983940|Testosterone enanthate|testosterone enanthate|mesh-list
101644880|NCT04983940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101644881|NCT04983940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101644882|NCT04983940|Anabolic Agents|anabolic agents|mesh-ancestor
101644883|NCT04983940|Hormones|hormones|mesh-ancestor
101644884|NCT04983940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101644885|NCT04983940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644886|NCT04983940|Androgens|androgens|mesh-ancestor
101644887|NCT04940637|Niraparib|niraparib|mesh-list
101644888|NCT04940637|Dostarlimab|dostarlimab|mesh-list
101644889|NCT04940637|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101644890|NCT04940637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101644891|NCT04940637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644892|NCT04940637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101644893|NCT04939090|Megestrol|megestrol|mesh-list
101644894|NCT04939090|Megestrol Acetate|megestrol acetate|mesh-list
101644895|NCT04939090|Olanzapine|olanzapine|mesh-list
101644896|NCT04939090|Antiemetics|antiemetics|mesh-ancestor
101644897|NCT04939090|Autonomic Agents|autonomic agents|mesh-ancestor
101644898|NCT04939090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101644899|NCT04939090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644900|NCT04939090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101644901|NCT04939090|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101644902|NCT04939090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101644903|NCT04939090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101644904|NCT04939090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101644905|NCT04939090|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101644906|NCT04939090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101597349|NCT01071798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101597350|NCT01071798|Immunologic Factors|immunologic factors|mesh-ancestor
101597351|NCT01071798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597352|NCT01071798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101597353|NCT00857311|Vaccines|vaccines|mesh-list
101597354|NCT00857311|Immunologic Factors|immunologic factors|mesh-ancestor
101597355|NCT00857311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644907|NCT04939090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101644908|NCT04939090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644909|NCT04939090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101644910|NCT04939090|Serotonin Agents|serotonin agents|mesh-ancestor
101644911|NCT04939090|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101644912|NCT04939090|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101358134|NCT01809808|Hormones|hormones|mesh-list
101644913|NCT04939090|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101644914|NCT04939090|Contraceptive Agents|contraceptive agents|mesh-ancestor
101644915|NCT04939090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101644916|NCT04939090|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101644917|NCT04939090|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101644918|NCT04939090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101644919|NCT04939090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101644920|NCT04939090|Appetite Stimulants|appetite stimulants|mesh-ancestor
101644921|NCT04939090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101644922|NCT04911660|Empagliflozin|empagliflozin|mesh-list
101644923|NCT04911660|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101644924|NCT04911660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644925|NCT04911660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101644926|NCT04911660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644927|NCT04881682|Immunoglobulins|immunoglobulins|mesh-list
101644928|NCT04881682|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101644930|NCT04881682|Immunologic Factors|immunologic factors|mesh-ancestor
101644931|NCT04881682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644932|NCT04839185|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
101644933|NCT04839185|Hematinics|hematinics|mesh-ancestor
101644934|NCT04839185|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101644935|NCT04839185|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101644936|NCT04809220|Dulaglutide|dulaglutide|mesh-list
101644938|NCT04809220|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
101644939|NCT04809220|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
101644940|NCT04809220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101644941|NCT04809220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644942|NCT04809220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101644943|NCT04809220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644944|NCT04806906|Azacitidine|azacitidine|mesh-list
101644945|NCT04806906|Cc-486|cc-486|mesh-list
101644946|NCT04806906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101644947|NCT04806906|Antimetabolites|antimetabolites|mesh-ancestor
101644948|NCT04806906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644949|NCT04806906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101644950|NCT04806906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101597366|NCT02874768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101644981|NCT04752059|Trastuzumab|trastuzumab|mesh-list
101644982|NCT04752059|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
101644983|NCT04752059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101644984|NCT04752059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101644985|NCT04752059|Immunoconjugates|immunoconjugates|mesh-ancestor
101644986|NCT04752059|Immunologic Factors|immunologic factors|mesh-ancestor
101644987|NCT04752059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101644989|NCT04750473|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101644990|NCT04750473|Chelating Agents|chelating agents|mesh-ancestor
101644991|NCT04750473|Sequestering Agents|sequestering agents|mesh-ancestor
101644992|NCT04750473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644993|NCT04750473|Anticoagulants|anticoagulants|mesh-ancestor
101644994|NCT04750473|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101644995|NCT04750473|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101644996|NCT04745351|Remdesivir|remdesivir|mesh-list
101644997|NCT04745351|Antimetabolites|antimetabolites|mesh-ancestor
101644998|NCT04745351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101644999|NCT04745351|Antiviral Agents|antiviral agents|mesh-ancestor
101645000|NCT04745351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101645001|NCT04735549|Hormones|hormones|mesh-list
101645002|NCT04735549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101645003|NCT04735549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645004|NCT04710277|Analgesics, Opioid|analgesics, opioid|mesh-list
101645005|NCT04710277|Narcotics|narcotics|mesh-ancestor
101645006|NCT04710277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101645007|NCT04710277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645008|NCT04710277|Analgesics|analgesics|mesh-ancestor
101645009|NCT04710277|Sensory System Agents|sensory system agents|mesh-ancestor
101645010|NCT04710277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101645011|NCT04665089|Erythromycin|erythromycin|mesh-list
101645012|NCT04665089|Erythromycin Estolate|erythromycin estolate|mesh-list
101645013|NCT04665089|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101645014|NCT04665089|Erythromycin stearate|erythromycin stearate|mesh-list
101645015|NCT04665089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101645016|NCT04665089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101645017|NCT04665089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101645018|NCT04665089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101645019|NCT04665089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101597368|NCT02874768|Adrenergic Agents|adrenergic agents|mesh-ancestor
101597369|NCT02874768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101597370|NCT02874768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597371|NCT02874768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101597372|NCT02874768|Anesthetics, General|anesthetics, general|mesh-ancestor
101597373|NCT02874768|Anesthetics|anesthetics|mesh-ancestor
101597374|NCT00857233|Memantine|memantine|mesh-list
101597375|NCT00857233|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101597376|NCT00857233|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101597377|NCT00857233|Dopamine Agents|dopamine agents|mesh-ancestor
101597378|NCT00857233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101597379|NCT00857233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597380|NCT00857233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597381|NCT00857233|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101597382|NCT00857233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101597383|NCT02740426|Pirarubicin|pirarubicin|mesh-list
101597384|NCT02740426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101597385|NCT02743234|Vancomycin|vancomycin|mesh-list
101597386|NCT02743234|Fidaxomicin|fidaxomicin|mesh-list
101597387|NCT02743234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101597388|NCT02743234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101597389|NCT02740270|Spartalizumab|spartalizumab|mesh-list
101597390|NCT02740270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101597391|NCT02740270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645020|NCT04665089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645021|NCT04612790|Benralizumab|benralizumab|mesh-list
101645022|NCT04612790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101645023|NCT04612790|Respiratory System Agents|respiratory system agents|mesh-ancestor
101645024|NCT04591002|Osimertinib|osimertinib|mesh-list
101645025|NCT04591002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645026|NCT04591002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101645027|NCT04591002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101645028|NCT04591002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645029|NCT04544111|Trametinib|trametinib|mesh-list
101645030|NCT04544111|Dabrafenib|dabrafenib|mesh-list
101645031|NCT04544111|Spartalizumab|spartalizumab|mesh-list
101645032|NCT04544111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645033|NCT04544111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101645034|NCT04544111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101645035|NCT04544111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645036|NCT04544111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101645037|NCT04544111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101645038|NCT04498780|Valsartan|valsartan|mesh-list
101645039|NCT04498780|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101645040|NCT04498780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101597392|NCT02740270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101597393|NCT02740270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101597394|NCT00856843|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101597395|NCT00856843|Laxatives|laxatives|mesh-ancestor
101597396|NCT00856843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101597397|NCT02740192|Bupivacaine|bupivacaine|mesh-list
101597398|NCT02740192|Ropivacaine|ropivacaine|mesh-list
101597399|NCT02740192|Anesthetics, Local|anesthetics, local|mesh-ancestor
101597400|NCT02740192|Anesthetics|anesthetics|mesh-ancestor
101597401|NCT02740192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101597402|NCT02740192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597403|NCT02740192|Sensory System Agents|sensory system agents|mesh-ancestor
101597404|NCT02740192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101597405|NCT02743390|Infliximab|infliximab|mesh-list
101597406|NCT02743390|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101597407|NCT02743390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101597408|NCT02743390|Dermatologic Agents|dermatologic agents|mesh-ancestor
101597409|NCT02743390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101597410|NCT02743390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101597411|NCT00856609|Exenatide|exenatide|mesh-list
101597412|NCT00856609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101597413|NCT00856609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597414|NCT00856609|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101597415|NCT00856609|Incretins|incretins|mesh-ancestor
101645041|NCT04498780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101645042|NCT04498780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101645043|NCT04498780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645044|NCT04493333|Calcium polycarbophil|calcium polycarbophil|mesh-list
101645045|NCT04493333|Psyllium|psyllium|mesh-list
101645046|NCT04493333|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101645047|NCT04493333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101645048|NCT04493333|Immunologic Factors|immunologic factors|mesh-ancestor
101645049|NCT04493333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645050|NCT04493333|Antidiarrheals|antidiarrheals|mesh-ancestor
101645051|NCT04493333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101645052|NCT04493333|Cathartics|cathartics|mesh-ancestor
101645053|NCT04427501|Bamlanivimab|bamlanivimab|mesh-list
101645054|NCT04427501|Antiviral Agents|antiviral agents|mesh-ancestor
101645055|NCT04427501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101645056|NCT04403165|Norepinephrine|norepinephrine|mesh-list
101645057|NCT04403165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101645058|NCT04403165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101645059|NCT04403165|Adrenergic Agents|adrenergic agents|mesh-ancestor
101645060|NCT04403165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101645061|NCT04403165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645062|NCT04403165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645063|NCT04403165|Sympathomimetics|sympathomimetics|mesh-ancestor
101645064|NCT04403165|Autonomic Agents|autonomic agents|mesh-ancestor
101645065|NCT04403165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101645066|NCT04403165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101645067|NCT04289779|Atezolizumab|atezolizumab|mesh-list
101645068|NCT04289779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101597416|NCT00856609|Hormones|hormones|mesh-ancestor
101597417|NCT00856609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101597418|NCT02739958|Propofol|propofol|mesh-list
101597419|NCT02739958|Isoflurane|isoflurane|mesh-list
101597420|NCT02739958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101597421|NCT02739958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101597422|NCT02739958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597423|NCT02739958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101597424|NCT02739958|Anesthetics, General|anesthetics, general|mesh-ancestor
101597425|NCT02739958|Anesthetics|anesthetics|mesh-ancestor
101597426|NCT02739958|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101597427|NCT02739880|Hyaluronic Acid|hyaluronic acid|mesh-list
101597428|NCT02739880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101597429|NCT02739880|Immunologic Factors|immunologic factors|mesh-ancestor
101597430|NCT02739880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597431|NCT02739880|Viscosupplements|viscosupplements|mesh-ancestor
101597432|NCT02739880|Protective Agents|protective agents|mesh-ancestor
101597433|NCT01071096|Botulinum Toxins|botulinum toxins|mesh-list
101597434|NCT01071096|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101597435|NCT01071096|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101597436|NCT01071096|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101597437|NCT01071096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101597438|NCT01071096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597439|NCT01071096|Cholinergic Agents|cholinergic agents|mesh-ancestor
101597440|NCT01071096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101597441|NCT01071096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597442|NCT01071096|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101597443|NCT01071096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101597444|NCT00856375|Irinotecan|irinotecan|mesh-list
101597445|NCT00856375|Etirinotecan pegol|etirinotecan pegol|mesh-list
101597446|NCT00856375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101645069|NCT04289779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645070|NCT04289779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101645071|NCT04289779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645072|NCT04271202|Erenumab|erenumab|mesh-list
101645073|NCT04271202|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
101645074|NCT04271202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645075|NCT04271202|Analgesics|analgesics|mesh-ancestor
101645076|NCT04271202|Sensory System Agents|sensory system agents|mesh-ancestor
101645077|NCT04271202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101645078|NCT04271202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645079|NCT04269213|Cytarabine|cytarabine|mesh-list
101645080|NCT04269213|Daunorubicin|daunorubicin|mesh-list
101597447|NCT00856375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101597448|NCT00856375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101597449|NCT00856375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597450|NCT00856375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101597451|NCT00856375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101597452|NCT01070784|Budesonide|budesonide|mesh-list
101597453|NCT01070784|Formoterol Fumarate|formoterol fumarate|mesh-list
101597454|NCT01070784|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101597455|NCT01070784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101597456|NCT01070784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101597457|NCT01070784|Autonomic Agents|autonomic agents|mesh-ancestor
101597458|NCT01070784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101597459|NCT01070784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597460|NCT01070784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101597461|NCT01070784|Respiratory System Agents|respiratory system agents|mesh-ancestor
101597462|NCT01070784|Glucocorticoids|glucocorticoids|mesh-ancestor
101597463|NCT01070784|Hormones|hormones|mesh-ancestor
101597464|NCT01070784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101645081|NCT04269213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101645082|NCT04269213|Antimetabolites|antimetabolites|mesh-ancestor
101645083|NCT04269213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645084|NCT04269213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645085|NCT04269213|Antiviral Agents|antiviral agents|mesh-ancestor
101645086|NCT04269213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101645087|NCT04269213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101645088|NCT04269213|Immunologic Factors|immunologic factors|mesh-ancestor
101645089|NCT04269213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645090|NCT04269213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101645091|NCT04269213|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101645092|NCT04269213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101645093|NCT04269213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101645094|NCT04228965|Varenicline|varenicline|mesh-list
101645095|NCT04228965|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101645096|NCT04228965|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101645097|NCT04228965|Cholinergic Agents|cholinergic agents|mesh-ancestor
101645098|NCT04228965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101645099|NCT04228965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645100|NCT04228965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645101|NCT04197687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101645102|NCT04197687|Trastuzumab|trastuzumab|mesh-list
101645103|NCT04197687|Pertuzumab|pertuzumab|mesh-list
101645104|NCT04197687|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101645105|NCT04197687|Maytansine|maytansine|mesh-list
101645106|NCT04197687|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
101645107|NCT04197687|Vaccines|vaccines|mesh-list
101645108|NCT04197687|Antibodies|antibodies|mesh-list
101645109|NCT04197687|Immunoglobulins|immunoglobulins|mesh-list
101645110|NCT04197687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101645111|NCT04197687|Sargramostim|sargramostim|mesh-list
101645112|NCT04197687|Immunoconjugates|immunoconjugates|mesh-list
101645113|NCT04197687|Immunologic Factors|immunologic factors|mesh-ancestor
101645114|NCT04197687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645115|NCT04197687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645116|NCT04197687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101597465|NCT01070784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101597466|NCT01070784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101597467|NCT01070784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101597468|NCT01070784|Adrenergic Agents|adrenergic agents|mesh-ancestor
101597469|NCT01070784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101597470|NCT01070784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597471|NCT02694874|Rosiglitazone|rosiglitazone|mesh-list
101597472|NCT02694874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101597473|NCT02694874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597474|NCT00837577|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101597475|NCT00837577|Voglibose|voglibose|mesh-list
101597476|NCT00837577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101597477|NCT00837577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597478|NCT00837577|Incretins|incretins|mesh-ancestor
101597479|NCT00837577|Hormones|hormones|mesh-ancestor
101597480|NCT00837577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101597481|NCT00837577|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101597482|NCT00837577|Protease Inhibitors|protease inhibitors|mesh-ancestor
101597483|NCT00837577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101597484|NCT00837577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645117|NCT04197687|Tubulin Modulators|tubulin modulators|mesh-ancestor
101645118|NCT04197687|Antimitotic Agents|antimitotic agents|mesh-ancestor
101645119|NCT04197687|Mitosis Modulators|mitosis modulators|mesh-ancestor
101645120|NCT04197687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645121|NCT04197687|Immunotoxins|immunotoxins|mesh-ancestor
101645122|NCT04130516|Pembrolizumab|pembrolizumab|mesh-list
101645123|NCT04130516|Antibodies|antibodies|mesh-list
101645124|NCT04130516|Immunologic Factors|immunologic factors|mesh-ancestor
101645125|NCT04130516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645126|NCT04130516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101645127|NCT04130516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645128|NCT04130516|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101645129|NCT04130516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645130|NCT03989778|Vitamin D|vitamin d|mesh-list
101645131|NCT03989778|Vitamins|vitamins|mesh-ancestor
101645132|NCT03989778|Micronutrients|micronutrients|mesh-ancestor
101645133|NCT03989778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645134|NCT03989778|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101302225|NCT01856192|Antimitotic Agents|antimitotic agents|mesh-ancestor
101645135|NCT03976063|Nifedipine|nifedipine|mesh-list
101645136|NCT03976063|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101645137|NCT03976063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101645138|NCT03976063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645139|NCT03976063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101645140|NCT03976063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645141|NCT03976063|Vasodilator Agents|vasodilator agents|mesh-ancestor
101645142|NCT03976063|Tocolytic Agents|tocolytic agents|mesh-ancestor
101645143|NCT03976063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101645144|NCT03962855|Ifetroban|ifetroban|mesh-list
101645145|NCT03962855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101645146|NCT03959527|Azithromycin|azithromycin|mesh-list
101645147|NCT03959527|Ceftriaxone|ceftriaxone|mesh-list
101597485|NCT00837577|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101597486|NCT01070550|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101597487|NCT01070550|Antiviral Agents|antiviral agents|mesh-ancestor
101597488|NCT01070550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101597489|NCT04189900|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101597490|NCT04189900|Luteolytic Agents|luteolytic agents|mesh-ancestor
101597491|NCT04189900|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101597492|NCT04189900|Contraceptive Agents|contraceptive agents|mesh-ancestor
101597493|NCT04189900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101597494|NCT04189900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597495|NCT04189900|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101597496|NCT04189900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101597497|NCT04189900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101597498|NCT00848107|Treprostinil|treprostinil|mesh-list
101645148|NCT03959527|Zoliflodacin|zoliflodacin|mesh-list
101645149|NCT03959527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101645150|NCT03959527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101645151|NCT03959527|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101645152|NCT03959527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101645153|NCT03959527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101645154|NCT03959527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645155|NCT03959527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645156|NCT03955172|Everolimus|everolimus|mesh-list
101645157|NCT03955172|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101645158|NCT03955172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101645159|NCT03955172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101645160|NCT03955172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645161|NCT03955172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101645162|NCT03955172|Immunologic Factors|immunologic factors|mesh-ancestor
101645163|NCT03955172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645164|NCT03955172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645165|NCT03947216|Pimavanserin|pimavanserin|mesh-list
101645166|NCT03947216|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101645167|NCT03947216|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101645168|NCT03947216|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101645169|NCT03947216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101645170|NCT03947216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101645171|NCT03947216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645172|NCT03947216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101645173|NCT03947216|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101645174|NCT03947216|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101645175|NCT03947216|Serotonin Agents|serotonin agents|mesh-ancestor
101645176|NCT03947216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101645177|NCT03947216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645178|NCT03889249|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101645179|NCT03889249|Tenecteplase|tenecteplase|mesh-list
101645180|NCT03889249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101645181|NCT03889249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101645182|NCT03889249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645183|NCT03844620|Trifluridine|trifluridine|mesh-list
101645184|NCT03844620|Antimetabolites|antimetabolites|mesh-ancestor
101645185|NCT03844620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645186|NCT03844620|Antiviral Agents|antiviral agents|mesh-ancestor
101645187|NCT03844620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101645188|NCT03841201|Nivolumab|nivolumab|mesh-list
101645189|NCT03841201|Lenvatinib|lenvatinib|mesh-list
101645190|NCT03841201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101645191|NCT03841201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645192|NCT03841201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101597499|NCT00848107|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101597500|NCT04030741|Metronidazole|metronidazole|mesh-list
101597501|NCT04030741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101597502|NCT04030741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101597503|NCT04030741|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101597504|NCT04030741|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101597505|NCT02736760|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
101597506|NCT02736760|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101597507|NCT02736760|Dermatologic Agents|dermatologic agents|mesh-ancestor
101597508|NCT05620108|Rocuronium|rocuronium|mesh-list
101597509|NCT05620108|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101597510|NCT05620108|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101358226|NCT00038519|Ritonavir|ritonavir|mesh-list
101597511|NCT05620108|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101645193|NCT03841201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645194|NCT03841201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101645195|NCT03841201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101645196|NCT03806166|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101645197|NCT03806166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101645198|NCT03733535|Benralizumab|benralizumab|mesh-list
101645199|NCT03733535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101645200|NCT03733535|Respiratory System Agents|respiratory system agents|mesh-ancestor
101645201|NCT03728972|Pembrolizumab|pembrolizumab|mesh-list
101645202|NCT03728972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101645203|NCT03728972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645204|NCT03728972|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101645205|NCT03728972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645206|NCT03719092|Vitamins|vitamins|mesh-list
101645207|NCT03719092|Vitamin A|vitamin a|mesh-list
101645208|NCT03719092|Retinol palmitate|retinol palmitate|mesh-list
101645209|NCT03719092|Micronutrients|micronutrients|mesh-ancestor
101645210|NCT03719092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645211|NCT03719092|Antioxidants|antioxidants|mesh-ancestor
101645212|NCT03719092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645213|NCT03719092|Protective Agents|protective agents|mesh-ancestor
101645214|NCT03719092|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101645215|NCT03719092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645216|NCT03661385|Nitric Oxide|nitric oxide|mesh-list
101645217|NCT03661385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101645218|NCT03661385|Autonomic Agents|autonomic agents|mesh-ancestor
101645219|NCT03661385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101645220|NCT03661385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645221|NCT03661385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101645222|NCT03661385|Respiratory System Agents|respiratory system agents|mesh-ancestor
101645223|NCT03661385|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101645224|NCT03661385|Antioxidants|antioxidants|mesh-ancestor
101645225|NCT03661385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645226|NCT03661385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101645227|NCT03661385|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101645228|NCT03661385|Vasodilator Agents|vasodilator agents|mesh-ancestor
101645229|NCT03661385|Gasotransmitters|gasotransmitters|mesh-ancestor
101645230|NCT03661385|Protective Agents|protective agents|mesh-ancestor
101645231|NCT03630055|Rivaroxaban|rivaroxaban|mesh-list
101645232|NCT03630055|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101645233|NCT03630055|Antithrombins|antithrombins|mesh-ancestor
101645234|NCT03630055|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101645235|NCT03630055|Protease Inhibitors|protease inhibitors|mesh-ancestor
101645236|NCT03630055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101645237|NCT03630055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645238|NCT03630055|Anticoagulants|anticoagulants|mesh-ancestor
101645239|NCT03617731|Dexamethasone|dexamethasone|mesh-list
101645240|NCT03617731|Lenalidomide|lenalidomide|mesh-list
101597512|NCT05620108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101597513|NCT05620108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597514|NCT00856297|Vaccines|vaccines|mesh-list
101597515|NCT00856297|Immunologic Factors|immunologic factors|mesh-ancestor
101597516|NCT00856297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597518|NCT02736604|Anesthetics|anesthetics|mesh-list
101597519|NCT02736604|Sevoflurane|sevoflurane|mesh-list
101597520|NCT02736604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101597521|NCT02736604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597522|NCT02736604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101597523|NCT02736604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101597524|NCT02736604|Anesthetics, General|anesthetics, general|mesh-ancestor
101597525|NCT02736604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101597526|NCT02736604|Analgesics|analgesics|mesh-ancestor
101597527|NCT02736604|Sensory System Agents|sensory system agents|mesh-ancestor
101597528|NCT02736604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101645241|NCT03617731|Bortezomib|bortezomib|mesh-list
101645242|NCT03617731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101645243|NCT03617731|Antiemetics|antiemetics|mesh-ancestor
101645244|NCT03617731|Autonomic Agents|autonomic agents|mesh-ancestor
101645245|NCT03617731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101645246|NCT03617731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645247|NCT03617731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101645248|NCT03617731|Glucocorticoids|glucocorticoids|mesh-ancestor
101645249|NCT03617731|Hormones|hormones|mesh-ancestor
101645250|NCT03617731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101645251|NCT03617731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101645252|NCT03617731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645253|NCT03617731|Immunologic Factors|immunologic factors|mesh-ancestor
101645254|NCT03617731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101645255|NCT03617731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101645256|NCT03617731|Growth Substances|growth substances|mesh-ancestor
101645257|NCT03617731|Growth Inhibitors|growth inhibitors|mesh-ancestor
101645258|NCT03531736|Cyclophosphamide|cyclophosphamide|mesh-list
101645259|NCT03531736|Fludarabine|fludarabine|mesh-list
101645260|NCT03531736|Rituximab|rituximab|mesh-list
101645261|NCT03531736|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101645262|NCT03531736|Thymoglobulin|thymoglobulin|mesh-list
101645263|NCT03531736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101645264|NCT03531736|Immunologic Factors|immunologic factors|mesh-ancestor
101645265|NCT03531736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645266|NCT03531736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101645267|NCT03531736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101645268|NCT03531736|Alkylating Agents|alkylating agents|mesh-ancestor
101645269|NCT03531736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645270|NCT03531736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645271|NCT03531736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101645272|NCT03531736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101645273|NCT03526874|Lidocaine|lidocaine|mesh-list
101645274|NCT03526874|Anesthetics, Local|anesthetics, local|mesh-ancestor
101645275|NCT03526874|Anesthetics|anesthetics|mesh-ancestor
101645276|NCT03526874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101645277|NCT03526874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645278|NCT03526874|Sensory System Agents|sensory system agents|mesh-ancestor
101645279|NCT03526874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101645280|NCT03526874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101645281|NCT03526874|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101645282|NCT03526874|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101597530|NCT02613013|Pilocarpine|pilocarpine|mesh-list
101597531|NCT02613013|Miotics|miotics|mesh-ancestor
101597532|NCT02613013|Autonomic Agents|autonomic agents|mesh-ancestor
101597533|NCT02613013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101597534|NCT02613013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597535|NCT02613013|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101597536|NCT02613013|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101597537|NCT02613013|Cholinergic Agents|cholinergic agents|mesh-ancestor
101597538|NCT02613013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101597539|NCT02613013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597540|NCT02613013|Anesthetics, Local|anesthetics, local|mesh-ancestor
101597541|NCT02613013|Anesthetics|anesthetics|mesh-ancestor
101597542|NCT02613013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101597543|NCT02613013|Sensory System Agents|sensory system agents|mesh-ancestor
101597544|NCT04306510|Antibodies|antibodies|mesh-list
101597545|NCT04306510|Immunoglobulins|immunoglobulins|mesh-list
101597546|NCT04306510|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101597547|NCT04306510|Immunologic Factors|immunologic factors|mesh-ancestor
101597548|NCT04306510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597549|NCT02611921|Ketamine|ketamine|mesh-list
101597550|NCT02611921|Analgesics|analgesics|mesh-ancestor
101597551|NCT02611921|Sensory System Agents|sensory system agents|mesh-ancestor
101597552|NCT02611921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101597553|NCT02611921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597554|NCT02611921|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101597555|NCT02611921|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101597556|NCT02611921|Anesthetics, General|anesthetics, general|mesh-ancestor
101597557|NCT02611921|Anesthetics|anesthetics|mesh-ancestor
101645283|NCT03526874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101645284|NCT03526874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645285|NCT03493789|Deoxyglucose|deoxyglucose|mesh-list
101645286|NCT03493789|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101645287|NCT03493789|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101645288|NCT03493789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645289|NCT03493789|Antimetabolites|antimetabolites|mesh-ancestor
101645290|NCT03493789|Antiviral Agents|antiviral agents|mesh-ancestor
101645291|NCT03493789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101645292|NCT03451799|Temozolomide|temozolomide|mesh-list
101645293|NCT03451799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101645294|NCT03451799|Alkylating Agents|alkylating agents|mesh-ancestor
101645295|NCT03451799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645296|NCT03451799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645297|NCT03439124|Cephalosporins|cephalosporins|mesh-list
101645298|NCT03439124|Ceftobiprole|ceftobiprole|mesh-list
101597558|NCT02611921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101597559|NCT02611921|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101645300|NCT03439124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101645301|NCT03439124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101645302|NCT03393741|Paclitaxel|paclitaxel|mesh-list
101645303|NCT03393741|Vinorelbine|vinorelbine|mesh-list
101645304|NCT03393741|Docetaxel|docetaxel|mesh-list
101645305|NCT03393741|Epothilones|epothilones|mesh-list
101645306|NCT03393741|Vinca Alkaloids|vinca alkaloids|mesh-list
101645307|NCT03393741|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101645308|NCT03393741|Taxane|taxane|mesh-list
101645309|NCT03393741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101645310|NCT03393741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645311|NCT03393741|Tubulin Modulators|tubulin modulators|mesh-ancestor
101645312|NCT03393741|Antimitotic Agents|antimitotic agents|mesh-ancestor
101645313|NCT03393741|Mitosis Modulators|mitosis modulators|mesh-ancestor
101645314|NCT03393741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645315|NCT03304093|Nivolumab|nivolumab|mesh-list
101645316|NCT03304093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101645317|NCT03304093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645318|NCT03304093|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101645319|NCT03304093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645320|NCT03279471|Sertraline|sertraline|mesh-list
101645321|NCT03279471|Antidepressive Agents|antidepressive agents|mesh-ancestor
101645322|NCT03279471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101645323|NCT03279471|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101645324|NCT03279471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101645325|NCT03279471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101645326|NCT03279471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645327|NCT03279471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101645328|NCT03279471|Serotonin Agents|serotonin agents|mesh-ancestor
101645329|NCT03279471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645330|NCT03267888|Pembrolizumab|pembrolizumab|mesh-list
101645331|NCT03267888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101645332|NCT03267888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645333|NCT03267888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101645334|NCT03267888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645335|NCT03263117|Anesthetics|anesthetics|mesh-list
101645336|NCT03263117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101645337|NCT03263117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645339|NCT03232918|Oxytocics|oxytocics|mesh-ancestor
101645340|NCT03232918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101645341|NCT03232918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645342|NCT03212989|Vorinostat|vorinostat|mesh-list
101645343|NCT03212989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645344|NCT03212989|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101645345|NCT03212989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101645346|NCT03212989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645347|NCT03158688|Dexamethasone|dexamethasone|mesh-list
101645348|NCT03158688|Daratumumab|daratumumab|mesh-list
101645349|NCT03158688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101645350|NCT03158688|Antiemetics|antiemetics|mesh-ancestor
101645351|NCT03158688|Autonomic Agents|autonomic agents|mesh-ancestor
101645352|NCT03158688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101645353|NCT03158688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645354|NCT03158688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101645355|NCT03158688|Glucocorticoids|glucocorticoids|mesh-ancestor
101645356|NCT03158688|Hormones|hormones|mesh-ancestor
101645357|NCT03158688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101645358|NCT03158688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101645359|NCT03158688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645360|NCT03138733|Daptomycin|daptomycin|mesh-list
101645361|NCT03138733|Ceftobiprole|ceftobiprole|mesh-list
101645362|NCT03138733|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
101645363|NCT03138733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101645364|NCT03138733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101645365|NCT03137173|Vancomycin|vancomycin|mesh-list
101645366|NCT03137173|Aztreonam|aztreonam|mesh-list
101645367|NCT03137173|Ceftobiprole|ceftobiprole|mesh-list
101645368|NCT03137173|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
101645369|NCT03137173|Cephalosporins|cephalosporins|mesh-list
101597561|NCT02611921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101597562|NCT02611921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597563|NCT02736448|Capecitabine|capecitabine|mesh-list
101597564|NCT02736448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101597565|NCT02736448|Antimetabolites|antimetabolites|mesh-ancestor
101597566|NCT02736448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597567|NCT02736448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101597568|NCT00703651|Vaccines|vaccines|mesh-list
101597569|NCT00703651|Immunologic Factors|immunologic factors|mesh-ancestor
101597570|NCT00703651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597571|NCT01046136|Phenylpropanolamine|phenylpropanolamine|mesh-list
101597572|NCT01046136|Guaifenesin|guaifenesin|mesh-list
101597573|NCT01046136|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
101645370|NCT03137173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101645371|NCT03137173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101645372|NCT03107988|Cyclophosphamide|cyclophosphamide|mesh-list
101645373|NCT03107988|Topotecan|topotecan|mesh-list
101645374|NCT03107988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101645375|NCT03107988|Immunologic Factors|immunologic factors|mesh-ancestor
101645376|NCT03107988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645377|NCT03107988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101645378|NCT03107988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101645379|NCT03107988|Alkylating Agents|alkylating agents|mesh-ancestor
101645380|NCT03107988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645381|NCT03107988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645382|NCT03107988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101645383|NCT03107988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101645384|NCT03107988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101645385|NCT03107988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101645386|NCT03089957|Urinastatin|urinastatin|mesh-list
101645387|NCT03089957|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101645388|NCT03089957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101645389|NCT03089957|Protease Inhibitors|protease inhibitors|mesh-ancestor
101645390|NCT03089957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101645391|NCT03089957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645392|NCT03080883|Apixaban|apixaban|mesh-list
101645393|NCT03080883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101645394|NCT03080883|Antithrombins|antithrombins|mesh-ancestor
101645395|NCT03080883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101645396|NCT03080883|Protease Inhibitors|protease inhibitors|mesh-ancestor
101645397|NCT03080883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101645398|NCT03080883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645399|NCT03080883|Anticoagulants|anticoagulants|mesh-ancestor
101645400|NCT03072147|Teriparatide|teriparatide|mesh-list
101645401|NCT03072147|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101645402|NCT03072147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645403|NCT03072147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101645404|NCT02835222|Cytarabine|cytarabine|mesh-list
101645405|NCT02835222|Daunorubicin|daunorubicin|mesh-list
101645406|NCT02835222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101645407|NCT02835222|Antimetabolites|antimetabolites|mesh-ancestor
101358255|NCT00038558|Doxorubicin|doxorubicin|mesh-list
101645408|NCT02835222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645409|NCT02835222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645410|NCT02835222|Antiviral Agents|antiviral agents|mesh-ancestor
101645411|NCT02835222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101645412|NCT02835222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101645413|NCT02835222|Immunologic Factors|immunologic factors|mesh-ancestor
101645414|NCT02835222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597575|NCT01046136|Respiratory System Agents|respiratory system agents|mesh-ancestor
101597576|NCT01046136|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101597577|NCT01046136|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101597578|NCT01046136|Adrenergic Agents|adrenergic agents|mesh-ancestor
101597579|NCT01046136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101597580|NCT01046136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264648|NCT01768780|Sensory System Agents|sensory system agents|mesh-ancestor
101597581|NCT01046136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597582|NCT01046136|Appetite Depressants|appetite depressants|mesh-ancestor
101597583|NCT01046136|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101597584|NCT01046136|Sympathomimetics|sympathomimetics|mesh-ancestor
101597585|NCT01046136|Autonomic Agents|autonomic agents|mesh-ancestor
101645415|NCT02835222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101645416|NCT02835222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101645417|NCT02835222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101645418|NCT02835222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101645419|NCT02723513|Xenon|xenon|mesh-list
101645420|NCT02723513|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101645421|NCT02723513|Anesthetics, General|anesthetics, general|mesh-ancestor
101645422|NCT02723513|Anesthetics|anesthetics|mesh-ancestor
101645423|NCT02723513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101645424|NCT02723513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645425|NCT02706054|Meloxicam|meloxicam|mesh-list
101645426|NCT02706054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101645427|NCT02706054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101645428|NCT02706054|Analgesics|analgesics|mesh-ancestor
101645429|NCT02706054|Sensory System Agents|sensory system agents|mesh-ancestor
101645430|NCT02706054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101645431|NCT02706054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645432|NCT02706054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101645433|NCT02706054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101645434|NCT02706054|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101645435|NCT02706054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101645436|NCT02706054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101645437|NCT02706054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645439|NCT02630641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101645440|NCT02630641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645441|NCT02600117|Tenofovir|tenofovir|mesh-list
101645442|NCT02600117|Antiviral Agents|antiviral agents|mesh-ancestor
101645443|NCT02600117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101645444|NCT02600117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101645445|NCT02600117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101645446|NCT02600117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101645447|NCT02600117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645448|NCT02600117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101645449|NCT02600117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101645450|NCT02599714|Fulvestrant|fulvestrant|mesh-list
101645451|NCT02599714|Palbociclib|palbociclib|mesh-list
101645452|NCT02599714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101645453|NCT02599714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645454|NCT02599714|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101645455|NCT02599714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101645456|NCT02599714|Hormone Antagonists|hormone antagonists|mesh-ancestor
101645457|NCT02599714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101645458|NCT02599714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645459|NCT02599714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101645460|NCT02599714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101358269|NCT00038558|Tubulin Modulators|tubulin modulators|mesh-ancestor
101645461|NCT02599714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645462|NCT02337634|Silymarin|silymarin|mesh-list
101597586|NCT01046136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101254534|NCT01699412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101597587|NCT01046136|Nasal Decongestants|nasal decongestants|mesh-ancestor
101597588|NCT01046136|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101597589|NCT02736682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101597590|NCT02736682|Metronidazole|metronidazole|mesh-list
101597591|NCT02736682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101597592|NCT02736682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101597593|NCT02736682|Antitubercular Agents|antitubercular agents|mesh-ancestor
101597594|NCT02736682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101645463|NCT02337634|Antioxidants|antioxidants|mesh-ancestor
101645464|NCT02337634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645465|NCT02337634|Protective Agents|protective agents|mesh-ancestor
101645466|NCT02337634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645467|NCT02288195|Capecitabine|capecitabine|mesh-list
101645468|NCT02288195|Oxaliplatin|oxaliplatin|mesh-list
101645469|NCT02288195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101645470|NCT02288195|Antimetabolites|antimetabolites|mesh-ancestor
101645471|NCT02288195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645472|NCT02288195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645473|NCT02265874|Nicotine|nicotine|mesh-list
101645474|NCT02265874|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101645475|NCT02265874|Autonomic Agents|autonomic agents|mesh-ancestor
101645476|NCT02265874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101645477|NCT02265874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645478|NCT02265874|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101645479|NCT02265874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101645480|NCT02265874|Cholinergic Agents|cholinergic agents|mesh-ancestor
101645481|NCT02265874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101645482|NCT02265874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645483|NCT02168140|Thioctic Acid|thioctic acid|mesh-list
101645484|NCT02168140|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101645485|NCT02168140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101645486|NCT02168140|Alkylating Agents|alkylating agents|mesh-ancestor
101645487|NCT02168140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645488|NCT02168140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645489|NCT02168140|Antioxidants|antioxidants|mesh-ancestor
101645490|NCT02168140|Protective Agents|protective agents|mesh-ancestor
101645491|NCT02168140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645492|NCT02168140|Vitamin B Complex|vitamin b complex|mesh-ancestor
101645493|NCT02168140|Vitamins|vitamins|mesh-ancestor
101645494|NCT02168140|Micronutrients|micronutrients|mesh-ancestor
101645495|NCT02087423|Durvalumab|durvalumab|mesh-list
101645496|NCT02087423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101645497|NCT02087423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645498|NCT01996436|Verapamil|verapamil|mesh-list
101645499|NCT01996436|Nicardipine|nicardipine|mesh-list
101645500|NCT01996436|Nitroglycerin|nitroglycerin|mesh-list
101645501|NCT01996436|Vasodilator Agents|vasodilator agents|mesh-ancestor
101645502|NCT01996436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101645503|NCT01996436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101645504|NCT01996436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101645505|NCT01996436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645506|NCT01996436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101645507|NCT01996436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645508|NCT01996436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101645509|NCT01845337|Capecitabine|capecitabine|mesh-list
101645510|NCT01845337|Tegafur|tegafur|mesh-list
101645511|NCT01845337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101645512|NCT01845337|Antimetabolites|antimetabolites|mesh-ancestor
101645513|NCT01845337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645514|NCT01845337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645515|NCT01760005|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101645516|NCT01760005|Immunologic Factors|immunologic factors|mesh-ancestor
101597596|NCT00701155|Insulin Detemir|insulin detemir|mesh-list
101597597|NCT00701155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101597598|NCT00701155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597599|NCT02874690|Methylphenidate|methylphenidate|mesh-list
101597600|NCT02874690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101597601|NCT02874690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597602|NCT02874690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101597603|NCT02874690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101597604|NCT02874690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101645517|NCT01760005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645518|NCT01613118|Irbesartan|irbesartan|mesh-list
101645519|NCT01613118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101645520|NCT01613118|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101645521|NCT01613118|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101645522|NCT01613118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645523|NCT00836537|Benazepril|benazepril|mesh-list
101645524|NCT00836537|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101645525|NCT00836537|Protease Inhibitors|protease inhibitors|mesh-ancestor
101645526|NCT00836537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101645527|NCT00836537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645528|NCT00836537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101645529|NCT00680901|Capecitabine|capecitabine|mesh-list
101645530|NCT00680901|Oxaliplatin|oxaliplatin|mesh-list
101645531|NCT00680901|Lapatinib|lapatinib|mesh-list
101645532|NCT00680901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101645533|NCT00680901|Antimetabolites|antimetabolites|mesh-ancestor
101645534|NCT00680901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645535|NCT00680901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645536|NCT00680901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101645537|NCT00680901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101645538|NCT00572169|Thalidomide|thalidomide|mesh-list
101645539|NCT00572169|Dexamethasone|dexamethasone|mesh-list
101645540|NCT00572169|Cyclophosphamide|cyclophosphamide|mesh-list
101645541|NCT00572169|Cisplatin|cisplatin|mesh-list
101645542|NCT00572169|Doxorubicin|doxorubicin|mesh-list
101645543|NCT00572169|Etoposide|etoposide|mesh-list
101645544|NCT00572169|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101645545|NCT00572169|Bortezomib|bortezomib|mesh-list
101645546|NCT00572169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101645547|NCT00572169|Immunologic Factors|immunologic factors|mesh-ancestor
101645548|NCT00572169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645549|NCT00572169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101645550|NCT00572169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101645551|NCT00572169|Alkylating Agents|alkylating agents|mesh-ancestor
101645552|NCT00572169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645553|NCT00572169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645554|NCT00572169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101645555|NCT00572169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101645556|NCT00572169|Antiemetics|antiemetics|mesh-ancestor
101645557|NCT00572169|Autonomic Agents|autonomic agents|mesh-ancestor
101645558|NCT00572169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101645559|NCT00572169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101645562|NCT00572169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101645563|NCT00572169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101645564|NCT00572169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101645565|NCT00572169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101645566|NCT00572169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101645567|NCT00572169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101645568|NCT00572169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101645569|NCT00572169|Leprostatic Agents|leprostatic agents|mesh-ancestor
101645570|NCT00572169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101597605|NCT02874690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597606|NCT02874690|Dopamine Agents|dopamine agents|mesh-ancestor
101597607|NCT02874690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101597608|NCT02738632|Amlodipine|amlodipine|mesh-list
101597609|NCT02738632|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101597610|NCT02738632|Telmisartan|telmisartan|mesh-list
101358286|NCT00202696|Nalmefene|nalmefene|mesh-list
101597611|NCT02738632|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
101597612|NCT02738632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101597613|NCT02738632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101597614|NCT02738632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101597615|NCT02738632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597616|NCT02738632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101645571|NCT00572169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101645572|NCT00572169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101645573|NCT00572169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101645574|NCT00572169|Growth Substances|growth substances|mesh-ancestor
101645575|NCT00572169|Growth Inhibitors|growth inhibitors|mesh-ancestor
101645580|NCT00941720|Cyclophosphamide|cyclophosphamide|mesh-list
101645581|NCT00941720|Busulfan|busulfan|mesh-list
101645582|NCT00941720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101302683|NCT02007161|Analgesics|analgesics|mesh-ancestor
101645583|NCT00941720|Immunologic Factors|immunologic factors|mesh-ancestor
101645584|NCT00941720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645585|NCT00941720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101645586|NCT00941720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101645587|NCT00941720|Alkylating Agents|alkylating agents|mesh-ancestor
101645588|NCT00941720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645589|NCT00941720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645590|NCT00941720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101645591|NCT02583568|Bevacizumab|bevacizumab|mesh-list
101645592|NCT02583568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101645593|NCT02583568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645594|NCT02583568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101645595|NCT02583568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101645596|NCT02583568|Growth Substances|growth substances|mesh-ancestor
101645597|NCT02583568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645598|NCT02583568|Growth Inhibitors|growth inhibitors|mesh-ancestor
101645599|NCT02852564|Ethacrynic Acid|ethacrynic acid|mesh-list
101645600|NCT02852564|Diuretics|diuretics|mesh-ancestor
101645601|NCT02852564|Natriuretic Agents|natriuretic agents|mesh-ancestor
101645602|NCT02852564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645603|NCT02852564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101645604|NCT02852564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645605|NCT05593042|Vaccines|vaccines|mesh-list
101645606|NCT05593042|Immunologic Factors|immunologic factors|mesh-ancestor
101645607|NCT05593042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645608|NCT05509816|Midazolam|midazolam|mesh-list
101645609|NCT05509816|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101645610|NCT05509816|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101645611|NCT05509816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101645612|NCT05509816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645613|NCT05509816|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101645614|NCT05509816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101645615|NCT05509816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101645616|NCT05509816|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101645617|NCT05509816|Anesthetics, General|anesthetics, general|mesh-ancestor
101645618|NCT05509816|Anesthetics|anesthetics|mesh-ancestor
101645619|NCT05509816|GABA Modulators|gaba modulators|mesh-ancestor
101645620|NCT05509816|GABA Agents|gaba agents|mesh-ancestor
101645621|NCT05509816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101597617|NCT02738632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597618|NCT02738632|Vasodilator Agents|vasodilator agents|mesh-ancestor
101597619|NCT02738632|Diuretics|diuretics|mesh-ancestor
101597620|NCT02738632|Natriuretic Agents|natriuretic agents|mesh-ancestor
101597621|NCT02738632|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101597622|NCT02738632|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101597623|NCT02738632|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101597624|NCT01070394|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101597625|NCT01070394|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101597626|NCT01070394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597627|NCT01070394|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101597628|NCT01070394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101597629|NCT01070394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101597630|NCT01070394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597631|NCT01070394|Dopamine Agents|dopamine agents|mesh-ancestor
101597632|NCT01070394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101597633|NCT00703807|Everolimus|everolimus|mesh-list
101597634|NCT00703807|Topotecan|topotecan|mesh-list
101597635|NCT00703807|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101597636|NCT00703807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101597637|NCT00703807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101645622|NCT05509816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645623|NCT04080310|Ezetimibe|ezetimibe|mesh-list
101645624|NCT04080310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
101645625|NCT04080310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101645626|NCT04080310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101645627|NCT04080310|Antimetabolites|antimetabolites|mesh-ancestor
101645628|NCT04080310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645629|NCT04080310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101645630|NCT04080310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101645631|NCT04078048|Vitamins|vitamins|mesh-list
101645632|NCT04078048|Vitamin E|vitamin e|mesh-list
101645633|NCT04078048|Antioxidants|antioxidants|mesh-list
101645634|NCT04078048|Micronutrients|micronutrients|mesh-ancestor
101645635|NCT04078048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645636|NCT04078048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645637|NCT04078048|Protective Agents|protective agents|mesh-ancestor
101645638|NCT00673387|Pramlintide|pramlintide|mesh-list
101645639|NCT00673387|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
101645640|NCT00673387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101645641|NCT00673387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645642|NCT00673387|Appetite Depressants|appetite depressants|mesh-ancestor
101645643|NCT00673387|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101645644|NCT00673387|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
101645645|NCT00673387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645647|NCT00933608|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101645648|NCT00933608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101645649|NCT00933608|Dopamine Agents|dopamine agents|mesh-ancestor
101645650|NCT00933608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101645651|NCT00933608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645652|NCT00933608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597638|NCT00703807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597639|NCT00703807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101597640|NCT00703807|Immunologic Factors|immunologic factors|mesh-ancestor
101597641|NCT00703807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597642|NCT00703807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101597643|NCT00703807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101597644|NCT00703807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101597645|NCT03649438|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
101597646|NCT03649438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101597647|NCT03649438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101597648|NCT03649438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597649|NCT03649438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101597650|NCT00701233|Botulinum Toxins|botulinum toxins|mesh-list
101597651|NCT00701233|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101597652|NCT00701233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101451774|NCT00203177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101645653|NCT00933608|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101645654|NCT00933608|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101645655|NCT05380310|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101645656|NCT02558023|Nicardipine|nicardipine|mesh-list
101645657|NCT02558023|Urapidil|urapidil|mesh-list
101645658|NCT02558023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101645659|NCT02558023|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101645660|NCT02558023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101645661|NCT02558023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645662|NCT02558023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101645663|NCT02558023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645664|NCT02558023|Vasodilator Agents|vasodilator agents|mesh-ancestor
101645665|NCT02558023|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101645666|NCT02558023|Serotonin Agents|serotonin agents|mesh-ancestor
101645667|NCT02558023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101645668|NCT02558023|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101645669|NCT02558023|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101645670|NCT02558023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101645671|NCT02558023|Adrenergic Agents|adrenergic agents|mesh-ancestor
101645672|NCT00607568|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101645673|NCT00607568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101645674|NCT00607568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101645675|NCT00607568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101645676|NCT00607568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645677|NCT00607568|Adrenergic Agents|adrenergic agents|mesh-ancestor
101645678|NCT00607568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101645679|NCT00607568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645680|NCT00606164|Bryostatin 1|bryostatin 1|mesh-list
101645681|NCT00606164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101645682|NCT00606164|Immunologic Factors|immunologic factors|mesh-ancestor
101645683|NCT00606164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645684|NCT00606164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645685|NCT00574951|Motesanib diphosphate|motesanib diphosphate|mesh-list
101645686|NCT00574951|Imetelstat|imetelstat|mesh-list
101645687|NCT00574951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101645688|NCT00574951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101645689|NCT00574951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645691|NCT02584816|Immunologic Factors|immunologic factors|mesh-ancestor
101597653|NCT00701233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597654|NCT00701233|Cholinergic Agents|cholinergic agents|mesh-ancestor
101597655|NCT00701233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101597656|NCT00701233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597657|NCT03633058|Ketamine|ketamine|mesh-list
101597658|NCT03633058|Analgesics|analgesics|mesh-ancestor
101597659|NCT03633058|Sensory System Agents|sensory system agents|mesh-ancestor
101597660|NCT03633058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101451775|NCT00203177|Protective Agents|protective agents|mesh-ancestor
101645692|NCT02584816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645693|NCT02584738|Methylprednisolone|methylprednisolone|mesh-list
101645694|NCT02584738|Prednisolone|prednisolone|mesh-list
101645695|NCT02584738|Magnesium Sulfate|magnesium sulfate|mesh-list
101645696|NCT02584738|Bromides|bromides|mesh-list
101645697|NCT02584738|Albuterol|albuterol|mesh-list
101645698|NCT02584738|Ipratropium|ipratropium|mesh-list
101645699|NCT02584738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101645700|NCT02584738|Antiemetics|antiemetics|mesh-ancestor
101645701|NCT02584738|Autonomic Agents|autonomic agents|mesh-ancestor
101645702|NCT02584738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101645703|NCT02584738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645704|NCT02584738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101645705|NCT02584738|Glucocorticoids|glucocorticoids|mesh-ancestor
101645706|NCT02584738|Hormones|hormones|mesh-ancestor
101645707|NCT02584738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101645708|NCT02584738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101645709|NCT02584738|Protective Agents|protective agents|mesh-ancestor
101645710|NCT02584738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101645711|NCT02584738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645712|NCT02584738|Anticonvulsants|anticonvulsants|mesh-ancestor
101645713|NCT02584738|Analgesics|analgesics|mesh-ancestor
101645714|NCT02584738|Sensory System Agents|sensory system agents|mesh-ancestor
101645715|NCT02584738|Anesthetics|anesthetics|mesh-ancestor
101358304|NCT00071838|Daclizumab|daclizumab|mesh-list
101645716|NCT02584738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101645717|NCT02584738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101645718|NCT02584738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101645719|NCT02584738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101645720|NCT02584738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645721|NCT02584738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101645722|NCT02584738|Tocolytic Agents|tocolytic agents|mesh-ancestor
101645723|NCT02584738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101645724|NCT02584738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101645725|NCT02584738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101645726|NCT02584738|Respiratory System Agents|respiratory system agents|mesh-ancestor
101645727|NCT02584738|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101645728|NCT02584738|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101645729|NCT02584738|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101645730|NCT02584738|Adrenergic Agents|adrenergic agents|mesh-ancestor
101645731|NCT02584738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101645732|NCT02584738|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101645733|NCT02584738|Cholinergic Agents|cholinergic agents|mesh-ancestor
101645734|NCT00765271|Ritonavir|ritonavir|mesh-list
101645735|NCT00765271|Darunavir|darunavir|mesh-list
101645736|NCT00765271|Raltegravir Potassium|raltegravir potassium|mesh-list
101645738|NCT00765271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101645739|NCT00765271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101645740|NCT00765271|Protease Inhibitors|protease inhibitors|mesh-ancestor
101645741|NCT00765271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101645742|NCT00765271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645743|NCT00765271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101645744|NCT00765271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101645745|NCT00765271|Antiviral Agents|antiviral agents|mesh-ancestor
101645746|NCT00765271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101645747|NCT00765271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101645748|NCT00765271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101645749|NCT00765271|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101597662|NCT03633058|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101597663|NCT03633058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101597664|NCT03633058|Anesthetics, General|anesthetics, general|mesh-ancestor
101597665|NCT03633058|Anesthetics|anesthetics|mesh-ancestor
101597666|NCT03633058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101597667|NCT03633058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101597668|NCT03633058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101597669|NCT03633058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101597670|NCT03633058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597671|NCT01070316|Everolimus|everolimus|mesh-list
101597672|NCT01070316|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101597673|NCT01070316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101645750|NCT00765271|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101645751|NCT00765271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101645752|NCT00765271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101645753|NCT04416568|Nivolumab|nivolumab|mesh-list
101645754|NCT04416568|Ipilimumab|ipilimumab|mesh-list
101645755|NCT04416568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101645756|NCT04416568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645757|NCT04416568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101645758|NCT04416568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645760|NCT02583022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101645761|NCT02583022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101645762|NCT02583022|Analgesics|analgesics|mesh-ancestor
101645763|NCT02583022|Sensory System Agents|sensory system agents|mesh-ancestor
101645764|NCT02583022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101645765|NCT02583022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645766|NCT02583022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101645767|NCT02583022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101645768|NCT02583022|Dermatologic Agents|dermatologic agents|mesh-ancestor
101645769|NCT02583022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101645770|NCT02583022|Immunologic Factors|immunologic factors|mesh-ancestor
101645771|NCT02583022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101645772|NCT02583022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101645773|NCT02583022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645774|NCT00764725|Sulfasalazine|sulfasalazine|mesh-list
101645775|NCT00764725|Infliximab|infliximab|mesh-list
101645776|NCT00764725|Methotrexate|methotrexate|mesh-list
101645777|NCT00764725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101645778|NCT00764725|Abortifacient Agents|abortifacient agents|mesh-ancestor
101645779|NCT00764725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101645780|NCT00764725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645781|NCT00764725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101645782|NCT00764725|Antimetabolites|antimetabolites|mesh-ancestor
101645783|NCT00764725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645784|NCT00764725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645785|NCT00764725|Dermatologic Agents|dermatologic agents|mesh-ancestor
101645786|NCT00764725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101645787|NCT00764725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101645788|NCT00764725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101645789|NCT00764725|Immunologic Factors|immunologic factors|mesh-ancestor
101645790|NCT00764725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101645791|NCT00764725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101645792|NCT00764725|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101645793|NCT00764725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101645794|NCT00764725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101645795|NCT00764725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101645796|NCT00764725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101645797|NCT00764725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101597674|NCT01070316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101597675|NCT01070316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597676|NCT01070316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101597677|NCT01070316|Immunologic Factors|immunologic factors|mesh-ancestor
101597678|NCT01070316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597679|NCT01070316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101597681|NCT02737774|Pemetrexed|pemetrexed|mesh-list
101597682|NCT02737774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101597683|NCT02737774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101597684|NCT02737774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645798|NCT00764725|Analgesics|analgesics|mesh-ancestor
101645799|NCT00764725|Sensory System Agents|sensory system agents|mesh-ancestor
101645800|NCT00764725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101645801|NCT00936884|Methylnaltrexone|methylnaltrexone|mesh-list
101645802|NCT00936884|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101645803|NCT00936884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645804|NCT00936884|Sensory System Agents|sensory system agents|mesh-ancestor
101645805|NCT00936884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101645807|NCT04077892|Montelukast|montelukast|mesh-list
101645808|NCT04077892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101645809|NCT04077892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101645810|NCT04077892|Autonomic Agents|autonomic agents|mesh-ancestor
101645811|NCT04077892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101645812|NCT04077892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645813|NCT04077892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101645814|NCT04077892|Respiratory System Agents|respiratory system agents|mesh-ancestor
101645815|NCT04077892|Glucocorticoids|glucocorticoids|mesh-ancestor
101645816|NCT04077892|Hormones|hormones|mesh-ancestor
101645817|NCT04077892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101645818|NCT04077892|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101645819|NCT04077892|Hormone Antagonists|hormone antagonists|mesh-ancestor
101645820|NCT04077892|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101645821|NCT04077892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101645822|NCT04077892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645823|NCT00606242|Fluticasone|fluticasone|mesh-list
101645824|NCT00606242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101645825|NCT00606242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101645826|NCT00606242|Autonomic Agents|autonomic agents|mesh-ancestor
101645827|NCT00606242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101645828|NCT00606242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645829|NCT00606242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101645830|NCT00606242|Respiratory System Agents|respiratory system agents|mesh-ancestor
101645831|NCT00606242|Dermatologic Agents|dermatologic agents|mesh-ancestor
101645832|NCT00606242|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101645833|NCT00607646|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101645834|NCT00607646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101645835|NCT00607646|Immunologic Factors|immunologic factors|mesh-ancestor
101645836|NCT00607646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645838|NCT00770263|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101645839|NCT00770263|Temsirolimus|temsirolimus|mesh-list
101645840|NCT00770263|MTOR Inhibitors|mtor inhibitors|mesh-list
101645841|NCT00770263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645842|NCT00770263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101645843|NCT00770263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101645844|NCT00770263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645845|NCT00770263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101645846|NCT00770263|Immunologic Factors|immunologic factors|mesh-ancestor
101645847|NCT00770263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645848|NCT00770263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101645849|NCT00770263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101645850|NCT00770263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101597685|NCT02737774|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101597686|NCT02737774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101597687|NCT02735590|Isoniazid|isoniazid|mesh-list
101597688|NCT02735590|Rifapentine|rifapentine|mesh-list
101597689|NCT02735590|Antitubercular Agents|antitubercular agents|mesh-ancestor
101597690|NCT02735590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101597691|NCT02735590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101597692|NCT02735590|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101597693|NCT02735590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101597694|NCT02735590|Antimetabolites|antimetabolites|mesh-ancestor
101597695|NCT02735590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597696|NCT02735590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101597697|NCT02735590|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101597698|NCT02735590|Leprostatic Agents|leprostatic agents|mesh-ancestor
101645851|NCT00770263|Antifungal Agents|antifungal agents|mesh-ancestor
101645852|NCT02691026|Pembrolizumab|pembrolizumab|mesh-list
101645853|NCT02691026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101645854|NCT02691026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645855|NCT02691026|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101645856|NCT02691026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645857|NCT05400148|Bupivacaine|bupivacaine|mesh-list
101645858|NCT05400148|Anesthetics, Local|anesthetics, local|mesh-ancestor
101645859|NCT05400148|Anesthetics|anesthetics|mesh-ancestor
101645860|NCT05400148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101645861|NCT05400148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645862|NCT05400148|Sensory System Agents|sensory system agents|mesh-ancestor
101645863|NCT05400148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101645864|NCT00765427|Retinol acetate|retinol acetate|mesh-list
101645865|NCT00765427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101645866|NCT00765427|Immunologic Factors|immunologic factors|mesh-ancestor
101645867|NCT00765427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645868|NCT00765427|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101645869|NCT00765427|Protective Agents|protective agents|mesh-ancestor
101645870|NCT00765427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645871|NCT02584582|Liraglutide|liraglutide|mesh-list
101645872|NCT02584582|Exenatide|exenatide|mesh-list
101645873|NCT02584582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101645874|NCT02584582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645875|NCT02584582|Incretins|incretins|mesh-ancestor
101645876|NCT02584582|Hormones|hormones|mesh-ancestor
101645877|NCT02584582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101645878|NCT02584582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101645879|NCT04266002|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101645880|NCT04266002|Antiviral Agents|antiviral agents|mesh-ancestor
101645881|NCT04266002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101645882|NCT00765973|Topotecan|topotecan|mesh-list
101358336|NCT00203125|Adrenergic Agents|adrenergic agents|mesh-ancestor
101645883|NCT00765973|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101645884|NCT00765973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101645885|NCT00765973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101645886|NCT00765973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645887|NCT00765973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645888|NCT00775177|Doxycycline|doxycycline|mesh-list
101645889|NCT00775177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101645890|NCT00775177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101645891|NCT00775177|Antimalarials|antimalarials|mesh-ancestor
101645892|NCT00775177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101645893|NCT00775177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101645894|NCT00770497|Pioglitazone|pioglitazone|mesh-list
101645895|NCT00770497|Ramipril|ramipril|mesh-list
101645896|NCT00770497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101597700|NCT05626348|Adalimumab|adalimumab|mesh-list
101597701|NCT05626348|Methotrexate|methotrexate|mesh-list
101597702|NCT05626348|Leflunomide|leflunomide|mesh-list
101597703|NCT05626348|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101597704|NCT05626348|Abortifacient Agents|abortifacient agents|mesh-ancestor
101597705|NCT05626348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101597706|NCT05626348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597707|NCT05626348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101597708|NCT05626348|Antimetabolites|antimetabolites|mesh-ancestor
101597709|NCT05626348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597710|NCT05626348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101597711|NCT05626348|Dermatologic Agents|dermatologic agents|mesh-ancestor
101597712|NCT05626348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101597713|NCT05626348|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101597714|NCT05626348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101597715|NCT05626348|Immunologic Factors|immunologic factors|mesh-ancestor
101597716|NCT05626348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101597717|NCT05626348|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101597718|NCT05626348|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101597719|NCT05626348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101597720|NCT05626348|Antimalarials|antimalarials|mesh-ancestor
101597721|NCT05626348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101597722|NCT05626348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101597723|NCT05626348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101597725|NCT02737696|Narcotics|narcotics|mesh-ancestor
101597726|NCT02737696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101597727|NCT02737696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597728|NCT02737696|Analgesics|analgesics|mesh-ancestor
101597729|NCT02737696|Sensory System Agents|sensory system agents|mesh-ancestor
101597730|NCT02737696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101597731|NCT02737228|Gemcitabine|gemcitabine|mesh-list
101597732|NCT02737228|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101597733|NCT02737228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101645897|NCT00770497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645898|NCT00770497|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101645899|NCT00770497|Protease Inhibitors|protease inhibitors|mesh-ancestor
101645900|NCT00770497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101597734|NCT02737228|Antimetabolites|antimetabolites|mesh-ancestor
101597735|NCT02737228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597736|NCT02737228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101597737|NCT02737228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101597738|NCT02737228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101597739|NCT01126541|Rituximab|rituximab|mesh-list
101597740|NCT01126541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101597741|NCT01126541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101597742|NCT01126541|Immunologic Factors|immunologic factors|mesh-ancestor
101597743|NCT01126541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597744|NCT01126541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101597745|NCT02737150|Anesthetics|anesthetics|mesh-list
101597746|NCT02737150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101597747|NCT02737150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597748|NCT02735356|Itraconazole|itraconazole|mesh-list
101597749|NCT02735356|Antifungal Agents|antifungal agents|mesh-ancestor
101597750|NCT02735356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101597751|NCT02735356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101597752|NCT02735356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101597753|NCT02735356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101597754|NCT02735356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597755|NCT02735356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101597756|NCT02735356|Hormone Antagonists|hormone antagonists|mesh-ancestor
101597757|NCT02735356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101597758|NCT02735356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597759|NCT02735356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101597760|NCT00625469|Bosentan|bosentan|mesh-list
101597777|NCT00637559|Esomeprazole|esomeprazole|mesh-list
101597778|NCT00637559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101597779|NCT00637559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101597780|NCT00637559|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101597781|NCT00637559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101597782|NCT00637559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597783|NCT00836875|Voriconazole|voriconazole|mesh-list
101597784|NCT00836875|Antifungal Agents|antifungal agents|mesh-ancestor
101597785|NCT00836875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101597786|NCT00836875|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101597787|NCT00836875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101597788|NCT00836875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101645901|NCT00770497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645902|NCT00770497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101645903|NCT02581696|Irsogladine|irsogladine|mesh-list
101645904|NCT02581696|Lafutidine|lafutidine|mesh-list
101645905|NCT02581696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645906|NCT02581696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101645907|NCT02581696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101645908|NCT02581696|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101645909|NCT02581696|Histamine Antagonists|histamine antagonists|mesh-ancestor
101645910|NCT02581696|Histamine Agents|histamine agents|mesh-ancestor
101645911|NCT02581696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101645912|NCT02581696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645913|NCT02581696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645914|NCT02581696|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101645915|NCT02581696|Protective Agents|protective agents|mesh-ancestor
101645916|NCT02581696|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101645917|NCT00607958|Ritonavir|ritonavir|mesh-list
101645918|NCT00607958|Tipranavir|tipranavir|mesh-list
101645919|NCT00607958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101645920|NCT00607958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101645921|NCT00607958|Protease Inhibitors|protease inhibitors|mesh-ancestor
101645922|NCT00607958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101645923|NCT00607958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645924|NCT00607958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101645925|NCT00607958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101645926|NCT00607958|Antiviral Agents|antiviral agents|mesh-ancestor
101645927|NCT00607958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101645928|NCT00607958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101645929|NCT00607958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101645930|NCT00770575|Pioglitazone|pioglitazone|mesh-list
101645931|NCT00770575|Atorvastatin|atorvastatin|mesh-list
101645932|NCT00770575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101645933|NCT00770575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101645934|NCT00770575|Antimetabolites|antimetabolites|mesh-ancestor
101645935|NCT00770575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645936|NCT00770575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101645937|NCT00770575|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101645938|NCT00770575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101645939|NCT00770575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101333333|NCT00016887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101645940|NCT00770575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645941|NCT00770731|Sirolimus|sirolimus|mesh-list
101645942|NCT00770731|Bortezomib|bortezomib|mesh-list
101645943|NCT00770731|Topotecan|topotecan|mesh-list
101645944|NCT00770731|Temsirolimus|temsirolimus|mesh-list
101645945|NCT00770731|MTOR Inhibitors|mtor inhibitors|mesh-list
101645946|NCT00770731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645947|NCT00770731|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101645948|NCT00770731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101597789|NCT00836875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597790|NCT00836875|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101597791|NCT00836875|Hormone Antagonists|hormone antagonists|mesh-ancestor
101597792|NCT00836875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101597793|NCT00836875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597794|NCT00836875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101597796|NCT02732314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101597798|NCT01125917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101597799|NCT01125917|Narcotics|narcotics|mesh-ancestor
101597800|NCT01125917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101597801|NCT01125917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597802|NCT01125917|Analgesics|analgesics|mesh-ancestor
101597803|NCT01125917|Sensory System Agents|sensory system agents|mesh-ancestor
101597804|NCT01125917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101537382|NCT01085097|Prednisolone phosphate|prednisolone phosphate|mesh-list
101537385|NCT01085097|Hormones|hormones|mesh-ancestor
101645949|NCT00770731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101645950|NCT00770731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645951|NCT00770731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101645952|NCT00770731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101645953|NCT00770731|Immunologic Factors|immunologic factors|mesh-ancestor
101645954|NCT00770731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645955|NCT00770731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101645956|NCT00770731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101645957|NCT00770731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101645958|NCT00770731|Antifungal Agents|antifungal agents|mesh-ancestor
101645959|NCT00775255|Clarithromycin|clarithromycin|mesh-list
101645960|NCT00775255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101645961|NCT00775255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101645962|NCT00775255|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101645963|NCT00775255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101645964|NCT00775255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645965|NCT00775255|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101645966|NCT00775255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101645968|NCT00606866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645969|NCT00606866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101645970|NCT00606866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101645971|NCT00606866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645972|NCT00766285|Vaccines|vaccines|mesh-list
101645973|NCT00766285|Immunologic Factors|immunologic factors|mesh-ancestor
101645974|NCT00766285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645975|NCT04265456|Acetaminophen|acetaminophen|mesh-list
101645976|NCT04265456|Pregabalin|pregabalin|mesh-list
101645977|NCT04265456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101645978|NCT04265456|Analgesics|analgesics|mesh-ancestor
101645979|NCT04265456|Sensory System Agents|sensory system agents|mesh-ancestor
101645980|NCT04265456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101645981|NCT04265456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101645982|NCT04265456|Antipyretics|antipyretics|mesh-ancestor
101645983|NCT04265456|Anticonvulsants|anticonvulsants|mesh-ancestor
101645984|NCT04265456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101645985|NCT04265456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101597805|NCT01125917|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101597807|NCT02732236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101597808|NCT02732236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101597809|NCT02732236|Immunologic Factors|immunologic factors|mesh-ancestor
101597810|NCT02732236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597811|NCT02732236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101597813|NCT01121549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101597814|NCT01121549|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101597815|NCT01121549|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101597816|NCT01121549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101597817|NCT01121549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597818|NCT01121549|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101597819|NCT01121549|Hormone Antagonists|hormone antagonists|mesh-ancestor
101645986|NCT04265456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645987|NCT04265456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101645988|NCT04265456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101645989|NCT04265456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101645990|NCT04265456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101645991|NCT04265456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101645992|NCT04379518|Interferons|interferons|mesh-list
101645993|NCT04379518|Interferon-alpha|interferon-alpha|mesh-list
101645994|NCT04379518|Interferon alpha-2|interferon alpha-2|mesh-list
101645995|NCT04379518|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
101645996|NCT04379518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101645997|NCT04379518|Antiviral Agents|antiviral agents|mesh-ancestor
101645998|NCT04379518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101645999|NCT04379518|Immunologic Factors|immunologic factors|mesh-ancestor
101646000|NCT04379518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646001|NCT04378426|Midazolam|midazolam|mesh-list
101646002|NCT04378426|Nitrous Oxide|nitrous oxide|mesh-list
101646003|NCT04378426|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101646004|NCT04378426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101646005|NCT04378426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101646006|NCT04378426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646007|NCT04378426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101646008|NCT04378426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101646009|NCT04378426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101646010|NCT04378426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101646011|NCT04378426|Anesthetics, General|anesthetics, general|mesh-ancestor
101646012|NCT04378426|Anesthetics|anesthetics|mesh-ancestor
101646013|NCT04378426|GABA Modulators|gaba modulators|mesh-ancestor
101646014|NCT04378426|GABA Agents|gaba agents|mesh-ancestor
101646015|NCT04378426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101646016|NCT04378426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646017|NCT04378426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101646018|NCT04378426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101646019|NCT04378426|Analgesics|analgesics|mesh-ancestor
101646020|NCT04378426|Sensory System Agents|sensory system agents|mesh-ancestor
101646021|NCT04378426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101646022|NCT02581462|Trastuzumab|trastuzumab|mesh-list
101646024|NCT02581462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101646025|NCT02581462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101646026|NCT00668863|Leucovorin|leucovorin|mesh-list
101646027|NCT00668863|Fluorouracil|fluorouracil|mesh-list
101646028|NCT00668863|Irinotecan|irinotecan|mesh-list
101646029|NCT00668863|Sunitinib|sunitinib|mesh-list
101646030|NCT00668863|Levoleucovorin|levoleucovorin|mesh-list
101646031|NCT00668863|Antimetabolites|antimetabolites|mesh-ancestor
101646032|NCT00668863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646033|NCT00668863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101646034|NCT00668863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101597820|NCT01121549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101597821|NCT01121549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597822|NCT00847405|Sumatriptan|sumatriptan|mesh-list
101597823|NCT00847405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101597824|NCT00847405|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101597825|NCT00847405|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101597826|NCT00847405|Serotonin Agents|serotonin agents|mesh-ancestor
101597827|NCT00847405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101597828|NCT00847405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597829|NCT00847405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597830|NCT02731846|Fluticasone|fluticasone|mesh-list
101597831|NCT02731846|Xhance|xhance|mesh-list
101597832|NCT02731846|Albuterol|albuterol|mesh-list
101597833|NCT02731846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101646035|NCT00668863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101646036|NCT00668863|Immunologic Factors|immunologic factors|mesh-ancestor
101646037|NCT00668863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646038|NCT00668863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101646039|NCT00668863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101646040|NCT00668863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101646041|NCT00668863|Antidotes|antidotes|mesh-ancestor
101646042|NCT00668863|Protective Agents|protective agents|mesh-ancestor
101646043|NCT00668863|Vitamin B Complex|vitamin b complex|mesh-ancestor
101646044|NCT00668863|Vitamins|vitamins|mesh-ancestor
101646045|NCT00668863|Micronutrients|micronutrients|mesh-ancestor
101646046|NCT00668863|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101646047|NCT00668863|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101646048|NCT00668863|Growth Substances|growth substances|mesh-ancestor
101646049|NCT00668863|Growth Inhibitors|growth inhibitors|mesh-ancestor
101646050|NCT00668863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101646051|NCT04077736|Aldesleukin|aldesleukin|mesh-list
101646052|NCT04077736|Interleukin-2|interleukin-2|mesh-list
101646053|NCT04077736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101646054|NCT04077736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101646055|NCT04077736|Analgesics|analgesics|mesh-ancestor
101646056|NCT04077736|Sensory System Agents|sensory system agents|mesh-ancestor
101646057|NCT04077736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101646058|NCT04077736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646059|NCT04077736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101646060|NCT04077736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101646061|NCT04077736|Antiviral Agents|antiviral agents|mesh-ancestor
101646062|NCT04077736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101646063|NCT00766441|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101646064|NCT00766441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101646065|NCT00766441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646066|NCT00766441|Incretins|incretins|mesh-ancestor
101646067|NCT00766441|Hormones|hormones|mesh-ancestor
101646068|NCT00766441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101646069|NCT00766441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101646070|NCT00766441|Protease Inhibitors|protease inhibitors|mesh-ancestor
101646071|NCT00766441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101646072|NCT00766441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646073|NCT00771043|Natalizumab|natalizumab|mesh-list
101646074|NCT00771043|Immunologic Factors|immunologic factors|mesh-ancestor
101646075|NCT00771043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646076|NCT04267250|Levonorgestrel|levonorgestrel|mesh-list
101646077|NCT04267250|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101646078|NCT04267250|Estradiol|estradiol|mesh-list
101646079|NCT04267250|PF-06700841|pf-06700841|mesh-list
101646080|NCT04267250|Estrogens|estrogens|mesh-ancestor
101646081|NCT04267250|Hormones|hormones|mesh-ancestor
101646082|NCT04267250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101597835|NCT02731846|Autonomic Agents|autonomic agents|mesh-ancestor
101597836|NCT02731846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101597837|NCT02731846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597838|NCT02731846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101597839|NCT02731846|Respiratory System Agents|respiratory system agents|mesh-ancestor
101597840|NCT02731846|Dermatologic Agents|dermatologic agents|mesh-ancestor
101597841|NCT02731846|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101597842|NCT02731846|Tocolytic Agents|tocolytic agents|mesh-ancestor
101597843|NCT02731846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101597844|NCT02731846|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101597845|NCT02731846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101597846|NCT02731846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101597847|NCT02731846|Adrenergic Agents|adrenergic agents|mesh-ancestor
101597848|NCT02731846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101597849|NCT02731846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597850|NCT04248712|Loratadine|loratadine|mesh-list
101597851|NCT04248712|Famotidine|famotidine|mesh-list
101597852|NCT04248712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101597853|NCT04248712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101597854|NCT04248712|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101597855|NCT04248712|Histamine Antagonists|histamine antagonists|mesh-ancestor
101597856|NCT04248712|Histamine Agents|histamine agents|mesh-ancestor
101597857|NCT04248712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101646083|NCT04267250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646084|NCT04267250|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101646085|NCT04267250|Contraceptive Agents|contraceptive agents|mesh-ancestor
101646086|NCT04267250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101646087|NCT04267250|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101646088|NCT04267250|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101646089|NCT04267250|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101646090|NCT04267250|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101646091|NCT04267250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101646092|NCT04267250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101646093|NCT04267250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646094|NCT00775489|Beclomethasone|beclomethasone|mesh-list
101646095|NCT00775489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101646096|NCT00775489|Glucocorticoids|glucocorticoids|mesh-ancestor
101646097|NCT00775489|Hormones|hormones|mesh-ancestor
101646098|NCT00775489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101646099|NCT00775489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646100|NCT00775489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101646101|NCT00775489|Respiratory System Agents|respiratory system agents|mesh-ancestor
101646102|NCT00771199|Fentanyl|fentanyl|mesh-list
101646103|NCT00771199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101646104|NCT00771199|Narcotics|narcotics|mesh-ancestor
101646105|NCT00771199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101646106|NCT00771199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646107|NCT00771199|Analgesics|analgesics|mesh-ancestor
101597858|NCT04248712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597859|NCT04248712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597860|NCT04248712|Antipruritics|antipruritics|mesh-ancestor
101597861|NCT04248712|Dermatologic Agents|dermatologic agents|mesh-ancestor
101597862|NCT04248712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101597863|NCT04248712|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101597864|NCT04248712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101597865|NCT02734732|Ciprofloxacin|ciprofloxacin|mesh-list
101597866|NCT02734732|Trimethoprim|trimethoprim|mesh-list
101597867|NCT02734732|Sulfamethoxazole|sulfamethoxazole|mesh-list
101597868|NCT02734732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101597869|NCT02734732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101646108|NCT00771199|Sensory System Agents|sensory system agents|mesh-ancestor
101646109|NCT00771199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101303208|NCT05410158|Ketamine|ketamine|mesh-list
101646110|NCT00771199|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101646111|NCT00771199|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101646112|NCT00771199|Anesthetics, General|anesthetics, general|mesh-ancestor
101646113|NCT00771199|Anesthetics|anesthetics|mesh-ancestor
101646114|NCT04264130|Artesunate|artesunate|mesh-list
101646115|NCT04264130|Lumefantrine|lumefantrine|mesh-list
101646116|NCT04264130|Artemether|artemether|mesh-list
101646117|NCT04264130|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101646118|NCT04264130|Pyronaridine|pyronaridine|mesh-list
101646119|NCT04264130|Artefenomel|artefenomel|mesh-list
101646120|NCT04264130|Ferroquine|ferroquine|mesh-list
101646121|NCT04264130|Antimalarials|antimalarials|mesh-ancestor
101646122|NCT04264130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101646123|NCT04264130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101646124|NCT04264130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101646125|NCT04264130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101646126|NCT04264130|Antiviral Agents|antiviral agents|mesh-ancestor
101646127|NCT04264130|Schistosomicides|schistosomicides|mesh-ancestor
101646128|NCT04264130|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101646129|NCT04264130|Anthelmintics|anthelmintics|mesh-ancestor
101646130|NCT02557867|Dexmedetomidine|dexmedetomidine|mesh-list
101646131|NCT02557867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101646132|NCT02557867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101646133|NCT02557867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646134|NCT02557867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101646135|NCT02557867|Analgesics|analgesics|mesh-ancestor
101646136|NCT02557867|Sensory System Agents|sensory system agents|mesh-ancestor
101646137|NCT02557867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101646138|NCT02557867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101646139|NCT02557867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101646140|NCT02557867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101646141|NCT02557867|Adrenergic Agents|adrenergic agents|mesh-ancestor
101646142|NCT02557867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101646143|NCT02557867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646144|NCT00605774|Epinephrine|epinephrine|mesh-list
101646145|NCT00605774|Racepinephrine|racepinephrine|mesh-list
101646146|NCT00605774|Epinephryl borate|epinephryl borate|mesh-list
101646147|NCT00605774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101646148|NCT00605774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101646149|NCT00605774|Adrenergic Agents|adrenergic agents|mesh-ancestor
101646150|NCT00605774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101646151|NCT00605774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646152|NCT00605774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646153|NCT00605774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101646154|NCT00605774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101646156|NCT00605774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101646157|NCT00605774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101646158|NCT00605774|Respiratory System Agents|respiratory system agents|mesh-ancestor
101646159|NCT00605774|Mydriatics|mydriatics|mesh-ancestor
101646160|NCT00605774|Sympathomimetics|sympathomimetics|mesh-ancestor
101597870|NCT02734732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101597871|NCT02734732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101597872|NCT02734732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101597873|NCT02734732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101597874|NCT02734732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101597875|NCT02734732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101597876|NCT02734732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101597877|NCT02734732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101597878|NCT02734732|Antimalarials|antimalarials|mesh-ancestor
101597879|NCT02734732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101218063|NCT01490268|Dsuvia|dsuvia|mesh-list
101597880|NCT02734732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101597881|NCT02734732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101597882|NCT02734732|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101597883|NCT02734732|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101597884|NCT02731378|Iron|iron|mesh-list
101597885|NCT02731378|Dextrans|dextrans|mesh-list
101597929|NCT00627354|Prednisone|prednisone|mesh-list
101597930|NCT00627354|Etoposide|etoposide|mesh-list
101597931|NCT00627354|Vinorelbine|vinorelbine|mesh-list
101597932|NCT00627354|Mitoxantrone|mitoxantrone|mesh-list
101597933|NCT00627354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101597934|NCT00627354|Glucocorticoids|glucocorticoids|mesh-ancestor
101597935|NCT00627354|Hormones|hormones|mesh-ancestor
101597936|NCT00627354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101597937|NCT00627354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101597997|NCT00855595|Dermatologic Agents|dermatologic agents|mesh-ancestor
101597998|NCT05433532|Azacitidine|azacitidine|mesh-list
101597999|NCT05433532|Venetoclax|venetoclax|mesh-list
101598000|NCT05433532|Flumatinib|flumatinib|mesh-list
101598001|NCT05433532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101598002|NCT05433532|Antimetabolites|antimetabolites|mesh-ancestor
101598003|NCT05433532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598004|NCT05433532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101598005|NCT05433532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101598006|NCT05433532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101598007|NCT00855439|Exenatide|exenatide|mesh-list
101598008|NCT00855439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101598009|NCT00855439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598010|NCT00855439|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101598011|NCT00855439|Incretins|incretins|mesh-ancestor
101598012|NCT00855439|Hormones|hormones|mesh-ancestor
101598013|NCT00855439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101598014|NCT01064856|Adalimumab|adalimumab|mesh-list
101598015|NCT01064856|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101598016|NCT01064856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101598017|NCT01064856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101598052|NCT02730364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101598053|NCT02730364|Analgesics|analgesics|mesh-ancestor
101598054|NCT02730364|Sensory System Agents|sensory system agents|mesh-ancestor
101598055|NCT02730364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101598056|NCT02730364|Antipyretics|antipyretics|mesh-ancestor
101598057|NCT02730364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598058|NCT02730364|Protective Agents|protective agents|mesh-ancestor
101598059|NCT02730364|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101598119|NCT02733250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598120|NCT02733250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101598121|NCT02733250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101598122|NCT03188068|Sirolimus|sirolimus|mesh-list
101598123|NCT03188068|Prednisolone|prednisolone|mesh-list
101598124|NCT03188068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101598125|NCT03188068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101598126|NCT03188068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101598127|NCT03188068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101598128|NCT03188068|Antifungal Agents|antifungal agents|mesh-ancestor
101598129|NCT03188068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101598130|NCT03188068|Immunologic Factors|immunologic factors|mesh-ancestor
101598131|NCT03188068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598132|NCT03188068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101598133|NCT03188068|Glucocorticoids|glucocorticoids|mesh-ancestor
101598134|NCT03188068|Hormones|hormones|mesh-ancestor
101598135|NCT03188068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101598136|NCT03188068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101598137|NCT01064310|Sunitinib|sunitinib|mesh-list
101598138|NCT01064310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101598172|NCT02726308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101598173|NCT02726308|Glucocorticoids|glucocorticoids|mesh-ancestor
101598174|NCT02726308|Hormones|hormones|mesh-ancestor
101598175|NCT02726308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101598176|NCT02726308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101598240|NCT00854581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101598242|NCT00854581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101598243|NCT00854581|Immunologic Factors|immunologic factors|mesh-ancestor
101598244|NCT00854581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598245|NCT00854581|Antimetabolites|antimetabolites|mesh-ancestor
101598246|NCT00854581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598247|NCT00854581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101598248|NCT00854581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101598249|NCT00854581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101598308|NCT02718820|Pembrolizumab|pembrolizumab|mesh-list
101598309|NCT02718820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101598310|NCT02718820|Tubulin Modulators|tubulin modulators|mesh-ancestor
101598311|NCT02718820|Antimitotic Agents|antimitotic agents|mesh-ancestor
101598379|NCT01121393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101598380|NCT01121393|Antimetabolites|antimetabolites|mesh-ancestor
101598381|NCT01121393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598382|NCT01121393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101598383|NCT01121393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101598384|NCT02882477|Metformin|metformin|mesh-list
101598448|NCT02714998|Dermatologic Agents|dermatologic agents|mesh-ancestor
101598449|NCT02714998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101598450|NCT02714998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101598451|NCT02714998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101598452|NCT02714998|Immunologic Factors|immunologic factors|mesh-ancestor
101598453|NCT02714998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101598454|NCT02714998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101598455|NCT00765310|Thioctic Acid|thioctic acid|mesh-list
101598456|NCT00765310|Antioxidants|antioxidants|mesh-ancestor
101598458|NCT00765310|Protective Agents|protective agents|mesh-ancestor
101598515|NCT02714842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598516|NCT02714530|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101598517|NCT02714530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101598585|NCT00611416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598586|NCT00611416|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101598587|NCT00611416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101598588|NCT00611416|Purinergic Agents|purinergic agents|mesh-ancestor
101598589|NCT00611416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101598590|NCT00611416|Antioxidants|antioxidants|mesh-ancestor
101598591|NCT00611416|Protective Agents|protective agents|mesh-ancestor
101598592|NCT00611416|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101598593|NCT00611416|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101598594|NCT00611416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101598596|NCT02712658|Terbutaline|terbutaline|mesh-list
101598647|NCT02711410|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101598648|NCT02711410|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101598649|NCT02711410|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101598650|NCT02711410|Purinergic Agents|purinergic agents|mesh-ancestor
101598651|NCT02711410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101598652|NCT02711410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598653|NCT02711410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598654|NCT02711176|Amoxicillin|amoxicillin|mesh-list
101598655|NCT02711176|Clarithromycin|clarithromycin|mesh-list
101598656|NCT02711176|Tinidazole|tinidazole|mesh-list
101598711|NCT02710396|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101598712|NCT02710396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101598713|NCT02710162|Capsaicin|capsaicin|mesh-list
101598714|NCT02710162|Antipruritics|antipruritics|mesh-ancestor
101598715|NCT02710162|Dermatologic Agents|dermatologic agents|mesh-ancestor
101598716|NCT02710162|Sensory System Agents|sensory system agents|mesh-ancestor
101598717|NCT02710162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101598718|NCT02710162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598719|NCT00611728|Irinotecan|irinotecan|mesh-list
101598720|NCT00611728|Sunitinib|sunitinib|mesh-list
101598721|NCT00611728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101598722|NCT00611728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101598723|NCT00611728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101598724|NCT00611728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598772|NCT02709382|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101598773|NCT02709382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101598774|NCT02709382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598775|NCT02708992|Azithromycin|azithromycin|mesh-list
101598777|NCT02708992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101598778|NCT02708992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101598779|NCT00611962|Paclitaxel|paclitaxel|mesh-list
101598780|NCT00611962|Oxaliplatin|oxaliplatin|mesh-list
101598840|NCT05378919|Antimetabolites|antimetabolites|mesh-ancestor
101598841|NCT05378919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101598842|NCT05378919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101598843|NCT05378919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101598844|NCT05378919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101598845|NCT05378919|Immunologic Factors|immunologic factors|mesh-ancestor
101598846|NCT05378919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598847|NCT05378919|Hematinics|hematinics|mesh-ancestor
101598848|NCT05378919|Vitamin B Complex|vitamin b complex|mesh-ancestor
101598849|NCT05378919|Vitamins|vitamins|mesh-ancestor
101598850|NCT05378919|Micronutrients|micronutrients|mesh-ancestor
101598851|NCT05378919|Antidotes|antidotes|mesh-ancestor
101598852|NCT05378919|Protective Agents|protective agents|mesh-ancestor
101598853|NCT00607581|Dexamethasone|dexamethasone|mesh-list
101598854|NCT00607581|Cyclophosphamide|cyclophosphamide|mesh-list
101598855|NCT00607581|Lenalidomide|lenalidomide|mesh-list
101598900|NCT05380479|Adrenergic Agents|adrenergic agents|mesh-ancestor
101598901|NCT05380479|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101598902|NCT05380479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101598903|NCT05380479|Serotonin Agents|serotonin agents|mesh-ancestor
101598904|NCT05380479|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101598905|NCT05380479|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101598906|NCT05380479|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101598908|NCT05380479|Contraceptive Agents|contraceptive agents|mesh-ancestor
101598968|NCT00606411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101598969|NCT00607737|Insulin Detemir|insulin detemir|mesh-list
101598972|NCT01120691|Glycopyrrolate|glycopyrrolate|mesh-list
101599039|NCT02724904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101599040|NCT02724904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101599108|NCT02724202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599109|NCT00605397|Trastuzumab|trastuzumab|mesh-list
101599111|NCT00605397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101599179|NCT00934947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101599180|NCT00934947|Adrenergic Agents|adrenergic agents|mesh-ancestor
101599181|NCT00934947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101599182|NCT00934947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599183|NCT00934947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599184|NCT00934947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101599247|NCT02722954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101599248|NCT02722954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101599249|NCT02722954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101599315|NCT01110707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101599316|NCT01110707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599318|NCT04931368|Methotrexate|methotrexate|mesh-list
101599319|NCT04931368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101599384|NCT04829422|Lazertinib|lazertinib|mesh-list
101599385|NCT04829422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101599386|NCT04829422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101599387|NCT04829422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599388|NCT02721862|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101599456|NCT00613132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101599457|NCT00613132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599458|NCT00613132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101599459|NCT00613132|Immunologic Factors|immunologic factors|mesh-ancestor
101599460|NCT00613132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599461|NCT00613132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101599462|NCT00613132|Antisickling Agents|antisickling agents|mesh-ancestor
101599463|NCT00613132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101599464|NCT04558216|Rifampin|rifampin|mesh-list
101599465|NCT04558216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101599466|NCT04558216|Antitubercular Agents|antitubercular agents|mesh-ancestor
101599467|NCT04558216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101599468|NCT04558216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101599469|NCT04558216|Leprostatic Agents|leprostatic agents|mesh-ancestor
101599470|NCT04558216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101599471|NCT04558216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101599472|NCT04558216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599473|NCT04558216|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101599474|NCT04558216|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101599479|NCT04120870|Ketamine|ketamine|mesh-list
101599507|NCT03747562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101599508|NCT03747562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599509|NCT03747562|Antimanic Agents|antimanic agents|mesh-ancestor
101599510|NCT01109849|Methylphenidate|methylphenidate|mesh-list
101599511|NCT01109849|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
101599512|NCT01109849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599513|NCT01109849|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101599515|NCT01109849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101599571|NCT02881619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101599645|NCT01107743|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
101599646|NCT01107743|Atorvastatin|atorvastatin|mesh-list
101599647|NCT01107743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101599648|NCT01107743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101599649|NCT01107743|Antimetabolites|antimetabolites|mesh-ancestor
101599650|NCT01107743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599651|NCT01107743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101599652|NCT01107743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101599653|NCT01107743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101599654|NCT01107743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101599655|NCT01107743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101599656|NCT01107743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101599657|NCT01107743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101599658|NCT01107743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599704|NCT03792256|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101599705|NCT03792256|Doxorubicin|doxorubicin|mesh-list
101599706|NCT03792256|Methotrexate|methotrexate|mesh-list
101599776|NCT03615508|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101599777|NCT03615508|Mydriatics|mydriatics|mesh-ancestor
101599778|NCT03615508|Autonomic Agents|autonomic agents|mesh-ancestor
101599848|NCT04310579|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101599850|NCT04310579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101599921|NCT03664882|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101599922|NCT03664882|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101599923|NCT03664882|Histamine Antagonists|histamine antagonists|mesh-ancestor
101599990|NCT00932373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101599991|NCT04265001|Hyaluronic Acid|hyaluronic acid|mesh-list
101599992|NCT04265001|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101599993|NCT04265001|Immunologic Factors|immunologic factors|mesh-ancestor
101599994|NCT04265001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101599995|NCT04265001|Viscosupplements|viscosupplements|mesh-ancestor
101600058|NCT03436498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600059|NCT03435952|Doxycycline|doxycycline|mesh-list
101600060|NCT03435952|Pembrolizumab|pembrolizumab|mesh-list
101600127|NCT02704546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101600130|NCT01032018|Sertraline|sertraline|mesh-list
101600131|NCT01032018|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101600132|NCT01032018|Antidepressive Agents|antidepressive agents|mesh-ancestor
101600213|NCT00609999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600214|NCT00627250|Amantadine|amantadine|mesh-list
101600284|NCT03172780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101600285|NCT03172780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101600286|NCT03172780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101600288|NCT03172780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600289|NCT05011617|Anesthetics|anesthetics|mesh-list
101600290|NCT05011617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101600291|NCT05011617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600292|NCT03169972|Factor VIII|factor viii|mesh-list
101600293|NCT03169972|BAX 855|bax 855|mesh-list
101600294|NCT03169972|Coagulants|coagulants|mesh-ancestor
101600295|NCT00926367|Clindamycin|clindamycin|mesh-list
101600296|NCT00926367|Clindamycin palmitate|clindamycin palmitate|mesh-list
101600297|NCT00926367|Clindamycin phosphate|clindamycin phosphate|mesh-list
101600298|NCT00926367|Adapalene|adapalene|mesh-list
101600299|NCT00926367|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101600300|NCT00926367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101600301|NCT00926367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101600302|NCT00926367|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101600303|NCT00926367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101600304|NCT00926367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600305|NCT00926367|Dermatologic Agents|dermatologic agents|mesh-ancestor
101600307|NCT00926367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101600339|NCT01114529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101600340|NCT00926289|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101600341|NCT00926289|Telmisartan|telmisartan|mesh-list
101600342|NCT00926289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101600408|NCT02601586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101600409|NCT02601586|Narcotics|narcotics|mesh-ancestor
101600410|NCT02601586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101600479|NCT01027884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600551|NCT01107353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600552|NCT02702206|Triamcinolone|triamcinolone|mesh-list
101600553|NCT02702206|Hyaluronic Acid|hyaluronic acid|mesh-list
101600554|NCT02702206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101600555|NCT02702206|Glucocorticoids|glucocorticoids|mesh-ancestor
101600556|NCT02702206|Hormones|hormones|mesh-ancestor
101600557|NCT02702206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101600558|NCT02702206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600619|NCT02698306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101600620|NCT02698306|Antiemetics|antiemetics|mesh-ancestor
101600621|NCT02698306|Autonomic Agents|autonomic agents|mesh-ancestor
101600622|NCT02698306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101600623|NCT02698306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600624|NCT02698306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101600625|NCT02698306|Glucocorticoids|glucocorticoids|mesh-ancestor
101600689|NCT04260711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101600690|NCT04260711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101600691|NCT04260711|Dermatologic Agents|dermatologic agents|mesh-ancestor
101600693|NCT00610623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101600694|NCT00610623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101600695|NCT02697838|Paclitaxel|paclitaxel|mesh-list
101600696|NCT02697838|Apatinib|apatinib|mesh-list
101600697|NCT02697838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101600698|NCT02697838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101600699|NCT02697838|Tubulin Modulators|tubulin modulators|mesh-ancestor
101600700|NCT02697838|Antimitotic Agents|antimitotic agents|mesh-ancestor
101600701|NCT02697838|Mitosis Modulators|mitosis modulators|mesh-ancestor
101600702|NCT02697838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101600703|NCT02697838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101600704|NCT02697838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101600705|NCT00928707|Hydroxyurea|hydroxyurea|mesh-list
101600706|NCT00928707|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
101600707|NCT00928707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101600708|NCT00928707|Antisickling Agents|antisickling agents|mesh-ancestor
101600713|NCT04956705|Vitamin D|vitamin d|mesh-list
101600745|NCT02705872|Anesthetics, General|anesthetics, general|mesh-ancestor
101600747|NCT02705872|Anesthetics, Local|anesthetics, local|mesh-ancestor
101600748|NCT02701348|Letrozole|letrozole|mesh-list
101600749|NCT02701348|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101600750|NCT02701348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101600751|NCT02701348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101600813|NCT02691910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101600814|NCT02691910|Analgesics|analgesics|mesh-ancestor
101600815|NCT02691910|Sensory System Agents|sensory system agents|mesh-ancestor
101600816|NCT02691910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101600818|NCT02691910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101600885|NCT03140488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600886|NCT00616408|Octreotide|octreotide|mesh-list
101600887|NCT00616408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101600888|NCT00616408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101600954|NCT01106027|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101600955|NCT01106027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101600956|NCT01106027|Immunologic Factors|immunologic factors|mesh-ancestor
101600957|NCT01106027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600958|NCT01027416|Tamoxifen|tamoxifen|mesh-list
101600959|NCT01027416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101600960|NCT01027416|Hormone Antagonists|hormone antagonists|mesh-ancestor
101600961|NCT01027416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101600962|NCT01027416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101600963|NCT01027416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101600964|NCT01027416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358493|NCT00204022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101600965|NCT01027416|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101600966|NCT01027416|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101600967|NCT01027416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101600968|NCT02873520|Immunomodulating Agents|immunomodulating agents|mesh-list
101600969|NCT02873520|Immunologic Factors|immunologic factors|mesh-ancestor
101600971|NCT05026203|Midazolam|midazolam|mesh-list
101601010|NCT00627744|Protease Inhibitors|protease inhibitors|mesh-ancestor
101601011|NCT00627744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101601012|NCT00627744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601080|NCT01104779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601081|NCT01104779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101601083|NCT00918957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101601084|NCT00918957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101601085|NCT04308161|Vitamin D|vitamin d|mesh-list
101601150|NCT01026324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601151|NCT04300686|Adalimumab|adalimumab|mesh-list
101601152|NCT04300686|Antibodies|antibodies|mesh-list
101601224|NCT02612545|Piperaquine|piperaquine|mesh-list
101601225|NCT02612545|Artenimol|artenimol|mesh-list
101601226|NCT02612545|Mefloquine|mefloquine|mesh-list
101601227|NCT02612545|Antimalarials|antimalarials|mesh-ancestor
101601228|NCT02612545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101601229|NCT02612545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101601230|NCT02612545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101601232|NCT00704743|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
101601233|NCT00704743|Protease Inhibitors|protease inhibitors|mesh-ancestor
101601234|NCT00704743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101601235|NCT00704743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601292|NCT01014624|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101601293|NCT01014624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101601294|NCT01014624|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101601301|NCT01021878|Icodextrin|icodextrin|mesh-list
101601362|NCT00704821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101601363|NCT00704821|Tubulin Modulators|tubulin modulators|mesh-ancestor
101601364|NCT00704821|Antimitotic Agents|antimitotic agents|mesh-ancestor
101601365|NCT00704821|Mitosis Modulators|mitosis modulators|mesh-ancestor
101601366|NCT00704821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601367|NCT00704899|Amitriptyline|amitriptyline|mesh-list
101601430|NCT00923091|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101601431|NCT00923091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101601432|NCT00923091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101601433|NCT00853957|Amlodipine|amlodipine|mesh-list
101601434|NCT00853957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101601435|NCT00853957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101601497|NCT02872818|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101601498|NCT02872818|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101601499|NCT02872818|Medroxyprogesterone|medroxyprogesterone|mesh-list
101601501|NCT02872818|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101601502|NCT02872818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101601503|NCT02872818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601504|NCT02872818|Estrogens|estrogens|mesh-ancestor
101601505|NCT02872818|Hormones|hormones|mesh-ancestor
101601507|NCT02872818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101601562|NCT01025232|Growth Inhibitors|growth inhibitors|mesh-ancestor
101601563|NCT01025232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101601564|NCT05321199|Tranexamic Acid|tranexamic acid|mesh-list
101601565|NCT05321199|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101601566|NCT05321199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101601633|NCT01096589|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101601634|NCT01096589|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101601635|NCT01096589|Coccidiostats|coccidiostats|mesh-ancestor
101601636|NCT01096589|Proton Ionophores|proton ionophores|mesh-ancestor
101601637|NCT01096589|Uncoupling Agents|uncoupling agents|mesh-ancestor
101601638|NCT01096589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101601639|NCT01096589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601702|NCT05252325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101601703|NCT05252325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601704|NCT05252325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101601705|NCT05252325|Immunologic Factors|immunologic factors|mesh-ancestor
101601706|NCT05252325|Viscosupplements|viscosupplements|mesh-ancestor
101601707|NCT05252325|Protective Agents|protective agents|mesh-ancestor
101601708|NCT01024920|Sunitinib|sunitinib|mesh-list
101601709|NCT01024920|Nintedanib|nintedanib|mesh-list
101601710|NCT01024920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101601767|NCT02879981|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101601769|NCT04307693|Lopinavir|lopinavir|mesh-list
101601770|NCT04307693|Hydroxychloroquine|hydroxychloroquine|mesh-list
101601771|NCT04307693|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101601772|NCT04307693|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101601773|NCT04307693|Protease Inhibitors|protease inhibitors|mesh-ancestor
101601774|NCT04307693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101601775|NCT04307693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601776|NCT04307693|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101601777|NCT04307693|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101601778|NCT04307693|Antiviral Agents|antiviral agents|mesh-ancestor
101601779|NCT04307693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101601782|NCT04307693|Antimalarials|antimalarials|mesh-ancestor
101601828|NCT01095653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601901|NCT00831181|Antimetabolites|antimetabolites|mesh-ancestor
101601902|NCT00831181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101601903|NCT00831181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101601904|NCT00831181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101601905|NCT00831181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101601906|NCT00831181|Immunologic Factors|immunologic factors|mesh-ancestor
101601907|NCT00831181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601909|NCT00831181|Protective Agents|protective agents|mesh-ancestor
101601967|NCT00917553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101601969|NCT04255251|Fluorides, Topical|fluorides, topical|mesh-list
101601970|NCT04255251|Cariostatic Agents|cariostatic agents|mesh-ancestor
101601971|NCT04255251|Protective Agents|protective agents|mesh-ancestor
101601972|NCT04255251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101601973|NCT01018680|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101601974|NCT01018680|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101601975|NCT01018680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101601976|NCT01018680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101601977|NCT01018680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602031|NCT01103063|Chloroquine|chloroquine|mesh-list
101602032|NCT01103063|Pyrimethamine|pyrimethamine|mesh-list
101602033|NCT01103063|Sulfadoxine|sulfadoxine|mesh-list
101602103|NCT01091675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101602104|NCT01091675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101602105|NCT01091675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602106|NCT02739412|Aldesleukin|aldesleukin|mesh-list
101602107|NCT02739412|Interleukin-2|interleukin-2|mesh-list
101602108|NCT02739412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101602109|NCT02739412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101602172|NCT00918333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101602173|NCT00918333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101602174|NCT00918333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602175|NCT00918333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101602176|NCT00918333|Immunologic Factors|immunologic factors|mesh-ancestor
101602177|NCT00918333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602178|NCT00918333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101602179|NCT01090973|Panobinostat|panobinostat|mesh-list
101602180|NCT01090973|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
101602181|NCT01090973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101602235|NCT04254471|Etoposide|etoposide|mesh-list
101602236|NCT04254471|Rabeprazole|rabeprazole|mesh-list
101602237|NCT04254471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101602238|NCT04254471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101602239|NCT04254471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101602240|NCT04254471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101602241|NCT04254471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101602242|NCT04254471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602243|NCT04254471|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101602244|NCT04254471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101602301|NCT04209166|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
101602302|NCT04209166|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
101602303|NCT04209166|Antidepressive Agents|antidepressive agents|mesh-ancestor
101602304|NCT04209166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101602305|NCT04209166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101602306|NCT04209166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101602400|NCT04213222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101602401|NCT04213222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101602402|NCT04213222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101602403|NCT04213222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101602404|NCT04213222|Growth Substances|growth substances|mesh-ancestor
101602405|NCT04213222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602406|NCT04213222|Growth Inhibitors|growth inhibitors|mesh-ancestor
101602407|NCT00621166|Ritonavir|ritonavir|mesh-list
101602408|NCT00621166|Lopinavir|lopinavir|mesh-list
101602409|NCT00621166|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101602410|NCT00621166|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101602411|NCT00621166|Protease Inhibitors|protease inhibitors|mesh-ancestor
101602412|NCT00621166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101602413|NCT00621166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602414|NCT00621166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101602415|NCT00621166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101602416|NCT00621166|Antiviral Agents|antiviral agents|mesh-ancestor
101602425|NCT00617968|Tubulin Modulators|tubulin modulators|mesh-ancestor
101602426|NCT00617968|Antimitotic Agents|antimitotic agents|mesh-ancestor
101602427|NCT00617968|Mitosis Modulators|mitosis modulators|mesh-ancestor
101602428|NCT00617968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602429|NCT00621400|Dexamethasone|dexamethasone|mesh-list
101602430|NCT00621400|Lenalidomide|lenalidomide|mesh-list
101602496|NCT02879513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602497|NCT02879513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101602568|NCT04306913|Adrenergic Agents|adrenergic agents|mesh-ancestor
101602569|NCT04306913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101602570|NCT04306913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602571|NCT04306913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602572|NCT04306913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101602573|NCT02299414|Antihypertensive Agents|antihypertensive agents|mesh-list
101602574|NCT02299414|Nifedipine|nifedipine|mesh-list
101602575|NCT02299414|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101602576|NCT02299414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101602577|NCT02299414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602578|NCT02299414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101259581|NCT01739192|Bupropion|bupropion|mesh-list
101602629|NCT01009554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101602630|NCT01009554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101602631|NCT04211896|Nivolumab|nivolumab|mesh-list
101602632|NCT04211896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101602636|NCT04188184|Epinephrine|epinephrine|mesh-list
101602699|NCT00621868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101602700|NCT00621868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602701|NCT01882660|Decitabine|decitabine|mesh-list
101602702|NCT01882660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101602703|NCT01882660|Antimetabolites|antimetabolites|mesh-ancestor
101602704|NCT01882660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602705|NCT01882660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101602706|NCT01882660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101602707|NCT01001832|Abatacept|abatacept|mesh-list
101602708|NCT01001832|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101602709|NCT01001832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602710|NCT01001832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101602765|NCT01190930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101602767|NCT01190930|Glucocorticoids|glucocorticoids|mesh-ancestor
101602768|NCT01190930|Hormones|hormones|mesh-ancestor
101602769|NCT01190930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101602770|NCT01190930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101602771|NCT01190930|Protease Inhibitors|protease inhibitors|mesh-ancestor
101602772|NCT01190930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101602788|NCT01190930|Antidotes|antidotes|mesh-ancestor
101602831|NCT00618280|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101602832|NCT00618280|Autonomic Agents|autonomic agents|mesh-ancestor
101602833|NCT00618280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101602834|NCT00618280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602835|NCT00618280|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101602836|NCT00618280|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101602837|NCT00618280|Cholinergic Agents|cholinergic agents|mesh-ancestor
101602838|NCT00618280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101602839|NCT00618280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101602840|NCT01101191|Oxycodone|oxycodone|mesh-list
101602841|NCT01101191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101602842|NCT01101191|Narcotics|narcotics|mesh-ancestor
101602843|NCT01101191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101602844|NCT01101191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101602845|NCT01101191|Analgesics|analgesics|mesh-ancestor
101602846|NCT01101191|Sensory System Agents|sensory system agents|mesh-ancestor
101602847|NCT01101191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101602848|NCT00622258|Everolimus|everolimus|mesh-list
101602849|NCT00622258|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101602850|NCT00622258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101602851|NCT00622258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101602857|NCT01812616|Nabiximols|nabiximols|mesh-list
101602886|NCT03563560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101602887|NCT03563560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101602888|NCT03563560|Growth Inhibitors|growth inhibitors|mesh-ancestor
101602889|NCT03563560|Growth Substances|growth substances|mesh-ancestor
101602890|NCT03563560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101602891|NCT03563560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101602893|NCT01178138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101602953|NCT02697058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101602955|NCT02697058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101602956|NCT02697058|Immunologic Factors|immunologic factors|mesh-ancestor
101602957|NCT02697058|Antidotes|antidotes|mesh-ancestor
101602958|NCT02697058|Protective Agents|protective agents|mesh-ancestor
101602959|NCT02697058|Vitamin B Complex|vitamin b complex|mesh-ancestor
101259942|NCT01741831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101602960|NCT02697058|Vitamins|vitamins|mesh-ancestor
101602961|NCT02697058|Micronutrients|micronutrients|mesh-ancestor
101602962|NCT00622414|Aflibercept|aflibercept|mesh-list
101602963|NCT00622414|Endothelial Growth Factors|endothelial growth factors|mesh-list
101602964|NCT00622414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101602965|NCT00622414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101602966|NCT00622414|Growth Substances|growth substances|mesh-ancestor
101603014|NCT04296162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101603015|NCT04296162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101603016|NCT04296162|Tubulin Modulators|tubulin modulators|mesh-ancestor
101603017|NCT04296162|Antimitotic Agents|antimitotic agents|mesh-ancestor
101603018|NCT04296162|Mitosis Modulators|mitosis modulators|mesh-ancestor
101603019|NCT00619996|Docetaxel|docetaxel|mesh-list
101603081|NCT02691442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101603082|NCT02691442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603083|NCT02691442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101603084|NCT02691442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101603085|NCT02691442|Autonomic Agents|autonomic agents|mesh-ancestor
101603086|NCT02691442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101603087|NCT02691442|Respiratory System Agents|respiratory system agents|mesh-ancestor
101603088|NCT02691442|Mydriatics|mydriatics|mesh-ancestor
101603089|NCT02691442|Sympathomimetics|sympathomimetics|mesh-ancestor
101603149|NCT01008618|Analgesics|analgesics|mesh-ancestor
101603150|NCT01008618|Sensory System Agents|sensory system agents|mesh-ancestor
101603151|NCT01008618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101603152|NCT01008618|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101603153|NCT01008618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101603156|NCT01001208|Etanercept|etanercept|mesh-list
101603220|NCT01193842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101603221|NCT01193842|Keratolytic Agents|keratolytic agents|mesh-ancestor
101603222|NCT01193842|Dermatologic Agents|dermatologic agents|mesh-ancestor
101603231|NCT01093612|Copper|copper|mesh-list
101603293|NCT04521946|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
101603295|NCT04521946|Thymoglobulin|thymoglobulin|mesh-list
101603296|NCT04521946|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101603297|NCT04521946|Immunoglobulins|immunoglobulins|mesh-list
101603298|NCT04521946|Antibodies|antibodies|mesh-list
101603299|NCT04521946|gamma-Globulins|gamma-globulins|mesh-list
101603300|NCT04521946|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101603301|NCT04521946|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101603302|NCT04521946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101603303|NCT04521946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101603358|NCT00638326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603360|NCT04314674|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101603361|NCT04314674|Diuretics|diuretics|mesh-ancestor
101603362|NCT04314674|Natriuretic Agents|natriuretic agents|mesh-ancestor
101603363|NCT04314674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603364|NCT00639262|Temozolomide|temozolomide|mesh-list
101603365|NCT00639262|Sorafenib|sorafenib|mesh-list
101603366|NCT00639262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101603367|NCT00639262|Alkylating Agents|alkylating agents|mesh-ancestor
101603368|NCT00639262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603369|NCT00639262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101603370|NCT00639262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101603371|NCT00639262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101603373|NCT02885558|Nifedipine|nifedipine|mesh-list
101603419|NCT02689180|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101603492|NCT00638638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101603493|NCT02684812|Tranexamic Acid|tranexamic acid|mesh-list
101603494|NCT02684812|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101603495|NCT02684812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101603496|NCT02684812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603497|NCT02684812|Hemostatics|hemostatics|mesh-ancestor
101603498|NCT02684812|Coagulants|coagulants|mesh-ancestor
101603499|NCT04203160|Cisplatin|cisplatin|mesh-list
101603500|NCT04203160|Gemcitabine|gemcitabine|mesh-list
101603501|NCT04203160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101603502|NCT04203160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101603503|NCT04203160|Antimetabolites|antimetabolites|mesh-ancestor
101603505|NCT01004250|Bevacizumab|bevacizumab|mesh-list
101603554|NCT02685046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101603568|NCT02688322|Sulbactam|sulbactam|mesh-list
101603627|NCT05663944|Immunologic Factors|immunologic factors|mesh-ancestor
101603628|NCT05663944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603629|NCT05663944|Hematinics|hematinics|mesh-ancestor
101603631|NCT02682862|Tiotropium Bromide|tiotropium bromide|mesh-list
101603633|NCT02682862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101603634|NCT02682862|Autonomic Agents|autonomic agents|mesh-ancestor
101603635|NCT02682862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101603696|NCT04184518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603697|NCT04184518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101603769|NCT00640276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603770|NCT00640276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101603771|NCT00640276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101603772|NCT02680132|Esomeprazole|esomeprazole|mesh-list
101603773|NCT02680132|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101603774|NCT02680132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101603775|NCT02680132|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101603776|NCT02680132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101603777|NCT02680132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603779|NCT02683564|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101603780|NCT02683564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101603781|NCT02683564|Dermatologic Agents|dermatologic agents|mesh-ancestor
101603782|NCT02683564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101603783|NCT02683564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101603831|NCT04205058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101603832|NCT04205058|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101603833|NCT04205058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101603834|NCT04205058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101603835|NCT04205058|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101603836|NCT04205058|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101603837|NCT04205058|Purinergic Agents|purinergic agents|mesh-ancestor
101603899|NCT02681848|Varenicline|varenicline|mesh-list
101603900|NCT02681848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101603972|NCT02681536|Contraceptive Agents|contraceptive agents|mesh-list
101603973|NCT02681536|Contraceptives, Oral|contraceptives, oral|mesh-list
101603974|NCT02681536|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
101603975|NCT02681536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101603982|NCT04183114|Vaccines|vaccines|mesh-list
101604043|NCT02678728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101604044|NCT02678728|Adrenergic Agents|adrenergic agents|mesh-ancestor
101604045|NCT02678728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101604046|NCT02678728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604047|NCT04180072|Bevacizumab|bevacizumab|mesh-list
101604048|NCT04180072|Atezolizumab|atezolizumab|mesh-list
101604049|NCT04180072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101604050|NCT04180072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101604051|NCT04180072|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101604052|NCT04180072|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101358588|NCT00204646|Ifosfamide|ifosfamide|mesh-list
101604053|NCT04180072|Growth Substances|growth substances|mesh-ancestor
101604054|NCT04180072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604055|NCT04180072|Growth Inhibitors|growth inhibitors|mesh-ancestor
101604056|NCT04180072|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101604105|NCT02675374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101604106|NCT02675374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604108|NCT02678260|Spartalizumab|spartalizumab|mesh-list
101604178|NCT04178512|BB 1101|bb 1101|mesh-list
101604179|NCT04178512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101604180|NCT04178512|Antiemetics|antiemetics|mesh-ancestor
101604181|NCT04178512|Autonomic Agents|autonomic agents|mesh-ancestor
101604182|NCT04178512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101604183|NCT04178512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604184|NCT04178512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101604185|NCT04178512|Glucocorticoids|glucocorticoids|mesh-ancestor
101604186|NCT04178512|Hormones|hormones|mesh-ancestor
101604187|NCT04178512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101604204|NCT01160198|Glycine|glycine|mesh-list
101604244|NCT02885168|Adrenergic Agents|adrenergic agents|mesh-ancestor
101604245|NCT02885168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101604246|NCT02885168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604247|NCT02885168|Protective Agents|protective agents|mesh-ancestor
101604248|NCT02885168|Anticoagulants|anticoagulants|mesh-ancestor
101604249|NCT02885168|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101604313|NCT02676622|Alkylating Agents|alkylating agents|mesh-ancestor
101604314|NCT02676622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604315|NCT02676622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101604316|NCT02676622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101604317|NCT02676622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101604318|NCT02676622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101604319|NCT02676622|Antiviral Agents|antiviral agents|mesh-ancestor
101604320|NCT02676622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101604321|NCT00644020|Fluorouracil|fluorouracil|mesh-list
101604322|NCT00644020|Mitomycins|mitomycins|mesh-list
101604323|NCT00644020|Mitomycin|mitomycin|mesh-list
101604324|NCT00644020|Antimetabolites|antimetabolites|mesh-ancestor
101604325|NCT00644020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604326|NCT00644020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101604327|NCT00644020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101604328|NCT00644020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101604329|NCT00644020|Immunologic Factors|immunologic factors|mesh-ancestor
101604373|NCT04178200|Bupivacaine|bupivacaine|mesh-list
101604374|NCT04178200|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101604375|NCT04178200|Anesthetics, Local|anesthetics, local|mesh-ancestor
101604376|NCT04178200|Anesthetics|anesthetics|mesh-ancestor
101604386|NCT02537158|Sorafenib|sorafenib|mesh-list
101604443|NCT04177342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101604444|NCT04177342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604445|NCT04177342|Analgesics|analgesics|mesh-ancestor
101604446|NCT04177342|Sensory System Agents|sensory system agents|mesh-ancestor
101604447|NCT04177342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101604448|NCT04177342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101604449|NCT04177342|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101604450|NCT04177342|Anesthetics, General|anesthetics, general|mesh-ancestor
101604451|NCT04177342|Anesthetics|anesthetics|mesh-ancestor
101604452|NCT05243524|Cyclophosphamide|cyclophosphamide|mesh-list
101604453|NCT05243524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101604454|NCT05243524|Immunologic Factors|immunologic factors|mesh-ancestor
101604455|NCT05243524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604456|NCT05243524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101604457|NCT05243524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101604458|NCT05243524|Alkylating Agents|alkylating agents|mesh-ancestor
101604459|NCT05243524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604500|NCT00644800|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101604501|NCT00644800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101604502|NCT00644800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101604503|NCT00644800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101604504|NCT00644800|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101604505|NCT00644800|Dopamine Agents|dopamine agents|mesh-ancestor
101604506|NCT02670616|Prednisolone|prednisolone|mesh-list
101604507|NCT02670616|Cyclophosphamide|cyclophosphamide|mesh-list
101604509|NCT02670616|Doxorubicin|doxorubicin|mesh-list
101604510|NCT02670616|Vincristine|vincristine|mesh-list
101604511|NCT02670616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101604566|NCT02670772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604567|NCT02670772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101604568|NCT02670772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101604569|NCT02670772|Antimetabolites|antimetabolites|mesh-ancestor
101604570|NCT02667730|Acetaminophen|acetaminophen|mesh-list
101604571|NCT02667730|Celecoxib|celecoxib|mesh-list
101604572|NCT02667730|Naproxen|naproxen|mesh-list
101604573|NCT02667730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101604600|NCT00628914|Dexetimide|dexetimide|mesh-list
101604634|NCT00645580|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101604635|NCT00645580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101604636|NCT00645580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101604704|NCT04173832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101604705|NCT04173832|Dopamine Agents|dopamine agents|mesh-ancestor
101604706|NCT04173832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101604707|NCT04173832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604708|NCT04173832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101604709|NCT04173832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101604710|NCT04173832|Analgesics|analgesics|mesh-ancestor
101604711|NCT04173832|Sensory System Agents|sensory system agents|mesh-ancestor
101604772|NCT04174378|Luteolytic Agents|luteolytic agents|mesh-ancestor
101604773|NCT04174378|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101604774|NCT04174378|Contraceptive Agents|contraceptive agents|mesh-ancestor
101604775|NCT04174378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101604780|NCT00645892|Adalimumab|adalimumab|mesh-list
101604842|NCT04292418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101604843|NCT04292418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101604844|NCT04292418|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101604845|NCT04292418|Antitubercular Agents|antitubercular agents|mesh-ancestor
101604846|NCT04292418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101604847|NCT04292418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101604849|NCT02666716|Antifungal Agents|antifungal agents|mesh-ancestor
101604850|NCT02666716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101604851|NCT02666716|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101604852|NCT02666716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101261823|NCT01752998|Analgesics, Opioid|analgesics, opioid|mesh-list
101604853|NCT02666716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101604854|NCT02666716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604876|NCT02669368|Rocuronium|rocuronium|mesh-list
101604899|NCT00645268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101604900|NCT00645268|Urological Agents|urological agents|mesh-ancestor
101604901|NCT02666014|Neostigmine|neostigmine|mesh-list
101604968|NCT00646594|Budesonide|budesonide|mesh-list
101604969|NCT00646594|Formoterol Fumarate|formoterol fumarate|mesh-list
101604970|NCT00646594|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101604971|NCT00646594|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101605039|NCT00648544|Pravastatin|pravastatin|mesh-list
101605040|NCT00648544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101605041|NCT00648544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101605042|NCT00648544|Antimetabolites|antimetabolites|mesh-ancestor
101605111|NCT00647608|Vasodilator Agents|vasodilator agents|mesh-ancestor
101605112|NCT02663440|Temozolomide|temozolomide|mesh-list
101605113|NCT02663440|Molgramostim|molgramostim|mesh-list
101605114|NCT02663440|Sargramostim|sargramostim|mesh-list
101605116|NCT02663440|Alkylating Agents|alkylating agents|mesh-ancestor
101605183|NCT02663050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101605184|NCT02663050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101605185|NCT02663050|Analgesics|analgesics|mesh-ancestor
101605186|NCT02663050|Sensory System Agents|sensory system agents|mesh-ancestor
101605187|NCT02663050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101605249|NCT04291794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101605250|NCT04291794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101605251|NCT04291794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605252|NCT04291794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101605253|NCT04291794|Anesthetics, General|anesthetics, general|mesh-ancestor
101605254|NCT04291794|Anesthetics|anesthetics|mesh-ancestor
101605255|NCT02662660|Acetaminophen|acetaminophen|mesh-list
101605256|NCT02662660|Dipyrone|dipyrone|mesh-list
101605317|NCT00702793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605388|NCT04170790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101605389|NCT00995670|Sevoflurane|sevoflurane|mesh-list
101605390|NCT00995670|Simvastatin|simvastatin|mesh-list
101605391|NCT00995670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605392|NCT00995670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101605393|NCT00995670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101605394|NCT00995670|Antimetabolites|antimetabolites|mesh-ancestor
101605457|NCT00648154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605459|NCT00648154|Hormone Antagonists|hormone antagonists|mesh-ancestor
101605460|NCT00648154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101605461|NCT00648154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605462|NCT02664142|Anesthetics|anesthetics|mesh-list
101605463|NCT02664142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101605464|NCT02664142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605465|NCT04169854|Lidocaine|lidocaine|mesh-list
101605466|NCT04169854|Anesthetics, Local|anesthetics, local|mesh-ancestor
101605467|NCT04169854|Anesthetics|anesthetics|mesh-ancestor
101605468|NCT04169854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101605469|NCT04169854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605470|NCT04169854|Sensory System Agents|sensory system agents|mesh-ancestor
101605471|NCT04169854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101605472|NCT04169854|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101605473|NCT04169854|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101605474|NCT04169854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101605475|NCT04169854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101605476|NCT04169854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605507|NCT00648310|Urological Agents|urological agents|mesh-ancestor
101605508|NCT00702871|Ranitidine|ranitidine|mesh-list
101605509|NCT00702871|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
101605510|NCT00702871|Sucralfate|sucralfate|mesh-list
101605511|NCT00702871|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101605512|NCT00702871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101605513|NCT00702871|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101605514|NCT00702871|Histamine Antagonists|histamine antagonists|mesh-ancestor
101605515|NCT00702871|Histamine Agents|histamine agents|mesh-ancestor
101605516|NCT00702871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101605517|NCT00702871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605518|NCT00702871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605519|NCT00830167|Pregabalin|pregabalin|mesh-list
101605520|NCT00830167|Analgesics|analgesics|mesh-ancestor
101605521|NCT00830167|Sensory System Agents|sensory system agents|mesh-ancestor
101605522|NCT00830167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101605523|NCT00830167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605524|NCT00830167|Anticonvulsants|anticonvulsants|mesh-ancestor
101605525|NCT00830167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101605565|NCT00843193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101605566|NCT00843193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605638|NCT00706069|Tubulin Modulators|tubulin modulators|mesh-ancestor
101605639|NCT00706069|Antimitotic Agents|antimitotic agents|mesh-ancestor
101605640|NCT00706069|Mitosis Modulators|mitosis modulators|mesh-ancestor
101605641|NCT01155284|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101605642|NCT01155284|Lansoprazole|lansoprazole|mesh-list
101605643|NCT01155284|Dexlansoprazole|dexlansoprazole|mesh-list
101605644|NCT01155284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101605645|NCT01155284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605646|NCT01155284|Incretins|incretins|mesh-ancestor
101605647|NCT01155284|Hormones|hormones|mesh-ancestor
101605705|NCT00706225|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101605707|NCT00706225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101605708|NCT00706225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605711|NCT00706225|Hormone Antagonists|hormone antagonists|mesh-ancestor
101605775|NCT00839527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101605776|NCT00839527|Immunologic Factors|immunologic factors|mesh-ancestor
101605777|NCT00839527|Incretins|incretins|mesh-ancestor
101358631|NCT00072228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101605779|NCT00839527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101605780|NCT00706927|Timolol|timolol|mesh-list
101605781|NCT00706927|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101605782|NCT00706927|Latanoprost|latanoprost|mesh-list
101605783|NCT00706927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101605784|NCT00706927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101605785|NCT00706927|Adrenergic Agents|adrenergic agents|mesh-ancestor
101605786|NCT00706927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101605787|NCT00706927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605788|NCT00706927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605835|NCT05500261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101605836|NCT05500261|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101605837|NCT05500261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101605838|NCT05500261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101605839|NCT05500261|Adrenergic Agents|adrenergic agents|mesh-ancestor
101605840|NCT05500261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101605841|NCT05500261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605842|NCT04116931|Clopidogrel|clopidogrel|mesh-list
101605843|NCT04116931|Ticagrelor|ticagrelor|mesh-list
101605844|NCT04116931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101605898|NCT02658760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101605899|NCT02658760|Adrenergic Agents|adrenergic agents|mesh-ancestor
101605900|NCT02658760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101605901|NCT02658760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605902|NCT02536690|Midazolam|midazolam|mesh-list
101605903|NCT02536690|Remifentanil|remifentanil|mesh-list
101605904|NCT02536690|Propofol|propofol|mesh-list
101605905|NCT02536690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101605906|NCT02536690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101605907|NCT02536690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101605908|NCT02536690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101605909|NCT02536690|Anesthetics, General|anesthetics, general|mesh-ancestor
101605910|NCT02536690|Anesthetics|anesthetics|mesh-ancestor
101605911|NCT02536690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101605912|NCT02536690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101605913|NCT02536690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101605914|NCT02536690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101605915|NCT02536690|GABA Modulators|gaba modulators|mesh-ancestor
101605916|NCT02536690|GABA Agents|gaba agents|mesh-ancestor
101605917|NCT02536690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101605918|NCT02536690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605920|NCT02536690|Narcotics|narcotics|mesh-ancestor
101605921|NCT02536690|Analgesics|analgesics|mesh-ancestor
101605922|NCT02536690|Sensory System Agents|sensory system agents|mesh-ancestor
101605923|NCT02536690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101605924|NCT00649090|Exemestane|exemestane|mesh-list
101605925|NCT00649090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101605926|NCT00649090|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101605927|NCT00649090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101605928|NCT00649090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101605929|NCT00649090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101605930|NCT00649090|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101605934|NCT00838903|Metformin|metformin|mesh-list
101605943|NCT00838903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101605944|NCT00838903|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101606014|NCT04167982|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101606015|NCT04167982|Dermatologic Agents|dermatologic agents|mesh-ancestor
101606016|NCT04167982|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101606017|NCT00649558|Pioglitazone|pioglitazone|mesh-list
101606018|NCT00649558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101606019|NCT00649558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606020|NCT02658526|Anesthetics|anesthetics|mesh-list
101606021|NCT02658526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101606022|NCT02658526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606023|NCT00650494|Valacyclovir|valacyclovir|mesh-list
101606024|NCT00650494|Antiviral Agents|antiviral agents|mesh-ancestor
101606025|NCT00650494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101606026|NCT02655874|Vaccines|vaccines|mesh-list
101606027|NCT02655874|Immunologic Factors|immunologic factors|mesh-ancestor
101606028|NCT02655874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606029|NCT00828139|Aflibercept|aflibercept|mesh-list
101606030|NCT00828139|Topotecan|topotecan|mesh-list
101606031|NCT00828139|Endothelial Growth Factors|endothelial growth factors|mesh-list
101606032|NCT00828139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101606033|NCT00828139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101606034|NCT00828139|Growth Substances|growth substances|mesh-ancestor
101606035|NCT00828139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606036|NCT00828139|Growth Inhibitors|growth inhibitors|mesh-ancestor
101606037|NCT00828139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101606038|NCT00828139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101606039|NCT00828139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101606040|NCT00828139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101606041|NCT00828139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606042|NCT02658214|Leucovorin|leucovorin|mesh-list
101606064|NCT02658214|Immunologic Factors|immunologic factors|mesh-ancestor
101606065|NCT02658214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101606066|NCT02658214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101606067|NCT02658214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101606069|NCT02658214|Protective Agents|protective agents|mesh-ancestor
101606070|NCT02658214|Vitamin B Complex|vitamin b complex|mesh-ancestor
101606071|NCT02658214|Vitamins|vitamins|mesh-ancestor
101606072|NCT02658214|Micronutrients|micronutrients|mesh-ancestor
101606073|NCT02658214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101606074|NCT02658214|Hematinics|hematinics|mesh-ancestor
101606075|NCT04169230|Citalopram|citalopram|mesh-list
101606076|NCT04169230|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101606077|NCT04169230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101606078|NCT04169230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101606125|NCT00838513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606127|NCT00649636|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101606128|NCT00649636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101606129|NCT00649636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101606130|NCT00649636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606131|NCT00649636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101606132|NCT00649636|Serotonin Agents|serotonin agents|mesh-ancestor
101606133|NCT00649636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606134|NCT00649636|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101606135|NCT00649636|Antidepressive Agents|antidepressive agents|mesh-ancestor
101606136|NCT00649636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101606137|NCT00649636|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101606138|NCT00649636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101606139|NCT00649636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101606140|NCT04030663|Nitroglycerin|nitroglycerin|mesh-list
101606141|NCT04030663|Papaverine|papaverine|mesh-list
101606142|NCT04030663|Vasodilator Agents|vasodilator agents|mesh-ancestor
101606143|NCT04030663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101606144|NCT04030663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101606145|NCT04030663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606146|NCT04030663|Urological Agents|urological agents|mesh-ancestor
101606147|NCT00700921|Lovastatin|lovastatin|mesh-list
101606148|NCT00700921|L 647318|l 647318|mesh-list
101606149|NCT00700921|Dihydromevinolin|dihydromevinolin|mesh-list
101606150|NCT00700921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101606151|NCT00700921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101606152|NCT00700921|Antimetabolites|antimetabolites|mesh-ancestor
101606153|NCT00700921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606154|NCT00700921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101606156|NCT00700921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101606167|NCT02657512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606168|NCT02657512|Anticoagulants|anticoagulants|mesh-ancestor
101606169|NCT02657512|Antidotes|antidotes|mesh-ancestor
101606170|NCT02657512|Protective Agents|protective agents|mesh-ancestor
101606171|NCT02657512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606172|NCT00818779|Amlodipine|amlodipine|mesh-list
101606173|NCT00818779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101606174|NCT00818779|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101606175|NCT00818779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101606176|NCT00818779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606177|NCT00818779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101606178|NCT00818779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606179|NCT00818779|Vasodilator Agents|vasodilator agents|mesh-ancestor
101606180|NCT00649714|Zonisamide|zonisamide|mesh-list
101606181|NCT00649714|Anticonvulsants|anticonvulsants|mesh-ancestor
101606182|NCT00649714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101606183|NCT00649714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101606184|NCT00649714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606185|NCT00649714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101606187|NCT00600028|Thalidomide|thalidomide|mesh-list
101606221|NCT02650102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101606222|NCT02650102|Antidepressive Agents|antidepressive agents|mesh-ancestor
101606228|NCT00650182|Fentanyl|fentanyl|mesh-list
101606294|NCT02649478|Sympathomimetics|sympathomimetics|mesh-ancestor
101606296|NCT04167592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101606297|NCT04168294|Propofol|propofol|mesh-list
101606298|NCT04168294|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101606299|NCT04168294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101606300|NCT04168294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606301|NCT04168294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101606302|NCT04168294|Anesthetics, General|anesthetics, general|mesh-ancestor
101606303|NCT04168294|Anesthetics|anesthetics|mesh-ancestor
101606361|NCT02644954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606362|NCT02644954|Dermatologic Agents|dermatologic agents|mesh-ancestor
101606363|NCT02644954|Keratolytic Agents|keratolytic agents|mesh-ancestor
101606364|NCT00650338|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101606365|NCT00650338|Latanoprost|latanoprost|mesh-list
101606366|NCT00650338|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101606367|NCT02644720|Dexamethasone|dexamethasone|mesh-list
101606368|NCT02644720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101606369|NCT02644720|Antiemetics|antiemetics|mesh-ancestor
101606370|NCT02644720|Autonomic Agents|autonomic agents|mesh-ancestor
101606371|NCT02644720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101606372|NCT02644720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606373|NCT02644720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101606374|NCT02644720|Glucocorticoids|glucocorticoids|mesh-ancestor
101606376|NCT02644720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101606377|NCT02644720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101606378|NCT02644720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101606379|NCT03542266|Azacitidine|azacitidine|mesh-list
101606381|NCT03542266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101606382|NCT03542266|Antimetabolites|antimetabolites|mesh-ancestor
101606383|NCT03542266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606384|NCT03542266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101606385|NCT03542266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101606413|NCT04166578|Sensory System Agents|sensory system agents|mesh-ancestor
101606414|NCT04166578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101606415|NCT04166578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101606416|NCT04166578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101606417|NCT04166578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101606418|NCT04166578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101263414|NCT01761994|Nafamostat|nafamostat|mesh-list
101606419|NCT04166578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606420|NCT04166734|Pembrolizumab|pembrolizumab|mesh-list
101606421|NCT04166734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101606422|NCT04166734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101606423|NCT04166734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101606424|NCT04166734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606425|NCT00651352|Nicotine|nicotine|mesh-list
101606426|NCT00651352|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101606427|NCT00651352|Autonomic Agents|autonomic agents|mesh-ancestor
101606428|NCT00651352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101606429|NCT00651352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606430|NCT00651352|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101606431|NCT00651352|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101606432|NCT00651352|Cholinergic Agents|cholinergic agents|mesh-ancestor
101606433|NCT00651352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101606462|NCT05758597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606468|NCT05758597|Anesthetics|anesthetics|mesh-ancestor
101606536|NCT02644252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606538|NCT02644252|Protective Agents|protective agents|mesh-ancestor
101606539|NCT02644252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606540|NCT02644252|Vitamins|vitamins|mesh-ancestor
101606541|NCT02644252|Micronutrients|micronutrients|mesh-ancestor
101606542|NCT00818389|Riluzole|riluzole|mesh-list
101606543|NCT00818389|Lithium Carbonate|lithium carbonate|mesh-list
101606544|NCT00818389|Antidepressive Agents|antidepressive agents|mesh-ancestor
101606545|NCT00818389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101606546|NCT00818389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101606547|NCT00818389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606548|NCT00818389|Antimanic Agents|antimanic agents|mesh-ancestor
101606549|NCT00818389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101606550|NCT00818389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101606551|NCT00818389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606552|NCT00818389|Anticonvulsants|anticonvulsants|mesh-ancestor
101606553|NCT00818389|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101606554|NCT00818389|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101606555|NCT00818389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101606556|NCT00818389|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101606557|NCT00818389|Protective Agents|protective agents|mesh-ancestor
101606558|NCT02640976|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101606559|NCT02640976|Cetrorelix|cetrorelix|mesh-list
101606560|NCT02640976|Menotropins|menotropins|mesh-list
101606583|NCT02640898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101606584|NCT02640898|Tubulin Modulators|tubulin modulators|mesh-ancestor
101606585|NCT02640898|Antimitotic Agents|antimitotic agents|mesh-ancestor
101606586|NCT02640898|Mitosis Modulators|mitosis modulators|mesh-ancestor
101606587|NCT02640898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606588|NCT02535910|Vitamin D|vitamin d|mesh-list
101606589|NCT02535910|Cholecalciferol|cholecalciferol|mesh-list
101606590|NCT02535910|Calcifediol|calcifediol|mesh-list
101606591|NCT02535910|Vitamins|vitamins|mesh-ancestor
101606592|NCT02535910|Micronutrients|micronutrients|mesh-ancestor
101606648|NCT04166890|Anesthetics, Local|anesthetics, local|mesh-ancestor
101606649|NCT04166890|Anesthetics|anesthetics|mesh-ancestor
101606650|NCT04166890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101606651|NCT04166890|Sensory System Agents|sensory system agents|mesh-ancestor
101606652|NCT00652912|Clonazepam|clonazepam|mesh-list
101606653|NCT00652912|Anticonvulsants|anticonvulsants|mesh-ancestor
101606654|NCT00652912|GABA Modulators|gaba modulators|mesh-ancestor
101606655|NCT00652912|GABA Agents|gaba agents|mesh-ancestor
101606656|NCT00652912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101606657|NCT00652912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606658|NCT00652912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101606659|NCT01168232|Epothilones|epothilones|mesh-list
101606660|NCT01168232|Epothilone B|epothilone b|mesh-list
101606661|NCT01168232|Tubulin Modulators|tubulin modulators|mesh-ancestor
101606662|NCT01168232|Antimitotic Agents|antimitotic agents|mesh-ancestor
101606663|NCT01168232|Mitosis Modulators|mitosis modulators|mesh-ancestor
101606664|NCT01168232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606665|NCT01168232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101606666|NCT00817531|Dasatinib|dasatinib|mesh-list
101606667|NCT00817531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101606668|NCT00817531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101606669|NCT00817531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101606670|NCT00817531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606671|NCT00651586|Ciprofloxacin|ciprofloxacin|mesh-list
101606672|NCT00651586|Gatifloxacin|gatifloxacin|mesh-list
101606673|NCT00651586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101606674|NCT00651586|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101606675|NCT00651586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101606684|NCT02640508|Lenvatinib|lenvatinib|mesh-list
101606695|NCT05259566|Menthol|menthol|mesh-list
101606696|NCT05259566|Antipruritics|antipruritics|mesh-ancestor
101606697|NCT05259566|Dermatologic Agents|dermatologic agents|mesh-ancestor
101606698|NCT02643550|Cetuximab|cetuximab|mesh-list
101606699|NCT02643550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101606700|NCT02643550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101606701|NCT00817063|Alitretinoin|alitretinoin|mesh-list
101606702|NCT00817063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101606704|NCT04313270|Evolocumab|evolocumab|mesh-list
101606705|NCT04313270|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101606706|NCT04313270|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101606707|NCT04313270|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101606708|NCT04313270|Antimetabolites|antimetabolites|mesh-ancestor
101606709|NCT04313270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606759|NCT00986154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101606760|NCT00986154|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101606761|NCT00986154|Antithrombins|antithrombins|mesh-ancestor
101606762|NCT00986154|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101606763|NCT00986154|Protease Inhibitors|protease inhibitors|mesh-ancestor
101606830|NCT00848965|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101606831|NCT00654082|Sildenafil Citrate|sildenafil citrate|mesh-list
101606832|NCT00654082|Vasodilator Agents|vasodilator agents|mesh-ancestor
101606904|NCT00816595|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
101606905|NCT00816595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101606906|NCT01166438|Solifenacin Succinate|solifenacin succinate|mesh-list
101606907|NCT01166438|Trospium chloride|trospium chloride|mesh-list
101606908|NCT01166438|Botulinum Toxins|botulinum toxins|mesh-list
101606909|NCT01166438|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101606910|NCT01166438|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101606911|NCT01166438|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101606972|NCT00654394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101606973|NCT00654394|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101606974|NCT00654394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101606975|NCT00653302|Metformin|metformin|mesh-list
101607046|NCT01153724|Antifungal Agents|antifungal agents|mesh-ancestor
101607047|NCT01153724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101607048|NCT01153724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101607061|NCT02885948|Naloxone|naloxone|mesh-list
101607114|NCT05367362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101607115|NCT05367362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101607116|NCT00984282|Sorafenib|sorafenib|mesh-list
101607117|NCT00984282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101607118|NCT00984282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101607119|NCT00984282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101607120|NCT00984282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607121|NCT04187196|Propofol|propofol|mesh-list
101607122|NCT04187196|Methohexital|methohexital|mesh-list
101607123|NCT04187196|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101607124|NCT04187196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101607125|NCT04187196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607126|NCT04187196|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101607127|NCT04187196|Anesthetics, General|anesthetics, general|mesh-ancestor
101607128|NCT04187196|Anesthetics|anesthetics|mesh-ancestor
101607129|NCT04292184|Sodium thiosulfate|sodium thiosulfate|mesh-list
101607130|NCT04292184|Antidotes|antidotes|mesh-ancestor
101607131|NCT04292184|Protective Agents|protective agents|mesh-ancestor
101607132|NCT04292184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607133|NCT04292184|Antioxidants|antioxidants|mesh-ancestor
101607134|NCT04292184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607141|NCT01147640|Meropenem|meropenem|mesh-list
101607168|NCT01121666|Hormones|hormones|mesh-ancestor
101607170|NCT01121666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607241|NCT04290936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101607242|NCT04290936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101607243|NCT04290936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607244|NCT04290936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101607245|NCT04290936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101607246|NCT00707941|Oseltamivir|oseltamivir|mesh-list
101607247|NCT00707941|Antiviral Agents|antiviral agents|mesh-ancestor
101607248|NCT00707941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101607249|NCT00707941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101607250|NCT00707941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607252|NCT00824473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101607253|NCT00824473|Autonomic Agents|autonomic agents|mesh-ancestor
101607254|NCT00824473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101607255|NCT00824473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607256|NCT00824473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101607257|NCT00824473|Respiratory System Agents|respiratory system agents|mesh-ancestor
101607258|NCT00824473|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101607259|NCT00824473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101607260|NCT00824473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607261|NCT00824473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101607262|NCT00824473|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101607263|NCT00824473|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101607264|NCT00824473|Histamine Antagonists|histamine antagonists|mesh-ancestor
101607265|NCT00824473|Histamine Agents|histamine agents|mesh-ancestor
101607266|NCT00824473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101607267|NCT04291092|Immunomodulating Agents|immunomodulating agents|mesh-list
101607268|NCT04291092|Immunologic Factors|immunologic factors|mesh-ancestor
101607286|NCT04290390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101607287|NCT04290390|Antifungal Agents|antifungal agents|mesh-ancestor
101607288|NCT04290390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101607289|NCT04290390|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101607290|NCT04290390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101607291|NCT04290390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101607292|NCT04290390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607293|NCT04290390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101607294|NCT04290390|Hormone Antagonists|hormone antagonists|mesh-ancestor
101607295|NCT04290390|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101607309|NCT04290858|Nitric Oxide|nitric oxide|mesh-list
101607348|NCT00814879|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101607349|NCT00814879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101607350|NCT00814879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101607351|NCT00814879|Antiviral Agents|antiviral agents|mesh-ancestor
101607352|NCT00814879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101607353|NCT00814879|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101607354|NCT00814879|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101607355|NCT00814879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101607356|NCT00814879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607357|NCT00814879|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101607358|NCT00814879|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101607359|NCT00814879|Protease Inhibitors|protease inhibitors|mesh-ancestor
101607360|NCT00814801|Galantamine|galantamine|mesh-list
101607361|NCT00814801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101607362|NCT00814801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101607363|NCT00814801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607364|NCT00814801|Cholinergic Agents|cholinergic agents|mesh-ancestor
101607365|NCT00814801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101607366|NCT00814801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607367|NCT00814801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101607404|NCT00978432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101607405|NCT00978432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607406|NCT00978432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101607407|NCT00978432|Immunologic Factors|immunologic factors|mesh-ancestor
101607408|NCT00978432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607409|NCT00978432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101607476|NCT00709267|Folic Acid|folic acid|mesh-list
101607477|NCT00709267|Hematinics|hematinics|mesh-ancestor
101607478|NCT00709267|Vitamin B Complex|vitamin b complex|mesh-ancestor
101607479|NCT00709267|Vitamins|vitamins|mesh-ancestor
101607480|NCT00709267|Micronutrients|micronutrients|mesh-ancestor
101607481|NCT00709267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607482|NCT00591565|Acamprosate|acamprosate|mesh-list
101607483|NCT00591565|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101607484|NCT00978120|Vaccines|vaccines|mesh-list
101607485|NCT00978120|Immunologic Factors|immunologic factors|mesh-ancestor
101607486|NCT00978120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607487|NCT01133678|Paclitaxel|paclitaxel|mesh-list
101607488|NCT01133678|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101607489|NCT01133678|Cisplatin|cisplatin|mesh-list
101607490|NCT01133678|Cetuximab|cetuximab|mesh-list
101607491|NCT01133678|Everolimus|everolimus|mesh-list
101607492|NCT01133678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101607493|NCT01133678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101607494|NCT01133678|Tubulin Modulators|tubulin modulators|mesh-ancestor
101607495|NCT01133678|Antimitotic Agents|antimitotic agents|mesh-ancestor
101607496|NCT01133678|Mitosis Modulators|mitosis modulators|mesh-ancestor
101607497|NCT01133678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607498|NCT01133678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101607499|NCT01133678|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101607500|NCT01133678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101607501|NCT01133678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101607502|NCT01133678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101607503|NCT01133678|Immunologic Factors|immunologic factors|mesh-ancestor
101607504|NCT01133678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607505|NCT00652132|Sodium thiosulfate|sodium thiosulfate|mesh-list
101607506|NCT00652132|Antidotes|antidotes|mesh-ancestor
101607507|NCT00652132|Protective Agents|protective agents|mesh-ancestor
101607508|NCT00652132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607509|NCT00652132|Antioxidants|antioxidants|mesh-ancestor
101607510|NCT00652132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607511|NCT00652132|Antitubercular Agents|antitubercular agents|mesh-ancestor
101607517|NCT00655174|Sertraline|sertraline|mesh-list
101607519|NCT00655174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101607520|NCT00655174|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101607521|NCT00655174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101607522|NCT00655174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101607523|NCT00655174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607524|NCT00655174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101607525|NCT00655174|Serotonin Agents|serotonin agents|mesh-ancestor
101607526|NCT00655174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607527|NCT00655174|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101607528|NCT00655174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101607529|NCT00655174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101607530|NCT00655174|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101607531|NCT00655174|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101607532|NCT00655174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101607533|NCT00655174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101607534|NCT00655174|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101607535|NCT00655018|Ascorbic Acid|ascorbic acid|mesh-list
101607536|NCT00655018|Tocopherols|tocopherols|mesh-list
101607537|NCT00655018|Vitamin E|vitamin e|mesh-list
101607538|NCT00655018|alpha-Tocopherol|alpha-tocopherol|mesh-list
101607539|NCT00655018|Vitamins|vitamins|mesh-ancestor
101607571|NCT02645734|Growth Inhibitors|growth inhibitors|mesh-ancestor
101607572|NCT01133522|Evolocumab|evolocumab|mesh-list
101607573|NCT01133522|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101607574|NCT01133522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101607575|NCT01133522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101607576|NCT01133522|Antimetabolites|antimetabolites|mesh-ancestor
101607577|NCT01133522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607578|NCT01133522|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101607579|NCT01133522|Protease Inhibitors|protease inhibitors|mesh-ancestor
101607580|NCT01133522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101607581|NCT01133522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101607582|NCT00682318|Ethanol|ethanol|mesh-list
101607583|NCT00682318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101607584|NCT00682318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101607585|NCT00682318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101607586|NCT00682318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607587|NCT02881892|Dialysis Solutions|dialysis solutions|mesh-list
101607588|NCT02881892|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101607589|NCT00655252|Everolimus|everolimus|mesh-list
101607590|NCT00655252|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101607592|NCT00655252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101607624|NCT00655330|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101607625|NCT00655330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607697|NCT02635282|Narcotics|narcotics|mesh-ancestor
101607698|NCT02635282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101607699|NCT02635282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101607700|NCT02635282|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101607768|NCT00656812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607769|NCT00656812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101607770|NCT00656110|Ethanol|ethanol|mesh-list
101607840|NCT04159870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101607841|NCT04159870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101607913|NCT00657748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101607914|NCT00657748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101607915|NCT00657748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607916|NCT00657748|Antimanic Agents|antimanic agents|mesh-ancestor
101607917|NCT00657748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101607918|NCT00657748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101607919|NCT00657748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607920|NCT00657748|Antifungal Agents|antifungal agents|mesh-ancestor
101607921|NCT00657748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101607922|NCT04161586|Prilocaine|prilocaine|mesh-list
101607923|NCT04161586|Anesthetics, Local|anesthetics, local|mesh-ancestor
101607924|NCT04161586|Anesthetics|anesthetics|mesh-ancestor
101607925|NCT04161586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101607926|NCT04161586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607927|NCT04161586|Sensory System Agents|sensory system agents|mesh-ancestor
101607973|NCT04162834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101607974|NCT04162834|Vasodilator Agents|vasodilator agents|mesh-ancestor
101607975|NCT04162834|Urological Agents|urological agents|mesh-ancestor
101607976|NCT00657904|Bicalutamide|bicalutamide|mesh-list
101607977|NCT00657904|Androgen Antagonists|androgen antagonists|mesh-ancestor
101607978|NCT00657904|Hormone Antagonists|hormone antagonists|mesh-ancestor
101607979|NCT00657904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101607980|NCT00657904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607981|NCT00657904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101607982|NCT02633878|Progesterone|progesterone|mesh-list
101607983|NCT02633878|Progestins|progestins|mesh-ancestor
101607984|NCT02633878|Hormones|hormones|mesh-ancestor
101607985|NCT02633878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101607986|NCT02633878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101607987|NCT00597766|Triamcinolone|triamcinolone|mesh-list
101607988|NCT00597766|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101608030|NCT00979992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608031|NCT00979992|Growth Inhibitors|growth inhibitors|mesh-ancestor
101608032|NCT00979992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101608033|NCT00979992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101608035|NCT01079741|Poly I-C|poly i-c|mesh-list
101608106|NCT02633176|Mitosis Modulators|mitosis modulators|mesh-ancestor
101608107|NCT02633176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608109|NCT02633176|Antimetabolites|antimetabolites|mesh-ancestor
101608178|NCT01076153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101608179|NCT01076153|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101608180|NCT01076153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101608181|NCT01076153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608182|NCT01076153|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101358701|NCT00072462|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101608183|NCT01076153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101608185|NCT01076075|Pioglitazone|pioglitazone|mesh-list
101608186|NCT01076075|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101608187|NCT01076075|Glimepiride|glimepiride|mesh-list
101608189|NCT01076075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101608190|NCT01076075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608191|NCT01076075|Incretins|incretins|mesh-ancestor
101608192|NCT01076075|Hormones|hormones|mesh-ancestor
101608193|NCT01076075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101608194|NCT01076075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101608236|NCT02632474|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101608237|NCT02632474|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101608238|NCT02632474|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101608239|NCT02632474|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101608240|NCT04156750|Metformin|metformin|mesh-list
101608305|NCT00626483|Immunologic Factors|immunologic factors|mesh-ancestor
101608306|NCT00626483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608307|NCT00626717|Riboflavin|riboflavin|mesh-list
101608375|NCT01077713|Bevacizumab|bevacizumab|mesh-list
101608376|NCT01077713|Gemcitabine|gemcitabine|mesh-list
101608377|NCT01077713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101608378|NCT01077713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101608379|NCT01077713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101608380|NCT01077713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101608394|NCT01077323|Exenatide|exenatide|mesh-list
101608444|NCT04047576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101608445|NCT04047576|Immunologic Factors|immunologic factors|mesh-ancestor
101608518|NCT03762564|Paclitaxel|paclitaxel|mesh-list
101608519|NCT03762564|Ramucirumab|ramucirumab|mesh-list
101608520|NCT03762564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101608521|NCT03762564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101608522|NCT03762564|Tubulin Modulators|tubulin modulators|mesh-ancestor
101608523|NCT03762564|Antimitotic Agents|antimitotic agents|mesh-ancestor
101608525|NCT03762564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608526|NCT00629616|Fulvestrant|fulvestrant|mesh-list
101608585|NCT00662272|Vaccines|vaccines|mesh-list
101608586|NCT00662272|Immunologic Factors|immunologic factors|mesh-ancestor
101608587|NCT00662272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608588|NCT04158856|Trastuzumab|trastuzumab|mesh-list
101608656|NCT02864472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608657|NCT02864472|Growth Inhibitors|growth inhibitors|mesh-ancestor
101608728|NCT00974220|Sensory System Agents|sensory system agents|mesh-ancestor
101608729|NCT00974220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101608730|NCT00974220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101608748|NCT00970944|Amantadine|amantadine|mesh-list
101608799|NCT05780229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608800|NCT05780151|Insulin Glargine|insulin glargine|mesh-list
101608873|NCT05774067|Hemostatics|hemostatics|mesh-ancestor
101608874|NCT05774067|Coagulants|coagulants|mesh-ancestor
101608875|NCT05774067|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101608876|NCT05774067|Natriuretic Agents|natriuretic agents|mesh-ancestor
101608877|NCT05774067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101608940|NCT05620784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101608941|NCT05620784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101608942|NCT05620784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101608944|NCT05616494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101608945|NCT05616494|Tubulin Modulators|tubulin modulators|mesh-ancestor
101608946|NCT05616494|Antimitotic Agents|antimitotic agents|mesh-ancestor
101359187|NCT00208039|Calfactant|calfactant|mesh-list
101609008|NCT05550402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609009|NCT05550402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101609010|NCT05550402|Respiratory System Agents|respiratory system agents|mesh-ancestor
101609011|NCT05550402|Tocolytic Agents|tocolytic agents|mesh-ancestor
101609012|NCT05550402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101609013|NCT05550402|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101609076|NCT05276596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609077|NCT05276596|Sympathomimetics|sympathomimetics|mesh-ancestor
101609078|NCT05276596|Autonomic Agents|autonomic agents|mesh-ancestor
101609150|NCT04907370|Immunologic Factors|immunologic factors|mesh-ancestor
101609151|NCT04907370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609152|NCT04907370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101609153|NCT04907370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101609154|NCT04907370|Antimetabolites|antimetabolites|mesh-ancestor
101609156|NCT04903054|Mycophenolic Acid|mycophenolic acid|mesh-list
101609220|NCT04770493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101609221|NCT04770493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609222|NCT04770493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101609223|NCT04770493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609229|NCT04741464|Tinzaparin|tinzaparin|mesh-list
101609289|NCT04300920|Antiviral Agents|antiviral agents|mesh-ancestor
101609290|NCT04300920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101609362|NCT03884101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101609363|NCT03884101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101609434|NCT03657810|Dermatologic Agents|dermatologic agents|mesh-ancestor
101609435|NCT03657810|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101609436|NCT03657810|Histamine Antagonists|histamine antagonists|mesh-ancestor
101609437|NCT03657810|Histamine Agents|histamine agents|mesh-ancestor
101609438|NCT03657810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101609505|NCT03321656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101609506|NCT03321656|Immunologic Factors|immunologic factors|mesh-ancestor
101609507|NCT03321656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609508|NCT03321656|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101609575|NCT02789982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609576|NCT02789982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609577|NCT02789982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101609578|NCT02789982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101609609|NCT02582008|Bupropion|bupropion|mesh-list
101609644|NCT02135133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609645|NCT01993836|Anesthetics|anesthetics|mesh-list
101609646|NCT01993836|Propofol|propofol|mesh-list
101609647|NCT01993836|Isoflurane|isoflurane|mesh-list
101609648|NCT01993836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101609649|NCT01993836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609650|NCT01993836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101609651|NCT01993836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101609652|NCT01993836|Anesthetics, General|anesthetics, general|mesh-ancestor
101609653|NCT01993836|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101362185|NCT00402766|Autonomic Agents|autonomic agents|mesh-ancestor
101609654|NCT01818739|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101609655|NCT01717586|Pravastatin|pravastatin|mesh-list
101609656|NCT01717586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101609707|NCT00782574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609708|NCT00753545|Olaparib|olaparib|mesh-list
101609709|NCT00753545|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101265021|NCT01770470|Hemostatics|hemostatics|mesh-ancestor
101609776|NCT00965094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101609777|NCT00965094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101609778|NCT00965094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101609779|NCT00965094|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101609845|NCT00625196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101609846|NCT00625196|Autonomic Agents|autonomic agents|mesh-ancestor
101609847|NCT00625196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101609848|NCT00625196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101609849|NCT00625196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101609850|NCT00625196|Respiratory System Agents|respiratory system agents|mesh-ancestor
101609851|NCT00625196|Dermatologic Agents|dermatologic agents|mesh-ancestor
101609852|NCT00625196|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101609917|NCT04312880|Tranexamic Acid|tranexamic acid|mesh-list
101609984|NCT04669041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101609985|NCT04669041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101609986|NCT04669041|Antimetabolites|antimetabolites|mesh-ancestor
101609987|NCT04669041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101609988|NCT04669041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101609990|NCT04669041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610053|NCT00915681|Protective Agents|protective agents|mesh-ancestor
101610054|NCT00915681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610055|NCT00915681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101610056|NCT00915681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101610057|NCT01128296|Hydroxychloroquine|hydroxychloroquine|mesh-list
101610058|NCT01128296|Gemcitabine|gemcitabine|mesh-list
101610059|NCT01128296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101610060|NCT01128296|Antimetabolites|antimetabolites|mesh-ancestor
101610061|NCT01128296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610062|NCT01128296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101610063|NCT01128296|Antimalarials|antimalarials|mesh-ancestor
101610064|NCT01128296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101610065|NCT01128296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101610112|NCT01141478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610113|NCT01114880|Adalimumab|adalimumab|mesh-list
101610114|NCT01114880|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101610115|NCT01114880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101610116|NCT01114880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101610117|NCT00625352|Gemcitabine|gemcitabine|mesh-list
101610118|NCT00625352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101610119|NCT00625352|Antimetabolites|antimetabolites|mesh-ancestor
101610120|NCT00625352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610121|NCT00625352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101610122|NCT04539873|Colchicine|colchicine|mesh-list
101610123|NCT04539873|Gout Suppressants|gout suppressants|mesh-ancestor
101610124|NCT04539873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101610125|NCT04539873|Tubulin Modulators|tubulin modulators|mesh-ancestor
101610126|NCT04539873|Antimitotic Agents|antimitotic agents|mesh-ancestor
101610127|NCT04539873|Mitosis Modulators|mitosis modulators|mesh-ancestor
101610128|NCT04539873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610129|NCT04539873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101610130|NCT02861040|Vincristine|vincristine|mesh-list
101610131|NCT02861040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101610132|NCT02861040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101610133|NCT02861040|Tubulin Modulators|tubulin modulators|mesh-ancestor
101610134|NCT02861040|Antimitotic Agents|antimitotic agents|mesh-ancestor
101610135|NCT02861040|Mitosis Modulators|mitosis modulators|mesh-ancestor
101610136|NCT02861040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610161|NCT02860962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267169|NCT01787344|Botulinum Toxins|botulinum toxins|mesh-list
101610162|NCT04432623|Benserazide|benserazide|mesh-list
101610167|NCT04432623|Dopamine Agents|dopamine agents|mesh-ancestor
101610232|NCT00961350|Sensory System Agents|sensory system agents|mesh-ancestor
101610233|NCT00961350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101610234|NCT00961350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610235|NCT00961350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101610236|NCT00961350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101610237|NCT00961350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101610238|NCT00961350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101610239|NCT00961350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610240|NCT00961350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101610241|NCT00961350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101610242|NCT00961350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610243|NCT00961350|Antipyretics|antipyretics|mesh-ancestor
101610244|NCT03537690|Paclitaxel|paclitaxel|mesh-list
101610245|NCT03537690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101610246|NCT03537690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101610247|NCT03537690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101610290|NCT00963924|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101610291|NCT00963924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101610292|NCT00963924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101610293|NCT00963924|Antitubercular Agents|antitubercular agents|mesh-ancestor
101610294|NCT00963924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101610358|NCT00965562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101610359|NCT00965562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101610360|NCT00965562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610361|NCT00659698|Pancrelipase|pancrelipase|mesh-list
101610362|NCT00659698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101610364|NCT00666796|Gabapentin|gabapentin|mesh-list
101610365|NCT00666796|Analgesics|analgesics|mesh-ancestor
101610366|NCT00666796|Sensory System Agents|sensory system agents|mesh-ancestor
101610425|NCT02631460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101610426|NCT04282824|Edetic Acid|edetic acid|mesh-list
101610427|NCT04282824|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101610428|NCT04282824|Chelating Agents|chelating agents|mesh-ancestor
101610429|NCT04282824|Sequestering Agents|sequestering agents|mesh-ancestor
101610449|NCT00667108|Gabapentin|gabapentin|mesh-list
101610495|NCT00663442|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101610496|NCT00663442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610497|NCT00663442|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101610498|NCT00663442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101610499|NCT00663442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101610500|NCT00663442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610502|NCT00663442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101610503|NCT00912015|Tramadol|tramadol|mesh-list
101610504|NCT00912015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101610505|NCT00912015|Narcotics|narcotics|mesh-ancestor
101610506|NCT00912015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101610507|NCT00912015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610508|NCT00912015|Analgesics|analgesics|mesh-ancestor
101610509|NCT00912015|Sensory System Agents|sensory system agents|mesh-ancestor
101610510|NCT00912015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101610511|NCT00960804|Tanezumab|tanezumab|mesh-list
101610512|NCT00960804|Analgesics|analgesics|mesh-ancestor
101610513|NCT00960804|Sensory System Agents|sensory system agents|mesh-ancestor
101610514|NCT00960804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101610515|NCT00960804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610516|NCT01126580|Metformin|metformin|mesh-list
101610517|NCT01126580|Dulaglutide|dulaglutide|mesh-list
101610518|NCT01126580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101610519|NCT01126580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610520|NCT00911157|Heparin|heparin|mesh-list
101610521|NCT00911157|Calcium heparin|calcium heparin|mesh-list
101610522|NCT00911157|PENTA|penta|mesh-list
101610523|NCT00911157|Fondaparinux|fondaparinux|mesh-list
101610524|NCT00911157|Anticoagulants|anticoagulants|mesh-ancestor
101610525|NCT00911157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101610526|NCT00911157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101610527|NCT00911157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610537|NCT00960570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610538|NCT00960570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610539|NCT00960570|Antiviral Agents|antiviral agents|mesh-ancestor
101610540|NCT00960570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101610541|NCT00960570|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101610542|NCT00960570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101610543|NCT00960570|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101610544|NCT00960570|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101610545|NCT00960570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101610546|NCT00960570|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101610547|NCT00960570|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101610548|NCT00960570|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101610549|NCT00960570|Antimetabolites|antimetabolites|mesh-ancestor
101610550|NCT00960570|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101610551|NCT04204278|Hyaluronic Acid|hyaluronic acid|mesh-list
101610552|NCT04204278|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101610553|NCT04204278|Immunologic Factors|immunologic factors|mesh-ancestor
101610554|NCT04204278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610555|NCT04204278|Viscosupplements|viscosupplements|mesh-ancestor
101610556|NCT04204278|Protective Agents|protective agents|mesh-ancestor
101610557|NCT00625430|Fludarabine|fludarabine|mesh-list
101610558|NCT00625430|Fludarabine phosphate|fludarabine phosphate|mesh-list
101610559|NCT00625430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101610560|NCT00625430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101610561|NCT00625430|Antimetabolites|antimetabolites|mesh-ancestor
101610562|NCT00625430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439424|NCT05365451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439425|NCT05365451|Uricosuric Agents|uricosuric agents|mesh-ancestor
101439426|NCT05365451|Gout Suppressants|gout suppressants|mesh-ancestor
101439427|NCT05365451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101439454|NCT05347485|Cyclophosphamide|cyclophosphamide|mesh-list
101439455|NCT05347485|Fludarabine|fludarabine|mesh-list
101439456|NCT05347485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101439457|NCT05347485|Immunologic Factors|immunologic factors|mesh-ancestor
101439458|NCT05347485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439459|NCT05347485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101439460|NCT05347485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101439461|NCT05347485|Alkylating Agents|alkylating agents|mesh-ancestor
101439466|NCT05338775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439468|NCT05338775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439469|NCT05328297|JNJ-55308942|jnj-55308942|mesh-list
101439470|NCT05328297|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
101439471|NCT05328297|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101439472|NCT05328297|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101610563|NCT00625430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101610564|NCT00625430|Immunologic Factors|immunologic factors|mesh-ancestor
101610638|NCT04284150|Anesthetics|anesthetics|mesh-ancestor
101610639|NCT04284150|GABA Modulators|gaba modulators|mesh-ancestor
101610640|NCT04284150|GABA Agents|gaba agents|mesh-ancestor
101610641|NCT03311334|Pembrolizumab|pembrolizumab|mesh-list
101610642|NCT03311334|Nivolumab|nivolumab|mesh-list
101610643|NCT03311334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101610644|NCT03311334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101610645|NCT03311334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101610646|NCT03311334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610647|NCT04313036|Defibrotide|defibrotide|mesh-list
101610648|NCT04313036|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101610649|NCT04313036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101610650|NCT04313036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610651|NCT04313036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101610652|NCT00879658|Siponimod|siponimod|mesh-list
101610696|NCT02860650|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
101610765|NCT02860494|Everolimus|everolimus|mesh-list
101610766|NCT02860494|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101610767|NCT02860494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101610768|NCT02860494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610769|NCT02860494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610770|NCT02860494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101610834|NCT00957528|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101610835|NCT00957528|Androgens|androgens|mesh-ancestor
101610836|NCT00957528|Hormones|hormones|mesh-ancestor
101610837|NCT00957528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101610838|NCT00957528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610839|NCT00957528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101610840|NCT00957528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101610841|NCT00957528|Anabolic Agents|anabolic agents|mesh-ancestor
101610842|NCT02857062|Emollients|emollients|mesh-list
101610843|NCT02857062|Dermatologic Agents|dermatologic agents|mesh-ancestor
101610844|NCT00958776|Peramivir|peramivir|mesh-list
101610845|NCT00958776|Antiviral Agents|antiviral agents|mesh-ancestor
101610846|NCT00958776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101610847|NCT00958776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610848|NCT00958776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610849|NCT02858856|Juzentaihoto|juzentaihoto|mesh-list
101610850|NCT02858856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101610851|NCT02858856|Mitogens|mitogens|mesh-ancestor
101610852|NCT02858856|Mitosis Modulators|mitosis modulators|mesh-ancestor
101610853|NCT02858856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610854|NCT02858622|Fentanyl|fentanyl|mesh-list
101610855|NCT02858622|Meperidine|meperidine|mesh-list
101610856|NCT02858622|Bupivacaine|bupivacaine|mesh-list
101610857|NCT02858622|Anesthetics, Local|anesthetics, local|mesh-ancestor
101610858|NCT02858622|Anesthetics|anesthetics|mesh-ancestor
101610859|NCT02858622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101610860|NCT02858622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610883|NCT00596830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610884|NCT00957372|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
101610885|NCT00957372|Anticonvulsants|anticonvulsants|mesh-ancestor
101610886|NCT00957372|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101610887|NCT00957372|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101610888|NCT00957372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101610889|NCT00957372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610890|NCT04270968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101610892|NCT05143164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101610893|NCT05143164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101610895|NCT05143164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101610945|NCT00668356|Antiviral Agents|antiviral agents|mesh-ancestor
101610946|NCT00668356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101610947|NCT00668356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101610948|NCT00668356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101610949|NCT00664222|Furosemide|furosemide|mesh-list
101610950|NCT00664222|Spironolactone|spironolactone|mesh-list
101610951|NCT00664222|Diuretics|diuretics|mesh-ancestor
101610953|NCT00664222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610954|NCT00664222|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101610955|NCT00664222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101610956|NCT00664222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101610957|NCT00664222|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101610958|NCT00664222|Hormone Antagonists|hormone antagonists|mesh-ancestor
101610959|NCT00664222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101610960|NCT00664222|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101610961|NCT00952614|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
101610962|NCT00952614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101610963|NCT00952614|Glucocorticoids|glucocorticoids|mesh-ancestor
101610964|NCT00952614|Hormones|hormones|mesh-ancestor
101610965|NCT00952614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101610966|NCT00952614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101610967|NCT00911859|Prednisone|prednisone|mesh-list
101610968|NCT00911859|Bortezomib|bortezomib|mesh-list
101610996|NCT00596752|Alprostadil|alprostadil|mesh-list
101610997|NCT00596752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101610998|NCT00596752|Vasodilator Agents|vasodilator agents|mesh-ancestor
101610999|NCT00596752|Urological Agents|urological agents|mesh-ancestor
101611000|NCT04151277|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101611001|NCT04151277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101611002|NCT00958074|Vorinostat|vorinostat|mesh-list
101611063|NCT00664846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611064|NCT00664846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101611094|NCT00669370|Docetaxel|docetaxel|mesh-list
101611136|NCT00910689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101611137|NCT04669717|Amoxicillin|amoxicillin|mesh-list
101611138|NCT04669717|Azithromycin|azithromycin|mesh-list
101611139|NCT04669717|Metronidazole|metronidazole|mesh-list
101611210|NCT00811057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101611211|NCT00811057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101611212|NCT00811057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101611213|NCT00811057|Gout Suppressants|gout suppressants|mesh-ancestor
101611214|NCT00811057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101611215|NCT00811057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101611217|NCT00879970|Pioglitazone|pioglitazone|mesh-list
101611218|NCT00879970|Rosiglitazone|rosiglitazone|mesh-list
101611219|NCT00879970|Vitamins|vitamins|mesh-ancestor
101611220|NCT00879970|Micronutrients|micronutrients|mesh-ancestor
101611221|NCT00879970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611222|NCT00879970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101611223|NCT00879970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101611224|NCT00808639|Doxorubicin|doxorubicin|mesh-list
101611225|NCT00808639|Methotrexate|methotrexate|mesh-list
101611226|NCT00808639|Vinblastine|vinblastine|mesh-list
101611227|NCT00808639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101611228|NCT00808639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101611229|NCT00808639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101611230|NCT00808639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101611231|NCT00808639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101611232|NCT00808639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611233|NCT00808639|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101611234|NCT00808639|Abortifacient Agents|abortifacient agents|mesh-ancestor
101611235|NCT00808639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101611236|NCT00808639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362280|NCT00044291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101611237|NCT00808639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101611238|NCT00808639|Antimetabolites|antimetabolites|mesh-ancestor
101611239|NCT00808639|Dermatologic Agents|dermatologic agents|mesh-ancestor
101611240|NCT00808639|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101611241|NCT00808639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101611242|NCT00808639|Immunologic Factors|immunologic factors|mesh-ancestor
101611243|NCT00808639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101611244|NCT00808639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101611245|NCT00808639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101611246|NCT00808639|Tubulin Modulators|tubulin modulators|mesh-ancestor
101611247|NCT00808639|Antimitotic Agents|antimitotic agents|mesh-ancestor
101439473|NCT05328297|Purinergic Agents|purinergic agents|mesh-ancestor
101611248|NCT00808639|Mitosis Modulators|mitosis modulators|mesh-ancestor
101611249|NCT00910299|Clopidogrel|clopidogrel|mesh-list
101611251|NCT00910299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101611252|NCT00910299|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101611255|NCT00910299|Purinergic Agents|purinergic agents|mesh-ancestor
101611320|NCT00914017|Antimetabolites|antimetabolites|mesh-ancestor
101611321|NCT00914017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611322|NCT00914017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101611323|NCT00914017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101611324|NCT00914017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101611326|NCT00671320|Valdecoxib|valdecoxib|mesh-list
101611327|NCT00671320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101611328|NCT00671320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101611329|NCT00671320|Analgesics|analgesics|mesh-ancestor
101611330|NCT00671320|Sensory System Agents|sensory system agents|mesh-ancestor
101611331|NCT00671320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101611332|NCT00671320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611333|NCT00671320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101611334|NCT00671320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101611335|NCT00671320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101611336|NCT00671320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101611337|NCT00671320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611338|NCT00671320|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101611339|NCT00676468|Montelukast|montelukast|mesh-list
101611340|NCT00676468|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101611341|NCT00676468|Respiratory System Agents|respiratory system agents|mesh-ancestor
101611342|NCT00676468|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101611343|NCT00676468|Hormone Antagonists|hormone antagonists|mesh-ancestor
101611344|NCT00676468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101611345|NCT00676468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611346|NCT00676468|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101611347|NCT00676468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101611348|NCT00676468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611349|NCT00591253|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
101611361|NCT00676702|Coagulants|coagulants|mesh-ancestor
101611362|NCT00676702|Vitamins|vitamins|mesh-ancestor
101611363|NCT00676702|Micronutrients|micronutrients|mesh-ancestor
101611364|NCT00676702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611435|NCT00676936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611436|NCT00676936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101611437|NCT00676936|Glucocorticoids|glucocorticoids|mesh-ancestor
101611439|NCT00676936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101611440|NCT00676936|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101611505|NCT00911716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611506|NCT00911716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101611507|NCT00911716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101611508|NCT00911716|Alkylating Agents|alkylating agents|mesh-ancestor
101611509|NCT00911716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611510|NCT00911716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101611511|NCT00911716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101611512|NCT00911716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101611513|NCT00911716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101611514|NCT00911716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101611515|NCT00911716|Growth Substances|growth substances|mesh-ancestor
101611516|NCT00911716|Growth Inhibitors|growth inhibitors|mesh-ancestor
101611517|NCT00911716|Tubulin Modulators|tubulin modulators|mesh-ancestor
101611518|NCT00911716|Antimitotic Agents|antimitotic agents|mesh-ancestor
101611519|NCT00911716|Mitosis Modulators|mitosis modulators|mesh-ancestor
101611521|NCT00595582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101611522|NCT00595582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101611523|NCT00595582|Analgesics|analgesics|mesh-ancestor
101611524|NCT00595582|Sensory System Agents|sensory system agents|mesh-ancestor
101611525|NCT00595582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101611526|NCT00595582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611527|NCT00595582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101611528|NCT00595582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101611529|NCT00595582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101611530|NCT00595582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101611531|NCT00595582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611532|NCT00680446|Immunoglobulins|immunoglobulins|mesh-list
101611533|NCT00680446|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101611534|NCT00680446|Antibodies|antibodies|mesh-list
101611535|NCT00680446|Immunoglobulin G|immunoglobulin g|mesh-list
101611536|NCT00680446|Immunologic Factors|immunologic factors|mesh-ancestor
101611537|NCT00680446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611546|NCT00672022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101611547|NCT00672022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611548|NCT00680602|Sertraline|sertraline|mesh-list
101611549|NCT00680602|Fluoxetine|fluoxetine|mesh-list
101611550|NCT00680602|Paroxetine|paroxetine|mesh-list
101611551|NCT00680602|Citalopram|citalopram|mesh-list
101611552|NCT00680602|Antidepressive Agents|antidepressive agents|mesh-ancestor
101611553|NCT00680602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101611559|NCT00680602|Serotonin Agents|serotonin agents|mesh-ancestor
101611612|NCT00810199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101611614|NCT00877006|Cyclophosphamide|cyclophosphamide|mesh-list
101611615|NCT00877006|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101611683|NCT00807937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101611684|NCT00807937|GABA Modulators|gaba modulators|mesh-ancestor
101611685|NCT00807937|GABA Agents|gaba agents|mesh-ancestor
101611686|NCT00807937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101611687|NCT00807937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611688|NCT00681148|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101611751|NCT02626936|Glucagon|glucagon|mesh-list
101611752|NCT02626936|Hormones|hormones|mesh-list
101611753|NCT02626936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101611754|NCT02626936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611757|NCT00912262|Capsaicin|capsaicin|mesh-list
101611823|NCT05752903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101611824|NCT05752903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611825|NCT05752903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101611826|NCT05752903|Anesthetics, General|anesthetics, general|mesh-ancestor
101611892|NCT01139450|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101611966|NCT02606617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101611967|NCT02606617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101611968|NCT00914095|Methylphenidate|methylphenidate|mesh-list
101612037|NCT02856750|Anticonvulsants|anticonvulsants|mesh-ancestor
101612038|NCT02856750|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101612039|NCT02856750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101362300|NCT00078351|Hylan|hylan|mesh-list
101612040|NCT02856750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101612041|NCT02856750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101612042|NCT02856750|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101612043|NCT02856750|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101612044|NCT02856750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101612046|NCT02856750|Antimanic Agents|antimanic agents|mesh-ancestor
101612103|NCT02606539|Methotrexate|methotrexate|mesh-list
101612104|NCT02606539|Levoleucovorin|levoleucovorin|mesh-list
101612105|NCT02606539|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101612106|NCT02606539|Abortifacient Agents|abortifacient agents|mesh-ancestor
101612107|NCT02606539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101612108|NCT02606539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612109|NCT02606539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101612110|NCT02606539|Antimetabolites|antimetabolites|mesh-ancestor
101612112|NCT02606539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101612171|NCT05660473|Glucocorticoids|glucocorticoids|mesh-ancestor
101612172|NCT05660473|Hormones|hormones|mesh-ancestor
101612173|NCT05660473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101612174|NCT05660473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101612175|NCT05660473|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101612240|NCT01254864|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101612241|NCT01254864|Hormone Antagonists|hormone antagonists|mesh-ancestor
101612242|NCT01254864|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101612243|NCT02854722|Calcium, Dietary|calcium, dietary|mesh-list
101612245|NCT02854722|Ergocalciferols|ergocalciferols|mesh-list
101612246|NCT02854722|Cholecalciferol|cholecalciferol|mesh-list
101612310|NCT00907335|Dermatologic Agents|dermatologic agents|mesh-ancestor
101612311|NCT00947154|Aripiprazole|aripiprazole|mesh-list
101612312|NCT00947154|Antidepressive Agents|antidepressive agents|mesh-ancestor
101612313|NCT00947154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101612389|NCT03198741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101612390|NCT03198741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101612391|NCT03198741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101612392|NCT03198741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612393|NCT03198741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101612394|NCT03198741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101612395|NCT03198741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101269430|NCT01814059|Sirolimus|sirolimus|mesh-list
101612396|NCT03198741|Antipyretics|antipyretics|mesh-ancestor
101612397|NCT03198741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101612398|NCT03198741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101612399|NCT03198741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101612400|NCT03198741|Purinergic Agents|purinergic agents|mesh-ancestor
101612401|NCT03198741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101612447|NCT00906087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101612448|NCT03525795|Ipilimumab|ipilimumab|mesh-list
101612519|NCT02853864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101612520|NCT02853864|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101362316|NCT05519917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101612521|NCT02853864|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101612529|NCT00907257|Tretinoin|tretinoin|mesh-list
101612589|NCT00679666|Micronutrients|micronutrients|mesh-ancestor
101612590|NCT00679666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612591|NCT00679666|Vitamin B Complex|vitamin b complex|mesh-ancestor
101612592|NCT00679666|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101612593|NCT00679666|Dermatologic Agents|dermatologic agents|mesh-ancestor
101612656|NCT00680134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101612657|NCT00680212|Beta Carotene|beta carotene|mesh-list
101612658|NCT00680212|Carotenoids|carotenoids|mesh-list
101612659|NCT00680212|Antioxidants|antioxidants|mesh-ancestor
101612660|NCT00680212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612661|NCT00680212|Protective Agents|protective agents|mesh-ancestor
101612662|NCT00680212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101612665|NCT00680212|Micronutrients|micronutrients|mesh-ancestor
101612725|NCT01111526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612727|NCT02881346|Betamethasone Valerate|betamethasone valerate|mesh-list
101612728|NCT02881346|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101612729|NCT02881346|Betamethasone benzoate|betamethasone benzoate|mesh-list
101612794|NCT01110200|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101612795|NCT01110200|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101612797|NCT01110200|Autonomic Agents|autonomic agents|mesh-ancestor
101612864|NCT01136174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101612865|NCT01136174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101612866|NCT01136174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101612935|NCT00905307|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101612936|NCT00905307|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101612938|NCT00905307|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101612939|NCT00905307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101612940|NCT00905307|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101612941|NCT00905307|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101612942|NCT00904839|Bevacizumab|bevacizumab|mesh-list
101612943|NCT00904839|Nintedanib|nintedanib|mesh-list
101612944|NCT00904839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101612945|NCT00904839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101612946|NCT00904839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101612947|NCT00904839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101613012|NCT01730313|Vitamin B Complex|vitamin b complex|mesh-ancestor
101613013|NCT01730313|Anticonvulsants|anticonvulsants|mesh-ancestor
101613014|NCT01730313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101613015|NCT01730313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613016|NCT01730313|GABA Agents|gaba agents|mesh-ancestor
101613017|NCT01730313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101613018|NCT01730313|Antimanic Agents|antimanic agents|mesh-ancestor
101613019|NCT01730313|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101613020|NCT01730313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101613021|NCT01730313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101613022|NCT01730313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101613023|NCT01730313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101613024|NCT01730313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101613025|NCT01730313|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101613030|NCT01104662|Vancomycin|vancomycin|mesh-list
101613072|NCT02880800|Analgesics|analgesics|mesh-ancestor
101613073|NCT02880800|Sensory System Agents|sensory system agents|mesh-ancestor
101613074|NCT02880800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101613075|NCT01107392|Botulinum Toxins|botulinum toxins|mesh-list
101613076|NCT01107392|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101613077|NCT01107392|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101613078|NCT01107392|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101613079|NCT01107392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101613080|NCT01107392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613081|NCT01107392|Cholinergic Agents|cholinergic agents|mesh-ancestor
101613082|NCT01107392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101613083|NCT01107392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613134|NCT02846493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101362347|NCT00074607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101613135|NCT02846493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613136|NCT02846493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101613137|NCT02846493|Glucocorticoids|glucocorticoids|mesh-ancestor
101613138|NCT02846493|Hormones|hormones|mesh-ancestor
101613139|NCT02846493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101613140|NCT02846493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101613141|NCT02846493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101613142|NCT02846493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101613143|NCT02846493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101613144|NCT02846493|Hormone Antagonists|hormone antagonists|mesh-ancestor
101613197|NCT00625898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101613198|NCT00625898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101613199|NCT00625898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101613200|NCT00625898|Growth Substances|growth substances|mesh-ancestor
101613201|NCT00625898|Growth Inhibitors|growth inhibitors|mesh-ancestor
101613202|NCT00625898|Tubulin Modulators|tubulin modulators|mesh-ancestor
101613266|NCT00941304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101613267|NCT00941304|Narcotics|narcotics|mesh-ancestor
101613270|NCT00941304|Analgesics|analgesics|mesh-ancestor
101613341|NCT02848443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101613342|NCT02848443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101613343|NCT02848443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101613413|NCT02845713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101613414|NCT02845713|Filaricides|filaricides|mesh-ancestor
101613415|NCT02845713|Antinematodal Agents|antinematodal agents|mesh-ancestor
101613416|NCT02845713|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101613417|NCT02845713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101613418|NCT00902265|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101613419|NCT00902265|Hemostatics|hemostatics|mesh-ancestor
101613420|NCT00902265|Coagulants|coagulants|mesh-ancestor
101613421|NCT00902265|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101613422|NCT00902265|Natriuretic Agents|natriuretic agents|mesh-ancestor
101613423|NCT00902265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101613424|NCT02848287|Ropivacaine|ropivacaine|mesh-list
101613425|NCT02848287|Anesthetics, Local|anesthetics, local|mesh-ancestor
101613426|NCT02848287|Anesthetics|anesthetics|mesh-ancestor
101613497|NCT00652431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101613498|NCT00652431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101613499|NCT00652431|Vasodilator Agents|vasodilator agents|mesh-ancestor
101613501|NCT00652431|Vitamins|vitamins|mesh-ancestor
101613567|NCT05336175|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
101613568|NCT05336175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101613569|NCT05336175|Vasodilator Agents|vasodilator agents|mesh-ancestor
101613571|NCT02842125|Nivolumab|nivolumab|mesh-list
101613572|NCT02842125|Capecitabine|capecitabine|mesh-list
101613573|NCT02842125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101613574|NCT02842125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101265282|NCT01772615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101613576|NCT02842125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613577|NCT02842125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101613578|NCT02842125|Antimetabolites|antimetabolites|mesh-ancestor
101613579|NCT03708549|Metformin|metformin|mesh-list
101613582|NCT00156117|Olanzapine|olanzapine|mesh-list
101613629|NCT00132717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101613630|NCT00132717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101613631|NCT00132717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101613632|NCT00127179|Finasteride|finasteride|mesh-list
101613633|NCT00127179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613635|NCT00127179|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101613697|NCT02851914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101613698|NCT02851914|Serotonin Agents|serotonin agents|mesh-ancestor
101613699|NCT02851914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101613704|NCT00938964|Lidocaine|lidocaine|mesh-list
101613766|NCT00941928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101613767|NCT00941928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101613768|NCT00941928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101613769|NCT00941928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101613838|NCT04268394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101613839|NCT04268394|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101613840|NCT04268394|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101613841|NCT04268394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101613842|NCT04268394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101613843|NCT04268394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101613844|NCT04268394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101613845|NCT04268394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101613846|NCT04268394|Anesthetics, General|anesthetics, general|mesh-ancestor
101613847|NCT04268394|Anesthetics|anesthetics|mesh-ancestor
101613848|NCT04268394|GABA Modulators|gaba modulators|mesh-ancestor
101613849|NCT04268394|GABA Agents|gaba agents|mesh-ancestor
101613850|NCT04268394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101613851|NCT04268394|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101613852|NCT04268394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101613853|NCT04268394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101613854|NCT04268394|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101613855|NCT04268394|Antifungal Agents|antifungal agents|mesh-ancestor
101613856|NCT04268394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101613857|NCT04268394|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101613858|NCT04268394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101613859|NCT04268394|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101613860|NCT04268394|Hormone Antagonists|hormone antagonists|mesh-ancestor
101613861|NCT04268394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101613862|NCT04268394|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101613863|NCT04268394|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101613864|NCT04268394|Antitubercular Agents|antitubercular agents|mesh-ancestor
101613865|NCT04268394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101613866|NCT04268394|Leprostatic Agents|leprostatic agents|mesh-ancestor
101543158|NCT04535804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101439474|NCT05328297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101487413|NCT00432588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101307767|NCT02043054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101307769|NCT02043054|Protease Inhibitors|protease inhibitors|mesh-ancestor
101439497|NCT05296070|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
101439498|NCT05296070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101439499|NCT05296070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439500|NCT05294146|Clofazimine|clofazimine|mesh-list
101439501|NCT05294146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101439502|NCT05294146|Leprostatic Agents|leprostatic agents|mesh-ancestor
101439503|NCT05294146|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101613867|NCT04268394|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101613868|NCT04268394|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101613873|NCT04268394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101613935|NCT00685672|Mydriatics|mydriatics|mesh-ancestor
101613936|NCT00685672|Sympathomimetics|sympathomimetics|mesh-ancestor
101613937|NCT00685672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101613938|NCT00683176|Choline|choline|mesh-list
101613939|NCT00683176|Fenofibrate|fenofibrate|mesh-list
101613940|NCT00683176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101614003|NCT04139824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101614004|NCT04139824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614005|NCT04139824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614074|NCT00684112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101614075|NCT00684112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101614076|NCT00684112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101614081|NCT00684112|Antimanic Agents|antimanic agents|mesh-ancestor
101614143|NCT00685126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101614144|NCT00685126|Adrenergic Agents|adrenergic agents|mesh-ancestor
101614145|NCT00685126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101614146|NCT00685126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614214|NCT00935532|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101614215|NCT00935532|Insulin Glargine|insulin glargine|mesh-list
101614216|NCT00935532|Exenatide|exenatide|mesh-list
101614217|NCT00935532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101614218|NCT00935532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614219|NCT00935532|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101614220|NCT00935532|Incretins|incretins|mesh-ancestor
101614221|NCT00935532|Hormones|hormones|mesh-ancestor
101614222|NCT00935532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101614223|NCT04138420|Bevacizumab|bevacizumab|mesh-list
101614224|NCT04138420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101614225|NCT04138420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101614226|NCT04138420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101614227|NCT04138420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101614228|NCT04138420|Growth Substances|growth substances|mesh-ancestor
101614229|NCT04138420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614230|NCT04138420|Growth Inhibitors|growth inhibitors|mesh-ancestor
101614231|NCT05378646|Interferons|interferons|mesh-list
101614232|NCT05378646|Interferon-gamma|interferon-gamma|mesh-list
101614233|NCT05378646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101614234|NCT05378646|Antiviral Agents|antiviral agents|mesh-ancestor
101614235|NCT05378646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101614236|NCT01093586|Cyclosporine|cyclosporine|mesh-list
101614237|NCT01093586|Mycophenolic Acid|mycophenolic acid|mesh-list
101614238|NCT01093586|Methylprednisolone|methylprednisolone|mesh-list
101614239|NCT01093586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101614240|NCT01093586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101614241|NCT01093586|Prednisolone|prednisolone|mesh-list
101614262|NCT01093586|Dermatologic Agents|dermatologic agents|mesh-ancestor
101614263|NCT01093586|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101614264|NCT01093586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101614265|NCT01093586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101614332|NCT01098110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101614333|NCT01098110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614405|NCT00873730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101614406|NCT00873730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101614407|NCT00873730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101614408|NCT00873730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101614409|NCT00873730|Immunologic Factors|immunologic factors|mesh-ancestor
101614410|NCT00689416|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101614411|NCT00689416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101614412|NCT00689416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101614413|NCT00689416|Antimetabolites|antimetabolites|mesh-ancestor
101614414|NCT00689416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614415|NCT00689416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101614416|NCT00689416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101614469|NCT05382390|Decitabine|decitabine|mesh-list
101614470|NCT05382390|Aclarubicin|aclarubicin|mesh-list
101614471|NCT05382390|Lenograstim|lenograstim|mesh-list
101614472|NCT05382390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101614473|NCT05382390|Antimetabolites|antimetabolites|mesh-ancestor
101614474|NCT05382390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614475|NCT05382390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101614476|NCT05382390|Antiviral Agents|antiviral agents|mesh-ancestor
101614477|NCT05382390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101614478|NCT05382390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101614536|NCT00871858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614537|NCT00871858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614539|NCT00673270|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101614540|NCT00673270|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101614541|NCT00673270|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101614542|NCT00673270|Fludrocortisone|fludrocortisone|mesh-list
101614543|NCT00673270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101614544|NCT00871780|Natalizumab|natalizumab|mesh-list
101614545|NCT00871780|Immunologic Factors|immunologic factors|mesh-ancestor
101614546|NCT00871780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614547|NCT00694408|Methylprednisolone|methylprednisolone|mesh-list
101614548|NCT00694408|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101614549|NCT00694408|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101614550|NCT00694408|Prednisolone|prednisolone|mesh-list
101614598|NCT04137640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101614599|NCT04137640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101614600|NCT04137640|Tubulin Modulators|tubulin modulators|mesh-ancestor
101614601|NCT04137640|Antimitotic Agents|antimitotic agents|mesh-ancestor
101614602|NCT04137640|Mitosis Modulators|mitosis modulators|mesh-ancestor
101614603|NCT04137640|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101614666|NCT00673582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614667|NCT00673582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101614668|NCT00673582|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101614669|NCT00673582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614670|NCT00912574|Molgramostim|molgramostim|mesh-list
101614671|NCT00912574|Sargramostim|sargramostim|mesh-list
101614672|NCT00912574|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101614673|NCT00912574|Freund's Adjuvant|freund's adjuvant|mesh-list
101614674|NCT00912574|Immunologic Factors|immunologic factors|mesh-ancestor
101614732|NCT00936858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101614733|NCT00936858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614734|NCT00936858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614735|NCT00936858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101614736|NCT00936858|Immunologic Factors|immunologic factors|mesh-ancestor
101614737|NCT00936858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614738|NCT00936858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101614739|NCT02624440|Clarithromycin|clarithromycin|mesh-list
101614740|NCT02624440|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101614741|NCT02624440|Trimethoprim|trimethoprim|mesh-list
101614742|NCT02624440|Sulfamethoxazole|sulfamethoxazole|mesh-list
101614743|NCT02624440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101614744|NCT02624440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101614745|NCT02624440|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101614746|NCT02624440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101614747|NCT02624440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614748|NCT02624440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101614749|NCT02624440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101614750|NCT02624440|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101614751|NCT02624440|Antimalarials|antimalarials|mesh-ancestor
101614752|NCT02624440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101614753|NCT02624440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101362417|NCT00078858|Fludarabine|fludarabine|mesh-list
101614754|NCT02624440|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101614755|NCT02624440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101614756|NCT02624440|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101614778|NCT00674050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101614779|NCT00674050|Autonomic Agents|autonomic agents|mesh-ancestor
101614780|NCT00674050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101614781|NCT00674050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101614782|NCT00674050|Respiratory System Agents|respiratory system agents|mesh-ancestor
101614848|NCT00607074|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101614849|NCT00607074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101614850|NCT00607074|Tubulin Modulators|tubulin modulators|mesh-ancestor
101614851|NCT00607074|Antimitotic Agents|antimitotic agents|mesh-ancestor
101614852|NCT00607074|Mitosis Modulators|mitosis modulators|mesh-ancestor
101614853|NCT00607074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614854|NCT00607074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101614855|NCT00607074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101614915|NCT00696748|Hormones|hormones|mesh-ancestor
101614916|NCT00696748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101614917|NCT00696748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101614918|NCT00696748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101614919|NCT00696748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101614921|NCT02621554|Resveratrol|resveratrol|mesh-list
101614983|NCT04135378|Antioxidants|antioxidants|mesh-ancestor
101614984|NCT04135378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101614985|NCT04135378|Protective Agents|protective agents|mesh-ancestor
101614986|NCT02878772|Aspirin|aspirin|mesh-list
101614987|NCT02878772|Vinpocetine|vinpocetine|mesh-list
101614988|NCT02878772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101614989|NCT02878772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101615049|NCT04267224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615050|NCT00675220|Insulin Aspart|insulin aspart|mesh-list
101615051|NCT00675220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101615121|NCT02622802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615122|NCT05158374|Aspirin|aspirin|mesh-list
101615123|NCT05158374|Metformin|metformin|mesh-list
101615124|NCT05158374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101615144|NCT00675688|Estrogens|estrogens|mesh-list
101615193|NCT00696592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101615194|NCT00696592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101615267|NCT00931944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615268|NCT00931944|Protective Agents|protective agents|mesh-ancestor
101615269|NCT00931944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615270|NCT00931944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101615271|NCT00931944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101615336|NCT04133506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615337|NCT04133506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101615404|NCT00593554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101615406|NCT01101308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101615407|NCT01101308|Narcotics|narcotics|mesh-ancestor
101615408|NCT01101308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101615475|NCT00931710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101615476|NCT00931710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101615478|NCT00931710|Natriuretic Agents|natriuretic agents|mesh-ancestor
101615479|NCT00931710|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101615480|NCT01100528|Interferons|interferons|mesh-list
101615546|NCT00608946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615547|NCT02615938|Hydroxychloroquine|hydroxychloroquine|mesh-list
101615548|NCT02615938|Antimalarials|antimalarials|mesh-ancestor
101615549|NCT02615938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101615555|NCT00926328|Triclosan|triclosan|mesh-list
101615618|NCT04263402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101615619|NCT04263402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101615620|NCT00868192|Bevacizumab|bevacizumab|mesh-list
101615621|NCT00868192|Pemetrexed|pemetrexed|mesh-list
101615633|NCT02615782|Tadalafil|tadalafil|mesh-list
101615690|NCT00862654|Hormone Antagonists|hormone antagonists|mesh-ancestor
101615691|NCT00862654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101615758|NCT00697138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101615759|NCT00609960|Midazolam|midazolam|mesh-list
101615760|NCT00609960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101615761|NCT00609960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101615762|NCT00609960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101615775|NCT04879134|Emetics|emetics|mesh-ancestor
101615830|NCT02619526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101615831|NCT02619526|Vasodilator Agents|vasodilator agents|mesh-ancestor
101615832|NCT02619526|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101615833|NCT02619526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101615834|NCT02619526|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101615835|NCT02619526|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101615836|NCT02619526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101615837|NCT04119622|Capecitabine|capecitabine|mesh-list
101615838|NCT04119622|Oxaliplatin|oxaliplatin|mesh-list
101615839|NCT04119622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101615840|NCT04119622|Antimetabolites|antimetabolites|mesh-ancestor
101615841|NCT04119622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101615842|NCT04119622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101615843|NCT00925548|Cyclophosphamide|cyclophosphamide|mesh-list
101615844|NCT00925548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101615845|NCT00925548|Immunologic Factors|immunologic factors|mesh-ancestor
101615846|NCT00925548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615847|NCT00925548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101615848|NCT00925548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101615849|NCT00925548|Alkylating Agents|alkylating agents|mesh-ancestor
101615882|NCT04132570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101615883|NCT04132570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101615884|NCT04132570|Respiratory System Agents|respiratory system agents|mesh-ancestor
101615885|NCT04132570|Glucocorticoids|glucocorticoids|mesh-ancestor
101615886|NCT04132570|Hormones|hormones|mesh-ancestor
101615887|NCT04132570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101615953|NCT04134598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101615954|NCT04134598|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101615955|NCT04134598|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101615956|NCT04134598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101615957|NCT04134598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616022|NCT02876432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101616023|NCT02876432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101616024|NCT02876432|Analgesics|analgesics|mesh-ancestor
101616095|NCT02607163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101616096|NCT02607163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616097|NCT02607163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101616098|NCT02607163|Analgesics|analgesics|mesh-ancestor
101616099|NCT02607163|Sensory System Agents|sensory system agents|mesh-ancestor
101616100|NCT02607163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101616102|NCT02607163|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101616162|NCT00859222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616164|NCT00858988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101616165|NCT00858988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101616237|NCT00857896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616238|NCT00857896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616239|NCT00857896|Urological Agents|urological agents|mesh-ancestor
101616307|NCT01074554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101616308|NCT01074554|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101616309|NCT01074554|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101616310|NCT01074554|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101616311|NCT01074554|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101616312|NCT01074554|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101616313|NCT01074554|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101616314|NCT00857584|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101616315|NCT00857584|Sertraline|sertraline|mesh-list
101616316|NCT00857584|Antidepressive Agents|antidepressive agents|mesh-ancestor
101616317|NCT00857584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101616318|NCT00857584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101616319|NCT00857584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101616320|NCT00857584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101616321|NCT00857584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616322|NCT00857584|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101616323|NCT00857584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101616324|NCT00857584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101616326|NCT00857584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101616358|NCT04118842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101616359|NCT04118842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616360|NCT04118842|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101616429|NCT00914797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101616430|NCT00798655|Cisplatin|cisplatin|mesh-list
101616431|NCT00798655|Panitumumab|panitumumab|mesh-list
101616432|NCT00798655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101616502|NCT00856180|Immunologic Factors|immunologic factors|mesh-ancestor
101616503|NCT00856180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101616504|NCT00856180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101616506|NCT00856180|Alkylating Agents|alkylating agents|mesh-ancestor
101616573|NCT00869518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101616574|NCT00869518|Antimalarials|antimalarials|mesh-ancestor
101616575|NCT00869518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101616576|NCT00869518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101616577|NCT00869518|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101616578|NCT00869518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101616586|NCT00869440|Midazolam|midazolam|mesh-list
101616643|NCT00092703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101616644|NCT00092703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101616645|NCT00092703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101616646|NCT00092703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101616647|NCT00092703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304298|NCT02012088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101365160|NCT00049361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101365163|NCT00049361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101304301|NCT02012088|Antimitotic Agents|antimitotic agents|mesh-ancestor
101304302|NCT02012088|Mitosis Modulators|mitosis modulators|mesh-ancestor
101365239|NCT00150787|Anticonvulsants|anticonvulsants|mesh-ancestor
101365240|NCT00150787|Nootropic Agents|nootropic agents|mesh-ancestor
101365241|NCT00150826|Quinapril|quinapril|mesh-list
101304305|NCT02012140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101333835|NCT00017316|Growth Substances|growth substances|mesh-ancestor
101365311|NCT00151138|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101365312|NCT00151138|Protective Agents|protective agents|mesh-ancestor
101365313|NCT00151138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365314|NCT00151138|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101304306|NCT02012140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101304307|NCT02012140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101365390|NCT00151450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101365461|NCT00406042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365553|NCT00151801|Interferon beta-1a|interferon beta-1a|mesh-list
101304310|NCT02012140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304311|NCT02012140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304312|NCT02012166|Insulin|insulin|mesh-list
101304313|NCT02012166|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101304314|NCT02012166|Octreotide|octreotide|mesh-list
101365627|NCT00152191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101365628|NCT00152191|Alkylating Agents|alkylating agents|mesh-ancestor
101304316|NCT02012166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101304317|NCT02012166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304318|NCT02012166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101304319|NCT02012166|Hormones|hormones|mesh-ancestor
101304320|NCT02012166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101304321|NCT02012166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101365693|NCT00152542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101365694|NCT00152542|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101304323|NCT02012244|Fentanyl|fentanyl|mesh-list
101304324|NCT02012244|Anesthetics|anesthetics|mesh-list
101365766|NCT00050180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101365767|NCT00050180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365836|NCT00083031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101365837|NCT00083031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101365909|NCT00083109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365910|NCT00083109|Antinematodal Agents|antinematodal agents|mesh-ancestor
101365911|NCT00083109|Anthelmintics|anthelmintics|mesh-ancestor
101365999|NCT00153634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366000|NCT00153634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366001|NCT00153634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101366002|NCT00153634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101304336|NCT02012309|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101304337|NCT02012309|Immunologic Factors|immunologic factors|mesh-ancestor
101366072|NCT00154024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101366073|NCT00154024|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101366074|NCT00154024|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101366075|NCT00154141|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101366076|NCT00154141|Hemostatics|hemostatics|mesh-ancestor
101366136|NCT00154336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101366137|NCT00154336|Antimetabolites|antimetabolites|mesh-ancestor
101366138|NCT00154336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366139|NCT00154336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366140|NCT00154336|Dermatologic Agents|dermatologic agents|mesh-ancestor
101304338|NCT02012309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304339|NCT02012322|Ubiquinone|ubiquinone|mesh-list
101304340|NCT02012322|Coenzyme Q10|coenzyme q10|mesh-list
101366208|NCT00406432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101366209|NCT00406432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101366210|NCT00406432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366214|NCT00406432|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101366216|NCT00406432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101366217|NCT00406432|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101366218|NCT00406432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101366219|NCT00406432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101304342|NCT02012322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366221|NCT00083343|Antifungal Agents|antifungal agents|mesh-ancestor
101366222|NCT00083343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101366223|NCT00083343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101366224|NCT00083343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366225|NCT00406471|Ranibizumab|ranibizumab|mesh-list
101366226|NCT00406471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101366227|NCT00406471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101366228|NCT00406471|Growth Substances|growth substances|mesh-ancestor
101366229|NCT00406471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366230|NCT00406471|Growth Inhibitors|growth inhibitors|mesh-ancestor
101366234|NCT00050921|Immunologic Factors|immunologic factors|mesh-ancestor
101366260|NCT00083460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101366261|NCT00083460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366262|NCT00083460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101366263|NCT00083460|Immunologic Factors|immunologic factors|mesh-ancestor
101366264|NCT00083460|Leprostatic Agents|leprostatic agents|mesh-ancestor
101366265|NCT00083460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101366266|NCT00083460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101366267|NCT00083460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101366268|NCT00083460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101366269|NCT00083460|Growth Substances|growth substances|mesh-ancestor
101366328|NCT00051077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366330|NCT00051077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101366331|NCT00051077|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101366332|NCT00051077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101366401|NCT00083538|Hormones|hormones|mesh-ancestor
101366402|NCT00083538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101366403|NCT00083538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101366404|NCT00083538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101366405|NCT00083538|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101304358|NCT02012387|Omalizumab|omalizumab|mesh-list
101366467|NCT00156403|Amlodipine|amlodipine|mesh-list
101366468|NCT00156403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101366469|NCT00156403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101366567|NCT00406861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101366568|NCT00406861|Respiratory System Agents|respiratory system agents|mesh-ancestor
101366569|NCT00406861|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101366570|NCT00406861|Hormone Antagonists|hormone antagonists|mesh-ancestor
101366571|NCT00406861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101366572|NCT00406861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366573|NCT00406861|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101366574|NCT00406861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101366575|NCT00406861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366576|NCT00044265|Ramipril|ramipril|mesh-list
101366577|NCT00044265|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101366635|NCT00051545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366636|NCT00051545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101366637|NCT00051545|Immunologic Factors|immunologic factors|mesh-ancestor
101366639|NCT00157885|Artesunate|artesunate|mesh-list
101366712|NCT00051701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101366713|NCT00051701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366714|NCT00158470|Lamivudine|lamivudine|mesh-list
101366715|NCT00158470|Efavirenz|efavirenz|mesh-list
101366716|NCT00158470|Didanosine|didanosine|mesh-list
101366798|NCT05568147|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101366799|NCT05568147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101366800|NCT05568147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101366801|NCT05568147|Antipyretics|antipyretics|mesh-ancestor
101366867|NCT00044460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366869|NCT00159484|Epothilone B|epothilone b|mesh-list
101366870|NCT00159484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101366871|NCT00159484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101366872|NCT00159484|Analgesics|analgesics|mesh-ancestor
101366965|NCT00407017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101366966|NCT00407017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101366967|NCT00407017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101366968|NCT00407017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366969|NCT00407017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366970|NCT00407017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366971|NCT00407017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101366972|NCT00407017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101366973|NCT00407017|Analgesics|analgesics|mesh-ancestor
101366974|NCT00407017|Sensory System Agents|sensory system agents|mesh-ancestor
101366975|NCT00407017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101366976|NCT00407017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101366977|NCT00407017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101366978|NCT00407017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101366980|NCT00407017|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101366981|NCT00160030|Cisplatin|cisplatin|mesh-list
101366982|NCT00160030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101367030|NCT00160342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101367031|NCT00160342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367032|NCT00160342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101367033|NCT00160342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101367034|NCT00160342|Anabolic Agents|anabolic agents|mesh-ancestor
101367035|NCT00160342|Androgens|androgens|mesh-ancestor
101367036|NCT00052364|Oxaliplatin|oxaliplatin|mesh-list
101367037|NCT00052364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101367112|NCT00160966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101367113|NCT00160966|Dermatologic Agents|dermatologic agents|mesh-ancestor
101367114|NCT00160966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101367195|NCT00161278|Paclitaxel|paclitaxel|mesh-list
101367196|NCT00161278|Carboplatin|carboplatin|mesh-list
101367197|NCT00161278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101367198|NCT00161278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101367199|NCT00161278|Tubulin Modulators|tubulin modulators|mesh-ancestor
101367200|NCT00161278|Antimitotic Agents|antimitotic agents|mesh-ancestor
101367201|NCT00161278|Mitosis Modulators|mitosis modulators|mesh-ancestor
101367256|NCT00161707|Protein C Inhibitor|protein c inhibitor|mesh-list
101367257|NCT00161707|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101367259|NCT00161707|Protease Inhibitors|protease inhibitors|mesh-ancestor
101367348|NCT00053105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101367349|NCT00053105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101367350|NCT00053105|Glucocorticoids|glucocorticoids|mesh-ancestor
101367431|NCT00162643|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101367432|NCT00162643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101367433|NCT00162643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101367497|NCT00162916|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101367498|NCT00162916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101367499|NCT00162916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101367563|NCT00163345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101367564|NCT00163345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367565|NCT00163345|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101367566|NCT00163384|Ciclesonide|ciclesonide|mesh-list
101367632|NCT02970383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101367633|NCT02970383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367634|NCT02970383|Analgesics|analgesics|mesh-ancestor
101367635|NCT02970383|Sensory System Agents|sensory system agents|mesh-ancestor
101367636|NCT02970383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101367637|NCT05502900|Melatonin|melatonin|mesh-list
101367704|NCT00164281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101367705|NCT00164281|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101367706|NCT00164281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101367707|NCT00164281|Antimetabolites|antimetabolites|mesh-ancestor
101367709|NCT00164281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101367778|NCT00164749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367779|NCT00164749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101367780|NCT00164749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101367781|NCT00164749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101367782|NCT00164749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101367783|NCT00164749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367784|NCT00164788|Esomeprazole|esomeprazole|mesh-list
101367785|NCT00164788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101367786|NCT00164788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101304435|NCT02012998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367850|NCT00165139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101367851|NCT00165139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101367852|NCT00165139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101367853|NCT00165139|Tubulin Modulators|tubulin modulators|mesh-ancestor
101367854|NCT00165139|Antimitotic Agents|antimitotic agents|mesh-ancestor
101367855|NCT00165139|Mitosis Modulators|mitosis modulators|mesh-ancestor
101367856|NCT00165139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101367857|NCT00165139|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101367858|NCT00053807|Interferons|interferons|mesh-list
101367859|NCT00053807|Interferon-alpha|interferon-alpha|mesh-list
101367860|NCT00053807|Aldesleukin|aldesleukin|mesh-list
101367861|NCT00053807|Fluorouracil|fluorouracil|mesh-list
101367862|NCT00053807|Antimetabolites|antimetabolites|mesh-ancestor
101304437|NCT02013102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101304438|NCT02013102|Antimetabolites|antimetabolites|mesh-ancestor
101304439|NCT02013102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304440|NCT02013102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101304441|NCT02013102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101367990|NCT00165451|Leprostatic Agents|leprostatic agents|mesh-ancestor
101367991|NCT00165451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101367992|NCT00165451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101368112|NCT00166465|Micronutrients|micronutrients|mesh-ancestor
101368113|NCT00166621|Buspirone|buspirone|mesh-list
101368114|NCT00166621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101304443|NCT02013115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101304444|NCT02013115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101304445|NCT02013115|Autonomic Agents|autonomic agents|mesh-ancestor
101368183|NCT00054431|Imatinib Mesylate|imatinib mesylate|mesh-list
101368184|NCT00054431|Decitabine|decitabine|mesh-list
101368185|NCT00054431|Azacitidine|azacitidine|mesh-list
101368188|NCT00054431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101368260|NCT00167518|Glucocorticoids|glucocorticoids|mesh-ancestor
101368261|NCT00167518|Hormones|hormones|mesh-ancestor
101368262|NCT00167518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101368339|NCT00167947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368340|NCT00167986|Vancomycin|vancomycin|mesh-list
101368341|NCT00167986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101368342|NCT00167986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101368343|NCT00168025|Immunoglobulins|immunoglobulins|mesh-list
101304451|NCT02013115|Hormones|hormones|mesh-ancestor
101368345|NCT00168025|Antibodies|antibodies|mesh-list
101368419|NCT00168532|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101368420|NCT00168532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101368421|NCT00168532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368422|NCT00168532|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101368423|NCT00168532|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101304453|NCT02013154|Paclitaxel|paclitaxel|mesh-list
101304454|NCT02013154|Pembrolizumab|pembrolizumab|mesh-list
101304455|NCT02013154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101368425|NCT00168532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101368487|NCT00054938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101368489|NCT00054938|Sensory System Agents|sensory system agents|mesh-ancestor
101368490|NCT00054938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101368491|NCT00054938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101368492|NCT00054938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101368493|NCT00054938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101368494|NCT00054938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101368495|NCT00054938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368496|NCT00054938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101368497|NCT00054938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101368498|NCT00054938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101368499|NCT00054938|Antipyretics|antipyretics|mesh-ancestor
101368529|NCT00169039|Clozapine|clozapine|mesh-list
101368564|NCT00169156|Rituximab|rituximab|mesh-list
101368584|NCT00169156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101368586|NCT00169156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101368587|NCT00169156|Tubulin Modulators|tubulin modulators|mesh-ancestor
101368588|NCT00169156|Antimitotic Agents|antimitotic agents|mesh-ancestor
101368589|NCT00169156|Mitosis Modulators|mitosis modulators|mesh-ancestor
101368665|NCT00169819|Anticoagulants|anticoagulants|mesh-ancestor
101368666|NCT00169819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101368667|NCT00055133|Paclitaxel|paclitaxel|mesh-list
101368668|NCT00055133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101368669|NCT00055133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368670|NCT00055133|Tubulin Modulators|tubulin modulators|mesh-ancestor
101368671|NCT00055133|Antimitotic Agents|antimitotic agents|mesh-ancestor
101368672|NCT00055133|Mitosis Modulators|mitosis modulators|mesh-ancestor
101368673|NCT00055133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368674|NCT00170053|Sirolimus|sirolimus|mesh-list
101362483|NCT00078975|Gemcitabine|gemcitabine|mesh-list
101368675|NCT00170053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101368676|NCT00170053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101368677|NCT00170053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101368678|NCT00170053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368679|NCT00170053|Antifungal Agents|antifungal agents|mesh-ancestor
101368685|NCT00055250|Antimetabolites|antimetabolites|mesh-ancestor
101368688|NCT00170209|Rifampin|rifampin|mesh-list
101368710|NCT02964091|Antiviral Agents|antiviral agents|mesh-ancestor
101368711|NCT02964091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101368713|NCT00170404|Folic Acid|folic acid|mesh-list
101368793|NCT00055484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368794|NCT00055484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101368795|NCT00055484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368874|NCT00171496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101368875|NCT00171535|Amlodipine|amlodipine|mesh-list
101368876|NCT00171535|Valsartan|valsartan|mesh-list
101368877|NCT00171535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101368878|NCT00171535|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101368949|NCT00171691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101368951|NCT00171691|Analgesics|analgesics|mesh-ancestor
101368952|NCT00171691|Sensory System Agents|sensory system agents|mesh-ancestor
101368953|NCT00171691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101368960|NCT00171769|Certoparin|certoparin|mesh-list
101369017|NCT00055757|Gemcitabine|gemcitabine|mesh-list
101369018|NCT00055757|Tipifarnib|tipifarnib|mesh-list
101369019|NCT00055757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101369020|NCT00055757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101369021|NCT00055757|Antimetabolites|antimetabolites|mesh-ancestor
101369022|NCT00055757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369023|NCT00399867|Simvastatin|simvastatin|mesh-list
101369024|NCT00399867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101369025|NCT00399867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101369092|NCT00055913|Growth Inhibitors|growth inhibitors|mesh-ancestor
101369093|NCT00055913|Immunologic Factors|immunologic factors|mesh-ancestor
101369094|NCT00055913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101369095|NCT00055913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101369096|NCT00055913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369097|NCT00045864|Aldesleukin|aldesleukin|mesh-list
101369098|NCT00045864|Rituximab|rituximab|mesh-list
101369099|NCT00045864|Interleukin-2|interleukin-2|mesh-list
101369100|NCT00045864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101369106|NCT00045864|Analgesics|analgesics|mesh-ancestor
101369161|NCT00046020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101369162|NCT00046020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369163|NCT00046020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101369164|NCT00046020|Antidepressive Agents|antidepressive agents|mesh-ancestor
101369211|NCT00174226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101369212|NCT00174226|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101369213|NCT00174226|Serotonin Agents|serotonin agents|mesh-ancestor
101369214|NCT00174304|Amlodipine|amlodipine|mesh-list
101369221|NCT00174304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101369289|NCT00056225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369290|NCT00174616|Capecitabine|capecitabine|mesh-list
101369291|NCT00174616|Oxaliplatin|oxaliplatin|mesh-list
101369292|NCT00174616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101369293|NCT00174616|Antimetabolites|antimetabolites|mesh-ancestor
101369294|NCT00174616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369360|NCT00046176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369362|NCT00046176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101369363|NCT00046176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101369364|NCT00046176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101369365|NCT00046176|Antimetabolites|antimetabolites|mesh-ancestor
101369366|NCT00174928|Lansoprazole|lansoprazole|mesh-list
101369367|NCT00174928|Dexlansoprazole|dexlansoprazole|mesh-list
101369368|NCT00174928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101369369|NCT00174928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101369371|NCT00174928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101369423|NCT00175396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101369446|NCT00175591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101369523|NCT00175981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101369524|NCT00175981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369525|NCT00175981|Urological Agents|urological agents|mesh-ancestor
101369526|NCT00175981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101369609|NCT00176449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101369610|NCT00176449|Antidepressive Agents|antidepressive agents|mesh-ancestor
101369611|NCT00176449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101369612|NCT00176449|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101369613|NCT00176449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101369614|NCT00176449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101369616|NCT00176449|Dopamine Agents|dopamine agents|mesh-ancestor
101528377|NCT04971356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101528378|NCT04971356|Analgesics|analgesics|mesh-ancestor
101528379|NCT04971356|Sensory System Agents|sensory system agents|mesh-ancestor
101369740|NCT00177580|Antimetabolites|antimetabolites|mesh-ancestor
101369741|NCT00177580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369742|NCT00177580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101369743|NCT00177580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101369744|NCT00177580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101369745|NCT04723342|Blinatumomab|blinatumomab|mesh-list
101369746|NCT04723342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101369747|NCT00177619|Alendronate|alendronate|mesh-list
101369748|NCT00177619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101369749|NCT00177619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369750|NCT00056810|4-Aminopyridine|4-aminopyridine|mesh-list
101369751|NCT00056810|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101369802|NCT00178828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101369803|NCT00178828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101369804|NCT00178828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369805|NCT00178828|Dopamine Agents|dopamine agents|mesh-ancestor
101369806|NCT00178828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101369807|NCT00178828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369808|NCT00178828|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101369809|NCT00178828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101369810|NCT00178828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101369812|NCT00178828|Serotonin Agents|serotonin agents|mesh-ancestor
101369871|NCT00179023|Respiratory System Agents|respiratory system agents|mesh-ancestor
101369873|NCT00179023|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101369874|NCT00179023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101369875|NCT00179023|Sympathomimetics|sympathomimetics|mesh-ancestor
101369876|NCT00179023|Adrenergic Agents|adrenergic agents|mesh-ancestor
101369877|NCT00179023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101369878|NCT00179023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369879|NCT00179023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101369880|NCT00179023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101369935|NCT00408382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369936|NCT00408382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101369937|NCT00408382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101369939|NCT00057122|Rifampin|rifampin|mesh-list
101369940|NCT00057122|Rifapentine|rifapentine|mesh-list
101369941|NCT00057122|Isoniazid|isoniazid|mesh-list
101369942|NCT00057122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101369943|NCT00057122|Antitubercular Agents|antitubercular agents|mesh-ancestor
101369944|NCT00057122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101369945|NCT00057122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101304547|NCT02013856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304549|NCT02013856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370012|NCT00179881|Growth Inhibitors|growth inhibitors|mesh-ancestor
101370013|NCT00179920|Carboplatin|carboplatin|mesh-list
101370014|NCT00179920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101370080|NCT00180622|Respiratory System Agents|respiratory system agents|mesh-ancestor
101370081|NCT00180622|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101370082|NCT00180622|Antioxidants|antioxidants|mesh-ancestor
101304550|NCT02013856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101304551|NCT02013856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101304552|NCT02013856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101304553|NCT02013895|Technetium Tc 99m DTPA-galactosyl-human serum albumin|technetium tc 99m dtpa-galactosyl-human serum albumin|mesh-list
101370090|NCT00180895|Rituximab|rituximab|mesh-list
101370149|NCT00181558|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101370151|NCT00181558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370250|NCT00408655|Mitosis Modulators|mitosis modulators|mesh-ancestor
101370252|NCT00408655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101370337|NCT00182884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370338|NCT00182884|Nootropic Agents|nootropic agents|mesh-ancestor
101370339|NCT00183001|Vitamin K|vitamin k|mesh-list
101370340|NCT00183001|Vitamins|vitamins|mesh-ancestor
101304561|NCT02013960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101370411|NCT02965248|Antimetabolites|antimetabolites|mesh-ancestor
101370425|NCT00183820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101304564|NCT02013986|Midazolam|midazolam|mesh-list
101304565|NCT02013986|Propofol|propofol|mesh-list
101370426|NCT00183820|Tubulin Modulators|tubulin modulators|mesh-ancestor
101370427|NCT00183820|Antimitotic Agents|antimitotic agents|mesh-ancestor
101370428|NCT00183820|Mitosis Modulators|mitosis modulators|mesh-ancestor
101370515|NCT00184171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101370516|NCT00057707|Modafinil|modafinil|mesh-list
101370517|NCT00057707|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101370518|NCT00057707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370608|NCT00184951|Antimetabolites|antimetabolites|mesh-ancestor
101370609|NCT00184951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370610|NCT00184951|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101370611|NCT00184951|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101370612|NCT00184951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101370614|NCT00184990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101370616|NCT00058331|Epoetin Alfa|epoetin alfa|mesh-list
101370670|NCT00185224|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101370671|NCT00185224|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101370672|NCT00185224|Contraceptive Agents|contraceptive agents|mesh-ancestor
101370673|NCT00185224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101370771|NCT00185887|Terbutaline|terbutaline|mesh-list
101370772|NCT00185887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101370773|NCT00185887|Autonomic Agents|autonomic agents|mesh-ancestor
101370774|NCT00185887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101370775|NCT00185887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370776|NCT00185887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101370853|NCT00186979|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
101370854|NCT00186979|Irinotecan|irinotecan|mesh-list
101370855|NCT00186979|Vincristine|vincristine|mesh-list
101370856|NCT00186979|Gefitinib|gefitinib|mesh-list
101370857|NCT00186979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101304592|NCT02013089|Sunitinib|sunitinib|mesh-list
101304593|NCT02013089|Imatinib Mesylate|imatinib mesylate|mesh-list
101370937|NCT00187174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101370938|NCT00187330|Acetylcysteine|acetylcysteine|mesh-list
101370939|NCT00187330|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101370940|NCT00187330|Antiviral Agents|antiviral agents|mesh-ancestor
101370941|NCT00187330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101370942|NCT00187330|Expectorants|expectorants|mesh-ancestor
101370944|NCT00187330|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101371015|NCT00058955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101371016|NCT00058955|Anesthetics, General|anesthetics, general|mesh-ancestor
101371017|NCT00058955|Anesthetics|anesthetics|mesh-ancestor
101371018|NCT00058955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101304594|NCT02013089|Gefitinib|gefitinib|mesh-list
101304595|NCT02013089|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101304596|NCT02013089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101304597|NCT02013089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101333840|NCT00041275|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101371079|NCT00188227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
101371080|NCT00188227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101371081|NCT00188227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101371082|NCT00188227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371151|NCT00409318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101371152|NCT00409318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371154|NCT00409318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101371155|NCT00409318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101371156|NCT00409318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101371157|NCT00409318|Immunologic Factors|immunologic factors|mesh-ancestor
101371158|NCT00409357|Alfuzosin|alfuzosin|mesh-list
101371215|NCT00059306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101371216|NCT00059306|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101304615|NCT02014337|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101304616|NCT02014337|Abortifacient Agents|abortifacient agents|mesh-ancestor
101371324|NCT00189709|Hormone Antagonists|hormone antagonists|mesh-ancestor
101371325|NCT00189709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101304617|NCT02014337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101304618|NCT02014337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304619|NCT02014337|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101371397|NCT00190099|Glucocorticoids|glucocorticoids|mesh-ancestor
101371398|NCT00190099|Hormones|hormones|mesh-ancestor
101371399|NCT00190099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101371400|NCT00190099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101304621|NCT02014337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101371503|NCT00190567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101371504|NCT00190567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371522|NCT00190606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371524|NCT00190606|Sensory System Agents|sensory system agents|mesh-ancestor
101371525|NCT00190606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101371526|NCT00190606|Antidepressive Agents|antidepressive agents|mesh-ancestor
101304623|NCT02014337|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101304624|NCT02014337|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101304625|NCT02014337|Hormone Antagonists|hormone antagonists|mesh-ancestor
101333841|NCT00041275|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101371527|NCT00190606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101371528|NCT00190606|Dopamine Agents|dopamine agents|mesh-ancestor
101371529|NCT00190645|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101371530|NCT00190645|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101371588|NCT00190996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101371589|NCT00190996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101371590|NCT00190996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101371594|NCT00190996|Analgesics|analgesics|mesh-ancestor
101371657|NCT04723030|Tubulin Modulators|tubulin modulators|mesh-ancestor
101371658|NCT04723030|Antimitotic Agents|antimitotic agents|mesh-ancestor
101371659|NCT04723030|Mitosis Modulators|mitosis modulators|mesh-ancestor
101371660|NCT04723030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371661|NCT00191503|Gemcitabine|gemcitabine|mesh-list
101371754|NCT00059813|Immunologic Factors|immunologic factors|mesh-ancestor
101371755|NCT00059813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371756|NCT00191971|Gemcitabine|gemcitabine|mesh-list
101371757|NCT00191971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101371758|NCT00191971|Antimetabolites|antimetabolites|mesh-ancestor
101371759|NCT00191971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371760|NCT00191971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371761|NCT00047502|Imatinib Mesylate|imatinib mesylate|mesh-list
101371762|NCT00047502|Lonafarnib|lonafarnib|mesh-list
101371763|NCT00047502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371765|NCT00047502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371831|NCT00192595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101371832|NCT00192595|Antimetabolites|antimetabolites|mesh-ancestor
101371833|NCT00192595|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101371945|NCT00193570|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101371946|NCT00193570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101371947|NCT00193570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371948|NCT00047736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101371949|NCT00047736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371950|NCT00047736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101371951|NCT00047736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101362506|NCT04457557|Anesthetics, Local|anesthetics, local|mesh-list
101371952|NCT00047736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371961|NCT00409591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371962|NCT00409591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101371983|NCT00060125|Tipifarnib|tipifarnib|mesh-list
101372014|NCT00060242|Fosbretabulin|fosbretabulin|mesh-list
101372015|NCT00060242|Combretastatin|combretastatin|mesh-list
101372016|NCT00060242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101372017|NCT00060242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101372018|NCT00060242|Tubulin Modulators|tubulin modulators|mesh-ancestor
101372095|NCT00194623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372096|NCT00194623|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101372097|NCT00194623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101372171|NCT00195286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101372172|NCT00195286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372173|NCT00084201|Amoxicillin|amoxicillin|mesh-list
101372174|NCT00084201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101372175|NCT00084201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101372176|NCT00195364|Etanercept|etanercept|mesh-list
101372179|NCT00195364|Analgesics|analgesics|mesh-ancestor
101372241|NCT00195598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101372242|NCT00195598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101372243|NCT00195598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372244|NCT00195598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101372245|NCT00195598|Serotonin Agents|serotonin agents|mesh-ancestor
101372246|NCT00195598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372247|NCT00195598|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101372248|NCT00195598|Antidepressive Agents|antidepressive agents|mesh-ancestor
101372249|NCT00195598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101372252|NCT00195598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101372310|NCT00195871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101372311|NCT00195871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101372312|NCT00195871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101372313|NCT00195871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101372314|NCT00195871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101372315|NCT00195871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101372316|NCT00195871|Tubulin Modulators|tubulin modulators|mesh-ancestor
101372317|NCT00195871|Antimitotic Agents|antimitotic agents|mesh-ancestor
101372318|NCT00195871|Mitosis Modulators|mitosis modulators|mesh-ancestor
101372319|NCT00195871|Antiviral Agents|antiviral agents|mesh-ancestor
101372320|NCT00195871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101372321|NCT00195871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101372322|NCT00195910|Morphine|morphine|mesh-list
101372323|NCT00195910|Hydromorphone|hydromorphone|mesh-list
101372324|NCT00195910|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101372365|NCT00084279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101372366|NCT00084279|Antimetabolites|antimetabolites|mesh-ancestor
101372367|NCT00084279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372368|NCT00084279|Immunologic Factors|immunologic factors|mesh-ancestor
101372376|NCT00196378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372438|NCT00196690|Cholinergic Agents|cholinergic agents|mesh-ancestor
101372444|NCT00084396|Letrozole|letrozole|mesh-list
101372445|NCT00084396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101372446|NCT00084396|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101372447|NCT00084396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101372448|NCT00084396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101372454|NCT00196846|Goserelin|goserelin|mesh-list
101372517|NCT00197197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101372518|NCT00197197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101372519|NCT00197197|Antiviral Agents|antiviral agents|mesh-ancestor
101372521|NCT00409903|Eprosartan|eprosartan|mesh-list
101372601|NCT00084669|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101372602|NCT00084669|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101372603|NCT00084669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101372604|NCT00084669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101372605|NCT00084669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372606|NCT00084669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101362518|NCT00079014|Doxorubicin|doxorubicin|mesh-list
101372607|NCT00084669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372608|NCT00084669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101372609|NCT00084669|Antidepressive Agents|antidepressive agents|mesh-ancestor
101372610|NCT00084669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101372611|NCT00084669|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101372612|NCT00084669|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101372613|NCT00084669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101372614|NCT00084669|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101372615|NCT00084669|GABA Agonists|gaba agonists|mesh-ancestor
101372616|NCT00084669|GABA Agents|gaba agents|mesh-ancestor
101372617|NCT00060866|Propranolol|propranolol|mesh-list
101372627|NCT00048360|Bupropion|bupropion|mesh-list
101372657|NCT00198055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101372658|NCT00198055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101372661|NCT00198094|Antidepressive Agents|antidepressive agents|mesh-ancestor
101372662|NCT00198094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101304664|NCT02014532|Hormone Antagonists|hormone antagonists|mesh-ancestor
101333842|NCT00041275|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101372663|NCT00198094|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101372664|NCT00198094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101372665|NCT00198094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101372666|NCT00198094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372667|NCT00198094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101372668|NCT00198094|Serotonin Agents|serotonin agents|mesh-ancestor
101372669|NCT00198094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372670|NCT00198094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101372671|NCT00198094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101372672|NCT00198094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101372673|NCT00198094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101372674|NCT00198094|GABA Modulators|gaba modulators|mesh-ancestor
101372675|NCT00198094|GABA Agents|gaba agents|mesh-ancestor
101372676|NCT00198172|Epirubicin|epirubicin|mesh-list
101372720|NCT00198367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101372721|NCT00198367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372722|NCT00198367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101372723|NCT00198367|Tubulin Modulators|tubulin modulators|mesh-ancestor
101372797|NCT00084786|Tubulin Modulators|tubulin modulators|mesh-ancestor
101372798|NCT00084786|Antimitotic Agents|antimitotic agents|mesh-ancestor
101372799|NCT00084786|Mitosis Modulators|mitosis modulators|mesh-ancestor
101372800|NCT00084786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372801|NCT00084786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101372871|NCT00199186|Antiemetics|antiemetics|mesh-ancestor
101372872|NCT00199186|Autonomic Agents|autonomic agents|mesh-ancestor
101372873|NCT00199186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101372945|NCT00199576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101372946|NCT00084942|Gemcitabine|gemcitabine|mesh-list
101372947|NCT00084942|Capecitabine|capecitabine|mesh-list
101372948|NCT00084942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101372949|NCT00084942|Antimetabolites|antimetabolites|mesh-ancestor
101372950|NCT00084942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373029|NCT00200434|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101373030|NCT00200434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101373031|NCT00200434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101373032|NCT00200434|Adrenergic Agents|adrenergic agents|mesh-ancestor
101373033|NCT00200434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101373116|NCT00200629|Purinergic Agents|purinergic agents|mesh-ancestor
101373122|NCT00048594|Aprepitant|aprepitant|mesh-list
101373186|NCT00410449|Vitamins|vitamins|mesh-ancestor
101373277|NCT00412789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373279|NCT00048828|Clozapine|clozapine|mesh-list
101373280|NCT00048828|Antiemetics|antiemetics|mesh-ancestor
101373281|NCT00048828|Autonomic Agents|autonomic agents|mesh-ancestor
101373348|NCT02968160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101373349|NCT02968160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101373350|NCT00222079|Esomeprazole|esomeprazole|mesh-list
101373351|NCT00222079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101373352|NCT00222079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101373353|NCT00222079|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101373425|NCT00222820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373427|NCT00085332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101373428|NCT00085332|Tubulin Modulators|tubulin modulators|mesh-ancestor
101373429|NCT00085332|Antimitotic Agents|antimitotic agents|mesh-ancestor
101373430|NCT00085332|Mitosis Modulators|mitosis modulators|mesh-ancestor
101373450|NCT00223015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101373516|NCT00085449|Fludarabine phosphate|fludarabine phosphate|mesh-list
101373517|NCT00085449|Melphalan|melphalan|mesh-list
101373518|NCT00085449|Alemtuzumab|alemtuzumab|mesh-list
101373519|NCT00085449|Cyclosporins|cyclosporins|mesh-list
101373599|NCT00223717|Natriuretic Agents|natriuretic agents|mesh-ancestor
101373600|NCT00223717|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101373601|NCT00223717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101373602|NCT00223717|Sympatholytics|sympatholytics|mesh-ancestor
101373603|NCT00223717|Autonomic Agents|autonomic agents|mesh-ancestor
101373677|NCT00061997|Vitamins|vitamins|mesh-ancestor
101373678|NCT00061997|Micronutrients|micronutrients|mesh-ancestor
101373780|NCT00062231|Ciprofloxacin|ciprofloxacin|mesh-list
101373781|NCT00062231|Clavulanic Acid|clavulanic acid|mesh-list
101373782|NCT00062231|Clavulanic Acids|clavulanic acids|mesh-list
101373783|NCT00062231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101373784|NCT00062231|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101373851|NCT00062270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101373852|NCT00062270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101373853|NCT00062270|Antimetabolites|antimetabolites|mesh-ancestor
101373854|NCT00062270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373925|NCT00095355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101373926|NCT00095355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101373927|NCT00095355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373928|NCT00095355|Anticonvulsants|anticonvulsants|mesh-ancestor
101373930|NCT00095355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101373931|NCT00225160|Acetylcarnitine|acetylcarnitine|mesh-list
101373932|NCT00225160|Vitamin B Complex|vitamin b complex|mesh-ancestor
101373933|NCT00225160|Vitamins|vitamins|mesh-ancestor
101373934|NCT00225160|Micronutrients|micronutrients|mesh-ancestor
101373935|NCT00225160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373943|NCT00062426|Leucovorin|leucovorin|mesh-list
101373991|NCT02962258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101373992|NCT02962258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373993|NCT02962258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101374059|NCT00225706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101374061|NCT00225706|Sensory System Agents|sensory system agents|mesh-ancestor
101374062|NCT00225706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101374063|NCT00225706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374064|NCT00225706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101374065|NCT00225706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101374066|NCT00225706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101374067|NCT00225706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101374068|NCT00225706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374069|NCT00095667|Lapatinib|lapatinib|mesh-list
101374070|NCT00095667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101374071|NCT00095667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101374072|NCT00095667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101374119|NCT00095745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101374121|NCT00226096|Clonidine|clonidine|mesh-list
101374122|NCT00226096|Nitroprusside|nitroprusside|mesh-list
101374123|NCT00226096|Labetalol|labetalol|mesh-list
101374124|NCT00226096|Hydralazine|hydralazine|mesh-list
101374125|NCT00226096|Nicardipine|nicardipine|mesh-list
101374126|NCT00226096|Phentolamine|phentolamine|mesh-list
101374127|NCT00226096|Urapidil|urapidil|mesh-list
101374128|NCT00226096|Enalaprilat|enalaprilat|mesh-list
101374129|NCT00226096|Nitroglycerin|nitroglycerin|mesh-list
101374130|NCT00226096|Esmolol|esmolol|mesh-list
101374131|NCT00226096|Glycerol|glycerol|mesh-list
101374132|NCT00226096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101374176|NCT00400374|Celecoxib|celecoxib|mesh-list
101374187|NCT00400374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374188|NCT00400374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101374189|NCT00400374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101374190|NCT00400374|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101374294|NCT00226837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101374295|NCT00226837|Analgesics|analgesics|mesh-ancestor
101374296|NCT00226837|Sensory System Agents|sensory system agents|mesh-ancestor
101374297|NCT00226837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101374298|NCT00226915|Paclitaxel|paclitaxel|mesh-list
101374299|NCT00226915|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101374300|NCT00226915|Carboplatin|carboplatin|mesh-list
101374369|NCT00096096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101374370|NCT00096096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101374372|NCT04721899|Vitamins|vitamins|mesh-ancestor
101374373|NCT04721899|Micronutrients|micronutrients|mesh-ancestor
101374374|NCT04721899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374375|NCT04721899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101374376|NCT00062972|Donepezil|donepezil|mesh-list
101374377|NCT00062972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101374378|NCT00062972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101374379|NCT00062972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374380|NCT00062972|Cholinergic Agents|cholinergic agents|mesh-ancestor
101374381|NCT00062972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101374382|NCT00062972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374383|NCT00062972|Nootropic Agents|nootropic agents|mesh-ancestor
101374384|NCT00227656|Interferons|interferons|mesh-list
101374385|NCT00227656|Interferon-alpha|interferon-alpha|mesh-list
101374386|NCT00227656|Interferon alpha-2|interferon alpha-2|mesh-list
101374387|NCT00227656|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101374388|NCT00227656|Capecitabine|capecitabine|mesh-list
101374445|NCT00096291|Doxorubicin|doxorubicin|mesh-list
101374446|NCT00096291|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101374447|NCT00096291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101374448|NCT00096291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101374449|NCT00096291|Tubulin Modulators|tubulin modulators|mesh-ancestor
101374450|NCT00096291|Antimitotic Agents|antimitotic agents|mesh-ancestor
101374451|NCT00096291|Mitosis Modulators|mitosis modulators|mesh-ancestor
101374466|NCT02967302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101374467|NCT02967302|Glucocorticoids|glucocorticoids|mesh-ancestor
101374468|NCT02967302|Hormones|hormones|mesh-ancestor
101374469|NCT02967302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101374470|NCT00096330|Folic Acid|folic acid|mesh-list
101374471|NCT00096330|Hematinics|hematinics|mesh-ancestor
101374472|NCT00096330|Vitamin B Complex|vitamin b complex|mesh-ancestor
101374473|NCT00096330|Vitamins|vitamins|mesh-ancestor
101374474|NCT00096330|Micronutrients|micronutrients|mesh-ancestor
101374475|NCT00096330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374476|NCT02962492|Dapagliflozin|dapagliflozin|mesh-list
101374477|NCT02962492|Exenatide|exenatide|mesh-list
101374478|NCT02962492|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101374483|NCT02962492|Incretins|incretins|mesh-ancestor
101374512|NCT00228046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101374531|NCT00228163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101374532|NCT00228163|Analgesics|analgesics|mesh-ancestor
101374533|NCT00228163|Sensory System Agents|sensory system agents|mesh-ancestor
101374536|NCT00228163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101374605|NCT00075543|Tubulin Modulators|tubulin modulators|mesh-ancestor
101374606|NCT00075543|Antimitotic Agents|antimitotic agents|mesh-ancestor
101374607|NCT00075543|Mitosis Modulators|mitosis modulators|mesh-ancestor
101374608|NCT00075543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374696|NCT02967653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374697|NCT02967653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101374698|NCT02967653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101374699|NCT02967653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101374700|NCT00229333|Escitalopram|escitalopram|mesh-list
101374701|NCT00229333|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101374708|NCT00229450|Estrogens|estrogens|mesh-list
101374709|NCT00229450|Hormones|hormones|mesh-ancestor
101374710|NCT00229450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101374711|NCT00229450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374712|NCT00229528|Paroxetine|paroxetine|mesh-list
101374713|NCT00229528|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101374714|NCT00229528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101374715|NCT00229528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101374716|NCT00229528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374717|NCT00229528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101374718|NCT00229528|Serotonin Agents|serotonin agents|mesh-ancestor
101374719|NCT00229528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374720|NCT00229528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101374721|NCT00229528|Antidepressive Agents|antidepressive agents|mesh-ancestor
101374722|NCT00229528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101374723|NCT00229528|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101374724|NCT00229528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101374725|NCT00229528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101374726|NCT00075699|Vincristine|vincristine|mesh-list
101374727|NCT00075699|Vinorelbine|vinorelbine|mesh-list
101374729|NCT00075699|Mitomycin|mitomycin|mesh-list
101374730|NCT00075699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101374731|NCT00075699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101439504|NCT05294146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101439505|NCT05284591|Daratumumab|daratumumab|mesh-list
101439506|NCT05284591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439507|NCT05252533|Ustekinumab|ustekinumab|mesh-list
101439508|NCT05252533|Dermatologic Agents|dermatologic agents|mesh-ancestor
101439509|NCT05246670|Palmidrol|palmidrol|mesh-list
101439510|NCT05246670|Analgesics|analgesics|mesh-ancestor
101439511|NCT05246670|Sensory System Agents|sensory system agents|mesh-ancestor
101439512|NCT05246670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101439513|NCT05246670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439514|NCT05246670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101374732|NCT00075699|Tubulin Modulators|tubulin modulators|mesh-ancestor
101374733|NCT00075699|Antimitotic Agents|antimitotic agents|mesh-ancestor
101374734|NCT00075699|Mitosis Modulators|mitosis modulators|mesh-ancestor
101374735|NCT00075699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374736|NCT00075699|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101374737|NCT00075699|Alkylating Agents|alkylating agents|mesh-ancestor
101374738|NCT00075699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101374739|NCT00075699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101374740|NCT00229567|Lidocaine|lidocaine|mesh-list
101374741|NCT00229567|Ketamine|ketamine|mesh-list
101374742|NCT00229567|Anesthetics, Local|anesthetics, local|mesh-ancestor
101374743|NCT00229567|Anesthetics|anesthetics|mesh-ancestor
101374744|NCT00229567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101374745|NCT00229567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374746|NCT00229567|Sensory System Agents|sensory system agents|mesh-ancestor
101374747|NCT00229567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101374748|NCT00229567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101374749|NCT00229567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101374788|NCT00096720|Antioxidants|antioxidants|mesh-ancestor
101374789|NCT00096720|Protective Agents|protective agents|mesh-ancestor
101374790|NCT00096720|Dopamine Agonists|dopamine agonists|mesh-ancestor
101374791|NCT00413608|Clopidogrel|clopidogrel|mesh-list
101374792|NCT00413608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101374793|NCT00413608|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101374795|NCT00413608|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101374860|NCT00230035|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101374861|NCT00230035|Antitubercular Agents|antitubercular agents|mesh-ancestor
101374862|NCT00230035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101374863|NCT00230035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101374864|NCT00230035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101374865|NCT00230035|Antiemetics|antiemetics|mesh-ancestor
101374866|NCT00230035|Autonomic Agents|autonomic agents|mesh-ancestor
101374867|NCT00230035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101374868|NCT00230035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101374869|NCT00230035|Glucocorticoids|glucocorticoids|mesh-ancestor
101374871|NCT00230035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101374872|NCT00230035|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101374873|NCT00230035|Protective Agents|protective agents|mesh-ancestor
101374875|NCT00063401|Carboplatin|carboplatin|mesh-list
101374876|NCT00063401|Cetuximab|cetuximab|mesh-list
101374908|NCT00424723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101374909|NCT00424723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374910|NCT00424723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101374927|NCT00097032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374928|NCT00097032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374994|NCT00075777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374995|NCT00075777|GABA Agents|gaba agents|mesh-ancestor
101374996|NCT00075777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101375067|NCT00231517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101375068|NCT00075894|Alanosine|alanosine|mesh-list
101375069|NCT00075894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101375070|NCT00075894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101375071|NCT00075894|Chelating Agents|chelating agents|mesh-ancestor
101375072|NCT00075894|Sequestering Agents|sequestering agents|mesh-ancestor
101375073|NCT00075894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375074|NCT00231556|Topiramate|topiramate|mesh-list
101375075|NCT00231556|Anticonvulsants|anticonvulsants|mesh-ancestor
101375076|NCT00231556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101375077|NCT00231556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375078|NCT00231595|Topiramate|topiramate|mesh-list
101375079|NCT00231595|Anticonvulsants|anticonvulsants|mesh-ancestor
101375080|NCT00231595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101375081|NCT00231595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375082|NCT00231634|Topiramate|topiramate|mesh-list
101375083|NCT00231634|Anticonvulsants|anticonvulsants|mesh-ancestor
101375084|NCT00231634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101375085|NCT00231634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375086|NCT00231673|Topiramate|topiramate|mesh-list
101375087|NCT00231673|Anticonvulsants|anticonvulsants|mesh-ancestor
101375088|NCT00231673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101375089|NCT00231673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375090|NCT00097188|Rituximab|rituximab|mesh-list
101304752|NCT02014922|alpha-Tocopherol|alpha-tocopherol|mesh-list
101304753|NCT02014922|Tocopherols|tocopherols|mesh-list
101375091|NCT00097188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101375092|NCT00097188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101375093|NCT00097188|Immunologic Factors|immunologic factors|mesh-ancestor
101375094|NCT00097188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375095|NCT00097188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101375097|NCT00231829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101375098|NCT00231829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101375110|NCT00075933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101375111|NCT00075933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101375112|NCT00075933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101375113|NCT00075933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101375140|NCT00232102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375142|NCT00097227|Paclitaxel|paclitaxel|mesh-list
101375209|NCT00232531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101375210|NCT00232531|Antimetabolites|antimetabolites|mesh-ancestor
101375211|NCT00232531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375212|NCT00232531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101375213|NCT00232531|Vasodilator Agents|vasodilator agents|mesh-ancestor
101375277|NCT00232687|Dopamine Agents|dopamine agents|mesh-ancestor
101375278|NCT00232687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101375279|NCT00232687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375280|NCT00232687|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101375281|NCT00232687|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101375282|NCT00232687|Serotonin Agents|serotonin agents|mesh-ancestor
101375283|NCT00232687|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101375284|NCT00232687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101375285|NCT00232687|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101375286|NCT00232687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101375287|NCT00232765|Sirolimus|sirolimus|mesh-list
101375288|NCT00232765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101375289|NCT00232765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101375290|NCT00232765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101375291|NCT00232765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101375292|NCT00232765|Antifungal Agents|antifungal agents|mesh-ancestor
101375293|NCT00232765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101375294|NCT00232765|Immunologic Factors|immunologic factors|mesh-ancestor
101375425|NCT00064142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101375426|NCT00064142|Coccidiostats|coccidiostats|mesh-ancestor
101375427|NCT00064142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101375428|NCT00064142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101378006|NCT00068276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101378008|NCT00250042|Arsenic Trioxide|arsenic trioxide|mesh-list
101378009|NCT00250042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378013|NCT00068315|Rituximab|rituximab|mesh-list
101304767|NCT02015156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101304768|NCT02015156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101304769|NCT02015169|Lapatinib|lapatinib|mesh-list
101378092|NCT00099957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101378094|NCT00250315|Dobutamine|dobutamine|mesh-list
101378162|NCT00250744|Antiemetics|antiemetics|mesh-ancestor
101378166|NCT00103623|Abarelix|abarelix|mesh-list
101378234|NCT00100074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378235|NCT00100074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101378236|NCT00100074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101378237|NCT00100074|Cholinergic Agents|cholinergic agents|mesh-ancestor
101378238|NCT00100074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101378240|NCT00100074|Respiratory System Agents|respiratory system agents|mesh-ancestor
101378305|NCT00100152|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101304776|NCT02015182|Anesthetics|anesthetics|mesh-ancestor
101304777|NCT02015182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101304778|NCT02015182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378306|NCT00100152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101378377|NCT00251680|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101378378|NCT00251680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101304779|NCT02015182|Sensory System Agents|sensory system agents|mesh-ancestor
101378448|NCT00399152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378449|NCT00399152|Growth Inhibitors|growth inhibitors|mesh-ancestor
101378450|NCT00399152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101378523|NCT00252889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101378524|NCT00252889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101378525|NCT00252889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378589|NCT00100464|Paroxetine|paroxetine|mesh-list
101378590|NCT00100464|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101304782|NCT02015260|Anticoagulants|anticoagulants|mesh-ancestor
101378655|NCT00253591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378657|NCT04719481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101378658|NCT04719481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101378659|NCT04719481|Antimetabolites|antimetabolites|mesh-ancestor
101378660|NCT04719481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378661|NCT04719481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101304786|NCT02015260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304789|NCT02015299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101378715|NCT00254176|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
101378716|NCT00254176|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101378717|NCT00254176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101378718|NCT00254254|Exenatide|exenatide|mesh-list
101378719|NCT00254254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101378720|NCT00254254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378786|NCT00104403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101378787|NCT00104403|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101378788|NCT00069836|Metformin|metformin|mesh-list
101378789|NCT00069836|Rosiglitazone|rosiglitazone|mesh-list
101378790|NCT00069836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101378865|NCT00255463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378866|NCT00255502|Metoprolol|metoprolol|mesh-list
101378867|NCT00255502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101378868|NCT00255502|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101378869|NCT00255502|Sympatholytics|sympatholytics|mesh-ancestor
101378897|NCT00070148|Megestrol|megestrol|mesh-list
101378964|NCT00070187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378965|NCT00070187|Antiviral Agents|antiviral agents|mesh-ancestor
101378966|NCT00070187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101379042|NCT00256321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101379043|NCT00256321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101379044|NCT00256321|Analgesics|analgesics|mesh-ancestor
101379045|NCT00256321|Sensory System Agents|sensory system agents|mesh-ancestor
101379046|NCT00256321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101379112|NCT00256828|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101379113|NCT00256828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101379114|NCT00256828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101379115|NCT00256828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379116|NCT00256828|Antiviral Agents|antiviral agents|mesh-ancestor
101379117|NCT00256828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101379118|NCT00256828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101379119|NCT00256828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101379120|NCT00256828|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101379121|NCT00256828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101379122|NCT00256828|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101379123|NCT00256828|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101379124|NCT00256828|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101379169|NCT00257062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101379170|NCT00257062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101379171|NCT00257062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101379172|NCT00257062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101379174|NCT00257062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379175|NCT00257062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379176|NCT00257062|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101379177|NCT00257062|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101379178|NCT00100854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101379179|NCT00100854|Fulvestrant|fulvestrant|mesh-list
101379180|NCT00100854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379181|NCT00100854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101379182|NCT00100854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101379183|NCT00100854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379184|NCT00100854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101379185|NCT00100854|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101379190|NCT00257140|Levofloxacin|levofloxacin|mesh-list
101379218|NCT00257452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379219|NCT00257452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379220|NCT00257452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101379222|NCT00257452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101379291|NCT00401115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101379292|NCT00401115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101379293|NCT00401115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379301|NCT00257959|Amiodarone|amiodarone|mesh-list
101379362|NCT00258232|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101379363|NCT00258232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101379364|NCT00258232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101379365|NCT00258232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101379415|NCT00258622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379417|NCT00423761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101304895|NCT02015949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101304896|NCT02015949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379450|NCT00101127|Docetaxel|docetaxel|mesh-list
101379517|NCT00071201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101379518|NCT00071201|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101379519|NCT00071201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101379520|NCT00071201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101379521|NCT00071201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379522|NCT00259636|Zonisamide|zonisamide|mesh-list
101379523|NCT00259636|Anticonvulsants|anticonvulsants|mesh-ancestor
101379524|NCT00259636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101379525|NCT00259636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101379526|NCT00259636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379527|NCT00259636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101379569|NCT00259792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101379570|NCT00259792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101379571|NCT00259792|Adrenergic Agents|adrenergic agents|mesh-ancestor
101379572|NCT00259792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101379573|NCT00259792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379574|NCT00105144|Caspofungin|caspofungin|mesh-list
101379631|NCT00260260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379632|NCT00260260|Analgesics|analgesics|mesh-ancestor
101379633|NCT00260260|Sensory System Agents|sensory system agents|mesh-ancestor
101379634|NCT00260260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101379635|NCT00105300|Adalimumab|adalimumab|mesh-list
101379636|NCT00105300|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101379637|NCT00105300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101304935|NCT02016261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101304936|NCT02016261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304937|NCT02016261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101304938|NCT02016261|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101379683|NCT00071747|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101379743|NCT00261586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101379744|NCT00261586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101379746|NCT00261586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101379747|NCT00261586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379748|NCT00261586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101379749|NCT00261586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101379750|NCT00261586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101379751|NCT00261586|Antipyretics|antipyretics|mesh-ancestor
101379752|NCT00261586|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101379753|NCT00261586|Gout Suppressants|gout suppressants|mesh-ancestor
101379822|NCT00261937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379824|NCT00105495|Deferoxamine|deferoxamine|mesh-list
101379825|NCT00105495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101379826|NCT00105495|Chelating Agents|chelating agents|mesh-ancestor
101379830|NCT00261976|Infliximab|infliximab|mesh-list
101379900|NCT00262327|Endostatins|endostatins|mesh-list
101379903|NCT00262327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101379905|NCT00262327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379906|NCT00262327|Growth Inhibitors|growth inhibitors|mesh-ancestor
101379971|NCT00072215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101379972|NCT00072215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379973|NCT00072215|Tubulin Modulators|tubulin modulators|mesh-ancestor
101379976|NCT00072215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380038|NCT00101673|Protease Inhibitors|protease inhibitors|mesh-ancestor
101380039|NCT00101673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101380040|NCT00101673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380041|NCT00263302|Dexamethasone|dexamethasone|mesh-list
101380042|NCT00263302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101380043|NCT00263302|Antiemetics|antiemetics|mesh-ancestor
101380044|NCT00263302|Autonomic Agents|autonomic agents|mesh-ancestor
101380101|NCT00264277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380102|NCT00264277|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101380103|NCT00264277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101380104|NCT00264277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380105|NCT00264277|Hemostatics|hemostatics|mesh-ancestor
101380180|NCT00265018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101380181|NCT00265018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380182|NCT00265018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101380183|NCT00265018|Tubulin Modulators|tubulin modulators|mesh-ancestor
101380184|NCT00265018|Antimitotic Agents|antimitotic agents|mesh-ancestor
101380187|NCT00265135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380188|NCT00106197|Bupropion|bupropion|mesh-list
101380189|NCT00106197|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101380190|NCT00106197|Antidepressive Agents|antidepressive agents|mesh-ancestor
101380191|NCT00106197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101380192|NCT00106197|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101380193|NCT00106197|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101380194|NCT00106197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101380195|NCT00106197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380196|NCT00106197|Dopamine Agents|dopamine agents|mesh-ancestor
101380197|NCT00106197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101380198|NCT00106197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380199|NCT00106197|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101380200|NCT00106197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101380205|NCT00265291|Fluoxetine|fluoxetine|mesh-list
101380229|NCT00265408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101380230|NCT00265408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380232|NCT00265408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101380301|NCT00102141|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101380302|NCT00102141|Estrogens|estrogens|mesh-ancestor
101380303|NCT00102141|Hormones|hormones|mesh-ancestor
101380304|NCT00102141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101380305|NCT00102141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380306|NCT00102141|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101380374|NCT00267163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101380375|NCT00267163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380376|NCT00267163|Cholinergic Agents|cholinergic agents|mesh-ancestor
101380377|NCT00267163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101380381|NCT00267319|(T,G)-A-L|(t,g)-a-l|mesh-list
101380443|NCT00425620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101380444|NCT00425620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101380445|NCT00425620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101380446|NCT00425620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101380447|NCT00425620|Antifungal Agents|antifungal agents|mesh-ancestor
101380448|NCT00267943|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101380449|NCT00267943|Telmisartan|telmisartan|mesh-list
101380450|NCT00267943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101380451|NCT00267943|Diuretics|diuretics|mesh-ancestor
101380452|NCT00267943|Natriuretic Agents|natriuretic agents|mesh-ancestor
101380453|NCT00267943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380454|NCT00267943|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101380455|NCT00267943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101380456|NCT00267943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380457|NCT00267943|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101380458|NCT00267943|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101380491|NCT00268216|Xhance|xhance|mesh-list
101380538|NCT00268255|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101380539|NCT00268255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380540|NCT00268255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101380541|NCT00268255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304989|NCT02016417|Gemcitabine|gemcitabine|mesh-list
101304990|NCT02016417|Docetaxel|docetaxel|mesh-list
101304991|NCT02016417|Fluorouracil|fluorouracil|mesh-list
101305002|NCT02016443|Tizanidine|tizanidine|mesh-list
101380594|NCT00268372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101380595|NCT00268372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101380596|NCT00268372|Immunologic Factors|immunologic factors|mesh-ancestor
101380671|NCT00268567|Leflunomide|leflunomide|mesh-list
101380672|NCT00268567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101362625|NCT00079131|Oblimersen|oblimersen|mesh-list
101380673|NCT00268567|Glucocorticoids|glucocorticoids|mesh-ancestor
101380674|NCT00268567|Hormones|hormones|mesh-ancestor
101380676|NCT00268567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380749|NCT00268918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380751|NCT00268918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101380752|NCT00268957|Sevelamer|sevelamer|mesh-list
101380753|NCT00268957|Chelating Agents|chelating agents|mesh-ancestor
101380754|NCT00268957|Sequestering Agents|sequestering agents|mesh-ancestor
101380756|NCT00073970|Celecoxib|celecoxib|mesh-list
101380769|NCT00102492|Casopitant|casopitant|mesh-list
101305017|NCT02016443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305018|NCT02016495|Thioctic Acid|thioctic acid|mesh-list
101380844|NCT00074204|Antimitotic Agents|antimitotic agents|mesh-ancestor
101380845|NCT00074204|Mitosis Modulators|mitosis modulators|mesh-ancestor
101380846|NCT00416143|Prednisone|prednisone|mesh-list
101305020|NCT02016495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305021|NCT02016495|Protective Agents|protective agents|mesh-ancestor
101380923|NCT00102609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101380924|NCT00102609|Antiemetics|antiemetics|mesh-ancestor
101305022|NCT02016495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305023|NCT02016495|Vitamin B Complex|vitamin b complex|mesh-ancestor
101305025|NCT02016495|Micronutrients|micronutrients|mesh-ancestor
101305026|NCT02016547|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101380996|NCT00270322|Narcotics|narcotics|mesh-ancestor
101380997|NCT00270322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101380998|NCT00270322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381075|NCT04730375|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101305027|NCT02016547|Abciximab|abciximab|mesh-list
101305032|NCT02016547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101305033|NCT02016664|Ketamine|ketamine|mesh-list
101381146|NCT00271336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101381225|NCT00272467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305035|NCT02016664|Sensory System Agents|sensory system agents|mesh-ancestor
101305036|NCT02016664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101305039|NCT02016664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101381296|NCT00273013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101381297|NCT00273013|Respiratory System Agents|respiratory system agents|mesh-ancestor
101381298|NCT00273013|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101381299|NCT00273013|Hormone Antagonists|hormone antagonists|mesh-ancestor
101381300|NCT00273013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101381301|NCT00273013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381302|NCT00273013|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101381304|NCT00273013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381356|NCT00401427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101381357|NCT00401427|Tubulin Modulators|tubulin modulators|mesh-ancestor
101381358|NCT00401427|Antimitotic Agents|antimitotic agents|mesh-ancestor
101381359|NCT00401427|Mitosis Modulators|mitosis modulators|mesh-ancestor
101381360|NCT00401427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381361|NCT00273481|Timolol|timolol|mesh-list
101381362|NCT00273481|Dorzolamide|dorzolamide|mesh-list
101381363|NCT00273481|Latanoprost|latanoprost|mesh-list
101381364|NCT00273481|Maleic acid|maleic acid|mesh-list
101381365|NCT00273481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101381366|NCT00273481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305040|NCT02016664|Anesthetics, General|anesthetics, general|mesh-ancestor
101381430|NCT00274027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381431|NCT00274027|Anticonvulsants|anticonvulsants|mesh-ancestor
101381432|NCT00075101|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
101381433|NCT00075101|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101381434|NCT00075101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101381435|NCT00075101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381496|NCT00416650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381498|NCT00274417|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101381499|NCT00274417|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101381500|NCT00274417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101381501|NCT00274417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381570|NCT00274807|Etoposide|etoposide|mesh-list
101381571|NCT00274807|Mitoxantrone|mitoxantrone|mesh-list
101381572|NCT00274807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101381577|NCT00274807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381645|NCT00108498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381646|NCT00108498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101381647|NCT00108498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101381710|NCT00108576|Anticonvulsants|anticonvulsants|mesh-ancestor
101381711|NCT00108576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101381712|NCT00108576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381736|NCT00278083|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101381737|NCT00278083|Antioxidants|antioxidants|mesh-ancestor
101381841|NCT00278941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101381842|NCT00278941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381843|NCT00279019|Tiotropium Bromide|tiotropium bromide|mesh-list
101381844|NCT00279019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101381845|NCT00279019|Autonomic Agents|autonomic agents|mesh-ancestor
101381846|NCT00279019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101381847|NCT00279019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381848|NCT00279019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101381849|NCT00279019|Respiratory System Agents|respiratory system agents|mesh-ancestor
101381850|NCT00279019|Parasympatholytics|parasympatholytics|mesh-ancestor
101381851|NCT00279019|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101381852|NCT00279019|Cholinergic Agents|cholinergic agents|mesh-ancestor
101381853|NCT00279019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101381854|NCT00279019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381897|NCT00279448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101381898|NCT00279448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101381900|NCT00075959|Disufenton sodium|disufenton sodium|mesh-list
101381971|NCT00416728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381972|NCT00416767|Leucovorin|leucovorin|mesh-list
101381973|NCT00416767|Fluorouracil|fluorouracil|mesh-list
101381974|NCT00416767|Irinotecan|irinotecan|mesh-list
101382043|NCT00280462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101382044|NCT00280462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101382045|NCT00280462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382046|NCT00280462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101382102|NCT00076388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382103|NCT00076388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101382104|NCT00076388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101382105|NCT00280774|Memantine|memantine|mesh-list
101382163|NCT00281125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101382164|NCT00281125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101382165|NCT00281125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101382166|NCT00109746|Chromium|chromium|mesh-list
101382167|NCT00109746|Picolinic acid|picolinic acid|mesh-list
101382233|NCT00416962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101382235|NCT00416962|Sensory System Agents|sensory system agents|mesh-ancestor
101382236|NCT00416962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101382237|NCT00109824|Decitabine|decitabine|mesh-list
101382238|NCT00109824|Azacitidine|azacitidine|mesh-list
101382324|NCT00281866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382325|NCT00281905|Cyclophosphamide|cyclophosphamide|mesh-list
101382326|NCT00281905|Carboplatin|carboplatin|mesh-list
101382327|NCT00281905|Methotrexate|methotrexate|mesh-list
101382328|NCT00281905|Vincristine|vincristine|mesh-list
101382329|NCT00281905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101382330|NCT00281905|Immunologic Factors|immunologic factors|mesh-ancestor
101382406|NCT00281983|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101382407|NCT00281983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101382408|NCT00281983|Immunologic Factors|immunologic factors|mesh-ancestor
101382409|NCT00281983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382489|NCT00282217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101382490|NCT00282217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101382491|NCT00282217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101382492|NCT00282217|Antifungal Agents|antifungal agents|mesh-ancestor
101382493|NCT00282217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101382494|NCT00282217|Immunologic Factors|immunologic factors|mesh-ancestor
101382495|NCT00282217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382496|NCT00282451|Insulin|insulin|mesh-list
101382497|NCT00282451|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101382553|NCT00283114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101382554|NCT00283114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101382555|NCT00076856|Temozolomide|temozolomide|mesh-list
101382560|NCT00283192|Sertraline|sertraline|mesh-list
101382626|NCT00283699|Tubulin Modulators|tubulin modulators|mesh-ancestor
101382627|NCT00283699|Antimitotic Agents|antimitotic agents|mesh-ancestor
101382628|NCT00283699|Mitosis Modulators|mitosis modulators|mesh-ancestor
101382629|NCT00283699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382698|NCT00077168|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101382699|NCT00077168|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101382700|NCT00077168|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101382701|NCT00077168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101382768|NCT00110721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382769|NCT00110721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101382771|NCT00110721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101382781|NCT00110760|Lidocaine|lidocaine|mesh-list
101382849|NCT00285727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382850|NCT00285727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382852|NCT00077402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101382916|NCT00286117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101382917|NCT00286117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101382918|NCT00286117|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101382919|NCT00286117|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101382920|NCT00286117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101382921|NCT00286117|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101382922|NCT00286117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101382980|NCT00111072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101382981|NCT00111072|Antiemetics|antiemetics|mesh-ancestor
101382982|NCT00111072|Autonomic Agents|autonomic agents|mesh-ancestor
101382983|NCT00111072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101382984|NCT00111072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383050|NCT00111150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101383051|NCT00111150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101383052|NCT00111150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383053|NCT00111150|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101383054|NCT00111150|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101383055|NCT00417430|Fulvestrant|fulvestrant|mesh-list
101383056|NCT00417430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101383057|NCT00417430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101383058|NCT00417430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101383059|NCT00417430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101383063|NCT00077753|Enoxaparin|enoxaparin|mesh-list
101383116|NCT00287170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383117|NCT00287170|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101383118|NCT00287170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101383119|NCT00287170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383120|NCT00287170|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101383121|NCT00287170|Vitamins|vitamins|mesh-ancestor
101383122|NCT00287170|Micronutrients|micronutrients|mesh-ancestor
101383123|NCT00287170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101383124|NCT00287170|Antimetabolites|antimetabolites|mesh-ancestor
101383187|NCT00287326|Analgesics|analgesics|mesh-ancestor
101383188|NCT00287326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101383189|NCT00287326|Sympatholytics|sympatholytics|mesh-ancestor
101383190|NCT00287326|Autonomic Agents|autonomic agents|mesh-ancestor
101383191|NCT00287326|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101383192|NCT00287326|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101383193|NCT00287326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101383194|NCT00287326|Adrenergic Agents|adrenergic agents|mesh-ancestor
101383195|NCT00287326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101383196|NCT00287326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383271|NCT00287950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383272|NCT00287950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101383273|NCT00287950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101383274|NCT00287950|Alkylating Agents|alkylating agents|mesh-ancestor
101383275|NCT00287950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383276|NCT00287950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101383277|NCT00287950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101383278|NCT00287950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101383279|NCT00287950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101383280|NCT00287950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101383281|NCT00287950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101383282|NCT00287950|Tubulin Modulators|tubulin modulators|mesh-ancestor
101383283|NCT00287950|Antimitotic Agents|antimitotic agents|mesh-ancestor
101383284|NCT00287950|Mitosis Modulators|mitosis modulators|mesh-ancestor
101383331|NCT00078182|Tenofovir|tenofovir|mesh-list
101383332|NCT00078182|Antiviral Agents|antiviral agents|mesh-ancestor
101383333|NCT00078182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101383334|NCT00078182|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101383335|NCT00078182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101383336|NCT00078182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101383337|NCT00078182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383338|NCT00078182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101383339|NCT00078182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101383340|NCT00111618|Vadimezan|vadimezan|mesh-list
101383341|NCT00111618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101383342|NCT00399425|Heparin|heparin|mesh-list
101383343|NCT00399425|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101383344|NCT00399425|Tinzaparin|tinzaparin|mesh-list
101383345|NCT00399425|Dalteparin|dalteparin|mesh-list
101383346|NCT00399425|Bemiparin|bemiparin|mesh-list
101383347|NCT00399425|Anticoagulants|anticoagulants|mesh-ancestor
101383392|NCT00111852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383393|NCT00289042|Enoxaparin|enoxaparin|mesh-list
101383394|NCT00289042|Anticoagulants|anticoagulants|mesh-ancestor
101383395|NCT00289042|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101383396|NCT00289042|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101383397|NCT00289042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383399|NCT00111891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101383400|NCT00111891|Antimetabolites|antimetabolites|mesh-ancestor
101383401|NCT00111891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305148|NCT02017639|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101383474|NCT00290173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101383475|NCT00290173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383476|NCT00290173|Tocolytic Agents|tocolytic agents|mesh-ancestor
101383477|NCT00290173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101383478|NCT00290173|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101383479|NCT00290173|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101383480|NCT00290173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101383548|NCT00290680|Analgesics|analgesics|mesh-ancestor
101383549|NCT00290680|Sensory System Agents|sensory system agents|mesh-ancestor
101383550|NCT00290680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101383551|NCT00290680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383552|NCT00290680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101383553|NCT00290680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101383557|NCT00290680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383559|NCT02960815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101383560|NCT02960815|Immunologic Factors|immunologic factors|mesh-ancestor
101383561|NCT02960815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383562|NCT02960815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101383613|NCT00291109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101383614|NCT00291109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383615|NCT00291109|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101383616|NCT00291109|Hormone Antagonists|hormone antagonists|mesh-ancestor
101383617|NCT00291109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101383618|NCT00291109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383619|NCT00291148|Pregabalin|pregabalin|mesh-list
101383620|NCT00291148|Paroxetine|paroxetine|mesh-list
101383621|NCT00291148|Analgesics|analgesics|mesh-ancestor
101383622|NCT00291148|Sensory System Agents|sensory system agents|mesh-ancestor
101383623|NCT00291148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101305158|NCT02018055|Aspirin|aspirin|mesh-list
101383672|NCT00112476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101383673|NCT00112476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101383674|NCT00112476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101383675|NCT00112476|Antifungal Agents|antifungal agents|mesh-ancestor
101383676|NCT00112476|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101383677|NCT00291538|Bortezomib|bortezomib|mesh-list
101383678|NCT00291538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101383679|NCT00291616|Interferons|interferons|mesh-list
101383680|NCT00291616|Interferon-alpha|interferon-alpha|mesh-list
101383681|NCT00291616|Interferon alpha-2|interferon alpha-2|mesh-list
101383682|NCT00291616|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101383683|NCT00291616|Thymalfasin|thymalfasin|mesh-list
101383684|NCT00291616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101383685|NCT00291616|Antiviral Agents|antiviral agents|mesh-ancestor
101383686|NCT00291616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101383687|NCT00291616|Immunologic Factors|immunologic factors|mesh-ancestor
101383690|NCT00078572|Capecitabine|capecitabine|mesh-list
101383734|NCT00112554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101383735|NCT00112554|Immunologic Factors|immunologic factors|mesh-ancestor
101383736|NCT00112554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383737|NCT04718311|Tacrolimus|tacrolimus|mesh-list
101383738|NCT04718311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101383739|NCT04718311|Immunologic Factors|immunologic factors|mesh-ancestor
101383740|NCT04718311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383741|NCT04718311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101383742|NCT04718311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101383743|NCT04718311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383744|NCT00078689|Daclizumab|daclizumab|mesh-list
101383753|NCT00078845|Amifostine|amifostine|mesh-list
101383798|NCT00275119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383800|NCT00275119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101383801|NCT00275119|Immunologic Factors|immunologic factors|mesh-ancestor
101383802|NCT00275119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383803|NCT00275080|Decitabine|decitabine|mesh-list
101383804|NCT00275080|Azacitidine|azacitidine|mesh-list
101383805|NCT00275080|Vorinostat|vorinostat|mesh-list
101383806|NCT00275080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101383807|NCT00275080|Antimetabolites|antimetabolites|mesh-ancestor
101383808|NCT00275080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383809|NCT00275080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101383810|NCT00275080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101305164|NCT02018055|Sensory System Agents|sensory system agents|mesh-ancestor
101305165|NCT02018055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101305166|NCT02018055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383860|NCT00102765|Sympathomimetics|sympathomimetics|mesh-ancestor
101383861|NCT00130390|Nitazoxanide|nitazoxanide|mesh-list
101383862|NCT00130390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101383863|NCT00130390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101383864|NCT00130312|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
101383865|NCT00130312|Anticoagulants|anticoagulants|mesh-ancestor
101383866|NCT00130312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101383867|NCT00130312|Antimetabolites|antimetabolites|mesh-ancestor
101383868|NCT00130312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383869|NCT00130312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101383870|NCT00130312|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101383871|NCT00130312|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101383872|NCT00130312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101383919|NCT00130195|Cyclophosphamide|cyclophosphamide|mesh-list
101383920|NCT00130195|Methotrexate|methotrexate|mesh-list
101383921|NCT00130195|Vincristine|vincristine|mesh-list
101383925|NCT00130195|Immunologic Factors|immunologic factors|mesh-ancestor
101383926|NCT00130195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383927|NCT00130195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101383928|NCT00130195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101383929|NCT00130195|Alkylating Agents|alkylating agents|mesh-ancestor
101383930|NCT00130195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383931|NCT00130195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101383932|NCT00130195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101333402|NCT00038623|Rituximab|rituximab|mesh-list
101305167|NCT02018055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101305168|NCT02018055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101305169|NCT02018055|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101383933|NCT00130195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101383934|NCT00130195|Antiemetics|antiemetics|mesh-ancestor
101383975|NCT00119340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383976|NCT00119340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101383977|NCT00119340|Antifungal Agents|antifungal agents|mesh-ancestor
101383978|NCT00119340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101383979|NCT00119340|Dermatologic Agents|dermatologic agents|mesh-ancestor
101383980|NCT00119340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101383981|NCT00119340|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101383982|NCT00119340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101383983|NCT00119340|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101383984|NCT00119340|Antitubercular Agents|antitubercular agents|mesh-ancestor
101383985|NCT00119340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101383986|NCT00130156|Doxazosin|doxazosin|mesh-list
101383987|NCT00130156|Bunazosin|bunazosin|mesh-list
101384045|NCT00129805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384046|NCT00129805|Antipyretics|antipyretics|mesh-ancestor
101384047|NCT00129805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101384048|NCT00129805|Serotonin Agents|serotonin agents|mesh-ancestor
101384049|NCT00129805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101384050|NCT00129727|Paclitaxel|paclitaxel|mesh-list
101384051|NCT00129727|Bevacizumab|bevacizumab|mesh-list
101384052|NCT00129727|Carboplatin|carboplatin|mesh-list
101384053|NCT00129727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101384054|NCT00129727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384120|NCT00298324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384121|NCT00298324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384122|NCT00298324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384136|NCT00079430|Carboplatin|carboplatin|mesh-list
101384137|NCT00079430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101384138|NCT00079430|Antibodies|antibodies|mesh-list
101384228|NCT00298909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384229|NCT00298909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101384230|NCT00298909|Vasodilator Agents|vasodilator agents|mesh-ancestor
101384231|NCT00298909|Vitamin B Complex|vitamin b complex|mesh-ancestor
101384299|NCT00299611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101384300|NCT00299611|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101384301|NCT00299611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101384302|NCT00299611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101384303|NCT00299611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384304|NCT00299611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101384392|NCT00418171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101384393|NCT00418171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101384394|NCT00418171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101384395|NCT00418171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101384396|NCT00418171|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101384401|NCT00418171|Serotonin Agents|serotonin agents|mesh-ancestor
101384462|NCT00300196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384463|NCT00119769|Hormones|hormones|mesh-list
101384464|NCT00119769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101384465|NCT00119769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384466|NCT00300313|Escitalopram|escitalopram|mesh-list
101384467|NCT00300313|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101384468|NCT00300313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101384528|NCT00300586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384530|NCT00086541|Ribavirin|ribavirin|mesh-list
101384533|NCT00086541|Antiviral Agents|antiviral agents|mesh-ancestor
101384608|NCT00301210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101384609|NCT00301210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384610|NCT00301210|Analgesics|analgesics|mesh-ancestor
101384611|NCT00301210|Sensory System Agents|sensory system agents|mesh-ancestor
101384705|NCT00086736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384706|NCT00086736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333408|NCT00038662|Atrasentan|atrasentan|mesh-list
101384707|NCT00086736|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101384708|NCT00086736|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101384776|NCT00086931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384777|NCT00086931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384778|NCT00292747|Ibuprofen|ibuprofen|mesh-list
101384779|NCT00292747|Drotaverin|drotaverin|mesh-list
101384780|NCT00292747|Papaverine|papaverine|mesh-list
101384783|NCT00292747|Analgesics|analgesics|mesh-ancestor
101384845|NCT00201955|Protective Agents|protective agents|mesh-ancestor
101384846|NCT00201955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384847|NCT00201955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384848|NCT00080795|Gemcitabine|gemcitabine|mesh-list
101384849|NCT00080795|Doxorubicin|doxorubicin|mesh-list
101384918|NCT00306358|Micronutrients|micronutrients|mesh-ancestor
101384919|NCT00306358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384920|NCT00306358|Vitamin B Complex|vitamin b complex|mesh-ancestor
101384921|NCT00306358|Hematinics|hematinics|mesh-ancestor
101384922|NCT00306397|Sirolimus|sirolimus|mesh-list
101384923|NCT00306397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101384924|NCT00306397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101384925|NCT00306397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101384926|NCT00306397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384927|NCT00306397|Antifungal Agents|antifungal agents|mesh-ancestor
101384928|NCT00306397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101384929|NCT00306397|Immunologic Factors|immunologic factors|mesh-ancestor
101384930|NCT00306397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384931|NCT00418600|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
101384932|NCT00418600|Ergocalciferols|ergocalciferols|mesh-list
101384933|NCT00418600|Vitamins|vitamins|mesh-ancestor
101384934|NCT00418600|Micronutrients|micronutrients|mesh-ancestor
101384935|NCT00418600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384979|NCT00301639|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101384980|NCT00301639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101384981|NCT00301639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385049|NCT00301951|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101385054|NCT00301951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385055|NCT00301951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101385056|NCT00301951|Immunologic Factors|immunologic factors|mesh-ancestor
101385057|NCT00301951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385081|NCT00120198|Rituximab|rituximab|mesh-list
101385117|NCT00302341|Sulfamethoxazole|sulfamethoxazole|mesh-list
101385119|NCT00302341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101385124|NCT00302341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101385125|NCT00302341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101385126|NCT00302341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101385127|NCT00302341|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101385128|NCT00302341|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101385186|NCT00081302|Mitosis Modulators|mitosis modulators|mesh-ancestor
101385187|NCT00081302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385188|NCT00081302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101385189|NCT00302653|Rasburicase|rasburicase|mesh-list
101385300|NCT00087399|Analgesics|analgesics|mesh-ancestor
101385301|NCT00087399|Sensory System Agents|sensory system agents|mesh-ancestor
101385367|NCT00399698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385368|NCT00399698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385369|NCT00399698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101385376|NCT00303589|beta-Lactams|beta-lactams|mesh-list
101385377|NCT00303589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101385440|NCT00081887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385446|NCT00303940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385449|NCT00304018|Fludarabine phosphate|fludarabine phosphate|mesh-list
101385450|NCT00304018|Etoposide|etoposide|mesh-list
101385451|NCT00304018|Busulfan|busulfan|mesh-list
101385513|NCT00082043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385514|NCT00082043|Hormone Antagonists|hormone antagonists|mesh-ancestor
101385515|NCT00082043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101385516|NCT00082043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385581|NCT00082199|Dopamine Agents|dopamine agents|mesh-ancestor
101385582|NCT00082199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101385586|NCT00082199|Serotonin Agents|serotonin agents|mesh-ancestor
101385651|NCT00082316|Dermatologic Agents|dermatologic agents|mesh-ancestor
101385652|NCT00082316|Sensory System Agents|sensory system agents|mesh-ancestor
101385653|NCT00082316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101385654|NCT00082316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385720|NCT00082472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101385721|NCT00082472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101385722|NCT00082472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101385723|NCT00087867|Bortezomib|bortezomib|mesh-list
101385724|NCT00087867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385725|NCT00082511|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101385726|NCT00082511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101385727|NCT00082511|Immunologic Factors|immunologic factors|mesh-ancestor
101385728|NCT00082511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385729|NCT00306046|Diphosphonates|diphosphonates|mesh-list
101385733|NCT00306124|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101385734|NCT00306124|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101385735|NCT00306124|Dopamine Agents|dopamine agents|mesh-ancestor
101385736|NCT00306124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101385780|NCT00082784|Growth Inhibitors|growth inhibitors|mesh-ancestor
101385781|NCT00082784|Growth Substances|growth substances|mesh-ancestor
101385782|NCT00082784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385783|NCT00082784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101385784|NCT00082784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101385786|NCT00306826|Pioglitazone|pioglitazone|mesh-list
101385851|NCT00307255|Antimetabolites|antimetabolites|mesh-ancestor
101385852|NCT00307411|Hormones|hormones|mesh-list
101385853|NCT00307411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101385928|NCT00307645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101385929|NCT00307645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101385930|NCT00307645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101385931|NCT00307645|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101386002|NCT00418639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101386003|NCT00418639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101386005|NCT00418678|Antiemetics|antiemetics|mesh-ancestor
101386006|NCT00418678|Autonomic Agents|autonomic agents|mesh-ancestor
101386007|NCT00418678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101386084|NCT00308542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101386085|NCT00308542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386086|NCT00308542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101386087|NCT00308542|Glucocorticoids|glucocorticoids|mesh-ancestor
101386157|NCT00309283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101386158|NCT00309283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386159|NCT00083525|Capecitabine|capecitabine|mesh-list
101386228|NCT00121017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101386229|NCT00121017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386230|NCT00121017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101386231|NCT00121017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101386232|NCT00121017|Antiviral Agents|antiviral agents|mesh-ancestor
101386233|NCT00121017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101386234|NCT00121017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101386294|NCT00309790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101386295|NCT00309790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101386296|NCT00309790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386366|NCT00083681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101386367|NCT00083681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101386368|NCT00083681|Growth Substances|growth substances|mesh-ancestor
101386369|NCT00083681|Growth Inhibitors|growth inhibitors|mesh-ancestor
101386371|NCT00121095|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
101386372|NCT00121095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101386373|NCT00121095|Tubulin Modulators|tubulin modulators|mesh-ancestor
101386374|NCT00121095|Antimitotic Agents|antimitotic agents|mesh-ancestor
101386375|NCT00121095|Mitosis Modulators|mitosis modulators|mesh-ancestor
101386433|NCT00309673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101386436|NCT00309673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101386437|NCT00309673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101386438|NCT00309673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101386439|NCT00309673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101386444|NCT00310765|Gabapentin|gabapentin|mesh-list
101386495|NCT00121329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101386496|NCT00121329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101386497|NCT00121329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101386498|NCT00121329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101386565|NCT00088998|Antimetabolites|antimetabolites|mesh-ancestor
101386566|NCT00311467|Interferons|interferons|mesh-list
101386567|NCT00311467|Capecitabine|capecitabine|mesh-list
101386568|NCT00311467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101386569|NCT00311467|Antimetabolites|antimetabolites|mesh-ancestor
101386570|NCT00311467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386572|NCT00311467|Antiviral Agents|antiviral agents|mesh-ancestor
101386640|NCT00311974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101386641|NCT00312013|Nadroparin|nadroparin|mesh-list
101386642|NCT00312013|Anticoagulants|anticoagulants|mesh-ancestor
101386643|NCT00312013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101386644|NCT00312013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101386645|NCT00312013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386647|NCT00121524|Amiodarone|amiodarone|mesh-list
101386654|NCT00121524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386706|NCT05567471|Vaccines|vaccines|mesh-list
101386707|NCT05567471|Immunologic Factors|immunologic factors|mesh-ancestor
101386708|NCT05567471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386709|NCT00089154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101386710|NCT00089154|Antibodies|antibodies|mesh-list
101386791|NCT00121563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101386792|NCT00121563|Anticonvulsants|anticonvulsants|mesh-ancestor
101386793|NCT00121563|Antiemetics|antiemetics|mesh-ancestor
101386794|NCT00121563|Autonomic Agents|autonomic agents|mesh-ancestor
101386795|NCT00121563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101386865|NCT04711161|Tubulin Modulators|tubulin modulators|mesh-ancestor
101386866|NCT04711161|Antimitotic Agents|antimitotic agents|mesh-ancestor
101386867|NCT04711161|Mitosis Modulators|mitosis modulators|mesh-ancestor
101386868|NCT04711161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386869|NCT00293644|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
101386934|NCT05567081|Glucocorticoids|glucocorticoids|mesh-ancestor
101386936|NCT05567081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101386937|NCT05567081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386938|NCT05567081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101386939|NCT05567081|Immunologic Factors|immunologic factors|mesh-ancestor
101387001|NCT00294463|Contraceptive Agents|contraceptive agents|mesh-ancestor
101387002|NCT00294463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101387003|NCT00294463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101387004|NCT00294463|Progestins|progestins|mesh-ancestor
101387005|NCT00294463|Androgen Antagonists|androgen antagonists|mesh-ancestor
101387016|NCT00294502|Minocycline|minocycline|mesh-list
101387066|NCT00121680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101387067|NCT00121680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387068|NCT00121680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387072|NCT00294892|Nevirapine|nevirapine|mesh-list
101387073|NCT00294892|Carbamazepine|carbamazepine|mesh-list
101387136|NCT00121797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101387138|NCT00089622|Lisuride|lisuride|mesh-list
101387222|NCT00121914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387224|NCT00295984|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101387225|NCT00295984|Autonomic Agents|autonomic agents|mesh-ancestor
101387226|NCT00295984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101387227|NCT00295984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387228|NCT00295984|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101387229|NCT00295984|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101387230|NCT00295984|Cholinergic Agents|cholinergic agents|mesh-ancestor
101387231|NCT00295984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101387232|NCT00295984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387233|NCT00296023|Methotrexate|methotrexate|mesh-list
101387234|NCT00296023|Fludarabine phosphate|fludarabine phosphate|mesh-list
101387235|NCT00296023|Fludarabine|fludarabine|mesh-list
101387236|NCT00296023|Busulfan|busulfan|mesh-list
101387237|NCT00296023|Tacrolimus|tacrolimus|mesh-list
101387238|NCT00296023|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101387239|NCT00296023|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101387240|NCT00296023|Abortifacient Agents|abortifacient agents|mesh-ancestor
101387241|NCT00296023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101387242|NCT00296023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387244|NCT00296023|Antimetabolites|antimetabolites|mesh-ancestor
101387275|NCT00296062|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101387276|NCT00296062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101387277|NCT00296062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101387311|NCT00296530|Xhance|xhance|mesh-list
101387349|NCT00090012|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101387351|NCT00090012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101387352|NCT00090012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387353|NCT00090012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101387354|NCT00090012|Serotonin Agents|serotonin agents|mesh-ancestor
101387355|NCT00090012|Antidepressive Agents|antidepressive agents|mesh-ancestor
101387357|NCT00296608|Fluorouracil|fluorouracil|mesh-list
101387414|NCT00297076|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101387415|NCT00297076|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101387416|NCT00297076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387417|NCT00297076|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101387479|NCT00297661|Antifungal Agents|antifungal agents|mesh-ancestor
101387480|NCT00297661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101387481|NCT00297661|Immunologic Factors|immunologic factors|mesh-ancestor
101387482|NCT00297661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387554|NCT00122226|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101387555|NCT00122226|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101387557|NCT05200559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101387622|NCT00313963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101387623|NCT00122343|Sirolimus|sirolimus|mesh-list
101387624|NCT00122343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101387625|NCT00122343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101387694|NCT00323011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387695|NCT00323011|Growth Inhibitors|growth inhibitors|mesh-ancestor
101387696|NCT00323011|Antimetabolites|antimetabolites|mesh-ancestor
101387697|NCT00323011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387698|NCT00323011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101387763|NCT00323323|Glucocorticoids|glucocorticoids|mesh-ancestor
101387764|NCT00323323|Hormones|hormones|mesh-ancestor
101387765|NCT00323323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101387766|NCT00323323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101387837|NCT00122538|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101387838|NCT00122538|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101387839|NCT00122538|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101387840|NCT00122538|Antimetabolites|antimetabolites|mesh-ancestor
101387841|NCT00313105|Lobeline|lobeline|mesh-list
101387907|NCT06003049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101387908|NCT06003049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387909|NCT06003049|Cholinergic Agents|cholinergic agents|mesh-ancestor
101387910|NCT06003049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101387911|NCT06002854|Insulin|insulin|mesh-list
101387912|NCT06002854|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101387979|NCT06002438|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101387980|NCT06002438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388055|NCT06001619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101388056|NCT06001593|Betahistine|betahistine|mesh-list
101388057|NCT06001593|Vasodilator Agents|vasodilator agents|mesh-ancestor
101388058|NCT06001593|Histamine Agonists|histamine agonists|mesh-ancestor
101388059|NCT06001593|Histamine Agents|histamine agents|mesh-ancestor
101388060|NCT06001593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101388063|NCT06001385|Mycophenolic Acid|mycophenolic acid|mesh-list
101388127|NCT06001125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101388128|NCT06001125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101388129|NCT06001112|Etoricoxib|etoricoxib|mesh-list
101362697|NCT03948568|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101388130|NCT06001112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101388131|NCT06001112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101388132|NCT06001112|Analgesics|analgesics|mesh-ancestor
101388133|NCT06001112|Sensory System Agents|sensory system agents|mesh-ancestor
101388150|NCT06000917|Carboplatin|carboplatin|mesh-list
101388199|NCT06000501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388201|NCT06000501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101388272|NCT05999994|Antimitotic Agents|antimitotic agents|mesh-ancestor
101388273|NCT05999994|Mitosis Modulators|mitosis modulators|mesh-ancestor
101388274|NCT05999994|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101388275|NCT05999994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101388348|NCT05999708|Tocolytic Agents|tocolytic agents|mesh-ancestor
101388349|NCT05999708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101388356|NCT05999487|Sympathomimetics|sympathomimetics|mesh-ancestor
101388357|NCT05999487|Autonomic Agents|autonomic agents|mesh-ancestor
101388358|NCT05999487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101388359|NCT05999487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388426|NCT05998941|Carboplatin|carboplatin|mesh-list
101388427|NCT05998941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101388428|NCT05998941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101388507|NCT05998551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101388508|NCT05998551|Anesthetics, General|anesthetics, general|mesh-ancestor
101388509|NCT05998525|Dapagliflozin|dapagliflozin|mesh-list
101388510|NCT05998525|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101388511|NCT05998525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388512|NCT05998525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101388576|NCT05997979|Sensory System Agents|sensory system agents|mesh-ancestor
101388577|NCT05997979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101388578|NCT05997979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388579|NCT05997901|Varenicline|varenicline|mesh-list
101388580|NCT05997901|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101388581|NCT05997901|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101388582|NCT05997901|Cholinergic Agents|cholinergic agents|mesh-ancestor
101388583|NCT05997901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101388584|NCT05997901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388586|NCT05997784|Nitric Oxide|nitric oxide|mesh-list
101388641|NCT05997433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101388642|NCT05997433|Antacids|antacids|mesh-ancestor
101388644|NCT05997433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101388727|NCT05997043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101388728|NCT05997043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388729|NCT05997043|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101388730|NCT05997017|Sirolimus|sirolimus|mesh-list
101388735|NCT05997017|Antifungal Agents|antifungal agents|mesh-ancestor
101388814|NCT05996224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388815|NCT05996224|Viscosupplements|viscosupplements|mesh-ancestor
101388896|NCT05995314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388897|NCT05995314|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101388898|NCT05995314|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101388899|NCT05995314|Purinergic Agents|purinergic agents|mesh-ancestor
101388973|NCT05989503|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
101388974|NCT05989503|Valsartan|valsartan|mesh-list
101305382|NCT02019186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305383|NCT02019186|Protective Agents|protective agents|mesh-ancestor
101305384|NCT02019290|Midazolam|midazolam|mesh-list
101389046|NCT05971602|Bedaquiline|bedaquiline|mesh-list
101389047|NCT05971602|Diarylquinolines|diarylquinolines|mesh-list
101389053|NCT05971602|Leprostatic Agents|leprostatic agents|mesh-ancestor
101389128|NCT05952713|Imipramine|imipramine|mesh-list
101389129|NCT05952713|Escitalopram|escitalopram|mesh-list
101305388|NCT02019290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305389|NCT02019290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101305390|NCT02019290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101389130|NCT05952713|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101389207|NCT05925023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101389208|NCT05925023|Immunologic Factors|immunologic factors|mesh-ancestor
101389294|NCT05896228|Respiratory System Agents|respiratory system agents|mesh-ancestor
101389295|NCT05896228|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101389296|NCT05896228|Hormone Antagonists|hormone antagonists|mesh-ancestor
101389297|NCT05896228|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101389298|NCT05896228|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101389299|NCT05896228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389300|NCT05896228|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101389301|NCT05896228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101389303|NCT05896228|Anesthetics, Local|anesthetics, local|mesh-ancestor
101389359|NCT05888493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101389360|NCT05888493|Alkylating Agents|alkylating agents|mesh-ancestor
101389361|NCT05888493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389362|NCT05888493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101389363|NCT05888493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101389364|NCT05888493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101389443|NCT05861999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101389444|NCT05861999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389445|NCT05861986|Risdiplam|risdiplam|mesh-list
101389446|NCT05861986|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101389447|NCT05861986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101389448|NCT05861986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389449|NCT05860296|Pembrolizumab|pembrolizumab|mesh-list
101389450|NCT05860296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101389454|NCT05846659|Pembrolizumab|pembrolizumab|mesh-list
101389511|NCT05836584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101389593|NCT05826964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389594|NCT05826964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101389595|NCT05826964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101389596|NCT05826964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101389597|NCT05826964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101389669|NCT05797246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389670|NCT05797246|Growth Inhibitors|growth inhibitors|mesh-ancestor
101389671|NCT05794230|Vaccines|vaccines|mesh-list
101389672|NCT05794230|Immunologic Factors|immunologic factors|mesh-ancestor
101389673|NCT05794230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389674|NCT05787613|Paclitaxel|paclitaxel|mesh-list
101389741|NCT05756673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101389742|NCT05756569|Pembrolizumab|pembrolizumab|mesh-list
101389743|NCT05756569|Immunoconjugates|immunoconjugates|mesh-list
101389744|NCT05756569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101389745|NCT05756569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101389748|NCT05756569|Immunologic Factors|immunologic factors|mesh-ancestor
101389816|NCT05726383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101389817|NCT05726383|Antiviral Agents|antiviral agents|mesh-ancestor
101389818|NCT05726383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101389819|NCT05722340|Anesthetics|anesthetics|mesh-list
101389820|NCT05722340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101389821|NCT05722340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389853|NCT05721027|Analgesics|analgesics|mesh-ancestor
101389854|NCT05721027|Sensory System Agents|sensory system agents|mesh-ancestor
101389855|NCT05721027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101389856|NCT05721027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101389857|NCT05721027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101389858|NCT05721027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389859|NCT05718856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101389908|NCT05706753|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101389909|NCT05706753|Diuretics|diuretics|mesh-ancestor
101389910|NCT05706753|Natriuretic Agents|natriuretic agents|mesh-ancestor
101389911|NCT05704985|Paclitaxel|paclitaxel|mesh-list
101389979|NCT05686863|Esketamine|esketamine|mesh-list
101389980|NCT05686863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101389981|NCT05686863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101389982|NCT05686863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389983|NCT05686863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101390052|NCT05663073|Irbesartan|irbesartan|mesh-list
101390053|NCT05663073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101390054|NCT05663073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101390055|NCT05663073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101390056|NCT05663073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390057|NCT05663073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101390058|NCT05663073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390059|NCT05663073|Vasodilator Agents|vasodilator agents|mesh-ancestor
101390060|NCT05663073|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101390061|NCT05663073|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101390112|NCT05646862|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
101390113|NCT05646862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101390114|NCT05646862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390180|NCT05605899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390181|NCT05605899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390185|NCT05605899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101390186|NCT05605899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101390187|NCT05605899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101390188|NCT05605899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101390189|NCT05605899|Glucocorticoids|glucocorticoids|mesh-ancestor
101390243|NCT05590624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101390244|NCT05590624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390433|NCT05546411|Antimetabolites|antimetabolites|mesh-ancestor
101390434|NCT05546411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390435|NCT05546411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101390436|NCT05546411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390508|NCT05514444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101390509|NCT05514444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390510|NCT05514444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101305480|NCT02019784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101177766|NCT05737680|Gout Suppressants|gout suppressants|mesh-ancestor
101390570|NCT05483933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390571|NCT05480865|Sotorasib|sotorasib|mesh-list
101305483|NCT02019797|Anesthetics, General|anesthetics, general|mesh-ancestor
101305484|NCT02019797|Anesthetics|anesthetics|mesh-ancestor
101390640|NCT05447910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390727|NCT05406700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390728|NCT05406700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390729|NCT05405452|Ethyl Chloride|ethyl chloride|mesh-list
101390730|NCT05405452|Anesthetics|anesthetics|mesh-ancestor
101390731|NCT05405452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101390732|NCT05405452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390733|NCT05405452|Anesthetics, Local|anesthetics, local|mesh-ancestor
101390734|NCT05405452|Sensory System Agents|sensory system agents|mesh-ancestor
101390739|NCT05401916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101390799|NCT05383495|Sensory System Agents|sensory system agents|mesh-ancestor
101390800|NCT05383495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101390801|NCT05383495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101390802|NCT05383495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101390803|NCT05383495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101390804|NCT05383495|Adrenergic Agents|adrenergic agents|mesh-ancestor
101390805|NCT05383495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101390806|NCT05383495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390820|NCT05382650|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101390821|NCT05382650|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101390875|NCT05362760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101390876|NCT05362760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390877|NCT05362760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101390883|NCT05357482|Hydroxyurea|hydroxyurea|mesh-list
101390884|NCT05357482|Immunologic Factors|immunologic factors|mesh-ancestor
101390885|NCT05357482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390886|NCT05357482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101390887|NCT05357482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101390888|NCT05357482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101390943|NCT05338970|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
101390944|NCT05338970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101390945|NCT05338970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390946|NCT05331664|Moxifloxacin|moxifloxacin|mesh-list
101390947|NCT05331664|Polymyxins|polymyxins|mesh-list
101390948|NCT05331664|Trimethoprim|trimethoprim|mesh-list
101390952|NCT05331664|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101390953|NCT05331664|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101390954|NCT05331664|Atropine|atropine|mesh-list
101390955|NCT05331664|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101390956|NCT05331664|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101390957|NCT05331664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101390958|NCT05331664|Glucocorticoids|glucocorticoids|mesh-ancestor
101390959|NCT05331664|Hormones|hormones|mesh-ancestor
101390960|NCT05331664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101390961|NCT05331664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390962|NCT05331664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101390963|NCT05331664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390964|NCT05331664|Autonomic Agents|autonomic agents|mesh-ancestor
101439515|NCT05246670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101439516|NCT05246670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101439517|NCT05246670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101439518|NCT05246670|Antiviral Agents|antiviral agents|mesh-ancestor
101439519|NCT05246670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101439520|NCT05246670|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101439521|NCT05246670|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101439522|NCT05246670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101439523|NCT05246670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439524|NCT05246670|Hormones|hormones|mesh-ancestor
101439525|NCT05246670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101439526|NCT05242484|Golimumab|golimumab|mesh-list
101439527|NCT05242484|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101439528|NCT05242484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101439529|NCT05242484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101439530|NCT05242484|Immunologic Factors|immunologic factors|mesh-ancestor
101439531|NCT05242484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439532|NCT05242471|Golimumab|golimumab|mesh-list
101439533|NCT05242471|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101439534|NCT05242471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101439535|NCT05242471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101439536|NCT05242471|Immunologic Factors|immunologic factors|mesh-ancestor
101439537|NCT05242471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439538|NCT05199285|Nivolumab|nivolumab|mesh-list
101439539|NCT05199285|Ipilimumab|ipilimumab|mesh-list
101439540|NCT05199285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101439541|NCT05199285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439542|NCT05199285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101439543|NCT05199285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439544|NCT05197049|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101439545|NCT05197049|Immunologic Factors|immunologic factors|mesh-ancestor
101439548|NCT05194293|Immunoglobulins|immunoglobulins|mesh-list
101439549|NCT05194293|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101439550|NCT05194293|Immunoglobulin G|immunoglobulin g|mesh-list
101439555|NCT05180097|Dexamethasone|dexamethasone|mesh-list
101390965|NCT05331664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101390966|NCT05331664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101390967|NCT05331664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101390968|NCT05331664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101390969|NCT05331664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101390970|NCT05331664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101390971|NCT05331664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390972|NCT05331664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101390973|NCT05331664|Contraceptive Agents|contraceptive agents|mesh-ancestor
101390974|NCT05331664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101390975|NCT05331664|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101390976|NCT05331664|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101390977|NCT05331664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101390978|NCT05331664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101390979|NCT05331664|Immunologic Factors|immunologic factors|mesh-ancestor
101390980|NCT05331664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101390981|NCT05331664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101390982|NCT05331664|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101390983|NCT05331664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101390984|NCT05331664|Respiratory System Agents|respiratory system agents|mesh-ancestor
101390985|NCT05331664|Mydriatics|mydriatics|mesh-ancestor
101390986|NCT05331664|Parasympatholytics|parasympatholytics|mesh-ancestor
101390987|NCT05331664|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101439556|NCT05180097|Gemcitabine|gemcitabine|mesh-list
101439557|NCT05180097|Pembrolizumab|pembrolizumab|mesh-list
101439558|NCT05180097|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101439559|NCT05180097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101439560|NCT05180097|Antiemetics|antiemetics|mesh-ancestor
101439561|NCT05180097|Autonomic Agents|autonomic agents|mesh-ancestor
101439562|NCT05180097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101439563|NCT05180097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439564|NCT05180097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101439565|NCT05180097|Glucocorticoids|glucocorticoids|mesh-ancestor
101307770|NCT02043054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101307771|NCT02043054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439567|NCT05180097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101439568|NCT05180097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101439569|NCT05180097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439570|NCT05180097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101439571|NCT05180097|Antimetabolites|antimetabolites|mesh-ancestor
101439572|NCT05180097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439573|NCT05180097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101439574|NCT05180097|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101439575|NCT05180097|Immunotoxins|immunotoxins|mesh-ancestor
101439577|NCT05180097|Immunologic Factors|immunologic factors|mesh-ancestor
101439578|NCT05168163|Atezolizumab|atezolizumab|mesh-list
101439579|NCT05168163|Lenvatinib|lenvatinib|mesh-list
101390991|NCT05331664|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101390992|NCT05331664|Antimalarials|antimalarials|mesh-ancestor
101390993|NCT05331664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101390994|NCT05331664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101390995|NCT05331664|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101390996|NCT05331664|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101390997|NCT05331664|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101390998|NCT05331664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101391002|NCT05323812|Edaravone|edaravone|mesh-list
101391003|NCT05323812|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101391004|NCT05323812|Antioxidants|antioxidants|mesh-ancestor
101391005|NCT05323812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391006|NCT05323812|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101391007|NCT05323812|Protective Agents|protective agents|mesh-ancestor
101305499|NCT02019810|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101305500|NCT02019810|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101178196|NCT01988922|Anesthetics, General|anesthetics, general|mesh-ancestor
101391008|NCT05323812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391009|NCT05322577|Nivolumab|nivolumab|mesh-list
101391010|NCT05322577|Bemarituzumab|bemarituzumab|mesh-list
101391011|NCT05322577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101391012|NCT05322577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439580|NCT05168163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101439581|NCT05168163|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101439582|NCT05168163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439583|NCT05168163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101439584|NCT05168163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439585|NCT05168163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101439586|NCT05168163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101439587|NCT05168163|Immunologic Factors|immunologic factors|mesh-ancestor
101439588|NCT05168163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439589|NCT05167825|Macitentan|macitentan|mesh-list
101439590|NCT05167825|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101439591|NCT05167825|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101439592|NCT05167825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439593|NCT05167825|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
101439594|NCT05154747|Rilpivirine|rilpivirine|mesh-list
101391013|NCT05322577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101391014|NCT05322577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391015|NCT05321940|Interferons|interferons|mesh-list
101391016|NCT05321940|Vaccines|vaccines|mesh-list
101391017|NCT05321940|Immunologic Factors|immunologic factors|mesh-ancestor
101391018|NCT05321940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391019|NCT05321940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391020|NCT05321940|Antiviral Agents|antiviral agents|mesh-ancestor
101391064|NCT05288023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101391065|NCT05288023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101391080|NCT05281471|Paclitaxel|paclitaxel|mesh-list
101391081|NCT05281471|Docetaxel|docetaxel|mesh-list
101391082|NCT05281471|Bevacizumab|bevacizumab|mesh-list
101391083|NCT05281471|Carboplatin|carboplatin|mesh-list
101391084|NCT05281471|Gemcitabine|gemcitabine|mesh-list
101391085|NCT05281471|Doxorubicin|doxorubicin|mesh-list
101439595|NCT05154747|Cabotegravir|cabotegravir|mesh-list
101439596|NCT05154747|Cabotegravir, rilpivirine drug combination|cabotegravir, rilpivirine drug combination|mesh-list
101439597|NCT05154747|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101439598|NCT05154747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101439599|NCT05154747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101439600|NCT05154747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439601|NCT05154747|Antiviral Agents|antiviral agents|mesh-ancestor
101439602|NCT05154747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101439603|NCT05154747|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101439604|NCT05154747|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101439605|NCT05154747|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101439606|NCT05154747|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101439607|NCT05153915|Tacrolimus|tacrolimus|mesh-list
101439608|NCT05153915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101439609|NCT05153915|Immunologic Factors|immunologic factors|mesh-ancestor
101439610|NCT05153915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439611|NCT05153915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101439612|NCT05153915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101439613|NCT05153915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439614|NCT05152927|Parathyroid Hormone|parathyroid hormone|mesh-list
101439615|NCT05152927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101439616|NCT05152927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439617|NCT05152628|Tacrolimus|tacrolimus|mesh-list
101439625|NCT05149768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101439626|NCT05149768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439628|NCT05149768|Immunoconjugates|immunoconjugates|mesh-ancestor
101439629|NCT05149768|Immunologic Factors|immunologic factors|mesh-ancestor
101439630|NCT05149768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439631|NCT05131204|Eculizumab|eculizumab|mesh-list
101439632|NCT05131204|Ravulizumab|ravulizumab|mesh-list
101439633|NCT05131204|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101439634|NCT05131204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101439635|NCT05131204|Immunologic Factors|immunologic factors|mesh-ancestor
101439636|NCT05131204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439637|NCT05128487|Pembrolizumab|pembrolizumab|mesh-list
101439638|NCT05128487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101307772|NCT02043171|Vitamin D|vitamin d|mesh-list
101307773|NCT02043171|Ergocalciferols|ergocalciferols|mesh-list
101439639|NCT05128487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439640|NCT05128487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101439641|NCT05128487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439642|NCT05123599|Tenofovir|tenofovir|mesh-list
101439643|NCT05123599|Antiviral Agents|antiviral agents|mesh-ancestor
101439644|NCT05123599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101439645|NCT05123599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101391086|NCT05281471|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101391088|NCT05281471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101391089|NCT05281471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391090|NCT05281471|Tubulin Modulators|tubulin modulators|mesh-ancestor
101391091|NCT05281471|Antimitotic Agents|antimitotic agents|mesh-ancestor
101391094|NCT05281471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101391096|NCT05281471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101391097|NCT05281471|Growth Substances|growth substances|mesh-ancestor
101391098|NCT05281471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391099|NCT05281471|Growth Inhibitors|growth inhibitors|mesh-ancestor
101391100|NCT05281471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101391101|NCT05281471|Antimetabolites|antimetabolites|mesh-ancestor
101391102|NCT05281471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101391103|NCT05281471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101391104|NCT05281471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101391105|NCT05281471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101391106|NCT05280405|Infliximab|infliximab|mesh-list
101391107|NCT05280405|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101391108|NCT05280405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101391109|NCT05280405|Dermatologic Agents|dermatologic agents|mesh-ancestor
101391110|NCT05280405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101391111|NCT05280405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101391112|NCT05275439|Azacitidine|azacitidine|mesh-list
101391113|NCT05275439|Venetoclax|venetoclax|mesh-list
101391114|NCT05275439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101391115|NCT05275439|Antimetabolites|antimetabolites|mesh-ancestor
101391116|NCT05275439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391117|NCT05275439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391118|NCT05275439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101439646|NCT05123599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101439647|NCT05123599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101439648|NCT05123599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439649|NCT05123599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101439650|NCT05123599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101439651|NCT05112939|Cabotegravir|cabotegravir|mesh-list
101439652|NCT05112939|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101439653|NCT05112939|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101439654|NCT05112939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101439655|NCT05112939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439656|NCT05112939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101439657|NCT05112939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101439658|NCT05112939|Antiviral Agents|antiviral agents|mesh-ancestor
101439659|NCT05112939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101391120|NCT05275023|Entecavir|entecavir|mesh-list
101391121|NCT05275023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101391122|NCT05275023|Antiviral Agents|antiviral agents|mesh-ancestor
101391123|NCT05275023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101391124|NCT05275023|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101305501|NCT02019810|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101305502|NCT02019810|Protective Agents|protective agents|mesh-ancestor
101305503|NCT02019836|Vitamin D|vitamin d|mesh-list
101305504|NCT02019836|Vitamins|vitamins|mesh-ancestor
101305505|NCT02019836|Micronutrients|micronutrients|mesh-ancestor
101305506|NCT02019836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305507|NCT02019836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101305508|NCT02020005|Nicotine|nicotine|mesh-list
101305509|NCT02020005|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101391125|NCT05275023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101391126|NCT05275023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101391127|NCT05275023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391128|NCT05275023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101391129|NCT05275023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101391130|NCT05275023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101391131|NCT05275023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391132|NCT05269355|Dacarbazine|dacarbazine|mesh-list
101362757|NCT00075231|Efavirenz|efavirenz|mesh-list
101391133|NCT05269355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101391134|NCT05269355|Alkylating Agents|alkylating agents|mesh-ancestor
101391135|NCT05269355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391136|NCT05269355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391137|NCT05263284|Venetoclax|venetoclax|mesh-list
101391139|NCT05263284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391140|NCT05263284|Analgesics|analgesics|mesh-ancestor
101391141|NCT05263284|Sensory System Agents|sensory system agents|mesh-ancestor
101391142|NCT05263284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101391143|NCT05263284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391144|NCT05263284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101391145|NCT05263284|Vasodilator Agents|vasodilator agents|mesh-ancestor
101391146|NCT05263284|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101391148|NCT05263284|Purinergic Agents|purinergic agents|mesh-ancestor
101391149|NCT05263284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101391150|NCT05263284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391151|NCT05260008|Epinephrine|epinephrine|mesh-list
101391152|NCT05260008|Bupivacaine|bupivacaine|mesh-list
101391153|NCT05260008|Anesthetics, Local|anesthetics, local|mesh-ancestor
101391154|NCT05260008|Anesthetics|anesthetics|mesh-ancestor
101391155|NCT05260008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101391156|NCT05260008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391157|NCT05260008|Sensory System Agents|sensory system agents|mesh-ancestor
101391158|NCT05260008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101391159|NCT05260008|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101391160|NCT05260008|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101391161|NCT05260008|Adrenergic Agents|adrenergic agents|mesh-ancestor
101391162|NCT05260008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101391163|NCT05260008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391213|NCT05250973|Daratumumab|daratumumab|mesh-list
101391214|NCT05250973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101391215|NCT05250973|Immunologic Factors|immunologic factors|mesh-ancestor
101391216|NCT05250973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391217|NCT05250973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101391218|NCT05250973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101391219|NCT05250973|Alkylating Agents|alkylating agents|mesh-ancestor
101391220|NCT05250973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391221|NCT05250973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391222|NCT05250973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101391223|NCT05250973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101391224|NCT05250973|Antiemetics|antiemetics|mesh-ancestor
101391225|NCT05250973|Autonomic Agents|autonomic agents|mesh-ancestor
101391226|NCT05250973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101391227|NCT05250973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101391228|NCT05250973|Glucocorticoids|glucocorticoids|mesh-ancestor
101391234|NCT05232929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101391235|NCT05232929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391236|NCT05227742|Psilocybin|psilocybin|mesh-list
101391237|NCT05227742|Hallucinogens|hallucinogens|mesh-ancestor
101391249|NCT05211323|Atezolizumab|atezolizumab|mesh-list
101391251|NCT05211323|Gemcitabine|gemcitabine|mesh-list
101391252|NCT05211323|Endothelial Growth Factors|endothelial growth factors|mesh-list
101391253|NCT05211323|Antibodies|antibodies|mesh-list
101391254|NCT05211323|Immunoglobulins|immunoglobulins|mesh-list
101391255|NCT05211323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101391256|NCT05211323|Immunoglobulin G|immunoglobulin g|mesh-list
101391257|NCT05211323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391258|NCT05211323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101391259|NCT05211323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101391260|NCT05211323|Growth Substances|growth substances|mesh-ancestor
101391261|NCT05211323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391262|NCT05211323|Growth Inhibitors|growth inhibitors|mesh-ancestor
101391263|NCT05211323|Immunologic Factors|immunologic factors|mesh-ancestor
101391264|NCT05211323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101391265|NCT05211323|Antimetabolites|antimetabolites|mesh-ancestor
101391266|NCT05211323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391267|NCT05211323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101391268|NCT05206773|Venglustat|venglustat|mesh-list
101391269|NCT05206773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101391270|NCT05206773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391271|NCT05190471|Decitabine|decitabine|mesh-list
101391272|NCT05190471|Oblimersen|oblimersen|mesh-list
101391273|NCT05190471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101391274|NCT05190471|Antimetabolites|antimetabolites|mesh-ancestor
101391275|NCT05190471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391276|NCT05190471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391277|NCT05190471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101391278|NCT05186974|Carboplatin|carboplatin|mesh-list
101391279|NCT05186974|Pembrolizumab|pembrolizumab|mesh-list
101391280|NCT05186974|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
101439665|NCT05106335|Docetaxel|docetaxel|mesh-list
101439666|NCT05106335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439667|NCT05106335|Tubulin Modulators|tubulin modulators|mesh-ancestor
101439668|NCT05106335|Antimitotic Agents|antimitotic agents|mesh-ancestor
101439669|NCT05106335|Mitosis Modulators|mitosis modulators|mesh-ancestor
101439670|NCT05106335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439671|NCT05092269|Ustekinumab|ustekinumab|mesh-list
101391282|NCT05186974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101391283|NCT05186974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101391284|NCT05186974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391285|NCT05186974|Immunoconjugates|immunoconjugates|mesh-ancestor
101391286|NCT05186974|Immunologic Factors|immunologic factors|mesh-ancestor
101391287|NCT05186974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391288|NCT05182151|Istradefylline|istradefylline|mesh-list
101391289|NCT05182151|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
101391290|NCT05182151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101391291|NCT05182151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101391292|NCT05182151|Purinergic Agents|purinergic agents|mesh-ancestor
101391293|NCT05182151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101391294|NCT05182151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391295|NCT05182151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391296|NCT05180799|Nivolumab|nivolumab|mesh-list
101391297|NCT05180799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101391298|NCT05180799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391299|NCT05180799|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101391300|NCT05180799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391321|NCT05171647|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
101391322|NCT05171647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101391323|NCT05171647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391324|NCT05171647|Immunologic Factors|immunologic factors|mesh-ancestor
101391325|NCT05171647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391326|NCT05171647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101391327|NCT05171647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101391328|NCT05171647|Antimetabolites|antimetabolites|mesh-ancestor
101456556|NCT04662385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101305515|NCT02020005|Cholinergic Agents|cholinergic agents|mesh-ancestor
101305516|NCT02020005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101333847|NCT00041275|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101188308|NCT01096368|Alkylating Agents|alkylating agents|mesh-ancestor
101439672|NCT05092269|Dermatologic Agents|dermatologic agents|mesh-ancestor
101439674|NCT05090085|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101391329|NCT05171647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391330|NCT05171647|Immunoconjugates|immunoconjugates|mesh-ancestor
101391331|NCT05170204|Durvalumab|durvalumab|mesh-list
101391332|NCT05170204|Pralsetinib|pralsetinib|mesh-list
101391333|NCT05170204|Entrectinib|entrectinib|mesh-list
101391334|NCT05170204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101391335|NCT05170204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391336|NCT05170204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101391337|NCT05170204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101391338|NCT05170204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391339|NCT05151744|Ranibizumab|ranibizumab|mesh-list
101391340|NCT05151744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101391341|NCT05151744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101391342|NCT05151744|Growth Substances|growth substances|mesh-ancestor
101362777|NCT00403312|Nicotine|nicotine|mesh-list
101391343|NCT05151744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391344|NCT05151744|Growth Inhibitors|growth inhibitors|mesh-ancestor
101391345|NCT05151744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391346|NCT05151731|Ranibizumab|ranibizumab|mesh-list
101391347|NCT05151731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101391348|NCT05151731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101391349|NCT05151731|Growth Substances|growth substances|mesh-ancestor
101391350|NCT05151731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391351|NCT05151731|Growth Inhibitors|growth inhibitors|mesh-ancestor
101391352|NCT05151731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391353|NCT05146739|Leucovorin|leucovorin|mesh-list
101391354|NCT05146739|Cytarabine|cytarabine|mesh-list
101391355|NCT05146739|Fludarabine|fludarabine|mesh-list
101391356|NCT05146739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391357|NCT05146739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101391358|NCT05146739|Antimetabolites|antimetabolites|mesh-ancestor
101391359|NCT05146739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391360|NCT05146739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101439675|NCT05090085|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101439676|NCT05090085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101439677|NCT05090085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439678|NCT05090085|Hormone Antagonists|hormone antagonists|mesh-ancestor
101439679|NCT05090085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101439680|NCT05090085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439681|NCT05083169|Dexamethasone|dexamethasone|mesh-list
101439682|NCT05083169|Bortezomib|bortezomib|mesh-list
101439683|NCT05083169|Daratumumab|daratumumab|mesh-list
101439684|NCT05083169|Pomalidomide|pomalidomide|mesh-list
101391399|NCT05111912|Liraglutide|liraglutide|mesh-list
101391400|NCT05111912|Glucagon|glucagon|mesh-list
101391401|NCT05111912|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101391402|NCT05111912|Incretins|incretins|mesh-ancestor
101391403|NCT05111912|Hormones|hormones|mesh-ancestor
101391404|NCT05111912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101391405|NCT05111912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391406|NCT05111912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101391407|NCT05111912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101391408|NCT05111626|Nivolumab|nivolumab|mesh-list
101439685|NCT05083169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101439686|NCT05083169|Antiemetics|antiemetics|mesh-ancestor
101439687|NCT05083169|Autonomic Agents|autonomic agents|mesh-ancestor
101439709|NCT05071664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101439710|NCT05071664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101439711|NCT05071664|Immunologic Factors|immunologic factors|mesh-ancestor
101439712|NCT05071664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391412|NCT05111626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101391413|NCT05111626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391414|NCT05103332|Amlodipine|amlodipine|mesh-list
101391415|NCT05103332|Olmesartan|olmesartan|mesh-list
101391416|NCT05103332|Indapamide|indapamide|mesh-list
101391417|NCT05103332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101391418|NCT05103332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101391419|NCT05103332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101391420|NCT05103332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391421|NCT05103332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101391422|NCT05103332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391423|NCT05103332|Vasodilator Agents|vasodilator agents|mesh-ancestor
101391424|NCT05103332|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101391425|NCT05103332|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101391426|NCT05103332|Diuretics|diuretics|mesh-ancestor
101391427|NCT05103332|Natriuretic Agents|natriuretic agents|mesh-ancestor
101391428|NCT05103332|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101391429|NCT05092958|Avelumab|avelumab|mesh-list
101391430|NCT05092958|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101391431|NCT05092958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101391432|NCT05092958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391433|NCT05092958|Immunologic Factors|immunologic factors|mesh-ancestor
101362778|NCT00403312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101391434|NCT05092958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391435|NCT05077904|Alprazolam|alprazolam|mesh-list
101391436|NCT05077904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101391437|NCT05077904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101391438|NCT05077904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307775|NCT02043171|Vitamins|vitamins|mesh-list
101391483|NCT05065918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101391484|NCT05065918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101305521|NCT02020122|Sensory System Agents|sensory system agents|mesh-ancestor
101305522|NCT02020122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101305523|NCT02020122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305524|NCT02020122|Anticonvulsants|anticonvulsants|mesh-ancestor
101305525|NCT02020122|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101305526|NCT02020122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101305527|NCT02020122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305528|NCT02020122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101305529|NCT02020122|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101305530|NCT02020122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101305531|NCT02020122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101305532|NCT02020122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101305533|NCT02020122|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101178549|NCT02064582|Leuprolide|leuprolide|mesh-list
101391485|NCT05065918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391486|NCT05065424|Atropine|atropine|mesh-list
101391487|NCT05065424|Fentanyl|fentanyl|mesh-list
101391488|NCT05065424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101391489|NCT05065424|Narcotics|narcotics|mesh-ancestor
101391490|NCT05065424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101391491|NCT05065424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391492|NCT05065424|Analgesics|analgesics|mesh-ancestor
101391493|NCT05065424|Sensory System Agents|sensory system agents|mesh-ancestor
101391494|NCT05065424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101391495|NCT05065424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101391496|NCT05065424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101391497|NCT05065424|Anesthetics, General|anesthetics, general|mesh-ancestor
101391498|NCT05065424|Anesthetics|anesthetics|mesh-ancestor
101391499|NCT05065424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188483|NCT00002898|Epirubicin|epirubicin|mesh-list
101439754|NCT05050097|Lenalidomide|lenalidomide|mesh-list
101439755|NCT05050097|Pomalidomide|pomalidomide|mesh-list
101439756|NCT05050097|Daratumumab|daratumumab|mesh-list
101439757|NCT05050097|Immunologic Factors|immunologic factors|mesh-ancestor
101439758|NCT05050097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439759|NCT05050097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101439783|NCT04956094|Antioxidants|antioxidants|mesh-ancestor
101188517|NCT00002940|Hydroxyurea|hydroxyurea|mesh-list
101391500|NCT05065424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101391501|NCT05065424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101391502|NCT05065424|Autonomic Agents|autonomic agents|mesh-ancestor
101391503|NCT05065424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101391504|NCT05065424|Respiratory System Agents|respiratory system agents|mesh-ancestor
101391505|NCT05065424|Mydriatics|mydriatics|mesh-ancestor
101391506|NCT05065424|Parasympatholytics|parasympatholytics|mesh-ancestor
101391507|NCT05065424|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101391508|NCT05065424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101391509|NCT05065424|Cholinergic Agents|cholinergic agents|mesh-ancestor
101391510|NCT05065424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101391511|NCT05063734|Aflibercept|aflibercept|mesh-list
101391512|NCT05063734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101391513|NCT05063734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101391514|NCT05063734|Growth Substances|growth substances|mesh-ancestor
101391515|NCT05063734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391516|NCT05063734|Growth Inhibitors|growth inhibitors|mesh-ancestor
101391517|NCT05063734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391518|NCT05063162|Rozanolixizumab|rozanolixizumab|mesh-list
101391526|NCT05061134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101391527|NCT05061134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391528|NCT05060822|Pirfenidone|pirfenidone|mesh-list
101391529|NCT05060822|Analgesics|analgesics|mesh-ancestor
101391530|NCT05060822|Sensory System Agents|sensory system agents|mesh-ancestor
101391531|NCT05060822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101391532|NCT05060822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305534|NCT02020122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101305535|NCT02020122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101391533|NCT05060822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101391534|NCT05060822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101391535|NCT05060822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101439784|NCT04956094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439785|NCT04956094|Protective Agents|protective agents|mesh-ancestor
101439786|NCT04956094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439787|NCT04940039|Risperidone|risperidone|mesh-list
101439788|NCT04940039|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101439789|NCT04940039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101439790|NCT04940039|Serotonin Agents|serotonin agents|mesh-ancestor
101439791|NCT04940039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101439792|NCT04940039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439793|NCT04940039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391536|NCT05060822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101391537|NCT05060822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391538|NCT05057494|Venetoclax|venetoclax|mesh-list
101391539|NCT05057494|Obinutuzumab|obinutuzumab|mesh-list
101391540|NCT05057494|Acalabrutinib|acalabrutinib|mesh-list
101391541|NCT05057494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391542|NCT05057494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101391543|NCT05053334|Omalizumab|omalizumab|mesh-list
101391544|NCT05053334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101391545|NCT05053334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101391546|NCT05053334|Respiratory System Agents|respiratory system agents|mesh-ancestor
101391547|NCT05050916|Vitamin D|vitamin d|mesh-list
101391548|NCT05050916|Vitamins|vitamins|mesh-ancestor
101391549|NCT05050916|Micronutrients|micronutrients|mesh-ancestor
101391550|NCT05050916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391551|NCT05050916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101391552|NCT05048797|Carboplatin|carboplatin|mesh-list
101391553|NCT05048797|Pembrolizumab|pembrolizumab|mesh-list
101391554|NCT05048797|Trastuzumab|trastuzumab|mesh-list
101391555|NCT05048797|Pemetrexed|pemetrexed|mesh-list
101391556|NCT05048797|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
101391557|NCT05048797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391558|NCT05048797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101391559|NCT05048797|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101391560|NCT05048797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391561|NCT05048797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101391562|NCT05048797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101391563|NCT05048797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101439794|NCT04940039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101439795|NCT04940039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101439796|NCT04940039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101439797|NCT04940039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101439798|NCT04940039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101439799|NCT04940039|Dopamine Agents|dopamine agents|mesh-ancestor
101439800|NCT04940039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101439801|NCT04940039|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101439802|NCT04936230|Atezolizumab|atezolizumab|mesh-list
101439803|NCT04936230|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101439804|NCT04936230|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101439805|NCT04936230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439806|NCT04936230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101439807|NCT04936230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439808|NCT04936230|Immunologic Factors|immunologic factors|mesh-ancestor
101439818|NCT04929392|Antimitotic Agents|antimitotic agents|mesh-ancestor
101439819|NCT04929392|Mitosis Modulators|mitosis modulators|mesh-ancestor
101439820|NCT04929392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439821|NCT04929392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101391564|NCT05048797|Immunoconjugates|immunoconjugates|mesh-ancestor
101391565|NCT05048797|Immunologic Factors|immunologic factors|mesh-ancestor
101391566|NCT05048797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391567|NCT05046795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101391568|NCT05045612|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101391569|NCT05045612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101391570|NCT05039619|Acetaminophen|acetaminophen|mesh-list
101391571|NCT05039619|Diphenhydramine|diphenhydramine|mesh-list
101391572|NCT05039619|Promethazine|promethazine|mesh-list
101391573|NCT05039619|Mycophenolic Acid|mycophenolic acid|mesh-list
101391574|NCT05039619|Prednisone|prednisone|mesh-list
101391575|NCT05039619|Methylprednisolone|methylprednisolone|mesh-list
101391576|NCT05039619|Obinutuzumab|obinutuzumab|mesh-list
101391577|NCT05039619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101391578|NCT05039619|Glucocorticoids|glucocorticoids|mesh-ancestor
101391579|NCT05039619|Hormones|hormones|mesh-ancestor
101391580|NCT05039619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101391581|NCT05039619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391582|NCT05039619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101391583|NCT05039619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391584|NCT05039619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101391585|NCT05039619|Analgesics|analgesics|mesh-ancestor
101391586|NCT05039619|Sensory System Agents|sensory system agents|mesh-ancestor
101391587|NCT05039619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101391588|NCT05039619|Antipyretics|antipyretics|mesh-ancestor
101391592|NCT05039619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101391593|NCT05039619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101391594|NCT05039619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101391595|NCT05039619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391597|NCT05039619|Autonomic Agents|autonomic agents|mesh-ancestor
101391598|NCT05039619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101391609|NCT05039619|Histamine Agents|histamine agents|mesh-ancestor
101391610|NCT05039619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101391611|NCT05039619|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101391612|NCT05039619|Antipruritics|antipruritics|mesh-ancestor
101391613|NCT05039619|Dermatologic Agents|dermatologic agents|mesh-ancestor
101391614|NCT05035407|Aldesleukin|aldesleukin|mesh-list
101391615|NCT05035407|Cyclophosphamide|cyclophosphamide|mesh-list
101391616|NCT05035407|Fludarabine|fludarabine|mesh-list
101391617|NCT05035407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101391618|NCT05035407|Immunologic Factors|immunologic factors|mesh-ancestor
101391619|NCT05035407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391620|NCT05035407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101391621|NCT05035407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101391622|NCT05035407|Alkylating Agents|alkylating agents|mesh-ancestor
101391623|NCT05035407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391624|NCT05035407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391625|NCT05035407|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101391626|NCT05035407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101391627|NCT05035407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101391628|NCT05035407|Antiviral Agents|antiviral agents|mesh-ancestor
101391629|NCT05035407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101391630|NCT05032157|Remibrutinib|remibrutinib|mesh-list
101391631|NCT05032157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101391632|NCT05032157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101391633|NCT05032157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391634|NCT05030311|Remibrutinib|remibrutinib|mesh-list
101391635|NCT05030311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101391636|NCT05030311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101391637|NCT05030311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391638|NCT05017012|Paclitaxel|paclitaxel|mesh-list
101391639|NCT05017012|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101391640|NCT05017012|Carboplatin|carboplatin|mesh-list
101391641|NCT05017012|Pembrolizumab|pembrolizumab|mesh-list
101391642|NCT05017012|Pemetrexed|pemetrexed|mesh-list
101391643|NCT05017012|Axitinib|axitinib|mesh-list
101391644|NCT05017012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101391645|NCT05017012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391649|NCT05017012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391650|NCT05017012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101391651|NCT05017012|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101391652|NCT05017012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101391653|NCT05017012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101391654|NCT05017012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101391655|NCT05017012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101391656|NCT05011383|Testosterone|testosterone|mesh-list
101391657|NCT05011383|Androgens|androgens|mesh-list
101391658|NCT05011383|Hormones|hormones|mesh-ancestor
101391659|NCT05011383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101391660|NCT05011383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391664|NCT05003895|Immunologic Factors|immunologic factors|mesh-ancestor
101391665|NCT05003895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391666|NCT05003895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101391667|NCT05003895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101391668|NCT05003895|Alkylating Agents|alkylating agents|mesh-ancestor
101391669|NCT05003895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391670|NCT05003895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391671|NCT05003895|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101391672|NCT04999761|Bevacizumab|bevacizumab|mesh-list
101391673|NCT04999761|Ramucirumab|ramucirumab|mesh-list
101391674|NCT04999761|Futibatinib|futibatinib|mesh-list
101391675|NCT04999761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101391676|NCT04999761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391677|NCT04999761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101391678|NCT04999761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101305540|NCT02020161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101391679|NCT04999761|Growth Substances|growth substances|mesh-ancestor
101391680|NCT04999761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391681|NCT04999761|Growth Inhibitors|growth inhibitors|mesh-ancestor
101391682|NCT04998812|Ocrelizumab|ocrelizumab|mesh-list
101391683|NCT04998812|Immunologic Factors|immunologic factors|mesh-ancestor
101391691|NCT04989491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391692|NCT04989491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101391693|NCT04984369|Cetuximab|cetuximab|mesh-list
101391694|NCT04984369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101391695|NCT04984369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391696|NCT04981158|Anesthetics|anesthetics|mesh-list
101391697|NCT04981158|Anesthetics, General|anesthetics, general|mesh-list
101391698|NCT04981158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101391699|NCT04981158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391700|NCT04980222|Prednisone|prednisone|mesh-list
101391701|NCT04980222|Cyclophosphamide|cyclophosphamide|mesh-list
101391702|NCT04980222|Rituximab|rituximab|mesh-list
101391703|NCT04980222|Doxorubicin|doxorubicin|mesh-list
101391704|NCT04980222|Vincristine|vincristine|mesh-list
101391705|NCT04980222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101391706|NCT04980222|Immunologic Factors|immunologic factors|mesh-ancestor
101391707|NCT04980222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391708|NCT04980222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101391709|NCT04980222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101391710|NCT04980222|Alkylating Agents|alkylating agents|mesh-ancestor
101391711|NCT04980222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391712|NCT04980222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391713|NCT04980222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101391714|NCT04980222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101391715|NCT04980222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101391716|NCT04980222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101391717|NCT04980222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101391718|NCT04980222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101391719|NCT04980222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101391720|NCT04980222|Glucocorticoids|glucocorticoids|mesh-ancestor
101391721|NCT04980222|Hormones|hormones|mesh-ancestor
101391722|NCT04980222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101391723|NCT04980222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101391730|NCT04969887|Nivolumab|nivolumab|mesh-list
101391731|NCT04969887|Ipilimumab|ipilimumab|mesh-list
101391732|NCT04969887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101391733|NCT04969887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391734|NCT04969887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101391738|NCT04964934|Palbociclib|palbociclib|mesh-list
101391739|NCT04964934|Anastrozole|anastrozole|mesh-list
101391740|NCT04964934|Hormones|hormones|mesh-list
101391741|NCT04964934|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101391742|NCT04964934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101391743|NCT04964934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391744|NCT04964934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391745|NCT04964934|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101391746|NCT04964934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101391747|NCT04964934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101391748|NCT04964934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391749|NCT04964934|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101391750|NCT04964934|Hormone Antagonists|hormone antagonists|mesh-ancestor
101391751|NCT04964934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101391752|NCT04964934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101391754|NCT04963296|Diphenhydramine|diphenhydramine|mesh-list
101391755|NCT04963296|Promethazine|promethazine|mesh-list
101391756|NCT04963296|Methylprednisolone|methylprednisolone|mesh-list
101305541|NCT02020161|Abortifacient Agents|abortifacient agents|mesh-ancestor
101305542|NCT02020161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101305543|NCT02020161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305544|NCT02020161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101391757|NCT04963296|Obinutuzumab|obinutuzumab|mesh-list
101391758|NCT04963296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101439822|NCT04929392|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101439823|NCT04929392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101439824|NCT04929392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101439825|NCT04923893|Dexamethasone|dexamethasone|mesh-list
101439826|NCT04923893|Cyclophosphamide|cyclophosphamide|mesh-list
101439827|NCT04923893|Fludarabine|fludarabine|mesh-list
101439828|NCT04923893|Lenalidomide|lenalidomide|mesh-list
101439829|NCT04923893|Bortezomib|bortezomib|mesh-list
101439830|NCT04923893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101439831|NCT04923893|Immunologic Factors|immunologic factors|mesh-ancestor
101439832|NCT04923893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439833|NCT04923893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101439834|NCT04923893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101439835|NCT04923893|Alkylating Agents|alkylating agents|mesh-ancestor
101439846|NCT04923893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101391760|NCT04963296|Sensory System Agents|sensory system agents|mesh-ancestor
101391761|NCT04963296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101391762|NCT04963296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391763|NCT04963296|Antipyretics|antipyretics|mesh-ancestor
101391764|NCT04963296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101391765|NCT04963296|Antiemetics|antiemetics|mesh-ancestor
101391766|NCT04963296|Autonomic Agents|autonomic agents|mesh-ancestor
101391767|NCT04963296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101391768|NCT04963296|Glucocorticoids|glucocorticoids|mesh-ancestor
101391769|NCT04963296|Hormones|hormones|mesh-ancestor
101391770|NCT04963296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101391771|NCT04963296|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101391772|NCT04963296|Protective Agents|protective agents|mesh-ancestor
101391773|NCT04963296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391774|NCT04963296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101391775|NCT04963296|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101391776|NCT04963296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101391777|NCT04963296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101391778|NCT04963296|Anesthetics, Local|anesthetics, local|mesh-ancestor
101391779|NCT04963296|Anesthetics|anesthetics|mesh-ancestor
101391780|NCT04963296|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101391781|NCT04963296|Histamine Antagonists|histamine antagonists|mesh-ancestor
101391782|NCT04963296|Histamine Agents|histamine agents|mesh-ancestor
101391783|NCT04963296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101391784|NCT04963296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188801|NCT00003150|Prednisone|prednisone|mesh-list
101439847|NCT04923893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101439848|NCT04923893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101439849|NCT04923893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101439850|NCT04923893|Growth Substances|growth substances|mesh-ancestor
101439851|NCT04923893|Growth Inhibitors|growth inhibitors|mesh-ancestor
101307777|NCT02043171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307778|NCT02043171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101439853|NCT04859946|Busulfan|busulfan|mesh-list
101439854|NCT04859946|Thiotepa|thiotepa|mesh-list
101439855|NCT04859946|Fludarabine|fludarabine|mesh-list
101439856|NCT04859946|Tacrolimus|tacrolimus|mesh-list
101439857|NCT04859946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101439858|NCT04859946|Immunologic Factors|immunologic factors|mesh-ancestor
101439859|NCT04859946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439860|NCT04859946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101439861|NCT04859946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101439862|NCT04859946|Alkylating Agents|alkylating agents|mesh-ancestor
101439863|NCT04859946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439864|NCT04859946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439865|NCT04859946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101439877|NCT04837014|Naproxen|naproxen|mesh-list
101439895|NCT04831294|Cannabidiol|cannabidiol|mesh-list
101439896|NCT04831294|Anticonvulsants|anticonvulsants|mesh-ancestor
101439897|NCT04829318|Esketamine|esketamine|mesh-list
101391834|NCT04935931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101391835|NCT04935931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391836|NCT04935931|Sensory System Agents|sensory system agents|mesh-ancestor
101391837|NCT04935931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101391838|NCT04933227|Capecitabine|capecitabine|mesh-list
101391839|NCT04933227|Oxaliplatin|oxaliplatin|mesh-list
101391840|NCT04933227|Atezolizumab|atezolizumab|mesh-list
101391841|NCT04933227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101391842|NCT04933227|Antimetabolites|antimetabolites|mesh-ancestor
101456557|NCT00216827|Betamethasone|betamethasone|mesh-list
101305545|NCT02020161|Antimetabolites|antimetabolites|mesh-ancestor
101305546|NCT02020161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305547|NCT02020161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101305548|NCT02020161|Dermatologic Agents|dermatologic agents|mesh-ancestor
101305549|NCT02020161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101391843|NCT04933227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391844|NCT04933227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391845|NCT04933227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101391846|NCT04933227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101391847|NCT04929041|Paclitaxel|paclitaxel|mesh-list
101391848|NCT04929041|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101391849|NCT04929041|Carboplatin|carboplatin|mesh-list
101391850|NCT04929041|Pembrolizumab|pembrolizumab|mesh-list
101391851|NCT04929041|Nivolumab|nivolumab|mesh-list
101391852|NCT04929041|Pemetrexed|pemetrexed|mesh-list
101391853|NCT04929041|Ipilimumab|ipilimumab|mesh-list
101391854|NCT04929041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101391855|NCT04929041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391856|NCT04929041|Tubulin Modulators|tubulin modulators|mesh-ancestor
101391857|NCT04929041|Antimitotic Agents|antimitotic agents|mesh-ancestor
101391858|NCT04929041|Mitosis Modulators|mitosis modulators|mesh-ancestor
101391859|NCT04929041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391860|NCT04929041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101391861|NCT04929041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101391862|NCT04929041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101439898|NCT04829318|Antidepressive Agents|antidepressive agents|mesh-ancestor
101439899|NCT04829318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101439900|NCT04828694|Naltrexone|naltrexone|mesh-list
101439901|NCT04828694|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101439902|NCT04828694|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101439903|NCT04828694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391863|NCT04929041|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101362829|NCT00045539|Vitamins|vitamins|mesh-ancestor
101391864|NCT04929041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101391865|NCT04926181|Androgens|androgens|mesh-list
101391866|NCT04926181|Hormones|hormones|mesh-ancestor
101391867|NCT04926181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101391876|NCT04921189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391877|NCT04921189|Protective Agents|protective agents|mesh-ancestor
101391878|NCT04921189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391880|NCT04921189|Micronutrients|micronutrients|mesh-ancestor
101391881|NCT04921189|Vitamin B Complex|vitamin b complex|mesh-ancestor
101391882|NCT04921189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101391883|NCT04910568|Dexamethasone|dexamethasone|mesh-list
101391884|NCT04910568|Daratumumab|daratumumab|mesh-list
101391885|NCT04910568|Pomalidomide|pomalidomide|mesh-list
101391886|NCT04910568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101391887|NCT04910568|Antiemetics|antiemetics|mesh-ancestor
101391888|NCT04910568|Autonomic Agents|autonomic agents|mesh-ancestor
101391889|NCT04910568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101391890|NCT04910568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391891|NCT04910568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101391892|NCT04910568|Glucocorticoids|glucocorticoids|mesh-ancestor
101391893|NCT04910568|Hormones|hormones|mesh-ancestor
101391894|NCT04910568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101391895|NCT04910568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101391896|NCT04910568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391897|NCT04910568|Immunologic Factors|immunologic factors|mesh-ancestor
101391898|NCT04910568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101391899|NCT04910568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101391900|NCT04910568|Growth Substances|growth substances|mesh-ancestor
101391901|NCT04910568|Growth Inhibitors|growth inhibitors|mesh-ancestor
101391902|NCT04906395|Tamoxifen|tamoxifen|mesh-list
101391903|NCT04906395|Letrozole|letrozole|mesh-list
101391904|NCT04906395|Anastrozole|anastrozole|mesh-list
101391905|NCT04906395|Exemestane|exemestane|mesh-list
101391906|NCT04906395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391907|NCT04906395|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101391908|NCT04906395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101439904|NCT04828694|Sensory System Agents|sensory system agents|mesh-ancestor
101439905|NCT04828694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101391909|NCT04906395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101391910|NCT04906395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391911|NCT04906395|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101391912|NCT04906395|Hormone Antagonists|hormone antagonists|mesh-ancestor
101391913|NCT04906395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101391914|NCT04906395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391915|NCT04906395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101391916|NCT04906395|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101305550|NCT02020161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101305551|NCT02020161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101305552|NCT02020161|Immunologic Factors|immunologic factors|mesh-ancestor
101391917|NCT04906395|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101391918|NCT04906395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101391920|NCT04905277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101391921|NCT04905277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101391922|NCT04905277|Sympatholytics|sympatholytics|mesh-ancestor
101391923|NCT04905277|Autonomic Agents|autonomic agents|mesh-ancestor
101391924|NCT04905277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101391925|NCT04905277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391926|NCT04905277|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101391927|NCT04905277|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101391928|NCT04905277|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101391929|NCT04905277|Adrenergic Agents|adrenergic agents|mesh-ancestor
101391930|NCT04905277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101391931|NCT04905277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391933|NCT04898894|Hydrocortisone|hydrocortisone|mesh-list
101391934|NCT04898894|Methotrexate|methotrexate|mesh-list
101391935|NCT04898894|Fludarabine phosphate|fludarabine phosphate|mesh-list
101362841|NCT00045617|Etoposide|etoposide|mesh-list
101391945|NCT04898894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391946|NCT04898894|Dermatologic Agents|dermatologic agents|mesh-ancestor
101391947|NCT04898894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101391993|NCT04885530|Fluticasone|fluticasone|mesh-list
101391994|NCT04885530|Xhance|xhance|mesh-list
101391995|NCT04885530|Ivermectin|ivermectin|mesh-list
101391996|NCT04885530|Fluvoxamine|fluvoxamine|mesh-list
101391997|NCT04885530|Montelukast|montelukast|mesh-list
101391998|NCT04885530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101391999|NCT04885530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392000|NCT04885530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101392001|NCT04885530|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101392002|NCT04885530|Autonomic Agents|autonomic agents|mesh-ancestor
101392008|NCT04885530|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101392009|NCT04885530|Hormone Antagonists|hormone antagonists|mesh-ancestor
101392010|NCT04885530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101392011|NCT04885530|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101392012|NCT04885530|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101392013|NCT04885530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188957|NCT00003276|Irinotecan|irinotecan|mesh-list
101439906|NCT04820309|Xanomeline|xanomeline|mesh-list
101439907|NCT04820309|Trospium chloride|trospium chloride|mesh-list
101439908|NCT04820309|Parasympatholytics|parasympatholytics|mesh-ancestor
101439909|NCT04820309|Autonomic Agents|autonomic agents|mesh-ancestor
101439910|NCT04820309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101392014|NCT04885530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101392015|NCT04885530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101392016|NCT04885530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101392017|NCT04885530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101392018|NCT04885530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101392019|NCT04885530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101305553|NCT02020161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101305554|NCT02020161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101305555|NCT02020161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101305556|NCT02020161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101305557|NCT02020161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101305558|NCT02020200|Methylphenidate|methylphenidate|mesh-list
101179036|NCT02276274|Protease Inhibitors|protease inhibitors|mesh-ancestor
101392020|NCT04885530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101392021|NCT04885530|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101392022|NCT04885530|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101392023|NCT04885530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101392024|NCT04885530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101392025|NCT04885530|Serotonin Agents|serotonin agents|mesh-ancestor
101392026|NCT04885530|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101392027|NCT04885530|Antidepressive Agents|antidepressive agents|mesh-ancestor
101392028|NCT04885530|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101392029|NCT04885530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101392030|NCT04885530|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101392032|NCT04884360|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101392033|NCT04884360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101392034|NCT04884360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392035|NCT04884360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392036|NCT04873362|Trastuzumab|trastuzumab|mesh-list
101392037|NCT04873362|Atezolizumab|atezolizumab|mesh-list
101392038|NCT04873362|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101392039|NCT04873362|Maytansine|maytansine|mesh-list
101188986|NCT00003330|Interleukin-12|interleukin-12|mesh-list
101439911|NCT04820309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439912|NCT04820309|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101439913|NCT04820309|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101439914|NCT04820309|Cholinergic Agents|cholinergic agents|mesh-ancestor
101439915|NCT04820309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101392040|NCT04873362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101392041|NCT04873362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392042|NCT04873362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101392043|NCT04873362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392044|NCT04873362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101392045|NCT04873362|Tubulin Modulators|tubulin modulators|mesh-ancestor
101392046|NCT04873362|Antimitotic Agents|antimitotic agents|mesh-ancestor
101392047|NCT04873362|Mitosis Modulators|mitosis modulators|mesh-ancestor
101392048|NCT04873362|Immunotoxins|immunotoxins|mesh-ancestor
101392049|NCT04873362|Immunoconjugates|immunoconjugates|mesh-ancestor
101392050|NCT04873362|Immunologic Factors|immunologic factors|mesh-ancestor
101392051|NCT04873362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392052|NCT04872790|Prednisone|prednisone|mesh-list
101392053|NCT04872790|Cortisone|cortisone|mesh-list
101392054|NCT04872790|Rituximab|rituximab|mesh-list
101392055|NCT04872790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101392056|NCT04872790|Methotrexate|methotrexate|mesh-list
101392057|NCT04872790|Venetoclax|venetoclax|mesh-list
101392058|NCT04872790|Dasatinib|dasatinib|mesh-list
101392059|NCT04872790|Antibodies|antibodies|mesh-list
101392060|NCT04872790|Immunoglobulins|immunoglobulins|mesh-list
101392061|NCT04872790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101392062|NCT04872790|Immunologic Factors|immunologic factors|mesh-ancestor
101392063|NCT04872790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392064|NCT04872790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392065|NCT04872790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101392066|NCT04872790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101392067|NCT04872790|Glucocorticoids|glucocorticoids|mesh-ancestor
101392068|NCT04872790|Hormones|hormones|mesh-ancestor
101392069|NCT04872790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101392070|NCT04872790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101392073|NCT04872790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101392074|NCT04872790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101392076|NCT04872790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392077|NCT04872790|Dermatologic Agents|dermatologic agents|mesh-ancestor
101392078|NCT04872790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101392079|NCT04872790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101439916|NCT04820309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392080|NCT04872790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101392081|NCT04872790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101392082|NCT04872790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101392083|NCT04856215|Antibodies|antibodies|mesh-list
101305559|NCT02020200|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101305560|NCT02020200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305561|NCT02020200|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101305562|NCT02020200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101305563|NCT02020200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101305564|NCT02020200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305566|NCT02020200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101305567|NCT02020213|Posaconazole|posaconazole|mesh-list
101305568|NCT02020213|Antifungal Agents|antifungal agents|mesh-ancestor
101305569|NCT02020213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101392084|NCT04856215|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101392085|NCT04856215|Immunologic Factors|immunologic factors|mesh-ancestor
101392086|NCT04856215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392087|NCT04849364|Pembrolizumab|pembrolizumab|mesh-list
101392088|NCT04849364|Capecitabine|capecitabine|mesh-list
101392089|NCT04849364|Talazoparib|talazoparib|mesh-list
101392090|NCT04849364|Inavolisib|inavolisib|mesh-list
101392091|NCT04849364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101392092|NCT04849364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392093|NCT04849364|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101392094|NCT04849364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392095|NCT04849364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101392096|NCT04849364|Antimetabolites|antimetabolites|mesh-ancestor
101392097|NCT04849364|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101392098|NCT04849364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101392099|NCT04849364|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
101392100|NCT04843111|Vaccines|vaccines|mesh-list
101392101|NCT04843111|Immunologic Factors|immunologic factors|mesh-ancestor
101189060|NCT00003378|Mitosis Modulators|mitosis modulators|mesh-ancestor
101439919|NCT04820309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101439920|NCT04820309|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101439921|NCT04820309|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101439922|NCT04802161|Cytarabine|cytarabine|mesh-list
101439923|NCT04802161|Daunorubicin|daunorubicin|mesh-list
101362856|NCT03442309|Fluorides|fluorides|mesh-list
101439924|NCT04802161|Pomalidomide|pomalidomide|mesh-list
101392102|NCT04843111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392103|NCT04838769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
101392104|NCT04838769|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
101392105|NCT04838769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101392106|NCT04838769|Adrenergic Agents|adrenergic agents|mesh-ancestor
101392107|NCT04838769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101392108|NCT04838769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392109|NCT04838769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392110|NCT04838769|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101392111|NCT04838769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101392112|NCT04838769|Hormone Antagonists|hormone antagonists|mesh-ancestor
101392113|NCT04838769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101392114|NCT04837196|Pembrolizumab|pembrolizumab|mesh-list
101392115|NCT04837196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101392116|NCT04837196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392117|NCT04837196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101392118|NCT04837196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392119|NCT04832854|Paclitaxel|paclitaxel|mesh-list
101392120|NCT04832854|Carboplatin|carboplatin|mesh-list
101392121|NCT04832854|Gemcitabine|gemcitabine|mesh-list
101392122|NCT04832854|Pemetrexed|pemetrexed|mesh-list
101392123|NCT04832854|Atezolizumab|atezolizumab|mesh-list
101439925|NCT04802161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101439926|NCT04802161|Antimetabolites|antimetabolites|mesh-ancestor
101439927|NCT04802161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439928|NCT04802161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439929|NCT04802161|Antiviral Agents|antiviral agents|mesh-ancestor
101439930|NCT04802161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101439931|NCT04802161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101439932|NCT04802161|Immunologic Factors|immunologic factors|mesh-ancestor
101439933|NCT04802161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439934|NCT04802161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101439935|NCT04802161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101439936|NCT04802161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101439943|NCT04801589|Dexmedetomidine|dexmedetomidine|mesh-list
101439944|NCT04801589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101439945|NCT04801589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101439946|NCT04801589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439947|NCT04801589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101307779|NCT02043171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101307780|NCT02043223|Vitamins|vitamins|mesh-list
101307781|NCT02043223|Vitamin A|vitamin a|mesh-list
101307782|NCT02043223|Retinol palmitate|retinol palmitate|mesh-list
101439949|NCT04801589|Sensory System Agents|sensory system agents|mesh-ancestor
101439950|NCT04801589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101439951|NCT04801589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101439952|NCT04801589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101439953|NCT04801589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101439954|NCT04801589|Adrenergic Agents|adrenergic agents|mesh-ancestor
101439955|NCT04801589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101392124|NCT04832854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101392125|NCT04832854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392126|NCT04832854|Tubulin Modulators|tubulin modulators|mesh-ancestor
101392127|NCT04832854|Antimitotic Agents|antimitotic agents|mesh-ancestor
101392128|NCT04832854|Mitosis Modulators|mitosis modulators|mesh-ancestor
101392129|NCT04832854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392130|NCT04832854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101392131|NCT04832854|Antimetabolites|antimetabolites|mesh-ancestor
101392132|NCT04832854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101392133|NCT04832854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101305570|NCT02020213|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101305571|NCT02020213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101305572|NCT02020213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101305573|NCT02020213|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101179165|NCT02287350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101362858|NCT03442309|Cariostatic Agents|cariostatic agents|mesh-ancestor
101392134|NCT04832854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101392135|NCT04832854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101392136|NCT04832854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101392138|NCT04808843|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101392139|NCT04808843|Contraceptive Agents|contraceptive agents|mesh-ancestor
101392140|NCT04808843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101392145|NCT04808843|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101392146|NCT04808843|Hormone Antagonists|hormone antagonists|mesh-ancestor
101392147|NCT04808843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101392148|NCT04808843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101392149|NCT04808843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392150|NCT04802837|Vancomycin|vancomycin|mesh-list
101392151|NCT04802837|Ridinilazole|ridinilazole|mesh-list
101189123|NCT00003414|Interferons|interferons|mesh-list
101439956|NCT04801589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439957|NCT04801589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101439958|NCT04801589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101439959|NCT04801589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101439960|NCT04801589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101439961|NCT04801589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101439962|NCT04801589|Anesthetics, General|anesthetics, general|mesh-ancestor
101439964|NCT04801589|GABA Modulators|gaba modulators|mesh-ancestor
101439965|NCT04801589|GABA Agents|gaba agents|mesh-ancestor
101439966|NCT04796948|Leucovorin|leucovorin|mesh-list
101439967|NCT04796948|Fluorouracil|fluorouracil|mesh-list
101439968|NCT04796948|Oxaliplatin|oxaliplatin|mesh-list
101439969|NCT04796948|Irinotecan|irinotecan|mesh-list
101439970|NCT04796948|Calcium|calcium|mesh-list
101392152|NCT04802837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101392153|NCT04802837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101392154|NCT04802759|Trastuzumab|trastuzumab|mesh-list
101392155|NCT04802759|Atezolizumab|atezolizumab|mesh-list
101392156|NCT04802759|Pertuzumab|pertuzumab|mesh-list
101392157|NCT04802759|Everolimus|everolimus|mesh-list
101392158|NCT04802759|Palbociclib|palbociclib|mesh-list
101392159|NCT04802759|Ipatasertib|ipatasertib|mesh-list
101392160|NCT04802759|Inavolisib|inavolisib|mesh-list
101392161|NCT04802759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101392162|NCT04802759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392163|NCT04802759|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101392164|NCT04802759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101392165|NCT04802759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101392166|NCT04802759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392167|NCT04802759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101392168|NCT04802759|Immunologic Factors|immunologic factors|mesh-ancestor
101392169|NCT04802759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392170|NCT04802759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101392171|NCT04802759|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
101392172|NCT04798612|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101392173|NCT04798612|Antiviral Agents|antiviral agents|mesh-ancestor
101392174|NCT04798612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101392175|NCT04796012|Irinotecan|irinotecan|mesh-list
101392176|NCT04796012|Vincristine|vincristine|mesh-list
101392177|NCT04796012|Temozolomide|temozolomide|mesh-list
101392178|NCT04796012|Atezolizumab|atezolizumab|mesh-list
101392179|NCT04796012|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101392180|NCT04796012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101392181|NCT04796012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101392182|NCT04796012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392183|NCT04796012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392184|NCT04796012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101392185|NCT04796012|Tubulin Modulators|tubulin modulators|mesh-ancestor
101392186|NCT04796012|Antimitotic Agents|antimitotic agents|mesh-ancestor
101392187|NCT04796012|Mitosis Modulators|mitosis modulators|mesh-ancestor
101392188|NCT04796012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101439971|NCT04796948|Levoleucovorin|levoleucovorin|mesh-list
101439972|NCT04796948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101392232|NCT04757883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392253|NCT04739761|Immunoconjugates|immunoconjugates|mesh-ancestor
101392254|NCT04739761|Immunologic Factors|immunologic factors|mesh-ancestor
101362883|NCT03399838|GABA Modulators|gaba modulators|mesh-ancestor
101392255|NCT04739761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392259|NCT04736199|Androgens|androgens|mesh-list
101392260|NCT04736199|Hormones|hormones|mesh-ancestor
101392261|NCT04736199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101392262|NCT04736199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392269|NCT04722172|Obinutuzumab|obinutuzumab|mesh-list
101392270|NCT04722172|Acalabrutinib|acalabrutinib|mesh-list
101392271|NCT04722172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101392272|NCT04722172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392273|NCT04721353|Prazosin|prazosin|mesh-list
101392274|NCT04721353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101392275|NCT04721353|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101392291|NCT04711252|Hormones|hormones|mesh-list
101392292|NCT04711252|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101392293|NCT04711252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101392294|NCT04711252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392295|NCT04711252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392296|NCT04711252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101439973|NCT04796948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439974|NCT04796948|Antimetabolites|antimetabolites|mesh-ancestor
101439975|NCT04796948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439976|NCT04796948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101439977|NCT04796948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439978|NCT04796948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101439979|NCT04796948|Immunologic Factors|immunologic factors|mesh-ancestor
101439980|NCT04796948|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101392297|NCT04711252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101392298|NCT04711252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392299|NCT04711252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101392300|NCT04711252|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101392301|NCT04711252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101392302|NCT04711252|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101392303|NCT04711252|Hormone Antagonists|hormone antagonists|mesh-ancestor
101392304|NCT04708145|Aflibercept|aflibercept|mesh-list
101392305|NCT04708145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101392306|NCT04708145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101305575|NCT02020213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101179303|NCT02330094|Antimanic Agents|antimanic agents|mesh-ancestor
101392307|NCT04708145|Growth Substances|growth substances|mesh-ancestor
101392308|NCT04708145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392309|NCT04708145|Growth Inhibitors|growth inhibitors|mesh-ancestor
101392310|NCT04708145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392311|NCT04708067|Atezolizumab|atezolizumab|mesh-list
101392312|NCT04708067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101392313|NCT04708067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392314|NCT04708067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101392315|NCT04708067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392325|NCT04696055|Pembrolizumab|pembrolizumab|mesh-list
101392326|NCT04696055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101392327|NCT04696055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392328|NCT04696055|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101392329|NCT04696055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392330|NCT04694846|Bupropion|bupropion|mesh-list
101392331|NCT04694846|Nicotine|nicotine|mesh-list
101392332|NCT04694846|Varenicline|varenicline|mesh-list
101392333|NCT04694846|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101189270|NCT00003606|Etoposide|etoposide|mesh-list
101439981|NCT04796948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101439982|NCT04796948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101439983|NCT04796948|Antidotes|antidotes|mesh-ancestor
101439984|NCT04796948|Protective Agents|protective agents|mesh-ancestor
101439985|NCT04796948|Vitamin B Complex|vitamin b complex|mesh-ancestor
101439986|NCT04796948|Vitamins|vitamins|mesh-ancestor
101439987|NCT04796948|Micronutrients|micronutrients|mesh-ancestor
101439988|NCT04722146|Lenalidomide|lenalidomide|mesh-list
101439989|NCT04722146|Pomalidomide|pomalidomide|mesh-list
101439990|NCT04722146|Bortezomib|bortezomib|mesh-list
101439991|NCT04722146|Daratumumab|daratumumab|mesh-list
101439992|NCT04722146|Nirogacestat|nirogacestat|mesh-list
101439993|NCT04722146|Immunologic Factors|immunologic factors|mesh-ancestor
101439994|NCT04722146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392335|NCT04694846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101392336|NCT04694846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392337|NCT04694846|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101392338|NCT04694846|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101392339|NCT04694846|Cholinergic Agents|cholinergic agents|mesh-ancestor
101392340|NCT04694846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101392341|NCT04694846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392342|NCT04694846|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101392345|NCT04694846|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101392346|NCT04694846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101392347|NCT04694846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101392348|NCT04694846|Dopamine Agents|dopamine agents|mesh-ancestor
101392349|NCT04694846|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101392350|NCT04694846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101392351|NCT04694846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101392352|NCT04692103|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101392353|NCT04692103|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101392354|NCT04692103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392356|NCT04686305|Trastuzumab|trastuzumab|mesh-list
101392357|NCT04686305|Pemetrexed|pemetrexed|mesh-list
101392358|NCT04686305|Durvalumab|durvalumab|mesh-list
101392359|NCT04686305|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
101392360|NCT04686305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392361|NCT04686305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101392362|NCT04686305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101392363|NCT04686305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392364|NCT04686305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101392365|NCT04686305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101392366|NCT04686305|Immunoconjugates|immunoconjugates|mesh-ancestor
101392367|NCT04686305|Immunologic Factors|immunologic factors|mesh-ancestor
101439995|NCT04722146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101439996|NCT04722146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101440005|NCT04692467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101440006|NCT04692467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101440007|NCT04692467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440011|NCT04692077|Tenofovir|tenofovir|mesh-list
101440012|NCT04692077|Emtricitabine|emtricitabine|mesh-list
101440013|NCT04692077|Cabotegravir|cabotegravir|mesh-list
101440014|NCT04692077|Antiviral Agents|antiviral agents|mesh-ancestor
101392368|NCT04686305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392370|NCT04685135|Adagrasib|adagrasib|mesh-list
101392371|NCT04685135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392372|NCT04685135|Tubulin Modulators|tubulin modulators|mesh-ancestor
101392373|NCT04685135|Antimitotic Agents|antimitotic agents|mesh-ancestor
101392374|NCT04685135|Mitosis Modulators|mitosis modulators|mesh-ancestor
101392375|NCT04685135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392376|NCT04680052|Rituximab|rituximab|mesh-list
101392377|NCT04680052|Lenalidomide|lenalidomide|mesh-list
101392378|NCT04680052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101392379|NCT04680052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392380|NCT04680052|Immunologic Factors|immunologic factors|mesh-ancestor
101392381|NCT04680052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392382|NCT04680052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101392383|NCT04680052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101392384|NCT04680052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101392385|NCT04680052|Growth Substances|growth substances|mesh-ancestor
101392386|NCT04680052|Growth Inhibitors|growth inhibitors|mesh-ancestor
101392387|NCT04676646|Spironolactone|spironolactone|mesh-list
101392388|NCT04676646|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101392389|NCT04676646|Hormone Antagonists|hormone antagonists|mesh-ancestor
101305576|NCT02020213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392390|NCT04676646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101392391|NCT04676646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392392|NCT04676646|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101392393|NCT04676646|Diuretics|diuretics|mesh-ancestor
101392394|NCT04676646|Natriuretic Agents|natriuretic agents|mesh-ancestor
101392395|NCT04671615|Palbociclib|palbociclib|mesh-list
101392396|NCT04671615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392397|NCT04671615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101440015|NCT04692077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101440016|NCT04692077|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101440017|NCT04692077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101440018|NCT04692077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101440019|NCT04692077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440020|NCT04692077|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101440021|NCT04692077|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101307783|NCT02043223|Micronutrients|micronutrients|mesh-ancestor
101307784|NCT02043223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307785|NCT02043223|Antioxidants|antioxidants|mesh-ancestor
101646161|NCT00605774|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101392398|NCT04671615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101392399|NCT04671615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392400|NCT04665843|Atezolizumab|atezolizumab|mesh-list
101392401|NCT04665843|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101392402|NCT04665843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392403|NCT04665843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101392404|NCT04665843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392405|NCT04661150|Capecitabine|capecitabine|mesh-list
101392406|NCT04661150|Oxaliplatin|oxaliplatin|mesh-list
101392407|NCT04661150|Trastuzumab|trastuzumab|mesh-list
101392408|NCT04661150|Atezolizumab|atezolizumab|mesh-list
101392409|NCT04661150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101392410|NCT04661150|Antimetabolites|antimetabolites|mesh-ancestor
101392411|NCT04661150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392412|NCT04661150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392413|NCT04661150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101392418|NCT04659382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392419|NCT04659382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101392420|NCT04659382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101392421|NCT04659382|Growth Substances|growth substances|mesh-ancestor
101392422|NCT04659382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392423|NCT04659382|Growth Inhibitors|growth inhibitors|mesh-ancestor
101392424|NCT04659382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101392425|NCT04659382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392426|NCT04652700|Tenofovir|tenofovir|mesh-list
101392427|NCT04652700|Emtricitabine|emtricitabine|mesh-list
101392428|NCT04652700|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101392429|NCT04652700|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
101392430|NCT04652700|Antiviral Agents|antiviral agents|mesh-ancestor
101392431|NCT04652700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101392432|NCT04652700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101392433|NCT04652700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101189365|NCT00003696|Doxorubicin|doxorubicin|mesh-list
101307786|NCT02043223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307787|NCT02043223|Protective Agents|protective agents|mesh-ancestor
101307788|NCT02043223|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101392434|NCT04652700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101392435|NCT04652700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392437|NCT04652700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101392438|NCT04651088|Potassium Citrate|potassium citrate|mesh-list
101392439|NCT04651088|Diuretics|diuretics|mesh-ancestor
101392440|NCT04651088|Natriuretic Agents|natriuretic agents|mesh-ancestor
101392441|NCT04651088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392442|NCT04651088|Expectorants|expectorants|mesh-ancestor
101392443|NCT04651088|Respiratory System Agents|respiratory system agents|mesh-ancestor
101392444|NCT04650854|Rozanolixizumab|rozanolixizumab|mesh-list
101392445|NCT04650854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101392446|NCT04650854|Immunologic Factors|immunologic factors|mesh-ancestor
101392447|NCT04650854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392448|NCT04647084|Lidocaine|lidocaine|mesh-list
101392449|NCT04647084|Anesthetics, Local|anesthetics, local|mesh-ancestor
101392450|NCT04647084|Anesthetics|anesthetics|mesh-ancestor
101392451|NCT04647084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101392452|NCT04647084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392453|NCT04647084|Sensory System Agents|sensory system agents|mesh-ancestor
101392454|NCT04647084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101392455|NCT04647084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101392456|NCT04647084|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101392457|NCT04647084|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101392458|NCT04647084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101392459|NCT04647084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305577|NCT02020213|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101305578|NCT02020213|Hormone Antagonists|hormone antagonists|mesh-ancestor
101333848|NCT00041275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101392460|NCT04643379|Carboplatin|carboplatin|mesh-list
101392461|NCT04643379|Pembrolizumab|pembrolizumab|mesh-list
101392463|NCT04643379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101307789|NCT02043223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101307790|NCT02043288|Gemcitabine|gemcitabine|mesh-list
101307791|NCT02043288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101307792|NCT02043288|Antimetabolites|antimetabolites|mesh-ancestor
101307793|NCT02043288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307794|NCT02043288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101307795|NCT02043314|Isoniazid|isoniazid|mesh-list
101307796|NCT02043314|Antitubercular Agents|antitubercular agents|mesh-ancestor
101307797|NCT02043314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101307798|NCT02043314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101392464|NCT04643379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101392465|NCT04643379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101392466|NCT04643379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392467|NCT04643379|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101392468|NCT04643379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101392469|NCT04630756|Acalabrutinib|acalabrutinib|mesh-list
101392470|NCT04630756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392471|NCT04630002|Ritonavir|ritonavir|mesh-list
101392472|NCT04630002|Darunavir|darunavir|mesh-list
101392473|NCT04630002|Etravirine|etravirine|mesh-list
101392474|NCT04630002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101392475|NCT04630002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101392476|NCT04630002|Protease Inhibitors|protease inhibitors|mesh-ancestor
101392477|NCT04630002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101392478|NCT04630002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392479|NCT04630002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101392480|NCT04630002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101392481|NCT04630002|Antiviral Agents|antiviral agents|mesh-ancestor
101392482|NCT04630002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101392485|NCT04630002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101392486|NCT04630002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101392487|NCT04629248|Acetaminophen|acetaminophen|mesh-list
101392488|NCT04629248|Diphenhydramine|diphenhydramine|mesh-list
101307799|NCT02043314|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101307800|NCT02043314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101307801|NCT02043314|Antimetabolites|antimetabolites|mesh-ancestor
101440022|NCT04692077|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101440023|NCT04692077|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101440024|NCT04683029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101440025|NCT04683029|Immunologic Factors|immunologic factors|mesh-ancestor
101440026|NCT04683029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440028|NCT04673357|Dermatologic Agents|dermatologic agents|mesh-ancestor
101440029|NCT04658862|Gemcitabine|gemcitabine|mesh-list
101440030|NCT04658862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440031|NCT04658862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101440032|NCT04658862|Antimetabolites|antimetabolites|mesh-ancestor
101440033|NCT04658862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440034|NCT04640623|Gemcitabine|gemcitabine|mesh-list
101440035|NCT04640623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101440036|NCT04640623|Antimetabolites|antimetabolites|mesh-ancestor
101440037|NCT04640623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440038|NCT04640623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440039|NCT04633239|Olaparib|olaparib|mesh-list
101440040|NCT04633239|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
101440041|NCT04633239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101440042|NCT04633239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440043|NCT04633239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440044|NCT04630028|Ustekinumab|ustekinumab|mesh-list
101440045|NCT04630028|Dermatologic Agents|dermatologic agents|mesh-ancestor
101440046|NCT04626791|Cytarabine|cytarabine|mesh-list
101440047|NCT04626791|Prednisone|prednisone|mesh-list
101440056|NCT04626791|Antibodies|antibodies|mesh-list
101392489|NCT04629248|Promethazine|promethazine|mesh-list
101392490|NCT04629248|Methylprednisolone|methylprednisolone|mesh-list
101392491|NCT04629248|Obinutuzumab|obinutuzumab|mesh-list
101392493|NCT04629248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101392494|NCT04629248|Immunologic Factors|immunologic factors|mesh-ancestor
101392495|NCT04629248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392496|NCT04629248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101392497|NCT04629248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101392498|NCT04629248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392499|NCT04629248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101392500|NCT04629248|Analgesics|analgesics|mesh-ancestor
101392501|NCT04629248|Sensory System Agents|sensory system agents|mesh-ancestor
101392502|NCT04629248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101392503|NCT04629248|Antipyretics|antipyretics|mesh-ancestor
101392504|NCT04629248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101392505|NCT04629248|Antiemetics|antiemetics|mesh-ancestor
101392506|NCT04629248|Autonomic Agents|autonomic agents|mesh-ancestor
101392507|NCT04629248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101392508|NCT04629248|Glucocorticoids|glucocorticoids|mesh-ancestor
101392510|NCT04629248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101392511|NCT04629248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101392512|NCT04629248|Protective Agents|protective agents|mesh-ancestor
101392513|NCT04629248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392514|NCT04629248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101392515|NCT04629248|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101392516|NCT04629248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101392517|NCT04629248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101392518|NCT04629248|Anesthetics, Local|anesthetics, local|mesh-ancestor
101392519|NCT04629248|Anesthetics|anesthetics|mesh-ancestor
101392520|NCT04629248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101440057|NCT04626791|Immunoglobulins|immunoglobulins|mesh-list
101440058|NCT04626791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101440059|NCT04626791|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101440060|NCT04626791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101440061|NCT04626791|Immunologic Factors|immunologic factors|mesh-ancestor
101307802|NCT02043314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307803|NCT02043314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101307804|NCT02043340|Photosensitizing Agents|photosensitizing agents|mesh-list
101440062|NCT04626791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440063|NCT04626791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101440064|NCT04626791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101440065|NCT04626791|Alkylating Agents|alkylating agents|mesh-ancestor
101392521|NCT04629248|Histamine Antagonists|histamine antagonists|mesh-ancestor
101392522|NCT04629248|Histamine Agents|histamine agents|mesh-ancestor
101392523|NCT04629248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101392524|NCT04629248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101392525|NCT04629248|Antipruritics|antipruritics|mesh-ancestor
101392526|NCT04629248|Dermatologic Agents|dermatologic agents|mesh-ancestor
101392527|NCT04626128|Aflibercept|aflibercept|mesh-list
101392528|NCT04626128|Axitinib|axitinib|mesh-list
101392529|NCT04626128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101392530|NCT04626128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101392531|NCT04626128|Growth Substances|growth substances|mesh-ancestor
101392532|NCT04626128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305579|NCT02020213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101392533|NCT04626128|Growth Inhibitors|growth inhibitors|mesh-ancestor
101392534|NCT04626128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392535|NCT04626128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101392536|NCT04626128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101392537|NCT04626128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392539|NCT04619797|Pembrolizumab|pembrolizumab|mesh-list
101392540|NCT04619797|Pemetrexed|pemetrexed|mesh-list
101392541|NCT04619797|Atezolizumab|atezolizumab|mesh-list
101392542|NCT04619797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392543|NCT04619797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101392544|NCT04619797|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101440066|NCT04626791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440067|NCT04626791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440068|NCT04626791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101440069|NCT04626791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101440070|NCT04626791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101440071|NCT04626791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101440072|NCT04626791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101440073|NCT04626791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101440074|NCT04626791|Glucocorticoids|glucocorticoids|mesh-ancestor
101440075|NCT04626791|Hormones|hormones|mesh-ancestor
101440076|NCT04626791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101440077|NCT04626791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101440078|NCT04626791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101440079|NCT04626791|Antimetabolites|antimetabolites|mesh-ancestor
101440080|NCT04626791|Antiviral Agents|antiviral agents|mesh-ancestor
101440089|NCT04606381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101440090|NCT04606381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440091|NCT04599855|Esketamine|esketamine|mesh-list
101440092|NCT04599855|Antidepressive Agents|antidepressive agents|mesh-ancestor
101440093|NCT04599855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101440094|NCT04586426|Daratumumab|daratumumab|mesh-list
101440095|NCT04586426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440096|NCT04585789|Tenofovir|tenofovir|mesh-list
101440097|NCT04585789|Entecavir|entecavir|mesh-list
101440098|NCT04585789|JNJ-56136379|jnj-56136379|mesh-list
101440099|NCT04585789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101392545|NCT04619797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392547|NCT04619797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101392548|NCT04619797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101392549|NCT04612751|Carboplatin|carboplatin|mesh-list
101392550|NCT04612751|Durvalumab|durvalumab|mesh-list
101392551|NCT04612751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392552|NCT04612751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101392553|NCT04609878|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101392554|NCT04609878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101392555|NCT04609878|Respiratory System Agents|respiratory system agents|mesh-ancestor
101392558|NCT04605731|Tremelimumab|tremelimumab|mesh-list
101392559|NCT04605731|Immunoglobulins|immunoglobulins|mesh-list
101392560|NCT04605731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101392561|NCT04605731|Immunoglobulin G|immunoglobulin g|mesh-list
101392562|NCT04605731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101392563|NCT04605731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392564|NCT04605731|Immunologic Factors|immunologic factors|mesh-ancestor
101392565|NCT04605731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392566|NCT04605731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101392567|NCT04605731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392568|NCT04605393|Dronabinol|dronabinol|mesh-list
101392569|NCT04605393|Cannabidiol|cannabidiol|mesh-list
101392570|NCT04605393|Anticonvulsants|anticonvulsants|mesh-ancestor
101392571|NCT04605393|Hallucinogens|hallucinogens|mesh-ancestor
101392572|NCT04605393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392573|NCT04605393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101392574|NCT04605393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101392575|NCT04605393|Analgesics|analgesics|mesh-ancestor
101189516|NCT00003852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440100|NCT04585789|Antiviral Agents|antiviral agents|mesh-ancestor
101440101|NCT04585789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101440102|NCT04585789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101440103|NCT04585789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101440104|NCT04585789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101440105|NCT04585789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440106|NCT04585789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101440107|NCT04585789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101440108|NCT04579224|Paclitaxel|paclitaxel|mesh-list
101440109|NCT04579224|Docetaxel|docetaxel|mesh-list
101440110|NCT04579224|Halichondrin B|halichondrin b|mesh-list
101440111|NCT04579224|Gemcitabine|gemcitabine|mesh-list
101440112|NCT04579224|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101646162|NCT04264286|Esmolol|esmolol|mesh-list
101392576|NCT04605393|Sensory System Agents|sensory system agents|mesh-ancestor
101392577|NCT04605393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101392578|NCT04605393|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101392579|NCT04605393|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101392580|NCT04605393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101392581|NCT04605393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392582|NCT04605393|Hormones|hormones|mesh-ancestor
101392583|NCT04605393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101392584|NCT04603807|Crizotinib|crizotinib|mesh-list
101392585|NCT04603807|Entrectinib|entrectinib|mesh-list
101392586|NCT04603807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392587|NCT04603807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101392588|NCT04603807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101392589|NCT04603807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392590|NCT04587427|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
101392591|NCT04587427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392592|NCT04580121|Acetaminophen|acetaminophen|mesh-list
101392593|NCT04580121|Diphenhydramine|diphenhydramine|mesh-list
101392594|NCT04580121|Promethazine|promethazine|mesh-list
101392595|NCT04580121|Dexamethasone|dexamethasone|mesh-list
101392596|NCT04580121|Dasatinib|dasatinib|mesh-list
101392597|NCT04580121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101392598|NCT04580121|Antiemetics|antiemetics|mesh-ancestor
101392599|NCT04580121|Autonomic Agents|autonomic agents|mesh-ancestor
101392600|NCT04580121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101392601|NCT04580121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189547|NCT00003870|Alkylating Agents|alkylating agents|mesh-ancestor
101440113|NCT04579224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101440114|NCT04579224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440115|NCT04579224|Tubulin Modulators|tubulin modulators|mesh-ancestor
101440116|NCT04579224|Antimitotic Agents|antimitotic agents|mesh-ancestor
101440117|NCT04579224|Mitosis Modulators|mitosis modulators|mesh-ancestor
101440118|NCT04579224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440119|NCT04579224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101440120|NCT04579224|Antimetabolites|antimetabolites|mesh-ancestor
101440121|NCT04577833|Prednisone|prednisone|mesh-list
101440122|NCT04577833|Abiraterone Acetate|abiraterone acetate|mesh-list
101440129|NCT04577833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101440130|NCT04577833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440131|NCT04577833|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101440132|NCT04577833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101440133|NCT04577833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440134|NCT04577833|Hormone Antagonists|hormone antagonists|mesh-ancestor
101440135|NCT04577833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101440136|NCT04577833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101307805|NCT02043340|Dermatologic Agents|dermatologic agents|mesh-ancestor
101307807|NCT02043717|Vitamins|vitamins|mesh-ancestor
101392602|NCT04580121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101392603|NCT04580121|Glucocorticoids|glucocorticoids|mesh-ancestor
101392605|NCT04580121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101392606|NCT04580121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101305580|NCT02020213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305581|NCT02020330|Lumefantrine|lumefantrine|mesh-list
101305582|NCT02020330|Artemether|artemether|mesh-list
101179595|NCT05602272|Anesthetics|anesthetics|mesh-list
101392607|NCT04580121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392608|NCT04580121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101392609|NCT04580121|Analgesics|analgesics|mesh-ancestor
101392610|NCT04580121|Sensory System Agents|sensory system agents|mesh-ancestor
101392611|NCT04580121|Antipyretics|antipyretics|mesh-ancestor
101392612|NCT04580121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101392613|NCT04580121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101392619|NCT04580121|Anesthetics|anesthetics|mesh-ancestor
101392666|NCT04566133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101392667|NCT04566133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392668|NCT04566133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101392669|NCT04558736|Cyclophosphamide|cyclophosphamide|mesh-list
101392670|NCT04558736|Fludarabine|fludarabine|mesh-list
101392671|NCT04558736|Thymoglobulin|thymoglobulin|mesh-list
101392672|NCT04558736|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101392673|NCT04558736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101392674|NCT04558736|Immunologic Factors|immunologic factors|mesh-ancestor
101392675|NCT04558736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392676|NCT04558736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101392677|NCT04558736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101392678|NCT04558736|Alkylating Agents|alkylating agents|mesh-ancestor
101392679|NCT04558736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392680|NCT04558736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392681|NCT04558736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101392682|NCT04543617|Atezolizumab|atezolizumab|mesh-list
101392683|NCT04543617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101456558|NCT00216827|Betamethasone Valerate|betamethasone valerate|mesh-list
101305583|NCT02020330|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101305584|NCT02020330|Antimalarials|antimalarials|mesh-ancestor
101305585|NCT02020330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101305586|NCT02020330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101305587|NCT02020330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101305588|NCT02020499|Lanreotide|lanreotide|mesh-list
101392684|NCT04543617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101392685|NCT04543617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392686|NCT04543617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101392710|NCT04528082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101392711|NCT04528082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101392712|NCT04528082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392713|NCT04526197|Celecoxib|celecoxib|mesh-list
101392714|NCT04526197|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
101392715|NCT04526197|Choline|choline|mesh-list
101392716|NCT04526197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101392717|NCT04526197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101392718|NCT04526197|Analgesics|analgesics|mesh-ancestor
101392719|NCT04526197|Sensory System Agents|sensory system agents|mesh-ancestor
101392720|NCT04526197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101392721|NCT04526197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392722|NCT04526197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101392723|NCT04526197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101392724|NCT04526197|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101392725|NCT04526197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101392726|NCT04526197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101392727|NCT04526197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392728|NCT04526197|Lipotropic Agents|lipotropic agents|mesh-ancestor
101392729|NCT04526197|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101392730|NCT04526197|Antimetabolites|antimetabolites|mesh-ancestor
101392731|NCT04526197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101392732|NCT04526197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101392733|NCT04526197|Nootropic Agents|nootropic agents|mesh-ancestor
101392734|NCT04526197|Chelating Agents|chelating agents|mesh-ancestor
101392735|NCT04526197|Sequestering Agents|sequestering agents|mesh-ancestor
101392736|NCT04526197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101392737|NCT04526197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101392738|NCT04526197|Growth Substances|growth substances|mesh-ancestor
101392739|NCT04526197|Growth Inhibitors|growth inhibitors|mesh-ancestor
101392740|NCT04526197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392741|NCT04520451|Glucocorticoids|glucocorticoids|mesh-list
101392750|NCT04513925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392751|NCT04513522|Nivolumab|nivolumab|mesh-list
101305589|NCT02020499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101305590|NCT02020551|Lidocaine|lidocaine|mesh-list
101392752|NCT04513522|Ipilimumab|ipilimumab|mesh-list
101392753|NCT04513522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101392754|NCT04513522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392755|NCT04513522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101392756|NCT04513522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392757|NCT04501614|Ponatinib|ponatinib|mesh-list
101392758|NCT04501614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392759|NCT04501614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101392760|NCT04501614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101392761|NCT04501614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392762|NCT04454203|Anesthetics|anesthetics|mesh-list
101392763|NCT04454203|Mepivacaine|mepivacaine|mesh-list
101392764|NCT04454203|Anesthetics, Local|anesthetics, local|mesh-list
101392765|NCT04454203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101392766|NCT04454203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392767|NCT04454203|Sensory System Agents|sensory system agents|mesh-ancestor
101392768|NCT04454203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101392769|NCT04449874|Bevacizumab|bevacizumab|mesh-list
101392777|NCT04449874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101392779|NCT04449874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392780|NCT04449874|Growth Inhibitors|growth inhibitors|mesh-ancestor
101392781|NCT04449874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101392782|NCT04449874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101392784|NCT04449874|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101392803|NCT04447027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101392804|NCT04447027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101392805|NCT04447027|Growth Substances|growth substances|mesh-ancestor
101392806|NCT04447027|Growth Inhibitors|growth inhibitors|mesh-ancestor
101392807|NCT04447027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101392808|NCT04447027|Antimetabolites|antimetabolites|mesh-ancestor
101392809|NCT04447027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392810|NCT04447027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101392811|NCT04447027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101392812|NCT04447027|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101392813|NCT04445688|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101392814|NCT04445688|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101392815|NCT04445688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101392816|NCT04445688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101392817|NCT04445688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392818|NCT04445688|Adrenergic Agents|adrenergic agents|mesh-ancestor
101392819|NCT04445688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101392820|NCT04445688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392821|NCT04434664|Metoprolol|metoprolol|mesh-list
101392822|NCT04434664|Amlodipine|amlodipine|mesh-list
101392823|NCT04434664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101392824|NCT04434664|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101392897|NCT04404088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392898|NCT04400175|Silicon|silicon|mesh-list
101392899|NCT04400175|Trace Elements|trace elements|mesh-ancestor
101392900|NCT04400175|Micronutrients|micronutrients|mesh-ancestor
101392901|NCT04400175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392902|NCT04396873|11C-PS13|11c-ps13|mesh-list
101392903|NCT04396873|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101392904|NCT04396873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392905|NCT04360551|Telmisartan|telmisartan|mesh-list
101392906|NCT04360551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101392907|NCT04360551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101392908|NCT04360551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101392909|NCT04360551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392910|NCT04341571|Metformin|metformin|mesh-list
101392911|NCT04341571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101392912|NCT04341571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392913|NCT04333576|Contraceptive Agents|contraceptive agents|mesh-list
101392914|NCT04333576|Contraceptives, Oral|contraceptives, oral|mesh-list
101392915|NCT04333576|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
101392916|NCT04333576|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101392917|NCT04333576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392918|NCT04333576|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101392919|NCT04303858|Atezolizumab|atezolizumab|mesh-list
101392920|NCT04303858|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101392921|NCT04303858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392922|NCT04303858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101392923|NCT04303858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392924|NCT04302025|Atezolizumab|atezolizumab|mesh-list
101392925|NCT04302025|Vemurafenib|vemurafenib|mesh-list
101392926|NCT04302025|Pralsetinib|pralsetinib|mesh-list
101392927|NCT04302025|Entrectinib|entrectinib|mesh-list
101392936|NCT04294810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392937|NCT04294810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101392938|NCT04294810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392940|NCT04294628|Camptothecin|camptothecin|mesh-list
101392941|NCT04294628|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
101392942|NCT04294628|Immunoconjugates|immunoconjugates|mesh-list
101392943|NCT04294628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101392944|NCT04294628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392945|NCT04294628|Immunologic Factors|immunologic factors|mesh-ancestor
101392946|NCT04294628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392947|NCT04294628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101392948|NCT04294628|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101392951|NCT04294628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392952|NCT04291703|Thymoglobulin|thymoglobulin|mesh-list
101392953|NCT04291703|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101392954|NCT04291703|Immunologic Factors|immunologic factors|mesh-ancestor
101392955|NCT04291703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392956|NCT04291703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101392957|NCT04288778|Metformin|metformin|mesh-list
101392958|NCT04288778|Canagliflozin|canagliflozin|mesh-list
101392959|NCT04288778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101392960|NCT04288778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392961|NCT04288778|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101392986|NCT04270409|Growth Inhibitors|growth inhibitors|mesh-ancestor
101392987|NCT04262687|Bevacizumab|bevacizumab|mesh-list
101392988|NCT04262687|Pembrolizumab|pembrolizumab|mesh-list
101392989|NCT04262687|Capecitabine|capecitabine|mesh-list
101392990|NCT04262687|Oxaliplatin|oxaliplatin|mesh-list
101392991|NCT04262687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101392992|NCT04262687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392993|NCT04262687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101392994|NCT04262687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101392995|NCT04262687|Growth Substances|growth substances|mesh-ancestor
101392996|NCT04262687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392997|NCT04262687|Growth Inhibitors|growth inhibitors|mesh-ancestor
101392998|NCT04262687|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101392999|NCT04262687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393000|NCT04262687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101393001|NCT04262687|Antimetabolites|antimetabolites|mesh-ancestor
101305598|NCT02020551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101305599|NCT02020551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101179958|NCT05425056|Sirolimus|sirolimus|mesh-list
101393002|NCT04246697|Acetaminophen|acetaminophen|mesh-list
101393003|NCT04246697|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101393004|NCT04246697|Morphine|morphine|mesh-list
101393005|NCT04246697|Oxycodone|oxycodone|mesh-list
101393006|NCT04246697|Gabapentin|gabapentin|mesh-list
101393007|NCT04246697|Bupivacaine|bupivacaine|mesh-list
101393008|NCT04246697|Anesthetics, Local|anesthetics, local|mesh-ancestor
101393009|NCT04246697|Anesthetics|anesthetics|mesh-ancestor
101393010|NCT04246697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101393011|NCT04246697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393012|NCT04246697|Sensory System Agents|sensory system agents|mesh-ancestor
101393013|NCT04246697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101393014|NCT04246697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101393015|NCT04246697|Narcotics|narcotics|mesh-ancestor
101393037|NCT04240002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101393038|NCT04240002|Antimetabolites|antimetabolites|mesh-ancestor
101393039|NCT04240002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393040|NCT04240002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101393041|NCT04240002|Immunologic Factors|immunologic factors|mesh-ancestor
101393042|NCT04240002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393043|NCT04240002|Antiviral Agents|antiviral agents|mesh-ancestor
101393044|NCT04240002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101393045|NCT04240002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101393046|NCT04233164|Methylprednisolone|methylprednisolone|mesh-list
101393047|NCT04233164|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101393048|NCT04233164|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101393049|NCT04233164|Prednisolone|prednisolone|mesh-list
101393050|NCT04233164|Prednisolone acetate|prednisolone acetate|mesh-list
101393051|NCT04233164|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101393052|NCT04233164|Prednisolone phosphate|prednisolone phosphate|mesh-list
101393053|NCT04233164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101393054|NCT04233164|Antiemetics|antiemetics|mesh-ancestor
101393055|NCT04233164|Autonomic Agents|autonomic agents|mesh-ancestor
101393056|NCT04233164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101393057|NCT04233164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393058|NCT04233164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101393059|NCT04233164|Glucocorticoids|glucocorticoids|mesh-ancestor
101393060|NCT04233164|Hormones|hormones|mesh-ancestor
101393061|NCT04233164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101393062|NCT04233164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101393063|NCT04233164|Protective Agents|protective agents|mesh-ancestor
101393064|NCT04233164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101393065|NCT04233164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393066|NCT04230265|Cyclophosphamide|cyclophosphamide|mesh-list
101393067|NCT04230265|Fludarabine|fludarabine|mesh-list
101393068|NCT04230265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101393069|NCT04230265|Immunologic Factors|immunologic factors|mesh-ancestor
101393070|NCT04230265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393071|NCT04230265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101393072|NCT04230265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101307808|NCT02043717|Micronutrients|micronutrients|mesh-ancestor
101307809|NCT02043717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190004|NCT00004206|Protective Agents|protective agents|mesh-ancestor
101393073|NCT04230265|Alkylating Agents|alkylating agents|mesh-ancestor
101393074|NCT04230265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393075|NCT04230265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393076|NCT04230265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101393077|NCT04227275|Cyclophosphamide|cyclophosphamide|mesh-list
101393078|NCT04227275|Fludarabine|fludarabine|mesh-list
101393079|NCT04227275|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101393080|NCT04227275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101393081|NCT04227275|Immunologic Factors|immunologic factors|mesh-ancestor
101333849|NCT00041275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393082|NCT04227275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393083|NCT04227275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101393084|NCT04227275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101393085|NCT04227275|Alkylating Agents|alkylating agents|mesh-ancestor
101393086|NCT04227275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393087|NCT04227275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393088|NCT04227275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101393099|NCT04224493|Growth Inhibitors|growth inhibitors|mesh-ancestor
101393100|NCT04222023|Immunoglobulins|immunoglobulins|mesh-list
101393101|NCT04222023|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101393103|NCT04222023|gamma-Globulins|gamma-globulins|mesh-list
101393131|NCT04209504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101393133|NCT04198649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101393134|NCT04198649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101393135|NCT04194944|Carboplatin|carboplatin|mesh-list
101393136|NCT04194944|Pembrolizumab|pembrolizumab|mesh-list
101393137|NCT04194944|Pemetrexed|pemetrexed|mesh-list
101393138|NCT04194944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393139|NCT04194944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101393140|NCT04194944|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101393141|NCT04194944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393142|NCT04194944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101393143|NCT04194944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101393144|NCT04194944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101393145|NCT04191499|Fulvestrant|fulvestrant|mesh-list
101393146|NCT04191499|Palbociclib|palbociclib|mesh-list
101393147|NCT04191499|Inavolisib|inavolisib|mesh-list
101393148|NCT04191499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101393149|NCT04191499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393150|NCT04191499|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101393151|NCT04191499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101393152|NCT04191499|Hormone Antagonists|hormone antagonists|mesh-ancestor
101393153|NCT04191499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101393154|NCT04191499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393155|NCT04191499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101393157|NCT04191499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393158|NCT04191499|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
101393159|NCT04177706|Ketamine|ketamine|mesh-list
101393160|NCT04177706|Analgesics|analgesics|mesh-ancestor
101393161|NCT04177706|Sensory System Agents|sensory system agents|mesh-ancestor
101393162|NCT04177706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101305601|NCT02020551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393170|NCT04177706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101393171|NCT04177706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101393172|NCT04177706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393174|NCT04177004|Cyclophosphamide|cyclophosphamide|mesh-list
101393175|NCT04177004|Etoposide|etoposide|mesh-list
101393176|NCT04177004|Etoposide phosphate|etoposide phosphate|mesh-list
101393177|NCT04177004|Podophyllotoxin|podophyllotoxin|mesh-list
101393178|NCT04177004|Tacrolimus|tacrolimus|mesh-list
101393179|NCT04177004|Mitogens|mitogens|mesh-list
101393180|NCT04177004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101393181|NCT04177004|Immunologic Factors|immunologic factors|mesh-ancestor
101393182|NCT04177004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393183|NCT04177004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101393184|NCT04177004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101393185|NCT04177004|Alkylating Agents|alkylating agents|mesh-ancestor
101393186|NCT04177004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393187|NCT04177004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393188|NCT04177004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101393189|NCT04177004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101393190|NCT04177004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101393191|NCT04177004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101393192|NCT04177004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101393193|NCT04177004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101393194|NCT04177004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101393195|NCT04177004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101393196|NCT04177004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101393197|NCT04177004|Antifungal Agents|antifungal agents|mesh-ancestor
101393198|NCT04177004|Mitosis Modulators|mitosis modulators|mesh-ancestor
101393199|NCT04177004|Keratolytic Agents|keratolytic agents|mesh-ancestor
101393200|NCT04177004|Dermatologic Agents|dermatologic agents|mesh-ancestor
101393201|NCT04177004|Tubulin Modulators|tubulin modulators|mesh-ancestor
101393213|NCT04175613|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101393214|NCT04175613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101393215|NCT04175613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393216|NCT04165772|Capecitabine|capecitabine|mesh-list
101393217|NCT04165772|Dostarlimab|dostarlimab|mesh-list
101393218|NCT04165772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101393219|NCT04165772|Antimetabolites|antimetabolites|mesh-ancestor
101393220|NCT04165772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393221|NCT04165772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393222|NCT04164069|Calcium, Dietary|calcium, dietary|mesh-list
101393224|NCT04164069|Folic Acid|folic acid|mesh-list
101393225|NCT04164069|Bevacizumab|bevacizumab|mesh-list
101393226|NCT04164069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101393227|NCT04164069|Fluorouracil|fluorouracil|mesh-list
101393228|NCT04164069|Oxaliplatin|oxaliplatin|mesh-list
101393229|NCT04164069|Dasatinib|dasatinib|mesh-list
101393230|NCT04164069|Endothelial Growth Factors|endothelial growth factors|mesh-list
101393238|NCT04164069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101393239|NCT04164069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101393241|NCT04164069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393242|NCT04164069|Growth Inhibitors|growth inhibitors|mesh-ancestor
101305603|NCT02020603|Racepinephrine|racepinephrine|mesh-list
101305604|NCT02020603|Hemostatics|hemostatics|mesh-list
101305605|NCT02020603|Epinephryl borate|epinephryl borate|mesh-list
101305606|NCT02020603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101305607|NCT02020603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101305608|NCT02020603|Adrenergic Agents|adrenergic agents|mesh-ancestor
101305618|NCT02020603|Mydriatics|mydriatics|mesh-ancestor
101393252|NCT04164069|Vitamin B Complex|vitamin b complex|mesh-ancestor
101393254|NCT04164069|Micronutrients|micronutrients|mesh-ancestor
101393255|NCT04164069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101393256|NCT04164069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101393257|NCT04164069|Hematinics|hematinics|mesh-ancestor
101393258|NCT04157517|Pembrolizumab|pembrolizumab|mesh-list
101393259|NCT04157517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101393260|NCT04157517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393261|NCT04157517|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101393262|NCT04157517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393263|NCT04152200|Lumasiran|lumasiran|mesh-list
101393264|NCT04152200|Renal Agents|renal agents|mesh-ancestor
101393265|NCT04140487|Azacitidine|azacitidine|mesh-list
101393266|NCT04140487|Venetoclax|venetoclax|mesh-list
101393267|NCT04140487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101393268|NCT04140487|Antimetabolites|antimetabolites|mesh-ancestor
101393269|NCT04140487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393270|NCT04140487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393271|NCT04140487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101393272|NCT04126473|Ivacaftor|ivacaftor|mesh-list
101393273|NCT04126473|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101393274|NCT04126473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101393275|NCT04126473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393276|NCT04124965|Rozanolixizumab|rozanolixizumab|mesh-list
101393277|NCT04124965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101393278|NCT04124965|Immunologic Factors|immunologic factors|mesh-ancestor
101393279|NCT04124965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393280|NCT04119336|Dexamethasone|dexamethasone|mesh-list
101393281|NCT04119336|Cyclophosphamide|cyclophosphamide|mesh-list
101393282|NCT04119336|Nivolumab|nivolumab|mesh-list
101393283|NCT04119336|Ixazomib|ixazomib|mesh-list
101393284|NCT04119336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101393285|NCT04119336|Immunologic Factors|immunologic factors|mesh-ancestor
101393286|NCT04119336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305620|NCT02020603|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101305622|NCT02020629|Lixisenatide|lixisenatide|mesh-list
101393287|NCT04119336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101393288|NCT04119336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101393290|NCT04119336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393291|NCT04119336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393292|NCT04119336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101393293|NCT04119336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101393294|NCT04119336|Antiemetics|antiemetics|mesh-ancestor
101393295|NCT04119336|Autonomic Agents|autonomic agents|mesh-ancestor
101393296|NCT04119336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101393297|NCT04119336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101393298|NCT04119336|Glucocorticoids|glucocorticoids|mesh-ancestor
101393299|NCT04119336|Hormones|hormones|mesh-ancestor
101393300|NCT04119336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101393301|NCT04119336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101393308|NCT04115163|Gemcitabine|gemcitabine|mesh-list
101393309|NCT04115163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101393310|NCT04115163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393311|NCT04115163|Tubulin Modulators|tubulin modulators|mesh-ancestor
101393312|NCT04115163|Antimitotic Agents|antimitotic agents|mesh-ancestor
101393313|NCT04115163|Mitosis Modulators|mitosis modulators|mesh-ancestor
101393314|NCT04115163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393315|NCT04115163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101393316|NCT04115163|Antimetabolites|antimetabolites|mesh-ancestor
101393317|NCT04113018|Dexamethasone|dexamethasone|mesh-list
101393318|NCT04113018|Lenalidomide|lenalidomide|mesh-list
101393319|NCT04113018|Daratumumab|daratumumab|mesh-list
101393320|NCT04113018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101393321|NCT04113018|Antiemetics|antiemetics|mesh-ancestor
101393322|NCT04113018|Autonomic Agents|autonomic agents|mesh-ancestor
101393323|NCT04113018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101393324|NCT04113018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393325|NCT04113018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101393326|NCT04113018|Glucocorticoids|glucocorticoids|mesh-ancestor
101393327|NCT04113018|Hormones|hormones|mesh-ancestor
101393328|NCT04113018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101393329|NCT04113018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101393393|NCT04047797|Glycine Agents|glycine agents|mesh-ancestor
101393394|NCT04047797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101393395|NCT04039867|Gemcitabine|gemcitabine|mesh-list
101393396|NCT04039867|Oxaliplatin|oxaliplatin|mesh-list
101393397|NCT04039867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101393398|NCT04039867|Antimetabolites|antimetabolites|mesh-ancestor
101393399|NCT04039867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393400|NCT04039867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393407|NCT04029038|Cyclophosphamide|cyclophosphamide|mesh-list
101393409|NCT04029038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101393410|NCT04029038|Immunologic Factors|immunologic factors|mesh-ancestor
101393411|NCT04029038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393412|NCT04029038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101393413|NCT04029038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101393414|NCT04029038|Alkylating Agents|alkylating agents|mesh-ancestor
101393415|NCT04029038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393416|NCT04029038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393417|NCT04029038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101393456|NCT03996772|Antithrombins|antithrombins|mesh-ancestor
101305628|NCT02020681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305629|NCT02018796|Misoprostol|misoprostol|mesh-list
101305630|NCT02018796|Mifepristone|mifepristone|mesh-list
101305631|NCT02018796|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101305632|NCT02018796|Abortifacient Agents|abortifacient agents|mesh-ancestor
101305633|NCT02018796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101393457|NCT03996772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101393458|NCT03996772|Protease Inhibitors|protease inhibitors|mesh-ancestor
101393459|NCT03996772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101393460|NCT03996772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393461|NCT03996772|Anticoagulants|anticoagulants|mesh-ancestor
101393462|NCT03996044|Anti-Infective Agents|anti-infective agents|mesh-list
101393463|NCT03996044|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101393464|NCT03984448|Prednisone|prednisone|mesh-list
101393465|NCT03984448|Cortisone|cortisone|mesh-list
101393466|NCT03984448|Cyclophosphamide|cyclophosphamide|mesh-list
101393467|NCT03984448|Rituximab|rituximab|mesh-list
101393468|NCT03984448|Doxorubicin|doxorubicin|mesh-list
101393469|NCT03984448|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101393470|NCT03984448|Etoposide|etoposide|mesh-list
101393511|NCT03971422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393512|NCT03946202|Hydrogen Peroxide|hydrogen peroxide|mesh-list
101393513|NCT03946202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101393514|NCT03946202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101393515|NCT03924869|Pembrolizumab|pembrolizumab|mesh-list
101393516|NCT03924869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101393517|NCT03924869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393518|NCT03924869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101393519|NCT03924869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393520|NCT03908593|Pantoprazole|pantoprazole|mesh-list
101393521|NCT03908593|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101393522|NCT03908593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101393523|NCT03908593|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101393524|NCT03908593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101305634|NCT02018796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305635|NCT02018796|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101305636|NCT02018796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101305637|NCT02018796|Oxytocics|oxytocics|mesh-ancestor
101305638|NCT02018796|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101393525|NCT03908593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393560|NCT03829501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101393561|NCT03829501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393562|NCT03827798|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101393563|NCT03827798|Immunologic Factors|immunologic factors|mesh-ancestor
101393564|NCT03827798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393565|NCT03821792|Prednisone|prednisone|mesh-list
101393566|NCT03821792|Cortisone|cortisone|mesh-list
101393567|NCT03821792|Abiraterone Acetate|abiraterone acetate|mesh-list
101393568|NCT03821792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101393569|NCT03821792|Glucocorticoids|glucocorticoids|mesh-ancestor
101393570|NCT03821792|Hormones|hormones|mesh-ancestor
101393571|NCT03821792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101393572|NCT03821792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393573|NCT03821792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101393574|NCT03821792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393575|NCT03821792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101393576|NCT03821792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101393577|NCT03821792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393578|NCT03821792|Hormone Antagonists|hormone antagonists|mesh-ancestor
101393607|NCT03766126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393608|NCT03766126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101393609|NCT03766126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101393610|NCT03766126|Alkylating Agents|alkylating agents|mesh-ancestor
101393611|NCT03766126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393612|NCT03766126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393613|NCT03766126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101393614|NCT03765788|Prednisolone|prednisolone|mesh-list
101393615|NCT03765788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101393616|NCT03765788|Glucocorticoids|glucocorticoids|mesh-ancestor
101393634|NCT03754725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393636|NCT03748641|Abiraterone Acetate|abiraterone acetate|mesh-list
101393637|NCT03748641|Niraparib|niraparib|mesh-list
101393638|NCT03748641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101393639|NCT03748641|Glucocorticoids|glucocorticoids|mesh-ancestor
101393640|NCT03748641|Hormones|hormones|mesh-ancestor
101393641|NCT03748641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101393642|NCT03748641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393643|NCT03748641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101393644|NCT03748641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393645|NCT03748641|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101393646|NCT03748641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101393647|NCT03748641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393648|NCT03748641|Hormone Antagonists|hormone antagonists|mesh-ancestor
101393649|NCT03748641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101363033|NCT00079638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101393650|NCT03748641|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101393651|NCT03744793|Pemetrexed|pemetrexed|mesh-list
101393652|NCT03744793|Avelumab|avelumab|mesh-list
101393653|NCT03744793|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101393654|NCT03744793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393655|NCT03744793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101393656|NCT03744793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393657|NCT03744793|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101393658|NCT03744793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101393659|NCT03744793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101393688|NCT03724747|BAY 2315497|bay 2315497|mesh-list
101393689|NCT03724747|Immunoconjugates|immunoconjugates|mesh-ancestor
101393690|NCT03724747|Immunologic Factors|immunologic factors|mesh-ancestor
101393691|NCT03724747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393693|NCT03719924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101305641|NCT02018796|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101305642|NCT02018796|Contraceptive Agents|contraceptive agents|mesh-ancestor
101305643|NCT02018796|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101305644|NCT02018796|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101305645|NCT02018796|Hormone Antagonists|hormone antagonists|mesh-ancestor
101305646|NCT02018796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101305647|NCT02018796|Luteolytic Agents|luteolytic agents|mesh-ancestor
101305648|NCT02018796|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101393695|NCT03719924|Tubulin Modulators|tubulin modulators|mesh-ancestor
101393696|NCT03719924|Antimitotic Agents|antimitotic agents|mesh-ancestor
101393697|NCT03719924|Mitosis Modulators|mitosis modulators|mesh-ancestor
101393698|NCT03719924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393700|NCT03713801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101393701|NCT03713801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393702|NCT03712605|Pembrolizumab|pembrolizumab|mesh-list
101393703|NCT03712605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101393704|NCT03712605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393705|NCT03712605|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101393706|NCT03712605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393707|NCT03699995|Lidocaine|lidocaine|mesh-list
101393708|NCT03699995|Anesthetics, Local|anesthetics, local|mesh-ancestor
101393709|NCT03699995|Anesthetics|anesthetics|mesh-ancestor
101393710|NCT03699995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101393711|NCT03699995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393712|NCT03699995|Sensory System Agents|sensory system agents|mesh-ancestor
101393713|NCT03699995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101393714|NCT03699995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101393720|NCT03693677|Gemcitabine|gemcitabine|mesh-list
101393721|NCT03693677|Irinotecan|irinotecan|mesh-list
101393722|NCT03693677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101393723|NCT03693677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393724|NCT03693677|Tubulin Modulators|tubulin modulators|mesh-ancestor
101393725|NCT03693677|Antimitotic Agents|antimitotic agents|mesh-ancestor
101393726|NCT03693677|Mitosis Modulators|mitosis modulators|mesh-ancestor
101393727|NCT03693677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393728|NCT03693677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101393729|NCT03693677|Antimetabolites|antimetabolites|mesh-ancestor
101393730|NCT03693677|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101393731|NCT03693677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101393732|NCT03693677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101393733|NCT03692403|Quinagolide|quinagolide|mesh-list
101393734|NCT03692403|Dopamine Agonists|dopamine agonists|mesh-ancestor
101393735|NCT03692403|Dopamine Agents|dopamine agents|mesh-ancestor
101393736|NCT03692403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101393737|NCT03692403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393738|NCT03692403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393739|NCT03689972|Natalizumab|natalizumab|mesh-list
101393740|NCT03689972|Immunologic Factors|immunologic factors|mesh-ancestor
101393741|NCT03689972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393742|NCT03683433|Azacitidine|azacitidine|mesh-list
101393743|NCT03683433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101393744|NCT03683433|Antimetabolites|antimetabolites|mesh-ancestor
101393745|NCT03683433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393746|NCT03683433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363036|NCT00079638|Vitamins|vitamins|mesh-ancestor
101393747|NCT03683433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101393748|NCT03681184|Lumasiran|lumasiran|mesh-list
101190615|NCT00005022|Etoposide|etoposide|mesh-list
101393762|NCT03649230|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101393763|NCT03649230|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101393764|NCT03649230|Serotonin Agents|serotonin agents|mesh-ancestor
101393765|NCT03649230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101393766|NCT03649230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393769|NCT03635983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393770|NCT03635983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101393771|NCT03635983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393772|NCT03626545|Docetaxel|docetaxel|mesh-list
101393773|NCT03626545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393774|NCT03626545|Tubulin Modulators|tubulin modulators|mesh-ancestor
101393775|NCT03626545|Antimitotic Agents|antimitotic agents|mesh-ancestor
101393776|NCT03626545|Mitosis Modulators|mitosis modulators|mesh-ancestor
101393777|NCT03626545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393778|NCT03620201|Atezolizumab|atezolizumab|mesh-list
101393779|NCT03620201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101393780|NCT03620201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393781|NCT03620201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101393782|NCT03620201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393783|NCT03587662|Gemcitabine|gemcitabine|mesh-list
101393784|NCT03587662|Doxorubicin|doxorubicin|mesh-list
101393785|NCT03587662|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101393786|NCT03587662|Daunorubicin|daunorubicin|mesh-list
101393787|NCT03587662|Ixazomib|ixazomib|mesh-list
101393788|NCT03587662|Glycine|glycine|mesh-list
101393813|NCT03578367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393814|NCT03568656|Atezolizumab|atezolizumab|mesh-list
101393816|NCT03568656|Abiraterone Acetate|abiraterone acetate|mesh-list
101393817|NCT03568656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101393818|NCT03568656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393819|NCT03568656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101393820|NCT03568656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393821|NCT03568656|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101393822|NCT03568656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101305652|NCT02021097|Levonorgestrel|levonorgestrel|mesh-list
101305653|NCT02021097|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101305654|NCT02021097|Estradiol|estradiol|mesh-list
101305655|NCT02021097|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101305656|NCT02021097|Estrogens|estrogens|mesh-ancestor
101393823|NCT03568656|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101393824|NCT03568656|Hormone Antagonists|hormone antagonists|mesh-ancestor
101393825|NCT03568656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101393826|NCT03568656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393827|NCT03568656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101393828|NCT03558867|Metformin|metformin|mesh-list
101393829|NCT03558867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101393830|NCT03558867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393831|NCT03557749|Dimercaprol|dimercaprol|mesh-list
101393832|NCT03557749|Chelating Agents|chelating agents|mesh-ancestor
101393833|NCT03557749|Sequestering Agents|sequestering agents|mesh-ancestor
101393834|NCT03557749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393835|NCT03548064|Vaccines|vaccines|mesh-list
101393858|NCT03512197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393859|NCT03505723|Tranexamic Acid|tranexamic acid|mesh-list
101393860|NCT03505723|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101393861|NCT03505723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101393862|NCT03505723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393863|NCT03505723|Hemostatics|hemostatics|mesh-ancestor
101393864|NCT03505723|Coagulants|coagulants|mesh-ancestor
101393865|NCT03502330|Nivolumab|nivolumab|mesh-list
101393866|NCT03502330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101393867|NCT03502330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393868|NCT03502330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101393869|NCT03502330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393919|NCT03463057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393920|NCT03463057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101393921|NCT03463057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393989|NCT03425838|Hormone Antagonists|hormone antagonists|mesh-ancestor
101393990|NCT03425838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101393991|NCT03425838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393992|NCT03425838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101393993|NCT03425838|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101393994|NCT03425838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101394015|NCT03407144|Prednisolone|prednisolone|mesh-list
101394016|NCT03407144|Cyclophosphamide|cyclophosphamide|mesh-list
101394057|NCT03382834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101394058|NCT03382834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394059|NCT03382834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101394060|NCT03382834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394122|NCT03332667|Vorinostat|vorinostat|mesh-list
101394123|NCT03332667|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
101394124|NCT03332667|Dinutuximab|dinutuximab|mesh-list
101394127|NCT03332667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394128|NCT03332667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394190|NCT03260504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101394192|NCT03260504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101394303|NCT03201965|Hormones|hormones|mesh-ancestor
101394304|NCT03201965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101394305|NCT03201965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101394306|NCT03182244|Cytarabine|cytarabine|mesh-list
101394307|NCT03182244|Fludarabine|fludarabine|mesh-list
101394378|NCT03121586|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101394379|NCT03121586|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101394380|NCT03121586|Serotonin Agents|serotonin agents|mesh-ancestor
101394381|NCT03121586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101394382|NCT03121586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394383|NCT03118492|Mycophenolic Acid|mycophenolic acid|mesh-list
101394384|NCT03118492|Cyclophosphamide|cyclophosphamide|mesh-list
101394386|NCT03118492|Mechlorethamine|mechlorethamine|mesh-list
101394387|NCT03118492|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
101394388|NCT03118492|Fludarabine|fludarabine|mesh-list
101394389|NCT03118492|Tacrolimus|tacrolimus|mesh-list
101394390|NCT03118492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101394434|NCT02973789|Docetaxel|docetaxel|mesh-list
101394540|NCT02861573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101394541|NCT02861573|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101394552|NCT02854436|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101394553|NCT02854436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101394555|NCT02854436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394625|NCT02638701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101394626|NCT02638701|Dermatologic Agents|dermatologic agents|mesh-ancestor
101394627|NCT02638701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101394628|NCT02638701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101394630|NCT02615184|Lansoprazole|lansoprazole|mesh-list
101394631|NCT02615184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101394632|NCT02615184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101394633|NCT02615184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101394634|NCT02615184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101394709|NCT02471391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394722|NCT02426125|Ramucirumab|ramucirumab|mesh-list
101394723|NCT02426125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394724|NCT02426125|Tubulin Modulators|tubulin modulators|mesh-ancestor
101394725|NCT02426125|Antimitotic Agents|antimitotic agents|mesh-ancestor
101394728|NCT02395497|Antibodies|antibodies|mesh-list
101394789|NCT02257736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394790|NCT02257736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101394868|NCT02046395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394869|NCT02046395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101394943|NCT01861106|Fludarabine|fludarabine|mesh-list
101394944|NCT01861106|Fludarabine phosphate|fludarabine phosphate|mesh-list
101394945|NCT01861106|Tacrolimus|tacrolimus|mesh-list
101305714|NCT02021240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101305715|NCT02021240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101305716|NCT02021240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101305717|NCT02021240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101333851|NCT00041275|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101395025|NCT01615029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395026|NCT01615029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101395070|NCT01367301|Antimitotic Agents|antimitotic agents|mesh-ancestor
101395071|NCT01367301|Mitosis Modulators|mitosis modulators|mesh-ancestor
101395072|NCT01367301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395073|NCT01352962|Carboplatin|carboplatin|mesh-list
101395074|NCT01352962|Gemcitabine|gemcitabine|mesh-list
101395079|NCT01352962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395080|NCT01352962|Immunologic Factors|immunologic factors|mesh-ancestor
101395123|NCT01166594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101395124|NCT01166594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101395125|NCT01166594|Growth Substances|growth substances|mesh-ancestor
101395126|NCT01166594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395127|NCT01166594|Growth Inhibitors|growth inhibitors|mesh-ancestor
101395181|NCT00871013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101395182|NCT00871013|Leprostatic Agents|leprostatic agents|mesh-ancestor
101395183|NCT00871013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101395184|NCT00871013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101395185|NCT00871013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101395186|NCT00871013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101395187|NCT00871013|Growth Substances|growth substances|mesh-ancestor
101395188|NCT00871013|Growth Inhibitors|growth inhibitors|mesh-ancestor
101395248|NCT00085202|Tubulin Modulators|tubulin modulators|mesh-ancestor
101395249|NCT00085202|Antimitotic Agents|antimitotic agents|mesh-ancestor
101395250|NCT00085202|Mitosis Modulators|mitosis modulators|mesh-ancestor
101395251|NCT00076310|Cisplatin|cisplatin|mesh-list
101395252|NCT00076310|Docetaxel|docetaxel|mesh-list
101395253|NCT00076310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101395254|NCT00076310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101395255|NCT00076310|Tubulin Modulators|tubulin modulators|mesh-ancestor
101395261|NCT00039130|Leucovorin|leucovorin|mesh-list
101395327|NCT00002889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101395328|NCT00002889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101395329|NCT00002889|Androgen Antagonists|androgen antagonists|mesh-ancestor
101395397|NCT00425152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395398|NCT00425152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101395400|NCT00425152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101395401|NCT00425152|Immunologic Factors|immunologic factors|mesh-ancestor
101395402|NCT00425152|Antidotes|antidotes|mesh-ancestor
101395467|NCT00314548|Urological Agents|urological agents|mesh-ancestor
101395468|NCT00314548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101395470|NCT00314626|Efavirenz|efavirenz|mesh-list
101395471|NCT00314626|Abacavir|abacavir|mesh-list
101395472|NCT00314626|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101395473|NCT00314626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101395539|NCT04943627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101395540|NCT04943627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101395541|NCT04943627|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101395542|NCT04943627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101395549|NCT00314743|Aprepitant|aprepitant|mesh-list
101395607|NCT04928339|Sensory System Agents|sensory system agents|mesh-ancestor
101395608|NCT04928339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101395609|NCT00091104|Aldesleukin|aldesleukin|mesh-list
101395610|NCT00091104|Cyclophosphamide|cyclophosphamide|mesh-list
101395611|NCT00091104|Fludarabine|fludarabine|mesh-list
101395612|NCT00091104|Fludarabine phosphate|fludarabine phosphate|mesh-list
101395613|NCT00091104|Freund's Adjuvant|freund's adjuvant|mesh-list
101395614|NCT00091104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101395615|NCT00091104|Immunologic Factors|immunologic factors|mesh-ancestor
101395616|NCT00091104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395617|NCT00091104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101395618|NCT00091104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101395619|NCT00091104|Alkylating Agents|alkylating agents|mesh-ancestor
101395620|NCT00091104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395621|NCT00091104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101395669|NCT00091143|Fludarabine|fludarabine|mesh-list
101395670|NCT00091143|Fludarabine phosphate|fludarabine phosphate|mesh-list
101395671|NCT00091143|Freund's Adjuvant|freund's adjuvant|mesh-list
101395672|NCT00091143|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
101395741|NCT04551170|Respiratory System Agents|respiratory system agents|mesh-ancestor
101395742|NCT04551170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101395743|NCT04551170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101395768|NCT04542278|Hormones|hormones|mesh-ancestor
101395809|NCT00122889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101395810|NCT00122889|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101395811|NCT00122889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101395812|NCT00122889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101395813|NCT00122889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101395814|NCT00122889|Antimetabolites|antimetabolites|mesh-ancestor
101395815|NCT00122889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101395816|NCT00122889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101395817|NCT00122889|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101395818|NCT04729868|Dexmedetomidine|dexmedetomidine|mesh-list
101395819|NCT04729868|Bupivacaine|bupivacaine|mesh-list
101395820|NCT04729868|Levobupivacaine|levobupivacaine|mesh-list
101395821|NCT04729868|Anesthetics, Local|anesthetics, local|mesh-ancestor
101395822|NCT04729868|Anesthetics|anesthetics|mesh-ancestor
101395829|NCT04729868|Analgesics|analgesics|mesh-ancestor
101395862|NCT00314977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395863|NCT00314977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101395876|NCT00315016|Eplerenone|eplerenone|mesh-list
101395877|NCT00315016|Fosinopril|fosinopril|mesh-list
101395954|NCT03031483|Immunologic Factors|immunologic factors|mesh-ancestor
101395955|NCT03031483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395956|NCT03031483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101395957|NCT03031483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101395958|NCT03031483|Growth Substances|growth substances|mesh-ancestor
101395959|NCT03031483|Growth Inhibitors|growth inhibitors|mesh-ancestor
101395960|NCT03031483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101395961|NCT03031483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101395962|NCT03031483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101395963|NCT03031483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101396022|NCT00123318|Epirubicin|epirubicin|mesh-list
101396023|NCT00123318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396108|NCT03883919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101396109|NCT03883919|Antimetabolites|antimetabolites|mesh-ancestor
101396189|NCT00092196|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101396266|NCT00123552|Lumefantrine|lumefantrine|mesh-list
101396267|NCT00123552|Artemether|artemether|mesh-list
101396268|NCT00123552|Pyrimethamine|pyrimethamine|mesh-list
101396269|NCT00123552|Sulfadoxine|sulfadoxine|mesh-list
101396270|NCT00123552|Amodiaquine|amodiaquine|mesh-list
101396271|NCT00123552|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101396285|NCT03352427|Everolimus|everolimus|mesh-list
101396311|NCT00092352|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101396312|NCT00092352|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101396313|NCT00092352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101396314|NCT00092352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396315|NCT00316498|Miglustat|miglustat|mesh-list
101305857|NCT02022358|Vitamins|vitamins|mesh-ancestor
101305858|NCT02022358|Micronutrients|micronutrients|mesh-ancestor
101396385|NCT03272477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101396386|NCT03272477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101396387|NCT03272477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101396388|NCT03272477|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101396389|NCT03272477|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101396390|NCT03272477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101396455|NCT02960035|Sensory System Agents|sensory system agents|mesh-ancestor
101396456|NCT02960035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101396463|NCT00317434|Lapatinib|lapatinib|mesh-list
101396527|NCT00420082|Fexofenadine|fexofenadine|mesh-list
101396528|NCT00420082|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101396529|NCT00420082|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101396624|NCT00329368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101396625|NCT00329368|Immunologic Factors|immunologic factors|mesh-ancestor
101396626|NCT00329368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396627|NCT00329368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101396694|NCT00123903|Protease Inhibitors|protease inhibitors|mesh-ancestor
101396695|NCT00123903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101396696|NCT00123903|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101396697|NCT00329680|Evening primrose oil|evening primrose oil|mesh-list
101396698|NCT00329680|Antioxidants|antioxidants|mesh-list
101396699|NCT00329680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396700|NCT00329680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396701|NCT00329680|Protective Agents|protective agents|mesh-ancestor
101396702|NCT00329680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101396703|NCT00329680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101396704|NCT00329680|Analgesics|analgesics|mesh-ancestor
101396705|NCT00329680|Sensory System Agents|sensory system agents|mesh-ancestor
101305875|NCT02022488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101305876|NCT02022488|Anesthetics, General|anesthetics, general|mesh-ancestor
101396758|NCT00093093|Antiviral Agents|antiviral agents|mesh-ancestor
101396759|NCT00093093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101396760|NCT00093093|Antimetabolites|antimetabolites|mesh-ancestor
101396762|NCT00093093|Immunologic Factors|immunologic factors|mesh-ancestor
101396829|NCT00323830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396830|NCT00323830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101396831|NCT00323830|Antimetabolites|antimetabolites|mesh-ancestor
101396833|NCT00317512|Chrysarobin|chrysarobin|mesh-list
101396899|NCT00324142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101396900|NCT00324142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101396901|NCT00324142|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
101396902|NCT00324142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101396903|NCT00324142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101396904|NCT00324298|Etoposide|etoposide|mesh-list
101396905|NCT00324298|Bleomycin|bleomycin|mesh-list
101396948|NCT00317785|Mycophenolic Acid|mycophenolic acid|mesh-list
101396949|NCT00317785|Cyclophosphamide|cyclophosphamide|mesh-list
101396951|NCT00317785|Tacrolimus|tacrolimus|mesh-list
101396952|NCT00317785|Cyclosporins|cyclosporins|mesh-list
101396953|NCT00317785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101396954|NCT00317785|Immunologic Factors|immunologic factors|mesh-ancestor
101305939|NCT02022722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101305940|NCT02022722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101305941|NCT02022722|Immunologic Factors|immunologic factors|mesh-ancestor
101305942|NCT02022722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101305943|NCT02022722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101305944|NCT02022761|Laninamivir|laninamivir|mesh-list
101305945|NCT02022761|Antiviral Agents|antiviral agents|mesh-ancestor
101305946|NCT02022761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101305947|NCT02022852|Capecitabine|capecitabine|mesh-list
101305948|NCT02022852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101397035|NCT00324688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101397036|NCT00324688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101397037|NCT00324688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101397038|NCT00324688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101397039|NCT00324688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397040|NCT00324688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101397041|NCT00324688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101397042|NCT00324727|Melphalan|melphalan|mesh-list
101397043|NCT00324727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101397044|NCT00324727|Alkylating Agents|alkylating agents|mesh-ancestor
101397045|NCT00324727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397046|NCT00324727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397047|NCT00324727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101397048|NCT00324727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101397049|NCT00324727|Immunologic Factors|immunologic factors|mesh-ancestor
101397050|NCT00324727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397051|NCT00324766|Simendan|simendan|mesh-list
101397052|NCT00324766|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101397053|NCT00324766|Vasodilator Agents|vasodilator agents|mesh-ancestor
101397054|NCT00324766|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101397055|NCT00324766|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101397056|NCT00324766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101397057|NCT00324766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397058|NCT00324766|Protective Agents|protective agents|mesh-ancestor
101397059|NCT00324766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397060|NCT00084578|Rosiglitazone|rosiglitazone|mesh-list
101397061|NCT00084578|Celecoxib|celecoxib|mesh-list
101397062|NCT00084578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101397063|NCT00084578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101397064|NCT00084578|Analgesics|analgesics|mesh-ancestor
101397065|NCT00084578|Sensory System Agents|sensory system agents|mesh-ancestor
101397066|NCT00084578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101305967|NCT02022930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101305968|NCT02022930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101305969|NCT02022930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101397083|NCT00093444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101397084|NCT00093444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101397085|NCT00093444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101397103|NCT00325000|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101397177|NCT00325390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397178|NCT00325429|Vildagliptin|vildagliptin|mesh-list
101397256|NCT00084890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397325|NCT00093600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101397326|NCT00093600|Antimetabolites|antimetabolites|mesh-ancestor
101397327|NCT00093600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397328|NCT00093600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397329|NCT00093600|Antiviral Agents|antiviral agents|mesh-ancestor
101397330|NCT00093600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101397331|NCT00093600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101397332|NCT00093600|Immunologic Factors|immunologic factors|mesh-ancestor
101397333|NCT00093600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306041|NCT02023424|Immunologic Factors|immunologic factors|mesh-ancestor
101306042|NCT02023424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306043|NCT02023424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101397334|NCT00093600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101397335|NCT00093600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101397388|NCT00326053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101397389|NCT00326053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101397390|NCT00326053|Autonomic Agents|autonomic agents|mesh-ancestor
101397391|NCT00326053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101397405|NCT00400088|Paroxetine|paroxetine|mesh-list
101397420|NCT00400088|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101397422|NCT00326092|Timolol|timolol|mesh-list
101397510|NCT00319345|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101397511|NCT00319345|Diuretics|diuretics|mesh-ancestor
101397512|NCT00319345|Natriuretic Agents|natriuretic agents|mesh-ancestor
101397513|NCT00319345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397593|NCT00326833|Hematinics|hematinics|mesh-ancestor
101397594|NCT00085748|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101397595|NCT00085748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101397596|NCT00085748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101397683|NCT00327145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101397693|NCT00085943|Ritonavir|ritonavir|mesh-list
101397776|NCT00320632|Adrenergic Agents|adrenergic agents|mesh-ancestor
101397777|NCT00320632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101397778|NCT00320632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397779|NCT00320827|Antibodies|antibodies|mesh-list
101397782|NCT00320983|Topotecan|topotecan|mesh-list
101397865|NCT05458180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101397866|NCT05458180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101397867|NCT05458180|Glucocorticoids|glucocorticoids|mesh-ancestor
101397868|NCT05458180|Hormones|hormones|mesh-ancestor
101397870|NCT05458180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101397940|NCT00321490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397941|NCT00321490|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101397942|NCT00321490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101397946|NCT00321490|Analgesics|analgesics|mesh-ancestor
101398011|NCT00086645|Citalopram|citalopram|mesh-list
101398012|NCT00086645|Escitalopram|escitalopram|mesh-list
101398013|NCT00086645|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101398014|NCT00086645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101398031|NCT00321802|Simvastatin|simvastatin|mesh-list
101398083|NCT00124644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101398084|NCT00124644|Antimetabolites|antimetabolites|mesh-ancestor
101398085|NCT00124644|Antiviral Agents|antiviral agents|mesh-ancestor
101398086|NCT00124644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101398087|NCT00124644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101398088|NCT00124644|Immunologic Factors|immunologic factors|mesh-ancestor
101398089|NCT00124644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398090|NCT00124644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101398091|NCT00086840|Sirolimus|sirolimus|mesh-list
101398105|NCT00124683|Bupropion|bupropion|mesh-list
101306101|NCT02023710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101306102|NCT02023710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101398161|NCT00094614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101398162|NCT00094614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101398163|NCT00094614|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101398164|NCT00094614|Autonomic Agents|autonomic agents|mesh-ancestor
101398165|NCT00094614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101398166|NCT00094614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398167|NCT00094614|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101398168|NCT00094614|Respiratory System Agents|respiratory system agents|mesh-ancestor
101398234|NCT00332293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398235|NCT00332293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101398312|NCT00419731|Antidepressive Agents|antidepressive agents|mesh-ancestor
101398313|NCT00419731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101398314|NCT00419731|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101398315|NCT00419731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101398316|NCT00419731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101398335|NCT00087425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101306106|NCT02023710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185144|NCT00569868|Bortezomib|bortezomib|mesh-list
101398336|NCT00087425|Immunologic Factors|immunologic factors|mesh-ancestor
101398340|NCT00330655|Memantine|memantine|mesh-list
101398419|NCT00331084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101398420|NCT00331084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101398421|NCT00331084|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101398425|NCT00331084|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101398426|NCT00331084|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101398427|NCT00420355|Ritonavir|ritonavir|mesh-list
101398428|NCT00420355|Lopinavir|lopinavir|mesh-list
101398429|NCT00420355|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101398430|NCT00420355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101398435|NCT00420355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101398487|NCT00087581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101398575|NCT00331786|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101398576|NCT00331786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101398577|NCT00331786|Antipyretics|antipyretics|mesh-ancestor
101398578|NCT00331786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101398579|NCT00331786|Autonomic Agents|autonomic agents|mesh-ancestor
101398580|NCT00331786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101398581|NCT00331786|Respiratory System Agents|respiratory system agents|mesh-ancestor
101398582|NCT00331786|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101398644|NCT00126633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101398645|NCT00126633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101398646|NCT00126633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101398647|NCT00126633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101398648|NCT00126633|Growth Substances|growth substances|mesh-ancestor
101398649|NCT00126633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398650|NCT00126633|Growth Inhibitors|growth inhibitors|mesh-ancestor
101398651|NCT00126633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101398652|NCT00126633|Antimetabolites|antimetabolites|mesh-ancestor
101398653|NCT00126633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398655|NCT00332020|Rivaroxaban|rivaroxaban|mesh-list
101398656|NCT00332020|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101398657|NCT00332020|Antithrombins|antithrombins|mesh-ancestor
101398658|NCT00332020|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101398659|NCT00332020|Protease Inhibitors|protease inhibitors|mesh-ancestor
101398660|NCT00332020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101398661|NCT00332020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398662|NCT00332020|Anticoagulants|anticoagulants|mesh-ancestor
101398705|NCT00126789|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101398706|NCT00126789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101398707|NCT00126789|Anesthetics, General|anesthetics, general|mesh-ancestor
101398708|NCT00126789|Anesthetics|anesthetics|mesh-ancestor
101398709|NCT05831969|Lenalidomide|lenalidomide|mesh-list
101398710|NCT05831969|Immunologic Factors|immunologic factors|mesh-ancestor
101398711|NCT05831969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398712|NCT05831969|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101398713|NCT05831969|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101398714|NCT05831969|Growth Substances|growth substances|mesh-ancestor
101398715|NCT05831969|Growth Inhibitors|growth inhibitors|mesh-ancestor
101398716|NCT05831969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101398717|NCT05831761|Lidocaine|lidocaine|mesh-list
101398718|NCT05831761|Analgesics|analgesics|mesh-list
101398719|NCT05831761|Anesthetics, Local|anesthetics, local|mesh-ancestor
101398720|NCT05831761|Anesthetics|anesthetics|mesh-ancestor
101398721|NCT05831761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101398722|NCT05831761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398723|NCT05831761|Sensory System Agents|sensory system agents|mesh-ancestor
101398724|NCT05831761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101398725|NCT05831761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101398726|NCT05831761|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101398727|NCT05831761|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101398730|NCT05831566|Budesonide|budesonide|mesh-list
101398752|NCT05831462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101398753|NCT05831462|Purinergic Agents|purinergic agents|mesh-ancestor
101398754|NCT05831462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101398755|NCT05831462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398756|NCT05831462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398780|NCT05831267|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101398781|NCT05831267|Hemostatics|hemostatics|mesh-ancestor
101398782|NCT05831267|Coagulants|coagulants|mesh-ancestor
101398783|NCT05831098|Antibodies|antibodies|mesh-list
101398784|NCT05831098|Immunologic Factors|immunologic factors|mesh-ancestor
101398785|NCT05831098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306118|NCT02023840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101306119|NCT02023840|Vasodilator Agents|vasodilator agents|mesh-ancestor
101398842|NCT05830071|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101398843|NCT05830071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101398844|NCT05830071|Cholinergic Agents|cholinergic agents|mesh-ancestor
101398845|NCT05830071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101398846|NCT05830071|Glucocorticoids|glucocorticoids|mesh-ancestor
101398847|NCT05830071|Hormones|hormones|mesh-ancestor
101398848|NCT05830071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101398849|NCT05828758|Amoxicillin|amoxicillin|mesh-list
101398850|NCT05828758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101398851|NCT05828758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101398858|NCT05820997|Ropivacaine|ropivacaine|mesh-list
101398859|NCT05820997|Anesthetics, Local|anesthetics, local|mesh-ancestor
101398860|NCT05820997|Anesthetics|anesthetics|mesh-ancestor
101398861|NCT05820997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101398862|NCT05820997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398863|NCT05820997|Sensory System Agents|sensory system agents|mesh-ancestor
101398864|NCT05820997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101398865|NCT05814523|Ganaxolone|ganaxolone|mesh-list
101398866|NCT05814523|Neurosteroids|neurosteroids|mesh-ancestor
101398867|NCT05814523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101398868|NCT05814523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398896|NCT05744648|Dermatologic Agents|dermatologic agents|mesh-ancestor
101398897|NCT05744648|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101398898|NCT05735353|Methamphetamine|methamphetamine|mesh-list
101398899|NCT05735353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101398900|NCT05735353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398901|NCT05735353|Sympathomimetics|sympathomimetics|mesh-ancestor
101398902|NCT05735353|Autonomic Agents|autonomic agents|mesh-ancestor
101398903|NCT05735353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101398904|NCT05735353|Dopamine Agents|dopamine agents|mesh-ancestor
101398963|NCT05628363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101398964|NCT05628363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398966|NCT05574400|Caffeine citrate|caffeine citrate|mesh-list
101398967|NCT05574400|Citric Acid|citric acid|mesh-list
101398968|NCT05574400|Sodium Citrate|sodium citrate|mesh-list
101398982|NCT05555862|Artesunate|artesunate|mesh-list
101399030|NCT05413330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101399031|NCT05413330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399035|NCT05413330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399037|NCT05271630|Immunomodulating Agents|immunomodulating agents|mesh-list
101399038|NCT05271630|Protease Inhibitors|protease inhibitors|mesh-ancestor
101399039|NCT05271630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101399041|NCT05271630|Immunologic Factors|immunologic factors|mesh-ancestor
101399098|NCT05145309|Cathartics|cathartics|mesh-ancestor
101399099|NCT05145309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101399166|NCT05097261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101399167|NCT05097261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101399168|NCT05097261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101399170|NCT05037032|Naltrexone|naltrexone|mesh-list
101399225|NCT04481204|Cisplatin|cisplatin|mesh-list
101399226|NCT04481204|Gemcitabine|gemcitabine|mesh-list
101399227|NCT04481204|Fluorouracil|fluorouracil|mesh-list
101399228|NCT04481204|Oxaliplatin|oxaliplatin|mesh-list
101399229|NCT04481204|Irinotecan|irinotecan|mesh-list
101399230|NCT04481204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101399231|NCT04481204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399232|NCT04481204|Tubulin Modulators|tubulin modulators|mesh-ancestor
101399233|NCT04481204|Antimitotic Agents|antimitotic agents|mesh-ancestor
101399310|NCT04302870|Dopamine Agents|dopamine agents|mesh-ancestor
101399311|NCT04302870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101399322|NCT04302870|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101399323|NCT04302870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101399397|NCT04006288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101399398|NCT04006288|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101399399|NCT04006288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101363055|NCT00079716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399499|NCT03643822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101399500|NCT03643822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101399575|NCT03123978|Anthelmintics|anthelmintics|mesh-ancestor
101399576|NCT03123978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101399577|NCT03123978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101399578|NCT03123978|Antinematodal Agents|antinematodal agents|mesh-ancestor
101399579|NCT03114072|Methamphetamine|methamphetamine|mesh-list
101399648|NCT02935205|Sensory System Agents|sensory system agents|mesh-ancestor
101399649|NCT02935205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101399650|NCT02935205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399651|NCT02935205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101399652|NCT02935205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101399653|NCT02935205|Gout Suppressants|gout suppressants|mesh-ancestor
101306197|NCT02024295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101306198|NCT02024295|Antimetabolites|antimetabolites|mesh-ancestor
101306199|NCT02024295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306200|NCT02024295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101306201|NCT02024295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101306202|NCT02024295|Nootropic Agents|nootropic agents|mesh-ancestor
101306204|NCT02024308|Fludarabine|fludarabine|mesh-list
101306205|NCT02024308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101306206|NCT02024308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101306207|NCT02024308|Antimetabolites|antimetabolites|mesh-ancestor
101399825|NCT02394834|Growth Substances|growth substances|mesh-ancestor
101399826|NCT02394834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399895|NCT02099825|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101399897|NCT02099825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101399908|NCT02099825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101399909|NCT02099825|Antitubercular Agents|antitubercular agents|mesh-ancestor
101306230|NCT02024425|Protective Agents|protective agents|mesh-ancestor
101306231|NCT02024425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306232|NCT02024555|Azithromycin|azithromycin|mesh-list
101306233|NCT02024555|Levofloxacin|levofloxacin|mesh-list
101306234|NCT02024555|Rifampin|rifampin|mesh-list
101306235|NCT02024555|Ethambutol|ethambutol|mesh-list
101306236|NCT02024555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101400001|NCT05952921|Disinfectants|disinfectants|mesh-ancestor
101400002|NCT05952882|Metformin|metformin|mesh-list
101400003|NCT05952882|Liraglutide|liraglutide|mesh-list
101400004|NCT05952882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101400005|NCT05952882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400006|NCT05952882|Incretins|incretins|mesh-ancestor
101400007|NCT05952882|Hormones|hormones|mesh-ancestor
101400008|NCT05952882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101400009|NCT05952596|Vaccines|vaccines|mesh-list
101400010|NCT05952596|Immunologic Factors|immunologic factors|mesh-ancestor
101400011|NCT05952596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400012|NCT05952557|Tamoxifen|tamoxifen|mesh-list
101400013|NCT05952557|Letrozole|letrozole|mesh-list
101400065|NCT05952089|GABA Agents|gaba agents|mesh-ancestor
101400066|NCT05952089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101400067|NCT05952089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400130|NCT05951465|Anesthetics, General|anesthetics, general|mesh-ancestor
101400131|NCT05951465|Anesthetics|anesthetics|mesh-ancestor
101400132|NCT05951465|Antidepressive Agents|antidepressive agents|mesh-ancestor
101400133|NCT05951465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101400134|NCT05951452|Oxytocin|oxytocin|mesh-list
101400135|NCT05951452|Testosterone|testosterone|mesh-list
101400136|NCT05951452|Oxytocics|oxytocics|mesh-ancestor
101400211|NCT05938699|Nitric Oxide|nitric oxide|mesh-list
101400212|NCT05938699|Lubricant Eye Drops|lubricant eye drops|mesh-list
101400213|NCT05938699|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101400214|NCT05938699|Autonomic Agents|autonomic agents|mesh-ancestor
101400215|NCT05938699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101400216|NCT05938699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400217|NCT05938699|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101400218|NCT05938699|Respiratory System Agents|respiratory system agents|mesh-ancestor
101400219|NCT05938699|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101400220|NCT05938699|Antioxidants|antioxidants|mesh-ancestor
101400221|NCT05938699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400222|NCT05938699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101400223|NCT05938699|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101400224|NCT05938699|Vasodilator Agents|vasodilator agents|mesh-ancestor
101400225|NCT05938699|Gasotransmitters|gasotransmitters|mesh-ancestor
101400228|NCT05938699|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101400229|NCT05938699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101400230|NCT05936671|Remifentanil|remifentanil|mesh-list
101400231|NCT05936671|Anesthetics|anesthetics|mesh-list
101400232|NCT05936671|Sevoflurane|sevoflurane|mesh-list
101306295|NCT02024659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101306296|NCT02024841|Docetaxel|docetaxel|mesh-list
101306297|NCT02024841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101306302|NCT02024906|Caseins|caseins|mesh-list
101400253|NCT05925179|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101400254|NCT05925179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101400255|NCT05925179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400257|NCT05921968|Lactoferrin|lactoferrin|mesh-list
101400258|NCT05921968|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101400259|NCT05921968|Trace Elements|trace elements|mesh-ancestor
101400260|NCT05921968|Micronutrients|micronutrients|mesh-ancestor
101400261|NCT05921968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400262|NCT05921968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101400263|NCT05921968|Hematinics|hematinics|mesh-ancestor
101400264|NCT05912062|Paclitaxel|paclitaxel|mesh-list
101400265|NCT05912062|Trastuzumab|trastuzumab|mesh-list
101400266|NCT05912062|Pertuzumab|pertuzumab|mesh-list
101400267|NCT05912062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101400274|NCT05904379|Paclitaxel|paclitaxel|mesh-list
101400322|NCT05871333|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101400323|NCT05871333|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101400324|NCT05871333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400325|NCT05860933|Itraconazole|itraconazole|mesh-list
101400326|NCT05860933|Carbamazepine|carbamazepine|mesh-list
101400377|NCT05794997|Bisoprolol|bisoprolol|mesh-list
101400378|NCT05794997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101400379|NCT05794997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101400380|NCT05794997|Adrenergic Agents|adrenergic agents|mesh-ancestor
101400381|NCT05794997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101400382|NCT05794997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400461|NCT05726110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400462|NCT05726110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101400463|NCT05726110|Antiviral Agents|antiviral agents|mesh-ancestor
101400464|NCT05726110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101400465|NCT05726110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101400466|NCT05726110|Immunologic Factors|immunologic factors|mesh-ancestor
101400528|NCT05645718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101400529|NCT05645718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101400531|NCT05645718|Dermatologic Agents|dermatologic agents|mesh-ancestor
101400550|NCT05635370|Cilostazol|cilostazol|mesh-list
101400594|NCT05559931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400595|NCT05559931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101400596|NCT05559931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101400597|NCT05559931|Serotonin Agents|serotonin agents|mesh-ancestor
101400598|NCT05559931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101400600|NCT05559931|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101400647|NCT05408429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400648|NCT05381948|Aflibercept|aflibercept|mesh-list
101400649|NCT05381948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101306368|NCT02025192|Capecitabine|capecitabine|mesh-list
101306369|NCT02025192|Trastuzumab|trastuzumab|mesh-list
101400713|NCT05286060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101400714|NCT05286060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101400726|NCT05253833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400727|NCT05242458|Ustekinumab|ustekinumab|mesh-list
101306372|NCT02025192|Antimetabolites|antimetabolites|mesh-ancestor
101187520|NCT00002652|Suramin|suramin|mesh-list
101400728|NCT05242458|Dermatologic Agents|dermatologic agents|mesh-ancestor
101400828|NCT05059600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400829|NCT05059600|GABA Modulators|gaba modulators|mesh-ancestor
101400830|NCT05059600|GABA Agents|gaba agents|mesh-ancestor
101400831|NCT05049902|Amoxicillin|amoxicillin|mesh-list
101400915|NCT04795661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400996|NCT04562285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306378|NCT02025218|Gefitinib|gefitinib|mesh-list
101306379|NCT02025218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101306380|NCT02025218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101306381|NCT02025218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101187744|NCT00002718|Hormones|hormones|mesh-ancestor
101401004|NCT04528004|Niacinamide|niacinamide|mesh-list
101401005|NCT04528004|Niacin|niacin|mesh-list
101401006|NCT04528004|Nicotinic Acids|nicotinic acids|mesh-list
101401007|NCT04528004|Vitamin B Complex|vitamin b complex|mesh-ancestor
101401008|NCT04528004|Vitamins|vitamins|mesh-ancestor
101401009|NCT04528004|Micronutrients|micronutrients|mesh-ancestor
101401010|NCT04528004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401016|NCT04500899|Phenylephrine|phenylephrine|mesh-list
101401071|NCT04293393|Antimitotic Agents|antimitotic agents|mesh-ancestor
101401072|NCT04293393|Mitosis Modulators|mitosis modulators|mesh-ancestor
101401074|NCT04293393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101401150|NCT04153032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101401151|NCT04153032|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101401152|NCT04153032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101401153|NCT04153032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306386|NCT02025348|Sympatholytics|sympatholytics|mesh-ancestor
101401223|NCT03678883|Paclitaxel|paclitaxel|mesh-list
101401224|NCT03678883|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101401225|NCT03678883|Carboplatin|carboplatin|mesh-list
101401226|NCT03678883|Gemcitabine|gemcitabine|mesh-list
101401227|NCT03678883|Doxorubicin|doxorubicin|mesh-list
101401228|NCT03678883|Irinotecan|irinotecan|mesh-list
101401229|NCT03678883|Lomustine|lomustine|mesh-list
101456564|NCT00216827|Glucocorticoids|glucocorticoids|mesh-ancestor
101306399|NCT02025361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101306400|NCT02025361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306401|NCT02025361|Sensory System Agents|sensory system agents|mesh-ancestor
101306407|NCT02025361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306408|NCT02025374|Bupivacaine|bupivacaine|mesh-list
101306409|NCT02025374|Levobupivacaine|levobupivacaine|mesh-list
101306410|NCT02025374|Anesthetics, Local|anesthetics, local|mesh-ancestor
101401455|NCT02592707|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
101401456|NCT02592707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101401457|NCT02592707|Autonomic Agents|autonomic agents|mesh-ancestor
101401458|NCT02592707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101401459|NCT02592707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401460|NCT02592707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101401461|NCT02592707|Glucocorticoids|glucocorticoids|mesh-ancestor
101401462|NCT02592707|Hormones|hormones|mesh-ancestor
101401463|NCT02592707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101401464|NCT02592707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101401465|NCT02592707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101401466|NCT02592707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401467|NCT02592707|Antipruritics|antipruritics|mesh-ancestor
101401468|NCT02592707|Dermatologic Agents|dermatologic agents|mesh-ancestor
101401469|NCT02592707|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101401470|NCT02592707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101401471|NCT02592707|Serotonin Agents|serotonin agents|mesh-ancestor
101401472|NCT02592707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101401473|NCT02592707|Chelating Agents|chelating agents|mesh-ancestor
101401474|NCT02592707|Sequestering Agents|sequestering agents|mesh-ancestor
101401500|NCT02326805|Metronidazole|metronidazole|mesh-list
101401501|NCT02326805|Vaccines|vaccines|mesh-list
101401502|NCT02326805|Immunologic Factors|immunologic factors|mesh-ancestor
101401503|NCT02326805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401507|NCT02326805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101401508|NCT02310321|Cytarabine|cytarabine|mesh-list
101401509|NCT02310321|Idarubicin|idarubicin|mesh-list
101306430|NCT02025465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101401527|NCT02288247|Antimitotic Agents|antimitotic agents|mesh-ancestor
101401528|NCT02288247|Mitosis Modulators|mitosis modulators|mesh-ancestor
101401530|NCT02288247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101401598|NCT00859781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101401599|NCT00859781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401600|NCT00859781|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101401601|NCT00792740|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
101401603|NCT00792740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101401665|NCT00125151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401667|NCT00087815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101401668|NCT00087815|Antiemetics|antiemetics|mesh-ancestor
101401669|NCT00087815|Autonomic Agents|autonomic agents|mesh-ancestor
101401670|NCT00087815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101363071|NCT00130507|Tubulin Modulators|tubulin modulators|mesh-ancestor
101401671|NCT00087815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401672|NCT00087815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101401742|NCT00125307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101401743|NCT00125307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101401744|NCT00125307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401746|NCT00127023|Immunologic Factors|immunologic factors|mesh-ancestor
101401817|NCT00333151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101401890|NCT00333424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401892|NCT00125463|Candesartan cilexetil|candesartan cilexetil|mesh-list
101401893|NCT00125463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101401894|NCT00125463|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101401895|NCT00125463|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101401896|NCT00125463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401897|NCT00088946|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101401902|NCT00421018|Montelukast|montelukast|mesh-list
101401948|NCT00334126|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101401949|NCT00334126|Serotonin Agents|serotonin agents|mesh-ancestor
101401950|NCT00334126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101401952|NCT00334126|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101402024|NCT00125541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402025|NCT00089258|Isotretinoin|isotretinoin|mesh-list
101402026|NCT00089258|Antibodies|antibodies|mesh-list
101402027|NCT00089258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101402099|NCT00089453|Immunologic Factors|immunologic factors|mesh-ancestor
101402100|NCT00089453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402101|NCT00089453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101402102|NCT00089453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101402108|NCT00089453|Antiemetics|antiemetics|mesh-ancestor
101402170|NCT00334867|Mitosis Modulators|mitosis modulators|mesh-ancestor
101402171|NCT00334867|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101402172|NCT00334867|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101402173|NCT00334867|Protective Agents|protective agents|mesh-ancestor
101402174|NCT04715152|Dexamethasone|dexamethasone|mesh-list
101402175|NCT04715152|Dexamethasone acetate|dexamethasone acetate|mesh-list
101402176|NCT04715152|Levobupivacaine|levobupivacaine|mesh-list
101402240|NCT00089726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402241|NCT00089726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101402242|NCT00343096|Lorazepam|lorazepam|mesh-list
101402258|NCT00335179|Imiquimod|imiquimod|mesh-list
101402316|NCT00343369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101402317|NCT00343369|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101402318|NCT00343369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101402319|NCT00343369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101402320|NCT00343369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101402321|NCT00343369|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101402322|NCT00343369|Abortifacient Agents|abortifacient agents|mesh-ancestor
101402323|NCT00343369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101402324|NCT00343369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101402325|NCT00343369|Antimetabolites|antimetabolites|mesh-ancestor
101402326|NCT00343369|Dermatologic Agents|dermatologic agents|mesh-ancestor
101402381|NCT00127920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101402382|NCT00127920|Growth Substances|growth substances|mesh-ancestor
101402383|NCT00127920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402384|NCT00127920|Growth Inhibitors|growth inhibitors|mesh-ancestor
101402385|NCT00343798|Cyclosporine|cyclosporine|mesh-list
101402386|NCT00343798|Mycophenolic Acid|mycophenolic acid|mesh-list
101402387|NCT00343798|Cyclophosphamide|cyclophosphamide|mesh-list
101402448|NCT00344149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101402449|NCT00344149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402522|NCT00402792|Narcotics|narcotics|mesh-ancestor
101402523|NCT00402792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101402524|NCT00402792|Antitussive Agents|antitussive agents|mesh-ancestor
101402525|NCT00402792|Respiratory System Agents|respiratory system agents|mesh-ancestor
101402604|NCT00344695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101402605|NCT00344695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101402607|NCT00344695|Dopamine Agents|dopamine agents|mesh-ancestor
101402672|NCT00090194|Immunoglobulins|immunoglobulins|mesh-list
101402673|NCT00090194|Antibodies|antibodies|mesh-list
101402674|NCT00090194|gamma-Globulins|gamma-globulins|mesh-list
101402675|NCT00090194|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101402676|NCT00090194|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101402746|NCT04708249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402748|NCT00090272|Cefotetan|cefotetan|mesh-list
101402823|NCT00346294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101402824|NCT00346294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402826|NCT00346294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101402827|NCT00346294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101402828|NCT00346294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101402829|NCT00346294|Immunologic Factors|immunologic factors|mesh-ancestor
101402830|NCT00346489|Fluorouracil|fluorouracil|mesh-list
101402831|NCT00346489|Mitomycins|mitomycins|mesh-list
101402894|NCT04728932|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101402895|NCT04728932|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101402896|NCT04728932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101402897|NCT04728932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402898|NCT04728932|Protective Agents|protective agents|mesh-ancestor
101402899|NCT04728932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402900|NCT00125892|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101402901|NCT00125892|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101402905|NCT00125892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101402961|NCT00126009|Antidepressive Agents|antidepressive agents|mesh-ancestor
101402962|NCT00346918|Sirolimus|sirolimus|mesh-list
101402963|NCT00346918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101402964|NCT00346918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101402965|NCT00346918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101403030|NCT00090896|Immunologic Factors|immunologic factors|mesh-ancestor
101403031|NCT00090896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403032|NCT00090896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101403033|NCT00090896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101403034|NCT00090896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101403104|NCT00347425|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101403105|NCT00126048|Atorvastatin|atorvastatin|mesh-list
101403106|NCT00126048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101403107|NCT00126048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101403108|NCT00126048|Antimetabolites|antimetabolites|mesh-ancestor
101403109|NCT00126048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403110|NCT00126048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101403111|NCT00126048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101403112|NCT00126048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101403113|NCT00126087|Dopamine|dopamine|mesh-list
101403114|NCT00126087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101403169|NCT00126204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101403248|NCT00426595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101403249|NCT00426595|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101403250|NCT00426595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101403251|NCT00426595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403252|NCT00426673|Brivaracetam|brivaracetam|mesh-list
101403253|NCT00426673|Anticonvulsants|anticonvulsants|mesh-ancestor
101403254|NCT00426712|1018 oligonucleotide|1018 oligonucleotide|mesh-list
101403255|NCT00426712|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101403256|NCT00426712|Immunologic Factors|immunologic factors|mesh-ancestor
101403257|NCT00426712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403258|NCT00091247|Tetracycline|tetracycline|mesh-list
101403322|NCT00126516|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101403323|NCT00126516|Protease Inhibitors|protease inhibitors|mesh-ancestor
101306518|NCT02025998|Respiratory System Agents|respiratory system agents|mesh-ancestor
101306519|NCT02025998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101403324|NCT00091520|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101403332|NCT04710888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101403333|NCT01058005|Interferons|interferons|mesh-list
101403395|NCT03929718|Hormone Antagonists|hormone antagonists|mesh-ancestor
101403401|NCT01056523|Cytarabine|cytarabine|mesh-list
101403402|NCT01056523|Ribavirin|ribavirin|mesh-list
101403403|NCT01056523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101306521|NCT02025998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306522|NCT02025998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101306523|NCT02025998|Vasodilator Agents|vasodilator agents|mesh-ancestor
101403455|NCT04704622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101403456|NCT04704622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101403457|NCT04704622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403458|NCT04704622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101403459|NCT04704622|Analgesics|analgesics|mesh-ancestor
101306539|NCT02026050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101403552|NCT00428350|Antidepressive Agents|antidepressive agents|mesh-ancestor
101403629|NCT00093002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403630|NCT00093119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101403631|NCT00093119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101403632|NCT00093158|Anticoagulants|anticoagulants|mesh-list
101403633|NCT00093158|Bivalirudin|bivalirudin|mesh-list
101306550|NCT02026219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306551|NCT02026310|Metformin|metformin|mesh-list
101405036|NCT00098423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405037|NCT00098423|Antiviral Agents|antiviral agents|mesh-ancestor
101405038|NCT00098423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101405039|NCT00098423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101405040|NCT00098423|Immunologic Factors|immunologic factors|mesh-ancestor
101405041|NCT00098423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405042|NCT01050790|Lenalidomide|lenalidomide|mesh-list
101405043|NCT01050790|Azacitidine|azacitidine|mesh-list
101405044|NCT01050790|Immunologic Factors|immunologic factors|mesh-ancestor
101405045|NCT01050790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405055|NCT00433927|Leucovorin|leucovorin|mesh-list
101306553|NCT02026310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101306554|NCT02026310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487391|NCT05198960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101406032|NCT00133458|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101406033|NCT00133458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101406034|NCT00133458|Tubulin Modulators|tubulin modulators|mesh-ancestor
101409243|NCT00466219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409244|NCT00144261|Nevirapine|nevirapine|mesh-list
101306555|NCT02026310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101306556|NCT02026310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101306557|NCT02026310|Immunologic Factors|immunologic factors|mesh-ancestor
101409245|NCT00144261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101417859|NCT00135785|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101417860|NCT00135785|Antidepressive Agents|antidepressive agents|mesh-ancestor
101417861|NCT00135785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101417862|NCT00135785|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101306559|NCT02026479|Dexamethasone acetate|dexamethasone acetate|mesh-list
101306560|NCT02026479|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101306561|NCT02026479|BB 1101|bb 1101|mesh-list
101306562|NCT02026479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101417863|NCT00135785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101417864|NCT00135785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101417865|NCT00135785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417866|NCT00135785|Dopamine Agents|dopamine agents|mesh-ancestor
101417867|NCT00135785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101417868|NCT00135785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417869|NCT00135785|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101417870|NCT00135785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101417871|NCT00135785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101417872|NCT00159081|Haloperidol|haloperidol|mesh-list
101417873|NCT00159081|Risperidone|risperidone|mesh-list
101417874|NCT00159081|Haloperidol decanoate|haloperidol decanoate|mesh-list
101417875|NCT00159081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101417876|NCT00159081|Serotonin Agents|serotonin agents|mesh-ancestor
101417877|NCT00159081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101417881|NCT00159081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101417882|NCT00159081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101417883|NCT00159081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101417884|NCT00159081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101417886|NCT00159081|Antiemetics|antiemetics|mesh-ancestor
101417887|NCT00159081|Autonomic Agents|autonomic agents|mesh-ancestor
101417888|NCT00159081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101417889|NCT00159081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101417899|NCT00159120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101417900|NCT00159120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101417978|NCT00152958|Antioxidants|antioxidants|mesh-ancestor
101417979|NCT00152958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417980|NCT00152958|Protective Agents|protective agents|mesh-ancestor
101417987|NCT00136175|Paclitaxel|paclitaxel|mesh-list
101418052|NCT00159510|Respiratory System Agents|respiratory system agents|mesh-ancestor
101418053|NCT00159510|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101418054|NCT00159510|Antioxidants|antioxidants|mesh-ancestor
101418141|NCT00136565|Immunologic Factors|immunologic factors|mesh-ancestor
101418142|NCT00136565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418163|NCT00159627|Diuretics|diuretics|mesh-ancestor
101418164|NCT00159627|Natriuretic Agents|natriuretic agents|mesh-ancestor
101418165|NCT00159627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418166|NCT00159666|Pregabalin|pregabalin|mesh-list
101418167|NCT00159666|Analgesics|analgesics|mesh-ancestor
101418236|NCT00137072|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101418237|NCT00137072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101418238|NCT00137072|Urological Agents|urological agents|mesh-ancestor
101418308|NCT00137657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101418309|NCT00137657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418310|NCT00137657|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101418311|NCT00137657|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101201019|NCT01402076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101418377|NCT00137852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101418378|NCT00137852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101418379|NCT00137852|Analgesics|analgesics|mesh-ancestor
101418380|NCT00137852|Sensory System Agents|sensory system agents|mesh-ancestor
101418381|NCT00137852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101418382|NCT00137852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418383|NCT00137852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101418384|NCT00137852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101418385|NCT00137852|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101418444|NCT00404222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418445|NCT00404222|Antipyretics|antipyretics|mesh-ancestor
101418446|NCT00404222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101418447|NCT00404222|Narcotics|narcotics|mesh-ancestor
101418448|NCT00404222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101418449|NCT00404222|Antitussive Agents|antitussive agents|mesh-ancestor
101418450|NCT00404222|Respiratory System Agents|respiratory system agents|mesh-ancestor
101418451|NCT00404222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101418452|NCT00404222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101418453|NCT00404222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101418454|NCT00160602|Certolizumab Pegol|certolizumab pegol|mesh-list
101418455|NCT00160602|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101418456|NCT00160602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101418457|NCT00160602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101418461|NCT00138242|Carboplatin|carboplatin|mesh-list
101418509|NCT00154167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101418510|NCT00154167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418513|NCT00138515|Vildagliptin|vildagliptin|mesh-list
101418582|NCT00154323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418658|NCT01243177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101418659|NCT01243177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101418732|NCT00161226|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101418734|NCT00161226|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101418736|NCT00139256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101418737|NCT00139256|Glucocorticoids|glucocorticoids|mesh-ancestor
101418738|NCT00139256|Hormones|hormones|mesh-ancestor
101418739|NCT00139256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101418743|NCT00161304|Methyltestosterone|methyltestosterone|mesh-list
101418800|NCT00139646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101418801|NCT00139646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418802|NCT00139646|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101418867|NCT00404261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418868|NCT00404261|Glucocorticoids|glucocorticoids|mesh-ancestor
101418870|NCT00404261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101418871|NCT00404261|Sympathomimetics|sympathomimetics|mesh-ancestor
101418872|NCT00406380|Bevacizumab|bevacizumab|mesh-list
101418947|NCT04724226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101418949|NCT04724343|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101419022|NCT01240135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101419023|NCT00140348|Immunomodulating Agents|immunomodulating agents|mesh-list
101419024|NCT00140348|Immunologic Factors|immunologic factors|mesh-ancestor
101419100|NCT00154869|Antimetabolites|antimetabolites|mesh-ancestor
101419101|NCT00154869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363092|NCT00130585|Vitamins|vitamins|mesh-ancestor
101419102|NCT00154869|Antiviral Agents|antiviral agents|mesh-ancestor
101419103|NCT00154869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101419104|NCT00140660|Rituximab|rituximab|mesh-list
101419105|NCT00140660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101419106|NCT00140660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101419107|NCT00140660|Immunologic Factors|immunologic factors|mesh-ancestor
101419174|NCT00140933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101419175|NCT00140933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101419176|NCT00140933|Analgesics|analgesics|mesh-ancestor
101419177|NCT00140933|Sensory System Agents|sensory system agents|mesh-ancestor
101419178|NCT00140933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101419179|NCT00140933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419180|NCT00140933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101419181|NCT00140933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101419182|NCT00140933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101419183|NCT00140933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101419243|NCT00407082|Glucocorticoids|glucocorticoids|mesh-ancestor
101419244|NCT00407082|Hormones|hormones|mesh-ancestor
101419245|NCT00407082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101419246|NCT00407082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419247|NCT00141089|Tegaserod|tegaserod|mesh-list
101419248|NCT00141089|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101419312|NCT04518124|Propranolol|propranolol|mesh-list
101419313|NCT04518124|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101419314|NCT04518124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101419381|NCT00404417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101419382|NCT00404417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101419383|NCT00404417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419384|NCT00404417|Cholinergic Agents|cholinergic agents|mesh-ancestor
101419385|NCT00404417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101419386|NCT00404417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419387|NCT00404417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101419388|NCT00404417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101419389|NCT04519762|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101419390|NCT04519762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101419392|NCT00162357|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101419447|NCT00155376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419448|NCT00155376|Analgesics|analgesics|mesh-ancestor
101419449|NCT00155376|Sensory System Agents|sensory system agents|mesh-ancestor
101419450|NCT00155376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101419513|NCT04517890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101419514|NCT04517890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419515|NCT04517890|Sensory System Agents|sensory system agents|mesh-ancestor
101419582|NCT04517188|Povidone|povidone|mesh-list
101419583|NCT04517188|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101419584|NCT04517188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101419585|NCT04517188|Trace Elements|trace elements|mesh-ancestor
101419586|NCT04517188|Micronutrients|micronutrients|mesh-ancestor
101419587|NCT04517188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306632|NCT02026817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101306633|NCT02026817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101306634|NCT02026817|Antimetabolites|antimetabolites|mesh-ancestor
101419648|NCT00141830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419649|NCT00141830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101419650|NCT00141830|Dermatologic Agents|dermatologic agents|mesh-ancestor
101419651|NCT00141830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101419718|NCT00162669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101419719|NCT00162669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101419720|NCT00162669|Growth Substances|growth substances|mesh-ancestor
101419805|NCT00505804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101419806|NCT00505804|Analgesics|analgesics|mesh-ancestor
101419807|NCT00505804|Sensory System Agents|sensory system agents|mesh-ancestor
101419880|NCT00142493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419881|NCT00142493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101419882|NCT00142493|Anesthetics, General|anesthetics, general|mesh-ancestor
101419883|NCT00142493|Anesthetics|anesthetics|mesh-ancestor
101419884|NCT00142493|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101419885|NCT00142493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101419968|NCT00404573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101419970|NCT00506272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101419971|NCT00506272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419972|NCT00506311|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101420035|NCT00163254|Abciximab|abciximab|mesh-list
101420036|NCT00163254|Anticoagulants|anticoagulants|mesh-ancestor
101420037|NCT00163254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101420038|NCT00143000|Ribavirin|ribavirin|mesh-list
101420039|NCT00143000|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101420109|NCT00143156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101420111|NCT00143156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101420112|NCT00143156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101420180|NCT00143429|Latanoprost|latanoprost|mesh-list
101420181|NCT00143429|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101420182|NCT00143429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101420183|NCT02598895|Carboplatin|carboplatin|mesh-list
101420184|NCT02598895|Docetaxel|docetaxel|mesh-list
101420251|NCT00156078|Analgesics|analgesics|mesh-ancestor
101420252|NCT00156078|Sensory System Agents|sensory system agents|mesh-ancestor
101420253|NCT00156078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101420254|NCT00156078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420255|NCT00156078|Anticonvulsants|anticonvulsants|mesh-ancestor
101420256|NCT00156078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101420257|NCT00156078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101420258|NCT00156078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420259|NCT00156078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101420260|NCT00156078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101420261|NCT00156078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101420311|NCT00143975|Immunoconjugates|immunoconjugates|mesh-ancestor
101420312|NCT00156312|Docetaxel|docetaxel|mesh-list
101420316|NCT00156312|Antimitotic Agents|antimitotic agents|mesh-ancestor
101420317|NCT00156312|Mitosis Modulators|mitosis modulators|mesh-ancestor
101420318|NCT00156312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420384|NCT00148005|Cholinergic Antagonists|cholinergic antagonists|mesh-list
101420385|NCT00148005|Cholinergic Agents|cholinergic agents|mesh-ancestor
101420386|NCT00148005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101420457|NCT00507091|Fluorouracil|fluorouracil|mesh-list
101420458|NCT00507091|Irinotecan|irinotecan|mesh-list
101420459|NCT00507091|Antimetabolites|antimetabolites|mesh-ancestor
101420465|NCT00507091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421368|NCT00470743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101421369|NCT00470743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421370|NCT00470743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101421373|NCT00470743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101421441|NCT00157872|Gout Suppressants|gout suppressants|mesh-ancestor
101421442|NCT00157872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101421443|NCT00157872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101421446|NCT03271255|Bevacizumab|bevacizumab|mesh-list
101421530|NCT00471640|Autonomic Agents|autonomic agents|mesh-ancestor
101421531|NCT00471640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101421532|NCT00471640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421533|NCT00471640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101421534|NCT00471640|Glucocorticoids|glucocorticoids|mesh-ancestor
101421634|NCT00472810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101421635|NCT00472810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101421636|NCT00337051|Propofol|propofol|mesh-list
101421637|NCT00337051|Sevoflurane|sevoflurane|mesh-list
101421638|NCT00337051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101421639|NCT00337051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101421640|NCT00337051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421641|NCT00337051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101421642|NCT00337051|Anesthetics, General|anesthetics, general|mesh-ancestor
101421720|NCT00473239|Micronutrients|micronutrients|mesh-ancestor
101421721|NCT00473239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421722|NCT00473239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101421803|NCT00405080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101421804|NCT00405080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421805|NCT00405080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101421806|NCT00405080|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101421807|NCT00405080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101421886|NCT00509431|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101421887|NCT00509431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101421888|NCT00509431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101421913|NCT00405158|Acetaminophen|acetaminophen|mesh-list
101421996|NCT02953210|GABA Modulators|gaba modulators|mesh-ancestor
101421997|NCT02953210|GABA Agents|gaba agents|mesh-ancestor
101421998|NCT02953210|Antipruritics|antipruritics|mesh-ancestor
101421999|NCT02953210|Dermatologic Agents|dermatologic agents|mesh-ancestor
101422000|NCT02953210|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101422022|NCT00509743|Diclofenac|diclofenac|mesh-list
101422060|NCT02958215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422061|NCT02958215|Protective Agents|protective agents|mesh-ancestor
101422148|NCT00338767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422149|NCT00338767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101422150|NCT00338767|Serotonin Agents|serotonin agents|mesh-ancestor
101422151|NCT00338767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422152|NCT00338767|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101422153|NCT00338767|Antidepressive Agents|antidepressive agents|mesh-ancestor
101422154|NCT00338767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101422155|NCT00338767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101422156|NCT00338767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101422157|NCT00338767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101422159|NCT00339001|Hematinics|hematinics|mesh-ancestor
101422160|NCT00150306|Sertraline|sertraline|mesh-list
101422161|NCT00150306|Antidepressive Agents|antidepressive agents|mesh-ancestor
101422168|NCT00150306|Serotonin Agents|serotonin agents|mesh-ancestor
101422205|NCT00425191|Antimitotic Agents|antimitotic agents|mesh-ancestor
101422206|NCT00425191|Mitosis Modulators|mitosis modulators|mesh-ancestor
101422207|NCT00339118|Doxorubicin|doxorubicin|mesh-list
101422208|NCT00339118|Cyclophosphamide|cyclophosphamide|mesh-list
101422209|NCT00339118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101422210|NCT00339118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422211|NCT00339118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101422212|NCT00339118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101422225|NCT00339196|Tretinoin|tretinoin|mesh-list
101422272|NCT00150423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101422348|NCT00339586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101422349|NCT00339586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101422350|NCT00339586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422351|NCT00158886|Topotecan|topotecan|mesh-list
101422352|NCT00158886|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101422353|NCT00158886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101422354|NCT00158886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101422355|NCT00158886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422356|NCT00158886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422357|NCT00510406|Tamsulosin|tamsulosin|mesh-list
101422358|NCT00510406|Solifenacin Succinate|solifenacin succinate|mesh-list
101422359|NCT00510406|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101422360|NCT00510406|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101422404|NCT00510445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101422405|NCT00150657|Bevacizumab|bevacizumab|mesh-list
101422410|NCT00150657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101422411|NCT00150657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101422412|NCT00150657|Growth Substances|growth substances|mesh-ancestor
101422413|NCT00150657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422414|NCT00150657|Growth Inhibitors|growth inhibitors|mesh-ancestor
101422415|NCT00150657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101422416|NCT00150657|Antimetabolites|antimetabolites|mesh-ancestor
101422417|NCT00150657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422419|NCT00511771|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101422420|NCT00511771|Serotonin Agents|serotonin agents|mesh-ancestor
101422467|NCT00165633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101422468|NCT00165633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422470|NCT00165633|Micronutrients|micronutrients|mesh-ancestor
101422471|NCT00165633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422472|NCT02952469|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101422473|NCT02952469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422485|NCT04695925|Carboplatin|carboplatin|mesh-list
101422486|NCT04695925|Pemetrexed|pemetrexed|mesh-list
101422487|NCT04695925|Osimertinib|osimertinib|mesh-list
101422488|NCT04695925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422489|NCT04695925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101422490|NCT04695925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422491|NCT04695925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101422492|NCT04695925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101422493|NCT04695925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101422494|NCT00511069|Bortezomib|bortezomib|mesh-list
101422495|NCT00511069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422496|NCT00165750|Donepezil|donepezil|mesh-list
101422497|NCT00165750|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101422498|NCT00165750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101422499|NCT00165750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422500|NCT00165750|Cholinergic Agents|cholinergic agents|mesh-ancestor
101422501|NCT00165750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101422502|NCT00165750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422503|NCT00165750|Nootropic Agents|nootropic agents|mesh-ancestor
101422504|NCT00511225|Cholecalciferol|cholecalciferol|mesh-list
101422505|NCT00511225|Vitamin D|vitamin d|mesh-list
101422506|NCT00511225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101422507|NCT00511225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422522|NCT04864067|Protective Agents|protective agents|mesh-ancestor
101422523|NCT04864067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422524|NCT04864067|Vitamin B Complex|vitamin b complex|mesh-ancestor
101422525|NCT04864067|Vitamins|vitamins|mesh-ancestor
101422596|NCT00512980|Gemcitabine|gemcitabine|mesh-list
101422597|NCT00512980|Doxorubicin|doxorubicin|mesh-list
101422598|NCT00512980|Vinblastine|vinblastine|mesh-list
101422599|NCT00512980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101422697|NCT00405236|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101422852|NCT00515320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101422853|NCT00515320|Serotonin Agents|serotonin agents|mesh-ancestor
101306747|NCT02027363|Antimetabolites|antimetabolites|mesh-ancestor
101306748|NCT02027363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306749|NCT02027363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422854|NCT00515320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422855|NCT00515320|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101422856|NCT00515320|Antidepressive Agents|antidepressive agents|mesh-ancestor
101422857|NCT00515320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101422860|NCT00515320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101422861|NCT00515359|Propofol|propofol|mesh-list
101422862|NCT00515359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101422863|NCT00515359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101422864|NCT00515359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422910|NCT00515593|Parathyroid Hormone|parathyroid hormone|mesh-list
101422911|NCT00515593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101422987|NCT00151242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101422988|NCT00151242|Keratolytic Agents|keratolytic agents|mesh-ancestor
101422989|NCT00151242|Dermatologic Agents|dermatologic agents|mesh-ancestor
101422990|NCT00516100|Pemetrexed|pemetrexed|mesh-list
101422991|NCT00516100|Bortezomib|bortezomib|mesh-list
101423072|NCT05861466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423073|NCT05861466|Growth Inhibitors|growth inhibitors|mesh-ancestor
101423074|NCT05861466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423075|NCT05861336|Paclitaxel|paclitaxel|mesh-list
101423151|NCT05860699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101423152|NCT05860699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101423153|NCT05860699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423155|NCT05860335|Paclitaxel|paclitaxel|mesh-list
101423156|NCT05860335|Nedaplatin|nedaplatin|mesh-list
101423157|NCT05860335|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101423158|NCT05860335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423159|NCT05860335|Tubulin Modulators|tubulin modulators|mesh-ancestor
101423160|NCT05860335|Antimitotic Agents|antimitotic agents|mesh-ancestor
101423161|NCT05860335|Mitosis Modulators|mitosis modulators|mesh-ancestor
101423162|NCT05860335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423216|NCT05860010|Anesthetics, Local|anesthetics, local|mesh-ancestor
101423217|NCT05860010|Anesthetics|anesthetics|mesh-ancestor
101423218|NCT05860010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101423219|NCT05860010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423289|NCT05858918|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101423290|NCT05858918|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101423291|NCT05858918|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101423292|NCT05858918|Purinergic Agents|purinergic agents|mesh-ancestor
101423293|NCT05858918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101423378|NCT05722782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101423379|NCT05722782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101423454|NCT05576792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423455|NCT05576792|Growth Inhibitors|growth inhibitors|mesh-ancestor
101423531|NCT05457582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101423532|NCT05457582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101423533|NCT05457582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101363102|NCT00130702|Gefitinib|gefitinib|mesh-list
101423534|NCT05457582|Protease Inhibitors|protease inhibitors|mesh-ancestor
101423535|NCT05375916|Hydromorphone|hydromorphone|mesh-list
101423536|NCT05375916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101423537|NCT05375916|Narcotics|narcotics|mesh-ancestor
101423538|NCT05375916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101423539|NCT05375916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423541|NCT05375916|Sensory System Agents|sensory system agents|mesh-ancestor
101423542|NCT05375916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101423543|NCT05359354|Vaccines|vaccines|mesh-list
101423544|NCT05359354|Immunologic Factors|immunologic factors|mesh-ancestor
101423545|NCT05359354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423546|NCT05346562|Cannabidiol|cannabidiol|mesh-list
101423547|NCT05346562|Anticonvulsants|anticonvulsants|mesh-ancestor
101423548|NCT05313529|Metformin|metformin|mesh-list
101423549|NCT05313529|Liraglutide|liraglutide|mesh-list
101423550|NCT05313529|Empagliflozin|empagliflozin|mesh-list
101423551|NCT05313529|Linagliptin|linagliptin|mesh-list
101423600|NCT05190705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101423601|NCT05190705|Antiemetics|antiemetics|mesh-ancestor
101423674|NCT04898231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101423749|NCT04797767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423750|NCT04797767|Analgesics|analgesics|mesh-ancestor
101423751|NCT04797767|Sensory System Agents|sensory system agents|mesh-ancestor
101423752|NCT04797767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101423753|NCT04797767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101423754|NCT04797767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101423755|NCT04797767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101423756|NCT04797767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101423757|NCT04787341|Panitumumab|panitumumab|mesh-list
101423758|NCT04787341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101423764|NCT04781972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101423765|NCT04781972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101423766|NCT04781972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423768|NCT04781972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101306782|NCT02027675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306783|NCT02027753|Metformin|metformin|mesh-list
101306784|NCT02027753|Insulin Glargine|insulin glargine|mesh-list
101423808|NCT04721015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423809|NCT04721015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101423810|NCT04721015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101423811|NCT04679389|Acetazolamide|acetazolamide|mesh-list
101423812|NCT04679389|Anticonvulsants|anticonvulsants|mesh-ancestor
101423813|NCT04679389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101423814|NCT04679389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101423815|NCT04679389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423816|NCT04679389|Diuretics|diuretics|mesh-ancestor
101423817|NCT04679389|Natriuretic Agents|natriuretic agents|mesh-ancestor
101423818|NCT04679389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423819|NCT04645589|Mycophenolic Acid|mycophenolic acid|mesh-list
101423820|NCT04645589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101423821|NCT04645589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423822|NCT04645589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101423823|NCT04645589|Antitubercular Agents|antitubercular agents|mesh-ancestor
101423824|NCT04645589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101423825|NCT04645589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101423826|NCT04645589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101423831|NCT04644016|Busulfan|busulfan|mesh-list
101423865|NCT04616196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423866|NCT04583956|Remdesivir|remdesivir|mesh-list
101423867|NCT04583956|Antimetabolites|antimetabolites|mesh-ancestor
101423868|NCT04583956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423869|NCT04583956|Antiviral Agents|antiviral agents|mesh-ancestor
101423870|NCT04583956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101423941|NCT04395989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423942|NCT04395989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101423944|NCT04395989|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101423950|NCT04393454|Sirolimus|sirolimus|mesh-list
101424001|NCT04195633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101424002|NCT04195633|Alkylating Agents|alkylating agents|mesh-ancestor
101424003|NCT04195633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424004|NCT04195633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424005|NCT04195633|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101424006|NCT04195633|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101424007|NCT04195633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101424008|NCT04195633|Antifungal Agents|antifungal agents|mesh-ancestor
101424009|NCT04195633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101424010|NCT04195633|Dermatologic Agents|dermatologic agents|mesh-ancestor
101424011|NCT04195633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101424012|NCT04195633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101424013|NCT04195633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101424014|NCT04195633|Antitubercular Agents|antitubercular agents|mesh-ancestor
101424015|NCT04195633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101424074|NCT03900793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101424075|NCT03900793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101424076|NCT03900793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101424078|NCT03897881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101424079|NCT03897881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424080|NCT03897881|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101424081|NCT03897881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424082|NCT03896880|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101424083|NCT03896880|Clotrimazole|clotrimazole|mesh-list
101424084|NCT03896880|Miconazole|miconazole|mesh-list
101424085|NCT03896880|Antifungal Agents|antifungal agents|mesh-list
101424086|NCT03896880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101424087|NCT03896880|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101424092|NCT03896880|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101424132|NCT03815019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101424133|NCT03815019|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101424134|NCT03815019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101424135|NCT03815019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424205|NCT03216187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101424206|NCT03216187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101424207|NCT03195270|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101424208|NCT03195270|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101424209|NCT03195270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424211|NCT03172754|Axitinib|axitinib|mesh-list
101424212|NCT03172754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101424213|NCT03172754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424279|NCT02811523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424280|NCT02750319|Acetylcysteine|acetylcysteine|mesh-list
101424348|NCT02144857|Dermatologic Agents|dermatologic agents|mesh-ancestor
101424349|NCT02144857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101424350|NCT02144857|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101424351|NCT02144857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101424352|NCT02144857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101424353|NCT02144857|Analgesics|analgesics|mesh-ancestor
101424354|NCT02144857|Sensory System Agents|sensory system agents|mesh-ancestor
101424355|NCT02144857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101424356|NCT02144857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101424357|NCT02144857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101424358|NCT02144857|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101424359|NCT02144857|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101424360|NCT02131597|Guadecitabine|guadecitabine|mesh-list
101424361|NCT02131597|Azacitidine|azacitidine|mesh-list
101424362|NCT02131597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424363|NCT02131597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101424368|NCT02095184|Anastrozole|anastrozole|mesh-list
101424369|NCT02095184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424370|NCT02095184|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101424371|NCT02095184|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101424372|NCT02095184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101424373|NCT02095184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424374|NCT02095184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101424375|NCT02095184|Hormone Antagonists|hormone antagonists|mesh-ancestor
101424376|NCT02095184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101424377|NCT02095184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424378|NCT02095184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101424379|NCT01252953|Oxazolidinones|oxazolidinones|mesh-list
101424380|NCT01252953|Anacetrapib|anacetrapib|mesh-list
101424381|NCT01252953|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101424382|NCT01252953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101424383|NCT01252953|Antimetabolites|antimetabolites|mesh-ancestor
101424391|NCT00937131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424392|NCT00937131|Immunologic Factors|immunologic factors|mesh-ancestor
101424393|NCT00937131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424394|NCT00937131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101424395|NCT00837616|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101424396|NCT00837616|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101424397|NCT00837616|Estradiol|estradiol|mesh-list
101424398|NCT00837616|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101424399|NCT00837616|Estrogens|estrogens|mesh-ancestor
101424400|NCT00837616|Hormones|hormones|mesh-ancestor
101424401|NCT00837616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101424402|NCT00837616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424403|NCT00837616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101424407|NCT00610051|Alprostadil|alprostadil|mesh-list
101424454|NCT00516958|Levofloxacin|levofloxacin|mesh-list
101424455|NCT00516958|Ofloxacin|ofloxacin|mesh-list
101424456|NCT00516958|Sodium Hypochlorite|sodium hypochlorite|mesh-list
101424457|NCT00516958|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101424528|NCT00517621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424641|NCT02949466|Immunologic Factors|immunologic factors|mesh-ancestor
101424642|NCT02949466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101424643|NCT02949466|Viscosupplements|viscosupplements|mesh-ancestor
101424644|NCT02949466|Protective Agents|protective agents|mesh-ancestor
101424645|NCT00151710|Pioglitazone|pioglitazone|mesh-list
101424646|NCT00151710|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101424647|NCT00151710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424648|NCT00519181|Valproic Acid|valproic acid|mesh-list
101424649|NCT00519181|Anticonvulsants|anticonvulsants|mesh-ancestor
101424650|NCT00519181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101424651|NCT00519181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424652|NCT00519181|GABA Agents|gaba agents|mesh-ancestor
101424659|NCT00166803|Rosiglitazone|rosiglitazone|mesh-list
101424705|NCT00166842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101424706|NCT00166842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424707|NCT02949193|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101424708|NCT02949193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101424709|NCT02949193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424710|NCT02949193|Incretins|incretins|mesh-ancestor
101424784|NCT02948920|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101424785|NCT02948920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424786|NCT02948920|Sympathomimetics|sympathomimetics|mesh-ancestor
101424787|NCT02948920|Autonomic Agents|autonomic agents|mesh-ancestor
101424788|NCT02948920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101424789|NCT02948920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101424790|NCT02948920|Adrenergic Agents|adrenergic agents|mesh-ancestor
101424791|NCT02948920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101424792|NCT02948920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424794|NCT00151827|Olmesartan|olmesartan|mesh-list
101424795|NCT00151827|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101424796|NCT00151827|Furosemide|furosemide|mesh-list
101424797|NCT00151827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101424798|NCT00151827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101424799|NCT00151827|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101424801|NCT00151827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424802|NCT00151827|Diuretics|diuretics|mesh-ancestor
101424803|NCT00151827|Natriuretic Agents|natriuretic agents|mesh-ancestor
101424804|NCT00151827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424807|NCT00519805|Dalteparin|dalteparin|mesh-list
101424834|NCT04457180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101424835|NCT04457180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101424836|NCT00520000|Carboplatin|carboplatin|mesh-list
101424837|NCT00520000|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101424838|NCT00520000|Paclitaxel|paclitaxel|mesh-list
101424839|NCT00520000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424840|NCT00520000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101424841|NCT00520000|Tubulin Modulators|tubulin modulators|mesh-ancestor
101424842|NCT00520000|Antimitotic Agents|antimitotic agents|mesh-ancestor
101424843|NCT00520000|Mitosis Modulators|mitosis modulators|mesh-ancestor
101424844|NCT00520000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424845|NCT00151944|Mesalamine|mesalamine|mesh-list
101424846|NCT00151944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101424847|NCT00151944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101424848|NCT00151944|Analgesics|analgesics|mesh-ancestor
101424849|NCT00151944|Sensory System Agents|sensory system agents|mesh-ancestor
101424854|NCT00520507|Olanzapine|olanzapine|mesh-list
101424897|NCT00152022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101424898|NCT00152022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424899|NCT00152022|Sympathomimetics|sympathomimetics|mesh-ancestor
101424900|NCT00152022|Autonomic Agents|autonomic agents|mesh-ancestor
101424979|NCT00521482|Thalidomide|thalidomide|mesh-list
101424980|NCT00521482|Temozolomide|temozolomide|mesh-list
101424981|NCT00521482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101424982|NCT00521482|Alkylating Agents|alkylating agents|mesh-ancestor
101424983|NCT00521482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424984|NCT00521482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424985|NCT00521482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101424986|NCT00521482|Immunologic Factors|immunologic factors|mesh-ancestor
101424987|NCT00521482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424988|NCT00521482|Leprostatic Agents|leprostatic agents|mesh-ancestor
101424989|NCT00521482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101424990|NCT00521482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101424991|NCT00521482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101424992|NCT00521482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101424996|NCT00521521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424997|NCT00521521|Tubulin Modulators|tubulin modulators|mesh-ancestor
101424998|NCT00521521|Antimitotic Agents|antimitotic agents|mesh-ancestor
101424999|NCT00521521|Mitosis Modulators|mitosis modulators|mesh-ancestor
101425000|NCT00521521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425001|NCT00152100|Alemtuzumab|alemtuzumab|mesh-list
101425002|NCT00152100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101425003|NCT00152100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101425004|NCT00522184|Etanercept|etanercept|mesh-list
101425030|NCT03458923|Sensory System Agents|sensory system agents|mesh-ancestor
101425031|NCT03458923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101425032|NCT03458923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101425033|NCT03458923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101425034|NCT03458923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101425035|NCT04186013|Atezolizumab|atezolizumab|mesh-list
101425036|NCT04186013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101425037|NCT04186013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425038|NCT04186013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101425039|NCT04186013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101425040|NCT00152139|Antibodies|antibodies|mesh-list
101425041|NCT00152139|Immunologic Factors|immunologic factors|mesh-ancestor
101425094|NCT00152178|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101425095|NCT00152178|Hormone Antagonists|hormone antagonists|mesh-ancestor
101425096|NCT00152178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101425097|NCT00152178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101425101|NCT00523120|Diclofenac|diclofenac|mesh-list
101425159|NCT04726553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101425160|NCT04726553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101425161|NCT02947945|Reslizumab|reslizumab|mesh-list
101425162|NCT02947945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101425163|NCT02947945|Respiratory System Agents|respiratory system agents|mesh-ancestor
101425164|NCT02948101|Cyclophosphamide|cyclophosphamide|mesh-list
101425165|NCT02948101|Antibodies|antibodies|mesh-list
101425166|NCT02948101|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101425167|NCT02948101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101425168|NCT02948101|Immunologic Factors|immunologic factors|mesh-ancestor
101425169|NCT02948101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425170|NCT02948101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101425171|NCT02948101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101425172|NCT02948101|Alkylating Agents|alkylating agents|mesh-ancestor
101425173|NCT02948101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425174|NCT02948101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101425175|NCT02948101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101425176|NCT02952157|Lidocaine|lidocaine|mesh-list
101425177|NCT02952157|Anesthetics, Local|anesthetics, local|mesh-ancestor
101425178|NCT02952157|Anesthetics|anesthetics|mesh-ancestor
101306862|NCT02028260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306863|NCT02028260|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101425179|NCT02952157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101425180|NCT02952157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425181|NCT02952157|Sensory System Agents|sensory system agents|mesh-ancestor
101425182|NCT02952157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101425183|NCT02952157|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101425184|NCT02952157|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101425203|NCT02951728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101425204|NCT02951728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101425205|NCT02951728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101425206|NCT02951728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101425209|NCT02951728|Glucocorticoids|glucocorticoids|mesh-ancestor
101425210|NCT02951728|Hormones|hormones|mesh-ancestor
101425211|NCT02951728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101425212|NCT02951728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101425213|NCT02951728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101425214|NCT02951728|Tubulin Modulators|tubulin modulators|mesh-ancestor
101425215|NCT02951728|Antimitotic Agents|antimitotic agents|mesh-ancestor
101425216|NCT02951728|Mitosis Modulators|mitosis modulators|mesh-ancestor
101425217|NCT02951728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101425218|NCT02951728|Antimetabolites|antimetabolites|mesh-ancestor
101425219|NCT04726046|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101425220|NCT04726046|Cefotetan|cefotetan|mesh-list
101425221|NCT04726046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101425222|NCT00523354|Infliximab|infliximab|mesh-list
101425223|NCT00523354|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101425224|NCT00523354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101425225|NCT00523354|Dermatologic Agents|dermatologic agents|mesh-ancestor
101425226|NCT00523354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101425227|NCT00523354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101425228|NCT00523393|Insulin|insulin|mesh-list
101425229|NCT00523393|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101425230|NCT00523393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101425231|NCT00523393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425232|NCT00523432|Sirolimus|sirolimus|mesh-list
101425233|NCT00523432|Topotecan|topotecan|mesh-list
101425234|NCT00523432|Temsirolimus|temsirolimus|mesh-list
101425235|NCT00523432|MTOR Inhibitors|mtor inhibitors|mesh-list
101425236|NCT00523432|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101425237|NCT00523432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101425238|NCT00523432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101425239|NCT00523432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425243|NCT00523432|Immunologic Factors|immunologic factors|mesh-ancestor
101425245|NCT00523432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101425246|NCT00523432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101425247|NCT00523432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101425248|NCT00523432|Antifungal Agents|antifungal agents|mesh-ancestor
101425249|NCT00512044|Anesthetics|anesthetics|mesh-list
101306864|NCT02028260|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101306865|NCT02028260|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101306866|NCT02028260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306867|NCT02028299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101306868|NCT02028312|Loteprednol Etabonate|loteprednol etabonate|mesh-list
101425250|NCT00512044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101425251|NCT00512044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425252|NCT04726007|Fibrinolytic Agents|fibrinolytic agents|mesh-list
101425253|NCT04726007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101425254|NCT04726007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425256|NCT00521950|Azathioprine|azathioprine|mesh-list
101425257|NCT00521950|Antimetabolites|antimetabolites|mesh-ancestor
101425258|NCT00521950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425259|NCT00521950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101425260|NCT00521950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101425261|NCT00521950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101425262|NCT00521950|Immunologic Factors|immunologic factors|mesh-ancestor
101425263|NCT00521950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425264|NCT00521950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101425265|NCT00521950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101425266|NCT00521950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101425267|NCT00523666|Galantamine|galantamine|mesh-list
101307810|NCT02043717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101307811|NCT02043730|Paclitaxel|paclitaxel|mesh-list
101307812|NCT02043730|Gemcitabine|gemcitabine|mesh-list
101440137|NCT04565990|Selexipag|selexipag|mesh-list
101440138|NCT04565990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101440139|NCT04563520|Coagulants|coagulants|mesh-list
101440140|NCT04563520|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
101440141|NCT04535544|Tenofovir|tenofovir|mesh-list
101440142|NCT04535544|Entecavir|entecavir|mesh-list
101440143|NCT04535544|Antiviral Agents|antiviral agents|mesh-ancestor
101440144|NCT04535544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101440145|NCT04535544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101440146|NCT04535544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101440147|NCT04535544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101440148|NCT04535544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440164|NCT04523207|Relugolix|relugolix|mesh-list
101440165|NCT04523207|Androgen Antagonists|androgen antagonists|mesh-ancestor
101440166|NCT04523207|Hormone Antagonists|hormone antagonists|mesh-ancestor
101425268|NCT00523666|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101425269|NCT00523666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101425270|NCT00523666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425271|NCT00523666|Cholinergic Agents|cholinergic agents|mesh-ancestor
101425272|NCT00523666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101425273|NCT00523666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425274|NCT00523666|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101425275|NCT00523666|Autonomic Agents|autonomic agents|mesh-ancestor
101425276|NCT00523666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101425277|NCT00523666|Nootropic Agents|nootropic agents|mesh-ancestor
101425278|NCT00167583|Interferons|interferons|mesh-list
101425279|NCT00167583|Interferon-alpha|interferon-alpha|mesh-list
101425280|NCT00167583|Interferon alpha-2|interferon alpha-2|mesh-list
101425284|NCT00167583|Antiviral Agents|antiviral agents|mesh-ancestor
101425285|NCT00167583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101425286|NCT00167583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101425287|NCT00167583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425288|NCT00167583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101425289|NCT00167583|Immunologic Factors|immunologic factors|mesh-ancestor
101425290|NCT00167583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425291|NCT00167583|Antifungal Agents|antifungal agents|mesh-ancestor
101425292|NCT00167583|Dermatologic Agents|dermatologic agents|mesh-ancestor
101425293|NCT00167583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101425294|NCT00167583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101425320|NCT00512395|Analgesics|analgesics|mesh-ancestor
101425321|NCT00512395|Sensory System Agents|sensory system agents|mesh-ancestor
101425322|NCT00512395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101425323|NCT00512395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101425324|NCT00512395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101425325|NCT00512395|Anesthetics, General|anesthetics, general|mesh-ancestor
101425326|NCT00512395|Anesthetics|anesthetics|mesh-ancestor
101425328|NCT00512473|Hormones|hormones|mesh-list
101425405|NCT00512824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425406|NCT00512824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101425407|NCT00512863|Adalimumab|adalimumab|mesh-list
101425408|NCT00512863|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101425409|NCT00512863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101425410|NCT00512863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101425411|NCT00524407|Epoetin Alfa|epoetin alfa|mesh-list
101306878|NCT02028403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306879|NCT02028416|Thymoglobulin|thymoglobulin|mesh-list
101425478|NCT03845348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101425479|NCT03845348|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101425480|NCT03845348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101425487|NCT03845348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101425489|NCT04723563|Anticoagulants|anticoagulants|mesh-ancestor
101425490|NCT04723563|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101425491|NCT04723563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101425492|NCT04723563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425493|NCT00525967|Acetaminophen|acetaminophen|mesh-list
101425494|NCT00525967|Methadone|methadone|mesh-list
101425495|NCT00525967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101425496|NCT00525967|Analgesics|analgesics|mesh-ancestor
101425497|NCT00525967|Sensory System Agents|sensory system agents|mesh-ancestor
101425498|NCT00525967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101425499|NCT00525967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425500|NCT00525967|Antipyretics|antipyretics|mesh-ancestor
101425538|NCT00524836|Histamine Agents|histamine agents|mesh-ancestor
101425539|NCT00524836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101425540|NCT00524836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425541|NCT00524836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425542|NCT00524875|Bevacizumab|bevacizumab|mesh-list
101425543|NCT00524875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101425544|NCT00524875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101425548|NCT00524875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425550|NCT00524914|Apomorphine|apomorphine|mesh-list
101425551|NCT00524914|Emetics|emetics|mesh-ancestor
101425552|NCT00524914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425553|NCT00524914|Autonomic Agents|autonomic agents|mesh-ancestor
101425554|NCT00524914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101425555|NCT00524914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101306880|NCT02028416|Immunologic Factors|immunologic factors|mesh-ancestor
101306881|NCT02028416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425556|NCT00524914|Dopamine Agonists|dopamine agonists|mesh-ancestor
101425557|NCT00524914|Dopamine Agents|dopamine agents|mesh-ancestor
101425596|NCT02947672|Autonomic Agents|autonomic agents|mesh-ancestor
101425597|NCT02947672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101425598|NCT02947672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425599|NCT02947672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101425600|NCT02947672|Glucocorticoids|glucocorticoids|mesh-ancestor
101425601|NCT02947672|Hormones|hormones|mesh-ancestor
101425602|NCT02947672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101425603|NCT02947672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101425604|NCT02947672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101425606|NCT03539627|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101425607|NCT03539627|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101425608|NCT03539627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425609|NCT02946268|Ropivacaine|ropivacaine|mesh-list
101425610|NCT02946268|Anesthetics, Local|anesthetics, local|mesh-ancestor
101425683|NCT00526513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101425684|NCT00526513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425685|NCT00168168|Lenograstim|lenograstim|mesh-list
101425686|NCT00168168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101425687|NCT00168168|Immunologic Factors|immunologic factors|mesh-ancestor
101425688|NCT00168168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425689|NCT03225755|Hormones|hormones|mesh-list
101425690|NCT03225755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101425691|NCT03225755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425692|NCT00525577|Probucol|probucol|mesh-list
101425693|NCT00525577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101425694|NCT00525577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101425695|NCT00525577|Antimetabolites|antimetabolites|mesh-ancestor
101425696|NCT00525577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425697|NCT00525577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101425698|NCT00525577|Antioxidants|antioxidants|mesh-ancestor
101425699|NCT00525577|Protective Agents|protective agents|mesh-ancestor
101425700|NCT00525577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425701|NCT03186755|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
101425702|NCT03186755|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101425703|NCT03186755|Hyaluronic Acid|hyaluronic acid|mesh-list
101425704|NCT03186755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101425705|NCT03186755|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101425706|NCT03186755|Immunologic Factors|immunologic factors|mesh-ancestor
101425707|NCT03186755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425708|NCT03186755|Viscosupplements|viscosupplements|mesh-ancestor
101425709|NCT03186755|Protective Agents|protective agents|mesh-ancestor
101425710|NCT03186755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101425728|NCT00525616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425729|NCT00525616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101425730|NCT00525694|Cocaine|cocaine|mesh-list
101425731|NCT00525694|Anesthetics, Local|anesthetics, local|mesh-ancestor
101425732|NCT00525694|Anesthetics|anesthetics|mesh-ancestor
101425733|NCT00525694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101425734|NCT00525694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425735|NCT00525694|Sensory System Agents|sensory system agents|mesh-ancestor
101425736|NCT00525694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101425737|NCT00525694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101425738|NCT00525694|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101425739|NCT00525694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101425741|NCT00525694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425743|NCT00525694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101425744|NCT02947243|Morphine|morphine|mesh-list
101425745|NCT02947243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101425746|NCT02947243|Narcotics|narcotics|mesh-ancestor
101425747|NCT02947243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101425748|NCT02947243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425749|NCT02947243|Analgesics|analgesics|mesh-ancestor
101425750|NCT02947243|Sensory System Agents|sensory system agents|mesh-ancestor
101425751|NCT02947243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101425752|NCT02946970|Quinine|quinine|mesh-list
101425753|NCT02946970|Antimalarials|antimalarials|mesh-ancestor
101425754|NCT02946970|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101425755|NCT02946970|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101425756|NCT02946970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101425757|NCT02946970|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101425758|NCT02946970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425775|NCT00407277|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101425776|NCT00407277|Autonomic Agents|autonomic agents|mesh-ancestor
101425777|NCT00407277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101425778|NCT00407277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425779|NCT00407277|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101425780|NCT00407277|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101425781|NCT00407277|Cholinergic Agents|cholinergic agents|mesh-ancestor
101425782|NCT00407277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101425783|NCT00407277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425784|NCT00527059|Simendan|simendan|mesh-list
101425785|NCT00527059|Spironolactone|spironolactone|mesh-list
101425786|NCT00527059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101425787|NCT00527059|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101425788|NCT00527059|Hormone Antagonists|hormone antagonists|mesh-ancestor
101425789|NCT00527059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101425790|NCT00527059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425791|NCT00527059|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101425792|NCT00527059|Diuretics|diuretics|mesh-ancestor
101425793|NCT00527059|Natriuretic Agents|natriuretic agents|mesh-ancestor
101425794|NCT00527059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101425795|NCT00527059|Adrenergic Agents|adrenergic agents|mesh-ancestor
101425796|NCT00527059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101425797|NCT00527059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306885|NCT02028429|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101425798|NCT00527059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101425799|NCT00527059|Vasodilator Agents|vasodilator agents|mesh-ancestor
101425800|NCT00527059|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101425801|NCT00527059|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101425802|NCT00527059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101425803|NCT00527059|Protective Agents|protective agents|mesh-ancestor
101425804|NCT03156452|Mycophenolic Acid|mycophenolic acid|mesh-list
101440167|NCT04523207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101440168|NCT04523207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440169|NCT04513912|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101440170|NCT04513912|Antidepressive Agents|antidepressive agents|mesh-ancestor
101440171|NCT04513912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101440172|NCT04513912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101440173|NCT04513912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101440174|NCT04513912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101440175|NCT04513912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425806|NCT03156452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101425877|NCT03058835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101425878|NCT03058835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425895|NCT00173667|Nifedipine|nifedipine|mesh-list
101425950|NCT02945644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101425951|NCT02945644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425952|NCT02945644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101425953|NCT02945644|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101425957|NCT02945644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101425958|NCT02945644|Serotonin Agents|serotonin agents|mesh-ancestor
101425959|NCT02945644|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101425960|NCT02945644|Antidepressive Agents|antidepressive agents|mesh-ancestor
101425961|NCT02460887|Cisplatin|cisplatin|mesh-list
101425962|NCT02460887|Gemcitabine|gemcitabine|mesh-list
101425963|NCT02460887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101425964|NCT02460887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101425965|NCT02460887|Antimetabolites|antimetabolites|mesh-ancestor
101425967|NCT02945527|Dexamethasone|dexamethasone|mesh-list
101426008|NCT00168402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426009|NCT00168402|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101426010|NCT00168402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101426011|NCT00529594|Etoricoxib|etoricoxib|mesh-list
101426012|NCT00529594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101426013|NCT00529594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101426014|NCT00529594|Analgesics|analgesics|mesh-ancestor
101426015|NCT00529594|Sensory System Agents|sensory system agents|mesh-ancestor
101426016|NCT00529594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101426017|NCT00529594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426018|NCT00529594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101426019|NCT00529594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101426020|NCT00529594|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101426069|NCT00168480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101426070|NCT00168480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101426071|NCT00168480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306902|NCT02028507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101306903|NCT02028507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101306904|NCT02028507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101426072|NCT00168480|Cholinergic Agents|cholinergic agents|mesh-ancestor
101426073|NCT00168480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101426139|NCT00527800|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101426140|NCT00527800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101426141|NCT00527800|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101426142|NCT00527800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101426143|NCT00527800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101426144|NCT00527800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426145|NCT00527800|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101426146|NCT00527800|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101306905|NCT02028507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101306906|NCT02028507|Hormone Antagonists|hormone antagonists|mesh-ancestor
101426147|NCT00527800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101426212|NCT00531310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101426213|NCT00531310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426214|NCT00531310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101426215|NCT00531310|Immunologic Factors|immunologic factors|mesh-ancestor
101426216|NCT00531310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426217|NCT00531310|Alkylating Agents|alkylating agents|mesh-ancestor
101426218|NCT00531310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101426219|NCT00531310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101426220|NCT00407862|Losartan|losartan|mesh-list
101426221|NCT00407862|Telmisartan|telmisartan|mesh-list
101426222|NCT00407862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101426223|NCT00407862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101426224|NCT00407862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101426225|NCT00407862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101426227|NCT00527995|Sildenafil Citrate|sildenafil citrate|mesh-list
101426279|NCT00528151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101426280|NCT00528151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101426281|NCT00528151|Analgesics|analgesics|mesh-ancestor
101426282|NCT00528151|Sensory System Agents|sensory system agents|mesh-ancestor
101426283|NCT00528151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101426308|NCT00168597|Vitamin A|vitamin a|mesh-list
101426350|NCT00528502|Anesthetics, Local|anesthetics, local|mesh-ancestor
101426351|NCT00528502|Anesthetics|anesthetics|mesh-ancestor
101426352|NCT00528502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101426353|NCT00528502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426354|NCT00528502|Sensory System Agents|sensory system agents|mesh-ancestor
101426355|NCT00528502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101426356|NCT00528502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101426357|NCT00528502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101426358|NCT00528502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101426359|NCT00528502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101426360|NCT00528502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426369|NCT00528619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101426370|NCT00528619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101426371|NCT00528619|Growth Substances|growth substances|mesh-ancestor
101426372|NCT00528619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426373|NCT00528619|Growth Inhibitors|growth inhibitors|mesh-ancestor
101426374|NCT00528619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101426375|NCT00168714|Interferons|interferons|mesh-list
101426376|NCT00168714|Interferon-beta|interferon-beta|mesh-list
101426377|NCT00168714|Interferon beta-1a|interferon beta-1a|mesh-list
101426379|NCT00168714|Antiviral Agents|antiviral agents|mesh-ancestor
101426402|NCT00528814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101426403|NCT00528814|Disinfectants|disinfectants|mesh-ancestor
101426404|NCT00168753|Alefacept|alefacept|mesh-list
101426405|NCT00168753|Dermatologic Agents|dermatologic agents|mesh-ancestor
101426406|NCT00168753|Immunologic Factors|immunologic factors|mesh-ancestor
101426407|NCT00168753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426408|NCT00528892|Raltegravir Potassium|raltegravir potassium|mesh-list
101426409|NCT00528892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101426410|NCT00528892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101426411|NCT00528892|Antiviral Agents|antiviral agents|mesh-ancestor
101426412|NCT00528892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101426413|NCT00528892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101426414|NCT00528892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101426415|NCT00528892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101426416|NCT00528892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426466|NCT02944396|Carboplatin|carboplatin|mesh-list
101426467|NCT02944396|Nivolumab|nivolumab|mesh-list
101426468|NCT02944396|Pemetrexed|pemetrexed|mesh-list
101426469|NCT02944396|Veliparib|veliparib|mesh-list
101426470|NCT02944396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101426546|NCT00168909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101426547|NCT00168909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426548|NCT00168909|Vitamins|vitamins|mesh-ancestor
101426549|NCT00168909|Micronutrients|micronutrients|mesh-ancestor
101426550|NCT00145379|Metformin|metformin|mesh-list
101426551|NCT00145379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101426552|NCT00145379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426553|NCT00168948|Pyrimethamine|pyrimethamine|mesh-list
101426554|NCT00168948|Antimalarials|antimalarials|mesh-ancestor
101426555|NCT00168948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101426556|NCT00168948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101426557|NCT00168948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101426558|NCT00168948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101426559|NCT00168948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101426560|NCT00168948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426570|NCT00530413|GABA Modulators|gaba modulators|mesh-ancestor
101426571|NCT00530413|GABA Agents|gaba agents|mesh-ancestor
101426572|NCT00530413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101426573|NCT00530413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101426574|NCT00530413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101426575|NCT00174330|Amlodipine|amlodipine|mesh-list
101426576|NCT00174330|Atorvastatin|atorvastatin|mesh-list
101426577|NCT00174330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101426578|NCT00174330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101426604|NCT00531895|Sensory System Agents|sensory system agents|mesh-ancestor
101426605|NCT00531895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101426606|NCT00531895|Antidepressive Agents|antidepressive agents|mesh-ancestor
101426607|NCT00531895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101426608|NCT00531895|Dopamine Agents|dopamine agents|mesh-ancestor
101426609|NCT02942914|Insulin Glargine|insulin glargine|mesh-list
101426610|NCT02942914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101426611|NCT02942914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426612|NCT00169026|Antipsychotic Agents|antipsychotic agents|mesh-list
101426613|NCT00169026|Clozapine|clozapine|mesh-list
101426614|NCT00169026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101426615|NCT00169026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101306924|NCT02028598|Sequestering Agents|sequestering agents|mesh-ancestor
101306925|NCT02028598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306926|NCT02028598|Vasodilator Agents|vasodilator agents|mesh-ancestor
101306927|NCT02028598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101426616|NCT00169026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426617|NCT00169026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101426618|NCT00169026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101426620|NCT00169026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101426621|NCT00169026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426622|NCT00169026|GABA Antagonists|gaba antagonists|mesh-ancestor
101426623|NCT00169026|GABA Agents|gaba agents|mesh-ancestor
101426629|NCT00531973|Epirubicin|epirubicin|mesh-list
101426630|NCT00531973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101426654|NCT05319301|Melatonin|melatonin|mesh-list
101426655|NCT05319301|Antioxidants|antioxidants|mesh-ancestor
101426656|NCT05319301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426657|NCT05319301|Protective Agents|protective agents|mesh-ancestor
101426658|NCT05319301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426659|NCT05319301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101426660|NCT00169065|Olanzapine|olanzapine|mesh-list
101426661|NCT00169065|Clozapine|clozapine|mesh-list
101426662|NCT00169065|Antiemetics|antiemetics|mesh-ancestor
101426663|NCT00169065|Autonomic Agents|autonomic agents|mesh-ancestor
101426666|NCT00169065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101426717|NCT02276911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101426718|NCT02276911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101426719|NCT02276911|Analgesics|analgesics|mesh-ancestor
101426781|NCT00145886|Parathyroid Hormone|parathyroid hormone|mesh-list
101426782|NCT00145886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426783|NCT00145886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101426784|NCT00174603|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101426785|NCT00174603|Antidepressive Agents|antidepressive agents|mesh-ancestor
101426786|NCT00174603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101426787|NCT00174603|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101426788|NCT00174603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101426789|NCT00174603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101426790|NCT00174603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426791|NCT02942563|Capecitabine|capecitabine|mesh-list
101426792|NCT02942563|Oxaliplatin|oxaliplatin|mesh-list
101426793|NCT02942563|Irinotecan|irinotecan|mesh-list
101426794|NCT02942563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101426795|NCT02942563|Antimetabolites|antimetabolites|mesh-ancestor
101426797|NCT02942563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101426838|NCT00174681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101487410|NCT00432588|Dinoprostone|dinoprostone|mesh-list
101426846|NCT00146042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101426847|NCT00146042|Tubulin Modulators|tubulin modulators|mesh-ancestor
101426848|NCT00146042|Antimitotic Agents|antimitotic agents|mesh-ancestor
101426911|NCT02942212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426912|NCT00146120|Etoposide|etoposide|mesh-list
101426981|NCT02277067|Oxytocics|oxytocics|mesh-ancestor
101426982|NCT00146276|Gemcitabine|gemcitabine|mesh-list
101426993|NCT00174798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426995|NCT02940808|Caffeine|caffeine|mesh-list
101426996|NCT02940808|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101426997|NCT02940808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426998|NCT02940808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101426999|NCT02940808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101427000|NCT02940808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427001|NCT02940808|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101427002|NCT02940808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101427003|NCT02940808|Purinergic Agents|purinergic agents|mesh-ancestor
101427004|NCT02940808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101427005|NCT00169416|Valacyclovir|valacyclovir|mesh-list
101427006|NCT00169416|Antiviral Agents|antiviral agents|mesh-ancestor
101427007|NCT00169416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101427008|NCT00174876|Aripiprazole|aripiprazole|mesh-list
101427009|NCT00174876|Antidepressive Agents|antidepressive agents|mesh-ancestor
101427010|NCT00174876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101427011|NCT00174876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101427012|NCT00174876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101427013|NCT00174876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101427014|NCT00174876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427015|NCT00174876|Dopamine Agonists|dopamine agonists|mesh-ancestor
101427016|NCT00174876|Dopamine Agents|dopamine agents|mesh-ancestor
101427017|NCT00174876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101427018|NCT00174876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427019|NCT00174876|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101427020|NCT00174876|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101427022|NCT00174876|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101427023|NCT00174876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101306953|NCT02028689|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101306954|NCT02028689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101427032|NCT02940379|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
101427033|NCT02940379|Metoprolol|metoprolol|mesh-list
101427034|NCT02940379|Midazolam|midazolam|mesh-list
101427035|NCT02940379|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101427036|NCT02940379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101427037|NCT02940379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101427038|NCT02940379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427039|NCT02940379|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101427040|NCT02940379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101427041|NCT02940379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101427042|NCT02940379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101427043|NCT02940379|Anesthetics, General|anesthetics, general|mesh-ancestor
101427044|NCT02940379|Anesthetics|anesthetics|mesh-ancestor
101427053|NCT02940379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101427054|NCT02940379|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101427055|NCT02940379|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101427056|NCT02940379|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101427057|NCT02940379|Adrenergic Agents|adrenergic agents|mesh-ancestor
101427058|NCT02940379|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101427059|NCT02940379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101427060|NCT00146549|Paclitaxel|paclitaxel|mesh-list
101427061|NCT00146549|Vinorelbine|vinorelbine|mesh-list
101427085|NCT00146588|Capecitabine|capecitabine|mesh-list
101427086|NCT00146588|Epirubicin|epirubicin|mesh-list
101427087|NCT00146588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101427088|NCT00146588|Immunologic Factors|immunologic factors|mesh-ancestor
101427089|NCT00146588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427090|NCT00146588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101427091|NCT00146588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101427092|NCT00146588|Alkylating Agents|alkylating agents|mesh-ancestor
101427093|NCT00146588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427094|NCT00146588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101427095|NCT00146588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101427096|NCT00146588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101427097|NCT00146588|Antimetabolites|antimetabolites|mesh-ancestor
101427098|NCT00146588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101427099|NCT00146588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101427100|NCT00146588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101427101|NCT00146588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101427103|NCT00175032|Celecoxib|celecoxib|mesh-list
101427104|NCT00175032|Naproxen|naproxen|mesh-list
101427105|NCT00175032|Lansoprazole|lansoprazole|mesh-list
101427106|NCT00175032|Dexlansoprazole|dexlansoprazole|mesh-list
101306955|NCT02028689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101306956|NCT02028689|Gout Suppressants|gout suppressants|mesh-ancestor
101306957|NCT02028689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101306958|NCT02028689|Uricosuric Agents|uricosuric agents|mesh-ancestor
101306959|NCT02028819|Dolutegravir|dolutegravir|mesh-list
101306960|NCT02028819|Ibalizumab|ibalizumab|mesh-list
101427107|NCT00175032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101427108|NCT00175032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101427127|NCT00146627|Eflornithine|eflornithine|mesh-list
101427128|NCT00146627|Nifurtimox|nifurtimox|mesh-list
101427129|NCT00146627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101427130|NCT00146627|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101427131|NCT00146627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101427132|NCT00146627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101427133|NCT00146627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101427134|NCT00146627|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
101427135|NCT00146627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101427136|NCT00146627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427137|NCT00169533|Lapatinib|lapatinib|mesh-list
101427138|NCT00169533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101427139|NCT00169533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101427140|NCT00169533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101427141|NCT00169533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427142|NCT00424229|Lenalidomide|lenalidomide|mesh-list
101427143|NCT00424229|Immunologic Factors|immunologic factors|mesh-ancestor
101427183|NCT00169572|Aprepitant|aprepitant|mesh-list
101363150|NCT00046358|Analgesics|analgesics|mesh-ancestor
101427195|NCT00169572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101427196|NCT00169572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101427197|NCT00169572|Antipruritics|antipruritics|mesh-ancestor
101427198|NCT00169572|Dermatologic Agents|dermatologic agents|mesh-ancestor
101427199|NCT00169572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101427205|NCT00146783|Pyrimethamine|pyrimethamine|mesh-list
101427265|NCT00175227|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101427266|NCT00175227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101427267|NCT00175227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427268|NCT00175227|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101427332|NCT02939248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427333|NCT02939248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101427334|NCT02938975|Permethrin|permethrin|mesh-list
101427335|NCT02938975|Insect Repellents|insect repellents|mesh-list
101427336|NCT02938975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101427337|NCT02938975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427338|NCT02938975|Protective Agents|protective agents|mesh-ancestor
101427339|NCT02938975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427340|NCT02939092|Chlorhexidine|chlorhexidine|mesh-list
101427341|NCT02939092|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101427342|NCT02939092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101427343|NCT02939092|Disinfectants|disinfectants|mesh-ancestor
101427344|NCT00175305|Octreotide|octreotide|mesh-list
101427400|NCT00147524|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101427401|NCT00147524|Protease Inhibitors|protease inhibitors|mesh-ancestor
101427402|NCT00147524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101427403|NCT00147524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427404|NCT00147524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101427405|NCT00147563|Eplerenone|eplerenone|mesh-list
101427406|NCT00147563|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101427407|NCT00147563|Hormone Antagonists|hormone antagonists|mesh-ancestor
101427468|NCT03458143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101427469|NCT03458143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427470|NCT03458143|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101427471|NCT03458143|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101427472|NCT03458143|Anesthetics, General|anesthetics, general|mesh-ancestor
101427540|NCT00147836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427542|NCT02931136|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101427543|NCT02931136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101427544|NCT02931136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427545|NCT02931136|Cholinergic Agents|cholinergic agents|mesh-ancestor
101427546|NCT02931136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101427547|NCT02931136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101306978|NCT02028910|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101306979|NCT02028910|Serotonin Agents|serotonin agents|mesh-ancestor
101306980|NCT02028910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101427549|NCT02931136|Protective Agents|protective agents|mesh-ancestor
101427602|NCT02930551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101427603|NCT02930551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101427604|NCT02930551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101427605|NCT02930551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101427606|NCT02930551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101427672|NCT00175695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101427673|NCT02930317|Factor VIII|factor viii|mesh-list
101427674|NCT02930317|Coagulants|coagulants|mesh-ancestor
101427675|NCT00148148|Amphotericin B|amphotericin b|mesh-list
101427676|NCT00148148|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101427698|NCT02929693|Gefitinib|gefitinib|mesh-list
101427749|NCT00170196|Glucocorticoids|glucocorticoids|mesh-ancestor
101427750|NCT00170196|Hormones|hormones|mesh-ancestor
101427751|NCT00170196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101427829|NCT03457597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101427830|NCT03457597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101427831|NCT03457597|Sympatholytics|sympatholytics|mesh-ancestor
101427832|NCT03457597|Autonomic Agents|autonomic agents|mesh-ancestor
101427833|NCT03457597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101427834|NCT03457597|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101427835|NCT03457597|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101427836|NCT03457597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101427837|NCT03457597|Adrenergic Agents|adrenergic agents|mesh-ancestor
101427838|NCT02929147|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
101427839|NCT02929147|Morphine|morphine|mesh-list
101427840|NCT02929147|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101427841|NCT02929147|Narcotics|narcotics|mesh-ancestor
101427842|NCT02929147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101427843|NCT02929147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427890|NCT02928328|Anesthetics|anesthetics|mesh-ancestor
101427891|NCT02928328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101427892|NCT02928328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427970|NCT02925832|Proxymetacaine|proxymetacaine|mesh-list
101427971|NCT02925832|Anesthetics|anesthetics|mesh-list
101427972|NCT02925832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101427973|NCT02925832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427974|NCT02925832|Sensory System Agents|sensory system agents|mesh-ancestor
101427975|NCT02925832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101427976|NCT00170430|Fluconazole|fluconazole|mesh-list
101428040|NCT02925559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428041|NCT00149240|Botulinum Toxins|botulinum toxins|mesh-list
101428042|NCT00149240|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101428043|NCT00149240|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101428044|NCT00149240|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101428115|NCT00170859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428116|NCT00170859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101428117|NCT00170859|Immunologic Factors|immunologic factors|mesh-ancestor
101428118|NCT00170859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428119|NCT00170859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101428120|NCT02917057|Exenatide|exenatide|mesh-list
101428124|NCT02917057|Incretins|incretins|mesh-ancestor
101428179|NCT02916238|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101428249|NCT04688632|Contraceptive Agents|contraceptive agents|mesh-ancestor
101428250|NCT04688632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101428251|NCT04688632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428252|NCT04688632|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101428253|NCT04688632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101428254|NCT04688632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101428255|NCT00171015|Valsartan|valsartan|mesh-list
101428256|NCT00171015|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101428257|NCT00171015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101428258|NCT00171015|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101428259|NCT00171015|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101428313|NCT05785585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428314|NCT05785585|Hematinics|hematinics|mesh-ancestor
101428315|NCT05785442|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101428316|NCT05785442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101428318|NCT05785429|Gout Suppressants|gout suppressants|mesh-ancestor
101428325|NCT05785377|Bupivacaine|bupivacaine|mesh-list
101428384|NCT05784987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428385|NCT05784987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101428386|NCT05784987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101428387|NCT05784987|Growth Substances|growth substances|mesh-ancestor
101428388|NCT05784987|Growth Inhibitors|growth inhibitors|mesh-ancestor
101428389|NCT05784987|Analgesics|analgesics|mesh-ancestor
101428390|NCT05784987|Sensory System Agents|sensory system agents|mesh-ancestor
101428391|NCT05784987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101428453|NCT05781321|Dopamine Agents|dopamine agents|mesh-ancestor
101428454|NCT05781321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101428455|NCT05781321|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101428456|NCT05781321|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101428458|NCT05780437|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
101428459|NCT05780437|Antimetabolites|antimetabolites|mesh-ancestor
101428460|NCT05780437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428519|NCT05724316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101428521|NCT05723705|Hematinics|hematinics|mesh-ancestor
101428522|NCT05634577|Pembrolizumab|pembrolizumab|mesh-list
101428523|NCT05634577|Mitotane|mitotane|mesh-list
101428524|NCT05634577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101428525|NCT05634577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101428526|NCT05634577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101428527|NCT05634577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428528|NCT05634577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101428529|NCT05616260|Acetazolamide|acetazolamide|mesh-list
101428530|NCT05616260|Anticonvulsants|anticonvulsants|mesh-ancestor
101428531|NCT05616260|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101428532|NCT05616260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101428533|NCT05616260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307042|NCT02029313|Hormone Antagonists|hormone antagonists|mesh-ancestor
101307043|NCT02029313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101307044|NCT02029313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428568|NCT05355935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101428630|NCT05292339|Analgesics|analgesics|mesh-ancestor
101428631|NCT05292339|Sensory System Agents|sensory system agents|mesh-ancestor
101428632|NCT05292339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101428633|NCT05292339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101428634|NCT05292339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101428635|NCT05291650|Hyaluronic Acid|hyaluronic acid|mesh-list
101428636|NCT05291650|Glucocorticoids|glucocorticoids|mesh-list
101428637|NCT05291650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101428700|NCT05091242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428701|NCT05028140|Pioglitazone|pioglitazone|mesh-list
101428702|NCT05028140|Empagliflozin|empagliflozin|mesh-list
101428703|NCT05028140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101428704|NCT05028140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428705|NCT05028140|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101428706|NCT05028140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428773|NCT04792502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101428779|NCT04777422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101428781|NCT04777422|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101428842|NCT04532918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101428843|NCT04532918|Antitubercular Agents|antitubercular agents|mesh-ancestor
101428850|NCT04532918|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101428851|NCT04532918|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101428856|NCT04532918|Antioxidants|antioxidants|mesh-ancestor
101428914|NCT04335669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101428933|NCT04310176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428934|NCT04310176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101429015|NCT04033055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429016|NCT04033055|Sensory System Agents|sensory system agents|mesh-ancestor
101429017|NCT04033055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101429018|NCT04015596|Naproxen|naproxen|mesh-list
101429019|NCT04015596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101429089|NCT03490344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101429090|NCT03490344|Growth Substances|growth substances|mesh-ancestor
101429091|NCT03490344|Growth Inhibitors|growth inhibitors|mesh-ancestor
101429157|NCT03433755|Evolocumab|evolocumab|mesh-list
101429158|NCT03433755|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101429159|NCT03433755|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101429160|NCT03433755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101429161|NCT03433755|Antimetabolites|antimetabolites|mesh-ancestor
101429162|NCT03433755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429163|NCT03433755|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101429164|NCT03433755|Protease Inhibitors|protease inhibitors|mesh-ancestor
101429165|NCT03433755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101429166|NCT03433755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101429167|NCT03406507|Ravulizumab|ravulizumab|mesh-list
101429230|NCT02726581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101429231|NCT02726581|Antiemetics|antiemetics|mesh-ancestor
101429232|NCT02726581|Autonomic Agents|autonomic agents|mesh-ancestor
101429233|NCT02726581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101429234|NCT02726581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429235|NCT02726581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101429236|NCT02726581|Glucocorticoids|glucocorticoids|mesh-ancestor
101429237|NCT02726581|Hormones|hormones|mesh-ancestor
101429238|NCT02726581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101429239|NCT02726581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101429240|NCT02726581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101429241|NCT02726581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101429242|NCT02726581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101429243|NCT02726581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429244|NCT02726581|Immunologic Factors|immunologic factors|mesh-ancestor
101429245|NCT02726581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101429246|NCT02726581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101429247|NCT02726581|Growth Substances|growth substances|mesh-ancestor
101429248|NCT02726581|Growth Inhibitors|growth inhibitors|mesh-ancestor
101429249|NCT02700048|Naloxone|naloxone|mesh-list
101429264|NCT02406209|Methylprednisolone|methylprednisolone|mesh-list
101363155|NCT00046358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101429265|NCT02406209|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101429266|NCT02406209|Prednisolone acetate|prednisolone acetate|mesh-list
101429267|NCT02406209|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101429271|NCT02406209|Hormones|hormones|mesh-ancestor
101429290|NCT02295722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101429291|NCT02295722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101429292|NCT02295722|Immunologic Factors|immunologic factors|mesh-ancestor
101429371|NCT00635700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101429372|NCT00635700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429373|NCT00635700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429374|NCT00635700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101429375|NCT00635700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101429376|NCT00635700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101429377|NCT00635700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101429378|NCT00635700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101429379|NCT00635700|Dopamine Agents|dopamine agents|mesh-ancestor
101429458|NCT02915809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429459|NCT00405860|Mycophenolic Acid|mycophenolic acid|mesh-list
101429530|NCT02914054|Antiemetics|antiemetics|mesh-ancestor
101429531|NCT02914054|Autonomic Agents|autonomic agents|mesh-ancestor
101429532|NCT02914054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101429534|NCT02914054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101429598|NCT00150215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429599|NCT00150215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101429600|NCT00150215|Serotonin Agents|serotonin agents|mesh-ancestor
101429601|NCT00171171|Deferasirox|deferasirox|mesh-list
101429602|NCT00171171|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101429603|NCT00171171|Chelating Agents|chelating agents|mesh-ancestor
101429604|NCT00171171|Sequestering Agents|sequestering agents|mesh-ancestor
101429664|NCT00150293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429665|NCT00150293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101429667|NCT00150293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101429668|NCT00150293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101429669|NCT00150293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101429670|NCT02913118|Amoxicillin|amoxicillin|mesh-list
101429671|NCT02913118|Azithromycin|azithromycin|mesh-list
101429672|NCT02913118|Doxycycline|doxycycline|mesh-list
101429673|NCT02913118|Minocycline|minocycline|mesh-list
101429674|NCT02913118|Cephalosporins|cephalosporins|mesh-list
101429675|NCT02913118|Fluoroquinolones|fluoroquinolones|mesh-list
101429676|NCT02913118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101429677|NCT02913118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101429678|NCT02913118|Antimalarials|antimalarials|mesh-ancestor
101429679|NCT02913118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101429680|NCT02913118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101429681|NCT02913118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101429682|NCT02913118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101429683|NCT02913118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429684|NCT00150332|Linezolid|linezolid|mesh-list
101429723|NCT02912182|Prednisolone|prednisolone|mesh-list
101429724|NCT02912182|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101429725|NCT02912182|Methylprednisolone|methylprednisolone|mesh-list
101429726|NCT02912182|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101429794|NCT00150527|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101429795|NCT00150527|Antidepressive Agents|antidepressive agents|mesh-ancestor
101429796|NCT00150527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101429797|NCT00171327|Valsartan|valsartan|mesh-list
101429802|NCT02911597|Naltrexone|naltrexone|mesh-list
101429877|NCT00150722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101429878|NCT00150722|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101429879|NCT00150722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101429880|NCT00150761|Levocetirizine|levocetirizine|mesh-list
101429955|NCT00532207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429956|NCT00532207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101429957|NCT04723836|Riboflavin|riboflavin|mesh-list
101429958|NCT04723836|Vitamins|vitamins|mesh-ancestor
101429959|NCT04723836|Micronutrients|micronutrients|mesh-ancestor
101307138|NCT02029794|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101430017|NCT00171522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430018|NCT00171522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430020|NCT02716012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101430022|NCT02716012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101307140|NCT02029794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101430092|NCT05467189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430093|NCT05467189|Alkylating Agents|alkylating agents|mesh-ancestor
101430165|NCT00532519|Serotonin Agents|serotonin agents|mesh-ancestor
101307142|NCT02029898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101307143|NCT02029898|Narcotics|narcotics|mesh-ancestor
101307144|NCT02029898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101430166|NCT00532519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430169|NCT00532519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101430236|NCT00171756|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101430237|NCT00171756|Adrenergic Agents|adrenergic agents|mesh-ancestor
101307145|NCT02029898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307146|NCT02029898|Analgesics|analgesics|mesh-ancestor
101307147|NCT02029898|Sensory System Agents|sensory system agents|mesh-ancestor
101430306|NCT05308030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430307|NCT05308030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101430375|NCT00151736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101430376|NCT00171990|Famciclovir|famciclovir|mesh-list
101430377|NCT00171990|Antiviral Agents|antiviral agents|mesh-ancestor
101307151|NCT02029924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307153|NCT02029937|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101307154|NCT02029937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101307155|NCT02029950|Cytarabine|cytarabine|mesh-list
101430439|NCT00151970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101430440|NCT00151970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430441|NCT00151970|Dopamine Agents|dopamine agents|mesh-ancestor
101430442|NCT00151970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101430444|NCT00152048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101430445|NCT00152048|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101430470|NCT00533026|Warfarin|warfarin|mesh-list
101307168|NCT02029950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101307169|NCT02029950|Antimetabolites|antimetabolites|mesh-ancestor
101307170|NCT02029950|Antiviral Agents|antiviral agents|mesh-ancestor
101430507|NCT00425451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101430572|NCT00164892|Sensory System Agents|sensory system agents|mesh-ancestor
101430573|NCT00164892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101430574|NCT00164892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430575|NCT00164892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101430576|NCT00164892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101430577|NCT00152399|Somatostatin|somatostatin|mesh-list
101307173|NCT02029950|Immunologic Factors|immunologic factors|mesh-ancestor
101430643|NCT04725422|Certolizumab Pegol|certolizumab pegol|mesh-list
101430645|NCT04725422|Methotrexate|methotrexate|mesh-list
101430646|NCT04725422|Leflunomide|leflunomide|mesh-list
101430647|NCT04725422|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101430716|NCT02936830|Protective Agents|protective agents|mesh-ancestor
101307174|NCT02029950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307175|NCT02029950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101307176|NCT02029950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101430717|NCT02936830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430718|NCT02936830|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101430719|NCT02936830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101430720|NCT02936830|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101430721|NCT00165048|Rofecoxib|rofecoxib|mesh-list
101430722|NCT00165048|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101430723|NCT00165048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101430724|NCT00165048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101430725|NCT00165048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430726|NCT00165048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101430728|NCT00165048|Analgesics|analgesics|mesh-ancestor
101430774|NCT00152828|Celecoxib|celecoxib|mesh-list
101430775|NCT00152828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101430776|NCT00152828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101430777|NCT00152828|Analgesics|analgesics|mesh-ancestor
101430778|NCT00152828|Sensory System Agents|sensory system agents|mesh-ancestor
101430779|NCT00152828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101430780|NCT00152828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430781|NCT00152828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101430782|NCT00152828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101430841|NCT02935972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101430842|NCT02935972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101430843|NCT02935972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101430844|NCT02935972|Anesthetics, General|anesthetics, general|mesh-ancestor
101430845|NCT02935972|GABA Modulators|gaba modulators|mesh-ancestor
101430913|NCT00152984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101430914|NCT00152984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430915|NCT00152984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101430916|NCT00152984|Respiratory System Agents|respiratory system agents|mesh-ancestor
101430917|NCT00152984|Parasympatholytics|parasympatholytics|mesh-ancestor
101430918|NCT00152984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101430982|NCT04689958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430983|NCT04689958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101430984|NCT00153140|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101430986|NCT00153140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101431052|NCT00165360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431054|NCT02933905|Ranibizumab|ranibizumab|mesh-list
101431055|NCT02933905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101431061|NCT02933788|Aspirin|aspirin|mesh-list
101431124|NCT00153491|Lumefantrine|lumefantrine|mesh-list
101431125|NCT00153491|Artemether|artemether|mesh-list
101431126|NCT00153491|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101431127|NCT00153491|Antimalarials|antimalarials|mesh-ancestor
101431128|NCT00153491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101431129|NCT00153491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101431130|NCT00153491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101431131|NCT02933437|Ajmaline|ajmaline|mesh-list
101431132|NCT02933437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101431193|NCT02932774|Loratadine|loratadine|mesh-list
101431194|NCT02932774|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101431195|NCT02932774|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101431196|NCT02932774|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101431197|NCT02932774|Histamine Antagonists|histamine antagonists|mesh-ancestor
101431198|NCT02932774|Histamine Agents|histamine agents|mesh-ancestor
101431199|NCT02932774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101431200|NCT02932774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431201|NCT02932774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431202|NCT02932774|Antipruritics|antipruritics|mesh-ancestor
101431203|NCT02932774|Dermatologic Agents|dermatologic agents|mesh-ancestor
101431204|NCT00180063|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
101431205|NCT00180063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101431206|NCT00180063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431207|NCT00153725|Aspirin|aspirin|mesh-list
101431208|NCT00153725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101431209|NCT00153725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101431210|NCT00153725|Analgesics|analgesics|mesh-ancestor
101431211|NCT00153725|Sensory System Agents|sensory system agents|mesh-ancestor
101431254|NCT00153881|Mitosis Modulators|mitosis modulators|mesh-ancestor
101431255|NCT00153881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431329|NCT02924974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101431330|NCT02924974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101431381|NCT02924506|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101431382|NCT02924506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101431383|NCT02924506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101431384|NCT02924506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431385|NCT02924311|Aflibercept|aflibercept|mesh-list
101431395|NCT02924233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101431398|NCT02923999|Antibodies|antibodies|mesh-list
101431457|NCT00154388|Imatinib Mesylate|imatinib mesylate|mesh-list
101431458|NCT00154388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101431459|NCT00154388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101431526|NCT02922166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431527|NCT02922127|Contraceptive Agents|contraceptive agents|mesh-list
101431599|NCT02921269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431602|NCT02920801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101431603|NCT02920801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431637|NCT00180882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101431639|NCT00180882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431640|NCT00180882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101431712|NCT02920060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101431713|NCT02920060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101431714|NCT00154739|Gemcitabine|gemcitabine|mesh-list
101431715|NCT00154739|Epirubicin|epirubicin|mesh-list
101307272|NCT02034253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307273|NCT02034253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431784|NCT02910076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101431785|NCT02910115|Oxytocin|oxytocin|mesh-list
101431786|NCT02910115|Oxytocics|oxytocics|mesh-ancestor
101431854|NCT00155402|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101431855|NCT00155402|Hemostatics|hemostatics|mesh-ancestor
101431856|NCT00155402|Coagulants|coagulants|mesh-ancestor
101431857|NCT00188643|Lamotrigine|lamotrigine|mesh-list
101431920|NCT00155558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101431921|NCT00155558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101431922|NCT00155558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101431923|NCT00155558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101431924|NCT00155558|Immunologic Factors|immunologic factors|mesh-ancestor
101431925|NCT00155558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431926|NCT00155558|Antidotes|antidotes|mesh-ancestor
101431927|NCT00155558|Protective Agents|protective agents|mesh-ancestor
101431928|NCT00155558|Vitamin B Complex|vitamin b complex|mesh-ancestor
101431983|NCT00181740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431984|NCT00181779|Aripiprazole|aripiprazole|mesh-list
101431985|NCT00181779|Antidepressive Agents|antidepressive agents|mesh-ancestor
101431986|NCT00181779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101431987|NCT00181779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101431988|NCT00181779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101432053|NCT04462627|Immunologic Factors|immunologic factors|mesh-ancestor
101432054|NCT04462627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432055|NCT00406601|Sorafenib|sorafenib|mesh-list
101432056|NCT00406601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101432126|NCT00181935|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101432127|NCT00181935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101432128|NCT00181935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101432200|NCT02081755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101432201|NCT02081755|Immunologic Factors|immunologic factors|mesh-ancestor
101432202|NCT02081755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432203|NCT02081755|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101432204|NCT02081755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101307298|NCT02035891|Mitosis Modulators|mitosis modulators|mesh-ancestor
101432286|NCT00156299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432287|NCT00156299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101307300|NCT02035891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101307302|NCT02035956|Immunologic Factors|immunologic factors|mesh-ancestor
101307303|NCT02035956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432432|NCT00156689|Levetiracetam|levetiracetam|mesh-list
101432433|NCT00156689|Anticonvulsants|anticonvulsants|mesh-ancestor
101432434|NCT00156689|Nootropic Agents|nootropic agents|mesh-ancestor
101432435|NCT00536614|Cetuximab|cetuximab|mesh-list
101432436|NCT00536614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101432437|NCT00536614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101432526|NCT00182442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101432527|NCT00182442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101432528|NCT00182442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432529|NCT00182442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101432530|NCT00182442|Serotonin Agents|serotonin agents|mesh-ancestor
101432531|NCT00182442|Antidepressive Agents|antidepressive agents|mesh-ancestor
101432532|NCT00536770|Calcitriol|calcitriol|mesh-list
101432533|NCT00536770|Gemcitabine|gemcitabine|mesh-list
101432534|NCT00536770|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101432535|NCT00536770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101432598|NCT00189501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432599|NCT00189501|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101432600|NCT00189501|Hormone Antagonists|hormone antagonists|mesh-ancestor
101307311|NCT02036255|Anticoagulants|anticoagulants|mesh-ancestor
101432683|NCT00189618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101432684|NCT00189618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101432685|NCT00189618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101432686|NCT00189618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101307314|NCT02036255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432687|NCT00189618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432760|NCT00534586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101432761|NCT00534586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101432762|NCT00534586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101307316|NCT02036255|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101432825|NCT00406913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101432826|NCT00406913|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101307323|NCT02038062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101432827|NCT00406913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101432828|NCT00406913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432830|NCT00406952|Antidepressive Agents|antidepressive agents|mesh-ancestor
101432893|NCT00182871|Androgens|androgens|mesh-ancestor
101432894|NCT00182871|Hormones|hormones|mesh-ancestor
101432895|NCT00182871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101432896|NCT00182871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432897|NCT00189774|Nateglinide|nateglinide|mesh-list
101432898|NCT00189774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101432899|NCT00189774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432900|NCT04686643|Niacin|niacin|mesh-list
101432969|NCT03669523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101432970|NCT03669523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432973|NCT00157976|Dermatologic Agents|dermatologic agents|mesh-ancestor
101433046|NCT00158171|Hematinics|hematinics|mesh-ancestor
101433047|NCT00158171|Vitamin B Complex|vitamin b complex|mesh-ancestor
101433049|NCT00158171|Micronutrients|micronutrients|mesh-ancestor
101433050|NCT03370783|Ethanol|ethanol|mesh-list
101433051|NCT03370783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101433116|NCT00158522|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101433117|NCT00158522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101433139|NCT05169229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101433140|NCT05169229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101433141|NCT00538018|Telithromycin|telithromycin|mesh-list
101433146|NCT00158678|Cisplatin|cisplatin|mesh-list
101433229|NCT00538603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101433230|NCT00538603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101433315|NCT00537121|Vitamins|vitamins|mesh-ancestor
101433316|NCT00537121|Micronutrients|micronutrients|mesh-ancestor
101433317|NCT00537121|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101433318|NCT00406991|Aspirin|aspirin|mesh-list
101433319|NCT00406991|Clopidogrel|clopidogrel|mesh-list
101433320|NCT00406991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101433321|NCT00406991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101433380|NCT00537472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101433381|NCT00537472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433382|NCT00537472|Sensory System Agents|sensory system agents|mesh-ancestor
101433454|NCT00183807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101433455|NCT00183807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101433456|NCT00183807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433457|NCT00183807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101433459|NCT00183807|Analgesics|analgesics|mesh-ancestor
101433526|NCT00540241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101433527|NCT00540241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101433528|NCT00159224|Ritonavir|ritonavir|mesh-list
101433529|NCT00159224|Lopinavir|lopinavir|mesh-list
101433530|NCT00159224|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101433531|NCT00159224|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101433532|NCT00159224|Protease Inhibitors|protease inhibitors|mesh-ancestor
101433533|NCT00159224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101433547|NCT00183924|Docetaxel|docetaxel|mesh-list
101433594|NCT00540787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
101433595|NCT00540787|Propafenone|propafenone|mesh-list
101433596|NCT00540787|Dofetilide|dofetilide|mesh-list
101433597|NCT00540787|Cifenline|cifenline|mesh-list
101433598|NCT00540787|Calcium Channel Blockers|calcium channel blockers|mesh-list
101433677|NCT00541177|Atropine|atropine|mesh-list
101433678|NCT00541177|Tropicamide|tropicamide|mesh-list
101433679|NCT00541177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101433680|NCT00541177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101433681|NCT00541177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101433682|NCT00541177|Autonomic Agents|autonomic agents|mesh-ancestor
101433683|NCT00541177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101433685|NCT00541177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101433742|NCT00541489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101433743|NCT00541489|Gout Suppressants|gout suppressants|mesh-ancestor
101433744|NCT00541489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101433745|NCT00541489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101433746|NCT00541489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433747|NCT00541489|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101433748|NCT00190437|Amoxicillin|amoxicillin|mesh-list
101433810|NCT00541918|Sevoflurane|sevoflurane|mesh-list
101433811|NCT00541918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101433812|NCT00541918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101433813|NCT00541918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433814|NCT00541918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101433815|NCT00541918|Anesthetics, General|anesthetics, general|mesh-ancestor
101433879|NCT00408915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433880|NCT00408915|Dopamine Agonists|dopamine agonists|mesh-ancestor
101433881|NCT00408915|Dopamine Agents|dopamine agents|mesh-ancestor
101433882|NCT00542347|Esomeprazole|esomeprazole|mesh-list
101433883|NCT00542347|Omeprazole|omeprazole|mesh-list
101433884|NCT00542347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101433885|NCT00542347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101433886|NCT00542347|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101433887|NCT00542347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101433888|NCT00542347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433889|NCT00190554|Cisplatin|cisplatin|mesh-list
101433898|NCT00159770|Olanzapine|olanzapine|mesh-list
101433946|NCT00184041|Glucocorticoids|glucocorticoids|mesh-ancestor
101433947|NCT00184041|Hormones|hormones|mesh-ancestor
101433948|NCT00184041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101434017|NCT00159809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434018|NCT00159809|Vasodilator Agents|vasodilator agents|mesh-ancestor
101434019|NCT00159809|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101434020|NCT00159809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101434091|NCT00184197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434092|NCT00543829|Tamoxifen|tamoxifen|mesh-list
101434093|NCT00543829|Docetaxel|docetaxel|mesh-list
101434094|NCT00543829|Doxorubicin|doxorubicin|mesh-list
101434095|NCT00543829|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101434097|NCT00543829|Tubulin Modulators|tubulin modulators|mesh-ancestor
101434159|NCT00544219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101434160|NCT00544219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101434161|NCT00544219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101434162|NCT00544219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101434163|NCT00544219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101434164|NCT00544219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101434223|NCT00544609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101434224|NCT00544609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101434225|NCT00544609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434226|NCT00544687|Mometasone Furoate|mometasone furoate|mesh-list
101434293|NCT00160316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101434294|NCT00160316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434295|NCT00160316|Progestins|progestins|mesh-ancestor
101434296|NCT00545194|Dinoprostone|dinoprostone|mesh-list
101434359|NCT00545389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434360|NCT00545389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101434362|NCT00545467|Aripiprazole|aripiprazole|mesh-list
101434432|NCT00546130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101434433|NCT00546130|Antiviral Agents|antiviral agents|mesh-ancestor
101434438|NCT00191178|Insulin|insulin|mesh-list
101434508|NCT00546559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434509|NCT00546559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101434510|NCT00546559|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101434566|NCT00547417|Vasodilator Agents|vasodilator agents|mesh-ancestor
101434567|NCT00547417|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101434568|NCT00547417|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101434569|NCT00547417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101434570|NCT00547417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434580|NCT00547495|Tadalafil|tadalafil|mesh-list
101434632|NCT00184665|Insulin, Isophane|insulin, isophane|mesh-list
101434633|NCT00184665|Isophane insulin, beef|isophane insulin, beef|mesh-list
101434634|NCT00184665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101434635|NCT00184665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434636|NCT04983238|Sodium thiosulfate|sodium thiosulfate|mesh-list
101434638|NCT04983238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101434640|NCT04983238|Antidotes|antidotes|mesh-ancestor
101434697|NCT00548002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101434726|NCT00184821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101434727|NCT00184821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434728|NCT00184821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101434729|NCT00184821|Vasodilator Agents|vasodilator agents|mesh-ancestor
101434823|NCT00184938|Narcotics|narcotics|mesh-ancestor
101434824|NCT00184938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101434825|NCT00184938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434832|NCT00549133|Irbesartan|irbesartan|mesh-list
101434901|NCT00161447|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101434902|NCT00161447|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101434903|NCT00161447|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101434904|NCT00161447|Hormone Antagonists|hormone antagonists|mesh-ancestor
101434905|NCT00191685|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101434906|NCT00191685|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101434966|NCT00185094|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101434967|NCT00185094|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101434968|NCT00185094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434969|NCT00185094|Sympatholytics|sympatholytics|mesh-ancestor
101434970|NCT00185094|Autonomic Agents|autonomic agents|mesh-ancestor
101434971|NCT00185094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101434972|NCT00185094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434973|NCT00185094|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101434974|NCT00185094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101434975|NCT00185094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101434976|NCT00185094|Adrenergic Agents|adrenergic agents|mesh-ancestor
101434977|NCT00185094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101435028|NCT00191802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435029|NCT00191802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101435030|NCT00550693|Chlorhexidine|chlorhexidine|mesh-list
101435031|NCT00550693|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101435032|NCT00550693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101435111|NCT00551122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435112|NCT00551122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101435113|NCT00551122|Antimetabolites|antimetabolites|mesh-ancestor
101435182|NCT00551590|Incretins|incretins|mesh-ancestor
101435183|NCT00551590|Hormones|hormones|mesh-ancestor
101435184|NCT00551590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101435185|NCT00551590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101435186|NCT00551590|Protease Inhibitors|protease inhibitors|mesh-ancestor
101435187|NCT00551590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101435188|NCT00551590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435189|NCT00161915|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101435190|NCT00161915|Hemostatics|hemostatics|mesh-ancestor
101435191|NCT00161915|Coagulants|coagulants|mesh-ancestor
101435260|NCT00162149|Protease Inhibitors|protease inhibitors|mesh-ancestor
101435261|NCT00162149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101435262|NCT00162149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435263|NCT00162149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101435264|NCT00162149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101435265|NCT00162149|Antiviral Agents|antiviral agents|mesh-ancestor
101435287|NCT00162227|Efavirenz|efavirenz|mesh-list
101307462|NCT02040636|Vaccines|vaccines|mesh-list
101307463|NCT02040636|Immunologic Factors|immunologic factors|mesh-ancestor
101307464|NCT02040636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307465|NCT02040649|Midazolam|midazolam|mesh-list
101307466|NCT02040649|Propofol|propofol|mesh-list
101435336|NCT00409071|Sinomenine|sinomenine|mesh-list
101435374|NCT00162383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101435375|NCT00162383|Sympatholytics|sympatholytics|mesh-ancestor
101435376|NCT00162383|Autonomic Agents|autonomic agents|mesh-ancestor
101435377|NCT00162383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101435378|NCT00162383|Adrenergic Agents|adrenergic agents|mesh-ancestor
101435379|NCT00162383|Anticonvulsants|anticonvulsants|mesh-ancestor
101435380|NCT00162422|Albuterol|albuterol|mesh-list
101435381|NCT00162422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101435382|NCT00162422|Autonomic Agents|autonomic agents|mesh-ancestor
101435383|NCT00162422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101435384|NCT00162422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435385|NCT00162422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101435386|NCT00162422|Respiratory System Agents|respiratory system agents|mesh-ancestor
101435395|NCT04355143|Colchicine|colchicine|mesh-list
101435441|NCT04095364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101435442|NCT04095364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101435464|NCT00162695|Etoposide|etoposide|mesh-list
101435487|NCT00162734|Antimetabolites|antimetabolites|mesh-ancestor
101435488|NCT00162734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435489|NCT00185796|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101435490|NCT00185796|Immunologic Factors|immunologic factors|mesh-ancestor
101435491|NCT00185796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435492|NCT00185796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101435493|NCT00162812|Epirubicin|epirubicin|mesh-list
101435495|NCT00162812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101435554|NCT03757585|Vitamin B Complex|vitamin b complex|mesh-ancestor
101435555|NCT03757585|Vitamins|vitamins|mesh-ancestor
101435556|NCT03757585|Micronutrients|micronutrients|mesh-ancestor
101435557|NCT00163046|Gabapentin|gabapentin|mesh-list
101435558|NCT00163046|Analgesics|analgesics|mesh-ancestor
101435572|NCT00185952|Nifedipine|nifedipine|mesh-list
101435625|NCT03434158|Olaparib|olaparib|mesh-list
101435626|NCT03434158|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101435712|NCT00186264|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101435713|NCT00186264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101435714|NCT00186264|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101435715|NCT00186264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101435716|NCT00186264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101435717|NCT00186264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435718|NCT00186264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101435719|NCT00186264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435720|NCT00186264|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101435721|NCT00186264|Antidepressive Agents|antidepressive agents|mesh-ancestor
101435722|NCT00186264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101435723|NCT00163319|Ciclesonide|ciclesonide|mesh-list
101435724|NCT00163319|Glucocorticoids|glucocorticoids|mesh-ancestor
101435725|NCT00163319|Hormones|hormones|mesh-ancestor
101435726|NCT00163319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101435727|NCT00163319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435728|NCT00163319|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101307520|NCT02040883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101307521|NCT02040883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307523|NCT02040883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101435751|NCT02556931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435752|NCT02556931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101435753|NCT02556931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101435754|NCT02556931|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101435755|NCT02556931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101435756|NCT02556931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101435757|NCT02556931|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101435818|NCT00163553|Sensory System Agents|sensory system agents|mesh-ancestor
101435819|NCT00163553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101435820|NCT00163553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101435822|NCT00163592|Hemostatics|hemostatics|mesh-ancestor
101435823|NCT00163592|Coagulants|coagulants|mesh-ancestor
101435824|NCT04683445|Pembrolizumab|pembrolizumab|mesh-list
101435884|NCT05807945|Anesthetics, Local|anesthetics, local|mesh-ancestor
101435894|NCT05807893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101435895|NCT05807893|Growth Substances|growth substances|mesh-ancestor
101435896|NCT05807893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435897|NCT05807893|Growth Inhibitors|growth inhibitors|mesh-ancestor
101435966|NCT05807165|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101435967|NCT05807165|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101435969|NCT05807100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101435970|NCT05807100|Antifungal Agents|antifungal agents|mesh-ancestor
101435971|NCT05807100|Keratolytic Agents|keratolytic agents|mesh-ancestor
101435972|NCT05807100|Dermatologic Agents|dermatologic agents|mesh-ancestor
101435973|NCT05807035|Vaccines|vaccines|mesh-list
101435974|NCT05807035|Immunologic Factors|immunologic factors|mesh-ancestor
101435975|NCT05807035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435976|NCT05781698|Mesalamine|mesalamine|mesh-list
101435977|NCT05781698|Fenofibrate|fenofibrate|mesh-list
101435978|NCT05781698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101435979|NCT05781698|Antimetabolites|antimetabolites|mesh-ancestor
101435980|NCT05781698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435981|NCT05781698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101435989|NCT05781698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101436045|NCT05674513|Ulipristal acetate|ulipristal acetate|mesh-list
101436046|NCT05674513|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101436047|NCT05674513|Contraceptive Agents|contraceptive agents|mesh-ancestor
101436048|NCT05674513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101436049|NCT05674513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436050|NCT05674513|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101436051|NCT05644340|Methamphetamine|methamphetamine|mesh-list
101436052|NCT05644340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101436053|NCT05644340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436118|NCT05591105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101436119|NCT05591105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436120|NCT05591105|Analgesics|analgesics|mesh-ancestor
101436121|NCT05591105|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101436207|NCT05113901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101436208|NCT05113901|Protective Agents|protective agents|mesh-ancestor
101436209|NCT05113901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101436210|NCT05113901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436211|NCT05075603|Tisagenlecleucel|tisagenlecleucel|mesh-list
101436212|NCT05075603|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
101436213|NCT05075603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101436215|NCT05065216|Kallikreins|kallikreins|mesh-list
101436274|NCT04854369|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101436275|NCT04854369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436276|NCT04833140|Estradiol|estradiol|mesh-list
101436347|NCT04577690|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101436348|NCT04577690|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101436349|NCT04577690|Autonomic Agents|autonomic agents|mesh-ancestor
101436422|NCT04303390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101436423|NCT04303390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101436424|NCT04075110|Montelukast|montelukast|mesh-list
101436425|NCT04075110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101436426|NCT04075110|Respiratory System Agents|respiratory system agents|mesh-ancestor
101436487|NCT03544099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436566|NCT03330028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436567|NCT03330028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101436568|NCT03330028|Glucocorticoids|glucocorticoids|mesh-ancestor
101436569|NCT03330028|Hormones|hormones|mesh-ancestor
101436570|NCT03330028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101436571|NCT03330028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101436572|NCT03330028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101436573|NCT03330028|Alkylating Agents|alkylating agents|mesh-ancestor
101436574|NCT03330028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101436575|NCT03330028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101436632|NCT02992743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436633|NCT02992743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101436634|NCT02992743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101436635|NCT02992743|Alkylating Agents|alkylating agents|mesh-ancestor
101436636|NCT02992743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436637|NCT02992743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436638|NCT02992743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101436709|NCT02427620|Antimitotic Agents|antimitotic agents|mesh-ancestor
101436710|NCT02427620|Mitosis Modulators|mitosis modulators|mesh-ancestor
101436711|NCT02415621|Abiraterone Acetate|abiraterone acetate|mesh-list
101436712|NCT02415621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436713|NCT02415621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101436714|NCT02415621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101436715|NCT02415621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436716|NCT02415621|Hormone Antagonists|hormone antagonists|mesh-ancestor
101436717|NCT02415621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101436718|NCT02415621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436719|NCT02415621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101436720|NCT02403505|Myeloma Proteins|myeloma proteins|mesh-list
101436721|NCT02403505|Paraproteins|paraproteins|mesh-list
101436722|NCT02403505|BCG Vaccine|bcg vaccine|mesh-list
101436740|NCT02324387|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
101436741|NCT02324387|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101436742|NCT02324387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436743|NCT02153944|Propranolol|propranolol|mesh-list
101436744|NCT02153944|Methylphenidate|methylphenidate|mesh-list
101436745|NCT02153944|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101307586|NCT02041338|Mitosis Modulators|mitosis modulators|mesh-ancestor
101307587|NCT02041338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307588|NCT02041338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101436746|NCT02153944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436747|NCT02153944|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101436748|NCT02153944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101436749|NCT02153944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101436750|NCT02153944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436751|NCT02153944|Dopamine Agents|dopamine agents|mesh-ancestor
101436765|NCT01527149|Dexamethasone|dexamethasone|mesh-list
101436766|NCT01527149|Dexamethasone acetate|dexamethasone acetate|mesh-list
101436767|NCT01527149|Cyclophosphamide|cyclophosphamide|mesh-list
101436768|NCT01527149|Doxorubicin|doxorubicin|mesh-list
101436769|NCT01527149|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101436770|NCT01527149|Methotrexate|methotrexate|mesh-list
101436771|NCT01527149|Vincristine|vincristine|mesh-list
101436772|NCT01527149|Ofatumumab|ofatumumab|mesh-list
101436773|NCT01527149|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101436774|NCT01527149|BB 1101|bb 1101|mesh-list
101436775|NCT01527149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101436776|NCT01527149|Immunologic Factors|immunologic factors|mesh-ancestor
101436777|NCT01527149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436778|NCT01527149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101436780|NCT01527149|Alkylating Agents|alkylating agents|mesh-ancestor
101436829|NCT01306045|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101436830|NCT01306045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101436831|NCT01306045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436832|NCT01306045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101436833|NCT01306045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101436834|NCT01306045|Growth Substances|growth substances|mesh-ancestor
101436835|NCT01306045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436836|NCT01306045|Growth Inhibitors|growth inhibitors|mesh-ancestor
101436837|NCT01198067|Pomalidomide|pomalidomide|mesh-list
101436838|NCT01198067|Immunologic Factors|immunologic factors|mesh-ancestor
101436839|NCT01198067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436840|NCT01198067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101436841|NCT01198067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101436842|NCT01198067|Growth Substances|growth substances|mesh-ancestor
101436843|NCT01198067|Growth Inhibitors|growth inhibitors|mesh-ancestor
101436844|NCT01198067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436845|NCT01196936|Tamoxifen|tamoxifen|mesh-list
101436846|NCT01196936|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101436847|NCT01196936|Hormone Antagonists|hormone antagonists|mesh-ancestor
101436848|NCT01196936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101436849|NCT01196936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436850|NCT01196936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101436851|NCT01196936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436852|NCT01196936|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101436853|NCT01196936|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101436854|NCT01196936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101436855|NCT01192568|Oxybutynin|oxybutynin|mesh-list
101436856|NCT01192568|Parasympatholytics|parasympatholytics|mesh-ancestor
101436859|NCT01192568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436861|NCT01192568|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101436862|NCT01192568|Cholinergic Agents|cholinergic agents|mesh-ancestor
101436863|NCT01192568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101436864|NCT01192568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436865|NCT01192568|Urological Agents|urological agents|mesh-ancestor
101436866|NCT01075971|Buprenorphine|buprenorphine|mesh-list
101436867|NCT01075971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101436869|NCT01075971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101436870|NCT01075971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436871|NCT01075971|Analgesics|analgesics|mesh-ancestor
101436872|NCT01075971|Sensory System Agents|sensory system agents|mesh-ancestor
101436873|NCT01075971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101436874|NCT01075971|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101436875|NCT00775749|Nicotine|nicotine|mesh-list
101436876|NCT00775749|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101436877|NCT00775749|Autonomic Agents|autonomic agents|mesh-ancestor
101436878|NCT00775749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101436879|NCT00775749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436880|NCT00775749|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101436881|NCT00775749|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101436882|NCT00775749|Cholinergic Agents|cholinergic agents|mesh-ancestor
101436924|NCT00163748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101436925|NCT00163748|Tubulin Modulators|tubulin modulators|mesh-ancestor
101436926|NCT00163748|Antimitotic Agents|antimitotic agents|mesh-ancestor
101436927|NCT00163748|Mitosis Modulators|mitosis modulators|mesh-ancestor
101436928|NCT00193011|Cyclophosphamide|cyclophosphamide|mesh-list
101436929|NCT00193011|Docetaxel|docetaxel|mesh-list
101436933|NCT00193011|Immunologic Factors|immunologic factors|mesh-ancestor
101333446|NCT00039013|Hormones|hormones|mesh-ancestor
101436934|NCT00193011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436935|NCT00193011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101436936|NCT00193011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101436937|NCT00193011|Alkylating Agents|alkylating agents|mesh-ancestor
101436938|NCT00193011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436939|NCT00193011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436940|NCT00193011|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101436941|NCT00193011|Tubulin Modulators|tubulin modulators|mesh-ancestor
101436942|NCT00193011|Antimitotic Agents|antimitotic agents|mesh-ancestor
101436943|NCT00193011|Mitosis Modulators|mitosis modulators|mesh-ancestor
101436944|NCT00193011|Antimetabolites|antimetabolites|mesh-ancestor
101436945|NCT00193011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101436946|NCT00193011|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101436947|NCT00193011|Abortifacient Agents|abortifacient agents|mesh-ancestor
101436953|NCT00193089|Docetaxel|docetaxel|mesh-list
101436973|NCT00193245|Antimitotic Agents|antimitotic agents|mesh-ancestor
101436974|NCT00193245|Mitosis Modulators|mitosis modulators|mesh-ancestor
101436975|NCT00193245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436976|NCT00193245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101436977|NCT00193245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101436978|NCT00193245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101436979|NCT00193284|Carboplatin|carboplatin|mesh-list
101436980|NCT00193284|Docetaxel|docetaxel|mesh-list
101437044|NCT00193440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437045|NCT00193440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101437046|NCT05077969|Celecoxib|celecoxib|mesh-list
101437047|NCT05077969|Famotidine|famotidine|mesh-list
101437048|NCT05077969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101437049|NCT05077969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101437050|NCT05077969|Analgesics|analgesics|mesh-ancestor
101437051|NCT05077969|Sensory System Agents|sensory system agents|mesh-ancestor
101437052|NCT05077969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101437053|NCT05077969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437054|NCT05077969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101437055|NCT05077969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101437056|NCT05077969|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101437057|NCT05077969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101437058|NCT05077969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101437059|NCT05077969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437060|NCT05077969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101440176|NCT04507503|Futibatinib|futibatinib|mesh-list
101440177|NCT04507503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440178|NCT04497961|Lenalidomide|lenalidomide|mesh-list
101440179|NCT04497961|Daratumumab|daratumumab|mesh-list
101440180|NCT04497961|Immunologic Factors|immunologic factors|mesh-ancestor
101440181|NCT04497961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440182|NCT04497961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101440183|NCT04497961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101440184|NCT04497961|Growth Substances|growth substances|mesh-ancestor
101440185|NCT04497961|Growth Inhibitors|growth inhibitors|mesh-ancestor
101440186|NCT04497961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440187|NCT04497844|Prednisone|prednisone|mesh-list
101440188|NCT04497844|Abiraterone Acetate|abiraterone acetate|mesh-list
101440189|NCT04497844|Niraparib|niraparib|mesh-list
101440190|NCT04497844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101440191|NCT04497844|Glucocorticoids|glucocorticoids|mesh-ancestor
101440192|NCT04497844|Hormones|hormones|mesh-ancestor
101440193|NCT04497844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101440194|NCT04497844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440195|NCT04497844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101440196|NCT04497844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440197|NCT04497844|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101440198|NCT04497844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101440204|NCT04487080|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
101440205|NCT04487080|Lazertinib|lazertinib|mesh-list
101440206|NCT04487080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440207|NCT04487080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101440213|NCT04464629|Methylprednisolone|methylprednisolone|mesh-list
101440214|NCT04464629|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101440215|NCT04464629|Prednisolone acetate|prednisolone acetate|mesh-list
101440216|NCT04464629|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101307813|NCT02043730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101307814|NCT02043730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101307815|NCT02043730|Tubulin Modulators|tubulin modulators|mesh-ancestor
101440217|NCT04464629|Prednisolone phosphate|prednisolone phosphate|mesh-list
101440218|NCT04464629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101440219|NCT04464629|Glucocorticoids|glucocorticoids|mesh-ancestor
101440220|NCT04464629|Hormones|hormones|mesh-ancestor
101440221|NCT04464629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101437061|NCT05077969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101437062|NCT05077969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101437063|NCT05077969|Histamine Antagonists|histamine antagonists|mesh-ancestor
101437064|NCT05077969|Histamine Agents|histamine agents|mesh-ancestor
101437065|NCT05077969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101437066|NCT00193518|Arsenic Trioxide|arsenic trioxide|mesh-list
101437067|NCT00193518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437068|NCT00164216|Artesunate|artesunate|mesh-list
101437069|NCT00164216|Mefloquine|mefloquine|mesh-list
101437070|NCT00164216|Antimalarials|antimalarials|mesh-ancestor
101437071|NCT00164216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101437072|NCT00164216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101437073|NCT00164216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101437075|NCT00164216|Antiviral Agents|antiviral agents|mesh-ancestor
101437076|NCT00164216|Schistosomicides|schistosomicides|mesh-ancestor
101437077|NCT00164216|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101437078|NCT00164216|Anthelmintics|anthelmintics|mesh-ancestor
101437079|NCT00193557|Bortezomib|bortezomib|mesh-list
101437080|NCT00193557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437081|NCT00164255|Artesunate|artesunate|mesh-list
101437082|NCT00164255|Pyrimethamine|pyrimethamine|mesh-list
101437083|NCT00164255|Sulfadoxine|sulfadoxine|mesh-list
101437084|NCT00164255|Antimalarials|antimalarials|mesh-ancestor
101437085|NCT00164255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101307609|NCT02041455|Analgesics|analgesics|mesh-ancestor
101437114|NCT04974814|Atorvastatin|atorvastatin|mesh-list
101437115|NCT04974814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101437116|NCT04974814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101437117|NCT04974814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101437118|NCT04974814|Antimetabolites|antimetabolites|mesh-ancestor
101437119|NCT04974814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437120|NCT04974814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101437121|NCT04974814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101437122|NCT04974814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101437123|NCT00164411|Vaccines|vaccines|mesh-list
101437124|NCT00164411|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101437125|NCT00164411|Immunologic Factors|immunologic factors|mesh-ancestor
101437126|NCT00164411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437136|NCT04902703|Molgramostim|molgramostim|mesh-list
101437175|NCT00193869|Dexamethasone|dexamethasone|mesh-list
101437176|NCT00193869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101437177|NCT00193869|Antiemetics|antiemetics|mesh-ancestor
101437178|NCT00193869|Autonomic Agents|autonomic agents|mesh-ancestor
101437179|NCT00193869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101437180|NCT00193869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437181|NCT00193869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101437182|NCT00193869|Glucocorticoids|glucocorticoids|mesh-ancestor
101437183|NCT00193869|Hormones|hormones|mesh-ancestor
101437184|NCT00193869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101437185|NCT00193869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101437187|NCT00176241|Paclitaxel|paclitaxel|mesh-list
101437188|NCT00176241|Gemcitabine|gemcitabine|mesh-list
101437189|NCT00176241|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101437190|NCT00176241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437191|NCT00176241|Tubulin Modulators|tubulin modulators|mesh-ancestor
101437192|NCT00176241|Antimitotic Agents|antimitotic agents|mesh-ancestor
101437193|NCT00176241|Mitosis Modulators|mitosis modulators|mesh-ancestor
101437194|NCT00176241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437195|NCT00176241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101437196|NCT00176241|Antimetabolites|antimetabolites|mesh-ancestor
101437197|NCT04742959|Paclitaxel|paclitaxel|mesh-list
101437198|NCT04742959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101437199|NCT04742959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437204|NCT00164801|Diltiazem|diltiazem|mesh-list
101437246|NCT04723940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101437247|NCT04723940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437248|NCT04723940|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101437250|NCT00164840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101437251|NCT00164840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101437252|NCT00164840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101437253|NCT00164840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101307614|NCT02041455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101307615|NCT02041455|Adrenergic Agents|adrenergic agents|mesh-ancestor
101437311|NCT04326673|Testosterone|testosterone|mesh-list
101437312|NCT04326673|Testosterone undecanoate|testosterone undecanoate|mesh-list
101437313|NCT04326673|Testosterone enanthate|testosterone enanthate|mesh-list
101437314|NCT04326673|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101437315|NCT04326673|Androgens|androgens|mesh-ancestor
101437316|NCT04326673|Hormones|hormones|mesh-ancestor
101437317|NCT04326673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101437318|NCT04326673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437319|NCT04326673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101437320|NCT04326673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437321|NCT04326673|Anabolic Agents|anabolic agents|mesh-ancestor
101437322|NCT00165074|Calfactant|calfactant|mesh-list
101437323|NCT00165074|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
101437380|NCT00176553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101437381|NCT00176553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101437382|NCT00176553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101437451|NCT03978208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101437452|NCT03978208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437453|NCT00165659|Donepezil|donepezil|mesh-list
101437454|NCT00165659|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101437455|NCT00165659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101437456|NCT00165659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437457|NCT00165659|Cholinergic Agents|cholinergic agents|mesh-ancestor
101437458|NCT00165659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101437518|NCT03697603|Serotonin Agents|serotonin agents|mesh-ancestor
101437519|NCT03697603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101437520|NCT03697603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437521|NCT03697603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437522|NCT03697603|Dopamine Agonists|dopamine agonists|mesh-ancestor
101437523|NCT03697603|Dopamine Agents|dopamine agents|mesh-ancestor
101437524|NCT00165854|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
101437525|NCT00165854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437526|NCT00165854|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101437527|NCT00165854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101437528|NCT00165854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437529|NCT00177060|Hydromorphone|hydromorphone|mesh-list
101437530|NCT00177060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101437531|NCT00177060|Narcotics|narcotics|mesh-ancestor
101437534|NCT00177060|Analgesics|analgesics|mesh-ancestor
101437584|NCT00166010|Natriuretic Agents|natriuretic agents|mesh-ancestor
101437585|NCT00166010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437586|NCT05336812|Venetoclax|venetoclax|mesh-list
101437587|NCT05336812|Obinutuzumab|obinutuzumab|mesh-list
101437588|NCT05336812|Acalabrutinib|acalabrutinib|mesh-list
101437589|NCT05336812|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101437653|NCT05311774|Narcotics|narcotics|mesh-ancestor
101437654|NCT05311774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101437655|NCT05311774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437656|NCT05311774|Analgesics|analgesics|mesh-ancestor
101437657|NCT05311774|Sensory System Agents|sensory system agents|mesh-ancestor
101437658|NCT05311774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101437659|NCT05311774|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101437660|NCT05311774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101437661|NCT05311774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101437662|NCT05311774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437663|NCT05311774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101437664|NCT05311774|Antidepressive Agents|antidepressive agents|mesh-ancestor
101437665|NCT05311774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101437666|NCT05311774|Dopamine Agents|dopamine agents|mesh-ancestor
101437667|NCT00194727|Capecitabine|capecitabine|mesh-list
101437715|NCT00166478|Analgesics|analgesics|mesh-ancestor
101437716|NCT00166478|Sensory System Agents|sensory system agents|mesh-ancestor
101437717|NCT00166478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101437718|NCT00166478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101437719|NCT00166478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101437720|NCT05282875|Immunosuppressive Agents|immunosuppressive agents|mesh-list
101437721|NCT05282875|Immunologic Factors|immunologic factors|mesh-ancestor
101437722|NCT05282875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437723|NCT00194766|Temozolomide|temozolomide|mesh-list
101437724|NCT00194766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101437725|NCT00194766|Alkylating Agents|alkylating agents|mesh-ancestor
101437726|NCT00194766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437728|NCT00166556|Alemtuzumab|alemtuzumab|mesh-list
101437777|NCT05124067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437781|NCT05124067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101437783|NCT05124067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437845|NCT00177372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101437846|NCT00177372|Oxytocics|oxytocics|mesh-ancestor
101437847|NCT00177372|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101437848|NCT00177372|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101437860|NCT04819399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101437861|NCT00177411|Hormones|hormones|mesh-list
101437862|NCT00177411|Parathyroid Hormone|parathyroid hormone|mesh-list
101437863|NCT00177411|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
101437864|NCT00177411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101437865|NCT00177411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437866|NCT00177411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101437867|NCT00195078|Gefitinib|gefitinib|mesh-list
101437868|NCT00195078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437869|NCT00195078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101437870|NCT00195078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101437871|NCT00195078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437872|NCT00167141|Contraceptive Agents|contraceptive agents|mesh-list
101437873|NCT00167141|Contraceptive Agents, Male|contraceptive agents, male|mesh-list
101437874|NCT00167141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101437915|NCT00177567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101437916|NCT00177567|Serotonin Agents|serotonin agents|mesh-ancestor
101437917|NCT00177567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101437918|NCT00177567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437919|NCT00177567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437920|NCT00177567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101437921|NCT00177567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101307640|NCT02041650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101307641|NCT02041650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101307642|NCT02041650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101307643|NCT02041650|Purinergic Agents|purinergic agents|mesh-ancestor
101307644|NCT02041650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101307645|NCT02041650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307646|NCT02041650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307647|NCT02041767|Ertapenem|ertapenem|mesh-list
101307648|NCT02041767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101307649|NCT02041767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101307650|NCT02041819|Nimotuzumab|nimotuzumab|mesh-list
101437922|NCT00177567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101437923|NCT00177567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101437924|NCT00177567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101437950|NCT00177567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101437951|NCT00177567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101437952|NCT00177567|Adrenergic Agents|adrenergic agents|mesh-ancestor
101437953|NCT00177567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101437954|NCT00177567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101438012|NCT04299880|Growth Substances|growth substances|mesh-ancestor
101438013|NCT04299880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438014|NCT04299880|Growth Inhibitors|growth inhibitors|mesh-ancestor
101438015|NCT04299880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101438016|NCT04299880|Antimetabolites|antimetabolites|mesh-ancestor
101438017|NCT04299880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101438085|NCT02906722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101438086|NCT00167687|Prazosin|prazosin|mesh-list
101438087|NCT00167687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101438088|NCT00167687|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101438089|NCT00167687|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101438090|NCT00167687|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101438091|NCT00167687|Adrenergic Agents|adrenergic agents|mesh-ancestor
101307677|NCT02042482|Micronutrients|micronutrients|mesh-ancestor
101307678|NCT02042482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307679|NCT02042482|Vitamins|vitamins|mesh-ancestor
101307680|NCT02042495|Metformin|metformin|mesh-list
101307681|NCT02042495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101438144|NCT02906059|Adavosertib|adavosertib|mesh-list
101438145|NCT02906059|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101438146|NCT02906059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101438147|NCT02906059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101438148|NCT02906059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438149|NCT02906059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101438208|NCT00177996|Antidepressive Agents|antidepressive agents|mesh-ancestor
101438209|NCT00177996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101438210|NCT00177996|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101438283|NCT00178035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101438284|NCT00178035|Antidepressive Agents|antidepressive agents|mesh-ancestor
101438285|NCT00178035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101307697|NCT02042599|Anesthetics|anesthetics|mesh-ancestor
101307698|NCT02042599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101307699|NCT02042599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307700|NCT02042612|Sevoflurane|sevoflurane|mesh-list
101438286|NCT00178035|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101438362|NCT02904304|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101438363|NCT02904304|Nasal Decongestants|nasal decongestants|mesh-ancestor
101438428|NCT02903524|Pirarubicin|pirarubicin|mesh-list
101307710|NCT02042664|Metformin|metformin|mesh-list
101307711|NCT02042664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101333869|NCT00017394|Growth Inhibitors|growth inhibitors|mesh-ancestor
101438429|NCT02903524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101438430|NCT02903524|Immunologic Factors|immunologic factors|mesh-ancestor
101438431|NCT02903524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438432|NCT02903524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101438442|NCT00168350|Memantine|memantine|mesh-list
101438503|NCT05995353|Immunologic Factors|immunologic factors|mesh-ancestor
101438504|NCT05995353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438513|NCT05995249|Efavirenz|efavirenz|mesh-list
101438514|NCT05995249|Erythromycin|erythromycin|mesh-list
101438515|NCT05995249|Erythromycin Estolate|erythromycin estolate|mesh-list
101438516|NCT05995249|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101307712|NCT02042664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438575|NCT05994742|Isoniazid|isoniazid|mesh-list
101438576|NCT05994742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101438577|NCT05994742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101438578|NCT05994742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101438579|NCT05994742|Antitubercular Agents|antitubercular agents|mesh-ancestor
101307718|NCT02042690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101307719|NCT02042690|Immunologic Factors|immunologic factors|mesh-ancestor
101307720|NCT02042690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438580|NCT05994742|Leprostatic Agents|leprostatic agents|mesh-ancestor
101438581|NCT05994742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101438582|NCT05994742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101438583|NCT05994742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438584|NCT05994742|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101438585|NCT05994742|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101438586|NCT05994742|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101438587|NCT05994742|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101438588|NCT05994742|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101438589|NCT05994742|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101438590|NCT05994742|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101438596|NCT05994742|Micronutrients|micronutrients|mesh-ancestor
101438597|NCT05994742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438598|NCT05994703|Cycloserine|cycloserine|mesh-list
101438599|NCT05994703|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101438600|NCT05994703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101438601|NCT05994703|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101438602|NCT05994703|Antitubercular Agents|antitubercular agents|mesh-ancestor
101438623|NCT05994547|GABA Agents|gaba agents|mesh-ancestor
101438624|NCT05994547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101438625|NCT05994547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438626|NCT05994456|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101438627|NCT05994456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438628|NCT05994456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101438629|NCT05994456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101438630|NCT05994378|Ganirelix|ganirelix|mesh-list
101438682|NCT05993975|Analgesics|analgesics|mesh-ancestor
101438683|NCT05993975|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101438684|NCT05993975|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101438685|NCT05993975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101438686|NCT05993975|Adrenergic Agents|adrenergic agents|mesh-ancestor
101438756|NCT05880459|Sensory System Agents|sensory system agents|mesh-ancestor
101438757|NCT05880459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101438758|NCT05880459|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101438759|NCT05880459|Anticonvulsants|anticonvulsants|mesh-ancestor
101438760|NCT05880459|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101438764|NCT05880459|Tocolytic Agents|tocolytic agents|mesh-ancestor
101438828|NCT05844995|Analgesics|analgesics|mesh-ancestor
101438829|NCT05844995|Sensory System Agents|sensory system agents|mesh-ancestor
101438830|NCT05844995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101438831|NCT05844995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438832|NCT05844995|Antipyretics|antipyretics|mesh-ancestor
101438898|NCT05763121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438899|NCT05763121|Protective Agents|protective agents|mesh-ancestor
101438900|NCT05763121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438901|NCT05763121|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101438902|NCT05763121|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101438903|NCT05763121|Dopamine Agonists|dopamine agonists|mesh-ancestor
101438904|NCT05763121|Dopamine Agents|dopamine agents|mesh-ancestor
101438968|NCT05712941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438969|NCT05712941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101438970|NCT05712941|Hormone Antagonists|hormone antagonists|mesh-ancestor
101439076|NCT05654623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439077|NCT05654623|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101439091|NCT05642026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439092|NCT05642026|Sensory System Agents|sensory system agents|mesh-ancestor
101439146|NCT05552222|Lenalidomide|lenalidomide|mesh-list
101439147|NCT05552222|Daratumumab|daratumumab|mesh-list
101439153|NCT05552222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101439227|NCT05515575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439228|NCT05515575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439229|NCT05498428|Carboplatin|carboplatin|mesh-list
101439230|NCT05498428|Pemetrexed|pemetrexed|mesh-list
101439231|NCT05498428|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
101439232|NCT05498428|Heparin|heparin|mesh-list
101439233|NCT05498428|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101439234|NCT05498428|Tinzaparin|tinzaparin|mesh-list
101439235|NCT05498428|Dalteparin|dalteparin|mesh-list
101439236|NCT05498428|Anticoagulants|anticoagulants|mesh-list
101439237|NCT05498428|Lazertinib|lazertinib|mesh-list
101439238|NCT05498428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439239|NCT05498428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101439283|NCT05453903|Daunorubicin|daunorubicin|mesh-list
101439284|NCT05453903|Venetoclax|venetoclax|mesh-list
101439285|NCT05453903|Idarubicin|idarubicin|mesh-list
101439286|NCT05453903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101439287|NCT05453903|Antimetabolites|antimetabolites|mesh-ancestor
101439288|NCT05453903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439462|NCT05347485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439463|NCT05347485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439464|NCT05347485|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101439465|NCT05338775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101439467|NCT05338775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101439551|NCT05194293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101439552|NCT05194293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439553|NCT05194293|Immunologic Factors|immunologic factors|mesh-ancestor
101439554|NCT05194293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439622|NCT05152628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101439623|NCT05152628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439624|NCT05149768|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101439627|NCT05149768|Immunotoxins|immunotoxins|mesh-ancestor
101439836|NCT04923893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439837|NCT04923893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439838|NCT04923893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101439839|NCT04923893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101439840|NCT04923893|Antiemetics|antiemetics|mesh-ancestor
101439841|NCT04923893|Autonomic Agents|autonomic agents|mesh-ancestor
101439842|NCT04923893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101439843|NCT04923893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101439844|NCT04923893|Glucocorticoids|glucocorticoids|mesh-ancestor
101439845|NCT04923893|Hormones|hormones|mesh-ancestor
101439852|NCT04859946|Cyclophosphamide|cyclophosphamide|mesh-list
101439917|NCT04820309|Urological Agents|urological agents|mesh-ancestor
101439918|NCT04820309|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101439997|NCT04722146|Growth Substances|growth substances|mesh-ancestor
101439998|NCT04722146|Growth Inhibitors|growth inhibitors|mesh-ancestor
101439999|NCT04722146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440000|NCT04722146|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101440001|NCT04722146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101440002|NCT04722146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440004|NCT04692467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101440048|NCT04626791|Cortisone|cortisone|mesh-list
101440049|NCT04626791|Cyclophosphamide|cyclophosphamide|mesh-list
101440050|NCT04626791|Rituximab|rituximab|mesh-list
101440051|NCT04626791|Doxorubicin|doxorubicin|mesh-list
101440052|NCT04626791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101440053|NCT04626791|Bortezomib|bortezomib|mesh-list
101440054|NCT04626791|Acalabrutinib|acalabrutinib|mesh-list
101440055|NCT04626791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101440123|NCT04577833|Niraparib|niraparib|mesh-list
101440124|NCT04577833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101440125|NCT04577833|Glucocorticoids|glucocorticoids|mesh-ancestor
101440126|NCT04577833|Hormones|hormones|mesh-ancestor
101440127|NCT04577833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101440128|NCT04577833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307806|NCT02043717|Vitamin D|vitamin d|mesh-list
101440199|NCT04497844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440200|NCT04497844|Hormone Antagonists|hormone antagonists|mesh-ancestor
101440201|NCT04497844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101440202|NCT04497844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101440222|NCT04464629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440223|NCT04464629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101440224|NCT04464629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440225|NCT04464629|Antiemetics|antiemetics|mesh-ancestor
101440226|NCT04464629|Autonomic Agents|autonomic agents|mesh-ancestor
101440299|NCT04312659|Infliximab|infliximab|mesh-list
101440227|NCT04464629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101440228|NCT04464629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101440229|NCT04464629|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101440230|NCT04464629|Protective Agents|protective agents|mesh-ancestor
101440231|NCT04459416|Analgesics, Opioid|analgesics, opioid|mesh-list
101440232|NCT04459416|Narcotics|narcotics|mesh-ancestor
101440233|NCT04459416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101440234|NCT04459416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440235|NCT04459416|Analgesics|analgesics|mesh-ancestor
101440236|NCT04459416|Sensory System Agents|sensory system agents|mesh-ancestor
101440237|NCT04459416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101440238|NCT04439539|Tenofovir|tenofovir|mesh-list
101440239|NCT04439539|JNJ-56136379|jnj-56136379|mesh-list
101440241|NCT04439539|Antiviral Agents|antiviral agents|mesh-ancestor
101440242|NCT04439539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101440243|NCT04439539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101440244|NCT04439539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101440245|NCT04439539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101440246|NCT04439539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440247|NCT04439539|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101440248|NCT04439539|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101440249|NCT04435782|Selexipag|selexipag|mesh-list
101440250|NCT04435782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101440251|NCT04432935|Lactoferrin|lactoferrin|mesh-list
101440252|NCT04432935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101440254|NCT04414722|Clavulanic Acid|clavulanic acid|mesh-list
101440255|NCT04414722|Clavulanic Acids|clavulanic acids|mesh-list
101440256|NCT04414722|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101440257|NCT04414722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101440258|NCT04414722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101440259|NCT04414722|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101440260|NCT04414722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101440680|NCT03819088|Zinc|zinc|mesh-list
101440261|NCT04414722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440262|NCT04392037|Dexamethasone|dexamethasone|mesh-list
101440263|NCT04392037|Cyclophosphamide|cyclophosphamide|mesh-list
101440264|NCT04392037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101440265|NCT04392037|Immunologic Factors|immunologic factors|mesh-ancestor
101440266|NCT04392037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440267|NCT04392037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101440268|NCT04392037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101440269|NCT04392037|Alkylating Agents|alkylating agents|mesh-ancestor
101440270|NCT04392037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440271|NCT04392037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440272|NCT04392037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101440273|NCT04392037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101440274|NCT04392037|Antiemetics|antiemetics|mesh-ancestor
101440275|NCT04392037|Autonomic Agents|autonomic agents|mesh-ancestor
101440276|NCT04392037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101440804|NCT03535298|Interferons|interferons|mesh-list
101440278|NCT04392037|Glucocorticoids|glucocorticoids|mesh-ancestor
101440291|NCT04372108|Ustekinumab|ustekinumab|mesh-list
101440292|NCT04372108|Dermatologic Agents|dermatologic agents|mesh-ancestor
101440300|NCT04312659|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101440301|NCT04312659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101440302|NCT04312659|Dermatologic Agents|dermatologic agents|mesh-ancestor
101440303|NCT04312659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101440304|NCT04312659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101307816|NCT02043730|Antimitotic Agents|antimitotic agents|mesh-ancestor
101307817|NCT02043730|Mitosis Modulators|mitosis modulators|mesh-ancestor
101307818|NCT02043730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440305|NCT04287062|Suvorexant|suvorexant|mesh-list
101440948|NCT03233347|Alkylating Agents|alkylating agents|mesh-ancestor
101440306|NCT04287062|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101440307|NCT04287062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101440308|NCT04287062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101440309|NCT04287062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440310|NCT04287062|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
101440311|NCT04287062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101440312|NCT04287062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440313|NCT04273945|Macitentan|macitentan|mesh-list
101440314|NCT04273945|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101440315|NCT04273945|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101440316|NCT04273945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440317|NCT04273945|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
101440319|NCT04271475|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101440320|NCT04271475|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101440321|NCT04271475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440322|NCT04271475|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
101440323|NCT04244552|Doxorubicin|doxorubicin|mesh-list
101440324|NCT04244552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101440325|NCT04244552|Pembrolizumab|pembrolizumab|mesh-list
101440326|NCT04244552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101440327|NCT04244552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440328|NCT04244552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101440329|NCT04244552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101440330|NCT04244552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101440331|NCT04244552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440332|NCT04244552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101440333|NCT04244552|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101440334|NCT04229368|Vitamin D|vitamin d|mesh-list
101440335|NCT04229368|Cholecalciferol|cholecalciferol|mesh-list
101440336|NCT04229368|Vitamins|vitamins|mesh-ancestor
101440337|NCT04229368|Micronutrients|micronutrients|mesh-ancestor
101440338|NCT04229368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440339|NCT04229368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101440340|NCT04229368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101440341|NCT04185402|Azithromycin|azithromycin|mesh-list
101440342|NCT04185402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101440343|NCT04185402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101440344|NCT04181827|Dexamethasone|dexamethasone|mesh-list
101440345|NCT04181827|Bortezomib|bortezomib|mesh-list
101440346|NCT04181827|Daratumumab|daratumumab|mesh-list
101440347|NCT04181827|Pomalidomide|pomalidomide|mesh-list
101440351|NCT04181827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101440352|NCT04181827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440353|NCT04181827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101440354|NCT04181827|Glucocorticoids|glucocorticoids|mesh-ancestor
101440355|NCT04181827|Hormones|hormones|mesh-ancestor
101440356|NCT04181827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101440357|NCT04181827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101440358|NCT04181827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440359|NCT04181827|Immunologic Factors|immunologic factors|mesh-ancestor
101440360|NCT04181827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101440361|NCT04181827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101440362|NCT04181827|Growth Substances|growth substances|mesh-ancestor
101440363|NCT04181827|Growth Inhibitors|growth inhibitors|mesh-ancestor
101440364|NCT04175600|Selexipag|selexipag|mesh-list
101440365|NCT04175600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101440366|NCT04172675|Gemcitabine|gemcitabine|mesh-list
101440367|NCT04172675|Mitomycins|mitomycins|mesh-list
101440368|NCT04172675|Mitomycin|mitomycin|mesh-list
101440369|NCT04172675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101440370|NCT04172675|Antimetabolites|antimetabolites|mesh-ancestor
101440371|NCT04172675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440372|NCT04172675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440373|NCT04172675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101440374|NCT04172675|Alkylating Agents|alkylating agents|mesh-ancestor
101441278|NCT01998971|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101307819|NCT02043730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101307820|NCT02043730|Antimetabolites|antimetabolites|mesh-ancestor
101307821|NCT02043756|Mitoxantrone|mitoxantrone|mesh-list
101307822|NCT02043756|Analgesics|analgesics|mesh-ancestor
101307823|NCT02043756|Sensory System Agents|sensory system agents|mesh-ancestor
101307824|NCT02043756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101307825|NCT02043756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307826|NCT02043756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101307827|NCT02043756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101307828|NCT02043756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101307829|NCT02043756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101307830|NCT02043756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307831|NCT02043821|Capecitabine|capecitabine|mesh-list
101307832|NCT02043821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101307833|NCT02043821|Antimetabolites|antimetabolites|mesh-ancestor
101307834|NCT02043821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440375|NCT04172675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101440376|NCT04172675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101440377|NCT04169828|Leucovorin|leucovorin|mesh-list
101440378|NCT04169828|Folic Acid|folic acid|mesh-list
101440379|NCT04169828|Methotrexate|methotrexate|mesh-list
101440380|NCT04169828|Ondansetron|ondansetron|mesh-list
101440381|NCT04169828|Levoleucovorin|levoleucovorin|mesh-list
101440382|NCT04169828|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101440383|NCT04169828|Abortifacient Agents|abortifacient agents|mesh-ancestor
101440384|NCT04169828|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101440385|NCT04169828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440386|NCT04169828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101440387|NCT04169828|Antimetabolites|antimetabolites|mesh-ancestor
101441341|NCT01286272|Deoxyglucose|deoxyglucose|mesh-list
101440388|NCT04169828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440389|NCT04169828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440390|NCT04169828|Dermatologic Agents|dermatologic agents|mesh-ancestor
101440391|NCT04169828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101440392|NCT04169828|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101440393|NCT04169828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101440394|NCT04169828|Immunologic Factors|immunologic factors|mesh-ancestor
101440395|NCT04169828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101440396|NCT04169828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101440397|NCT04169828|Antidotes|antidotes|mesh-ancestor
101440398|NCT04169828|Protective Agents|protective agents|mesh-ancestor
101440399|NCT04169828|Vitamin B Complex|vitamin b complex|mesh-ancestor
101440400|NCT04169828|Vitamins|vitamins|mesh-ancestor
101440401|NCT04169828|Micronutrients|micronutrients|mesh-ancestor
101440402|NCT04169828|Antiemetics|antiemetics|mesh-ancestor
101440403|NCT04169828|Autonomic Agents|autonomic agents|mesh-ancestor
101440404|NCT04169828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101440405|NCT04169828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101440406|NCT04169828|Antipruritics|antipruritics|mesh-ancestor
101440407|NCT04169828|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101440408|NCT04169828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101440409|NCT04169828|Serotonin Agents|serotonin agents|mesh-ancestor
101440410|NCT04169828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101440411|NCT04169828|Hematinics|hematinics|mesh-ancestor
101440412|NCT04157348|Benralizumab|benralizumab|mesh-list
101440413|NCT04157348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101440414|NCT04157348|Respiratory System Agents|respiratory system agents|mesh-ancestor
101440415|NCT04133636|Dexamethasone|dexamethasone|mesh-list
101440416|NCT04133636|Lenalidomide|lenalidomide|mesh-list
101440417|NCT04133636|Bortezomib|bortezomib|mesh-list
101441387|NCT01011478|Antimetabolites|antimetabolites|mesh-ancestor
101440418|NCT04133636|Daratumumab|daratumumab|mesh-list
101440419|NCT04133636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101307835|NCT02043821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101307837|NCT02043886|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101440420|NCT04133636|Antiemetics|antiemetics|mesh-ancestor
101440421|NCT04133636|Autonomic Agents|autonomic agents|mesh-ancestor
101440422|NCT04133636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101440423|NCT04133636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440453|NCT04082533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101440455|NCT04077463|Pemetrexed|pemetrexed|mesh-list
101440456|NCT04077463|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
101440457|NCT04077463|Lazertinib|lazertinib|mesh-list
101440458|NCT04077463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440459|NCT04077463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101440460|NCT04077463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440462|NCT04077463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101440463|NCT04077463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101440464|NCT04077463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101440465|NCT04034095|Prednisolone|prednisolone|mesh-list
101440466|NCT04034095|Docetaxel|docetaxel|mesh-list
101440467|NCT04034095|Bicalutamide|bicalutamide|mesh-list
101440468|NCT04034095|Androgens|androgens|mesh-list
101440469|NCT04034095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440470|NCT04034095|Tubulin Modulators|tubulin modulators|mesh-ancestor
101440471|NCT04034095|Antimitotic Agents|antimitotic agents|mesh-ancestor
101440478|NCT04034095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440479|NCT04034095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101440481|NCT04034095|Hormone Antagonists|hormone antagonists|mesh-ancestor
101440482|NCT03989271|Quercetin|quercetin|mesh-list
101440483|NCT03989271|Antioxidants|antioxidants|mesh-ancestor
101440484|NCT03989271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440485|NCT03989271|Protective Agents|protective agents|mesh-ancestor
101440486|NCT03989271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440487|NCT03961334|Aspirin|aspirin|mesh-list
101440488|NCT03961334|Dabigatran|dabigatran|mesh-list
101440489|NCT03961334|Apixaban|apixaban|mesh-list
101440490|NCT03961334|Edoxaban|edoxaban|mesh-list
101440491|NCT03961334|Clopidogrel|clopidogrel|mesh-list
101440492|NCT03961334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101440493|NCT03961334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101440494|NCT03961334|Analgesics|analgesics|mesh-ancestor
101440495|NCT03961334|Sensory System Agents|sensory system agents|mesh-ancestor
101440496|NCT03961334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101441621|NCT00168779|Valsartan|valsartan|mesh-list
101440497|NCT03961334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440498|NCT03961334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101440499|NCT03961334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101440500|NCT03961334|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101440501|NCT03961334|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101440502|NCT03961334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440503|NCT03961334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101440504|NCT03961334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101440505|NCT03961334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101440506|NCT03961334|Antipyretics|antipyretics|mesh-ancestor
101440507|NCT03961334|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101440508|NCT03961334|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101440509|NCT03961334|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101440510|NCT03961334|Purinergic Agents|purinergic agents|mesh-ancestor
101440511|NCT03961334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101440512|NCT03961334|Antithrombins|antithrombins|mesh-ancestor
101440513|NCT03961334|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101440514|NCT03961334|Protease Inhibitors|protease inhibitors|mesh-ancestor
101440515|NCT03961334|Anticoagulants|anticoagulants|mesh-ancestor
101440516|NCT03961334|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101440517|NCT03933163|Resveratrol|resveratrol|mesh-list
101440518|NCT03933163|Antioxidants|antioxidants|mesh-ancestor
101440519|NCT03933163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440520|NCT03933163|Protective Agents|protective agents|mesh-ancestor
101440521|NCT03933163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440522|NCT03933163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101440523|NCT03933163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101440525|NCT03930953|Obinutuzumab|obinutuzumab|mesh-list
101440526|NCT03930953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101440527|NCT03930953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101307838|NCT02043886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101440528|NCT03930953|Immunologic Factors|immunologic factors|mesh-ancestor
101440529|NCT03930953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440530|NCT03930953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101440531|NCT03914625|Calcium, Dietary|calcium, dietary|mesh-list
101440532|NCT03914625|Leucovorin|leucovorin|mesh-list
101440533|NCT03914625|Folic Acid|folic acid|mesh-list
101440534|NCT03914625|Cytarabine|cytarabine|mesh-list
101440535|NCT03914625|Dexamethasone|dexamethasone|mesh-list
101440536|NCT03914625|Dexamethasone acetate|dexamethasone acetate|mesh-list
101440537|NCT03914625|Prednisone|prednisone|mesh-list
101440538|NCT03914625|Prednisolone|prednisolone|mesh-list
101440539|NCT03914625|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101440540|NCT03914625|Methylprednisolone|methylprednisolone|mesh-list
101440541|NCT03914625|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101440546|NCT03914625|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101440547|NCT03914625|Cortisone|cortisone|mesh-list
101440548|NCT03914625|Cyclophosphamide|cyclophosphamide|mesh-list
101440549|NCT03914625|Doxorubicin|doxorubicin|mesh-list
101440550|NCT03914625|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101440551|NCT03914625|Methotrexate|methotrexate|mesh-list
101440552|NCT03914625|Vincristine|vincristine|mesh-list
101440553|NCT03914625|Asparaginase|asparaginase|mesh-list
101440554|NCT03914625|Mercaptopurine|mercaptopurine|mesh-list
101440555|NCT03914625|Pegaspargase|pegaspargase|mesh-list
101440556|NCT03914625|Thioguanine|thioguanine|mesh-list
101440557|NCT03914625|Blinatumomab|blinatumomab|mesh-list
101440558|NCT03914625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101440559|NCT03914625|Muromonab-CD3|muromonab-cd3|mesh-list
101440560|NCT03914625|Antibodies|antibodies|mesh-list
101440561|NCT03914625|Immunoglobulins|immunoglobulins|mesh-list
101440562|NCT03914625|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101440563|NCT03914625|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101440564|NCT03914625|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101440565|NCT03914625|Prednisolone phosphate|prednisolone phosphate|mesh-list
101440567|NCT03914625|Calcium|calcium|mesh-list
101440568|NCT03914625|2-Aminopurine|2-aminopurine|mesh-list
101440569|NCT03914625|Levoleucovorin|levoleucovorin|mesh-list
101440570|NCT03914625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101440571|NCT03914625|Immunologic Factors|immunologic factors|mesh-ancestor
101440572|NCT03914625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440573|NCT03914625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101440574|NCT03914625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101440575|NCT03914625|Alkylating Agents|alkylating agents|mesh-ancestor
101440576|NCT03914625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440577|NCT03914625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440578|NCT03914625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101440579|NCT03914625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101440580|NCT03914625|Antiemetics|antiemetics|mesh-ancestor
101440581|NCT03914625|Autonomic Agents|autonomic agents|mesh-ancestor
101440582|NCT03914625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101441991|NCT00169832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440583|NCT03914625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101440584|NCT03914625|Glucocorticoids|glucocorticoids|mesh-ancestor
101440585|NCT03914625|Hormones|hormones|mesh-ancestor
101440586|NCT03914625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101440587|NCT03914625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101440588|NCT03914625|Protease Inhibitors|protease inhibitors|mesh-ancestor
101440589|NCT03914625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101440590|NCT03914625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101440591|NCT03914625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101440592|NCT03914625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101440593|NCT03914625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101440594|NCT03914625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101440595|NCT03914625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101440596|NCT03914625|Abortifacient Agents|abortifacient agents|mesh-ancestor
101440597|NCT03914625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101440598|NCT03914625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101440599|NCT03914625|Antimetabolites|antimetabolites|mesh-ancestor
101440600|NCT03914625|Dermatologic Agents|dermatologic agents|mesh-ancestor
101440601|NCT03914625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101363208|NCT00131053|Antimetabolites|antimetabolites|mesh-ancestor
101440602|NCT03914625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101440603|NCT03914625|Antiviral Agents|antiviral agents|mesh-ancestor
101440604|NCT03914625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101440606|NCT03914625|Protective Agents|protective agents|mesh-ancestor
101440607|NCT03914625|Vitamin B Complex|vitamin b complex|mesh-ancestor
101440608|NCT03914625|Vitamins|vitamins|mesh-ancestor
101440609|NCT03914625|Micronutrients|micronutrients|mesh-ancestor
101307839|NCT02043886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307840|NCT02043886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101307841|NCT02043886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307842|NCT02043912|Haloperidol|haloperidol|mesh-list
101307843|NCT02043912|Haloperidol decanoate|haloperidol decanoate|mesh-list
101440610|NCT03914625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101440611|NCT03914625|Tubulin Modulators|tubulin modulators|mesh-ancestor
101440612|NCT03914625|Antimitotic Agents|antimitotic agents|mesh-ancestor
101440613|NCT03914625|Mitosis Modulators|mitosis modulators|mesh-ancestor
101440614|NCT03914625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101440615|NCT03914625|Hematinics|hematinics|mesh-ancestor
101440616|NCT03913104|Mifepristone|mifepristone|mesh-list
101440617|NCT03913104|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101442132|NCT00169988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101440625|NCT03913104|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101440627|NCT03913104|Hormone Antagonists|hormone antagonists|mesh-ancestor
101440628|NCT03913104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101440629|NCT03913104|Luteolytic Agents|luteolytic agents|mesh-ancestor
101440630|NCT03913104|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101440631|NCT03913104|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101440632|NCT03904693|Tadalafil|tadalafil|mesh-list
101440633|NCT03904693|Macitentan|macitentan|mesh-list
101440634|NCT03904693|Vasodilator Agents|vasodilator agents|mesh-ancestor
101440635|NCT03904693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101440636|NCT03904693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101440637|NCT03904693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101440638|NCT03904693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440639|NCT03904693|Urological Agents|urological agents|mesh-ancestor
101440640|NCT03904693|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101440641|NCT03904693|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101440642|NCT03904693|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
101440643|NCT03901963|Lenalidomide|lenalidomide|mesh-list
101440644|NCT03901963|Daratumumab|daratumumab|mesh-list
101440645|NCT03901963|Immunologic Factors|immunologic factors|mesh-ancestor
101440646|NCT03901963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440647|NCT03901963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101440648|NCT03901963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101440649|NCT03901963|Growth Substances|growth substances|mesh-ancestor
101440650|NCT03901963|Growth Inhibitors|growth inhibitors|mesh-ancestor
101440651|NCT03901963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440652|NCT03854370|Chlorhexidine|chlorhexidine|mesh-list
101440653|NCT03854370|Povidone-Iodine|povidone-iodine|mesh-list
101440654|NCT03854370|Povidone|povidone|mesh-list
101440655|NCT03854370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101440656|NCT03854370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101440657|NCT03854370|Disinfectants|disinfectants|mesh-ancestor
101440658|NCT03854370|Plasma Substitutes|plasma substitutes|mesh-ancestor
101440659|NCT03854370|Blood Substitutes|blood substitutes|mesh-ancestor
101440660|NCT03845517|PF-06700841|pf-06700841|mesh-list
101440661|NCT03845517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101440662|NCT03845517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101440663|NCT03845517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440664|NCT03844061|Mycophenolic Acid|mycophenolic acid|mesh-list
101440665|NCT03844061|Rituximab|rituximab|mesh-list
101440666|NCT03844061|Belimumab|belimumab|mesh-list
101440667|NCT03844061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101440668|NCT03844061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440669|NCT03844061|Immunologic Factors|immunologic factors|mesh-ancestor
101440670|NCT03844061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440671|NCT03844061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101440672|NCT03844061|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101440673|NCT03844061|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101440674|NCT03844061|Antitubercular Agents|antitubercular agents|mesh-ancestor
101440675|NCT03844061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101440676|NCT03844061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101440677|NCT03844061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101440678|NCT03844061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440679|NCT03844061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101307844|NCT02043912|Antiemetics|antiemetics|mesh-ancestor
101307845|NCT02043912|Autonomic Agents|autonomic agents|mesh-ancestor
101307846|NCT02043912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101307847|NCT02043912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440681|NCT03819088|Zinc Sulfate|zinc sulfate|mesh-list
101440682|NCT03819088|Trace Elements|trace elements|mesh-ancestor
101440683|NCT03819088|Micronutrients|micronutrients|mesh-ancestor
101440684|NCT03819088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440685|NCT03819088|Astringents|astringents|mesh-ancestor
101440697|NCT03767244|Androgens|androgens|mesh-list
101440698|NCT03767244|Hormones|hormones|mesh-ancestor
101442346|NCT00170729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101440699|NCT03767244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101440700|NCT03767244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440701|NCT03735901|Levodopa|levodopa|mesh-list
101440702|NCT03735901|Carbidopa|carbidopa|mesh-list
101440703|NCT03735901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101440704|NCT03735901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101440705|NCT03735901|Dopamine Agents|dopamine agents|mesh-ancestor
101440706|NCT03735901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101440707|NCT03735901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440708|NCT03735901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440709|NCT03735901|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101440710|NCT03735901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101440711|NCT03729349|Golimumab|golimumab|mesh-list
101440712|NCT03729349|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101442414|NCT01356940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101440713|NCT03729349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101440714|NCT03729349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101440715|NCT03729349|Immunologic Factors|immunologic factors|mesh-ancestor
101440716|NCT03729349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440717|NCT03712202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101440718|NCT03712202|Nivolumab|nivolumab|mesh-list
101440719|NCT03712202|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101440720|NCT03712202|Doxorubicin|doxorubicin|mesh-list
101440721|NCT03712202|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101440722|NCT03712202|Daunorubicin|daunorubicin|mesh-list
101440723|NCT03712202|Bleomycin|bleomycin|mesh-list
101440724|NCT03712202|Dacarbazine|dacarbazine|mesh-list
101440725|NCT03712202|Vinblastine|vinblastine|mesh-list
101440726|NCT03712202|Antibodies|antibodies|mesh-list
101440727|NCT03712202|Immunoglobulins|immunoglobulins|mesh-list
101440728|NCT03712202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101440729|NCT03712202|Imidazole|imidazole|mesh-list
101440730|NCT03712202|Immunoconjugates|immunoconjugates|mesh-list
101440731|NCT03712202|Immunologic Factors|immunologic factors|mesh-ancestor
101440732|NCT03712202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440733|NCT03712202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440734|NCT03712202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101440735|NCT03712202|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101440736|NCT03712202|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101440737|NCT03712202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101440738|NCT03712202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442559|NCT00171470|Tegaserod|tegaserod|mesh-list
101440739|NCT03712202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101440741|NCT03712202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101440742|NCT03712202|Alkylating Agents|alkylating agents|mesh-ancestor
101440743|NCT03712202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101440744|NCT03712202|Tubulin Modulators|tubulin modulators|mesh-ancestor
101440745|NCT03712202|Antimitotic Agents|antimitotic agents|mesh-ancestor
101440746|NCT03712202|Mitosis Modulators|mitosis modulators|mesh-ancestor
101440747|NCT03652064|Dexamethasone|dexamethasone|mesh-list
101440748|NCT03652064|Lenalidomide|lenalidomide|mesh-list
101440749|NCT03652064|Bortezomib|bortezomib|mesh-list
101440750|NCT03652064|Daratumumab|daratumumab|mesh-list
101307848|NCT02043912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101307849|NCT02043912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101307850|NCT02043912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101307851|NCT02043912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101307852|NCT02043912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101307853|NCT02043912|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101307854|NCT02043912|Dopamine Agents|dopamine agents|mesh-ancestor
101307855|NCT02043912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101307856|NCT02043912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307857|NCT02043912|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101307859|NCT02043977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101440751|NCT03652064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101440752|NCT03652064|Antiemetics|antiemetics|mesh-ancestor
101440753|NCT03652064|Autonomic Agents|autonomic agents|mesh-ancestor
101440754|NCT03652064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101440755|NCT03652064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440756|NCT03652064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101440757|NCT03652064|Glucocorticoids|glucocorticoids|mesh-ancestor
101440758|NCT03652064|Hormones|hormones|mesh-ancestor
101440759|NCT03652064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101440769|NCT03598998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101440770|NCT03598998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440771|NCT03598998|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101440772|NCT03598998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440773|NCT03598998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101440774|NCT03598998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101440775|NCT03596645|Infliximab|infliximab|mesh-list
101440776|NCT03596645|Golimumab|golimumab|mesh-list
101440777|NCT03596645|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101440778|NCT03596645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101440779|NCT03596645|Dermatologic Agents|dermatologic agents|mesh-ancestor
101440780|NCT03596645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101440781|NCT03596645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101442667|NCT00171743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101440782|NCT03596645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101440783|NCT03596645|Immunologic Factors|immunologic factors|mesh-ancestor
101440784|NCT03596645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440785|NCT03573310|JNJ-64619178|jnj-64619178|mesh-list
101440786|NCT03573310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101440787|NCT03573310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440788|NCT03553186|Tranexamic Acid|tranexamic acid|mesh-list
101440789|NCT03553186|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101440790|NCT03553186|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101442718|NCT05054023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101440791|NCT03553186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440792|NCT03553186|Hemostatics|hemostatics|mesh-ancestor
101440793|NCT03553186|Coagulants|coagulants|mesh-ancestor
101440794|NCT03538938|Nicotine|nicotine|mesh-list
101440795|NCT03538938|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101440796|NCT03538938|Autonomic Agents|autonomic agents|mesh-ancestor
101440797|NCT03538938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101440798|NCT03538938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440799|NCT03538938|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101440800|NCT03538938|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101440801|NCT03538938|Cholinergic Agents|cholinergic agents|mesh-ancestor
101440802|NCT03538938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101440803|NCT03538938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440805|NCT03535298|Interferon-beta|interferon-beta|mesh-list
101440806|NCT03535298|Teriflunomide|teriflunomide|mesh-list
101440807|NCT03535298|Alemtuzumab|alemtuzumab|mesh-list
101440808|NCT03535298|Ofatumumab|ofatumumab|mesh-list
101440809|NCT03535298|Cladribine|cladribine|mesh-list
101440810|NCT03535298|Glatiramer Acetate|glatiramer acetate|mesh-list
101440811|NCT03535298|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101440812|NCT03535298|Ocrelizumab|ocrelizumab|mesh-list
101307860|NCT02043977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101307861|NCT02043977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307862|NCT02043977|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101307863|NCT02043977|Anesthetics, General|anesthetics, general|mesh-ancestor
101440813|NCT03535298|Natalizumab|natalizumab|mesh-list
101440814|NCT03535298|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101440815|NCT03535298|(T,G)-A-L|(t,g)-a-l|mesh-list
101440816|NCT03535298|Ozanimod|ozanimod|mesh-list
101440817|NCT03535298|Ponesimod|ponesimod|mesh-list
101440818|NCT03535298|Siponimod|siponimod|mesh-list
101442834|NCT04934449|Salicylic Acid|salicylic acid|mesh-list
101440819|NCT03535298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101440820|NCT03535298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440821|NCT03535298|Immunologic Factors|immunologic factors|mesh-ancestor
101440822|NCT03535298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440823|NCT03535298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101440824|NCT03535298|Antiviral Agents|antiviral agents|mesh-ancestor
101440825|NCT03535298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101440826|NCT03535298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101440827|NCT03535298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101487414|NCT00432588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440832|NCT03535298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101440833|NCT03535298|Analgesics|analgesics|mesh-ancestor
101440834|NCT03535298|Sensory System Agents|sensory system agents|mesh-ancestor
101440835|NCT03535298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101440836|NCT03535298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101440837|NCT03493178|Acetylcysteine|acetylcysteine|mesh-list
101440838|NCT03493178|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101440839|NCT03493178|Glycine|glycine|mesh-list
101440840|NCT03493178|Antiviral Agents|antiviral agents|mesh-ancestor
101440841|NCT03493178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101440842|NCT03493178|Expectorants|expectorants|mesh-ancestor
101440843|NCT03493178|Respiratory System Agents|respiratory system agents|mesh-ancestor
101440844|NCT03493178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101440845|NCT03493178|Antioxidants|antioxidants|mesh-ancestor
101440846|NCT03493178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440847|NCT03493178|Protective Agents|protective agents|mesh-ancestor
101440848|NCT03493178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440849|NCT03493178|Antidotes|antidotes|mesh-ancestor
101440850|NCT03493178|Glycine Agents|glycine agents|mesh-ancestor
101440851|NCT03493178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101440852|NCT03473743|Carboplatin|carboplatin|mesh-list
101440853|NCT03473743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440854|NCT03466411|Ustekinumab|ustekinumab|mesh-list
101440855|NCT03466411|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101440856|NCT03466411|Dermatologic Agents|dermatologic agents|mesh-ancestor
101440857|NCT03466411|Immunologic Factors|immunologic factors|mesh-ancestor
101440858|NCT03466411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440859|NCT03422328|Macitentan|macitentan|mesh-list
101440860|NCT03422328|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101440861|NCT03422328|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101440862|NCT03422328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440863|NCT03422328|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
101440864|NCT03406650|Durvalumab|durvalumab|mesh-list
101440865|NCT03406650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101440866|NCT03406650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440867|NCT03390504|Docetaxel|docetaxel|mesh-list
101528403|NCT01214239|Hormones|hormones|mesh-ancestor
101440868|NCT03390504|Pembrolizumab|pembrolizumab|mesh-list
101440869|NCT03390504|Mitogens|mitogens|mesh-list
101440870|NCT03390504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440871|NCT03390504|Tubulin Modulators|tubulin modulators|mesh-ancestor
101440872|NCT03390504|Antimitotic Agents|antimitotic agents|mesh-ancestor
101443050|NCT02158585|Lamotrigine|lamotrigine|mesh-list
101440873|NCT03390504|Mitosis Modulators|mitosis modulators|mesh-ancestor
101440874|NCT03390504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440875|NCT03390504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101440876|NCT03390504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101440878|NCT03384641|Antitubercular Agents|antitubercular agents|mesh-ancestor
101440879|NCT03384641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101440880|NCT03384641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101440881|NCT03377725|Decitabine|decitabine|mesh-list
101443208|NCT02057380|Hormones|hormones|mesh-ancestor
101440883|NCT03377725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101440884|NCT03377725|Antimetabolites|antimetabolites|mesh-ancestor
101307865|NCT02044120|Irinotecan|irinotecan|mesh-list
101307866|NCT02044120|Temozolomide|temozolomide|mesh-list
101440885|NCT03377725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440886|NCT03377725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440887|NCT03377725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101440888|NCT03346135|Melphalan|melphalan|mesh-list
101440889|NCT03346135|Mechlorethamine|mechlorethamine|mesh-list
101440890|NCT03346135|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
101440891|NCT03346135|Daratumumab|daratumumab|mesh-list
101440892|NCT03346135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101440893|NCT03346135|Alkylating Agents|alkylating agents|mesh-ancestor
101440894|NCT03346135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440895|NCT03346135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440896|NCT03346135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101440897|NCT03346135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101363226|NCT00131326|Viscosupplements|viscosupplements|mesh-ancestor
101440898|NCT03346135|Immunologic Factors|immunologic factors|mesh-ancestor
101440904|NCT03282916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101440905|NCT03244384|Pembrolizumab|pembrolizumab|mesh-list
101440906|NCT03244384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101440907|NCT03244384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440908|NCT03244384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101440909|NCT03244384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440910|NCT03234972|Dexamethasone|dexamethasone|mesh-list
101440911|NCT03234972|Bortezomib|bortezomib|mesh-list
101440912|NCT03234972|Daratumumab|daratumumab|mesh-list
101440913|NCT03234972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101440914|NCT03234972|Antiemetics|antiemetics|mesh-ancestor
101440915|NCT03234972|Autonomic Agents|autonomic agents|mesh-ancestor
101440916|NCT03234972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101440917|NCT03234972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440918|NCT03234972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101440919|NCT03234972|Glucocorticoids|glucocorticoids|mesh-ancestor
101440921|NCT03234972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101440922|NCT03234972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101440923|NCT03234972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440924|NCT03233347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101440925|NCT03233347|Nivolumab|nivolumab|mesh-list
101440926|NCT03233347|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101440927|NCT03233347|Doxorubicin|doxorubicin|mesh-list
101440928|NCT03233347|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101440929|NCT03233347|Daunorubicin|daunorubicin|mesh-list
101440930|NCT03233347|Dacarbazine|dacarbazine|mesh-list
101440931|NCT03233347|Vinblastine|vinblastine|mesh-list
101440932|NCT03233347|Antibodies|antibodies|mesh-list
101440933|NCT03233347|Immunoglobulins|immunoglobulins|mesh-list
101440934|NCT03233347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101440935|NCT03233347|Imidazole|imidazole|mesh-list
101440936|NCT03233347|Immunoconjugates|immunoconjugates|mesh-list
101440937|NCT03233347|Immunologic Factors|immunologic factors|mesh-ancestor
101440938|NCT03233347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440939|NCT03233347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440940|NCT03233347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101440941|NCT03233347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101440942|NCT03233347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101440943|NCT03233347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101440944|NCT03233347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440945|NCT03233347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101443473|NCT00555022|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101440946|NCT03233347|Immunotoxins|immunotoxins|mesh-ancestor
101440947|NCT03233347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101440949|NCT03233347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101440950|NCT03233347|Tubulin Modulators|tubulin modulators|mesh-ancestor
101440951|NCT03233347|Antimitotic Agents|antimitotic agents|mesh-ancestor
101440952|NCT03233347|Mitosis Modulators|mitosis modulators|mesh-ancestor
101440953|NCT03232073|Ponesimod|ponesimod|mesh-list
101440954|NCT03232073|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101443618|NCT01756924|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101440955|NCT03232073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440956|NCT03232073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101440957|NCT03232073|Immunologic Factors|immunologic factors|mesh-ancestor
101440958|NCT03232073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443702|NCT00203736|Artesunate|artesunate|mesh-list
101440959|NCT03229382|Obinutuzumab|obinutuzumab|mesh-list
101440960|NCT03229382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101307867|NCT02044120|Niraparib|niraparib|mesh-list
101307868|NCT02044120|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101307869|NCT02044120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101307870|NCT02044120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101440961|NCT03229382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440962|NCT03218488|Ustekinumab|ustekinumab|mesh-list
101440963|NCT03218488|Dermatologic Agents|dermatologic agents|mesh-ancestor
101440964|NCT03217812|Prednisone|prednisone|mesh-list
101440965|NCT03217812|Bortezomib|bortezomib|mesh-list
101440966|NCT03217812|Melphalan|melphalan|mesh-list
101440967|NCT03217812|Daratumumab|daratumumab|mesh-list
101440968|NCT03217812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101440969|NCT03217812|Glucocorticoids|glucocorticoids|mesh-ancestor
101440970|NCT03217812|Hormones|hormones|mesh-ancestor
101443878|NCT00199017|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101440971|NCT03217812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101440976|NCT03217812|Alkylating Agents|alkylating agents|mesh-ancestor
101440977|NCT03217812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440978|NCT03217812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101440979|NCT03217812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101440980|NCT03217812|Immunologic Factors|immunologic factors|mesh-ancestor
101440981|NCT03215693|Ensartinib|ensartinib|mesh-list
101440982|NCT03215693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440983|NCT03215693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101440984|NCT03215693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101440985|NCT03215693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440986|NCT03199885|Paclitaxel|paclitaxel|mesh-list
101440987|NCT03199885|Docetaxel|docetaxel|mesh-list
101440988|NCT03199885|Trastuzumab|trastuzumab|mesh-list
101440989|NCT03199885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101440990|NCT03199885|Atezolizumab|atezolizumab|mesh-list
101440991|NCT03199885|Pertuzumab|pertuzumab|mesh-list
101440992|NCT03199885|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
101440993|NCT03199885|Antibodies|antibodies|mesh-list
101440994|NCT03199885|Immunoglobulins|immunoglobulins|mesh-list
101440995|NCT03199885|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101444090|NCT00555373|Antifungal Agents|antifungal agents|mesh-ancestor
101440996|NCT03199885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101440997|NCT03199885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440998|NCT03199885|Tubulin Modulators|tubulin modulators|mesh-ancestor
101440999|NCT03199885|Antimitotic Agents|antimitotic agents|mesh-ancestor
101441000|NCT03199885|Mitosis Modulators|mitosis modulators|mesh-ancestor
101441001|NCT03199885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441002|NCT03199885|Immunologic Factors|immunologic factors|mesh-ancestor
101441003|NCT03199885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441004|NCT03199885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101441005|NCT03199885|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101441006|NCT03187106|Metronidazole|metronidazole|mesh-list
101441007|NCT03187106|Cephalexin|cephalexin|mesh-list
101441008|NCT03187106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101441009|NCT03187106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101441010|NCT03187106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101441011|NCT03187106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101441012|NCT03170518|Canagliflozin|canagliflozin|mesh-list
101444152|NCT00199368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441013|NCT03170518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101441014|NCT03170518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441015|NCT03170518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101441016|NCT03170518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441017|NCT03159702|Fludarabine|fludarabine|mesh-list
101441018|NCT03159702|Melphalan|melphalan|mesh-list
101441019|NCT03159702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101444201|NCT04675372|GABA Modulators|gaba modulators|mesh-ancestor
101441020|NCT03159702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441021|NCT03159702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101441022|NCT03159702|Immunologic Factors|immunologic factors|mesh-ancestor
101441023|NCT03159702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441024|NCT03159702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101441026|NCT03159702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101441027|NCT03044977|Octreotide|octreotide|mesh-list
101441028|NCT03044977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101441029|NCT03044977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101441030|NCT03044977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441031|NCT03009201|Doxorubicin|doxorubicin|mesh-list
101441032|NCT03009201|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101307871|NCT02044120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441033|NCT03009201|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101441034|NCT03009201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441035|NCT03009201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101441036|NCT03009201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101441037|NCT03009201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101441038|NCT03009201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441040|NCT02985957|Nivolumab|nivolumab|mesh-list
101441041|NCT02985957|Ipilimumab|ipilimumab|mesh-list
101363234|NCT00131404|Hormones|hormones|mesh-ancestor
101441042|NCT02985957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101441048|NCT02985957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441049|NCT02985957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101441050|NCT02985957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101441051|NCT02985957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441052|NCT02985749|Oxytocin|oxytocin|mesh-list
101441053|NCT02985749|Oxytocics|oxytocics|mesh-ancestor
101441054|NCT02985749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101441055|NCT02985749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441056|NCT02975934|Docetaxel|docetaxel|mesh-list
101441057|NCT02975934|Abiraterone Acetate|abiraterone acetate|mesh-list
101441058|NCT02975934|Rucaparib|rucaparib|mesh-list
101441059|NCT02975934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441060|NCT02975934|Tubulin Modulators|tubulin modulators|mesh-ancestor
101441061|NCT02975934|Antimitotic Agents|antimitotic agents|mesh-ancestor
101441062|NCT02975934|Mitosis Modulators|mitosis modulators|mesh-ancestor
101441063|NCT02975934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441064|NCT02975934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101441065|NCT02975934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101441066|NCT02975934|Hormone Antagonists|hormone antagonists|mesh-ancestor
101441067|NCT02975934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101441068|NCT02975934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441069|NCT02975934|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101441070|NCT02975934|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101441071|NCT02932410|Macitentan|macitentan|mesh-list
101441072|NCT02932410|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101441073|NCT02932410|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101441074|NCT02932410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444437|NCT00204555|Immunologic Factors|immunologic factors|mesh-ancestor
101441075|NCT02932410|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
101441076|NCT02905591|Ascorbic Acid|ascorbic acid|mesh-list
101441077|NCT02905591|Paclitaxel|paclitaxel|mesh-list
101441078|NCT02905591|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101441079|NCT02905591|Carboplatin|carboplatin|mesh-list
101441080|NCT02905591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101441081|NCT02905591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441082|NCT02905591|Tubulin Modulators|tubulin modulators|mesh-ancestor
101441083|NCT02905591|Antimitotic Agents|antimitotic agents|mesh-ancestor
101441084|NCT02905591|Mitosis Modulators|mitosis modulators|mesh-ancestor
101441085|NCT02905591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441086|NCT02905591|Vitamins|vitamins|mesh-ancestor
101441087|NCT02905591|Micronutrients|micronutrients|mesh-ancestor
101441088|NCT02905591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441089|NCT02905591|Antioxidants|antioxidants|mesh-ancestor
101441090|NCT02905591|Protective Agents|protective agents|mesh-ancestor
101441091|NCT02635672|Pembrolizumab|pembrolizumab|mesh-list
101441092|NCT02635672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101441093|NCT02635672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441094|NCT02635672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101444492|NCT03252808|Antimetabolites|antimetabolites|mesh-ancestor
101444493|NCT03191461|Adenosine|adenosine|mesh-list
101441095|NCT02635672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441096|NCT02609776|Carboplatin|carboplatin|mesh-list
101441097|NCT02609776|Pemetrexed|pemetrexed|mesh-list
101441098|NCT02609776|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
101441099|NCT02609776|Lazertinib|lazertinib|mesh-list
101441100|NCT02609776|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101441101|NCT02609776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441102|NCT02609776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101441103|NCT02609776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307873|NCT02044120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101441105|NCT02609776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101441106|NCT02609776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101441107|NCT02609776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101441108|NCT02609776|Immunologic Factors|immunologic factors|mesh-ancestor
101441109|NCT02609776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441110|NCT02589600|Vitamin D|vitamin d|mesh-list
101441120|NCT02531516|Hormone Antagonists|hormone antagonists|mesh-ancestor
101441121|NCT02531516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101441122|NCT02531516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441123|NCT02531516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441124|NCT02465060|Nivolumab|nivolumab|mesh-list
101441125|NCT02465060|Trastuzumab|trastuzumab|mesh-list
101441126|NCT02465060|Pertuzumab|pertuzumab|mesh-list
101441127|NCT02465060|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101441129|NCT02465060|Sunitinib|sunitinib|mesh-list
101441130|NCT02465060|Dasatinib|dasatinib|mesh-list
101441131|NCT02465060|Palbociclib|palbociclib|mesh-list
101441132|NCT02465060|Trametinib|trametinib|mesh-list
101441133|NCT02465060|Osimertinib|osimertinib|mesh-list
101441134|NCT02465060|Afatinib|afatinib|mesh-list
101441135|NCT02465060|Dabrafenib|dabrafenib|mesh-list
101441136|NCT02465060|Crizotinib|crizotinib|mesh-list
101441137|NCT02465060|Maytansine|maytansine|mesh-list
101441138|NCT02465060|Ipatasertib|ipatasertib|mesh-list
101441139|NCT02465060|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
101441140|NCT02465060|GSK2636771|gsk2636771|mesh-list
101441141|NCT02465060|Antibodies|antibodies|mesh-list
101441142|NCT02465060|Immunoglobulins|immunoglobulins|mesh-list
101441143|NCT02465060|Immunoglobulin G|immunoglobulin g|mesh-list
101441144|NCT02465060|Adavosertib|adavosertib|mesh-list
101441145|NCT02465060|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101441146|NCT02465060|Immunoconjugates|immunoconjugates|mesh-list
101441147|NCT02465060|Immunologic Factors|immunologic factors|mesh-ancestor
101441148|NCT02465060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441149|NCT02465060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101441150|NCT02465060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441151|NCT02465060|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101441152|NCT02465060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441153|NCT02465060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101441154|NCT02465060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101441155|NCT02465060|Growth Substances|growth substances|mesh-ancestor
101441156|NCT02465060|Growth Inhibitors|growth inhibitors|mesh-ancestor
101441157|NCT02465060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101441158|NCT02465060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101441159|NCT02465060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101441160|NCT02465060|Tubulin Modulators|tubulin modulators|mesh-ancestor
101441161|NCT02465060|Antimitotic Agents|antimitotic agents|mesh-ancestor
101441162|NCT02465060|Mitosis Modulators|mitosis modulators|mesh-ancestor
101441163|NCT02465060|Immunotoxins|immunotoxins|mesh-ancestor
101441164|NCT02428985|Riociguat|riociguat|mesh-list
101441165|NCT02428985|Enzyme Activators|enzyme activators|mesh-ancestor
101444745|NCT02372578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101444746|NCT02372578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101441166|NCT02428985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441167|NCT02365597|Metformin|metformin|mesh-list
101441168|NCT02365597|Midazolam|midazolam|mesh-list
101441169|NCT02365597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101441170|NCT02365597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441172|NCT02365597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101441173|NCT02365597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101441174|NCT02365597|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101441175|NCT02365597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101441177|NCT02365597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101441178|NCT02365597|Anesthetics, General|anesthetics, general|mesh-ancestor
101441179|NCT02365597|Anesthetics|anesthetics|mesh-ancestor
101441180|NCT02365597|GABA Modulators|gaba modulators|mesh-ancestor
101441181|NCT02365597|GABA Agents|gaba agents|mesh-ancestor
101441182|NCT02365597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101441187|NCT02339571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101441188|NCT02339571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441189|NCT02339571|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101441190|NCT02339571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441191|NCT02339571|Immunologic Factors|immunologic factors|mesh-ancestor
101307876|NCT02044133|Vitamin D|vitamin d|mesh-list
101307877|NCT02044133|Vitamins|vitamins|mesh-ancestor
101307878|NCT02044133|Micronutrients|micronutrients|mesh-ancestor
101307879|NCT02044133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441192|NCT02339571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441193|NCT02222155|Cyclophosphamide|cyclophosphamide|mesh-list
101441194|NCT02222155|Rituximab|rituximab|mesh-list
101441195|NCT02222155|Glucocorticoids|glucocorticoids|mesh-list
101444930|NCT02207257|Edoxaban|edoxaban|mesh-list
101441196|NCT02222155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101441197|NCT02222155|Immunologic Factors|immunologic factors|mesh-ancestor
101441198|NCT02222155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441199|NCT02222155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101441200|NCT02222155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101441201|NCT02222155|Alkylating Agents|alkylating agents|mesh-ancestor
101441202|NCT02222155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441203|NCT02222155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441204|NCT02222155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101441205|NCT02222155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101441206|NCT02222155|Hormones|hormones|mesh-ancestor
101441207|NCT02222155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101441208|NCT02123758|Prednisone|prednisone|mesh-list
101441209|NCT02123758|Abiraterone Acetate|abiraterone acetate|mesh-list
101441210|NCT02123758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101441211|NCT02123758|Glucocorticoids|glucocorticoids|mesh-ancestor
101441212|NCT02123758|Hormones|hormones|mesh-ancestor
101441213|NCT02123758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101441214|NCT02123758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441215|NCT02123758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101441216|NCT02123758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441217|NCT02123758|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101441218|NCT02123758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101441219|NCT02123758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441220|NCT02123758|Hormone Antagonists|hormone antagonists|mesh-ancestor
101441221|NCT02123758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101441222|NCT02020070|Ipilimumab|ipilimumab|mesh-list
101441223|NCT02020070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101441224|NCT02020070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441225|NCT02020070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101441226|NCT02020070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441227|NCT01998971|Acetaminophen|acetaminophen|mesh-list
101441228|NCT01998971|Diphenhydramine|diphenhydramine|mesh-list
101441229|NCT01998971|Promethazine|promethazine|mesh-list
101441230|NCT01998971|Thalidomide|thalidomide|mesh-list
101441231|NCT01998971|Dexamethasone|dexamethasone|mesh-list
101441232|NCT01998971|Prednisone|prednisone|mesh-list
101441233|NCT01998971|Lenalidomide|lenalidomide|mesh-list
101441234|NCT01998971|Melphalan|melphalan|mesh-list
101441235|NCT01998971|Bortezomib|bortezomib|mesh-list
101441236|NCT01998971|Daratumumab|daratumumab|mesh-list
101441237|NCT01998971|Pomalidomide|pomalidomide|mesh-list
101441238|NCT01998971|Montelukast|montelukast|mesh-list
101441239|NCT01998971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101441240|NCT01998971|Antiemetics|antiemetics|mesh-ancestor
101441241|NCT01998971|Autonomic Agents|autonomic agents|mesh-ancestor
101441242|NCT01998971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101441243|NCT01998971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441244|NCT01998971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101441245|NCT01998971|Glucocorticoids|glucocorticoids|mesh-ancestor
101441246|NCT01998971|Hormones|hormones|mesh-ancestor
101441247|NCT01998971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101441248|NCT01998971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101445077|NCT00200499|Nebivolol|nebivolol|mesh-list
101441249|NCT01998971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441250|NCT01998971|Immunologic Factors|immunologic factors|mesh-ancestor
101441251|NCT01998971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101441252|NCT01998971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101441253|NCT01998971|Growth Substances|growth substances|mesh-ancestor
101441254|NCT01998971|Growth Inhibitors|growth inhibitors|mesh-ancestor
101441262|NCT01998971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101441263|NCT01998971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101441264|NCT01998971|Leprostatic Agents|leprostatic agents|mesh-ancestor
101441265|NCT01998971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101307880|NCT02044133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101307882|NCT02044146|Ticagrelor|ticagrelor|mesh-list
101307883|NCT02044146|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101307884|NCT02044146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101307885|NCT02044146|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101441266|NCT01998971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101441267|NCT01998971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101445104|NCT00177749|Posaconazole|posaconazole|mesh-list
101363256|NCT00397709|Leprostatic Agents|leprostatic agents|mesh-ancestor
101441268|NCT01998971|Respiratory System Agents|respiratory system agents|mesh-ancestor
101441269|NCT01998971|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101441270|NCT01998971|Hormone Antagonists|hormone antagonists|mesh-ancestor
101441271|NCT01998971|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101441272|NCT01998971|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101441273|NCT01998971|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101441274|NCT01998971|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101441275|NCT01998971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101441276|NCT01998971|Anesthetics, Local|anesthetics, local|mesh-ancestor
101441277|NCT01998971|Anesthetics|anesthetics|mesh-ancestor
101441279|NCT01998971|Histamine Antagonists|histamine antagonists|mesh-ancestor
101441280|NCT01998971|Histamine Agents|histamine agents|mesh-ancestor
101441281|NCT01998971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101441282|NCT01998971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101441283|NCT01998971|Antipruritics|antipruritics|mesh-ancestor
101441284|NCT01998971|Dermatologic Agents|dermatologic agents|mesh-ancestor
101441285|NCT01896999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101441286|NCT01896999|Nivolumab|nivolumab|mesh-list
101441287|NCT01896999|Ipilimumab|ipilimumab|mesh-list
101441288|NCT01896999|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101441289|NCT01896999|Antibodies|antibodies|mesh-list
101441290|NCT01896999|Immunoglobulins|immunoglobulins|mesh-list
101441291|NCT01896999|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101441292|NCT01896999|Immunoconjugates|immunoconjugates|mesh-list
101441293|NCT01896999|Immunologic Factors|immunologic factors|mesh-ancestor
101441294|NCT01896999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441295|NCT01896999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441296|NCT01896999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101441297|NCT01896999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445157|NCT04654195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101441298|NCT01896999|Immunotoxins|immunotoxins|mesh-ancestor
101441299|NCT01828112|Docetaxel|docetaxel|mesh-list
101441300|NCT01828112|Pemetrexed|pemetrexed|mesh-list
101441301|NCT01828112|Ceritinib|ceritinib|mesh-list
101441302|NCT01828112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441303|NCT01828112|Tubulin Modulators|tubulin modulators|mesh-ancestor
101441304|NCT01828112|Antimitotic Agents|antimitotic agents|mesh-ancestor
101441305|NCT01828112|Mitosis Modulators|mitosis modulators|mesh-ancestor
101441306|NCT01828112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441307|NCT01828112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101441308|NCT01828112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101441309|NCT01828112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101441310|NCT01828112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101441311|NCT01792687|Prednisone|prednisone|mesh-list
101441312|NCT01792687|Abiraterone Acetate|abiraterone acetate|mesh-list
101441313|NCT01792687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101441314|NCT01792687|Glucocorticoids|glucocorticoids|mesh-ancestor
101441315|NCT01792687|Hormones|hormones|mesh-ancestor
101441316|NCT01792687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101441317|NCT01792687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441318|NCT01792687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101441319|NCT01792687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441320|NCT01792687|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101441321|NCT01792687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101441322|NCT01792687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441325|NCT01465100|Liver Extracts|liver extracts|mesh-list
101441326|NCT01465100|Hematinics|hematinics|mesh-ancestor
101441327|NCT01430390|Cyclophosphamide|cyclophosphamide|mesh-list
101441328|NCT01430390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101441329|NCT01430390|Immunologic Factors|immunologic factors|mesh-ancestor
101441330|NCT01430390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307886|NCT02044146|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101307887|NCT02044146|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101441331|NCT01430390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101441332|NCT01430390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101441333|NCT01430390|Alkylating Agents|alkylating agents|mesh-ancestor
101441334|NCT01430390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441335|NCT01430390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441336|NCT01430390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101441337|NCT01364857|GTPase-Activating Proteins|gtpase-activating proteins|mesh-list
101441338|NCT01364857|GTP Phosphohydrolase Activators|gtp phosphohydrolase activators|mesh-ancestor
101441339|NCT01364857|Enzyme Activators|enzyme activators|mesh-ancestor
101441340|NCT01364857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441343|NCT01286272|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101441344|NCT01286272|Ofatumumab|ofatumumab|mesh-list
101441345|NCT01286272|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101441346|NCT01286272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101441347|NCT01286272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441348|NCT01286272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101441349|NCT01286272|Alkylating Agents|alkylating agents|mesh-ancestor
101441350|NCT01286272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441351|NCT01286272|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101441352|NCT01286272|Antimetabolites|antimetabolites|mesh-ancestor
101441353|NCT01286272|Antiviral Agents|antiviral agents|mesh-ancestor
101441354|NCT01286272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101441355|NCT01286272|Immunologic Factors|immunologic factors|mesh-ancestor
101441356|NCT01286272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441357|NCT01093326|Ponesimod|ponesimod|mesh-list
101441358|NCT01093326|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101441359|NCT01093326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441360|NCT01093326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101441361|NCT01093326|Immunologic Factors|immunologic factors|mesh-ancestor
101441362|NCT01093326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441363|NCT01065454|Riociguat|riociguat|mesh-list
101441364|NCT01065454|Enzyme Activators|enzyme activators|mesh-ancestor
101441365|NCT01065454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441366|NCT01029002|Vitamin D|vitamin d|mesh-list
101441367|NCT01029002|Vitamins|vitamins|mesh-ancestor
101441368|NCT01029002|Micronutrients|micronutrients|mesh-ancestor
101445218|NCT00178100|Paroxetine|paroxetine|mesh-list
101441369|NCT01029002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441370|NCT01029002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101441371|NCT01013649|Gemcitabine|gemcitabine|mesh-list
101441372|NCT01013649|Fluorouracil|fluorouracil|mesh-list
101441373|NCT01013649|Capecitabine|capecitabine|mesh-list
101441374|NCT01013649|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101441375|NCT01013649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101441376|NCT01013649|Antimetabolites|antimetabolites|mesh-ancestor
101441377|NCT01013649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441378|NCT01013649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441379|NCT01013649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101441380|NCT01013649|Immunologic Factors|immunologic factors|mesh-ancestor
101441381|NCT01013649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441382|NCT01013649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101441383|NCT01013649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101441384|NCT01011478|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101441385|NCT01011478|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101441386|NCT01011478|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101441388|NCT01011478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441389|NCT01011478|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101441390|NCT01011478|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101441391|NCT01011478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101441392|NCT00980460|Sirolimus|sirolimus|mesh-list
101445293|NCT04652323|Calcium|calcium|mesh-list
101441394|NCT00980460|Doxorubicin|doxorubicin|mesh-list
101441395|NCT00980460|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101441407|NCT00980460|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101441408|NCT00980460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101441409|NCT00980460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101441410|NCT00980460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101307888|NCT02044146|Purinergic Agents|purinergic agents|mesh-ancestor
101307889|NCT02044146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101307890|NCT02044146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441411|NCT00980460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441412|NCT00980460|Antimetabolites|antimetabolites|mesh-ancestor
101441413|NCT00980460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101441414|NCT00980460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101441415|NCT00980460|Immunologic Factors|immunologic factors|mesh-ancestor
101441416|NCT00980460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441417|NCT00980460|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101441418|NCT00980460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101441419|NCT00980460|Tubulin Modulators|tubulin modulators|mesh-ancestor
101441420|NCT00980460|Antimitotic Agents|antimitotic agents|mesh-ancestor
101441421|NCT00980460|Mitosis Modulators|mitosis modulators|mesh-ancestor
101441422|NCT00980460|Hematinics|hematinics|mesh-ancestor
101441423|NCT00980460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101441424|NCT00980460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101441425|NCT00980460|Antifungal Agents|antifungal agents|mesh-ancestor
101441426|NCT00980460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101441427|NCT00980460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101441428|NCT00980460|Protective Agents|protective agents|mesh-ancestor
101441429|NCT00799864|Tenofovir|tenofovir|mesh-list
101441430|NCT00799864|Lamivudine|lamivudine|mesh-list
101441431|NCT00799864|Emtricitabine|emtricitabine|mesh-list
101308069|NCT02045667|Mexiletine|mexiletine|mesh-list
101441432|NCT00799864|Zidovudine|zidovudine|mesh-list
101441433|NCT00799864|Abacavir|abacavir|mesh-list
101441434|NCT00799864|Rilpivirine|rilpivirine|mesh-list
101441435|NCT00799864|Antiviral Agents|antiviral agents|mesh-ancestor
101441436|NCT00799864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101441437|NCT00799864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101441438|NCT00799864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101441440|NCT00799864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441441|NCT00799864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101441442|NCT00799864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101441443|NCT00799864|Antimetabolites|antimetabolites|mesh-ancestor
101441444|NCT00695279|Vaccines|vaccines|mesh-list
101441445|NCT00695279|Immunologic Factors|immunologic factors|mesh-ancestor
101441446|NCT00695279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445562|NCT00560326|Immunologic Factors|immunologic factors|mesh-ancestor
101441447|NCT00606346|Infliximab|infliximab|mesh-list
101441448|NCT00606346|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101441449|NCT00606346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101441450|NCT00606346|Dermatologic Agents|dermatologic agents|mesh-ancestor
101445653|NCT00201396|Vitamins|vitamins|mesh-ancestor
101441451|NCT00606346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101441452|NCT00606346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101441453|NCT00272714|Afimoxifene|afimoxifene|mesh-list
101441454|NCT00272714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441455|NCT00272714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101445743|NCT00179231|GABA Agents|gaba agents|mesh-ancestor
101441456|NCT00272714|Hormone Antagonists|hormone antagonists|mesh-ancestor
101441457|NCT00272714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101441458|NCT00272714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441459|NCT00272714|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101441460|NCT00272714|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101441461|NCT00217737|Calcium, Dietary|calcium, dietary|mesh-list
101441462|NCT00217737|Leucovorin|leucovorin|mesh-list
101441463|NCT00217737|Folic Acid|folic acid|mesh-list
101441464|NCT00217737|Bevacizumab|bevacizumab|mesh-list
101441484|NCT00217737|Antimetabolites|antimetabolites|mesh-ancestor
101441485|NCT00217737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441486|NCT00217737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101441487|NCT00217737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101441488|NCT00217737|Antidotes|antidotes|mesh-ancestor
101441489|NCT00217737|Protective Agents|protective agents|mesh-ancestor
101441490|NCT00217737|Vitamin B Complex|vitamin b complex|mesh-ancestor
101441491|NCT00217737|Vitamins|vitamins|mesh-ancestor
101441492|NCT00217737|Micronutrients|micronutrients|mesh-ancestor
101441493|NCT00217737|Hematinics|hematinics|mesh-ancestor
101441494|NCT02903719|Ropivacaine|ropivacaine|mesh-list
101441495|NCT02903719|Anesthetics, Local|anesthetics, local|mesh-ancestor
101441496|NCT02903719|Anesthetics|anesthetics|mesh-ancestor
101441497|NCT02903719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101441498|NCT02903719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441499|NCT02903719|Sensory System Agents|sensory system agents|mesh-ancestor
101307891|NCT02044146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307892|NCT02044224|Dexmedetomidine|dexmedetomidine|mesh-list
101307893|NCT02044224|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101445868|NCT04630288|Ticagrelor|ticagrelor|mesh-list
101307894|NCT02044224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101307895|NCT02044224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441500|NCT02903719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101441501|NCT00178269|Docetaxel|docetaxel|mesh-list
101441502|NCT00178269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441503|NCT00178269|Tubulin Modulators|tubulin modulators|mesh-ancestor
101441504|NCT00178269|Antimitotic Agents|antimitotic agents|mesh-ancestor
101441505|NCT00178269|Mitosis Modulators|mitosis modulators|mesh-ancestor
101445944|NCT00201981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101441506|NCT00178269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441507|NCT02903251|Oxytocin|oxytocin|mesh-list
101441508|NCT02903251|Oxytocics|oxytocics|mesh-ancestor
101441509|NCT02903251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101441510|NCT02903251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441511|NCT00168467|Ramipril|ramipril|mesh-list
101441512|NCT00168467|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101441513|NCT00168467|Protease Inhibitors|protease inhibitors|mesh-ancestor
101441514|NCT00168467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101446132|NCT00202020|Aspirin|aspirin|mesh-list
101441515|NCT00168467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446174|NCT00577057|Capecitabine|capecitabine|mesh-list
101441516|NCT00168467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101441517|NCT00195936|Cinacalcet|cinacalcet|mesh-list
101441518|NCT00195936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101441519|NCT00195936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441520|NCT00195936|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101441540|NCT02902861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101441541|NCT02902861|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101441542|NCT02902861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101441543|NCT02902861|Immunologic Factors|immunologic factors|mesh-ancestor
101441544|NCT02902861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101441545|NCT02902861|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101441546|NCT02903017|Tranexamic Acid|tranexamic acid|mesh-list
101441547|NCT02903017|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101441548|NCT02903017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101441549|NCT02903017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441550|NCT02903017|Hemostatics|hemostatics|mesh-ancestor
101441551|NCT02903017|Coagulants|coagulants|mesh-ancestor
101441552|NCT02902744|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
101441553|NCT02902744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101441554|NCT02902744|Glucocorticoids|glucocorticoids|mesh-ancestor
101441556|NCT02902744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101441557|NCT02902744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441558|NCT00168584|Vitamin A|vitamin a|mesh-list
101441559|NCT00168584|Vitamins|vitamins|mesh-ancestor
101441560|NCT00168584|Micronutrients|micronutrients|mesh-ancestor
101441561|NCT00168584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441562|NCT02902666|Acetaminophen|acetaminophen|mesh-list
101441563|NCT02902666|Codeine|codeine|mesh-list
101441564|NCT02902666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101441565|NCT02902666|Analgesics|analgesics|mesh-ancestor
101441566|NCT02902666|Sensory System Agents|sensory system agents|mesh-ancestor
101441567|NCT02902666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101441568|NCT02902666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441569|NCT02902666|Antipyretics|antipyretics|mesh-ancestor
101441570|NCT02902666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101441571|NCT02902666|Narcotics|narcotics|mesh-ancestor
101308108|NCT02045849|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101441572|NCT02902666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101441580|NCT02902354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441581|NCT02902354|Vasodilator Agents|vasodilator agents|mesh-ancestor
101441582|NCT02902354|Tocolytic Agents|tocolytic agents|mesh-ancestor
101441583|NCT02902354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101441585|NCT00168623|Vitamins|vitamins|mesh-ancestor
101441586|NCT00168623|Micronutrients|micronutrients|mesh-ancestor
101441587|NCT00168623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441588|NCT02902315|Vitamins|vitamins|mesh-list
101441589|NCT02902315|Ascorbic Acid|ascorbic acid|mesh-list
101441590|NCT02902315|Tocopherols|tocopherols|mesh-list
101441591|NCT02902315|alpha-Tocopherol|alpha-tocopherol|mesh-list
101441592|NCT02902315|Micronutrients|micronutrients|mesh-ancestor
101441593|NCT02902315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441594|NCT02902315|Antioxidants|antioxidants|mesh-ancestor
101307896|NCT02044224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101441595|NCT02902315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441596|NCT02902315|Protective Agents|protective agents|mesh-ancestor
101441597|NCT02902432|Endostar protein|endostar protein|mesh-list
101441598|NCT02902432|Endostatins|endostatins|mesh-list
101441599|NCT02902432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101441600|NCT02902432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101441601|NCT02902432|Growth Substances|growth substances|mesh-ancestor
101441602|NCT02902432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441603|NCT02902432|Growth Inhibitors|growth inhibitors|mesh-ancestor
101441604|NCT02902432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308124|NCT02045940|Anabolic Agents|anabolic agents|mesh-ancestor
101441610|NCT02902042|Pembrolizumab|pembrolizumab|mesh-list
101441611|NCT02902042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101441612|NCT02902042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441613|NCT02902042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101446565|NCT00209079|Mitosis Modulators|mitosis modulators|mesh-ancestor
101441614|NCT02902042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441615|NCT00168740|Rituximab|rituximab|mesh-list
101441616|NCT00168740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101441617|NCT00168740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441618|NCT00168740|Immunologic Factors|immunologic factors|mesh-ancestor
101441619|NCT00168740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441620|NCT00168740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101441622|NCT00168779|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101441623|NCT00168779|Telmisartan|telmisartan|mesh-list
101441624|NCT00168779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101441625|NCT00168779|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101441626|NCT00168779|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101441627|NCT00168779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441628|NCT00168779|Diuretics|diuretics|mesh-ancestor
101441629|NCT00168779|Natriuretic Agents|natriuretic agents|mesh-ancestor
101441630|NCT00168779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446724|NCT04576390|Serotonin Agents|serotonin agents|mesh-ancestor
101446725|NCT04576390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101441631|NCT00168779|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101441632|NCT00168779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101441634|NCT00168857|Telmisartan|telmisartan|mesh-list
101446786|NCT00584155|Ofloxacin|ofloxacin|mesh-list
101441635|NCT00168857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101441636|NCT00168857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101441637|NCT00168857|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101441638|NCT00168857|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101441639|NCT00168857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441640|NCT00196131|Morphine|morphine|mesh-list
101441641|NCT00196131|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101441642|NCT00196131|Narcotics|narcotics|mesh-ancestor
101441643|NCT00196131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101441644|NCT00196131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446857|NCT00584662|Phenylephrine|phenylephrine|mesh-list
101446858|NCT00584662|Oxymetazoline|oxymetazoline|mesh-list
101446859|NCT00584662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101441651|NCT00168896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441652|NCT00168896|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101441653|NCT00168896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101441654|NCT00168896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101441655|NCT00168896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441656|NCT00168896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101441657|NCT00168896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101441658|NCT02901418|Immunoglobulins|immunoglobulins|mesh-list
101441659|NCT02901418|Immunologic Factors|immunologic factors|mesh-ancestor
101441660|NCT02901418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441661|NCT02901379|Atorvastatin|atorvastatin|mesh-list
101441663|NCT02901379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101441664|NCT02901379|Antimetabolites|antimetabolites|mesh-ancestor
101441665|NCT02901379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441666|NCT02901379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101441667|NCT02901379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101441668|NCT02901379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101441669|NCT02901106|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101441670|NCT02901106|Dermatologic Agents|dermatologic agents|mesh-ancestor
101441671|NCT02901106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101441672|NCT02901106|Immunologic Factors|immunologic factors|mesh-ancestor
101441673|NCT02901106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441674|NCT02901145|Cyclophosphamide|cyclophosphamide|mesh-list
101441675|NCT02901145|Nivolumab|nivolumab|mesh-list
101441676|NCT02901145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101441677|NCT02901145|Immunologic Factors|immunologic factors|mesh-ancestor
101307897|NCT02044224|Analgesics|analgesics|mesh-ancestor
101307898|NCT02044224|Sensory System Agents|sensory system agents|mesh-ancestor
101441678|NCT02901145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441679|NCT02901145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101441680|NCT02901145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101441681|NCT02901145|Alkylating Agents|alkylating agents|mesh-ancestor
101441682|NCT02901145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441683|NCT02901145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441684|NCT02901145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101441685|NCT02901145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101441686|NCT02901145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101441687|NCT02901301|Pembrolizumab|pembrolizumab|mesh-list
101441688|NCT02901301|Capecitabine|capecitabine|mesh-list
101441689|NCT02901301|Trastuzumab|trastuzumab|mesh-list
101441690|NCT02901301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441691|NCT02901301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101441692|NCT02901301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101441693|NCT02901301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441694|NCT02901301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101441695|NCT02901301|Antimetabolites|antimetabolites|mesh-ancestor
101441696|NCT00169013|Gabapentin|gabapentin|mesh-list
101441697|NCT00169013|Analgesics|analgesics|mesh-ancestor
101441698|NCT00169013|Sensory System Agents|sensory system agents|mesh-ancestor
101441699|NCT00169013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101441700|NCT00169013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441701|NCT00169013|Anticonvulsants|anticonvulsants|mesh-ancestor
101441702|NCT00169013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101441703|NCT00169013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101441704|NCT00169013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101441705|NCT00169013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101441706|NCT00169013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101441707|NCT00169013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101441708|NCT00169013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101441709|NCT00169013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441710|NCT00169013|Antimanic Agents|antimanic agents|mesh-ancestor
101441711|NCT00169091|Haloperidol|haloperidol|mesh-list
101441712|NCT00169091|Haloperidol decanoate|haloperidol decanoate|mesh-list
101441713|NCT00169091|Clozapine|clozapine|mesh-list
101447079|NCT00587119|Budesonide|budesonide|mesh-list
101441717|NCT00169091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441719|NCT00169091|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101441720|NCT00169091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101441721|NCT00169091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101441722|NCT00169091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101441723|NCT00169091|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101441724|NCT00169091|Dopamine Agents|dopamine agents|mesh-ancestor
101441725|NCT00169091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101441726|NCT00169091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441727|NCT00169091|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101441728|NCT00169091|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101441729|NCT00169091|Serotonin Agents|serotonin agents|mesh-ancestor
101441730|NCT00169091|GABA Antagonists|gaba antagonists|mesh-ancestor
101441731|NCT00169091|GABA Agents|gaba agents|mesh-ancestor
101441732|NCT00169130|Cyclophosphamide|cyclophosphamide|mesh-list
101441733|NCT00169130|Doxorubicin|doxorubicin|mesh-list
101441734|NCT00169130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101441735|NCT00169130|Immunologic Factors|immunologic factors|mesh-ancestor
101447091|NCT00216567|Anticonvulsants|anticonvulsants|mesh-ancestor
101447120|NCT00209703|Vitamins|vitamins|mesh-ancestor
101441736|NCT00169130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441737|NCT00169130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101441738|NCT00169130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101441739|NCT00169130|Alkylating Agents|alkylating agents|mesh-ancestor
101441740|NCT00169130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441741|NCT00169130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441742|NCT00169130|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101441743|NCT00169130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101447152|NCT00182429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101441744|NCT00169130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101441745|NCT00169130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101441746|NCT00169130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101441748|NCT00178620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101441749|NCT00178620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101441750|NCT00178620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441751|NCT00169169|Rituximab|rituximab|mesh-list
101307899|NCT02044224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101307900|NCT02044224|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101441752|NCT00169169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101441753|NCT00169169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441754|NCT00169169|Immunologic Factors|immunologic factors|mesh-ancestor
101441755|NCT00169169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441756|NCT00169169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101441757|NCT00169208|Rituximab|rituximab|mesh-list
101441758|NCT00169208|Fludarabine|fludarabine|mesh-list
101441759|NCT00169208|Mitoxantrone|mitoxantrone|mesh-list
101441760|NCT00169208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101441761|NCT00169208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441762|NCT00169208|Immunologic Factors|immunologic factors|mesh-ancestor
101441763|NCT00169208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441764|NCT00169208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101441765|NCT00169208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441766|NCT00169208|Analgesics|analgesics|mesh-ancestor
101441767|NCT00169208|Sensory System Agents|sensory system agents|mesh-ancestor
101441768|NCT00169208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101441769|NCT00169208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101441770|NCT00169208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101441771|NCT00169208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101441772|NCT00178698|Interferons|interferons|mesh-list
101441773|NCT00178698|Gemcitabine|gemcitabine|mesh-list
101441774|NCT00178698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441775|NCT00178698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101447279|NCT00182663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101441776|NCT00178698|Antimetabolites|antimetabolites|mesh-ancestor
101441777|NCT00178698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441778|NCT00178698|Antiviral Agents|antiviral agents|mesh-ancestor
101441779|NCT00178698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101441780|NCT00169247|Cetuximab|cetuximab|mesh-list
101441781|NCT00169247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441782|NCT00169247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101441783|NCT02899702|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101441784|NCT02899702|Immunologic Factors|immunologic factors|mesh-ancestor
101441785|NCT02899702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441790|NCT02899507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101441791|NCT02899507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101441792|NCT02899507|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101441793|NCT02899507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101441794|NCT02899507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441795|NCT00178854|Risperidone|risperidone|mesh-list
101441796|NCT00178854|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101441797|NCT00178854|Serotonin Agents|serotonin agents|mesh-ancestor
101441798|NCT00178854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101441799|NCT00178854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441800|NCT00178854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441801|NCT00178854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101441802|NCT00178854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101441803|NCT00178854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101441804|NCT00178854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101441805|NCT00178854|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101447403|NCT00589186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441806|NCT00178854|Dopamine Agents|dopamine agents|mesh-ancestor
101441807|NCT00196365|Levonorgestrel|levonorgestrel|mesh-list
101441808|NCT00196365|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101441809|NCT00196365|Contraceptive Agents|contraceptive agents|mesh-ancestor
101441810|NCT00196365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101441811|NCT00196365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441812|NCT00196365|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101441813|NCT00196365|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101441814|NCT00196365|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101441815|NCT02898961|Gentamicins|gentamicins|mesh-list
101441816|NCT02898961|Amikacin|amikacin|mesh-list
101441817|NCT02898961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101441818|NCT02898961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101441819|NCT02898961|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101441820|NCT02898961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101441821|NCT02898961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441822|NCT00553618|Aldesleukin|aldesleukin|mesh-list
101441823|NCT00553618|Dacarbazine|dacarbazine|mesh-list
101441824|NCT00553618|Interleukin-2|interleukin-2|mesh-list
101441825|NCT00553618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101307901|NCT02044224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101307902|NCT02044224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101307903|NCT02044224|Adrenergic Agents|adrenergic agents|mesh-ancestor
101441826|NCT00553618|Alkylating Agents|alkylating agents|mesh-ancestor
101441827|NCT00553618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441828|NCT00553618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441830|NCT00553618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101441831|NCT00553618|Antiviral Agents|antiviral agents|mesh-ancestor
101441832|NCT00553618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101441833|NCT00553618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101441834|NCT00553618|Analgesics|analgesics|mesh-ancestor
101441835|NCT00553618|Sensory System Agents|sensory system agents|mesh-ancestor
101441836|NCT00553618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101441837|NCT00553618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441838|NCT02898376|Tocopherols|tocopherols|mesh-list
101441839|NCT02898376|Vitamin E|vitamin e|mesh-list
101441840|NCT02898376|Tocotrienols|tocotrienols|mesh-list
101441841|NCT02898376|alpha-Tocopherol|alpha-tocopherol|mesh-list
101441842|NCT02898376|Pentoxifylline|pentoxifylline|mesh-list
101441843|NCT02898376|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101441844|NCT02898376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101441845|NCT02898376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441846|NCT02898376|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101441847|NCT02898376|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101441848|NCT02898376|Protective Agents|protective agents|mesh-ancestor
101441849|NCT02898376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441850|NCT02898376|Vasodilator Agents|vasodilator agents|mesh-ancestor
101441851|NCT02898376|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101441852|NCT02898376|Antioxidants|antioxidants|mesh-ancestor
101441853|NCT02898376|Vitamins|vitamins|mesh-ancestor
101441854|NCT02898376|Micronutrients|micronutrients|mesh-ancestor
101441855|NCT00408174|Balsalazide|balsalazide|mesh-list
101447581|NCT00476593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441856|NCT00408174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101487415|NCT00432588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101441859|NCT00408174|Sensory System Agents|sensory system agents|mesh-ancestor
101441860|NCT00408174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101441861|NCT00408174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441862|NCT00408174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101441863|NCT00408174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101441864|NCT00408174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101441865|NCT00169520|Docetaxel|docetaxel|mesh-list
101441866|NCT00169520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441867|NCT00169520|Tubulin Modulators|tubulin modulators|mesh-ancestor
101441868|NCT00169520|Antimitotic Agents|antimitotic agents|mesh-ancestor
101441869|NCT00169520|Mitosis Modulators|mitosis modulators|mesh-ancestor
101441870|NCT00169520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441871|NCT02897986|Vinorelbine|vinorelbine|mesh-list
101441872|NCT02897986|Propranolol|propranolol|mesh-list
101441873|NCT02897986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101447623|NCT00476476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101441874|NCT02897986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441875|NCT02897986|Tubulin Modulators|tubulin modulators|mesh-ancestor
101441876|NCT02897986|Antimitotic Agents|antimitotic agents|mesh-ancestor
101441877|NCT02897986|Mitosis Modulators|mitosis modulators|mesh-ancestor
101441878|NCT02897986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441879|NCT02897986|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101441880|NCT02897986|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101441881|NCT02897986|Adrenergic Agents|adrenergic agents|mesh-ancestor
101441882|NCT02897986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101441883|NCT02897986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441884|NCT02897986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101441885|NCT02897986|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101447678|NCT00476008|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101441886|NCT02897986|Vasodilator Agents|vasodilator agents|mesh-ancestor
101441888|NCT00169559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101441889|NCT00169559|Antimetabolites|antimetabolites|mesh-ancestor
101447762|NCT00183950|Noscapine|noscapine|mesh-list
101441890|NCT00169559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441891|NCT00169559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101441892|NCT00408213|Mycophenolic Acid|mycophenolic acid|mesh-list
101441893|NCT00408213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101441894|NCT00408213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101447854|NCT00475228|Levonorgestrel|levonorgestrel|mesh-list
101441895|NCT00408213|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101441896|NCT00408213|Antitubercular Agents|antitubercular agents|mesh-ancestor
101307904|NCT02044224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101333871|NCT00017394|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101441897|NCT00408213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101441898|NCT00408213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101441899|NCT00408213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101441900|NCT00408213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441901|NCT00408252|Sunitinib|sunitinib|mesh-list
101441902|NCT00408252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441903|NCT00408252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101441904|NCT00408252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101441905|NCT00408252|Growth Substances|growth substances|mesh-ancestor
101441906|NCT00408252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447910|NCT00210561|Narcotics|narcotics|mesh-ancestor
101441907|NCT00408252|Growth Inhibitors|growth inhibitors|mesh-ancestor
101441908|NCT00408252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101441909|NCT00408252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101441910|NCT00408252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441911|NCT02897869|Amikacin|amikacin|mesh-list
101441912|NCT02897869|Murepavadin|murepavadin|mesh-list
101441913|NCT02897869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101441914|NCT02897869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101441915|NCT02897830|Dexamethasone|dexamethasone|mesh-list
101441916|NCT02897830|Lenalidomide|lenalidomide|mesh-list
101441917|NCT02897830|Ixazomib|ixazomib|mesh-list
101308191|NCT02046421|Hormone Antagonists|hormone antagonists|mesh-ancestor
101308193|NCT02046421|Luteolytic Agents|luteolytic agents|mesh-ancestor
101441918|NCT02897830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101441919|NCT02897830|Antiemetics|antiemetics|mesh-ancestor
101441920|NCT02897830|Autonomic Agents|autonomic agents|mesh-ancestor
101441921|NCT02897830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101441922|NCT02897830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441923|NCT02897830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101441924|NCT02897830|Glucocorticoids|glucocorticoids|mesh-ancestor
101441925|NCT02897830|Hormones|hormones|mesh-ancestor
101441926|NCT02897830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101448016|NCT00184574|Metformin|metformin|mesh-list
101441927|NCT02897830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101441928|NCT02897830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441929|NCT02897830|Immunologic Factors|immunologic factors|mesh-ancestor
101441930|NCT02897830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101441933|NCT02897830|Growth Inhibitors|growth inhibitors|mesh-ancestor
101441934|NCT02897830|Protease Inhibitors|protease inhibitors|mesh-ancestor
101441935|NCT02897830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101441936|NCT02897830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441938|NCT02897557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101441939|NCT02897596|Grazoprevir|grazoprevir|mesh-list
101441940|NCT02897596|Antiviral Agents|antiviral agents|mesh-ancestor
101441941|NCT02897596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101441942|NCT04681027|Oxymorphone|oxymorphone|mesh-list
101441943|NCT04681027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101441944|NCT04681027|Narcotics|narcotics|mesh-ancestor
101441945|NCT04681027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101441946|NCT04681027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441947|NCT04681027|Analgesics|analgesics|mesh-ancestor
101441948|NCT04681027|Sensory System Agents|sensory system agents|mesh-ancestor
101441949|NCT04681027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101441950|NCT04681027|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101441951|NCT00408330|Azelaic acid|azelaic acid|mesh-list
101441952|NCT00408330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441953|NCT00408330|Dermatologic Agents|dermatologic agents|mesh-ancestor
101441954|NCT00408369|Pafuramidine|pafuramidine|mesh-list
101441955|NCT00408369|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101441956|NCT00408369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101441957|NCT00408369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101441958|NCT00408369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101441960|NCT02897206|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
101441961|NCT02897206|Cilastatin|cilastatin|mesh-list
101441962|NCT02897206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101441963|NCT02897206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101441964|NCT02897206|Protease Inhibitors|protease inhibitors|mesh-ancestor
101441965|NCT02897206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101441966|NCT02897206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441967|NCT02897401|Carbon Monoxide|carbon monoxide|mesh-list
101441968|NCT02897401|Antimetabolites|antimetabolites|mesh-ancestor
101441969|NCT02897401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441970|NCT02897401|Gasotransmitters|gasotransmitters|mesh-ancestor
101441971|NCT02897401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101441972|NCT02897401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307905|NCT02044224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307907|NCT02044250|Clopidogrel|clopidogrel|mesh-list
101333872|NCT00017394|Tubulin Modulators|tubulin modulators|mesh-ancestor
101441973|NCT02897011|Methotrexate|methotrexate|mesh-list
101441974|NCT02897011|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101441975|NCT02897011|Abortifacient Agents|abortifacient agents|mesh-ancestor
101441976|NCT02897011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101441977|NCT02897011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441978|NCT02897011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101441979|NCT02897011|Antimetabolites|antimetabolites|mesh-ancestor
101448175|NCT00218166|GABA Agents|gaba agents|mesh-ancestor
101441980|NCT02897011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441981|NCT02897011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441982|NCT02897011|Dermatologic Agents|dermatologic agents|mesh-ancestor
101441983|NCT02897011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101448247|NCT00185510|Antiemetics|antiemetics|mesh-ancestor
101441984|NCT02897011|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101441985|NCT02897011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101441986|NCT02897011|Immunologic Factors|immunologic factors|mesh-ancestor
101441987|NCT02897011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101441988|NCT02897011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101441989|NCT00169832|Rosiglitazone|rosiglitazone|mesh-list
101441990|NCT00169832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101441993|NCT00196599|Efavirenz|efavirenz|mesh-list
101441994|NCT00196599|Didanosine|didanosine|mesh-list
101441995|NCT00196599|Antiviral Agents|antiviral agents|mesh-ancestor
101441996|NCT00196599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101441997|NCT00196599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101441998|NCT00196599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101441999|NCT00196599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101442000|NCT00196599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442001|NCT00196599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101442002|NCT00196599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101442003|NCT00196599|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101442004|NCT00196599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101442020|NCT02896621|Amlodipine|amlodipine|mesh-list
101442021|NCT02896621|Chlorthalidone|chlorthalidone|mesh-list
101442022|NCT02896621|Amiloride|amiloride|mesh-list
101442023|NCT02896621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101442024|NCT02896621|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101442025|NCT02896621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101442026|NCT02896621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442027|NCT02896621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101442028|NCT02896621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442030|NCT02896621|Diuretics|diuretics|mesh-ancestor
101442031|NCT02896621|Natriuretic Agents|natriuretic agents|mesh-ancestor
101442032|NCT02896621|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101442033|NCT02896621|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
101442034|NCT02896621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101442035|NCT02896621|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101442036|NCT02896621|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101442037|NCT02896582|Cytarabine|cytarabine|mesh-list
101442038|NCT02896582|Dexamethasone|dexamethasone|mesh-list
101442039|NCT02896582|Etoposide|etoposide|mesh-list
101442040|NCT02896582|Melphalan|melphalan|mesh-list
101442041|NCT02896582|Cisplatin|cisplatin|mesh-list
101442042|NCT02896582|Obinutuzumab|obinutuzumab|mesh-list
101442043|NCT02896582|Carmustine|carmustine|mesh-list
101442044|NCT02896582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101442045|NCT02896582|Antiemetics|antiemetics|mesh-ancestor
101442046|NCT02896582|Autonomic Agents|autonomic agents|mesh-ancestor
101442047|NCT02896582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101442048|NCT02896582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442049|NCT02896582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101442050|NCT02896582|Glucocorticoids|glucocorticoids|mesh-ancestor
101442051|NCT02896582|Hormones|hormones|mesh-ancestor
101442052|NCT02896582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101442053|NCT02896582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101442054|NCT02896582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101442055|NCT02896582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101307908|NCT02044250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101307909|NCT02044250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101442056|NCT02896582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101442057|NCT02896582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101442058|NCT02896582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101442059|NCT02896582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442060|NCT02896582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101442062|NCT02896582|Antiviral Agents|antiviral agents|mesh-ancestor
101442066|NCT02896582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101442068|NCT02896582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101442069|NCT02896582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101442070|NCT00196638|Interferons|interferons|mesh-list
101442071|NCT00196638|Interferon-alpha|interferon-alpha|mesh-list
101442072|NCT00196638|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101442073|NCT00196638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101442074|NCT00196638|Antiviral Agents|antiviral agents|mesh-ancestor
101442075|NCT00196638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101442076|NCT00196638|Immunologic Factors|immunologic factors|mesh-ancestor
101442077|NCT00196638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442078|NCT02896270|Valproic Acid|valproic acid|mesh-list
101442079|NCT02896270|Anticonvulsants|anticonvulsants|mesh-ancestor
101442080|NCT02896270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101442081|NCT02896270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442082|NCT02896270|GABA Agents|gaba agents|mesh-ancestor
101442083|NCT02896270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101442084|NCT02896270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442085|NCT02896270|Antimanic Agents|antimanic agents|mesh-ancestor
101442086|NCT02896270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101442087|NCT02896270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101442088|NCT02896270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101442089|NCT00196677|Vitamins|vitamins|mesh-list
101442090|NCT00196677|Micronutrients|micronutrients|mesh-ancestor
101442091|NCT00196677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442092|NCT02895958|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
101442093|NCT02895958|Antiviral Agents|antiviral agents|mesh-ancestor
101442094|NCT02895958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101442095|NCT00169949|Aripiprazole|aripiprazole|mesh-list
101442096|NCT00169949|Antidepressive Agents|antidepressive agents|mesh-ancestor
101442097|NCT00169949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101442098|NCT00169949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101442099|NCT00169949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101442100|NCT00169949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101442101|NCT00169949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442102|NCT00169949|Dopamine Agonists|dopamine agonists|mesh-ancestor
101442103|NCT00169949|Dopamine Agents|dopamine agents|mesh-ancestor
101442104|NCT00169949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101442105|NCT00169949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442106|NCT00169949|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101442107|NCT00169949|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101442109|NCT00169949|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101442110|NCT00169949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101442111|NCT00169949|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101442112|NCT00169949|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101442113|NCT00196755|Calcium|calcium|mesh-list
101442114|NCT00196755|Sevelamer|sevelamer|mesh-list
101442115|NCT00196755|Calcium acetate|calcium acetate|mesh-list
101442116|NCT00196755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101442117|NCT00196755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442118|NCT00196755|Chelating Agents|chelating agents|mesh-ancestor
101442119|NCT00196755|Sequestering Agents|sequestering agents|mesh-ancestor
101442120|NCT00196755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442121|NCT00169988|Risperidone|risperidone|mesh-list
101442122|NCT00169988|Sertraline|sertraline|mesh-list
101442123|NCT00169988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101442124|NCT00169988|Serotonin Agents|serotonin agents|mesh-ancestor
101442125|NCT00169988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101442126|NCT00169988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442127|NCT00169988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442128|NCT00169988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101442129|NCT00169988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101307910|NCT02044250|Analgesics|analgesics|mesh-ancestor
101307911|NCT02044250|Sensory System Agents|sensory system agents|mesh-ancestor
101307912|NCT02044250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101448911|NCT00189761|Tacrolimus|tacrolimus|mesh-list
101442130|NCT00169988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101442131|NCT00169988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101442133|NCT00169988|Dopamine Agents|dopamine agents|mesh-ancestor
101442134|NCT00169988|Antidepressive Agents|antidepressive agents|mesh-ancestor
101442139|NCT02895529|Caspofungin|caspofungin|mesh-list
101448960|NCT00189839|Tacrolimus|tacrolimus|mesh-list
101442140|NCT02895529|Antifungal Agents|antifungal agents|mesh-ancestor
101442141|NCT02895529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101442142|NCT02895529|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101442143|NCT02895529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101442144|NCT02895529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101442145|NCT02895529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442146|NCT02895529|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101442147|NCT02895529|Hormone Antagonists|hormone antagonists|mesh-ancestor
101442148|NCT02895529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101442149|NCT02895529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442150|NCT02895529|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101442151|NCT02895061|Alfacalcidol|alfacalcidol|mesh-list
101442152|NCT02895061|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
101449142|NCT00190463|Amphotericin B|amphotericin b|mesh-list
101442153|NCT02895061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101442154|NCT02895061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442156|NCT02895061|Micronutrients|micronutrients|mesh-ancestor
101442157|NCT00170183|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101442158|NCT00170183|Natriuretic Agents|natriuretic agents|mesh-ancestor
101442159|NCT00170183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442160|NCT00170222|Doxycycline|doxycycline|mesh-list
101442161|NCT00170222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101442162|NCT00170222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101442163|NCT00170222|Antimalarials|antimalarials|mesh-ancestor
101442164|NCT00170222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101442165|NCT00170222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101442166|NCT02894983|Calpastatin|calpastatin|mesh-list
101442167|NCT02894983|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
101442168|NCT02894983|Protease Inhibitors|protease inhibitors|mesh-ancestor
101442169|NCT02894983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101442170|NCT02894983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442171|NCT02895022|Lidocaine|lidocaine|mesh-list
101442172|NCT02895022|Anesthetics, Local|anesthetics, local|mesh-ancestor
101442173|NCT02895022|Anesthetics|anesthetics|mesh-ancestor
101442174|NCT02895022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101442175|NCT02895022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442176|NCT02895022|Sensory System Agents|sensory system agents|mesh-ancestor
101442177|NCT02895022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101442178|NCT02895022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101442179|NCT02895022|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101442180|NCT02895022|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101442181|NCT02895022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101442182|NCT02895022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442184|NCT00409851|Valsartan|valsartan|mesh-list
101442185|NCT00409851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101442186|NCT00409851|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101442187|NCT00409851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101442188|NCT00409851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442189|NCT00409851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101442190|NCT00409851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442191|NCT00409851|Vasodilator Agents|vasodilator agents|mesh-ancestor
101442192|NCT00409851|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101442193|NCT00409851|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101442194|NCT00409890|Scopolamine|scopolamine|mesh-list
101442195|NCT00409890|Bromides|bromides|mesh-list
101442196|NCT00409890|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101442197|NCT00409890|Anticonvulsants|anticonvulsants|mesh-ancestor
101442198|NCT00409890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101442199|NCT00409890|Antiemetics|antiemetics|mesh-ancestor
101442200|NCT00409890|Autonomic Agents|autonomic agents|mesh-ancestor
101442201|NCT00409890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101307913|NCT02044250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307914|NCT02044250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101307915|NCT02044250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101442202|NCT00409890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442207|NCT00409890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101442208|NCT00409890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442209|NCT00409890|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101442210|NCT00409890|Parasympatholytics|parasympatholytics|mesh-ancestor
101442212|NCT05423821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101442213|NCT05423821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442214|NCT00170378|Enoxaparin|enoxaparin|mesh-list
101442215|NCT00170378|Anticoagulants|anticoagulants|mesh-ancestor
101442216|NCT00170378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101442217|NCT00170378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101442218|NCT00170378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442219|NCT00179244|Bupropion|bupropion|mesh-list
101442220|NCT00179244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101442221|NCT00179244|Antidepressive Agents|antidepressive agents|mesh-ancestor
101442222|NCT00179244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101442223|NCT00179244|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101442224|NCT00179244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101442225|NCT00179244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101442226|NCT00179244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442227|NCT00179244|Dopamine Agents|dopamine agents|mesh-ancestor
101442228|NCT00179244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101442229|NCT00179244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442230|NCT00179244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101442231|NCT00179244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101442233|NCT05423197|Panitumumab|panitumumab|mesh-list
101442234|NCT05423197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101442235|NCT05423197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101442236|NCT00196872|Cyclophosphamide|cyclophosphamide|mesh-list
101442237|NCT00196872|Epirubicin|epirubicin|mesh-list
101442238|NCT00196872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101442239|NCT00196872|Immunologic Factors|immunologic factors|mesh-ancestor
101442240|NCT00196872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442241|NCT00196872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101442242|NCT00196872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101442243|NCT00196872|Alkylating Agents|alkylating agents|mesh-ancestor
101442244|NCT00196872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442245|NCT00196872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101442246|NCT00196872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101442247|NCT00196872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101442248|NCT00196872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101442249|NCT00196872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101450089|NCT00192764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101442250|NCT00196872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101442251|NCT00170456|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101442252|NCT00170456|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101442253|NCT00170456|Immunologic Factors|immunologic factors|mesh-ancestor
101442254|NCT00170456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442256|NCT00170456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442257|NCT00170456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101442258|NCT00179283|Sertraline|sertraline|mesh-list
101442259|NCT00179283|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101442260|NCT00179283|Antidepressive Agents|antidepressive agents|mesh-ancestor
101442261|NCT00179283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101450227|NCT00193193|Alkylating Agents|alkylating agents|mesh-ancestor
101442262|NCT00179283|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101442263|NCT00179283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101442264|NCT00179283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101450298|NCT00193388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101442265|NCT00179283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442266|NCT00179283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101442267|NCT00179283|Serotonin Agents|serotonin agents|mesh-ancestor
101442268|NCT00179283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442269|NCT00179283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101450370|NCT00215982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101442270|NCT00179283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101442271|NCT05420350|Lamotrigine|lamotrigine|mesh-list
101307916|NCT02044250|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101307917|NCT02044250|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101442276|NCT05420350|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101442277|NCT05420350|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101442278|NCT05420350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101442279|NCT05420350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442281|NCT05420350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101442282|NCT05420350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442283|NCT05420350|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101442284|NCT05420350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101442285|NCT05420350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101442286|NCT05420350|Anticonvulsants|anticonvulsants|mesh-ancestor
101442287|NCT05420350|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101442288|NCT05420350|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101442289|NCT05420350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101442290|NCT05420350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101442291|NCT05420350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101442292|NCT05420350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101442293|NCT03097939|Nivolumab|nivolumab|mesh-list
101442294|NCT03097939|Ipilimumab|ipilimumab|mesh-list
101442295|NCT03097939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101442296|NCT03097939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101442297|NCT03097939|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101450755|NCT00206622|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101442298|NCT03097939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442299|NCT03014635|Botulinum Toxins|botulinum toxins|mesh-list
101442300|NCT03014635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101442301|NCT03014635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101442302|NCT03014635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101442303|NCT03014635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101442304|NCT03014635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442305|NCT03014635|Cholinergic Agents|cholinergic agents|mesh-ancestor
101442306|NCT03014635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101442307|NCT03014635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442308|NCT03014635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101442309|NCT03014635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101442310|NCT00170573|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101442311|NCT00170573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101442312|NCT00170573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101442314|NCT02885272|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101442315|NCT02885272|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101442316|NCT02885272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442317|NCT02885272|Antimetabolites|antimetabolites|mesh-ancestor
101442318|NCT02885272|Antiviral Agents|antiviral agents|mesh-ancestor
101442319|NCT02885272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101451187|NCT00126230|Docetaxel|docetaxel|mesh-list
101442320|NCT02793583|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101442321|NCT02793583|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101442322|NCT02793583|Alkylating Agents|alkylating agents|mesh-ancestor
101442323|NCT02793583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442324|NCT02793583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101442325|NCT00170612|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101442326|NCT00170612|Immunologic Factors|immunologic factors|mesh-ancestor
101442327|NCT00170612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442328|NCT00170690|Treosulfan|treosulfan|mesh-list
101442329|NCT00170690|Busulfan|busulfan|mesh-list
101442330|NCT00170690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101442331|NCT00170690|Alkylating Agents|alkylating agents|mesh-ancestor
101442332|NCT00170690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442333|NCT00170690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101442334|NCT00170690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101442335|NCT00170690|Immunologic Factors|immunologic factors|mesh-ancestor
101442336|NCT00170690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451408|NCT00195728|Antitussive Agents|antitussive agents|mesh-ancestor
101442337|NCT00170690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101442338|NCT00196989|Pioglitazone|pioglitazone|mesh-list
101442339|NCT00196989|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101442344|NCT00170729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101442345|NCT00170729|Prednisolone acetate|prednisolone acetate|mesh-list
101442347|NCT00170729|Prednisolone phosphate|prednisolone phosphate|mesh-list
101442348|NCT00170729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101442349|NCT00170729|Glucocorticoids|glucocorticoids|mesh-ancestor
101307918|NCT02044250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307919|NCT02044250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101442350|NCT00170729|Hormones|hormones|mesh-ancestor
101442351|NCT00170729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101442352|NCT00170729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442353|NCT00170729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101308416|NCT02047175|Telmisartan|telmisartan|mesh-list
101442354|NCT00170729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101442355|NCT00170729|Antiemetics|antiemetics|mesh-ancestor
101442356|NCT00170729|Autonomic Agents|autonomic agents|mesh-ancestor
101442357|NCT00170729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101442358|NCT00170729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101442359|NCT00170729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101442360|NCT00170729|Protective Agents|protective agents|mesh-ancestor
101442361|NCT00170768|Oxybutynin|oxybutynin|mesh-list
101442362|NCT00170768|Darifenacin|darifenacin|mesh-list
101442363|NCT00170768|Parasympatholytics|parasympatholytics|mesh-ancestor
101442364|NCT00170768|Autonomic Agents|autonomic agents|mesh-ancestor
101442365|NCT00170768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101442366|NCT00170768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442367|NCT00170768|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101442368|NCT00170768|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101442369|NCT00170768|Cholinergic Agents|cholinergic agents|mesh-ancestor
101442370|NCT00170768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101628476|NCT00715429|Vitamin D|vitamin d|mesh-list
101442371|NCT00170768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442372|NCT00170768|Urological Agents|urological agents|mesh-ancestor
101442373|NCT02655562|Montelukast|montelukast|mesh-list
101442374|NCT02655562|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101442375|NCT02655562|Respiratory System Agents|respiratory system agents|mesh-ancestor
101442376|NCT02655562|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101442377|NCT02655562|Hormone Antagonists|hormone antagonists|mesh-ancestor
101442378|NCT02655562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101442379|NCT02655562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442380|NCT02655562|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101442381|NCT02655562|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101442382|NCT02655562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442384|NCT00170885|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101442385|NCT00170885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101442386|NCT00170885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101442387|NCT00170885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442388|NCT00170885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101442389|NCT00170885|Immunologic Factors|immunologic factors|mesh-ancestor
101442390|NCT00170885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442391|NCT00170885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101442392|NCT02607748|Listerine|listerine|mesh-list
101442393|NCT02607748|Fluorides|fluorides|mesh-list
101442394|NCT02607748|Sodium Fluoride|sodium fluoride|mesh-list
101442395|NCT02607748|Cariostatic Agents|cariostatic agents|mesh-ancestor
101442396|NCT02607748|Protective Agents|protective agents|mesh-ancestor
101442397|NCT02607748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442398|NCT02607748|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101442399|NCT02607748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101442400|NCT02502253|Resveratrol|resveratrol|mesh-list
101442401|NCT02502253|Antioxidants|antioxidants|mesh-ancestor
101442402|NCT02502253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442403|NCT02502253|Protective Agents|protective agents|mesh-ancestor
101628961|NCT04110028|Niacin|niacin|mesh-list
101442404|NCT02502253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442405|NCT02502253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101363304|NCT00080145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101442406|NCT02502253|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101442407|NCT00170924|Valsartan|valsartan|mesh-list
101442408|NCT00170924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101442409|NCT00170924|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101442412|NCT01356940|4-Aminopyridine|4-aminopyridine|mesh-list
101442413|NCT01356940|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101442415|NCT01356940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442416|NCT00170963|Amlodipine|amlodipine|mesh-list
101442417|NCT00170963|Valsartan|valsartan|mesh-list
101442418|NCT00170963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101442419|NCT00170963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101307920|NCT02044250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101442420|NCT00170963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101442421|NCT00170963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442422|NCT00170963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101442423|NCT00170963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442424|NCT00170963|Vasodilator Agents|vasodilator agents|mesh-ancestor
101629188|NCT02591095|Navitoclax|navitoclax|mesh-list
101442425|NCT00170963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101442426|NCT00170963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101442427|NCT02492776|Omeprazole|omeprazole|mesh-list
101442428|NCT02492776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101442429|NCT02492776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101442430|NCT02492776|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101442431|NCT02492776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101442432|NCT02492776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442433|NCT00171002|Amlodipine|amlodipine|mesh-list
101442435|NCT00171002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101442436|NCT00171002|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101442437|NCT00171002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101442438|NCT00171002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442439|NCT00171002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101442440|NCT00171002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442441|NCT00171002|Vasodilator Agents|vasodilator agents|mesh-ancestor
101442442|NCT00171002|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101442443|NCT00171002|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101442444|NCT05400031|Propolis|propolis|mesh-list
101442445|NCT05400031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101442446|NCT00171041|Valsartan|valsartan|mesh-list
101442447|NCT00171041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101442448|NCT00171041|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101442449|NCT00171041|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101629374|NCT04106050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442450|NCT00171041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442451|NCT05393674|Nivolumab|nivolumab|mesh-list
101442452|NCT05393674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101442453|NCT05393674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101442454|NCT05393674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101442455|NCT05393674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442456|NCT05392699|Interleukin-12|interleukin-12|mesh-list
101442457|NCT05392699|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101442458|NCT05392699|Immunologic Factors|immunologic factors|mesh-ancestor
101442459|NCT05392699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442460|NCT05392699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101629511|NCT02705313|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
101442461|NCT05392699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101442462|NCT05392699|Growth Substances|growth substances|mesh-ancestor
101442463|NCT05392699|Growth Inhibitors|growth inhibitors|mesh-ancestor
101442464|NCT05392699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101442465|NCT00171080|Valsartan|valsartan|mesh-list
101442466|NCT00171080|Irbesartan|irbesartan|mesh-list
101442467|NCT00171080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101442468|NCT00171080|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101442469|NCT00171080|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101442470|NCT00171080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442471|NCT02229877|Omeprazole|omeprazole|mesh-list
101442472|NCT02229877|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101442473|NCT02229877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101442474|NCT02229877|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101442475|NCT02229877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101442476|NCT02229877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442477|NCT00171119|Valsartan|valsartan|mesh-list
101442478|NCT00171119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101442484|NCT05379790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101629869|NCT00919555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101442486|NCT05379790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442487|NCT05379790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101442489|NCT05349448|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101442490|NCT05349448|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101442491|NCT05349448|Dexmedetomidine|dexmedetomidine|mesh-list
101442492|NCT05349448|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101442493|NCT05349448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101307921|NCT02044250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101307922|NCT02044250|Antipyretics|antipyretics|mesh-ancestor
101442494|NCT05349448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101442495|NCT05349448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442496|NCT05349448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101442497|NCT05349448|Analgesics|analgesics|mesh-ancestor
101442498|NCT05349448|Sensory System Agents|sensory system agents|mesh-ancestor
101630072|NCT02700087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101442499|NCT05349448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101442500|NCT05349448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101442501|NCT05349448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101442502|NCT05349448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101442503|NCT05349448|Adrenergic Agents|adrenergic agents|mesh-ancestor
101442504|NCT05349448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101442505|NCT05349448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442506|NCT05349448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101442507|NCT05349448|Glucocorticoids|glucocorticoids|mesh-ancestor
101442509|NCT05349448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101442510|NCT05349448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101442511|NCT05349448|Immunologic Factors|immunologic factors|mesh-ancestor
101442512|NCT05349448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101442513|NCT00171353|Valsartan|valsartan|mesh-list
101442514|NCT00171353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101630365|NCT00617643|Nevirapine|nevirapine|mesh-list
101442515|NCT00171353|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101442516|NCT00171353|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101442517|NCT00171353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442518|NCT01656343|Abatacept|abatacept|mesh-list
101442519|NCT01656343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
101442520|NCT01656343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101442521|NCT01656343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442522|NCT01656343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101442523|NCT01656343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101442524|NCT01656343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101442525|NCT01656343|Immunologic Factors|immunologic factors|mesh-ancestor
101442526|NCT01656343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442527|NCT01656343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101442528|NCT01656343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101442529|NCT01539811|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101442530|NCT01539811|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101442531|NCT01539811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101442532|NCT01539811|Antitubercular Agents|antitubercular agents|mesh-ancestor
101442533|NCT00171392|Mycophenolic Acid|mycophenolic acid|mesh-list
101442534|NCT00171392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101442535|NCT00171392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101442536|NCT00171392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101442537|NCT00171392|Antitubercular Agents|antitubercular agents|mesh-ancestor
101442538|NCT00171392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101442539|NCT00171392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101442540|NCT00171392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101442541|NCT00171392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442543|NCT00171431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101442545|NCT00171431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101442551|NCT01330030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101442552|NCT01330030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101442553|NCT01330030|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101442554|NCT01330030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101631001|NCT00773734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101442555|NCT01330030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442556|NCT01330030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101442557|NCT01330030|Protective Agents|protective agents|mesh-ancestor
101442558|NCT01330030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442560|NCT00171470|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101442561|NCT00171470|Serotonin Agents|serotonin agents|mesh-ancestor
101442562|NCT00171470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101631143|NCT04214145|Mydriatics|mydriatics|mesh-ancestor
101442563|NCT00171470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442564|NCT00171470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442566|NCT00171509|Cyclosporins|cyclosporins|mesh-list
101307923|NCT02044250|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101442567|NCT00171509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101442568|NCT00171509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442569|NCT00171509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101442570|NCT00171509|Immunologic Factors|immunologic factors|mesh-ancestor
101442571|NCT00171509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442572|NCT00171509|Antifungal Agents|antifungal agents|mesh-ancestor
101442573|NCT00171509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101442574|NCT00171509|Dermatologic Agents|dermatologic agents|mesh-ancestor
101442575|NCT00171509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101442576|NCT00171509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101442577|NCT00179712|Topotecan|topotecan|mesh-list
101442578|NCT00179712|Lenalidomide|lenalidomide|mesh-list
101442579|NCT00179712|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101442580|NCT00179712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101442581|NCT00179712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101442582|NCT00179712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442583|NCT00179712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101442584|NCT00179712|Immunologic Factors|immunologic factors|mesh-ancestor
101442585|NCT00179712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631283|NCT01005680|Antimetabolites|antimetabolites|mesh-ancestor
101442586|NCT00179712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101442587|NCT00179712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101442588|NCT00179712|Growth Substances|growth substances|mesh-ancestor
101442589|NCT00179712|Growth Inhibitors|growth inhibitors|mesh-ancestor
101442590|NCT00611572|Flumazenil|flumazenil|mesh-list
101442592|NCT00611572|Protective Agents|protective agents|mesh-ancestor
101442593|NCT00611572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442594|NCT00611572|GABA Modulators|gaba modulators|mesh-ancestor
101442595|NCT00611572|GABA Agents|gaba agents|mesh-ancestor
101442596|NCT00611572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101442597|NCT00611572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442598|NCT00197340|Ropivacaine|ropivacaine|mesh-list
101442599|NCT00197340|Anesthetics, Local|anesthetics, local|mesh-ancestor
101442601|NCT00197340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101442602|NCT00197340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442603|NCT00197340|Sensory System Agents|sensory system agents|mesh-ancestor
101442604|NCT00197340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101631568|NCT02578537|Clopidogrel|clopidogrel|mesh-list
101442606|NCT00171587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101442607|NCT00171587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101442608|NCT00171587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442609|NCT05265052|Oxycodone|oxycodone|mesh-list
101442610|NCT05265052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101442611|NCT05265052|Narcotics|narcotics|mesh-ancestor
101442612|NCT05265052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101442613|NCT05265052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442614|NCT05265052|Analgesics|analgesics|mesh-ancestor
101442615|NCT05265052|Sensory System Agents|sensory system agents|mesh-ancestor
101442616|NCT05265052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101442617|NCT00171626|Diclofenac|diclofenac|mesh-list
101442631|NCT00171665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101442633|NCT00171665|Sensory System Agents|sensory system agents|mesh-ancestor
101442634|NCT00171665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101442635|NCT00171665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631857|NCT00999908|Tiotropium Bromide|tiotropium bromide|mesh-list
101442636|NCT00171665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101442637|NCT00171665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101442638|NCT00171665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101442639|NCT00171665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101442640|NCT00171665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442641|NCT00179751|Gemcitabine|gemcitabine|mesh-list
101442642|NCT00179751|Lenalidomide|lenalidomide|mesh-list
101442643|NCT00179751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101442644|NCT00179751|Antimetabolites|antimetabolites|mesh-ancestor
101442645|NCT00179751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442646|NCT00179751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101442647|NCT00179751|Immunologic Factors|immunologic factors|mesh-ancestor
101442648|NCT00179751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632068|NCT04211103|Pembrolizumab|pembrolizumab|mesh-list
101442649|NCT00179751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101442650|NCT00179751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101442651|NCT00179751|Growth Substances|growth substances|mesh-ancestor
101442652|NCT00179751|Growth Inhibitors|growth inhibitors|mesh-ancestor
101307924|NCT02044250|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101307925|NCT02044250|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101307926|NCT02044250|Purinergic Agents|purinergic agents|mesh-ancestor
101307927|NCT02044250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101442654|NCT05223478|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101442655|NCT05223478|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101442656|NCT05223478|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101442657|NCT05223478|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101442658|NCT05223478|Adrenergic Agents|adrenergic agents|mesh-ancestor
101442659|NCT05223478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101442660|NCT05223478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442661|NCT05223478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442662|NCT05223478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101442663|NCT00171743|Cyclosporine|cyclosporine|mesh-list
101442664|NCT00171743|Cyclosporins|cyclosporins|mesh-list
101442665|NCT00171743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101442666|NCT00171743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442668|NCT00171743|Immunologic Factors|immunologic factors|mesh-ancestor
101442669|NCT00171743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442670|NCT00171743|Antifungal Agents|antifungal agents|mesh-ancestor
101442671|NCT00171743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101442672|NCT00171743|Dermatologic Agents|dermatologic agents|mesh-ancestor
101442673|NCT00171743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101442674|NCT00171743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101442675|NCT00171782|Valsartan|valsartan|mesh-list
101442680|NCT00171782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442682|NCT00171782|Natriuretic Agents|natriuretic agents|mesh-ancestor
101442683|NCT00171782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442684|NCT00171782|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101442685|NCT00171782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101442686|NCT00197379|Roxithromycin|roxithromycin|mesh-list
101442687|NCT00197379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101442688|NCT00197379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101442689|NCT00197418|Amoxicillin|amoxicillin|mesh-list
101442690|NCT00197418|Metronidazole|metronidazole|mesh-list
101442691|NCT00197418|Clarithromycin|clarithromycin|mesh-list
101442692|NCT00197418|Rabeprazole|rabeprazole|mesh-list
101442693|NCT00197418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101442694|NCT00197418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101632270|NCT04208841|Sulfamethazine|sulfamethazine|mesh-list
101442695|NCT00197418|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101442696|NCT00197418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101442697|NCT00197418|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101442698|NCT00197418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101442699|NCT00197418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442700|NCT00197418|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101632315|NCT04138641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101442701|NCT00197418|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101442702|NCT00197418|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101442703|NCT00197418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101442704|NCT00197418|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101442705|NCT00171821|Deferasirox|deferasirox|mesh-list
101442706|NCT00171821|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101442707|NCT00171821|Chelating Agents|chelating agents|mesh-ancestor
101442708|NCT00171821|Sequestering Agents|sequestering agents|mesh-ancestor
101442709|NCT00171821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442710|NCT05054023|Piroxicam|piroxicam|mesh-list
101442711|NCT05054023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101442712|NCT05054023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101442713|NCT05054023|Analgesics|analgesics|mesh-ancestor
101442714|NCT05054023|Sensory System Agents|sensory system agents|mesh-ancestor
101442715|NCT05054023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101442716|NCT05054023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442717|NCT05054023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101632592|NCT04296422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101442719|NCT05054023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101442720|NCT05054023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101442721|NCT05054023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442722|NCT00171860|Imatinib Mesylate|imatinib mesylate|mesh-list
101442723|NCT00171860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101307928|NCT02044354|Docetaxel|docetaxel|mesh-list
101307929|NCT02044354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101307930|NCT02044354|Tubulin Modulators|tubulin modulators|mesh-ancestor
101307931|NCT02044354|Antimitotic Agents|antimitotic agents|mesh-ancestor
101442724|NCT00171860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101442725|NCT00171860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101442726|NCT00171860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442728|NCT00553930|Ribavirin|ribavirin|mesh-list
101442730|NCT00553930|Interferon alpha-2|interferon alpha-2|mesh-list
101442731|NCT00553930|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101442732|NCT00553930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101442733|NCT00553930|Antiviral Agents|antiviral agents|mesh-ancestor
101442734|NCT00553930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101442735|NCT00553930|Antimetabolites|antimetabolites|mesh-ancestor
101442736|NCT00553930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442737|NCT00553930|Immunologic Factors|immunologic factors|mesh-ancestor
101442738|NCT00553930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442739|NCT00171899|Imatinib Mesylate|imatinib mesylate|mesh-list
101442740|NCT00171899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101442741|NCT00171899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101442742|NCT00171899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101442743|NCT00171899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442744|NCT00171938|Imatinib Mesylate|imatinib mesylate|mesh-list
101442747|NCT00171938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101442748|NCT00171938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442749|NCT00171977|Imatinib Mesylate|imatinib mesylate|mesh-list
101442750|NCT00171977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101442751|NCT00171977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101442752|NCT00171977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101442753|NCT00171977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442754|NCT02240407|Acetaminophen|acetaminophen|mesh-list
101442755|NCT02240407|Diphenhydramine|diphenhydramine|mesh-list
101442756|NCT02240407|Promethazine|promethazine|mesh-list
101442757|NCT02240407|Sirolimus|sirolimus|mesh-list
101442758|NCT02240407|Rituximab|rituximab|mesh-list
101442759|NCT02240407|Lidocaine|lidocaine|mesh-list
101442760|NCT02240407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101442761|NCT02240407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101442762|NCT02240407|Immunologic Factors|immunologic factors|mesh-ancestor
101633007|NCT01253161|Hormones|hormones|mesh-ancestor
101442763|NCT02240407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442764|NCT02240407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101442765|NCT02240407|Anesthetics, Local|anesthetics, local|mesh-ancestor
101442766|NCT02240407|Anesthetics|anesthetics|mesh-ancestor
101442767|NCT02240407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101442768|NCT02240407|Sensory System Agents|sensory system agents|mesh-ancestor
101442769|NCT02240407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101442770|NCT02240407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101442771|NCT02240407|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101442772|NCT02240407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101442773|NCT02240407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101442774|NCT02240407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442775|NCT02240407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101442776|NCT02240407|Analgesics|analgesics|mesh-ancestor
101442777|NCT02240407|Antipyretics|antipyretics|mesh-ancestor
101442778|NCT02240407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101442779|NCT02240407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101442780|NCT02240407|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101442781|NCT02240407|Antifungal Agents|antifungal agents|mesh-ancestor
101442782|NCT02240407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101442783|NCT02240407|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101442784|NCT02240407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101442785|NCT02240407|Antiemetics|antiemetics|mesh-ancestor
101442786|NCT02240407|Autonomic Agents|autonomic agents|mesh-ancestor
101442787|NCT02240407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101442788|NCT02240407|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101442789|NCT02240407|Histamine Antagonists|histamine antagonists|mesh-ancestor
101442790|NCT02240407|Histamine Agents|histamine agents|mesh-ancestor
101442791|NCT02240407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101442792|NCT02240407|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101442793|NCT02240407|Antipruritics|antipruritics|mesh-ancestor
101442794|NCT02240407|Dermatologic Agents|dermatologic agents|mesh-ancestor
101307932|NCT02044354|Mitosis Modulators|mitosis modulators|mesh-ancestor
101307933|NCT02044354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307934|NCT02044549|Oxytocin|oxytocin|mesh-list
101307935|NCT02044549|Carbetocin|carbetocin|mesh-list
101633420|NCT00715351|Insulin|insulin|mesh-list
101442795|NCT00172016|Zoledronic Acid|zoledronic acid|mesh-list
101442796|NCT00172016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101442797|NCT00172016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442799|NCT04958122|Cefixime|cefixime|mesh-list
101442800|NCT04958122|Penicillin G Benzathine|penicillin g benzathine|mesh-list
101442801|NCT04958122|Penicillin G|penicillin g|mesh-list
101442802|NCT04958122|Penicillin G Procaine|penicillin g procaine|mesh-list
101442803|NCT04958122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101442804|NCT04958122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101442805|NCT00197613|Lamivudine|lamivudine|mesh-list
101442806|NCT00197613|Zidovudine|zidovudine|mesh-list
101442807|NCT00197613|Efavirenz|efavirenz|mesh-list
101442808|NCT00197613|Nevirapine|nevirapine|mesh-list
101442809|NCT00197613|Didanosine|didanosine|mesh-list
101442810|NCT00197613|Stavudine|stavudine|mesh-list
101442811|NCT00197613|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101442812|NCT00197613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101442813|NCT00197613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101633547|NCT00712855|Sorafenib|sorafenib|mesh-list
101442814|NCT00197613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442815|NCT00197613|Antiviral Agents|antiviral agents|mesh-ancestor
101442816|NCT00197613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101442817|NCT00197613|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101442818|NCT00197613|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101442819|NCT00197613|Antimetabolites|antimetabolites|mesh-ancestor
101442820|NCT00197613|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101442823|NCT00197613|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101442824|NCT00197613|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101442825|NCT00197613|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101442826|NCT00180024|Irbesartan|irbesartan|mesh-list
101442827|NCT00180024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101442828|NCT00180024|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101442829|NCT00180024|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101442830|NCT00180024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442832|NCT00172055|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101442833|NCT00172055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442835|NCT04934449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101442836|NCT04934449|Antifungal Agents|antifungal agents|mesh-ancestor
101442837|NCT04934449|Keratolytic Agents|keratolytic agents|mesh-ancestor
101442838|NCT04934449|Dermatologic Agents|dermatologic agents|mesh-ancestor
101442839|NCT03455179|Methamphetamine|methamphetamine|mesh-list
101633757|NCT00916630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101442840|NCT03455179|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101442841|NCT03455179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442842|NCT03455179|Sympathomimetics|sympathomimetics|mesh-ancestor
101442843|NCT03455179|Autonomic Agents|autonomic agents|mesh-ancestor
101633819|NCT00756886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101442844|NCT03455179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101442845|NCT03455179|Dopamine Agents|dopamine agents|mesh-ancestor
101442846|NCT03455179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101442847|NCT03455179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442848|NCT03455179|Adrenergic Agents|adrenergic agents|mesh-ancestor
101442849|NCT03455179|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101442850|NCT03455179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101442851|NCT03455179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101442852|NCT03455179|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101442853|NCT00202293|Olanzapine|olanzapine|mesh-list
101442855|NCT00202293|Antiemetics|antiemetics|mesh-ancestor
101442856|NCT00202293|Autonomic Agents|autonomic agents|mesh-ancestor
101442857|NCT00202293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101442858|NCT00202293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442859|NCT00202293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101442860|NCT00202293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101442861|NCT00202293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101442862|NCT00202293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101442863|NCT00202293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101442864|NCT00202293|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101307936|NCT02044549|Methylergonovine|methylergonovine|mesh-list
101307937|NCT02044549|Syntometrine|syntometrine|mesh-list
101307938|NCT02044549|Oxytocics|oxytocics|mesh-ancestor
101307939|NCT02044549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101307940|NCT02044549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307941|NCT02044601|Paclitaxel|paclitaxel|mesh-list
101442865|NCT00202293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101442866|NCT00202293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101442867|NCT00202293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442868|NCT00202293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101442869|NCT00202293|Serotonin Agents|serotonin agents|mesh-ancestor
101442870|NCT00202293|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101442871|NCT00202293|Dopamine Agents|dopamine agents|mesh-ancestor
101442872|NCT00197730|Folic Acid|folic acid|mesh-list
101442873|NCT00197730|Vitamin B Complex|vitamin b complex|mesh-list
101442874|NCT00197730|Vitamins|vitamins|mesh-ancestor
101442875|NCT00197730|Micronutrients|micronutrients|mesh-ancestor
101442876|NCT00197730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442877|NCT00197730|Hematinics|hematinics|mesh-ancestor
101442878|NCT00172172|Calcium|calcium|mesh-list
101442879|NCT00172172|Parathyroid Hormone|parathyroid hormone|mesh-list
101442880|NCT00172172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101442881|NCT00172172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442882|NCT02908711|Ropivacaine|ropivacaine|mesh-list
101442883|NCT02908711|Anesthetics, Local|anesthetics, local|mesh-ancestor
101442884|NCT02908711|Anesthetics|anesthetics|mesh-ancestor
101634151|NCT03292809|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101442885|NCT02908711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101442886|NCT02908711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442887|NCT02908711|Sensory System Agents|sensory system agents|mesh-ancestor
101442888|NCT02908711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101442889|NCT04681846|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101442890|NCT04681846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101442891|NCT02908438|Hormones|hormones|mesh-list
101442895|NCT00172367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101442896|NCT00172367|Antioxidants|antioxidants|mesh-ancestor
101442897|NCT00172367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442898|NCT00172367|Protective Agents|protective agents|mesh-ancestor
101442899|NCT00172367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442900|NCT00172367|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101442901|NCT00172367|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101442902|NCT00172367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101442903|NCT04632316|Cyclophosphamide|cyclophosphamide|mesh-list
101442904|NCT04632316|Fludarabine|fludarabine|mesh-list
101442905|NCT04632316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101442906|NCT04632316|Immunologic Factors|immunologic factors|mesh-ancestor
101442907|NCT04632316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442908|NCT04632316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101442909|NCT04632316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101442910|NCT04632316|Alkylating Agents|alkylating agents|mesh-ancestor
101442911|NCT04632316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442912|NCT04632316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101442913|NCT04632316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101442914|NCT00197886|Norepinephrine|norepinephrine|mesh-list
101442915|NCT00197886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101442916|NCT00197886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101442917|NCT00197886|Adrenergic Agents|adrenergic agents|mesh-ancestor
101634354|NCT04095754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101442918|NCT00197886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101442919|NCT00197886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442920|NCT00197886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634425|NCT00720421|Lorazepam|lorazepam|mesh-list
101442922|NCT00197886|Autonomic Agents|autonomic agents|mesh-ancestor
101442923|NCT00197886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101442924|NCT00197886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101442925|NCT02908165|Sorafenib|sorafenib|mesh-list
101442926|NCT02908165|Chlorotrianisene|chlorotrianisene|mesh-list
101442927|NCT02908165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101442928|NCT02908165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101442929|NCT02908165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101442930|NCT02908165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442931|NCT02908165|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101307943|NCT02044601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101307944|NCT02044601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101442932|NCT02908165|Estrogens|estrogens|mesh-ancestor
101442933|NCT02908165|Hormones|hormones|mesh-ancestor
101442934|NCT02908165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101442935|NCT02908165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442936|NCT02908165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101442937|NCT04534270|Dapagliflozin|dapagliflozin|mesh-list
101442938|NCT04534270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101442939|NCT04534270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442940|NCT04534270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101442941|NCT04534270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442942|NCT02908282|Povidone|povidone|mesh-list
101442943|NCT02908282|Plasma Substitutes|plasma substitutes|mesh-ancestor
101442944|NCT02908282|Blood Substitutes|blood substitutes|mesh-ancestor
101442945|NCT02908126|Oxytocin|oxytocin|mesh-list
101442946|NCT02908126|Oxytocics|oxytocics|mesh-ancestor
101442947|NCT02908126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101442948|NCT02908126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442949|NCT00202605|Amphetamine|amphetamine|mesh-list
101442950|NCT00202605|Dextroamphetamine|dextroamphetamine|mesh-list
101442951|NCT00202605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101442952|NCT00202605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442953|NCT00202605|Sympathomimetics|sympathomimetics|mesh-ancestor
101442954|NCT00202605|Autonomic Agents|autonomic agents|mesh-ancestor
101442955|NCT00202605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101442956|NCT00202605|Dopamine Agents|dopamine agents|mesh-ancestor
101442957|NCT00202605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101442958|NCT00202605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442959|NCT00202605|Adrenergic Agents|adrenergic agents|mesh-ancestor
101442960|NCT00202605|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101442963|NCT00202605|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101442965|NCT00198120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101442966|NCT00198120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101442967|NCT00198120|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101442968|NCT00198120|Antitubercular Agents|antitubercular agents|mesh-ancestor
101442969|NCT00198120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101442970|NCT00198120|Antimetabolites|antimetabolites|mesh-ancestor
101442971|NCT00198120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442972|NCT00198159|Gefitinib|gefitinib|mesh-list
101442973|NCT00198159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101442974|NCT00198159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101442975|NCT00198159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101634900|NCT04183881|Dermatologic Agents|dermatologic agents|mesh-ancestor
101442976|NCT00198159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442978|NCT02907307|Miconazole|miconazole|mesh-list
101442979|NCT02907307|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101442980|NCT02907307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101442981|NCT02907307|Antifungal Agents|antifungal agents|mesh-ancestor
101442982|NCT02907307|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101442983|NCT02907307|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101442984|NCT02907307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101635040|NCT02682693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101442985|NCT02907307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442986|NCT02907307|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101442987|NCT02907307|Hormone Antagonists|hormone antagonists|mesh-ancestor
101442988|NCT02907307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101442989|NCT02907307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442990|NCT02907307|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101442991|NCT02907307|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101442993|NCT00553345|Selenium|selenium|mesh-list
101442994|NCT00553345|Vitamins|vitamins|mesh-ancestor
101442995|NCT00553345|Micronutrients|micronutrients|mesh-ancestor
101442996|NCT00553345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442997|NCT00553345|Antioxidants|antioxidants|mesh-ancestor
101442998|NCT00553345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442999|NCT00553345|Protective Agents|protective agents|mesh-ancestor
101443000|NCT00553345|Trace Elements|trace elements|mesh-ancestor
101443001|NCT00407771|Tirofiban|tirofiban|mesh-list
101443002|NCT00407771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101307945|NCT02044601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101307946|NCT02044601|Tubulin Modulators|tubulin modulators|mesh-ancestor
101307947|NCT02044601|Antimitotic Agents|antimitotic agents|mesh-ancestor
101307948|NCT02044601|Mitosis Modulators|mitosis modulators|mesh-ancestor
101635316|NCT02682225|Ketamine|ketamine|mesh-list
101443003|NCT00407771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101443004|NCT00407771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443005|NCT00407771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101528386|NCT04971356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528387|NCT04971356|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101528388|NCT04971356|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101528389|NCT04971356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528391|NCT04971356|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101528392|NCT04971356|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101528393|NCT04971356|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101528394|NCT04971356|Purinergic Agents|purinergic agents|mesh-ancestor
101635608|NCT00735241|Immunologic Factors|immunologic factors|mesh-ancestor
101528395|NCT04971356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101528396|NCT01214395|Tea Tree Oil|tea tree oil|mesh-list
101528397|NCT01214395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101635705|NCT02600260|Enoxaparin|enoxaparin|mesh-list
101528398|NCT01214395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101528399|NCT01214239|Linagliptin|linagliptin|mesh-list
101528400|NCT01214239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101528401|NCT01214239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528402|NCT01214239|Incretins|incretins|mesh-ancestor
101528404|NCT01214239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101528405|NCT01214239|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101528406|NCT01214239|Protease Inhibitors|protease inhibitors|mesh-ancestor
101635820|NCT02675049|Analgesics|analgesics|mesh-ancestor
101528407|NCT01214239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528408|NCT01214239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528410|NCT01214044|Citalopram|citalopram|mesh-list
101443006|NCT00198198|Aripiprazole|aripiprazole|mesh-list
101443007|NCT00198198|Antidepressive Agents|antidepressive agents|mesh-ancestor
101443008|NCT00198198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101443009|NCT00198198|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101443010|NCT00198198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101443011|NCT00198198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101443012|NCT00198198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443013|NCT00198198|Dopamine Agonists|dopamine agonists|mesh-ancestor
101443015|NCT00198198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101443016|NCT00198198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443017|NCT00198198|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101635966|NCT02674191|Anesthetics|anesthetics|mesh-ancestor
101443018|NCT00198198|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101443019|NCT00198198|Serotonin Agents|serotonin agents|mesh-ancestor
101443020|NCT00198198|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101443021|NCT00198198|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101443022|NCT00198198|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101443023|NCT00198198|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101443024|NCT02206087|Heparin|heparin|mesh-list
101443025|NCT02206087|Calcium heparin|calcium heparin|mesh-list
101443026|NCT02206087|Anticoagulants|anticoagulants|mesh-ancestor
101443027|NCT02206087|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101443028|NCT02206087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101443029|NCT02206087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443030|NCT00198237|Docetaxel|docetaxel|mesh-list
101443031|NCT00198237|Capecitabine|capecitabine|mesh-list
101443032|NCT00198237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443033|NCT00198237|Tubulin Modulators|tubulin modulators|mesh-ancestor
101443034|NCT00198237|Antimitotic Agents|antimitotic agents|mesh-ancestor
101443035|NCT00198237|Mitosis Modulators|mitosis modulators|mesh-ancestor
101443036|NCT00198237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443037|NCT00198237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101443038|NCT00198237|Antimetabolites|antimetabolites|mesh-ancestor
101443039|NCT00198354|Paclitaxel|paclitaxel|mesh-list
101443040|NCT00198354|Gemcitabine|gemcitabine|mesh-list
101443041|NCT00198354|Carboplatin|carboplatin|mesh-list
101443042|NCT00198354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101443043|NCT00198354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443044|NCT00198354|Tubulin Modulators|tubulin modulators|mesh-ancestor
101307949|NCT02044601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307950|NCT02044601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101307951|NCT02044601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101307952|NCT02044627|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
101307953|NCT02044627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101307954|NCT02044627|Antimetabolites|antimetabolites|mesh-ancestor
101307955|NCT02044627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443045|NCT00198354|Antimitotic Agents|antimitotic agents|mesh-ancestor
101443046|NCT00198354|Mitosis Modulators|mitosis modulators|mesh-ancestor
101443047|NCT00198354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443048|NCT00198354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101636447|NCT02666001|Methadone|methadone|mesh-list
101443049|NCT00198354|Antimetabolites|antimetabolites|mesh-ancestor
101443051|NCT02158585|Anticonvulsants|anticonvulsants|mesh-ancestor
101443052|NCT02158585|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101443053|NCT02158585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101443054|NCT02158585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443055|NCT02158585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101443056|NCT02158585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443057|NCT02158585|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101443058|NCT02158585|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101443059|NCT02158585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101443060|NCT02158585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101443083|NCT04677868|Abortifacient Agents|abortifacient agents|mesh-ancestor
101443084|NCT04677868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101293815|NCT01971814|Infliximab|infliximab|mesh-list
101443085|NCT04677868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443086|NCT04677868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101443087|NCT04677868|Antimetabolites|antimetabolites|mesh-ancestor
101636802|NCT00740467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443088|NCT04677868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443089|NCT04677868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443090|NCT04677868|Dermatologic Agents|dermatologic agents|mesh-ancestor
101443091|NCT04677868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101443092|NCT04677868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101443093|NCT04677868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101443094|NCT04677868|Immunologic Factors|immunologic factors|mesh-ancestor
101443095|NCT04677868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101443096|NCT04677868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101443097|NCT00198393|Gemcitabine|gemcitabine|mesh-list
101443098|NCT00198393|Docetaxel|docetaxel|mesh-list
101443099|NCT00198393|Gefitinib|gefitinib|mesh-list
101443100|NCT00198393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101443101|NCT00198393|Antimetabolites|antimetabolites|mesh-ancestor
101443102|NCT00198393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443103|NCT00198393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443104|NCT00198393|Tubulin Modulators|tubulin modulators|mesh-ancestor
101443105|NCT00198393|Antimitotic Agents|antimitotic agents|mesh-ancestor
101443106|NCT00198393|Mitosis Modulators|mitosis modulators|mesh-ancestor
101443107|NCT00198393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101443108|NCT00198393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101443109|NCT02103322|Imatinib Mesylate|imatinib mesylate|mesh-list
101443110|NCT02103322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443111|NCT02103322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101443112|NCT02103322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101443113|NCT02103322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443114|NCT00554827|Vitamins|vitamins|mesh-list
101443121|NCT00554827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443123|NCT00554827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101443124|NCT00554827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101443125|NCT00554827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443126|NCT00554827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443127|NCT00203034|Rasagiline|rasagiline|mesh-list
101443128|NCT00203034|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101443129|NCT00203034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101307956|NCT02044627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101307957|NCT02044627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101307958|NCT02044627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101307959|NCT02044627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307960|NCT02044653|Darbepoetin alfa|darbepoetin alfa|mesh-list
101443130|NCT00203034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443132|NCT00203034|Protective Agents|protective agents|mesh-ancestor
101443133|NCT00203034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443134|NCT00203073|Mitoxantrone|mitoxantrone|mesh-list
101443135|NCT00203073|Glatiramer Acetate|glatiramer acetate|mesh-list
101443136|NCT00203073|(T,G)-A-L|(t,g)-a-l|mesh-list
101443137|NCT00203073|Analgesics|analgesics|mesh-ancestor
101443138|NCT00203073|Sensory System Agents|sensory system agents|mesh-ancestor
101443139|NCT00203073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101443140|NCT00203073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443141|NCT00203073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443142|NCT00203073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101443143|NCT00203073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101443144|NCT00203073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101637423|NCT00967616|Antidotes|antidotes|mesh-ancestor
101443145|NCT00203073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443146|NCT00203073|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101443147|NCT00203073|Immunologic Factors|immunologic factors|mesh-ancestor
101443148|NCT00203073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101443149|NCT00203073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101443150|NCT00198432|Paclitaxel|paclitaxel|mesh-list
101443152|NCT00198432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101443153|NCT00198432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443154|NCT00198432|Tubulin Modulators|tubulin modulators|mesh-ancestor
101443155|NCT00198432|Antimitotic Agents|antimitotic agents|mesh-ancestor
101443156|NCT00198432|Mitosis Modulators|mitosis modulators|mesh-ancestor
101443157|NCT00198432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443158|NCT02072863|Prednisone|prednisone|mesh-list
101443159|NCT02072863|Melphalan|melphalan|mesh-list
101443160|NCT02072863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101443161|NCT02072863|Glucocorticoids|glucocorticoids|mesh-ancestor
101443162|NCT02072863|Hormones|hormones|mesh-ancestor
101443163|NCT02072863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101443164|NCT02072863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637646|NCT00964886|Dopamine Agents|dopamine agents|mesh-ancestor
101443165|NCT02072863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101443166|NCT02072863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443167|NCT02072863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101443168|NCT02072863|Alkylating Agents|alkylating agents|mesh-ancestor
101443169|NCT02072863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443170|NCT02072863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101443171|NCT02072863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101443172|NCT02072863|Immunologic Factors|immunologic factors|mesh-ancestor
101443173|NCT02072161|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
101443175|NCT02072161|Antimetabolites|antimetabolites|mesh-ancestor
101443176|NCT02072161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443177|NCT02072161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101443178|NCT02072161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101443179|NCT02072161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101443180|NCT02072161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443181|NCT00203112|Minocycline|minocycline|mesh-list
101443182|NCT00203112|Glatiramer Acetate|glatiramer acetate|mesh-list
101443183|NCT00203112|(T,G)-A-L|(t,g)-a-l|mesh-list
101443184|NCT00203112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101443189|NCT00203112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101443190|NCT00203112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101443191|NCT02057380|Dexamethasone|dexamethasone|mesh-list
101443192|NCT02057380|Paclitaxel|paclitaxel|mesh-list
101443193|NCT02057380|Bortezomib|bortezomib|mesh-list
101443194|NCT02057380|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101443195|NCT02057380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101443196|NCT02057380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443197|NCT02057380|Tubulin Modulators|tubulin modulators|mesh-ancestor
101443198|NCT02057380|Antimitotic Agents|antimitotic agents|mesh-ancestor
101443199|NCT02057380|Mitosis Modulators|mitosis modulators|mesh-ancestor
101307961|NCT02044653|Hematinics|hematinics|mesh-ancestor
101307962|NCT02044809|Cannabidiol|cannabidiol|mesh-list
101307963|NCT02044809|Anticonvulsants|anticonvulsants|mesh-ancestor
101307965|NCT02044952|Triptolide|triptolide|mesh-list
101443200|NCT02057380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443201|NCT02057380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101443202|NCT02057380|Antiemetics|antiemetics|mesh-ancestor
101638285|NCT05766631|Methadone|methadone|mesh-list
101443204|NCT02057380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101443205|NCT02057380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443206|NCT02057380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101443207|NCT02057380|Glucocorticoids|glucocorticoids|mesh-ancestor
101443209|NCT02057380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101443210|NCT02057380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101443211|NCT02057380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101443212|NCT02057380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101443214|NCT02052778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443215|NCT02050828|Ranibizumab|ranibizumab|mesh-list
101443216|NCT02050828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101443217|NCT02050828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101443218|NCT02050828|Growth Substances|growth substances|mesh-ancestor
101443219|NCT02050828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443220|NCT02050828|Growth Inhibitors|growth inhibitors|mesh-ancestor
101443221|NCT02050828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443222|NCT02046694|Allopurinol|allopurinol|mesh-list
101443223|NCT02046694|Antimetabolites|antimetabolites|mesh-ancestor
101638471|NCT05597462|Minocycline|minocycline|mesh-list
101443224|NCT02046694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443225|NCT02046694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101443226|NCT02046694|Gout Suppressants|gout suppressants|mesh-ancestor
101443227|NCT02046694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101443228|NCT02046694|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101443230|NCT02046694|Protective Agents|protective agents|mesh-ancestor
101443231|NCT02046694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443232|NCT00203190|Topiramate|topiramate|mesh-list
101443233|NCT00203190|Anticonvulsants|anticonvulsants|mesh-ancestor
101443234|NCT00203190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101443235|NCT00203190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443236|NCT02019589|Progesterone|progesterone|mesh-list
101443237|NCT02019589|Progestins|progestins|mesh-ancestor
101443238|NCT02019589|Hormones|hormones|mesh-ancestor
101443239|NCT02019589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101638625|NCT05203172|Cetuximab|cetuximab|mesh-list
101443240|NCT02019589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443241|NCT02018926|Azacitidine|azacitidine|mesh-list
101443242|NCT02018926|Mocetinostat|mocetinostat|mesh-list
101443243|NCT02018926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101443244|NCT02018926|Antimetabolites|antimetabolites|mesh-ancestor
101443245|NCT02018926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443246|NCT02018926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443247|NCT02018926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101443248|NCT02018926|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101443249|NCT01989325|Dexamethasone|dexamethasone|mesh-list
101443250|NCT01989325|Filanesib|filanesib|mesh-list
101443251|NCT01989325|Lenograstim|lenograstim|mesh-list
101443252|NCT01989325|Proteasome Inhibitors|proteasome inhibitors|mesh-list
101443253|NCT01989325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101443254|NCT01989325|Antiemetics|antiemetics|mesh-ancestor
101443255|NCT01989325|Autonomic Agents|autonomic agents|mesh-ancestor
101443256|NCT01989325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101443259|NCT01989325|Glucocorticoids|glucocorticoids|mesh-ancestor
101443260|NCT01989325|Hormones|hormones|mesh-ancestor
101443261|NCT01989325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101443262|NCT01989325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101443263|NCT01989325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443264|NCT01989325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101443265|NCT01989325|Immunologic Factors|immunologic factors|mesh-ancestor
101443266|NCT01989325|Protease Inhibitors|protease inhibitors|mesh-ancestor
101443267|NCT01989325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101443268|NCT01989325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307966|NCT02044952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101307968|NCT02044952|Analgesics|analgesics|mesh-ancestor
101307969|NCT02044952|Sensory System Agents|sensory system agents|mesh-ancestor
101443269|NCT01989325|Antimitotic Agents|antimitotic agents|mesh-ancestor
101443270|NCT01989325|Mitosis Modulators|mitosis modulators|mesh-ancestor
101443271|NCT01978366|Halofuginone|halofuginone|mesh-list
101443272|NCT01978366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443273|NCT01978366|Coccidiostats|coccidiostats|mesh-ancestor
101443274|NCT01978366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101443275|NCT01978366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101638888|NCT04727307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101443276|NCT01978366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101443277|NCT01978366|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101443278|NCT01978366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101443279|NCT01978366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443280|NCT01978366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101443281|NCT01978366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101443282|NCT01978366|Growth Substances|growth substances|mesh-ancestor
101443283|NCT01978366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443284|NCT01978366|Growth Inhibitors|growth inhibitors|mesh-ancestor
101443285|NCT02962986|Phenylephrine|phenylephrine|mesh-list
101443286|NCT02962986|Oxymetazoline|oxymetazoline|mesh-list
101443287|NCT02962986|Norepinephrine|norepinephrine|mesh-list
101443288|NCT02962986|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101443289|NCT02962986|Mydriatics|mydriatics|mesh-ancestor
101443290|NCT02962986|Autonomic Agents|autonomic agents|mesh-ancestor
101443291|NCT02962986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101443292|NCT02962986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443293|NCT02962986|Sympathomimetics|sympathomimetics|mesh-ancestor
101443294|NCT02962986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101443295|NCT02962986|Nasal Decongestants|nasal decongestants|mesh-ancestor
101443296|NCT02962986|Respiratory System Agents|respiratory system agents|mesh-ancestor
101443297|NCT02962986|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101443298|NCT02962986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101443299|NCT02962986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101639045|NCT04494425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101639046|NCT04494425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639047|NCT04494425|Tubulin Modulators|tubulin modulators|mesh-ancestor
101639048|NCT04494425|Antimitotic Agents|antimitotic agents|mesh-ancestor
101639049|NCT04494425|Mitosis Modulators|mitosis modulators|mesh-ancestor
101639050|NCT04494425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639051|NCT04494425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101639052|NCT04494425|Antimetabolites|antimetabolites|mesh-ancestor
101639053|NCT04494425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101639054|NCT04494425|Immunoconjugates|immunoconjugates|mesh-ancestor
101443300|NCT02962986|Adrenergic Agents|adrenergic agents|mesh-ancestor
101443301|NCT02962986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101443302|NCT02962986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443303|NCT02962986|Protective Agents|protective agents|mesh-ancestor
101443304|NCT04677361|Pembrolizumab|pembrolizumab|mesh-list
101443305|NCT04677361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101443306|NCT04677361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443307|NCT04677361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101443308|NCT04677361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443309|NCT01968733|Moxifloxacin|moxifloxacin|mesh-list
101443311|NCT01968733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101443312|NCT01968733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101639102|NCT04218539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101443313|NCT01968733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101443314|NCT01968733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101443315|NCT01968733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101443316|NCT01968733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443317|NCT01968733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443319|NCT00410553|Halichondrin B|halichondrin b|mesh-list
101639168|NCT04068103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101443320|NCT00410553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101443322|NCT00410553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443323|NCT00410553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443324|NCT00410553|Tubulin Modulators|tubulin modulators|mesh-ancestor
101443325|NCT00410553|Antimitotic Agents|antimitotic agents|mesh-ancestor
101443326|NCT00410553|Mitosis Modulators|mitosis modulators|mesh-ancestor
101443327|NCT00410592|Esomeprazole|esomeprazole|mesh-list
101443328|NCT00410592|Pantoprazole|pantoprazole|mesh-list
101443329|NCT00410592|Lansoprazole|lansoprazole|mesh-list
101443330|NCT00410592|Dexlansoprazole|dexlansoprazole|mesh-list
101443334|NCT00410592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101443335|NCT00410592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443336|NCT00410631|Cyclophosphamide|cyclophosphamide|mesh-list
101443339|NCT00410631|Dacarbazine|dacarbazine|mesh-list
101443340|NCT00410631|Carboplatin|carboplatin|mesh-list
101443341|NCT00410631|Doxorubicin|doxorubicin|mesh-list
101443342|NCT00410631|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101307970|NCT02044952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101307971|NCT02044952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443343|NCT00410631|Etoposide|etoposide|mesh-list
101443344|NCT00410631|Vincristine|vincristine|mesh-list
101443345|NCT00410631|Topotecan|topotecan|mesh-list
101443346|NCT00410631|Etoposide phosphate|etoposide phosphate|mesh-list
101443348|NCT00410631|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
101443349|NCT00410631|Isotretinoin|isotretinoin|mesh-list
101443350|NCT00410631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101443351|NCT00410631|Immunologic Factors|immunologic factors|mesh-ancestor
101443352|NCT00410631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443353|NCT00410631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101443354|NCT00410631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101443355|NCT00410631|Alkylating Agents|alkylating agents|mesh-ancestor
101443356|NCT00410631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443357|NCT00410631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443358|NCT00410631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101443359|NCT00410631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101443360|NCT00410631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101443361|NCT00410631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101443362|NCT00410631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101443363|NCT00410631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101443364|NCT00410631|Tubulin Modulators|tubulin modulators|mesh-ancestor
101443365|NCT00410631|Antimitotic Agents|antimitotic agents|mesh-ancestor
101443366|NCT00410631|Mitosis Modulators|mitosis modulators|mesh-ancestor
101443367|NCT00410631|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101443368|NCT00410631|Dermatologic Agents|dermatologic agents|mesh-ancestor
101443369|NCT00410631|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101443370|NCT01930357|Vaccines|vaccines|mesh-list
101443371|NCT01930357|Immunologic Factors|immunologic factors|mesh-ancestor
101443372|NCT01930357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443373|NCT01913158|Hydrocortisone|hydrocortisone|mesh-list
101443374|NCT01913158|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101443375|NCT01913158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101443376|NCT01903954|Ribavirin|ribavirin|mesh-list
101443377|NCT01903954|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101443378|NCT01903954|Antimetabolites|antimetabolites|mesh-ancestor
101443379|NCT01903954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443380|NCT01903954|Antiviral Agents|antiviral agents|mesh-ancestor
101443381|NCT01903954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101443382|NCT01893190|Nimodipine|nimodipine|mesh-list
101443383|NCT01893190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101443384|NCT01893190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101443385|NCT01893190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101443386|NCT01893190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443387|NCT01893190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101443388|NCT01893190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443390|NCT00198588|Argatroban|argatroban|mesh-list
101443391|NCT00198588|Antithrombins|antithrombins|mesh-ancestor
101443392|NCT00198588|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101443393|NCT00198588|Protease Inhibitors|protease inhibitors|mesh-ancestor
101443394|NCT00198588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101443395|NCT00198588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443396|NCT00198588|Anticoagulants|anticoagulants|mesh-ancestor
101443397|NCT00198588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101443398|NCT01887886|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101443399|NCT01887886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443400|NCT01887886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101443401|NCT01887886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101443402|NCT01887886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443403|NCT01877395|Vaccines|vaccines|mesh-list
101443407|NCT01874626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101443408|NCT01874626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101443409|NCT01874626|Analgesics|analgesics|mesh-ancestor
101443410|NCT01874626|Sensory System Agents|sensory system agents|mesh-ancestor
101443411|NCT01874626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101443412|NCT01874626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443413|NCT01874626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101443414|NCT01874626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101443415|NCT01874626|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101307973|NCT02044952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101307974|NCT02044952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443416|NCT01874626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101443417|NCT01874626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443418|NCT00410748|Hydromorphone|hydromorphone|mesh-list
101443419|NCT00410748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101443420|NCT00410748|Narcotics|narcotics|mesh-ancestor
101443421|NCT00410748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101443422|NCT00410748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443423|NCT00410748|Analgesics|analgesics|mesh-ancestor
101443424|NCT00410748|Sensory System Agents|sensory system agents|mesh-ancestor
101443425|NCT00410748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101443426|NCT00198627|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101443427|NCT00198627|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101443428|NCT00198627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101443429|NCT00198627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101443430|NCT00198627|Antimalarials|antimalarials|mesh-ancestor
101443431|NCT00198627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101443432|NCT00198627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101443433|NCT01862224|Methotrexate|methotrexate|mesh-list
101443434|NCT01862224|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101443435|NCT01862224|Abortifacient Agents|abortifacient agents|mesh-ancestor
101443436|NCT01862224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101443437|NCT01862224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443438|NCT01862224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101443439|NCT01862224|Antimetabolites|antimetabolites|mesh-ancestor
101443440|NCT01862224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443441|NCT01862224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443442|NCT01862224|Dermatologic Agents|dermatologic agents|mesh-ancestor
101443443|NCT01862224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101443444|NCT01862224|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101443445|NCT01862224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101443446|NCT01862224|Immunologic Factors|immunologic factors|mesh-ancestor
101443447|NCT01862224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101443448|NCT01862224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101443449|NCT01859962|Ribavirin|ribavirin|mesh-list
101443450|NCT01859962|Antimetabolites|antimetabolites|mesh-ancestor
101443451|NCT01859962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443452|NCT01859962|Antiviral Agents|antiviral agents|mesh-ancestor
101443453|NCT01859962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101443454|NCT00173888|Cisplatin|cisplatin|mesh-list
101443455|NCT00173888|Gemcitabine|gemcitabine|mesh-list
101443456|NCT00173888|Docetaxel|docetaxel|mesh-list
101443457|NCT00173888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443458|NCT00173888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101443459|NCT00173888|Antimetabolites|antimetabolites|mesh-ancestor
101443460|NCT00173888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443461|NCT00173888|Tubulin Modulators|tubulin modulators|mesh-ancestor
101443462|NCT00173888|Antimitotic Agents|antimitotic agents|mesh-ancestor
101443463|NCT00173888|Mitosis Modulators|mitosis modulators|mesh-ancestor
101443465|NCT00555022|Tiotropium Bromide|tiotropium bromide|mesh-list
101443466|NCT00555022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101443467|NCT00555022|Autonomic Agents|autonomic agents|mesh-ancestor
101443468|NCT00555022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101443469|NCT00555022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443470|NCT00555022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101443471|NCT00555022|Respiratory System Agents|respiratory system agents|mesh-ancestor
101443472|NCT00555022|Parasympatholytics|parasympatholytics|mesh-ancestor
101443474|NCT00555022|Cholinergic Agents|cholinergic agents|mesh-ancestor
101443475|NCT00555022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101443493|NCT00555100|Autonomic Agents|autonomic agents|mesh-ancestor
101443494|NCT00555100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101443495|NCT00555100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639624|NCT02773030|Bortezomib|bortezomib|mesh-list
101443496|NCT00555100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101443497|NCT00555100|Glucocorticoids|glucocorticoids|mesh-ancestor
101443498|NCT00555100|Hormones|hormones|mesh-ancestor
101443499|NCT00555100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101307975|NCT02044952|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
101307976|NCT02044952|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101307977|NCT02044952|Contraceptive Agents|contraceptive agents|mesh-ancestor
101443500|NCT00555100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101443501|NCT00555100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443502|NCT00555100|Immunologic Factors|immunologic factors|mesh-ancestor
101443503|NCT00555100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101443504|NCT00555100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101443505|NCT00555100|Growth Substances|growth substances|mesh-ancestor
101443506|NCT00555100|Growth Inhibitors|growth inhibitors|mesh-ancestor
101443508|NCT00555139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101443509|NCT00555139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101443510|NCT00555139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443511|NCT00555139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101443512|NCT00555139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101443513|NCT00555139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101443514|NCT00555139|GABA Modulators|gaba modulators|mesh-ancestor
101443515|NCT00555139|GABA Agents|gaba agents|mesh-ancestor
101443516|NCT00555139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101443517|NCT00555139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443519|NCT00203463|Anticonvulsants|anticonvulsants|mesh-ancestor
101443520|NCT00203463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101443521|NCT00203463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443522|NCT00407849|Triamcinolone|triamcinolone|mesh-list
101443523|NCT00407849|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101443524|NCT00407849|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101443525|NCT00407849|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101443526|NCT00407849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101443527|NCT00407849|Glucocorticoids|glucocorticoids|mesh-ancestor
101443528|NCT00407849|Hormones|hormones|mesh-ancestor
101443529|NCT00407849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101443530|NCT00407849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443531|NCT00407849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101443532|NCT00407849|Immunologic Factors|immunologic factors|mesh-ancestor
101443533|NCT00407849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101443534|NCT00407849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443539|NCT00407927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101443540|NCT00407927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443541|NCT00407927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443542|NCT01818076|Botulinum Toxins|botulinum toxins|mesh-list
101443543|NCT01818076|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101443544|NCT01818076|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101443545|NCT01818076|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101443546|NCT01818076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101640032|NCT02599168|Anesthetics|anesthetics|mesh-ancestor
101443547|NCT01818076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443548|NCT01818076|Cholinergic Agents|cholinergic agents|mesh-ancestor
101443549|NCT01818076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101443550|NCT01818076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443551|NCT01818076|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101443552|NCT01818076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101443554|NCT01807546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443555|NCT01807546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101443556|NCT01807546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101443557|NCT01807546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443559|NCT03454984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443560|NCT01785433|Tiotropium Bromide|tiotropium bromide|mesh-list
101443561|NCT01785433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101443562|NCT01785433|Autonomic Agents|autonomic agents|mesh-ancestor
101443563|NCT01785433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101443564|NCT01785433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443565|NCT01785433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101443566|NCT01785433|Respiratory System Agents|respiratory system agents|mesh-ancestor
101443567|NCT01785433|Parasympatholytics|parasympatholytics|mesh-ancestor
101443568|NCT01785433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101443569|NCT01785433|Cholinergic Agents|cholinergic agents|mesh-ancestor
101443570|NCT01785433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101443571|NCT01785433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307978|NCT02044952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101640145|NCT00742924|Antidotes|antidotes|mesh-ancestor
101307979|NCT02044952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101307980|NCT02044952|Immunologic Factors|immunologic factors|mesh-ancestor
101307981|NCT02044952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101443573|NCT00203580|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101443575|NCT00203580|Anticoagulants|anticoagulants|mesh-ancestor
101443576|NCT00203580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101443577|NCT00203580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101443578|NCT00203580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443579|NCT01777555|Levodopa|levodopa|mesh-list
101443580|NCT01777555|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101443581|NCT01777555|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101443582|NCT01777555|Dopamine Agents|dopamine agents|mesh-ancestor
101443583|NCT01777555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101443584|NCT01777555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443585|NCT01777555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443587|NCT01773928|Immunologic Factors|immunologic factors|mesh-ancestor
101443588|NCT01773928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443589|NCT01768975|Dapansutrile|dapansutrile|mesh-list
101443590|NCT01768975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101443591|NCT01756924|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101443592|NCT01756924|Vancomycin|vancomycin|mesh-list
101443593|NCT01756924|Ciprofloxacin|ciprofloxacin|mesh-list
101443594|NCT01756924|Levofloxacin|levofloxacin|mesh-list
101443595|NCT01756924|Rifampin|rifampin|mesh-list
101443596|NCT01756924|Cefazolin|cefazolin|mesh-list
101443597|NCT01756924|Ceftriaxone|ceftriaxone|mesh-list
101443598|NCT01756924|Linezolid|linezolid|mesh-list
101443599|NCT01756924|Daptomycin|daptomycin|mesh-list
101443600|NCT01756924|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101443601|NCT01756924|Oxacillin|oxacillin|mesh-list
101443602|NCT01756924|Fusidic Acid|fusidic acid|mesh-list
101443603|NCT01756924|Nafcillin|nafcillin|mesh-list
101443604|NCT01756924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101443605|NCT01756924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101443606|NCT01756924|Antitubercular Agents|antitubercular agents|mesh-ancestor
101443607|NCT01756924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101443608|NCT01756924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101443617|NCT01756924|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101443619|NCT01756924|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101443620|NCT01756924|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101443621|NCT01756924|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101443622|NCT01756924|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101443623|NCT01756924|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101443625|NCT01756924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101443626|NCT01756924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101443627|NCT01756339|Moxifloxacin|moxifloxacin|mesh-list
101443628|NCT01756339|Solithromycin|solithromycin|mesh-list
101443629|NCT01756339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101443630|NCT01756339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101443631|NCT01756339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101443632|NCT01756339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101443633|NCT01756339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101443634|NCT01756339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443635|NCT01756339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443636|NCT00174200|Risperidone|risperidone|mesh-list
101443637|NCT00174200|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101443638|NCT00174200|Serotonin Agents|serotonin agents|mesh-ancestor
101443639|NCT00174200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101443640|NCT00174200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443641|NCT00174200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443642|NCT00174200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101443643|NCT00174200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101640478|NCT01032239|Baclofen|baclofen|mesh-list
101443644|NCT00174200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101443645|NCT00174200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101443646|NCT00174200|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101443647|NCT00174200|Dopamine Agents|dopamine agents|mesh-ancestor
101443648|NCT00203658|Tinzaparin|tinzaparin|mesh-list
101443649|NCT00203658|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101307982|NCT02044952|Alkylating Agents|alkylating agents|mesh-ancestor
101307983|NCT02044952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101307984|NCT02044965|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101307985|NCT02044965|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101307986|NCT02044965|Trimethoprim|trimethoprim|mesh-list
101443650|NCT00203658|Dalteparin|dalteparin|mesh-list
101443651|NCT00203658|Anticoagulants|anticoagulants|mesh-ancestor
101443652|NCT00203658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101443653|NCT00203658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101443654|NCT00203658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443655|NCT00174239|Levodopa|levodopa|mesh-list
101443656|NCT00174239|Carbidopa|carbidopa|mesh-list
101443657|NCT00174239|Cabergoline|cabergoline|mesh-list
101443658|NCT00174239|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101443659|NCT00174239|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101443660|NCT00174239|Dopamine Agents|dopamine agents|mesh-ancestor
101443661|NCT00174239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101443662|NCT00174239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443663|NCT00174239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443664|NCT00174239|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101443665|NCT00174239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101443666|NCT00174239|Dopamine Agonists|dopamine agonists|mesh-ancestor
101443667|NCT00203697|Minocycline|minocycline|mesh-list
101443668|NCT00203697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101443669|NCT00203697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101443670|NCT00174317|Celecoxib|celecoxib|mesh-list
101443671|NCT00174317|Diclofenac|diclofenac|mesh-list
101443672|NCT00174317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101443682|NCT00174317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101443683|NCT00174317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443684|NCT01737892|Epinephrine|epinephrine|mesh-list
101443685|NCT01737892|Racepinephrine|racepinephrine|mesh-list
101443686|NCT01737892|Epinephryl borate|epinephryl borate|mesh-list
101443687|NCT01737892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101443688|NCT01737892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101443689|NCT01737892|Adrenergic Agents|adrenergic agents|mesh-ancestor
101443690|NCT01737892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101640532|NCT04557085|Cenobamate|cenobamate|mesh-list
101443691|NCT01737892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443692|NCT01737892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443693|NCT01737892|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101443694|NCT01737892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101443695|NCT01737892|Autonomic Agents|autonomic agents|mesh-ancestor
101443696|NCT01737892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101443697|NCT01737892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101443698|NCT01737892|Respiratory System Agents|respiratory system agents|mesh-ancestor
101443699|NCT01737892|Mydriatics|mydriatics|mesh-ancestor
101443700|NCT01737892|Sympathomimetics|sympathomimetics|mesh-ancestor
101443701|NCT01737892|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101443703|NCT00203736|Pyrimethamine|pyrimethamine|mesh-list
101443704|NCT00203736|Sulfadoxine|sulfadoxine|mesh-list
101443705|NCT00203736|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101443706|NCT00203736|Antimalarials|antimalarials|mesh-ancestor
101443707|NCT00203736|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101640627|NCT00921505|Antipyretics|antipyretics|mesh-ancestor
101443708|NCT00203736|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101443709|NCT00203736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101443710|NCT00203736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443711|NCT00203736|Antiviral Agents|antiviral agents|mesh-ancestor
101443712|NCT00203736|Schistosomicides|schistosomicides|mesh-ancestor
101443713|NCT00203736|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101443714|NCT00203736|Anthelmintics|anthelmintics|mesh-ancestor
101443715|NCT00203736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101443716|NCT00203736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101443717|NCT00203736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443718|NCT00203736|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101443719|NCT01719016|Adenosine|adenosine|mesh-list
101443720|NCT01719016|Analgesics|analgesics|mesh-ancestor
101443721|NCT01719016|Sensory System Agents|sensory system agents|mesh-ancestor
101443722|NCT01719016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101443723|NCT01719016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443724|NCT01719016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101307987|NCT02044965|Sulfamethoxazole|sulfamethoxazole|mesh-list
101307988|NCT02044965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101307989|NCT02044965|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101443725|NCT01719016|Vasodilator Agents|vasodilator agents|mesh-ancestor
101443726|NCT01719016|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101443727|NCT01719016|Purinergic Agonists|purinergic agonists|mesh-ancestor
101443728|NCT01719016|Purinergic Agents|purinergic agents|mesh-ancestor
101443729|NCT01719016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101443730|NCT01719016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443731|NCT00174356|Paclitaxel|paclitaxel|mesh-list
101443732|NCT00174356|Carboplatin|carboplatin|mesh-list
101443733|NCT00174356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101443734|NCT00174356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443735|NCT00174356|Tubulin Modulators|tubulin modulators|mesh-ancestor
101443736|NCT00174356|Antimitotic Agents|antimitotic agents|mesh-ancestor
101443737|NCT00174356|Mitosis Modulators|mitosis modulators|mesh-ancestor
101443738|NCT00174356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443760|NCT00203775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101443761|NCT00203775|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101443762|NCT00203775|Dopamine Agents|dopamine agents|mesh-ancestor
101443763|NCT00555256|Sirolimus|sirolimus|mesh-list
101443764|NCT00555256|Sunitinib|sunitinib|mesh-list
101443765|NCT00555256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443766|NCT00555256|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101443767|NCT00555256|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101443768|NCT00555256|Growth Substances|growth substances|mesh-ancestor
101443769|NCT00555256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443770|NCT00555256|Growth Inhibitors|growth inhibitors|mesh-ancestor
101443771|NCT00555256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101640964|NCT00957944|Rotigotine|rotigotine|mesh-list
101443773|NCT00555256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443774|NCT00555256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101443775|NCT00555256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101443776|NCT00555256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101443777|NCT00555256|Antifungal Agents|antifungal agents|mesh-ancestor
101443778|NCT00555256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101443779|NCT00555256|Immunologic Factors|immunologic factors|mesh-ancestor
101443780|NCT00174434|Paclitaxel|paclitaxel|mesh-list
101443781|NCT00174434|Sunitinib|sunitinib|mesh-list
101443782|NCT00174434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101443783|NCT00174434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443784|NCT00174434|Tubulin Modulators|tubulin modulators|mesh-ancestor
101443785|NCT00174434|Antimitotic Agents|antimitotic agents|mesh-ancestor
101443786|NCT00174434|Mitosis Modulators|mitosis modulators|mesh-ancestor
101443787|NCT00174434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443788|NCT00174434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101443789|NCT00174434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101443790|NCT00174434|Growth Substances|growth substances|mesh-ancestor
101443791|NCT00174434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443810|NCT00203814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443812|NCT00174473|Voriconazole|voriconazole|mesh-list
101443813|NCT00174473|Antifungal Agents|antifungal agents|mesh-ancestor
101443814|NCT00174473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101443815|NCT00174473|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101443816|NCT00174473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101443817|NCT00174473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101443818|NCT00174473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443819|NCT00174473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101443820|NCT00174473|Hormone Antagonists|hormone antagonists|mesh-ancestor
101443821|NCT00174473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101443822|NCT00174473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443823|NCT00174473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101443824|NCT00174512|Moxifloxacin|moxifloxacin|mesh-list
101641097|NCT02100956|Oxytocin|oxytocin|mesh-list
101443825|NCT00174512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101443826|NCT00174512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101443827|NCT00174512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101443828|NCT00174512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101443829|NCT00174512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101443830|NCT00174512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443831|NCT00174512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101307990|NCT02044965|Antimalarials|antimalarials|mesh-ancestor
101307991|NCT02044965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101307992|NCT02044965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101307993|NCT02044965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101443833|NCT00199017|Dexamethasone|dexamethasone|mesh-list
101443834|NCT00199017|Prednisolone|prednisolone|mesh-list
101443835|NCT00199017|Cyclophosphamide|cyclophosphamide|mesh-list
101443836|NCT00199017|Methotrexate|methotrexate|mesh-list
101443837|NCT00199017|Vincristine|vincristine|mesh-list
101443838|NCT00199017|Doxorubicin|doxorubicin|mesh-list
101443839|NCT00199017|Daunorubicin|daunorubicin|mesh-list
101443840|NCT00199017|Asparaginase|asparaginase|mesh-list
101443841|NCT00199017|Mercaptopurine|mercaptopurine|mesh-list
101443843|NCT00199017|Thioguanine|thioguanine|mesh-list
101443844|NCT00199017|Vindesine|vindesine|mesh-list
101443845|NCT00199017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101443846|NCT00199017|Immunologic Factors|immunologic factors|mesh-ancestor
101443847|NCT00199017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443848|NCT00199017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101443849|NCT00199017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101443850|NCT00199017|Alkylating Agents|alkylating agents|mesh-ancestor
101443863|NCT00199017|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101443865|NCT00199017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101443866|NCT00199017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101443867|NCT00199017|Antimetabolites|antimetabolites|mesh-ancestor
101443868|NCT00199017|Dermatologic Agents|dermatologic agents|mesh-ancestor
101443869|NCT00199017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101443870|NCT00199017|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101443871|NCT00199017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101443872|NCT00199017|Antiviral Agents|antiviral agents|mesh-ancestor
101443873|NCT00199017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101443874|NCT00199017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101443875|NCT00199017|Tubulin Modulators|tubulin modulators|mesh-ancestor
101443876|NCT00199017|Antimitotic Agents|antimitotic agents|mesh-ancestor
101443877|NCT00199017|Mitosis Modulators|mitosis modulators|mesh-ancestor
101443879|NCT00199017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101443880|NCT00199017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101443881|NCT01665391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101443882|NCT01665391|Immunologic Factors|immunologic factors|mesh-ancestor
101443883|NCT01665391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443884|NCT01660633|Melphalan|melphalan|mesh-list
101443885|NCT01660633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101443886|NCT01660633|Alkylating Agents|alkylating agents|mesh-ancestor
101443887|NCT01660633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443888|NCT01660633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443889|NCT01660633|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101443890|NCT01660633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101443891|NCT01660633|Immunologic Factors|immunologic factors|mesh-ancestor
101443892|NCT01660633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443893|NCT00174551|Prazosin|prazosin|mesh-list
101443894|NCT00174551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101443895|NCT00174551|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101443896|NCT00174551|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101443897|NCT00174551|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101443898|NCT00174551|Adrenergic Agents|adrenergic agents|mesh-ancestor
101641322|NCT00689221|Temozolomide|temozolomide|mesh-list
101443899|NCT00174551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101443900|NCT00174551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443901|NCT00174551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443903|NCT04676659|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101443904|NCT04676659|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101443905|NCT04676659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443906|NCT00174590|Risperidone|risperidone|mesh-list
101443907|NCT00174590|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101443908|NCT00174590|Serotonin Agents|serotonin agents|mesh-ancestor
101443909|NCT00174590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101443913|NCT00174590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101443914|NCT00174590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101307994|NCT02044965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101307995|NCT02044965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101307996|NCT02044965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101307997|NCT02044965|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101307998|NCT02044965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101307999|NCT02044978|Zoledronic Acid|zoledronic acid|mesh-list
101308000|NCT02044978|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101308001|NCT02044978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443915|NCT00174590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101443916|NCT00174590|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101443917|NCT00174590|Dopamine Agents|dopamine agents|mesh-ancestor
101443918|NCT01652482|Leucovorin|leucovorin|mesh-list
101443919|NCT01652482|Fluorouracil|fluorouracil|mesh-list
101443920|NCT01652482|Irinotecan|irinotecan|mesh-list
101443921|NCT01652482|Cetuximab|cetuximab|mesh-list
101443922|NCT01652482|Antimetabolites|antimetabolites|mesh-ancestor
101641675|NCT00949988|Rituximab|rituximab|mesh-list
101443923|NCT01652482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443924|NCT01652482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101443925|NCT01652482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443926|NCT01652482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101443927|NCT01652482|Immunologic Factors|immunologic factors|mesh-ancestor
101443928|NCT01652482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443929|NCT01652482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101443930|NCT01652482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101443931|NCT01652482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101443932|NCT01652482|Antidotes|antidotes|mesh-ancestor
101443933|NCT01652482|Protective Agents|protective agents|mesh-ancestor
101443934|NCT01652482|Vitamin B Complex|vitamin b complex|mesh-ancestor
101443936|NCT01652482|Micronutrients|micronutrients|mesh-ancestor
101443937|NCT01652482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101443938|NCT00174629|Gemcitabine|gemcitabine|mesh-list
101443939|NCT00174629|Docetaxel|docetaxel|mesh-list
101443940|NCT00174629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101443941|NCT00174629|Antimetabolites|antimetabolites|mesh-ancestor
101443942|NCT00174629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443943|NCT00174629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443945|NCT00174629|Antimitotic Agents|antimitotic agents|mesh-ancestor
101443946|NCT00174629|Mitosis Modulators|mitosis modulators|mesh-ancestor
101443947|NCT02962947|Propranolol|propranolol|mesh-list
101443948|NCT02962947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101443949|NCT02962947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101443950|NCT02962947|Adrenergic Agents|adrenergic agents|mesh-ancestor
101443951|NCT02962947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101443952|NCT02962947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443953|NCT02962947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642077|NCT02561923|Rivaroxaban|rivaroxaban|mesh-list
101443954|NCT02962947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101443955|NCT02962947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101443956|NCT02962947|Vasodilator Agents|vasodilator agents|mesh-ancestor
101443958|NCT00555334|Entecavir|entecavir|mesh-list
101443959|NCT00555334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101443960|NCT00555334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101443961|NCT00555334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101443962|NCT00555334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443963|NCT00555334|Antiviral Agents|antiviral agents|mesh-ancestor
101443964|NCT00555334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101443965|NCT00555334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101443966|NCT00555334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101443967|NCT01640080|Esketamine|esketamine|mesh-list
101443968|NCT01640080|Antidepressive Agents|antidepressive agents|mesh-ancestor
101443969|NCT01640080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101443970|NCT00174668|Insulin|insulin|mesh-list
101443971|NCT00174668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101443972|NCT00174668|Insulin Glargine|insulin glargine|mesh-list
101443973|NCT00174668|Insulin glulisine|insulin glulisine|mesh-list
101443974|NCT00174668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101308002|NCT02045017|Dexamethasone|dexamethasone|mesh-list
101308003|NCT02045017|Pomalidomide|pomalidomide|mesh-list
101308004|NCT02045017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101308005|NCT02045017|Antiemetics|antiemetics|mesh-ancestor
101443975|NCT00174668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443976|NCT00174707|Cyclophosphamide|cyclophosphamide|mesh-list
101443977|NCT00174707|Docetaxel|docetaxel|mesh-list
101443978|NCT00174707|Methotrexate|methotrexate|mesh-list
101443979|NCT00174707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101443980|NCT00174707|Immunologic Factors|immunologic factors|mesh-ancestor
101443981|NCT00174707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443982|NCT00174707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101443983|NCT00174707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101443994|NCT00174707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101443996|NCT00174707|Dermatologic Agents|dermatologic agents|mesh-ancestor
101443997|NCT00174707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101443998|NCT00174707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101443999|NCT00174707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101444002|NCT00199134|Letrozole|letrozole|mesh-list
101444003|NCT00199134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101444004|NCT00199134|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101444005|NCT00199134|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101444006|NCT00199134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101642563|NCT00685945|Vasodilator Agents|vasodilator agents|mesh-ancestor
101444007|NCT00199134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444008|NCT00199134|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101444009|NCT00199134|Hormone Antagonists|hormone antagonists|mesh-ancestor
101444010|NCT00199134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101444011|NCT00199134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444012|NCT00174824|Insulin Glargine|insulin glargine|mesh-list
101444013|NCT00174824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101444014|NCT00174824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444015|NCT00174863|SR 31747|sr 31747|mesh-list
101444016|NCT00174863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101444017|NCT00174863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444018|NCT00174863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101444019|NCT00174863|Immunologic Factors|immunologic factors|mesh-ancestor
101444020|NCT00174863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444021|NCT00712582|Cyclophosphamide|cyclophosphamide|mesh-list
101444022|NCT00712582|Ifosfamide|ifosfamide|mesh-list
101444023|NCT00712582|Isophosphamide mustard|isophosphamide mustard|mesh-list
101444024|NCT00712582|Carmustine|carmustine|mesh-list
101444025|NCT00712582|Rituximab|rituximab|mesh-list
101444026|NCT00712582|Carboplatin|carboplatin|mesh-list
101444027|NCT00712582|Etoposide|etoposide|mesh-list
101444028|NCT00712582|Etoposide phosphate|etoposide phosphate|mesh-list
101444029|NCT00712582|Mitoxantrone|mitoxantrone|mesh-list
101444030|NCT00712582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101444031|NCT00712582|Immunologic Factors|immunologic factors|mesh-ancestor
101444032|NCT00712582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444033|NCT00712582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101642786|NCT00752479|Hormones|hormones|mesh-ancestor
101444035|NCT00712582|Alkylating Agents|alkylating agents|mesh-ancestor
101444036|NCT00712582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444037|NCT00712582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101444038|NCT00712582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101444039|NCT00712582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101444040|NCT00712582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101444041|NCT00712582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101444042|NCT00712582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101444043|NCT00712582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101444044|NCT00712582|Analgesics|analgesics|mesh-ancestor
101444045|NCT00712582|Sensory System Agents|sensory system agents|mesh-ancestor
101444046|NCT00712582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101444047|NCT00174902|Aspirin|aspirin|mesh-list
101444052|NCT00174902|Sensory System Agents|sensory system agents|mesh-ancestor
101444053|NCT00174902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101444054|NCT00174902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444055|NCT00174902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101444056|NCT00174902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101444057|NCT00174902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101444058|NCT00174902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101444059|NCT00174902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308006|NCT02045017|Autonomic Agents|autonomic agents|mesh-ancestor
101308007|NCT02045017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101308008|NCT02045017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444060|NCT00174902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101444061|NCT00174902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101444062|NCT00174902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101444063|NCT00174902|Antipyretics|antipyretics|mesh-ancestor
101444064|NCT00174902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101444065|NCT00174902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101444066|NCT00174902|Adrenergic Agents|adrenergic agents|mesh-ancestor
101444067|NCT00174902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101444068|NCT00174902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101444069|NCT00174902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101444070|NCT00174902|Vasodilator Agents|vasodilator agents|mesh-ancestor
101444071|NCT00373711|Iodine|iodine|mesh-list
101444072|NCT00373711|Cadexomer iodine|cadexomer iodine|mesh-list
101444073|NCT00373711|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101444074|NCT00373711|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101444075|NCT00373711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101444076|NCT00373711|Trace Elements|trace elements|mesh-ancestor
101444077|NCT00373711|Micronutrients|micronutrients|mesh-ancestor
101444078|NCT00373711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444079|NCT00373711|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101444080|NCT00373711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444081|NCT00199212|Trastuzumab|trastuzumab|mesh-list
101444082|NCT00199212|Bortezomib|bortezomib|mesh-list
101444083|NCT00199212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101444084|NCT00199212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101444085|NCT00555373|Sirolimus|sirolimus|mesh-list
101444086|NCT00555373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101444087|NCT00555373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101444088|NCT00555373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101444089|NCT00555373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101444091|NCT00555373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101444092|NCT00555373|Immunologic Factors|immunologic factors|mesh-ancestor
101444093|NCT00555373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444094|NCT00555412|Loxapine|loxapine|mesh-list
101444095|NCT00555412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101444096|NCT00555412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101444097|NCT00555412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101444098|NCT00555412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444099|NCT00555412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101444100|NCT00555412|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101444101|NCT00555412|Dopamine Agents|dopamine agents|mesh-ancestor
101444102|NCT00555412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101444103|NCT00555412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444104|NCT04676776|Levonorgestrel|levonorgestrel|mesh-list
101642973|NCT00748891|Cediranib|cediranib|mesh-list
101444105|NCT04676776|Mifepristone|mifepristone|mesh-list
101444106|NCT04676776|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101444107|NCT04676776|Contraceptive Agents|contraceptive agents|mesh-ancestor
101444108|NCT04676776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101444109|NCT04676776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444110|NCT04676776|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101444111|NCT04676776|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101444112|NCT04676776|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101444113|NCT04676776|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101444114|NCT04676776|Abortifacient Agents|abortifacient agents|mesh-ancestor
101444115|NCT04676776|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101444116|NCT04676776|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101444117|NCT04676776|Hormone Antagonists|hormone antagonists|mesh-ancestor
101444118|NCT04676776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101444121|NCT00175253|Alemtuzumab|alemtuzumab|mesh-list
101444122|NCT00175253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101444123|NCT00175253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101444124|NCT00199329|Ondansetron|ondansetron|mesh-list
101444125|NCT00199329|Antiemetics|antiemetics|mesh-ancestor
101444126|NCT00199329|Autonomic Agents|autonomic agents|mesh-ancestor
101444127|NCT00199329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101444128|NCT00199329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444129|NCT00199329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101444130|NCT00199329|Antipruritics|antipruritics|mesh-ancestor
101308009|NCT02045017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101308010|NCT02045017|Glucocorticoids|glucocorticoids|mesh-ancestor
101308011|NCT02045017|Hormones|hormones|mesh-ancestor
101333873|NCT00017394|Antimitotic Agents|antimitotic agents|mesh-ancestor
101444131|NCT00199329|Dermatologic Agents|dermatologic agents|mesh-ancestor
101444132|NCT00199329|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101444133|NCT00199329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101444134|NCT00199329|Serotonin Agents|serotonin agents|mesh-ancestor
101444135|NCT00199329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101643184|NCT00757315|Immunologic Factors|immunologic factors|mesh-ancestor
101643256|NCT00725296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101444136|NCT00199329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444137|NCT00555607|Prednisolone|prednisolone|mesh-list
101444138|NCT00555607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101444139|NCT00555607|Glucocorticoids|glucocorticoids|mesh-ancestor
101444140|NCT00555607|Hormones|hormones|mesh-ancestor
101643331|NCT00723190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101528420|NCT01214044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101444141|NCT00555607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101444142|NCT00555607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444143|NCT00555607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101444144|NCT00555607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101444145|NCT00199368|Istradefylline|istradefylline|mesh-list
101444146|NCT00199368|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
101444147|NCT00199368|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101444148|NCT00199368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101444149|NCT00199368|Purinergic Agents|purinergic agents|mesh-ancestor
101444150|NCT00199368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101444151|NCT00199368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444153|NCT04675528|Paclitaxel|paclitaxel|mesh-list
101444154|NCT04675528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101444155|NCT04675528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101444156|NCT04675528|Tubulin Modulators|tubulin modulators|mesh-ancestor
101444157|NCT04675528|Antimitotic Agents|antimitotic agents|mesh-ancestor
101444158|NCT04675528|Mitosis Modulators|mitosis modulators|mesh-ancestor
101444159|NCT04675528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444161|NCT04675177|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
101444162|NCT04675177|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101444163|NCT00175370|Vancomycin|vancomycin|mesh-list
101444164|NCT00175370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101444165|NCT00175370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101444166|NCT00204243|Naltrexone|naltrexone|mesh-list
101444167|NCT00204243|Methadone|methadone|mesh-list
101444168|NCT00204243|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101444169|NCT00204243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101444170|NCT00204243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444171|NCT00204243|Sensory System Agents|sensory system agents|mesh-ancestor
101444172|NCT00204243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101444173|NCT00204243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101444174|NCT00204243|Narcotics|narcotics|mesh-ancestor
101444175|NCT00204243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101444176|NCT00204243|Analgesics|analgesics|mesh-ancestor
101444177|NCT00204243|Antitussive Agents|antitussive agents|mesh-ancestor
101444178|NCT00204243|Respiratory System Agents|respiratory system agents|mesh-ancestor
101444179|NCT04675372|Midazolam|midazolam|mesh-list
101444180|NCT04675372|Dexmedetomidine|dexmedetomidine|mesh-list
101444181|NCT04675372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101444182|NCT04675372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101444183|NCT04675372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444184|NCT04675372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101444185|NCT04675372|Analgesics|analgesics|mesh-ancestor
101444186|NCT04675372|Sensory System Agents|sensory system agents|mesh-ancestor
101444187|NCT04675372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101444188|NCT04675372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101643690|NCT05039944|Irinotecan|irinotecan|mesh-list
101444189|NCT04675372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101444190|NCT04675372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101444195|NCT04675372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101444196|NCT04675372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101444197|NCT04675372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101444198|NCT04675372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101444199|NCT04675372|Anesthetics, General|anesthetics, general|mesh-ancestor
101444200|NCT04675372|Anesthetics|anesthetics|mesh-ancestor
101308012|NCT02045017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101308013|NCT02045017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101643799|NCT00760981|Imatinib Mesylate|imatinib mesylate|mesh-list
101308014|NCT02045017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308015|NCT02045017|Immunologic Factors|immunologic factors|mesh-ancestor
101308016|NCT02045017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101308017|NCT02045017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101308018|NCT02045017|Growth Substances|growth substances|mesh-ancestor
101308019|NCT02045017|Growth Inhibitors|growth inhibitors|mesh-ancestor
101308020|NCT02045030|Aflibercept|aflibercept|mesh-list
101308021|NCT02045030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101308022|NCT02045030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101643876|NCT02558959|Irinotecan|irinotecan|mesh-list
101308023|NCT02045030|Growth Substances|growth substances|mesh-ancestor
101333874|NCT00017394|Mitosis Modulators|mitosis modulators|mesh-ancestor
101444202|NCT04675372|GABA Agents|gaba agents|mesh-ancestor
101444203|NCT04424602|Cyclophosphamide|cyclophosphamide|mesh-list
101444204|NCT04424602|Dimethoate|dimethoate|mesh-list
101444205|NCT04424602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101444206|NCT04424602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101444207|NCT04424602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444208|NCT04424602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101444209|NCT04424602|Cholinergic Agents|cholinergic agents|mesh-ancestor
101643933|NCT04895410|Growth Substances|growth substances|mesh-ancestor
101444210|NCT04424602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101444211|NCT04424602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444212|NCT04424602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101444213|NCT04424602|Immunologic Factors|immunologic factors|mesh-ancestor
101444214|NCT04424602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101444215|NCT04424602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101444216|NCT04424602|Alkylating Agents|alkylating agents|mesh-ancestor
101444217|NCT04424602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101644009|NCT00678379|Lidocaine|lidocaine|mesh-list
101444218|NCT00199407|Istradefylline|istradefylline|mesh-list
101444219|NCT00199407|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
101444220|NCT00199407|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101444221|NCT00199407|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101444222|NCT00199407|Purinergic Agents|purinergic agents|mesh-ancestor
101444223|NCT00199407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101444224|NCT00199407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444225|NCT00199407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444226|NCT00199446|Istradefylline|istradefylline|mesh-list
101444227|NCT00199446|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
101444228|NCT00199446|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101444229|NCT00199446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101444230|NCT00199446|Purinergic Agents|purinergic agents|mesh-ancestor
101444231|NCT00199446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101444232|NCT00199446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444233|NCT00199446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444234|NCT04306393|Nitric Oxide|nitric oxide|mesh-list
101444235|NCT04306393|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101444236|NCT04306393|Autonomic Agents|autonomic agents|mesh-ancestor
101444237|NCT04306393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101444238|NCT04306393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444239|NCT04306393|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101444240|NCT04306393|Respiratory System Agents|respiratory system agents|mesh-ancestor
101444241|NCT04306393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101444242|NCT04306393|Antioxidants|antioxidants|mesh-ancestor
101444243|NCT04306393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444244|NCT04306393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101444245|NCT04306393|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101444246|NCT04306393|Vasodilator Agents|vasodilator agents|mesh-ancestor
101444247|NCT04306393|Gasotransmitters|gasotransmitters|mesh-ancestor
101308024|NCT02045030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308025|NCT02045030|Growth Inhibitors|growth inhibitors|mesh-ancestor
101308026|NCT02045030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101444248|NCT04306393|Protective Agents|protective agents|mesh-ancestor
101444249|NCT00204321|Sirolimus|sirolimus|mesh-list
101444250|NCT00204321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101444251|NCT00204321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101444252|NCT00204321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101444253|NCT00204321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101444254|NCT00204321|Antifungal Agents|antifungal agents|mesh-ancestor
101444255|NCT00204321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101444256|NCT00204321|Immunologic Factors|immunologic factors|mesh-ancestor
101444257|NCT00204321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444258|NCT00175565|Fluticasone|fluticasone|mesh-list
101444259|NCT00175565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101444260|NCT00175565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101444276|NCT04230187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101444277|NCT04230187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101444278|NCT04230187|Growth Substances|growth substances|mesh-ancestor
101444279|NCT04230187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444280|NCT04230187|Growth Inhibitors|growth inhibitors|mesh-ancestor
101444281|NCT04230187|Antimetabolites|antimetabolites|mesh-ancestor
101444282|NCT04230187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444283|NCT04230187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101444284|NCT04230187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101444285|NCT04230187|Immunologic Factors|immunologic factors|mesh-ancestor
101444286|NCT04230187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101444287|NCT04230187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101444288|NCT04230187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101444289|NCT04230187|Antidotes|antidotes|mesh-ancestor
101444290|NCT04230187|Protective Agents|protective agents|mesh-ancestor
101444291|NCT04230187|Vitamin B Complex|vitamin b complex|mesh-ancestor
101444292|NCT04230187|Vitamins|vitamins|mesh-ancestor
101444293|NCT04230187|Micronutrients|micronutrients|mesh-ancestor
101444294|NCT00175643|Imiquimod|imiquimod|mesh-list
101444295|NCT00175643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101444296|NCT00175643|Immunologic Factors|immunologic factors|mesh-ancestor
101444297|NCT00175643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444298|NCT00175643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101444299|NCT00175643|Interferon Inducers|interferon inducers|mesh-ancestor
101444300|NCT00204438|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101444301|NCT00204438|Desogestrel|desogestrel|mesh-list
101444302|NCT00204438|Estradiol|estradiol|mesh-list
101444303|NCT00204438|Estrogens|estrogens|mesh-ancestor
101444304|NCT00204438|Hormones|hormones|mesh-ancestor
101444305|NCT00204438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101444306|NCT00204438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444307|NCT00204438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101444308|NCT00204438|Contraceptive Agents|contraceptive agents|mesh-ancestor
101444309|NCT00204438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101444310|NCT00204438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101444312|NCT00204438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101444313|NCT00204438|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101444314|NCT00204438|Progestins|progestins|mesh-ancestor
101444315|NCT00175682|Prazosin|prazosin|mesh-list
101444316|NCT00175682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101444317|NCT00175682|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101444318|NCT00175682|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101644371|NCT04080388|Diuretics|diuretics|mesh-list
101444319|NCT00175682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101444320|NCT00175682|Adrenergic Agents|adrenergic agents|mesh-ancestor
101444321|NCT00175682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101444322|NCT00175682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444350|NCT04171453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101444351|NCT04171453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101444352|NCT04111315|Dipyrone|dipyrone|mesh-list
101444353|NCT04111315|Ibuprofen|ibuprofen|mesh-list
101444354|NCT04111315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101644572|NCT05850611|Methylene Blue|methylene blue|mesh-list
101444356|NCT04111315|Analgesics|analgesics|mesh-ancestor
101444357|NCT04111315|Sensory System Agents|sensory system agents|mesh-ancestor
101308027|NCT02045056|Gemfibrozil|gemfibrozil|mesh-list
101308028|NCT02045056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101308029|NCT02045056|Antimetabolites|antimetabolites|mesh-ancestor
101444358|NCT04111315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101444359|NCT04111315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444360|NCT04111315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101444361|NCT04111315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101444362|NCT04111315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101444363|NCT04111315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101444364|NCT04111315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444365|NCT04111315|Antipyretics|antipyretics|mesh-ancestor
101444366|NCT00199563|Sildenafil Citrate|sildenafil citrate|mesh-list
101444367|NCT00199563|Vasodilator Agents|vasodilator agents|mesh-ancestor
101444368|NCT00199563|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101444371|NCT00199563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444372|NCT00199563|Urological Agents|urological agents|mesh-ancestor
101444373|NCT04679506|Cytarabine|cytarabine|mesh-list
101444374|NCT04679506|Etoposide|etoposide|mesh-list
101444375|NCT04679506|Cladribine|cladribine|mesh-list
101444376|NCT04679506|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101444377|NCT04679506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101444378|NCT04679506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101444379|NCT04679506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101444380|NCT04679506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101444381|NCT04679506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444382|NCT04679506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101444383|NCT04679506|Antimetabolites|antimetabolites|mesh-ancestor
101444384|NCT04679506|Antiviral Agents|antiviral agents|mesh-ancestor
101444385|NCT04679506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101444386|NCT04679506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101444387|NCT04679506|Immunologic Factors|immunologic factors|mesh-ancestor
101444388|NCT04679506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444389|NCT02962830|Sufentanil|sufentanil|mesh-list
101444390|NCT02962830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101444391|NCT02962830|Narcotics|narcotics|mesh-ancestor
101363392|NCT00132379|Tubulin Modulators|tubulin modulators|mesh-ancestor
101444392|NCT02962830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101444393|NCT02962830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444394|NCT02962830|Analgesics|analgesics|mesh-ancestor
101444395|NCT02962830|Sensory System Agents|sensory system agents|mesh-ancestor
101444396|NCT02962830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101444397|NCT02962830|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101444398|NCT02962830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101444399|NCT02962830|Anesthetics, General|anesthetics, general|mesh-ancestor
101444400|NCT02962830|Anesthetics|anesthetics|mesh-ancestor
101444401|NCT00199602|Heparin|heparin|mesh-list
101444402|NCT00199602|Anticoagulants|anticoagulants|mesh-ancestor
101444403|NCT00199602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101444404|NCT00199602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101444405|NCT00199602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444406|NCT00554125|Sirolimus|sirolimus|mesh-list
101444407|NCT00554125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101444408|NCT00554125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101644937|NCT04809220|Biguanides|biguanides|mesh-list
101444410|NCT00554125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101444411|NCT00554125|Antifungal Agents|antifungal agents|mesh-ancestor
101444412|NCT00554125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101444413|NCT00554125|Immunologic Factors|immunologic factors|mesh-ancestor
101444414|NCT00554125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444415|NCT00175838|Aspirin|aspirin|mesh-list
101444416|NCT00175838|Hydroxyurea|hydroxyurea|mesh-list
101444417|NCT00175838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101444418|NCT00175838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101444419|NCT00175838|Analgesics|analgesics|mesh-ancestor
101444420|NCT00175838|Sensory System Agents|sensory system agents|mesh-ancestor
101444421|NCT00175838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101444422|NCT00175838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444423|NCT00175838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101444424|NCT00175838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101444425|NCT00175838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101444426|NCT00175838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101444427|NCT00175838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444428|NCT00175838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101308030|NCT02045056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444429|NCT00175838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101444430|NCT00175838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101444432|NCT00175838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101444433|NCT00175838|Antisickling Agents|antisickling agents|mesh-ancestor
101444434|NCT00175838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101444435|NCT00204555|Imiquimod|imiquimod|mesh-list
101444436|NCT00204555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101444438|NCT00204555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444439|NCT00204555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101444440|NCT00204555|Interferon Inducers|interferon inducers|mesh-ancestor
101444442|NCT00175955|Anticonvulsants|anticonvulsants|mesh-ancestor
101444461|NCT03430882|Tubulin Modulators|tubulin modulators|mesh-ancestor
101444462|NCT03430882|Antimitotic Agents|antimitotic agents|mesh-ancestor
101444463|NCT03430882|Mitosis Modulators|mitosis modulators|mesh-ancestor
101444464|NCT03430882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444465|NCT00199758|Gemcitabine|gemcitabine|mesh-list
101444466|NCT00199758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101444467|NCT00199758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101444468|NCT00199758|Antimetabolites|antimetabolites|mesh-ancestor
101444469|NCT00199758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444470|NCT03291886|Exemestane|exemestane|mesh-list
101444472|NCT03291886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101444473|NCT03291886|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101444474|NCT03291886|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101444475|NCT03291886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101444476|NCT03291886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444477|NCT03291886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101444479|NCT03291886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101444480|NCT03291886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444481|NCT03291886|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101444482|NCT03252808|Paclitaxel|paclitaxel|mesh-list
101444483|NCT03252808|Gemcitabine|gemcitabine|mesh-list
101444484|NCT03252808|Tegafur|tegafur|mesh-list
101444485|NCT03252808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101363397|NCT00132379|Immunologic Factors|immunologic factors|mesh-ancestor
101444486|NCT03252808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101444487|NCT03252808|Tubulin Modulators|tubulin modulators|mesh-ancestor
101444488|NCT03252808|Antimitotic Agents|antimitotic agents|mesh-ancestor
101444489|NCT03252808|Mitosis Modulators|mitosis modulators|mesh-ancestor
101444490|NCT03252808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444491|NCT03252808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101444494|NCT03191461|Analgesics|analgesics|mesh-ancestor
101444495|NCT03191461|Sensory System Agents|sensory system agents|mesh-ancestor
101444496|NCT03191461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101444497|NCT03191461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444498|NCT03191461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101444499|NCT03191461|Vasodilator Agents|vasodilator agents|mesh-ancestor
101444500|NCT03191461|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101444506|NCT00199953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101444507|NCT00199953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101444508|NCT00199953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101645438|NCT02630641|Hormones|hormones|mesh-list
101444509|NCT00199953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101444510|NCT00199953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444511|NCT03184090|Palbociclib|palbociclib|mesh-list
101444512|NCT03184090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101444513|NCT03184090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101444514|NCT03184090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101444515|NCT03184090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444516|NCT03160846|Milrinone|milrinone|mesh-list
101444517|NCT03160846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101444518|NCT03160846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101444519|NCT03160846|Vasodilator Agents|vasodilator agents|mesh-ancestor
101444520|NCT03160846|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101444521|NCT03160846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101444522|NCT03160846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101308031|NCT02045056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101444523|NCT03160846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444524|NCT03160846|Protective Agents|protective agents|mesh-ancestor
101444525|NCT03160846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444526|NCT00204789|Eflornithine|eflornithine|mesh-list
101444527|NCT00204789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101444528|NCT00204789|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101444529|NCT00204789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101645561|NCT00572169|Hormones|hormones|mesh-ancestor
101444530|NCT00204789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101444531|NCT00204789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101444532|NCT00204789|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
101444533|NCT00204789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101444534|NCT00204789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444535|NCT00176540|Dextromethorphan|dextromethorphan|mesh-list
101444536|NCT00176540|Antitussive Agents|antitussive agents|mesh-ancestor
101444537|NCT00176540|Respiratory System Agents|respiratory system agents|mesh-ancestor
101444538|NCT00176540|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101444539|NCT00176540|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101444540|NCT00176540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101444541|NCT00176540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101645690|NCT02584816|Vaccines|vaccines|mesh-list
101444584|NCT00176618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101444585|NCT00176618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444586|NCT00176618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101444587|NCT02675959|Defibrotide|defibrotide|mesh-list
101444588|NCT02675959|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101444589|NCT02675959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101444590|NCT02675959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444591|NCT02675959|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101444592|NCT00410787|Hydromorphone|hydromorphone|mesh-list
101444593|NCT00410787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101444594|NCT00410787|Narcotics|narcotics|mesh-ancestor
101444595|NCT00410787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101444596|NCT00410787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444597|NCT00410787|Analgesics|analgesics|mesh-ancestor
101444598|NCT00410787|Sensory System Agents|sensory system agents|mesh-ancestor
101444599|NCT00410787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101444601|NCT00554164|Cyclophosphamide|cyclophosphamide|mesh-list
101444602|NCT00554164|Doxorubicin|doxorubicin|mesh-list
101444603|NCT00554164|Vincristine|vincristine|mesh-list
101444604|NCT00554164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101308032|NCT02045056|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101308033|NCT02045056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101444605|NCT00554164|Immunologic Factors|immunologic factors|mesh-ancestor
101444606|NCT00554164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444607|NCT00554164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101444608|NCT00554164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101444609|NCT00554164|Alkylating Agents|alkylating agents|mesh-ancestor
101646155|NCT00605774|Autonomic Agents|autonomic agents|mesh-ancestor
101444610|NCT00554164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444611|NCT00554164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101444612|NCT00554164|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101444613|NCT00554164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101444614|NCT00554164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101646231|NCT00775879|Sevoflurane|sevoflurane|mesh-list
101444615|NCT00554164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101444616|NCT00554164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101444617|NCT00554164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101444618|NCT00554164|Glucocorticoids|glucocorticoids|mesh-ancestor
101444619|NCT00554164|Hormones|hormones|mesh-ancestor
101444620|NCT00554164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101444621|NCT00554164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101444622|NCT00554164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101444623|NCT00554164|Tubulin Modulators|tubulin modulators|mesh-ancestor
101444624|NCT00554164|Antimitotic Agents|antimitotic agents|mesh-ancestor
101444625|NCT00554164|Mitosis Modulators|mitosis modulators|mesh-ancestor
101444626|NCT02572141|Leucovorin|leucovorin|mesh-list
101444627|NCT02572141|Fluorouracil|fluorouracil|mesh-list
101444628|NCT02572141|Capecitabine|capecitabine|mesh-list
101444629|NCT02572141|Oxaliplatin|oxaliplatin|mesh-list
101444631|NCT02572141|Antimetabolites|antimetabolites|mesh-ancestor
101444636|NCT02572141|Immunologic Factors|immunologic factors|mesh-ancestor
101444637|NCT02572141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444638|NCT02572141|Antidotes|antidotes|mesh-ancestor
101444639|NCT02572141|Protective Agents|protective agents|mesh-ancestor
101444640|NCT02572141|Vitamin B Complex|vitamin b complex|mesh-ancestor
101444641|NCT02572141|Vitamins|vitamins|mesh-ancestor
101444642|NCT02572141|Micronutrients|micronutrients|mesh-ancestor
101444643|NCT02470039|Insulin|insulin|mesh-list
101444644|NCT02470039|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101444645|NCT02470039|Insulin Glargine|insulin glargine|mesh-list
101444646|NCT02470039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101444647|NCT02470039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444648|NCT00554203|Sulfasalazine|sulfasalazine|mesh-list
101444649|NCT00554203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101444650|NCT00554203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101444651|NCT00554203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101444652|NCT00554203|Analgesics|analgesics|mesh-ancestor
101444653|NCT00554203|Sensory System Agents|sensory system agents|mesh-ancestor
101444654|NCT00554203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101444655|NCT00554203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444656|NCT00554203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101444657|NCT00554203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101444658|NCT00554203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101444659|NCT00554242|Ascorbic Acid|ascorbic acid|mesh-list
101444660|NCT00554242|Grape Seed Extract|grape seed extract|mesh-list
101444661|NCT00554242|Antioxidants|antioxidants|mesh-ancestor
101444662|NCT00554242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444663|NCT00554242|Protective Agents|protective agents|mesh-ancestor
101444664|NCT00554242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444666|NCT00554242|Micronutrients|micronutrients|mesh-ancestor
101444667|NCT00554242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101444668|NCT00554242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101444669|NCT00176735|Capecitabine|capecitabine|mesh-list
101444670|NCT00176735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101444671|NCT00176735|Antimetabolites|antimetabolites|mesh-ancestor
101444672|NCT00176735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444673|NCT00176735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101444674|NCT00410943|Hydromorphone|hydromorphone|mesh-list
101444675|NCT00410943|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101444676|NCT00410943|Narcotics|narcotics|mesh-ancestor
101444677|NCT00410943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101444678|NCT00410943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444679|NCT00410943|Analgesics|analgesics|mesh-ancestor
101444680|NCT00410943|Sensory System Agents|sensory system agents|mesh-ancestor
101308034|NCT02045056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101308036|NCT02045069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101308037|NCT02045069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101308038|NCT02045290|Metformin|metformin|mesh-list
101444681|NCT00410943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101444682|NCT00176774|Leucovorin|leucovorin|mesh-list
101444683|NCT00176774|Fluorouracil|fluorouracil|mesh-list
101444684|NCT00176774|Irinotecan|irinotecan|mesh-list
101444685|NCT00176774|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
101444686|NCT00176774|Antimetabolites|antimetabolites|mesh-ancestor
101444687|NCT00176774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444688|NCT00176774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101444689|NCT00176774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101444690|NCT00176774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101444691|NCT00176774|Immunologic Factors|immunologic factors|mesh-ancestor
101444692|NCT00176774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444693|NCT00176774|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101444695|NCT00176774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101444696|NCT00176774|Antidotes|antidotes|mesh-ancestor
101444697|NCT00176774|Protective Agents|protective agents|mesh-ancestor
101444698|NCT00176774|Vitamin B Complex|vitamin b complex|mesh-ancestor
101444699|NCT00176774|Vitamins|vitamins|mesh-ancestor
101444700|NCT00176774|Micronutrients|micronutrients|mesh-ancestor
101444701|NCT00176774|Chelating Agents|chelating agents|mesh-ancestor
101444702|NCT00176774|Sequestering Agents|sequestering agents|mesh-ancestor
101444703|NCT00176774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101444704|NCT00176774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101444710|NCT02421679|Cyclobenzaprine|cyclobenzaprine|mesh-list
101444711|NCT02421679|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101444712|NCT02421679|Antidepressive Agents|antidepressive agents|mesh-ancestor
101444713|NCT02421679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101444714|NCT02421679|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101444715|NCT02421679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444716|NCT02421679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101444717|NCT02421679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101444718|NCT02421679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101444719|NCT02421679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101444720|NCT00410982|Rituximab|rituximab|mesh-list
101444721|NCT00410982|Gemcitabine|gemcitabine|mesh-list
101444722|NCT00410982|Melphalan|melphalan|mesh-list
101444723|NCT00410982|Busulfan|busulfan|mesh-list
101444724|NCT00410982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101444725|NCT00410982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101444726|NCT00410982|Immunologic Factors|immunologic factors|mesh-ancestor
101444727|NCT00410982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444728|NCT00410982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101444729|NCT00410982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101444730|NCT00410982|Antimetabolites|antimetabolites|mesh-ancestor
101647093|NCT00780169|Sorafenib|sorafenib|mesh-list
101444731|NCT00410982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444733|NCT00410982|Alkylating Agents|alkylating agents|mesh-ancestor
101444734|NCT00410982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101444735|NCT00410982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101444736|NCT02372578|Pregabalin|pregabalin|mesh-list
101444737|NCT02372578|Analgesics|analgesics|mesh-ancestor
101444738|NCT02372578|Sensory System Agents|sensory system agents|mesh-ancestor
101444739|NCT02372578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101444740|NCT02372578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444741|NCT02372578|Anticonvulsants|anticonvulsants|mesh-ancestor
101444742|NCT02372578|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101444743|NCT02372578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101444744|NCT02372578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444747|NCT02372578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101444748|NCT02372578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101444749|NCT02372578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101444750|NCT00554398|Raltegravir Potassium|raltegravir potassium|mesh-list
101444751|NCT00554398|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101444752|NCT00554398|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101444753|NCT00554398|Antiviral Agents|antiviral agents|mesh-ancestor
101308039|NCT02045290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101308040|NCT02045290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308041|NCT02045368|Methotrexate|methotrexate|mesh-list
101444754|NCT00554398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101444755|NCT00554398|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101444756|NCT00554398|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101444757|NCT00554398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101444758|NCT00554398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444759|NCT00554476|Triamcinolone|triamcinolone|mesh-list
101444760|NCT00554476|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101647286|NCT00780637|Bradykinin|bradykinin|mesh-list
101444761|NCT00554476|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101444762|NCT00554476|Indomethacin|indomethacin|mesh-list
101444763|NCT00554476|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101444764|NCT00554476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101444765|NCT00554476|Glucocorticoids|glucocorticoids|mesh-ancestor
101444766|NCT00554476|Hormones|hormones|mesh-ancestor
101444767|NCT00554476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101444768|NCT00554476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444770|NCT00554476|Immunologic Factors|immunologic factors|mesh-ancestor
101444771|NCT00554476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101444772|NCT00554476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444773|NCT00554476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101444774|NCT00554476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101444775|NCT00554476|Analgesics|analgesics|mesh-ancestor
101444776|NCT00554476|Sensory System Agents|sensory system agents|mesh-ancestor
101444777|NCT00554476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101444778|NCT00554476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101444779|NCT00554476|Gout Suppressants|gout suppressants|mesh-ancestor
101444780|NCT00554476|Tocolytic Agents|tocolytic agents|mesh-ancestor
101444781|NCT00554476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101444782|NCT00554476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101444783|NCT02336698|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101444784|NCT02336698|Immunologic Factors|immunologic factors|mesh-ancestor
101444785|NCT02336698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444786|NCT00204906|Vitamin D|vitamin d|mesh-list
101444787|NCT00204906|Vitamins|vitamins|mesh-ancestor
101444788|NCT00204906|Micronutrients|micronutrients|mesh-ancestor
101444789|NCT00204906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647492|NCT00791011|Bortezomib|bortezomib|mesh-list
101444790|NCT00204906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101647562|NCT00663741|Sorafenib|sorafenib|mesh-list
101444792|NCT02335918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101444793|NCT02335918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101444794|NCT02335918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101444795|NCT02335918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444796|NCT00176813|Celecoxib|celecoxib|mesh-list
101444797|NCT00176813|Gemcitabine|gemcitabine|mesh-list
101444798|NCT00176813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101444799|NCT00176813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101444800|NCT00176813|Antimetabolites|antimetabolites|mesh-ancestor
101444801|NCT00176813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444802|NCT00176813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101444803|NCT00176813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101444804|NCT00176813|Analgesics|analgesics|mesh-ancestor
101444805|NCT00176813|Sensory System Agents|sensory system agents|mesh-ancestor
101444806|NCT00176813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101444807|NCT00176813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444808|NCT00176813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101444809|NCT00176813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101444810|NCT00176813|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101444811|NCT00176813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101444812|NCT00176813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101444813|NCT04678531|Tea Tree Oil|tea tree oil|mesh-list
101647628|NCT02631135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101444814|NCT04678531|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101444815|NCT04678531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101444816|NCT02320708|Acetaminophen|acetaminophen|mesh-list
101444817|NCT02320708|Ibuprofen|ibuprofen|mesh-list
101444818|NCT02320708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101444819|NCT02320708|Analgesics|analgesics|mesh-ancestor
101444820|NCT02320708|Sensory System Agents|sensory system agents|mesh-ancestor
101308042|NCT02045368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101444821|NCT02320708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101444822|NCT02320708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444823|NCT02320708|Antipyretics|antipyretics|mesh-ancestor
101444824|NCT02320708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101444825|NCT02320708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101444826|NCT02320708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101444827|NCT02320708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101444828|NCT02320708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101444829|NCT02320708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444830|NCT02309671|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101444832|NCT02309671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101444833|NCT02309671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444834|NCT02296645|Ethanol|ethanol|mesh-list
101444835|NCT02296645|Chlorhexidine|chlorhexidine|mesh-list
101444836|NCT02296645|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101444837|NCT02296645|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101444838|NCT02296645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101444839|NCT02296645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101444840|NCT02296645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444841|NCT02296645|Disinfectants|disinfectants|mesh-ancestor
101444842|NCT02296645|Dermatologic Agents|dermatologic agents|mesh-ancestor
101444843|NCT02295865|Toreforant|toreforant|mesh-list
101444844|NCT02295865|Histamine Antagonists|histamine antagonists|mesh-ancestor
101444845|NCT02295865|Histamine Agents|histamine agents|mesh-ancestor
101444846|NCT02295865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101444847|NCT02295865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444848|NCT02295865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444850|NCT02282215|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101444852|NCT02282215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444853|NCT00176969|Capsaicin|capsaicin|mesh-list
101444854|NCT00176969|Antipruritics|antipruritics|mesh-ancestor
101444855|NCT00176969|Dermatologic Agents|dermatologic agents|mesh-ancestor
101444856|NCT00176969|Sensory System Agents|sensory system agents|mesh-ancestor
101444857|NCT00176969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101444858|NCT00176969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444859|NCT00204945|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101444860|NCT00204945|Natriuretic Agents|natriuretic agents|mesh-ancestor
101444861|NCT00204945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444862|NCT00177008|Aripiprazole|aripiprazole|mesh-list
101444863|NCT00177008|Antidepressive Agents|antidepressive agents|mesh-ancestor
101444864|NCT00177008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101444865|NCT00177008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101444866|NCT00177008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101444867|NCT00177008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101444868|NCT00177008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444869|NCT00177008|Dopamine Agonists|dopamine agonists|mesh-ancestor
101444870|NCT00177008|Dopamine Agents|dopamine agents|mesh-ancestor
101444871|NCT00177008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101444872|NCT00177008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444873|NCT00177008|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101444874|NCT00177008|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101444875|NCT00177008|Serotonin Agents|serotonin agents|mesh-ancestor
101444876|NCT00177008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101444877|NCT00177008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101444878|NCT00177008|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101444879|NCT00177008|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101444880|NCT04677985|Analgesics|analgesics|mesh-list
101444881|NCT04677985|Menthol|menthol|mesh-list
101444882|NCT04677985|Sensory System Agents|sensory system agents|mesh-ancestor
101444883|NCT04677985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101444884|NCT04677985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444885|NCT04677985|Antipruritics|antipruritics|mesh-ancestor
101444886|NCT04677985|Dermatologic Agents|dermatologic agents|mesh-ancestor
101444887|NCT00554632|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101444888|NCT00554632|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101444889|NCT00554632|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101444890|NCT00554632|Norgestimate|norgestimate|mesh-list
101444891|NCT00554632|Norelgestromin|norelgestromin|mesh-list
101444892|NCT00554632|Ortho Evra|ortho evra|mesh-list
101444893|NCT00554632|Estradiol|estradiol|mesh-list
101308043|NCT02045368|Abortifacient Agents|abortifacient agents|mesh-ancestor
101308044|NCT02045368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101308045|NCT02045368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308046|NCT02045368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101444894|NCT00554632|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101444895|NCT00554632|Estrogens|estrogens|mesh-ancestor
101444896|NCT00554632|Hormones|hormones|mesh-ancestor
101444897|NCT00554632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101444898|NCT00554632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444899|NCT00554632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101444900|NCT00554632|Contraceptive Agents|contraceptive agents|mesh-ancestor
101444901|NCT00554632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101444902|NCT00554632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101444903|NCT00554632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101444904|NCT00554632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101444905|NCT00554632|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101444907|NCT00204984|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101444908|NCT00204984|Natriuretic Agents|natriuretic agents|mesh-ancestor
101444909|NCT00204984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444910|NCT00204984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101444911|NCT00204984|Vasodilator Agents|vasodilator agents|mesh-ancestor
101444912|NCT02236195|Mocetinostat|mocetinostat|mesh-list
101444913|NCT02236195|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101444914|NCT02236195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101647953|NCT04152759|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101444915|NCT02236195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444916|NCT02236156|Metronidazole|metronidazole|mesh-list
101444917|NCT02236156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101444918|NCT02236156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101444919|NCT02236156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101444920|NCT02236156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101444921|NCT00177086|Alfuzosin|alfuzosin|mesh-list
101444922|NCT00177086|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101444927|NCT00177086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444929|NCT00177086|Urological Agents|urological agents|mesh-ancestor
101444931|NCT02207257|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101444932|NCT02207257|Antithrombins|antithrombins|mesh-ancestor
101444933|NCT02207257|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101444934|NCT02207257|Protease Inhibitors|protease inhibitors|mesh-ancestor
101444935|NCT02207257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101444936|NCT02207257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444937|NCT02207257|Anticoagulants|anticoagulants|mesh-ancestor
101444938|NCT00554710|Methylprednisolone|methylprednisolone|mesh-list
101444939|NCT00554710|Budesonide|budesonide|mesh-list
101444940|NCT00554710|Infliximab|infliximab|mesh-list
101444941|NCT00554710|Azathioprine|azathioprine|mesh-list
101444942|NCT00554710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101444943|NCT00554710|Antiemetics|antiemetics|mesh-ancestor
101444944|NCT00554710|Autonomic Agents|autonomic agents|mesh-ancestor
101444945|NCT00554710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101444946|NCT00554710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444947|NCT00554710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101444948|NCT00554710|Glucocorticoids|glucocorticoids|mesh-ancestor
101444949|NCT00554710|Hormones|hormones|mesh-ancestor
101444950|NCT00554710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101444951|NCT00554710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101444952|NCT00554710|Protective Agents|protective agents|mesh-ancestor
101444953|NCT00554710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101444954|NCT00554710|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101648076|NCT00787657|Interferons|interferons|mesh-list
101444955|NCT00554710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101444956|NCT00554710|Respiratory System Agents|respiratory system agents|mesh-ancestor
101444957|NCT00554710|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101444958|NCT00554710|Dermatologic Agents|dermatologic agents|mesh-ancestor
101444959|NCT00554710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101444960|NCT00554710|Antimetabolites|antimetabolites|mesh-ancestor
101444961|NCT00554710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444962|NCT00554710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101444963|NCT00554710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101444964|NCT00554710|Immunologic Factors|immunologic factors|mesh-ancestor
101308047|NCT02045368|Antimetabolites|antimetabolites|mesh-ancestor
101308048|NCT02045368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308050|NCT02045368|Dermatologic Agents|dermatologic agents|mesh-ancestor
101444965|NCT00200187|Anesthetics|anesthetics|mesh-list
101444966|NCT00200187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101333463|NCT00039091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101444967|NCT00200187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444968|NCT04659109|Glenzocimab|glenzocimab|mesh-list
101444969|NCT04659109|Anticoagulants|anticoagulants|mesh-ancestor
101444970|NCT00177242|Gefitinib|gefitinib|mesh-list
101444971|NCT00177242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101444972|NCT00177242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101444973|NCT00177242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101444974|NCT00177242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444975|NCT04659070|Telmisartan|telmisartan|mesh-list
101444976|NCT04659070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101444977|NCT04659070|Ezetimibe|ezetimibe|mesh-list
101444978|NCT04659070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101444979|NCT04659070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101444980|NCT04659070|Antimetabolites|antimetabolites|mesh-ancestor
101444981|NCT04659070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444982|NCT04659070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101444983|NCT04659070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101444984|NCT04659070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101444985|NCT04659070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101444986|NCT04659070|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101444987|NCT04659070|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101444988|NCT00177281|Belotecan|belotecan|mesh-list
101444989|NCT00177281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101444990|NCT00177281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101444991|NCT00177281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101444992|NCT00177281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444997|NCT00200226|Misoprostol|misoprostol|mesh-list
101444998|NCT00200226|Vitamins|vitamins|mesh-ancestor
101444999|NCT00200226|Micronutrients|micronutrients|mesh-ancestor
101445000|NCT00200226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445001|NCT00200226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101445002|NCT00200226|Abortifacient Agents|abortifacient agents|mesh-ancestor
101445003|NCT00200226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101445004|NCT00200226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101445005|NCT00200226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101445006|NCT00200226|Oxytocics|oxytocics|mesh-ancestor
101445007|NCT00200226|Vitamin B Complex|vitamin b complex|mesh-ancestor
101445008|NCT04658329|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101445009|NCT04658329|Antiviral Agents|antiviral agents|mesh-ancestor
101445010|NCT04658329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101445011|NCT00557557|Oxaliplatin|oxaliplatin|mesh-list
101445012|NCT00557557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101445013|NCT04658134|Glycine|glycine|mesh-list
101445014|NCT04658134|Glycine Agents|glycine agents|mesh-ancestor
101445015|NCT04658134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101445016|NCT04658134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445017|NCT04658134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445018|NCT00200382|Bortezomib|bortezomib|mesh-list
101445019|NCT00200382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101445020|NCT04657744|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101445021|NCT04657744|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101445022|NCT04657744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445023|NCT04657744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101445024|NCT04657744|Immunologic Factors|immunologic factors|mesh-ancestor
101445025|NCT04657744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445026|NCT00177398|Insulin|insulin|mesh-list
101445027|NCT00177398|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101445028|NCT00177398|Insulin Glargine|insulin glargine|mesh-list
101445029|NCT00177398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101445030|NCT00177398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445031|NCT00200421|Atenolol|atenolol|mesh-list
101445032|NCT00200421|Nebivolol|nebivolol|mesh-list
101445033|NCT00200421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101445034|NCT00200421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101308051|NCT02045368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101308052|NCT02045368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101308053|NCT02045368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101308054|NCT02045368|Immunologic Factors|immunologic factors|mesh-ancestor
101308055|NCT02045368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101445035|NCT00200421|Sympatholytics|sympatholytics|mesh-ancestor
101445036|NCT00200421|Autonomic Agents|autonomic agents|mesh-ancestor
101445037|NCT00200421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101445038|NCT00200421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445039|NCT00200421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101363412|NCT00132535|Pyrimethamine|pyrimethamine|mesh-list
101445040|NCT00200421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101445041|NCT00200421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101445042|NCT00200421|Adrenergic Agents|adrenergic agents|mesh-ancestor
101445043|NCT00200421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101445044|NCT00200421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445045|NCT00200421|Vasodilator Agents|vasodilator agents|mesh-ancestor
101528421|NCT01214044|Parasympatholytics|parasympatholytics|mesh-ancestor
101445046|NCT00200421|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101445047|NCT00200421|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101445048|NCT00200421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101445049|NCT04656106|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101445050|NCT04656106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101648799|NCT00801151|Vinorelbine|vinorelbine|mesh-list
101445051|NCT04656106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445052|NCT04656262|Cyclophosphamide|cyclophosphamide|mesh-list
101445053|NCT04656262|Doxorubicin|doxorubicin|mesh-list
101445054|NCT04656262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101648865|NCT00929240|Bevacizumab|bevacizumab|mesh-list
101445055|NCT04656262|Immunologic Factors|immunologic factors|mesh-ancestor
101445056|NCT04656262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445057|NCT04656262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101445058|NCT04656262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101445059|NCT04656262|Alkylating Agents|alkylating agents|mesh-ancestor
101648939|NCT00677001|R 306465|r 306465|mesh-list
101445060|NCT04656262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445061|NCT04656262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101445062|NCT04656262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101445063|NCT04656262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101445064|NCT04656262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101445076|NCT00200460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445078|NCT00200499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101445079|NCT00200499|Vasodilator Agents|vasodilator agents|mesh-ancestor
101445080|NCT00200499|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101445081|NCT00200499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101445082|NCT00200499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101445083|NCT00200499|Adrenergic Agents|adrenergic agents|mesh-ancestor
101445084|NCT00200499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101445085|NCT00200499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445086|NCT00200499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445087|NCT00200538|Memantine|memantine|mesh-list
101445088|NCT00200538|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101445089|NCT00200538|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101445090|NCT00200538|Dopamine Agents|dopamine agents|mesh-ancestor
101445091|NCT00200538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101445092|NCT00200538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445093|NCT00200538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445094|NCT00200538|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101445095|NCT00200538|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101445096|NCT00177710|Amphotericin B|amphotericin b|mesh-list
101445097|NCT00177710|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101445098|NCT00177710|Amebicides|amebicides|mesh-ancestor
101445099|NCT00177710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101445100|NCT00177710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101445101|NCT00177710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101445102|NCT00177710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101445103|NCT00177710|Antifungal Agents|antifungal agents|mesh-ancestor
101445105|NCT00177749|Antifungal Agents|antifungal agents|mesh-ancestor
101445106|NCT00177749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101445107|NCT00177749|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101649358|NCT00797017|Anesthetics|anesthetics|mesh-ancestor
101445108|NCT00177749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101308056|NCT02045368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101308058|NCT02045589|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101445109|NCT00177749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101649492|NCT02866955|Tamoxifen|tamoxifen|mesh-list
101445110|NCT00177749|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101445111|NCT00177749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101445112|NCT00177749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101445113|NCT00177749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445114|NCT00177749|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101445115|NCT00177749|Hormone Antagonists|hormone antagonists|mesh-ancestor
101649564|NCT00688857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101445116|NCT00177749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101445117|NCT00177749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445118|NCT00205491|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101445119|NCT00205491|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101445120|NCT00205491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101445121|NCT00205491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101445122|NCT00205491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445123|NCT00205491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101445124|NCT00205491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445125|NCT00205491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101445133|NCT04654741|Ganirelix|ganirelix|mesh-list
101445134|NCT04654741|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101445135|NCT04654741|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101445136|NCT04654741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101445137|NCT04654741|Contraceptive Agents|contraceptive agents|mesh-ancestor
101445138|NCT04654741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101445139|NCT04654741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445140|NCT04654741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101445141|NCT04654741|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101445142|NCT04654741|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101445143|NCT04654741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101445144|NCT04654741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101445145|NCT04654741|Hormone Antagonists|hormone antagonists|mesh-ancestor
101445146|NCT04654741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101445147|NCT04654195|Cyclophosphamide|cyclophosphamide|mesh-list
101445148|NCT04654195|Doxorubicin|doxorubicin|mesh-list
101445149|NCT04654195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101445150|NCT04654195|Immunologic Factors|immunologic factors|mesh-ancestor
101445151|NCT04654195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445152|NCT04654195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101445153|NCT04654195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101445154|NCT04654195|Alkylating Agents|alkylating agents|mesh-ancestor
101445155|NCT04654195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445156|NCT04654195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101445158|NCT04654195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101445159|NCT04654195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101445160|NCT04654195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101445161|NCT04654195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101445163|NCT00200616|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101445164|NCT03454789|Lidocaine|lidocaine|mesh-list
101445165|NCT03454789|Anesthetics, Local|anesthetics, local|mesh-ancestor
101445166|NCT03454789|Anesthetics|anesthetics|mesh-ancestor
101445167|NCT03454789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101445168|NCT03454789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445169|NCT03454789|Sensory System Agents|sensory system agents|mesh-ancestor
101445170|NCT03454789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101445171|NCT03454789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101445172|NCT03454789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101445173|NCT03454789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101445174|NCT03454789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101445175|NCT03454789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445176|NCT00200655|Pravastatin|pravastatin|mesh-list
101445177|NCT00200655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101445178|NCT00200655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101445179|NCT00200655|Antimetabolites|antimetabolites|mesh-ancestor
101649956|NCT05832034|Antibodies|antibodies|mesh-list
101308059|NCT02045589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101308060|NCT02045589|Antimetabolites|antimetabolites|mesh-ancestor
101650022|NCT05807399|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101308061|NCT02045589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308062|NCT02045589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101445180|NCT00200655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445181|NCT00200655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101445182|NCT00200655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101445183|NCT00200655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101445184|NCT04653493|Cyclophosphamide|cyclophosphamide|mesh-list
101445185|NCT04653493|Fludarabine|fludarabine|mesh-list
101445186|NCT04653493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101445187|NCT04653493|Immunologic Factors|immunologic factors|mesh-ancestor
101445188|NCT04653493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445189|NCT04653493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101445190|NCT04653493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101445191|NCT04653493|Alkylating Agents|alkylating agents|mesh-ancestor
101445200|NCT00200694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101445201|NCT00200694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445203|NCT00200694|Natriuretic Agents|natriuretic agents|mesh-ancestor
101445204|NCT00200694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445205|NCT00200694|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101445206|NCT00200694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101445207|NCT00200694|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101445208|NCT00200694|Protease Inhibitors|protease inhibitors|mesh-ancestor
101445209|NCT00200694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101445210|NCT00557713|Bevacizumab|bevacizumab|mesh-list
101445211|NCT00557713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101445212|NCT00557713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101445213|NCT00557713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101445214|NCT00557713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101445215|NCT00557713|Growth Substances|growth substances|mesh-ancestor
101445216|NCT00557713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445217|NCT00557713|Growth Inhibitors|growth inhibitors|mesh-ancestor
101445219|NCT00178100|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101445220|NCT00178100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101445221|NCT00178100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101445222|NCT00178100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445223|NCT00178100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101445224|NCT00178100|Serotonin Agents|serotonin agents|mesh-ancestor
101445225|NCT00178100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445226|NCT00178100|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101445227|NCT00178100|Antidepressive Agents|antidepressive agents|mesh-ancestor
101445228|NCT00178100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101445229|NCT00178100|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101445230|NCT00178100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101445231|NCT00178100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101445232|NCT04653415|Methylprednisolone|methylprednisolone|mesh-list
101445233|NCT04653415|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101650146|NCT05594615|Midazolam|midazolam|mesh-list
101445234|NCT04653415|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101445235|NCT04653415|Prednisolone|prednisolone|mesh-list
101445236|NCT04653415|Prednisolone acetate|prednisolone acetate|mesh-list
101445237|NCT04653415|Gabapentin|gabapentin|mesh-list
101445238|NCT04653415|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101445239|NCT04653415|Prednisolone phosphate|prednisolone phosphate|mesh-list
101445240|NCT04653415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101445241|NCT04653415|Antiemetics|antiemetics|mesh-ancestor
101445242|NCT04653415|Autonomic Agents|autonomic agents|mesh-ancestor
101445243|NCT04653415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101445244|NCT04653415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445245|NCT04653415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101445246|NCT04653415|Glucocorticoids|glucocorticoids|mesh-ancestor
101445248|NCT04653415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101445249|NCT04653415|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101445250|NCT04653415|Protective Agents|protective agents|mesh-ancestor
101308063|NCT02045602|Gemcitabine|gemcitabine|mesh-list
101308064|NCT02045602|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101308065|NCT02045602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101308066|NCT02045602|Antimetabolites|antimetabolites|mesh-ancestor
101445251|NCT04653415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101445252|NCT04653415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101445253|NCT04653415|Analgesics|analgesics|mesh-ancestor
101445254|NCT04653415|Sensory System Agents|sensory system agents|mesh-ancestor
101445255|NCT04653415|Anticonvulsants|anticonvulsants|mesh-ancestor
101445256|NCT04653415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101445266|NCT00557791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101445267|NCT00557791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101445268|NCT00557791|Growth Substances|growth substances|mesh-ancestor
101445269|NCT00557791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445270|NCT00557791|Growth Inhibitors|growth inhibitors|mesh-ancestor
101445271|NCT00557791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101445272|NCT04652284|Amoxicillin|amoxicillin|mesh-list
101445273|NCT04652284|Clarithromycin|clarithromycin|mesh-list
101445274|NCT04652284|Rifabutin|rifabutin|mesh-list
101445275|NCT04652284|Tinidazole|tinidazole|mesh-list
101445276|NCT04652284|Esomeprazole|esomeprazole|mesh-list
101445277|NCT04652284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101445278|NCT04652284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101445279|NCT04652284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101445280|NCT04652284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101445281|NCT04652284|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101445282|NCT04652284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101445283|NCT04652284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650328|NCT05174832|Tubulin Modulators|tubulin modulators|mesh-ancestor
101445284|NCT04652284|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101445285|NCT04652284|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101445286|NCT04652284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101445287|NCT04652284|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101445288|NCT04652284|Antitubercular Agents|antitubercular agents|mesh-ancestor
101445289|NCT04652284|Alkylating Agents|alkylating agents|mesh-ancestor
101445290|NCT04652284|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
101445291|NCT04652284|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101445292|NCT04652284|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101445294|NCT04652323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101445295|NCT04652323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445296|NCT04652011|Analgesics|analgesics|mesh-list
101445297|NCT04652011|Sensory System Agents|sensory system agents|mesh-ancestor
101445298|NCT04652011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101445299|NCT04652011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445300|NCT04652128|Zoledronic Acid|zoledronic acid|mesh-list
101445301|NCT04652128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101445302|NCT04652128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445303|NCT00205725|Olanzapine|olanzapine|mesh-list
101445304|NCT00205725|Ziprasidone|ziprasidone|mesh-list
101445305|NCT00205725|Antiemetics|antiemetics|mesh-ancestor
101445306|NCT00205725|Autonomic Agents|autonomic agents|mesh-ancestor
101445307|NCT00205725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101445308|NCT00205725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445309|NCT00205725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101445310|NCT00205725|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101445311|NCT00205725|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101445312|NCT00205725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101445313|NCT00205725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101445314|NCT00205725|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101445315|NCT00205725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101445316|NCT00205725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101445317|NCT00205725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445318|NCT00205725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101445319|NCT00205725|Serotonin Agents|serotonin agents|mesh-ancestor
101445320|NCT00205725|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101445324|NCT00178373|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101445325|NCT00178373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445326|NCT00178373|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101445327|NCT00178373|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101445328|NCT00178373|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101308067|NCT02045602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308068|NCT02045602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101445329|NCT00178373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445331|NCT00205764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101445332|NCT00205764|Alkylating Agents|alkylating agents|mesh-ancestor
101445333|NCT00205764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445334|NCT00205764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101650647|NCT03479502|Glucocorticoids|glucocorticoids|mesh-ancestor
101445335|NCT00205764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101445336|NCT00205764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101445337|NCT00205764|Immunologic Factors|immunologic factors|mesh-ancestor
101445338|NCT00205764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445340|NCT00558142|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101445341|NCT00558142|Antiviral Agents|antiviral agents|mesh-ancestor
101445342|NCT00558142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101445343|NCT00558142|Expectorants|expectorants|mesh-ancestor
101650778|NCT02473497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101445344|NCT00558142|Respiratory System Agents|respiratory system agents|mesh-ancestor
101445345|NCT00558142|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101445346|NCT00558142|Antioxidants|antioxidants|mesh-ancestor
101445347|NCT00558142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445348|NCT00558142|Protective Agents|protective agents|mesh-ancestor
101445349|NCT00558142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445350|NCT00558142|Antidotes|antidotes|mesh-ancestor
101445351|NCT00205842|Alvimopan|alvimopan|mesh-list
101445352|NCT00205842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101445353|NCT00178451|Abciximab|abciximab|mesh-list
101445354|NCT00178451|Anticoagulants|anticoagulants|mesh-ancestor
101445355|NCT00178451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101445356|NCT00206115|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101445357|NCT00206115|Antidepressive Agents|antidepressive agents|mesh-ancestor
101445358|NCT00206115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101650984|NCT00696033|Lorazepam|lorazepam|mesh-list
101445359|NCT00206115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101445360|NCT00206115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101445361|NCT00206115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101445362|NCT00206115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445363|NCT00206154|Budesonide|budesonide|mesh-list
101651063|NCT04001621|Capecitabine|capecitabine|mesh-list
101445364|NCT00206154|Formoterol Fumarate|formoterol fumarate|mesh-list
101445365|NCT00206154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101445366|NCT00206154|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101445367|NCT00206154|Autonomic Agents|autonomic agents|mesh-ancestor
101445368|NCT00206154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101445369|NCT00206154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445370|NCT00206154|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101445371|NCT00206154|Respiratory System Agents|respiratory system agents|mesh-ancestor
101445372|NCT00206154|Glucocorticoids|glucocorticoids|mesh-ancestor
101445373|NCT00206154|Hormones|hormones|mesh-ancestor
101445374|NCT00206154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101445375|NCT00206154|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101445376|NCT00206154|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101445377|NCT00206154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101445378|NCT00206154|Adrenergic Agents|adrenergic agents|mesh-ancestor
101445379|NCT00206154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101445380|NCT00206154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445381|NCT00559702|Natalizumab|natalizumab|mesh-list
101445382|NCT00559702|Immunologic Factors|immunologic factors|mesh-ancestor
101445383|NCT00559702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445384|NCT00559741|Leucovorin|leucovorin|mesh-list
101445385|NCT00559741|Fluorouracil|fluorouracil|mesh-list
101445386|NCT00559741|Irinotecan|irinotecan|mesh-list
101445387|NCT00559741|Cetuximab|cetuximab|mesh-list
101445388|NCT00559741|Calcium|calcium|mesh-list
101445389|NCT00559741|Levoleucovorin|levoleucovorin|mesh-list
101445390|NCT00559741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101445391|NCT00559741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445392|NCT00559741|Antimetabolites|antimetabolites|mesh-ancestor
101445393|NCT00559741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445405|NCT00559741|Micronutrients|micronutrients|mesh-ancestor
101445406|NCT00559741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101445407|NCT00178763|Interferons|interferons|mesh-list
101445408|NCT00178763|Interferon-alpha|interferon-alpha|mesh-list
101445410|NCT00178763|Gemcitabine|gemcitabine|mesh-list
101445411|NCT00178763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308070|NCT02045667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101445412|NCT00178763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101445413|NCT00178763|Antimetabolites|antimetabolites|mesh-ancestor
101445414|NCT00178763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445415|NCT00178763|Antiviral Agents|antiviral agents|mesh-ancestor
101651244|NCT02620839|Cisplatin|cisplatin|mesh-list
101445416|NCT00178763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101445417|NCT00178763|Immunologic Factors|immunologic factors|mesh-ancestor
101445418|NCT00178763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445419|NCT00559858|Pyridoxine|pyridoxine|mesh-list
101445420|NCT00559858|Vitamin B 6|vitamin b 6|mesh-list
101445421|NCT00559858|Vitamin B Complex|vitamin b complex|mesh-ancestor
101445422|NCT00559858|Vitamins|vitamins|mesh-ancestor
101445423|NCT00559858|Micronutrients|micronutrients|mesh-ancestor
101445424|NCT00559858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445425|NCT00559975|Vaccines|vaccines|mesh-list
101445426|NCT00559975|Immunologic Factors|immunologic factors|mesh-ancestor
101651318|NCT03965117|Norepinephrine|norepinephrine|mesh-list
101445427|NCT00559975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445428|NCT00206193|Misoprostol|misoprostol|mesh-list
101445429|NCT00206193|Sulprostone|sulprostone|mesh-list
101445430|NCT00206193|Mifepristone|mifepristone|mesh-list
101445431|NCT00206193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101445432|NCT00206193|Abortifacient Agents|abortifacient agents|mesh-ancestor
101445433|NCT00206193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101445434|NCT00206193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445435|NCT00206193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101445436|NCT00206193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101445437|NCT00206193|Oxytocics|oxytocics|mesh-ancestor
101445438|NCT00206193|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101445439|NCT00206193|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101445440|NCT00206193|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101445441|NCT00206193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101445442|NCT00206193|Contraceptive Agents|contraceptive agents|mesh-ancestor
101445443|NCT00206193|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101445444|NCT00206193|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101445445|NCT00206193|Hormone Antagonists|hormone antagonists|mesh-ancestor
101445446|NCT00206193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101651583|NCT02863835|Albuterol|albuterol|mesh-list
101445447|NCT00206193|Luteolytic Agents|luteolytic agents|mesh-ancestor
101445448|NCT00206193|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101445449|NCT00206193|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101445450|NCT04638439|Entecavir|entecavir|mesh-list
101445451|NCT04638439|Nivolumab|nivolumab|mesh-list
101445452|NCT04638439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101445453|NCT04638439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101445454|NCT04638439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101445455|NCT04638439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445456|NCT04638439|Antiviral Agents|antiviral agents|mesh-ancestor
101445457|NCT04638439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101445458|NCT00178802|Interferons|interferons|mesh-list
101445459|NCT00178802|Doxorubicin|doxorubicin|mesh-list
101445483|NCT00408278|Analgesics|analgesics|mesh-ancestor
101445484|NCT00408278|Sensory System Agents|sensory system agents|mesh-ancestor
101445485|NCT00408278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101445486|NCT00408278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445487|NCT00408278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101445488|NCT00408278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101445489|NCT00408278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101445490|NCT00408278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101445491|NCT00408278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445492|NCT00560092|Magnesium Sulfate|magnesium sulfate|mesh-list
101445493|NCT00560092|Analgesics|analgesics|mesh-ancestor
101445494|NCT00560092|Sensory System Agents|sensory system agents|mesh-ancestor
101445495|NCT00560092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101445496|NCT00560092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445497|NCT00560092|Anesthetics|anesthetics|mesh-ancestor
101445498|NCT00560092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101445499|NCT00560092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101445500|NCT00560092|Anticonvulsants|anticonvulsants|mesh-ancestor
101445501|NCT00560092|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101445502|NCT00560092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101445503|NCT00560092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308071|NCT02045667|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101308072|NCT02045667|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101445504|NCT00560092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101445506|NCT00560092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101445507|NCT00560170|Simvastatin|simvastatin|mesh-list
101445513|NCT00560170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445514|NCT00560170|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101445515|NCT00560170|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101445516|NCT00560170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101445517|NCT04637152|Valsartan|valsartan|mesh-list
101445518|NCT04637152|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101445519|NCT04637152|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101445520|NCT04637152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101445521|NCT04637152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101445522|NCT04637152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445523|NCT04636918|Cyclosporine|cyclosporine|mesh-list
101445524|NCT04636918|Cyclosporins|cyclosporins|mesh-list
101445525|NCT04636918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101445526|NCT04636918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445527|NCT04636918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101652132|NCT02613585|Permethrin|permethrin|mesh-list
101445528|NCT04636918|Immunologic Factors|immunologic factors|mesh-ancestor
101445529|NCT04636918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445530|NCT04636918|Antifungal Agents|antifungal agents|mesh-ancestor
101445531|NCT04636918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101445532|NCT04636918|Dermatologic Agents|dermatologic agents|mesh-ancestor
101445533|NCT04636918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101445534|NCT04636918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101445536|NCT00560209|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101445537|NCT00560209|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101445538|NCT00560209|Adrenergic Agents|adrenergic agents|mesh-ancestor
101445539|NCT00560209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101445540|NCT00560209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445541|NCT00560209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445542|NCT00560209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101445543|NCT04636957|Ciprofloxacin|ciprofloxacin|mesh-list
101445544|NCT04636957|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
101445545|NCT04636957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101445546|NCT04636957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101445547|NCT04636957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101445548|NCT04636957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101445549|NCT04636957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101445550|NCT04636957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101445551|NCT04636957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445552|NCT04636957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101445553|NCT04636957|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101445554|NCT04636957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101445555|NCT04636957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101445556|NCT04636957|Glucocorticoids|glucocorticoids|mesh-ancestor
101445557|NCT04636957|Hormones|hormones|mesh-ancestor
101445558|NCT04636957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101445559|NCT04636957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445560|NCT00560326|Tacrolimus|tacrolimus|mesh-list
101445561|NCT00560326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101445563|NCT00560326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445564|NCT00560326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101445565|NCT00560326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101445566|NCT00560326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445567|NCT00560443|Ketorolac|ketorolac|mesh-list
101445568|NCT00560443|Tramadol|tramadol|mesh-list
101445569|NCT00560443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101445570|NCT00560443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101445571|NCT00560443|Analgesics|analgesics|mesh-ancestor
101445572|NCT00560443|Sensory System Agents|sensory system agents|mesh-ancestor
101445573|NCT00560443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101445574|NCT00560443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445575|NCT00560443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101308073|NCT02045667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101445591|NCT00179114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101445592|NCT00179114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445593|NCT00179114|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101445594|NCT00179114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101445596|NCT00179114|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101445597|NCT00179114|GABA Agonists|gaba agonists|mesh-ancestor
101445599|NCT00201318|Lamivudine|lamivudine|mesh-list
101445600|NCT00201318|Cyclophosphamide|cyclophosphamide|mesh-list
101445601|NCT00201318|Doxorubicin|doxorubicin|mesh-list
101445603|NCT00201318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101445604|NCT00201318|Immunologic Factors|immunologic factors|mesh-ancestor
101445605|NCT00201318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445606|NCT00201318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101445607|NCT00201318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101445608|NCT00201318|Alkylating Agents|alkylating agents|mesh-ancestor
101445609|NCT00201318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445610|NCT00201318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101445612|NCT00201318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101445613|NCT00201318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101445614|NCT00201318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101445615|NCT00201318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101445616|NCT00201318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101652804|NCT00811291|Calcium, Dietary|calcium, dietary|mesh-list
101445617|NCT00201318|Tubulin Modulators|tubulin modulators|mesh-ancestor
101445618|NCT00201318|Antimitotic Agents|antimitotic agents|mesh-ancestor
101445619|NCT00201318|Mitosis Modulators|mitosis modulators|mesh-ancestor
101445620|NCT00201318|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101445621|NCT00201318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101445623|NCT00201318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101445624|NCT00201318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101445625|NCT00201318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101445626|NCT00201357|Thalidomide|thalidomide|mesh-list
101652878|NCT02612259|Tryptophan|tryptophan|mesh-list
101445627|NCT00201357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101445628|NCT00201357|Immunologic Factors|immunologic factors|mesh-ancestor
101445629|NCT00201357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445630|NCT00201357|Leprostatic Agents|leprostatic agents|mesh-ancestor
101445631|NCT00201357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101445632|NCT00201357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101445633|NCT00201357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101445634|NCT00201357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101445635|NCT00201357|Growth Substances|growth substances|mesh-ancestor
101445640|NCT00201396|Epirubicin|epirubicin|mesh-list
101445641|NCT00201396|Mitomycins|mitomycins|mesh-list
101445642|NCT00201396|Mitomycin|mitomycin|mesh-list
101445643|NCT00201396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101445644|NCT00201396|Antimetabolites|antimetabolites|mesh-ancestor
101445645|NCT00201396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445646|NCT00201396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101445647|NCT00201396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101445648|NCT00201396|Immunologic Factors|immunologic factors|mesh-ancestor
101445649|NCT00201396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445650|NCT00201396|Antidotes|antidotes|mesh-ancestor
101445651|NCT00201396|Protective Agents|protective agents|mesh-ancestor
101445652|NCT00201396|Vitamin B Complex|vitamin b complex|mesh-ancestor
101445654|NCT00201396|Micronutrients|micronutrients|mesh-ancestor
101445655|NCT00201396|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101445656|NCT00201396|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101445657|NCT00201396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101445658|NCT00201396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101445659|NCT00201396|Alkylating Agents|alkylating agents|mesh-ancestor
101445660|NCT00201396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101445661|NCT00201435|Paclitaxel|paclitaxel|mesh-list
101445662|NCT00201435|Docetaxel|docetaxel|mesh-list
101445663|NCT00201435|Capecitabine|capecitabine|mesh-list
101445664|NCT00201435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101445665|NCT00201435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101445666|NCT00201435|Tubulin Modulators|tubulin modulators|mesh-ancestor
101445667|NCT00201435|Antimitotic Agents|antimitotic agents|mesh-ancestor
101308074|NCT02045667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308075|NCT02045693|Buprenorphine|buprenorphine|mesh-list
101308076|NCT02045693|Methadone|methadone|mesh-list
101652946|NCT00815893|Anesthetics|anesthetics|mesh-ancestor
101445668|NCT00201435|Mitosis Modulators|mitosis modulators|mesh-ancestor
101445669|NCT00201435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445670|NCT00201435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101445671|NCT00201435|Antimetabolites|antimetabolites|mesh-ancestor
101445672|NCT00560599|Chlorhexidine|chlorhexidine|mesh-list
101445673|NCT00560599|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101445674|NCT00560599|Mupirocin|mupirocin|mesh-list
101445675|NCT00560599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101445676|NCT00560599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101445677|NCT00560599|Disinfectants|disinfectants|mesh-ancestor
101445678|NCT00560599|Dermatologic Agents|dermatologic agents|mesh-ancestor
101445679|NCT00560599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101445680|NCT00560599|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101445681|NCT00560599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101445682|NCT00560599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445683|NCT04635553|Praziquantel|praziquantel|mesh-list
101445684|NCT04635553|Anthelmintics|anthelmintics|mesh-ancestor
101445685|NCT04635553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101445686|NCT04635553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101445687|NCT00560638|Loteprednol Etabonate|loteprednol etabonate|mesh-list
101445688|NCT00560638|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101445689|NCT04634656|Lidocaine|lidocaine|mesh-list
101445690|NCT04634656|Anesthetics, Local|anesthetics, local|mesh-ancestor
101445691|NCT04634656|Anesthetics|anesthetics|mesh-ancestor
101445692|NCT04634656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101445693|NCT04634656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445694|NCT04634656|Sensory System Agents|sensory system agents|mesh-ancestor
101445695|NCT04634656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101445696|NCT04634656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101445697|NCT04634656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101445698|NCT04634656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101445699|NCT04634656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101445700|NCT04634656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445702|NCT04634500|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101445703|NCT04634500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445705|NCT04634500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445706|NCT04633954|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101445707|NCT04633954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101445708|NCT04633954|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101445709|NCT04633954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101445731|NCT00179231|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101445732|NCT00179231|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101445733|NCT00179231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101445734|NCT00179231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101445735|NCT00179231|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101445736|NCT00179231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101445737|NCT00179231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101445738|NCT00179231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445739|NCT00179231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101445741|NCT00179231|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101445742|NCT00179231|GABA Antagonists|gaba antagonists|mesh-ancestor
101445744|NCT00201669|Clofarabine|clofarabine|mesh-list
101445745|NCT00201669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101445746|NCT00201669|Antimetabolites|antimetabolites|mesh-ancestor
101445747|NCT00201669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445748|NCT00201669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101445749|NCT00201708|Cyclophosphamide|cyclophosphamide|mesh-list
101445750|NCT00201708|Docetaxel|docetaxel|mesh-list
101445751|NCT00201708|Doxorubicin|doxorubicin|mesh-list
101445752|NCT00201708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101445753|NCT00201708|Immunologic Factors|immunologic factors|mesh-ancestor
101445754|NCT00201708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445755|NCT00201708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101445756|NCT00201708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101308077|NCT02045693|Naloxone|naloxone|mesh-list
101308078|NCT02045693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101308079|NCT02045693|Narcotics|narcotics|mesh-ancestor
101445757|NCT00201708|Alkylating Agents|alkylating agents|mesh-ancestor
101445758|NCT00201708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445759|NCT00201708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101445760|NCT00201708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101445761|NCT00201708|Tubulin Modulators|tubulin modulators|mesh-ancestor
101445773|NCT04632121|Vitamins|vitamins|mesh-ancestor
101445774|NCT04632121|Micronutrients|micronutrients|mesh-ancestor
101445775|NCT04632121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445776|NCT00179699|Pemetrexed|pemetrexed|mesh-list
101445777|NCT00179699|Lenalidomide|lenalidomide|mesh-list
101445778|NCT00179699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101445779|NCT00179699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101445780|NCT00179699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445781|NCT00179699|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101445782|NCT00179699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101445783|NCT00179699|Immunologic Factors|immunologic factors|mesh-ancestor
101445784|NCT00179699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445785|NCT00179699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101445786|NCT00179699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101445787|NCT00179699|Growth Substances|growth substances|mesh-ancestor
101445788|NCT00179699|Growth Inhibitors|growth inhibitors|mesh-ancestor
101445789|NCT00201747|Mitomycins|mitomycins|mesh-list
101445790|NCT00201747|Mitomycin|mitomycin|mesh-list
101445791|NCT00201747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101445792|NCT00201747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101445793|NCT00201747|Alkylating Agents|alkylating agents|mesh-ancestor
101445794|NCT00201747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445795|NCT00201747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101445796|NCT00201747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101445797|NCT00179738|Lenalidomide|lenalidomide|mesh-list
101445798|NCT00179738|Immunologic Factors|immunologic factors|mesh-ancestor
101363428|NCT00132652|Lamivudine|lamivudine|mesh-list
101445799|NCT00179738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445800|NCT00179738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101445801|NCT00179738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101445802|NCT00179738|Growth Substances|growth substances|mesh-ancestor
101445803|NCT00179738|Growth Inhibitors|growth inhibitors|mesh-ancestor
101445804|NCT00179738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101445805|NCT04631341|Melatonin|melatonin|mesh-list
101445806|NCT04631341|Antioxidants|antioxidants|mesh-ancestor
101445807|NCT04631341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653656|NCT00813241|Celecoxib|celecoxib|mesh-list
101445808|NCT04631341|Protective Agents|protective agents|mesh-ancestor
101445809|NCT04631341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445810|NCT04631341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101445811|NCT04723238|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101445812|NCT04723238|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101445813|NCT04723238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101445814|NCT04723238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101445815|NCT04723238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445816|NCT04723238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101445817|NCT04723238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445819|NCT04723238|Sensory System Agents|sensory system agents|mesh-ancestor
101445820|NCT04723238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101445821|NCT04723238|Antidepressive Agents|antidepressive agents|mesh-ancestor
101445822|NCT04723238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101445823|NCT04723238|Dopamine Agents|dopamine agents|mesh-ancestor
101445825|NCT00201786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101445829|NCT04630522|Vitamin D|vitamin d|mesh-list
101445830|NCT04630522|Calcium, Dietary|calcium, dietary|mesh-list
101445831|NCT04630522|Calcium|calcium|mesh-list
101445832|NCT04630522|Vitamins|vitamins|mesh-ancestor
101445833|NCT04630522|Micronutrients|micronutrients|mesh-ancestor
101445834|NCT04630522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445835|NCT04630522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101445836|NCT04630522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101445837|NCT00179816|Cyclophosphamide|cyclophosphamide|mesh-list
101445838|NCT00179816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101445839|NCT00179816|Immunologic Factors|immunologic factors|mesh-ancestor
101445840|NCT00179816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308080|NCT02045693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101308081|NCT02045693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308082|NCT02045693|Analgesics|analgesics|mesh-ancestor
101308083|NCT02045693|Sensory System Agents|sensory system agents|mesh-ancestor
101445841|NCT00179816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101445842|NCT00179816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101445843|NCT00179816|Alkylating Agents|alkylating agents|mesh-ancestor
101445844|NCT00179816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445845|NCT00179816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101445846|NCT00179816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101445847|NCT04630444|Riluzole|riluzole|mesh-list
101445848|NCT04630444|Anticonvulsants|anticonvulsants|mesh-ancestor
101445849|NCT04630444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101445850|NCT04630444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101445851|NCT04630444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101445852|NCT04630444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445853|NCT04630444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445854|NCT04630444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101445855|NCT04630444|Protective Agents|protective agents|mesh-ancestor
101445856|NCT00186810|Cyclophosphamide|cyclophosphamide|mesh-list
101445858|NCT00186810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101445859|NCT00186810|Immunologic Factors|immunologic factors|mesh-ancestor
101445860|NCT00186810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445861|NCT00186810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101445862|NCT00186810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101445863|NCT00186810|Alkylating Agents|alkylating agents|mesh-ancestor
101654019|NCT00634933|Prednisone|prednisone|mesh-list
101654029|NCT00634933|Hormones|hormones|mesh-ancestor
101445864|NCT00186810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445865|NCT00186810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101445866|NCT00186810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101445867|NCT04630288|Clopidogrel|clopidogrel|mesh-list
101445869|NCT04630288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101445870|NCT04630288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101445871|NCT04630288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101445872|NCT04630288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101445873|NCT04630288|Purinergic Agents|purinergic agents|mesh-ancestor
101445874|NCT04630288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101445875|NCT04630288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445876|NCT04630288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445877|NCT00561028|Antibodies|antibodies|mesh-list
101445878|NCT00561028|Immunologic Factors|immunologic factors|mesh-ancestor
101445879|NCT00561028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445880|NCT00561067|Methylprednisolone|methylprednisolone|mesh-list
101445881|NCT00561067|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101654305|NCT00902564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101445882|NCT00561067|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101445883|NCT00561067|Prednisolone|prednisolone|mesh-list
101445884|NCT00561067|Prednisolone acetate|prednisolone acetate|mesh-list
101445885|NCT00561067|Epoetin Alfa|epoetin alfa|mesh-list
101445886|NCT00561067|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101445888|NCT00561067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101445889|NCT00561067|Antiemetics|antiemetics|mesh-ancestor
101445890|NCT00561067|Autonomic Agents|autonomic agents|mesh-ancestor
101445891|NCT00561067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101445892|NCT00561067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445893|NCT00561067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101445894|NCT00561067|Glucocorticoids|glucocorticoids|mesh-ancestor
101445896|NCT00561067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101445918|NCT00186849|Carboplatin|carboplatin|mesh-list
101445919|NCT00186849|Doxorubicin|doxorubicin|mesh-list
101445920|NCT00186849|Etoposide|etoposide|mesh-list
101445921|NCT00186849|Topotecan|topotecan|mesh-list
101445922|NCT00186849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101445923|NCT00186849|Immunologic Factors|immunologic factors|mesh-ancestor
101445924|NCT00186849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445925|NCT00186849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101445926|NCT00186849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101445927|NCT00186849|Alkylating Agents|alkylating agents|mesh-ancestor
101308084|NCT02045693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101308085|NCT02045693|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101308086|NCT02045693|Antitussive Agents|antitussive agents|mesh-ancestor
101308087|NCT02045693|Respiratory System Agents|respiratory system agents|mesh-ancestor
101308088|NCT02045797|Gepotidacin|gepotidacin|mesh-list
101308089|NCT02045797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101445928|NCT00186849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445929|NCT00186849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101445930|NCT00186849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101445931|NCT00186849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101445932|NCT00186849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101445933|NCT00186849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101445934|NCT00186849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101654709|NCT04201808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101445935|NCT00186849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101445936|NCT00186849|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101445937|NCT00201981|Rebamipide|rebamipide|mesh-list
101445938|NCT00201981|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101445939|NCT00201981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101445940|NCT00201981|Antioxidants|antioxidants|mesh-ancestor
101654777|NCT04224584|Sensory System Agents|sensory system agents|mesh-ancestor
101445941|NCT00201981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445942|NCT00201981|Protective Agents|protective agents|mesh-ancestor
101445943|NCT00201981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445946|NCT00561223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101654920|NCT02840526|Fentanyl|fentanyl|mesh-list
101655001|NCT02839122|Tadalafil|tadalafil|mesh-list
101445947|NCT00561223|Vasodilator Agents|vasodilator agents|mesh-ancestor
101445948|NCT00180011|Omalizumab|omalizumab|mesh-list
101445949|NCT00180011|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101445950|NCT00180011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101655087|NCT02837640|Levodopa|levodopa|mesh-list
101445951|NCT00180011|Respiratory System Agents|respiratory system agents|mesh-ancestor
101445952|NCT00186966|Cytarabine|cytarabine|mesh-list
101445953|NCT00186966|Cyclophosphamide|cyclophosphamide|mesh-list
101445956|NCT00186966|Fludarabine|fludarabine|mesh-list
101445957|NCT00186966|Etoposide|etoposide|mesh-list
101445958|NCT00186966|Daunorubicin|daunorubicin|mesh-list
101445959|NCT00186966|Thioguanine|thioguanine|mesh-list
101445960|NCT00186966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101445961|NCT00186966|Immunologic Factors|immunologic factors|mesh-ancestor
101445962|NCT00186966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445963|NCT00186966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101445964|NCT00186966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101445965|NCT00186966|Alkylating Agents|alkylating agents|mesh-ancestor
101445966|NCT00186966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445967|NCT00186966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101445968|NCT00186966|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101445969|NCT00186966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101445970|NCT00186966|Antimetabolites|antimetabolites|mesh-ancestor
101445971|NCT00186966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101445972|NCT00186966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101445973|NCT00186966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101445974|NCT00186966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101445975|NCT00186966|Antiviral Agents|antiviral agents|mesh-ancestor
101445976|NCT00186966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101445977|NCT00186966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101445978|NCT00180050|Budesonide|budesonide|mesh-list
101445979|NCT00180050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101445980|NCT00180050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101445981|NCT00180050|Autonomic Agents|autonomic agents|mesh-ancestor
101445982|NCT00180050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101445983|NCT00180050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445984|NCT00180050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101445985|NCT00180050|Respiratory System Agents|respiratory system agents|mesh-ancestor
101445987|NCT00180050|Hormones|hormones|mesh-ancestor
101655267|NCT05878158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101445988|NCT00180050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101445989|NCT00575302|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101445990|NCT00575302|Hormones|hormones|mesh-ancestor
101308090|NCT02045797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101445991|NCT00575302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101445992|NCT00575302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445993|NCT00575341|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101655436|NCT05663658|Morphine|morphine|mesh-list
101445994|NCT00575341|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101445995|NCT00575341|Immunologic Factors|immunologic factors|mesh-ancestor
101445996|NCT00575341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445997|NCT00180089|Budesonide|budesonide|mesh-list
101445998|NCT00180089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101445999|NCT00180089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101446000|NCT00180089|Autonomic Agents|autonomic agents|mesh-ancestor
101446001|NCT00180089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101446002|NCT00180089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446003|NCT00180089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101446004|NCT00180089|Respiratory System Agents|respiratory system agents|mesh-ancestor
101446005|NCT00180089|Glucocorticoids|glucocorticoids|mesh-ancestor
101446006|NCT00180089|Hormones|hormones|mesh-ancestor
101446007|NCT00180089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101446008|NCT00575419|Acetylcysteine|acetylcysteine|mesh-list
101446009|NCT00575419|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101446010|NCT00575419|Antiviral Agents|antiviral agents|mesh-ancestor
101446012|NCT00575419|Expectorants|expectorants|mesh-ancestor
101446013|NCT00575419|Respiratory System Agents|respiratory system agents|mesh-ancestor
101655787|NCT04532528|Antithrombins|antithrombins|mesh-ancestor
101446014|NCT00575419|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101446015|NCT00575419|Antioxidants|antioxidants|mesh-ancestor
101446016|NCT00575419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446017|NCT00575419|Protective Agents|protective agents|mesh-ancestor
101446018|NCT00575419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446019|NCT00575419|Antidotes|antidotes|mesh-ancestor
101446020|NCT00180128|Cytarabine|cytarabine|mesh-list
101446021|NCT00180128|Daunorubicin|daunorubicin|mesh-list
101446022|NCT00180128|Mitoxantrone|mitoxantrone|mesh-list
101446023|NCT00180128|Idarubicin|idarubicin|mesh-list
101446024|NCT00180128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101446025|NCT00180128|Antimetabolites|antimetabolites|mesh-ancestor
101446026|NCT00180128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446027|NCT00180128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101446028|NCT00180128|Antiviral Agents|antiviral agents|mesh-ancestor
101446032|NCT00180128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446033|NCT00180128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101446034|NCT00180128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101446035|NCT00180128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101446036|NCT00180128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101446037|NCT00180128|Analgesics|analgesics|mesh-ancestor
101446038|NCT00180128|Sensory System Agents|sensory system agents|mesh-ancestor
101446039|NCT00180128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101446040|NCT00575614|Prucalopride|prucalopride|mesh-list
101446041|NCT00575614|Laxatives|laxatives|mesh-ancestor
101446042|NCT00575614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101446043|NCT00575614|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101446044|NCT00575614|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101446045|NCT00575614|Serotonin Agents|serotonin agents|mesh-ancestor
101655976|NCT03675737|Antimetabolites|antimetabolites|mesh-ancestor
101446047|NCT00575614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446048|NCT00575614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446050|NCT00575848|Glycine Agents|glycine agents|mesh-ancestor
101446051|NCT00575848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101446052|NCT00575848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656115|NCT02723331|Antimetabolites|antimetabolites|mesh-ancestor
101446053|NCT00575848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446054|NCT00576238|Betamethasone|betamethasone|mesh-list
101446055|NCT00576238|Betamethasone Valerate|betamethasone valerate|mesh-list
101656191|NCT02051218|Denosumab|denosumab|mesh-list
101446056|NCT00576238|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101446057|NCT00576238|Betamethasone benzoate|betamethasone benzoate|mesh-list
101446058|NCT00576238|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101446059|NCT00576238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101446060|NCT00576238|Glucocorticoids|glucocorticoids|mesh-ancestor
101446062|NCT00576238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101656256|NCT00890149|Antiemetics|antiemetics|mesh-ancestor
101446063|NCT00576238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446064|NCT00576238|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101446065|NCT00576238|Respiratory System Agents|respiratory system agents|mesh-ancestor
101446067|NCT00576394|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101446068|NCT00576394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101446069|NCT00576394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446070|NCT00576433|Rituximab|rituximab|mesh-list
101446071|NCT00576433|Methotrexate|methotrexate|mesh-list
101656394|NCT00633438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101446072|NCT00576433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101446074|NCT00576433|Immunologic Factors|immunologic factors|mesh-ancestor
101446075|NCT00576433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446076|NCT00576433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101656567|NCT00704444|Ezetimibe|ezetimibe|mesh-list
101446077|NCT00576433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101446078|NCT00576433|Abortifacient Agents|abortifacient agents|mesh-ancestor
101446079|NCT00576433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101446080|NCT00576433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101446081|NCT00576433|Antimetabolites|antimetabolites|mesh-ancestor
101446082|NCT00576433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446083|NCT00576433|Dermatologic Agents|dermatologic agents|mesh-ancestor
101446084|NCT00576433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101446085|NCT00576433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101446086|NCT00576433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101656682|NCT00832377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101446087|NCT00576433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101446088|NCT00576511|Prucalopride|prucalopride|mesh-list
101446089|NCT00576511|Laxatives|laxatives|mesh-ancestor
101446090|NCT00576511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101446091|NCT00576511|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101446092|NCT00576511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101446093|NCT00576511|Serotonin Agents|serotonin agents|mesh-ancestor
101446094|NCT00576511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101446095|NCT00576511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446096|NCT00576511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446097|NCT00576550|Betamethasone|betamethasone|mesh-list
101446098|NCT00576550|Betamethasone Valerate|betamethasone valerate|mesh-list
101446116|NCT00576706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101446117|NCT00576706|Oxytocics|oxytocics|mesh-ancestor
101446118|NCT00576706|Antioxidants|antioxidants|mesh-ancestor
101656908|NCT00891930|Irinotecan|irinotecan|mesh-list
101446119|NCT00576706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446120|NCT00576706|Protective Agents|protective agents|mesh-ancestor
101446121|NCT00576706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101446122|NCT00576784|Pioglitazone|pioglitazone|mesh-list
101446123|NCT00576784|Glimepiride|glimepiride|mesh-list
101446124|NCT00576784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101446125|NCT00576784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446126|NCT00576784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101446127|NCT00576784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101446128|NCT00576784|Immunologic Factors|immunologic factors|mesh-ancestor
101446129|NCT00576862|Insulin Glargine|insulin glargine|mesh-list
101446130|NCT00576862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101446131|NCT00576862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446133|NCT00202020|Cilostazol|cilostazol|mesh-list
101446134|NCT00202020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101446135|NCT00202020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101446136|NCT00202020|Analgesics|analgesics|mesh-ancestor
101446137|NCT00202020|Sensory System Agents|sensory system agents|mesh-ancestor
101446138|NCT00202020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101446139|NCT00202020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446140|NCT00202020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101657253|NCT02829060|Gentamicins|gentamicins|mesh-list
101446141|NCT00202020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101446142|NCT00202020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101446143|NCT00202020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101446144|NCT00202020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446145|NCT00202020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101446146|NCT00202020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101446147|NCT00202020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101446149|NCT00202020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101446150|NCT00202020|Autonomic Agents|autonomic agents|mesh-ancestor
101446151|NCT00202020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101446152|NCT00202020|Respiratory System Agents|respiratory system agents|mesh-ancestor
101446153|NCT00202020|Vasodilator Agents|vasodilator agents|mesh-ancestor
101446154|NCT00202020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101657397|NCT04243434|Hormones|hormones|mesh-ancestor
101446155|NCT00202020|Protective Agents|protective agents|mesh-ancestor
101308091|NCT02045797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308092|NCT02045797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101446160|NCT00577018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101446161|NCT00577018|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101446162|NCT00577018|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101657461|NCT02827266|Epoetin Alfa|epoetin alfa|mesh-list
101446163|NCT00577018|Serotonin Agents|serotonin agents|mesh-ancestor
101446164|NCT00577018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101446165|NCT00577018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446166|NCT00577018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446167|NCT04578847|Imatinib Mesylate|imatinib mesylate|mesh-list
101446168|NCT04578847|Dasatinib|dasatinib|mesh-list
101446169|NCT04578847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101446170|NCT04578847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101446171|NCT04578847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101446172|NCT04578847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446173|NCT00577057|Fluorouracil|fluorouracil|mesh-list
101446175|NCT00577057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101446176|NCT00577057|Antimetabolites|antimetabolites|mesh-ancestor
101657589|NCT04958538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101446177|NCT00577057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446178|NCT00577057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101446179|NCT00577057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101446180|NCT00577057|Immunologic Factors|immunologic factors|mesh-ancestor
101446181|NCT00577057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446182|NCT00187005|Cytarabine|cytarabine|mesh-list
101446183|NCT00187005|Dexamethasone|dexamethasone|mesh-list
101446184|NCT00187005|Prednisone|prednisone|mesh-list
101446185|NCT00187005|Cyclophosphamide|cyclophosphamide|mesh-list
101446186|NCT00187005|Methotrexate|methotrexate|mesh-list
101446187|NCT00187005|Etoposide|etoposide|mesh-list
101446188|NCT00187005|Vincristine|vincristine|mesh-list
101446190|NCT00187005|Asparaginase|asparaginase|mesh-list
101446191|NCT00187005|Mercaptopurine|mercaptopurine|mesh-list
101446192|NCT00187005|Idarubicin|idarubicin|mesh-list
101446193|NCT00187005|Pegaspargase|pegaspargase|mesh-list
101446194|NCT00187005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101446195|NCT00187005|Immunologic Factors|immunologic factors|mesh-ancestor
101446196|NCT00187005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446197|NCT00187005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101446198|NCT00187005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101446200|NCT00187005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446201|NCT00187005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101446202|NCT00187005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101446203|NCT00187005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101446205|NCT00187005|Autonomic Agents|autonomic agents|mesh-ancestor
101446206|NCT00187005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101446207|NCT00187005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101446208|NCT00187005|Glucocorticoids|glucocorticoids|mesh-ancestor
101446209|NCT00187005|Hormones|hormones|mesh-ancestor
101446210|NCT00187005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101446211|NCT00187005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101446212|NCT00187005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101446213|NCT00187005|Abortifacient Agents|abortifacient agents|mesh-ancestor
101446214|NCT00187005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101446215|NCT00187005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101446216|NCT00187005|Antimetabolites|antimetabolites|mesh-ancestor
101446217|NCT00187005|Dermatologic Agents|dermatologic agents|mesh-ancestor
101446218|NCT00187005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101446219|NCT00187005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101446220|NCT00187005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101446221|NCT00187005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101446222|NCT00187005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101446223|NCT00187005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101446224|NCT00187005|Antiviral Agents|antiviral agents|mesh-ancestor
101446225|NCT00187005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101446226|NCT00187005|Tubulin Modulators|tubulin modulators|mesh-ancestor
101446227|NCT00187005|Antimitotic Agents|antimitotic agents|mesh-ancestor
101446228|NCT00187005|Mitosis Modulators|mitosis modulators|mesh-ancestor
101446231|NCT00202059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101308093|NCT02045810|Levobupivacaine|levobupivacaine|mesh-list
101308094|NCT02045810|Anesthetics, Local|anesthetics, local|mesh-ancestor
101446232|NCT00202059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446233|NCT00577369|Desflurane|desflurane|mesh-list
101446234|NCT00577369|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101446235|NCT00577369|Anesthetics, General|anesthetics, general|mesh-ancestor
101446236|NCT00577369|Anesthetics|anesthetics|mesh-ancestor
101446237|NCT00577369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101446238|NCT00577369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446239|NCT00577681|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101446240|NCT00577681|Antiviral Agents|antiviral agents|mesh-ancestor
101446241|NCT00577681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101446242|NCT00577798|Doxorubicin|doxorubicin|mesh-list
101446243|NCT00577798|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101446244|NCT00577798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101446245|NCT00577798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101446246|NCT00577798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101446247|NCT00577798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101446248|NCT00577798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101446249|NCT00577798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446250|NCT00187083|Dexamethasone|dexamethasone|mesh-list
101446251|NCT00187083|Methotrexate|methotrexate|mesh-list
101446252|NCT00187083|Fludarabine|fludarabine|mesh-list
101446253|NCT00187083|Etoposide|etoposide|mesh-list
101446254|NCT00187083|Vincristine|vincristine|mesh-list
101446255|NCT00187083|Topotecan|topotecan|mesh-list
101446256|NCT00187083|Asparaginase|asparaginase|mesh-list
101446257|NCT00187083|Mercaptopurine|mercaptopurine|mesh-list
101446258|NCT00187083|Idarubicin|idarubicin|mesh-list
101446259|NCT00187083|Pegaspargase|pegaspargase|mesh-list
101446260|NCT00187083|Teniposide|teniposide|mesh-list
101446261|NCT00187083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101446262|NCT00187083|Antiemetics|antiemetics|mesh-ancestor
101446263|NCT00187083|Autonomic Agents|autonomic agents|mesh-ancestor
101446264|NCT00187083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101363454|NCT00132925|Triamcinolone|triamcinolone|mesh-list
101446265|NCT00187083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446266|NCT00187083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101446267|NCT00187083|Glucocorticoids|glucocorticoids|mesh-ancestor
101446268|NCT00187083|Hormones|hormones|mesh-ancestor
101446269|NCT00187083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101446270|NCT00187083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101446271|NCT00187083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101446272|NCT00187083|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101446273|NCT00187083|Abortifacient Agents|abortifacient agents|mesh-ancestor
101446274|NCT00187083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101446275|NCT00187083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101446276|NCT00187083|Antimetabolites|antimetabolites|mesh-ancestor
101446277|NCT00187083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446278|NCT00187083|Dermatologic Agents|dermatologic agents|mesh-ancestor
101446279|NCT00187083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101446280|NCT00187083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101446281|NCT00187083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101446282|NCT00187083|Immunologic Factors|immunologic factors|mesh-ancestor
101446283|NCT00187083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101446284|NCT00187083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101446285|NCT00187083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101446286|NCT00187083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101446287|NCT00187083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101446288|NCT00187083|Tubulin Modulators|tubulin modulators|mesh-ancestor
101446289|NCT00187083|Antimitotic Agents|antimitotic agents|mesh-ancestor
101446290|NCT00187083|Mitosis Modulators|mitosis modulators|mesh-ancestor
101446291|NCT00187083|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101446292|NCT00187083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101446294|NCT00577837|Etidronic Acid|etidronic acid|mesh-list
101446295|NCT00577837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101446296|NCT00577837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101446297|NCT00577837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446298|NCT00577837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101446299|NCT00577837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446300|NCT00577837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101446301|NCT00578149|Paclitaxel|paclitaxel|mesh-list
101446302|NCT00578149|Bevacizumab|bevacizumab|mesh-list
101446309|NCT00578149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308095|NCT02045810|Anesthetics|anesthetics|mesh-ancestor
101308096|NCT02045810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101308097|NCT02045810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308098|NCT02045810|Sensory System Agents|sensory system agents|mesh-ancestor
101308099|NCT02045810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101308100|NCT02045849|Itraconazole|itraconazole|mesh-list
101308101|NCT02045849|Gepotidacin|gepotidacin|mesh-list
101308102|NCT02045849|Antifungal Agents|antifungal agents|mesh-ancestor
101308103|NCT02045849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101308104|NCT02045849|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101308105|NCT02045849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101446310|NCT00578149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101446311|NCT00578149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101446312|NCT00578149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101446313|NCT00578149|Growth Substances|growth substances|mesh-ancestor
101446314|NCT00578149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446315|NCT00578149|Growth Inhibitors|growth inhibitors|mesh-ancestor
101446316|NCT00187122|Cytarabine|cytarabine|mesh-list
101446317|NCT00187122|Dexamethasone|dexamethasone|mesh-list
101446318|NCT00187122|Prednisone|prednisone|mesh-list
101446319|NCT00187122|Cyclophosphamide|cyclophosphamide|mesh-list
101446320|NCT00187122|Methotrexate|methotrexate|mesh-list
101446322|NCT00187122|Vincristine|vincristine|mesh-list
101446323|NCT00187122|Asparaginase|asparaginase|mesh-list
101446324|NCT00187122|Mercaptopurine|mercaptopurine|mesh-list
101446325|NCT00187122|Daunorubicin|daunorubicin|mesh-list
101446326|NCT00187122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101446327|NCT00187122|Immunologic Factors|immunologic factors|mesh-ancestor
101658505|NCT02545777|Diclofenac|diclofenac|mesh-list
101446328|NCT00187122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446329|NCT00187122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101363455|NCT00132925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101446330|NCT00187122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101446331|NCT00187122|Alkylating Agents|alkylating agents|mesh-ancestor
101446332|NCT00187122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446333|NCT00187122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101446334|NCT00187122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101446335|NCT00187122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101446336|NCT00187122|Antiemetics|antiemetics|mesh-ancestor
101446337|NCT00187122|Autonomic Agents|autonomic agents|mesh-ancestor
101446338|NCT00187122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101446339|NCT00187122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101446340|NCT00187122|Glucocorticoids|glucocorticoids|mesh-ancestor
101446341|NCT00187122|Hormones|hormones|mesh-ancestor
101446342|NCT00187122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101446343|NCT00187122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101446344|NCT00187122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101446345|NCT00187122|Abortifacient Agents|abortifacient agents|mesh-ancestor
101446346|NCT00187122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101446347|NCT00187122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101446348|NCT00187122|Antimetabolites|antimetabolites|mesh-ancestor
101446349|NCT00187122|Dermatologic Agents|dermatologic agents|mesh-ancestor
101446350|NCT00187122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101446351|NCT00187122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101446352|NCT00187122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101446353|NCT00187122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101446354|NCT00187122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101446355|NCT00187122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101446356|NCT00187122|Antiviral Agents|antiviral agents|mesh-ancestor
101446357|NCT00187122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101446358|NCT00187122|Tubulin Modulators|tubulin modulators|mesh-ancestor
101446359|NCT00187122|Antimitotic Agents|antimitotic agents|mesh-ancestor
101446360|NCT00187122|Mitosis Modulators|mitosis modulators|mesh-ancestor
101446361|NCT00187122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101446363|NCT00180635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101308106|NCT02045849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101658902|NCT00857077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101308107|NCT02045849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308110|NCT02045849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101658968|NCT02807298|Lidocaine|lidocaine|mesh-list
101308111|NCT02045849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308112|NCT02045849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101308113|NCT02045849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101308114|NCT02045849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308115|NCT02045914|Calcium|calcium|mesh-list
101308116|NCT02045914|Ionophores|ionophores|mesh-list
101308117|NCT02045914|Ionomycin|ionomycin|mesh-list
101308119|NCT02045914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101446364|NCT00180635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446365|NCT00578266|Cyclophosphamide|cyclophosphamide|mesh-list
101446366|NCT00578266|Alemtuzumab|alemtuzumab|mesh-list
101446367|NCT00578266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101659122|NCT00854035|Hormones|hormones|mesh-ancestor
101446368|NCT00578266|Immunologic Factors|immunologic factors|mesh-ancestor
101446369|NCT00578266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446370|NCT00578266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101446371|NCT00578266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101446376|NCT00578266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101446377|NCT04578496|Afamelanotide|afamelanotide|mesh-list
101446378|NCT04578496|Dermatologic Agents|dermatologic agents|mesh-ancestor
101446379|NCT00579046|Darbepoetin alfa|darbepoetin alfa|mesh-list
101446380|NCT00579046|Hematinics|hematinics|mesh-ancestor
101446381|NCT00579085|Ketamine|ketamine|mesh-list
101446382|NCT00579085|Analgesics|analgesics|mesh-ancestor
101446383|NCT00579085|Sensory System Agents|sensory system agents|mesh-ancestor
101446384|NCT00579085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101446385|NCT00579085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446386|NCT00579085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101659319|NCT00858715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101446387|NCT00579085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101446388|NCT00579085|Anesthetics, General|anesthetics, general|mesh-ancestor
101446389|NCT00579085|Anesthetics|anesthetics|mesh-ancestor
101446390|NCT00579085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101446391|NCT00579085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101446392|NCT00579085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101446393|NCT00579085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101446394|NCT00579085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446395|NCT00187161|Cytarabine|cytarabine|mesh-list
101446396|NCT00187161|Cyclophosphamide|cyclophosphamide|mesh-list
101446397|NCT00187161|Doxorubicin|doxorubicin|mesh-list
101446398|NCT00187161|Methotrexate|methotrexate|mesh-list
101446399|NCT00187161|Etoposide|etoposide|mesh-list
101446400|NCT00187161|Vincristine|vincristine|mesh-list
101446401|NCT00187161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101659540|NCT05979311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101446402|NCT00187161|Immunologic Factors|immunologic factors|mesh-ancestor
101446403|NCT00187161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446404|NCT00187161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101446405|NCT00187161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101446406|NCT00187161|Alkylating Agents|alkylating agents|mesh-ancestor
101659613|NCT05978648|Paclitaxel|paclitaxel|mesh-list
101446407|NCT00187161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446409|NCT00187161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101446410|NCT00187161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101446411|NCT00187161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101446412|NCT00187161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101308120|NCT02045914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308121|NCT02045914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101308122|NCT02045914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308123|NCT02045940|GSK2881078|gsk2881078|mesh-list
101446413|NCT00187161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101446414|NCT00187161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101446415|NCT00187161|Abortifacient Agents|abortifacient agents|mesh-ancestor
101446416|NCT00187161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101446417|NCT00187161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101446418|NCT00187161|Antimetabolites|antimetabolites|mesh-ancestor
101446419|NCT00187161|Dermatologic Agents|dermatologic agents|mesh-ancestor
101446420|NCT00187161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101446421|NCT00187161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101446422|NCT00187161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101446423|NCT00187161|Antiviral Agents|antiviral agents|mesh-ancestor
101446424|NCT00187161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101446425|NCT00187161|Tubulin Modulators|tubulin modulators|mesh-ancestor
101446427|NCT00187161|Mitosis Modulators|mitosis modulators|mesh-ancestor
101446428|NCT00579475|Mifepristone|mifepristone|mesh-list
101446429|NCT00579475|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101446430|NCT00579475|Abortifacient Agents|abortifacient agents|mesh-ancestor
101446431|NCT00579475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101446432|NCT00579475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446433|NCT00579475|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101446434|NCT00579475|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101446435|NCT00579475|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101446436|NCT00579475|Contraceptive Agents|contraceptive agents|mesh-ancestor
101446437|NCT00579475|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101446438|NCT00579475|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101446439|NCT00579475|Hormone Antagonists|hormone antagonists|mesh-ancestor
101446440|NCT00579475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101446441|NCT00579475|Luteolytic Agents|luteolytic agents|mesh-ancestor
101446442|NCT00579475|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101446452|NCT00579592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101446453|NCT00579592|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101446455|NCT00579592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101446456|NCT00579592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101446457|NCT00579592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101660175|NCT05480800|Vaccines|vaccines|mesh-list
101446458|NCT00579592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446459|NCT00180791|Carboplatin|carboplatin|mesh-list
101446460|NCT00180791|Etoposide|etoposide|mesh-list
101446461|NCT00180791|Melphalan|melphalan|mesh-list
101446462|NCT00180791|Thiotepa|thiotepa|mesh-list
101446463|NCT00180791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101446464|NCT00180791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101446465|NCT00180791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101446466|NCT00180791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101446468|NCT00180791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660393|NCT04974528|Insulin Aspart|insulin aspart|mesh-list
101446469|NCT00180791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101363463|NCT00046787|Lurtotecan|lurtotecan|mesh-list
101446470|NCT00180791|Alkylating Agents|alkylating agents|mesh-ancestor
101446471|NCT00180791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101446472|NCT00180791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101446473|NCT00180791|Immunologic Factors|immunologic factors|mesh-ancestor
101446474|NCT00180791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446475|NCT01054248|Artesunate|artesunate|mesh-list
101446476|NCT01054248|Piperaquine|piperaquine|mesh-list
101446477|NCT01054248|Artenimol|artenimol|mesh-list
101446478|NCT01054248|Mefloquine|mefloquine|mesh-list
101446479|NCT01054248|Antimalarials|antimalarials|mesh-ancestor
101446480|NCT01054248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101446481|NCT01054248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101446482|NCT01054248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101446483|NCT01054248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101446484|NCT01054248|Antiviral Agents|antiviral agents|mesh-ancestor
101446485|NCT01054248|Schistosomicides|schistosomicides|mesh-ancestor
101446486|NCT01054248|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101446487|NCT01054248|Anthelmintics|anthelmintics|mesh-ancestor
101446488|NCT00180830|Imatinib Mesylate|imatinib mesylate|mesh-list
101308125|NCT02045940|Hormones|hormones|mesh-ancestor
101308126|NCT02045940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101446489|NCT00180830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101446490|NCT00180830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101446491|NCT00180830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101660698|NCT04410991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101446492|NCT00180830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446493|NCT00202176|Bromides|bromides|mesh-list
101446494|NCT00202176|Ipratropium|ipratropium|mesh-list
101446495|NCT00202176|Anticonvulsants|anticonvulsants|mesh-ancestor
101446496|NCT00202176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101446497|NCT00202176|Autonomic Agents|autonomic agents|mesh-ancestor
101446498|NCT00202176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101446499|NCT00202176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446500|NCT00202176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101446501|NCT00202176|Respiratory System Agents|respiratory system agents|mesh-ancestor
101660787|NCT04154189|Etoposide|etoposide|mesh-list
101446502|NCT00202176|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101446504|NCT00202176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101446505|NCT00202176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446506|NCT00580060|Molgramostim|molgramostim|mesh-list
101446507|NCT00580060|Sargramostim|sargramostim|mesh-list
101446508|NCT00580060|Immunologic Factors|immunologic factors|mesh-ancestor
101446509|NCT00580060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446523|NCT00180908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101446524|NCT00180908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446525|NCT00180908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101446526|NCT00180908|Antimetabolites|antimetabolites|mesh-ancestor
101446527|NCT00180908|Dermatologic Agents|dermatologic agents|mesh-ancestor
101446528|NCT00180908|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101660917|NCT03682068|Antimetabolites|antimetabolites|mesh-ancestor
101446529|NCT00180908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101446530|NCT00180908|Immunologic Factors|immunologic factors|mesh-ancestor
101446531|NCT00180908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101446532|NCT00180908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101446533|NCT00180908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101446534|NCT00180908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101446535|NCT00180908|Alkylating Agents|alkylating agents|mesh-ancestor
101446536|NCT00580450|Thymalfasin|thymalfasin|mesh-list
101446537|NCT00580450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101446538|NCT00580450|Immunologic Factors|immunologic factors|mesh-ancestor
101446539|NCT00580450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446540|NCT00180947|Vinorelbine|vinorelbine|mesh-list
101446541|NCT00180947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101446542|NCT00180947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101446543|NCT00180947|Tubulin Modulators|tubulin modulators|mesh-ancestor
101446544|NCT00180947|Antimitotic Agents|antimitotic agents|mesh-ancestor
101446545|NCT00180947|Mitosis Modulators|mitosis modulators|mesh-ancestor
101446546|NCT00180947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446547|NCT00581035|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101446548|NCT00581035|Immunologic Factors|immunologic factors|mesh-ancestor
101446549|NCT00581035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446550|NCT00581425|Interferons|interferons|mesh-list
101446551|NCT00581425|Interferon-alpha|interferon-alpha|mesh-list
101446552|NCT00581425|Imiquimod|imiquimod|mesh-list
101446553|NCT00581425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101446554|NCT00581425|Antiviral Agents|antiviral agents|mesh-ancestor
101446555|NCT00581425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101446556|NCT00581425|Immunologic Factors|immunologic factors|mesh-ancestor
101446557|NCT00581425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446558|NCT00581425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101446559|NCT00581425|Interferon Inducers|interferon inducers|mesh-ancestor
101446560|NCT00209079|Docetaxel|docetaxel|mesh-list
101446561|NCT00209079|Imatinib Mesylate|imatinib mesylate|mesh-list
101446562|NCT00209079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101446563|NCT00209079|Tubulin Modulators|tubulin modulators|mesh-ancestor
101446564|NCT00209079|Antimitotic Agents|antimitotic agents|mesh-ancestor
101446566|NCT00209079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446567|NCT00209079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101446568|NCT00209079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101446569|NCT04576975|Dexmedetomidine|dexmedetomidine|mesh-list
101446570|NCT04576975|Ketamine|ketamine|mesh-list
101446571|NCT04576975|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101446581|NCT04576975|Adrenergic Agents|adrenergic agents|mesh-ancestor
101446583|NCT04576975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446584|NCT04576975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101446585|NCT04576975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101446586|NCT04576975|Anesthetics, General|anesthetics, general|mesh-ancestor
101446587|NCT04576975|Anesthetics|anesthetics|mesh-ancestor
101446588|NCT04576975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101446589|NCT04576975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101446590|NCT00209118|Paroxetine|paroxetine|mesh-list
101446591|NCT00209118|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101661162|NCT02232152|Antioxidants|antioxidants|mesh-ancestor
101446592|NCT00209118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101446593|NCT00209118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101446594|NCT00209118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446595|NCT00209118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101446596|NCT00209118|Serotonin Agents|serotonin agents|mesh-ancestor
101446597|NCT00209118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661228|NCT01950520|Pindolol|pindolol|mesh-list
101446598|NCT00209118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101446599|NCT00209118|Antidepressive Agents|antidepressive agents|mesh-ancestor
101446600|NCT00209118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101446601|NCT00209118|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101661300|NCT01758432|Apixaban|apixaban|mesh-list
101446602|NCT00209118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101446603|NCT00209118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101446605|NCT00181025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101446606|NCT00181025|Alkylating Agents|alkylating agents|mesh-ancestor
101446607|NCT00181025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446608|NCT00181025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101446609|NCT00181025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101446610|NCT00181025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101446612|NCT00181025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446614|NCT00209313|Antiviral Agents|antiviral agents|mesh-ancestor
101446615|NCT00209313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101446617|NCT00582634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101446618|NCT00582634|Tubulin Modulators|tubulin modulators|mesh-ancestor
101446619|NCT00582634|Antimitotic Agents|antimitotic agents|mesh-ancestor
101661584|NCT00860119|GABA Modulators|gaba modulators|mesh-ancestor
101446620|NCT00582634|Mitosis Modulators|mitosis modulators|mesh-ancestor
101446621|NCT00582634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446622|NCT00209352|Acyclovir|acyclovir|mesh-list
101446623|NCT00209352|Antiviral Agents|antiviral agents|mesh-ancestor
101446624|NCT00209352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101446625|NCT00181142|Daclizumab|daclizumab|mesh-list
101661658|NCT02798250|Insulin|insulin|mesh-list
101446626|NCT00181142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101446627|NCT00181142|Immunologic Factors|immunologic factors|mesh-ancestor
101446628|NCT00181142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446629|NCT00582985|Antibodies|antibodies|mesh-list
101446630|NCT00582985|Immunologic Factors|immunologic factors|mesh-ancestor
101446631|NCT00582985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446632|NCT00187551|Enfuvirtide|enfuvirtide|mesh-list
101446633|NCT00187551|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101446634|NCT00187551|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101446639|NCT00187551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101446640|NCT00181181|Atorvastatin|atorvastatin|mesh-list
101446641|NCT00181181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101446642|NCT00181181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101446643|NCT00181181|Antimetabolites|antimetabolites|mesh-ancestor
101446644|NCT00181181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446645|NCT00181181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101446646|NCT00181181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101446647|NCT00181181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101446648|NCT00181220|Valproic Acid|valproic acid|mesh-list
101446649|NCT00181220|Anticonvulsants|anticonvulsants|mesh-ancestor
101446650|NCT00181220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101661846|NCT02939183|Immunologic Factors|immunologic factors|mesh-ancestor
101446651|NCT00181220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446652|NCT00181220|GABA Agents|gaba agents|mesh-ancestor
101308127|NCT02045940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308128|NCT02045953|Albuterol|albuterol|mesh-list
101308129|NCT02045953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101446653|NCT00181220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101446654|NCT00181220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446655|NCT00181220|Antimanic Agents|antimanic agents|mesh-ancestor
101446656|NCT00181220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101446657|NCT00181220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101446658|NCT00181220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101446660|NCT00583063|Sunitinib|sunitinib|mesh-list
101446661|NCT00583063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101446662|NCT00583063|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101446663|NCT00583063|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101446664|NCT00583063|Growth Substances|growth substances|mesh-ancestor
101446665|NCT00583063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446666|NCT00583063|Growth Inhibitors|growth inhibitors|mesh-ancestor
101446667|NCT00583063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101446668|NCT00583063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101446669|NCT00583063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446670|NCT00583063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101446671|NCT00583063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101446672|NCT00583063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101446673|NCT00583063|Antifungal Agents|antifungal agents|mesh-ancestor
101446674|NCT00583063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101446675|NCT00583063|Immunologic Factors|immunologic factors|mesh-ancestor
101446676|NCT00181298|Memantine|memantine|mesh-list
101446677|NCT00181298|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101446678|NCT00181298|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101446679|NCT00181298|Dopamine Agents|dopamine agents|mesh-ancestor
101446680|NCT00181298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101446681|NCT00181298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446682|NCT00181298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446683|NCT00181298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101446684|NCT00181298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101446686|NCT00583180|Antipruritics|antipruritics|mesh-ancestor
101446687|NCT00583180|Dermatologic Agents|dermatologic agents|mesh-ancestor
101446688|NCT00583180|Sensory System Agents|sensory system agents|mesh-ancestor
101528422|NCT01214044|Autonomic Agents|autonomic agents|mesh-ancestor
101446689|NCT00583180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101446690|NCT00583180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446691|NCT00583258|Alfuzosin|alfuzosin|mesh-list
101446692|NCT00583258|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101446693|NCT00583258|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101446694|NCT00583258|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101446695|NCT00583258|Adrenergic Agents|adrenergic agents|mesh-ancestor
101446696|NCT00583258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101446697|NCT00583258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446698|NCT00583258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446699|NCT00583258|Urological Agents|urological agents|mesh-ancestor
101446700|NCT00181532|Celecoxib|celecoxib|mesh-list
101662472|NCT00617305|Urological Agents|urological agents|mesh-ancestor
101446701|NCT00181532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101446702|NCT00181532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101446716|NCT04576390|Autonomic Agents|autonomic agents|mesh-ancestor
101363472|NCT00133081|Anticonvulsants|anticonvulsants|mesh-list
101446717|NCT04576390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101446718|NCT04576390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446719|NCT04576390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101446720|NCT04576390|Antipruritics|antipruritics|mesh-ancestor
101446721|NCT04576390|Dermatologic Agents|dermatologic agents|mesh-ancestor
101446722|NCT04576390|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101446723|NCT04576390|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101446726|NCT04576390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446727|NCT00181571|Methylphenidate|methylphenidate|mesh-list
101446728|NCT00181571|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101446729|NCT00181571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446730|NCT00181571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101446731|NCT00181571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101446732|NCT00181571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101308130|NCT02045953|Autonomic Agents|autonomic agents|mesh-ancestor
101308131|NCT02045953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101308132|NCT02045953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308133|NCT02045953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101446733|NCT00181571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446734|NCT00181571|Dopamine Agents|dopamine agents|mesh-ancestor
101446735|NCT00181571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101446736|NCT00187707|Gabapentin|gabapentin|mesh-list
101446737|NCT00187707|Analgesics|analgesics|mesh-ancestor
101446738|NCT00187707|Sensory System Agents|sensory system agents|mesh-ancestor
101446739|NCT00187707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101446740|NCT00187707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446741|NCT00187707|Anticonvulsants|anticonvulsants|mesh-ancestor
101446742|NCT00187707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101446743|NCT00187707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101446744|NCT00187707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101446745|NCT00187707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101446746|NCT00187707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101446747|NCT00187707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101446748|NCT00187707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101446749|NCT00187707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446750|NCT00187707|Antimanic Agents|antimanic agents|mesh-ancestor
101446751|NCT00187746|Adefovir|adefovir|mesh-list
101446752|NCT00187746|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101446753|NCT00187746|Antiviral Agents|antiviral agents|mesh-ancestor
101446754|NCT00187746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101446755|NCT00187746|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101663027|NCT02786550|Botulinum Toxins|botulinum toxins|mesh-list
101446756|NCT00187746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101446757|NCT00187746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101446758|NCT00187746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446760|NCT00181688|Gefitinib|gefitinib|mesh-list
101446761|NCT00181688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101446762|NCT00181688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101446763|NCT00181688|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101446764|NCT00181688|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101446769|NCT00181688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101663253|NCT00880321|Anesthetics|anesthetics|mesh-ancestor
101446771|NCT00181688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101446772|NCT00209469|Alendronate|alendronate|mesh-list
101446773|NCT00209469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101446774|NCT00209469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446775|NCT00181727|Valproic Acid|valproic acid|mesh-list
101446776|NCT00181727|Anticonvulsants|anticonvulsants|mesh-ancestor
101663380|NCT05275686|Xhance|xhance|mesh-list
101446777|NCT00181727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101446778|NCT00181727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446780|NCT00181727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101446781|NCT00181727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446782|NCT00181727|Antimanic Agents|antimanic agents|mesh-ancestor
101446783|NCT00181727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101446784|NCT00181727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101446787|NCT00584155|Levofloxacin|levofloxacin|mesh-list
101446788|NCT00584155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101446789|NCT00584155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101446790|NCT00584155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101333466|NCT00039169|IDN 5109|idn 5109|mesh-list
101446791|NCT00584155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101446792|NCT00584155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101446793|NCT00584155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101446794|NCT00584155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446795|NCT00584155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101446796|NCT00584155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101446797|NCT00584155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101446798|NCT00411372|Fluticasone|fluticasone|mesh-list
101446799|NCT00411372|Xhance|xhance|mesh-list
101446800|NCT00411372|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101446801|NCT00411372|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101308134|NCT02045953|Respiratory System Agents|respiratory system agents|mesh-ancestor
101308135|NCT02045953|Tocolytic Agents|tocolytic agents|mesh-ancestor
101663529|NCT05328024|Immunologic Factors|immunologic factors|mesh-ancestor
101308136|NCT02045953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101446802|NCT00411372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101663663|NCT02937116|Antimetabolites|antimetabolites|mesh-ancestor
101446803|NCT00411372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101446804|NCT00411372|Autonomic Agents|autonomic agents|mesh-ancestor
101446805|NCT00411372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101446806|NCT00411372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446807|NCT00411372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101446808|NCT00411372|Respiratory System Agents|respiratory system agents|mesh-ancestor
101446809|NCT00411372|Dermatologic Agents|dermatologic agents|mesh-ancestor
101446810|NCT00411372|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101446811|NCT00411372|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101446812|NCT00411372|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101446813|NCT00411372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101446814|NCT00411372|Adrenergic Agents|adrenergic agents|mesh-ancestor
101446815|NCT00411372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101446816|NCT00411372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446817|NCT00411372|Glucocorticoids|glucocorticoids|mesh-ancestor
101446819|NCT00411372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101446820|NCT00411372|Sympathomimetics|sympathomimetics|mesh-ancestor
101446821|NCT00181922|Ziprasidone|ziprasidone|mesh-list
101446822|NCT00181922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101446823|NCT00181922|Serotonin Agents|serotonin agents|mesh-ancestor
101446824|NCT00181922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101446825|NCT00181922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446826|NCT00181922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446827|NCT00181922|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101446828|NCT00181922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101446829|NCT00181922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101446830|NCT00181922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101446831|NCT00181922|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101446832|NCT00181922|Dopamine Agents|dopamine agents|mesh-ancestor
101446839|NCT00182039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446840|NCT00182039|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101446841|NCT00182039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101446842|NCT00182039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101446843|NCT00182039|Adrenergic Agents|adrenergic agents|mesh-ancestor
101446844|NCT00182039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101446845|NCT00182039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446846|NCT00584389|Rimonabant|rimonabant|mesh-list
101446847|NCT00584389|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101446848|NCT00584389|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
101446849|NCT00584389|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101446850|NCT00584389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101446851|NCT00584389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446852|NCT00584389|Hormones|hormones|mesh-ancestor
101446853|NCT00584389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101446854|NCT00584389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446855|NCT00216372|Lanreotide|lanreotide|mesh-list
101446856|NCT00216372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101446860|NCT00584662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101446861|NCT00584662|Adrenergic Agents|adrenergic agents|mesh-ancestor
101446862|NCT00584662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101446863|NCT00584662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333470|NCT00001304|Calcium|calcium|mesh-list
101446864|NCT00584662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446865|NCT00584662|Sympathomimetics|sympathomimetics|mesh-ancestor
101446866|NCT00584662|Autonomic Agents|autonomic agents|mesh-ancestor
101446867|NCT00584662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101446868|NCT00584662|Nasal Decongestants|nasal decongestants|mesh-ancestor
101446869|NCT00584662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101446870|NCT00584662|Respiratory System Agents|respiratory system agents|mesh-ancestor
101446871|NCT00584662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101446872|NCT00584662|Mydriatics|mydriatics|mesh-ancestor
101446873|NCT00584662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101446874|NCT00584662|Protective Agents|protective agents|mesh-ancestor
101446875|NCT00584779|Gabapentin|gabapentin|mesh-list
101308137|NCT02045953|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101308138|NCT02045953|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101308139|NCT02045953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101308140|NCT02045953|Adrenergic Agents|adrenergic agents|mesh-ancestor
101308141|NCT02045953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101446876|NCT00584779|Analgesics|analgesics|mesh-ancestor
101446877|NCT00584779|Sensory System Agents|sensory system agents|mesh-ancestor
101446878|NCT00584779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101446879|NCT00584779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446880|NCT00584779|Anticonvulsants|anticonvulsants|mesh-ancestor
101446881|NCT00584779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101446882|NCT00584779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101446883|NCT00584779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101446884|NCT00584779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101446885|NCT00584779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101446886|NCT00584779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101446887|NCT00584779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101446888|NCT00584779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446889|NCT00584779|Antimanic Agents|antimanic agents|mesh-ancestor
101446890|NCT00216411|Botulinum Toxins|botulinum toxins|mesh-list
101446891|NCT00216411|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101446892|NCT00216411|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101446893|NCT00216411|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101446894|NCT00216411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101446895|NCT00216411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446896|NCT00216411|Cholinergic Agents|cholinergic agents|mesh-ancestor
101446897|NCT00216411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101446898|NCT00216411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446905|NCT00585091|Autonomic Agents|autonomic agents|mesh-ancestor
101446906|NCT00585091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101446907|NCT00585091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446908|NCT00585091|Sympathomimetics|sympathomimetics|mesh-ancestor
101446909|NCT00585091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101446910|NCT00585091|Nasal Decongestants|nasal decongestants|mesh-ancestor
101446911|NCT00585091|Respiratory System Agents|respiratory system agents|mesh-ancestor
101446912|NCT00585091|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101446913|NCT00585091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101446914|NCT00585091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101446915|NCT00585091|Adrenergic Agents|adrenergic agents|mesh-ancestor
101446916|NCT00585091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101446917|NCT00585091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664384|NCT02833610|Denosumab|denosumab|mesh-list
101446918|NCT00585091|Protective Agents|protective agents|mesh-ancestor
101446919|NCT00216450|Rabeprazole|rabeprazole|mesh-list
101446920|NCT00216450|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101446921|NCT00216450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101446922|NCT00216450|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101446923|NCT00216450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101446924|NCT00216450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446926|NCT00585442|Calcitriol|calcitriol|mesh-list
101446927|NCT00585442|Vitamins|vitamins|mesh-ancestor
101446928|NCT00585442|Micronutrients|micronutrients|mesh-ancestor
101446929|NCT00585442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446930|NCT00585442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101446931|NCT00585442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101363476|NCT00133198|Protective Agents|protective agents|mesh-ancestor
101446932|NCT00585442|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101664678|NCT02856503|Vitamin D|vitamin d|mesh-list
101446933|NCT00585442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101446934|NCT00585442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446935|NCT00585442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101446937|NCT00585520|Progestins|progestins|mesh-ancestor
101446938|NCT00585520|Hormones|hormones|mesh-ancestor
101446939|NCT00585520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101446940|NCT00585520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308142|NCT02045953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308143|NCT02045992|Caffeine|caffeine|mesh-list
101664737|NCT00946985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101308144|NCT02045992|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101446941|NCT00216489|Rabeprazole|rabeprazole|mesh-list
101446942|NCT00216489|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101446943|NCT00216489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101446944|NCT00216489|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101446945|NCT00216489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101446946|NCT00216489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446947|NCT00585754|Guanfacine|guanfacine|mesh-list
101446948|NCT00585754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101446949|NCT00585754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101446950|NCT00585754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101446951|NCT00585754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101446952|NCT00585754|Adrenergic Agents|adrenergic agents|mesh-ancestor
101446953|NCT00585754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101446954|NCT00585754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446955|NCT00585754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446956|NCT00209547|Fospropofol|fospropofol|mesh-list
101446957|NCT00209547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101446958|NCT00209547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101446959|NCT00209547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446960|NCT00585871|Metoprolol|metoprolol|mesh-list
101446961|NCT00585871|Clonidine|clonidine|mesh-list
101446962|NCT00585871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101446963|NCT00585871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101446964|NCT00585871|Sympatholytics|sympatholytics|mesh-ancestor
101446965|NCT00585871|Autonomic Agents|autonomic agents|mesh-ancestor
101446966|NCT00585871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101446976|NCT00585871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101446977|NCT00585871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101446978|NCT00585871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101446980|NCT03452722|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101446981|NCT03452722|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101446982|NCT03452722|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101665147|NCT02766036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101446983|NCT03452722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446985|NCT00408551|Fluorouracil|fluorouracil|mesh-list
101446986|NCT00408551|Floxuridine|floxuridine|mesh-list
101446987|NCT00408551|Oxaliplatin|oxaliplatin|mesh-list
101446988|NCT00408551|Irinotecan|irinotecan|mesh-list
101446989|NCT00408551|Calcium|calcium|mesh-list
101446990|NCT00408551|Levoleucovorin|levoleucovorin|mesh-list
101446991|NCT00408551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101446992|NCT00408551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446994|NCT00408551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446995|NCT00408551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101446996|NCT00408551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101446997|NCT00408551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101446998|NCT00408551|Immunologic Factors|immunologic factors|mesh-ancestor
101446999|NCT00408551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101447000|NCT00408551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101447001|NCT00408551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101447002|NCT00408551|Antidotes|antidotes|mesh-ancestor
101447003|NCT00408551|Protective Agents|protective agents|mesh-ancestor
101447004|NCT00408551|Vitamin B Complex|vitamin b complex|mesh-ancestor
101447006|NCT00408551|Micronutrients|micronutrients|mesh-ancestor
101447007|NCT04575415|Bevacizumab|bevacizumab|mesh-list
101447008|NCT04575415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101447009|NCT04575415|Gefitinib|gefitinib|mesh-list
101447010|NCT04575415|Osimertinib|osimertinib|mesh-list
101447011|NCT04575415|Afatinib|afatinib|mesh-list
101447012|NCT04575415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101447013|NCT04575415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101447014|NCT04575415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101447015|NCT04575415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101447016|NCT04575415|Growth Substances|growth substances|mesh-ancestor
101447017|NCT04575415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447018|NCT04575415|Growth Inhibitors|growth inhibitors|mesh-ancestor
101308145|NCT02045992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308146|NCT02045992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101308147|NCT02045992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101308148|NCT02045992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447019|NCT04575415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101447020|NCT04575415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101447021|NCT04575415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447022|NCT00209625|Leucovorin|leucovorin|mesh-list
101447023|NCT00209625|Fluorouracil|fluorouracil|mesh-list
101447024|NCT00209625|Irinotecan|irinotecan|mesh-list
101447025|NCT00209625|Antimetabolites|antimetabolites|mesh-ancestor
101447026|NCT00209625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447027|NCT00209625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101447028|NCT00209625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101447029|NCT00209625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101447030|NCT00209625|Immunologic Factors|immunologic factors|mesh-ancestor
101447031|NCT00209625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447032|NCT00209625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101447033|NCT00209625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101447046|NCT00216528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101447047|NCT00216528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101447048|NCT00216528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101447049|NCT00216528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101447050|NCT00216528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101447051|NCT00216528|Dopamine Agents|dopamine agents|mesh-ancestor
101447052|NCT00182312|Caffeine|caffeine|mesh-list
101447053|NCT00182312|Caffeine citrate|caffeine citrate|mesh-list
101447054|NCT00182312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447055|NCT00182312|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101447056|NCT00182312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447057|NCT00182312|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101447058|NCT00182312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101447059|NCT00182312|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101447061|NCT00182312|Purinergic Agents|purinergic agents|mesh-ancestor
101447062|NCT00182312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101447063|NCT00209664|Irinotecan|irinotecan|mesh-list
101447064|NCT00209664|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101447065|NCT00209664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101447066|NCT00209664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101447067|NCT00209664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447068|NCT00209664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101447069|NCT04575493|Ciprofloxacin|ciprofloxacin|mesh-list
101447070|NCT04575493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101447071|NCT04575493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101447072|NCT04575493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101447073|NCT04575493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101447074|NCT04575493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101447075|NCT04575493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447076|NCT04575493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101447077|NCT04575493|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101447078|NCT04575493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101447080|NCT00587119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101447081|NCT00587119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101447082|NCT00587119|Autonomic Agents|autonomic agents|mesh-ancestor
101447083|NCT00587119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101447084|NCT00587119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447085|NCT00587119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101447086|NCT00587119|Respiratory System Agents|respiratory system agents|mesh-ancestor
101447087|NCT00587119|Glucocorticoids|glucocorticoids|mesh-ancestor
101447088|NCT00587119|Hormones|hormones|mesh-ancestor
101666180|NCT00894751|Anesthetics|anesthetics|mesh-ancestor
101363488|NCT00046826|Antimitotic Agents|antimitotic agents|mesh-ancestor
101447089|NCT00587119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101447090|NCT00216567|Topiramate|topiramate|mesh-list
101666250|NCT00901069|Azacitidine|azacitidine|mesh-list
101447092|NCT00216567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101447093|NCT00216567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447094|NCT00182351|Fibrin fragment D|fibrin fragment d|mesh-list
101447095|NCT00182351|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101447096|NCT00182351|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101308149|NCT02045992|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101308150|NCT02045992|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101308151|NCT02045992|Purinergic Agents|purinergic agents|mesh-ancestor
101447097|NCT00182351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447105|NCT00587470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447107|NCT00209703|Fluorouracil|fluorouracil|mesh-list
101447108|NCT00209703|Oxaliplatin|oxaliplatin|mesh-list
101447109|NCT00209703|Levoleucovorin|levoleucovorin|mesh-list
101447110|NCT00209703|Antimetabolites|antimetabolites|mesh-ancestor
101447111|NCT00209703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447112|NCT00209703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101447113|NCT00209703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101447114|NCT00209703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101447115|NCT00209703|Immunologic Factors|immunologic factors|mesh-ancestor
101447116|NCT00209703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447118|NCT00209703|Protective Agents|protective agents|mesh-ancestor
101447119|NCT00209703|Vitamin B Complex|vitamin b complex|mesh-ancestor
101447121|NCT00209703|Micronutrients|micronutrients|mesh-ancestor
101447122|NCT04575103|Antipsychotic Agents|antipsychotic agents|mesh-list
101447123|NCT04575103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101447124|NCT04575103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101447125|NCT04575103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447126|NCT04575103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101447127|NCT00587548|Diethylenetriamine|diethylenetriamine|mesh-list
101447128|NCT00587548|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101447129|NCT00587548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447131|NCT00216606|Anticonvulsants|anticonvulsants|mesh-ancestor
101447132|NCT00216606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101447133|NCT00216606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447134|NCT00587665|Ketamine|ketamine|mesh-list
101447135|NCT00587665|Analgesics|analgesics|mesh-ancestor
101447136|NCT00587665|Sensory System Agents|sensory system agents|mesh-ancestor
101447137|NCT00587665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101447138|NCT00587665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447139|NCT00587665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101447140|NCT00587665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101447141|NCT00587665|Anesthetics, General|anesthetics, general|mesh-ancestor
101447142|NCT00587665|Anesthetics|anesthetics|mesh-ancestor
101447143|NCT00587665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101447144|NCT00587665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101447145|NCT00587665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101447146|NCT00587665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101447147|NCT00587665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447148|NCT00182429|Metronidazole|metronidazole|mesh-list
101447149|NCT00182429|Rifampin|rifampin|mesh-list
101447150|NCT00182429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101447151|NCT00182429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101447153|NCT00182429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101447154|NCT00182429|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101447155|NCT00182429|Antitubercular Agents|antitubercular agents|mesh-ancestor
101447156|NCT00182429|Leprostatic Agents|leprostatic agents|mesh-ancestor
101447157|NCT00182429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101447158|NCT00182429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101447159|NCT00182429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447160|NCT00182429|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101447161|NCT00182429|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101666716|NCT02540395|Prednisolone acetate|prednisolone acetate|mesh-list
101447162|NCT00182429|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101447163|NCT00182429|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101447167|NCT00216645|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101447168|NCT00216645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101447169|NCT00216645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101447170|NCT00216645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101447171|NCT00216645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101447172|NCT00216645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101308152|NCT02045992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101666782|NCT00602693|Antioxidants|antioxidants|mesh-ancestor
101447173|NCT00216645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447176|NCT00588016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101447177|NCT00588016|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101447178|NCT00588016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101447179|NCT00588016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101447180|NCT00588016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447181|NCT00588016|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101447183|NCT00588016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101447184|NCT00588016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447185|NCT00588016|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101447186|NCT00216684|Fentanyl|fentanyl|mesh-list
101447187|NCT00216684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101447188|NCT00216684|Narcotics|narcotics|mesh-ancestor
101447189|NCT00216684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101447190|NCT00216684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447191|NCT00216684|Analgesics|analgesics|mesh-ancestor
101447192|NCT00216684|Sensory System Agents|sensory system agents|mesh-ancestor
101447193|NCT00216684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101447194|NCT00216684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101447195|NCT00216684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101447196|NCT00216684|Anesthetics, General|anesthetics, general|mesh-ancestor
101447197|NCT00216684|Anesthetics|anesthetics|mesh-ancestor
101447198|NCT00588133|Tranexamic Acid|tranexamic acid|mesh-list
101447199|NCT00588133|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101447200|NCT00588133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101447201|NCT00588133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447202|NCT00588133|Hemostatics|hemostatics|mesh-ancestor
101447203|NCT00588133|Coagulants|coagulants|mesh-ancestor
101447204|NCT00588172|Metformin|metformin|mesh-list
101447205|NCT00588172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101447206|NCT00588172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447207|NCT00182507|Olanzapine|olanzapine|mesh-list
101447208|NCT00182507|Antiemetics|antiemetics|mesh-ancestor
101447209|NCT00182507|Autonomic Agents|autonomic agents|mesh-ancestor
101447210|NCT00182507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101447211|NCT00182507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447212|NCT00182507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101447213|NCT00182507|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101447214|NCT00182507|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101447215|NCT00182507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101447216|NCT00182507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101447217|NCT00182507|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101447218|NCT00182507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101447219|NCT00182507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101447220|NCT00182507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447221|NCT00182507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101447222|NCT00182507|Serotonin Agents|serotonin agents|mesh-ancestor
101447223|NCT00209742|Leucovorin|leucovorin|mesh-list
101447224|NCT00209742|polysaccharide-K|polysaccharide-k|mesh-list
101447225|NCT00209742|Tegafur|tegafur|mesh-list
101447226|NCT00209742|Levoleucovorin|levoleucovorin|mesh-list
101447227|NCT00209742|Antidotes|antidotes|mesh-ancestor
101447228|NCT00209742|Protective Agents|protective agents|mesh-ancestor
101447229|NCT00209742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447230|NCT00209742|Vitamin B Complex|vitamin b complex|mesh-ancestor
101447231|NCT00209742|Vitamins|vitamins|mesh-ancestor
101447232|NCT00209742|Micronutrients|micronutrients|mesh-ancestor
101447233|NCT00209742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101447234|NCT00209742|Antimetabolites|antimetabolites|mesh-ancestor
101447238|NCT00209742|Immunologic Factors|immunologic factors|mesh-ancestor
101447239|NCT00209742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101447241|NCT00209742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101447242|NCT00209742|Interferon Inducers|interferon inducers|mesh-ancestor
101447243|NCT00209742|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101447244|NCT00216723|Aripiprazole|aripiprazole|mesh-list
101447245|NCT00216723|Antidepressive Agents|antidepressive agents|mesh-ancestor
101447246|NCT00216723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101447247|NCT00216723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101447248|NCT00216723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101447249|NCT00216723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101308153|NCT02046044|Digoxin|digoxin|mesh-list
101308154|NCT02046044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101308155|NCT02046044|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101308156|NCT02046044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101447250|NCT00216723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447251|NCT00216723|Dopamine Agonists|dopamine agonists|mesh-ancestor
101447252|NCT00216723|Dopamine Agents|dopamine agents|mesh-ancestor
101447253|NCT00216723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101447254|NCT00216723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447255|NCT00216723|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101447256|NCT00216723|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101447257|NCT00216723|Serotonin Agents|serotonin agents|mesh-ancestor
101447258|NCT00216723|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101447259|NCT00216723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101447260|NCT00216723|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101447261|NCT00216723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101447262|NCT00209781|Pyrimethamine|pyrimethamine|mesh-list
101447263|NCT00209781|Sulfadoxine|sulfadoxine|mesh-list
101447264|NCT00209781|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101447265|NCT00209781|Antimalarials|antimalarials|mesh-ancestor
101447266|NCT00209781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101447267|NCT00209781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101447268|NCT00209781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101447269|NCT00209781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101447270|NCT00209781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101447271|NCT00209781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447272|NCT00209781|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101447273|NCT00182663|Clarithromycin|clarithromycin|mesh-list
101667543|NCT00005112|Hormones|hormones|mesh-list
101447275|NCT00182663|Dexamethasone|dexamethasone|mesh-list
101447276|NCT00182663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101447277|NCT00182663|Antiemetics|antiemetics|mesh-ancestor
101447278|NCT00182663|Autonomic Agents|autonomic agents|mesh-ancestor
101447280|NCT00182663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447281|NCT00182663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101447282|NCT00182663|Glucocorticoids|glucocorticoids|mesh-ancestor
101447283|NCT00182663|Hormones|hormones|mesh-ancestor
101447284|NCT00182663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101447285|NCT00182663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101447286|NCT00182663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101447287|NCT00182663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101447288|NCT00182663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101447289|NCT00182663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101447290|NCT00182663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101447291|NCT00182663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447292|NCT00182663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101447293|NCT00182663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101447294|NCT00182663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101447295|NCT00182663|Immunologic Factors|immunologic factors|mesh-ancestor
101447296|NCT00182663|Leprostatic Agents|leprostatic agents|mesh-ancestor
101447297|NCT00182663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101447298|NCT00182663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101447299|NCT00182663|Growth Substances|growth substances|mesh-ancestor
101447300|NCT00182663|Growth Inhibitors|growth inhibitors|mesh-ancestor
101447301|NCT00216762|Rituximab|rituximab|mesh-list
101447302|NCT00216762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101667634|NCT02538367|Prucalopride|prucalopride|mesh-list
101447303|NCT00216762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101447304|NCT00216762|Immunologic Factors|immunologic factors|mesh-ancestor
101447311|NCT00182702|Mitosis Modulators|mitosis modulators|mesh-ancestor
101447312|NCT00182702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447313|NCT00182702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101447314|NCT00588835|Dexamethasone|dexamethasone|mesh-list
101447315|NCT00588835|Ondansetron|ondansetron|mesh-list
101447316|NCT00588835|Aprepitant|aprepitant|mesh-list
101447317|NCT00588835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101447318|NCT00588835|Antiemetics|antiemetics|mesh-ancestor
101447319|NCT00588835|Autonomic Agents|autonomic agents|mesh-ancestor
101447320|NCT00588835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101447321|NCT00588835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447322|NCT00588835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101447323|NCT00588835|Glucocorticoids|glucocorticoids|mesh-ancestor
101308158|NCT02046044|Protective Agents|protective agents|mesh-ancestor
101308159|NCT02046044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308160|NCT02046109|Chlorhexidine|chlorhexidine|mesh-list
101308161|NCT02046109|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101308162|NCT02046109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101308163|NCT02046109|Disinfectants|disinfectants|mesh-ancestor
101308164|NCT02046187|Temozolomide|temozolomide|mesh-list
101447325|NCT00588835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101447326|NCT00588835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101447327|NCT00588835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101447328|NCT00588835|Antipruritics|antipruritics|mesh-ancestor
101447329|NCT00588835|Dermatologic Agents|dermatologic agents|mesh-ancestor
101447330|NCT00588835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101447331|NCT00588835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101447332|NCT00588835|Serotonin Agents|serotonin agents|mesh-ancestor
101447333|NCT00588835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101447334|NCT00588835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447335|NCT00588835|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101447336|NCT00209859|Cyclosporine|cyclosporine|mesh-list
101447337|NCT00209859|Betamethasone|betamethasone|mesh-list
101447338|NCT00209859|Methotrexate|methotrexate|mesh-list
101447339|NCT00209859|Cyclosporins|cyclosporins|mesh-list
101447340|NCT00209859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101447341|NCT00209859|Abortifacient Agents|abortifacient agents|mesh-ancestor
101447342|NCT00209859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101447343|NCT00209859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447344|NCT00209859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101447345|NCT00209859|Antimetabolites|antimetabolites|mesh-ancestor
101447346|NCT00209859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447347|NCT00209859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101447348|NCT00209859|Dermatologic Agents|dermatologic agents|mesh-ancestor
101447349|NCT00209859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101447350|NCT00209859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101447351|NCT00209859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101447352|NCT00209859|Immunologic Factors|immunologic factors|mesh-ancestor
101447353|NCT00209859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101447354|NCT00209859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101447355|NCT00209859|Antifungal Agents|antifungal agents|mesh-ancestor
101447356|NCT00209859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101447357|NCT00209859|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101447358|NCT00209859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101447359|NCT00209859|Glucocorticoids|glucocorticoids|mesh-ancestor
101447361|NCT00209859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101447362|NCT00209859|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101447363|NCT00209859|Respiratory System Agents|respiratory system agents|mesh-ancestor
101447364|NCT00588913|Zoledronic Acid|zoledronic acid|mesh-list
101447365|NCT00588913|Aldesleukin|aldesleukin|mesh-list
101447366|NCT00588913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101447367|NCT00588913|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101447368|NCT00588913|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101447369|NCT00588913|Antiviral Agents|antiviral agents|mesh-ancestor
101447370|NCT00588913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101447371|NCT00588913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101447372|NCT00588913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447373|NCT00182741|Calcitriol|calcitriol|mesh-list
101447374|NCT00182741|Prednisone|prednisone|mesh-list
101447375|NCT00182741|Mitoxantrone|mitoxantrone|mesh-list
101447376|NCT00182741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101447378|NCT00182741|Hormones|hormones|mesh-ancestor
101447379|NCT00182741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101447380|NCT00182741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308165|NCT02046187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101308167|NCT02046187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447381|NCT00182741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101447382|NCT00182741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101447383|NCT00182741|Analgesics|analgesics|mesh-ancestor
101447384|NCT00182741|Sensory System Agents|sensory system agents|mesh-ancestor
101447385|NCT00182741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101447386|NCT00182741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101447387|NCT00182741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101447388|NCT00182741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101447389|NCT00182741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447390|NCT00182741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101447391|NCT00182741|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101447392|NCT00182741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101447393|NCT00182741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101447394|NCT00182741|Vitamins|vitamins|mesh-ancestor
101447395|NCT00182741|Micronutrients|micronutrients|mesh-ancestor
101668205|NCT00908323|Vaccines|vaccines|mesh-list
101447396|NCT00182741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101447398|NCT00589186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101447399|NCT00589186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101447400|NCT00589186|Analgesics|analgesics|mesh-ancestor
101447401|NCT00589186|Sensory System Agents|sensory system agents|mesh-ancestor
101447402|NCT00589186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101447404|NCT00589186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101447405|NCT00589186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101447406|NCT00589186|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101447407|NCT00589186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101447408|NCT00589186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101447409|NCT00589186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447410|NCT00589264|Copper|copper|mesh-list
101447411|NCT00589264|Trace Elements|trace elements|mesh-ancestor
101447412|NCT00589264|Micronutrients|micronutrients|mesh-ancestor
101447413|NCT00589264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447414|NCT00589381|Fenretinide|fenretinide|mesh-list
101447415|NCT00589381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101447416|NCT00589381|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101447417|NCT00589381|Protective Agents|protective agents|mesh-ancestor
101447418|NCT00589381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447419|NCT00182819|Temozolomide|temozolomide|mesh-list
101447420|NCT00182819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101447421|NCT00182819|Alkylating Agents|alkylating agents|mesh-ancestor
101668273|NCT04240496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101447422|NCT00182819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447423|NCT00182819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101447424|NCT00216840|Betamethasone|betamethasone|mesh-list
101447425|NCT00216840|Betamethasone Valerate|betamethasone valerate|mesh-list
101447426|NCT00216840|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101447427|NCT00216840|Betamethasone benzoate|betamethasone benzoate|mesh-list
101447428|NCT00216840|Calcipotriene|calcipotriene|mesh-list
101447429|NCT00216840|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101447430|NCT00216840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101447431|NCT00216840|Glucocorticoids|glucocorticoids|mesh-ancestor
101447433|NCT00216840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101447434|NCT00216840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447435|NCT00216840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101447436|NCT00216840|Respiratory System Agents|respiratory system agents|mesh-ancestor
101668336|NCT00931645|Hormones|hormones|mesh-ancestor
101447437|NCT00216840|Dermatologic Agents|dermatologic agents|mesh-ancestor
101447438|NCT00589732|Valsartan|valsartan|mesh-list
101447439|NCT00589732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101668385|NCT05658692|Anesthetics, General|anesthetics, general|mesh-ancestor
101447440|NCT00589732|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101447441|NCT00589732|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101447442|NCT00589732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447443|NCT00216879|Betamethasone|betamethasone|mesh-list
101447444|NCT00216879|Betamethasone Valerate|betamethasone valerate|mesh-list
101447445|NCT00216879|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101447446|NCT00216879|Betamethasone benzoate|betamethasone benzoate|mesh-list
101447447|NCT00216879|Calcipotriene|calcipotriene|mesh-list
101447448|NCT00216879|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101308168|NCT02046187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308169|NCT02046304|Gemcitabine|gemcitabine|mesh-list
101308170|NCT02046304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101308171|NCT02046304|Antimetabolites|antimetabolites|mesh-ancestor
101447449|NCT00216879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101447450|NCT00216879|Glucocorticoids|glucocorticoids|mesh-ancestor
101447454|NCT00216879|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101447455|NCT00216879|Respiratory System Agents|respiratory system agents|mesh-ancestor
101447456|NCT00216879|Dermatologic Agents|dermatologic agents|mesh-ancestor
101447458|NCT00589927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101447459|NCT00589927|Autonomic Agents|autonomic agents|mesh-ancestor
101447460|NCT00589927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101447461|NCT00589927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447462|NCT00589927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101447463|NCT00589927|Respiratory System Agents|respiratory system agents|mesh-ancestor
101447464|NCT00589927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101447465|NCT00589927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101447466|NCT00589927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447467|NCT00589927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101447468|NCT00589927|Vasodilator Agents|vasodilator agents|mesh-ancestor
101447469|NCT00589927|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101447470|NCT00589927|Protective Agents|protective agents|mesh-ancestor
101447471|NCT00589927|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101447472|NCT00589927|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101447473|NCT00589927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101447474|NCT00209937|Gaboxadol|gaboxadol|mesh-list
101447475|NCT00209937|Analgesics|analgesics|mesh-ancestor
101447476|NCT00209937|Sensory System Agents|sensory system agents|mesh-ancestor
101447477|NCT00209937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101447478|NCT00209937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447479|NCT00209937|Anticonvulsants|anticonvulsants|mesh-ancestor
101447480|NCT00209937|GABA Agonists|gaba agonists|mesh-ancestor
101447481|NCT00209937|GABA Agents|gaba agents|mesh-ancestor
101447482|NCT00209937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101447483|NCT00209937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447485|NCT00590278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101447486|NCT00590278|Antimetabolites|antimetabolites|mesh-ancestor
101447487|NCT00590278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447488|NCT00590278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101447489|NCT00590278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101447490|NCT00590278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101447491|NCT00216918|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101447492|NCT00216918|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101447493|NCT00216918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101447494|NCT00216918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101447495|NCT00216918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447496|NCT00216918|Adrenergic Agents|adrenergic agents|mesh-ancestor
101668789|NCT00775203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101447497|NCT00216918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101447498|NCT00216918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447499|NCT04574791|Tizanidine|tizanidine|mesh-list
101447500|NCT04574791|Analgesics|analgesics|mesh-ancestor
101447501|NCT04574791|Sensory System Agents|sensory system agents|mesh-ancestor
101447502|NCT04574791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101668849|NCT04480190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101447503|NCT04574791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447504|NCT04574791|Anticonvulsants|anticonvulsants|mesh-ancestor
101447505|NCT04574791|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101447506|NCT04574791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101447507|NCT04574791|Parasympatholytics|parasympatholytics|mesh-ancestor
101447508|NCT04574791|Autonomic Agents|autonomic agents|mesh-ancestor
101447509|NCT04574791|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101447510|NCT04574791|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101447511|NCT04574791|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101447512|NCT04574791|Adrenergic Agents|adrenergic agents|mesh-ancestor
101668918|NCT02819102|Protease Inhibitors|protease inhibitors|mesh-ancestor
101447513|NCT04574791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101447514|NCT04574791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447516|NCT00590629|Nicotinic Acids|nicotinic acids|mesh-list
101308172|NCT02046304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308173|NCT02046304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101447517|NCT00590629|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101447518|NCT00590629|Antimetabolites|antimetabolites|mesh-ancestor
101447519|NCT00590629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447520|NCT00590629|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101447525|NCT00590629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447526|NCT00590785|Tamoxifen|tamoxifen|mesh-list
101447527|NCT00590785|Ciprofloxacin|ciprofloxacin|mesh-list
101447528|NCT00590785|Cyclophosphamide|cyclophosphamide|mesh-list
101447529|NCT00590785|Doxorubicin|doxorubicin|mesh-list
101447530|NCT00590785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101447531|NCT00590785|Immunologic Factors|immunologic factors|mesh-ancestor
101447532|NCT00590785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447533|NCT00590785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101447534|NCT00590785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101447535|NCT00590785|Alkylating Agents|alkylating agents|mesh-ancestor
101447536|NCT00590785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447537|NCT00590785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101447538|NCT00590785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101447539|NCT00590785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101447540|NCT00590785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101447541|NCT00590785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101447542|NCT00590785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101447543|NCT00590785|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101447544|NCT00590785|Hormone Antagonists|hormone antagonists|mesh-ancestor
101447545|NCT00590785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101668981|NCT02731950|Magnesium Sulfate|magnesium sulfate|mesh-list
101447547|NCT00590785|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101447548|NCT00590785|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101447549|NCT00590785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101447550|NCT00590785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101447551|NCT00590785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101447552|NCT00590785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101447553|NCT00590785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101447554|NCT00477295|Carbamazepine|carbamazepine|mesh-list
101447555|NCT00477295|Zonisamide|zonisamide|mesh-list
101447556|NCT00477295|Anticonvulsants|anticonvulsants|mesh-ancestor
101447557|NCT00477295|Antimanic Agents|antimanic agents|mesh-ancestor
101447558|NCT00477295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101447559|NCT00477295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101447560|NCT00477295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447561|NCT00477295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101447562|NCT00477295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101447563|NCT00477295|Analgesics|analgesics|mesh-ancestor
101447564|NCT00477295|Sensory System Agents|sensory system agents|mesh-ancestor
101447565|NCT00477295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101447566|NCT00477295|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101447567|NCT00477295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101447568|NCT00477295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669228|NCT02814500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101447569|NCT00477295|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101447570|NCT00477295|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101447571|NCT00477295|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101447572|NCT00477295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101447573|NCT00476593|Dexamethasone|dexamethasone|mesh-list
101447574|NCT00476593|Diclofenac|diclofenac|mesh-list
101447575|NCT00476593|Lactitol|lactitol|mesh-list
101447576|NCT00476593|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101447577|NCT00476593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101447578|NCT00476593|Antiemetics|antiemetics|mesh-ancestor
101447579|NCT00476593|Autonomic Agents|autonomic agents|mesh-ancestor
101447580|NCT00476593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101447582|NCT00476593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101447583|NCT00476593|Glucocorticoids|glucocorticoids|mesh-ancestor
101447585|NCT00476593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101447586|NCT00476593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101447587|NCT00476593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101447588|NCT00476593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101669582|NCT05685628|Charcoal|charcoal|mesh-list
101308174|NCT02046421|Carboplatin|carboplatin|mesh-list
101308175|NCT02046421|Gemcitabine|gemcitabine|mesh-list
101308176|NCT02046421|Mifepristone|mifepristone|mesh-list
101447589|NCT00476593|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101447590|NCT00476593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101447591|NCT00476593|Analgesics|analgesics|mesh-ancestor
101669641|NCT05617963|Durvalumab|durvalumab|mesh-list
101447594|NCT00476593|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101447595|NCT00476593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101447596|NCT00476593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447597|NCT00476593|Cathartics|cathartics|mesh-ancestor
101447598|NCT00210132|Ropivacaine|ropivacaine|mesh-list
101447599|NCT00210132|Anesthetics, Local|anesthetics, local|mesh-ancestor
101447600|NCT00210132|Anesthetics|anesthetics|mesh-ancestor
101447601|NCT00210132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101447602|NCT00210132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447603|NCT00210132|Sensory System Agents|sensory system agents|mesh-ancestor
101447604|NCT00210132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101447605|NCT00183404|Olanzapine|olanzapine|mesh-list
101447606|NCT00183404|Antiemetics|antiemetics|mesh-ancestor
101447607|NCT00183404|Autonomic Agents|autonomic agents|mesh-ancestor
101447608|NCT00183404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101447609|NCT00183404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447610|NCT00183404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101447611|NCT00183404|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101447612|NCT00183404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101447613|NCT00183404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101447614|NCT00183404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101447615|NCT00183404|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101447616|NCT00183404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101447617|NCT00183404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101447618|NCT00183404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669692|NCT05487950|Protease Inhibitors|protease inhibitors|mesh-ancestor
101447619|NCT00183404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101447620|NCT00183404|Serotonin Agents|serotonin agents|mesh-ancestor
101447621|NCT00476476|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101447622|NCT00476476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101447624|NCT00476476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101447625|NCT00476476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447626|NCT00183560|Antidepressive Agents|antidepressive agents|mesh-list
101447627|NCT00183560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101447628|NCT00217152|Mycophenolic Acid|mycophenolic acid|mesh-list
101447629|NCT00217152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101447630|NCT00217152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101669809|NCT05211804|Growth Inhibitors|growth inhibitors|mesh-ancestor
101447631|NCT00217152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101447632|NCT00217152|Antitubercular Agents|antitubercular agents|mesh-ancestor
101447633|NCT00217152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101447634|NCT00217152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101447635|NCT00217152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101447636|NCT00217152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447637|NCT00210210|Ketamine|ketamine|mesh-list
101447638|NCT00210210|Analgesics|analgesics|mesh-ancestor
101447639|NCT00210210|Sensory System Agents|sensory system agents|mesh-ancestor
101447640|NCT00210210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101447641|NCT00210210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447642|NCT00210210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101447643|NCT00210210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101447644|NCT00210210|Anesthetics, General|anesthetics, general|mesh-ancestor
101447645|NCT00210210|Anesthetics|anesthetics|mesh-ancestor
101447646|NCT00210210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101447647|NCT00210210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101447648|NCT00210210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101447649|NCT00210210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101447650|NCT00210210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447651|NCT00476086|Gemcitabine|gemcitabine|mesh-list
101447652|NCT00476086|Oxaliplatin|oxaliplatin|mesh-list
101447653|NCT00476086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101447654|NCT00476086|Antimetabolites|antimetabolites|mesh-ancestor
101447655|NCT00476086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447656|NCT00476086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670099|NCT04305158|Analgesics|analgesics|mesh-ancestor
101308177|NCT02046421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308178|NCT02046421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101308179|NCT02046421|Antimetabolites|antimetabolites|mesh-ancestor
101670173|NCT04052334|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101308180|NCT02046421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447657|NCT00476047|Tositumomab I-131|tositumomab i-131|mesh-list
101447658|NCT00476047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101447660|NCT00217191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101447661|NCT00217191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101447666|NCT00217191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101447667|NCT00217191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101447668|NCT00217191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101447669|NCT00217191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101670335|NCT03153410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101447670|NCT00217191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447672|NCT00476008|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101670406|NCT02772003|Growth Substances|growth substances|mesh-ancestor
101447674|NCT00476008|Dopamine Agents|dopamine agents|mesh-ancestor
101447675|NCT00476008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101670480|NCT02340169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363504|NCT00133237|Sirolimus|sirolimus|mesh-list
101447676|NCT00476008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447677|NCT00476008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447679|NCT00476008|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101447680|NCT00412035|Botulinum Toxins|botulinum toxins|mesh-list
101447681|NCT00412035|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101447682|NCT00412035|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101447683|NCT00412035|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101670582|NCT00472654|Vitamin D|vitamin d|mesh-list
101447684|NCT00412035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101447685|NCT00412035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447686|NCT00412035|Cholinergic Agents|cholinergic agents|mesh-ancestor
101447687|NCT00412035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101447688|NCT00412035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447689|NCT00412035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101447690|NCT00412035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101447691|NCT00183833|Capecitabine|capecitabine|mesh-list
101447692|NCT00183833|Imatinib Mesylate|imatinib mesylate|mesh-list
101447693|NCT00183833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101670714|NCT02810132|Metformin|metformin|mesh-list
101447694|NCT00183833|Antimetabolites|antimetabolites|mesh-ancestor
101447695|NCT00183833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447696|NCT00183833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101447697|NCT00183833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101670790|NCT02812940|Everolimus|everolimus|mesh-list
101447698|NCT00183833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101447699|NCT00183911|Leucovorin|leucovorin|mesh-list
101447700|NCT00183911|Fluorouracil|fluorouracil|mesh-list
101447701|NCT00183911|Floxuridine|floxuridine|mesh-list
101447702|NCT00183911|Antimetabolites|antimetabolites|mesh-ancestor
101447703|NCT00183911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447704|NCT00183911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101447705|NCT00183911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101447707|NCT00183911|Immunologic Factors|immunologic factors|mesh-ancestor
101447708|NCT00183911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447709|NCT00183911|Antidotes|antidotes|mesh-ancestor
101447710|NCT00183911|Protective Agents|protective agents|mesh-ancestor
101447711|NCT00183911|Vitamin B Complex|vitamin b complex|mesh-ancestor
101447712|NCT00183911|Vitamins|vitamins|mesh-ancestor
101447713|NCT00183911|Micronutrients|micronutrients|mesh-ancestor
101447714|NCT00412152|Oxycodone|oxycodone|mesh-list
101447715|NCT00412152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101447716|NCT00412152|Narcotics|narcotics|mesh-ancestor
101447717|NCT00412152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101447718|NCT00412152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447719|NCT00412152|Analgesics|analgesics|mesh-ancestor
101447720|NCT00412152|Sensory System Agents|sensory system agents|mesh-ancestor
101447721|NCT00412152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101447722|NCT02963402|Adalimumab|adalimumab|mesh-list
101447723|NCT02963402|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101670983|NCT04262765|Amlodipine|amlodipine|mesh-list
101447724|NCT02963402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101447725|NCT02963402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101447726|NCT00210327|Bortezomib|bortezomib|mesh-list
101447727|NCT00210327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101671046|NCT00926965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101308181|NCT02046421|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101308182|NCT02046421|Abortifacient Agents|abortifacient agents|mesh-ancestor
101308183|NCT02046421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101447730|NCT00425516|Fluorouracil|fluorouracil|mesh-list
101447731|NCT00425516|Epirubicin|epirubicin|mesh-list
101447732|NCT00425516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101447733|NCT00425516|Immunologic Factors|immunologic factors|mesh-ancestor
101671189|NCT02805452|Solifenacin Succinate|solifenacin succinate|mesh-list
101447757|NCT00412191|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101447758|NCT00412191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101447759|NCT00412191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101447760|NCT00412191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101447761|NCT00412191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101447763|NCT00183950|Antitussive Agents|antitussive agents|mesh-ancestor
101447764|NCT00183950|Respiratory System Agents|respiratory system agents|mesh-ancestor
101447765|NCT00210366|Idarubicin|idarubicin|mesh-list
101671332|NCT05905757|Tramadol|tramadol|mesh-list
101447766|NCT00210366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101447767|NCT00210366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101447768|NCT00210366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101447769|NCT00210366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101447770|NCT00210366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101447771|NCT00210366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447772|NCT00408785|Botulinum Toxins|botulinum toxins|mesh-list
101447773|NCT00408785|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101671485|NCT05825924|Nicotine|nicotine|mesh-list
101447774|NCT00408785|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101447775|NCT00408785|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101447776|NCT00408785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101447777|NCT00408785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447778|NCT00408785|Cholinergic Agents|cholinergic agents|mesh-ancestor
101447779|NCT00408785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101447780|NCT00408785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447781|NCT00408785|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101447782|NCT00408785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101447796|NCT00475657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101447797|NCT00475657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101447798|NCT00210405|Micronutrients|micronutrients|mesh-list
101447799|NCT00210405|Trace Elements|trace elements|mesh-list
101447800|NCT00210405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447801|NCT00408941|Propofol|propofol|mesh-list
101447802|NCT00408941|Prilocaine|prilocaine|mesh-list
101447803|NCT00408941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101447804|NCT00408941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101447805|NCT00408941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447806|NCT00408941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101447807|NCT00408941|Anesthetics, General|anesthetics, general|mesh-ancestor
101447808|NCT00408941|Anesthetics|anesthetics|mesh-ancestor
101447809|NCT00408941|Anesthetics, Local|anesthetics, local|mesh-ancestor
101447810|NCT00408941|Sensory System Agents|sensory system agents|mesh-ancestor
101447811|NCT00408941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101447812|NCT00475423|Rituximab|rituximab|mesh-list
101447813|NCT00475423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101447814|NCT00475423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101447815|NCT00475423|Immunologic Factors|immunologic factors|mesh-ancestor
101447816|NCT00475423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447817|NCT00475423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101447818|NCT00210444|Botulinum Toxins|botulinum toxins|mesh-list
101447819|NCT00210444|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101447820|NCT00210444|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101447821|NCT00210444|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101447822|NCT00210444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101447823|NCT00210444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447825|NCT00210444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101447826|NCT00210444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447827|NCT00210444|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101447828|NCT00210444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101447829|NCT00475306|Diphenhydramine|diphenhydramine|mesh-list
101308184|NCT02046421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308185|NCT02046421|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101447830|NCT00475306|Promethazine|promethazine|mesh-list
101447831|NCT00475306|Metoclopramide|metoclopramide|mesh-list
101447832|NCT00475306|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101447833|NCT00475306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101447834|NCT00475306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101447835|NCT00475306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447836|NCT00475306|Anesthetics, Local|anesthetics, local|mesh-ancestor
101447837|NCT00475306|Anesthetics|anesthetics|mesh-ancestor
101447838|NCT00475306|Sensory System Agents|sensory system agents|mesh-ancestor
101447839|NCT00475306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101447840|NCT00475306|Antiemetics|antiemetics|mesh-ancestor
101447841|NCT00475306|Autonomic Agents|autonomic agents|mesh-ancestor
101447842|NCT00475306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101447846|NCT00475306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101671818|NCT05177848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101447847|NCT00475306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447849|NCT00475306|Antipruritics|antipruritics|mesh-ancestor
101447850|NCT00475306|Dermatologic Agents|dermatologic agents|mesh-ancestor
101447851|NCT00475306|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101447853|NCT00475306|Dopamine Agents|dopamine agents|mesh-ancestor
101447855|NCT00475228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101447856|NCT00475228|Contraceptive Agents|contraceptive agents|mesh-ancestor
101447857|NCT00475228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101447858|NCT00475228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447859|NCT00475228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101447860|NCT00475228|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101447861|NCT00475228|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101447862|NCT00183989|Rituximab|rituximab|mesh-list
101447863|NCT00183989|Fludarabine|fludarabine|mesh-list
101447864|NCT00183989|Mitoxantrone|mitoxantrone|mesh-list
101447865|NCT00183989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101447866|NCT00183989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101447867|NCT00183989|Immunologic Factors|immunologic factors|mesh-ancestor
101447868|NCT00183989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447869|NCT00183989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101447870|NCT00183989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447871|NCT00183989|Analgesics|analgesics|mesh-ancestor
101447872|NCT00183989|Sensory System Agents|sensory system agents|mesh-ancestor
101447873|NCT00183989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101447874|NCT00183989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101447875|NCT00183989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101447876|NCT00183989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101447877|NCT00184067|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101447878|NCT00184067|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101447879|NCT00184067|Immunologic Factors|immunologic factors|mesh-ancestor
101447880|NCT00184067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447881|NCT00184106|Paroxetine|paroxetine|mesh-list
101672160|NCT04052880|Glucocorticoids|glucocorticoids|mesh-ancestor
101447882|NCT00184106|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101447883|NCT00184106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101447884|NCT00184106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101447885|NCT00184106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447886|NCT00184106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101447887|NCT00184106|Serotonin Agents|serotonin agents|mesh-ancestor
101447888|NCT00184106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447889|NCT00184106|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101447890|NCT00184106|Antidepressive Agents|antidepressive agents|mesh-ancestor
101447891|NCT00184106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101447892|NCT00184106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101447893|NCT00184106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101447894|NCT00184106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101447896|NCT00210483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101447897|NCT00210483|Serotonin Agents|serotonin agents|mesh-ancestor
101447898|NCT00210483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101447899|NCT00210483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447900|NCT00210483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447901|NCT00210561|Acetaminophen|acetaminophen|mesh-list
101447902|NCT00210561|Tramadol|tramadol|mesh-list
101308186|NCT02046421|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101308187|NCT02046421|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101308188|NCT02046421|Contraceptive Agents|contraceptive agents|mesh-ancestor
101308189|NCT02046421|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101447903|NCT00210561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101447904|NCT00210561|Analgesics|analgesics|mesh-ancestor
101447905|NCT00210561|Sensory System Agents|sensory system agents|mesh-ancestor
101447906|NCT00210561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101672358|NCT03390686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101447907|NCT00210561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447909|NCT00210561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101447911|NCT00210561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101447912|NCT00210600|Epoetin Alfa|epoetin alfa|mesh-list
101447916|NCT00217386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101447917|NCT00217386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101447918|NCT00217386|Analgesics|analgesics|mesh-ancestor
101447919|NCT00217386|Sensory System Agents|sensory system agents|mesh-ancestor
101447920|NCT00217386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101447921|NCT00217386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447922|NCT00217386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101447923|NCT00217386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101447924|NCT00217386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101447925|NCT00217386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101447926|NCT00217386|Immunologic Factors|immunologic factors|mesh-ancestor
101447927|NCT00217503|Zidovudine|zidovudine|mesh-list
101447928|NCT00217503|Valganciclovir|valganciclovir|mesh-list
101447929|NCT00217503|Ganciclovir|ganciclovir|mesh-list
101447930|NCT00217503|Cyclophosphamide|cyclophosphamide|mesh-list
101447931|NCT00217503|Bevacizumab|bevacizumab|mesh-list
101447932|NCT00217503|Doxorubicin|doxorubicin|mesh-list
101447933|NCT00217503|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101447934|NCT00217503|Etoposide|etoposide|mesh-list
101447935|NCT00217503|Bortezomib|bortezomib|mesh-list
101672481|NCT02996825|Antimetabolites|antimetabolites|mesh-ancestor
101447936|NCT00217503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101447937|NCT00217503|Immunologic Factors|immunologic factors|mesh-ancestor
101447938|NCT00217503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447939|NCT00217503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101447940|NCT00217503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101447941|NCT00217503|Alkylating Agents|alkylating agents|mesh-ancestor
101447942|NCT00217503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447943|NCT00217503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101447944|NCT00217503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101447945|NCT00217503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101447946|NCT00217503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101447947|NCT00217503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101447948|NCT00217503|Growth Substances|growth substances|mesh-ancestor
101447949|NCT00217503|Growth Inhibitors|growth inhibitors|mesh-ancestor
101447950|NCT00217503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101447951|NCT00217503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101447952|NCT00217503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101447953|NCT00217503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101447954|NCT00217503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101447955|NCT00217503|Antimetabolites|antimetabolites|mesh-ancestor
101447956|NCT00217503|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101447957|NCT00217503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101447958|NCT00217503|Antiviral Agents|antiviral agents|mesh-ancestor
101447959|NCT00217503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101447960|NCT00217503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101672618|NCT02017717|Growth Inhibitors|growth inhibitors|mesh-ancestor
101447961|NCT00217503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101447962|NCT00217542|Interferons|interferons|mesh-list
101447963|NCT00217542|Interferon-alpha|interferon-alpha|mesh-list
101447964|NCT00217542|Interferon alpha-2|interferon alpha-2|mesh-list
101447965|NCT00217542|Azacitidine|azacitidine|mesh-list
101447966|NCT00217542|Amifostine|amifostine|mesh-list
101447967|NCT00217542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101447968|NCT00217542|Antiviral Agents|antiviral agents|mesh-ancestor
101447969|NCT00217542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101447970|NCT00217542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101447971|NCT00217542|Antimetabolites|antimetabolites|mesh-ancestor
101447972|NCT00217542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308190|NCT02046421|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101308192|NCT02046421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101308194|NCT02046421|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101308195|NCT02046421|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101308196|NCT02046447|Trihexyphenidyl|trihexyphenidyl|mesh-list
101308197|NCT02046447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101308198|NCT02046447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101308199|NCT02046447|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101308200|NCT02046447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101308201|NCT02046447|Cholinergic Agents|cholinergic agents|mesh-ancestor
101308202|NCT02046447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101308203|NCT02046447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308204|NCT02046447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308205|NCT02046460|Aspirin|aspirin|mesh-list
101308206|NCT02046460|Vitamin K|vitamin k|mesh-list
101308207|NCT02046460|Warfarin|warfarin|mesh-list
101308208|NCT02046460|Acenocoumarol|acenocoumarol|mesh-list
101308209|NCT02046460|Phenprocoumon|phenprocoumon|mesh-list
101308210|NCT02046460|Vitamins|vitamins|mesh-ancestor
101308211|NCT02046460|Micronutrients|micronutrients|mesh-ancestor
101308212|NCT02046460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308213|NCT02046460|Anticoagulants|anticoagulants|mesh-ancestor
101308214|NCT02046460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101308215|NCT02046460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101308216|NCT02046460|Analgesics|analgesics|mesh-ancestor
101308217|NCT02046460|Sensory System Agents|sensory system agents|mesh-ancestor
101447973|NCT00217542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101447974|NCT00217542|Immunologic Factors|immunologic factors|mesh-ancestor
101447975|NCT00217542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447976|NCT00217542|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101447977|NCT00217542|Protective Agents|protective agents|mesh-ancestor
101447978|NCT00210717|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101447979|NCT00210717|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101447980|NCT00210717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101447981|NCT00210717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101447982|NCT00210717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447983|NCT00210717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101447984|NCT00210717|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101447985|NCT00210717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101447986|NCT00210717|Serotonin Agents|serotonin agents|mesh-ancestor
101447987|NCT00210717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101447994|NCT00184496|Narcotics|narcotics|mesh-ancestor
101447995|NCT00184496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101447996|NCT00184496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447997|NCT00184496|Analgesics|analgesics|mesh-ancestor
101447998|NCT00184496|Sensory System Agents|sensory system agents|mesh-ancestor
101308218|NCT02046460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101308219|NCT02046460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101308220|NCT02046460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101308221|NCT02046460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101447999|NCT00184496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101448000|NCT00184496|Antitussive Agents|antitussive agents|mesh-ancestor
101448001|NCT00184496|Respiratory System Agents|respiratory system agents|mesh-ancestor
101448002|NCT00210756|Epoetin Alfa|epoetin alfa|mesh-list
101448003|NCT00210756|Hematinics|hematinics|mesh-ancestor
101448004|NCT00217659|Anastrozole|anastrozole|mesh-list
101448005|NCT00217659|Goserelin|goserelin|mesh-list
101448006|NCT00217659|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101448008|NCT00217659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101448009|NCT00217659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101448010|NCT00217659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101448011|NCT00217659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448012|NCT00217659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101448013|NCT00217659|Hormone Antagonists|hormone antagonists|mesh-ancestor
101448014|NCT00217659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101448015|NCT00217659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448017|NCT00184574|Insulin Aspart|insulin aspart|mesh-list
101448018|NCT00184574|Biphasic Insulins|biphasic insulins|mesh-list
101448019|NCT00184574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101448020|NCT00184574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448022|NCT00210795|Hematinics|hematinics|mesh-ancestor
101448023|NCT00217698|Gemcitabine|gemcitabine|mesh-list
101448024|NCT00217698|Gefitinib|gefitinib|mesh-list
101448025|NCT00217698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101448026|NCT00217698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101673053|NCT00003283|Prednisone|prednisone|mesh-list
101448027|NCT00217698|Antimetabolites|antimetabolites|mesh-ancestor
101448028|NCT00217698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448029|NCT00217698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101448030|NCT00217698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101448032|NCT00184613|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101448033|NCT00184613|Insulin Glargine|insulin glargine|mesh-list
101448034|NCT00184613|Insulin Aspart|insulin aspart|mesh-list
101448035|NCT00184613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101448036|NCT00184613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448037|NCT00210834|Epoetin Alfa|epoetin alfa|mesh-list
101448038|NCT00210834|Hematinics|hematinics|mesh-ancestor
101448039|NCT00217815|Efungumab|efungumab|mesh-list
101448040|NCT00217815|Docetaxel|docetaxel|mesh-list
101448041|NCT00217815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101448042|NCT00217815|Tubulin Modulators|tubulin modulators|mesh-ancestor
101448043|NCT00217815|Antimitotic Agents|antimitotic agents|mesh-ancestor
101448044|NCT00217815|Mitosis Modulators|mitosis modulators|mesh-ancestor
101448045|NCT00217815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448046|NCT00217815|Antifungal Agents|antifungal agents|mesh-ancestor
101448047|NCT00217815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101448048|NCT04722471|Progesterone|progesterone|mesh-list
101448049|NCT04722471|Progestins|progestins|mesh-ancestor
101448050|NCT04722471|Hormones|hormones|mesh-ancestor
101448051|NCT04722471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101448052|NCT04722471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448053|NCT00210873|Topiramate|topiramate|mesh-list
101448054|NCT00210873|Anticonvulsants|anticonvulsants|mesh-ancestor
101448055|NCT00210873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101363521|NCT00399672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101448056|NCT00210873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448057|NCT00210912|Topiramate|topiramate|mesh-list
101448058|NCT00210912|Anticonvulsants|anticonvulsants|mesh-ancestor
101448059|NCT00210912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101448060|NCT00210912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448064|NCT00184847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101448065|NCT00184847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448066|NCT00184847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101448067|NCT00184847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101448068|NCT00184847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448069|NCT00184847|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101448070|NCT00184847|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101308222|NCT02046460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101308223|NCT02046460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448071|NCT00184847|Purinergic Agents|purinergic agents|mesh-ancestor
101448072|NCT00184847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101448073|NCT00184847|Analgesics|analgesics|mesh-ancestor
101448074|NCT00184847|Sensory System Agents|sensory system agents|mesh-ancestor
101448075|NCT00184847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101448076|NCT00184847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101448077|NCT00184847|Vasodilator Agents|vasodilator agents|mesh-ancestor
101448078|NCT00184847|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101448079|NCT00184847|Purinergic Agonists|purinergic agonists|mesh-ancestor
101448080|NCT00184847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101448081|NCT00184847|Cholinergic Agents|cholinergic agents|mesh-ancestor
101448082|NCT00184886|Methotrexate|methotrexate|mesh-list
101448083|NCT00184886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101448084|NCT00184886|Abortifacient Agents|abortifacient agents|mesh-ancestor
101448085|NCT00184886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101448086|NCT00184886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448087|NCT00184886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101673587|NCT02773212|Dopamine Agents|dopamine agents|mesh-ancestor
101448089|NCT00184886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448090|NCT00184886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101448092|NCT00184886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101448093|NCT00184886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101448094|NCT00184886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101448095|NCT00184886|Immunologic Factors|immunologic factors|mesh-ancestor
101448096|NCT00184886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101448097|NCT00184886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101448098|NCT00217932|Valproic Acid|valproic acid|mesh-list
101448099|NCT00217932|Anticonvulsants|anticonvulsants|mesh-ancestor
101448100|NCT00217932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101448101|NCT00217932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448102|NCT00217932|GABA Agents|gaba agents|mesh-ancestor
101448103|NCT00217932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101448104|NCT00217932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448105|NCT00217932|Antimanic Agents|antimanic agents|mesh-ancestor
101448106|NCT00217932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101448107|NCT00217932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101448108|NCT00217932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101448109|NCT00210990|Doripenem|doripenem|mesh-list
101448110|NCT00210990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101448111|NCT00210990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101448113|NCT00185003|Potassium Channel Blockers|potassium channel blockers|mesh-list
101448114|NCT00185003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448115|NCT00185003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101448116|NCT00185003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448117|NCT00185003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101448119|NCT00185120|Olmesartan|olmesartan|mesh-list
101448120|NCT00185120|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101448121|NCT00185120|Benazepril|benazepril|mesh-list
101448122|NCT00185120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101448123|NCT00185120|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101448124|NCT00185120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101674078|NCT00939835|Serotonin Agents|serotonin agents|mesh-ancestor
101448125|NCT00185120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448126|NCT00185120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101448127|NCT00185120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448128|NCT00185120|Vasodilator Agents|vasodilator agents|mesh-ancestor
101448129|NCT00185120|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101448130|NCT00185120|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101448131|NCT00185120|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101448132|NCT00185120|Protease Inhibitors|protease inhibitors|mesh-ancestor
101448137|NCT00218049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101674286|NCT00925769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101448138|NCT00218049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448140|NCT00218049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101674360|NCT00609011|Temozolomide|temozolomide|mesh-list
101448141|NCT00218049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448142|NCT00185159|Olmesartan|olmesartan|mesh-list
101448143|NCT00185159|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101308224|NCT02046460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101308225|NCT02046460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101308226|NCT02046460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101308227|NCT02046460|Antipyretics|antipyretics|mesh-ancestor
101308228|NCT02046460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101308229|NCT02046460|Hemostatics|hemostatics|mesh-ancestor
101308230|NCT02046460|Coagulants|coagulants|mesh-ancestor
101308231|NCT02046486|Ticagrelor|ticagrelor|mesh-list
101308232|NCT02046486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101308233|NCT02046486|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101308234|NCT02046486|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101308235|NCT02046486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101308236|NCT02046486|Purinergic Agents|purinergic agents|mesh-ancestor
101308237|NCT02046486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101674499|NCT00611039|Ritonavir|ritonavir|mesh-list
101308238|NCT02046486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308239|NCT02046486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448144|NCT00185159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101448145|NCT00185159|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101448146|NCT00185159|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101674566|NCT00770211|Botulinum Toxins|botulinum toxins|mesh-list
101448147|NCT00185159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448148|NCT00218127|Methadyl Acetate|methadyl acetate|mesh-list
101448149|NCT00218127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101448150|NCT00218127|Narcotics|narcotics|mesh-ancestor
101448151|NCT00218127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101674633|NCT04256525|Antipyretics|antipyretics|mesh-ancestor
101448152|NCT00218127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448153|NCT00218127|Analgesics|analgesics|mesh-ancestor
101448154|NCT00218127|Sensory System Agents|sensory system agents|mesh-ancestor
101448155|NCT00218127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101448156|NCT00185198|Testosterone|testosterone|mesh-list
101448157|NCT00185198|Androgens|androgens|mesh-ancestor
101448158|NCT00185198|Hormones|hormones|mesh-ancestor
101448159|NCT00185198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101448160|NCT00185198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448161|NCT00185237|Estradiol|estradiol|mesh-list
101448162|NCT00185237|Estrogens|estrogens|mesh-ancestor
101448163|NCT00185237|Hormones|hormones|mesh-ancestor
101448164|NCT00185237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101448165|NCT00185237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448166|NCT00218166|Triazolam|triazolam|mesh-list
101448167|NCT00218166|Tiagabine|tiagabine|mesh-list
101448168|NCT00218166|Baclofen|baclofen|mesh-list
101448169|NCT00218166|GABA Agonists|gaba agonists|mesh-list
101448170|NCT00218166|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101448171|NCT00218166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448172|NCT00218166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101448173|NCT00218166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101448174|NCT00218166|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101448176|NCT00218166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101448177|NCT00218166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448178|NCT00218166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101448179|NCT00218166|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101448180|NCT00218166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101448181|NCT00218166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101448182|NCT00218166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101448183|NCT00218166|GABA Modulators|gaba modulators|mesh-ancestor
101448184|NCT00218166|Anticonvulsants|anticonvulsants|mesh-ancestor
101448185|NCT00218166|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
101448186|NCT00218166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101363526|NCT00133276|Escitalopram|escitalopram|mesh-list
101448187|NCT00218166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101448188|NCT00185315|Iloprost|iloprost|mesh-list
101448189|NCT00185315|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101448190|NCT00185315|Vasodilator Agents|vasodilator agents|mesh-ancestor
101448191|NCT00409019|Tenofovir|tenofovir|mesh-list
101448192|NCT00409019|Adefovir|adefovir|mesh-list
101448193|NCT00409019|Telbivudine|telbivudine|mesh-list
101448194|NCT00409019|Antiviral Agents|antiviral agents|mesh-ancestor
101448195|NCT00409019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101448196|NCT00409019|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101448197|NCT00409019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101448198|NCT00409019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101448199|NCT00409019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448200|NCT00409019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101448201|NCT00409019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101448202|NCT00211146|Epoetin Alfa|epoetin alfa|mesh-list
101448203|NCT00211146|Hematinics|hematinics|mesh-ancestor
101448204|NCT00211224|Riluzole|riluzole|mesh-list
101448211|NCT00211224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101448212|NCT00211224|Protective Agents|protective agents|mesh-ancestor
101448214|NCT00409097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101448215|NCT00409097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448216|NCT00218205|Celecoxib|celecoxib|mesh-list
101448217|NCT00218205|Epirubicin|epirubicin|mesh-list
101448218|NCT00218205|Estramustine|estramustine|mesh-list
101448219|NCT00218205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101448220|NCT00218205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101448221|NCT00218205|Analgesics|analgesics|mesh-ancestor
101448222|NCT00218205|Sensory System Agents|sensory system agents|mesh-ancestor
101448223|NCT00218205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101448224|NCT00218205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448225|NCT00218205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101448226|NCT00218205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101448227|NCT00218205|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101448228|NCT00218205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101675036|NCT06004674|Enoxaparin|enoxaparin|mesh-list
101448229|NCT00218205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101448230|NCT00218205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448231|NCT00218205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101448232|NCT00218205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101448233|NCT00218205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101448234|NCT00218205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101448235|NCT00218205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101448236|NCT00218205|Alkylating Agents|alkylating agents|mesh-ancestor
101448237|NCT00218205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101675104|NCT06003972|(T,G)-A-L|(t,g)-a-l|mesh-list
101448238|NCT00185510|Methylprednisolone|methylprednisolone|mesh-list
101448239|NCT00185510|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101448240|NCT00185510|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101448241|NCT00185510|Prednisolone|prednisolone|mesh-list
101448242|NCT00185510|Prednisolone acetate|prednisolone acetate|mesh-list
101448243|NCT00185510|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
101448244|NCT00185510|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101448245|NCT00185510|Prednisolone phosphate|prednisolone phosphate|mesh-list
101448246|NCT00185510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101448248|NCT00185510|Autonomic Agents|autonomic agents|mesh-ancestor
101448249|NCT00185510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101448250|NCT00185510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448251|NCT00185510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101448252|NCT00185510|Glucocorticoids|glucocorticoids|mesh-ancestor
101448253|NCT00185510|Hormones|hormones|mesh-ancestor
101448254|NCT00185510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101448255|NCT00185510|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101448256|NCT00185510|Protective Agents|protective agents|mesh-ancestor
101448257|NCT00185510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101448258|NCT00185510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101448260|NCT00218244|Nicotine|nicotine|mesh-list
101448261|NCT00218244|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101448262|NCT00218244|Autonomic Agents|autonomic agents|mesh-ancestor
101448263|NCT00218244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101448264|NCT00218244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448265|NCT00218244|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101448266|NCT00218244|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101448267|NCT00218244|Cholinergic Agents|cholinergic agents|mesh-ancestor
101448268|NCT00218244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101308241|NCT02046499|Ergonovine|ergonovine|mesh-list
101308242|NCT02046499|Syntometrine|syntometrine|mesh-list
101308243|NCT02046499|Oxytocics|oxytocics|mesh-ancestor
101308244|NCT02046499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101308245|NCT02046499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308246|NCT02046538|Leucovorin|leucovorin|mesh-list
101675290|NCT05873244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675291|NCT05873244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101675292|NCT05873244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101675293|NCT05873244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675294|NCT05869136|Hyaluronic Acid|hyaluronic acid|mesh-list
101675295|NCT05869136|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101675296|NCT05869136|Immunologic Factors|immunologic factors|mesh-ancestor
101675297|NCT05869136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675298|NCT05869136|Viscosupplements|viscosupplements|mesh-ancestor
101675299|NCT05869136|Protective Agents|protective agents|mesh-ancestor
101675300|NCT05862194|Lazertinib|lazertinib|mesh-list
101675301|NCT05862194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101675302|NCT05862194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101675303|NCT05862194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675304|NCT05855811|Dostarlimab|dostarlimab|mesh-list
101675305|NCT05855811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675323|NCT05845814|Pembrolizumab|pembrolizumab|mesh-list
101308248|NCT02046538|Oxaliplatin|oxaliplatin|mesh-list
101308249|NCT02046538|Irinotecan|irinotecan|mesh-list
101308250|NCT02046538|Antimetabolites|antimetabolites|mesh-ancestor
101308251|NCT02046538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308252|NCT02046538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101308253|NCT02046538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675352|NCT05801835|Antiviral Agents|antiviral agents|mesh-ancestor
101448269|NCT00218244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448270|NCT00218244|Respiratory System Agents|respiratory system agents|mesh-ancestor
101448271|NCT00211302|Aripiprazole|aripiprazole|mesh-list
101448272|NCT00211302|Antidepressive Agents|antidepressive agents|mesh-ancestor
101448283|NCT00211302|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101448284|NCT00211302|Serotonin Agents|serotonin agents|mesh-ancestor
101675422|NCT05765851|Trastuzumab|trastuzumab|mesh-list
101448285|NCT00211302|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101448286|NCT00211302|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101448287|NCT00211302|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101448288|NCT00211302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101448289|NCT00218283|Nicotine|nicotine|mesh-list
101448290|NCT00218283|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101448292|NCT00218283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101448293|NCT00218283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448294|NCT00218283|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101448295|NCT00218283|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101448296|NCT00218283|Cholinergic Agents|cholinergic agents|mesh-ancestor
101448297|NCT00218283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101448298|NCT00218283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448300|NCT00185705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101448301|NCT00185705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101448302|NCT00185705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101448303|NCT00185705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448304|NCT00211341|Vitamin A|vitamin a|mesh-list
101448305|NCT00211341|Vitamins|vitamins|mesh-ancestor
101448306|NCT00211341|Micronutrients|micronutrients|mesh-ancestor
101448307|NCT00211341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448308|NCT00185783|Hydrocortisone|hydrocortisone|mesh-list
101448309|NCT00185783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101448310|NCT00185861|Arsenic Trioxide|arsenic trioxide|mesh-list
101448311|NCT00185861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101448312|NCT00211380|Aripiprazole|aripiprazole|mesh-list
101448313|NCT00211380|Antidepressive Agents|antidepressive agents|mesh-ancestor
101448314|NCT00211380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101448315|NCT00211380|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101448316|NCT00211380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101448317|NCT00211380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101448318|NCT00211380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448319|NCT00211380|Dopamine Agonists|dopamine agonists|mesh-ancestor
101448320|NCT00211380|Dopamine Agents|dopamine agents|mesh-ancestor
101448321|NCT00211380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101448322|NCT00211380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448323|NCT00211380|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101448324|NCT00211380|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101448325|NCT00211380|Serotonin Agents|serotonin agents|mesh-ancestor
101448326|NCT00211380|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101448327|NCT00211380|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101448328|NCT00211380|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101308254|NCT02046538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101308255|NCT02046538|Immunologic Factors|immunologic factors|mesh-ancestor
101308256|NCT02046538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308257|NCT02046538|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101448329|NCT00211380|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101448330|NCT00185939|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101448331|NCT00185939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101448332|NCT00185939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101448333|NCT00185939|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101448334|NCT00185939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101448346|NCT00218361|Narcotics|narcotics|mesh-ancestor
101448347|NCT00218361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101448348|NCT00218361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448349|NCT00218361|Analgesics|analgesics|mesh-ancestor
101448350|NCT00218361|Sensory System Agents|sensory system agents|mesh-ancestor
101448351|NCT00218361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101448352|NCT00218517|Selegiline|selegiline|mesh-list
101675752|NCT05353829|Immunologic Factors|immunologic factors|mesh-ancestor
101675753|NCT05353829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101675754|NCT05353829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101675755|NCT05352815|Insulin|insulin|mesh-list
101675756|NCT05352815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101675758|NCT05345509|Donepezil|donepezil|mesh-list
101448353|NCT00218517|Antidepressive Agents|antidepressive agents|mesh-ancestor
101448354|NCT00218517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101448355|NCT00218517|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101448356|NCT00218517|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101448357|NCT00218517|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101448358|NCT00218517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101448359|NCT00218517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448360|NCT00218517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101448361|NCT00218517|Protective Agents|protective agents|mesh-ancestor
101448362|NCT00218517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448363|NCT00211419|Triamcinolone|triamcinolone|mesh-list
101448364|NCT00211419|Anecortave|anecortave|mesh-list
101448365|NCT00211419|Verteporfin|verteporfin|mesh-list
101448366|NCT00211419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101448367|NCT00211419|Glucocorticoids|glucocorticoids|mesh-ancestor
101448368|NCT00211419|Hormones|hormones|mesh-ancestor
101448369|NCT00211419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101448370|NCT00211419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675965|NCT05113940|Anesthetics|anesthetics|mesh-ancestor
101448372|NCT00211419|Dermatologic Agents|dermatologic agents|mesh-ancestor
101448373|NCT00211419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101448374|NCT00211419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101448375|NCT00211419|Growth Substances|growth substances|mesh-ancestor
101448376|NCT00211419|Growth Inhibitors|growth inhibitors|mesh-ancestor
101448377|NCT00211419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101448378|NCT00211458|Anecortave|anecortave|mesh-list
101448379|NCT00211458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101448380|NCT00211458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101448381|NCT00211458|Growth Substances|growth substances|mesh-ancestor
101448382|NCT00211458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448383|NCT00211458|Growth Inhibitors|growth inhibitors|mesh-ancestor
101448384|NCT00211458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101448385|NCT00211497|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
101448386|NCT00211497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101448387|NCT00186329|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101448388|NCT00186329|Natriuretic Agents|natriuretic agents|mesh-ancestor
101448389|NCT00186329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448390|NCT00211614|Lansoprazole|lansoprazole|mesh-list
101448391|NCT00211614|Dexlansoprazole|dexlansoprazole|mesh-list
101448392|NCT00211614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101448393|NCT00211614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101448394|NCT00211614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101448395|NCT00211614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101448396|NCT00211614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448403|NCT00186797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448404|NCT00186797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101448405|NCT00186797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101448406|NCT00186797|Alkylating Agents|alkylating agents|mesh-ancestor
101676235|NCT04493853|Abiraterone Acetate|abiraterone acetate|mesh-list
101448407|NCT00186797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448408|NCT00186797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676304|NCT04313881|Azacitidine|azacitidine|mesh-list
101448409|NCT00186797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101448410|NCT00211653|Acetylcysteine|acetylcysteine|mesh-list
101308258|NCT02046538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101308259|NCT02046538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101448411|NCT00211653|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101448412|NCT00211653|Antiviral Agents|antiviral agents|mesh-ancestor
101448413|NCT00211653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101448414|NCT00211653|Expectorants|expectorants|mesh-ancestor
101448415|NCT00211653|Respiratory System Agents|respiratory system agents|mesh-ancestor
101448416|NCT00211653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101448417|NCT00211653|Antioxidants|antioxidants|mesh-ancestor
101448418|NCT00211653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448419|NCT00211653|Protective Agents|protective agents|mesh-ancestor
101448420|NCT00211653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448421|NCT00211653|Antidotes|antidotes|mesh-ancestor
101448422|NCT00187031|Topotecan|topotecan|mesh-list
101448423|NCT00187031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101448424|NCT00187031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101448425|NCT00187031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101448426|NCT00187031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448427|NCT00187031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101448428|NCT00187070|Cytarabine|cytarabine|mesh-list
101676383|NCT04216290|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101448429|NCT00187070|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101448431|NCT00187070|Prednisone|prednisone|mesh-list
101448432|NCT00187070|Cyclophosphamide|cyclophosphamide|mesh-list
101448434|NCT00187070|Carboplatin|carboplatin|mesh-list
101448435|NCT00187070|Doxorubicin|doxorubicin|mesh-list
101448436|NCT00187070|Methotrexate|methotrexate|mesh-list
101448437|NCT00187070|Etoposide|etoposide|mesh-list
101448438|NCT00187070|Vincristine|vincristine|mesh-list
101448439|NCT00187070|Vinblastine|vinblastine|mesh-list
101448440|NCT00187070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101448441|NCT00187070|Immunologic Factors|immunologic factors|mesh-ancestor
101448442|NCT00187070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448443|NCT00187070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101448444|NCT00187070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101448445|NCT00187070|Alkylating Agents|alkylating agents|mesh-ancestor
101448446|NCT00187070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448447|NCT00187070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676710|NCT03615105|Rituximab|rituximab|mesh-list
101448448|NCT00187070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101448449|NCT00187070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101448450|NCT00187070|Antiemetics|antiemetics|mesh-ancestor
101448451|NCT00187070|Autonomic Agents|autonomic agents|mesh-ancestor
101448452|NCT00187070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101448453|NCT00187070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101448454|NCT00187070|Glucocorticoids|glucocorticoids|mesh-ancestor
101448455|NCT00187070|Hormones|hormones|mesh-ancestor
101448456|NCT00187070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101448457|NCT00187070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101448458|NCT00187070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101448459|NCT00187070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101448460|NCT00187070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101448461|NCT00187070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101448462|NCT00187070|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101448463|NCT00187070|Abortifacient Agents|abortifacient agents|mesh-ancestor
101448464|NCT00187070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101448465|NCT00187070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101448466|NCT00187070|Antimetabolites|antimetabolites|mesh-ancestor
101448467|NCT00187070|Dermatologic Agents|dermatologic agents|mesh-ancestor
101448468|NCT00187070|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101448470|NCT00187070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101448471|NCT00187070|Antiviral Agents|antiviral agents|mesh-ancestor
101448472|NCT00187070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101448473|NCT00187070|Tubulin Modulators|tubulin modulators|mesh-ancestor
101448474|NCT00187070|Antimitotic Agents|antimitotic agents|mesh-ancestor
101448475|NCT00187070|Mitosis Modulators|mitosis modulators|mesh-ancestor
101448476|NCT00187070|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101448477|NCT00187070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101448478|NCT00187070|Antimalarials|antimalarials|mesh-ancestor
101448479|NCT00187070|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101448480|NCT00187070|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101448481|NCT00211848|Interferons|interferons|mesh-list
101448483|NCT00211848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308261|NCT02046538|Protective Agents|protective agents|mesh-ancestor
101308262|NCT02046538|Vitamin B Complex|vitamin b complex|mesh-ancestor
101308263|NCT02046538|Vitamins|vitamins|mesh-ancestor
101308264|NCT02046538|Micronutrients|micronutrients|mesh-ancestor
101448484|NCT00211848|Antiviral Agents|antiviral agents|mesh-ancestor
101448485|NCT00211848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101448486|NCT00211848|Antimetabolites|antimetabolites|mesh-ancestor
101448487|NCT00211848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448489|NCT00412347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101448490|NCT00412347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448491|NCT00187499|Fluticasone|fluticasone|mesh-list
101448492|NCT00187499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101448493|NCT00187499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101448494|NCT00187499|Autonomic Agents|autonomic agents|mesh-ancestor
101677138|NCT01997879|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101448495|NCT00187499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101448496|NCT00187499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448497|NCT00187499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101448498|NCT00187499|Respiratory System Agents|respiratory system agents|mesh-ancestor
101448499|NCT00187499|Dermatologic Agents|dermatologic agents|mesh-ancestor
101448500|NCT00187499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101448501|NCT00212004|Pioglitazone|pioglitazone|mesh-list
101448502|NCT00212004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101448503|NCT00212004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448504|NCT00187577|Bimatoprost|bimatoprost|mesh-list
101448505|NCT00187577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101448506|NCT00187577|Latanoprost|latanoprost|mesh-list
101448507|NCT00187577|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101448508|NCT00187577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101448509|NCT00212043|Carboplatin|carboplatin|mesh-list
101448510|NCT00212043|Gemcitabine|gemcitabine|mesh-list
101448511|NCT00212043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101448512|NCT00212043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101448513|NCT00212043|Antimetabolites|antimetabolites|mesh-ancestor
101448514|NCT00212043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448515|NCT00212082|Docetaxel|docetaxel|mesh-list
101448516|NCT00212082|Doxorubicin|doxorubicin|mesh-list
101448517|NCT00212082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101448518|NCT00212082|Tubulin Modulators|tubulin modulators|mesh-ancestor
101448519|NCT00212082|Antimitotic Agents|antimitotic agents|mesh-ancestor
101448520|NCT00212082|Mitosis Modulators|mitosis modulators|mesh-ancestor
101448521|NCT00212082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448522|NCT00212082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101448523|NCT00212082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101448524|NCT00212082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101448525|NCT00212082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101448526|NCT00219219|Zoledronic Acid|zoledronic acid|mesh-list
101448527|NCT00219219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101448528|NCT00219219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448529|NCT00187928|Topiramate|topiramate|mesh-list
101448530|NCT00187928|Anticonvulsants|anticonvulsants|mesh-ancestor
101448531|NCT00187928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101448532|NCT00187928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448533|NCT00212199|Orlistat|orlistat|mesh-list
101448534|NCT00212199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101448535|NCT00212199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448536|NCT00212199|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101448537|NCT00212199|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101448538|NCT00219258|Zoledronic Acid|zoledronic acid|mesh-list
101448539|NCT00219258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101448540|NCT00219258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448541|NCT00188006|Heparin|heparin|mesh-list
101448542|NCT00188006|Anticoagulants|anticoagulants|mesh-ancestor
101448543|NCT00188006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101448544|NCT00188006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101487416|NCT00432588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101448547|NCT00188045|Spironolactone|spironolactone|mesh-list
101448548|NCT00188045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101448549|NCT00188045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101448550|NCT00188045|Adrenergic Agents|adrenergic agents|mesh-ancestor
101448551|NCT00188045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101448552|NCT00188045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448553|NCT00188045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448554|NCT00188045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101448555|NCT00188045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101448557|NCT00188045|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101448558|NCT00188045|Hormone Antagonists|hormone antagonists|mesh-ancestor
101448559|NCT00188045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101448560|NCT00188045|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101448561|NCT00188045|Diuretics|diuretics|mesh-ancestor
101448562|NCT00188045|Natriuretic Agents|natriuretic agents|mesh-ancestor
101448563|NCT00212277|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101448564|NCT00212277|Norethindrone|norethindrone|mesh-list
101448565|NCT00212277|Norethindrone Acetate|norethindrone acetate|mesh-list
101448566|NCT00212277|Estradiol|estradiol|mesh-list
101448567|NCT00212277|Estrogens|estrogens|mesh-ancestor
101448568|NCT00212277|Hormones|hormones|mesh-ancestor
101448569|NCT00212277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101448570|NCT00212277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448571|NCT00212277|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101448572|NCT00212277|Contraceptive Agents|contraceptive agents|mesh-ancestor
101677590|NCT03110822|Growth Substances|growth substances|mesh-ancestor
101448573|NCT00212277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101448574|NCT00212277|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101448575|NCT00212277|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101448576|NCT00212277|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101448577|NCT00212277|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101448578|NCT00212316|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
101448579|NCT00212316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101448580|NCT00219375|Sivelestat|sivelestat|mesh-list
101448581|NCT00219375|Glycine|glycine|mesh-list
101448582|NCT00219375|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101448583|NCT00219375|Protease Inhibitors|protease inhibitors|mesh-ancestor
101448584|NCT00219375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101448585|NCT00219375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448586|NCT00219375|Glycine Agents|glycine agents|mesh-ancestor
101448587|NCT00219375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101448588|NCT00219375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448589|NCT00188240|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101448590|NCT00188240|Antiviral Agents|antiviral agents|mesh-ancestor
101448591|NCT00188240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101448592|NCT00188396|Citalopram|citalopram|mesh-list
101448593|NCT00188396|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101448594|NCT00188396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101448595|NCT00188396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101448596|NCT00188396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448597|NCT00188396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101448598|NCT00188396|Serotonin Agents|serotonin agents|mesh-ancestor
101448599|NCT00188396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677681|NCT00634556|Levodopa|levodopa|mesh-list
101448600|NCT00188396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101448601|NCT00188396|Antidepressive Agents|antidepressive agents|mesh-ancestor
101448602|NCT00188396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101448604|NCT00219570|Clindamycin palmitate|clindamycin palmitate|mesh-list
101448605|NCT00219570|Clindamycin phosphate|clindamycin phosphate|mesh-list
101448606|NCT00219570|Nadifloxacin|nadifloxacin|mesh-list
101448607|NCT00219570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101448608|NCT00219570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101448609|NCT00219570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101448610|NCT00219570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101448611|NCT00219570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448612|NCT00219570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101448613|NCT00219570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101448614|NCT00219570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101448615|NCT00212472|Factor VIII|factor viii|mesh-list
101448635|NCT00188630|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101448636|NCT00188630|Antiviral Agents|antiviral agents|mesh-ancestor
101448637|NCT00188630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101448639|NCT00188630|Respiratory System Agents|respiratory system agents|mesh-ancestor
101448640|NCT00188630|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101448641|NCT00188630|Antioxidants|antioxidants|mesh-ancestor
101448642|NCT00188630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448643|NCT00188630|Protective Agents|protective agents|mesh-ancestor
101308266|NCT02046551|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101308267|NCT02046551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101677841|NCT02784626|Anesthetics|anesthetics|mesh-ancestor
101308269|NCT02046551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448644|NCT00188630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448645|NCT00188630|Antidotes|antidotes|mesh-ancestor
101448646|NCT00188669|Tocopherols|tocopherols|mesh-list
101448648|NCT00188669|Tocotrienols|tocotrienols|mesh-list
101448649|NCT00188669|alpha-Tocopherol|alpha-tocopherol|mesh-list
101448650|NCT00188669|Pentoxifylline|pentoxifylline|mesh-list
101448651|NCT00188669|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101448652|NCT00188669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101448653|NCT00188669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448654|NCT00188669|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101448655|NCT00188669|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101448657|NCT00188669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448658|NCT00188669|Vasodilator Agents|vasodilator agents|mesh-ancestor
101448659|NCT00188669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101448660|NCT00188669|Antioxidants|antioxidants|mesh-ancestor
101448661|NCT00188669|Vitamins|vitamins|mesh-ancestor
101448662|NCT00188669|Micronutrients|micronutrients|mesh-ancestor
101448663|NCT00409214|Talaporfin|talaporfin|mesh-list
101448664|NCT00409214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101448665|NCT00409214|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101448666|NCT00409214|Dermatologic Agents|dermatologic agents|mesh-ancestor
101448668|NCT02963051|Disulfiram|disulfiram|mesh-list
101448669|NCT02963051|Trace Elements|trace elements|mesh-ancestor
101448670|NCT02963051|Micronutrients|micronutrients|mesh-ancestor
101678107|NCT02721888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101448671|NCT02963051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448672|NCT02963051|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101448673|NCT02963051|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
101448674|NCT02963051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101448675|NCT02963051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448676|NCT00219726|Imatinib Mesylate|imatinib mesylate|mesh-list
101448683|NCT00409253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101448684|NCT00409253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101448685|NCT00409253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101448686|NCT00409253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448687|NCT00409253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101448688|NCT00409253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448689|NCT00409253|Vasodilator Agents|vasodilator agents|mesh-ancestor
101448690|NCT00409253|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101448691|NCT00409253|Serotonin Agents|serotonin agents|mesh-ancestor
101678247|NCT04257851|Sumatriptan|sumatriptan|mesh-list
101448692|NCT00409253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101448693|NCT00409253|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101448694|NCT00409253|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101448695|NCT00409253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101448696|NCT00409253|Adrenergic Agents|adrenergic agents|mesh-ancestor
101448697|NCT00219765|Cytarabine|cytarabine|mesh-list
101448698|NCT00219765|Imatinib Mesylate|imatinib mesylate|mesh-list
101448699|NCT00219765|Daunorubicin|daunorubicin|mesh-list
101448700|NCT00219765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101448701|NCT00219765|Antimetabolites|antimetabolites|mesh-ancestor
101448702|NCT00219765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448703|NCT00219765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101448704|NCT00219765|Antiviral Agents|antiviral agents|mesh-ancestor
101448705|NCT00219765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101448706|NCT00219765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101448707|NCT00219765|Immunologic Factors|immunologic factors|mesh-ancestor
101448708|NCT00219765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448709|NCT00219765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101448710|NCT00219765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101448711|NCT00219765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101448712|NCT00219765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101448713|NCT00219765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101448715|NCT00212589|Folic Acid|folic acid|mesh-list
101308270|NCT02046551|Adrenergic Agents|adrenergic agents|mesh-ancestor
101308271|NCT02046551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101308272|NCT02046551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308273|NCT02046577|Vitamin D|vitamin d|mesh-list
101308274|NCT02046577|Cholecalciferol|cholecalciferol|mesh-list
101308275|NCT02046577|Vitamins|vitamins|mesh-ancestor
101308276|NCT02046577|Micronutrients|micronutrients|mesh-ancestor
101308277|NCT02046577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308278|NCT02046577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101308279|NCT02046577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101448716|NCT00212589|Fluorouracil|fluorouracil|mesh-list
101448717|NCT00212589|Capecitabine|capecitabine|mesh-list
101448718|NCT00212589|Levoleucovorin|levoleucovorin|mesh-list
101448719|NCT00212589|Antimetabolites|antimetabolites|mesh-ancestor
101448720|NCT00212589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448721|NCT00212589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101448722|NCT00212589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101448723|NCT00212589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101448724|NCT00212589|Immunologic Factors|immunologic factors|mesh-ancestor
101448725|NCT00212589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448726|NCT00212589|Antidotes|antidotes|mesh-ancestor
101448727|NCT00212589|Protective Agents|protective agents|mesh-ancestor
101448728|NCT00212589|Vitamin B Complex|vitamin b complex|mesh-ancestor
101448730|NCT00212589|Micronutrients|micronutrients|mesh-ancestor
101448731|NCT00212589|Hematinics|hematinics|mesh-ancestor
101448732|NCT00188825|Basiliximab|basiliximab|mesh-list
101448733|NCT00188825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101678712|NCT04942886|Entecavir|entecavir|mesh-list
101448734|NCT00188825|Immunologic Factors|immunologic factors|mesh-ancestor
101448735|NCT00188825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448736|NCT00219804|Tetrabenazine|tetrabenazine|mesh-list
101448737|NCT00219804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101448738|NCT00219804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101448739|NCT00219804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101448740|NCT00219804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448741|NCT00219804|Adrenergic Agents|adrenergic agents|mesh-ancestor
101448742|NCT00219804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101448743|NCT00219804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448744|NCT00188864|Dexamethasone|dexamethasone|mesh-list
101448745|NCT00188864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101448746|NCT00188864|Antiemetics|antiemetics|mesh-ancestor
101448747|NCT00188864|Autonomic Agents|autonomic agents|mesh-ancestor
101448748|NCT00188864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101448753|NCT00188864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101448754|NCT00188864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101448755|NCT00188864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101448756|NCT00188942|Olanzapine|olanzapine|mesh-list
101448757|NCT00188942|Fluoxetine|fluoxetine|mesh-list
101448758|NCT00188942|Antiemetics|antiemetics|mesh-ancestor
101448759|NCT00188942|Autonomic Agents|autonomic agents|mesh-ancestor
101679068|NCT02775968|Cefamandole|cefamandole|mesh-list
101448760|NCT00188942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101448761|NCT00188942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448762|NCT00188942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101448764|NCT00188942|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101448765|NCT00188942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101448766|NCT00188942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101448767|NCT00188942|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101448768|NCT00188942|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101448769|NCT00188942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101448770|NCT00188942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448771|NCT00188942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101448772|NCT00188942|Serotonin Agents|serotonin agents|mesh-ancestor
101448773|NCT00188942|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101448774|NCT00188942|Antidepressive Agents|antidepressive agents|mesh-ancestor
101308280|NCT02046629|Teriflunomide|teriflunomide|mesh-list
101308281|NCT02046629|Cholestyramine Resin|cholestyramine resin|mesh-list
101308282|NCT02046629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101308283|NCT02046629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101308284|NCT02046629|Analgesics|analgesics|mesh-ancestor
101308285|NCT02046629|Sensory System Agents|sensory system agents|mesh-ancestor
101308286|NCT02046629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101448775|NCT00188942|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101448776|NCT00188942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101448777|NCT00188942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101448778|NCT00219882|Turmeric extract|turmeric extract|mesh-list
101448779|NCT00219882|Antioxidants|antioxidants|mesh-ancestor
101448780|NCT00219882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448781|NCT00219882|Protective Agents|protective agents|mesh-ancestor
101448782|NCT00219882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448783|NCT00189020|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101448784|NCT00189020|Immunologic Factors|immunologic factors|mesh-ancestor
101448785|NCT00189020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448787|NCT00219921|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101448788|NCT00219921|Narcotics|narcotics|mesh-ancestor
101448789|NCT00219921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101448790|NCT00219921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448791|NCT00219921|Analgesics|analgesics|mesh-ancestor
101448792|NCT00219921|Sensory System Agents|sensory system agents|mesh-ancestor
101448793|NCT00219921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101448794|NCT00212823|Almotriptan|almotriptan|mesh-list
101448795|NCT00212823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101448796|NCT00212823|Serotonin Agents|serotonin agents|mesh-ancestor
101448797|NCT00212823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101448798|NCT00212823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448799|NCT00212823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448800|NCT00189059|Amitriptyline|amitriptyline|mesh-list
101448801|NCT00189059|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101448802|NCT00189059|Antidepressive Agents|antidepressive agents|mesh-ancestor
101448803|NCT00189059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101448804|NCT00189059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101448805|NCT00189059|Analgesics|analgesics|mesh-ancestor
101448806|NCT00189059|Sensory System Agents|sensory system agents|mesh-ancestor
101448807|NCT00189059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101679613|NCT02676297|Tiotropium Bromide|tiotropium bromide|mesh-list
101448808|NCT00189059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448809|NCT00189059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101448810|NCT00189059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101448811|NCT00189059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101448812|NCT00189059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448814|NCT00189059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101448815|NCT00189176|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
101448816|NCT00189176|Chelating Agents|chelating agents|mesh-ancestor
101448817|NCT00189176|Sequestering Agents|sequestering agents|mesh-ancestor
101487417|NCT00432588|Oxytocics|oxytocics|mesh-ancestor
101448820|NCT00189176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101448821|NCT00189176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101448822|NCT00189176|Growth Substances|growth substances|mesh-ancestor
101679746|NCT02762942|Misoprostol|misoprostol|mesh-list
101448823|NCT00189176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448824|NCT00189176|Growth Inhibitors|growth inhibitors|mesh-ancestor
101448825|NCT00189176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101448826|NCT00189371|Paclitaxel|paclitaxel|mesh-list
101448827|NCT00189371|Carboplatin|carboplatin|mesh-list
101448828|NCT00189371|Epoetin Alfa|epoetin alfa|mesh-list
101448829|NCT00189371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101448830|NCT00189371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101448831|NCT00189371|Tubulin Modulators|tubulin modulators|mesh-ancestor
101448832|NCT00189371|Antimitotic Agents|antimitotic agents|mesh-ancestor
101448833|NCT00189371|Mitosis Modulators|mitosis modulators|mesh-ancestor
101679884|NCT00917579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101448834|NCT00189371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308287|NCT02046629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448836|NCT00189410|Carboplatin|carboplatin|mesh-list
101448838|NCT00189410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101448839|NCT00189410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101448840|NCT00189410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101448841|NCT00189410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101448842|NCT00189410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101680024|NCT04177173|Methotrexate|methotrexate|mesh-list
101448843|NCT00189410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101448844|NCT00189410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448847|NCT00189566|Topotecan|topotecan|mesh-list
101448848|NCT00189566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101448849|NCT00189566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101448850|NCT00189566|Tubulin Modulators|tubulin modulators|mesh-ancestor
101448852|NCT00189566|Mitosis Modulators|mitosis modulators|mesh-ancestor
101448853|NCT00189566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448854|NCT00189566|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101448855|NCT00189566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101448856|NCT00189566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101448857|NCT00220116|Capecitabine|capecitabine|mesh-list
101448858|NCT00220116|Oxaliplatin|oxaliplatin|mesh-list
101448859|NCT00220116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101448860|NCT00220116|Antimetabolites|antimetabolites|mesh-ancestor
101448861|NCT00220116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448863|NCT02963129|Mupirocin|mupirocin|mesh-list
101448864|NCT02963129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101448865|NCT02963129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101448866|NCT02963129|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101448867|NCT02963129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101680237|NCT04679012|Etoposide|etoposide|mesh-list
101448868|NCT02963129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448869|NCT00220155|Gemcitabine|gemcitabine|mesh-list
101448870|NCT00220155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101448871|NCT00220155|Antimetabolites|antimetabolites|mesh-ancestor
101680293|NCT00613782|Anabolic Agents|anabolic agents|mesh-ancestor
101448872|NCT00220155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448873|NCT00220155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101448875|NCT00189644|Fluorouracil|fluorouracil|mesh-list
101448876|NCT00189644|Epirubicin|epirubicin|mesh-list
101448877|NCT00189644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101448878|NCT00189644|Immunologic Factors|immunologic factors|mesh-ancestor
101448879|NCT00189644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448880|NCT00189644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101448881|NCT00189644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101448882|NCT00189644|Alkylating Agents|alkylating agents|mesh-ancestor
101448883|NCT00189644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448884|NCT00189644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101448885|NCT00189644|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101448886|NCT00189644|Antimetabolites|antimetabolites|mesh-ancestor
101448887|NCT00189644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101448888|NCT00189644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101448889|NCT00189644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101448890|NCT00189644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101448891|NCT00189644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101448896|NCT00189683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101448897|NCT00189722|Tacrolimus|tacrolimus|mesh-list
101448898|NCT00189722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101448899|NCT00189722|Immunologic Factors|immunologic factors|mesh-ancestor
101448900|NCT00189722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448901|NCT00189722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101448902|NCT00189722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101448903|NCT00189722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448904|NCT00220194|Leuprolide|leuprolide|mesh-list
101448905|NCT00220194|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101448907|NCT00220194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101448908|NCT00220194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448909|NCT00220194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101680714|NCT05343546|Copper|copper|mesh-list
101448910|NCT00220194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101448912|NCT00189761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101448913|NCT00189761|Immunologic Factors|immunologic factors|mesh-ancestor
101308288|NCT02046629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101308289|NCT02046629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101308290|NCT02046629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101448914|NCT00189761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448915|NCT00189761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101448916|NCT00189761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101448917|NCT00189761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448918|NCT00213096|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101448919|NCT00213096|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101448920|NCT00213096|Levonorgestrel|levonorgestrel|mesh-list
101448921|NCT00213096|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101448922|NCT00213096|ST 1435|st 1435|mesh-list
101448923|NCT00213096|Contraceptive Agents|contraceptive agents|mesh-list
101448924|NCT00213096|Contraceptives, Oral|contraceptives, oral|mesh-list
101448925|NCT00213096|Estradiol|estradiol|mesh-list
101448926|NCT00213096|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101448927|NCT00213096|Estrogens|estrogens|mesh-ancestor
101448928|NCT00213096|Hormones|hormones|mesh-ancestor
101448929|NCT00213096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101448930|NCT00213096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448931|NCT00213096|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101448932|NCT00213096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101680978|NCT02752724|Anesthetics, General|anesthetics, general|mesh-ancestor
101448933|NCT00213096|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101448934|NCT00213096|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101681047|NCT02759510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101448935|NCT00213096|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101448936|NCT00189800|Solifenacin Succinate|solifenacin succinate|mesh-list
101448937|NCT00189800|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101448938|NCT00189800|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101448939|NCT00189800|Cholinergic Agents|cholinergic agents|mesh-ancestor
101448940|NCT00189800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101448941|NCT00189800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448942|NCT00189800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448943|NCT00189800|Urological Agents|urological agents|mesh-ancestor
101448944|NCT00220233|Amlodipine|amlodipine|mesh-list
101448945|NCT00220233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101448946|NCT00220233|Olmesartan|olmesartan|mesh-list
101448947|NCT00220233|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101448948|NCT00220233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101448949|NCT00220233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101448950|NCT00220233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101448951|NCT00220233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448952|NCT00220233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101448953|NCT00220233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448954|NCT00220233|Vasodilator Agents|vasodilator agents|mesh-ancestor
101448955|NCT00220233|Diuretics|diuretics|mesh-ancestor
101448956|NCT00220233|Natriuretic Agents|natriuretic agents|mesh-ancestor
101448957|NCT00220233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101448958|NCT00220233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101448959|NCT00220233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101681250|NCT02705664|Amorolfine|amorolfine|mesh-list
101448969|NCT00189878|Abortifacient Agents|abortifacient agents|mesh-ancestor
101448970|NCT00189878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101448971|NCT00189878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448972|NCT00189878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101448973|NCT00189878|Antimetabolites|antimetabolites|mesh-ancestor
101448974|NCT00189878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448975|NCT00189878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101448976|NCT00189878|Dermatologic Agents|dermatologic agents|mesh-ancestor
101448977|NCT00189878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101448978|NCT00189878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101448979|NCT00189878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101448980|NCT00189878|Immunologic Factors|immunologic factors|mesh-ancestor
101448981|NCT00189878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101448982|NCT00189878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101448983|NCT00220311|Fludarabine|fludarabine|mesh-list
101448984|NCT00220311|Fludarabine phosphate|fludarabine phosphate|mesh-list
101448985|NCT00220311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101448986|NCT00220311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101448987|NCT00220311|Antimetabolites|antimetabolites|mesh-ancestor
101308291|NCT02046629|Immunologic Factors|immunologic factors|mesh-ancestor
101681454|NCT02701608|Levofloxacin|levofloxacin|mesh-list
101308292|NCT02046629|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101308293|NCT02046629|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101448988|NCT00220311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448989|NCT00220311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101448990|NCT00220311|Immunologic Factors|immunologic factors|mesh-ancestor
101448991|NCT00220311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448992|NCT00189917|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
101448993|NCT00189917|Antiviral Agents|antiviral agents|mesh-ancestor
101448994|NCT00189917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101448995|NCT00189956|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
101448997|NCT00189956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101448998|NCT00213252|Prednisolone|prednisolone|mesh-list
101448999|NCT00213252|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101449000|NCT00213252|Methylprednisolone|methylprednisolone|mesh-list
101449001|NCT00213252|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101449002|NCT00213252|Prednisolone acetate|prednisolone acetate|mesh-list
101449003|NCT00213252|Montelukast|montelukast|mesh-list
101449004|NCT00213252|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101449005|NCT00213252|Prednisolone phosphate|prednisolone phosphate|mesh-list
101449006|NCT00213252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101449007|NCT00213252|Glucocorticoids|glucocorticoids|mesh-ancestor
101681805|NCT04032626|Lenalidomide|lenalidomide|mesh-list
101449009|NCT00213252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101449010|NCT00213252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449011|NCT00213252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101449012|NCT00213252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101449013|NCT00213252|Antiemetics|antiemetics|mesh-ancestor
101449014|NCT00213252|Autonomic Agents|autonomic agents|mesh-ancestor
101449015|NCT00213252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101449016|NCT00213252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101449017|NCT00213252|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101449018|NCT00213252|Protective Agents|protective agents|mesh-ancestor
101449019|NCT00213252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101449020|NCT00213252|Respiratory System Agents|respiratory system agents|mesh-ancestor
101449021|NCT00213252|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101682186|NCT02736032|Estradiol|estradiol|mesh-list
101449022|NCT00213252|Hormone Antagonists|hormone antagonists|mesh-ancestor
101449023|NCT00213252|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101449058|NCT00190034|Protective Agents|protective agents|mesh-ancestor
101449059|NCT00190034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449061|NCT00412503|Temozolomide|temozolomide|mesh-list
101449062|NCT00412503|Topotecan|topotecan|mesh-list
101449063|NCT00412503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101682236|NCT04318730|Apatinib|apatinib|mesh-list
101449064|NCT00412503|Alkylating Agents|alkylating agents|mesh-ancestor
101449065|NCT00412503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449066|NCT00412503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101449067|NCT00412503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101449068|NCT00412503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101449069|NCT00412503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101449070|NCT00412581|Lenalidomide|lenalidomide|mesh-list
101449071|NCT00412581|Dacarbazine|dacarbazine|mesh-list
101449072|NCT00412581|Immunologic Factors|immunologic factors|mesh-ancestor
101449073|NCT00412581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449074|NCT00412581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101449075|NCT00412581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101449076|NCT00412581|Growth Substances|growth substances|mesh-ancestor
101449077|NCT00412581|Growth Inhibitors|growth inhibitors|mesh-ancestor
101449078|NCT00412581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101449079|NCT00412581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101449080|NCT00412581|Alkylating Agents|alkylating agents|mesh-ancestor
101449081|NCT00412581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449082|NCT00190151|Ciprofloxacin|ciprofloxacin|mesh-list
101682365|NCT02631941|Budesonide|budesonide|mesh-list
101449083|NCT00190151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101449084|NCT00190151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101449085|NCT00190151|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101449086|NCT00190151|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101449087|NCT00190151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101449088|NCT00190151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308295|NCT02046629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308296|NCT02046629|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101308297|NCT02046668|Spironolactone|spironolactone|mesh-list
101308298|NCT02046668|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101308299|NCT02046668|Hormone Antagonists|hormone antagonists|mesh-ancestor
101308300|NCT02046668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101308301|NCT02046668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308302|NCT02046668|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101308303|NCT02046668|Diuretics|diuretics|mesh-ancestor
101308304|NCT02046668|Natriuretic Agents|natriuretic agents|mesh-ancestor
101449089|NCT00190151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101449090|NCT00190151|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101449091|NCT00190151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101449092|NCT00190229|Cyclophosphamide|cyclophosphamide|mesh-list
101449093|NCT00190229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101449094|NCT00190229|Immunologic Factors|immunologic factors|mesh-ancestor
101449095|NCT00190229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449096|NCT00190229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101449097|NCT00190229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101449098|NCT00190229|Alkylating Agents|alkylating agents|mesh-ancestor
101449099|NCT00190229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449100|NCT00190229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101682792|NCT02732522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101449101|NCT00190229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101449102|NCT00190268|Amifampridine|amifampridine|mesh-list
101449103|NCT00190268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101449104|NCT00190268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101449105|NCT00190268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449106|NCT00190268|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101449107|NCT00190268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101449108|NCT00190268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449109|NCT00220350|Leuprolide|leuprolide|mesh-list
101449110|NCT00220350|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101449111|NCT00220350|Fertility Agents|fertility agents|mesh-ancestor
101449112|NCT00220350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101449113|NCT00220350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682932|NCT02757872|Micronutrients|micronutrients|mesh-ancestor
101449114|NCT00220350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101449139|NCT00190424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101449140|NCT00190424|Immunologic Factors|immunologic factors|mesh-ancestor
101449141|NCT00190424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682998|NCT02719418|Dalteparin|dalteparin|mesh-list
101449143|NCT00190463|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101449144|NCT00190463|Amebicides|amebicides|mesh-ancestor
101449145|NCT00190463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101449146|NCT00190463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101449147|NCT00190463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101449148|NCT00190463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101449149|NCT00190463|Antifungal Agents|antifungal agents|mesh-ancestor
101449151|NCT00213486|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101449152|NCT00213486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101449153|NCT00213486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101449154|NCT00213486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449155|NCT00213486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101449157|NCT00190502|Immunologic Factors|immunologic factors|mesh-ancestor
101449158|NCT00190502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449159|NCT00122837|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101683283|NCT00764270|Thioctic Acid|thioctic acid|mesh-list
101449160|NCT00122837|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101449161|NCT00122837|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101449162|NCT00122837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101308306|NCT02046720|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101308307|NCT02046720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101449163|NCT00122837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101449178|NCT00190580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449180|NCT00220506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101449181|NCT00220506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449182|NCT00220506|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101449183|NCT00220506|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101449184|NCT00220506|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101683489|NCT02649075|Antibodies|antibodies|mesh-list
101449185|NCT00220506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449186|NCT00190619|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101449187|NCT00190619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101449188|NCT00190619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101449189|NCT00190619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101449190|NCT00190619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449191|NCT00190619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101683637|NCT04166253|Alfacalcidol|alfacalcidol|mesh-list
101449192|NCT00190619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449193|NCT00190619|Analgesics|analgesics|mesh-ancestor
101449194|NCT00190619|Sensory System Agents|sensory system agents|mesh-ancestor
101449195|NCT00190619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101449196|NCT00190619|Antidepressive Agents|antidepressive agents|mesh-ancestor
101449197|NCT00190619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101449198|NCT00190619|Dopamine Agents|dopamine agents|mesh-ancestor
101449199|NCT00213564|Infliximab|infliximab|mesh-list
101449200|NCT00213564|Methotrexate|methotrexate|mesh-list
101449201|NCT00213564|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101449202|NCT00213564|Abortifacient Agents|abortifacient agents|mesh-ancestor
101449203|NCT00213564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101449204|NCT00213564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449205|NCT00213564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101449206|NCT00213564|Antimetabolites|antimetabolites|mesh-ancestor
101449207|NCT00213564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683712|NCT02709902|Adapalene|adapalene|mesh-list
101449208|NCT00213564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101449210|NCT00213564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101449211|NCT00213564|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101449212|NCT00213564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101449213|NCT00213564|Immunologic Factors|immunologic factors|mesh-ancestor
101449214|NCT00213564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101449215|NCT00213564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101449216|NCT00213564|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101449217|NCT00213564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101449218|NCT00213564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101449230|NCT00190736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449231|NCT00220584|Donepezil|donepezil|mesh-list
101449232|NCT00220584|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101449233|NCT00220584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101449234|NCT00220584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683902|NCT02707874|Anesthetics|anesthetics|mesh-ancestor
101449235|NCT00220584|Cholinergic Agents|cholinergic agents|mesh-ancestor
101449236|NCT00220584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101449237|NCT00220584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449238|NCT00220584|Nootropic Agents|nootropic agents|mesh-ancestor
101449239|NCT00190814|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101449240|NCT00190814|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101449241|NCT00190814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101449242|NCT00190814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101449243|NCT00190814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449244|NCT00190814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101449245|NCT00190814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449246|NCT00190814|Analgesics|analgesics|mesh-ancestor
101449247|NCT00190814|Sensory System Agents|sensory system agents|mesh-ancestor
101449248|NCT00190814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101449249|NCT00190814|Antidepressive Agents|antidepressive agents|mesh-ancestor
101449250|NCT00190814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101449251|NCT00190814|Dopamine Agents|dopamine agents|mesh-ancestor
101684184|NCT00884793|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101308308|NCT02046720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308309|NCT02046720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101308310|NCT02046720|Anesthetics, General|anesthetics, general|mesh-ancestor
101308312|NCT02046733|Nivolumab|nivolumab|mesh-list
101308313|NCT02046733|Ipilimumab|ipilimumab|mesh-list
101449252|NCT00220623|Antidepressive Agents|antidepressive agents|mesh-list
101449253|NCT00220623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101449255|NCT00220818|Dexlansoprazole|dexlansoprazole|mesh-list
101449256|NCT00220818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101449257|NCT00220818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101449258|NCT00220818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101449259|NCT00220818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101684320|NCT00657423|Docetaxel|docetaxel|mesh-list
101449260|NCT00220818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449262|NCT00213759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101449263|NCT00213759|Immunologic Factors|immunologic factors|mesh-ancestor
101684386|NCT05342792|Capecitabine|capecitabine|mesh-list
101449264|NCT00213759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449266|NCT00190853|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101449267|NCT00190853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101449268|NCT00190853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101449269|NCT00190853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449270|NCT00190853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101449271|NCT00190853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449272|NCT00190853|Analgesics|analgesics|mesh-ancestor
101449273|NCT00190853|Sensory System Agents|sensory system agents|mesh-ancestor
101684523|NCT00659997|Tubulin Modulators|tubulin modulators|mesh-ancestor
101449274|NCT00190853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101449275|NCT00190853|Antidepressive Agents|antidepressive agents|mesh-ancestor
101449276|NCT00190853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101449277|NCT00190853|Dopamine Agents|dopamine agents|mesh-ancestor
101449278|NCT00190892|Carbamazepine|carbamazepine|mesh-list
101449279|NCT00190892|Olanzapine|olanzapine|mesh-list
101449280|NCT00190892|Antiemetics|antiemetics|mesh-ancestor
101449281|NCT00190892|Autonomic Agents|autonomic agents|mesh-ancestor
101449285|NCT00190892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101449286|NCT00190892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101449287|NCT00190892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101449288|NCT00190892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101449289|NCT00190892|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101449290|NCT00190892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101449291|NCT00190892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101449292|NCT00190892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449293|NCT00190892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101449294|NCT00190892|Serotonin Agents|serotonin agents|mesh-ancestor
101449295|NCT00190892|Anticonvulsants|anticonvulsants|mesh-ancestor
101449296|NCT00190892|Antimanic Agents|antimanic agents|mesh-ancestor
101449297|NCT00190892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101449299|NCT00190892|Sensory System Agents|sensory system agents|mesh-ancestor
101449300|NCT00190892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101449301|NCT00190892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101449302|NCT00190892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101449303|NCT00220857|Rabeprazole|rabeprazole|mesh-list
101449305|NCT00220857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101449306|NCT00220857|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101449307|NCT00220857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101449308|NCT00220857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449309|NCT00190931|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101449310|NCT00190931|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101449311|NCT00190931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101449312|NCT00190931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101449313|NCT00190931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449314|NCT00190931|Adrenergic Agents|adrenergic agents|mesh-ancestor
101449315|NCT00190931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101308314|NCT02046733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101308315|NCT02046733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308316|NCT02046733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101308317|NCT02046733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308318|NCT02046785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101308320|NCT02046850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101308321|NCT02046850|Antitubercular Agents|antitubercular agents|mesh-ancestor
101308322|NCT02046850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101308323|NCT02046850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101308324|NCT02046850|Leprostatic Agents|leprostatic agents|mesh-ancestor
101308325|NCT02046850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101308326|NCT02046850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101308327|NCT02046850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308328|NCT02046850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101308329|NCT02046850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101308330|NCT02046850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101308331|NCT02046850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101308332|NCT02046850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101308333|NCT02046850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101308334|NCT02046915|Dexamethasone|dexamethasone|mesh-list
101308335|NCT02046915|Cyclophosphamide|cyclophosphamide|mesh-list
101308336|NCT02046915|Pomalidomide|pomalidomide|mesh-list
101308337|NCT02046915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101308338|NCT02046915|Immunologic Factors|immunologic factors|mesh-ancestor
101449316|NCT00190931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449317|NCT00220896|Donepezil|donepezil|mesh-list
101449318|NCT00220896|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101449319|NCT00220896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101685288|NCT02703194|Prednisone|prednisone|mesh-list
101449320|NCT00220896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449321|NCT00220896|Cholinergic Agents|cholinergic agents|mesh-ancestor
101449322|NCT00220896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101449323|NCT00220896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449324|NCT00220896|Nootropic Agents|nootropic agents|mesh-ancestor
101449325|NCT00190970|Ruboxistaurin|ruboxistaurin|mesh-list
101449326|NCT00190970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101449327|NCT00190970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449328|NCT00191009|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101449329|NCT00191009|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101449330|NCT00191009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101449331|NCT00191009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101449332|NCT00191009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449333|NCT00191009|Adrenergic Agents|adrenergic agents|mesh-ancestor
101449334|NCT00191009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101449335|NCT00191009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449336|NCT00191048|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101308339|NCT02046915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308340|NCT02046915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101308341|NCT02046915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101685483|NCT00615602|Lenograstim|lenograstim|mesh-list
101308342|NCT02046915|Alkylating Agents|alkylating agents|mesh-ancestor
101308343|NCT02046915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449337|NCT00191048|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101449338|NCT00191048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101449339|NCT00191048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101449340|NCT00191048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449341|NCT00191048|Adrenergic Agents|adrenergic agents|mesh-ancestor
101449342|NCT00191048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101449343|NCT00191048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449344|NCT00123149|Epoetin Alfa|epoetin alfa|mesh-list
101449345|NCT00123149|Hematinics|hematinics|mesh-ancestor
101449346|NCT00191087|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101449347|NCT00191087|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101449348|NCT00191087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101685756|NCT00615758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101449355|NCT00191087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101449356|NCT00191087|Antidepressive Agents|antidepressive agents|mesh-ancestor
101449357|NCT00191087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101509097|NCT05317767|Vaccines|vaccines|mesh-list
101449358|NCT00191087|Dopamine Agents|dopamine agents|mesh-ancestor
101449359|NCT00191126|Gemcitabine|gemcitabine|mesh-list
101449360|NCT00191126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101449361|NCT00191126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101511119|NCT00528983|Cc-486|cc-486|mesh-list
101449362|NCT00191126|Antimetabolites|antimetabolites|mesh-ancestor
101449363|NCT00191126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449365|NCT00221052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101449366|NCT00221052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101449367|NCT00221052|Analgesics|analgesics|mesh-ancestor
101449368|NCT00221052|Sensory System Agents|sensory system agents|mesh-ancestor
101449369|NCT00221052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101449370|NCT00221052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449371|NCT00221052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101449372|NCT00221052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101449373|NCT00221052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101449374|NCT00221052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686099|NCT00620646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101449375|NCT00221052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449376|NCT00191204|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101449377|NCT00191204|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101449378|NCT00191204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101449379|NCT00191204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101449380|NCT00191204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449381|NCT00191204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101449382|NCT00191204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449383|NCT00191204|Analgesics|analgesics|mesh-ancestor
101449384|NCT00191204|Sensory System Agents|sensory system agents|mesh-ancestor
101449385|NCT00191204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101449386|NCT00191204|Antidepressive Agents|antidepressive agents|mesh-ancestor
101449387|NCT00191204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101449388|NCT00191204|Dopamine Agents|dopamine agents|mesh-ancestor
101449389|NCT00123227|Rosiglitazone|rosiglitazone|mesh-list
101449390|NCT00123227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101449391|NCT00123227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449392|NCT00191243|Gemcitabine|gemcitabine|mesh-list
101449394|NCT00191243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101449395|NCT00191243|Antimetabolites|antimetabolites|mesh-ancestor
101449396|NCT00191243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449397|NCT00191243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101449398|NCT00191243|Tubulin Modulators|tubulin modulators|mesh-ancestor
101449399|NCT00191243|Antimitotic Agents|antimitotic agents|mesh-ancestor
101449400|NCT00191243|Mitosis Modulators|mitosis modulators|mesh-ancestor
101449401|NCT00214032|Pycnogenols|pycnogenols|mesh-list
101449402|NCT00214032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101449403|NCT00214032|Immunologic Factors|immunologic factors|mesh-ancestor
101449404|NCT00214032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449405|NCT00214032|Antioxidants|antioxidants|mesh-ancestor
101686371|NCT02844803|Metformin|metformin|mesh-list
101449406|NCT00214032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449407|NCT00214032|Protective Agents|protective agents|mesh-ancestor
101449408|NCT00214032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101449410|NCT00123266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101449411|NCT00123266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101449412|NCT00123266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449413|NCT00191321|Teriparatide|teriparatide|mesh-list
101449414|NCT00191321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101449415|NCT00191321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449419|NCT00123305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101449420|NCT00123305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101449421|NCT00123305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449423|NCT00214110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101449424|NCT00214110|Hormone Antagonists|hormone antagonists|mesh-ancestor
101449425|NCT00214110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101449426|NCT00214110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449427|NCT00214110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101449428|NCT00214110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101449429|NCT00214110|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101449430|NCT00214110|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101449431|NCT00214110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101449432|NCT00191399|Olanzapine|olanzapine|mesh-list
101449433|NCT00191399|Fluoxetine|fluoxetine|mesh-list
101449434|NCT00191399|Antiemetics|antiemetics|mesh-ancestor
101449435|NCT00191399|Autonomic Agents|autonomic agents|mesh-ancestor
101449436|NCT00191399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101449437|NCT00191399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449438|NCT00191399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101449439|NCT00191399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101449440|NCT00191399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101449441|NCT00191399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101449442|NCT00191399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101449443|NCT00191399|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101449444|NCT00191399|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101449445|NCT00191399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101449446|NCT00191399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449447|NCT00191399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101449448|NCT00191399|Serotonin Agents|serotonin agents|mesh-ancestor
101449449|NCT00191399|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101686708|NCT00212771|Olanzapine|olanzapine|mesh-list
101449450|NCT00191399|Antidepressive Agents|antidepressive agents|mesh-ancestor
101449451|NCT00191399|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101449452|NCT00191399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101449453|NCT00191399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101449454|NCT00191438|Gemcitabine|gemcitabine|mesh-list
101449455|NCT00191438|Capecitabine|capecitabine|mesh-list
101449456|NCT00191438|Docetaxel|docetaxel|mesh-list
101449457|NCT00191438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101449458|NCT00191438|Antimetabolites|antimetabolites|mesh-ancestor
101449459|NCT00191438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449460|NCT00191438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101449461|NCT00191438|Tubulin Modulators|tubulin modulators|mesh-ancestor
101449462|NCT00191438|Antimitotic Agents|antimitotic agents|mesh-ancestor
101449463|NCT00191438|Mitosis Modulators|mitosis modulators|mesh-ancestor
101449464|NCT00221286|Interferons|interferons|mesh-list
101449465|NCT00221286|Tenofovir|tenofovir|mesh-list
101449466|NCT00221286|Interferon-alpha|interferon-alpha|mesh-list
101449467|NCT00221286|Interferon alpha-2|interferon alpha-2|mesh-list
101449468|NCT00221286|Emtricitabine|emtricitabine|mesh-list
101449469|NCT00221286|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101449470|NCT00221286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101449472|NCT00221286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101449473|NCT00221286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101449474|NCT00221286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101449475|NCT00221286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101449476|NCT00221286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449477|NCT00221286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101449478|NCT00221286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101308344|NCT02046915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308345|NCT02046915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101308347|NCT02046915|Antiemetics|antiemetics|mesh-ancestor
101308348|NCT02046915|Autonomic Agents|autonomic agents|mesh-ancestor
101449479|NCT00221286|Immunologic Factors|immunologic factors|mesh-ancestor
101449480|NCT00221286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449482|NCT00123383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101687097|NCT00622674|Cetuximab|cetuximab|mesh-list
101449483|NCT00123383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449484|NCT00123383|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101449485|NCT00123383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101449491|NCT00214266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101449493|NCT00214266|Immunologic Factors|immunologic factors|mesh-ancestor
101449494|NCT00214266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449495|NCT00214266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101449496|NCT00214266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101449497|NCT00214266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101449498|NCT00214266|Antitubercular Agents|antitubercular agents|mesh-ancestor
101449499|NCT00214266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101449500|NCT00214266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101449502|NCT00214266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449503|NCT00221325|Rituximab|rituximab|mesh-list
101449504|NCT00221325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101449505|NCT00221325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101449506|NCT00221325|Immunologic Factors|immunologic factors|mesh-ancestor
101449507|NCT00221325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449508|NCT00221325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101449509|NCT00123461|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
101449510|NCT00123461|Vitamins|vitamins|mesh-ancestor
101449511|NCT00123461|Micronutrients|micronutrients|mesh-ancestor
101449512|NCT00123461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449513|NCT00123461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101449514|NCT00191516|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101449515|NCT00191516|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101449516|NCT00191516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101449517|NCT00191516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101449518|NCT00191516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449519|NCT00191516|Adrenergic Agents|adrenergic agents|mesh-ancestor
101449520|NCT00191516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101449521|NCT00191516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449522|NCT00191555|Haloperidol|haloperidol|mesh-list
101449523|NCT00191555|Olanzapine|olanzapine|mesh-list
101449524|NCT00191555|Haloperidol decanoate|haloperidol decanoate|mesh-list
101449525|NCT00191555|Antiemetics|antiemetics|mesh-ancestor
101449526|NCT00191555|Autonomic Agents|autonomic agents|mesh-ancestor
101687652|NCT02842931|Prednisone|prednisone|mesh-list
101449527|NCT00191555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101449528|NCT00191555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449529|NCT00191555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101449530|NCT00191555|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101449531|NCT00191555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101449532|NCT00191555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101449533|NCT00191555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101687791|NCT02673606|Estradiol|estradiol|mesh-list
101449534|NCT00191555|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101449535|NCT00191555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101449536|NCT00191555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101449537|NCT00191555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449538|NCT00191555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101449539|NCT00191555|Serotonin Agents|serotonin agents|mesh-ancestor
101449540|NCT00191555|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101449541|NCT00191555|Dopamine Agents|dopamine agents|mesh-ancestor
101449542|NCT00191555|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101449543|NCT00221364|Azithromycin|azithromycin|mesh-list
101449544|NCT00221364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101449545|NCT00221364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101449547|NCT00123539|Hormones|hormones|mesh-ancestor
101308349|NCT02046915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101308350|NCT02046915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101308351|NCT02046915|Glucocorticoids|glucocorticoids|mesh-ancestor
101449548|NCT00123539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101449549|NCT00123539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449550|NCT00191594|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101449551|NCT00191594|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101449552|NCT00191594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101449565|NCT00221442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101449566|NCT00221442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101449567|NCT00221442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449568|NCT00221442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101449569|NCT00221442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449570|NCT00123578|Pentobarbital|pentobarbital|mesh-list
101449571|NCT00123578|Lorazepam|lorazepam|mesh-list
101449572|NCT00123578|Anticonvulsants|anticonvulsants|mesh-ancestor
101449574|NCT00123578|Autonomic Agents|autonomic agents|mesh-ancestor
101688282|NCT00646932|Vitamins|vitamins|mesh-ancestor
101449575|NCT00123578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101449576|NCT00123578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449577|NCT00123578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101449578|NCT00123578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101449579|NCT00123578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101449580|NCT00123578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101688358|NCT02836847|Cetuximab|cetuximab|mesh-list
101449581|NCT00123578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101449582|NCT00123578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101449583|NCT00123578|GABA Modulators|gaba modulators|mesh-ancestor
101449585|NCT00123578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101449586|NCT00123578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449587|NCT00123578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101449588|NCT00221481|Valproic Acid|valproic acid|mesh-list
101449589|NCT00221481|Olanzapine|olanzapine|mesh-list
101449590|NCT00221481|Antiemetics|antiemetics|mesh-ancestor
101449591|NCT00221481|Autonomic Agents|autonomic agents|mesh-ancestor
101449592|NCT00221481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101449593|NCT00221481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449594|NCT00221481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101449595|NCT00221481|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101449596|NCT00221481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101449597|NCT00221481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101449598|NCT00221481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101449599|NCT00221481|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101449600|NCT00221481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101449601|NCT00221481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101449602|NCT00221481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449603|NCT00221481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101449604|NCT00221481|Serotonin Agents|serotonin agents|mesh-ancestor
101449605|NCT00221481|Anticonvulsants|anticonvulsants|mesh-ancestor
101449606|NCT00221481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101449607|NCT00221481|GABA Agents|gaba agents|mesh-ancestor
101449608|NCT00221481|Antimanic Agents|antimanic agents|mesh-ancestor
101449609|NCT00191633|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101449610|NCT00191633|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101688631|NCT00648726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101449611|NCT00191633|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101449612|NCT00191633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101688708|NCT02838719|BB 1101|bb 1101|mesh-list
101449613|NCT00191633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449616|NCT00191633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449617|NCT00221520|Midazolam|midazolam|mesh-list
101449618|NCT00221520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101449619|NCT00221520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101449620|NCT00221520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101449621|NCT00221520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449622|NCT00221520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101449623|NCT00221520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101449624|NCT00221520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101363563|NCT00133354|Hormones|hormones|mesh-list
101308353|NCT02046915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101449625|NCT00221520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101449626|NCT00221520|Anesthetics, General|anesthetics, general|mesh-ancestor
101449627|NCT00221520|Anesthetics|anesthetics|mesh-ancestor
101449628|NCT00221520|GABA Modulators|gaba modulators|mesh-ancestor
101449629|NCT00221520|GABA Agents|gaba agents|mesh-ancestor
101449630|NCT00221520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101449631|NCT00221520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449632|NCT00191672|Paclitaxel|paclitaxel|mesh-list
101449633|NCT00191672|Docetaxel|docetaxel|mesh-list
101449634|NCT00191672|Gemcitabine|gemcitabine|mesh-list
101449635|NCT00191672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101689046|NCT05234606|Pembrolizumab|pembrolizumab|mesh-list
101449636|NCT00191672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101449637|NCT00191672|Tubulin Modulators|tubulin modulators|mesh-ancestor
101449638|NCT00191672|Antimitotic Agents|antimitotic agents|mesh-ancestor
101449639|NCT00191672|Mitosis Modulators|mitosis modulators|mesh-ancestor
101449640|NCT00191672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449641|NCT00191672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101449642|NCT00191672|Antimetabolites|antimetabolites|mesh-ancestor
101449643|NCT00214578|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101689167|NCT04247087|Hemostatics|hemostatics|mesh-ancestor
101449644|NCT00214578|Antidepressive Agents|antidepressive agents|mesh-ancestor
101449645|NCT00214578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101449646|NCT00214578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101449647|NCT00214578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101449648|NCT00214578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101449649|NCT00214578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449651|NCT00191711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101449652|NCT00191711|Antimetabolites|antimetabolites|mesh-ancestor
101449653|NCT00191711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449654|NCT00191711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101449656|NCT00221637|Anticonvulsants|anticonvulsants|mesh-ancestor
101449657|NCT00221637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101449658|NCT00221637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449659|NCT00221637|GABA Agents|gaba agents|mesh-ancestor
101449660|NCT00221637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101449661|NCT00221637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449662|NCT00221637|Antimanic Agents|antimanic agents|mesh-ancestor
101449663|NCT00221637|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101449664|NCT00221637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101449665|NCT00221637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101449668|NCT00123656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101449669|NCT00123656|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101449670|NCT00123656|Autonomic Agents|autonomic agents|mesh-ancestor
101449671|NCT00123656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101449672|NCT00123656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449673|NCT00123656|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101449674|NCT00123656|Respiratory System Agents|respiratory system agents|mesh-ancestor
101449675|NCT00123656|Dermatologic Agents|dermatologic agents|mesh-ancestor
101449676|NCT00123656|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101689442|NCT00650052|Zonisamide|zonisamide|mesh-list
101449677|NCT00123656|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101449678|NCT00123656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101449679|NCT00123656|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101449680|NCT00123656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101449681|NCT00123656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449682|NCT00214617|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101449683|NCT00214617|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101449684|NCT00214617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101449685|NCT00214617|Antimetabolites|antimetabolites|mesh-ancestor
101449686|NCT00214617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449687|NCT00214617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101449693|NCT00191750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449694|NCT00191750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101449695|NCT00191750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101449696|NCT00214695|Dialysis Solutions|dialysis solutions|mesh-list
101449697|NCT00214695|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101449698|NCT00221754|Pravastatin|pravastatin|mesh-list
101449699|NCT00221754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101449700|NCT00221754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101449701|NCT00221754|Antimetabolites|antimetabolites|mesh-ancestor
101308354|NCT02046915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101308355|NCT02046915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101449702|NCT00221754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449703|NCT00221754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101449704|NCT00221754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101449705|NCT00221754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101449707|NCT00191828|Antiemetics|antiemetics|mesh-ancestor
101449708|NCT00191828|Autonomic Agents|autonomic agents|mesh-ancestor
101689703|NCT02650206|Hormones|hormones|mesh-ancestor
101449709|NCT00191828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101449710|NCT00191828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449711|NCT00191828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101449712|NCT00191828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101449713|NCT00191828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101689764|NCT02647086|Anesthetics|anesthetics|mesh-ancestor
101449714|NCT00191828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101449715|NCT00191828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101449716|NCT00191828|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101449717|NCT00191828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101449718|NCT00191828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101449719|NCT00191828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449720|NCT00191828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101449721|NCT00191828|Serotonin Agents|serotonin agents|mesh-ancestor
101449722|NCT00191867|Teriparatide|teriparatide|mesh-list
101449723|NCT00191867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101449724|NCT00191867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449725|NCT00191867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101449726|NCT00123851|Capecitabine|capecitabine|mesh-list
101449727|NCT00123851|Oxaliplatin|oxaliplatin|mesh-list
101449728|NCT00123851|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101449729|NCT00123851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101449730|NCT00123851|Antimetabolites|antimetabolites|mesh-ancestor
101449731|NCT00123851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449732|NCT00123851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101449733|NCT00123851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101449734|NCT00123851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101449736|NCT00123890|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101449737|NCT00123890|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101449738|NCT00123890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449739|NCT00123890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101449740|NCT00123890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101449741|NCT00123890|Antiviral Agents|antiviral agents|mesh-ancestor
101449742|NCT00123890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101449743|NCT00412698|Rimonabant|rimonabant|mesh-list
101449744|NCT00412698|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101449745|NCT00412698|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
101449746|NCT00412698|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101449747|NCT00412698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101449748|NCT00412698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449750|NCT00412698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101449751|NCT00412698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449752|NCT00123929|Docetaxel|docetaxel|mesh-list
101449753|NCT00123929|Doxorubicin|doxorubicin|mesh-list
101449754|NCT00123929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101449755|NCT00123929|Tubulin Modulators|tubulin modulators|mesh-ancestor
101449758|NCT00123929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449760|NCT00123929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101449761|NCT00123929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101449762|NCT00123929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101449763|NCT00475033|Vaccines|vaccines|mesh-list
101449764|NCT00475033|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101449765|NCT00475033|Immunologic Factors|immunologic factors|mesh-ancestor
101449766|NCT00475033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449767|NCT00192062|Gemcitabine|gemcitabine|mesh-list
101449768|NCT00192062|Vinorelbine|vinorelbine|mesh-list
101449769|NCT00192062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101449770|NCT00192062|Antimetabolites|antimetabolites|mesh-ancestor
101449771|NCT00192062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449772|NCT00192062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308356|NCT02046915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101449773|NCT00192062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101449774|NCT00192062|Tubulin Modulators|tubulin modulators|mesh-ancestor
101449775|NCT00192062|Antimitotic Agents|antimitotic agents|mesh-ancestor
101449776|NCT00192062|Mitosis Modulators|mitosis modulators|mesh-ancestor
101449777|NCT00192101|Gemcitabine|gemcitabine|mesh-list
101449778|NCT00192101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101449779|NCT00192101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101449780|NCT00192101|Antimetabolites|antimetabolites|mesh-ancestor
101449781|NCT00192101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449782|NCT00215007|Levofloxacin|levofloxacin|mesh-list
101449783|NCT00215007|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101449784|NCT00215007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101449785|NCT00215007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101449786|NCT00215007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101449787|NCT00215007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101690497|NCT04243109|Pomalidomide|pomalidomide|mesh-list
101449789|NCT00215007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449790|NCT00215007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101449791|NCT00215007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101449792|NCT00215007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101449793|NCT00474994|Sunitinib|sunitinib|mesh-list
101449794|NCT00474994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101449795|NCT00474994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101449796|NCT00474994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101449797|NCT00474994|Growth Substances|growth substances|mesh-ancestor
101449798|NCT00474994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449799|NCT00474994|Growth Inhibitors|growth inhibitors|mesh-ancestor
101449800|NCT00474994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101449801|NCT00474994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101449802|NCT00474994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449803|NCT00474955|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101449804|NCT00474955|Antiviral Agents|antiviral agents|mesh-ancestor
101449805|NCT00474955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101449806|NCT00215046|Methotrexate|methotrexate|mesh-list
101449807|NCT00215046|Vinblastine|vinblastine|mesh-list
101449808|NCT00215046|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101449809|NCT00215046|Abortifacient Agents|abortifacient agents|mesh-ancestor
101449810|NCT00215046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101449811|NCT00215046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449812|NCT00215046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101449813|NCT00215046|Antimetabolites|antimetabolites|mesh-ancestor
101449814|NCT00215046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449815|NCT00215046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101449816|NCT00215046|Dermatologic Agents|dermatologic agents|mesh-ancestor
101449817|NCT00215046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101449818|NCT00215046|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101449819|NCT00215046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101449820|NCT00215046|Immunologic Factors|immunologic factors|mesh-ancestor
101449821|NCT00215046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101449822|NCT00215046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101449823|NCT00215046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101449824|NCT00215046|Tubulin Modulators|tubulin modulators|mesh-ancestor
101449825|NCT00215046|Antimitotic Agents|antimitotic agents|mesh-ancestor
101449831|NCT00124124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101449832|NCT00124124|Immunologic Factors|immunologic factors|mesh-ancestor
101449833|NCT00124124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449834|NCT00474253|Rocuronium|rocuronium|mesh-list
101449835|NCT00474253|Succinylcholine|succinylcholine|mesh-list
101449836|NCT00474253|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101449837|NCT00474253|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101449838|NCT00474253|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101449839|NCT00474253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101449840|NCT00474253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449841|NCT00474253|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
101449842|NCT00221871|Ketamine|ketamine|mesh-list
101449843|NCT00221871|Analgesics|analgesics|mesh-ancestor
101449844|NCT00221871|Sensory System Agents|sensory system agents|mesh-ancestor
101449845|NCT00221871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101449846|NCT00221871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308357|NCT02046915|Growth Substances|growth substances|mesh-ancestor
101308358|NCT02046915|Growth Inhibitors|growth inhibitors|mesh-ancestor
101308359|NCT02047006|Rivaroxaban|rivaroxaban|mesh-list
101308360|NCT02047006|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101449847|NCT00221871|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101449848|NCT00221871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101449849|NCT00221871|Anesthetics, General|anesthetics, general|mesh-ancestor
101449850|NCT00221871|Anesthetics|anesthetics|mesh-ancestor
101449851|NCT00221871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101449852|NCT00221871|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101449853|NCT00221871|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101449854|NCT00221871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101449855|NCT00221871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449857|NCT00474058|Dopamine Agonists|dopamine agonists|mesh-ancestor
101449858|NCT00474058|Dopamine Agents|dopamine agents|mesh-ancestor
101449859|NCT00474058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101449860|NCT00474058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449861|NCT00474058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449862|NCT02277730|Phenylephrine|phenylephrine|mesh-list
101449863|NCT02277730|Oxymetazoline|oxymetazoline|mesh-list
101449864|NCT02277730|Ephedrine|ephedrine|mesh-list
101449865|NCT02277730|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
101690878|NCT04239833|Gefitinib|gefitinib|mesh-list
101449867|NCT02277730|Mydriatics|mydriatics|mesh-ancestor
101449868|NCT02277730|Autonomic Agents|autonomic agents|mesh-ancestor
101449869|NCT02277730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101449870|NCT02277730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449871|NCT02277730|Sympathomimetics|sympathomimetics|mesh-ancestor
101449872|NCT02277730|Nasal Decongestants|nasal decongestants|mesh-ancestor
101449873|NCT02277730|Respiratory System Agents|respiratory system agents|mesh-ancestor
101449874|NCT02277730|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101449875|NCT02277730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101449876|NCT02277730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101449877|NCT02277730|Adrenergic Agents|adrenergic agents|mesh-ancestor
101449878|NCT02277730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101449879|NCT02277730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449880|NCT02277730|Protective Agents|protective agents|mesh-ancestor
101691147|NCT04208516|Lidocaine|lidocaine|mesh-list
101449881|NCT02277730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101449882|NCT04571437|Capecitabine|capecitabine|mesh-list
101449883|NCT04571437|Letrozole|letrozole|mesh-list
101691216|NCT02821247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101449884|NCT04571437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101449885|NCT04571437|Antimetabolites|antimetabolites|mesh-ancestor
101449886|NCT04571437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449887|NCT04571437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101449888|NCT04571437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101449889|NCT04571437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101449891|NCT04571437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101449892|NCT04571437|Hormone Antagonists|hormone antagonists|mesh-ancestor
101646163|NCT04264286|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101449893|NCT04571437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101449894|NCT04571437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449895|NCT00215124|Lenograstim|lenograstim|mesh-list
101449898|NCT00215124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449901|NCT00473824|gamma-Globulins|gamma-globulins|mesh-list
101691434|NCT02815319|Hormones|hormones|mesh-ancestor
101449902|NCT00473824|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101449903|NCT00473824|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101449904|NCT00473824|Immunologic Factors|immunologic factors|mesh-ancestor
101449905|NCT00473824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449906|NCT00215163|Paroxetine|paroxetine|mesh-list
101691493|NCT02684786|Sensory System Agents|sensory system agents|mesh-ancestor
101449907|NCT00215163|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101449908|NCT00215163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101449909|NCT00215163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101449910|NCT00215163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449911|NCT00215163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101449912|NCT00215163|Serotonin Agents|serotonin agents|mesh-ancestor
101308362|NCT02047006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101308363|NCT02047006|Protease Inhibitors|protease inhibitors|mesh-ancestor
101449913|NCT00215163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449914|NCT00215163|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101449915|NCT00215163|Antidepressive Agents|antidepressive agents|mesh-ancestor
101449916|NCT00215163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101449917|NCT00215163|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101449918|NCT00215163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101449919|NCT00215163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101449920|NCT00215202|Gefitinib|gefitinib|mesh-list
101449921|NCT00215202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101449922|NCT00215202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101449923|NCT00215202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101449924|NCT00215202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449925|NCT00215241|Risperidone|risperidone|mesh-list
101449926|NCT00215241|Sertraline|sertraline|mesh-list
101449927|NCT00215241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101449928|NCT00215241|Serotonin Agents|serotonin agents|mesh-ancestor
101449929|NCT00215241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101449930|NCT00215241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449931|NCT00215241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449933|NCT00215241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101449934|NCT00215241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101449935|NCT00215241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101449936|NCT00215241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101449937|NCT00215241|Dopamine Agents|dopamine agents|mesh-ancestor
101449938|NCT00215241|Antidepressive Agents|antidepressive agents|mesh-ancestor
101449939|NCT00215241|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101449940|NCT00215241|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101449941|NCT00215241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101449943|NCT00124241|Telbivudine|telbivudine|mesh-list
101449944|NCT00124241|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101449945|NCT00124241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101449946|NCT00124241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101449947|NCT00124241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449948|NCT00124241|Antiviral Agents|antiviral agents|mesh-ancestor
101449949|NCT00124241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101449950|NCT00124241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101449951|NCT00124241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101449952|NCT00124280|Everolimus|everolimus|mesh-list
101449953|NCT00124280|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101449954|NCT00124280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101449955|NCT00124280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101691979|NCT04183634|Rotigotine|rotigotine|mesh-list
101449956|NCT00124280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449957|NCT00124280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101449958|NCT00124280|Immunologic Factors|immunologic factors|mesh-ancestor
101449959|NCT00124280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449960|NCT00124280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101449961|NCT00215280|Ivermectin|ivermectin|mesh-list
101449963|NCT00215280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101449964|NCT00215280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101449965|NCT00215280|Anthelmintics|anthelmintics|mesh-ancestor
101449966|NCT00215280|Anticestodal Agents|anticestodal agents|mesh-ancestor
101449967|NCT00215280|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101449972|NCT00215280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692096|NCT02806817|Growth Inhibitors|growth inhibitors|mesh-ancestor
101449973|NCT00215280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101449975|NCT00192413|Immunologic Factors|immunologic factors|mesh-ancestor
101449976|NCT00192413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449977|NCT00215358|Formoterol Fumarate|formoterol fumarate|mesh-list
101449978|NCT00215358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101449979|NCT00215358|Autonomic Agents|autonomic agents|mesh-ancestor
101449981|NCT00215358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449982|NCT00215358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101449983|NCT00215358|Respiratory System Agents|respiratory system agents|mesh-ancestor
101449984|NCT00215358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101449985|NCT00215358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101449986|NCT00215358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101692309|NCT03973177|Disinfectants|disinfectants|mesh-ancestor
101449987|NCT00215358|Adrenergic Agents|adrenergic agents|mesh-ancestor
101308364|NCT02047006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101308365|NCT02047006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308368|NCT02047019|Candesartan cilexetil|candesartan cilexetil|mesh-list
101308369|NCT02047019|Nifedipine|nifedipine|mesh-list
101449988|NCT00215358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101692381|NCT02805725|Alkylating Agents|alkylating agents|mesh-ancestor
101449989|NCT00215358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449990|NCT00192569|Interferons|interferons|mesh-list
101449991|NCT00192569|Ribavirin|ribavirin|mesh-list
101449992|NCT00192569|Interferon-alpha|interferon-alpha|mesh-list
101449993|NCT00192569|Interferon alpha-2|interferon alpha-2|mesh-list
101449994|NCT00192569|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101449995|NCT00192569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101449996|NCT00192569|Antiviral Agents|antiviral agents|mesh-ancestor
101449997|NCT00192569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101449998|NCT00192569|Antimetabolites|antimetabolites|mesh-ancestor
101449999|NCT00192569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450000|NCT00192569|Immunologic Factors|immunologic factors|mesh-ancestor
101450001|NCT00192569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450002|NCT00215397|Formoterol Fumarate|formoterol fumarate|mesh-list
101450003|NCT00215397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101450004|NCT00215397|Autonomic Agents|autonomic agents|mesh-ancestor
101450005|NCT00215397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101450006|NCT00215397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450007|NCT00215397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101450008|NCT00215397|Respiratory System Agents|respiratory system agents|mesh-ancestor
101450009|NCT00215397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101450010|NCT00215397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101450011|NCT00215397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101450012|NCT00215397|Adrenergic Agents|adrenergic agents|mesh-ancestor
101450013|NCT00215397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101450014|NCT00215397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450016|NCT00192608|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101450017|NCT00192608|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101450018|NCT00192608|Protease Inhibitors|protease inhibitors|mesh-ancestor
101450019|NCT00192608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101450020|NCT00192608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450021|NCT00192608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101450022|NCT00192608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101450023|NCT00192608|Antiviral Agents|antiviral agents|mesh-ancestor
101450024|NCT00192608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101450025|NCT00192608|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101450026|NCT00192608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101450027|NCT00215436|Formoterol Fumarate|formoterol fumarate|mesh-list
101450028|NCT00215436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101450029|NCT00215436|Autonomic Agents|autonomic agents|mesh-ancestor
101450030|NCT00215436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101450031|NCT00215436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692952|NCT02797067|Glycerol|glycerol|mesh-list
101450032|NCT00215436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101450033|NCT00215436|Respiratory System Agents|respiratory system agents|mesh-ancestor
101450034|NCT00215436|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101450035|NCT00215436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101693013|NCT02635230|Aspirin|aspirin|mesh-list
101450036|NCT00215436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101450037|NCT00215436|Adrenergic Agents|adrenergic agents|mesh-ancestor
101450041|NCT00215514|Epirubicin|epirubicin|mesh-list
101450042|NCT00215514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101450043|NCT00215514|Antimetabolites|antimetabolites|mesh-ancestor
101450044|NCT00215514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450045|NCT00215514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101450046|NCT00215514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101450047|NCT00215514|Immunologic Factors|immunologic factors|mesh-ancestor
101450048|NCT00215514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450049|NCT00215514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101450050|NCT00215514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101450051|NCT00215514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101308370|NCT02047019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101308371|NCT02047019|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101308372|NCT02047019|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101450053|NCT00192725|Tryptophan|tryptophan|mesh-list
101693225|NCT02789969|Fentanyl|fentanyl|mesh-list
101450054|NCT00192725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101450056|NCT00192725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101450057|NCT00215592|Zonisamide|zonisamide|mesh-list
101450058|NCT00215592|Anticonvulsants|anticonvulsants|mesh-ancestor
101450059|NCT00215592|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101693299|NCT02634528|Insulin|insulin|mesh-list
101450060|NCT00215592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101450061|NCT00215592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363572|NCT00133354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101450062|NCT00215592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101450063|NCT00215592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450064|NCT00222144|Docetaxel|docetaxel|mesh-list
101693360|NCT04016246|Propofol|propofol|mesh-list
101450065|NCT00222144|Imatinib Mesylate|imatinib mesylate|mesh-list
101450066|NCT00222144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101450067|NCT00222144|Tubulin Modulators|tubulin modulators|mesh-ancestor
101450068|NCT00222144|Antimitotic Agents|antimitotic agents|mesh-ancestor
101450069|NCT00222144|Mitosis Modulators|mitosis modulators|mesh-ancestor
101693433|NCT02673866|Pregabalin|pregabalin|mesh-list
101450070|NCT00222144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450071|NCT00222144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101450072|NCT00222144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101450074|NCT00222183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101450075|NCT00222183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101450076|NCT00222183|Analgesics|analgesics|mesh-ancestor
101450077|NCT00222183|Sensory System Agents|sensory system agents|mesh-ancestor
101450078|NCT00222183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101450079|NCT00222183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450080|NCT00222183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101450081|NCT00222183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101693641|NCT03651011|Aflibercept|aflibercept|mesh-list
101450083|NCT00222183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101450084|NCT00222183|Immunologic Factors|immunologic factors|mesh-ancestor
101450085|NCT00222183|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101450086|NCT00222183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101693712|NCT02670434|Pitavastatin|pitavastatin|mesh-list
101450087|NCT00222183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450088|NCT00192764|Cyclophosphamide|cyclophosphamide|mesh-list
101450090|NCT00192764|Immunologic Factors|immunologic factors|mesh-ancestor
101450091|NCT00192764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450092|NCT00192764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101450093|NCT00192764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101450094|NCT00192764|Alkylating Agents|alkylating agents|mesh-ancestor
101450095|NCT00192764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450096|NCT00192764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101450097|NCT00192764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101450099|NCT00411957|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101693849|NCT01563289|Analgesics|analgesics|mesh-ancestor
101450100|NCT00411957|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101450101|NCT00411957|Protease Inhibitors|protease inhibitors|mesh-ancestor
101450102|NCT00411957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101450103|NCT00411957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450104|NCT00411957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101450105|NCT00411957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101450106|NCT00411957|Antiviral Agents|antiviral agents|mesh-ancestor
101450107|NCT00411957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101450108|NCT00192803|Candesartan|candesartan|mesh-list
101450113|NCT00192803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450115|NCT00192842|Gemcitabine|gemcitabine|mesh-list
101450116|NCT00192842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101450117|NCT00192842|Antimetabolites|antimetabolites|mesh-ancestor
101450118|NCT00192842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694058|NCT00659568|Metformin|metformin|mesh-list
101450119|NCT00192842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101450120|NCT00192842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101450121|NCT00192842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101694157|NCT02669030|Suvorexant|suvorexant|mesh-list
101308373|NCT02047019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450122|NCT00192842|Analgesics|analgesics|mesh-ancestor
101450123|NCT00192842|Sensory System Agents|sensory system agents|mesh-ancestor
101450124|NCT00192842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101450125|NCT00192842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450126|NCT00192842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101450127|NCT00192842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101450128|NCT00192842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101450129|NCT00411996|Ritonavir|ritonavir|mesh-list
101450130|NCT00411996|Indinavir|indinavir|mesh-list
101450131|NCT00411996|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101450132|NCT00411996|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101450133|NCT00411996|Protease Inhibitors|protease inhibitors|mesh-ancestor
101450134|NCT00411996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101450135|NCT00411996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450136|NCT00411996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101450137|NCT00411996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101450138|NCT00411996|Antiviral Agents|antiviral agents|mesh-ancestor
101450139|NCT00411996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101450140|NCT00411996|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101450141|NCT00411996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101450142|NCT00222261|Aspirin|aspirin|mesh-list
101450143|NCT00222261|Clopidogrel|clopidogrel|mesh-list
101450144|NCT00222261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101450145|NCT00222261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101450146|NCT00222261|Analgesics|analgesics|mesh-ancestor
101450147|NCT00222261|Sensory System Agents|sensory system agents|mesh-ancestor
101450148|NCT00222261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101450149|NCT00222261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450150|NCT00222261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101450151|NCT00222261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101450152|NCT00222261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101450153|NCT00222261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101450154|NCT00222261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450155|NCT00222261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101450156|NCT00222261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101450157|NCT00222261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101450158|NCT00222261|Antipyretics|antipyretics|mesh-ancestor
101450159|NCT00222261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101450160|NCT00222261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101450161|NCT00222261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101450162|NCT00222261|Purinergic Agents|purinergic agents|mesh-ancestor
101450163|NCT00222261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101450164|NCT00192959|Propofol|propofol|mesh-list
101450165|NCT00192959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101450166|NCT00192959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101450167|NCT00192959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450168|NCT00192959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101450169|NCT00192959|Anesthetics, General|anesthetics, general|mesh-ancestor
101450170|NCT00192959|Anesthetics|anesthetics|mesh-ancestor
101450171|NCT00215631|Tadalafil|tadalafil|mesh-list
101450172|NCT00215631|Vasodilator Agents|vasodilator agents|mesh-ancestor
101450173|NCT00215631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101450174|NCT00215631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101450175|NCT00215631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101450176|NCT00215631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694762|NCT00645632|Antimetabolites|antimetabolites|mesh-ancestor
101450177|NCT00215631|Urological Agents|urological agents|mesh-ancestor
101450181|NCT00193076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101450182|NCT00193076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101694819|NCT00969085|Turmeric extract|turmeric extract|mesh-list
101450184|NCT00193076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450185|NCT00193076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101450186|NCT00193115|Cyclophosphamide|cyclophosphamide|mesh-list
101450188|NCT00193115|Doxorubicin|doxorubicin|mesh-list
101450189|NCT00193115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101450190|NCT00193115|Immunologic Factors|immunologic factors|mesh-ancestor
101450191|NCT00193115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450192|NCT00193115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101450193|NCT00193115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101450194|NCT00193115|Alkylating Agents|alkylating agents|mesh-ancestor
101352302|NCT00039234|Aldesleukin|aldesleukin|mesh-list
101450195|NCT00193115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450196|NCT00193115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308374|NCT02047019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101695035|NCT02624973|Trastuzumab|trastuzumab|mesh-list
101308375|NCT02047019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101450197|NCT00193115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101450198|NCT00193115|Tubulin Modulators|tubulin modulators|mesh-ancestor
101450199|NCT00193115|Antimitotic Agents|antimitotic agents|mesh-ancestor
101450200|NCT00193115|Mitosis Modulators|mitosis modulators|mesh-ancestor
101695113|NCT00647972|Serotonin Agents|serotonin agents|mesh-ancestor
101450201|NCT00193115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101450202|NCT00193115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101450203|NCT00193115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101450204|NCT00193115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101450205|NCT00193154|Bevacizumab|bevacizumab|mesh-list
101450206|NCT00193154|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101450207|NCT00193154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101450208|NCT00193154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101695187|NCT00969631|Metformin|metformin|mesh-list
101450209|NCT00193154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101450210|NCT00193154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101450211|NCT00193154|Growth Substances|growth substances|mesh-ancestor
101450212|NCT00193154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450213|NCT00193154|Growth Inhibitors|growth inhibitors|mesh-ancestor
101450214|NCT00193154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101450215|NCT00193154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101450216|NCT00193154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450217|NCT00193193|Paclitaxel|paclitaxel|mesh-list
101450218|NCT00193193|Carboplatin|carboplatin|mesh-list
101450219|NCT00193193|Estramustine|estramustine|mesh-list
101450220|NCT00193193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101450221|NCT00193193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101450222|NCT00193193|Tubulin Modulators|tubulin modulators|mesh-ancestor
101450223|NCT00193193|Antimitotic Agents|antimitotic agents|mesh-ancestor
101450224|NCT00193193|Mitosis Modulators|mitosis modulators|mesh-ancestor
101450225|NCT00193193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695385|NCT02663960|Citric Acid|citric acid|mesh-list
101450226|NCT00193193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101450228|NCT00193193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101450230|NCT00193232|Bortezomib|bortezomib|mesh-list
101450231|NCT00193232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101450232|NCT00193232|Tubulin Modulators|tubulin modulators|mesh-ancestor
101695464|NCT00648518|Metformin|metformin|mesh-list
101450233|NCT00193232|Antimitotic Agents|antimitotic agents|mesh-ancestor
101450234|NCT00193232|Mitosis Modulators|mitosis modulators|mesh-ancestor
101450235|NCT00193232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450236|NCT00222495|Olanzapine|olanzapine|mesh-list
101450237|NCT00222495|Risperidone|risperidone|mesh-list
101450238|NCT00222495|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101695522|NCT05195645|Abatacept|abatacept|mesh-list
101450239|NCT00222495|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101450240|NCT00222495|Serotonin Agents|serotonin agents|mesh-ancestor
101450241|NCT00222495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101450242|NCT00222495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450243|NCT00222495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695671|NCT00980551|Carboplatin|carboplatin|mesh-list
101450244|NCT00222495|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101450245|NCT00222495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101450246|NCT00222495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101450247|NCT00222495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101450248|NCT00222495|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101450249|NCT00222495|Dopamine Agents|dopamine agents|mesh-ancestor
101450250|NCT00222495|Antiemetics|antiemetics|mesh-ancestor
101450251|NCT00222495|Autonomic Agents|autonomic agents|mesh-ancestor
101450256|NCT00222495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101450257|NCT00222495|Antidepressive Agents|antidepressive agents|mesh-ancestor
101450259|NCT00193271|Estramustine|estramustine|mesh-list
101450260|NCT00193271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101450261|NCT00193271|Tubulin Modulators|tubulin modulators|mesh-ancestor
101450262|NCT00193271|Antimitotic Agents|antimitotic agents|mesh-ancestor
101450263|NCT00193271|Mitosis Modulators|mitosis modulators|mesh-ancestor
101695736|NCT05340803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101450264|NCT00193271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450265|NCT00193271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101450266|NCT00193271|Alkylating Agents|alkylating agents|mesh-ancestor
101450267|NCT00193271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101450268|NCT00222534|Acetazolamide|acetazolamide|mesh-list
101450269|NCT00222534|Anticonvulsants|anticonvulsants|mesh-ancestor
101450270|NCT00222534|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101450271|NCT00222534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101308376|NCT02047019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101308377|NCT02047019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308378|NCT02047019|Vasodilator Agents|vasodilator agents|mesh-ancestor
101308379|NCT02047019|Tocolytic Agents|tocolytic agents|mesh-ancestor
101450272|NCT00222534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450273|NCT00222534|Diuretics|diuretics|mesh-ancestor
101450274|NCT00222534|Natriuretic Agents|natriuretic agents|mesh-ancestor
101450275|NCT00222534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450276|NCT00193310|Paclitaxel|paclitaxel|mesh-list
101450277|NCT00193310|Carboplatin|carboplatin|mesh-list
101450278|NCT00193310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101450279|NCT00193310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101450280|NCT00193310|Tubulin Modulators|tubulin modulators|mesh-ancestor
101450281|NCT00193310|Antimitotic Agents|antimitotic agents|mesh-ancestor
101450282|NCT00193310|Mitosis Modulators|mitosis modulators|mesh-ancestor
101450283|NCT00193310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450284|NCT00193349|Carboplatin|carboplatin|mesh-list
101450286|NCT00193349|Imatinib Mesylate|imatinib mesylate|mesh-list
101450287|NCT00193349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101450288|NCT00193349|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101450289|NCT00193349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101450290|NCT00193349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101450291|NCT00193349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450292|NCT00193349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101450293|NCT00193388|Topotecan|topotecan|mesh-list
101450294|NCT00193388|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101450295|NCT00193388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101450296|NCT00193388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101450297|NCT00193388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450299|NCT00215709|Docetaxel|docetaxel|mesh-list
101450300|NCT00215709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101450301|NCT00215709|Tubulin Modulators|tubulin modulators|mesh-ancestor
101450302|NCT00215709|Antimitotic Agents|antimitotic agents|mesh-ancestor
101450303|NCT00215709|Mitosis Modulators|mitosis modulators|mesh-ancestor
101450304|NCT00215709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450305|NCT00193466|Rituximab|rituximab|mesh-list
101450306|NCT00193466|Fludarabine|fludarabine|mesh-list
101450307|NCT00193466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101450308|NCT00193466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101450309|NCT00193466|Immunologic Factors|immunologic factors|mesh-ancestor
101450310|NCT00193466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450311|NCT00193466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101450312|NCT00215748|Dexamethasone|dexamethasone|mesh-list
101450313|NCT00215748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101450314|NCT00215748|Antiemetics|antiemetics|mesh-ancestor
101450315|NCT00215748|Autonomic Agents|autonomic agents|mesh-ancestor
101450316|NCT00215748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101450317|NCT00215748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450318|NCT00215748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101450319|NCT00215748|Glucocorticoids|glucocorticoids|mesh-ancestor
101450320|NCT00215748|Hormones|hormones|mesh-ancestor
101450321|NCT00215748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101450322|NCT00215748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101450327|NCT00215826|Immunologic Factors|immunologic factors|mesh-ancestor
101450328|NCT00215826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450329|NCT00193544|Thalidomide|thalidomide|mesh-list
101450330|NCT00193544|Arsenic Trioxide|arsenic trioxide|mesh-list
101450331|NCT00193544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101450332|NCT00193544|Immunologic Factors|immunologic factors|mesh-ancestor
101450333|NCT00193544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450334|NCT00193544|Leprostatic Agents|leprostatic agents|mesh-ancestor
101450335|NCT00193544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101450336|NCT00193544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101450337|NCT00193544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101696106|NCT00697671|Etoposide|etoposide|mesh-list
101450338|NCT00193544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101450339|NCT00193544|Growth Substances|growth substances|mesh-ancestor
101450340|NCT00193544|Growth Inhibitors|growth inhibitors|mesh-ancestor
101308380|NCT02047019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101696173|NCT00978211|Hormones|hormones|mesh-ancestor
101308382|NCT02047136|Histamine Agonists|histamine agonists|mesh-ancestor
101308383|NCT02047136|Histamine Agents|histamine agents|mesh-ancestor
101450341|NCT00193544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101450342|NCT00215865|Ribavirin|ribavirin|mesh-list
101450343|NCT00215865|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101450344|NCT00215865|Antimetabolites|antimetabolites|mesh-ancestor
101450345|NCT00215865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450346|NCT00215865|Antiviral Agents|antiviral agents|mesh-ancestor
101450347|NCT00215865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101450348|NCT00124358|Buprenorphine|buprenorphine|mesh-list
101450349|NCT00124358|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101450350|NCT00124358|Narcotics|narcotics|mesh-ancestor
101450351|NCT00124358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101450352|NCT00124358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450353|NCT00124358|Analgesics|analgesics|mesh-ancestor
101450354|NCT00124358|Sensory System Agents|sensory system agents|mesh-ancestor
101450355|NCT00124358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101696307|NCT04226963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450356|NCT00124358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101450357|NCT00193583|Carboplatin|carboplatin|mesh-list
101450358|NCT00193583|Topotecan|topotecan|mesh-list
101450359|NCT00193583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101450360|NCT00193583|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101450361|NCT00193583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101450362|NCT00193583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101450363|NCT00193583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450364|NCT00215982|Capecitabine|capecitabine|mesh-list
101450365|NCT00215982|Oxaliplatin|oxaliplatin|mesh-list
101450366|NCT00215982|Irinotecan|irinotecan|mesh-list
101450367|NCT00215982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101450368|NCT00215982|Antimetabolites|antimetabolites|mesh-ancestor
101450369|NCT00215982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450371|NCT00215982|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101450372|NCT00215982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101696385|NCT00867009|Pemetrexed|pemetrexed|mesh-list
101450373|NCT00215982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101450374|NCT00124397|Atorvastatin|atorvastatin|mesh-list
101450375|NCT00124397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101450376|NCT00124397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101450377|NCT00124397|Antimetabolites|antimetabolites|mesh-ancestor
101696439|NCT04132713|Antimetabolites|antimetabolites|mesh-ancestor
101450378|NCT00124397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450379|NCT00124397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101450380|NCT00124397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101450381|NCT00124397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101450383|NCT00216021|Oxaliplatin|oxaliplatin|mesh-list
101450384|NCT00216021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101450385|NCT00216021|Antimetabolites|antimetabolites|mesh-ancestor
101450386|NCT00216021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450387|NCT00216021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101450388|NCT00409526|Iloprost|iloprost|mesh-list
101450389|NCT00409526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101450390|NCT00409526|Vasodilator Agents|vasodilator agents|mesh-ancestor
101450391|NCT00216138|Docetaxel|docetaxel|mesh-list
101450393|NCT00216138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101450394|NCT00216138|Tubulin Modulators|tubulin modulators|mesh-ancestor
101450403|NCT00216177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101450404|NCT00216177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101450405|NCT00216177|Dermatologic Agents|dermatologic agents|mesh-ancestor
101696722|NCT00984997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101450406|NCT00216177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101450407|NCT00216216|Pemetrexed|pemetrexed|mesh-list
101450408|NCT00216216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101450409|NCT00216216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101450410|NCT00216216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450411|NCT00216216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101450412|NCT00216216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101450413|NCT00473746|Dexamethasone|dexamethasone|mesh-list
101450414|NCT00473746|Prednisone|prednisone|mesh-list
101308384|NCT02047136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101308385|NCT02047136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450416|NCT00473746|Abiraterone Acetate|abiraterone acetate|mesh-list
101450417|NCT00473746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101450418|NCT00473746|Antiemetics|antiemetics|mesh-ancestor
101450419|NCT00473746|Autonomic Agents|autonomic agents|mesh-ancestor
101450420|NCT00473746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101450421|NCT00473746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450423|NCT00473746|Glucocorticoids|glucocorticoids|mesh-ancestor
101450424|NCT00473746|Hormones|hormones|mesh-ancestor
101450425|NCT00473746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101450426|NCT00473746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101450427|NCT00473746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101450428|NCT00473746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101450429|NCT00473746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101450430|NCT00473746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450431|NCT00473746|Hormone Antagonists|hormone antagonists|mesh-ancestor
101450432|NCT00473746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101450433|NCT00409643|Amlodipine|amlodipine|mesh-list
101450434|NCT00409643|Valsartan|valsartan|mesh-list
101450435|NCT00409643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101450436|NCT00409643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101450437|NCT00409643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101450438|NCT00409643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450439|NCT00409643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101450440|NCT00409643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450441|NCT00409643|Vasodilator Agents|vasodilator agents|mesh-ancestor
101450442|NCT00409643|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101450443|NCT00409643|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101450444|NCT00216294|Secretin|secretin|mesh-list
101450445|NCT00216294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101450447|NCT00216294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101450448|NCT00216294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450449|NCT00409721|Memantine|memantine|mesh-list
101450450|NCT00409721|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101696983|NCT00600938|Deferasirox|deferasirox|mesh-list
101450451|NCT00409721|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101450452|NCT00409721|Dopamine Agents|dopamine agents|mesh-ancestor
101450453|NCT00409721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101450454|NCT00409721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450455|NCT00409721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450456|NCT00409721|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101450457|NCT00409721|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101450458|NCT00193622|Bevacizumab|bevacizumab|mesh-list
101450459|NCT00193622|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101450460|NCT00193622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101450464|NCT00193622|Growth Substances|growth substances|mesh-ancestor
101450465|NCT00193622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450466|NCT00193622|Growth Inhibitors|growth inhibitors|mesh-ancestor
101450467|NCT00193622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101450468|NCT00193622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101450469|NCT00193622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450470|NCT00473590|Bevacizumab|bevacizumab|mesh-list
101450471|NCT00473590|Bortezomib|bortezomib|mesh-list
101450472|NCT00473590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101450473|NCT00473590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101450474|NCT00473590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101450475|NCT00473590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101450476|NCT00473590|Growth Substances|growth substances|mesh-ancestor
101450477|NCT00473590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450478|NCT00473590|Growth Inhibitors|growth inhibitors|mesh-ancestor
101450479|NCT00223275|Naltrexone|naltrexone|mesh-list
101450480|NCT00223275|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101450481|NCT00223275|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101450482|NCT00223275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450483|NCT00223275|Sensory System Agents|sensory system agents|mesh-ancestor
101450484|NCT00223275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101450485|NCT00124787|Dimenhydrinate|dimenhydrinate|mesh-list
101450486|NCT00124787|Antiemetics|antiemetics|mesh-ancestor
101308386|NCT02047136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308388|NCT02047149|Dasatinib|dasatinib|mesh-list
101308389|NCT02047149|Hydroxyurea|hydroxyurea|mesh-list
101450487|NCT00124787|Autonomic Agents|autonomic agents|mesh-ancestor
101450488|NCT00124787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101450489|NCT00124787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450490|NCT00124787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101450491|NCT00124787|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101450492|NCT00124787|Histamine Antagonists|histamine antagonists|mesh-ancestor
101450493|NCT00124787|Histamine Agents|histamine agents|mesh-ancestor
101450494|NCT00124787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101450495|NCT00124787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450496|NCT00193661|Testosterone|testosterone|mesh-list
101450498|NCT00193661|Hormones|hormones|mesh-ancestor
101450499|NCT00193661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101450500|NCT00193661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450501|NCT00206232|Spironolactone|spironolactone|mesh-list
101450502|NCT00206232|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101450504|NCT00206232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101450505|NCT00206232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450506|NCT00206232|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101363588|NCT00046904|Analgesics|analgesics|mesh-ancestor
101450508|NCT00206232|Natriuretic Agents|natriuretic agents|mesh-ancestor
101450509|NCT00193700|Testosterone|testosterone|mesh-list
101450510|NCT00193700|Androgens|androgens|mesh-ancestor
101697736|NCT04156152|Fluorides|fluorides|mesh-list
101450511|NCT00193700|Hormones|hormones|mesh-ancestor
101450512|NCT00193700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101697812|NCT04167566|Artemisinins|artemisinins|mesh-list
101450513|NCT00193700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450514|NCT00124826|Insulin|insulin|mesh-list
101450515|NCT00124826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101450516|NCT00124826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450517|NCT00193739|Paclitaxel|paclitaxel|mesh-list
101450519|NCT00193739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101450520|NCT00193739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101450521|NCT00193739|Tubulin Modulators|tubulin modulators|mesh-ancestor
101450522|NCT00193739|Antimitotic Agents|antimitotic agents|mesh-ancestor
101450523|NCT00193739|Mitosis Modulators|mitosis modulators|mesh-ancestor
101450524|NCT00193739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450525|NCT00206310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101697959|NCT02649920|Dinoprostone|dinoprostone|mesh-list
101450526|NCT00206310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101450527|NCT00206310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101450528|NCT00206310|Antimetabolites|antimetabolites|mesh-ancestor
101450529|NCT00206310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450530|NCT00206310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101450531|NCT00206310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101450546|NCT00125021|Antimetabolites|antimetabolites|mesh-ancestor
101450547|NCT00125021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450548|NCT00125021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101450549|NCT00125021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101450550|NCT00125021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101450551|NCT00193856|Zoledronic Acid|zoledronic acid|mesh-list
101450552|NCT00193856|Leuprolide|leuprolide|mesh-list
101450553|NCT00193856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101698092|NCT02762591|Serotonin Agents|serotonin agents|mesh-ancestor
101450554|NCT00193856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450555|NCT00193856|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101450556|NCT00193856|Fertility Agents|fertility agents|mesh-ancestor
101450557|NCT00193856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101450558|NCT00193856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101450559|NCT00193856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101450560|NCT00223509|Lamotrigine|lamotrigine|mesh-list
101450561|NCT00223509|Anticonvulsants|anticonvulsants|mesh-ancestor
101450562|NCT00223509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101450563|NCT00223509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101450564|NCT00223509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698153|NCT00668304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101450565|NCT00223509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101450566|NCT00223509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450567|NCT00223509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101450568|NCT00223509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101450569|NCT00223509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101450570|NCT00223509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101450571|NCT00223509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101450572|NCT00193895|Carboplatin|carboplatin|mesh-list
101450573|NCT00193895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101450575|NCT00223548|Protective Agents|protective agents|mesh-ancestor
101450576|NCT00223548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450577|NCT00125060|Simvastatin|simvastatin|mesh-list
101450578|NCT00125060|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101450579|NCT00125060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101450580|NCT00125060|Antimetabolites|antimetabolites|mesh-ancestor
101450581|NCT00125060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450582|NCT00125060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101450583|NCT00125060|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101450584|NCT00125060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101450585|NCT00223626|Topiramate|topiramate|mesh-list
101450586|NCT00223626|Anticonvulsants|anticonvulsants|mesh-ancestor
101450587|NCT00223626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101450588|NCT00223626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450589|NCT00223743|Zonisamide|zonisamide|mesh-list
101450590|NCT00223743|Anticonvulsants|anticonvulsants|mesh-ancestor
101450598|NCT00193973|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101450599|NCT00193973|Abortifacient Agents|abortifacient agents|mesh-ancestor
101450600|NCT00193973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101450601|NCT00193973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450602|NCT00193973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101450603|NCT00193973|Antimetabolites|antimetabolites|mesh-ancestor
101450604|NCT00193973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450605|NCT00193973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101450606|NCT00193973|Dermatologic Agents|dermatologic agents|mesh-ancestor
101450607|NCT00193973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101450608|NCT00193973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101450609|NCT00193973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101450610|NCT00193973|Immunologic Factors|immunologic factors|mesh-ancestor
101450611|NCT00193973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101450612|NCT00193973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101450613|NCT00193973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101450614|NCT00193973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101450615|NCT00193973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101450616|NCT00411879|Vasopressins|vasopressins|mesh-list
101450617|NCT00411879|Arginine Vasopressin|arginine vasopressin|mesh-list
101450618|NCT00411879|Epinephrine|epinephrine|mesh-list
101450619|NCT00411879|Racepinephrine|racepinephrine|mesh-list
101450620|NCT00411879|Epinephryl borate|epinephryl borate|mesh-list
101450621|NCT00411879|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101450622|NCT00411879|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101450623|NCT00411879|Adrenergic Agents|adrenergic agents|mesh-ancestor
101450624|NCT00411879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101450625|NCT00411879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450626|NCT00411879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450627|NCT00411879|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101450628|NCT00411879|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101450630|NCT00411879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101450631|NCT00411879|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101698266|NCT00580606|Glycerol|glycerol|mesh-list
101450632|NCT00411879|Respiratory System Agents|respiratory system agents|mesh-ancestor
101450633|NCT00411879|Mydriatics|mydriatics|mesh-ancestor
101450634|NCT00411879|Sympathomimetics|sympathomimetics|mesh-ancestor
101450635|NCT00411879|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101450636|NCT00411879|Hemostatics|hemostatics|mesh-ancestor
101450637|NCT00411879|Coagulants|coagulants|mesh-ancestor
101450638|NCT00411879|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101450639|NCT00411879|Natriuretic Agents|natriuretic agents|mesh-ancestor
101450640|NCT00193505|Rituximab|rituximab|mesh-list
101450641|NCT00193505|Carboplatin|carboplatin|mesh-list
101450642|NCT00193505|Etoposide|etoposide|mesh-list
101450643|NCT00193505|Ifosfamide|ifosfamide|mesh-list
101450644|NCT00193505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101450645|NCT00193505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101450646|NCT00193505|Immunologic Factors|immunologic factors|mesh-ancestor
101450647|NCT00193505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450648|NCT00193505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101308391|NCT02047149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101308392|NCT02047149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101450649|NCT00193505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101450650|NCT00193505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101450651|NCT00193505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101450652|NCT00193505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101450653|NCT00193505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450654|NCT00193505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101450655|NCT00193505|Alkylating Agents|alkylating agents|mesh-ancestor
101450656|NCT00223860|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101450658|NCT00223860|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101450667|NCT00125255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450668|NCT00125255|Sensory System Agents|sensory system agents|mesh-ancestor
101450669|NCT00125255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101450670|NCT00125255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101450671|NCT00125255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101450672|NCT00125255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101698507|NCT02758067|Brexpiprazole|brexpiprazole|mesh-list
101450673|NCT00125255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101450674|NCT00125255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450675|NCT00223938|Ferric gluconate|ferric gluconate|mesh-list
101450676|NCT00223938|Ferric Compounds|ferric compounds|mesh-list
101450677|NCT00223938|Hematinics|hematinics|mesh-ancestor
101450678|NCT00125294|Methadone|methadone|mesh-list
101450679|NCT00125294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101450680|NCT00125294|Narcotics|narcotics|mesh-ancestor
101450681|NCT00125294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101450682|NCT00125294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450683|NCT00125294|Analgesics|analgesics|mesh-ancestor
101450684|NCT00125294|Sensory System Agents|sensory system agents|mesh-ancestor
101450685|NCT00125294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101450686|NCT00125294|Antitussive Agents|antitussive agents|mesh-ancestor
101450687|NCT00125294|Respiratory System Agents|respiratory system agents|mesh-ancestor
101450689|NCT00206466|Doxorubicin|doxorubicin|mesh-list
101450690|NCT00206466|Cyclophosphamide|cyclophosphamide|mesh-list
101450691|NCT00206466|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101450692|NCT00206466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101698743|NCT02657096|Hybenx|hybenx|mesh-list
101450693|NCT00206466|Tubulin Modulators|tubulin modulators|mesh-ancestor
101450694|NCT00206466|Antimitotic Agents|antimitotic agents|mesh-ancestor
101450695|NCT00206466|Mitosis Modulators|mitosis modulators|mesh-ancestor
101450696|NCT00206466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450697|NCT00206466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101450698|NCT00206466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101450699|NCT00206466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101450700|NCT00206466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101450701|NCT00206466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101450702|NCT00206466|Immunologic Factors|immunologic factors|mesh-ancestor
101450703|NCT00206466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450705|NCT00206466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101450706|NCT00206466|Alkylating Agents|alkylating agents|mesh-ancestor
101450707|NCT00206466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101450708|NCT00224094|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101450710|NCT00224094|Hormones|hormones|mesh-ancestor
101450711|NCT00224094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101450712|NCT00224094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450713|NCT00125411|Docetaxel|docetaxel|mesh-list
101450714|NCT00125411|Satraplatin|satraplatin|mesh-list
101450715|NCT00125411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101450716|NCT00125411|Tubulin Modulators|tubulin modulators|mesh-ancestor
101450717|NCT00125411|Antimitotic Agents|antimitotic agents|mesh-ancestor
101450718|NCT00125411|Mitosis Modulators|mitosis modulators|mesh-ancestor
101450719|NCT00125411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450720|NCT00206505|Docetaxel|docetaxel|mesh-list
101699064|NCT02644694|Antiemetics|antiemetics|mesh-ancestor
101450721|NCT00206505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101450723|NCT00206505|Antimitotic Agents|antimitotic agents|mesh-ancestor
101450724|NCT00206505|Mitosis Modulators|mitosis modulators|mesh-ancestor
101450732|NCT00206544|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101450733|NCT00206544|Hormone Antagonists|hormone antagonists|mesh-ancestor
101450734|NCT00206544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101450735|NCT00206544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101450736|NCT00206544|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101450737|NCT00206544|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101450738|NCT00206544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101450740|NCT00194324|Clotrimazole|clotrimazole|mesh-list
101450741|NCT00194324|Antifungal Agents|antifungal agents|mesh-ancestor
101450742|NCT00194324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101450743|NCT00194324|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101450744|NCT00194324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101450745|NCT00194324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101450746|NCT00194324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450747|NCT00194324|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101450748|NCT00194324|Hormone Antagonists|hormone antagonists|mesh-ancestor
101450749|NCT00194324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101450750|NCT00194324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450751|NCT00194324|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101450752|NCT00194324|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101450753|NCT00194324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101699344|NCT00652808|Naproxen|naproxen|mesh-list
101450754|NCT00206622|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101450756|NCT00206622|Levonorgestrel|levonorgestrel|mesh-list
101450757|NCT00206622|Estradiol|estradiol|mesh-list
101450758|NCT00206622|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101450759|NCT00206622|Estrogens|estrogens|mesh-ancestor
101450760|NCT00206622|Hormones|hormones|mesh-ancestor
101450761|NCT00206622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101450762|NCT00206622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450763|NCT00206622|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101450764|NCT00206622|Contraceptive Agents|contraceptive agents|mesh-ancestor
101450765|NCT00206622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101450766|NCT00206622|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101450767|NCT00206622|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101450768|NCT00206622|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101450769|NCT00194402|Niacin|niacin|mesh-list
101450770|NCT00194402|Niacinamide|niacinamide|mesh-list
101450771|NCT00194402|Nicotinic Acids|nicotinic acids|mesh-list
101450772|NCT00194402|Atorvastatin|atorvastatin|mesh-list
101450773|NCT00194402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101450774|NCT00194402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101450775|NCT00194402|Antimetabolites|antimetabolites|mesh-ancestor
101450776|NCT00194402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450777|NCT00194402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101450778|NCT00194402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101450779|NCT00194402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101450780|NCT00194402|Vasodilator Agents|vasodilator agents|mesh-ancestor
101450781|NCT00194402|Vitamin B Complex|vitamin b complex|mesh-ancestor
101450783|NCT00194402|Micronutrients|micronutrients|mesh-ancestor
101450784|NCT00194402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450785|NCT00473512|Dexamethasone|dexamethasone|mesh-list
101450786|NCT00473512|Abiraterone Acetate|abiraterone acetate|mesh-list
101450787|NCT00473512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101450788|NCT00473512|Antiemetics|antiemetics|mesh-ancestor
101450789|NCT00473512|Autonomic Agents|autonomic agents|mesh-ancestor
101450798|NCT00473512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101450799|NCT00473512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101450800|NCT00473512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450801|NCT00473512|Hormone Antagonists|hormone antagonists|mesh-ancestor
101450802|NCT00473512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101450803|NCT00125489|Chloroquine|chloroquine|mesh-list
101450804|NCT00125489|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
101450805|NCT00125489|Pyrimethamine|pyrimethamine|mesh-list
101450806|NCT00125489|Sulfadoxine|sulfadoxine|mesh-list
101450807|NCT00125489|Amebicides|amebicides|mesh-ancestor
101450808|NCT00125489|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101450809|NCT00125489|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101450810|NCT00125489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101450811|NCT00125489|Antimalarials|antimalarials|mesh-ancestor
101450812|NCT00125489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101450813|NCT00125489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101699611|NCT04330690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101308393|NCT02047149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308394|NCT02047149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101450815|NCT00125489|Analgesics|analgesics|mesh-ancestor
101450816|NCT00125489|Sensory System Agents|sensory system agents|mesh-ancestor
101450817|NCT00125489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101450818|NCT00125489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450819|NCT00125489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101450820|NCT00125489|Filaricides|filaricides|mesh-ancestor
101450821|NCT00125489|Antinematodal Agents|antinematodal agents|mesh-ancestor
101450822|NCT00125489|Anthelmintics|anthelmintics|mesh-ancestor
101450823|NCT00125489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101450824|NCT00125489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101450825|NCT00125489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450826|NCT00125489|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101450827|NCT00206661|Molgramostim|molgramostim|mesh-list
101450828|NCT00206661|Sargramostim|sargramostim|mesh-list
101450829|NCT00206661|Immunologic Factors|immunologic factors|mesh-ancestor
101450830|NCT00206661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450831|NCT00206661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101450832|NCT00473434|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101450833|NCT00473434|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101450834|NCT00473434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101450835|NCT00473434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101450836|NCT00473434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450837|NCT00473434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101450838|NCT00473434|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101450839|NCT00473434|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101450840|NCT00473434|Serotonin Agents|serotonin agents|mesh-ancestor
101450841|NCT00473434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101363596|NCT00046904|Immunologic Factors|immunologic factors|mesh-ancestor
101450842|NCT00473434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450843|NCT00473434|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101450844|NCT00473434|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101450845|NCT00473434|Dopamine Agents|dopamine agents|mesh-ancestor
101450847|NCT00125567|Carbidopa|carbidopa|mesh-list
101450848|NCT00125567|Entacapone|entacapone|mesh-list
101450849|NCT00125567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101699863|NCT00990301|Moexipril|moexipril|mesh-list
101450850|NCT00125567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101450851|NCT00125567|Dopamine Agents|dopamine agents|mesh-ancestor
101450852|NCT00125567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101450853|NCT00125567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450854|NCT00125567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450857|NCT00125567|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101450858|NCT00473083|Minocycline|minocycline|mesh-list
101450859|NCT00473083|Clindamycin|clindamycin|mesh-list
101450860|NCT00473083|Clindamycin palmitate|clindamycin palmitate|mesh-list
101450861|NCT00473083|Clindamycin phosphate|clindamycin phosphate|mesh-list
101450862|NCT00473083|Triamcinolone|triamcinolone|mesh-list
101450863|NCT00473083|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101450864|NCT00473083|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101450865|NCT00473083|Hydrocortisone|hydrocortisone|mesh-list
101450866|NCT00473083|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101450867|NCT00473083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101450868|NCT00473083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450869|NCT00473083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101450870|NCT00473083|Glucocorticoids|glucocorticoids|mesh-ancestor
101450871|NCT00473083|Hormones|hormones|mesh-ancestor
101450872|NCT00473083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101450873|NCT00473083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450874|NCT00473083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101450875|NCT00473083|Immunologic Factors|immunologic factors|mesh-ancestor
101450876|NCT00473083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101450877|NCT00473083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101450878|NCT00473083|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101450879|NCT00194480|Interferons|interferons|mesh-list
101450880|NCT00194480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101450881|NCT00194480|Antiviral Agents|antiviral agents|mesh-ancestor
101450882|NCT00194480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101450883|NCT00472420|Rituximab|rituximab|mesh-list
101450884|NCT00472420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101450885|NCT00472420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308395|NCT02047149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101308397|NCT02047149|Sensory System Agents|sensory system agents|mesh-ancestor
101450886|NCT00472420|Immunologic Factors|immunologic factors|mesh-ancestor
101450887|NCT00472420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450888|NCT00472420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101450889|NCT00194519|Acyclovir|acyclovir|mesh-list
101450890|NCT00194519|Antiviral Agents|antiviral agents|mesh-ancestor
101450891|NCT00194519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101450892|NCT00206700|Sargramostim|sargramostim|mesh-list
101450893|NCT00206700|Immunologic Factors|immunologic factors|mesh-ancestor
101450894|NCT00206700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450895|NCT00125645|Irbesartan|irbesartan|mesh-list
101450896|NCT00125645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101450897|NCT00125645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101450898|NCT00125645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101450899|NCT00125645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450900|NCT00125684|Morphine|morphine|mesh-list
101450901|NCT00125684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101450902|NCT00125684|Narcotics|narcotics|mesh-ancestor
101450903|NCT00125684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101450904|NCT00125684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450905|NCT00125684|Analgesics|analgesics|mesh-ancestor
101450906|NCT00125684|Sensory System Agents|sensory system agents|mesh-ancestor
101450907|NCT00125684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101450908|NCT00194597|Sildenafil Citrate|sildenafil citrate|mesh-list
101450909|NCT00194597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450910|NCT00194597|Vasodilator Agents|vasodilator agents|mesh-ancestor
101450911|NCT00194597|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101450912|NCT00194597|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101450913|NCT00194597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101450914|NCT00194597|Urological Agents|urological agents|mesh-ancestor
101450915|NCT00206739|Pyrimethamine|pyrimethamine|mesh-list
101450916|NCT00206739|Sulfadoxine|sulfadoxine|mesh-list
101450917|NCT00206739|Antimalarials|antimalarials|mesh-ancestor
101450918|NCT00206739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101450919|NCT00206739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101450920|NCT00206739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101700158|NCT02646800|Micafungin|micafungin|mesh-list
101450921|NCT00206739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101450922|NCT00206739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101450923|NCT00206739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450924|NCT00206739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101450925|NCT00206778|Lamotrigine|lamotrigine|mesh-list
101450926|NCT00206778|Valproic Acid|valproic acid|mesh-list
101450927|NCT00206778|Anticonvulsants|anticonvulsants|mesh-ancestor
101450928|NCT00206778|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101450941|NCT00206778|Antimanic Agents|antimanic agents|mesh-ancestor
101450942|NCT00125801|Hydromorphone|hydromorphone|mesh-list
101450943|NCT00125801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101700308|NCT01822015|Cytarabine|cytarabine|mesh-list
101450944|NCT00125801|Narcotics|narcotics|mesh-ancestor
101450945|NCT00125801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101450946|NCT00125801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450947|NCT00125801|Analgesics|analgesics|mesh-ancestor
101450948|NCT00125801|Sensory System Agents|sensory system agents|mesh-ancestor
101450949|NCT00125801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101450950|NCT00125840|Clofarabine|clofarabine|mesh-list
101450951|NCT00125840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101450952|NCT00125840|Antimetabolites|antimetabolites|mesh-ancestor
101450953|NCT00125840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450954|NCT00125840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101450955|NCT00224445|Ritonavir|ritonavir|mesh-list
101450956|NCT00224445|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101450957|NCT00224445|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101450958|NCT00224445|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101450959|NCT00224445|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101450960|NCT00224445|Protease Inhibitors|protease inhibitors|mesh-ancestor
101450962|NCT00224445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450963|NCT00224445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101450964|NCT00224445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101450965|NCT00224445|Antiviral Agents|antiviral agents|mesh-ancestor
101450966|NCT00224445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101450967|NCT00224445|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101308398|NCT02047149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101450968|NCT00224445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101450969|NCT00224445|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101450970|NCT00224445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101450972|NCT00194753|Cyclophosphamide|cyclophosphamide|mesh-list
101450973|NCT00194753|Doxorubicin|doxorubicin|mesh-list
101450974|NCT00194753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101450975|NCT00194753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101450976|NCT00194753|Tubulin Modulators|tubulin modulators|mesh-ancestor
101450977|NCT00194753|Antimitotic Agents|antimitotic agents|mesh-ancestor
101450978|NCT00194753|Mitosis Modulators|mitosis modulators|mesh-ancestor
101450979|NCT00194753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450980|NCT00194753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101450981|NCT00194753|Immunologic Factors|immunologic factors|mesh-ancestor
101450982|NCT00194753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450983|NCT00194753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101450984|NCT00194753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101450985|NCT00194753|Alkylating Agents|alkylating agents|mesh-ancestor
101450986|NCT00194753|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101450987|NCT00194753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101450988|NCT00194753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101450989|NCT00194753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101450990|NCT00194753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101451007|NCT00472303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101451009|NCT00472303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101451010|NCT00472303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451011|NCT00472303|Analgesics|analgesics|mesh-ancestor
101700689|NCT00683202|Analgesics|analgesics|mesh-ancestor
101451012|NCT00472303|Sensory System Agents|sensory system agents|mesh-ancestor
101363602|NCT00046943|Atrasentan|atrasentan|mesh-list
101451013|NCT00472303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101451014|NCT00472303|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101451015|NCT00472303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101451016|NCT00472303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101451017|NCT00472303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451018|NCT00472303|Adrenergic Agents|adrenergic agents|mesh-ancestor
101451019|NCT00472303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101451020|NCT00125996|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101451021|NCT00125996|Hematinics|hematinics|mesh-ancestor
101451022|NCT00206934|Dexetimide|dexetimide|mesh-list
101451023|NCT00206934|Citalopram|citalopram|mesh-list
101451024|NCT00206934|Escitalopram|escitalopram|mesh-list
101451025|NCT00206934|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101700831|NCT00683514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101451026|NCT00206934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101451027|NCT00206934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101451028|NCT00206934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451029|NCT00206934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101451030|NCT00206934|Serotonin Agents|serotonin agents|mesh-ancestor
101451031|NCT00206934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700911|NCT00537823|Vitamins|vitamins|mesh-ancestor
101451032|NCT00206934|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101451033|NCT00206934|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101451034|NCT00206934|Parasympatholytics|parasympatholytics|mesh-ancestor
101451035|NCT00206934|Autonomic Agents|autonomic agents|mesh-ancestor
101451036|NCT00206934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101451037|NCT00206934|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101451038|NCT00206934|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101451039|NCT00206934|Cholinergic Agents|cholinergic agents|mesh-ancestor
101451040|NCT00206934|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101451041|NCT00206934|Antidepressive Agents|antidepressive agents|mesh-ancestor
101451042|NCT00206934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101451043|NCT00194909|Sildenafil Citrate|sildenafil citrate|mesh-list
101451044|NCT00194909|Vasodilator Agents|vasodilator agents|mesh-ancestor
101451045|NCT00194909|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101451046|NCT00194909|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101451047|NCT00194909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101451048|NCT00194909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451053|NCT00224640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451054|NCT00194948|Escitalopram|escitalopram|mesh-list
101451055|NCT00194948|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101451056|NCT00194948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101451057|NCT00194948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101451058|NCT00194948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700966|NCT00684216|Anastrozole|anastrozole|mesh-list
101451059|NCT00194948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101451060|NCT00194948|Serotonin Agents|serotonin agents|mesh-ancestor
101451061|NCT00194948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451062|NCT00206973|Mannitol|mannitol|mesh-list
101451063|NCT00206973|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101451064|NCT00206973|Diuretics|diuretics|mesh-ancestor
101451065|NCT00206973|Natriuretic Agents|natriuretic agents|mesh-ancestor
101451066|NCT00206973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451067|NCT00471445|Ketamine|ketamine|mesh-list
101451068|NCT00471445|Amitriptyline|amitriptyline|mesh-list
101451069|NCT00471445|Analgesics|analgesics|mesh-ancestor
101451070|NCT00471445|Sensory System Agents|sensory system agents|mesh-ancestor
101451071|NCT00471445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101451072|NCT00471445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701233|NCT00685776|Anacetrapib|anacetrapib|mesh-list
101451073|NCT00471445|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101451074|NCT00471445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101451075|NCT00471445|Anesthetics, General|anesthetics, general|mesh-ancestor
101451076|NCT00471445|Anesthetics|anesthetics|mesh-ancestor
101451077|NCT00471445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101451078|NCT00471445|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101451079|NCT00471445|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101451080|NCT00471445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101451081|NCT00471445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701374|NCT00720850|Growth Inhibitors|growth inhibitors|mesh-ancestor
101451082|NCT00471445|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101451083|NCT00471445|Antidepressive Agents|antidepressive agents|mesh-ancestor
101451084|NCT00471445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101451085|NCT00471445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101451086|NCT00471445|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101451087|NCT00471445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101451088|NCT00471445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101451089|NCT00471445|Adrenergic Agents|adrenergic agents|mesh-ancestor
101451090|NCT00207051|Cetuximab|cetuximab|mesh-list
101701589|NCT00721552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101451091|NCT00207051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101451092|NCT00207051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101451093|NCT00402467|Enoxaparin|enoxaparin|mesh-list
101451094|NCT00402467|Rivaroxaban|rivaroxaban|mesh-list
101451095|NCT00402467|Enoxaparin sodium|enoxaparin sodium|mesh-list
101701663|NCT00718276|Vitamin D|vitamin d|mesh-list
101451096|NCT00402467|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101451097|NCT00402467|Antithrombins|antithrombins|mesh-ancestor
101451098|NCT00402467|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101451099|NCT00402467|Protease Inhibitors|protease inhibitors|mesh-ancestor
101451100|NCT00402467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101451101|NCT00402467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451102|NCT00402467|Anticoagulants|anticoagulants|mesh-ancestor
101451103|NCT00402467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101451104|NCT00402467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101451105|NCT00224679|Aspirin|aspirin|mesh-list
101451106|NCT00224679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101701745|NCT02730689|Ezetimibe|ezetimibe|mesh-list
101451107|NCT00224679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101451108|NCT00224679|Analgesics|analgesics|mesh-ancestor
101451109|NCT00224679|Sensory System Agents|sensory system agents|mesh-ancestor
101451110|NCT00224679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101451111|NCT00224679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451113|NCT00224679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101451114|NCT00224679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101451115|NCT00224679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101701866|NCT00722956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101451116|NCT00224679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451117|NCT00224679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101451118|NCT00224679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101451119|NCT00224679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101451165|NCT00409760|Valsartan|valsartan|mesh-list
101451166|NCT00409760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101451167|NCT00409760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101451168|NCT00409760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101451169|NCT00409760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451170|NCT00409760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101451171|NCT00409760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451172|NCT00409760|Vasodilator Agents|vasodilator agents|mesh-ancestor
101451173|NCT00409760|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101451174|NCT00409760|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101451176|NCT00413127|Anesthetics, Local|anesthetics, local|mesh-ancestor
101451177|NCT00413127|Anesthetics|anesthetics|mesh-ancestor
101451178|NCT00413127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101451179|NCT00413127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451181|NCT00413127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101451182|NCT00413127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101451183|NCT00413127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101451184|NCT00413127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101451185|NCT00413127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101451186|NCT00413127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451188|NCT00126230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101451189|NCT00126230|Tubulin Modulators|tubulin modulators|mesh-ancestor
101451190|NCT00126230|Antimitotic Agents|antimitotic agents|mesh-ancestor
101451191|NCT00126230|Mitosis Modulators|mitosis modulators|mesh-ancestor
101451192|NCT00126230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451194|NCT00207363|Ribavirin|ribavirin|mesh-list
101451195|NCT00207363|Interferon-alpha|interferon-alpha|mesh-list
101451196|NCT00207363|Interferon alpha-2|interferon alpha-2|mesh-list
101451197|NCT00207363|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101451198|NCT00207363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101451199|NCT00207363|Antiviral Agents|antiviral agents|mesh-ancestor
101451200|NCT00207363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101451201|NCT00207363|Antimetabolites|antimetabolites|mesh-ancestor
101451202|NCT00207363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451203|NCT00207363|Immunologic Factors|immunologic factors|mesh-ancestor
101451204|NCT00207363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451205|NCT00126269|Gemcitabine|gemcitabine|mesh-list
101451206|NCT00126269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101451207|NCT00126269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101451208|NCT00126269|Antimetabolites|antimetabolites|mesh-ancestor
101451209|NCT00126269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451210|NCT00207402|Rosiglitazone|rosiglitazone|mesh-list
101451211|NCT00207402|Interferons|interferons|mesh-list
101451212|NCT00207402|Ribavirin|ribavirin|mesh-list
101451213|NCT00207402|Interferon alfacon-1|interferon alfacon-1|mesh-list
101451214|NCT00207402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101451215|NCT00207402|Antiviral Agents|antiviral agents|mesh-ancestor
101451216|NCT00207402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101451217|NCT00207402|Antimetabolites|antimetabolites|mesh-ancestor
101451218|NCT00207402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451219|NCT00207402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101451220|NCT00207402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451221|NCT00195299|Sirolimus|sirolimus|mesh-list
101451222|NCT00195299|Temsirolimus|temsirolimus|mesh-list
101451223|NCT00195299|MTOR Inhibitors|mtor inhibitors|mesh-list
101451224|NCT00195299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101451225|NCT00195299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528423|NCT01214044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101451230|NCT00195299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702695|NCT05373004|Enalaprilat|enalaprilat|mesh-list
101451231|NCT00195299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101451232|NCT00195299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101451233|NCT00195299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101451234|NCT00195299|Antifungal Agents|antifungal agents|mesh-ancestor
101451235|NCT00471328|Sunitinib|sunitinib|mesh-list
101451236|NCT00471328|Imatinib Mesylate|imatinib mesylate|mesh-list
101451237|NCT00471328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101451238|NCT00471328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101451240|NCT00471328|Growth Substances|growth substances|mesh-ancestor
101451241|NCT00471328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451242|NCT00471328|Growth Inhibitors|growth inhibitors|mesh-ancestor
101451243|NCT00471328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101702936|NCT02637284|BPC 157|bpc 157|mesh-list
101451245|NCT00471328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451246|NCT00225030|Antihypertensive Agents|antihypertensive agents|mesh-list
101451247|NCT00126308|Mannitol|mannitol|mesh-list
101451248|NCT00126308|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101308399|NCT02047149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702983|NCT02624622|Chlorhexidine|chlorhexidine|mesh-list
101308400|NCT02047149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101451250|NCT00126308|Natriuretic Agents|natriuretic agents|mesh-ancestor
101451251|NCT00126308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451252|NCT00195377|Etanercept|etanercept|mesh-list
101451253|NCT00195377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101451254|NCT00195377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101451256|NCT00195377|Sensory System Agents|sensory system agents|mesh-ancestor
101451257|NCT00195377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101451258|NCT00195377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703124|NCT00714064|Antidotes|antidotes|mesh-ancestor
101451259|NCT00195377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101451260|NCT00195377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101451261|NCT00195377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101451262|NCT00195377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101451263|NCT00195377|Immunologic Factors|immunologic factors|mesh-ancestor
101451264|NCT00225108|Tinzaparin|tinzaparin|mesh-list
101451265|NCT00225108|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101451266|NCT00225108|Dalteparin|dalteparin|mesh-list
101451267|NCT00225108|Anticoagulants|anticoagulants|mesh-ancestor
101451268|NCT00225108|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101451269|NCT00225108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101451270|NCT00225108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451271|NCT00195416|Etanercept|etanercept|mesh-list
101451272|NCT00195416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101451273|NCT00195416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101451274|NCT00195416|Analgesics|analgesics|mesh-ancestor
101451275|NCT00195416|Sensory System Agents|sensory system agents|mesh-ancestor
101451276|NCT00195416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101451277|NCT00195416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451278|NCT00195416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101451279|NCT00195416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101451280|NCT00195416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101451281|NCT00195416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101451282|NCT00195416|Immunologic Factors|immunologic factors|mesh-ancestor
101451283|NCT00195455|Estradiol|estradiol|mesh-list
101451284|NCT00195455|Estrogens|estrogens|mesh-ancestor
101451285|NCT00195455|Hormones|hormones|mesh-ancestor
101451286|NCT00195455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101451287|NCT00195455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451288|NCT00126347|Folic Acid|folic acid|mesh-list
101451289|NCT00126347|Betaine|betaine|mesh-list
101451290|NCT00126347|Hematinics|hematinics|mesh-ancestor
101451291|NCT00126347|Vitamin B Complex|vitamin b complex|mesh-ancestor
101451292|NCT00126347|Vitamins|vitamins|mesh-ancestor
101451293|NCT00126347|Micronutrients|micronutrients|mesh-ancestor
101451294|NCT00126347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451295|NCT00126347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101451296|NCT00126347|Lipotropic Agents|lipotropic agents|mesh-ancestor
101451297|NCT00126347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101451301|NCT00225225|Rosiglitazone|rosiglitazone|mesh-list
101451302|NCT00225225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101451303|NCT00225225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451305|NCT00126386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101451306|NCT00126386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451308|NCT00225264|Glimepiride|glimepiride|mesh-list
101451309|NCT00225264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101451310|NCT00225264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451311|NCT00225264|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101451312|NCT00225264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101451313|NCT00225264|Immunologic Factors|immunologic factors|mesh-ancestor
101451314|NCT00126464|Tamoxifen|tamoxifen|mesh-list
101451315|NCT00126464|Fulvestrant|fulvestrant|mesh-list
101451316|NCT00126464|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101451317|NCT00126464|Hormone Antagonists|hormone antagonists|mesh-ancestor
101451318|NCT00126464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101451319|NCT00126464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451320|NCT00126464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101451321|NCT00126464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101451322|NCT00126464|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101451323|NCT00126464|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101451324|NCT00126464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101451325|NCT00126464|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101451326|NCT00195533|Tazobactam|tazobactam|mesh-list
101451327|NCT00195533|Piperacillin|piperacillin|mesh-list
101451328|NCT00195533|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101451329|NCT00195533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101451330|NCT00195533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101451331|NCT00195533|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101451332|NCT00195533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101451333|NCT00195533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451334|NCT00207558|Folic Acid|folic acid|mesh-list
101451335|NCT00207558|Hematinics|hematinics|mesh-ancestor
101451336|NCT00207558|Vitamin B Complex|vitamin b complex|mesh-ancestor
101451337|NCT00207558|Vitamins|vitamins|mesh-ancestor
101451338|NCT00207558|Micronutrients|micronutrients|mesh-ancestor
101451339|NCT00207558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451341|NCT00195572|Levoleucovorin|levoleucovorin|mesh-list
101451342|NCT00195572|Antidotes|antidotes|mesh-ancestor
101451343|NCT00195572|Protective Agents|protective agents|mesh-ancestor
101703522|NCT02625636|Glucagon|glucagon|mesh-list
101451344|NCT00195572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451345|NCT00195572|Vitamin B Complex|vitamin b complex|mesh-ancestor
101451346|NCT00195572|Vitamins|vitamins|mesh-ancestor
101451347|NCT00195572|Micronutrients|micronutrients|mesh-ancestor
101451348|NCT00202280|Folic Acid|folic acid|mesh-list
101451349|NCT00202280|Vitamin B 12|vitamin b 12|mesh-list
101451350|NCT00202280|Hydroxocobalamin|hydroxocobalamin|mesh-list
101451351|NCT00202280|Vitamins|vitamins|mesh-ancestor
101451352|NCT00202280|Micronutrients|micronutrients|mesh-ancestor
101451353|NCT00202280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451354|NCT00202280|Hematinics|hematinics|mesh-ancestor
101451355|NCT00202280|Vitamin B Complex|vitamin b complex|mesh-ancestor
101451356|NCT00225303|Etravirine|etravirine|mesh-list
101451357|NCT00225303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101451358|NCT00225303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101451359|NCT00225303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101451360|NCT00225303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451361|NCT00225303|Antiviral Agents|antiviral agents|mesh-ancestor
101451362|NCT00225303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101451363|NCT00225342|Rosiglitazone|rosiglitazone|mesh-list
101451364|NCT00225342|Gliclazide|gliclazide|mesh-list
101451365|NCT00225342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101451366|NCT00225342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451367|NCT00195611|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101451368|NCT00195611|Immunologic Factors|immunologic factors|mesh-ancestor
101451369|NCT00195611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451371|NCT00470470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101451372|NCT00470470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101451379|NCT00195689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703779|NCT02722733|Lenograstim|lenograstim|mesh-list
101451380|NCT00195689|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101451382|NCT00195689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101451383|NCT00470275|Cytarabine|cytarabine|mesh-list
101451384|NCT00470275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101451385|NCT00470275|Antimetabolites|antimetabolites|mesh-ancestor
101646164|NCT04264286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101451386|NCT00470275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451387|NCT00470275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101451388|NCT00470275|Antiviral Agents|antiviral agents|mesh-ancestor
101451389|NCT00470275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101451390|NCT00470275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101703992|NCT04426240|Cyclosporins|cyclosporins|mesh-list
101451391|NCT00470275|Immunologic Factors|immunologic factors|mesh-ancestor
101451392|NCT00470275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451394|NCT00225381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101451395|NCT00225381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451397|NCT00195728|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
101451398|NCT00195728|Hydrocodone|hydrocodone|mesh-list
101451399|NCT00195728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101451400|NCT00195728|Analgesics|analgesics|mesh-ancestor
101451401|NCT00195728|Sensory System Agents|sensory system agents|mesh-ancestor
101451402|NCT00195728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101451403|NCT00195728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451404|NCT00195728|Antipyretics|antipyretics|mesh-ancestor
101451405|NCT00195728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101451406|NCT00195728|Narcotics|narcotics|mesh-ancestor
101451407|NCT00195728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101451409|NCT00195728|Respiratory System Agents|respiratory system agents|mesh-ancestor
101451410|NCT00195728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101451411|NCT00195728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101451412|NCT00195728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101451413|NCT00470158|Iron|iron|mesh-list
101451414|NCT00470158|Zinc|zinc|mesh-list
101451415|NCT00470158|Trace Elements|trace elements|mesh-ancestor
101451416|NCT00470158|Micronutrients|micronutrients|mesh-ancestor
101451417|NCT00470158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451418|NCT00472186|Lansoprazole|lansoprazole|mesh-list
101451419|NCT00472186|Dexlansoprazole|dexlansoprazole|mesh-list
101451420|NCT00472186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101451421|NCT00472186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101451422|NCT00472186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101451423|NCT00472186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101451424|NCT00472186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451425|NCT00195767|Valproic Acid|valproic acid|mesh-list
101451426|NCT00195767|Anticonvulsants|anticonvulsants|mesh-ancestor
101451427|NCT00195767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101451428|NCT00195767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451429|NCT00195767|GABA Agents|gaba agents|mesh-ancestor
101451430|NCT00195767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101451431|NCT00195767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451433|NCT00195767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101451434|NCT00195767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101451435|NCT00195767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101451436|NCT00207675|Infliximab|infliximab|mesh-list
101407766|NCT03279133|Ledipasvir|ledipasvir|mesh-list
101451437|NCT00207675|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101451438|NCT00207675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101451439|NCT00207675|Dermatologic Agents|dermatologic agents|mesh-ancestor
101451440|NCT00207675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101451441|NCT00207675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101451442|NCT00202358|Atenolol|atenolol|mesh-list
101451443|NCT00202358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101451457|NCT00479713|Ezetimibe|ezetimibe|mesh-list
101451458|NCT00479713|Calcium|calcium|mesh-list
101451459|NCT00479713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101451460|NCT00479713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451461|NCT00479713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101451462|NCT00479713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101451463|NCT00479713|Antimetabolites|antimetabolites|mesh-ancestor
101451464|NCT00479713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451465|NCT00479713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101451466|NCT00479713|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101451467|NCT00479713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101451468|NCT00207753|Ivermectin|ivermectin|mesh-list
101451469|NCT00207753|Albendazole|albendazole|mesh-list
101451470|NCT00207753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101451471|NCT00207753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101451472|NCT00207753|Anthelmintics|anthelmintics|mesh-ancestor
101451473|NCT00207753|Anticestodal Agents|anticestodal agents|mesh-ancestor
101451474|NCT00207753|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101451475|NCT00207753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101451476|NCT00207753|Tubulin Modulators|tubulin modulators|mesh-ancestor
101451477|NCT00207753|Antimitotic Agents|antimitotic agents|mesh-ancestor
101451478|NCT00207753|Mitosis Modulators|mitosis modulators|mesh-ancestor
101451479|NCT00207753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451480|NCT00207753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101451481|NCT00202397|Riluzole|riluzole|mesh-list
101451482|NCT00202397|Anticonvulsants|anticonvulsants|mesh-ancestor
101451483|NCT00202397|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101451484|NCT00202397|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101451485|NCT00202397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101451486|NCT00202397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451487|NCT00202397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451488|NCT00202397|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101451489|NCT00202397|Protective Agents|protective agents|mesh-ancestor
101451490|NCT00478972|Rimonabant|rimonabant|mesh-list
101451491|NCT00478972|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101451492|NCT00478972|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
101308404|NCT02047149|Hormone Antagonists|hormone antagonists|mesh-ancestor
101308405|NCT02047149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101308406|NCT02047149|Antisickling Agents|antisickling agents|mesh-ancestor
101308407|NCT02047149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101308408|NCT02047162|Bismuth|bismuth|mesh-list
101308409|NCT02047162|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
101308410|NCT02047162|Antacids|antacids|mesh-ancestor
101308411|NCT02047162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308412|NCT02047162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101451493|NCT00478972|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101451494|NCT00478972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101451495|NCT00478972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451496|NCT00478972|Hormones|hormones|mesh-ancestor
101451497|NCT00478972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101451498|NCT00478972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451499|NCT00207792|Lenograstim|lenograstim|mesh-list
101451500|NCT00207792|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101451501|NCT00207792|Immunologic Factors|immunologic factors|mesh-ancestor
101451516|NCT00477529|Tubulin Modulators|tubulin modulators|mesh-ancestor
101451517|NCT00477529|Antimitotic Agents|antimitotic agents|mesh-ancestor
101451518|NCT00477529|Mitosis Modulators|mitosis modulators|mesh-ancestor
101451519|NCT00477529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451520|NCT00472693|Bevacizumab|bevacizumab|mesh-list
101451521|NCT00472693|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101451522|NCT00472693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101451523|NCT00472693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101451524|NCT00472693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101451525|NCT00472693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101451526|NCT00472693|Growth Substances|growth substances|mesh-ancestor
101451527|NCT00472693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451528|NCT00472693|Growth Inhibitors|growth inhibitors|mesh-ancestor
101451529|NCT00195845|Galantamine|galantamine|mesh-list
101451530|NCT00195845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101451531|NCT00195845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101451532|NCT00195845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451533|NCT00195845|Cholinergic Agents|cholinergic agents|mesh-ancestor
101451534|NCT00195845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101451535|NCT00195845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451536|NCT00195845|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101451537|NCT00195845|Autonomic Agents|autonomic agents|mesh-ancestor
101451538|NCT00195845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101451539|NCT00195845|Nootropic Agents|nootropic agents|mesh-ancestor
101451540|NCT00202514|Valproic Acid|valproic acid|mesh-list
101451541|NCT00202514|Anticonvulsants|anticonvulsants|mesh-ancestor
101451542|NCT00202514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101451543|NCT00202514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451544|NCT00202514|GABA Agents|gaba agents|mesh-ancestor
101451545|NCT00202514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101451546|NCT00202514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451547|NCT00202514|Antimanic Agents|antimanic agents|mesh-ancestor
101451548|NCT00202514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101451549|NCT00202514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101451550|NCT00202514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101451551|NCT00207831|Tegafur|tegafur|mesh-list
101451552|NCT00207831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101451553|NCT00207831|Antimetabolites|antimetabolites|mesh-ancestor
101451554|NCT00207831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451555|NCT00207831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101451556|NCT00195923|Clindamycin|clindamycin|mesh-list
101451557|NCT00195923|Clindamycin palmitate|clindamycin palmitate|mesh-list
101451558|NCT00195923|Clindamycin phosphate|clindamycin phosphate|mesh-list
101451559|NCT00195923|Gentamicins|gentamicins|mesh-list
101451560|NCT00195923|Ceftazidime|ceftazidime|mesh-list
101451561|NCT00195923|Ampicillin|ampicillin|mesh-list
101308413|NCT02047162|Antidiarrheals|antidiarrheals|mesh-ancestor
101308415|NCT02047175|Amlodipine|amlodipine|mesh-list
101308417|NCT02047175|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101308418|NCT02047175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101308419|NCT02047175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101705207|NCT01008709|beta-Endorphin|beta-endorphin|mesh-list
101308420|NCT02047175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101308421|NCT02047175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308422|NCT02047175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101308423|NCT02047175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308424|NCT02047175|Vasodilator Agents|vasodilator agents|mesh-ancestor
101451562|NCT00195923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101451584|NCT00202592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101451585|NCT00202592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451586|NCT00202592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101451587|NCT00411333|Triamcinolone|triamcinolone|mesh-list
101451589|NCT00411333|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101451590|NCT00411333|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101451591|NCT00411333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101451592|NCT00411333|Glucocorticoids|glucocorticoids|mesh-ancestor
101451593|NCT00411333|Hormones|hormones|mesh-ancestor
101705427|NCT00913029|Timolol|timolol|mesh-list
101451594|NCT00411333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101451595|NCT00411333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451596|NCT00411333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101451597|NCT00411333|Immunologic Factors|immunologic factors|mesh-ancestor
101451598|NCT00411333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101451599|NCT00411333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451600|NCT00225849|Aspirin|aspirin|mesh-list
101451601|NCT00225849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101451602|NCT00225849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101451603|NCT00225849|Analgesics|analgesics|mesh-ancestor
101451604|NCT00225849|Sensory System Agents|sensory system agents|mesh-ancestor
101451605|NCT00225849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101451606|NCT00225849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451607|NCT00225849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101451608|NCT00225849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101451609|NCT00225849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101451610|NCT00225849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101451611|NCT00225849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451620|NCT00202787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101451621|NCT00202787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101451622|NCT00202787|Antimetabolites|antimetabolites|mesh-ancestor
101451623|NCT00202787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451624|NCT00202787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101451625|NCT00202787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101451626|NCT00202787|Immunologic Factors|immunologic factors|mesh-ancestor
101451627|NCT00202787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451628|NCT00202787|Antidotes|antidotes|mesh-ancestor
101451629|NCT00202787|Protective Agents|protective agents|mesh-ancestor
101451630|NCT00202787|Vitamin B Complex|vitamin b complex|mesh-ancestor
101451631|NCT00202787|Vitamins|vitamins|mesh-ancestor
101451632|NCT00202787|Micronutrients|micronutrients|mesh-ancestor
101451633|NCT00424437|Insulin|insulin|mesh-list
101451634|NCT00424437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101451635|NCT00424437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101451636|NCT00424437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451637|NCT00202865|Infliximab|infliximab|mesh-list
101308426|NCT02047175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101308427|NCT02047175|Antimetabolites|antimetabolites|mesh-ancestor
101308428|NCT02047175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101308429|NCT02047175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101308430|NCT02047175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101308431|NCT02047175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101308432|NCT02047175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101308433|NCT02047175|Vitamin B Complex|vitamin b complex|mesh-ancestor
101451638|NCT00202865|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101451639|NCT00202865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101451640|NCT00202865|Dermatologic Agents|dermatologic agents|mesh-ancestor
101451641|NCT00202865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101451642|NCT00202865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101451643|NCT00226005|Vatalanib|vatalanib|mesh-list
101451644|NCT00226005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101451645|NCT00226005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101451646|NCT00226005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451647|NCT00196352|Levonorgestrel|levonorgestrel|mesh-list
101451648|NCT00196352|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101451649|NCT00196352|Contraceptive Agents|contraceptive agents|mesh-ancestor
101451650|NCT00196352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101451651|NCT00196352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451652|NCT00196352|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101451653|NCT00196352|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101451654|NCT00196352|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101451655|NCT00226044|Omeprazole|omeprazole|mesh-list
101451656|NCT00226044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101451657|NCT00226044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101451658|NCT00226044|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101451659|NCT00226044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101451660|NCT00226044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451661|NCT00202982|Glatiramer Acetate|glatiramer acetate|mesh-list
101451662|NCT00202982|(T,G)-A-L|(t,g)-a-l|mesh-list
101451663|NCT00202982|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101451664|NCT00202982|Immunologic Factors|immunologic factors|mesh-ancestor
101451665|NCT00202982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451667|NCT00202982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101451668|NCT00207948|Ritonavir|ritonavir|mesh-list
101451669|NCT00207948|Lopinavir|lopinavir|mesh-list
101706180|NCT03828773|Fluconazole|fluconazole|mesh-list
101451670|NCT00207948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101451671|NCT00207948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101451672|NCT00207948|Protease Inhibitors|protease inhibitors|mesh-ancestor
101451673|NCT00207948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101451674|NCT00207948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451676|NCT00207948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101451677|NCT00207948|Antiviral Agents|antiviral agents|mesh-ancestor
101451678|NCT00207948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101451679|NCT00207948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101451680|NCT00207948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101451681|NCT00196391|Progesterone|progesterone|mesh-list
101451688|NCT00203060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101451689|NCT00203060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451690|NCT00203060|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101451691|NCT00203060|Protective Agents|protective agents|mesh-ancestor
101451692|NCT00203060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451693|NCT00226122|Indomethacin|indomethacin|mesh-list
101451694|NCT00226122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101451695|NCT00226122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101451696|NCT00226122|Analgesics|analgesics|mesh-ancestor
101451697|NCT00226122|Sensory System Agents|sensory system agents|mesh-ancestor
101706446|NCT04649489|Growth Inhibitors|growth inhibitors|mesh-ancestor
101451698|NCT00226122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101451699|NCT00226122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451700|NCT00226122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101451701|NCT00226122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101308435|NCT02047175|Micronutrients|micronutrients|mesh-ancestor
101308436|NCT02047201|Docetaxel|docetaxel|mesh-list
101308437|NCT02047201|Fluorouracil|fluorouracil|mesh-list
101308438|NCT02047201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308439|NCT02047201|Tubulin Modulators|tubulin modulators|mesh-ancestor
101308440|NCT02047201|Antimitotic Agents|antimitotic agents|mesh-ancestor
101706594|NCT00882908|Ribavirin|ribavirin|mesh-list
101308441|NCT02047201|Mitosis Modulators|mitosis modulators|mesh-ancestor
101451702|NCT00226122|Gout Suppressants|gout suppressants|mesh-ancestor
101451703|NCT00226122|Tocolytic Agents|tocolytic agents|mesh-ancestor
101451704|NCT00226122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101451705|NCT00226122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101451706|NCT00226122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101451707|NCT00226122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628328|NCT00720109|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101628329|NCT00720109|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101628330|NCT00720109|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101628331|NCT00720109|Cortisone|cortisone|mesh-list
101628332|NCT00720109|Cyclophosphamide|cyclophosphamide|mesh-list
101628333|NCT00720109|Ifosfamide|ifosfamide|mesh-list
101628334|NCT00720109|Isophosphamide mustard|isophosphamide mustard|mesh-list
101628335|NCT00720109|Methotrexate|methotrexate|mesh-list
101628336|NCT00720109|Etoposide|etoposide|mesh-list
101628337|NCT00720109|Vincristine|vincristine|mesh-list
101628338|NCT00720109|Etoposide phosphate|etoposide phosphate|mesh-list
101628339|NCT00720109|Daunorubicin|daunorubicin|mesh-list
101628340|NCT00720109|Asparaginase|asparaginase|mesh-list
101628341|NCT00720109|Dasatinib|dasatinib|mesh-list
101628342|NCT00720109|Mercaptopurine|mercaptopurine|mesh-list
101628343|NCT00720109|Podophyllotoxin|podophyllotoxin|mesh-list
101628344|NCT00720109|Pegaspargase|pegaspargase|mesh-list
101628345|NCT00720109|Lenograstim|lenograstim|mesh-list
101628346|NCT00720109|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101628347|NCT00720109|Prednisolone phosphate|prednisolone phosphate|mesh-list
101628349|NCT00720109|Calcium|calcium|mesh-list
101628350|NCT00720109|Levoleucovorin|levoleucovorin|mesh-list
101628351|NCT00720109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101628352|NCT00720109|Immunologic Factors|immunologic factors|mesh-ancestor
101628353|NCT00720109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628354|NCT00720109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101628355|NCT00720109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101628356|NCT00720109|Alkylating Agents|alkylating agents|mesh-ancestor
101628357|NCT00720109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628358|NCT00720109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101628359|NCT00720109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101628360|NCT00720109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101628361|NCT00720109|Antiemetics|antiemetics|mesh-ancestor
101628362|NCT00720109|Autonomic Agents|autonomic agents|mesh-ancestor
101628363|NCT00720109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101707143|NCT00713596|Hemostatics|hemostatics|mesh-ancestor
101628364|NCT00720109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101628365|NCT00720109|Glucocorticoids|glucocorticoids|mesh-ancestor
101628367|NCT00720109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101628368|NCT00720109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101628369|NCT00720109|Protease Inhibitors|protease inhibitors|mesh-ancestor
101628370|NCT00720109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628371|NCT00720109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101628372|NCT00720109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101628373|NCT00720109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101628374|NCT00720109|Abortifacient Agents|abortifacient agents|mesh-ancestor
101628375|NCT00720109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101628376|NCT00720109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101628377|NCT00720109|Antimetabolites|antimetabolites|mesh-ancestor
101628378|NCT00720109|Dermatologic Agents|dermatologic agents|mesh-ancestor
101628379|NCT00720109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101628380|NCT00720109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101628381|NCT00720109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101628383|NCT00720109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101628384|NCT00720109|Antiviral Agents|antiviral agents|mesh-ancestor
101628385|NCT00720109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101285491|NCT01935531|Immunologic Factors|immunologic factors|mesh-ancestor
101628386|NCT00720109|Antidotes|antidotes|mesh-ancestor
101628387|NCT00720109|Protective Agents|protective agents|mesh-ancestor
101628388|NCT00720109|Vitamin B Complex|vitamin b complex|mesh-ancestor
101628390|NCT00720109|Micronutrients|micronutrients|mesh-ancestor
101628391|NCT00720109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101628392|NCT00720109|Tubulin Modulators|tubulin modulators|mesh-ancestor
101628393|NCT00720109|Antimitotic Agents|antimitotic agents|mesh-ancestor
101628394|NCT00720109|Mitosis Modulators|mitosis modulators|mesh-ancestor
101628395|NCT00720109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101628396|NCT00720109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101628399|NCT00720109|Keratolytic Agents|keratolytic agents|mesh-ancestor
101628406|NCT02590627|Piperaquine|piperaquine|mesh-list
101628407|NCT02590627|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101628408|NCT02590627|Artenimol|artenimol|mesh-list
101628409|NCT02590627|Antimalarials|antimalarials|mesh-ancestor
101628410|NCT02590627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101628411|NCT02590627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101628412|NCT02590627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101628413|NCT01015118|Paclitaxel|paclitaxel|mesh-list
101628414|NCT01015118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101628415|NCT01015118|Carboplatin|carboplatin|mesh-list
101628416|NCT01015118|Nintedanib|nintedanib|mesh-list
101628417|NCT01015118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101628418|NCT01015118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101628419|NCT01015118|Tubulin Modulators|tubulin modulators|mesh-ancestor
101628420|NCT01015118|Antimitotic Agents|antimitotic agents|mesh-ancestor
101628421|NCT01015118|Mitosis Modulators|mitosis modulators|mesh-ancestor
101628422|NCT01015118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628423|NCT01015118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101628424|NCT01015118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628425|NCT02415153|Pomalidomide|pomalidomide|mesh-list
101628426|NCT02415153|Immunologic Factors|immunologic factors|mesh-ancestor
101628427|NCT02415153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707614|NCT02633930|Bismuth|bismuth|mesh-list
101628428|NCT02415153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101628429|NCT02415153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101628430|NCT02415153|Growth Substances|growth substances|mesh-ancestor
101628431|NCT02415153|Growth Inhibitors|growth inhibitors|mesh-ancestor
101628432|NCT02415153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101628433|NCT04111822|Tranexamic Acid|tranexamic acid|mesh-list
101628434|NCT04111822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101628435|NCT04111822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101628436|NCT04111822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628437|NCT04111822|Hemostatics|hemostatics|mesh-ancestor
101628438|NCT04111822|Coagulants|coagulants|mesh-ancestor
101628439|NCT00628160|Terlipressin|terlipressin|mesh-list
101628440|NCT00628160|Dopamine|dopamine|mesh-list
101628441|NCT00628160|Norepinephrine|norepinephrine|mesh-list
101628442|NCT00628160|Adrenergic Agents|adrenergic agents|mesh-list
101707747|NCT00517699|Rituximab|rituximab|mesh-list
101628443|NCT00628160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101628444|NCT00628160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101628445|NCT00628160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101628446|NCT00628160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628447|NCT00628160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628448|NCT00628160|Sympathomimetics|sympathomimetics|mesh-ancestor
101628449|NCT00628160|Autonomic Agents|autonomic agents|mesh-ancestor
101628450|NCT00628160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101628451|NCT00628160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101628452|NCT00628160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101628453|NCT00628160|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101628454|NCT00628160|Dopamine Agents|dopamine agents|mesh-ancestor
101628455|NCT00628160|Protective Agents|protective agents|mesh-ancestor
101628456|NCT02274285|Vaccines|vaccines|mesh-list
101628457|NCT02274285|Immunologic Factors|immunologic factors|mesh-ancestor
101628458|NCT02274285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628459|NCT02283112|Anti-Infective Agents|anti-infective agents|mesh-list
101628460|NCT02283112|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101628461|NCT02283112|Antiviral Agents|antiviral agents|mesh-list
101628462|NCT02283112|Contraceptive Agents|contraceptive agents|mesh-list
101628463|NCT02283112|Contraceptives, Oral|contraceptives, oral|mesh-list
101628464|NCT02283112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101628465|NCT02283112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628466|NCT02283112|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101628469|NCT00614835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101628470|NCT00614835|Antimetabolites|antimetabolites|mesh-ancestor
101628471|NCT00614835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628472|NCT00614835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101628473|NCT00614835|Tubulin Modulators|tubulin modulators|mesh-ancestor
101628474|NCT00614835|Antimitotic Agents|antimitotic agents|mesh-ancestor
101628475|NCT00614835|Mitosis Modulators|mitosis modulators|mesh-ancestor
101628477|NCT00715429|Ergocalciferols|ergocalciferols|mesh-list
101628478|NCT00715429|Vitamins|vitamins|mesh-ancestor
101628479|NCT00715429|Micronutrients|micronutrients|mesh-ancestor
101628480|NCT00715429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628481|NCT00715429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101628482|NCT00715429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101628483|NCT02606032|Metronidazole|metronidazole|mesh-list
101628485|NCT02606032|Terbinafine|terbinafine|mesh-list
101628486|NCT02606032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101628487|NCT02606032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101628488|NCT02606032|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101628489|NCT02606032|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101628490|NCT02606032|Antimalarials|antimalarials|mesh-ancestor
101628491|NCT02606032|Antifungal Agents|antifungal agents|mesh-ancestor
101628492|NCT02606032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628493|NCT02606032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628494|NCT02145507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101628495|NCT01743651|Baclofen|baclofen|mesh-list
101628496|NCT01743651|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101628497|NCT01743651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628498|NCT01743651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101628499|NCT01743651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101628501|NCT01743651|GABA Agonists|gaba agonists|mesh-ancestor
101628502|NCT01743651|GABA Agents|gaba agents|mesh-ancestor
101628503|NCT01743651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101628504|NCT01743651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628506|NCT00715117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101708659|NCT00662636|Dasatinib|dasatinib|mesh-list
101628507|NCT00715117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101628508|NCT00715117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628509|NCT00715117|Sensory System Agents|sensory system agents|mesh-ancestor
101708728|NCT00668096|Urological Agents|urological agents|mesh-ancestor
101628510|NCT00715117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101628511|NCT00723229|Acyclovir|acyclovir|mesh-list
101628512|NCT00723229|Antiviral Agents|antiviral agents|mesh-ancestor
101628513|NCT00723229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101628514|NCT01093521|Gallium nitrate|gallium nitrate|mesh-list
101628515|NCT01093521|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101628516|NCT01093521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628517|NCT01093521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101628518|NCT01030718|Dasatinib|dasatinib|mesh-list
101628519|NCT01030718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101628520|NCT01030718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101628521|NCT01030718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628522|NCT01030718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628523|NCT00722761|Drospirenone|drospirenone|mesh-list
101628524|NCT00722761|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101628525|NCT00722761|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
101628526|NCT00722761|Estradiol|estradiol|mesh-list
101628527|NCT00722761|Estrogens|estrogens|mesh-ancestor
101628528|NCT00722761|Hormones|hormones|mesh-ancestor
101628529|NCT00722761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101628530|NCT00722761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628531|NCT00722761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101628532|NCT00722761|Contraceptive Agents|contraceptive agents|mesh-ancestor
101628533|NCT00722761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101628534|NCT00722761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101628535|NCT00722761|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101628536|NCT00722761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101628537|NCT00722761|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101628538|NCT00722761|Hormone Antagonists|hormone antagonists|mesh-ancestor
101628539|NCT00722761|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101628540|NCT00722761|Diuretics|diuretics|mesh-ancestor
101628541|NCT00722761|Natriuretic Agents|natriuretic agents|mesh-ancestor
101628542|NCT00628238|Rituximab|rituximab|mesh-list
101628543|NCT00628238|Lenalidomide|lenalidomide|mesh-list
101628544|NCT00628238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101628545|NCT00628238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101628546|NCT00628238|Immunologic Factors|immunologic factors|mesh-ancestor
101628547|NCT00628238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628548|NCT00628238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101451708|NCT00196469|Heparin|heparin|mesh-list
101628549|NCT00628238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101628550|NCT00628238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101628551|NCT00628238|Growth Substances|growth substances|mesh-ancestor
101628552|NCT00628238|Growth Inhibitors|growth inhibitors|mesh-ancestor
101628553|NCT05132179|Sodium Hypochlorite|sodium hypochlorite|mesh-list
101628554|NCT05132179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101628555|NCT05132179|Disinfectants|disinfectants|mesh-ancestor
101628556|NCT05132179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101628558|NCT01019486|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
101628559|NCT01019486|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
101628560|NCT01019486|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101628561|NCT01019486|Purinergic Agonists|purinergic agonists|mesh-ancestor
101708915|NCT04729205|Mitomycins|mitomycins|mesh-list
101628563|NCT01019486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101628564|NCT01019486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628565|NCT01019486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628566|NCT01019486|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101628567|NCT02803203|Bevacizumab|bevacizumab|mesh-list
101628568|NCT02803203|Osimertinib|osimertinib|mesh-list
101628569|NCT02803203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101628570|NCT02803203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101628571|NCT02803203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101628572|NCT02803203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101628573|NCT02803203|Growth Substances|growth substances|mesh-ancestor
101628574|NCT02803203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628575|NCT02803203|Growth Inhibitors|growth inhibitors|mesh-ancestor
101628576|NCT02803203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101628577|NCT02803203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628578|NCT02803203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628579|NCT00714493|Infliximab|infliximab|mesh-list
101628580|NCT00714493|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101628581|NCT00714493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101628582|NCT00714493|Dermatologic Agents|dermatologic agents|mesh-ancestor
101628583|NCT00714493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101628584|NCT00714493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101628585|NCT01013870|Atorvastatin|atorvastatin|mesh-list
101628586|NCT01013870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101628587|NCT01013870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101628588|NCT01013870|Antimetabolites|antimetabolites|mesh-ancestor
101628589|NCT01013870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628590|NCT01013870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101628591|NCT01013870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101628592|NCT01013870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628593|NCT05020184|Cimetidine|cimetidine|mesh-list
101628594|NCT05020184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101628595|NCT05020184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101628596|NCT05020184|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101628597|NCT05020184|Histamine Antagonists|histamine antagonists|mesh-ancestor
101628598|NCT05020184|Histamine Agents|histamine agents|mesh-ancestor
101628599|NCT05020184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101628600|NCT05020184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628601|NCT05020184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628602|NCT05020184|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101628603|NCT05020184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101628604|NCT05020184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628605|NCT00628316|Caffeine|caffeine|mesh-list
101628606|NCT00628316|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101628607|NCT00628316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628608|NCT00628316|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101628609|NCT00628316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628610|NCT00628316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628611|NCT00628316|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101628613|NCT00628316|Purinergic Agents|purinergic agents|mesh-ancestor
101628614|NCT00628316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101628615|NCT01018862|Azelastine|azelastine|mesh-list
101628616|NCT01018862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101628617|NCT01018862|Autonomic Agents|autonomic agents|mesh-ancestor
101628618|NCT01018862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101709447|NCT01009957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628619|NCT01018862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628620|NCT01018862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101628621|NCT01018862|Respiratory System Agents|respiratory system agents|mesh-ancestor
101628622|NCT01018862|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101628623|NCT01018862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628624|NCT01018862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628625|NCT01018862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101628626|NCT01018862|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101628627|NCT01018862|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101628628|NCT01018862|Histamine Antagonists|histamine antagonists|mesh-ancestor
101628629|NCT01018862|Histamine Agents|histamine agents|mesh-ancestor
101628630|NCT01018862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101628632|NCT01018394|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101628633|NCT01018394|Autonomic Agents|autonomic agents|mesh-ancestor
101628634|NCT01018394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101628635|NCT01018394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709672|NCT00616499|Gefitinib|gefitinib|mesh-list
101628636|NCT01018394|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101628637|NCT01018394|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101628638|NCT01018394|Cholinergic Agents|cholinergic agents|mesh-ancestor
101628639|NCT01018394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101709726|NCT00503581|Megestrol|megestrol|mesh-list
101628640|NCT01018394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628641|NCT04301336|Zinc|zinc|mesh-list
101628642|NCT04301336|Folic Acid|folic acid|mesh-list
101628643|NCT04301336|Vitamin B Complex|vitamin b complex|mesh-list
101628644|NCT04301336|Hydroxyurea|hydroxyurea|mesh-list
101628645|NCT04301336|Morphine|morphine|mesh-list
101628646|NCT04301336|Zinc Sulfate|zinc sulfate|mesh-list
101628647|NCT04301336|Simvastatin|simvastatin|mesh-list
101628648|NCT04301336|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101628649|NCT04301336|Narcotics|narcotics|mesh-ancestor
101628650|NCT04301336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101628651|NCT04301336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628652|NCT04301336|Analgesics|analgesics|mesh-ancestor
101628653|NCT04301336|Sensory System Agents|sensory system agents|mesh-ancestor
101628654|NCT04301336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101628655|NCT04301336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101628656|NCT04301336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101628657|NCT04301336|Antimetabolites|antimetabolites|mesh-ancestor
101628658|NCT04301336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628659|NCT04301336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101628660|NCT04301336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101628661|NCT04301336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628662|NCT04301336|Trace Elements|trace elements|mesh-ancestor
101628663|NCT04301336|Micronutrients|micronutrients|mesh-ancestor
101628664|NCT04301336|Hematinics|hematinics|mesh-ancestor
101628666|NCT04301336|Astringents|astringents|mesh-ancestor
101710086|NCT00679250|Cetirizine|cetirizine|mesh-list
101628667|NCT04301336|Dermatologic Agents|dermatologic agents|mesh-ancestor
101628668|NCT04301336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101628669|NCT04301336|Antisickling Agents|antisickling agents|mesh-ancestor
101628670|NCT04301336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101628671|NCT00627848|Rivastigmine|rivastigmine|mesh-list
101628672|NCT00627848|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101710226|NCT00619541|Fluorouracil|fluorouracil|mesh-list
101628673|NCT00627848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628674|NCT00627848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628675|NCT00627848|Cholinergic Agents|cholinergic agents|mesh-ancestor
101628676|NCT00627848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101628677|NCT00627848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628678|NCT00627848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101628679|NCT00627848|Protective Agents|protective agents|mesh-ancestor
101628681|NCT04299854|Oxytocics|oxytocics|mesh-ancestor
101628682|NCT04299854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101628683|NCT04299854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628684|NCT01017146|Tazarotene|tazarotene|mesh-list
101628685|NCT01017146|Dermatologic Agents|dermatologic agents|mesh-ancestor
101628686|NCT01017146|Keratolytic Agents|keratolytic agents|mesh-ancestor
101628687|NCT02872064|Verteporfin|verteporfin|mesh-list
101628688|NCT02872064|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101628689|NCT02872064|Dermatologic Agents|dermatologic agents|mesh-ancestor
101628690|NCT04205240|Mycophenolic Acid|mycophenolic acid|mesh-list
101628692|NCT04205240|Melphalan|melphalan|mesh-list
101628693|NCT04205240|Mechlorethamine|mechlorethamine|mesh-list
101628694|NCT04205240|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
101285801|NCT01937325|Ivacaftor|ivacaftor|mesh-list
101710356|NCT04595266|Leucovorin|leucovorin|mesh-list
101628695|NCT04205240|Fludarabine|fludarabine|mesh-list
101628696|NCT04205240|Daratumumab|daratumumab|mesh-list
101628697|NCT04205240|Tacrolimus|tacrolimus|mesh-list
101628698|NCT04205240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101628699|NCT04205240|Immunologic Factors|immunologic factors|mesh-ancestor
101628700|NCT04205240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628701|NCT04205240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101628702|NCT04205240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101628703|NCT04205240|Alkylating Agents|alkylating agents|mesh-ancestor
101628704|NCT04205240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628705|NCT04205240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101628706|NCT04205240|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101628707|NCT04205240|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101628708|NCT04205240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628709|NCT04205240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101628710|NCT04205240|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101628711|NCT04205240|Antitubercular Agents|antitubercular agents|mesh-ancestor
101628712|NCT04205240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101628713|NCT04205240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101628714|NCT01010750|Amphetamine|amphetamine|mesh-list
101628715|NCT01010750|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101628716|NCT01010750|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101628717|NCT01010750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628718|NCT01010750|Sympathomimetics|sympathomimetics|mesh-ancestor
101628719|NCT01010750|Autonomic Agents|autonomic agents|mesh-ancestor
101628720|NCT01010750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101628721|NCT01010750|Dopamine Agents|dopamine agents|mesh-ancestor
101628722|NCT01010750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101628723|NCT01010750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628724|NCT01010750|Adrenergic Agents|adrenergic agents|mesh-ancestor
101628725|NCT01010750|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101628726|NCT01010750|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101628727|NCT01010750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101628728|NCT01010750|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101628729|NCT01012622|Methylphenidate|methylphenidate|mesh-list
101628730|NCT01012622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101628731|NCT01012622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628732|NCT01012622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101628733|NCT01012622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101628734|NCT01012622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101628735|NCT01012622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628736|NCT01012622|Dopamine Agents|dopamine agents|mesh-ancestor
101628737|NCT01012622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101628738|NCT00722371|Metformin|metformin|mesh-list
101628739|NCT00722371|Pioglitazone|pioglitazone|mesh-list
101628740|NCT00722371|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101628741|NCT00722371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101628742|NCT00722371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628743|NCT00722371|Incretins|incretins|mesh-ancestor
101628744|NCT00722371|Hormones|hormones|mesh-ancestor
101628745|NCT00722371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101628746|NCT00722371|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101710560|NCT04209803|Minoxidil|minoxidil|mesh-list
101628747|NCT00722371|Protease Inhibitors|protease inhibitors|mesh-ancestor
101628748|NCT00722371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628749|NCT00722371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628750|NCT02871986|Estrogens|estrogens|mesh-list
101628751|NCT02871986|Hormones|hormones|mesh-ancestor
101628752|NCT02871986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101628753|NCT02871986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628754|NCT00722137|Prednisone|prednisone|mesh-list
101628755|NCT00722137|Cyclophosphamide|cyclophosphamide|mesh-list
101628756|NCT00722137|Rituximab|rituximab|mesh-list
101628757|NCT00722137|Doxorubicin|doxorubicin|mesh-list
101628758|NCT00722137|Vincristine|vincristine|mesh-list
101628759|NCT00722137|Bortezomib|bortezomib|mesh-list
101628760|NCT00722137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101628761|NCT00722137|Immunologic Factors|immunologic factors|mesh-ancestor
101628762|NCT00722137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628763|NCT00722137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101628764|NCT00722137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101628765|NCT00722137|Alkylating Agents|alkylating agents|mesh-ancestor
101628766|NCT00722137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628767|NCT00722137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101628768|NCT00722137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101628769|NCT00722137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101285889|NCT01937767|Fentanyl|fentanyl|mesh-list
101628770|NCT00722137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101628771|NCT00722137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101628772|NCT00722137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101628773|NCT00722137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628774|NCT00722137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101628776|NCT00722137|Hormones|hormones|mesh-ancestor
101628777|NCT00722137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101628778|NCT00722137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101628779|NCT00722137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101628780|NCT00722137|Tubulin Modulators|tubulin modulators|mesh-ancestor
101628781|NCT00722137|Antimitotic Agents|antimitotic agents|mesh-ancestor
101628782|NCT00722137|Mitosis Modulators|mitosis modulators|mesh-ancestor
101628783|NCT04114396|Antibodies|antibodies|mesh-list
101628784|NCT04114396|Immunologic Factors|immunologic factors|mesh-ancestor
101628785|NCT04114396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628786|NCT00796666|Sildenafil Citrate|sildenafil citrate|mesh-list
101628787|NCT00796666|Sitaxsentan|sitaxsentan|mesh-list
101628788|NCT00796666|Vasodilator Agents|vasodilator agents|mesh-ancestor
101628789|NCT00796666|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101628790|NCT00796666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101628791|NCT00796666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628792|NCT00796666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628793|NCT00796666|Urological Agents|urological agents|mesh-ancestor
101628794|NCT00796666|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101628795|NCT00799708|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101628796|NCT00799708|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101628797|NCT00799708|Estradiol|estradiol|mesh-list
101628798|NCT00799708|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101628799|NCT00799708|Estrogens|estrogens|mesh-ancestor
101628800|NCT00799708|Hormones|hormones|mesh-ancestor
101646165|NCT04264286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101628801|NCT00799708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101628802|NCT00799708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628803|NCT00799708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101628804|NCT00799708|Contraceptive Agents|contraceptive agents|mesh-ancestor
101628805|NCT00799708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101628806|NCT00799708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101628807|NCT00796510|Sildenafil Citrate|sildenafil citrate|mesh-list
101628808|NCT00796510|Sitaxsentan|sitaxsentan|mesh-list
101628809|NCT00796510|Vasodilator Agents|vasodilator agents|mesh-ancestor
101628810|NCT00796510|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101628811|NCT00796510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101628812|NCT00796510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628813|NCT00796510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628814|NCT00796510|Urological Agents|urological agents|mesh-ancestor
101628815|NCT00796510|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101628816|NCT04111432|Vaccines|vaccines|mesh-list
101628817|NCT04111432|Immunologic Factors|immunologic factors|mesh-ancestor
101710846|NCT04212845|Dexamethasone|dexamethasone|mesh-list
101628818|NCT04111432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628819|NCT00915070|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
101628820|NCT00915070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101628821|NCT00915070|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101451709|NCT00196469|Anticoagulants|anticoagulants|mesh-ancestor
101628822|NCT00915070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628823|NCT00588640|Methadone|methadone|mesh-list
101628824|NCT00588640|D-methadone|d-methadone|mesh-list
101628825|NCT00588640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101628826|NCT00588640|Narcotics|narcotics|mesh-ancestor
101628827|NCT00588640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101710904|NCT00620789|Dexetimide|dexetimide|mesh-list
101628828|NCT00588640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628829|NCT00588640|Analgesics|analgesics|mesh-ancestor
101628830|NCT00588640|Sensory System Agents|sensory system agents|mesh-ancestor
101628831|NCT00588640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101628832|NCT00588640|Antitussive Agents|antitussive agents|mesh-ancestor
101628833|NCT00588640|Respiratory System Agents|respiratory system agents|mesh-ancestor
101628834|NCT00588640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101628836|NCT01016912|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101628837|NCT01016912|Antimetabolites|antimetabolites|mesh-ancestor
101628838|NCT01016912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628839|NCT01016912|Antiviral Agents|antiviral agents|mesh-ancestor
101628840|NCT01016912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101628841|NCT02604940|Dexmedetomidine|dexmedetomidine|mesh-list
101628842|NCT02604940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101628843|NCT02604940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101628844|NCT02604940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628845|NCT02604940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101628846|NCT02604940|Analgesics|analgesics|mesh-ancestor
101628847|NCT02604940|Sensory System Agents|sensory system agents|mesh-ancestor
101628848|NCT02604940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101628849|NCT02604940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101628850|NCT02604940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101628851|NCT02604940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101628852|NCT02604940|Adrenergic Agents|adrenergic agents|mesh-ancestor
101628853|NCT02604940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101646166|NCT04264286|Adrenergic Agents|adrenergic agents|mesh-ancestor
101628854|NCT02604940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628855|NCT02605798|Sofosbuvir|sofosbuvir|mesh-list
101628856|NCT02605798|Antiviral Agents|antiviral agents|mesh-ancestor
101628857|NCT02605798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101628858|NCT00802672|Ciclopirox|ciclopirox|mesh-list
101628859|NCT00802672|Antifungal Agents|antifungal agents|mesh-ancestor
101628860|NCT00802672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101628861|NCT04113772|Nitisinone|nitisinone|mesh-list
101628862|NCT04113772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628863|NCT04113772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628864|NCT04113928|Mechlorethamine|mechlorethamine|mesh-list
101628865|NCT04113928|Alkylating Agents|alkylating agents|mesh-ancestor
101628866|NCT04113928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628867|NCT04113928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101628868|NCT04113928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101628869|NCT04115800|Sirolimus|sirolimus|mesh-list
101628870|NCT04115800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101628871|NCT04115800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101628872|NCT04115800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101628873|NCT04115800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101628874|NCT04115800|Antifungal Agents|antifungal agents|mesh-ancestor
101628875|NCT04115800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101628876|NCT04115800|Immunologic Factors|immunologic factors|mesh-ancestor
101628877|NCT04115800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628878|NCT04115410|Cisplatin|cisplatin|mesh-list
101628879|NCT04115410|Carboplatin|carboplatin|mesh-list
101628880|NCT04115410|Gemcitabine|gemcitabine|mesh-list
101628881|NCT04115410|Docetaxel|docetaxel|mesh-list
101628882|NCT04115410|Pemetrexed|pemetrexed|mesh-list
101628883|NCT04115410|Vinorelbine|vinorelbine|mesh-list
101628884|NCT04115410|Gefitinib|gefitinib|mesh-list
101628885|NCT04115410|Mitomycins|mitomycins|mesh-list
101628886|NCT04115410|Mitomycin|mitomycin|mesh-list
101628887|NCT04115410|Osimertinib|osimertinib|mesh-list
101628888|NCT04115410|Afatinib|afatinib|mesh-list
101628889|NCT04115410|Vinblastine|vinblastine|mesh-list
101628890|NCT04115410|Crizotinib|crizotinib|mesh-list
101628891|NCT04115410|Ceritinib|ceritinib|mesh-list
101628892|NCT04115410|Antineoplastic Agents|antineoplastic agents|mesh-list
101628893|NCT04115410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101628894|NCT04115410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101628895|NCT04115410|Antimetabolites|antimetabolites|mesh-ancestor
101628896|NCT04115410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628897|NCT04115410|Tubulin Modulators|tubulin modulators|mesh-ancestor
101628898|NCT04115410|Antimitotic Agents|antimitotic agents|mesh-ancestor
101628899|NCT04115410|Mitosis Modulators|mitosis modulators|mesh-ancestor
101628900|NCT04115410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628901|NCT04115410|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101628902|NCT04115410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101628903|NCT04115410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101628904|NCT04115410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101628905|NCT04115410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101628906|NCT04115410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101628907|NCT04115410|Alkylating Agents|alkylating agents|mesh-ancestor
101628908|NCT02604628|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101628909|NCT02604628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101628911|NCT02604784|Doxorubicin|doxorubicin|mesh-list
101628912|NCT02604784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101628913|NCT02604784|Oxaliplatin|oxaliplatin|mesh-list
101628914|NCT02604784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101628915|NCT02604784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101628916|NCT02604784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101628917|NCT02604784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101628918|NCT02604784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628919|NCT02604784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628920|NCT04110808|Phentolamine|phentolamine|mesh-list
101628921|NCT04110808|Antihypertensive Agents|antihypertensive agents|mesh-list
101628922|NCT04110808|Nitroglycerin|nitroglycerin|mesh-list
101628923|NCT04110808|Anesthetics|anesthetics|mesh-list
101628924|NCT04110808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101628925|NCT04110808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628926|NCT04110808|Vasodilator Agents|vasodilator agents|mesh-ancestor
101628927|NCT04110808|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101628928|NCT04110808|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101628929|NCT04110808|Adrenergic Agents|adrenergic agents|mesh-ancestor
101628930|NCT04110808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101628931|NCT04110808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628933|NCT00714259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101628934|NCT00796120|Doxorubicin|doxorubicin|mesh-list
101628935|NCT00796120|Ifosfamide|ifosfamide|mesh-list
101628936|NCT00796120|Trabectedin|trabectedin|mesh-list
101628937|NCT00796120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101628938|NCT00796120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101628939|NCT00796120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101628940|NCT00796120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101628941|NCT00796120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628942|NCT00796120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628943|NCT00796120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101628944|NCT00796120|Alkylating Agents|alkylating agents|mesh-ancestor
101628945|NCT00795886|Sirolimus|sirolimus|mesh-list
101711466|NCT00692120|Vitamin D|vitamin d|mesh-list
101628946|NCT00795886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101628947|NCT00795886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101628948|NCT00795886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101628949|NCT00795886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101628950|NCT00795886|Antifungal Agents|antifungal agents|mesh-ancestor
101628951|NCT00795886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101711540|NCT00681746|Flumazenil|flumazenil|mesh-list
101628952|NCT00795886|Immunologic Factors|immunologic factors|mesh-ancestor
101628953|NCT00795886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628954|NCT04110418|Terlipressin|terlipressin|mesh-list
101628955|NCT04110418|Methylene Blue|methylene blue|mesh-list
101628956|NCT04110418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628957|NCT04110418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628958|NCT04110418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101369123|NCT04631484|Niacin|niacin|mesh-list
101628959|NCT04110418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101628960|NCT04110028|Niacinamide|niacinamide|mesh-list
101628962|NCT04110028|Nicotinic Acids|nicotinic acids|mesh-list
101628963|NCT04110028|Vitamin B Complex|vitamin b complex|mesh-ancestor
101628965|NCT04110028|Micronutrients|micronutrients|mesh-ancestor
101628966|NCT04110028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628967|NCT04110028|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101628968|NCT04110028|Antimetabolites|antimetabolites|mesh-ancestor
101628969|NCT04110028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628970|NCT04110028|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101628971|NCT04110028|Vasodilator Agents|vasodilator agents|mesh-ancestor
101628972|NCT02589457|Tenofovir|tenofovir|mesh-list
101628973|NCT02589457|Antiviral Agents|antiviral agents|mesh-ancestor
101628974|NCT02589457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101628975|NCT02589457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101628976|NCT02589457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101363633|NCT00047021|Analgesics|analgesics|mesh-ancestor
101628977|NCT02589457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628978|NCT02589457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628980|NCT02589457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101628981|NCT00718861|Zoledronic Acid|zoledronic acid|mesh-list
101628982|NCT00718861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101628983|NCT00718861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101628984|NCT05310643|Nivolumab|nivolumab|mesh-list
101628985|NCT05310643|Ipilimumab|ipilimumab|mesh-list
101712022|NCT02625740|Paclitaxel|paclitaxel|mesh-list
101628986|NCT05310643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101628987|NCT05310643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101712093|NCT00689156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101628988|NCT05310643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101628989|NCT05310643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628990|NCT05257213|Heparin|heparin|mesh-list
101628991|NCT05257213|Anticoagulants|anticoagulants|mesh-ancestor
101628992|NCT05257213|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101628993|NCT05257213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101628994|NCT05257213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101628995|NCT00918853|Pancrelipase|pancrelipase|mesh-list
101628996|NCT00918853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101628997|NCT01016600|Lenalidomide|lenalidomide|mesh-list
101628999|NCT01016600|Immunologic Factors|immunologic factors|mesh-ancestor
101629000|NCT01016600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629001|NCT01016600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101629002|NCT01016600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101712307|NCT00695630|Antidotes|antidotes|mesh-ancestor
101629003|NCT01016600|Growth Substances|growth substances|mesh-ancestor
101629004|NCT01016600|Growth Inhibitors|growth inhibitors|mesh-ancestor
101629005|NCT01016600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101629006|NCT01016600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101629007|NCT01016600|Antimetabolites|antimetabolites|mesh-ancestor
101629008|NCT01016600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712385|NCT00690170|Analgesics|analgesics|mesh-ancestor
101629009|NCT01016600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101629011|NCT05175235|Nivolumab|nivolumab|mesh-list
101629012|NCT05175235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101629013|NCT05175235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101629014|NCT05175235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101629015|NCT05175235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629016|NCT04298684|Metformin|metformin|mesh-list
101629017|NCT04298684|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101629018|NCT04298684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101629019|NCT04298684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629020|NCT04298684|Incretins|incretins|mesh-ancestor
101629021|NCT04298684|Hormones|hormones|mesh-ancestor
101629022|NCT04298684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101629023|NCT04298684|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101629024|NCT04298684|Protease Inhibitors|protease inhibitors|mesh-ancestor
101629025|NCT04298684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101629026|NCT04298684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629027|NCT04298372|Lenalidomide|lenalidomide|mesh-list
101629028|NCT04298372|Immunologic Factors|immunologic factors|mesh-ancestor
101629029|NCT04298372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629030|NCT04298372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101629031|NCT04298372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101629032|NCT04298372|Growth Substances|growth substances|mesh-ancestor
101629033|NCT04298372|Growth Inhibitors|growth inhibitors|mesh-ancestor
101629034|NCT04298372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101629035|NCT01010204|Varenicline|varenicline|mesh-list
101629036|NCT01010204|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101629037|NCT01010204|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101629038|NCT01010204|Cholinergic Agents|cholinergic agents|mesh-ancestor
101712579|NCT04134650|Metformin|metformin|mesh-list
101629039|NCT01010204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101629040|NCT01010204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629041|NCT01010204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629042|NCT00718549|Cyclophosphamide|cyclophosphamide|mesh-list
101629044|NCT00718549|Cladribine|cladribine|mesh-list
101629045|NCT00718549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101629046|NCT00718549|Immunologic Factors|immunologic factors|mesh-ancestor
101629047|NCT00718549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629048|NCT00718549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101629049|NCT00718549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101629050|NCT00718549|Alkylating Agents|alkylating agents|mesh-ancestor
101629051|NCT00718549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629052|NCT00718549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101629053|NCT00718549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101629054|NCT00718549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101629055|NCT00793624|Formoterol Fumarate|formoterol fumarate|mesh-list
101629056|NCT00793624|Olodaterol|olodaterol|mesh-list
101629057|NCT00793624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101629058|NCT00793624|Autonomic Agents|autonomic agents|mesh-ancestor
101629059|NCT00793624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101629060|NCT00793624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629061|NCT00793624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101629062|NCT00793624|Respiratory System Agents|respiratory system agents|mesh-ancestor
101629063|NCT00793624|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101712774|NCT02686853|Antifungal Agents|antifungal agents|mesh-ancestor
101629064|NCT00793624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101629065|NCT00793624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101629066|NCT00793624|Adrenergic Agents|adrenergic agents|mesh-ancestor
101629067|NCT00793624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101629068|NCT00793624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629069|NCT00919243|Prednisone|prednisone|mesh-list
101629070|NCT00919243|Allopurinol|allopurinol|mesh-list
101629071|NCT00919243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101629072|NCT00919243|Glucocorticoids|glucocorticoids|mesh-ancestor
101286173|NCT01939509|Bisoprolol|bisoprolol|mesh-list
101629073|NCT00919243|Hormones|hormones|mesh-ancestor
101629074|NCT00919243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101629075|NCT00919243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629076|NCT00919243|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101629077|NCT00919243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101629078|NCT00919243|Antimetabolites|antimetabolites|mesh-ancestor
101629079|NCT00919243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629080|NCT00919243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101629081|NCT00919243|Gout Suppressants|gout suppressants|mesh-ancestor
101629082|NCT00919243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101629083|NCT00919243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101629084|NCT00919243|Antioxidants|antioxidants|mesh-ancestor
101629085|NCT00919243|Protective Agents|protective agents|mesh-ancestor
101629086|NCT00794950|Sunitinib|sunitinib|mesh-list
101629087|NCT00794950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101629088|NCT00794950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101629089|NCT00794950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101629090|NCT00794950|Growth Substances|growth substances|mesh-ancestor
101629091|NCT00794950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629092|NCT00794950|Growth Inhibitors|growth inhibitors|mesh-ancestor
101629093|NCT00794950|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101629094|NCT00794950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101629095|NCT00794950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629096|NCT02591173|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
101629097|NCT02591173|Angiotensin II|angiotensin ii|mesh-list
101629098|NCT02591173|Angiotensinogen|angiotensinogen|mesh-list
101629099|NCT02591173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101629100|NCT02591173|Vasodilator Agents|vasodilator agents|mesh-ancestor
101629101|NCT02591173|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101629102|NCT02591173|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101629103|NCT02591173|Protease Inhibitors|protease inhibitors|mesh-ancestor
101629104|NCT02591173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101629105|NCT02591173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629106|NCT00793546|Exemestane|exemestane|mesh-list
101629107|NCT00793546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101629108|NCT00793546|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101629109|NCT00793546|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101629110|NCT00793546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101629111|NCT00793546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629112|NCT00793546|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101629113|NCT00793546|Hormone Antagonists|hormone antagonists|mesh-ancestor
101629114|NCT00793546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101629115|NCT00793546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629116|NCT02604238|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101713098|NCT00847626|Chlorthalidone|chlorthalidone|mesh-list
101629117|NCT02604238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101629118|NCT02604238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101629119|NCT02604238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629121|NCT00798694|Latanoprost|latanoprost|mesh-list
101629122|NCT00798694|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101629123|NCT00798694|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101629124|NCT00798694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101629125|NCT00718315|Erythromycin|erythromycin|mesh-list
101629126|NCT00718315|Erythromycin Estolate|erythromycin estolate|mesh-list
101629127|NCT00718315|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101629128|NCT00718315|Erythromycin stearate|erythromycin stearate|mesh-list
101629130|NCT00718315|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101629131|NCT00718315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101629132|NCT00718315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101629133|NCT00718315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101629134|NCT00718315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629135|NCT00718315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101629136|NCT00718315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101629137|NCT00718315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101629138|NCT00718315|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101629139|NCT00798304|Vaccines|vaccines|mesh-list
101629140|NCT00798304|Immunologic Factors|immunologic factors|mesh-ancestor
101629141|NCT00798304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629142|NCT04109872|Lenalidomide|lenalidomide|mesh-list
101629143|NCT04109872|Immunologic Factors|immunologic factors|mesh-ancestor
101629144|NCT04109872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629145|NCT04109872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101629146|NCT04109872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101629147|NCT04109872|Growth Substances|growth substances|mesh-ancestor
101629148|NCT04109872|Growth Inhibitors|growth inhibitors|mesh-ancestor
101629149|NCT04109872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101629150|NCT00793780|Naltrexone|naltrexone|mesh-list
101629151|NCT00793780|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101629152|NCT00793780|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101629153|NCT00793780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629154|NCT00793780|Sensory System Agents|sensory system agents|mesh-ancestor
101629155|NCT00793780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101629156|NCT04107220|Valsartan|valsartan|mesh-list
101629157|NCT04107220|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101629158|NCT04107220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101629159|NCT04107220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101629160|NCT04107220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101629161|NCT04107220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629162|NCT02591017|Ketamine|ketamine|mesh-list
101629163|NCT02591017|Morphine|morphine|mesh-list
101629164|NCT02591017|Chitosan|chitosan|mesh-list
101629165|NCT02591017|Analgesics|analgesics|mesh-ancestor
101629166|NCT02591017|Sensory System Agents|sensory system agents|mesh-ancestor
101629167|NCT02591017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101629168|NCT02591017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629169|NCT02591017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101629170|NCT02591017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101629171|NCT02591017|Anesthetics, General|anesthetics, general|mesh-ancestor
101629172|NCT02591017|Anesthetics|anesthetics|mesh-ancestor
101629173|NCT02591017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101629174|NCT02591017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101629175|NCT02591017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101629176|NCT02591017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101629177|NCT02591017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629178|NCT02591017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101629180|NCT02591017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101629181|NCT02591017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101629182|NCT02591017|Antimetabolites|antimetabolites|mesh-ancestor
101629183|NCT02591017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101629184|NCT02591017|Chelating Agents|chelating agents|mesh-ancestor
101629185|NCT02591017|Sequestering Agents|sequestering agents|mesh-ancestor
101629186|NCT02591017|Hemostatics|hemostatics|mesh-ancestor
101629187|NCT02591017|Coagulants|coagulants|mesh-ancestor
101713937|NCT00699530|Cabergoline|cabergoline|mesh-list
101629189|NCT02591095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101629190|NCT02588755|Chlorotrianisene|chlorotrianisene|mesh-list
101629191|NCT02588755|Tegafur|tegafur|mesh-list
101629192|NCT02588755|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101629193|NCT02588755|Estrogens|estrogens|mesh-ancestor
101629194|NCT02588755|Hormones|hormones|mesh-ancestor
101629195|NCT02588755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101629196|NCT02588755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629197|NCT02588755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101629198|NCT02588755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101629199|NCT02588755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101629200|NCT02588755|Antimetabolites|antimetabolites|mesh-ancestor
101629201|NCT02588755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629202|NCT00919321|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101629203|NCT00919321|Immunologic Factors|immunologic factors|mesh-ancestor
101629204|NCT00919321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629205|NCT02643303|Durvalumab|durvalumab|mesh-list
101629206|NCT02643303|Tremelimumab|tremelimumab|mesh-list
101629208|NCT02643303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101629209|NCT02643303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101629210|NCT02643303|Interferon Inducers|interferon inducers|mesh-ancestor
101629211|NCT02643303|Immunologic Factors|immunologic factors|mesh-ancestor
101629212|NCT02643303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629213|NCT00615147|Fibrin fragment D|fibrin fragment d|mesh-list
101629214|NCT00615147|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101629215|NCT00615147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101629216|NCT00615147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629217|NCT00615147|Hemostatics|hemostatics|mesh-ancestor
101629218|NCT00615147|Coagulants|coagulants|mesh-ancestor
101629219|NCT01029717|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101629220|NCT01029717|Minocycline|minocycline|mesh-list
101629221|NCT01029717|Rifampin|rifampin|mesh-list
101629222|NCT01029717|Heparin|heparin|mesh-list
101629223|NCT01029717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101629224|NCT01029717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101629226|NCT01029717|Anticoagulants|anticoagulants|mesh-ancestor
101629227|NCT01029717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101629228|NCT01029717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101629229|NCT01029717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629230|NCT01029717|Leprostatic Agents|leprostatic agents|mesh-ancestor
101629231|NCT01029717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101629232|NCT01029717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101629233|NCT01029717|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101714450|NCT02678975|Copper|copper|mesh-list
101629234|NCT01029717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101629235|NCT01029717|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101629236|NCT01029717|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101629237|NCT01029717|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101629238|NCT01029717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101629240|NCT00790036|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101714498|NCT04181489|Hormones|hormones|mesh-ancestor
101629241|NCT00790036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101629242|NCT00790036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101629243|NCT00790036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629244|NCT00790036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101629245|NCT00790036|Immunologic Factors|immunologic factors|mesh-ancestor
101629246|NCT00790036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714558|NCT00642551|Vitamin K|vitamin k|mesh-list
101629247|NCT00790036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101629248|NCT05563168|Diltiazem|diltiazem|mesh-list
101629249|NCT05563168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101629250|NCT05563168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101629251|NCT05563168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101629252|NCT05563168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629253|NCT05563168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101629254|NCT05563168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372117|NCT00194935|Topotecan|topotecan|mesh-list
101629255|NCT05563168|Vasodilator Agents|vasodilator agents|mesh-ancestor
101629256|NCT00789958|Gemcitabine|gemcitabine|mesh-list
101629257|NCT00789958|Capecitabine|capecitabine|mesh-list
101629258|NCT00789958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101629259|NCT00789958|Antimetabolites|antimetabolites|mesh-ancestor
101629260|NCT00789958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629261|NCT00789958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101629262|NCT00789880|Vitamin D|vitamin d|mesh-list
101629263|NCT00789880|Ergocalciferols|ergocalciferols|mesh-list
101629264|NCT00789880|Cholecalciferol|cholecalciferol|mesh-list
101629265|NCT00789880|Vitamins|vitamins|mesh-list
101629266|NCT00789880|Micronutrients|micronutrients|mesh-ancestor
101629267|NCT00789880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629268|NCT00789880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101629269|NCT00789880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101629271|NCT00915616|Antioxidants|antioxidants|mesh-ancestor
101629272|NCT00915616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629273|NCT00915616|Protective Agents|protective agents|mesh-ancestor
101629274|NCT00915616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629275|NCT00915616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101629276|NCT00914836|Betamethasone|betamethasone|mesh-list
101629277|NCT00914836|Betamethasone Valerate|betamethasone valerate|mesh-list
101629278|NCT00914836|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101629279|NCT00914836|Betamethasone benzoate|betamethasone benzoate|mesh-list
101629280|NCT00914836|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
101629281|NCT00914836|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101629282|NCT00914836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101629283|NCT00914836|Glucocorticoids|glucocorticoids|mesh-ancestor
101629284|NCT00914836|Hormones|hormones|mesh-ancestor
101629285|NCT00914836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101629286|NCT00914836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629287|NCT00914836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101629288|NCT00914836|Respiratory System Agents|respiratory system agents|mesh-ancestor
101629290|NCT04106752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101629291|NCT04106752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629292|NCT04106752|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101629293|NCT04106752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101646167|NCT04264286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101629294|NCT04106752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286400|NCT01940718|Testosterone enanthate|testosterone enanthate|mesh-list
101629295|NCT04106752|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101629296|NCT04106752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101629297|NCT04106752|Purinergic Agents|purinergic agents|mesh-ancestor
101629298|NCT04106752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101629299|NCT00792298|Suvorexant|suvorexant|mesh-list
101629300|NCT00792298|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101629301|NCT00792298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101629302|NCT00792298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101629303|NCT00792298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629304|NCT00792298|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
101629305|NCT00792298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101629306|NCT00792298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629308|NCT04108468|Methotrexate|methotrexate|mesh-list
101629309|NCT04108468|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101629310|NCT04108468|Abortifacient Agents|abortifacient agents|mesh-ancestor
101629311|NCT04108468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101629312|NCT04108468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629313|NCT04108468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101629314|NCT04108468|Antimetabolites|antimetabolites|mesh-ancestor
101629315|NCT04108468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629316|NCT04108468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101629317|NCT04108468|Dermatologic Agents|dermatologic agents|mesh-ancestor
101629318|NCT04108468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101629319|NCT04108468|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101629320|NCT04108468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101629321|NCT04108468|Immunologic Factors|immunologic factors|mesh-ancestor
101629322|NCT04108468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101629323|NCT04108468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101629324|NCT04108468|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101629325|NCT04108468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101629326|NCT02603068|Treprostinil|treprostinil|mesh-list
101629327|NCT02603068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101629328|NCT00718081|Sufentanil|sufentanil|mesh-list
101629329|NCT00718081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101629330|NCT00718081|Narcotics|narcotics|mesh-ancestor
101629331|NCT00718081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101629332|NCT00718081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629333|NCT00718081|Analgesics|analgesics|mesh-ancestor
101629334|NCT00718081|Sensory System Agents|sensory system agents|mesh-ancestor
101629335|NCT00718081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101629337|NCT00718081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101629338|NCT00718081|Anesthetics, General|anesthetics, general|mesh-ancestor
101629339|NCT00718081|Anesthetics|anesthetics|mesh-ancestor
101629340|NCT00788710|Etoricoxib|etoricoxib|mesh-list
101629341|NCT00788710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101629342|NCT00788710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101629344|NCT00788710|Sensory System Agents|sensory system agents|mesh-ancestor
101629345|NCT00788710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101629346|NCT00788710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629347|NCT00788710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101629348|NCT00788710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101629349|NCT00788710|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101629350|NCT00788710|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101629351|NCT00788710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101629352|NCT00788710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629353|NCT04084093|Pulmonary Surfactants|pulmonary surfactants|mesh-list
101629354|NCT04084093|Respiratory System Agents|respiratory system agents|mesh-ancestor
101629356|NCT04083625|Oxytocics|oxytocics|mesh-ancestor
101629357|NCT04083625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101629358|NCT04083625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629359|NCT00787930|Valproic Acid|valproic acid|mesh-list
101629360|NCT00787930|Anticonvulsants|anticonvulsants|mesh-ancestor
101629361|NCT00787930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101629362|NCT00787930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629363|NCT00787930|GABA Agents|gaba agents|mesh-ancestor
101629364|NCT00787930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101629365|NCT00787930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629366|NCT00787930|Antimanic Agents|antimanic agents|mesh-ancestor
101629367|NCT00787930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101629368|NCT00787930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101629369|NCT00787930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101629370|NCT04106050|Lidocaine|lidocaine|mesh-list
101629371|NCT04106050|Anesthetics, Local|anesthetics, local|mesh-ancestor
101629372|NCT04106050|Anesthetics|anesthetics|mesh-ancestor
101629373|NCT04106050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101629375|NCT04106050|Sensory System Agents|sensory system agents|mesh-ancestor
101629376|NCT04106050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101629377|NCT04106050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101629378|NCT04106050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101629379|NCT04106050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101629380|NCT04106050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101629381|NCT04106050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629382|NCT00588094|Rituximab|rituximab|mesh-list
101629383|NCT00588094|Carboplatin|carboplatin|mesh-list
101629384|NCT00588094|Etoposide|etoposide|mesh-list
101629385|NCT00588094|Ifosfamide|ifosfamide|mesh-list
101629386|NCT00588094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101629387|NCT00588094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101629388|NCT00588094|Immunologic Factors|immunologic factors|mesh-ancestor
101629389|NCT00588094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629390|NCT00588094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101629391|NCT00588094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101629392|NCT00588094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101715568|NCT00650039|Valdecoxib|valdecoxib|mesh-list
101629393|NCT00588094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101629394|NCT00588094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101629395|NCT00588094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629396|NCT00588094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101629397|NCT00588094|Alkylating Agents|alkylating agents|mesh-ancestor
101629398|NCT03373383|Padsevonil|padsevonil|mesh-list
101629399|NCT03373383|Anticonvulsants|anticonvulsants|mesh-ancestor
101629400|NCT02605252|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101629401|NCT02605252|Antiviral Agents|antiviral agents|mesh-ancestor
101629402|NCT02605252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101629403|NCT00482157|Vitamin D|vitamin d|mesh-list
101629404|NCT00482157|Calcitriol|calcitriol|mesh-list
101629405|NCT00482157|Vitamins|vitamins|mesh-ancestor
101629406|NCT00482157|Micronutrients|micronutrients|mesh-ancestor
101629407|NCT00482157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629408|NCT00482157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101629409|NCT00482157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101629410|NCT00482157|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101629411|NCT00482157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101629412|NCT00482157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629413|NCT00482157|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101629414|NCT02706015|Dipyrone|dipyrone|mesh-list
101629415|NCT02706015|Dihydroergotamine|dihydroergotamine|mesh-list
101629416|NCT02706015|Caffeine|caffeine|mesh-list
101629417|NCT02706015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101629418|NCT02706015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629419|NCT02706015|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101363639|NCT00133627|Ketotifen|ketotifen|mesh-list
101629420|NCT02706015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101629421|NCT02706015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629422|NCT02706015|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101629423|NCT02706015|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101629424|NCT02706015|Purinergic Agents|purinergic agents|mesh-ancestor
101629425|NCT02706015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101629426|NCT02706015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101629427|NCT02706015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101629428|NCT02706015|Analgesics|analgesics|mesh-ancestor
101629429|NCT02706015|Sensory System Agents|sensory system agents|mesh-ancestor
101629430|NCT02706015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101629431|NCT02706015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101629432|NCT02706015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101629433|NCT02706015|Antipyretics|antipyretics|mesh-ancestor
101629434|NCT02706015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101629435|NCT02706015|Dopamine Agonists|dopamine agonists|mesh-ancestor
101629436|NCT02706015|Dopamine Agents|dopamine agents|mesh-ancestor
101629437|NCT02707575|Ranibizumab|ranibizumab|mesh-list
101629438|NCT02707575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101715707|NCT02654093|Vitamins|vitamins|mesh-ancestor
101629439|NCT02707575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101629440|NCT02707575|Growth Substances|growth substances|mesh-ancestor
101715771|NCT00600821|Bevacizumab|bevacizumab|mesh-list
101629441|NCT02707575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629442|NCT02707575|Growth Inhibitors|growth inhibitors|mesh-ancestor
101629443|NCT02707575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101629444|NCT00919399|Tamoxifen|tamoxifen|mesh-list
101629445|NCT00919399|Exemestane|exemestane|mesh-list
101629446|NCT00919399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101629447|NCT00919399|Hormone Antagonists|hormone antagonists|mesh-ancestor
101629448|NCT00919399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101629449|NCT00919399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629450|NCT00919399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101629451|NCT00919399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101629452|NCT00919399|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101629453|NCT00919399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101629454|NCT00919399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101629455|NCT00919399|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101629456|NCT00919399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101629457|NCT00919399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101715981|NCT02661347|Risperidone|risperidone|mesh-list
101629458|NCT00919399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629459|NCT00784654|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101629460|NCT00784654|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101629461|NCT00784654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629462|NCT00784654|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101629463|NCT00784654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101629464|NCT00784654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101629465|NCT00784654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629466|NCT00784654|Dopamine Agents|dopamine agents|mesh-ancestor
101629467|NCT00784654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101629468|NCT02588287|Tenofovir|tenofovir|mesh-list
101629469|NCT02588287|Antiviral Agents|antiviral agents|mesh-ancestor
101629470|NCT02588287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101629471|NCT02588287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101629472|NCT02588287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101629473|NCT02588287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101629474|NCT02588287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629475|NCT02588287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101629476|NCT02588287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101629477|NCT02707107|Cefepime-zidebactam|cefepime-zidebactam|mesh-list
101629478|NCT02707107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101629479|NCT02707107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101629481|NCT02707263|Calcium heparin|calcium heparin|mesh-list
101629482|NCT02707263|Anticoagulants|anticoagulants|mesh-ancestor
101629483|NCT02707263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101629484|NCT02707263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101629485|NCT02707263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629487|NCT02705547|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101629489|NCT02705547|Antimetabolites|antimetabolites|mesh-ancestor
101629490|NCT02705547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716393|NCT02649413|Prednisone|prednisone|mesh-list
101629491|NCT02705547|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101629492|NCT02705547|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101629493|NCT02705547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101629494|NCT00615303|Simethicone|simethicone|mesh-list
101629495|NCT00615303|Antifoaming Agents|antifoaming agents|mesh-ancestor
101629496|NCT00615303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629497|NCT00615303|Emollients|emollients|mesh-ancestor
101629498|NCT00615303|Dermatologic Agents|dermatologic agents|mesh-ancestor
101629499|NCT00787150|Warfarin|warfarin|mesh-list
101629500|NCT00787150|Apixaban|apixaban|mesh-list
101629501|NCT00787150|Anticoagulants|anticoagulants|mesh-ancestor
101629502|NCT00787150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101629503|NCT00787150|Antithrombins|antithrombins|mesh-ancestor
101629504|NCT00787150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101629505|NCT00787150|Protease Inhibitors|protease inhibitors|mesh-ancestor
101629506|NCT00787150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101629507|NCT00787150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629508|NCT03606837|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101629509|NCT03606837|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101629510|NCT03606837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629512|NCT02705313|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101629513|NCT02705313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629514|NCT00786838|Trabectedin|trabectedin|mesh-list
101629515|NCT00786838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101629516|NCT00786838|Alkylating Agents|alkylating agents|mesh-ancestor
101629517|NCT00786838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629518|NCT00786838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101629520|NCT02604004|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101629521|NCT02604004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101629522|NCT02604004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101629523|NCT02604004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629524|NCT02604004|Antiviral Agents|antiviral agents|mesh-ancestor
101716602|NCT00653315|Tramadol|tramadol|mesh-list
101629525|NCT02604004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101629526|NCT02604004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101629527|NCT02604004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101629528|NCT05095207|Bicalutamide|bicalutamide|mesh-list
101629529|NCT05095207|Androgen Antagonists|androgen antagonists|mesh-ancestor
101629530|NCT05095207|Hormone Antagonists|hormone antagonists|mesh-ancestor
101646168|NCT04264286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629531|NCT05095207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101629532|NCT05095207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629533|NCT05095207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101629535|NCT03354039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101629536|NCT03354039|Hormone Antagonists|hormone antagonists|mesh-ancestor
101629537|NCT03354039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101629538|NCT03354039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629539|NCT03354039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101629540|NCT03354039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101629541|NCT03354039|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101629542|NCT03354039|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101629543|NCT03354039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101629544|NCT04105426|Antioxidants|antioxidants|mesh-list
101629545|NCT04105426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629546|NCT04105426|Protective Agents|protective agents|mesh-ancestor
101629547|NCT04105426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629548|NCT02704923|Atropine|atropine|mesh-list
101629549|NCT02704923|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101717013|NCT00742144|Ofatumumab|ofatumumab|mesh-list
101629550|NCT02704923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101629551|NCT02704923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101629552|NCT02704923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101629553|NCT02704923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101629554|NCT02704923|Autonomic Agents|autonomic agents|mesh-ancestor
101629555|NCT02704923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101717079|NCT00703638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101629556|NCT02704923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629557|NCT02704923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101363644|NCT00133627|Histamine Agents|histamine agents|mesh-ancestor
101629558|NCT02704923|Respiratory System Agents|respiratory system agents|mesh-ancestor
101629559|NCT02704923|Mydriatics|mydriatics|mesh-ancestor
101629560|NCT02704923|Parasympatholytics|parasympatholytics|mesh-ancestor
101629561|NCT02704923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101629562|NCT02704923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101629563|NCT02704923|Cholinergic Agents|cholinergic agents|mesh-ancestor
101629564|NCT02704923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101717150|NCT02118467|Mydriatics|mydriatics|mesh-ancestor
101629565|NCT02704923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629567|NCT04815967|Botulinum Toxins|botulinum toxins|mesh-list
101629568|NCT04815967|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101629569|NCT04815967|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101717216|NCT04057300|Ticagrelor|ticagrelor|mesh-list
101629570|NCT04815967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101629571|NCT04815967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101629572|NCT04815967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717294|NCT04163471|Hemostatics|hemostatics|mesh-list
101629573|NCT04815967|Cholinergic Agents|cholinergic agents|mesh-ancestor
101629574|NCT04815967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101207995|NCT03200015|Metformin|metformin|mesh-list
101629575|NCT04815967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629577|NCT04815967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101629578|NCT04815967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101629579|NCT02704767|Apatinib|apatinib|mesh-list
101629580|NCT02704767|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101629583|NCT02704767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101629584|NCT02704767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629585|NCT02587273|Fentanyl|fentanyl|mesh-list
101629586|NCT02587273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101629587|NCT02587273|Narcotics|narcotics|mesh-ancestor
101629588|NCT02587273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101629589|NCT02587273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629590|NCT02587273|Analgesics|analgesics|mesh-ancestor
101629591|NCT02587273|Sensory System Agents|sensory system agents|mesh-ancestor
101629592|NCT02587273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101629593|NCT02587273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101629594|NCT02587273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101629595|NCT02587273|Anesthetics, General|anesthetics, general|mesh-ancestor
101629597|NCT02704299|Immunomodulating Agents|immunomodulating agents|mesh-list
101629598|NCT02704299|Immunologic Factors|immunologic factors|mesh-ancestor
101629599|NCT02704299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629600|NCT02587741|Metformin|metformin|mesh-list
101629601|NCT02587741|Acarbose|acarbose|mesh-list
101629602|NCT02587741|Gliclazide|gliclazide|mesh-list
101629603|NCT02587741|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101629604|NCT02587741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101629605|NCT02587741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717640|NCT04162535|Lidocaine|lidocaine|mesh-list
101629606|NCT02587741|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101629607|NCT02587741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101629608|NCT02587741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629609|NCT02703363|Minocycline|minocycline|mesh-list
101629611|NCT02703363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101629612|NCT02703363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101629613|NCT02703363|Analgesics|analgesics|mesh-ancestor
101629614|NCT02703363|Sensory System Agents|sensory system agents|mesh-ancestor
101629615|NCT02703363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101629616|NCT02703363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629617|NCT02703363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101629618|NCT02703363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101629619|NCT02703363|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101629620|NCT02703363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101629621|NCT02703363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101629622|NCT02703363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629623|NCT02703363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101629624|NCT02703363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101629625|NCT05018221|Vitamins|vitamins|mesh-list
101629626|NCT05018221|Vitamin K|vitamin k|mesh-list
101629627|NCT05018221|Vitamin K 1|vitamin k 1|mesh-list
101629628|NCT05018221|Sodium thiosulfate|sodium thiosulfate|mesh-list
101629629|NCT05018221|Magnesium citrate|magnesium citrate|mesh-list
101629630|NCT05018221|Citric Acid|citric acid|mesh-list
101629631|NCT05018221|Sodium Citrate|sodium citrate|mesh-list
101629632|NCT05018221|Micronutrients|micronutrients|mesh-ancestor
101629633|NCT05018221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717835|NCT05862064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717836|NCT05862064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101717837|NCT05862064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101717838|NCT05862064|Alkylating Agents|alkylating agents|mesh-ancestor
101717839|NCT05862064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101717840|NCT05862064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101717841|NCT05862064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101717842|NCT05862064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101629634|NCT05018221|Anticoagulants|anticoagulants|mesh-ancestor
101629635|NCT05018221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101629636|NCT05018221|Chelating Agents|chelating agents|mesh-ancestor
101629637|NCT05018221|Sequestering Agents|sequestering agents|mesh-ancestor
101629638|NCT05018221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629639|NCT05018221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101629640|NCT05018221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101629641|NCT05018221|Hemostatics|hemostatics|mesh-ancestor
101629642|NCT05018221|Coagulants|coagulants|mesh-ancestor
101629643|NCT05018221|Antidotes|antidotes|mesh-ancestor
101629644|NCT05018221|Protective Agents|protective agents|mesh-ancestor
101629645|NCT05018221|Antioxidants|antioxidants|mesh-ancestor
101629646|NCT05018221|Antitubercular Agents|antitubercular agents|mesh-ancestor
101629648|NCT05018221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101629649|NCT05018221|Cathartics|cathartics|mesh-ancestor
101629650|NCT05018221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101629651|NCT00615381|Insulin|insulin|mesh-list
101629652|NCT00615381|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101629653|NCT00615381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101629654|NCT00615381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629655|NCT00785980|Ciprofloxacin|ciprofloxacin|mesh-list
101629656|NCT00785980|Quinine|quinine|mesh-list
101629657|NCT00785980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101629658|NCT00785980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101629659|NCT00785980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101629660|NCT00785980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101629662|NCT00785980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629663|NCT00785980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101629664|NCT00785980|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101629665|NCT00785980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101629666|NCT00785980|Antimalarials|antimalarials|mesh-ancestor
101629667|NCT00785980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101629668|NCT00785980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101629669|NCT00785980|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101718253|NCT04634799|Plasminogen Inactivators|plasminogen inactivators|mesh-list
101629670|NCT00785980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629671|NCT00785980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101629672|NCT00785980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101629673|NCT00785980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101629674|NCT00785980|Analgesics|analgesics|mesh-ancestor
101629675|NCT00785980|Sensory System Agents|sensory system agents|mesh-ancestor
101629676|NCT04805073|Promethazine|promethazine|mesh-list
101629677|NCT04805073|Diphenhydramine|diphenhydramine|mesh-list
101629678|NCT04805073|Antipruritics|antipruritics|mesh-ancestor
101629679|NCT04805073|Dermatologic Agents|dermatologic agents|mesh-ancestor
101629680|NCT04805073|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101629681|NCT04805073|Histamine Antagonists|histamine antagonists|mesh-ancestor
101629682|NCT04805073|Histamine Agents|histamine agents|mesh-ancestor
101629683|NCT04805073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101629684|NCT04805073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629685|NCT04805073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629686|NCT04805073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101629687|NCT04805073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101629688|NCT04805073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101629689|NCT04805073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101629690|NCT04805073|Anesthetics, Local|anesthetics, local|mesh-ancestor
101718459|NCT03950674|Hormones|hormones|mesh-ancestor
101629691|NCT04805073|Anesthetics|anesthetics|mesh-ancestor
101629692|NCT04805073|Sensory System Agents|sensory system agents|mesh-ancestor
101629693|NCT04805073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101629694|NCT04805073|Antiemetics|antiemetics|mesh-ancestor
101629695|NCT04805073|Autonomic Agents|autonomic agents|mesh-ancestor
101629696|NCT04805073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101629697|NCT00915694|Nelfinavir|nelfinavir|mesh-list
101629698|NCT00915694|Temozolomide|temozolomide|mesh-list
101629699|NCT00915694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101629700|NCT00915694|Alkylating Agents|alkylating agents|mesh-ancestor
101629701|NCT00915694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629702|NCT00915694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101629703|NCT00915694|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101629704|NCT00915694|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101629705|NCT00915694|Protease Inhibitors|protease inhibitors|mesh-ancestor
101629706|NCT00915694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101629707|NCT00915694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101629708|NCT00915694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101629709|NCT00915694|Antiviral Agents|antiviral agents|mesh-ancestor
101629710|NCT00915694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101629712|NCT02703051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101629713|NCT02703051|Immunologic Factors|immunologic factors|mesh-ancestor
101629714|NCT02703051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629715|NCT00785512|Nebivolol|nebivolol|mesh-list
101629716|NCT00785512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101629717|NCT00785512|Vasodilator Agents|vasodilator agents|mesh-ancestor
101629718|NCT00785512|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101629719|NCT00785512|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101629720|NCT00785512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101629721|NCT00785512|Adrenergic Agents|adrenergic agents|mesh-ancestor
101629722|NCT00785512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101629723|NCT00785512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629724|NCT00785512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629725|NCT02702817|Naproxen|naproxen|mesh-list
101629726|NCT02702817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101629727|NCT02702817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101629728|NCT02702817|Analgesics|analgesics|mesh-ancestor
101629729|NCT02702817|Sensory System Agents|sensory system agents|mesh-ancestor
101629730|NCT02702817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101629731|NCT02702817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718657|NCT02964559|Pembrolizumab|pembrolizumab|mesh-list
101629732|NCT02702817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101629733|NCT02702817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101629735|NCT02702817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101629736|NCT02702817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101629737|NCT02702817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629738|NCT02702739|Ribavirin|ribavirin|mesh-list
101629739|NCT02702739|Sofosbuvir|sofosbuvir|mesh-list
101629740|NCT02702739|Simeprevir|simeprevir|mesh-list
101629741|NCT02702739|Antimetabolites|antimetabolites|mesh-ancestor
101629742|NCT02702739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629743|NCT02702739|Antiviral Agents|antiviral agents|mesh-ancestor
101629744|NCT02702739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101629745|NCT02702739|Protease Inhibitors|protease inhibitors|mesh-ancestor
101629746|NCT02702739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101629747|NCT02602444|Ticagrelor|ticagrelor|mesh-list
101629748|NCT02602444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101629749|NCT02602444|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101629750|NCT02602444|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101629751|NCT02602444|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101629752|NCT02602444|Purinergic Agents|purinergic agents|mesh-ancestor
101629753|NCT02602444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101629754|NCT02602444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629755|NCT02602444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629756|NCT02702661|Anesthetics|anesthetics|mesh-list
101629757|NCT02702661|Levobupivacaine|levobupivacaine|mesh-list
101629758|NCT02702661|Anesthetics, Local|anesthetics, local|mesh-list
101629759|NCT02702661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101629760|NCT02702661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629761|NCT02702661|Sensory System Agents|sensory system agents|mesh-ancestor
101629762|NCT02702661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101629763|NCT02702349|Penicillins|penicillins|mesh-list
101629764|NCT02702349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101629765|NCT02702349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101629766|NCT04104334|Remifentanil|remifentanil|mesh-list
101629767|NCT04104334|Desflurane|desflurane|mesh-list
101629769|NCT04104334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101629770|NCT04104334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629771|NCT04104334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101629772|NCT04104334|Narcotics|narcotics|mesh-ancestor
101629773|NCT04104334|Analgesics|analgesics|mesh-ancestor
101629774|NCT04104334|Sensory System Agents|sensory system agents|mesh-ancestor
101629775|NCT04104334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101629776|NCT04104334|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101629777|NCT04104334|Anesthetics, General|anesthetics, general|mesh-ancestor
101629778|NCT04215393|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101629779|NCT04215393|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101629780|NCT02602600|Liraglutide|liraglutide|mesh-list
101629781|NCT02602600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101629782|NCT02602600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629783|NCT02602600|Incretins|incretins|mesh-ancestor
101629784|NCT02602600|Hormones|hormones|mesh-ancestor
101629785|NCT02602600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101629786|NCT00615615|Levetiracetam|levetiracetam|mesh-list
101629787|NCT00615615|Anticonvulsants|anticonvulsants|mesh-ancestor
101629788|NCT00615615|Nootropic Agents|nootropic agents|mesh-ancestor
101629789|NCT00784810|Acetaminophen|acetaminophen|mesh-list
101629790|NCT00784810|Oxycodone|oxycodone|mesh-list
101629791|NCT00784810|Codeine|codeine|mesh-list
101629792|NCT00784810|Naloxone|naloxone|mesh-list
101629793|NCT00784810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101629794|NCT00784810|Analgesics|analgesics|mesh-ancestor
101629795|NCT00784810|Sensory System Agents|sensory system agents|mesh-ancestor
101629796|NCT00784810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101451710|NCT00196469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101629797|NCT00784810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629798|NCT00784810|Antipyretics|antipyretics|mesh-ancestor
101629799|NCT00784810|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101629800|NCT00784810|Narcotics|narcotics|mesh-ancestor
101629801|NCT00784810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101629802|NCT00784810|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101718745|NCT02000089|Hormones|hormones|mesh-ancestor
101629803|NCT00784810|Antitussive Agents|antitussive agents|mesh-ancestor
101629804|NCT00784810|Respiratory System Agents|respiratory system agents|mesh-ancestor
101629805|NCT02603770|Lovastatin|lovastatin|mesh-list
101629806|NCT02603770|L 647318|l 647318|mesh-list
101629807|NCT02603770|Dihydromevinolin|dihydromevinolin|mesh-list
101629808|NCT02603770|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101629809|NCT02603770|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101629810|NCT02603770|Antimetabolites|antimetabolites|mesh-ancestor
101629811|NCT02603770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629812|NCT02603770|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101629813|NCT02603770|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101629814|NCT02603770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101629815|NCT04081909|Fentanyl|fentanyl|mesh-list
101629816|NCT04081909|Dexmedetomidine|dexmedetomidine|mesh-list
101629817|NCT04081909|Ketamine|ketamine|mesh-list
101286926|NCT01944033|Terbutaline|terbutaline|mesh-list
101629818|NCT04081909|Remifentanil|remifentanil|mesh-list
101629819|NCT04081909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101629820|NCT04081909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101629821|NCT04081909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629822|NCT04081909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101629823|NCT04081909|Analgesics|analgesics|mesh-ancestor
101629824|NCT04081909|Sensory System Agents|sensory system agents|mesh-ancestor
101629825|NCT04081909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101629826|NCT04081909|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101629827|NCT04081909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101629828|NCT04081909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101629829|NCT04081909|Adrenergic Agents|adrenergic agents|mesh-ancestor
101629830|NCT04081909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101629831|NCT04081909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629832|NCT04081909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101363674|NCT00047099|Docetaxel|docetaxel|mesh-list
101629833|NCT04081909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101629834|NCT04081909|Anesthetics, General|anesthetics, general|mesh-ancestor
101629835|NCT04081909|Anesthetics|anesthetics|mesh-ancestor
101629836|NCT04081909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101629837|NCT04081909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101629838|NCT04081909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101629839|NCT04081909|Narcotics|narcotics|mesh-ancestor
101629840|NCT04081909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101629841|NCT03272217|Bevacizumab|bevacizumab|mesh-list
101629842|NCT03272217|Atezolizumab|atezolizumab|mesh-list
101629843|NCT03272217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101629844|NCT03272217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101629845|NCT03272217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101629846|NCT03272217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101629847|NCT03272217|Growth Substances|growth substances|mesh-ancestor
101629848|NCT03272217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629849|NCT03272217|Growth Inhibitors|growth inhibitors|mesh-ancestor
101629850|NCT03272217|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101629851|NCT03272217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629852|NCT03262701|Hydrogen Peroxide|hydrogen peroxide|mesh-list
101629853|NCT03262701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101629854|NCT03262701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101629855|NCT00915382|Cisplatin|cisplatin|mesh-list
101629856|NCT00915382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101629857|NCT05344443|Lemborexant|lemborexant|mesh-list
101629858|NCT05344443|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
101629859|NCT05344443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101629860|NCT05344443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629861|NCT05344443|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101629862|NCT05344443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101629863|NCT05344443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101629864|NCT05344443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629865|NCT00919555|Pioglitazone|pioglitazone|mesh-list
101629866|NCT00919555|Tretinoin|tretinoin|mesh-list
101629867|NCT00919555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101629868|NCT00919555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629870|NCT00919555|Keratolytic Agents|keratolytic agents|mesh-ancestor
101629871|NCT00919555|Dermatologic Agents|dermatologic agents|mesh-ancestor
101629872|NCT02979093|Oxytocin|oxytocin|mesh-list
101629873|NCT02979093|Oxytocics|oxytocics|mesh-ancestor
101629874|NCT02979093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101629875|NCT02979093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629876|NCT02588131|Durvalumab|durvalumab|mesh-list
101629877|NCT02588131|Tremelimumab|tremelimumab|mesh-list
101629878|NCT02588131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101629879|NCT02588131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101629880|NCT04766983|Dimercaprol|dimercaprol|mesh-list
101629881|NCT04766983|Chelating Agents|chelating agents|mesh-ancestor
101629882|NCT04766983|Sequestering Agents|sequestering agents|mesh-ancestor
101629883|NCT04766983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629884|NCT04766437|Ticagrelor|ticagrelor|mesh-list
101629885|NCT04766437|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101629886|NCT04766437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101629887|NCT04766437|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101629888|NCT04766437|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101629889|NCT04766437|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101629890|NCT04766437|Purinergic Agents|purinergic agents|mesh-ancestor
101629891|NCT04766437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101629892|NCT04766437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629893|NCT04766437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629895|NCT00776230|Immunologic Factors|immunologic factors|mesh-ancestor
101629896|NCT00776230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629897|NCT05561959|Nitroglycerin|nitroglycerin|mesh-list
101629898|NCT05561959|Vasodilator Agents|vasodilator agents|mesh-ancestor
101629899|NCT02586259|Budesonide|budesonide|mesh-list
101629900|NCT02586259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101629901|NCT02586259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101629902|NCT02586259|Autonomic Agents|autonomic agents|mesh-ancestor
101629903|NCT02586259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101629904|NCT02586259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629905|NCT02586259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101629906|NCT02586259|Respiratory System Agents|respiratory system agents|mesh-ancestor
101629907|NCT02586259|Glucocorticoids|glucocorticoids|mesh-ancestor
101629908|NCT02586259|Hormones|hormones|mesh-ancestor
101629909|NCT02586259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101629910|NCT00775606|Ritonavir|ritonavir|mesh-list
101629911|NCT00775606|Lopinavir|lopinavir|mesh-list
101629912|NCT00775606|Efavirenz|efavirenz|mesh-list
101629913|NCT00775606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101629914|NCT00775606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101629915|NCT00775606|Protease Inhibitors|protease inhibitors|mesh-ancestor
101629916|NCT00775606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101629917|NCT00775606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629918|NCT00775606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101629919|NCT00775606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101629920|NCT00775606|Antiviral Agents|antiviral agents|mesh-ancestor
101629921|NCT00775606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101629922|NCT00775606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101629923|NCT00775606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101629924|NCT00775606|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101629925|NCT00775606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101629926|NCT00775606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101629927|NCT00775606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101629928|NCT00775606|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101629929|NCT00775606|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101629930|NCT00775606|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101629931|NCT04761601|Paclitaxel|paclitaxel|mesh-list
101629932|NCT04761601|Gemcitabine|gemcitabine|mesh-list
101629933|NCT04761601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101629934|NCT04761601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101629935|NCT04761601|Tubulin Modulators|tubulin modulators|mesh-ancestor
101629936|NCT04761601|Antimitotic Agents|antimitotic agents|mesh-ancestor
101629937|NCT04761601|Mitosis Modulators|mitosis modulators|mesh-ancestor
101629938|NCT04761601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629939|NCT04761601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101629940|NCT04761601|Antimetabolites|antimetabolites|mesh-ancestor
101629941|NCT02960763|Aripiprazole|aripiprazole|mesh-list
101629942|NCT02960763|Lithium Carbonate|lithium carbonate|mesh-list
101629943|NCT02960763|Bupropion|bupropion|mesh-list
101629944|NCT02960763|Nortriptyline|nortriptyline|mesh-list
101629945|NCT02960763|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101629946|NCT02960763|Antidepressive Agents|antidepressive agents|mesh-ancestor
101629947|NCT02960763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101629948|NCT02960763|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101629949|NCT02960763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101629950|NCT02960763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101629951|NCT02960763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629952|NCT02960763|Dopamine Agents|dopamine agents|mesh-ancestor
101629953|NCT02960763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101629954|NCT02960763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629955|NCT02960763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101629956|NCT02960763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101629957|NCT02960763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101629958|NCT02960763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101629959|NCT02960763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101629960|NCT02960763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101629961|NCT02960763|Dopamine Agonists|dopamine agonists|mesh-ancestor
101629962|NCT02960763|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101629963|NCT02960763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101629964|NCT02960763|Serotonin Agents|serotonin agents|mesh-ancestor
101629965|NCT02960763|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101629966|NCT02960763|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101629967|NCT02960763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101629968|NCT02960763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101287074|NCT01945437|Analgesics|analgesics|mesh-ancestor
101629969|NCT02960763|Antimanic Agents|antimanic agents|mesh-ancestor
101629970|NCT02960763|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101629971|NCT02960763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101629972|NCT02960763|Adrenergic Agents|adrenergic agents|mesh-ancestor
101629973|NCT00775528|Pancrelipase|pancrelipase|mesh-list
101629974|NCT00775528|Pancreatin|pancreatin|mesh-list
101629975|NCT00775528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101629976|NCT04977271|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101629977|NCT04977271|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101629978|NCT04977271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101629979|NCT04977271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101629980|NCT04977271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629981|NCT04977271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101629982|NCT04977271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629983|NCT04977271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101629984|NCT04977271|Antidepressive Agents|antidepressive agents|mesh-ancestor
101629985|NCT04977271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101629986|NCT02701179|Lidocaine|lidocaine|mesh-list
101629987|NCT02701179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101629988|NCT02701179|Anesthetics, Local|anesthetics, local|mesh-ancestor
101629989|NCT02701179|Anesthetics|anesthetics|mesh-ancestor
101629990|NCT02701179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101629991|NCT02701179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101629992|NCT02701179|Sensory System Agents|sensory system agents|mesh-ancestor
101629993|NCT02701179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101629994|NCT02701179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101629995|NCT02701179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101629996|NCT02701179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101629997|NCT02701179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101629998|NCT02701179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101629999|NCT02586961|Betamethasone|betamethasone|mesh-list
101630000|NCT02586961|Betamethasone Valerate|betamethasone valerate|mesh-list
101630001|NCT02586961|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101630002|NCT02586961|Betamethasone benzoate|betamethasone benzoate|mesh-list
101630003|NCT02586961|Epinephrine|epinephrine|mesh-list
101630004|NCT02586961|Racepinephrine|racepinephrine|mesh-list
101630005|NCT02586961|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101630006|NCT02586961|Epinephryl borate|epinephryl borate|mesh-list
101630007|NCT02586961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101630008|NCT02586961|Glucocorticoids|glucocorticoids|mesh-ancestor
101630010|NCT02586961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101630011|NCT02586961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630012|NCT02586961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101630013|NCT02586961|Respiratory System Agents|respiratory system agents|mesh-ancestor
101630014|NCT02586961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101630015|NCT02586961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101630016|NCT02586961|Adrenergic Agents|adrenergic agents|mesh-ancestor
101630017|NCT02586961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101630018|NCT02586961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630019|NCT02586961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101630020|NCT02586961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101630021|NCT02586961|Autonomic Agents|autonomic agents|mesh-ancestor
101630022|NCT02586961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101630023|NCT02586961|Mydriatics|mydriatics|mesh-ancestor
101630024|NCT02586961|Sympathomimetics|sympathomimetics|mesh-ancestor
101630025|NCT02586961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101630026|NCT02700711|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101630027|NCT02700711|Methylphenidate|methylphenidate|mesh-list
101630028|NCT02700711|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101630029|NCT02700711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630030|NCT02700711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101630031|NCT02700711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101630032|NCT02700711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101630033|NCT02700711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630034|NCT02700711|Dopamine Agents|dopamine agents|mesh-ancestor
101630035|NCT02700711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101630036|NCT02700711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101630037|NCT02700711|Analgesics|analgesics|mesh-ancestor
101630038|NCT02700711|Sensory System Agents|sensory system agents|mesh-ancestor
101630039|NCT02700711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101630040|NCT02700711|Antidepressive Agents|antidepressive agents|mesh-ancestor
101630041|NCT02700711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101630042|NCT04215159|Gemcitabine|gemcitabine|mesh-list
101630043|NCT04215159|Trastuzumab|trastuzumab|mesh-list
101630045|NCT04215159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101630046|NCT04215159|Antimetabolites|antimetabolites|mesh-ancestor
101630047|NCT04215159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363690|NCT00047099|Antimetabolites|antimetabolites|mesh-ancestor
101630048|NCT04215159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101630049|NCT04215159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101630050|NCT04215159|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101630051|NCT04215159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101630052|NCT04215159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101630053|NCT00775450|Vaccines|vaccines|mesh-list
101630054|NCT00775450|Immunologic Factors|immunologic factors|mesh-ancestor
101630055|NCT00775450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630056|NCT02700477|Fenugreek seed meal|fenugreek seed meal|mesh-list
101630057|NCT02700477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101630058|NCT02700477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630059|NCT02699385|Domperidone|domperidone|mesh-list
101630060|NCT02699385|Antiemetics|antiemetics|mesh-ancestor
101630061|NCT02699385|Autonomic Agents|autonomic agents|mesh-ancestor
101630062|NCT02699385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101630063|NCT02699385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630064|NCT02699385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101630065|NCT02699385|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101630066|NCT02699385|Dopamine Agents|dopamine agents|mesh-ancestor
101630067|NCT02699385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101630068|NCT02699385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630069|NCT02700087|Famotidine|famotidine|mesh-list
101630070|NCT02700087|Ranitidine|ranitidine|mesh-list
101630071|NCT02700087|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
101630073|NCT02700087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101630074|NCT02700087|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101630075|NCT02700087|Histamine Antagonists|histamine antagonists|mesh-ancestor
101630076|NCT02700087|Histamine Agents|histamine agents|mesh-ancestor
101630077|NCT02700087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101630078|NCT02700087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719126|NCT00911573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101630079|NCT02700087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630080|NCT02586181|Calcium, Dietary|calcium, dietary|mesh-list
101630081|NCT02586181|Vitamin D|vitamin d|mesh-list
101630082|NCT02586181|Ergocalciferols|ergocalciferols|mesh-list
101630083|NCT02586181|Cholecalciferol|cholecalciferol|mesh-list
101630084|NCT02586181|Vitamins|vitamins|mesh-list
101630085|NCT02586181|Folic Acid|folic acid|mesh-list
101630086|NCT02586181|Calcium|calcium|mesh-list
101630087|NCT02586181|Micronutrients|micronutrients|mesh-ancestor
101630088|NCT02586181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630089|NCT02586181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101630090|NCT02586181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101630091|NCT02586181|Vitamin B Complex|vitamin b complex|mesh-ancestor
101630092|NCT02586181|Hematinics|hematinics|mesh-ancestor
101630093|NCT03181035|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
101630094|NCT03181035|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101630095|NCT03181035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630096|NCT00775138|Amikacin|amikacin|mesh-list
101630097|NCT00775138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101630098|NCT00775138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101630099|NCT03236805|Ketamine|ketamine|mesh-list
101630100|NCT03236805|Morphine|morphine|mesh-list
101630101|NCT03236805|Analgesics|analgesics|mesh-ancestor
101630102|NCT03236805|Sensory System Agents|sensory system agents|mesh-ancestor
101630103|NCT03236805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101630104|NCT03236805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630105|NCT03236805|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101630106|NCT03236805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101630107|NCT03236805|Anesthetics, General|anesthetics, general|mesh-ancestor
101630108|NCT03236805|Anesthetics|anesthetics|mesh-ancestor
101630109|NCT03236805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101630110|NCT03236805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101630111|NCT03236805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101630112|NCT03236805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101630113|NCT03236805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630115|NCT03236805|Narcotics|narcotics|mesh-ancestor
101630116|NCT02698995|Acetaminophen|acetaminophen|mesh-list
101630117|NCT02698995|Dexamethasone|dexamethasone|mesh-list
101630118|NCT02698995|Lidocaine|lidocaine|mesh-list
101630119|NCT02698995|Morphine|morphine|mesh-list
101630120|NCT02698995|Ropivacaine|ropivacaine|mesh-list
101630121|NCT02698995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101630122|NCT02698995|Antiemetics|antiemetics|mesh-ancestor
101630123|NCT02698995|Autonomic Agents|autonomic agents|mesh-ancestor
101630124|NCT02698995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101630125|NCT02698995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630126|NCT02698995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101630127|NCT02698995|Glucocorticoids|glucocorticoids|mesh-ancestor
101630128|NCT02698995|Hormones|hormones|mesh-ancestor
101630129|NCT02698995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101630130|NCT02698995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101630131|NCT02698995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101630132|NCT02698995|Anesthetics, Local|anesthetics, local|mesh-ancestor
101630133|NCT02698995|Anesthetics|anesthetics|mesh-ancestor
101630134|NCT02698995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101630135|NCT02698995|Sensory System Agents|sensory system agents|mesh-ancestor
101630136|NCT02698995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101630137|NCT02698995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101719231|NCT00663221|Vitamin D|vitamin d|mesh-list
101630138|NCT02698995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101630139|NCT02698995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101630140|NCT02698995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630141|NCT02698995|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101630143|NCT02698995|Analgesics|analgesics|mesh-ancestor
101630144|NCT02698995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101630145|NCT02698995|Antipyretics|antipyretics|mesh-ancestor
101630146|NCT00920101|Atorvastatin|atorvastatin|mesh-list
101630147|NCT00920101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101630148|NCT00920101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101630149|NCT00920101|Antimetabolites|antimetabolites|mesh-ancestor
101630150|NCT00920101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630151|NCT00920101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101630152|NCT00920101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101630153|NCT00920101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101630155|NCT00616785|Etoposide|etoposide|mesh-list
101630156|NCT00616785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101630157|NCT00616785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101630158|NCT00616785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101630159|NCT00616785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101630160|NCT00616785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630161|NCT00616785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101630162|NCT00616785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101630163|NCT00616005|Irinotecan|irinotecan|mesh-list
101630164|NCT00616005|Temozolomide|temozolomide|mesh-list
101630165|NCT00616005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101630166|NCT00616005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101630167|NCT00616005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101719272|NCT02631239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101630168|NCT00616005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630169|NCT00616005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101630170|NCT00616005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101630171|NCT00616005|Alkylating Agents|alkylating agents|mesh-ancestor
101630172|NCT02698527|Lidocaine|lidocaine|mesh-list
101630173|NCT02698527|Anesthetics, Local|anesthetics, local|mesh-ancestor
101630174|NCT02698527|Anesthetics|anesthetics|mesh-ancestor
101630175|NCT02698527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101630176|NCT02698527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630177|NCT02698527|Sensory System Agents|sensory system agents|mesh-ancestor
101630178|NCT02698527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101630179|NCT02698527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101630180|NCT02698527|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101630181|NCT02698527|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101630182|NCT02698527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101630183|NCT02698527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630185|NCT04215237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101630186|NCT04215237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101630187|NCT04215237|Antimetabolites|antimetabolites|mesh-ancestor
101719326|NCT00669695|Atorvastatin|atorvastatin|mesh-list
101630188|NCT04215237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630189|NCT04215237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101630190|NCT04215237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101630191|NCT04215237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101630193|NCT02586649|Tiotropium Bromide|tiotropium bromide|mesh-list
101630194|NCT02586649|Cholinergic Antagonists|cholinergic antagonists|mesh-list
101630195|NCT02586649|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101630196|NCT02586649|Autonomic Agents|autonomic agents|mesh-ancestor
101630197|NCT02586649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101630198|NCT02586649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630199|NCT02586649|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101630200|NCT02586649|Respiratory System Agents|respiratory system agents|mesh-ancestor
101630201|NCT02586649|Parasympatholytics|parasympatholytics|mesh-ancestor
101630202|NCT02586649|Cholinergic Agents|cholinergic agents|mesh-ancestor
101630203|NCT02586649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101630204|NCT02586649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630205|NCT02586649|Anticonvulsants|anticonvulsants|mesh-ancestor
101630206|NCT04213833|Lidocaine|lidocaine|mesh-list
101630207|NCT04213833|Dexmedetomidine|dexmedetomidine|mesh-list
101630208|NCT04213833|Propofol|propofol|mesh-list
101630209|NCT04213833|Anesthetics, Local|anesthetics, local|mesh-ancestor
101630210|NCT04213833|Anesthetics|anesthetics|mesh-ancestor
101630211|NCT04213833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101630212|NCT04213833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630213|NCT04213833|Sensory System Agents|sensory system agents|mesh-ancestor
101630214|NCT04213833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101630215|NCT04213833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101630216|NCT04213833|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101630217|NCT04213833|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101630218|NCT04213833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101630219|NCT04213833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630220|NCT04213833|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101630221|NCT04213833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101630222|NCT04213833|Analgesics|analgesics|mesh-ancestor
101630223|NCT04213833|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101630224|NCT04213833|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101630225|NCT04213833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101630226|NCT04213833|Adrenergic Agents|adrenergic agents|mesh-ancestor
101630227|NCT04213833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101630228|NCT04213833|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101630229|NCT04213833|Anesthetics, General|anesthetics, general|mesh-ancestor
101630230|NCT04605991|Insulin Glargine|insulin glargine|mesh-list
101630231|NCT04605991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101630232|NCT04605991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630233|NCT00783796|Everolimus|everolimus|mesh-list
101630234|NCT00783796|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101630235|NCT00783796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101630236|NCT00783796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101630237|NCT00783796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630238|NCT00783796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101630239|NCT00783796|Immunologic Factors|immunologic factors|mesh-ancestor
101630240|NCT00783796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630241|NCT00783796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101630242|NCT00637065|Bosentan|bosentan|mesh-list
101630243|NCT00637065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101630244|NCT00637065|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101630245|NCT00637065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630246|NCT00616863|Oxcarbazepine|oxcarbazepine|mesh-list
101630247|NCT00616863|Anticonvulsants|anticonvulsants|mesh-ancestor
101630248|NCT00616863|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101630249|NCT00616863|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101630250|NCT00616863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101630251|NCT00616863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630252|NCT00616863|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101630253|NCT00616863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101630254|NCT04947553|Dextromethorphan|dextromethorphan|mesh-list
101630255|NCT04947553|Bupropion|bupropion|mesh-list
101630256|NCT04947553|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101630257|NCT04947553|Antidepressive Agents|antidepressive agents|mesh-ancestor
101630258|NCT04947553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101630259|NCT04947553|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101630260|NCT04947553|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101630261|NCT04947553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101630262|NCT04947553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630263|NCT04947553|Dopamine Agents|dopamine agents|mesh-ancestor
101630264|NCT04947553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101287374|NCT04411940|Autonomic Agents|autonomic agents|mesh-ancestor
101630265|NCT04947553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630266|NCT04947553|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101630267|NCT04947553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101630268|NCT04947553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101630269|NCT04947553|Antitussive Agents|antitussive agents|mesh-ancestor
101630270|NCT04947553|Respiratory System Agents|respiratory system agents|mesh-ancestor
101630271|NCT04947553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101630272|NCT04947553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101630273|NCT04079647|Immunomodulating Agents|immunomodulating agents|mesh-list
101630274|NCT04079647|Immunologic Factors|immunologic factors|mesh-ancestor
101630275|NCT04079647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630277|NCT00617253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101630278|NCT00617253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101630279|NCT00617253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101630280|NCT00617253|Growth Substances|growth substances|mesh-ancestor
101630281|NCT00617253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630282|NCT00617253|Growth Inhibitors|growth inhibitors|mesh-ancestor
101630283|NCT00617253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101630285|NCT00617253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630286|NCT02585947|Tenofovir|tenofovir|mesh-list
101630287|NCT02585947|Antiviral Agents|antiviral agents|mesh-ancestor
101630288|NCT02585947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101630289|NCT02585947|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101630290|NCT02585947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101630291|NCT02585947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101630292|NCT02585947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630293|NCT02585947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101630294|NCT02585947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101630295|NCT02607891|Cannabidiol|cannabidiol|mesh-list
101630296|NCT02607891|Anticonvulsants|anticonvulsants|mesh-ancestor
101630297|NCT02607813|Spartalizumab|spartalizumab|mesh-list
101630298|NCT02607813|Naporafenib|naporafenib|mesh-list
101630299|NCT02607813|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101630300|NCT02607813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630301|NCT02607813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101630302|NCT02607813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101630303|NCT02607813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101630304|NCT02607813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101630305|NCT04079725|Mitomycins|mitomycins|mesh-list
101630306|NCT04079725|Mitomycin|mitomycin|mesh-list
101630307|NCT04079725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101630308|NCT04079725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101630309|NCT04079725|Alkylating Agents|alkylating agents|mesh-ancestor
101630310|NCT04079725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630311|NCT04079725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101630312|NCT04079725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101630313|NCT00783718|Vedolizumab|vedolizumab|mesh-list
101630314|NCT00783718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101630315|NCT04213287|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
101630316|NCT04213287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630317|NCT04213287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101630318|NCT04213287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101630319|NCT04213287|Analgesics|analgesics|mesh-ancestor
101630320|NCT04213287|Sensory System Agents|sensory system agents|mesh-ancestor
101630321|NCT04213287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101630322|NCT04213287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101630323|NCT04213287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101630324|NCT02585791|Glycerol|glycerol|mesh-list
101630325|NCT02585791|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101630326|NCT02585791|Protective Agents|protective agents|mesh-ancestor
101630327|NCT02585791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630328|NCT04913389|Acetazolamide|acetazolamide|mesh-list
101630329|NCT04913389|Anticonvulsants|anticonvulsants|mesh-ancestor
101630330|NCT04913389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101630331|NCT04913389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101630332|NCT04913389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630333|NCT04913389|Diuretics|diuretics|mesh-ancestor
101630334|NCT04913389|Natriuretic Agents|natriuretic agents|mesh-ancestor
101630335|NCT04913389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630336|NCT04904965|Propofol|propofol|mesh-list
101630337|NCT04904965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101630338|NCT04904965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101287449|NCT03559660|Immunologic Factors|immunologic factors|mesh-ancestor
101630339|NCT04904965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630340|NCT04904965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101630341|NCT04904965|Anesthetics, General|anesthetics, general|mesh-ancestor
101630342|NCT04904965|Anesthetics|anesthetics|mesh-ancestor
101630344|NCT00617565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101630345|NCT00617565|Insulin Aspart|insulin aspart|mesh-list
101630346|NCT00617565|Biphasic Insulins|biphasic insulins|mesh-list
101630347|NCT00617565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101630348|NCT00617565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630349|NCT04079413|Insulin|insulin|mesh-list
101630350|NCT04079413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101630351|NCT04079413|Insulin Aspart|insulin aspart|mesh-list
101630352|NCT04079413|Insulin, Long-Acting|insulin, long-acting|mesh-list
101630353|NCT04079413|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101630354|NCT04079413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101630355|NCT04079413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630356|NCT00915460|Interferons|interferons|mesh-list
101630357|NCT00915460|Interferon-beta|interferon-beta|mesh-list
101630358|NCT00915460|Interferon beta-1a|interferon beta-1a|mesh-list
101630359|NCT00915460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101630360|NCT00915460|Antiviral Agents|antiviral agents|mesh-ancestor
101630361|NCT00915460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101630362|NCT00915460|Immunologic Factors|immunologic factors|mesh-ancestor
101630363|NCT00915460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630364|NCT00915460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101630366|NCT00617643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101630367|NCT00617643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101630368|NCT00617643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101630369|NCT00617643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630370|NCT00617643|Antiviral Agents|antiviral agents|mesh-ancestor
101630371|NCT00617643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101630372|NCT00617643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101630373|NCT00617643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101630374|NCT00617643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101630375|NCT00617643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101630376|NCT02584075|Metformin|metformin|mesh-list
101630377|NCT02584075|Exenatide|exenatide|mesh-list
101630378|NCT02584075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101630379|NCT02584075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630380|NCT02584075|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101630381|NCT02584075|Incretins|incretins|mesh-ancestor
101630382|NCT02584075|Hormones|hormones|mesh-ancestor
101630383|NCT02584075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101630384|NCT02585479|Oxaliplatin|oxaliplatin|mesh-list
101630385|NCT02585479|Ethiodized Oil|ethiodized oil|mesh-list
101630386|NCT02585479|Pirarubicin|pirarubicin|mesh-list
101630387|NCT02585479|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
101630388|NCT02585479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101630389|NCT02585479|Hemostatics|hemostatics|mesh-ancestor
101630390|NCT02585479|Coagulants|coagulants|mesh-ancestor
101630391|NCT00583453|Celecoxib|celecoxib|mesh-list
101630392|NCT00583453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101630393|NCT00583453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101630394|NCT00583453|Analgesics|analgesics|mesh-ancestor
101630395|NCT00583453|Sensory System Agents|sensory system agents|mesh-ancestor
101630396|NCT00583453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101630397|NCT00583453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630398|NCT00583453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101630399|NCT00583453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101630400|NCT00583453|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101630401|NCT00583453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101630402|NCT00583453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101630403|NCT00583453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630404|NCT02584231|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101630405|NCT02584231|Hemostatics|hemostatics|mesh-ancestor
101630407|NCT02584231|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101630408|NCT02584231|Natriuretic Agents|natriuretic agents|mesh-ancestor
101630409|NCT02584231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630410|NCT04630873|Botulinum Toxins|botulinum toxins|mesh-list
101630411|NCT04630873|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101630412|NCT04630873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101630413|NCT04630873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630414|NCT04630873|Cholinergic Agents|cholinergic agents|mesh-ancestor
101630415|NCT04630873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101630416|NCT04630873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630417|NCT02584153|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101630418|NCT02584153|Hemostatics|hemostatics|mesh-ancestor
101333483|NCT00039208|Leucovorin|leucovorin|mesh-list
101630419|NCT02584153|Coagulants|coagulants|mesh-ancestor
101630420|NCT02585401|Aflibercept|aflibercept|mesh-list
101630421|NCT02585401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101630422|NCT02585401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101630423|NCT02585401|Growth Substances|growth substances|mesh-ancestor
101630424|NCT02585401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630425|NCT02585401|Growth Inhibitors|growth inhibitors|mesh-ancestor
101630426|NCT02585401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101630427|NCT04874311|Doxorubicin|doxorubicin|mesh-list
101630428|NCT04874311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101630429|NCT04874311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101630430|NCT04874311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101630431|NCT04874311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101630432|NCT04874311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101630433|NCT04874311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630434|NCT04873453|Cannabidiol|cannabidiol|mesh-list
101630435|NCT04873453|Anticonvulsants|anticonvulsants|mesh-ancestor
101630436|NCT04080349|Misoprostol|misoprostol|mesh-list
101630437|NCT04080349|Dinoprostone|dinoprostone|mesh-list
101630438|NCT04080349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101630439|NCT04080349|Abortifacient Agents|abortifacient agents|mesh-ancestor
101630440|NCT04080349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101719665|NCT00879437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101630441|NCT04080349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630443|NCT04080349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101630444|NCT04080349|Oxytocics|oxytocics|mesh-ancestor
101630445|NCT02585011|Epinephrine|epinephrine|mesh-list
101630446|NCT02585011|Ropivacaine|ropivacaine|mesh-list
101630447|NCT02585011|Anesthetics, Local|anesthetics, local|mesh-ancestor
101630448|NCT02585011|Anesthetics|anesthetics|mesh-ancestor
101630449|NCT02585011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101630450|NCT02585011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630451|NCT02585011|Sensory System Agents|sensory system agents|mesh-ancestor
101630452|NCT02585011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101630453|NCT02585011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101630454|NCT02585011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101630455|NCT02585011|Adrenergic Agents|adrenergic agents|mesh-ancestor
101630456|NCT02585011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101630457|NCT02585011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630458|NCT02585011|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101630459|NCT02585011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101630460|NCT02585011|Autonomic Agents|autonomic agents|mesh-ancestor
101630461|NCT02585011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101630462|NCT02585011|Respiratory System Agents|respiratory system agents|mesh-ancestor
101630463|NCT02585011|Mydriatics|mydriatics|mesh-ancestor
101630464|NCT02585011|Sympathomimetics|sympathomimetics|mesh-ancestor
101630465|NCT02585011|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101630466|NCT00920725|Insulin|insulin|mesh-list
101630467|NCT00920725|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101630468|NCT00920725|Insulin Aspart|insulin aspart|mesh-list
101630469|NCT00920725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101630470|NCT00920725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630471|NCT02583451|Lemborexant|lemborexant|mesh-list
101630472|NCT02583451|Zopiclone|zopiclone|mesh-list
101630473|NCT02583451|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
101630474|NCT02583451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101630475|NCT02583451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630476|NCT02583451|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101630477|NCT02583451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101630478|NCT02583451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101630479|NCT02583451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630480|NCT05435911|Propofol|propofol|mesh-list
101630481|NCT05435911|Flumazenil|flumazenil|mesh-list
101630482|NCT05435911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101630483|NCT05435911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101630484|NCT05435911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630485|NCT05435911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101630486|NCT05435911|Anesthetics, General|anesthetics, general|mesh-ancestor
101630487|NCT05435911|Anesthetics|anesthetics|mesh-ancestor
101630488|NCT05435911|Antidotes|antidotes|mesh-ancestor
101630489|NCT05435911|Protective Agents|protective agents|mesh-ancestor
101630490|NCT05435911|GABA Modulators|gaba modulators|mesh-ancestor
101630491|NCT05435911|GABA Agents|gaba agents|mesh-ancestor
101630492|NCT05435911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101630493|NCT05435911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630495|NCT04472299|Anesthetics, Local|anesthetics, local|mesh-ancestor
101630496|NCT04472299|Anesthetics|anesthetics|mesh-ancestor
101630497|NCT04472299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101630498|NCT04472299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630499|NCT04472299|Sensory System Agents|sensory system agents|mesh-ancestor
101719748|NCT00676637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101630501|NCT02583685|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101630502|NCT02583685|Interferon-alpha|interferon-alpha|mesh-list
101630503|NCT02583685|Ribavirin|ribavirin|mesh-list
101630504|NCT02583685|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
101630505|NCT02583685|Simeprevir|simeprevir|mesh-list
101630506|NCT02583685|Antiviral Agents|antiviral agents|mesh-ancestor
101630507|NCT02583685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101630508|NCT02583685|Immunologic Factors|immunologic factors|mesh-ancestor
101630509|NCT02583685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630510|NCT02583685|Antimetabolites|antimetabolites|mesh-ancestor
101630511|NCT02583685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630512|NCT02583685|Protease Inhibitors|protease inhibitors|mesh-ancestor
101630513|NCT02583685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101630514|NCT04606771|Osimertinib|osimertinib|mesh-list
101630515|NCT04606771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101630516|NCT04606771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101630517|NCT04606771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101630518|NCT04606771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630519|NCT04504123|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101630520|NCT04504123|Doxycycline|doxycycline|mesh-list
101630521|NCT04504123|Tetracycline|tetracycline|mesh-list
101630522|NCT04504123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101630523|NCT04504123|Antimalarials|antimalarials|mesh-ancestor
101630524|NCT04504123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101630525|NCT04504123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101630526|NCT04504123|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101630527|NCT04504123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101630528|NCT04504123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630529|NCT02584543|Vaccines|vaccines|mesh-list
101630530|NCT02584543|Immunologic Factors|immunologic factors|mesh-ancestor
101630531|NCT02584543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630532|NCT04077853|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
101630533|NCT04077853|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
101630534|NCT04077853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101630535|NCT04077853|Hormone Antagonists|hormone antagonists|mesh-ancestor
101630536|NCT04077853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101630537|NCT04077853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630538|NCT04077853|Progestins|progestins|mesh-ancestor
101630539|NCT04077853|Hormones|hormones|mesh-ancestor
101630540|NCT04502407|Cisplatin|cisplatin|mesh-list
101630541|NCT04502407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101630542|NCT00583219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101630543|NCT00583219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101630544|NCT00583219|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
101630545|NCT00583219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101719861|NCT00677729|Tocolytic Agents|tocolytic agents|mesh-ancestor
101630546|NCT00583219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101630547|NCT00583219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630548|NCT00583219|Cholinergic Agents|cholinergic agents|mesh-ancestor
101630549|NCT00583219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101630550|NCT00583219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630551|NCT00583219|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101630552|NCT00583219|Protective Agents|protective agents|mesh-ancestor
101630553|NCT00583219|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101630554|NCT00583219|Antioxidants|antioxidants|mesh-ancestor
101630555|NCT00583219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101630556|NCT00583219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101630558|NCT04501939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101630559|NCT05674669|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
101630560|NCT05674669|Hallucinogens|hallucinogens|mesh-ancestor
101630561|NCT05674669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630562|NCT05674669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101630563|NCT05674669|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101630564|NCT05674669|Serotonin Agents|serotonin agents|mesh-ancestor
101630565|NCT05674669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101630566|NCT05674669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630567|NCT05674669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101630569|NCT04116073|Immunologic Factors|immunologic factors|mesh-ancestor
101630570|NCT04116073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630571|NCT02581501|Gemcitabine|gemcitabine|mesh-list
101630572|NCT02581501|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101630573|NCT02581501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101630574|NCT02581501|Antimetabolites|antimetabolites|mesh-ancestor
101630575|NCT02581501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630576|NCT02581501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101630577|NCT01072175|Trametinib|trametinib|mesh-list
101630578|NCT01072175|Dabrafenib|dabrafenib|mesh-list
101630579|NCT01072175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101630580|NCT01072175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101630581|NCT01072175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101630582|NCT01072175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630583|NCT04078711|Losartan|losartan|mesh-list
101630584|NCT04078711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101630585|NCT04078711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101630586|NCT04078711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101630587|NCT04078711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101630588|NCT04078711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630589|NCT04304573|Calcium|calcium|mesh-list
101630590|NCT04304573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101630591|NCT04304573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630592|NCT04426669|Aldesleukin|aldesleukin|mesh-list
101630593|NCT04426669|Cyclophosphamide|cyclophosphamide|mesh-list
101630594|NCT04426669|Fludarabine|fludarabine|mesh-list
101630595|NCT04426669|Interleukin-2|interleukin-2|mesh-list
101630596|NCT04426669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101630597|NCT04426669|Immunologic Factors|immunologic factors|mesh-ancestor
101630598|NCT04426669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630599|NCT04426669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101630600|NCT04426669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101630601|NCT04426669|Alkylating Agents|alkylating agents|mesh-ancestor
101630602|NCT04426669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630604|NCT04426669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101630605|NCT04426669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101630606|NCT04426669|Analgesics|analgesics|mesh-ancestor
101630607|NCT04426669|Sensory System Agents|sensory system agents|mesh-ancestor
101630608|NCT04426669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101630609|NCT04426669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101630610|NCT04426669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101630611|NCT04426669|Antiviral Agents|antiviral agents|mesh-ancestor
101630612|NCT04426669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101630613|NCT02874989|Dasatinib|dasatinib|mesh-list
101630614|NCT02874989|Quercetin|quercetin|mesh-list
101630615|NCT02874989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101630616|NCT02874989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101630617|NCT02874989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101630618|NCT02874989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630619|NCT02874989|Antioxidants|antioxidants|mesh-ancestor
101630620|NCT02874989|Protective Agents|protective agents|mesh-ancestor
101630621|NCT02874989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630622|NCT01071317|Naproxen|naproxen|mesh-list
101630623|NCT01071317|Sumatriptan|sumatriptan|mesh-list
101630624|NCT01071317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101630625|NCT01071317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101630626|NCT01071317|Analgesics|analgesics|mesh-ancestor
101630627|NCT01071317|Sensory System Agents|sensory system agents|mesh-ancestor
101720002|NCT00678977|Gemcitabine|gemcitabine|mesh-list
101630628|NCT01071317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101630629|NCT01071317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630630|NCT01071317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101630631|NCT01071317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101630632|NCT01071317|Gout Suppressants|gout suppressants|mesh-ancestor
101630633|NCT01071317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101630634|NCT01071317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101630635|NCT01071317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630636|NCT01071317|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101630637|NCT01071317|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101630638|NCT01071317|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101630639|NCT01071317|Serotonin Agents|serotonin agents|mesh-ancestor
101630640|NCT01071317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101630641|NCT00783094|Tadalafil|tadalafil|mesh-list
101630642|NCT00783094|Vasodilator Agents|vasodilator agents|mesh-ancestor
101630643|NCT00783094|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101630644|NCT00783094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101630645|NCT00783094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101630646|NCT00783094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630647|NCT00783094|Urological Agents|urological agents|mesh-ancestor
101630648|NCT00790582|Lithium Carbonate|lithium carbonate|mesh-list
101630649|NCT00790582|Antidepressive Agents|antidepressive agents|mesh-ancestor
101630650|NCT00790582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101630651|NCT00790582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101630652|NCT00790582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630653|NCT00790582|Antimanic Agents|antimanic agents|mesh-ancestor
101630654|NCT00790582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101630655|NCT00790582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101630656|NCT00790582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630658|NCT02583217|Remifentanil|remifentanil|mesh-list
101630659|NCT02583217|Propofol|propofol|mesh-list
101630660|NCT02583217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101630661|NCT02583217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101630662|NCT02583217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630663|NCT02583217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101630664|NCT02583217|Anesthetics, General|anesthetics, general|mesh-ancestor
101630665|NCT02583217|Anesthetics|anesthetics|mesh-ancestor
101630666|NCT02583217|Analgesics|analgesics|mesh-ancestor
101630667|NCT02583217|Sensory System Agents|sensory system agents|mesh-ancestor
101630668|NCT02583217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101630669|NCT02583217|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101630670|NCT02583217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101630671|NCT02583217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101630672|NCT02583217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101630673|NCT02583217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630674|NCT02583217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101630675|NCT02583217|Narcotics|narcotics|mesh-ancestor
101630676|NCT00774046|Cytarabine|cytarabine|mesh-list
101630677|NCT00774046|Etoposide|etoposide|mesh-list
101630678|NCT00774046|Mitoxantrone|mitoxantrone|mesh-list
101630679|NCT00774046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101630680|NCT00774046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101630681|NCT00774046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101630682|NCT00774046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101630683|NCT00774046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101630684|NCT00774046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630685|NCT00774046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101630686|NCT00774046|Antimetabolites|antimetabolites|mesh-ancestor
101630687|NCT00774046|Antiviral Agents|antiviral agents|mesh-ancestor
101630688|NCT00774046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101630689|NCT00774046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101630690|NCT00774046|Immunologic Factors|immunologic factors|mesh-ancestor
101630691|NCT00774046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630692|NCT00774046|Analgesics|analgesics|mesh-ancestor
101630693|NCT00774046|Sensory System Agents|sensory system agents|mesh-ancestor
101630694|NCT00774046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101630695|NCT01046903|Dalteparin|dalteparin|mesh-list
101630696|NCT01046903|Tinzaparin|tinzaparin|mesh-list
101630697|NCT01046903|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101630698|NCT01046903|Anticoagulants|anticoagulants|mesh-ancestor
101630699|NCT01046903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101630700|NCT01046903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101630701|NCT01046903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630702|NCT02581423|Capecitabine|capecitabine|mesh-list
101630703|NCT02581423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101630704|NCT02581423|Antimetabolites|antimetabolites|mesh-ancestor
101630705|NCT02581423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630706|NCT02581423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101630707|NCT04102072|Dobutamine|dobutamine|mesh-list
101630708|NCT04102072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101630710|NCT04102072|Autonomic Agents|autonomic agents|mesh-ancestor
101630711|NCT04102072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101630712|NCT04102072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630713|NCT04102072|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101630714|NCT04102072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101630715|NCT04102072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101287818|NCT03485534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101630716|NCT04102072|Adrenergic Agents|adrenergic agents|mesh-ancestor
101630717|NCT04102072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101630718|NCT04102072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630719|NCT04102072|Protective Agents|protective agents|mesh-ancestor
101630720|NCT02875457|Cisplatin|cisplatin|mesh-list
101630721|NCT02875457|Etoposide|etoposide|mesh-list
101630722|NCT02875457|Etoposide phosphate|etoposide phosphate|mesh-list
101630723|NCT02875457|Apatinib|apatinib|mesh-list
101630724|NCT02875457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101630725|NCT02875457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101630726|NCT02875457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101630727|NCT02875457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101630728|NCT02875457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101630729|NCT02875457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630730|NCT02875457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101630731|NCT00773968|Epoetin Alfa|epoetin alfa|mesh-list
101630732|NCT00773968|Hematinics|hematinics|mesh-ancestor
101630733|NCT04060381|Ibuprofen|ibuprofen|mesh-list
101630734|NCT04060381|Dopamine|dopamine|mesh-list
101630735|NCT04060381|Epinephrine|epinephrine|mesh-list
101630736|NCT04060381|Norepinephrine|norepinephrine|mesh-list
101630737|NCT04060381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101630738|NCT04060381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101630739|NCT04060381|Analgesics|analgesics|mesh-ancestor
101630740|NCT04060381|Sensory System Agents|sensory system agents|mesh-ancestor
101630741|NCT04060381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101630742|NCT04060381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630743|NCT04060381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101630744|NCT04060381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101630745|NCT04060381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101630746|NCT04060381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101630747|NCT04060381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630748|NCT04060381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101630749|NCT04060381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101630750|NCT04060381|Adrenergic Agents|adrenergic agents|mesh-ancestor
101630751|NCT04060381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101630752|NCT04060381|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101630753|NCT04060381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101630754|NCT04060381|Autonomic Agents|autonomic agents|mesh-ancestor
101630755|NCT04060381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101630756|NCT04060381|Respiratory System Agents|respiratory system agents|mesh-ancestor
101630757|NCT04060381|Mydriatics|mydriatics|mesh-ancestor
101630758|NCT04060381|Sympathomimetics|sympathomimetics|mesh-ancestor
101630759|NCT04060381|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101630760|NCT04060381|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101630761|NCT04060381|Dopamine Agents|dopamine agents|mesh-ancestor
101630762|NCT04060381|Protective Agents|protective agents|mesh-ancestor
101630763|NCT00782626|Everolimus|everolimus|mesh-list
101630764|NCT00782626|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101630765|NCT00782626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101630766|NCT00782626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101630767|NCT00782626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630768|NCT00782626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101630769|NCT00782626|Immunologic Factors|immunologic factors|mesh-ancestor
101630770|NCT00782626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630771|NCT00782626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101630772|NCT04076371|Olanzapine|olanzapine|mesh-list
101630773|NCT04076371|Risperidone|risperidone|mesh-list
101630774|NCT04076371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101630775|NCT04076371|Ziprasidone|ziprasidone|mesh-list
101630776|NCT04076371|Sertraline|sertraline|mesh-list
101630777|NCT04076371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101630778|NCT04076371|Serotonin Agents|serotonin agents|mesh-ancestor
101630779|NCT04076371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101630780|NCT04076371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630781|NCT04076371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630782|NCT04076371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101630783|NCT04076371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101630784|NCT04076371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101630785|NCT04076371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101630786|NCT04076371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101630789|NCT04076371|Autonomic Agents|autonomic agents|mesh-ancestor
101287903|NCT02625610|Leucovorin|leucovorin|mesh-list
101630790|NCT04076371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101630791|NCT04076371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101630792|NCT04076371|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101630793|NCT04076371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101630794|NCT04076371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101630795|NCT04076371|Antidepressive Agents|antidepressive agents|mesh-ancestor
101630796|NCT04076371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101630797|NCT04076371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101630798|NCT01071083|Interferons|interferons|mesh-list
101630799|NCT01071083|Interferon-beta|interferon-beta|mesh-list
101630800|NCT01071083|Interferon beta-1a|interferon beta-1a|mesh-list
101630801|NCT01071083|Methylprednisolone|methylprednisolone|mesh-list
101630802|NCT01071083|Glatiramer Acetate|glatiramer acetate|mesh-list
101630803|NCT01071083|Natalizumab|natalizumab|mesh-list
101630804|NCT01071083|(T,G)-A-L|(t,g)-a-l|mesh-list
101630805|NCT01071083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101630806|NCT01071083|Antiviral Agents|antiviral agents|mesh-ancestor
101630807|NCT01071083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101630808|NCT01071083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101630809|NCT01071083|Antiemetics|antiemetics|mesh-ancestor
101630810|NCT01071083|Autonomic Agents|autonomic agents|mesh-ancestor
101630811|NCT01071083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101630812|NCT01071083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630813|NCT01071083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101630814|NCT01071083|Glucocorticoids|glucocorticoids|mesh-ancestor
101630815|NCT01071083|Hormones|hormones|mesh-ancestor
101646169|NCT04264286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630816|NCT01071083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101630817|NCT01071083|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101630819|NCT01071083|Immunologic Factors|immunologic factors|mesh-ancestor
101630820|NCT01071083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101630821|NCT01071083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101630822|NCT01071083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101630823|NCT03973333|Atezolizumab|atezolizumab|mesh-list
101630824|NCT03973333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101630825|NCT03973333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630826|NCT03973333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101630827|NCT03973333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101630828|NCT03968341|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101630829|NCT03968341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101630830|NCT04078399|Interferons|interferons|mesh-list
101630831|NCT04078399|Azacitidine|azacitidine|mesh-list
101630832|NCT04078399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101630833|NCT04078399|Antiviral Agents|antiviral agents|mesh-ancestor
101630834|NCT04078399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101630835|NCT04078399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101630836|NCT04078399|Antimetabolites|antimetabolites|mesh-ancestor
101630837|NCT04078399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630838|NCT04078399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101630839|NCT05189509|Plasminogen|plasminogen|mesh-list
101630840|NCT05189509|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101630841|NCT05189509|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101630842|NCT05189509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101630843|NCT05189509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630844|NCT03897751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101630845|NCT01010126|Sirolimus|sirolimus|mesh-list
101630846|NCT01010126|Bevacizumab|bevacizumab|mesh-list
101630847|NCT01010126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101630848|NCT01010126|Temsirolimus|temsirolimus|mesh-list
101630849|NCT01010126|MTOR Inhibitors|mtor inhibitors|mesh-list
101630850|NCT01010126|Endothelial Growth Factors|endothelial growth factors|mesh-list
101630851|NCT01010126|Antibodies|antibodies|mesh-list
101630852|NCT01010126|Immunoglobulins|immunoglobulins|mesh-list
101630853|NCT01010126|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101630854|NCT01010126|Immunoglobulin G|immunoglobulin g|mesh-list
101630855|NCT01010126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101630856|NCT01010126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101630857|NCT01010126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101630858|NCT01010126|Growth Substances|growth substances|mesh-ancestor
101534700|NCT00569465|Antioxidants|antioxidants|mesh-ancestor
101630859|NCT01010126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630860|NCT01010126|Growth Inhibitors|growth inhibitors|mesh-ancestor
101630861|NCT01010126|Immunologic Factors|immunologic factors|mesh-ancestor
101630862|NCT01010126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101630863|NCT01010126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101630864|NCT01010126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101630865|NCT01010126|Antifungal Agents|antifungal agents|mesh-ancestor
101630866|NCT01010126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101630867|NCT01010126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101630868|NCT01010126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101287966|NCT05414942|Analgesics|analgesics|mesh-ancestor
101630869|NCT01010126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630871|NCT04076137|Antibodies|antibodies|mesh-list
101630872|NCT04076137|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101630873|NCT04076137|Immunologic Factors|immunologic factors|mesh-ancestor
101630874|NCT04076137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630875|NCT04076137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101630876|NCT04076137|Antimetabolites|antimetabolites|mesh-ancestor
101630877|NCT04076137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630878|NCT04076137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101630879|NCT04076137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101630880|NCT03879577|Tamoxifen|tamoxifen|mesh-list
101630881|NCT03879577|Docetaxel|docetaxel|mesh-list
101630882|NCT03879577|Trastuzumab|trastuzumab|mesh-list
101630883|NCT03879577|Letrozole|letrozole|mesh-list
101630884|NCT03879577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101630885|NCT03879577|Tubulin Modulators|tubulin modulators|mesh-ancestor
101630886|NCT03879577|Antimitotic Agents|antimitotic agents|mesh-ancestor
101630887|NCT03879577|Mitosis Modulators|mitosis modulators|mesh-ancestor
101630888|NCT03879577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630889|NCT03879577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101630890|NCT03879577|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101630891|NCT03879577|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101630892|NCT03879577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101630893|NCT03879577|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101630894|NCT03879577|Hormone Antagonists|hormone antagonists|mesh-ancestor
101630895|NCT03879577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101630896|NCT03879577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630897|NCT03879577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101630898|NCT03879577|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101630899|NCT03879577|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101630900|NCT03879577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101630901|NCT00617799|Aldesleukin|aldesleukin|mesh-list
101630902|NCT00617799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101630903|NCT00617799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101630904|NCT00617799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101630905|NCT00617799|Antiviral Agents|antiviral agents|mesh-ancestor
101630906|NCT00617799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101630908|NCT00617877|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101630909|NCT00617877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101630910|NCT00617877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101630911|NCT00617877|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101630912|NCT00617877|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101630913|NCT00617877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630914|NCT00617877|Diuretics|diuretics|mesh-ancestor
101630915|NCT00617877|Natriuretic Agents|natriuretic agents|mesh-ancestor
101630916|NCT00617877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630917|NCT00617877|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101630918|NCT00617877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101630919|NCT00617955|Aprotinin|aprotinin|mesh-list
101630920|NCT00617955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630921|NCT00617955|Hemostatics|hemostatics|mesh-ancestor
101630922|NCT00617955|Coagulants|coagulants|mesh-ancestor
101630923|NCT00617955|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101630924|NCT00617955|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101630925|NCT00617955|Protease Inhibitors|protease inhibitors|mesh-ancestor
101630926|NCT00617955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101630927|NCT02582437|Analgesics, Opioid|analgesics, opioid|mesh-list
101630928|NCT02582437|Narcotics|narcotics|mesh-ancestor
101630929|NCT02582437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101630930|NCT02582437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630931|NCT02582437|Analgesics|analgesics|mesh-ancestor
101630932|NCT02582437|Sensory System Agents|sensory system agents|mesh-ancestor
101630933|NCT02582437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101630934|NCT05674201|Dexmedetomidine|dexmedetomidine|mesh-list
101630935|NCT05674201|Remifentanil|remifentanil|mesh-list
101630936|NCT05674201|Propofol|propofol|mesh-list
101630937|NCT05674201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101630938|NCT05674201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101630939|NCT05674201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630940|NCT05674201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101630941|NCT05674201|Analgesics|analgesics|mesh-ancestor
101630942|NCT05674201|Sensory System Agents|sensory system agents|mesh-ancestor
101288051|NCT05413902|Mydriatics|mydriatics|mesh-ancestor
101630943|NCT05674201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101630944|NCT05674201|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101630945|NCT05674201|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101630946|NCT05674201|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101630947|NCT05674201|Adrenergic Agents|adrenergic agents|mesh-ancestor
101630948|NCT05674201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101630949|NCT05674201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630950|NCT05674201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101630951|NCT05674201|Anesthetics, General|anesthetics, general|mesh-ancestor
101630952|NCT05674201|Anesthetics|anesthetics|mesh-ancestor
101630953|NCT05674201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101630954|NCT05674201|Narcotics|narcotics|mesh-ancestor
101630955|NCT01070303|Adalimumab|adalimumab|mesh-list
101630956|NCT01070303|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101630957|NCT01070303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101630958|NCT01070303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101630959|NCT00618111|Granisetron|granisetron|mesh-list
101630960|NCT00618111|Antiemetics|antiemetics|mesh-ancestor
101630961|NCT00618111|Autonomic Agents|autonomic agents|mesh-ancestor
101630962|NCT00618111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101630963|NCT00618111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630964|NCT00618111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101630965|NCT00618111|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101630966|NCT00618111|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101630967|NCT00618111|Serotonin Agents|serotonin agents|mesh-ancestor
101646170|NCT02582476|Bumetanide|bumetanide|mesh-list
101630968|NCT00618111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101630969|NCT00618111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630971|NCT01009814|Fostemsavir|fostemsavir|mesh-list
101630972|NCT01009814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101630973|NCT01009814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101630974|NCT01009814|Protease Inhibitors|protease inhibitors|mesh-ancestor
101630975|NCT01009814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101630976|NCT01009814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630977|NCT01009814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101630978|NCT01009814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101630979|NCT01009814|Antiviral Agents|antiviral agents|mesh-ancestor
101630980|NCT01009814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101630981|NCT01009814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101630982|NCT01009814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101630983|NCT01009814|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101630984|NCT01009814|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101630985|NCT03824587|Calcium, Dietary|calcium, dietary|mesh-list
101630986|NCT03824587|Calcium Carbonate|calcium carbonate|mesh-list
101630987|NCT03824587|Calcium|calcium|mesh-list
101630988|NCT03824587|Sevelamer|sevelamer|mesh-list
101630989|NCT03824587|Calcium acetate|calcium acetate|mesh-list
101630990|NCT03824587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101630991|NCT03824587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101630992|NCT03824587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101630993|NCT03824587|Chelating Agents|chelating agents|mesh-ancestor
101630994|NCT03824587|Sequestering Agents|sequestering agents|mesh-ancestor
101630995|NCT03824587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101630996|NCT03824587|Antacids|antacids|mesh-ancestor
101630997|NCT03824587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101630998|NCT00773734|Thalidomide|thalidomide|mesh-list
101630999|NCT00773734|Apremilast|apremilast|mesh-list
101631000|NCT00773734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101631002|NCT00773734|Analgesics|analgesics|mesh-ancestor
101631003|NCT00773734|Sensory System Agents|sensory system agents|mesh-ancestor
101631004|NCT00773734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101631005|NCT00773734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631006|NCT00773734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101631007|NCT00773734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101631008|NCT00773734|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101631009|NCT00773734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101631010|NCT00773734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101631011|NCT00773734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631012|NCT00773734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101631013|NCT00773734|Immunologic Factors|immunologic factors|mesh-ancestor
101631014|NCT00773734|Leprostatic Agents|leprostatic agents|mesh-ancestor
101631015|NCT00773734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101631016|NCT00773734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101288120|NCT05310916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631017|NCT00773734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101631018|NCT00773734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101631019|NCT00773734|Growth Substances|growth substances|mesh-ancestor
101631020|NCT00773734|Growth Inhibitors|growth inhibitors|mesh-ancestor
101631021|NCT00773734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101631022|NCT04297202|Apatinib|apatinib|mesh-list
101631023|NCT04297202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101631024|NCT04297202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101631025|NCT04297202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101631026|NCT04297202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631027|NCT02691897|Melatonin|melatonin|mesh-list
101631028|NCT02691897|Antioxidants|antioxidants|mesh-ancestor
101631029|NCT02691897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631030|NCT02691897|Protective Agents|protective agents|mesh-ancestor
101631031|NCT02691897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631032|NCT02691897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101631033|NCT03067155|Antiviral Agents|antiviral agents|mesh-list
101631034|NCT03067155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101631035|NCT01009580|Insulin|insulin|mesh-list
101631036|NCT01009580|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101631037|NCT01009580|Insulin Aspart|insulin aspart|mesh-list
101631038|NCT01009580|Insulin, Long-Acting|insulin, long-acting|mesh-list
101646171|NCT02582476|Diuretics|diuretics|mesh-ancestor
101631039|NCT01009580|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101631041|NCT01009580|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101631042|NCT01009580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101631043|NCT01009580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631044|NCT01009346|Cisplatin|cisplatin|mesh-list
101631045|NCT01009346|Carboplatin|carboplatin|mesh-list
101631046|NCT01009346|Cetuximab|cetuximab|mesh-list
101631047|NCT01009346|Everolimus|everolimus|mesh-list
101631048|NCT01009346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101631049|NCT01009346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101631050|NCT01009346|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101631051|NCT01009346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101631052|NCT01009346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101631053|NCT01009346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631054|NCT01009346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101631055|NCT01009346|Immunologic Factors|immunologic factors|mesh-ancestor
101631056|NCT01009346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631057|NCT04101682|Bupivacaine|bupivacaine|mesh-list
101631058|NCT04101682|Anesthetics, Local|anesthetics, local|mesh-ancestor
101631059|NCT04101682|Anesthetics|anesthetics|mesh-ancestor
101631060|NCT04101682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101631061|NCT04101682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631062|NCT04101682|Sensory System Agents|sensory system agents|mesh-ancestor
101631063|NCT04101682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101631064|NCT01001702|Aripiprazole|aripiprazole|mesh-list
101631065|NCT01001702|Antidepressive Agents|antidepressive agents|mesh-ancestor
101631066|NCT01001702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101631067|NCT01001702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101631068|NCT01001702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101631069|NCT01001702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101631070|NCT01001702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631071|NCT01001702|Dopamine Agonists|dopamine agonists|mesh-ancestor
101631072|NCT01001702|Dopamine Agents|dopamine agents|mesh-ancestor
101631073|NCT01001702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101631074|NCT01001702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631075|NCT01001702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101631076|NCT01001702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101631077|NCT01001702|Serotonin Agents|serotonin agents|mesh-ancestor
101631078|NCT01001702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101631079|NCT01001702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101631080|NCT01001702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101631081|NCT01001702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101631082|NCT02602210|Hydrocortisone|hydrocortisone|mesh-list
101631083|NCT02602210|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101631084|NCT02602210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101631085|NCT00618345|Everolimus|everolimus|mesh-list
101631086|NCT00618345|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101631087|NCT00618345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101720633|NCT05941715|Faricimab|faricimab|mesh-list
101631088|NCT00618345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101631089|NCT00618345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631090|NCT00618345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101631091|NCT00618345|Immunologic Factors|immunologic factors|mesh-ancestor
101631092|NCT00618345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631093|NCT00618345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101631094|NCT02601898|Thioctic Acid|thioctic acid|mesh-list
101631095|NCT02601898|Progesterone|progesterone|mesh-list
101631096|NCT02601898|Progestins|progestins|mesh-ancestor
101631097|NCT02601898|Hormones|hormones|mesh-ancestor
101631098|NCT02601898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101631099|NCT02601898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631100|NCT02601898|Antioxidants|antioxidants|mesh-ancestor
101631101|NCT02601898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631102|NCT02601898|Protective Agents|protective agents|mesh-ancestor
101631103|NCT02601898|Vitamin B Complex|vitamin b complex|mesh-ancestor
101631104|NCT02601898|Vitamins|vitamins|mesh-ancestor
101631105|NCT02601898|Micronutrients|micronutrients|mesh-ancestor
101631106|NCT00618423|Ketamine|ketamine|mesh-list
101631107|NCT00618423|Analgesics|analgesics|mesh-ancestor
101631108|NCT00618423|Sensory System Agents|sensory system agents|mesh-ancestor
101631109|NCT00618423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101631110|NCT00618423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631111|NCT00618423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101631112|NCT00618423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101720654|NCT05886582|Rotigotine|rotigotine|mesh-list
101631113|NCT00618423|Anesthetics, General|anesthetics, general|mesh-ancestor
101631114|NCT00618423|Anesthetics|anesthetics|mesh-ancestor
101631115|NCT00618423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101631116|NCT00618423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101631117|NCT00618423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101631118|NCT00618423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101631119|NCT00618423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631120|NCT04101760|Lenograstim|lenograstim|mesh-list
101631121|NCT04101760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101631122|NCT04101760|Immunologic Factors|immunologic factors|mesh-ancestor
101631123|NCT04101760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631124|NCT00616551|Octreotide|octreotide|mesh-list
101631125|NCT00616551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101631126|NCT00616551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101631127|NCT00616551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101631128|NCT04478942|Misoprostol|misoprostol|mesh-list
101631129|NCT04478942|Oxytocin|oxytocin|mesh-list
101631130|NCT04478942|Oxytocics|oxytocics|mesh-ancestor
101631131|NCT04478942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101631132|NCT04478942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631133|NCT04478942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101631134|NCT04478942|Abortifacient Agents|abortifacient agents|mesh-ancestor
101631135|NCT04478942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101631136|NCT04478942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101631137|NCT04214145|Phenylephrine|phenylephrine|mesh-list
101631138|NCT04214145|Vasopressins|vasopressins|mesh-list
101631139|NCT04214145|Arginine Vasopressin|arginine vasopressin|mesh-list
101631140|NCT04214145|Oxymetazoline|oxymetazoline|mesh-list
101631141|NCT04214145|Norepinephrine|norepinephrine|mesh-list
101631142|NCT04214145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101631144|NCT04214145|Autonomic Agents|autonomic agents|mesh-ancestor
101631145|NCT04214145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101631146|NCT04214145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631147|NCT04214145|Sympathomimetics|sympathomimetics|mesh-ancestor
101631148|NCT04214145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101631149|NCT04214145|Nasal Decongestants|nasal decongestants|mesh-ancestor
101631150|NCT04214145|Respiratory System Agents|respiratory system agents|mesh-ancestor
101631151|NCT04214145|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101631152|NCT04214145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101631153|NCT04214145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101631154|NCT04214145|Adrenergic Agents|adrenergic agents|mesh-ancestor
101631155|NCT04214145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101631156|NCT04214145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631157|NCT04214145|Protective Agents|protective agents|mesh-ancestor
101631158|NCT04214145|Hemostatics|hemostatics|mesh-ancestor
101631159|NCT04214145|Coagulants|coagulants|mesh-ancestor
101631160|NCT04214145|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101631161|NCT04214145|Natriuretic Agents|natriuretic agents|mesh-ancestor
101631162|NCT04212429|Moxifloxacin|moxifloxacin|mesh-list
101631163|NCT04212429|Levofloxacin|levofloxacin|mesh-list
101631164|NCT04212429|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101631165|NCT04212429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101288271|NCT03626922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101631166|NCT04212429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101631167|NCT04212429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101631168|NCT04212429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101631169|NCT04212429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101631170|NCT04212429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101631171|NCT04212429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631172|NCT04212429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101631173|NCT04212429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101631174|NCT04212429|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101631175|NCT04212429|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101631176|NCT01068665|Insulin|insulin|mesh-list
101631177|NCT01068665|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101631178|NCT01068665|Insulin Glargine|insulin glargine|mesh-list
101631179|NCT01068665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101631180|NCT01068665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631181|NCT00618501|Leucovorin|leucovorin|mesh-list
101631182|NCT00618501|Cytarabine|cytarabine|mesh-list
101631183|NCT00618501|Prednisolone|prednisolone|mesh-list
101631184|NCT00618501|Hydrocortisone|hydrocortisone|mesh-list
101631185|NCT00618501|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101631186|NCT00618501|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101631187|NCT00618501|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101631188|NCT00618501|Methotrexate|methotrexate|mesh-list
101631189|NCT00618501|Etoposide|etoposide|mesh-list
101631190|NCT00618501|Vincristine|vincristine|mesh-list
101631191|NCT00618501|Imatinib Mesylate|imatinib mesylate|mesh-list
101631192|NCT00618501|Daunorubicin|daunorubicin|mesh-list
101631193|NCT00618501|Levoleucovorin|levoleucovorin|mesh-list
101631194|NCT00618501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631195|NCT00618501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101631196|NCT00618501|Abortifacient Agents|abortifacient agents|mesh-ancestor
101631197|NCT00618501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101631198|NCT00618501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101631199|NCT00618501|Antimetabolites|antimetabolites|mesh-ancestor
101631200|NCT00618501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631201|NCT00618501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101631202|NCT00618501|Dermatologic Agents|dermatologic agents|mesh-ancestor
101631203|NCT00618501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101631204|NCT00618501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101631205|NCT00618501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101631206|NCT00618501|Immunologic Factors|immunologic factors|mesh-ancestor
101631207|NCT00618501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101631208|NCT00618501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101631209|NCT00618501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101631210|NCT00618501|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101631211|NCT00618501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101631212|NCT00618501|Antiviral Agents|antiviral agents|mesh-ancestor
101631213|NCT00618501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101631214|NCT00618501|Antidotes|antidotes|mesh-ancestor
101631215|NCT00618501|Protective Agents|protective agents|mesh-ancestor
101631216|NCT00618501|Vitamin B Complex|vitamin b complex|mesh-ancestor
101631217|NCT00618501|Vitamins|vitamins|mesh-ancestor
101631218|NCT00618501|Micronutrients|micronutrients|mesh-ancestor
101631219|NCT00618501|Tubulin Modulators|tubulin modulators|mesh-ancestor
101631220|NCT00618501|Antimitotic Agents|antimitotic agents|mesh-ancestor
101720785|NCT05671081|Analgesics|analgesics|mesh-list
101631221|NCT00618501|Mitosis Modulators|mitosis modulators|mesh-ancestor
101631222|NCT00618501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101631223|NCT00618501|Glucocorticoids|glucocorticoids|mesh-ancestor
101631224|NCT00618501|Hormones|hormones|mesh-ancestor
101631225|NCT00618501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101631226|NCT00618501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101631227|NCT00618501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101631228|NCT00618501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101631229|NCT00772954|Vaccines|vaccines|mesh-list
101631230|NCT00772954|Immunologic Factors|immunologic factors|mesh-ancestor
101631231|NCT00772954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631232|NCT05322681|Pregabalin|pregabalin|mesh-list
101631233|NCT05322681|Analgesics|analgesics|mesh-ancestor
101631234|NCT05322681|Sensory System Agents|sensory system agents|mesh-ancestor
101631235|NCT05322681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101631236|NCT05322681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631237|NCT05322681|Anticonvulsants|anticonvulsants|mesh-ancestor
101631238|NCT05322681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101631239|NCT05322681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101631240|NCT05322681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631241|NCT05322681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101631242|NCT05322681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101631243|NCT05322681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101631244|NCT05322681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101631245|NCT05322681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101631246|NCT05322603|Diclofenac|diclofenac|mesh-list
101631247|NCT05322603|Morphine|morphine|mesh-list
101631248|NCT05322603|Analgesics|analgesics|mesh-list
101631249|NCT05322603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
101631250|NCT05322603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101631251|NCT05322603|Narcotics|narcotics|mesh-ancestor
101631252|NCT05322603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101631253|NCT05322603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631254|NCT05322603|Sensory System Agents|sensory system agents|mesh-ancestor
101631255|NCT05322603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101631256|NCT05322603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101631257|NCT05322603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101631258|NCT05322603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101631259|NCT05322603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101631260|NCT05322603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101631261|NCT05322603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631262|NCT00618579|Warfarin|warfarin|mesh-list
101631263|NCT00618579|Anticoagulants|anticoagulants|mesh-ancestor
101631264|NCT00781768|Ondansetron|ondansetron|mesh-list
101631265|NCT00781768|Aprepitant|aprepitant|mesh-list
101631266|NCT00781768|Antiemetics|antiemetics|mesh-ancestor
101631267|NCT00781768|Autonomic Agents|autonomic agents|mesh-ancestor
101631268|NCT00781768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101631269|NCT00781768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631270|NCT00781768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101631271|NCT00781768|Antipruritics|antipruritics|mesh-ancestor
101631272|NCT00781768|Dermatologic Agents|dermatologic agents|mesh-ancestor
101631273|NCT00781768|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101631274|NCT00781768|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101631275|NCT00781768|Serotonin Agents|serotonin agents|mesh-ancestor
101631276|NCT00781768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101646172|NCT02582476|Natriuretic Agents|natriuretic agents|mesh-ancestor
101631277|NCT00781768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631278|NCT00781768|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101631279|NCT01005680|Gemcitabine|gemcitabine|mesh-list
101631280|NCT01005680|Pemetrexed|pemetrexed|mesh-list
101631281|NCT01005680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101631282|NCT01005680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101631284|NCT01005680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631285|NCT01005680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101631286|NCT01005680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101631287|NCT01005680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101631288|NCT04101370|Bosentan|bosentan|mesh-list
101631289|NCT04101370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101631290|NCT04101370|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101631291|NCT04101370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631292|NCT00618657|Paclitaxel|paclitaxel|mesh-list
101631293|NCT00618657|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101631294|NCT00618657|Bevacizumab|bevacizumab|mesh-list
101631295|NCT00618657|Carboplatin|carboplatin|mesh-list
101631296|NCT00618657|Trastuzumab|trastuzumab|mesh-list
101631297|NCT00618657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101631298|NCT00618657|Antibodies|antibodies|mesh-list
101631299|NCT00618657|Immunoglobulins|immunoglobulins|mesh-list
101631300|NCT00618657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101631301|NCT00618657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101631302|NCT00618657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101631303|NCT00618657|Tubulin Modulators|tubulin modulators|mesh-ancestor
101631304|NCT00618657|Antimitotic Agents|antimitotic agents|mesh-ancestor
101631305|NCT00618657|Mitosis Modulators|mitosis modulators|mesh-ancestor
101631306|NCT00618657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631307|NCT00618657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101631308|NCT00618657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101631309|NCT00618657|Growth Substances|growth substances|mesh-ancestor
101631310|NCT00618657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631311|NCT00618657|Growth Inhibitors|growth inhibitors|mesh-ancestor
101631312|NCT00618657|Immunologic Factors|immunologic factors|mesh-ancestor
101631313|NCT04188249|Golimumab|golimumab|mesh-list
101631314|NCT04188249|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101631315|NCT04188249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101631316|NCT04188249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101631317|NCT04188249|Immunologic Factors|immunologic factors|mesh-ancestor
101631318|NCT04188249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631319|NCT01005602|Digoxin|digoxin|mesh-list
101720941|NCT05413018|Cc-486|cc-486|mesh-list
101631320|NCT01005602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101631321|NCT01005602|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101631322|NCT01005602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101631323|NCT01005602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631324|NCT01005602|Protective Agents|protective agents|mesh-ancestor
101631325|NCT01005602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631326|NCT05490940|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101631327|NCT05490940|Hemostatics|hemostatics|mesh-ancestor
101631328|NCT05490940|Coagulants|coagulants|mesh-ancestor
101631329|NCT04304261|Metformin|metformin|mesh-list
101631330|NCT04304261|Dapagliflozin|dapagliflozin|mesh-list
101631331|NCT04304261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101631332|NCT04304261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631333|NCT04304261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101631334|NCT04304261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631347|NCT00768430|Midazolam|midazolam|mesh-list
101631348|NCT00768430|Ketamine|ketamine|mesh-list
101631349|NCT00768430|Analgesics|analgesics|mesh-ancestor
101631350|NCT00768430|Sensory System Agents|sensory system agents|mesh-ancestor
101631351|NCT00768430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101631352|NCT00768430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631353|NCT00768430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101631354|NCT00768430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101631355|NCT00768430|Anesthetics, General|anesthetics, general|mesh-ancestor
101631356|NCT00768430|Anesthetics|anesthetics|mesh-ancestor
101631357|NCT00768430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101631358|NCT00768430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101631359|NCT00768430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101631360|NCT00768430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101631361|NCT00768430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631362|NCT00768430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101631363|NCT00768430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101631364|NCT00768430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101631365|NCT00768430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101631366|NCT00768430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101631367|NCT00768430|GABA Modulators|gaba modulators|mesh-ancestor
101631368|NCT00768430|GABA Agents|gaba agents|mesh-ancestor
101631369|NCT04101136|Atorvastatin|atorvastatin|mesh-list
101631370|NCT04101136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101631371|NCT04101136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101631372|NCT04101136|Antimetabolites|antimetabolites|mesh-ancestor
101631373|NCT04101136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631374|NCT04101136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101631375|NCT04101136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101631376|NCT04101136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101631377|NCT00618969|Busulfan|busulfan|mesh-list
101631378|NCT00618969|Melphalan|melphalan|mesh-list
101631379|NCT00618969|Alkylating Agents|alkylating agents|mesh-ancestor
101631380|NCT00618969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631381|NCT00618969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101631382|NCT00618969|Immunologic Factors|immunologic factors|mesh-ancestor
101631383|NCT00618969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631384|NCT00618969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101631385|NCT00618969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101631386|NCT00618969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101631387|NCT01064297|Lamotrigine|lamotrigine|mesh-list
101631388|NCT01064297|Anticonvulsants|anticonvulsants|mesh-list
101631389|NCT01064297|Valproic Acid|valproic acid|mesh-list
101631390|NCT01064297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101631391|NCT01064297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101631392|NCT01064297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631393|NCT01064297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101631394|NCT01064297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631395|NCT01064297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101631397|NCT01064297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101631398|NCT01064297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101631399|NCT01064297|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101631400|NCT01064297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101631401|NCT01064297|GABA Agents|gaba agents|mesh-ancestor
101631402|NCT01064297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101631403|NCT01064297|Antimanic Agents|antimanic agents|mesh-ancestor
101631404|NCT00781456|Contraceptive Agents|contraceptive agents|mesh-list
101631405|NCT00781456|Levonorgestrel|levonorgestrel|mesh-list
101631406|NCT00781456|Contraceptives, Oral|contraceptives, oral|mesh-list
101631407|NCT00781456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101631408|NCT00781456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631409|NCT00781456|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101631410|NCT00781456|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101631411|NCT00781456|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101631412|NCT00582907|Rilonacept|rilonacept|mesh-list
101631413|NCT00582907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101631414|NCT01062113|Celecoxib|celecoxib|mesh-list
101631415|NCT01062113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101631416|NCT01062113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101631417|NCT01062113|Analgesics|analgesics|mesh-ancestor
101631418|NCT01062113|Sensory System Agents|sensory system agents|mesh-ancestor
101631419|NCT01062113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101631420|NCT01062113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631421|NCT01062113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101631422|NCT01062113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101631423|NCT01062113|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101631424|NCT01062113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101631425|NCT01062113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101631426|NCT01062113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631427|NCT00916396|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101631428|NCT00916396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101631429|NCT00916396|Immunologic Factors|immunologic factors|mesh-ancestor
101631430|NCT00916396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631431|NCT04075201|Vaccines|vaccines|mesh-list
101631432|NCT04075201|Immunologic Factors|immunologic factors|mesh-ancestor
101631433|NCT04075201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631434|NCT01038869|Azelaic acid|azelaic acid|mesh-list
101631435|NCT01038869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101631436|NCT01038869|Dermatologic Agents|dermatologic agents|mesh-ancestor
101631437|NCT02580331|Metformin|metformin|mesh-list
101631438|NCT02580331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101631439|NCT02580331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631440|NCT00767806|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101631441|NCT00767806|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101631442|NCT00767806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101631443|NCT00767806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101631444|NCT00767806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631445|NCT00767806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101631446|NCT00767806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631447|NCT00767806|Analgesics|analgesics|mesh-ancestor
101631448|NCT00767806|Sensory System Agents|sensory system agents|mesh-ancestor
101631449|NCT00767806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101631450|NCT00767806|Antidepressive Agents|antidepressive agents|mesh-ancestor
101631451|NCT00767806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101631452|NCT00767806|Dopamine Agents|dopamine agents|mesh-ancestor
101631453|NCT00780910|Ribavirin|ribavirin|mesh-list
101631454|NCT00780910|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101631455|NCT00780910|Antimetabolites|antimetabolites|mesh-ancestor
101631456|NCT00780910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631457|NCT00780910|Antiviral Agents|antiviral agents|mesh-ancestor
101631458|NCT00780910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101631459|NCT02582203|Vancomycin|vancomycin|mesh-list
101631460|NCT02582203|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
101631461|NCT02582203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101631462|NCT02582203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101631464|NCT05035927|Hallucinogens|hallucinogens|mesh-ancestor
101631465|NCT05035927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631466|NCT05035927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101631467|NCT00771472|Vorinostat|vorinostat|mesh-list
101333511|NCT00039364|Imatinib Mesylate|imatinib mesylate|mesh-list
101631468|NCT00771472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101631469|NCT00771472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101631470|NCT00771472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101631471|NCT00771472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631472|NCT00771316|Meropenem|meropenem|mesh-list
101631473|NCT00771316|Ertapenem|ertapenem|mesh-list
101631474|NCT00771316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101631475|NCT00771316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101631476|NCT00770770|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
101631477|NCT00770770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101631478|NCT00770770|Glucocorticoids|glucocorticoids|mesh-ancestor
101631479|NCT00770770|Hormones|hormones|mesh-ancestor
101631480|NCT00770770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101631481|NCT00770770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631482|NCT00766636|Gemcitabine|gemcitabine|mesh-list
101631483|NCT00766636|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101631484|NCT00766636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101631485|NCT00766636|Antimetabolites|antimetabolites|mesh-ancestor
101631486|NCT00766636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631487|NCT00766636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101631488|NCT00766636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101631489|NCT00766636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101631490|NCT04348045|Durvalumab|durvalumab|mesh-list
101631491|NCT04348045|Olaparib|olaparib|mesh-list
101631492|NCT04348045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101631493|NCT04348045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101631494|NCT04348045|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101631495|NCT04348045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101631496|NCT04348045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631497|NCT02581969|Factor VIII|factor viii|mesh-list
101631498|NCT02581969|Coagulants|coagulants|mesh-ancestor
101631499|NCT00770692|Eszopiclone|eszopiclone|mesh-list
101721120|NCT05152901|Mydriatics|mydriatics|mesh-ancestor
101631500|NCT00770692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101631501|NCT00770692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101631502|NCT00770692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631503|NCT02816203|Hemostatics|hemostatics|mesh-list
101631504|NCT02816203|Coagulants|coagulants|mesh-ancestor
101631505|NCT04099732|Dabigatran|dabigatran|mesh-list
101631506|NCT04099732|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101631507|NCT04099732|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101631508|NCT04099732|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101631509|NCT04099732|Antimetabolites|antimetabolites|mesh-ancestor
101631510|NCT04099732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631511|NCT04099732|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101631512|NCT04099732|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101631513|NCT04099732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101631514|NCT04099732|Antithrombins|antithrombins|mesh-ancestor
101631515|NCT04099732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101631516|NCT04099732|Protease Inhibitors|protease inhibitors|mesh-ancestor
101631517|NCT04099732|Anticoagulants|anticoagulants|mesh-ancestor
101631518|NCT03183115|Lugol's solution|lugol's solution|mesh-list
101631519|NCT03183115|Hemostatics|hemostatics|mesh-ancestor
101631520|NCT03183115|Coagulants|coagulants|mesh-ancestor
101631521|NCT02743897|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
101631522|NCT02743897|Antiviral Agents|antiviral agents|mesh-ancestor
101631523|NCT02743897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101631524|NCT02743819|Pembrolizumab|pembrolizumab|mesh-list
101631525|NCT02743819|Ipilimumab|ipilimumab|mesh-list
101721155|NCT05064319|Anticonvulsants|anticonvulsants|mesh-ancestor
101631526|NCT02743819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101631527|NCT02743819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101631528|NCT02743819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101631529|NCT02743819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631531|NCT04074421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101631532|NCT04074421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101631533|NCT04074421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101631534|NCT02579707|Ivosidenib|ivosidenib|mesh-list
101631535|NCT02579707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101631536|NCT02579707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101631537|NCT02579707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631538|NCT02713009|Vitamin D|vitamin d|mesh-list
101631539|NCT02713009|Ergocalciferols|ergocalciferols|mesh-list
101631540|NCT02713009|Cholecalciferol|cholecalciferol|mesh-list
101631541|NCT02713009|Vitamins|vitamins|mesh-list
101631542|NCT02713009|Micronutrients|micronutrients|mesh-ancestor
101631543|NCT02713009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631544|NCT02713009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101631545|NCT02713009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101631546|NCT03085225|Durvalumab|durvalumab|mesh-list
101631547|NCT03085225|Trabectedin|trabectedin|mesh-list
101631548|NCT03085225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101631549|NCT03085225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101631550|NCT03085225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101631551|NCT03085225|Alkylating Agents|alkylating agents|mesh-ancestor
101631552|NCT03085225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631554|NCT02705287|Ergocalciferols|ergocalciferols|mesh-list
101631555|NCT02705287|Cholecalciferol|cholecalciferol|mesh-list
101631556|NCT02705287|Vitamins|vitamins|mesh-list
101631557|NCT02705287|Micronutrients|micronutrients|mesh-ancestor
101631558|NCT02705287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631559|NCT02705287|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101631560|NCT02705287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101631561|NCT04295408|Ropivacaine|ropivacaine|mesh-list
101631562|NCT04295408|Anesthetics, Local|anesthetics, local|mesh-ancestor
101631563|NCT04295408|Anesthetics|anesthetics|mesh-ancestor
101631564|NCT04295408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101209974|NCT01449045|Artemether|artemether|mesh-list
101631565|NCT04295408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631566|NCT04295408|Sensory System Agents|sensory system agents|mesh-ancestor
101631567|NCT04295408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101631569|NCT02578537|Ticagrelor|ticagrelor|mesh-list
101631570|NCT02578537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101631571|NCT02578537|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101631572|NCT02578537|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101631573|NCT02578537|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101631574|NCT02578537|Purinergic Agents|purinergic agents|mesh-ancestor
101631575|NCT02578537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101631576|NCT02578537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631577|NCT02578537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631578|NCT03011671|Temozolomide|temozolomide|mesh-list
101631579|NCT03011671|Acetazolamide|acetazolamide|mesh-list
101631580|NCT03011671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101631581|NCT03011671|Alkylating Agents|alkylating agents|mesh-ancestor
101631582|NCT03011671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631583|NCT03011671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101631584|NCT03011671|Anticonvulsants|anticonvulsants|mesh-ancestor
101631585|NCT03011671|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101631586|NCT03011671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101631587|NCT03011671|Diuretics|diuretics|mesh-ancestor
101631588|NCT03011671|Natriuretic Agents|natriuretic agents|mesh-ancestor
101631589|NCT03011671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631590|NCT00628706|Dronabinol|dronabinol|mesh-list
101631591|NCT00628706|Hallucinogens|hallucinogens|mesh-ancestor
101631592|NCT00628706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631593|NCT00628706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101631594|NCT00628706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101631595|NCT00628706|Analgesics|analgesics|mesh-ancestor
101631596|NCT00628706|Sensory System Agents|sensory system agents|mesh-ancestor
101631597|NCT00628706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101631598|NCT00628706|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101631599|NCT00628706|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101631600|NCT00628706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101631601|NCT00628706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631602|NCT00628706|Hormones|hormones|mesh-ancestor
101631603|NCT00628706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101631604|NCT01001234|Rizatriptan|rizatriptan|mesh-list
101631605|NCT01001234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101631606|NCT01001234|Serotonin Agents|serotonin agents|mesh-ancestor
101631607|NCT01001234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101631608|NCT01001234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631609|NCT01001234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631610|NCT01004510|Zoledronic Acid|zoledronic acid|mesh-list
101631611|NCT01004510|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101631612|NCT01004510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631613|NCT02609503|Pembrolizumab|pembrolizumab|mesh-list
101631614|NCT02609503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101631615|NCT02609503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101631616|NCT02609503|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101631617|NCT02609503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631618|NCT04073953|Primaquine|primaquine|mesh-list
101631619|NCT04073953|Antimalarials|antimalarials|mesh-ancestor
101631620|NCT04073953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101631621|NCT04073953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101631622|NCT04073953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101631623|NCT01004432|Golimumab|golimumab|mesh-list
101631624|NCT01004432|Methotrexate|methotrexate|mesh-list
101631625|NCT01004432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101631626|NCT01004432|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101631627|NCT01004432|Abortifacient Agents|abortifacient agents|mesh-ancestor
101631628|NCT01004432|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101631629|NCT01004432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631630|NCT01004432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101631631|NCT01004432|Antimetabolites|antimetabolites|mesh-ancestor
101631632|NCT01004432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631633|NCT01004432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101631634|NCT01004432|Dermatologic Agents|dermatologic agents|mesh-ancestor
101631635|NCT01004432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101631636|NCT01004432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101631637|NCT01004432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101631638|NCT01004432|Immunologic Factors|immunologic factors|mesh-ancestor
101631639|NCT01004432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101631640|NCT01004432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101631641|NCT01004432|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101631642|NCT01004432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101631643|NCT02539537|Leucovorin|leucovorin|mesh-list
101631644|NCT02539537|Folic Acid|folic acid|mesh-list
101631645|NCT02539537|Gemcitabine|gemcitabine|mesh-list
101631646|NCT02539537|Fluorouracil|fluorouracil|mesh-list
101631647|NCT02539537|Oxaliplatin|oxaliplatin|mesh-list
101631648|NCT02539537|Irinotecan|irinotecan|mesh-list
101631649|NCT02539537|Levoleucovorin|levoleucovorin|mesh-list
101631650|NCT02539537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101631651|NCT02539537|Antimetabolites|antimetabolites|mesh-ancestor
101631652|NCT02539537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631653|NCT02539537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101631654|NCT02539537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101631655|NCT02539537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101631656|NCT02539537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101631657|NCT02539537|Antidotes|antidotes|mesh-ancestor
101631658|NCT02539537|Protective Agents|protective agents|mesh-ancestor
101631659|NCT02539537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631660|NCT02539537|Vitamin B Complex|vitamin b complex|mesh-ancestor
101631661|NCT02539537|Vitamins|vitamins|mesh-ancestor
101631662|NCT02539537|Micronutrients|micronutrients|mesh-ancestor
101631663|NCT02539537|Hematinics|hematinics|mesh-ancestor
101631664|NCT02539537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101631665|NCT02539537|Immunologic Factors|immunologic factors|mesh-ancestor
101631666|NCT02576275|Rituximab|rituximab|mesh-list
101631667|NCT02576275|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101631668|NCT02576275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101631669|NCT02576275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101631670|NCT02576275|Immunologic Factors|immunologic factors|mesh-ancestor
101631671|NCT02576275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631672|NCT02576275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101631673|NCT02576275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101631674|NCT02576275|Alkylating Agents|alkylating agents|mesh-ancestor
101631675|NCT02576275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631676|NCT01000610|Methylprednisolone|methylprednisolone|mesh-list
101631677|NCT01000610|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101631678|NCT01000610|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101631679|NCT01000610|Prednisolone|prednisolone|mesh-list
101631680|NCT01000610|Prednisolone acetate|prednisolone acetate|mesh-list
101631681|NCT01000610|Rituximab|rituximab|mesh-list
101631682|NCT01000610|Methotrexate|methotrexate|mesh-list
101631683|NCT01000610|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101631684|NCT01000610|Prednisolone phosphate|prednisolone phosphate|mesh-list
101721447|NCT04022005|Rituximab|rituximab|mesh-list
101631685|NCT01000610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101631686|NCT01000610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101631688|NCT01000610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631689|NCT01000610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101631690|NCT01000610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101631691|NCT01000610|Abortifacient Agents|abortifacient agents|mesh-ancestor
101631692|NCT01000610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101631693|NCT01000610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101631694|NCT01000610|Antimetabolites|antimetabolites|mesh-ancestor
101631695|NCT01000610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631696|NCT01000610|Dermatologic Agents|dermatologic agents|mesh-ancestor
101631697|NCT01000610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101631698|NCT01000610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101631699|NCT01000610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101631700|NCT01000610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101631701|NCT01000610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101631703|NCT01000610|Autonomic Agents|autonomic agents|mesh-ancestor
101631704|NCT01000610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101631705|NCT01000610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101631706|NCT01000610|Glucocorticoids|glucocorticoids|mesh-ancestor
101631707|NCT01000610|Hormones|hormones|mesh-ancestor
101631708|NCT01000610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101631709|NCT01000610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101631710|NCT01000610|Protective Agents|protective agents|mesh-ancestor
101631711|NCT01000610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101631712|NCT02523469|Nivolumab|nivolumab|mesh-list
101631713|NCT02523469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101631714|NCT02523469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101631715|NCT02523469|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101631716|NCT02523469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631718|NCT00586924|Immunotoxins|immunotoxins|mesh-ancestor
101631719|NCT00586924|Immunoconjugates|immunoconjugates|mesh-ancestor
101631720|NCT00586924|Immunologic Factors|immunologic factors|mesh-ancestor
101631721|NCT00586924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631722|NCT00586924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101631723|NCT04211961|Scopolamine|scopolamine|mesh-list
101631724|NCT04211961|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101631725|NCT04211961|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101631726|NCT04211961|Antiemetics|antiemetics|mesh-ancestor
101631727|NCT04211961|Autonomic Agents|autonomic agents|mesh-ancestor
101631728|NCT04211961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101631729|NCT04211961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631730|NCT04211961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101631731|NCT04211961|Mydriatics|mydriatics|mesh-ancestor
101631732|NCT04211961|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101631733|NCT04211961|Cholinergic Agents|cholinergic agents|mesh-ancestor
101631734|NCT04211961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101631735|NCT04211961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631736|NCT04211961|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101631737|NCT04211961|Parasympatholytics|parasympatholytics|mesh-ancestor
101631738|NCT01000376|Ketoconazole|ketoconazole|mesh-list
101631739|NCT01000376|Antifungal Agents|antifungal agents|mesh-ancestor
101631740|NCT01000376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101631741|NCT01000376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101631742|NCT01000376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101631743|NCT01000376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101631744|NCT01000376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631745|NCT01000376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101631747|NCT01000376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101631748|NCT01000376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631749|NCT01000376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101631750|NCT01038635|Lenalidomide|lenalidomide|mesh-list
101631751|NCT01038635|Azacitidine|azacitidine|mesh-list
101631752|NCT01038635|Immunologic Factors|immunologic factors|mesh-ancestor
101631753|NCT01038635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631754|NCT01038635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101631755|NCT01038635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101631756|NCT01038635|Growth Substances|growth substances|mesh-ancestor
101631757|NCT01038635|Growth Inhibitors|growth inhibitors|mesh-ancestor
101631758|NCT01038635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101631759|NCT01038635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101631760|NCT01038635|Antimetabolites|antimetabolites|mesh-ancestor
101631761|NCT01038635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631762|NCT01038635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101631763|NCT00619203|Acetaminophen|acetaminophen|mesh-list
101631764|NCT00619203|Glycerol|glycerol|mesh-list
101631765|NCT00619203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101631767|NCT00619203|Sensory System Agents|sensory system agents|mesh-ancestor
101631768|NCT00619203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101631769|NCT00619203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631770|NCT00619203|Antipyretics|antipyretics|mesh-ancestor
101631771|NCT00619203|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101631772|NCT00619203|Protective Agents|protective agents|mesh-ancestor
101631774|NCT04072471|Gout Suppressants|gout suppressants|mesh-ancestor
101631775|NCT04072471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101631776|NCT04072471|Uricosuric Agents|uricosuric agents|mesh-ancestor
101631777|NCT01000064|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101631778|NCT01000064|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101631779|NCT01000064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631780|NCT01000064|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101631781|NCT01000064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101631782|NCT01000064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101631783|NCT01000064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631784|NCT01000064|Dopamine Agents|dopamine agents|mesh-ancestor
101631785|NCT01000064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101631786|NCT01812603|Nabiximols|nabiximols|mesh-list
101631787|NCT01812603|Analgesics|analgesics|mesh-ancestor
101631788|NCT01812603|Sensory System Agents|sensory system agents|mesh-ancestor
101631789|NCT01812603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101631790|NCT01812603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631791|NCT04211805|Tenofovir|tenofovir|mesh-list
101631792|NCT04211805|Vaccines|vaccines|mesh-list
101631793|NCT04211805|Immunologic Factors|immunologic factors|mesh-ancestor
101631794|NCT04211805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631795|NCT04211805|Antiviral Agents|antiviral agents|mesh-ancestor
101631796|NCT04211805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101631797|NCT04211805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101631798|NCT04211805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101631799|NCT04211805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101631800|NCT04211805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631801|NCT04211805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101631802|NCT04211805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101631803|NCT02874287|Hydroxychloroquine|hydroxychloroquine|mesh-list
101631804|NCT02874287|Antimalarials|antimalarials|mesh-ancestor
101631805|NCT02874287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101631806|NCT02874287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101631807|NCT02874287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101631808|NCT02874287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101631809|NCT02874287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631810|NCT02874287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101631811|NCT00580801|Interferons|interferons|mesh-list
101631812|NCT00580801|Ribavirin|ribavirin|mesh-list
101631813|NCT00580801|Interferon-alpha|interferon-alpha|mesh-list
101631814|NCT00580801|Interferon alpha-2|interferon alpha-2|mesh-list
101631815|NCT00580801|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101631816|NCT00580801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101631817|NCT00580801|Antiviral Agents|antiviral agents|mesh-ancestor
101631818|NCT00580801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101631819|NCT00580801|Antimetabolites|antimetabolites|mesh-ancestor
101631820|NCT00580801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631821|NCT00580801|Immunologic Factors|immunologic factors|mesh-ancestor
101631822|NCT00580801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631823|NCT00619671|Rituximab|rituximab|mesh-list
101631824|NCT00619671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101631825|NCT00619671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101631826|NCT00619671|Immunologic Factors|immunologic factors|mesh-ancestor
101631827|NCT00619671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631828|NCT00619671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101631829|NCT00628550|Vasopressins|vasopressins|mesh-list
101631830|NCT00628550|Arginine Vasopressin|arginine vasopressin|mesh-list
101631831|NCT00628550|Epinephrine|epinephrine|mesh-list
101631832|NCT00628550|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101631833|NCT00628550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101631834|NCT00628550|Adrenergic Agents|adrenergic agents|mesh-ancestor
101631835|NCT00628550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101631836|NCT00628550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631837|NCT00628550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631838|NCT00628550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101631839|NCT00628550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101631840|NCT00628550|Autonomic Agents|autonomic agents|mesh-ancestor
101631841|NCT00628550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101631842|NCT00628550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101631843|NCT00628550|Respiratory System Agents|respiratory system agents|mesh-ancestor
101631844|NCT00628550|Mydriatics|mydriatics|mesh-ancestor
101631845|NCT00628550|Sympathomimetics|sympathomimetics|mesh-ancestor
101631846|NCT00628550|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101631847|NCT00628550|Hemostatics|hemostatics|mesh-ancestor
101631848|NCT00628550|Coagulants|coagulants|mesh-ancestor
101631849|NCT00628550|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101631850|NCT00628550|Natriuretic Agents|natriuretic agents|mesh-ancestor
101631851|NCT01059539|Cariprazine|cariprazine|mesh-list
101631852|NCT01059539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101631853|NCT01059539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101631854|NCT01059539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101631855|NCT01059539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631856|NCT01059539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101631858|NCT00999908|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101631859|NCT00999908|Autonomic Agents|autonomic agents|mesh-ancestor
101631860|NCT00999908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101631861|NCT00999908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631862|NCT00999908|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101631863|NCT00999908|Respiratory System Agents|respiratory system agents|mesh-ancestor
101631864|NCT00999908|Parasympatholytics|parasympatholytics|mesh-ancestor
101631865|NCT00999908|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101631866|NCT00999908|Cholinergic Agents|cholinergic agents|mesh-ancestor
101631867|NCT00999908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101631868|NCT00999908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631870|NCT02576119|BMS-955176|bms-955176|mesh-list
101631871|NCT02576119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101631872|NCT02576119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101631873|NCT02576119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101631874|NCT02576119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101631875|NCT02576119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101631876|NCT02576119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631877|NCT02576119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101631878|NCT02576119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101631879|NCT02576119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101631880|NCT02576119|Antiviral Agents|antiviral agents|mesh-ancestor
101631881|NCT02871518|Cisplatin|cisplatin|mesh-list
101631882|NCT02871518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101631883|NCT04304144|Dexamethasone|dexamethasone|mesh-list
101631884|NCT04304144|Cyclophosphamide|cyclophosphamide|mesh-list
101631885|NCT04304144|Bortezomib|bortezomib|mesh-list
101631886|NCT04304144|Daratumumab|daratumumab|mesh-list
101631887|NCT04304144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101631888|NCT04304144|Immunologic Factors|immunologic factors|mesh-ancestor
101631889|NCT04304144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631890|NCT04304144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101631891|NCT04304144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101631892|NCT04304144|Alkylating Agents|alkylating agents|mesh-ancestor
101631893|NCT04304144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631894|NCT04304144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101631895|NCT04304144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101631896|NCT04304144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101631897|NCT04304144|Antiemetics|antiemetics|mesh-ancestor
101631898|NCT04304144|Autonomic Agents|autonomic agents|mesh-ancestor
101631899|NCT04304144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101631900|NCT04304144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101631901|NCT04304144|Glucocorticoids|glucocorticoids|mesh-ancestor
101631902|NCT04304144|Hormones|hormones|mesh-ancestor
101631903|NCT04304144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101631904|NCT04304144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101631905|NCT04676867|Dalcetrapib|dalcetrapib|mesh-list
101631906|NCT04676867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101631907|NCT04676867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101631908|NCT04676867|Antimetabolites|antimetabolites|mesh-ancestor
101631909|NCT04676867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631910|NCT04676867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101631911|NCT00770224|Prednisone|prednisone|mesh-list
101631912|NCT00770224|Cyclophosphamide|cyclophosphamide|mesh-list
101631913|NCT00770224|Rituximab|rituximab|mesh-list
101631914|NCT00770224|Doxorubicin|doxorubicin|mesh-list
101631915|NCT00770224|Vincristine|vincristine|mesh-list
101631916|NCT00770224|Tositumomab I-131|tositumomab i-131|mesh-list
101631917|NCT00770224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101631918|NCT00770224|Immunologic Factors|immunologic factors|mesh-ancestor
101631919|NCT00770224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631920|NCT00770224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101631921|NCT00770224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101631922|NCT00770224|Alkylating Agents|alkylating agents|mesh-ancestor
101451711|NCT00196469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101631923|NCT00770224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631924|NCT00770224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101631925|NCT00770224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101631926|NCT00770224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101631927|NCT00770224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101631928|NCT00770224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101631929|NCT00770224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101631931|NCT00770224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101631932|NCT00770224|Glucocorticoids|glucocorticoids|mesh-ancestor
101631933|NCT00770224|Hormones|hormones|mesh-ancestor
101631934|NCT00770224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101631935|NCT00770224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101631936|NCT00770224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101631937|NCT00770224|Tubulin Modulators|tubulin modulators|mesh-ancestor
101631938|NCT00770224|Antimitotic Agents|antimitotic agents|mesh-ancestor
101631939|NCT00770224|Mitosis Modulators|mitosis modulators|mesh-ancestor
101631940|NCT02399215|Nintedanib|nintedanib|mesh-list
101631941|NCT02399215|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101631942|NCT02399215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101631943|NCT02399215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101631944|NCT02399215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101631945|NCT02399215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631946|NCT02389465|Celecoxib|celecoxib|mesh-list
101631947|NCT02389465|Dexetimide|dexetimide|mesh-list
101631948|NCT02389465|Citalopram|citalopram|mesh-list
101631949|NCT02389465|Escitalopram|escitalopram|mesh-list
101631950|NCT02389465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101631951|NCT02389465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101631952|NCT02389465|Analgesics|analgesics|mesh-ancestor
101631953|NCT02389465|Sensory System Agents|sensory system agents|mesh-ancestor
101631954|NCT02389465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101631955|NCT02389465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631956|NCT02389465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101631957|NCT02389465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101631958|NCT02389465|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101631959|NCT02389465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101631960|NCT02389465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101631961|NCT02389465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631962|NCT02389465|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101631963|NCT02389465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101631964|NCT02389465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101631965|NCT02389465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101631966|NCT02389465|Serotonin Agents|serotonin agents|mesh-ancestor
101631967|NCT02389465|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101631968|NCT02389465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101631969|NCT02389465|Parasympatholytics|parasympatholytics|mesh-ancestor
101631970|NCT02389465|Autonomic Agents|autonomic agents|mesh-ancestor
101631971|NCT02389465|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101631972|NCT02389465|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101631973|NCT02389465|Cholinergic Agents|cholinergic agents|mesh-ancestor
101631974|NCT02389465|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101631975|NCT02389465|Antidepressive Agents|antidepressive agents|mesh-ancestor
101631976|NCT02389465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101631977|NCT01057589|Folic Acid|folic acid|mesh-list
101631978|NCT01057589|Vitamin B 12|vitamin b 12|mesh-list
101631979|NCT01057589|Pemetrexed|pemetrexed|mesh-list
101631980|NCT01057589|Cetuximab|cetuximab|mesh-list
101631981|NCT01057589|Vitamins|vitamins|mesh-ancestor
101631982|NCT01057589|Micronutrients|micronutrients|mesh-ancestor
101631983|NCT01057589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631984|NCT01057589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101631985|NCT01057589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101631986|NCT01057589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101631987|NCT01057589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101631988|NCT01057589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101631989|NCT01057589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101631990|NCT01057589|Hematinics|hematinics|mesh-ancestor
101631991|NCT01057589|Vitamin B Complex|vitamin b complex|mesh-ancestor
101631992|NCT02575885|Nicotine|nicotine|mesh-list
101631993|NCT02575885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101631994|NCT02575885|Autonomic Agents|autonomic agents|mesh-ancestor
101631995|NCT02575885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101631996|NCT02575885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101631997|NCT02575885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101631998|NCT02575885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101631999|NCT02575885|Cholinergic Agents|cholinergic agents|mesh-ancestor
101632000|NCT02575885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101632001|NCT02575885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632003|NCT02575729|Glucocorticoids|glucocorticoids|mesh-list
101632004|NCT02575729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101632005|NCT02575729|Hormones|hormones|mesh-ancestor
101632006|NCT02575729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101632007|NCT02575729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632008|NCT02575729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101632009|NCT02575729|Respiratory System Agents|respiratory system agents|mesh-ancestor
101632010|NCT02575651|Fluzoparib|fluzoparib|mesh-list
101632011|NCT02575651|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101632012|NCT02575651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101632013|NCT02575651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632014|NCT02575651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101632015|NCT01716117|Calcium Carbonate|calcium carbonate|mesh-list
101632016|NCT01716117|Antacids|antacids|mesh-ancestor
101632017|NCT01716117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632018|NCT01716117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101632019|NCT00579553|Progesterone|progesterone|mesh-list
101632020|NCT00579553|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
101632021|NCT00579553|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
101632022|NCT00579553|Progestins|progestins|mesh-ancestor
101632023|NCT00579553|Hormones|hormones|mesh-ancestor
101632024|NCT00579553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101632025|NCT00579553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632026|NCT00579553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101632027|NCT00579553|Hormone Antagonists|hormone antagonists|mesh-ancestor
101632028|NCT04209933|Potassium Citrate|potassium citrate|mesh-list
101632029|NCT04209933|Bismuth|bismuth|mesh-list
101632030|NCT04209933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632031|NCT04209933|Antacids|antacids|mesh-ancestor
101632032|NCT04209933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101632033|NCT04209933|Diuretics|diuretics|mesh-ancestor
101632034|NCT04209933|Natriuretic Agents|natriuretic agents|mesh-ancestor
101632035|NCT04209933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632036|NCT04209933|Expectorants|expectorants|mesh-ancestor
101632037|NCT04209933|Respiratory System Agents|respiratory system agents|mesh-ancestor
101632038|NCT00619905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101722017|NCT00755950|Silymarin|silymarin|mesh-list
101632039|NCT00619905|Immunologic Factors|immunologic factors|mesh-ancestor
101632040|NCT00619905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632041|NCT04209699|Deucravacitinib|deucravacitinib|mesh-list
101632042|NCT04209699|Famotidine|famotidine|mesh-list
101632043|NCT04209699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101632044|NCT04209699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101632045|NCT04209699|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101632046|NCT04209699|Histamine Antagonists|histamine antagonists|mesh-ancestor
101632047|NCT04209699|Histamine Agents|histamine agents|mesh-ancestor
101632048|NCT04209699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101632049|NCT04209699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632050|NCT04209699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632051|NCT04209699|Dermatologic Agents|dermatologic agents|mesh-ancestor
101632052|NCT04209699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101632053|NCT04209699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101632054|NCT00620295|Gemcitabine|gemcitabine|mesh-list
101632055|NCT00620295|Bortezomib|bortezomib|mesh-list
101632056|NCT00620295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101632057|NCT00620295|Antimetabolites|antimetabolites|mesh-ancestor
101632058|NCT00620295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632059|NCT00620295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101632060|NCT00581893|Phenytoin|phenytoin|mesh-list
101632061|NCT00581893|Anticonvulsants|anticonvulsants|mesh-ancestor
101632062|NCT00581893|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101632063|NCT00581893|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101632064|NCT00581893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101632065|NCT00581893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632066|NCT00581893|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101210477|NCT05962255|Furosemide|furosemide|mesh-list
101632067|NCT00581893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101632069|NCT04211103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101632070|NCT04211103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379446|NCT00104949|Trastuzumab|trastuzumab|mesh-list
101632071|NCT04211103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101632072|NCT04211103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632073|NCT04209777|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101632074|NCT04209777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101632075|NCT02334865|Lenalidomide|lenalidomide|mesh-list
101632076|NCT02334865|Sargramostim|sargramostim|mesh-list
101632077|NCT02334865|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101632078|NCT02334865|Freund's Adjuvant|freund's adjuvant|mesh-list
101632079|NCT02334865|Immunologic Factors|immunologic factors|mesh-ancestor
101632080|NCT02334865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632081|NCT02334865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101632082|NCT02334865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101632083|NCT02334865|Growth Substances|growth substances|mesh-ancestor
101632084|NCT02334865|Growth Inhibitors|growth inhibitors|mesh-ancestor
101632085|NCT02334865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101632086|NCT02334865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101632087|NCT04073719|Acetic Acid|acetic acid|mesh-list
101632088|NCT04073719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101632089|NCT04073719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101632090|NCT00379431|Methylprednisolone|methylprednisolone|mesh-list
101632091|NCT00379431|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101632092|NCT00379431|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101632093|NCT00379431|Prednisolone|prednisolone|mesh-list
101632094|NCT00379431|Prednisolone acetate|prednisolone acetate|mesh-list
101632095|NCT00379431|Rituximab|rituximab|mesh-list
101632096|NCT00379431|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101632097|NCT00379431|Prednisolone phosphate|prednisolone phosphate|mesh-list
101632098|NCT00379431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101632099|NCT00379431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101632100|NCT00379431|Immunologic Factors|immunologic factors|mesh-ancestor
101632101|NCT00379431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632102|NCT00379431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101632103|NCT00379431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101632104|NCT00379431|Antiemetics|antiemetics|mesh-ancestor
101632105|NCT00379431|Autonomic Agents|autonomic agents|mesh-ancestor
101632106|NCT00379431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101632107|NCT00379431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101632108|NCT00379431|Glucocorticoids|glucocorticoids|mesh-ancestor
101632109|NCT00379431|Hormones|hormones|mesh-ancestor
101646173|NCT02582476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632110|NCT00379431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101632111|NCT00379431|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101632112|NCT00379431|Protective Agents|protective agents|mesh-ancestor
101632113|NCT00379431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101632114|NCT04954989|Epoetin Alfa|epoetin alfa|mesh-list
101632115|NCT04954989|Hematinics|hematinics|mesh-ancestor
101632116|NCT00621699|Ezetimibe|ezetimibe|mesh-list
101632117|NCT00621699|Tacrolimus|tacrolimus|mesh-list
101632118|NCT00621699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101632119|NCT00621699|Immunologic Factors|immunologic factors|mesh-ancestor
101632120|NCT00621699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632121|NCT00621699|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101632122|NCT00621699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101632123|NCT00621699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632124|NCT00621699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101632125|NCT00621699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101632126|NCT00621699|Antimetabolites|antimetabolites|mesh-ancestor
101632127|NCT00621699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101632128|NCT00612183|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101632129|NCT00612183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101632130|NCT00612183|Alkylating Agents|alkylating agents|mesh-ancestor
101632131|NCT00612183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632132|NCT00612183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101632133|NCT00770146|Mipomersen|mipomersen|mesh-list
101632134|NCT00770146|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101632135|NCT00770146|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101632136|NCT00770146|Antimetabolites|antimetabolites|mesh-ancestor
101632137|NCT00770146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632138|NCT00770146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101632139|NCT00915850|Cisplatin|cisplatin|mesh-list
101632140|NCT00915850|Docetaxel|docetaxel|mesh-list
101632141|NCT00915850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101632142|NCT00915850|Tubulin Modulators|tubulin modulators|mesh-ancestor
101632143|NCT00915850|Antimitotic Agents|antimitotic agents|mesh-ancestor
101632144|NCT00915850|Mitosis Modulators|mitosis modulators|mesh-ancestor
101775306|NCT00936195|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101632145|NCT00915850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632147|NCT04208763|Colistin|colistin|mesh-list
101632148|NCT04208763|Tigecycline|tigecycline|mesh-list
101632149|NCT04208763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101632150|NCT04208763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101632151|NCT04208763|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101632152|NCT04208763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101632153|NCT04208763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632154|NCT00620919|Secretin|secretin|mesh-list
101632155|NCT00620919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101632156|NCT00620919|Hormones|hormones|mesh-ancestor
101632157|NCT00620919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101632158|NCT00620919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632159|NCT00916552|Epoetin Alfa|epoetin alfa|mesh-list
101632160|NCT00916552|Hematinics|hematinics|mesh-ancestor
101632161|NCT03950037|Albendazole|albendazole|mesh-list
101632162|NCT03950037|Anthelmintics|anthelmintics|mesh-ancestor
101632163|NCT03950037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101632164|NCT03950037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101632165|NCT03950037|Anticestodal Agents|anticestodal agents|mesh-ancestor
101632166|NCT03950037|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101632167|NCT03950037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101632168|NCT03950037|Tubulin Modulators|tubulin modulators|mesh-ancestor
101632169|NCT03950037|Antimitotic Agents|antimitotic agents|mesh-ancestor
101632170|NCT03950037|Mitosis Modulators|mitosis modulators|mesh-ancestor
101632171|NCT03950037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632172|NCT03950037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101632173|NCT04188171|Polidocanol|polidocanol|mesh-list
101632174|NCT04188171|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
101632175|NCT04188171|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101632176|NCT00620997|Proxymetacaine|proxymetacaine|mesh-list
101632177|NCT00620997|Anesthetics, Local|anesthetics, local|mesh-ancestor
101632178|NCT00620997|Anesthetics|anesthetics|mesh-ancestor
101632179|NCT00620997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101632180|NCT00620997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632181|NCT00620997|Sensory System Agents|sensory system agents|mesh-ancestor
101632182|NCT00620997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101632183|NCT00622011|Risperidone|risperidone|mesh-list
101632184|NCT00622011|Zotepine|zotepine|mesh-list
101632185|NCT00622011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101632186|NCT00622011|Serotonin Agents|serotonin agents|mesh-ancestor
101632187|NCT00622011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101632188|NCT00622011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632189|NCT00622011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632190|NCT00622011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101632191|NCT00622011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101632192|NCT00622011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101632193|NCT00622011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101632194|NCT00622011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101632195|NCT00622011|Dopamine Agents|dopamine agents|mesh-ancestor
101632196|NCT03936309|Lidocaine|lidocaine|mesh-list
101632197|NCT03936309|Anesthetics, Local|anesthetics, local|mesh-ancestor
101632198|NCT03936309|Anesthetics|anesthetics|mesh-ancestor
101632199|NCT03936309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101632200|NCT03936309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632201|NCT03936309|Sensory System Agents|sensory system agents|mesh-ancestor
101632202|NCT03936309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101632203|NCT03936309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101632204|NCT03936309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101632205|NCT03936309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101632206|NCT03936309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101632207|NCT03936309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632208|NCT04208373|Itraconazole|itraconazole|mesh-list
101632209|NCT04208373|Etravirine|etravirine|mesh-list
101632210|NCT04208373|Antifungal Agents|antifungal agents|mesh-ancestor
101632211|NCT04208373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101632212|NCT04208373|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101632213|NCT04208373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101632214|NCT04208373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101632215|NCT04208373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632216|NCT04208373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101632217|NCT04208373|Hormone Antagonists|hormone antagonists|mesh-ancestor
101632218|NCT04208373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101632219|NCT04208373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632220|NCT04208373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101632221|NCT04208373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101632222|NCT04208373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101632223|NCT04208373|Antiviral Agents|antiviral agents|mesh-ancestor
101632224|NCT00622245|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101632225|NCT00622245|Antidepressive Agents|antidepressive agents|mesh-ancestor
101632226|NCT00622245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101632227|NCT00622245|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101632228|NCT00622245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101632229|NCT00622245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101632230|NCT00622245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632231|NCT01056341|Propranolol|propranolol|mesh-list
101632232|NCT01056341|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101632233|NCT01056341|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101632234|NCT01056341|Adrenergic Agents|adrenergic agents|mesh-ancestor
101632235|NCT01056341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101632236|NCT01056341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632237|NCT01056341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632238|NCT01056341|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101632239|NCT01056341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101632240|NCT01056341|Vasodilator Agents|vasodilator agents|mesh-ancestor
101632241|NCT00999518|Tanezumab|tanezumab|mesh-list
101632242|NCT00999518|Analgesics|analgesics|mesh-ancestor
101632243|NCT00999518|Sensory System Agents|sensory system agents|mesh-ancestor
101632244|NCT00999518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101632245|NCT00999518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632246|NCT00621387|Ofloxacin|ofloxacin|mesh-list
101632247|NCT00621387|Roxithromycin|roxithromycin|mesh-list
101632248|NCT00621387|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101632249|NCT00621387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101632250|NCT00621387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101632251|NCT00621387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101632252|NCT00621387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101632253|NCT00621387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101722217|NCT00705588|Tadalafil|tadalafil|mesh-list
101632254|NCT00621387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632255|NCT00621387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101632256|NCT00621387|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101632257|NCT00621387|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101632258|NCT02873273|Dexamethasone|dexamethasone|mesh-list
101632259|NCT02873273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101632260|NCT02873273|Antiemetics|antiemetics|mesh-ancestor
101632261|NCT02873273|Autonomic Agents|autonomic agents|mesh-ancestor
101632262|NCT02873273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101632263|NCT02873273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632264|NCT02873273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101632265|NCT02873273|Glucocorticoids|glucocorticoids|mesh-ancestor
101632266|NCT02873273|Hormones|hormones|mesh-ancestor
101632267|NCT02873273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101632268|NCT02873273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101632269|NCT02873273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101632271|NCT04208841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101632272|NCT01056263|Axitinib|axitinib|mesh-list
101632273|NCT01056263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101632274|NCT01056263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101632275|NCT01056263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101632276|NCT01056263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632277|NCT00637143|Cyclosporine|cyclosporine|mesh-list
101632278|NCT00637143|Tacrolimus|tacrolimus|mesh-list
101632279|NCT00637143|Cyclosporins|cyclosporins|mesh-list
101632280|NCT00637143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101632281|NCT00637143|Immunologic Factors|immunologic factors|mesh-ancestor
101632282|NCT00637143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632283|NCT00637143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101632284|NCT00637143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101632285|NCT00637143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632286|NCT00637143|Antifungal Agents|antifungal agents|mesh-ancestor
101632287|NCT00637143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101632288|NCT00637143|Dermatologic Agents|dermatologic agents|mesh-ancestor
101632289|NCT00637143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101632290|NCT01056107|Glucagon|glucagon|mesh-list
101632291|NCT01056107|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101632292|NCT01056107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101632293|NCT01056107|Hormones|hormones|mesh-ancestor
101722257|NCT00840294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101632294|NCT01056107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101632295|NCT01056107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632297|NCT03548805|Mitomycins|mitomycins|mesh-list
101632298|NCT03548805|Mitomycin|mitomycin|mesh-list
101632299|NCT03548805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101632300|NCT03548805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101632301|NCT03548805|Alkylating Agents|alkylating agents|mesh-ancestor
101632302|NCT03548805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632303|NCT03548805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101632304|NCT03548805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101632305|NCT01003886|Doxazosin|doxazosin|mesh-list
101632306|NCT01003886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101632307|NCT01003886|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101632308|NCT01003886|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101632309|NCT01003886|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101632310|NCT01003886|Adrenergic Agents|adrenergic agents|mesh-ancestor
101632311|NCT01003886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101632312|NCT01003886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632313|NCT01003886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632314|NCT04138641|Cangrelor|cangrelor|mesh-list
101632316|NCT04138641|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101632317|NCT04138641|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101632318|NCT04138641|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101632319|NCT04138641|Purinergic Agents|purinergic agents|mesh-ancestor
101632320|NCT04138641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101632321|NCT04138641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632322|NCT04138641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632323|NCT01003184|Exenatide|exenatide|mesh-list
101632324|NCT01003184|Insulin Detemir|insulin detemir|mesh-list
101722293|NCT02560636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101722294|NCT02560636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101722295|NCT02560636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722296|NCT00758212|Vaccines|vaccines|mesh-list
101722297|NCT00758212|Immunologic Factors|immunologic factors|mesh-ancestor
101722298|NCT00758212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379745|NCT00261586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101722328|NCT00680056|Formoterol Fumarate|formoterol fumarate|mesh-list
101722329|NCT00680056|Tiotropium Bromide|tiotropium bromide|mesh-list
101722330|NCT00680056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101722331|NCT00680056|Autonomic Agents|autonomic agents|mesh-ancestor
101722332|NCT00680056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101722333|NCT00680056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722334|NCT00680056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101722335|NCT00680056|Respiratory System Agents|respiratory system agents|mesh-ancestor
101722336|NCT00680056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101632325|NCT01003184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101632326|NCT01003184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632327|NCT01003184|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101632328|NCT01003184|Incretins|incretins|mesh-ancestor
101632329|NCT01003184|Hormones|hormones|mesh-ancestor
101632330|NCT01003184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101632331|NCT04314219|Cyclophosphamide|cyclophosphamide|mesh-list
101632332|NCT04314219|Methotrexate|methotrexate|mesh-list
101632333|NCT04314219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101632334|NCT04314219|Immunologic Factors|immunologic factors|mesh-ancestor
101632335|NCT04314219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632336|NCT04314219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101632337|NCT04314219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101632338|NCT04314219|Alkylating Agents|alkylating agents|mesh-ancestor
101333523|NCT00039403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101632339|NCT04314219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632340|NCT04314219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101632341|NCT04314219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101632342|NCT04314219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101632343|NCT04314219|Abortifacient Agents|abortifacient agents|mesh-ancestor
101632344|NCT04314219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101632345|NCT04314219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101632346|NCT04314219|Antimetabolites|antimetabolites|mesh-ancestor
101632347|NCT04314219|Dermatologic Agents|dermatologic agents|mesh-ancestor
101632348|NCT04314219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101632349|NCT04314219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101632350|NCT04314219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101632351|NCT02407119|Amoxicillin|amoxicillin|mesh-list
101632352|NCT02407119|Clarithromycin|clarithromycin|mesh-list
101632353|NCT02407119|Omeprazole|omeprazole|mesh-list
101632354|NCT02407119|Rabeprazole|rabeprazole|mesh-list
101632355|NCT02407119|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101632356|NCT02407119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101632357|NCT02407119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101632358|NCT02407119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101632359|NCT02407119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101632360|NCT02407119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101632361|NCT02407119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632362|NCT02407119|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101632363|NCT02407119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101632364|NCT02407119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101632365|NCT01008410|Budesonide|budesonide|mesh-list
101632366|NCT01008410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101632367|NCT01008410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101632368|NCT01008410|Autonomic Agents|autonomic agents|mesh-ancestor
101632369|NCT01008410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101632370|NCT01008410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632371|NCT01008410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101632372|NCT01008410|Respiratory System Agents|respiratory system agents|mesh-ancestor
101632373|NCT01008410|Glucocorticoids|glucocorticoids|mesh-ancestor
101632374|NCT01008410|Hormones|hormones|mesh-ancestor
101289468|NCT01952626|Antipruritics|antipruritics|mesh-ancestor
101632375|NCT01008410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101632376|NCT00627653|Fenofibrate|fenofibrate|mesh-list
101632377|NCT00627653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101632378|NCT00627653|Antimetabolites|antimetabolites|mesh-ancestor
101632379|NCT00627653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632380|NCT00627653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101632381|NCT02347917|Pemetrexed|pemetrexed|mesh-list
101632382|NCT02347917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101632383|NCT02347917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101632384|NCT02347917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632385|NCT02347917|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101632386|NCT02347917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101632387|NCT01972035|Valacyclovir|valacyclovir|mesh-list
101632388|NCT01972035|Valganciclovir|valganciclovir|mesh-list
101632389|NCT01972035|Antiviral Agents|antiviral agents|mesh-ancestor
101632390|NCT01972035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101632391|NCT00622479|Sorafenib|sorafenib|mesh-list
101632392|NCT00622479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101632393|NCT00622479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101632394|NCT00622479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101632395|NCT00622479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632396|NCT01207011|Docetaxel|docetaxel|mesh-list
101632397|NCT01207011|Amrubicin|amrubicin|mesh-list
101632398|NCT01207011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101632399|NCT01207011|Tubulin Modulators|tubulin modulators|mesh-ancestor
101632400|NCT01207011|Antimitotic Agents|antimitotic agents|mesh-ancestor
101632401|NCT01207011|Mitosis Modulators|mitosis modulators|mesh-ancestor
101632402|NCT01207011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632403|NCT05264805|Bupivacaine|bupivacaine|mesh-list
101632404|NCT05264805|Anesthetics, Local|anesthetics, local|mesh-ancestor
101632405|NCT05264805|Anesthetics|anesthetics|mesh-ancestor
101632406|NCT05264805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101632407|NCT05264805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632408|NCT05264805|Sensory System Agents|sensory system agents|mesh-ancestor
101632409|NCT05264805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101632410|NCT05264493|Naloxone|naloxone|mesh-list
101632411|NCT05264493|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101632412|NCT05264493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632413|NCT05264493|Sensory System Agents|sensory system agents|mesh-ancestor
101632414|NCT05264493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101632415|NCT00612261|Triamcinolone|triamcinolone|mesh-list
101632416|NCT00612261|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101632417|NCT00612261|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101632418|NCT00612261|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101632419|NCT00612261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101632420|NCT00612261|Glucocorticoids|glucocorticoids|mesh-ancestor
101632421|NCT00612261|Hormones|hormones|mesh-ancestor
101632422|NCT00612261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101632423|NCT00612261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632424|NCT00612261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101632425|NCT00612261|Immunologic Factors|immunologic factors|mesh-ancestor
101632426|NCT00612261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101632427|NCT00612261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632428|NCT00636909|Cyclosporine|cyclosporine|mesh-list
101632429|NCT00636909|Cyclophosphamide|cyclophosphamide|mesh-list
101632430|NCT00636909|Methotrexate|methotrexate|mesh-list
101632431|NCT00636909|Fludarabine|fludarabine|mesh-list
101632432|NCT00636909|Cyclosporins|cyclosporins|mesh-list
101632433|NCT00636909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101632434|NCT00636909|Immunologic Factors|immunologic factors|mesh-ancestor
101632435|NCT00636909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632436|NCT00636909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101632437|NCT00636909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101632438|NCT00636909|Alkylating Agents|alkylating agents|mesh-ancestor
101632439|NCT00636909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632440|NCT00636909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101632441|NCT00636909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101632442|NCT00636909|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101632443|NCT00636909|Abortifacient Agents|abortifacient agents|mesh-ancestor
101632444|NCT00636909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101632445|NCT00636909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101632446|NCT00636909|Antimetabolites|antimetabolites|mesh-ancestor
101632447|NCT00636909|Dermatologic Agents|dermatologic agents|mesh-ancestor
101632448|NCT00636909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101632449|NCT00636909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101632450|NCT00636909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101632451|NCT00636909|Antifungal Agents|antifungal agents|mesh-ancestor
101210879|NCT05801315|Glycine|glycine|mesh-list
101632452|NCT00636909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101632453|NCT00636909|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101632454|NCT02697669|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101632455|NCT02697669|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101632456|NCT02697669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632457|NCT02697201|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101632458|NCT02697201|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101632459|NCT02697201|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101632460|NCT02697201|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101632462|NCT02697045|Antidepressive Agents|antidepressive agents|mesh-ancestor
101632463|NCT02697045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101632464|NCT02697045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101632465|NCT02697045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101632466|NCT02697045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101632467|NCT02697045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632468|NCT02697045|Dopamine Agonists|dopamine agonists|mesh-ancestor
101632469|NCT02697045|Dopamine Agents|dopamine agents|mesh-ancestor
101632470|NCT02697045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101632471|NCT02697045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632472|NCT02697045|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101632473|NCT02697045|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101632474|NCT02697045|Serotonin Agents|serotonin agents|mesh-ancestor
101632475|NCT02697045|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101632476|NCT02697045|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101632477|NCT02697045|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101632478|NCT02697045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101632479|NCT01007942|Trastuzumab|trastuzumab|mesh-list
101632480|NCT01007942|Everolimus|everolimus|mesh-list
101632481|NCT01007942|Vinorelbine|vinorelbine|mesh-list
101632482|NCT01007942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101632483|NCT01007942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101632484|NCT01007942|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101632485|NCT01007942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101632486|NCT01007942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101632487|NCT01007942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632488|NCT01007942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101632489|NCT01007942|Immunologic Factors|immunologic factors|mesh-ancestor
101632490|NCT01007942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632491|NCT01007942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101632492|NCT01007942|Tubulin Modulators|tubulin modulators|mesh-ancestor
101632493|NCT01007942|Antimitotic Agents|antimitotic agents|mesh-ancestor
101632494|NCT01007942|Mitosis Modulators|mitosis modulators|mesh-ancestor
101632495|NCT01023035|Ribavirin|ribavirin|mesh-list
101632496|NCT01023035|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101632497|NCT01023035|Epoetin Alfa|epoetin alfa|mesh-list
101632498|NCT01023035|Antimetabolites|antimetabolites|mesh-ancestor
101632499|NCT01023035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632500|NCT01023035|Antiviral Agents|antiviral agents|mesh-ancestor
101632501|NCT01023035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101632502|NCT01023035|Hematinics|hematinics|mesh-ancestor
101632503|NCT01028651|Treprostinil|treprostinil|mesh-list
101632504|NCT01028651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101632505|NCT00627731|Methylprednisolone|methylprednisolone|mesh-list
101632506|NCT00627731|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101632507|NCT00627731|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101632508|NCT00627731|Prednisolone|prednisolone|mesh-list
101632509|NCT00627731|Prednisolone acetate|prednisolone acetate|mesh-list
101632510|NCT00627731|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101632511|NCT00627731|Prednisolone phosphate|prednisolone phosphate|mesh-list
101632512|NCT00627731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101632513|NCT00627731|Antiemetics|antiemetics|mesh-ancestor
101632514|NCT00627731|Autonomic Agents|autonomic agents|mesh-ancestor
101632515|NCT00627731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101632516|NCT00627731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632517|NCT00627731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101632518|NCT00627731|Glucocorticoids|glucocorticoids|mesh-ancestor
101632519|NCT00627731|Hormones|hormones|mesh-ancestor
101632520|NCT00627731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101632521|NCT00627731|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101632522|NCT00627731|Protective Agents|protective agents|mesh-ancestor
101632523|NCT00627731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101632524|NCT00627731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101632525|NCT01028027|Loteprednol Etabonate|loteprednol etabonate|mesh-list
101632526|NCT01028027|Tobramycin|tobramycin|mesh-list
101632527|NCT01028027|Dexamethasone|dexamethasone|mesh-list
101632528|NCT01028027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101632529|NCT01028027|Antiemetics|antiemetics|mesh-ancestor
101632530|NCT01028027|Autonomic Agents|autonomic agents|mesh-ancestor
101632531|NCT01028027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101632532|NCT01028027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632533|NCT01028027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101632534|NCT01028027|Glucocorticoids|glucocorticoids|mesh-ancestor
101632535|NCT01028027|Hormones|hormones|mesh-ancestor
101632536|NCT01028027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101632537|NCT01028027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101632538|NCT01028027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101632539|NCT01028027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101632540|NCT01028027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101632541|NCT01028027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101632542|NCT01007552|Bevacizumab|bevacizumab|mesh-list
101632543|NCT01007552|Gemcitabine|gemcitabine|mesh-list
101632544|NCT01007552|Capecitabine|capecitabine|mesh-list
101632545|NCT01007552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101632546|NCT01007552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101632547|NCT01007552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101632548|NCT01007552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101632549|NCT01007552|Growth Substances|growth substances|mesh-ancestor
101632550|NCT01007552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632551|NCT01007552|Growth Inhibitors|growth inhibitors|mesh-ancestor
101632552|NCT01007552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101632553|NCT01007552|Antimetabolites|antimetabolites|mesh-ancestor
101632554|NCT01007552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632555|NCT02870036|Leucovorin|leucovorin|mesh-list
101632556|NCT02870036|Thalidomide|thalidomide|mesh-list
101632557|NCT02870036|Fluorouracil|fluorouracil|mesh-list
101632558|NCT02870036|Calcium|calcium|mesh-list
101632559|NCT02870036|Levoleucovorin|levoleucovorin|mesh-list
101632560|NCT02870036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101632561|NCT02870036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632562|NCT02870036|Antimetabolites|antimetabolites|mesh-ancestor
101722570|NCT00761332|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101722571|NCT00761332|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101722578|NCT03321201|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101722579|NCT03321201|Hemostatics|hemostatics|mesh-ancestor
101722580|NCT03321201|Coagulants|coagulants|mesh-ancestor
101722581|NCT02612220|Hemostatics|hemostatics|mesh-list
101722582|NCT02612220|Coagulants|coagulants|mesh-ancestor
101632563|NCT02870036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632564|NCT02870036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101632565|NCT02870036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101632566|NCT02870036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101632567|NCT02870036|Immunologic Factors|immunologic factors|mesh-ancestor
101632568|NCT02870036|Antidotes|antidotes|mesh-ancestor
101632569|NCT02870036|Protective Agents|protective agents|mesh-ancestor
101632570|NCT02870036|Vitamin B Complex|vitamin b complex|mesh-ancestor
101632571|NCT02870036|Vitamins|vitamins|mesh-ancestor
101632572|NCT02870036|Micronutrients|micronutrients|mesh-ancestor
101632573|NCT02870036|Leprostatic Agents|leprostatic agents|mesh-ancestor
101632574|NCT02870036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101632575|NCT02870036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101632576|NCT02870036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101632577|NCT02870036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101632578|NCT02870036|Growth Substances|growth substances|mesh-ancestor
101632579|NCT02870036|Growth Inhibitors|growth inhibitors|mesh-ancestor
101632580|NCT04296422|Ibuprofen|ibuprofen|mesh-list
101632581|NCT04296422|Diclofenac|diclofenac|mesh-list
101632582|NCT04296422|Naproxen|naproxen|mesh-list
101632583|NCT04296422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101632584|NCT04296422|Piroxicam|piroxicam|mesh-list
101632585|NCT04296422|Contraceptive Agents|contraceptive agents|mesh-list
101632586|NCT04296422|Contraceptives, Oral|contraceptives, oral|mesh-list
101632587|NCT04296422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101632588|NCT04296422|Analgesics|analgesics|mesh-ancestor
101632589|NCT04296422|Sensory System Agents|sensory system agents|mesh-ancestor
101632590|NCT04296422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101632591|NCT04296422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632593|NCT04296422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101632594|NCT04296422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101632595|NCT04296422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101632596|NCT04296422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632597|NCT04296422|Gout Suppressants|gout suppressants|mesh-ancestor
101632598|NCT04296422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101632599|NCT04296422|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101632600|NCT00998738|Calcium, Dietary|calcium, dietary|mesh-list
101632601|NCT00998738|Magnesium Sulfate|magnesium sulfate|mesh-list
101632603|NCT00998738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101632604|NCT00998738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632605|NCT00998738|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101632606|NCT00998738|Analgesics|analgesics|mesh-ancestor
101632607|NCT00998738|Sensory System Agents|sensory system agents|mesh-ancestor
101632608|NCT00998738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101632609|NCT00998738|Anesthetics|anesthetics|mesh-ancestor
101632610|NCT00998738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101632611|NCT00998738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101632612|NCT00998738|Anticonvulsants|anticonvulsants|mesh-ancestor
101632613|NCT00998738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101632614|NCT00998738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101722671|NCT02558452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101632615|NCT00998738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632616|NCT00998738|Tocolytic Agents|tocolytic agents|mesh-ancestor
101632617|NCT00998738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101632618|NCT00997334|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101632619|NCT00997334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101632620|NCT00997334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101632621|NCT00997334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101632622|NCT00997334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632623|NCT04369664|Atorvastatin|atorvastatin|mesh-list
101632625|NCT04369664|Evolocumab|evolocumab|mesh-list
101632626|NCT04369664|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
101632627|NCT04369664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101632628|NCT04369664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101632629|NCT04369664|Antimetabolites|antimetabolites|mesh-ancestor
101632630|NCT04369664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632631|NCT04369664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101632632|NCT04369664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101632633|NCT04369664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101632634|NCT04369664|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101632635|NCT04369664|Protease Inhibitors|protease inhibitors|mesh-ancestor
101632636|NCT04296578|Selenious Acid|selenious acid|mesh-list
101632637|NCT04296578|Sodium Selenite|sodium selenite|mesh-list
101632638|NCT04296578|Prednisone|prednisone|mesh-list
101632639|NCT04296578|Abiraterone Acetate|abiraterone acetate|mesh-list
101632640|NCT04296578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101722728|NCT02558218|Hormones|hormones|mesh-ancestor
101632641|NCT04296578|Glucocorticoids|glucocorticoids|mesh-ancestor
101632642|NCT04296578|Hormones|hormones|mesh-ancestor
101632643|NCT04296578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101632644|NCT04296578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632645|NCT04296578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101632646|NCT04296578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101632647|NCT04296578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101632648|NCT04296578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101632649|NCT04296578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632650|NCT04296578|Hormone Antagonists|hormone antagonists|mesh-ancestor
101632651|NCT04296578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101632652|NCT04296578|Trace Elements|trace elements|mesh-ancestor
101632653|NCT04296578|Micronutrients|micronutrients|mesh-ancestor
101632654|NCT00996944|Ropinirole|ropinirole|mesh-list
101632655|NCT00996944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101632656|NCT00996944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101632657|NCT00996944|Dopamine Agonists|dopamine agonists|mesh-ancestor
101632658|NCT00996944|Dopamine Agents|dopamine agents|mesh-ancestor
101632659|NCT00996944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101632660|NCT00996944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632661|NCT00996944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632662|NCT01027949|Treprostinil|treprostinil|mesh-list
101632663|NCT01027949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101632664|NCT01038323|Milnacipran|milnacipran|mesh-list
101632665|NCT01038323|Levomilnacipran|levomilnacipran|mesh-list
101632666|NCT01038323|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101632667|NCT01038323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101775307|NCT00936195|Protease Inhibitors|protease inhibitors|mesh-ancestor
101632668|NCT01038323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101632669|NCT01038323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632670|NCT01038323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101632671|NCT01038323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632672|NCT01038323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101632673|NCT01038323|Analgesics|analgesics|mesh-ancestor
101632674|NCT01038323|Sensory System Agents|sensory system agents|mesh-ancestor
101722773|NCT00759070|Tenofovir|tenofovir|mesh-list
101632675|NCT01038323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101632676|NCT01038323|Antidepressive Agents|antidepressive agents|mesh-ancestor
101632677|NCT01038323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101632678|NCT01027871|Insulin Glargine|insulin glargine|mesh-list
101632679|NCT01027871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101632680|NCT01027871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632681|NCT04301375|Paclitaxel|paclitaxel|mesh-list
101632682|NCT04301375|Trastuzumab|trastuzumab|mesh-list
101632683|NCT04301375|Pertuzumab|pertuzumab|mesh-list
101632684|NCT04301375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101632685|NCT04301375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101632686|NCT04301375|Tubulin Modulators|tubulin modulators|mesh-ancestor
101632687|NCT04301375|Antimitotic Agents|antimitotic agents|mesh-ancestor
101632688|NCT04301375|Mitosis Modulators|mitosis modulators|mesh-ancestor
101632689|NCT04301375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632690|NCT04301375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101632691|NCT01021553|Diketopiperazines|diketopiperazines|mesh-list
101632692|NCT01021553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101632693|NCT01021553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101632694|NCT01026389|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
101632695|NCT01026389|Chelating Agents|chelating agents|mesh-ancestor
101632696|NCT01026389|Sequestering Agents|sequestering agents|mesh-ancestor
101632697|NCT01026389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632698|NCT01025843|Candesartan|candesartan|mesh-list
101632699|NCT01025843|Candesartan cilexetil|candesartan cilexetil|mesh-list
101632700|NCT01025843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101632701|NCT01025843|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101632702|NCT01025843|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101632703|NCT01025843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632704|NCT02873351|Levodopa|levodopa|mesh-list
101632705|NCT02873351|Carbidopa|carbidopa|mesh-list
101632706|NCT02873351|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101632707|NCT02873351|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101632708|NCT02873351|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101632709|NCT02873351|Dopamine Agents|dopamine agents|mesh-ancestor
101632710|NCT02873351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101632711|NCT02873351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632712|NCT02873351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632713|NCT02873351|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101632714|NCT02873351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101632715|NCT02873351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101632716|NCT02873351|Immunologic Factors|immunologic factors|mesh-ancestor
101632717|NCT02873351|Dopamine Agonists|dopamine agonists|mesh-ancestor
101632718|NCT04299971|Methotrexate|methotrexate|mesh-list
101632719|NCT04299971|Tofacitinib|tofacitinib|mesh-list
101632720|NCT04299971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101632721|NCT04299971|Abortifacient Agents|abortifacient agents|mesh-ancestor
101632722|NCT04299971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101632723|NCT04299971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632724|NCT04299971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101632725|NCT04299971|Antimetabolites|antimetabolites|mesh-ancestor
101632726|NCT04299971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632727|NCT04299971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101632728|NCT04299971|Dermatologic Agents|dermatologic agents|mesh-ancestor
101632729|NCT04299971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101632730|NCT04299971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101632731|NCT04299971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101632732|NCT04299971|Immunologic Factors|immunologic factors|mesh-ancestor
101632733|NCT04299971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101632734|NCT04299971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101632735|NCT04299971|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101632736|NCT04299971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101632737|NCT01020305|Sirolimus|sirolimus|mesh-list
101632738|NCT01020305|Temsirolimus|temsirolimus|mesh-list
101632739|NCT01020305|MTOR Inhibitors|mtor inhibitors|mesh-list
101632740|NCT01020305|Bicalutamide|bicalutamide|mesh-list
101632741|NCT01020305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101632742|NCT01020305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101632743|NCT01020305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632744|NCT01020305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101632745|NCT01020305|Immunologic Factors|immunologic factors|mesh-ancestor
101632746|NCT01020305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632747|NCT01020305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101632748|NCT01020305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101632749|NCT01020305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101632750|NCT01020305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101632751|NCT01020305|Antifungal Agents|antifungal agents|mesh-ancestor
101632752|NCT01020305|Androgen Antagonists|androgen antagonists|mesh-ancestor
101632753|NCT01020305|Hormone Antagonists|hormone antagonists|mesh-ancestor
101632754|NCT01020305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101632755|NCT00627575|Lamotrigine|lamotrigine|mesh-list
101632756|NCT00627575|Phenytoin|phenytoin|mesh-list
101632757|NCT00627575|Atorvastatin|atorvastatin|mesh-list
101632758|NCT00627575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101632759|NCT00627575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101632760|NCT00627575|Antimetabolites|antimetabolites|mesh-ancestor
101632761|NCT00627575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632762|NCT00627575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101632763|NCT00627575|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101632764|NCT00627575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101632765|NCT00627575|Anticonvulsants|anticonvulsants|mesh-ancestor
101632766|NCT00627575|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101632767|NCT00627575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101632768|NCT00627575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101632769|NCT00627575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632770|NCT00627575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101632771|NCT00627575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101632772|NCT00627575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101632773|NCT00627575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101632774|NCT00627575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101632775|NCT00627575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101632776|NCT00627575|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101632777|NCT00627575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101632778|NCT00627809|Streptokinase|streptokinase|mesh-list
101632779|NCT00627809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101632780|NCT00627809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101632781|NCT00627809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632782|NCT01024751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101632783|NCT02872649|Warfarin|warfarin|mesh-list
101632784|NCT02872649|Dabigatran|dabigatran|mesh-list
101632785|NCT02872649|Phenprocoumon|phenprocoumon|mesh-list
101632786|NCT02872649|Anticoagulants|anticoagulants|mesh-ancestor
101632787|NCT02872649|Antithrombins|antithrombins|mesh-ancestor
101632788|NCT02872649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101632789|NCT02872649|Protease Inhibitors|protease inhibitors|mesh-ancestor
101632790|NCT02872649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101632791|NCT02872649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632792|NCT01019369|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101632793|NCT01019369|Medroxyprogesterone|medroxyprogesterone|mesh-list
101632794|NCT01019369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101632795|NCT01019369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101632796|NCT01019369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101632797|NCT01019369|Contraceptive Agents|contraceptive agents|mesh-ancestor
101632798|NCT01019369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101632799|NCT01019369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632800|NCT01019369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101632801|NCT01019369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101632802|NCT01019369|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101632803|NCT01019369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101632804|NCT01019369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101632805|NCT01018511|Tamsulosin|tamsulosin|mesh-list
101632806|NCT01018511|Solifenacin Succinate|solifenacin succinate|mesh-list
101632807|NCT01018511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101632808|NCT01018511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101632809|NCT01018511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101632810|NCT01018511|Adrenergic Agents|adrenergic agents|mesh-ancestor
101632811|NCT01018511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101632812|NCT01018511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632813|NCT01018511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632814|NCT01018511|Urological Agents|urological agents|mesh-ancestor
101632815|NCT01018511|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101632816|NCT01018511|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101632817|NCT01018511|Cholinergic Agents|cholinergic agents|mesh-ancestor
101632819|NCT00996476|Antiviral Agents|antiviral agents|mesh-ancestor
101632820|NCT00996476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101632821|NCT00996476|Protease Inhibitors|protease inhibitors|mesh-ancestor
101632822|NCT00996476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101289924|NCT05790161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101632823|NCT00996476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632825|NCT02269267|Dasatinib|dasatinib|mesh-list
101632826|NCT02269267|Tin Fluorides|tin fluorides|mesh-list
101632827|NCT02269267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101632828|NCT02269267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101632829|NCT02269267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101632830|NCT02269267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632831|NCT02269267|Cariostatic Agents|cariostatic agents|mesh-ancestor
101632832|NCT02269267|Protective Agents|protective agents|mesh-ancestor
101632833|NCT02269267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632834|NCT02575495|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101632835|NCT02575495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101632836|NCT02575495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101363710|NCT00133822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101632838|NCT02575261|Immunomodulating Agents|immunomodulating agents|mesh-list
101632839|NCT02575261|Immunologic Factors|immunologic factors|mesh-ancestor
101632840|NCT02575261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632841|NCT01017731|Diphenhydramine|diphenhydramine|mesh-list
101632842|NCT01017731|Promethazine|promethazine|mesh-list
101632843|NCT01017731|Moxifloxacin|moxifloxacin|mesh-list
101632844|NCT01017731|Ramucirumab|ramucirumab|mesh-list
101632845|NCT01017731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101632846|NCT01017731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101632847|NCT01017731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101632848|NCT01017731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101632849|NCT01017731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101632850|NCT01017731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632851|NCT01017731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101632852|NCT01017731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632853|NCT01017731|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101632854|NCT01017731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101632855|NCT01017731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101632856|NCT01017731|Anesthetics, Local|anesthetics, local|mesh-ancestor
101632857|NCT01017731|Anesthetics|anesthetics|mesh-ancestor
101632858|NCT01017731|Sensory System Agents|sensory system agents|mesh-ancestor
101632859|NCT01017731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101632860|NCT01017731|Antiemetics|antiemetics|mesh-ancestor
101723139|NCT00775294|Maraviroc|maraviroc|mesh-list
101632862|NCT01017731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101632863|NCT01017731|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101632864|NCT01017731|Histamine Antagonists|histamine antagonists|mesh-ancestor
101632865|NCT01017731|Histamine Agents|histamine agents|mesh-ancestor
101632866|NCT01017731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101632867|NCT01017731|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101632868|NCT01017731|Antipruritics|antipruritics|mesh-ancestor
101632869|NCT01017731|Dermatologic Agents|dermatologic agents|mesh-ancestor
101632870|NCT02575183|Varenicline|varenicline|mesh-list
101632871|NCT02575183|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101632872|NCT02575183|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101632873|NCT02575183|Cholinergic Agents|cholinergic agents|mesh-ancestor
101632874|NCT02575183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101632875|NCT02575183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632876|NCT02575183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632877|NCT02255305|Anti-Infective Agents|anti-infective agents|mesh-list
101632878|NCT02255305|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101632879|NCT00779584|Gemcitabine|gemcitabine|mesh-list
101632880|NCT00779584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101632881|NCT00779584|Antimetabolites|antimetabolites|mesh-ancestor
101632882|NCT00779584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632883|NCT00779584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101632884|NCT00779506|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101632885|NCT00779506|Antidepressive Agents|antidepressive agents|mesh-ancestor
101632886|NCT00779506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101632887|NCT00779506|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101632888|NCT00779506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101632889|NCT00779506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101632890|NCT00779506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632891|NCT01385059|Axitinib|axitinib|mesh-list
101632892|NCT01385059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101632893|NCT01385059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101632894|NCT01385059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101632895|NCT01385059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632897|NCT00769132|Niacinamide|niacinamide|mesh-list
101632898|NCT00769132|Nicotinic Acids|nicotinic acids|mesh-list
101632899|NCT00769132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101632900|NCT00769132|Antimetabolites|antimetabolites|mesh-ancestor
101632901|NCT00769132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632902|NCT00769132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101632903|NCT00769132|Vasodilator Agents|vasodilator agents|mesh-ancestor
101632904|NCT00769132|Vitamin B Complex|vitamin b complex|mesh-ancestor
101632905|NCT00769132|Vitamins|vitamins|mesh-ancestor
101632906|NCT00769132|Micronutrients|micronutrients|mesh-ancestor
101632907|NCT00769132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632908|NCT04070755|Minocycline|minocycline|mesh-list
101632909|NCT04070755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101723277|NCT00775996|GABA Agents|gaba agents|mesh-ancestor
101632910|NCT04070755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101632911|NCT04100434|Evolocumab|evolocumab|mesh-list
101632912|NCT04100434|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101632913|NCT04100434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101632914|NCT04100434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101632915|NCT04100434|Antimetabolites|antimetabolites|mesh-ancestor
101632916|NCT04100434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632917|NCT04100434|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101632918|NCT04100434|Protease Inhibitors|protease inhibitors|mesh-ancestor
101632919|NCT04100434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101632920|NCT04100434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101632921|NCT00991952|Irinotecan|irinotecan|mesh-list
101632922|NCT00991952|Alvocidib|alvocidib|mesh-list
101632923|NCT00991952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101632924|NCT00991952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101632925|NCT00991952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101632926|NCT00991952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632927|NCT00991952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101632928|NCT00991952|Growth Inhibitors|growth inhibitors|mesh-ancestor
101632929|NCT00991952|Growth Substances|growth substances|mesh-ancestor
101632930|NCT00991952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632931|NCT00991952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101632932|NCT00779038|Fentanyl|fentanyl|mesh-list
101632933|NCT00779038|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101632934|NCT00779038|Narcotics|narcotics|mesh-ancestor
101632935|NCT00779038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101632936|NCT00779038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632937|NCT00779038|Analgesics|analgesics|mesh-ancestor
101632938|NCT00779038|Sensory System Agents|sensory system agents|mesh-ancestor
101632939|NCT00779038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101632940|NCT00779038|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101632941|NCT00779038|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101632942|NCT00779038|Anesthetics, General|anesthetics, general|mesh-ancestor
101632943|NCT00779038|Anesthetics|anesthetics|mesh-ancestor
101632944|NCT04292990|Fentanyl|fentanyl|mesh-list
101632945|NCT04292990|Morphine|morphine|mesh-list
101632946|NCT04292990|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101632947|NCT04292990|Narcotics|narcotics|mesh-ancestor
101632948|NCT04292990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101632949|NCT04292990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632950|NCT04292990|Analgesics|analgesics|mesh-ancestor
101632951|NCT04292990|Sensory System Agents|sensory system agents|mesh-ancestor
101632952|NCT04292990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101632953|NCT04292990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101632954|NCT04292990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101632955|NCT04292990|Anesthetics, General|anesthetics, general|mesh-ancestor
101632956|NCT04292990|Anesthetics|anesthetics|mesh-ancestor
101632957|NCT02868632|Durvalumab|durvalumab|mesh-list
101632958|NCT02868632|Tremelimumab|tremelimumab|mesh-list
101632959|NCT02868632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101632960|NCT02868632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101632961|NCT04021498|Simvastatin|simvastatin|mesh-list
101632962|NCT04021498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101632963|NCT04021498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101632964|NCT04021498|Antimetabolites|antimetabolites|mesh-ancestor
101632965|NCT04021498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632966|NCT04021498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101632967|NCT04021498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101632968|NCT04021498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101632969|NCT00994682|Pioglitazone|pioglitazone|mesh-list
101632970|NCT00994682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101632971|NCT00994682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632972|NCT00994448|Bupropion|bupropion|mesh-list
101632973|NCT00994448|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101632974|NCT00994448|Antidepressive Agents|antidepressive agents|mesh-ancestor
101632975|NCT00994448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101632976|NCT00994448|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101632977|NCT00994448|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101632978|NCT00994448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101632979|NCT00994448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632980|NCT00994448|Dopamine Agents|dopamine agents|mesh-ancestor
101632981|NCT00994448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101632982|NCT00994448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632983|NCT00994448|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101632984|NCT00994448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101632985|NCT00994448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101632986|NCT04292444|Oxytocin|oxytocin|mesh-list
101632987|NCT04292444|Oxytocics|oxytocics|mesh-ancestor
101632988|NCT04292444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101632989|NCT04292444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101632990|NCT01017575|Ribavirin|ribavirin|mesh-list
101632991|NCT01017575|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101632992|NCT01017575|Antimetabolites|antimetabolites|mesh-ancestor
101632993|NCT01017575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101632994|NCT01017575|Antiviral Agents|antiviral agents|mesh-ancestor
101632995|NCT01017575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101632996|NCT01017263|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101632997|NCT01017263|Dextroamphetamine|dextroamphetamine|mesh-list
101632998|NCT01017263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101632999|NCT01017263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633000|NCT01017263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101633001|NCT01017263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101633002|NCT01017263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101633003|NCT01017263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633004|NCT01017263|Dopamine Agents|dopamine agents|mesh-ancestor
101633005|NCT01017263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101633006|NCT01253161|Pasireotide|pasireotide|mesh-list
101633008|NCT01253161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101723396|NCT00679679|Metformin|metformin|mesh-list
101633009|NCT01253161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633010|NCT00709423|Moxaverine|moxaverine|mesh-list
101633011|NCT00709423|Parasympatholytics|parasympatholytics|mesh-ancestor
101633012|NCT00709423|Autonomic Agents|autonomic agents|mesh-ancestor
101633013|NCT00709423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101633014|NCT00709423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633015|NCT00627887|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101633016|NCT00627887|Antidepressive Agents|antidepressive agents|mesh-ancestor
101633017|NCT00627887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101633018|NCT00627887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633019|NCT00627887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633020|NCT00627887|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101633021|NCT00627887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101633022|NCT00627887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101633023|NCT00627887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101633024|NCT00627887|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101633025|NCT02576665|Flucytosine|flucytosine|mesh-list
101633026|NCT02576665|Antifungal Agents|antifungal agents|mesh-ancestor
101633027|NCT02576665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101633028|NCT02576665|Antimetabolites|antimetabolites|mesh-ancestor
101633029|NCT02576665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633030|NCT00627965|Sildenafil Citrate|sildenafil citrate|mesh-list
101633031|NCT00627965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633032|NCT00627965|Vasodilator Agents|vasodilator agents|mesh-ancestor
101633033|NCT00627965|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101633034|NCT00627965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101633035|NCT00627965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101633036|NCT00627965|Urological Agents|urological agents|mesh-ancestor
101633037|NCT02576353|Fentanyl|fentanyl|mesh-list
101633038|NCT02576353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101633039|NCT02576353|Narcotics|narcotics|mesh-ancestor
101633040|NCT02576353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101633041|NCT02576353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633043|NCT02576353|Sensory System Agents|sensory system agents|mesh-ancestor
101633044|NCT02576353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101633045|NCT02576353|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101633046|NCT02576353|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101633047|NCT02576353|Anesthetics, General|anesthetics, general|mesh-ancestor
101290142|NCT05044962|Etonogestrel|etonogestrel|mesh-list
101633048|NCT02576353|Anesthetics|anesthetics|mesh-ancestor
101633050|NCT01016015|Temsirolimus|temsirolimus|mesh-list
101633051|NCT01016015|MTOR Inhibitors|mtor inhibitors|mesh-list
101633052|NCT01016015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101633053|NCT01016015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101633054|NCT01016015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101633055|NCT01016015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101633056|NCT01016015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101633057|NCT01016015|Antifungal Agents|antifungal agents|mesh-ancestor
101633058|NCT01016015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101633059|NCT01016015|Immunologic Factors|immunologic factors|mesh-ancestor
101633060|NCT01016015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633061|NCT01016015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101633062|NCT01016015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101633063|NCT01016015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633064|NCT00628043|Epoetin Alfa|epoetin alfa|mesh-list
101633065|NCT00628043|Hematinics|hematinics|mesh-ancestor
101633066|NCT00709657|Bevacizumab|bevacizumab|mesh-list
101633067|NCT00709657|Ranibizumab|ranibizumab|mesh-list
101633068|NCT00709657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101633069|NCT00709657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101633070|NCT00709657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101723488|NCT02556970|Antipyretics|antipyretics|mesh-ancestor
101633071|NCT00709657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101633072|NCT00709657|Growth Substances|growth substances|mesh-ancestor
101633073|NCT00709657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633074|NCT00709657|Growth Inhibitors|growth inhibitors|mesh-ancestor
101633075|NCT04073173|Analgesics, Opioid|analgesics, opioid|mesh-list
101633076|NCT04073173|Analgesics|analgesics|mesh-list
101633077|NCT04073173|Narcotics|narcotics|mesh-ancestor
101633078|NCT04073173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101633079|NCT04073173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633080|NCT04073173|Sensory System Agents|sensory system agents|mesh-ancestor
101633081|NCT04073173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101633082|NCT00628121|Cetrorelix|cetrorelix|mesh-list
101633083|NCT00628121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101633084|NCT00628121|Fertility Agents|fertility agents|mesh-ancestor
101633085|NCT00628121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101633086|NCT00628121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633087|NCT00628121|Hormone Antagonists|hormone antagonists|mesh-ancestor
101633088|NCT00628121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101633089|NCT00709969|Lumefantrine|lumefantrine|mesh-list
101633090|NCT00709969|Artemether|artemether|mesh-list
101633091|NCT00709969|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101633092|NCT00709969|Antimalarials|antimalarials|mesh-ancestor
101633093|NCT00709969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101633094|NCT00709969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101633095|NCT00709969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101633096|NCT00710125|Doxorubicin|doxorubicin|mesh-list
101633097|NCT00710125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101633098|NCT00710125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101633099|NCT00710125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101633100|NCT00710125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101633101|NCT00710125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101633102|NCT00710125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633103|NCT02573701|Risperidone|risperidone|mesh-list
101633104|NCT02573701|Antipsychotic Agents|antipsychotic agents|mesh-list
101633105|NCT02573701|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101633107|NCT02573701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101633108|NCT02573701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633109|NCT02573701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633110|NCT02573701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101633111|NCT02573701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101633112|NCT02573701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101633113|NCT02573701|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101633114|NCT02573701|Dopamine Agents|dopamine agents|mesh-ancestor
101633115|NCT01017029|Mycophenolic Acid|mycophenolic acid|mesh-list
101633116|NCT01017029|Everolimus|everolimus|mesh-list
101633117|NCT01017029|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101633118|NCT01017029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101633119|NCT01017029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101633120|NCT01017029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633121|NCT01017029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101633122|NCT01017029|Immunologic Factors|immunologic factors|mesh-ancestor
101633123|NCT01017029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633124|NCT01017029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101633125|NCT01017029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101633126|NCT01017029|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101633127|NCT01017029|Antitubercular Agents|antitubercular agents|mesh-ancestor
101633128|NCT01017029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101633129|NCT01017029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101633130|NCT00714649|Cetuximab|cetuximab|mesh-list
101633131|NCT00714649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101633132|NCT00714649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101633133|NCT00710359|Vitamins|vitamins|mesh-list
101633134|NCT00710359|Vitamin B 12|vitamin b 12|mesh-list
101633135|NCT00710359|Hydroxocobalamin|hydroxocobalamin|mesh-list
101633136|NCT00710359|Vitamin B Complex|vitamin b complex|mesh-list
101633137|NCT00710359|Micronutrients|micronutrients|mesh-ancestor
101633138|NCT00710359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633139|NCT00710359|Hematinics|hematinics|mesh-ancestor
101633140|NCT02578849|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101633141|NCT02578849|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101633142|NCT02578849|Immunologic Factors|immunologic factors|mesh-ancestor
101633143|NCT02578849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633144|NCT02578849|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101633145|NCT02578849|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101633146|NCT02578849|Dopamine Agonists|dopamine agonists|mesh-ancestor
101633147|NCT02578849|Dopamine Agents|dopamine agents|mesh-ancestor
101633148|NCT02578849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101633149|NCT02578849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633150|NCT00710437|Dexmedetomidine|dexmedetomidine|mesh-list
101633151|NCT00710437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101633152|NCT00710437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101633153|NCT00710437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633154|NCT00710437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101633155|NCT00710437|Analgesics|analgesics|mesh-ancestor
101633156|NCT00710437|Sensory System Agents|sensory system agents|mesh-ancestor
101633157|NCT00710437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101633158|NCT00710437|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101633159|NCT00710437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101633160|NCT00710437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101633161|NCT00710437|Adrenergic Agents|adrenergic agents|mesh-ancestor
101633162|NCT00710437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101633163|NCT00710437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633164|NCT02574715|Levonorgestrel|levonorgestrel|mesh-list
101633165|NCT02574715|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101633166|NCT02574715|Contraceptive Agents|contraceptive agents|mesh-ancestor
101633167|NCT02574715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101633168|NCT02574715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633169|NCT02574715|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101633170|NCT02574715|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101633171|NCT02574715|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101633172|NCT00714883|Sirolimus|sirolimus|mesh-list
101633173|NCT00714883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101723699|NCT02626247|Vitamin A|vitamin a|mesh-list
101633174|NCT00714883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101633175|NCT00714883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101633176|NCT00714883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101633177|NCT00714883|Antifungal Agents|antifungal agents|mesh-ancestor
101633178|NCT00714883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101633179|NCT00714883|Immunologic Factors|immunologic factors|mesh-ancestor
101633180|NCT00714883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633181|NCT00710827|Testosterone undecanoate|testosterone undecanoate|mesh-list
101633182|NCT00710827|Androgens|androgens|mesh-ancestor
101633183|NCT00710827|Hormones|hormones|mesh-ancestor
101633184|NCT00710827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101633185|NCT00710827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633186|NCT01034657|Panobinostat|panobinostat|mesh-list
101633187|NCT01034657|Epoetin Alfa|epoetin alfa|mesh-list
101633188|NCT01034657|Hematinics|hematinics|mesh-ancestor
101633189|NCT01034657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101633190|NCT01034657|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101633191|NCT01034657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101633192|NCT01034657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633193|NCT01014767|Leucovorin|leucovorin|mesh-list
101633194|NCT01014767|Dactinomycin|dactinomycin|mesh-list
101633195|NCT01014767|Cyclophosphamide|cyclophosphamide|mesh-list
101633196|NCT01014767|Temozolomide|temozolomide|mesh-list
101633197|NCT01014767|Cisplatin|cisplatin|mesh-list
101633198|NCT01014767|Carboplatin|carboplatin|mesh-list
101290302|NCT04650698|Hemostatics|hemostatics|mesh-ancestor
101633199|NCT01014767|Doxorubicin|doxorubicin|mesh-list
101633200|NCT01014767|Methotrexate|methotrexate|mesh-list
101633201|NCT01014767|Irinotecan|irinotecan|mesh-list
101633202|NCT01014767|Etoposide|etoposide|mesh-list
101633203|NCT01014767|Vincristine|vincristine|mesh-list
101633204|NCT01014767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101633205|NCT01014767|Immunologic Factors|immunologic factors|mesh-ancestor
101633206|NCT01014767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633207|NCT01014767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101633208|NCT01014767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101633209|NCT01014767|Alkylating Agents|alkylating agents|mesh-ancestor
101633210|NCT01014767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633211|NCT01014767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101633212|NCT01014767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101633213|NCT01014767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101633214|NCT01014767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101633215|NCT01014767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101633216|NCT01014767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101633217|NCT01014767|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101633218|NCT01014767|Abortifacient Agents|abortifacient agents|mesh-ancestor
101633219|NCT01014767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101633220|NCT01014767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101633221|NCT01014767|Antimetabolites|antimetabolites|mesh-ancestor
101633222|NCT01014767|Dermatologic Agents|dermatologic agents|mesh-ancestor
101633223|NCT01014767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101633224|NCT01014767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101633225|NCT01014767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101633226|NCT01014767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101633228|NCT01014767|Protective Agents|protective agents|mesh-ancestor
101633229|NCT01014767|Vitamin B Complex|vitamin b complex|mesh-ancestor
101633230|NCT01014767|Vitamins|vitamins|mesh-ancestor
101633231|NCT01014767|Micronutrients|micronutrients|mesh-ancestor
101633232|NCT01014767|Tubulin Modulators|tubulin modulators|mesh-ancestor
101633233|NCT01014767|Antimitotic Agents|antimitotic agents|mesh-ancestor
101633234|NCT01014767|Mitosis Modulators|mitosis modulators|mesh-ancestor
101633235|NCT01014767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101633236|NCT01014767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101633237|NCT01014767|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101633238|NCT01014689|Lymecycline|lymecycline|mesh-list
101633239|NCT01014689|Adapalene|adapalene|mesh-list
101633240|NCT01014689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101633241|NCT01014689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101633242|NCT01014689|Analgesics|analgesics|mesh-ancestor
101633243|NCT01014689|Sensory System Agents|sensory system agents|mesh-ancestor
101633244|NCT01014689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101633245|NCT01014689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633246|NCT01014689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101633247|NCT01014689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101633248|NCT01014689|Dermatologic Agents|dermatologic agents|mesh-ancestor
101633249|NCT01014689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101633250|NCT01014689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101633251|NCT01014533|Gabapentin|gabapentin|mesh-list
101633252|NCT01014533|Analgesics|analgesics|mesh-ancestor
101633253|NCT01014533|Sensory System Agents|sensory system agents|mesh-ancestor
101633254|NCT01014533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101633255|NCT01014533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633256|NCT01014533|Anticonvulsants|anticonvulsants|mesh-ancestor
101633257|NCT01014533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101633258|NCT01014533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101633259|NCT01014533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101633260|NCT01014533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101633261|NCT01014533|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101633262|NCT01014533|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101633263|NCT01014533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101633264|NCT01014533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633265|NCT01014533|Antimanic Agents|antimanic agents|mesh-ancestor
101633266|NCT02013427|Naproxen|naproxen|mesh-list
101633268|NCT02013427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101633269|NCT02013427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101633270|NCT02013427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101633271|NCT02013427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101633272|NCT02013427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633273|NCT02013427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101633274|NCT02013427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101633275|NCT02013427|Analgesics|analgesics|mesh-ancestor
101633277|NCT02013427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101633278|NCT02013427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633279|NCT02013427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101633280|NCT02013427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101633281|NCT02013427|Gout Suppressants|gout suppressants|mesh-ancestor
101633282|NCT02013427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101633283|NCT01014143|Chlorhexidine|chlorhexidine|mesh-list
101633284|NCT01014143|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101633285|NCT01014143|Triclosan|triclosan|mesh-list
101633286|NCT01014143|Fluorides|fluorides|mesh-list
101633287|NCT01014143|Cariostatic Agents|cariostatic agents|mesh-ancestor
101633288|NCT01014143|Protective Agents|protective agents|mesh-ancestor
101633289|NCT01014143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633290|NCT01014143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101633291|NCT01014143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101633292|NCT01014143|Disinfectants|disinfectants|mesh-ancestor
101633293|NCT01014143|Dermatologic Agents|dermatologic agents|mesh-ancestor
101633294|NCT01014143|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101633295|NCT01014143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101633296|NCT01014143|Antimetabolites|antimetabolites|mesh-ancestor
101633297|NCT01014143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633298|NCT01014143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101633299|NCT00714961|Clopidogrel|clopidogrel|mesh-list
101633300|NCT00714961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101633301|NCT00714961|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101633302|NCT00714961|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101633303|NCT00714961|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101633304|NCT00714961|Purinergic Agents|purinergic agents|mesh-ancestor
101633305|NCT00714961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101633306|NCT00714961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633307|NCT00714961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633308|NCT02574403|Eculizumab|eculizumab|mesh-list
101633309|NCT02574403|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101633310|NCT02574403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101633311|NCT02574403|Immunologic Factors|immunologic factors|mesh-ancestor
101633312|NCT02574403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633313|NCT01013753|Formoterol Fumarate|formoterol fumarate|mesh-list
101633314|NCT01013753|Olodaterol|olodaterol|mesh-list
101633315|NCT01013753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101633316|NCT01013753|Autonomic Agents|autonomic agents|mesh-ancestor
101633317|NCT01013753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101723917|NCT00681941|Sevelamer|sevelamer|mesh-list
101633318|NCT01013753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633319|NCT01013753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101633320|NCT01013753|Respiratory System Agents|respiratory system agents|mesh-ancestor
101633321|NCT01013753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101633322|NCT01013753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101633323|NCT01013753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101633324|NCT01013753|Adrenergic Agents|adrenergic agents|mesh-ancestor
101633325|NCT01013753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101633326|NCT01013753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633328|NCT00715039|Paroxetine|paroxetine|mesh-list
101633329|NCT00715039|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101633330|NCT00715039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101633331|NCT00715039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101633332|NCT00715039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633333|NCT00715039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101633334|NCT00715039|Serotonin Agents|serotonin agents|mesh-ancestor
101633335|NCT00715039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633336|NCT00715039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101633337|NCT00715039|Antidepressive Agents|antidepressive agents|mesh-ancestor
101633338|NCT00715039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101633339|NCT00715039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101633340|NCT00715039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101633341|NCT00715039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101633343|NCT00715039|Antiemetics|antiemetics|mesh-ancestor
101633344|NCT00715039|Autonomic Agents|autonomic agents|mesh-ancestor
101633345|NCT00715039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101633346|NCT00715039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101633347|NCT00715039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101290444|NCT04006210|Dopamine Agents|dopamine agents|mesh-ancestor
101633348|NCT00715039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101633349|NCT00715039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101633350|NCT00715039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101633351|NCT00715039|GABA Modulators|gaba modulators|mesh-ancestor
101633352|NCT00715039|GABA Agents|gaba agents|mesh-ancestor
101633353|NCT00711295|Vaccines|vaccines|mesh-list
101633354|NCT00711295|Immunologic Factors|immunologic factors|mesh-ancestor
101633355|NCT00711295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633356|NCT02871869|Buformin|buformin|mesh-list
101633357|NCT02871869|Prednisone|prednisone|mesh-list
101633358|NCT02871869|Cyclophosphamide|cyclophosphamide|mesh-list
101633359|NCT02871869|Rituximab|rituximab|mesh-list
101633360|NCT02871869|Epirubicin|epirubicin|mesh-list
101633361|NCT02871869|Vindesine|vindesine|mesh-list
101633362|NCT02871869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101633363|NCT02871869|Immunologic Factors|immunologic factors|mesh-ancestor
101633364|NCT02871869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633365|NCT02871869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101633366|NCT02871869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101633367|NCT02871869|Alkylating Agents|alkylating agents|mesh-ancestor
101633368|NCT02871869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633369|NCT02871869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101633370|NCT02871869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101633371|NCT02871869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101633372|NCT02871869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101633373|NCT02871869|Glucocorticoids|glucocorticoids|mesh-ancestor
101633374|NCT02871869|Hormones|hormones|mesh-ancestor
101633375|NCT02871869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101633376|NCT02871869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101633377|NCT02871869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101633378|NCT02871869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101633379|NCT02871869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101633380|NCT02871869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724069|NCT02556658|Anesthetics|anesthetics|mesh-list
101633381|NCT02871869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101633382|NCT02871869|Tubulin Modulators|tubulin modulators|mesh-ancestor
101633383|NCT02871869|Antimitotic Agents|antimitotic agents|mesh-ancestor
101633384|NCT02871869|Mitosis Modulators|mitosis modulators|mesh-ancestor
101633385|NCT02871869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101633387|NCT01013597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101633388|NCT01013597|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101633389|NCT01013597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101633390|NCT01013597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633391|NCT00715273|Niacin|niacin|mesh-list
101633392|NCT00715273|Niacinamide|niacinamide|mesh-list
101633393|NCT00715273|Nicotinic Acids|nicotinic acids|mesh-list
101633394|NCT00715273|Atorvastatin|atorvastatin|mesh-list
101633395|NCT00715273|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
101633396|NCT00715273|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101633397|NCT00715273|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101633398|NCT00715273|Antimetabolites|antimetabolites|mesh-ancestor
101633399|NCT00715273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633400|NCT00715273|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101633401|NCT00715273|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101633402|NCT00715273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101633403|NCT00715273|Vasodilator Agents|vasodilator agents|mesh-ancestor
101633404|NCT00715273|Vitamin B Complex|vitamin b complex|mesh-ancestor
101633405|NCT00715273|Vitamins|vitamins|mesh-ancestor
101724131|NCT00922649|Insulin|insulin|mesh-list
101633406|NCT00715273|Micronutrients|micronutrients|mesh-ancestor
101633407|NCT00715273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633408|NCT01013285|Bevacizumab|bevacizumab|mesh-list
101633409|NCT01013285|Temozolomide|temozolomide|mesh-list
101633410|NCT01013285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101633411|NCT01013285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101633412|NCT01013285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101633413|NCT01013285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101633414|NCT01013285|Growth Substances|growth substances|mesh-ancestor
101633415|NCT01013285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333534|NCT00039481|Oblimersen|oblimersen|mesh-list
101633416|NCT01013285|Growth Inhibitors|growth inhibitors|mesh-ancestor
101633417|NCT01013285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101633418|NCT01013285|Alkylating Agents|alkylating agents|mesh-ancestor
101633419|NCT01013285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633421|NCT00715351|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101633422|NCT00715351|Insulin Detemir|insulin detemir|mesh-list
101633423|NCT00715351|Isophane Insulin, Human|isophane insulin, human|mesh-list
101633424|NCT00715351|Insulin, Isophane|insulin, isophane|mesh-list
101633425|NCT00715351|Isophane insulin, beef|isophane insulin, beef|mesh-list
101633426|NCT00715351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101633427|NCT00715351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633429|NCT04245085|Bevacizumab|bevacizumab|mesh-list
101633430|NCT04245085|Carboplatin|carboplatin|mesh-list
101633431|NCT04245085|Pemetrexed|pemetrexed|mesh-list
101633432|NCT04245085|Atezolizumab|atezolizumab|mesh-list
101633433|NCT04245085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101633434|NCT04245085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101633435|NCT04245085|Tubulin Modulators|tubulin modulators|mesh-ancestor
101633436|NCT04245085|Antimitotic Agents|antimitotic agents|mesh-ancestor
101633437|NCT04245085|Mitosis Modulators|mitosis modulators|mesh-ancestor
101633438|NCT04245085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633439|NCT04245085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101633440|NCT04245085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101633441|NCT04245085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101633442|NCT04245085|Growth Substances|growth substances|mesh-ancestor
101633443|NCT04245085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633444|NCT04245085|Growth Inhibitors|growth inhibitors|mesh-ancestor
101633445|NCT04245085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101633446|NCT04245085|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101633447|NCT04245085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101633448|NCT04245085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101633449|NCT00711841|Dexamethasone|dexamethasone|mesh-list
101633450|NCT00711841|Dexamethasone acetate|dexamethasone acetate|mesh-list
101633452|NCT00711841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101633453|NCT00711841|Antiemetics|antiemetics|mesh-ancestor
101633454|NCT00711841|Autonomic Agents|autonomic agents|mesh-ancestor
101633455|NCT00711841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101633456|NCT00711841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633457|NCT00711841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101633458|NCT00711841|Glucocorticoids|glucocorticoids|mesh-ancestor
101633459|NCT00711841|Hormones|hormones|mesh-ancestor
101633460|NCT00711841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101633461|NCT00711841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101633462|NCT00711841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101633463|NCT00711841|Protease Inhibitors|protease inhibitors|mesh-ancestor
101633464|NCT00711841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101633465|NCT00711841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633466|NCT00711919|Pitavastatin|pitavastatin|mesh-list
101633467|NCT00711919|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101633468|NCT00711919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101633469|NCT00711919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101633470|NCT00711919|Antimetabolites|antimetabolites|mesh-ancestor
101633471|NCT00711919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633472|NCT00711919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101633473|NCT00711919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101633474|NCT00715663|Insulin Aspart|insulin aspart|mesh-list
101633475|NCT00715663|Biphasic Insulins|biphasic insulins|mesh-list
101633476|NCT00715663|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101633477|NCT00715663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101633478|NCT00715663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633479|NCT00712465|Digoxin|digoxin|mesh-list
101633480|NCT00712465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101633481|NCT00712465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101633482|NCT00712465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101633483|NCT00712465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633484|NCT00712465|Protective Agents|protective agents|mesh-ancestor
101633485|NCT00712465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633486|NCT00715975|Clobetasol|clobetasol|mesh-list
101633487|NCT00715975|Halobetasol|halobetasol|mesh-list
101633488|NCT00715975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101633489|NCT00715975|Glucocorticoids|glucocorticoids|mesh-ancestor
101633490|NCT00715975|Hormones|hormones|mesh-ancestor
101633491|NCT00715975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101633492|NCT00715975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633493|NCT00715975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101633495|NCT02572687|Ramucirumab|ramucirumab|mesh-list
101633496|NCT02572687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101633497|NCT02572687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101633498|NCT00712777|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101633499|NCT00712777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101633500|NCT00712777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101633501|NCT00712777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101633502|NCT00712777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101633503|NCT00712777|Adrenergic Agents|adrenergic agents|mesh-ancestor
101633504|NCT00712777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101633505|NCT00712777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633506|NCT00712777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633507|NCT00603447|Dexamethasone|dexamethasone|mesh-list
101633508|NCT00603447|Lenalidomide|lenalidomide|mesh-list
101633509|NCT00603447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101633510|NCT00603447|Antiemetics|antiemetics|mesh-ancestor
101633511|NCT00603447|Autonomic Agents|autonomic agents|mesh-ancestor
101633512|NCT00603447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101633513|NCT00603447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633514|NCT00603447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101633515|NCT00603447|Glucocorticoids|glucocorticoids|mesh-ancestor
101633516|NCT00603447|Hormones|hormones|mesh-ancestor
101633517|NCT00603447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101633518|NCT00603447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101633519|NCT00603447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101633520|NCT00603447|Immunologic Factors|immunologic factors|mesh-ancestor
101633521|NCT00603447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101633522|NCT00603447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101633523|NCT00603447|Growth Substances|growth substances|mesh-ancestor
101633524|NCT00603447|Growth Inhibitors|growth inhibitors|mesh-ancestor
101633525|NCT00718705|Josamycin|josamycin|mesh-list
101724394|NCT00769210|Antimetabolites|antimetabolites|mesh-ancestor
101633526|NCT00718705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101633527|NCT00718705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101633528|NCT00639015|Phenylephrine|phenylephrine|mesh-list
101633529|NCT00639015|Oxymetazoline|oxymetazoline|mesh-list
101633530|NCT00639015|Norepinephrine|norepinephrine|mesh-list
101633531|NCT00639015|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101633532|NCT00639015|Mydriatics|mydriatics|mesh-ancestor
101633533|NCT00639015|Autonomic Agents|autonomic agents|mesh-ancestor
101633534|NCT00639015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101633535|NCT00639015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633536|NCT00639015|Sympathomimetics|sympathomimetics|mesh-ancestor
101633537|NCT00639015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101633538|NCT00639015|Nasal Decongestants|nasal decongestants|mesh-ancestor
101633539|NCT00639015|Respiratory System Agents|respiratory system agents|mesh-ancestor
101633540|NCT00639015|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101633541|NCT00639015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101633542|NCT00639015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101633543|NCT00639015|Adrenergic Agents|adrenergic agents|mesh-ancestor
101633544|NCT00639015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101633545|NCT00639015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633546|NCT00639015|Protective Agents|protective agents|mesh-ancestor
101633548|NCT00712855|Mapatumumab|mapatumumab|mesh-list
101633549|NCT00712855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101633550|NCT00712855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101633551|NCT00712855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101633552|NCT00712855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633553|NCT02537925|Celecoxib|celecoxib|mesh-list
101633554|NCT02537925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
101633555|NCT02537925|Nedaplatin|nedaplatin|mesh-list
101633556|NCT02537925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101633557|NCT02537925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101633558|NCT02537925|Analgesics|analgesics|mesh-ancestor
101633559|NCT02537925|Sensory System Agents|sensory system agents|mesh-ancestor
101633560|NCT02537925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101633561|NCT02537925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633563|NCT02537925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101633564|NCT02537925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101633565|NCT02537925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101633566|NCT02537925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633567|NCT02537925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101633568|NCT00713011|Nifedipine|nifedipine|mesh-list
101633569|NCT00713011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101633570|NCT00713011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101633571|NCT00713011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633572|NCT00713011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101633573|NCT00713011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290692|NCT03114865|Dexamethasone|dexamethasone|mesh-list
101633575|NCT00713011|Tocolytic Agents|tocolytic agents|mesh-ancestor
101633576|NCT00713011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101633577|NCT04185675|Anesthetics|anesthetics|mesh-list
101633578|NCT04185675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101633579|NCT04185675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633580|NCT04208061|Ritonavir|ritonavir|mesh-list
101633581|NCT04208061|Darunavir|darunavir|mesh-list
101633582|NCT04208061|Dabigatran|dabigatran|mesh-list
101633583|NCT04208061|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101633584|NCT04208061|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101633585|NCT04208061|Protease Inhibitors|protease inhibitors|mesh-ancestor
101633586|NCT04208061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101633587|NCT04208061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633588|NCT04208061|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101633589|NCT04208061|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101633590|NCT04208061|Antiviral Agents|antiviral agents|mesh-ancestor
101633591|NCT04208061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101633592|NCT04208061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101633593|NCT04208061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101633594|NCT04208061|Antithrombins|antithrombins|mesh-ancestor
101633595|NCT04208061|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101633596|NCT04208061|Anticoagulants|anticoagulants|mesh-ancestor
101633597|NCT00988208|Prednisone|prednisone|mesh-list
101633598|NCT00988208|Docetaxel|docetaxel|mesh-list
101633599|NCT00988208|Lenalidomide|lenalidomide|mesh-list
101633600|NCT00988208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101633601|NCT00988208|Tubulin Modulators|tubulin modulators|mesh-ancestor
101633602|NCT00988208|Antimitotic Agents|antimitotic agents|mesh-ancestor
101633603|NCT00988208|Mitosis Modulators|mitosis modulators|mesh-ancestor
101633604|NCT00988208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633605|NCT00988208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101633606|NCT00988208|Glucocorticoids|glucocorticoids|mesh-ancestor
101633607|NCT00988208|Hormones|hormones|mesh-ancestor
101633608|NCT00988208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101633609|NCT00988208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633610|NCT00988208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101633611|NCT00988208|Immunologic Factors|immunologic factors|mesh-ancestor
101633612|NCT00988208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101633613|NCT00988208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101633614|NCT00988208|Growth Substances|growth substances|mesh-ancestor
101633615|NCT00988208|Growth Inhibitors|growth inhibitors|mesh-ancestor
101633616|NCT00639249|SA 4503|sa 4503|mesh-list
101633617|NCT00639249|Nootropic Agents|nootropic agents|mesh-ancestor
101633618|NCT04185831|Everolimus|everolimus|mesh-list
101633619|NCT04185831|Atezolizumab|atezolizumab|mesh-list
101633620|NCT04185831|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101633621|NCT04185831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101633622|NCT04185831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724592|NCT00865124|Spironolactone|spironolactone|mesh-list
101633623|NCT04185831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633624|NCT04185831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101633625|NCT04185831|Immunologic Factors|immunologic factors|mesh-ancestor
101633626|NCT04185831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633627|NCT04185831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101633628|NCT04185831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101633629|NCT04185831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101633630|NCT02686983|Betamethasone|betamethasone|mesh-list
101633631|NCT02686983|Anesthetics|anesthetics|mesh-list
101633632|NCT02686983|Anesthetics, Local|anesthetics, local|mesh-list
101633633|NCT02686983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101633634|NCT02686983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633635|NCT02686983|Sensory System Agents|sensory system agents|mesh-ancestor
101633636|NCT02686983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101633637|NCT02686983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101633638|NCT02686983|Glucocorticoids|glucocorticoids|mesh-ancestor
101633639|NCT02686983|Hormones|hormones|mesh-ancestor
101633640|NCT02686983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101633641|NCT02686983|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101633642|NCT02686983|Respiratory System Agents|respiratory system agents|mesh-ancestor
101633644|NCT02686905|Vitamin D|vitamin d|mesh-list
101633645|NCT02686905|Vitamins|vitamins|mesh-list
101633646|NCT02686905|Hydroxocobalamin|hydroxocobalamin|mesh-list
101633647|NCT02686905|Vitamin B 12|vitamin b 12|mesh-list
101633648|NCT02686905|Calcium|calcium|mesh-list
101633649|NCT02686905|Micronutrients|micronutrients|mesh-ancestor
101633650|NCT02686905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633651|NCT02686905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101633652|NCT02686905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101633653|NCT02686905|Hematinics|hematinics|mesh-ancestor
101633654|NCT02686905|Vitamin B Complex|vitamin b complex|mesh-ancestor
101633655|NCT00990704|Maxacalcitol|maxacalcitol|mesh-list
101633656|NCT00990704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101633657|NCT00990704|Dermatologic Agents|dermatologic agents|mesh-ancestor
101633658|NCT00990704|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101633659|NCT00990704|Protective Agents|protective agents|mesh-ancestor
101633660|NCT00990704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633661|NCT00639327|Irinotecan|irinotecan|mesh-list
101633662|NCT00639327|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101633663|NCT00639327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101633664|NCT00639327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101633665|NCT00639327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633666|NCT00639327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101633667|NCT02686749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
101633668|NCT04089553|Durvalumab|durvalumab|mesh-list
101633669|NCT04089553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101633670|NCT04089553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101633671|NCT02867852|Abiraterone Acetate|abiraterone acetate|mesh-list
101633672|NCT02867852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101724694|NCT00784420|Raltegravir Potassium|raltegravir potassium|mesh-list
101633673|NCT02867852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101633674|NCT02867852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101633675|NCT02867852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633676|NCT02867852|Hormone Antagonists|hormone antagonists|mesh-ancestor
101633677|NCT02867852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101633678|NCT02867852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633679|NCT02867852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101633680|NCT02686827|Vitamin D|vitamin d|mesh-list
101633681|NCT02686827|Ergocalciferols|ergocalciferols|mesh-list
101633682|NCT02686827|Vitamins|vitamins|mesh-ancestor
101633683|NCT02686827|Micronutrients|micronutrients|mesh-ancestor
101633684|NCT02686827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633685|NCT02686827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101633686|NCT02686827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101633687|NCT00713167|Grape Seed Extract|grape seed extract|mesh-list
101633688|NCT00713167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101633689|NCT00713167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101633690|NCT00713167|Antioxidants|antioxidants|mesh-ancestor
101633691|NCT00713167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633692|NCT00713167|Protective Agents|protective agents|mesh-ancestor
101633693|NCT00713167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633694|NCT00716521|Zolpidem|zolpidem|mesh-list
101633695|NCT00716521|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101633696|NCT00716521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101633697|NCT00716521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101633698|NCT00716521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633699|NCT00716521|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101633700|NCT00716521|GABA Agonists|gaba agonists|mesh-ancestor
101633701|NCT00716521|GABA Agents|gaba agents|mesh-ancestor
101633702|NCT00716521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101633703|NCT00716521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633704|NCT00993668|Certolizumab Pegol|certolizumab pegol|mesh-list
101633705|NCT00993668|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101633706|NCT00993668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101633707|NCT00993668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101633708|NCT00993668|Immunologic Factors|immunologic factors|mesh-ancestor
101633709|NCT00993668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633710|NCT00993668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101633712|NCT00778102|Bevacizumab|bevacizumab|mesh-list
101633713|NCT00778102|Oxaliplatin|oxaliplatin|mesh-list
101633714|NCT00778102|Irinotecan|irinotecan|mesh-list
101633715|NCT00778102|Fluorouracil|fluorouracil|mesh-list
101633716|NCT00778102|Levoleucovorin|levoleucovorin|mesh-list
101775308|NCT00936195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101633717|NCT00778102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101633718|NCT00778102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101633719|NCT00778102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101633720|NCT00778102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101633721|NCT00778102|Growth Substances|growth substances|mesh-ancestor
101633722|NCT00778102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633723|NCT00778102|Growth Inhibitors|growth inhibitors|mesh-ancestor
101633724|NCT00778102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101633725|NCT00778102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101633726|NCT00778102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101633727|NCT00778102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633729|NCT00778102|Protective Agents|protective agents|mesh-ancestor
101633730|NCT00778102|Vitamin B Complex|vitamin b complex|mesh-ancestor
101633731|NCT00778102|Vitamins|vitamins|mesh-ancestor
101633732|NCT00778102|Micronutrients|micronutrients|mesh-ancestor
101633733|NCT00778102|Antimetabolites|antimetabolites|mesh-ancestor
101633734|NCT00778102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101633735|NCT00778102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101633736|NCT00778102|Immunologic Factors|immunologic factors|mesh-ancestor
101633737|NCT00713557|Tirofiban|tirofiban|mesh-list
101633738|NCT00713557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101633739|NCT00713557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101633740|NCT00713557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724778|NCT00691457|Disinfectants|disinfectants|mesh-ancestor
101633741|NCT00713557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101633742|NCT00719095|Naltrexone|naltrexone|mesh-list
101633743|NCT00719095|Buprenorphine|buprenorphine|mesh-list
101633744|NCT00719095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101633745|NCT00719095|Narcotics|narcotics|mesh-ancestor
101633746|NCT00719095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101633747|NCT00719095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633748|NCT00719095|Analgesics|analgesics|mesh-ancestor
101633749|NCT00719095|Sensory System Agents|sensory system agents|mesh-ancestor
101633750|NCT00719095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101633751|NCT00719095|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101633752|NCT00719095|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101633753|NCT00916630|Pemetrexed|pemetrexed|mesh-list
101633754|NCT00916630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101633755|NCT00916630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101633756|NCT00916630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633758|NCT00916630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101633759|NCT02572375|Phenylpropanolamine|phenylpropanolamine|mesh-list
101633760|NCT02572375|Codeine|codeine|mesh-list
101633761|NCT02572375|Guaifenesin|guaifenesin|mesh-list
101633762|NCT02572375|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
101633763|NCT02572375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101633764|NCT02572375|Narcotics|narcotics|mesh-ancestor
101633765|NCT02572375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101724823|NCT05298683|Anesthetics|anesthetics|mesh-ancestor
101633766|NCT02572375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633767|NCT02572375|Analgesics|analgesics|mesh-ancestor
101633768|NCT02572375|Sensory System Agents|sensory system agents|mesh-ancestor
101633769|NCT02572375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101633770|NCT02572375|Antitussive Agents|antitussive agents|mesh-ancestor
101633771|NCT02572375|Respiratory System Agents|respiratory system agents|mesh-ancestor
101633772|NCT02572375|Expectorants|expectorants|mesh-ancestor
101633773|NCT02572375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101633774|NCT02572375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101633775|NCT02572375|Adrenergic Agents|adrenergic agents|mesh-ancestor
101633776|NCT02572375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101633777|NCT02572375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633778|NCT02572375|Appetite Depressants|appetite depressants|mesh-ancestor
101633779|NCT02572375|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101633780|NCT02572375|Sympathomimetics|sympathomimetics|mesh-ancestor
101633781|NCT02572375|Autonomic Agents|autonomic agents|mesh-ancestor
101633782|NCT02572375|Nasal Decongestants|nasal decongestants|mesh-ancestor
101633783|NCT02572375|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101633784|NCT00716911|Ganciclovir|ganciclovir|mesh-list
101633785|NCT00716911|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101633786|NCT00716911|Antiviral Agents|antiviral agents|mesh-ancestor
101633787|NCT00716911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101633788|NCT00716911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101633789|NCT00716911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101633790|NCT00716911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633791|NCT00612495|Fluorouracil|fluorouracil|mesh-list
101633792|NCT00612495|Oxaliplatin|oxaliplatin|mesh-list
101633793|NCT00612495|Antimetabolites|antimetabolites|mesh-ancestor
101633794|NCT00612495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633795|NCT00612495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101633796|NCT00612495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101633797|NCT00612495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101633798|NCT00612495|Immunologic Factors|immunologic factors|mesh-ancestor
101633799|NCT00612495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633800|NCT00719173|Cyclophosphamide|cyclophosphamide|mesh-list
101633801|NCT00719173|Aprepitant|aprepitant|mesh-list
101633802|NCT00719173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101633803|NCT00719173|Immunologic Factors|immunologic factors|mesh-ancestor
101633804|NCT00719173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633805|NCT00719173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101633806|NCT00719173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101633807|NCT00719173|Alkylating Agents|alkylating agents|mesh-ancestor
101633808|NCT00719173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633809|NCT00719173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101633810|NCT00719173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101633811|NCT00719173|Antiemetics|antiemetics|mesh-ancestor
101633812|NCT00719173|Autonomic Agents|autonomic agents|mesh-ancestor
101633813|NCT00719173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101633814|NCT00719173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101633815|NCT00719173|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101633816|NCT00719173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101633817|NCT00756886|Atorvastatin|atorvastatin|mesh-list
101633818|NCT00756886|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101633820|NCT00756886|Antimetabolites|antimetabolites|mesh-ancestor
101633821|NCT00756886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633822|NCT00756886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101633823|NCT00756886|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101633824|NCT00756886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101633825|NCT00756730|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101633826|NCT00756730|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101633827|NCT00756730|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101633828|NCT00756730|Protease Inhibitors|protease inhibitors|mesh-ancestor
101633829|NCT00756730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101633830|NCT00756730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633831|NCT00756730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101633832|NCT00756730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101633833|NCT00756730|Antiviral Agents|antiviral agents|mesh-ancestor
101633834|NCT00756730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101633835|NCT02573935|Clarithromycin|clarithromycin|mesh-list
101633836|NCT02573935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101633837|NCT02573935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101633838|NCT02573935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101633839|NCT02573935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101633840|NCT02573935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633841|NCT02573935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101633842|NCT02573935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101633843|NCT00984620|Interferons|interferons|mesh-list
101633844|NCT00984620|Ribavirin|ribavirin|mesh-list
101633845|NCT00984620|Interferon-alpha|interferon-alpha|mesh-list
101633846|NCT00984620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101633847|NCT00984620|Antiviral Agents|antiviral agents|mesh-ancestor
101633848|NCT00984620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101633849|NCT00984620|Antimetabolites|antimetabolites|mesh-ancestor
101633850|NCT00984620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633851|NCT00984620|Immunologic Factors|immunologic factors|mesh-ancestor
101633852|NCT00984620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633853|NCT00717145|Risedronic Acid|risedronic acid|mesh-list
101633854|NCT00717145|Etidronic Acid|etidronic acid|mesh-list
101633855|NCT00717145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101633856|NCT00717145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101633857|NCT00717145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633858|NCT00717145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101633859|NCT00717145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633860|NCT00717145|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101633861|NCT00639483|Celecoxib|celecoxib|mesh-list
101633862|NCT00639483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101633863|NCT00639483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101633864|NCT00639483|Analgesics|analgesics|mesh-ancestor
101633865|NCT00639483|Sensory System Agents|sensory system agents|mesh-ancestor
101633866|NCT00639483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101633867|NCT00639483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263025|NCT01760148|Immunologic Factors|immunologic factors|mesh-ancestor
101633868|NCT00639483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101633869|NCT00639483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101633870|NCT00639483|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101633871|NCT00639483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101633872|NCT00639483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101633873|NCT00639483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633875|NCT00777946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101633876|NCT00777946|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101633877|NCT00777946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101633878|NCT00777946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633879|NCT00777946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101633880|NCT00777946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633881|NCT00777946|Vasodilator Agents|vasodilator agents|mesh-ancestor
101633882|NCT02686047|Hyaluronic Acid|hyaluronic acid|mesh-list
101633884|NCT02686047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101633885|NCT02686047|Immunologic Factors|immunologic factors|mesh-ancestor
101633886|NCT02686047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633887|NCT02686047|Viscosupplements|viscosupplements|mesh-ancestor
101633888|NCT02686047|Protective Agents|protective agents|mesh-ancestor
101633889|NCT00713947|Amoxicillin|amoxicillin|mesh-list
101633890|NCT00713947|Metronidazole|metronidazole|mesh-list
101633891|NCT00713947|Clarithromycin|clarithromycin|mesh-list
101633892|NCT00713947|Pantoprazole|pantoprazole|mesh-list
101633893|NCT00713947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101633894|NCT00713947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101633895|NCT00713947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101633896|NCT00713947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101633897|NCT00713947|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101633898|NCT00713947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101633899|NCT00713947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633900|NCT00713947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101633901|NCT00713947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101633902|NCT00713947|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101633903|NCT00713947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101633904|NCT00713947|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101633905|NCT00990314|Epoprostenol|epoprostenol|mesh-list
101633906|NCT00990314|Beraprost|beraprost|mesh-list
101633907|NCT00990314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101633908|NCT00990314|Vasodilator Agents|vasodilator agents|mesh-ancestor
101633909|NCT00990314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101633910|NCT00909831|Hydroxychloroquine|hydroxychloroquine|mesh-list
101633911|NCT00909831|Sirolimus|sirolimus|mesh-list
101633912|NCT00909831|Temsirolimus|temsirolimus|mesh-list
101633913|NCT00909831|MTOR Inhibitors|mtor inhibitors|mesh-list
101633914|NCT00909831|Antimalarials|antimalarials|mesh-ancestor
101633915|NCT00909831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101633916|NCT00909831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101633917|NCT00909831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101633918|NCT00909831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101633919|NCT00909831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633920|NCT00909831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101633921|NCT00909831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101633922|NCT00909831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101633923|NCT00909831|Immunologic Factors|immunologic factors|mesh-ancestor
101633924|NCT00909831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633925|NCT00909831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101633926|NCT00909831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101633927|NCT00909831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101633928|NCT00909831|Antifungal Agents|antifungal agents|mesh-ancestor
101633929|NCT00717379|Mycophenolic Acid|mycophenolic acid|mesh-list
101633930|NCT00717379|Prednisone|prednisone|mesh-list
101633931|NCT00717379|Methylprednisolone|methylprednisolone|mesh-list
101633932|NCT00717379|Tacrolimus|tacrolimus|mesh-list
101633933|NCT00717379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101633934|NCT00717379|Glucocorticoids|glucocorticoids|mesh-ancestor
101633935|NCT00717379|Hormones|hormones|mesh-ancestor
101633936|NCT00717379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101633937|NCT00717379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633938|NCT00717379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101633939|NCT00717379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101633940|NCT00717379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101633942|NCT00717379|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101633943|NCT00717379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101633944|NCT00717379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633945|NCT00717379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101633946|NCT00717379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101633947|NCT00717379|Antitubercular Agents|antitubercular agents|mesh-ancestor
101633948|NCT00717379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101633949|NCT00717379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101633950|NCT00717379|Antiemetics|antiemetics|mesh-ancestor
101633951|NCT00717379|Autonomic Agents|autonomic agents|mesh-ancestor
101633952|NCT00717379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101633953|NCT00717379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101633954|NCT00717379|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101633955|NCT00717379|Protective Agents|protective agents|mesh-ancestor
101633956|NCT02867306|Methotrexate|methotrexate|mesh-list
101633957|NCT02867306|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101633958|NCT02867306|Abortifacient Agents|abortifacient agents|mesh-ancestor
101633959|NCT02867306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101633960|NCT02867306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633961|NCT02867306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101633962|NCT02867306|Antimetabolites|antimetabolites|mesh-ancestor
101633963|NCT02867306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633964|NCT02867306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101633965|NCT02867306|Dermatologic Agents|dermatologic agents|mesh-ancestor
101633966|NCT02867306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101633967|NCT02867306|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101633968|NCT02867306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101633969|NCT02867306|Immunologic Factors|immunologic factors|mesh-ancestor
101633970|NCT02867306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101725155|NCT00459667|Interferon beta-1b|interferon beta-1b|mesh-list
101633971|NCT02867306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101633972|NCT00777556|Levonorgestrel|levonorgestrel|mesh-list
101633973|NCT00777556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101633974|NCT00777556|Contraceptive Agents|contraceptive agents|mesh-ancestor
101633975|NCT00777556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101633976|NCT00777556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633977|NCT00777556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101633978|NCT00777556|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101633979|NCT00777556|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101633980|NCT02685657|Cyclophosphamide|cyclophosphamide|mesh-list
101633982|NCT02685657|Doxorubicin|doxorubicin|mesh-list
101633983|NCT02685657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101633984|NCT02685657|Immunologic Factors|immunologic factors|mesh-ancestor
101633985|NCT02685657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101633986|NCT02685657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101633987|NCT02685657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101633988|NCT02685657|Alkylating Agents|alkylating agents|mesh-ancestor
101633989|NCT02685657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101633990|NCT02685657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101633991|NCT02685657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101633992|NCT02685657|Tubulin Modulators|tubulin modulators|mesh-ancestor
101633993|NCT02685657|Antimitotic Agents|antimitotic agents|mesh-ancestor
101633994|NCT02685657|Mitosis Modulators|mitosis modulators|mesh-ancestor
101633995|NCT02685657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101633996|NCT02685657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101725197|NCT00784186|Oxytocics|oxytocics|mesh-ancestor
101633997|NCT02685657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101633998|NCT02685657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101633999|NCT04290884|Tranexamic Acid|tranexamic acid|mesh-list
101634000|NCT04290884|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101634001|NCT04290884|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101634002|NCT04290884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634003|NCT04290884|Hemostatics|hemostatics|mesh-ancestor
101634004|NCT04290884|Coagulants|coagulants|mesh-ancestor
101634005|NCT00719407|Epoetin Alfa|epoetin alfa|mesh-list
101634006|NCT00719407|Hematinics|hematinics|mesh-ancestor
101634007|NCT00714025|Everolimus|everolimus|mesh-list
101634008|NCT00714025|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101634009|NCT00714025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101634010|NCT00714025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101634011|NCT00714025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634013|NCT00714025|Immunologic Factors|immunologic factors|mesh-ancestor
101634014|NCT00714025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634015|NCT00714025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101634016|NCT02685345|Firuglipel|firuglipel|mesh-list
101634017|NCT02685345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101634018|NCT02685345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634020|NCT02869100|Fluorides|fluorides|mesh-list
101634021|NCT02869100|Sodium Fluoride|sodium fluoride|mesh-list
101634022|NCT02869100|Cariostatic Agents|cariostatic agents|mesh-ancestor
101634023|NCT02869100|Protective Agents|protective agents|mesh-ancestor
101634024|NCT02869100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634025|NCT02869100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101634026|NCT02869100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101634027|NCT04096768|Dexmedetomidine|dexmedetomidine|mesh-list
101634028|NCT04096768|Ketamine|ketamine|mesh-list
101634029|NCT04096768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101634030|NCT04096768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101634031|NCT04096768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634032|NCT04096768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101634033|NCT04096768|Analgesics|analgesics|mesh-ancestor
101634034|NCT04096768|Sensory System Agents|sensory system agents|mesh-ancestor
101634035|NCT04096768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101634036|NCT04096768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101634037|NCT04096768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101634038|NCT04096768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101634039|NCT04096768|Adrenergic Agents|adrenergic agents|mesh-ancestor
101634040|NCT04096768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101634041|NCT04096768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634042|NCT04096768|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101634043|NCT04096768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101634044|NCT04096768|Anesthetics, General|anesthetics, general|mesh-ancestor
101634045|NCT04096768|Anesthetics|anesthetics|mesh-ancestor
101634046|NCT04096768|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101634047|NCT04096768|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101634048|NCT00714103|Adenosine|adenosine|mesh-list
101634049|NCT00714103|Analgesics|analgesics|mesh-ancestor
101634050|NCT00714103|Sensory System Agents|sensory system agents|mesh-ancestor
101634051|NCT00714103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101634052|NCT00714103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634053|NCT00714103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101634054|NCT00714103|Vasodilator Agents|vasodilator agents|mesh-ancestor
101634055|NCT00714103|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101634056|NCT00714103|Purinergic Agonists|purinergic agonists|mesh-ancestor
101634057|NCT00714103|Purinergic Agents|purinergic agents|mesh-ancestor
101634058|NCT00714103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101634059|NCT00714103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634060|NCT00993044|Bevacizumab|bevacizumab|mesh-list
101634061|NCT00993044|Irinotecan|irinotecan|mesh-list
101634062|NCT00993044|Vincristine|vincristine|mesh-list
101634063|NCT00993044|Temozolomide|temozolomide|mesh-list
101634064|NCT00993044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101634065|NCT00993044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101725354|NCT04015908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101634066|NCT00993044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101634067|NCT00993044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101634068|NCT00993044|Growth Substances|growth substances|mesh-ancestor
101634069|NCT00993044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634070|NCT00993044|Growth Inhibitors|growth inhibitors|mesh-ancestor
101634071|NCT00993044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101634072|NCT00993044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101634073|NCT00993044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101634074|NCT00993044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634075|NCT00993044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101634076|NCT00993044|Tubulin Modulators|tubulin modulators|mesh-ancestor
101634077|NCT00993044|Antimitotic Agents|antimitotic agents|mesh-ancestor
101634078|NCT00993044|Mitosis Modulators|mitosis modulators|mesh-ancestor
101634079|NCT00993044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101634080|NCT00993044|Alkylating Agents|alkylating agents|mesh-ancestor
101634081|NCT00714181|Hydroxychloroquine|hydroxychloroquine|mesh-list
101634082|NCT00714181|Temozolomide|temozolomide|mesh-list
101634083|NCT00714181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101634084|NCT00714181|Alkylating Agents|alkylating agents|mesh-ancestor
101634085|NCT00714181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634086|NCT00714181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101634087|NCT00714181|Antimalarials|antimalarials|mesh-ancestor
101634088|NCT00714181|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101634089|NCT00714181|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101634090|NCT00714181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101634091|NCT00714181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101634092|NCT00714181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101634093|NCT02600806|Azithromycin|azithromycin|mesh-list
101634094|NCT02600806|Levofloxacin|levofloxacin|mesh-list
101634095|NCT02600806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101634096|NCT02600806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101634097|NCT02600806|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101634098|NCT02600806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101634099|NCT02600806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101634100|NCT02600806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101634101|NCT02600806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291206|NCT01953978|Narcotics|narcotics|mesh-ancestor
101634102|NCT02600806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101634103|NCT02600806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101634104|NCT02600806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101634106|NCT00639873|Artesunate|artesunate|mesh-list
101634107|NCT00639873|Quinine|quinine|mesh-list
101634108|NCT00639873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101634109|NCT00639873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101634110|NCT00639873|Antimalarials|antimalarials|mesh-ancestor
101634111|NCT00639873|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101634112|NCT00639873|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101634113|NCT00639873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101634114|NCT00639873|Antiviral Agents|antiviral agents|mesh-ancestor
101634115|NCT00639873|Schistosomicides|schistosomicides|mesh-ancestor
101634116|NCT00639873|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101634117|NCT00639873|Anthelmintics|anthelmintics|mesh-ancestor
101634118|NCT00639873|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101634119|NCT00639873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634120|NCT00639873|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101634121|NCT00639873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101634122|NCT00639873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101634123|NCT00639873|Analgesics|analgesics|mesh-ancestor
101634124|NCT00639873|Sensory System Agents|sensory system agents|mesh-ancestor
101634125|NCT04291118|Budesonide|budesonide|mesh-list
101634126|NCT04291118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101634127|NCT04291118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101634128|NCT04291118|Autonomic Agents|autonomic agents|mesh-ancestor
101634129|NCT04291118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101634130|NCT04291118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634131|NCT04291118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101634132|NCT04291118|Respiratory System Agents|respiratory system agents|mesh-ancestor
101634133|NCT04291118|Glucocorticoids|glucocorticoids|mesh-ancestor
101634134|NCT04291118|Hormones|hormones|mesh-ancestor
101634135|NCT04291118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101634136|NCT02868944|Sufentanil|sufentanil|mesh-list
101634137|NCT02868944|Morphine|morphine|mesh-list
101634138|NCT02868944|Levobupivacaine|levobupivacaine|mesh-list
101634139|NCT02868944|Anesthetics|anesthetics|mesh-list
101634140|NCT02868944|Anesthetics, Local|anesthetics, local|mesh-list
101634141|NCT02868944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101634142|NCT02868944|Narcotics|narcotics|mesh-ancestor
101634143|NCT02868944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101634144|NCT02868944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634145|NCT02868944|Analgesics|analgesics|mesh-ancestor
101634146|NCT02868944|Sensory System Agents|sensory system agents|mesh-ancestor
101634147|NCT02868944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101634148|NCT02868944|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101634149|NCT02868944|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101634150|NCT02868944|Anesthetics, General|anesthetics, general|mesh-ancestor
101634156|NCT04096690|Pegaspargase|pegaspargase|mesh-list
101634157|NCT04096690|Antibodies|antibodies|mesh-list
101634158|NCT04096690|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101634159|NCT04096690|Immunologic Factors|immunologic factors|mesh-ancestor
101634160|NCT04096690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634161|NCT04096690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101634165|NCT00719797|Leucovorin|leucovorin|mesh-list
101634166|NCT00719797|Bevacizumab|bevacizumab|mesh-list
101634167|NCT00719797|Fluorouracil|fluorouracil|mesh-list
101634168|NCT00719797|Oxaliplatin|oxaliplatin|mesh-list
101634169|NCT00719797|Irinotecan|irinotecan|mesh-list
101634170|NCT00719797|Calcium|calcium|mesh-list
101634172|NCT00719797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101634173|NCT00719797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101634174|NCT00719797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101634175|NCT00719797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101634176|NCT00719797|Growth Substances|growth substances|mesh-ancestor
101634177|NCT00719797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634178|NCT00719797|Growth Inhibitors|growth inhibitors|mesh-ancestor
101634179|NCT00719797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101634180|NCT00719797|Antimetabolites|antimetabolites|mesh-ancestor
101634181|NCT00719797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634182|NCT00719797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101634183|NCT00719797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101634184|NCT00719797|Immunologic Factors|immunologic factors|mesh-ancestor
101634185|NCT00719797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101634186|NCT00719797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101634187|NCT00719797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101634188|NCT00719797|Antidotes|antidotes|mesh-ancestor
101634189|NCT00719797|Protective Agents|protective agents|mesh-ancestor
101634190|NCT00719797|Vitamin B Complex|vitamin b complex|mesh-ancestor
101634191|NCT00719797|Vitamins|vitamins|mesh-ancestor
101634192|NCT00719797|Micronutrients|micronutrients|mesh-ancestor
101634193|NCT00979628|Insulin|insulin|mesh-list
101634194|NCT00979628|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101634195|NCT00979628|Insulin Glargine|insulin glargine|mesh-list
101634196|NCT00979628|Insulin glulisine|insulin glulisine|mesh-list
101634197|NCT00979628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101634198|NCT00979628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634199|NCT00719875|Vorinostat|vorinostat|mesh-list
101634200|NCT00719875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
101634201|NCT00719875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101634202|NCT00719875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101634203|NCT00719875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634204|NCT02685111|Lenograstim|lenograstim|mesh-list
101634205|NCT02685111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101634206|NCT02685111|Immunologic Factors|immunologic factors|mesh-ancestor
101634207|NCT02685111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634208|NCT00717925|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
101634209|NCT00717925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101634210|NCT00717925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101634211|NCT00717925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101634212|NCT00717925|Immunotoxins|immunotoxins|mesh-ancestor
101634213|NCT00717925|Immunoconjugates|immunoconjugates|mesh-ancestor
101634215|NCT00717925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634216|NCT03258723|Metformin|metformin|mesh-list
101634217|NCT03258723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101634218|NCT03258723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634219|NCT00640029|Meloxicam|meloxicam|mesh-list
101634220|NCT00640029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101634221|NCT00640029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101634222|NCT00640029|Analgesics|analgesics|mesh-ancestor
101634223|NCT00640029|Sensory System Agents|sensory system agents|mesh-ancestor
101634224|NCT00640029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101634225|NCT00640029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634226|NCT00640029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101634227|NCT00640029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101634228|NCT00640029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101634229|NCT00640029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101634230|NCT00640029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101634231|NCT00640029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634232|NCT02684799|Cenicriviroc|cenicriviroc|mesh-list
101634233|NCT02684799|Omeprazole|omeprazole|mesh-list
101634234|NCT02684799|Famotidine|famotidine|mesh-list
101634235|NCT02684799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101634236|NCT02684799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101634237|NCT02684799|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101634238|NCT02684799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101634239|NCT02684799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634240|NCT02684799|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101634241|NCT02684799|Histamine Antagonists|histamine antagonists|mesh-ancestor
101634242|NCT02684799|Histamine Agents|histamine agents|mesh-ancestor
101634243|NCT02684799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101634244|NCT02684799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634245|NCT02684799|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101634247|NCT02684799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101634248|NCT02684799|Antiviral Agents|antiviral agents|mesh-ancestor
101725640|NCT00871169|Irinotecan|irinotecan|mesh-list
101634249|NCT02684799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101634250|NCT02685189|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
101634251|NCT02685189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101634252|NCT02685189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634254|NCT00992108|Anesthetics, Local|anesthetics, local|mesh-ancestor
101634255|NCT00992108|Anesthetics|anesthetics|mesh-ancestor
101634256|NCT00992108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101634257|NCT00992108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634258|NCT00992108|Sensory System Agents|sensory system agents|mesh-ancestor
101634259|NCT00992108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101634260|NCT00992108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101634261|NCT00992108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101634262|NCT00992108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101634263|NCT00992108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101634264|NCT00992108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634265|NCT00752986|Fulvestrant|fulvestrant|mesh-list
101634266|NCT00752986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101634267|NCT00752986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101634268|NCT00752986|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101634269|NCT00752986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101634270|NCT00752986|Hormone Antagonists|hormone antagonists|mesh-ancestor
101634271|NCT00752986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101634272|NCT00752986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634273|NCT02684487|Vitamin D|vitamin d|mesh-list
101634274|NCT02684487|Cholecalciferol|cholecalciferol|mesh-list
101634275|NCT02684487|Vitamins|vitamins|mesh-ancestor
101634276|NCT02684487|Micronutrients|micronutrients|mesh-ancestor
101634277|NCT02684487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634278|NCT02684487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101634279|NCT02684487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101634280|NCT02684409|Sumatriptan|sumatriptan|mesh-list
101634281|NCT02684409|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101634282|NCT02684409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101634283|NCT02684409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101634284|NCT02684409|Serotonin Agents|serotonin agents|mesh-ancestor
101634285|NCT02684409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101634286|NCT02684409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634287|NCT02684409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634288|NCT00762892|Tenofovir|tenofovir|mesh-list
101634289|NCT00762892|Emtricitabine|emtricitabine|mesh-list
101634290|NCT00762892|Raltegravir Potassium|raltegravir potassium|mesh-list
101634291|NCT00762892|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101634292|NCT00762892|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101634293|NCT00762892|Antiviral Agents|antiviral agents|mesh-ancestor
101634294|NCT00762892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101634295|NCT00762892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101634296|NCT00762892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101634297|NCT00762892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101634298|NCT00762892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634299|NCT00762892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101634300|NCT00762892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101634301|NCT00762892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101634302|NCT00762892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101634303|NCT00762892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101634304|NCT00762892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101634305|NCT00762892|Protease Inhibitors|protease inhibitors|mesh-ancestor
101634306|NCT04290572|Isotretinoin|isotretinoin|mesh-list
101634307|NCT04290572|Dermatologic Agents|dermatologic agents|mesh-ancestor
101634308|NCT04069429|Heparin|heparin|mesh-list
101634309|NCT04069429|Anticoagulants|anticoagulants|mesh-ancestor
101634310|NCT04069429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101634311|NCT04069429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101634312|NCT04069429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634313|NCT00755716|Topiramate|topiramate|mesh-list
101634314|NCT00755716|Nicotine|nicotine|mesh-list
101634315|NCT00755716|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101634316|NCT00755716|Autonomic Agents|autonomic agents|mesh-ancestor
101634317|NCT00755716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101634318|NCT00755716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634320|NCT00755716|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101634321|NCT00755716|Cholinergic Agents|cholinergic agents|mesh-ancestor
101634322|NCT00755716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101634323|NCT00755716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634324|NCT00755716|Anticonvulsants|anticonvulsants|mesh-ancestor
101634325|NCT00755716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101634326|NCT00629252|Risperidone|risperidone|mesh-list
101634327|NCT00629252|Sertindole|sertindole|mesh-list
101634328|NCT00629252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101634329|NCT00629252|Serotonin Agents|serotonin agents|mesh-ancestor
101634330|NCT00629252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101634331|NCT00629252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634332|NCT00629252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634333|NCT00629252|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101634334|NCT00629252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101634335|NCT00629252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101634336|NCT00629252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101634337|NCT00629252|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101634338|NCT00629252|Dopamine Agents|dopamine agents|mesh-ancestor
101634339|NCT04096144|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
101634340|NCT04096144|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101634341|NCT04096144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101634342|NCT04096144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634343|NCT04095754|Dexmedetomidine|dexmedetomidine|mesh-list
101634344|NCT04095754|Anesthetics|anesthetics|mesh-list
101634345|NCT04095754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101634346|NCT04095754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634347|NCT04095754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101634348|NCT04095754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101634349|NCT04095754|Analgesics|analgesics|mesh-ancestor
101634350|NCT04095754|Sensory System Agents|sensory system agents|mesh-ancestor
101634351|NCT04095754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101634352|NCT04095754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101634353|NCT04095754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101634355|NCT04095754|Adrenergic Agents|adrenergic agents|mesh-ancestor
101634356|NCT04095754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101634357|NCT04095754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634358|NCT00720265|Tacrolimus|tacrolimus|mesh-list
101634359|NCT00720265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101634360|NCT00720265|Immunologic Factors|immunologic factors|mesh-ancestor
101634361|NCT00720265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634362|NCT00720265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101634363|NCT00720265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101634364|NCT00720265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634365|NCT02600650|Testosterone|testosterone|mesh-list
101634366|NCT02600650|Androgens|androgens|mesh-ancestor
101634367|NCT02600650|Hormones|hormones|mesh-ancestor
101634368|NCT02600650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101725827|NCT00851084|Leucovorin|leucovorin|mesh-list
101634369|NCT02600650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634371|NCT03084471|Tremelimumab|tremelimumab|mesh-list
101634372|NCT03084471|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101634373|NCT03084471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101634374|NCT03084471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101634375|NCT03084471|Immunologic Factors|immunologic factors|mesh-ancestor
101634376|NCT03084471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634377|NCT00718471|Heparin|heparin|mesh-list
101634378|NCT00718471|Enoxaparin|enoxaparin|mesh-list
101634379|NCT00718471|Calcium heparin|calcium heparin|mesh-list
101634380|NCT00718471|Anticoagulants|anticoagulants|mesh-ancestor
101634381|NCT00718471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101634382|NCT00718471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101634383|NCT00718471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634384|NCT00723307|Metformin|metformin|mesh-list
101634385|NCT00723307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101634386|NCT00723307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634387|NCT00723385|Vitamin D|vitamin d|mesh-list
101634388|NCT00723385|Cholecalciferol|cholecalciferol|mesh-list
101634389|NCT00723385|Vitamins|vitamins|mesh-ancestor
101634390|NCT00723385|Micronutrients|micronutrients|mesh-ancestor
101634391|NCT00723385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634392|NCT00723385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101634393|NCT00723385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101634395|NCT00754936|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101634396|NCT00754936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101634397|NCT00754936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101634398|NCT00754936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634399|NCT00754936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101634400|NCT00754936|Serotonin Agents|serotonin agents|mesh-ancestor
101634401|NCT00754936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291502|NCT01955694|Eplerenone|eplerenone|mesh-list
101634402|NCT02684019|Magnesium Sulfate|magnesium sulfate|mesh-list
101634403|NCT02684019|Dexmedetomidine|dexmedetomidine|mesh-list
101634404|NCT02684019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101634405|NCT02684019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101634406|NCT02684019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634407|NCT02684019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101634409|NCT02684019|Sensory System Agents|sensory system agents|mesh-ancestor
101634410|NCT02684019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101634411|NCT02684019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101634412|NCT02684019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101634413|NCT02684019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101634414|NCT02684019|Adrenergic Agents|adrenergic agents|mesh-ancestor
101634415|NCT02684019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101634416|NCT02684019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634417|NCT02684019|Anesthetics|anesthetics|mesh-ancestor
101634418|NCT02684019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101634419|NCT02684019|Anticonvulsants|anticonvulsants|mesh-ancestor
101634420|NCT02684019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101634421|NCT02684019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101634422|NCT02684019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101634423|NCT02684019|Tocolytic Agents|tocolytic agents|mesh-ancestor
101634424|NCT02684019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101634426|NCT00720421|Anticonvulsants|anticonvulsants|mesh-ancestor
101634427|NCT00720421|Antiemetics|antiemetics|mesh-ancestor
101634428|NCT00720421|Autonomic Agents|autonomic agents|mesh-ancestor
101634429|NCT00720421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101634430|NCT00720421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634431|NCT00720421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101634432|NCT00720421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101634433|NCT00720421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101634434|NCT00720421|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101634435|NCT00720421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101634436|NCT00720421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101634437|NCT00720421|GABA Modulators|gaba modulators|mesh-ancestor
101634438|NCT00720421|GABA Agents|gaba agents|mesh-ancestor
101634439|NCT00720421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101634440|NCT00720421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634441|NCT02689713|Voriconazole|voriconazole|mesh-list
101634442|NCT02689713|Antifungal Agents|antifungal agents|mesh-ancestor
101634443|NCT02689713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101634444|NCT02689713|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101634445|NCT02689713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101634446|NCT02689713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101634447|NCT02689713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634448|NCT02689713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101634449|NCT02689713|Hormone Antagonists|hormone antagonists|mesh-ancestor
101634450|NCT02689713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101634451|NCT02689713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725961|NCT00814320|Antibodies|antibodies|mesh-list
101634452|NCT02689713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101634453|NCT02601508|Rocuronium|rocuronium|mesh-list
101634454|NCT02601508|Atracurium|atracurium|mesh-list
101634455|NCT02601508|Cisatracurium|cisatracurium|mesh-list
101634456|NCT02601508|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101634457|NCT02601508|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101634458|NCT02601508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101634459|NCT02601508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101634460|NCT02601508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634461|NCT02601508|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101634462|NCT02601508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101634463|NCT02601508|Cholinergic Agents|cholinergic agents|mesh-ancestor
101634464|NCT02601508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101634465|NCT02601508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634466|NCT02570581|Acetaminophen|acetaminophen|mesh-list
101634468|NCT02570581|Furosemide|furosemide|mesh-list
101634469|NCT02570581|Memantine|memantine|mesh-list
101634470|NCT02570581|Alprazolam|alprazolam|mesh-list
101634471|NCT02570581|Zopiclone|zopiclone|mesh-list
101634472|NCT02570581|Oxazepam|oxazepam|mesh-list
101634473|NCT02570581|Donepezil|donepezil|mesh-list
101634474|NCT02570581|Clopidogrel|clopidogrel|mesh-list
101634475|NCT02570581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101634476|NCT02570581|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101634477|NCT02570581|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101634478|NCT02570581|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101634479|NCT02570581|Purinergic Agents|purinergic agents|mesh-ancestor
101634480|NCT02570581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101634481|NCT02570581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634482|NCT02570581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634483|NCT02570581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101634484|NCT02570581|Analgesics|analgesics|mesh-ancestor
101634485|NCT02570581|Sensory System Agents|sensory system agents|mesh-ancestor
101634486|NCT02570581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101634487|NCT02570581|Antipyretics|antipyretics|mesh-ancestor
101634488|NCT02570581|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101634489|NCT02570581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101634490|NCT02570581|Cholinergic Agents|cholinergic agents|mesh-ancestor
101634491|NCT02570581|Nootropic Agents|nootropic agents|mesh-ancestor
101634492|NCT02570581|Diuretics|diuretics|mesh-ancestor
101634493|NCT02570581|Natriuretic Agents|natriuretic agents|mesh-ancestor
101634494|NCT02570581|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101634495|NCT02570581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101634497|NCT02570581|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101634498|NCT02570581|Dopamine Agents|dopamine agents|mesh-ancestor
101634499|NCT02570581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101634500|NCT02570581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101634501|NCT02570581|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101634502|NCT02570581|Protease Inhibitors|protease inhibitors|mesh-ancestor
101634503|NCT02570581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101634504|NCT02570581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101634505|NCT02570581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101634506|NCT02570581|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101634507|NCT02570581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101634508|NCT02570581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101634509|NCT02570581|GABA Modulators|gaba modulators|mesh-ancestor
101634510|NCT02570581|GABA Agents|gaba agents|mesh-ancestor
101634511|NCT00640263|Ritonavir|ritonavir|mesh-list
101634512|NCT00640263|Lopinavir|lopinavir|mesh-list
101634513|NCT00640263|Lamivudine|lamivudine|mesh-list
101634514|NCT00640263|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101634515|NCT00640263|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101634516|NCT00640263|Protease Inhibitors|protease inhibitors|mesh-ancestor
101634517|NCT00640263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101634518|NCT00640263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634519|NCT00640263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101634520|NCT00640263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101634521|NCT00640263|Antiviral Agents|antiviral agents|mesh-ancestor
101634522|NCT00640263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101634523|NCT00640263|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101634524|NCT00640263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101634525|NCT00640263|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101634526|NCT00640263|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101634527|NCT02683863|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101634528|NCT02683863|Dermatologic Agents|dermatologic agents|mesh-ancestor
101634529|NCT02683863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101634530|NCT02683863|Immunologic Factors|immunologic factors|mesh-ancestor
101634531|NCT02683863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634532|NCT02865668|Metformin|metformin|mesh-list
101634533|NCT02865668|Canagliflozin|canagliflozin|mesh-list
101634534|NCT02865668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101634535|NCT02865668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634536|NCT02865668|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101634537|NCT02865668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634538|NCT02867930|Dexmedetomidine|dexmedetomidine|mesh-list
101634539|NCT02867930|Ketamine|ketamine|mesh-list
101634540|NCT02867930|Propofol|propofol|mesh-list
101634541|NCT02867930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101634542|NCT02867930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101634543|NCT02867930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634545|NCT02867930|Analgesics|analgesics|mesh-ancestor
101634546|NCT02867930|Sensory System Agents|sensory system agents|mesh-ancestor
101634547|NCT02867930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101634548|NCT02867930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101634549|NCT02867930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101634550|NCT02867930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101634551|NCT02867930|Adrenergic Agents|adrenergic agents|mesh-ancestor
101634552|NCT02867930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101634553|NCT02867930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634554|NCT02867930|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101291648|NCT01956786|Vasodilator Agents|vasodilator agents|mesh-ancestor
101634556|NCT02867930|Anesthetics|anesthetics|mesh-ancestor
101634557|NCT02867930|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101634558|NCT02867930|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101634559|NCT02867930|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101634560|NCT02570893|Paclitaxel|paclitaxel|mesh-list
101634561|NCT02570893|Carboplatin|carboplatin|mesh-list
101634562|NCT02570893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101634563|NCT02570893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101634564|NCT02570893|Tubulin Modulators|tubulin modulators|mesh-ancestor
101634565|NCT02570893|Antimitotic Agents|antimitotic agents|mesh-ancestor
101634566|NCT02570893|Mitosis Modulators|mitosis modulators|mesh-ancestor
101634567|NCT02570893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634568|NCT02538081|Risperidone|risperidone|mesh-list
101634569|NCT02538081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101634570|NCT02538081|Serotonin Agents|serotonin agents|mesh-ancestor
101634571|NCT02538081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101634572|NCT02538081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634573|NCT02538081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634574|NCT02538081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101634575|NCT02538081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101634576|NCT02538081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101634577|NCT02538081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101634578|NCT02538081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101634579|NCT02538081|Dopamine Agents|dopamine agents|mesh-ancestor
101634580|NCT02570971|Mannitol|mannitol|mesh-list
101634581|NCT02570971|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101634582|NCT02570971|Diuretics|diuretics|mesh-ancestor
101634583|NCT02570971|Natriuretic Agents|natriuretic agents|mesh-ancestor
101634584|NCT02570971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634585|NCT02866214|Febuxostat|febuxostat|mesh-list
101634586|NCT02866214|Gout Suppressants|gout suppressants|mesh-ancestor
101634587|NCT02866214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101634588|NCT02866448|Aspirin|aspirin|mesh-list
101634589|NCT02866448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101634590|NCT02866448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101634591|NCT02866448|Analgesics|analgesics|mesh-ancestor
101634592|NCT02866448|Sensory System Agents|sensory system agents|mesh-ancestor
101634593|NCT02866448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101634594|NCT02866448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634595|NCT02866448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101634596|NCT02866448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101634597|NCT02866448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101634598|NCT02866448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101634599|NCT02866448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634600|NCT02866448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101634601|NCT02866448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101634602|NCT02866448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101634603|NCT02866448|Antipyretics|antipyretics|mesh-ancestor
101634604|NCT00578227|Vaccines|vaccines|mesh-list
101634605|NCT00578227|Immunologic Factors|immunologic factors|mesh-ancestor
101634606|NCT00578227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634607|NCT00720577|Pioglitazone|pioglitazone|mesh-list
101634608|NCT00720577|Losartan|losartan|mesh-list
101634609|NCT00720577|Simvastatin|simvastatin|mesh-list
101634610|NCT00720577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101634611|NCT00720577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101634612|NCT00720577|Antimetabolites|antimetabolites|mesh-ancestor
101634613|NCT00720577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634614|NCT00720577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101634615|NCT00720577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101634616|NCT00720577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101634617|NCT00720577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101634618|NCT00720577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634619|NCT00720577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101634620|NCT00720577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101634621|NCT00720577|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101634622|NCT00720577|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101634623|NCT05373277|Ticagrelor|ticagrelor|mesh-list
101634624|NCT05373277|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101634625|NCT05373277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101634626|NCT05373277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101634627|NCT05373277|Antimetabolites|antimetabolites|mesh-ancestor
101634628|NCT05373277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634629|NCT05373277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101634630|NCT05373277|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101634632|NCT05373277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101634633|NCT05373277|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101634634|NCT05373277|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101634635|NCT05373277|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101634636|NCT05373277|Purinergic Agents|purinergic agents|mesh-ancestor
101634637|NCT05373277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101634638|NCT05373277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634639|NCT00724321|Iloprost|iloprost|mesh-list
101634640|NCT00724321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101634641|NCT00724321|Vasodilator Agents|vasodilator agents|mesh-ancestor
101634642|NCT00720811|Acetaminophen|acetaminophen|mesh-list
101634643|NCT00720811|Amoxicillin|amoxicillin|mesh-list
101634644|NCT00720811|Lumefantrine|lumefantrine|mesh-list
101634645|NCT00720811|Artemether|artemether|mesh-list
101634646|NCT00720811|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101634647|NCT00720811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101634648|NCT00720811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101634649|NCT00720811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101634650|NCT00720811|Analgesics|analgesics|mesh-ancestor
101634651|NCT00720811|Sensory System Agents|sensory system agents|mesh-ancestor
101634652|NCT00720811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101634653|NCT00720811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634654|NCT00720811|Antipyretics|antipyretics|mesh-ancestor
101634655|NCT00720811|Antimalarials|antimalarials|mesh-ancestor
101634656|NCT00720811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101634657|NCT00720811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101634658|NCT00724633|Dialysis Solutions|dialysis solutions|mesh-list
101634659|NCT00724633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101634660|NCT00577993|Interferons|interferons|mesh-list
101634661|NCT00577993|Interferon-alpha|interferon-alpha|mesh-list
101634662|NCT00577993|Interferon alpha-2|interferon alpha-2|mesh-list
101634663|NCT00577993|Dexamethasone|dexamethasone|mesh-list
101634664|NCT00577993|Prednisone|prednisone|mesh-list
101634665|NCT00577993|Prednisolone|prednisolone|mesh-list
101634666|NCT00577993|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101634667|NCT00577993|Methylprednisolone|methylprednisolone|mesh-list
101634668|NCT00577993|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101634669|NCT00577993|Prednisolone acetate|prednisolone acetate|mesh-list
101634670|NCT00577993|Cyclophosphamide|cyclophosphamide|mesh-list
101634671|NCT00577993|Rituximab|rituximab|mesh-list
101634672|NCT00577993|Doxorubicin|doxorubicin|mesh-list
101634673|NCT00577993|Fludarabine|fludarabine|mesh-list
101634674|NCT00577993|Etoposide|etoposide|mesh-list
101634675|NCT00577993|Vincristine|vincristine|mesh-list
101634676|NCT00577993|Mitoxantrone|mitoxantrone|mesh-list
101634677|NCT00577993|Bleomycin|bleomycin|mesh-list
101634678|NCT00577993|Procarbazine|procarbazine|mesh-list
101634679|NCT00577993|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101634680|NCT00577993|Prednisolone phosphate|prednisolone phosphate|mesh-list
101634681|NCT00577993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101634682|NCT00577993|Immunologic Factors|immunologic factors|mesh-ancestor
101634683|NCT00577993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634684|NCT00577993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101634685|NCT00577993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101634686|NCT00577993|Alkylating Agents|alkylating agents|mesh-ancestor
101634687|NCT00577993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634688|NCT00577993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101634689|NCT00577993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101634690|NCT00577993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101634691|NCT00577993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101634693|NCT00577993|Autonomic Agents|autonomic agents|mesh-ancestor
101634694|NCT00577993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101634695|NCT00577993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101634697|NCT00577993|Hormones|hormones|mesh-ancestor
101634698|NCT00577993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101634699|NCT00577993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101634700|NCT00577993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101634701|NCT00577993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101634702|NCT00577993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101634703|NCT00577993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101634704|NCT00577993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101634705|NCT00577993|Antiviral Agents|antiviral agents|mesh-ancestor
101634706|NCT00577993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101634707|NCT00577993|Tubulin Modulators|tubulin modulators|mesh-ancestor
101634708|NCT00577993|Antimitotic Agents|antimitotic agents|mesh-ancestor
101634709|NCT00577993|Mitosis Modulators|mitosis modulators|mesh-ancestor
101634710|NCT00577993|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101634711|NCT00577993|Protective Agents|protective agents|mesh-ancestor
101634712|NCT00577993|Analgesics|analgesics|mesh-ancestor
101634713|NCT00577993|Sensory System Agents|sensory system agents|mesh-ancestor
101634714|NCT00975806|Lenalidomide|lenalidomide|mesh-list
101634715|NCT00975806|Sunitinib|sunitinib|mesh-list
101634716|NCT00975806|Immunologic Factors|immunologic factors|mesh-ancestor
101634717|NCT00975806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634718|NCT00975806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101634719|NCT00975806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101634720|NCT00975806|Growth Substances|growth substances|mesh-ancestor
101634721|NCT00975806|Growth Inhibitors|growth inhibitors|mesh-ancestor
101634722|NCT00975806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101634723|NCT00975806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101634724|NCT00975806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101634725|NCT00975806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634727|NCT00721201|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101634728|NCT00721201|Abortifacient Agents|abortifacient agents|mesh-ancestor
101634729|NCT00721201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101634730|NCT00721201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634731|NCT00721201|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101634732|NCT00721201|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101634733|NCT00721201|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101634734|NCT00721201|Contraceptive Agents|contraceptive agents|mesh-ancestor
101634735|NCT00721201|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101634736|NCT00721201|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101634737|NCT00721201|Hormone Antagonists|hormone antagonists|mesh-ancestor
101634738|NCT00721201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101634739|NCT00721201|Luteolytic Agents|luteolytic agents|mesh-ancestor
101634740|NCT00721201|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101634741|NCT00721201|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101634742|NCT02866370|Paclitaxel|paclitaxel|mesh-list
101634743|NCT02866370|Carboplatin|carboplatin|mesh-list
101634744|NCT02866370|Doxorubicin|doxorubicin|mesh-list
101634745|NCT02866370|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101634746|NCT02866370|Topotecan|topotecan|mesh-list
101634747|NCT02866370|Nintedanib|nintedanib|mesh-list
101634748|NCT02866370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101634749|NCT02866370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101634750|NCT02866370|Tubulin Modulators|tubulin modulators|mesh-ancestor
101634751|NCT02866370|Antimitotic Agents|antimitotic agents|mesh-ancestor
101634752|NCT02866370|Mitosis Modulators|mitosis modulators|mesh-ancestor
101726254|NCT00798616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101634753|NCT02866370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634754|NCT02866370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101634755|NCT02866370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101634756|NCT02866370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101634757|NCT02866370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101634758|NCT02866370|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101634759|NCT02866370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101634761|NCT00978068|Lopinavir|lopinavir|mesh-list
101634762|NCT00978068|Nevirapine|nevirapine|mesh-list
101634763|NCT00978068|Efavirenz|efavirenz|mesh-list
101634764|NCT00978068|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
101634765|NCT00978068|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101634766|NCT00978068|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101634767|NCT00978068|Protease Inhibitors|protease inhibitors|mesh-ancestor
101634768|NCT00978068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101634769|NCT00978068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634770|NCT00978068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101634771|NCT00978068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101634773|NCT00978068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101634774|NCT00978068|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101634775|NCT00978068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101634776|NCT00978068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101634777|NCT00978068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101634778|NCT00978068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101634779|NCT00978068|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101634780|NCT00978068|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101634781|NCT00978068|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101634782|NCT00629642|Solifenacin Succinate|solifenacin succinate|mesh-list
101634784|NCT00629642|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101634785|NCT00629642|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101634786|NCT00629642|Cholinergic Agents|cholinergic agents|mesh-ancestor
101634787|NCT00629642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101634788|NCT00629642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634789|NCT00629642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634790|NCT00629642|Urological Agents|urological agents|mesh-ancestor
101634791|NCT00629642|Parasympatholytics|parasympatholytics|mesh-ancestor
101634792|NCT00629642|Autonomic Agents|autonomic agents|mesh-ancestor
101634793|NCT00629642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101634795|NCT02865356|Cyclosporins|cyclosporins|mesh-list
101634796|NCT02865356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101634797|NCT02865356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634798|NCT02865356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101634799|NCT02865356|Immunologic Factors|immunologic factors|mesh-ancestor
101634800|NCT02865356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634801|NCT02865356|Antifungal Agents|antifungal agents|mesh-ancestor
101634802|NCT02865356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101634803|NCT02865356|Dermatologic Agents|dermatologic agents|mesh-ancestor
101634804|NCT02865356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101634805|NCT02865356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101634806|NCT04287842|Sevoflurane|sevoflurane|mesh-list
101634807|NCT04287842|Desflurane|desflurane|mesh-list
101634808|NCT04287842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101634809|NCT04287842|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101634810|NCT04287842|Anesthetics, General|anesthetics, general|mesh-ancestor
101634811|NCT04287842|Anesthetics|anesthetics|mesh-ancestor
101634812|NCT04287842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101634813|NCT04287842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634814|NCT00721747|Cyclophosphamide|cyclophosphamide|mesh-list
101634815|NCT00721747|Docetaxel|docetaxel|mesh-list
101634816|NCT00721747|Doxorubicin|doxorubicin|mesh-list
101634817|NCT00721747|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101634818|NCT00721747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101634819|NCT00721747|Immunologic Factors|immunologic factors|mesh-ancestor
101634820|NCT00721747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634821|NCT00721747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101634822|NCT00721747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101634823|NCT00721747|Alkylating Agents|alkylating agents|mesh-ancestor
101634824|NCT00721747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634825|NCT00721747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101634826|NCT00721747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101634827|NCT00721747|Tubulin Modulators|tubulin modulators|mesh-ancestor
101634828|NCT00721747|Antimitotic Agents|antimitotic agents|mesh-ancestor
101634829|NCT00721747|Mitosis Modulators|mitosis modulators|mesh-ancestor
101634830|NCT00721747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101634831|NCT00721747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101634832|NCT00721747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101634833|NCT00721747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101634835|NCT00603525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101634836|NCT02570191|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101634837|NCT02570191|Antiviral Agents|antiviral agents|mesh-ancestor
101634838|NCT02570191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101634839|NCT02689401|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
101634840|NCT02689401|Hematinics|hematinics|mesh-ancestor
101634841|NCT02689401|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101634842|NCT02689401|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101634843|NCT00640575|Triamcinolone|triamcinolone|mesh-list
101634844|NCT00640575|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101634845|NCT00640575|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101634846|NCT00640575|Lidocaine|lidocaine|mesh-list
101634847|NCT00640575|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101634848|NCT00640575|Anesthetics, Local|anesthetics, local|mesh-ancestor
101634849|NCT00640575|Anesthetics|anesthetics|mesh-ancestor
101634850|NCT00640575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101634851|NCT00640575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634852|NCT00640575|Sensory System Agents|sensory system agents|mesh-ancestor
101634853|NCT00640575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101634854|NCT00640575|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101291963|NCT01959100|Azithromycin|azithromycin|mesh-list
101634855|NCT00640575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101634856|NCT00640575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101634857|NCT00640575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101634858|NCT00640575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634859|NCT00640575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101634860|NCT00640575|Glucocorticoids|glucocorticoids|mesh-ancestor
101634861|NCT00640575|Hormones|hormones|mesh-ancestor
101634862|NCT00640575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101634863|NCT00640575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101634864|NCT00640575|Immunologic Factors|immunologic factors|mesh-ancestor
101634865|NCT00640575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101634866|NCT04067791|Melatonin|melatonin|mesh-list
101634867|NCT04067791|Antioxidants|antioxidants|mesh-ancestor
101634868|NCT04067791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634869|NCT04067791|Protective Agents|protective agents|mesh-ancestor
101634870|NCT04067791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634871|NCT04067791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101634872|NCT00762034|Paclitaxel|paclitaxel|mesh-list
101634873|NCT00762034|Bevacizumab|bevacizumab|mesh-list
101634874|NCT00762034|Carboplatin|carboplatin|mesh-list
101634875|NCT00762034|Pemetrexed|pemetrexed|mesh-list
101634876|NCT00762034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101634877|NCT00762034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101634878|NCT00762034|Tubulin Modulators|tubulin modulators|mesh-ancestor
101634879|NCT00762034|Antimitotic Agents|antimitotic agents|mesh-ancestor
101634880|NCT00762034|Mitosis Modulators|mitosis modulators|mesh-ancestor
101634881|NCT00762034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634882|NCT00762034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101634883|NCT00762034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101634884|NCT00762034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101634885|NCT00762034|Growth Substances|growth substances|mesh-ancestor
101634886|NCT00762034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634887|NCT00762034|Growth Inhibitors|growth inhibitors|mesh-ancestor
101634888|NCT00762034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101634889|NCT00762034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101634890|NCT00762034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101634891|NCT02387229|Rivaroxaban|rivaroxaban|mesh-list
101634892|NCT02387229|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101634893|NCT02387229|Antithrombins|antithrombins|mesh-ancestor
101634894|NCT02387229|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101634895|NCT02387229|Protease Inhibitors|protease inhibitors|mesh-ancestor
101634896|NCT02387229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101634897|NCT02387229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634898|NCT02387229|Anticoagulants|anticoagulants|mesh-ancestor
101634899|NCT04183881|Brodalumab|brodalumab|mesh-list
101634901|NCT04093648|Cyclophosphamide|cyclophosphamide|mesh-list
101634902|NCT04093648|Fludarabine|fludarabine|mesh-list
101634903|NCT04093648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101634904|NCT04093648|Immunologic Factors|immunologic factors|mesh-ancestor
101634905|NCT04093648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634906|NCT04093648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101634907|NCT04093648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101634908|NCT04093648|Alkylating Agents|alkylating agents|mesh-ancestor
101634909|NCT04093648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634910|NCT04093648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101634911|NCT04093648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101634912|NCT04184115|Scopolamine|scopolamine|mesh-list
101634913|NCT04184115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101634914|NCT04184115|Antiemetics|antiemetics|mesh-ancestor
101634915|NCT04184115|Autonomic Agents|autonomic agents|mesh-ancestor
101634916|NCT04184115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101634917|NCT04184115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634918|NCT04184115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101634919|NCT04184115|Mydriatics|mydriatics|mesh-ancestor
101634920|NCT04184115|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101634921|NCT04184115|Cholinergic Agents|cholinergic agents|mesh-ancestor
101634922|NCT04184115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101634923|NCT04184115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634924|NCT04184115|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101634925|NCT00722215|Nifedipine|nifedipine|mesh-list
101634926|NCT00722215|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-list
101634927|NCT00722215|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101634928|NCT00722215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101634929|NCT00722215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634930|NCT00722215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101634931|NCT00722215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634932|NCT00722215|Vasodilator Agents|vasodilator agents|mesh-ancestor
101634933|NCT00722215|Tocolytic Agents|tocolytic agents|mesh-ancestor
101634934|NCT00722215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101634935|NCT00722215|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101634936|NCT00640809|Ibuprofen|ibuprofen|mesh-list
101634937|NCT00640809|Celecoxib|celecoxib|mesh-list
101634938|NCT00640809|Omeprazole|omeprazole|mesh-list
101634939|NCT00640809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101634940|NCT00640809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101634941|NCT00640809|Analgesics|analgesics|mesh-ancestor
101634942|NCT00640809|Sensory System Agents|sensory system agents|mesh-ancestor
101634943|NCT00640809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101634944|NCT00640809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634945|NCT00640809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101634946|NCT00640809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101634947|NCT00640809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101634948|NCT00640809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101634949|NCT00640809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634950|NCT00640809|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101634951|NCT00640809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101634952|NCT00640809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101634953|NCT00640809|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101634954|NCT00754624|Insulin|insulin|mesh-list
101634955|NCT00754624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101634956|NCT00754624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634957|NCT05630209|Doxorubicin|doxorubicin|mesh-list
101634958|NCT05630209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101634959|NCT05630209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101634960|NCT05630209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101634961|NCT05630209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101634962|NCT05630209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101634963|NCT05630209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634964|NCT00722293|Doxorubicin|doxorubicin|mesh-list
101634965|NCT00722293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101634966|NCT00722293|Epirubicin|epirubicin|mesh-list
101634967|NCT00722293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101634968|NCT00722293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101634969|NCT00722293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101634970|NCT00722293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101634971|NCT00722293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101634972|NCT00722293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634973|NCT00726505|Dapagliflozin|dapagliflozin|mesh-list
101634974|NCT00726505|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101634975|NCT00726505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634976|NCT00726505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101634977|NCT00726505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634978|NCT02683005|Sofosbuvir|sofosbuvir|mesh-list
101634979|NCT02683005|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
101634980|NCT02683005|Ledipasvir|ledipasvir|mesh-list
101634981|NCT02683005|Antiviral Agents|antiviral agents|mesh-ancestor
101634982|NCT02683005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101634983|NCT03583957|Caffeine|caffeine|mesh-list
101634984|NCT03583957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101634985|NCT03583957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634986|NCT03583957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101634987|NCT03583957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101634988|NCT03583957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101634989|NCT03583957|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101634990|NCT03583957|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101634991|NCT03583957|Purinergic Agents|purinergic agents|mesh-ancestor
101634992|NCT03583957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101634993|NCT02176863|Immunoglobulins|immunoglobulins|mesh-list
101634994|NCT02176863|gamma-Globulins|gamma-globulins|mesh-list
101634995|NCT02176863|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101634996|NCT02176863|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101634997|NCT02176863|Immunologic Factors|immunologic factors|mesh-ancestor
101634998|NCT02176863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101634999|NCT02571283|Epinephrine|epinephrine|mesh-list
101635000|NCT02571283|Bupivacaine|bupivacaine|mesh-list
101635001|NCT02571283|Anesthetics, Local|anesthetics, local|mesh-ancestor
101635002|NCT02571283|Anesthetics|anesthetics|mesh-ancestor
101635003|NCT02571283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101635004|NCT02571283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635005|NCT02571283|Sensory System Agents|sensory system agents|mesh-ancestor
101292096|NCT01960205|Protease Inhibitors|protease inhibitors|mesh-ancestor
101635006|NCT02571283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101635007|NCT02571283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635008|NCT02571283|Autonomic Agents|autonomic agents|mesh-ancestor
101635009|NCT02571283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101635010|NCT02571283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101635011|NCT02571283|Adrenergic Agents|adrenergic agents|mesh-ancestor
101635012|NCT02571283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101635013|NCT02571283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101635014|NCT02571283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101635015|NCT02571283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101635016|NCT02571283|Respiratory System Agents|respiratory system agents|mesh-ancestor
101635017|NCT02571283|Mydriatics|mydriatics|mesh-ancestor
101635018|NCT02571283|Sympathomimetics|sympathomimetics|mesh-ancestor
101635019|NCT02571283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101635020|NCT02682693|Denosumab|denosumab|mesh-list
101635021|NCT02682693|Paclitaxel|paclitaxel|mesh-list
101635022|NCT02682693|Cyclophosphamide|cyclophosphamide|mesh-list
101635023|NCT02682693|Carboplatin|carboplatin|mesh-list
101635024|NCT02682693|Trastuzumab|trastuzumab|mesh-list
101635025|NCT02682693|Epirubicin|epirubicin|mesh-list
101635026|NCT02682693|Pertuzumab|pertuzumab|mesh-list
101635027|NCT02682693|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101635028|NCT02682693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101635029|NCT02682693|Tubulin Modulators|tubulin modulators|mesh-ancestor
101635030|NCT02682693|Antimitotic Agents|antimitotic agents|mesh-ancestor
101635031|NCT02682693|Mitosis Modulators|mitosis modulators|mesh-ancestor
101635032|NCT02682693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635033|NCT02682693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101635034|NCT02682693|Immunologic Factors|immunologic factors|mesh-ancestor
101635035|NCT02682693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635036|NCT02682693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101635037|NCT02682693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101635038|NCT02682693|Alkylating Agents|alkylating agents|mesh-ancestor
101635039|NCT02682693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101635041|NCT02682693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101635042|NCT02682693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101635043|NCT02682693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101635044|NCT02682693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101635045|NCT02682693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101635046|NCT02571517|Methylprednisolone|methylprednisolone|mesh-list
101635047|NCT02571517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101635048|NCT02571517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101635049|NCT02571517|Prednisolone|prednisolone|mesh-list
101635050|NCT02571517|Prednisolone acetate|prednisolone acetate|mesh-list
101635051|NCT02571517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101635052|NCT02571517|Prednisolone phosphate|prednisolone phosphate|mesh-list
101635053|NCT02571517|Glucocorticoids|glucocorticoids|mesh-list
101635054|NCT02571517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101635055|NCT02571517|Antiemetics|antiemetics|mesh-ancestor
101635056|NCT02571517|Autonomic Agents|autonomic agents|mesh-ancestor
101635057|NCT02571517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101635058|NCT02571517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635059|NCT02571517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101635061|NCT02571517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101635062|NCT02571517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101635063|NCT02571517|Protective Agents|protective agents|mesh-ancestor
101635064|NCT02571517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101635065|NCT02571517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101635066|NCT00586846|Doxorubicin|doxorubicin|mesh-list
101635067|NCT00586846|Methotrexate|methotrexate|mesh-list
101635068|NCT00586846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101635069|NCT00586846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101635070|NCT00586846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101635071|NCT00586846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101635072|NCT00586846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101635073|NCT00586846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635074|NCT00586846|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101635075|NCT00586846|Abortifacient Agents|abortifacient agents|mesh-ancestor
101635076|NCT00586846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101635077|NCT00586846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635078|NCT00586846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101635079|NCT00586846|Antimetabolites|antimetabolites|mesh-ancestor
101635080|NCT00586846|Dermatologic Agents|dermatologic agents|mesh-ancestor
101635081|NCT00586846|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101635082|NCT00586846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101635083|NCT00586846|Immunologic Factors|immunologic factors|mesh-ancestor
101635084|NCT00586846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101635085|NCT00586846|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101635088|NCT04144465|Norepinephrine|norepinephrine|mesh-list
101635089|NCT04144465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101635090|NCT04144465|Mydriatics|mydriatics|mesh-ancestor
101635091|NCT04144465|Autonomic Agents|autonomic agents|mesh-ancestor
101635092|NCT04144465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101635093|NCT04144465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635094|NCT04144465|Sympathomimetics|sympathomimetics|mesh-ancestor
101635095|NCT04144465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101635096|NCT04144465|Nasal Decongestants|nasal decongestants|mesh-ancestor
101635097|NCT04144465|Respiratory System Agents|respiratory system agents|mesh-ancestor
101635098|NCT04144465|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101635099|NCT04144465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101635100|NCT04144465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101635101|NCT04144465|Adrenergic Agents|adrenergic agents|mesh-ancestor
101635102|NCT04144465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101635103|NCT04144465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635104|NCT04144465|Protective Agents|protective agents|mesh-ancestor
101635106|NCT00754390|Calcium|calcium|mesh-list
101635107|NCT00754390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101635108|NCT00754390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635109|NCT00754390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101635110|NCT04066621|Ceftriaxone|ceftriaxone|mesh-list
101635111|NCT04066621|Sulbactam|sulbactam|mesh-list
101635112|NCT04066621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101635113|NCT04066621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101635114|NCT04066621|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101635115|NCT04066621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101635116|NCT04066621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635117|NCT00629564|Esomeprazole|esomeprazole|mesh-list
101635118|NCT00629564|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101635119|NCT00629564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101635120|NCT00629564|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101635121|NCT00629564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101635122|NCT00629564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635123|NCT02865824|Aspirin|aspirin|mesh-list
101635124|NCT02865824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101635125|NCT02865824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101635126|NCT02865824|Analgesics|analgesics|mesh-ancestor
101635127|NCT02865824|Sensory System Agents|sensory system agents|mesh-ancestor
101635128|NCT02865824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101635129|NCT02865824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635130|NCT02865824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101635131|NCT02865824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101635132|NCT02865824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101635133|NCT02865824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101635134|NCT02865824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635135|NCT02865824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101635136|NCT02865824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101635137|NCT02865824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101635138|NCT02865824|Antipyretics|antipyretics|mesh-ancestor
101635139|NCT02570035|Mirabegron|mirabegron|mesh-list
101635140|NCT02570035|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101635141|NCT02570035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101635142|NCT02570035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101635143|NCT02570035|Adrenergic Agents|adrenergic agents|mesh-ancestor
101635144|NCT02570035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101635145|NCT02570035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635146|NCT02570035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635147|NCT02570035|Urological Agents|urological agents|mesh-ancestor
101635148|NCT02865980|Povidone-Iodine|povidone-iodine|mesh-list
101635149|NCT02865980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101635150|NCT02865980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101635151|NCT04098796|Antibodies|antibodies|mesh-list
101635152|NCT04098796|Immunologic Factors|immunologic factors|mesh-ancestor
101635153|NCT04098796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635154|NCT00522145|XL647|xl647|mesh-list
101635155|NCT00522145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101635156|NCT00522145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101635157|NCT00522145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101635158|NCT00522145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635159|NCT00726973|Ranibizumab|ranibizumab|mesh-list
101635160|NCT00726973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101635161|NCT00726973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101635162|NCT00726973|Growth Substances|growth substances|mesh-ancestor
101635163|NCT00726973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635164|NCT00726973|Growth Inhibitors|growth inhibitors|mesh-ancestor
101635165|NCT00726973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101635167|NCT02571361|Ibuprofen|ibuprofen|mesh-list
101635168|NCT02571361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101635169|NCT02571361|Analgesics|analgesics|mesh-ancestor
101635170|NCT02571361|Sensory System Agents|sensory system agents|mesh-ancestor
101635171|NCT02571361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101635172|NCT02571361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635173|NCT02571361|Antipyretics|antipyretics|mesh-ancestor
101635174|NCT02571361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101635175|NCT02571361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101635176|NCT02571361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101635177|NCT02571361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101635178|NCT02571361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101635179|NCT02571361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635180|NCT04290104|Ampicillin|ampicillin|mesh-list
101635181|NCT04290104|Sulbactam|sulbactam|mesh-list
101635182|NCT04290104|Sultamicillin|sultamicillin|mesh-list
101635183|NCT04290104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101635184|NCT04290104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101635185|NCT04290104|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101635186|NCT04290104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101635187|NCT04290104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635188|NCT02571205|Testosterone|testosterone|mesh-list
101635189|NCT02571205|Androgens|androgens|mesh-ancestor
101635190|NCT02571205|Hormones|hormones|mesh-ancestor
101635191|NCT02571205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101635192|NCT02571205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635193|NCT04290026|Metoclopramide|metoclopramide|mesh-list
101635194|NCT04290026|Granisetron|granisetron|mesh-list
101635195|NCT04290026|Antiemetics|antiemetics|mesh-ancestor
101635196|NCT04290026|Autonomic Agents|autonomic agents|mesh-ancestor
101635197|NCT04290026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101635198|NCT04290026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635199|NCT04290026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101635200|NCT04290026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101635201|NCT04290026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101635202|NCT04290026|Dopamine Agents|dopamine agents|mesh-ancestor
101635203|NCT04290026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101635204|NCT04290026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726790|NCT00663052|Etanercept|etanercept|mesh-list
101635205|NCT04290026|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101635206|NCT04290026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101635207|NCT04290026|Serotonin Agents|serotonin agents|mesh-ancestor
101635208|NCT00640887|Ritonavir|ritonavir|mesh-list
101635209|NCT00640887|Lopinavir|lopinavir|mesh-list
101635210|NCT00640887|Nevirapine|nevirapine|mesh-list
101635211|NCT00640887|Efavirenz|efavirenz|mesh-list
101635212|NCT00640887|Rifabutin|rifabutin|mesh-list
101635213|NCT00640887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101635214|NCT00640887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101635215|NCT00640887|Protease Inhibitors|protease inhibitors|mesh-ancestor
101635216|NCT00640887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101635217|NCT00640887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635218|NCT00640887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101635219|NCT00640887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101635220|NCT00640887|Antiviral Agents|antiviral agents|mesh-ancestor
101635221|NCT00640887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101635222|NCT00640887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101635223|NCT00640887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101635224|NCT00640887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101635225|NCT00640887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101635226|NCT00640887|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101635227|NCT00640887|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101635228|NCT00640887|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101635229|NCT00640887|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101635230|NCT00640887|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101292320|NCT01962181|Dopamine Agents|dopamine agents|mesh-ancestor
101635231|NCT00640887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101635232|NCT00640887|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101635233|NCT00640887|Antitubercular Agents|antitubercular agents|mesh-ancestor
101635234|NCT05615623|Doxorubicin|doxorubicin|mesh-list
101635235|NCT05615623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101635236|NCT05615623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101635237|NCT05615623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101726825|NCT00707330|Clarithromycin|clarithromycin|mesh-list
101635238|NCT05615623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101635239|NCT05615623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101635240|NCT05615623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635241|NCT00730093|Vitamin B 12|vitamin b 12|mesh-list
101635242|NCT00730093|Hydroxocobalamin|hydroxocobalamin|mesh-list
101635243|NCT00730093|Vitamins|vitamins|mesh-ancestor
101635244|NCT00730093|Micronutrients|micronutrients|mesh-ancestor
101635245|NCT00730093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635246|NCT00730093|Vitamin B Complex|vitamin b complex|mesh-ancestor
101635247|NCT00730093|Hematinics|hematinics|mesh-ancestor
101635248|NCT00727129|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101635249|NCT00727129|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101635250|NCT00727129|Estradiol|estradiol|mesh-list
101635251|NCT00727129|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101635252|NCT00727129|Estrogens|estrogens|mesh-ancestor
101635253|NCT00727129|Hormones|hormones|mesh-ancestor
101635254|NCT00727129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101635255|NCT00727129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635256|NCT00727129|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101635257|NCT00727129|Contraceptive Agents|contraceptive agents|mesh-ancestor
101635258|NCT00727129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101635259|NCT00727129|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101635260|NCT04183725|Oseltamivir|oseltamivir|mesh-list
101635261|NCT04183725|Antiviral Agents|antiviral agents|mesh-ancestor
101635262|NCT04183725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101635263|NCT04183725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101635264|NCT04183725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635265|NCT00730249|Methylphenidate|methylphenidate|mesh-list
101635266|NCT00730249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101635267|NCT00730249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635268|NCT00730249|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101635269|NCT00730249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101635270|NCT00730249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101635271|NCT00730249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635272|NCT00730249|Dopamine Agents|dopamine agents|mesh-ancestor
101726865|NCT00591006|Anticonvulsants|anticonvulsants|mesh-ancestor
101635273|NCT00730249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101635274|NCT02570347|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101635275|NCT02570347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101635276|NCT02570347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101635277|NCT02570347|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101635278|NCT02570347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101635279|NCT02570347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635280|NCT01632657|Sumatriptan|sumatriptan|mesh-list
101635281|NCT01632657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101635282|NCT01632657|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101635283|NCT01632657|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101635284|NCT01632657|Serotonin Agents|serotonin agents|mesh-ancestor
101635285|NCT01632657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101635286|NCT01632657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635287|NCT01632657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635288|NCT00727207|Everolimus|everolimus|mesh-list
101635289|NCT00727207|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101635290|NCT00727207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101635291|NCT00727207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101635292|NCT00727207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635293|NCT00727207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101635295|NCT00727207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635296|NCT00727207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101635297|NCT02682459|Lisinopril|lisinopril|mesh-list
101635298|NCT02682459|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101635299|NCT02682459|Protease Inhibitors|protease inhibitors|mesh-ancestor
101635300|NCT02682459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101635301|NCT02682459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635302|NCT02682459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101635303|NCT02682459|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101635304|NCT02682459|Protective Agents|protective agents|mesh-ancestor
101635305|NCT02682459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635307|NCT02620579|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101635308|NCT02620579|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101635309|NCT02620579|Adrenergic Agents|adrenergic agents|mesh-ancestor
101635310|NCT02620579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101635311|NCT02620579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635312|NCT02620579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635313|NCT02620579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101635314|NCT02620579|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101213757|NCT01460212|Sertraline|sertraline|mesh-list
101635315|NCT02620579|Vasodilator Agents|vasodilator agents|mesh-ancestor
101635317|NCT02682225|Esketamine|esketamine|mesh-list
101635318|NCT02682225|Analgesics|analgesics|mesh-ancestor
101635319|NCT02682225|Sensory System Agents|sensory system agents|mesh-ancestor
101635320|NCT02682225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101635321|NCT02682225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635322|NCT02682225|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101635323|NCT02682225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101635324|NCT02682225|Anesthetics, General|anesthetics, general|mesh-ancestor
101635325|NCT02682225|Anesthetics|anesthetics|mesh-ancestor
101635326|NCT02682225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101635327|NCT02682225|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101635328|NCT02682225|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101635329|NCT02682225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101635330|NCT02682225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635331|NCT02682225|Antidepressive Agents|antidepressive agents|mesh-ancestor
101635332|NCT02682225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101635333|NCT04066231|Erythromycin|erythromycin|mesh-list
101635334|NCT04066231|Erythromycin Estolate|erythromycin estolate|mesh-list
101635335|NCT04066231|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101635336|NCT04066231|Erythromycin stearate|erythromycin stearate|mesh-list
101635337|NCT04066231|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
101635338|NCT04066231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101635339|NCT04066231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101635340|NCT04066231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101635341|NCT04066231|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101635342|NCT04066231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101635343|NCT04066231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635344|NCT04183491|Interferons|interferons|mesh-list
101635345|NCT04183491|Interferon-beta|interferon-beta|mesh-list
101635346|NCT04183491|Interferon beta-1a|interferon beta-1a|mesh-list
101635347|NCT04183491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101635348|NCT04183491|Antiviral Agents|antiviral agents|mesh-ancestor
101635349|NCT04183491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101635350|NCT04183491|Immunologic Factors|immunologic factors|mesh-ancestor
101635351|NCT04183491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635352|NCT04183491|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101635353|NCT03702283|Penicillins|penicillins|mesh-list
101635354|NCT03702283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101635355|NCT03702283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101635356|NCT00727753|Bevacizumab|bevacizumab|mesh-list
101635357|NCT00727753|Ranibizumab|ranibizumab|mesh-list
101635358|NCT00727753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101635359|NCT00727753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101635360|NCT00727753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101635361|NCT00727753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101635362|NCT00727753|Growth Substances|growth substances|mesh-ancestor
101635363|NCT00727753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635364|NCT00727753|Growth Inhibitors|growth inhibitors|mesh-ancestor
101635365|NCT00727831|Leucovorin|leucovorin|mesh-list
101635366|NCT00727831|Methotrexate|methotrexate|mesh-list
101635367|NCT00727831|Calcium|calcium|mesh-list
101635368|NCT00727831|Levoleucovorin|levoleucovorin|mesh-list
101635369|NCT00727831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101635370|NCT00727831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635371|NCT00727831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101635372|NCT00727831|Abortifacient Agents|abortifacient agents|mesh-ancestor
101635373|NCT00727831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101635374|NCT00727831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101635375|NCT00727831|Antimetabolites|antimetabolites|mesh-ancestor
101635376|NCT00727831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635377|NCT00727831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101635378|NCT00727831|Dermatologic Agents|dermatologic agents|mesh-ancestor
101635379|NCT00727831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101635380|NCT00727831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101635381|NCT00727831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101635382|NCT00727831|Immunologic Factors|immunologic factors|mesh-ancestor
101635383|NCT00727831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101635384|NCT00727831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101635385|NCT00727831|Antidotes|antidotes|mesh-ancestor
101635386|NCT00727831|Protective Agents|protective agents|mesh-ancestor
101635387|NCT00727831|Vitamin B Complex|vitamin b complex|mesh-ancestor
101635388|NCT00727831|Vitamins|vitamins|mesh-ancestor
101635389|NCT00727831|Micronutrients|micronutrients|mesh-ancestor
101635390|NCT00727987|Golimumab|golimumab|mesh-list
101635391|NCT00727987|Methotrexate|methotrexate|mesh-list
101635392|NCT00727987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101635393|NCT00727987|Abortifacient Agents|abortifacient agents|mesh-ancestor
101635394|NCT00727987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101635395|NCT00727987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635396|NCT00727987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101635397|NCT00727987|Antimetabolites|antimetabolites|mesh-ancestor
101726967|NCT00826280|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101635398|NCT00727987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635400|NCT00727987|Dermatologic Agents|dermatologic agents|mesh-ancestor
101635401|NCT00727987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101635402|NCT00727987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101635403|NCT00727987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101635404|NCT00727987|Immunologic Factors|immunologic factors|mesh-ancestor
101635405|NCT00727987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101635406|NCT00727987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101635407|NCT00727987|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101635408|NCT00727987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101635409|NCT02681913|Adenosine|adenosine|mesh-list
101635410|NCT02681913|Analgesics|analgesics|mesh-ancestor
101635411|NCT02681913|Sensory System Agents|sensory system agents|mesh-ancestor
101635412|NCT02681913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101635413|NCT02681913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635414|NCT02681913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101635415|NCT02681913|Vasodilator Agents|vasodilator agents|mesh-ancestor
101635416|NCT02681913|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101635417|NCT02681913|Purinergic Agonists|purinergic agonists|mesh-ancestor
101635418|NCT02681913|Purinergic Agents|purinergic agents|mesh-ancestor
101635419|NCT02681913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101635420|NCT02681913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635421|NCT02681679|Bromfenac|bromfenac|mesh-list
101635422|NCT02681679|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101635423|NCT02681679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101635424|NCT02681679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101635425|NCT02681679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101635426|NCT02681679|Analgesics|analgesics|mesh-ancestor
101635427|NCT02681679|Sensory System Agents|sensory system agents|mesh-ancestor
101635428|NCT02681679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101635429|NCT02681679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635430|NCT02681679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101635431|NCT02681679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101635432|NCT04183257|Vitamin D|vitamin d|mesh-list
101635433|NCT04183257|Ergocalciferols|ergocalciferols|mesh-list
101635434|NCT04183257|Cholecalciferol|cholecalciferol|mesh-list
101635435|NCT04183257|Vitamins|vitamins|mesh-list
101363766|NCT00080847|Rituximab|rituximab|mesh-list
101635436|NCT04183257|Micronutrients|micronutrients|mesh-ancestor
101635437|NCT04183257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635438|NCT04183257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101635439|NCT04183257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101635440|NCT00641433|Sulfadiazine|sulfadiazine|mesh-list
101635441|NCT00641433|Silver Sulfadiazine|silver sulfadiazine|mesh-list
101635442|NCT00641433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101635443|NCT00641433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101635444|NCT00641433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101635445|NCT00641433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101635447|NCT00641433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101635448|NCT00641589|Epoetin Alfa|epoetin alfa|mesh-list
101635450|NCT00734383|Propofol|propofol|mesh-list
101635451|NCT00734383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101292547|NCT01964040|Anesthetics|anesthetics|mesh-ancestor
101635452|NCT00734383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101635453|NCT00734383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635454|NCT00734383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101635455|NCT00734383|Anesthetics, General|anesthetics, general|mesh-ancestor
101635456|NCT00734383|Anesthetics|anesthetics|mesh-ancestor
101635457|NCT00586612|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101635458|NCT00586612|Immunologic Factors|immunologic factors|mesh-ancestor
101635459|NCT00586612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635460|NCT02680977|Levodopa|levodopa|mesh-list
101635461|NCT02680977|Benserazide|benserazide|mesh-list
101635462|NCT02680977|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101635463|NCT02680977|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101635464|NCT02680977|Dopamine Agents|dopamine agents|mesh-ancestor
101635465|NCT02680977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101635466|NCT02680977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635467|NCT02680977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635468|NCT02680977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101635469|NCT00734695|Vitamins|vitamins|mesh-list
101635470|NCT00734695|Ascorbic Acid|ascorbic acid|mesh-list
101635471|NCT00734695|Micronutrients|micronutrients|mesh-ancestor
101635472|NCT00734695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635473|NCT00734695|Antioxidants|antioxidants|mesh-ancestor
101635474|NCT00734695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635475|NCT00734695|Protective Agents|protective agents|mesh-ancestor
101635476|NCT00586690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101635477|NCT00586690|Antibodies|antibodies|mesh-list
101635478|NCT00586690|Immunoglobulins|immunoglobulins|mesh-list
101635479|NCT00586690|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101635480|NCT00586690|Immunologic Factors|immunologic factors|mesh-ancestor
101635481|NCT00586690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635482|NCT00586690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101635483|NCT00728611|Hyaluronic Acid|hyaluronic acid|mesh-list
101727101|NCT00801580|Doxorubicin|doxorubicin|mesh-list
101635484|NCT00728611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101635485|NCT00728611|Immunologic Factors|immunologic factors|mesh-ancestor
101635486|NCT00728611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635487|NCT00728611|Viscosupplements|viscosupplements|mesh-ancestor
101635488|NCT00728611|Protective Agents|protective agents|mesh-ancestor
101635489|NCT05663775|Mesalamine|mesalamine|mesh-list
101635490|NCT05663775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101635491|NCT05663775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101635492|NCT05663775|Analgesics|analgesics|mesh-ancestor
101635493|NCT05663775|Sensory System Agents|sensory system agents|mesh-ancestor
101635494|NCT05663775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101635495|NCT05663775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635496|NCT05663775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101635497|NCT05663775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101635498|NCT00909987|Bevacizumab|bevacizumab|mesh-list
101635499|NCT00909987|Capecitabine|capecitabine|mesh-list
101635500|NCT00909987|Oxaliplatin|oxaliplatin|mesh-list
101635501|NCT00909987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101635502|NCT00909987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101635503|NCT00909987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101635504|NCT00909987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101635505|NCT00909987|Growth Substances|growth substances|mesh-ancestor
101635506|NCT00909987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635507|NCT00909987|Growth Inhibitors|growth inhibitors|mesh-ancestor
101635508|NCT00909987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101635510|NCT00909987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635511|NCT00729001|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101635512|NCT00729001|Immunologic Factors|immunologic factors|mesh-ancestor
101635513|NCT00729001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635514|NCT00760474|Pregabalin|pregabalin|mesh-list
101635515|NCT00760474|Analgesics|analgesics|mesh-ancestor
101635516|NCT00760474|Sensory System Agents|sensory system agents|mesh-ancestor
101635517|NCT00760474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101635518|NCT00760474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635519|NCT00760474|Anticonvulsants|anticonvulsants|mesh-ancestor
101635520|NCT00760474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101635521|NCT00760474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101635522|NCT00760474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635523|NCT00760474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101635524|NCT00760474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101635525|NCT00760474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101635526|NCT00760474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101635527|NCT00760474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101635528|NCT02843035|Venglustat|venglustat|mesh-list
101635529|NCT02843035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101292623|NCT01964287|Antimetabolites|antimetabolites|mesh-ancestor
101635530|NCT02843035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635531|NCT02680119|Esomeprazole|esomeprazole|mesh-list
101635532|NCT02680119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101635533|NCT02680119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101635534|NCT02680119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101635535|NCT02680119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101635536|NCT02680119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635537|NCT00734773|Cytarabine|cytarabine|mesh-list
101635538|NCT00734773|Rituximab|rituximab|mesh-list
101635539|NCT00734773|Methotrexate|methotrexate|mesh-list
101635540|NCT00734773|Vincristine|vincristine|mesh-list
101635541|NCT00734773|Procarbazine|procarbazine|mesh-list
101635542|NCT00734773|Motexafin gadolinium|motexafin gadolinium|mesh-list
101635543|NCT00734773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101635544|NCT00734773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101635545|NCT00734773|Immunologic Factors|immunologic factors|mesh-ancestor
101635546|NCT00734773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635547|NCT00734773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101635548|NCT00734773|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101635549|NCT00734773|Abortifacient Agents|abortifacient agents|mesh-ancestor
101635550|NCT00734773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101635551|NCT00734773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101635552|NCT00734773|Antimetabolites|antimetabolites|mesh-ancestor
101635553|NCT00734773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635554|NCT00734773|Dermatologic Agents|dermatologic agents|mesh-ancestor
101635555|NCT00734773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101635556|NCT00734773|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101635557|NCT00734773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101635558|NCT00734773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101635559|NCT00734773|Antiviral Agents|antiviral agents|mesh-ancestor
101635560|NCT00734773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101635561|NCT00734773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101635562|NCT00734773|Tubulin Modulators|tubulin modulators|mesh-ancestor
101635563|NCT00734773|Antimitotic Agents|antimitotic agents|mesh-ancestor
101635564|NCT00734773|Mitosis Modulators|mitosis modulators|mesh-ancestor
101635565|NCT00734773|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101635566|NCT04289090|Propofol|propofol|mesh-list
101635567|NCT04289090|Sevoflurane|sevoflurane|mesh-list
101635568|NCT04289090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101635569|NCT04289090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101635570|NCT04289090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635571|NCT04289090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101635572|NCT04289090|Anesthetics, General|anesthetics, general|mesh-ancestor
101635573|NCT04289090|Anesthetics|anesthetics|mesh-ancestor
101635574|NCT04289090|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101635575|NCT04289090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101635576|NCT00975416|Oxytocin|oxytocin|mesh-list
101635577|NCT00975416|Oxytocics|oxytocics|mesh-ancestor
101635578|NCT00975416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101727292|NCT00802828|Famotidine|famotidine|mesh-list
101635580|NCT02679963|Olaparib|olaparib|mesh-list
101635581|NCT02679963|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101635582|NCT02679963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101635583|NCT02679963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635584|NCT02679963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101635585|NCT00760084|Decitabine|decitabine|mesh-list
101635586|NCT00760084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101635587|NCT00760084|Antimetabolites|antimetabolites|mesh-ancestor
101635588|NCT00760084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635589|NCT00760084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101635590|NCT00760084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101635591|NCT00735241|Leucovorin|leucovorin|mesh-list
101635592|NCT00735241|Folic Acid|folic acid|mesh-list
101635593|NCT00735241|Bevacizumab|bevacizumab|mesh-list
101635594|NCT00735241|Fluorouracil|fluorouracil|mesh-list
101635595|NCT00735241|Oxaliplatin|oxaliplatin|mesh-list
101635597|NCT00735241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101635598|NCT00735241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101635599|NCT00735241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101635600|NCT00735241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101635601|NCT00735241|Growth Substances|growth substances|mesh-ancestor
101635602|NCT00735241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635603|NCT00735241|Growth Inhibitors|growth inhibitors|mesh-ancestor
101635604|NCT00735241|Antimetabolites|antimetabolites|mesh-ancestor
101727346|NCT00803764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101635605|NCT00735241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635606|NCT00735241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101635607|NCT00735241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101635610|NCT00735241|Protective Agents|protective agents|mesh-ancestor
101635611|NCT00735241|Vitamin B Complex|vitamin b complex|mesh-ancestor
101635612|NCT00735241|Vitamins|vitamins|mesh-ancestor
101635613|NCT00735241|Micronutrients|micronutrients|mesh-ancestor
101635614|NCT00735241|Hematinics|hematinics|mesh-ancestor
101635615|NCT00729313|Lanreotide|lanreotide|mesh-list
101635616|NCT00729313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101635617|NCT00641979|Budesonide|budesonide|mesh-list
101635618|NCT00641979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101635619|NCT00641979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101635620|NCT00641979|Autonomic Agents|autonomic agents|mesh-ancestor
101635621|NCT00641979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101635622|NCT00641979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635623|NCT00641979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101635624|NCT00641979|Respiratory System Agents|respiratory system agents|mesh-ancestor
101635625|NCT00641979|Glucocorticoids|glucocorticoids|mesh-ancestor
101635626|NCT00641979|Hormones|hormones|mesh-ancestor
101635627|NCT00641979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101635628|NCT02679339|Lidocaine|lidocaine|mesh-list
101635629|NCT02679339|Anesthetics, Local|anesthetics, local|mesh-ancestor
101635630|NCT02679339|Anesthetics|anesthetics|mesh-ancestor
101635631|NCT02679339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101635632|NCT02679339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635633|NCT02679339|Sensory System Agents|sensory system agents|mesh-ancestor
101635634|NCT02679339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101635635|NCT02679339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101635636|NCT02679339|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101635637|NCT02679339|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101635638|NCT02679339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101635639|NCT02679339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635640|NCT02679261|Atorvastatin|atorvastatin|mesh-list
101635641|NCT02679261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101635642|NCT02679261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101635643|NCT02679261|Antimetabolites|antimetabolites|mesh-ancestor
101635644|NCT02679261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635645|NCT02679261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101635646|NCT02679261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101635647|NCT02679261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101635648|NCT00752206|Saracatinib|saracatinib|mesh-list
101635649|NCT00752206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101635650|NCT00752206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101635651|NCT00752206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635652|NCT02678949|Fluticasone|fluticasone|mesh-list
101635653|NCT02678949|Xhance|xhance|mesh-list
101635654|NCT02678949|Albuterol|albuterol|mesh-list
101635655|NCT02678949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101635656|NCT02678949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101635657|NCT02678949|Autonomic Agents|autonomic agents|mesh-ancestor
101635658|NCT02678949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101635659|NCT02678949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635660|NCT02678949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101635661|NCT02678949|Respiratory System Agents|respiratory system agents|mesh-ancestor
101635662|NCT02678949|Dermatologic Agents|dermatologic agents|mesh-ancestor
101635663|NCT02678949|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101635664|NCT02678949|Tocolytic Agents|tocolytic agents|mesh-ancestor
101635665|NCT02678949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101635666|NCT02678949|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101635667|NCT02678949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101635668|NCT02678949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101635669|NCT02678949|Adrenergic Agents|adrenergic agents|mesh-ancestor
101635670|NCT02678949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101727436|NCT00823472|Hormone Antagonists|hormone antagonists|mesh-ancestor
101635671|NCT02678949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635672|NCT00642135|Phenylephrine|phenylephrine|mesh-list
101635673|NCT00642135|Oxymetazoline|oxymetazoline|mesh-list
101635674|NCT00642135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101635675|NCT00642135|Tropicamide|tropicamide|mesh-list
101635676|NCT00642135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101635677|NCT00642135|Mydriatics|mydriatics|mesh-ancestor
101635678|NCT00642135|Autonomic Agents|autonomic agents|mesh-ancestor
101635679|NCT00642135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101635680|NCT00642135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635681|NCT00642135|Sympathomimetics|sympathomimetics|mesh-ancestor
101292776|NCT01965041|Aflibercept|aflibercept|mesh-list
101635682|NCT00642135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101635683|NCT00642135|Nasal Decongestants|nasal decongestants|mesh-ancestor
101635684|NCT00642135|Respiratory System Agents|respiratory system agents|mesh-ancestor
101635685|NCT00642135|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101635686|NCT00642135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101635687|NCT00642135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101635688|NCT00642135|Adrenergic Agents|adrenergic agents|mesh-ancestor
101635689|NCT00642135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101635690|NCT00642135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635691|NCT00642135|Protective Agents|protective agents|mesh-ancestor
101635692|NCT00642135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101635693|NCT00642135|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101635694|NCT00642135|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101635695|NCT00642135|Cholinergic Agents|cholinergic agents|mesh-ancestor
101635696|NCT00642291|Emtricitabine|emtricitabine|mesh-list
101635697|NCT00642291|Antiviral Agents|antiviral agents|mesh-ancestor
101635698|NCT00642291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101635699|NCT00642291|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101635700|NCT00642291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101635701|NCT00642291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101635702|NCT00642291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635703|NCT00642291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101635704|NCT00642291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101635706|NCT02600260|Enoxaparin sodium|enoxaparin sodium|mesh-list
101635707|NCT02600260|Anticoagulants|anticoagulants|mesh-ancestor
101635708|NCT02600260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101635709|NCT02600260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101635710|NCT02600260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635711|NCT02537379|Ribavirin|ribavirin|mesh-list
101635712|NCT02537379|Antimetabolites|antimetabolites|mesh-ancestor
101635713|NCT02537379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635714|NCT02537379|Antiviral Agents|antiviral agents|mesh-ancestor
101635715|NCT02537379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101635716|NCT04179747|Sildenafil Citrate|sildenafil citrate|mesh-list
101635717|NCT04179747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635718|NCT04179747|Vasodilator Agents|vasodilator agents|mesh-ancestor
101635719|NCT04179747|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101635720|NCT04179747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101635721|NCT04179747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101635722|NCT04179747|Urological Agents|urological agents|mesh-ancestor
101635723|NCT04204772|Charcoal|charcoal|mesh-list
101635724|NCT04204772|Antidotes|antidotes|mesh-ancestor
101635725|NCT04204772|Protective Agents|protective agents|mesh-ancestor
101635726|NCT04204772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635727|NCT02675205|Aspirin|aspirin|mesh-list
101635728|NCT02675205|Clopidogrel|clopidogrel|mesh-list
101635730|NCT02675205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101635731|NCT02675205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101635732|NCT02675205|Analgesics|analgesics|mesh-ancestor
101635733|NCT02675205|Sensory System Agents|sensory system agents|mesh-ancestor
101635734|NCT02675205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101635735|NCT02675205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635736|NCT02675205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101635737|NCT02675205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101635738|NCT02675205|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101635739|NCT02675205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101635740|NCT02675205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635741|NCT02675205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101635742|NCT02675205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101635743|NCT02675205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101635744|NCT02675205|Antipyretics|antipyretics|mesh-ancestor
101635745|NCT02675205|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101635746|NCT02675205|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101635747|NCT02675205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101635748|NCT02675205|Purinergic Agents|purinergic agents|mesh-ancestor
101635749|NCT02675205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101635750|NCT00753454|Certolizumab Pegol|certolizumab pegol|mesh-list
101635751|NCT00753454|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101635752|NCT00753454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101635753|NCT00753454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101635754|NCT00753454|Immunologic Factors|immunologic factors|mesh-ancestor
101635755|NCT00753454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635756|NCT00753454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101635757|NCT00643539|Azithromycin|azithromycin|mesh-list
101635758|NCT00643539|Amoxicillin|amoxicillin|mesh-list
101635759|NCT00643539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101635760|NCT00643539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101635761|NCT00759148|Moxifloxacin|moxifloxacin|mesh-list
101635762|NCT00759148|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101635763|NCT00759148|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101635764|NCT00759148|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101635765|NCT00759148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101635766|NCT00759148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101635767|NCT00759148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101635768|NCT00759148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101635769|NCT00759148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101635770|NCT00759148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635771|NCT00759148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101635772|NCT00759148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101635773|NCT00759148|Contraceptive Agents|contraceptive agents|mesh-ancestor
101635774|NCT00759148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101635775|NCT00759148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635776|NCT00759148|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101635777|NCT00759148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101635778|NCT00759148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101635779|NCT00910065|Aspirin|aspirin|mesh-list
101635780|NCT00910065|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
101635781|NCT00910065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101635782|NCT00910065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101635783|NCT00910065|Analgesics|analgesics|mesh-ancestor
101635784|NCT00910065|Sensory System Agents|sensory system agents|mesh-ancestor
101635785|NCT00910065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101635786|NCT00910065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635787|NCT00910065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101635788|NCT00910065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101635789|NCT00910065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101727610|NCT00822692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101635791|NCT00910065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635792|NCT00910065|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101635793|NCT00910065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101635794|NCT00910065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101635795|NCT00910065|Antipyretics|antipyretics|mesh-ancestor
101635796|NCT02601040|Vaccines|vaccines|mesh-list
101635797|NCT02601040|Immunologic Factors|immunologic factors|mesh-ancestor
101635798|NCT02601040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635799|NCT04179513|Methotrexate|methotrexate|mesh-list
101635800|NCT04179513|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101635801|NCT04179513|Abortifacient Agents|abortifacient agents|mesh-ancestor
101635802|NCT04179513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101635803|NCT04179513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635804|NCT04179513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101635805|NCT04179513|Antimetabolites|antimetabolites|mesh-ancestor
101635806|NCT04179513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635807|NCT04179513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101635808|NCT04179513|Dermatologic Agents|dermatologic agents|mesh-ancestor
101635809|NCT04179513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101635810|NCT04179513|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101635811|NCT04179513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101635812|NCT04179513|Immunologic Factors|immunologic factors|mesh-ancestor
101635813|NCT04179513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101635814|NCT04179513|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101635815|NCT02675049|Dexmedetomidine|dexmedetomidine|mesh-list
101635816|NCT02675049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101635817|NCT02675049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101635818|NCT02675049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635819|NCT02675049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101635821|NCT02675049|Sensory System Agents|sensory system agents|mesh-ancestor
101635822|NCT02675049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101635823|NCT02675049|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101727659|NCT02608242|Vasodilator Agents|vasodilator agents|mesh-ancestor
101635824|NCT02675049|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101635825|NCT02675049|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101635826|NCT02675049|Adrenergic Agents|adrenergic agents|mesh-ancestor
101635827|NCT02675049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101635828|NCT02675049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635829|NCT02674737|Flurbiprofen|flurbiprofen|mesh-list
101635830|NCT02674737|Dexmedetomidine|dexmedetomidine|mesh-list
101635832|NCT02674737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101635833|NCT02674737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101635834|NCT02674737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635835|NCT02674737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101635836|NCT02674737|Analgesics|analgesics|mesh-ancestor
101635837|NCT02674737|Sensory System Agents|sensory system agents|mesh-ancestor
101635838|NCT02674737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101635839|NCT02674737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101635840|NCT02674737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101635841|NCT02674737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101635842|NCT02674737|Adrenergic Agents|adrenergic agents|mesh-ancestor
101635843|NCT02674737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101635844|NCT02674737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635845|NCT02674737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101635846|NCT02674737|Narcotics|narcotics|mesh-ancestor
101635847|NCT02674737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101635848|NCT02674737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101635849|NCT02674737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101635850|NCT02674737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101635851|NCT02674737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101635852|NCT02674893|Liraglutide|liraglutide|mesh-list
101635853|NCT02674893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101635854|NCT02674893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635855|NCT02674893|Incretins|incretins|mesh-ancestor
101635856|NCT02674893|Hormones|hormones|mesh-ancestor
101635857|NCT02674893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101635859|NCT02717455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101635860|NCT02717455|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101635861|NCT02717455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101635862|NCT02717455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635863|NCT02674581|Fostemsavir|fostemsavir|mesh-list
101635864|NCT02674581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101635865|NCT02674581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101635866|NCT02674581|Antiviral Agents|antiviral agents|mesh-ancestor
101635867|NCT02674581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101635868|NCT02674581|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101635869|NCT02674581|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101635870|NCT02674581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635871|NCT04065919|Epinephrine|epinephrine|mesh-list
101635872|NCT04065919|Bupivacaine|bupivacaine|mesh-list
101635873|NCT04065919|Anesthetics, Local|anesthetics, local|mesh-ancestor
101635874|NCT04065919|Anesthetics|anesthetics|mesh-ancestor
101635875|NCT04065919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101635876|NCT04065919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635877|NCT04065919|Sensory System Agents|sensory system agents|mesh-ancestor
101635878|NCT04065919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101635879|NCT04065919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101635880|NCT04065919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101635881|NCT04065919|Adrenergic Agents|adrenergic agents|mesh-ancestor
101635882|NCT04065919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101727748|NCT00839072|Serotonin Agents|serotonin agents|mesh-ancestor
101635883|NCT04065919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635884|NCT04065919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101635885|NCT04065919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101635886|NCT04065919|Autonomic Agents|autonomic agents|mesh-ancestor
101635887|NCT04065919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101635888|NCT04065919|Respiratory System Agents|respiratory system agents|mesh-ancestor
101635889|NCT04065919|Mydriatics|mydriatics|mesh-ancestor
101635890|NCT04065919|Sympathomimetics|sympathomimetics|mesh-ancestor
101635891|NCT04065919|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101635892|NCT04065529|Zinc|zinc|mesh-list
101635893|NCT04065529|Trace Elements|trace elements|mesh-ancestor
101535028|NCT00572390|Hormones|hormones|mesh-ancestor
101635894|NCT04065529|Micronutrients|micronutrients|mesh-ancestor
101635895|NCT04065529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635897|NCT04179045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101635898|NCT04179045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101635899|NCT04179045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101635900|NCT04179045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101635901|NCT04179045|Antifungal Agents|antifungal agents|mesh-ancestor
101635902|NCT04179045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101635903|NCT04179045|Immunologic Factors|immunologic factors|mesh-ancestor
101635904|NCT04179045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292995|NCT01966575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101635905|NCT00970268|Bromides|bromides|mesh-list
101635906|NCT00970268|Anticonvulsants|anticonvulsants|mesh-ancestor
101635907|NCT02674113|Bupivacaine|bupivacaine|mesh-list
101635908|NCT02674113|Anesthetics|anesthetics|mesh-list
101635909|NCT02674113|Anesthetics, Local|anesthetics, local|mesh-ancestor
101635910|NCT02674113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101635911|NCT02674113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635912|NCT02674113|Sensory System Agents|sensory system agents|mesh-ancestor
101635913|NCT02674113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101635915|NCT00644085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101635916|NCT00644085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101635917|NCT00644085|Analgesics|analgesics|mesh-ancestor
101635918|NCT00644085|Sensory System Agents|sensory system agents|mesh-ancestor
101635919|NCT00644085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101635920|NCT00644085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635921|NCT00644085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101635922|NCT00644085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101635923|NCT00644085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101635924|NCT00644085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101635925|NCT00644085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727798|NCT00913484|Disulfiram|disulfiram|mesh-list
101635926|NCT00644085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101635927|NCT00644085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101635928|NCT00644085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101635929|NCT00644085|Antipyretics|antipyretics|mesh-ancestor
101635930|NCT00731575|Prednisolone|prednisolone|mesh-list
101635931|NCT00731575|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101635932|NCT00731575|Methylprednisolone|methylprednisolone|mesh-list
101635933|NCT00731575|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101635934|NCT00731575|Prednisolone acetate|prednisolone acetate|mesh-list
101635935|NCT00731575|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101635936|NCT00731575|Prednisolone phosphate|prednisolone phosphate|mesh-list
101635937|NCT00731575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101635938|NCT00731575|Glucocorticoids|glucocorticoids|mesh-ancestor
101635940|NCT00731575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101635941|NCT00731575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635942|NCT00731575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101635943|NCT00731575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101635944|NCT00731575|Antiemetics|antiemetics|mesh-ancestor
101635945|NCT00731575|Autonomic Agents|autonomic agents|mesh-ancestor
101635946|NCT00731575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101635947|NCT00731575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101635948|NCT00731575|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101635949|NCT00731575|Protective Agents|protective agents|mesh-ancestor
101635950|NCT02674191|Clindamycin|clindamycin|mesh-list
101635951|NCT02674191|Clindamycin palmitate|clindamycin palmitate|mesh-list
101635952|NCT02674191|Clindamycin phosphate|clindamycin phosphate|mesh-list
101635953|NCT02674191|Povidone-Iodine|povidone-iodine|mesh-list
101635954|NCT02674191|Mepivacaine|mepivacaine|mesh-list
101635955|NCT02674191|Benzocaine|benzocaine|mesh-list
101635956|NCT02674191|Povidone|povidone|mesh-list
101635957|NCT02674191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101635958|NCT02674191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101635959|NCT02674191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101635960|NCT02674191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101635961|NCT02674191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635962|NCT02674191|Plasma Substitutes|plasma substitutes|mesh-ancestor
101635963|NCT02674191|Blood Substitutes|blood substitutes|mesh-ancestor
101635964|NCT02674191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101635965|NCT02674191|Anesthetics, Local|anesthetics, local|mesh-ancestor
101635967|NCT02674191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101635968|NCT02674191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635969|NCT02674191|Sensory System Agents|sensory system agents|mesh-ancestor
101635971|NCT00736021|Escitalopram|escitalopram|mesh-list
101635972|NCT00736021|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101635973|NCT00736021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101635974|NCT00736021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101635975|NCT00736021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635976|NCT00736021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101635977|NCT00736021|Serotonin Agents|serotonin agents|mesh-ancestor
101635978|NCT00736021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727879|NCT00818168|Infliximab|infliximab|mesh-list
101635979|NCT04178655|Tranexamic Acid|tranexamic acid|mesh-list
101635980|NCT04178655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101635981|NCT04178655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101635982|NCT04178655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635983|NCT04178655|Hemostatics|hemostatics|mesh-ancestor
101635984|NCT04178655|Coagulants|coagulants|mesh-ancestor
101635985|NCT00738517|Immunoglobulins|immunoglobulins|mesh-list
101635986|NCT00738517|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101635987|NCT00738517|Antibodies|antibodies|mesh-list
101635988|NCT00738517|Immunologic Factors|immunologic factors|mesh-ancestor
101635989|NCT00738517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635990|NCT02673879|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101635991|NCT02673879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101635992|NCT02673879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101635993|NCT02673879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101635994|NCT00738595|Nicotine|nicotine|mesh-list
101635995|NCT00738595|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101635996|NCT00738595|Autonomic Agents|autonomic agents|mesh-ancestor
101635997|NCT00738595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101635998|NCT00738595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101635999|NCT00738595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101636000|NCT00738595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101636001|NCT00738595|Cholinergic Agents|cholinergic agents|mesh-ancestor
101636002|NCT00738595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101636003|NCT00738595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636004|NCT05273775|Vitamin K|vitamin k|mesh-list
101636005|NCT05273775|Vitamin K 1|vitamin k 1|mesh-list
101636006|NCT05273775|Digoxin|digoxin|mesh-list
101636007|NCT05273775|Midazolam|midazolam|mesh-list
101636008|NCT05273775|Omeprazole|omeprazole|mesh-list
101636009|NCT05273775|Warfarin|warfarin|mesh-list
101636010|NCT05273775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101636011|NCT05273775|Vitamins|vitamins|mesh-ancestor
101636012|NCT05273775|Micronutrients|micronutrients|mesh-ancestor
101636013|NCT05273775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636014|NCT05273775|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101636015|NCT05273775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101636016|NCT05273775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101636017|NCT05273775|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101636018|NCT05273775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101636019|NCT05273775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101636020|NCT05273775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101636021|NCT05273775|Anesthetics, General|anesthetics, general|mesh-ancestor
101636022|NCT05273775|Anesthetics|anesthetics|mesh-ancestor
101636023|NCT05273775|GABA Modulators|gaba modulators|mesh-ancestor
101636024|NCT05273775|GABA Agents|gaba agents|mesh-ancestor
101333566|NCT00039520|Docetaxel|docetaxel|mesh-list
101636025|NCT05273775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101636026|NCT05273775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636027|NCT05273775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101636028|NCT05273775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101636029|NCT05273775|Antimetabolites|antimetabolites|mesh-ancestor
101636030|NCT05273775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101636031|NCT05273775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101636032|NCT05273775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101636033|NCT05273775|Anticoagulants|anticoagulants|mesh-ancestor
101636034|NCT05273775|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101636035|NCT05273775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101636036|NCT05273775|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101636037|NCT05273775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101636038|NCT05273775|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101636039|NCT05273775|Protective Agents|protective agents|mesh-ancestor
101636040|NCT05273775|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101636041|NCT05273775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101636042|NCT05273775|Hemostatics|hemostatics|mesh-ancestor
101636043|NCT05273775|Coagulants|coagulants|mesh-ancestor
101636044|NCT02671851|Acetaminophen|acetaminophen|mesh-list
101636045|NCT02671851|Dipyrone|dipyrone|mesh-list
101636046|NCT02671851|Fentanyl|fentanyl|mesh-list
101636047|NCT02671851|Tramadol|tramadol|mesh-list
101636048|NCT02671851|Bupivacaine|bupivacaine|mesh-list
101636049|NCT02671851|Anesthetics, Local|anesthetics, local|mesh-ancestor
101636050|NCT02671851|Anesthetics|anesthetics|mesh-ancestor
101636051|NCT02671851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101636052|NCT02671851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636053|NCT02671851|Sensory System Agents|sensory system agents|mesh-ancestor
101636054|NCT02671851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101636055|NCT02671851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101636056|NCT02671851|Narcotics|narcotics|mesh-ancestor
101636057|NCT02671851|Analgesics|analgesics|mesh-ancestor
101636058|NCT02671851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101636059|NCT02671851|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101636060|NCT02671851|Anesthetics, General|anesthetics, general|mesh-ancestor
101636061|NCT02671851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101636062|NCT02671851|Antipyretics|antipyretics|mesh-ancestor
101636063|NCT02671851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101636064|NCT02671851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101636065|NCT02671851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101636066|NCT02135419|Fluorouracil|fluorouracil|mesh-list
101636067|NCT02135419|Imiquimod|imiquimod|mesh-list
101636068|NCT02135419|Antimetabolites|antimetabolites|mesh-ancestor
101636069|NCT02135419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636070|NCT02135419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101636071|NCT02135419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101636072|NCT02135419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101636073|NCT02135419|Immunologic Factors|immunologic factors|mesh-ancestor
101636074|NCT02135419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636075|NCT02135419|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101385447|NCT00304018|Prednisone|prednisone|mesh-list
101636076|NCT02135419|Interferon Inducers|interferon inducers|mesh-ancestor
101636077|NCT04177095|Sirolimus|sirolimus|mesh-list
101636078|NCT04177095|Prednisone|prednisone|mesh-list
101636079|NCT04177095|Everolimus|everolimus|mesh-list
101636080|NCT04177095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101636081|NCT04177095|Glucocorticoids|glucocorticoids|mesh-ancestor
101636082|NCT04177095|Hormones|hormones|mesh-ancestor
101636083|NCT04177095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101636084|NCT04177095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636085|NCT04177095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101636086|NCT04177095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101636087|NCT04177095|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101636088|NCT04177095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101636089|NCT04177095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101636090|NCT04177095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636091|NCT04177095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101636092|NCT04177095|Immunologic Factors|immunologic factors|mesh-ancestor
101636093|NCT04177095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101636094|NCT04177095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101636095|NCT04177095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101636096|NCT04177095|Antifungal Agents|antifungal agents|mesh-ancestor
101636097|NCT02671695|Amlodipine|amlodipine|mesh-list
101636098|NCT02671695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101636099|NCT02671695|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101636100|NCT02671695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101636101|NCT02671695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636102|NCT02671695|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101636103|NCT02671695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636104|NCT02671695|Vasodilator Agents|vasodilator agents|mesh-ancestor
101636105|NCT00644631|Sildenafil Citrate|sildenafil citrate|mesh-list
101728069|NCT02604459|Narcotics|narcotics|mesh-ancestor
101636106|NCT00644631|Vasodilator Agents|vasodilator agents|mesh-ancestor
101636107|NCT00644631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101636108|NCT00644631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101636109|NCT00644631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101636110|NCT00644631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636111|NCT00644631|Urological Agents|urological agents|mesh-ancestor
101636113|NCT02671383|Darunavir|darunavir|mesh-list
101636114|NCT02671383|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101636115|NCT02671383|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101636116|NCT02671383|Protease Inhibitors|protease inhibitors|mesh-ancestor
101636117|NCT02671383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101636118|NCT02671383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636119|NCT02671383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101636120|NCT02671383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101636121|NCT02671383|Antiviral Agents|antiviral agents|mesh-ancestor
101636122|NCT02671383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101636123|NCT02671383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101636124|NCT02671383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101636126|NCT00738751|Panobinostat|panobinostat|mesh-list
101636127|NCT00738751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
101636128|NCT00738751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101636129|NCT00738751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101636130|NCT00738751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101636131|NCT00738751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636132|NCT05243823|Estradiol|estradiol|mesh-list
101636133|NCT05243823|Estrogens|estrogens|mesh-ancestor
101636134|NCT05243823|Hormones|hormones|mesh-ancestor
101636135|NCT05243823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101636136|NCT05243823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636137|NCT00736801|Fluticasone|fluticasone|mesh-list
101636138|NCT00736801|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101636139|NCT00736801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101636140|NCT00736801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101636141|NCT00736801|Autonomic Agents|autonomic agents|mesh-ancestor
101636142|NCT00736801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101636143|NCT00736801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636144|NCT00736801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101636145|NCT00736801|Respiratory System Agents|respiratory system agents|mesh-ancestor
101636146|NCT00736801|Dermatologic Agents|dermatologic agents|mesh-ancestor
101636147|NCT00736801|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101636148|NCT00736801|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101636149|NCT00736801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101636150|NCT00736801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101636151|NCT00736801|Adrenergic Agents|adrenergic agents|mesh-ancestor
101636152|NCT00736801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101636153|NCT00736801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636154|NCT00738829|Rituximab|rituximab|mesh-list
101636155|NCT00738829|Fludarabine|fludarabine|mesh-list
101636156|NCT00738829|Fludarabine phosphate|fludarabine phosphate|mesh-list
101636157|NCT00738829|Lenalidomide|lenalidomide|mesh-list
101636158|NCT00738829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101636159|NCT00738829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101636160|NCT00738829|Immunologic Factors|immunologic factors|mesh-ancestor
101636161|NCT00738829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636162|NCT00738829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101636163|NCT00738829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101636164|NCT00738829|Antimetabolites|antimetabolites|mesh-ancestor
101636165|NCT00738829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636166|NCT00738829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101636167|NCT00738829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101636168|NCT00738829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101636169|NCT00738829|Growth Substances|growth substances|mesh-ancestor
101636170|NCT00738829|Growth Inhibitors|growth inhibitors|mesh-ancestor
101636171|NCT02671227|Bupivacaine|bupivacaine|mesh-list
101636172|NCT02671227|Anesthetics, Local|anesthetics, local|mesh-ancestor
101636173|NCT02671227|Anesthetics|anesthetics|mesh-ancestor
101636174|NCT02671227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101636175|NCT02671227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636176|NCT02671227|Sensory System Agents|sensory system agents|mesh-ancestor
101636177|NCT02671227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101636178|NCT00644709|Atorvastatin|atorvastatin|mesh-list
101636179|NCT00644709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101636180|NCT00644709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101636181|NCT00644709|Antimetabolites|antimetabolites|mesh-ancestor
101636182|NCT00644709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636183|NCT00644709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101636184|NCT00644709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101636185|NCT00644709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101636186|NCT00738985|Simvastatin|simvastatin|mesh-list
101636187|NCT00738985|Ezetimibe|ezetimibe|mesh-list
101636188|NCT00738985|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
101636189|NCT00738985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101636190|NCT00738985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101636191|NCT00738985|Antimetabolites|antimetabolites|mesh-ancestor
101636192|NCT00738985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636193|NCT00738985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101636194|NCT00738985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101636195|NCT00738985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101636196|NCT05216211|Bupivacaine|bupivacaine|mesh-list
101636197|NCT05216211|Anesthetics, Local|anesthetics, local|mesh-ancestor
101636198|NCT05216211|Anesthetics|anesthetics|mesh-ancestor
101636199|NCT05216211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101636200|NCT05216211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636201|NCT05216211|Sensory System Agents|sensory system agents|mesh-ancestor
101636202|NCT05216211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101636203|NCT00732121|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101636204|NCT00732121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101636205|NCT00732121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636206|NCT00732121|Incretins|incretins|mesh-ancestor
101636207|NCT00732121|Hormones|hormones|mesh-ancestor
101293290|NCT01968239|Growth Inhibitors|growth inhibitors|mesh-ancestor
101636208|NCT00732121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101636209|NCT00732121|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101636210|NCT00732121|Protease Inhibitors|protease inhibitors|mesh-ancestor
101636211|NCT00732121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101636212|NCT00732121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636213|NCT02537223|Cisplatin|cisplatin|mesh-list
101636214|NCT02537223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101636215|NCT02568943|Panobinostat|panobinostat|mesh-list
101636216|NCT02568943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101636217|NCT02568943|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101636218|NCT02568943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101636219|NCT02568943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636220|NCT00732277|Hydrocortisone|hydrocortisone|mesh-list
101636221|NCT00732277|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101636222|NCT00732277|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101636223|NCT00732277|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101636224|NCT00732277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101636225|NCT00739453|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101636226|NCT00739453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101636227|NCT00739453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101636228|NCT00739453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101636229|NCT00739453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636230|NCT02668497|Botulinum Toxins|botulinum toxins|mesh-list
101636231|NCT02668497|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101636232|NCT02668497|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101636233|NCT02668497|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
101636234|NCT02668497|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101363784|NCT00080847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101636235|NCT02668497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101636236|NCT02668497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636237|NCT02668497|Cholinergic Agents|cholinergic agents|mesh-ancestor
101636238|NCT02668497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101636239|NCT02668497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636240|NCT02668497|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101636241|NCT02668497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101636242|NCT00737113|Hormones|hormones|mesh-list
101636243|NCT00737113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101636244|NCT00737113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636245|NCT00737191|Olanzapine|olanzapine|mesh-list
101636246|NCT00737191|Antiemetics|antiemetics|mesh-ancestor
101636247|NCT00737191|Autonomic Agents|autonomic agents|mesh-ancestor
101636248|NCT00737191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101636249|NCT00737191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636250|NCT00737191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101636251|NCT00737191|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101636252|NCT00737191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101636253|NCT00737191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101636254|NCT00737191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101636255|NCT00737191|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101636256|NCT00737191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101636257|NCT00737191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101636258|NCT00737191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636259|NCT00737191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101636260|NCT00737191|Serotonin Agents|serotonin agents|mesh-ancestor
101636261|NCT04175067|Antioxidants|antioxidants|mesh-list
101636262|NCT04175067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636263|NCT04175067|Protective Agents|protective agents|mesh-ancestor
101636264|NCT04175067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636265|NCT00758602|Mycophenolic Acid|mycophenolic acid|mesh-list
101636266|NCT00758602|Tacrolimus|tacrolimus|mesh-list
101636267|NCT00758602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101636268|NCT00758602|Immunologic Factors|immunologic factors|mesh-ancestor
101636269|NCT00758602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636270|NCT00758602|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101636271|NCT00758602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101636272|NCT00758602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636273|NCT00758602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101636274|NCT00758602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101636275|NCT00758602|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101636276|NCT00758602|Antitubercular Agents|antitubercular agents|mesh-ancestor
101636277|NCT00758602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101636278|NCT00758602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101636279|NCT02667561|Methyltestosterone|methyltestosterone|mesh-list
101636280|NCT02667561|Testosterone|testosterone|mesh-list
101636281|NCT02667561|Testosterone undecanoate|testosterone undecanoate|mesh-list
101636282|NCT02667561|Testosterone enanthate|testosterone enanthate|mesh-list
101636283|NCT02667561|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101636284|NCT02667561|Androgens|androgens|mesh-ancestor
101636285|NCT02667561|Hormones|hormones|mesh-ancestor
101636286|NCT02667561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101636287|NCT02667561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636288|NCT02667561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101636289|NCT02667561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101636290|NCT02667561|Anabolic Agents|anabolic agents|mesh-ancestor
101636291|NCT00732511|Metoprolol|metoprolol|mesh-list
101636292|NCT00732511|Carvedilol|carvedilol|mesh-list
101636293|NCT00732511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101636294|NCT00732511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101636295|NCT00732511|Sympatholytics|sympatholytics|mesh-ancestor
101636296|NCT00732511|Autonomic Agents|autonomic agents|mesh-ancestor
101636297|NCT00732511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101636298|NCT00732511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636299|NCT00732511|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101636300|NCT00732511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101636301|NCT00732511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101636302|NCT00732511|Adrenergic Agents|adrenergic agents|mesh-ancestor
101636303|NCT00732511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101636304|NCT00732511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636305|NCT00732511|Antioxidants|antioxidants|mesh-ancestor
101636306|NCT00732511|Protective Agents|protective agents|mesh-ancestor
101636307|NCT00732511|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101636308|NCT00732511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101636309|NCT00732511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101636310|NCT00732511|Vasodilator Agents|vasodilator agents|mesh-ancestor
101636311|NCT00732511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101636312|NCT00732511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101636313|NCT00739531|Nitric Oxide|nitric oxide|mesh-list
101636314|NCT00739531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101636315|NCT00739531|Autonomic Agents|autonomic agents|mesh-ancestor
101636316|NCT00739531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101636317|NCT00739531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636318|NCT00739531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101636319|NCT00739531|Respiratory System Agents|respiratory system agents|mesh-ancestor
101636320|NCT00739531|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101636321|NCT00739531|Antioxidants|antioxidants|mesh-ancestor
101636322|NCT00739531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636323|NCT00739531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101636324|NCT00739531|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101636325|NCT00739531|Vasodilator Agents|vasodilator agents|mesh-ancestor
101636326|NCT00739531|Gasotransmitters|gasotransmitters|mesh-ancestor
101636327|NCT00739531|Protective Agents|protective agents|mesh-ancestor
101636329|NCT00739609|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101636330|NCT00739609|Antidepressive Agents|antidepressive agents|mesh-ancestor
101636331|NCT00739609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101636332|NCT00645723|Colistin|colistin|mesh-list
101636333|NCT00645723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101636334|NCT00645723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101636335|NCT00711529|Gabapentin|gabapentin|mesh-list
101636336|NCT00711529|Analgesics|analgesics|mesh-ancestor
101636337|NCT00711529|Sensory System Agents|sensory system agents|mesh-ancestor
101636338|NCT00711529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101636339|NCT00711529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636340|NCT00711529|Anticonvulsants|anticonvulsants|mesh-ancestor
101636341|NCT00711529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101636342|NCT00711529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101636343|NCT00711529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101636344|NCT00711529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101636345|NCT00711529|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101636346|NCT00711529|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101636347|NCT00711529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101636348|NCT00711529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636350|NCT00732589|Lidocaine|lidocaine|mesh-list
101636351|NCT00732589|Anesthetics, Local|anesthetics, local|mesh-ancestor
101636352|NCT00732589|Anesthetics|anesthetics|mesh-ancestor
101636353|NCT00732589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101636354|NCT00732589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636355|NCT00732589|Sensory System Agents|sensory system agents|mesh-ancestor
101636356|NCT00732589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101636357|NCT00732589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101636358|NCT00732589|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101636359|NCT00732589|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101636360|NCT00732589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101636361|NCT00732589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636362|NCT00645879|Citric Acid|citric acid|mesh-list
101636363|NCT00645879|Sodium Citrate|sodium citrate|mesh-list
101636364|NCT00645879|Anticoagulants|anticoagulants|mesh-ancestor
101636365|NCT00645879|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101636366|NCT00645879|Chelating Agents|chelating agents|mesh-ancestor
101636367|NCT00645879|Sequestering Agents|sequestering agents|mesh-ancestor
101636368|NCT00645879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636369|NCT00737659|Mycophenolic Acid|mycophenolic acid|mesh-list
101636370|NCT00737659|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101636371|NCT00737659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101636372|NCT00737659|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101636373|NCT00737659|Antitubercular Agents|antitubercular agents|mesh-ancestor
101636374|NCT00737659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101636375|NCT00737659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101636376|NCT00737659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101363803|NCT00047177|Oxaliplatin|oxaliplatin|mesh-list
101636377|NCT00737659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636379|NCT02666703|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101636380|NCT02666703|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101636381|NCT02666703|Prednisolone|prednisolone|mesh-list
101636382|NCT02666703|Prednisolone acetate|prednisolone acetate|mesh-list
101636383|NCT02666703|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101636384|NCT02666703|Prednisolone phosphate|prednisolone phosphate|mesh-list
101636385|NCT02666703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101636386|NCT02666703|Antiemetics|antiemetics|mesh-ancestor
101636387|NCT02666703|Autonomic Agents|autonomic agents|mesh-ancestor
101636388|NCT02666703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101636389|NCT02666703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636390|NCT02666703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101636391|NCT02666703|Glucocorticoids|glucocorticoids|mesh-ancestor
101636392|NCT02666703|Hormones|hormones|mesh-ancestor
101636393|NCT02666703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101636394|NCT02666703|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101636395|NCT02666703|Protective Agents|protective agents|mesh-ancestor
101636396|NCT02666703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101636397|NCT02666703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101636398|NCT05560009|Levodopa|levodopa|mesh-list
101636399|NCT05560009|Fluorides|fluorides|mesh-list
101636400|NCT05560009|Cariostatic Agents|cariostatic agents|mesh-ancestor
101636401|NCT05560009|Protective Agents|protective agents|mesh-ancestor
101636402|NCT05560009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636403|NCT05560009|Dopamine Agents|dopamine agents|mesh-ancestor
101636404|NCT05560009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101636405|NCT05560009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636406|NCT05560009|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101636407|NCT05560009|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101636408|NCT04174131|Lidocaine|lidocaine|mesh-list
101636409|NCT04174131|Hyaluronic Acid|hyaluronic acid|mesh-list
101636410|NCT04174131|Anesthetics, Local|anesthetics, local|mesh-ancestor
101636411|NCT04174131|Anesthetics|anesthetics|mesh-ancestor
101636412|NCT04174131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101636413|NCT04174131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636414|NCT04174131|Sensory System Agents|sensory system agents|mesh-ancestor
101636415|NCT04174131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101636416|NCT04174131|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101728357|NCT00588354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101636417|NCT04174131|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101636418|NCT04174131|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101636419|NCT04174131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101636420|NCT04174131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636421|NCT04174131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101636422|NCT04174131|Immunologic Factors|immunologic factors|mesh-ancestor
101636424|NCT04174131|Protective Agents|protective agents|mesh-ancestor
101636425|NCT00646035|Ergocalciferols|ergocalciferols|mesh-list
101636426|NCT00646035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101636427|NCT00646035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293515|NCT01969695|Venetoclax|venetoclax|mesh-list
101636428|NCT00646035|Vitamins|vitamins|mesh-ancestor
101636429|NCT00646035|Micronutrients|micronutrients|mesh-ancestor
101636430|NCT00646035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101636432|NCT00646191|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101636433|NCT00646191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101636434|NCT00646191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101636435|NCT02666157|Rivaroxaban|rivaroxaban|mesh-list
101636436|NCT02666157|Apixaban|apixaban|mesh-list
101636437|NCT02666157|Dabigatran|dabigatran|mesh-list
101636438|NCT02666157|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101636439|NCT02666157|Antithrombins|antithrombins|mesh-ancestor
101636440|NCT02666157|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101636441|NCT02666157|Protease Inhibitors|protease inhibitors|mesh-ancestor
101636442|NCT02666157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101636443|NCT02666157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636444|NCT02666157|Anticoagulants|anticoagulants|mesh-ancestor
101636445|NCT02666001|Fostemsavir|fostemsavir|mesh-list
101636446|NCT02666001|Buprenorphine|buprenorphine|mesh-list
101636448|NCT02666001|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101636449|NCT02666001|Narcotics|narcotics|mesh-ancestor
101636450|NCT02666001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101636451|NCT02666001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636452|NCT02666001|Analgesics|analgesics|mesh-ancestor
101636453|NCT02666001|Sensory System Agents|sensory system agents|mesh-ancestor
101636454|NCT02666001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101636455|NCT02666001|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101636456|NCT02666001|Antitussive Agents|antitussive agents|mesh-ancestor
101636457|NCT02666001|Respiratory System Agents|respiratory system agents|mesh-ancestor
101636458|NCT02666001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101636459|NCT02666001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101636460|NCT02666001|Antiviral Agents|antiviral agents|mesh-ancestor
101636461|NCT02666001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101636462|NCT02666001|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101636463|NCT02666001|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101636464|NCT02666001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636465|NCT02665845|Mesalamine|mesalamine|mesh-list
101636466|NCT02665845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101636467|NCT02665845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101636468|NCT02665845|Analgesics|analgesics|mesh-ancestor
101636469|NCT02665845|Sensory System Agents|sensory system agents|mesh-ancestor
101636470|NCT02665845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101636471|NCT02665845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636472|NCT02665845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101636473|NCT02665845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101636474|NCT00646425|Basiliximab|basiliximab|mesh-list
101636475|NCT00646425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101636476|NCT00646425|Immunologic Factors|immunologic factors|mesh-ancestor
101636477|NCT00646425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636478|NCT04837209|Niraparib|niraparib|mesh-list
101636479|NCT04837209|Dostarlimab|dostarlimab|mesh-list
101636480|NCT04837209|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101636481|NCT04837209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101636482|NCT04837209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636483|NCT04837209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101636484|NCT02665533|Dexamethasone|dexamethasone|mesh-list
101636485|NCT02665533|Dexamethasone acetate|dexamethasone acetate|mesh-list
101636486|NCT02665533|Diclofenac|diclofenac|mesh-list
101636487|NCT02665533|Codeine|codeine|mesh-list
101636488|NCT02665533|BB 1101|bb 1101|mesh-list
101636489|NCT02665533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101636490|NCT02665533|Antiemetics|antiemetics|mesh-ancestor
101636491|NCT02665533|Autonomic Agents|autonomic agents|mesh-ancestor
101636492|NCT02665533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101636493|NCT02665533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636494|NCT02665533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101636495|NCT02665533|Glucocorticoids|glucocorticoids|mesh-ancestor
101636496|NCT02665533|Hormones|hormones|mesh-ancestor
101636497|NCT02665533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101636498|NCT02665533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101636499|NCT02665533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101636500|NCT02665533|Protease Inhibitors|protease inhibitors|mesh-ancestor
101636501|NCT02665533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101636502|NCT02665533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636503|NCT02665533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101636504|NCT02665533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101636505|NCT02665533|Analgesics|analgesics|mesh-ancestor
101636506|NCT02665533|Sensory System Agents|sensory system agents|mesh-ancestor
101636507|NCT02665533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101636508|NCT02665533|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101636509|NCT02665533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101636510|NCT02665533|Narcotics|narcotics|mesh-ancestor
101636511|NCT02665533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101636512|NCT02665533|Antitussive Agents|antitussive agents|mesh-ancestor
101636513|NCT02665533|Respiratory System Agents|respiratory system agents|mesh-ancestor
101636514|NCT00646503|Telbivudine|telbivudine|mesh-list
101636515|NCT00646503|Antiviral Agents|antiviral agents|mesh-ancestor
101636516|NCT00646503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101636517|NCT00646503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101636518|NCT00646503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101333592|NCT00001328|Ganciclovir|ganciclovir|mesh-list
101636519|NCT00646503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636520|NCT04173039|Antibodies|antibodies|mesh-list
101636521|NCT04173039|Immunologic Factors|immunologic factors|mesh-ancestor
101636522|NCT04173039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636523|NCT00646659|Carboplatin|carboplatin|mesh-list
101636524|NCT00646659|Docetaxel|docetaxel|mesh-list
101636525|NCT00646659|Fluorouracil|fluorouracil|mesh-list
101636526|NCT00646659|Cetuximab|cetuximab|mesh-list
101636527|NCT00646659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101636528|NCT00646659|Tubulin Modulators|tubulin modulators|mesh-ancestor
101636529|NCT00646659|Antimitotic Agents|antimitotic agents|mesh-ancestor
101636530|NCT00646659|Mitosis Modulators|mitosis modulators|mesh-ancestor
101636531|NCT00646659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636532|NCT00646659|Antimetabolites|antimetabolites|mesh-ancestor
101636533|NCT00646659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101636534|NCT00646659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101636535|NCT00646659|Immunologic Factors|immunologic factors|mesh-ancestor
101636536|NCT00646659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636537|NCT00646659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101636538|NCT00648531|Balsalazide|balsalazide|mesh-list
101636539|NCT00648531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101636540|NCT00648531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101636542|NCT00648531|Sensory System Agents|sensory system agents|mesh-ancestor
101636543|NCT00648531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101636544|NCT00648531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636545|NCT00648531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101636546|NCT00648531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101636547|NCT00648531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101636548|NCT00648765|Anagrelide|anagrelide|mesh-list
101636549|NCT00648765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101636550|NCT00648765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101636551|NCT00648765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636552|NCT00648765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101636553|NCT00648843|Oxybutynin|oxybutynin|mesh-list
101636554|NCT00648843|Parasympatholytics|parasympatholytics|mesh-ancestor
101636555|NCT00648843|Autonomic Agents|autonomic agents|mesh-ancestor
101636556|NCT00648843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101636557|NCT00648843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636558|NCT00648843|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101636559|NCT00648843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101636560|NCT00648843|Cholinergic Agents|cholinergic agents|mesh-ancestor
101636561|NCT00648843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101636562|NCT00648843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636563|NCT00648843|Urological Agents|urological agents|mesh-ancestor
101636564|NCT02662959|Irinotecan|irinotecan|mesh-list
101636565|NCT02662959|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101636566|NCT02662959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101636567|NCT02662959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101636568|NCT02662959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636569|NCT02662959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101636571|NCT02662647|Decitabine|decitabine|mesh-list
101636572|NCT02662647|Aclacinomycins|aclacinomycins|mesh-list
101636573|NCT02662647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101636574|NCT02662647|Antimetabolites|antimetabolites|mesh-ancestor
101636575|NCT02662647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636576|NCT02662647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101636577|NCT02662647|Antiviral Agents|antiviral agents|mesh-ancestor
101636578|NCT02662647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101636579|NCT02662647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101636580|NCT02662647|Immunologic Factors|immunologic factors|mesh-ancestor
101636581|NCT02662647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636582|NCT02662647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101636583|NCT02662647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101636584|NCT02662647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101636585|NCT02662725|Ipilimumab|ipilimumab|mesh-list
101636586|NCT02662725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101636587|NCT02662725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101636588|NCT02662725|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101636589|NCT02662725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636590|NCT00648921|Olanzapine|olanzapine|mesh-list
101636591|NCT00648921|Antiemetics|antiemetics|mesh-ancestor
101636592|NCT00648921|Autonomic Agents|autonomic agents|mesh-ancestor
101636593|NCT00648921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101636594|NCT00648921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636595|NCT00648921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101636596|NCT00648921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101636597|NCT00648921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101636598|NCT00648921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101636599|NCT00648921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101636600|NCT00648921|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101636601|NCT00648921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101636602|NCT00648921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101636603|NCT00648921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636604|NCT00648921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101636605|NCT00648921|Serotonin Agents|serotonin agents|mesh-ancestor
101636606|NCT02662491|Calcium, Dietary|calcium, dietary|mesh-list
101636607|NCT02662491|Vitamin D|vitamin d|mesh-list
101636608|NCT02662491|Ergocalciferols|ergocalciferols|mesh-list
101636609|NCT02662491|Cholecalciferol|cholecalciferol|mesh-list
101636610|NCT02662491|Vitamins|vitamins|mesh-list
101636611|NCT02662491|Calcium|calcium|mesh-list
101636612|NCT02662491|Micronutrients|micronutrients|mesh-ancestor
101636613|NCT02662491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728603|NCT00811928|Posaconazole|posaconazole|mesh-list
101636614|NCT02662491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101636615|NCT02662491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101636616|NCT00648999|Ritonavir|ritonavir|mesh-list
101636617|NCT00648999|Lopinavir|lopinavir|mesh-list
101636618|NCT00648999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101636619|NCT00648999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101636620|NCT00648999|Protease Inhibitors|protease inhibitors|mesh-ancestor
101636621|NCT00648999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101636622|NCT00648999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636623|NCT00648999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101636624|NCT00648999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101636625|NCT00648999|Antiviral Agents|antiviral agents|mesh-ancestor
101636626|NCT00648999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101636627|NCT00648999|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101636628|NCT00648999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101636629|NCT02661711|Aflibercept|aflibercept|mesh-list
101636630|NCT02661711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101636631|NCT02661711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101636632|NCT02661711|Growth Substances|growth substances|mesh-ancestor
101636633|NCT02661711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636634|NCT02661711|Growth Inhibitors|growth inhibitors|mesh-ancestor
101636635|NCT02661711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101636636|NCT02661789|Goserelin|goserelin|mesh-list
101728647|NCT00848549|Antimanic Agents|antimanic agents|mesh-ancestor
101636637|NCT02661789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101636638|NCT02661789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101636639|NCT02661477|Interferons|interferons|mesh-list
101636640|NCT02661477|Interferon-alpha|interferon-alpha|mesh-list
101636641|NCT02661477|Interferon alpha-2|interferon alpha-2|mesh-list
101636642|NCT02661477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101636643|NCT02661477|Antiviral Agents|antiviral agents|mesh-ancestor
101636644|NCT02661477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101636645|NCT02661477|Immunologic Factors|immunologic factors|mesh-ancestor
101636646|NCT02661477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636648|NCT00649077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101636649|NCT00649077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101636650|NCT00649077|Analgesics|analgesics|mesh-ancestor
101636651|NCT00649077|Sensory System Agents|sensory system agents|mesh-ancestor
101636652|NCT00649077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101636653|NCT00649077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636654|NCT00649077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101636655|NCT00649077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101636656|NCT00649077|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101293741|NCT01971515|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101636657|NCT00649077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101636658|NCT00649077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101636659|NCT00649077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636660|NCT02656251|Ethanol|ethanol|mesh-list
101636661|NCT02656251|Chlorhexidine|chlorhexidine|mesh-list
101636662|NCT02656251|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101636663|NCT02656251|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101636664|NCT02656251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101636665|NCT02656251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101636666|NCT02656251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636667|NCT02656251|Disinfectants|disinfectants|mesh-ancestor
101636668|NCT02656251|Dermatologic Agents|dermatologic agents|mesh-ancestor
101636669|NCT02656095|Heparin|heparin|mesh-list
101636670|NCT02656095|Anticoagulants|anticoagulants|mesh-ancestor
101636671|NCT02656095|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101636672|NCT02656095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101636673|NCT02656095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636674|NCT00649935|Azithromycin|azithromycin|mesh-list
101636675|NCT00649935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101636676|NCT00649935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101636677|NCT02655705|Cyclosporine|cyclosporine|mesh-list
101636678|NCT02655705|Methotrexate|methotrexate|mesh-list
101636679|NCT02655705|Cyclosporins|cyclosporins|mesh-list
101636680|NCT02655705|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101636681|NCT02655705|Abortifacient Agents|abortifacient agents|mesh-ancestor
101636682|NCT02655705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101636683|NCT02655705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636684|NCT02655705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101636685|NCT02655705|Antimetabolites|antimetabolites|mesh-ancestor
101636686|NCT02655705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636687|NCT02655705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101636688|NCT02655705|Dermatologic Agents|dermatologic agents|mesh-ancestor
101636689|NCT02655705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101636690|NCT02655705|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101636691|NCT02655705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101636692|NCT02655705|Immunologic Factors|immunologic factors|mesh-ancestor
101636693|NCT02655705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101636694|NCT02655705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101636695|NCT02655705|Antifungal Agents|antifungal agents|mesh-ancestor
101636696|NCT02655705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101636697|NCT02655705|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101636698|NCT02655471|Zidovudine|zidovudine|mesh-list
101636699|NCT02655471|Raltegravir Potassium|raltegravir potassium|mesh-list
101636700|NCT02655471|Antimetabolites|antimetabolites|mesh-ancestor
101728752|NCT05758064|Hormones|hormones|mesh-ancestor
101636701|NCT02655471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636702|NCT02655471|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101636703|NCT02655471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101636705|NCT02655471|Antiviral Agents|antiviral agents|mesh-ancestor
101636706|NCT02655471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101636707|NCT02655471|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101636708|NCT02655471|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101636709|NCT02655471|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101636710|NCT02655471|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101636711|NCT00650013|Midodrine|midodrine|mesh-list
101636712|NCT00650013|Sympathomimetics|sympathomimetics|mesh-ancestor
101636713|NCT00650013|Autonomic Agents|autonomic agents|mesh-ancestor
101636714|NCT00650013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101636715|NCT00650013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636716|NCT00650013|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101636717|NCT00650013|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101636718|NCT00650013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101636719|NCT00650013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101636720|NCT00650013|Adrenergic Agents|adrenergic agents|mesh-ancestor
101636721|NCT00650013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101636722|NCT00650013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636723|NCT00712933|Belimumab|belimumab|mesh-list
101636724|NCT00712933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101636725|NCT00712933|Immunologic Factors|immunologic factors|mesh-ancestor
101636726|NCT00712933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636727|NCT02654847|Norepinephrine|norepinephrine|mesh-list
101636728|NCT02654847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101636729|NCT02654847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101636730|NCT02654847|Adrenergic Agents|adrenergic agents|mesh-ancestor
101636731|NCT02654847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101636732|NCT02654847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636733|NCT02654847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636734|NCT02654847|Sympathomimetics|sympathomimetics|mesh-ancestor
101636735|NCT02654847|Autonomic Agents|autonomic agents|mesh-ancestor
101636736|NCT02654847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101636737|NCT02654847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101636738|NCT02536209|Oxycodone|oxycodone|mesh-list
101636739|NCT02536209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101636740|NCT02536209|Narcotics|narcotics|mesh-ancestor
101636741|NCT02536209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101636742|NCT02536209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636743|NCT02536209|Analgesics|analgesics|mesh-ancestor
101636744|NCT02536209|Sensory System Agents|sensory system agents|mesh-ancestor
101636745|NCT02536209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101636746|NCT00732745|Docetaxel|docetaxel|mesh-list
101636747|NCT00732745|Oxaliplatin|oxaliplatin|mesh-list
101636748|NCT00732745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101636749|NCT00732745|Tubulin Modulators|tubulin modulators|mesh-ancestor
101636750|NCT00732745|Antimitotic Agents|antimitotic agents|mesh-ancestor
101636751|NCT00732745|Mitosis Modulators|mitosis modulators|mesh-ancestor
101636752|NCT00732745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636753|NCT00737815|Magnesium citrate|magnesium citrate|mesh-list
101636754|NCT00737815|Cathartics|cathartics|mesh-ancestor
101636755|NCT00737815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101636756|NCT02654379|Rituximab|rituximab|mesh-list
101636757|NCT02654379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101636758|NCT02654379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101636759|NCT02654379|Immunologic Factors|immunologic factors|mesh-ancestor
101636760|NCT02654379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636761|NCT02654379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101728831|NCT00810316|GABA Modulators|gaba modulators|mesh-ancestor
101636762|NCT04341129|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
101636763|NCT04341129|Chelating Agents|chelating agents|mesh-ancestor
101636764|NCT04341129|Sequestering Agents|sequestering agents|mesh-ancestor
101636765|NCT04341129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636766|NCT00712543|Lactulose|lactulose|mesh-list
101636767|NCT00712543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101636768|NCT00650169|Clopidogrel|clopidogrel|mesh-list
101636769|NCT00650169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101636770|NCT00650169|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101636771|NCT00650169|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101636772|NCT00650169|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101636773|NCT00650169|Purinergic Agents|purinergic agents|mesh-ancestor
101636774|NCT00650169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101636775|NCT00650169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636776|NCT00650169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636777|NCT04064125|Minocycline|minocycline|mesh-list
101636778|NCT04064125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101636779|NCT04064125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101636780|NCT00740389|Etravirine|etravirine|mesh-list
101636781|NCT00740389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101636782|NCT00740389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101636783|NCT00740389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101636784|NCT00740389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636785|NCT00740389|Antiviral Agents|antiviral agents|mesh-ancestor
101636786|NCT00740389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101636787|NCT00740467|Cyclosporine|cyclosporine|mesh-list
101636788|NCT00740467|Mycophenolic Acid|mycophenolic acid|mesh-list
101636789|NCT00740467|Cyclophosphamide|cyclophosphamide|mesh-list
101636790|NCT00740467|Busulfan|busulfan|mesh-list
101636791|NCT00740467|Fludarabine|fludarabine|mesh-list
101636792|NCT00740467|Fludarabine phosphate|fludarabine phosphate|mesh-list
101636793|NCT00740467|Cyclosporins|cyclosporins|mesh-list
101636794|NCT00740467|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101636795|NCT00740467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101636796|NCT00740467|Immunologic Factors|immunologic factors|mesh-ancestor
101636797|NCT00740467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636798|NCT00740467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101636799|NCT00740467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101636800|NCT00740467|Alkylating Agents|alkylating agents|mesh-ancestor
101636801|NCT00740467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636803|NCT00740467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101636804|NCT00740467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101636805|NCT00740467|Antimetabolites|antimetabolites|mesh-ancestor
101636806|NCT00740467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101636807|NCT00740467|Antifungal Agents|antifungal agents|mesh-ancestor
101636808|NCT00740467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101636809|NCT00740467|Dermatologic Agents|dermatologic agents|mesh-ancestor
101636810|NCT00740467|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101636811|NCT00740467|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101636812|NCT00740467|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101636813|NCT00740467|Antitubercular Agents|antitubercular agents|mesh-ancestor
101636814|NCT00740467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101636815|NCT00740545|Enoxaparin|enoxaparin|mesh-list
101636816|NCT00740545|Anticoagulants|anticoagulants|mesh-ancestor
101636817|NCT00740545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101636818|NCT00740545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101636819|NCT00740545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636820|NCT02653833|Tadalafil|tadalafil|mesh-list
101636821|NCT02653833|Vasodilator Agents|vasodilator agents|mesh-ancestor
101636822|NCT02653833|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101636823|NCT02653833|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101636824|NCT02653833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101636825|NCT02653833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636826|NCT02653833|Urological Agents|urological agents|mesh-ancestor
101636827|NCT00733057|Minocycline|minocycline|mesh-list
101636828|NCT00733057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101636829|NCT00733057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101636830|NCT00737971|Triamcinolone|triamcinolone|mesh-list
101636831|NCT00737971|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101636832|NCT00737971|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101636833|NCT00737971|Bevacizumab|bevacizumab|mesh-list
101636834|NCT00737971|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101636835|NCT00737971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101636836|NCT00737971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101636837|NCT00737971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101636838|NCT00737971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101636839|NCT00737971|Growth Substances|growth substances|mesh-ancestor
101636840|NCT00737971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636841|NCT00737971|Growth Inhibitors|growth inhibitors|mesh-ancestor
101636842|NCT00737971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101636843|NCT00737971|Glucocorticoids|glucocorticoids|mesh-ancestor
101636844|NCT00737971|Hormones|hormones|mesh-ancestor
101636845|NCT00737971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101636846|NCT00737971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101636847|NCT00737971|Immunologic Factors|immunologic factors|mesh-ancestor
101636848|NCT00737971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101636849|NCT00737971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636850|NCT00650247|Sumatriptan|sumatriptan|mesh-list
101636851|NCT00650247|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101636852|NCT00650247|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101636853|NCT00650247|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101636854|NCT00650247|Serotonin Agents|serotonin agents|mesh-ancestor
101636855|NCT00650247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101636856|NCT00650247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636857|NCT00650247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636858|NCT02568709|Oxytocin|oxytocin|mesh-list
101636859|NCT02568709|Oxytocics|oxytocics|mesh-ancestor
101636860|NCT02568709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101636861|NCT02568709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636862|NCT04316169|Hydroxychloroquine|hydroxychloroquine|mesh-list
101636863|NCT04316169|Letrozole|letrozole|mesh-list
101636864|NCT04316169|Fulvestrant|fulvestrant|mesh-list
101636865|NCT04316169|Anastrozole|anastrozole|mesh-list
101636866|NCT04316169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101636867|NCT04316169|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101636868|NCT04316169|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101636869|NCT04316169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101636870|NCT04316169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636871|NCT04316169|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101636872|NCT04316169|Hormone Antagonists|hormone antagonists|mesh-ancestor
101636873|NCT04316169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101636874|NCT04316169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636875|NCT04316169|Antimalarials|antimalarials|mesh-ancestor
101636876|NCT04316169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101636877|NCT04316169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101636878|NCT04316169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101636879|NCT04316169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101636880|NCT04316169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101636881|NCT04316169|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101636882|NCT02653209|Pioglitazone|pioglitazone|mesh-list
101636883|NCT02653209|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101636884|NCT02653209|Canagliflozin|canagliflozin|mesh-list
101636885|NCT02653209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101636886|NCT02653209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636887|NCT02653209|Incretins|incretins|mesh-ancestor
101636888|NCT02653209|Hormones|hormones|mesh-ancestor
101636889|NCT02653209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101636890|NCT02653209|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101636891|NCT02653209|Protease Inhibitors|protease inhibitors|mesh-ancestor
101636892|NCT02653209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101636893|NCT02653209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636894|NCT02653209|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101636895|NCT02653131|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101636896|NCT02653131|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
101636897|NCT02653131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101636898|NCT02653131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636899|NCT02653131|Incretins|incretins|mesh-ancestor
101636900|NCT02653131|Hormones|hormones|mesh-ancestor
101636901|NCT02653131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101636902|NCT02653131|Protease Inhibitors|protease inhibitors|mesh-ancestor
101636903|NCT02653131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101636904|NCT02653131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636905|NCT02652585|Naltrexone|naltrexone|mesh-list
101636906|NCT02652585|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101636907|NCT02652585|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101636908|NCT02652585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636909|NCT02652585|Sensory System Agents|sensory system agents|mesh-ancestor
101636910|NCT02652585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101636911|NCT00741169|Rifampin|rifampin|mesh-list
101636912|NCT00741169|Simeprevir|simeprevir|mesh-list
101636913|NCT00741169|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101636914|NCT00741169|Antitubercular Agents|antitubercular agents|mesh-ancestor
101636915|NCT00741169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101636916|NCT00741169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101636917|NCT00741169|Leprostatic Agents|leprostatic agents|mesh-ancestor
101636918|NCT00741169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101636919|NCT00741169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101636920|NCT00741169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636921|NCT00741169|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101636922|NCT00741169|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101636923|NCT00741169|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101636924|NCT00741169|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101636925|NCT00741169|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101636926|NCT00741169|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101636927|NCT00741169|Antiviral Agents|antiviral agents|mesh-ancestor
101636928|NCT00741169|Protease Inhibitors|protease inhibitors|mesh-ancestor
101636929|NCT00741325|Plerixafor|plerixafor|mesh-list
101636930|NCT00741325|Lenograstim|lenograstim|mesh-list
101636931|NCT00741325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101636932|NCT00741325|Immunologic Factors|immunologic factors|mesh-ancestor
101636933|NCT00741325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636934|NCT00741325|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101636935|NCT00741325|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101636936|NCT00741325|Antiviral Agents|antiviral agents|mesh-ancestor
101636937|NCT00741325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101636938|NCT02652741|Enalapril|enalapril|mesh-list
101636939|NCT02652741|Enalaprilat|enalaprilat|mesh-list
101636940|NCT02652741|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101636941|NCT02652741|Protease Inhibitors|protease inhibitors|mesh-ancestor
101636942|NCT02652741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101636943|NCT02652741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636944|NCT02652741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101636946|NCT02652507|Ketamine|ketamine|mesh-list
101636947|NCT02652507|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101636948|NCT02652507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101636949|NCT02652507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636950|NCT02652507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101636951|NCT02652507|Analgesics|analgesics|mesh-ancestor
101636952|NCT02652507|Sensory System Agents|sensory system agents|mesh-ancestor
101636953|NCT02652507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101636954|NCT02652507|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101636955|NCT02652507|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101636956|NCT02652507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101636957|NCT02652507|Adrenergic Agents|adrenergic agents|mesh-ancestor
101636958|NCT02652507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101363811|NCT00080886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101636959|NCT02652507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636960|NCT02652507|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101636961|NCT02652507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101636962|NCT02652507|Anesthetics, General|anesthetics, general|mesh-ancestor
101636963|NCT02652507|Anesthetics|anesthetics|mesh-ancestor
101636964|NCT02652507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101636965|NCT02652507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101636966|NCT05742295|Vitamin K|vitamin k|mesh-list
101636967|NCT05742295|Vitamins|vitamins|mesh-ancestor
101636968|NCT05742295|Micronutrients|micronutrients|mesh-ancestor
101636969|NCT05742295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636970|NCT05742295|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101636971|NCT05742295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101636972|NCT05742295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636973|NCT05742295|Hemostatics|hemostatics|mesh-ancestor
101636974|NCT05742295|Coagulants|coagulants|mesh-ancestor
101636975|NCT02652273|Abatacept|abatacept|mesh-list
101636976|NCT02652273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101636977|NCT02652273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636978|NCT02652273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101636979|NCT02652273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101636980|NCT02652273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101636981|NCT02652273|Immunologic Factors|immunologic factors|mesh-ancestor
101636982|NCT02652273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636983|NCT02652273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101636984|NCT00650325|Sertraline|sertraline|mesh-list
101636985|NCT00650325|Antidepressive Agents|antidepressive agents|mesh-ancestor
101636986|NCT00650325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101636987|NCT00650325|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101636988|NCT00650325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101636989|NCT00650325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101636990|NCT00650325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636991|NCT00650325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101636992|NCT00650325|Serotonin Agents|serotonin agents|mesh-ancestor
101636993|NCT00650325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101636994|NCT00650403|Paroxetine|paroxetine|mesh-list
101636995|NCT00650403|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101636996|NCT00650403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101636997|NCT00650403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101636998|NCT00650403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101636999|NCT00650403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101637000|NCT00650403|Serotonin Agents|serotonin agents|mesh-ancestor
101637001|NCT00650403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637002|NCT00650403|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101637003|NCT00650403|Antidepressive Agents|antidepressive agents|mesh-ancestor
101637004|NCT00650403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101637005|NCT00650403|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101637006|NCT00650403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101637007|NCT00650403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101637008|NCT02568319|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101637009|NCT02568319|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101637010|NCT02568319|Autonomic Agents|autonomic agents|mesh-ancestor
101637011|NCT02568319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101637012|NCT02568319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637013|NCT02568319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101637014|NCT02568319|Respiratory System Agents|respiratory system agents|mesh-ancestor
101637015|NCT02568319|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101637016|NCT02568319|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101637017|NCT02568319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101637018|NCT02568319|Adrenergic Agents|adrenergic agents|mesh-ancestor
101637019|NCT02568319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101637020|NCT02568319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637022|NCT00920803|Antioxidants|antioxidants|mesh-ancestor
101637023|NCT00920803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637025|NCT00920803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637026|NCT00920803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101637027|NCT00920803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101637028|NCT03912363|Insulin|insulin|mesh-list
101637029|NCT03912363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101637030|NCT03912363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637031|NCT05740969|Fluorouracil|fluorouracil|mesh-list
101637032|NCT05740969|Imiquimod|imiquimod|mesh-list
101637033|NCT05740969|Melatonin|melatonin|mesh-list
101637034|NCT05740969|Antimetabolites|antimetabolites|mesh-ancestor
101637035|NCT05740969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637036|NCT05740969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101637037|NCT05740969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101637038|NCT05740969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101637039|NCT05740969|Immunologic Factors|immunologic factors|mesh-ancestor
101637040|NCT05740969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637041|NCT05740969|Antioxidants|antioxidants|mesh-ancestor
101637042|NCT05740969|Protective Agents|protective agents|mesh-ancestor
101637043|NCT05740969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101637044|NCT05740969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101637045|NCT05740969|Interferon Inducers|interferon inducers|mesh-ancestor
101637046|NCT02568241|Interferons|interferons|mesh-list
101637047|NCT02568241|Interferon-alpha|interferon-alpha|mesh-list
101637048|NCT02568241|Interferon alpha-2|interferon alpha-2|mesh-list
101637049|NCT02568241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101637050|NCT02568241|Antiviral Agents|antiviral agents|mesh-ancestor
101637051|NCT02568241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101637052|NCT02568241|Immunologic Factors|immunologic factors|mesh-ancestor
101637053|NCT02568241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637054|NCT05551897|Itraconazole|itraconazole|mesh-list
101637055|NCT05551897|Antifungal Agents|antifungal agents|mesh-ancestor
101637056|NCT05551897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101637057|NCT05551897|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101637058|NCT05551897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101637059|NCT05551897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101637060|NCT05551897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637061|NCT05551897|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101637062|NCT05551897|Hormone Antagonists|hormone antagonists|mesh-ancestor
101637063|NCT05551897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101637064|NCT05551897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637065|NCT05551897|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101637066|NCT02647671|Calcium Carbonate|calcium carbonate|mesh-list
101637067|NCT02647671|Calcium|calcium|mesh-list
101637068|NCT02647671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101637069|NCT02647671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637070|NCT02647671|Antacids|antacids|mesh-ancestor
101637071|NCT02647671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637072|NCT02647671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101637073|NCT04578613|Rituximab|rituximab|mesh-list
101637074|NCT04578613|Chlorambucil|chlorambucil|mesh-list
101637075|NCT04578613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101637076|NCT04578613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101637077|NCT04578613|Immunologic Factors|immunologic factors|mesh-ancestor
101729253|NCT00446797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101637078|NCT04578613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637080|NCT04578613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101637081|NCT04578613|Alkylating Agents|alkylating agents|mesh-ancestor
101637082|NCT04578613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637083|NCT02647515|Ranibizumab|ranibizumab|mesh-list
101637084|NCT02647515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101637085|NCT02647515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101637086|NCT02647515|Growth Substances|growth substances|mesh-ancestor
101637087|NCT02647515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637088|NCT02647515|Growth Inhibitors|growth inhibitors|mesh-ancestor
101637089|NCT02647515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101637090|NCT03818763|Factor VIII|factor viii|mesh-list
101637091|NCT03818763|Coagulants|coagulants|mesh-ancestor
101637092|NCT02647047|Acetaminophen|acetaminophen|mesh-list
101637093|NCT02647047|Ketorolac|ketorolac|mesh-list
101637094|NCT02647047|Sufentanil|sufentanil|mesh-list
101637095|NCT02647047|Ropivacaine|ropivacaine|mesh-list
101637096|NCT02647047|Anesthetics, Local|anesthetics, local|mesh-ancestor
101637097|NCT02647047|Anesthetics|anesthetics|mesh-ancestor
101637098|NCT02647047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101637099|NCT02647047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637100|NCT02647047|Sensory System Agents|sensory system agents|mesh-ancestor
101637101|NCT02647047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101637102|NCT02647047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101637103|NCT02647047|Analgesics|analgesics|mesh-ancestor
101637104|NCT02647047|Antipyretics|antipyretics|mesh-ancestor
101637105|NCT02647047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101637106|NCT02647047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101637107|NCT02647047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101637108|NCT02647047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101637109|NCT02647047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101637110|NCT02647047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637111|NCT02647047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101637112|NCT02647047|Narcotics|narcotics|mesh-ancestor
101637113|NCT02647047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101637114|NCT02647047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101637115|NCT02647047|Anesthetics, General|anesthetics, general|mesh-ancestor
101637116|NCT00651651|Budesonide|budesonide|mesh-list
101637117|NCT00651651|Formoterol Fumarate|formoterol fumarate|mesh-list
101637118|NCT00651651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101637119|NCT00651651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101637120|NCT00651651|Autonomic Agents|autonomic agents|mesh-ancestor
101637121|NCT00651651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101637122|NCT00651651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637123|NCT00651651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101637124|NCT00651651|Respiratory System Agents|respiratory system agents|mesh-ancestor
101637125|NCT00651651|Glucocorticoids|glucocorticoids|mesh-ancestor
101637126|NCT00651651|Hormones|hormones|mesh-ancestor
101637127|NCT00651651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101637128|NCT00651651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101637129|NCT00651651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101637130|NCT00651651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101637131|NCT00651651|Adrenergic Agents|adrenergic agents|mesh-ancestor
101637132|NCT00651651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101637133|NCT00651651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637134|NCT00709111|Maraviroc|maraviroc|mesh-list
101637135|NCT00709111|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101637136|NCT00709111|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101637137|NCT00709111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637138|NCT00709111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101637139|NCT00709111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101637140|NCT00709111|Antiviral Agents|antiviral agents|mesh-ancestor
101637141|NCT00709111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101637142|NCT00709111|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101637143|NCT00651729|Botulinum Toxins|botulinum toxins|mesh-list
101637144|NCT00651729|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101637145|NCT00651729|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101637146|NCT00651729|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101637147|NCT00651729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101637148|NCT00651729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637149|NCT00651729|Cholinergic Agents|cholinergic agents|mesh-ancestor
101637150|NCT00651729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101637151|NCT00651729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637152|NCT00651729|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101637153|NCT00651729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101637154|NCT02646735|Fulvestrant|fulvestrant|mesh-list
101637155|NCT02646735|Exemestane|exemestane|mesh-list
101637156|NCT02646735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101637157|NCT02646735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101637158|NCT02646735|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101637159|NCT02646735|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101637160|NCT02646735|Hormone Antagonists|hormone antagonists|mesh-ancestor
101637161|NCT02646735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101637162|NCT02646735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637163|NCT02646735|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101637164|NCT02646735|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101637165|NCT02646735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101637166|NCT02646735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637167|NCT02646501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
101637169|NCT02646657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101637170|NCT00652041|Thalidomide|thalidomide|mesh-list
101637171|NCT00652041|Bortezomib|bortezomib|mesh-list
101637172|NCT00652041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101637173|NCT00652041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101637174|NCT00652041|Immunologic Factors|immunologic factors|mesh-ancestor
101637175|NCT00652041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637176|NCT00652041|Leprostatic Agents|leprostatic agents|mesh-ancestor
101637177|NCT00652041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101637178|NCT00652041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101637179|NCT00652041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101637180|NCT00652041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101637181|NCT00652041|Growth Substances|growth substances|mesh-ancestor
101637182|NCT00652041|Growth Inhibitors|growth inhibitors|mesh-ancestor
101637184|NCT02646111|Antimetabolites|antimetabolites|mesh-ancestor
101637185|NCT02646111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637186|NCT02646111|Antiviral Agents|antiviral agents|mesh-ancestor
101637187|NCT02646111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101637188|NCT00652119|Paclitaxel|paclitaxel|mesh-list
101637189|NCT00652119|Bevacizumab|bevacizumab|mesh-list
101637190|NCT00652119|Carboplatin|carboplatin|mesh-list
101637191|NCT00652119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101637192|NCT00652119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101637193|NCT00652119|Tubulin Modulators|tubulin modulators|mesh-ancestor
101637194|NCT00652119|Antimitotic Agents|antimitotic agents|mesh-ancestor
101637195|NCT00652119|Mitosis Modulators|mitosis modulators|mesh-ancestor
101637196|NCT00652119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637197|NCT00652119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101637198|NCT00652119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101637199|NCT00652119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101637200|NCT00652119|Growth Substances|growth substances|mesh-ancestor
101637201|NCT00652119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637202|NCT00652119|Growth Inhibitors|growth inhibitors|mesh-ancestor
101637203|NCT05740657|Fentanyl|fentanyl|mesh-list
101637204|NCT05740657|Sufentanil|sufentanil|mesh-list
101637205|NCT05740657|Morphine|morphine|mesh-list
101637206|NCT05740657|Remifentanil|remifentanil|mesh-list
101637207|NCT05740657|Oxycodone|oxycodone|mesh-list
101637208|NCT05740657|Hydromorphone|hydromorphone|mesh-list
101637209|NCT05740657|Alfentanil|alfentanil|mesh-list
101637210|NCT05740657|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101637211|NCT05740657|Narcotics|narcotics|mesh-ancestor
101637212|NCT05740657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101637213|NCT05740657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637214|NCT05740657|Analgesics|analgesics|mesh-ancestor
101637215|NCT05740657|Sensory System Agents|sensory system agents|mesh-ancestor
101637216|NCT05740657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101637217|NCT05740657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101637218|NCT05740657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101637219|NCT05740657|Anesthetics, General|anesthetics, general|mesh-ancestor
101637220|NCT05740657|Anesthetics|anesthetics|mesh-ancestor
101637221|NCT02646267|Warfarin|warfarin|mesh-list
101637222|NCT02646267|Dabigatran|dabigatran|mesh-list
101637223|NCT02646267|Anticoagulants|anticoagulants|mesh-ancestor
101637224|NCT02646267|Antithrombins|antithrombins|mesh-ancestor
101729410|NCT00863057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101637225|NCT02646267|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101637226|NCT02646267|Protease Inhibitors|protease inhibitors|mesh-ancestor
101637227|NCT02646267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101637228|NCT02646267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637229|NCT02646189|Interferons|interferons|mesh-list
101637230|NCT02646189|Interferon-alpha|interferon-alpha|mesh-list
101637231|NCT02646189|Interferon alpha-2|interferon alpha-2|mesh-list
101637232|NCT02646189|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101637233|NCT02646189|REP 2139|rep 2139|mesh-list
101637234|NCT02646189|Thymalfasin|thymalfasin|mesh-list
101637235|NCT02646189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101637236|NCT02646189|Antiviral Agents|antiviral agents|mesh-ancestor
101637237|NCT02646189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101637238|NCT02646189|Immunologic Factors|immunologic factors|mesh-ancestor
101637239|NCT02646189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637240|NCT02646189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101637241|NCT02645565|Methylprednisolone|methylprednisolone|mesh-list
101637242|NCT02645565|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101637243|NCT02645565|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101637244|NCT02645565|Prednisolone|prednisolone|mesh-list
101637245|NCT02645565|Prednisolone acetate|prednisolone acetate|mesh-list
101637246|NCT02645565|Cyclophosphamide|cyclophosphamide|mesh-list
101637247|NCT02645565|Azathioprine|azathioprine|mesh-list
101637248|NCT02645565|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101637249|NCT02645565|Prednisolone phosphate|prednisolone phosphate|mesh-list
101637250|NCT02645565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101637251|NCT02645565|Immunologic Factors|immunologic factors|mesh-ancestor
101637252|NCT02645565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637253|NCT02645565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101637254|NCT02645565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101637255|NCT02645565|Alkylating Agents|alkylating agents|mesh-ancestor
101637256|NCT02645565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637257|NCT02645565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101729459|NCT00808054|Lidocaine|lidocaine|mesh-list
101637258|NCT02645565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101637259|NCT02645565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101637260|NCT02645565|Antiemetics|antiemetics|mesh-ancestor
101637261|NCT02645565|Autonomic Agents|autonomic agents|mesh-ancestor
101637262|NCT02645565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101637263|NCT02645565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101637264|NCT02645565|Glucocorticoids|glucocorticoids|mesh-ancestor
101637265|NCT02645565|Hormones|hormones|mesh-ancestor
101637266|NCT02645565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101637267|NCT02645565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101637268|NCT02645565|Protective Agents|protective agents|mesh-ancestor
101637269|NCT02645565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101637270|NCT02645565|Antimetabolites|antimetabolites|mesh-ancestor
101637271|NCT02645565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101637272|NCT00699907|Flutamide|flutamide|mesh-list
101637273|NCT00699907|Androgen Antagonists|androgen antagonists|mesh-ancestor
101637274|NCT00699907|Hormone Antagonists|hormone antagonists|mesh-ancestor
101637275|NCT00699907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101637276|NCT00699907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637277|NCT00699907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101637278|NCT00699907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101637279|NCT00599313|Sunitinib|sunitinib|mesh-list
101637280|NCT00599313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101637281|NCT00599313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101637282|NCT00599313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101637283|NCT00599313|Growth Substances|growth substances|mesh-ancestor
101637284|NCT00599313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637285|NCT00599313|Growth Inhibitors|growth inhibitors|mesh-ancestor
101637286|NCT00599313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101637287|NCT00599313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101637288|NCT00599313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637289|NCT03159897|Doxorubicin|doxorubicin|mesh-list
101637290|NCT03159897|Bleomycin|bleomycin|mesh-list
101637291|NCT03159897|Dacarbazine|dacarbazine|mesh-list
101637292|NCT03159897|Vinblastine|vinblastine|mesh-list
101637293|NCT03159897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101637294|NCT03159897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101637295|NCT03159897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101637296|NCT03159897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101637297|NCT03159897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101637298|NCT03159897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637299|NCT03159897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101637300|NCT03159897|Alkylating Agents|alkylating agents|mesh-ancestor
101637301|NCT03159897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101637302|NCT03159897|Tubulin Modulators|tubulin modulators|mesh-ancestor
101637303|NCT03159897|Antimitotic Agents|antimitotic agents|mesh-ancestor
101637304|NCT03159897|Mitosis Modulators|mitosis modulators|mesh-ancestor
101637305|NCT00708175|Pioglitazone|pioglitazone|mesh-list
101637306|NCT00708175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101637307|NCT00708175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637308|NCT05740345|Metformin|metformin|mesh-list
101637309|NCT05740345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101637310|NCT05740345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637311|NCT02641431|Ajmaline|ajmaline|mesh-list
101637312|NCT02641431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101637313|NCT02641431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101637314|NCT02641431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101637315|NCT02641431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101637316|NCT02641431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637317|NCT00733525|Fluoxetine|fluoxetine|mesh-list
101637318|NCT00733525|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101637319|NCT00733525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101637320|NCT00733525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101637321|NCT00733525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637322|NCT00733525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101637323|NCT00733525|Serotonin Agents|serotonin agents|mesh-ancestor
101637324|NCT00733525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637325|NCT00733525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101637326|NCT00733525|Antidepressive Agents|antidepressive agents|mesh-ancestor
101637327|NCT00733525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101637328|NCT00733525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101637329|NCT00733525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101637330|NCT00733525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101637332|NCT02567149|Antiviral Agents|antiviral agents|mesh-ancestor
101637333|NCT02567149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101637334|NCT02567149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101637335|NCT02567149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637337|NCT00707239|Tigecycline|tigecycline|mesh-list
101637338|NCT00707239|Cilastatin|cilastatin|mesh-list
101637339|NCT00707239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101637340|NCT00707239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101637341|NCT00707239|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101637342|NCT00707239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101637343|NCT00707239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637344|NCT00707239|Protease Inhibitors|protease inhibitors|mesh-ancestor
101637345|NCT00968708|Alogliptin|alogliptin|mesh-list
101637346|NCT00968708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101637347|NCT00968708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637348|NCT00968708|Incretins|incretins|mesh-ancestor
101637349|NCT00968708|Hormones|hormones|mesh-ancestor
101637350|NCT00968708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101637351|NCT00968708|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101637353|NCT00968708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101637354|NCT00968708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637355|NCT05417269|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101637356|NCT05417269|Dermatologic Agents|dermatologic agents|mesh-ancestor
101637357|NCT05417269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101637358|NCT05417269|Immunologic Factors|immunologic factors|mesh-ancestor
101637359|NCT05417269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637360|NCT04062565|Treprostinil|treprostinil|mesh-list
101637361|NCT04062565|Riociguat|riociguat|mesh-list
101637362|NCT04062565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101637363|NCT04062565|Enzyme Activators|enzyme activators|mesh-ancestor
101637364|NCT04062565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637365|NCT00967694|Nitrous Oxide|nitrous oxide|mesh-list
101637366|NCT00967694|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101637367|NCT00967694|Anesthetics, General|anesthetics, general|mesh-ancestor
101637368|NCT00967694|Anesthetics|anesthetics|mesh-ancestor
101637369|NCT00967694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101637370|NCT00967694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637371|NCT00967694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101637372|NCT00967694|Analgesics|analgesics|mesh-ancestor
101637373|NCT00967694|Sensory System Agents|sensory system agents|mesh-ancestor
101637374|NCT00967694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101637375|NCT04288700|Timolol|timolol|mesh-list
101637376|NCT04288700|Propranolol|propranolol|mesh-list
101637377|NCT04288700|Captopril|captopril|mesh-list
101637378|NCT04288700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101637379|NCT04288700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101637380|NCT04288700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101637381|NCT04288700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637382|NCT04288700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101637383|NCT04288700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101637384|NCT04288700|Adrenergic Agents|adrenergic agents|mesh-ancestor
101637385|NCT04288700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101637386|NCT04288700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637387|NCT04288700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101637388|NCT04288700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101637389|NCT04288700|Vasodilator Agents|vasodilator agents|mesh-ancestor
101637390|NCT04288700|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101637391|NCT04288700|Protease Inhibitors|protease inhibitors|mesh-ancestor
101637392|NCT02863406|Dimercaprol|dimercaprol|mesh-list
101637394|NCT02863406|Sequestering Agents|sequestering agents|mesh-ancestor
101637395|NCT02863406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637396|NCT03664232|JNJ-42165279|jnj-42165279|mesh-list
101637397|NCT03664232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101637398|NCT03664232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637399|NCT00629720|Alfuzosin|alfuzosin|mesh-list
101637400|NCT00629720|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101637401|NCT00629720|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101294493|NCT01977209|Gossypol|gossypol|mesh-list
101637402|NCT00629720|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101637403|NCT00629720|Adrenergic Agents|adrenergic agents|mesh-ancestor
101637404|NCT00629720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101637405|NCT00629720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637406|NCT00629720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637407|NCT00629720|Urological Agents|urological agents|mesh-ancestor
101637409|NCT00967616|Fluorouracil|fluorouracil|mesh-list
101637410|NCT00967616|Irinotecan|irinotecan|mesh-list
101637411|NCT00967616|Efatutazone|efatutazone|mesh-list
101637412|NCT00967616|Levoleucovorin|levoleucovorin|mesh-list
101637413|NCT00967616|Antimetabolites|antimetabolites|mesh-ancestor
101637414|NCT00967616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637415|NCT00967616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101637416|NCT00967616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101637417|NCT00967616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101637418|NCT00967616|Immunologic Factors|immunologic factors|mesh-ancestor
101637419|NCT00967616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637420|NCT00967616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101637421|NCT00967616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101637422|NCT00967616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101637424|NCT00967616|Protective Agents|protective agents|mesh-ancestor
101637425|NCT00967616|Vitamin B Complex|vitamin b complex|mesh-ancestor
101637426|NCT00967616|Vitamins|vitamins|mesh-ancestor
101637427|NCT00967616|Micronutrients|micronutrients|mesh-ancestor
101637428|NCT04288232|Aflibercept|aflibercept|mesh-list
101637429|NCT04288232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101637430|NCT04288232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101637431|NCT04288232|Growth Substances|growth substances|mesh-ancestor
101637432|NCT04288232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637433|NCT04288232|Growth Inhibitors|growth inhibitors|mesh-ancestor
101637434|NCT04288232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101637435|NCT02864264|Interferons|interferons|mesh-list
101637436|NCT02864264|Interferon-gamma|interferon-gamma|mesh-list
101637437|NCT02864264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101637438|NCT02864264|Antiviral Agents|antiviral agents|mesh-ancestor
101637439|NCT02864264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101637440|NCT02640417|Vitamin B Complex|vitamin b complex|mesh-list
101637441|NCT02640417|Vitamins|vitamins|mesh-ancestor
101637442|NCT02640417|Micronutrients|micronutrients|mesh-ancestor
101637443|NCT02640417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637444|NCT02640495|Artesunate|artesunate|mesh-list
101637445|NCT02640495|Antimalarials|antimalarials|mesh-ancestor
101637446|NCT02640495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101637447|NCT02640495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101637448|NCT02640495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101637449|NCT02640495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101637450|NCT02640495|Antiviral Agents|antiviral agents|mesh-ancestor
101637451|NCT02640495|Schistosomicides|schistosomicides|mesh-ancestor
101637452|NCT02640495|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101637453|NCT02640495|Anthelmintics|anthelmintics|mesh-ancestor
101637454|NCT00653757|Leuprolide|leuprolide|mesh-list
101637455|NCT00653757|Goserelin|goserelin|mesh-list
101637456|NCT00653757|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101637457|NCT00653757|Fertility Agents|fertility agents|mesh-ancestor
101637458|NCT00653757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101637459|NCT00653757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637460|NCT00653757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101637461|NCT00653757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101637462|NCT00654225|Atorvastatin|atorvastatin|mesh-list
101637463|NCT00654225|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101637464|NCT00654225|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101637465|NCT00654225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101637466|NCT00654225|Antimetabolites|antimetabolites|mesh-ancestor
101637467|NCT00654225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637468|NCT00654225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101637469|NCT00654225|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101637470|NCT00654225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101637471|NCT00974090|Glimepiride|glimepiride|mesh-list
101637472|NCT00974090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101637473|NCT00974090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101637474|NCT00974090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637475|NCT00974090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101637476|NCT00974090|Immunologic Factors|immunologic factors|mesh-ancestor
101637477|NCT00654303|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101637478|NCT00654303|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101637479|NCT00654303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101637480|NCT00654303|Antimetabolites|antimetabolites|mesh-ancestor
101637481|NCT00654303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637482|NCT00654303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101637483|NCT00654303|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101637484|NCT00654303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101637486|NCT02639091|Anetumab ravtansine|anetumab ravtansine|mesh-list
101637487|NCT02639091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101637488|NCT02639091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101637489|NCT02639091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637490|NCT02639091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101637491|NCT02639091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101637492|NCT02639091|Immunoconjugates|immunoconjugates|mesh-ancestor
101637493|NCT02639091|Immunologic Factors|immunologic factors|mesh-ancestor
101637494|NCT02639091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637495|NCT00654459|Policosanol|policosanol|mesh-list
101637496|NCT00654459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101637497|NCT00654459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101637498|NCT00654459|Antimetabolites|antimetabolites|mesh-ancestor
101637499|NCT00654459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637500|NCT00654459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101637501|NCT00654459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101637502|NCT00654537|Atorvastatin|atorvastatin|mesh-list
101637503|NCT00654537|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101637504|NCT00654537|Simvastatin|simvastatin|mesh-list
101637505|NCT00654537|Pravastatin|pravastatin|mesh-list
101637506|NCT00654537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101637507|NCT00654537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101637508|NCT00654537|Antimetabolites|antimetabolites|mesh-ancestor
101637509|NCT00654537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637510|NCT00654537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101637511|NCT00654537|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101637512|NCT00654537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101637513|NCT02638857|Epirubicin|epirubicin|mesh-list
101637514|NCT02638857|Mitomycins|mitomycins|mesh-list
101637515|NCT02638857|Mitomycin|mitomycin|mesh-list
101637516|NCT02638857|Ethiodized Oil|ethiodized oil|mesh-list
101637517|NCT02638857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101637518|NCT02638857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101637519|NCT02638857|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101637520|NCT02638857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101637521|NCT02638857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101637522|NCT02638857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637523|NCT02638857|Alkylating Agents|alkylating agents|mesh-ancestor
101637524|NCT02638857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101637526|NCT02638545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101637527|NCT02638545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101637528|NCT02638545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637529|NCT02638545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101637530|NCT02638545|Analgesics|analgesics|mesh-ancestor
101637531|NCT02638545|Sensory System Agents|sensory system agents|mesh-ancestor
101637532|NCT02638545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101637533|NCT02638545|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101637534|NCT02638545|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101637535|NCT02638545|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101637536|NCT02638545|Adrenergic Agents|adrenergic agents|mesh-ancestor
101637537|NCT02638545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101637538|NCT02638545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637539|NCT02638233|Sofosbuvir|sofosbuvir|mesh-list
101637540|NCT02638233|Ledipasvir|ledipasvir|mesh-list
101637541|NCT02638233|Antiviral Agents|antiviral agents|mesh-ancestor
101637542|NCT02638233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101637543|NCT04285268|Rituximab|rituximab|mesh-list
101637544|NCT04285268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101637545|NCT04285268|Bortezomib|bortezomib|mesh-list
101637546|NCT04285268|Venetoclax|venetoclax|mesh-list
101637547|NCT04285268|Antibodies|antibodies|mesh-list
101637548|NCT04285268|Immunoglobulins|immunoglobulins|mesh-list
101637549|NCT04285268|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101637550|NCT04285268|Immunologic Factors|immunologic factors|mesh-ancestor
101637551|NCT04285268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637552|NCT04285268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101637553|NCT04285268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101637554|NCT00699751|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
101637555|NCT00699751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101294657|NCT01978483|Denosumab|denosumab|mesh-list
101637556|NCT01842399|Resveratrol|resveratrol|mesh-list
101637557|NCT01842399|Antioxidants|antioxidants|mesh-ancestor
101637558|NCT01842399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637559|NCT01842399|Protective Agents|protective agents|mesh-ancestor
101637560|NCT01842399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637561|NCT01842399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101637562|NCT01842399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101637564|NCT00970502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101637565|NCT00970502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101637566|NCT00970502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101637567|NCT00970502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101637568|NCT00970502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637569|NCT00970502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101637570|NCT00970502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101637572|NCT00970502|Sensory System Agents|sensory system agents|mesh-ancestor
101637573|NCT00970502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101637574|NCT00970502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637575|NCT00970502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101637576|NCT00970502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101637577|NCT00970502|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101637578|NCT00970502|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101637579|NCT02635893|Cycloserine|cycloserine|mesh-list
101637580|NCT02635893|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101637581|NCT02635893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101637582|NCT02635893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101637583|NCT02635893|Antitubercular Agents|antitubercular agents|mesh-ancestor
101637584|NCT02635893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101637585|NCT02635893|Antimetabolites|antimetabolites|mesh-ancestor
101637586|NCT02635893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637587|NCT02567773|Itraconazole|itraconazole|mesh-list
101637588|NCT02567773|GSK2881078|gsk2881078|mesh-list
101637589|NCT02567773|Antifungal Agents|antifungal agents|mesh-ancestor
101637590|NCT02567773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101637591|NCT02567773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101637592|NCT02567773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101637593|NCT02567773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101637594|NCT02567773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637595|NCT02567773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101637596|NCT02567773|Hormone Antagonists|hormone antagonists|mesh-ancestor
101637597|NCT02567773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101637598|NCT02567773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637599|NCT02567773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101637600|NCT02567773|Anabolic Agents|anabolic agents|mesh-ancestor
101637601|NCT02567773|Hormones|hormones|mesh-ancestor
101637602|NCT00967226|Prednisolone|prednisolone|mesh-list
101637603|NCT00967226|Propranolol|propranolol|mesh-list
101637604|NCT00967226|Prednisolone phosphate|prednisolone phosphate|mesh-list
101637605|NCT00967226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101637606|NCT00967226|Glucocorticoids|glucocorticoids|mesh-ancestor
101637607|NCT00967226|Hormones|hormones|mesh-ancestor
101637608|NCT00967226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101637609|NCT00967226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637610|NCT00967226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101637611|NCT00967226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101637612|NCT00967226|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101637613|NCT00967226|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101637614|NCT00967226|Adrenergic Agents|adrenergic agents|mesh-ancestor
101637615|NCT00967226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101637616|NCT00967226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637617|NCT00967226|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101637618|NCT00967226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101637619|NCT00967226|Vasodilator Agents|vasodilator agents|mesh-ancestor
101637621|NCT00706381|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101637622|NCT00706381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101637623|NCT00964886|Benztropine|benztropine|mesh-list
101637624|NCT00964886|Desipramine|desipramine|mesh-list
101637625|NCT00964886|Clomipramine|clomipramine|mesh-list
101637626|NCT00964886|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101637627|NCT00964886|Antidepressive Agents|antidepressive agents|mesh-ancestor
101637628|NCT00964886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101637629|NCT00964886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101637630|NCT00964886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363822|NCT00080886|Antiviral Agents|antiviral agents|mesh-ancestor
101637631|NCT00964886|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101637632|NCT00964886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101637633|NCT00964886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101637634|NCT00964886|Adrenergic Agents|adrenergic agents|mesh-ancestor
101637635|NCT00964886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101637636|NCT00964886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637637|NCT00964886|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101637638|NCT00964886|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101637639|NCT00964886|Parasympatholytics|parasympatholytics|mesh-ancestor
101637641|NCT00964886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101637642|NCT00964886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101637643|NCT00964886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101637644|NCT00964886|Cholinergic Agents|cholinergic agents|mesh-ancestor
101637645|NCT00964886|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101637647|NCT00964886|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101637648|NCT00964886|Serotonin Agents|serotonin agents|mesh-ancestor
101637649|NCT02861222|Doxorubicin|doxorubicin|mesh-list
101637650|NCT02861222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101637651|NCT02861222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101637652|NCT02861222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101637653|NCT02861222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101637654|NCT02861222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101637655|NCT02861222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637656|NCT04062019|Aldesleukin|aldesleukin|mesh-list
101637657|NCT04062019|Interleukin-2|interleukin-2|mesh-list
101637658|NCT04062019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101637660|NCT04062019|Analgesics|analgesics|mesh-ancestor
101637661|NCT04062019|Sensory System Agents|sensory system agents|mesh-ancestor
101637662|NCT04062019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101637663|NCT04062019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637664|NCT04062019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101637665|NCT04062019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101637666|NCT04062019|Antiviral Agents|antiviral agents|mesh-ancestor
101637667|NCT04062019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101637668|NCT04061863|Nivolumab|nivolumab|mesh-list
101637669|NCT04061863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101637670|NCT04061863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101637671|NCT04061863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101637672|NCT04061863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637673|NCT02861378|Phentolamine|phentolamine|mesh-list
101637674|NCT02861378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101637675|NCT02861378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101637676|NCT02861378|Adrenergic Agents|adrenergic agents|mesh-ancestor
101637677|NCT02861378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101637678|NCT02861378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637679|NCT02861378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637680|NCT02861378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101637681|NCT03630224|Plasma-lyte 148|plasma-lyte 148|mesh-list
101637682|NCT03630224|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101637683|NCT03630224|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101637684|NCT00705757|Bimatoprost|bimatoprost|mesh-list
101637685|NCT00705757|Travoprost|travoprost|mesh-list
101637686|NCT00705757|Latanoprost|latanoprost|mesh-list
101637687|NCT00705757|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101637688|NCT00705757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101637689|NCT00705757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101637690|NCT04284644|Propofol|propofol|mesh-list
101637691|NCT04284644|Sevoflurane|sevoflurane|mesh-list
101637692|NCT04284644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101637693|NCT04284644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101637694|NCT04284644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637695|NCT04284644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101637696|NCT04284644|Anesthetics, General|anesthetics, general|mesh-ancestor
101637698|NCT04284644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101637699|NCT04284644|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101637700|NCT05330143|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101637701|NCT05330143|Antiviral Agents|antiviral agents|mesh-ancestor
101637702|NCT05330143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101637703|NCT04284722|Metformin|metformin|mesh-list
101637704|NCT04284722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101637705|NCT04284722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637706|NCT04283240|Sildenafil Citrate|sildenafil citrate|mesh-list
101637707|NCT04283240|Vasodilator Agents|vasodilator agents|mesh-ancestor
101637708|NCT04283240|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101637709|NCT04283240|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101637710|NCT04283240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101637711|NCT04283240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637712|NCT04283240|Urological Agents|urological agents|mesh-ancestor
101637713|NCT03588884|Cholecalciferol|cholecalciferol|mesh-list
101637715|NCT03588884|Calcifediol|calcifediol|mesh-list
101637716|NCT03588884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101637717|NCT03588884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637718|NCT03588884|Vitamins|vitamins|mesh-ancestor
101637719|NCT03588884|Micronutrients|micronutrients|mesh-ancestor
101637720|NCT03588884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101637721|NCT02862782|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101637722|NCT02862782|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101637723|NCT02862782|Luteolytic Agents|luteolytic agents|mesh-ancestor
101637724|NCT02862782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101637725|NCT02862782|Contraceptive Agents|contraceptive agents|mesh-ancestor
101637726|NCT02862782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101637727|NCT02862782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637728|NCT02862782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101637729|NCT02862782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101637730|NCT02862782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101637731|NCT04283162|Calcium, Dietary|calcium, dietary|mesh-list
101637732|NCT04283162|Calcium Dobesilate|calcium dobesilate|mesh-list
101637733|NCT04283162|Calcium|calcium|mesh-list
101637734|NCT04283162|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101637735|NCT04283162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637736|NCT04283162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101637737|NCT04283162|Hemostatics|hemostatics|mesh-ancestor
101637738|NCT04283162|Coagulants|coagulants|mesh-ancestor
101637739|NCT00758524|Eplerenone|eplerenone|mesh-list
101637740|NCT00758524|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101637741|NCT00758524|Hormone Antagonists|hormone antagonists|mesh-ancestor
101637742|NCT00758524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101637743|NCT00758524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637744|NCT00758524|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101637745|NCT00758524|Diuretics|diuretics|mesh-ancestor
101637746|NCT00758524|Natriuretic Agents|natriuretic agents|mesh-ancestor
101637747|NCT00758524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101637748|NCT02601196|Ulipristal acetate|ulipristal acetate|mesh-list
101637749|NCT02601196|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101637750|NCT02601196|Contraceptive Agents|contraceptive agents|mesh-ancestor
101637751|NCT02601196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101637752|NCT02601196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637753|NCT02601196|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101637754|NCT00757588|Insulin|insulin|mesh-list
101637755|NCT00757588|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101637756|NCT00757588|Saxagliptin|saxagliptin|mesh-list
101637757|NCT00757588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101637758|NCT00757588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637759|NCT00757588|Incretins|incretins|mesh-ancestor
101637760|NCT00757588|Hormones|hormones|mesh-ancestor
101637761|NCT00757588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101637762|NCT00757588|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101637763|NCT00757588|Protease Inhibitors|protease inhibitors|mesh-ancestor
101637764|NCT00757588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101637765|NCT00757588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637766|NCT00917254|Enoxaparin|enoxaparin|mesh-list
101637767|NCT00917254|Anticoagulants|anticoagulants|mesh-ancestor
101637768|NCT00917254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101637769|NCT00917254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101729937|NCT00482053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101637770|NCT00917254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637771|NCT02599792|Ivacaftor|ivacaftor|mesh-list
101637772|NCT02599792|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101637773|NCT02599792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101637774|NCT02599792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637776|NCT00705679|Emtricitabine|emtricitabine|mesh-list
101637777|NCT00705679|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101637778|NCT00705679|Antiviral Agents|antiviral agents|mesh-ancestor
101637779|NCT00705679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101637780|NCT00705679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101294867|NCT01980407|Vitamins|vitamins|mesh-ancestor
101363828|NCT00134212|Epinephrine|epinephrine|mesh-list
101637781|NCT00705679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101637782|NCT00705679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101637783|NCT00705679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637784|NCT00705679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101637785|NCT00705679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101637786|NCT04092868|Protamines|protamines|mesh-list
101637787|NCT04092868|Heparin Antagonists|heparin antagonists|mesh-ancestor
101637788|NCT04092868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637789|NCT04092868|Coagulants|coagulants|mesh-ancestor
101637790|NCT05695573|Cystatins|cystatins|mesh-list
101637791|NCT05695573|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
101637792|NCT05695573|Protease Inhibitors|protease inhibitors|mesh-ancestor
101637793|NCT05695573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101637794|NCT05695573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637795|NCT00916942|Lidocaine|lidocaine|mesh-list
101637796|NCT00916942|Prilocaine|prilocaine|mesh-list
101637797|NCT00916942|Capsaicin|capsaicin|mesh-list
101637798|NCT00916942|Anesthetics, Local|anesthetics, local|mesh-ancestor
101637799|NCT00916942|Anesthetics|anesthetics|mesh-ancestor
101637800|NCT00916942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101637801|NCT00916942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637802|NCT00916942|Sensory System Agents|sensory system agents|mesh-ancestor
101637803|NCT00916942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101637804|NCT00916942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101637805|NCT00916942|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101637806|NCT00916942|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101637807|NCT00916942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101637808|NCT00916942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637809|NCT00916942|Antipruritics|antipruritics|mesh-ancestor
101637810|NCT00916942|Dermatologic Agents|dermatologic agents|mesh-ancestor
101637811|NCT00751114|Metformin|metformin|mesh-list
101637812|NCT00751114|Insulin Glargine|insulin glargine|mesh-list
101637813|NCT00751114|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101637814|NCT00751114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101637815|NCT00751114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637816|NCT00751114|Incretins|incretins|mesh-ancestor
101637817|NCT00751114|Hormones|hormones|mesh-ancestor
101637818|NCT00751114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101637819|NCT00751114|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101637820|NCT00751114|Protease Inhibitors|protease inhibitors|mesh-ancestor
101637821|NCT00751114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101637822|NCT00751114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637823|NCT00960440|Tofacitinib|tofacitinib|mesh-list
101637824|NCT00960440|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101637825|NCT00960440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101637826|NCT00960440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101637827|NCT00960440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637828|NCT04092478|Anesthetics|anesthetics|mesh-list
101637829|NCT04092478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101637830|NCT04092478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637831|NCT02598466|Abatacept|abatacept|mesh-list
101637832|NCT02598466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101637833|NCT02598466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637834|NCT02598466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101637835|NCT02598466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101637836|NCT02598466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101637837|NCT02598466|Immunologic Factors|immunologic factors|mesh-ancestor
101637838|NCT02598466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637839|NCT02598466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101637840|NCT05973422|Insulin|insulin|mesh-list
101637841|NCT05973422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101637842|NCT05973422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637843|NCT05973370|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101637845|NCT05973370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101637846|NCT05973318|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101637847|NCT05973318|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101637848|NCT05973305|Dorzolamide|dorzolamide|mesh-list
101637849|NCT05973305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101637850|NCT05973305|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101637851|NCT05973305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101637852|NCT05973305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637853|NCT05973253|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101294941|NCT01980810|Antimitotic Agents|antimitotic agents|mesh-ancestor
101729999|NCT03995563|Hormones|hormones|mesh-ancestor
101637854|NCT05973253|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101637856|NCT05973253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101637857|NCT05973253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637858|NCT05973253|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101637859|NCT05973253|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101637860|NCT05973253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101637861|NCT05973253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101637862|NCT05973188|Warfarin|warfarin|mesh-list
101637863|NCT05973188|Rivaroxaban|rivaroxaban|mesh-list
101637864|NCT05973188|Apixaban|apixaban|mesh-list
101637865|NCT05973188|Anticoagulants|anticoagulants|mesh-ancestor
101637866|NCT05973188|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101637867|NCT05973188|Antithrombins|antithrombins|mesh-ancestor
101637868|NCT05973188|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101637869|NCT05973188|Protease Inhibitors|protease inhibitors|mesh-ancestor
101637870|NCT05973188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101637871|NCT05973188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637872|NCT05973071|Contraceptive Agents|contraceptive agents|mesh-list
101637873|NCT05973071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101637874|NCT05973071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637875|NCT05972967|Ravulizumab|ravulizumab|mesh-list
101637876|NCT05972967|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101637877|NCT05972967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101637878|NCT05972967|Immunologic Factors|immunologic factors|mesh-ancestor
101637879|NCT05972967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637880|NCT05972928|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101637881|NCT05972928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101637882|NCT05972928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637883|NCT05972928|Incretins|incretins|mesh-ancestor
101637884|NCT05972928|Hormones|hormones|mesh-ancestor
101637885|NCT05972928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101637886|NCT05972928|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101637887|NCT05972928|Protease Inhibitors|protease inhibitors|mesh-ancestor
101637888|NCT05972928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101637889|NCT05972928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637890|NCT05972902|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101637891|NCT05972902|Cetrorelix|cetrorelix|mesh-list
101637892|NCT05972902|Dydrogesterone|dydrogesterone|mesh-list
101637893|NCT05972902|Luteolytic Agents|luteolytic agents|mesh-ancestor
101637894|NCT05972902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101637895|NCT05972902|Contraceptive Agents|contraceptive agents|mesh-ancestor
101637896|NCT05972902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101637897|NCT05972902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637898|NCT05972902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101637899|NCT05972902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101637900|NCT05972902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101637901|NCT05972902|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101637902|NCT05972902|Fertility Agents|fertility agents|mesh-ancestor
101637903|NCT05972902|Hormone Antagonists|hormone antagonists|mesh-ancestor
101637904|NCT05972902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101637905|NCT05972902|Progestins|progestins|mesh-ancestor
101637906|NCT05972902|Hormones|hormones|mesh-ancestor
101637907|NCT05972785|Calcium Channel Blockers|calcium channel blockers|mesh-list
101637908|NCT05972785|Calcium|calcium|mesh-list
101637909|NCT05972785|Diuretics|diuretics|mesh-list
101637910|NCT05972785|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101637911|NCT05972785|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101637912|NCT05972785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637913|NCT05972785|Natriuretic Agents|natriuretic agents|mesh-ancestor
101637914|NCT05972785|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101637915|NCT05972785|Adrenergic Agents|adrenergic agents|mesh-ancestor
101637916|NCT05972785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101637917|NCT05972785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637919|NCT05972772|Azithromycin|azithromycin|mesh-list
101637920|NCT05972772|Doxycycline|doxycycline|mesh-list
101637921|NCT05972772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101637922|NCT05972772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101637923|NCT05972772|Antimalarials|antimalarials|mesh-ancestor
101637924|NCT05972772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101333600|NCT00017160|Ifosfamide|ifosfamide|mesh-list
101637925|NCT05972772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101637926|NCT05972720|Cyclophosphamide|cyclophosphamide|mesh-list
101295018|NCT01981499|Histamine Agents|histamine agents|mesh-ancestor
101637927|NCT05972720|Fludarabine|fludarabine|mesh-list
101637928|NCT05972720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101637929|NCT05972720|Immunologic Factors|immunologic factors|mesh-ancestor
101637930|NCT05972720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637931|NCT05972720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101637932|NCT05972720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101637933|NCT05972720|Alkylating Agents|alkylating agents|mesh-ancestor
101637934|NCT05972720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637944|NCT05972681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101637945|NCT05972681|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101637946|NCT05972681|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101637947|NCT05972681|Adrenergic Agents|adrenergic agents|mesh-ancestor
101637948|NCT05972681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101637949|NCT05972681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637950|NCT05972681|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101637951|NCT05972681|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101637952|NCT05972681|Autonomic Agents|autonomic agents|mesh-ancestor
101637953|NCT05972681|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101637954|NCT05972681|Respiratory System Agents|respiratory system agents|mesh-ancestor
101637955|NCT05972681|Mydriatics|mydriatics|mesh-ancestor
101637956|NCT05972681|Sympathomimetics|sympathomimetics|mesh-ancestor
101637957|NCT05972681|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101637967|NCT05972603|Vancomycin|vancomycin|mesh-list
101637968|NCT05972603|Povidone-Iodine|povidone-iodine|mesh-list
101637969|NCT05972603|Povidone|povidone|mesh-list
101637970|NCT05972603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101637971|NCT05972603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101637972|NCT05972603|Plasma Substitutes|plasma substitutes|mesh-ancestor
101637973|NCT05972603|Blood Substitutes|blood substitutes|mesh-ancestor
101637974|NCT05972603|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101637975|NCT05972564|Empagliflozin|empagliflozin|mesh-list
101637976|NCT05972564|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101637977|NCT05972564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101637978|NCT05972564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101637979|NCT05972564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637980|NCT05972551|Diphosphonates|diphosphonates|mesh-list
101637985|NCT05972512|Vitamins|vitamins|mesh-ancestor
101637986|NCT05972512|Micronutrients|micronutrients|mesh-ancestor
101637987|NCT05972512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637988|NCT05972473|Aflibercept|aflibercept|mesh-list
101637989|NCT05972473|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101637990|NCT05972473|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101637991|NCT05972473|Growth Substances|growth substances|mesh-ancestor
101637992|NCT05972473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637993|NCT05972473|Growth Inhibitors|growth inhibitors|mesh-ancestor
101637994|NCT05972473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101637995|NCT05972434|Sunscreening Agents|sunscreening agents|mesh-list
101637996|NCT05972434|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101637997|NCT05972434|Protective Agents|protective agents|mesh-ancestor
101637998|NCT05972434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101637999|NCT05972434|Dermatologic Agents|dermatologic agents|mesh-ancestor
101638000|NCT05972018|Epinephrine|epinephrine|mesh-list
101638001|NCT05972018|Bupivacaine|bupivacaine|mesh-list
101638002|NCT05972018|Ropivacaine|ropivacaine|mesh-list
101638003|NCT05972018|Anesthetics, Local|anesthetics, local|mesh-ancestor
101638004|NCT05972018|Anesthetics|anesthetics|mesh-ancestor
101638005|NCT05972018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101638006|NCT05972018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638007|NCT05972018|Sensory System Agents|sensory system agents|mesh-ancestor
101638008|NCT05972018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101638009|NCT05972018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101638010|NCT05972018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101638011|NCT05972018|Adrenergic Agents|adrenergic agents|mesh-ancestor
101638012|NCT05972018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101638013|NCT05972018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638014|NCT05972018|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101638015|NCT05972018|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101638016|NCT05972018|Autonomic Agents|autonomic agents|mesh-ancestor
101638017|NCT05972018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101638018|NCT05972018|Respiratory System Agents|respiratory system agents|mesh-ancestor
101638019|NCT05972018|Mydriatics|mydriatics|mesh-ancestor
101638020|NCT05972018|Sympathomimetics|sympathomimetics|mesh-ancestor
101638021|NCT05972018|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101638022|NCT05971849|Hormones|hormones|mesh-list
101638023|NCT05971849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101638024|NCT05971849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638025|NCT05971810|Chlorhexidine|chlorhexidine|mesh-list
101638026|NCT05971810|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101638027|NCT05971810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101638028|NCT05971810|Disinfectants|disinfectants|mesh-ancestor
101638033|NCT05971680|Vitamins|vitamins|mesh-list
101638034|NCT05971680|Thiamine|thiamine|mesh-list
101638035|NCT05971680|Vitamin B Complex|vitamin b complex|mesh-list
101638036|NCT05971680|Contraceptive Agents|contraceptive agents|mesh-list
101638037|NCT05971680|Micronutrients|micronutrients|mesh-ancestor
101638038|NCT05971680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638039|NCT05971680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101638040|NCT05971654|Azithromycin|azithromycin|mesh-list
101638041|NCT05971654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101638042|NCT05971654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101638043|NCT05971563|Caseins|caseins|mesh-list
101638044|NCT05971563|Chelating Agents|chelating agents|mesh-ancestor
101638045|NCT05971563|Sequestering Agents|sequestering agents|mesh-ancestor
101638046|NCT05971563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638047|NCT05971550|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101638048|NCT05971550|Ceftriaxone|ceftriaxone|mesh-list
101638049|NCT05971550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101638050|NCT05971537|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101638051|NCT05971537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101638052|NCT05971537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101638053|NCT05971537|Antitubercular Agents|antitubercular agents|mesh-ancestor
101638054|NCT05971485|Melatonin|melatonin|mesh-list
101638055|NCT05971485|Antioxidants|antioxidants|mesh-ancestor
101638056|NCT05971485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638057|NCT05971485|Protective Agents|protective agents|mesh-ancestor
101638058|NCT05971485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638059|NCT05971485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101638060|NCT05971394|Sirolimus|sirolimus|mesh-list
101638061|NCT05971394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101638062|NCT05971394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101638063|NCT05971394|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101638064|NCT05971394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101638065|NCT05971394|Antifungal Agents|antifungal agents|mesh-ancestor
101638066|NCT05971394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101638067|NCT05971394|Immunologic Factors|immunologic factors|mesh-ancestor
101638068|NCT05971394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638069|NCT05971355|Emollients|emollients|mesh-list
101638070|NCT05971355|Dermatologic Agents|dermatologic agents|mesh-ancestor
101638071|NCT05971186|Ibuprofen|ibuprofen|mesh-list
101638072|NCT05971186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101638073|NCT05971186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101638074|NCT05971186|Analgesics|analgesics|mesh-ancestor
101638075|NCT05971186|Sensory System Agents|sensory system agents|mesh-ancestor
101638076|NCT05971186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101638077|NCT05971186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638078|NCT05971186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101638079|NCT05971186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101638080|NCT05971186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101638081|NCT05971186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101638082|NCT05971186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638083|NCT05971004|Methylprednisolone|methylprednisolone|mesh-list
101638084|NCT05971004|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101638085|NCT05971004|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101638086|NCT05971004|Prednisolone|prednisolone|mesh-list
101638087|NCT05971004|Prednisolone acetate|prednisolone acetate|mesh-list
101638088|NCT05971004|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101638089|NCT05971004|Prednisolone phosphate|prednisolone phosphate|mesh-list
101638090|NCT05971004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101638091|NCT05971004|Antiemetics|antiemetics|mesh-ancestor
101638092|NCT05971004|Autonomic Agents|autonomic agents|mesh-ancestor
101638093|NCT05971004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101638094|NCT05971004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638095|NCT05971004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101638096|NCT05971004|Glucocorticoids|glucocorticoids|mesh-ancestor
101638097|NCT05971004|Hormones|hormones|mesh-ancestor
101638098|NCT05971004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101638099|NCT05971004|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101638100|NCT05971004|Protective Agents|protective agents|mesh-ancestor
101638101|NCT05971004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101638102|NCT05971004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101638103|NCT05967052|Pregabalin|pregabalin|mesh-list
101638104|NCT05967052|Analgesics|analgesics|mesh-ancestor
101638105|NCT05967052|Sensory System Agents|sensory system agents|mesh-ancestor
101638106|NCT05967052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101638107|NCT05967052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638108|NCT05967052|Anticonvulsants|anticonvulsants|mesh-ancestor
101638109|NCT05967052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101638110|NCT05967052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101638111|NCT05967052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638112|NCT05967052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101638113|NCT05967052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101638114|NCT05967052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101638115|NCT05967052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101638116|NCT05967052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101730180|NCT00816790|Tazobactam|tazobactam|mesh-list
101638117|NCT05966584|Fulvestrant|fulvestrant|mesh-list
101638118|NCT05966584|Benralizumab|benralizumab|mesh-list
101638119|NCT05966584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101638120|NCT05966584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101638121|NCT05966584|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101638122|NCT05966584|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101638123|NCT05966584|Hormone Antagonists|hormone antagonists|mesh-ancestor
101638124|NCT05966584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101638125|NCT05966584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638126|NCT05966584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101638127|NCT05966584|Respiratory System Agents|respiratory system agents|mesh-ancestor
101638128|NCT05963139|Morphine|morphine|mesh-list
101638129|NCT05963139|Bupivacaine|bupivacaine|mesh-list
101638130|NCT05963139|Anesthetics, Local|anesthetics, local|mesh-ancestor
101638131|NCT05963139|Anesthetics|anesthetics|mesh-ancestor
101638132|NCT05963139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101638133|NCT05963139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638134|NCT05963139|Sensory System Agents|sensory system agents|mesh-ancestor
101638135|NCT05963139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101638136|NCT05963139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101638137|NCT05963139|Narcotics|narcotics|mesh-ancestor
101638138|NCT05963139|Analgesics|analgesics|mesh-ancestor
101638139|NCT05945147|Midazolam|midazolam|mesh-list
101638140|NCT05945147|Ketamine|ketamine|mesh-list
101638141|NCT05945147|Analgesics|analgesics|mesh-ancestor
101638142|NCT05945147|Sensory System Agents|sensory system agents|mesh-ancestor
101638143|NCT05945147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101638144|NCT05945147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638145|NCT05945147|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101638146|NCT05945147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101638147|NCT05945147|Anesthetics, General|anesthetics, general|mesh-ancestor
101638148|NCT05945147|Anesthetics|anesthetics|mesh-ancestor
101638149|NCT05945147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101638150|NCT05945147|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101638151|NCT05945147|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101638152|NCT05945147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101638153|NCT05945147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638154|NCT05945147|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101638155|NCT05945147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101295238|NCT01983501|Tucatinib|tucatinib|mesh-list
101638156|NCT05945147|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101638157|NCT05945147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101638158|NCT05945147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101638159|NCT05945147|GABA Modulators|gaba modulators|mesh-ancestor
101638160|NCT05945147|GABA Agents|gaba agents|mesh-ancestor
101638161|NCT05930808|Bisoprolol|bisoprolol|mesh-list
101638162|NCT05930808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101638163|NCT05930808|Sympatholytics|sympatholytics|mesh-ancestor
101638164|NCT05930808|Autonomic Agents|autonomic agents|mesh-ancestor
101638165|NCT05930808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101638166|NCT05930808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638167|NCT05930808|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101638168|NCT05930808|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101638169|NCT05930808|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101638170|NCT05930808|Adrenergic Agents|adrenergic agents|mesh-ancestor
101638171|NCT05930808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101638172|NCT05930808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638173|NCT05924256|Leuprolide|leuprolide|mesh-list
101638174|NCT05924256|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101638175|NCT05924256|Fertility Agents|fertility agents|mesh-ancestor
101638176|NCT05924256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101638177|NCT05924256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638178|NCT05924256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101638179|NCT05924256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101638180|NCT05916352|Caffeine|caffeine|mesh-list
101638181|NCT05916352|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101638182|NCT05916352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638183|NCT05916352|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101638184|NCT05916352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101638185|NCT05916352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638186|NCT05916352|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101638187|NCT05916352|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101638188|NCT05916352|Purinergic Agents|purinergic agents|mesh-ancestor
101638235|NCT05890586|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101638253|NCT05859464|Pembrolizumab|pembrolizumab|mesh-list
101638254|NCT05859464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101638255|NCT05859464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101638256|NCT05859464|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101638257|NCT05859464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638258|NCT05855967|Ixekizumab|ixekizumab|mesh-list
101638259|NCT05855967|Dermatologic Agents|dermatologic agents|mesh-ancestor
101638260|NCT05844735|Ciprofloxacin|ciprofloxacin|mesh-list
101730329|NCT04581382|Nivolumab|nivolumab|mesh-list
101638261|NCT05844735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101638262|NCT05844735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101638263|NCT05844735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101638264|NCT05844735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101638265|NCT05844735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101638266|NCT05844735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638267|NCT05844735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101638268|NCT05844735|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101638269|NCT05844735|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101638270|NCT05821374|Deucravacitinib|deucravacitinib|mesh-list
101638271|NCT05821374|Dermatologic Agents|dermatologic agents|mesh-ancestor
101638272|NCT05821374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101638273|NCT05821374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101638274|NCT05821374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638275|NCT05813964|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101638276|NCT05813964|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
101638277|NCT05813964|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101638278|NCT05813964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101638279|NCT05813964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101638280|NCT05813964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638281|NCT05813964|Antiviral Agents|antiviral agents|mesh-ancestor
101638282|NCT05813964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101638283|NCT05813964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101638284|NCT05813964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101638286|NCT05766631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101638287|NCT05766631|Narcotics|narcotics|mesh-ancestor
101638288|NCT05766631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101638289|NCT05766631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638295|NCT05766371|Pembrolizumab|pembrolizumab|mesh-list
101638296|NCT05766371|177Lu-PSMA-617|177lu-psma-617|mesh-list
101638297|NCT05766371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101638298|NCT05766371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101638299|NCT05766371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101638300|NCT05766371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638301|NCT05766371|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101638302|NCT05748834|Doxorubicin|doxorubicin|mesh-list
101638303|NCT05748834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101638305|NCT05748834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101638306|NCT05748834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101638307|NCT05748834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101638308|NCT05748834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101638309|NCT05748834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101638310|NCT05748834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638311|NCT05748834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101638312|NCT05746572|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
101638313|NCT05746572|Hallucinogens|hallucinogens|mesh-ancestor
101638314|NCT05746572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638315|NCT05746572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101638316|NCT05746572|Serotonin Agents|serotonin agents|mesh-ancestor
101638317|NCT05746572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101638318|NCT05746572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638319|NCT05746572|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101638320|NCT05746572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101638321|NCT05746572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101638322|NCT05746572|Adrenergic Agents|adrenergic agents|mesh-ancestor
101638323|NCT05741294|Tirbanibulin|tirbanibulin|mesh-list
101638324|NCT05741294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101638325|NCT05741294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638326|NCT05741060|Equol|equol|mesh-list
101638327|NCT05741060|Phytoestrogens|phytoestrogens|mesh-ancestor
101638328|NCT05741060|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101638329|NCT05741060|Estrogens|estrogens|mesh-ancestor
101638330|NCT05741060|Hormones|hormones|mesh-ancestor
101638331|NCT05741060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101638332|NCT05741060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638333|NCT05739006|Pembrolizumab|pembrolizumab|mesh-list
101638334|NCT05739006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101638335|NCT05739006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101638336|NCT05739006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101638337|NCT05739006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638338|NCT05700630|Vorinostat|vorinostat|mesh-list
101638339|NCT05700630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101638340|NCT05700630|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101638341|NCT05700630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101638462|NCT05624996|Immunologic Factors|immunologic factors|mesh-ancestor
101638463|NCT05624996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638464|NCT05624996|Keratolytic Agents|keratolytic agents|mesh-ancestor
101638465|NCT05624996|Dermatologic Agents|dermatologic agents|mesh-ancestor
101638467|NCT05612594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101638468|NCT05612594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638469|NCT05612594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101638470|NCT05612594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638472|NCT05597462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101638473|NCT05597462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101638474|NCT05574101|Cemiplimab|cemiplimab|mesh-list
101638475|NCT05574101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101638476|NCT05574101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101638477|NCT05484687|Anesthetics|anesthetics|mesh-list
101638478|NCT05484687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101638479|NCT05484687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638480|NCT05480384|Nivolumab|nivolumab|mesh-list
101638481|NCT05480384|Trastuzumab|trastuzumab|mesh-list
101638482|NCT05480384|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
101638483|NCT05480384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101638484|NCT05480384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101638485|NCT05480384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101638486|NCT05480384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638487|NCT05480384|Immunoconjugates|immunoconjugates|mesh-ancestor
101638488|NCT05480384|Immunologic Factors|immunologic factors|mesh-ancestor
101638489|NCT05480384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638490|NCT05469412|Midazolam|midazolam|mesh-list
101638491|NCT05469412|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101638492|NCT05469412|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101638493|NCT05469412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101638494|NCT05469412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638495|NCT05469412|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101638496|NCT05469412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101638497|NCT05469412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101638498|NCT05469412|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101638499|NCT05469412|Anesthetics, General|anesthetics, general|mesh-ancestor
101638500|NCT05469412|Anesthetics|anesthetics|mesh-ancestor
101638501|NCT05469412|GABA Modulators|gaba modulators|mesh-ancestor
101638502|NCT05469412|GABA Agents|gaba agents|mesh-ancestor
101638503|NCT05469412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101638504|NCT05469412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638523|NCT05440708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101638524|NCT05440708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101638525|NCT05440708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101638526|NCT05440708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101638527|NCT05440708|Growth Substances|growth substances|mesh-ancestor
101638528|NCT05440708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638529|NCT05440708|Growth Inhibitors|growth inhibitors|mesh-ancestor
101638530|NCT05440708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101638531|NCT05440708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638532|NCT05438602|Ritonavir|ritonavir|mesh-list
101638533|NCT05438602|Nirmatrelvir|nirmatrelvir|mesh-list
101638534|NCT05438602|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101638535|NCT05438602|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101638536|NCT05438602|Protease Inhibitors|protease inhibitors|mesh-ancestor
101638537|NCT05438602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101638538|NCT05438602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638539|NCT05438602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101638540|NCT05438602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101638541|NCT05438602|Antiviral Agents|antiviral agents|mesh-ancestor
101638542|NCT05438602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101638543|NCT05438602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101638544|NCT05438602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101638545|NCT05408845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101638546|NCT05408845|Trastuzumab|trastuzumab|mesh-list
101638547|NCT05408845|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101638548|NCT05408845|Docetaxel|docetaxel|mesh-list
101638549|NCT05408845|Maytansine|maytansine|mesh-list
101638550|NCT05408845|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
101638551|NCT05408845|Antibodies|antibodies|mesh-list
101638552|NCT05408845|Immunoglobulins|immunoglobulins|mesh-list
101638553|NCT05408845|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101638554|NCT05408845|Immunoconjugates|immunoconjugates|mesh-list
101638555|NCT05408845|Immunologic Factors|immunologic factors|mesh-ancestor
101638556|NCT05408845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638557|NCT05408845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101638558|NCT05408845|Tubulin Modulators|tubulin modulators|mesh-ancestor
101638559|NCT05408845|Antimitotic Agents|antimitotic agents|mesh-ancestor
101638560|NCT05408845|Mitosis Modulators|mitosis modulators|mesh-ancestor
101638561|NCT05408845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638562|NCT05408845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101638563|NCT05408845|Immunotoxins|immunotoxins|mesh-ancestor
101638564|NCT05343455|Doxycycline|doxycycline|mesh-list
101638565|NCT05343455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101638566|NCT05343455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101638567|NCT05343455|Antimalarials|antimalarials|mesh-ancestor
101638568|NCT05343455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101638569|NCT05343455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101638570|NCT05327686|Pembrolizumab|pembrolizumab|mesh-list
101638571|NCT05327686|Nivolumab|nivolumab|mesh-list
101638572|NCT05327686|Ipilimumab|ipilimumab|mesh-list
101638573|NCT05327686|Avelumab|avelumab|mesh-list
101638574|NCT05327686|Lenvatinib|lenvatinib|mesh-list
101638575|NCT05327686|Axitinib|axitinib|mesh-list
101638576|NCT05327686|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101638577|NCT05327686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101638578|NCT05327686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101638579|NCT05327686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101638580|NCT05327686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638581|NCT05327686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101638582|NCT05327686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101638583|NCT05327686|Immunologic Factors|immunologic factors|mesh-ancestor
101638584|NCT05327686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638595|NCT05303324|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
101638597|NCT05303324|Lipotropic Agents|lipotropic agents|mesh-ancestor
101638598|NCT05303324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101638599|NCT05303324|Antimetabolites|antimetabolites|mesh-ancestor
101638600|NCT05303324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638601|NCT05303324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101638602|NCT05303324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101638603|NCT05303324|Nootropic Agents|nootropic agents|mesh-ancestor
101638604|NCT05303324|Chelating Agents|chelating agents|mesh-ancestor
101638605|NCT05303324|Sequestering Agents|sequestering agents|mesh-ancestor
101638606|NCT05303324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101638607|NCT05303324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101638608|NCT05303324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101638609|NCT05303324|Growth Substances|growth substances|mesh-ancestor
101638610|NCT05303324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638611|NCT05303324|Growth Inhibitors|growth inhibitors|mesh-ancestor
101638612|NCT05303324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101638613|NCT05238207|Psyllium|psyllium|mesh-list
101638614|NCT05238207|Cathartics|cathartics|mesh-ancestor
101638615|NCT05238207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101638616|NCT05238025|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
101638617|NCT05238025|Antiviral Agents|antiviral agents|mesh-ancestor
101638618|NCT05238025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101638619|NCT05213104|Flecainide|flecainide|mesh-list
101638620|NCT05213104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101638621|NCT05213104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101638622|NCT05213104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101638623|NCT05213104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101638624|NCT05213104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638626|NCT05203172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101638627|NCT05203172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101638628|NCT05195177|Anesthetics|anesthetics|mesh-list
101638629|NCT05195177|Anesthetics, Local|anesthetics, local|mesh-list
101638630|NCT05195177|Histamine|histamine|mesh-list
101638631|NCT05195177|Histamine Antagonists|histamine antagonists|mesh-list
101638632|NCT05195177|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
101638633|NCT05195177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101638634|NCT05195177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638635|NCT05195177|Sensory System Agents|sensory system agents|mesh-ancestor
101638636|NCT05195177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101638637|NCT05195177|Histamine Agonists|histamine agonists|mesh-ancestor
101638638|NCT05195177|Histamine Agents|histamine agents|mesh-ancestor
101638639|NCT05195177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101638640|NCT05195177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638641|NCT05165433|Pembrolizumab|pembrolizumab|mesh-list
101638642|NCT05165433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101638643|NCT05165433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101638644|NCT05165433|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101638645|NCT05165433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638646|NCT05150431|Parecoxib|parecoxib|mesh-list
101638647|NCT05150431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101638648|NCT05150431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101638649|NCT05150431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101638650|NCT05150431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638651|NCT05150431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101638652|NCT05150431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101638653|NCT05150431|Analgesics|analgesics|mesh-ancestor
101638654|NCT05150431|Sensory System Agents|sensory system agents|mesh-ancestor
101638655|NCT05150431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101638656|NCT05150431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638657|NCT05150431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101638658|NCT05150431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101638659|NCT05141006|Botulinum Toxins|botulinum toxins|mesh-list
101638660|NCT05141006|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101638661|NCT05141006|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101638662|NCT05141006|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101638663|NCT05141006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101638664|NCT05141006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638665|NCT05141006|Cholinergic Agents|cholinergic agents|mesh-ancestor
101638666|NCT05141006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101638667|NCT05141006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638668|NCT05141006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101638669|NCT05141006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101638670|NCT05077527|Cyclophosphamide|cyclophosphamide|mesh-list
101638671|NCT05077527|Fludarabine|fludarabine|mesh-list
101638672|NCT05077527|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
101638673|NCT05077527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101638674|NCT05077527|Immunologic Factors|immunologic factors|mesh-ancestor
101638675|NCT05077527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638676|NCT05077527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101638677|NCT05077527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101638678|NCT05077527|Alkylating Agents|alkylating agents|mesh-ancestor
101638679|NCT05077527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638680|NCT05077527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101638681|NCT05077527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101638682|NCT05077527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101638684|NCT05074810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101638685|NCT05074810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638686|NCT05074810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101638687|NCT05074810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101638688|NCT05055323|Pyrvinium|pyrvinium|mesh-list
101638689|NCT05055323|Anthelmintics|anthelmintics|mesh-ancestor
101638690|NCT05055323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101638691|NCT05055323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101638692|NCT05053152|Relugolix|relugolix|mesh-list
101638693|NCT05053152|Androgen Antagonists|androgen antagonists|mesh-ancestor
101638694|NCT05053152|Hormone Antagonists|hormone antagonists|mesh-ancestor
101638695|NCT05053152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101638696|NCT05053152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638711|NCT05050084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101638712|NCT05050084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638713|NCT05050084|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101638714|NCT05050084|Fertility Agents|fertility agents|mesh-ancestor
101638715|NCT05050084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101638716|NCT05050084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101638717|NCT05050084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101638718|NCT05050084|Androgen Antagonists|androgen antagonists|mesh-ancestor
101638719|NCT05050084|Hormone Antagonists|hormone antagonists|mesh-ancestor
101638720|NCT05050084|Luteolytic Agents|luteolytic agents|mesh-ancestor
101638721|NCT05050084|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101638722|NCT05050084|Contraceptive Agents|contraceptive agents|mesh-ancestor
101638723|NCT05050084|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101638724|NCT05050084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101638725|NCT05050084|Antidepressive Agents|antidepressive agents|mesh-ancestor
101638726|NCT05050084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101638727|NCT05045066|Vitamin D|vitamin d|mesh-list
101638728|NCT05045066|Cholecalciferol|cholecalciferol|mesh-list
101638729|NCT05045066|Vitamins|vitamins|mesh-ancestor
101638730|NCT05045066|Micronutrients|micronutrients|mesh-ancestor
101638731|NCT05045066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638732|NCT05045066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101638733|NCT05045066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101638791|NCT04947501|Immunologic Factors|immunologic factors|mesh-ancestor
101638792|NCT04947501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388149|NCT06000917|Paclitaxel|paclitaxel|mesh-list
101638794|NCT04947501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101638795|NCT04947501|Alkylating Agents|alkylating agents|mesh-ancestor
101638796|NCT04947501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638797|NCT04947501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101638798|NCT04947501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101638799|NCT04947501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101638800|NCT04947501|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101638801|NCT04947501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101638802|NCT04947501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101638803|NCT04947501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101638804|NCT04947501|Tubulin Modulators|tubulin modulators|mesh-ancestor
101638805|NCT04947501|Antimitotic Agents|antimitotic agents|mesh-ancestor
101638806|NCT04947501|Mitosis Modulators|mitosis modulators|mesh-ancestor
101638807|NCT04947501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101638808|NCT04909853|Ritonavir|ritonavir|mesh-list
101638809|NCT04909853|Nirmatrelvir|nirmatrelvir|mesh-list
101638810|NCT04909853|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101638811|NCT04909853|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101638812|NCT04909853|Protease Inhibitors|protease inhibitors|mesh-ancestor
101638813|NCT04909853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101638814|NCT04909853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638815|NCT04909853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101638816|NCT04909853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101638817|NCT04909853|Antiviral Agents|antiviral agents|mesh-ancestor
101638818|NCT04909853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101730745|NCT00819988|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101638839|NCT04852887|Hormone Antagonists|hormone antagonists|mesh-ancestor
101638840|NCT04852887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101638841|NCT04852887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638842|NCT04852887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101638843|NCT04852887|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101638844|NCT04852887|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101638845|NCT04852887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101638852|NCT04804644|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101638853|NCT04804644|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101638854|NCT04804644|Dopamine Agents|dopamine agents|mesh-ancestor
101638855|NCT04804644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101638856|NCT04804644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638857|NCT04804644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638858|NCT04804644|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101638859|NCT04804644|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101638860|NCT04786548|Celecoxib|celecoxib|mesh-list
101638861|NCT04786548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101638862|NCT04786548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101638863|NCT04786548|Analgesics|analgesics|mesh-ancestor
101638864|NCT04786548|Sensory System Agents|sensory system agents|mesh-ancestor
101638865|NCT04786548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101638866|NCT04786548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638867|NCT04786548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101638868|NCT04786548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101638869|NCT04786548|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101638870|NCT04786548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101638871|NCT04786548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101638872|NCT04786548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638873|NCT04773353|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101638874|NCT04773353|Hormones|hormones|mesh-ancestor
101638875|NCT04773353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101730832|NCT05572476|Etoposide|etoposide|mesh-list
101638876|NCT04773353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638877|NCT04733534|Dasatinib|dasatinib|mesh-list
101638878|NCT04733534|Quercetin|quercetin|mesh-list
101638879|NCT04733534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101638880|NCT04733534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101638881|NCT04733534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101638882|NCT04733534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638883|NCT04733534|Antioxidants|antioxidants|mesh-ancestor
101638884|NCT04733534|Protective Agents|protective agents|mesh-ancestor
101638885|NCT04733534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638886|NCT04727307|Bevacizumab|bevacizumab|mesh-list
101638887|NCT04727307|Atezolizumab|atezolizumab|mesh-list
101638889|NCT04727307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101638890|NCT04727307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101638891|NCT04727307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101638892|NCT04727307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101638893|NCT04727307|Growth Substances|growth substances|mesh-ancestor
101638894|NCT04727307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638895|NCT04727307|Growth Inhibitors|growth inhibitors|mesh-ancestor
101638896|NCT04727307|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101638897|NCT04727307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638898|NCT04727307|Immunologic Factors|immunologic factors|mesh-ancestor
101638900|NCT04683939|Gemcitabine|gemcitabine|mesh-list
101638901|NCT04683939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101638902|NCT04683939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101638903|NCT04683939|Tubulin Modulators|tubulin modulators|mesh-ancestor
101638904|NCT04683939|Antimitotic Agents|antimitotic agents|mesh-ancestor
101638905|NCT04683939|Mitosis Modulators|mitosis modulators|mesh-ancestor
101730876|NCT00823030|Anesthetics, Local|anesthetics, local|mesh-ancestor
101638906|NCT04683939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638907|NCT04683939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101638908|NCT04683939|Antimetabolites|antimetabolites|mesh-ancestor
101638909|NCT04680598|Antiviral Agents|antiviral agents|mesh-list
101638910|NCT04680598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101638911|NCT04669002|Olaparib|olaparib|mesh-list
101638912|NCT04669002|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101638913|NCT04669002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101638914|NCT04669002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638915|NCT04669002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101638916|NCT04640493|Dapagliflozin|dapagliflozin|mesh-list
101638917|NCT04640493|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101638918|NCT04640493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638919|NCT04640493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101638920|NCT04640493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638921|NCT04622319|Trastuzumab|trastuzumab|mesh-list
101638922|NCT04622319|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101638923|NCT04622319|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
101638924|NCT04622319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101638925|NCT04622319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101638926|NCT04622319|Tubulin Modulators|tubulin modulators|mesh-ancestor
101638927|NCT04622319|Antimitotic Agents|antimitotic agents|mesh-ancestor
101638928|NCT04622319|Mitosis Modulators|mitosis modulators|mesh-ancestor
101638929|NCT04622319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638930|NCT04622319|Immunotoxins|immunotoxins|mesh-ancestor
101638931|NCT04622319|Immunoconjugates|immunoconjugates|mesh-ancestor
101638932|NCT04622319|Immunologic Factors|immunologic factors|mesh-ancestor
101638933|NCT04622319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638934|NCT04607421|Leucovorin|leucovorin|mesh-list
101638935|NCT04607421|Bevacizumab|bevacizumab|mesh-list
101638936|NCT04607421|Cetuximab|cetuximab|mesh-list
101638937|NCT04607421|Fluorouracil|fluorouracil|mesh-list
101638938|NCT04607421|Capecitabine|capecitabine|mesh-list
101638939|NCT04607421|Oxaliplatin|oxaliplatin|mesh-list
101638940|NCT04607421|Irinotecan|irinotecan|mesh-list
101638941|NCT04607421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101638942|NCT04607421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101638943|NCT04607421|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101638944|NCT04607421|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101638945|NCT04607421|Growth Substances|growth substances|mesh-ancestor
101638946|NCT04607421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638947|NCT04607421|Growth Inhibitors|growth inhibitors|mesh-ancestor
101638948|NCT04607421|Antimetabolites|antimetabolites|mesh-ancestor
101638949|NCT04607421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638950|NCT04607421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101638951|NCT04607421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101638952|NCT04607421|Immunologic Factors|immunologic factors|mesh-ancestor
101638953|NCT04607421|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101638954|NCT04607421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101638955|NCT04607421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101638956|NCT04607421|Antidotes|antidotes|mesh-ancestor
101638957|NCT04607421|Protective Agents|protective agents|mesh-ancestor
101638958|NCT04607421|Vitamin B Complex|vitamin b complex|mesh-ancestor
101638959|NCT04607421|Vitamins|vitamins|mesh-ancestor
101638960|NCT04607421|Micronutrients|micronutrients|mesh-ancestor
101638961|NCT04590963|Cetuximab|cetuximab|mesh-list
101638962|NCT04590963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101638963|NCT04590963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101638964|NCT04588246|Memantine|memantine|mesh-list
101638965|NCT04588246|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101638966|NCT04588246|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101638974|NCT04528173|Fentanyl|fentanyl|mesh-list
101638975|NCT04528173|Dexmedetomidine|dexmedetomidine|mesh-list
101638976|NCT04528173|Morphine|morphine|mesh-list
101638977|NCT04528173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101638978|NCT04528173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101638979|NCT04528173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101638980|NCT04528173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101638981|NCT04528173|Analgesics|analgesics|mesh-ancestor
101638982|NCT04528173|Sensory System Agents|sensory system agents|mesh-ancestor
101638983|NCT04528173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101638984|NCT04528173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101638985|NCT04528173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101638986|NCT04528173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101638987|NCT04528173|Adrenergic Agents|adrenergic agents|mesh-ancestor
101638988|NCT04528173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101638989|NCT04528173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101638990|NCT04528173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101638991|NCT04528173|Narcotics|narcotics|mesh-ancestor
101638992|NCT04528173|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101638993|NCT04528173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101638994|NCT04528173|Anesthetics, General|anesthetics, general|mesh-ancestor
101638995|NCT04528173|Anesthetics|anesthetics|mesh-ancestor
101638996|NCT04528173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101638997|NCT04528173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101638998|NCT04528173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101638999|NCT04528173|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101639000|NCT04528173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101639008|NCT04519944|Edoxaban|edoxaban|mesh-list
101639009|NCT04519944|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101639010|NCT04519944|Antithrombins|antithrombins|mesh-ancestor
101639011|NCT04519944|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101639012|NCT04519944|Protease Inhibitors|protease inhibitors|mesh-ancestor
101639013|NCT04519944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101639014|NCT04519944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639015|NCT04519944|Anticoagulants|anticoagulants|mesh-ancestor
101639016|NCT04513717|Leuprolide|leuprolide|mesh-list
101639017|NCT04513717|Goserelin|goserelin|mesh-list
101639018|NCT04513717|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101639019|NCT04513717|Flutamide|flutamide|mesh-list
101639020|NCT04513717|Bicalutamide|bicalutamide|mesh-list
101639021|NCT04513717|Tryptophan|tryptophan|mesh-list
101639022|NCT04513717|Buserelin|buserelin|mesh-list
101639023|NCT04513717|Hormones|hormones|mesh-list
101639024|NCT04513717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101639025|NCT04513717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639026|NCT04513717|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101639027|NCT04513717|Fertility Agents|fertility agents|mesh-ancestor
101639028|NCT04513717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101639029|NCT04513717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101639030|NCT04513717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639031|NCT04513717|Androgen Antagonists|androgen antagonists|mesh-ancestor
101639032|NCT04513717|Hormone Antagonists|hormone antagonists|mesh-ancestor
101639033|NCT04513717|Luteolytic Agents|luteolytic agents|mesh-ancestor
101730996|NCT00828802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101639034|NCT04513717|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101639035|NCT04513717|Contraceptive Agents|contraceptive agents|mesh-ancestor
101639036|NCT04513717|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101639037|NCT04513717|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101639038|NCT04513717|Antidepressive Agents|antidepressive agents|mesh-ancestor
101639039|NCT04513717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101639041|NCT04494425|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101639042|NCT04494425|Capecitabine|capecitabine|mesh-list
101639043|NCT04494425|Trastuzumab|trastuzumab|mesh-list
101639044|NCT04494425|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
101639055|NCT04494425|Immunologic Factors|immunologic factors|mesh-ancestor
101639056|NCT04494425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639057|NCT04454437|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
101639058|NCT04454437|Immunoconjugates|immunoconjugates|mesh-ancestor
101296145|NCT01989611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101639059|NCT04454437|Immunologic Factors|immunologic factors|mesh-ancestor
101639060|NCT04454437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639072|NCT04430452|Durvalumab|durvalumab|mesh-list
101639073|NCT04430452|Ipilimumab|ipilimumab|mesh-list
101639074|NCT04430452|Tremelimumab|tremelimumab|mesh-list
101639075|NCT04430452|Immunoglobulins|immunoglobulins|mesh-list
101639076|NCT04430452|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101639077|NCT04430452|Immunoglobulin G|immunoglobulin g|mesh-list
101639078|NCT04430452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101639079|NCT04430452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639080|NCT04430452|Immunologic Factors|immunologic factors|mesh-ancestor
101639081|NCT04430452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639082|NCT04430452|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101639083|NCT04430452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639084|NCT04353661|Azithromycin|azithromycin|mesh-list
101639085|NCT04353661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101639086|NCT04353661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101639087|NCT04321330|Atezolizumab|atezolizumab|mesh-list
101639088|NCT04321330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101639089|NCT04321330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639090|NCT04321330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101639091|NCT04321330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639092|NCT04251533|Paclitaxel|paclitaxel|mesh-list
101639093|NCT04251533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101639094|NCT04251533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101731036|NCT04105023|Genistein|genistein|mesh-list
101639095|NCT04251533|Tubulin Modulators|tubulin modulators|mesh-ancestor
101639096|NCT04251533|Antimitotic Agents|antimitotic agents|mesh-ancestor
101639097|NCT04251533|Mitosis Modulators|mitosis modulators|mesh-ancestor
101363838|NCT00134212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101639098|NCT04251533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639099|NCT04218539|Psilocybin|psilocybin|mesh-list
101639100|NCT04218539|Hallucinogens|hallucinogens|mesh-ancestor
101639101|NCT04218539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639103|NCT04158141|Cisplatin|cisplatin|mesh-list
101639104|NCT04158141|Carboplatin|carboplatin|mesh-list
101639105|NCT04158141|Pemetrexed|pemetrexed|mesh-list
101639106|NCT04158141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639107|NCT04158141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101639108|NCT04158141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639109|NCT04158141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101639110|NCT04158141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101639111|NCT04154982|Acetylcysteine|acetylcysteine|mesh-list
101639112|NCT04154982|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101639113|NCT04154982|Antiviral Agents|antiviral agents|mesh-ancestor
101639114|NCT04154982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101639115|NCT04154982|Expectorants|expectorants|mesh-ancestor
101639116|NCT04154982|Respiratory System Agents|respiratory system agents|mesh-ancestor
101639117|NCT04154982|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101639118|NCT04154982|Antioxidants|antioxidants|mesh-ancestor
101639119|NCT04154982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639121|NCT04154982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639122|NCT04154982|Antidotes|antidotes|mesh-ancestor
101639123|NCT04145258|Aspirin|aspirin|mesh-list
101639124|NCT04145258|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101639125|NCT04145258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101639126|NCT04145258|Analgesics|analgesics|mesh-ancestor
101639127|NCT04145258|Sensory System Agents|sensory system agents|mesh-ancestor
101639128|NCT04145258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101639129|NCT04145258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639130|NCT04145258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101639131|NCT04145258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101639132|NCT04145258|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101639133|NCT04145258|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101639134|NCT04145258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639135|NCT04145258|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101639136|NCT04145258|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101639137|NCT04145258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101639139|NCT04134260|Hormones|hormones|mesh-list
101639140|NCT04134260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101639141|NCT04134260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639142|NCT04113616|Cytarabine|cytarabine|mesh-list
101639143|NCT04113616|Decitabine|decitabine|mesh-list
101639144|NCT04113616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101731068|NCT02550262|Fentanyl|fentanyl|mesh-list
101639145|NCT04113616|Antimetabolites|antimetabolites|mesh-ancestor
101639146|NCT04113616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639147|NCT04113616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639148|NCT04113616|Antiviral Agents|antiviral agents|mesh-ancestor
101639149|NCT04113616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101639150|NCT04113616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101639151|NCT04113616|Immunologic Factors|immunologic factors|mesh-ancestor
101639152|NCT04113616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639153|NCT04113616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101639154|NCT04075747|Venetoclax|venetoclax|mesh-list
101639155|NCT04075747|Midostaurin|midostaurin|mesh-list
101639156|NCT04075747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639157|NCT04075747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101639158|NCT04075747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101639159|NCT04075747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639160|NCT04068103|Calcium, Dietary|calcium, dietary|mesh-list
101639161|NCT04068103|Leucovorin|leucovorin|mesh-list
101639162|NCT04068103|Folic Acid|folic acid|mesh-list
101639163|NCT04068103|Fluorouracil|fluorouracil|mesh-list
101639164|NCT04068103|Capecitabine|capecitabine|mesh-list
101639165|NCT04068103|Oxaliplatin|oxaliplatin|mesh-list
101639166|NCT04068103|Calcium|calcium|mesh-list
101639167|NCT04068103|Levoleucovorin|levoleucovorin|mesh-list
101639169|NCT04068103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639170|NCT04068103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101639171|NCT04068103|Antimetabolites|antimetabolites|mesh-ancestor
101639172|NCT04068103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639173|NCT04068103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101639174|NCT04068103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639175|NCT04068103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101639176|NCT04068103|Immunologic Factors|immunologic factors|mesh-ancestor
101639177|NCT04068103|Antidotes|antidotes|mesh-ancestor
101639178|NCT04068103|Protective Agents|protective agents|mesh-ancestor
101639179|NCT04068103|Vitamin B Complex|vitamin b complex|mesh-ancestor
101639180|NCT04068103|Vitamins|vitamins|mesh-ancestor
101639181|NCT04068103|Micronutrients|micronutrients|mesh-ancestor
101639182|NCT04068103|Hematinics|hematinics|mesh-ancestor
101639183|NCT04040231|Nivolumab|nivolumab|mesh-list
101639184|NCT04040231|Sargramostim|sargramostim|mesh-list
101639185|NCT04040231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101639186|NCT04040231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639187|NCT04040231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101639188|NCT04040231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639189|NCT04040231|Immunologic Factors|immunologic factors|mesh-ancestor
101639190|NCT04040231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639191|NCT04037254|Niraparib|niraparib|mesh-list
101639192|NCT04037254|Hormones|hormones|mesh-list
101639193|NCT04037254|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101639194|NCT04037254|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101731094|NCT00829114|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101639196|NCT04037254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639197|NCT04037254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101639198|NCT04037254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101639199|NCT04037254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639200|NCT04037254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639201|NCT04035486|Carboplatin|carboplatin|mesh-list
101639202|NCT04035486|Pemetrexed|pemetrexed|mesh-list
101639203|NCT04035486|Osimertinib|osimertinib|mesh-list
101639204|NCT04035486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639205|NCT04035486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101639206|NCT04035486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639207|NCT04035486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101639208|NCT04035486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101639209|NCT04035486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101639210|NCT04026256|Denosumab|denosumab|mesh-list
101639211|NCT04026256|Teriparatide|teriparatide|mesh-list
101639212|NCT04026256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101639213|NCT04026256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639214|NCT04026256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101639215|NCT04012138|Insulin|insulin|mesh-list
101639216|NCT04012138|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101639217|NCT04012138|Insulin Aspart|insulin aspart|mesh-list
101639218|NCT04012138|Albuterol|albuterol|mesh-list
101639219|NCT04012138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101639220|NCT04012138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639221|NCT04012138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101639222|NCT04012138|Autonomic Agents|autonomic agents|mesh-ancestor
101639223|NCT04012138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101639224|NCT04012138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101639225|NCT04012138|Respiratory System Agents|respiratory system agents|mesh-ancestor
101639226|NCT04012138|Tocolytic Agents|tocolytic agents|mesh-ancestor
101639227|NCT04012138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101639228|NCT04012138|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101639229|NCT04012138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101639230|NCT04012138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101639231|NCT04012138|Adrenergic Agents|adrenergic agents|mesh-ancestor
101639232|NCT04012138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101639233|NCT04012138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639234|NCT03928288|Cabergoline|cabergoline|mesh-list
101639235|NCT03928288|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101639236|NCT03928288|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101639237|NCT03928288|Dopamine Agonists|dopamine agonists|mesh-ancestor
101639238|NCT03928288|Dopamine Agents|dopamine agents|mesh-ancestor
101639239|NCT03928288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101639240|NCT03928288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639241|NCT03928288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639242|NCT03880019|Temozolomide|temozolomide|mesh-list
101639244|NCT03880019|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
101639245|NCT03880019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101639246|NCT03880019|Alkylating Agents|alkylating agents|mesh-ancestor
101639247|NCT03880019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639248|NCT03880019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639249|NCT03880019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101639252|NCT03801876|Paclitaxel|paclitaxel|mesh-list
101639253|NCT03801876|Docetaxel|docetaxel|mesh-list
101639254|NCT03801876|Carboplatin|carboplatin|mesh-list
101639255|NCT03801876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101639256|NCT03801876|Fluorouracil|fluorouracil|mesh-list
101639257|NCT03801876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101639258|NCT03801876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639259|NCT03801876|Tubulin Modulators|tubulin modulators|mesh-ancestor
101639260|NCT03801876|Antimitotic Agents|antimitotic agents|mesh-ancestor
101639261|NCT03801876|Mitosis Modulators|mitosis modulators|mesh-ancestor
101639262|NCT03801876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639263|NCT03801876|Antimetabolites|antimetabolites|mesh-ancestor
101639264|NCT03801876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101639265|NCT03801876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101639266|NCT03801876|Immunologic Factors|immunologic factors|mesh-ancestor
101639267|NCT03801876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639268|NCT03789604|Antibodies|antibodies|mesh-list
101639269|NCT03789604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101639270|NCT03789604|Immunologic Factors|immunologic factors|mesh-ancestor
101639271|NCT03789604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639272|NCT03767348|Nivolumab|nivolumab|mesh-list
101639273|NCT03767348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101639274|NCT03767348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639275|NCT03767348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101639276|NCT03767348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639277|NCT03735875|Venetoclax|venetoclax|mesh-list
101639278|NCT03735875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639279|NCT03735420|Xanthohumol|xanthohumol|mesh-list
101639280|NCT03735420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639281|NCT03735420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101639282|NCT03735420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101639283|NCT03735420|Growth Substances|growth substances|mesh-ancestor
101731163|NCT00915564|Protease Inhibitors|protease inhibitors|mesh-ancestor
101639284|NCT03735420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639285|NCT03735420|Growth Inhibitors|growth inhibitors|mesh-ancestor
101639286|NCT03715933|Carboplatin|carboplatin|mesh-list
101639287|NCT03715933|Fluorouracil|fluorouracil|mesh-list
101639288|NCT03715933|Irinotecan|irinotecan|mesh-list
101639289|NCT03715933|Pemetrexed|pemetrexed|mesh-list
101639291|NCT03715933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639292|NCT03715933|Antimetabolites|antimetabolites|mesh-ancestor
101639293|NCT03715933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639294|NCT03715933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101639295|NCT03715933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101639296|NCT03715933|Immunologic Factors|immunologic factors|mesh-ancestor
101639297|NCT03715933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639298|NCT03715933|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101639299|NCT03715933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101639300|NCT03715933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101639301|NCT03715933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101639302|NCT03715933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101639303|NCT03715933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101639304|NCT03715933|Alkylating Agents|alkylating agents|mesh-ancestor
101639305|NCT03662074|Gemcitabine|gemcitabine|mesh-list
101639306|NCT03662074|Nivolumab|nivolumab|mesh-list
101639307|NCT03662074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101639308|NCT03662074|Antimetabolites|antimetabolites|mesh-ancestor
101639309|NCT03662074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639310|NCT03662074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639311|NCT03662074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101639312|NCT03662074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101639313|NCT03602859|Niraparib|niraparib|mesh-list
101639314|NCT03602859|Dostarlimab|dostarlimab|mesh-list
101639315|NCT03602859|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101639316|NCT03602859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101639317|NCT03602859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639318|NCT03602859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639319|NCT03573401|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101639320|NCT03573401|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101639321|NCT03573401|Dermatologic Agents|dermatologic agents|mesh-ancestor
101639322|NCT03542175|Rucaparib|rucaparib|mesh-list
101639323|NCT03542175|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101639324|NCT03542175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101639325|NCT03542175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639326|NCT03542175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639327|NCT03519230|Pamiparib|pamiparib|mesh-list
101639328|NCT03519230|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101639329|NCT03519230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101639330|NCT03519230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639331|NCT03519230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639332|NCT03505762|Prednisone|prednisone|mesh-list
101639333|NCT03505762|Cortisone|cortisone|mesh-list
101639334|NCT03505762|Cyclophosphamide|cyclophosphamide|mesh-list
101639335|NCT03505762|Rituximab|rituximab|mesh-list
101639336|NCT03505762|Doxorubicin|doxorubicin|mesh-list
101639337|NCT03505762|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101639338|NCT03505762|Vincristine|vincristine|mesh-list
101639339|NCT03505762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101639340|NCT03505762|Antibodies|antibodies|mesh-list
101639341|NCT03505762|Immunoglobulins|immunoglobulins|mesh-list
101639342|NCT03505762|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101639343|NCT03505762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101639344|NCT03505762|Immunologic Factors|immunologic factors|mesh-ancestor
101639345|NCT03505762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639346|NCT03505762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101639347|NCT03505762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101639349|NCT03505762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639350|NCT03505762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639351|NCT03505762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101639352|NCT03505762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101639353|NCT03505762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101639354|NCT03505762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101639355|NCT03505762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101639356|NCT03505762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101639357|NCT03505762|Glucocorticoids|glucocorticoids|mesh-ancestor
101639358|NCT03505762|Hormones|hormones|mesh-ancestor
101639359|NCT03505762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101639360|NCT03505762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101639361|NCT03505762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101639362|NCT03505762|Tubulin Modulators|tubulin modulators|mesh-ancestor
101639363|NCT03505762|Antimitotic Agents|antimitotic agents|mesh-ancestor
101639364|NCT03505762|Mitosis Modulators|mitosis modulators|mesh-ancestor
101639365|NCT03483038|Irinotecan|irinotecan|mesh-list
101639366|NCT03483038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101639367|NCT03483038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101639368|NCT03483038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101639369|NCT03483038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639370|NCT03483038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639371|NCT03439046|Letrozole|letrozole|mesh-list
101639372|NCT03439046|Fulvestrant|fulvestrant|mesh-list
101639373|NCT03439046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639374|NCT03439046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101639375|NCT03439046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101639376|NCT03439046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101639377|NCT03439046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639378|NCT03439046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101639379|NCT03439046|Hormone Antagonists|hormone antagonists|mesh-ancestor
101646174|NCT02582476|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101639383|NCT03439046|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101639388|NCT03406156|Venetoclax|venetoclax|mesh-list
101639389|NCT03406156|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101639390|NCT03406156|Obinutuzumab|obinutuzumab|mesh-list
101639391|NCT03406156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639392|NCT03406156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101639393|NCT03406156|Alkylating Agents|alkylating agents|mesh-ancestor
101639394|NCT03406156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639395|NCT03406156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101639396|NCT03402503|Montelukast|montelukast|mesh-list
101639397|NCT03402503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101639398|NCT03402503|Respiratory System Agents|respiratory system agents|mesh-ancestor
101639399|NCT03402503|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101639400|NCT03402503|Hormone Antagonists|hormone antagonists|mesh-ancestor
101639401|NCT03402503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101639402|NCT03402503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639403|NCT03402503|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101639404|NCT03402503|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101639405|NCT03402503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639406|NCT03395197|Talazoparib|talazoparib|mesh-list
101639407|NCT03395197|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101639408|NCT03395197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101639409|NCT03395197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639410|NCT03395197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639411|NCT03389412|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101639412|NCT03389412|Hemostatics|hemostatics|mesh-ancestor
101639413|NCT03389412|Coagulants|coagulants|mesh-ancestor
101639414|NCT03389412|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101639415|NCT03389412|Natriuretic Agents|natriuretic agents|mesh-ancestor
101639416|NCT03389412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639418|NCT03358472|Pembrolizumab|pembrolizumab|mesh-list
101639419|NCT03358472|Fluorouracil|fluorouracil|mesh-list
101639420|NCT03358472|Cetuximab|cetuximab|mesh-list
101639421|NCT03358472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639422|NCT03358472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101639423|NCT03358472|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101639424|NCT03358472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639425|NCT03358472|Antimetabolites|antimetabolites|mesh-ancestor
101639426|NCT03358472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101639427|NCT03358472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101639428|NCT03358472|Immunologic Factors|immunologic factors|mesh-ancestor
101639429|NCT03358472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639430|NCT03327805|Choline|choline|mesh-list
101639431|NCT03327805|Lipotropic Agents|lipotropic agents|mesh-ancestor
101639432|NCT03327805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101639433|NCT03327805|Antimetabolites|antimetabolites|mesh-ancestor
101639434|NCT03327805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639435|NCT03327805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101639436|NCT03327805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101639437|NCT03327805|Nootropic Agents|nootropic agents|mesh-ancestor
101639438|NCT03260023|Avelumab|avelumab|mesh-list
101639439|NCT03260023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101639440|NCT03260023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639441|NCT03220477|Pembrolizumab|pembrolizumab|mesh-list
101639442|NCT03220477|Guadecitabine|guadecitabine|mesh-list
101639443|NCT03220477|Mocetinostat|mocetinostat|mesh-list
101639444|NCT03220477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101639445|NCT03220477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639446|NCT03220477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101639447|NCT03220477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639448|NCT03220477|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101639449|NCT03220477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101639450|NCT03220022|Prednisone|prednisone|mesh-list
101639452|NCT03220022|Cyclophosphamide|cyclophosphamide|mesh-list
101639453|NCT03220022|Rituximab|rituximab|mesh-list
101639454|NCT03220022|Doxorubicin|doxorubicin|mesh-list
101639455|NCT03220022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101639456|NCT03220022|Etoposide|etoposide|mesh-list
101639457|NCT03220022|Vincristine|vincristine|mesh-list
101639458|NCT03220022|Etoposide phosphate|etoposide phosphate|mesh-list
101639459|NCT03220022|Podophyllotoxin|podophyllotoxin|mesh-list
101639460|NCT03220022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101639461|NCT03220022|Antibodies|antibodies|mesh-list
101639462|NCT03220022|Immunoglobulins|immunoglobulins|mesh-list
101639463|NCT03220022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101639464|NCT03220022|Lenograstim|lenograstim|mesh-list
101639465|NCT03220022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101639466|NCT03220022|Immunologic Factors|immunologic factors|mesh-ancestor
101639467|NCT03220022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639468|NCT03220022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101639469|NCT03220022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101639470|NCT03220022|Alkylating Agents|alkylating agents|mesh-ancestor
101639471|NCT03220022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639472|NCT03220022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639473|NCT03220022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101639474|NCT03220022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101639475|NCT03220022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101639476|NCT03220022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101639477|NCT03220022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101639478|NCT03220022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101639479|NCT03220022|Glucocorticoids|glucocorticoids|mesh-ancestor
101639480|NCT03220022|Hormones|hormones|mesh-ancestor
101639481|NCT03220022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101639482|NCT03220022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101639483|NCT03220022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101639484|NCT03220022|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101639485|NCT03220022|Tubulin Modulators|tubulin modulators|mesh-ancestor
101639486|NCT03220022|Antimitotic Agents|antimitotic agents|mesh-ancestor
101639487|NCT03220022|Mitosis Modulators|mitosis modulators|mesh-ancestor
101639488|NCT03220022|Keratolytic Agents|keratolytic agents|mesh-ancestor
101639489|NCT03220022|Dermatologic Agents|dermatologic agents|mesh-ancestor
101639490|NCT03212742|Temozolomide|temozolomide|mesh-list
101639491|NCT03212742|Olaparib|olaparib|mesh-list
101639492|NCT03212742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101639493|NCT03212742|Alkylating Agents|alkylating agents|mesh-ancestor
101639494|NCT03212742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639496|NCT03212742|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101639497|NCT03212742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101639498|NCT03212274|Olaparib|olaparib|mesh-list
101639499|NCT03212274|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
101639500|NCT03212274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101639501|NCT03212274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639502|NCT03212274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639503|NCT03131908|Pembrolizumab|pembrolizumab|mesh-list
101639504|NCT03131908|GSK2636771|gsk2636771|mesh-list
101639505|NCT03131908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101639506|NCT03131908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639507|NCT03131908|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101639508|NCT03131908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639509|NCT03131908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101639510|NCT03131908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101639511|NCT03095612|Docetaxel|docetaxel|mesh-list
101639512|NCT03095612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101296588|NCT01992796|Olmesartan|olmesartan|mesh-list
101639513|NCT03095612|Tubulin Modulators|tubulin modulators|mesh-ancestor
101639514|NCT03095612|Antimitotic Agents|antimitotic agents|mesh-ancestor
101639515|NCT03095612|Mitosis Modulators|mitosis modulators|mesh-ancestor
101639516|NCT03095612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639517|NCT03068624|Aldesleukin|aldesleukin|mesh-list
101639518|NCT03068624|Cyclophosphamide|cyclophosphamide|mesh-list
101639519|NCT03068624|Ipilimumab|ipilimumab|mesh-list
101639520|NCT03068624|Interleukin-2|interleukin-2|mesh-list
101639521|NCT03068624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101639522|NCT03068624|Immunologic Factors|immunologic factors|mesh-ancestor
101639523|NCT03068624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639524|NCT03068624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101639525|NCT03068624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101639526|NCT03068624|Alkylating Agents|alkylating agents|mesh-ancestor
101639527|NCT03068624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639528|NCT03068624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639529|NCT03068624|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101639530|NCT03068624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101639531|NCT03068624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101639532|NCT03068624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101639533|NCT03068624|Analgesics|analgesics|mesh-ancestor
101639534|NCT03068624|Sensory System Agents|sensory system agents|mesh-ancestor
101639535|NCT03068624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101639536|NCT03068624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101639537|NCT03068624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101639538|NCT03068624|Antiviral Agents|antiviral agents|mesh-ancestor
101639539|NCT03068624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101639540|NCT03028350|Ifetroban|ifetroban|mesh-list
101639541|NCT03028350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101639542|NCT03025256|Nivolumab|nivolumab|mesh-list
101639543|NCT03025256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101639544|NCT03025256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639545|NCT03025256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101639546|NCT03025256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639548|NCT03017820|Interferons|interferons|mesh-list
101639549|NCT03017820|Interferon-beta|interferon-beta|mesh-list
101639550|NCT03017820|Cyclophosphamide|cyclophosphamide|mesh-list
101639551|NCT03017820|Nivolumab|nivolumab|mesh-list
101639552|NCT03017820|Ipilimumab|ipilimumab|mesh-list
101639553|NCT03017820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101639554|NCT03017820|Immunologic Factors|immunologic factors|mesh-ancestor
101639555|NCT03017820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639556|NCT03017820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101639557|NCT03017820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101639558|NCT03017820|Alkylating Agents|alkylating agents|mesh-ancestor
101639559|NCT03017820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639560|NCT03017820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639561|NCT03017820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101639562|NCT03017820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101639563|NCT03017820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101639564|NCT03017820|Antiviral Agents|antiviral agents|mesh-ancestor
101639565|NCT03017820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101639566|NCT03017820|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101639567|NCT03017820|Trace Elements|trace elements|mesh-ancestor
101639568|NCT03017820|Micronutrients|micronutrients|mesh-ancestor
101639570|NCT03000439|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101639571|NCT03000439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101639572|NCT03000439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101639573|NCT03000439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639574|NCT02918370|Aripiprazole|aripiprazole|mesh-list
101639575|NCT02918370|Antidepressive Agents|antidepressive agents|mesh-ancestor
101639576|NCT02918370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101639577|NCT02918370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101639578|NCT02918370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101639579|NCT02918370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101639580|NCT02918370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639581|NCT02918370|Dopamine Agonists|dopamine agonists|mesh-ancestor
101639582|NCT02918370|Dopamine Agents|dopamine agents|mesh-ancestor
101639583|NCT02918370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101639584|NCT02918370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639585|NCT02918370|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101639586|NCT02918370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101639587|NCT02918370|Serotonin Agents|serotonin agents|mesh-ancestor
101639588|NCT02918370|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101639589|NCT02918370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101639590|NCT02918370|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101639591|NCT02918370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101639592|NCT02914405|Nivolumab|nivolumab|mesh-list
101639593|NCT02914405|Dinutuximab|dinutuximab|mesh-list
101639594|NCT02914405|Immunoglobulins|immunoglobulins|mesh-list
101639595|NCT02914405|Immunoglobulin G|immunoglobulin g|mesh-list
101639596|NCT02914405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101639597|NCT02914405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639598|NCT02914405|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101639599|NCT02914405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639600|NCT02914405|Immunologic Factors|immunologic factors|mesh-ancestor
101639601|NCT02914405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639602|NCT02868567|4-Aminopyridine|4-aminopyridine|mesh-list
101639603|NCT02868567|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101639604|NCT02868567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101639605|NCT02868567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639606|NCT02864394|Docetaxel|docetaxel|mesh-list
101639607|NCT02864394|Pembrolizumab|pembrolizumab|mesh-list
101639608|NCT02864394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639609|NCT02864394|Tubulin Modulators|tubulin modulators|mesh-ancestor
101639610|NCT02864394|Antimitotic Agents|antimitotic agents|mesh-ancestor
101639611|NCT02864394|Mitosis Modulators|mitosis modulators|mesh-ancestor
101639612|NCT02864394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639613|NCT02864394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101639614|NCT02864394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101639615|NCT02861898|Cetuximab|cetuximab|mesh-list
101639616|NCT02861898|Mannitol|mannitol|mesh-list
101639617|NCT02861898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101639618|NCT02861898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639619|NCT02861898|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101639620|NCT02861898|Diuretics|diuretics|mesh-ancestor
101639621|NCT02861898|Natriuretic Agents|natriuretic agents|mesh-ancestor
101639622|NCT02861898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639623|NCT02773030|Dexamethasone|dexamethasone|mesh-list
101639625|NCT02773030|Daratumumab|daratumumab|mesh-list
101639626|NCT02773030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101639627|NCT02773030|Antiemetics|antiemetics|mesh-ancestor
101639628|NCT02773030|Autonomic Agents|autonomic agents|mesh-ancestor
101639629|NCT02773030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101639630|NCT02773030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639631|NCT02773030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101639632|NCT02773030|Glucocorticoids|glucocorticoids|mesh-ancestor
101639633|NCT02773030|Hormones|hormones|mesh-ancestor
101639634|NCT02773030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101639635|NCT02773030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101639636|NCT02773030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639637|NCT02724228|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
101639638|NCT02724228|Natriuretic Agents|natriuretic agents|mesh-ancestor
101639639|NCT02724228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639640|NCT02723955|Paclitaxel|paclitaxel|mesh-list
101639641|NCT02723955|Docetaxel|docetaxel|mesh-list
101639642|NCT02723955|Carboplatin|carboplatin|mesh-list
101639643|NCT02723955|Gemcitabine|gemcitabine|mesh-list
101639644|NCT02723955|Pembrolizumab|pembrolizumab|mesh-list
101639645|NCT02723955|Fluorouracil|fluorouracil|mesh-list
101639646|NCT02723955|Pemetrexed|pemetrexed|mesh-list
101639647|NCT02723955|Dostarlimab|dostarlimab|mesh-list
101639648|NCT02723955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101639649|NCT02723955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639650|NCT02723955|Tubulin Modulators|tubulin modulators|mesh-ancestor
101639651|NCT02723955|Antimitotic Agents|antimitotic agents|mesh-ancestor
101639652|NCT02723955|Mitosis Modulators|mitosis modulators|mesh-ancestor
101639653|NCT02723955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639654|NCT02723955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101639655|NCT02723955|Antimetabolites|antimetabolites|mesh-ancestor
101639656|NCT02723955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101639657|NCT02723955|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101639658|NCT02723955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101639659|NCT02723955|Immunologic Factors|immunologic factors|mesh-ancestor
101639660|NCT02723955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639661|NCT02723955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101639704|NCT02582905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101639706|NCT02566304|Mycophenolic Acid|mycophenolic acid|mesh-list
101639707|NCT02566304|Cyclophosphamide|cyclophosphamide|mesh-list
101639708|NCT02566304|Fludarabine|fludarabine|mesh-list
101639709|NCT02566304|Fludarabine phosphate|fludarabine phosphate|mesh-list
101639710|NCT02566304|Tacrolimus|tacrolimus|mesh-list
101639711|NCT02566304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101639712|NCT02566304|Immunologic Factors|immunologic factors|mesh-ancestor
101639713|NCT02566304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639714|NCT02566304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101639715|NCT02566304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101639716|NCT02566304|Alkylating Agents|alkylating agents|mesh-ancestor
101639717|NCT02566304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639718|NCT02566304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639720|NCT02566304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101639721|NCT02566304|Antimetabolites|antimetabolites|mesh-ancestor
101639722|NCT02566304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101639723|NCT02566304|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101639724|NCT02566304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101639725|NCT02566304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101639726|NCT02566304|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101639727|NCT02566304|Antitubercular Agents|antitubercular agents|mesh-ancestor
101639728|NCT02566304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101639735|NCT02520778|Osimertinib|osimertinib|mesh-list
101639736|NCT02520778|Navitoclax|navitoclax|mesh-list
101639737|NCT02520778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639738|NCT02520778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101639739|NCT02520778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101639740|NCT02520778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639741|NCT02400216|Cholic Acids|cholic acids|mesh-list
101639742|NCT02400216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101639743|NCT02358031|Carboplatin|carboplatin|mesh-list
101639744|NCT02358031|Pembrolizumab|pembrolizumab|mesh-list
101639745|NCT02358031|Cetuximab|cetuximab|mesh-list
101639746|NCT02358031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639747|NCT02358031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101639748|NCT02358031|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101639749|NCT02358031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639750|NCT02270814|Paclitaxel|paclitaxel|mesh-list
101639751|NCT02270814|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101639752|NCT02270814|Cisplatin|cisplatin|mesh-list
101639753|NCT02270814|Carboplatin|carboplatin|mesh-list
101639754|NCT02270814|Cetuximab|cetuximab|mesh-list
101639755|NCT02270814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101639756|NCT02270814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639757|NCT02270814|Tubulin Modulators|tubulin modulators|mesh-ancestor
101639758|NCT02270814|Antimitotic Agents|antimitotic agents|mesh-ancestor
101639759|NCT02270814|Mitosis Modulators|mitosis modulators|mesh-ancestor
101639760|NCT02270814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639761|NCT02270814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101639762|NCT02258451|Everolimus|everolimus|mesh-list
101639763|NCT02258451|Exemestane|exemestane|mesh-list
101639764|NCT02258451|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
101639765|NCT02258451|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101639766|NCT02258451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101639767|NCT02258451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101639768|NCT02258451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639769|NCT02258451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101639770|NCT02258451|Immunologic Factors|immunologic factors|mesh-ancestor
101639771|NCT02258451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639772|NCT02258451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639773|NCT02258451|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101639774|NCT02258451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101639775|NCT02258451|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101639776|NCT02258451|Hormone Antagonists|hormone antagonists|mesh-ancestor
101639777|NCT02258451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101639778|NCT01946529|Cyclophosphamide|cyclophosphamide|mesh-list
101639779|NCT01946529|Temozolomide|temozolomide|mesh-list
101639780|NCT01946529|Ifosfamide|ifosfamide|mesh-list
101639781|NCT01946529|Bevacizumab|bevacizumab|mesh-list
101639782|NCT01946529|Doxorubicin|doxorubicin|mesh-list
101639783|NCT01946529|Etoposide|etoposide|mesh-list
101639784|NCT01946529|Vincristine|vincristine|mesh-list
101639785|NCT01946529|Sorafenib|sorafenib|mesh-list
101639786|NCT01946529|Temsirolimus|temsirolimus|mesh-list
101639787|NCT01946529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101639788|NCT01946529|Immunologic Factors|immunologic factors|mesh-ancestor
101639789|NCT01946529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639790|NCT01946529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101639791|NCT01946529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101639792|NCT01946529|Alkylating Agents|alkylating agents|mesh-ancestor
101639793|NCT01946529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639794|NCT01946529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639796|NCT01946529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101639797|NCT01946529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101639798|NCT01946529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101639799|NCT01946529|Growth Substances|growth substances|mesh-ancestor
101639800|NCT01946529|Growth Inhibitors|growth inhibitors|mesh-ancestor
101639801|NCT01946529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101639802|NCT01946529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101639803|NCT01946529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101639804|NCT01946529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101639805|NCT01946529|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101639806|NCT01946529|Tubulin Modulators|tubulin modulators|mesh-ancestor
101639807|NCT01946529|Antimitotic Agents|antimitotic agents|mesh-ancestor
101639808|NCT01946529|Mitosis Modulators|mitosis modulators|mesh-ancestor
101639809|NCT01946529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101639810|NCT01946529|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101639811|NCT01899989|Carboplatin|carboplatin|mesh-list
101639812|NCT01899989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101296888|NCT01995058|Hormones|hormones|mesh-ancestor
101639813|NCT01386710|Bevacizumab|bevacizumab|mesh-list
101639814|NCT01386710|Carboplatin|carboplatin|mesh-list
101639815|NCT01386710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101639816|NCT01386710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639817|NCT01386710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101639835|NCT00878254|Doxorubicin|doxorubicin|mesh-list
101639836|NCT00878254|Methotrexate|methotrexate|mesh-list
101639837|NCT00878254|Etoposide|etoposide|mesh-list
101639838|NCT00878254|Vincristine|vincristine|mesh-list
101639839|NCT00878254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101639840|NCT00878254|Immunologic Factors|immunologic factors|mesh-ancestor
101639841|NCT00878254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639842|NCT00878254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101639843|NCT00878254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101639844|NCT00878254|Alkylating Agents|alkylating agents|mesh-ancestor
101639845|NCT00878254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639846|NCT00878254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639847|NCT00878254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101639848|NCT00878254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101639849|NCT00878254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101639850|NCT00878254|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101639851|NCT00878254|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101639852|NCT00878254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101639853|NCT00878254|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101639854|NCT00878254|Abortifacient Agents|abortifacient agents|mesh-ancestor
101639855|NCT00878254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101639856|NCT00878254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101639857|NCT00878254|Antimetabolites|antimetabolites|mesh-ancestor
101639858|NCT00878254|Dermatologic Agents|dermatologic agents|mesh-ancestor
101639859|NCT00878254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101639860|NCT00878254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101639861|NCT00878254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101639862|NCT00878254|Antiviral Agents|antiviral agents|mesh-ancestor
101639863|NCT00878254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101639864|NCT00878254|Antidotes|antidotes|mesh-ancestor
101639865|NCT00878254|Protective Agents|protective agents|mesh-ancestor
101639866|NCT00878254|Vitamin B Complex|vitamin b complex|mesh-ancestor
101639867|NCT00878254|Vitamins|vitamins|mesh-ancestor
101639868|NCT00878254|Micronutrients|micronutrients|mesh-ancestor
101639869|NCT00878254|Tubulin Modulators|tubulin modulators|mesh-ancestor
101639874|NCT00813423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639875|NCT00813423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101639876|NCT00813423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101639877|NCT00813423|Growth Substances|growth substances|mesh-ancestor
101639878|NCT00813423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639879|NCT00813423|Growth Inhibitors|growth inhibitors|mesh-ancestor
101639880|NCT00813423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101639881|NCT00813423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101639882|NCT00813423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639883|NCT00813423|Antimalarials|antimalarials|mesh-ancestor
101639884|NCT00813423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101639885|NCT00813423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101639886|NCT00813423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101639887|NCT00813423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101639891|NCT00146562|Paclitaxel|paclitaxel|mesh-list
101639892|NCT00146562|Cyclophosphamide|cyclophosphamide|mesh-list
101639893|NCT00146562|Doxorubicin|doxorubicin|mesh-list
101639894|NCT00146562|Darbepoetin alfa|darbepoetin alfa|mesh-list
101639895|NCT00146562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101639896|NCT00146562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639897|NCT00146562|Tubulin Modulators|tubulin modulators|mesh-ancestor
101639898|NCT00146562|Antimitotic Agents|antimitotic agents|mesh-ancestor
101639899|NCT00146562|Mitosis Modulators|mitosis modulators|mesh-ancestor
101639900|NCT00146562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639901|NCT00146562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101639902|NCT00146562|Immunologic Factors|immunologic factors|mesh-ancestor
101639903|NCT00146562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639904|NCT00146562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101639905|NCT00146562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101639906|NCT00146562|Alkylating Agents|alkylating agents|mesh-ancestor
101639907|NCT00146562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101639908|NCT00146562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101639909|NCT00146562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101639910|NCT00146562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101639911|NCT00146562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101639912|NCT00146562|Hematinics|hematinics|mesh-ancestor
101639913|NCT04089592|Fentanyl|fentanyl|mesh-list
101639914|NCT04089592|Dexmedetomidine|dexmedetomidine|mesh-list
101639915|NCT04089592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101639916|NCT04089592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101639917|NCT04089592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639918|NCT04089592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101639919|NCT04089592|Analgesics|analgesics|mesh-ancestor
101639920|NCT04089592|Sensory System Agents|sensory system agents|mesh-ancestor
101639921|NCT04089592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101639922|NCT04089592|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101639923|NCT04089592|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101639924|NCT04089592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101639925|NCT04089592|Adrenergic Agents|adrenergic agents|mesh-ancestor
101639926|NCT04089592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101639927|NCT04089592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639928|NCT04089592|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101639929|NCT04089592|Narcotics|narcotics|mesh-ancestor
101639930|NCT04089592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101639931|NCT04089592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101639932|NCT04089592|Anesthetics, General|anesthetics, general|mesh-ancestor
101639933|NCT04089592|Anesthetics|anesthetics|mesh-ancestor
101639934|NCT00751036|Imatinib Mesylate|imatinib mesylate|mesh-list
101639935|NCT00751036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639936|NCT00751036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101639937|NCT00751036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101639938|NCT00751036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639939|NCT00961298|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101639940|NCT00961298|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101639941|NCT00961298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101639942|NCT00961298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101639943|NCT00961298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639944|NCT00961298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101639945|NCT00961298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639946|NCT00961298|Analgesics|analgesics|mesh-ancestor
101639947|NCT00961298|Sensory System Agents|sensory system agents|mesh-ancestor
101639948|NCT00961298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101639949|NCT00961298|Antidepressive Agents|antidepressive agents|mesh-ancestor
101639950|NCT00961298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101639951|NCT00961298|Dopamine Agents|dopamine agents|mesh-ancestor
101639952|NCT00744328|Sertraline|sertraline|mesh-list
101639953|NCT00744328|Estradiol|estradiol|mesh-list
101639955|NCT00744328|Hormones|hormones|mesh-ancestor
101639956|NCT00744328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101639957|NCT00744328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639958|NCT00744328|Antidepressive Agents|antidepressive agents|mesh-ancestor
101639959|NCT00744328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101639960|NCT00744328|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101639961|NCT00744328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101639962|NCT00744328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101639963|NCT00744328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639964|NCT00744328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101639965|NCT00744328|Serotonin Agents|serotonin agents|mesh-ancestor
101639967|NCT04019782|Viscosupplements|viscosupplements|mesh-ancestor
101639968|NCT04019782|Protective Agents|protective agents|mesh-ancestor
101639969|NCT04019782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639970|NCT02599480|Mirabegron|mirabegron|mesh-list
101639971|NCT02599480|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101639972|NCT02599480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101639973|NCT02599480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101639974|NCT02599480|Adrenergic Agents|adrenergic agents|mesh-ancestor
101639975|NCT02599480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101639976|NCT02599480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101639977|NCT02599480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639978|NCT02599480|Urological Agents|urological agents|mesh-ancestor
101639979|NCT03245840|Budesonide|budesonide|mesh-list
101639980|NCT03245840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101639981|NCT03245840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101639982|NCT03245840|Autonomic Agents|autonomic agents|mesh-ancestor
101639983|NCT03245840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101639984|NCT03245840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639985|NCT03245840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101639986|NCT03245840|Respiratory System Agents|respiratory system agents|mesh-ancestor
101639987|NCT03245840|Glucocorticoids|glucocorticoids|mesh-ancestor
101639988|NCT03245840|Hormones|hormones|mesh-ancestor
101639989|NCT03245840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101639990|NCT04091698|Ubiquinone|ubiquinone|mesh-list
101639991|NCT04091698|Coenzyme Q10|coenzyme q10|mesh-list
101639992|NCT04091698|Micronutrients|micronutrients|mesh-ancestor
101639993|NCT04091698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101639994|NCT04091698|Vitamins|vitamins|mesh-ancestor
101639995|NCT04281290|Bleomycin|bleomycin|mesh-list
101639996|NCT04281290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101639997|NCT04281290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101639998|NCT04091932|Pembrolizumab|pembrolizumab|mesh-list
101639999|NCT04091932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101640000|NCT04091932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101640001|NCT04091932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101640002|NCT04091932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640003|NCT00959894|Tenofovir|tenofovir|mesh-list
101640004|NCT00959894|Emtricitabine|emtricitabine|mesh-list
101640005|NCT00959894|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101640006|NCT00959894|Etravirine|etravirine|mesh-list
101640007|NCT00959894|Antiviral Agents|antiviral agents|mesh-ancestor
101640008|NCT00959894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101640009|NCT00959894|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101640010|NCT00959894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101363863|NCT00080925|Etoposide|etoposide|mesh-list
101640011|NCT00959894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101640012|NCT00959894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640013|NCT00959894|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101640014|NCT00959894|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101640015|NCT02599168|Dexmedetomidine|dexmedetomidine|mesh-list
101640016|NCT02599168|Propofol|propofol|mesh-list
101640017|NCT02599168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101640018|NCT02599168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101640019|NCT02599168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640021|NCT02599168|Analgesics|analgesics|mesh-ancestor
101731757|NCT00773136|Bimatoprost|bimatoprost|mesh-list
101640022|NCT02599168|Sensory System Agents|sensory system agents|mesh-ancestor
101640023|NCT02599168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101640024|NCT02599168|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101640025|NCT02599168|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101640026|NCT02599168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101640027|NCT02599168|Adrenergic Agents|adrenergic agents|mesh-ancestor
101640028|NCT02599168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101640029|NCT02599168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640030|NCT02599168|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101640031|NCT02599168|Anesthetics, General|anesthetics, general|mesh-ancestor
101640033|NCT00746590|Tretazicar|tretazicar|mesh-list
101640034|NCT00746590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101640035|NCT01032629|Canagliflozin|canagliflozin|mesh-list
101640036|NCT01032629|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101640037|NCT01032629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640038|NCT01032629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101640039|NCT01032629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640040|NCT04205201|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101640041|NCT04205201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101640042|NCT04205201|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101640043|NCT04205201|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101640044|NCT04205201|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101640045|NCT04205201|Adrenergic Agents|adrenergic agents|mesh-ancestor
101640046|NCT04205201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101640047|NCT04205201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640048|NCT04205201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640049|NCT00749944|Varenicline|varenicline|mesh-list
101640050|NCT00749944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101640051|NCT00749944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101640052|NCT00749944|Cholinergic Agents|cholinergic agents|mesh-ancestor
101640053|NCT00749944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101640054|NCT00749944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640055|NCT00749944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640056|NCT02597140|Lidocaine|lidocaine|mesh-list
101640057|NCT02597140|Propofol|propofol|mesh-list
101640058|NCT02597140|Anesthetics, Local|anesthetics, local|mesh-ancestor
101640059|NCT02597140|Anesthetics|anesthetics|mesh-ancestor
101640060|NCT02597140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101640061|NCT02597140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640062|NCT02597140|Sensory System Agents|sensory system agents|mesh-ancestor
101640063|NCT02597140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101640064|NCT02597140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101640065|NCT02597140|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101640066|NCT02597140|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101640067|NCT02597140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101640068|NCT02597140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640069|NCT02597140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101640070|NCT02597140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101640071|NCT02597140|Anesthetics, General|anesthetics, general|mesh-ancestor
101640072|NCT02598310|Paclitaxel|paclitaxel|mesh-list
101640073|NCT02598310|Trastuzumab|trastuzumab|mesh-list
101640074|NCT02598310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101640075|NCT02598310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101640076|NCT02598310|Tubulin Modulators|tubulin modulators|mesh-ancestor
101640077|NCT02598310|Antimitotic Agents|antimitotic agents|mesh-ancestor
101640078|NCT02598310|Mitosis Modulators|mitosis modulators|mesh-ancestor
101640079|NCT02598310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640080|NCT02598310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101640081|NCT04091074|Clopidogrel|clopidogrel|mesh-list
101640082|NCT04091074|Ticagrelor|ticagrelor|mesh-list
101640083|NCT04091074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101640084|NCT04091074|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101640085|NCT04091074|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101640086|NCT04091074|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101640087|NCT04091074|Purinergic Agents|purinergic agents|mesh-ancestor
101640088|NCT04091074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101640089|NCT04091074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640090|NCT04091074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640091|NCT00749398|Infliximab|infliximab|mesh-list
101640093|NCT00749398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101640094|NCT00749398|Dermatologic Agents|dermatologic agents|mesh-ancestor
101640095|NCT00749398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101640096|NCT00749398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101640097|NCT01012973|Aflibercept|aflibercept|mesh-list
101640098|NCT01012973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101640099|NCT01012973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101640100|NCT01012973|Growth Substances|growth substances|mesh-ancestor
101640101|NCT01012973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640102|NCT01012973|Growth Inhibitors|growth inhibitors|mesh-ancestor
101640103|NCT01012973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101640104|NCT03974464|Arginine Vasopressin|arginine vasopressin|mesh-list
101640105|NCT03974464|Hemostatics|hemostatics|mesh-ancestor
101640106|NCT03974464|Coagulants|coagulants|mesh-ancestor
101640107|NCT03974464|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101640108|NCT03974464|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101640109|NCT03974464|Natriuretic Agents|natriuretic agents|mesh-ancestor
101640110|NCT03974464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640111|NCT00742924|Zoledronic Acid|zoledronic acid|mesh-list
101640112|NCT00742924|Leucovorin|leucovorin|mesh-list
101640113|NCT00742924|Cisplatin|cisplatin|mesh-list
101640114|NCT00742924|Doxorubicin|doxorubicin|mesh-list
101640115|NCT00742924|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101297188|NCT01996930|Silver Nitrate|silver nitrate|mesh-list
101640116|NCT00742924|Methotrexate|methotrexate|mesh-list
101640117|NCT00742924|Etoposide|etoposide|mesh-list
101640118|NCT00742924|Ifosfamide|ifosfamide|mesh-list
101640119|NCT00742924|Isophosphamide mustard|isophosphamide mustard|mesh-list
101640120|NCT00742924|Dexrazoxane|dexrazoxane|mesh-list
101640121|NCT00742924|Razoxane|razoxane|mesh-list
101640122|NCT00742924|Imidazole|imidazole|mesh-list
101640123|NCT00742924|Lenograstim|lenograstim|mesh-list
101640124|NCT00742924|Levoleucovorin|levoleucovorin|mesh-list
101640125|NCT00742924|Mesna|mesna|mesh-list
101640126|NCT00742924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101640127|NCT00742924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101640128|NCT00742924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101640129|NCT00742924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101640130|NCT00742924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101640131|NCT00742924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640132|NCT00742924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640133|NCT00742924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101640134|NCT00742924|Abortifacient Agents|abortifacient agents|mesh-ancestor
101640135|NCT00742924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101640136|NCT00742924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101640137|NCT00742924|Antimetabolites|antimetabolites|mesh-ancestor
101640138|NCT00742924|Dermatologic Agents|dermatologic agents|mesh-ancestor
101640139|NCT00742924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101640140|NCT00742924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101640141|NCT00742924|Immunologic Factors|immunologic factors|mesh-ancestor
101640142|NCT00742924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101640143|NCT00742924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101640144|NCT00742924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101640146|NCT00742924|Protective Agents|protective agents|mesh-ancestor
101640147|NCT00742924|Vitamin B Complex|vitamin b complex|mesh-ancestor
101640148|NCT00742924|Vitamins|vitamins|mesh-ancestor
101640149|NCT00742924|Micronutrients|micronutrients|mesh-ancestor
101640150|NCT00742924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101640151|NCT00742924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101640152|NCT00742924|Alkylating Agents|alkylating agents|mesh-ancestor
101640153|NCT00742924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101640154|NCT00742924|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101640155|NCT00742924|Antimitotic Agents|antimitotic agents|mesh-ancestor
101640156|NCT00742924|Mitosis Modulators|mitosis modulators|mesh-ancestor
101640157|NCT02596984|Caspofungin|caspofungin|mesh-list
101640158|NCT02596984|Antifungal Agents|antifungal agents|mesh-ancestor
101640159|NCT02596984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101640160|NCT02596984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101640161|NCT02596984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640162|NCT00698815|Pemetrexed|pemetrexed|mesh-list
101640163|NCT00698815|Sunitinib|sunitinib|mesh-list
101640164|NCT00698815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101640165|NCT00698815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101640166|NCT00698815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640167|NCT00698815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101640168|NCT00698815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101640169|NCT00698815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101640170|NCT00698815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101640171|NCT00698815|Growth Substances|growth substances|mesh-ancestor
101640172|NCT00698815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640173|NCT00698815|Growth Inhibitors|growth inhibitors|mesh-ancestor
101640174|NCT00698815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101640175|NCT02599090|Temozolomide|temozolomide|mesh-list
101640176|NCT02599090|Sorafenib|sorafenib|mesh-list
101640177|NCT02599090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101640178|NCT02599090|Alkylating Agents|alkylating agents|mesh-ancestor
101640179|NCT02599090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640180|NCT02599090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101640181|NCT02599090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101640182|NCT02599090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101640183|NCT00745498|Bevacizumab|bevacizumab|mesh-list
101640184|NCT00745498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101640185|NCT00745498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101640186|NCT00745498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101640187|NCT00745498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101640188|NCT00745498|Growth Substances|growth substances|mesh-ancestor
101640189|NCT00745498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640190|NCT00745498|Growth Inhibitors|growth inhibitors|mesh-ancestor
101640191|NCT02596828|Sirolimus|sirolimus|mesh-list
101640192|NCT02596828|Irinotecan|irinotecan|mesh-list
101640193|NCT02596828|Temozolomide|temozolomide|mesh-list
101640194|NCT02596828|Dasatinib|dasatinib|mesh-list
101640195|NCT02596828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101640196|NCT02596828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101640197|NCT02596828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101640198|NCT02596828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640199|NCT02596828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101640200|NCT02596828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101640201|NCT02596828|Alkylating Agents|alkylating agents|mesh-ancestor
101640202|NCT02596828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101640203|NCT02596828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101640204|NCT02596828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101640205|NCT02596828|Antifungal Agents|antifungal agents|mesh-ancestor
101640206|NCT02596828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101640207|NCT02596828|Immunologic Factors|immunologic factors|mesh-ancestor
101640208|NCT02596828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640209|NCT02596828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101640210|NCT03896815|INCB054329|incb054329|mesh-list
101640211|NCT03896815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101640212|NCT02598856|Naloxone|naloxone|mesh-list
101640213|NCT02598856|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101732007|NCT00767325|Abortifacient Agents|abortifacient agents|mesh-ancestor
101640214|NCT02598856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640215|NCT02598856|Sensory System Agents|sensory system agents|mesh-ancestor
101640216|NCT02598856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101640217|NCT04827979|Daratumumab|daratumumab|mesh-list
101640218|NCT04827979|Abatacept|abatacept|mesh-list
101640219|NCT04827979|Immunoglobulins|immunoglobulins|mesh-list
101640220|NCT04827979|Immunoglobulin G|immunoglobulin g|mesh-list
101640221|NCT04827979|Immunologic Factors|immunologic factors|mesh-ancestor
101640222|NCT04827979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640223|NCT04827979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101640224|NCT04827979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101640225|NCT04827979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640226|NCT04827979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101640227|NCT04827979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101640228|NCT04827979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101640229|NCT02597998|BI 409306|bi 409306|mesh-list
101640230|NCT02597998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101640231|NCT02597998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101640232|NCT02597998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640233|NCT02595658|Insulin, Short-Acting|insulin, short-acting|mesh-list
101640234|NCT02595658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101640235|NCT02595658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640236|NCT00576901|Bevacizumab|bevacizumab|mesh-list
101640237|NCT00576901|Docetaxel|docetaxel|mesh-list
101640238|NCT00576901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101640239|NCT00576901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101640240|NCT00576901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101640241|NCT00576901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101640242|NCT00576901|Growth Substances|growth substances|mesh-ancestor
101640243|NCT00576901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640244|NCT00576901|Growth Inhibitors|growth inhibitors|mesh-ancestor
101640245|NCT00576901|Tubulin Modulators|tubulin modulators|mesh-ancestor
101640246|NCT00576901|Antimitotic Agents|antimitotic agents|mesh-ancestor
101640247|NCT00576901|Mitosis Modulators|mitosis modulators|mesh-ancestor
101640248|NCT00576901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640250|NCT00699283|Anticonvulsants|anticonvulsants|mesh-ancestor
101640251|NCT04062721|Immunomodulating Agents|immunomodulating agents|mesh-list
101640252|NCT04062721|Immunologic Factors|immunologic factors|mesh-ancestor
101640253|NCT04062721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640254|NCT01023815|Cyclosporine|cyclosporine|mesh-list
101640255|NCT01023815|Everolimus|everolimus|mesh-list
101640256|NCT01023815|Cyclosporins|cyclosporins|mesh-list
101640257|NCT01023815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101640258|NCT01023815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640259|NCT01023815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101640260|NCT01023815|Immunologic Factors|immunologic factors|mesh-ancestor
101640261|NCT01023815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640262|NCT01023815|Antifungal Agents|antifungal agents|mesh-ancestor
101640263|NCT01023815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101640264|NCT01023815|Dermatologic Agents|dermatologic agents|mesh-ancestor
101640265|NCT01023815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101640266|NCT01023815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101640267|NCT01023815|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101640268|NCT01023815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101640269|NCT01023815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101640270|NCT02567383|Docetaxel|docetaxel|mesh-list
101640271|NCT02567383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101640272|NCT02567383|Tubulin Modulators|tubulin modulators|mesh-ancestor
101640273|NCT02567383|Antimitotic Agents|antimitotic agents|mesh-ancestor
101640274|NCT02567383|Mitosis Modulators|mitosis modulators|mesh-ancestor
101640275|NCT02567383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640276|NCT01023659|Bupropion|bupropion|mesh-list
101640277|NCT01023659|Varenicline|varenicline|mesh-list
101640278|NCT01023659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101640279|NCT01023659|Antidepressive Agents|antidepressive agents|mesh-ancestor
101640280|NCT01023659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101640281|NCT01023659|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101640282|NCT01023659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101640283|NCT01023659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101640284|NCT01023659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640285|NCT01023659|Dopamine Agents|dopamine agents|mesh-ancestor
101640286|NCT01023659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101640287|NCT01023659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640288|NCT01023659|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101640289|NCT01023659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101640290|NCT01023659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101640291|NCT01023659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101640292|NCT01023659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101640293|NCT01023659|Cholinergic Agents|cholinergic agents|mesh-ancestor
101640294|NCT00740116|Tranexamic Acid|tranexamic acid|mesh-list
101640295|NCT00740116|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101640296|NCT00740116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101640297|NCT00740116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640298|NCT00740116|Hemostatics|hemostatics|mesh-ancestor
101640299|NCT00740116|Coagulants|coagulants|mesh-ancestor
101640300|NCT02567461|Aspirin|aspirin|mesh-list
101640301|NCT02567461|Edoxaban|edoxaban|mesh-list
101640302|NCT02567461|Clopidogrel|clopidogrel|mesh-list
101640303|NCT02567461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101640304|NCT02567461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101640305|NCT02567461|Analgesics|analgesics|mesh-ancestor
101640306|NCT02567461|Sensory System Agents|sensory system agents|mesh-ancestor
101640307|NCT02567461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101640308|NCT02567461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640309|NCT02567461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101640310|NCT02567461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101640311|NCT02567461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101640312|NCT02567461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101640313|NCT02567461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640314|NCT02567461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101640315|NCT02567461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101640316|NCT02567461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101640317|NCT02567461|Antipyretics|antipyretics|mesh-ancestor
101640318|NCT02567461|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101640319|NCT02567461|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101640321|NCT02567461|Purinergic Agents|purinergic agents|mesh-ancestor
101640322|NCT02567461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101640323|NCT02567461|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101640324|NCT02567461|Antithrombins|antithrombins|mesh-ancestor
101640325|NCT02567461|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101640326|NCT02567461|Protease Inhibitors|protease inhibitors|mesh-ancestor
101640327|NCT02567461|Anticoagulants|anticoagulants|mesh-ancestor
101640328|NCT00698581|Brivaracetam|brivaracetam|mesh-list
101640329|NCT00698581|Anticonvulsants|anticonvulsants|mesh-ancestor
101640330|NCT02595346|Hydroxychloroquine|hydroxychloroquine|mesh-list
101640331|NCT02595346|Antimalarials|antimalarials|mesh-ancestor
101640332|NCT02595346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101640333|NCT02595346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101640334|NCT02595346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101640335|NCT02595346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101640336|NCT02595346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640337|NCT02595346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101640338|NCT01023581|Metformin|metformin|mesh-list
101640339|NCT01023581|Alogliptin|alogliptin|mesh-list
101640340|NCT01023581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101640341|NCT01023581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640342|NCT01023581|Incretins|incretins|mesh-ancestor
101640343|NCT01023581|Hormones|hormones|mesh-ancestor
101640344|NCT01023581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101640345|NCT01023581|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101640346|NCT01023581|Protease Inhibitors|protease inhibitors|mesh-ancestor
101640347|NCT01023581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101640348|NCT01023581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640349|NCT05571787|Rabeprazole|rabeprazole|mesh-list
101640350|NCT05571787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101640351|NCT05571787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101640352|NCT05571787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101640353|NCT05571787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101640354|NCT05571787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640355|NCT04063189|Clarithromycin|clarithromycin|mesh-list
101640356|NCT04063189|Dexamethasone|dexamethasone|mesh-list
101640357|NCT04063189|Lenalidomide|lenalidomide|mesh-list
101640358|NCT04063189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101640359|NCT04063189|Antiemetics|antiemetics|mesh-ancestor
101640360|NCT04063189|Autonomic Agents|autonomic agents|mesh-ancestor
101640361|NCT04063189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101640362|NCT04063189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640363|NCT04063189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101640364|NCT04063189|Glucocorticoids|glucocorticoids|mesh-ancestor
101640366|NCT04063189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101640367|NCT04063189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101640368|NCT04063189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101640369|NCT04063189|Immunologic Factors|immunologic factors|mesh-ancestor
101640370|NCT04063189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101640371|NCT04063189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101640372|NCT04063189|Growth Substances|growth substances|mesh-ancestor
101640373|NCT04063189|Growth Inhibitors|growth inhibitors|mesh-ancestor
101640374|NCT04063189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101640376|NCT04063189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101640377|NCT04063189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101640378|NCT04063189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640379|NCT04063189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101640380|NCT04063189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101640381|NCT02567929|Propofol|propofol|mesh-list
101640382|NCT02567929|Sevoflurane|sevoflurane|mesh-list
101640383|NCT02567929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101640384|NCT02567929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101640385|NCT02567929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640386|NCT02567929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101640387|NCT02567929|Anesthetics, General|anesthetics, general|mesh-ancestor
101640388|NCT02567929|Anesthetics|anesthetics|mesh-ancestor
101640389|NCT02567929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101640390|NCT02567929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101640391|NCT05188417|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101640392|NCT05188417|Tirofiban|tirofiban|mesh-list
101640393|NCT05188417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101640394|NCT05188417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101640395|NCT05188417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640396|NCT05188417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101640397|NCT00962780|Vaccines|vaccines|mesh-list
101640398|NCT00962780|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101640399|NCT00962780|Immunologic Factors|immunologic factors|mesh-ancestor
101640400|NCT00962780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640401|NCT02567851|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101640402|NCT02567851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101640403|NCT02567851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101640404|NCT02567851|Immunotoxins|immunotoxins|mesh-ancestor
101640405|NCT02567851|Immunoconjugates|immunoconjugates|mesh-ancestor
101640406|NCT02567851|Immunologic Factors|immunologic factors|mesh-ancestor
101640407|NCT02567851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640408|NCT00739882|Antibodies|antibodies|mesh-list
101640409|NCT00739882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101640410|NCT00739882|Immunologic Factors|immunologic factors|mesh-ancestor
101640411|NCT00739882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640412|NCT00961220|Carmustine|carmustine|mesh-list
101640413|NCT00961220|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
101640414|NCT00961220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101640415|NCT00961220|Alkylating Agents|alkylating agents|mesh-ancestor
101640416|NCT00961220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640417|NCT00961220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101640418|NCT00961220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101640419|NCT00734656|Ethanol|ethanol|mesh-list
101640420|NCT00734656|Dutasteride|dutasteride|mesh-list
101640421|NCT00734656|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101640422|NCT00734656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101640423|NCT00734656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101640424|NCT00734656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640425|NCT00734656|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101640426|NCT00734656|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101640427|NCT00734656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101640428|NCT00734656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640429|NCT00734656|Hormone Antagonists|hormone antagonists|mesh-ancestor
101640430|NCT00734656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101640431|NCT04644289|Durvalumab|durvalumab|mesh-list
101640432|NCT04644289|Olaparib|olaparib|mesh-list
101640433|NCT04644289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101640434|NCT04644289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101640435|NCT04644289|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101640436|NCT04644289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101640437|NCT04644289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640438|NCT02565979|Resveratrol|resveratrol|mesh-list
101640439|NCT02565979|Antioxidants|antioxidants|mesh-ancestor
101640440|NCT02565979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640441|NCT02565979|Protective Agents|protective agents|mesh-ancestor
101640442|NCT02565979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640443|NCT02565979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101640444|NCT02565979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101640445|NCT04062175|Azithromycin|azithromycin|mesh-list
101640446|NCT04062175|Cephalosporins|cephalosporins|mesh-list
101640447|NCT04062175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101640448|NCT04062175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101640449|NCT02859584|Hydrocortisone|hydrocortisone|mesh-list
101640450|NCT02859584|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101640451|NCT02859584|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101640452|NCT02859584|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101640453|NCT02859584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101640454|NCT04391569|Ganaxolone|ganaxolone|mesh-list
101640455|NCT04391569|Neurosteroids|neurosteroids|mesh-ancestor
101640456|NCT04391569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101640457|NCT04391569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640458|NCT04391569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640459|NCT04391569|GABA Modulators|gaba modulators|mesh-ancestor
101640460|NCT04391569|GABA Agents|gaba agents|mesh-ancestor
101640461|NCT05324917|Rituximab|rituximab|mesh-list
101640462|NCT05324917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101640463|NCT05324917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101640464|NCT05324917|Immunologic Factors|immunologic factors|mesh-ancestor
101640465|NCT05324917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640466|NCT05324917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101640467|NCT00739648|Levofloxacin|levofloxacin|mesh-list
101640468|NCT00739648|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101640469|NCT00739648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101640470|NCT00739648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101640471|NCT00739648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101640472|NCT00739648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101640473|NCT00739648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101640474|NCT00739648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640475|NCT00739648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101732416|NCT00839423|Serotonin Agents|serotonin agents|mesh-ancestor
101640476|NCT00739648|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101640477|NCT00739648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101640479|NCT01032239|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101640480|NCT01032239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640481|NCT01032239|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101640482|NCT01032239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101640483|NCT01032239|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101640484|NCT01032239|GABA Agonists|gaba agonists|mesh-ancestor
101640485|NCT01032239|GABA Agents|gaba agents|mesh-ancestor
101640486|NCT01032239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101640487|NCT01032239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640488|NCT02871713|Morphine|morphine|mesh-list
101640489|NCT02871713|Ropivacaine|ropivacaine|mesh-list
101640490|NCT02871713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101640491|NCT02871713|Narcotics|narcotics|mesh-ancestor
101640492|NCT02871713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101640493|NCT02871713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640494|NCT02871713|Analgesics|analgesics|mesh-ancestor
101640495|NCT02871713|Sensory System Agents|sensory system agents|mesh-ancestor
101640496|NCT02871713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101640497|NCT02871713|Anesthetics, Local|anesthetics, local|mesh-ancestor
101640498|NCT02871713|Anesthetics|anesthetics|mesh-ancestor
101640499|NCT04342975|Niacinamide|niacinamide|mesh-list
101640501|NCT04342975|Nicotinic Acids|nicotinic acids|mesh-list
101640502|NCT04342975|Vitamin B Complex|vitamin b complex|mesh-ancestor
101640503|NCT04342975|Vitamins|vitamins|mesh-ancestor
101640504|NCT04342975|Micronutrients|micronutrients|mesh-ancestor
101640505|NCT04342975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640506|NCT04342975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101640507|NCT04342975|Antimetabolites|antimetabolites|mesh-ancestor
101640508|NCT04342975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640509|NCT04342975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101640510|NCT04342975|Vasodilator Agents|vasodilator agents|mesh-ancestor
101640511|NCT00734578|Guanfacine|guanfacine|mesh-list
101640512|NCT00734578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101640513|NCT00734578|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101640514|NCT00734578|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101640515|NCT00734578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101640516|NCT00734578|Adrenergic Agents|adrenergic agents|mesh-ancestor
101640517|NCT00734578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101640518|NCT00734578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640519|NCT00734578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640520|NCT00637715|Alfuzosin|alfuzosin|mesh-list
101640521|NCT00637715|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101640522|NCT00637715|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101732454|NCT00859313|Sufentanil|sufentanil|mesh-list
101640523|NCT00637715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101640524|NCT00637715|Adrenergic Agents|adrenergic agents|mesh-ancestor
101640525|NCT00637715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101640526|NCT00637715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640527|NCT00637715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640528|NCT00637715|Urological Agents|urological agents|mesh-ancestor
101640529|NCT02596282|Anesthetics|anesthetics|mesh-list
101640530|NCT02596282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101640531|NCT02596282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640533|NCT04557085|Anticonvulsants|anticonvulsants|mesh-ancestor
101640534|NCT02593708|Paclitaxel|paclitaxel|mesh-list
101640535|NCT02593708|Trastuzumab|trastuzumab|mesh-list
101640536|NCT02593708|Pertuzumab|pertuzumab|mesh-list
101640537|NCT02593708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101640538|NCT02593708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101640539|NCT02593708|Tubulin Modulators|tubulin modulators|mesh-ancestor
101640540|NCT02593708|Antimitotic Agents|antimitotic agents|mesh-ancestor
101640541|NCT02593708|Mitosis Modulators|mitosis modulators|mesh-ancestor
101640542|NCT02593708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640543|NCT02593708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101640544|NCT00959192|Saponin QA-21V1|saponin qa-21v1|mesh-list
101640545|NCT00959192|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101640546|NCT00959192|Immunologic Factors|immunologic factors|mesh-ancestor
101640547|NCT00959192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640548|NCT00696787|Pregabalin|pregabalin|mesh-list
101640549|NCT00696787|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101640551|NCT00696787|Sensory System Agents|sensory system agents|mesh-ancestor
101640552|NCT00696787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101640553|NCT00696787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640554|NCT00696787|Anticonvulsants|anticonvulsants|mesh-ancestor
101640555|NCT00696787|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101640556|NCT00696787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101640557|NCT00696787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640558|NCT00696787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101640559|NCT00696787|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101640560|NCT00696787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101640561|NCT00696787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101640562|NCT00696787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101640563|NCT00696787|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101640564|NCT00696787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101640565|NCT00696787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101640566|NCT00696787|Antidepressive Agents|antidepressive agents|mesh-ancestor
101297650|NCT02000206|Narcotics|narcotics|mesh-ancestor
101640567|NCT01012037|Linagliptin|linagliptin|mesh-list
101640568|NCT01012037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101640569|NCT01012037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640570|NCT01012037|Incretins|incretins|mesh-ancestor
101640571|NCT01012037|Hormones|hormones|mesh-ancestor
101640572|NCT01012037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101640573|NCT01012037|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101640574|NCT01012037|Protease Inhibitors|protease inhibitors|mesh-ancestor
101732539|NCT04104984|Progesterone|progesterone|mesh-list
101640575|NCT01012037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101640576|NCT01012037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640577|NCT00630110|Docetaxel|docetaxel|mesh-list
101640578|NCT00630110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101640579|NCT00630110|Tubulin Modulators|tubulin modulators|mesh-ancestor
101640580|NCT00630110|Antimitotic Agents|antimitotic agents|mesh-ancestor
101640581|NCT00630110|Mitosis Modulators|mitosis modulators|mesh-ancestor
101640582|NCT00630110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640583|NCT00734032|Darapladib|darapladib|mesh-list
101640584|NCT00734032|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
101640585|NCT00734032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101640586|NCT00734032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640587|NCT04284098|Dexmedetomidine|dexmedetomidine|mesh-list
101640588|NCT04284098|Bupivacaine|bupivacaine|mesh-list
101640589|NCT04284098|Anesthetics, Local|anesthetics, local|mesh-ancestor
101640590|NCT04284098|Anesthetics|anesthetics|mesh-ancestor
101640591|NCT04284098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101640592|NCT04284098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640593|NCT04284098|Sensory System Agents|sensory system agents|mesh-ancestor
101640594|NCT04284098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101640595|NCT04284098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101640596|NCT04284098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101640597|NCT04284098|Analgesics|analgesics|mesh-ancestor
101640598|NCT04284098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101640599|NCT04284098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101640600|NCT04284098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101640601|NCT04284098|Adrenergic Agents|adrenergic agents|mesh-ancestor
101640602|NCT04284098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101640603|NCT04284098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640604|NCT01010633|Loteprednol Etabonate|loteprednol etabonate|mesh-list
101640605|NCT01010633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101640606|NCT00733954|Clobetasol|clobetasol|mesh-list
101640607|NCT00733954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101640608|NCT00733954|Glucocorticoids|glucocorticoids|mesh-ancestor
101640609|NCT00733954|Hormones|hormones|mesh-ancestor
101640610|NCT00733954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101640611|NCT00733954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640612|NCT02595268|Pitavastatin|pitavastatin|mesh-list
101640613|NCT02595268|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101640614|NCT02595268|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101640615|NCT02595268|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101640616|NCT02595268|Antimetabolites|antimetabolites|mesh-ancestor
101640617|NCT02595268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640618|NCT02595268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101640619|NCT02595268|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101640621|NCT00921505|Ibuprofen|ibuprofen|mesh-list
101640622|NCT00921505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101640623|NCT00921505|Analgesics|analgesics|mesh-ancestor
101640624|NCT00921505|Sensory System Agents|sensory system agents|mesh-ancestor
101640625|NCT00921505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101640626|NCT00921505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640628|NCT00921505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101640629|NCT00921505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101640630|NCT00921505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101640631|NCT00921505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101640632|NCT00921505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101640633|NCT00921505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640634|NCT04280588|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101640635|NCT04280588|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101640636|NCT04280588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640637|NCT04280588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101640638|NCT04280588|Immunologic Factors|immunologic factors|mesh-ancestor
101640639|NCT04280588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640640|NCT04298021|Durvalumab|durvalumab|mesh-list
101640641|NCT04298021|Olaparib|olaparib|mesh-list
101297721|NCT02000804|Darapladib|darapladib|mesh-list
101640642|NCT04298021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101640643|NCT04298021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101640644|NCT04298021|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101640645|NCT04298021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101640646|NCT04298021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640647|NCT02595190|Gabapentin|gabapentin|mesh-list
101640648|NCT02595190|Tramadol|tramadol|mesh-list
101640649|NCT02595190|Analgesics|analgesics|mesh-ancestor
101640650|NCT02595190|Sensory System Agents|sensory system agents|mesh-ancestor
101640651|NCT02595190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101640652|NCT02595190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640653|NCT02595190|Anticonvulsants|anticonvulsants|mesh-ancestor
101640654|NCT02595190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101640655|NCT02595190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101640656|NCT02595190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101640657|NCT02595190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101640658|NCT02595190|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101640659|NCT02595190|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101640660|NCT02595190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101640661|NCT02595190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640662|NCT02595190|Antimanic Agents|antimanic agents|mesh-ancestor
101640663|NCT02595190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101640664|NCT02595190|Narcotics|narcotics|mesh-ancestor
101640665|NCT04061473|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101640666|NCT04061473|Empagliflozin|empagliflozin|mesh-list
101640667|NCT04061473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101640668|NCT04061473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640669|NCT04061473|Incretins|incretins|mesh-ancestor
101640670|NCT04061473|Hormones|hormones|mesh-ancestor
101640671|NCT04061473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101640672|NCT04061473|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101640673|NCT04061473|Protease Inhibitors|protease inhibitors|mesh-ancestor
101640674|NCT04061473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101640675|NCT04061473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640676|NCT04061473|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101640677|NCT04502693|Vaccines|vaccines|mesh-list
101640678|NCT04502693|Immunologic Factors|immunologic factors|mesh-ancestor
101640679|NCT04502693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640680|NCT00733408|Paclitaxel|paclitaxel|mesh-list
101640681|NCT00733408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101640682|NCT00733408|Bevacizumab|bevacizumab|mesh-list
101640683|NCT00733408|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101640684|NCT00733408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101640686|NCT00733408|Immunoglobulins|immunoglobulins|mesh-list
101640687|NCT00733408|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101640688|NCT00733408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101640689|NCT00733408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101640690|NCT00733408|Tubulin Modulators|tubulin modulators|mesh-ancestor
101640691|NCT00733408|Antimitotic Agents|antimitotic agents|mesh-ancestor
101640692|NCT00733408|Mitosis Modulators|mitosis modulators|mesh-ancestor
101640693|NCT00733408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640694|NCT00733408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101640695|NCT00733408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101640696|NCT00733408|Growth Substances|growth substances|mesh-ancestor
101640697|NCT00733408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640698|NCT00733408|Growth Inhibitors|growth inhibitors|mesh-ancestor
101640699|NCT00733408|Immunologic Factors|immunologic factors|mesh-ancestor
101640700|NCT00733408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101640701|NCT00733408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101640702|NCT04296383|Azithromycin|azithromycin|mesh-list
101640703|NCT04296383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101640704|NCT04296383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101640705|NCT00576823|Alfuzosin|alfuzosin|mesh-list
101640706|NCT00576823|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101640707|NCT00576823|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101640708|NCT00576823|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101640709|NCT00576823|Adrenergic Agents|adrenergic agents|mesh-ancestor
101640710|NCT00576823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101640711|NCT00576823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640712|NCT00576823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640713|NCT00576823|Urological Agents|urological agents|mesh-ancestor
101640714|NCT00732940|Belimumab|belimumab|mesh-list
101640715|NCT00732940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101640716|NCT00732940|Immunologic Factors|immunologic factors|mesh-ancestor
101640717|NCT00732940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640719|NCT00962390|Phytoestrogens|phytoestrogens|mesh-ancestor
101640720|NCT00962390|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101640721|NCT00962390|Estrogens|estrogens|mesh-ancestor
101640722|NCT00962390|Hormones|hormones|mesh-ancestor
101640723|NCT00962390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101640724|NCT00962390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640725|NCT00742807|Alfentanil|alfentanil|mesh-list
101640726|NCT00742807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101640727|NCT00742807|Narcotics|narcotics|mesh-ancestor
101640728|NCT00742807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101640729|NCT00742807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640730|NCT00742807|Analgesics|analgesics|mesh-ancestor
101640731|NCT00742807|Sensory System Agents|sensory system agents|mesh-ancestor
101640732|NCT00742807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101640733|NCT00742807|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101640734|NCT00742807|Anesthetics, General|anesthetics, general|mesh-ancestor
101640735|NCT00742807|Anesthetics|anesthetics|mesh-ancestor
101640736|NCT03221257|Mycophenolic Acid|mycophenolic acid|mesh-list
101640737|NCT03221257|Pirfenidone|pirfenidone|mesh-list
101640738|NCT03221257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101640739|NCT03221257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101640740|NCT03221257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101640741|NCT03221257|Antitubercular Agents|antitubercular agents|mesh-ancestor
101640742|NCT03221257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101640743|NCT03221257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101640744|NCT03221257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101640745|NCT03221257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640747|NCT03221257|Sensory System Agents|sensory system agents|mesh-ancestor
101640748|NCT03221257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101640749|NCT03221257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640750|NCT03221257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101640751|NCT03221257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101640752|NCT03221257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101640753|NCT03221257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101640754|NCT00960986|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101640755|NCT00960986|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101640756|NCT00960986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101640757|NCT00960986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101640758|NCT00960986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640759|NCT00960986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101640760|NCT00960986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640761|NCT00960986|Analgesics|analgesics|mesh-ancestor
101640762|NCT00960986|Sensory System Agents|sensory system agents|mesh-ancestor
101640763|NCT00960986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101640764|NCT00960986|Antidepressive Agents|antidepressive agents|mesh-ancestor
101640765|NCT00960986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101640766|NCT00960986|Dopamine Agents|dopamine agents|mesh-ancestor
101640767|NCT00732238|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101640768|NCT00732238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101640770|NCT00958880|Mydriatics|mydriatics|mesh-ancestor
101640771|NCT00958880|Autonomic Agents|autonomic agents|mesh-ancestor
101640772|NCT00958880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101640773|NCT00958880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640774|NCT00958880|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101640775|NCT00958880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101640776|NCT00958880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101640777|NCT00958880|Adrenergic Agents|adrenergic agents|mesh-ancestor
101640778|NCT00958880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101640779|NCT00958880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640780|NCT00958880|Urological Agents|urological agents|mesh-ancestor
101640781|NCT02595034|Clindamycin|clindamycin|mesh-list
101640782|NCT02595034|Clindamycin palmitate|clindamycin palmitate|mesh-list
101640783|NCT02595034|Clindamycin phosphate|clindamycin phosphate|mesh-list
101640784|NCT02595034|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101640785|NCT02595034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101640786|NCT02595034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101640787|NCT02595034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101640788|NCT02595034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101640789|NCT02595034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640790|NCT02595034|Dermatologic Agents|dermatologic agents|mesh-ancestor
101640792|NCT00958724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101640793|NCT00958724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101640794|NCT00958724|Tubulin Modulators|tubulin modulators|mesh-ancestor
101640795|NCT00958724|Antimitotic Agents|antimitotic agents|mesh-ancestor
101640796|NCT00958724|Mitosis Modulators|mitosis modulators|mesh-ancestor
101640797|NCT00958724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640798|NCT00738400|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101640799|NCT00738400|Vasodilator Agents|vasodilator agents|mesh-ancestor
101640800|NCT00738400|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101640801|NCT00738400|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101640802|NCT00738400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101640803|NCT00738400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640804|NCT00738400|Urological Agents|urological agents|mesh-ancestor
101640805|NCT00958568|Olanzapine|olanzapine|mesh-list
101640806|NCT00958568|Fluoxetine|fluoxetine|mesh-list
101640807|NCT00958568|Antiemetics|antiemetics|mesh-ancestor
101640808|NCT00958568|Autonomic Agents|autonomic agents|mesh-ancestor
101732703|NCT00707135|Sirolimus|sirolimus|mesh-list
101640809|NCT00958568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101640810|NCT00958568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640811|NCT00958568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101640812|NCT00958568|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101640813|NCT00958568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101640814|NCT00958568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101640815|NCT00958568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101640816|NCT00958568|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101640817|NCT00958568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101640818|NCT00958568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101640819|NCT00958568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640820|NCT00958568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101640821|NCT00958568|Serotonin Agents|serotonin agents|mesh-ancestor
101640822|NCT00958568|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101640823|NCT00958568|Antidepressive Agents|antidepressive agents|mesh-ancestor
101640824|NCT00958568|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101640825|NCT00958568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101640826|NCT00958568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101640827|NCT00630500|Memantine|memantine|mesh-list
101640828|NCT00630500|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101640829|NCT00630500|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101640830|NCT00630500|Dopamine Agents|dopamine agents|mesh-ancestor
101640831|NCT00630500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101640832|NCT00630500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640833|NCT00630500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640834|NCT00630500|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101640835|NCT00630500|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101640836|NCT02858804|Cytarabine|cytarabine|mesh-list
101640837|NCT02858804|Thalidomide|thalidomide|mesh-list
101640838|NCT02858804|Dexamethasone|dexamethasone|mesh-list
101640839|NCT02858804|Prednisone|prednisone|mesh-list
101640840|NCT02858804|Cyclophosphamide|cyclophosphamide|mesh-list
101640841|NCT02858804|Rituximab|rituximab|mesh-list
101640842|NCT02858804|Doxorubicin|doxorubicin|mesh-list
101640843|NCT02858804|Etoposide|etoposide|mesh-list
101640844|NCT02858804|Vincristine|vincristine|mesh-list
101640845|NCT02858804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101640846|NCT02858804|Immunologic Factors|immunologic factors|mesh-ancestor
101640847|NCT02858804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640848|NCT02858804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101640849|NCT02858804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101640850|NCT02858804|Alkylating Agents|alkylating agents|mesh-ancestor
101640851|NCT02858804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640852|NCT02858804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101640853|NCT02858804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101640854|NCT02858804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101640855|NCT02858804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101640856|NCT02858804|Antiemetics|antiemetics|mesh-ancestor
101640857|NCT02858804|Autonomic Agents|autonomic agents|mesh-ancestor
101640858|NCT02858804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101640859|NCT02858804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101640860|NCT02858804|Glucocorticoids|glucocorticoids|mesh-ancestor
101640861|NCT02858804|Hormones|hormones|mesh-ancestor
101640862|NCT02858804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101640863|NCT02858804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101640864|NCT02858804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101640865|NCT02858804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101640866|NCT02858804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101640867|NCT02858804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101640868|NCT02858804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101640869|NCT02858804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101640870|NCT02858804|Antimetabolites|antimetabolites|mesh-ancestor
101640871|NCT02858804|Antiviral Agents|antiviral agents|mesh-ancestor
101640872|NCT02858804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101640873|NCT02858804|Tubulin Modulators|tubulin modulators|mesh-ancestor
101640874|NCT02858804|Antimitotic Agents|antimitotic agents|mesh-ancestor
101640875|NCT02858804|Mitosis Modulators|mitosis modulators|mesh-ancestor
101640876|NCT02858804|Leprostatic Agents|leprostatic agents|mesh-ancestor
101640877|NCT02858804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101640878|NCT02858804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101640879|NCT02858804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101640880|NCT02858804|Growth Substances|growth substances|mesh-ancestor
101640881|NCT02858804|Growth Inhibitors|growth inhibitors|mesh-ancestor
101640882|NCT00958256|Cyclophosphamide|cyclophosphamide|mesh-list
101640883|NCT00958256|Rituximab|rituximab|mesh-list
101640884|NCT00958256|Bortezomib|bortezomib|mesh-list
101640885|NCT00958256|Lenograstim|lenograstim|mesh-list
101640886|NCT00958256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101640887|NCT00958256|Immunologic Factors|immunologic factors|mesh-ancestor
101640888|NCT00958256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640889|NCT00958256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101640890|NCT00958256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101640891|NCT00958256|Alkylating Agents|alkylating agents|mesh-ancestor
101640892|NCT00958256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640893|NCT00958256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101640894|NCT00958256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101640895|NCT00958256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101640896|NCT00958256|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101640897|NCT01006265|Ponesimod|ponesimod|mesh-list
101640898|NCT01006265|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101640899|NCT01006265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640900|NCT01006265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101640901|NCT01006265|Immunologic Factors|immunologic factors|mesh-ancestor
101640902|NCT01006265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640903|NCT02861690|Paclitaxel|paclitaxel|mesh-list
101640904|NCT02861690|Nedaplatin|nedaplatin|mesh-list
101640905|NCT02861690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101640906|NCT02861690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101640907|NCT02861690|Tubulin Modulators|tubulin modulators|mesh-ancestor
101640908|NCT02861690|Antimitotic Agents|antimitotic agents|mesh-ancestor
101640909|NCT02861690|Mitosis Modulators|mitosis modulators|mesh-ancestor
101640910|NCT02861690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640911|NCT05141552|Dapagliflozin|dapagliflozin|mesh-list
101640912|NCT05141552|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101640913|NCT05141552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640915|NCT05141552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640916|NCT02564107|Ibandronic Acid|ibandronic acid|mesh-list
101640917|NCT02564107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101640918|NCT02564107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640919|NCT00628667|Esomeprazole|esomeprazole|mesh-list
101640920|NCT00628667|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101640921|NCT00628667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101640922|NCT00628667|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101640923|NCT00628667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101640924|NCT00628667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640926|NCT02858258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101640927|NCT02858258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101640928|NCT02858258|Immunologic Factors|immunologic factors|mesh-ancestor
101640929|NCT02858258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640930|NCT02858258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101640931|NCT01008995|Ustekinumab|ustekinumab|mesh-list
101640932|NCT01008995|Dermatologic Agents|dermatologic agents|mesh-ancestor
101640933|NCT04295993|Norepinephrine|norepinephrine|mesh-list
101640934|NCT04295993|Methylene Blue|methylene blue|mesh-list
101640935|NCT04295993|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101640936|NCT04295993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101640937|NCT04295993|Adrenergic Agents|adrenergic agents|mesh-ancestor
101298022|NCT02002260|Estradiol|estradiol|mesh-list
101640938|NCT04295993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101640939|NCT04295993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640940|NCT04295993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640942|NCT04295993|Autonomic Agents|autonomic agents|mesh-ancestor
101640943|NCT04295993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101640944|NCT04295993|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101640945|NCT04295993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101640946|NCT00743587|Naproxen|naproxen|mesh-list
101640947|NCT00743587|Oxycodone|oxycodone|mesh-list
101640948|NCT00743587|Tramadol|tramadol|mesh-list
101640949|NCT00743587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101640950|NCT00743587|Narcotics|narcotics|mesh-ancestor
101640951|NCT00743587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101640952|NCT00743587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640953|NCT00743587|Analgesics|analgesics|mesh-ancestor
101640954|NCT00743587|Sensory System Agents|sensory system agents|mesh-ancestor
101640955|NCT00743587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101640956|NCT00743587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101640957|NCT00743587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101640958|NCT00743587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101640959|NCT00743587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101640960|NCT00743587|Gout Suppressants|gout suppressants|mesh-ancestor
101640961|NCT00743587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101640962|NCT00743587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101640963|NCT00743587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640965|NCT00957944|Dopamine Agonists|dopamine agonists|mesh-ancestor
101640966|NCT00957944|Dopamine Agents|dopamine agents|mesh-ancestor
101640967|NCT00957944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101640968|NCT00957944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640969|NCT00957944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640970|NCT02871323|Durvalumab|durvalumab|mesh-list
101640971|NCT02871323|Immunoglobulins|immunoglobulins|mesh-list
101640972|NCT02871323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101640973|NCT02871323|Immunoglobulin G|immunoglobulin g|mesh-list
101640974|NCT02871323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101640975|NCT02871323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101640976|NCT02871323|Immunologic Factors|immunologic factors|mesh-ancestor
101640977|NCT02871323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101640978|NCT04296149|Octreotide|octreotide|mesh-list
101640979|NCT04296149|Edotreotide|edotreotide|mesh-list
101640980|NCT04296149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101640981|NCT04296149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101640982|NCT04296149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101640983|NCT04296149|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101640984|NCT04296149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640985|NCT01005875|Sorafenib|sorafenib|mesh-list
101640986|NCT01005875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101640987|NCT01005875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101640988|NCT01005875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101535477|NCT01137604|Bevacizumab|bevacizumab|mesh-list
101640989|NCT01005875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640990|NCT02701088|Mitomycins|mitomycins|mesh-list
101640991|NCT02701088|Mitomycin|mitomycin|mesh-list
101640992|NCT02701088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101640993|NCT02701088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101640994|NCT02701088|Alkylating Agents|alkylating agents|mesh-ancestor
101640995|NCT02701088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101640996|NCT02701088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101640997|NCT02701088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101640998|NCT04279106|Chlorhexidine|chlorhexidine|mesh-list
101640999|NCT04279106|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101641000|NCT04279106|Listerine|listerine|mesh-list
101641001|NCT04279106|Fluorides|fluorides|mesh-list
101641002|NCT04279106|Sodium Fluoride|sodium fluoride|mesh-list
101641003|NCT04279106|Cariostatic Agents|cariostatic agents|mesh-ancestor
101641004|NCT04279106|Protective Agents|protective agents|mesh-ancestor
101641005|NCT04279106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641006|NCT04279106|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101641007|NCT04279106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101641008|NCT04279106|Disinfectants|disinfectants|mesh-ancestor
101641009|NCT04279106|Dermatologic Agents|dermatologic agents|mesh-ancestor
101641010|NCT00743743|Resveratrol|resveratrol|mesh-list
101641011|NCT00743743|Antioxidants|antioxidants|mesh-ancestor
101641012|NCT00743743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641013|NCT00743743|Protective Agents|protective agents|mesh-ancestor
101298096|NCT02002611|Warfarin|warfarin|mesh-list
101641014|NCT00743743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641015|NCT00743743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101641016|NCT00743743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101641018|NCT01005719|Lansoprazole|lansoprazole|mesh-list
101641019|NCT01005719|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
101641020|NCT01005719|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101641021|NCT01005719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101641022|NCT01005719|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101641023|NCT01005719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101641024|NCT01005719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641025|NCT02856854|Cocaine|cocaine|mesh-list
101641026|NCT02856854|Oxazepam|oxazepam|mesh-list
101641027|NCT02856854|Metyrapone|metyrapone|mesh-list
101641028|NCT02856854|Anesthetics, Local|anesthetics, local|mesh-ancestor
101641029|NCT02856854|Anesthetics|anesthetics|mesh-ancestor
101641030|NCT02856854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101641031|NCT02856854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641032|NCT02856854|Sensory System Agents|sensory system agents|mesh-ancestor
101732987|NCT04097847|Vitamin E|vitamin e|mesh-list
101641033|NCT02856854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101641034|NCT02856854|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101641035|NCT02856854|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101641036|NCT02856854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101641037|NCT02856854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101641038|NCT02856854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641039|NCT02856854|Dopamine Agents|dopamine agents|mesh-ancestor
101641040|NCT02856854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101641041|NCT02856854|Antimetabolites|antimetabolites|mesh-ancestor
101641042|NCT02856854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101641043|NCT02856854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101641044|NCT02856854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101641045|NCT02856854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101641046|NCT02856854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101641047|NCT02856854|GABA Modulators|gaba modulators|mesh-ancestor
101641048|NCT02856854|GABA Agents|gaba agents|mesh-ancestor
101641049|NCT02857166|Antibodies|antibodies|mesh-list
101641050|NCT02857166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101641051|NCT02857166|Immunologic Factors|immunologic factors|mesh-ancestor
101641052|NCT02857166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641053|NCT02856932|Methamphetamine|methamphetamine|mesh-list
101641054|NCT02856932|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101641055|NCT02856932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641056|NCT02856932|Sympathomimetics|sympathomimetics|mesh-ancestor
101641057|NCT02856932|Autonomic Agents|autonomic agents|mesh-ancestor
101641058|NCT02856932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101641059|NCT02856932|Dopamine Agents|dopamine agents|mesh-ancestor
101641060|NCT02856932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101641061|NCT02856932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641062|NCT02856932|Adrenergic Agents|adrenergic agents|mesh-ancestor
101641063|NCT02856932|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101641064|NCT02856932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101641065|NCT02856932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101641066|NCT02856932|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101641068|NCT02563951|Antiemetics|antiemetics|mesh-ancestor
101641069|NCT02563951|Autonomic Agents|autonomic agents|mesh-ancestor
101641070|NCT02563951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101641071|NCT02563951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641072|NCT02563951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101641073|NCT02563951|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101733030|NCT00833027|Hormones|hormones|mesh-ancestor
101641074|NCT02563951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101641075|NCT02563951|Serotonin Agents|serotonin agents|mesh-ancestor
101641076|NCT02563951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101641077|NCT02563951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641078|NCT00953576|Ketoconazole|ketoconazole|mesh-list
101641079|NCT00953576|Hydrocortisone|hydrocortisone|mesh-list
101641080|NCT00953576|Lapatinib|lapatinib|mesh-list
101641081|NCT00953576|Dutasteride|dutasteride|mesh-list
101641082|NCT00953576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101641083|NCT00953576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101641084|NCT00953576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101641085|NCT00953576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101641086|NCT00953576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641087|NCT00953576|Antifungal Agents|antifungal agents|mesh-ancestor
101641088|NCT00953576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101641089|NCT00953576|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101641090|NCT00953576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101641091|NCT00953576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101641092|NCT00953576|Hormone Antagonists|hormone antagonists|mesh-ancestor
101641093|NCT00953576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101641094|NCT00953576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733057|NCT00754572|Abortifacient Agents|abortifacient agents|mesh-ancestor
101641095|NCT00953576|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101641096|NCT00953576|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101641098|NCT02100956|Oxytocics|oxytocics|mesh-ancestor
101641099|NCT02100956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101641100|NCT02100956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641101|NCT02073968|Paclitaxel|paclitaxel|mesh-list
101641102|NCT02073968|Carboplatin|carboplatin|mesh-list
101641103|NCT02073968|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101641104|NCT02073968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101641105|NCT02073968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101641106|NCT02073968|Tubulin Modulators|tubulin modulators|mesh-ancestor
101641107|NCT02073968|Antimitotic Agents|antimitotic agents|mesh-ancestor
101641108|NCT02073968|Mitosis Modulators|mitosis modulators|mesh-ancestor
101641109|NCT02073968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641110|NCT01005329|Paclitaxel|paclitaxel|mesh-list
101641111|NCT01005329|Bevacizumab|bevacizumab|mesh-list
101641112|NCT01005329|Cisplatin|cisplatin|mesh-list
101641113|NCT01005329|Carboplatin|carboplatin|mesh-list
101641114|NCT01005329|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101641115|NCT01005329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101641116|NCT01005329|Endothelial Growth Factors|endothelial growth factors|mesh-list
101641117|NCT01005329|Antibodies|antibodies|mesh-list
101641118|NCT01005329|Immunoglobulins|immunoglobulins|mesh-list
101641119|NCT01005329|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101641120|NCT01005329|Immunoglobulin G|immunoglobulin g|mesh-list
101641121|NCT01005329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101641122|NCT01005329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101641123|NCT01005329|Tubulin Modulators|tubulin modulators|mesh-ancestor
101641124|NCT01005329|Antimitotic Agents|antimitotic agents|mesh-ancestor
101641125|NCT01005329|Mitosis Modulators|mitosis modulators|mesh-ancestor
101641126|NCT01005329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641127|NCT01005329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101733110|NCT00761514|Adalimumab|adalimumab|mesh-list
101641128|NCT01005329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101641129|NCT01005329|Growth Substances|growth substances|mesh-ancestor
101641130|NCT01005329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641131|NCT01005329|Growth Inhibitors|growth inhibitors|mesh-ancestor
101641132|NCT01005329|Immunologic Factors|immunologic factors|mesh-ancestor
101641133|NCT00921349|Nadolol|nadolol|mesh-list
101641134|NCT00921349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101641135|NCT00921349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101641136|NCT00921349|Adrenergic Agents|adrenergic agents|mesh-ancestor
101641137|NCT00921349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101641138|NCT00921349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641139|NCT00921349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641140|NCT00921349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101641141|NCT00921349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101641142|NCT00921349|Sympatholytics|sympatholytics|mesh-ancestor
101641143|NCT00921349|Autonomic Agents|autonomic agents|mesh-ancestor
101641144|NCT00921349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101641145|NCT01005251|Lesogaberan|lesogaberan|mesh-list
101641146|NCT01005251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101641147|NCT01005251|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101641148|NCT01005251|GABA Agonists|gaba agonists|mesh-ancestor
101641149|NCT01005251|GABA Agents|gaba agents|mesh-ancestor
101641150|NCT01005251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101641151|NCT01005251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641152|NCT01005251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641153|NCT03048578|Liraglutide|liraglutide|mesh-list
101641154|NCT03048578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101641155|NCT03048578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641156|NCT03048578|Incretins|incretins|mesh-ancestor
101641157|NCT03048578|Hormones|hormones|mesh-ancestor
101641158|NCT03048578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101641159|NCT02856776|Vitamin D|vitamin d|mesh-list
101641160|NCT02856776|Cholecalciferol|cholecalciferol|mesh-list
101641161|NCT02856776|Vitamins|vitamins|mesh-ancestor
101641162|NCT02856776|Micronutrients|micronutrients|mesh-ancestor
101641163|NCT02856776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298240|NCT02003885|Desflurane|desflurane|mesh-list
101641164|NCT02856776|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101641165|NCT02856776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101641166|NCT04296851|Niclosamide|niclosamide|mesh-list
101641167|NCT04296851|Anticestodal Agents|anticestodal agents|mesh-ancestor
101641168|NCT04296851|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101641170|NCT04296851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101641171|NCT04296851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101641172|NCT04296851|Antinematodal Agents|antinematodal agents|mesh-ancestor
101641173|NCT02858024|Dapivirine|dapivirine|mesh-list
101641174|NCT02858024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101641175|NCT02858024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101641176|NCT02858024|Antiviral Agents|antiviral agents|mesh-ancestor
101641177|NCT02858024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101641178|NCT02857946|Linagliptin|linagliptin|mesh-list
101641179|NCT02857946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101641180|NCT02857946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641181|NCT02857946|Incretins|incretins|mesh-ancestor
101641182|NCT02857946|Hormones|hormones|mesh-ancestor
101641183|NCT02857946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101641184|NCT02857946|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101641185|NCT02857946|Protease Inhibitors|protease inhibitors|mesh-ancestor
101641186|NCT02857946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101641187|NCT02857946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641188|NCT02857712|Axitinib|axitinib|mesh-list
101641189|NCT02857712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101641190|NCT02857712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101641191|NCT02857712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101641192|NCT02857712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641193|NCT00696241|Olmesartan|olmesartan|mesh-list
101641194|NCT00696241|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101641195|NCT00696241|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
101641196|NCT00696241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101641197|NCT00696241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101641198|NCT00696241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101641199|NCT00696241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641200|NCT00630968|Levetiracetam|levetiracetam|mesh-list
101641201|NCT00630968|Anticonvulsants|anticonvulsants|mesh-ancestor
101641202|NCT00630968|Nootropic Agents|nootropic agents|mesh-ancestor
101641203|NCT00952484|Immunoglobulin G|immunoglobulin g|mesh-list
101641204|NCT00952484|Immunologic Factors|immunologic factors|mesh-ancestor
101641205|NCT00952484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641206|NCT00689611|Bupropion|bupropion|mesh-list
101641207|NCT00689611|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101641208|NCT00689611|Antidepressive Agents|antidepressive agents|mesh-ancestor
101641209|NCT00689611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101641210|NCT00689611|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101641211|NCT00689611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101733186|NCT00761280|Temozolomide|temozolomide|mesh-list
101641213|NCT00689611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641214|NCT00689611|Dopamine Agents|dopamine agents|mesh-ancestor
101641215|NCT00689611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101641216|NCT00689611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641217|NCT00689611|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101641218|NCT00689611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101641219|NCT00689611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101641220|NCT02563795|Fentanyl|fentanyl|mesh-list
101641221|NCT02563795|Bupivacaine|bupivacaine|mesh-list
101641222|NCT02563795|Anesthetics, Local|anesthetics, local|mesh-ancestor
101641223|NCT02563795|Anesthetics|anesthetics|mesh-ancestor
101641224|NCT02563795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101641225|NCT02563795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641226|NCT02563795|Sensory System Agents|sensory system agents|mesh-ancestor
101641227|NCT02563795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101641228|NCT02563795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101641229|NCT02563795|Narcotics|narcotics|mesh-ancestor
101641230|NCT02563795|Analgesics|analgesics|mesh-ancestor
101733240|NCT00760266|Diuretics|diuretics|mesh-ancestor
101641231|NCT02563795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101641232|NCT02563795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101641233|NCT02563795|Anesthetics, General|anesthetics, general|mesh-ancestor
101641235|NCT04281680|Pasireotide|pasireotide|mesh-list
101641236|NCT04281680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101641237|NCT04281680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101641238|NCT04281680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101641239|NCT04281680|Hormones|hormones|mesh-ancestor
101641240|NCT04281680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101641241|NCT04281680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641242|NCT00744445|Epoetin Alfa|epoetin alfa|mesh-list
101641243|NCT00744445|Hematinics|hematinics|mesh-ancestor
101641244|NCT02854748|Empagliflozin|empagliflozin|mesh-list
101641245|NCT02854748|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101641246|NCT02854748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641247|NCT02854748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101641248|NCT02854748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641250|NCT03881917|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
101641251|NCT03881917|Protease Inhibitors|protease inhibitors|mesh-ancestor
101641252|NCT03881917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101641253|NCT03881917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641254|NCT00744679|Natalizumab|natalizumab|mesh-list
101641255|NCT00744679|Immunologic Factors|immunologic factors|mesh-ancestor
101641256|NCT00744679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641257|NCT04060459|Paclitaxel|paclitaxel|mesh-list
101641258|NCT04060459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101641259|NCT04060459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101641260|NCT04060459|Tubulin Modulators|tubulin modulators|mesh-ancestor
101641261|NCT04060459|Antimitotic Agents|antimitotic agents|mesh-ancestor
101641262|NCT04060459|Mitosis Modulators|mitosis modulators|mesh-ancestor
101641263|NCT04060459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641264|NCT01007435|Methotrexate|methotrexate|mesh-list
101641265|NCT01007435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101641266|NCT01007435|Abortifacient Agents|abortifacient agents|mesh-ancestor
101641267|NCT01007435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101641268|NCT01007435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641269|NCT01007435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101641270|NCT01007435|Antimetabolites|antimetabolites|mesh-ancestor
101641271|NCT01007435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641272|NCT01007435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101641273|NCT01007435|Dermatologic Agents|dermatologic agents|mesh-ancestor
101641274|NCT01007435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101641275|NCT01007435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101733294|NCT00589784|Sunitinib|sunitinib|mesh-list
101641277|NCT01007435|Immunologic Factors|immunologic factors|mesh-ancestor
101641278|NCT01007435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101641279|NCT01007435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101641280|NCT00948896|Pyrimethamine|pyrimethamine|mesh-list
101641281|NCT00948896|Piperaquine|piperaquine|mesh-list
101641282|NCT00948896|Sulfadoxine|sulfadoxine|mesh-list
101641283|NCT00948896|Trimethoprim|trimethoprim|mesh-list
101641284|NCT00948896|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101641285|NCT00948896|Artenimol|artenimol|mesh-list
101641286|NCT00948896|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101641287|NCT00948896|Sulfamethoxazole|sulfamethoxazole|mesh-list
101641288|NCT00948896|Antimalarials|antimalarials|mesh-ancestor
101641289|NCT00948896|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101641290|NCT00948896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101641291|NCT00948896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101641292|NCT00948896|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101641293|NCT00948896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101641294|NCT00948896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641295|NCT00948896|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101641296|NCT00948896|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101641297|NCT00948896|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101641298|NCT00948896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101641299|NCT00948896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101641300|NCT01004159|Irinotecan|irinotecan|mesh-list
101641301|NCT01004159|Cetuximab|cetuximab|mesh-list
101641302|NCT01004159|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101733306|NCT05742854|Oxytocin|oxytocin|mesh-list
101641303|NCT01004159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101641304|NCT01004159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101641305|NCT01004159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641306|NCT01004159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101641307|NCT01004159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101641308|NCT00948818|Linaclotide|linaclotide|mesh-list
101641309|NCT00948818|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
101641310|NCT00948818|Enzyme Activators|enzyme activators|mesh-ancestor
101641311|NCT00948818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641312|NCT00948818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101641313|NCT02854592|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101641314|NCT02854592|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101641315|NCT02854592|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101641316|NCT02854592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641317|NCT00948506|Cidofovir|cidofovir|mesh-list
101641318|NCT00948506|Antiviral Agents|antiviral agents|mesh-ancestor
101641319|NCT00948506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101641320|NCT00948506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101641321|NCT00948506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641323|NCT00689221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101641324|NCT00689221|Alkylating Agents|alkylating agents|mesh-ancestor
101641325|NCT00689221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641326|NCT00689221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101641327|NCT04060771|Dexamethasone|dexamethasone|mesh-list
101641328|NCT04060771|Palonosetron|palonosetron|mesh-list
101641329|NCT04060771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101641331|NCT04060771|Autonomic Agents|autonomic agents|mesh-ancestor
101641332|NCT04060771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101641333|NCT04060771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641334|NCT04060771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101641335|NCT04060771|Glucocorticoids|glucocorticoids|mesh-ancestor
101641336|NCT04060771|Hormones|hormones|mesh-ancestor
101641337|NCT04060771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101641338|NCT04060771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101641339|NCT04060771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101641340|NCT04060771|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101641341|NCT04060771|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101641342|NCT04060771|Serotonin Agents|serotonin agents|mesh-ancestor
101641343|NCT04060771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101641344|NCT04060771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641345|NCT00744913|Nicotine|nicotine|mesh-list
101641346|NCT00744913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101641347|NCT00744913|Autonomic Agents|autonomic agents|mesh-ancestor
101641348|NCT00744913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101641349|NCT00744913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641350|NCT00744913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101641351|NCT00744913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101641352|NCT00744913|Cholinergic Agents|cholinergic agents|mesh-ancestor
101641353|NCT00744913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101641354|NCT00744913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641355|NCT01875445|Inositol|inositol|mesh-list
101641356|NCT01875445|Vitamin B Complex|vitamin b complex|mesh-ancestor
101641357|NCT01875445|Vitamins|vitamins|mesh-ancestor
101641358|NCT01875445|Micronutrients|micronutrients|mesh-ancestor
101641359|NCT01875445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641360|NCT00745069|Tapentadol|tapentadol|mesh-list
101641361|NCT00745069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101641362|NCT00745069|Narcotics|narcotics|mesh-ancestor
101641363|NCT00745069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101641364|NCT00745069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641365|NCT00745069|Analgesics|analgesics|mesh-ancestor
101641366|NCT00745069|Sensory System Agents|sensory system agents|mesh-ancestor
101641367|NCT00745069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101641368|NCT00745069|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101641369|NCT00745069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101641370|NCT00745069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101641371|NCT00745069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641372|NCT00745069|Adrenergic Agents|adrenergic agents|mesh-ancestor
101641373|NCT00745069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101641374|NCT00745147|Laxatives|laxatives|mesh-list
101641375|NCT00745147|Lactulose|lactulose|mesh-list
101641376|NCT00745147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101641377|NCT00688909|Letrozole|letrozole|mesh-list
101641378|NCT00688909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101641379|NCT00688909|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101641380|NCT00688909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101641381|NCT00688909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101641382|NCT00688909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641383|NCT00688909|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101641384|NCT00688909|Hormone Antagonists|hormone antagonists|mesh-ancestor
101641385|NCT00688909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101641386|NCT00688909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641388|NCT00948428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101641389|NCT00948428|Immunologic Factors|immunologic factors|mesh-ancestor
101641390|NCT00948428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641391|NCT00948428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101641392|NCT00948428|Interferon Inducers|interferon inducers|mesh-ancestor
101641393|NCT00948194|Nitric Oxide|nitric oxide|mesh-list
101641394|NCT00948194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101641395|NCT00948194|Autonomic Agents|autonomic agents|mesh-ancestor
101641396|NCT00948194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101641397|NCT00948194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641398|NCT00948194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101641399|NCT00948194|Respiratory System Agents|respiratory system agents|mesh-ancestor
101641400|NCT00948194|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101641401|NCT00948194|Antioxidants|antioxidants|mesh-ancestor
101641402|NCT00948194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641403|NCT00948194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101641404|NCT00948194|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101641405|NCT00948194|Vasodilator Agents|vasodilator agents|mesh-ancestor
101641406|NCT00948194|Gasotransmitters|gasotransmitters|mesh-ancestor
101641407|NCT00948194|Protective Agents|protective agents|mesh-ancestor
101641408|NCT00691483|Varenicline|varenicline|mesh-list
101641409|NCT00691483|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101641410|NCT00691483|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101641411|NCT00691483|Cholinergic Agents|cholinergic agents|mesh-ancestor
101641412|NCT00691483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101641413|NCT00691483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641414|NCT00691483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641415|NCT00691093|Fesoterodine|fesoterodine|mesh-list
101641416|NCT00691093|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101641417|NCT00691093|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101641418|NCT00691093|Cholinergic Agents|cholinergic agents|mesh-ancestor
101641419|NCT00691093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101641420|NCT00691093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641421|NCT00691093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641422|NCT00691093|Urological Agents|urological agents|mesh-ancestor
101641423|NCT03646825|Antioxidants|antioxidants|mesh-list
101641424|NCT03646825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641425|NCT03646825|Protective Agents|protective agents|mesh-ancestor
101641426|NCT03646825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641427|NCT00745225|Pioglitazone|pioglitazone|mesh-list
101641428|NCT00745225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101641429|NCT00745225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641430|NCT02856542|Betamethasone|betamethasone|mesh-list
101641431|NCT02856542|Betamethasone Valerate|betamethasone valerate|mesh-list
101641432|NCT02856542|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101641433|NCT02856542|Betamethasone benzoate|betamethasone benzoate|mesh-list
101641434|NCT02856542|Calcipotriene|calcipotriene|mesh-list
101641435|NCT02856542|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101641436|NCT02856542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101641437|NCT02856542|Glucocorticoids|glucocorticoids|mesh-ancestor
101641438|NCT02856542|Hormones|hormones|mesh-ancestor
101641439|NCT02856542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101641440|NCT02856542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641441|NCT02856542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101641442|NCT02856542|Respiratory System Agents|respiratory system agents|mesh-ancestor
101641443|NCT02856542|Dermatologic Agents|dermatologic agents|mesh-ancestor
101641445|NCT00688753|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101641446|NCT00688753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101641447|NCT00688753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101641448|NCT00688753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641449|NCT00688753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101641450|NCT00688753|Immunologic Factors|immunologic factors|mesh-ancestor
101641451|NCT00688753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641452|NCT00688753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101641453|NCT04204382|Levofloxacin|levofloxacin|mesh-list
101641454|NCT04204382|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101641455|NCT04204382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101641456|NCT04204382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101641457|NCT04204382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101641458|NCT04204382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101641459|NCT04204382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101641460|NCT04204382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641461|NCT04204382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101641462|NCT04204382|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101641463|NCT04204382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101641464|NCT02856230|Paclitaxel|paclitaxel|mesh-list
101641465|NCT02856230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101641466|NCT02856230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101641467|NCT02856230|Tubulin Modulators|tubulin modulators|mesh-ancestor
101641468|NCT02856230|Antimitotic Agents|antimitotic agents|mesh-ancestor
101641469|NCT02856230|Mitosis Modulators|mitosis modulators|mesh-ancestor
101641470|NCT02856230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641471|NCT00631124|Drospirenone|drospirenone|mesh-list
101641472|NCT00631124|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101641473|NCT00631124|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101641474|NCT00631124|Estradiol|estradiol|mesh-list
101641475|NCT00631124|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101641476|NCT00631124|Estrogens|estrogens|mesh-ancestor
101641477|NCT00631124|Hormones|hormones|mesh-ancestor
101641478|NCT00631124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101641479|NCT00631124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641480|NCT00631124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101641481|NCT00631124|Contraceptive Agents|contraceptive agents|mesh-ancestor
101641482|NCT00631124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101641483|NCT00631124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101641484|NCT00631124|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101641485|NCT00631124|Hormone Antagonists|hormone antagonists|mesh-ancestor
101641486|NCT00631124|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101641487|NCT00631124|Diuretics|diuretics|mesh-ancestor
101641488|NCT00631124|Natriuretic Agents|natriuretic agents|mesh-ancestor
101641489|NCT02855684|Insulin|insulin|mesh-list
101641490|NCT02855684|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101641491|NCT02855684|Insulin Glargine|insulin glargine|mesh-list
101641492|NCT02855684|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101641493|NCT02855684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641494|NCT01667744|Citalopram|citalopram|mesh-list
101641495|NCT01667744|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101641496|NCT01667744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101641497|NCT01667744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101641498|NCT01667744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641499|NCT01667744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101641500|NCT01667744|Serotonin Agents|serotonin agents|mesh-ancestor
101641501|NCT01667744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641502|NCT01667744|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101641503|NCT01667744|Antidepressive Agents|antidepressive agents|mesh-ancestor
101641504|NCT01667744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101641505|NCT04274270|Endostar protein|endostar protein|mesh-list
101641506|NCT04274270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101641507|NCT04274270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101641508|NCT04274270|Growth Substances|growth substances|mesh-ancestor
101641509|NCT04274270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641510|NCT04274270|Growth Inhibitors|growth inhibitors|mesh-ancestor
101641511|NCT04274270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101641512|NCT02855294|Drospirenone|drospirenone|mesh-list
101641513|NCT02855294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101641514|NCT02855294|Hormone Antagonists|hormone antagonists|mesh-ancestor
101641515|NCT02855294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101641516|NCT02855294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641517|NCT02855294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101641518|NCT02855294|Diuretics|diuretics|mesh-ancestor
101641519|NCT02855294|Natriuretic Agents|natriuretic agents|mesh-ancestor
101641520|NCT00950690|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101641521|NCT00950690|Latanoprost|latanoprost|mesh-list
101641522|NCT00950690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101641523|NCT02855138|Isotretinoin|isotretinoin|mesh-list
101641524|NCT02855138|Dermatologic Agents|dermatologic agents|mesh-ancestor
101641525|NCT00694369|Acetaminophen|acetaminophen|mesh-list
101641527|NCT00694369|Etoricoxib|etoricoxib|mesh-list
101641528|NCT00694369|Codeine|codeine|mesh-list
101641529|NCT00694369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101641530|NCT00694369|Analgesics|analgesics|mesh-ancestor
101641531|NCT00694369|Sensory System Agents|sensory system agents|mesh-ancestor
101641532|NCT00694369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101641533|NCT00694369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641534|NCT00694369|Antipyretics|antipyretics|mesh-ancestor
101641535|NCT00694369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101641536|NCT00694369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101641537|NCT00694369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101641538|NCT00694369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101641539|NCT00694369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101641540|NCT00694369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641541|NCT00694369|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101641542|NCT00694369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101641543|NCT00694369|Narcotics|narcotics|mesh-ancestor
101641544|NCT00694369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101641545|NCT00694369|Antitussive Agents|antitussive agents|mesh-ancestor
101641546|NCT00694369|Respiratory System Agents|respiratory system agents|mesh-ancestor
101641547|NCT00745693|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
101641548|NCT00745693|BQ 788|bq 788|mesh-list
101641549|NCT00745693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101641550|NCT00745693|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101641551|NCT00745693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641552|NCT00745693|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
101641553|NCT02563405|Doxazosin|doxazosin|mesh-list
101641554|NCT02563405|Nifedipine|nifedipine|mesh-list
101641555|NCT02563405|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101641556|NCT02563405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101641557|NCT02563405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641558|NCT02563405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101641559|NCT02563405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641560|NCT02563405|Vasodilator Agents|vasodilator agents|mesh-ancestor
101641561|NCT02563405|Tocolytic Agents|tocolytic agents|mesh-ancestor
101641562|NCT02563405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101641563|NCT02563405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101641564|NCT02563405|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101641565|NCT02563405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101641566|NCT02563405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101641567|NCT02563405|Adrenergic Agents|adrenergic agents|mesh-ancestor
101641568|NCT02563405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101641569|NCT03412747|Adalimumab|adalimumab|mesh-list
101641570|NCT03412747|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101641571|NCT03412747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101641572|NCT03412747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101641573|NCT00513019|Lamotrigine|lamotrigine|mesh-list
101641574|NCT00513019|Anticonvulsants|anticonvulsants|mesh-list
101641575|NCT00513019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101641576|NCT00513019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101641577|NCT00513019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641578|NCT00513019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101641579|NCT00513019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641580|NCT00513019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101641581|NCT00513019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101641582|NCT00513019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101641583|NCT00513019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101641584|NCT00513019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101641585|NCT00053677|Naltrexone|naltrexone|mesh-list
101641586|NCT00053677|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101641587|NCT00053677|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101641588|NCT00053677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641589|NCT00053677|Sensory System Agents|sensory system agents|mesh-ancestor
101641590|NCT00053677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101641591|NCT00954512|Leucovorin|leucovorin|mesh-list
101641592|NCT00954512|Folic Acid|folic acid|mesh-list
101641593|NCT00954512|Carboplatin|carboplatin|mesh-list
101641594|NCT00954512|Gemcitabine|gemcitabine|mesh-list
101641595|NCT00954512|Trastuzumab|trastuzumab|mesh-list
101641596|NCT00954512|Irinotecan|irinotecan|mesh-list
101641597|NCT00954512|Cetuximab|cetuximab|mesh-list
101641598|NCT00954512|Everolimus|everolimus|mesh-list
101641599|NCT00954512|Epirubicin|epirubicin|mesh-list
101641600|NCT00954512|Levoleucovorin|levoleucovorin|mesh-list
101641601|NCT00954512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101641602|NCT00954512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641603|NCT00954512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101641604|NCT00954512|Antimetabolites|antimetabolites|mesh-ancestor
101641605|NCT00954512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101641606|NCT00954512|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101641607|NCT00954512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101641608|NCT00954512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101641609|NCT00954512|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101641610|NCT00954512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101641611|NCT00954512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101641612|NCT00954512|Immunologic Factors|immunologic factors|mesh-ancestor
101641613|NCT00954512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641614|NCT00954512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101641615|NCT00954512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101641617|NCT00954512|Protective Agents|protective agents|mesh-ancestor
101641618|NCT00954512|Vitamin B Complex|vitamin b complex|mesh-ancestor
101641619|NCT00954512|Vitamins|vitamins|mesh-ancestor
101641620|NCT00954512|Micronutrients|micronutrients|mesh-ancestor
101641621|NCT00954512|Hematinics|hematinics|mesh-ancestor
101641622|NCT00691015|Cytarabine|cytarabine|mesh-list
101641623|NCT00691015|Cyclophosphamide|cyclophosphamide|mesh-list
101641624|NCT00691015|Melphalan|melphalan|mesh-list
101641625|NCT00691015|Busulfan|busulfan|mesh-list
101641626|NCT00691015|Carmustine|carmustine|mesh-list
101641627|NCT00691015|Rituximab|rituximab|mesh-list
101641628|NCT00691015|Fludarabine|fludarabine|mesh-list
101641629|NCT00691015|Fludarabine phosphate|fludarabine phosphate|mesh-list
101641630|NCT00691015|Etoposide|etoposide|mesh-list
101641631|NCT00691015|Thymoglobulin|thymoglobulin|mesh-list
101641632|NCT00691015|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101641633|NCT00691015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101641634|NCT00691015|Immunologic Factors|immunologic factors|mesh-ancestor
101641635|NCT00691015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641636|NCT00691015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101641637|NCT00691015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101641638|NCT00691015|Alkylating Agents|alkylating agents|mesh-ancestor
101641639|NCT00691015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641640|NCT00691015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101641641|NCT00691015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101641642|NCT00691015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101733710|NCT00751023|Modafinil|modafinil|mesh-list
101641643|NCT00691015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101641644|NCT00691015|Antimetabolites|antimetabolites|mesh-ancestor
101641645|NCT00691015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101641646|NCT00691015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101333613|NCT00039832|Abciximab|abciximab|mesh-list
101641647|NCT00691015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101641648|NCT00691015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101641649|NCT00691015|Antiviral Agents|antiviral agents|mesh-ancestor
101641650|NCT00691015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101641651|NCT00950300|Cyclophosphamide|cyclophosphamide|mesh-list
101641652|NCT00950300|Docetaxel|docetaxel|mesh-list
101641653|NCT00950300|Fluorouracil|fluorouracil|mesh-list
101641654|NCT00950300|Trastuzumab|trastuzumab|mesh-list
101641655|NCT00950300|Epirubicin|epirubicin|mesh-list
101641656|NCT00950300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101641657|NCT00950300|Immunologic Factors|immunologic factors|mesh-ancestor
101641658|NCT00950300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641659|NCT00950300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101641660|NCT00950300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101641661|NCT00950300|Alkylating Agents|alkylating agents|mesh-ancestor
101641662|NCT00950300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641663|NCT00950300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101641664|NCT00950300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101641665|NCT00950300|Tubulin Modulators|tubulin modulators|mesh-ancestor
101641666|NCT00950300|Antimitotic Agents|antimitotic agents|mesh-ancestor
101641667|NCT00950300|Mitosis Modulators|mitosis modulators|mesh-ancestor
101641668|NCT00950300|Antimetabolites|antimetabolites|mesh-ancestor
101641669|NCT00950300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101641670|NCT00950300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101641671|NCT00950300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101641672|NCT00950300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101641673|NCT00950300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101641674|NCT00950300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101641676|NCT00949988|Dasatinib|dasatinib|mesh-list
101641677|NCT00949988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101641678|NCT00949988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101641679|NCT00949988|Immunologic Factors|immunologic factors|mesh-ancestor
101641680|NCT00949988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641681|NCT00949988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101641682|NCT00949988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101641683|NCT00949988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101641684|NCT00949988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641685|NCT00731692|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101641686|NCT00731692|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101641687|NCT00731692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641688|NCT00731692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101641689|NCT00731692|Immunologic Factors|immunologic factors|mesh-ancestor
101641690|NCT00731692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641692|NCT02593474|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101641693|NCT02593474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101641694|NCT02593474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641695|NCT02593474|Sensory System Agents|sensory system agents|mesh-ancestor
101641696|NCT02593474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101641697|NCT00687193|Tofacitinib|tofacitinib|mesh-list
101641698|NCT00687193|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101641699|NCT00687193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101641700|NCT00687193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101641701|NCT00687193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641702|NCT00917878|Calcium|calcium|mesh-list
101641703|NCT00917878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101641704|NCT00917878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641705|NCT00730912|Loratadine|loratadine|mesh-list
101641706|NCT00730912|Antipruritics|antipruritics|mesh-ancestor
101641707|NCT00730912|Dermatologic Agents|dermatologic agents|mesh-ancestor
101641708|NCT00730912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101641709|NCT00730912|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101641710|NCT00730912|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101641711|NCT00730912|Histamine Antagonists|histamine antagonists|mesh-ancestor
101641712|NCT00730912|Histamine Agents|histamine agents|mesh-ancestor
101641713|NCT00730912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101641714|NCT00730912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641715|NCT00730912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641716|NCT00730756|Fluticasone|fluticasone|mesh-list
101641718|NCT00730756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101333620|NCT00039988|Albuterol|albuterol|mesh-list
101641719|NCT00730756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101641720|NCT00730756|Autonomic Agents|autonomic agents|mesh-ancestor
101641721|NCT00730756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101641722|NCT00730756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641723|NCT00730756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101641724|NCT00730756|Respiratory System Agents|respiratory system agents|mesh-ancestor
101641725|NCT00730756|Dermatologic Agents|dermatologic agents|mesh-ancestor
101641726|NCT00730756|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101641727|NCT00730132|Ezetimibe|ezetimibe|mesh-list
101641728|NCT00730132|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101641729|NCT00730132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101641730|NCT00730132|Antimetabolites|antimetabolites|mesh-ancestor
101641731|NCT00730132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641732|NCT00730132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101641733|NCT00737464|Epoetin Alfa|epoetin alfa|mesh-list
101641734|NCT00737464|Hematinics|hematinics|mesh-ancestor
101641735|NCT00729586|Tamoxifen|tamoxifen|mesh-list
101641736|NCT00729586|Sirolimus|sirolimus|mesh-list
101641738|NCT00729586|Megestrol|megestrol|mesh-list
101641739|NCT00729586|Megestrol Acetate|megestrol acetate|mesh-list
101641740|NCT00729586|MTOR Inhibitors|mtor inhibitors|mesh-list
101641741|NCT00729586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641742|NCT00729586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101641743|NCT00729586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101641744|NCT00729586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101641745|NCT00729586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101641746|NCT00729586|Antifungal Agents|antifungal agents|mesh-ancestor
101641747|NCT00729586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101641748|NCT00729586|Immunologic Factors|immunologic factors|mesh-ancestor
101641749|NCT00729586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641750|NCT00729586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101641751|NCT00729586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101641752|NCT00729586|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101641753|NCT00729586|Hormone Antagonists|hormone antagonists|mesh-ancestor
101641754|NCT00729586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101641755|NCT00729586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101641756|NCT00729586|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101641757|NCT00729586|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101641758|NCT00729586|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101641759|NCT00729586|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101641760|NCT00729586|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101641761|NCT00729586|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101641762|NCT00729586|Contraceptive Agents|contraceptive agents|mesh-ancestor
101641763|NCT00729586|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101641764|NCT00729586|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101641765|NCT00729586|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101641766|NCT00729586|Appetite Stimulants|appetite stimulants|mesh-ancestor
101641767|NCT00729586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101641768|NCT00949910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101641769|NCT00949910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101641770|NCT00949910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101641771|NCT00949910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101641772|NCT00949910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641773|NCT02594800|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101641774|NCT02594800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101641775|NCT02594800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101641776|NCT02594800|Antimetabolites|antimetabolites|mesh-ancestor
101641777|NCT02594800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641778|NCT02594800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101641779|NCT02594800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101641780|NCT02594800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101641781|NCT02593162|Ribavirin|ribavirin|mesh-list
101641782|NCT02593162|Antimetabolites|antimetabolites|mesh-ancestor
101641783|NCT02593162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641784|NCT02593162|Antiviral Agents|antiviral agents|mesh-ancestor
101641785|NCT02593162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101641786|NCT00686959|Paclitaxel|paclitaxel|mesh-list
101641787|NCT00686959|Etoposide|etoposide|mesh-list
101641788|NCT00686959|Vinorelbine|vinorelbine|mesh-list
101641789|NCT00686959|Carboplatin|carboplatin|mesh-list
101641790|NCT00686959|Pemetrexed|pemetrexed|mesh-list
101641791|NCT00686959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101641792|NCT00686959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101641793|NCT00686959|Tubulin Modulators|tubulin modulators|mesh-ancestor
101641794|NCT00686959|Antimitotic Agents|antimitotic agents|mesh-ancestor
101641795|NCT00686959|Mitosis Modulators|mitosis modulators|mesh-ancestor
101641796|NCT00686959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641797|NCT00686959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101641798|NCT00686959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101641799|NCT00686959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101641800|NCT00686959|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101641801|NCT00686959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101641802|NCT04088110|Trastuzumab|trastuzumab|mesh-list
101641803|NCT04088110|Letrozole|letrozole|mesh-list
101641804|NCT04088110|Anastrozole|anastrozole|mesh-list
101641805|NCT04088110|Exemestane|exemestane|mesh-list
101641806|NCT04088110|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101641807|NCT04088110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101641808|NCT04088110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101641809|NCT04088110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101641810|NCT04088110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101641811|NCT04088110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641812|NCT04088110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101641813|NCT04088110|Hormone Antagonists|hormone antagonists|mesh-ancestor
101641814|NCT04088110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101641815|NCT04088110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641816|NCT04088110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101641817|NCT04088266|Buprenorphine|buprenorphine|mesh-list
101641818|NCT04088266|Naloxone|naloxone|mesh-list
101641819|NCT04088266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101641820|NCT04088266|Narcotics|narcotics|mesh-ancestor
101641821|NCT04088266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101641822|NCT04088266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641823|NCT04088266|Analgesics|analgesics|mesh-ancestor
101641824|NCT04088266|Sensory System Agents|sensory system agents|mesh-ancestor
101641825|NCT04088266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101641826|NCT04088266|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101641827|NCT05311579|Niraparib|niraparib|mesh-list
101641828|NCT05311579|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101641829|NCT05311579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101641830|NCT05311579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641831|NCT05311579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101641832|NCT00602342|Terbinafine|terbinafine|mesh-list
101641833|NCT00602342|Antifungal Agents|antifungal agents|mesh-ancestor
101641834|NCT00602342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101641835|NCT00602342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101641836|NCT00602342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641837|NCT00602498|Clarithromycin|clarithromycin|mesh-list
101641838|NCT00602498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101641839|NCT00602498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101641840|NCT00602498|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101641841|NCT00602498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101641842|NCT00602498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641843|NCT00602498|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101641844|NCT00602498|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101641846|NCT00749359|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101641847|NCT00749359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101641848|NCT00749359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101641849|NCT00749359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641850|NCT00749359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101641851|NCT00749359|Serotonin Agents|serotonin agents|mesh-ancestor
101641852|NCT00749359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641853|NCT00749359|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101641854|NCT00749359|Antidepressive Agents|antidepressive agents|mesh-ancestor
101641855|NCT00749359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101641856|NCT00749359|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101641857|NCT00749359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101641858|NCT00749359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101641859|NCT00946088|Progesterone|progesterone|mesh-list
101641860|NCT00946088|Progestins|progestins|mesh-ancestor
101641861|NCT00946088|Hormones|hormones|mesh-ancestor
101641862|NCT00946088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101641863|NCT00946088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641864|NCT02562313|Insulin Lispro|insulin lispro|mesh-list
101641865|NCT02562313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101641866|NCT02562313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641867|NCT00736996|Pioglitazone|pioglitazone|mesh-list
101641868|NCT00736996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101641869|NCT00736996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641870|NCT00741949|Propofol|propofol|mesh-list
101641871|NCT00741949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101641872|NCT00741949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101641873|NCT00741949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641874|NCT00741949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101641875|NCT00741949|Anesthetics, General|anesthetics, general|mesh-ancestor
101641876|NCT00741949|Anesthetics|anesthetics|mesh-ancestor
101641877|NCT01410344|Vidarabine|vidarabine|mesh-list
101641878|NCT01410344|Cyclophosphamide|cyclophosphamide|mesh-list
101641879|NCT01410344|Melphalan|melphalan|mesh-list
101641880|NCT01410344|Busulfan|busulfan|mesh-list
101641881|NCT01410344|Fludarabine|fludarabine|mesh-list
101641882|NCT01410344|Fludarabine phosphate|fludarabine phosphate|mesh-list
101641883|NCT01410344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101641884|NCT01410344|Immunologic Factors|immunologic factors|mesh-ancestor
101641885|NCT01410344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641886|NCT01410344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101641887|NCT01410344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101641888|NCT01410344|Alkylating Agents|alkylating agents|mesh-ancestor
101641889|NCT01410344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641890|NCT01410344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101641891|NCT01410344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101641892|NCT01410344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101641893|NCT01410344|Antimetabolites|antimetabolites|mesh-ancestor
101641894|NCT01410344|Antiviral Agents|antiviral agents|mesh-ancestor
101641895|NCT01410344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101641896|NCT02594410|Lercanidipine|lercanidipine|mesh-list
101641897|NCT02594410|Clopidogrel|clopidogrel|mesh-list
101641898|NCT02594410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101641899|NCT02594410|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101641900|NCT02594410|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101641901|NCT02594410|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101641902|NCT02594410|Purinergic Agents|purinergic agents|mesh-ancestor
101641903|NCT02594410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101641904|NCT02594410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734038|NCT00813917|Cholinergic Agents|cholinergic agents|mesh-ancestor
101641905|NCT02594410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641907|NCT02594410|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101641908|NCT02594410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101641909|NCT02594410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101641910|NCT00954122|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101641911|NCT00954122|Antidepressive Agents|antidepressive agents|mesh-ancestor
101641912|NCT00954122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101641913|NCT00954122|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101641914|NCT00954122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101641915|NCT00954122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101641916|NCT00954122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641917|NCT00586066|Memantine|memantine|mesh-list
101641918|NCT00586066|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101641919|NCT00586066|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101641920|NCT00586066|Dopamine Agents|dopamine agents|mesh-ancestor
101641921|NCT00586066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101641922|NCT00586066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641923|NCT00586066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641924|NCT00586066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101641925|NCT00586066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101641926|NCT00630890|Capecitabine|capecitabine|mesh-list
101641927|NCT00630890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101641928|NCT00630890|Antimetabolites|antimetabolites|mesh-ancestor
101641929|NCT00630890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641930|NCT00630890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101641931|NCT00728494|Ribavirin|ribavirin|mesh-list
101641932|NCT00728494|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101641933|NCT00728494|Interferon-alpha|interferon-alpha|mesh-list
101641934|NCT00728494|Antimetabolites|antimetabolites|mesh-ancestor
101641935|NCT00728494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641936|NCT00728494|Antiviral Agents|antiviral agents|mesh-ancestor
101641937|NCT00728494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101641938|NCT00728494|Immunologic Factors|immunologic factors|mesh-ancestor
101641939|NCT00728494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641940|NCT02854904|Dexmedetomidine|dexmedetomidine|mesh-list
101641941|NCT02854904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101641942|NCT02854904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101641943|NCT02854904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641944|NCT02854904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101641945|NCT02854904|Analgesics|analgesics|mesh-ancestor
101641946|NCT02854904|Sensory System Agents|sensory system agents|mesh-ancestor
101641947|NCT02854904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101641948|NCT02854904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101641949|NCT02854904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101641950|NCT02854904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101641951|NCT02854904|Adrenergic Agents|adrenergic agents|mesh-ancestor
101641952|NCT02854904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101641953|NCT02854904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641954|NCT00728416|Mometasone Furoate|mometasone furoate|mesh-list
101641955|NCT00728416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101641956|NCT00728416|Dermatologic Agents|dermatologic agents|mesh-ancestor
101641957|NCT00728416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101641959|NCT00941330|Docetaxel|docetaxel|mesh-list
101641960|NCT00941330|Exemestane|exemestane|mesh-list
101641961|NCT00941330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101641962|NCT00941330|Immunologic Factors|immunologic factors|mesh-ancestor
101641963|NCT00941330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641964|NCT00941330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101641965|NCT00941330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101641966|NCT00941330|Alkylating Agents|alkylating agents|mesh-ancestor
101641967|NCT00941330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641968|NCT00941330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101641969|NCT00941330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101641970|NCT00941330|Tubulin Modulators|tubulin modulators|mesh-ancestor
101641971|NCT00941330|Antimitotic Agents|antimitotic agents|mesh-ancestor
101734116|NCT00918021|Serotonin Agents|serotonin agents|mesh-ancestor
101641972|NCT00941330|Mitosis Modulators|mitosis modulators|mesh-ancestor
101641973|NCT00941330|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101641974|NCT00941330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101641975|NCT00941330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101641976|NCT00941330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101641977|NCT00941330|Hormone Antagonists|hormone antagonists|mesh-ancestor
101641978|NCT00941330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101641979|NCT00736450|Prednisone|prednisone|mesh-list
101641980|NCT00736450|Cyclophosphamide|cyclophosphamide|mesh-list
101641981|NCT00736450|Rituximab|rituximab|mesh-list
101641982|NCT00736450|Doxorubicin|doxorubicin|mesh-list
101641983|NCT00736450|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101641984|NCT00736450|Vincristine|vincristine|mesh-list
101641985|NCT00736450|Oblimersen|oblimersen|mesh-list
101641986|NCT00736450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101641987|NCT00736450|Immunologic Factors|immunologic factors|mesh-ancestor
101641988|NCT00736450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101641989|NCT00736450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101641990|NCT00736450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101641991|NCT00736450|Alkylating Agents|alkylating agents|mesh-ancestor
101641992|NCT00736450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101641993|NCT00736450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101641994|NCT00736450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101641995|NCT00736450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101734160|NCT04088175|Antipruritics|antipruritics|mesh-ancestor
101641996|NCT00736450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101641997|NCT00736450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101641998|NCT00736450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101641999|NCT00736450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101642000|NCT00736450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101642003|NCT00736450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101642004|NCT00736450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101642005|NCT00736450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101642006|NCT00736450|Tubulin Modulators|tubulin modulators|mesh-ancestor
101642007|NCT00736450|Antimitotic Agents|antimitotic agents|mesh-ancestor
101642008|NCT00736450|Mitosis Modulators|mitosis modulators|mesh-ancestor
101642009|NCT00686881|Interferons|interferons|mesh-list
101642010|NCT00686881|Interferon-alpha|interferon-alpha|mesh-list
101642011|NCT00686881|Interferon alpha-2|interferon alpha-2|mesh-list
101642012|NCT00686881|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101642013|NCT00686881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101642014|NCT00686881|Antiviral Agents|antiviral agents|mesh-ancestor
101642015|NCT00686881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101642016|NCT00686881|Immunologic Factors|immunologic factors|mesh-ancestor
101642017|NCT00686881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642018|NCT02857244|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101642019|NCT02857244|Modafinil|modafinil|mesh-list
101642020|NCT02857244|Donepezil|donepezil|mesh-list
101642021|NCT02857244|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101642022|NCT02857244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101642023|NCT02857244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101642024|NCT02857244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642025|NCT02857244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101642026|NCT02857244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642027|NCT02857244|Analgesics|analgesics|mesh-ancestor
101642028|NCT02857244|Sensory System Agents|sensory system agents|mesh-ancestor
101642029|NCT02857244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101642030|NCT02857244|Antidepressive Agents|antidepressive agents|mesh-ancestor
101642031|NCT02857244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101642032|NCT02857244|Dopamine Agents|dopamine agents|mesh-ancestor
101642033|NCT02857244|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101642034|NCT02857244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101642035|NCT02857244|Cholinergic Agents|cholinergic agents|mesh-ancestor
101642037|NCT02857244|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101642038|NCT02857244|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101642039|NCT02857244|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101642040|NCT02857244|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101642041|NCT04273256|Inositol|inositol|mesh-list
101642042|NCT04273256|Vitamin B Complex|vitamin b complex|mesh-ancestor
101642043|NCT04273256|Vitamins|vitamins|mesh-ancestor
101642044|NCT04273256|Micronutrients|micronutrients|mesh-ancestor
101642045|NCT04273256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642046|NCT00921661|Aflibercept|aflibercept|mesh-list
101642047|NCT00921661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101642048|NCT00921661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101642049|NCT00921661|Growth Substances|growth substances|mesh-ancestor
101642050|NCT00921661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642051|NCT00921661|Growth Inhibitors|growth inhibitors|mesh-ancestor
101642052|NCT00921661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101642053|NCT04088032|Durvalumab|durvalumab|mesh-list
101642054|NCT04088032|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101642055|NCT04088032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101642056|NCT04088032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101734253|NCT02609087|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101642057|NCT04088032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101642058|NCT04088032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101642059|NCT04088032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642060|NCT04088032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101642061|NCT04088032|Hormone Antagonists|hormone antagonists|mesh-ancestor
101642062|NCT04088032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101642063|NCT04088032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642064|NCT00688597|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
101642065|NCT00688597|Antiviral Agents|antiviral agents|mesh-ancestor
101642066|NCT00688597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101642067|NCT00688597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101642068|NCT00688597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642069|NCT00735904|Gemcitabine|gemcitabine|mesh-list
101642070|NCT00735904|Axitinib|axitinib|mesh-list
101642071|NCT00735904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101642072|NCT00735904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101642073|NCT00735904|Antimetabolites|antimetabolites|mesh-ancestor
101642074|NCT00735904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642075|NCT00735904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101642076|NCT00735904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101642078|NCT02561923|Tranexamic Acid|tranexamic acid|mesh-list
101642079|NCT02561923|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101642080|NCT02561923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101642081|NCT02561923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642082|NCT02561923|Hemostatics|hemostatics|mesh-ancestor
101642083|NCT02561923|Coagulants|coagulants|mesh-ancestor
101642084|NCT02561923|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101642085|NCT02561923|Antithrombins|antithrombins|mesh-ancestor
101642086|NCT02561923|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101642087|NCT02561923|Protease Inhibitors|protease inhibitors|mesh-ancestor
101642088|NCT02561923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101642089|NCT02561923|Anticoagulants|anticoagulants|mesh-ancestor
101642090|NCT00918190|Dexamethasone|dexamethasone|mesh-list
101642091|NCT00918190|Dexamethasone acetate|dexamethasone acetate|mesh-list
101642093|NCT00918190|Ondansetron|ondansetron|mesh-list
101642094|NCT00918190|BB 1101|bb 1101|mesh-list
101642095|NCT00918190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101642096|NCT00918190|Antiemetics|antiemetics|mesh-ancestor
101642097|NCT00918190|Autonomic Agents|autonomic agents|mesh-ancestor
101642098|NCT00918190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101642099|NCT00918190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642100|NCT00918190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101642101|NCT00918190|Glucocorticoids|glucocorticoids|mesh-ancestor
101642102|NCT00918190|Hormones|hormones|mesh-ancestor
101642103|NCT00918190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101642104|NCT00918190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101642105|NCT00918190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101642106|NCT00918190|Protease Inhibitors|protease inhibitors|mesh-ancestor
101642107|NCT00918190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101642108|NCT00918190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642109|NCT00918190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101642110|NCT00918190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101642111|NCT00918190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101642112|NCT00918190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101642113|NCT00918190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101642114|NCT00918190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101642115|NCT00918190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101642116|NCT00918190|Anesthetics, General|anesthetics, general|mesh-ancestor
101642117|NCT00918190|Anesthetics|anesthetics|mesh-ancestor
101642118|NCT00918190|GABA Modulators|gaba modulators|mesh-ancestor
101642119|NCT00918190|GABA Agents|gaba agents|mesh-ancestor
101642120|NCT00918190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101642121|NCT00918190|Antipruritics|antipruritics|mesh-ancestor
101642122|NCT00918190|Dermatologic Agents|dermatologic agents|mesh-ancestor
101642123|NCT00918190|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101642124|NCT00918190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101642125|NCT00918190|Serotonin Agents|serotonin agents|mesh-ancestor
101642126|NCT02563327|Pyridoxine|pyridoxine|mesh-list
101642127|NCT02563327|Vitamin B 6|vitamin b 6|mesh-list
101642128|NCT02563327|Moxifloxacin|moxifloxacin|mesh-list
101642129|NCT02563327|Rifampin|rifampin|mesh-list
101642130|NCT02563327|Isoniazid|isoniazid|mesh-list
101642131|NCT02563327|Pyrazinamide|pyrazinamide|mesh-list
101642132|NCT02563327|Ethambutol|ethambutol|mesh-list
101642133|NCT02563327|Rifapentine|rifapentine|mesh-list
101642134|NCT02563327|Vitamins|vitamins|mesh-ancestor
101642135|NCT02563327|Micronutrients|micronutrients|mesh-ancestor
101642136|NCT02563327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642137|NCT02563327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101642138|NCT02563327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101642139|NCT02563327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101642140|NCT02563327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101642141|NCT02563327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101642142|NCT02563327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642143|NCT02563327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101642144|NCT02563327|Vitamin B Complex|vitamin b complex|mesh-ancestor
101642145|NCT02563327|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101642146|NCT02563327|Antitubercular Agents|antitubercular agents|mesh-ancestor
101642147|NCT02563327|Leprostatic Agents|leprostatic agents|mesh-ancestor
101642148|NCT02563327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101642149|NCT02563327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101642150|NCT02563327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101642151|NCT02563327|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101642152|NCT02563327|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101642153|NCT02563327|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101642154|NCT02563327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101642155|NCT02563327|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101642156|NCT02563327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101642157|NCT02563327|Antimetabolites|antimetabolites|mesh-ancestor
101642158|NCT02563327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101642160|NCT00918034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101642161|NCT00918034|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101642162|NCT00918034|Dermatologic Agents|dermatologic agents|mesh-ancestor
101642163|NCT02593942|Remifentanil|remifentanil|mesh-list
101642164|NCT02593942|Propofol|propofol|mesh-list
101642165|NCT02593942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101642166|NCT02593942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101642167|NCT02593942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642168|NCT02593942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101642169|NCT02593942|Anesthetics, General|anesthetics, general|mesh-ancestor
101642170|NCT02593942|Anesthetics|anesthetics|mesh-ancestor
101642171|NCT02593942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101642172|NCT02593942|Narcotics|narcotics|mesh-ancestor
101734447|NCT05754242|Vitamins|vitamins|mesh-ancestor
101642173|NCT02593942|Analgesics|analgesics|mesh-ancestor
101642174|NCT02593942|Sensory System Agents|sensory system agents|mesh-ancestor
101642175|NCT02593942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101642176|NCT00742339|Octreotide|octreotide|mesh-list
101642177|NCT00742339|Terlipressin|terlipressin|mesh-list
101642178|NCT00742339|Midodrine|midodrine|mesh-list
101642179|NCT00742339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101642180|NCT00742339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101642181|NCT00742339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101642182|NCT00742339|Sympathomimetics|sympathomimetics|mesh-ancestor
101642183|NCT00742339|Autonomic Agents|autonomic agents|mesh-ancestor
101642184|NCT00742339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101642185|NCT00742339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642186|NCT00742339|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101642187|NCT00742339|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101642188|NCT00742339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101642189|NCT00742339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101642190|NCT00742339|Adrenergic Agents|adrenergic agents|mesh-ancestor
101642191|NCT00742339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101642192|NCT00742339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642193|NCT00742339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101642195|NCT02592772|Nicotine|nicotine|mesh-list
101642196|NCT02592772|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101642197|NCT02592772|Autonomic Agents|autonomic agents|mesh-ancestor
101642198|NCT02592772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101642199|NCT02592772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642200|NCT02592772|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101642201|NCT02592772|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101642202|NCT02592772|Cholinergic Agents|cholinergic agents|mesh-ancestor
101642203|NCT02592772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101642204|NCT02592772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642205|NCT02592772|Antipruritics|antipruritics|mesh-ancestor
101642206|NCT02592772|Dermatologic Agents|dermatologic agents|mesh-ancestor
101642207|NCT00631202|Epoetin Alfa|epoetin alfa|mesh-list
101642208|NCT00631202|Hematinics|hematinics|mesh-ancestor
101642209|NCT02851784|Immunomodulating Agents|immunomodulating agents|mesh-list
101642210|NCT02851784|Immunologic Factors|immunologic factors|mesh-ancestor
101642211|NCT02851784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642212|NCT00721630|Capecitabine|capecitabine|mesh-list
101642213|NCT00721630|Lapatinib|lapatinib|mesh-list
101642214|NCT00721630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101642215|NCT00721630|Antimetabolites|antimetabolites|mesh-ancestor
101642216|NCT00721630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642217|NCT00721630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101642218|NCT00721630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101642219|NCT00721630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101642220|NCT00686725|Temozolomide|temozolomide|mesh-list
101642221|NCT00686725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101642222|NCT00686725|Alkylating Agents|alkylating agents|mesh-ancestor
101642223|NCT00686725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642224|NCT00686725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101642225|NCT04055623|Aldesleukin|aldesleukin|mesh-list
101642226|NCT04055623|Interleukin-2|interleukin-2|mesh-list
101642227|NCT04055623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101642228|NCT04055623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101642229|NCT04055623|Analgesics|analgesics|mesh-ancestor
101642230|NCT04055623|Sensory System Agents|sensory system agents|mesh-ancestor
101642231|NCT04055623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101642232|NCT04055623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642233|NCT04055623|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101642234|NCT04055623|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101642235|NCT04055623|Antiviral Agents|antiviral agents|mesh-ancestor
101642236|NCT04055623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101642237|NCT02561845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101642238|NCT02561845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101642239|NCT02561845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101642240|NCT02561845|Antimetabolites|antimetabolites|mesh-ancestor
101642241|NCT02561845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642242|NCT02561845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101642243|NCT02561845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101642245|NCT00727246|Choline|choline|mesh-list
101642246|NCT00727246|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
101642247|NCT00727246|Lipotropic Agents|lipotropic agents|mesh-ancestor
101642248|NCT00727246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101642249|NCT00727246|Antimetabolites|antimetabolites|mesh-ancestor
101642250|NCT00727246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642251|NCT00727246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101642252|NCT00727246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101642253|NCT00727246|Nootropic Agents|nootropic agents|mesh-ancestor
101642254|NCT05381558|Triamcinolone|triamcinolone|mesh-list
101642255|NCT05381558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101642256|NCT05381558|Glucocorticoids|glucocorticoids|mesh-ancestor
101642257|NCT05381558|Hormones|hormones|mesh-ancestor
101642258|NCT05381558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101642259|NCT05381558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642260|NCT04055233|Biguanides|biguanides|mesh-list
101642261|NCT04055233|Polihexanide|polihexanide|mesh-list
101642262|NCT04055233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101642263|NCT04055233|Disinfectants|disinfectants|mesh-ancestor
101642264|NCT04055233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101642265|NCT04055233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642266|NCT04268966|Brincidofovir|brincidofovir|mesh-list
101642267|NCT04268966|Antiviral Agents|antiviral agents|mesh-ancestor
101642268|NCT04268966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101642269|NCT04269278|Dexmedetomidine|dexmedetomidine|mesh-list
101642270|NCT04269278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101734572|NCT02605460|Immunologic Factors|immunologic factors|mesh-ancestor
101642271|NCT04269278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101642272|NCT04269278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642273|NCT04269278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101642274|NCT04269278|Analgesics|analgesics|mesh-ancestor
101642275|NCT04269278|Sensory System Agents|sensory system agents|mesh-ancestor
101642276|NCT04269278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101642277|NCT04269278|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101642278|NCT04269278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101642279|NCT04269278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101642280|NCT04269278|Adrenergic Agents|adrenergic agents|mesh-ancestor
101642281|NCT04269278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101642282|NCT04269278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642283|NCT02853578|Budesonide|budesonide|mesh-list
101642284|NCT02853578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101642285|NCT02853578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101642286|NCT02853578|Autonomic Agents|autonomic agents|mesh-ancestor
101642287|NCT02853578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101642288|NCT02853578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642289|NCT02853578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101642290|NCT02853578|Respiratory System Agents|respiratory system agents|mesh-ancestor
101642291|NCT02853578|Glucocorticoids|glucocorticoids|mesh-ancestor
101642292|NCT02853578|Hormones|hormones|mesh-ancestor
101642293|NCT02853578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101642294|NCT02592694|Tenecteplase|tenecteplase|mesh-list
101642295|NCT02592694|Tirofiban|tirofiban|mesh-list
101642296|NCT02592694|Bivalirudin|bivalirudin|mesh-list
101642297|NCT02592694|Antithrombins|antithrombins|mesh-ancestor
101642298|NCT02592694|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101642299|NCT02592694|Protease Inhibitors|protease inhibitors|mesh-ancestor
101642300|NCT02592694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101642301|NCT02592694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642302|NCT02592694|Anticoagulants|anticoagulants|mesh-ancestor
101642303|NCT02592694|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101642304|NCT02592694|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101642305|NCT02592694|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101642306|NCT02591836|Atorvastatin|atorvastatin|mesh-list
101734619|NCT02604914|Levodopa|levodopa|mesh-list
101642307|NCT02591836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101642308|NCT02591836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101642309|NCT02591836|Antimetabolites|antimetabolites|mesh-ancestor
101642310|NCT02591836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642311|NCT02591836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101642312|NCT02591836|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101642313|NCT02591836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101642314|NCT02851472|Nitric Oxide|nitric oxide|mesh-list
101642315|NCT02851472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101642316|NCT02851472|Autonomic Agents|autonomic agents|mesh-ancestor
101642317|NCT02851472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101642318|NCT02851472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642319|NCT02851472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101642320|NCT02851472|Respiratory System Agents|respiratory system agents|mesh-ancestor
101642321|NCT02851472|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101642322|NCT02851472|Antioxidants|antioxidants|mesh-ancestor
101642323|NCT02851472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642324|NCT02851472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101642325|NCT02851472|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101642326|NCT02851472|Vasodilator Agents|vasodilator agents|mesh-ancestor
101642327|NCT02851472|Gasotransmitters|gasotransmitters|mesh-ancestor
101642328|NCT02851472|Protective Agents|protective agents|mesh-ancestor
101642329|NCT00687973|Atenolol|atenolol|mesh-list
101642330|NCT00687973|Amlodipine|amlodipine|mesh-list
101642331|NCT00687973|Valsartan|valsartan|mesh-list
101642332|NCT00687973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101642333|NCT00687973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101642334|NCT00687973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101642335|NCT00687973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642336|NCT00687973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101642337|NCT00687973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642338|NCT00687973|Vasodilator Agents|vasodilator agents|mesh-ancestor
101642339|NCT00687973|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101642340|NCT00687973|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101642341|NCT00687973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101642342|NCT00687973|Sympatholytics|sympatholytics|mesh-ancestor
101642343|NCT00687973|Autonomic Agents|autonomic agents|mesh-ancestor
101642344|NCT00687973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101642345|NCT00687973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101642346|NCT00687973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101642347|NCT00687973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101642348|NCT00687973|Adrenergic Agents|adrenergic agents|mesh-ancestor
101642349|NCT00687973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101642350|NCT00747097|Gemcitabine|gemcitabine|mesh-list
101642351|NCT00747097|Cetuximab|cetuximab|mesh-list
101642352|NCT00747097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101642353|NCT00747097|Antimetabolites|antimetabolites|mesh-ancestor
101642354|NCT00747097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642355|NCT00747097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101642356|NCT00747097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101642357|NCT00747331|Fenoldopam|fenoldopam|mesh-list
101642358|NCT00747331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101642359|NCT00747331|Vasodilator Agents|vasodilator agents|mesh-ancestor
101642360|NCT00747331|Dopamine Agonists|dopamine agonists|mesh-ancestor
101642361|NCT00747331|Dopamine Agents|dopamine agents|mesh-ancestor
101642362|NCT00747331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101642363|NCT00747331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642364|NCT00747331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642365|NCT00747409|Insulin|insulin|mesh-list
101642366|NCT00747409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101642367|NCT00747409|Insulin Aspart|insulin aspart|mesh-list
101642368|NCT00747409|Insulin Detemir|insulin detemir|mesh-list
101642369|NCT00747409|Insulin, Long-Acting|insulin, long-acting|mesh-list
101642370|NCT00747409|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101642371|NCT00747409|Insulin, Isophane|insulin, isophane|mesh-list
101642372|NCT00747409|Isophane Insulin, Human|isophane insulin, human|mesh-list
101642373|NCT00747409|Isophane insulin, beef|isophane insulin, beef|mesh-list
101642374|NCT00747409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101642375|NCT00747409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642376|NCT00752011|Carboplatin|carboplatin|mesh-list
101642377|NCT00752011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101642378|NCT00721396|Vaccines|vaccines|mesh-list
101642379|NCT00721396|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101642380|NCT00721396|Immunologic Factors|immunologic factors|mesh-ancestor
101642381|NCT00721396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642382|NCT00943826|Bevacizumab|bevacizumab|mesh-list
101642383|NCT00943826|Temozolomide|temozolomide|mesh-list
101642384|NCT00943826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101642385|NCT00943826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101642386|NCT00943826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101642387|NCT00943826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101642388|NCT00943826|Growth Substances|growth substances|mesh-ancestor
101734685|NCT02608931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101642389|NCT00943826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642390|NCT00943826|Growth Inhibitors|growth inhibitors|mesh-ancestor
101642391|NCT00943826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101642392|NCT00943826|Alkylating Agents|alkylating agents|mesh-ancestor
101642393|NCT00943826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642394|NCT04268888|Nivolumab|nivolumab|mesh-list
101642395|NCT04268888|Chlorotrianisene|chlorotrianisene|mesh-list
101642396|NCT04268888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101642397|NCT04268888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101642398|NCT04268888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101642399|NCT04268888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642400|NCT04268888|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101642401|NCT04268888|Estrogens|estrogens|mesh-ancestor
101642402|NCT04268888|Hormones|hormones|mesh-ancestor
101642403|NCT04268888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101642404|NCT04268888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642405|NCT04268888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101642406|NCT00603356|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101642407|NCT00603356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101642408|NCT00603356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101642409|NCT00603356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101642410|NCT00603356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642411|NCT02851394|Tramadol|tramadol|mesh-list
101642413|NCT02851394|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101642414|NCT02851394|Narcotics|narcotics|mesh-ancestor
101642415|NCT02851394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101642416|NCT02851394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642417|NCT02851394|Analgesics|analgesics|mesh-ancestor
101642418|NCT02851394|Sensory System Agents|sensory system agents|mesh-ancestor
101642419|NCT02851394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101642420|NCT02851394|Anesthetics, Local|anesthetics, local|mesh-ancestor
101642421|NCT02851394|Anesthetics|anesthetics|mesh-ancestor
101642422|NCT00603434|Methylphenidate|methylphenidate|mesh-list
101642423|NCT00603434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101642424|NCT00603434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642425|NCT00603434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101642426|NCT00603434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101642427|NCT00603434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101642428|NCT00603434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642430|NCT00603434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101642431|NCT01004003|Sorafenib|sorafenib|mesh-list
101642432|NCT01004003|Nintedanib|nintedanib|mesh-list
101642433|NCT01004003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101642434|NCT01004003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101642435|NCT01004003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101642436|NCT01004003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642437|NCT00943670|Trastuzumab|trastuzumab|mesh-list
101642438|NCT00943670|Pertuzumab|pertuzumab|mesh-list
101642439|NCT00943670|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101642441|NCT00943670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101642442|NCT00943670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101642443|NCT00943670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101642444|NCT00943670|Tubulin Modulators|tubulin modulators|mesh-ancestor
101642445|NCT00943670|Antimitotic Agents|antimitotic agents|mesh-ancestor
101642446|NCT00943670|Mitosis Modulators|mitosis modulators|mesh-ancestor
101642447|NCT00943670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642448|NCT00943670|Immunotoxins|immunotoxins|mesh-ancestor
101642449|NCT00943670|Immunoconjugates|immunoconjugates|mesh-ancestor
101642450|NCT00943670|Immunologic Factors|immunologic factors|mesh-ancestor
101734767|NCT00591149|Docetaxel|docetaxel|mesh-list
101642451|NCT00943670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642452|NCT02851004|Pembrolizumab|pembrolizumab|mesh-list
101642453|NCT02851004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101642454|NCT02851004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101642455|NCT02851004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101642456|NCT02851004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642457|NCT00938366|Cladribine|cladribine|mesh-list
101642458|NCT00938366|Pantoprazole|pantoprazole|mesh-list
101642459|NCT00938366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101642460|NCT00938366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101642461|NCT00938366|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101642462|NCT00938366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101642463|NCT00938366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642464|NCT00938366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101642465|NCT00938366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101642466|NCT00938366|Immunologic Factors|immunologic factors|mesh-ancestor
101642467|NCT00938366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642468|NCT00943592|Melphalan|melphalan|mesh-list
101642469|NCT00943592|Alemtuzumab|alemtuzumab|mesh-list
101642470|NCT00943592|Clofarabine|clofarabine|mesh-list
101642471|NCT00943592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101642472|NCT00943592|Alkylating Agents|alkylating agents|mesh-ancestor
101642473|NCT00943592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642474|NCT00943592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101642475|NCT00943592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101642476|NCT00943592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101642477|NCT00943592|Immunologic Factors|immunologic factors|mesh-ancestor
101642478|NCT00943592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642479|NCT00943592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101642480|NCT00943592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101642481|NCT00943592|Antimetabolites|antimetabolites|mesh-ancestor
101642482|NCT00943124|Niacin|niacin|mesh-list
101642484|NCT00943124|Nicotinic Acids|nicotinic acids|mesh-list
101642485|NCT00943124|Simvastatin|simvastatin|mesh-list
101642486|NCT00943124|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101642487|NCT00943124|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101642488|NCT00943124|Antimetabolites|antimetabolites|mesh-ancestor
101642489|NCT00943124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642490|NCT00943124|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101642491|NCT00943124|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101642492|NCT00943124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101642493|NCT00943124|Vasodilator Agents|vasodilator agents|mesh-ancestor
101642494|NCT00943124|Vitamin B Complex|vitamin b complex|mesh-ancestor
101642495|NCT00943124|Vitamins|vitamins|mesh-ancestor
101642496|NCT00943124|Micronutrients|micronutrients|mesh-ancestor
101642497|NCT00943124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642498|NCT00492050|Valacyclovir|valacyclovir|mesh-list
101642499|NCT00492050|Rituximab|rituximab|mesh-list
101642500|NCT00492050|Bortezomib|bortezomib|mesh-list
101642501|NCT00492050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101642502|NCT00492050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101642503|NCT00492050|Immunologic Factors|immunologic factors|mesh-ancestor
101642504|NCT00492050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642505|NCT00492050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101642506|NCT00492050|Antiviral Agents|antiviral agents|mesh-ancestor
101642507|NCT00492050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101642508|NCT00940316|Irinotecan|irinotecan|mesh-list
101642509|NCT00940316|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101642510|NCT00940316|Panitumumab|panitumumab|mesh-list
101642511|NCT00940316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101642512|NCT00940316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101642513|NCT00940316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101642514|NCT00940316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299584|NCT05651594|Vitamins|vitamins|mesh-ancestor
101642515|NCT00940316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101642516|NCT00940316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101642517|NCT00940316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101642518|NCT02850848|Entecavir|entecavir|mesh-list
101642519|NCT02850848|Antiviral Agents|antiviral agents|mesh-ancestor
101642520|NCT02850848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101642521|NCT05381168|Calcium, Dietary|calcium, dietary|mesh-list
101642522|NCT05381168|Calcium Carbonate|calcium carbonate|mesh-list
101642523|NCT05381168|Calcium|calcium|mesh-list
101642524|NCT05381168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101642525|NCT05381168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642526|NCT05381168|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101642527|NCT05381168|Antacids|antacids|mesh-ancestor
101642528|NCT05381168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642529|NCT05381168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101642530|NCT00726388|Diclofenac|diclofenac|mesh-list
101642531|NCT00726388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101642532|NCT00726388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101642533|NCT00726388|Analgesics|analgesics|mesh-ancestor
101642534|NCT00726388|Sensory System Agents|sensory system agents|mesh-ancestor
101642535|NCT00726388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101642536|NCT00726388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642537|NCT00726388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101642538|NCT00726388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101642539|NCT00726388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101642540|NCT00726388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101642541|NCT00726388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642542|NCT00572455|Latanoprost|latanoprost|mesh-list
101642543|NCT00572455|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101642544|NCT00572455|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101642545|NCT00752323|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101642546|NCT00752323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101642547|NCT00752323|Dermatologic Agents|dermatologic agents|mesh-ancestor
101642548|NCT00686335|Prednisone|prednisone|mesh-list
101642549|NCT00686335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101642550|NCT00686335|Glucocorticoids|glucocorticoids|mesh-ancestor
101642551|NCT00686335|Hormones|hormones|mesh-ancestor
101642552|NCT00686335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101642553|NCT00686335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642554|NCT00686335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101642555|NCT00686335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101642557|NCT00685945|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
101642558|NCT00685945|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
101642559|NCT00685945|Sildenafil Citrate|sildenafil citrate|mesh-list
101642560|NCT00685945|Bradykinin|bradykinin|mesh-list
101642561|NCT00685945|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
101642562|NCT00685945|Kininogens|kininogens|mesh-list
101642564|NCT00685945|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101642565|NCT00685945|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101642566|NCT00685945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101642567|NCT00685945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642568|NCT00685945|Urological Agents|urological agents|mesh-ancestor
101642569|NCT00685945|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101642570|NCT00685945|Diuretics|diuretics|mesh-ancestor
101642571|NCT00685945|Natriuretic Agents|natriuretic agents|mesh-ancestor
101642572|NCT00685945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642573|NCT00685945|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101642574|NCT00685945|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
101642575|NCT00685945|Protease Inhibitors|protease inhibitors|mesh-ancestor
101642577|NCT00747487|Antioxidants|antioxidants|mesh-ancestor
101642578|NCT00747487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642579|NCT00747487|Protective Agents|protective agents|mesh-ancestor
101642580|NCT00747487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642581|NCT00750217|Buprenorphine|buprenorphine|mesh-list
101642582|NCT00750217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101642583|NCT00750217|Narcotics|narcotics|mesh-ancestor
101642584|NCT00750217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101642585|NCT00750217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642586|NCT00750217|Analgesics|analgesics|mesh-ancestor
101642587|NCT00750217|Sensory System Agents|sensory system agents|mesh-ancestor
101642588|NCT00750217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101642589|NCT00750217|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101299668|NCT05561543|Peppermint oil|peppermint oil|mesh-list
101642590|NCT00687739|Leuprolide|leuprolide|mesh-list
101642592|NCT00687739|Estrogens|estrogens|mesh-ancestor
101642593|NCT00687739|Hormones|hormones|mesh-ancestor
101642594|NCT00687739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101642595|NCT00687739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734926|NCT02604134|Fluorides|fluorides|mesh-list
101734927|NCT02604134|Fluorides, Topical|fluorides, topical|mesh-list
101642596|NCT00687739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101642597|NCT00687739|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101642598|NCT00687739|Fertility Agents|fertility agents|mesh-ancestor
101642599|NCT00687739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101642600|NCT00687739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101642601|NCT00752401|Vitamin D|vitamin d|mesh-list
101642602|NCT00752401|Cholecalciferol|cholecalciferol|mesh-list
101642603|NCT00752401|Vitamins|vitamins|mesh-ancestor
101642604|NCT00752401|Micronutrients|micronutrients|mesh-ancestor
101642605|NCT00752401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642606|NCT00752401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101642607|NCT00752401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101642608|NCT00750451|Heparin|heparin|mesh-list
101642609|NCT00750451|Enoxaparin|enoxaparin|mesh-list
101642610|NCT00750451|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101642611|NCT00750451|Tinzaparin|tinzaparin|mesh-list
101642612|NCT00750451|Dalteparin|dalteparin|mesh-list
101642613|NCT00750451|Enoxaparin sodium|enoxaparin sodium|mesh-list
101642614|NCT00750451|Anticoagulants|anticoagulants|mesh-ancestor
101642615|NCT00750451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101642616|NCT00750451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101642617|NCT00750451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642618|NCT00747721|Dexmedetomidine|dexmedetomidine|mesh-list
101642619|NCT00747721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101642620|NCT00747721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101642621|NCT00747721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642622|NCT00747721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101642623|NCT00747721|Analgesics|analgesics|mesh-ancestor
101642624|NCT00747721|Sensory System Agents|sensory system agents|mesh-ancestor
101642625|NCT00747721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101642626|NCT00747721|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101642627|NCT00747721|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101642628|NCT00747721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101642629|NCT00747721|Adrenergic Agents|adrenergic agents|mesh-ancestor
101642630|NCT00747721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101642631|NCT00747721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642632|NCT01006889|Exenatide|exenatide|mesh-list
101642633|NCT01006889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101642634|NCT01006889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642635|NCT01006889|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101642636|NCT01006889|Incretins|incretins|mesh-ancestor
101642637|NCT01006889|Hormones|hormones|mesh-ancestor
101642638|NCT01006889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101642639|NCT02561767|Mycophenolic Acid|mycophenolic acid|mesh-list
101642640|NCT02561767|Tacrolimus|tacrolimus|mesh-list
101642641|NCT02561767|Basiliximab|basiliximab|mesh-list
101642642|NCT02561767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101642643|NCT02561767|Immunologic Factors|immunologic factors|mesh-ancestor
101642644|NCT02561767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642645|NCT02561767|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101642646|NCT02561767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101642647|NCT02561767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642648|NCT02561767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101642649|NCT02561767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101642650|NCT02561767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101642651|NCT02561767|Antitubercular Agents|antitubercular agents|mesh-ancestor
101642652|NCT02561767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101642653|NCT02561767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101642654|NCT00747799|Fluorouracil|fluorouracil|mesh-list
101642656|NCT00747799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101642657|NCT00747799|Antimetabolites|antimetabolites|mesh-ancestor
101642658|NCT00747799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642659|NCT00747799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101642660|NCT00747799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101642661|NCT00747799|Immunologic Factors|immunologic factors|mesh-ancestor
101642662|NCT00747799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642663|NCT00747799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101642664|NCT00747799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101642665|NCT04294823|Esomeprazole|esomeprazole|mesh-list
101642666|NCT04294823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101642667|NCT04294823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101642668|NCT04294823|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101642669|NCT04294823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101642670|NCT04294823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642671|NCT04294511|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101735065|NCT04113668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101642672|NCT04294511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642673|NCT04294511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101642674|NCT04294511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101642677|NCT01001429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101642678|NCT01001429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101642679|NCT01001429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642680|NCT01001429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101642681|NCT01001429|Analgesics|analgesics|mesh-ancestor
101642682|NCT01001429|Sensory System Agents|sensory system agents|mesh-ancestor
101642683|NCT01001429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101642684|NCT01001429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101642685|NCT01001429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101642686|NCT01001429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101642687|NCT01001429|Adrenergic Agents|adrenergic agents|mesh-ancestor
101642688|NCT01001429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101642689|NCT01001429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642690|NCT01001429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101642691|NCT01001429|Anesthetics, General|anesthetics, general|mesh-ancestor
101642692|NCT01001429|Anesthetics|anesthetics|mesh-ancestor
101642693|NCT01000961|Cysteamine|cysteamine|mesh-list
101642694|NCT01000961|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
101642695|NCT01000961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642696|NCT01000805|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101642697|NCT01000805|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101642698|NCT01000805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101642699|NCT01000805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101735114|NCT00725205|Ribavirin|ribavirin|mesh-list
101642700|NCT01000805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642701|NCT01000805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101642702|NCT01000805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642703|NCT01000805|Analgesics|analgesics|mesh-ancestor
101642704|NCT01000805|Sensory System Agents|sensory system agents|mesh-ancestor
101642705|NCT01000805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101642706|NCT01000805|Antidepressive Agents|antidepressive agents|mesh-ancestor
101642707|NCT01000805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101642708|NCT01000805|Dopamine Agents|dopamine agents|mesh-ancestor
101642709|NCT00684307|Vitamin K|vitamin k|mesh-list
101642710|NCT00684307|Warfarin|warfarin|mesh-list
101642711|NCT00684307|Vitamins|vitamins|mesh-ancestor
101642712|NCT00684307|Micronutrients|micronutrients|mesh-ancestor
101642713|NCT00684307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642714|NCT00684307|Anticoagulants|anticoagulants|mesh-ancestor
101642715|NCT00684307|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101642716|NCT00684307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101642717|NCT00684307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642718|NCT00684307|Hemostatics|hemostatics|mesh-ancestor
101642719|NCT00684307|Coagulants|coagulants|mesh-ancestor
101642720|NCT00683917|Leuprolide|leuprolide|mesh-list
101642721|NCT00683917|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101642722|NCT00683917|Fertility Agents|fertility agents|mesh-ancestor
101642723|NCT00683917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101642724|NCT00683917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642725|NCT00683917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101642726|NCT00683917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101642727|NCT00750529|Donepezil|donepezil|mesh-list
101642728|NCT00750529|Galantamine|galantamine|mesh-list
101642729|NCT00750529|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101642730|NCT00750529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101642731|NCT00750529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642732|NCT00750529|Cholinergic Agents|cholinergic agents|mesh-ancestor
101735159|NCT00724893|Interferons|interferons|mesh-list
101642733|NCT00750529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101642734|NCT00750529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642735|NCT00750529|Nootropic Agents|nootropic agents|mesh-ancestor
101642736|NCT00750529|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101642737|NCT00750529|Autonomic Agents|autonomic agents|mesh-ancestor
101642738|NCT00750529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101642739|NCT00747877|Cyclophosphamide|cyclophosphamide|mesh-list
101642740|NCT00747877|Melphalan|melphalan|mesh-list
101642741|NCT00747877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101642742|NCT00747877|Immunologic Factors|immunologic factors|mesh-ancestor
101642743|NCT00747877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642744|NCT00747877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101642745|NCT00747877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101642746|NCT00747877|Alkylating Agents|alkylating agents|mesh-ancestor
101642747|NCT00747877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642748|NCT00747877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101642749|NCT00747877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101642750|NCT00750763|Picosulfate sodium|picosulfate sodium|mesh-list
101642751|NCT00750763|Cathartics|cathartics|mesh-ancestor
101642752|NCT00750763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101642753|NCT00752479|Cyclosporine|cyclosporine|mesh-list
101642754|NCT00752479|Mycophenolic Acid|mycophenolic acid|mesh-list
101642755|NCT00752479|Methylprednisolone|methylprednisolone|mesh-list
101642756|NCT00752479|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101642757|NCT00752479|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101642758|NCT00752479|Prednisolone|prednisolone|mesh-list
101642759|NCT00752479|Prednisolone acetate|prednisolone acetate|mesh-list
101642760|NCT00752479|Cyclosporins|cyclosporins|mesh-list
101642761|NCT00752479|Basiliximab|basiliximab|mesh-list
101642762|NCT00752479|Thymoglobulin|thymoglobulin|mesh-list
101642763|NCT00752479|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101642764|NCT00752479|Prednisolone phosphate|prednisolone phosphate|mesh-list
101642765|NCT00752479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101642766|NCT00752479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642767|NCT00752479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101642768|NCT00752479|Immunologic Factors|immunologic factors|mesh-ancestor
101642769|NCT00752479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642770|NCT00752479|Antifungal Agents|antifungal agents|mesh-ancestor
101642771|NCT00752479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101735256|NCT00738894|Dipyridamole|dipyridamole|mesh-list
101642772|NCT00752479|Dermatologic Agents|dermatologic agents|mesh-ancestor
101642773|NCT00752479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101642774|NCT00752479|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101642775|NCT00752479|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101642776|NCT00752479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101642777|NCT00752479|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101642778|NCT00752479|Antitubercular Agents|antitubercular agents|mesh-ancestor
101642779|NCT00752479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101642780|NCT00752479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101642781|NCT00752479|Antiemetics|antiemetics|mesh-ancestor
101642782|NCT00752479|Autonomic Agents|autonomic agents|mesh-ancestor
101642783|NCT00752479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101642784|NCT00752479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101642785|NCT00752479|Glucocorticoids|glucocorticoids|mesh-ancestor
101642787|NCT00752479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101642788|NCT00752479|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101642789|NCT00752479|Protective Agents|protective agents|mesh-ancestor
101642790|NCT00752479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101642791|NCT00752635|Moxifloxacin|moxifloxacin|mesh-list
101642792|NCT00752635|Cyproterone Acetate|cyproterone acetate|mesh-list
101642793|NCT00752635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101642794|NCT00752635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101642795|NCT00752635|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101642796|NCT00752635|Norgestimate|norgestimate|mesh-list
101642797|NCT00752635|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101642798|NCT00752635|Estradiol|estradiol|mesh-list
101642799|NCT00752635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101642800|NCT00752635|Cyproterone|cyproterone|mesh-list
101642801|NCT00752635|Estrogens|estrogens|mesh-ancestor
101642802|NCT00752635|Hormones|hormones|mesh-ancestor
101642803|NCT00752635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101642804|NCT00752635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642805|NCT00752635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101642806|NCT00752635|Contraceptive Agents|contraceptive agents|mesh-ancestor
101642807|NCT00752635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101642808|NCT00752635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101642809|NCT00752635|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101642810|NCT00752635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101642811|NCT00752635|Androgen Antagonists|androgen antagonists|mesh-ancestor
101642812|NCT00752635|Hormone Antagonists|hormone antagonists|mesh-ancestor
101642813|NCT00752635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101642814|NCT00752635|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101642815|NCT00752635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101642816|NCT00752635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101642817|NCT00752635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101642818|NCT00752635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101642819|NCT00752635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101642820|NCT00752635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101642821|NCT00752635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642822|NCT00752635|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101642823|NCT00750997|Dextrans|dextrans|mesh-list
101642824|NCT00750997|Anticoagulants|anticoagulants|mesh-ancestor
101642825|NCT00750997|Plasma Substitutes|plasma substitutes|mesh-ancestor
101642826|NCT00750997|Blood Substitutes|blood substitutes|mesh-ancestor
101642827|NCT00748345|Caspofungin|caspofungin|mesh-list
101642828|NCT00748345|Antifungal Agents|antifungal agents|mesh-ancestor
101642829|NCT00748345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101642830|NCT00748345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101642831|NCT00748345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642832|NCT00752869|Dutasteride|dutasteride|mesh-list
101642833|NCT00752869|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101642834|NCT00752869|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101642835|NCT00752869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101642836|NCT00752869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642837|NCT00752869|Hormone Antagonists|hormone antagonists|mesh-ancestor
101642838|NCT00752869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101642839|NCT00752869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642840|NCT00751153|Raltegravir Potassium|raltegravir potassium|mesh-list
101642841|NCT00751153|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101642842|NCT00751153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101642843|NCT00751153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101642844|NCT00751153|Antiviral Agents|antiviral agents|mesh-ancestor
101642845|NCT00751153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101642846|NCT00751153|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101642847|NCT00751153|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101642848|NCT00751153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101642849|NCT00751153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642850|NCT00751153|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101642851|NCT00751153|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101642852|NCT00751153|Protease Inhibitors|protease inhibitors|mesh-ancestor
101642853|NCT00748423|Nitric Oxide|nitric oxide|mesh-list
101642854|NCT00748423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101642855|NCT00748423|Autonomic Agents|autonomic agents|mesh-ancestor
101642856|NCT00748423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101642857|NCT00748423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642858|NCT00748423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101642859|NCT00748423|Respiratory System Agents|respiratory system agents|mesh-ancestor
101642860|NCT00748423|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101642861|NCT00748423|Antioxidants|antioxidants|mesh-ancestor
101642862|NCT00748423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642863|NCT00748423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101642864|NCT00748423|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101642865|NCT00748423|Vasodilator Agents|vasodilator agents|mesh-ancestor
101642866|NCT00748423|Gasotransmitters|gasotransmitters|mesh-ancestor
101642867|NCT00748423|Protective Agents|protective agents|mesh-ancestor
101642868|NCT00687271|Atorvastatin|atorvastatin|mesh-list
101642869|NCT00687271|Calcium|calcium|mesh-list
101642870|NCT00687271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101642871|NCT00687271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642872|NCT00687271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101642873|NCT00687271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101642874|NCT00687271|Antimetabolites|antimetabolites|mesh-ancestor
101642875|NCT00687271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642876|NCT00687271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101642877|NCT00687271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101642878|NCT00687271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101642879|NCT02562625|Pembrolizumab|pembrolizumab|mesh-list
101642880|NCT02562625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101642881|NCT02562625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101642882|NCT02562625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101642883|NCT02562625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642884|NCT00752947|Moxifloxacin|moxifloxacin|mesh-list
101642885|NCT00752947|Metronidazole|metronidazole|mesh-list
101642886|NCT00752947|Levofloxacin|levofloxacin|mesh-list
101642887|NCT00752947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101642888|NCT00752947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101642889|NCT00752947|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101642890|NCT00752947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101642891|NCT00752947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101642892|NCT00752947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642893|NCT00752947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101642894|NCT00752947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101642895|NCT00752947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101642896|NCT00752947|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101642897|NCT00752947|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101642898|NCT00752947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101642900|NCT04614545|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101642901|NCT04614545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642902|NCT04614545|Appetite Depressants|appetite depressants|mesh-ancestor
101642903|NCT04614545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101642904|NCT04614545|Sympathomimetics|sympathomimetics|mesh-ancestor
101642905|NCT04614545|Autonomic Agents|autonomic agents|mesh-ancestor
101642906|NCT04614545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101642907|NCT04614545|Adrenergic Agents|adrenergic agents|mesh-ancestor
101642908|NCT04614545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101642909|NCT04614545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642910|NCT01031381|Bevacizumab|bevacizumab|mesh-list
101642911|NCT01031381|Everolimus|everolimus|mesh-list
101642912|NCT01031381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101642913|NCT01031381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101642914|NCT01031381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101642915|NCT01031381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101642917|NCT01031381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642918|NCT01031381|Growth Inhibitors|growth inhibitors|mesh-ancestor
101642919|NCT01031381|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101642920|NCT01031381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101642921|NCT01031381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101642922|NCT01031381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642923|NCT01031381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101642924|NCT01031381|Immunologic Factors|immunologic factors|mesh-ancestor
101642925|NCT00685399|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101642926|NCT00685399|Immunologic Factors|immunologic factors|mesh-ancestor
101642927|NCT00685399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642928|NCT00751699|Mesalamine|mesalamine|mesh-list
101642929|NCT00751699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101642930|NCT00751699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101642931|NCT00751699|Analgesics|analgesics|mesh-ancestor
101642932|NCT00751699|Sensory System Agents|sensory system agents|mesh-ancestor
101642933|NCT00751699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101642934|NCT00751699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642935|NCT00751699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101642936|NCT00751699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101642937|NCT00753103|Mycophenolic Acid|mycophenolic acid|mesh-list
101642938|NCT00753103|Methylprednisolone|methylprednisolone|mesh-list
101642939|NCT00753103|Prednisolone|prednisolone|mesh-list
101642940|NCT00753103|Infliximab|infliximab|mesh-list
101642941|NCT00753103|Cyclophosphamide|cyclophosphamide|mesh-list
101642942|NCT00753103|Azathioprine|azathioprine|mesh-list
101642943|NCT00753103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101642944|NCT00753103|Immunologic Factors|immunologic factors|mesh-ancestor
101642945|NCT00753103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642946|NCT00753103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101642947|NCT00753103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101642948|NCT00753103|Alkylating Agents|alkylating agents|mesh-ancestor
101642949|NCT00753103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642950|NCT00753103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101642951|NCT00753103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101642952|NCT00753103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101642953|NCT00753103|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101642954|NCT00753103|Antitubercular Agents|antitubercular agents|mesh-ancestor
101642955|NCT00753103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101642956|NCT00753103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101642957|NCT00753103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101642958|NCT00753103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101642960|NCT00753103|Autonomic Agents|autonomic agents|mesh-ancestor
101642961|NCT00753103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101642962|NCT00753103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101642963|NCT00753103|Glucocorticoids|glucocorticoids|mesh-ancestor
101642964|NCT00753103|Hormones|hormones|mesh-ancestor
101642965|NCT00753103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101642966|NCT00753103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101642967|NCT00753103|Protective Agents|protective agents|mesh-ancestor
101642968|NCT00753103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101642969|NCT00753103|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101642970|NCT00753103|Dermatologic Agents|dermatologic agents|mesh-ancestor
101642971|NCT00753103|Antimetabolites|antimetabolites|mesh-ancestor
101642972|NCT00753103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101642974|NCT00748891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101642975|NCT00748891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101642976|NCT00748891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101642977|NCT00748891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642978|NCT00685165|Primidone|primidone|mesh-list
101642979|NCT00685165|Anticonvulsants|anticonvulsants|mesh-ancestor
101642980|NCT00685165|GABA Modulators|gaba modulators|mesh-ancestor
101642982|NCT00685165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101642983|NCT00685165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101642984|NCT00685165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642985|NCT00749047|Pioglitazone|pioglitazone|mesh-list
101642986|NCT00749047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101642987|NCT00749047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642988|NCT05393713|Antibodies|antibodies|mesh-list
101642989|NCT05393713|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101642990|NCT05393713|Immunologic Factors|immunologic factors|mesh-ancestor
101642991|NCT05393713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642992|NCT00751855|Hydrocortisone|hydrocortisone|mesh-list
101642993|NCT00751855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101642994|NCT00755833|Insulin Aspart|insulin aspart|mesh-list
101642995|NCT00755833|Biphasic Insulins|biphasic insulins|mesh-list
101642996|NCT00755833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101642997|NCT00755833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101642998|NCT00753493|Topiramate|topiramate|mesh-list
101642999|NCT00753493|Anticonvulsants|anticonvulsants|mesh-ancestor
101643000|NCT00753493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101643001|NCT00753493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643002|NCT00753571|Cardiac Glycosides|cardiac glycosides|mesh-list
101643003|NCT00753571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101643004|NCT00753571|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101643005|NCT00753571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101643006|NCT00753571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643007|NCT00753571|Protective Agents|protective agents|mesh-ancestor
101643008|NCT00753571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643009|NCT00753727|Sunitinib|sunitinib|mesh-list
101643010|NCT00753727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101643011|NCT00753727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101643012|NCT00753727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101643014|NCT00753727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643015|NCT00753727|Growth Inhibitors|growth inhibitors|mesh-ancestor
101643016|NCT00753727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101643017|NCT00753727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101643018|NCT00753727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643019|NCT00755989|Morphine|morphine|mesh-list
101643020|NCT00755989|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101643021|NCT00755989|Narcotics|narcotics|mesh-ancestor
101643022|NCT00755989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101643023|NCT00755989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643024|NCT00755989|Analgesics|analgesics|mesh-ancestor
101643025|NCT00755989|Sensory System Agents|sensory system agents|mesh-ancestor
101643026|NCT00755989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101643027|NCT00756067|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101643028|NCT00756067|Immunologic Factors|immunologic factors|mesh-ancestor
101643029|NCT00756067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643030|NCT04053205|Paclitaxel|paclitaxel|mesh-list
101643031|NCT04053205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101643032|NCT04053205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101643033|NCT04053205|Tubulin Modulators|tubulin modulators|mesh-ancestor
101643034|NCT04053205|Antimitotic Agents|antimitotic agents|mesh-ancestor
101643035|NCT04053205|Mitosis Modulators|mitosis modulators|mesh-ancestor
101643036|NCT04053205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643037|NCT02559973|Buprenorphine|buprenorphine|mesh-list
101643038|NCT02559973|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101643039|NCT02559973|Naloxone|naloxone|mesh-list
101643040|NCT02559973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101643041|NCT02559973|Narcotics|narcotics|mesh-ancestor
101643042|NCT02559973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101643043|NCT02559973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101643044|NCT02559973|Analgesics|analgesics|mesh-ancestor
101643045|NCT02559973|Sensory System Agents|sensory system agents|mesh-ancestor
101643046|NCT02559973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101643047|NCT02559973|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101643048|NCT00753883|Simvastatin|simvastatin|mesh-list
101643049|NCT00753883|Ezetimibe|ezetimibe|mesh-list
101643050|NCT00753883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101643051|NCT00753883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101643052|NCT00753883|Antimetabolites|antimetabolites|mesh-ancestor
101643053|NCT00753883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101643054|NCT00753883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101643055|NCT00753883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101712207|NCT00594464|Dopamine Agents|dopamine agents|mesh-ancestor
101712208|NCT00594464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101712209|NCT00594464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712210|NCT00594464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712211|NCT00682760|Botulinum Toxins|botulinum toxins|mesh-list
101712212|NCT00682760|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101712213|NCT00682760|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101712214|NCT00682760|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101712215|NCT00682760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101369657|NCT00398489|Tamoxifen|tamoxifen|mesh-list
101712216|NCT00682760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712217|NCT00682760|Cholinergic Agents|cholinergic agents|mesh-ancestor
101712218|NCT00682760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101712219|NCT00682760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712220|NCT00682760|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101796199|NCT01014832|Insulin|insulin|mesh-list
101712221|NCT00682760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101712222|NCT05326269|Terbutaline|terbutaline|mesh-list
101712223|NCT05326269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101712224|NCT05326269|Autonomic Agents|autonomic agents|mesh-ancestor
101712225|NCT05326269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101712226|NCT05326269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712227|NCT05326269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101712228|NCT05326269|Respiratory System Agents|respiratory system agents|mesh-ancestor
101712229|NCT05326269|Sympathomimetics|sympathomimetics|mesh-ancestor
101712230|NCT05326269|Tocolytic Agents|tocolytic agents|mesh-ancestor
101712231|NCT05326269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101712232|NCT05326269|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101796338|NCT05228249|Antimetabolites|antimetabolites|mesh-ancestor
101712233|NCT05326269|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101712234|NCT05326269|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101712235|NCT05326269|Adrenergic Agents|adrenergic agents|mesh-ancestor
101712236|NCT05326269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101712237|NCT05326269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712238|NCT02624570|Midostaurin|midostaurin|mesh-list
101712239|NCT02624570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101712240|NCT02624570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101712241|NCT02624570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101712242|NCT02624570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712243|NCT04665453|Dexmedetomidine|dexmedetomidine|mesh-list
101712244|NCT04665453|Melatonin|melatonin|mesh-list
101712245|NCT04665453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101712246|NCT04665453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101712247|NCT04665453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712248|NCT04665453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101712249|NCT04665453|Analgesics|analgesics|mesh-ancestor
101712250|NCT04665453|Sensory System Agents|sensory system agents|mesh-ancestor
101712251|NCT04665453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101712252|NCT04665453|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101712253|NCT04665453|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101712254|NCT04665453|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101712255|NCT04665453|Adrenergic Agents|adrenergic agents|mesh-ancestor
101712256|NCT04665453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101712257|NCT04665453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712258|NCT04665453|Antioxidants|antioxidants|mesh-ancestor
101712259|NCT04665453|Protective Agents|protective agents|mesh-ancestor
101712260|NCT00695240|Bupivacaine|bupivacaine|mesh-list
101796537|NCT00873626|Ciprofloxacin|ciprofloxacin|mesh-list
101712261|NCT00695240|Anesthetics, Local|anesthetics, local|mesh-ancestor
101712262|NCT00695240|Anesthetics|anesthetics|mesh-ancestor
101712263|NCT00695240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101712264|NCT00695240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712265|NCT00695240|Sensory System Agents|sensory system agents|mesh-ancestor
101712266|NCT00695240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101712267|NCT00689702|Capecitabine|capecitabine|mesh-list
101712268|NCT00689702|Cetuximab|cetuximab|mesh-list
101712269|NCT00689702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101712270|NCT00689702|Antimetabolites|antimetabolites|mesh-ancestor
101712271|NCT00689702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712272|NCT00689702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101712273|NCT00689702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101712274|NCT00689780|Midazolam|midazolam|mesh-list
101712275|NCT00689780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101712276|NCT00689780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101712277|NCT00689780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101712278|NCT00689780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712279|NCT00689780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101712280|NCT00689780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101712281|NCT00689780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101712282|NCT00689780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101796661|NCT00869180|Analgesics|analgesics|mesh-ancestor
101712283|NCT00689780|Anesthetics, General|anesthetics, general|mesh-ancestor
101712284|NCT00689780|Anesthetics|anesthetics|mesh-ancestor
101712285|NCT00689780|GABA Modulators|gaba modulators|mesh-ancestor
101712286|NCT00689780|GABA Agents|gaba agents|mesh-ancestor
101712287|NCT00689780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101712288|NCT00689780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712289|NCT00689858|Cilostazol|cilostazol|mesh-list
101712290|NCT00689858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101712291|NCT00689858|Autonomic Agents|autonomic agents|mesh-ancestor
101712292|NCT00689858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101712293|NCT00689858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712294|NCT00689858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101712295|NCT00689858|Respiratory System Agents|respiratory system agents|mesh-ancestor
101712296|NCT00689858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101712297|NCT00689858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101712298|NCT00689858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712299|NCT00689858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101712300|NCT00689858|Vasodilator Agents|vasodilator agents|mesh-ancestor
101712301|NCT00689858|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101712302|NCT00689858|Protective Agents|protective agents|mesh-ancestor
101712303|NCT00689858|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101712304|NCT00689858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101712305|NCT00689858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101712306|NCT00695630|Flumazenil|flumazenil|mesh-list
101712308|NCT00695630|Protective Agents|protective agents|mesh-ancestor
101712309|NCT00695630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712310|NCT00695630|GABA Modulators|gaba modulators|mesh-ancestor
101712311|NCT00695630|GABA Agents|gaba agents|mesh-ancestor
101712312|NCT00695630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101712313|NCT00695630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712314|NCT01614899|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
101712315|NCT01614899|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101712316|NCT01614899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101712317|NCT01614899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101712318|NCT01614899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712319|NCT01614899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101712321|NCT01614899|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101712322|NCT01614899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101712323|NCT01614899|Adrenergic Agents|adrenergic agents|mesh-ancestor
101712324|NCT01614899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101712325|NCT01614899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712326|NCT01614899|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101712327|NCT01614899|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101712328|NCT01614899|Serotonin Agents|serotonin agents|mesh-ancestor
101712329|NCT01614899|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101712330|NCT01614899|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101712331|NCT01614899|Dopamine Agents|dopamine agents|mesh-ancestor
101712332|NCT00690014|Probenecid|probenecid|mesh-list
101712333|NCT00690014|Uricosuric Agents|uricosuric agents|mesh-ancestor
101712334|NCT00690014|Gout Suppressants|gout suppressants|mesh-ancestor
101712335|NCT00690014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101712337|NCT00683306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101712338|NCT00683306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101712339|NCT00683306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101712340|NCT00683306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712341|NCT01475123|Nicorandil|nicorandil|mesh-list
101712342|NCT01475123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101712343|NCT01475123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101712344|NCT01475123|Vasodilator Agents|vasodilator agents|mesh-ancestor
101712345|NCT01475123|Vitamin B Complex|vitamin b complex|mesh-ancestor
101712346|NCT01475123|Vitamins|vitamins|mesh-ancestor
101712347|NCT01475123|Micronutrients|micronutrients|mesh-ancestor
101712348|NCT01475123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712349|NCT04135898|Bevacizumab|bevacizumab|mesh-list
101712350|NCT04135898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101712351|NCT04135898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101712352|NCT04135898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101712353|NCT04135898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101712354|NCT04135898|Growth Substances|growth substances|mesh-ancestor
101712355|NCT04135898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712356|NCT04135898|Growth Inhibitors|growth inhibitors|mesh-ancestor
101712357|NCT04208399|JNJ-56136379|jnj-56136379|mesh-list
101712358|NCT04208399|Antiviral Agents|antiviral agents|mesh-ancestor
101712359|NCT04208399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101712360|NCT00912392|Carboplatin|carboplatin|mesh-list
101712361|NCT00912392|Etoposide|etoposide|mesh-list
101712362|NCT00912392|Endostar protein|endostar protein|mesh-list
101712363|NCT00912392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101712364|NCT00912392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101712365|NCT00912392|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101712366|NCT00912392|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101712367|NCT00912392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101797035|NCT03412643|Alkylating Agents|alkylating agents|mesh-ancestor
101712368|NCT00912392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712369|NCT00912392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101712370|NCT00912392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101712371|NCT00912392|Growth Substances|growth substances|mesh-ancestor
101712372|NCT00912392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712373|NCT00912392|Growth Inhibitors|growth inhibitors|mesh-ancestor
101712374|NCT00690170|Ketamine|ketamine|mesh-list
101712375|NCT00690170|Nicotine|nicotine|mesh-list
101712376|NCT00690170|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101712377|NCT00690170|Autonomic Agents|autonomic agents|mesh-ancestor
101712378|NCT00690170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101712379|NCT00690170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712380|NCT00690170|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101712381|NCT00690170|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101712382|NCT00690170|Cholinergic Agents|cholinergic agents|mesh-ancestor
101712383|NCT00690170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101712384|NCT00690170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712386|NCT00690170|Sensory System Agents|sensory system agents|mesh-ancestor
101797163|NCT00935298|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101712387|NCT00690170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101712388|NCT00690170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101712389|NCT00690170|Anesthetics, General|anesthetics, general|mesh-ancestor
101712390|NCT00690170|Anesthetics|anesthetics|mesh-ancestor
101712391|NCT00690170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101712392|NCT00690170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101712393|NCT00690170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101712394|NCT00689624|Leucovorin|leucovorin|mesh-list
101712396|NCT00689624|Oxaliplatin|oxaliplatin|mesh-list
101712397|NCT00689624|Irinotecan|irinotecan|mesh-list
101712398|NCT00689624|Cetuximab|cetuximab|mesh-list
101712399|NCT00689624|Antimetabolites|antimetabolites|mesh-ancestor
101797230|NCT04074551|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101712400|NCT00689624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712401|NCT00689624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101712402|NCT00689624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101712403|NCT00689624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101712404|NCT00689624|Immunologic Factors|immunologic factors|mesh-ancestor
101712405|NCT00689624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712406|NCT00689624|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101712407|NCT00689624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101712408|NCT00689624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101712410|NCT00689624|Protective Agents|protective agents|mesh-ancestor
101712411|NCT00689624|Vitamin B Complex|vitamin b complex|mesh-ancestor
101712412|NCT00689624|Vitamins|vitamins|mesh-ancestor
101712413|NCT00689624|Micronutrients|micronutrients|mesh-ancestor
101712414|NCT00689624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101712415|NCT00696098|Butyric Acid|butyric acid|mesh-list
101712416|NCT00696098|Histamine Antagonists|histamine antagonists|mesh-ancestor
101712417|NCT00696098|Histamine Agents|histamine agents|mesh-ancestor
101712418|NCT00696098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101712419|NCT00696098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712420|NCT00696098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712421|NCT02623478|Insulin Lispro|insulin lispro|mesh-list
101712422|NCT02623478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101712423|NCT02623478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712424|NCT00684164|Conivaptan|conivaptan|mesh-list
101712425|NCT00684164|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101712426|NCT00684164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712427|NCT00684164|Natriuretic Agents|natriuretic agents|mesh-ancestor
101712428|NCT00684164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712429|NCT04135508|Adalimumab|adalimumab|mesh-list
101712430|NCT04135508|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101712431|NCT04135508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101712432|NCT04135508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101712434|NCT02622854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101712435|NCT02622854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712436|NCT02616770|Perflubron|perflubron|mesh-list
101712437|NCT02616770|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101712438|NCT00499369|Leucovorin|leucovorin|mesh-list
101712439|NCT00499369|Bevacizumab|bevacizumab|mesh-list
101712440|NCT00499369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101712441|NCT00499369|Cetuximab|cetuximab|mesh-list
101712442|NCT00499369|Fluorouracil|fluorouracil|mesh-list
101712443|NCT00499369|Irinotecan|irinotecan|mesh-list
101712444|NCT00499369|Antibodies|antibodies|mesh-list
101712445|NCT00499369|Immunoglobulins|immunoglobulins|mesh-list
101712446|NCT00499369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101712447|NCT00499369|Levoleucovorin|levoleucovorin|mesh-list
101712448|NCT00499369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101712449|NCT00499369|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101712450|NCT00499369|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101712451|NCT00499369|Growth Substances|growth substances|mesh-ancestor
101712452|NCT00499369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712453|NCT00499369|Growth Inhibitors|growth inhibitors|mesh-ancestor
101712454|NCT00499369|Immunologic Factors|immunologic factors|mesh-ancestor
101712455|NCT00499369|Antimetabolites|antimetabolites|mesh-ancestor
101712456|NCT00499369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712457|NCT00499369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101712458|NCT00499369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101712459|NCT00499369|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101712460|NCT00499369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101712461|NCT00499369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101712462|NCT00499369|Antidotes|antidotes|mesh-ancestor
101712463|NCT00499369|Protective Agents|protective agents|mesh-ancestor
101712464|NCT00499369|Vitamin B Complex|vitamin b complex|mesh-ancestor
101712465|NCT00499369|Vitamins|vitamins|mesh-ancestor
101712466|NCT00499369|Micronutrients|micronutrients|mesh-ancestor
101712467|NCT02616692|Sorafenib|sorafenib|mesh-list
101712468|NCT02616692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101712469|NCT02616692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101712470|NCT02616692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101712471|NCT02616692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712472|NCT01014637|Antifungal Agents|antifungal agents|mesh-list
101712474|NCT01014637|Miconazole|miconazole|mesh-list
101712475|NCT01014637|Amorolfine|amorolfine|mesh-list
101712476|NCT01014637|Ciclopirox|ciclopirox|mesh-list
101712477|NCT01014637|Keratolytic Agents|keratolytic agents|mesh-list
101712478|NCT01014637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101712479|NCT01014637|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101797530|NCT04387240|Artesunate|artesunate|mesh-list
101712480|NCT01014637|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101712481|NCT01014637|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101712482|NCT01014637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101712483|NCT01014637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712484|NCT01014637|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101712485|NCT01014637|Hormone Antagonists|hormone antagonists|mesh-ancestor
101712486|NCT01014637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101712487|NCT01014637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712488|NCT01014637|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101712489|NCT01014637|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101712490|NCT01014637|Dermatologic Agents|dermatologic agents|mesh-ancestor
101712491|NCT00696566|Rifampin|rifampin|mesh-list
101712493|NCT00696566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101712494|NCT00696566|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101712495|NCT00696566|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101712496|NCT00696566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101712497|NCT00696566|Purinergic Agents|purinergic agents|mesh-ancestor
101712498|NCT00696566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101712499|NCT00696566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712500|NCT00696566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712501|NCT00696566|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101712502|NCT00696566|Antitubercular Agents|antitubercular agents|mesh-ancestor
101712503|NCT00696566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101712504|NCT00696566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101712505|NCT00696566|Leprostatic Agents|leprostatic agents|mesh-ancestor
101797721|NCT00888758|Sirolimus|sirolimus|mesh-list
101712506|NCT00696566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101712507|NCT00696566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101363906|NCT00047255|Antimitotic Agents|antimitotic agents|mesh-ancestor
101712508|NCT00696566|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101712509|NCT00696566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101712510|NCT00696566|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101712511|NCT00696566|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101712512|NCT00696566|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101712513|NCT00696566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101712514|NCT01017133|Deoxyglucose|deoxyglucose|mesh-list
101712515|NCT01017133|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101712516|NCT01017133|Fluorides|fluorides|mesh-list
101712517|NCT01017133|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101712518|NCT01017133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712519|NCT01017133|Cariostatic Agents|cariostatic agents|mesh-ancestor
101712520|NCT01017133|Protective Agents|protective agents|mesh-ancestor
101712521|NCT01017133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712522|NCT01017133|Antimetabolites|antimetabolites|mesh-ancestor
101712523|NCT01017133|Antiviral Agents|antiviral agents|mesh-ancestor
101712524|NCT01017133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101712525|NCT00869258|Gemcitabine|gemcitabine|mesh-list
101712526|NCT00869258|Capecitabine|capecitabine|mesh-list
101712527|NCT00869258|Docetaxel|docetaxel|mesh-list
101712528|NCT00869258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101712529|NCT00869258|Antimetabolites|antimetabolites|mesh-ancestor
101712530|NCT00869258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712531|NCT00869258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101712532|NCT00869258|Tubulin Modulators|tubulin modulators|mesh-ancestor
101712533|NCT00869258|Antimitotic Agents|antimitotic agents|mesh-ancestor
101712534|NCT00869258|Mitosis Modulators|mitosis modulators|mesh-ancestor
101712535|NCT00696644|Teriparatide|teriparatide|mesh-list
101712536|NCT00696644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101712537|NCT00696644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712538|NCT00696644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101712539|NCT01017367|Antibodies|antibodies|mesh-list
101712540|NCT01017367|Immunologic Factors|immunologic factors|mesh-ancestor
101712541|NCT01017367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712542|NCT00696722|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101712543|NCT00696722|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101712544|NCT00696722|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101712545|NCT00696722|Protease Inhibitors|protease inhibitors|mesh-ancestor
101712546|NCT00696722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101712547|NCT00696722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712549|NCT00696722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101712550|NCT00696722|Antiviral Agents|antiviral agents|mesh-ancestor
101712551|NCT00696722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101712552|NCT00696956|Paclitaxel|paclitaxel|mesh-list
101712553|NCT00696956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101712554|NCT00696956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797977|NCT04074317|Insulin|insulin|mesh-list
101712555|NCT00696956|Tubulin Modulators|tubulin modulators|mesh-ancestor
101712556|NCT00696956|Antimitotic Agents|antimitotic agents|mesh-ancestor
101712557|NCT00696956|Mitosis Modulators|mitosis modulators|mesh-ancestor
101712558|NCT00696956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712559|NCT02616848|Everolimus|everolimus|mesh-list
101712560|NCT02616848|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101712561|NCT02616848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101712562|NCT02616848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101712563|NCT02616848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712564|NCT02616848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101712565|NCT02616848|Immunologic Factors|immunologic factors|mesh-ancestor
101712566|NCT02616848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712567|NCT02616848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101712568|NCT02620124|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101712569|NCT02620124|Hormones|hormones|mesh-list
101712570|NCT02620124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101712571|NCT02620124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712572|NCT02620124|Luteolytic Agents|luteolytic agents|mesh-ancestor
101712573|NCT02620124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101712574|NCT02620124|Contraceptive Agents|contraceptive agents|mesh-ancestor
101712575|NCT02620124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101712576|NCT02620124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101712577|NCT02620124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101712578|NCT02620124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101712580|NCT04134650|Linagliptin|linagliptin|mesh-list
101712581|NCT04134650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101712582|NCT04134650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712583|NCT04134650|Incretins|incretins|mesh-ancestor
101712584|NCT04134650|Hormones|hormones|mesh-ancestor
101712585|NCT04134650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101712586|NCT04134650|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101712587|NCT04134650|Protease Inhibitors|protease inhibitors|mesh-ancestor
101712588|NCT04134650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101712589|NCT04134650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712590|NCT00488683|Vaccines|vaccines|mesh-list
101712591|NCT00488683|Immunologic Factors|immunologic factors|mesh-ancestor
101798244|NCT00609518|Hematinics|hematinics|mesh-ancestor
101712592|NCT00488683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712593|NCT02563288|Dexmedetomidine|dexmedetomidine|mesh-list
101712594|NCT02563288|Esmolol|esmolol|mesh-list
101712595|NCT02563288|Adrenergic Agents|adrenergic agents|mesh-list
101712596|NCT02563288|Adrenergic Agonists|adrenergic agonists|mesh-list
101712597|NCT02563288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-list
101712598|NCT02563288|Adrenergic Antagonists|adrenergic antagonists|mesh-list
101712599|NCT02563288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101712600|NCT02563288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101712601|NCT02563288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712602|NCT02563288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101712604|NCT02563288|Sensory System Agents|sensory system agents|mesh-ancestor
101712605|NCT02563288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101712606|NCT02563288|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101712607|NCT02563288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101798303|NCT00886574|Autonomic Agents|autonomic agents|mesh-ancestor
101712608|NCT02563288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712609|NCT02563288|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101712610|NCT02563288|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101712611|NCT00711269|Risperidone|risperidone|mesh-list
101712612|NCT00711269|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
101712613|NCT00711269|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101712614|NCT00711269|Serotonin Agents|serotonin agents|mesh-ancestor
101712615|NCT00711269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101712616|NCT00711269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712617|NCT00711269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712618|NCT00711269|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101712619|NCT00711269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101712620|NCT00711269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101712621|NCT00711269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101712622|NCT00711269|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101712623|NCT00711269|Dopamine Agents|dopamine agents|mesh-ancestor
101712624|NCT00711269|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101712625|NCT00711269|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101712626|NCT00711269|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101712627|NCT00711269|Adrenergic Agents|adrenergic agents|mesh-ancestor
101712628|NCT00711269|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101712629|NCT00711269|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101712630|NCT01014793|Cabergoline|cabergoline|mesh-list
101712631|NCT01014793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101712632|NCT01014793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101712633|NCT01014793|Dopamine Agonists|dopamine agonists|mesh-ancestor
101712634|NCT01014793|Dopamine Agents|dopamine agents|mesh-ancestor
101798496|NCT00606320|Aripiprazole|aripiprazole|mesh-list
101712635|NCT01014793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101712636|NCT01014793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712637|NCT01014793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712639|NCT00286169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101712640|NCT00693472|Propranolol|propranolol|mesh-list
101712641|NCT00693472|Haloperidol|haloperidol|mesh-list
101712642|NCT00693472|Haloperidol decanoate|haloperidol decanoate|mesh-list
101712643|NCT00693472|Cholinergic Antagonists|cholinergic antagonists|mesh-list
101712644|NCT00693472|Antiemetics|antiemetics|mesh-ancestor
101712645|NCT00693472|Autonomic Agents|autonomic agents|mesh-ancestor
101712646|NCT00693472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101712647|NCT00693472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712648|NCT00693472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101712649|NCT00693472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101712650|NCT00693472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101712651|NCT00693472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101712652|NCT00693472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101712653|NCT00693472|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101712654|NCT00693472|Dopamine Agents|dopamine agents|mesh-ancestor
101712655|NCT00693472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101712656|NCT00693472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712657|NCT00693472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101712658|NCT00693472|Cholinergic Agents|cholinergic agents|mesh-ancestor
101712659|NCT00693472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101712660|NCT00693472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101712661|NCT00693472|Adrenergic Agents|adrenergic agents|mesh-ancestor
101798786|NCT01076491|Mannitol|mannitol|mesh-list
101712662|NCT00693472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101712663|NCT00693472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101712664|NCT00693472|Vasodilator Agents|vasodilator agents|mesh-ancestor
101712666|NCT00498433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101798837|NCT05225961|Analgesics|analgesics|mesh-ancestor
101712667|NCT00498433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101712668|NCT00498433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101712669|NCT00498433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712670|NCT00498433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101712671|NCT00498433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712673|NCT02689583|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101712674|NCT02689583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101712676|NCT02689583|Antitubercular Agents|antitubercular agents|mesh-ancestor
101712677|NCT00746746|Interferons|interferons|mesh-list
101712678|NCT00746746|Interferon-alpha|interferon-alpha|mesh-list
101712679|NCT00746746|Interferon alpha-2|interferon alpha-2|mesh-list
101712680|NCT00746746|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101712681|NCT00746746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101712682|NCT00746746|Antiviral Agents|antiviral agents|mesh-ancestor
101712683|NCT00746746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101712684|NCT00746746|Immunologic Factors|immunologic factors|mesh-ancestor
101712685|NCT00746746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712686|NCT00498355|Ranibizumab|ranibizumab|mesh-list
101712687|NCT00498355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101712688|NCT00498355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101712689|NCT00498355|Growth Substances|growth substances|mesh-ancestor
101712690|NCT00498355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712691|NCT00498355|Growth Inhibitors|growth inhibitors|mesh-ancestor
101712692|NCT00498355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101712693|NCT04539223|Evolocumab|evolocumab|mesh-list
101712694|NCT04539223|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101198402|NCT01397006|Pregabalin|pregabalin|mesh-list
101712695|NCT04539223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101712696|NCT04539223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101712697|NCT04539223|Antimetabolites|antimetabolites|mesh-ancestor
101712698|NCT04539223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712699|NCT04539223|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101712700|NCT04539223|Protease Inhibitors|protease inhibitors|mesh-ancestor
101712701|NCT04539223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101712702|NCT04539223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101712703|NCT01011751|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101712704|NCT01011751|Leuprolide|leuprolide|mesh-list
101712705|NCT01011751|Flutamide|flutamide|mesh-list
101712706|NCT01011751|Cyproterone Acetate|cyproterone acetate|mesh-list
101712707|NCT01011751|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101712708|NCT01011751|Medroxyprogesterone|medroxyprogesterone|mesh-list
101712709|NCT01011751|Cyproterone|cyproterone|mesh-list
101712710|NCT01011751|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101712711|NCT01011751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101712712|NCT01011751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101712713|NCT01011751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712715|NCT01011751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712716|NCT01011751|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101799236|NCT00524589|Hormones|hormones|mesh-ancestor
101712717|NCT01011751|Antidepressive Agents|antidepressive agents|mesh-ancestor
101712718|NCT01011751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101712719|NCT01011751|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101712720|NCT01011751|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101712721|NCT01011751|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101712722|NCT01011751|Contraceptive Agents|contraceptive agents|mesh-ancestor
101712723|NCT01011751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101712724|NCT01011751|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101712725|NCT01011751|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101799303|NCT00133705|Abortifacient Agents|abortifacient agents|mesh-ancestor
101712726|NCT01011751|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101712727|NCT01011751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101712728|NCT01011751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101712729|NCT01011751|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101712730|NCT01011751|Fertility Agents|fertility agents|mesh-ancestor
101712731|NCT01011751|Androgen Antagonists|androgen antagonists|mesh-ancestor
101712732|NCT01011751|Hormone Antagonists|hormone antagonists|mesh-ancestor
101712733|NCT01011751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101712734|NCT02686619|Cyclosporine|cyclosporine|mesh-list
101712735|NCT02686619|Sirolimus|sirolimus|mesh-list
101712736|NCT02686619|Prednisolone|prednisolone|mesh-list
101712737|NCT02686619|Cyclosporins|cyclosporins|mesh-list
101712738|NCT02686619|Daclizumab|daclizumab|mesh-list
101712739|NCT02686619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101712740|NCT02686619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712741|NCT02686619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101712742|NCT02686619|Immunologic Factors|immunologic factors|mesh-ancestor
101712743|NCT02686619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712744|NCT02686619|Antifungal Agents|antifungal agents|mesh-ancestor
101712745|NCT02686619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101712746|NCT02686619|Dermatologic Agents|dermatologic agents|mesh-ancestor
101712747|NCT02686619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101712748|NCT02686619|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101712749|NCT02686619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101712750|NCT02686619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101712751|NCT02686619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101712752|NCT02686619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101712753|NCT02686619|Glucocorticoids|glucocorticoids|mesh-ancestor
101712754|NCT02686619|Hormones|hormones|mesh-ancestor
101712755|NCT02686619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101712756|NCT02686619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101712757|NCT00688636|Infliximab|infliximab|mesh-list
101712758|NCT00688636|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101712759|NCT00688636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101712760|NCT00688636|Dermatologic Agents|dermatologic agents|mesh-ancestor
101712761|NCT00688636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101712763|NCT00870740|Daclizumab|daclizumab|mesh-list
101712764|NCT00870740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101712765|NCT00870740|Immunologic Factors|immunologic factors|mesh-ancestor
101712766|NCT00870740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712767|NCT02686853|Amphotericin B|amphotericin b|mesh-list
101712768|NCT02686853|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101712769|NCT02686853|Amebicides|amebicides|mesh-ancestor
101712770|NCT02686853|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101712771|NCT02686853|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101712772|NCT02686853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101712773|NCT02686853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101712775|NCT01017679|Gefitinib|gefitinib|mesh-list
101712776|NCT01017679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799712|NCT00487084|Lidocaine|lidocaine|mesh-list
101712777|NCT01017679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101712778|NCT01017679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101712779|NCT01017679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712780|NCT04130672|Hemostatics|hemostatics|mesh-list
101712781|NCT04130672|Coagulants|coagulants|mesh-ancestor
101712782|NCT00743314|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
101712783|NCT00743314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101712784|NCT00743314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712786|NCT02685449|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101712787|NCT02685449|Insulin Aspart|insulin aspart|mesh-list
101712788|NCT02685449|Insulin Lispro|insulin lispro|mesh-list
101712789|NCT02685449|Insulin glulisine|insulin glulisine|mesh-list
101712790|NCT02685449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101712791|NCT02685449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712792|NCT00697034|Capsaicin|capsaicin|mesh-list
101712793|NCT00697034|Antipruritics|antipruritics|mesh-ancestor
101712794|NCT00697034|Dermatologic Agents|dermatologic agents|mesh-ancestor
101712795|NCT00697034|Sensory System Agents|sensory system agents|mesh-ancestor
101712796|NCT00697034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101712797|NCT00697034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712798|NCT00506779|Paclitaxel|paclitaxel|mesh-list
101712799|NCT00506779|Imatinib Mesylate|imatinib mesylate|mesh-list
101712800|NCT00506779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101712801|NCT00506779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101712802|NCT00506779|Tubulin Modulators|tubulin modulators|mesh-ancestor
101712803|NCT00506779|Antimitotic Agents|antimitotic agents|mesh-ancestor
101712804|NCT00506779|Mitosis Modulators|mitosis modulators|mesh-ancestor
101712805|NCT00506779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712806|NCT00506779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101712807|NCT00506779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101712808|NCT04185233|Nitrous Oxide|nitrous oxide|mesh-list
101712809|NCT04185233|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101712810|NCT04185233|Anesthetics, General|anesthetics, general|mesh-ancestor
101712811|NCT04185233|Anesthetics|anesthetics|mesh-ancestor
101712812|NCT04185233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101799967|NCT00519285|Growth Substances|growth substances|mesh-ancestor
101712813|NCT04185233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712814|NCT04185233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101712815|NCT04185233|Analgesics|analgesics|mesh-ancestor
101712816|NCT04185233|Sensory System Agents|sensory system agents|mesh-ancestor
101712817|NCT04185233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101712818|NCT04185077|Heparin|heparin|mesh-list
101712819|NCT04185077|Calcium heparin|calcium heparin|mesh-list
101712820|NCT04185077|Bivalirudin|bivalirudin|mesh-list
101712821|NCT04185077|Antithrombins|antithrombins|mesh-list
101712822|NCT04185077|Thrombin|thrombin|mesh-list
101712823|NCT04185077|Anticoagulants|anticoagulants|mesh-ancestor
101712824|NCT04185077|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101712825|NCT04185077|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101712826|NCT04185077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712827|NCT04185077|Hemostatics|hemostatics|mesh-ancestor
101712828|NCT04185077|Coagulants|coagulants|mesh-ancestor
101712829|NCT04185077|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101712830|NCT04185077|Protease Inhibitors|protease inhibitors|mesh-ancestor
101712831|NCT04185077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101712832|NCT02686385|Acetylcysteine|acetylcysteine|mesh-list
101712833|NCT02686385|Prednisolone|prednisolone|mesh-list
101712834|NCT02686385|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101712835|NCT02686385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101712836|NCT02686385|Glucocorticoids|glucocorticoids|mesh-ancestor
101712837|NCT02686385|Hormones|hormones|mesh-ancestor
101712838|NCT02686385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101712839|NCT02686385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712840|NCT02686385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101712841|NCT02686385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101712842|NCT02686385|Protective Agents|protective agents|mesh-ancestor
101712843|NCT02686385|Antiviral Agents|antiviral agents|mesh-ancestor
101712844|NCT02686385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101712845|NCT02686385|Expectorants|expectorants|mesh-ancestor
101712846|NCT02686385|Respiratory System Agents|respiratory system agents|mesh-ancestor
101712847|NCT02686385|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101712849|NCT02686385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712850|NCT02686385|Antidotes|antidotes|mesh-ancestor
101712851|NCT02686151|Dexamethasone|dexamethasone|mesh-list
101712852|NCT02686151|Letrozole|letrozole|mesh-list
101712853|NCT02686151|Polygeline|polygeline|mesh-list
101712854|NCT02686151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101712855|NCT02686151|Antiemetics|antiemetics|mesh-ancestor
101712856|NCT02686151|Autonomic Agents|autonomic agents|mesh-ancestor
101712857|NCT02686151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101712858|NCT02686151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712859|NCT02686151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101712860|NCT02686151|Glucocorticoids|glucocorticoids|mesh-ancestor
101712861|NCT02686151|Hormones|hormones|mesh-ancestor
101712862|NCT02686151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101712863|NCT02686151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101712864|NCT02686151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101712865|NCT02686151|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101712866|NCT02686151|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101712867|NCT02686151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101712868|NCT02686151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712869|NCT02686151|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101712870|NCT02686151|Hormone Antagonists|hormone antagonists|mesh-ancestor
101712871|NCT02686151|Plasma Substitutes|plasma substitutes|mesh-ancestor
101712872|NCT02686151|Blood Substitutes|blood substitutes|mesh-ancestor
101712873|NCT00868790|Metformin|metformin|mesh-list
101800304|NCT04069949|Sorafenib|sorafenib|mesh-list
101712874|NCT00868790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101712875|NCT00868790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712876|NCT00496483|Tacrolimus|tacrolimus|mesh-list
101712877|NCT00496483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101712878|NCT00496483|Immunologic Factors|immunologic factors|mesh-ancestor
101712879|NCT00496483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712880|NCT00496483|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101712881|NCT00496483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101712882|NCT00496483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712883|NCT02614352|Candesartan|candesartan|mesh-list
101712884|NCT02614352|Candesartan cilexetil|candesartan cilexetil|mesh-list
101712885|NCT02614352|Atorvastatin|atorvastatin|mesh-list
101712886|NCT02614352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101712887|NCT02614352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101712888|NCT02614352|Antimetabolites|antimetabolites|mesh-ancestor
101800488|NCT00956748|Antiemetics|antiemetics|mesh-ancestor
101712889|NCT02614352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712890|NCT02614352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101712891|NCT02614352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101800558|NCT05300958|Deferoxamine|deferoxamine|mesh-list
101712892|NCT02614352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101712893|NCT02614352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101712894|NCT02614352|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101712895|NCT02614352|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101712896|NCT01018225|Darifenacin|darifenacin|mesh-list
101712897|NCT01018225|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101712898|NCT01018225|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101712899|NCT01018225|Cholinergic Agents|cholinergic agents|mesh-ancestor
101712900|NCT01018225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101712901|NCT01018225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712902|NCT01018225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712903|NCT01018225|Urological Agents|urological agents|mesh-ancestor
101712904|NCT03528551|Factor VIII|factor viii|mesh-list
101712905|NCT03528551|Coagulants|coagulants|mesh-ancestor
101712906|NCT02685137|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
101712926|NCT02685059|Cyclophosphamide|cyclophosphamide|mesh-list
101712927|NCT02685059|Durvalumab|durvalumab|mesh-list
101712928|NCT02685059|Epirubicin|epirubicin|mesh-list
101712929|NCT02685059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101712930|NCT02685059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101712931|NCT02685059|Tubulin Modulators|tubulin modulators|mesh-ancestor
101712932|NCT02685059|Antimitotic Agents|antimitotic agents|mesh-ancestor
101712933|NCT02685059|Mitosis Modulators|mitosis modulators|mesh-ancestor
101712934|NCT02685059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712935|NCT02685059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101712936|NCT02685059|Immunologic Factors|immunologic factors|mesh-ancestor
101712937|NCT02685059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712938|NCT02685059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101712939|NCT02685059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101712940|NCT02685059|Alkylating Agents|alkylating agents|mesh-ancestor
101712941|NCT02685059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101712942|NCT02685059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101712943|NCT02685059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101712944|NCT02685059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101712945|NCT02685059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101712946|NCT02685059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101712947|NCT00603239|Exenatide|exenatide|mesh-list
101712948|NCT00603239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101712949|NCT00603239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712950|NCT00603239|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101712951|NCT00603239|Incretins|incretins|mesh-ancestor
101712952|NCT00603239|Hormones|hormones|mesh-ancestor
101800953|NCT00948402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101712953|NCT00603239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101712954|NCT00699114|Acetaminophen|acetaminophen|mesh-list
101712955|NCT00699114|Ibuprofen|ibuprofen|mesh-list
101712956|NCT00699114|Codeine|codeine|mesh-list
101712957|NCT00699114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101712958|NCT00699114|Analgesics|analgesics|mesh-ancestor
101712959|NCT00699114|Sensory System Agents|sensory system agents|mesh-ancestor
101712960|NCT00699114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101712961|NCT00699114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712962|NCT00699114|Antipyretics|antipyretics|mesh-ancestor
101712963|NCT00699114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101712964|NCT00699114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101712965|NCT00699114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101712966|NCT00699114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101712967|NCT00699114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101712968|NCT00699114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712969|NCT00699114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101712970|NCT00699114|Narcotics|narcotics|mesh-ancestor
101712971|NCT00699114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101712972|NCT00699114|Antitussive Agents|antitussive agents|mesh-ancestor
101712973|NCT00699114|Respiratory System Agents|respiratory system agents|mesh-ancestor
101801146|NCT00712439|Analgesics|analgesics|mesh-ancestor
101712975|NCT00639587|Ketotifen|ketotifen|mesh-list
101712976|NCT00639587|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101712977|NCT00639587|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101712978|NCT00639587|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101712979|NCT00639587|Histamine Antagonists|histamine antagonists|mesh-ancestor
101712980|NCT00639587|Histamine Agents|histamine agents|mesh-ancestor
101712981|NCT00639587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101712982|NCT00639587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712983|NCT00639587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712984|NCT00639587|Antipruritics|antipruritics|mesh-ancestor
101712985|NCT00639587|Dermatologic Agents|dermatologic agents|mesh-ancestor
101712986|NCT00700518|Nitroglycerin|nitroglycerin|mesh-list
101712987|NCT00700518|Vasodilator Agents|vasodilator agents|mesh-ancestor
101712988|NCT00852540|Linezolid|linezolid|mesh-list
101712989|NCT00852540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101712990|NCT00852540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101712991|NCT00852540|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101712992|NCT00852540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101712993|NCT00852540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712994|NCT00701298|Interferons|interferons|mesh-list
101712995|NCT00701298|Interferon-alpha|interferon-alpha|mesh-list
101712996|NCT00701298|Interferon alpha-2|interferon alpha-2|mesh-list
101712997|NCT00701298|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101712998|NCT00701298|Decitabine|decitabine|mesh-list
101712999|NCT00701298|Azacitidine|azacitidine|mesh-list
101713001|NCT00701298|Antiviral Agents|antiviral agents|mesh-ancestor
101713002|NCT00701298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101713003|NCT00701298|Immunologic Factors|immunologic factors|mesh-ancestor
101713004|NCT00701298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713005|NCT00701298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101713006|NCT00701298|Antimetabolites|antimetabolites|mesh-ancestor
101713007|NCT00701298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713008|NCT00701298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101713009|NCT00860574|Methotrexate|methotrexate|mesh-list
101713010|NCT00860574|Fludarabine phosphate|fludarabine phosphate|mesh-list
101713011|NCT00860574|Fludarabine|fludarabine|mesh-list
101713012|NCT00860574|Treosulfan|treosulfan|mesh-list
101713013|NCT00860574|Tacrolimus|tacrolimus|mesh-list
101801147|NCT00712439|Sensory System Agents|sensory system agents|mesh-ancestor
101713014|NCT00860574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101713015|NCT00860574|Abortifacient Agents|abortifacient agents|mesh-ancestor
101713016|NCT00860574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101713017|NCT00860574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713018|NCT00860574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101713019|NCT00860574|Antimetabolites|antimetabolites|mesh-ancestor
101713020|NCT00860574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713021|NCT00860574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101713022|NCT00860574|Dermatologic Agents|dermatologic agents|mesh-ancestor
101713023|NCT00860574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101713024|NCT00860574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101713025|NCT00860574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101713026|NCT00860574|Immunologic Factors|immunologic factors|mesh-ancestor
101713027|NCT00860574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101713028|NCT00860574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101713029|NCT00860574|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101713030|NCT00860574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101713031|NCT00860574|Alkylating Agents|alkylating agents|mesh-ancestor
101713032|NCT00496015|Acetaminophen|acetaminophen|mesh-list
101713033|NCT00496015|Vaccines|vaccines|mesh-list
101713034|NCT00496015|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101713035|NCT00496015|Immunologic Factors|immunologic factors|mesh-ancestor
101713036|NCT00496015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713037|NCT00496015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101713038|NCT00496015|Analgesics|analgesics|mesh-ancestor
101713039|NCT00496015|Sensory System Agents|sensory system agents|mesh-ancestor
101713040|NCT00496015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101713041|NCT00496015|Antipyretics|antipyretics|mesh-ancestor
101713042|NCT01018381|Ethanol|ethanol|mesh-list
101713043|NCT01018381|Entecavir|entecavir|mesh-list
101713044|NCT01018381|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101713045|NCT01018381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101713046|NCT01018381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101713047|NCT01018381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713048|NCT01018381|Antiviral Agents|antiviral agents|mesh-ancestor
101713049|NCT00487825|Methotrexate|methotrexate|mesh-list
101713050|NCT00487825|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101713051|NCT00487825|Abortifacient Agents|abortifacient agents|mesh-ancestor
101713052|NCT00487825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101713053|NCT00487825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713054|NCT00487825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101713055|NCT00487825|Antimetabolites|antimetabolites|mesh-ancestor
101801365|NCT01022632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101713056|NCT00487825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713057|NCT00487825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101713058|NCT00487825|Dermatologic Agents|dermatologic agents|mesh-ancestor
101713059|NCT00487825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101713060|NCT00487825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101713061|NCT00487825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101713062|NCT00487825|Immunologic Factors|immunologic factors|mesh-ancestor
101713063|NCT00487825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101713064|NCT00487825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101713065|NCT00487747|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101713067|NCT00487747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101713068|NCT01012141|Docetaxel|docetaxel|mesh-list
101713069|NCT01012141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101713070|NCT01012141|Tubulin Modulators|tubulin modulators|mesh-ancestor
101713071|NCT01012141|Antimitotic Agents|antimitotic agents|mesh-ancestor
101713072|NCT01012141|Mitosis Modulators|mitosis modulators|mesh-ancestor
101713073|NCT01012141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713074|NCT00487435|Tapentadol|tapentadol|mesh-list
101801366|NCT01022632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101713077|NCT00487435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101713078|NCT00487435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713079|NCT00487435|Analgesics|analgesics|mesh-ancestor
101713080|NCT00487435|Sensory System Agents|sensory system agents|mesh-ancestor
101713081|NCT00487435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101713082|NCT00487435|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101713083|NCT00487435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101713084|NCT00487435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101713085|NCT00487435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713086|NCT00487435|Adrenergic Agents|adrenergic agents|mesh-ancestor
101713087|NCT00487435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101713088|NCT00495625|Sunitinib|sunitinib|mesh-list
101713089|NCT00495625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101713090|NCT00495625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101713091|NCT00495625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101713092|NCT00495625|Growth Substances|growth substances|mesh-ancestor
101713093|NCT00495625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713094|NCT00495625|Growth Inhibitors|growth inhibitors|mesh-ancestor
101713095|NCT00495625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101713096|NCT00495625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101713097|NCT00495625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713099|NCT00847626|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
101713100|NCT00847626|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101713101|NCT00847626|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101713102|NCT00847626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713103|NCT00847626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101713104|NCT00847626|Diuretics|diuretics|mesh-ancestor
101713105|NCT00847626|Natriuretic Agents|natriuretic agents|mesh-ancestor
101713106|NCT00847626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713107|NCT00847626|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101713108|NCT00847626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101713109|NCT04115904|Ibuprofen|ibuprofen|mesh-list
101713110|NCT04115904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101713111|NCT04115904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101713112|NCT04115904|Analgesics|analgesics|mesh-ancestor
101713113|NCT04115904|Sensory System Agents|sensory system agents|mesh-ancestor
101713114|NCT04115904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101363921|NCT00134368|Immunologic Factors|immunologic factors|mesh-ancestor
101713115|NCT04115904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713116|NCT04115904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101713117|NCT04115904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101713118|NCT04115904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101713119|NCT04115904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101713120|NCT04115904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713121|NCT05297994|Vaccines|vaccines|mesh-list
101713122|NCT05297994|Immunologic Factors|immunologic factors|mesh-ancestor
101713123|NCT05297994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713124|NCT04116138|Antisecretory factor|antisecretory factor|mesh-list
101713125|NCT04116138|Antidiarrheals|antidiarrheals|mesh-ancestor
101713126|NCT04116138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101713127|NCT00860262|Amlodipine|amlodipine|mesh-list
101713128|NCT00860262|Telmisartan|telmisartan|mesh-list
101713129|NCT00860262|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
101713130|NCT00860262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101713131|NCT00860262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101713132|NCT00860262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101713133|NCT00860262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713134|NCT00860262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101713135|NCT00860262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713136|NCT00860262|Vasodilator Agents|vasodilator agents|mesh-ancestor
101713137|NCT00860262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101713138|NCT00860262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101713139|NCT00700830|Insulin Detemir|insulin detemir|mesh-list
101713140|NCT00700830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101801420|NCT03537586|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101713141|NCT00700830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713142|NCT00860028|Varenicline|varenicline|mesh-list
101713143|NCT00860028|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101713144|NCT00860028|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101713145|NCT00860028|Cholinergic Agents|cholinergic agents|mesh-ancestor
101713146|NCT00860028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101713147|NCT00860028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713148|NCT00860028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713150|NCT00701532|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101713151|NCT00701532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713152|NCT00701532|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101713153|NCT00701532|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101713154|NCT00701532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101713155|NCT00701532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713156|NCT00846768|Olodaterol|olodaterol|mesh-list
101713157|NCT00846768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101713158|NCT00846768|Autonomic Agents|autonomic agents|mesh-ancestor
101713159|NCT00846768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101713160|NCT00846768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713161|NCT00846768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101713162|NCT00846768|Respiratory System Agents|respiratory system agents|mesh-ancestor
101713163|NCT00863798|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101713164|NCT00863798|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101713165|NCT00863798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101713166|NCT00863798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101713167|NCT00863798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713168|NCT00863798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101713169|NCT00863798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713170|NCT00863798|Antidepressive Agents|antidepressive agents|mesh-ancestor
101713171|NCT00863798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101713172|NCT00697658|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101713173|NCT00697658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101713174|NCT00697658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101713175|NCT00697658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101713176|NCT00697658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713177|NCT00697658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101713178|NCT00697658|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101713179|NCT00697658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101713180|NCT00697658|Serotonin Agents|serotonin agents|mesh-ancestor
101713181|NCT00697658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101713182|NCT00697658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713183|NCT00697658|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101713184|NCT00697658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101713185|NCT00697658|Dopamine Agents|dopamine agents|mesh-ancestor
101713186|NCT00699426|Esomeprazole|esomeprazole|mesh-list
101713187|NCT00699426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101713188|NCT00699426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101713189|NCT00699426|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101713190|NCT00699426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101713191|NCT00699426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713192|NCT00593606|Rotigotine|rotigotine|mesh-list
101713193|NCT00593606|Dopamine Agonists|dopamine agonists|mesh-ancestor
101713194|NCT00593606|Dopamine Agents|dopamine agents|mesh-ancestor
101713195|NCT00593606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101713196|NCT00593606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713197|NCT00593606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713199|NCT02614118|Ketorolac|ketorolac|mesh-list
101713200|NCT02614118|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101713201|NCT02614118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101713202|NCT02614118|Analgesics|analgesics|mesh-ancestor
101713203|NCT02614118|Sensory System Agents|sensory system agents|mesh-ancestor
101713204|NCT02614118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101801427|NCT03537586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801428|NCT00722033|Indomethacin|indomethacin|mesh-list
101801431|NCT00722033|Analgesics|analgesics|mesh-ancestor
101713205|NCT02614118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801434|NCT00722033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713207|NCT02614118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101713208|NCT02614118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101713209|NCT02614118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101713210|NCT02614118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101713211|NCT02614118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101713212|NCT02614118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713213|NCT04134416|Donepezil|donepezil|mesh-list
101713214|NCT04134416|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101713215|NCT04134416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101713216|NCT04134416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713217|NCT04134416|Cholinergic Agents|cholinergic agents|mesh-ancestor
101713218|NCT04134416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101713219|NCT04134416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713220|NCT04134416|Nootropic Agents|nootropic agents|mesh-ancestor
101713221|NCT04134182|Nivolumab|nivolumab|mesh-list
101713222|NCT04134182|Ipilimumab|ipilimumab|mesh-list
101713223|NCT04134182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101713224|NCT04134182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101713225|NCT04134182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101713226|NCT04134182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713227|NCT00870584|Omalizumab|omalizumab|mesh-list
101713228|NCT00870584|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101713229|NCT00870584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101713230|NCT00870584|Respiratory System Agents|respiratory system agents|mesh-ancestor
101713231|NCT02614508|Ofatumumab|ofatumumab|mesh-list
101713232|NCT02614508|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101713233|NCT02614508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101713234|NCT02614508|Immunologic Factors|immunologic factors|mesh-ancestor
101713235|NCT02614508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713236|NCT02616068|Loxoprofen|loxoprofen|mesh-list
101713237|NCT02616068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101713238|NCT02616068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101713239|NCT02616068|Analgesics|analgesics|mesh-ancestor
101713240|NCT02616068|Sensory System Agents|sensory system agents|mesh-ancestor
101713241|NCT02616068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101713242|NCT02616068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713243|NCT02616068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101713244|NCT02616068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101713245|NCT04127084|Empagliflozin|empagliflozin|mesh-list
101713246|NCT04127084|Canagliflozin|canagliflozin|mesh-list
101713247|NCT04127084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101713248|NCT04127084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713249|NCT04127084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101713250|NCT04127084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713251|NCT00870194|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101713252|NCT00870194|Exenatide|exenatide|mesh-list
101713253|NCT00870194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101713254|NCT00870194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713255|NCT00870194|Incretins|incretins|mesh-ancestor
101713256|NCT00870194|Hormones|hormones|mesh-ancestor
101713257|NCT00870194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101713258|NCT00870194|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101713259|NCT00870194|Protease Inhibitors|protease inhibitors|mesh-ancestor
101713260|NCT00870194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101713261|NCT00870194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713262|NCT00870194|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101713263|NCT00690430|Octreotide|octreotide|mesh-list
101713264|NCT00690430|Pasireotide|pasireotide|mesh-list
101713265|NCT00690430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101713266|NCT00690430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101713267|NCT00690430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101713268|NCT00690430|Hormones|hormones|mesh-ancestor
101801435|NCT00722033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101713269|NCT00690430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101713270|NCT00690430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713271|NCT04126304|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101713273|NCT04126304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101713274|NCT02563054|Fluorouracil|fluorouracil|mesh-list
101713275|NCT02563054|Capecitabine|capecitabine|mesh-list
101713276|NCT02563054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101713277|NCT02563054|Antimetabolites|antimetabolites|mesh-ancestor
101713278|NCT02563054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713279|NCT02563054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101713280|NCT02563054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101713281|NCT02563054|Immunologic Factors|immunologic factors|mesh-ancestor
101713282|NCT02563054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713283|NCT02614040|Plasma-lyte 148|plasma-lyte 148|mesh-list
101713284|NCT02614040|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101713285|NCT02614040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101713286|NCT00743470|Ritonavir|ritonavir|mesh-list
101713287|NCT00743470|Lopinavir|lopinavir|mesh-list
101713288|NCT00743470|Rifabutin|rifabutin|mesh-list
101713289|NCT00743470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101713290|NCT00743470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101713291|NCT00743470|Protease Inhibitors|protease inhibitors|mesh-ancestor
101713292|NCT00743470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101713293|NCT00743470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713294|NCT00743470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101713295|NCT00743470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101713296|NCT00743470|Antiviral Agents|antiviral agents|mesh-ancestor
101713297|NCT00743470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101713298|NCT00743470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101713299|NCT00743470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101713300|NCT00743470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101713301|NCT00743470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101713302|NCT00743470|Antitubercular Agents|antitubercular agents|mesh-ancestor
101713303|NCT00688324|Acamprosate|acamprosate|mesh-list
101713304|NCT00688324|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101713305|NCT02619578|Remifentanil|remifentanil|mesh-list
101713307|NCT02619578|Vecuronium Bromide|vecuronium bromide|mesh-list
101713308|NCT02619578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101713309|NCT02619578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101713310|NCT02619578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713311|NCT02619578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101713312|NCT02619578|Anesthetics, General|anesthetics, general|mesh-ancestor
101713313|NCT02619578|Anesthetics|anesthetics|mesh-ancestor
101713314|NCT02619578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101713315|NCT02619578|Narcotics|narcotics|mesh-ancestor
101713316|NCT02619578|Analgesics|analgesics|mesh-ancestor
101713317|NCT02619578|Sensory System Agents|sensory system agents|mesh-ancestor
101713318|NCT02619578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101713319|NCT02619578|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101713320|NCT02619578|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101713321|NCT02619578|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101713322|NCT02619578|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101713323|NCT02619578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101713324|NCT02619578|Cholinergic Agents|cholinergic agents|mesh-ancestor
101713325|NCT02619578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101713326|NCT02619578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713327|NCT02615912|Castor Oil|castor oil|mesh-list
101713328|NCT02615912|Cathartics|cathartics|mesh-ancestor
101713329|NCT02615912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101713330|NCT04123652|Lidocaine|lidocaine|mesh-list
101713331|NCT04123652|Ketamine|ketamine|mesh-list
101713332|NCT04123652|Anesthetics, Local|anesthetics, local|mesh-ancestor
101713333|NCT04123652|Anesthetics|anesthetics|mesh-ancestor
101713334|NCT04123652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101713335|NCT04123652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713336|NCT04123652|Sensory System Agents|sensory system agents|mesh-ancestor
101801443|NCT00894374|Artesunate|artesunate|mesh-list
101713337|NCT04123652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101713338|NCT04123652|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101713339|NCT04123652|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101713340|NCT04123652|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101713341|NCT04123652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101713342|NCT04123652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713343|NCT04123652|Analgesics|analgesics|mesh-ancestor
101713344|NCT04123652|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101713345|NCT04123652|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101713346|NCT04123652|Anesthetics, General|anesthetics, general|mesh-ancestor
101713347|NCT04123652|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101713348|NCT04123652|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101713349|NCT04123652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101713350|NCT00862940|Memantine|memantine|mesh-list
101713351|NCT00862940|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101713352|NCT00862940|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101713353|NCT00862940|Dopamine Agents|dopamine agents|mesh-ancestor
101713354|NCT00862940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101713355|NCT00862940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713356|NCT00862940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713357|NCT00862940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101713358|NCT00862940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101713359|NCT04122716|Liraglutide|liraglutide|mesh-list
101713360|NCT04122716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101713361|NCT04122716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713362|NCT04122716|Incretins|incretins|mesh-ancestor
101713363|NCT04122716|Hormones|hormones|mesh-ancestor
101713364|NCT04122716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101713365|NCT00868166|Riluzole|riluzole|mesh-list
101713366|NCT00868166|Anticonvulsants|anticonvulsants|mesh-ancestor
101713367|NCT00868166|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101713368|NCT00868166|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101713370|NCT00868166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713371|NCT00868166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713372|NCT00868166|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101713373|NCT00868166|Protective Agents|protective agents|mesh-ancestor
101713374|NCT00858780|Etanercept|etanercept|mesh-list
101713375|NCT00858780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101713376|NCT00858780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101713377|NCT00858780|Analgesics|analgesics|mesh-ancestor
101713378|NCT00858780|Sensory System Agents|sensory system agents|mesh-ancestor
101713379|NCT00858780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101713380|NCT00858780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713381|NCT00858780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101713382|NCT00858780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101713383|NCT00858780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101713384|NCT00858780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101713385|NCT00858780|Immunologic Factors|immunologic factors|mesh-ancestor
101713386|NCT02619266|Megestrol|megestrol|mesh-list
101713387|NCT02619266|Megestrol Acetate|megestrol acetate|mesh-list
101713388|NCT02619266|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101713389|NCT02619266|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101713390|NCT02619266|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101713391|NCT02619266|Contraceptive Agents|contraceptive agents|mesh-ancestor
101713392|NCT02619266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101713393|NCT02619266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713394|NCT02619266|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101713395|NCT02619266|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101713396|NCT02619266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101713397|NCT02619266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101713398|NCT02619266|Appetite Stimulants|appetite stimulants|mesh-ancestor
101713399|NCT02619266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101713400|NCT00699062|Montelukast|montelukast|mesh-list
101713401|NCT00699062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101713402|NCT00699062|Respiratory System Agents|respiratory system agents|mesh-ancestor
101713403|NCT00699062|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101713404|NCT00699062|Hormone Antagonists|hormone antagonists|mesh-ancestor
101713405|NCT00699062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101713406|NCT00699062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713407|NCT00699062|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101713408|NCT00699062|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101713409|NCT00699062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713410|NCT02619032|Fentanyl|fentanyl|mesh-list
101713411|NCT02619032|Remifentanil|remifentanil|mesh-list
101713412|NCT02619032|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101713413|NCT02619032|Narcotics|narcotics|mesh-ancestor
101713414|NCT02619032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101713415|NCT02619032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713416|NCT02619032|Analgesics|analgesics|mesh-ancestor
101713417|NCT02619032|Sensory System Agents|sensory system agents|mesh-ancestor
101713418|NCT02619032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101713419|NCT02619032|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101713420|NCT02619032|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101713421|NCT02619032|Anesthetics, General|anesthetics, general|mesh-ancestor
101713422|NCT02619032|Anesthetics|anesthetics|mesh-ancestor
101713423|NCT00858234|Bortezomib|bortezomib|mesh-list
101713424|NCT00858234|Vorinostat|vorinostat|mesh-list
101713425|NCT00858234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101713426|NCT00858234|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101713427|NCT00858234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101713428|NCT00858234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713429|NCT00697814|Clomiphene|clomiphene|mesh-list
101713430|NCT00697814|Enclomiphene|enclomiphene|mesh-list
101713431|NCT00697814|Zuclomiphene|zuclomiphene|mesh-list
101713432|NCT00697814|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101713433|NCT00697814|Hormone Antagonists|hormone antagonists|mesh-ancestor
101713434|NCT00697814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101713435|NCT00697814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713436|NCT00697814|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101713437|NCT00697814|Fertility Agents|fertility agents|mesh-ancestor
101713438|NCT00697814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101713439|NCT00697814|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101713440|NCT00697814|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101713441|NCT00862082|Sorafenib|sorafenib|mesh-list
101713442|NCT00862082|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
101713443|NCT00862082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101713444|NCT00862082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101713445|NCT00862082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101713446|NCT00862082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713447|NCT00862082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101713448|NCT00862082|Alkylating Agents|alkylating agents|mesh-ancestor
101713449|NCT00849186|Sunitinib|sunitinib|mesh-list
101713450|NCT00849186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101713451|NCT00849186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101713452|NCT00849186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101713453|NCT00849186|Growth Substances|growth substances|mesh-ancestor
101713454|NCT00849186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713455|NCT00849186|Growth Inhibitors|growth inhibitors|mesh-ancestor
101713456|NCT00849186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101713457|NCT00849186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101713458|NCT00849186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713459|NCT00692770|Sorafenib|sorafenib|mesh-list
101713460|NCT00692770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101713461|NCT00692770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101713462|NCT00692770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801465|NCT00901550|Infliximab|infliximab|mesh-list
101801466|NCT00901550|Methotrexate|methotrexate|mesh-list
101713463|NCT00692770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713464|NCT00867308|Lenalidomide|lenalidomide|mesh-list
101713465|NCT00867308|Immunologic Factors|immunologic factors|mesh-ancestor
101713466|NCT00867308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713467|NCT00867308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101713468|NCT00867308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101713469|NCT00867308|Growth Substances|growth substances|mesh-ancestor
101713470|NCT00867308|Growth Inhibitors|growth inhibitors|mesh-ancestor
101713471|NCT00867308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101713473|NCT02618876|Bupivacaine|bupivacaine|mesh-list
101713474|NCT02618876|Anesthetics, Local|anesthetics, local|mesh-ancestor
101713475|NCT02618876|Anesthetics|anesthetics|mesh-ancestor
101713476|NCT02618876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101713477|NCT02618876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713478|NCT02618876|Sensory System Agents|sensory system agents|mesh-ancestor
101713479|NCT02618876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101713480|NCT02618876|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101713481|NCT02618876|Narcotics|narcotics|mesh-ancestor
101713482|NCT02618876|Analgesics|analgesics|mesh-ancestor
101713483|NCT04119752|Curcumin|curcumin|mesh-list
101713484|NCT04119752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101713485|NCT04119752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101713486|NCT04119752|Analgesics|analgesics|mesh-ancestor
101713487|NCT04119752|Sensory System Agents|sensory system agents|mesh-ancestor
101713488|NCT04119752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101713489|NCT04119752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713490|NCT04119752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101713491|NCT04119752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101713492|NCT04119752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101713493|NCT04119752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101370929|NCT00187174|Everolimus|everolimus|mesh-list
101713494|NCT04119752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713496|NCT00866918|Vitamin A|vitamin a|mesh-list
101713497|NCT00866918|Cytarabine|cytarabine|mesh-list
101713498|NCT00866918|Methotrexate|methotrexate|mesh-list
101713499|NCT00866918|Mercaptopurine|mercaptopurine|mesh-list
101713500|NCT00866918|Mitoxantrone|mitoxantrone|mesh-list
101713501|NCT00866918|Idarubicin|idarubicin|mesh-list
101713502|NCT00866918|Tretinoin|tretinoin|mesh-list
101713503|NCT00866918|Retinol palmitate|retinol palmitate|mesh-list
101713504|NCT00866918|Arsenic Trioxide|arsenic trioxide|mesh-list
101713505|NCT00866918|Micronutrients|micronutrients|mesh-ancestor
101713506|NCT00866918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713507|NCT00866918|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101713508|NCT00866918|Abortifacient Agents|abortifacient agents|mesh-ancestor
101713509|NCT00866918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101713510|NCT00866918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101713511|NCT00866918|Antimetabolites|antimetabolites|mesh-ancestor
101713512|NCT00866918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713513|NCT00866918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101713514|NCT00866918|Dermatologic Agents|dermatologic agents|mesh-ancestor
101713515|NCT00866918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101713516|NCT00866918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101713517|NCT00866918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101713518|NCT00866918|Immunologic Factors|immunologic factors|mesh-ancestor
101713519|NCT00866918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101713520|NCT00866918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101713521|NCT00866918|Antiviral Agents|antiviral agents|mesh-ancestor
101713522|NCT00866918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101713523|NCT00866918|Analgesics|analgesics|mesh-ancestor
101713524|NCT00866918|Sensory System Agents|sensory system agents|mesh-ancestor
101713525|NCT00866918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101713526|NCT00866918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101713527|NCT00866918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101713528|NCT00866918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101801474|NCT00901550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101713529|NCT00866918|Keratolytic Agents|keratolytic agents|mesh-ancestor
101713531|NCT00866918|Protective Agents|protective agents|mesh-ancestor
101713532|NCT00866918|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101713533|NCT00861692|Argatroban|argatroban|mesh-list
101713534|NCT00861692|Antithrombins|antithrombins|mesh-ancestor
101713535|NCT00861692|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101713536|NCT00861692|Protease Inhibitors|protease inhibitors|mesh-ancestor
101713537|NCT00861692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101713538|NCT00861692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713539|NCT00861692|Anticoagulants|anticoagulants|mesh-ancestor
101713540|NCT00861692|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101713541|NCT03131765|Poly I-C|poly i-c|mesh-list
101713542|NCT03131765|Antiviral Agents|antiviral agents|mesh-ancestor
101713543|NCT03131765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101713544|NCT03131765|Interferon Inducers|interferon inducers|mesh-ancestor
101713545|NCT03131765|Immunologic Factors|immunologic factors|mesh-ancestor
101713546|NCT03131765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713547|NCT02689037|Aspirin|aspirin|mesh-list
101713548|NCT02689037|Clopidogrel|clopidogrel|mesh-list
101713549|NCT02689037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101713550|NCT02689037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101713551|NCT02689037|Analgesics|analgesics|mesh-ancestor
101713552|NCT02689037|Sensory System Agents|sensory system agents|mesh-ancestor
101713553|NCT02689037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101713554|NCT02689037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713555|NCT02689037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101713556|NCT02689037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101713557|NCT02689037|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101713558|NCT02689037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101713559|NCT02689037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713560|NCT02689037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101713561|NCT02689037|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101713562|NCT02689037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101713563|NCT02689037|Antipyretics|antipyretics|mesh-ancestor
101713564|NCT02689037|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101713565|NCT02689037|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101713566|NCT02689037|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101713567|NCT02689037|Purinergic Agents|purinergic agents|mesh-ancestor
101713568|NCT02689037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101713569|NCT04184921|Aspirin|aspirin|mesh-list
101713570|NCT04184921|Osimertinib|osimertinib|mesh-list
101713571|NCT04184921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101713572|NCT04184921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101713573|NCT04184921|Analgesics|analgesics|mesh-ancestor
101713574|NCT04184921|Sensory System Agents|sensory system agents|mesh-ancestor
101713575|NCT04184921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101713576|NCT04184921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713577|NCT04184921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101713578|NCT04184921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101713579|NCT04184921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101713580|NCT04184921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101713581|NCT04184921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713582|NCT04184921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101713583|NCT04184921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101713584|NCT04184921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101713585|NCT04184921|Antipyretics|antipyretics|mesh-ancestor
101713586|NCT04184921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101713587|NCT04184921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101713588|NCT00602927|Varenicline|varenicline|mesh-list
101713589|NCT00602927|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101713590|NCT00602927|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101713591|NCT00602927|Cholinergic Agents|cholinergic agents|mesh-ancestor
101713592|NCT00602927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101713593|NCT00602927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713594|NCT00602927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713595|NCT00639743|Tenecteplase|tenecteplase|mesh-list
101713596|NCT00639743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101713597|NCT00639743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101713598|NCT00639743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713599|NCT00602537|Lithium Carbonate|lithium carbonate|mesh-list
101713600|NCT00602537|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101713601|NCT00602537|Antidepressive Agents|antidepressive agents|mesh-ancestor
101713602|NCT00602537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101713603|NCT00602537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101713604|NCT00602537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713605|NCT00602537|Antimanic Agents|antimanic agents|mesh-ancestor
101713606|NCT00602537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101713607|NCT00602537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101713608|NCT00602537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713609|NCT00602537|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101713610|NCT00602537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101713611|NCT00602537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101713612|NCT00602537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101713613|NCT00602537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101713614|NCT02688803|Paclitaxel|paclitaxel|mesh-list
101713615|NCT02688803|Docetaxel|docetaxel|mesh-list
101713616|NCT02688803|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101713617|NCT02688803|Cyclophosphamide|cyclophosphamide|mesh-list
101713618|NCT02688803|Doxorubicin|doxorubicin|mesh-list
101713619|NCT02688803|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101713620|NCT02688803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101713621|NCT02688803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101713622|NCT02688803|Tubulin Modulators|tubulin modulators|mesh-ancestor
101713623|NCT02688803|Antimitotic Agents|antimitotic agents|mesh-ancestor
101713624|NCT02688803|Mitosis Modulators|mitosis modulators|mesh-ancestor
101713625|NCT02688803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713626|NCT02688803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101713627|NCT02688803|Immunologic Factors|immunologic factors|mesh-ancestor
101713628|NCT02688803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713629|NCT02688803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101713630|NCT02688803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101713631|NCT02688803|Alkylating Agents|alkylating agents|mesh-ancestor
101713632|NCT02688803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101713633|NCT02688803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101713634|NCT02688803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101713635|NCT02688803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101713636|NCT02688803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101713637|NCT02684669|Naloxone|naloxone|mesh-list
101713638|NCT02684669|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101713639|NCT02684669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713640|NCT02684669|Sensory System Agents|sensory system agents|mesh-ancestor
101713641|NCT02684669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101713642|NCT02976935|Xenon|xenon|mesh-list
101713643|NCT02976935|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101713644|NCT02976935|Anesthetics, General|anesthetics, general|mesh-ancestor
101713645|NCT02976935|Anesthetics|anesthetics|mesh-ancestor
101713646|NCT02976935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101713647|NCT02976935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713649|NCT00861614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101713650|NCT00861614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101713651|NCT00861614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101713652|NCT00861614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713653|NCT00861380|Vaccines|vaccines|mesh-list
101713654|NCT00861380|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101713655|NCT00861380|Immunologic Factors|immunologic factors|mesh-ancestor
101801487|NCT02573051|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
101801502|NCT02539940|Paclitaxel|paclitaxel|mesh-list
101713656|NCT00861380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713657|NCT00495391|Ribavirin|ribavirin|mesh-list
101713658|NCT00495391|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101713659|NCT00495391|Nitazoxanide|nitazoxanide|mesh-list
101713660|NCT00495391|Antimetabolites|antimetabolites|mesh-ancestor
101713661|NCT00495391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713662|NCT00495391|Antiviral Agents|antiviral agents|mesh-ancestor
101713663|NCT00495391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101713664|NCT00495391|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101713666|NCT04378621|Infliximab|infliximab|mesh-list
101713667|NCT04378621|Golimumab|golimumab|mesh-list
101713668|NCT04378621|Certolizumab Pegol|certolizumab pegol|mesh-list
101713669|NCT04378621|Etanercept|etanercept|mesh-list
101713670|NCT04378621|Tofacitinib|tofacitinib|mesh-list
101713671|NCT04378621|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
101713672|NCT04378621|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101713673|NCT04378621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101713674|NCT04378621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101713675|NCT04378621|Dermatologic Agents|dermatologic agents|mesh-ancestor
101713676|NCT04378621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101713677|NCT04378621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101713678|NCT04378621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101713679|NCT04378621|Analgesics|analgesics|mesh-ancestor
101713680|NCT04378621|Sensory System Agents|sensory system agents|mesh-ancestor
101713681|NCT04378621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101713682|NCT04378621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713683|NCT04378621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101713684|NCT04378621|Immunologic Factors|immunologic factors|mesh-ancestor
101713685|NCT04378621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101713686|NCT04378621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101713687|NCT04378621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713688|NCT00869960|Ritonavir|ritonavir|mesh-list
101713689|NCT00869960|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101713690|NCT00869960|Tenofovir|tenofovir|mesh-list
101713691|NCT00869960|Emtricitabine|emtricitabine|mesh-list
101713692|NCT00869960|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101713693|NCT00869960|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101713694|NCT00869960|Protease Inhibitors|protease inhibitors|mesh-ancestor
101713695|NCT00869960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101333645|NCT00040027|Immunologic Factors|immunologic factors|mesh-ancestor
101713696|NCT00869960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713697|NCT00869960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101713698|NCT00869960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101713699|NCT00869960|Antiviral Agents|antiviral agents|mesh-ancestor
101713700|NCT00869960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101713701|NCT00869960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101713702|NCT00869960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101713703|NCT00869960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101713704|NCT00869960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101713705|NCT02618564|Sennosides|sennosides|mesh-list
101713706|NCT02618564|Laxatives|laxatives|mesh-ancestor
101713707|NCT02618564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101713708|NCT02615366|Tranexamic Acid|tranexamic acid|mesh-list
101713709|NCT02615366|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101713710|NCT02615366|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101713711|NCT02615366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713712|NCT02615366|Hemostatics|hemostatics|mesh-ancestor
101713713|NCT02615366|Coagulants|coagulants|mesh-ancestor
101713714|NCT00699296|Panobinostat|panobinostat|mesh-list
101713715|NCT00699296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101801504|NCT02539940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101713716|NCT00699296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101713717|NCT00699296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101713718|NCT00699296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713719|NCT04119674|Temozolomide|temozolomide|mesh-list
101713720|NCT04119674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101713721|NCT04119674|Alkylating Agents|alkylating agents|mesh-ancestor
101713722|NCT04119674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713723|NCT04119674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101713724|NCT00494299|Sorafenib|sorafenib|mesh-list
101713725|NCT00494299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101713726|NCT00494299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101713727|NCT00494299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101713728|NCT00494299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713729|NCT05298176|Carboplatin|carboplatin|mesh-list
101713730|NCT05298176|Pemetrexed|pemetrexed|mesh-list
101713731|NCT05298176|Osimertinib|osimertinib|mesh-list
101713732|NCT05298176|Afatinib|afatinib|mesh-list
101713733|NCT05298176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101713734|NCT05298176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101713735|NCT05298176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713736|NCT05298176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101713737|NCT05298176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101713738|NCT05298176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101713739|NCT02615288|Vitamin D|vitamin d|mesh-list
101713740|NCT02615288|Cholecalciferol|cholecalciferol|mesh-list
101713742|NCT02615288|Micronutrients|micronutrients|mesh-ancestor
101713743|NCT02615288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713744|NCT02615288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101713745|NCT02615288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101713746|NCT02618096|Oxytocin|oxytocin|mesh-list
101713747|NCT02618096|Dinoprostone|dinoprostone|mesh-list
101713748|NCT02618096|Oxytocics|oxytocics|mesh-ancestor
101713749|NCT02618096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101713750|NCT02618096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713751|NCT04134026|Epoetin Alfa|epoetin alfa|mesh-list
101713752|NCT04134026|Hematinics|hematinics|mesh-ancestor
101713753|NCT02963831|Cyclophosphamide|cyclophosphamide|mesh-list
101713754|NCT02963831|Durvalumab|durvalumab|mesh-list
101713755|NCT02963831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101713756|NCT02963831|Immunologic Factors|immunologic factors|mesh-ancestor
101713757|NCT02963831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713758|NCT02963831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101713759|NCT02963831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101713760|NCT02963831|Alkylating Agents|alkylating agents|mesh-ancestor
101713761|NCT02963831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713762|NCT02963831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101713763|NCT02963831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101713764|NCT02963831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101713765|NCT00859898|Metformin|metformin|mesh-list
101713766|NCT00859898|Dapagliflozin|dapagliflozin|mesh-list
101713767|NCT00859898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101713768|NCT00859898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713769|NCT00859898|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101713770|NCT00859898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713771|NCT02684123|Apremilast|apremilast|mesh-list
101713772|NCT02684123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101713773|NCT02684123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101713774|NCT02684123|Analgesics|analgesics|mesh-ancestor
101713775|NCT02684123|Sensory System Agents|sensory system agents|mesh-ancestor
101713776|NCT02684123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101713777|NCT02684123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713778|NCT02684123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101713779|NCT02684123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101713780|NCT02684123|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101801521|NCT01028092|Dermatologic Agents|dermatologic agents|mesh-ancestor
101801522|NCT01028092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101713781|NCT02684123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101713782|NCT02684123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101713783|NCT02684123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713784|NCT00638729|Clonidine|clonidine|mesh-list
101713785|NCT00638729|Midazolam|midazolam|mesh-list
101713786|NCT00638729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101713787|NCT00638729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101713788|NCT00638729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101713789|NCT00638729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713790|NCT00638729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101713791|NCT00638729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101713792|NCT00638729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101713793|NCT00638729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101713794|NCT00638729|Anesthetics, General|anesthetics, general|mesh-ancestor
101713795|NCT00638729|Anesthetics|anesthetics|mesh-ancestor
101713796|NCT00638729|GABA Modulators|gaba modulators|mesh-ancestor
101713798|NCT00638729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101713799|NCT00638729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713800|NCT00638729|Analgesics|analgesics|mesh-ancestor
101713801|NCT00638729|Sensory System Agents|sensory system agents|mesh-ancestor
101713802|NCT00638729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101713803|NCT00638729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101713804|NCT00638729|Sympatholytics|sympatholytics|mesh-ancestor
101713805|NCT00638729|Autonomic Agents|autonomic agents|mesh-ancestor
101713806|NCT00638729|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101713807|NCT00638729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101713808|NCT00638729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101713809|NCT00638729|Adrenergic Agents|adrenergic agents|mesh-ancestor
101713810|NCT00697892|Ritonavir|ritonavir|mesh-list
101713811|NCT00697892|Lopinavir|lopinavir|mesh-list
101713812|NCT00697892|Efavirenz|efavirenz|mesh-list
101713813|NCT00697892|Lumefantrine|lumefantrine|mesh-list
101713814|NCT00697892|Artemether|artemether|mesh-list
101713815|NCT00697892|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101713816|NCT00697892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101713817|NCT00697892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101713819|NCT00697892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101713820|NCT00697892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713821|NCT00697892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101713822|NCT00697892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101713823|NCT00697892|Antiviral Agents|antiviral agents|mesh-ancestor
101713824|NCT00697892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101713825|NCT00697892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101713826|NCT00697892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101713827|NCT00697892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101713828|NCT00697892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101713829|NCT00697892|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101713830|NCT00697892|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101713831|NCT00697892|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101713832|NCT00697892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101713833|NCT00697892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101801538|NCT00905918|Vitamin E|vitamin e|mesh-list
101713834|NCT00697892|Antimalarials|antimalarials|mesh-ancestor
101713835|NCT00697892|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101713836|NCT00697892|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101713837|NCT00699452|Candesartan|candesartan|mesh-list
101713838|NCT00699452|Candesartan cilexetil|candesartan cilexetil|mesh-list
101713839|NCT00699452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101713840|NCT00699452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101333648|NCT00001343|Oxandrolone|oxandrolone|mesh-list
101713841|NCT00699452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101713842|NCT00699452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713843|NCT02683733|Aminosalicylic Acid|aminosalicylic acid|mesh-list
101713844|NCT02683733|Curcumin|curcumin|mesh-list
101713845|NCT02683733|Mesalamine|mesalamine|mesh-list
101713846|NCT02683733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101713847|NCT02683733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101713848|NCT02683733|Analgesics|analgesics|mesh-ancestor
101713849|NCT02683733|Sensory System Agents|sensory system agents|mesh-ancestor
101713850|NCT02683733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101713851|NCT02683733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713852|NCT02683733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101713853|NCT02683733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101713854|NCT02683733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101713855|NCT02683733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101713856|NCT02683733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713857|NCT02683733|Antitubercular Agents|antitubercular agents|mesh-ancestor
101713858|NCT02683733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101713859|NCT02683733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101713860|NCT02683655|Apatinib|apatinib|mesh-list
101713861|NCT02683655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101713862|NCT02683655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101713863|NCT02683655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101713864|NCT02683655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713865|NCT00494221|Leucovorin|leucovorin|mesh-list
101713866|NCT00494221|Fluorouracil|fluorouracil|mesh-list
101371303|NCT00189553|Doxorubicin|doxorubicin|mesh-list
101713867|NCT00494221|Oxaliplatin|oxaliplatin|mesh-list
101713868|NCT00494221|Cediranib|cediranib|mesh-list
101713869|NCT00494221|Levoleucovorin|levoleucovorin|mesh-list
101713870|NCT00494221|Antimetabolites|antimetabolites|mesh-ancestor
101713871|NCT00494221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713872|NCT00494221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101713873|NCT00494221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101713874|NCT00494221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101713875|NCT00494221|Immunologic Factors|immunologic factors|mesh-ancestor
101713876|NCT00494221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713877|NCT00494221|Antidotes|antidotes|mesh-ancestor
101713878|NCT00494221|Protective Agents|protective agents|mesh-ancestor
101713879|NCT00494221|Vitamin B Complex|vitamin b complex|mesh-ancestor
101713880|NCT00494221|Vitamins|vitamins|mesh-ancestor
101713881|NCT00494221|Micronutrients|micronutrients|mesh-ancestor
101713882|NCT00494221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101713883|NCT00494221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101713884|NCT00909935|Dexmedetomidine|dexmedetomidine|mesh-list
101713885|NCT00909935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101713886|NCT00909935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101713887|NCT00909935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713888|NCT00909935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101713889|NCT00909935|Analgesics|analgesics|mesh-ancestor
101713890|NCT00909935|Sensory System Agents|sensory system agents|mesh-ancestor
101713891|NCT00909935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101713892|NCT00909935|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101713893|NCT00909935|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101713894|NCT00909935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101713895|NCT00909935|Adrenergic Agents|adrenergic agents|mesh-ancestor
101801555|NCT00901784|Topiramate|topiramate|mesh-list
101713896|NCT00909935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101713897|NCT00909935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713899|NCT00857948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101713900|NCT00857948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101713901|NCT02688491|Sunitinib|sunitinib|mesh-list
101713902|NCT02688491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101713903|NCT02688491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101713904|NCT02688491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101713905|NCT02688491|Growth Substances|growth substances|mesh-ancestor
101713906|NCT02688491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713907|NCT02688491|Growth Inhibitors|growth inhibitors|mesh-ancestor
101713908|NCT02688491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101713909|NCT02688491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101713910|NCT02688491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713911|NCT00857792|Regadenoson|regadenoson|mesh-list
101713912|NCT00857792|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
101713913|NCT00857792|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101713914|NCT00857792|Purinergic Agonists|purinergic agonists|mesh-ancestor
101713915|NCT00857792|Purinergic Agents|purinergic agents|mesh-ancestor
101713916|NCT00857792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101713917|NCT00857792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713918|NCT00857792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713919|NCT02613494|Glycopyrrolate|glycopyrrolate|mesh-list
101713920|NCT02613494|Scopolamine|scopolamine|mesh-list
101713921|NCT02613494|Bromides|bromides|mesh-list
101713922|NCT02613494|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101713923|NCT02613494|Anticonvulsants|anticonvulsants|mesh-ancestor
101713924|NCT02613494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101713925|NCT02613494|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101713926|NCT02613494|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101713927|NCT02613494|Cholinergic Agents|cholinergic agents|mesh-ancestor
101713928|NCT02613494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101713929|NCT02613494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713930|NCT02613494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713931|NCT02613494|Antiemetics|antiemetics|mesh-ancestor
101713932|NCT02613494|Autonomic Agents|autonomic agents|mesh-ancestor
101713933|NCT02613494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101713934|NCT02613494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101713935|NCT02613494|Mydriatics|mydriatics|mesh-ancestor
101713936|NCT02613494|Parasympatholytics|parasympatholytics|mesh-ancestor
101713938|NCT00699530|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101713939|NCT00699530|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101713940|NCT00699530|Dopamine Agonists|dopamine agonists|mesh-ancestor
101713941|NCT00699530|Dopamine Agents|dopamine agents|mesh-ancestor
101713942|NCT00699530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101713943|NCT00699530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713944|NCT00699530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713945|NCT02617862|Anesthetics|anesthetics|mesh-list
101713946|NCT02617862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101713947|NCT02617862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713949|NCT00601835|Immunologic Factors|immunologic factors|mesh-ancestor
101713950|NCT00601835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713951|NCT00640367|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101713952|NCT00640367|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101713953|NCT00640367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101713954|NCT00640367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713955|NCT00697502|Capecitabine|capecitabine|mesh-list
101713956|NCT00697502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101801565|NCT00905996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801566|NCT00905996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101801567|NCT00905996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101713957|NCT00697502|Antimetabolites|antimetabolites|mesh-ancestor
101713958|NCT00697502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713959|NCT00697502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101713960|NCT00857246|Irinotecan|irinotecan|mesh-list
101713961|NCT00857246|Cetuximab|cetuximab|mesh-list
101713962|NCT00857246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101713963|NCT00857246|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101713964|NCT00857246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101713965|NCT00857246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101713966|NCT00857246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713967|NCT00857246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101713968|NCT00699686|Insulin Glargine|insulin glargine|mesh-list
101713969|NCT00699686|Insulin Detemir|insulin detemir|mesh-list
101713970|NCT00699686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101713971|NCT00699686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713972|NCT00640679|Clopidogrel|clopidogrel|mesh-list
101713973|NCT00640679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101713974|NCT00640679|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101713975|NCT00640679|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101713976|NCT00640679|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101713977|NCT00640679|Purinergic Agents|purinergic agents|mesh-ancestor
101713978|NCT00640679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101713979|NCT00640679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713980|NCT00640679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713981|NCT02682953|Plerixafor|plerixafor|mesh-list
101713982|NCT02682953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101713983|NCT02682953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101713984|NCT02682953|Antiviral Agents|antiviral agents|mesh-ancestor
101713985|NCT02682953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101713986|NCT02683031|Ionophores|ionophores|mesh-list
101713987|NCT02683031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101713988|NCT02683031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101713989|NCT04184141|Alprazolam|alprazolam|mesh-list
101713990|NCT04184141|Hydroxyzine|hydroxyzine|mesh-list
101713991|NCT04184141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101713992|NCT04184141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101713993|NCT04184141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101713994|NCT04184141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101713995|NCT04184141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101713996|NCT04184141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101713997|NCT04184141|GABA Modulators|gaba modulators|mesh-ancestor
101713998|NCT04184141|GABA Agents|gaba agents|mesh-ancestor
101713999|NCT04184141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101714000|NCT04184141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714001|NCT04184141|Antipruritics|antipruritics|mesh-ancestor
101714002|NCT04184141|Dermatologic Agents|dermatologic agents|mesh-ancestor
101714003|NCT04184141|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101188612|NCT00003000|Analgesics|analgesics|mesh-ancestor
101714004|NCT04184141|Histamine Antagonists|histamine antagonists|mesh-ancestor
101714005|NCT04184141|Histamine Agents|histamine agents|mesh-ancestor
101714006|NCT02682329|Hydrogen Peroxide|hydrogen peroxide|mesh-list
101714007|NCT02682329|Carbamide Peroxide|carbamide peroxide|mesh-list
101714008|NCT02682329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101714009|NCT02682329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101714010|NCT00640991|Insulin|insulin|mesh-list
101714011|NCT00640991|Insulin Glargine|insulin glargine|mesh-list
101714012|NCT00640991|Insulin glulisine|insulin glulisine|mesh-list
101714013|NCT00640991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101714014|NCT00640991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714015|NCT00638807|Celecoxib|celecoxib|mesh-list
101714016|NCT00638807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101714017|NCT00638807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101714018|NCT00638807|Analgesics|analgesics|mesh-ancestor
101714019|NCT00638807|Sensory System Agents|sensory system agents|mesh-ancestor
101714020|NCT00638807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101714021|NCT00638807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714022|NCT00638807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101714023|NCT00638807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101801578|NCT02573987|Anesthetics, Local|anesthetics, local|mesh-ancestor
101714032|NCT00856856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714033|NCT00856856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101714034|NCT00856856|Immunologic Factors|immunologic factors|mesh-ancestor
101714035|NCT00856856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714036|NCT00856856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101714038|NCT00782327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101714039|NCT00782327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101714040|NCT00782327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101714041|NCT00782327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101714042|NCT00782327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714044|NCT00559091|Antimetabolites|antimetabolites|mesh-ancestor
101714045|NCT00559091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714046|NCT00559091|Antiviral Agents|antiviral agents|mesh-ancestor
101714047|NCT00559091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101714048|NCT02682017|Fucoidan|fucoidan|mesh-list
101714049|NCT02682017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101714050|NCT02682017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101714051|NCT02682017|Anticoagulants|anticoagulants|mesh-ancestor
101714052|NCT02682017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101714061|NCT00603473|Gabapentin|gabapentin|mesh-list
101714062|NCT00603473|Analgesics|analgesics|mesh-ancestor
101714063|NCT00603473|Sensory System Agents|sensory system agents|mesh-ancestor
101714064|NCT00603473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101714065|NCT00603473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714066|NCT00603473|Anticonvulsants|anticonvulsants|mesh-ancestor
101714067|NCT00603473|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101714068|NCT00603473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101714069|NCT00603473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101714070|NCT00603473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101714071|NCT00603473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101714072|NCT00603473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101714073|NCT00603473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101714074|NCT00603473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714075|NCT00603473|Antimanic Agents|antimanic agents|mesh-ancestor
101714076|NCT02688023|Leucovorin|leucovorin|mesh-list
101714077|NCT02688023|Fluorouracil|fluorouracil|mesh-list
101714078|NCT02688023|Capecitabine|capecitabine|mesh-list
101714079|NCT02688023|Oxaliplatin|oxaliplatin|mesh-list
101714080|NCT02688023|Irinotecan|irinotecan|mesh-list
101714081|NCT02688023|Antimetabolites|antimetabolites|mesh-ancestor
101714082|NCT02688023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714083|NCT02688023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101714084|NCT02688023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101714085|NCT02688023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101714086|NCT02688023|Immunologic Factors|immunologic factors|mesh-ancestor
101714087|NCT02688023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714088|NCT02688023|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101714089|NCT02688023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101714090|NCT02688023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101714091|NCT02688023|Antidotes|antidotes|mesh-ancestor
101714092|NCT02688023|Protective Agents|protective agents|mesh-ancestor
101714093|NCT02688023|Vitamin B Complex|vitamin b complex|mesh-ancestor
101714094|NCT02688023|Vitamins|vitamins|mesh-ancestor
101714095|NCT02688023|Micronutrients|micronutrients|mesh-ancestor
101714096|NCT00910013|Ropivacaine|ropivacaine|mesh-list
101714098|NCT00910013|Anesthetics|anesthetics|mesh-ancestor
101714099|NCT00910013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101714100|NCT00910013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714101|NCT00910013|Sensory System Agents|sensory system agents|mesh-ancestor
101714102|NCT00910013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101714103|NCT04182191|Tenoxicam|tenoxicam|mesh-list
101714104|NCT04182191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101714105|NCT04182191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101714106|NCT04182191|Analgesics|analgesics|mesh-ancestor
101714107|NCT04182191|Sensory System Agents|sensory system agents|mesh-ancestor
101714108|NCT04182191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101714109|NCT04182191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714110|NCT04182191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101714111|NCT04182191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101714112|NCT04182191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101714113|NCT04182191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101714114|NCT04182191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714115|NCT02680379|Minocycline|minocycline|mesh-list
101714116|NCT02680379|Lovastatin|lovastatin|mesh-list
101714117|NCT02680379|L 647318|l 647318|mesh-list
101714118|NCT02680379|Dihydromevinolin|dihydromevinolin|mesh-list
101714119|NCT02680379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101714120|NCT02680379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101801611|NCT02540876|Ilorasertib|ilorasertib|mesh-list
101714122|NCT02680379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101714123|NCT02680379|Antimetabolites|antimetabolites|mesh-ancestor
101714124|NCT02680379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714125|NCT02680379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101714126|NCT02680379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101714127|NCT02680379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101714128|NCT03996421|Ferrous fumarate|ferrous fumarate|mesh-list
101714129|NCT03996421|Trace Elements|trace elements|mesh-ancestor
101714130|NCT03996421|Micronutrients|micronutrients|mesh-ancestor
101714131|NCT03996421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714132|NCT00641693|Budesonide|budesonide|mesh-list
101714133|NCT00641693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101714134|NCT00641693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101714135|NCT00641693|Autonomic Agents|autonomic agents|mesh-ancestor
101714136|NCT00641693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101714137|NCT00641693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714138|NCT00641693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101714139|NCT00641693|Respiratory System Agents|respiratory system agents|mesh-ancestor
101714140|NCT00641693|Glucocorticoids|glucocorticoids|mesh-ancestor
101714141|NCT00641693|Hormones|hormones|mesh-ancestor
101714142|NCT00641693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101714143|NCT04183361|Cortisone|cortisone|mesh-list
101714144|NCT04183361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101714145|NCT02687867|Vitamin K|vitamin k|mesh-list
101714146|NCT02687867|Dabigatran|dabigatran|mesh-list
101714147|NCT02687867|Vitamins|vitamins|mesh-ancestor
101714148|NCT02687867|Micronutrients|micronutrients|mesh-ancestor
101714149|NCT02687867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714150|NCT02687867|Antithrombins|antithrombins|mesh-ancestor
101714151|NCT02687867|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101714152|NCT02687867|Protease Inhibitors|protease inhibitors|mesh-ancestor
101714153|NCT02687867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101714154|NCT02687867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714155|NCT02687867|Anticoagulants|anticoagulants|mesh-ancestor
101714156|NCT02687867|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101714157|NCT02687867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101714158|NCT02687867|Hemostatics|hemostatics|mesh-ancestor
101714159|NCT02687867|Coagulants|coagulants|mesh-ancestor
101714160|NCT02681783|Aflibercept|aflibercept|mesh-list
101714161|NCT02681783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101714162|NCT02681783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101714163|NCT02681783|Growth Substances|growth substances|mesh-ancestor
101714164|NCT02681783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714165|NCT02681783|Growth Inhibitors|growth inhibitors|mesh-ancestor
101714166|NCT02681783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101714167|NCT00486811|Oxycodone|oxycodone|mesh-list
101714168|NCT00486811|Tapentadol|tapentadol|mesh-list
101714169|NCT00486811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101714170|NCT00486811|Narcotics|narcotics|mesh-ancestor
101714171|NCT00486811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101714172|NCT00486811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714173|NCT00486811|Analgesics|analgesics|mesh-ancestor
101714174|NCT00486811|Sensory System Agents|sensory system agents|mesh-ancestor
101714175|NCT00486811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101714176|NCT00486811|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101714177|NCT00486811|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101714178|NCT00486811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101714179|NCT00486811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714180|NCT00486811|Adrenergic Agents|adrenergic agents|mesh-ancestor
101714181|NCT00486811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101714182|NCT00921700|Acetaminophen|acetaminophen|mesh-list
101714183|NCT00921700|Ibuprofen|ibuprofen|mesh-list
101714184|NCT00921700|Codeine|codeine|mesh-list
101714185|NCT00921700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101714186|NCT00921700|Analgesics|analgesics|mesh-ancestor
101714187|NCT00921700|Sensory System Agents|sensory system agents|mesh-ancestor
101714188|NCT00921700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101714189|NCT00921700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714190|NCT00921700|Antipyretics|antipyretics|mesh-ancestor
101714191|NCT00921700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101714192|NCT00921700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101714193|NCT00921700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101714194|NCT00921700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101714195|NCT00921700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101714196|NCT00921700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714197|NCT00921700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101714198|NCT00921700|Narcotics|narcotics|mesh-ancestor
101714199|NCT00921700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101714200|NCT00921700|Antitussive Agents|antitussive agents|mesh-ancestor
101714201|NCT00921700|Respiratory System Agents|respiratory system agents|mesh-ancestor
101714202|NCT02678195|Amoxicillin|amoxicillin|mesh-list
101714203|NCT02678195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101714204|NCT02678195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101714205|NCT03996577|Lidocaine|lidocaine|mesh-list
101714206|NCT03996577|Anesthetics, Local|anesthetics, local|mesh-ancestor
101714207|NCT03996577|Anesthetics|anesthetics|mesh-ancestor
101714208|NCT03996577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101714209|NCT03996577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714210|NCT03996577|Sensory System Agents|sensory system agents|mesh-ancestor
101714211|NCT03996577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101714212|NCT03996577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101714213|NCT03996577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101714214|NCT03996577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101714215|NCT03996577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101451729|NCT00208065|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101714216|NCT03996577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714217|NCT02681705|Temozolomide|temozolomide|mesh-list
101714218|NCT02681705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101714219|NCT02681705|Alkylating Agents|alkylating agents|mesh-ancestor
101714220|NCT02681705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714221|NCT02681705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101714222|NCT00921622|Vitamin D|vitamin d|mesh-list
101714223|NCT00921622|Vitamins|vitamins|mesh-list
101714224|NCT00921622|Micronutrients|micronutrients|mesh-ancestor
101714225|NCT00921622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714226|NCT00921622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101714227|NCT02681471|Mannitol|mannitol|mesh-list
101714228|NCT02681471|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101714229|NCT02681471|Diuretics|diuretics|mesh-ancestor
101714230|NCT02681471|Natriuretic Agents|natriuretic agents|mesh-ancestor
101714231|NCT02681471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714232|NCT00642395|Bortezomib|bortezomib|mesh-list
101714233|NCT00642395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101714234|NCT01018615|Silymarin|silymarin|mesh-list
101714235|NCT01018615|Antioxidants|antioxidants|mesh-ancestor
101714236|NCT01018615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714237|NCT01018615|Protective Agents|protective agents|mesh-ancestor
101714238|NCT01018615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714239|NCT00743782|Hormones|hormones|mesh-list
101714240|NCT00743782|Parathyroid Hormone|parathyroid hormone|mesh-list
101714241|NCT00743782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101714242|NCT00743782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714243|NCT00743782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101714244|NCT02678117|Magnesium Sulfate|magnesium sulfate|mesh-list
101714245|NCT02678117|Pregabalin|pregabalin|mesh-list
101714246|NCT02678117|Analgesics|analgesics|mesh-ancestor
101714247|NCT02678117|Sensory System Agents|sensory system agents|mesh-ancestor
101714248|NCT02678117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101714249|NCT02678117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714251|NCT02678117|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101714252|NCT02678117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101714253|NCT02678117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714254|NCT02678117|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101714255|NCT02678117|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101714256|NCT02678117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101714257|NCT02678117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101714258|NCT02678117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101714259|NCT02678117|Anesthetics|anesthetics|mesh-ancestor
101714260|NCT02678117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101714261|NCT02678117|Tocolytic Agents|tocolytic agents|mesh-ancestor
101714262|NCT02678117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101714263|NCT01018849|Vitamin D|vitamin d|mesh-list
101714264|NCT01018849|Cholecalciferol|cholecalciferol|mesh-list
101714265|NCT01018849|Vitamins|vitamins|mesh-ancestor
101714266|NCT01018849|Micronutrients|micronutrients|mesh-ancestor
101714267|NCT01018849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714268|NCT01018849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101714269|NCT01018849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101714270|NCT04102319|Hepcidins|hepcidins|mesh-list
101714271|NCT04102319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101714272|NCT00743860|Darapladib|darapladib|mesh-list
101714273|NCT00743860|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
101714274|NCT00743860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101714275|NCT00743860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714276|NCT00747526|Rabeprazole|rabeprazole|mesh-list
101714277|NCT00747526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101714278|NCT00747526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101714279|NCT00747526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101714280|NCT00747526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101714281|NCT00747526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714282|NCT00747604|Mecasermin|mecasermin|mesh-list
101714283|NCT00747604|Growth Substances|growth substances|mesh-ancestor
101714284|NCT00747604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714285|NCT02151604|Xenon|xenon|mesh-list
101714286|NCT02151604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101714287|NCT02151604|Anesthetics, General|anesthetics, general|mesh-ancestor
101714288|NCT02151604|Anesthetics|anesthetics|mesh-ancestor
101714289|NCT02151604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101714290|NCT02151604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714291|NCT00466921|Lenalidomide|lenalidomide|mesh-list
101714292|NCT00466921|Immunologic Factors|immunologic factors|mesh-ancestor
101714293|NCT00466921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714294|NCT00466921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101714295|NCT00466921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101714296|NCT00466921|Growth Substances|growth substances|mesh-ancestor
101714297|NCT00466921|Growth Inhibitors|growth inhibitors|mesh-ancestor
101714298|NCT00466921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101714299|NCT00601523|Pramipexole|pramipexole|mesh-list
101714300|NCT00601523|Antioxidants|antioxidants|mesh-ancestor
101714301|NCT00601523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714302|NCT00601523|Protective Agents|protective agents|mesh-ancestor
101714303|NCT00601523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714304|NCT00601523|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101714305|NCT00601523|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101714306|NCT00601523|Dopamine Agonists|dopamine agonists|mesh-ancestor
101714307|NCT00601523|Dopamine Agents|dopamine agents|mesh-ancestor
101714308|NCT00601523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101714309|NCT00466687|Bevacizumab|bevacizumab|mesh-list
101714310|NCT00466687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101714311|NCT00466687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101714312|NCT00466687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101714313|NCT00466687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101714314|NCT00466687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101714315|NCT00466687|Growth Substances|growth substances|mesh-ancestor
101714316|NCT00466687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714317|NCT00466687|Growth Inhibitors|growth inhibitors|mesh-ancestor
101714318|NCT00466687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101714319|NCT00466687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101714320|NCT00466687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714321|NCT01522768|Paclitaxel|paclitaxel|mesh-list
101714322|NCT01522768|Afatinib|afatinib|mesh-list
101371741|NCT00191932|Analgesics|analgesics|mesh-ancestor
101714323|NCT01522768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101714324|NCT01522768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101714325|NCT01522768|Tubulin Modulators|tubulin modulators|mesh-ancestor
101714326|NCT01522768|Antimitotic Agents|antimitotic agents|mesh-ancestor
101714327|NCT01522768|Mitosis Modulators|mitosis modulators|mesh-ancestor
101714328|NCT01522768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714329|NCT01522768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101714330|NCT01522768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101714331|NCT01759459|Lidocaine|lidocaine|mesh-list
101714332|NCT01759459|Anesthetics, Local|anesthetics, local|mesh-ancestor
101714333|NCT01759459|Anesthetics|anesthetics|mesh-ancestor
101714334|NCT01759459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101714335|NCT01759459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714336|NCT01759459|Sensory System Agents|sensory system agents|mesh-ancestor
101714337|NCT01759459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101714338|NCT01759459|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101714339|NCT01759459|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101714340|NCT01759459|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101714341|NCT01759459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101714342|NCT01759459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714343|NCT02562742|Ribavirin|ribavirin|mesh-list
101714344|NCT02562742|Antimetabolites|antimetabolites|mesh-ancestor
101714345|NCT02562742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714346|NCT02562742|Antiviral Agents|antiviral agents|mesh-ancestor
101714347|NCT02562742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101714348|NCT00744016|Mesalamine|mesalamine|mesh-list
101714349|NCT00744016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101714350|NCT00744016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101714351|NCT00744016|Analgesics|analgesics|mesh-ancestor
101714352|NCT00744016|Sensory System Agents|sensory system agents|mesh-ancestor
101714353|NCT00744016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101714354|NCT00744016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714355|NCT00744016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101714356|NCT00744016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101714357|NCT04182737|Immunoglobulins|immunoglobulins|mesh-list
101714358|NCT04182737|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101714359|NCT04182737|Antibodies|antibodies|mesh-list
101714360|NCT04182737|Immunoglobulin M|immunoglobulin m|mesh-list
101714361|NCT04182737|Immunoglobulin A|immunoglobulin a|mesh-list
101714362|NCT04182737|Immunologic Factors|immunologic factors|mesh-ancestor
101714363|NCT04182737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714364|NCT04181645|Paclitaxel|paclitaxel|mesh-list
101714365|NCT04181645|Gemcitabine|gemcitabine|mesh-list
101714366|NCT04181645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101714367|NCT04181645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101714368|NCT04181645|Tubulin Modulators|tubulin modulators|mesh-ancestor
101714369|NCT04181645|Antimitotic Agents|antimitotic agents|mesh-ancestor
101714370|NCT04181645|Mitosis Modulators|mitosis modulators|mesh-ancestor
101714371|NCT04181645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714372|NCT04181645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101714373|NCT04181645|Antimetabolites|antimetabolites|mesh-ancestor
101714374|NCT02679833|Vitamin B 12|vitamin b 12|mesh-list
101714375|NCT02679833|Hydroxocobalamin|hydroxocobalamin|mesh-list
101714376|NCT02679833|Vitamin B Complex|vitamin b complex|mesh-ancestor
101714377|NCT02679833|Vitamins|vitamins|mesh-ancestor
101714378|NCT02679833|Micronutrients|micronutrients|mesh-ancestor
101801670|NCT00713921|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101714379|NCT02679833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714381|NCT00641927|Lithium Carbonate|lithium carbonate|mesh-list
101714382|NCT00641927|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101714383|NCT00641927|Antidepressive Agents|antidepressive agents|mesh-ancestor
101714384|NCT00641927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101714385|NCT00641927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101714386|NCT00641927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714387|NCT00641927|Antimanic Agents|antimanic agents|mesh-ancestor
101714388|NCT00641927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101714389|NCT00641927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101714390|NCT00641927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714391|NCT00641927|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101714392|NCT00641927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101714393|NCT00641927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101714394|NCT00641927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101714395|NCT00641927|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101714396|NCT02677571|Morphine|morphine|mesh-list
101714397|NCT02677571|Levobupivacaine|levobupivacaine|mesh-list
101714398|NCT02677571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101714399|NCT02677571|Narcotics|narcotics|mesh-ancestor
101714400|NCT02677571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101714401|NCT02677571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714402|NCT02677571|Analgesics|analgesics|mesh-ancestor
101714403|NCT02677571|Sensory System Agents|sensory system agents|mesh-ancestor
101714404|NCT02677571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101714405|NCT02677571|Anesthetics, Local|anesthetics, local|mesh-ancestor
101714406|NCT02677571|Anesthetics|anesthetics|mesh-ancestor
101714407|NCT04181567|Agomelatine|agomelatine|mesh-list
101714408|NCT04181567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101714409|NCT04181567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101714410|NCT04181567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714411|NCT05664191|Simendan|simendan|mesh-list
101714412|NCT05664191|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101714413|NCT05664191|Vasodilator Agents|vasodilator agents|mesh-ancestor
101714414|NCT05664191|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101714415|NCT05664191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101714416|NCT05664191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101714417|NCT05664191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714418|NCT05664191|Protective Agents|protective agents|mesh-ancestor
101714419|NCT05664191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714420|NCT02676011|Atropine|atropine|mesh-list
101714421|NCT02676011|Succinylcholine|succinylcholine|mesh-list
101189218|NCT00003564|Isotretinoin|isotretinoin|mesh-list
101714422|NCT02676011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101714423|NCT02676011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101714424|NCT02676011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101714425|NCT02676011|Autonomic Agents|autonomic agents|mesh-ancestor
101801681|NCT04072601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101801682|NCT04072601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101801692|NCT03476369|Ticagrelor|ticagrelor|mesh-list
101714426|NCT02676011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101714427|NCT02676011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714428|NCT02676011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101714429|NCT02676011|Respiratory System Agents|respiratory system agents|mesh-ancestor
101714430|NCT02676011|Mydriatics|mydriatics|mesh-ancestor
101714431|NCT02676011|Parasympatholytics|parasympatholytics|mesh-ancestor
101714432|NCT02676011|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101714433|NCT02676011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101714434|NCT02676011|Cholinergic Agents|cholinergic agents|mesh-ancestor
101714435|NCT02676011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101714436|NCT02676011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714437|NCT02676011|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
101714438|NCT02676011|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101714439|NCT02676011|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101714440|NCT05662943|Aflibercept|aflibercept|mesh-list
101714441|NCT05662943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101714442|NCT05662943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101714443|NCT05662943|Growth Substances|growth substances|mesh-ancestor
101714444|NCT05662943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714445|NCT05662943|Growth Inhibitors|growth inhibitors|mesh-ancestor
101714446|NCT05662943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101714447|NCT05663255|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101714448|NCT05663255|Azithromycin|azithromycin|mesh-list
101714449|NCT05663255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101714451|NCT02678975|Temozolomide|temozolomide|mesh-list
101714452|NCT02678975|Lomustine|lomustine|mesh-list
101714453|NCT02678975|Disulfiram|disulfiram|mesh-list
101714454|NCT02678975|Alkylating Agents|alkylating agents|mesh-list
101714455|NCT02678975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101714456|NCT02678975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714457|NCT02678975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101714458|NCT02678975|Trace Elements|trace elements|mesh-ancestor
101714459|NCT02678975|Micronutrients|micronutrients|mesh-ancestor
101714460|NCT02678975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714461|NCT02678975|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101714462|NCT02678975|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
101714463|NCT02678975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101714464|NCT02677415|Anesthetics|anesthetics|mesh-list
101714465|NCT02677415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
101714466|NCT02677415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101714467|NCT02677415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714468|NCT02677415|Anesthetics, General|anesthetics, general|mesh-ancestor
101714469|NCT00454051|Omalizumab|omalizumab|mesh-list
101714470|NCT00454051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101714471|NCT00454051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101714472|NCT00454051|Respiratory System Agents|respiratory system agents|mesh-ancestor
101714473|NCT04181489|Prednisolone|prednisolone|mesh-list
101714474|NCT04181489|Cyclophosphamide|cyclophosphamide|mesh-list
101714475|NCT04181489|Rituximab|rituximab|mesh-list
101714476|NCT04181489|Doxorubicin|doxorubicin|mesh-list
101714477|NCT04181489|Vincristine|vincristine|mesh-list
101714478|NCT04181489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101714479|NCT04181489|Immunologic Factors|immunologic factors|mesh-ancestor
101714480|NCT04181489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714481|NCT04181489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101714482|NCT04181489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101714483|NCT04181489|Alkylating Agents|alkylating agents|mesh-ancestor
101714484|NCT04181489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801706|NCT03476369|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101801707|NCT03476369|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101714485|NCT04181489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101714486|NCT04181489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101714487|NCT04181489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101714488|NCT04181489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101714489|NCT04181489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101714490|NCT04181489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101714491|NCT04181489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101714492|NCT04181489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101714493|NCT04181489|Tubulin Modulators|tubulin modulators|mesh-ancestor
101714494|NCT04181489|Antimitotic Agents|antimitotic agents|mesh-ancestor
101714495|NCT04181489|Mitosis Modulators|mitosis modulators|mesh-ancestor
101714496|NCT04181489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101714497|NCT04181489|Glucocorticoids|glucocorticoids|mesh-ancestor
101714499|NCT04181489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101714500|NCT04181489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101714501|NCT02537561|Cisplatin|cisplatin|mesh-list
101714502|NCT02537561|Gemcitabine|gemcitabine|mesh-list
101714503|NCT02537561|Talazoparib|talazoparib|mesh-list
101714504|NCT02537561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101714505|NCT02537561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101714506|NCT02537561|Antimetabolites|antimetabolites|mesh-ancestor
101714507|NCT02537561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714508|NCT02537561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101714509|NCT02537561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101714510|NCT02676089|Tiotropium Bromide|tiotropium bromide|mesh-list
101714511|NCT02676089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101714512|NCT02676089|Autonomic Agents|autonomic agents|mesh-ancestor
101714513|NCT02676089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101714514|NCT02676089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714515|NCT02676089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101714516|NCT02676089|Respiratory System Agents|respiratory system agents|mesh-ancestor
101714517|NCT02676089|Parasympatholytics|parasympatholytics|mesh-ancestor
101714518|NCT02676089|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101714519|NCT02676089|Cholinergic Agents|cholinergic agents|mesh-ancestor
101714520|NCT02676089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101714521|NCT02676089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714522|NCT02679131|Belinostat|belinostat|mesh-list
101714523|NCT02679131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101714524|NCT02679131|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101714525|NCT02679131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101333656|NCT00040066|Anesthetics|anesthetics|mesh-ancestor
101714526|NCT02679131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714527|NCT00484939|Bevacizumab|bevacizumab|mesh-list
101714528|NCT00484939|Capecitabine|capecitabine|mesh-list
101714529|NCT00484939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101714530|NCT00484939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101714531|NCT00484939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101714532|NCT00484939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101714533|NCT00484939|Growth Substances|growth substances|mesh-ancestor
101714534|NCT00484939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714535|NCT00484939|Growth Inhibitors|growth inhibitors|mesh-ancestor
101801721|NCT00723047|Hemostatics|hemostatics|mesh-ancestor
101801722|NCT00723047|Coagulants|coagulants|mesh-ancestor
101801723|NCT00450814|Cyclophosphamide|cyclophosphamide|mesh-list
101801724|NCT00450814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101801725|NCT00450814|Immunologic Factors|immunologic factors|mesh-ancestor
101801726|NCT00450814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801727|NCT00450814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101801728|NCT00450814|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101801729|NCT00450814|Alkylating Agents|alkylating agents|mesh-ancestor
101801730|NCT00450814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714536|NCT00484939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101714537|NCT00484939|Antimetabolites|antimetabolites|mesh-ancestor
101714538|NCT00484939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714539|NCT00642161|Budesonide|budesonide|mesh-list
101714540|NCT00642161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101714541|NCT00642161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101714542|NCT00642161|Autonomic Agents|autonomic agents|mesh-ancestor
101714543|NCT00642161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101714544|NCT00642161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714545|NCT00642161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101714546|NCT00642161|Respiratory System Agents|respiratory system agents|mesh-ancestor
101714547|NCT00642161|Glucocorticoids|glucocorticoids|mesh-ancestor
101714548|NCT00642161|Hormones|hormones|mesh-ancestor
101714549|NCT00642161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101714550|NCT05663177|Vinorelbine|vinorelbine|mesh-list
101714551|NCT05663177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101714552|NCT05663177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101714553|NCT05663177|Tubulin Modulators|tubulin modulators|mesh-ancestor
101714554|NCT05663177|Antimitotic Agents|antimitotic agents|mesh-ancestor
101714555|NCT05663177|Mitosis Modulators|mitosis modulators|mesh-ancestor
101714556|NCT05663177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714557|NCT00642551|Vitamin K 2|vitamin k 2|mesh-list
101714559|NCT00642551|Menaquinone 7|menaquinone 7|mesh-list
101714560|NCT00642551|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101714561|NCT00642551|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101714562|NCT00642551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714563|NCT00642551|Hemostatics|hemostatics|mesh-ancestor
101714564|NCT00642551|Coagulants|coagulants|mesh-ancestor
101714565|NCT00642551|Vitamins|vitamins|mesh-ancestor
101714566|NCT00642551|Micronutrients|micronutrients|mesh-ancestor
101714567|NCT00642551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714568|NCT04181957|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101714569|NCT04181957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101714570|NCT04181957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714571|NCT04181957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101714572|NCT04181957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101714573|NCT04181957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101714574|NCT04181957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714575|NCT04181957|Dopamine Agents|dopamine agents|mesh-ancestor
101714576|NCT04181957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101714577|NCT00643409|Azithromycin|azithromycin|mesh-list
101714578|NCT00643409|Levofloxacin|levofloxacin|mesh-list
101714579|NCT00643409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101714580|NCT00643409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101714581|NCT00643409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101714582|NCT00643409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101714583|NCT00643409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101714584|NCT00643409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101714585|NCT00643409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714586|NCT00643409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101714587|NCT00643409|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101714588|NCT00643409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101714589|NCT04180007|Apatinib|apatinib|mesh-list
101714590|NCT04180007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101714591|NCT04180007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101714592|NCT04180007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801731|NCT00450814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101801732|NCT00450814|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101801733|NCT02571491|Ketamine|ketamine|mesh-list
101801734|NCT02571491|Morphine|morphine|mesh-list
101801735|NCT02571491|Remifentanil|remifentanil|mesh-list
101801736|NCT02571491|Analgesics|analgesics|mesh-ancestor
101801737|NCT02571491|Sensory System Agents|sensory system agents|mesh-ancestor
101801738|NCT02571491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101714593|NCT04180007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714594|NCT02675309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101714595|NCT02675309|Simvastatin|simvastatin|mesh-list
101714596|NCT02675309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101714597|NCT02675309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101714598|NCT02675309|Antimetabolites|antimetabolites|mesh-ancestor
101714599|NCT02675309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714600|NCT02675309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101714601|NCT02675309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101714602|NCT02675309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101714603|NCT01025245|Remifentanil|remifentanil|mesh-list
101714604|NCT01025245|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101714605|NCT01025245|Narcotics|narcotics|mesh-ancestor
101714606|NCT01025245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101714607|NCT01025245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714608|NCT01025245|Analgesics|analgesics|mesh-ancestor
101714609|NCT01025245|Sensory System Agents|sensory system agents|mesh-ancestor
101714610|NCT01025245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101714611|NCT02677259|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101714612|NCT02677259|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101714613|NCT02677259|Estradiol|estradiol|mesh-list
101714614|NCT02677259|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101714615|NCT02677259|Progesterone|progesterone|mesh-list
101714616|NCT02677259|Estrogens|estrogens|mesh-ancestor
101714617|NCT02677259|Hormones|hormones|mesh-ancestor
101714618|NCT02677259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101714619|NCT02677259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714620|NCT02677259|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101714621|NCT02677259|Contraceptive Agents|contraceptive agents|mesh-ancestor
101372033|NCT00194038|Aripiprazole|aripiprazole|mesh-list
101714622|NCT02677259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101714623|NCT02677259|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101714624|NCT02677259|Progestins|progestins|mesh-ancestor
101714625|NCT02675387|Lidocaine|lidocaine|mesh-list
101714626|NCT02675387|Anesthetics, Local|anesthetics, local|mesh-ancestor
101714627|NCT02675387|Anesthetics|anesthetics|mesh-ancestor
101714628|NCT02675387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101714629|NCT02675387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714630|NCT02675387|Sensory System Agents|sensory system agents|mesh-ancestor
101714631|NCT02675387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101714632|NCT02675387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101714633|NCT02675387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101714634|NCT02675387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101714635|NCT02675387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101714636|NCT02675387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714637|NCT02678507|Analgesics, Opioid|analgesics, opioid|mesh-list
101714638|NCT02678507|Narcotics|narcotics|mesh-ancestor
101714639|NCT02678507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101714640|NCT02678507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714641|NCT02678507|Analgesics|analgesics|mesh-ancestor
101714642|NCT02678507|Sensory System Agents|sensory system agents|mesh-ancestor
101714643|NCT02678507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101801739|NCT02571491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801740|NCT02571491|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101801741|NCT02571491|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101801742|NCT02571491|Anesthetics, General|anesthetics, general|mesh-ancestor
101801743|NCT02571491|Anesthetics|anesthetics|mesh-ancestor
101714644|NCT00464737|Rotigotine|rotigotine|mesh-list
101714645|NCT00464737|Dopamine Agonists|dopamine agonists|mesh-ancestor
101714646|NCT00464737|Dopamine Agents|dopamine agents|mesh-ancestor
101714647|NCT00464737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101714648|NCT00464737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714649|NCT00464737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714650|NCT02678585|Lidocaine|lidocaine|mesh-list
101714651|NCT02678585|Nalbuphine|nalbuphine|mesh-list
101714652|NCT02678585|Anesthetics, Local|anesthetics, local|mesh-ancestor
101714653|NCT02678585|Anesthetics|anesthetics|mesh-ancestor
101714654|NCT02678585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101714655|NCT02678585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714656|NCT02678585|Sensory System Agents|sensory system agents|mesh-ancestor
101714657|NCT02678585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101714658|NCT02678585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101714659|NCT02678585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101714660|NCT02678585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101714661|NCT02678585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101714662|NCT02678585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714663|NCT02678585|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101714664|NCT02678585|Narcotics|narcotics|mesh-ancestor
101714665|NCT02678585|Analgesics|analgesics|mesh-ancestor
101714666|NCT00453349|Moxifloxacin|moxifloxacin|mesh-list
101714667|NCT00453349|Metronidazole|metronidazole|mesh-list
101714668|NCT00453349|Levofloxacin|levofloxacin|mesh-list
101714669|NCT00453349|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101714670|NCT00453349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101714671|NCT00453349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101714672|NCT00453349|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101714673|NCT00453349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101714674|NCT00453349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101714675|NCT00453349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714676|NCT00453349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101714677|NCT00453349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101714678|NCT00453349|Contraceptive Agents|contraceptive agents|mesh-ancestor
101714679|NCT00453349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101714680|NCT00453349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714681|NCT00453349|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101714682|NCT00453349|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101714683|NCT00453349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101714684|NCT00453349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101714685|NCT00453349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101714686|NCT00453349|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101714687|NCT00453349|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101714688|NCT00453349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101714689|NCT02675153|Sirolimus|sirolimus|mesh-list
101714690|NCT02675153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101714691|NCT02675153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101714692|NCT02675153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101714693|NCT02675153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101714694|NCT02675153|Antifungal Agents|antifungal agents|mesh-ancestor
101714695|NCT02675153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101714696|NCT02675153|Immunologic Factors|immunologic factors|mesh-ancestor
101801755|NCT00723515|Calcium|calcium|mesh-list
101801756|NCT00723515|Fluorides|fluorides|mesh-list
101801757|NCT00723515|Sodium Fluoride|sodium fluoride|mesh-list
101801758|NCT00723515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101801759|NCT00723515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801760|NCT00723515|Cariostatic Agents|cariostatic agents|mesh-ancestor
101801761|NCT00723515|Protective Agents|protective agents|mesh-ancestor
101801762|NCT00723515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101714697|NCT02675153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714698|NCT04179617|Nicotine|nicotine|mesh-list
101714699|NCT04179617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101714700|NCT04179617|Autonomic Agents|autonomic agents|mesh-ancestor
101714701|NCT04179617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101714702|NCT04179617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714703|NCT04179617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101714704|NCT04179617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101714705|NCT04179617|Cholinergic Agents|cholinergic agents|mesh-ancestor
101714706|NCT04179617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101714707|NCT04179617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714708|NCT00464269|Brivaracetam|brivaracetam|mesh-list
101714709|NCT00464269|Anticonvulsants|anticonvulsants|mesh-ancestor
101714710|NCT00642863|Vitamin D|vitamin d|mesh-list
101714711|NCT00642863|Vitamins|vitamins|mesh-list
101714712|NCT00642863|Vitamin A|vitamin a|mesh-list
101714713|NCT00642863|Retinol palmitate|retinol palmitate|mesh-list
101714714|NCT00642863|Micronutrients|micronutrients|mesh-ancestor
101714715|NCT00642863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714716|NCT00642863|Antioxidants|antioxidants|mesh-ancestor
101714717|NCT00642863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714718|NCT00642863|Protective Agents|protective agents|mesh-ancestor
101714719|NCT00642863|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101714720|NCT00642863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101714721|NCT00642863|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101714722|NCT02674997|Factor VIII|factor viii|mesh-list
101714723|NCT02674997|Coagulants|coagulants|mesh-ancestor
101714724|NCT04178291|Erythritol|erythritol|mesh-list
101714725|NCT04178291|Vasodilator Agents|vasodilator agents|mesh-ancestor
101714726|NCT00643643|Maraviroc|maraviroc|mesh-list
101714727|NCT00643643|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101714728|NCT00643643|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101714729|NCT00643643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714730|NCT00643643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101714731|NCT00643643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101714732|NCT00643643|Antiviral Agents|antiviral agents|mesh-ancestor
101714733|NCT00643643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101714734|NCT00643643|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101714735|NCT02676869|Pembrolizumab|pembrolizumab|mesh-list
101714736|NCT02676869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101714737|NCT02676869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101714738|NCT02676869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101714739|NCT02676869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714740|NCT02673047|Botulinum Toxins|botulinum toxins|mesh-list
101714741|NCT02673047|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101714742|NCT02673047|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101714743|NCT02673047|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101714744|NCT02673047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101714745|NCT02673047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714746|NCT02673047|Cholinergic Agents|cholinergic agents|mesh-ancestor
101714747|NCT02673047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101714748|NCT02673047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714749|NCT02673047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101714750|NCT02673047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101714751|NCT05584319|Empagliflozin|empagliflozin|mesh-list
101714752|NCT05584319|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101801763|NCT00723515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101801764|NCT01028170|Furosemide|furosemide|mesh-list
101801765|NCT01028170|Diuretics|diuretics|mesh-ancestor
101801766|NCT01028170|Natriuretic Agents|natriuretic agents|mesh-ancestor
101801767|NCT01028170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801768|NCT01028170|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101801769|NCT01028170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101801770|NCT01028170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801771|NCT00518115|Exenatide|exenatide|mesh-list
101714753|NCT05584319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714754|NCT05584319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101714755|NCT05584319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714756|NCT02676323|Leucovorin|leucovorin|mesh-list
101714757|NCT02676323|Cytarabine|cytarabine|mesh-list
101714758|NCT02676323|Hydrocortisone|hydrocortisone|mesh-list
101714759|NCT02676323|Methotrexate|methotrexate|mesh-list
101714760|NCT02676323|Fludarabine phosphate|fludarabine phosphate|mesh-list
101714761|NCT02676323|Fludarabine|fludarabine|mesh-list
101714762|NCT02676323|Panobinostat|panobinostat|mesh-list
101714763|NCT02676323|Levoleucovorin|levoleucovorin|mesh-list
101714764|NCT02676323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714765|NCT02676323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101714766|NCT02676323|Abortifacient Agents|abortifacient agents|mesh-ancestor
101714767|NCT02676323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101714768|NCT02676323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101714769|NCT02676323|Antimetabolites|antimetabolites|mesh-ancestor
101714770|NCT02676323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714771|NCT02676323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101714772|NCT02676323|Dermatologic Agents|dermatologic agents|mesh-ancestor
101714773|NCT02676323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101714774|NCT02676323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101714775|NCT02676323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101714776|NCT02676323|Immunologic Factors|immunologic factors|mesh-ancestor
101714777|NCT02676323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101714778|NCT02676323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101714779|NCT02676323|Antiviral Agents|antiviral agents|mesh-ancestor
101714780|NCT02676323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101714781|NCT02676323|Antidotes|antidotes|mesh-ancestor
101714782|NCT02676323|Protective Agents|protective agents|mesh-ancestor
101714783|NCT02676323|Vitamin B Complex|vitamin b complex|mesh-ancestor
101714784|NCT02676323|Vitamins|vitamins|mesh-ancestor
101714785|NCT02676323|Micronutrients|micronutrients|mesh-ancestor
101714786|NCT02676323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101714787|NCT02676323|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101714788|NCT00643799|Celecoxib|celecoxib|mesh-list
101714789|NCT00643799|Naproxen|naproxen|mesh-list
101714790|NCT00643799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101714791|NCT00643799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101714792|NCT00643799|Analgesics|analgesics|mesh-ancestor
101714793|NCT00643799|Sensory System Agents|sensory system agents|mesh-ancestor
101714794|NCT00643799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101714795|NCT00643799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714796|NCT00643799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101714797|NCT00643799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101714798|NCT00643799|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101714799|NCT00643799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101714800|NCT00643799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101714801|NCT00643799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714802|NCT00643799|Gout Suppressants|gout suppressants|mesh-ancestor
101714803|NCT05348213|Decitabine|decitabine|mesh-list
101714804|NCT05348213|Pomalidomide|pomalidomide|mesh-list
101714805|NCT05348213|Zanubrutinib|zanubrutinib|mesh-list
101714806|NCT05348213|Tofacitinib|tofacitinib|mesh-list
101714807|NCT05348213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101714808|NCT05348213|Antimetabolites|antimetabolites|mesh-ancestor
101714809|NCT05348213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714810|NCT05348213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101714811|NCT05348213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101714812|NCT05348213|Immunologic Factors|immunologic factors|mesh-ancestor
101801773|NCT00518115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101714813|NCT05348213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714814|NCT05348213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101714815|NCT05348213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101714816|NCT05348213|Growth Substances|growth substances|mesh-ancestor
101714817|NCT05348213|Growth Inhibitors|growth inhibitors|mesh-ancestor
101714818|NCT05348213|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101714819|NCT05348213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101714820|NCT00643877|Oxaliplatin|oxaliplatin|mesh-list
101714821|NCT00643877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101714822|NCT02674295|Esketamine|esketamine|mesh-list
101714823|NCT02674295|Antidepressive Agents|antidepressive agents|mesh-ancestor
101714824|NCT02674295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101714825|NCT04179071|Famotidine|famotidine|mesh-list
101714826|NCT04179071|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101714827|NCT04179071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101714828|NCT04179071|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101714829|NCT04179071|Histamine Antagonists|histamine antagonists|mesh-ancestor
101714830|NCT04179071|Histamine Agents|histamine agents|mesh-ancestor
101714831|NCT04179071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101714832|NCT04179071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714833|NCT04179071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714835|NCT02674139|Trace Elements|trace elements|mesh-ancestor
101714836|NCT02674139|Micronutrients|micronutrients|mesh-ancestor
101714837|NCT02674139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714838|NCT00644033|Frovatriptan|frovatriptan|mesh-list
101714839|NCT00644033|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101714840|NCT00644033|Serotonin Agents|serotonin agents|mesh-ancestor
101714841|NCT00644033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101714842|NCT00644033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714843|NCT00644033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714844|NCT00484315|Paclitaxel|paclitaxel|mesh-list
101714845|NCT00484315|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101714846|NCT00484315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101714847|NCT00484315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101714849|NCT00484315|Antimitotic Agents|antimitotic agents|mesh-ancestor
101714850|NCT00484315|Mitosis Modulators|mitosis modulators|mesh-ancestor
101714851|NCT00484315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714852|NCT01019083|Zinc|zinc|mesh-list
101714853|NCT01019083|Albendazole|albendazole|mesh-list
101714854|NCT01019083|Secnidazole|secnidazole|mesh-list
101714855|NCT01019083|Zinc Sulfate|zinc sulfate|mesh-list
101714856|NCT01019083|Trace Elements|trace elements|mesh-ancestor
101714857|NCT01019083|Micronutrients|micronutrients|mesh-ancestor
101714858|NCT01019083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714859|NCT01019083|Anthelmintics|anthelmintics|mesh-ancestor
101714860|NCT01019083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101714861|NCT01019083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101714862|NCT01019083|Anticestodal Agents|anticestodal agents|mesh-ancestor
101714863|NCT01019083|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101714864|NCT01019083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101714865|NCT01019083|Tubulin Modulators|tubulin modulators|mesh-ancestor
101714866|NCT01019083|Antimitotic Agents|antimitotic agents|mesh-ancestor
101714867|NCT01019083|Mitosis Modulators|mitosis modulators|mesh-ancestor
101714868|NCT01019083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714869|NCT01019083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101714870|NCT01019083|Astringents|astringents|mesh-ancestor
101714871|NCT01019083|Dermatologic Agents|dermatologic agents|mesh-ancestor
101714872|NCT00463801|Daptomycin|daptomycin|mesh-list
101714873|NCT00463801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101714874|NCT00463801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101714875|NCT02672345|Sevoflurane|sevoflurane|mesh-list
101714876|NCT02672345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101801788|NCT00450658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101714877|NCT02672345|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101714878|NCT02672345|Anesthetics, General|anesthetics, general|mesh-ancestor
101714879|NCT02672345|Anesthetics|anesthetics|mesh-ancestor
101714880|NCT02672345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101714881|NCT02672345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714882|NCT02537249|Dexmedetomidine|dexmedetomidine|mesh-list
101714883|NCT02537249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101714884|NCT02537249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101714885|NCT02537249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714886|NCT02537249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101714887|NCT02537249|Analgesics|analgesics|mesh-ancestor
101714888|NCT02537249|Sensory System Agents|sensory system agents|mesh-ancestor
101714889|NCT02537249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101714890|NCT02537249|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101714891|NCT02537249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101714892|NCT02537249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101714893|NCT02537249|Adrenergic Agents|adrenergic agents|mesh-ancestor
101714894|NCT02537249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101714895|NCT02537249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714896|NCT00644111|Hydromorphone|hydromorphone|mesh-list
101714897|NCT00644111|Bupivacaine|bupivacaine|mesh-list
101714898|NCT00644111|Anesthetics, Local|anesthetics, local|mesh-ancestor
101714899|NCT00644111|Anesthetics|anesthetics|mesh-ancestor
101714900|NCT00644111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101714901|NCT00644111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714902|NCT00644111|Sensory System Agents|sensory system agents|mesh-ancestor
101714903|NCT00644111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101714904|NCT00644111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101714905|NCT00644111|Narcotics|narcotics|mesh-ancestor
101714906|NCT00644111|Analgesics|analgesics|mesh-ancestor
101714907|NCT00644891|Amoxicillin|amoxicillin|mesh-list
101714908|NCT00644891|Cefdinir|cefdinir|mesh-list
101714909|NCT00644891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101714910|NCT00644891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101714911|NCT05203445|Pembrolizumab|pembrolizumab|mesh-list
101714912|NCT05203445|Olaparib|olaparib|mesh-list
101714913|NCT05203445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101714914|NCT05203445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101714915|NCT05203445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101714916|NCT05203445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714917|NCT05203445|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101714918|NCT05203445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101714919|NCT04178057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101714920|NCT04178057|Antibodies|antibodies|mesh-list
101714921|NCT04178057|Immunoglobulins|immunoglobulins|mesh-list
101714922|NCT04178057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101714923|NCT04178057|Mitogens|mitogens|mesh-list
101372334|NCT00195988|Immunologic Factors|immunologic factors|mesh-ancestor
101714924|NCT04178057|Endothelial Growth Factors|endothelial growth factors|mesh-list
101714925|NCT04178057|Immunologic Factors|immunologic factors|mesh-ancestor
101714926|NCT04178057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714927|NCT04178057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101714928|NCT04178057|Mitosis Modulators|mitosis modulators|mesh-ancestor
101714929|NCT04178057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714930|NCT04178057|Growth Substances|growth substances|mesh-ancestor
101714931|NCT04177043|Antibodies|antibodies|mesh-list
101714932|NCT04177043|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
101714933|NCT04177043|Immunologic Factors|immunologic factors|mesh-ancestor
101714934|NCT04177043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714935|NCT02670785|Estradiol|estradiol|mesh-list
101714936|NCT02670785|Estrogens|estrogens|mesh-ancestor
101801802|NCT02572505|Antiviral Agents|antiviral agents|mesh-ancestor
101714937|NCT02670785|Hormones|hormones|mesh-ancestor
101714938|NCT02670785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101714939|NCT02670785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714940|NCT02670317|Prednisone|prednisone|mesh-list
101714942|NCT02670317|Doxorubicin|doxorubicin|mesh-list
101714943|NCT02670317|Vincristine|vincristine|mesh-list
101714944|NCT02670317|Obinutuzumab|obinutuzumab|mesh-list
101714945|NCT02670317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101714946|NCT02670317|Immunologic Factors|immunologic factors|mesh-ancestor
101714947|NCT02670317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714948|NCT02670317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101714949|NCT02670317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101714950|NCT02670317|Alkylating Agents|alkylating agents|mesh-ancestor
101714951|NCT02670317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714952|NCT02670317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101714953|NCT02670317|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101714954|NCT02670317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101714955|NCT02670317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101714956|NCT02670317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101714957|NCT02670317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101714958|NCT02670317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101714959|NCT02670317|Glucocorticoids|glucocorticoids|mesh-ancestor
101714960|NCT02670317|Hormones|hormones|mesh-ancestor
101714961|NCT02670317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101714962|NCT02670317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101714963|NCT02670317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101714964|NCT02670317|Tubulin Modulators|tubulin modulators|mesh-ancestor
101714965|NCT02670317|Antimitotic Agents|antimitotic agents|mesh-ancestor
101714966|NCT02670317|Mitosis Modulators|mitosis modulators|mesh-ancestor
101714967|NCT02670317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101714968|NCT02671565|Hyaluronic Acid|hyaluronic acid|mesh-list
101714969|NCT02671565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101714970|NCT02671565|Immunologic Factors|immunologic factors|mesh-ancestor
101714971|NCT02671565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714972|NCT02671565|Viscosupplements|viscosupplements|mesh-ancestor
101714973|NCT02671565|Protective Agents|protective agents|mesh-ancestor
101714974|NCT02537405|Rivaroxaban|rivaroxaban|mesh-list
101714975|NCT02537405|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101801815|NCT01010139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101714976|NCT02537405|Antithrombins|antithrombins|mesh-ancestor
101714977|NCT02537405|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101714978|NCT02537405|Protease Inhibitors|protease inhibitors|mesh-ancestor
101714979|NCT02537405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101714980|NCT02537405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714981|NCT02537405|Anticoagulants|anticoagulants|mesh-ancestor
101714982|NCT04175171|Trastuzumab|trastuzumab|mesh-list
101714983|NCT04175171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101714984|NCT04175171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101714985|NCT04175093|N,N-dimethylarginine|n,n-dimethylarginine|mesh-list
101714986|NCT04175093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101714987|NCT04175093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101714988|NCT00645125|Amoxicillin|amoxicillin|mesh-list
101714989|NCT00645125|Cefdinir|cefdinir|mesh-list
101714990|NCT00645125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101714991|NCT00645125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101714992|NCT02669459|Imiquimod|imiquimod|mesh-list
101714993|NCT02669459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101714994|NCT02669459|Immunologic Factors|immunologic factors|mesh-ancestor
101714995|NCT02669459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101714996|NCT02669459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101714997|NCT02669459|Interferon Inducers|interferon inducers|mesh-ancestor
101372417|NCT00196612|Efavirenz|efavirenz|mesh-list
101714998|NCT04176887|Phenytoin|phenytoin|mesh-list
101714999|NCT04176887|Levetiracetam|levetiracetam|mesh-list
101715000|NCT04176887|Anticonvulsants|anticonvulsants|mesh-ancestor
101715001|NCT04176887|Nootropic Agents|nootropic agents|mesh-ancestor
101715002|NCT04176887|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101715003|NCT04176887|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101715004|NCT04176887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101715005|NCT04176887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715006|NCT04176887|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101715007|NCT04176887|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101715008|NCT04174937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101715009|NCT04174937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101715010|NCT00645203|Cefdinir|cefdinir|mesh-list
101715011|NCT00645203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101715012|NCT00645203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101715013|NCT02669303|Methylprednisolone|methylprednisolone|mesh-list
101715014|NCT02669303|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101200797|NCT01400568|Xhance|xhance|mesh-list
101715015|NCT02669303|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101715016|NCT02669303|Prednisolone|prednisolone|mesh-list
101715017|NCT02669303|Prednisolone acetate|prednisolone acetate|mesh-list
101715018|NCT02669303|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101715019|NCT02669303|Prednisolone phosphate|prednisolone phosphate|mesh-list
101715020|NCT02669303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101715021|NCT02669303|Antiemetics|antiemetics|mesh-ancestor
101715022|NCT02669303|Autonomic Agents|autonomic agents|mesh-ancestor
101715023|NCT02669303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101715024|NCT02669303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715025|NCT02669303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101715026|NCT02669303|Glucocorticoids|glucocorticoids|mesh-ancestor
101715028|NCT02669303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101801852|NCT01010295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101715030|NCT02669303|Protective Agents|protective agents|mesh-ancestor
101715031|NCT02669303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101715032|NCT02669303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101715033|NCT00645281|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101715034|NCT00645281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101715035|NCT00645281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101715036|NCT00645281|Cholinergic Agents|cholinergic agents|mesh-ancestor
101715037|NCT00645281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101715038|NCT00645281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715039|NCT00645281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715040|NCT00645281|Urological Agents|urological agents|mesh-ancestor
101715041|NCT02668679|Hormones|hormones|mesh-list
101715042|NCT02668679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101715043|NCT02668679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715044|NCT00645437|Levofloxacin|levofloxacin|mesh-list
101715045|NCT00645437|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101715046|NCT00645437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101715047|NCT00645437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101715048|NCT00645437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101715049|NCT00645437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101715050|NCT00645437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101715051|NCT00645437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715052|NCT00645437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101715053|NCT00645437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101715054|NCT00645437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101715055|NCT02537171|Apatinib|apatinib|mesh-list
101715056|NCT02537171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101715057|NCT02537171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101715058|NCT02537171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101715059|NCT02537171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715060|NCT00645515|Risperidone|risperidone|mesh-list
101715061|NCT00645515|Ziprasidone|ziprasidone|mesh-list
101715062|NCT00645515|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101715063|NCT00645515|Serotonin Agents|serotonin agents|mesh-ancestor
101715064|NCT00645515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101715065|NCT00645515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715066|NCT00645515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715067|NCT00645515|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101715068|NCT00645515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101715069|NCT00645515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101715070|NCT00645515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101715071|NCT00645515|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101715072|NCT00645515|Dopamine Agents|dopamine agents|mesh-ancestor
101715073|NCT00644735|Esomeprazole|esomeprazole|mesh-list
101715074|NCT00644735|Lansoprazole|lansoprazole|mesh-list
101715075|NCT00644735|Dexlansoprazole|dexlansoprazole|mesh-list
101715076|NCT00644735|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101715077|NCT00644735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101715078|NCT00644735|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101715079|NCT00644735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101715080|NCT00644735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715081|NCT02667743|Paclitaxel|paclitaxel|mesh-list
101715082|NCT02667743|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101715083|NCT02667743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101715084|NCT02667743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101715085|NCT02667743|Tubulin Modulators|tubulin modulators|mesh-ancestor
101715086|NCT02667743|Antimitotic Agents|antimitotic agents|mesh-ancestor
101801871|NCT01010451|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101715087|NCT02667743|Mitosis Modulators|mitosis modulators|mesh-ancestor
101715088|NCT02667743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715090|NCT02666651|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101715091|NCT02666651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715092|NCT02666651|Natriuretic Agents|natriuretic agents|mesh-ancestor
101715093|NCT02666651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715094|NCT02671175|Piperaquine|piperaquine|mesh-list
101715095|NCT02671175|Artenimol|artenimol|mesh-list
101715096|NCT02671175|Artemisinins|artemisinins|mesh-list
101715097|NCT02671175|Antimalarials|antimalarials|mesh-ancestor
101715098|NCT02671175|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101715099|NCT02671175|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101715100|NCT02671175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101715101|NCT02671097|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101715102|NCT02671097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101715103|NCT02671097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101715104|NCT02671097|Antimetabolites|antimetabolites|mesh-ancestor
101715105|NCT02671097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715106|NCT02671097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101715107|NCT02671097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101715108|NCT02671097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101715109|NCT02667197|Analgesics, Opioid|analgesics, opioid|mesh-list
101715110|NCT02667197|Narcotics|narcotics|mesh-ancestor
101715111|NCT02667197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101715112|NCT02667197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715113|NCT02667197|Analgesics|analgesics|mesh-ancestor
101715114|NCT02667197|Sensory System Agents|sensory system agents|mesh-ancestor
101715115|NCT02667197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101715116|NCT00463567|Formoterol Fumarate|formoterol fumarate|mesh-list
101715117|NCT00463567|Tiotropium Bromide|tiotropium bromide|mesh-list
101715118|NCT00463567|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101715119|NCT00463567|Autonomic Agents|autonomic agents|mesh-ancestor
101715120|NCT00463567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101715121|NCT00463567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715122|NCT00463567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101715123|NCT00463567|Respiratory System Agents|respiratory system agents|mesh-ancestor
101715124|NCT00463567|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101715125|NCT00463567|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101715126|NCT00463567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101715127|NCT00463567|Adrenergic Agents|adrenergic agents|mesh-ancestor
101715128|NCT00463567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101715129|NCT00463567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715130|NCT00463567|Parasympatholytics|parasympatholytics|mesh-ancestor
101715131|NCT00463567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101715132|NCT00463567|Cholinergic Agents|cholinergic agents|mesh-ancestor
101715133|NCT00646061|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101715134|NCT00646061|Parasympatholytics|parasympatholytics|mesh-ancestor
101715135|NCT00646061|Autonomic Agents|autonomic agents|mesh-ancestor
101715136|NCT00646061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101715137|NCT00646061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715138|NCT00646061|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101715139|NCT00646061|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101715140|NCT00646061|Cholinergic Agents|cholinergic agents|mesh-ancestor
101715141|NCT00646061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101715142|NCT00646061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715143|NCT00646841|Doxazosin|doxazosin|mesh-list
101715144|NCT00646841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101715145|NCT00646841|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101801886|NCT00604214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101715146|NCT00646841|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101715147|NCT00646841|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101715148|NCT00646841|Adrenergic Agents|adrenergic agents|mesh-ancestor
101715149|NCT00646841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101715150|NCT00646841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715151|NCT00646841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715152|NCT04786067|Abatacept|abatacept|mesh-list
101715153|NCT04786067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101715154|NCT04786067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715155|NCT04786067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101715156|NCT04786067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101715157|NCT04786067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101715158|NCT04786067|Immunologic Factors|immunologic factors|mesh-ancestor
101715159|NCT04786067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715160|NCT04786067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101715161|NCT00646139|Tirbanibulin|tirbanibulin|mesh-list
101715162|NCT00646139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101715163|NCT00646139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715164|NCT00484159|Lidocaine|lidocaine|mesh-list
101715165|NCT00484159|Bupivacaine|bupivacaine|mesh-list
101715166|NCT00484159|Anesthetics, Local|anesthetics, local|mesh-ancestor
101715167|NCT00484159|Anesthetics|anesthetics|mesh-ancestor
101715168|NCT00484159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101715169|NCT00484159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715170|NCT00484159|Sensory System Agents|sensory system agents|mesh-ancestor
101715171|NCT00484159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101451730|NCT00208065|Serotonin Agents|serotonin agents|mesh-ancestor
101715172|NCT00484159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101715173|NCT00484159|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101715174|NCT00484159|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101715175|NCT00484159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101715176|NCT00484159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715177|NCT02666417|Iron|iron|mesh-list
101715178|NCT02666417|Trace Elements|trace elements|mesh-ancestor
101715179|NCT02666417|Micronutrients|micronutrients|mesh-ancestor
101715180|NCT02666417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715181|NCT00910637|Gestodene|gestodene|mesh-list
101715182|NCT00910637|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101715183|NCT00910637|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101715184|NCT00910637|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101715185|NCT00910637|Contraceptive Agents|contraceptive agents|mesh-ancestor
101715186|NCT00910637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101715187|NCT00910637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715188|NCT00910637|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101715189|NCT00910637|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101715190|NCT00910637|Progestins|progestins|mesh-ancestor
101715191|NCT00910637|Hormones|hormones|mesh-ancestor
101715192|NCT00910637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101715193|NCT00462865|Bevacizumab|bevacizumab|mesh-list
101715194|NCT00462865|Gemcitabine|gemcitabine|mesh-list
101715195|NCT00462865|Capecitabine|capecitabine|mesh-list
101715196|NCT00462865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101715197|NCT00462865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101715198|NCT00462865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101715199|NCT00462865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101715200|NCT00462865|Growth Substances|growth substances|mesh-ancestor
101715201|NCT00462865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715202|NCT00462865|Growth Inhibitors|growth inhibitors|mesh-ancestor
101715203|NCT00462865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101715204|NCT00462865|Antimetabolites|antimetabolites|mesh-ancestor
101715205|NCT00462865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715206|NCT02667353|Anesthetics|anesthetics|mesh-list
101715207|NCT02667353|Etomidate|etomidate|mesh-list
101715208|NCT02667353|Succinylcholine|succinylcholine|mesh-list
101715209|NCT02667353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101715210|NCT02667353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715211|NCT02667353|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101715213|NCT02667353|Anesthetics, General|anesthetics, general|mesh-ancestor
101715214|NCT02667353|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
101715215|NCT02667353|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101715216|NCT02667353|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101715217|NCT02667353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101715218|NCT00462709|Complement C1s|complement c1s|mesh-list
101715219|NCT00462709|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
101372659|NCT00198094|Alprazolam|alprazolam|mesh-list
101715220|NCT00462709|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
101715221|NCT00462709|Immunologic Factors|immunologic factors|mesh-ancestor
101715222|NCT00462709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715223|NCT00462709|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101715224|NCT00462709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101715225|NCT02664857|Vitamin D|vitamin d|mesh-list
101715226|NCT02664857|Ergocalciferols|ergocalciferols|mesh-list
101715227|NCT02664857|Cholecalciferol|cholecalciferol|mesh-list
101715228|NCT02664857|Vitamins|vitamins|mesh-list
101715229|NCT02664857|Micronutrients|micronutrients|mesh-ancestor
101715230|NCT02664857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715231|NCT02664857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101715232|NCT02664857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101715234|NCT02665871|Immunologic Factors|immunologic factors|mesh-ancestor
101715235|NCT02665871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715236|NCT00647543|Atorvastatin|atorvastatin|mesh-list
101715237|NCT00647543|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101715238|NCT00647543|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101715239|NCT00647543|Antimetabolites|antimetabolites|mesh-ancestor
101715240|NCT00647543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715241|NCT00647543|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101715242|NCT00647543|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101715243|NCT00647543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101715244|NCT00647621|Phenytoin|phenytoin|mesh-list
101715245|NCT00647621|Anticonvulsants|anticonvulsants|mesh-ancestor
101715246|NCT00647621|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101715247|NCT00647621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101715248|NCT00647621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101715249|NCT00647621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715250|NCT00647621|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101715251|NCT00647621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101715252|NCT00461305|Drospirenone|drospirenone|mesh-list
101715253|NCT00461305|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101715254|NCT00461305|Hormone Antagonists|hormone antagonists|mesh-ancestor
101715255|NCT00461305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101715256|NCT00461305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715257|NCT00461305|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101715258|NCT00461305|Diuretics|diuretics|mesh-ancestor
101715259|NCT00461305|Natriuretic Agents|natriuretic agents|mesh-ancestor
101715260|NCT01022671|Belotecan|belotecan|mesh-list
101715261|NCT01022671|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101715262|NCT01022671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101715263|NCT01022671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101715264|NCT01022671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715265|NCT01022671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101715266|NCT01022749|Vaccines|vaccines|mesh-list
101715267|NCT01022749|Immunologic Factors|immunologic factors|mesh-ancestor
101715268|NCT01022749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715269|NCT00645905|Adalimumab|adalimumab|mesh-list
101715270|NCT00645905|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101715271|NCT00645905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101715272|NCT00645905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101715273|NCT00647777|Olanzapine|olanzapine|mesh-list
101715274|NCT00647777|Antiemetics|antiemetics|mesh-ancestor
101715275|NCT00647777|Autonomic Agents|autonomic agents|mesh-ancestor
101715276|NCT00647777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101715277|NCT00647777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715278|NCT00647777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101715279|NCT00647777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101715280|NCT00647777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101715281|NCT00647777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101715282|NCT00647777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101715283|NCT00647777|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101715284|NCT00647777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101715285|NCT00647777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101715286|NCT00647777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715287|NCT00647777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101715288|NCT00647777|Serotonin Agents|serotonin agents|mesh-ancestor
101715289|NCT04173611|Bupivacaine|bupivacaine|mesh-list
101715290|NCT04173611|Anesthetics, Local|anesthetics, local|mesh-ancestor
101715291|NCT04173611|Anesthetics|anesthetics|mesh-ancestor
101715292|NCT04173611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101189765|NCT00004056|Cytarabine|cytarabine|mesh-list
101715293|NCT04173611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715294|NCT04173611|Sensory System Agents|sensory system agents|mesh-ancestor
101715295|NCT04173611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101715296|NCT02665637|Trastuzumab|trastuzumab|mesh-list
101715297|NCT02665637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101715298|NCT02665637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101715299|NCT04733183|Dacarbazine|dacarbazine|mesh-list
101715300|NCT04733183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101715301|NCT04733183|Alkylating Agents|alkylating agents|mesh-ancestor
101715302|NCT04733183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715303|NCT04733183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101715304|NCT00648011|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101715305|NCT00648011|Quinapril|quinapril|mesh-list
101715306|NCT00648011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101715307|NCT00648011|Diuretics|diuretics|mesh-ancestor
101715308|NCT00648011|Natriuretic Agents|natriuretic agents|mesh-ancestor
101715309|NCT00648011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715310|NCT00648011|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101715311|NCT00648011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101715312|NCT00648011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715313|NCT00648011|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101715314|NCT00648011|Protease Inhibitors|protease inhibitors|mesh-ancestor
101715315|NCT00648011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101715316|NCT00646529|Budesonide|budesonide|mesh-list
101715317|NCT00646529|Formoterol Fumarate|formoterol fumarate|mesh-list
101715318|NCT00646529|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101715319|NCT00646529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101715320|NCT00646529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101715321|NCT00646529|Autonomic Agents|autonomic agents|mesh-ancestor
101715322|NCT00646529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101715323|NCT00646529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715324|NCT00646529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101801917|NCT00509925|Insulin, Isophane|insulin, isophane|mesh-list
101801919|NCT00509925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101801920|NCT00509925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801921|NCT05277974|Dexamethasone|dexamethasone|mesh-list
101801922|NCT05277974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101801923|NCT05277974|Antiemetics|antiemetics|mesh-ancestor
101801924|NCT05277974|Autonomic Agents|autonomic agents|mesh-ancestor
101801925|NCT05277974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101715325|NCT00646529|Respiratory System Agents|respiratory system agents|mesh-ancestor
101715327|NCT00646529|Hormones|hormones|mesh-ancestor
101715328|NCT00646529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101715329|NCT00646529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101715330|NCT00646529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101715331|NCT00646529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101715332|NCT00646529|Adrenergic Agents|adrenergic agents|mesh-ancestor
101715333|NCT00646529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101715334|NCT00646529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715335|NCT00646607|Leucovorin|leucovorin|mesh-list
101715336|NCT00646607|Fluorouracil|fluorouracil|mesh-list
101715337|NCT00646607|Oxaliplatin|oxaliplatin|mesh-list
101715338|NCT00646607|Levoleucovorin|levoleucovorin|mesh-list
101715339|NCT00646607|Antimetabolites|antimetabolites|mesh-ancestor
101715340|NCT00646607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715341|NCT00646607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101715342|NCT00646607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101715343|NCT00646607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101715344|NCT00646607|Immunologic Factors|immunologic factors|mesh-ancestor
101715345|NCT00646607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715346|NCT00646607|Antidotes|antidotes|mesh-ancestor
101715347|NCT00646607|Protective Agents|protective agents|mesh-ancestor
101715348|NCT00646607|Vitamin B Complex|vitamin b complex|mesh-ancestor
101715349|NCT00646607|Vitamins|vitamins|mesh-ancestor
101715350|NCT00646607|Micronutrients|micronutrients|mesh-ancestor
101715351|NCT00856544|Tofacitinib|tofacitinib|mesh-list
101715352|NCT00856544|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101715353|NCT00856544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101715354|NCT00856544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101715355|NCT00856544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715356|NCT00648245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101715357|NCT00648323|Doxazosin|doxazosin|mesh-list
101715358|NCT00648323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101715359|NCT00648323|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101715360|NCT00648323|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101715361|NCT00648323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101715362|NCT00648323|Adrenergic Agents|adrenergic agents|mesh-ancestor
101715363|NCT00648323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101715364|NCT00648323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715365|NCT00648323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715366|NCT00856388|Fludarabine|fludarabine|mesh-list
101715367|NCT00856388|Fludarabine phosphate|fludarabine phosphate|mesh-list
101715368|NCT00856388|Melphalan|melphalan|mesh-list
101372785|NCT00409942|Torsemide|torsemide|mesh-list
101715369|NCT00856388|Thymoglobulin|thymoglobulin|mesh-list
101715370|NCT00856388|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101715371|NCT00856388|Immunoglobulins|immunoglobulins|mesh-list
101715372|NCT00856388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101715373|NCT00856388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101715374|NCT00856388|Antimetabolites|antimetabolites|mesh-ancestor
101715375|NCT00856388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715376|NCT00856388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101715377|NCT00856388|Immunologic Factors|immunologic factors|mesh-ancestor
101715378|NCT00856388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715380|NCT00856388|Alkylating Agents|alkylating agents|mesh-ancestor
101715381|NCT00856388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101715382|NCT00648401|Verapamil|verapamil|mesh-list
101715383|NCT00648401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101715384|NCT00648401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101715385|NCT00648401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101715386|NCT00648401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801932|NCT05277974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101801933|NCT00504777|Rituximab|rituximab|mesh-list
101801934|NCT00504777|Methotrexate|methotrexate|mesh-list
101801935|NCT00504777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101715387|NCT00648401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101715388|NCT00648401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715389|NCT00648401|Vasodilator Agents|vasodilator agents|mesh-ancestor
101715390|NCT02663999|Diazepam|diazepam|mesh-list
101715391|NCT02663999|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101715392|NCT02663999|Anticonvulsants|anticonvulsants|mesh-ancestor
101715393|NCT02663999|Antiemetics|antiemetics|mesh-ancestor
101715394|NCT02663999|Autonomic Agents|autonomic agents|mesh-ancestor
101715395|NCT02663999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101715396|NCT02663999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715397|NCT02663999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101715398|NCT02663999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101715399|NCT02663999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101715400|NCT02663999|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101715401|NCT02663999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101715402|NCT02663999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101715403|NCT02663999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101715404|NCT02663999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101715405|NCT02663999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101715406|NCT02663999|Anesthetics, General|anesthetics, general|mesh-ancestor
101715407|NCT02663999|Anesthetics|anesthetics|mesh-ancestor
101715408|NCT02663999|GABA Modulators|gaba modulators|mesh-ancestor
101715409|NCT02663999|GABA Agents|gaba agents|mesh-ancestor
101715410|NCT02663999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101715411|NCT02663999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715412|NCT04171427|Lithium Carbonate|lithium carbonate|mesh-list
101715413|NCT04171427|Antidepressive Agents|antidepressive agents|mesh-ancestor
101715414|NCT04171427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101715415|NCT04171427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101715416|NCT04171427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715417|NCT04171427|Antimanic Agents|antimanic agents|mesh-ancestor
101715418|NCT04171427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101715419|NCT04171427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101715420|NCT04171427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715421|NCT04171739|Itraconazole|itraconazole|mesh-list
101715422|NCT04171739|Olorofim|olorofim|mesh-list
101715423|NCT04171739|Rifampin|rifampin|mesh-list
101715424|NCT04171739|Antifungal Agents|antifungal agents|mesh-ancestor
101715425|NCT04171739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101715426|NCT04171739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101715427|NCT04171739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101715428|NCT04171739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101715429|NCT04171739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715430|NCT04171739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101715431|NCT04171739|Hormone Antagonists|hormone antagonists|mesh-ancestor
101715432|NCT04171739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101715433|NCT04171739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715434|NCT04171739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101715435|NCT04171739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101715436|NCT04171739|Antitubercular Agents|antitubercular agents|mesh-ancestor
101715437|NCT04171739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101715438|NCT04171739|Leprostatic Agents|leprostatic agents|mesh-ancestor
101715439|NCT04171739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101715440|NCT04171739|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101715441|NCT04171739|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101372852|NCT00199186|Cytarabine|cytarabine|mesh-list
101715442|NCT04171739|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101715443|NCT04171739|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101715444|NCT04171739|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101715445|NCT04171739|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101715446|NCT02656121|Vitamin D|vitamin d|mesh-list
101715447|NCT02656121|Clomiphene|clomiphene|mesh-list
101801941|NCT00504777|Abortifacient Agents|abortifacient agents|mesh-ancestor
101801942|NCT00504777|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101801944|NCT00504777|Antimetabolites|antimetabolites|mesh-ancestor
101715448|NCT02656121|Vitamins|vitamins|mesh-ancestor
101715449|NCT02656121|Micronutrients|micronutrients|mesh-ancestor
101715450|NCT02656121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715451|NCT02656121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101715452|NCT02656121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101715453|NCT02656121|Hormone Antagonists|hormone antagonists|mesh-ancestor
101715454|NCT02656121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101715455|NCT02656121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101715456|NCT02656121|Fertility Agents|fertility agents|mesh-ancestor
101715457|NCT02656121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101715458|NCT02656121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101715459|NCT02656121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101715461|NCT00648713|Antifungal Agents|antifungal agents|mesh-ancestor
101715462|NCT00648713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101715463|NCT00648713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101715464|NCT00648713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715465|NCT00649883|Vaccines|vaccines|mesh-list
101715466|NCT00649883|Immunologic Factors|immunologic factors|mesh-ancestor
101715467|NCT00649883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715468|NCT00648791|Finasteride|finasteride|mesh-list
101715469|NCT00648791|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101715470|NCT00648791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101715471|NCT00648791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101715472|NCT00648791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715473|NCT00648791|Hormone Antagonists|hormone antagonists|mesh-ancestor
101715474|NCT00648791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101715475|NCT00648791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715476|NCT00648791|Urological Agents|urological agents|mesh-ancestor
101715477|NCT00649181|Metolazone|metolazone|mesh-list
101715478|NCT00649181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101715479|NCT00649181|Diuretics|diuretics|mesh-ancestor
101715480|NCT00649181|Natriuretic Agents|natriuretic agents|mesh-ancestor
101715481|NCT00649181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715482|NCT00649181|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101715483|NCT00649181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101715484|NCT00649181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715485|NCT02655965|Clonidine|clonidine|mesh-list
101715486|NCT02655965|Ropivacaine|ropivacaine|mesh-list
101715487|NCT02655965|Anesthetics, Local|anesthetics, local|mesh-ancestor
101715488|NCT02655965|Anesthetics|anesthetics|mesh-ancestor
101715489|NCT02655965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101363967|NCT00134641|Antimetabolites|antimetabolites|mesh-ancestor
101715490|NCT02655965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715491|NCT02655965|Sensory System Agents|sensory system agents|mesh-ancestor
101715492|NCT02655965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101715493|NCT02655965|Analgesics|analgesics|mesh-ancestor
101715494|NCT02655965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101715495|NCT02655965|Sympatholytics|sympatholytics|mesh-ancestor
101715496|NCT02655965|Autonomic Agents|autonomic agents|mesh-ancestor
101715497|NCT02655965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101715498|NCT02655965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101715499|NCT02655965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101715500|NCT02655965|Adrenergic Agents|adrenergic agents|mesh-ancestor
101715501|NCT02655965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101715502|NCT02655965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715503|NCT04170179|Lenvatinib|lenvatinib|mesh-list
101801950|NCT00504777|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101801951|NCT03968263|Hydrocodone|hydrocodone|mesh-list
101801952|NCT03968263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101801953|NCT03968263|Narcotics|narcotics|mesh-ancestor
101715504|NCT04170179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101715505|NCT04170179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101801965|NCT00895076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101715506|NCT04170179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101715507|NCT04170179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715508|NCT02659085|Ketamine|ketamine|mesh-list
101715509|NCT02659085|Analgesics|analgesics|mesh-ancestor
101715510|NCT02659085|Sensory System Agents|sensory system agents|mesh-ancestor
101715511|NCT02659085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101715512|NCT02659085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715513|NCT02659085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101715514|NCT02659085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101372926|NCT00199576|Methylprednisolone|methylprednisolone|mesh-list
101715515|NCT02659085|Anesthetics, General|anesthetics, general|mesh-ancestor
101715516|NCT02659085|Anesthetics|anesthetics|mesh-ancestor
101715517|NCT02659085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101715518|NCT02659085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101715519|NCT02659085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101262879|NCT01759589|Narcotics|narcotics|mesh-ancestor
101715520|NCT02659085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101715521|NCT02659085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715522|NCT04171193|Isoflurane|isoflurane|mesh-list
101715523|NCT04171193|Sertraline|sertraline|mesh-list
101715524|NCT04171193|Antidepressive Agents|antidepressive agents|mesh-ancestor
101715525|NCT04171193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101715526|NCT04171193|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101715527|NCT04171193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101715528|NCT04171193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101715529|NCT04171193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715530|NCT04171193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101715531|NCT04171193|Serotonin Agents|serotonin agents|mesh-ancestor
101715532|NCT04171193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715533|NCT04171193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101715534|NCT04171193|Anesthetics, General|anesthetics, general|mesh-ancestor
101715535|NCT04171193|Anesthetics|anesthetics|mesh-ancestor
101715536|NCT04171193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101715537|NCT02663141|Bevacizumab|bevacizumab|mesh-list
101715538|NCT02663141|Losartan|losartan|mesh-list
101715539|NCT02663141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101715540|NCT02663141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101715541|NCT02663141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101715542|NCT02663141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101715543|NCT02663141|Growth Substances|growth substances|mesh-ancestor
101715544|NCT02663141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715545|NCT02663141|Growth Inhibitors|growth inhibitors|mesh-ancestor
101715546|NCT02663141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101715547|NCT02663141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101715548|NCT02663141|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101715549|NCT02663141|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101715550|NCT02663141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715551|NCT04171349|Dexmedetomidine|dexmedetomidine|mesh-list
101715552|NCT04171349|Carticaine|carticaine|mesh-list
101715553|NCT04171349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101363969|NCT00134641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101715554|NCT04171349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101715555|NCT04171349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715556|NCT04171349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101715557|NCT04171349|Analgesics|analgesics|mesh-ancestor
101801966|NCT00895076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801967|NCT00895076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101715558|NCT04171349|Sensory System Agents|sensory system agents|mesh-ancestor
101715559|NCT04171349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101715560|NCT04171349|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101715561|NCT04171349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101715562|NCT04171349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101715563|NCT04171349|Adrenergic Agents|adrenergic agents|mesh-ancestor
101715564|NCT04171349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101715565|NCT04171349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715566|NCT04171349|Anesthetics, Local|anesthetics, local|mesh-ancestor
101715569|NCT00650039|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101715570|NCT00650039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101715571|NCT00650039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101715572|NCT00650039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715573|NCT00650039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101715574|NCT00650039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101715575|NCT00650039|Analgesics|analgesics|mesh-ancestor
101715576|NCT00650039|Sensory System Agents|sensory system agents|mesh-ancestor
101715577|NCT00650039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101715578|NCT00650039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715579|NCT00650039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101715580|NCT00650039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101715581|NCT00649259|Oxybutynin|oxybutynin|mesh-list
101715582|NCT00649259|Parasympatholytics|parasympatholytics|mesh-ancestor
101715583|NCT00649259|Autonomic Agents|autonomic agents|mesh-ancestor
101715584|NCT00649259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101715585|NCT00649259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715586|NCT00649259|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101715587|NCT00649259|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101715588|NCT00649259|Cholinergic Agents|cholinergic agents|mesh-ancestor
101715589|NCT00649259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101715590|NCT00649259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715591|NCT00649259|Urological Agents|urological agents|mesh-ancestor
101715593|NCT04401059|Osimertinib|osimertinib|mesh-list
101715594|NCT04401059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101715595|NCT04401059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101715596|NCT04401059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101715597|NCT04401059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715598|NCT02658773|Lidocaine|lidocaine|mesh-list
101715599|NCT02658773|Prilocaine|prilocaine|mesh-list
101715600|NCT02658773|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
101715601|NCT02658773|Anesthetics, Local|anesthetics, local|mesh-ancestor
101715602|NCT02658773|Anesthetics|anesthetics|mesh-ancestor
101715603|NCT02658773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101715604|NCT02658773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715605|NCT02658773|Sensory System Agents|sensory system agents|mesh-ancestor
101715606|NCT02658773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101715607|NCT02658773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101715608|NCT02658773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101715609|NCT02658773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101715610|NCT02658773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101715611|NCT02658773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715612|NCT02658773|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
101715613|NCT00648869|Metformin|metformin|mesh-list
101715614|NCT00648869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101715615|NCT00648869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715616|NCT04169945|Erythritol|erythritol|mesh-list
101715617|NCT04169945|Vasodilator Agents|vasodilator agents|mesh-ancestor
101715618|NCT04169867|Nivolumab|nivolumab|mesh-list
101715619|NCT04169867|Ipilimumab|ipilimumab|mesh-list
101715620|NCT04169867|Atezolizumab|atezolizumab|mesh-list
101715621|NCT04169867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101715622|NCT04169867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101715623|NCT04169867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101715624|NCT04169867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715625|NCT02655029|Amlodipine|amlodipine|mesh-list
101715626|NCT02655029|Perindopril|perindopril|mesh-list
101715627|NCT02655029|Indapamide|indapamide|mesh-list
101715628|NCT02655029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101715629|NCT02655029|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101715630|NCT02655029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101715631|NCT02655029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715632|NCT02655029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101715633|NCT02655029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715634|NCT02655029|Vasodilator Agents|vasodilator agents|mesh-ancestor
101715635|NCT02655029|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101715636|NCT02655029|Protease Inhibitors|protease inhibitors|mesh-ancestor
101715637|NCT02655029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101715638|NCT02655029|Diuretics|diuretics|mesh-ancestor
101715639|NCT02655029|Natriuretic Agents|natriuretic agents|mesh-ancestor
101715640|NCT02655029|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101715641|NCT02536859|Insulin|insulin|mesh-list
101715642|NCT02536859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101715643|NCT02536859|Insulin Glargine|insulin glargine|mesh-list
101715644|NCT02536859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101715645|NCT02536859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715646|NCT02536937|Eliglustat|eliglustat|mesh-list
101715647|NCT02536937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101715648|NCT02536937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715649|NCT02654561|Heparin|heparin|mesh-list
101715650|NCT02654561|Calcium heparin|calcium heparin|mesh-list
101715651|NCT02654561|Anticoagulants|anticoagulants|mesh-ancestor
101715652|NCT02654561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101715653|NCT02654561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101715654|NCT02654561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715655|NCT02654405|Butyric Acid|butyric acid|mesh-list
101802067|NCT00902954|Letrozole|letrozole|mesh-list
101715656|NCT02654405|Histamine Antagonists|histamine antagonists|mesh-ancestor
101715657|NCT02654405|Histamine Agents|histamine agents|mesh-ancestor
101715658|NCT02654405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101715659|NCT02654405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715660|NCT02654405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715661|NCT00649415|Valdecoxib|valdecoxib|mesh-list
101715662|NCT00649415|Piroxicam|piroxicam|mesh-list
101373083|NCT00061256|Vitamin D|vitamin d|mesh-list
101715663|NCT00649415|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101715664|NCT00649415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101715665|NCT00649415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101802103|NCT00122317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101201357|NCT01404104|Sirolimus|sirolimus|mesh-list
101715666|NCT00649415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802106|NCT00908336|Docetaxel|docetaxel|mesh-list
101715667|NCT00649415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101715668|NCT00649415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101715669|NCT00649415|Analgesics|analgesics|mesh-ancestor
101715670|NCT00649415|Sensory System Agents|sensory system agents|mesh-ancestor
101715671|NCT00649415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101715672|NCT00649415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715673|NCT00649415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101715674|NCT00649415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101715675|NCT00650117|Fentanyl|fentanyl|mesh-list
101715676|NCT00650117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101715677|NCT00650117|Narcotics|narcotics|mesh-ancestor
101715678|NCT00650117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101715679|NCT00650117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715680|NCT00650117|Analgesics|analgesics|mesh-ancestor
101715681|NCT00650117|Sensory System Agents|sensory system agents|mesh-ancestor
101715682|NCT00650117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101715683|NCT00650117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101715684|NCT00650117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101715685|NCT00650117|Anesthetics, General|anesthetics, general|mesh-ancestor
101715686|NCT00650117|Anesthetics|anesthetics|mesh-ancestor
101715687|NCT00648947|Clopidogrel|clopidogrel|mesh-list
101715688|NCT00648947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101715689|NCT00648947|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101715690|NCT00648947|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101715691|NCT00648947|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101715692|NCT00648947|Purinergic Agents|purinergic agents|mesh-ancestor
101715693|NCT00648947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101802166|NCT03513406|Autonomic Agents|autonomic agents|mesh-ancestor
101715694|NCT00648947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363972|NCT00134641|Antimitotic Agents|antimitotic agents|mesh-ancestor
101715695|NCT00648947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715696|NCT00649493|Rabeprazole|rabeprazole|mesh-list
101715697|NCT00649493|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101715698|NCT00649493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101715699|NCT00649493|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101715700|NCT00649493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101715701|NCT00649493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715702|NCT02654093|Cholecalciferol|cholecalciferol|mesh-list
101715703|NCT02654093|Vitamin D|vitamin d|mesh-list
101715704|NCT02654093|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101451731|NCT00203099|Acetylcysteine|acetylcysteine|mesh-list
101715705|NCT02654093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101715706|NCT02654093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715708|NCT02654093|Micronutrients|micronutrients|mesh-ancestor
101715709|NCT02654093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101715710|NCT02654093|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101715711|NCT02654093|Hormone Antagonists|hormone antagonists|mesh-ancestor
101715712|NCT02654093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101715713|NCT02654093|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101715714|NCT02654093|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101715715|NCT04168619|Methotrexate|methotrexate|mesh-list
101715716|NCT04168619|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101715717|NCT04168619|Abortifacient Agents|abortifacient agents|mesh-ancestor
101715718|NCT04168619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101715719|NCT04168619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715720|NCT04168619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101715721|NCT04168619|Antimetabolites|antimetabolites|mesh-ancestor
101715722|NCT04168619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715723|NCT04168619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101715724|NCT04168619|Dermatologic Agents|dermatologic agents|mesh-ancestor
101715725|NCT04168619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101715726|NCT04168619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101715727|NCT04168619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101715728|NCT04168619|Immunologic Factors|immunologic factors|mesh-ancestor
101715729|NCT04168619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101715730|NCT04168619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101715731|NCT02654171|Ziresovir|ziresovir|mesh-list
101802211|NCT00727103|Cholinergic Agents|cholinergic agents|mesh-ancestor
101715733|NCT02654171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101715734|NCT00650195|Metolazone|metolazone|mesh-list
101715735|NCT00650195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101715736|NCT00650195|Diuretics|diuretics|mesh-ancestor
101715737|NCT00650195|Natriuretic Agents|natriuretic agents|mesh-ancestor
101715738|NCT00650195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715739|NCT00650195|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101715740|NCT00650195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101715741|NCT00650195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715742|NCT04170959|Metformin|metformin|mesh-list
101715743|NCT04170959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101715744|NCT04170959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715746|NCT00848354|Methotrexate|methotrexate|mesh-list
101715747|NCT00848354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101715748|NCT00848354|Abortifacient Agents|abortifacient agents|mesh-ancestor
101715749|NCT00848354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101715750|NCT00848354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715751|NCT00848354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101715752|NCT00848354|Antimetabolites|antimetabolites|mesh-ancestor
101715753|NCT00848354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715754|NCT00848354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101715755|NCT00848354|Dermatologic Agents|dermatologic agents|mesh-ancestor
101715756|NCT00848354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101715757|NCT00848354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101715758|NCT00848354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101715759|NCT00848354|Immunologic Factors|immunologic factors|mesh-ancestor
101715760|NCT00848354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101715761|NCT00848354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101715762|NCT00848354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101715763|NCT00848354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101715765|NCT00848354|Sensory System Agents|sensory system agents|mesh-ancestor
101715766|NCT00848354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101715767|NCT00848354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101715768|NCT00848354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101715769|NCT00600821|Paclitaxel|paclitaxel|mesh-list
101715770|NCT00600821|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101715772|NCT00600821|Carboplatin|carboplatin|mesh-list
101715773|NCT00600821|Axitinib|axitinib|mesh-list
101715774|NCT00600821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101715775|NCT00600821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101715776|NCT00600821|Tubulin Modulators|tubulin modulators|mesh-ancestor
101715777|NCT00600821|Antimitotic Agents|antimitotic agents|mesh-ancestor
101715778|NCT00600821|Mitosis Modulators|mitosis modulators|mesh-ancestor
101715779|NCT00600821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715780|NCT00600821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101715781|NCT00600821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101715782|NCT00600821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101715783|NCT00600821|Growth Substances|growth substances|mesh-ancestor
101715784|NCT00600821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715785|NCT00600821|Growth Inhibitors|growth inhibitors|mesh-ancestor
101802364|NCT00903734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101715786|NCT00600821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101715787|NCT00600821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101715788|NCT00699764|Vaccines|vaccines|mesh-list
101715789|NCT00699764|Immunologic Factors|immunologic factors|mesh-ancestor
101715790|NCT00699764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715791|NCT02653703|Ethanol|ethanol|mesh-list
101715792|NCT02653703|Menthol|menthol|mesh-list
101715793|NCT02653703|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101715794|NCT02653703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101715795|NCT02653703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101715796|NCT02653703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715797|NCT02653703|Antipruritics|antipruritics|mesh-ancestor
101715798|NCT02653703|Dermatologic Agents|dermatologic agents|mesh-ancestor
101715799|NCT00649571|Doxycycline|doxycycline|mesh-list
101715800|NCT00649571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101715801|NCT00649571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101715802|NCT00649571|Antimalarials|antimalarials|mesh-ancestor
101715803|NCT00649571|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101715804|NCT00649571|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101715805|NCT02662283|Acteoside|acteoside|mesh-list
101715806|NCT02662283|Prednisolone|prednisolone|mesh-list
101715807|NCT02662283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101715808|NCT02662283|Glucocorticoids|glucocorticoids|mesh-ancestor
101715809|NCT02662283|Hormones|hormones|mesh-ancestor
101715810|NCT02662283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101373228|NCT00221494|Serotonin Agents|serotonin agents|mesh-ancestor
101715811|NCT02662283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715812|NCT02662283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101715813|NCT02662283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101715814|NCT02662283|Protective Agents|protective agents|mesh-ancestor
101715815|NCT02662283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101715816|NCT02662283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101715817|NCT02662283|Antioxidants|antioxidants|mesh-ancestor
101715818|NCT02662283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715819|NCT02662283|Chelating Agents|chelating agents|mesh-ancestor
101715820|NCT02662283|Sequestering Agents|sequestering agents|mesh-ancestor
101715821|NCT02662283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101715822|NCT02662283|Immunologic Factors|immunologic factors|mesh-ancestor
101715824|NCT02657603|Anesthetics, Local|anesthetics, local|mesh-ancestor
101715825|NCT02657603|Anesthetics|anesthetics|mesh-ancestor
101715826|NCT02657603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101715827|NCT02657603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715828|NCT02657603|Sensory System Agents|sensory system agents|mesh-ancestor
101715829|NCT02657603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101715830|NCT02657603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101715831|NCT02657603|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101715832|NCT02657603|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101715833|NCT02657603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101715834|NCT02657603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715835|NCT02657447|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
101715836|NCT02657447|Chelating Agents|chelating agents|mesh-ancestor
101715837|NCT02657447|Sequestering Agents|sequestering agents|mesh-ancestor
101715838|NCT02657447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715840|NCT00649649|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101715841|NCT00649649|Protease Inhibitors|protease inhibitors|mesh-ancestor
101715842|NCT00649649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101715843|NCT00649649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715844|NCT00649649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101715845|NCT02657291|Ropivacaine|ropivacaine|mesh-list
101715846|NCT02657291|Anesthetics, Local|anesthetics, local|mesh-ancestor
101715847|NCT02657291|Anesthetics|anesthetics|mesh-ancestor
101715848|NCT02657291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101715849|NCT02657291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715850|NCT02657291|Sensory System Agents|sensory system agents|mesh-ancestor
101715851|NCT02657291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101715852|NCT00699920|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101715853|NCT00699920|Antimalarials|antimalarials|mesh-ancestor
101715854|NCT00699920|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101715855|NCT00699920|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101715856|NCT00699920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101715857|NCT02661893|Rifampin|rifampin|mesh-list
101715858|NCT02661893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101715859|NCT02661893|Antitubercular Agents|antitubercular agents|mesh-ancestor
101715860|NCT02661893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101715861|NCT02661893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101715862|NCT02661893|Leprostatic Agents|leprostatic agents|mesh-ancestor
101715863|NCT02661893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101715864|NCT02661893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101715865|NCT02661893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715866|NCT02661893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101715867|NCT02661893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101715868|NCT02661893|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101715869|NCT02661893|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101715870|NCT02661893|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101715871|NCT02661893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101715872|NCT00855920|Indomethacin|indomethacin|mesh-list
101715873|NCT00855920|Rilonacept|rilonacept|mesh-list
101715874|NCT00855920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101715875|NCT00855920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101715876|NCT00855920|Analgesics|analgesics|mesh-ancestor
101715877|NCT00855920|Sensory System Agents|sensory system agents|mesh-ancestor
101715878|NCT00855920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101715879|NCT00855920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715880|NCT00855920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101715881|NCT00855920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101715882|NCT00855920|Gout Suppressants|gout suppressants|mesh-ancestor
101373309|NCT00221845|Telmisartan|telmisartan|mesh-list
101802449|NCT00908180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101802450|NCT00908180|Immunologic Factors|immunologic factors|mesh-ancestor
101715883|NCT00855920|Tocolytic Agents|tocolytic agents|mesh-ancestor
101802459|NCT00908180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101715884|NCT00855920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101715885|NCT00855920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101715886|NCT00855920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101715887|NCT00855920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715888|NCT02657213|Insulin|insulin|mesh-list
101715889|NCT02657213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101715890|NCT02657213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101715891|NCT02657213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715892|NCT00649727|Oxybutynin|oxybutynin|mesh-list
101715893|NCT00649727|Parasympatholytics|parasympatholytics|mesh-ancestor
101715894|NCT00649727|Autonomic Agents|autonomic agents|mesh-ancestor
101715895|NCT00649727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101715896|NCT00649727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715897|NCT00649727|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101715898|NCT00649727|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101715899|NCT00649727|Cholinergic Agents|cholinergic agents|mesh-ancestor
101715900|NCT00649727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101715901|NCT00649727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715902|NCT00649727|Urological Agents|urological agents|mesh-ancestor
101715903|NCT00650273|Azithromycin|azithromycin|mesh-list
101715904|NCT00650273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101715905|NCT00650273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101715906|NCT00698126|Insulin|insulin|mesh-list
101715907|NCT00698126|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101715908|NCT00698126|Insulin Aspart|insulin aspart|mesh-list
101715909|NCT00698126|Biphasic Insulins|biphasic insulins|mesh-list
101715910|NCT00698126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101333661|NCT00040066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101715911|NCT00698126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715912|NCT02661425|Immunoglobulins|immunoglobulins|mesh-list
101715913|NCT02661425|Immunologic Factors|immunologic factors|mesh-ancestor
101715914|NCT02661425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715915|NCT02656901|Anesthetics|anesthetics|mesh-list
101715916|NCT02656901|Sevoflurane|sevoflurane|mesh-list
101715917|NCT02656901|Desflurane|desflurane|mesh-list
101715918|NCT02656901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101715919|NCT02656901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715920|NCT02656901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101715921|NCT02656901|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101715922|NCT02656901|Anesthetics, General|anesthetics, general|mesh-ancestor
101715923|NCT00847886|Methotrexate|methotrexate|mesh-list
101715924|NCT00847886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101715925|NCT00847886|Abortifacient Agents|abortifacient agents|mesh-ancestor
101715926|NCT00847886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101715927|NCT00847886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715928|NCT00847886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101715929|NCT00847886|Antimetabolites|antimetabolites|mesh-ancestor
101715930|NCT00847886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715931|NCT00847886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101715932|NCT00847886|Dermatologic Agents|dermatologic agents|mesh-ancestor
101715933|NCT00847886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101715934|NCT00847886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101715935|NCT00847886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101715936|NCT00847886|Immunologic Factors|immunologic factors|mesh-ancestor
101802460|NCT04480463|Aflibercept|aflibercept|mesh-list
101802461|NCT04480463|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101802462|NCT04480463|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101802463|NCT04480463|Growth Substances|growth substances|mesh-ancestor
101802464|NCT04480463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802465|NCT04480463|Growth Inhibitors|growth inhibitors|mesh-ancestor
101715937|NCT00847886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101715938|NCT00847886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101715939|NCT00847808|Dexlansoprazole|dexlansoprazole|mesh-list
101715940|NCT00847808|Lansoprazole|lansoprazole|mesh-list
101715941|NCT00847808|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101715942|NCT00847808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101715943|NCT00847808|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101715944|NCT00847808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101715945|NCT00847808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715946|NCT02656979|Latanoprost|latanoprost|mesh-list
101715947|NCT02656979|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101715948|NCT02656979|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101715949|NCT04017455|Bevacizumab|bevacizumab|mesh-list
101715950|NCT04017455|Atezolizumab|atezolizumab|mesh-list
101715951|NCT04017455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101715952|NCT04017455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101715953|NCT04017455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101715954|NCT04017455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101715955|NCT04017455|Growth Substances|growth substances|mesh-ancestor
101715956|NCT04017455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715957|NCT04017455|Growth Inhibitors|growth inhibitors|mesh-ancestor
101715958|NCT04017455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101715959|NCT04017455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715960|NCT05298020|Paclitaxel|paclitaxel|mesh-list
101715962|NCT05298020|Endostar protein|endostar protein|mesh-list
101715963|NCT05298020|Endostatins|endostatins|mesh-list
101715964|NCT05298020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101715965|NCT05298020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101715966|NCT05298020|Tubulin Modulators|tubulin modulators|mesh-ancestor
101715967|NCT05298020|Antimitotic Agents|antimitotic agents|mesh-ancestor
101715968|NCT05298020|Mitosis Modulators|mitosis modulators|mesh-ancestor
101715969|NCT05298020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715970|NCT05298020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101715971|NCT05298020|Antimetabolites|antimetabolites|mesh-ancestor
101715972|NCT05298020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715973|NCT05298020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101715974|NCT05298020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101715975|NCT05298020|Growth Substances|growth substances|mesh-ancestor
101715976|NCT05298020|Growth Inhibitors|growth inhibitors|mesh-ancestor
101715977|NCT04170647|Plasminogen|plasminogen|mesh-list
101715978|NCT04170647|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101715979|NCT04170647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101715980|NCT04170647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715982|NCT02661347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101715983|NCT02661347|Serotonin Agents|serotonin agents|mesh-ancestor
101715984|NCT02661347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101715985|NCT02661347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715986|NCT02661347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101715987|NCT02661347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101715988|NCT02661347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101715989|NCT02661347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101715990|NCT02661347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101715991|NCT02661347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101715992|NCT02661347|Dopamine Agents|dopamine agents|mesh-ancestor
101715993|NCT00649805|Verapamil|verapamil|mesh-list
101715994|NCT00649805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101715995|NCT00649805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101715996|NCT00649805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101802473|NCT03997539|Tubulin Modulators|tubulin modulators|mesh-ancestor
101802474|NCT03997539|Antimitotic Agents|antimitotic agents|mesh-ancestor
101802475|NCT03997539|Mitosis Modulators|mitosis modulators|mesh-ancestor
101715997|NCT00649805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101715998|NCT00649805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101715999|NCT00649805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716000|NCT00649805|Vasodilator Agents|vasodilator agents|mesh-ancestor
101716001|NCT02656589|Capecitabine|capecitabine|mesh-list
101716002|NCT02656589|Trastuzumab|trastuzumab|mesh-list
101716003|NCT02656589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101716004|NCT02656589|Antimetabolites|antimetabolites|mesh-ancestor
101716005|NCT02656589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716006|NCT02656589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101716007|NCT02656589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101716008|NCT00600353|Dexamethasone|dexamethasone|mesh-list
101716009|NCT00600353|Aprepitant|aprepitant|mesh-list
101716010|NCT00600353|Palonosetron|palonosetron|mesh-list
101716011|NCT00600353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101716012|NCT00600353|Antiemetics|antiemetics|mesh-ancestor
101716013|NCT00600353|Autonomic Agents|autonomic agents|mesh-ancestor
101716014|NCT00600353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101716015|NCT00600353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716016|NCT00600353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101716017|NCT00600353|Glucocorticoids|glucocorticoids|mesh-ancestor
101716018|NCT00600353|Hormones|hormones|mesh-ancestor
101716019|NCT00600353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101716020|NCT00600353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101716021|NCT00600353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101716022|NCT00600353|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101716023|NCT00600353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101716024|NCT00600353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716025|NCT00600353|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101716026|NCT00600353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101716027|NCT00600353|Serotonin Agents|serotonin agents|mesh-ancestor
101716028|NCT02661191|Cholecalciferol|cholecalciferol|mesh-list
101716029|NCT02661191|Vitamin D|vitamin d|mesh-list
101716030|NCT02661191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101716031|NCT02661191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716032|NCT02661191|Vitamins|vitamins|mesh-ancestor
101716033|NCT02661191|Micronutrients|micronutrients|mesh-ancestor
101716034|NCT02661191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101716036|NCT00691210|Niacin|niacin|mesh-list
101716037|NCT00691210|Nicotinic Acids|nicotinic acids|mesh-list
101716038|NCT00691210|Etoposide|etoposide|mesh-list
101716039|NCT00691210|Vorinostat|vorinostat|mesh-list
101716040|NCT00691210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101716041|NCT00691210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101716042|NCT00691210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101311110|NCT03996148|Dexmedetomidine|dexmedetomidine|mesh-list
101716043|NCT00691210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101716044|NCT00691210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101716045|NCT00691210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716046|NCT00691210|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101716047|NCT00691210|Vitamin B Complex|vitamin b complex|mesh-ancestor
101716048|NCT00691210|Vitamins|vitamins|mesh-ancestor
101716049|NCT00691210|Micronutrients|micronutrients|mesh-ancestor
101716050|NCT00691210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716051|NCT00691210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101716052|NCT00691210|Antimetabolites|antimetabolites|mesh-ancestor
101716053|NCT00691210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101716054|NCT00691210|Vasodilator Agents|vasodilator agents|mesh-ancestor
101716055|NCT02652065|Acetylcholine|acetylcholine|mesh-list
101716056|NCT02652065|Vasodilator Agents|vasodilator agents|mesh-ancestor
101716057|NCT02652065|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101716058|NCT02652065|Cholinergic Agents|cholinergic agents|mesh-ancestor
101716059|NCT02652065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101716060|NCT02652065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716061|NCT02652065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716062|NCT00650429|Ziprasidone|ziprasidone|mesh-list
101716063|NCT00650429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101716064|NCT00650429|Serotonin Agents|serotonin agents|mesh-ancestor
101716065|NCT00650429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101716066|NCT00650429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716067|NCT00650429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716068|NCT00650429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101716069|NCT00650429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101716070|NCT00650429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101716071|NCT00650429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101716072|NCT00650429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101716073|NCT00650429|Dopamine Agents|dopamine agents|mesh-ancestor
101716074|NCT00691132|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
101716075|NCT00691132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101716076|NCT00691132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716077|NCT00691132|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101716078|NCT00691132|Protective Agents|protective agents|mesh-ancestor
101716079|NCT00691132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716080|NCT00691132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101716081|NCT02651753|Calcium, Dietary|calcium, dietary|mesh-list
101716082|NCT02651753|Atorvastatin|atorvastatin|mesh-list
101716083|NCT02651753|Fenofibrate|fenofibrate|mesh-list
101716084|NCT02651753|Calcium|calcium|mesh-list
101716085|NCT02651753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101716086|NCT02651753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716087|NCT02651753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101716088|NCT02651753|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101716089|NCT02651753|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101716090|NCT02651753|Antimetabolites|antimetabolites|mesh-ancestor
101716091|NCT02651753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716092|NCT02651753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101716093|NCT02651753|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101716094|NCT02651753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101716095|NCT00855218|Sorafenib|sorafenib|mesh-list
101716096|NCT00855218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101716097|NCT00855218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101716098|NCT00855218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101716099|NCT00855218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716100|NCT00748150|Vaccines|vaccines|mesh-list
101716101|NCT00748150|Immunologic Factors|immunologic factors|mesh-ancestor
101716102|NCT00748150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716103|NCT02651519|Ropivacaine|ropivacaine|mesh-list
101716104|NCT02651519|Anesthetics, Local|anesthetics, local|mesh-ancestor
101716105|NCT02651519|Anesthetics|anesthetics|mesh-ancestor
101716106|NCT02651519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101716107|NCT02651519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716108|NCT02651519|Sensory System Agents|sensory system agents|mesh-ancestor
101716109|NCT02651519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101716110|NCT02651441|Gemcitabine|gemcitabine|mesh-list
101716111|NCT02651441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101716112|NCT02651441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101716113|NCT02651441|Antimetabolites|antimetabolites|mesh-ancestor
101716114|NCT02651441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716115|NCT01063348|Acetylcysteine|acetylcysteine|mesh-list
101716116|NCT01063348|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101716117|NCT01063348|Antiviral Agents|antiviral agents|mesh-ancestor
101716118|NCT01063348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101716119|NCT01063348|Expectorants|expectorants|mesh-ancestor
101716120|NCT01063348|Respiratory System Agents|respiratory system agents|mesh-ancestor
101716121|NCT01063348|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101716122|NCT01063348|Antioxidants|antioxidants|mesh-ancestor
101716123|NCT01063348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716124|NCT01063348|Protective Agents|protective agents|mesh-ancestor
101716125|NCT01063348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716126|NCT01063348|Antidotes|antidotes|mesh-ancestor
101716127|NCT00855062|Minocycline|minocycline|mesh-list
101716128|NCT00855062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101716129|NCT00855062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101716130|NCT00744250|Pancrelipase|pancrelipase|mesh-list
101716132|NCT00744250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101716133|NCT02651207|Lidocaine|lidocaine|mesh-list
101716134|NCT02651207|Ethyl Chloride|ethyl chloride|mesh-list
101716135|NCT02651207|Contraceptive Agents|contraceptive agents|mesh-list
101716136|NCT02651207|Anesthetics, Local|anesthetics, local|mesh-ancestor
101716137|NCT02651207|Anesthetics|anesthetics|mesh-ancestor
101716138|NCT02651207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101716139|NCT02651207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716140|NCT02651207|Sensory System Agents|sensory system agents|mesh-ancestor
101716141|NCT02651207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101716142|NCT02651207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101716143|NCT02651207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101716144|NCT02651207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101716145|NCT02651207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101716146|NCT02651207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716147|NCT02651207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101716148|NCT02564536|Decitabine|decitabine|mesh-list
101716149|NCT02564536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101716150|NCT02564536|Antimetabolites|antimetabolites|mesh-ancestor
101716151|NCT02564536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716152|NCT02564536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101716153|NCT02564536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101716154|NCT00600119|Naloxegol|naloxegol|mesh-list
101716155|NCT00600119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101716156|NCT00600119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716157|NCT00600119|Sensory System Agents|sensory system agents|mesh-ancestor
101716158|NCT00600119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101716159|NCT00866294|Paroxetine|paroxetine|mesh-list
101716160|NCT00866294|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101802524|NCT00728273|Micronutrients|micronutrients|mesh-list
101802525|NCT00728273|Trace Elements|trace elements|mesh-list
101802526|NCT00728273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716162|NCT00866294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101716163|NCT00866294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716164|NCT00866294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101716165|NCT00866294|Serotonin Agents|serotonin agents|mesh-ancestor
101716166|NCT00866294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716167|NCT00866294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101716168|NCT00866294|Antidepressive Agents|antidepressive agents|mesh-ancestor
101716169|NCT00866294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101716170|NCT00866294|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101802542|NCT04286867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716171|NCT00866294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101716172|NCT00866294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101716173|NCT02660255|Cannabidiol|cannabidiol|mesh-list
101716174|NCT02660255|Anticonvulsants|anticonvulsants|mesh-ancestor
101716175|NCT00649103|Quinapril|quinapril|mesh-list
101716176|NCT00649103|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101716177|NCT00649103|Protease Inhibitors|protease inhibitors|mesh-ancestor
101716178|NCT00649103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101716179|NCT00649103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716180|NCT00649103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101716181|NCT02660177|Dipyrone|dipyrone|mesh-list
101716182|NCT02660177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101716184|NCT02660177|Analgesics|analgesics|mesh-ancestor
101716185|NCT02660177|Sensory System Agents|sensory system agents|mesh-ancestor
101716186|NCT02660177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101716187|NCT02660177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716188|NCT02660177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101716189|NCT02660177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101716190|NCT02660177|Antipyretics|antipyretics|mesh-ancestor
101716191|NCT00701246|Folic Acid|folic acid|mesh-list
101716192|NCT00701246|Vitamin B Complex|vitamin b complex|mesh-list
101716193|NCT00701246|Hematinics|hematinics|mesh-ancestor
101716194|NCT00701246|Vitamins|vitamins|mesh-ancestor
101716195|NCT00701246|Micronutrients|micronutrients|mesh-ancestor
101716196|NCT00701246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716197|NCT02648711|Leucovorin|leucovorin|mesh-list
101716198|NCT02648711|Bevacizumab|bevacizumab|mesh-list
101716199|NCT02648711|Oxaliplatin|oxaliplatin|mesh-list
101716200|NCT02648711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101716201|NCT02648711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101716202|NCT02648711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101716203|NCT02648711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101716204|NCT02648711|Growth Substances|growth substances|mesh-ancestor
101716205|NCT02648711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716206|NCT02648711|Growth Inhibitors|growth inhibitors|mesh-ancestor
101716207|NCT02648711|Antidotes|antidotes|mesh-ancestor
101716208|NCT02648711|Protective Agents|protective agents|mesh-ancestor
101716209|NCT02648711|Vitamin B Complex|vitamin b complex|mesh-ancestor
101716210|NCT02648711|Vitamins|vitamins|mesh-ancestor
101716211|NCT02648711|Micronutrients|micronutrients|mesh-ancestor
101716212|NCT00854360|Beclomethasone|beclomethasone|mesh-list
101802543|NCT00730535|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101802544|NCT00730535|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101802551|NCT00904202|Lidocaine|lidocaine|mesh-list
101716213|NCT00854360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101716214|NCT00854360|Glucocorticoids|glucocorticoids|mesh-ancestor
101716215|NCT00854360|Hormones|hormones|mesh-ancestor
101716216|NCT00854360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101716217|NCT00854360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716218|NCT00854360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101716219|NCT00854360|Respiratory System Agents|respiratory system agents|mesh-ancestor
101716220|NCT00650351|Ciprofloxacin|ciprofloxacin|mesh-list
101716221|NCT00650351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101716222|NCT00650351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101716223|NCT00650351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101716224|NCT00650351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101716225|NCT00650351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101716226|NCT00650351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716227|NCT00650351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101716228|NCT00650351|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101716229|NCT00650351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101716230|NCT02648633|Nivolumab|nivolumab|mesh-list
101716231|NCT02648633|Valproic Acid|valproic acid|mesh-list
101716232|NCT02648633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101716233|NCT02648633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101716234|NCT02648633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101716235|NCT02648633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716236|NCT02648633|Anticonvulsants|anticonvulsants|mesh-ancestor
101716237|NCT02648633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101716238|NCT02648633|GABA Agents|gaba agents|mesh-ancestor
101716239|NCT02648633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101716240|NCT02648633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716241|NCT02648633|Antimanic Agents|antimanic agents|mesh-ancestor
101716242|NCT02648633|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101716243|NCT02648633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101716244|NCT02648633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101716245|NCT00853970|Bromfenac|bromfenac|mesh-list
101716246|NCT00853970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101716247|NCT00853970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101716248|NCT00853970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101716249|NCT00853970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101716250|NCT00853970|Analgesics|analgesics|mesh-ancestor
101716251|NCT00853970|Sensory System Agents|sensory system agents|mesh-ancestor
101716252|NCT00853970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101716253|NCT00853970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716254|NCT00853970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101716255|NCT00853970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101716256|NCT00651287|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101716257|NCT00651287|Quinapril|quinapril|mesh-list
101716258|NCT00651287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101716259|NCT00651287|Diuretics|diuretics|mesh-ancestor
101716260|NCT00651287|Natriuretic Agents|natriuretic agents|mesh-ancestor
101716261|NCT00651287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716262|NCT00651287|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101716263|NCT00651287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101716264|NCT00651287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716265|NCT00651287|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101716266|NCT00651287|Protease Inhibitors|protease inhibitors|mesh-ancestor
101716267|NCT00651287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101716268|NCT02650427|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101716269|NCT02650427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101802562|NCT00904202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101802563|NCT00904202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802564|NCT00904202|Analgesics|analgesics|mesh-ancestor
101716270|NCT02650427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716271|NCT02650427|Incretins|incretins|mesh-ancestor
101716272|NCT02650427|Hormones|hormones|mesh-ancestor
101716273|NCT02650427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101716274|NCT02650427|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101716275|NCT02650427|Protease Inhibitors|protease inhibitors|mesh-ancestor
101716276|NCT02650427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101716277|NCT02650427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716278|NCT02644811|Anesthetics|anesthetics|mesh-list
101716279|NCT02644811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101716280|NCT02644811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716281|NCT00651443|Galiximab|galiximab|mesh-list
101716282|NCT00651443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101716283|NCT00651443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101716284|NCT00650897|Escitalopram|escitalopram|mesh-list
101716285|NCT00650897|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101716286|NCT00650897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101716287|NCT00650897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101716288|NCT00650897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716289|NCT00650897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101716290|NCT00650897|Serotonin Agents|serotonin agents|mesh-ancestor
101716291|NCT00650897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716292|NCT02644499|Folic Acid|folic acid|mesh-list
101716293|NCT02644499|Hydroxychloroquine|hydroxychloroquine|mesh-list
101716294|NCT02644499|Prednisolone|prednisolone|mesh-list
101716295|NCT02644499|Methotrexate|methotrexate|mesh-list
101716296|NCT02644499|Leflunomide|leflunomide|mesh-list
101716297|NCT02644499|Glucocorticoids|glucocorticoids|mesh-list
101716298|NCT02644499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101716299|NCT02644499|Abortifacient Agents|abortifacient agents|mesh-ancestor
101716300|NCT02644499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101716301|NCT02644499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716302|NCT02644499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101716303|NCT02644499|Antimetabolites|antimetabolites|mesh-ancestor
101716304|NCT02644499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716305|NCT02644499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101716306|NCT02644499|Dermatologic Agents|dermatologic agents|mesh-ancestor
101716307|NCT02644499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101716308|NCT02644499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101716309|NCT02644499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101716310|NCT02644499|Immunologic Factors|immunologic factors|mesh-ancestor
101716311|NCT02644499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101716312|NCT02644499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101716313|NCT02644499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101716314|NCT02644499|Hormones|hormones|mesh-ancestor
101716315|NCT02644499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101716316|NCT02644499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101716317|NCT02644499|Antimalarials|antimalarials|mesh-ancestor
101716318|NCT02644499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101716319|NCT02644499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101716320|NCT02644499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101716321|NCT02644499|Hematinics|hematinics|mesh-ancestor
101716322|NCT02644499|Vitamin B Complex|vitamin b complex|mesh-ancestor
101716323|NCT02644499|Vitamins|vitamins|mesh-ancestor
101716324|NCT02644499|Micronutrients|micronutrients|mesh-ancestor
101716325|NCT00652691|Cyclophosphamide|cyclophosphamide|mesh-list
101716326|NCT00652691|Carboplatin|carboplatin|mesh-list
101802575|NCT00927836|Immunologic Factors|immunologic factors|mesh-ancestor
101716327|NCT00652691|Topotecan|topotecan|mesh-list
101716328|NCT00652691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101716329|NCT00652691|Immunologic Factors|immunologic factors|mesh-ancestor
101716330|NCT00652691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716331|NCT00652691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101716332|NCT00652691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101373753|NCT00224458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101716333|NCT00652691|Alkylating Agents|alkylating agents|mesh-ancestor
101716334|NCT00652691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716335|NCT00652691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101716336|NCT00652691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101716337|NCT00652691|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101716338|NCT00652691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101716339|NCT00652691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101716340|NCT02649179|Ropivacaine|ropivacaine|mesh-list
101716341|NCT02649179|Anesthetics, Local|anesthetics, local|mesh-ancestor
101716342|NCT02649179|Anesthetics|anesthetics|mesh-ancestor
101716343|NCT02649179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101716344|NCT02649179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716345|NCT02649179|Sensory System Agents|sensory system agents|mesh-ancestor
101716346|NCT02649179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101716347|NCT02644577|Metformin|metformin|mesh-list
101716348|NCT02644577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101716349|NCT02644577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716350|NCT02644421|Lidocaine|lidocaine|mesh-list
101716351|NCT02644421|Anesthetics, Local|anesthetics, local|mesh-ancestor
101716352|NCT02644421|Anesthetics|anesthetics|mesh-ancestor
101716353|NCT02644421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101716354|NCT02644421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716355|NCT02644421|Sensory System Agents|sensory system agents|mesh-ancestor
101716356|NCT02644421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101716357|NCT02644421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101716358|NCT02644421|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101716359|NCT02644421|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101716360|NCT02644421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101716361|NCT02644421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716362|NCT00651599|Drospirenone|drospirenone|mesh-list
101716363|NCT00651599|Estradiol|estradiol|mesh-list
101716364|NCT00651599|Estrogens|estrogens|mesh-ancestor
101716365|NCT00651599|Hormones|hormones|mesh-ancestor
101716366|NCT00651599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101716367|NCT00651599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716368|NCT00651599|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101716369|NCT00651599|Hormone Antagonists|hormone antagonists|mesh-ancestor
101716370|NCT00651599|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101716371|NCT00651599|Diuretics|diuretics|mesh-ancestor
101716372|NCT00651599|Natriuretic Agents|natriuretic agents|mesh-ancestor
101716373|NCT02647151|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101716374|NCT02647151|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
101716375|NCT02647151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101716376|NCT02647151|Dermatologic Agents|dermatologic agents|mesh-ancestor
101716377|NCT02536391|Ipatasertib|ipatasertib|mesh-list
101716378|NCT02536391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101716379|NCT02536391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101716380|NCT02536391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101716381|NCT02536391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716382|NCT02644187|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101716383|NCT02644187|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101716384|NCT02644187|Dermatologic Agents|dermatologic agents|mesh-ancestor
101716385|NCT00651131|Daptomycin|daptomycin|mesh-list
101716386|NCT00651131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101716387|NCT00651131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101716388|NCT04167137|Atezolizumab|atezolizumab|mesh-list
101716389|NCT04167137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101802592|NCT00928148|Dopamine Agents|dopamine agents|mesh-ancestor
101802593|NCT00928148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101716390|NCT04167137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716391|NCT04167137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101716392|NCT04167137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101716394|NCT02649413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101716395|NCT02649413|Glucocorticoids|glucocorticoids|mesh-ancestor
101716396|NCT02649413|Hormones|hormones|mesh-ancestor
101716397|NCT02649413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101716398|NCT02649413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716399|NCT02649413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101716400|NCT02649413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101716401|NCT02643563|Epinephrine|epinephrine|mesh-list
101716402|NCT02643563|Bupivacaine|bupivacaine|mesh-list
101716403|NCT02643563|Ropivacaine|ropivacaine|mesh-list
101716404|NCT02643563|Anesthetics, Local|anesthetics, local|mesh-ancestor
101716406|NCT02643563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101716407|NCT02643563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373824|NCT00224809|Analgesics|analgesics|mesh-ancestor
101716408|NCT02643563|Sensory System Agents|sensory system agents|mesh-ancestor
101716409|NCT02643563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101716410|NCT02643563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101716411|NCT02643563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101716412|NCT02643563|Adrenergic Agents|adrenergic agents|mesh-ancestor
101716413|NCT02643563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101716414|NCT02643563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716415|NCT02643563|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101716416|NCT02643563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101716417|NCT02643563|Autonomic Agents|autonomic agents|mesh-ancestor
101716418|NCT02643563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101716419|NCT02643563|Respiratory System Agents|respiratory system agents|mesh-ancestor
101716420|NCT02643563|Mydriatics|mydriatics|mesh-ancestor
101716421|NCT02643563|Sympathomimetics|sympathomimetics|mesh-ancestor
101716422|NCT02643563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101716423|NCT00651209|Tenofovir|tenofovir|mesh-list
101716424|NCT00651209|Antiviral Agents|antiviral agents|mesh-ancestor
101716425|NCT00651209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101716426|NCT00651209|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101716427|NCT00651209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101716428|NCT00651209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101716429|NCT00651209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716430|NCT00651209|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101716431|NCT00651209|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101716432|NCT00652925|Celecoxib|celecoxib|mesh-list
101716433|NCT00652925|Naproxen|naproxen|mesh-list
101716434|NCT00652925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101716435|NCT00652925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101716436|NCT00652925|Analgesics|analgesics|mesh-ancestor
101716437|NCT00652925|Sensory System Agents|sensory system agents|mesh-ancestor
101716438|NCT00652925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101716439|NCT00652925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716440|NCT00652925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101716441|NCT00652925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101716442|NCT00652925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101716443|NCT00652925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101716444|NCT00652925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101716445|NCT00652925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716446|NCT00652925|Gout Suppressants|gout suppressants|mesh-ancestor
101716447|NCT00653003|Leflunomide|leflunomide|mesh-list
101716448|NCT00653003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101716449|NCT00653003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716450|NCT00653003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101716451|NCT00653003|Immunologic Factors|immunologic factors|mesh-ancestor
101716452|NCT00653003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802600|NCT02430077|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
101802601|NCT02430077|Cathartics|cathartics|mesh-ancestor
101716453|NCT02643719|Topiramate|topiramate|mesh-list
101716454|NCT02643719|Naproxen|naproxen|mesh-list
101716455|NCT02643719|Sumatriptan|sumatriptan|mesh-list
101716456|NCT02643719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101716457|NCT02643719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101716458|NCT02643719|Analgesics|analgesics|mesh-ancestor
101716459|NCT02643719|Sensory System Agents|sensory system agents|mesh-ancestor
101716460|NCT02643719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101716461|NCT02643719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716462|NCT02643719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101716463|NCT02643719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101716464|NCT02643719|Gout Suppressants|gout suppressants|mesh-ancestor
101716465|NCT02643719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101716466|NCT02643719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101716467|NCT02643719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716468|NCT02643719|Anticonvulsants|anticonvulsants|mesh-ancestor
101716469|NCT02643719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101716470|NCT02643719|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101716471|NCT02643719|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101716472|NCT02643719|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101716473|NCT02643719|Serotonin Agents|serotonin agents|mesh-ancestor
101716474|NCT02643719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101716475|NCT02649101|Thalidomide|thalidomide|mesh-list
101716476|NCT02649101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101716477|NCT02649101|Immunologic Factors|immunologic factors|mesh-ancestor
101262885|NCT01759706|Diazepam|diazepam|mesh-list
101716478|NCT02649101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716479|NCT02649101|Leprostatic Agents|leprostatic agents|mesh-ancestor
101716480|NCT02649101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101716481|NCT02649101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101716482|NCT02649101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101716483|NCT02649101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101716484|NCT02649101|Growth Substances|growth substances|mesh-ancestor
101716485|NCT02649101|Growth Inhibitors|growth inhibitors|mesh-ancestor
101716486|NCT02649101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101716487|NCT00700154|Insulin|insulin|mesh-list
101716488|NCT00700154|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101716489|NCT00700154|Insulin Aspart|insulin aspart|mesh-list
101716490|NCT00700154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101716491|NCT00700154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716492|NCT00651911|Rasburicase|rasburicase|mesh-list
101716493|NCT00651911|Gout Suppressants|gout suppressants|mesh-ancestor
101716494|NCT00651911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101716495|NCT02643407|Docetaxel|docetaxel|mesh-list
101716496|NCT02643407|Nedaplatin|nedaplatin|mesh-list
101716497|NCT02643407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101716498|NCT02643407|Tubulin Modulators|tubulin modulators|mesh-ancestor
101716499|NCT02643407|Antimitotic Agents|antimitotic agents|mesh-ancestor
101716500|NCT02643407|Mitosis Modulators|mitosis modulators|mesh-ancestor
101716501|NCT02643407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716502|NCT02643329|Gliclazide|gliclazide|mesh-list
101716503|NCT02643329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101716504|NCT02643329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716505|NCT02643017|Dexmedetomidine|dexmedetomidine|mesh-list
101716506|NCT02643017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101716507|NCT02643017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101716508|NCT02643017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716509|NCT02643017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101716510|NCT02643017|Analgesics|analgesics|mesh-ancestor
101716511|NCT02643017|Sensory System Agents|sensory system agents|mesh-ancestor
101716512|NCT02643017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101716513|NCT02643017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101716514|NCT02643017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101716515|NCT02643017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101716516|NCT02643017|Adrenergic Agents|adrenergic agents|mesh-ancestor
101716517|NCT02643017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101716518|NCT02643017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802610|NCT00904436|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101802614|NCT00728585|Mitogens|mitogens|mesh-list
101716519|NCT02643173|Anesthetics|anesthetics|mesh-list
101716520|NCT02643173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
101716521|NCT02643173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101716522|NCT02643173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716523|NCT02643173|Anesthetics, General|anesthetics, general|mesh-ancestor
101716524|NCT02646137|Chlorotrianisene|chlorotrianisene|mesh-list
101716525|NCT02646137|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101716526|NCT02646137|Estrogens|estrogens|mesh-ancestor
101716527|NCT02646137|Hormones|hormones|mesh-ancestor
101716528|NCT02646137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101716529|NCT02646137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716530|NCT02646137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101716531|NCT02646137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101716532|NCT00653549|Torsemide|torsemide|mesh-list
101716533|NCT00653549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101716534|NCT00653549|Diuretics|diuretics|mesh-ancestor
101716535|NCT00653549|Natriuretic Agents|natriuretic agents|mesh-ancestor
101716536|NCT00653549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716537|NCT00653549|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101716538|NCT00653549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101716539|NCT00653549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716540|NCT02642861|Cyclobenzaprine|cyclobenzaprine|mesh-list
101716541|NCT02642861|Calcium Carbonate|calcium carbonate|mesh-list
101716542|NCT02642861|Calcium|calcium|mesh-list
101716543|NCT02642861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101716544|NCT02642861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716545|NCT02642861|Antacids|antacids|mesh-ancestor
101716546|NCT02642861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716547|NCT02642861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101716548|NCT02642861|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101716549|NCT02642861|Antidepressive Agents|antidepressive agents|mesh-ancestor
101716550|NCT02642861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101716551|NCT02642861|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101716552|NCT02642861|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101716553|NCT02642861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101716554|NCT02642861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101716555|NCT02642861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101716557|NCT02641457|Aflibercept|aflibercept|mesh-list
101716558|NCT02641457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101716559|NCT02641457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101716560|NCT02641457|Growth Substances|growth substances|mesh-ancestor
101716561|NCT02641457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716562|NCT02641457|Growth Inhibitors|growth inhibitors|mesh-ancestor
101716563|NCT02641457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101716564|NCT02642939|Mifepristone|mifepristone|mesh-list
101716565|NCT02642939|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101716566|NCT02642939|Abortifacient Agents|abortifacient agents|mesh-ancestor
101716567|NCT02642939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101716568|NCT02642939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716569|NCT02642939|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101716570|NCT02642939|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101716571|NCT02642939|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101716572|NCT02642939|Contraceptive Agents|contraceptive agents|mesh-ancestor
101716573|NCT02642939|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101716574|NCT02642939|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101716575|NCT02642939|Hormone Antagonists|hormone antagonists|mesh-ancestor
101716576|NCT02642939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101716577|NCT02642939|Luteolytic Agents|luteolytic agents|mesh-ancestor
101716578|NCT02642939|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101716579|NCT02642939|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101802618|NCT00730769|Ganciclovir|ganciclovir|mesh-list
101802619|NCT00730769|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101802620|NCT00730769|Antiviral Agents|antiviral agents|mesh-ancestor
101716580|NCT02641301|Morphine|morphine|mesh-list
101716581|NCT02641301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101716582|NCT02641301|Narcotics|narcotics|mesh-ancestor
101716583|NCT02641301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101716584|NCT02641301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716585|NCT02641301|Analgesics|analgesics|mesh-ancestor
101716586|NCT02641301|Sensory System Agents|sensory system agents|mesh-ancestor
101716587|NCT02641301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101716588|NCT02640989|Vaccines|vaccines|mesh-list
101716589|NCT02640989|Immunologic Factors|immunologic factors|mesh-ancestor
101451732|NCT00203099|Glatiramer Acetate|glatiramer acetate|mesh-list
101716590|NCT02640989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716591|NCT02645747|Aflibercept|aflibercept|mesh-list
101716592|NCT02645747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101716593|NCT02645747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101716594|NCT02645747|Growth Substances|growth substances|mesh-ancestor
101716595|NCT02645747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716596|NCT02645747|Growth Inhibitors|growth inhibitors|mesh-ancestor
101716597|NCT02645747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101716598|NCT00653237|Chlorhexidine|chlorhexidine|mesh-list
101716599|NCT00653237|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101716600|NCT00653237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101716601|NCT00653237|Disinfectants|disinfectants|mesh-ancestor
101716603|NCT00653315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101716604|NCT00653315|Narcotics|narcotics|mesh-ancestor
101716605|NCT00653315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101716606|NCT00653315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716607|NCT00653315|Analgesics|analgesics|mesh-ancestor
101716608|NCT00653315|Sensory System Agents|sensory system agents|mesh-ancestor
101716609|NCT00653315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101716610|NCT02640833|Venetoclax|venetoclax|mesh-list
101716611|NCT02640833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101716612|NCT00653393|Tranylcypromine|tranylcypromine|mesh-list
101716613|NCT00653393|Antidepressive Agents|antidepressive agents|mesh-ancestor
101716614|NCT00653393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101716615|NCT00653393|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101716616|NCT00653393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101716617|NCT00653393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716618|NCT00653393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101716619|NCT00653393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101262886|NCT01759706|Ondansetron|ondansetron|mesh-list
101716620|NCT00653393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101716621|NCT00653393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716622|NCT02645903|Morphine|morphine|mesh-list
101363986|NCT00134758|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101716623|NCT02645903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101716624|NCT02645903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716625|NCT02645903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101716626|NCT02645903|Narcotics|narcotics|mesh-ancestor
101716627|NCT02645903|Analgesics|analgesics|mesh-ancestor
101716628|NCT02645903|Sensory System Agents|sensory system agents|mesh-ancestor
101716629|NCT02645903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101716630|NCT02645981|Sorafenib|sorafenib|mesh-list
101374052|NCT00225667|Irbesartan|irbesartan|mesh-list
101716631|NCT02645981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101716632|NCT02645981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101716633|NCT02645981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101716634|NCT02645981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716635|NCT02535767|Primaquine|primaquine|mesh-list
101716636|NCT02535767|Antimalarials|antimalarials|mesh-ancestor
101716637|NCT02535767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101716638|NCT02535767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101716639|NCT02535767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101716640|NCT02640443|Sulfamethoxazole|sulfamethoxazole|mesh-list
101716641|NCT02640443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101802628|NCT00728663|Tubulin Modulators|tubulin modulators|mesh-ancestor
101802629|NCT00728663|Antimitotic Agents|antimitotic agents|mesh-ancestor
101802630|NCT00728663|Mitosis Modulators|mitosis modulators|mesh-ancestor
101716642|NCT02640365|Leucovorin|leucovorin|mesh-list
101716643|NCT02640365|Bevacizumab|bevacizumab|mesh-list
101716644|NCT02640365|Irinotecan|irinotecan|mesh-list
101716645|NCT02640365|Camptothecin|camptothecin|mesh-list
101716646|NCT02640365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101716647|NCT02640365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101716648|NCT02640365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101716649|NCT02640365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101716650|NCT02640365|Growth Substances|growth substances|mesh-ancestor
101716651|NCT02640365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716652|NCT02640365|Growth Inhibitors|growth inhibitors|mesh-ancestor
101716653|NCT02640365|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101716654|NCT02640365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101716655|NCT02640365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101716656|NCT02640365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716657|NCT02640365|Antidotes|antidotes|mesh-ancestor
101716658|NCT02640365|Protective Agents|protective agents|mesh-ancestor
101716659|NCT02640365|Vitamin B Complex|vitamin b complex|mesh-ancestor
101716660|NCT02640365|Vitamins|vitamins|mesh-ancestor
101716661|NCT02640365|Micronutrients|micronutrients|mesh-ancestor
101716662|NCT02640365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101716663|NCT02642003|Lenograstim|lenograstim|mesh-list
101716664|NCT02642003|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101716665|NCT02642003|Immunologic Factors|immunologic factors|mesh-ancestor
101716666|NCT02642003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716667|NCT02641847|Cyclophosphamide|cyclophosphamide|mesh-list
101716668|NCT02641847|Gemcitabine|gemcitabine|mesh-list
101716669|NCT02641847|Docetaxel|docetaxel|mesh-list
101716670|NCT02641847|Doxorubicin|doxorubicin|mesh-list
101716671|NCT02641847|Epirubicin|epirubicin|mesh-list
101716672|NCT02641847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101716673|NCT02641847|Immunologic Factors|immunologic factors|mesh-ancestor
101716674|NCT02641847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716675|NCT02641847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101716676|NCT02641847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101716677|NCT02641847|Alkylating Agents|alkylating agents|mesh-ancestor
101716678|NCT02641847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716679|NCT02641847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101716680|NCT02641847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101716681|NCT02641847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101716682|NCT02641847|Antimetabolites|antimetabolites|mesh-ancestor
101716683|NCT02641847|Tubulin Modulators|tubulin modulators|mesh-ancestor
101716684|NCT02641847|Antimitotic Agents|antimitotic agents|mesh-ancestor
101716685|NCT02641847|Mitosis Modulators|mitosis modulators|mesh-ancestor
101716686|NCT02641847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101716687|NCT02641847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101716688|NCT02641847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101716689|NCT02641847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101716690|NCT00599027|Mometasone Furoate|mometasone furoate|mesh-list
101716691|NCT00599027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101716692|NCT00599027|Dermatologic Agents|dermatologic agents|mesh-ancestor
101363989|NCT00081042|Paclitaxel|paclitaxel|mesh-list
101716693|NCT00599027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101716694|NCT00652379|Octreotide|octreotide|mesh-list
101716695|NCT00652379|Lanreotide|lanreotide|mesh-list
101716696|NCT00652379|Somatostatin|somatostatin|mesh-list
101716697|NCT00652379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101716698|NCT00652379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101716699|NCT00652379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101716701|NCT00652379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101716702|NCT00652379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716703|NCT04164797|Endostar protein|endostar protein|mesh-list
101716704|NCT04164797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101716705|NCT04164797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101716706|NCT04164797|Growth Substances|growth substances|mesh-ancestor
101716707|NCT04164797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716708|NCT04164797|Growth Inhibitors|growth inhibitors|mesh-ancestor
101716709|NCT04164797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101716710|NCT00654017|Sildenafil Citrate|sildenafil citrate|mesh-list
101716711|NCT00654017|Vasodilator Agents|vasodilator agents|mesh-ancestor
101802638|NCT00729131|Etanercept|etanercept|mesh-list
101802641|NCT00729131|Analgesics|analgesics|mesh-ancestor
101716712|NCT00654017|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101716713|NCT00654017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101716714|NCT00654017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101716715|NCT00654017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716716|NCT00654017|Urological Agents|urological agents|mesh-ancestor
101716717|NCT02639819|Aminocaproic Acid|aminocaproic acid|mesh-list
101716718|NCT02639819|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101716719|NCT02639819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101716720|NCT02639819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716721|NCT02639819|Hemostatics|hemostatics|mesh-ancestor
101716722|NCT02639819|Coagulants|coagulants|mesh-ancestor
101716723|NCT02639741|Vitamins|vitamins|mesh-list
101716724|NCT02639741|Ascorbic Acid|ascorbic acid|mesh-list
101716725|NCT02639741|Melatonin|melatonin|mesh-list
101716726|NCT02639741|Micronutrients|micronutrients|mesh-ancestor
101716727|NCT02639741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716728|NCT02639741|Antioxidants|antioxidants|mesh-ancestor
101716729|NCT02639741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716730|NCT02639741|Protective Agents|protective agents|mesh-ancestor
101716731|NCT02639741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101716732|NCT04164719|Cyclobenzaprine|cyclobenzaprine|mesh-list
101716733|NCT04164719|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101716734|NCT04164719|Antidepressive Agents|antidepressive agents|mesh-ancestor
101716735|NCT04164719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101716736|NCT04164719|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101716737|NCT04164719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716738|NCT04164719|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101716739|NCT04164719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101716740|NCT04164719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101716741|NCT04164719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101716742|NCT00654173|Atorvastatin|atorvastatin|mesh-list
101716743|NCT00654173|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101716744|NCT00654173|Simvastatin|simvastatin|mesh-list
101716745|NCT00654173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101716746|NCT00654173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101716747|NCT00654173|Antimetabolites|antimetabolites|mesh-ancestor
101716748|NCT00654173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716749|NCT00654173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101716750|NCT00654173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101716751|NCT00654173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101716752|NCT02645279|Midazolam|midazolam|mesh-list
101716753|NCT02645279|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101716754|NCT02645279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101716755|NCT02645279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101716756|NCT02645279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716757|NCT02645279|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101716758|NCT02645279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101716759|NCT02645279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101716760|NCT02645279|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101716761|NCT02645279|Anesthetics, General|anesthetics, general|mesh-ancestor
101716762|NCT02645279|Anesthetics|anesthetics|mesh-ancestor
101716763|NCT02645279|GABA Modulators|gaba modulators|mesh-ancestor
101716764|NCT02645279|GABA Agents|gaba agents|mesh-ancestor
101716765|NCT02645279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101716766|NCT02645279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716767|NCT04164329|Anesthetics|anesthetics|mesh-list
101716768|NCT04164329|Anesthetics, General|anesthetics, general|mesh-list
101716769|NCT04164329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101716770|NCT04164329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716771|NCT02639039|Cortisone|cortisone|mesh-list
101716772|NCT02639039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101716773|NCT00655265|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
101716774|NCT00655265|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101716775|NCT00655265|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101716776|NCT00655265|Antimetabolites|antimetabolites|mesh-ancestor
101716777|NCT00655265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716778|NCT00655265|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101716779|NCT02562664|Metformin|metformin|mesh-list
101716780|NCT02562664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101716782|NCT00654407|Atorvastatin|atorvastatin|mesh-list
101716783|NCT00654407|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101716784|NCT00654407|Simvastatin|simvastatin|mesh-list
101716785|NCT00654407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101716786|NCT00654407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101716787|NCT00654407|Antimetabolites|antimetabolites|mesh-ancestor
101716788|NCT00654407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716789|NCT00654407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101716790|NCT00654407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101716791|NCT00654407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101716793|NCT00691054|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101716794|NCT00691054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101716795|NCT00691054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101716796|NCT00691054|Tubulin Modulators|tubulin modulators|mesh-ancestor
101716797|NCT00691054|Antimitotic Agents|antimitotic agents|mesh-ancestor
101716798|NCT00691054|Mitosis Modulators|mitosis modulators|mesh-ancestor
101716799|NCT00691054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716800|NCT00598871|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101716801|NCT00598871|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101716802|NCT00744406|Sertraline|sertraline|mesh-list
101716803|NCT00744406|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101716804|NCT00744406|Antidepressive Agents|antidepressive agents|mesh-list
101716805|NCT00744406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101716806|NCT00744406|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101716807|NCT00744406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101716808|NCT00744406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101716809|NCT00744406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716810|NCT00744406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101716811|NCT00744406|Serotonin Agents|serotonin agents|mesh-ancestor
101716812|NCT00744406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716813|NCT00744406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101716814|NCT00744406|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101716815|NCT00690820|Pancrelipase|pancrelipase|mesh-list
101716816|NCT00690820|Pancreatin|pancreatin|mesh-list
101716817|NCT00690820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101716818|NCT02562508|Vaccines|vaccines|mesh-list
101716819|NCT02562508|Immunologic Factors|immunologic factors|mesh-ancestor
101716820|NCT02562508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716821|NCT00689338|Fluconazole|fluconazole|mesh-list
101716822|NCT00689338|Voriconazole|voriconazole|mesh-list
101716823|NCT00689338|Anidulafungin|anidulafungin|mesh-list
101716824|NCT00689338|Antifungal Agents|antifungal agents|mesh-ancestor
101716825|NCT00689338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101716826|NCT00689338|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101716827|NCT00689338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101716828|NCT00689338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101716829|NCT00689338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716830|NCT00689338|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101716831|NCT00689338|Hormone Antagonists|hormone antagonists|mesh-ancestor
101716832|NCT00689338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101716833|NCT00689338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716834|NCT00689338|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101716835|NCT00689338|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101716836|NCT00689338|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101802652|NCT00729287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716837|NCT00686998|Olanzapine|olanzapine|mesh-list
101716838|NCT00686998|Antiemetics|antiemetics|mesh-ancestor
101716839|NCT00686998|Autonomic Agents|autonomic agents|mesh-ancestor
101716840|NCT00686998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101716841|NCT00686998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716842|NCT00686998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101716843|NCT00686998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101716844|NCT00686998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101716845|NCT00686998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101716846|NCT00686998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101716847|NCT00686998|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101716848|NCT00686998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101716849|NCT00686998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101716850|NCT00686998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716851|NCT00686998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101716852|NCT00686998|Serotonin Agents|serotonin agents|mesh-ancestor
101716853|NCT00744640|Gemcitabine|gemcitabine|mesh-list
101716854|NCT00744640|Capecitabine|capecitabine|mesh-list
101716855|NCT00744640|Oxaliplatin|oxaliplatin|mesh-list
101716856|NCT00744640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101716857|NCT00744640|Antimetabolites|antimetabolites|mesh-ancestor
101374271|NCT00062699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101716858|NCT00744640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716859|NCT00744640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101716861|NCT00848718|Docetaxel|docetaxel|mesh-list
101716862|NCT00848718|Carboplatin|carboplatin|mesh-list
101716863|NCT00848718|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101716864|NCT00848718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101716865|NCT00848718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101716866|NCT00848718|Tubulin Modulators|tubulin modulators|mesh-ancestor
101716867|NCT00848718|Antimitotic Agents|antimitotic agents|mesh-ancestor
101716868|NCT00848718|Mitosis Modulators|mitosis modulators|mesh-ancestor
101716869|NCT00848718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716870|NCT00848718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101716871|NCT00848718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101716872|NCT02612844|Insulin Aspart|insulin aspart|mesh-list
101716873|NCT02612844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101716874|NCT02612844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716875|NCT00883337|Interferons|interferons|mesh-list
101716876|NCT00883337|Interferon-beta|interferon-beta|mesh-list
101716877|NCT00883337|Interferon beta-1a|interferon beta-1a|mesh-list
101716878|NCT00883337|Teriflunomide|teriflunomide|mesh-list
101716879|NCT00883337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101716880|NCT00883337|Antiviral Agents|antiviral agents|mesh-ancestor
101716881|NCT00883337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101716882|NCT00883337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101716883|NCT00883337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101716884|NCT00883337|Analgesics|analgesics|mesh-ancestor
101716885|NCT00883337|Sensory System Agents|sensory system agents|mesh-ancestor
101716886|NCT00883337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101716887|NCT00883337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716888|NCT00883337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101716889|NCT00883337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101716890|NCT00883337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101802670|NCT02569463|Analgesics|analgesics|mesh-ancestor
101716891|NCT00883337|Immunologic Factors|immunologic factors|mesh-ancestor
101716892|NCT00883337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101716893|NCT04163783|Zanubrutinib|zanubrutinib|mesh-list
101716894|NCT04163783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101716895|NCT04163783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101716896|NCT04163783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101716897|NCT04163783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716898|NCT00654485|Atorvastatin|atorvastatin|mesh-list
101716899|NCT00654485|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101716900|NCT00654485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101716901|NCT00654485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101716902|NCT00654485|Antimetabolites|antimetabolites|mesh-ancestor
101716903|NCT00654485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716904|NCT00654485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101716905|NCT00654485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101716906|NCT00654485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101716907|NCT00837876|Sorafenib|sorafenib|mesh-list
101716908|NCT00837876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101716909|NCT00837876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101716910|NCT00837876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101716911|NCT00837876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716912|NCT00655421|Tolonium Chloride|tolonium chloride|mesh-list
101716913|NCT00655421|Hemostatics|hemostatics|mesh-ancestor
101716914|NCT00655421|Coagulants|coagulants|mesh-ancestor
101716915|NCT00655421|Heparin Antagonists|heparin antagonists|mesh-ancestor
101716916|NCT00655421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716918|NCT00707070|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101716919|NCT00707070|Immunologic Factors|immunologic factors|mesh-ancestor
101716920|NCT00707070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716921|NCT00707070|Keratolytic Agents|keratolytic agents|mesh-ancestor
101716922|NCT00707070|Dermatologic Agents|dermatologic agents|mesh-ancestor
101716923|NCT00686920|Rifaximin|rifaximin|mesh-list
101716924|NCT00686920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101716925|NCT00686920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101716926|NCT00686920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101716927|NCT02562118|Letrozole|letrozole|mesh-list
101716928|NCT02562118|Lenvatinib|lenvatinib|mesh-list
101716929|NCT02562118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101716930|NCT02562118|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101716931|NCT02562118|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101716932|NCT02562118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101716933|NCT02562118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802711|NCT02538926|Prednisone|prednisone|mesh-list
101716935|NCT02562118|Hormone Antagonists|hormone antagonists|mesh-ancestor
101716936|NCT02562118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101190397|NCT00004734|Vitamin B 12|vitamin b 12|mesh-list
101716937|NCT02562118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716938|NCT02562118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101716939|NCT00744718|Bevacizumab|bevacizumab|mesh-list
101716940|NCT00744718|Carboplatin|carboplatin|mesh-list
101716941|NCT00744718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101716942|NCT00744718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101716943|NCT00744718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101716944|NCT00744718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101716945|NCT00744718|Growth Substances|growth substances|mesh-ancestor
101716946|NCT00744718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716947|NCT00744718|Growth Inhibitors|growth inhibitors|mesh-ancestor
101716948|NCT00741910|Semapimod|semapimod|mesh-list
101716949|NCT00741910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101716950|NCT00741910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101716951|NCT00741910|Analgesics|analgesics|mesh-ancestor
101716952|NCT00741910|Sensory System Agents|sensory system agents|mesh-ancestor
101716953|NCT00741910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101716954|NCT00741910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716955|NCT00741910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101716956|NCT00741910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101716957|NCT00741910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101716958|NCT00741910|Immunologic Factors|immunologic factors|mesh-ancestor
101716959|NCT00845832|Rituximab|rituximab|mesh-list
101716960|NCT00845832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101716961|NCT00845832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101716962|NCT00845832|Immunologic Factors|immunologic factors|mesh-ancestor
101716963|NCT00845832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716964|NCT00845832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101716965|NCT00703482|Coenzyme Q10|coenzyme q10|mesh-list
101716966|NCT00703482|Ubiquinone|ubiquinone|mesh-list
101716967|NCT00703482|Fenofibrate|fenofibrate|mesh-list
101716968|NCT00703482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101716969|NCT00703482|Antimetabolites|antimetabolites|mesh-ancestor
101716970|NCT00703482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716971|NCT00703482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101716972|NCT00703482|Vitamins|vitamins|mesh-ancestor
101716973|NCT00703482|Micronutrients|micronutrients|mesh-ancestor
101716974|NCT00703482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716975|NCT00885755|Capecitabine|capecitabine|mesh-list
101716976|NCT00885755|Trastuzumab|trastuzumab|mesh-list
101716977|NCT00885755|Taxane|taxane|mesh-list
101716978|NCT00885755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101716979|NCT00885755|Antimetabolites|antimetabolites|mesh-ancestor
101716980|NCT00885755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716981|NCT00885755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363997|NCT00047333|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101716982|NCT00885755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101716983|NCT00749710|Clopidogrel|clopidogrel|mesh-list
101716984|NCT00749710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101716985|NCT00749710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101716986|NCT00749710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101716987|NCT00749710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101716988|NCT00749710|Purinergic Agents|purinergic agents|mesh-ancestor
101716989|NCT00749710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101716990|NCT00749710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802799|NCT00729911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101716991|NCT00749710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101716992|NCT00749866|Gentamicins|gentamicins|mesh-list
101716993|NCT00749866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101716994|NCT00749866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101716995|NCT00749866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101716996|NCT00749866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101716997|NCT00749866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101716998|NCT04058236|Polygeline|polygeline|mesh-list
101716999|NCT04058236|Plasma Substitutes|plasma substitutes|mesh-ancestor
101717000|NCT04058236|Blood Substitutes|blood substitutes|mesh-ancestor
101717001|NCT00742066|Felodipine|felodipine|mesh-list
101717002|NCT00742066|Irbesartan|irbesartan|mesh-list
101717003|NCT00742066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101717004|NCT00742066|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101717005|NCT00742066|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101717006|NCT00742066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374423|NCT00227773|Mitosis Modulators|mitosis modulators|mesh-ancestor
101717007|NCT00742066|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101717008|NCT00742066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101717009|NCT00742066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101717010|NCT00742066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101717011|NCT00742066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717012|NCT00742066|Vasodilator Agents|vasodilator agents|mesh-ancestor
101717014|NCT00742144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101717015|NCT00845676|Interferons|interferons|mesh-list
101717016|NCT00845676|Ribavirin|ribavirin|mesh-list
101717017|NCT00845676|Interferon-alpha|interferon-alpha|mesh-list
101717018|NCT00845676|Interferon alpha-2|interferon alpha-2|mesh-list
101717019|NCT00845676|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101717020|NCT00845676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101717021|NCT00845676|Antiviral Agents|antiviral agents|mesh-ancestor
101717022|NCT00845676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101717023|NCT00845676|Antimetabolites|antimetabolites|mesh-ancestor
101717024|NCT00845676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717025|NCT00845676|Immunologic Factors|immunologic factors|mesh-ancestor
101717026|NCT00845676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717027|NCT00742300|Cyclophosphamide|cyclophosphamide|mesh-list
101717028|NCT00742300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101717029|NCT00742300|Immunologic Factors|immunologic factors|mesh-ancestor
101717030|NCT00742300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717031|NCT00742300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101717032|NCT00742300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101717033|NCT00742300|Alkylating Agents|alkylating agents|mesh-ancestor
101717034|NCT00742300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717035|NCT00742300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101717036|NCT00742300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101717037|NCT02611908|Obinutuzumab|obinutuzumab|mesh-list
101717038|NCT02611908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101717039|NCT02611908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101717040|NCT02561884|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101717041|NCT02561884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101717042|NCT02561884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101717043|NCT02561884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101717044|NCT02561884|Antimetabolites|antimetabolites|mesh-ancestor
101717045|NCT02561884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717046|NCT02561884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101717047|NCT02561884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101717048|NCT02561884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101717049|NCT02561884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101717050|NCT02561884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101717051|NCT02561884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101717052|NCT00655655|Everolimus|everolimus|mesh-list
101717053|NCT00655655|Vatalanib|vatalanib|mesh-list
101717054|NCT00655655|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101717055|NCT00655655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101717056|NCT00655655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101802816|NCT04018703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101802817|NCT04018703|Analgesics|analgesics|mesh-ancestor
101717057|NCT00655655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717058|NCT00655655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101717059|NCT00655655|Immunologic Factors|immunologic factors|mesh-ancestor
101717060|NCT00655655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717061|NCT00655655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101717062|NCT00844896|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
101717063|NCT00844896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101717064|NCT00844896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717066|NCT05483400|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101717067|NCT05483400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717068|NCT05483400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101717069|NCT05483400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101717070|NCT00837330|Ranibizumab|ranibizumab|mesh-list
101717071|NCT00837330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101717072|NCT00837330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101717073|NCT00837330|Growth Substances|growth substances|mesh-ancestor
101717074|NCT00837330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717075|NCT00837330|Growth Inhibitors|growth inhibitors|mesh-ancestor
101717076|NCT00837330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101717077|NCT00703638|Pemetrexed|pemetrexed|mesh-list
101717078|NCT00703638|Sorafenib|sorafenib|mesh-list
101717080|NCT00703638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101717081|NCT00703638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717082|NCT00703638|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101717083|NCT00703638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101717084|NCT00703638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101717085|NCT02637479|Deoxyglucose|deoxyglucose|mesh-list
101717086|NCT02637479|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101717087|NCT02637479|Antimetabolites|antimetabolites|mesh-ancestor
101717088|NCT02637479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717089|NCT02637479|Antiviral Agents|antiviral agents|mesh-ancestor
101717090|NCT02637479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101717091|NCT02637479|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101717092|NCT00885365|Tobramycin|tobramycin|mesh-list
101717093|NCT00885365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101717094|NCT00885365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101717095|NCT00827112|Ritonavir|ritonavir|mesh-list
101717096|NCT00827112|Lopinavir|lopinavir|mesh-list
101717097|NCT00827112|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101717098|NCT00827112|Darunavir|darunavir|mesh-list
101717099|NCT00827112|Tenofovir|tenofovir|mesh-list
101717100|NCT00827112|Emtricitabine|emtricitabine|mesh-list
101717101|NCT00827112|Maraviroc|maraviroc|mesh-list
101717102|NCT00827112|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101717103|NCT00827112|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101717104|NCT00827112|Protease Inhibitors|protease inhibitors|mesh-ancestor
101717105|NCT00827112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101717106|NCT00827112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717107|NCT00827112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101717108|NCT00827112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101717109|NCT00827112|Antiviral Agents|antiviral agents|mesh-ancestor
101717110|NCT00827112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101717111|NCT00827112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101717112|NCT00827112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101717113|NCT00827112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101717114|NCT00827112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101717115|NCT00827112|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101717116|NCT00827112|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101717117|NCT00827112|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101717118|NCT00689104|Mirabegron|mirabegron|mesh-list
101717119|NCT00689104|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101717120|NCT00689104|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101717121|NCT00689104|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101717122|NCT00689104|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101802832|NCT04018703|Anesthetics|anesthetics|mesh-ancestor
101717123|NCT00689104|Adrenergic Agents|adrenergic agents|mesh-ancestor
101717124|NCT00689104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101717125|NCT00689104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717126|NCT00689104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717127|NCT00689104|Urological Agents|urological agents|mesh-ancestor
101717128|NCT00689104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101717129|NCT00689104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101717130|NCT00689104|Cholinergic Agents|cholinergic agents|mesh-ancestor
101717131|NCT02118467|Phenylephrine|phenylephrine|mesh-list
101717132|NCT02118467|Vasopressins|vasopressins|mesh-list
101717133|NCT02118467|Arginine Vasopressin|arginine vasopressin|mesh-list
101717134|NCT02118467|Epinephrine|epinephrine|mesh-list
101717135|NCT02118467|Oxymetazoline|oxymetazoline|mesh-list
101717136|NCT02118467|Norepinephrine|norepinephrine|mesh-list
101717137|NCT02118467|Synephrine|synephrine|mesh-list
101717138|NCT02118467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101717139|NCT02118467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101717140|NCT02118467|Adrenergic Agents|adrenergic agents|mesh-ancestor
101717141|NCT02118467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101717142|NCT02118467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717143|NCT02118467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717144|NCT02118467|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101717145|NCT02118467|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101717146|NCT02118467|Autonomic Agents|autonomic agents|mesh-ancestor
101717147|NCT02118467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101717148|NCT02118467|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101717149|NCT02118467|Respiratory System Agents|respiratory system agents|mesh-ancestor
101717151|NCT02118467|Sympathomimetics|sympathomimetics|mesh-ancestor
101717152|NCT02118467|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101717153|NCT02118467|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101717154|NCT02118467|Nasal Decongestants|nasal decongestants|mesh-ancestor
101717155|NCT02118467|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101717156|NCT02118467|Protective Agents|protective agents|mesh-ancestor
101717157|NCT02118467|Hemostatics|hemostatics|mesh-ancestor
101717158|NCT02118467|Coagulants|coagulants|mesh-ancestor
101717159|NCT02118467|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101717160|NCT02118467|Natriuretic Agents|natriuretic agents|mesh-ancestor
101717161|NCT00702156|Bisoprolol|bisoprolol|mesh-list
101717162|NCT00702156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101717163|NCT00702156|Sympatholytics|sympatholytics|mesh-ancestor
101717164|NCT00702156|Autonomic Agents|autonomic agents|mesh-ancestor
101717165|NCT00702156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101717166|NCT00702156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717167|NCT00702156|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101717168|NCT00702156|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101717169|NCT00702156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101717170|NCT00702156|Adrenergic Agents|adrenergic agents|mesh-ancestor
101717171|NCT00702156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101717172|NCT00702156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717173|NCT02638415|Carvedilol|carvedilol|mesh-list
101717174|NCT02638415|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101717175|NCT02638415|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101717176|NCT02638415|Adrenergic Agents|adrenergic agents|mesh-ancestor
101717177|NCT02638415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101717178|NCT02638415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717179|NCT02638415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717180|NCT02638415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101717181|NCT02638415|Antioxidants|antioxidants|mesh-ancestor
101717182|NCT02638415|Protective Agents|protective agents|mesh-ancestor
101717183|NCT02638415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101717184|NCT02638415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101717185|NCT02638415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101717186|NCT02638415|Vasodilator Agents|vasodilator agents|mesh-ancestor
101717187|NCT02638415|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101717188|NCT02638415|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101802841|NCT04065581|Metformin|metformin|mesh-list
101717189|NCT00703872|Interferons|interferons|mesh-list
101717190|NCT00703872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101717191|NCT00703872|Antiviral Agents|antiviral agents|mesh-ancestor
101717192|NCT00703872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101717193|NCT00689026|Lubiprostone|lubiprostone|mesh-list
101717194|NCT00689026|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101717195|NCT00689026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101717196|NCT00689026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717197|NCT00598559|Acetaminophen|acetaminophen|mesh-list
101717198|NCT00598559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101717199|NCT00598559|Analgesics|analgesics|mesh-ancestor
101717200|NCT00598559|Sensory System Agents|sensory system agents|mesh-ancestor
101717201|NCT00598559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101717202|NCT00598559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717203|NCT00598559|Antipyretics|antipyretics|mesh-ancestor
101717204|NCT00686686|Infliximab|infliximab|mesh-list
101717205|NCT00686686|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101717206|NCT00686686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101717207|NCT00686686|Dermatologic Agents|dermatologic agents|mesh-ancestor
101717208|NCT00686686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101717209|NCT00686686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101717210|NCT02637167|Rifaximin|rifaximin|mesh-list
101717211|NCT02637167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101717212|NCT02637167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101717213|NCT02637167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101717214|NCT04057300|Aspirin|aspirin|mesh-list
101717215|NCT04057300|Clopidogrel|clopidogrel|mesh-list
101717217|NCT04057300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101717218|NCT04057300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101717219|NCT04057300|Analgesics|analgesics|mesh-ancestor
101717220|NCT04057300|Sensory System Agents|sensory system agents|mesh-ancestor
101717221|NCT04057300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101717222|NCT04057300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717223|NCT04057300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101717224|NCT04057300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101717225|NCT04057300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101717226|NCT04057300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101717227|NCT04057300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717228|NCT04057300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101717229|NCT04057300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101717230|NCT04057300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101717231|NCT04057300|Antipyretics|antipyretics|mesh-ancestor
101717232|NCT04057300|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101717233|NCT04057300|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101717234|NCT04057300|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101717235|NCT04057300|Purinergic Agents|purinergic agents|mesh-ancestor
101717236|NCT04057300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101717237|NCT00750100|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101717238|NCT00750100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101717239|NCT00750100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717240|NCT00655109|Fluticasone|fluticasone|mesh-list
101717241|NCT00655109|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
101717242|NCT00655109|Lubricant Eye Drops|lubricant eye drops|mesh-list
101717243|NCT00655109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101717244|NCT00655109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101717245|NCT00655109|Autonomic Agents|autonomic agents|mesh-ancestor
101717246|NCT00655109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101802848|NCT00733889|Docetaxel|docetaxel|mesh-list
101717247|NCT00655109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717248|NCT00655109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101717249|NCT00655109|Respiratory System Agents|respiratory system agents|mesh-ancestor
101717250|NCT00655109|Dermatologic Agents|dermatologic agents|mesh-ancestor
101717251|NCT00655109|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101717252|NCT00655109|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101717253|NCT00655109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101717254|NCT00655109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101717255|NCT00655109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101717256|NCT00655109|Analgesics|analgesics|mesh-ancestor
101717257|NCT00655109|Sensory System Agents|sensory system agents|mesh-ancestor
101717258|NCT00655109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101717259|NCT00655109|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101717260|NCT00655109|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101717261|NCT00655109|Histamine Antagonists|histamine antagonists|mesh-ancestor
101717262|NCT00655109|Histamine Agents|histamine agents|mesh-ancestor
101717263|NCT00655109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101717264|NCT00655109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717265|NCT02632877|Pirfenidone|pirfenidone|mesh-list
101717266|NCT02632877|Ketanserin|ketanserin|mesh-list
101717267|NCT02632877|Analgesics|analgesics|mesh-ancestor
101717268|NCT02632877|Sensory System Agents|sensory system agents|mesh-ancestor
101717269|NCT02632877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101717270|NCT02632877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717271|NCT02632877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101717272|NCT02632877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101717273|NCT02632877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101717274|NCT02632877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101717275|NCT02632877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101717276|NCT02632877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101717277|NCT02632877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101717278|NCT02632877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101717279|NCT02632877|Serotonin Agents|serotonin agents|mesh-ancestor
101717280|NCT02632877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101717281|NCT02632877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717282|NCT00656123|Cyclophosphamide|cyclophosphamide|mesh-list
101717283|NCT00656123|Molgramostim|molgramostim|mesh-list
101717284|NCT00656123|Sargramostim|sargramostim|mesh-list
101717285|NCT00656123|Immunologic Factors|immunologic factors|mesh-ancestor
101717286|NCT00656123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717287|NCT00656123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101717289|NCT00656123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101717290|NCT00656123|Alkylating Agents|alkylating agents|mesh-ancestor
101717291|NCT00656123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717292|NCT00656123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101717293|NCT00656123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101717295|NCT04163471|Coagulants|coagulants|mesh-ancestor
101717296|NCT00657449|Valdecoxib|valdecoxib|mesh-list
101717297|NCT00657449|Rofecoxib|rofecoxib|mesh-list
101717298|NCT00657449|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101717299|NCT00657449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101717300|NCT00657449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101717301|NCT00657449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717302|NCT00657449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101717303|NCT00657449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101717304|NCT00657449|Analgesics|analgesics|mesh-ancestor
101717305|NCT00657449|Sensory System Agents|sensory system agents|mesh-ancestor
101717306|NCT00657449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101717307|NCT00657449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717308|NCT00657449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101374728|NCT00075699|Mitomycins|mitomycins|mesh-list
101717309|NCT00657449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101717310|NCT04160195|Cyclophosphamide|cyclophosphamide|mesh-list
101802862|NCT00733967|Varenicline|varenicline|mesh-list
101717311|NCT04160195|Fludarabine|fludarabine|mesh-list
101717312|NCT04160195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101717313|NCT04160195|Immunologic Factors|immunologic factors|mesh-ancestor
101717314|NCT04160195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717315|NCT04160195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101717316|NCT04160195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101717317|NCT04160195|Alkylating Agents|alkylating agents|mesh-ancestor
101717318|NCT04160195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717319|NCT04160195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101717320|NCT04160195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101717321|NCT00911261|Oxymorphone|oxymorphone|mesh-list
101717322|NCT00911261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101717323|NCT00911261|Narcotics|narcotics|mesh-ancestor
101717324|NCT00911261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101717325|NCT00911261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717326|NCT00911261|Analgesics|analgesics|mesh-ancestor
101717327|NCT00911261|Sensory System Agents|sensory system agents|mesh-ancestor
101717328|NCT00911261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101717329|NCT00911261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101717330|NCT00686374|Adalimumab|adalimumab|mesh-list
101717331|NCT00686374|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101717332|NCT00686374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101717333|NCT00686374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101717334|NCT00750178|Vorinostat|vorinostat|mesh-list
101717335|NCT00750178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101717336|NCT00750178|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101717337|NCT00750178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101717338|NCT00750178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717339|NCT00750334|Clofarabine|clofarabine|mesh-list
101717340|NCT00750334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101717341|NCT00750334|Antimetabolites|antimetabolites|mesh-ancestor
101717342|NCT00750334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717343|NCT00750334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101717344|NCT00745186|Glucagon|glucagon|mesh-list
101717345|NCT00745186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101717346|NCT00745186|Hormones|hormones|mesh-ancestor
101717347|NCT00745186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101717348|NCT00745186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717349|NCT00750724|Hyaluronic Acid|hyaluronic acid|mesh-list
101717350|NCT00750724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101717351|NCT00750724|Immunologic Factors|immunologic factors|mesh-ancestor
101717352|NCT00750724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717353|NCT00750724|Viscosupplements|viscosupplements|mesh-ancestor
101717354|NCT00750724|Protective Agents|protective agents|mesh-ancestor
101717355|NCT00752518|Bortezomib|bortezomib|mesh-list
101717356|NCT00752518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101717357|NCT00752596|Azimilide|azimilide|mesh-list
101717358|NCT00752596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101717359|NCT00752596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101717360|NCT00752596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101802873|NCT00738569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101717361|NCT00752596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717362|NCT00752596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101717363|NCT00752596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717365|NCT00750802|Anticonvulsants|anticonvulsants|mesh-ancestor
101717367|NCT00750802|Autonomic Agents|autonomic agents|mesh-ancestor
101717368|NCT00750802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101717369|NCT00750802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717370|NCT00750802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101717371|NCT00750802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101717372|NCT00750802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101717373|NCT00750802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101717374|NCT00750802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101717375|NCT00750802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101717376|NCT00750802|GABA Modulators|gaba modulators|mesh-ancestor
101717377|NCT00750802|GABA Agents|gaba agents|mesh-ancestor
101717378|NCT00750802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101717379|NCT00750802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717380|NCT00751504|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101717381|NCT00751504|Antidepressive Agents|antidepressive agents|mesh-ancestor
101717382|NCT00751504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101717383|NCT00751504|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101374800|NCT00229918|Triamcinolone|triamcinolone|mesh-list
101717384|NCT00751504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101717385|NCT00751504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101717386|NCT00751504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717388|NCT00576628|Hematinics|hematinics|mesh-ancestor
101717389|NCT00683878|Pioglitazone|pioglitazone|mesh-list
101717390|NCT00683878|Dapagliflozin|dapagliflozin|mesh-list
101717391|NCT00683878|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
101717392|NCT00683878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101717393|NCT00683878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717394|NCT00683878|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101717395|NCT00683878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717396|NCT00884741|Bevacizumab|bevacizumab|mesh-list
101717397|NCT00884741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101717398|NCT00884741|Temozolomide|temozolomide|mesh-list
101717399|NCT00884741|Endothelial Growth Factors|endothelial growth factors|mesh-list
101717400|NCT00884741|Antibodies|antibodies|mesh-list
101717401|NCT00884741|Immunoglobulins|immunoglobulins|mesh-list
101717402|NCT00884741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101717403|NCT00884741|Immunoglobulin G|immunoglobulin g|mesh-list
101717404|NCT00884741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101717405|NCT00884741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101717406|NCT00884741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101717407|NCT00884741|Growth Substances|growth substances|mesh-ancestor
101717408|NCT00884741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717409|NCT00884741|Growth Inhibitors|growth inhibitors|mesh-ancestor
101717410|NCT00884741|Immunologic Factors|immunologic factors|mesh-ancestor
101717411|NCT00884741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101717412|NCT00884741|Alkylating Agents|alkylating agents|mesh-ancestor
101717413|NCT00884741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717414|NCT00657527|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101717415|NCT00657527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101717416|NCT00657527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101717417|NCT00657527|Antimetabolites|antimetabolites|mesh-ancestor
101717418|NCT00657527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717419|NCT00657527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101802899|NCT00507819|Urological Agents|urological agents|mesh-ancestor
101717420|NCT00657527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101717421|NCT00657527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101717423|NCT00598481|Alkylating Agents|alkylating agents|mesh-ancestor
101717424|NCT00598481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717425|NCT00598481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101717426|NCT00598481|Immunologic Factors|immunologic factors|mesh-ancestor
101190461|NCT00004800|Vaccines|vaccines|mesh-list
101717427|NCT00598481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717428|NCT00598481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101717429|NCT00598481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101717430|NCT00598481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101717431|NCT04159649|Letrozole|letrozole|mesh-list
101717432|NCT04159649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101717433|NCT04159649|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101717434|NCT04159649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101717435|NCT04159649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101717436|NCT04159649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717437|NCT04159649|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101717438|NCT04159649|Hormone Antagonists|hormone antagonists|mesh-ancestor
101717439|NCT04159649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101717440|NCT04159649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717441|NCT00880763|Interferons|interferons|mesh-list
101717442|NCT00880763|Ribavirin|ribavirin|mesh-list
101717443|NCT00880763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101717444|NCT00880763|Antiviral Agents|antiviral agents|mesh-ancestor
101717445|NCT00880763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101717446|NCT00880763|Antimetabolites|antimetabolites|mesh-ancestor
101717447|NCT00880763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717448|NCT00884273|Goserelin|goserelin|mesh-list
101717449|NCT00884273|Bicalutamide|bicalutamide|mesh-list
101717450|NCT00884273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101717451|NCT00884273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101717452|NCT00884273|Androgen Antagonists|androgen antagonists|mesh-ancestor
101717453|NCT00884273|Hormone Antagonists|hormone antagonists|mesh-ancestor
101717454|NCT00884273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101717455|NCT00884273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717456|NCT00657761|Enfuvirtide|enfuvirtide|mesh-list
101374874|NCT00063401|Paclitaxel|paclitaxel|mesh-list
101717457|NCT00657761|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101717458|NCT00657761|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101717459|NCT00657761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717460|NCT00657761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101717461|NCT00657761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101717462|NCT00657761|Antiviral Agents|antiviral agents|mesh-ancestor
101717463|NCT00657761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101717464|NCT00657839|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101717465|NCT00657839|Vasodilator Agents|vasodilator agents|mesh-ancestor
101717466|NCT00657839|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101717467|NCT00657839|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101717468|NCT00657839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101717469|NCT00657839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717470|NCT00657839|Urological Agents|urological agents|mesh-ancestor
101717471|NCT00884117|Oseltamivir|oseltamivir|mesh-list
101717472|NCT00884117|Antiviral Agents|antiviral agents|mesh-ancestor
101717473|NCT00884117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101717474|NCT00884117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101802916|NCT02569073|Dronabinol|dronabinol|mesh-list
101717475|NCT00884117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717476|NCT04159181|Lactulose|lactulose|mesh-list
101717477|NCT04159181|Picosulfate sodium|picosulfate sodium|mesh-list
101717478|NCT04159181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101717479|NCT04159181|Cathartics|cathartics|mesh-ancestor
101717480|NCT00884039|Hydrocortisone|hydrocortisone|mesh-list
101717481|NCT00884039|Anecortave|anecortave|mesh-list
101717482|NCT00884039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101717483|NCT00884039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101717484|NCT00884039|Growth Substances|growth substances|mesh-ancestor
101717485|NCT00884039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717486|NCT00884039|Growth Inhibitors|growth inhibitors|mesh-ancestor
101717487|NCT00884039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101717488|NCT00884039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101717489|NCT00657995|Pancrelipase|pancrelipase|mesh-list
101717490|NCT00657995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101717491|NCT02632565|Lidocaine|lidocaine|mesh-list
101717492|NCT02632565|Anesthetics, Local|anesthetics, local|mesh-ancestor
101717493|NCT02632565|Anesthetics|anesthetics|mesh-ancestor
101717494|NCT02632565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101717495|NCT02632565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717496|NCT02632565|Sensory System Agents|sensory system agents|mesh-ancestor
101717497|NCT02632565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101717498|NCT02632565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101717499|NCT02632565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101717500|NCT02632565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101717501|NCT02632565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101717502|NCT02632565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717504|NCT04158947|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101717505|NCT04158947|Afatinib|afatinib|mesh-list
101717506|NCT04158947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101717507|NCT04158947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101717508|NCT04158947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101717509|NCT04158947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101717510|NCT04158947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717511|NCT04158947|Tubulin Modulators|tubulin modulators|mesh-ancestor
101717512|NCT04158947|Antimitotic Agents|antimitotic agents|mesh-ancestor
101717513|NCT04158947|Mitosis Modulators|mitosis modulators|mesh-ancestor
101717514|NCT04158947|Immunotoxins|immunotoxins|mesh-ancestor
101717515|NCT04158947|Immunoconjugates|immunoconjugates|mesh-ancestor
101717516|NCT04158947|Immunologic Factors|immunologic factors|mesh-ancestor
101717517|NCT04158947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717518|NCT00835770|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101717519|NCT00835770|Dermatologic Agents|dermatologic agents|mesh-ancestor
101717520|NCT00835770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101717521|NCT00835770|Immunologic Factors|immunologic factors|mesh-ancestor
101717522|NCT00835770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717523|NCT04163237|Sorafenib|sorafenib|mesh-list
101717524|NCT04163237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101717525|NCT04163237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101717526|NCT04163237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101717527|NCT04163237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717528|NCT00880685|Memantine|memantine|mesh-list
101717529|NCT00880685|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101717530|NCT00880685|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101717531|NCT00880685|Dopamine Agents|dopamine agents|mesh-ancestor
101717532|NCT00880685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101717533|NCT00880685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717534|NCT00880685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717535|NCT00880685|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101717536|NCT00880685|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101717537|NCT02612298|Metoprolol|metoprolol|mesh-list
101717538|NCT02612298|Arotinolol|arotinolol|mesh-list
101717539|NCT02612298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101717540|NCT02612298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101802930|NCT00732563|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101717541|NCT02612298|Sympatholytics|sympatholytics|mesh-ancestor
101717542|NCT02612298|Autonomic Agents|autonomic agents|mesh-ancestor
101717543|NCT02612298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101717544|NCT02612298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717545|NCT02612298|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101717546|NCT02612298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101717547|NCT02612298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101717548|NCT02612298|Adrenergic Agents|adrenergic agents|mesh-ancestor
101717549|NCT02612298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101717550|NCT02612298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717551|NCT02612298|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101717552|NCT00880607|Morphine|morphine|mesh-list
101717553|NCT00880607|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101717554|NCT00880607|Narcotics|narcotics|mesh-ancestor
101717555|NCT00880607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101717556|NCT00880607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717557|NCT00880607|Analgesics|analgesics|mesh-ancestor
101717558|NCT00880607|Sensory System Agents|sensory system agents|mesh-ancestor
101717559|NCT00880607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101717560|NCT00656435|Bevacizumab|bevacizumab|mesh-list
101717561|NCT00656435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101717562|NCT00656435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101717563|NCT00656435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101717564|NCT00656435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101717565|NCT00656435|Growth Substances|growth substances|mesh-ancestor
101717566|NCT00656435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190468|NCT00004842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101717567|NCT00656435|Growth Inhibitors|growth inhibitors|mesh-ancestor
101717568|NCT02636231|Endostatins|endostatins|mesh-list
101717569|NCT02636231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101717570|NCT02636231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101717571|NCT02636231|Growth Substances|growth substances|mesh-ancestor
101717572|NCT02636231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717573|NCT02636231|Growth Inhibitors|growth inhibitors|mesh-ancestor
101717574|NCT02636231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101717575|NCT00658463|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101717576|NCT00658463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101717577|NCT00658463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101717578|NCT00658463|Antimetabolites|antimetabolites|mesh-ancestor
101717579|NCT00658463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717580|NCT00658463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101717581|NCT00658463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101717582|NCT00658463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101717583|NCT00656591|Methotrexate|methotrexate|mesh-list
101717584|NCT00656591|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101717585|NCT00656591|Abortifacient Agents|abortifacient agents|mesh-ancestor
101717586|NCT00656591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101717587|NCT00656591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717588|NCT00656591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101717589|NCT00656591|Antimetabolites|antimetabolites|mesh-ancestor
101717590|NCT00656591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717591|NCT00656591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101717592|NCT00656591|Dermatologic Agents|dermatologic agents|mesh-ancestor
101717593|NCT00656591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101717594|NCT00656591|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101717595|NCT00656591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101717596|NCT00656591|Immunologic Factors|immunologic factors|mesh-ancestor
101717597|NCT00656591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101717598|NCT00656591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101802941|NCT00734123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101717600|NCT00658931|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101717601|NCT00658931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101717602|NCT00658931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101717603|NCT00658931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717604|NCT00658931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101717605|NCT00658931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717607|NCT00658931|Sensory System Agents|sensory system agents|mesh-ancestor
101717608|NCT00658931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101717609|NCT00658931|Antidepressive Agents|antidepressive agents|mesh-ancestor
101717610|NCT00658931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101717611|NCT00658931|Dopamine Agents|dopamine agents|mesh-ancestor
101717612|NCT00834912|Tramadol|tramadol|mesh-list
101717613|NCT00834912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101717614|NCT00834912|Narcotics|narcotics|mesh-ancestor
101717615|NCT00834912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101717616|NCT00834912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717617|NCT00834912|Analgesics|analgesics|mesh-ancestor
101717618|NCT00834912|Sensory System Agents|sensory system agents|mesh-ancestor
101717619|NCT00834912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101717620|NCT02535689|Tofacitinib|tofacitinib|mesh-list
101717621|NCT02535689|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101717622|NCT02535689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101717623|NCT02535689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101717624|NCT02535689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717625|NCT02632331|Gabapentin|gabapentin|mesh-list
101717626|NCT02632331|Analgesics|analgesics|mesh-ancestor
101717627|NCT02632331|Sensory System Agents|sensory system agents|mesh-ancestor
101717628|NCT02632331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101717629|NCT02632331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717630|NCT02632331|Anticonvulsants|anticonvulsants|mesh-ancestor
101717631|NCT02632331|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101717632|NCT02632331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101717633|NCT02632331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101717634|NCT02632331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101717635|NCT02632331|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101717636|NCT02632331|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101717637|NCT02632331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101717638|NCT02632331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717639|NCT02632331|Antimanic Agents|antimanic agents|mesh-ancestor
101717641|NCT04162535|Propofol|propofol|mesh-list
101717642|NCT04162535|Anesthetics|anesthetics|mesh-list
101717643|NCT04162535|Sevoflurane|sevoflurane|mesh-list
101717644|NCT04162535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
101717645|NCT04162535|Anesthetics, Local|anesthetics, local|mesh-ancestor
101717646|NCT04162535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101717647|NCT04162535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717648|NCT04162535|Sensory System Agents|sensory system agents|mesh-ancestor
101717649|NCT04162535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101717650|NCT04162535|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101717651|NCT04162535|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101717652|NCT04162535|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101717653|NCT04162535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101717654|NCT04162535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717655|NCT04162535|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101717656|NCT04162535|Anesthetics, General|anesthetics, general|mesh-ancestor
101717657|NCT04162535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101717658|NCT04162535|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101717659|NCT02632019|Gemcitabine|gemcitabine|mesh-list
101717660|NCT02632019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101717661|NCT02632019|Antimetabolites|antimetabolites|mesh-ancestor
101802953|NCT00734123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101802955|NCT00734123|Antipyretics|antipyretics|mesh-ancestor
101717662|NCT02632019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717663|NCT02632019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101717664|NCT00883493|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101717665|NCT00883493|Lithium Carbonate|lithium carbonate|mesh-list
101717666|NCT00883493|Antidepressive Agents|antidepressive agents|mesh-ancestor
101717667|NCT00883493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101717668|NCT00883493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101717669|NCT00883493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101717670|NCT00883493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101717671|NCT00883493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717672|NCT00883493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101717673|NCT00883493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717674|NCT00883493|Antimanic Agents|antimanic agents|mesh-ancestor
101717676|NCT00659321|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101717677|NCT00659321|Autonomic Agents|autonomic agents|mesh-ancestor
101717678|NCT00659321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101717679|NCT00659321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717681|NCT00659321|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101717682|NCT00659321|Cholinergic Agents|cholinergic agents|mesh-ancestor
101717683|NCT00659321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101717684|NCT00659321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717685|NCT00659399|PENTA|penta|mesh-list
101717686|NCT00659399|Fondaparinux|fondaparinux|mesh-list
101717687|NCT00659399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101717688|NCT00659399|Antithrombins|antithrombins|mesh-ancestor
101717689|NCT00659399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101717690|NCT00659399|Protease Inhibitors|protease inhibitors|mesh-ancestor
101717691|NCT00659399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101717692|NCT00659399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717693|NCT00659399|Anticoagulants|anticoagulants|mesh-ancestor
101717694|NCT00659399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101717695|NCT00659399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101717696|NCT00659477|Insulin Glargine|insulin glargine|mesh-list
101717697|NCT00659477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101717698|NCT00659477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717699|NCT00911339|Atorvastatin|atorvastatin|mesh-list
101717700|NCT00911339|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101717701|NCT00911339|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101717702|NCT00911339|Antimetabolites|antimetabolites|mesh-ancestor
101717703|NCT00911339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717704|NCT00911339|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101717705|NCT00911339|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101717706|NCT00911339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101717707|NCT05863195|Leucovorin|leucovorin|mesh-list
101717708|NCT05863195|Bevacizumab|bevacizumab|mesh-list
101717709|NCT05863195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101717710|NCT05863195|Cetuximab|cetuximab|mesh-list
101717711|NCT05863195|Panitumumab|panitumumab|mesh-list
101717712|NCT05863195|Fluorouracil|fluorouracil|mesh-list
101717713|NCT05863195|Oxaliplatin|oxaliplatin|mesh-list
101717714|NCT05863195|Irinotecan|irinotecan|mesh-list
101717715|NCT05863195|Floxuridine|floxuridine|mesh-list
101717716|NCT05863195|Endothelial Growth Factors|endothelial growth factors|mesh-list
101717717|NCT05863195|Antibodies|antibodies|mesh-list
101717718|NCT05863195|Immunoglobulins|immunoglobulins|mesh-list
101717719|NCT05863195|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101717720|NCT05863195|Immunoglobulin G|immunoglobulin g|mesh-list
101717721|NCT05863195|Deoxyuridine|deoxyuridine|mesh-list
101717722|NCT05863195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101717723|NCT05863195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101717724|NCT05863195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101717725|NCT05863195|Growth Substances|growth substances|mesh-ancestor
101717726|NCT05863195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717727|NCT05863195|Growth Inhibitors|growth inhibitors|mesh-ancestor
101717728|NCT05863195|Immunologic Factors|immunologic factors|mesh-ancestor
101717730|NCT05863195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717731|NCT05863195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101717732|NCT05863195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101717733|NCT05863195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101717734|NCT05863195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101717735|NCT05863195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101717736|NCT05863195|Antidotes|antidotes|mesh-ancestor
101717737|NCT05863195|Protective Agents|protective agents|mesh-ancestor
101717738|NCT05863195|Vitamin B Complex|vitamin b complex|mesh-ancestor
101717739|NCT05863195|Vitamins|vitamins|mesh-ancestor
101717740|NCT05863195|Micronutrients|micronutrients|mesh-ancestor
101717741|NCT05863104|Glycopyrrolate|glycopyrrolate|mesh-list
101717742|NCT05863104|Bromides|bromides|mesh-list
101717743|NCT05863104|Anticonvulsants|anticonvulsants|mesh-ancestor
101717744|NCT05863104|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101717745|NCT05863104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101717746|NCT05863104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101717747|NCT05863104|Cholinergic Agents|cholinergic agents|mesh-ancestor
101717748|NCT05863104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101717749|NCT05863104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717750|NCT05863104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717751|NCT05863052|Immunomodulating Agents|immunomodulating agents|mesh-list
101717752|NCT05863052|Immunologic Factors|immunologic factors|mesh-ancestor
101717753|NCT05863052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717754|NCT05862792|Bupivacaine|bupivacaine|mesh-list
101717755|NCT05862792|Anesthetics, Local|anesthetics, local|mesh-ancestor
101717756|NCT05862792|Anesthetics|anesthetics|mesh-ancestor
101717757|NCT05862792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101717758|NCT05862792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717759|NCT05862792|Sensory System Agents|sensory system agents|mesh-ancestor
101717760|NCT05862792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101717761|NCT05862753|Etomidate|etomidate|mesh-list
101717762|NCT05862753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101717763|NCT05862753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101717764|NCT05862753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717765|NCT05862753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101717766|NCT05862753|Anesthetics, General|anesthetics, general|mesh-ancestor
101717767|NCT05862753|Anesthetics|anesthetics|mesh-ancestor
101717768|NCT05862714|Itraconazole|itraconazole|mesh-list
101717769|NCT05862714|Fluconazole|fluconazole|mesh-list
101717770|NCT05862714|Antifungal Agents|antifungal agents|mesh-ancestor
101717771|NCT05862714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101717772|NCT05862714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101717773|NCT05862714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101717774|NCT05862714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101717775|NCT05862714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717776|NCT05862714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101717777|NCT05862714|Hormone Antagonists|hormone antagonists|mesh-ancestor
101717778|NCT05862714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101717779|NCT05862714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717780|NCT05862714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101717781|NCT05862714|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101717782|NCT05862714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101717783|NCT05862701|Permethrin|permethrin|mesh-list
101717784|NCT05862701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101717785|NCT05862701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717786|NCT05862688|Anti-Infective Agents|anti-infective agents|mesh-list
101717787|NCT05862688|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101802974|NCT00734279|Leuprolide|leuprolide|mesh-list
101802975|NCT00734279|Ganirelix|ganirelix|mesh-list
101802976|NCT00734279|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101717788|NCT05862519|Testosterone|testosterone|mesh-list
101717789|NCT05862519|Androgens|androgens|mesh-ancestor
101717790|NCT05862519|Hormones|hormones|mesh-ancestor
101717791|NCT05862519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101717792|NCT05862519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717793|NCT05862428|Misoprostol|misoprostol|mesh-list
101717794|NCT05862428|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101203497|NCT01417806|Topotecan|topotecan|mesh-list
101717795|NCT05862428|Abortifacient Agents|abortifacient agents|mesh-ancestor
101717796|NCT05862428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101717797|NCT05862428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717798|NCT05862428|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101717799|NCT05862428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101717800|NCT05862428|Oxytocics|oxytocics|mesh-ancestor
101717801|NCT05862402|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101717802|NCT05862402|Gentamicins|gentamicins|mesh-list
101717803|NCT05862402|Meropenem|meropenem|mesh-list
101717804|NCT05862402|Imipenem|imipenem|mesh-list
101717805|NCT05862402|Amikacin|amikacin|mesh-list
101717806|NCT05862402|Ceftazidime|ceftazidime|mesh-list
101717807|NCT05862402|Colistin|colistin|mesh-list
101717808|NCT05862402|Tigecycline|tigecycline|mesh-list
101717809|NCT05862402|Avibactam|avibactam|mesh-list
101717810|NCT05862402|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101717811|NCT05862402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101717812|NCT05862402|Antitubercular Agents|antitubercular agents|mesh-ancestor
101717813|NCT05862402|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101717814|NCT05862402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101717815|NCT05862402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717816|NCT05862402|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101717817|NCT05862220|Fibrin fragment D|fibrin fragment d|mesh-list
101717818|NCT05862220|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101717819|NCT05862220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101717820|NCT05862220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717821|NCT05862220|Hemostatics|hemostatics|mesh-ancestor
101717822|NCT05862220|Coagulants|coagulants|mesh-ancestor
101717823|NCT05862064|Paclitaxel|paclitaxel|mesh-list
101717824|NCT05862064|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101717825|NCT05862064|Cyclophosphamide|cyclophosphamide|mesh-list
101717826|NCT05862064|Epirubicin|epirubicin|mesh-list
101717827|NCT05862064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101717828|NCT05862064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101717829|NCT05862064|Tubulin Modulators|tubulin modulators|mesh-ancestor
101717830|NCT05862064|Antimitotic Agents|antimitotic agents|mesh-ancestor
101717831|NCT05862064|Mitosis Modulators|mitosis modulators|mesh-ancestor
101717832|NCT05862064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717833|NCT05862064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101717843|NCT05862064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101717853|NCT05861791|Ketorolac|ketorolac|mesh-list
101717854|NCT05861791|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101717855|NCT05861791|Fentanyl|fentanyl|mesh-list
101717856|NCT05861791|Nefopam|nefopam|mesh-list
101717857|NCT05861791|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101717858|NCT05861791|Narcotics|narcotics|mesh-ancestor
101717859|NCT05861791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101717860|NCT05861791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717861|NCT05861791|Analgesics|analgesics|mesh-ancestor
101717862|NCT05861791|Sensory System Agents|sensory system agents|mesh-ancestor
101717863|NCT05861791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101717864|NCT05861791|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101717865|NCT05861791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101717866|NCT05861791|Anesthetics, General|anesthetics, general|mesh-ancestor
101717867|NCT05861791|Anesthetics|anesthetics|mesh-ancestor
101717868|NCT05861791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101717869|NCT05861791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101717870|NCT05861791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101717871|NCT05861791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101717872|NCT05861791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101802988|NCT00442936|Serotonin Agents|serotonin agents|mesh-ancestor
101717873|NCT05861791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101717874|NCT05861791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717876|NCT05861713|Antiemetics|antiemetics|mesh-ancestor
101717877|NCT05861713|Autonomic Agents|autonomic agents|mesh-ancestor
101717878|NCT05861713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101717879|NCT05861713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717880|NCT05861713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101717881|NCT05861713|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101717882|NCT05861713|Histamine Antagonists|histamine antagonists|mesh-ancestor
101717883|NCT05861713|Histamine Agents|histamine agents|mesh-ancestor
101717884|NCT05861713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101717885|NCT05861713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717886|NCT05861687|Amoxicillin|amoxicillin|mesh-list
101717887|NCT05861687|Clarithromycin|clarithromycin|mesh-list
101717888|NCT05861687|Esomeprazole|esomeprazole|mesh-list
101717889|NCT05861687|Lansoprazole|lansoprazole|mesh-list
101717890|NCT05861687|Dexlansoprazole|dexlansoprazole|mesh-list
101717891|NCT05861687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101717892|NCT05861687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101717893|NCT05861687|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101717894|NCT05861687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101717895|NCT05861687|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101717896|NCT05861687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101717897|NCT05861687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717898|NCT05861687|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101717899|NCT05861687|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101451733|NCT00203099|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101717900|NCT05861687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101717902|NCT05861648|Hematinics|hematinics|mesh-ancestor
101717903|NCT05861648|Vitamin B Complex|vitamin b complex|mesh-ancestor
101717904|NCT05861648|Vitamins|vitamins|mesh-ancestor
101717905|NCT05861648|Micronutrients|micronutrients|mesh-ancestor
101717906|NCT05861648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717907|NCT05861635|Tislelizumab|tislelizumab|mesh-list
101717908|NCT05861635|Disitamab vedotin|disitamab vedotin|mesh-list
101717909|NCT05861635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101717911|NCT05861635|Immunoconjugates|immunoconjugates|mesh-ancestor
101717912|NCT05861635|Immunologic Factors|immunologic factors|mesh-ancestor
101717913|NCT05861635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717914|NCT05861609|Analgesics|analgesics|mesh-list
101717915|NCT05861609|Sensory System Agents|sensory system agents|mesh-ancestor
101717916|NCT05861609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101717917|NCT05861609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717918|NCT05857384|Acetazolamide|acetazolamide|mesh-list
101717919|NCT05857384|Dronabinol|dronabinol|mesh-list
101717920|NCT05857384|Anticonvulsants|anticonvulsants|mesh-ancestor
101717921|NCT05857384|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101717922|NCT05857384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101717923|NCT05857384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717924|NCT05857384|Diuretics|diuretics|mesh-ancestor
101717925|NCT05857384|Natriuretic Agents|natriuretic agents|mesh-ancestor
101717926|NCT05857384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717927|NCT05857384|Hallucinogens|hallucinogens|mesh-ancestor
101717928|NCT05857384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101717929|NCT05857384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101717930|NCT05857384|Analgesics|analgesics|mesh-ancestor
101717931|NCT05857384|Sensory System Agents|sensory system agents|mesh-ancestor
101717932|NCT05857384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101717933|NCT05857384|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101717934|NCT05857384|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101717935|NCT05857384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101717936|NCT05857384|Hormones|hormones|mesh-ancestor
101717937|NCT05857384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101717938|NCT05773326|Sirolimus|sirolimus|mesh-list
101717939|NCT05773326|Temsirolimus|temsirolimus|mesh-list
101717940|NCT05773326|MTOR Inhibitors|mtor inhibitors|mesh-list
101717941|NCT05773326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101717942|NCT05773326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101717943|NCT05773326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717944|NCT05773326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101717945|NCT05773326|Immunologic Factors|immunologic factors|mesh-ancestor
101717946|NCT05773326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717947|NCT05773326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101717948|NCT05773326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101717949|NCT05773326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101717950|NCT05773326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101717951|NCT05773326|Antifungal Agents|antifungal agents|mesh-ancestor
101717952|NCT05765071|Botulinum Toxins|botulinum toxins|mesh-list
101717953|NCT05765071|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101717954|NCT05765071|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101717955|NCT05765071|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101717956|NCT05765071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101717957|NCT05765071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717958|NCT05765071|Cholinergic Agents|cholinergic agents|mesh-ancestor
101717959|NCT05765071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101717960|NCT05765071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717961|NCT05765071|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101717962|NCT05765071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101717963|NCT05750745|Fluorides|fluorides|mesh-list
101717964|NCT05750745|Cariostatic Agents|cariostatic agents|mesh-ancestor
101717965|NCT05750745|Protective Agents|protective agents|mesh-ancestor
101717966|NCT05750745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717967|NCT05746897|Pembrolizumab|pembrolizumab|mesh-list
101803027|NCT00733031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101717968|NCT05746897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101717969|NCT05746897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101717970|NCT05746897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101717971|NCT05746897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717973|NCT05686564|Lipotropic Agents|lipotropic agents|mesh-ancestor
101717974|NCT05686564|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101717975|NCT05686564|Antimetabolites|antimetabolites|mesh-ancestor
101717976|NCT05686564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717977|NCT05686564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101717978|NCT05686564|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101717979|NCT05686564|Nootropic Agents|nootropic agents|mesh-ancestor
101717980|NCT05672355|Vaccines|vaccines|mesh-list
101717981|NCT05672355|Immunologic Factors|immunologic factors|mesh-ancestor
101717982|NCT05672355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101717983|NCT05671900|Gemcitabine|gemcitabine|mesh-list
101717984|NCT05671900|Docetaxel|docetaxel|mesh-list
101717985|NCT05671900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101717986|NCT05671900|Antimetabolites|antimetabolites|mesh-ancestor
101717987|NCT05671900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717988|NCT05671900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101717989|NCT05671900|Tubulin Modulators|tubulin modulators|mesh-ancestor
101717990|NCT05671900|Antimitotic Agents|antimitotic agents|mesh-ancestor
101717991|NCT05671900|Mitosis Modulators|mitosis modulators|mesh-ancestor
101717992|NCT05594147|Sorafenib|sorafenib|mesh-list
101717993|NCT05594147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101717994|NCT05594147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101717995|NCT05594147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101717996|NCT05594147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101717997|NCT05533242|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
101717998|NCT05533242|Immunologic Factors|immunologic factors|mesh-ancestor
101717999|NCT05533242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718000|NCT05489185|Tranexamic Acid|tranexamic acid|mesh-list
101718001|NCT05489185|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101718002|NCT05489185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101718003|NCT05489185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718004|NCT05489185|Hemostatics|hemostatics|mesh-ancestor
101718005|NCT05489185|Coagulants|coagulants|mesh-ancestor
101718006|NCT05487586|Ceftazidime|ceftazidime|mesh-list
101718007|NCT05487586|Avibactam|avibactam|mesh-list
101718008|NCT05487586|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
101718009|NCT05487586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101718010|NCT05487586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101718011|NCT05487586|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101718012|NCT05487586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101718013|NCT05487586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718014|NCT05465304|Azithromycin|azithromycin|mesh-list
101718015|NCT05465304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101718016|NCT05465304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101718017|NCT05458024|Vitamin D|vitamin d|mesh-list
101718018|NCT05458024|Ergocalciferols|ergocalciferols|mesh-list
101718019|NCT05458024|Cholecalciferol|cholecalciferol|mesh-list
101718020|NCT05458024|Vitamins|vitamins|mesh-list
101718021|NCT05458024|Micronutrients|micronutrients|mesh-ancestor
101718022|NCT05458024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718023|NCT05458024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101718024|NCT05458024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101718025|NCT05456685|Carboplatin|carboplatin|mesh-list
101718026|NCT05456685|Maytansine|maytansine|mesh-list
101718027|NCT05456685|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
101718028|NCT05456685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101718029|NCT05456685|Immunoconjugates|immunoconjugates|mesh-ancestor
101718030|NCT05456685|Immunologic Factors|immunologic factors|mesh-ancestor
101803054|NCT04065269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101803055|NCT04065269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101803056|NCT04065269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803057|NCT04065269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101718031|NCT05456685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718032|NCT05456685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101718033|NCT05456685|Tubulin Modulators|tubulin modulators|mesh-ancestor
101718034|NCT05456685|Antimitotic Agents|antimitotic agents|mesh-ancestor
101718035|NCT05456685|Mitosis Modulators|mitosis modulators|mesh-ancestor
101718036|NCT05456685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718037|NCT05370313|Nicotine|nicotine|mesh-list
101718038|NCT05370313|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101718039|NCT05370313|Autonomic Agents|autonomic agents|mesh-ancestor
101718040|NCT05370313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101718041|NCT05370313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718042|NCT05370313|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101718043|NCT05370313|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101718044|NCT05370313|Cholinergic Agents|cholinergic agents|mesh-ancestor
101718045|NCT05370313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101718046|NCT05370313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718047|NCT05368623|Mydriatics|mydriatics|mesh-list
101718048|NCT05368623|Autonomic Agents|autonomic agents|mesh-ancestor
101718049|NCT05368623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101718050|NCT05368623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718051|NCT05357768|Formaldehyde|formaldehyde|mesh-list
101718052|NCT05357768|Disinfectants|disinfectants|mesh-ancestor
101718053|NCT05357768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101718054|NCT05324449|Cannabidiol|cannabidiol|mesh-list
101718055|NCT05324449|Anticonvulsants|anticonvulsants|mesh-ancestor
101718056|NCT05304871|Cefazolin|cefazolin|mesh-list
101718057|NCT05304871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101718058|NCT05304871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101718059|NCT05281406|Carboplatin|carboplatin|mesh-list
101718060|NCT05281406|Pemetrexed|pemetrexed|mesh-list
101375485|NCT00233584|Hormones|hormones|mesh-ancestor
101718061|NCT05281406|Osimertinib|osimertinib|mesh-list
101718062|NCT05281406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101718063|NCT05281406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101718064|NCT05281406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718065|NCT05281406|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101718066|NCT05281406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101718067|NCT05281406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101718068|NCT05265299|Aspirin|aspirin|mesh-list
101718069|NCT05265299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101718070|NCT05265299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101718071|NCT05265299|Analgesics|analgesics|mesh-ancestor
101718072|NCT05265299|Sensory System Agents|sensory system agents|mesh-ancestor
101718073|NCT05265299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101718074|NCT05265299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718075|NCT05265299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101718076|NCT05265299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101718077|NCT05265299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101718078|NCT05265299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101718079|NCT05265299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718080|NCT05265299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101718081|NCT05265299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101718082|NCT05265299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101718083|NCT05265299|Antipyretics|antipyretics|mesh-ancestor
101803062|NCT00515619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101718084|NCT05233722|Sirolimus|sirolimus|mesh-list
101718085|NCT05233722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803065|NCT01815359|Mitomycins|mitomycins|mesh-list
101718086|NCT05233722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101803066|NCT01815359|Mitomycin|mitomycin|mesh-list
101718087|NCT05233722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101718088|NCT05233722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101718089|NCT05233722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101718090|NCT05233722|Antifungal Agents|antifungal agents|mesh-ancestor
101718091|NCT05233722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101718092|NCT05233722|Immunologic Factors|immunologic factors|mesh-ancestor
101718093|NCT05221892|Thiamine|thiamine|mesh-list
101718094|NCT05221892|Pyridoxine|pyridoxine|mesh-list
101718095|NCT05221892|Vitamin B 12|vitamin b 12|mesh-list
101718096|NCT05221892|Hydroxocobalamin|hydroxocobalamin|mesh-list
101718097|NCT05221892|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
101718098|NCT05221892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718099|NCT05221892|Vitamin B Complex|vitamin b complex|mesh-ancestor
101718101|NCT05221892|Micronutrients|micronutrients|mesh-ancestor
101718102|NCT05221892|Hematinics|hematinics|mesh-ancestor
101718103|NCT05221892|GABA Agents|gaba agents|mesh-ancestor
101718104|NCT05221892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101718105|NCT05221892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718106|NCT05161338|Estradiol|estradiol|mesh-list
101718107|NCT05161338|Progesterone|progesterone|mesh-list
101718108|NCT05161338|Estrogens|estrogens|mesh-ancestor
101718109|NCT05161338|Hormones|hormones|mesh-ancestor
101718110|NCT05161338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101718111|NCT05161338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718112|NCT05161338|Progestins|progestins|mesh-ancestor
101718113|NCT05108428|Capecitabine|capecitabine|mesh-list
101451734|NCT00203099|(T,G)-A-L|(t,g)-a-l|mesh-list
101718114|NCT05108428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101718115|NCT05108428|Antimetabolites|antimetabolites|mesh-ancestor
101718116|NCT05108428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718117|NCT05108428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101718118|NCT05045794|Liver Extracts|liver extracts|mesh-list
101718119|NCT05045794|Hematinics|hematinics|mesh-ancestor
101718120|NCT05044936|Cannabidiol|cannabidiol|mesh-list
101718121|NCT05044936|Anticonvulsants|anticonvulsants|mesh-ancestor
101718122|NCT05036408|Coal Tar|coal tar|mesh-list
101718123|NCT05036408|Keratolytic Agents|keratolytic agents|mesh-ancestor
101718124|NCT05036408|Dermatologic Agents|dermatologic agents|mesh-ancestor
101718125|NCT05033743|Secnidazole|secnidazole|mesh-list
101718126|NCT05033743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101718127|NCT05033743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101718128|NCT05033743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101718129|NCT05021900|Tenalisib|tenalisib|mesh-list
101718130|NCT05021900|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
101718131|NCT05021900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101718132|NCT05021900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718133|NCT05014646|Cholestyramine Resin|cholestyramine resin|mesh-list
101718134|NCT05014646|Leflunomide|leflunomide|mesh-list
101718135|NCT05014646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101718136|NCT05014646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375558|NCT00234091|Ritonavir|ritonavir|mesh-list
101718137|NCT05014646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101718138|NCT05014646|Immunologic Factors|immunologic factors|mesh-ancestor
101718139|NCT05014646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718140|NCT05014646|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101718141|NCT05014646|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101718142|NCT05014646|Antimetabolites|antimetabolites|mesh-ancestor
101718143|NCT05014646|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101718144|NCT04979806|Meropenem|meropenem|mesh-list
101718145|NCT04979806|Cefepime|cefepime|mesh-list
101718146|NCT04979806|Cefepime-zidebactam|cefepime-zidebactam|mesh-list
101718147|NCT04979806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101718148|NCT04979806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101718149|NCT04971954|Nicotine|nicotine|mesh-list
101718150|NCT04971954|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101718151|NCT04971954|Autonomic Agents|autonomic agents|mesh-ancestor
101718152|NCT04971954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101718153|NCT04971954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803080|NCT00449644|Antitubercular Agents|antitubercular agents|mesh-ancestor
101718154|NCT04971954|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101718155|NCT04971954|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101718156|NCT04971954|Cholinergic Agents|cholinergic agents|mesh-ancestor
101718157|NCT04971954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101718158|NCT04971954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718159|NCT04942340|Dexmedetomidine|dexmedetomidine|mesh-list
101718160|NCT04942340|Caffeine|caffeine|mesh-list
101718161|NCT04942340|Atipamezole|atipamezole|mesh-list
101718162|NCT04942340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101718163|NCT04942340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101718164|NCT04942340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718165|NCT04942340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101718166|NCT04942340|Analgesics|analgesics|mesh-ancestor
101718167|NCT04942340|Sensory System Agents|sensory system agents|mesh-ancestor
101718168|NCT04942340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101718169|NCT04942340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101718170|NCT04942340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101718171|NCT04942340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101718172|NCT04942340|Adrenergic Agents|adrenergic agents|mesh-ancestor
101718173|NCT04942340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101718174|NCT04942340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718175|NCT04942340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101718176|NCT04942340|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101718177|NCT04942340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101718178|NCT04942340|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101718179|NCT04942340|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101718180|NCT04942340|Purinergic Agents|purinergic agents|mesh-ancestor
101718181|NCT04942340|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101718182|NCT04942340|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101718183|NCT04942340|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101718185|NCT04905654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101718186|NCT04905654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101718187|NCT04905654|Autonomic Agents|autonomic agents|mesh-ancestor
101718188|NCT04905654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101718189|NCT04905654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718190|NCT04905654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101718191|NCT04905654|Respiratory System Agents|respiratory system agents|mesh-ancestor
101718192|NCT04905654|Parasympatholytics|parasympatholytics|mesh-ancestor
101718193|NCT04905654|Vasodilator Agents|vasodilator agents|mesh-ancestor
101718194|NCT04857398|Insulin|insulin|mesh-list
101718195|NCT04857398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101718196|NCT04857398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718197|NCT04826432|Pasireotide|pasireotide|mesh-list
101718198|NCT04826432|Hormones|hormones|mesh-ancestor
101718199|NCT04826432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101718200|NCT04826432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718201|NCT04812548|Azacitidine|azacitidine|mesh-list
101718202|NCT04812548|Venetoclax|venetoclax|mesh-list
101718203|NCT04812548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101718204|NCT04812548|Antimetabolites|antimetabolites|mesh-ancestor
101718205|NCT04812548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718206|NCT04812548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101718207|NCT04812548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101718208|NCT04702022|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101718209|NCT04702022|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101718210|NCT04702022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718211|NCT04698525|Valproic Acid|valproic acid|mesh-list
101718212|NCT04698525|Memantine|memantine|mesh-list
101718213|NCT04698525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101718214|NCT04698525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101718215|NCT04698525|Dopamine Agents|dopamine agents|mesh-ancestor
101718216|NCT04698525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101718217|NCT04698525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718218|NCT04698525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718219|NCT04698525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101718220|NCT04698525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101718221|NCT04698525|Anticonvulsants|anticonvulsants|mesh-ancestor
101718222|NCT04698525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101718223|NCT04698525|GABA Agents|gaba agents|mesh-ancestor
101718224|NCT04698525|Antimanic Agents|antimanic agents|mesh-ancestor
101718225|NCT04698525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101718226|NCT04698525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101718227|NCT04698525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101718228|NCT04667104|Tenofovir|tenofovir|mesh-list
101718229|NCT04667104|Entecavir|entecavir|mesh-list
101718230|NCT04667104|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101718231|NCT04667104|Antiviral Agents|antiviral agents|mesh-ancestor
101718232|NCT04667104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101718233|NCT04667104|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101718234|NCT04667104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101718235|NCT04667104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101718236|NCT04667104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718237|NCT04667104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101718238|NCT04667104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101718239|NCT04659369|Nivolumab|nivolumab|mesh-list
101718240|NCT04659369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101718241|NCT04659369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101718242|NCT04659369|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101718243|NCT04659369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718244|NCT04651439|Lenograstim|lenograstim|mesh-list
101718245|NCT04651439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101718246|NCT04651439|Immunologic Factors|immunologic factors|mesh-ancestor
101718247|NCT04651439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718248|NCT04635774|Insulin|insulin|mesh-list
101718249|NCT04635774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101718250|NCT04635774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718252|NCT04634799|Plasminogen Activator Inhibitor 1|plasminogen activator inhibitor 1|mesh-list
101718254|NCT04634799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101718255|NCT04634799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101718256|NCT04634799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718257|NCT04634799|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101718258|NCT04634799|Protease Inhibitors|protease inhibitors|mesh-ancestor
101718259|NCT04634799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101718260|NCT04603365|Temozolomide|temozolomide|mesh-list
101718261|NCT04603365|Pamiparib|pamiparib|mesh-list
101718262|NCT04603365|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
101718263|NCT04603365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101718264|NCT04603365|Alkylating Agents|alkylating agents|mesh-ancestor
101718265|NCT04603365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718266|NCT04603365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101803100|NCT01023100|Tofacitinib|tofacitinib|mesh-list
101718267|NCT04603365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101718268|NCT04565015|Immunoglobulins|immunoglobulins|mesh-list
101718269|NCT04565015|gamma-Globulins|gamma-globulins|mesh-list
101718270|NCT04565015|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101718271|NCT04565015|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101718272|NCT04565015|Immunologic Factors|immunologic factors|mesh-ancestor
101718273|NCT04565015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718274|NCT04560660|Midazolam|midazolam|mesh-list
101718275|NCT04560660|Ketamine|ketamine|mesh-list
101718276|NCT04560660|Analgesics|analgesics|mesh-ancestor
101718277|NCT04560660|Sensory System Agents|sensory system agents|mesh-ancestor
101718278|NCT04560660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101718279|NCT04560660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718280|NCT04560660|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101718281|NCT04560660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101718282|NCT04560660|Anesthetics, General|anesthetics, general|mesh-ancestor
101718283|NCT04560660|Anesthetics|anesthetics|mesh-ancestor
101718284|NCT04560660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101718285|NCT04560660|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101718286|NCT04560660|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101718287|NCT04560660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101718288|NCT04560660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718289|NCT04560660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101718290|NCT04560660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101718291|NCT04560660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101718292|NCT04560660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101718293|NCT04560660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101718294|NCT04560660|GABA Modulators|gaba modulators|mesh-ancestor
101718295|NCT04560660|GABA Agents|gaba agents|mesh-ancestor
101718296|NCT04556526|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
101718297|NCT04556526|Antiviral Agents|antiviral agents|mesh-ancestor
101718298|NCT04556526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101718299|NCT04517435|Prednisone|prednisone|mesh-list
101718300|NCT04517435|Cyclophosphamide|cyclophosphamide|mesh-list
101718301|NCT04517435|Rituximab|rituximab|mesh-list
101718302|NCT04517435|Doxorubicin|doxorubicin|mesh-list
101718303|NCT04517435|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101718304|NCT04517435|Vincristine|vincristine|mesh-list
101718305|NCT04517435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101718306|NCT04517435|Immunologic Factors|immunologic factors|mesh-ancestor
101718307|NCT04517435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718308|NCT04517435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101718309|NCT04517435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101718310|NCT04517435|Alkylating Agents|alkylating agents|mesh-ancestor
101718311|NCT04517435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718312|NCT04517435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101718313|NCT04517435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101718314|NCT04517435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101718315|NCT04517435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101718316|NCT04517435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101718317|NCT04517435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101718318|NCT04517435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101718319|NCT04517435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101718320|NCT04517435|Glucocorticoids|glucocorticoids|mesh-ancestor
101718321|NCT04517435|Hormones|hormones|mesh-ancestor
101451735|NCT00203099|Antiviral Agents|antiviral agents|mesh-ancestor
101718322|NCT04517435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101718323|NCT04517435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101718324|NCT04517435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101803128|NCT00739193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101718325|NCT04517435|Tubulin Modulators|tubulin modulators|mesh-ancestor
101718326|NCT04517435|Antimitotic Agents|antimitotic agents|mesh-ancestor
101718327|NCT04517435|Mitosis Modulators|mitosis modulators|mesh-ancestor
101718328|NCT04478617|Metronidazole|metronidazole|mesh-list
101718329|NCT04478617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101718330|NCT04478617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101718331|NCT04478617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101718332|NCT04478617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101718333|NCT04431518|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
101718334|NCT04431518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101718335|NCT04431518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101718336|NCT04431518|Antiviral Agents|antiviral agents|mesh-ancestor
101718337|NCT04431518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101718338|NCT04424966|Infigratinib|infigratinib|mesh-list
101718339|NCT04424966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101718340|NCT04340258|Pembrolizumab|pembrolizumab|mesh-list
101718341|NCT04340258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101718342|NCT04340258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101718343|NCT04340258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101718344|NCT04340258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718345|NCT04301271|Simvastatin|simvastatin|mesh-list
101718346|NCT04301271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101718347|NCT04301271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101718348|NCT04301271|Antimetabolites|antimetabolites|mesh-ancestor
101718349|NCT04301271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718350|NCT04301271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101718351|NCT04301271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101718352|NCT04301271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101718353|NCT04228783|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
101718354|NCT04228783|Antiviral Agents|antiviral agents|mesh-ancestor
101718355|NCT04228783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101718356|NCT04188119|Aspirin|aspirin|mesh-list
101718357|NCT04188119|Avelumab|avelumab|mesh-list
101718358|NCT04188119|Lansoprazole|lansoprazole|mesh-list
101718359|NCT04188119|Dexlansoprazole|dexlansoprazole|mesh-list
101718360|NCT04188119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101718361|NCT04188119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101718362|NCT04188119|Analgesics|analgesics|mesh-ancestor
101375783|NCT00064649|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101718363|NCT04188119|Sensory System Agents|sensory system agents|mesh-ancestor
101718364|NCT04188119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101718365|NCT04188119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718366|NCT04188119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101718367|NCT04188119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101718368|NCT04188119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101718369|NCT04188119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101718370|NCT04188119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718371|NCT04188119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101718372|NCT04188119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101718373|NCT04188119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101718374|NCT04188119|Antipyretics|antipyretics|mesh-ancestor
101718375|NCT04188119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101718376|NCT04188119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101718377|NCT04188119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101718378|NCT04188119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101718379|NCT04188119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101718380|NCT04174170|Sertraline|sertraline|mesh-list
101718381|NCT04174170|Brexpiprazole|brexpiprazole|mesh-list
101718382|NCT04174170|Antidepressive Agents|antidepressive agents|mesh-ancestor
101718383|NCT04174170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101718384|NCT04174170|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101718385|NCT04174170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101190697|NCT00005118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101718386|NCT04174170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101718387|NCT04174170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718388|NCT04174170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101718389|NCT04174170|Serotonin Agents|serotonin agents|mesh-ancestor
101718390|NCT04174170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718391|NCT04174170|Dopamine Agonists|dopamine agonists|mesh-ancestor
101718392|NCT04174170|Dopamine Agents|dopamine agents|mesh-ancestor
101718393|NCT04142658|Warfarin|warfarin|mesh-list
101718394|NCT04142658|Apixaban|apixaban|mesh-list
101718395|NCT04142658|Anticoagulants|anticoagulants|mesh-ancestor
101718396|NCT04142658|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101718397|NCT04142658|Antithrombins|antithrombins|mesh-ancestor
101718398|NCT04142658|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101718399|NCT04142658|Protease Inhibitors|protease inhibitors|mesh-ancestor
101718400|NCT04142658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101718401|NCT04142658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718402|NCT04138394|Ascorbic Acid|ascorbic acid|mesh-list
101718403|NCT04138394|Vitamins|vitamins|mesh-ancestor
101718404|NCT04138394|Micronutrients|micronutrients|mesh-ancestor
101718405|NCT04138394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718406|NCT04138394|Antioxidants|antioxidants|mesh-ancestor
101718407|NCT04138394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718408|NCT04138394|Protective Agents|protective agents|mesh-ancestor
101718409|NCT04129931|Imatinib Mesylate|imatinib mesylate|mesh-list
101718410|NCT04129931|Broncho-Vaxom|broncho-vaxom|mesh-list
101718411|NCT04129931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101718412|NCT04129931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101718413|NCT04129931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101718414|NCT04129931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718415|NCT04129931|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101718416|NCT04129931|Immunologic Factors|immunologic factors|mesh-ancestor
101718417|NCT04129931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718418|NCT04124614|Sertraline|sertraline|mesh-list
101718419|NCT04124614|Brexpiprazole|brexpiprazole|mesh-list
101718420|NCT04124614|Antidepressive Agents|antidepressive agents|mesh-ancestor
101718421|NCT04124614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101718422|NCT04124614|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101718423|NCT04124614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101718424|NCT04124614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101718425|NCT04124614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718426|NCT04124614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101718427|NCT04124614|Serotonin Agents|serotonin agents|mesh-ancestor
101803161|NCT00459706|Analgesics|analgesics|mesh-ancestor
101718428|NCT04124614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718429|NCT04124614|Dopamine Agonists|dopamine agonists|mesh-ancestor
101718430|NCT04124614|Dopamine Agents|dopamine agents|mesh-ancestor
101718431|NCT04095442|Benzocaine|benzocaine|mesh-list
101718432|NCT04095442|Anesthetics, Local|anesthetics, local|mesh-ancestor
101718433|NCT04095442|Anesthetics|anesthetics|mesh-ancestor
101718434|NCT04095442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101718435|NCT04095442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718436|NCT04095442|Sensory System Agents|sensory system agents|mesh-ancestor
101718437|NCT04095442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101718438|NCT04082780|Rifamycins|rifamycins|mesh-list
101718439|NCT04082780|Rifamycin SV|rifamycin sv|mesh-list
101718440|NCT04082780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101718441|NCT04082780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101718442|NCT04082780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101718443|NCT03977363|Anticoagulants|anticoagulants|mesh-list
101718444|NCT03950674|Folic Acid|folic acid|mesh-list
101718445|NCT03950674|Vitamin B 12|vitamin b 12|mesh-list
101718446|NCT03950674|Dexamethasone|dexamethasone|mesh-list
101718447|NCT03950674|Carboplatin|carboplatin|mesh-list
101718448|NCT03950674|Pembrolizumab|pembrolizumab|mesh-list
101718449|NCT03950674|Pemetrexed|pemetrexed|mesh-list
101718450|NCT03950674|Vitamins|vitamins|mesh-ancestor
101718451|NCT03950674|Micronutrients|micronutrients|mesh-ancestor
101718452|NCT03950674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718453|NCT03950674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101718454|NCT03950674|Antiemetics|antiemetics|mesh-ancestor
101718455|NCT03950674|Autonomic Agents|autonomic agents|mesh-ancestor
101718456|NCT03950674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101718457|NCT03950674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101718458|NCT03950674|Glucocorticoids|glucocorticoids|mesh-ancestor
101718460|NCT03950674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101718461|NCT03950674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101718462|NCT03950674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101718463|NCT03950674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101718464|NCT03950674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101718465|NCT03950674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718466|NCT03950674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101718467|NCT03950674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101718468|NCT03950674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101718469|NCT03950674|Hematinics|hematinics|mesh-ancestor
101718470|NCT03950674|Vitamin B Complex|vitamin b complex|mesh-ancestor
101803187|NCT00735761|Hydrocortisone|hydrocortisone|mesh-list
101718471|NCT03911661|Warfarin|warfarin|mesh-list
101718472|NCT03911661|Anticoagulants|anticoagulants|mesh-ancestor
101718473|NCT03909477|Xenon|xenon|mesh-list
101803188|NCT00735761|Antiviral Agents|antiviral agents|mesh-ancestor
101718474|NCT03909477|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101718475|NCT03909477|Anesthetics, General|anesthetics, general|mesh-ancestor
101718476|NCT03909477|Anesthetics|anesthetics|mesh-ancestor
101718477|NCT03909477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101718478|NCT03909477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718480|NCT03874052|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
101718481|NCT03874052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101718482|NCT03874052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101718483|NCT03874052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101718484|NCT03874052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718486|NCT03851159|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101718487|NCT03851159|Diuretics|diuretics|mesh-ancestor
101718488|NCT03851159|Natriuretic Agents|natriuretic agents|mesh-ancestor
101718489|NCT03851159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718490|NCT04491877|Vaccines|vaccines|mesh-list
101718491|NCT04491877|Immunologic Factors|immunologic factors|mesh-ancestor
101718492|NCT04491877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718493|NCT03829410|Bevacizumab|bevacizumab|mesh-list
101718494|NCT03829410|Onvansertib|onvansertib|mesh-list
101718495|NCT03829410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101718496|NCT03829410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101718497|NCT03829410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101718498|NCT03829410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101718499|NCT03829410|Growth Substances|growth substances|mesh-ancestor
101718500|NCT03829410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718501|NCT03829410|Growth Inhibitors|growth inhibitors|mesh-ancestor
101718502|NCT03829410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101718503|NCT03829410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101718504|NCT03829410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718505|NCT03711604|Tenalisib|tenalisib|mesh-list
101718506|NCT03711604|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
101718507|NCT03711604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101718508|NCT03711604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718509|NCT03708627|Bimatoprost|bimatoprost|mesh-list
101718510|NCT03708627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101718511|NCT03702621|Bupivacaine|bupivacaine|mesh-list
101718512|NCT03702621|Anesthetics, Local|anesthetics, local|mesh-ancestor
101718513|NCT03702621|Anesthetics|anesthetics|mesh-ancestor
101718514|NCT03702621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101718515|NCT03702621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718516|NCT03702621|Sensory System Agents|sensory system agents|mesh-ancestor
101718517|NCT03702621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101718518|NCT03688295|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101718519|NCT03688295|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101718520|NCT03688295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101718521|NCT03688295|Antitubercular Agents|antitubercular agents|mesh-ancestor
101718523|NCT03684876|Natriuretic Agents|natriuretic agents|mesh-ancestor
101718524|NCT03684876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718525|NCT03655665|Ofloxacin|ofloxacin|mesh-list
101718526|NCT03655665|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101190742|NCT00005586|Antidotes|antidotes|mesh-ancestor
101803219|NCT01011621|Betamethasone Valerate|betamethasone valerate|mesh-list
101718527|NCT03655665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101718528|NCT03655665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101718529|NCT03655665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101718530|NCT03655665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101718531|NCT03655665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101718532|NCT03655665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718533|NCT03655665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101718534|NCT03655665|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101718535|NCT03655665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101718536|NCT03641690|Anti-Infective Agents|anti-infective agents|mesh-list
101718537|NCT03641690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101718538|NCT03604627|Calcium|calcium|mesh-list
101718539|NCT03604627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101718540|NCT03604627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718541|NCT03516656|Heparin|heparin|mesh-list
101718542|NCT03516656|Calcium heparin|calcium heparin|mesh-list
101718543|NCT03516656|Anticoagulants|anticoagulants|mesh-ancestor
101718544|NCT03516656|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101718545|NCT03516656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101718546|NCT03516656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718547|NCT03479268|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101718548|NCT03479268|Pevonedistat|pevonedistat|mesh-list
101718549|NCT03479268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204243|NCT01422590|Mitiglinide|mitiglinide|mesh-list
101718551|NCT03459092|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101718552|NCT03459092|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101718553|NCT03459092|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101718554|NCT03459092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101718555|NCT03459092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718556|NCT03459092|Cholinergic Agents|cholinergic agents|mesh-ancestor
101718557|NCT03459092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101718558|NCT03459092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718559|NCT03459092|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101718560|NCT03459092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101718561|NCT03437421|Vitamin D|vitamin d|mesh-list
101718562|NCT03437421|Cholecalciferol|cholecalciferol|mesh-list
101718563|NCT03437421|Vitamins|vitamins|mesh-ancestor
101718564|NCT03437421|Micronutrients|micronutrients|mesh-ancestor
101718565|NCT03437421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718566|NCT03437421|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101718567|NCT03437421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101718568|NCT03416270|Ertugliflozin|ertugliflozin|mesh-list
101718569|NCT03416270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101718570|NCT03416270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718571|NCT03416270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101718572|NCT03416270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718573|NCT03414034|Prednisone|prednisone|mesh-list
101718574|NCT03414034|Onvansertib|onvansertib|mesh-list
101718575|NCT03414034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101718576|NCT03414034|Glucocorticoids|glucocorticoids|mesh-ancestor
101718577|NCT03414034|Hormones|hormones|mesh-ancestor
101718578|NCT03414034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101718579|NCT03414034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718580|NCT03414034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101718581|NCT03414034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101718582|NCT03414034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101718583|NCT03414034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101718584|NCT03414034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718585|NCT03361436|Halichondrin B|halichondrin b|mesh-list
101718586|NCT03361436|Tubulin Modulators|tubulin modulators|mesh-ancestor
101718587|NCT03361436|Antimitotic Agents|antimitotic agents|mesh-ancestor
101718588|NCT03361436|Mitosis Modulators|mitosis modulators|mesh-ancestor
101718589|NCT03361436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718590|NCT03361436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101718591|NCT03284866|Vaccines|vaccines|mesh-list
101718592|NCT03284866|Immunologic Factors|immunologic factors|mesh-ancestor
101718593|NCT03284866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718594|NCT03260894|Pembrolizumab|pembrolizumab|mesh-list
101718595|NCT03260894|Sunitinib|sunitinib|mesh-list
101718596|NCT03260894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101718597|NCT03260894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101718598|NCT03260894|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101718599|NCT03260894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718600|NCT03260894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101718601|NCT03260894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101718602|NCT03260894|Growth Substances|growth substances|mesh-ancestor
101718603|NCT03260894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718604|NCT03260894|Growth Inhibitors|growth inhibitors|mesh-ancestor
101718605|NCT03260894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101718606|NCT03260894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101718607|NCT03245008|Fasinumab|fasinumab|mesh-list
101718608|NCT03245008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101718609|NCT03245008|Analgesics|analgesics|mesh-ancestor
101718610|NCT03245008|Sensory System Agents|sensory system agents|mesh-ancestor
101718611|NCT03245008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101718612|NCT03245008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718613|NCT03220893|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
101718614|NCT03220893|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101718615|NCT03220893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718616|NCT03203473|Nivolumab|nivolumab|mesh-list
101718617|NCT03203473|Ipilimumab|ipilimumab|mesh-list
101718618|NCT03203473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101718619|NCT03203473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101718620|NCT03203473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101718621|NCT03203473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718622|NCT03185208|Lithium Carbonate|lithium carbonate|mesh-list
101718623|NCT03185208|Antidepressive Agents|antidepressive agents|mesh-ancestor
101718624|NCT03185208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101718625|NCT03185208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101718626|NCT03185208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718627|NCT03185208|Antimanic Agents|antimanic agents|mesh-ancestor
101718628|NCT03185208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101718629|NCT03185208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101718630|NCT03185208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718631|NCT03142568|Sildenafil Citrate|sildenafil citrate|mesh-list
101718632|NCT03142568|Vasodilator Agents|vasodilator agents|mesh-ancestor
101718633|NCT03142568|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101718634|NCT03142568|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101718635|NCT03142568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101718636|NCT03142568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718637|NCT03142568|Urological Agents|urological agents|mesh-ancestor
101718638|NCT03115567|Triamcinolone|triamcinolone|mesh-list
101718639|NCT03115567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101718640|NCT03115567|Glucocorticoids|glucocorticoids|mesh-ancestor
101718641|NCT03115567|Hormones|hormones|mesh-ancestor
101718642|NCT03115567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101718643|NCT03115567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718644|NCT03051659|Pembrolizumab|pembrolizumab|mesh-list
101718645|NCT03051659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101803258|NCT00515073|Paclitaxel|paclitaxel|mesh-list
101718646|NCT03051659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101718647|NCT03051659|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101718648|NCT03051659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718649|NCT02982902|Immunomodulating Agents|immunomodulating agents|mesh-list
101718650|NCT02982902|Immunologic Factors|immunologic factors|mesh-ancestor
101718651|NCT02982902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718652|NCT02971761|Pembrolizumab|pembrolizumab|mesh-list
101718653|NCT02971761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101718654|NCT02971761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101718655|NCT02971761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101451736|NCT00203099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101190748|NCT00005592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101718656|NCT02971761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718658|NCT02964559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101718659|NCT02964559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101718660|NCT02964559|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101718661|NCT02964559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376132|NCT00237523|Iodine|iodine|mesh-list
101718662|NCT02893293|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
101718663|NCT02893293|Hematinics|hematinics|mesh-ancestor
101718664|NCT02893293|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101718665|NCT02893293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101718666|NCT02860000|Fulvestrant|fulvestrant|mesh-list
101718667|NCT02860000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101718668|NCT02860000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101718669|NCT02860000|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101718670|NCT02860000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101718671|NCT02860000|Hormone Antagonists|hormone antagonists|mesh-ancestor
101718672|NCT02860000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101718673|NCT02860000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718674|NCT02724878|Bevacizumab|bevacizumab|mesh-list
101718675|NCT02724878|Atezolizumab|atezolizumab|mesh-list
101718676|NCT02724878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101718677|NCT02724878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101718678|NCT02724878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101718679|NCT02724878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101718680|NCT02724878|Growth Substances|growth substances|mesh-ancestor
101718681|NCT02724878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718682|NCT02724878|Growth Inhibitors|growth inhibitors|mesh-ancestor
101718683|NCT02724878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101718684|NCT02724878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718685|NCT02691923|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101718686|NCT02691923|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101718687|NCT02691923|Dermatologic Agents|dermatologic agents|mesh-ancestor
101718688|NCT02672475|Paclitaxel|paclitaxel|mesh-list
101718689|NCT02672475|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101718690|NCT02672475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101718691|NCT02672475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101718692|NCT02672475|Tubulin Modulators|tubulin modulators|mesh-ancestor
101718693|NCT02672475|Antimitotic Agents|antimitotic agents|mesh-ancestor
101718694|NCT02672475|Mitosis Modulators|mitosis modulators|mesh-ancestor
101718695|NCT02672475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718696|NCT02578680|Folic Acid|folic acid|mesh-list
101718697|NCT02578680|Vitamin B 12|vitamin b 12|mesh-list
101718698|NCT02578680|Dexamethasone|dexamethasone|mesh-list
101718699|NCT02578680|Carboplatin|carboplatin|mesh-list
101718700|NCT02578680|Pembrolizumab|pembrolizumab|mesh-list
101718701|NCT02578680|Pemetrexed|pemetrexed|mesh-list
101718702|NCT02578680|Vitamins|vitamins|mesh-ancestor
101718703|NCT02578680|Micronutrients|micronutrients|mesh-ancestor
101718704|NCT02578680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718705|NCT02578680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101718706|NCT02578680|Antiemetics|antiemetics|mesh-ancestor
101718707|NCT02578680|Autonomic Agents|autonomic agents|mesh-ancestor
101803273|NCT00515073|Hormones|hormones|mesh-ancestor
101718708|NCT02578680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101718709|NCT02578680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101718711|NCT02578680|Hormones|hormones|mesh-ancestor
101718712|NCT02578680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101718713|NCT02578680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101718714|NCT02578680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101718715|NCT02578680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101718716|NCT02578680|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101718717|NCT02578680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718718|NCT02578680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101718719|NCT02578680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101718720|NCT02578680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101718721|NCT02578680|Hematinics|hematinics|mesh-ancestor
101718722|NCT02578680|Vitamin B Complex|vitamin b complex|mesh-ancestor
101718723|NCT02385266|Cycloserine|cycloserine|mesh-list
101718724|NCT02385266|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101718725|NCT02385266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101718726|NCT02385266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101718727|NCT02385266|Antitubercular Agents|antitubercular agents|mesh-ancestor
101718728|NCT02385266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101718729|NCT02385266|Antimetabolites|antimetabolites|mesh-ancestor
101718730|NCT02385266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718731|NCT02351765|Cisplatin|cisplatin|mesh-list
101718732|NCT02351765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101718733|NCT02251431|Exenatide|exenatide|mesh-list
101718734|NCT02251431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101718735|NCT02251431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376164|NCT04709770|Simethicone|simethicone|mesh-list
101718736|NCT02251431|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101718737|NCT02251431|Incretins|incretins|mesh-ancestor
101718738|NCT02251431|Hormones|hormones|mesh-ancestor
101718739|NCT02251431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101718740|NCT02191488|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101718741|NCT02191488|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101718742|NCT02191488|Dermatologic Agents|dermatologic agents|mesh-ancestor
101718743|NCT02000089|Secretin|secretin|mesh-list
101718744|NCT02000089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101718746|NCT02000089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101718747|NCT02000089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718748|NCT01494441|Calcium, Dietary|calcium, dietary|mesh-list
101718749|NCT01494441|Calcium|calcium|mesh-list
101718750|NCT01494441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101718751|NCT01494441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718752|NCT01494441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101718753|NCT01367002|Paclitaxel|paclitaxel|mesh-list
101718754|NCT01367002|Carboplatin|carboplatin|mesh-list
101718755|NCT01367002|Trastuzumab|trastuzumab|mesh-list
101718756|NCT01367002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101718757|NCT01367002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101718758|NCT01367002|Tubulin Modulators|tubulin modulators|mesh-ancestor
101718759|NCT01367002|Antimitotic Agents|antimitotic agents|mesh-ancestor
101718760|NCT01367002|Mitosis Modulators|mitosis modulators|mesh-ancestor
101718761|NCT01367002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718762|NCT01367002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101718764|NCT00858273|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101718765|NCT00858273|Antioxidants|antioxidants|mesh-list
101718766|NCT00858273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101718767|NCT00858273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718768|NCT00858273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718770|NCT04158167|Oxytocin|oxytocin|mesh-list
101718771|NCT04158167|Oxytocics|oxytocics|mesh-ancestor
101718772|NCT04158167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101718773|NCT04158167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718774|NCT00659555|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101718775|NCT00659555|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101718776|NCT02635607|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101718777|NCT02635607|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101718778|NCT02635607|Ganirelix|ganirelix|mesh-list
101718779|NCT02635607|Luteolytic Agents|luteolytic agents|mesh-ancestor
101718780|NCT02635607|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101718781|NCT02635607|Contraceptive Agents|contraceptive agents|mesh-ancestor
101718782|NCT02635607|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101718783|NCT02635607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718784|NCT02635607|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101718785|NCT02635607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101718786|NCT02635607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101718787|NCT02635607|Hormones|hormones|mesh-ancestor
101718788|NCT02635607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101718789|NCT02635607|Hormone Antagonists|hormone antagonists|mesh-ancestor
101718790|NCT00660257|Vaccines|vaccines|mesh-list
101718791|NCT00660257|Immunologic Factors|immunologic factors|mesh-ancestor
101718792|NCT00660257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718793|NCT00844428|Eculizumab|eculizumab|mesh-list
101718794|NCT00844428|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101718795|NCT00844428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101718796|NCT00844428|Immunologic Factors|immunologic factors|mesh-ancestor
101718797|NCT00844428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718798|NCT00660335|Secretin|secretin|mesh-list
101718799|NCT00660335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101718800|NCT00660335|Hormones|hormones|mesh-ancestor
101718801|NCT00660335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101718802|NCT00660335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718803|NCT00707772|Ribavirin|ribavirin|mesh-list
101718804|NCT00707772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101718805|NCT00707772|Interferon-alpha|interferon-alpha|mesh-list
101718806|NCT00707772|Antimetabolites|antimetabolites|mesh-ancestor
101718807|NCT00707772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718808|NCT00707772|Antiviral Agents|antiviral agents|mesh-ancestor
101718809|NCT00707772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101718810|NCT00707772|Immunologic Factors|immunologic factors|mesh-ancestor
101718811|NCT00707772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718812|NCT00834834|Fluoxetine|fluoxetine|mesh-list
101718813|NCT00834834|Citalopram|citalopram|mesh-list
101718814|NCT00834834|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101718815|NCT00834834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101718816|NCT00834834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101718817|NCT00834834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718818|NCT00834834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101718820|NCT00834834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718821|NCT00834834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101718822|NCT00834834|Antidepressive Agents|antidepressive agents|mesh-ancestor
101718823|NCT00834834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101718824|NCT00834834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101718825|NCT00834834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101718826|NCT00834834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101718827|NCT00834366|Tramadol|tramadol|mesh-list
101718828|NCT00834366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101718829|NCT00834366|Narcotics|narcotics|mesh-ancestor
101718830|NCT00834366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101718831|NCT00834366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718832|NCT00834366|Analgesics|analgesics|mesh-ancestor
101718833|NCT00834366|Sensory System Agents|sensory system agents|mesh-ancestor
101718834|NCT00834366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101718835|NCT00704574|Insulin Detemir|insulin detemir|mesh-list
101718836|NCT00704574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101718837|NCT00704574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718838|NCT00660647|Adalimumab|adalimumab|mesh-list
101718839|NCT00660647|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101718840|NCT00660647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101718841|NCT00660647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101718842|NCT04156451|Furosemide|furosemide|mesh-list
101718843|NCT04156451|Diuretics|diuretics|mesh-ancestor
101718844|NCT04156451|Natriuretic Agents|natriuretic agents|mesh-ancestor
101718845|NCT04156451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718846|NCT04156451|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101718847|NCT04156451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101718848|NCT04156451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718849|NCT00660725|Gemcitabine|gemcitabine|mesh-list
101718850|NCT00660725|Oxaliplatin|oxaliplatin|mesh-list
101718851|NCT00660725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101718852|NCT00660725|Antimetabolites|antimetabolites|mesh-ancestor
101718853|NCT00660725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718854|NCT00660725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101718855|NCT00844194|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101718856|NCT00844194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101718857|NCT00844194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101718858|NCT00844194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101718859|NCT00844194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718860|NCT00844194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101718861|NCT00844194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718862|NCT00844194|Analgesics|analgesics|mesh-ancestor
101718863|NCT00844194|Sensory System Agents|sensory system agents|mesh-ancestor
101718864|NCT00844194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101718865|NCT00844194|Antidepressive Agents|antidepressive agents|mesh-ancestor
101718866|NCT00844194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101718867|NCT00844194|Dopamine Agents|dopamine agents|mesh-ancestor
101718868|NCT00660803|Fulvestrant|fulvestrant|mesh-list
101718869|NCT00660803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101718870|NCT00660803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101718871|NCT00660803|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101718872|NCT00660803|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101718873|NCT00660803|Hormone Antagonists|hormone antagonists|mesh-ancestor
101718874|NCT00660803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101718875|NCT00660803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803318|NCT04065035|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101718876|NCT00661115|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101718877|NCT00661115|Vasodilator Agents|vasodilator agents|mesh-ancestor
101718878|NCT00661115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101718879|NCT00661115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101718880|NCT00661115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101718881|NCT00661115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718882|NCT00661115|Urological Agents|urological agents|mesh-ancestor
101718883|NCT04157699|Tenofovir|tenofovir|mesh-list
101718884|NCT04157699|Antiviral Agents|antiviral agents|mesh-ancestor
101718885|NCT04157699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101718886|NCT04157699|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101718887|NCT04157699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101718888|NCT04157699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101718889|NCT04157699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718890|NCT04157699|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101718891|NCT04157699|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101718892|NCT00665717|Raltegravir Potassium|raltegravir potassium|mesh-list
101718893|NCT00665717|Pravastatin|pravastatin|mesh-list
101718894|NCT00665717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101718895|NCT00665717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101718896|NCT00665717|Antiviral Agents|antiviral agents|mesh-ancestor
101718897|NCT00665717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101718898|NCT00665717|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101718899|NCT00665717|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101718900|NCT00665717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101718901|NCT00665717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718902|NCT00665717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101718903|NCT00665717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101718904|NCT00665717|Antimetabolites|antimetabolites|mesh-ancestor
101718905|NCT00665717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101718906|NCT00665717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101718907|NCT02611596|Ranolazine|ranolazine|mesh-list
101190962|NCT00356460|Antibodies|antibodies|mesh-list
101718908|NCT02611596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101718909|NCT02611596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101718910|NCT02611596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718911|NCT00661349|Ritonavir|ritonavir|mesh-list
101718912|NCT00661349|Lopinavir|lopinavir|mesh-list
101718913|NCT00661349|Nevirapine|nevirapine|mesh-list
101718915|NCT00661349|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101718916|NCT00661349|Protease Inhibitors|protease inhibitors|mesh-ancestor
101718917|NCT00661349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101718918|NCT00661349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718919|NCT00661349|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101718920|NCT00661349|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101803334|NCT00514917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718921|NCT00661349|Antiviral Agents|antiviral agents|mesh-ancestor
101718922|NCT00661349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101718923|NCT00661349|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101718924|NCT00661349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101718925|NCT00661349|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101718926|NCT00661349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101718927|NCT00661349|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101718928|NCT00661349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101718929|NCT00665873|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101718930|NCT00665873|Amoxicillin|amoxicillin|mesh-list
101718931|NCT00665873|Clavulanic Acids|clavulanic acids|mesh-list
101718932|NCT00665873|Clavulanic Acid|clavulanic acid|mesh-list
101718933|NCT00665873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101718934|NCT00665873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101718935|NCT00665873|Antitubercular Agents|antitubercular agents|mesh-ancestor
101718936|NCT00665873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101718937|NCT00665873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718938|NCT00665873|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101718939|NCT00707850|Ribavirin|ribavirin|mesh-list
101718940|NCT00707850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101718941|NCT00707850|Interferon-alpha|interferon-alpha|mesh-list
101718942|NCT00707850|Antimetabolites|antimetabolites|mesh-ancestor
101718943|NCT00707850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718944|NCT00707850|Antiviral Agents|antiviral agents|mesh-ancestor
101718945|NCT00707850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101718946|NCT00707850|Immunologic Factors|immunologic factors|mesh-ancestor
101718947|NCT00707850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718948|NCT00665951|Ritonavir|ritonavir|mesh-list
101718949|NCT00665951|Lopinavir|lopinavir|mesh-list
101718950|NCT00665951|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101718951|NCT00665951|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101718952|NCT00665951|Protease Inhibitors|protease inhibitors|mesh-ancestor
101718953|NCT00665951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101718954|NCT00665951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718955|NCT00665951|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101718956|NCT00665951|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101718957|NCT00665951|Antiviral Agents|antiviral agents|mesh-ancestor
101718958|NCT00665951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101718959|NCT00665951|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101718960|NCT00665951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101718961|NCT00661739|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101718962|NCT00661739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101718963|NCT00661739|Alkylating Agents|alkylating agents|mesh-ancestor
101718964|NCT00661739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718965|NCT00661739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101718966|NCT00878969|Valsartan|valsartan|mesh-list
101718967|NCT00878969|Ramipril|ramipril|mesh-list
101718968|NCT00878969|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101718969|NCT00878969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101718970|NCT00878969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101718971|NCT00878969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101718972|NCT00878969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718973|NCT00878969|Protease Inhibitors|protease inhibitors|mesh-ancestor
101718974|NCT00878969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101718975|NCT00843492|PENTA|penta|mesh-list
101718976|NCT00843492|Nadroparin|nadroparin|mesh-list
101718977|NCT00843492|Fondaparinux|fondaparinux|mesh-list
101803363|NCT00504075|Immunoglobulins|immunoglobulins|mesh-list
101803365|NCT00504075|Antibodies|antibodies|mesh-list
101718978|NCT00843492|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101718979|NCT00843492|Antithrombins|antithrombins|mesh-ancestor
101718980|NCT00843492|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101718981|NCT00843492|Protease Inhibitors|protease inhibitors|mesh-ancestor
101718982|NCT00843492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101718983|NCT00843492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718984|NCT00843492|Anticoagulants|anticoagulants|mesh-ancestor
101718985|NCT00843492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101718986|NCT00843492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101718987|NCT00666107|Vaccines|vaccines|mesh-list
101718988|NCT00666107|Immunologic Factors|immunologic factors|mesh-ancestor
101718989|NCT00666107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101718990|NCT00666185|Fluconazole|fluconazole|mesh-list
101718991|NCT00666185|Micafungin|micafungin|mesh-list
101718992|NCT00666185|Antifungal Agents|antifungal agents|mesh-ancestor
101718993|NCT00666185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101718994|NCT00666185|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101718995|NCT00666185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101718996|NCT00666185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101718997|NCT00666185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101718998|NCT00666185|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101718999|NCT00666185|Hormone Antagonists|hormone antagonists|mesh-ancestor
101719000|NCT00666185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101719001|NCT00666185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719002|NCT00666185|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101719003|NCT00666185|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101719004|NCT00913224|Diclofenac|diclofenac|mesh-list
101719005|NCT00913224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101719006|NCT00913224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101719007|NCT00913224|Analgesics|analgesics|mesh-ancestor
101719008|NCT00913224|Sensory System Agents|sensory system agents|mesh-ancestor
101719009|NCT00913224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101719010|NCT00913224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719011|NCT00913224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101719012|NCT00913224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101719013|NCT00913224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101719014|NCT00913224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101719015|NCT00913224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719016|NCT00666341|Immunomodulating Agents|immunomodulating agents|mesh-list
101719017|NCT00666341|Immunologic Factors|immunologic factors|mesh-list
101719018|NCT00666341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719019|NCT00661973|Budesonide|budesonide|mesh-list
101719020|NCT00661973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101719021|NCT00661973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101719022|NCT00661973|Autonomic Agents|autonomic agents|mesh-ancestor
101719023|NCT00661973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101719024|NCT00661973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719025|NCT00661973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101719026|NCT00661973|Respiratory System Agents|respiratory system agents|mesh-ancestor
101719027|NCT00661973|Glucocorticoids|glucocorticoids|mesh-ancestor
101719028|NCT00661973|Hormones|hormones|mesh-ancestor
101719029|NCT00661973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101719030|NCT00666575|Gabapentin|gabapentin|mesh-list
101719031|NCT00666575|Analgesics|analgesics|mesh-ancestor
101719032|NCT00666575|Sensory System Agents|sensory system agents|mesh-ancestor
101376455|NCT02961829|Micronutrients|micronutrients|mesh-ancestor
101719033|NCT00666575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101191065|NCT00357474|Ethanol|ethanol|mesh-list
101803380|NCT00741143|Sequestering Agents|sequestering agents|mesh-ancestor
101719034|NCT00666575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719035|NCT00666575|Anticonvulsants|anticonvulsants|mesh-ancestor
101719036|NCT00666575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101719037|NCT00666575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101719038|NCT00666575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101719039|NCT00666575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101719040|NCT00666575|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101719041|NCT00666575|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101719042|NCT00666575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101719043|NCT00666575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719044|NCT00666575|Antimanic Agents|antimanic agents|mesh-ancestor
101719045|NCT00666653|Pramipexole|pramipexole|mesh-list
101719046|NCT00666653|Antioxidants|antioxidants|mesh-ancestor
101719047|NCT00666653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719048|NCT00666653|Protective Agents|protective agents|mesh-ancestor
101719049|NCT00666653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719050|NCT00666653|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101719051|NCT00666653|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101719052|NCT00666653|Dopamine Agonists|dopamine agonists|mesh-ancestor
101719053|NCT00666653|Dopamine Agents|dopamine agents|mesh-ancestor
101719054|NCT00666653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101719055|NCT00707928|Nitroglycerin|nitroglycerin|mesh-list
101719056|NCT00707928|Vasodilator Agents|vasodilator agents|mesh-ancestor
101719057|NCT00666809|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101719058|NCT00666809|Vasodilator Agents|vasodilator agents|mesh-ancestor
101719059|NCT00666809|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101719060|NCT00666809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101719061|NCT00666809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101719062|NCT00666809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719063|NCT00666809|Urological Agents|urological agents|mesh-ancestor
101719064|NCT00666887|Minocycline|minocycline|mesh-list
101719065|NCT00666887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101719066|NCT00666887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101719067|NCT00667043|Fentanyl|fentanyl|mesh-list
101719068|NCT00667043|Midazolam|midazolam|mesh-list
101719069|NCT00667043|Remifentanil|remifentanil|mesh-list
101719070|NCT00667043|Propofol|propofol|mesh-list
101719071|NCT00667043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101719072|NCT00667043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101719073|NCT00667043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719074|NCT00667043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101719075|NCT00667043|Anesthetics, General|anesthetics, general|mesh-ancestor
101719076|NCT00667043|Anesthetics|anesthetics|mesh-ancestor
101803397|NCT00736541|Respiratory System Agents|respiratory system agents|mesh-ancestor
101719077|NCT00667043|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101719078|NCT00667043|Narcotics|narcotics|mesh-ancestor
101719079|NCT00667043|Analgesics|analgesics|mesh-ancestor
101719080|NCT00667043|Sensory System Agents|sensory system agents|mesh-ancestor
101719081|NCT00667043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101719082|NCT00667043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101719083|NCT00667043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101719084|NCT00667043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101719085|NCT00667043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101719086|NCT00667043|GABA Modulators|gaba modulators|mesh-ancestor
101719087|NCT00667043|GABA Agents|gaba agents|mesh-ancestor
101719088|NCT00667043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101719089|NCT00667043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719090|NCT02631473|Ritonavir|ritonavir|mesh-list
101719091|NCT02631473|Lopinavir|lopinavir|mesh-list
101719092|NCT02631473|Efavirenz|efavirenz|mesh-list
101719093|NCT02631473|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101719094|NCT02631473|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101719095|NCT02631473|Protease Inhibitors|protease inhibitors|mesh-ancestor
101719096|NCT02631473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101719097|NCT02631473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719098|NCT02631473|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101719099|NCT02631473|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101719100|NCT02631473|Antiviral Agents|antiviral agents|mesh-ancestor
101719101|NCT02631473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101719102|NCT02631473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101719103|NCT02631473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101719104|NCT02631473|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101376541|NCT00239512|Ibuprofen|ibuprofen|mesh-list
101719105|NCT02631473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101719106|NCT02631473|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101719107|NCT02631473|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101719108|NCT02631473|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101719109|NCT02631473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101719110|NCT02631473|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101719112|NCT00825162|Immunologic Factors|immunologic factors|mesh-ancestor
101719113|NCT00825162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719114|NCT00662441|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101719115|NCT00662441|Vasodilator Agents|vasodilator agents|mesh-ancestor
101719116|NCT00662441|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101719117|NCT00662441|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101719118|NCT00662441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101719119|NCT00662441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719120|NCT00662441|Urological Agents|urological agents|mesh-ancestor
101719121|NCT00911573|Vancomycin|vancomycin|mesh-list
101719122|NCT00911573|Clindamycin|clindamycin|mesh-list
101719123|NCT00911573|Clindamycin palmitate|clindamycin palmitate|mesh-list
101719124|NCT00911573|Clindamycin phosphate|clindamycin phosphate|mesh-list
101719125|NCT00911573|Tigecycline|tigecycline|mesh-list
101719127|NCT00911573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101719128|NCT00911573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101719129|NCT00911573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101719130|NCT00911573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719131|NCT00667433|Tenofovir|tenofovir|mesh-list
101719132|NCT00667433|Emtricitabine|emtricitabine|mesh-list
101719133|NCT00667433|Raltegravir Potassium|raltegravir potassium|mesh-list
101719134|NCT00667433|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101719135|NCT00667433|Antiviral Agents|antiviral agents|mesh-ancestor
101719136|NCT00667433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101719137|NCT00667433|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101803425|NCT01080469|Tacrolimus|tacrolimus|mesh-list
101719138|NCT00667433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101719139|NCT00667433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101719140|NCT00667433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719142|NCT00667433|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101719143|NCT00667433|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101719144|NCT00667433|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101719145|NCT00662519|Lenograstim|lenograstim|mesh-list
101719146|NCT00662519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101719147|NCT00662519|Immunologic Factors|immunologic factors|mesh-ancestor
101719148|NCT00662519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719150|NCT00667901|Anticonvulsants|anticonvulsants|mesh-ancestor
101719151|NCT00667901|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101719152|NCT00667901|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101719153|NCT00667901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101719154|NCT00667901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719155|NCT00667901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719156|NCT00667901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101719157|NCT00667901|Protective Agents|protective agents|mesh-ancestor
101719158|NCT00667979|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101719159|NCT00667979|Vasodilator Agents|vasodilator agents|mesh-ancestor
101719160|NCT00667979|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101719161|NCT00667979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101719162|NCT00667979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101719163|NCT00667979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719164|NCT00667979|Urological Agents|urological agents|mesh-ancestor
101719165|NCT00668057|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101719166|NCT00668057|Vasodilator Agents|vasodilator agents|mesh-ancestor
101719167|NCT00668057|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101719168|NCT00668057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101719169|NCT00668057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101719170|NCT00668057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719171|NCT00668057|Urological Agents|urological agents|mesh-ancestor
101719172|NCT00668135|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101719173|NCT00668135|Vasodilator Agents|vasodilator agents|mesh-ancestor
101719174|NCT00668135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101719175|NCT00668135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101719176|NCT00668135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101451737|NCT00203099|Expectorants|expectorants|mesh-ancestor
101719177|NCT00668135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719178|NCT00668135|Urological Agents|urological agents|mesh-ancestor
101719179|NCT02630303|Coal Tar|coal tar|mesh-list
101719180|NCT02630303|Keratolytic Agents|keratolytic agents|mesh-ancestor
101719182|NCT04155983|Ropivacaine|ropivacaine|mesh-list
101719183|NCT04155983|Anesthetics, Local|anesthetics, local|mesh-ancestor
101719184|NCT04155983|Anesthetics|anesthetics|mesh-ancestor
101719185|NCT04155983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101719186|NCT04155983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719187|NCT04155983|Sensory System Agents|sensory system agents|mesh-ancestor
101719188|NCT04155983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101719189|NCT00668603|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101719190|NCT00668603|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101719191|NCT00668603|Estradiol|estradiol|mesh-list
101719192|NCT00668603|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101719193|NCT00668603|Estrogens|estrogens|mesh-ancestor
101803441|NCT00711191|Antibodies|antibodies|mesh-list
101803445|NCT00741221|Bevacizumab|bevacizumab|mesh-list
101719194|NCT00668603|Hormones|hormones|mesh-ancestor
101719195|NCT00668603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101719196|NCT00668603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719197|NCT00668603|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101719198|NCT00668603|Contraceptive Agents|contraceptive agents|mesh-ancestor
101719199|NCT00668603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101719200|NCT00668603|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101719201|NCT00662987|Amoxicillin|amoxicillin|mesh-list
101719202|NCT00662987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101719203|NCT00662987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101719204|NCT00668759|Amiodarone|amiodarone|mesh-list
101719205|NCT00668759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101719206|NCT00668759|Vasodilator Agents|vasodilator agents|mesh-ancestor
101719207|NCT00668759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101719208|NCT00668759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101719209|NCT00668759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719210|NCT00668759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101719211|NCT00668759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101719212|NCT00668759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101719213|NCT00668759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101719214|NCT00668759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101719215|NCT00668759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101719216|NCT00668759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101719217|NCT00668837|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101719218|NCT00668837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101719219|NCT00668837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101719220|NCT00668837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101719221|NCT00668837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719222|NCT00668837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101719223|NCT00668837|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101364077|NCT00135187|Antiemetics|antiemetics|mesh-ancestor
101719224|NCT00668837|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101719225|NCT00668837|Serotonin Agents|serotonin agents|mesh-ancestor
101191183|NCT00359814|Cyclosporine|cyclosporine|mesh-list
101719226|NCT00668837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101719227|NCT00668837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719228|NCT00668837|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101719229|NCT00668837|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101719230|NCT00668837|Dopamine Agents|dopamine agents|mesh-ancestor
101719232|NCT00663221|Calcium|calcium|mesh-list
101719233|NCT00663221|Vitamins|vitamins|mesh-ancestor
101719234|NCT00663221|Micronutrients|micronutrients|mesh-ancestor
101719235|NCT00663221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719236|NCT00663221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101719237|NCT00663221|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101719238|NCT00824850|Vaccines|vaccines|mesh-list
101719239|NCT00824850|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101719240|NCT00824850|Immunologic Factors|immunologic factors|mesh-ancestor
101719241|NCT00824850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719242|NCT00596687|Insulin|insulin|mesh-list
101719243|NCT00596687|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101719244|NCT00596687|Insulin Glargine|insulin glargine|mesh-list
101719245|NCT00596687|Insulin glulisine|insulin glulisine|mesh-list
101719246|NCT00596687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101719247|NCT00596687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719248|NCT02631239|Dexamethasone|dexamethasone|mesh-list
101719249|NCT02631239|Methotrexate|methotrexate|mesh-list
101719250|NCT02631239|Etoposide|etoposide|mesh-list
101719251|NCT02631239|Pegaspargase|pegaspargase|mesh-list
101719252|NCT02631239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101719253|NCT02631239|Antiemetics|antiemetics|mesh-ancestor
101719254|NCT02631239|Autonomic Agents|autonomic agents|mesh-ancestor
101719255|NCT02631239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101719256|NCT02631239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719259|NCT02631239|Hormones|hormones|mesh-ancestor
101719260|NCT02631239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101719261|NCT02631239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101719262|NCT02631239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101719263|NCT02631239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101719264|NCT02631239|Abortifacient Agents|abortifacient agents|mesh-ancestor
101719265|NCT02631239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101719266|NCT02631239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101719267|NCT02631239|Antimetabolites|antimetabolites|mesh-ancestor
101719268|NCT02631239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719269|NCT02631239|Dermatologic Agents|dermatologic agents|mesh-ancestor
101719270|NCT02631239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101719271|NCT02631239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101719273|NCT02631239|Immunologic Factors|immunologic factors|mesh-ancestor
101719274|NCT02631239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101719275|NCT02631239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101719276|NCT02631239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101719277|NCT02631239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101719278|NCT02631239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101719279|NCT00663377|Losartan|losartan|mesh-list
101719280|NCT00663377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101719281|NCT00663377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101719282|NCT00663377|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101719283|NCT00663377|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101719284|NCT00663377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719285|NCT00669149|Aspirin|aspirin|mesh-list
101719286|NCT00669149|Heparin|heparin|mesh-list
101719287|NCT00669149|Enoxaparin|enoxaparin|mesh-list
101719288|NCT00669149|Bivalirudin|bivalirudin|mesh-list
101719289|NCT00669149|Clopidogrel|clopidogrel|mesh-list
101719290|NCT00669149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101719291|NCT00669149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101719292|NCT00669149|Analgesics|analgesics|mesh-ancestor
101719293|NCT00669149|Sensory System Agents|sensory system agents|mesh-ancestor
101719294|NCT00669149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101719295|NCT00669149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719296|NCT00669149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101719297|NCT00669149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101719298|NCT00669149|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101719299|NCT00669149|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101719300|NCT00669149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719301|NCT00669149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101719302|NCT00669149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101719303|NCT00669149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101719304|NCT00669149|Antipyretics|antipyretics|mesh-ancestor
101719305|NCT00669149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101719306|NCT00669149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101719307|NCT00669149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101719308|NCT00669149|Purinergic Agents|purinergic agents|mesh-ancestor
101719309|NCT00669149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101719310|NCT00669149|Anticoagulants|anticoagulants|mesh-ancestor
101719311|NCT00669149|Antithrombins|antithrombins|mesh-ancestor
101719312|NCT00669149|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101719313|NCT00669149|Protease Inhibitors|protease inhibitors|mesh-ancestor
101719314|NCT00663455|Cyclosporine|cyclosporine|mesh-list
101719315|NCT00663455|Cyclosporins|cyclosporins|mesh-list
101191252|NCT00361452|Mydriatics|mydriatics|mesh-ancestor
101719316|NCT00663455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101719317|NCT00663455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719318|NCT00663455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101719319|NCT00663455|Immunologic Factors|immunologic factors|mesh-ancestor
101719320|NCT00663455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719321|NCT00663455|Antifungal Agents|antifungal agents|mesh-ancestor
101719322|NCT00663455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101719323|NCT00663455|Dermatologic Agents|dermatologic agents|mesh-ancestor
101719324|NCT00663455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101719325|NCT00663455|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101719327|NCT00669695|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101719328|NCT00669695|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101719329|NCT00669695|Antimetabolites|antimetabolites|mesh-ancestor
101719330|NCT00669695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719331|NCT00669695|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101719332|NCT00669695|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101719334|NCT00663689|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101719335|NCT00663689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101719336|NCT00663689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101719337|NCT00663689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101803601|NCT00930488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101719338|NCT00663689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719340|NCT00669773|Doxorubicin|doxorubicin|mesh-list
101719341|NCT00669773|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101719342|NCT00669773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101719343|NCT00669773|Tubulin Modulators|tubulin modulators|mesh-ancestor
101719344|NCT00669773|Antimitotic Agents|antimitotic agents|mesh-ancestor
101719345|NCT00669773|Mitosis Modulators|mitosis modulators|mesh-ancestor
101719346|NCT00669773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719347|NCT00669773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101719348|NCT00669773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101719349|NCT00669773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101719350|NCT00669773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101719351|NCT00824616|Insulin|insulin|mesh-list
101719352|NCT00824616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101719353|NCT00824616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719354|NCT00663845|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101719355|NCT00663845|Vasodilator Agents|vasodilator agents|mesh-ancestor
101719356|NCT00663845|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101719357|NCT00663845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101719358|NCT00663845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101719359|NCT00663845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719360|NCT00663845|Urological Agents|urological agents|mesh-ancestor
101719361|NCT00708240|Escitalopram|escitalopram|mesh-list
101719362|NCT00708240|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101719363|NCT00708240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101719364|NCT00708240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101719365|NCT00708240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719366|NCT00708240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101719367|NCT00708240|Serotonin Agents|serotonin agents|mesh-ancestor
101719368|NCT00708240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719369|NCT04155515|Ribavirin|ribavirin|mesh-list
101719370|NCT04155515|Yimitasvir|yimitasvir|mesh-list
101719371|NCT04155515|Antimetabolites|antimetabolites|mesh-ancestor
101719372|NCT04155515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719373|NCT04155515|Antiviral Agents|antiviral agents|mesh-ancestor
101719374|NCT04155515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101719375|NCT00664001|Antioxidants|antioxidants|mesh-list
101719376|NCT00664001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719377|NCT00664001|Protective Agents|protective agents|mesh-ancestor
101719378|NCT00664001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719379|NCT00824382|Olodaterol|olodaterol|mesh-list
101719380|NCT00824382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101719381|NCT00824382|Autonomic Agents|autonomic agents|mesh-ancestor
101719382|NCT00824382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101719383|NCT00824382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719384|NCT00824382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101719385|NCT00824382|Respiratory System Agents|respiratory system agents|mesh-ancestor
101719386|NCT00670319|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101719387|NCT00670319|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101719388|NCT00670319|Hormone Antagonists|hormone antagonists|mesh-ancestor
101719389|NCT00670319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101719390|NCT00670319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719391|NCT00670319|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101719392|NCT00670319|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101719393|NCT00670319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101719394|NCT00708318|Fentanyl|fentanyl|mesh-list
101719395|NCT00708318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101719396|NCT00708318|Narcotics|narcotics|mesh-ancestor
101719397|NCT00708318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101719398|NCT00708318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719399|NCT00708318|Analgesics|analgesics|mesh-ancestor
101719400|NCT00708318|Sensory System Agents|sensory system agents|mesh-ancestor
101719401|NCT00708318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101719402|NCT00708318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101803618|NCT00736931|Antiemetics|antiemetics|mesh-ancestor
101719403|NCT00708318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101719404|NCT00708318|Anesthetics, General|anesthetics, general|mesh-ancestor
101719405|NCT00708318|Anesthetics|anesthetics|mesh-ancestor
101719406|NCT00670475|Piroxicam|piroxicam|mesh-list
101719407|NCT00670475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101719408|NCT00670475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101719409|NCT00670475|Analgesics|analgesics|mesh-ancestor
101719410|NCT00670475|Sensory System Agents|sensory system agents|mesh-ancestor
101719411|NCT00670475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101719412|NCT00670475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719413|NCT00670475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101719414|NCT00670475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101719415|NCT00670475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101719416|NCT00670475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101719417|NCT00670475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719418|NCT04154033|Naltrexone|naltrexone|mesh-list
101719419|NCT04154033|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101719420|NCT04154033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101719421|NCT04154033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719422|NCT04154033|Sensory System Agents|sensory system agents|mesh-ancestor
101719423|NCT04154033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101719424|NCT05530356|Dextrans|dextrans|mesh-list
101719425|NCT05530356|Anticoagulants|anticoagulants|mesh-ancestor
101719426|NCT05530356|Plasma Substitutes|plasma substitutes|mesh-ancestor
101719427|NCT05530356|Blood Substitutes|blood substitutes|mesh-ancestor
101719428|NCT00664313|Linezolid|linezolid|mesh-list
101719429|NCT00664313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101719430|NCT00664313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101719431|NCT00664313|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101719432|NCT00664313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101719433|NCT00664313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719434|NCT00670553|Panobinostat|panobinostat|mesh-list
101719435|NCT00670553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101719436|NCT00670553|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101719437|NCT00670553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101719438|NCT00670553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719439|NCT00833040|Sufentanil|sufentanil|mesh-list
101719440|NCT00833040|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101719441|NCT00833040|Narcotics|narcotics|mesh-ancestor
101719442|NCT00833040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101719443|NCT00833040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719444|NCT00833040|Analgesics|analgesics|mesh-ancestor
101719445|NCT00833040|Sensory System Agents|sensory system agents|mesh-ancestor
101719446|NCT00833040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101719447|NCT00833040|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101719448|NCT00833040|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101719449|NCT00833040|Anesthetics, General|anesthetics, general|mesh-ancestor
101719450|NCT00833040|Anesthetics|anesthetics|mesh-ancestor
101719451|NCT02629835|Dexamethasone|dexamethasone|mesh-list
101191339|NCT00363792|Nitroglycerin|nitroglycerin|mesh-list
101719452|NCT02629835|Dexamethasone acetate|dexamethasone acetate|mesh-list
101803625|NCT00736931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101719453|NCT02629835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101719454|NCT02629835|BB 1101|bb 1101|mesh-list
101719455|NCT02629835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101719456|NCT02629835|Antiemetics|antiemetics|mesh-ancestor
101719457|NCT02629835|Autonomic Agents|autonomic agents|mesh-ancestor
101719458|NCT02629835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101719459|NCT02629835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719460|NCT02629835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101719461|NCT02629835|Glucocorticoids|glucocorticoids|mesh-ancestor
101719462|NCT02629835|Hormones|hormones|mesh-ancestor
101719463|NCT02629835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101719464|NCT02629835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101719465|NCT02629835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101719466|NCT02629835|Protease Inhibitors|protease inhibitors|mesh-ancestor
101719467|NCT02629835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101719468|NCT02629835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719469|NCT00664469|Atorvastatin|atorvastatin|mesh-list
101719470|NCT00664469|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101719471|NCT00664469|Simvastatin|simvastatin|mesh-list
101719472|NCT00664469|Ezetimibe|ezetimibe|mesh-list
101719473|NCT00664469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101719474|NCT00664469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101719475|NCT00664469|Antimetabolites|antimetabolites|mesh-ancestor
101719476|NCT00664469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719477|NCT00664469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101376900|NCT00098982|Leucovorin|leucovorin|mesh-list
101719478|NCT00664469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101719479|NCT00664469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101719480|NCT00843024|Naproxen|naproxen|mesh-list
101719481|NCT00843024|Sumatriptan|sumatriptan|mesh-list
101719482|NCT00843024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101719483|NCT00843024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101719484|NCT00843024|Analgesics|analgesics|mesh-ancestor
101719485|NCT00843024|Sensory System Agents|sensory system agents|mesh-ancestor
101719486|NCT00843024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101719487|NCT00843024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719488|NCT00843024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101719489|NCT00843024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101719490|NCT00843024|Gout Suppressants|gout suppressants|mesh-ancestor
101719491|NCT00843024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101719492|NCT00843024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101719493|NCT00843024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719494|NCT00843024|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101719495|NCT00843024|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101719496|NCT00843024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101719497|NCT00843024|Serotonin Agents|serotonin agents|mesh-ancestor
101719498|NCT00843024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101719499|NCT04154813|Topiramate|topiramate|mesh-list
101719500|NCT04154813|Fluoxetine|fluoxetine|mesh-list
101719501|NCT04154813|Anticonvulsants|anticonvulsants|mesh-ancestor
101719502|NCT04154813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101719503|NCT04154813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719504|NCT04154813|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101719505|NCT04154813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101719506|NCT04154813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101719507|NCT04154813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719508|NCT04154813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101719509|NCT04154813|Serotonin Agents|serotonin agents|mesh-ancestor
101719510|NCT04154813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101719511|NCT04154813|Antidepressive Agents|antidepressive agents|mesh-ancestor
101719512|NCT04154813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101719513|NCT04154813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101719514|NCT04154813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101719515|NCT04154813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101719516|NCT00664703|Methylphenidate|methylphenidate|mesh-list
101719517|NCT00664703|Lobeline|lobeline|mesh-list
101719518|NCT00664703|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101719519|NCT00664703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719520|NCT00664703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101719521|NCT00664703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101719522|NCT00664703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101719523|NCT00664703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719524|NCT00664703|Dopamine Agents|dopamine agents|mesh-ancestor
101719525|NCT00664703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101719526|NCT00664703|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101719527|NCT00664703|Autonomic Agents|autonomic agents|mesh-ancestor
101719528|NCT00664703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101719529|NCT00664703|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101719530|NCT00664703|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101191404|NCT00365742|Simvastatin|simvastatin|mesh-list
101719531|NCT00664703|Cholinergic Agents|cholinergic agents|mesh-ancestor
101719532|NCT00664703|Respiratory System Agents|respiratory system agents|mesh-ancestor
101719533|NCT00670787|Losartan|losartan|mesh-list
101719534|NCT00670787|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101719535|NCT00670787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101719536|NCT00670787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101719537|NCT00670787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101719538|NCT00670787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101719539|NCT00670787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719540|NCT00670787|Diuretics|diuretics|mesh-ancestor
101719541|NCT00670787|Natriuretic Agents|natriuretic agents|mesh-ancestor
101719542|NCT00670787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719543|NCT00670787|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101719544|NCT00670787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101719545|NCT00664781|Rucaparib|rucaparib|mesh-list
101719546|NCT00664781|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101719547|NCT00664781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101719548|NCT00664781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376975|NCT00242164|Dialysis Solutions|dialysis solutions|mesh-list
101719549|NCT00664781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101719550|NCT00832650|Solifenacin Succinate|solifenacin succinate|mesh-list
101719552|NCT00832650|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101803682|NCT05661461|Temsirolimus|temsirolimus|mesh-list
101719553|NCT00832650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101719554|NCT00832650|Cholinergic Agents|cholinergic agents|mesh-ancestor
101719555|NCT00832650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101719556|NCT00832650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719557|NCT00832650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719558|NCT00832650|Urological Agents|urological agents|mesh-ancestor
101719559|NCT00708396|Escitalopram|escitalopram|mesh-list
101719560|NCT00708396|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101719561|NCT00708396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101719562|NCT00708396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101719563|NCT00708396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719564|NCT00708396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101719565|NCT00708396|Serotonin Agents|serotonin agents|mesh-ancestor
101719566|NCT00708396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719567|NCT00665093|Insulin|insulin|mesh-list
101719568|NCT00665093|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101719569|NCT00665093|Insulin Aspart|insulin aspart|mesh-list
101719570|NCT00665093|Insulin Detemir|insulin detemir|mesh-list
101719571|NCT00665093|Biphasic Insulins|biphasic insulins|mesh-list
101719572|NCT00665093|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101719573|NCT00665093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101719574|NCT00665093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719576|NCT00595517|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101719577|NCT00595517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101719578|NCT00595517|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101719579|NCT00595517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101719580|NCT00595517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719581|NCT00911651|Bromides|bromides|mesh-list
101719582|NCT00911651|Albuterol|albuterol|mesh-list
101719583|NCT00911651|Ipratropium|ipratropium|mesh-list
101719584|NCT00911651|Anticonvulsants|anticonvulsants|mesh-ancestor
101719585|NCT00911651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101719586|NCT00911651|Autonomic Agents|autonomic agents|mesh-ancestor
101191443|NCT00366834|Protease Inhibitors|protease inhibitors|mesh-ancestor
101719587|NCT00911651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101719588|NCT00911651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719589|NCT00911651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101719590|NCT00911651|Respiratory System Agents|respiratory system agents|mesh-ancestor
101719591|NCT00911651|Tocolytic Agents|tocolytic agents|mesh-ancestor
101719592|NCT00911651|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101719593|NCT00911651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101719594|NCT00911651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101719595|NCT00911651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101719596|NCT00911651|Adrenergic Agents|adrenergic agents|mesh-ancestor
101719597|NCT00911651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101719598|NCT00911651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719599|NCT00911651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101719600|NCT00911651|Cholinergic Agents|cholinergic agents|mesh-ancestor
101719601|NCT00665327|Moxifloxacin|moxifloxacin|mesh-list
101719602|NCT00665327|Levofloxacin|levofloxacin|mesh-list
101719603|NCT00665327|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101719604|NCT00665327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101719605|NCT00665327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101719606|NCT00665327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101719607|NCT00665327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101719608|NCT00665327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101719609|NCT00665327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719610|NCT00665327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101719611|NCT00665327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101719612|NCT00665327|Contraceptive Agents|contraceptive agents|mesh-ancestor
101719613|NCT00665327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101719614|NCT00665327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719615|NCT00665327|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101719616|NCT00665327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101719617|NCT00665327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101719618|NCT00665327|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101719619|NCT00665327|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101719620|NCT00665327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101719621|NCT00823836|Ropinirole|ropinirole|mesh-list
101719622|NCT00823836|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101719623|NCT00823836|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101719624|NCT00823836|Dopamine Agonists|dopamine agonists|mesh-ancestor
101719625|NCT00823836|Dopamine Agents|dopamine agents|mesh-ancestor
101719626|NCT00823836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101719627|NCT00823836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719628|NCT00823836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719629|NCT04154735|Rifaximin|rifaximin|mesh-list
101719630|NCT04154735|Cyclophosphamide|cyclophosphamide|mesh-list
101719631|NCT04154735|Fludarabine|fludarabine|mesh-list
101719632|NCT04154735|Alemtuzumab|alemtuzumab|mesh-list
101719633|NCT04154735|Tacrolimus|tacrolimus|mesh-list
101719634|NCT04154735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101719635|NCT04154735|Immunologic Factors|immunologic factors|mesh-ancestor
101719636|NCT04154735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719637|NCT04154735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101719638|NCT04154735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101719639|NCT04154735|Alkylating Agents|alkylating agents|mesh-ancestor
101719640|NCT04154735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719641|NCT04154735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101719642|NCT04154735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101719643|NCT04154735|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101719644|NCT04154735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101719645|NCT04154735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101719646|NCT04154735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101262920|NCT01759706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101719647|NCT04154735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101719648|NCT04154735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101719649|NCT00705042|Etanercept|etanercept|mesh-list
101719650|NCT00705042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101719651|NCT00705042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101719652|NCT00705042|Analgesics|analgesics|mesh-ancestor
101719653|NCT00705042|Sensory System Agents|sensory system agents|mesh-ancestor
101719654|NCT00705042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101719655|NCT00705042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719656|NCT00705042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101719657|NCT00705042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101719658|NCT00705042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101719659|NCT00705042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101719660|NCT00705042|Immunologic Factors|immunologic factors|mesh-ancestor
101719661|NCT00879437|Bevacizumab|bevacizumab|mesh-list
101719662|NCT00879437|Valproic Acid|valproic acid|mesh-list
101719663|NCT00879437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101719664|NCT00879437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101719666|NCT00879437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101719667|NCT00879437|Growth Substances|growth substances|mesh-ancestor
101719668|NCT00879437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719669|NCT00879437|Growth Inhibitors|growth inhibitors|mesh-ancestor
101719670|NCT00879437|Anticonvulsants|anticonvulsants|mesh-ancestor
101719671|NCT00879437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101719672|NCT00879437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719673|NCT00879437|GABA Agents|gaba agents|mesh-ancestor
101719674|NCT00879437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101719675|NCT00879437|Antimanic Agents|antimanic agents|mesh-ancestor
101719676|NCT00879437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101719677|NCT00879437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101719678|NCT00879437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101719679|NCT00665639|Caspofungin|caspofungin|mesh-list
101719680|NCT00665639|Micafungin|micafungin|mesh-list
101719681|NCT00665639|Antifungal Agents|antifungal agents|mesh-ancestor
101719682|NCT00665639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101719683|NCT00665639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101719684|NCT00665639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719685|NCT04153253|Aflibercept|aflibercept|mesh-list
101719686|NCT04153253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101719687|NCT04153253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101719688|NCT04153253|Growth Substances|growth substances|mesh-ancestor
101719689|NCT04153253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719690|NCT04153253|Growth Inhibitors|growth inhibitors|mesh-ancestor
101719691|NCT04153253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101719692|NCT00671645|Bevacizumab|bevacizumab|mesh-list
101719693|NCT00671645|Capecitabine|capecitabine|mesh-list
101719694|NCT00671645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101719695|NCT00671645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101719696|NCT00671645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101719697|NCT00671645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101719698|NCT00671645|Growth Substances|growth substances|mesh-ancestor
101719699|NCT00671645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719700|NCT00671645|Growth Inhibitors|growth inhibitors|mesh-ancestor
101719701|NCT00671645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101719702|NCT00671645|Antimetabolites|antimetabolites|mesh-ancestor
101719703|NCT00671645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719704|NCT02629523|Afatinib|afatinib|mesh-list
101719705|NCT02629523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101719706|NCT02629523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101719707|NCT02629523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101719708|NCT02629523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719709|NCT00671801|Irinotecan|irinotecan|mesh-list
101719710|NCT00671801|Lenalidomide|lenalidomide|mesh-list
101719711|NCT00671801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101719712|NCT00671801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101719713|NCT00671801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101719714|NCT00671801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719715|NCT00671801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101719716|NCT00671801|Immunologic Factors|immunologic factors|mesh-ancestor
101719717|NCT00671801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719718|NCT00671801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101719719|NCT00671801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101719720|NCT00671801|Growth Substances|growth substances|mesh-ancestor
101719721|NCT00671801|Growth Inhibitors|growth inhibitors|mesh-ancestor
101719723|NCT00676559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101719724|NCT00676559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101719725|NCT00676559|Growth Substances|growth substances|mesh-ancestor
101719726|NCT00676559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719727|NCT00676559|Growth Inhibitors|growth inhibitors|mesh-ancestor
101719728|NCT00676559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101719729|NCT00672113|Nifedipine|nifedipine|mesh-list
101719730|NCT00672113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101719731|NCT00672113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101803790|NCT00566852|Dopamine Agents|dopamine agents|mesh-ancestor
101719732|NCT00672113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719733|NCT00672113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101719734|NCT00672113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719735|NCT00672113|Vasodilator Agents|vasodilator agents|mesh-ancestor
101719736|NCT00672113|Tocolytic Agents|tocolytic agents|mesh-ancestor
101719737|NCT00672113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101719739|NCT00676637|Travoprost|travoprost|mesh-list
101719740|NCT00676637|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101719741|NCT00676637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101719742|NCT00676637|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101719743|NCT00676637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101719744|NCT00676637|Adrenergic Agents|adrenergic agents|mesh-ancestor
101719745|NCT00676637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101719746|NCT00676637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719747|NCT00676637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719749|NCT00676637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101719750|NCT00672347|Clonidine|clonidine|mesh-list
101719751|NCT00672347|Morphine|morphine|mesh-list
101719752|NCT00672347|Bupivacaine|bupivacaine|mesh-list
101719753|NCT00672347|Anesthetics, Local|anesthetics, local|mesh-ancestor
101719754|NCT00672347|Anesthetics|anesthetics|mesh-ancestor
101719755|NCT00672347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101719756|NCT00672347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719757|NCT00672347|Sensory System Agents|sensory system agents|mesh-ancestor
101719758|NCT00672347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101719759|NCT00672347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101719760|NCT00672347|Narcotics|narcotics|mesh-ancestor
101719761|NCT00672347|Analgesics|analgesics|mesh-ancestor
101719762|NCT00672347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101719763|NCT00672347|Sympatholytics|sympatholytics|mesh-ancestor
101719764|NCT00672347|Autonomic Agents|autonomic agents|mesh-ancestor
101719765|NCT00672347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101719766|NCT00672347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101719767|NCT00672347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101719768|NCT00672347|Adrenergic Agents|adrenergic agents|mesh-ancestor
101719769|NCT00672347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101719770|NCT00672347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719771|NCT00676871|Blinatumomab|blinatumomab|mesh-list
101377203|NCT00244153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101719773|NCT00677027|Lentinan|lentinan|mesh-list
101719774|NCT00677027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101719775|NCT00677027|Immunologic Factors|immunologic factors|mesh-ancestor
101719776|NCT00677027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719777|NCT00677027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101719778|NCT00595127|Cyclophosphamide|cyclophosphamide|mesh-list
101719779|NCT00595127|Fludarabine|fludarabine|mesh-list
101719780|NCT00595127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101719781|NCT00595127|Immunologic Factors|immunologic factors|mesh-ancestor
101719782|NCT00595127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719783|NCT00595127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101719784|NCT00595127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101719785|NCT00595127|Alkylating Agents|alkylating agents|mesh-ancestor
101719786|NCT00595127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719787|NCT00595127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101719788|NCT00595127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101719789|NCT00672659|Dexetimide|dexetimide|mesh-list
101719790|NCT00672659|Pipamperone|pipamperone|mesh-list
101719791|NCT00672659|Citalopram|citalopram|mesh-list
101719792|NCT00672659|Escitalopram|escitalopram|mesh-list
101719793|NCT00672659|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101719794|NCT00672659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101719795|NCT00672659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101719796|NCT00672659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803814|NCT00442546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101719798|NCT00672659|Serotonin Agents|serotonin agents|mesh-ancestor
101719799|NCT00672659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719800|NCT00672659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101719801|NCT00672659|Antidepressive Agents|antidepressive agents|mesh-ancestor
101719802|NCT00672659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101719803|NCT00672659|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101719804|NCT00672659|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101719805|NCT00672659|Parasympatholytics|parasympatholytics|mesh-ancestor
101719806|NCT00672659|Autonomic Agents|autonomic agents|mesh-ancestor
101719807|NCT00672659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101719808|NCT00672659|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101719809|NCT00672659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101719810|NCT00672659|Cholinergic Agents|cholinergic agents|mesh-ancestor
101719811|NCT00672659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101719812|NCT00672659|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101719813|NCT00672659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101719814|NCT00672659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101719815|NCT00877487|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101719816|NCT00877487|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101719817|NCT00877487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719818|NCT00877487|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101719819|NCT00877487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101719820|NCT00877487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101719821|NCT00877487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719822|NCT00877487|Dopamine Agents|dopamine agents|mesh-ancestor
101719823|NCT00877487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101719824|NCT00677261|Anesthetics|anesthetics|mesh-list
101719825|NCT00677261|Anesthetics, Local|anesthetics, local|mesh-list
101719826|NCT00677261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101719827|NCT00677261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719828|NCT00677261|Sensory System Agents|sensory system agents|mesh-ancestor
101719829|NCT00677261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101719830|NCT00912119|Aminocaproic Acid|aminocaproic acid|mesh-list
101719831|NCT00912119|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101719832|NCT00912119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101719833|NCT00912119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719834|NCT00912119|Hemostatics|hemostatics|mesh-ancestor
101719835|NCT00912119|Coagulants|coagulants|mesh-ancestor
101719836|NCT00677339|Vitamin D|vitamin d|mesh-list
101719837|NCT00677339|Ergocalciferols|ergocalciferols|mesh-list
101719838|NCT00677339|Cholecalciferol|cholecalciferol|mesh-list
101719839|NCT00677339|Vitamins|vitamins|mesh-list
101719840|NCT00677339|Micronutrients|micronutrients|mesh-ancestor
101719841|NCT00677339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719842|NCT00677339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101719843|NCT00677339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101719844|NCT00672971|Permethrin|permethrin|mesh-list
101719845|NCT00672971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101719846|NCT00672971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719847|NCT00673205|Bicalutamide|bicalutamide|mesh-list
101719848|NCT00673205|Androgen Antagonists|androgen antagonists|mesh-ancestor
101719849|NCT00673205|Hormone Antagonists|hormone antagonists|mesh-ancestor
101719850|NCT00673205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101719851|NCT00673205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719852|NCT00673205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101803824|NCT00566696|Mycophenolic Acid|mycophenolic acid|mesh-list
101719853|NCT00677729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101719854|NCT00677729|Albuterol|albuterol|mesh-list
101719855|NCT00677729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101719856|NCT00677729|Autonomic Agents|autonomic agents|mesh-ancestor
101719857|NCT00677729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101719858|NCT00677729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719859|NCT00677729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101191632|NCT00370734|Botulinum Toxins|botulinum toxins|mesh-list
101719860|NCT00677729|Respiratory System Agents|respiratory system agents|mesh-ancestor
101719862|NCT00677729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101719863|NCT00677729|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101719864|NCT00677729|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101719865|NCT00677729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101719866|NCT00677729|Adrenergic Agents|adrenergic agents|mesh-ancestor
101719867|NCT00677729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101719868|NCT00677729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719869|NCT02628197|Vitamin D|vitamin d|mesh-list
101719871|NCT02628197|Vitamins|vitamins|mesh-ancestor
101719872|NCT02628197|Micronutrients|micronutrients|mesh-ancestor
101719873|NCT02628197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719874|NCT02628197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101719875|NCT02628197|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101719876|NCT00673829|Interleukin-2|interleukin-2|mesh-list
101719877|NCT00673829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101719878|NCT00673829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101719879|NCT00673829|Analgesics|analgesics|mesh-ancestor
101719880|NCT00673829|Sensory System Agents|sensory system agents|mesh-ancestor
101719881|NCT00673829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101719882|NCT00673829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719883|NCT04152629|Methylphenidate|methylphenidate|mesh-list
101719884|NCT04152629|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101719885|NCT04152629|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101719886|NCT04152629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719887|NCT04152629|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101719888|NCT04152629|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101719889|NCT04152629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101719890|NCT04152629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719891|NCT04152629|Dopamine Agents|dopamine agents|mesh-ancestor
101719892|NCT04152629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101719893|NCT02535299|Metformin|metformin|mesh-list
101719894|NCT02535299|Liraglutide|liraglutide|mesh-list
101719895|NCT02535299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101719896|NCT02535299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719897|NCT02535299|Incretins|incretins|mesh-ancestor
101719898|NCT02535299|Hormones|hormones|mesh-ancestor
101719899|NCT02535299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101719900|NCT00674063|Alefacept|alefacept|mesh-list
101719901|NCT00674063|Dermatologic Agents|dermatologic agents|mesh-ancestor
101719902|NCT00674063|Immunologic Factors|immunologic factors|mesh-ancestor
101719903|NCT00674063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719904|NCT04151459|Metformin|metformin|mesh-list
101719905|NCT04151459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101719906|NCT04151459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803845|NCT00566696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101719908|NCT00674141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101719909|NCT00674141|Antiemetics|antiemetics|mesh-ancestor
101719910|NCT00674141|Autonomic Agents|autonomic agents|mesh-ancestor
101719911|NCT00674141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101719912|NCT00674141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719913|NCT00674141|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101719914|NCT00674141|Glucocorticoids|glucocorticoids|mesh-ancestor
101719915|NCT00674141|Hormones|hormones|mesh-ancestor
101719916|NCT00674141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101719917|NCT00674141|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101719918|NCT00674141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101719919|NCT00678275|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101719920|NCT00678275|Immunologic Factors|immunologic factors|mesh-ancestor
101719921|NCT00678275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719922|NCT00678275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101719923|NCT02627807|Cisplatin|cisplatin|mesh-list
101719924|NCT02627807|Gemcitabine|gemcitabine|mesh-list
101719925|NCT02627807|Docetaxel|docetaxel|mesh-list
101719926|NCT02627807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101719927|NCT02627807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101719928|NCT02627807|Antimetabolites|antimetabolites|mesh-ancestor
101719929|NCT02627807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719930|NCT02627807|Tubulin Modulators|tubulin modulators|mesh-ancestor
101719931|NCT02627807|Antimitotic Agents|antimitotic agents|mesh-ancestor
101719932|NCT02627807|Mitosis Modulators|mitosis modulators|mesh-ancestor
101719933|NCT00678431|Resveratrol|resveratrol|mesh-list
101719934|NCT00678431|Antioxidants|antioxidants|mesh-ancestor
101719935|NCT00678431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719936|NCT00678431|Protective Agents|protective agents|mesh-ancestor
101719937|NCT00678431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719938|NCT00678431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101719939|NCT00678431|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101719940|NCT00678509|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101719941|NCT00678509|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101719942|NCT00678509|Immunologic Factors|immunologic factors|mesh-ancestor
101719943|NCT00678509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719944|NCT00674687|Gabapentin|gabapentin|mesh-list
101719945|NCT00674687|Analgesics|analgesics|mesh-ancestor
101719947|NCT00674687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101719948|NCT00674687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719949|NCT00674687|Anticonvulsants|anticonvulsants|mesh-ancestor
101191700|NCT00372294|Hormones|hormones|mesh-ancestor
101719950|NCT00674687|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101719951|NCT00674687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101719952|NCT00674687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101719953|NCT00674687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101719954|NCT00674687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101719955|NCT00674687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101719956|NCT00674687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101719957|NCT00674687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719958|NCT00674687|Antimanic Agents|antimanic agents|mesh-ancestor
101719959|NCT00656747|Amoxicillin|amoxicillin|mesh-list
101719960|NCT00656747|Moxifloxacin|moxifloxacin|mesh-list
101719961|NCT00656747|Clavulanic Acids|clavulanic acids|mesh-list
101719962|NCT00656747|Clavulanic Acid|clavulanic acid|mesh-list
101719963|NCT00656747|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101719964|NCT00656747|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101719965|NCT00656747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101719966|NCT00656747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101719967|NCT00656747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101719968|NCT00656747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101719969|NCT00656747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101719970|NCT00656747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719971|NCT00656747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101719972|NCT00656747|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101719973|NCT00656747|Contraceptive Agents|contraceptive agents|mesh-ancestor
101719974|NCT00656747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101719975|NCT00656747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719976|NCT00656747|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101719977|NCT00656747|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101719978|NCT00656747|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101719979|NCT00656747|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101719980|NCT00678743|Simvastatin|simvastatin|mesh-list
101719981|NCT00678743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101719982|NCT00678743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101719983|NCT00678743|Antimetabolites|antimetabolites|mesh-ancestor
101719984|NCT00678743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101719985|NCT00678743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101719986|NCT00678743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101719987|NCT00678743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101719988|NCT04152317|Misoprostol|misoprostol|mesh-list
101719989|NCT04152317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101719990|NCT04152317|Abortifacient Agents|abortifacient agents|mesh-ancestor
101719991|NCT04152317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101719992|NCT04152317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101719993|NCT04152317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101719994|NCT04152317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101719995|NCT04152317|Oxytocics|oxytocics|mesh-ancestor
101719996|NCT02628665|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
101719997|NCT02628665|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
101719998|NCT02628665|Trioxsalen|trioxsalen|mesh-list
101719999|NCT02628665|Photosensitizing Agents|photosensitizing agents|mesh-list
101191713|NCT00372294|Coccidiostats|coccidiostats|mesh-ancestor
101720000|NCT02628665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101720001|NCT02628665|Dermatologic Agents|dermatologic agents|mesh-ancestor
101720003|NCT00678977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101720004|NCT00678977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101720005|NCT00678977|Antimetabolites|antimetabolites|mesh-ancestor
101720006|NCT00678977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720007|NCT00674921|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101803910|NCT00938132|Warfarin|warfarin|mesh-list
101720008|NCT00674921|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101720009|NCT00674921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101720010|NCT00674921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101720011|NCT00674921|Antimalarials|antimalarials|mesh-ancestor
101720012|NCT00674921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101720013|NCT00674921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101720014|NCT00674999|Bacitracin|bacitracin|mesh-list
101720015|NCT00674999|Nystatin|nystatin|mesh-list
101720016|NCT00674999|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101720017|NCT00674999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101720018|NCT00674999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101720019|NCT00674999|Antifungal Agents|antifungal agents|mesh-ancestor
101720021|NCT00674999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101720022|NCT00674999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720023|NCT00882713|Epoetin Alfa|epoetin alfa|mesh-list
101720024|NCT00882713|Hematinics|hematinics|mesh-ancestor
101720025|NCT04151381|Aminophylline|aminophylline|mesh-list
101720026|NCT04151381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101720027|NCT04151381|Autonomic Agents|autonomic agents|mesh-ancestor
101720028|NCT04151381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101720029|NCT04151381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720030|NCT04151381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101720031|NCT04151381|Respiratory System Agents|respiratory system agents|mesh-ancestor
101720032|NCT04151381|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101720033|NCT04151381|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101720034|NCT04151381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101720035|NCT04151381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720036|NCT04151381|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101720037|NCT04151381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101720038|NCT04151381|Purinergic Agents|purinergic agents|mesh-ancestor
101720039|NCT04151381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101720040|NCT04151381|Protective Agents|protective agents|mesh-ancestor
101720041|NCT00809133|Paclitaxel|paclitaxel|mesh-list
101720042|NCT00809133|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101720043|NCT00809133|Bevacizumab|bevacizumab|mesh-list
101720044|NCT00809133|Carboplatin|carboplatin|mesh-list
101720045|NCT00809133|Afatinib|afatinib|mesh-list
101720046|NCT00809133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101720047|NCT00809133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101720048|NCT00809133|Tubulin Modulators|tubulin modulators|mesh-ancestor
101720049|NCT00809133|Antimitotic Agents|antimitotic agents|mesh-ancestor
101720050|NCT00809133|Mitosis Modulators|mitosis modulators|mesh-ancestor
101720051|NCT00809133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720052|NCT00809133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101720053|NCT00809133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101720054|NCT00809133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101720055|NCT00809133|Growth Substances|growth substances|mesh-ancestor
101720056|NCT00809133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720057|NCT00809133|Growth Inhibitors|growth inhibitors|mesh-ancestor
101720058|NCT00809133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101720059|NCT00809133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101720060|NCT00912275|Vinorelbine|vinorelbine|mesh-list
101720061|NCT00912275|Lapatinib|lapatinib|mesh-list
101720062|NCT00912275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101720063|NCT00912275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101720064|NCT00912275|Tubulin Modulators|tubulin modulators|mesh-ancestor
101720065|NCT00912275|Antimitotic Agents|antimitotic agents|mesh-ancestor
101720066|NCT00912275|Mitosis Modulators|mitosis modulators|mesh-ancestor
101720067|NCT00912275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720068|NCT00912275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101720069|NCT00912275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101720070|NCT00882557|Daptomycin|daptomycin|mesh-list
101720071|NCT00882557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101720072|NCT00882557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101720074|NCT02627573|Cyclophosphamide|cyclophosphamide|mesh-list
101720075|NCT02627573|Busulfan|busulfan|mesh-list
101720076|NCT02627573|Fludarabine|fludarabine|mesh-list
101720077|NCT02627573|Fludarabine phosphate|fludarabine phosphate|mesh-list
101720078|NCT02627573|Tacrolimus|tacrolimus|mesh-list
101720079|NCT02627573|Thymoglobulin|thymoglobulin|mesh-list
101720080|NCT02627573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101720081|NCT02627573|Immunologic Factors|immunologic factors|mesh-ancestor
101720082|NCT02627573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720083|NCT02627573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101720084|NCT02627573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101720085|NCT02627573|Alkylating Agents|alkylating agents|mesh-ancestor
101720086|NCT02627573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720087|NCT02627573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101720088|NCT02627573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101720089|NCT02627573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101720090|NCT02627573|Antimetabolites|antimetabolites|mesh-ancestor
101720091|NCT02627573|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101720092|NCT02627573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101720093|NCT02627573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101720094|NCT02627573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101262925|NCT01759719|Chromium|chromium|mesh-list
101720095|NCT02627573|Antitubercular Agents|antitubercular agents|mesh-ancestor
101720096|NCT02627573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101720097|NCT02627573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101720098|NCT00675545|Carboplatin|carboplatin|mesh-list
101720099|NCT00675545|Docetaxel|docetaxel|mesh-list
101720100|NCT00675545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101720101|NCT00675545|Tubulin Modulators|tubulin modulators|mesh-ancestor
101720102|NCT00675545|Antimitotic Agents|antimitotic agents|mesh-ancestor
101720103|NCT00675545|Mitosis Modulators|mitosis modulators|mesh-ancestor
101720104|NCT00675545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720105|NCT00679523|Tavaborole|tavaborole|mesh-list
101720106|NCT00679523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101720107|NCT00679523|Antifungal Agents|antifungal agents|mesh-ancestor
101720108|NCT00679523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101720109|NCT00675701|Moxifloxacin|moxifloxacin|mesh-list
101720110|NCT00675701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101720111|NCT00675701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101720112|NCT00675701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101720113|NCT00675701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101720114|NCT00675701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101720115|NCT00675701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720116|NCT00675701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101720117|NCT00808899|Cyclophosphamide|cyclophosphamide|mesh-list
101720118|NCT00808899|Doxorubicin|doxorubicin|mesh-list
101720119|NCT00808899|Irinotecan|irinotecan|mesh-list
101720120|NCT00808899|Etoposide|etoposide|mesh-list
101720121|NCT00808899|Topotecan|topotecan|mesh-list
101720122|NCT00808899|Temsirolimus|temsirolimus|mesh-list
101720123|NCT00808899|Tretinoin|tretinoin|mesh-list
101720124|NCT00808899|Isotretinoin|isotretinoin|mesh-list
101720125|NCT00808899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101720126|NCT00808899|Immunologic Factors|immunologic factors|mesh-ancestor
101720127|NCT00808899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720128|NCT00808899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101720129|NCT00808899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101720130|NCT00808899|Alkylating Agents|alkylating agents|mesh-ancestor
101720131|NCT00808899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720132|NCT00808899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101720133|NCT00808899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101720134|NCT00808899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101720135|NCT00808899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101720136|NCT00808899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101720137|NCT00808899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101720138|NCT00808899|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101720139|NCT00808899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101720140|NCT00808899|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101720141|NCT00808899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101720142|NCT00808899|Keratolytic Agents|keratolytic agents|mesh-ancestor
101720143|NCT00808899|Dermatologic Agents|dermatologic agents|mesh-ancestor
101720144|NCT00808665|Dexmedetomidine|dexmedetomidine|mesh-list
101720145|NCT00808665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101720146|NCT00808665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101720147|NCT00808665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720148|NCT00808665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101720150|NCT00808665|Sensory System Agents|sensory system agents|mesh-ancestor
101720151|NCT00808665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101720152|NCT00808665|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101720153|NCT00808665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101720154|NCT00808665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101720155|NCT00808665|Adrenergic Agents|adrenergic agents|mesh-ancestor
101720156|NCT00808665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101720157|NCT00808665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720158|NCT00808509|Adalimumab|adalimumab|mesh-list
101720159|NCT00808509|Methotrexate|methotrexate|mesh-list
101720160|NCT00808509|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101720161|NCT00808509|Abortifacient Agents|abortifacient agents|mesh-ancestor
101720162|NCT00808509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101720163|NCT00808509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720164|NCT00808509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101720165|NCT00808509|Antimetabolites|antimetabolites|mesh-ancestor
101720166|NCT00808509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720167|NCT00808509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101720168|NCT00808509|Dermatologic Agents|dermatologic agents|mesh-ancestor
101720169|NCT00808509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101720170|NCT00808509|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101720171|NCT00808509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101720173|NCT00808509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101720174|NCT00808509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101720175|NCT00808509|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101720176|NCT00808509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101720177|NCT04444869|Cisplatin|cisplatin|mesh-list
101720178|NCT04444869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101720179|NCT04276857|Leucovorin|leucovorin|mesh-list
101720180|NCT04276857|Paclitaxel|paclitaxel|mesh-list
101720181|NCT04276857|Gemcitabine|gemcitabine|mesh-list
101720182|NCT04276857|Oxaliplatin|oxaliplatin|mesh-list
101720183|NCT04276857|Irinotecan|irinotecan|mesh-list
101720184|NCT04276857|Folfirinox|folfirinox|mesh-list
101720185|NCT04276857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101720186|NCT04276857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101720187|NCT04276857|Tubulin Modulators|tubulin modulators|mesh-ancestor
101720188|NCT04276857|Antimitotic Agents|antimitotic agents|mesh-ancestor
101720189|NCT04276857|Mitosis Modulators|mitosis modulators|mesh-ancestor
101720190|NCT04276857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720191|NCT04276857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101720192|NCT04276857|Antimetabolites|antimetabolites|mesh-ancestor
101720193|NCT04276857|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101720194|NCT04276857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101720195|NCT04276857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101720196|NCT04276857|Antidotes|antidotes|mesh-ancestor
101720197|NCT04276857|Protective Agents|protective agents|mesh-ancestor
101720198|NCT04276857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720199|NCT04276857|Vitamin B Complex|vitamin b complex|mesh-ancestor
101720200|NCT04276857|Vitamins|vitamins|mesh-ancestor
101720201|NCT04276857|Micronutrients|micronutrients|mesh-ancestor
101720202|NCT00807573|Paclitaxel|paclitaxel|mesh-list
101720203|NCT00807573|Bevacizumab|bevacizumab|mesh-list
101720204|NCT00807573|Pemetrexed|pemetrexed|mesh-list
101720205|NCT00807573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101720206|NCT00807573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101720207|NCT00807573|Tubulin Modulators|tubulin modulators|mesh-ancestor
101720208|NCT00807573|Antimitotic Agents|antimitotic agents|mesh-ancestor
101720209|NCT00807573|Mitosis Modulators|mitosis modulators|mesh-ancestor
101720210|NCT00807573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720211|NCT00807573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101720212|NCT00807573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101720213|NCT00807573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101720214|NCT00807573|Growth Substances|growth substances|mesh-ancestor
101720215|NCT00807573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720216|NCT00807573|Growth Inhibitors|growth inhibitors|mesh-ancestor
101720217|NCT00807573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101720218|NCT00807573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101720219|NCT00807573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101720220|NCT00842712|Cisplatin|cisplatin|mesh-list
101720221|NCT00842712|Gemcitabine|gemcitabine|mesh-list
101720222|NCT00842712|Cetuximab|cetuximab|mesh-list
101720223|NCT00842712|Vinorelbine|vinorelbine|mesh-list
101720224|NCT00842712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101720225|NCT00842712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101720226|NCT00842712|Antimetabolites|antimetabolites|mesh-ancestor
101720227|NCT00842712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720228|NCT00842712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101720229|NCT00842712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101720230|NCT00842712|Tubulin Modulators|tubulin modulators|mesh-ancestor
101720231|NCT00842712|Antimitotic Agents|antimitotic agents|mesh-ancestor
101720232|NCT00842712|Mitosis Modulators|mitosis modulators|mesh-ancestor
101720233|NCT00705120|Cyclosporine|cyclosporine|mesh-list
101720234|NCT00705120|Cyclophosphamide|cyclophosphamide|mesh-list
101720235|NCT00705120|Busulfan|busulfan|mesh-list
101191868|NCT00378144|Ephedrine|ephedrine|mesh-list
101720236|NCT00705120|Cyclosporins|cyclosporins|mesh-list
101720237|NCT00705120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101720238|NCT00705120|Immunologic Factors|immunologic factors|mesh-ancestor
101720239|NCT00705120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720240|NCT00705120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101720241|NCT00705120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101720242|NCT00705120|Alkylating Agents|alkylating agents|mesh-ancestor
101720243|NCT00705120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720244|NCT00705120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101720245|NCT00705120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101720246|NCT00705120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101720247|NCT00705120|Antifungal Agents|antifungal agents|mesh-ancestor
101720248|NCT00705120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101720250|NCT00705120|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101720251|NCT00842244|Capecitabine|capecitabine|mesh-list
101720252|NCT00842244|Axitinib|axitinib|mesh-list
101720253|NCT00842244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101720254|NCT00842244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101720255|NCT00842244|Antimetabolites|antimetabolites|mesh-ancestor
101720256|NCT00842244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720257|NCT00842244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101720258|NCT00842244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101720259|NCT00832416|Tramadol|tramadol|mesh-list
101720260|NCT00832416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101720261|NCT00832416|Narcotics|narcotics|mesh-ancestor
101720262|NCT00832416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101720263|NCT00832416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720264|NCT00832416|Analgesics|analgesics|mesh-ancestor
101720265|NCT00832416|Sensory System Agents|sensory system agents|mesh-ancestor
101720266|NCT00832416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101720267|NCT00705198|Temozolomide|temozolomide|mesh-list
101720268|NCT00705198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101720269|NCT00705198|Alkylating Agents|alkylating agents|mesh-ancestor
101720270|NCT00705198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720271|NCT00705198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101720272|NCT00702936|Telmisartan|telmisartan|mesh-list
101720274|NCT00702936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101720275|NCT00702936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101720276|NCT00702936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101720277|NCT00702936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720278|NCT00702936|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101720279|NCT00702936|Protease Inhibitors|protease inhibitors|mesh-ancestor
101720280|NCT00702936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101720281|NCT00683800|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101720282|NCT00683800|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101191905|NCT00378612|Sirolimus|sirolimus|mesh-list
101720283|NCT00683800|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101720284|NCT00683800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101720285|NCT00683800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720286|NCT00683800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101720287|NCT00683800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720288|NCT00683800|Antidepressive Agents|antidepressive agents|mesh-ancestor
101720289|NCT00683800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101720290|NCT00683644|Zinc|zinc|mesh-list
101720291|NCT00683644|Zinc Sulfate|zinc sulfate|mesh-list
101720292|NCT00683644|Trace Elements|trace elements|mesh-ancestor
101720293|NCT00683644|Micronutrients|micronutrients|mesh-ancestor
101720294|NCT00683644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720295|NCT00683644|Astringents|astringents|mesh-ancestor
101720296|NCT00683644|Dermatologic Agents|dermatologic agents|mesh-ancestor
101377729|NCT00247585|Ethanol|ethanol|mesh-list
101720297|NCT00753064|Prazosin|prazosin|mesh-list
101720298|NCT00753064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101720299|NCT00753064|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101720301|NCT00753064|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101720302|NCT00753064|Adrenergic Agents|adrenergic agents|mesh-ancestor
101720303|NCT00753064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101720304|NCT00753064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720305|NCT00753064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720306|NCT00751738|Azimilide|azimilide|mesh-list
101720307|NCT00751738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101720308|NCT00751738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101720309|NCT00751738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101720310|NCT00751738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720311|NCT00751738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101720312|NCT00751738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720313|NCT04060264|Eculizumab|eculizumab|mesh-list
101720314|NCT04060264|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101720315|NCT04060264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101720316|NCT04060264|Immunologic Factors|immunologic factors|mesh-ancestor
101720317|NCT04060264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720318|NCT00684814|Zolpidem|zolpidem|mesh-list
101720319|NCT00684814|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101191931|NCT00380406|Leuprolide|leuprolide|mesh-list
101720320|NCT00684814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101720321|NCT00684814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101803963|NCT01562990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803966|NCT01562990|Antimetabolites|antimetabolites|mesh-ancestor
101720322|NCT00684814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720323|NCT00684814|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101720324|NCT00684814|GABA Agonists|gaba agonists|mesh-ancestor
101720325|NCT00684814|GABA Agents|gaba agents|mesh-ancestor
101720326|NCT00684814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101720327|NCT00684814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720328|NCT00576472|Methylphenidate|methylphenidate|mesh-list
101720329|NCT00576472|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101720330|NCT00576472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720331|NCT00576472|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101720332|NCT00576472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101720333|NCT00576472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101720334|NCT00576472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720335|NCT00576472|Dopamine Agents|dopamine agents|mesh-ancestor
101720336|NCT00576472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101720337|NCT00823212|Aspirin|aspirin|mesh-list
101720338|NCT00823212|Ticlopidine|ticlopidine|mesh-list
101720339|NCT00823212|Clopidogrel|clopidogrel|mesh-list
101720340|NCT00823212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101720341|NCT00823212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101720342|NCT00823212|Analgesics|analgesics|mesh-ancestor
101720343|NCT00823212|Sensory System Agents|sensory system agents|mesh-ancestor
101720344|NCT00823212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101720345|NCT00823212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720346|NCT00823212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101720347|NCT00823212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101720348|NCT00823212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101720349|NCT00823212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101720350|NCT00823212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720351|NCT00823212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101720352|NCT00823212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101720353|NCT00823212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101720354|NCT00823212|Antipyretics|antipyretics|mesh-ancestor
101720355|NCT00823212|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101720356|NCT00823212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101720357|NCT00823212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101720358|NCT00823212|Purinergic Agents|purinergic agents|mesh-ancestor
101720359|NCT00823212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101720360|NCT00823212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101720361|NCT00823212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101720362|NCT02561494|Nefopam|nefopam|mesh-list
101720363|NCT02561494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101720364|NCT02561494|Analgesics|analgesics|mesh-ancestor
101720365|NCT02561494|Sensory System Agents|sensory system agents|mesh-ancestor
101720366|NCT02561494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101720367|NCT02561494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720368|NCT05958693|Lumefantrine|lumefantrine|mesh-list
101720369|NCT05958693|Artemether|artemether|mesh-list
101720370|NCT05958693|Primaquine|primaquine|mesh-list
101720371|NCT05958693|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101720372|NCT05958693|Antimalarials|antimalarials|mesh-ancestor
101720373|NCT05958693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101720374|NCT05958693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101720375|NCT05958693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101720376|NCT05958589|Levobupivacaine|levobupivacaine|mesh-list
101720377|NCT05958589|Anesthetics|anesthetics|mesh-ancestor
101720378|NCT05958589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101720379|NCT05958589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720380|NCT05958589|Anesthetics, Local|anesthetics, local|mesh-ancestor
101720381|NCT05958589|Sensory System Agents|sensory system agents|mesh-ancestor
101720382|NCT05958589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101720383|NCT05958342|Vasopressins|vasopressins|mesh-list
101720384|NCT05958342|Arginine Vasopressin|arginine vasopressin|mesh-list
101720385|NCT05958342|Calcium|calcium|mesh-list
101720386|NCT05958342|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101720387|NCT05958342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720388|NCT05958342|Hemostatics|hemostatics|mesh-ancestor
101720389|NCT05958342|Coagulants|coagulants|mesh-ancestor
101720390|NCT05958342|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101720391|NCT05958342|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101720392|NCT05958342|Natriuretic Agents|natriuretic agents|mesh-ancestor
101720393|NCT05958303|Antioxidants|antioxidants|mesh-list
101720394|NCT05958303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720395|NCT05958303|Protective Agents|protective agents|mesh-ancestor
101720396|NCT05958303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720397|NCT05958277|Vitamins|vitamins|mesh-list
101720398|NCT05958277|Vitamin B 12|vitamin b 12|mesh-list
101720399|NCT05958277|Niacinamide|niacinamide|mesh-list
101720400|NCT05958277|Vitamin B Complex|vitamin b complex|mesh-list
101720401|NCT05958277|Micronutrients|micronutrients|mesh-ancestor
101720402|NCT05958277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720403|NCT05958173|Capsaicin|capsaicin|mesh-list
101720404|NCT05958173|Piperine|piperine|mesh-list
101720405|NCT05958173|Antipruritics|antipruritics|mesh-ancestor
101720406|NCT05958173|Dermatologic Agents|dermatologic agents|mesh-ancestor
101720407|NCT05958173|Sensory System Agents|sensory system agents|mesh-ancestor
101720408|NCT05958173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101720409|NCT05958173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720410|NCT05958173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101720411|NCT05958173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101720412|NCT05958173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720413|NCT05958160|Topiramate|topiramate|mesh-list
101720414|NCT05958160|Anticonvulsants|anticonvulsants|mesh-ancestor
101720415|NCT05958160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101720416|NCT05958160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720417|NCT05958069|Minocycline|minocycline|mesh-list
101720418|NCT05958069|Anticonvulsants|anticonvulsants|mesh-list
101720419|NCT05958069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101720420|NCT05958069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101720421|NCT05957991|Metformin|metformin|mesh-list
101720422|NCT05957991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101720423|NCT05957991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720424|NCT05957978|Paromomycin|paromomycin|mesh-list
101720425|NCT05957978|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
101720426|NCT05957978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101720427|NCT05957978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101720428|NCT05957978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101720429|NCT05957978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101720430|NCT05957978|Schistosomicides|schistosomicides|mesh-ancestor
101720431|NCT05957978|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101720432|NCT05957978|Anthelmintics|anthelmintics|mesh-ancestor
101720433|NCT05957913|Tenofovir|tenofovir|mesh-list
101720434|NCT05957913|Emtricitabine|emtricitabine|mesh-list
101720435|NCT05957913|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101720436|NCT05957913|Antiviral Agents|antiviral agents|mesh-ancestor
101720437|NCT05957913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101720438|NCT05957913|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101720439|NCT05957913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101720440|NCT05957913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101720441|NCT05957913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720442|NCT05957913|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101720443|NCT05957913|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101720444|NCT05957887|Dapagliflozin|dapagliflozin|mesh-list
101720445|NCT05957887|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101720446|NCT05957887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720447|NCT05957887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101720448|NCT05957887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720449|NCT05957822|Tranexamic Acid|tranexamic acid|mesh-list
101720450|NCT05957822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101720451|NCT05957822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101720466|NCT05957666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720467|NCT05957666|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101720468|NCT05957666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101720469|NCT05957666|Oxytocics|oxytocics|mesh-ancestor
101720471|NCT05957653|Sufentanil|sufentanil|mesh-list
101720472|NCT05957653|Anesthetics, Local|anesthetics, local|mesh-ancestor
101720473|NCT05957653|Anesthetics|anesthetics|mesh-ancestor
101720474|NCT05957653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101720475|NCT05957653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720476|NCT05957653|Sensory System Agents|sensory system agents|mesh-ancestor
101720477|NCT05957653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101720478|NCT05957653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101720479|NCT05957653|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101720480|NCT05957653|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101720481|NCT05957653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101720482|NCT05957653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720483|NCT05957653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101720484|NCT05957653|Narcotics|narcotics|mesh-ancestor
101720485|NCT05957653|Analgesics|analgesics|mesh-ancestor
101720486|NCT05957653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101720487|NCT05957653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101720488|NCT05957653|Anesthetics, General|anesthetics, general|mesh-ancestor
101720489|NCT05957510|Carboplatin|carboplatin|mesh-list
101720490|NCT05957510|Etoposide|etoposide|mesh-list
101720491|NCT05957510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101720492|NCT05957510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101720493|NCT05957510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101720494|NCT05957510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101720495|NCT05957510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101720496|NCT05957510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720497|NCT05957432|Amoxicillin|amoxicillin|mesh-list
101720498|NCT05957432|Clarithromycin|clarithromycin|mesh-list
101720499|NCT05957432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101720500|NCT05957432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101720501|NCT05957432|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101720502|NCT05957432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101720503|NCT05957432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720504|NCT05957432|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101720505|NCT05957432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101720506|NCT05957328|Ascorbic Acid|ascorbic acid|mesh-list
101803999|NCT00933374|Tubulin Modulators|tubulin modulators|mesh-ancestor
101720507|NCT05957328|Antioxidants|antioxidants|mesh-ancestor
101720508|NCT05957328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720509|NCT05957328|Protective Agents|protective agents|mesh-ancestor
101720510|NCT05957328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720511|NCT05957328|Vitamins|vitamins|mesh-ancestor
101720512|NCT05957328|Micronutrients|micronutrients|mesh-ancestor
101720513|NCT05957302|Fentanyl|fentanyl|mesh-list
101720514|NCT05957302|Ketamine|ketamine|mesh-list
101720515|NCT05957302|Analgesics|analgesics|mesh-ancestor
101720516|NCT05957302|Sensory System Agents|sensory system agents|mesh-ancestor
101720517|NCT05957302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101720518|NCT05957302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720519|NCT05957302|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101377949|NCT00249691|Anticonvulsants|anticonvulsants|mesh-ancestor
101720520|NCT05957302|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101720521|NCT05957302|Anesthetics, General|anesthetics, general|mesh-ancestor
101720522|NCT05957302|Anesthetics|anesthetics|mesh-ancestor
101720523|NCT05957302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101720524|NCT05957302|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101720525|NCT05957302|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101720527|NCT05957302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720528|NCT05957302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101720529|NCT05957302|Narcotics|narcotics|mesh-ancestor
101720530|NCT05957302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101720531|NCT05957250|FAPI-46|fapi-46|mesh-list
101720532|NCT05957250|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101720533|NCT05957250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720534|NCT05957211|Cyclosporine|cyclosporine|mesh-list
101720535|NCT05957211|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101720536|NCT05957211|Cyclosporins|cyclosporins|mesh-list
101720537|NCT05957211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101720538|NCT05957211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720539|NCT05957211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101720540|NCT05957211|Immunologic Factors|immunologic factors|mesh-ancestor
101720541|NCT05957211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720542|NCT05957211|Antifungal Agents|antifungal agents|mesh-ancestor
101720543|NCT05957211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101720544|NCT05957211|Dermatologic Agents|dermatologic agents|mesh-ancestor
101720545|NCT05957211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101720546|NCT05957211|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101720547|NCT05957211|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101720548|NCT05957094|Citalopram|citalopram|mesh-list
101720549|NCT05957094|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101720550|NCT05957094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101720551|NCT05957094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101720552|NCT05957094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720553|NCT05957094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101720554|NCT05957094|Serotonin Agents|serotonin agents|mesh-ancestor
101720555|NCT05957094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720556|NCT05957094|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101720557|NCT05957094|Antidepressive Agents|antidepressive agents|mesh-ancestor
101720558|NCT05957094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101720559|NCT05957081|Pembrolizumab|pembrolizumab|mesh-list
101720560|NCT05957081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101720561|NCT05957081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101720562|NCT05957081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101720563|NCT05957081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804018|NCT00933452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720565|NCT05957055|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101720566|NCT05957055|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101720567|NCT05957055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720568|NCT05957055|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101720569|NCT05957055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101720570|NCT05957055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101720571|NCT05957055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720572|NCT05957055|Dopamine Agents|dopamine agents|mesh-ancestor
101720573|NCT05957055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101720574|NCT05956899|Ondansetron|ondansetron|mesh-list
101192137|NCT00385398|Temozolomide|temozolomide|mesh-list
101720575|NCT05956899|Palonosetron|palonosetron|mesh-list
101720576|NCT05956899|Antiemetics|antiemetics|mesh-ancestor
101720577|NCT05956899|Autonomic Agents|autonomic agents|mesh-ancestor
101720578|NCT05956899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101720579|NCT05956899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720580|NCT05956899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101720581|NCT05956899|Antipruritics|antipruritics|mesh-ancestor
101720582|NCT05956899|Dermatologic Agents|dermatologic agents|mesh-ancestor
101720583|NCT05956899|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101720584|NCT05956899|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101720585|NCT05956899|Serotonin Agents|serotonin agents|mesh-ancestor
101720586|NCT05956899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101720587|NCT05956899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720588|NCT05954104|Calcipotriene|calcipotriene|mesh-list
101720589|NCT05954104|Dermatologic Agents|dermatologic agents|mesh-ancestor
101720590|NCT05951712|Acetylcysteine|acetylcysteine|mesh-list
101720591|NCT05951712|Simethicone|simethicone|mesh-list
101720592|NCT05951712|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101720593|NCT05951712|Antiviral Agents|antiviral agents|mesh-ancestor
101720594|NCT05951712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101720595|NCT05951712|Expectorants|expectorants|mesh-ancestor
101720596|NCT05951712|Respiratory System Agents|respiratory system agents|mesh-ancestor
101720597|NCT05951712|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101720598|NCT05951712|Antioxidants|antioxidants|mesh-ancestor
101720599|NCT05951712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720600|NCT05951712|Protective Agents|protective agents|mesh-ancestor
101720601|NCT05951712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720602|NCT05951712|Antidotes|antidotes|mesh-ancestor
101720603|NCT05951712|Antifoaming Agents|antifoaming agents|mesh-ancestor
101720604|NCT05951712|Emollients|emollients|mesh-ancestor
101720605|NCT05951712|Dermatologic Agents|dermatologic agents|mesh-ancestor
101720606|NCT05951595|Artesunate|artesunate|mesh-list
101720607|NCT05951595|Lumefantrine|lumefantrine|mesh-list
101720608|NCT05951595|Artemether|artemether|mesh-list
101720609|NCT05951595|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101720610|NCT05951595|Amodiaquine|amodiaquine|mesh-list
101720611|NCT05951595|Antimalarials|antimalarials|mesh-ancestor
101720612|NCT05951595|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101720613|NCT05951595|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101720614|NCT05951595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101720615|NCT05951595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101720616|NCT05951595|Antiviral Agents|antiviral agents|mesh-ancestor
101720617|NCT05951595|Schistosomicides|schistosomicides|mesh-ancestor
101720618|NCT05951595|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101720619|NCT05951595|Anthelmintics|anthelmintics|mesh-ancestor
101804036|NCT00447382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101720621|NCT05947448|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
101720622|NCT05947448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720623|NCT05947448|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101720624|NCT05947448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101720625|NCT05947448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101720626|NCT05947448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720627|NCT05947448|Vasodilator Agents|vasodilator agents|mesh-ancestor
101720628|NCT05947448|Tocolytic Agents|tocolytic agents|mesh-ancestor
101720629|NCT05947448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101720630|NCT05947448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101720631|NCT05947448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101720634|NCT05941715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101720635|NCT05941715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101720636|NCT05941715|Growth Substances|growth substances|mesh-ancestor
101720637|NCT05941715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720638|NCT05941715|Growth Inhibitors|growth inhibitors|mesh-ancestor
101720639|NCT05941715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101720640|NCT05936203|Insulin|insulin|mesh-list
101720641|NCT05936203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101720642|NCT05936203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720643|NCT05929157|Artesunate|artesunate|mesh-list
101720644|NCT05929157|Pyronaridine|pyronaridine|mesh-list
101720645|NCT05929157|Antimalarials|antimalarials|mesh-ancestor
101720646|NCT05929157|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101720647|NCT05929157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101720648|NCT05929157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101720649|NCT05929157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101720650|NCT05929157|Antiviral Agents|antiviral agents|mesh-ancestor
101720651|NCT05929157|Schistosomicides|schistosomicides|mesh-ancestor
101720652|NCT05929157|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101720653|NCT05929157|Anthelmintics|anthelmintics|mesh-ancestor
101720655|NCT05886582|Dopamine Agonists|dopamine agonists|mesh-ancestor
101720656|NCT05886582|Dopamine Agents|dopamine agents|mesh-ancestor
101720657|NCT05886582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101720658|NCT05886582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720659|NCT05886582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720660|NCT05861167|Ustekinumab|ustekinumab|mesh-list
101720661|NCT05861167|Dermatologic Agents|dermatologic agents|mesh-ancestor
101720662|NCT05828459|Paclitaxel|paclitaxel|mesh-list
101720663|NCT05828459|Bevacizumab|bevacizumab|mesh-list
101720664|NCT05828459|Lenalidomide|lenalidomide|mesh-list
101720665|NCT05828459|Pomalidomide|pomalidomide|mesh-list
101720666|NCT05828459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101720667|NCT05828459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101720668|NCT05828459|Tubulin Modulators|tubulin modulators|mesh-ancestor
101720669|NCT05828459|Antimitotic Agents|antimitotic agents|mesh-ancestor
101720670|NCT05828459|Mitosis Modulators|mitosis modulators|mesh-ancestor
101720671|NCT05828459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720672|NCT05828459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101720673|NCT05828459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101804058|NCT00933998|Vitamins|vitamins|mesh-ancestor
101720674|NCT05828459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101720675|NCT05828459|Growth Substances|growth substances|mesh-ancestor
101720676|NCT05828459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720677|NCT05828459|Growth Inhibitors|growth inhibitors|mesh-ancestor
101720678|NCT05828459|Immunologic Factors|immunologic factors|mesh-ancestor
101720679|NCT05820763|Dexamethasone|dexamethasone|mesh-list
101720680|NCT05820763|Lenalidomide|lenalidomide|mesh-list
101720681|NCT05820763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101720682|NCT05820763|Antiemetics|antiemetics|mesh-ancestor
101720683|NCT05820763|Autonomic Agents|autonomic agents|mesh-ancestor
101720684|NCT05820763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101720685|NCT05820763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720686|NCT05820763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101720687|NCT05820763|Glucocorticoids|glucocorticoids|mesh-ancestor
101720688|NCT05820763|Hormones|hormones|mesh-ancestor
101720689|NCT05820763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101720690|NCT05820763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101720691|NCT05820763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101720692|NCT05820763|Immunologic Factors|immunologic factors|mesh-ancestor
101720693|NCT05820763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101720694|NCT05820763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101720695|NCT05820763|Growth Substances|growth substances|mesh-ancestor
101720696|NCT05820763|Growth Inhibitors|growth inhibitors|mesh-ancestor
101720697|NCT05819619|Ibuprofen|ibuprofen|mesh-list
101720698|NCT05819619|Ondansetron|ondansetron|mesh-list
101720699|NCT05819619|Misoprostol|misoprostol|mesh-list
101720700|NCT05819619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101720701|NCT05819619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101720702|NCT05819619|Analgesics|analgesics|mesh-ancestor
101720703|NCT05819619|Sensory System Agents|sensory system agents|mesh-ancestor
101720704|NCT05819619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101720705|NCT05819619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720706|NCT05819619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101720707|NCT05819619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101720708|NCT05819619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101720709|NCT05819619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101720710|NCT05819619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720711|NCT05819619|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101720712|NCT05819619|Abortifacient Agents|abortifacient agents|mesh-ancestor
101720713|NCT05819619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101720714|NCT05819619|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101720715|NCT05819619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101720716|NCT05819619|Oxytocics|oxytocics|mesh-ancestor
101720717|NCT05819619|Antiemetics|antiemetics|mesh-ancestor
101720718|NCT05819619|Autonomic Agents|autonomic agents|mesh-ancestor
101720719|NCT05819619|Antipruritics|antipruritics|mesh-ancestor
101720720|NCT05819619|Dermatologic Agents|dermatologic agents|mesh-ancestor
101720721|NCT05819619|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101720722|NCT05819619|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101720723|NCT05819619|Serotonin Agents|serotonin agents|mesh-ancestor
101720724|NCT05819619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101720725|NCT05809895|Paclitaxel|paclitaxel|mesh-list
101720726|NCT05809895|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101720727|NCT05809895|Carboplatin|carboplatin|mesh-list
101720728|NCT05809895|Gemcitabine|gemcitabine|mesh-list
101720729|NCT05809895|Pembrolizumab|pembrolizumab|mesh-list
101720730|NCT05809895|Tislelizumab|tislelizumab|mesh-list
101720731|NCT05809895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101720732|NCT05809895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101720733|NCT05809895|Tubulin Modulators|tubulin modulators|mesh-ancestor
101720734|NCT05809895|Antimitotic Agents|antimitotic agents|mesh-ancestor
101720735|NCT05809895|Mitosis Modulators|mitosis modulators|mesh-ancestor
101720736|NCT05809895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720737|NCT05809895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101720738|NCT05809895|Antimetabolites|antimetabolites|mesh-ancestor
101720739|NCT05809895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101192319|NCT02998242|Apatinib|apatinib|mesh-list
101720740|NCT05809895|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101720741|NCT05791097|Paclitaxel|paclitaxel|mesh-list
101720742|NCT05791097|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101720743|NCT05791097|Carboplatin|carboplatin|mesh-list
101720744|NCT05791097|Pembrolizumab|pembrolizumab|mesh-list
101720745|NCT05791097|Pemetrexed|pemetrexed|mesh-list
101720746|NCT05791097|Tislelizumab|tislelizumab|mesh-list
101720747|NCT05791097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101720748|NCT05791097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101720749|NCT05791097|Tubulin Modulators|tubulin modulators|mesh-ancestor
101378171|NCT00250861|Rituximab|rituximab|mesh-list
101720750|NCT05791097|Antimitotic Agents|antimitotic agents|mesh-ancestor
101720751|NCT05791097|Mitosis Modulators|mitosis modulators|mesh-ancestor
101720752|NCT05791097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720753|NCT05791097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101720754|NCT05791097|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101720755|NCT05791097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101720756|NCT05791097|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101720757|NCT05791097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101720758|NCT05715281|Atezolizumab|atezolizumab|mesh-list
101720759|NCT05715281|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101720760|NCT05715281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101720761|NCT05715281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364118|NCT00145210|Sympatholytics|sympatholytics|mesh-ancestor
101720762|NCT05715281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101720763|NCT05715281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101720764|NCT05715281|Immunologic Factors|immunologic factors|mesh-ancestor
101720765|NCT05715281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720766|NCT05689021|Prednisone|prednisone|mesh-list
101720767|NCT05689021|Cortisone|cortisone|mesh-list
101720768|NCT05689021|Abiraterone Acetate|abiraterone acetate|mesh-list
101720769|NCT05689021|Niraparib|niraparib|mesh-list
101720770|NCT05689021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101720771|NCT05689021|Glucocorticoids|glucocorticoids|mesh-ancestor
101720772|NCT05689021|Hormones|hormones|mesh-ancestor
101720773|NCT05689021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101720774|NCT05689021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720775|NCT05689021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101720776|NCT05689021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101720777|NCT05689021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101720778|NCT05689021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101720779|NCT05689021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720780|NCT05689021|Hormone Antagonists|hormone antagonists|mesh-ancestor
101192346|NCT02996214|Paclitaxel|paclitaxel|mesh-list
101720781|NCT05689021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101720782|NCT05689021|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101720783|NCT05671081|Magnesium Sulfate|magnesium sulfate|mesh-list
101720784|NCT05671081|Dexmedetomidine|dexmedetomidine|mesh-list
101720786|NCT05671081|Narcotics|narcotics|mesh-list
101720787|NCT05671081|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101720788|NCT05671081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101720789|NCT05671081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720790|NCT05671081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101720791|NCT05671081|Sensory System Agents|sensory system agents|mesh-ancestor
101720792|NCT05671081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101720793|NCT05671081|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101720794|NCT05671081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101720795|NCT05671081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101720796|NCT05671081|Adrenergic Agents|adrenergic agents|mesh-ancestor
101720797|NCT05671081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101720798|NCT05671081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720799|NCT05671081|Anesthetics|anesthetics|mesh-ancestor
101720800|NCT05671081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101720801|NCT05671081|Anticonvulsants|anticonvulsants|mesh-ancestor
101720802|NCT05671081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101720803|NCT05671081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101720804|NCT05671081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101720805|NCT05671081|Tocolytic Agents|tocolytic agents|mesh-ancestor
101720806|NCT05671081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101720807|NCT05664659|Misoprostol|misoprostol|mesh-list
101720808|NCT05664659|Oxytocin|oxytocin|mesh-list
101720809|NCT05664659|Carbetocin|carbetocin|mesh-list
101720810|NCT05664659|Oxytocics|oxytocics|mesh-ancestor
101720811|NCT05664659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101720812|NCT05664659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720813|NCT05664659|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101720814|NCT05664659|Abortifacient Agents|abortifacient agents|mesh-ancestor
101720815|NCT05664659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101720816|NCT05664659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101720817|NCT05647551|Lidocaine|lidocaine|mesh-list
101720818|NCT05647551|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101720819|NCT05647551|Anesthetics, Local|anesthetics, local|mesh-ancestor
101720820|NCT05647551|Anesthetics|anesthetics|mesh-ancestor
101720821|NCT05647551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101720822|NCT05647551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720823|NCT05647551|Sensory System Agents|sensory system agents|mesh-ancestor
101720824|NCT05647551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101720825|NCT05647551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101720826|NCT05647551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101720827|NCT05647551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101720828|NCT05647551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101720829|NCT05647551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720830|NCT05647551|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101720831|NCT05647551|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101720832|NCT05647551|Cholinergic Agents|cholinergic agents|mesh-ancestor
101720833|NCT05647551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101720834|NCT05627479|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101720835|NCT05626478|Dexamethasone|dexamethasone|mesh-list
101720836|NCT05626478|Prednisolone|prednisolone|mesh-list
101720837|NCT05626478|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101720838|NCT05626478|Methylprednisolone|methylprednisolone|mesh-list
101720839|NCT05626478|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101720840|NCT05626478|Prednisolone acetate|prednisolone acetate|mesh-list
101720841|NCT05626478|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101720842|NCT05626478|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101720843|NCT05626478|Prednisolone phosphate|prednisolone phosphate|mesh-list
101720844|NCT05626478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101720845|NCT05626478|Antiemetics|antiemetics|mesh-ancestor
101720846|NCT05626478|Autonomic Agents|autonomic agents|mesh-ancestor
101720847|NCT05626478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101720848|NCT05626478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720849|NCT05626478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101720850|NCT05626478|Glucocorticoids|glucocorticoids|mesh-ancestor
101720852|NCT05626478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101720853|NCT05626478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101720854|NCT05626478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101720855|NCT05626478|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101720856|NCT05626478|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101720857|NCT05626478|Protective Agents|protective agents|mesh-ancestor
101720858|NCT05619172|Cetuximab|cetuximab|mesh-list
101720859|NCT05619172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101720860|NCT05619172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101720861|NCT05600309|Pembrolizumab|pembrolizumab|mesh-list
101720862|NCT05600309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101804105|NCT00577031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101804111|NCT00565448|Docetaxel|docetaxel|mesh-list
101720863|NCT05600309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101720864|NCT05600309|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101720865|NCT05600309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720866|NCT05591144|Prednisone|prednisone|mesh-list
101720867|NCT05591144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101720868|NCT05591144|Glucocorticoids|glucocorticoids|mesh-ancestor
101720869|NCT05591144|Hormones|hormones|mesh-ancestor
101720870|NCT05591144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101720871|NCT05591144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720872|NCT05591144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101720873|NCT05591144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101720874|NCT05589597|Nivolumab|nivolumab|mesh-list
101720875|NCT05589597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101720876|NCT05589597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101720877|NCT05589597|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101720878|NCT05589597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720879|NCT05538897|Megestrol|megestrol|mesh-list
101720880|NCT05538897|Megestrol Acetate|megestrol acetate|mesh-list
101720881|NCT05538897|Ipatasertib|ipatasertib|mesh-list
101720882|NCT05538897|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101720883|NCT05538897|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101720884|NCT05538897|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101720885|NCT05538897|Contraceptive Agents|contraceptive agents|mesh-ancestor
101720886|NCT05538897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101720887|NCT05538897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720888|NCT05538897|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101720889|NCT05538897|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101720890|NCT05538897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101720891|NCT05538897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101720892|NCT05538897|Appetite Stimulants|appetite stimulants|mesh-ancestor
101720893|NCT05538897|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101720894|NCT05538897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101720895|NCT05538897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101720896|NCT05538897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720897|NCT05487755|Tadalafil|tadalafil|mesh-list
101364135|NCT00145405|Lanreotide|lanreotide|mesh-list
101720898|NCT05487755|Pentoxifylline|pentoxifylline|mesh-list
101720899|NCT05487755|Vasodilator Agents|vasodilator agents|mesh-ancestor
101720900|NCT05487755|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101720901|NCT05487755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101720902|NCT05487755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101720903|NCT05487755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720904|NCT05487755|Urological Agents|urological agents|mesh-ancestor
101720905|NCT05487755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101720906|NCT05487755|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101720907|NCT05487755|Protective Agents|protective agents|mesh-ancestor
101720908|NCT05487755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720909|NCT05487755|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101720911|NCT05481645|Paclitaxel|paclitaxel|mesh-list
101720912|NCT05481645|Docetaxel|docetaxel|mesh-list
101720913|NCT05481645|Carboplatin|carboplatin|mesh-list
101720914|NCT05481645|Gemcitabine|gemcitabine|mesh-list
101720915|NCT05481645|Doxorubicin|doxorubicin|mesh-list
101720916|NCT05481645|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101720917|NCT05481645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101720918|NCT05481645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101720919|NCT05481645|Tubulin Modulators|tubulin modulators|mesh-ancestor
101720920|NCT05481645|Antimitotic Agents|antimitotic agents|mesh-ancestor
101720921|NCT05481645|Mitosis Modulators|mitosis modulators|mesh-ancestor
101720922|NCT05481645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720923|NCT05481645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101720925|NCT05481645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101720926|NCT05481645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101720927|NCT05481645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101720928|NCT05481645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101720929|NCT05478837|Cyclophosphamide|cyclophosphamide|mesh-list
101804115|NCT00565448|Antimitotic Agents|antimitotic agents|mesh-ancestor
101720930|NCT05478837|Fludarabine|fludarabine|mesh-list
101720931|NCT05478837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101720932|NCT05478837|Immunologic Factors|immunologic factors|mesh-ancestor
101720933|NCT05478837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720934|NCT05478837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101720935|NCT05478837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101720936|NCT05478837|Alkylating Agents|alkylating agents|mesh-ancestor
101720937|NCT05478837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720938|NCT05478837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101720939|NCT05478837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101720940|NCT05413018|Azacitidine|azacitidine|mesh-list
101720942|NCT05413018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101720943|NCT05413018|Antimetabolites|antimetabolites|mesh-ancestor
101720944|NCT05413018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720945|NCT05413018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101192486|NCT02995746|Autonomic Agents|autonomic agents|mesh-ancestor
101720946|NCT05413018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101720947|NCT05397652|Tranexamic Acid|tranexamic acid|mesh-list
101720948|NCT05397652|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101720949|NCT05397652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101720950|NCT05397652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720951|NCT05397652|Hemostatics|hemostatics|mesh-ancestor
101720952|NCT05397652|Coagulants|coagulants|mesh-ancestor
101720953|NCT05397405|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
101720954|NCT05397405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101720955|NCT05397405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101720956|NCT05397405|Antimetabolites|antimetabolites|mesh-ancestor
101720957|NCT05397405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720958|NCT05397405|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101720959|NCT05397405|Protease Inhibitors|protease inhibitors|mesh-ancestor
101720960|NCT05397405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101720961|NCT05397405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101720963|NCT05371600|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101720964|NCT05371600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101720965|NCT05371600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101720966|NCT05371600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720967|NCT05371600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101720968|NCT05371600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101720969|NCT05371600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101720970|NCT05371600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101720971|NCT05371600|Anesthetics, General|anesthetics, general|mesh-ancestor
101720972|NCT05371600|Anesthetics|anesthetics|mesh-ancestor
101720973|NCT05371600|GABA Modulators|gaba modulators|mesh-ancestor
101720974|NCT05371600|GABA Agents|gaba agents|mesh-ancestor
101720976|NCT05371600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720977|NCT05370911|Psilocybin|psilocybin|mesh-list
101720978|NCT05370911|Hallucinogens|hallucinogens|mesh-ancestor
101720979|NCT05370911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720980|NCT05370911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101720981|NCT05345522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101720982|NCT05345522|Antibodies|antibodies|mesh-list
101720983|NCT05345522|Immunoglobulins|immunoglobulins|mesh-list
101720984|NCT05345522|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101720985|NCT05345522|Immunologic Factors|immunologic factors|mesh-ancestor
101720986|NCT05345522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101720987|NCT05345522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101720988|NCT05342584|Cytarabine|cytarabine|mesh-list
101720989|NCT05342584|Daunorubicin|daunorubicin|mesh-list
101720990|NCT05342584|Venetoclax|venetoclax|mesh-list
101720991|NCT05342584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101720992|NCT05342584|Antimetabolites|antimetabolites|mesh-ancestor
101720993|NCT05342584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101720994|NCT05342584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101720995|NCT05342584|Antiviral Agents|antiviral agents|mesh-ancestor
101720996|NCT05342584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101720997|NCT05342584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101720998|NCT05342584|Immunologic Factors|immunologic factors|mesh-ancestor
101720999|NCT05342584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721004|NCT05340504|Acetylcysteine|acetylcysteine|mesh-list
101721005|NCT05340504|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101721006|NCT05340504|Antiviral Agents|antiviral agents|mesh-ancestor
101721007|NCT05340504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101721008|NCT05340504|Expectorants|expectorants|mesh-ancestor
101721009|NCT05340504|Respiratory System Agents|respiratory system agents|mesh-ancestor
101721010|NCT05340504|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101721011|NCT05340504|Antioxidants|antioxidants|mesh-ancestor
101721012|NCT05340504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721013|NCT05340504|Protective Agents|protective agents|mesh-ancestor
101721014|NCT05340504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721015|NCT05340504|Antidotes|antidotes|mesh-ancestor
101721016|NCT05338658|Pembrolizumab|pembrolizumab|mesh-list
101721017|NCT05338658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101721018|NCT05338658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721019|NCT05338658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101721020|NCT05338658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721021|NCT05333549|Istradefylline|istradefylline|mesh-list
101721022|NCT05333549|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
101721023|NCT05333549|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101721024|NCT05333549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101721025|NCT05333549|Purinergic Agents|purinergic agents|mesh-ancestor
101192557|NCT01271088|Antioxidants|antioxidants|mesh-ancestor
101721026|NCT05333549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101721027|NCT05333549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721028|NCT05333549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721034|NCT05278715|Carboplatin|carboplatin|mesh-list
101721035|NCT05278715|Vincristine|vincristine|mesh-list
101721036|NCT05278715|Endostatins|endostatins|mesh-list
101721037|NCT05278715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721038|NCT05278715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101721039|NCT05278715|Tubulin Modulators|tubulin modulators|mesh-ancestor
101721040|NCT05278715|Antimitotic Agents|antimitotic agents|mesh-ancestor
101721041|NCT05278715|Mitosis Modulators|mitosis modulators|mesh-ancestor
101721042|NCT05278715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721043|NCT05278715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101721044|NCT05278715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101721045|NCT05278715|Growth Substances|growth substances|mesh-ancestor
101721046|NCT05278715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721047|NCT05278715|Growth Inhibitors|growth inhibitors|mesh-ancestor
101721048|NCT05262738|Misoprostol|misoprostol|mesh-list
101721049|NCT05262738|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101721050|NCT05262738|Abortifacient Agents|abortifacient agents|mesh-ancestor
101721051|NCT05262738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101721052|NCT05262738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721053|NCT05262738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101721054|NCT05262738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101721055|NCT05262738|Oxytocics|oxytocics|mesh-ancestor
101721057|NCT05256719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101721058|NCT05256719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721059|NCT05256719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101721060|NCT05256719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721061|NCT05256719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101721062|NCT05256719|Immunologic Factors|immunologic factors|mesh-ancestor
101721063|NCT05256719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721064|NCT05256719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101721065|NCT05244226|Fentanyl|fentanyl|mesh-list
101721066|NCT05244226|Methadone|methadone|mesh-list
101721067|NCT05244226|Hydromorphone|hydromorphone|mesh-list
101721068|NCT05244226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101192609|NCT01272414|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101721069|NCT05244226|Narcotics|narcotics|mesh-ancestor
101721070|NCT05244226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101721071|NCT05244226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721072|NCT05244226|Analgesics|analgesics|mesh-ancestor
101721073|NCT05244226|Sensory System Agents|sensory system agents|mesh-ancestor
101721074|NCT05244226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101721075|NCT05244226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101721076|NCT05244226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101721077|NCT05244226|Anesthetics, General|anesthetics, general|mesh-ancestor
101721078|NCT05244226|Anesthetics|anesthetics|mesh-ancestor
101721079|NCT05244226|Antitussive Agents|antitussive agents|mesh-ancestor
101721080|NCT05244226|Respiratory System Agents|respiratory system agents|mesh-ancestor
101721081|NCT05232851|Pembrolizumab|pembrolizumab|mesh-list
101721082|NCT05232851|Vaccines|vaccines|mesh-list
101721083|NCT05232851|Immunologic Factors|immunologic factors|mesh-ancestor
101721084|NCT05232851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721085|NCT05232851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101721086|NCT05232851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721087|NCT05232851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101721088|NCT05232851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721089|NCT05193019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
101721090|NCT05176223|Edetic Acid|edetic acid|mesh-list
101721091|NCT05176223|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101721092|NCT05176223|Chelating Agents|chelating agents|mesh-ancestor
101721093|NCT05176223|Sequestering Agents|sequestering agents|mesh-ancestor
101721094|NCT05176223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721095|NCT05176223|Anticoagulants|anticoagulants|mesh-ancestor
101721096|NCT05176223|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101721097|NCT05176223|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101721098|NCT05157464|Losartan|losartan|mesh-list
101721099|NCT05157464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101721100|NCT05157464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101721101|NCT05157464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101721102|NCT05157464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101721103|NCT05157464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721104|NCT05156385|Antihypertensive Agents|antihypertensive agents|mesh-list
101721105|NCT05152901|Epinephrine|epinephrine|mesh-list
101721106|NCT05152901|Racepinephrine|racepinephrine|mesh-list
101721107|NCT05152901|Epinephryl borate|epinephryl borate|mesh-list
101721108|NCT05152901|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101721109|NCT05152901|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101721110|NCT05152901|Adrenergic Agents|adrenergic agents|mesh-ancestor
101721111|NCT05152901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101721112|NCT05152901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721113|NCT05152901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721114|NCT05152901|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101721115|NCT05152901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101721116|NCT05152901|Autonomic Agents|autonomic agents|mesh-ancestor
101192662|NCT01276704|Hormones|hormones|mesh-ancestor
101721117|NCT05152901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101721118|NCT05152901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101721119|NCT05152901|Respiratory System Agents|respiratory system agents|mesh-ancestor
101721121|NCT05152901|Sympathomimetics|sympathomimetics|mesh-ancestor
101804145|NCT00934154|Glucocorticoids|glucocorticoids|mesh-ancestor
101721122|NCT05152901|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101721124|NCT05133531|Ravulizumab|ravulizumab|mesh-list
101721125|NCT05133531|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101721126|NCT05133531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101721127|NCT05133531|Immunologic Factors|immunologic factors|mesh-ancestor
101721128|NCT05133531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721129|NCT05124210|Sotrovimab|sotrovimab|mesh-list
101721130|NCT05124210|Antiviral Agents|antiviral agents|mesh-ancestor
101721131|NCT05124210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101721132|NCT05124080|Deucravacitinib|deucravacitinib|mesh-list
101721133|NCT05124080|Dermatologic Agents|dermatologic agents|mesh-ancestor
101721134|NCT05124080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101721135|NCT05124080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101721136|NCT05124080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721137|NCT05118399|Bupivacaine|bupivacaine|mesh-list
101721138|NCT05118399|Anesthetics, Local|anesthetics, local|mesh-ancestor
101721139|NCT05118399|Anesthetics|anesthetics|mesh-ancestor
101721140|NCT05118399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101721141|NCT05118399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721142|NCT05118399|Sensory System Agents|sensory system agents|mesh-ancestor
101721143|NCT05118399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101721144|NCT05098938|Acyclovir|acyclovir|mesh-list
101721145|NCT05098938|Antiviral Agents|antiviral agents|mesh-ancestor
101721146|NCT05098938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101721147|NCT05074433|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
101721148|NCT05074433|Antiviral Agents|antiviral agents|mesh-ancestor
101721149|NCT05074433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101721150|NCT05064319|Gabapentin|gabapentin|mesh-list
101721151|NCT05064319|Analgesics|analgesics|mesh-ancestor
101721152|NCT05064319|Sensory System Agents|sensory system agents|mesh-ancestor
101721153|NCT05064319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101721154|NCT05064319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192690|NCT01279434|Vitamins|vitamins|mesh-list
101721156|NCT05064319|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101721157|NCT05064319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101721158|NCT05064319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101721159|NCT05064319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101721160|NCT05064319|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101721161|NCT05064319|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101721162|NCT05064319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101721163|NCT05064319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721164|NCT05064319|Antimanic Agents|antimanic agents|mesh-ancestor
101721165|NCT05063994|Hydrocortisone|hydrocortisone|mesh-list
101721166|NCT05063994|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101721167|NCT05063994|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101721168|NCT05063994|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101721169|NCT05063994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101721170|NCT04970355|Erenumab|erenumab|mesh-list
101721171|NCT04970355|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
101721172|NCT04970355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721173|NCT04970355|Analgesics|analgesics|mesh-ancestor
101721174|NCT04970355|Sensory System Agents|sensory system agents|mesh-ancestor
101721175|NCT04970355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101721176|NCT04970355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721177|NCT04952571|Bevacizumab|bevacizumab|mesh-list
101721178|NCT04952571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101721179|NCT04952571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721180|NCT04952571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101721181|NCT04952571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101721182|NCT04952571|Growth Substances|growth substances|mesh-ancestor
101721183|NCT04952571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721184|NCT04952571|Growth Inhibitors|growth inhibitors|mesh-ancestor
101721185|NCT04945733|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
101721186|NCT04945733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101804154|NCT00934154|Growth Substances|growth substances|mesh-ancestor
101804155|NCT00934154|Growth Inhibitors|growth inhibitors|mesh-ancestor
101721187|NCT04945733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721188|NCT04940390|Dihydroergotamine|dihydroergotamine|mesh-list
101721189|NCT04940390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101721190|NCT04940390|Dopamine Agonists|dopamine agonists|mesh-ancestor
101721191|NCT04940390|Dopamine Agents|dopamine agents|mesh-ancestor
101721192|NCT04940390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101721193|NCT04940390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721194|NCT04940390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721195|NCT04940390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101721196|NCT04940390|Analgesics|analgesics|mesh-ancestor
101721197|NCT04940390|Sensory System Agents|sensory system agents|mesh-ancestor
101721198|NCT04940390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101721199|NCT04939142|Dexamethasone|dexamethasone|mesh-list
101721200|NCT04939142|Dexamethasone acetate|dexamethasone acetate|mesh-list
101721201|NCT04939142|Bortezomib|bortezomib|mesh-list
101721202|NCT04939142|BB 1101|bb 1101|mesh-list
101721203|NCT04939142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101721204|NCT04939142|Antiemetics|antiemetics|mesh-ancestor
101721205|NCT04939142|Autonomic Agents|autonomic agents|mesh-ancestor
101721206|NCT04939142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101721207|NCT04939142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721208|NCT04939142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101721209|NCT04939142|Glucocorticoids|glucocorticoids|mesh-ancestor
101721210|NCT04939142|Hormones|hormones|mesh-ancestor
101721211|NCT04939142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101721212|NCT04939142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101721213|NCT04939142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721214|NCT04939142|Protease Inhibitors|protease inhibitors|mesh-ancestor
101721215|NCT04939142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101721216|NCT04939142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721217|NCT04909450|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101721218|NCT04909450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101721219|NCT04767984|Calcium, Dietary|calcium, dietary|mesh-list
101721220|NCT04767984|Atorvastatin|atorvastatin|mesh-list
101721222|NCT04767984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101721223|NCT04767984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721224|NCT04767984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101721225|NCT04767984|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101721226|NCT04767984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101721227|NCT04767984|Antimetabolites|antimetabolites|mesh-ancestor
101721228|NCT04767984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721229|NCT04767984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101721230|NCT04767984|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101721231|NCT04767984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101721232|NCT04722354|Abscisic Acid|abscisic acid|mesh-list
101721233|NCT04722354|Plant Growth Regulators|plant growth regulators|mesh-ancestor
101721234|NCT04722354|Growth Substances|growth substances|mesh-ancestor
101721235|NCT04722354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721236|NCT04721977|Capecitabine|capecitabine|mesh-list
101721237|NCT04721977|Trastuzumab|trastuzumab|mesh-list
101721238|NCT04721977|Tucatinib|tucatinib|mesh-list
101721239|NCT04721977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101721240|NCT04721977|Antimetabolites|antimetabolites|mesh-ancestor
101721241|NCT04721977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721242|NCT04721977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721243|NCT04721977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101721244|NCT04721977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101721245|NCT04721977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101721246|NCT04657302|Obinutuzumab|obinutuzumab|mesh-list
101721247|NCT04657302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101721248|NCT04657302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721249|NCT04608019|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101721250|NCT04608019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101721251|NCT04607954|Durvalumab|durvalumab|mesh-list
101721252|NCT04607954|Immunoglobulins|immunoglobulins|mesh-list
101721253|NCT04607954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101721255|NCT04607954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101721256|NCT04607954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721257|NCT04607954|Immunologic Factors|immunologic factors|mesh-ancestor
101721258|NCT04607954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721259|NCT04585841|Cannabidiol|cannabidiol|mesh-list
101721260|NCT04585841|Anticonvulsants|anticonvulsants|mesh-ancestor
101721261|NCT04583007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101721262|NCT04583007|Immunologic Factors|immunologic factors|mesh-ancestor
101721263|NCT04583007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721264|NCT04557020|Gemcitabine|gemcitabine|mesh-list
101721265|NCT04557020|Antibodies|antibodies|mesh-list
101721266|NCT04557020|Immunologic Factors|immunologic factors|mesh-ancestor
101721267|NCT04557020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721268|NCT04557020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721269|NCT04557020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101721270|NCT04557020|Antimetabolites|antimetabolites|mesh-ancestor
101721271|NCT04557020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721272|NCT04525014|Irinotecan|irinotecan|mesh-list
101721273|NCT04525014|Temozolomide|temozolomide|mesh-list
101721274|NCT04525014|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101721275|NCT04525014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101364145|NCT00145444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101721276|NCT04525014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101721277|NCT04525014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721278|NCT04525014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721279|NCT04525014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101721280|NCT04525014|Alkylating Agents|alkylating agents|mesh-ancestor
101721281|NCT04521361|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
101721282|NCT04521361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721283|NCT04521140|Dexamethasone|dexamethasone|mesh-list
101721284|NCT04521140|Prednisolone|prednisolone|mesh-list
101721285|NCT04521140|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101721286|NCT04521140|Methylprednisolone|methylprednisolone|mesh-list
101721287|NCT04521140|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101721288|NCT04521140|Prednisolone acetate|prednisolone acetate|mesh-list
101721289|NCT04521140|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101721290|NCT04521140|Prednisolone phosphate|prednisolone phosphate|mesh-list
101721291|NCT04521140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101721292|NCT04521140|Antiemetics|antiemetics|mesh-ancestor
101721293|NCT04521140|Autonomic Agents|autonomic agents|mesh-ancestor
101721294|NCT04521140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101721296|NCT04521140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101721297|NCT04521140|Glucocorticoids|glucocorticoids|mesh-ancestor
101721298|NCT04521140|Hormones|hormones|mesh-ancestor
101721299|NCT04521140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101721300|NCT04521140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101721301|NCT04521140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721302|NCT04521140|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101721303|NCT04521140|Protective Agents|protective agents|mesh-ancestor
101721304|NCT04507178|Nadroparin|nadroparin|mesh-list
101721305|NCT04507178|Anticoagulants|anticoagulants|mesh-ancestor
101721306|NCT04507178|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101721307|NCT04507178|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101721308|NCT04507178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721309|NCT04493060|Niraparib|niraparib|mesh-list
101721310|NCT04493060|Dostarlimab|dostarlimab|mesh-list
101721311|NCT04493060|Immunoglobulins|immunoglobulins|mesh-list
101721312|NCT04493060|Immunoglobulin G|immunoglobulin g|mesh-list
101721313|NCT04493060|Immunologic Factors|immunologic factors|mesh-ancestor
101721314|NCT04493060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721315|NCT04493060|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101804172|NCT00939458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101721316|NCT04493060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101721317|NCT04493060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721318|NCT04493060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721319|NCT04485949|Temozolomide|temozolomide|mesh-list
101721320|NCT04485949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101721321|NCT04485949|Alkylating Agents|alkylating agents|mesh-ancestor
101721322|NCT04485949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721323|NCT04485949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721324|NCT04457258|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101721325|NCT04457258|FAPI-46|fapi-46|mesh-list
101721326|NCT04457258|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101721327|NCT04457258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721328|NCT04449861|Durvalumab|durvalumab|mesh-list
101721329|NCT04449861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101721330|NCT04449861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721331|NCT04423211|Leuprolide|leuprolide|mesh-list
101721332|NCT04423211|Goserelin|goserelin|mesh-list
101721333|NCT04423211|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101721334|NCT04423211|Tryptophan|tryptophan|mesh-list
101721335|NCT04423211|Relugolix|relugolix|mesh-list
101721336|NCT04423211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101721337|NCT04423211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721338|NCT04423211|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101721339|NCT04423211|Fertility Agents|fertility agents|mesh-ancestor
101721340|NCT04423211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101721341|NCT04423211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101721342|NCT04423211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721343|NCT04423211|Luteolytic Agents|luteolytic agents|mesh-ancestor
101721344|NCT04423211|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101721345|NCT04423211|Contraceptive Agents|contraceptive agents|mesh-ancestor
101721346|NCT04423211|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101721347|NCT04423211|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101721348|NCT04423211|Antidepressive Agents|antidepressive agents|mesh-ancestor
101721349|NCT04423211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101721350|NCT04423211|Androgen Antagonists|androgen antagonists|mesh-ancestor
101721351|NCT04423211|Hormone Antagonists|hormone antagonists|mesh-ancestor
101721352|NCT04392375|Nifedipine|nifedipine|mesh-list
101721353|NCT04392375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101721354|NCT04392375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101721355|NCT04392375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721356|NCT04392375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101721357|NCT04392375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721358|NCT04392375|Vasodilator Agents|vasodilator agents|mesh-ancestor
101721359|NCT04392375|Tocolytic Agents|tocolytic agents|mesh-ancestor
101721360|NCT04392375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101721361|NCT04336982|Azacitidine|azacitidine|mesh-list
101721362|NCT04336982|Venetoclax|venetoclax|mesh-list
101721363|NCT04336982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101721364|NCT04336982|Antimetabolites|antimetabolites|mesh-ancestor
101721365|NCT04336982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721366|NCT04336982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721367|NCT04336982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101721368|NCT04314570|Ropivacaine|ropivacaine|mesh-list
101721370|NCT04314570|Anesthetics|anesthetics|mesh-ancestor
101721371|NCT04314570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101721372|NCT04314570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721373|NCT04314570|Sensory System Agents|sensory system agents|mesh-ancestor
101721374|NCT04314570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101721375|NCT04278573|Vitamin D|vitamin d|mesh-list
101721376|NCT04278573|Cholecalciferol|cholecalciferol|mesh-list
101721377|NCT04278573|Vitamins|vitamins|mesh-ancestor
101721378|NCT04278573|Micronutrients|micronutrients|mesh-ancestor
101721379|NCT04278573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721380|NCT04278573|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101721381|NCT04278573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101721382|NCT04252742|Erenumab|erenumab|mesh-list
101721383|NCT04252742|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
101721384|NCT04252742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721385|NCT04252742|Analgesics|analgesics|mesh-ancestor
101721386|NCT04252742|Sensory System Agents|sensory system agents|mesh-ancestor
101721387|NCT04252742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101721388|NCT04252742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721389|NCT04247542|Vancomycin|vancomycin|mesh-list
101721390|NCT04247542|Ibezapolstat|ibezapolstat|mesh-list
101721391|NCT04247542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101721392|NCT04247542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101721393|NCT04247542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101721394|NCT04247542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101721395|NCT04247542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721396|NCT04234568|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
101721397|NCT04234568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721398|NCT04234568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101721399|NCT04233580|Chlorhexidine|chlorhexidine|mesh-list
101721400|NCT04233580|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101721401|NCT04233580|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101721402|NCT04233580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101721403|NCT04233580|Disinfectants|disinfectants|mesh-ancestor
101721404|NCT04233580|Dermatologic Agents|dermatologic agents|mesh-ancestor
101721405|NCT04201197|Dronabinol|dronabinol|mesh-list
101721406|NCT04201197|Hallucinogens|hallucinogens|mesh-ancestor
101721407|NCT04201197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721408|NCT04201197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101721409|NCT04201197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101721410|NCT04201197|Analgesics|analgesics|mesh-ancestor
101721411|NCT04201197|Sensory System Agents|sensory system agents|mesh-ancestor
101721412|NCT04201197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101721413|NCT04201197|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101721414|NCT04201197|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101721415|NCT04201197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101721416|NCT04201197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721417|NCT04201197|Hormones|hormones|mesh-ancestor
101721418|NCT04201197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101721419|NCT04107740|TA 0910|ta 0910|mesh-list
101721420|NCT04107740|Nootropic Agents|nootropic agents|mesh-ancestor
101721421|NCT04104139|Trifluridine|trifluridine|mesh-list
101721422|NCT04104139|Antimetabolites|antimetabolites|mesh-ancestor
101721423|NCT04104139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721424|NCT04104139|Antiviral Agents|antiviral agents|mesh-ancestor
101721425|NCT04104139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101721426|NCT04085315|Osimertinib|osimertinib|mesh-list
101721427|NCT04085315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721428|NCT04085315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101721429|NCT04085315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101721430|NCT04085315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721431|NCT04082520|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
101721432|NCT04082520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721433|NCT04082520|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101721434|NCT04064060|Luspatercept|luspatercept|mesh-list
101721435|NCT04064060|Hematinics|hematinics|mesh-ancestor
101721436|NCT04028050|Carboplatin|carboplatin|mesh-list
101721437|NCT04028050|Etoposide|etoposide|mesh-list
101721438|NCT04028050|Atezolizumab|atezolizumab|mesh-list
101721439|NCT04028050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721440|NCT04028050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101721441|NCT04028050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101804196|NCT00934232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101804197|NCT01013571|Insulin|insulin|mesh-list
101721443|NCT04028050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101721444|NCT04028050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721445|NCT04028050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101192878|NCT00249288|Folic Acid|folic acid|mesh-list
101721446|NCT04028050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101721448|NCT04022005|Gemcitabine|gemcitabine|mesh-list
101721449|NCT04022005|Oxaliplatin|oxaliplatin|mesh-list
101721450|NCT04022005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101721451|NCT04022005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721452|NCT04022005|Immunologic Factors|immunologic factors|mesh-ancestor
101721453|NCT04022005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721454|NCT04022005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101721455|NCT04022005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101721456|NCT04022005|Antimetabolites|antimetabolites|mesh-ancestor
101721457|NCT04022005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721458|NCT04016805|Venetoclax|venetoclax|mesh-list
101721459|NCT04016805|Acalabrutinib|acalabrutinib|mesh-list
101721460|NCT04016805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721461|NCT03979885|Nicotine|nicotine|mesh-list
101721462|NCT03979885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101721463|NCT03979885|Autonomic Agents|autonomic agents|mesh-ancestor
101721464|NCT03979885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101721465|NCT03979885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721466|NCT03979885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101721467|NCT03979885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101721468|NCT03979885|Cholinergic Agents|cholinergic agents|mesh-ancestor
101721469|NCT03979885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101721470|NCT03979885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721471|NCT03972527|Analgesics|analgesics|mesh-list
101721472|NCT03972527|Sensory System Agents|sensory system agents|mesh-ancestor
101721473|NCT03972527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101721474|NCT03972527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721475|NCT03968393|Rivaroxaban|rivaroxaban|mesh-list
101721476|NCT03968393|Apixaban|apixaban|mesh-list
101721477|NCT03968393|Edoxaban|edoxaban|mesh-list
101721478|NCT03968393|Dabigatran|dabigatran|mesh-list
101721479|NCT03968393|Anticoagulants|anticoagulants|mesh-list
101721480|NCT03968393|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101721481|NCT03968393|Antithrombins|antithrombins|mesh-ancestor
101721482|NCT03968393|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101721483|NCT03968393|Protease Inhibitors|protease inhibitors|mesh-ancestor
101721484|NCT03968393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101721485|NCT03968393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721486|NCT03959358|Lenalidomide|lenalidomide|mesh-list
101721487|NCT03959358|Pomalidomide|pomalidomide|mesh-list
101721488|NCT03959358|Immunologic Factors|immunologic factors|mesh-ancestor
101721489|NCT03959358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721490|NCT03959358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101721491|NCT03959358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101721492|NCT03959358|Growth Substances|growth substances|mesh-ancestor
101721493|NCT03959358|Growth Inhibitors|growth inhibitors|mesh-ancestor
101721494|NCT03959358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721495|NCT03941730|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101721496|NCT03941730|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101721497|NCT03941730|Estradiol|estradiol|mesh-list
101721498|NCT03941730|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101721499|NCT03941730|Estrogens|estrogens|mesh-ancestor
101721500|NCT03941730|Hormones|hormones|mesh-ancestor
101192890|NCT00247962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101721501|NCT03941730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101721502|NCT03941730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721503|NCT03941730|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101721504|NCT03941730|Contraceptive Agents|contraceptive agents|mesh-ancestor
101721505|NCT03941730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101721506|NCT03941730|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101721507|NCT03866239|Atezolizumab|atezolizumab|mesh-list
101721508|NCT03866239|Obinutuzumab|obinutuzumab|mesh-list
101721509|NCT03866239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101721510|NCT03866239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721511|NCT03866239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101721512|NCT03866239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721513|NCT03739814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101721514|NCT03739814|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
101721515|NCT03739814|Blinatumomab|blinatumomab|mesh-list
101721516|NCT03739814|Antibodies|antibodies|mesh-list
101721517|NCT03739814|Immunoglobulins|immunoglobulins|mesh-list
101721518|NCT03739814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101721519|NCT03739814|Muromonab-CD3|muromonab-cd3|mesh-list
101721520|NCT03739814|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101721521|NCT03739814|Immunologic Factors|immunologic factors|mesh-ancestor
101721522|NCT03739814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721523|NCT03739814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721524|NCT03739814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101721525|NCT03739814|Immunotoxins|immunotoxins|mesh-ancestor
101721526|NCT03739814|Immunoconjugates|immunoconjugates|mesh-ancestor
101721527|NCT03739814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101721528|NCT03719768|Avelumab|avelumab|mesh-list
101721529|NCT03719768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101721530|NCT03719768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721531|NCT03714308|Aflibercept|aflibercept|mesh-list
101721532|NCT03714308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101721533|NCT03714308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101721534|NCT03714308|Growth Substances|growth substances|mesh-ancestor
101721535|NCT03714308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721536|NCT03714308|Growth Inhibitors|growth inhibitors|mesh-ancestor
101721537|NCT03714308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721538|NCT03713593|Pembrolizumab|pembrolizumab|mesh-list
101721539|NCT03713593|Lenvatinib|lenvatinib|mesh-list
101721540|NCT03713593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101721541|NCT03713593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721542|NCT03713593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101192913|NCT00247416|Antimetabolites|antimetabolites|mesh-ancestor
101721543|NCT03713593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721544|NCT03713593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101721545|NCT03713593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101721546|NCT03702270|Penicillins|penicillins|mesh-list
101721547|NCT03702270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101721548|NCT03702270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101721549|NCT03687957|Temozolomide|temozolomide|mesh-list
101721550|NCT03687957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101721551|NCT03687957|Alkylating Agents|alkylating agents|mesh-ancestor
101721552|NCT03687957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721553|NCT03687957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721554|NCT03617679|Rucaparib|rucaparib|mesh-list
101721555|NCT03617679|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101721556|NCT03617679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101804221|NCT00738335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101721557|NCT03617679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721558|NCT03617679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721559|NCT03580369|Omalizumab|omalizumab|mesh-list
101721560|NCT03580369|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101721561|NCT03580369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101721562|NCT03580369|Respiratory System Agents|respiratory system agents|mesh-ancestor
101721563|NCT03554083|Atezolizumab|atezolizumab|mesh-list
101721564|NCT03554083|Vemurafenib|vemurafenib|mesh-list
101721565|NCT03554083|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101721566|NCT03554083|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101721567|NCT03554083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721568|NCT03554083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101721569|NCT03554083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721570|NCT03554083|Immunologic Factors|immunologic factors|mesh-ancestor
101721571|NCT03554083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721572|NCT03554083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101721573|NCT03554083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101721574|NCT03539900|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
101721575|NCT03539900|Naltrexone|naltrexone|mesh-list
101721576|NCT03539900|Bupropion|bupropion|mesh-list
101721577|NCT03539900|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101721578|NCT03539900|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101721579|NCT03539900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721580|NCT03539900|Sensory System Agents|sensory system agents|mesh-ancestor
101721581|NCT03539900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101721582|NCT03539900|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101721583|NCT03539900|Antidepressive Agents|antidepressive agents|mesh-ancestor
101721584|NCT03539900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101721585|NCT03539900|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101721586|NCT03539900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101721587|NCT03539900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101721588|NCT03539900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721589|NCT03539900|Dopamine Agents|dopamine agents|mesh-ancestor
101721590|NCT03539900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101721645|NCT03399539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101721647|NCT03399539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721648|NCT03399539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721649|NCT03399539|Protease Inhibitors|protease inhibitors|mesh-ancestor
101721650|NCT03399539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101721651|NCT03399539|Dermatologic Agents|dermatologic agents|mesh-ancestor
101721652|NCT03399539|Glycine Agents|glycine agents|mesh-ancestor
101721653|NCT03399539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101721654|NCT03374254|Leucovorin|leucovorin|mesh-list
101721655|NCT03374254|Pembrolizumab|pembrolizumab|mesh-list
101721656|NCT03374254|Fluorouracil|fluorouracil|mesh-list
101721657|NCT03374254|Oxaliplatin|oxaliplatin|mesh-list
101721658|NCT03374254|Irinotecan|irinotecan|mesh-list
101721659|NCT03374254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101721660|NCT03374254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721661|NCT03374254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101721662|NCT03374254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721663|NCT03374254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721664|NCT03374254|Antimetabolites|antimetabolites|mesh-ancestor
101721665|NCT03374254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101721666|NCT03374254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101721667|NCT03374254|Immunologic Factors|immunologic factors|mesh-ancestor
101804244|NCT04409795|Incretins|incretins|mesh-ancestor
101721668|NCT03374254|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101721669|NCT03374254|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101721670|NCT03374254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101721671|NCT03374254|Antidotes|antidotes|mesh-ancestor
101721672|NCT03374254|Protective Agents|protective agents|mesh-ancestor
101721673|NCT03374254|Vitamin B Complex|vitamin b complex|mesh-ancestor
101721674|NCT03374254|Vitamins|vitamins|mesh-ancestor
101721675|NCT03374254|Micronutrients|micronutrients|mesh-ancestor
101721676|NCT03358706|Vitamin K|vitamin k|mesh-list
101721677|NCT03358706|Midazolam|midazolam|mesh-list
101721678|NCT03358706|Dextromethorphan|dextromethorphan|mesh-list
101721679|NCT03358706|Caffeine|caffeine|mesh-list
101721680|NCT03358706|Ustekinumab|ustekinumab|mesh-list
101721681|NCT03358706|Omeprazole|omeprazole|mesh-list
101721682|NCT03358706|Warfarin|warfarin|mesh-list
101721683|NCT03358706|Vitamins|vitamins|mesh-ancestor
101721684|NCT03358706|Micronutrients|micronutrients|mesh-ancestor
101721685|NCT03358706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721686|NCT03358706|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101721687|NCT03358706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101721688|NCT03358706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101721689|NCT03358706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101721690|NCT03358706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101721691|NCT03358706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101721692|NCT03358706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101721693|NCT03358706|Anesthetics, General|anesthetics, general|mesh-ancestor
101721694|NCT03358706|Anesthetics|anesthetics|mesh-ancestor
101721695|NCT03358706|GABA Modulators|gaba modulators|mesh-ancestor
101721696|NCT03358706|GABA Agents|gaba agents|mesh-ancestor
101721697|NCT03358706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101721698|NCT03358706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721699|NCT03358706|Anticoagulants|anticoagulants|mesh-ancestor
101721700|NCT03358706|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101721701|NCT03358706|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101721702|NCT03358706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101721703|NCT03358706|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101721704|NCT03358706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101721705|NCT03358706|Purinergic Agents|purinergic agents|mesh-ancestor
101721706|NCT03358706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101721707|NCT03358706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101721708|NCT03358706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101721709|NCT03358706|Dermatologic Agents|dermatologic agents|mesh-ancestor
101721710|NCT03358706|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101721711|NCT03358706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101721712|NCT03358706|Hemostatics|hemostatics|mesh-ancestor
101721713|NCT03358706|Coagulants|coagulants|mesh-ancestor
101721714|NCT03358706|Antitussive Agents|antitussive agents|mesh-ancestor
101721715|NCT03358706|Respiratory System Agents|respiratory system agents|mesh-ancestor
101721716|NCT03358706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101721717|NCT03358706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101721718|NCT03338920|Sumatriptan|sumatriptan|mesh-list
101721719|NCT03338920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101721720|NCT03338920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101721721|NCT03338920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101721722|NCT03338920|Serotonin Agents|serotonin agents|mesh-ancestor
101721723|NCT03338920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101721724|NCT03338920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721725|NCT03338920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721726|NCT03331289|Dapagliflozin|dapagliflozin|mesh-list
101721727|NCT03331289|Exenatide|exenatide|mesh-list
101721728|NCT03331289|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101721729|NCT03331289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721730|NCT03331289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101804260|NCT01015209|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101721731|NCT03331289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721732|NCT03331289|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101721733|NCT03331289|Incretins|incretins|mesh-ancestor
101721735|NCT03331289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101721736|NCT03321643|Rituximab|rituximab|mesh-list
101721737|NCT03321643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101721738|NCT03321643|Atezolizumab|atezolizumab|mesh-list
101721739|NCT03321643|Gemcitabine|gemcitabine|mesh-list
101721740|NCT03321643|Oxaliplatin|oxaliplatin|mesh-list
101721741|NCT03321643|Antibodies|antibodies|mesh-list
101721742|NCT03321643|Immunoglobulins|immunoglobulins|mesh-list
101721743|NCT03321643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101721744|NCT03321643|Immunologic Factors|immunologic factors|mesh-ancestor
101721745|NCT03321643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721746|NCT03321643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721747|NCT03321643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101721748|NCT03321643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101721749|NCT03321643|Antimetabolites|antimetabolites|mesh-ancestor
101721750|NCT03321643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721751|NCT03321643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101721752|NCT03220776|Acetylcysteine|acetylcysteine|mesh-list
101721753|NCT03220776|Gabapentin|gabapentin|mesh-list
101721754|NCT03220776|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101721755|NCT03220776|Analgesics|analgesics|mesh-ancestor
101721756|NCT03220776|Sensory System Agents|sensory system agents|mesh-ancestor
101721757|NCT03220776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101721758|NCT03220776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721759|NCT03220776|Anticonvulsants|anticonvulsants|mesh-ancestor
101721760|NCT03220776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101721761|NCT03220776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101721762|NCT03220776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101721763|NCT03220776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101721764|NCT03220776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101721765|NCT03220776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101721766|NCT03220776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101721767|NCT03220776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721768|NCT03220776|Antimanic Agents|antimanic agents|mesh-ancestor
101721769|NCT03220776|Antiviral Agents|antiviral agents|mesh-ancestor
101721770|NCT03220776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101721771|NCT03220776|Expectorants|expectorants|mesh-ancestor
101721772|NCT03220776|Respiratory System Agents|respiratory system agents|mesh-ancestor
101721773|NCT03220776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101721774|NCT03220776|Antioxidants|antioxidants|mesh-ancestor
101721775|NCT03220776|Protective Agents|protective agents|mesh-ancestor
101721776|NCT03220776|Antidotes|antidotes|mesh-ancestor
101721777|NCT03215810|Cyclophosphamide|cyclophosphamide|mesh-list
101721778|NCT03215810|Nivolumab|nivolumab|mesh-list
101721779|NCT03215810|Fludarabine|fludarabine|mesh-list
101721780|NCT03215810|Interleukin-2|interleukin-2|mesh-list
101721781|NCT03215810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101721782|NCT03215810|Immunologic Factors|immunologic factors|mesh-ancestor
101721783|NCT03215810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721784|NCT03215810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101721785|NCT03215810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101721786|NCT03215810|Alkylating Agents|alkylating agents|mesh-ancestor
101193040|NCT04295772|Islatravir|islatravir|mesh-list
101721787|NCT03215810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721788|NCT03215810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721789|NCT03215810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101721790|NCT03215810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101721791|NCT03215810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101721792|NCT03215810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101804274|NCT01015209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101721793|NCT03215810|Analgesics|analgesics|mesh-ancestor
101721794|NCT03215810|Sensory System Agents|sensory system agents|mesh-ancestor
101804275|NCT01015209|Antimetabolites|antimetabolites|mesh-ancestor
101804277|NCT01015209|Chelating Agents|chelating agents|mesh-ancestor
101721795|NCT03215810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101721796|NCT03036930|Vaccines|vaccines|mesh-list
101721797|NCT03036930|Immunologic Factors|immunologic factors|mesh-ancestor
101721798|NCT03036930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721799|NCT03032406|Hydroxychloroquine|hydroxychloroquine|mesh-list
101721800|NCT03032406|Everolimus|everolimus|mesh-list
101721801|NCT03032406|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101721802|NCT03032406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101721803|NCT03032406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101721804|NCT03032406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721805|NCT03032406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101721806|NCT03032406|Immunologic Factors|immunologic factors|mesh-ancestor
101379221|NCT00257452|Autonomic Agents|autonomic agents|mesh-ancestor
101721807|NCT03032406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721808|NCT03032406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721809|NCT03032406|Antimalarials|antimalarials|mesh-ancestor
101721810|NCT03032406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101721811|NCT03032406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101721812|NCT03032406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101721813|NCT03032406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101721814|NCT03008408|Everolimus|everolimus|mesh-list
101721815|NCT03008408|Letrozole|letrozole|mesh-list
101721816|NCT03008408|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101721817|NCT03008408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101721818|NCT03008408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101721819|NCT03008408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721820|NCT03008408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101721821|NCT03008408|Immunologic Factors|immunologic factors|mesh-ancestor
101721823|NCT03008408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721824|NCT03008408|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101721825|NCT03008408|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101721826|NCT03008408|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101721827|NCT03008408|Hormone Antagonists|hormone antagonists|mesh-ancestor
101721828|NCT03008408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101721829|NCT02977468|Pembrolizumab|pembrolizumab|mesh-list
101721830|NCT02977468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101721831|NCT02977468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721832|NCT02977468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101721833|NCT02977468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721834|NCT02955355|Immunoglobulins|immunoglobulins|mesh-list
101721835|NCT02955355|Immunologic Factors|immunologic factors|mesh-ancestor
101721836|NCT02955355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721837|NCT02953457|Durvalumab|durvalumab|mesh-list
101721838|NCT02953457|Ipilimumab|ipilimumab|mesh-list
101721839|NCT02953457|Olaparib|olaparib|mesh-list
101721840|NCT02953457|Tremelimumab|tremelimumab|mesh-list
101364152|NCT00145444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101721841|NCT02953457|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
101721842|NCT02953457|Immunoglobulins|immunoglobulins|mesh-list
101721843|NCT02953457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101721844|NCT02953457|Immunoglobulin G|immunoglobulin g|mesh-list
101721845|NCT02953457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101721846|NCT02953457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721847|NCT02953457|Immunologic Factors|immunologic factors|mesh-ancestor
101721848|NCT02953457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721849|NCT02953457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101721850|NCT02953457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721851|NCT02953457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101721852|NCT02893917|Olaparib|olaparib|mesh-list
101721853|NCT02893917|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
101721854|NCT02893917|Cediranib|cediranib|mesh-list
101721855|NCT02893917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101721856|NCT02893917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721857|NCT02893917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721858|NCT02893917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101721859|NCT02891538|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
101721860|NCT02891538|Antioxidants|antioxidants|mesh-ancestor
101804287|NCT04948463|Cefepime|cefepime|mesh-list
101721861|NCT02891538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721862|NCT02891538|Protective Agents|protective agents|mesh-ancestor
101721863|NCT02891538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721864|NCT02891538|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101721865|NCT02891538|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101721866|NCT02891538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721867|NCT02891538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101721868|NCT02817659|Glucagon|glucagon|mesh-list
101721869|NCT02817659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101721870|NCT02817659|Hormones|hormones|mesh-ancestor
101721871|NCT02817659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101721872|NCT02817659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721873|NCT02677922|Azacitidine|azacitidine|mesh-list
101193096|NCT02017704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721874|NCT02677922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101721875|NCT02677922|Antimetabolites|antimetabolites|mesh-ancestor
101721876|NCT02677922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721877|NCT02677922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721878|NCT02677922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101721879|NCT02593175|Paclitaxel|paclitaxel|mesh-list
101721880|NCT02593175|Carboplatin|carboplatin|mesh-list
101721881|NCT02593175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101721882|NCT02593175|Panitumumab|panitumumab|mesh-list
101721883|NCT02593175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101721884|NCT02593175|Antibodies|antibodies|mesh-list
101721885|NCT02593175|Immunoglobulins|immunoglobulins|mesh-list
101721886|NCT02593175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101721887|NCT02593175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101721888|NCT02593175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721889|NCT02593175|Tubulin Modulators|tubulin modulators|mesh-ancestor
101721890|NCT02593175|Antimitotic Agents|antimitotic agents|mesh-ancestor
101721891|NCT02593175|Mitosis Modulators|mitosis modulators|mesh-ancestor
101721892|NCT02593175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721893|NCT02593175|Immunologic Factors|immunologic factors|mesh-ancestor
101721894|NCT02593175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721895|NCT02565628|PF-06669571|pf-06669571|mesh-list
101721896|NCT02565628|Dopamine Agonists|dopamine agonists|mesh-ancestor
101721897|NCT02565628|Dopamine Agents|dopamine agents|mesh-ancestor
101721898|NCT02565628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101721899|NCT02565628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721900|NCT02565628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721901|NCT02496585|Prednisone|prednisone|mesh-list
101721902|NCT02496585|Nintedanib|nintedanib|mesh-list
101721903|NCT02496585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101721904|NCT02496585|Glucocorticoids|glucocorticoids|mesh-ancestor
101721905|NCT02496585|Hormones|hormones|mesh-ancestor
101721906|NCT02496585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101721907|NCT02496585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721908|NCT02496585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101721909|NCT02496585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721910|NCT02496585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101721911|NCT02496585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101451738|NCT00203099|Respiratory System Agents|respiratory system agents|mesh-ancestor
101721912|NCT02496585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721913|NCT02486640|Interferons|interferons|mesh-list
101721914|NCT02486640|Interferon-beta|interferon-beta|mesh-list
101721915|NCT02486640|Interferon beta-1b|interferon beta-1b|mesh-list
101721916|NCT02486640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721917|NCT02486640|Antiviral Agents|antiviral agents|mesh-ancestor
101721918|NCT02486640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101721919|NCT02486640|Immunologic Factors|immunologic factors|mesh-ancestor
101721920|NCT02486640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804297|NCT04948463|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101721921|NCT02486640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101721922|NCT02330991|Temozolomide|temozolomide|mesh-list
101721923|NCT02330991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101721924|NCT02330991|Alkylating Agents|alkylating agents|mesh-ancestor
101721925|NCT02330991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721926|NCT02330991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721927|NCT02117791|Riociguat|riociguat|mesh-list
101721928|NCT02117791|Enzyme Activators|enzyme activators|mesh-ancestor
101721929|NCT02117791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721930|NCT01582737|Rivaroxaban|rivaroxaban|mesh-list
101721931|NCT01582737|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101721932|NCT01582737|Antithrombins|antithrombins|mesh-ancestor
101721933|NCT01582737|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101721934|NCT01582737|Protease Inhibitors|protease inhibitors|mesh-ancestor
101721935|NCT01582737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101721936|NCT01582737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721937|NCT01582737|Anticoagulants|anticoagulants|mesh-ancestor
101721938|NCT01321567|Rabeprazole|rabeprazole|mesh-list
101721939|NCT01321567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101721940|NCT01321567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101721941|NCT01321567|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101721942|NCT01321567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101721943|NCT01321567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721944|NCT01290445|Varenicline|varenicline|mesh-list
101721945|NCT01290445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101721946|NCT01290445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101721947|NCT01290445|Cholinergic Agents|cholinergic agents|mesh-ancestor
101721948|NCT01290445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101721949|NCT01290445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721950|NCT01290445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721951|NCT01251718|Donepezil|donepezil|mesh-list
101721952|NCT01251718|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101721953|NCT01251718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101193173|NCT03219762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721954|NCT01251718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721955|NCT01251718|Cholinergic Agents|cholinergic agents|mesh-ancestor
101721956|NCT01251718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101721957|NCT01251718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721958|NCT01251718|Nootropic Agents|nootropic agents|mesh-ancestor
101721959|NCT01211405|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
101721960|NCT01211405|Hallucinogens|hallucinogens|mesh-ancestor
101721961|NCT01211405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721962|NCT01211405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101721963|NCT01211405|Serotonin Agents|serotonin agents|mesh-ancestor
101721964|NCT01211405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101721965|NCT01211405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721966|NCT01211405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101721967|NCT01211405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101721968|NCT01211405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101721969|NCT01211405|Adrenergic Agents|adrenergic agents|mesh-ancestor
101721970|NCT01012817|Topotecan|topotecan|mesh-list
101721971|NCT01012817|Veliparib|veliparib|mesh-list
101721972|NCT01012817|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101721973|NCT01012817|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101721974|NCT01012817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101721975|NCT01012817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721976|NCT01012817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101721977|NCT01012817|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101721978|NCT00581828|Vitamin D|vitamin d|mesh-list
101721979|NCT00581828|Ergocalciferols|ergocalciferols|mesh-list
101721980|NCT00581828|Cholecalciferol|cholecalciferol|mesh-list
101721981|NCT00581828|Vitamins|vitamins|mesh-list
101721982|NCT00581828|Micronutrients|micronutrients|mesh-ancestor
101721983|NCT00581828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804310|NCT00111241|Letrozole|letrozole|mesh-list
101721984|NCT00581828|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101721985|NCT00581828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101721986|NCT00220337|Lacosamide|lacosamide|mesh-list
101721987|NCT00220337|Anticonvulsants|anticonvulsants|mesh-ancestor
101721988|NCT00220337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101721989|NCT00220337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101721990|NCT00220337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101721991|NCT00220337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721992|NCT00090064|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
101721993|NCT00090064|Hallucinogens|hallucinogens|mesh-ancestor
101721994|NCT00090064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101721995|NCT00090064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101721996|NCT00090064|Serotonin Agents|serotonin agents|mesh-ancestor
101721997|NCT00090064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101721998|NCT00090064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101721999|NCT00090064|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101722000|NCT00090064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101722001|NCT00090064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101722002|NCT00090064|Adrenergic Agents|adrenergic agents|mesh-ancestor
101722003|NCT00576316|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101722004|NCT00576316|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101722005|NCT00576316|Respiratory System Agents|respiratory system agents|mesh-ancestor
101722006|NCT00745810|Complement System Proteins|complement system proteins|mesh-list
101722007|NCT00745810|Immunologic Factors|immunologic factors|mesh-ancestor
101722008|NCT00745810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722009|NCT00755872|Risedronic Acid|risedronic acid|mesh-list
101722010|NCT00755872|Etidronic Acid|etidronic acid|mesh-list
101722011|NCT00755872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101722012|NCT00755872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101722013|NCT00755872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722014|NCT00755872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101722015|NCT00755872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722016|NCT00755872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101722018|NCT00755950|Antioxidants|antioxidants|mesh-ancestor
101722019|NCT00755950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722020|NCT00755950|Protective Agents|protective agents|mesh-ancestor
101722021|NCT00755950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722022|NCT00705354|Bacitracin|bacitracin|mesh-list
101722023|NCT00705354|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101722024|NCT00705354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101722025|NCT00705354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101722026|NCT00575380|Azithromycin|azithromycin|mesh-list
101722027|NCT00575380|Moxifloxacin|moxifloxacin|mesh-list
101722028|NCT00575380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101722029|NCT00575380|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101722030|NCT00575380|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101722031|NCT00575380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101722032|NCT00575380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101722033|NCT00575380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101722034|NCT00575380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101722035|NCT00575380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101722036|NCT00575380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722037|NCT00575380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101722038|NCT00575380|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101722039|NCT00575380|Contraceptive Agents|contraceptive agents|mesh-ancestor
101722040|NCT00575380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101722041|NCT00575380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722042|NCT00575380|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101722043|NCT00575380|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101722044|NCT00575380|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101804317|NCT00111241|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101722045|NCT00840996|Lidocaine|lidocaine|mesh-list
101722046|NCT00840996|Anesthetics, Local|anesthetics, local|mesh-ancestor
101722047|NCT00840996|Anesthetics|anesthetics|mesh-ancestor
101722048|NCT00840996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101722049|NCT00840996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722050|NCT00840996|Sensory System Agents|sensory system agents|mesh-ancestor
101364160|NCT00145483|Vasodilator Agents|vasodilator agents|mesh-ancestor
101722051|NCT00840996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101722052|NCT00840996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101722053|NCT00840996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101722054|NCT00840996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101722055|NCT00840996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101722056|NCT00840996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722057|NCT00756184|Travoprost|travoprost|mesh-list
101722058|NCT00756184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101722059|NCT00756340|Bevacizumab|bevacizumab|mesh-list
101722060|NCT00756340|Everolimus|everolimus|mesh-list
101722061|NCT00756340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101722062|NCT00756340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101722063|NCT00756340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101722064|NCT00756340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101722065|NCT00756340|Growth Substances|growth substances|mesh-ancestor
101722066|NCT00756340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193292|NCT03211728|Analgesics|analgesics|mesh-ancestor
101722067|NCT00756340|Growth Inhibitors|growth inhibitors|mesh-ancestor
101722068|NCT00756340|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101722069|NCT00756340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101722070|NCT00756340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101722071|NCT00756340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722072|NCT00756340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101722073|NCT00756340|Immunologic Factors|immunologic factors|mesh-ancestor
101722074|NCT00705510|Cyclosporine|cyclosporine|mesh-list
101722075|NCT00705510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101722076|NCT00705510|Cyclosporins|cyclosporins|mesh-list
101722077|NCT00705510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101722078|NCT00705510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722079|NCT00705510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101722080|NCT00705510|Immunologic Factors|immunologic factors|mesh-ancestor
101722081|NCT00705510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722082|NCT00705510|Antifungal Agents|antifungal agents|mesh-ancestor
101722083|NCT00705510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101722084|NCT00705510|Dermatologic Agents|dermatologic agents|mesh-ancestor
101722085|NCT00705510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101722086|NCT00705510|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101722087|NCT00705510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101722088|NCT00680914|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101722089|NCT00680914|Immunologic Factors|immunologic factors|mesh-ancestor
101722090|NCT00680914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722091|NCT00680836|Rifaximin|rifaximin|mesh-list
101722092|NCT00680836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101722093|NCT00680836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101722094|NCT00680836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101722095|NCT05428306|Acetaminophen|acetaminophen|mesh-list
101722096|NCT05428306|Ibuprofen|ibuprofen|mesh-list
101722097|NCT05428306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101722098|NCT05428306|Analgesics|analgesics|mesh-ancestor
101722099|NCT05428306|Sensory System Agents|sensory system agents|mesh-ancestor
101722100|NCT05428306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101722101|NCT05428306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722102|NCT05428306|Antipyretics|antipyretics|mesh-ancestor
101722103|NCT05428306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101722104|NCT05428306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101722105|NCT05428306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101804327|NCT00492297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722106|NCT05428306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101722108|NCT05428306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722110|NCT05424796|Coagulants|coagulants|mesh-ancestor
101722111|NCT00757198|Remifentanil|remifentanil|mesh-list
101262941|NCT01759771|Vitamin D|vitamin d|mesh-list
101722112|NCT00757198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101722113|NCT00757198|Narcotics|narcotics|mesh-ancestor
101722114|NCT00757198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101722115|NCT00757198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722116|NCT00757198|Analgesics|analgesics|mesh-ancestor
101722117|NCT00757198|Sensory System Agents|sensory system agents|mesh-ancestor
101364166|NCT00145522|Tibolone|tibolone|mesh-list
101722118|NCT00757198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101722119|NCT00679432|Budesonide|budesonide|mesh-list
101722120|NCT00679432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101722121|NCT00679432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101722122|NCT00679432|Autonomic Agents|autonomic agents|mesh-ancestor
101722123|NCT00679432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101722124|NCT00679432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722125|NCT00679432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101722126|NCT00679432|Respiratory System Agents|respiratory system agents|mesh-ancestor
101722127|NCT00679432|Glucocorticoids|glucocorticoids|mesh-ancestor
101722128|NCT00679432|Hormones|hormones|mesh-ancestor
101722129|NCT00679432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101722130|NCT02560870|Chlorhexidine|chlorhexidine|mesh-list
101722131|NCT02560870|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101722132|NCT02560870|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101722133|NCT02560870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101722134|NCT02560870|Disinfectants|disinfectants|mesh-ancestor
101722135|NCT02560870|Dermatologic Agents|dermatologic agents|mesh-ancestor
101722136|NCT04050826|Lidocaine|lidocaine|mesh-list
101722137|NCT04050826|Prilocaine|prilocaine|mesh-list
101722138|NCT04050826|Anesthetics, Local|anesthetics, local|mesh-ancestor
101722139|NCT04050826|Anesthetics|anesthetics|mesh-ancestor
101722140|NCT04050826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101722141|NCT04050826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722142|NCT04050826|Sensory System Agents|sensory system agents|mesh-ancestor
101722143|NCT04050826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101722144|NCT04050826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101722145|NCT04050826|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101722146|NCT04050826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101722147|NCT04050826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101722148|NCT04050826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722149|NCT00757978|Memantine|memantine|mesh-list
101722150|NCT00757978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101722151|NCT00757978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101722152|NCT00757978|Dopamine Agents|dopamine agents|mesh-ancestor
101722153|NCT00757978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101722154|NCT00757978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722155|NCT00757978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722156|NCT00757978|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101722157|NCT00757978|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101722158|NCT00754702|Vinorelbine|vinorelbine|mesh-list
101722159|NCT00754702|Lapatinib|lapatinib|mesh-list
101722160|NCT00754702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101722161|NCT00754702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101722162|NCT00754702|Tubulin Modulators|tubulin modulators|mesh-ancestor
101722163|NCT00754702|Antimitotic Agents|antimitotic agents|mesh-ancestor
101722164|NCT00754702|Mitosis Modulators|mitosis modulators|mesh-ancestor
101722165|NCT00754702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722166|NCT00754702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101804341|NCT00934466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101722167|NCT00754702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101722169|NCT00754780|Analgesics|analgesics|mesh-ancestor
101722170|NCT00754780|Sensory System Agents|sensory system agents|mesh-ancestor
101722171|NCT00754780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101722172|NCT00754780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722173|NCT00754780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101722174|NCT00754780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101722175|NCT00754780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101379594|NCT00259870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101722177|NCT00754780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101722178|NCT00822900|Progesterone|progesterone|mesh-list
101722179|NCT00822900|Progestins|progestins|mesh-ancestor
101722180|NCT00822900|Hormones|hormones|mesh-ancestor
101722181|NCT00822900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101722182|NCT00822900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722183|NCT00682786|Fluorouracil|fluorouracil|mesh-list
101722184|NCT00682786|Irinotecan|irinotecan|mesh-list
101722185|NCT00682786|Antimetabolites|antimetabolites|mesh-ancestor
101722186|NCT00682786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193380|NCT01832922|Rituximab|rituximab|mesh-list
101722187|NCT00682786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101722188|NCT00682786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101722189|NCT00682786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101722190|NCT00682786|Immunologic Factors|immunologic factors|mesh-ancestor
101722191|NCT00682786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722192|NCT00682786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101722193|NCT00682786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101722194|NCT00682786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101722195|NCT00840450|Paclitaxel|paclitaxel|mesh-list
101722196|NCT00840450|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101722197|NCT00840450|Imatinib Mesylate|imatinib mesylate|mesh-list
101722198|NCT00840450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101722199|NCT00840450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101722200|NCT00840450|Tubulin Modulators|tubulin modulators|mesh-ancestor
101722201|NCT00840450|Antimitotic Agents|antimitotic agents|mesh-ancestor
101722202|NCT00840450|Mitosis Modulators|mitosis modulators|mesh-ancestor
101722203|NCT00840450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722204|NCT00840450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101722205|NCT00840450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101722206|NCT00754858|Belotecan|belotecan|mesh-list
101722207|NCT00754858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101722208|NCT00754858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101722209|NCT00754858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101722210|NCT00754858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101722211|NCT00754858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722212|NCT00755014|Ethanol|ethanol|mesh-list
101722213|NCT00755014|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101722214|NCT00755014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101722215|NCT00755014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101722216|NCT00755014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722218|NCT00705588|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101722219|NCT00705588|Vasodilator Agents|vasodilator agents|mesh-ancestor
101722220|NCT00705588|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101722221|NCT00705588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101722222|NCT00705588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101722223|NCT00705588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722224|NCT00705588|Urological Agents|urological agents|mesh-ancestor
101722225|NCT00755170|Bevacizumab|bevacizumab|mesh-list
101722226|NCT00755170|Vinorelbine|vinorelbine|mesh-list
101722227|NCT00755170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101722228|NCT00755170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101722229|NCT00755170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101722230|NCT00755170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101804351|NCT00921245|Urological Agents|urological agents|mesh-ancestor
101722231|NCT00755170|Growth Substances|growth substances|mesh-ancestor
101722232|NCT00755170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722233|NCT00755170|Growth Inhibitors|growth inhibitors|mesh-ancestor
101722234|NCT00755170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101722235|NCT00755170|Tubulin Modulators|tubulin modulators|mesh-ancestor
101722236|NCT00755170|Antimitotic Agents|antimitotic agents|mesh-ancestor
101722237|NCT00755170|Mitosis Modulators|mitosis modulators|mesh-ancestor
101722238|NCT00755170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722239|NCT00705822|Prednisone|prednisone|mesh-list
101722240|NCT00705822|Hydrocortisone|hydrocortisone|mesh-list
101722241|NCT00705822|Docetaxel|docetaxel|mesh-list
101722242|NCT00705822|Estramustine|estramustine|mesh-list
101722243|NCT00705822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101722244|NCT00705822|Tubulin Modulators|tubulin modulators|mesh-ancestor
101722245|NCT00705822|Antimitotic Agents|antimitotic agents|mesh-ancestor
101722246|NCT00705822|Mitosis Modulators|mitosis modulators|mesh-ancestor
101722247|NCT00705822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722248|NCT00705822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101722249|NCT00705822|Glucocorticoids|glucocorticoids|mesh-ancestor
101722250|NCT00705822|Hormones|hormones|mesh-ancestor
101722251|NCT00705822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101722252|NCT00705822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722253|NCT00705822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101722254|NCT00705822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101722255|NCT00705822|Alkylating Agents|alkylating agents|mesh-ancestor
101722256|NCT00840294|Ciprofloxacin|ciprofloxacin|mesh-list
101722258|NCT00840294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101722259|NCT00840294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101722260|NCT00840294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101722261|NCT00840294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101722262|NCT00840294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722263|NCT00840294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101722264|NCT00840294|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101722265|NCT00840294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101722266|NCT00755404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101722268|NCT00703170|Doxorubicin|doxorubicin|mesh-list
101722269|NCT00703170|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101722270|NCT00703170|Temsirolimus|temsirolimus|mesh-list
101722271|NCT00703170|MTOR Inhibitors|mtor inhibitors|mesh-list
101722272|NCT00703170|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101722273|NCT00703170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101722274|NCT00703170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101722275|NCT00703170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101722276|NCT00703170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101722277|NCT00703170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722278|NCT00703170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101722279|NCT00703170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101722280|NCT00703170|Immunologic Factors|immunologic factors|mesh-ancestor
101722281|NCT00703170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722282|NCT00703170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101722283|NCT00703170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101722284|NCT00703170|Antifungal Agents|antifungal agents|mesh-ancestor
101722285|NCT05370040|Vaccines|vaccines|mesh-list
101722286|NCT05370040|Immunologic Factors|immunologic factors|mesh-ancestor
101722287|NCT05370040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722288|NCT00758134|Trastuzumab|trastuzumab|mesh-list
101722289|NCT00758134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101722290|NCT00758134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101722291|NCT02560636|Pembrolizumab|pembrolizumab|mesh-list
101722292|NCT02560636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101722337|NCT00680056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101722338|NCT00680056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101722339|NCT00680056|Adrenergic Agents|adrenergic agents|mesh-ancestor
101722340|NCT00680056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101722341|NCT00680056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804361|NCT00940238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722342|NCT00680056|Parasympatholytics|parasympatholytics|mesh-ancestor
101722343|NCT00680056|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101722344|NCT00680056|Cholinergic Agents|cholinergic agents|mesh-ancestor
101722345|NCT00758368|Apomorphine|apomorphine|mesh-list
101722346|NCT00758368|Emetics|emetics|mesh-ancestor
101722347|NCT00758368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722348|NCT00758368|Autonomic Agents|autonomic agents|mesh-ancestor
101722349|NCT00758368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101722350|NCT00758368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101722351|NCT00758368|Dopamine Agonists|dopamine agonists|mesh-ancestor
101722352|NCT00758368|Dopamine Agents|dopamine agents|mesh-ancestor
101722353|NCT00758368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101722354|NCT00758368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722355|NCT05435560|Dexmedetomidine|dexmedetomidine|mesh-list
101722356|NCT05435560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101722357|NCT05435560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101722358|NCT05435560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722359|NCT05435560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101722360|NCT05435560|Analgesics|analgesics|mesh-ancestor
101722361|NCT05435560|Sensory System Agents|sensory system agents|mesh-ancestor
101722362|NCT05435560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101722363|NCT05435560|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101722364|NCT05435560|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101722365|NCT05435560|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101722366|NCT05435560|Adrenergic Agents|adrenergic agents|mesh-ancestor
101722367|NCT05435560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101722368|NCT05435560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722369|NCT00680992|Denosumab|denosumab|mesh-list
101722370|NCT00680992|Immunoglobulins|immunoglobulins|mesh-list
101722371|NCT00680992|Immunoglobulin G|immunoglobulin g|mesh-list
101722372|NCT00680992|Immunologic Factors|immunologic factors|mesh-ancestor
101722373|NCT00680992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722374|NCT00680992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101722375|NCT02559154|Thalidomide|thalidomide|mesh-list
101722376|NCT02559154|Dexamethasone|dexamethasone|mesh-list
101722377|NCT02559154|Cyclophosphamide|cyclophosphamide|mesh-list
101722378|NCT02559154|Doxorubicin|doxorubicin|mesh-list
101722379|NCT02559154|Bortezomib|bortezomib|mesh-list
101722380|NCT02559154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101722381|NCT02559154|Immunologic Factors|immunologic factors|mesh-ancestor
101722382|NCT02559154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722383|NCT02559154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101722384|NCT02559154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101722385|NCT02559154|Alkylating Agents|alkylating agents|mesh-ancestor
101722386|NCT02559154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722387|NCT02559154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101722388|NCT02559154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101722389|NCT02559154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101722390|NCT02559154|Antiemetics|antiemetics|mesh-ancestor
101722391|NCT02559154|Autonomic Agents|autonomic agents|mesh-ancestor
101722392|NCT02559154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101722393|NCT02559154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101722394|NCT02559154|Glucocorticoids|glucocorticoids|mesh-ancestor
101722395|NCT02559154|Hormones|hormones|mesh-ancestor
101722396|NCT02559154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101722397|NCT02559154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101722398|NCT02559154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101379823|NCT00105495|Deferiprone|deferiprone|mesh-list
101722399|NCT02559154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101722400|NCT02559154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101722401|NCT02559154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101722402|NCT02559154|Leprostatic Agents|leprostatic agents|mesh-ancestor
101804369|NCT00940238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101722403|NCT02559154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101722404|NCT02559154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101722405|NCT02559154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101722406|NCT02559154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101722407|NCT02559154|Growth Substances|growth substances|mesh-ancestor
101722408|NCT02559154|Growth Inhibitors|growth inhibitors|mesh-ancestor
101722409|NCT00678886|Muromonab-CD3|muromonab-cd3|mesh-list
101722410|NCT00678886|Immunologic Factors|immunologic factors|mesh-ancestor
101722411|NCT00678886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722412|NCT00678886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101722413|NCT05747469|Lidocaine|lidocaine|mesh-list
101722414|NCT05747469|Anesthetics, Local|anesthetics, local|mesh-list
101722415|NCT05747469|Anesthetics|anesthetics|mesh-list
101722416|NCT05747469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101722417|NCT05747469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722418|NCT05747469|Sensory System Agents|sensory system agents|mesh-ancestor
101722419|NCT05747469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101722420|NCT05747469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101722421|NCT05747469|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101722422|NCT05747469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101722423|NCT05747469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101722424|NCT05747469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722426|NCT00804843|Atorvastatin|atorvastatin|mesh-list
101722427|NCT00804843|Simvastatin|simvastatin|mesh-list
101722428|NCT00804843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101722429|NCT00804843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101722430|NCT00804843|Antimetabolites|antimetabolites|mesh-ancestor
101722431|NCT00804843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722432|NCT00804843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101722433|NCT00804843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101722434|NCT00804843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101722435|NCT00804843|Vasodilator Agents|vasodilator agents|mesh-ancestor
101722436|NCT00804843|Vitamin B Complex|vitamin b complex|mesh-ancestor
101722437|NCT00804843|Vitamins|vitamins|mesh-ancestor
101722438|NCT00804843|Micronutrients|micronutrients|mesh-ancestor
101722439|NCT00804843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722440|NCT00822120|Prednisone|prednisone|mesh-list
101722441|NCT00822120|Cyclophosphamide|cyclophosphamide|mesh-list
101722442|NCT00822120|Dacarbazine|dacarbazine|mesh-list
101722443|NCT00822120|Doxorubicin|doxorubicin|mesh-list
101722444|NCT00822120|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101722445|NCT00822120|Etoposide|etoposide|mesh-list
101722446|NCT00822120|Vincristine|vincristine|mesh-list
101722447|NCT00822120|Bleomycin|bleomycin|mesh-list
101722448|NCT00822120|Vinblastine|vinblastine|mesh-list
101722449|NCT00822120|Procarbazine|procarbazine|mesh-list
101722450|NCT00822120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101722451|NCT00822120|Immunologic Factors|immunologic factors|mesh-ancestor
101722452|NCT00822120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722453|NCT00822120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101722454|NCT00822120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101722455|NCT00822120|Alkylating Agents|alkylating agents|mesh-ancestor
101722456|NCT00822120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722457|NCT00822120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101722458|NCT00822120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101722459|NCT00822120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101722460|NCT00822120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101722461|NCT00822120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101722462|NCT00822120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101722463|NCT00822120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101722464|NCT00822120|Glucocorticoids|glucocorticoids|mesh-ancestor
101722465|NCT00822120|Hormones|hormones|mesh-ancestor
101722466|NCT00822120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101722467|NCT00822120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101722468|NCT00822120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101722469|NCT00822120|Tubulin Modulators|tubulin modulators|mesh-ancestor
101722470|NCT00822120|Antimitotic Agents|antimitotic agents|mesh-ancestor
101804387|NCT02565719|Interferons|interferons|mesh-list
101722471|NCT00822120|Mitosis Modulators|mitosis modulators|mesh-ancestor
101722472|NCT00804687|Pseudoephedrine|pseudoephedrine|mesh-list
101722473|NCT00804687|Ephedrine|ephedrine|mesh-list
101722474|NCT00804687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101722475|NCT00804687|Autonomic Agents|autonomic agents|mesh-ancestor
101722476|NCT00804687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101722477|NCT00804687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722479|NCT00804687|Respiratory System Agents|respiratory system agents|mesh-ancestor
101722480|NCT00804687|Nasal Decongestants|nasal decongestants|mesh-ancestor
101722481|NCT00804687|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101722482|NCT00804687|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101722483|NCT00804687|Sympathomimetics|sympathomimetics|mesh-ancestor
101722484|NCT00804687|Adrenergic Agents|adrenergic agents|mesh-ancestor
101722485|NCT00804687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101722486|NCT00804687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722487|NCT00678652|Vaccines|vaccines|mesh-list
101722488|NCT00678652|Immunologic Factors|immunologic factors|mesh-ancestor
101722489|NCT00678652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722490|NCT02607657|Eplerenone|eplerenone|mesh-list
101722491|NCT02607657|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101722492|NCT02607657|Hormone Antagonists|hormone antagonists|mesh-ancestor
101722493|NCT02607657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101722494|NCT02607657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722495|NCT02607657|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101722496|NCT02607657|Diuretics|diuretics|mesh-ancestor
101722497|NCT02607657|Natriuretic Agents|natriuretic agents|mesh-ancestor
101722498|NCT02607657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101722499|NCT00574912|Insulin|insulin|mesh-list
101722500|NCT00574912|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101722501|NCT00574912|Insulin Glargine|insulin glargine|mesh-list
101722502|NCT00574912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101722503|NCT00574912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722504|NCT00922896|Gemcitabine|gemcitabine|mesh-list
101722505|NCT00922896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101722506|NCT00922896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101722507|NCT00922896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101722508|NCT00922896|Antimetabolites|antimetabolites|mesh-ancestor
101722509|NCT00922896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722510|NCT00922896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101722511|NCT00922896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101722512|NCT00761020|Mefloquine|mefloquine|mesh-list
101722513|NCT00761020|Antimalarials|antimalarials|mesh-ancestor
101722514|NCT00761020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101722515|NCT00761020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101722516|NCT00761020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101722517|NCT00804141|Bromides|bromides|mesh-list
101722518|NCT00804141|Methylnaltrexone|methylnaltrexone|mesh-list
101722519|NCT00804141|Anticonvulsants|anticonvulsants|mesh-ancestor
101722520|NCT00804141|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101722521|NCT00804141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722522|NCT00804141|Sensory System Agents|sensory system agents|mesh-ancestor
101722523|NCT00804141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101722524|NCT00677092|Imatinib Mesylate|imatinib mesylate|mesh-list
101722525|NCT00677092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101722526|NCT00677092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101804392|NCT02565719|REP 2139|rep 2139|mesh-list
101722527|NCT00677092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101722528|NCT00677092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722529|NCT02607579|Ropivacaine|ropivacaine|mesh-list
101722530|NCT02607579|Anesthetics, Local|anesthetics, local|mesh-ancestor
101722531|NCT02607579|Anesthetics|anesthetics|mesh-ancestor
101722532|NCT02607579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101722533|NCT02607579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722534|NCT02607579|Sensory System Agents|sensory system agents|mesh-ancestor
101722535|NCT02607579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101722536|NCT03539367|Acetazolamide|acetazolamide|mesh-list
101722537|NCT03539367|Anticonvulsants|anticonvulsants|mesh-ancestor
101722538|NCT03539367|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101722539|NCT03539367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101722540|NCT03539367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722541|NCT03539367|Diuretics|diuretics|mesh-ancestor
101722542|NCT03539367|Natriuretic Agents|natriuretic agents|mesh-ancestor
101722543|NCT03539367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722544|NCT03416361|Vitamin D|vitamin d|mesh-list
101722545|NCT03416361|Cholecalciferol|cholecalciferol|mesh-list
101722546|NCT03416361|Vitamins|vitamins|mesh-ancestor
101722547|NCT03416361|Micronutrients|micronutrients|mesh-ancestor
101722548|NCT03416361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722549|NCT03416361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101262955|NCT01759875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101722550|NCT03416361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101722551|NCT00761254|Domperidone|domperidone|mesh-list
101722552|NCT00761254|Antiemetics|antiemetics|mesh-ancestor
101722553|NCT00761254|Autonomic Agents|autonomic agents|mesh-ancestor
101722554|NCT00761254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101722555|NCT00761254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722556|NCT00761254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101722557|NCT00761254|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101722558|NCT00761254|Dopamine Agents|dopamine agents|mesh-ancestor
101722559|NCT00761254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101722560|NCT00761254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722561|NCT00761332|Teriparatide|teriparatide|mesh-list
101722562|NCT00761332|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101722563|NCT00761332|Diphosphonates|diphosphonates|mesh-list
101722564|NCT00761332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101722565|NCT00761332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722566|NCT00761332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101722567|NCT00761332|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101722568|NCT00761332|Hormone Antagonists|hormone antagonists|mesh-ancestor
101722569|NCT00761332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101722583|NCT04627246|Vaccines|vaccines|mesh-list
101722584|NCT04627246|Immunologic Factors|immunologic factors|mesh-ancestor
101722585|NCT04627246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722586|NCT00761644|Sirolimus|sirolimus|mesh-list
101722587|NCT00761644|Bevacizumab|bevacizumab|mesh-list
101722588|NCT00761644|Doxorubicin|doxorubicin|mesh-list
101722589|NCT00761644|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101722590|NCT00761644|Temsirolimus|temsirolimus|mesh-list
101722591|NCT00761644|MTOR Inhibitors|mtor inhibitors|mesh-list
101722592|NCT00761644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101722593|NCT00761644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101722594|NCT00761644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101722595|NCT00761644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101722596|NCT00761644|Growth Substances|growth substances|mesh-ancestor
101722597|NCT00761644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722598|NCT00761644|Growth Inhibitors|growth inhibitors|mesh-ancestor
101722599|NCT00761644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101722600|NCT00761644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101722601|NCT00761644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101804409|NCT00111007|Tubulin Modulators|tubulin modulators|mesh-ancestor
101722602|NCT00761644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101722603|NCT00761644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722604|NCT00761644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101722605|NCT00761644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101722606|NCT00761644|Immunologic Factors|immunologic factors|mesh-ancestor
101722607|NCT00761644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101722608|NCT00761644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101722609|NCT00761644|Antifungal Agents|antifungal agents|mesh-ancestor
101722610|NCT02559388|Montelukast|montelukast|mesh-list
101722611|NCT02559388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101722612|NCT02559388|Respiratory System Agents|respiratory system agents|mesh-ancestor
101722613|NCT02559388|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101722614|NCT02559388|Hormone Antagonists|hormone antagonists|mesh-ancestor
101722615|NCT02559388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101722616|NCT02559388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722617|NCT02559388|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101722618|NCT02559388|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101722619|NCT02559388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722620|NCT03168256|Apremilast|apremilast|mesh-list
101722621|NCT03168256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101722622|NCT03168256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101722624|NCT03168256|Sensory System Agents|sensory system agents|mesh-ancestor
101722625|NCT03168256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101722626|NCT03168256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722627|NCT03168256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101722628|NCT03168256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101722629|NCT03168256|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101722630|NCT03168256|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101722631|NCT03168256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101722632|NCT03168256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722633|NCT00761722|Azacitidine|azacitidine|mesh-list
101722634|NCT00761722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101722635|NCT00761722|Antimetabolites|antimetabolites|mesh-ancestor
101722636|NCT00761722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722637|NCT00761722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101722638|NCT00761722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101722639|NCT04507906|Nivolumab|nivolumab|mesh-list
101722640|NCT04507906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101722641|NCT04507906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101722642|NCT04507906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101722643|NCT04507906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722644|NCT00762190|Insulin|insulin|mesh-list
101722645|NCT00762190|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101722646|NCT00762190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101722647|NCT00762190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722648|NCT00762346|Zoledronic Acid|zoledronic acid|mesh-list
101722649|NCT00762346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101722650|NCT00762346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722651|NCT00762658|Betamethasone|betamethasone|mesh-list
101722652|NCT00762658|Tacrolimus|tacrolimus|mesh-list
101722653|NCT00762658|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101722654|NCT00762658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101722655|NCT00762658|Immunologic Factors|immunologic factors|mesh-ancestor
101722656|NCT00762658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722657|NCT00762658|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101722658|NCT00762658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101722659|NCT00762658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722660|NCT00762658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101722661|NCT00762658|Glucocorticoids|glucocorticoids|mesh-ancestor
101804423|NCT00699335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101722662|NCT00762658|Hormones|hormones|mesh-ancestor
101804426|NCT00699335|Anesthetics|anesthetics|mesh-ancestor
101722663|NCT00762658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101722665|NCT00762658|Respiratory System Agents|respiratory system agents|mesh-ancestor
101722666|NCT02558452|Tacrolimus|tacrolimus|mesh-list
101722667|NCT02558452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101722668|NCT02558452|Immunologic Factors|immunologic factors|mesh-ancestor
101722669|NCT02558452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722670|NCT02558452|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101193863|NCT01729806|Rituximab|rituximab|mesh-list
101722672|NCT02558452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722673|NCT00762736|Pioglitazone|pioglitazone|mesh-list
101722674|NCT00762736|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
101722675|NCT00762736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101722676|NCT00762736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722677|NCT00762736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101722678|NCT00762736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101722679|NCT00762736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722680|NCT02915224|Obinutuzumab|obinutuzumab|mesh-list
101722681|NCT02915224|Chlorambucil|chlorambucil|mesh-list
101722682|NCT02915224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101722683|NCT02915224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101722684|NCT02915224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101722685|NCT02915224|Alkylating Agents|alkylating agents|mesh-ancestor
101722686|NCT02915224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722687|NCT02813824|Aspirin|aspirin|mesh-list
101722688|NCT02813824|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
101722689|NCT02813824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101722690|NCT02813824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101722691|NCT02813824|Analgesics|analgesics|mesh-ancestor
101722692|NCT02813824|Sensory System Agents|sensory system agents|mesh-ancestor
101722693|NCT02813824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101722694|NCT02813824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722695|NCT02813824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101722696|NCT02813824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101722697|NCT02813824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101722698|NCT02813824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101722699|NCT02813824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722700|NCT02813824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101722701|NCT02813824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101722702|NCT02813824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101722703|NCT02813824|Antipyretics|antipyretics|mesh-ancestor
101722704|NCT00673894|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101722705|NCT00673894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101722706|NCT00673894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722707|NCT00673894|Incretins|incretins|mesh-ancestor
101722708|NCT00673894|Hormones|hormones|mesh-ancestor
101722709|NCT00673894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101722710|NCT00673894|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101722711|NCT00673894|Protease Inhibitors|protease inhibitors|mesh-ancestor
101722712|NCT00673894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101722713|NCT00673894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722714|NCT00763204|Betamethasone|betamethasone|mesh-list
101722715|NCT00763204|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101722716|NCT00763204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101722717|NCT00763204|Glucocorticoids|glucocorticoids|mesh-ancestor
101722718|NCT00763204|Hormones|hormones|mesh-ancestor
101722719|NCT00763204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101722720|NCT00763204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722721|NCT00763204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101722722|NCT00763204|Respiratory System Agents|respiratory system agents|mesh-ancestor
101722723|NCT02558218|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
101722724|NCT02558218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101722725|NCT02558218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101722726|NCT02558218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101722727|NCT02558218|Glucocorticoids|glucocorticoids|mesh-ancestor
101722729|NCT02558218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101722730|NCT02558218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722731|NCT02558218|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101722732|NCT02558218|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101722733|NCT00763438|Sertindole|sertindole|mesh-list
101722734|NCT00763438|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101722735|NCT00763438|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101722736|NCT00763438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101722737|NCT00763438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722738|NCT00763438|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101722739|NCT02559232|Anticoagulants|anticoagulants|mesh-list
101722740|NCT00673816|Sunitinib|sunitinib|mesh-list
101722741|NCT00673816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101722742|NCT00673816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101722743|NCT00673816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101722744|NCT00673816|Growth Substances|growth substances|mesh-ancestor
101722745|NCT00673816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722746|NCT00673816|Growth Inhibitors|growth inhibitors|mesh-ancestor
101722747|NCT00673816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101722748|NCT00673816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101722749|NCT00673816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722750|NCT00763906|Norepinephrine|norepinephrine|mesh-list
101722751|NCT00763906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101722752|NCT00763906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101722753|NCT00763906|Adrenergic Agents|adrenergic agents|mesh-ancestor
101722754|NCT00763906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101722755|NCT00763906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722756|NCT00763906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722757|NCT00763906|Sympathomimetics|sympathomimetics|mesh-ancestor
101722758|NCT00763906|Autonomic Agents|autonomic agents|mesh-ancestor
101722759|NCT00763906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101722760|NCT00763906|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101722761|NCT00764062|Amoxicillin|amoxicillin|mesh-list
101722762|NCT00764062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101722763|NCT00764062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101722764|NCT00758914|Vitamin E|vitamin e|mesh-list
101722765|NCT00758914|Vitamins|vitamins|mesh-ancestor
101722767|NCT00758914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722768|NCT00758914|Antioxidants|antioxidants|mesh-ancestor
101722769|NCT00758914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722770|NCT00758914|Protective Agents|protective agents|mesh-ancestor
101722771|NCT00759070|Ritonavir|ritonavir|mesh-list
101722772|NCT00759070|Lopinavir|lopinavir|mesh-list
101722774|NCT00759070|Emtricitabine|emtricitabine|mesh-list
101722776|NCT00759070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101722777|NCT00759070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101722778|NCT00759070|Protease Inhibitors|protease inhibitors|mesh-ancestor
101722779|NCT00759070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101722780|NCT00759070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722782|NCT00759070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101722783|NCT00759070|Antiviral Agents|antiviral agents|mesh-ancestor
101722784|NCT00759070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101722785|NCT00759070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101722786|NCT00759070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101722787|NCT00759070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101722788|NCT00759070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101722789|NCT00759070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101722790|NCT00759070|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101722791|NCT00759070|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101722792|NCT00759070|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101722793|NCT00759070|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101722794|NCT00764140|Mitogens|mitogens|mesh-list
101722795|NCT00764140|Mitosis Modulators|mitosis modulators|mesh-ancestor
101722796|NCT00764140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722797|NCT00672958|Vortioxetine|vortioxetine|mesh-list
101722798|NCT00672958|Antidepressive Agents|antidepressive agents|mesh-ancestor
101722799|NCT00672958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101722800|NCT00672958|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101722801|NCT00672958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101722802|NCT00672958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101722803|NCT00672958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722804|NCT00672958|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101722805|NCT00672958|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101722806|NCT00672958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101722807|NCT00672958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722808|NCT00672958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101722809|NCT00672958|Serotonin Agents|serotonin agents|mesh-ancestor
101722810|NCT00672958|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101722811|NCT00672958|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101722812|NCT00672958|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101722813|NCT00672958|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101722814|NCT00764374|Z 338|z 338|mesh-list
101722815|NCT00764374|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101722816|NCT00764374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101722817|NCT00764374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722818|NCT00764374|Cholinergic Agents|cholinergic agents|mesh-ancestor
101722819|NCT00764374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101722820|NCT00764374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722821|NCT00764374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101722822|NCT00759226|Leucovorin|leucovorin|mesh-list
101722823|NCT00759226|Folic Acid|folic acid|mesh-list
101722824|NCT00759226|Cisplatin|cisplatin|mesh-list
101722825|NCT00759226|Gemcitabine|gemcitabine|mesh-list
101722826|NCT00759226|Levoleucovorin|levoleucovorin|mesh-list
101722827|NCT00759226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101722828|NCT00759226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101722829|NCT00759226|Antimetabolites|antimetabolites|mesh-ancestor
101722830|NCT00759226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722831|NCT00759226|Antidotes|antidotes|mesh-ancestor
101722832|NCT00759226|Protective Agents|protective agents|mesh-ancestor
101722833|NCT00759226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722834|NCT00759226|Vitamin B Complex|vitamin b complex|mesh-ancestor
101722835|NCT00759226|Vitamins|vitamins|mesh-ancestor
101722836|NCT00759226|Micronutrients|micronutrients|mesh-ancestor
101722837|NCT00759226|Hematinics|hematinics|mesh-ancestor
101722838|NCT00672646|Naproxen|naproxen|mesh-list
101722839|NCT00672646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101722840|NCT00672646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101722841|NCT00672646|Analgesics|analgesics|mesh-ancestor
101722842|NCT00672646|Sensory System Agents|sensory system agents|mesh-ancestor
101722843|NCT00672646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101722844|NCT00672646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722845|NCT00672646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101722846|NCT00672646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101380279|NCT00415831|Levodopa|levodopa|mesh-list
101722847|NCT00672646|Gout Suppressants|gout suppressants|mesh-ancestor
101722848|NCT00672646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101722849|NCT00672646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101722850|NCT00672646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722851|NCT00759460|Olanzapine|olanzapine|mesh-list
101722852|NCT00759460|Sertindole|sertindole|mesh-list
101722853|NCT00759460|Antiemetics|antiemetics|mesh-ancestor
101722854|NCT00759460|Autonomic Agents|autonomic agents|mesh-ancestor
101722855|NCT00759460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101722856|NCT00759460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722857|NCT00759460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101722858|NCT00759460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101722859|NCT00759460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101722860|NCT00759460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101722861|NCT00759460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101722862|NCT00759460|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101722863|NCT00759460|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101722864|NCT00759460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101722865|NCT00759460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722866|NCT00759460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101722867|NCT00759460|Serotonin Agents|serotonin agents|mesh-ancestor
101722868|NCT00765154|Ritonavir|ritonavir|mesh-list
101722869|NCT00765154|Darunavir|darunavir|mesh-list
101722870|NCT00765154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101722871|NCT00765154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101722872|NCT00765154|Protease Inhibitors|protease inhibitors|mesh-ancestor
101722873|NCT00765154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101722874|NCT00765154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722875|NCT00765154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101722876|NCT00765154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101722877|NCT00765154|Antiviral Agents|antiviral agents|mesh-ancestor
101722878|NCT00765154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101722879|NCT00765154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101722880|NCT00765154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101722881|NCT00672490|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101722882|NCT00672490|Antidepressive Agents|antidepressive agents|mesh-ancestor
101722883|NCT00672490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101722884|NCT00672490|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101722885|NCT00672490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101722886|NCT00672490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101722887|NCT00672490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722888|NCT00770302|Saxagliptin|saxagliptin|mesh-list
101722889|NCT00770302|Incretins|incretins|mesh-ancestor
101722890|NCT00770302|Hormones|hormones|mesh-ancestor
101722891|NCT00770302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101722892|NCT00770302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722893|NCT00770302|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101722894|NCT00770302|Protease Inhibitors|protease inhibitors|mesh-ancestor
101722895|NCT00770302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101722896|NCT00770302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722897|NCT00770302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101722898|NCT02557984|Naltrexone|naltrexone|mesh-list
101364186|NCT00145561|Saquinavir|saquinavir|mesh-list
101722899|NCT02557984|Amisulpride|amisulpride|mesh-list
101804483|NCT04013048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101722901|NCT02557984|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101722902|NCT02557984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722903|NCT02557984|Sensory System Agents|sensory system agents|mesh-ancestor
101722904|NCT02557984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101722905|NCT02557984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101722906|NCT02557984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101722907|NCT02557984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101722908|NCT02557984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101722909|NCT02557984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101722911|NCT02557984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101722912|NCT02557984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722913|NCT02557984|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101722914|NCT02557984|Antidepressive Agents|antidepressive agents|mesh-ancestor
101722915|NCT00759928|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101722916|NCT00759928|Sorafenib|sorafenib|mesh-list
101722917|NCT00759928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101722918|NCT00759928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101722919|NCT00759928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101722920|NCT00759928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722922|NCT00670930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101722923|NCT00670930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101722924|NCT00670930|Respiratory System Agents|respiratory system agents|mesh-ancestor
101722925|NCT00770536|Doxorubicin|doxorubicin|mesh-list
101722926|NCT00770536|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101722927|NCT00770536|Topotecan|topotecan|mesh-list
101722928|NCT00770536|Trebananib|trebananib|mesh-list
101722929|NCT00770536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101722930|NCT00770536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101722931|NCT00770536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101722932|NCT00770536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101722933|NCT00770536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101722934|NCT00770536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722935|NCT00770536|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101722936|NCT00770536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101722937|NCT00770536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101722938|NCT00770536|Growth Substances|growth substances|mesh-ancestor
101722939|NCT00770536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722940|NCT00770536|Growth Inhibitors|growth inhibitors|mesh-ancestor
101722941|NCT00771004|Pioglitazone|pioglitazone|mesh-list
101722942|NCT00771004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101722943|NCT00771004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722944|NCT00674362|Certolizumab Pegol|certolizumab pegol|mesh-list
101722945|NCT00674362|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101722946|NCT00674362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101722947|NCT00674362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101722948|NCT00674362|Immunologic Factors|immunologic factors|mesh-ancestor
101722949|NCT00674362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722950|NCT00674362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101722951|NCT00820950|Betamethasone|betamethasone|mesh-list
101722952|NCT00820950|Betamethasone Valerate|betamethasone valerate|mesh-list
101722953|NCT00820950|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101722954|NCT00820950|Betamethasone benzoate|betamethasone benzoate|mesh-list
101722955|NCT00820950|Calcipotriene|calcipotriene|mesh-list
101722956|NCT00820950|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101722957|NCT00820950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101722958|NCT00820950|Glucocorticoids|glucocorticoids|mesh-ancestor
101722959|NCT00820950|Hormones|hormones|mesh-ancestor
101722960|NCT00820950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101722961|NCT00820950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722962|NCT00820950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101722963|NCT00820950|Respiratory System Agents|respiratory system agents|mesh-ancestor
101722964|NCT00820950|Dermatologic Agents|dermatologic agents|mesh-ancestor
101722965|NCT00765934|Lidocaine|lidocaine|mesh-list
101722966|NCT00765934|Tetracaine|tetracaine|mesh-list
101722967|NCT00765934|Anesthetics, Local|anesthetics, local|mesh-ancestor
101722968|NCT00765934|Anesthetics|anesthetics|mesh-ancestor
101722969|NCT00765934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101722970|NCT00765934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722971|NCT00765934|Sensory System Agents|sensory system agents|mesh-ancestor
101722972|NCT00765934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101722973|NCT00765934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101364187|NCT00145561|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101722974|NCT00765934|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101722975|NCT00765934|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101722976|NCT00765934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101722977|NCT00765934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722978|NCT04049344|Oxaliplatin|oxaliplatin|mesh-list
101722979|NCT04049344|Decitabine|decitabine|mesh-list
101722980|NCT04049344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101722981|NCT04049344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101722982|NCT04049344|Antimetabolites|antimetabolites|mesh-ancestor
101722983|NCT04049344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101722985|NCT00670306|Cetrorelix|cetrorelix|mesh-list
101722986|NCT00670306|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101722987|NCT00670306|Fertility Agents|fertility agents|mesh-ancestor
101722988|NCT00670306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101722989|NCT00670306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722990|NCT00670306|Hormone Antagonists|hormone antagonists|mesh-ancestor
101722991|NCT00670306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101722992|NCT00709254|Fentanyl|fentanyl|mesh-list
101722993|NCT00709254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101722994|NCT00709254|Narcotics|narcotics|mesh-ancestor
101722995|NCT00709254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101722996|NCT00709254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101722997|NCT00709254|Analgesics|analgesics|mesh-ancestor
101722998|NCT00709254|Sensory System Agents|sensory system agents|mesh-ancestor
101722999|NCT00709254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101723000|NCT00709254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101723001|NCT00709254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101723002|NCT00709254|Anesthetics, General|anesthetics, general|mesh-ancestor
101723003|NCT00709254|Anesthetics|anesthetics|mesh-ancestor
101723004|NCT00760318|Levetiracetam|levetiracetam|mesh-list
101723005|NCT00760318|Anticonvulsants|anticonvulsants|mesh-ancestor
101723006|NCT00760318|Nootropic Agents|nootropic agents|mesh-ancestor
101723007|NCT00591630|Cytarabine|cytarabine|mesh-list
101723008|NCT00591630|Rituximab|rituximab|mesh-list
101723009|NCT00591630|Etoposide|etoposide|mesh-list
101723010|NCT00591630|Melphalan|melphalan|mesh-list
101723011|NCT00591630|Carmustine|carmustine|mesh-list
101723012|NCT00591630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101723013|NCT00591630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101723014|NCT00591630|Immunologic Factors|immunologic factors|mesh-ancestor
101723015|NCT00591630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723016|NCT00591630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101723017|NCT00591630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101723018|NCT00591630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101723019|NCT00591630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101723020|NCT00591630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101461842|NCT00235794|Sirolimus|sirolimus|mesh-list
101723021|NCT00591630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723022|NCT00591630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101723023|NCT00591630|Antimetabolites|antimetabolites|mesh-ancestor
101723024|NCT00591630|Antiviral Agents|antiviral agents|mesh-ancestor
101723025|NCT00591630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101723026|NCT00591630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101723027|NCT00591630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101723028|NCT00591630|Alkylating Agents|alkylating agents|mesh-ancestor
101723029|NCT00591630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101723030|NCT00771394|Tamsulosin|tamsulosin|mesh-list
101723031|NCT00771394|Solifenacin Succinate|solifenacin succinate|mesh-list
101723032|NCT00771394|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101723033|NCT00771394|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101723034|NCT00771394|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101723035|NCT00771394|Adrenergic Agents|adrenergic agents|mesh-ancestor
101723036|NCT00771394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101723037|NCT00771394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194126|NCT03400254|Gedatolisib|gedatolisib|mesh-list
101723038|NCT00771394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723039|NCT00771394|Urological Agents|urological agents|mesh-ancestor
101723040|NCT00771394|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101723041|NCT00771394|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101723042|NCT00771394|Cholinergic Agents|cholinergic agents|mesh-ancestor
101723043|NCT00670228|Insulin|insulin|mesh-list
101723044|NCT00670228|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101723045|NCT00670228|Insulin Glargine|insulin glargine|mesh-list
101723046|NCT00670228|Insulin glulisine|insulin glulisine|mesh-list
101723047|NCT00670228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101723048|NCT00670228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723049|NCT00766246|Bevacizumab|bevacizumab|mesh-list
101723050|NCT00766246|Carboplatin|carboplatin|mesh-list
101723051|NCT00766246|Docetaxel|docetaxel|mesh-list
101723052|NCT00766246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101723053|NCT00766246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101723054|NCT00766246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101723055|NCT00766246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101723056|NCT00766246|Growth Substances|growth substances|mesh-ancestor
101723057|NCT00766246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723058|NCT00766246|Growth Inhibitors|growth inhibitors|mesh-ancestor
101723059|NCT00766246|Tubulin Modulators|tubulin modulators|mesh-ancestor
101723060|NCT00766246|Antimitotic Agents|antimitotic agents|mesh-ancestor
101723061|NCT00766246|Mitosis Modulators|mitosis modulators|mesh-ancestor
101723062|NCT00766246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723063|NCT00766402|Acetaminophen|acetaminophen|mesh-list
101723064|NCT00766402|Diclofenac|diclofenac|mesh-list
101723065|NCT00766402|Tramadol|tramadol|mesh-list
101723066|NCT00766402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101723067|NCT00766402|Analgesics|analgesics|mesh-ancestor
101723068|NCT00766402|Sensory System Agents|sensory system agents|mesh-ancestor
101723069|NCT00766402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101723070|NCT00766402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723071|NCT00766402|Antipyretics|antipyretics|mesh-ancestor
101723072|NCT00766402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101723073|NCT00766402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101723074|NCT00766402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101723075|NCT00766402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101723076|NCT00766402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101723077|NCT00766402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723078|NCT00766402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101723079|NCT00766402|Narcotics|narcotics|mesh-ancestor
101723080|NCT00766402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101723081|NCT00771706|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101723082|NCT00771706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101723083|NCT00771706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723084|NCT00760864|Methotrexate|methotrexate|mesh-list
101723085|NCT00760864|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101723086|NCT00760864|Abortifacient Agents|abortifacient agents|mesh-ancestor
101723087|NCT00760864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101723088|NCT00760864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723089|NCT00760864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101723090|NCT00760864|Antimetabolites|antimetabolites|mesh-ancestor
101723091|NCT00760864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723092|NCT00760864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101723093|NCT00760864|Dermatologic Agents|dermatologic agents|mesh-ancestor
101723094|NCT00760864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101723095|NCT00760864|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101723096|NCT00760864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101723097|NCT00760864|Immunologic Factors|immunologic factors|mesh-ancestor
101723098|NCT00760864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101723099|NCT00760864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101723100|NCT00766480|Fluorouracil|fluorouracil|mesh-list
101723101|NCT00766480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101723102|NCT00766480|Antimetabolites|antimetabolites|mesh-ancestor
101723103|NCT00766480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723104|NCT00766480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101723105|NCT00766480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101723106|NCT00766480|Immunologic Factors|immunologic factors|mesh-ancestor
101723107|NCT00766480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723109|NCT00772174|Pioglitazone|pioglitazone|mesh-list
101723110|NCT00772174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101723111|NCT00772174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723112|NCT00772564|Atorvastatin|atorvastatin|mesh-list
101723113|NCT00772564|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101723114|NCT00772564|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101723115|NCT00772564|Antimetabolites|antimetabolites|mesh-ancestor
101723116|NCT00772564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723117|NCT00772564|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101723118|NCT00772564|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101723119|NCT00772564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101723120|NCT00766870|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101723121|NCT00766870|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101723122|NCT00766870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101723123|NCT00766870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101723124|NCT00766870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723125|NCT00766870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101723126|NCT00766870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723127|NCT00766870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101723128|NCT00766870|Antidepressive Agents|antidepressive agents|mesh-ancestor
101723129|NCT00766870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101723130|NCT00772720|Raltegravir Potassium|raltegravir potassium|mesh-list
101723131|NCT00772720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101723132|NCT00772720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101723133|NCT00772720|Antiviral Agents|antiviral agents|mesh-ancestor
101723134|NCT00772720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101723135|NCT00772720|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101723136|NCT00772720|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101723137|NCT00772720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101723138|NCT00772720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723140|NCT00775294|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101723141|NCT00775294|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101723142|NCT00775294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723143|NCT00775294|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101723144|NCT00775294|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101723145|NCT00775294|Antiviral Agents|antiviral agents|mesh-ancestor
101723146|NCT00775294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101723147|NCT00775294|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101723148|NCT00772798|Paclitaxel|paclitaxel|mesh-list
101723149|NCT00772798|Carboplatin|carboplatin|mesh-list
101723150|NCT00772798|Vorinostat|vorinostat|mesh-list
101723151|NCT00772798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101723153|NCT00772798|Tubulin Modulators|tubulin modulators|mesh-ancestor
101723154|NCT00772798|Antimitotic Agents|antimitotic agents|mesh-ancestor
101723155|NCT00772798|Mitosis Modulators|mitosis modulators|mesh-ancestor
101723156|NCT00772798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723157|NCT00772798|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101723158|NCT00772798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101723159|NCT00570778|Glycopyrrolate|glycopyrrolate|mesh-list
101723160|NCT00570778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101723161|NCT00570778|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101723162|NCT00570778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101723163|NCT00570778|Cholinergic Agents|cholinergic agents|mesh-ancestor
101723164|NCT00570778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101723165|NCT00570778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723166|NCT00570778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723167|NCT00775372|Clarithromycin|clarithromycin|mesh-list
101723168|NCT00775372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101723169|NCT00775372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101723170|NCT00775372|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101723171|NCT00775372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101723172|NCT00775372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723173|NCT00775372|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101723174|NCT00775372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101723175|NCT00668746|Minocycline|minocycline|mesh-list
101723176|NCT00668746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101723177|NCT00668746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101723178|NCT04047940|Metformin|metformin|mesh-list
101723179|NCT04047940|Valsartan|valsartan|mesh-list
101723180|NCT04047940|Atorvastatin|atorvastatin|mesh-list
101723181|NCT04047940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101723182|NCT04047940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723183|NCT04047940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101723184|NCT04047940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101723185|NCT04047940|Antimetabolites|antimetabolites|mesh-ancestor
101723186|NCT04047940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723187|NCT04047940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101723188|NCT04047940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101723189|NCT04047940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101723190|NCT04047940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101723191|NCT04047940|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101723192|NCT04047940|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101723193|NCT00773188|Bevacizumab|bevacizumab|mesh-list
101723194|NCT00773188|Vinorelbine|vinorelbine|mesh-list
101723195|NCT00773188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101723196|NCT00773188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101723197|NCT00773188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101804548|NCT00940550|GABA Modulators|gaba modulators|mesh-ancestor
101723198|NCT00773188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101723199|NCT00773188|Growth Substances|growth substances|mesh-ancestor
101723200|NCT00773188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723201|NCT00773188|Growth Inhibitors|growth inhibitors|mesh-ancestor
101723202|NCT00773188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101723203|NCT00773188|Tubulin Modulators|tubulin modulators|mesh-ancestor
101723204|NCT00773188|Antimitotic Agents|antimitotic agents|mesh-ancestor
101723205|NCT00773188|Mitosis Modulators|mitosis modulators|mesh-ancestor
101723206|NCT00773188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723207|NCT00767260|Insulin|insulin|mesh-list
101723208|NCT00767260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101723209|NCT00767260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723210|NCT00767494|Travoprost|travoprost|mesh-list
101723211|NCT00767494|Brinzolamide|brinzolamide|mesh-list
101723212|NCT00767494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101723213|NCT00767494|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101723214|NCT00767494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101723215|NCT00767494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723216|NCT00773578|Nitric Oxide|nitric oxide|mesh-list
101723217|NCT00773578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101723218|NCT00773578|Autonomic Agents|autonomic agents|mesh-ancestor
101723219|NCT00773578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101380670|NCT00268567|Prednisone|prednisone|mesh-list
101723220|NCT00773578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723221|NCT00773578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101723222|NCT00773578|Respiratory System Agents|respiratory system agents|mesh-ancestor
101723223|NCT00773578|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101723225|NCT00773578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723226|NCT00773578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101723227|NCT00773578|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101723228|NCT00773578|Vasodilator Agents|vasodilator agents|mesh-ancestor
101723229|NCT00773578|Gasotransmitters|gasotransmitters|mesh-ancestor
101723230|NCT00773578|Protective Agents|protective agents|mesh-ancestor
101723231|NCT00775762|Aspirin|aspirin|mesh-list
101723232|NCT00775762|Clopidogrel|clopidogrel|mesh-list
101723233|NCT00775762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101723234|NCT00775762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101723235|NCT00775762|Analgesics|analgesics|mesh-ancestor
101723236|NCT00775762|Sensory System Agents|sensory system agents|mesh-ancestor
101723237|NCT00775762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101723238|NCT00775762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723239|NCT00775762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101723240|NCT00775762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101723241|NCT00775762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101723242|NCT00775762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101723243|NCT00775762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723244|NCT00775762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101723245|NCT00775762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101723246|NCT00775762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101723247|NCT00775762|Antipyretics|antipyretics|mesh-ancestor
101804577|NCT00445978|Vasodilator Agents|vasodilator agents|mesh-ancestor
101723248|NCT00775762|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101723249|NCT00775762|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101723250|NCT00775762|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101723251|NCT00775762|Purinergic Agents|purinergic agents|mesh-ancestor
101723252|NCT00775762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101723253|NCT00775840|Candesartan|candesartan|mesh-list
101723254|NCT00775840|Candesartan cilexetil|candesartan cilexetil|mesh-list
101723255|NCT00775840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101723256|NCT00775840|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101723257|NCT00775840|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101723258|NCT00775840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723259|NCT00775918|Doxycycline|doxycycline|mesh-list
101723260|NCT00775918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101723261|NCT00775918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101723262|NCT00775918|Antimalarials|antimalarials|mesh-ancestor
101723263|NCT00775918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101723264|NCT00775918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101723265|NCT00878189|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
101723266|NCT00878189|Nirogacestat|nirogacestat|mesh-list
101194213|NCT02242344|Telmisartan|telmisartan|mesh-list
101723267|NCT00878189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101723268|NCT00878189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723269|NCT00775996|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
101723270|NCT00775996|Anticonvulsants|anticonvulsants|mesh-ancestor
101723271|NCT00775996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101723272|NCT00775996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101723273|NCT00775996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101723274|NCT00775996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723275|NCT00775996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101723276|NCT00775996|GABA Modulators|gaba modulators|mesh-ancestor
101723278|NCT00775996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101723279|NCT00775996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723280|NCT00773812|Mecamylamine|mecamylamine|mesh-list
101723281|NCT00773812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101723282|NCT00773812|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
101723283|NCT00773812|Autonomic Agents|autonomic agents|mesh-ancestor
101723284|NCT00773812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101723285|NCT00773812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723286|NCT00773812|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101723287|NCT00773812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101723288|NCT00773812|Cholinergic Agents|cholinergic agents|mesh-ancestor
101723289|NCT00773812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101723290|NCT00773812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723291|NCT00767728|Mesalamine|mesalamine|mesh-list
101723292|NCT00767728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101723293|NCT00767728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101723294|NCT00767728|Analgesics|analgesics|mesh-ancestor
101723295|NCT00767728|Sensory System Agents|sensory system agents|mesh-ancestor
101723296|NCT00767728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101723297|NCT00767728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723298|NCT00767728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101723299|NCT00767728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101723300|NCT00776074|Leuprolide|leuprolide|mesh-list
101723301|NCT00776074|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101723302|NCT00776074|Fertility Agents|fertility agents|mesh-ancestor
101723303|NCT00776074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101723304|NCT00776074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723305|NCT00776074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101723306|NCT00776074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101723307|NCT02628587|Clopidogrel|clopidogrel|mesh-list
101723308|NCT02628587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101723309|NCT02628587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101723310|NCT02628587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101723311|NCT02628587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101723312|NCT02628587|Purinergic Agents|purinergic agents|mesh-ancestor
101723313|NCT02628587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101723314|NCT02628587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723315|NCT02628587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723316|NCT02634437|Ulipristal acetate|ulipristal acetate|mesh-list
101723317|NCT02634437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101723318|NCT02634437|Contraceptive Agents|contraceptive agents|mesh-ancestor
101723319|NCT02634437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101723320|NCT02634437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723321|NCT02634437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101723322|NCT00668200|Vitamin D|vitamin d|mesh-list
101364202|NCT00145639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101723323|NCT00668200|Zoledronic Acid|zoledronic acid|mesh-list
101723324|NCT00668200|Calcium|calcium|mesh-list
101723325|NCT00668200|Vitamins|vitamins|mesh-ancestor
101723326|NCT00668200|Micronutrients|micronutrients|mesh-ancestor
101723327|NCT00668200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723328|NCT00668200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101723329|NCT00668200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101723330|NCT00679601|Tavaborole|tavaborole|mesh-list
101723331|NCT00679601|Antifungal Agents|antifungal agents|mesh-ancestor
101723332|NCT00679601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101723333|NCT00675779|Atorvastatin|atorvastatin|mesh-list
101723334|NCT00675779|Contraceptive Agents|contraceptive agents|mesh-list
101723335|NCT00675779|Contraceptives, Oral|contraceptives, oral|mesh-list
101723336|NCT00675779|Dacuronium|dacuronium|mesh-list
101723337|NCT00675779|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101723338|NCT00675779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101723339|NCT00675779|Antimetabolites|antimetabolites|mesh-ancestor
101723340|NCT00675779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723341|NCT00675779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101723342|NCT00675779|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101723343|NCT00675779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101723344|NCT00675779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101723345|NCT00675779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723346|NCT00675779|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101723347|NCT00675779|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101723348|NCT00675779|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101723349|NCT00675779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101723350|NCT00675779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101723351|NCT00774280|Cyclophosphamide|cyclophosphamide|mesh-list
101723352|NCT00774280|Busulfan|busulfan|mesh-list
101723353|NCT00774280|Fludarabine|fludarabine|mesh-list
101723354|NCT00774280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101723355|NCT00774280|Immunologic Factors|immunologic factors|mesh-ancestor
101723356|NCT00774280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723357|NCT00774280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101723358|NCT00774280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101723359|NCT00774280|Alkylating Agents|alkylating agents|mesh-ancestor
101723360|NCT00774280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723361|NCT00774280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101723362|NCT00774280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101723363|NCT04151147|Mitogens|mitogens|mesh-list
101723364|NCT04151147|Mitosis Modulators|mitosis modulators|mesh-ancestor
101723365|NCT04151147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723366|NCT00774358|Aldesleukin|aldesleukin|mesh-list
101804612|NCT00940784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101723368|NCT00774358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101723369|NCT00774358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101723370|NCT00774358|Analgesics|analgesics|mesh-ancestor
101723371|NCT00774358|Sensory System Agents|sensory system agents|mesh-ancestor
101723372|NCT00774358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101723373|NCT00774358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723374|NCT00774358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101723375|NCT00774358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101723376|NCT00774358|Antiviral Agents|antiviral agents|mesh-ancestor
101723377|NCT00774358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101723378|NCT02627417|Dapsone|dapsone|mesh-list
101723379|NCT02627417|Prednisone|prednisone|mesh-list
101723380|NCT02627417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101723381|NCT02627417|Glucocorticoids|glucocorticoids|mesh-ancestor
101723382|NCT02627417|Hormones|hormones|mesh-ancestor
101723383|NCT02627417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101723384|NCT02627417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723385|NCT02627417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101723386|NCT02627417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101723387|NCT02627417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101723388|NCT02627417|Antimalarials|antimalarials|mesh-ancestor
101194314|NCT02244294|Tamsulosin|tamsulosin|mesh-list
101723389|NCT02627417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101723390|NCT02627417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101723391|NCT02627417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101723392|NCT02627417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101723393|NCT02627417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723394|NCT02627417|Leprostatic Agents|leprostatic agents|mesh-ancestor
101723395|NCT02627417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101723397|NCT00679679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101723398|NCT00679679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723399|NCT00838578|Irinotecan|irinotecan|mesh-list
101723400|NCT00838578|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101723401|NCT00838578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101723402|NCT00838578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101723403|NCT00838578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723404|NCT00838578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101723405|NCT02634515|Insulin|insulin|mesh-list
101723406|NCT02634515|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101723407|NCT02634515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101723408|NCT02634515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723409|NCT00705900|Calcipotriene|calcipotriene|mesh-list
101723410|NCT00705900|Dermatologic Agents|dermatologic agents|mesh-ancestor
101723411|NCT00679835|Daptomycin|daptomycin|mesh-list
101723412|NCT00679835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101723413|NCT00679835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101723414|NCT00774904|Losartan|losartan|mesh-list
101723415|NCT00774904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101723416|NCT00774904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101723417|NCT00774904|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101723418|NCT00774904|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101723419|NCT00774904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723420|NCT00829296|Metoprolol|metoprolol|mesh-list
101723421|NCT00829296|Nebivolol|nebivolol|mesh-list
101723422|NCT00829296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101723423|NCT00829296|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101723424|NCT00829296|Sympatholytics|sympatholytics|mesh-ancestor
101723425|NCT00829296|Autonomic Agents|autonomic agents|mesh-ancestor
101723426|NCT00829296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101723427|NCT00829296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723428|NCT00829296|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101723429|NCT00829296|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101723430|NCT00829296|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101723431|NCT00829296|Adrenergic Agents|adrenergic agents|mesh-ancestor
101723432|NCT00829296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101723433|NCT00829296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723434|NCT00829296|Vasodilator Agents|vasodilator agents|mesh-ancestor
101723435|NCT00829296|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101723436|NCT00829296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101723437|NCT00829296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101723438|NCT00774982|Mercaptopurine|mercaptopurine|mesh-list
101723439|NCT00774982|Antimetabolites|antimetabolites|mesh-ancestor
101723440|NCT00774982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723441|NCT00774982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101380875|NCT00269737|Anesthetics|anesthetics|mesh-ancestor
101723442|NCT00774982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101723443|NCT00774982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101723444|NCT00774982|Immunologic Factors|immunologic factors|mesh-ancestor
101723445|NCT00774982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723446|NCT00774982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101723447|NCT00774982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101723449|NCT00881621|Lapatinib|lapatinib|mesh-list
101723450|NCT00881621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101723451|NCT00881621|Antimetabolites|antimetabolites|mesh-ancestor
101723452|NCT00881621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723453|NCT00881621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101723454|NCT00881621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101723455|NCT00881621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101723456|NCT02634281|Varenicline|varenicline|mesh-list
101723457|NCT02634281|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101723458|NCT02634281|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101723459|NCT02634281|Cholinergic Agents|cholinergic agents|mesh-ancestor
101723460|NCT02634281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101723461|NCT02634281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723462|NCT02634281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723463|NCT00818766|Vancomycin|vancomycin|mesh-list
101723464|NCT00818766|Cefazolin|cefazolin|mesh-list
101723465|NCT00818766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101723466|NCT00818766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101723467|NCT00779350|Sertraline|sertraline|mesh-list
101723468|NCT00779350|Antidepressive Agents|antidepressive agents|mesh-ancestor
101723469|NCT00779350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101723470|NCT00779350|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101723471|NCT00779350|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101723472|NCT00779350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101723473|NCT00779350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723474|NCT00779350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101723475|NCT00779350|Serotonin Agents|serotonin agents|mesh-ancestor
101723476|NCT00779350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723477|NCT00705978|Pancreatin|pancreatin|mesh-list
101723478|NCT00705978|Pancrelipase|pancrelipase|mesh-list
101723479|NCT00705978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101723480|NCT02556970|Acetaminophen|acetaminophen|mesh-list
101723481|NCT02556970|Diclofenac|diclofenac|mesh-list
101723482|NCT02556970|Levobupivacaine|levobupivacaine|mesh-list
101723483|NCT02556970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101723484|NCT02556970|Analgesics|analgesics|mesh-ancestor
101723485|NCT02556970|Sensory System Agents|sensory system agents|mesh-ancestor
101723486|NCT02556970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101723487|NCT02556970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723489|NCT02556970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101723490|NCT02556970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101723491|NCT02556970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101723492|NCT02556970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101723493|NCT02556970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101723494|NCT02556970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723495|NCT02556970|Anesthetics, Local|anesthetics, local|mesh-ancestor
101723496|NCT02556970|Anesthetics|anesthetics|mesh-ancestor
101723497|NCT02556970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101723499|NCT00594815|Cytarabine|cytarabine|mesh-list
101723500|NCT00594815|Rituximab|rituximab|mesh-list
101723501|NCT00594815|Methotrexate|methotrexate|mesh-list
101723502|NCT00594815|Vincristine|vincristine|mesh-list
101723503|NCT00594815|Procarbazine|procarbazine|mesh-list
101723504|NCT00594815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101723505|NCT00594815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101723506|NCT00594815|Immunologic Factors|immunologic factors|mesh-ancestor
101723507|NCT00594815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723508|NCT00594815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101723509|NCT00594815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101723510|NCT00594815|Abortifacient Agents|abortifacient agents|mesh-ancestor
101723511|NCT00594815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101723512|NCT00594815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101723513|NCT00594815|Antimetabolites|antimetabolites|mesh-ancestor
101723514|NCT00594815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723515|NCT00594815|Dermatologic Agents|dermatologic agents|mesh-ancestor
101723516|NCT00594815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101723517|NCT00594815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101380952|NCT00269971|Epoetin Alfa|epoetin alfa|mesh-list
101723518|NCT00594815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101723519|NCT00594815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101723520|NCT00594815|Antiviral Agents|antiviral agents|mesh-ancestor
101723521|NCT00594815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101804663|NCT04061057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723522|NCT00594815|Antidotes|antidotes|mesh-ancestor
101723523|NCT00594815|Protective Agents|protective agents|mesh-ancestor
101723524|NCT00594815|Vitamin B Complex|vitamin b complex|mesh-ancestor
101723525|NCT00594815|Vitamins|vitamins|mesh-ancestor
101723526|NCT00594815|Micronutrients|micronutrients|mesh-ancestor
101723527|NCT00594815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101723528|NCT00594815|Tubulin Modulators|tubulin modulators|mesh-ancestor
101723529|NCT00594815|Antimitotic Agents|antimitotic agents|mesh-ancestor
101723530|NCT00594815|Mitosis Modulators|mitosis modulators|mesh-ancestor
101723531|NCT00776542|Minocycline|minocycline|mesh-list
101723532|NCT00776542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101723533|NCT00776542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101723534|NCT00776620|Glimepiride|glimepiride|mesh-list
101194409|NCT02248428|Antiemetics|antiemetics|mesh-ancestor
101723535|NCT00776620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101723536|NCT00776620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101723537|NCT00776620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723538|NCT00776620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101723539|NCT00776620|Immunologic Factors|immunologic factors|mesh-ancestor
101723540|NCT00776698|Bevacizumab|bevacizumab|mesh-list
101723541|NCT00776698|Etoposide|etoposide|mesh-list
101723542|NCT00776698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101723543|NCT00776698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101723544|NCT00776698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101723545|NCT00776698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101723546|NCT00776698|Growth Substances|growth substances|mesh-ancestor
101723547|NCT00776698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723548|NCT00776698|Growth Inhibitors|growth inhibitors|mesh-ancestor
101723549|NCT00776698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101723550|NCT00776698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101723551|NCT00776698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101723552|NCT00776698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101723553|NCT00776698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723554|NCT04150757|Ketamine|ketamine|mesh-list
101723555|NCT04150757|Analgesics|analgesics|mesh-ancestor
101723556|NCT04150757|Sensory System Agents|sensory system agents|mesh-ancestor
101723557|NCT04150757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101723558|NCT04150757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723559|NCT04150757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101723560|NCT04150757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101723561|NCT04150757|Anesthetics, General|anesthetics, general|mesh-ancestor
101723562|NCT04150757|Anesthetics|anesthetics|mesh-ancestor
101723563|NCT04150757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101723564|NCT04150757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101723565|NCT04150757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101723566|NCT04150757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101723567|NCT04150757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723568|NCT04150367|Rifampin|rifampin|mesh-list
101723569|NCT04150367|Isoniazid|isoniazid|mesh-list
101723570|NCT04150367|Ethambutol|ethambutol|mesh-list
101723571|NCT04150367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101723572|NCT04150367|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101723573|NCT04150367|Antitubercular Agents|antitubercular agents|mesh-ancestor
101723574|NCT04150367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101723575|NCT04150367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101723577|NCT04150367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101723578|NCT04150367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101723579|NCT04150367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723580|NCT04150367|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101723581|NCT04150367|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101723582|NCT04150367|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101723583|NCT04150367|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101723584|NCT04150367|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101723585|NCT04150367|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101804695|NCT05472779|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101804696|NCT05472779|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101723586|NCT04150367|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101723587|NCT04150367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101723588|NCT04150367|Antimetabolites|antimetabolites|mesh-ancestor
101723589|NCT04150367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101723590|NCT02634203|Riociguat|riociguat|mesh-list
101723591|NCT02634203|Enzyme Activators|enzyme activators|mesh-ancestor
101723592|NCT02634203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723593|NCT00681005|Rabeprazole|rabeprazole|mesh-list
101723594|NCT00681005|Pantoprazole|pantoprazole|mesh-list
101723595|NCT00681005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101723596|NCT00681005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101723597|NCT00681005|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101723598|NCT00681005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101723599|NCT00681005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723600|NCT02633969|Indomethacin|indomethacin|mesh-list
101723601|NCT02633969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101723602|NCT02633969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101723603|NCT02633969|Analgesics|analgesics|mesh-ancestor
101723604|NCT02633969|Sensory System Agents|sensory system agents|mesh-ancestor
101723605|NCT02633969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101723606|NCT02633969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723607|NCT02633969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101723608|NCT02633969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101723609|NCT02633969|Gout Suppressants|gout suppressants|mesh-ancestor
101723610|NCT02633969|Tocolytic Agents|tocolytic agents|mesh-ancestor
101723611|NCT02633969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101723612|NCT02633969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101723613|NCT02633969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101723614|NCT02633969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723616|NCT00684827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101723617|NCT00684827|Autonomic Agents|autonomic agents|mesh-ancestor
101723618|NCT00684827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101723619|NCT00684827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723620|NCT00684827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101723621|NCT00684827|Respiratory System Agents|respiratory system agents|mesh-ancestor
101723622|NCT00684827|Tocolytic Agents|tocolytic agents|mesh-ancestor
101723623|NCT00684827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101723624|NCT00684827|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101723625|NCT00684827|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101723626|NCT00684827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101723627|NCT00684827|Adrenergic Agents|adrenergic agents|mesh-ancestor
101723628|NCT00684827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101723629|NCT00684827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723630|NCT00820170|Paclitaxel|paclitaxel|mesh-list
101723631|NCT00820170|Dasatinib|dasatinib|mesh-list
101723632|NCT00820170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101723633|NCT00820170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101723634|NCT00820170|Tubulin Modulators|tubulin modulators|mesh-ancestor
101723635|NCT00820170|Antimitotic Agents|antimitotic agents|mesh-ancestor
101723636|NCT00820170|Mitosis Modulators|mitosis modulators|mesh-ancestor
101723637|NCT00820170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723638|NCT00820170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101723639|NCT00820170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101723640|NCT02627027|Metformin|metformin|mesh-list
101723641|NCT02627027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101723642|NCT02627027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723643|NCT00709332|Folic Acid|folic acid|mesh-list
101804705|NCT05472779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101723644|NCT00709332|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101723645|NCT00709332|Norgestimate|norgestimate|mesh-list
101723646|NCT00709332|Estradiol|estradiol|mesh-list
101723647|NCT00709332|Estrogens|estrogens|mesh-ancestor
101723648|NCT00709332|Hormones|hormones|mesh-ancestor
101723649|NCT00709332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101723650|NCT00709332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723651|NCT00709332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101723652|NCT00709332|Contraceptive Agents|contraceptive agents|mesh-ancestor
101723653|NCT00709332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101723654|NCT00709332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101723655|NCT00709332|Hematinics|hematinics|mesh-ancestor
101723656|NCT00709332|Vitamin B Complex|vitamin b complex|mesh-ancestor
101723657|NCT00709332|Vitamins|vitamins|mesh-ancestor
101723658|NCT00709332|Micronutrients|micronutrients|mesh-ancestor
101723659|NCT00709332|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101723660|NCT00709332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101723661|NCT00709332|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101723662|NCT00684905|Leuprolide|leuprolide|mesh-list
101723663|NCT00684905|Bicalutamide|bicalutamide|mesh-list
101723664|NCT00684905|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101723665|NCT00684905|Fertility Agents|fertility agents|mesh-ancestor
101723666|NCT00684905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101723667|NCT00684905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723668|NCT00684905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101723669|NCT00684905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101723670|NCT00684905|Androgen Antagonists|androgen antagonists|mesh-ancestor
101723671|NCT00684905|Hormone Antagonists|hormone antagonists|mesh-ancestor
101723672|NCT00684905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101723673|NCT00685061|Alemtuzumab|alemtuzumab|mesh-list
101723674|NCT00685061|Thymoglobulin|thymoglobulin|mesh-list
101723675|NCT00685061|Daclizumab|daclizumab|mesh-list
101723676|NCT00685061|Immunologic Factors|immunologic factors|mesh-ancestor
101723677|NCT00685061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723678|NCT00685061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101723679|NCT00685061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101723680|NCT00685061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101723681|NCT02633813|Naftifine|naftifine|mesh-list
101723682|NCT02633813|Antifungal Agents|antifungal agents|mesh-ancestor
101723683|NCT02633813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101723684|NCT00818454|Albuterol|albuterol|mesh-list
101723685|NCT00818454|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101723686|NCT00818454|Autonomic Agents|autonomic agents|mesh-ancestor
101723687|NCT00818454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101723688|NCT00818454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723689|NCT00818454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101723690|NCT00818454|Respiratory System Agents|respiratory system agents|mesh-ancestor
101723691|NCT00818454|Tocolytic Agents|tocolytic agents|mesh-ancestor
101723692|NCT00818454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101723693|NCT00818454|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101723694|NCT00818454|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101723695|NCT00818454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101723696|NCT00818454|Adrenergic Agents|adrenergic agents|mesh-ancestor
101723697|NCT00818454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101723698|NCT00818454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723700|NCT02626247|Vitamins|vitamins|mesh-ancestor
101723701|NCT02626247|Micronutrients|micronutrients|mesh-ancestor
101723702|NCT02626247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723703|NCT00828984|Laxatives|laxatives|mesh-list
101804730|NCT02566187|Atorvastatin|atorvastatin|mesh-list
101723704|NCT00828984|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101723705|NCT00828984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101723706|NCT00819390|Chloroquine|chloroquine|mesh-list
101723707|NCT00819390|Amebicides|amebicides|mesh-ancestor
101723708|NCT00819390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101723709|NCT00819390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101723710|NCT00819390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101723711|NCT00819390|Antimalarials|antimalarials|mesh-ancestor
101723712|NCT00819390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101723713|NCT00876395|Paclitaxel|paclitaxel|mesh-list
101723714|NCT00876395|Trastuzumab|trastuzumab|mesh-list
101723715|NCT00876395|Everolimus|everolimus|mesh-list
101723716|NCT00876395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101723717|NCT00876395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101723718|NCT00876395|Tubulin Modulators|tubulin modulators|mesh-ancestor
101723719|NCT00876395|Antimitotic Agents|antimitotic agents|mesh-ancestor
101723720|NCT00876395|Mitosis Modulators|mitosis modulators|mesh-ancestor
101262979|NCT01759940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101723721|NCT00876395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723722|NCT00876395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101723723|NCT00876395|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101723724|NCT00876395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101723725|NCT00876395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101723726|NCT00876395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101723727|NCT00876395|Immunologic Factors|immunologic factors|mesh-ancestor
101723728|NCT00876395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723729|NCT05758662|Listerine|listerine|mesh-list
101723730|NCT05758662|Fluorides|fluorides|mesh-list
101723731|NCT05758662|Sodium Fluoride|sodium fluoride|mesh-list
101723732|NCT05758662|Cariostatic Agents|cariostatic agents|mesh-ancestor
101723733|NCT05758662|Protective Agents|protective agents|mesh-ancestor
101723734|NCT05758662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723735|NCT05758662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101723736|NCT05758662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101723737|NCT02633657|Gabapentin|gabapentin|mesh-list
101723738|NCT02633657|Analgesics|analgesics|mesh-ancestor
101723739|NCT02633657|Sensory System Agents|sensory system agents|mesh-ancestor
101723740|NCT02633657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101723741|NCT02633657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723742|NCT02633657|Anticonvulsants|anticonvulsants|mesh-ancestor
101723743|NCT02633657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101723744|NCT02633657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101723745|NCT02633657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101723746|NCT02633657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101723747|NCT02633657|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101723748|NCT02633657|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101723749|NCT02633657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101723750|NCT02633657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723751|NCT02633657|Antimanic Agents|antimanic agents|mesh-ancestor
101723752|NCT02626169|Clopidogrel|clopidogrel|mesh-list
101723753|NCT02626169|Ticagrelor|ticagrelor|mesh-list
101723754|NCT02626169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101723755|NCT02626169|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101723756|NCT02626169|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101723757|NCT02626169|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101723758|NCT02626169|Purinergic Agents|purinergic agents|mesh-ancestor
101723759|NCT02626169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101723760|NCT02626169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723761|NCT02626169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723762|NCT04139915|Dactolisib|dactolisib|mesh-list
101723763|NCT04139915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101723764|NCT04148183|Metformin|metformin|mesh-list
101723765|NCT04148183|Rosiglitazone|rosiglitazone|mesh-list
101723766|NCT04148183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101723767|NCT04148183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723768|NCT00681395|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101723769|NCT00681395|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101723770|NCT00681395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101723771|NCT00681395|Antimetabolites|antimetabolites|mesh-ancestor
101723772|NCT00681395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723773|NCT00681395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101723774|NCT00681395|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101723775|NCT00681395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101723776|NCT02633579|Erythromycin|erythromycin|mesh-list
101723777|NCT02633579|Erythromycin Estolate|erythromycin estolate|mesh-list
101723778|NCT02633579|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101723779|NCT02633579|Erythromycin stearate|erythromycin stearate|mesh-list
101723780|NCT02633579|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
101723781|NCT02633579|Atropine|atropine|mesh-list
101723782|NCT02633579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101723783|NCT02633579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101723784|NCT02633579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101723785|NCT02633579|Autonomic Agents|autonomic agents|mesh-ancestor
101723786|NCT02633579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101723787|NCT02633579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723788|NCT02633579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101723789|NCT02633579|Respiratory System Agents|respiratory system agents|mesh-ancestor
101723790|NCT02633579|Mydriatics|mydriatics|mesh-ancestor
101723791|NCT02633579|Parasympatholytics|parasympatholytics|mesh-ancestor
101723792|NCT02633579|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101723793|NCT02633579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101723794|NCT02633579|Cholinergic Agents|cholinergic agents|mesh-ancestor
101723796|NCT02633579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723797|NCT02633579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101723798|NCT02633579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101723799|NCT02633579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101723800|NCT02633579|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101723801|NCT02633579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101723802|NCT00685529|Formoterol Fumarate|formoterol fumarate|mesh-list
101723803|NCT00685529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101723804|NCT00685529|Autonomic Agents|autonomic agents|mesh-ancestor
101723805|NCT00685529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101723806|NCT00685529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723807|NCT00685529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101723808|NCT00685529|Respiratory System Agents|respiratory system agents|mesh-ancestor
101723809|NCT00685529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101723810|NCT00685529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101723811|NCT00685529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101723812|NCT00685529|Adrenergic Agents|adrenergic agents|mesh-ancestor
101723813|NCT00685529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101723814|NCT00685529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723815|NCT00685607|Simethicone|simethicone|mesh-list
101723816|NCT00685607|Loperamide|loperamide|mesh-list
101723817|NCT00685607|Antidiarrheals|antidiarrheals|mesh-list
101723818|NCT00685607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101723819|NCT00685607|Antifoaming Agents|antifoaming agents|mesh-ancestor
101723820|NCT00685607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723821|NCT00685607|Emollients|emollients|mesh-ancestor
101723822|NCT00685607|Dermatologic Agents|dermatologic agents|mesh-ancestor
101723823|NCT00657059|Mycophenolic Acid|mycophenolic acid|mesh-list
101723824|NCT00657059|Prednisone|prednisone|mesh-list
101723825|NCT00657059|Methylprednisolone|methylprednisolone|mesh-list
101723826|NCT00657059|Irbesartan|irbesartan|mesh-list
101723827|NCT00657059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101723828|NCT00657059|Glucocorticoids|glucocorticoids|mesh-ancestor
101723829|NCT00657059|Hormones|hormones|mesh-ancestor
101723830|NCT00657059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101804750|NCT05324891|Adrenergic Agents|adrenergic agents|mesh-ancestor
101804751|NCT05324891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101723831|NCT00657059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723832|NCT00657059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101723833|NCT00657059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101723834|NCT00657059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101723835|NCT00657059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101723836|NCT00657059|Antitubercular Agents|antitubercular agents|mesh-ancestor
101723837|NCT00657059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101723838|NCT00657059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101723839|NCT00657059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101723840|NCT00657059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723841|NCT00657059|Antiemetics|antiemetics|mesh-ancestor
101723842|NCT00657059|Autonomic Agents|autonomic agents|mesh-ancestor
101723843|NCT00657059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101723844|NCT00657059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101723845|NCT00657059|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101723846|NCT00657059|Protective Agents|protective agents|mesh-ancestor
101723847|NCT00657059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101723848|NCT00657059|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101723849|NCT00657059|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101723850|NCT00667732|Exenatide|exenatide|mesh-list
101723851|NCT00667732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101723852|NCT00667732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723853|NCT00667732|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101723854|NCT00667732|Incretins|incretins|mesh-ancestor
101723855|NCT00667732|Hormones|hormones|mesh-ancestor
101723856|NCT00667732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101723857|NCT04161209|Citalopram|citalopram|mesh-list
101723858|NCT04161209|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101723859|NCT04161209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101723860|NCT04161209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101723861|NCT04161209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723862|NCT04161209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101723863|NCT04161209|Serotonin Agents|serotonin agents|mesh-ancestor
101723864|NCT04161209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723865|NCT04161209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101723866|NCT04161209|Antidepressive Agents|antidepressive agents|mesh-ancestor
101723867|NCT04161209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101723868|NCT04161053|Rifaximin|rifaximin|mesh-list
101723869|NCT04161053|Nitazoxanide|nitazoxanide|mesh-list
101723870|NCT04161053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101723871|NCT04161053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101723872|NCT04161053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101723873|NCT04161053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101723874|NCT00685841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101723875|NCT00685841|Formoterol Fumarate|formoterol fumarate|mesh-list
101723876|NCT00685841|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101723877|NCT00685841|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101723878|NCT00685841|Autonomic Agents|autonomic agents|mesh-ancestor
101723879|NCT00685841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101723880|NCT00685841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723881|NCT00685841|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101723882|NCT00685841|Respiratory System Agents|respiratory system agents|mesh-ancestor
101723883|NCT00685841|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101723884|NCT00685841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101804763|NCT00445432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101723885|NCT00685841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101723886|NCT00685841|Adrenergic Agents|adrenergic agents|mesh-ancestor
101723887|NCT00685841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101723888|NCT00685841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723889|NCT00681785|Dalteparin|dalteparin|mesh-list
101723890|NCT00681785|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101723891|NCT00681785|Anticoagulants|anticoagulants|mesh-ancestor
101723892|NCT00681785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101723893|NCT00681785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101723894|NCT00681785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723895|NCT00671788|Dasatinib|dasatinib|mesh-list
101723896|NCT00671788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101723897|NCT00671788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101723898|NCT00671788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101723899|NCT00671788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723900|NCT02626481|Dexamethasone|dexamethasone|mesh-list
101723901|NCT02626481|Daratumumab|daratumumab|mesh-list
101723902|NCT02626481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101723903|NCT02626481|Antiemetics|antiemetics|mesh-ancestor
101723904|NCT02626481|Autonomic Agents|autonomic agents|mesh-ancestor
101723905|NCT02626481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101723906|NCT02626481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723907|NCT02626481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101723908|NCT02626481|Glucocorticoids|glucocorticoids|mesh-ancestor
101723909|NCT02626481|Hormones|hormones|mesh-ancestor
101723910|NCT02626481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101723911|NCT02626481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101723912|NCT02626481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101723913|NCT00777166|Oxytocin|oxytocin|mesh-list
101723914|NCT00777166|Oxytocics|oxytocics|mesh-ancestor
101723915|NCT00777166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101194648|NCT00553644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101723916|NCT00777166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723918|NCT00681941|Chelating Agents|chelating agents|mesh-ancestor
101723919|NCT00681941|Sequestering Agents|sequestering agents|mesh-ancestor
101723920|NCT00681941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723921|NCT00657137|Capecitabine|capecitabine|mesh-list
101723922|NCT00657137|Lapatinib|lapatinib|mesh-list
101723923|NCT00657137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101723924|NCT00657137|Antimetabolites|antimetabolites|mesh-ancestor
101723925|NCT00657137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723926|NCT00657137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101723927|NCT00657137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101723928|NCT00657137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101723929|NCT00777244|Mitotane|mitotane|mesh-list
101723930|NCT00777244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101723931|NCT00777244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101723932|NCT04160897|Tenofovir|tenofovir|mesh-list
101723933|NCT04160897|Entecavir|entecavir|mesh-list
101723934|NCT04160897|Antiviral Agents|antiviral agents|mesh-ancestor
101723935|NCT04160897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101723936|NCT04160897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101723937|NCT04160897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101723938|NCT04160897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101723939|NCT04160897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723940|NCT04160897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101723941|NCT04160897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101723943|NCT00777322|Dextrans|dextrans|mesh-list
101723944|NCT00777322|Vitamin B Complex|vitamin b complex|mesh-ancestor
101723945|NCT00777322|Vitamins|vitamins|mesh-ancestor
101723946|NCT00777322|Micronutrients|micronutrients|mesh-ancestor
101723947|NCT00777322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723948|NCT00777322|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101723949|NCT00777322|Dermatologic Agents|dermatologic agents|mesh-ancestor
101723950|NCT00777322|Anticoagulants|anticoagulants|mesh-ancestor
101723951|NCT00777322|Plasma Substitutes|plasma substitutes|mesh-ancestor
101804784|NCT02565641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101723952|NCT00777322|Blood Substitutes|blood substitutes|mesh-ancestor
101723953|NCT00682019|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101723954|NCT00682019|Vasodilator Agents|vasodilator agents|mesh-ancestor
101723955|NCT00682019|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101723956|NCT00682019|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101723957|NCT00682019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101723958|NCT00682019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723959|NCT00682019|Urological Agents|urological agents|mesh-ancestor
101723960|NCT00779896|Tazarotene|tazarotene|mesh-list
101723961|NCT00779896|Dermatologic Agents|dermatologic agents|mesh-ancestor
101723962|NCT00779896|Keratolytic Agents|keratolytic agents|mesh-ancestor
101723963|NCT02556268|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101723964|NCT02556268|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101723965|NCT02556268|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101723966|NCT02556268|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
101723967|NCT02556268|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
101723968|NCT02556268|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
101723969|NCT02556268|Riociguat|riociguat|mesh-list
101723970|NCT02556268|Protease Inhibitors|protease inhibitors|mesh-list
101723971|NCT02556268|Antiviral Agents|antiviral agents|mesh-ancestor
101723972|NCT02556268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101723973|NCT02556268|Enzyme Activators|enzyme activators|mesh-ancestor
101723974|NCT02556268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723975|NCT02556268|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101723976|NCT02556268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101723977|NCT02556268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101723978|NCT02556268|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101723979|NCT02556268|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101723980|NCT00875615|Carboplatin|carboplatin|mesh-list
101723981|NCT00875615|Sorafenib|sorafenib|mesh-list
101723982|NCT00875615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101723983|NCT00875615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101723984|NCT00875615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101723985|NCT00875615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101723986|NCT02626559|Bupivacaine|bupivacaine|mesh-list
101723987|NCT02626559|Anesthetics, Local|anesthetics, local|mesh-ancestor
101723988|NCT02626559|Anesthetics|anesthetics|mesh-ancestor
101723989|NCT02626559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101723990|NCT02626559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723991|NCT02626559|Sensory System Agents|sensory system agents|mesh-ancestor
101723992|NCT02626559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101723993|NCT00768508|Naltrexone|naltrexone|mesh-list
101723994|NCT00768508|Ondansetron|ondansetron|mesh-list
101723995|NCT00768508|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101723996|NCT00768508|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101723997|NCT00768508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101723998|NCT00768508|Sensory System Agents|sensory system agents|mesh-ancestor
101723999|NCT00768508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101724000|NCT00768508|Antiemetics|antiemetics|mesh-ancestor
101724001|NCT00768508|Autonomic Agents|autonomic agents|mesh-ancestor
101724002|NCT00768508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101724003|NCT00768508|Antipruritics|antipruritics|mesh-ancestor
101724004|NCT00768508|Dermatologic Agents|dermatologic agents|mesh-ancestor
101724005|NCT00768508|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101724006|NCT00768508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101724007|NCT00768508|Serotonin Agents|serotonin agents|mesh-ancestor
101724008|NCT00768508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101724009|NCT00768508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724010|NCT00682487|Hydrocortisone|hydrocortisone|mesh-list
101724011|NCT00682487|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101724012|NCT00682487|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101724013|NCT00682487|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101724014|NCT00682487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101724015|NCT00777478|Sunitinib|sunitinib|mesh-list
101724016|NCT00777478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101724017|NCT00777478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101724018|NCT00777478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101724019|NCT00777478|Growth Substances|growth substances|mesh-ancestor
101724020|NCT00777478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724021|NCT00777478|Growth Inhibitors|growth inhibitors|mesh-ancestor
101724022|NCT00777478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101724023|NCT00777478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724024|NCT00777478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724025|NCT00780598|Tosedostat|tosedostat|mesh-list
101724026|NCT00780598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724027|NCT00780598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724028|NCT00780754|Dutasteride|dutasteride|mesh-list
101724029|NCT00780754|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101724030|NCT00780754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101724031|NCT00780754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724032|NCT00780754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724033|NCT00780754|Hormone Antagonists|hormone antagonists|mesh-ancestor
101724034|NCT00780754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101724035|NCT00780754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724036|NCT00780832|Caffeine|caffeine|mesh-list
101724037|NCT00780832|Cholinergic Antagonists|cholinergic antagonists|mesh-list
101724038|NCT00780832|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101724039|NCT00780832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724040|NCT00780832|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101724041|NCT00780832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724042|NCT00780832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381483|NCT00274339|Lansoprazole|lansoprazole|mesh-list
101364227|NCT00145990|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101724043|NCT00780832|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101724044|NCT00780832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101724045|NCT00780832|Purinergic Agents|purinergic agents|mesh-ancestor
101724046|NCT00780832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101724047|NCT00780832|Cholinergic Agents|cholinergic agents|mesh-ancestor
101724048|NCT00597701|Lorazepam|lorazepam|mesh-list
101724049|NCT00597701|Baclofen|baclofen|mesh-list
101724050|NCT00597701|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101724051|NCT00597701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724052|NCT00597701|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101724053|NCT00597701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101724054|NCT00597701|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101724055|NCT00597701|GABA Agonists|gaba agonists|mesh-ancestor
101724056|NCT00597701|GABA Agents|gaba agents|mesh-ancestor
101724057|NCT00597701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101724058|NCT00597701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724059|NCT00597701|Anticonvulsants|anticonvulsants|mesh-ancestor
101724060|NCT00597701|Antiemetics|antiemetics|mesh-ancestor
101724061|NCT00597701|Autonomic Agents|autonomic agents|mesh-ancestor
101724062|NCT00597701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101724063|NCT00597701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101724064|NCT00597701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101724065|NCT00597701|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101724066|NCT00597701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101724067|NCT00597701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101724068|NCT00597701|GABA Modulators|gaba modulators|mesh-ancestor
101724070|NCT02556658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101724071|NCT02556658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724072|NCT00682721|Valacyclovir|valacyclovir|mesh-list
101724073|NCT00682721|Antiviral Agents|antiviral agents|mesh-ancestor
101804810|NCT04060979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101724074|NCT00682721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101724075|NCT02556814|Dexamethasone|dexamethasone|mesh-list
101724076|NCT02556814|Caffeic acid|caffeic acid|mesh-list
101724077|NCT02556814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101724078|NCT02556814|Antiemetics|antiemetics|mesh-ancestor
101724079|NCT02556814|Autonomic Agents|autonomic agents|mesh-ancestor
101724080|NCT02556814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101724081|NCT02556814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724082|NCT02556814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101724083|NCT02556814|Glucocorticoids|glucocorticoids|mesh-ancestor
101724084|NCT02556814|Hormones|hormones|mesh-ancestor
101724085|NCT02556814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101724086|NCT02556814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101724087|NCT02556814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101724088|NCT02556814|Antioxidants|antioxidants|mesh-ancestor
101724089|NCT02556814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724091|NCT00682955|Zinc|zinc|mesh-list
101724092|NCT00682955|Zinc Sulfate|zinc sulfate|mesh-list
101724093|NCT00682955|Trace Elements|trace elements|mesh-ancestor
101724094|NCT00682955|Micronutrients|micronutrients|mesh-ancestor
101724095|NCT00682955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724096|NCT00682955|Astringents|astringents|mesh-ancestor
101724097|NCT00682955|Dermatologic Agents|dermatologic agents|mesh-ancestor
101724098|NCT00686621|Posaconazole|posaconazole|mesh-list
101724099|NCT00686621|Antifungal Agents|antifungal agents|mesh-ancestor
101724100|NCT00686621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101724101|NCT00686621|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101724102|NCT00686621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101724103|NCT00686621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101724104|NCT00686621|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101724105|NCT00686621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101724106|NCT00686621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724107|NCT00686621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724108|NCT00686621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101724109|NCT00686621|Hormone Antagonists|hormone antagonists|mesh-ancestor
101724110|NCT00686621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101724111|NCT00686621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724112|NCT00683111|Esomeprazole|esomeprazole|mesh-list
101724113|NCT00683111|Famotidine|famotidine|mesh-list
101724114|NCT00683111|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101724115|NCT00683111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101724116|NCT00683111|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101724117|NCT00683111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724118|NCT00683111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724119|NCT00683111|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101724121|NCT00683111|Histamine Agents|histamine agents|mesh-ancestor
101724122|NCT00683111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101724123|NCT00683111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724124|NCT04138901|Ropivacaine|ropivacaine|mesh-list
101724125|NCT04138901|Anesthetics, Local|anesthetics, local|mesh-ancestor
101724126|NCT04138901|Anesthetics|anesthetics|mesh-ancestor
101724127|NCT04138901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101724128|NCT04138901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804820|NCT00458302|Darunavir|darunavir|mesh-list
101724129|NCT04138901|Sensory System Agents|sensory system agents|mesh-ancestor
101724130|NCT04138901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101724132|NCT00922649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101724133|NCT00922649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724135|NCT04142411|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101724136|NCT04142411|Hyaluronic Acid|hyaluronic acid|mesh-list
101724137|NCT04142411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101724138|NCT04142411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724139|NCT04142411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101724140|NCT04142411|Immunologic Factors|immunologic factors|mesh-ancestor
101724141|NCT04142411|Viscosupplements|viscosupplements|mesh-ancestor
101724142|NCT04142411|Protective Agents|protective agents|mesh-ancestor
101724143|NCT00683189|Warfarin|warfarin|mesh-list
101724144|NCT00683189|Anticoagulants|anticoagulants|mesh-ancestor
101724145|NCT00667576|Maxacalcitol|maxacalcitol|mesh-list
101724146|NCT00667576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101724147|NCT00667576|Dermatologic Agents|dermatologic agents|mesh-ancestor
101724148|NCT00667576|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101724149|NCT00667576|Protective Agents|protective agents|mesh-ancestor
101724150|NCT00667576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724151|NCT04141787|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101724152|NCT04141787|Cefazolin|cefazolin|mesh-list
101724153|NCT04141787|Ceftriaxone|ceftriaxone|mesh-list
101724154|NCT04141787|Daptomycin|daptomycin|mesh-list
101724155|NCT04141787|Cloxacillin|cloxacillin|mesh-list
101724156|NCT04141787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101724157|NCT02557594|Tenofovir|tenofovir|mesh-list
101724158|NCT02557594|Antiviral Agents|antiviral agents|mesh-ancestor
101724159|NCT02557594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101724160|NCT02557594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101724161|NCT02557594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101724162|NCT02557594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724163|NCT02557594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724164|NCT02557594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101724165|NCT02557594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101724166|NCT00687011|Dexamethasone|dexamethasone|mesh-list
101724167|NCT00687011|Palonosetron|palonosetron|mesh-list
101724168|NCT00687011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101724169|NCT00687011|Antiemetics|antiemetics|mesh-ancestor
101724170|NCT00687011|Autonomic Agents|autonomic agents|mesh-ancestor
101724171|NCT00687011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101724172|NCT00687011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724173|NCT00687011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101724174|NCT00687011|Glucocorticoids|glucocorticoids|mesh-ancestor
101724175|NCT00687011|Hormones|hormones|mesh-ancestor
101724176|NCT00687011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101724177|NCT00687011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101724178|NCT00687011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101724179|NCT00687011|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101724180|NCT00687011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101724181|NCT00687011|Serotonin Agents|serotonin agents|mesh-ancestor
101724182|NCT00687011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101724183|NCT00687011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724184|NCT00683267|Capsaicin|capsaicin|mesh-list
101724185|NCT00683267|Antipruritics|antipruritics|mesh-ancestor
101724186|NCT00683267|Dermatologic Agents|dermatologic agents|mesh-ancestor
101724187|NCT00683267|Sensory System Agents|sensory system agents|mesh-ancestor
101724188|NCT00683267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101724189|NCT00683267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724190|NCT00683345|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101724191|NCT00683345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101724192|NCT00687245|Esomeprazole|esomeprazole|mesh-list
101724193|NCT00687245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101724194|NCT00687245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101724195|NCT00687245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101724196|NCT00687245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724197|NCT00687245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724198|NCT00690521|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101724200|NCT00690521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101724201|NCT00690521|Diuretics|diuretics|mesh-ancestor
101724202|NCT00690521|Natriuretic Agents|natriuretic agents|mesh-ancestor
101724203|NCT00690521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724204|NCT00690521|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101724205|NCT00690521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101724206|NCT00690521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724207|NCT00666718|Insulin|insulin|mesh-list
101724208|NCT00666718|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101724209|NCT00666718|Insulin Glargine|insulin glargine|mesh-list
101724210|NCT00666718|Insulin Lispro|insulin lispro|mesh-list
101724211|NCT00666718|Protamines|protamines|mesh-list
101724212|NCT00666718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101724213|NCT00666718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724214|NCT00666718|Heparin Antagonists|heparin antagonists|mesh-ancestor
101724215|NCT00666718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724216|NCT00666718|Coagulants|coagulants|mesh-ancestor
101724217|NCT00683735|Metformin|metformin|mesh-list
101724218|NCT00683735|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101724219|NCT00683735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101724220|NCT00683735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724221|NCT00683735|Incretins|incretins|mesh-ancestor
101724222|NCT00683735|Hormones|hormones|mesh-ancestor
101724223|NCT00683735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101724224|NCT00683735|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101724225|NCT00683735|Protease Inhibitors|protease inhibitors|mesh-ancestor
101724226|NCT00683735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724227|NCT00683735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724228|NCT04139681|Menthol|menthol|mesh-list
101724229|NCT04139681|Antipruritics|antipruritics|mesh-ancestor
101724230|NCT04139681|Dermatologic Agents|dermatologic agents|mesh-ancestor
101724231|NCT04047394|Rasburicase|rasburicase|mesh-list
101724232|NCT04047394|Gout Suppressants|gout suppressants|mesh-ancestor
101724233|NCT04047394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101724234|NCT02625779|Valproic Acid|valproic acid|mesh-list
101724235|NCT02625779|Anticonvulsants|anticonvulsants|mesh-ancestor
101724236|NCT02625779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101194794|NCT03834012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724237|NCT02625779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724238|NCT02625779|GABA Agents|gaba agents|mesh-ancestor
101724239|NCT02625779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101724240|NCT02625779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724241|NCT02625779|Antimanic Agents|antimanic agents|mesh-ancestor
101724242|NCT02625779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101724243|NCT02625779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101724244|NCT02625779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101724246|NCT00667420|Epirubicin|epirubicin|mesh-list
101724247|NCT00667420|Panitumumab|panitumumab|mesh-list
101724248|NCT00667420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101724249|NCT00667420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724250|NCT00667420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101724251|NCT00667420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101724252|NCT00667420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101724253|NCT00667420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724254|NCT00667420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101724255|NCT04141319|Ketorolac|ketorolac|mesh-list
101724256|NCT04141319|Epinephrine|epinephrine|mesh-list
101724257|NCT04141319|Ropivacaine|ropivacaine|mesh-list
101724258|NCT04141319|Anesthetics, Local|anesthetics, local|mesh-ancestor
101724259|NCT04141319|Anesthetics|anesthetics|mesh-ancestor
101724260|NCT04141319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101724261|NCT04141319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724262|NCT04141319|Sensory System Agents|sensory system agents|mesh-ancestor
101724263|NCT04141319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101724264|NCT04141319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101724265|NCT04141319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101724266|NCT04141319|Adrenergic Agents|adrenergic agents|mesh-ancestor
101724268|NCT04141319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724269|NCT04141319|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101724270|NCT04141319|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101724271|NCT04141319|Autonomic Agents|autonomic agents|mesh-ancestor
101724272|NCT04141319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101724273|NCT04141319|Respiratory System Agents|respiratory system agents|mesh-ancestor
101724274|NCT04141319|Mydriatics|mydriatics|mesh-ancestor
101724275|NCT04141319|Sympathomimetics|sympathomimetics|mesh-ancestor
101724276|NCT04141319|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101724277|NCT04141319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101724278|NCT04141319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101724279|NCT04141319|Analgesics|analgesics|mesh-ancestor
101724280|NCT04141319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101724281|NCT04141319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101724282|NCT04141319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101724283|NCT04141319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724284|NCT00683891|Clozapine|clozapine|mesh-list
101724285|NCT00683891|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101724286|NCT00683891|Serotonin Agents|serotonin agents|mesh-ancestor
101724287|NCT00683891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101724288|NCT00683891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724289|NCT00683891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724290|NCT00683891|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101724291|NCT00683891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101724292|NCT00683891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101724293|NCT00683891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101724294|NCT00683891|GABA Antagonists|gaba antagonists|mesh-ancestor
101724295|NCT00683891|GABA Agents|gaba agents|mesh-ancestor
101724296|NCT00683969|Mycophenolic Acid|mycophenolic acid|mesh-list
101724297|NCT00683969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101724298|NCT00683969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101724299|NCT00683969|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101724300|NCT00683969|Antitubercular Agents|antitubercular agents|mesh-ancestor
101724301|NCT00683969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101724302|NCT00683969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101724303|NCT00683969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724304|NCT00683969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724305|NCT00778024|Fluoxetine|fluoxetine|mesh-list
101724306|NCT00778024|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101724307|NCT00778024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101724308|NCT00778024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101724309|NCT00778024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724310|NCT00778024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101724311|NCT00778024|Serotonin Agents|serotonin agents|mesh-ancestor
101724312|NCT00778024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724313|NCT00778024|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101724314|NCT00778024|Antidepressive Agents|antidepressive agents|mesh-ancestor
101724315|NCT00778024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101724316|NCT00778024|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101724317|NCT00778024|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101724318|NCT00778024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101804859|NCT00561470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101804860|NCT00561470|Immunologic Factors|immunologic factors|mesh-ancestor
101724320|NCT00853658|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101724321|NCT00853658|Protease Inhibitors|protease inhibitors|mesh-ancestor
101724322|NCT00853658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724323|NCT00853658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724324|NCT00853658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101724325|NCT00690677|Panobinostat|panobinostat|mesh-list
101724326|NCT00690677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101724327|NCT00690677|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101724328|NCT00690677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724329|NCT00690677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724330|NCT00781300|Loteprednol Etabonate|loteprednol etabonate|mesh-list
101724331|NCT00781300|Dexamethasone|dexamethasone|mesh-list
101724332|NCT00781300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101724333|NCT00781300|Antiemetics|antiemetics|mesh-ancestor
101724334|NCT00781300|Autonomic Agents|autonomic agents|mesh-ancestor
101724335|NCT00781300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101724336|NCT00781300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724337|NCT00781300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101724338|NCT00781300|Glucocorticoids|glucocorticoids|mesh-ancestor
101724340|NCT00781300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101724341|NCT00781300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101724342|NCT00781300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101724343|NCT00781300|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101724344|NCT00781378|Plasminogen|plasminogen|mesh-list
101724345|NCT00781378|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101724346|NCT00781378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101724347|NCT00781378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101724348|NCT00781378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724349|NCT02625389|Ethiodized Oil|ethiodized oil|mesh-list
101724350|NCT02625389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101724351|NCT00666562|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
101724352|NCT00666562|Antioxidants|antioxidants|mesh-ancestor
101724353|NCT00666562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724354|NCT00666562|Protective Agents|protective agents|mesh-ancestor
101724355|NCT00666562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724356|NCT00666562|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101724357|NCT00666562|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101724358|NCT00666562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101724359|NCT00666562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101724360|NCT00769054|Ropivacaine|ropivacaine|mesh-list
101724361|NCT00769054|Anesthetics, Local|anesthetics, local|mesh-ancestor
101724362|NCT00769054|Anesthetics|anesthetics|mesh-ancestor
101724363|NCT00769054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101724364|NCT00769054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724365|NCT00769054|Sensory System Agents|sensory system agents|mesh-ancestor
101724366|NCT00769054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101724367|NCT04138979|Cyclophosphamide|cyclophosphamide|mesh-list
101724368|NCT04138979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101724369|NCT04138979|Immunologic Factors|immunologic factors|mesh-ancestor
101724370|NCT04138979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724371|NCT04138979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101724372|NCT04138979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101724373|NCT04138979|Alkylating Agents|alkylating agents|mesh-ancestor
101724374|NCT04138979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724375|NCT04138979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101724376|NCT04138979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101724377|NCT00666328|Clevidipine|clevidipine|mesh-list
101724378|NCT00666328|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101804885|NCT01323244|Simeprevir|simeprevir|mesh-list
101724379|NCT00666328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101724380|NCT00666328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724381|NCT00666328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101724382|NCT00666328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724384|NCT00778180|Furosemide|furosemide|mesh-list
101724385|NCT00778180|Diuretics|diuretics|mesh-ancestor
101724386|NCT00778180|Natriuretic Agents|natriuretic agents|mesh-ancestor
101724387|NCT00778180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724388|NCT00778180|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101724389|NCT00778180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101724390|NCT00778180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724391|NCT00769210|Simvastatin|simvastatin|mesh-list
101724392|NCT00769210|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101724393|NCT00769210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101724395|NCT00769210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724396|NCT00769210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101724397|NCT00769210|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101724398|NCT00769210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724399|NCT00690911|Adalimumab|adalimumab|mesh-list
101724400|NCT00690911|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101724401|NCT00690911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101724402|NCT00690911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101724403|NCT00781846|Sirolimus|sirolimus|mesh-list
101724404|NCT00781846|Bevacizumab|bevacizumab|mesh-list
101724405|NCT00781846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101724406|NCT00781846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101724407|NCT00781846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101724408|NCT00781846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101724409|NCT00781846|Growth Substances|growth substances|mesh-ancestor
101724410|NCT00781846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724411|NCT00781846|Growth Inhibitors|growth inhibitors|mesh-ancestor
101724412|NCT00781846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101724413|NCT00781846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101724414|NCT00781846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101724415|NCT00781846|Antifungal Agents|antifungal agents|mesh-ancestor
101724416|NCT00781846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101724417|NCT00781846|Immunologic Factors|immunologic factors|mesh-ancestor
101724418|NCT00853580|Lovastatin|lovastatin|mesh-list
101724419|NCT00853580|L 647318|l 647318|mesh-list
101724420|NCT00853580|Dihydromevinolin|dihydromevinolin|mesh-list
101724421|NCT00853580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101724422|NCT00853580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101724423|NCT00853580|Antimetabolites|antimetabolites|mesh-ancestor
101724424|NCT00853580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724425|NCT00853580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101724426|NCT00853580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101724427|NCT00853580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724428|NCT00688493|Dapagliflozin|dapagliflozin|mesh-list
101724429|NCT00688493|Moxifloxacin|moxifloxacin|mesh-list
101724430|NCT00688493|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101724431|NCT00688493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101724432|NCT00688493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101724433|NCT00688493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101724434|NCT00688493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101724435|NCT00688493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724436|NCT00688493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724437|NCT00688493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101724438|NCT00688493|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101724439|NCT00688493|Contraceptive Agents|contraceptive agents|mesh-ancestor
101724440|NCT00688493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101724441|NCT00688493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804895|NCT03840226|Magnesium Oxide|magnesium oxide|mesh-list
101804896|NCT03840226|Antacids|antacids|mesh-ancestor
101724442|NCT00688493|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101724443|NCT00688493|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101724444|NCT00688493|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101724445|NCT00688493|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101724446|NCT00688493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101724447|NCT00778414|Amoxicillin|amoxicillin|mesh-list
101724448|NCT00778414|Clavulanic Acids|clavulanic acids|mesh-list
101724449|NCT00778414|Clavulanic Acid|clavulanic acid|mesh-list
101724450|NCT00778414|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101724451|NCT00778414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101724452|NCT00778414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101724453|NCT00778414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724454|NCT00778414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724455|NCT00778414|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101724456|NCT00769288|2'-fluoro-5-ethylarabinosyluracil|2'-fluoro-5-ethylarabinosyluracil|mesh-list
101724457|NCT00769288|Deoxyuridine|deoxyuridine|mesh-list
101724458|NCT00769288|Antimetabolites|antimetabolites|mesh-ancestor
101724459|NCT00769288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724460|NCT00769288|Antiviral Agents|antiviral agents|mesh-ancestor
101724461|NCT00769288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101724462|NCT00769288|Growth Inhibitors|growth inhibitors|mesh-ancestor
101724463|NCT00769288|Growth Substances|growth substances|mesh-ancestor
101724464|NCT00769288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724465|NCT00912938|Zoledronic Acid|zoledronic acid|mesh-list
101724466|NCT00912938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101724467|NCT00912938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724468|NCT00688805|Propranolol|propranolol|mesh-list
101724469|NCT00688805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101724470|NCT00688805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101724471|NCT00688805|Adrenergic Agents|adrenergic agents|mesh-ancestor
101724472|NCT00688805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101724473|NCT00688805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724474|NCT00688805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724475|NCT00688805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101724476|NCT00688805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101724477|NCT00688805|Vasodilator Agents|vasodilator agents|mesh-ancestor
101724478|NCT04136639|Proanthocyanidin|proanthocyanidin|mesh-list
101724479|NCT04136639|Grape Seed Extract|grape seed extract|mesh-list
101724480|NCT04136639|Fluorides|fluorides|mesh-list
101724481|NCT04136639|Sodium Fluoride|sodium fluoride|mesh-list
101724482|NCT04136639|Cariostatic Agents|cariostatic agents|mesh-ancestor
101724483|NCT04136639|Protective Agents|protective agents|mesh-ancestor
101724484|NCT04136639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724485|NCT04136639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101724486|NCT04136639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101724487|NCT04136639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101724488|NCT04136639|Antioxidants|antioxidants|mesh-ancestor
101724489|NCT04136639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724490|NCT04136639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101724491|NCT04136639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101724492|NCT02613026|Cyclophosphamide|cyclophosphamide|mesh-list
101724493|NCT02613026|Docetaxel|docetaxel|mesh-list
101724494|NCT02613026|Pirarubicin|pirarubicin|mesh-list
101724495|NCT02613026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101724496|NCT02613026|Immunologic Factors|immunologic factors|mesh-ancestor
101724497|NCT02613026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724498|NCT02613026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101724499|NCT02613026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101724500|NCT02613026|Alkylating Agents|alkylating agents|mesh-ancestor
101724501|NCT02613026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724502|NCT02613026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101724503|NCT02613026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101724504|NCT02613026|Tubulin Modulators|tubulin modulators|mesh-ancestor
101724505|NCT02613026|Antimitotic Agents|antimitotic agents|mesh-ancestor
101804905|NCT00561392|Rivastigmine|rivastigmine|mesh-list
101724506|NCT02613026|Mitosis Modulators|mitosis modulators|mesh-ancestor
101724507|NCT00778726|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101724508|NCT00778726|Benazepril|benazepril|mesh-list
101724509|NCT00778726|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101724510|NCT00778726|Diuretics|diuretics|mesh-ancestor
101724511|NCT00778726|Natriuretic Agents|natriuretic agents|mesh-ancestor
101724512|NCT00778726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724513|NCT00778726|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101724514|NCT00778726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101724515|NCT00778726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724516|NCT00778726|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101724517|NCT00778726|Protease Inhibitors|protease inhibitors|mesh-ancestor
101724518|NCT00778726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724519|NCT00688883|Fludarabine|fludarabine|mesh-list
101724520|NCT00688883|Fludarabine phosphate|fludarabine phosphate|mesh-list
101724521|NCT00688883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101724522|NCT00688883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101724523|NCT00688883|Antimetabolites|antimetabolites|mesh-ancestor
101724524|NCT00688883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724525|NCT00688883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101724526|NCT00688883|Immunologic Factors|immunologic factors|mesh-ancestor
101724527|NCT00688883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724528|NCT00769522|Cyclophosphamide|cyclophosphamide|mesh-list
101724529|NCT00769522|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101724531|NCT00769522|Fludarabine|fludarabine|mesh-list
101724532|NCT00769522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101724533|NCT00769522|Immunologic Factors|immunologic factors|mesh-ancestor
101724534|NCT00769522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724535|NCT00769522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101194958|NCT05767827|Lidocaine|lidocaine|mesh-list
101724536|NCT00769522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101724537|NCT00769522|Alkylating Agents|alkylating agents|mesh-ancestor
101724538|NCT00769522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724539|NCT00769522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101724540|NCT00769522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101724541|NCT00769522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101724542|NCT00688961|Aspirin|aspirin|mesh-list
101724543|NCT00688961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101724544|NCT00688961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101724545|NCT00688961|Analgesics|analgesics|mesh-ancestor
101724546|NCT00688961|Sensory System Agents|sensory system agents|mesh-ancestor
101724547|NCT00688961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101724548|NCT00688961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724549|NCT00688961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101724550|NCT00688961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101724551|NCT00688961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101724552|NCT00688961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101724553|NCT00688961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724554|NCT00688961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101724555|NCT00688961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101724556|NCT00688961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724557|NCT00688961|Antipyretics|antipyretics|mesh-ancestor
101724558|NCT00782470|Factor VIII|factor viii|mesh-list
101724559|NCT00782470|Coagulants|coagulants|mesh-ancestor
101724560|NCT00865280|Moxifloxacin|moxifloxacin|mesh-list
101724561|NCT00865280|Linezolid|linezolid|mesh-list
101724562|NCT00865280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101724563|NCT00865280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101724564|NCT00865280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101804916|NCT00694109|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101804917|NCT00694109|Antimetabolites|antimetabolites|mesh-ancestor
101724565|NCT00865280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101724566|NCT00865280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724567|NCT00865280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724568|NCT00865280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101724569|NCT00865280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101724570|NCT04136327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101724571|NCT00782548|Morphine|morphine|mesh-list
101724572|NCT00782548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101724573|NCT00782548|Narcotics|narcotics|mesh-ancestor
101724574|NCT00782548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101724575|NCT00782548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724576|NCT00782548|Analgesics|analgesics|mesh-ancestor
101724577|NCT00782548|Sensory System Agents|sensory system agents|mesh-ancestor
101724578|NCT00782548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101724579|NCT00689195|Curcumin|curcumin|mesh-list
101724580|NCT00689195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101724581|NCT00689195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101724582|NCT00689195|Analgesics|analgesics|mesh-ancestor
101724583|NCT00689195|Sensory System Agents|sensory system agents|mesh-ancestor
101724584|NCT00689195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101724585|NCT00689195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724586|NCT00689195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101724587|NCT00689195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101724588|NCT00689195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101724589|NCT00689195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724590|NCT00689195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724591|NCT00865124|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101724593|NCT00865124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101724594|NCT00865124|Diuretics|diuretics|mesh-ancestor
101724595|NCT00865124|Natriuretic Agents|natriuretic agents|mesh-ancestor
101724596|NCT00865124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724597|NCT00865124|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101724598|NCT00865124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101724599|NCT00865124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804930|NCT00940862|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101804933|NCT03068741|Ceftriaxone|ceftriaxone|mesh-list
101724600|NCT00865124|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101724601|NCT00865124|Hormone Antagonists|hormone antagonists|mesh-ancestor
101724602|NCT00865124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101724603|NCT00865124|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101724604|NCT00691067|Mifepristone|mifepristone|mesh-list
101724605|NCT00691067|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101724606|NCT00691067|Abortifacient Agents|abortifacient agents|mesh-ancestor
101724607|NCT00691067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101724608|NCT00691067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724609|NCT00691067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101724610|NCT00691067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101724611|NCT00691067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101724612|NCT00691067|Contraceptive Agents|contraceptive agents|mesh-ancestor
101724613|NCT00691067|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101724614|NCT00691067|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101724615|NCT00691067|Hormone Antagonists|hormone antagonists|mesh-ancestor
101724616|NCT00691067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101724617|NCT00691067|Luteolytic Agents|luteolytic agents|mesh-ancestor
101724618|NCT00691067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101724619|NCT00691067|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101724620|NCT00691145|Tacrolimus|tacrolimus|mesh-list
101724621|NCT00691145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101724622|NCT00691145|Immunologic Factors|immunologic factors|mesh-ancestor
101724623|NCT00691145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724624|NCT00691145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101724625|NCT00691145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724626|NCT00691145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724627|NCT00694967|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
101724628|NCT00694967|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
101724629|NCT00694967|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101724630|NCT00694967|Hormone Antagonists|hormone antagonists|mesh-ancestor
101724631|NCT00694967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101724632|NCT00694967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724633|NCT00694967|Progestins|progestins|mesh-ancestor
101724634|NCT00694967|Hormones|hormones|mesh-ancestor
101724635|NCT00695045|Morphine|morphine|mesh-list
101724636|NCT00695045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101724637|NCT00695045|Narcotics|narcotics|mesh-ancestor
101724638|NCT00695045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101724639|NCT00695045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195019|NCT05767632|Mirabegron|mirabegron|mesh-list
101724640|NCT00695045|Analgesics|analgesics|mesh-ancestor
101724641|NCT00695045|Sensory System Agents|sensory system agents|mesh-ancestor
101724642|NCT00695045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101724643|NCT02624453|Fluconazole|fluconazole|mesh-list
101724644|NCT02624453|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101724645|NCT02624453|Antifungal Agents|antifungal agents|mesh-ancestor
101724646|NCT02624453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101724647|NCT02624453|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101724648|NCT02624453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101724649|NCT02624453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724650|NCT02624453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724651|NCT02624453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101724652|NCT02624453|Hormone Antagonists|hormone antagonists|mesh-ancestor
101724653|NCT02624453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101724654|NCT02624453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724655|NCT02624453|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101724656|NCT02624453|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101724657|NCT02624453|Antiviral Agents|antiviral agents|mesh-ancestor
101724658|NCT00819234|Pramlintide|pramlintide|mesh-list
101724659|NCT00819234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101724660|NCT00819234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724661|NCT00695201|Oxaliplatin|oxaliplatin|mesh-list
101724663|NCT00695201|Floxuridine|floxuridine|mesh-list
101724664|NCT00695201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101724665|NCT00695201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101724666|NCT00695201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101724667|NCT00695201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724668|NCT00695201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724669|NCT00695201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101724671|NCT00689585|Ethosuximide|ethosuximide|mesh-list
101724672|NCT00689585|Anticonvulsants|anticonvulsants|mesh-ancestor
101724673|NCT00783016|Morphine|morphine|mesh-list
101724674|NCT00783016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101724675|NCT00783016|Narcotics|narcotics|mesh-ancestor
101724676|NCT00783016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101724677|NCT00783016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724678|NCT00783016|Analgesics|analgesics|mesh-ancestor
101724679|NCT00783016|Sensory System Agents|sensory system agents|mesh-ancestor
101724680|NCT00783016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101724681|NCT00769990|Genistein|genistein|mesh-list
101724682|NCT00769990|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101724683|NCT00769990|Protective Agents|protective agents|mesh-ancestor
101724684|NCT00769990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724685|NCT00769990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101724686|NCT00769990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101724687|NCT00769990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724688|NCT00769990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724689|NCT00769990|Phytoestrogens|phytoestrogens|mesh-ancestor
101724690|NCT00769990|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101724691|NCT00769990|Estrogens|estrogens|mesh-ancestor
101724692|NCT00769990|Hormones|hormones|mesh-ancestor
101724693|NCT00769990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101195031|NCT05767515|Inositol|inositol|mesh-list
101724695|NCT00784420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101724696|NCT00784420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101724697|NCT00784420|Antiviral Agents|antiviral agents|mesh-ancestor
101724698|NCT00784420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101724699|NCT00784420|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101724700|NCT00784420|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101724701|NCT00784420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724702|NCT00784420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724703|NCT02555800|Cidofovir|cidofovir|mesh-list
101724704|NCT02555800|Bevacizumab|bevacizumab|mesh-list
101724705|NCT02555800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101724706|NCT02555800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101724707|NCT02555800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101724708|NCT02555800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101724709|NCT02555800|Growth Substances|growth substances|mesh-ancestor
101724710|NCT02555800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724711|NCT02555800|Growth Inhibitors|growth inhibitors|mesh-ancestor
101724712|NCT02555800|Antiviral Agents|antiviral agents|mesh-ancestor
101724713|NCT02555800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101724714|NCT02555800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724715|NCT02555800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724716|NCT00783172|Gemcitabine|gemcitabine|mesh-list
101724717|NCT00783172|Mitogens|mitogens|mesh-list
101724718|NCT00783172|Enkephalins|enkephalins|mesh-list
101724719|NCT00783172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101724720|NCT00783172|Antimetabolites|antimetabolites|mesh-ancestor
101724721|NCT00783172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724722|NCT00783172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101724723|NCT00783172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724724|NCT00783172|Mitosis Modulators|mitosis modulators|mesh-ancestor
101724725|NCT00783172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101724726|NCT00783250|Albuterol|albuterol|mesh-list
101724727|NCT00783250|Tiotropium Bromide|tiotropium bromide|mesh-list
101724728|NCT00783250|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101724729|NCT00783250|Autonomic Agents|autonomic agents|mesh-ancestor
101724730|NCT00783250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101724731|NCT00783250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804977|NCT03817853|Obinutuzumab|obinutuzumab|mesh-list
101724732|NCT00783250|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101724733|NCT00783250|Respiratory System Agents|respiratory system agents|mesh-ancestor
101724734|NCT00783250|Parasympatholytics|parasympatholytics|mesh-ancestor
101724735|NCT00783250|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101724736|NCT00783250|Cholinergic Agents|cholinergic agents|mesh-ancestor
101724737|NCT00783250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101724738|NCT00783250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195074|NCT05755789|Cefoxitin|cefoxitin|mesh-list
101724739|NCT00783250|Tocolytic Agents|tocolytic agents|mesh-ancestor
101724740|NCT00783250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101724741|NCT00783250|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101724742|NCT00783250|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101724743|NCT00783250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101724744|NCT00783250|Adrenergic Agents|adrenergic agents|mesh-ancestor
101724745|NCT02555644|Cetuximab|cetuximab|mesh-list
101724746|NCT02555644|Prexasertib|prexasertib|mesh-list
101724747|NCT02555644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101724748|NCT02555644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101724749|NCT02555644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101724750|NCT02555644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724751|NCT02555644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724752|NCT00871403|Pemetrexed|pemetrexed|mesh-list
101724753|NCT00871403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101724754|NCT00871403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724755|NCT00871403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724756|NCT00871403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101724757|NCT00871403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101724758|NCT00691379|Paclitaxel|paclitaxel|mesh-list
101724759|NCT00691379|Bevacizumab|bevacizumab|mesh-list
101724760|NCT00691379|Carboplatin|carboplatin|mesh-list
101724761|NCT00691379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101724762|NCT00691379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101724763|NCT00691379|Tubulin Modulators|tubulin modulators|mesh-ancestor
101724764|NCT00691379|Antimitotic Agents|antimitotic agents|mesh-ancestor
101724765|NCT00691379|Mitosis Modulators|mitosis modulators|mesh-ancestor
101724766|NCT00691379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724767|NCT00691379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101724768|NCT00691379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101724769|NCT00691379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101724770|NCT00691379|Growth Substances|growth substances|mesh-ancestor
101724771|NCT00691379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724772|NCT00691379|Growth Inhibitors|growth inhibitors|mesh-ancestor
101724773|NCT02624531|Cisplatin|cisplatin|mesh-list
101724774|NCT02624531|Taxane|taxane|mesh-list
101195110|NCT05644145|Vaccines|vaccines|mesh-list
101724775|NCT02624531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101724776|NCT00691457|Contact Lens Solutions|contact lens solutions|mesh-list
101724777|NCT00691457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101724779|NCT00691457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101724780|NCT04136015|Dasatinib|dasatinib|mesh-list
101724781|NCT04136015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101724782|NCT04136015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101724783|NCT04136015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724784|NCT04136015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724785|NCT02624063|Sofosbuvir|sofosbuvir|mesh-list
101724786|NCT02624063|Simeprevir|simeprevir|mesh-list
101724787|NCT02624063|Antiviral Agents|antiviral agents|mesh-ancestor
101724788|NCT02624063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101724789|NCT02624063|Protease Inhibitors|protease inhibitors|mesh-ancestor
101724790|NCT02624063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724791|NCT02624063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724792|NCT05298683|Acetaminophen|acetaminophen|mesh-list
101724793|NCT05298683|Diphenhydramine|diphenhydramine|mesh-list
101724794|NCT05298683|Promethazine|promethazine|mesh-list
101724795|NCT05298683|Dexamethasone|dexamethasone|mesh-list
101724796|NCT05298683|Pomalidomide|pomalidomide|mesh-list
101724797|NCT05298683|Ranitidine|ranitidine|mesh-list
101724798|NCT05298683|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
101724799|NCT05298683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101724800|NCT05298683|Antiemetics|antiemetics|mesh-ancestor
101724801|NCT05298683|Autonomic Agents|autonomic agents|mesh-ancestor
101724802|NCT05298683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101724803|NCT05298683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724804|NCT05298683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101724805|NCT05298683|Glucocorticoids|glucocorticoids|mesh-ancestor
101724806|NCT05298683|Hormones|hormones|mesh-ancestor
101724807|NCT05298683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101724808|NCT05298683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101724809|NCT05298683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101724810|NCT05298683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101724811|NCT05298683|Analgesics|analgesics|mesh-ancestor
101724812|NCT05298683|Sensory System Agents|sensory system agents|mesh-ancestor
101724813|NCT05298683|Antipyretics|antipyretics|mesh-ancestor
101724814|NCT05298683|Immunologic Factors|immunologic factors|mesh-ancestor
101724815|NCT05298683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101724816|NCT05298683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101724817|NCT05298683|Growth Substances|growth substances|mesh-ancestor
101724818|NCT05298683|Growth Inhibitors|growth inhibitors|mesh-ancestor
101724819|NCT05298683|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101724820|NCT05298683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101724821|NCT05298683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101724822|NCT05298683|Anesthetics, Local|anesthetics, local|mesh-ancestor
101724824|NCT05298683|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101724825|NCT05298683|Histamine Antagonists|histamine antagonists|mesh-ancestor
101724826|NCT05298683|Histamine Agents|histamine agents|mesh-ancestor
101724827|NCT05298683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101724828|NCT05298683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724829|NCT05298683|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101724830|NCT05298683|Antipruritics|antipruritics|mesh-ancestor
101724831|NCT05298683|Dermatologic Agents|dermatologic agents|mesh-ancestor
101724832|NCT05298683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101724833|NCT05298683|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101724834|NCT00853112|Sildenafil Citrate|sildenafil citrate|mesh-list
101724835|NCT00853112|Vasodilator Agents|vasodilator agents|mesh-ancestor
101724836|NCT00853112|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101724837|NCT00853112|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101724838|NCT00853112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724839|NCT00853112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724840|NCT00853112|Urological Agents|urological agents|mesh-ancestor
101724841|NCT02624141|Epoetin Alfa|epoetin alfa|mesh-list
101724842|NCT02624141|Hematinics|hematinics|mesh-ancestor
101724843|NCT00691613|Epoetin Alfa|epoetin alfa|mesh-list
101724844|NCT00691613|Hematinics|hematinics|mesh-ancestor
101724845|NCT00460603|Bevacizumab|bevacizumab|mesh-list
101724846|NCT00460603|Axitinib|axitinib|mesh-list
101724847|NCT00460603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101724848|NCT00460603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101724849|NCT00460603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101724850|NCT00460603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101724851|NCT00460603|Growth Substances|growth substances|mesh-ancestor
101724852|NCT00460603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724853|NCT00460603|Growth Inhibitors|growth inhibitors|mesh-ancestor
101724854|NCT00460603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101724855|NCT00460603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724856|NCT00460603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724857|NCT00696059|Adalimumab|adalimumab|mesh-list
101724858|NCT00696059|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101804999|NCT03817853|Mitosis Modulators|mitosis modulators|mesh-ancestor
101724859|NCT00696059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101724860|NCT00696059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101724862|NCT00700466|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101724863|NCT00700466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101724864|NCT00700466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101724865|NCT00700466|Sympatholytics|sympatholytics|mesh-ancestor
101724866|NCT00700466|Autonomic Agents|autonomic agents|mesh-ancestor
101724867|NCT00700466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101724868|NCT00700466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724869|NCT00700466|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101724870|NCT00700466|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101724871|NCT00700466|Adrenergic Agents|adrenergic agents|mesh-ancestor
101724872|NCT00700466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101451739|NCT00203099|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101724873|NCT00700466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724874|NCT00700544|Norethandrolone|norethandrolone|mesh-list
101724875|NCT00700544|Anabolic Agents|anabolic agents|mesh-ancestor
101724876|NCT00700544|Hormones|hormones|mesh-ancestor
101263020|NCT01760148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101724877|NCT00700544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101724878|NCT00700544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724879|NCT02612792|Atorvastatin|atorvastatin|mesh-list
101724880|NCT02612792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101724881|NCT02612792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101724882|NCT02612792|Antimetabolites|antimetabolites|mesh-ancestor
101724883|NCT02612792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724884|NCT02612792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101724885|NCT02612792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101724886|NCT02612792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724887|NCT00662038|Pirfenidone|pirfenidone|mesh-list
101724888|NCT00662038|Analgesics|analgesics|mesh-ancestor
101724889|NCT00662038|Sensory System Agents|sensory system agents|mesh-ancestor
101724890|NCT00662038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101724891|NCT00662038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724892|NCT00662038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101724893|NCT00662038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101724894|NCT00662038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101724895|NCT00662038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101724896|NCT00662038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101724897|NCT00701792|Liver Extracts|liver extracts|mesh-list
101724898|NCT00701792|Hematinics|hematinics|mesh-ancestor
101724899|NCT00784498|Midazolam|midazolam|mesh-list
101724900|NCT00784498|Ketamine|ketamine|mesh-list
101724901|NCT00784498|Propofol|propofol|mesh-list
101724902|NCT00784498|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101724903|NCT00784498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101724904|NCT00784498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724905|NCT00784498|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101724906|NCT00784498|Anesthetics, General|anesthetics, general|mesh-ancestor
101724907|NCT00784498|Anesthetics|anesthetics|mesh-ancestor
101724908|NCT00784498|Analgesics|analgesics|mesh-ancestor
101724909|NCT00784498|Sensory System Agents|sensory system agents|mesh-ancestor
101724910|NCT00784498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101724911|NCT00784498|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101724912|NCT00784498|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101724913|NCT00784498|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101364248|NCT00146146|Dutasteride|dutasteride|mesh-list
101364249|NCT00146146|Testosterone|testosterone|mesh-list
101724914|NCT00784498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101724915|NCT00784498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724916|NCT00784498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101724917|NCT00784498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101805010|NCT00944840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101724918|NCT00784498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101724919|NCT00784498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101724920|NCT00784498|GABA Modulators|gaba modulators|mesh-ancestor
101724921|NCT00784498|GABA Agents|gaba agents|mesh-ancestor
101724922|NCT01022983|Simendan|simendan|mesh-list
101724923|NCT01022983|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101724924|NCT01022983|Vasodilator Agents|vasodilator agents|mesh-ancestor
101724925|NCT01022983|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101724926|NCT01022983|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101724927|NCT01022983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724928|NCT01022983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724929|NCT01022983|Protective Agents|protective agents|mesh-ancestor
101724930|NCT01022983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724931|NCT00912860|Interferons|interferons|mesh-list
101724932|NCT00912860|Interferon-beta|interferon-beta|mesh-list
101724933|NCT00912860|Interferon beta-1a|interferon beta-1a|mesh-list
101724934|NCT00912860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101724935|NCT00912860|Antiviral Agents|antiviral agents|mesh-ancestor
101724936|NCT00912860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101724937|NCT00912860|Immunologic Factors|immunologic factors|mesh-ancestor
101724938|NCT00912860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724939|NCT00912860|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101724940|NCT02623673|Dexamethasone|dexamethasone|mesh-list
101724941|NCT02623673|Bevacizumab|bevacizumab|mesh-list
101724942|NCT02623673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101724943|NCT02623673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101724944|NCT02623673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101382378|NCT00281944|Leucovorin|leucovorin|mesh-list
101724945|NCT02623673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101724946|NCT02623673|Growth Substances|growth substances|mesh-ancestor
101724947|NCT02623673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724948|NCT02623673|Growth Inhibitors|growth inhibitors|mesh-ancestor
101724949|NCT02623673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101724950|NCT02623673|Antiemetics|antiemetics|mesh-ancestor
101724951|NCT02623673|Autonomic Agents|autonomic agents|mesh-ancestor
101724952|NCT02623673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101724953|NCT02623673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101724954|NCT02623673|Glucocorticoids|glucocorticoids|mesh-ancestor
101724955|NCT02623673|Hormones|hormones|mesh-ancestor
101724956|NCT02623673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101724957|NCT02623673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101724958|NCT00784732|Mometasone Furoate|mometasone furoate|mesh-list
101805024|NCT00944918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101724959|NCT00784732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101724960|NCT00784732|Dermatologic Agents|dermatologic agents|mesh-ancestor
101724961|NCT00784732|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101724962|NCT00459979|Sunitinib|sunitinib|mesh-list
101724963|NCT00459979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101724964|NCT00459979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101724965|NCT00459979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101724966|NCT00459979|Growth Substances|growth substances|mesh-ancestor
101724967|NCT00459979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724968|NCT00459979|Growth Inhibitors|growth inhibitors|mesh-ancestor
101724969|NCT00459979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101724970|NCT00459979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101724971|NCT00459979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724972|NCT00783484|Maraviroc|maraviroc|mesh-list
101724973|NCT00783484|Darunavir|darunavir|mesh-list
101724974|NCT00783484|Midazolam|midazolam|mesh-list
101724975|NCT00783484|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101724976|NCT00783484|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101724977|NCT00783484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101724978|NCT00783484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101724979|NCT00783484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101724980|NCT00783484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101724981|NCT00783484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101724982|NCT00783484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101724983|NCT00783484|Anesthetics, General|anesthetics, general|mesh-ancestor
101724984|NCT00783484|Anesthetics|anesthetics|mesh-ancestor
101724985|NCT00783484|GABA Modulators|gaba modulators|mesh-ancestor
101724986|NCT00783484|GABA Agents|gaba agents|mesh-ancestor
101724987|NCT00783484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101724988|NCT00783484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101724989|NCT00783484|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101724990|NCT00783484|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101724991|NCT00783484|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101724992|NCT00783484|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101724993|NCT00783484|Antiviral Agents|antiviral agents|mesh-ancestor
101724994|NCT00783484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101724995|NCT00783484|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101724996|NCT00783484|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101724997|NCT00783484|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101724998|NCT00783484|Protease Inhibitors|protease inhibitors|mesh-ancestor
101724999|NCT00783484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101725000|NCT00828672|Bevacizumab|bevacizumab|mesh-list
101725001|NCT00828672|Capecitabine|capecitabine|mesh-list
101725002|NCT00828672|Oxaliplatin|oxaliplatin|mesh-list
101725003|NCT00828672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101725004|NCT00828672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101725005|NCT00828672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101725006|NCT00828672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101725007|NCT00828672|Growth Substances|growth substances|mesh-ancestor
101725008|NCT00828672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725009|NCT00828672|Growth Inhibitors|growth inhibitors|mesh-ancestor
101725010|NCT00828672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101725011|NCT00828672|Antimetabolites|antimetabolites|mesh-ancestor
101725012|NCT00828672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725013|NCT00784888|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101725014|NCT00784888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101725015|NCT00784888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101725016|NCT00784888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725017|NCT00784888|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101725018|NCT00784888|Hormone Antagonists|hormone antagonists|mesh-ancestor
101725019|NCT00784888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101725020|NCT00784888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725021|NCT00873119|Paclitaxel|paclitaxel|mesh-list
101725022|NCT00873119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101725023|NCT00873119|Carboplatin|carboplatin|mesh-list
101725024|NCT00873119|Belinostat|belinostat|mesh-list
101805056|NCT03995134|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101725025|NCT00873119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101725026|NCT00873119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101725027|NCT00873119|Tubulin Modulators|tubulin modulators|mesh-ancestor
101725028|NCT00873119|Antimitotic Agents|antimitotic agents|mesh-ancestor
101725029|NCT00873119|Mitosis Modulators|mitosis modulators|mesh-ancestor
101725030|NCT00873119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725031|NCT00873119|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101725032|NCT00873119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101725033|NCT00661726|Decitabine|decitabine|mesh-list
101725034|NCT00661726|Azacitidine|azacitidine|mesh-list
101725035|NCT00661726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101725036|NCT00661726|Antimetabolites|antimetabolites|mesh-ancestor
101725037|NCT00661726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725038|NCT00661726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101725039|NCT00661726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101725040|NCT00706680|Cyclosporine|cyclosporine|mesh-list
101725041|NCT00706680|Mycophenolic Acid|mycophenolic acid|mesh-list
101725042|NCT00706680|Prednisone|prednisone|mesh-list
101725043|NCT00706680|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101725044|NCT00706680|Cyclosporins|cyclosporins|mesh-list
101725045|NCT00706680|Thymoglobulin|thymoglobulin|mesh-list
101725046|NCT00706680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101725047|NCT00706680|Glucocorticoids|glucocorticoids|mesh-ancestor
101725048|NCT00706680|Hormones|hormones|mesh-ancestor
101725049|NCT00706680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101725050|NCT00706680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725051|NCT00706680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101725052|NCT00706680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101725053|NCT00706680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101725054|NCT00706680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725055|NCT00706680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101725056|NCT00706680|Immunologic Factors|immunologic factors|mesh-ancestor
101725057|NCT00706680|Antifungal Agents|antifungal agents|mesh-ancestor
101725058|NCT00706680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101725059|NCT00706680|Dermatologic Agents|dermatologic agents|mesh-ancestor
101725060|NCT00706680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101725061|NCT00706680|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101725062|NCT00706680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101725063|NCT00706680|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101725064|NCT00706680|Antitubercular Agents|antitubercular agents|mesh-ancestor
101725065|NCT00706680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101725066|NCT00706680|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101725067|NCT00706680|Protective Agents|protective agents|mesh-ancestor
101725068|NCT02624999|Cisplatin|cisplatin|mesh-list
101725069|NCT02624999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101725070|NCT02612480|Aspirin|aspirin|mesh-list
101725071|NCT02612480|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
101725072|NCT02612480|Clopidogrel|clopidogrel|mesh-list
101725073|NCT02612480|Ticagrelor|ticagrelor|mesh-list
101725074|NCT02612480|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101725075|NCT02612480|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101725076|NCT02612480|Analgesics|analgesics|mesh-ancestor
101725077|NCT02612480|Sensory System Agents|sensory system agents|mesh-ancestor
101725078|NCT02612480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101725079|NCT02612480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725080|NCT02612480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101725081|NCT02612480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101725082|NCT02612480|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101725083|NCT02612480|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101725084|NCT02612480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725085|NCT02612480|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101725086|NCT02612480|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101725087|NCT02612480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101725088|NCT02612480|Antipyretics|antipyretics|mesh-ancestor
101725089|NCT02612480|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101725090|NCT02612480|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101725091|NCT02612480|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101725092|NCT02612480|Purinergic Agents|purinergic agents|mesh-ancestor
101725093|NCT02612480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101725095|NCT00784966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101725096|NCT00784966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101725097|NCT00784966|Analgesics|analgesics|mesh-ancestor
101725098|NCT00784966|Sensory System Agents|sensory system agents|mesh-ancestor
101725099|NCT00784966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101725100|NCT00784966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725101|NCT00784966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101725102|NCT00784966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101725103|NCT00784966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101725104|NCT00784966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101725105|NCT00784966|Immunologic Factors|immunologic factors|mesh-ancestor
101725106|NCT02623595|Molgramostim|molgramostim|mesh-list
101725107|NCT02623595|Sargramostim|sargramostim|mesh-list
101725108|NCT02623595|Immunologic Factors|immunologic factors|mesh-ancestor
101725109|NCT02623595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725110|NCT02623595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101725112|NCT00665392|Fluorouracil|fluorouracil|mesh-list
101725113|NCT00665392|Cetuximab|cetuximab|mesh-list
101725114|NCT00665392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101725115|NCT00665392|Tubulin Modulators|tubulin modulators|mesh-ancestor
101725116|NCT00665392|Antimitotic Agents|antimitotic agents|mesh-ancestor
101725117|NCT00665392|Mitosis Modulators|mitosis modulators|mesh-ancestor
101725118|NCT00665392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725119|NCT00665392|Antimetabolites|antimetabolites|mesh-ancestor
101725120|NCT00665392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101725121|NCT00665392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101725122|NCT00665392|Immunologic Factors|immunologic factors|mesh-ancestor
101725123|NCT00665392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725124|NCT00665392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101725125|NCT00851630|Lamivudine|lamivudine|mesh-list
101725126|NCT00851630|Zidovudine|zidovudine|mesh-list
101725127|NCT00851630|Abacavir|abacavir|mesh-list
101725128|NCT00851630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101725129|NCT00851630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101725130|NCT00851630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101725131|NCT00851630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725132|NCT00851630|Antiviral Agents|antiviral agents|mesh-ancestor
101725133|NCT00851630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101725134|NCT00851630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101725135|NCT00851630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101725136|NCT00851630|Antimetabolites|antimetabolites|mesh-ancestor
101725137|NCT05298761|Lidocaine|lidocaine|mesh-list
101725138|NCT05298761|Nalbuphine|nalbuphine|mesh-list
101725139|NCT05298761|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101725140|NCT05298761|Narcotics|narcotics|mesh-ancestor
101725141|NCT05298761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101725142|NCT05298761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725143|NCT05298761|Analgesics|analgesics|mesh-ancestor
101725144|NCT05298761|Sensory System Agents|sensory system agents|mesh-ancestor
101725145|NCT05298761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101725146|NCT05298761|Anesthetics, Local|anesthetics, local|mesh-ancestor
101725147|NCT05298761|Anesthetics|anesthetics|mesh-ancestor
101725148|NCT05298761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101725149|NCT05298761|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101725150|NCT05298761|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101725151|NCT05298761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101805078|NCT01024192|Zolpidem|zolpidem|mesh-list
101725152|NCT05298761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725153|NCT00459667|Interferons|interferons|mesh-list
101725154|NCT00459667|Interferon-beta|interferon-beta|mesh-list
101725156|NCT00459667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101725157|NCT00459667|Antiviral Agents|antiviral agents|mesh-ancestor
101725158|NCT00459667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101725159|NCT00459667|Immunologic Factors|immunologic factors|mesh-ancestor
101725160|NCT00459667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725161|NCT00459667|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101725162|NCT02621255|Bupivacaine|bupivacaine|mesh-list
101725163|NCT02621255|Anesthetics|anesthetics|mesh-list
101725164|NCT02621255|Sevoflurane|sevoflurane|mesh-list
101725165|NCT02621255|Anesthetics, Local|anesthetics, local|mesh-ancestor
101725166|NCT02621255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101725167|NCT02621255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725168|NCT02621255|Sensory System Agents|sensory system agents|mesh-ancestor
101725169|NCT02621255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101725170|NCT02621255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101725171|NCT02621255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101725172|NCT02621255|Anesthetics, General|anesthetics, general|mesh-ancestor
101725173|NCT00828204|Interferons|interferons|mesh-list
101725174|NCT00828204|Interferon-beta|interferon-beta|mesh-list
101725175|NCT00828204|Interferon beta-1a|interferon beta-1a|mesh-list
101725176|NCT00828204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101725177|NCT00828204|Antiviral Agents|antiviral agents|mesh-ancestor
101725178|NCT00828204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101725179|NCT00828204|Immunologic Factors|immunologic factors|mesh-ancestor
101725180|NCT00828204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725181|NCT00828204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101725182|NCT00696215|Rasagiline|rasagiline|mesh-list
101725183|NCT00696215|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101725184|NCT00696215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101725185|NCT00696215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725186|NCT00696215|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101725187|NCT00696215|Protective Agents|protective agents|mesh-ancestor
101725188|NCT00696215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725189|NCT00784186|Misoprostol|misoprostol|mesh-list
101725190|NCT00784186|Mifepristone|mifepristone|mesh-list
101725191|NCT00784186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101725192|NCT00784186|Abortifacient Agents|abortifacient agents|mesh-ancestor
101725193|NCT00784186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101725194|NCT00784186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725195|NCT00784186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101725196|NCT00784186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101725198|NCT00784186|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101725199|NCT00784186|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101725200|NCT00784186|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101725201|NCT00784186|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101725202|NCT00784186|Contraceptive Agents|contraceptive agents|mesh-ancestor
101725203|NCT00784186|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101725204|NCT00784186|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101725205|NCT00784186|Hormone Antagonists|hormone antagonists|mesh-ancestor
101725206|NCT00784186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101725207|NCT00784186|Luteolytic Agents|luteolytic agents|mesh-ancestor
101725208|NCT00784186|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101725209|NCT00784186|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101725210|NCT00851552|Rituximab|rituximab|mesh-list
101725211|NCT00851552|Doxorubicin|doxorubicin|mesh-list
101725212|NCT00851552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101725213|NCT00851552|Bortezomib|bortezomib|mesh-list
101725214|NCT00851552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101725215|NCT00851552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101725216|NCT00851552|Immunologic Factors|immunologic factors|mesh-ancestor
101805089|NCT01024270|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101725217|NCT00851552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725218|NCT00851552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101725219|NCT00851552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101725220|NCT00851552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101725221|NCT00851552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101725222|NCT00851552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101725223|NCT00851552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725224|NCT00785122|Cyclophosphamide|cyclophosphamide|mesh-list
101725225|NCT00785122|Molgramostim|molgramostim|mesh-list
101725227|NCT00785122|Sargramostim|sargramostim|mesh-list
101725228|NCT00785122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101725229|NCT00785122|Immunologic Factors|immunologic factors|mesh-ancestor
101725230|NCT00785122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725231|NCT00785122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101725232|NCT00785122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101725233|NCT00785122|Alkylating Agents|alkylating agents|mesh-ancestor
101725234|NCT00785122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725235|NCT00785122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101725236|NCT00785122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101725237|NCT00785122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101725238|NCT00785122|Interferon Inducers|interferon inducers|mesh-ancestor
101725239|NCT04116554|Bupivacaine|bupivacaine|mesh-list
101725240|NCT04116554|Anesthetics, Local|anesthetics, local|mesh-ancestor
101725241|NCT04116554|Anesthetics|anesthetics|mesh-ancestor
101725242|NCT04116554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101725243|NCT04116554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725244|NCT04116554|Sensory System Agents|sensory system agents|mesh-ancestor
101451740|NCT00203099|Antioxidants|antioxidants|mesh-ancestor
101725245|NCT04116554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101382674|NCT00284323|Vasodilator Agents|vasodilator agents|mesh-ancestor
101725246|NCT00700856|Pioglitazone|pioglitazone|mesh-list
101725247|NCT00700856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101725248|NCT00700856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725250|NCT00790114|Caffeine|caffeine|mesh-list
101725251|NCT00790114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101725252|NCT00790114|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101725253|NCT00790114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101725254|NCT00790114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725255|NCT00790114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101725256|NCT00790114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101725257|NCT00790114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101725258|NCT00790114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101725259|NCT00790114|Anesthetics, General|anesthetics, general|mesh-ancestor
101725260|NCT00790114|Anesthetics|anesthetics|mesh-ancestor
101725261|NCT00790114|GABA Modulators|gaba modulators|mesh-ancestor
101725262|NCT00790114|GABA Agents|gaba agents|mesh-ancestor
101725263|NCT00790114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101725264|NCT00790114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725265|NCT00790114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101725266|NCT00790114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101725267|NCT00790114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101725268|NCT00790114|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101725269|NCT00790114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101725270|NCT00790114|Purinergic Agents|purinergic agents|mesh-ancestor
101725271|NCT01023139|Sibutramine|sibutramine|mesh-list
101725272|NCT01023139|Antidepressive Agents|antidepressive agents|mesh-ancestor
101725273|NCT01023139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101725274|NCT01023139|Appetite Depressants|appetite depressants|mesh-ancestor
101725275|NCT01023139|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101725276|NCT00459043|Docetaxel|docetaxel|mesh-list
101725277|NCT00459043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101725278|NCT00459043|Tubulin Modulators|tubulin modulators|mesh-ancestor
101725279|NCT00459043|Antimitotic Agents|antimitotic agents|mesh-ancestor
101725280|NCT00459043|Mitosis Modulators|mitosis modulators|mesh-ancestor
101805101|NCT00944996|Clomipramine|clomipramine|mesh-list
101725281|NCT00459043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725282|NCT00795262|Thioctic Acid|thioctic acid|mesh-list
101725284|NCT00795262|Antioxidants|antioxidants|mesh-ancestor
101725285|NCT00795262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725286|NCT00795262|Protective Agents|protective agents|mesh-ancestor
101725287|NCT00795262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725288|NCT00795262|Vitamin B Complex|vitamin b complex|mesh-ancestor
101725289|NCT00795262|Vitamins|vitamins|mesh-ancestor
101725290|NCT00795262|Micronutrients|micronutrients|mesh-ancestor
101725291|NCT00795262|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101725292|NCT00795262|Protease Inhibitors|protease inhibitors|mesh-ancestor
101725293|NCT00795262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101725294|NCT00795262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101725295|NCT00785200|Chlorhexidine|chlorhexidine|mesh-list
101725296|NCT00785200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101725297|NCT00785200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101725298|NCT00785200|Disinfectants|disinfectants|mesh-ancestor
101725299|NCT00817206|Tacrolimus|tacrolimus|mesh-list
101725300|NCT00817206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101725301|NCT00817206|Immunologic Factors|immunologic factors|mesh-ancestor
101725302|NCT00817206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725303|NCT00817206|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101725304|NCT00817206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101725305|NCT00817206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725306|NCT02611518|Metformin|metformin|mesh-list
101195454|NCT04671043|Caffeine|caffeine|mesh-list
101725307|NCT02611518|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101725308|NCT02611518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101725309|NCT02611518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725310|NCT02611518|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101725311|NCT02611518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101725312|NCT02611518|Antimetabolites|antimetabolites|mesh-ancestor
101725313|NCT02611518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725314|NCT02611518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101263031|NCT01760161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725315|NCT02611518|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101725316|NCT02611518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101725317|NCT01023607|Atorvastatin|atorvastatin|mesh-list
101725318|NCT01023607|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101725319|NCT01023607|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101725320|NCT01023607|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101725321|NCT01023607|Antimetabolites|antimetabolites|mesh-ancestor
101725322|NCT01023607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725323|NCT01023607|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101725324|NCT01023607|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101725325|NCT01023607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101725326|NCT00665002|Sargramostim|sargramostim|mesh-list
101725327|NCT00665002|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101725328|NCT00665002|Immunologic Factors|immunologic factors|mesh-ancestor
101725329|NCT00665002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725330|NCT00665002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101725332|NCT00660010|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101725333|NCT00660010|Fertility Agents|fertility agents|mesh-ancestor
101725334|NCT00660010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101725335|NCT00660010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725336|NCT00660010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101725337|NCT00660010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101725338|NCT04015908|Acetaminophen|acetaminophen|mesh-list
101725339|NCT04015908|Celecoxib|celecoxib|mesh-list
101725340|NCT04015908|Pregabalin|pregabalin|mesh-list
101725341|NCT04015908|Oxycodone|oxycodone|mesh-list
101725342|NCT04015908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101725343|NCT04015908|Analgesics|analgesics|mesh-ancestor
101725344|NCT04015908|Sensory System Agents|sensory system agents|mesh-ancestor
101805109|NCT00944996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725345|NCT04015908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101725346|NCT04015908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725347|NCT04015908|Antipyretics|antipyretics|mesh-ancestor
101725348|NCT04015908|Anticonvulsants|anticonvulsants|mesh-ancestor
101725349|NCT04015908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101725350|NCT04015908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101725351|NCT04015908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725352|NCT04015908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101725353|NCT04015908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101407771|NCT00108017|Maleic acid|maleic acid|mesh-list
101195490|NCT04570293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101725355|NCT04015908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101725356|NCT04015908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101725357|NCT04015908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101725358|NCT04015908|Narcotics|narcotics|mesh-ancestor
101725359|NCT04015908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101725360|NCT04015908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101725361|NCT04015908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101725362|NCT04015908|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101725363|NCT04015908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101725364|NCT04015908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101725365|NCT00790816|Lapatinib|lapatinib|mesh-list
101725366|NCT00790816|Antineoplastic Agents|antineoplastic agents|mesh-list
101725367|NCT00790816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101725368|NCT00790816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101725369|NCT00790816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725370|NCT00873041|Deferasirox|deferasirox|mesh-list
101725371|NCT00873041|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101725372|NCT00873041|Chelating Agents|chelating agents|mesh-ancestor
101725373|NCT00873041|Sequestering Agents|sequestering agents|mesh-ancestor
101725374|NCT00873041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725375|NCT00795496|Histamine|histamine|mesh-list
101725376|NCT00795496|Histamine Agonists|histamine agonists|mesh-ancestor
101725377|NCT00795496|Histamine Agents|histamine agents|mesh-ancestor
101725378|NCT00795496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101725379|NCT00795496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725380|NCT00795496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725381|NCT00795574|Infliximab|infliximab|mesh-list
101725382|NCT00795574|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101725383|NCT00795574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101725384|NCT00795574|Dermatologic Agents|dermatologic agents|mesh-ancestor
101725385|NCT00795574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101725386|NCT00795574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101725387|NCT00785434|Escitalopram|escitalopram|mesh-list
101725388|NCT00785434|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101725389|NCT00785434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101725390|NCT00785434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101725391|NCT00785434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725392|NCT00785434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101725393|NCT00785434|Serotonin Agents|serotonin agents|mesh-ancestor
101725394|NCT00785434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725395|NCT00790894|Epothilones|epothilones|mesh-list
101382818|NCT00285376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101725396|NCT00790894|Tubulin Modulators|tubulin modulators|mesh-ancestor
101725397|NCT00790894|Antimitotic Agents|antimitotic agents|mesh-ancestor
101725398|NCT00790894|Mitosis Modulators|mitosis modulators|mesh-ancestor
101725399|NCT00790894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725400|NCT00790894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101725401|NCT02623127|Sunitinib|sunitinib|mesh-list
101725402|NCT02623127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101725403|NCT02623127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101462447|NCT00179959|Mupirocin|mupirocin|mesh-list
101725404|NCT02623127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101725405|NCT02623127|Growth Substances|growth substances|mesh-ancestor
101725406|NCT02623127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725407|NCT02623127|Growth Inhibitors|growth inhibitors|mesh-ancestor
101725408|NCT02623127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101725409|NCT02623127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101725410|NCT02623127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725411|NCT05263492|Pembrolizumab|pembrolizumab|mesh-list
101725412|NCT05263492|Lenvatinib|lenvatinib|mesh-list
101725413|NCT05263492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101725414|NCT05263492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101725415|NCT05263492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101725416|NCT05263492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725417|NCT05263492|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101725418|NCT05263492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101725419|NCT04134611|Hyaluronic Acid|hyaluronic acid|mesh-list
101725420|NCT04134611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101725421|NCT04134611|Immunologic Factors|immunologic factors|mesh-ancestor
101725422|NCT04134611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725423|NCT04134611|Viscosupplements|viscosupplements|mesh-ancestor
101725424|NCT04134611|Protective Agents|protective agents|mesh-ancestor
101725425|NCT02620631|Morphine|morphine|mesh-list
101725426|NCT02620631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101725427|NCT02620631|Narcotics|narcotics|mesh-ancestor
101725428|NCT02620631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101725429|NCT02620631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725430|NCT02620631|Analgesics|analgesics|mesh-ancestor
101725431|NCT02620631|Sensory System Agents|sensory system agents|mesh-ancestor
101725432|NCT02620631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101725433|NCT04030572|Clonidine|clonidine|mesh-list
101725434|NCT04030572|Analgesics|analgesics|mesh-ancestor
101725435|NCT04030572|Sensory System Agents|sensory system agents|mesh-ancestor
101725436|NCT04030572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101725437|NCT04030572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725438|NCT04030572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101725439|NCT04030572|Sympatholytics|sympatholytics|mesh-ancestor
101725440|NCT04030572|Autonomic Agents|autonomic agents|mesh-ancestor
101725441|NCT04030572|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101725442|NCT04030572|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101725443|NCT04030572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101725444|NCT04030572|Adrenergic Agents|adrenergic agents|mesh-ancestor
101725445|NCT04030572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101725446|NCT04030572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725447|NCT00795808|Metformin|metformin|mesh-list
101725448|NCT00795808|Clomiphene|clomiphene|mesh-list
101725449|NCT00795808|Enclomiphene|enclomiphene|mesh-list
101725450|NCT00795808|Zuclomiphene|zuclomiphene|mesh-list
101725451|NCT00795808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101725452|NCT00795808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725453|NCT00795808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101725454|NCT00795808|Hormone Antagonists|hormone antagonists|mesh-ancestor
101725455|NCT00795808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101725456|NCT00795808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101725457|NCT00795808|Fertility Agents|fertility agents|mesh-ancestor
101725458|NCT00795808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101725459|NCT00795808|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101725460|NCT00795808|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101725461|NCT04135781|Paclitaxel|paclitaxel|mesh-list
101725463|NCT04135781|Capecitabine|capecitabine|mesh-list
101725464|NCT04135781|Oxaliplatin|oxaliplatin|mesh-list
101725465|NCT04135781|Tegafur|tegafur|mesh-list
101725466|NCT04135781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101725467|NCT04135781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101725468|NCT04135781|Tubulin Modulators|tubulin modulators|mesh-ancestor
101725469|NCT04135781|Antimitotic Agents|antimitotic agents|mesh-ancestor
101725470|NCT04135781|Mitosis Modulators|mitosis modulators|mesh-ancestor
101805133|NCT01031212|Vadimezan|vadimezan|mesh-list
101805134|NCT01031212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101725471|NCT04135781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725472|NCT04135781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101725473|NCT04135781|Antimetabolites|antimetabolites|mesh-ancestor
101725475|NCT04135313|Oxaliplatin|oxaliplatin|mesh-list
101725476|NCT04135313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101725477|NCT04135313|Antimetabolites|antimetabolites|mesh-ancestor
101725478|NCT04135313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725479|NCT04135313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101725480|NCT00692159|Pemetrexed|pemetrexed|mesh-list
101725481|NCT00692159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101725482|NCT00692159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101725483|NCT00692159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725484|NCT00692159|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101725485|NCT00692159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101725486|NCT00692315|Vitamin B 12|vitamin b 12|mesh-list
101725487|NCT00692315|Vitamins|vitamins|mesh-ancestor
101725488|NCT00692315|Micronutrients|micronutrients|mesh-ancestor
101364276|NCT00146380|Lamivudine|lamivudine|mesh-list
101725489|NCT00692315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725490|NCT00692315|Vitamin B Complex|vitamin b complex|mesh-ancestor
101725491|NCT02623049|Anticoagulants|anticoagulants|mesh-list
101725492|NCT02608944|Adenosine|adenosine|mesh-list
101725493|NCT02608944|Regadenoson|regadenoson|mesh-list
101725494|NCT02608944|Analgesics|analgesics|mesh-ancestor
101725495|NCT02608944|Sensory System Agents|sensory system agents|mesh-ancestor
101725496|NCT02608944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101725497|NCT02608944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725498|NCT02608944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101725499|NCT02608944|Vasodilator Agents|vasodilator agents|mesh-ancestor
101725500|NCT02608944|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101725501|NCT02608944|Purinergic Agonists|purinergic agonists|mesh-ancestor
101725502|NCT02608944|Purinergic Agents|purinergic agents|mesh-ancestor
101725503|NCT02608944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101725504|NCT02608944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195609|NCT04288427|Finasteride|finasteride|mesh-list
101725505|NCT02608944|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
101725506|NCT00913614|SR 46349B|sr 46349b|mesh-list
101725507|NCT00913614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101725508|NCT00913614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101725509|NCT00913614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725510|NCT00913614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101725511|NCT00913614|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101725512|NCT00913614|Serotonin Agents|serotonin agents|mesh-ancestor
101725513|NCT00913614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101725514|NCT00913614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725515|NCT00664534|Insulin|insulin|mesh-list
101725516|NCT00664534|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101725517|NCT00664534|Insulin Glargine|insulin glargine|mesh-list
101725518|NCT00664534|Insulin Lispro|insulin lispro|mesh-list
101725519|NCT00664534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101725520|NCT00664534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725521|NCT00913848|Valproic Acid|valproic acid|mesh-list
101725522|NCT00913848|Anticonvulsants|anticonvulsants|mesh-ancestor
101725523|NCT00913848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101805141|NCT01031212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101805142|NCT01031212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101725524|NCT00913848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725525|NCT00913848|GABA Agents|gaba agents|mesh-ancestor
101725526|NCT00913848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101725527|NCT00913848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725528|NCT00913848|Antimanic Agents|antimanic agents|mesh-ancestor
101725529|NCT00913848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101725530|NCT00913848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101725531|NCT00913848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101725532|NCT02620163|Amlodipine|amlodipine|mesh-list
101725533|NCT02620163|Telmisartan|telmisartan|mesh-list
101725534|NCT02620163|Chlorthalidone|chlorthalidone|mesh-list
101725535|NCT02620163|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
101725536|NCT02620163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101725537|NCT02620163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101725538|NCT02620163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101725539|NCT02620163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725540|NCT02620163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101725541|NCT02620163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725542|NCT02620163|Vasodilator Agents|vasodilator agents|mesh-ancestor
101725543|NCT02620163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101725544|NCT02620163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101725545|NCT02620163|Diuretics|diuretics|mesh-ancestor
101725546|NCT02620163|Natriuretic Agents|natriuretic agents|mesh-ancestor
101725547|NCT02620163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101725548|NCT05758116|Tislelizumab|tislelizumab|mesh-list
101725549|NCT05758116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101725550|NCT05758116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101725551|NCT00912821|Dialysis Solutions|dialysis solutions|mesh-list
101725552|NCT00912821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101725553|NCT00570310|Pregabalin|pregabalin|mesh-list
101725554|NCT00570310|Analgesics|analgesics|mesh-ancestor
101725555|NCT00570310|Sensory System Agents|sensory system agents|mesh-ancestor
101725556|NCT00570310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101725557|NCT00570310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725558|NCT00570310|Anticonvulsants|anticonvulsants|mesh-ancestor
101725559|NCT00570310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101725560|NCT00570310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101725561|NCT00570310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725562|NCT00570310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101725563|NCT00570310|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101725564|NCT00570310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101725565|NCT00570310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101725566|NCT00570310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101725567|NCT00696995|Insulin Aspart|insulin aspart|mesh-list
101725568|NCT00696995|Biphasic Insulins|biphasic insulins|mesh-list
101725569|NCT00696995|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101725570|NCT00696995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101725571|NCT00696995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725572|NCT00664066|Epoetin Alfa|epoetin alfa|mesh-list
101725573|NCT00664066|Hematinics|hematinics|mesh-ancestor
101725574|NCT04676958|Vitamin K|vitamin k|mesh-list
101725575|NCT04676958|Vitamin K 2|vitamin k 2|mesh-list
101725576|NCT04676958|Vitamins|vitamins|mesh-ancestor
101725577|NCT04676958|Micronutrients|micronutrients|mesh-ancestor
101725578|NCT04676958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725579|NCT04676958|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101725580|NCT04676958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101725581|NCT04676958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725582|NCT04676958|Hemostatics|hemostatics|mesh-ancestor
101725583|NCT04676958|Coagulants|coagulants|mesh-ancestor
101725584|NCT02619929|Vinorelbine|vinorelbine|mesh-list
101725585|NCT02619929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101725586|NCT02619929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101725587|NCT02619929|Tubulin Modulators|tubulin modulators|mesh-ancestor
101725588|NCT02619929|Antimitotic Agents|antimitotic agents|mesh-ancestor
101725590|NCT02619929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725591|NCT00796198|Latanoprost|latanoprost|mesh-list
101725592|NCT00796198|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101725593|NCT00796198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101725594|NCT02622503|Rituximab|rituximab|mesh-list
101725595|NCT02622503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101725596|NCT02622503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101725597|NCT02622503|Immunologic Factors|immunologic factors|mesh-ancestor
101725598|NCT02622503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725599|NCT02622503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101195669|NCT04061746|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101725600|NCT00814710|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101725601|NCT00814710|Immunologic Factors|immunologic factors|mesh-ancestor
101725602|NCT00814710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725603|NCT00796276|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101725604|NCT00796276|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101725605|NCT00796276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101725606|NCT00796276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101725607|NCT00796276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725608|NCT00796276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101725609|NCT00796276|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101725610|NCT00796276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101725612|NCT00796276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101725613|NCT00796276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725614|NCT00796276|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101725615|NCT00796276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101725616|NCT00796276|Dopamine Agents|dopamine agents|mesh-ancestor
101725617|NCT00796432|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101725618|NCT00796432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101725619|NCT00796432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101725620|NCT00796432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101364297|NCT00081588|Protease Inhibitors|protease inhibitors|mesh-ancestor
101725621|NCT00796432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725622|NCT00796432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101383046|NCT00111150|Tenofovir|tenofovir|mesh-list
101725623|NCT00796432|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101725624|NCT00796432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101725625|NCT00796432|Serotonin Agents|serotonin agents|mesh-ancestor
101725626|NCT00796432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101725627|NCT00796432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725628|NCT00796432|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101725629|NCT00796432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101725630|NCT00796432|Dopamine Agents|dopamine agents|mesh-ancestor
101725631|NCT00786058|Fluorouracil|fluorouracil|mesh-list
101725632|NCT00786058|Antimetabolites|antimetabolites|mesh-ancestor
101725633|NCT00786058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725634|NCT00786058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101195693|NCT03965689|Paclitaxel|paclitaxel|mesh-list
101725635|NCT00786058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101725636|NCT00786058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101725637|NCT00786058|Immunologic Factors|immunologic factors|mesh-ancestor
101725638|NCT00786058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725639|NCT00871169|Oxaliplatin|oxaliplatin|mesh-list
101725641|NCT00871169|Cetuximab|cetuximab|mesh-list
101725642|NCT00871169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101725643|NCT00871169|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101725644|NCT00871169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101725645|NCT00871169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101725646|NCT00871169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725647|NCT00871169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101725648|NCT00791284|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101725649|NCT00791284|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101725650|NCT00791284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101725651|NCT00791284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101805173|NCT00941174|Leucovorin|leucovorin|mesh-list
101805174|NCT00941174|Calcium|calcium|mesh-list
101805175|NCT00941174|Levoleucovorin|levoleucovorin|mesh-list
101725652|NCT00791284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725653|NCT00791284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101725654|NCT00791284|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101725655|NCT00791284|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101725656|NCT00791284|Serotonin Agents|serotonin agents|mesh-ancestor
101725657|NCT00791284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101725658|NCT00791284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725659|NCT00791284|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101725660|NCT00791284|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101725661|NCT00791284|Dopamine Agents|dopamine agents|mesh-ancestor
101725663|NCT00814632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101725664|NCT00814632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101725665|NCT00814632|Analgesics|analgesics|mesh-ancestor
101725666|NCT00814632|Sensory System Agents|sensory system agents|mesh-ancestor
101725667|NCT00814632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101725668|NCT00814632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725669|NCT00814632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101725670|NCT00814632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101725671|NCT00814632|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101725672|NCT00814632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101725673|NCT00814632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101725674|NCT00814632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725675|NCT00786136|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101725676|NCT00786136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101725677|NCT00786136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101725678|NCT00786136|Antimetabolites|antimetabolites|mesh-ancestor
101725679|NCT00786136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263042|NCT01760226|Prednisone|prednisone|mesh-list
101725680|NCT00786136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101725681|NCT00786136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101725682|NCT00786136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101725683|NCT02554942|Epoetin Alfa|epoetin alfa|mesh-list
101725684|NCT02554942|Hematinics|hematinics|mesh-ancestor
101725685|NCT02619773|Mupirocin|mupirocin|mesh-list
101725686|NCT02619773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101725687|NCT02619773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101725688|NCT02619773|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101725689|NCT02619773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101725690|NCT02619773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725691|NCT02555488|Methylene Blue|methylene blue|mesh-list
101725692|NCT02555488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101725693|NCT02555488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725694|NCT02554864|Lidocaine|lidocaine|mesh-list
101725695|NCT02554864|Ropivacaine|ropivacaine|mesh-list
101725696|NCT02554864|Anesthetics, Local|anesthetics, local|mesh-ancestor
101725697|NCT02554864|Anesthetics|anesthetics|mesh-ancestor
101725698|NCT02554864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101725699|NCT02554864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725700|NCT02554864|Sensory System Agents|sensory system agents|mesh-ancestor
101725701|NCT02554864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101725702|NCT02554864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101725703|NCT02554864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101725704|NCT02554864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101725705|NCT02554864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101725706|NCT02554864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725707|NCT00851318|Certolizumab Pegol|certolizumab pegol|mesh-list
101725708|NCT00851318|Methotrexate|methotrexate|mesh-list
101725709|NCT00851318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101725710|NCT00851318|Abortifacient Agents|abortifacient agents|mesh-ancestor
101725711|NCT00851318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101725712|NCT00851318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725713|NCT00851318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101725714|NCT00851318|Antimetabolites|antimetabolites|mesh-ancestor
101805182|NCT00941174|Micronutrients|micronutrients|mesh-ancestor
101805183|NCT00440518|Lacosamide|lacosamide|mesh-list
101725715|NCT00851318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725716|NCT00851318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101725718|NCT00851318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101725719|NCT00851318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101725720|NCT00851318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101725721|NCT00851318|Immunologic Factors|immunologic factors|mesh-ancestor
101725722|NCT00851318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101725723|NCT00851318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101725724|NCT00851318|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101725725|NCT00851318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101725726|NCT00786370|Dexmedetomidine|dexmedetomidine|mesh-list
101725727|NCT00786370|Propofol|propofol|mesh-list
101725728|NCT00786370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101725729|NCT00786370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101725730|NCT00786370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725731|NCT00786370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101725732|NCT00786370|Analgesics|analgesics|mesh-ancestor
101725733|NCT00786370|Sensory System Agents|sensory system agents|mesh-ancestor
101725734|NCT00786370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101725735|NCT00786370|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101725736|NCT00786370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101725737|NCT00786370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101725738|NCT00786370|Adrenergic Agents|adrenergic agents|mesh-ancestor
101725739|NCT00786370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101725740|NCT00786370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725741|NCT00786370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101725742|NCT00786370|Anesthetics, General|anesthetics, general|mesh-ancestor
101725743|NCT00786370|Anesthetics|anesthetics|mesh-ancestor
101725744|NCT00796900|Dantrolene|dantrolene|mesh-list
101725745|NCT00796900|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101725746|NCT00796900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725747|NCT00796900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101725748|NCT00796900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101725749|NCT00791830|Irbesartan|irbesartan|mesh-list
101725750|NCT00791830|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101725751|NCT00791830|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101725752|NCT00791830|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101725753|NCT00791830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725755|NCT00786448|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101725756|NCT00786448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101725757|NCT00786448|Cholinergic Agents|cholinergic agents|mesh-ancestor
101725758|NCT00786448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101725759|NCT00786448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725760|NCT00786448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725761|NCT00786448|Urological Agents|urological agents|mesh-ancestor
101725762|NCT04137653|Paclitaxel|paclitaxel|mesh-list
101725763|NCT04137653|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101725764|NCT04137653|Carboplatin|carboplatin|mesh-list
101725765|NCT04137653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101725766|NCT04137653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101725767|NCT04137653|Tubulin Modulators|tubulin modulators|mesh-ancestor
101725768|NCT04137653|Antimitotic Agents|antimitotic agents|mesh-ancestor
101725769|NCT04137653|Mitosis Modulators|mitosis modulators|mesh-ancestor
101725770|NCT04137653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725771|NCT00797056|Aspirin|aspirin|mesh-list
101725772|NCT00797056|Clopidogrel|clopidogrel|mesh-list
101725773|NCT00797056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101725774|NCT00797056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101725775|NCT00797056|Analgesics|analgesics|mesh-ancestor
101725776|NCT00797056|Sensory System Agents|sensory system agents|mesh-ancestor
101725777|NCT00797056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101725778|NCT00797056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725779|NCT00797056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101725780|NCT00797056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101725781|NCT00797056|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101725782|NCT00797056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101725783|NCT00797056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725784|NCT00797056|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101725785|NCT00797056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101725786|NCT00797056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101725787|NCT00797056|Antipyretics|antipyretics|mesh-ancestor
101725788|NCT00797056|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101725789|NCT00797056|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101725790|NCT00797056|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101725791|NCT00797056|Purinergic Agents|purinergic agents|mesh-ancestor
101725792|NCT00797056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101725793|NCT00593957|Dextromethorphan|dextromethorphan|mesh-list
101725794|NCT00593957|Antitussive Agents|antitussive agents|mesh-ancestor
101725795|NCT00593957|Respiratory System Agents|respiratory system agents|mesh-ancestor
101725796|NCT00593957|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101725797|NCT00593957|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101725798|NCT00593957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101725799|NCT00593957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725800|NCT00593957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725801|NCT00697151|Aspirin|aspirin|mesh-list
101725802|NCT00697151|Warfarin|warfarin|mesh-list
101725803|NCT00697151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101725804|NCT00697151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101725805|NCT00697151|Analgesics|analgesics|mesh-ancestor
101725806|NCT00697151|Sensory System Agents|sensory system agents|mesh-ancestor
101725807|NCT00697151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101725808|NCT00697151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725809|NCT00697151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101725810|NCT00697151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101725811|NCT00697151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101725812|NCT00697151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101725813|NCT00697151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725814|NCT00697151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101725815|NCT00697151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101725816|NCT00697151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101725817|NCT00697151|Antipyretics|antipyretics|mesh-ancestor
101725818|NCT00697151|Anticoagulants|anticoagulants|mesh-ancestor
101725819|NCT02621957|Pravastatin|pravastatin|mesh-list
101725820|NCT02621957|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101725821|NCT02621957|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101725822|NCT02621957|Antimetabolites|antimetabolites|mesh-ancestor
101725823|NCT02621957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725825|NCT02621957|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101725826|NCT02621957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101725828|NCT00851084|Folic Acid|folic acid|mesh-list
101725829|NCT00851084|Oxaliplatin|oxaliplatin|mesh-list
101725830|NCT00851084|Aflibercept|aflibercept|mesh-list
101333694|NCT00040261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725831|NCT00851084|Levoleucovorin|levoleucovorin|mesh-list
101725832|NCT00851084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101725833|NCT00851084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101725834|NCT00851084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101725835|NCT00851084|Growth Substances|growth substances|mesh-ancestor
101725836|NCT00851084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725837|NCT00851084|Growth Inhibitors|growth inhibitors|mesh-ancestor
101725838|NCT00851084|Antidotes|antidotes|mesh-ancestor
101725839|NCT00851084|Protective Agents|protective agents|mesh-ancestor
101725840|NCT00851084|Vitamin B Complex|vitamin b complex|mesh-ancestor
101725841|NCT00851084|Vitamins|vitamins|mesh-ancestor
101725842|NCT00851084|Micronutrients|micronutrients|mesh-ancestor
101725843|NCT00851084|Hematinics|hematinics|mesh-ancestor
101725844|NCT02617199|Fentanyl|fentanyl|mesh-list
101725845|NCT02617199|Analgesics|analgesics|mesh-list
101725847|NCT02617199|Anesthetics|anesthetics|mesh-ancestor
101725848|NCT02617199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101725849|NCT02617199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725850|NCT02617199|Anesthetics, Local|anesthetics, local|mesh-ancestor
101725851|NCT02617199|Sensory System Agents|sensory system agents|mesh-ancestor
101725853|NCT02617199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101725854|NCT02617199|Narcotics|narcotics|mesh-ancestor
101725855|NCT02617199|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101725856|NCT02617199|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101725857|NCT02617199|Anesthetics, General|anesthetics, general|mesh-ancestor
101725858|NCT00845858|Metoclopramide|metoclopramide|mesh-list
101725859|NCT00845858|Antiemetics|antiemetics|mesh-ancestor
101725860|NCT00845858|Autonomic Agents|autonomic agents|mesh-ancestor
101725861|NCT00845858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101725862|NCT00845858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725863|NCT00845858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101725864|NCT00845858|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101725865|NCT00845858|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101725866|NCT00845858|Dopamine Agents|dopamine agents|mesh-ancestor
101725867|NCT00845858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101725868|NCT00845858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725869|NCT02619149|Tazobactam|tazobactam|mesh-list
101725870|NCT02619149|Piperacillin|piperacillin|mesh-list
101725871|NCT02619149|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101725872|NCT02619149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101725873|NCT02619149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101725874|NCT02619149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101725875|NCT02619149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101725876|NCT02619149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725877|NCT04134065|Vitamin D|vitamin d|mesh-list
101725878|NCT04134065|Vitamins|vitamins|mesh-ancestor
101725879|NCT04134065|Micronutrients|micronutrients|mesh-ancestor
101725880|NCT04134065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725881|NCT04134065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101725882|NCT02616731|Tranexamic Acid|tranexamic acid|mesh-list
101725883|NCT02616731|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101725884|NCT02616731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101725885|NCT02616731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725886|NCT02616731|Hemostatics|hemostatics|mesh-ancestor
101725887|NCT02616731|Coagulants|coagulants|mesh-ancestor
101725888|NCT00850460|Atorvastatin|atorvastatin|mesh-list
101725889|NCT00850460|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101725890|NCT00850460|Simvastatin|simvastatin|mesh-list
101725891|NCT00850460|Pravastatin|pravastatin|mesh-list
101725892|NCT00850460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101725893|NCT00850460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101725894|NCT00850460|Antimetabolites|antimetabolites|mesh-ancestor
101725895|NCT00850460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725896|NCT00850460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101725897|NCT00850460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101725898|NCT00850460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101725899|NCT00661492|Cetuximab|cetuximab|mesh-list
101725900|NCT00661492|Mitoxantrone|mitoxantrone|mesh-list
101725901|NCT00661492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101725902|NCT00661492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101725903|NCT00661492|Analgesics|analgesics|mesh-ancestor
101725904|NCT00661492|Sensory System Agents|sensory system agents|mesh-ancestor
101725905|NCT00661492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101725906|NCT00661492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725907|NCT00661492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101195907|NCT02995252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101725908|NCT00661492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101725909|NCT00661492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101725910|NCT00661492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725911|NCT00693251|Sirolimus|sirolimus|mesh-list
101725912|NCT00693251|Paclitaxel|paclitaxel|mesh-list
101725913|NCT00693251|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101725914|NCT00693251|Everolimus|everolimus|mesh-list
101725915|NCT00693251|Temsirolimus|temsirolimus|mesh-list
101725916|NCT00693251|MTOR Inhibitors|mtor inhibitors|mesh-list
101725917|NCT00693251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101805209|NCT00945308|Eptifibatide|eptifibatide|mesh-list
101725918|NCT00693251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101725919|NCT00693251|Tubulin Modulators|tubulin modulators|mesh-ancestor
101725920|NCT00693251|Antimitotic Agents|antimitotic agents|mesh-ancestor
101725921|NCT00693251|Mitosis Modulators|mitosis modulators|mesh-ancestor
101383398|NCT00111891|Niacin|niacin|mesh-list
101725922|NCT00693251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725923|NCT00693251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101725924|NCT00693251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101725925|NCT00693251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101725926|NCT00693251|Immunologic Factors|immunologic factors|mesh-ancestor
101725927|NCT00693251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725928|NCT00693251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101725929|NCT00693251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101725930|NCT00693251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101725931|NCT00693251|Antifungal Agents|antifungal agents|mesh-ancestor
101725932|NCT00792376|Diclofenac|diclofenac|mesh-list
101725933|NCT00792376|Etoricoxib|etoricoxib|mesh-list
101725934|NCT00792376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101725935|NCT00792376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101725936|NCT00792376|Analgesics|analgesics|mesh-ancestor
101725937|NCT00792376|Sensory System Agents|sensory system agents|mesh-ancestor
101725938|NCT00792376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101725939|NCT00792376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725940|NCT00792376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101725941|NCT00792376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101725942|NCT00792376|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101725943|NCT00792376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101725944|NCT00792376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725945|NCT00792376|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101725946|NCT00592358|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101725947|NCT00592358|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101725948|NCT00592358|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101725949|NCT00592358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101725950|NCT00592358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725951|NCT00592358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101725952|NCT00592358|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101725953|NCT00592358|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101725954|NCT00592358|Serotonin Agents|serotonin agents|mesh-ancestor
101725955|NCT00592358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101195938|NCT02817360|Ramipril|ramipril|mesh-list
101725956|NCT00592358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725957|NCT00592358|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101725958|NCT00592358|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101725959|NCT00592358|Dopamine Agents|dopamine agents|mesh-ancestor
101725960|NCT00814320|Immunoglobulins|immunoglobulins|mesh-list
101725962|NCT00814320|gamma-Globulins|gamma-globulins|mesh-list
101725963|NCT00814320|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101725964|NCT00814320|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101725965|NCT00814320|Immunoglobulin G|immunoglobulin g|mesh-list
101725966|NCT00814320|Immunologic Factors|immunologic factors|mesh-ancestor
101725967|NCT00814320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725968|NCT00869999|Rituximab|rituximab|mesh-list
101725969|NCT00869999|Everolimus|everolimus|mesh-list
101725970|NCT00869999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101725971|NCT00869999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101725972|NCT00869999|Immunologic Factors|immunologic factors|mesh-ancestor
101725973|NCT00869999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725974|NCT00869999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101725975|NCT00869999|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101725976|NCT00869999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101725977|NCT00869999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101725978|NCT00869999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101725979|NCT00869999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101725980|NCT04030988|Dexamethasone|dexamethasone|mesh-list
101725981|NCT04030988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101725982|NCT04030988|Antiemetics|antiemetics|mesh-ancestor
101725983|NCT04030988|Autonomic Agents|autonomic agents|mesh-ancestor
101805217|NCT01030042|Oxaliplatin|oxaliplatin|mesh-list
101725984|NCT04030988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101725985|NCT04030988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725986|NCT04030988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101725987|NCT04030988|Glucocorticoids|glucocorticoids|mesh-ancestor
101725989|NCT04030988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101725990|NCT04030988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101725991|NCT04030988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101725992|NCT00703352|Eplerenone|eplerenone|mesh-list
101725993|NCT00703352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101725994|NCT00703352|Hormone Antagonists|hormone antagonists|mesh-ancestor
101725995|NCT00703352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101725996|NCT00703352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101725997|NCT00703352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101725998|NCT00703352|Diuretics|diuretics|mesh-ancestor
101725999|NCT00703352|Natriuretic Agents|natriuretic agents|mesh-ancestor
101726000|NCT00703352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101726001|NCT00703430|Memantine|memantine|mesh-list
101726002|NCT00703430|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101726003|NCT00703430|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101726004|NCT00703430|Dopamine Agents|dopamine agents|mesh-ancestor
101726005|NCT00703430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101726006|NCT00703430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726007|NCT00703430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726008|NCT00703430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101726009|NCT00703430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101726010|NCT00797836|Interferons|interferons|mesh-list
101726011|NCT00797836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101726012|NCT00797836|Antiviral Agents|antiviral agents|mesh-ancestor
101726013|NCT00797836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101726014|NCT00693407|Capsaicin|capsaicin|mesh-list
101726015|NCT00693407|Antipruritics|antipruritics|mesh-ancestor
101726016|NCT00693407|Dermatologic Agents|dermatologic agents|mesh-ancestor
101726017|NCT00693407|Sensory System Agents|sensory system agents|mesh-ancestor
101726018|NCT00693407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101726019|NCT00693407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726020|NCT02618603|Triamcinolone|triamcinolone|mesh-list
101726021|NCT02618603|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101726022|NCT02618603|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101726023|NCT02618603|Botulinum Toxins|botulinum toxins|mesh-list
101726024|NCT02618603|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101726025|NCT02618603|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101726026|NCT02618603|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101726027|NCT02618603|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101726028|NCT02618603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101196001|NCT02678377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101196003|NCT02678377|Cholinergic Agents|cholinergic agents|mesh-ancestor
101726029|NCT02618603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726030|NCT02618603|Cholinergic Agents|cholinergic agents|mesh-ancestor
101726031|NCT02618603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101726032|NCT02618603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726033|NCT02618603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101726034|NCT02618603|Glucocorticoids|glucocorticoids|mesh-ancestor
101726035|NCT02618603|Hormones|hormones|mesh-ancestor
101726036|NCT02618603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101726037|NCT02618603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101726038|NCT02618603|Immunologic Factors|immunologic factors|mesh-ancestor
101726039|NCT02618603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101726040|NCT02618603|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101726041|NCT02618603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101726042|NCT02616497|Aspirin|aspirin|mesh-list
101726043|NCT02616497|Triflusal|triflusal|mesh-list
101726044|NCT02616497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101726045|NCT02616497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101726046|NCT02616497|Analgesics|analgesics|mesh-ancestor
101805226|NCT01030042|Protective Agents|protective agents|mesh-ancestor
101805229|NCT01030042|Vitamins|vitamins|mesh-ancestor
101726047|NCT02616497|Sensory System Agents|sensory system agents|mesh-ancestor
101726048|NCT02616497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101726049|NCT02616497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726050|NCT02616497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101726051|NCT02616497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101726052|NCT02616497|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101726053|NCT02616497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101726054|NCT02616497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726055|NCT02616497|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101726056|NCT02616497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101726057|NCT02616497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101726058|NCT02616497|Antipyretics|antipyretics|mesh-ancestor
101726059|NCT00570232|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101726060|NCT00570232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101726061|NCT00570232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101726062|NCT00570232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101726063|NCT00570232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726064|NCT05755854|Cyclophosphamide|cyclophosphamide|mesh-list
101726065|NCT05755854|Fludarabine|fludarabine|mesh-list
101726066|NCT05755854|Fludarabine phosphate|fludarabine phosphate|mesh-list
101726067|NCT05755854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101726068|NCT05755854|Immunologic Factors|immunologic factors|mesh-ancestor
101726069|NCT05755854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726070|NCT05755854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101726071|NCT05755854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101726072|NCT05755854|Alkylating Agents|alkylating agents|mesh-ancestor
101726073|NCT05755854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726074|NCT05755854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101726075|NCT05755854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101726076|NCT05755854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101726077|NCT05755854|Antimetabolites|antimetabolites|mesh-ancestor
101726078|NCT00787384|Imatinib Mesylate|imatinib mesylate|mesh-list
101726079|NCT00787384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101726080|NCT00787384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101726081|NCT00787384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101726082|NCT00787384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726083|NCT02616419|Lidocaine|lidocaine|mesh-list
101726084|NCT02616419|Anesthetics, Local|anesthetics, local|mesh-ancestor
101726085|NCT02616419|Anesthetics|anesthetics|mesh-ancestor
101726086|NCT02616419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101726087|NCT02616419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726088|NCT02616419|Sensory System Agents|sensory system agents|mesh-ancestor
101726089|NCT02616419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101726090|NCT02616419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101726091|NCT02616419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101726092|NCT02616419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101726093|NCT02616419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101726094|NCT02616419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726095|NCT00798070|Cyclophosphamide|cyclophosphamide|mesh-list
101726096|NCT00798070|Fluorouracil|fluorouracil|mesh-list
101726097|NCT00798070|Docetaxel|docetaxel|mesh-list
101726098|NCT00798070|Epirubicin|epirubicin|mesh-list
101726099|NCT00798070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101726100|NCT00798070|Immunologic Factors|immunologic factors|mesh-ancestor
101726101|NCT00798070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726102|NCT00798070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101726103|NCT00798070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101726104|NCT00798070|Alkylating Agents|alkylating agents|mesh-ancestor
101726105|NCT00798070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726106|NCT00798070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101196095|NCT02381353|Bupivacaine|bupivacaine|mesh-list
101726107|NCT00798070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101726108|NCT00798070|Antimetabolites|antimetabolites|mesh-ancestor
101726109|NCT00798070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101726110|NCT00798070|Tubulin Modulators|tubulin modulators|mesh-ancestor
101726111|NCT00798070|Antimitotic Agents|antimitotic agents|mesh-ancestor
101726112|NCT00798070|Mitosis Modulators|mitosis modulators|mesh-ancestor
101726113|NCT00798070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101726114|NCT00798070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101726115|NCT00798070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101726116|NCT00798070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101726117|NCT00809328|Azithromycin|azithromycin|mesh-list
101726119|NCT00809328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101726120|NCT00798148|Carboplatin|carboplatin|mesh-list
101726121|NCT00798148|Etoposide|etoposide|mesh-list
101726122|NCT00798148|Melphalan|melphalan|mesh-list
101726123|NCT00798148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101726124|NCT00798148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101726125|NCT00798148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101726126|NCT00798148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101726127|NCT00798148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101726128|NCT00798148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726129|NCT00798148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101726130|NCT00798148|Alkylating Agents|alkylating agents|mesh-ancestor
101726131|NCT00798148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101726132|NCT00798148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101726133|NCT00798148|Immunologic Factors|immunologic factors|mesh-ancestor
101726134|NCT00798148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726135|NCT00787462|Pregabalin|pregabalin|mesh-list
101726136|NCT00787462|Analgesics|analgesics|mesh-ancestor
101726137|NCT00787462|Sensory System Agents|sensory system agents|mesh-ancestor
101726138|NCT00787462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101726139|NCT00787462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726140|NCT00787462|Anticonvulsants|anticonvulsants|mesh-ancestor
101726141|NCT00787462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101726142|NCT00787462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101726143|NCT00787462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726144|NCT00787462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101726145|NCT00787462|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101726146|NCT00787462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101726147|NCT00787462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101726148|NCT00787462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101726149|NCT00792766|Everolimus|everolimus|mesh-list
101726150|NCT00792766|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101726151|NCT00792766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101726152|NCT00792766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101196120|NCT01992653|Obinutuzumab|obinutuzumab|mesh-list
101726153|NCT00792766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726154|NCT00792766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101726155|NCT00792766|Immunologic Factors|immunologic factors|mesh-ancestor
101726156|NCT00792766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726157|NCT00792766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101726158|NCT00798460|Lamivudine|lamivudine|mesh-list
101805247|NCT01030120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101726160|NCT00798460|Clevudine|clevudine|mesh-list
101726161|NCT00798460|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101726162|NCT00798460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101726163|NCT00798460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101726164|NCT00798460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726165|NCT00798460|Antiviral Agents|antiviral agents|mesh-ancestor
101726166|NCT00798460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101726167|NCT00798460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101726168|NCT00798460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101726169|NCT02615873|Levodopa|levodopa|mesh-list
101726170|NCT02615873|Carbidopa|carbidopa|mesh-list
101726171|NCT02615873|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101726172|NCT02615873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101726173|NCT02615873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101726174|NCT02615873|Dopamine Agents|dopamine agents|mesh-ancestor
101726175|NCT02615873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101726176|NCT02615873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726177|NCT02615873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726178|NCT02615873|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101726179|NCT02615873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101726180|NCT02615873|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101726181|NCT02615873|Immunologic Factors|immunologic factors|mesh-ancestor
101726182|NCT02615873|Dopamine Agonists|dopamine agonists|mesh-ancestor
101726183|NCT00814164|Daunorubicin|daunorubicin|mesh-list
101726184|NCT00814164|Clofarabine|clofarabine|mesh-list
101726185|NCT00814164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101726186|NCT00814164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101726187|NCT00814164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101726188|NCT00814164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101726189|NCT00814164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101726190|NCT00814164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726191|NCT00814164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101196153|NCT01763671|Bevacizumab|bevacizumab|mesh-list
101726192|NCT00814164|Antimetabolites|antimetabolites|mesh-ancestor
101726194|NCT02609334|Histamine Antagonists|histamine antagonists|mesh-ancestor
101726195|NCT02609334|Histamine Agents|histamine agents|mesh-ancestor
101726196|NCT02609334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101726197|NCT02609334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726198|NCT02609334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726199|NCT00659230|Dopamine|dopamine|mesh-list
101726200|NCT00659230|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101726201|NCT00659230|Sympathomimetics|sympathomimetics|mesh-ancestor
101726202|NCT00659230|Autonomic Agents|autonomic agents|mesh-ancestor
101726203|NCT00659230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101726204|NCT00659230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726205|NCT00659230|Dopamine Agents|dopamine agents|mesh-ancestor
101726206|NCT00659230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101726207|NCT00659230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726208|NCT00659230|Protective Agents|protective agents|mesh-ancestor
101726209|NCT00809094|Acetylcysteine|acetylcysteine|mesh-list
101726210|NCT00809094|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101726211|NCT00809094|Antiviral Agents|antiviral agents|mesh-ancestor
101726212|NCT00809094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101726213|NCT00809094|Expectorants|expectorants|mesh-ancestor
101726214|NCT00809094|Respiratory System Agents|respiratory system agents|mesh-ancestor
101726215|NCT00809094|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101726216|NCT00809094|Antioxidants|antioxidants|mesh-ancestor
101726217|NCT00809094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805270|NCT00945620|Ropivacaine|ropivacaine|mesh-list
101726218|NCT00809094|Protective Agents|protective agents|mesh-ancestor
101726219|NCT00809094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726220|NCT00809094|Antidotes|antidotes|mesh-ancestor
101726221|NCT02615639|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101726222|NCT02615639|Interferon-alpha|interferon-alpha|mesh-list
101726223|NCT02615639|Entecavir|entecavir|mesh-list
101726224|NCT02615639|Telbivudine|telbivudine|mesh-list
101726225|NCT02615639|Interferon alpha-2|interferon alpha-2|mesh-list
101726226|NCT02615639|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
101726227|NCT02615639|Vaccines|vaccines|mesh-list
101726228|NCT02615639|Immunologic Factors|immunologic factors|mesh-ancestor
101726229|NCT02615639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726230|NCT02615639|Antiviral Agents|antiviral agents|mesh-ancestor
101726231|NCT02615639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101726232|NCT02615639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101726233|NCT02615639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101726234|NCT02615639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726235|NCT02615639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101726236|NCT00798616|Methylprednisolone|methylprednisolone|mesh-list
101726237|NCT00798616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101726238|NCT00798616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101726239|NCT00798616|Prednisolone|prednisolone|mesh-list
101726240|NCT00798616|Prednisolone acetate|prednisolone acetate|mesh-list
101726241|NCT00798616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101726242|NCT00798616|Prednisolone phosphate|prednisolone phosphate|mesh-list
101726243|NCT00798616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101726244|NCT00798616|Antiemetics|antiemetics|mesh-ancestor
101726245|NCT00798616|Autonomic Agents|autonomic agents|mesh-ancestor
101726246|NCT00798616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101726247|NCT00798616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726248|NCT00798616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101726249|NCT00798616|Glucocorticoids|glucocorticoids|mesh-ancestor
101726250|NCT00798616|Hormones|hormones|mesh-ancestor
101726251|NCT00798616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101726252|NCT00798616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101726253|NCT00798616|Protective Agents|protective agents|mesh-ancestor
101196248|NCT01685268|Hormones|hormones|mesh-ancestor
101726255|NCT00798616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101726256|NCT02618057|Levofloxacin|levofloxacin|mesh-list
101726257|NCT02618057|Prednisolone|prednisolone|mesh-list
101726258|NCT02618057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101726259|NCT02618057|Glucocorticoids|glucocorticoids|mesh-ancestor
101726260|NCT02618057|Hormones|hormones|mesh-ancestor
101726261|NCT02618057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101333697|NCT00040300|Racivir|racivir|mesh-list
101726262|NCT02618057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726263|NCT02618057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101726264|NCT02618057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101726265|NCT02618057|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101726266|NCT02618057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101726267|NCT02618057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101726268|NCT02618057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101726269|NCT02618057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101726270|NCT02618057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101726271|NCT02618057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726272|NCT02618057|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101726273|NCT02618057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101726274|NCT04137029|Bromides|bromides|mesh-list
101726275|NCT04137029|Formoterol Fumarate|formoterol fumarate|mesh-list
101726276|NCT04137029|Tiotropium Bromide|tiotropium bromide|mesh-list
101726277|NCT04137029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101726278|NCT04137029|Autonomic Agents|autonomic agents|mesh-ancestor
101726279|NCT04137029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101726280|NCT04137029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726281|NCT04137029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101726282|NCT04137029|Respiratory System Agents|respiratory system agents|mesh-ancestor
101726283|NCT04137029|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101726290|NCT04137029|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101726291|NCT04137029|Cholinergic Agents|cholinergic agents|mesh-ancestor
101726292|NCT04137029|Anticonvulsants|anticonvulsants|mesh-ancestor
101726293|NCT00787774|Raltegravir Potassium|raltegravir potassium|mesh-list
101726294|NCT00787774|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101726295|NCT00787774|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101726296|NCT00787774|Antiviral Agents|antiviral agents|mesh-ancestor
101726297|NCT00787774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101726298|NCT00787774|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101726299|NCT00787774|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101196285|NCT01384448|Sympathomimetics|sympathomimetics|mesh-ancestor
101726300|NCT00787774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101726301|NCT00787774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726302|NCT00452413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101726303|NCT00452413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101726304|NCT00452413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101726305|NCT00452413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101726306|NCT00452413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726307|NCT00798772|Micronutrients|micronutrients|mesh-list
101726308|NCT00798772|Trace Elements|trace elements|mesh-list
101726309|NCT00798772|Antioxidants|antioxidants|mesh-list
101726310|NCT00798772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726311|NCT00798772|Protective Agents|protective agents|mesh-ancestor
101726312|NCT00798772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726313|NCT00867503|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101726314|NCT00867503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101726315|NCT00867503|Alkylating Agents|alkylating agents|mesh-ancestor
101726316|NCT00867503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726317|NCT00867503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101726324|NCT02615561|Pantothenic Acid|pantothenic acid|mesh-list
101726325|NCT02615561|Vitamin B Complex|vitamin b complex|mesh-ancestor
101726326|NCT02615561|Vitamins|vitamins|mesh-ancestor
101726327|NCT02615561|Micronutrients|micronutrients|mesh-ancestor
101726328|NCT02615561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726329|NCT00793234|Enoxaparin|enoxaparin|mesh-list
101726330|NCT00793234|Anticoagulants|anticoagulants|mesh-ancestor
101726331|NCT00793234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101726332|NCT00793234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101726333|NCT00793234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726334|NCT00697775|Vaccines|vaccines|mesh-list
101726335|NCT00697775|Immunologic Factors|immunologic factors|mesh-ancestor
101726336|NCT00697775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726337|NCT04133051|Bupivacaine|bupivacaine|mesh-list
101726338|NCT04133051|Anesthetics, Local|anesthetics, local|mesh-ancestor
101726339|NCT04133051|Anesthetics|anesthetics|mesh-ancestor
101196312|NCT01384578|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101726340|NCT04133051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101726341|NCT04133051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726342|NCT04133051|Sensory System Agents|sensory system agents|mesh-ancestor
101726343|NCT04133051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101726344|NCT00788242|Insulin|insulin|mesh-list
101726345|NCT00788242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101726346|NCT00788242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726347|NCT04031027|Apremilast|apremilast|mesh-list
101726348|NCT04031027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101726349|NCT04031027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101726351|NCT04031027|Sensory System Agents|sensory system agents|mesh-ancestor
101726352|NCT04031027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101726353|NCT04031027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726354|NCT04031027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101726355|NCT04031027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101726356|NCT04031027|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101726357|NCT04031027|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101726358|NCT04031027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101726359|NCT04031027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726360|NCT02609802|Sevoflurane|sevoflurane|mesh-list
101726361|NCT02609802|Desflurane|desflurane|mesh-list
101726362|NCT02609802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101726363|NCT02609802|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101726364|NCT02609802|Anesthetics, General|anesthetics, general|mesh-ancestor
101726365|NCT02609802|Anesthetics|anesthetics|mesh-ancestor
101726366|NCT02609802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101726367|NCT02609802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726368|NCT02609646|Vancomycin|vancomycin|mesh-list
101726369|NCT02609646|Meropenem|meropenem|mesh-list
101726370|NCT02609646|Tazobactam|tazobactam|mesh-list
101383839|NCT00102765|Xhance|xhance|mesh-list
101726371|NCT02609646|Linezolid|linezolid|mesh-list
101726372|NCT02609646|Piperacillin|piperacillin|mesh-list
101726373|NCT02609646|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101726374|NCT02609646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101726375|NCT02609646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101726376|NCT02609646|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101726377|NCT02609646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101726378|NCT02609646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726379|NCT02609646|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101726380|NCT02610504|Hyaluronic Acid|hyaluronic acid|mesh-list
101726381|NCT02610504|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101726382|NCT02610504|Immunologic Factors|immunologic factors|mesh-ancestor
101726383|NCT02610504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196365|NCT01384994|Vitamins|vitamins|mesh-ancestor
101726384|NCT02610504|Viscosupplements|viscosupplements|mesh-ancestor
101726385|NCT02610504|Protective Agents|protective agents|mesh-ancestor
101726386|NCT04132583|Diclofenac|diclofenac|mesh-list
101726387|NCT04132583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101726388|NCT04132583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101726389|NCT04132583|Analgesics|analgesics|mesh-ancestor
101726390|NCT04132583|Sensory System Agents|sensory system agents|mesh-ancestor
101726391|NCT04132583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101726392|NCT04132583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726393|NCT04132583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101726394|NCT04132583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101726395|NCT04132583|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101726396|NCT04132583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101726397|NCT04132583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726398|NCT05754762|Remifentanil|remifentanil|mesh-list
101726399|NCT05754762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101726400|NCT05754762|Narcotics|narcotics|mesh-ancestor
101726401|NCT05754762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101726402|NCT05754762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726403|NCT05754762|Analgesics|analgesics|mesh-ancestor
101726404|NCT05754762|Sensory System Agents|sensory system agents|mesh-ancestor
101726405|NCT05754762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101726406|NCT05326152|Immunomodulating Agents|immunomodulating agents|mesh-list
101726407|NCT05326152|Immunologic Factors|immunologic factors|mesh-ancestor
101726408|NCT05326152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726409|NCT00914004|Desipramine|desipramine|mesh-list
101726410|NCT00914004|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101726411|NCT00914004|Antidepressive Agents|antidepressive agents|mesh-ancestor
101726412|NCT00914004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101726413|NCT00914004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101726414|NCT00914004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726415|NCT00914004|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101196388|NCT01385228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101726416|NCT00914004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101726417|NCT00914004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101726418|NCT00914004|Adrenergic Agents|adrenergic agents|mesh-ancestor
101726419|NCT00914004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101726420|NCT00914004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726421|NCT00867113|Imatinib Mesylate|imatinib mesylate|mesh-list
101726422|NCT00867113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101726423|NCT00867113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101726424|NCT00867113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101726425|NCT00867113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726427|NCT02608710|Gout Suppressants|gout suppressants|mesh-ancestor
101726428|NCT02608710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101726429|NCT04030260|Antibodies|antibodies|mesh-list
101726430|NCT04030260|Immunoglobulins|immunoglobulins|mesh-list
101726431|NCT04030260|Immunologic Factors|immunologic factors|mesh-ancestor
101726432|NCT04030260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726433|NCT00697385|Tranexamic Acid|tranexamic acid|mesh-list
101726434|NCT00697385|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101726435|NCT00697385|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101726436|NCT00697385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726437|NCT00697385|Hemostatics|hemostatics|mesh-ancestor
101726438|NCT00697385|Coagulants|coagulants|mesh-ancestor
101726439|NCT00451555|Fulvestrant|fulvestrant|mesh-list
101726440|NCT00451555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101726441|NCT00451555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101726442|NCT00451555|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101726443|NCT00451555|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101726444|NCT00451555|Hormone Antagonists|hormone antagonists|mesh-ancestor
101726445|NCT00451555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101726446|NCT00451555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726448|NCT00867035|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101726449|NCT00867035|Chlorine dioxide|chlorine dioxide|mesh-list
101726450|NCT00867035|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101726451|NCT00867035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101726452|NCT00867035|Disinfectants|disinfectants|mesh-ancestor
101726453|NCT00867035|Dermatologic Agents|dermatologic agents|mesh-ancestor
101726454|NCT00867035|Dental Disinfectants|dental disinfectants|mesh-ancestor
101726455|NCT05754684|Aldesleukin|aldesleukin|mesh-list
101726456|NCT05754684|Interleukin-2|interleukin-2|mesh-list
101726457|NCT05754684|Molgramostim|molgramostim|mesh-list
101726458|NCT05754684|Dinutuximab|dinutuximab|mesh-list
101726459|NCT05754684|Spironolactone|spironolactone|mesh-list
101726460|NCT05754684|Sargramostim|sargramostim|mesh-list
101196437|NCT01385891|Etoposide|etoposide|mesh-list
101726461|NCT05754684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101726462|NCT05754684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101726463|NCT05754684|Analgesics|analgesics|mesh-ancestor
101726465|NCT05754684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101726466|NCT05754684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726467|NCT05754684|Immunologic Factors|immunologic factors|mesh-ancestor
101726468|NCT05754684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101726469|NCT05754684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101726470|NCT05754684|Antiviral Agents|antiviral agents|mesh-ancestor
101726471|NCT05754684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101726472|NCT05754684|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101726473|NCT05754684|Hormone Antagonists|hormone antagonists|mesh-ancestor
101726474|NCT05754684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101726475|NCT05754684|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101726476|NCT05754684|Diuretics|diuretics|mesh-ancestor
101726477|NCT05754684|Natriuretic Agents|natriuretic agents|mesh-ancestor
101726478|NCT00694187|Zaleplon|zaleplon|mesh-list
101726479|NCT00694187|Anticonvulsants|anticonvulsants|mesh-ancestor
101726480|NCT00694187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101726481|NCT00694187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101726482|NCT00694187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726483|NCT00694187|GABA Modulators|gaba modulators|mesh-ancestor
101726484|NCT00694187|GABA Agents|gaba agents|mesh-ancestor
101726485|NCT00694187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101726486|NCT00694187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726487|NCT02617121|Gabapentin|gabapentin|mesh-list
101726488|NCT02617121|Ramosetron|ramosetron|mesh-list
101726489|NCT02617121|Analgesics|analgesics|mesh-ancestor
101726490|NCT02617121|Sensory System Agents|sensory system agents|mesh-ancestor
101726491|NCT02617121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101726492|NCT02617121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726493|NCT02617121|Anticonvulsants|anticonvulsants|mesh-ancestor
101726494|NCT02617121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101726495|NCT02617121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101726496|NCT02617121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101726497|NCT02617121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101726498|NCT02617121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101726499|NCT02617121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101726500|NCT02617121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101726501|NCT02617121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726502|NCT02617121|Antimanic Agents|antimanic agents|mesh-ancestor
101726503|NCT02617121|Antiemetics|antiemetics|mesh-ancestor
101726504|NCT02617121|Autonomic Agents|autonomic agents|mesh-ancestor
101726505|NCT02617121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101726506|NCT02617121|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101726507|NCT02617121|Serotonin Agents|serotonin agents|mesh-ancestor
101726508|NCT02609490|Olmesartan|olmesartan|mesh-list
101726509|NCT02609490|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101726510|NCT02609490|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
101726511|NCT02609490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101726512|NCT02609490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101726513|NCT02609490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101726514|NCT02609490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726515|NCT02610348|Vaccines|vaccines|mesh-list
101726516|NCT02610348|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101726517|NCT02610348|Immunologic Factors|immunologic factors|mesh-ancestor
101726518|NCT02610348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726519|NCT05757336|Paclitaxel|paclitaxel|mesh-list
101726520|NCT05757336|Bevacizumab|bevacizumab|mesh-list
101726521|NCT05757336|Gemcitabine|gemcitabine|mesh-list
101726522|NCT05757336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101726523|NCT05757336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101726524|NCT05757336|Tubulin Modulators|tubulin modulators|mesh-ancestor
101726525|NCT05757336|Antimitotic Agents|antimitotic agents|mesh-ancestor
101726526|NCT05757336|Mitosis Modulators|mitosis modulators|mesh-ancestor
101805337|NCT00942344|Losartan|losartan|mesh-list
101726527|NCT05757336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726528|NCT05757336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101726529|NCT05757336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101726530|NCT05757336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101726531|NCT05757336|Growth Substances|growth substances|mesh-ancestor
101726532|NCT05757336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726533|NCT05757336|Growth Inhibitors|growth inhibitors|mesh-ancestor
101726534|NCT05757336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101726535|NCT05757336|Antimetabolites|antimetabolites|mesh-ancestor
101726536|NCT00871871|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101726538|NCT00871871|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
101726539|NCT00871871|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
101726540|NCT00871871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101726542|NCT00871871|Natriuretic Agents|natriuretic agents|mesh-ancestor
101726543|NCT00871871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726544|NCT00871871|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101726545|NCT00871871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101726546|NCT00871871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726547|NCT00871871|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101726548|NCT00871871|Vasodilator Agents|vasodilator agents|mesh-ancestor
101726549|NCT00871871|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101726550|NCT02608788|Ketorolac|ketorolac|mesh-list
101726551|NCT02608788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101726552|NCT02608788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101726553|NCT02608788|Analgesics|analgesics|mesh-ancestor
101726554|NCT02608788|Sensory System Agents|sensory system agents|mesh-ancestor
101726555|NCT02608788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101726556|NCT02608788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726557|NCT02608788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101726558|NCT02608788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101726559|NCT02608788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101726560|NCT02608788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101726561|NCT02608788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726562|NCT04132349|Ulipristal acetate|ulipristal acetate|mesh-list
101726563|NCT04132349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101726564|NCT04132349|Contraceptive Agents|contraceptive agents|mesh-ancestor
101726565|NCT04132349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101726566|NCT04132349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726567|NCT04132349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101726568|NCT04961190|Paroxetine|paroxetine|mesh-list
101726569|NCT04961190|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101726570|NCT04961190|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101726571|NCT04961190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101726572|NCT04961190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101726573|NCT04961190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726574|NCT04961190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101726575|NCT04961190|Serotonin Agents|serotonin agents|mesh-ancestor
101726576|NCT04961190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726577|NCT04961190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101726578|NCT04961190|Antidepressive Agents|antidepressive agents|mesh-ancestor
101726579|NCT04961190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101726580|NCT04961190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101726581|NCT04961190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101726582|NCT04961190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101726583|NCT04961190|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101726584|NCT00849680|Vaccines|vaccines|mesh-list
101726585|NCT00849680|Immunologic Factors|immunologic factors|mesh-ancestor
101726586|NCT00849680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726587|NCT00866723|Bevacizumab|bevacizumab|mesh-list
101726588|NCT00866723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101726590|NCT00866723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101726591|NCT00866723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101726592|NCT00866723|Growth Substances|growth substances|mesh-ancestor
101196533|NCT01386294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101726593|NCT00866723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726594|NCT00866723|Growth Inhibitors|growth inhibitors|mesh-ancestor
101384030|NCT00129805|Aspirin|aspirin|mesh-list
101726595|NCT02613455|Triamcinolone|triamcinolone|mesh-list
101726596|NCT02613455|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101726597|NCT02613455|Lidocaine|lidocaine|mesh-list
101726598|NCT02613455|Anesthetics, Local|anesthetics, local|mesh-ancestor
101726599|NCT02613455|Anesthetics|anesthetics|mesh-ancestor
101726600|NCT02613455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101726601|NCT02613455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726602|NCT02613455|Sensory System Agents|sensory system agents|mesh-ancestor
101726603|NCT02613455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101726604|NCT02613455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101726605|NCT02613455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101726606|NCT02613455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101726607|NCT02613455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101726608|NCT02613455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726609|NCT02613455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101726610|NCT02613455|Glucocorticoids|glucocorticoids|mesh-ancestor
101726611|NCT02613455|Hormones|hormones|mesh-ancestor
101726612|NCT02613455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101726613|NCT02613455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101726614|NCT02613455|Immunologic Factors|immunologic factors|mesh-ancestor
101726615|NCT00703586|Maraviroc|maraviroc|mesh-list
101726616|NCT00703586|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101726617|NCT00703586|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101726618|NCT00703586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726619|NCT00703586|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101726620|NCT00703586|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101726621|NCT00703586|Antiviral Agents|antiviral agents|mesh-ancestor
101726622|NCT00703586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101726623|NCT00703586|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101726624|NCT04130399|Folfirinox|folfirinox|mesh-list
101726625|NCT04130399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101726626|NCT00849056|rGLP-1 protein|rglp-1 protein|mesh-list
101726627|NCT00849056|Incretins|incretins|mesh-ancestor
101726628|NCT00849056|Hormones|hormones|mesh-ancestor
101726629|NCT00849056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101726630|NCT00849056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726631|NCT02612948|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101726632|NCT02612948|Antidepressive Agents|antidepressive agents|mesh-ancestor
101726633|NCT02612948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101726634|NCT02612948|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101726635|NCT02612948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101726636|NCT02612948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101726637|NCT02612948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726638|NCT00706862|Lactoferrin|lactoferrin|mesh-list
101726639|NCT00706862|Talactoferrin alfa|talactoferrin alfa|mesh-list
101726640|NCT00706862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101726641|NCT00706862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101726642|NCT02612714|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101726643|NCT02612714|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101726644|NCT02612714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101726645|NCT02612714|Antimetabolites|antimetabolites|mesh-ancestor
101726646|NCT02612714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726647|NCT02612714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101726648|NCT02612714|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101726649|NCT02612714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101726650|NCT00837434|Adalimumab|adalimumab|mesh-list
101726651|NCT00837434|Etanercept|etanercept|mesh-list
101726652|NCT00837434|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101726653|NCT00837434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101726654|NCT00837434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101726655|NCT00837434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101726656|NCT00837434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101726657|NCT00837434|Analgesics|analgesics|mesh-ancestor
101726658|NCT00837434|Sensory System Agents|sensory system agents|mesh-ancestor
101726659|NCT00837434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101726660|NCT00837434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726661|NCT00837434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101726662|NCT00837434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101726663|NCT00837434|Immunologic Factors|immunologic factors|mesh-ancestor
101726664|NCT00703742|Escitalopram|escitalopram|mesh-list
101726665|NCT00703742|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101726666|NCT00703742|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101726667|NCT00703742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101726668|NCT00703742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726669|NCT00703742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101726670|NCT00703742|Serotonin Agents|serotonin agents|mesh-ancestor
101726671|NCT00703742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726672|NCT00702182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101726673|NCT00702182|Vinorelbine|vinorelbine|mesh-list
101726674|NCT00702182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101726675|NCT00702182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101726676|NCT00702182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101726677|NCT00702182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726678|NCT00702182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101726679|NCT00702182|Tubulin Modulators|tubulin modulators|mesh-ancestor
101726680|NCT00702182|Antimitotic Agents|antimitotic agents|mesh-ancestor
101726681|NCT00702182|Mitosis Modulators|mitosis modulators|mesh-ancestor
101726682|NCT00702260|Ramipril|ramipril|mesh-list
101726683|NCT00702260|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101726684|NCT00702260|Protease Inhibitors|protease inhibitors|mesh-ancestor
101726685|NCT00702260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101726686|NCT00702260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726687|NCT00702260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101726688|NCT00702416|Acetaminophen|acetaminophen|mesh-list
101726689|NCT00702416|Fentanyl|fentanyl|mesh-list
101726690|NCT00702416|Morphine|morphine|mesh-list
101726691|NCT00702416|Analgesics, Opioid|analgesics, opioid|mesh-list
101726692|NCT00702416|Narcotics|narcotics|mesh-list
101726693|NCT00702416|Analgesics|analgesics|mesh-list
101726694|NCT00702416|Anesthetics|anesthetics|mesh-list
101726695|NCT00702416|Ropivacaine|ropivacaine|mesh-list
101726696|NCT00702416|Anesthetics, Local|anesthetics, local|mesh-list
101726697|NCT00702416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101726698|NCT00702416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726699|NCT00702416|Sensory System Agents|sensory system agents|mesh-ancestor
101726700|NCT00702416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101726701|NCT00702416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101726702|NCT00702416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101726703|NCT00702416|Anesthetics, General|anesthetics, general|mesh-ancestor
101726704|NCT00702416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101726705|NCT00702416|Antipyretics|antipyretics|mesh-ancestor
101726706|NCT00827918|Olanzapine|olanzapine|mesh-list
101726707|NCT00827918|Antiemetics|antiemetics|mesh-ancestor
101726708|NCT00827918|Autonomic Agents|autonomic agents|mesh-ancestor
101726709|NCT00827918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101726710|NCT00827918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726711|NCT00827918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101726712|NCT00827918|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101726713|NCT00827918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101726714|NCT00827918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101726715|NCT00827918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101726716|NCT00827918|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101364308|NCT00047723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101726717|NCT00827918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101726718|NCT00827918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101726719|NCT00827918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726720|NCT00827918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101726722|NCT00813150|Dexamethasone|dexamethasone|mesh-list
101726723|NCT00813150|Cyclophosphamide|cyclophosphamide|mesh-list
101726724|NCT00813150|Bortezomib|bortezomib|mesh-list
101726725|NCT00813150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101726726|NCT00813150|Immunologic Factors|immunologic factors|mesh-ancestor
101726727|NCT00813150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726728|NCT00813150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101726729|NCT00813150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101726730|NCT00813150|Alkylating Agents|alkylating agents|mesh-ancestor
101726731|NCT00813150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726732|NCT00813150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101726733|NCT00813150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101726734|NCT00813150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101726735|NCT00813150|Antiemetics|antiemetics|mesh-ancestor
101726736|NCT00813150|Autonomic Agents|autonomic agents|mesh-ancestor
101726737|NCT00813150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101726738|NCT00813150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101726739|NCT00813150|Glucocorticoids|glucocorticoids|mesh-ancestor
101726740|NCT00813150|Hormones|hormones|mesh-ancestor
101196685|NCT01386996|Budesonide|budesonide|mesh-list
101726741|NCT00813150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101726742|NCT00813150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101384179|NCT00079469|Bupropion|bupropion|mesh-list
101726743|NCT00807846|Celecoxib|celecoxib|mesh-list
101726744|NCT00807846|Naproxen|naproxen|mesh-list
101726745|NCT00807846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101726746|NCT00807846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101726748|NCT00807846|Sensory System Agents|sensory system agents|mesh-ancestor
101726749|NCT00807846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101726750|NCT00807846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726751|NCT00807846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101726752|NCT00807846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101726753|NCT00807846|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101726754|NCT00807846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101726755|NCT00807846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101726756|NCT00807846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726757|NCT00807846|Gout Suppressants|gout suppressants|mesh-ancestor
101726758|NCT00810108|Ritonavir|ritonavir|mesh-list
101726759|NCT00810108|Lopinavir|lopinavir|mesh-list
101726760|NCT00810108|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101805380|NCT00952952|Mesalamine|mesalamine|mesh-list
101726761|NCT00810108|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101726762|NCT00810108|Protease Inhibitors|protease inhibitors|mesh-ancestor
101726763|NCT00810108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101726764|NCT00810108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726765|NCT00810108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101726766|NCT00810108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101726767|NCT00810108|Antiviral Agents|antiviral agents|mesh-ancestor
101726768|NCT00810108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101726769|NCT00810108|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101726770|NCT00810108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101726771|NCT00827606|Atorvastatin|atorvastatin|mesh-list
101726772|NCT00827606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101726773|NCT00827606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101726774|NCT00827606|Antimetabolites|antimetabolites|mesh-ancestor
101726775|NCT00827606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726776|NCT00827606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101726777|NCT00827606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101726778|NCT00827606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101726779|NCT04016220|Budesonide|budesonide|mesh-list
101726780|NCT04016220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101726781|NCT04016220|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101726782|NCT04016220|Autonomic Agents|autonomic agents|mesh-ancestor
101726783|NCT04016220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101726784|NCT04016220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726785|NCT04016220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101726786|NCT04016220|Respiratory System Agents|respiratory system agents|mesh-ancestor
101726787|NCT04016220|Glucocorticoids|glucocorticoids|mesh-ancestor
101726788|NCT04016220|Hormones|hormones|mesh-ancestor
101364310|NCT00146497|Budesonide|budesonide|mesh-list
101726789|NCT04016220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101726791|NCT00663052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101726792|NCT00663052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101726793|NCT00663052|Analgesics|analgesics|mesh-ancestor
101726794|NCT00663052|Sensory System Agents|sensory system agents|mesh-ancestor
101726795|NCT00663052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101726796|NCT00663052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726797|NCT00663052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101726798|NCT00663052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101726799|NCT00663052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101726800|NCT00663052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101726801|NCT00663052|Immunologic Factors|immunologic factors|mesh-ancestor
101726802|NCT05599880|Bortezomib|bortezomib|mesh-list
101726803|NCT05599880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101726804|NCT00707252|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101726805|NCT00707252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101726806|NCT00707252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101726807|NCT00707252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101805410|NCT00120289|Niacin|niacin|mesh-list
101726808|NCT00707252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726809|NCT00826748|Beclomethasone|beclomethasone|mesh-list
101726810|NCT00826748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101726811|NCT00826748|Glucocorticoids|glucocorticoids|mesh-ancestor
101726812|NCT00826748|Hormones|hormones|mesh-ancestor
101726813|NCT00826748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101726814|NCT00826748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726815|NCT00826748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101726816|NCT00826748|Respiratory System Agents|respiratory system agents|mesh-ancestor
101726817|NCT00922844|Sevoflurane|sevoflurane|mesh-list
101726818|NCT00922844|Isoflurane|isoflurane|mesh-list
101726819|NCT00922844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101726821|NCT00922844|Anesthetics, General|anesthetics, general|mesh-ancestor
101726822|NCT00922844|Anesthetics|anesthetics|mesh-ancestor
101726823|NCT00922844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101726824|NCT00922844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726826|NCT00707330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101726827|NCT00707330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101726828|NCT00707330|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101726829|NCT00707330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101726830|NCT00707330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726831|NCT00707330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101726832|NCT00707330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101726833|NCT00707408|Imatinib Mesylate|imatinib mesylate|mesh-list
101726834|NCT00707408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101726835|NCT00707408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101726836|NCT00707408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101726837|NCT00707408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726838|NCT00788320|Vitamin D|vitamin d|mesh-list
101726839|NCT00788320|Cholecalciferol|cholecalciferol|mesh-list
101726840|NCT00788320|Vitamins|vitamins|mesh-ancestor
101726841|NCT00788320|Micronutrients|micronutrients|mesh-ancestor
101726842|NCT00788320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726843|NCT00788320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101726844|NCT00788320|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101726845|NCT00807144|Tacrolimus|tacrolimus|mesh-list
101726846|NCT00807144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101726847|NCT00807144|Immunologic Factors|immunologic factors|mesh-ancestor
101726848|NCT00807144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726849|NCT00807144|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101726850|NCT00807144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101726851|NCT00807144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726852|NCT00799240|Cisplatin|cisplatin|mesh-list
101726853|NCT00799240|Pemetrexed|pemetrexed|mesh-list
101726854|NCT00799240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101726855|NCT00799240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101726856|NCT00799240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101726857|NCT00799240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726858|NCT00799240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101726859|NCT00799240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101726860|NCT00799240|Immunologic Factors|immunologic factors|mesh-ancestor
101726861|NCT00799240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726862|NCT00591006|Hydrocortisone|hydrocortisone|mesh-list
101364311|NCT00146497|Pulmonary Surfactants|pulmonary surfactants|mesh-list
101726863|NCT00591006|Phenytoin|phenytoin|mesh-list
101726864|NCT00591006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101726866|NCT00591006|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101726867|NCT00591006|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101726868|NCT00591006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101726869|NCT00591006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726870|NCT00591006|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101726871|NCT00591006|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101726872|NCT00788398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101726873|NCT00844844|Eculizumab|eculizumab|mesh-list
101726874|NCT00844844|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101726875|NCT00844844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101726876|NCT00844844|Immunologic Factors|immunologic factors|mesh-ancestor
101726877|NCT00844844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726878|NCT05748054|Fluorides|fluorides|mesh-list
101726879|NCT05748054|Cariostatic Agents|cariostatic agents|mesh-ancestor
101726880|NCT05748054|Protective Agents|protective agents|mesh-ancestor
101726881|NCT05748054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726882|NCT00702572|Paclitaxel|paclitaxel|mesh-list
101726883|NCT00702572|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101726884|NCT00702572|Bevacizumab|bevacizumab|mesh-list
101726885|NCT00702572|Carboplatin|carboplatin|mesh-list
101726886|NCT00702572|Vorinostat|vorinostat|mesh-list
101726887|NCT00702572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101726888|NCT00702572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101726889|NCT00702572|Tubulin Modulators|tubulin modulators|mesh-ancestor
101726890|NCT00702572|Antimitotic Agents|antimitotic agents|mesh-ancestor
101726891|NCT00702572|Mitosis Modulators|mitosis modulators|mesh-ancestor
101726892|NCT00702572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726893|NCT00702572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101726894|NCT00702572|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101726895|NCT00702572|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101726896|NCT00702572|Growth Substances|growth substances|mesh-ancestor
101726897|NCT00702572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726898|NCT00702572|Growth Inhibitors|growth inhibitors|mesh-ancestor
101726899|NCT00702572|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101726900|NCT00702572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101726902|NCT00793468|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101726903|NCT00793468|Autonomic Agents|autonomic agents|mesh-ancestor
101726904|NCT00793468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101726905|NCT00793468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726906|NCT00793468|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101726907|NCT00793468|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101726908|NCT00793468|Cholinergic Agents|cholinergic agents|mesh-ancestor
101726909|NCT00793468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101726910|NCT00793468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726911|NCT00836810|Prednisone|prednisone|mesh-list
101726912|NCT00836810|Prednisolone|prednisolone|mesh-list
101726913|NCT00836810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101726914|NCT00836810|Glucocorticoids|glucocorticoids|mesh-ancestor
101726915|NCT00836810|Hormones|hormones|mesh-ancestor
101726916|NCT00836810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101726917|NCT00836810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726918|NCT00836810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101726919|NCT00836810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101726920|NCT00658684|Fesoterodine|fesoterodine|mesh-list
101726921|NCT00658684|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101726922|NCT00658684|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101726923|NCT00658684|Cholinergic Agents|cholinergic agents|mesh-ancestor
101726924|NCT00658684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101726925|NCT00658684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726926|NCT00658684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726927|NCT00658684|Urological Agents|urological agents|mesh-ancestor
101726928|NCT00660400|Azacitidine|azacitidine|mesh-list
101726929|NCT00660400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101726930|NCT00660400|Antimetabolites|antimetabolites|mesh-ancestor
101726931|NCT00660400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726932|NCT00660400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101726933|NCT00660400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101726934|NCT00826514|Tanezumab|tanezumab|mesh-list
101726935|NCT00826514|Analgesics|analgesics|mesh-ancestor
101196876|NCT01388517|Vitamins|vitamins|mesh-ancestor
101726936|NCT00826514|Sensory System Agents|sensory system agents|mesh-ancestor
101726937|NCT00826514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101726938|NCT00826514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726939|NCT00800566|Clofarabine|clofarabine|mesh-list
101726940|NCT00800566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101726941|NCT00800566|Antimetabolites|antimetabolites|mesh-ancestor
101726942|NCT00800566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726943|NCT00800566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101726944|NCT00793858|Ciclesonide|ciclesonide|mesh-list
101726945|NCT00793858|Glucocorticoids|glucocorticoids|mesh-ancestor
101726946|NCT00793858|Hormones|hormones|mesh-ancestor
101726947|NCT00793858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101726948|NCT00793858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726949|NCT00793858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101726950|NCT00800722|Sirolimus|sirolimus|mesh-list
101726951|NCT00800722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101726952|NCT00800722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101726953|NCT00800722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101726954|NCT00800722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101726955|NCT00800722|Antifungal Agents|antifungal agents|mesh-ancestor
101726956|NCT00800722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101726957|NCT00800722|Immunologic Factors|immunologic factors|mesh-ancestor
101726958|NCT00800722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726959|NCT00826280|Caffeine|caffeine|mesh-list
101726960|NCT00826280|Regadenoson|regadenoson|mesh-list
101726961|NCT00826280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101726962|NCT00826280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726963|NCT00826280|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101726964|NCT00826280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101726965|NCT00826280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726966|NCT00826280|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101196925|NCT01388621|Carboplatin|carboplatin|mesh-list
101726968|NCT00826280|Purinergic Agents|purinergic agents|mesh-ancestor
101726969|NCT00826280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101726970|NCT00826280|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
101726971|NCT00826280|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101726972|NCT00826280|Purinergic Agonists|purinergic agonists|mesh-ancestor
101726973|NCT00800800|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101726974|NCT00800800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101726975|NCT00800800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101726976|NCT00800800|Antimetabolites|antimetabolites|mesh-ancestor
101726977|NCT00800800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726978|NCT00800800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101726979|NCT00800800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101726980|NCT00800800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101726982|NCT00703898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101726983|NCT00703898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101726984|NCT00703898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101726985|NCT00703898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101726986|NCT00703898|Antiviral Agents|antiviral agents|mesh-ancestor
101726987|NCT00703898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101726988|NCT00703898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101726989|NCT00703898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101726990|NCT00703898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101726991|NCT00703898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101726992|NCT04030442|Morphine|morphine|mesh-list
101726993|NCT04030442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101726994|NCT04030442|Narcotics|narcotics|mesh-ancestor
101726995|NCT04030442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101726996|NCT04030442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101726997|NCT04030442|Analgesics|analgesics|mesh-ancestor
101726998|NCT04030442|Sensory System Agents|sensory system agents|mesh-ancestor
101726999|NCT04030442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101727000|NCT00801034|Calcium|calcium|mesh-list
101196964|NCT01388842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101727001|NCT00801034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101727002|NCT00801034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727003|NCT04130477|Nickel|nickel|mesh-list
101727004|NCT04130477|Trace Elements|trace elements|mesh-ancestor
101727005|NCT04130477|Micronutrients|micronutrients|mesh-ancestor
101727006|NCT04130477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727007|NCT00794326|Dialysis Solutions|dialysis solutions|mesh-list
101727008|NCT00794326|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101727009|NCT00702728|Furosemide|furosemide|mesh-list
101727010|NCT00702728|Diuretics|diuretics|mesh-ancestor
101727011|NCT00702728|Natriuretic Agents|natriuretic agents|mesh-ancestor
101727012|NCT00702728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727013|NCT00702728|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101727014|NCT00702728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101727015|NCT00702728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727016|NCT04132115|Vancomycin|vancomycin|mesh-list
101727017|NCT04132115|Gentamicins|gentamicins|mesh-list
101727018|NCT04132115|Meropenem|meropenem|mesh-list
101727019|NCT04132115|Tazobactam|tazobactam|mesh-list
101727020|NCT04132115|Linezolid|linezolid|mesh-list
101727021|NCT04132115|Piperacillin|piperacillin|mesh-list
101727022|NCT04132115|Daptomycin|daptomycin|mesh-list
101727023|NCT04132115|Amikacin|amikacin|mesh-list
101727024|NCT04132115|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101727025|NCT04132115|Ceftobiprole|ceftobiprole|mesh-list
101727026|NCT04132115|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
101727027|NCT04132115|Acyclovir|acyclovir|mesh-list
101727028|NCT04132115|Ganciclovir|ganciclovir|mesh-list
101805510|NCT01024660|Nootropic Agents|nootropic agents|mesh-ancestor
101727029|NCT04132115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101727030|NCT04132115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101727031|NCT04132115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101727032|NCT04132115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101727033|NCT04132115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727034|NCT04132115|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101727035|NCT04132115|Antiviral Agents|antiviral agents|mesh-ancestor
101727037|NCT00801268|Cathartics|cathartics|mesh-ancestor
101727038|NCT00801268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101727039|NCT00801268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101727040|NCT00801268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101727041|NCT00801268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727042|NCT02614937|Squalamine|squalamine|mesh-list
101727043|NCT02614937|Ranibizumab|ranibizumab|mesh-list
101727044|NCT02614937|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101727045|NCT02614937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101727046|NCT02614937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101727047|NCT02614937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101727048|NCT02614937|Growth Substances|growth substances|mesh-ancestor
101727049|NCT02614937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727050|NCT02614937|Growth Inhibitors|growth inhibitors|mesh-ancestor
101727051|NCT02614937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101727052|NCT02614937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101727053|NCT02614937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101727054|NCT02614937|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101727055|NCT02614937|Protective Agents|protective agents|mesh-ancestor
101727056|NCT00707642|Vaccines|vaccines|mesh-list
101727057|NCT00707642|Immunologic Factors|immunologic factors|mesh-ancestor
101197045|NCT01389427|Sirolimus|sirolimus|mesh-list
101727058|NCT00707642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727059|NCT00789568|Moxifloxacin|moxifloxacin|mesh-list
101727060|NCT00789568|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101727061|NCT00789568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101727062|NCT00789568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101727063|NCT00789568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101727064|NCT00789568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101727065|NCT00789568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101727066|NCT00789568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727067|NCT00789568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101727068|NCT00789568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101727069|NCT00789568|Contraceptive Agents|contraceptive agents|mesh-ancestor
101727070|NCT00789568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101727071|NCT00789568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727072|NCT00789568|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101727073|NCT00789568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101727074|NCT00789568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101727075|NCT00789646|Lidocaine|lidocaine|mesh-list
101727076|NCT00789646|Anesthetics, Local|anesthetics, local|mesh-ancestor
101727077|NCT00789646|Anesthetics|anesthetics|mesh-ancestor
101727078|NCT00789646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101364319|NCT00146497|Glucocorticoids|glucocorticoids|mesh-ancestor
101727079|NCT00789646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727080|NCT00789646|Sensory System Agents|sensory system agents|mesh-ancestor
101727081|NCT00789646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101727082|NCT00789646|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101727083|NCT00789646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101727084|NCT00789646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101727085|NCT00789646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101727086|NCT00789646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727087|NCT00856973|Eszopiclone|eszopiclone|mesh-list
101727088|NCT00856973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101727089|NCT00856973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101727090|NCT00856973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727091|NCT00794638|Rituximab|rituximab|mesh-list
101727092|NCT00794638|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101727093|NCT00794638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101727094|NCT00794638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101727095|NCT00794638|Immunologic Factors|immunologic factors|mesh-ancestor
101727096|NCT00794638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727097|NCT00794638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101727098|NCT00794638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101727099|NCT00794638|Alkylating Agents|alkylating agents|mesh-ancestor
101727100|NCT00794638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727102|NCT00801580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101727103|NCT00801580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101727104|NCT00801580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101727105|NCT00801580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101727106|NCT00801580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101727107|NCT00801580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101727108|NCT00801580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727109|NCT00805194|Docetaxel|docetaxel|mesh-list
101727110|NCT00805194|Nintedanib|nintedanib|mesh-list
101727111|NCT00805194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101727112|NCT00805194|Tubulin Modulators|tubulin modulators|mesh-ancestor
101727113|NCT00805194|Antimitotic Agents|antimitotic agents|mesh-ancestor
101727114|NCT00805194|Mitosis Modulators|mitosis modulators|mesh-ancestor
101727115|NCT00805194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727116|NCT00805194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101727117|NCT00805194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101727118|NCT00657046|Droxidopa|droxidopa|mesh-list
101727119|NCT00657046|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101727120|NCT00657046|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101727121|NCT00707798|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101727122|NCT00707798|Immunologic Factors|immunologic factors|mesh-ancestor
101727123|NCT00707798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727124|NCT00801736|Paclitaxel|paclitaxel|mesh-list
101727125|NCT00801736|Cisplatin|cisplatin|mesh-list
101727126|NCT00801736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101727127|NCT00801736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101727128|NCT00801736|Tubulin Modulators|tubulin modulators|mesh-ancestor
101727129|NCT00801736|Antimitotic Agents|antimitotic agents|mesh-ancestor
101727130|NCT00801736|Mitosis Modulators|mitosis modulators|mesh-ancestor
101727131|NCT00801736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727132|NCT00856661|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
101727133|NCT00856661|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101727134|NCT00856661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101727135|NCT00856661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727136|NCT02606994|Diphenhydramine|diphenhydramine|mesh-list
101727137|NCT02606994|Lidocaine|lidocaine|mesh-list
101727138|NCT02606994|Anesthetics, Local|anesthetics, local|mesh-ancestor
101727139|NCT02606994|Anesthetics|anesthetics|mesh-ancestor
101727140|NCT02606994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101727141|NCT02606994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727143|NCT02606994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101727144|NCT02606994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101727145|NCT02606994|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101727146|NCT02606994|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101727147|NCT02606994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101727148|NCT02606994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727149|NCT02606994|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101727150|NCT02606994|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101727151|NCT02606994|Antiemetics|antiemetics|mesh-ancestor
101727152|NCT02606994|Autonomic Agents|autonomic agents|mesh-ancestor
101727153|NCT02606994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101727154|NCT02606994|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101727155|NCT02606994|Histamine Antagonists|histamine antagonists|mesh-ancestor
101727156|NCT02606994|Histamine Agents|histamine agents|mesh-ancestor
101727157|NCT02606994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101727159|NCT00844376|Atorvastatin|atorvastatin|mesh-list
101727160|NCT00844376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101727161|NCT00844376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101727162|NCT00844376|Antimetabolites|antimetabolites|mesh-ancestor
101727163|NCT00844376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727164|NCT00844376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101727165|NCT00844376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101727166|NCT00844376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101727167|NCT04046302|Dinoprostone|dinoprostone|mesh-list
101727168|NCT04046302|Oxytocics|oxytocics|mesh-ancestor
101727169|NCT04046302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101727170|NCT04046302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727171|NCT00914394|Phenylephrine|phenylephrine|mesh-list
101727172|NCT00914394|Oxymetazoline|oxymetazoline|mesh-list
101727173|NCT00914394|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
101727174|NCT00914394|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101727175|NCT00914394|Mydriatics|mydriatics|mesh-ancestor
101727176|NCT00914394|Autonomic Agents|autonomic agents|mesh-ancestor
101727177|NCT00914394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101727178|NCT00914394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727179|NCT00914394|Sympathomimetics|sympathomimetics|mesh-ancestor
101727180|NCT00914394|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101727181|NCT00914394|Nasal Decongestants|nasal decongestants|mesh-ancestor
101727182|NCT00914394|Respiratory System Agents|respiratory system agents|mesh-ancestor
101727183|NCT00914394|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101727184|NCT00914394|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101727185|NCT00914394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101727186|NCT00914394|Adrenergic Agents|adrenergic agents|mesh-ancestor
101727187|NCT00914394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101727188|NCT00914394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727189|NCT00914394|Protective Agents|protective agents|mesh-ancestor
101727190|NCT00914394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384644|NCT00301483|HBOC 201|hboc 201|mesh-list
101727191|NCT04045678|Rotigotine|rotigotine|mesh-list
101727192|NCT04045678|Dopamine Agonists|dopamine agonists|mesh-ancestor
101727193|NCT04045678|Dopamine Agents|dopamine agents|mesh-ancestor
101727194|NCT04045678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101727195|NCT04045678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727196|NCT04045678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727197|NCT00658606|Alefacept|alefacept|mesh-list
101727198|NCT00658606|Dermatologic Agents|dermatologic agents|mesh-ancestor
101727199|NCT00658606|Immunologic Factors|immunologic factors|mesh-ancestor
101727200|NCT00658606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727201|NCT00795106|Capsaicin|capsaicin|mesh-list
101727202|NCT00795106|Antipruritics|antipruritics|mesh-ancestor
101727203|NCT00795106|Dermatologic Agents|dermatologic agents|mesh-ancestor
101727204|NCT00795106|Sensory System Agents|sensory system agents|mesh-ancestor
101727205|NCT00795106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101727206|NCT00795106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727207|NCT00589290|Belinostat|belinostat|mesh-list
101727208|NCT00589290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101727209|NCT00589290|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101727210|NCT00589290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101727211|NCT00589290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727212|NCT00802048|Ropivacaine|ropivacaine|mesh-list
101727213|NCT00802048|Anesthetics, Local|anesthetics, local|mesh-list
101727214|NCT00802048|Anesthetics|anesthetics|mesh-list
101727215|NCT00802048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101727216|NCT00802048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727218|NCT00802048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101727219|NCT00809536|Metformin|metformin|mesh-list
101727220|NCT00809536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101727221|NCT00809536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727222|NCT00809692|Histamine|histamine|mesh-list
101727223|NCT00809692|Histamine phosphate|histamine phosphate|mesh-list
101727224|NCT00809692|Histamine Agonists|histamine agonists|mesh-ancestor
101727225|NCT00809692|Histamine Agents|histamine agents|mesh-ancestor
101727226|NCT00809692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101364320|NCT00146497|Hormones|hormones|mesh-ancestor
101727227|NCT00809692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727228|NCT00809692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727229|NCT00843284|Pregabalin|pregabalin|mesh-list
101727230|NCT00843284|Analgesics|analgesics|mesh-ancestor
101727231|NCT00843284|Sensory System Agents|sensory system agents|mesh-ancestor
101727232|NCT00843284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101727233|NCT00843284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727234|NCT00843284|Anticonvulsants|anticonvulsants|mesh-ancestor
101727235|NCT00843284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101727236|NCT00843284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101727237|NCT00843284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727238|NCT00843284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101727239|NCT00843284|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101727240|NCT00843284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101727241|NCT00843284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101727242|NCT00843284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101727243|NCT00802282|Psilocybin|psilocybin|mesh-list
101727244|NCT00802282|Hallucinogens|hallucinogens|mesh-ancestor
101727245|NCT00802282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727246|NCT00802282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101727247|NCT00652834|Mycophenolic Acid|mycophenolic acid|mesh-list
101727248|NCT00652834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101727249|NCT00652834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101727250|NCT00652834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101727251|NCT00652834|Antitubercular Agents|antitubercular agents|mesh-ancestor
101727252|NCT00652834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101727253|NCT00652834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101727254|NCT00652834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101727255|NCT00652834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727256|NCT00825812|Atropine|atropine|mesh-list
101727257|NCT00825812|Neostigmine|neostigmine|mesh-list
101727258|NCT00825812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101727259|NCT00825812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101727260|NCT00825812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101727261|NCT00825812|Autonomic Agents|autonomic agents|mesh-ancestor
101727262|NCT00825812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101727263|NCT00825812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727264|NCT00825812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101727265|NCT00825812|Respiratory System Agents|respiratory system agents|mesh-ancestor
101727266|NCT00825812|Mydriatics|mydriatics|mesh-ancestor
101727267|NCT00825812|Parasympatholytics|parasympatholytics|mesh-ancestor
101727268|NCT00825812|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101727269|NCT00825812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101727270|NCT00825812|Cholinergic Agents|cholinergic agents|mesh-ancestor
101727271|NCT00825812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101727272|NCT00825812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727273|NCT00825812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101727274|NCT00825812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101727275|NCT00825812|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101727276|NCT00802594|Pafuramidine|pafuramidine|mesh-list
101727277|NCT00802594|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101727278|NCT00802594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101727279|NCT00802594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101727280|NCT00802594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101727281|NCT00707876|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
101727282|NCT00707876|Hematinics|hematinics|mesh-ancestor
101727283|NCT00707876|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101727284|NCT00707876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101727285|NCT02606448|Bupivacaine|bupivacaine|mesh-list
101727286|NCT02606448|Anesthetics, Local|anesthetics, local|mesh-ancestor
101727287|NCT02606448|Anesthetics|anesthetics|mesh-ancestor
101727288|NCT02606448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101263079|NCT01760226|Mitosis Modulators|mitosis modulators|mesh-ancestor
101727289|NCT02606448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727290|NCT02606448|Sensory System Agents|sensory system agents|mesh-ancestor
101727291|NCT02606448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101727293|NCT00802828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101727294|NCT00802828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101727295|NCT00802828|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101727296|NCT00802828|Histamine Antagonists|histamine antagonists|mesh-ancestor
101727297|NCT00802828|Histamine Agents|histamine agents|mesh-ancestor
101727298|NCT00802828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101727299|NCT00802828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727300|NCT00802828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727301|NCT00802906|Bevacizumab|bevacizumab|mesh-list
101727302|NCT00802906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101727303|NCT00802906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101727304|NCT00802906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101727305|NCT00802906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101727306|NCT00802906|Growth Substances|growth substances|mesh-ancestor
101727307|NCT00802906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727308|NCT00802906|Growth Inhibitors|growth inhibitors|mesh-ancestor
101727309|NCT00803218|Fluticasone|fluticasone|mesh-list
101727310|NCT00803218|Xhance|xhance|mesh-list
101727311|NCT00803218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101727312|NCT00803218|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101727313|NCT00803218|Autonomic Agents|autonomic agents|mesh-ancestor
101727314|NCT00803218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101727315|NCT00803218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727316|NCT00803218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101727317|NCT00803218|Respiratory System Agents|respiratory system agents|mesh-ancestor
101727318|NCT00803218|Dermatologic Agents|dermatologic agents|mesh-ancestor
101727319|NCT00803218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101727320|NCT00824564|Tranexamic Acid|tranexamic acid|mesh-list
101727321|NCT00824564|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101727322|NCT00824564|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101727323|NCT00824564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727324|NCT00824564|Hemostatics|hemostatics|mesh-ancestor
101727325|NCT00824564|Coagulants|coagulants|mesh-ancestor
101727326|NCT00803374|Ipilimumab|ipilimumab|mesh-list
101727327|NCT00803374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101727328|NCT00803374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101727329|NCT00803374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101727330|NCT00803374|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101727331|NCT00803374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727332|NCT00803374|Immunologic Factors|immunologic factors|mesh-ancestor
101727333|NCT00803374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727334|NCT00803530|Ascorbic Acid|ascorbic acid|mesh-list
101727336|NCT00803530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727337|NCT00803530|Protective Agents|protective agents|mesh-ancestor
101727338|NCT00803530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727339|NCT00803530|Vitamins|vitamins|mesh-ancestor
101727340|NCT00803530|Micronutrients|micronutrients|mesh-ancestor
101727341|NCT00803764|Naproxen|naproxen|mesh-list
101727342|NCT00803764|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101727343|NCT00803764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101727344|NCT00803764|Analgesics|analgesics|mesh-ancestor
101727345|NCT00803764|Sensory System Agents|sensory system agents|mesh-ancestor
101727347|NCT00803764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727348|NCT00803764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101727349|NCT00803764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101727350|NCT00803764|Gout Suppressants|gout suppressants|mesh-ancestor
101727351|NCT00803764|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101727352|NCT00803764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101727353|NCT00803764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727354|NCT00704366|Saracatinib|saracatinib|mesh-list
101727355|NCT00704366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101727356|NCT00704366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101727357|NCT00704366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727358|NCT00708266|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101727359|NCT00708266|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101727360|NCT00708266|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101727361|NCT00708266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101727363|NCT00803842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101727364|NCT00803842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101727365|NCT00803842|Antimalarials|antimalarials|mesh-ancestor
101727366|NCT00803842|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101727367|NCT00803842|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101727368|NCT00658528|Esomeprazole|esomeprazole|mesh-list
101727369|NCT00658528|Rabeprazole|rabeprazole|mesh-list
101727370|NCT00658528|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101727371|NCT00658528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101727372|NCT00658528|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101727373|NCT00658528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101364322|NCT02957890|Vaccines|vaccines|mesh-list
101727374|NCT00658528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727375|NCT00856583|Risperidone|risperidone|mesh-list
101727376|NCT00856583|Sertindole|sertindole|mesh-list
101727377|NCT00856583|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101727378|NCT00856583|Serotonin Agents|serotonin agents|mesh-ancestor
101727379|NCT00856583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101727380|NCT00856583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727381|NCT00856583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727382|NCT00856583|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101727383|NCT00856583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101727384|NCT00856583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101727385|NCT00856583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101727386|NCT00856583|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101727387|NCT00856583|Dopamine Agents|dopamine agents|mesh-ancestor
101727388|NCT00803244|Immunomodulating Agents|immunomodulating agents|mesh-list
101727389|NCT00803244|Immunologic Factors|immunologic factors|mesh-ancestor
101727390|NCT00803244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727391|NCT05753280|Vitamin D|vitamin d|mesh-list
101727392|NCT05753280|Vitamins|vitamins|mesh-ancestor
101727393|NCT05753280|Micronutrients|micronutrients|mesh-ancestor
101727394|NCT05753280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727395|NCT05753280|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101727396|NCT00824408|Pemetrexed|pemetrexed|mesh-list
101727397|NCT00824408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101727398|NCT00824408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101727399|NCT00824408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727400|NCT00824408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101727401|NCT00824408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101727402|NCT02611700|Paclitaxel|paclitaxel|mesh-list
101727403|NCT02611700|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101727404|NCT02611700|Cisplatin|cisplatin|mesh-list
101727405|NCT02611700|Nimotuzumab|nimotuzumab|mesh-list
101727406|NCT02611700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101727407|NCT02611700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101727408|NCT02611700|Tubulin Modulators|tubulin modulators|mesh-ancestor
101727409|NCT02611700|Antimitotic Agents|antimitotic agents|mesh-ancestor
101727410|NCT02611700|Mitosis Modulators|mitosis modulators|mesh-ancestor
101727411|NCT02611700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727412|NCT02611700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101727413|NCT00708344|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101727414|NCT00708344|Irbesartan|irbesartan|mesh-list
101727415|NCT00708344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101727416|NCT00708344|Diuretics|diuretics|mesh-ancestor
101727417|NCT00708344|Natriuretic Agents|natriuretic agents|mesh-ancestor
101727418|NCT00708344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727420|NCT00708344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101727421|NCT00708344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727422|NCT00708344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101727423|NCT00708344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101727424|NCT00866333|Entinostat|entinostat|mesh-list
101727425|NCT00866333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101727426|NCT00866333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101727427|NCT00866333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101727428|NCT00866333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727429|NCT00834080|Naltrexone|naltrexone|mesh-list
101727430|NCT00834080|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101727431|NCT00834080|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101727432|NCT00834080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727433|NCT00834080|Sensory System Agents|sensory system agents|mesh-ancestor
101727434|NCT00834080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101727435|NCT00823472|Ganirelix|ganirelix|mesh-list
101263082|NCT01760252|Irinotecan|irinotecan|mesh-list
101727437|NCT00823472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101727438|NCT00823472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727439|NCT04118699|Rifaximin|rifaximin|mesh-list
101727440|NCT04118699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101727441|NCT04118699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101727442|NCT04118699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101727443|NCT00856193|Glycopyrrolate|glycopyrrolate|mesh-list
101727444|NCT00856193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101727445|NCT00856193|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101727446|NCT00856193|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101727447|NCT00856193|Cholinergic Agents|cholinergic agents|mesh-ancestor
101727448|NCT00856193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101727449|NCT00856193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727450|NCT00856193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727451|NCT04130087|Selegiline|selegiline|mesh-list
101727452|NCT04130087|Antidepressive Agents|antidepressive agents|mesh-ancestor
101727453|NCT04130087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101727454|NCT04130087|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101727455|NCT04130087|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101727456|NCT04130087|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101727457|NCT04130087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101727458|NCT04130087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727459|NCT04130087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101727460|NCT04130087|Protective Agents|protective agents|mesh-ancestor
101727461|NCT04130087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727462|NCT00652366|Gemcitabine|gemcitabine|mesh-list
101727463|NCT00652366|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101205560|NCT01426646|Cisplatin|cisplatin|mesh-list
101727464|NCT00652366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101727465|NCT00652366|Antimetabolites|antimetabolites|mesh-ancestor
101727466|NCT00652366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727467|NCT00652366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101727468|NCT00652366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101727469|NCT00652366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101727470|NCT00841568|Tolvaptan|tolvaptan|mesh-list
101727471|NCT00841568|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101727472|NCT00841568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727473|NCT00841568|Natriuretic Agents|natriuretic agents|mesh-ancestor
101727474|NCT00841568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727475|NCT00855959|Budesonide|budesonide|mesh-list
101727476|NCT00855959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101727477|NCT00855959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101727478|NCT00855959|Autonomic Agents|autonomic agents|mesh-ancestor
101727479|NCT00855959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101197311|NCT01390883|PENTA|penta|mesh-list
101727480|NCT00855959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727481|NCT00855959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101727482|NCT00855959|Respiratory System Agents|respiratory system agents|mesh-ancestor
101727483|NCT00855959|Glucocorticoids|glucocorticoids|mesh-ancestor
101727484|NCT00855959|Hormones|hormones|mesh-ancestor
101727485|NCT00855959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101727486|NCT00704600|Nelfinavir|nelfinavir|mesh-list
101727487|NCT00704600|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101727488|NCT00704600|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101727489|NCT00704600|Protease Inhibitors|protease inhibitors|mesh-ancestor
101727490|NCT00704600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101727491|NCT00704600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727492|NCT00704600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101727493|NCT00704600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101727494|NCT00704600|Antiviral Agents|antiviral agents|mesh-ancestor
101727495|NCT00704600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101727496|NCT00699881|Cetuximab|cetuximab|mesh-list
101727497|NCT00699881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101727498|NCT00699881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101727499|NCT00708578|Metformin|metformin|mesh-list
101727500|NCT00708578|Insulin Glargine|insulin glargine|mesh-list
101727501|NCT00708578|Glimepiride|glimepiride|mesh-list
101727502|NCT00708578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101727503|NCT00708578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727504|NCT00708578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101727505|NCT00708578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101727506|NCT00708578|Immunologic Factors|immunologic factors|mesh-ancestor
101727507|NCT00704678|Sevelamer|sevelamer|mesh-list
101727508|NCT00704678|Chelating Agents|chelating agents|mesh-ancestor
101727509|NCT00704678|Sequestering Agents|sequestering agents|mesh-ancestor
101263084|NCT01760252|Antimetabolites|antimetabolites|mesh-ancestor
101727510|NCT00704678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727511|NCT00708656|Mesalamine|mesalamine|mesh-list
101727512|NCT00708656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101727513|NCT00708656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101727514|NCT00708656|Analgesics|analgesics|mesh-ancestor
101727515|NCT00708656|Sensory System Agents|sensory system agents|mesh-ancestor
101727516|NCT00708656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101727517|NCT00708656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727518|NCT00708656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101727519|NCT00708656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101727520|NCT00913328|Montelukast|montelukast|mesh-list
101727521|NCT00913328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101727522|NCT00913328|Respiratory System Agents|respiratory system agents|mesh-ancestor
101727523|NCT00913328|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101727524|NCT00913328|Hormone Antagonists|hormone antagonists|mesh-ancestor
101727525|NCT00913328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101727526|NCT00913328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727527|NCT00913328|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101727528|NCT00913328|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101727529|NCT00913328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727530|NCT00804310|Lapatinib|lapatinib|mesh-list
101727531|NCT00804310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101727532|NCT00804310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101727533|NCT00804310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101727534|NCT00804310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727535|NCT04118777|Ropivacaine|ropivacaine|mesh-list
101727536|NCT04118777|Anesthetics, Local|anesthetics, local|mesh-ancestor
101727537|NCT04118777|Anesthetics|anesthetics|mesh-ancestor
101727538|NCT04118777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101727539|NCT04118777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727540|NCT04118777|Sensory System Agents|sensory system agents|mesh-ancestor
101727541|NCT04118777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101727542|NCT00708812|Paclitaxel|paclitaxel|mesh-list
101727543|NCT00708812|Carboplatin|carboplatin|mesh-list
101727544|NCT00708812|Endostar protein|endostar protein|mesh-list
101727545|NCT00708812|Endostatins|endostatins|mesh-list
101727546|NCT00708812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101727547|NCT00708812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101727548|NCT00708812|Tubulin Modulators|tubulin modulators|mesh-ancestor
101727549|NCT00708812|Antimitotic Agents|antimitotic agents|mesh-ancestor
101727550|NCT00708812|Mitosis Modulators|mitosis modulators|mesh-ancestor
101727551|NCT00708812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727552|NCT00708812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101727553|NCT00708812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101727554|NCT00708812|Growth Substances|growth substances|mesh-ancestor
101727555|NCT00708812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727556|NCT00708812|Growth Inhibitors|growth inhibitors|mesh-ancestor
101727557|NCT04127747|Rituximab|rituximab|mesh-list
101727558|NCT04127747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101727559|NCT04127747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101727560|NCT04127747|Immunologic Factors|immunologic factors|mesh-ancestor
101727561|NCT04127747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727562|NCT04127747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101727563|NCT00822926|Botulinum Toxins|botulinum toxins|mesh-list
101727564|NCT00822926|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101727565|NCT00822926|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101727566|NCT00822926|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101727567|NCT00822926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101727568|NCT00822926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727569|NCT00822926|Cholinergic Agents|cholinergic agents|mesh-ancestor
101727570|NCT00822926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101727571|NCT00822926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727572|NCT00822926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101727573|NCT00822926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101727574|NCT00822770|Plerixafor|plerixafor|mesh-list
101727575|NCT00822770|Fludarabine|fludarabine|mesh-list
101727576|NCT00822770|Fludarabine phosphate|fludarabine phosphate|mesh-list
101727577|NCT00822770|Busulfan|busulfan|mesh-list
101727578|NCT00822770|Thymoglobulin|thymoglobulin|mesh-list
101727579|NCT00822770|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101727580|NCT00822770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101727581|NCT00822770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101727582|NCT00822770|Antimetabolites|antimetabolites|mesh-ancestor
101727583|NCT00822770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727584|NCT00822770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101727585|NCT00822770|Immunologic Factors|immunologic factors|mesh-ancestor
101727586|NCT00822770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727587|NCT00822770|Antiviral Agents|antiviral agents|mesh-ancestor
101727588|NCT00822770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101364341|NCT00146614|Methotrexate|methotrexate|mesh-list
101727589|NCT00822770|Alkylating Agents|alkylating agents|mesh-ancestor
101727590|NCT00822770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101727591|NCT00822770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101727592|NCT00822770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101727593|NCT00822770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101727594|NCT02842086|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101727595|NCT02842086|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
101727596|NCT02842086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101727597|NCT02842086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101727598|NCT02842086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101727599|NCT02842086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727600|NCT02842086|Antiviral Agents|antiviral agents|mesh-ancestor
101727601|NCT02842086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101727602|NCT02842086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101727603|NCT02842086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101727604|NCT00822692|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101727605|NCT00822692|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101727606|NCT00822692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101727607|NCT00822692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101727608|NCT00822692|Antimalarials|antimalarials|mesh-ancestor
101727609|NCT00822692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101197404|NCT01391221|Analgesics|analgesics|mesh-ancestor
101727611|NCT02607111|Dalteparin|dalteparin|mesh-list
101727612|NCT02607111|Tinzaparin|tinzaparin|mesh-list
101727613|NCT02607111|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101727614|NCT02607111|Anticoagulants|anticoagulants|mesh-ancestor
101727615|NCT02607111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101727616|NCT02607111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101727617|NCT02607111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727618|NCT00703196|Folic Acid|folic acid|mesh-list
101727619|NCT00703196|Hematinics|hematinics|mesh-ancestor
101727620|NCT00703196|Vitamin B Complex|vitamin b complex|mesh-ancestor
101727621|NCT00703196|Vitamins|vitamins|mesh-ancestor
101727622|NCT00703196|Micronutrients|micronutrients|mesh-ancestor
101727623|NCT00703196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727624|NCT00913250|Interferon beta-1a|interferon beta-1a|mesh-list
101727625|NCT00913250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101727626|NCT00913250|Immunologic Factors|immunologic factors|mesh-ancestor
101727627|NCT00913250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727628|NCT00913250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101727629|NCT00913250|Antiviral Agents|antiviral agents|mesh-ancestor
101727630|NCT00913250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101727631|NCT00914277|Sildenafil Citrate|sildenafil citrate|mesh-list
101727632|NCT00914277|Vasodilator Agents|vasodilator agents|mesh-ancestor
101727633|NCT00914277|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101727634|NCT00914277|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101727635|NCT00914277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101727636|NCT00914277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727637|NCT00914277|Urological Agents|urological agents|mesh-ancestor
101727638|NCT00704756|Ribavirin|ribavirin|mesh-list
101727639|NCT00704756|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101805688|NCT00110305|Antiviral Agents|antiviral agents|mesh-ancestor
101727640|NCT00704756|Interferon-alpha|interferon-alpha|mesh-list
101727641|NCT00704756|Antimetabolites|antimetabolites|mesh-ancestor
101727642|NCT00704756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727643|NCT00704756|Antiviral Agents|antiviral agents|mesh-ancestor
101727644|NCT00704756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101727645|NCT00704756|Immunologic Factors|immunologic factors|mesh-ancestor
101727646|NCT00704756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727647|NCT00806442|Borage oil|borage oil|mesh-list
101727648|NCT00806442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101727649|NCT02608242|Amlodipine|amlodipine|mesh-list
101727650|NCT02608242|Telmisartan|telmisartan|mesh-list
101727651|NCT02608242|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
101727652|NCT02608242|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101727653|NCT02608242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101727654|NCT02608242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101727655|NCT02608242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101727656|NCT02608242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727657|NCT02608242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101727658|NCT02608242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727660|NCT02608242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101727661|NCT02608242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101727662|NCT02608242|Antimetabolites|antimetabolites|mesh-ancestor
101727663|NCT02608242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101727664|NCT02608242|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101727665|NCT02608242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101727666|NCT02608242|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101727667|NCT02608242|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101727668|NCT02607696|Zolpidem|zolpidem|mesh-list
101727669|NCT02607696|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101727670|NCT02607696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101727671|NCT02607696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101727672|NCT02607696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727673|NCT02607696|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101727674|NCT02607696|GABA Agonists|gaba agonists|mesh-ancestor
101727675|NCT02607696|GABA Agents|gaba agents|mesh-ancestor
101727676|NCT02607696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101727677|NCT02607696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727678|NCT00839852|Cariprazine|cariprazine|mesh-list
101727679|NCT00839852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101727680|NCT00839852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101727681|NCT00839852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101727682|NCT00839852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727683|NCT00839852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101727684|NCT02604849|Gentamicins|gentamicins|mesh-list
101727685|NCT02604849|Neomycin|neomycin|mesh-list
101727686|NCT02604849|Streptomycin|streptomycin|mesh-list
101727687|NCT02604849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101727688|NCT02604849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101727689|NCT02604849|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101727690|NCT02604849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101727691|NCT02604849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727692|NCT00709046|Pantoprazole|pantoprazole|mesh-list
101727693|NCT00709046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101727694|NCT00709046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101727695|NCT00709046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101727696|NCT00709046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101727697|NCT00709046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727698|NCT00820898|Gemcitabine|gemcitabine|mesh-list
101727699|NCT00820898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101727700|NCT00820898|Antimetabolites|antimetabolites|mesh-ancestor
101727701|NCT00820898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727702|NCT00820898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101727703|NCT00865709|Leucovorin|leucovorin|mesh-list
101727704|NCT00865709|Oxaliplatin|oxaliplatin|mesh-list
101727705|NCT00865709|Fluorouracil|fluorouracil|mesh-list
101727706|NCT00865709|Sorafenib|sorafenib|mesh-list
101727707|NCT00865709|Levoleucovorin|levoleucovorin|mesh-list
101727708|NCT00865709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101727709|NCT00865709|Antidotes|antidotes|mesh-ancestor
101727710|NCT00865709|Protective Agents|protective agents|mesh-ancestor
101727711|NCT00865709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727712|NCT00865709|Vitamin B Complex|vitamin b complex|mesh-ancestor
101727713|NCT00865709|Vitamins|vitamins|mesh-ancestor
101727714|NCT00865709|Micronutrients|micronutrients|mesh-ancestor
101727715|NCT00865709|Antimetabolites|antimetabolites|mesh-ancestor
101727716|NCT00865709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727717|NCT00865709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101727718|NCT00865709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101727719|NCT00865709|Immunologic Factors|immunologic factors|mesh-ancestor
101727720|NCT00865709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101727721|NCT00865709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101727722|NCT00839306|Rabeprazole|rabeprazole|mesh-list
101727723|NCT00839306|Ranitidine|ranitidine|mesh-list
101727724|NCT00839306|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
101727725|NCT00839306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101727726|NCT00839306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101727727|NCT00839306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101727728|NCT00839306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101727729|NCT00839306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727731|NCT00839306|Histamine Antagonists|histamine antagonists|mesh-ancestor
101727732|NCT00839306|Histamine Agents|histamine agents|mesh-ancestor
101727733|NCT00839306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101727734|NCT00839306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727735|NCT04131335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101727736|NCT04131335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101727737|NCT00839072|Trazodone|trazodone|mesh-list
101727738|NCT00839072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101727739|NCT00839072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101727740|NCT00839072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101727741|NCT00839072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727742|NCT00839072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101727743|NCT00839072|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101727744|NCT00839072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101727745|NCT00839072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101727746|NCT00839072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727747|NCT00839072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101727749|NCT00839072|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101727750|NCT00839072|Antidepressive Agents|antidepressive agents|mesh-ancestor
101727751|NCT00704990|Vitamins|vitamins|mesh-list
101727752|NCT00704990|Ascorbic Acid|ascorbic acid|mesh-list
101727753|NCT00704990|Vitamin B 6|vitamin b 6|mesh-list
101727754|NCT00704990|Pyridoxal|pyridoxal|mesh-list
101727755|NCT00704990|Pyridoxine|pyridoxine|mesh-list
101727757|NCT00704990|Vitamin B Complex|vitamin b complex|mesh-list
101727758|NCT00704990|Micronutrients|micronutrients|mesh-ancestor
101727759|NCT00704990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727760|NCT00704990|Trace Elements|trace elements|mesh-ancestor
101727761|NCT00704990|Antioxidants|antioxidants|mesh-ancestor
101727762|NCT00704990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727763|NCT00704990|Protective Agents|protective agents|mesh-ancestor
101727764|NCT03553836|Pembrolizumab|pembrolizumab|mesh-list
101727765|NCT03553836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101727766|NCT03553836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101727767|NCT03553836|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101727768|NCT03553836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727769|NCT02607774|Midazolam|midazolam|mesh-list
101727770|NCT02607774|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101727771|NCT02607774|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101805868|NCT00454636|Cisplatin|cisplatin|mesh-list
101727772|NCT02607774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101727773|NCT02607774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727774|NCT02607774|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101727775|NCT02607774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101727776|NCT02607774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101727777|NCT02607774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101727778|NCT02607774|Anesthetics, General|anesthetics, general|mesh-ancestor
101727779|NCT02607774|Anesthetics|anesthetics|mesh-ancestor
101727780|NCT02607774|GABA Modulators|gaba modulators|mesh-ancestor
101727781|NCT02607774|GABA Agents|gaba agents|mesh-ancestor
101727782|NCT02607774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101727783|NCT02607774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727784|NCT00838916|Insulin Glargine|insulin glargine|mesh-list
101727785|NCT00838916|rGLP-1 protein|rglp-1 protein|mesh-list
101727786|NCT00838916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101727787|NCT00838916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727788|NCT00838916|Incretins|incretins|mesh-ancestor
101727789|NCT00838916|Hormones|hormones|mesh-ancestor
101727790|NCT00838916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101727791|NCT00838682|Omeprazole|omeprazole|mesh-list
101727792|NCT00838682|Rabeprazole|rabeprazole|mesh-list
101197555|NCT01392430|Antimalarials|antimalarials|mesh-ancestor
101727793|NCT00838682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101727794|NCT00838682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101727795|NCT00838682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101727796|NCT00838682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101727797|NCT00838682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727799|NCT00913484|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101727800|NCT00913484|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
101727801|NCT00913484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101727802|NCT00913484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727804|NCT00803712|Ergocalciferols|ergocalciferols|mesh-list
101727806|NCT00803712|Vitamins|vitamins|mesh-list
101727807|NCT00803712|Cinacalcet|cinacalcet|mesh-list
101727808|NCT00803712|Micronutrients|micronutrients|mesh-ancestor
101727809|NCT00803712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727810|NCT00803712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101727811|NCT00803712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101727812|NCT00803712|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101727813|NCT00803712|Hormone Antagonists|hormone antagonists|mesh-ancestor
101364348|NCT00146614|Antimetabolites|antimetabolites|mesh-ancestor
101727814|NCT00803712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101727815|NCT00803634|Antihypertensive Agents|antihypertensive agents|mesh-list
101727816|NCT00803634|Diltiazem|diltiazem|mesh-list
101727817|NCT00803634|Nitroprusside|nitroprusside|mesh-list
101727818|NCT00803634|Nicardipine|nicardipine|mesh-list
101727819|NCT00803634|Clevidipine|clevidipine|mesh-list
101727820|NCT00803634|Isosorbide|isosorbide|mesh-list
101727821|NCT00803634|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
101727822|NCT00803634|Nitroglycerin|nitroglycerin|mesh-list
101727823|NCT00803634|Vasodilator Agents|vasodilator agents|mesh-ancestor
101727824|NCT00803634|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101727825|NCT00803634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101197568|NCT01392534|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101727826|NCT00803634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727827|NCT00803634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101727828|NCT00803634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727829|NCT00803634|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101727830|NCT00803634|Diuretics|diuretics|mesh-ancestor
101727831|NCT00803634|Natriuretic Agents|natriuretic agents|mesh-ancestor
101727832|NCT00803634|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101727833|NCT00838526|Rabeprazole|rabeprazole|mesh-list
101727834|NCT00838526|Ranitidine|ranitidine|mesh-list
101727835|NCT00838526|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
101727836|NCT00838526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101727837|NCT00838526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101805960|NCT02565173|Analgesics|analgesics|mesh-ancestor
101727838|NCT00838526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101727839|NCT00838526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101727840|NCT00838526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727841|NCT00838526|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101727842|NCT00838526|Histamine Antagonists|histamine antagonists|mesh-ancestor
101727843|NCT00838526|Histamine Agents|histamine agents|mesh-ancestor
101727844|NCT00838526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101727845|NCT00838526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727846|NCT00914472|Heparin|heparin|mesh-list
101727847|NCT00914472|Calcium heparin|calcium heparin|mesh-list
101727848|NCT00914472|Anticoagulants|anticoagulants|mesh-ancestor
101727849|NCT00914472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101727850|NCT00914472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101727851|NCT00914472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727852|NCT02611466|Naproxen|naproxen|mesh-list
101727853|NCT02611466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101727854|NCT02611466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101727855|NCT02611466|Analgesics|analgesics|mesh-ancestor
101727856|NCT02611466|Sensory System Agents|sensory system agents|mesh-ancestor
101727857|NCT02611466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101727858|NCT02611466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727859|NCT02611466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101727860|NCT02611466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101727861|NCT02611466|Gout Suppressants|gout suppressants|mesh-ancestor
101727862|NCT02611466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101727863|NCT02611466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101727864|NCT02611466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727865|NCT02688270|Nitroglycerin|nitroglycerin|mesh-list
101727866|NCT02688270|Vasodilator Agents|vasodilator agents|mesh-ancestor
101727867|NCT02610920|Iron|iron|mesh-list
101727868|NCT02610920|Trace Elements|trace elements|mesh-ancestor
101727869|NCT02610920|Micronutrients|micronutrients|mesh-ancestor
101727870|NCT02610920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727871|NCT00913562|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101727872|NCT00913562|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101727873|NCT00913562|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101727874|NCT00913562|Antimetabolites|antimetabolites|mesh-ancestor
101727875|NCT00913562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727876|NCT00913562|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101727877|NCT00913562|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101727878|NCT00913562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101727880|NCT00818168|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101727881|NCT00818168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101727882|NCT00818168|Dermatologic Agents|dermatologic agents|mesh-ancestor
101727883|NCT00818168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101727884|NCT00818168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101727885|NCT02607540|Cisplatin|cisplatin|mesh-list
101364350|NCT00146614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101727886|NCT02607540|Fluorouracil|fluorouracil|mesh-list
101727887|NCT02607540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101727888|NCT02607540|Antimetabolites|antimetabolites|mesh-ancestor
101727889|NCT02607540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727890|NCT02607540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101727891|NCT02607540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101727892|NCT02607540|Immunologic Factors|immunologic factors|mesh-ancestor
101727893|NCT02607540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727895|NCT00705692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101727896|NCT00705692|Immunologic Factors|immunologic factors|mesh-ancestor
101727897|NCT00705692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727898|NCT00705692|Antinematodal Agents|antinematodal agents|mesh-ancestor
101727899|NCT00705692|Anthelmintics|anthelmintics|mesh-ancestor
101727900|NCT00705692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101727901|NCT00705692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101727902|NCT00705692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101727903|NCT00705770|Hydrocortisone|hydrocortisone|mesh-list
101727904|NCT00705770|Anecortave|anecortave|mesh-list
101727905|NCT00705770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101727906|NCT00705770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101727907|NCT00705770|Growth Substances|growth substances|mesh-ancestor
101727908|NCT00705770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727909|NCT00705770|Growth Inhibitors|growth inhibitors|mesh-ancestor
101727910|NCT00705770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101727911|NCT00705770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101727912|NCT00796653|Formoterol Fumarate|formoterol fumarate|mesh-list
101727913|NCT00796653|Olodaterol|olodaterol|mesh-list
101727914|NCT00796653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101727915|NCT00796653|Autonomic Agents|autonomic agents|mesh-ancestor
101727916|NCT00796653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101727917|NCT00796653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727918|NCT00796653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101727919|NCT00796653|Respiratory System Agents|respiratory system agents|mesh-ancestor
101806018|NCT00690443|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101727920|NCT00796653|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101727921|NCT00796653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101727922|NCT00796653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101727923|NCT00796653|Adrenergic Agents|adrenergic agents|mesh-ancestor
101727924|NCT00796653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101727925|NCT00796653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727926|NCT00806286|Paclitaxel|paclitaxel|mesh-list
101727927|NCT00806286|Carboplatin|carboplatin|mesh-list
101727928|NCT00806286|Efatutazone|efatutazone|mesh-list
101727929|NCT00806286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101727930|NCT00806286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101727931|NCT00806286|Tubulin Modulators|tubulin modulators|mesh-ancestor
101727932|NCT00806286|Antimitotic Agents|antimitotic agents|mesh-ancestor
101727933|NCT00806286|Mitosis Modulators|mitosis modulators|mesh-ancestor
101727934|NCT00806286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727935|NCT03537924|Acetazolamide|acetazolamide|mesh-list
101727936|NCT03537924|Anticonvulsants|anticonvulsants|mesh-ancestor
101727937|NCT03537924|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101727938|NCT03537924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101727939|NCT03537924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727940|NCT03537924|Diuretics|diuretics|mesh-ancestor
101727941|NCT03537924|Natriuretic Agents|natriuretic agents|mesh-ancestor
101727942|NCT03537924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727943|NCT00590538|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
101727944|NCT00590538|Genistein|genistein|mesh-list
101727945|NCT00590538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101727946|NCT00590538|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101727947|NCT00590538|Protective Agents|protective agents|mesh-ancestor
101727948|NCT00590538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727949|NCT00590538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101727950|NCT00590538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101727951|NCT00590538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727953|NCT00590538|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101727954|NCT00590538|Estrogens|estrogens|mesh-ancestor
101727955|NCT00590538|Hormones|hormones|mesh-ancestor
101806061|NCT01084057|Antimitotic Agents|antimitotic agents|mesh-ancestor
101727956|NCT00590538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101727959|NCT02608320|Narcotics|narcotics|mesh-ancestor
101364351|NCT00146614|Dermatologic Agents|dermatologic agents|mesh-ancestor
101727960|NCT02608320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101727961|NCT02608320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727962|NCT02608320|Analgesics|analgesics|mesh-ancestor
101727963|NCT02608320|Sensory System Agents|sensory system agents|mesh-ancestor
101727964|NCT02608320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101727965|NCT02608320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101727966|NCT02608320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101727967|NCT02608320|Anesthetics, General|anesthetics, general|mesh-ancestor
101727968|NCT02608320|Anesthetics|anesthetics|mesh-ancestor
101727969|NCT01731444|Phenylephrine|phenylephrine|mesh-list
101727970|NCT01731444|Oxymetazoline|oxymetazoline|mesh-list
101727971|NCT01731444|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101727972|NCT01731444|Mydriatics|mydriatics|mesh-ancestor
101727973|NCT01731444|Autonomic Agents|autonomic agents|mesh-ancestor
101727974|NCT01731444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101727975|NCT01731444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727976|NCT01731444|Sympathomimetics|sympathomimetics|mesh-ancestor
101727977|NCT01731444|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101727978|NCT01731444|Nasal Decongestants|nasal decongestants|mesh-ancestor
101727979|NCT01731444|Respiratory System Agents|respiratory system agents|mesh-ancestor
101727980|NCT01731444|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101727981|NCT01731444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101727982|NCT01731444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101727983|NCT01731444|Adrenergic Agents|adrenergic agents|mesh-ancestor
101727984|NCT01731444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101727985|NCT01731444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101727986|NCT01731444|Protective Agents|protective agents|mesh-ancestor
101727987|NCT05728788|Antineoplastic Agents|antineoplastic agents|mesh-list
101727988|NCT02608164|Vitamin D|vitamin d|mesh-list
101727989|NCT02608164|Cholecalciferol|cholecalciferol|mesh-list
101727990|NCT02608164|Vitamins|vitamins|mesh-ancestor
101727991|NCT02608164|Micronutrients|micronutrients|mesh-ancestor
101727992|NCT02608164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101727993|NCT02608164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101727994|NCT02608164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101727995|NCT00796419|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
101727996|NCT00796419|Plasma Substitutes|plasma substitutes|mesh-ancestor
101727997|NCT00796419|Blood Substitutes|blood substitutes|mesh-ancestor
101727998|NCT04110873|Ubiquinone|ubiquinone|mesh-list
101727999|NCT04110873|Micronutrients|micronutrients|mesh-ancestor
101728000|NCT04110873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728001|NCT02604615|Capecitabine|capecitabine|mesh-list
101728002|NCT02604615|Oxaliplatin|oxaliplatin|mesh-list
101728003|NCT02604615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101728004|NCT02604615|Antimetabolites|antimetabolites|mesh-ancestor
101728005|NCT02604615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728006|NCT02604615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101728007|NCT00796107|Letrozole|letrozole|mesh-list
101728008|NCT00796107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101728009|NCT00796107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101728010|NCT00796107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101728011|NCT00796107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101728012|NCT00796107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728013|NCT00796107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101728014|NCT00796107|Hormone Antagonists|hormone antagonists|mesh-ancestor
101728015|NCT00796107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101728016|NCT00796107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728017|NCT00805740|Caspofungin|caspofungin|mesh-list
101728018|NCT00805740|Anidulafungin|anidulafungin|mesh-list
101728019|NCT00805740|Antifungal Agents|antifungal agents|mesh-ancestor
101728020|NCT00805740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101728021|NCT00805740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101728022|NCT00805740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728023|NCT05613075|Hyaluronic Acid|hyaluronic acid|mesh-list
101728024|NCT05613075|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101728025|NCT05613075|Immunologic Factors|immunologic factors|mesh-ancestor
101728026|NCT05613075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728027|NCT05613075|Viscosupplements|viscosupplements|mesh-ancestor
101728028|NCT05613075|Protective Agents|protective agents|mesh-ancestor
101728029|NCT01227876|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101728030|NCT01227876|Methylprednisolone|methylprednisolone|mesh-list
101728031|NCT01227876|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101728032|NCT01227876|Prednisolone|prednisolone|mesh-list
101728033|NCT01227876|Prednisolone acetate|prednisolone acetate|mesh-list
101728034|NCT01227876|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101728035|NCT01227876|Prednisolone phosphate|prednisolone phosphate|mesh-list
101728036|NCT01227876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101728037|NCT01227876|Antiemetics|antiemetics|mesh-ancestor
101728038|NCT01227876|Autonomic Agents|autonomic agents|mesh-ancestor
101728039|NCT01227876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101728040|NCT01227876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728041|NCT01227876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101728042|NCT01227876|Glucocorticoids|glucocorticoids|mesh-ancestor
101728044|NCT01227876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101728045|NCT01227876|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101728046|NCT01227876|Protective Agents|protective agents|mesh-ancestor
101728047|NCT01227876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101728048|NCT01227876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101728049|NCT00795639|Sitaxsentan|sitaxsentan|mesh-list
101728050|NCT00795639|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101728051|NCT00795639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728052|NCT05297292|Ranibizumab|ranibizumab|mesh-list
101728053|NCT05297292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101728054|NCT05297292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101728055|NCT05297292|Growth Substances|growth substances|mesh-ancestor
101728056|NCT05297292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728057|NCT05297292|Growth Inhibitors|growth inhibitors|mesh-ancestor
101728058|NCT05297292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101728059|NCT02604459|Fentanyl|fentanyl|mesh-list
101728060|NCT02604459|Anesthetics|anesthetics|mesh-list
101728061|NCT02604459|Propofol|propofol|mesh-list
101728062|NCT02604459|Sevoflurane|sevoflurane|mesh-list
101728063|NCT02604459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101728064|NCT02604459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728065|NCT02604459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101728066|NCT02604459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101728067|NCT02604459|Anesthetics, General|anesthetics, general|mesh-ancestor
101728068|NCT02604459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101728070|NCT02604459|Analgesics|analgesics|mesh-ancestor
101728071|NCT02604459|Sensory System Agents|sensory system agents|mesh-ancestor
101728072|NCT02604459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101728073|NCT02604459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101728074|NCT02604459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101728075|NCT02604459|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101728076|NCT02604225|Methoxyflurane|methoxyflurane|mesh-list
101728077|NCT02604225|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101728078|NCT02604225|Anesthetics, General|anesthetics, general|mesh-ancestor
101728079|NCT02604225|Anesthetics|anesthetics|mesh-ancestor
101728080|NCT02604225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101728081|NCT02604225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728082|NCT02607072|Aspirin|aspirin|mesh-list
101728083|NCT02607072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101728084|NCT02607072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101728085|NCT02607072|Analgesics|analgesics|mesh-ancestor
101728086|NCT02607072|Sensory System Agents|sensory system agents|mesh-ancestor
101728087|NCT02607072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101728088|NCT02607072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728089|NCT02607072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101728090|NCT02607072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101728091|NCT02607072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101728092|NCT02607072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101728093|NCT02607072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728094|NCT02607072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101728095|NCT02607072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101728096|NCT02607072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101728097|NCT02607072|Antipyretics|antipyretics|mesh-ancestor
101728098|NCT04110093|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101728099|NCT04110093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728100|NCT04110093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101728101|NCT04110093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101728102|NCT00588237|Paclitaxel|paclitaxel|mesh-list
101728103|NCT00588237|Bevacizumab|bevacizumab|mesh-list
101728104|NCT00588237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101728105|NCT00588237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101728106|NCT00588237|Tubulin Modulators|tubulin modulators|mesh-ancestor
101728107|NCT00588237|Antimitotic Agents|antimitotic agents|mesh-ancestor
101364354|NCT00146614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101728108|NCT00588237|Mitosis Modulators|mitosis modulators|mesh-ancestor
101728109|NCT00588237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728110|NCT00588237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101728111|NCT00588237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101728112|NCT00588237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101728113|NCT00588237|Growth Substances|growth substances|mesh-ancestor
101728114|NCT00588237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728115|NCT00588237|Growth Inhibitors|growth inhibitors|mesh-ancestor
101728116|NCT02605746|Ceritinib|ceritinib|mesh-list
101728117|NCT02605746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101728118|NCT02605746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101728119|NCT02605746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101728120|NCT02605746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728121|NCT04109859|Methylene Blue|methylene blue|mesh-list
101728122|NCT04109859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101728123|NCT04109859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728124|NCT00790023|Ciclesonide|ciclesonide|mesh-list
101728125|NCT00790023|Glucocorticoids|glucocorticoids|mesh-ancestor
101728126|NCT00790023|Hormones|hormones|mesh-ancestor
101728127|NCT00790023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101728128|NCT00790023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728129|NCT00790023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101728130|NCT00588822|Rituximab|rituximab|mesh-list
101728131|NCT00588822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101728132|NCT00588822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101728133|NCT00588822|Immunologic Factors|immunologic factors|mesh-ancestor
101728134|NCT00588822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728135|NCT00588822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101728136|NCT05563467|Pembrolizumab|pembrolizumab|mesh-list
101728137|NCT05563467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101728138|NCT05563467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101728139|NCT05563467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101728140|NCT05563467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728141|NCT00589914|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101728142|NCT00589914|Risperidone|risperidone|mesh-list
101728143|NCT00589914|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101728144|NCT00589914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101728145|NCT00589914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101728146|NCT00589914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728147|NCT00589914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101728148|NCT00589914|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101728149|NCT00589914|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101728150|NCT00589914|Serotonin Agents|serotonin agents|mesh-ancestor
101728151|NCT00589914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101728152|NCT00589914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728153|NCT00589914|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101728154|NCT00589914|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101728155|NCT00589914|Dopamine Agents|dopamine agents|mesh-ancestor
101728156|NCT00789555|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
101728157|NCT00789555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101728158|NCT00789555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101728159|NCT00789555|Analgesics|analgesics|mesh-ancestor
101728160|NCT00789555|Sensory System Agents|sensory system agents|mesh-ancestor
101728161|NCT00789555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101728162|NCT00789555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728163|NCT00789555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101728164|NCT00789555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101728165|NCT00789555|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101728166|NCT00789555|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101728167|NCT00789555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101728168|NCT00789555|Histamine Antagonists|histamine antagonists|mesh-ancestor
101728169|NCT00789555|Histamine Agents|histamine agents|mesh-ancestor
101728170|NCT00789555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101728171|NCT00789555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728172|NCT03770455|Avelumab|avelumab|mesh-list
101728173|NCT03770455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101728174|NCT03770455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101728175|NCT01026337|Sunitinib|sunitinib|mesh-list
101728176|NCT01026337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101728177|NCT01026337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101728178|NCT01026337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101728179|NCT01026337|Growth Substances|growth substances|mesh-ancestor
101728180|NCT01026337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728181|NCT01026337|Growth Inhibitors|growth inhibitors|mesh-ancestor
101728182|NCT01026337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101728183|NCT01026337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101728184|NCT01026337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728185|NCT03746275|Aspirin|aspirin|mesh-list
101728186|NCT03746275|Rivaroxaban|rivaroxaban|mesh-list
101728187|NCT03746275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101728188|NCT03746275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101728189|NCT03746275|Analgesics|analgesics|mesh-ancestor
101728190|NCT03746275|Sensory System Agents|sensory system agents|mesh-ancestor
101728192|NCT03746275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728193|NCT03746275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101728194|NCT03746275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101728195|NCT03746275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101728196|NCT03746275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101728197|NCT03746275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728198|NCT03746275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101806245|NCT03463265|Sirolimus|sirolimus|mesh-list
101728199|NCT03746275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101728200|NCT03746275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101728201|NCT03746275|Antipyretics|antipyretics|mesh-ancestor
101728202|NCT03746275|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101728203|NCT03746275|Antithrombins|antithrombins|mesh-ancestor
101728204|NCT03746275|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101728205|NCT03746275|Protease Inhibitors|protease inhibitors|mesh-ancestor
101728206|NCT03746275|Anticoagulants|anticoagulants|mesh-ancestor
101728207|NCT01026415|Rifampin|rifampin|mesh-list
101728208|NCT01026415|Ketoconazole|ketoconazole|mesh-list
101728209|NCT01026415|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101728210|NCT01026415|Midazolam|midazolam|mesh-list
101728211|NCT01026415|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101728212|NCT01026415|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101728213|NCT01026415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101728214|NCT01026415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101728215|NCT01026415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728216|NCT01026415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101728217|NCT01026415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101728218|NCT01026415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101728219|NCT01026415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101728220|NCT01026415|Anesthetics, General|anesthetics, general|mesh-ancestor
101728221|NCT01026415|Anesthetics|anesthetics|mesh-ancestor
101728222|NCT01026415|GABA Modulators|gaba modulators|mesh-ancestor
101728223|NCT01026415|GABA Agents|gaba agents|mesh-ancestor
101728224|NCT01026415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101728225|NCT01026415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728226|NCT01026415|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101728227|NCT01026415|Antitubercular Agents|antitubercular agents|mesh-ancestor
101728228|NCT01026415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101728229|NCT01026415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101728230|NCT01026415|Leprostatic Agents|leprostatic agents|mesh-ancestor
101728231|NCT01026415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101728232|NCT01026415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101728233|NCT01026415|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101728234|NCT01026415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101728235|NCT01026415|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101728236|NCT01026415|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101728237|NCT01026415|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101728238|NCT01026415|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101728239|NCT01026415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101728240|NCT01026415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101728241|NCT01026415|Immunotoxins|immunotoxins|mesh-ancestor
101728242|NCT01026415|Immunoconjugates|immunoconjugates|mesh-ancestor
101385669|NCT00305422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101728243|NCT01026415|Immunologic Factors|immunologic factors|mesh-ancestor
101728244|NCT01026415|Antifungal Agents|antifungal agents|mesh-ancestor
101728245|NCT01026415|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101728246|NCT01026415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101728247|NCT01026415|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101728248|NCT01026415|Hormone Antagonists|hormone antagonists|mesh-ancestor
101728249|NCT01026415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101728250|NCT01026415|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101728251|NCT01026727|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101728252|NCT01026727|Antiviral Agents|antiviral agents|mesh-ancestor
101728253|NCT01026727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101728254|NCT02604966|Artesunate|artesunate|mesh-list
101728255|NCT02604966|Antimalarials|antimalarials|mesh-ancestor
101728256|NCT02604966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101728257|NCT02604966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101197910|NCT01394419|Antioxidants|antioxidants|mesh-ancestor
101728258|NCT02604966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101728259|NCT02604966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101728260|NCT02604966|Antiviral Agents|antiviral agents|mesh-ancestor
101728261|NCT02604966|Schistosomicides|schistosomicides|mesh-ancestor
101728262|NCT02604966|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101728263|NCT02604966|Anthelmintics|anthelmintics|mesh-ancestor
101728264|NCT00914160|Diclofenac|diclofenac|mesh-list
101728265|NCT00914160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101728266|NCT00914160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101728267|NCT00914160|Analgesics|analgesics|mesh-ancestor
101728268|NCT00914160|Sensory System Agents|sensory system agents|mesh-ancestor
101728269|NCT00914160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101728270|NCT00914160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728271|NCT00914160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101728272|NCT00914160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101728273|NCT00914160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101728274|NCT00914160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101728275|NCT00914160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728276|NCT00450619|Metronidazole|metronidazole|mesh-list
101728277|NCT00450619|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
101728278|NCT00450619|Vaccines|vaccines|mesh-list
101728279|NCT00450619|Sargramostim|sargramostim|mesh-list
101728280|NCT00450619|Immunologic Factors|immunologic factors|mesh-ancestor
101728281|NCT00450619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728282|NCT00450619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101728283|NCT00450619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101728284|NCT00450619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101728285|NCT00450619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101728286|NCT00450619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101728287|NCT00450619|Analgesics|analgesics|mesh-ancestor
101728288|NCT00450619|Sensory System Agents|sensory system agents|mesh-ancestor
101728289|NCT00450619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101728290|NCT00802074|Ritonavir|ritonavir|mesh-list
101728291|NCT00802074|Fosamprenavir|fosamprenavir|mesh-list
101728292|NCT00802074|Raltegravir Potassium|raltegravir potassium|mesh-list
101728293|NCT00802074|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101728294|NCT00802074|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101728295|NCT00802074|Protease Inhibitors|protease inhibitors|mesh-ancestor
101728296|NCT00802074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101728297|NCT00802074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728298|NCT00802074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101728299|NCT00802074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101728300|NCT00802074|Antiviral Agents|antiviral agents|mesh-ancestor
101728301|NCT00802074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101728302|NCT00802074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101728303|NCT00802074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101728304|NCT00802074|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101728305|NCT00802074|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101728306|NCT04112394|Anesthetics|anesthetics|mesh-list
101728307|NCT04112394|Anesthetics, Local|anesthetics, local|mesh-list
101728308|NCT04112394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101728309|NCT04112394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728310|NCT04112394|Sensory System Agents|sensory system agents|mesh-ancestor
101728311|NCT04112394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101728312|NCT00450385|Prednisone|prednisone|mesh-list
101728313|NCT00450385|Cyclophosphamide|cyclophosphamide|mesh-list
101728314|NCT00450385|Rituximab|rituximab|mesh-list
101728315|NCT00450385|Doxorubicin|doxorubicin|mesh-list
101728316|NCT00450385|Vincristine|vincristine|mesh-list
101728317|NCT00450385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101728318|NCT00450385|Immunologic Factors|immunologic factors|mesh-ancestor
101728319|NCT00450385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728320|NCT00450385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101728321|NCT00450385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101728322|NCT00450385|Alkylating Agents|alkylating agents|mesh-ancestor
101728323|NCT00450385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728324|NCT00450385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101728325|NCT00450385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101728326|NCT00450385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101728327|NCT00450385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101728328|NCT00450385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101728329|NCT00450385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101728330|NCT00450385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101728331|NCT00450385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101728332|NCT00450385|Glucocorticoids|glucocorticoids|mesh-ancestor
101728334|NCT00450385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101728335|NCT00450385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101728336|NCT00450385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101728337|NCT00450385|Tubulin Modulators|tubulin modulators|mesh-ancestor
101728338|NCT00450385|Antimitotic Agents|antimitotic agents|mesh-ancestor
101728339|NCT00450385|Mitosis Modulators|mitosis modulators|mesh-ancestor
101728340|NCT00588354|Triamcinolone|triamcinolone|mesh-list
101728341|NCT00588354|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101728342|NCT00588354|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101728343|NCT00588354|Lidocaine|lidocaine|mesh-list
101728344|NCT00588354|Clonidine|clonidine|mesh-list
101728345|NCT00588354|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101728346|NCT00588354|Anesthetics, Local|anesthetics, local|mesh-ancestor
101728347|NCT00588354|Anesthetics|anesthetics|mesh-ancestor
101728348|NCT00588354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101728349|NCT00588354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806366|NCT03623646|Immunologic Factors|immunologic factors|mesh-ancestor
101728350|NCT00588354|Sensory System Agents|sensory system agents|mesh-ancestor
101728351|NCT00588354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101728352|NCT00588354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101728353|NCT00588354|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101728354|NCT00588354|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101728355|NCT00588354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101728356|NCT00588354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728358|NCT00588354|Glucocorticoids|glucocorticoids|mesh-ancestor
101728359|NCT00588354|Hormones|hormones|mesh-ancestor
101728360|NCT00588354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101728361|NCT00588354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101728362|NCT00588354|Immunologic Factors|immunologic factors|mesh-ancestor
101728363|NCT00588354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101728364|NCT00588354|Analgesics|analgesics|mesh-ancestor
101728365|NCT00588354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101728366|NCT00588354|Sympatholytics|sympatholytics|mesh-ancestor
101728367|NCT00588354|Autonomic Agents|autonomic agents|mesh-ancestor
101728368|NCT00588354|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101728369|NCT00588354|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101728370|NCT00588354|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101728371|NCT00588354|Adrenergic Agents|adrenergic agents|mesh-ancestor
101728372|NCT00588354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101728373|NCT00449761|Panobinostat|panobinostat|mesh-list
101728374|NCT00449761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101728375|NCT00449761|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101728376|NCT00449761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101728377|NCT00449761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728378|NCT00800982|Etanercept|etanercept|mesh-list
101728379|NCT00800982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101728380|NCT00800982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101728381|NCT00800982|Analgesics|analgesics|mesh-ancestor
101728382|NCT00800982|Sensory System Agents|sensory system agents|mesh-ancestor
101728383|NCT00800982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101333708|NCT00040378|Antioxidants|antioxidants|mesh-ancestor
101728384|NCT00800982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728385|NCT00800982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101728386|NCT00800982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101728387|NCT00800982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101728388|NCT00800982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101728389|NCT00800982|Immunologic Factors|immunologic factors|mesh-ancestor
101728390|NCT01019395|Daptomycin|daptomycin|mesh-list
101728391|NCT01019395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101728392|NCT01019395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101728393|NCT00830960|Clopidogrel|clopidogrel|mesh-list
101728394|NCT00830960|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101728395|NCT00830960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101728396|NCT00830960|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101728397|NCT00830960|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101728398|NCT00830960|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101728399|NCT00830960|Purinergic Agents|purinergic agents|mesh-ancestor
101728400|NCT00830960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101728401|NCT00830960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728402|NCT00830960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728403|NCT01026961|Acetaminophen|acetaminophen|mesh-list
101728404|NCT01026961|Dimethindene|dimethindene|mesh-list
101728405|NCT01026961|Phenylephrine|phenylephrine|mesh-list
101728406|NCT01026961|Oxymetazoline|oxymetazoline|mesh-list
101728407|NCT01026961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101728408|NCT01026961|Analgesics|analgesics|mesh-ancestor
101728409|NCT01026961|Sensory System Agents|sensory system agents|mesh-ancestor
101728410|NCT01026961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101728411|NCT01026961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728412|NCT01026961|Antipyretics|antipyretics|mesh-ancestor
101728413|NCT01026961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728414|NCT01026961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101728415|NCT01026961|Mydriatics|mydriatics|mesh-ancestor
101728416|NCT01026961|Autonomic Agents|autonomic agents|mesh-ancestor
101728417|NCT01026961|Sympathomimetics|sympathomimetics|mesh-ancestor
101728418|NCT01026961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101728419|NCT01026961|Nasal Decongestants|nasal decongestants|mesh-ancestor
101728420|NCT01026961|Respiratory System Agents|respiratory system agents|mesh-ancestor
101728421|NCT01026961|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101728422|NCT01026961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101728423|NCT01026961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101728424|NCT01026961|Adrenergic Agents|adrenergic agents|mesh-ancestor
101728425|NCT01026961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101728426|NCT01026961|Protective Agents|protective agents|mesh-ancestor
101728427|NCT01026961|Antipruritics|antipruritics|mesh-ancestor
101728428|NCT01026961|Dermatologic Agents|dermatologic agents|mesh-ancestor
101728429|NCT01026961|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101728430|NCT01026961|Histamine Antagonists|histamine antagonists|mesh-ancestor
101728431|NCT01026961|Histamine Agents|histamine agents|mesh-ancestor
101728432|NCT01026961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101728433|NCT01566253|Acetaminophen|acetaminophen|mesh-list
101728434|NCT01566253|Ketoprofen|ketoprofen|mesh-list
101728435|NCT01566253|Morphine|morphine|mesh-list
101728436|NCT01566253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101728437|NCT01566253|Narcotics|narcotics|mesh-ancestor
101728438|NCT01566253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101728439|NCT01566253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728440|NCT01566253|Analgesics|analgesics|mesh-ancestor
101728441|NCT01566253|Sensory System Agents|sensory system agents|mesh-ancestor
101728442|NCT01566253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101728443|NCT01566253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101728444|NCT01566253|Antipyretics|antipyretics|mesh-ancestor
101728445|NCT01566253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101728446|NCT01566253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101728447|NCT01566253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101728448|NCT01566253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101728449|NCT01566253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101728450|NCT01566253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728451|NCT03849313|Adalimumab|adalimumab|mesh-list
101728452|NCT03849313|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101728453|NCT03849313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101728454|NCT03849313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101728455|NCT04111614|Tofacitinib|tofacitinib|mesh-list
101728456|NCT04111614|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101728457|NCT04111614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101728458|NCT04111614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101728459|NCT04111614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728460|NCT01023919|Sirolimus|sirolimus|mesh-list
101728461|NCT01023919|Paclitaxel|paclitaxel|mesh-list
101728462|NCT01023919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101728463|NCT01023919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101728464|NCT01023919|Tubulin Modulators|tubulin modulators|mesh-ancestor
101728465|NCT01023919|Antimitotic Agents|antimitotic agents|mesh-ancestor
101728466|NCT01023919|Mitosis Modulators|mitosis modulators|mesh-ancestor
101728467|NCT01023919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728468|NCT01023919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101728469|NCT01023919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101385896|NCT00307606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101728470|NCT01023919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101728471|NCT01023919|Antifungal Agents|antifungal agents|mesh-ancestor
101728472|NCT01023919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101728474|NCT01023919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728476|NCT04028622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101728477|NCT04028622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728478|NCT00830804|Ritonavir|ritonavir|mesh-list
101728479|NCT00830804|Darunavir|darunavir|mesh-list
101728480|NCT00830804|Raltegravir Potassium|raltegravir potassium|mesh-list
101198173|NCT01395654|Rifampin|rifampin|mesh-list
101728481|NCT00830804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101728482|NCT00830804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101728483|NCT00830804|Protease Inhibitors|protease inhibitors|mesh-ancestor
101728484|NCT00830804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101728485|NCT00830804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728486|NCT00830804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101728487|NCT00830804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101728488|NCT00830804|Antiviral Agents|antiviral agents|mesh-ancestor
101728489|NCT00830804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101728490|NCT00830804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101728491|NCT00830804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101728492|NCT00830804|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101728493|NCT00830804|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101728494|NCT00789477|Aflibercept|aflibercept|mesh-list
101728495|NCT00789477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101728496|NCT00789477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101728497|NCT00789477|Growth Substances|growth substances|mesh-ancestor
101728498|NCT00789477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728499|NCT00789477|Growth Inhibitors|growth inhibitors|mesh-ancestor
101728500|NCT00789477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101728501|NCT01024075|Dexamethasone|dexamethasone|mesh-list
101728502|NCT01024075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101728503|NCT01024075|Antiemetics|antiemetics|mesh-ancestor
101728504|NCT01024075|Autonomic Agents|autonomic agents|mesh-ancestor
101728505|NCT01024075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101728506|NCT01024075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728507|NCT01024075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101728508|NCT01024075|Glucocorticoids|glucocorticoids|mesh-ancestor
101728509|NCT01024075|Hormones|hormones|mesh-ancestor
101728510|NCT01024075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101728511|NCT01024075|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101728512|NCT01024075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101728513|NCT05756348|Protective Agents|protective agents|mesh-list
101728514|NCT05756348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728515|NCT00913874|Valproic Acid|valproic acid|mesh-list
101728516|NCT00913874|Anticonvulsants|anticonvulsants|mesh-ancestor
101728517|NCT00913874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101728518|NCT00913874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728519|NCT00913874|GABA Agents|gaba agents|mesh-ancestor
101728520|NCT00913874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101198207|NCT01395667|Vitamins|vitamins|mesh-ancestor
101728521|NCT00913874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728522|NCT00913874|Antimanic Agents|antimanic agents|mesh-ancestor
101728523|NCT00913874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101728524|NCT00913874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101728525|NCT00913874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101728526|NCT00796614|Tamsulosin|tamsulosin|mesh-list
101728527|NCT00796614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101728528|NCT00796614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101728529|NCT00796614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101728530|NCT00796614|Adrenergic Agents|adrenergic agents|mesh-ancestor
101728531|NCT00796614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101728532|NCT00796614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728533|NCT00796614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728534|NCT00796614|Urological Agents|urological agents|mesh-ancestor
101728535|NCT02603445|Idelalisib|idelalisib|mesh-list
101728536|NCT02603445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101728537|NCT02603445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101728538|NCT02603445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728539|NCT02603679|Tamoxifen|tamoxifen|mesh-list
101728540|NCT02603679|Paclitaxel|paclitaxel|mesh-list
101728541|NCT02603679|Letrozole|letrozole|mesh-list
101728542|NCT02603679|Palbociclib|palbociclib|mesh-list
101728543|NCT02603679|Anastrozole|anastrozole|mesh-list
101728544|NCT02603679|Exemestane|exemestane|mesh-list
101728545|NCT02603679|Goserelin|goserelin|mesh-list
101728546|NCT02603679|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101728547|NCT02603679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101728549|NCT02603679|Tubulin Modulators|tubulin modulators|mesh-ancestor
101728550|NCT02603679|Antimitotic Agents|antimitotic agents|mesh-ancestor
101728551|NCT02603679|Mitosis Modulators|mitosis modulators|mesh-ancestor
101728552|NCT02603679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728553|NCT02603679|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101728554|NCT02603679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101728555|NCT02603679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101728556|NCT02603679|Hormone Antagonists|hormone antagonists|mesh-ancestor
101728557|NCT02603679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101728558|NCT02603679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728559|NCT02603679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101728560|NCT02603679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101728561|NCT02603679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101728562|NCT02603679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101728563|NCT02603679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101728564|NCT03995485|Sofosbuvir|sofosbuvir|mesh-list
101728565|NCT03995485|Antiviral Agents|antiviral agents|mesh-ancestor
101728566|NCT03995485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101728567|NCT02605434|Levodopa|levodopa|mesh-list
101728568|NCT02605434|Carbidopa|carbidopa|mesh-list
101728569|NCT02605434|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101728570|NCT02605434|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101728571|NCT02605434|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101728572|NCT02605434|Dopamine Agents|dopamine agents|mesh-ancestor
101728573|NCT02605434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101728574|NCT02605434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728575|NCT02605434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728576|NCT02605434|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101728577|NCT02605434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101728578|NCT02605434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101728579|NCT02605434|Immunologic Factors|immunologic factors|mesh-ancestor
101728580|NCT02605434|Dopamine Agonists|dopamine agonists|mesh-ancestor
101728581|NCT00863681|Riociguat|riociguat|mesh-list
101728582|NCT00863681|Enzyme Activators|enzyme activators|mesh-ancestor
101728583|NCT00863681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728584|NCT05758298|Nicotine|nicotine|mesh-list
101728585|NCT05758298|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101728586|NCT05758298|Autonomic Agents|autonomic agents|mesh-ancestor
101728587|NCT05758298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101728588|NCT05758298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728589|NCT05758298|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101728590|NCT05758298|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101728591|NCT05758298|Cholinergic Agents|cholinergic agents|mesh-ancestor
101728592|NCT05758298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101728593|NCT05758298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728594|NCT00789321|Amlodipine|amlodipine|mesh-list
101728595|NCT00789321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101728596|NCT00789321|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101728597|NCT00789321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101728598|NCT00789321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728599|NCT00789321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101728600|NCT00789321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728601|NCT00789321|Vasodilator Agents|vasodilator agents|mesh-ancestor
101728602|NCT00811928|Fluconazole|fluconazole|mesh-list
101198263|NCT01395875|Autonomic Agents|autonomic agents|mesh-ancestor
101728604|NCT00811928|Antifungal Agents|antifungal agents|mesh-ancestor
101728605|NCT00811928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101728606|NCT00811928|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101728607|NCT00811928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101728608|NCT00811928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101728609|NCT00811928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728610|NCT00811928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101728611|NCT00811928|Hormone Antagonists|hormone antagonists|mesh-ancestor
101728612|NCT00811928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101728613|NCT00811928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728614|NCT00811928|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101728615|NCT00811928|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101728616|NCT00811928|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101728617|NCT00811928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101728618|NCT00811928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101728619|NCT00448669|Tenofovir|tenofovir|mesh-list
101728620|NCT00448669|Emtricitabine|emtricitabine|mesh-list
101728621|NCT00448669|Antiviral Agents|antiviral agents|mesh-ancestor
101728622|NCT00448669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101728623|NCT00448669|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101728624|NCT00448669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101728625|NCT00448669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101728626|NCT00448669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728627|NCT00448669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101728628|NCT00448669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101728629|NCT00591734|Bevacizumab|bevacizumab|mesh-list
101728630|NCT00591734|Everolimus|everolimus|mesh-list
101728631|NCT00591734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101728632|NCT00591734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101728633|NCT00591734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101728634|NCT00591734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101728635|NCT00591734|Growth Substances|growth substances|mesh-ancestor
101728636|NCT00591734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728637|NCT00591734|Growth Inhibitors|growth inhibitors|mesh-ancestor
101728638|NCT00591734|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101728639|NCT00591734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101728640|NCT00591734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101728641|NCT00591734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728642|NCT00591734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101728643|NCT00591734|Immunologic Factors|immunologic factors|mesh-ancestor
101728644|NCT00848549|Carbamazepine|carbamazepine|mesh-list
101728645|NCT00848549|Zonisamide|zonisamide|mesh-list
101728646|NCT00848549|Anticonvulsants|anticonvulsants|mesh-ancestor
101728648|NCT00848549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101728649|NCT00848549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101728650|NCT00848549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728651|NCT00848549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101728652|NCT00848549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101728653|NCT00848549|Analgesics|analgesics|mesh-ancestor
101728654|NCT00848549|Sensory System Agents|sensory system agents|mesh-ancestor
101806435|NCT00956306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101728655|NCT00848549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101728656|NCT00848549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101728657|NCT00848549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101728658|NCT00848549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728659|NCT00848549|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101728660|NCT00848549|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101728661|NCT00848549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101728662|NCT00848549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101728663|NCT00788151|Vaccines|vaccines|mesh-list
101728664|NCT00788151|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101728665|NCT00788151|Immunologic Factors|immunologic factors|mesh-ancestor
101728666|NCT00788151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728667|NCT04116359|Cisplatin|cisplatin|mesh-list
101728668|NCT04116359|Etoposide|etoposide|mesh-list
101728669|NCT04116359|Etoposide phosphate|etoposide phosphate|mesh-list
101728670|NCT04116359|Podophyllotoxin|podophyllotoxin|mesh-list
101728671|NCT04116359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101728672|NCT04116359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101728673|NCT04116359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101728674|NCT04116359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101728675|NCT04116359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101728676|NCT04116359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728677|NCT04116359|Keratolytic Agents|keratolytic agents|mesh-ancestor
101728678|NCT04116359|Dermatologic Agents|dermatologic agents|mesh-ancestor
101728679|NCT04116359|Tubulin Modulators|tubulin modulators|mesh-ancestor
101728680|NCT04116359|Antimitotic Agents|antimitotic agents|mesh-ancestor
101728681|NCT04116359|Mitosis Modulators|mitosis modulators|mesh-ancestor
101728682|NCT04118153|Abatacept|abatacept|mesh-list
101728683|NCT04118153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101728684|NCT04118153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728685|NCT04118153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101728686|NCT04118153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101728687|NCT04118153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101728688|NCT04118153|Immunologic Factors|immunologic factors|mesh-ancestor
101728689|NCT04118153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728690|NCT04118153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101728691|NCT00848393|Fentanyl|fentanyl|mesh-list
101728692|NCT00848393|Dexmedetomidine|dexmedetomidine|mesh-list
101386124|NCT00120939|Dermatologic Agents|dermatologic agents|mesh-ancestor
101728693|NCT00848393|Citric Acid|citric acid|mesh-list
101728694|NCT00848393|Sodium Citrate|sodium citrate|mesh-list
101728695|NCT00848393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101728696|NCT00848393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101728697|NCT00848393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728698|NCT00848393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101728699|NCT00848393|Analgesics|analgesics|mesh-ancestor
101728700|NCT00848393|Sensory System Agents|sensory system agents|mesh-ancestor
101728701|NCT00848393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101728702|NCT00848393|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101728703|NCT00848393|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101728704|NCT00848393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101728705|NCT00848393|Adrenergic Agents|adrenergic agents|mesh-ancestor
101728706|NCT00848393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101728707|NCT00848393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728708|NCT00848393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101728709|NCT00848393|Narcotics|narcotics|mesh-ancestor
101728710|NCT00848393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101728711|NCT00848393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101728712|NCT00848393|Anesthetics, General|anesthetics, general|mesh-ancestor
101728713|NCT00848393|Anesthetics|anesthetics|mesh-ancestor
101728714|NCT00848393|Anticoagulants|anticoagulants|mesh-ancestor
101728715|NCT00848393|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101728716|NCT00848393|Chelating Agents|chelating agents|mesh-ancestor
101728717|NCT00848393|Sequestering Agents|sequestering agents|mesh-ancestor
101728718|NCT00815516|Amphotericin B|amphotericin b|mesh-list
101728719|NCT00815516|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101728721|NCT00815516|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
101728722|NCT00815516|Deoxycholic Acid|deoxycholic acid|mesh-list
101728723|NCT00815516|Amebicides|amebicides|mesh-ancestor
101728724|NCT00815516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101728725|NCT00815516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101728726|NCT00815516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101728727|NCT00815516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101728728|NCT00815516|Antifungal Agents|antifungal agents|mesh-ancestor
101728729|NCT00815516|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101728730|NCT00815516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101728731|NCT00705926|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101728732|NCT00705926|Antiviral Agents|antiviral agents|mesh-ancestor
101728733|NCT00705926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101728734|NCT00787917|Omalizumab|omalizumab|mesh-list
101728735|NCT00787917|Itraconazole|itraconazole|mesh-list
101728736|NCT00787917|Antifungal Agents|antifungal agents|mesh-ancestor
101728737|NCT00787917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101728738|NCT00787917|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101728739|NCT00787917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101728740|NCT00787917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101728741|NCT00787917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728742|NCT00787917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101728743|NCT00787917|Hormone Antagonists|hormone antagonists|mesh-ancestor
101728744|NCT00787917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101728745|NCT00787917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728746|NCT00787917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101728747|NCT00787917|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101728748|NCT00787917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101728749|NCT00787917|Respiratory System Agents|respiratory system agents|mesh-ancestor
101728750|NCT05758064|Dydrogesterone|dydrogesterone|mesh-list
101728751|NCT05758064|Progestins|progestins|mesh-ancestor
101728753|NCT05758064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101728754|NCT05758064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364375|NCT00042978|Carboplatin|carboplatin|mesh-list
101728755|NCT00829244|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101728756|NCT00829244|Hormones|hormones|mesh-ancestor
101728757|NCT00829244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101728758|NCT00829244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728759|NCT00787605|Amlodipine|amlodipine|mesh-list
101728760|NCT00787605|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101728761|NCT00787605|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101728762|NCT00787605|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101728763|NCT00787605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101728764|NCT00787605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728765|NCT00787605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101728766|NCT00787605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728768|NCT00787605|Diuretics|diuretics|mesh-ancestor
101728769|NCT00787605|Natriuretic Agents|natriuretic agents|mesh-ancestor
101728770|NCT00787605|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101728772|NCT00448591|Taxane|taxane|mesh-list
101728773|NCT00448591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101728774|NCT00448591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101728775|NCT00448591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101728776|NCT00448591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101728777|NCT00448591|Growth Substances|growth substances|mesh-ancestor
101728778|NCT00448591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728779|NCT00448591|Growth Inhibitors|growth inhibitors|mesh-ancestor
101728780|NCT00787527|Prednisone|prednisone|mesh-list
101728781|NCT00787527|Cyclophosphamide|cyclophosphamide|mesh-list
101728782|NCT00787527|Doxorubicin|doxorubicin|mesh-list
101728783|NCT00787527|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101728784|NCT00787527|Vincristine|vincristine|mesh-list
101728785|NCT00787527|Vorinostat|vorinostat|mesh-list
101728786|NCT00787527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101728787|NCT00787527|Immunologic Factors|immunologic factors|mesh-ancestor
101728788|NCT00787527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728789|NCT00787527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101728790|NCT00787527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101728791|NCT00787527|Alkylating Agents|alkylating agents|mesh-ancestor
101728792|NCT00787527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728793|NCT00787527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101728794|NCT00787527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101728795|NCT00787527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101728796|NCT00787527|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101728797|NCT00787527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101728798|NCT00787527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101728799|NCT00787527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101728800|NCT00787527|Glucocorticoids|glucocorticoids|mesh-ancestor
101728801|NCT00787527|Hormones|hormones|mesh-ancestor
101728802|NCT00787527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101728803|NCT00787527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101728804|NCT00787527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101728805|NCT00787527|Tubulin Modulators|tubulin modulators|mesh-ancestor
101728806|NCT00787527|Antimitotic Agents|antimitotic agents|mesh-ancestor
101728807|NCT00787527|Mitosis Modulators|mitosis modulators|mesh-ancestor
101728808|NCT00787527|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101728809|NCT00804388|Vitamin E|vitamin e|mesh-list
101728810|NCT00804388|Vitamins|vitamins|mesh-ancestor
101728811|NCT00804388|Micronutrients|micronutrients|mesh-ancestor
101728812|NCT00804388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728813|NCT00804388|Antioxidants|antioxidants|mesh-ancestor
101728814|NCT00804388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728815|NCT00804388|Protective Agents|protective agents|mesh-ancestor
101728816|NCT00806962|Vaccines|vaccines|mesh-list
101728817|NCT00806962|Immunologic Factors|immunologic factors|mesh-ancestor
101728818|NCT00806962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728819|NCT02553226|Oxytocin|oxytocin|mesh-list
101728820|NCT02553226|Oxytocics|oxytocics|mesh-ancestor
101728821|NCT02553226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101728822|NCT02553226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728823|NCT00810316|Clonazepam|clonazepam|mesh-list
101728824|NCT00810316|Alprazolam|alprazolam|mesh-list
101728825|NCT00810316|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101728826|NCT00810316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101728827|NCT00810316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728828|NCT00810316|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101728829|NCT00810316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101728830|NCT00810316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101728832|NCT00810316|GABA Agents|gaba agents|mesh-ancestor
101728833|NCT00810316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101728834|NCT00810316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728835|NCT00810316|Anticonvulsants|anticonvulsants|mesh-ancestor
101728836|NCT00448435|Fluticasone|fluticasone|mesh-list
101728838|NCT00448435|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101728839|NCT00448435|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101728840|NCT00448435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101728841|NCT00448435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101728842|NCT00448435|Autonomic Agents|autonomic agents|mesh-ancestor
101728843|NCT00448435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101728844|NCT00448435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728845|NCT00448435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101728846|NCT00448435|Respiratory System Agents|respiratory system agents|mesh-ancestor
101728847|NCT00448435|Dermatologic Agents|dermatologic agents|mesh-ancestor
101728848|NCT00448435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101728849|NCT00448435|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101728850|NCT00448435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101728851|NCT00448435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101728852|NCT00448435|Adrenergic Agents|adrenergic agents|mesh-ancestor
101728853|NCT00448435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101728854|NCT00448435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728855|NCT00448435|Glucocorticoids|glucocorticoids|mesh-ancestor
101728857|NCT00448435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101728858|NCT00448435|Sympathomimetics|sympathomimetics|mesh-ancestor
101728859|NCT00804622|Tenofovir|tenofovir|mesh-list
101728860|NCT00804622|Telbivudine|telbivudine|mesh-list
101728861|NCT00804622|Antiviral Agents|antiviral agents|mesh-ancestor
101728862|NCT00804622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101728863|NCT00804622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101728864|NCT00804622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101728865|NCT00804622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101728866|NCT00804622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728867|NCT00804622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101728868|NCT00804622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101728869|NCT02603055|Vaccines|vaccines|mesh-list
101728870|NCT02603055|Immunologic Factors|immunologic factors|mesh-ancestor
101728871|NCT02603055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728872|NCT02602743|Ketamine|ketamine|mesh-list
101728873|NCT02602743|Remifentanil|remifentanil|mesh-list
101728874|NCT02602743|Propofol|propofol|mesh-list
101198472|NCT01397331|Anesthetics|anesthetics|mesh-ancestor
101728875|NCT02602743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101728876|NCT02602743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101728877|NCT02602743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728878|NCT02602743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101728879|NCT02602743|Anesthetics, General|anesthetics, general|mesh-ancestor
101728880|NCT02602743|Anesthetics|anesthetics|mesh-ancestor
101728881|NCT02602743|Analgesics|analgesics|mesh-ancestor
101728882|NCT02602743|Sensory System Agents|sensory system agents|mesh-ancestor
101728883|NCT02602743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101728884|NCT02602743|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101728885|NCT02602743|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101728886|NCT02602743|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101728887|NCT02602743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101728888|NCT02602743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728889|NCT02602743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101728890|NCT02602743|Narcotics|narcotics|mesh-ancestor
101728891|NCT00807118|Fesoterodine|fesoterodine|mesh-list
101728892|NCT00807118|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101728893|NCT00807118|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101728894|NCT00807118|Cholinergic Agents|cholinergic agents|mesh-ancestor
101728895|NCT00807118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101728896|NCT00807118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728897|NCT00807118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728898|NCT00807118|Urological Agents|urological agents|mesh-ancestor
101728899|NCT00448279|Trastuzumab|trastuzumab|mesh-list
101728900|NCT00448279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101728901|NCT00448279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101728902|NCT00804856|Cytarabine|cytarabine|mesh-list
101728903|NCT00804856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101728904|NCT00804856|Antimetabolites|antimetabolites|mesh-ancestor
101206995|NCT01434888|Timolol|timolol|mesh-list
101728905|NCT00804856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728907|NCT00804856|Antiviral Agents|antiviral agents|mesh-ancestor
101728908|NCT00804856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101728909|NCT00804856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101728910|NCT00804856|Immunologic Factors|immunologic factors|mesh-ancestor
101728911|NCT00804856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728912|NCT00810706|Exemestane|exemestane|mesh-list
101728913|NCT00810706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101728914|NCT00810706|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101728915|NCT00810706|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101728916|NCT00810706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101198503|NCT05268601|Sotrovimab|sotrovimab|mesh-list
101728917|NCT00810706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728918|NCT00810706|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101728919|NCT00810706|Hormone Antagonists|hormone antagonists|mesh-ancestor
101728920|NCT00810706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101728921|NCT00810706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728924|NCT00807196|Fludarabine|fludarabine|mesh-list
101728925|NCT00807196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101728926|NCT00807196|Immunologic Factors|immunologic factors|mesh-ancestor
101728927|NCT00807196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728928|NCT00807196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101728929|NCT00807196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101728930|NCT00807196|Alkylating Agents|alkylating agents|mesh-ancestor
101728931|NCT00807196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728932|NCT00807196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101728933|NCT00807196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101728934|NCT00807196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101728935|NCT00448123|Tamsulosin|tamsulosin|mesh-list
101728936|NCT00448123|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101728937|NCT00448123|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101728938|NCT00448123|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101728939|NCT00448123|Adrenergic Agents|adrenergic agents|mesh-ancestor
101728940|NCT00448123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101728941|NCT00448123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728942|NCT00448123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728943|NCT00448123|Urological Agents|urological agents|mesh-ancestor
101728944|NCT00804934|Ranibizumab|ranibizumab|mesh-list
101728945|NCT00804934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101728946|NCT00804934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101728947|NCT00804934|Growth Substances|growth substances|mesh-ancestor
101728948|NCT00804934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728949|NCT00804934|Growth Inhibitors|growth inhibitors|mesh-ancestor
101728950|NCT00804934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101728951|NCT00805012|Docetaxel|docetaxel|mesh-list
101728952|NCT00805012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101728953|NCT00805012|Tubulin Modulators|tubulin modulators|mesh-ancestor
101728954|NCT00805012|Antimitotic Agents|antimitotic agents|mesh-ancestor
101728955|NCT00805012|Mitosis Modulators|mitosis modulators|mesh-ancestor
101728956|NCT00805012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728957|NCT00447499|Lanreotide|lanreotide|mesh-list
101728958|NCT00447499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101728959|NCT00805090|Itraconazole|itraconazole|mesh-list
101728960|NCT00805090|Diclofenac|diclofenac|mesh-list
101198537|NCT04975269|Acetazolamide|acetazolamide|mesh-list
101728961|NCT00805090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101728962|NCT00805090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101728963|NCT00805090|Analgesics|analgesics|mesh-ancestor
101728964|NCT00805090|Sensory System Agents|sensory system agents|mesh-ancestor
101728965|NCT00805090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101728966|NCT00805090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728967|NCT00805090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101728968|NCT00805090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101728969|NCT00805090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101728970|NCT00805090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101728971|NCT00805090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728972|NCT00805090|Antifungal Agents|antifungal agents|mesh-ancestor
101728973|NCT00805090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101728974|NCT00805090|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101728975|NCT00805090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101728976|NCT00805090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101728977|NCT00805090|Hormone Antagonists|hormone antagonists|mesh-ancestor
101728978|NCT00805090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101728979|NCT00805090|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101728981|NCT00810862|Lactitol|lactitol|mesh-list
101728982|NCT00810862|Cathartics|cathartics|mesh-ancestor
101728983|NCT00810862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101263110|NCT01760421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101728984|NCT00810862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101728985|NCT00810862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101728986|NCT00810862|Analgesics|analgesics|mesh-ancestor
101728987|NCT00810862|Sensory System Agents|sensory system agents|mesh-ancestor
101728988|NCT00810862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101728989|NCT00810862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101728990|NCT00810862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101728991|NCT00810862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101728992|NCT00810862|Dermatologic Agents|dermatologic agents|mesh-ancestor
101728993|NCT00810862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101728994|NCT00810862|Immunologic Factors|immunologic factors|mesh-ancestor
101728995|NCT00810862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101728996|NCT00810862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101728997|NCT00810862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101728998|NCT00800436|Trastuzumab|trastuzumab|mesh-list
101728999|NCT00800436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101729000|NCT00800436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101729001|NCT00810940|Mannitol|mannitol|mesh-list
101729002|NCT00810940|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101729003|NCT00810940|Diuretics|diuretics|mesh-ancestor
101729004|NCT00810940|Natriuretic Agents|natriuretic agents|mesh-ancestor
101729005|NCT00810940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729006|NCT00655564|Alefacept|alefacept|mesh-list
101729007|NCT00655564|Dermatologic Agents|dermatologic agents|mesh-ancestor
101198572|NCT04453449|Midazolam|midazolam|mesh-list
101729008|NCT00655564|Immunologic Factors|immunologic factors|mesh-ancestor
101729009|NCT00655564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729010|NCT00447421|Pemetrexed|pemetrexed|mesh-list
101729011|NCT00447421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101729012|NCT00447421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101729013|NCT00447421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729014|NCT00447421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101806514|NCT00744107|Micronutrients|micronutrients|mesh-ancestor
101806516|NCT00117637|Interferons|interferons|mesh-list
101729015|NCT00447421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101729017|NCT00651118|Xhance|xhance|mesh-list
101729018|NCT00651118|Azelastine|azelastine|mesh-list
101729019|NCT00651118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101729020|NCT00651118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101729021|NCT00651118|Autonomic Agents|autonomic agents|mesh-ancestor
101729022|NCT00651118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101729023|NCT00651118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729024|NCT00651118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101729025|NCT00651118|Respiratory System Agents|respiratory system agents|mesh-ancestor
101729026|NCT00651118|Dermatologic Agents|dermatologic agents|mesh-ancestor
101729027|NCT00651118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101729028|NCT00651118|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101729029|NCT00651118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101729030|NCT00651118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729031|NCT00651118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101729032|NCT00651118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101729033|NCT00651118|Histamine Antagonists|histamine antagonists|mesh-ancestor
101729034|NCT00651118|Histamine Agents|histamine agents|mesh-ancestor
101729035|NCT00651118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101729036|NCT00447265|Etanercept|etanercept|mesh-list
101729037|NCT00447265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101729038|NCT00447265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101729039|NCT00447265|Analgesics|analgesics|mesh-ancestor
101729040|NCT00447265|Sensory System Agents|sensory system agents|mesh-ancestor
101729041|NCT00447265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101729042|NCT00447265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729043|NCT00447265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101729044|NCT00447265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101729045|NCT00447265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101729046|NCT00447265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101729047|NCT00447265|Immunologic Factors|immunologic factors|mesh-ancestor
101729048|NCT03641755|Olaparib|olaparib|mesh-list
101729049|NCT03641755|Sapacitabine|sapacitabine|mesh-list
101729050|NCT03641755|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101729051|NCT03641755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101729052|NCT03641755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729053|NCT03641755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101729054|NCT00657358|Lidocaine|lidocaine|mesh-list
101729055|NCT00657358|Anesthetics, Local|anesthetics, local|mesh-ancestor
101729056|NCT00657358|Anesthetics|anesthetics|mesh-ancestor
101729057|NCT00657358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101729058|NCT00657358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729060|NCT00657358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101729061|NCT00657358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101729062|NCT00657358|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101729063|NCT00657358|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101729064|NCT00657358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101729065|NCT00657358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729066|NCT00457639|Cholic Acids|cholic acids|mesh-list
101729067|NCT00457639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101729068|NCT00800202|Paclitaxel|paclitaxel|mesh-list
101729069|NCT00800202|Bevacizumab|bevacizumab|mesh-list
101729070|NCT00800202|Carboplatin|carboplatin|mesh-list
101729071|NCT00800202|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101729072|NCT00800202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101729073|NCT00800202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101729074|NCT00800202|Tubulin Modulators|tubulin modulators|mesh-ancestor
101729075|NCT00800202|Antimitotic Agents|antimitotic agents|mesh-ancestor
101729076|NCT00800202|Mitosis Modulators|mitosis modulators|mesh-ancestor
101729077|NCT00800202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806539|NCT01084291|Vaccines|vaccines|mesh-list
101729078|NCT00800202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101729079|NCT00800202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101729080|NCT00800202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101729081|NCT00800202|Growth Substances|growth substances|mesh-ancestor
101729082|NCT00800202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729083|NCT00800202|Growth Inhibitors|growth inhibitors|mesh-ancestor
101729084|NCT00800202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101729085|NCT00800202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101729086|NCT00811096|Chloroquine|chloroquine|mesh-list
101729087|NCT00811096|Tinidazole|tinidazole|mesh-list
101729088|NCT00811096|Amebicides|amebicides|mesh-ancestor
101729089|NCT00811096|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101729090|NCT00811096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101729091|NCT00811096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101729092|NCT00811096|Antimalarials|antimalarials|mesh-ancestor
101198643|NCT03040726|Palonosetron|palonosetron|mesh-list
101729093|NCT00811096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101729094|NCT00811096|Alkylating Agents|alkylating agents|mesh-ancestor
101729095|NCT00811096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729096|NCT00811096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101729097|NCT00811096|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
101729098|NCT05146804|Sulforaphane|sulforaphane|mesh-list
101729099|NCT05146804|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101729100|NCT05146804|Protective Agents|protective agents|mesh-ancestor
101729101|NCT05146804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729102|NCT05146804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101729103|NCT00655486|Lacosamide|lacosamide|mesh-list
101729104|NCT00655486|Anticonvulsants|anticonvulsants|mesh-ancestor
101729105|NCT00655486|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101729106|NCT00655486|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101729107|NCT00655486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101729108|NCT00655486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729109|NCT04111302|Dezocine|dezocine|mesh-list
101729110|NCT04111302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101729111|NCT04111302|Narcotics|narcotics|mesh-ancestor
101729112|NCT04111302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101729113|NCT04111302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729114|NCT04111302|Analgesics|analgesics|mesh-ancestor
101729115|NCT04111302|Sensory System Agents|sensory system agents|mesh-ancestor
101729116|NCT04111302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101729117|NCT04111848|Ketamine|ketamine|mesh-list
101729118|NCT04111848|Analgesics|analgesics|mesh-ancestor
101729119|NCT04111848|Sensory System Agents|sensory system agents|mesh-ancestor
101729120|NCT04111848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101729121|NCT04111848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729122|NCT04111848|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101729123|NCT04111848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101729124|NCT04111848|Anesthetics, General|anesthetics, general|mesh-ancestor
101729125|NCT04111848|Anesthetics|anesthetics|mesh-ancestor
101729126|NCT04111848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101729127|NCT04111848|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101729128|NCT04111848|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101729129|NCT04111848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101729130|NCT04111848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729131|NCT00457015|Ecallantide|ecallantide|mesh-list
101729132|NCT00457015|Analgesics|analgesics|mesh-ancestor
101729133|NCT00457015|Sensory System Agents|sensory system agents|mesh-ancestor
101729134|NCT00457015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101729135|NCT00457015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729136|NCT00457015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101729137|NCT00457015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101729138|NCT00457015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101729139|NCT00457015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101729140|NCT00654940|Pregabalin|pregabalin|mesh-list
101729141|NCT00654940|Analgesics|analgesics|mesh-ancestor
101386571|NCT00311467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101729142|NCT00654940|Sensory System Agents|sensory system agents|mesh-ancestor
101729143|NCT00654940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101729144|NCT00654940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729145|NCT00654940|Anticonvulsants|anticonvulsants|mesh-ancestor
101729146|NCT00654940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101729147|NCT00654940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101729148|NCT00654940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729149|NCT00654940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101729150|NCT00654940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101729151|NCT00654940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101729152|NCT00654940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101729153|NCT00654940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101729154|NCT00588666|Bevacizumab|bevacizumab|mesh-list
101729155|NCT00588666|Carboplatin|carboplatin|mesh-list
101729156|NCT00588666|Gemcitabine|gemcitabine|mesh-list
101729157|NCT00588666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101729158|NCT00588666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101729159|NCT00588666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101729160|NCT00588666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101729161|NCT00588666|Growth Substances|growth substances|mesh-ancestor
101729162|NCT00588666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729163|NCT00588666|Growth Inhibitors|growth inhibitors|mesh-ancestor
101729164|NCT00588666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101729165|NCT00588666|Antimetabolites|antimetabolites|mesh-ancestor
101729166|NCT00588666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729167|NCT00805558|Moxifloxacin|moxifloxacin|mesh-list
101729168|NCT00805558|Metronidazole|metronidazole|mesh-list
101729169|NCT00805558|Ciprofloxacin|ciprofloxacin|mesh-list
101729170|NCT00805558|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101729171|NCT00805558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101729172|NCT00805558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101729173|NCT00805558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101729174|NCT00805558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101729175|NCT00805558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101729176|NCT00805558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729177|NCT00805558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101729178|NCT00805558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101729179|NCT00805558|Contraceptive Agents|contraceptive agents|mesh-ancestor
101729180|NCT00805558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101729181|NCT00805558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729182|NCT00805558|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101729183|NCT00805558|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101729184|NCT00805558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101729185|NCT00805558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101729186|NCT00805558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101729187|NCT00805558|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101729188|NCT00805558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101729189|NCT01019785|Ergocalciferols|ergocalciferols|mesh-list
101729191|NCT01019785|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101364388|NCT00405730|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101729192|NCT01019785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729193|NCT01019785|Vitamins|vitamins|mesh-ancestor
101729194|NCT01019785|Micronutrients|micronutrients|mesh-ancestor
101729195|NCT01019785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101729196|NCT02604186|Botulinum Toxins|botulinum toxins|mesh-list
101729197|NCT02604186|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101729198|NCT02604186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101729199|NCT02604186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729200|NCT02604186|Cholinergic Agents|cholinergic agents|mesh-ancestor
101729201|NCT02604186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101729202|NCT02604186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198767|NCT05273528|Vaccines|vaccines|mesh-list
101729203|NCT01024543|Phenylephrine|phenylephrine|mesh-list
101729204|NCT01024543|Oxymetazoline|oxymetazoline|mesh-list
101729205|NCT01024543|Angiotensin II|angiotensin ii|mesh-list
101729206|NCT01024543|Giapreza|giapreza|mesh-list
101729207|NCT01024543|Angiotensinogen|angiotensinogen|mesh-list
101729208|NCT01024543|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101729209|NCT01024543|Mydriatics|mydriatics|mesh-ancestor
101729210|NCT01024543|Autonomic Agents|autonomic agents|mesh-ancestor
101729211|NCT01024543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101729212|NCT01024543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729213|NCT01024543|Sympathomimetics|sympathomimetics|mesh-ancestor
101729214|NCT01024543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101386646|NCT00121524|Atropine|atropine|mesh-list
101729215|NCT01024543|Nasal Decongestants|nasal decongestants|mesh-ancestor
101729216|NCT01024543|Respiratory System Agents|respiratory system agents|mesh-ancestor
101729217|NCT01024543|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101729218|NCT01024543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101729219|NCT01024543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101729220|NCT01024543|Adrenergic Agents|adrenergic agents|mesh-ancestor
101729221|NCT01024543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101729222|NCT01024543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729223|NCT01024543|Protective Agents|protective agents|mesh-ancestor
101729224|NCT01024543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101729225|NCT01024543|Protease Inhibitors|protease inhibitors|mesh-ancestor
101729226|NCT01024543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101729227|NCT00811330|Atorvastatin|atorvastatin|mesh-list
101729228|NCT00811330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101729229|NCT00811330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101729230|NCT00811330|Antimetabolites|antimetabolites|mesh-ancestor
101729231|NCT00811330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729232|NCT00811330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101729233|NCT00811330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101729234|NCT00811330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101729235|NCT00811408|Cidofovir|cidofovir|mesh-list
101729236|NCT00811408|Carboplatin|carboplatin|mesh-list
101729237|NCT00811408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101729238|NCT00811408|Antiviral Agents|antiviral agents|mesh-ancestor
101729239|NCT00811408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101729240|NCT00811408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101729241|NCT00811408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729242|NCT00446797|Celecoxib|celecoxib|mesh-list
101729243|NCT00446797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101729244|NCT00446797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101729245|NCT00446797|Analgesics|analgesics|mesh-ancestor
101729246|NCT00446797|Sensory System Agents|sensory system agents|mesh-ancestor
101729247|NCT00446797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101729248|NCT00446797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729250|NCT00446797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101729251|NCT00446797|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101729252|NCT00446797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101729254|NCT00446797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729255|NCT00855335|Ritonavir|ritonavir|mesh-list
101729256|NCT00855335|Darunavir|darunavir|mesh-list
101729257|NCT00855335|Cobicistat|cobicistat|mesh-list
101729258|NCT00855335|Rilpivirine|rilpivirine|mesh-list
101729259|NCT00855335|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
101729260|NCT00855335|Etravirine|etravirine|mesh-list
101729261|NCT00855335|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101729262|NCT00855335|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101729263|NCT00855335|Protease Inhibitors|protease inhibitors|mesh-ancestor
101729264|NCT00855335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101729265|NCT00855335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729266|NCT00855335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101729267|NCT00855335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101729268|NCT00855335|Antiviral Agents|antiviral agents|mesh-ancestor
101729269|NCT00855335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101729270|NCT00855335|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101729271|NCT00855335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101729272|NCT00855335|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101729273|NCT00855335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101729274|NCT00811486|Spironolactone|spironolactone|mesh-list
101729275|NCT00811486|Conivaptan|conivaptan|mesh-list
101729276|NCT00811486|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101729278|NCT00811486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101729279|NCT00811486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729280|NCT00811486|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101729281|NCT00811486|Diuretics|diuretics|mesh-ancestor
101729282|NCT00811486|Natriuretic Agents|natriuretic agents|mesh-ancestor
101729283|NCT00811486|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101729284|NCT00811486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729285|NCT04114188|Prednisolone|prednisolone|mesh-list
101729286|NCT04114188|Infliximab|infliximab|mesh-list
101729287|NCT04114188|Tacrolimus|tacrolimus|mesh-list
101729288|NCT04114188|Thymoglobulin|thymoglobulin|mesh-list
101729289|NCT04114188|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101729290|NCT04114188|Immunoglobulins|immunoglobulins|mesh-list
101729291|NCT04114188|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101729292|NCT04114188|Antibodies|antibodies|mesh-list
101729293|NCT04114188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101729294|NCT04114188|Immunologic Factors|immunologic factors|mesh-ancestor
101729295|NCT04114188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729296|NCT04114188|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101729297|NCT04114188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101729298|NCT04114188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729299|NCT04114188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101729300|NCT04114188|Glucocorticoids|glucocorticoids|mesh-ancestor
101729301|NCT04114188|Hormones|hormones|mesh-ancestor
101729302|NCT04114188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101729303|NCT04114188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101729304|NCT04114188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101729305|NCT04114188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101729306|NCT04114188|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101729307|NCT04114188|Dermatologic Agents|dermatologic agents|mesh-ancestor
101729308|NCT04114188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101729309|NCT00811876|Leuprolide|leuprolide|mesh-list
101729310|NCT00811876|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101729311|NCT00811876|Fertility Agents|fertility agents|mesh-ancestor
101729312|NCT00811876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101729313|NCT00811876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806603|NCT00957866|Antimetabolites|antimetabolites|mesh-ancestor
101729314|NCT00811876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101729315|NCT00811876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101729316|NCT00915252|Cytarabine|cytarabine|mesh-list
101729317|NCT00915252|Azacitidine|azacitidine|mesh-list
101729318|NCT00915252|Daunorubicin|daunorubicin|mesh-list
101729319|NCT00915252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101729320|NCT00915252|Antimetabolites|antimetabolites|mesh-ancestor
101729321|NCT00915252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729322|NCT00915252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101729323|NCT00915252|Antiviral Agents|antiviral agents|mesh-ancestor
101729324|NCT00915252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101729325|NCT00915252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101729326|NCT00915252|Immunologic Factors|immunologic factors|mesh-ancestor
101729327|NCT00915252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729328|NCT00915252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101729329|NCT00915252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101729330|NCT00915252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101729331|NCT00915252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101729332|NCT00593489|Insulin|insulin|mesh-list
101729333|NCT00593489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101729334|NCT00593489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729335|NCT00446641|Cilostazol|cilostazol|mesh-list
101729336|NCT00446641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101729337|NCT00446641|Autonomic Agents|autonomic agents|mesh-ancestor
101198845|NCT05271188|Anesthetics, Local|anesthetics, local|mesh-list
101729338|NCT00446641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101729339|NCT00446641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729340|NCT00446641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101729341|NCT00446641|Respiratory System Agents|respiratory system agents|mesh-ancestor
101729342|NCT00446641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101729343|NCT00446641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101729344|NCT00446641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729345|NCT00446641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101729346|NCT00446641|Vasodilator Agents|vasodilator agents|mesh-ancestor
101729347|NCT00446641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101729348|NCT00446641|Protective Agents|protective agents|mesh-ancestor
101729349|NCT00446641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101729350|NCT00446641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101729351|NCT00446641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101729352|NCT00646282|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
101729353|NCT00646282|Vitamins|vitamins|mesh-ancestor
101729354|NCT00646282|Micronutrients|micronutrients|mesh-ancestor
101729355|NCT00646282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729356|NCT00646282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101729357|NCT00792636|Naproxen|naproxen|mesh-list
101729358|NCT00792636|Sumatriptan|sumatriptan|mesh-list
101729359|NCT00792636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101729360|NCT00792636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101729361|NCT00792636|Analgesics|analgesics|mesh-ancestor
101729362|NCT00792636|Sensory System Agents|sensory system agents|mesh-ancestor
101729363|NCT00792636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101729364|NCT00792636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729365|NCT00792636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101729366|NCT00792636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101729367|NCT00792636|Gout Suppressants|gout suppressants|mesh-ancestor
101729368|NCT00792636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101729369|NCT00792636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101198893|NCT05270434|Dipyrone|dipyrone|mesh-list
101729370|NCT00792636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729371|NCT00792636|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101729372|NCT00792636|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101729373|NCT00792636|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101729374|NCT00792636|Serotonin Agents|serotonin agents|mesh-ancestor
101729375|NCT00792636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101729376|NCT00446563|Losartan|losartan|mesh-list
101729377|NCT00446563|Amlodipine|amlodipine|mesh-list
101729378|NCT00446563|Valsartan|valsartan|mesh-list
101729379|NCT00446563|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101729380|NCT00446563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101729381|NCT00446563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101729382|NCT00446563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101729383|NCT00446563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729384|NCT00446563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101729385|NCT00446563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729386|NCT00446563|Vasodilator Agents|vasodilator agents|mesh-ancestor
101729387|NCT00446563|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101729388|NCT00446563|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101729389|NCT00446563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101729390|NCT00446563|Diuretics|diuretics|mesh-ancestor
101729391|NCT00446563|Natriuretic Agents|natriuretic agents|mesh-ancestor
101729392|NCT00446563|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101729393|NCT00650806|Canagliflozin|canagliflozin|mesh-list
101729394|NCT00650806|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101729395|NCT00650806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729396|NCT00650806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101729397|NCT00650806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729398|NCT00863057|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101729399|NCT00863057|Methadone|methadone|mesh-list
101729400|NCT00863057|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101729401|NCT00863057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101729402|NCT00863057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101729403|NCT00863057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729404|NCT00863057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101729405|NCT00863057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729406|NCT00863057|Analgesics|analgesics|mesh-ancestor
101729407|NCT00863057|Sensory System Agents|sensory system agents|mesh-ancestor
101729408|NCT00863057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101729409|NCT00863057|Antidepressive Agents|antidepressive agents|mesh-ancestor
101729411|NCT00863057|Dopamine Agents|dopamine agents|mesh-ancestor
101729412|NCT00863057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101729413|NCT00863057|Narcotics|narcotics|mesh-ancestor
101729414|NCT00863057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101729415|NCT00863057|Antitussive Agents|antitussive agents|mesh-ancestor
101729416|NCT00863057|Respiratory System Agents|respiratory system agents|mesh-ancestor
101729417|NCT00814216|Fluticasone|fluticasone|mesh-list
101729418|NCT00814216|Xhance|xhance|mesh-list
101729419|NCT00814216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101729420|NCT00814216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101729421|NCT00814216|Autonomic Agents|autonomic agents|mesh-ancestor
101729422|NCT00814216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101263116|NCT01760460|Oxazolidinones|oxazolidinones|mesh-list
101729423|NCT00814216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729424|NCT00814216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101729425|NCT00814216|Respiratory System Agents|respiratory system agents|mesh-ancestor
101729426|NCT00814216|Dermatologic Agents|dermatologic agents|mesh-ancestor
101729427|NCT00814216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101729428|NCT00829166|Capecitabine|capecitabine|mesh-list
101729429|NCT00829166|Trastuzumab|trastuzumab|mesh-list
101729430|NCT00829166|Lapatinib|lapatinib|mesh-list
101729431|NCT00829166|Maytansine|maytansine|mesh-list
101729432|NCT00829166|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101729433|NCT00829166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101729434|NCT00829166|Antimetabolites|antimetabolites|mesh-ancestor
101729435|NCT00829166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729436|NCT00829166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101729437|NCT00829166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101729438|NCT00829166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101729439|NCT00829166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101729440|NCT00829166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101729441|NCT00829166|Tubulin Modulators|tubulin modulators|mesh-ancestor
101729442|NCT00829166|Antimitotic Agents|antimitotic agents|mesh-ancestor
101729443|NCT00829166|Mitosis Modulators|mitosis modulators|mesh-ancestor
101729444|NCT00829166|Immunotoxins|immunotoxins|mesh-ancestor
101729445|NCT00829166|Immunoconjugates|immunoconjugates|mesh-ancestor
101729446|NCT00829166|Immunologic Factors|immunologic factors|mesh-ancestor
101729447|NCT00829166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729448|NCT00799266|Zoledronic Acid|zoledronic acid|mesh-list
101729449|NCT00799266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101729450|NCT00799266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729451|NCT00650104|Ropinirole|ropinirole|mesh-list
101729452|NCT00650104|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101729453|NCT00650104|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101729454|NCT00650104|Dopamine Agonists|dopamine agonists|mesh-ancestor
101729455|NCT00650104|Dopamine Agents|dopamine agents|mesh-ancestor
101729456|NCT00650104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101729457|NCT00650104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729458|NCT00650104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729460|NCT00808054|Prilocaine|prilocaine|mesh-list
101729461|NCT00808054|Anesthetics, Local|anesthetics, local|mesh-ancestor
101729462|NCT00808054|Anesthetics|anesthetics|mesh-ancestor
101729463|NCT00808054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101729464|NCT00808054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729465|NCT00808054|Sensory System Agents|sensory system agents|mesh-ancestor
101729466|NCT00808054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101729467|NCT00808054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101729468|NCT00808054|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101729469|NCT00808054|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101729470|NCT00808054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101729471|NCT00808054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729472|NCT05102734|Nitroglycerin|nitroglycerin|mesh-list
101729473|NCT05102734|Vasodilator Agents|vasodilator agents|mesh-ancestor
101729474|NCT00814528|Imiquimod|imiquimod|mesh-list
101729475|NCT00814528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101729476|NCT00814528|Immunologic Factors|immunologic factors|mesh-ancestor
101729477|NCT00814528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729478|NCT00814528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101729479|NCT00814528|Interferon Inducers|interferon inducers|mesh-ancestor
101729480|NCT00814606|Ribavirin|ribavirin|mesh-list
101729481|NCT00814606|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101729482|NCT00814606|Antimetabolites|antimetabolites|mesh-ancestor
101729483|NCT00814606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729484|NCT00814606|Antiviral Agents|antiviral agents|mesh-ancestor
101729485|NCT00814606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101729486|NCT00814762|Vaccines|vaccines|mesh-list
101729487|NCT00814762|Immunologic Factors|immunologic factors|mesh-ancestor
101729488|NCT00814762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729489|NCT00654238|Sorafenib|sorafenib|mesh-list
101729490|NCT00654238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101729491|NCT00654238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101729492|NCT00654238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101729493|NCT00654238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729494|NCT00862979|Cyclosporine|cyclosporine|mesh-list
101729495|NCT00862979|Mycophenolic Acid|mycophenolic acid|mesh-list
101729496|NCT00862979|Everolimus|everolimus|mesh-list
101729497|NCT00862979|Tacrolimus|tacrolimus|mesh-list
101729498|NCT00862979|Cyclosporins|cyclosporins|mesh-list
101729499|NCT00862979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101729500|NCT00862979|Immunologic Factors|immunologic factors|mesh-ancestor
101729501|NCT00862979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729502|NCT00862979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101729503|NCT00862979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101729504|NCT00862979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729505|NCT00862979|Antifungal Agents|antifungal agents|mesh-ancestor
101729506|NCT00862979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101729507|NCT00862979|Dermatologic Agents|dermatologic agents|mesh-ancestor
101729508|NCT00862979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101729510|NCT00862979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101729511|NCT00862979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101729512|NCT00862979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101729513|NCT00862979|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101729514|NCT00862979|Antitubercular Agents|antitubercular agents|mesh-ancestor
101729515|NCT00862979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101729516|NCT02605356|Dexamethasone|dexamethasone|mesh-list
101729517|NCT02605356|Bortezomib|bortezomib|mesh-list
101729518|NCT02605356|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
101729519|NCT02605356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101729520|NCT02605356|Antiemetics|antiemetics|mesh-ancestor
101729521|NCT02605356|Autonomic Agents|autonomic agents|mesh-ancestor
101729522|NCT02605356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101729523|NCT02605356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729524|NCT02605356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101729525|NCT02605356|Glucocorticoids|glucocorticoids|mesh-ancestor
101729526|NCT02605356|Hormones|hormones|mesh-ancestor
101729527|NCT02605356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101729528|NCT02605356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101729529|NCT02605356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101729530|NCT00812266|Carboplatin|carboplatin|mesh-list
101729531|NCT00812266|Etoposide|etoposide|mesh-list
101729532|NCT00812266|Topotecan|topotecan|mesh-list
101729533|NCT00812266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101729534|NCT00812266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101729535|NCT00812266|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101729536|NCT00812266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101729537|NCT00812266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101729538|NCT00812266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729539|NCT00812266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101729540|NCT00814918|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101729541|NCT00814918|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101729542|NCT00814918|Dermatologic Agents|dermatologic agents|mesh-ancestor
101729543|NCT04113954|Prilocaine|prilocaine|mesh-list
101729544|NCT04113954|Mepivacaine|mepivacaine|mesh-list
101729545|NCT04113954|Anesthetics, Local|anesthetics, local|mesh-ancestor
101729546|NCT04113954|Anesthetics|anesthetics|mesh-ancestor
101729547|NCT04113954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101729548|NCT04113954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729549|NCT04113954|Sensory System Agents|sensory system agents|mesh-ancestor
101729550|NCT04113954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101729551|NCT00812344|Ketoconazole|ketoconazole|mesh-list
101729552|NCT00812344|Antifungal Agents|antifungal agents|mesh-ancestor
101729553|NCT00812344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101729554|NCT00812344|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101729555|NCT00812344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101729556|NCT00812344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101729557|NCT00812344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729558|NCT00812344|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101729559|NCT00812344|Hormone Antagonists|hormone antagonists|mesh-ancestor
101729560|NCT00812344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101729561|NCT00812344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729562|NCT00812344|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101729563|NCT00446251|Mycophenolic Acid|mycophenolic acid|mesh-list
101729564|NCT00446251|Rituximab|rituximab|mesh-list
101729565|NCT00446251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101729566|NCT00446251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101729567|NCT00446251|Immunologic Factors|immunologic factors|mesh-ancestor
101729568|NCT00446251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729569|NCT00446251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101729570|NCT00446251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101263119|NCT01760460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101729571|NCT00446251|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101729572|NCT00446251|Antitubercular Agents|antitubercular agents|mesh-ancestor
101729573|NCT00446251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101729574|NCT00446251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101729575|NCT00446251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101729576|NCT00446251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729577|NCT00812422|Ibuprofen|ibuprofen|mesh-list
101729578|NCT00812422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101729579|NCT00812422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101729580|NCT00812422|Analgesics|analgesics|mesh-ancestor
101729581|NCT00812422|Sensory System Agents|sensory system agents|mesh-ancestor
101729582|NCT00812422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101729583|NCT00812422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729584|NCT00812422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101729585|NCT00812422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101729586|NCT00812422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101729587|NCT00812422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101729588|NCT00812422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729589|NCT04110834|Itraconazole|itraconazole|mesh-list
101729590|NCT04110834|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
101729591|NCT04110834|Antifungal Agents|antifungal agents|mesh-ancestor
101806657|NCT00948740|Ergocalciferols|ergocalciferols|mesh-list
101729592|NCT04110834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101729593|NCT04110834|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101729594|NCT04110834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101729595|NCT04110834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101729596|NCT04110834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729597|NCT04110834|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101729598|NCT04110834|Hormone Antagonists|hormone antagonists|mesh-ancestor
101729599|NCT04110834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101729600|NCT04110834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729601|NCT04110834|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101729602|NCT00812578|Cholecalciferol|cholecalciferol|mesh-list
101729603|NCT00812578|Vitamin D|vitamin d|mesh-list
101729604|NCT00812578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101729605|NCT00812578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729606|NCT00812578|Vitamins|vitamins|mesh-ancestor
101729607|NCT00812578|Micronutrients|micronutrients|mesh-ancestor
101729608|NCT00812578|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101729609|NCT00796224|Azithromycin|azithromycin|mesh-list
101729610|NCT00796224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101729611|NCT00796224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101729612|NCT00808366|Antifungal Agents|antifungal agents|mesh-list
101729613|NCT00808366|Clotrimazole|clotrimazole|mesh-list
101729614|NCT00808366|Miconazole|miconazole|mesh-list
101729615|NCT00808366|Keratolytic Agents|keratolytic agents|mesh-list
101199195|NCT04961801|Methotrexate|methotrexate|mesh-list
101364401|NCT00405769|Red yeast rice|red yeast rice|mesh-list
101729616|NCT00808366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101729617|NCT00808366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101729618|NCT00808366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101729619|NCT00808366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101729620|NCT00808366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101729621|NCT00808366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729622|NCT00808366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101729623|NCT00808366|Hormone Antagonists|hormone antagonists|mesh-ancestor
101729624|NCT00808366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101729625|NCT00808366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729626|NCT00808366|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101729627|NCT00808366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101729628|NCT00808366|Dermatologic Agents|dermatologic agents|mesh-ancestor
101729629|NCT04045522|Zoledronic Acid|zoledronic acid|mesh-list
101729630|NCT04045522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101729631|NCT04045522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729632|NCT02551276|Albuterol|albuterol|mesh-list
101729633|NCT02551276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101729634|NCT02551276|Autonomic Agents|autonomic agents|mesh-ancestor
101806704|NCT00108355|Sympathomimetics|sympathomimetics|mesh-ancestor
101729635|NCT02551276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101729636|NCT02551276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729637|NCT02551276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101729638|NCT02551276|Respiratory System Agents|respiratory system agents|mesh-ancestor
101729639|NCT02551276|Tocolytic Agents|tocolytic agents|mesh-ancestor
101729640|NCT02551276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101263120|NCT01760460|Antimetabolites|antimetabolites|mesh-ancestor
101729641|NCT02551276|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101729642|NCT02551276|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101729643|NCT02551276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101729644|NCT02551276|Adrenergic Agents|adrenergic agents|mesh-ancestor
101729645|NCT02551276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101729646|NCT02551276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729647|NCT00848081|Tadalafil|tadalafil|mesh-list
101729648|NCT00848081|Vasodilator Agents|vasodilator agents|mesh-ancestor
101729649|NCT00848081|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101729650|NCT00848081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101729651|NCT00848081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101729652|NCT00848081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729653|NCT00848081|Urological Agents|urological agents|mesh-ancestor
101729654|NCT00815464|Antiviral Agents|antiviral agents|mesh-list
101729655|NCT00815464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101729656|NCT04111380|Paclitaxel|paclitaxel|mesh-list
101729657|NCT04111380|Cisplatin|cisplatin|mesh-list
101729658|NCT04111380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101729659|NCT04111380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101729660|NCT04111380|Tubulin Modulators|tubulin modulators|mesh-ancestor
101729661|NCT04111380|Antimitotic Agents|antimitotic agents|mesh-ancestor
101387096|NCT00089427|Temozolomide|temozolomide|mesh-list
101729662|NCT04111380|Mitosis Modulators|mitosis modulators|mesh-ancestor
101729663|NCT04111380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729664|NCT04117919|Triamcinolone|triamcinolone|mesh-list
101729665|NCT04117919|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101729666|NCT04117919|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101729667|NCT04117919|Hydrocortisone|hydrocortisone|mesh-list
101729668|NCT04117919|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101729669|NCT04117919|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101729670|NCT04117919|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101729671|NCT04117919|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101729672|NCT04117919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101729673|NCT04117919|Glucocorticoids|glucocorticoids|mesh-ancestor
101729674|NCT04117919|Hormones|hormones|mesh-ancestor
101729675|NCT04117919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101729676|NCT04117919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729677|NCT04117919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101729678|NCT04117919|Immunologic Factors|immunologic factors|mesh-ancestor
101729679|NCT04117919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101729680|NCT04117919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729681|NCT00701285|Pravastatin|pravastatin|mesh-list
101729682|NCT00701285|Pitavastatin|pitavastatin|mesh-list
101729683|NCT00701285|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101729684|NCT00701285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101729685|NCT00701285|Antimetabolites|antimetabolites|mesh-ancestor
101806733|NCT00968760|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101729686|NCT00701285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729687|NCT00701285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101729688|NCT00701285|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101729689|NCT00701285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101729691|NCT02604498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101729692|NCT02604498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101729693|NCT00700037|Atorvastatin|atorvastatin|mesh-list
101729694|NCT00700037|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101729695|NCT00700037|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101729696|NCT00700037|Antimetabolites|antimetabolites|mesh-ancestor
101729697|NCT00700037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729698|NCT00700037|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101729699|NCT00700037|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101729700|NCT00700037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101729701|NCT00815542|Dinoprostone|dinoprostone|mesh-list
101729702|NCT00815542|Oxytocics|oxytocics|mesh-ancestor
101729703|NCT00815542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101729704|NCT00815542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729705|NCT00791778|Sorafenib|sorafenib|mesh-list
101729706|NCT00791778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101729707|NCT00791778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101729708|NCT00791778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101729709|NCT00791778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729710|NCT02604576|Bromopride|bromopride|mesh-list
101729711|NCT02604576|Metoclopramide|metoclopramide|mesh-list
101729712|NCT02604576|Simethicone|simethicone|mesh-list
101729713|NCT02604576|Antifoaming Agents|antifoaming agents|mesh-ancestor
101729714|NCT02604576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729715|NCT02604576|Emollients|emollients|mesh-ancestor
101729716|NCT02604576|Dermatologic Agents|dermatologic agents|mesh-ancestor
101729717|NCT02604576|Antiemetics|antiemetics|mesh-ancestor
101729718|NCT02604576|Autonomic Agents|autonomic agents|mesh-ancestor
101729719|NCT02604576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101729720|NCT02604576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729721|NCT02604576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101729722|NCT02604576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101729723|NCT02604576|Dopamine Agents|dopamine agents|mesh-ancestor
101729724|NCT02604576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101729725|NCT02604576|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101729726|NCT04110132|Bupivacaine|bupivacaine|mesh-list
101729727|NCT04110132|Anesthetics, Local|anesthetics, local|mesh-ancestor
101729728|NCT04110132|Anesthetics|anesthetics|mesh-ancestor
101729729|NCT04110132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101729730|NCT04110132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729731|NCT04110132|Sensory System Agents|sensory system agents|mesh-ancestor
101729732|NCT04110132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101729733|NCT00795600|Insulin|insulin|mesh-list
101729734|NCT00795600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101729735|NCT00795600|Insulin Detemir|insulin detemir|mesh-list
101729736|NCT00795600|Isophane Insulin, Human|isophane insulin, human|mesh-list
101729737|NCT00795600|Insulin, Isophane|insulin, isophane|mesh-list
101729738|NCT00795600|Isophane insulin, beef|isophane insulin, beef|mesh-list
101729739|NCT00795600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101729740|NCT00795600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729741|NCT00795132|Cyclosporine|cyclosporine|mesh-list
101729742|NCT00795132|Mycophenolic Acid|mycophenolic acid|mesh-list
101729744|NCT00795132|Busulfan|busulfan|mesh-list
101729745|NCT00795132|Cyclosporins|cyclosporins|mesh-list
101729746|NCT00795132|Thymoglobulin|thymoglobulin|mesh-list
101729747|NCT00795132|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101729748|NCT00795132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101729749|NCT00795132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729750|NCT00795132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101729751|NCT00795132|Immunologic Factors|immunologic factors|mesh-ancestor
101729752|NCT00795132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729753|NCT00795132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101729754|NCT00795132|Antifungal Agents|antifungal agents|mesh-ancestor
101729755|NCT00795132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101729756|NCT00795132|Dermatologic Agents|dermatologic agents|mesh-ancestor
101729757|NCT00795132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101729758|NCT00795132|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101729759|NCT00795132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101729760|NCT00795132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101729761|NCT00795132|Antitubercular Agents|antitubercular agents|mesh-ancestor
101729762|NCT00795132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101729763|NCT00795132|Alkylating Agents|alkylating agents|mesh-ancestor
101729764|NCT00795132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101729765|NCT00795132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101729766|NCT02604420|Eculizumab|eculizumab|mesh-list
101729767|NCT02604420|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101729768|NCT02604420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101729769|NCT02604420|Immunologic Factors|immunologic factors|mesh-ancestor
101199369|NCT04368091|Sirolimus|sirolimus|mesh-list
101729770|NCT02604420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729771|NCT04110210|Morphine|morphine|mesh-list
101729772|NCT04110210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101729773|NCT04110210|Narcotics|narcotics|mesh-ancestor
101729774|NCT04110210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101729775|NCT04110210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729776|NCT04110210|Analgesics|analgesics|mesh-ancestor
101729777|NCT04110210|Sensory System Agents|sensory system agents|mesh-ancestor
101729778|NCT04110210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101729779|NCT00647296|Pramipexole|pramipexole|mesh-list
101729780|NCT00647296|Antioxidants|antioxidants|mesh-ancestor
101729781|NCT00647296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729782|NCT00647296|Protective Agents|protective agents|mesh-ancestor
101729783|NCT00647296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729784|NCT00647296|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101729785|NCT00647296|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101729786|NCT00647296|Dopamine Agonists|dopamine agonists|mesh-ancestor
101729787|NCT00647296|Dopamine Agents|dopamine agents|mesh-ancestor
101729788|NCT00647296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101729789|NCT00813202|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101729790|NCT00813202|Natriuretic Agents|natriuretic agents|mesh-ancestor
101729791|NCT00813202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729792|NCT00646906|Aspirin|aspirin|mesh-list
101729793|NCT00646906|Acetaminophen|acetaminophen|mesh-list
101729794|NCT00646906|Ibuprofen|ibuprofen|mesh-list
101729795|NCT00646906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101729796|NCT00646906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101729797|NCT00646906|Analgesics|analgesics|mesh-ancestor
101729798|NCT00646906|Sensory System Agents|sensory system agents|mesh-ancestor
101729799|NCT00646906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101729800|NCT00646906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199394|NCT04302168|Nootropic Agents|nootropic agents|mesh-ancestor
101729801|NCT00646906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101729802|NCT00646906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101729803|NCT00646906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101729804|NCT00646906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101729805|NCT00646906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729806|NCT00646906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101729807|NCT00646906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101729808|NCT00646906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101729809|NCT00646906|Antipyretics|antipyretics|mesh-ancestor
101729810|NCT00813436|Oxytocin|oxytocin|mesh-list
101729811|NCT00813436|Oxytocics|oxytocics|mesh-ancestor
101729812|NCT00813436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101729813|NCT00813436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729814|NCT00808678|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101729815|NCT00808678|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101729816|NCT00808678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101729817|NCT00808678|Antimetabolites|antimetabolites|mesh-ancestor
101729818|NCT00808678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729819|NCT00808678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101729820|NCT00808678|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101729821|NCT00808678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101729822|NCT00815854|Folic Acid|folic acid|mesh-list
101729823|NCT00815854|Hematinics|hematinics|mesh-ancestor
101729824|NCT00815854|Vitamin B Complex|vitamin b complex|mesh-ancestor
101729825|NCT00815854|Vitamins|vitamins|mesh-ancestor
101729826|NCT00815854|Micronutrients|micronutrients|mesh-ancestor
101729827|NCT00815854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729828|NCT00817648|Risperidone|risperidone|mesh-list
101729829|NCT00817648|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101729830|NCT00817648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101729831|NCT00817648|Serotonin Agents|serotonin agents|mesh-ancestor
101729832|NCT00817648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101729833|NCT00817648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729834|NCT00817648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729835|NCT00817648|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101729836|NCT00817648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101729837|NCT00817648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101729838|NCT00817648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101729839|NCT00817648|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101729840|NCT00817648|Dopamine Agents|dopamine agents|mesh-ancestor
101729841|NCT00817648|Antidepressive Agents|antidepressive agents|mesh-ancestor
101729842|NCT00829010|Vaccines|vaccines|mesh-list
101729843|NCT00829010|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101729844|NCT00829010|Immunologic Factors|immunologic factors|mesh-ancestor
101729845|NCT00829010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729846|NCT00644332|Ranolazine|ranolazine|mesh-list
101729847|NCT00644332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101729848|NCT00644332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101729849|NCT00644332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729850|NCT00808912|Sildenafil Citrate|sildenafil citrate|mesh-list
101729851|NCT00808912|Vasodilator Agents|vasodilator agents|mesh-ancestor
101729852|NCT00808912|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101729853|NCT00808912|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101729854|NCT00808912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101729855|NCT00808912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729856|NCT00808912|Urological Agents|urological agents|mesh-ancestor
101729857|NCT02551042|Factor VIII|factor viii|mesh-list
101729858|NCT02551042|Coagulants|coagulants|mesh-ancestor
101729859|NCT00445939|Adalimumab|adalimumab|mesh-list
101729860|NCT00445939|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101729861|NCT00445939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101729862|NCT00445939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101729863|NCT00816244|Atorvastatin|atorvastatin|mesh-list
101729864|NCT00816244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101729865|NCT00816244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101729866|NCT00816244|Antimetabolites|antimetabolites|mesh-ancestor
101729867|NCT00816244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729868|NCT00816244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101729869|NCT00816244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101729870|NCT00816244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101729871|NCT00817960|Methylphenidate|methylphenidate|mesh-list
101806779|NCT00094861|Mitosis Modulators|mitosis modulators|mesh-ancestor
101729872|NCT00817960|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101729873|NCT00817960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729874|NCT00817960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101729875|NCT00817960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101729876|NCT00817960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101729877|NCT00817960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729878|NCT00817960|Dopamine Agents|dopamine agents|mesh-ancestor
101729879|NCT00817960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101729880|NCT00818038|Natalizumab|natalizumab|mesh-list
101729881|NCT00818038|Immunologic Factors|immunologic factors|mesh-ancestor
101729882|NCT00818038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729883|NCT00482053|Acetaminophen|acetaminophen|mesh-list
101729884|NCT00482053|Diphenhydramine|diphenhydramine|mesh-list
101729885|NCT00482053|Promethazine|promethazine|mesh-list
101729886|NCT00482053|Cyclosporine|cyclosporine|mesh-list
101729887|NCT00482053|Mycophenolic Acid|mycophenolic acid|mesh-list
101729888|NCT00482053|Methylprednisolone|methylprednisolone|mesh-list
101387336|NCT00296530|Hormones|hormones|mesh-ancestor
101729889|NCT00482053|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101729890|NCT00482053|Hydrocortisone|hydrocortisone|mesh-list
101729891|NCT00482053|Cyclophosphamide|cyclophosphamide|mesh-list
101729892|NCT00482053|Carmustine|carmustine|mesh-list
101729893|NCT00482053|Rituximab|rituximab|mesh-list
101729894|NCT00482053|Etoposide|etoposide|mesh-list
101729895|NCT00482053|Cyclosporins|cyclosporins|mesh-list
101729896|NCT00482053|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101729897|NCT00482053|Lenograstim|lenograstim|mesh-list
101729898|NCT00482053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101729899|NCT00482053|Immunologic Factors|immunologic factors|mesh-ancestor
101729900|NCT00482053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729901|NCT00482053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101729902|NCT00482053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101729903|NCT00482053|Alkylating Agents|alkylating agents|mesh-ancestor
101729904|NCT00482053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729905|NCT00482053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101729906|NCT00482053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101729907|NCT00482053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101729908|NCT00482053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101729909|NCT00482053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101729910|NCT00482053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101729911|NCT00482053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101729912|NCT00482053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101729913|NCT00482053|Antifungal Agents|antifungal agents|mesh-ancestor
101729914|NCT00482053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101729915|NCT00482053|Dermatologic Agents|dermatologic agents|mesh-ancestor
101729916|NCT00482053|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101729917|NCT00482053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101729918|NCT00482053|Analgesics|analgesics|mesh-ancestor
101729919|NCT00482053|Sensory System Agents|sensory system agents|mesh-ancestor
101729920|NCT00482053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101729921|NCT00482053|Antipyretics|antipyretics|mesh-ancestor
101729922|NCT00482053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101729923|NCT00482053|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101729924|NCT00482053|Antitubercular Agents|antitubercular agents|mesh-ancestor
101729925|NCT00482053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101729926|NCT00482053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101729927|NCT00482053|Antiemetics|antiemetics|mesh-ancestor
101729928|NCT00482053|Autonomic Agents|autonomic agents|mesh-ancestor
101729929|NCT00482053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101729930|NCT00482053|Glucocorticoids|glucocorticoids|mesh-ancestor
101729931|NCT00482053|Hormones|hormones|mesh-ancestor
101729932|NCT00482053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101729933|NCT00482053|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101729934|NCT00482053|Protective Agents|protective agents|mesh-ancestor
101729935|NCT00482053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101729936|NCT00482053|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101729938|NCT00482053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101729939|NCT00482053|Anesthetics, Local|anesthetics, local|mesh-ancestor
101729940|NCT00482053|Anesthetics|anesthetics|mesh-ancestor
101729941|NCT00482053|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101729942|NCT00482053|Histamine Antagonists|histamine antagonists|mesh-ancestor
101729943|NCT00482053|Histamine Agents|histamine agents|mesh-ancestor
101729944|NCT00482053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101729945|NCT00482053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101729946|NCT00482053|Antipruritics|antipruritics|mesh-ancestor
101729947|NCT00455923|Fluticasone|fluticasone|mesh-list
101729948|NCT00455923|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101729949|NCT00455923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101729950|NCT00455923|Autonomic Agents|autonomic agents|mesh-ancestor
101729951|NCT00455923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101729952|NCT00455923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729953|NCT00455923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101729954|NCT00455923|Respiratory System Agents|respiratory system agents|mesh-ancestor
101729955|NCT00455923|Glucocorticoids|glucocorticoids|mesh-ancestor
101729956|NCT00455923|Hormones|hormones|mesh-ancestor
101729957|NCT00455923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101729958|NCT00455923|Sympathomimetics|sympathomimetics|mesh-ancestor
101729959|NCT00455923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101729960|NCT00455923|Dermatologic Agents|dermatologic agents|mesh-ancestor
101729961|NCT00455923|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101729962|NCT00642616|Insulin|insulin|mesh-list
101729963|NCT00642616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101387409|NCT00296959|Topiramate|topiramate|mesh-list
101729964|NCT00642616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729965|NCT00809068|Tibolone|tibolone|mesh-list
101729966|NCT00809068|Fenofibrate|fenofibrate|mesh-list
101729967|NCT00809068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101729968|NCT00809068|Antimetabolites|antimetabolites|mesh-ancestor
101729969|NCT00809068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729970|NCT00809068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101729971|NCT00809068|Androgen Antagonists|androgen antagonists|mesh-ancestor
101729972|NCT00809068|Hormone Antagonists|hormone antagonists|mesh-ancestor
101729973|NCT00809068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101729974|NCT00809068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729975|NCT00809068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101729976|NCT00809068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101729977|NCT00809068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101729978|NCT00809068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101729979|NCT00809068|Anabolic Agents|anabolic agents|mesh-ancestor
101729980|NCT00809068|Hormones|hormones|mesh-ancestor
101729981|NCT03844945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101729982|NCT03844945|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101729983|NCT01027117|Sildenafil Citrate|sildenafil citrate|mesh-list
101729984|NCT01027117|Vasodilator Agents|vasodilator agents|mesh-ancestor
101729985|NCT01027117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101729986|NCT01027117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101729987|NCT01027117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101729988|NCT01027117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101729989|NCT01027117|Urological Agents|urological agents|mesh-ancestor
101729990|NCT03995563|Dexamethasone|dexamethasone|mesh-list
101729991|NCT03995563|Ropivacaine|ropivacaine|mesh-list
101729992|NCT03995563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101729993|NCT03995563|Antiemetics|antiemetics|mesh-ancestor
101729994|NCT03995563|Autonomic Agents|autonomic agents|mesh-ancestor
101729995|NCT03995563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101729996|NCT03995563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101729997|NCT03995563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101729998|NCT03995563|Glucocorticoids|glucocorticoids|mesh-ancestor
101730000|NCT03995563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101730001|NCT03995563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101730002|NCT03995563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101730003|NCT03995563|Anesthetics, Local|anesthetics, local|mesh-ancestor
101730005|NCT03995563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101730006|NCT03995563|Sensory System Agents|sensory system agents|mesh-ancestor
101730007|NCT00445003|Triamcinolone|triamcinolone|mesh-list
101730008|NCT00445003|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101730009|NCT00445003|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101730010|NCT00445003|Ranibizumab|ranibizumab|mesh-list
101730011|NCT00445003|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101730012|NCT00445003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101730013|NCT00445003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101730014|NCT00445003|Growth Substances|growth substances|mesh-ancestor
101730015|NCT00445003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730016|NCT00445003|Growth Inhibitors|growth inhibitors|mesh-ancestor
101730017|NCT00445003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101730018|NCT00445003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101730019|NCT00445003|Glucocorticoids|glucocorticoids|mesh-ancestor
101730020|NCT00445003|Hormones|hormones|mesh-ancestor
101730021|NCT00445003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101730022|NCT00445003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101730023|NCT00445003|Immunologic Factors|immunologic factors|mesh-ancestor
101730024|NCT00445003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101730025|NCT00445003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730026|NCT00642460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101730027|NCT00642460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101730028|NCT00642460|Methotrexate|methotrexate|mesh-list
101730029|NCT00642460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101730030|NCT00642460|Abortifacient Agents|abortifacient agents|mesh-ancestor
101730031|NCT00642460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101730032|NCT00642460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730033|NCT00642460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101730034|NCT00642460|Antimetabolites|antimetabolites|mesh-ancestor
101730035|NCT00642460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730036|NCT00642460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101730037|NCT00642460|Dermatologic Agents|dermatologic agents|mesh-ancestor
101730038|NCT00642460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101730039|NCT00642460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101730040|NCT00642460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101730041|NCT00642460|Immunologic Factors|immunologic factors|mesh-ancestor
101730042|NCT00642460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101730043|NCT00642460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101730044|NCT00642460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101730045|NCT00642460|Analgesics|analgesics|mesh-ancestor
101730046|NCT00642460|Sensory System Agents|sensory system agents|mesh-ancestor
101730047|NCT00642460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101730049|NCT00814658|Galantamine|galantamine|mesh-list
101730050|NCT00814658|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101730051|NCT00814658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101730052|NCT00814658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730053|NCT00814658|Cholinergic Agents|cholinergic agents|mesh-ancestor
101730054|NCT00814658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101730055|NCT00814658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730056|NCT00814658|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101730057|NCT00814658|Autonomic Agents|autonomic agents|mesh-ancestor
101730058|NCT00814658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101730059|NCT00814658|Nootropic Agents|nootropic agents|mesh-ancestor
101730060|NCT00814658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101730061|NCT00814658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101730062|NCT00814658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101730063|NCT00814658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101730064|NCT00814658|Vasodilator Agents|vasodilator agents|mesh-ancestor
101730065|NCT00816634|Paclitaxel|paclitaxel|mesh-list
101730066|NCT00816634|Capecitabine|capecitabine|mesh-list
101730067|NCT00816634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101730068|NCT00816634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101730069|NCT00816634|Tubulin Modulators|tubulin modulators|mesh-ancestor
101730070|NCT00816634|Antimitotic Agents|antimitotic agents|mesh-ancestor
101730071|NCT00816634|Mitosis Modulators|mitosis modulators|mesh-ancestor
101730072|NCT00816634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730073|NCT00816634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101730074|NCT00816634|Antimetabolites|antimetabolites|mesh-ancestor
101730075|NCT00642304|Epoetin Alfa|epoetin alfa|mesh-list
101730076|NCT00642304|Hematinics|hematinics|mesh-ancestor
101730077|NCT00814580|Oxycodone|oxycodone|mesh-list
101730078|NCT00814580|Tapentadol|tapentadol|mesh-list
101730079|NCT00814580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101730080|NCT00814580|Narcotics|narcotics|mesh-ancestor
101730081|NCT00814580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101730082|NCT00814580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730083|NCT00814580|Analgesics|analgesics|mesh-ancestor
101730084|NCT00814580|Sensory System Agents|sensory system agents|mesh-ancestor
101730085|NCT00814580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101730086|NCT00814580|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101730087|NCT00814580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101730088|NCT00814580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101730089|NCT00814580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730090|NCT00814580|Adrenergic Agents|adrenergic agents|mesh-ancestor
101730091|NCT00814580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101730092|NCT00643162|Escitalopram|escitalopram|mesh-list
101730093|NCT00643162|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101730094|NCT00643162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101730095|NCT00643162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101730096|NCT00643162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730097|NCT00643162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101730098|NCT00643162|Serotonin Agents|serotonin agents|mesh-ancestor
101730099|NCT00643162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730100|NCT00814502|Zolpidem|zolpidem|mesh-list
101730101|NCT00814502|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101730102|NCT00814502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101730103|NCT00814502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101730104|NCT00814502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730105|NCT00814502|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101730106|NCT00814502|GABA Agonists|gaba agonists|mesh-ancestor
101730107|NCT00814502|GABA Agents|gaba agents|mesh-ancestor
101730108|NCT00814502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101730109|NCT00814502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730110|NCT00653224|Levocetirizine|levocetirizine|mesh-list
101730111|NCT00653224|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101730112|NCT00653224|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101730113|NCT00653224|Histamine Antagonists|histamine antagonists|mesh-ancestor
101730114|NCT00653224|Histamine Agents|histamine agents|mesh-ancestor
101730115|NCT00653224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101730116|NCT00653224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730117|NCT00653224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730119|NCT00444925|Fesoterodine|fesoterodine|mesh-list
101730120|NCT00444925|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101730121|NCT00444925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101730122|NCT00444925|Cholinergic Agents|cholinergic agents|mesh-ancestor
101730123|NCT00444925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101730124|NCT00444925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730125|NCT00444925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730127|NCT00641056|Insulin Glargine|insulin glargine|mesh-list
101730128|NCT00641056|Exenatide|exenatide|mesh-list
101730129|NCT00641056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101730130|NCT00641056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730131|NCT00641056|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101730132|NCT00641056|Incretins|incretins|mesh-ancestor
101730133|NCT00641056|Hormones|hormones|mesh-ancestor
101730134|NCT00641056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101730135|NCT00569374|Modafinil|modafinil|mesh-list
101730136|NCT00569374|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101730137|NCT00569374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730138|NCT00569374|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101730139|NCT00569374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101730140|NCT00569374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101730141|NCT00569374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730142|NCT00828464|Clobetasol|clobetasol|mesh-list
101730143|NCT00828464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101730144|NCT00828464|Glucocorticoids|glucocorticoids|mesh-ancestor
101730145|NCT00828464|Hormones|hormones|mesh-ancestor
101730146|NCT00828464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101730147|NCT00828464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730148|NCT00816712|Methyltestosterone|methyltestosterone|mesh-list
101730149|NCT00816712|Testosterone|testosterone|mesh-list
101730150|NCT00816712|Testosterone undecanoate|testosterone undecanoate|mesh-list
101730151|NCT00816712|Testosterone enanthate|testosterone enanthate|mesh-list
101730152|NCT00816712|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101730153|NCT00816712|Androgens|androgens|mesh-ancestor
101730154|NCT00816712|Hormones|hormones|mesh-ancestor
101730155|NCT00816712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101730156|NCT00816712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730157|NCT00816712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101730158|NCT00816712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101730159|NCT00816712|Anabolic Agents|anabolic agents|mesh-ancestor
101730160|NCT00818194|Cyclosporine|cyclosporine|mesh-list
101730162|NCT00818194|Cyclosporins|cyclosporins|mesh-list
101730163|NCT00818194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101730164|NCT00818194|Immunologic Factors|immunologic factors|mesh-ancestor
101730165|NCT00818194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730166|NCT00818194|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101730167|NCT00818194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101730168|NCT00818194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730169|NCT00818194|Antifungal Agents|antifungal agents|mesh-ancestor
101730170|NCT00818194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101730171|NCT00818194|Dermatologic Agents|dermatologic agents|mesh-ancestor
101730172|NCT00818194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101730173|NCT02610686|Chloroquine|chloroquine|mesh-list
101199893|NCT02745535|Antiviral Agents|antiviral agents|mesh-ancestor
101199894|NCT02745535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101199895|NCT02729701|Bazedoxifene|bazedoxifene|mesh-list
101199896|NCT02729701|Estrogens|estrogens|mesh-list
101199897|NCT02729701|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101199898|NCT02729701|Hormones|hormones|mesh-ancestor
101199899|NCT02729701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101199900|NCT02729701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199901|NCT02729701|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101364439|NCT00146926|Lidocaine|lidocaine|mesh-list
101199902|NCT02729701|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101199904|NCT02729701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101199905|NCT02719314|Methylprednisolone|methylprednisolone|mesh-list
101199906|NCT02719314|Glucocorticoids|glucocorticoids|mesh-list
101199907|NCT02719314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101199908|NCT02719314|Antiemetics|antiemetics|mesh-ancestor
101199909|NCT02719314|Autonomic Agents|autonomic agents|mesh-ancestor
101199910|NCT02719314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101199911|NCT02719314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199912|NCT02719314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101199913|NCT02719314|Hormones|hormones|mesh-ancestor
101199914|NCT02719314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101199915|NCT02719314|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101199916|NCT02719314|Protective Agents|protective agents|mesh-ancestor
101730174|NCT02610686|Amebicides|amebicides|mesh-ancestor
101730175|NCT02610686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101730176|NCT02610686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101730177|NCT02610686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101730178|NCT02610686|Antimalarials|antimalarials|mesh-ancestor
101730179|NCT02610686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101730181|NCT00816790|Piperacillin|piperacillin|mesh-list
101730182|NCT00816790|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101730183|NCT00816790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101730184|NCT00816790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101730185|NCT00816790|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101730186|NCT00816790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101730187|NCT00816790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730188|NCT00818350|Sunitinib|sunitinib|mesh-list
101730189|NCT00818350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101730190|NCT00818350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101730191|NCT00818350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101730192|NCT00818350|Growth Substances|growth substances|mesh-ancestor
101730193|NCT00818350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730194|NCT00818350|Growth Inhibitors|growth inhibitors|mesh-ancestor
101730195|NCT00818350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101730196|NCT00818350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101730197|NCT00818350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730198|NCT00810602|Vorinostat|vorinostat|mesh-list
101730199|NCT00810602|Tacrolimus|tacrolimus|mesh-list
101730200|NCT00810602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101730201|NCT00810602|Immunologic Factors|immunologic factors|mesh-ancestor
101730202|NCT00810602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730203|NCT00810602|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101730204|NCT00810602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101730205|NCT00810602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730206|NCT00810602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101730207|NCT00810602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101730208|NCT00816868|Capecitabine|capecitabine|mesh-list
101730209|NCT00816868|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101730210|NCT00816868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101730211|NCT00816868|Antimetabolites|antimetabolites|mesh-ancestor
101730212|NCT00816868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730213|NCT00816868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101730214|NCT00816868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101730215|NCT00816868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101730216|NCT05500586|Glucagon|glucagon|mesh-list
101730217|NCT05500586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101730218|NCT05500586|Hormones|hormones|mesh-ancestor
101730219|NCT05500586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101730220|NCT05500586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730221|NCT00791700|Maraviroc|maraviroc|mesh-list
101730222|NCT00791700|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101730223|NCT00791700|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101200017|NCT02578368|Fluorouracil|fluorouracil|mesh-list
101730224|NCT00791700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730225|NCT00791700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101730226|NCT00791700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101730227|NCT00791700|Antiviral Agents|antiviral agents|mesh-ancestor
101730228|NCT00791700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101730229|NCT00791700|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101730230|NCT00628108|Levocetirizine|levocetirizine|mesh-list
101806846|NCT00969696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364443|NCT00146926|Anesthetics|anesthetics|mesh-ancestor
101730231|NCT00628108|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101730232|NCT00628108|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101730233|NCT00628108|Histamine Antagonists|histamine antagonists|mesh-ancestor
101730234|NCT00628108|Histamine Agents|histamine agents|mesh-ancestor
101730235|NCT00628108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101730236|NCT00628108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730237|NCT00628108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730238|NCT00821392|Febuxostat|febuxostat|mesh-list
101730239|NCT00821392|Gout Suppressants|gout suppressants|mesh-ancestor
101730240|NCT00821392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101730241|NCT00591578|Valsartan|valsartan|mesh-list
101730242|NCT00591578|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
101730243|NCT00591578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101730244|NCT00591578|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101730245|NCT00591578|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101730246|NCT00591578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730247|NCT00797862|Amlodipine|amlodipine|mesh-list
101730248|NCT00797862|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101730249|NCT00797862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101730250|NCT00797862|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101730251|NCT00797862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101730252|NCT00797862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730253|NCT00797862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101730254|NCT00797862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730255|NCT00797862|Vasodilator Agents|vasodilator agents|mesh-ancestor
101730256|NCT00797862|Diuretics|diuretics|mesh-ancestor
101730257|NCT00797862|Natriuretic Agents|natriuretic agents|mesh-ancestor
101730258|NCT00797862|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101730259|NCT00817258|Cisplatin|cisplatin|mesh-list
101730260|NCT00817258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101730261|NCT00794820|Cyclophosphamide|cyclophosphamide|mesh-list
101730262|NCT00794820|Rituximab|rituximab|mesh-list
101730263|NCT00794820|Fludarabine|fludarabine|mesh-list
101730264|NCT00794820|Fludarabine phosphate|fludarabine phosphate|mesh-list
101730265|NCT00794820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101730266|NCT00794820|Immunologic Factors|immunologic factors|mesh-ancestor
101730267|NCT00794820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730268|NCT00794820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101730269|NCT00794820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101730270|NCT00794820|Alkylating Agents|alkylating agents|mesh-ancestor
101730271|NCT00794820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730272|NCT00794820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101730273|NCT00794820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101730274|NCT00794820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101730275|NCT00794820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101730276|NCT00794820|Antimetabolites|antimetabolites|mesh-ancestor
101730277|NCT00455533|Paclitaxel|paclitaxel|mesh-list
101730278|NCT00455533|Epothilones|epothilones|mesh-list
101730279|NCT00455533|Cyclophosphamide|cyclophosphamide|mesh-list
101730280|NCT00455533|Doxorubicin|doxorubicin|mesh-list
101730281|NCT00455533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101730282|NCT00455533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101730283|NCT00455533|Tubulin Modulators|tubulin modulators|mesh-ancestor
101730284|NCT00455533|Antimitotic Agents|antimitotic agents|mesh-ancestor
101730285|NCT00455533|Mitosis Modulators|mitosis modulators|mesh-ancestor
101730286|NCT00455533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730287|NCT00455533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101730288|NCT00455533|Immunologic Factors|immunologic factors|mesh-ancestor
101730289|NCT00455533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730290|NCT00455533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101730291|NCT00455533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101730292|NCT00455533|Alkylating Agents|alkylating agents|mesh-ancestor
101730293|NCT00455533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101730294|NCT00455533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101730295|NCT00455533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101730296|NCT00455533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101730297|NCT00455533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101730298|NCT00818584|Micafungin|micafungin|mesh-list
101730299|NCT00818584|Antifungal Agents|antifungal agents|mesh-ancestor
101730300|NCT00818584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101730301|NCT02610530|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101730302|NCT02610530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730303|NCT00923000|Morphine|morphine|mesh-list
101730304|NCT00923000|Nalbuphine|nalbuphine|mesh-list
101730305|NCT00923000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101730306|NCT00923000|Narcotics|narcotics|mesh-ancestor
101730307|NCT00923000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101730308|NCT00923000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730309|NCT00923000|Analgesics|analgesics|mesh-ancestor
101730311|NCT00923000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101730312|NCT01019863|Oxaliplatin|oxaliplatin|mesh-list
101730313|NCT01019863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101730314|NCT00642850|Epoetin Alfa|epoetin alfa|mesh-list
101730315|NCT00642850|Hematinics|hematinics|mesh-ancestor
101730316|NCT00455455|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101730317|NCT00913952|Clomipramine|clomipramine|mesh-list
101730318|NCT00913952|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101730319|NCT00913952|Antidepressive Agents|antidepressive agents|mesh-ancestor
101730320|NCT00913952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101730321|NCT00913952|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101730322|NCT00913952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101730323|NCT00913952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101730324|NCT00913952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730325|NCT00913952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101730326|NCT00913952|Serotonin Agents|serotonin agents|mesh-ancestor
101730327|NCT00913952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730328|NCT04581382|Pembrolizumab|pembrolizumab|mesh-list
101730330|NCT04581382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101730331|NCT04581382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101730332|NCT04581382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101730333|NCT04581382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730334|NCT00818818|Meglumine Antimoniate|meglumine antimoniate|mesh-list
101730335|NCT00818818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101730336|NCT00818818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101730337|NCT00818818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101387809|NCT00090675|Gefitinib|gefitinib|mesh-list
101730338|NCT03840811|Ciprofloxacin|ciprofloxacin|mesh-list
101730340|NCT03840811|Cefixime|cefixime|mesh-list
101730341|NCT03840811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101730342|NCT03840811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101730343|NCT03840811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101730344|NCT03840811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101730345|NCT03840811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101730346|NCT03840811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730347|NCT03840811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101730348|NCT03840811|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101730349|NCT03840811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101730350|NCT00640510|Olanzapine|olanzapine|mesh-list
101730351|NCT00640510|Antiemetics|antiemetics|mesh-ancestor
101730352|NCT00640510|Autonomic Agents|autonomic agents|mesh-ancestor
101730353|NCT00640510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101730354|NCT00640510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730355|NCT00640510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101730356|NCT00640510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101730357|NCT00640510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101806873|NCT00964080|Leucovorin|leucovorin|mesh-list
101730358|NCT00640510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101730359|NCT00640510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101730360|NCT00640510|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101730361|NCT00640510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101730362|NCT00640510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101730363|NCT00640510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730364|NCT00640510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101730365|NCT00640510|Serotonin Agents|serotonin agents|mesh-ancestor
101730366|NCT00913718|Fluoxetine|fluoxetine|mesh-list
101730367|NCT00913718|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101730368|NCT00913718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101730369|NCT00913718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101730370|NCT00913718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730371|NCT00913718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101730372|NCT00913718|Serotonin Agents|serotonin agents|mesh-ancestor
101177963|NCT03462342|Olaparib|olaparib|mesh-list
101730373|NCT00913718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730374|NCT00913718|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101730375|NCT00913718|Antidepressive Agents|antidepressive agents|mesh-ancestor
101730376|NCT00913718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101730377|NCT00913718|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101730378|NCT00913718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101730379|NCT00913718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101730380|NCT00813800|Varenicline|varenicline|mesh-list
101730381|NCT00813800|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101730382|NCT00813800|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101730383|NCT00813800|Cholinergic Agents|cholinergic agents|mesh-ancestor
101730384|NCT00813800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101730385|NCT00813800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730386|NCT00813800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730387|NCT00627016|Dexlansoprazole|dexlansoprazole|mesh-list
101730388|NCT00627016|Lansoprazole|lansoprazole|mesh-list
101730389|NCT00627016|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101730390|NCT00627016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101730391|NCT00627016|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101730392|NCT00627016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101730393|NCT00627016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730394|NCT00794664|Mipomersen|mipomersen|mesh-list
101730395|NCT00794664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101730396|NCT00794664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101730397|NCT00794664|Antimetabolites|antimetabolites|mesh-ancestor
101730398|NCT00794664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730399|NCT00794664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101730400|NCT00444535|Bevacizumab|bevacizumab|mesh-list
101730401|NCT00444535|Lapatinib|lapatinib|mesh-list
101730402|NCT00444535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101730403|NCT00444535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101730404|NCT00444535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101730405|NCT00444535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101730406|NCT00444535|Growth Substances|growth substances|mesh-ancestor
101730407|NCT00444535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730408|NCT00444535|Growth Inhibitors|growth inhibitors|mesh-ancestor
101730409|NCT00444535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101730410|NCT00444535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101730411|NCT00444535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730413|NCT04110288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101730414|NCT04110288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101730415|NCT04110288|Tubulin Modulators|tubulin modulators|mesh-ancestor
101730416|NCT04110288|Antimitotic Agents|antimitotic agents|mesh-ancestor
101730417|NCT04110288|Mitosis Modulators|mitosis modulators|mesh-ancestor
101730418|NCT04110288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730419|NCT00826306|Sunscreening Agents|sunscreening agents|mesh-list
101730420|NCT00826306|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101730421|NCT00826306|Protective Agents|protective agents|mesh-ancestor
101730422|NCT00826306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730423|NCT00826306|Dermatologic Agents|dermatologic agents|mesh-ancestor
101730424|NCT05753852|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
101730425|NCT05753852|Antiviral Agents|antiviral agents|mesh-ancestor
101730426|NCT05753852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101364453|NCT00146926|Analgesics|analgesics|mesh-ancestor
101730427|NCT05753852|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101730428|NCT05753852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101730429|NCT00821782|Azithromycin|azithromycin|mesh-list
101730430|NCT00821782|Levofloxacin|levofloxacin|mesh-list
101730431|NCT00821782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101730432|NCT00821782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101730433|NCT00821782|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101730434|NCT00821782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101730435|NCT00821782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101730436|NCT00821782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101730437|NCT00821782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730438|NCT00821782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101730439|NCT00821782|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101730440|NCT00821782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101730441|NCT00847613|Tofacitinib|tofacitinib|mesh-list
101730442|NCT00847613|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101730443|NCT00847613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101730444|NCT00847613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101730445|NCT00847613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730446|NCT00794196|Antidepressive Agents|antidepressive agents|mesh-list
101730447|NCT00794196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101730448|NCT00807092|Insulin|insulin|mesh-list
101730449|NCT00807092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101730450|NCT00807092|Metformin|metformin|mesh-list
101730451|NCT00807092|Insulin Aspart|insulin aspart|mesh-list
101730452|NCT00807092|Biphasic Insulins|biphasic insulins|mesh-list
101730453|NCT00807092|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101200251|NCT01515306|Ramucirumab|ramucirumab|mesh-list
101730454|NCT00807092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101730455|NCT00807092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730456|NCT04112550|Acetaminophen|acetaminophen|mesh-list
101730457|NCT04112550|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
101730458|NCT04112550|Oxycodone|oxycodone|mesh-list
101730459|NCT04112550|Methadone|methadone|mesh-list
101730460|NCT04112550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101730461|NCT04112550|Analgesics|analgesics|mesh-ancestor
101730462|NCT04112550|Sensory System Agents|sensory system agents|mesh-ancestor
101730463|NCT04112550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101730464|NCT04112550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730465|NCT04112550|Antipyretics|antipyretics|mesh-ancestor
101730466|NCT04112550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101730467|NCT04112550|Narcotics|narcotics|mesh-ancestor
101730468|NCT04112550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101730469|NCT04112550|Antitussive Agents|antitussive agents|mesh-ancestor
101730470|NCT04112550|Respiratory System Agents|respiratory system agents|mesh-ancestor
101730471|NCT04112550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101730472|NCT04112550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101730473|NCT04112550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101730474|NCT00640042|Morphine|morphine|mesh-list
101730475|NCT00640042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101730476|NCT00640042|Narcotics|narcotics|mesh-ancestor
101730477|NCT00640042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101730478|NCT00640042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730479|NCT00640042|Analgesics|analgesics|mesh-ancestor
101730480|NCT00640042|Sensory System Agents|sensory system agents|mesh-ancestor
101200333|NCT00678730|Dronabinol|dronabinol|mesh-list
101730481|NCT00640042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101730482|NCT00807014|Adapalene|adapalene|mesh-list
101730483|NCT00807014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101730484|NCT00807014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101387926|NCT06002646|Chromium|chromium|mesh-list
101730485|NCT00807014|Analgesics|analgesics|mesh-ancestor
101730486|NCT00807014|Sensory System Agents|sensory system agents|mesh-ancestor
101730487|NCT00807014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101730488|NCT00807014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730489|NCT00807014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101730490|NCT00807014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101730491|NCT00807014|Dermatologic Agents|dermatologic agents|mesh-ancestor
101730492|NCT00794040|Methylphenidate|methylphenidate|mesh-list
101730494|NCT00794040|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101730495|NCT00794040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730496|NCT00794040|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101730497|NCT00794040|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101730498|NCT00794040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101178110|NCT01086540|Antipruritics|antipruritics|mesh-ancestor
101730499|NCT00794040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730500|NCT00794040|Dopamine Agents|dopamine agents|mesh-ancestor
101730501|NCT00794040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101730502|NCT00794040|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101730503|NCT00794040|Serotonin Agents|serotonin agents|mesh-ancestor
101730504|NCT00794040|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101730505|NCT00794040|Antidepressive Agents|antidepressive agents|mesh-ancestor
101730506|NCT00794040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101730508|NCT04109742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101730509|NCT04109742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101730510|NCT04109742|Analgesics|analgesics|mesh-ancestor
101730511|NCT04109742|Sensory System Agents|sensory system agents|mesh-ancestor
101730512|NCT04109742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101730513|NCT04109742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730514|NCT04109742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101730515|NCT04109742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101730516|NCT04109742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101730517|NCT04109742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101730518|NCT04109742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730519|NCT00813488|Fentanyl|fentanyl|mesh-list
101730520|NCT00813488|Oxycodone|oxycodone|mesh-list
101730521|NCT00813488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101730522|NCT00813488|Narcotics|narcotics|mesh-ancestor
101730523|NCT00813488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101730524|NCT00813488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730525|NCT00813488|Analgesics|analgesics|mesh-ancestor
101730526|NCT00813488|Sensory System Agents|sensory system agents|mesh-ancestor
101730527|NCT00813488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101730528|NCT00813488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101730529|NCT00813488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101730530|NCT00813488|Anesthetics, General|anesthetics, general|mesh-ancestor
101730531|NCT00813488|Anesthetics|anesthetics|mesh-ancestor
101730532|NCT00797316|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101730533|NCT00797316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101730534|NCT00797316|Diuretics|diuretics|mesh-ancestor
101730535|NCT00797316|Natriuretic Agents|natriuretic agents|mesh-ancestor
101730536|NCT00797316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730537|NCT00797316|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101730538|NCT00797316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101730539|NCT00797316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730540|NCT05640336|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101730541|NCT05640336|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101730542|NCT05640336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101730543|NCT05640336|Antitubercular Agents|antitubercular agents|mesh-ancestor
101730544|NCT05753696|Losartan|losartan|mesh-list
101730545|NCT05753696|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
101730546|NCT05753696|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101730547|NCT05753696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101730548|NCT05753696|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101730549|NCT05753696|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101730550|NCT05753696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730552|NCT04107480|Dopamine Agonists|dopamine agonists|mesh-list
101730553|NCT04107480|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101730554|NCT04107480|Sympathomimetics|sympathomimetics|mesh-ancestor
101730555|NCT04107480|Autonomic Agents|autonomic agents|mesh-ancestor
101730556|NCT04107480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101730557|NCT04107480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730558|NCT04107480|Dopamine Agents|dopamine agents|mesh-ancestor
101730559|NCT04107480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101730560|NCT04107480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730561|NCT04107480|Protective Agents|protective agents|mesh-ancestor
101730562|NCT00915408|Dexamethasone|dexamethasone|mesh-list
101730563|NCT00915408|Cyclophosphamide|cyclophosphamide|mesh-list
101730564|NCT00915408|Lenalidomide|lenalidomide|mesh-list
101730565|NCT00915408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101730566|NCT00915408|Immunologic Factors|immunologic factors|mesh-ancestor
101730567|NCT00915408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730568|NCT00915408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101730569|NCT00915408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101730570|NCT00915408|Alkylating Agents|alkylating agents|mesh-ancestor
101730571|NCT00915408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730572|NCT00915408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101730573|NCT00915408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101730574|NCT00915408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101730575|NCT00915408|Antiemetics|antiemetics|mesh-ancestor
101730576|NCT00915408|Autonomic Agents|autonomic agents|mesh-ancestor
101730577|NCT00915408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101730578|NCT00915408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101730579|NCT00915408|Glucocorticoids|glucocorticoids|mesh-ancestor
101730580|NCT00915408|Hormones|hormones|mesh-ancestor
101730581|NCT00915408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101730582|NCT00915408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101730583|NCT00915408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101730584|NCT00915408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101730585|NCT00915408|Growth Substances|growth substances|mesh-ancestor
101730586|NCT00915408|Growth Inhibitors|growth inhibitors|mesh-ancestor
101730587|NCT00791076|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
101730588|NCT00791076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101730589|NCT00791076|Hormones|hormones|mesh-ancestor
101730590|NCT00791076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101730591|NCT00791076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730592|NCT02610062|AGS67E|ags67e|mesh-list
101730593|NCT02610062|Immunoconjugates|immunoconjugates|mesh-ancestor
101730594|NCT02610062|Immunologic Factors|immunologic factors|mesh-ancestor
101730595|NCT02610062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730596|NCT00625378|Sorafenib|sorafenib|mesh-list
101730597|NCT00625378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101730598|NCT00625378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101730599|NCT00625378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101730600|NCT00625378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730601|NCT00806624|Warfarin|warfarin|mesh-list
101730602|NCT00806624|Edoxaban|edoxaban|mesh-list
101730603|NCT00806624|Anticoagulants|anticoagulants|mesh-ancestor
101730604|NCT00806624|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101730605|NCT00806624|Antithrombins|antithrombins|mesh-ancestor
101730606|NCT00806624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101730607|NCT00806624|Protease Inhibitors|protease inhibitors|mesh-ancestor
101730608|NCT00806624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101730609|NCT00806624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730610|NCT00624832|Omalizumab|omalizumab|mesh-list
101730611|NCT00624832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101730612|NCT00624832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101730613|NCT00624832|Respiratory System Agents|respiratory system agents|mesh-ancestor
101730614|NCT05753150|Primaquine|primaquine|mesh-list
101730615|NCT05753150|Tafenoquine|tafenoquine|mesh-list
101730616|NCT05753150|Antimalarials|antimalarials|mesh-ancestor
101730617|NCT05753150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101730618|NCT05753150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101730619|NCT05753150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101730620|NCT00826852|Carboplatin|carboplatin|mesh-list
101730621|NCT00826852|Docetaxel|docetaxel|mesh-list
101730622|NCT00826852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101730623|NCT00826852|Tubulin Modulators|tubulin modulators|mesh-ancestor
101730624|NCT00826852|Antimitotic Agents|antimitotic agents|mesh-ancestor
101730625|NCT00826852|Mitosis Modulators|mitosis modulators|mesh-ancestor
101730626|NCT00826852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730627|NCT00826930|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
101730628|NCT00826930|Antioxidants|antioxidants|mesh-ancestor
101730629|NCT00826930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730630|NCT00826930|Protective Agents|protective agents|mesh-ancestor
101730631|NCT00826930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730632|NCT00826930|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101730633|NCT00826930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101730634|NCT00913796|Potassium Citrate|potassium citrate|mesh-list
101730635|NCT00913796|Diuretics|diuretics|mesh-ancestor
101730636|NCT00913796|Natriuretic Agents|natriuretic agents|mesh-ancestor
101730637|NCT00913796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730638|NCT00913796|Expectorants|expectorants|mesh-ancestor
101730639|NCT00913796|Respiratory System Agents|respiratory system agents|mesh-ancestor
101730640|NCT00633880|Droxidopa|droxidopa|mesh-list
101730641|NCT00633880|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101730642|NCT00633880|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101730643|NCT04029428|Octreotide|octreotide|mesh-list
101730644|NCT04029428|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
101730645|NCT04029428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101730646|NCT04029428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730647|NCT04029428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101730648|NCT04029428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101730649|NCT04029428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101730650|NCT00819520|Ivermectin|ivermectin|mesh-list
101730651|NCT00819520|Malathion|malathion|mesh-list
101730652|NCT00819520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101730653|NCT00819520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101730654|NCT00819520|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101730655|NCT00819520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101730656|NCT00819520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730657|NCT00819520|Cholinergic Agents|cholinergic agents|mesh-ancestor
101730658|NCT00819520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101730659|NCT00819520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730660|NCT00631696|Pregabalin|pregabalin|mesh-list
101730661|NCT00631696|Analgesics|analgesics|mesh-ancestor
101730662|NCT00631696|Sensory System Agents|sensory system agents|mesh-ancestor
101730663|NCT00631696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101730664|NCT00631696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730665|NCT00631696|Anticonvulsants|anticonvulsants|mesh-ancestor
101730666|NCT00631696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101730667|NCT00631696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101730668|NCT00631696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730669|NCT00631696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101730670|NCT00631696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101730671|NCT00631696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101730672|NCT00631696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101730673|NCT00631696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101730674|NCT02608112|Methotrexate|methotrexate|mesh-list
101730675|NCT02608112|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101730677|NCT02608112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101730678|NCT02608112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730679|NCT02608112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101730680|NCT02608112|Antimetabolites|antimetabolites|mesh-ancestor
101730681|NCT02608112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730683|NCT02608112|Dermatologic Agents|dermatologic agents|mesh-ancestor
101730684|NCT02608112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101730685|NCT02608112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101730686|NCT02608112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101730687|NCT02608112|Immunologic Factors|immunologic factors|mesh-ancestor
101730688|NCT02608112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101730689|NCT02608112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101730690|NCT04375384|Cetuximab|cetuximab|mesh-list
101730691|NCT04375384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101730692|NCT04375384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101730693|NCT02549326|Vitamin D|vitamin d|mesh-list
101730694|NCT02549326|Cholecalciferol|cholecalciferol|mesh-list
101730695|NCT02549326|Vitamins|vitamins|mesh-ancestor
101730696|NCT02549326|Micronutrients|micronutrients|mesh-ancestor
101730697|NCT02549326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730698|NCT02549326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101730699|NCT02549326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101730700|NCT00819676|Nitric Oxide|nitric oxide|mesh-list
101730701|NCT00819676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101730702|NCT00819676|Autonomic Agents|autonomic agents|mesh-ancestor
101730703|NCT00819676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101730704|NCT00819676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730705|NCT00819676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101730706|NCT00819676|Respiratory System Agents|respiratory system agents|mesh-ancestor
101730707|NCT00819676|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101730708|NCT00819676|Antioxidants|antioxidants|mesh-ancestor
101730709|NCT00819676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730711|NCT00819676|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101730712|NCT00819676|Vasodilator Agents|vasodilator agents|mesh-ancestor
101730713|NCT00819676|Gasotransmitters|gasotransmitters|mesh-ancestor
101730714|NCT00819676|Protective Agents|protective agents|mesh-ancestor
101730715|NCT00827320|Levetiracetam|levetiracetam|mesh-list
101730716|NCT00827320|Anticonvulsants|anticonvulsants|mesh-ancestor
101730717|NCT00827320|Nootropic Agents|nootropic agents|mesh-ancestor
101730718|NCT00819754|Bevacizumab|bevacizumab|mesh-list
101730719|NCT00819754|Capecitabine|capecitabine|mesh-list
101730720|NCT00819754|Oxaliplatin|oxaliplatin|mesh-list
101730721|NCT00819754|Irinotecan|irinotecan|mesh-list
101730722|NCT00819754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101730723|NCT00819754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101730724|NCT00819754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101364475|NCT00147121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101730725|NCT00819754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101730726|NCT00819754|Growth Substances|growth substances|mesh-ancestor
101730727|NCT00819754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730728|NCT00819754|Growth Inhibitors|growth inhibitors|mesh-ancestor
101730729|NCT00819754|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101730730|NCT00819754|Antimetabolites|antimetabolites|mesh-ancestor
101730731|NCT00819754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730732|NCT00819754|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101730733|NCT00819754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101730734|NCT00819754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101730735|NCT00819988|Pregabalin|pregabalin|mesh-list
101730736|NCT00819988|Analgesics|analgesics|mesh-ancestor
101730737|NCT00819988|Sensory System Agents|sensory system agents|mesh-ancestor
101730738|NCT00819988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101730739|NCT00819988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730740|NCT00819988|Anticonvulsants|anticonvulsants|mesh-ancestor
101200626|NCT01398722|Insulin|insulin|mesh-list
101730741|NCT00819988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101730742|NCT00819988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101730743|NCT00819988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730744|NCT00819988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101730746|NCT00819988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101730747|NCT00819988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101730748|NCT00819988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101730750|NCT00827554|Anticoagulants|anticoagulants|mesh-ancestor
101730751|NCT00827554|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101730752|NCT00827554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101730753|NCT00827554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730755|NCT00847145|Immunologic Factors|immunologic factors|mesh-ancestor
101730756|NCT00847145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730757|NCT00701597|Bosentan|bosentan|mesh-list
101730758|NCT00701597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101730759|NCT00701597|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101730760|NCT00701597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730761|NCT00700193|Vaccines|vaccines|mesh-list
101730762|NCT00700193|Immunologic Factors|immunologic factors|mesh-ancestor
101730763|NCT00700193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730764|NCT00846521|Acarbose|acarbose|mesh-list
101730765|NCT00846521|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101730766|NCT00846521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101730767|NCT00846521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730768|NCT00846521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101730769|NCT00846521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730770|NCT00698945|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101730771|NCT00698945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101730772|NCT00698945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101730773|NCT00698945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101730774|NCT00698945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101730775|NCT00698945|Adrenergic Agents|adrenergic agents|mesh-ancestor
101730776|NCT00698945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101730777|NCT00698945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730778|NCT00698945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730779|NCT00862823|Tenofovir|tenofovir|mesh-list
101730780|NCT00862823|Emtricitabine|emtricitabine|mesh-list
101730781|NCT00862823|Efavirenz|efavirenz|mesh-list
101730782|NCT00862823|Antiviral Agents|antiviral agents|mesh-ancestor
101730783|NCT00862823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101388219|NCT06000137|Flurbiprofen|flurbiprofen|mesh-list
101730784|NCT00862823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101730785|NCT00862823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101730786|NCT00862823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101730787|NCT00862823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730788|NCT00862823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101730789|NCT00862823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101730790|NCT00862823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101730791|NCT00862823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101730792|NCT00862823|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101730793|NCT00862823|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101730794|NCT00862823|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101730795|NCT00862823|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101730796|NCT00790842|Dexamethasone|dexamethasone|mesh-list
101730797|NCT00790842|Lenalidomide|lenalidomide|mesh-list
101730798|NCT00790842|Heparin|heparin|mesh-list
101730799|NCT00790842|Calcium heparin|calcium heparin|mesh-list
101730800|NCT00790842|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101730801|NCT00790842|Tinzaparin|tinzaparin|mesh-list
101730802|NCT00790842|Dalteparin|dalteparin|mesh-list
101730803|NCT00790842|Anticoagulants|anticoagulants|mesh-list
101730804|NCT00790842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101730805|NCT00790842|Antiemetics|antiemetics|mesh-ancestor
101730806|NCT00790842|Autonomic Agents|autonomic agents|mesh-ancestor
101730807|NCT00790842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101730808|NCT00790842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730809|NCT00790842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101730810|NCT00790842|Glucocorticoids|glucocorticoids|mesh-ancestor
101730811|NCT00790842|Hormones|hormones|mesh-ancestor
101730812|NCT00790842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101730813|NCT00790842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101730814|NCT00790842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101730815|NCT00790842|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101730816|NCT00790842|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101730817|NCT00790842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730818|NCT00790842|Immunologic Factors|immunologic factors|mesh-ancestor
101730819|NCT00790842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101730820|NCT00790842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101730821|NCT00790842|Growth Substances|growth substances|mesh-ancestor
101730822|NCT00790842|Growth Inhibitors|growth inhibitors|mesh-ancestor
101730824|NCT04104204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101730825|NCT04104204|Narcotics|narcotics|mesh-ancestor
101730826|NCT04104204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101730827|NCT04104204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730828|NCT04104204|Analgesics|analgesics|mesh-ancestor
101730829|NCT04104204|Sensory System Agents|sensory system agents|mesh-ancestor
101730830|NCT04104204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101730831|NCT05572476|Carboplatin|carboplatin|mesh-list
101730833|NCT05572476|Durvalumab|durvalumab|mesh-list
101730834|NCT05572476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101730835|NCT05572476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101730836|NCT05572476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101730837|NCT05572476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101730838|NCT05572476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101730839|NCT05572476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730840|NCT05572476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101730841|NCT00574288|Dexamethasone|dexamethasone|mesh-list
101730842|NCT00574288|Methylprednisolone|methylprednisolone|mesh-list
101730843|NCT00574288|Daratumumab|daratumumab|mesh-list
101730844|NCT00574288|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101730845|NCT00574288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101730846|NCT00574288|Antiemetics|antiemetics|mesh-ancestor
101730847|NCT00574288|Autonomic Agents|autonomic agents|mesh-ancestor
101730848|NCT00574288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101730849|NCT00574288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730850|NCT00574288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101730851|NCT00574288|Glucocorticoids|glucocorticoids|mesh-ancestor
101730852|NCT00574288|Hormones|hormones|mesh-ancestor
101730853|NCT00574288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101730854|NCT00574288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101730855|NCT00574288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101730856|NCT00574288|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101388296|NCT05999942|Amikacin|amikacin|mesh-list
101730857|NCT00574288|Protective Agents|protective agents|mesh-ancestor
101730858|NCT00574288|Immunologic Factors|immunologic factors|mesh-ancestor
101730859|NCT00790452|Aspirin|aspirin|mesh-list
101730860|NCT00790452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101730861|NCT00790452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101730862|NCT00790452|Analgesics|analgesics|mesh-ancestor
101730863|NCT00790452|Sensory System Agents|sensory system agents|mesh-ancestor
101730864|NCT00790452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101730865|NCT00790452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730866|NCT00790452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101730867|NCT00790452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101730868|NCT00790452|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101730869|NCT00790452|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101730870|NCT00790452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730871|NCT00790452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101730872|NCT00790452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101730873|NCT00790452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101730874|NCT00790452|Antipyretics|antipyretics|mesh-ancestor
101730875|NCT00823030|Lidocaine|lidocaine|mesh-list
101730877|NCT00823030|Anesthetics|anesthetics|mesh-ancestor
101730878|NCT00823030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101730879|NCT00823030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730880|NCT00823030|Sensory System Agents|sensory system agents|mesh-ancestor
101730881|NCT00823030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101730882|NCT00823030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101730883|NCT00823030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101730884|NCT00823030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101730885|NCT00823030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101730886|NCT00823030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730888|NCT00823186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101730889|NCT00823186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101730890|NCT00823186|Tubulin Modulators|tubulin modulators|mesh-ancestor
101730891|NCT00823186|Antimitotic Agents|antimitotic agents|mesh-ancestor
101730892|NCT00823186|Mitosis Modulators|mitosis modulators|mesh-ancestor
101730893|NCT00823186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730894|NCT00626392|Aspirin|aspirin|mesh-list
101730896|NCT00626392|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101730897|NCT00626392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101730898|NCT00626392|Analgesics|analgesics|mesh-ancestor
101730899|NCT00626392|Sensory System Agents|sensory system agents|mesh-ancestor
101730900|NCT00626392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101730901|NCT00626392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730902|NCT00626392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101730903|NCT00626392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101730904|NCT00626392|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101730905|NCT00626392|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101730906|NCT00626392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730907|NCT00626392|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101730908|NCT00626392|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101730909|NCT00626392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101730910|NCT00626392|Antipyretics|antipyretics|mesh-ancestor
101730911|NCT00626392|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101730912|NCT00626392|Antimetabolites|antimetabolites|mesh-ancestor
101730913|NCT00626392|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101730914|NCT00626392|Vasodilator Agents|vasodilator agents|mesh-ancestor
101730915|NCT00626392|Vitamin B Complex|vitamin b complex|mesh-ancestor
101730916|NCT00626392|Vitamins|vitamins|mesh-ancestor
101730917|NCT00626392|Micronutrients|micronutrients|mesh-ancestor
101730918|NCT00820690|Paclitaxel|paclitaxel|mesh-list
101730919|NCT00820690|Cyclophosphamide|cyclophosphamide|mesh-list
101730920|NCT00820690|Doxorubicin|doxorubicin|mesh-list
101730921|NCT00820690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101200763|NCT01400165|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101730922|NCT00820690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101730923|NCT00820690|Tubulin Modulators|tubulin modulators|mesh-ancestor
101730924|NCT00820690|Antimitotic Agents|antimitotic agents|mesh-ancestor
101730925|NCT00820690|Mitosis Modulators|mitosis modulators|mesh-ancestor
101730926|NCT00820690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730927|NCT00820690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101730928|NCT00820690|Immunologic Factors|immunologic factors|mesh-ancestor
101730929|NCT00820690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730930|NCT00820690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101730931|NCT00820690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101388388|NCT05999383|Nicotine|nicotine|mesh-list
101730932|NCT00820690|Alkylating Agents|alkylating agents|mesh-ancestor
101730933|NCT00820690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101730934|NCT00820690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101730935|NCT00820690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101730936|NCT00820690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101730937|NCT00820690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101730938|NCT00820768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101730939|NCT00820768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101730940|NCT00624052|Amlodipine|amlodipine|mesh-list
101730941|NCT00624052|Telmisartan|telmisartan|mesh-list
101730942|NCT00624052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101806958|NCT00746681|Anticonvulsants|anticonvulsants|mesh-ancestor
101730943|NCT00624052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101730944|NCT00624052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101730945|NCT00624052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730946|NCT00624052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101730947|NCT00624052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730948|NCT00624052|Vasodilator Agents|vasodilator agents|mesh-ancestor
101730949|NCT00624052|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101730950|NCT00624052|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101730951|NCT00821080|Sirolimus|sirolimus|mesh-list
101730952|NCT00821080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101730953|NCT00821080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101730954|NCT00821080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101730955|NCT00821080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101730956|NCT00821080|Antifungal Agents|antifungal agents|mesh-ancestor
101730957|NCT00821080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101730958|NCT00821080|Immunologic Factors|immunologic factors|mesh-ancestor
101730959|NCT00821080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730960|NCT04044430|Nivolumab|nivolumab|mesh-list
101730961|NCT04044430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101730962|NCT04044430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101730963|NCT04044430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101730964|NCT04044430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730966|NCT00821158|Antioxidants|antioxidants|mesh-list
101730967|NCT00821158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730968|NCT00821158|Protective Agents|protective agents|mesh-ancestor
101730969|NCT00821158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730970|NCT00828646|BMS 708163|bms 708163|mesh-list
101730971|NCT00828646|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101730972|NCT00828646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101730973|NCT00828646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730974|NCT02548936|Simvastatin|simvastatin|mesh-list
101730975|NCT02548936|Ezetimibe|ezetimibe|mesh-list
101730976|NCT02548936|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
101730977|NCT02548936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101730978|NCT02548936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101730979|NCT02548936|Antimetabolites|antimetabolites|mesh-ancestor
101730980|NCT02548936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730981|NCT02548936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101730982|NCT02548936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101730983|NCT02548936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101730984|NCT00828802|Lenalidomide|lenalidomide|mesh-list
101730985|NCT00828802|Decitabine|decitabine|mesh-list
101730986|NCT00828802|Immunologic Factors|immunologic factors|mesh-ancestor
101730987|NCT00828802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101730988|NCT00828802|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101730989|NCT00828802|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101730990|NCT00828802|Growth Substances|growth substances|mesh-ancestor
101730991|NCT00828802|Growth Inhibitors|growth inhibitors|mesh-ancestor
101730992|NCT00828802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101730993|NCT00828802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101730994|NCT00828802|Antimetabolites|antimetabolites|mesh-ancestor
101200838|NCT01400685|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101200840|NCT01400685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101730995|NCT00828802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101730997|NCT00785577|Pregabalin|pregabalin|mesh-list
101730998|NCT00785577|Analgesics|analgesics|mesh-ancestor
101730999|NCT00785577|Sensory System Agents|sensory system agents|mesh-ancestor
101731000|NCT00785577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101731001|NCT00785577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731002|NCT00785577|Anticonvulsants|anticonvulsants|mesh-ancestor
101731003|NCT00785577|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101731004|NCT00785577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101731005|NCT00785577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731006|NCT00785577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101731007|NCT00785577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101731008|NCT00785577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101731009|NCT00785577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101731010|NCT00785577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101731011|NCT00830830|Hyaluronic Acid|hyaluronic acid|mesh-list
101364486|NCT04732104|Anesthetics|anesthetics|mesh-ancestor
101731012|NCT00830830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101731013|NCT00830830|Immunologic Factors|immunologic factors|mesh-ancestor
101731014|NCT00830830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731015|NCT00830830|Viscosupplements|viscosupplements|mesh-ancestor
101731016|NCT00830830|Protective Agents|protective agents|mesh-ancestor
101731017|NCT00828958|Risperidone|risperidone|mesh-list
101731018|NCT00828958|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101731019|NCT00828958|Serotonin Agents|serotonin agents|mesh-ancestor
101731020|NCT00828958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101731021|NCT00828958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731022|NCT00828958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731023|NCT00828958|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101731024|NCT00828958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101731025|NCT00828958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101731026|NCT00828958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101731027|NCT00828958|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101731028|NCT00828958|Dopamine Agents|dopamine agents|mesh-ancestor
101731029|NCT02548780|Doxorubicin|doxorubicin|mesh-list
101731030|NCT02548780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101731031|NCT02548780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101731032|NCT02548780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101731033|NCT02548780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101731034|NCT02548780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101731035|NCT02548780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731037|NCT04105023|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101731038|NCT04105023|Protective Agents|protective agents|mesh-ancestor
101731039|NCT04105023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731040|NCT04105023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101731041|NCT04105023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101731042|NCT04105023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101731043|NCT04105023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731044|NCT04105023|Phytoestrogens|phytoestrogens|mesh-ancestor
101731045|NCT04105023|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101731046|NCT04105023|Estrogens|estrogens|mesh-ancestor
101731047|NCT04105023|Hormones|hormones|mesh-ancestor
101731048|NCT04105023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101731049|NCT04104867|Domperidone|domperidone|mesh-list
101731050|NCT04104867|Antiemetics|antiemetics|mesh-ancestor
101731051|NCT04104867|Autonomic Agents|autonomic agents|mesh-ancestor
101731052|NCT04104867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101731053|NCT04104867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731054|NCT04104867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101731055|NCT04104867|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101731056|NCT04104867|Dopamine Agents|dopamine agents|mesh-ancestor
101731057|NCT04104867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101731058|NCT04104867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731059|NCT00789828|Everolimus|everolimus|mesh-list
101731060|NCT00789828|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101731061|NCT00789828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101731062|NCT00789828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101731063|NCT00789828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200916|NCT01401036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731064|NCT00789828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101731065|NCT00789828|Immunologic Factors|immunologic factors|mesh-ancestor
101731066|NCT00789828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731067|NCT00789828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101731069|NCT02550262|Bupivacaine|bupivacaine|mesh-list
101731070|NCT02550262|Anesthetics, Local|anesthetics, local|mesh-ancestor
101731071|NCT02550262|Anesthetics|anesthetics|mesh-ancestor
101731072|NCT02550262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101731073|NCT02550262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731074|NCT02550262|Sensory System Agents|sensory system agents|mesh-ancestor
101200964|NCT01401491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731075|NCT02550262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101731076|NCT02550262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101731077|NCT02550262|Narcotics|narcotics|mesh-ancestor
101731078|NCT02550262|Analgesics|analgesics|mesh-ancestor
101731079|NCT02550262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101731080|NCT02550262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101731081|NCT02550262|Anesthetics, General|anesthetics, general|mesh-ancestor
101731082|NCT02550418|Budesonide|budesonide|mesh-list
101731083|NCT02550418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101731084|NCT02550418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101731085|NCT02550418|Autonomic Agents|autonomic agents|mesh-ancestor
101731086|NCT02550418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101731087|NCT02550418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731088|NCT02550418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101731089|NCT02550418|Respiratory System Agents|respiratory system agents|mesh-ancestor
101731090|NCT02550418|Glucocorticoids|glucocorticoids|mesh-ancestor
101731091|NCT02550418|Hormones|hormones|mesh-ancestor
101731092|NCT02550418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101731093|NCT00829114|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101731095|NCT00829114|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101731096|NCT00829114|Estradiol|estradiol|mesh-list
101731097|NCT00829114|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101731098|NCT00829114|Estrogens|estrogens|mesh-ancestor
101731099|NCT00829114|Hormones|hormones|mesh-ancestor
101731100|NCT00829114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101731101|NCT00829114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731102|NCT00829114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101731103|NCT00829114|Contraceptive Agents|contraceptive agents|mesh-ancestor
101731104|NCT00829114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101731105|NCT00829114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101731106|NCT00829114|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101731107|NCT00829114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101731108|NCT00790296|Hormones|hormones|mesh-list
101731109|NCT00790296|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
101731110|NCT00790296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101731111|NCT00790296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731112|NCT00829192|Afamelanotide|afamelanotide|mesh-list
101731114|NCT00623194|Insulin|insulin|mesh-list
101731115|NCT00623194|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101731116|NCT00623194|Insulin Aspart|insulin aspart|mesh-list
101731117|NCT00623194|Insulin Detemir|insulin detemir|mesh-list
101731118|NCT00623194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101201009|NCT01402024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101731119|NCT00623194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731120|NCT00784368|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101731121|NCT02548468|Mycophenolic Acid|mycophenolic acid|mesh-list
101731122|NCT02548468|Cyclophosphamide|cyclophosphamide|mesh-list
101731123|NCT02548468|Fludarabine|fludarabine|mesh-list
101731124|NCT02548468|Fludarabine phosphate|fludarabine phosphate|mesh-list
101731125|NCT02548468|Tacrolimus|tacrolimus|mesh-list
101731126|NCT02548468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101731127|NCT02548468|Immunologic Factors|immunologic factors|mesh-ancestor
101731128|NCT02548468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731129|NCT02548468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101731130|NCT02548468|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101731131|NCT02548468|Alkylating Agents|alkylating agents|mesh-ancestor
101731132|NCT02548468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731133|NCT02548468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101731134|NCT02548468|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101731135|NCT02548468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101731136|NCT02548468|Antimetabolites|antimetabolites|mesh-ancestor
101731137|NCT02548468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101731138|NCT02548468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101731139|NCT02548468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101731140|NCT02548468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101731141|NCT02548468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101731142|NCT02548468|Antitubercular Agents|antitubercular agents|mesh-ancestor
101731143|NCT02548468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101731144|NCT00829660|Acarbose|acarbose|mesh-list
101731145|NCT00829660|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101731146|NCT00829660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101731147|NCT00829660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731148|NCT00829660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101731149|NCT00829660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731150|NCT00915564|Simeprevir|simeprevir|mesh-list
101731151|NCT00915564|Methadone|methadone|mesh-list
101731152|NCT00915564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101731153|NCT00915564|Narcotics|narcotics|mesh-ancestor
101731154|NCT00915564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101731155|NCT00915564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731156|NCT00915564|Analgesics|analgesics|mesh-ancestor
101731157|NCT00915564|Sensory System Agents|sensory system agents|mesh-ancestor
101731158|NCT00915564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101731159|NCT00915564|Antitussive Agents|antitussive agents|mesh-ancestor
101731160|NCT00915564|Respiratory System Agents|respiratory system agents|mesh-ancestor
101731161|NCT00915564|Antiviral Agents|antiviral agents|mesh-ancestor
101201068|NCT01402193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101731162|NCT00915564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101731164|NCT00915564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101731165|NCT00915564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731166|NCT02603406|Epoetin Alfa|epoetin alfa|mesh-list
101731167|NCT02603406|Hematinics|hematinics|mesh-ancestor
101731168|NCT04106700|Apixaban|apixaban|mesh-list
101731169|NCT04106700|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101731170|NCT04106700|Antithrombins|antithrombins|mesh-ancestor
101731171|NCT04106700|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101731172|NCT04106700|Protease Inhibitors|protease inhibitors|mesh-ancestor
101731173|NCT04106700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101731174|NCT04106700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731175|NCT04106700|Anticoagulants|anticoagulants|mesh-ancestor
101731176|NCT00831376|Albuterol|albuterol|mesh-list
101731177|NCT00831376|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101731178|NCT00831376|Autonomic Agents|autonomic agents|mesh-ancestor
101731179|NCT00831376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101731180|NCT00831376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731181|NCT00831376|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101731182|NCT00831376|Respiratory System Agents|respiratory system agents|mesh-ancestor
101731183|NCT00831376|Tocolytic Agents|tocolytic agents|mesh-ancestor
101731184|NCT00831376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101731185|NCT00831376|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101731186|NCT00831376|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101731187|NCT00831376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101731188|NCT00831376|Adrenergic Agents|adrenergic agents|mesh-ancestor
101731190|NCT00831376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731191|NCT02602470|Metronidazole|metronidazole|mesh-list
101731192|NCT02602470|Azelaic acid|azelaic acid|mesh-list
101731193|NCT02602470|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101731194|NCT02602470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101731195|NCT02602470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101731196|NCT02602470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101731197|NCT02602470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101731198|NCT02602470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101731199|NCT02602470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101731200|NCT02602470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101731201|NCT02602470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101731202|NCT02602470|Adrenergic Agents|adrenergic agents|mesh-ancestor
101731203|NCT02602470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101731204|NCT02602470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731205|NCT02602470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201124|NCT01402596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101201129|NCT01402596|Anesthetics|anesthetics|mesh-ancestor
101731206|NCT02602470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101731207|NCT02602470|Dermatologic Agents|dermatologic agents|mesh-ancestor
101731208|NCT00824200|Tamsulosin|tamsulosin|mesh-list
101731209|NCT00824200|Adrenergic Agents|adrenergic agents|mesh-list
101731210|NCT00824200|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
101731211|NCT00824200|Adrenergic Antagonists|adrenergic antagonists|mesh-list
101731212|NCT00824200|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101731213|NCT00824200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101731214|NCT00824200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731215|NCT00824200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731216|NCT00824200|Urological Agents|urological agents|mesh-ancestor
101731217|NCT00829894|Risperidone|risperidone|mesh-list
101731218|NCT00829894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101731219|NCT00829894|Serotonin Agents|serotonin agents|mesh-ancestor
101731220|NCT00829894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101731221|NCT00829894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731222|NCT00829894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731223|NCT00829894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101731224|NCT00829894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101731225|NCT00829894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101731226|NCT00829894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101731227|NCT00829894|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101731228|NCT00829894|Dopamine Agents|dopamine agents|mesh-ancestor
101731229|NCT00622726|Bevacizumab|bevacizumab|mesh-list
101731230|NCT00622726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101388664|NCT05997303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101731231|NCT00622726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101731232|NCT00622726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101731233|NCT00622726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101731234|NCT00622726|Growth Substances|growth substances|mesh-ancestor
101731235|NCT00622726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731236|NCT00622726|Growth Inhibitors|growth inhibitors|mesh-ancestor
101731237|NCT00830050|Naproxen|naproxen|mesh-list
101731238|NCT00830050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101731239|NCT00830050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101731240|NCT00830050|Analgesics|analgesics|mesh-ancestor
101731241|NCT00830050|Sensory System Agents|sensory system agents|mesh-ancestor
101731242|NCT00830050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101731243|NCT00830050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731244|NCT00830050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101731245|NCT00830050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101731246|NCT00830050|Gout Suppressants|gout suppressants|mesh-ancestor
101731247|NCT00830050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101731248|NCT00830050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101731249|NCT00830050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731250|NCT00623428|Ribavirin|ribavirin|mesh-list
101731251|NCT00623428|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101731252|NCT00623428|Antimetabolites|antimetabolites|mesh-ancestor
101731253|NCT00623428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731254|NCT00623428|Antiviral Agents|antiviral agents|mesh-ancestor
101731255|NCT00623428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101731256|NCT00824668|Insulin|insulin|mesh-list
101731257|NCT00824668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101731258|NCT00824668|Insulin Glargine|insulin glargine|mesh-list
101731259|NCT00824668|Insulin Aspart|insulin aspart|mesh-list
101731260|NCT00824668|Biphasic Insulins|biphasic insulins|mesh-list
101731261|NCT00824668|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101731262|NCT00824668|Insulin glulisine|insulin glulisine|mesh-list
101731263|NCT00824668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101731264|NCT00824668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731265|NCT00832234|Dexamethasone|dexamethasone|mesh-list
101731266|NCT00832234|Rituximab|rituximab|mesh-list
101731267|NCT00832234|Bortezomib|bortezomib|mesh-list
101731268|NCT00832234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101731269|NCT00832234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101731270|NCT00832234|Immunologic Factors|immunologic factors|mesh-ancestor
101731271|NCT00832234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731272|NCT00832234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101731273|NCT00832234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101731274|NCT00832234|Antiemetics|antiemetics|mesh-ancestor
101731275|NCT00832234|Autonomic Agents|autonomic agents|mesh-ancestor
101731276|NCT00832234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101731277|NCT00832234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101731278|NCT00832234|Glucocorticoids|glucocorticoids|mesh-ancestor
101731279|NCT00832234|Hormones|hormones|mesh-ancestor
101731280|NCT00832234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101731281|NCT00832234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101731282|NCT05036980|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
101731283|NCT05036980|Antioxidants|antioxidants|mesh-ancestor
101731284|NCT05036980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731285|NCT05036980|Protective Agents|protective agents|mesh-ancestor
101731286|NCT05036980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731287|NCT05036980|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101731288|NCT05036980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101731289|NCT00837850|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
101731290|NCT00837850|Vasodilator Agents|vasodilator agents|mesh-ancestor
101731291|NCT00837850|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101731292|NCT00837850|Protective Agents|protective agents|mesh-ancestor
101731293|NCT00837850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731294|NCT00784134|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101731295|NCT00784134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101731296|NCT00784134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101731297|NCT00784134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731298|NCT00837928|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101731299|NCT00837928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101731300|NCT00837928|Alkylating Agents|alkylating agents|mesh-ancestor
101731301|NCT00837928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731302|NCT00837928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101731303|NCT04102566|Ibuprofen|ibuprofen|mesh-list
101731304|NCT04102566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101731305|NCT04102566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101388747|NCT05996588|Propofol|propofol|mesh-list
101731307|NCT04102566|Sensory System Agents|sensory system agents|mesh-ancestor
101731308|NCT04102566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101731309|NCT04102566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731310|NCT04102566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101731311|NCT04102566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101731312|NCT04102566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101731313|NCT04102566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101731314|NCT04102566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731315|NCT04102176|Tin Fluorides|tin fluorides|mesh-list
101731316|NCT04102176|Cariostatic Agents|cariostatic agents|mesh-ancestor
101731317|NCT04102176|Protective Agents|protective agents|mesh-ancestor
101731318|NCT04102176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731319|NCT00783432|Azelastine|azelastine|mesh-list
101731320|NCT00783432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101731321|NCT00783432|Autonomic Agents|autonomic agents|mesh-ancestor
101731322|NCT00783432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101731323|NCT00783432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731324|NCT00783432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101731325|NCT00783432|Respiratory System Agents|respiratory system agents|mesh-ancestor
101731326|NCT00783432|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101731327|NCT00783432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101731328|NCT00783432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731329|NCT00783432|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101731330|NCT00783432|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101731331|NCT00783432|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101731332|NCT00783432|Histamine Antagonists|histamine antagonists|mesh-ancestor
101731333|NCT00783432|Histamine Agents|histamine agents|mesh-ancestor
101731334|NCT00783432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101731335|NCT00789360|Loxapine|loxapine|mesh-list
101731336|NCT00789360|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101731337|NCT00789360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101731338|NCT00789360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101731339|NCT00789360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731340|NCT00789360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101731341|NCT00789360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101731342|NCT00789360|Dopamine Agents|dopamine agents|mesh-ancestor
101731343|NCT00789360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101731344|NCT00789360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731345|NCT05526924|Fluorouracil|fluorouracil|mesh-list
101731346|NCT05526924|Tislelizumab|tislelizumab|mesh-list
101731347|NCT05526924|Hydroxyurea|hydroxyurea|mesh-list
101201305|NCT01403740|Azathioprine|azathioprine|mesh-list
101731348|NCT05526924|Pamiparib|pamiparib|mesh-list
101731349|NCT05526924|Antimetabolites|antimetabolites|mesh-ancestor
101731350|NCT05526924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731351|NCT05526924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101731352|NCT05526924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101731353|NCT05526924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101731354|NCT05526924|Immunologic Factors|immunologic factors|mesh-ancestor
101731355|NCT05526924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731356|NCT05526924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101731357|NCT05526924|Antisickling Agents|antisickling agents|mesh-ancestor
101731358|NCT05526924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101731359|NCT05526924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101731360|NCT05526924|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101731361|NCT00782418|Exenatide|exenatide|mesh-list
101731362|NCT00782418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101731363|NCT00782418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731364|NCT00782418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101731365|NCT00782418|Incretins|incretins|mesh-ancestor
101731366|NCT00782418|Hormones|hormones|mesh-ancestor
101731367|NCT00782418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101731368|NCT00782340|Droxidopa|droxidopa|mesh-list
101731369|NCT00782340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101731370|NCT00782340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101731371|NCT00774852|Prednisone|prednisone|mesh-list
101731372|NCT00774852|Cyclophosphamide|cyclophosphamide|mesh-list
101731373|NCT00774852|Abatacept|abatacept|mesh-list
101731374|NCT00774852|Azathioprine|azathioprine|mesh-list
101731375|NCT00774852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101731376|NCT00774852|Immunologic Factors|immunologic factors|mesh-ancestor
101731377|NCT00774852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731378|NCT00774852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101731379|NCT00774852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101731380|NCT00774852|Alkylating Agents|alkylating agents|mesh-ancestor
101731381|NCT00774852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731382|NCT00774852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101731383|NCT00774852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101731384|NCT00774852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101731385|NCT00774852|Glucocorticoids|glucocorticoids|mesh-ancestor
101731386|NCT00774852|Hormones|hormones|mesh-ancestor
101731387|NCT00774852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101731388|NCT00774852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101731389|NCT00774852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101731390|NCT00774852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101201347|NCT01404013|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101731391|NCT00774852|Antimetabolites|antimetabolites|mesh-ancestor
101731392|NCT00774852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101731393|NCT00774306|Phenytoin|phenytoin|mesh-list
101731394|NCT00774306|Levetiracetam|levetiracetam|mesh-list
101731395|NCT00774306|Valproic Acid|valproic acid|mesh-list
101731396|NCT00774306|Anticonvulsants|anticonvulsants|mesh-ancestor
101731397|NCT00774306|Nootropic Agents|nootropic agents|mesh-ancestor
101731398|NCT00774306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101731399|NCT00774306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731400|NCT00774306|GABA Agents|gaba agents|mesh-ancestor
101731401|NCT00774306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101731402|NCT00774306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731403|NCT00774306|Antimanic Agents|antimanic agents|mesh-ancestor
101731404|NCT00774306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101731405|NCT00774306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101731406|NCT00774306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101731407|NCT00774306|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101731408|NCT00774306|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101731409|NCT00774306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101731410|NCT00774306|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101731411|NCT00774306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101731412|NCT04105920|Hyaluronic Acid|hyaluronic acid|mesh-list
101731413|NCT04105920|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101731414|NCT04105920|Immunologic Factors|immunologic factors|mesh-ancestor
101731415|NCT04105920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731416|NCT04105920|Viscosupplements|viscosupplements|mesh-ancestor
101731417|NCT04105920|Protective Agents|protective agents|mesh-ancestor
101731418|NCT04105764|Bromides|bromides|mesh-list
101731419|NCT04105764|Rocuronium|rocuronium|mesh-list
101731420|NCT04105764|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
101731421|NCT04105764|Anticonvulsants|anticonvulsants|mesh-ancestor
101731422|NCT04105764|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101731423|NCT04105764|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101731424|NCT04105764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101731425|NCT04105764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731426|NCT00781326|Nimodipine|nimodipine|mesh-list
101731427|NCT00781326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101731428|NCT00781326|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101731429|NCT00781326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101731430|NCT00781326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731431|NCT00781326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101731432|NCT00781326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731433|NCT00781326|Vasodilator Agents|vasodilator agents|mesh-ancestor
101731434|NCT00773838|Dexamethasone|dexamethasone|mesh-list
101731435|NCT00773838|Bortezomib|bortezomib|mesh-list
101731436|NCT00773838|Vorinostat|vorinostat|mesh-list
101731437|NCT00773838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101731438|NCT00773838|Antiemetics|antiemetics|mesh-ancestor
101731439|NCT00773838|Autonomic Agents|autonomic agents|mesh-ancestor
101731440|NCT00773838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101731441|NCT00773838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731442|NCT00773838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101731443|NCT00773838|Glucocorticoids|glucocorticoids|mesh-ancestor
101731444|NCT00773838|Hormones|hormones|mesh-ancestor
101731445|NCT00773838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101731446|NCT00773838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101731447|NCT00773838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101731448|NCT00773838|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101731449|NCT00773838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101731450|NCT00773838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731451|NCT00787644|Pioglitazone|pioglitazone|mesh-list
101731452|NCT00787644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101731453|NCT00787644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731454|NCT02602002|Remifentanil|remifentanil|mesh-list
101731455|NCT02602002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101731456|NCT02602002|Narcotics|narcotics|mesh-ancestor
101731457|NCT02602002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101731458|NCT02602002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731459|NCT02602002|Analgesics|analgesics|mesh-ancestor
101731460|NCT02602002|Sensory System Agents|sensory system agents|mesh-ancestor
101731461|NCT02602002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101731462|NCT00787566|Granisetron|granisetron|mesh-list
101731463|NCT00787566|Antiemetics|antiemetics|mesh-ancestor
101731464|NCT00787566|Autonomic Agents|autonomic agents|mesh-ancestor
101731465|NCT00787566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101731466|NCT00787566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731467|NCT00787566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101731468|NCT00787566|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101731469|NCT00787566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101731470|NCT00787566|Serotonin Agents|serotonin agents|mesh-ancestor
101731471|NCT00787566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101731472|NCT00787566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731474|NCT02602938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101731475|NCT02602938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101731476|NCT02602938|Analgesics|analgesics|mesh-ancestor
101731477|NCT02602938|Sensory System Agents|sensory system agents|mesh-ancestor
101731478|NCT02602938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101731479|NCT02602938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731480|NCT02602938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101731481|NCT02602938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101731482|NCT02602938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101731483|NCT02602938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101731484|NCT02602938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731485|NCT02602938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101731486|NCT02602938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101731487|NCT02602938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101731488|NCT02602938|Antipyretics|antipyretics|mesh-ancestor
101731489|NCT00787254|Lansoprazole|lansoprazole|mesh-list
101731490|NCT00787254|Dexlansoprazole|dexlansoprazole|mesh-list
101731491|NCT00787254|Gefarnate|gefarnate|mesh-list
101731492|NCT00787254|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101731493|NCT00787254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101731494|NCT00787254|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101731495|NCT00787254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101731496|NCT00787254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731497|NCT00922402|Insulin|insulin|mesh-list
101731498|NCT00922402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101731499|NCT00922402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731500|NCT02550028|Levetiracetam|levetiracetam|mesh-list
101731501|NCT02550028|Phenobarbital|phenobarbital|mesh-list
101731502|NCT02550028|Anticonvulsants|anticonvulsants|mesh-ancestor
101731503|NCT02550028|Nootropic Agents|nootropic agents|mesh-ancestor
101731504|NCT02550028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101731505|NCT02550028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101731506|NCT02550028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731507|NCT02550028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101731508|NCT02550028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101731509|NCT02550028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101731510|NCT02550028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731511|NCT02550028|GABA Modulators|gaba modulators|mesh-ancestor
101731512|NCT02550028|GABA Agents|gaba agents|mesh-ancestor
101731513|NCT02550028|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101201531|NCT01404676|Glimepiride|glimepiride|mesh-list
101731514|NCT02550028|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101731515|NCT02550028|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101731516|NCT04105374|Flucytosine|flucytosine|mesh-list
101731517|NCT04105374|Temozolomide|temozolomide|mesh-list
101731518|NCT04105374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101731519|NCT04105374|Alkylating Agents|alkylating agents|mesh-ancestor
101731520|NCT04105374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731521|NCT04105374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101731522|NCT04105374|Antifungal Agents|antifungal agents|mesh-ancestor
101731523|NCT04105374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101731524|NCT04105374|Antimetabolites|antimetabolites|mesh-ancestor
101731525|NCT04102878|Anesthetics|anesthetics|mesh-list
101731526|NCT04102878|Anesthetics, Local|anesthetics, local|mesh-list
101731527|NCT04102878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101731528|NCT04102878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731529|NCT04102878|Sensory System Agents|sensory system agents|mesh-ancestor
101731530|NCT04102878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101731531|NCT00838240|Cytarabine|cytarabine|mesh-list
101731532|NCT00838240|Clofarabine|clofarabine|mesh-list
101731533|NCT00838240|Idarubicin|idarubicin|mesh-list
101731534|NCT00838240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101731535|NCT00838240|Antimetabolites|antimetabolites|mesh-ancestor
101731536|NCT00838240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731537|NCT00838240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101731538|NCT00838240|Antiviral Agents|antiviral agents|mesh-ancestor
101731539|NCT00838240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101731540|NCT00838240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101731541|NCT00838240|Immunologic Factors|immunologic factors|mesh-ancestor
101731542|NCT00838240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731543|NCT00838240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101731544|NCT00838240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101731545|NCT00838240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101731546|NCT00838240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101731547|NCT00773292|Cyclosporine|cyclosporine|mesh-list
101731548|NCT00773292|Cyclosporins|cyclosporins|mesh-list
101731549|NCT00773292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101731550|NCT00773292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731551|NCT00773292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101731552|NCT00773292|Immunologic Factors|immunologic factors|mesh-ancestor
101731553|NCT00773292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731554|NCT00773292|Antifungal Agents|antifungal agents|mesh-ancestor
101731555|NCT00773292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101731556|NCT00773292|Dermatologic Agents|dermatologic agents|mesh-ancestor
101731557|NCT00773292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101731558|NCT00773292|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101731559|NCT00838396|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
101731561|NCT00838396|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101731562|NCT00838396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731563|NCT00838396|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101731564|NCT00838396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101731565|NCT00838396|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101731566|NCT00838396|GABA Agonists|gaba agonists|mesh-ancestor
101731567|NCT00838396|GABA Agents|gaba agents|mesh-ancestor
101731568|NCT00838396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101731569|NCT00838396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731570|NCT00838864|Ceftriaxone|ceftriaxone|mesh-list
101731571|NCT00838864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101731572|NCT00838864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101731573|NCT00833326|Docetaxel|docetaxel|mesh-list
101731574|NCT00833326|Antimitotic Agents|antimitotic agents|mesh-list
101731575|NCT00833326|Mitogens|mitogens|mesh-list
101731576|NCT00833326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101731577|NCT00833326|Tubulin Modulators|tubulin modulators|mesh-ancestor
101731578|NCT00833326|Mitosis Modulators|mitosis modulators|mesh-ancestor
101731579|NCT00833326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731580|NCT00833404|Nicotine|nicotine|mesh-list
101731581|NCT00833404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101731582|NCT00833404|Autonomic Agents|autonomic agents|mesh-ancestor
101731583|NCT00833404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101731584|NCT00833404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731585|NCT00833404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101731586|NCT00833404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101201624|NCT01404871|Serotonin Agents|serotonin agents|mesh-ancestor
101731587|NCT00833404|Cholinergic Agents|cholinergic agents|mesh-ancestor
101731588|NCT00833404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101731589|NCT00833404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731590|NCT00621322|Vaccines|vaccines|mesh-list
101731591|NCT00621322|Immunologic Factors|immunologic factors|mesh-ancestor
101731592|NCT00621322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731593|NCT00839488|Pantoprazole|pantoprazole|mesh-list
101731594|NCT00839488|Famotidine|famotidine|mesh-list
101731595|NCT00839488|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101731596|NCT00839488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101731597|NCT00839488|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101731598|NCT00839488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101731599|NCT00839488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731600|NCT00839488|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101731601|NCT00839488|Histamine Antagonists|histamine antagonists|mesh-ancestor
101731602|NCT00839488|Histamine Agents|histamine agents|mesh-ancestor
101731603|NCT00839488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101731604|NCT00839488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731605|NCT00834184|Nikkomycin|nikkomycin|mesh-list
101731606|NCT00834184|Antifungal Agents|antifungal agents|mesh-ancestor
101731607|NCT00834184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101731608|NCT00834184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101731609|NCT00834184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731610|NCT00834262|Insulin|insulin|mesh-list
101731611|NCT00834262|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101731612|NCT00834262|Insulin Aspart|insulin aspart|mesh-list
101731613|NCT00834262|Insulin, Long-Acting|insulin, long-acting|mesh-list
101731614|NCT00834262|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101731615|NCT00834262|Biphasic Insulins|biphasic insulins|mesh-list
101731616|NCT00834262|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101731617|NCT00834262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101731618|NCT00834262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731619|NCT00853385|Adalimumab|adalimumab|mesh-list
101731620|NCT00853385|Tofacitinib|tofacitinib|mesh-list
101731621|NCT00853385|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101201646|NCT01405118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101201648|NCT01405118|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101731622|NCT00853385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101731623|NCT00853385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101731624|NCT00853385|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101731625|NCT00853385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101731626|NCT00853385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101731627|NCT00853385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731628|NCT00622336|Lenalidomide|lenalidomide|mesh-list
101731629|NCT00622336|Immunologic Factors|immunologic factors|mesh-ancestor
101731630|NCT00622336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731631|NCT00622336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101731632|NCT00622336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101731633|NCT00622336|Growth Substances|growth substances|mesh-ancestor
101731634|NCT00622336|Growth Inhibitors|growth inhibitors|mesh-ancestor
101731635|NCT00622336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101731636|NCT00846365|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101731637|NCT00846365|Olmesartan|olmesartan|mesh-list
101731638|NCT00846365|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101731639|NCT00846365|Chlorthalidone|chlorthalidone|mesh-list
101731640|NCT00846365|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
101731641|NCT00846365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101731642|NCT00846365|Diuretics|diuretics|mesh-ancestor
101731643|NCT00846365|Natriuretic Agents|natriuretic agents|mesh-ancestor
101731644|NCT00846365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731645|NCT00846365|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101731646|NCT00846365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101807137|NCT04010942|Clomiphene|clomiphene|mesh-list
101731647|NCT00846365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731648|NCT00846365|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101731649|NCT00846365|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101731650|NCT00834730|Ketamine|ketamine|mesh-list
101731651|NCT00834730|Analgesics|analgesics|mesh-ancestor
101731652|NCT00834730|Sensory System Agents|sensory system agents|mesh-ancestor
101731653|NCT00834730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101731654|NCT00834730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731655|NCT00834730|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101731656|NCT00834730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101731657|NCT00834730|Anesthetics, General|anesthetics, general|mesh-ancestor
101731658|NCT00834730|Anesthetics|anesthetics|mesh-ancestor
101731659|NCT00834730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101731660|NCT00834730|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101731661|NCT00834730|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101731662|NCT00834730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101731663|NCT00834730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731664|NCT02601924|Anesthetics|anesthetics|mesh-list
101731665|NCT02601924|Anesthetics, Local|anesthetics, local|mesh-list
101731666|NCT02601924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101731667|NCT02601924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731668|NCT02601924|Sensory System Agents|sensory system agents|mesh-ancestor
101731669|NCT02601924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101731670|NCT00840112|Vitamin E|vitamin e|mesh-list
101731671|NCT00840112|Tocopherols|tocopherols|mesh-list
101731672|NCT00840112|alpha-Tocopherol|alpha-tocopherol|mesh-list
101731673|NCT00840112|Vitamins|vitamins|mesh-ancestor
101731674|NCT00840112|Micronutrients|micronutrients|mesh-ancestor
101731675|NCT00840112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731676|NCT00840112|Antioxidants|antioxidants|mesh-ancestor
101731677|NCT00840112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731678|NCT00840112|Protective Agents|protective agents|mesh-ancestor
101731679|NCT04101474|Ketamine|ketamine|mesh-list
101731680|NCT04101474|Analgesics|analgesics|mesh-ancestor
101731681|NCT04101474|Sensory System Agents|sensory system agents|mesh-ancestor
101731682|NCT04101474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101731683|NCT04101474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731684|NCT04101474|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101731685|NCT04101474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101731686|NCT04101474|Anesthetics, General|anesthetics, general|mesh-ancestor
101731687|NCT04101474|Anesthetics|anesthetics|mesh-ancestor
101731688|NCT04101474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101731689|NCT04101474|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101731690|NCT04101474|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101731691|NCT04101474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101731692|NCT04101474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731693|NCT04101708|Amoxicillin|amoxicillin|mesh-list
101731694|NCT04101708|Clarithromycin|clarithromycin|mesh-list
101731695|NCT04101708|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
101731696|NCT04101708|Lansoprazole|lansoprazole|mesh-list
101731697|NCT04101708|Dexlansoprazole|dexlansoprazole|mesh-list
101731698|NCT04101708|Bismuth|bismuth|mesh-list
101731699|NCT04101708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101731700|NCT04101708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101731701|NCT04101708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101731702|NCT04101708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101731703|NCT04101708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731704|NCT04101708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101731705|NCT04101708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101731706|NCT04101708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101731707|NCT04101708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101731708|NCT04101708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101731709|NCT04101708|Antacids|antacids|mesh-ancestor
101731710|NCT00779142|Methotrexate|methotrexate|mesh-list
101731711|NCT00779142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101731712|NCT00779142|Abortifacient Agents|abortifacient agents|mesh-ancestor
101731713|NCT00779142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101731714|NCT00779142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731715|NCT00779142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101731716|NCT00779142|Antimetabolites|antimetabolites|mesh-ancestor
101731717|NCT00779142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731718|NCT00779142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101731719|NCT00779142|Dermatologic Agents|dermatologic agents|mesh-ancestor
101364514|NCT00147355|Antipyretics|antipyretics|mesh-ancestor
101731720|NCT00779142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101731721|NCT00779142|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101731722|NCT00779142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101731723|NCT00779142|Immunologic Factors|immunologic factors|mesh-ancestor
101731724|NCT00779142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101731725|NCT00779142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101731726|NCT00840346|Panobinostat|panobinostat|mesh-list
101731727|NCT00840346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101731728|NCT00840346|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101731729|NCT00840346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101731730|NCT00840346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731732|NCT04105140|Oxytocics|oxytocics|mesh-ancestor
101731733|NCT04105140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101731734|NCT04105140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731735|NCT00840580|Moxifloxacin|moxifloxacin|mesh-list
101731736|NCT00840580|Levofloxacin|levofloxacin|mesh-list
101731737|NCT00840580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101731738|NCT00840580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101731739|NCT00840580|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101731740|NCT00840580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101731741|NCT00840580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101731742|NCT00840580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101731743|NCT00840580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101731744|NCT00840580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101731745|NCT00840580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731746|NCT00840580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101731747|NCT00840580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101731748|NCT00840580|Contraceptive Agents|contraceptive agents|mesh-ancestor
101731749|NCT00840580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101731750|NCT00840580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201843|NCT01406002|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101201846|NCT01406002|Antithrombins|antithrombins|mesh-ancestor
101731751|NCT00840580|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101731752|NCT00840580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101731753|NCT00840580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101731754|NCT00840580|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101731755|NCT00840580|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101731756|NCT00840580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101731758|NCT00773136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101731759|NCT02602860|Levetiracetam|levetiracetam|mesh-list
101731760|NCT02602860|Brivaracetam|brivaracetam|mesh-list
101731761|NCT02602860|Anticonvulsants|anticonvulsants|mesh-ancestor
101731762|NCT02602860|Nootropic Agents|nootropic agents|mesh-ancestor
101731763|NCT00825058|Paroxetine|paroxetine|mesh-list
101731764|NCT00825058|Amibegron|amibegron|mesh-list
101731765|NCT00825058|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
101731766|NCT00825058|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101731767|NCT00825058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101731768|NCT00825058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101731769|NCT00825058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731770|NCT00825058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101731771|NCT00825058|Serotonin Agents|serotonin agents|mesh-ancestor
101731772|NCT00825058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731773|NCT00825058|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101731774|NCT00825058|Antidepressive Agents|antidepressive agents|mesh-ancestor
101731775|NCT00825058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101731776|NCT00825058|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101731777|NCT00825058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101731778|NCT00825058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101731779|NCT00825058|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101731780|NCT00825058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101731781|NCT00825058|Adrenergic Agents|adrenergic agents|mesh-ancestor
101731782|NCT00825058|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101731783|NCT00701831|Insulin Glargine|insulin glargine|mesh-list
101731784|NCT00701831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101731785|NCT00701831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731786|NCT00835744|Clomiphene|clomiphene|mesh-list
101731787|NCT00835744|Enclomiphene|enclomiphene|mesh-list
101201882|NCT01406171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101731788|NCT00835744|Zuclomiphene|zuclomiphene|mesh-list
101731789|NCT00835744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101731790|NCT00835744|Hormone Antagonists|hormone antagonists|mesh-ancestor
101201907|NCT01406262|Hormones|hormones|mesh-ancestor
101731791|NCT00835744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101731792|NCT00835744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731793|NCT00835744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101731794|NCT00835744|Fertility Agents|fertility agents|mesh-ancestor
101731795|NCT00835744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101731796|NCT00835744|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101731797|NCT00835744|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101731798|NCT00778830|Cetuximab|cetuximab|mesh-list
101731799|NCT00778830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101731800|NCT00778830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101731801|NCT00772668|Prednisone|prednisone|mesh-list
101731802|NCT00772668|Cyclophosphamide|cyclophosphamide|mesh-list
101731803|NCT00772668|Rituximab|rituximab|mesh-list
101731804|NCT00772668|Bortezomib|bortezomib|mesh-list
101731805|NCT00772668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101731806|NCT00772668|Immunologic Factors|immunologic factors|mesh-ancestor
101731807|NCT00772668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731808|NCT00772668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101731809|NCT00772668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101731810|NCT00772668|Alkylating Agents|alkylating agents|mesh-ancestor
101731811|NCT00772668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731812|NCT00772668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101731813|NCT00772668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101731814|NCT00772668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101731815|NCT00772668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101731816|NCT00772668|Glucocorticoids|glucocorticoids|mesh-ancestor
101731817|NCT00772668|Hormones|hormones|mesh-ancestor
101731818|NCT00772668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101731819|NCT00772668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101731820|NCT00786474|Dalteparin|dalteparin|mesh-list
101731821|NCT00786474|Tinzaparin|tinzaparin|mesh-list
101731822|NCT00786474|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101731823|NCT00786474|Anticoagulants|anticoagulants|mesh-ancestor
101731824|NCT00786474|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101731825|NCT00786474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101731826|NCT00786474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731828|NCT00784875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101731829|NCT00784875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101731830|NCT00784875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101731831|NCT00784875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731832|NCT00784875|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101731833|NCT00784875|GABA Agonists|gaba agonists|mesh-ancestor
101731834|NCT00784875|GABA Agents|gaba agents|mesh-ancestor
101731835|NCT00784875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101731836|NCT00784875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731837|NCT00701909|Ketamine|ketamine|mesh-list
101731838|NCT00701909|Morphine|morphine|mesh-list
101201989|NCT01406639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101731839|NCT00701909|Analgesics|analgesics|mesh-ancestor
101731840|NCT00701909|Sensory System Agents|sensory system agents|mesh-ancestor
101731841|NCT00701909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101731842|NCT00701909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731843|NCT00701909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101731844|NCT00701909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101731845|NCT00701909|Anesthetics, General|anesthetics, general|mesh-ancestor
101731846|NCT00701909|Anesthetics|anesthetics|mesh-ancestor
101731847|NCT00701909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101731848|NCT00701909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101731849|NCT00701909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101731850|NCT00701909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101731851|NCT00701909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731852|NCT00701909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101731853|NCT00701909|Narcotics|narcotics|mesh-ancestor
101731854|NCT00699023|Simvastatin|simvastatin|mesh-list
101731855|NCT00699023|Ezetimibe|ezetimibe|mesh-list
101364522|NCT00147355|Serotonin Agents|serotonin agents|mesh-ancestor
101731856|NCT00699023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101731857|NCT00699023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101731858|NCT00699023|Antimetabolites|antimetabolites|mesh-ancestor
101731859|NCT00699023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731860|NCT00699023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101731861|NCT00699023|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101731862|NCT00699023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101731863|NCT00853229|Pregabalin|pregabalin|mesh-list
101731864|NCT00853229|Analgesics|analgesics|mesh-ancestor
101731865|NCT00853229|Sensory System Agents|sensory system agents|mesh-ancestor
101731866|NCT00853229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101731867|NCT00853229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731868|NCT00853229|Anticonvulsants|anticonvulsants|mesh-ancestor
101731869|NCT00853229|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101731870|NCT00853229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101731871|NCT00853229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731872|NCT00853229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101731873|NCT00853229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101731874|NCT00853229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101731875|NCT00853229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101731876|NCT00853229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101731877|NCT00853073|Bevacizumab|bevacizumab|mesh-list
101731878|NCT00853073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101731879|NCT00853073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101731880|NCT00853073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101731881|NCT00853073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101731882|NCT00853073|Growth Substances|growth substances|mesh-ancestor
101731883|NCT00853073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731884|NCT00853073|Growth Inhibitors|growth inhibitors|mesh-ancestor
101807197|NCT00547248|Vaccines|vaccines|mesh-list
101731886|NCT00845897|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101731887|NCT00845897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101731888|NCT00845897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731889|NCT00845897|Cholinergic Agents|cholinergic agents|mesh-ancestor
101731890|NCT00845897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101731891|NCT00845897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731892|NCT04120337|Lidocaine|lidocaine|mesh-list
101731893|NCT04120337|Anesthetics, Local|anesthetics, local|mesh-ancestor
101731894|NCT04120337|Anesthetics|anesthetics|mesh-ancestor
101731895|NCT04120337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101731896|NCT04120337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731897|NCT04120337|Sensory System Agents|sensory system agents|mesh-ancestor
101731898|NCT04120337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101731899|NCT04120337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101731900|NCT04120337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101731901|NCT04120337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101731902|NCT04120337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101731903|NCT04120337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731904|NCT00592319|Celecoxib|celecoxib|mesh-list
101731905|NCT00592319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101731906|NCT00592319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101731907|NCT00592319|Analgesics|analgesics|mesh-ancestor
101731908|NCT00592319|Sensory System Agents|sensory system agents|mesh-ancestor
101731909|NCT00592319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101731910|NCT00592319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731911|NCT00592319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101731912|NCT00592319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101731913|NCT00592319|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101731914|NCT00592319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101731915|NCT00592319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101731916|NCT00592319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731917|NCT00862121|Mesalamine|mesalamine|mesh-list
101731918|NCT00862121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101731919|NCT00862121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101731920|NCT00862121|Analgesics|analgesics|mesh-ancestor
101731921|NCT00862121|Sensory System Agents|sensory system agents|mesh-ancestor
101731922|NCT00862121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101731923|NCT00862121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731924|NCT00862121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101731925|NCT00862121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101731926|NCT00784719|Cyclosporine|cyclosporine|mesh-list
101731927|NCT00784719|Cyclosporins|cyclosporins|mesh-list
101731928|NCT00784719|Tofacitinib|tofacitinib|mesh-list
101731929|NCT00784719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101731930|NCT00784719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731931|NCT00784719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101731932|NCT00784719|Immunologic Factors|immunologic factors|mesh-ancestor
101731933|NCT00784719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731934|NCT00784719|Antifungal Agents|antifungal agents|mesh-ancestor
101202091|NCT01408004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101731935|NCT00784719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101731936|NCT00784719|Dermatologic Agents|dermatologic agents|mesh-ancestor
101731937|NCT00784719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101731938|NCT00784719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101731939|NCT00784719|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101731940|NCT00784719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101731941|NCT00852917|Tramadol|tramadol|mesh-list
101731942|NCT00852917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101731943|NCT00852917|Narcotics|narcotics|mesh-ancestor
101731944|NCT00852917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101731945|NCT00852917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731946|NCT00852917|Analgesics|analgesics|mesh-ancestor
101731947|NCT00852917|Sensory System Agents|sensory system agents|mesh-ancestor
101731948|NCT00852917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101731950|NCT00700583|Terazosin|terazosin|mesh-list
101731951|NCT00700583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101731952|NCT00700583|Diuretics|diuretics|mesh-ancestor
101731953|NCT00700583|Natriuretic Agents|natriuretic agents|mesh-ancestor
101731954|NCT00700583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731955|NCT00700583|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101731956|NCT00700583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101731957|NCT00700583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731958|NCT00700583|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101731959|NCT00700583|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101731960|NCT00700583|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101731961|NCT00700583|Adrenergic Agents|adrenergic agents|mesh-ancestor
101731962|NCT00700583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101731963|NCT00700583|Urological Agents|urological agents|mesh-ancestor
101731964|NCT00913055|Octreotide|octreotide|mesh-list
101731965|NCT00913055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101731966|NCT00913055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101731967|NCT00913055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101731968|NCT04117139|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101731969|NCT04117139|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101731970|NCT04117139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731971|NCT00845429|Vaccines|vaccines|mesh-list
101731972|NCT00845429|Immunologic Factors|immunologic factors|mesh-ancestor
101731973|NCT00845429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731974|NCT00844883|Sorafenib|sorafenib|mesh-list
101731975|NCT00844883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101731976|NCT00844883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101731978|NCT00844883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731980|NCT00851903|Insulin Glargine|insulin glargine|mesh-list
101731981|NCT00851903|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101731982|NCT00851903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101731983|NCT00851903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731984|NCT00851903|Incretins|incretins|mesh-ancestor
101731985|NCT00851903|Hormones|hormones|mesh-ancestor
101731986|NCT00851903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101731987|NCT00851903|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101731988|NCT00851903|Protease Inhibitors|protease inhibitors|mesh-ancestor
101731989|NCT00851903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101731990|NCT00851903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101731991|NCT00587457|Immunotoxin HA22|immunotoxin ha22|mesh-list
101731992|NCT00587457|Immunotoxins|immunotoxins|mesh-ancestor
101731993|NCT00587457|Immunoconjugates|immunoconjugates|mesh-ancestor
101731994|NCT00587457|Immunologic Factors|immunologic factors|mesh-ancestor
101731995|NCT00587457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101731996|NCT00587457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101731997|NCT00851747|Deoxycholic Acid|deoxycholic acid|mesh-list
101731998|NCT00851747|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101731999|NCT00851747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101732000|NCT04099563|Abrocitinib|abrocitinib|mesh-list
101732001|NCT04099563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101732002|NCT04099563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101732003|NCT04099563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732004|NCT00767325|Methotrexate|methotrexate|mesh-list
101732005|NCT00767325|Abatacept|abatacept|mesh-list
101732006|NCT00767325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101732008|NCT00767325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101732009|NCT00767325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732010|NCT00767325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101732011|NCT00767325|Antimetabolites|antimetabolites|mesh-ancestor
101732012|NCT00767325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732013|NCT00767325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101732015|NCT00767325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101732016|NCT00767325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101732017|NCT00767325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101732018|NCT00767325|Immunologic Factors|immunologic factors|mesh-ancestor
101732019|NCT00767325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101732020|NCT00767325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101732021|NCT00767325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101732022|NCT00767325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101732023|NCT00851591|Psyllium|psyllium|mesh-list
101732024|NCT00851591|Cathartics|cathartics|mesh-ancestor
101732025|NCT00851591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101732026|NCT02612363|Dexmedetomidine|dexmedetomidine|mesh-list
101732027|NCT02612363|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101732028|NCT02612363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101732029|NCT02612363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732030|NCT02612363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101732031|NCT02612363|Analgesics|analgesics|mesh-ancestor
101732032|NCT02612363|Sensory System Agents|sensory system agents|mesh-ancestor
101732033|NCT02612363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101732034|NCT02612363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101732035|NCT02612363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101732036|NCT02612363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101732037|NCT02612363|Adrenergic Agents|adrenergic agents|mesh-ancestor
101732038|NCT02612363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101732039|NCT02612363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732040|NCT00702767|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101732041|NCT00702767|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101732042|NCT00702767|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101732043|NCT00702767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101732044|NCT00912899|Noscapine|noscapine|mesh-list
101732045|NCT00912899|Antitussive Agents|antitussive agents|mesh-ancestor
101732046|NCT00912899|Respiratory System Agents|respiratory system agents|mesh-ancestor
101732047|NCT00700895|Warfarin|warfarin|mesh-list
101732048|NCT00700895|Anticoagulants|anticoagulants|mesh-ancestor
101732049|NCT00861341|Aspirin|aspirin|mesh-list
101732050|NCT00861341|Pioglitazone|pioglitazone|mesh-list
101732051|NCT00861341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101732052|NCT00861341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101389489|NCT05843188|Antidotes|antidotes|mesh-ancestor
101732053|NCT00861341|Analgesics|analgesics|mesh-ancestor
101732054|NCT00861341|Sensory System Agents|sensory system agents|mesh-ancestor
101732055|NCT00861341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101732056|NCT00861341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732057|NCT00861341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101732058|NCT00861341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101732059|NCT00861341|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101732060|NCT00861341|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101732061|NCT00861341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732062|NCT00861341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101732063|NCT00861341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101732064|NCT00861341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101732065|NCT00861341|Antipyretics|antipyretics|mesh-ancestor
101732066|NCT00861341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101732067|NCT00766467|Modafinil|modafinil|mesh-list
101732068|NCT00766467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101732069|NCT00766467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732070|NCT00766467|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101732071|NCT00766467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101732072|NCT00766467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101732073|NCT00766467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732074|NCT00850499|Rituximab|rituximab|mesh-list
101732075|NCT00850499|Fludarabine|fludarabine|mesh-list
101732076|NCT00850499|Bortezomib|bortezomib|mesh-list
101732077|NCT00850499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101732078|NCT00850499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101732079|NCT00850499|Immunologic Factors|immunologic factors|mesh-ancestor
101732080|NCT00850499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732081|NCT00850499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101732082|NCT00844805|Infliximab|infliximab|mesh-list
101732083|NCT00844805|Naproxen|naproxen|mesh-list
101732084|NCT00844805|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101732085|NCT00844805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101732086|NCT00844805|Dermatologic Agents|dermatologic agents|mesh-ancestor
101732087|NCT00844805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101732088|NCT00844805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101732089|NCT00844805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101732090|NCT00844805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101732091|NCT00844805|Analgesics|analgesics|mesh-ancestor
101732092|NCT00844805|Sensory System Agents|sensory system agents|mesh-ancestor
101732093|NCT00844805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101732094|NCT00844805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732095|NCT00844805|Gout Suppressants|gout suppressants|mesh-ancestor
101732096|NCT00844805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101732097|NCT00844805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101732098|NCT00844805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732099|NCT00765999|Linaclotide|linaclotide|mesh-list
101732100|NCT00765999|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
101732101|NCT00765999|Enzyme Activators|enzyme activators|mesh-ancestor
101732102|NCT00765999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732103|NCT00765999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101732104|NCT04099407|Pirfenidone|pirfenidone|mesh-list
101732105|NCT04099407|Analgesics|analgesics|mesh-ancestor
101732106|NCT04099407|Sensory System Agents|sensory system agents|mesh-ancestor
101732107|NCT04099407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101732108|NCT04099407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732109|NCT04099407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101732110|NCT04099407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101732111|NCT04099407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101732112|NCT04099407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101732113|NCT04099407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101732114|NCT00765063|Dalteparin|dalteparin|mesh-list
101732115|NCT00765063|Anticoagulants|anticoagulants|mesh-ancestor
101732116|NCT00765063|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101732117|NCT00765063|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101732118|NCT00765063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732119|NCT00764751|Calcipotriene|calcipotriene|mesh-list
101732120|NCT00764751|Dermatologic Agents|dermatologic agents|mesh-ancestor
101732121|NCT00764517|Rituximab|rituximab|mesh-list
101732122|NCT00764517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101732124|NCT00764517|Cladribine|cladribine|mesh-list
101732125|NCT00764517|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
101732126|NCT00764517|Antibodies|antibodies|mesh-list
101732127|NCT00764517|Immunoglobulins|immunoglobulins|mesh-list
101389568|NCT05828966|Tocolytic Agents|tocolytic agents|mesh-ancestor
101732128|NCT00764517|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101732129|NCT00764517|Immunologic Factors|immunologic factors|mesh-ancestor
101732130|NCT00764517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732131|NCT00764517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101732132|NCT00764517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101732133|NCT00764517|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101732134|NCT00764517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101732135|NCT00764517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732136|NCT00764517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101732137|NCT00764517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101732138|NCT00764517|Antimetabolites|antimetabolites|mesh-ancestor
101732139|NCT00764361|Doxycycline|doxycycline|mesh-list
101732140|NCT00764361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101732141|NCT00764361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101732142|NCT00764361|Antimalarials|antimalarials|mesh-ancestor
101732143|NCT00764361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101732144|NCT00764361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101732145|NCT00763971|Methylphenidate|methylphenidate|mesh-list
101732146|NCT00763971|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101732147|NCT00763971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101732148|NCT00763971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732149|NCT00763971|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101732150|NCT00763971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101732151|NCT00763971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101732152|NCT00763971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732153|NCT00763971|Dopamine Agents|dopamine agents|mesh-ancestor
101732154|NCT00763971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101732155|NCT00763815|Metformin|metformin|mesh-list
101732156|NCT00763815|Pioglitazone|pioglitazone|mesh-list
101732157|NCT00763815|Lixisenatide|lixisenatide|mesh-list
101732158|NCT00763815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101732159|NCT00763815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732160|NCT00763269|Silicon|silicon|mesh-list
101732161|NCT00763269|Triclosan|triclosan|mesh-list
101732162|NCT00763269|Fluorides|fluorides|mesh-list
101732163|NCT00763269|Cariostatic Agents|cariostatic agents|mesh-ancestor
101732164|NCT00763269|Protective Agents|protective agents|mesh-ancestor
101732165|NCT00763269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732166|NCT00763269|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101732167|NCT00763269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101732168|NCT00763269|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101732169|NCT00763269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101732170|NCT00763269|Antimetabolites|antimetabolites|mesh-ancestor
101732171|NCT00763269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732172|NCT00763269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101732173|NCT00763269|Trace Elements|trace elements|mesh-ancestor
101732174|NCT00763269|Micronutrients|micronutrients|mesh-ancestor
101732175|NCT00763035|Dobutamine|dobutamine|mesh-list
101732176|NCT00763035|Regadenoson|regadenoson|mesh-list
101732177|NCT00763035|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101732178|NCT00763035|Sympathomimetics|sympathomimetics|mesh-ancestor
101732179|NCT00763035|Autonomic Agents|autonomic agents|mesh-ancestor
101732180|NCT00763035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101732181|NCT00763035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732182|NCT00763035|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101732183|NCT00763035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101202233|NCT01408836|Prednisolone phosphate|prednisolone phosphate|mesh-list
101732184|NCT00763035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101732185|NCT00763035|Adrenergic Agents|adrenergic agents|mesh-ancestor
101732186|NCT00763035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101732187|NCT00763035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732188|NCT00763035|Protective Agents|protective agents|mesh-ancestor
101732189|NCT00763035|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
101732190|NCT00763035|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101732191|NCT00763035|Purinergic Agonists|purinergic agonists|mesh-ancestor
101732192|NCT00763035|Purinergic Agents|purinergic agents|mesh-ancestor
101732193|NCT00844649|Paclitaxel|paclitaxel|mesh-list
101732194|NCT00844649|Gemcitabine|gemcitabine|mesh-list
101732195|NCT00844649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101732196|NCT00844649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101732197|NCT00844649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101732198|NCT00844649|Tubulin Modulators|tubulin modulators|mesh-ancestor
101732199|NCT00844649|Antimitotic Agents|antimitotic agents|mesh-ancestor
101732200|NCT00844649|Mitosis Modulators|mitosis modulators|mesh-ancestor
101732201|NCT00844649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732202|NCT00844649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101732203|NCT00844649|Antimetabolites|antimetabolites|mesh-ancestor
101732205|NCT04098861|Latanoprost|latanoprost|mesh-list
101732206|NCT04098861|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101732207|NCT04098861|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101732208|NCT04098861|Adrenergic Agents|adrenergic agents|mesh-ancestor
101732209|NCT04098861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101732210|NCT04098861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807240|NCT00964704|Bevacizumab|bevacizumab|mesh-list
101732211|NCT04098861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732212|NCT04098861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101732213|NCT04098861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101732214|NCT04098861|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101732215|NCT04098861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101732216|NCT00850343|Certolizumab Pegol|certolizumab pegol|mesh-list
101732217|NCT00850343|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101732218|NCT00850343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101732219|NCT00850343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101732220|NCT00850343|Immunologic Factors|immunologic factors|mesh-ancestor
101732221|NCT00850343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732222|NCT00850343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101732223|NCT00849875|Dacarbazine|dacarbazine|mesh-list
101732224|NCT00849875|Imidazole|imidazole|mesh-list
101732225|NCT00849875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101732226|NCT00849875|Alkylating Agents|alkylating agents|mesh-ancestor
101732227|NCT00849875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732228|NCT00849875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101732229|NCT00849875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101732230|NCT00844415|Dabigatran|dabigatran|mesh-list
101732231|NCT00844415|Antithrombins|antithrombins|mesh-ancestor
101732232|NCT00844415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101732233|NCT00844415|Protease Inhibitors|protease inhibitors|mesh-ancestor
101732234|NCT00844415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101732235|NCT00844415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732236|NCT00844415|Anticoagulants|anticoagulants|mesh-ancestor
101732237|NCT00843635|Tadalafil|tadalafil|mesh-list
101732238|NCT00843635|Vasodilator Agents|vasodilator agents|mesh-ancestor
101732239|NCT00843635|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101732240|NCT00843635|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101732241|NCT00843635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101732242|NCT00843635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732243|NCT00843635|Urological Agents|urological agents|mesh-ancestor
101732244|NCT00699179|Insulin Aspart|insulin aspart|mesh-list
101732245|NCT00699179|Biphasic Insulins|biphasic insulins|mesh-list
101732246|NCT00699179|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101732247|NCT00699179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101732248|NCT00699179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732249|NCT04116827|Tamoxifen|tamoxifen|mesh-list
101732250|NCT04116827|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101732251|NCT04116827|Hormone Antagonists|hormone antagonists|mesh-ancestor
101732252|NCT04116827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101732254|NCT04116827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101732255|NCT04116827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101732256|NCT04116827|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101732257|NCT04116827|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101732258|NCT04116827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101732259|NCT00849017|rGLP-1 protein|rglp-1 protein|mesh-list
101732260|NCT00849017|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101732261|NCT00849017|Incretins|incretins|mesh-ancestor
101732262|NCT00849017|Hormones|hormones|mesh-ancestor
101732263|NCT00849017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101732264|NCT00849017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732265|NCT00842309|Cycloserine|cycloserine|mesh-list
101732266|NCT00842309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101732267|NCT00842309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101732268|NCT00842309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101732269|NCT00842309|Antitubercular Agents|antitubercular agents|mesh-ancestor
101732270|NCT00842309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101732271|NCT00842309|Antimetabolites|antimetabolites|mesh-ancestor
101732272|NCT00842309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732273|NCT00842153|Clobetasol|clobetasol|mesh-list
101732274|NCT00842153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101732275|NCT00842153|Glucocorticoids|glucocorticoids|mesh-ancestor
101732276|NCT00842153|Hormones|hormones|mesh-ancestor
101389723|NCT05767736|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101732277|NCT00842153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101732278|NCT00842153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732279|NCT00762411|N2-((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-L-alaninamide|n2-((2s)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-n1-((7s)-5-methyl-6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-l-alaninamide|mesh-list
101732280|NCT00762411|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101732281|NCT00762411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101732282|NCT00762411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732283|NCT00841763|Vaccines|vaccines|mesh-list
101202241|NCT01408836|Antiemetics|antiemetics|mesh-ancestor
101202242|NCT01408836|Autonomic Agents|autonomic agents|mesh-ancestor
101732284|NCT00841763|Immunologic Factors|immunologic factors|mesh-ancestor
101732285|NCT00841763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732286|NCT00785538|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101732287|NCT00785538|Immunologic Factors|immunologic factors|mesh-ancestor
101732288|NCT00785538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732289|NCT02602704|Bazedoxifene|bazedoxifene|mesh-list
101732290|NCT02602704|Calcium|calcium|mesh-list
101732291|NCT02602704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101732292|NCT02602704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732293|NCT02602704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101732294|NCT02602704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101732295|NCT02602704|Hormone Antagonists|hormone antagonists|mesh-ancestor
101732296|NCT02602704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101732297|NCT02602704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101732298|NCT00860405|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
101732299|NCT00860405|Plasma Substitutes|plasma substitutes|mesh-ancestor
101732300|NCT00860405|Blood Substitutes|blood substitutes|mesh-ancestor
101732301|NCT00703313|Moxifloxacin|moxifloxacin|mesh-list
101732302|NCT00703313|Levofloxacin|levofloxacin|mesh-list
101732303|NCT00703313|Gatifloxacin|gatifloxacin|mesh-list
101732304|NCT00703313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101732305|NCT00703313|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101732306|NCT00703313|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101732307|NCT00703313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101732308|NCT00703313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101732309|NCT00703313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101732310|NCT00703313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101732311|NCT00703313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101732312|NCT00703313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732313|NCT00703313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101732314|NCT00703313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101732315|NCT00703313|Contraceptive Agents|contraceptive agents|mesh-ancestor
101732316|NCT00703313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101732317|NCT00703313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732318|NCT00703313|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101732319|NCT00703313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101732320|NCT00703313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101732321|NCT00703313|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101732322|NCT00703313|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101732323|NCT00703313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101732324|NCT00703079|Octreotide|octreotide|mesh-list
101732325|NCT00703079|Lanreotide|lanreotide|mesh-list
101732326|NCT00703079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101732327|NCT00703079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101732328|NCT00703079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101732329|NCT00840827|Cyclosporine|cyclosporine|mesh-list
101732330|NCT00840827|Lenalidomide|lenalidomide|mesh-list
101732331|NCT00840827|Cyclosporins|cyclosporins|mesh-list
101732332|NCT00840827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101202281|NCT01408979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732333|NCT00840827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732334|NCT00840827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101732335|NCT00840827|Immunologic Factors|immunologic factors|mesh-ancestor
101732336|NCT00840827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732337|NCT00840827|Antifungal Agents|antifungal agents|mesh-ancestor
101732338|NCT00840827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101732340|NCT00840827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101732341|NCT00840827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101732342|NCT00840827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101732343|NCT00840827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101732344|NCT00840827|Growth Substances|growth substances|mesh-ancestor
101732345|NCT00840827|Growth Inhibitors|growth inhibitors|mesh-ancestor
101732346|NCT00840827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101732347|NCT00703469|Nivolumab|nivolumab|mesh-list
101732348|NCT00703469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101732350|NCT00703469|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101732351|NCT00703469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732352|NCT02612207|Bilirubin|bilirubin|mesh-list
101732353|NCT02612207|Antioxidants|antioxidants|mesh-ancestor
101732354|NCT02612207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732355|NCT02612207|Protective Agents|protective agents|mesh-ancestor
101732356|NCT02612207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732357|NCT00859937|Dasatinib|dasatinib|mesh-list
101732358|NCT00859937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101732359|NCT00859937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101732360|NCT00859937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101732361|NCT00859937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732362|NCT04030715|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101732363|NCT04030715|Bismuth|bismuth|mesh-list
101732364|NCT04030715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101732365|NCT04030715|Antacids|antacids|mesh-ancestor
101732366|NCT04030715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732367|NCT04030715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101732368|NCT00592007|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101732369|NCT00592007|Fulvestrant|fulvestrant|mesh-list
101732370|NCT00592007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101732371|NCT00592007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101732372|NCT00592007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101732373|NCT00592007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732374|NCT00592007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101732375|NCT00592007|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101732376|NCT00592007|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101732377|NCT00592007|Hormone Antagonists|hormone antagonists|mesh-ancestor
101732378|NCT00592007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101732379|NCT00592007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732380|NCT00591851|Paclitaxel|paclitaxel|mesh-list
101732381|NCT00591851|Cyclophosphamide|cyclophosphamide|mesh-list
101732382|NCT00591851|Doxorubicin|doxorubicin|mesh-list
101732383|NCT00591851|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101732384|NCT00591851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101732385|NCT00591851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101732386|NCT00591851|Tubulin Modulators|tubulin modulators|mesh-ancestor
101732387|NCT00591851|Antimitotic Agents|antimitotic agents|mesh-ancestor
101732388|NCT00591851|Mitosis Modulators|mitosis modulators|mesh-ancestor
101732389|NCT00591851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732390|NCT00591851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101732391|NCT00591851|Immunologic Factors|immunologic factors|mesh-ancestor
101732392|NCT00591851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732393|NCT00591851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101732394|NCT00591851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101732395|NCT00591851|Alkylating Agents|alkylating agents|mesh-ancestor
101732396|NCT00591851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101732397|NCT00591851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101732398|NCT00591851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101732399|NCT00591851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101732400|NCT00591851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101732401|NCT00839423|Vortioxetine|vortioxetine|mesh-list
101732402|NCT00839423|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101732403|NCT00839423|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101732404|NCT00839423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101732405|NCT00839423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101732406|NCT00839423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732407|NCT00839423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101202334|NCT01409174|Analgesics|analgesics|mesh-ancestor
101202335|NCT01409174|Sensory System Agents|sensory system agents|mesh-ancestor
101202339|NCT01409187|Interferons|interferons|mesh-list
101732408|NCT00839423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732409|NCT00839423|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101732410|NCT00839423|Antidepressive Agents|antidepressive agents|mesh-ancestor
101732411|NCT00839423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101732412|NCT00839423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101732413|NCT00839423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101732414|NCT00839423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101732415|NCT00839423|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101732417|NCT00839423|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101732418|NCT00839423|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101732419|NCT00839423|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101732420|NCT00839423|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101732421|NCT00859469|Gemcitabine|gemcitabine|mesh-list
101732422|NCT00859469|Oxaliplatin|oxaliplatin|mesh-list
101732423|NCT00859469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101732424|NCT00859469|Antimetabolites|antimetabolites|mesh-ancestor
101732425|NCT00859469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732426|NCT00859469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101732428|NCT00703625|Docetaxel|docetaxel|mesh-list
101732429|NCT00703625|Temsirolimus|temsirolimus|mesh-list
101732430|NCT00703625|MTOR Inhibitors|mtor inhibitors|mesh-list
101732431|NCT00703625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101732432|NCT00703625|Tubulin Modulators|tubulin modulators|mesh-ancestor
101732433|NCT00703625|Antimitotic Agents|antimitotic agents|mesh-ancestor
101732434|NCT00703625|Mitosis Modulators|mitosis modulators|mesh-ancestor
101732435|NCT00703625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732436|NCT00703625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101807299|NCT00961844|Temozolomide|temozolomide|mesh-list
101732437|NCT00703625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101732438|NCT00703625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101732439|NCT00703625|Immunologic Factors|immunologic factors|mesh-ancestor
101732440|NCT00703625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732441|NCT00703625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101732442|NCT00703625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101732443|NCT00703625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101732444|NCT00703625|Antifungal Agents|antifungal agents|mesh-ancestor
101732445|NCT00703703|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101732446|NCT00703703|Darifenacin|darifenacin|mesh-list
101732447|NCT00703703|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101732448|NCT00703703|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101732449|NCT00703703|Cholinergic Agents|cholinergic agents|mesh-ancestor
101202385|NCT01409408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202387|NCT01409408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732450|NCT00703703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101732451|NCT00703703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732452|NCT00703703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732453|NCT00703703|Urological Agents|urological agents|mesh-ancestor
101732455|NCT00859313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101732456|NCT00859313|Narcotics|narcotics|mesh-ancestor
101732457|NCT00859313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101732458|NCT00859313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732459|NCT00859313|Analgesics|analgesics|mesh-ancestor
101732460|NCT00859313|Sensory System Agents|sensory system agents|mesh-ancestor
101732461|NCT00859313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101732462|NCT00859313|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101732463|NCT00859313|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101732464|NCT00859313|Anesthetics, General|anesthetics, general|mesh-ancestor
101732465|NCT00859313|Anesthetics|anesthetics|mesh-ancestor
101732466|NCT02611973|Aspirin|aspirin|mesh-list
101732467|NCT02611973|Hydroxyurea|hydroxyurea|mesh-list
101732468|NCT02611973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101732469|NCT02611973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101732470|NCT02611973|Analgesics|analgesics|mesh-ancestor
101732471|NCT02611973|Sensory System Agents|sensory system agents|mesh-ancestor
101732472|NCT02611973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101732473|NCT02611973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732474|NCT02611973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101732475|NCT02611973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101732476|NCT02611973|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101732477|NCT02611973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101732478|NCT02611973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202417|NCT01409616|Analgesics|analgesics|mesh-ancestor
101732479|NCT02611973|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101732480|NCT02611973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101732481|NCT02611973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101732482|NCT02611973|Antipyretics|antipyretics|mesh-ancestor
101732483|NCT02611973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101732484|NCT02611973|Antisickling Agents|antisickling agents|mesh-ancestor
101732485|NCT02611973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101732486|NCT00771810|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
101732488|NCT00771810|Vasodilator Agents|vasodilator agents|mesh-ancestor
101732489|NCT00836927|Sirolimus|sirolimus|mesh-list
101732490|NCT00836927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101732491|NCT00836927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101732492|NCT00836927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101732493|NCT00836927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101732494|NCT00836927|Antifungal Agents|antifungal agents|mesh-ancestor
101732496|NCT00836927|Immunologic Factors|immunologic factors|mesh-ancestor
101732497|NCT00836927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732498|NCT00703235|Bevacizumab|bevacizumab|mesh-list
101732499|NCT00703235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101732500|NCT00703235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101732501|NCT00703235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101807310|NCT00686777|Antiviral Agents|antiviral agents|mesh-ancestor
101732502|NCT00703235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101732503|NCT00703235|Growth Substances|growth substances|mesh-ancestor
101732504|NCT00703235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732505|NCT00703235|Growth Inhibitors|growth inhibitors|mesh-ancestor
101732506|NCT02612051|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101732507|NCT00771030|Brodalumab|brodalumab|mesh-list
101732508|NCT00771030|Dermatologic Agents|dermatologic agents|mesh-ancestor
101732509|NCT00768300|Ambrisentan|ambrisentan|mesh-list
101732510|NCT00768300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101732511|NCT00768222|Triclosan|triclosan|mesh-list
101732512|NCT00768222|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101732513|NCT00768222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101732514|NCT00768222|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101732515|NCT00768222|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101732516|NCT00768222|Antimetabolites|antimetabolites|mesh-ancestor
101732517|NCT00768222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732518|NCT00768222|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101732519|NCT00768144|Sunitinib|sunitinib|mesh-list
101732520|NCT00768144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101732521|NCT00768144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101732522|NCT00768144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101732523|NCT00768144|Growth Substances|growth substances|mesh-ancestor
101732524|NCT00768144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732525|NCT00768144|Growth Inhibitors|growth inhibitors|mesh-ancestor
101732526|NCT00768144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101732527|NCT00768144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101732528|NCT00768144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732529|NCT00784836|Interferons|interferons|mesh-list
101732530|NCT00784836|Interferon-beta|interferon-beta|mesh-list
101202468|NCT01409499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101732531|NCT00784836|Interferon beta-1a|interferon beta-1a|mesh-list
101732532|NCT00784836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101732533|NCT00784836|Antiviral Agents|antiviral agents|mesh-ancestor
101732534|NCT00784836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101732535|NCT00784836|Immunologic Factors|immunologic factors|mesh-ancestor
101732536|NCT00784836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732537|NCT00784836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101732538|NCT04104984|Tocolytic Agents|tocolytic agents|mesh-list
101732540|NCT04104984|Progestins|progestins|mesh-ancestor
101732541|NCT04104984|Hormones|hormones|mesh-ancestor
101732542|NCT04104984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101732543|NCT04104984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732544|NCT04104984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101732545|NCT00767520|Dasatinib|dasatinib|mesh-list
101732546|NCT00767520|Exemestane|exemestane|mesh-list
101732547|NCT00767520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101732548|NCT00767520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101732549|NCT00767520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101732550|NCT00767520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732551|NCT00767520|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101732552|NCT00767520|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101732553|NCT00767520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101732554|NCT00767520|Hormone Antagonists|hormone antagonists|mesh-ancestor
101732555|NCT00767520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101732556|NCT00767520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732557|NCT00858845|Clonidine|clonidine|mesh-list
101732558|NCT00858845|Analgesics|analgesics|mesh-ancestor
101732559|NCT00858845|Sensory System Agents|sensory system agents|mesh-ancestor
101732560|NCT00858845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101732561|NCT00858845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732562|NCT00858845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101732563|NCT00858845|Sympatholytics|sympatholytics|mesh-ancestor
101732564|NCT00858845|Autonomic Agents|autonomic agents|mesh-ancestor
101732565|NCT00858845|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101732566|NCT00858845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101732567|NCT00858845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101732568|NCT00858845|Adrenergic Agents|adrenergic agents|mesh-ancestor
101732569|NCT00858845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101732570|NCT00858845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732572|NCT05591339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101732573|NCT05591339|Immunologic Factors|immunologic factors|mesh-ancestor
101732574|NCT05591339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732575|NCT00770562|Dexamethasone|dexamethasone|mesh-list
101732576|NCT00770562|Rituximab|rituximab|mesh-list
101180232|NCT03873402|Nivolumab|nivolumab|mesh-list
101732577|NCT00770562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101732578|NCT00770562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101732579|NCT00770562|Immunologic Factors|immunologic factors|mesh-ancestor
101732580|NCT00770562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732581|NCT00770562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101732582|NCT00770562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101732583|NCT00770562|Antiemetics|antiemetics|mesh-ancestor
101732584|NCT00770562|Autonomic Agents|autonomic agents|mesh-ancestor
101732585|NCT00770562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101732586|NCT00770562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101732587|NCT00770562|Glucocorticoids|glucocorticoids|mesh-ancestor
101732588|NCT00770562|Hormones|hormones|mesh-ancestor
101732589|NCT00770562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101732590|NCT00770562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101732591|NCT00836693|Tadalafil|tadalafil|mesh-list
101732592|NCT00836693|Vasodilator Agents|vasodilator agents|mesh-ancestor
101732593|NCT00836693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101732594|NCT00836693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101732595|NCT00836693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101732596|NCT00836693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732597|NCT00836693|Urological Agents|urological agents|mesh-ancestor
101732598|NCT00770484|Propranolol|propranolol|mesh-list
101732599|NCT00770484|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101732600|NCT00770484|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101732601|NCT00770484|Adrenergic Agents|adrenergic agents|mesh-ancestor
101732602|NCT00770484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101732603|NCT00770484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732604|NCT00770484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732605|NCT00770484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101732606|NCT00770484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101732607|NCT00770484|Vasodilator Agents|vasodilator agents|mesh-ancestor
101732608|NCT00835679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101732609|NCT00835679|Cetuximab|cetuximab|mesh-list
101732610|NCT00835679|Dasatinib|dasatinib|mesh-list
101732611|NCT00835679|Antibodies|antibodies|mesh-list
101732612|NCT00835679|Immunoglobulins|immunoglobulins|mesh-list
101732613|NCT00835679|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101732614|NCT00835679|Immunologic Factors|immunologic factors|mesh-ancestor
101732615|NCT00835679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732616|NCT00835679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807330|NCT01563068|Calcipotriene|calcipotriene|mesh-list
101202589|NCT01411124|Anesthetics, Local|anesthetics, local|mesh-ancestor
101732617|NCT00835679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101732618|NCT00835679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101732619|NCT00835679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732621|NCT00766506|Morphine|morphine|mesh-list
101732622|NCT00766506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101732623|NCT00766506|Narcotics|narcotics|mesh-ancestor
101732624|NCT00766506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101732625|NCT00766506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732626|NCT00766506|Analgesics|analgesics|mesh-ancestor
101732627|NCT00766506|Sensory System Agents|sensory system agents|mesh-ancestor
101732628|NCT00766506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101732629|NCT00766506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101732630|NCT00766506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101732631|NCT00766506|Anesthetics, General|anesthetics, general|mesh-ancestor
101732632|NCT00766506|Anesthetics|anesthetics|mesh-ancestor
101732633|NCT00770328|Pentoxifylline|pentoxifylline|mesh-list
101732634|NCT00770328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101732635|NCT00770328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101732636|NCT00770328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732637|NCT00770328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101732638|NCT00770328|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101732640|NCT00770328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732641|NCT00770328|Vasodilator Agents|vasodilator agents|mesh-ancestor
101732642|NCT00770328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101732643|NCT00770328|Antioxidants|antioxidants|mesh-ancestor
101732644|NCT05500092|Cisplatin|cisplatin|mesh-list
101732645|NCT05500092|Gemcitabine|gemcitabine|mesh-list
101732646|NCT05500092|Docetaxel|docetaxel|mesh-list
101202643|NCT01411423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101732647|NCT05500092|Nivolumab|nivolumab|mesh-list
101732648|NCT05500092|Pemetrexed|pemetrexed|mesh-list
101732649|NCT05500092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101732650|NCT05500092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101732651|NCT05500092|Antimetabolites|antimetabolites|mesh-ancestor
101732652|NCT05500092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732653|NCT05500092|Tubulin Modulators|tubulin modulators|mesh-ancestor
101732654|NCT05500092|Antimitotic Agents|antimitotic agents|mesh-ancestor
101732655|NCT05500092|Mitosis Modulators|mitosis modulators|mesh-ancestor
101732656|NCT05500092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101732657|NCT05500092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101732658|NCT05500092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101732659|NCT05500092|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101732660|NCT05500092|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101732661|NCT00916500|Cisplatin|cisplatin|mesh-list
101732662|NCT00916500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101732663|NCT03110094|Adalimumab|adalimumab|mesh-list
101732664|NCT03110094|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101732665|NCT03110094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101732666|NCT03110094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101732667|NCT02600988|Vitamin D|vitamin d|mesh-list
101732668|NCT02600988|Ergocalciferols|ergocalciferols|mesh-list
101732669|NCT02600988|Cholecalciferol|cholecalciferol|mesh-list
101732670|NCT02600988|Vitamins|vitamins|mesh-list
101732671|NCT02600988|Micronutrients|micronutrients|mesh-ancestor
101732672|NCT02600988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732673|NCT02600988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101732674|NCT02600988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101732675|NCT04097574|Menthol|menthol|mesh-list
101732676|NCT04097574|Antipruritics|antipruritics|mesh-ancestor
101732677|NCT04097574|Dermatologic Agents|dermatologic agents|mesh-ancestor
101732678|NCT00766038|Hormones|hormones|mesh-list
101732679|NCT00766038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101732680|NCT00766038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732681|NCT00765882|Linaclotide|linaclotide|mesh-list
101732682|NCT00765882|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
101732683|NCT00765882|Enzyme Activators|enzyme activators|mesh-ancestor
101732684|NCT00765882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732685|NCT00765882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101732686|NCT00913367|Insulin|insulin|mesh-list
101732687|NCT00913367|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101732688|NCT00913367|Metformin|metformin|mesh-list
101732689|NCT00913367|Insulin Glargine|insulin glargine|mesh-list
101732690|NCT00913367|Glimepiride|glimepiride|mesh-list
101732691|NCT00913367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101732692|NCT00913367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732693|NCT00913367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101732694|NCT00913367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101732695|NCT00913367|Immunologic Factors|immunologic factors|mesh-ancestor
101732696|NCT00828113|Varenicline|varenicline|mesh-list
101732697|NCT00828113|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101732698|NCT00828113|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101732699|NCT00828113|Cholinergic Agents|cholinergic agents|mesh-ancestor
101732700|NCT00828113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101732701|NCT00828113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732702|NCT00828113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732704|NCT00707135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101732705|NCT00707135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101732706|NCT00707135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101732707|NCT00707135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101732708|NCT00707135|Antifungal Agents|antifungal agents|mesh-ancestor
101732709|NCT00707135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101732710|NCT00707135|Immunologic Factors|immunologic factors|mesh-ancestor
101732712|NCT00769704|Molgramostim|molgramostim|mesh-list
101732713|NCT00769704|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
101732714|NCT00769704|Sargramostim|sargramostim|mesh-list
101732715|NCT00769704|Immunologic Factors|immunologic factors|mesh-ancestor
101732716|NCT00769704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732717|NCT00769704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101732718|NCT00769704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101732719|NCT00818753|Heparin|heparin|mesh-list
101390169|NCT05605899|Doxorubicin|doxorubicin|mesh-list
101732720|NCT00818753|Calcium heparin|calcium heparin|mesh-list
101202728|NCT01412073|Abortifacient Agents|abortifacient agents|mesh-ancestor
101202729|NCT01412073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101732721|NCT00818753|Dabigatran|dabigatran|mesh-list
101732722|NCT00818753|Anticoagulants|anticoagulants|mesh-ancestor
101732723|NCT00818753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101732724|NCT00818753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101732725|NCT00818753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732727|NCT00818753|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101732728|NCT00818753|Protease Inhibitors|protease inhibitors|mesh-ancestor
101732729|NCT00818753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101732730|NCT00704249|Nevirapine|nevirapine|mesh-list
101732731|NCT00704249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101732732|NCT00704249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101732733|NCT00704249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101732734|NCT00704249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732735|NCT00704249|Antiviral Agents|antiviral agents|mesh-ancestor
101732736|NCT00704249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101732737|NCT00704249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101732738|NCT00704249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101732739|NCT00704249|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101732740|NCT00704249|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101732741|NCT00765726|Factor VIII|factor viii|mesh-list
101732742|NCT00765726|Coagulants|coagulants|mesh-ancestor
101732743|NCT04100226|Vitamin D|vitamin d|mesh-list
101732744|NCT04100226|Cholecalciferol|cholecalciferol|mesh-list
101732745|NCT04100226|Calcium Carbonate|calcium carbonate|mesh-list
101732746|NCT04100226|Vitamins|vitamins|mesh-ancestor
101732747|NCT04100226|Micronutrients|micronutrients|mesh-ancestor
101732749|NCT04100226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101732750|NCT04100226|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101732751|NCT04100226|Antacids|antacids|mesh-ancestor
101732752|NCT04100226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202776|NCT01412567|Vaccines|vaccines|mesh-list
101732753|NCT04100226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101732754|NCT00765336|Minocycline|minocycline|mesh-list
101732755|NCT00765336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101732756|NCT00765336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101732757|NCT00818519|Drospirenone|drospirenone|mesh-list
101732758|NCT00818519|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101732759|NCT00818519|Hormone Antagonists|hormone antagonists|mesh-ancestor
101732760|NCT00818519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101732761|NCT00818519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732762|NCT00818519|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101732763|NCT00818519|Diuretics|diuretics|mesh-ancestor
101732764|NCT00818519|Natriuretic Agents|natriuretic agents|mesh-ancestor
101732765|NCT00827567|Everolimus|everolimus|mesh-list
101732766|NCT00827567|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101732767|NCT00827567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101732768|NCT00827567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101732769|NCT00827567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732770|NCT00827567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101732771|NCT00827567|Immunologic Factors|immunologic factors|mesh-ancestor
101732772|NCT00827567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732773|NCT00827567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101732774|NCT00765102|Bortezomib|bortezomib|mesh-list
101732775|NCT00765102|Romidepsin|romidepsin|mesh-list
101732776|NCT00765102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101732777|NCT00765102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101732778|NCT00765102|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101732779|NCT00765102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101732780|NCT00765102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732781|NCT00809354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101732782|NCT00809354|Tanezumab|tanezumab|mesh-list
101732783|NCT00809354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101732784|NCT00809354|Analgesics|analgesics|mesh-ancestor
101732785|NCT00809354|Sensory System Agents|sensory system agents|mesh-ancestor
101732787|NCT00809354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732788|NCT00809354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101732789|NCT00809354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101732790|NCT00834899|Eptifibatide|eptifibatide|mesh-list
101732791|NCT00834899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101732792|NCT00764946|Raltegravir Potassium|raltegravir potassium|mesh-list
101732793|NCT00764946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101732794|NCT00764946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101732795|NCT00764946|Antiviral Agents|antiviral agents|mesh-ancestor
101732796|NCT00764946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101732797|NCT00764946|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101732798|NCT00764946|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101732800|NCT00764946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732801|NCT00764868|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101732802|NCT00764868|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101732803|NCT00764868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732804|NCT00764868|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101732805|NCT00764868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101732806|NCT00764868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101732807|NCT00764868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732808|NCT00764868|Dopamine Agents|dopamine agents|mesh-ancestor
101732809|NCT00764868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101732810|NCT03990896|Talazoparib|talazoparib|mesh-list
101732811|NCT03990896|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101732812|NCT03990896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101732813|NCT03990896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732814|NCT03990896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101732815|NCT00756444|Panitumumab|panitumumab|mesh-list
101732816|NCT00756444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101732817|NCT00756444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101732818|NCT00753012|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101732819|NCT00753012|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101732820|NCT00753012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732821|NCT00753012|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101732822|NCT00753012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101732823|NCT00753012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101732824|NCT00753012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732825|NCT00753012|Dopamine Agents|dopamine agents|mesh-ancestor
101732826|NCT00753012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101732827|NCT00806156|Etirinotecan pegol|etirinotecan pegol|mesh-list
101732828|NCT00806156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101732829|NCT00806156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101732830|NCT00806156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101732831|NCT00806156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101732832|NCT00806156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732833|NCT00764478|Asenapine|asenapine|mesh-list
101732834|NCT00764478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101732835|NCT00764478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101732836|NCT00764478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101732837|NCT00764478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732838|NCT00764478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101732839|NCT00805766|Infliximab|infliximab|mesh-list
101732840|NCT00805766|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101202870|NCT01413230|Cholecalciferol|cholecalciferol|mesh-list
101732841|NCT00805766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101732842|NCT00805766|Dermatologic Agents|dermatologic agents|mesh-ancestor
101732843|NCT00805766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101732844|NCT00805766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101732845|NCT00764322|Tamoxifen|tamoxifen|mesh-list
101732846|NCT00764322|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101732847|NCT00764322|Hormone Antagonists|hormone antagonists|mesh-ancestor
101732848|NCT00764322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101732849|NCT00764322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732850|NCT00764322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101732851|NCT00764322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101732852|NCT00764322|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101732853|NCT00764322|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101732854|NCT00764322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101732855|NCT03908060|Morphine|morphine|mesh-list
101732856|NCT03908060|Methadone|methadone|mesh-list
101732857|NCT03908060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101732859|NCT03908060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101732860|NCT03908060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732861|NCT03908060|Analgesics|analgesics|mesh-ancestor
101732862|NCT03908060|Sensory System Agents|sensory system agents|mesh-ancestor
101732863|NCT03908060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101732864|NCT03908060|Antitussive Agents|antitussive agents|mesh-ancestor
101732865|NCT03908060|Respiratory System Agents|respiratory system agents|mesh-ancestor
101732866|NCT00752856|Ritonavir|ritonavir|mesh-list
101732867|NCT00752856|Lopinavir|lopinavir|mesh-list
101732868|NCT00752856|Tenofovir|tenofovir|mesh-list
101732869|NCT00752856|Emtricitabine|emtricitabine|mesh-list
101732870|NCT00752856|Raltegravir Potassium|raltegravir potassium|mesh-list
101732871|NCT00752856|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101732872|NCT00752856|Efavirenz|efavirenz|mesh-list
101732873|NCT00752856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101732874|NCT00752856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101732875|NCT00752856|Protease Inhibitors|protease inhibitors|mesh-ancestor
101732876|NCT00752856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101732877|NCT00752856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202908|NCT01413620|Vitamins|vitamins|mesh-list
101732878|NCT00752856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101732879|NCT00752856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101732880|NCT00752856|Antiviral Agents|antiviral agents|mesh-ancestor
101732881|NCT00752856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101732882|NCT00752856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101732883|NCT00752856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101732884|NCT00752856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101732885|NCT00752856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101732886|NCT00752856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101732887|NCT00752856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101732888|NCT00752856|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101732889|NCT00752856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101732890|NCT00752856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101732891|NCT00752856|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101732892|NCT00752856|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101732893|NCT00805142|Tapentadol|tapentadol|mesh-list
101732894|NCT00805142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101732895|NCT00805142|Narcotics|narcotics|mesh-ancestor
101732896|NCT00805142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101732897|NCT00805142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732898|NCT00805142|Analgesics|analgesics|mesh-ancestor
101732899|NCT00805142|Sensory System Agents|sensory system agents|mesh-ancestor
101732900|NCT00805142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101732901|NCT00805142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101732902|NCT00805142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101732903|NCT00805142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101732904|NCT00805142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732905|NCT00805142|Adrenergic Agents|adrenergic agents|mesh-ancestor
101732906|NCT00805142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101732907|NCT00761631|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101732908|NCT00761631|Immunologic Factors|immunologic factors|mesh-ancestor
101732909|NCT00761631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732910|NCT00761319|Travoprost|travoprost|mesh-list
101732911|NCT00761319|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101732912|NCT00761319|Latanoprost|latanoprost|mesh-list
101732913|NCT00761319|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101732914|NCT00761319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101732915|NCT00704639|Carboplatin|carboplatin|mesh-list
101732916|NCT00704639|Cetuximab|cetuximab|mesh-list
101732917|NCT00704639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101732918|NCT00704639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101732919|NCT00826943|Cetirizine|cetirizine|mesh-list
101732920|NCT00826943|Levocetirizine|levocetirizine|mesh-list
101732921|NCT00826943|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101732922|NCT00826943|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101732923|NCT00826943|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101732924|NCT00826943|Histamine Antagonists|histamine antagonists|mesh-ancestor
101732925|NCT00826943|Histamine Agents|histamine agents|mesh-ancestor
101732926|NCT00826943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101732927|NCT00826943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732928|NCT00826943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732929|NCT00707369|Amoxicillin|amoxicillin|mesh-list
101732930|NCT00707369|Metronidazole|metronidazole|mesh-list
101732933|NCT00707369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101732934|NCT00707369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101732935|NCT00760929|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101732936|NCT00760929|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101732937|NCT00760929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101732938|NCT00760929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101732939|NCT00760929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101732940|NCT00760929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732941|NCT00760929|Immunologic Factors|immunologic factors|mesh-ancestor
101732942|NCT00760929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732943|NCT00704951|Posaconazole|posaconazole|mesh-list
101732944|NCT00704951|Antifungal Agents|antifungal agents|mesh-ancestor
101732945|NCT00704951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101732946|NCT00704951|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101732947|NCT00704951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101732948|NCT00704951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101732949|NCT00704951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101732950|NCT00704951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101732951|NCT00704951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101732952|NCT00704951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732953|NCT00704951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101732954|NCT00704951|Hormone Antagonists|hormone antagonists|mesh-ancestor
101732955|NCT00704951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101807428|NCT00105469|Tobramycin|tobramycin|mesh-list
101732956|NCT00704951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732958|NCT00759915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101732959|NCT00759915|Narcotics|narcotics|mesh-ancestor
101732960|NCT00759915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101732961|NCT00759915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732962|NCT00759915|Analgesics|analgesics|mesh-ancestor
101732963|NCT00759915|Sensory System Agents|sensory system agents|mesh-ancestor
101732964|NCT00759915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101732965|NCT00759759|Morphine|morphine|mesh-list
101732966|NCT00759759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101732967|NCT00759759|Narcotics|narcotics|mesh-ancestor
101732968|NCT00759759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101732969|NCT00759759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732970|NCT00759759|Analgesics|analgesics|mesh-ancestor
101732971|NCT00759759|Sensory System Agents|sensory system agents|mesh-ancestor
101732972|NCT00759759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101732973|NCT00759681|Thrombin|thrombin|mesh-list
101732974|NCT00759681|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
101732975|NCT00759681|Hemostatics|hemostatics|mesh-ancestor
101732976|NCT00759681|Coagulants|coagulants|mesh-ancestor
101732977|NCT00826241|Temozolomide|temozolomide|mesh-list
101732978|NCT00826241|Lapatinib|lapatinib|mesh-list
101732979|NCT00826241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101732980|NCT00826241|Alkylating Agents|alkylating agents|mesh-ancestor
101732981|NCT00826241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202959|NCT01414231|Immunologic Factors|immunologic factors|mesh-ancestor
101202960|NCT01414231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732982|NCT00826241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101732983|NCT00826241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101732984|NCT00826241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101732985|NCT04097847|Clodronic Acid|clodronic acid|mesh-list
101732986|NCT04097847|Tocopherols|tocopherols|mesh-list
101732988|NCT04097847|Tocotrienols|tocotrienols|mesh-list
101732989|NCT04097847|alpha-Tocopherol|alpha-tocopherol|mesh-list
101732990|NCT04097847|Pentoxifylline|pentoxifylline|mesh-list
101732991|NCT04097847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101732992|NCT04097847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101732993|NCT04097847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101732994|NCT04097847|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101732995|NCT04097847|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101732996|NCT04097847|Protective Agents|protective agents|mesh-ancestor
101732997|NCT04097847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101732998|NCT04097847|Vasodilator Agents|vasodilator agents|mesh-ancestor
101732999|NCT04097847|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101733000|NCT04097847|Antioxidants|antioxidants|mesh-ancestor
101733001|NCT04097847|Vitamins|vitamins|mesh-ancestor
101733002|NCT04097847|Micronutrients|micronutrients|mesh-ancestor
101733003|NCT04097847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101733004|NCT00762372|Nitrous Oxide|nitrous oxide|mesh-list
101733005|NCT00762372|Sevoflurane|sevoflurane|mesh-list
101733006|NCT00762372|Desflurane|desflurane|mesh-list
101733007|NCT00762372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101733009|NCT00762372|Anesthetics, General|anesthetics, general|mesh-ancestor
101733010|NCT00762372|Anesthetics|anesthetics|mesh-ancestor
101733011|NCT00762372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101733012|NCT00762372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733013|NCT00762372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101733014|NCT00762372|Analgesics|analgesics|mesh-ancestor
101390467|NCT05536154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101733015|NCT00762372|Sensory System Agents|sensory system agents|mesh-ancestor
101733016|NCT00762372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101733017|NCT00833261|Paclitaxel|paclitaxel|mesh-list
101733019|NCT00833261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101733020|NCT00833261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101733021|NCT00833261|Tubulin Modulators|tubulin modulators|mesh-ancestor
101733022|NCT00833261|Antimitotic Agents|antimitotic agents|mesh-ancestor
101733023|NCT00833261|Mitosis Modulators|mitosis modulators|mesh-ancestor
101733024|NCT00833261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733025|NCT00833261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101733026|NCT00833027|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101733027|NCT00833027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101733028|NCT00833027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733031|NCT00833027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101733032|NCT00833027|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101733033|NCT00833027|Protease Inhibitors|protease inhibitors|mesh-ancestor
101733034|NCT00833027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101733035|NCT00833027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733036|NCT00752622|Infliximab|infliximab|mesh-list
101733037|NCT00752622|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101733038|NCT00752622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101733039|NCT00752622|Dermatologic Agents|dermatologic agents|mesh-ancestor
101733040|NCT00752622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101733041|NCT00752622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101733042|NCT00754650|Bevacizumab|bevacizumab|mesh-list
101733043|NCT00754650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101733044|NCT00754650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101733045|NCT00754650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101733046|NCT00754650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101733047|NCT00754650|Growth Substances|growth substances|mesh-ancestor
101733048|NCT00754650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733049|NCT00754650|Growth Inhibitors|growth inhibitors|mesh-ancestor
101733050|NCT02611271|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101733051|NCT02611271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101733052|NCT00825305|Vaccines|vaccines|mesh-list
101733053|NCT00825305|Immunologic Factors|immunologic factors|mesh-ancestor
101733054|NCT00825305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733055|NCT00754572|Methotrexate|methotrexate|mesh-list
101733056|NCT00754572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101203025|NCT01414881|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101733058|NCT00754572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101733059|NCT00754572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733060|NCT00754572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101733061|NCT00754572|Antimetabolites|antimetabolites|mesh-ancestor
101733062|NCT00754572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733063|NCT00754572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101733064|NCT00754572|Dermatologic Agents|dermatologic agents|mesh-ancestor
101733065|NCT00754572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101733066|NCT00754572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101733067|NCT00754572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101733068|NCT00754572|Immunologic Factors|immunologic factors|mesh-ancestor
101733069|NCT00754572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101733070|NCT00754572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101733071|NCT00824993|Ibandronic Acid|ibandronic acid|mesh-list
101733072|NCT00824993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733073|NCT00824993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101733074|NCT04095312|Pancrelipase|pancrelipase|mesh-list
101733075|NCT04095312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101733076|NCT04095390|Capecitabine|capecitabine|mesh-list
101733077|NCT04095390|Letrozole|letrozole|mesh-list
101733078|NCT04095390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101733079|NCT04095390|Antimetabolites|antimetabolites|mesh-ancestor
101263182|NCT01760642|Antifungal Agents|antifungal agents|mesh-ancestor
101733080|NCT04095390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733082|NCT04095390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101733083|NCT04095390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101733084|NCT04095390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101733085|NCT04095390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101364568|NCT04725682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101733087|NCT04095390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101733088|NCT04095390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733089|NCT00754338|Dipivefrin|dipivefrin|mesh-list
101733090|NCT00754338|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101733091|NCT00754338|Adrenergic Agents|adrenergic agents|mesh-ancestor
101733092|NCT00754338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101733093|NCT00754338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733094|NCT00754338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733095|NCT00708149|Lansoprazole|lansoprazole|mesh-list
101733096|NCT00708149|Dexlansoprazole|dexlansoprazole|mesh-list
101733097|NCT00708149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101733098|NCT00708149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101733099|NCT00708149|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101733100|NCT00708149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101733101|NCT00708149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733102|NCT04016051|Clarithromycin|clarithromycin|mesh-list
101733103|NCT04016051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101733104|NCT04016051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101733105|NCT04016051|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101733106|NCT04016051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101733107|NCT04016051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733108|NCT04016051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101733109|NCT04016051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101733111|NCT00761514|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101733112|NCT00761514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101733113|NCT00761514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101733114|NCT00831779|Dapagliflozin|dapagliflozin|mesh-list
101733115|NCT00831779|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101733116|NCT00831779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733117|NCT00831779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101733118|NCT00831779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733119|NCT00758043|Ribavirin|ribavirin|mesh-list
101733120|NCT00758043|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101733121|NCT00758043|Antimetabolites|antimetabolites|mesh-ancestor
101733122|NCT00758043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733123|NCT00758043|Antiviral Agents|antiviral agents|mesh-ancestor
101733124|NCT00758043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101733125|NCT00831701|Tamsulosin|tamsulosin|mesh-list
101733126|NCT00831701|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101733127|NCT00831701|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101733128|NCT00831701|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101733129|NCT00831701|Adrenergic Agents|adrenergic agents|mesh-ancestor
101733130|NCT00831701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101733131|NCT00831701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733132|NCT00831701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733133|NCT00831701|Urological Agents|urological agents|mesh-ancestor
101733134|NCT00705419|Tenofovir|tenofovir|mesh-list
101733135|NCT00705419|Emtricitabine|emtricitabine|mesh-list
101733136|NCT00705419|Maleic acid|maleic acid|mesh-list
101733137|NCT00705419|Antiviral Agents|antiviral agents|mesh-ancestor
101733138|NCT00705419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101733139|NCT00705419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101733140|NCT00705419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101733141|NCT00705419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101733142|NCT00705419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733143|NCT00705419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101733144|NCT00705419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101733145|NCT05425355|Acetaminophen|acetaminophen|mesh-list
101733146|NCT05425355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101733147|NCT05425355|Analgesics|analgesics|mesh-ancestor
101807480|NCT00105235|Antifungal Agents|antifungal agents|mesh-ancestor
101733148|NCT05425355|Sensory System Agents|sensory system agents|mesh-ancestor
101733149|NCT05425355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101733150|NCT05425355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733151|NCT05425355|Antipyretics|antipyretics|mesh-ancestor
101733153|NCT04093713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101733154|NCT00831311|Vaccines|vaccines|mesh-list
101733155|NCT00831311|Immunologic Factors|immunologic factors|mesh-ancestor
101733156|NCT00831311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733157|NCT00831233|Goserelin|goserelin|mesh-list
101733158|NCT00831233|Bicalutamide|bicalutamide|mesh-list
101733159|NCT00831233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101733160|NCT00831233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101733161|NCT00831233|Androgen Antagonists|androgen antagonists|mesh-ancestor
101733162|NCT00831233|Hormone Antagonists|hormone antagonists|mesh-ancestor
101733163|NCT00831233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101733164|NCT00831233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733165|NCT05438277|Methylprednisolone|methylprednisolone|mesh-list
101733166|NCT05438277|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101733167|NCT05438277|Triamcinolone|triamcinolone|mesh-list
101733169|NCT05438277|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101733170|NCT05438277|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101733171|NCT05438277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101733172|NCT05438277|Antiemetics|antiemetics|mesh-ancestor
101733173|NCT05438277|Autonomic Agents|autonomic agents|mesh-ancestor
101733174|NCT05438277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101733175|NCT05438277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733176|NCT05438277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101733177|NCT05438277|Glucocorticoids|glucocorticoids|mesh-ancestor
101733178|NCT05438277|Hormones|hormones|mesh-ancestor
101733179|NCT05438277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101733180|NCT05438277|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101733181|NCT05438277|Protective Agents|protective agents|mesh-ancestor
101733182|NCT05438277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101733183|NCT05438277|Immunologic Factors|immunologic factors|mesh-ancestor
101203124|NCT01415596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101733184|NCT05438277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101733185|NCT05438277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733187|NCT00761280|Carmustine|carmustine|mesh-list
101733188|NCT00761280|Lomustine|lomustine|mesh-list
101733189|NCT00761280|Trabedersen|trabedersen|mesh-list
101733190|NCT00761280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101733191|NCT00761280|Alkylating Agents|alkylating agents|mesh-ancestor
101733192|NCT00761280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733193|NCT00761280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101733194|NCT00916890|Fentanyl|fentanyl|mesh-list
101733195|NCT00916890|Morphine|morphine|mesh-list
101733196|NCT00916890|Oxycodone|oxycodone|mesh-list
101733197|NCT00916890|Buprenorphine|buprenorphine|mesh-list
101733198|NCT00916890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101733199|NCT00916890|Narcotics|narcotics|mesh-ancestor
101733200|NCT00916890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101733201|NCT00916890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733202|NCT00916890|Analgesics|analgesics|mesh-ancestor
101733203|NCT00916890|Sensory System Agents|sensory system agents|mesh-ancestor
101733204|NCT00916890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101733205|NCT00916890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101733206|NCT00916890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101733207|NCT00916890|Anesthetics, General|anesthetics, general|mesh-ancestor
101733208|NCT00916890|Anesthetics|anesthetics|mesh-ancestor
101733209|NCT00916890|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101733210|NCT02599701|Gabapentin|gabapentin|mesh-list
101733211|NCT02599701|Analgesics|analgesics|mesh-ancestor
101733212|NCT02599701|Sensory System Agents|sensory system agents|mesh-ancestor
101733213|NCT02599701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101807490|NCT03962803|Vaccines|vaccines|mesh-list
101733214|NCT02599701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733216|NCT02599701|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101733217|NCT02599701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101203175|NCT01415765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101733218|NCT02599701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101733219|NCT02599701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101733220|NCT02599701|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101733221|NCT02599701|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101733222|NCT02599701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101733223|NCT02599701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733224|NCT02599701|Antimanic Agents|antimanic agents|mesh-ancestor
101733225|NCT00824291|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101733226|NCT00824291|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101733227|NCT00824291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101733228|NCT00824291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101733229|NCT00824291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733230|NCT00824291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101733231|NCT00824291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733232|NCT00824291|Antidepressive Agents|antidepressive agents|mesh-ancestor
101733233|NCT00824291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101733234|NCT00752232|Saponin QA-21V1|saponin qa-21v1|mesh-list
101733235|NCT00752232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101733236|NCT00752232|Immunologic Factors|immunologic factors|mesh-ancestor
101733237|NCT00752232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733238|NCT00760266|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101733239|NCT00760266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101733241|NCT00760266|Natriuretic Agents|natriuretic agents|mesh-ancestor
101733242|NCT00760266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733243|NCT00760266|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101733244|NCT00760266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101733245|NCT00760266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733246|NCT00753714|Gemcitabine|gemcitabine|mesh-list
101733247|NCT00753714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101733248|NCT00753714|Antimetabolites|antimetabolites|mesh-ancestor
101733249|NCT00753714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733250|NCT00753714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101733251|NCT00759954|Morphine|morphine|mesh-list
101733252|NCT00759954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101733253|NCT00759954|Narcotics|narcotics|mesh-ancestor
101733254|NCT00759954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101733255|NCT00759954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733256|NCT00759954|Analgesics|analgesics|mesh-ancestor
101733257|NCT00759954|Sensory System Agents|sensory system agents|mesh-ancestor
101733258|NCT00759954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101733259|NCT00804908|Temozolomide|temozolomide|mesh-list
101733260|NCT00804908|Veliparib|veliparib|mesh-list
101733261|NCT00804908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101733262|NCT00804908|Alkylating Agents|alkylating agents|mesh-ancestor
101733263|NCT00804908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733264|NCT00804908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101733265|NCT00804908|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101733266|NCT00804908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101733268|NCT02608034|Rifampin|rifampin|mesh-list
101733269|NCT02608034|Vemurafenib|vemurafenib|mesh-list
101733270|NCT02608034|Antifungal Agents|antifungal agents|mesh-ancestor
101203221|NCT01416038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101733271|NCT02608034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101733272|NCT02608034|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101733273|NCT02608034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101733274|NCT02608034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101733275|NCT02608034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733276|NCT02608034|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101733277|NCT02608034|Hormone Antagonists|hormone antagonists|mesh-ancestor
101733278|NCT02608034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101733279|NCT02608034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733280|NCT02608034|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101733281|NCT02608034|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101733282|NCT02608034|Antitubercular Agents|antitubercular agents|mesh-ancestor
101733283|NCT02608034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101733284|NCT02608034|Leprostatic Agents|leprostatic agents|mesh-ancestor
101733285|NCT02608034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101733286|NCT02608034|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101733287|NCT02608034|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101733288|NCT02608034|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101733289|NCT02608034|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101733290|NCT02608034|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101733291|NCT02608034|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101733292|NCT02608034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101733293|NCT02608034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101733295|NCT00589784|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-list
101203239|NCT01416116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101203241|NCT01416116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101733296|NCT00589784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101733297|NCT00589784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101733298|NCT00589784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101733299|NCT00589784|Growth Substances|growth substances|mesh-ancestor
101733300|NCT00589784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733301|NCT00589784|Growth Inhibitors|growth inhibitors|mesh-ancestor
101733302|NCT00589784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101733303|NCT00589784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101733304|NCT00589784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733305|NCT00589784|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101733307|NCT05742854|Carbetocin|carbetocin|mesh-list
101733308|NCT05742854|Oxytocics|oxytocics|mesh-ancestor
101733309|NCT05742854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101733310|NCT05742854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733311|NCT00823979|Etravirine|etravirine|mesh-list
101733312|NCT00823979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101733313|NCT00823979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101733314|NCT00823979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101733315|NCT00823979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733317|NCT00823979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101733318|NCT04094766|Immunomodulating Agents|immunomodulating agents|mesh-list
101733319|NCT04094766|Immunologic Factors|immunologic factors|mesh-ancestor
101733320|NCT04094766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733321|NCT02606864|Nifurtimox|nifurtimox|mesh-list
101733322|NCT02606864|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101733323|NCT02606864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101733324|NCT02606864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101733325|NCT02606864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101733326|NCT00823901|Clindamycin|clindamycin|mesh-list
101733327|NCT00823901|Clindamycin palmitate|clindamycin palmitate|mesh-list
101733328|NCT00823901|Clindamycin phosphate|clindamycin phosphate|mesh-list
101733329|NCT00823901|Tretinoin|tretinoin|mesh-list
101733330|NCT00823901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101733331|NCT00823901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101733332|NCT00823901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101733333|NCT00823901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101733334|NCT00823901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733335|NCT00823901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101733336|NCT00823901|Keratolytic Agents|keratolytic agents|mesh-ancestor
101733337|NCT00823901|Dermatologic Agents|dermatologic agents|mesh-ancestor
101733338|NCT00823823|Calpastatin|calpastatin|mesh-list
101733339|NCT00823823|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
101733340|NCT00823823|Protease Inhibitors|protease inhibitors|mesh-ancestor
101733341|NCT00823823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101733342|NCT00823823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203294|NCT01416480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101733343|NCT02926898|Fenfluramine|fenfluramine|mesh-list
101733344|NCT02926898|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101733345|NCT02926898|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101733346|NCT02926898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101733347|NCT02926898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733348|NCT02926898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101733349|NCT02926898|Serotonin Agents|serotonin agents|mesh-ancestor
101733350|NCT02926898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733351|NCT00759564|Lactams|lactams|mesh-list
101733352|NCT00759564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101733353|NCT00759564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101733354|NCT00816023|Ecallantide|ecallantide|mesh-list
101733355|NCT00816023|Analgesics|analgesics|mesh-ancestor
101733356|NCT00816023|Sensory System Agents|sensory system agents|mesh-ancestor
101733357|NCT00816023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101733358|NCT00816023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364576|NCT00043095|Gemcitabine|gemcitabine|mesh-list
101733359|NCT00816023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101733360|NCT00816023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101733361|NCT00816023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101733362|NCT00816023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101733363|NCT00815633|Alefacept|alefacept|mesh-list
101733364|NCT00815633|Dermatologic Agents|dermatologic agents|mesh-ancestor
101733365|NCT00815633|Immunologic Factors|immunologic factors|mesh-ancestor
101733366|NCT00815633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733367|NCT02610881|Iron|iron|mesh-list
101733368|NCT02610881|Trace Elements|trace elements|mesh-list
101733369|NCT02610881|Folic Acid|folic acid|mesh-list
101733370|NCT02610881|Micronutrients|micronutrients|mesh-list
101733371|NCT02610881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733372|NCT02610881|Hematinics|hematinics|mesh-ancestor
101733373|NCT02610881|Vitamin B Complex|vitamin b complex|mesh-ancestor
101733374|NCT02610881|Vitamins|vitamins|mesh-ancestor
101733375|NCT00830765|Progesterone|progesterone|mesh-list
101733376|NCT00830765|Progestins|progestins|mesh-ancestor
101733377|NCT00830765|Hormones|hormones|mesh-ancestor
101733378|NCT00830765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101733379|NCT00830765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733380|NCT04093206|Vitamins|vitamins|mesh-list
101733381|NCT04093206|Ascorbic Acid|ascorbic acid|mesh-list
101733382|NCT04093206|Micronutrients|micronutrients|mesh-ancestor
101733383|NCT04093206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733384|NCT04093206|Antioxidants|antioxidants|mesh-ancestor
101733385|NCT04093206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733386|NCT04093206|Protective Agents|protective agents|mesh-ancestor
101733387|NCT00830375|Memantine|memantine|mesh-list
101733388|NCT00830375|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101733389|NCT00830375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101733390|NCT00830375|Dopamine Agents|dopamine agents|mesh-ancestor
101733391|NCT00830375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101733392|NCT00830375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733393|NCT00830375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733394|NCT00830375|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101733395|NCT00830375|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101733396|NCT00708539|Progesterone|progesterone|mesh-list
101733397|NCT00708539|Progestins|progestins|mesh-ancestor
101733399|NCT00708539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101733400|NCT00708539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733401|NCT00914420|Trapidil|trapidil|mesh-list
101733402|NCT00914420|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101733403|NCT00914420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101733404|NCT00914420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733405|NCT00914420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101733406|NCT00914420|Vasodilator Agents|vasodilator agents|mesh-ancestor
101733407|NCT04094532|Bupivacaine|bupivacaine|mesh-list
101733408|NCT04094532|Anesthetics, Local|anesthetics, local|mesh-ancestor
101733409|NCT04094532|Anesthetics|anesthetics|mesh-ancestor
101733410|NCT04094532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101733411|NCT04094532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733412|NCT04094532|Sensory System Agents|sensory system agents|mesh-ancestor
101733413|NCT04094532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101733414|NCT00708773|Irinotecan|irinotecan|mesh-list
101733415|NCT00708773|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101733416|NCT00708773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101733417|NCT00708773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101733418|NCT00708773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733419|NCT00708773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101733420|NCT05758259|Vitamin D|vitamin d|mesh-list
101733421|NCT05758259|Ergocalciferols|ergocalciferols|mesh-list
101733422|NCT05758259|Cholecalciferol|cholecalciferol|mesh-list
101733423|NCT05758259|Vitamins|vitamins|mesh-list
101733424|NCT05758259|Micronutrients|micronutrients|mesh-ancestor
101733425|NCT05758259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733426|NCT05758259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101733427|NCT05758259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101733428|NCT00803738|Terconazole|terconazole|mesh-list
101733429|NCT00803738|Antifungal Agents|antifungal agents|mesh-ancestor
101733430|NCT00803738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101733431|NCT00591266|Amlodipine|amlodipine|mesh-list
101733432|NCT00591266|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
101733433|NCT00591266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101733434|NCT00591266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101733435|NCT00591266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101733436|NCT00591266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733437|NCT00591266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101733438|NCT00591266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733439|NCT00591266|Vasodilator Agents|vasodilator agents|mesh-ancestor
101733440|NCT00591266|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101733441|NCT00591266|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101733442|NCT04093050|Vasopressins|vasopressins|mesh-list
101733443|NCT04093050|Hemostatics|hemostatics|mesh-ancestor
101733444|NCT04093050|Coagulants|coagulants|mesh-ancestor
101733445|NCT04093050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101733446|NCT04093050|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101733447|NCT04093050|Natriuretic Agents|natriuretic agents|mesh-ancestor
101733448|NCT04093050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733450|NCT00758394|Triclosan|triclosan|mesh-list
101733451|NCT00758394|Fluorides|fluorides|mesh-list
101733452|NCT00758394|Sodium Fluoride|sodium fluoride|mesh-list
101733453|NCT00758394|Fluorophosphate|fluorophosphate|mesh-list
101733454|NCT00758394|Cariostatic Agents|cariostatic agents|mesh-ancestor
101733455|NCT00758394|Protective Agents|protective agents|mesh-ancestor
101733456|NCT00758394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733457|NCT00758394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101733458|NCT00758394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101733459|NCT00758394|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101733460|NCT00758394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101733461|NCT00758394|Antimetabolites|antimetabolites|mesh-ancestor
101733462|NCT00758394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733463|NCT00758394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101733464|NCT04450394|Insulin|insulin|mesh-list
101733465|NCT04450394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101733466|NCT04450394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733467|NCT00758160|Methylphenidate|methylphenidate|mesh-list
101733468|NCT00758160|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101733469|NCT00758160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733470|NCT00758160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101733471|NCT00758160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101733472|NCT00758160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101733473|NCT00758160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733474|NCT00758160|Dopamine Agents|dopamine agents|mesh-ancestor
101733475|NCT00758160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101733477|NCT02606552|Clopidogrel|clopidogrel|mesh-list
101733478|NCT02606552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101733479|NCT02606552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101203391|NCT01417169|Micafungin|micafungin|mesh-list
101733480|NCT02606552|Analgesics|analgesics|mesh-ancestor
101733481|NCT02606552|Sensory System Agents|sensory system agents|mesh-ancestor
101733482|NCT02606552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101733483|NCT02606552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733484|NCT02606552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101733485|NCT02606552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101733486|NCT02606552|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101733487|NCT02606552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101733488|NCT02606552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733489|NCT02606552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101733490|NCT02606552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101733491|NCT02606552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101733492|NCT02606552|Antipyretics|antipyretics|mesh-ancestor
101733493|NCT02606552|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101733494|NCT02606552|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101733495|NCT02606552|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101733496|NCT02606552|Purinergic Agents|purinergic agents|mesh-ancestor
101733497|NCT02606552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101733498|NCT02852486|Pioglitazone|pioglitazone|mesh-list
101733499|NCT02852486|Imatinib Mesylate|imatinib mesylate|mesh-list
101733500|NCT02852486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101733501|NCT02852486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733502|NCT02852486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101733503|NCT02852486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101733504|NCT02852486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101733505|NCT02852486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733506|NCT02608736|Valproic Acid|valproic acid|mesh-list
101733507|NCT02608736|Anticonvulsants|anticonvulsants|mesh-ancestor
101733508|NCT02608736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101203424|NCT01417403|Hydroxychloroquine|hydroxychloroquine|mesh-list
101807552|NCT00545688|Docetaxel|docetaxel|mesh-list
101733509|NCT02608736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733510|NCT02608736|GABA Agents|gaba agents|mesh-ancestor
101733511|NCT02608736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101733512|NCT02608736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733513|NCT02608736|Antimanic Agents|antimanic agents|mesh-ancestor
101733514|NCT02608736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101733515|NCT02608736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101733516|NCT02608736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101733518|NCT02607410|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101733519|NCT02607410|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101733520|NCT02607410|Insulin, Isophane|insulin, isophane|mesh-list
101733521|NCT02607410|Isophane Insulin, Human|isophane insulin, human|mesh-list
101733522|NCT02607410|Isophane insulin, beef|isophane insulin, beef|mesh-list
101733523|NCT02607410|Insulin, Long-Acting|insulin, long-acting|mesh-list
101733524|NCT02607410|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
101733525|NCT02607410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101733526|NCT02607410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733527|NCT02607410|Incretins|incretins|mesh-ancestor
101733528|NCT02607410|Hormones|hormones|mesh-ancestor
101733529|NCT02607410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101733530|NCT02607410|Protease Inhibitors|protease inhibitors|mesh-ancestor
101733531|NCT02607410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101733532|NCT02607410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733533|NCT05693090|Osimertinib|osimertinib|mesh-list
101733534|NCT05693090|Tipifarnib|tipifarnib|mesh-list
101733535|NCT05693090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101733536|NCT05693090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101733537|NCT05693090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101733538|NCT05693090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733539|NCT00751296|Lenalidomide|lenalidomide|mesh-list
101733540|NCT00751296|Immunologic Factors|immunologic factors|mesh-ancestor
101733541|NCT00751296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733542|NCT00751296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101733543|NCT00751296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101733544|NCT00751296|Growth Substances|growth substances|mesh-ancestor
101733545|NCT00751296|Growth Inhibitors|growth inhibitors|mesh-ancestor
101733546|NCT00751296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101733547|NCT04093518|Estradiol|estradiol|mesh-list
101733548|NCT04093518|Estrogens|estrogens|mesh-ancestor
101733549|NCT04093518|Hormones|hormones|mesh-ancestor
101733550|NCT04093518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101733551|NCT04093518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733552|NCT02606084|Esketamine|esketamine|mesh-list
101733553|NCT02606084|Antidepressive Agents|antidepressive agents|mesh-ancestor
101733554|NCT02606084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101733555|NCT02607488|Lidocaine|lidocaine|mesh-list
101733556|NCT02607488|Anesthetics, Local|anesthetics, local|mesh-ancestor
101733557|NCT02607488|Anesthetics|anesthetics|mesh-ancestor
101733558|NCT02607488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101733559|NCT02607488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733560|NCT02607488|Sensory System Agents|sensory system agents|mesh-ancestor
101733561|NCT02607488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101733562|NCT02607488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101733563|NCT02607488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101733564|NCT02607488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101733565|NCT02607488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101733566|NCT02607488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733567|NCT00914498|Lidocaine|lidocaine|mesh-list
101733568|NCT00914498|Anesthetics, Local|anesthetics, local|mesh-ancestor
101733569|NCT00914498|Anesthetics|anesthetics|mesh-ancestor
101807569|NCT00546078|Vaccines|vaccines|mesh-list
101364597|NCT00147628|Citric Acid|citric acid|mesh-list
101733570|NCT00914498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101733571|NCT00914498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733572|NCT00914498|Sensory System Agents|sensory system agents|mesh-ancestor
101733573|NCT00914498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101733574|NCT00914498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101733575|NCT00914498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101733576|NCT00914498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101733577|NCT00914498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101733578|NCT00914498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733580|NCT00751881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101733581|NCT00751881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101733582|NCT00751881|Analgesics|analgesics|mesh-ancestor
101733583|NCT00751881|Sensory System Agents|sensory system agents|mesh-ancestor
101733584|NCT00751881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101733585|NCT00751881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733586|NCT00751881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101733587|NCT00751881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101733588|NCT00751881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101733589|NCT00751881|Immunologic Factors|immunologic factors|mesh-ancestor
101733590|NCT02599779|Pembrolizumab|pembrolizumab|mesh-list
101733591|NCT02599779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101733592|NCT02599779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101733593|NCT02599779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101733594|NCT02599779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733595|NCT02597556|Albendazole|albendazole|mesh-list
101733596|NCT02597556|Anthelmintics|anthelmintics|mesh-ancestor
101733597|NCT02597556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101733598|NCT02597556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101733599|NCT02597556|Anticestodal Agents|anticestodal agents|mesh-ancestor
101733600|NCT02597556|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101733601|NCT02597556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101733602|NCT02597556|Tubulin Modulators|tubulin modulators|mesh-ancestor
101733603|NCT02597556|Antimitotic Agents|antimitotic agents|mesh-ancestor
101733604|NCT02597556|Mitosis Modulators|mitosis modulators|mesh-ancestor
101733605|NCT02597556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733606|NCT02597556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101733607|NCT02599857|Bisoprolol|bisoprolol|mesh-list
101733608|NCT02599857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101733609|NCT02599857|Sympatholytics|sympatholytics|mesh-ancestor
101733610|NCT02599857|Autonomic Agents|autonomic agents|mesh-ancestor
101733611|NCT02599857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101733612|NCT02599857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733613|NCT02599857|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101733614|NCT02599857|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101733615|NCT02599857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101733617|NCT02599857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101733618|NCT02599857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733619|NCT05406726|Palmidrol|palmidrol|mesh-list
101733620|NCT05406726|Analgesics|analgesics|mesh-ancestor
101733621|NCT05406726|Sensory System Agents|sensory system agents|mesh-ancestor
101733622|NCT05406726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101733623|NCT05406726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733624|NCT05406726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101733625|NCT05406726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101733626|NCT05406726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101733627|NCT05406726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101733628|NCT05406726|Antiviral Agents|antiviral agents|mesh-ancestor
101733629|NCT05406726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101733630|NCT05406726|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101733631|NCT05406726|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101733632|NCT05406726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101203540|NCT01418118|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101203541|NCT01418118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101733633|NCT05406726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364600|NCT00147628|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101733635|NCT05406726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101733636|NCT02599623|Anesthetics|anesthetics|mesh-list
101733637|NCT02599623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101733638|NCT02599623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733639|NCT02597400|Metformin|metformin|mesh-list
101733640|NCT02597400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101733641|NCT02597400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733642|NCT00830063|Naproxen|naproxen|mesh-list
101733643|NCT00830063|Tanezumab|tanezumab|mesh-list
101733644|NCT00830063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101733645|NCT00830063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101733646|NCT00830063|Analgesics|analgesics|mesh-ancestor
101733647|NCT00830063|Sensory System Agents|sensory system agents|mesh-ancestor
101733648|NCT00830063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101733649|NCT00830063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733650|NCT00830063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101733651|NCT00830063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101733652|NCT00830063|Gout Suppressants|gout suppressants|mesh-ancestor
101733653|NCT00830063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101733654|NCT00830063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101733655|NCT00830063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733656|NCT04092621|Amiodarone|amiodarone|mesh-list
101733657|NCT04092621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101733658|NCT04092621|Vasodilator Agents|vasodilator agents|mesh-ancestor
101733659|NCT04092621|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101733660|NCT04092621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101733661|NCT04092621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733662|NCT04092621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101733663|NCT04092621|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101733664|NCT04092621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101733665|NCT04092621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101733666|NCT04092621|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101733667|NCT04092621|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101733668|NCT04092621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101733670|NCT00751101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101733671|NCT00751101|Autonomic Agents|autonomic agents|mesh-ancestor
101733672|NCT00751101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101733673|NCT00751101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733674|NCT00751101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101733675|NCT00751101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101733676|NCT00751101|Cholinergic Agents|cholinergic agents|mesh-ancestor
101733677|NCT00751101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101733678|NCT00751101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733679|NCT04092309|Valsartan|valsartan|mesh-list
101733680|NCT04092309|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101733681|NCT04092309|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101733682|NCT04092309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101733683|NCT04092309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101733684|NCT04092309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101391138|NCT05263284|Adenosine|adenosine|mesh-list
101733685|NCT04092309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733686|NCT04092309|Protease Inhibitors|protease inhibitors|mesh-ancestor
101733687|NCT04092309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101733689|NCT02598414|Cariostatic Agents|cariostatic agents|mesh-ancestor
101733690|NCT02598414|Protective Agents|protective agents|mesh-ancestor
101733691|NCT02598414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733692|NCT04020003|Simendan|simendan|mesh-list
101733693|NCT04020003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101807596|NCT00546000|Fluticasone|fluticasone|mesh-list
101733694|NCT04020003|Vasodilator Agents|vasodilator agents|mesh-ancestor
101733695|NCT04020003|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101733696|NCT04020003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101733697|NCT04020003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101733698|NCT04020003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733699|NCT04020003|Protective Agents|protective agents|mesh-ancestor
101733700|NCT04020003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733701|NCT03977142|Chrysarobin|chrysarobin|mesh-list
101733702|NCT03977142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101733703|NCT03977142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101733704|NCT03977142|Analgesics|analgesics|mesh-ancestor
101733705|NCT03977142|Sensory System Agents|sensory system agents|mesh-ancestor
101733706|NCT03977142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101203610|NCT01418417|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101733707|NCT03977142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733708|NCT03977142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101733709|NCT03977142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101733711|NCT00751023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101733712|NCT00751023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733713|NCT00751023|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101733714|NCT00751023|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101733715|NCT00751023|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101733716|NCT00751023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733717|NCT00917592|Amoxicillin|amoxicillin|mesh-list
101733718|NCT00917592|Clavulanic Acids|clavulanic acids|mesh-list
101733719|NCT00917592|Clavulanic Acid|clavulanic acid|mesh-list
101733720|NCT00917592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101733721|NCT00917592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101733722|NCT00917592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101733723|NCT00917592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733724|NCT00917592|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101733725|NCT04091412|3-n-butylphthalide|3-n-butylphthalide|mesh-list
101733726|NCT04091412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101733727|NCT04091412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101733728|NCT04091412|Protective Agents|protective agents|mesh-ancestor
101733729|NCT04091412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203651|NCT01418586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101733730|NCT02599311|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101733731|NCT02599311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101733732|NCT02599311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101733733|NCT02599311|Cholinergic Agents|cholinergic agents|mesh-ancestor
101733734|NCT02599311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101733735|NCT02599311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733736|NCT02599311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733737|NCT02599311|Urological Agents|urological agents|mesh-ancestor
101733738|NCT00591773|Chlorthalidone|chlorthalidone|mesh-list
101733739|NCT00591773|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
101733740|NCT00591773|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101733741|NCT00591773|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101733742|NCT00591773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733743|NCT00591773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101733744|NCT00591773|Diuretics|diuretics|mesh-ancestor
101733745|NCT00591773|Natriuretic Agents|natriuretic agents|mesh-ancestor
101733746|NCT00591773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203655|NCT01418599|Alfuzosin|alfuzosin|mesh-list
101733747|NCT00591773|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101733748|NCT00591773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101733749|NCT00750867|Immunoglobulins|immunoglobulins|mesh-list
101733750|NCT00750867|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101733751|NCT00750867|Antibodies|antibodies|mesh-list
101733752|NCT00750867|gamma-Globulins|gamma-globulins|mesh-list
101733753|NCT00750867|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101733754|NCT00750867|Immunologic Factors|immunologic factors|mesh-ancestor
101733755|NCT00750867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733756|NCT00744042|Immunoglobulin G|immunoglobulin g|mesh-list
101733757|NCT00744042|Immunologic Factors|immunologic factors|mesh-ancestor
101733758|NCT00744042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733760|NCT04091763|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
101733761|NCT04091763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101733763|NCT00829829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101733764|NCT00829439|Levodopa|levodopa|mesh-list
101733765|NCT00829439|Carbidopa|carbidopa|mesh-list
101733766|NCT00829439|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101733767|NCT00829439|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101733768|NCT00829439|Dopamine Agents|dopamine agents|mesh-ancestor
101733769|NCT00829439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101733770|NCT00829439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733771|NCT00829439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733772|NCT00829439|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101733773|NCT00829439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101733774|NCT02599077|Dienogest|dienogest|mesh-list
101733775|NCT02599077|Levonorgestrel|levonorgestrel|mesh-list
101733776|NCT02599077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101733777|NCT02599077|Contraceptive Agents|contraceptive agents|mesh-ancestor
101733778|NCT02599077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101733779|NCT02599077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733780|NCT02599077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101733781|NCT02599077|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101733782|NCT02599077|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101733783|NCT02599077|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101733784|NCT02599077|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101733785|NCT02599077|Hormone Antagonists|hormone antagonists|mesh-ancestor
101733786|NCT02599077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101733787|NCT02599077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101733788|NCT02599077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101733789|NCT00829283|Orlistat|orlistat|mesh-list
101733790|NCT00829283|Sibutramine|sibutramine|mesh-list
101733791|NCT00829283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101733792|NCT00829283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733793|NCT00829283|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101733794|NCT00829283|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101733795|NCT00829283|Antidepressive Agents|antidepressive agents|mesh-ancestor
101733796|NCT00829283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101733797|NCT00829283|Appetite Depressants|appetite depressants|mesh-ancestor
101733798|NCT05758025|Parathyroid Hormone|parathyroid hormone|mesh-list
101733799|NCT05758025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101733800|NCT05758025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733801|NCT00706277|Fentanyl|fentanyl|mesh-list
101733802|NCT00706277|Remifentanil|remifentanil|mesh-list
101733803|NCT00706277|Nitrous Oxide|nitrous oxide|mesh-list
101733804|NCT00706277|Propofol|propofol|mesh-list
101733805|NCT00706277|Sevoflurane|sevoflurane|mesh-list
101733806|NCT00706277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101733807|NCT00706277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101733808|NCT00706277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733809|NCT00706277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101733811|NCT00706277|Anesthetics|anesthetics|mesh-ancestor
101733812|NCT00706277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101733813|NCT00706277|Narcotics|narcotics|mesh-ancestor
101733814|NCT00706277|Analgesics|analgesics|mesh-ancestor
101733815|NCT00706277|Sensory System Agents|sensory system agents|mesh-ancestor
101733816|NCT00706277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101733817|NCT00706277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101733818|NCT00706277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101733819|NCT00706277|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101733820|NCT00706277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101733821|NCT00749463|Nicotine|nicotine|mesh-list
101733822|NCT00749463|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101733823|NCT00749463|Autonomic Agents|autonomic agents|mesh-ancestor
101807617|NCT00968162|Fludarabine|fludarabine|mesh-list
101733824|NCT00749463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101203725|NCT01418794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733825|NCT00749463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733826|NCT00749463|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101733827|NCT00749463|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101733828|NCT00749463|Cholinergic Agents|cholinergic agents|mesh-ancestor
101733829|NCT00749463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101733830|NCT00749463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733831|NCT00821327|Gemcitabine|gemcitabine|mesh-list
101733832|NCT00821327|Sunitinib|sunitinib|mesh-list
101733833|NCT00821327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101733834|NCT00821327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101733835|NCT00821327|Antimetabolites|antimetabolites|mesh-ancestor
101733836|NCT00821327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733837|NCT00821327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101733838|NCT00821327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101733839|NCT00821327|Growth Substances|growth substances|mesh-ancestor
101733840|NCT00821327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733841|NCT00821327|Growth Inhibitors|growth inhibitors|mesh-ancestor
101733842|NCT00821327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101733843|NCT00821327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101733844|NCT00709007|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101733845|NCT00709007|Antiviral Agents|antiviral agents|mesh-ancestor
101733846|NCT00709007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101733847|NCT00821093|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101733848|NCT00821093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101733849|NCT00821093|Autonomic Agents|autonomic agents|mesh-ancestor
101733850|NCT00821093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101733851|NCT00821093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733852|NCT00821093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101733853|NCT00821093|Respiratory System Agents|respiratory system agents|mesh-ancestor
101733854|NCT00821093|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101733855|NCT00821093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101733856|NCT00821093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101733857|NCT00821093|Adrenergic Agents|adrenergic agents|mesh-ancestor
101733858|NCT00821093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101733859|NCT00821093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733860|NCT00709163|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101733861|NCT00709163|Natriuretic Agents|natriuretic agents|mesh-ancestor
101733862|NCT00709163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733863|NCT02611505|Esketamine|esketamine|mesh-list
101733864|NCT02611505|Antidepressive Agents|antidepressive agents|mesh-ancestor
101733865|NCT02611505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101733866|NCT00743652|Vaccines|vaccines|mesh-list
101733867|NCT00743652|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101733868|NCT00743652|Immunologic Factors|immunologic factors|mesh-ancestor
101733869|NCT00743652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733870|NCT00748215|Antidiarrheals|antidiarrheals|mesh-list
101733871|NCT00748215|Loperamide|loperamide|mesh-list
101733872|NCT00748215|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
101733873|NCT00748215|Calcium|calcium|mesh-list
101733874|NCT00748215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101733875|NCT00748215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733876|NCT00748215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101733877|NCT00917163|Sirolimus|sirolimus|mesh-list
101733878|NCT00917163|Everolimus|everolimus|mesh-list
101733879|NCT00917163|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101733880|NCT00917163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101733881|NCT00917163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101733882|NCT00917163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733883|NCT00917163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101733884|NCT00917163|Immunologic Factors|immunologic factors|mesh-ancestor
101733885|NCT00917163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807627|NCT00501969|Rotigotine|rotigotine|mesh-list
101733886|NCT00917163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101733887|NCT00917163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101733888|NCT00917163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101733889|NCT00917163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101733890|NCT00917163|Antifungal Agents|antifungal agents|mesh-ancestor
101733891|NCT00749892|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101733892|NCT00749892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101733893|NCT00749892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101733894|NCT00749892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101733895|NCT00749892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733896|NCT00749580|Raltegravir Potassium|raltegravir potassium|mesh-list
101733897|NCT00749580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101733898|NCT00749580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101733899|NCT00749580|Antiviral Agents|antiviral agents|mesh-ancestor
101733900|NCT00749580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101733901|NCT00749580|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101733902|NCT00749580|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101733903|NCT00749580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101733904|NCT00749580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733905|NCT00747006|Insulin Lispro|insulin lispro|mesh-list
101733906|NCT00747006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101364626|NCT00081744|Tigecycline|tigecycline|mesh-list
101733907|NCT00747006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733909|NCT04091178|Vitamins|vitamins|mesh-ancestor
101733910|NCT04091178|Micronutrients|micronutrients|mesh-ancestor
101733911|NCT04091178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733912|NCT04091178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101733913|NCT00917358|Interferons|interferons|mesh-list
101733914|NCT00917358|Interferon-alpha|interferon-alpha|mesh-list
101733915|NCT00917358|Interferon alpha-2|interferon alpha-2|mesh-list
101733916|NCT00917358|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101733917|NCT00917358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101203804|NCT01419405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101733918|NCT00917358|Antiviral Agents|antiviral agents|mesh-ancestor
101733919|NCT00917358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101733920|NCT00917358|Immunologic Factors|immunologic factors|mesh-ancestor
101733921|NCT00917358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733922|NCT00743340|Emtricitabine|emtricitabine|mesh-list
101733923|NCT00743340|Antiviral Agents|antiviral agents|mesh-ancestor
101733924|NCT00743340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101733925|NCT00743340|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101733926|NCT00743340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101733927|NCT00743340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101733928|NCT00743340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733929|NCT00743340|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101733930|NCT00743340|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101733931|NCT00749190|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101733932|NCT00749190|Empagliflozin|empagliflozin|mesh-list
101733933|NCT00749190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101733934|NCT00749190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733935|NCT00749190|Incretins|incretins|mesh-ancestor
101733936|NCT00749190|Hormones|hormones|mesh-ancestor
101733937|NCT00749190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101733938|NCT00749190|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101733939|NCT00749190|Protease Inhibitors|protease inhibitors|mesh-ancestor
101733940|NCT00749190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101733941|NCT00749190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733942|NCT00749190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101733943|NCT00748566|Ziprasidone|ziprasidone|mesh-list
101733944|NCT00748566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101733945|NCT00748566|Serotonin Agents|serotonin agents|mesh-ancestor
101263202|NCT01760694|Vitamins|vitamins|mesh-ancestor
101733946|NCT00748566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101733947|NCT00748566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733948|NCT00748566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733949|NCT00748566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101733950|NCT00748566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101733951|NCT00748566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101733952|NCT00748566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101733953|NCT00748566|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101733954|NCT00748566|Dopamine Agents|dopamine agents|mesh-ancestor
101733955|NCT02597166|Sofosbuvir|sofosbuvir|mesh-list
101733956|NCT02597166|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
101733957|NCT02597166|Ledipasvir|ledipasvir|mesh-list
101733958|NCT02597166|Antiviral Agents|antiviral agents|mesh-ancestor
101733959|NCT02597166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101733960|NCT00743106|Fenoldopam|fenoldopam|mesh-list
101733961|NCT00743106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101203839|NCT01419847|Ciclopirox|ciclopirox|mesh-list
101733962|NCT00743106|Vasodilator Agents|vasodilator agents|mesh-ancestor
101733963|NCT00743106|Dopamine Agonists|dopamine agonists|mesh-ancestor
101733964|NCT00743106|Dopamine Agents|dopamine agents|mesh-ancestor
101733965|NCT00743106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101733966|NCT00743106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733967|NCT00743106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733968|NCT02597322|Axitinib|axitinib|mesh-list
101733969|NCT02597322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101733970|NCT02597322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101733971|NCT02597322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101733972|NCT02597322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733973|NCT00738699|Paclitaxel|paclitaxel|mesh-list
101733974|NCT00738699|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101733975|NCT00738699|Farletuzumab|farletuzumab|mesh-list
101733976|NCT00738699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101733977|NCT00738699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101733978|NCT00738699|Tubulin Modulators|tubulin modulators|mesh-ancestor
101733979|NCT00738699|Antimitotic Agents|antimitotic agents|mesh-ancestor
101733980|NCT00738699|Mitosis Modulators|mitosis modulators|mesh-ancestor
101733981|NCT00738699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733982|NCT00814307|Tofacitinib|tofacitinib|mesh-list
101733983|NCT00814307|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101391442|NCT05077904|GABA Modulators|gaba modulators|mesh-ancestor
101733984|NCT00814307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101733985|NCT00814307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101733986|NCT00814307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733987|NCT02596776|Deuterium Oxide|deuterium oxide|mesh-list
101733988|NCT02596776|Propranolol|propranolol|mesh-list
101733989|NCT02596776|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101733990|NCT02596776|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101733991|NCT02596776|Adrenergic Agents|adrenergic agents|mesh-ancestor
101733992|NCT02596776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101733993|NCT02596776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101733994|NCT02596776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101733995|NCT02596776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101733996|NCT02596776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101733997|NCT02596776|Vasodilator Agents|vasodilator agents|mesh-ancestor
101733998|NCT02596776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101733999|NCT02596776|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101734000|NCT02596776|Protective Agents|protective agents|mesh-ancestor
101734001|NCT00748098|Gabapentin|gabapentin|mesh-list
101734002|NCT00748098|Analgesics|analgesics|mesh-ancestor
101734003|NCT00748098|Sensory System Agents|sensory system agents|mesh-ancestor
101734004|NCT00748098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101734005|NCT00748098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734006|NCT00748098|Anticonvulsants|anticonvulsants|mesh-ancestor
101734007|NCT00748098|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101734008|NCT00748098|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101734009|NCT00748098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101734010|NCT00748098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101734011|NCT00748098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101734012|NCT00748098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101734013|NCT00748098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101734014|NCT00748098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734015|NCT00748098|Antimanic Agents|antimanic agents|mesh-ancestor
101734016|NCT00813995|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101734017|NCT00813995|Metformin|metformin|mesh-list
101734018|NCT00813995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101734019|NCT00813995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734020|NCT00813995|Incretins|incretins|mesh-ancestor
101734021|NCT00813995|Hormones|hormones|mesh-ancestor
101734022|NCT00813995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101734023|NCT00813995|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101734024|NCT00813995|Protease Inhibitors|protease inhibitors|mesh-ancestor
101734025|NCT00813995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101734026|NCT00813995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734027|NCT00737529|Lenalidomide|lenalidomide|mesh-list
101734028|NCT00737529|Immunologic Factors|immunologic factors|mesh-ancestor
101734029|NCT00737529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734030|NCT00737529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101734031|NCT00737529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101734032|NCT00737529|Growth Substances|growth substances|mesh-ancestor
101734033|NCT00737529|Growth Inhibitors|growth inhibitors|mesh-ancestor
101734034|NCT00737529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101734035|NCT00813917|Varenicline|varenicline|mesh-list
101734036|NCT00813917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101734037|NCT00813917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101203926|NCT01420523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734039|NCT00813917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101734040|NCT00813917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734041|NCT00813917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734042|NCT02598102|Diclofenac|diclofenac|mesh-list
101734043|NCT02598102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101734044|NCT02598102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101734045|NCT02598102|Analgesics|analgesics|mesh-ancestor
101734046|NCT02598102|Sensory System Agents|sensory system agents|mesh-ancestor
101734047|NCT02598102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101734048|NCT02598102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734049|NCT02598102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101734050|NCT02598102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101734051|NCT02598102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101734052|NCT02598102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101734053|NCT02598102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734054|NCT02610647|Anesthetics|anesthetics|mesh-list
101734055|NCT02610647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101734056|NCT02610647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734057|NCT02595918|Nivolumab|nivolumab|mesh-list
101734058|NCT02595918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101734059|NCT02595918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101734060|NCT02595918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101734061|NCT02595918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734063|NCT02595840|Afatinib|afatinib|mesh-list
101734064|NCT02595840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101734065|NCT02595840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101734066|NCT02595840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734067|NCT02595840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101734068|NCT02595840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101734069|NCT02595840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101734070|NCT02594241|Prednisolone|prednisolone|mesh-list
101734071|NCT02594241|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101734072|NCT02594241|Methylprednisolone|methylprednisolone|mesh-list
101734073|NCT02594241|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101734074|NCT02594241|Prednisolone acetate|prednisolone acetate|mesh-list
101734075|NCT02594241|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101734076|NCT02594241|Prednisolone phosphate|prednisolone phosphate|mesh-list
101734077|NCT02594241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101734078|NCT02594241|Glucocorticoids|glucocorticoids|mesh-ancestor
101734079|NCT02594241|Hormones|hormones|mesh-ancestor
101203950|NCT01420666|Sensory System Agents|sensory system agents|mesh-ancestor
101203951|NCT01420666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101734080|NCT02594241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101734081|NCT02594241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734082|NCT02594241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101734083|NCT02594241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101734084|NCT02594241|Antiemetics|antiemetics|mesh-ancestor
101734085|NCT02594241|Autonomic Agents|autonomic agents|mesh-ancestor
101734086|NCT02594241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101734087|NCT02594241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101734088|NCT02594241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101734089|NCT02594241|Protective Agents|protective agents|mesh-ancestor
101734090|NCT00585975|Bromfenac|bromfenac|mesh-list
101734091|NCT00585975|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101734093|NCT00585975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101734094|NCT00585975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101734095|NCT00585975|Analgesics|analgesics|mesh-ancestor
101734096|NCT00585975|Sensory System Agents|sensory system agents|mesh-ancestor
101734097|NCT00585975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101734098|NCT00585975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734099|NCT00585975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101734100|NCT00585975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101734101|NCT00918021|Olanzapine|olanzapine|mesh-list
101734102|NCT00918021|Antiemetics|antiemetics|mesh-ancestor
101734103|NCT00918021|Autonomic Agents|autonomic agents|mesh-ancestor
101734104|NCT00918021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101734105|NCT00918021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734106|NCT00918021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101734107|NCT00918021|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101734108|NCT00918021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101734109|NCT00918021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101734110|NCT00918021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101734111|NCT00918021|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101734112|NCT00918021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101734113|NCT00918021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101734114|NCT00918021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734115|NCT00918021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101734117|NCT00585585|Betahistine|betahistine|mesh-list
101734118|NCT00585585|Vasodilator Agents|vasodilator agents|mesh-ancestor
101734119|NCT00585585|Histamine Agonists|histamine agonists|mesh-ancestor
101734120|NCT00585585|Histamine Agents|histamine agents|mesh-ancestor
101734121|NCT00585585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101734122|NCT00585585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734123|NCT00585585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734124|NCT02593695|Fluoxetine|fluoxetine|mesh-list
101734125|NCT02593695|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101734126|NCT02593695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101734127|NCT02593695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101734128|NCT02593695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734129|NCT02593695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101734130|NCT02593695|Serotonin Agents|serotonin agents|mesh-ancestor
101734131|NCT02593695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734132|NCT02593695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101734133|NCT02593695|Antidepressive Agents|antidepressive agents|mesh-ancestor
101734134|NCT02593695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101734135|NCT02593695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101734136|NCT02593695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101734137|NCT02593695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101734138|NCT00734097|Esomeprazole|esomeprazole|mesh-list
101734139|NCT00734097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101734140|NCT00734097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101734141|NCT00734097|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101734142|NCT00734097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101734143|NCT00734097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734144|NCT00819767|Valsartan|valsartan|mesh-list
101734145|NCT00819767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101734146|NCT00819767|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101734147|NCT00819767|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101734148|NCT00819767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734149|NCT04088175|Menthol|menthol|mesh-list
101734150|NCT04088175|Nicotine|nicotine|mesh-list
101734151|NCT04088175|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101734152|NCT04088175|Autonomic Agents|autonomic agents|mesh-ancestor
101734153|NCT04088175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101734154|NCT04088175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734155|NCT04088175|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101734156|NCT04088175|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101734157|NCT04088175|Cholinergic Agents|cholinergic agents|mesh-ancestor
101734158|NCT04088175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101204066|NCT01421368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101204067|NCT01421368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101734159|NCT04088175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734161|NCT04088175|Dermatologic Agents|dermatologic agents|mesh-ancestor
101734162|NCT00733005|Mometasone Furoate|mometasone furoate|mesh-list
101734163|NCT00733005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101734164|NCT00733005|Dermatologic Agents|dermatologic agents|mesh-ancestor
101734165|NCT00733005|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101734166|NCT05756621|Topiramate|topiramate|mesh-list
101734167|NCT05756621|Lacosamide|lacosamide|mesh-list
101734168|NCT05756621|Phenytoin|phenytoin|mesh-list
101734169|NCT05756621|Midazolam|midazolam|mesh-list
101734170|NCT05756621|Ketamine|ketamine|mesh-list
101734171|NCT05756621|Levetiracetam|levetiracetam|mesh-list
101734172|NCT05756621|Thiopental|thiopental|mesh-list
101734173|NCT05756621|Anticonvulsants|anticonvulsants|mesh-list
101734174|NCT05756621|Propofol|propofol|mesh-list
101734175|NCT05756621|Anesthetics|anesthetics|mesh-list
101734176|NCT05756621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101734177|NCT05756621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101734178|NCT05756621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734179|NCT05756621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101734180|NCT05756621|Anesthetics, General|anesthetics, general|mesh-ancestor
101734181|NCT05756621|Analgesics|analgesics|mesh-ancestor
101734182|NCT05756621|Sensory System Agents|sensory system agents|mesh-ancestor
101734183|NCT05756621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101734184|NCT05756621|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101734185|NCT05756621|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101734186|NCT05756621|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101734187|NCT05756621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101734188|NCT05756621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734189|NCT05756621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101734190|NCT05756621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101734191|NCT05756621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101734192|NCT05756621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101364636|NCT00147862|Hemostatics|hemostatics|mesh-ancestor
101734193|NCT05756621|GABA Modulators|gaba modulators|mesh-ancestor
101734194|NCT05756621|GABA Agents|gaba agents|mesh-ancestor
101734195|NCT05756621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101734196|NCT05756621|Nootropic Agents|nootropic agents|mesh-ancestor
101734197|NCT05756621|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101734198|NCT05756621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101734199|NCT05756621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101734200|NCT05756621|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101734201|NCT05756621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101734202|NCT00732381|Mometasone Furoate|mometasone furoate|mesh-list
101734203|NCT00732381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101734204|NCT00732381|Dermatologic Agents|dermatologic agents|mesh-ancestor
101734205|NCT00732381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101734206|NCT00732303|Pemetrexed|pemetrexed|mesh-list
101734207|NCT00732303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101734208|NCT00732303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101734209|NCT00732303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734210|NCT00732303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101734211|NCT00732303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101734212|NCT00813761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101734213|NCT00732069|Valsartan|valsartan|mesh-list
101734214|NCT00732069|Ramipril|ramipril|mesh-list
101734215|NCT00732069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101734216|NCT00732069|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101734217|NCT00732069|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101734218|NCT00732069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734219|NCT00732069|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101734220|NCT00732069|Protease Inhibitors|protease inhibitors|mesh-ancestor
101734221|NCT00732069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101734222|NCT02593383|Clindamycin|clindamycin|mesh-list
101734223|NCT02593383|Clindamycin palmitate|clindamycin palmitate|mesh-list
101734224|NCT02593383|Clindamycin phosphate|clindamycin phosphate|mesh-list
101734225|NCT02593383|Adapalene|adapalene|mesh-list
101734226|NCT02593383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101734227|NCT02593383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101734228|NCT02593383|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101734229|NCT02593383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101734230|NCT02593383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734231|NCT02593383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101734232|NCT02593383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101734233|NCT02593383|Analgesics|analgesics|mesh-ancestor
101734234|NCT02593383|Sensory System Agents|sensory system agents|mesh-ancestor
101734235|NCT02593383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101734236|NCT02593383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734237|NCT02593383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101734238|NCT02593383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101734239|NCT02593383|Dermatologic Agents|dermatologic agents|mesh-ancestor
101734240|NCT00731679|Rifaximin|rifaximin|mesh-list
101734241|NCT00731679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101734242|NCT00731679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101734243|NCT00731679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101734244|NCT02609087|Propofol|propofol|mesh-list
101734245|NCT02609087|Sevoflurane|sevoflurane|mesh-list
101734246|NCT02609087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101734247|NCT02609087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101734248|NCT02609087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734249|NCT02609087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101734250|NCT02609087|Anesthetics, General|anesthetics, general|mesh-ancestor
101734251|NCT02609087|Anesthetics|anesthetics|mesh-ancestor
101734252|NCT02609087|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101204133|NCT01421940|Udenafil|udenafil|mesh-list
101734254|NCT00731133|Disulfiram|disulfiram|mesh-list
101734255|NCT00731133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101734256|NCT00731133|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
101734257|NCT00731133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101734258|NCT00731133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734259|NCT00730275|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101734260|NCT00730275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101734261|NCT00730275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734262|NCT00730275|Incretins|incretins|mesh-ancestor
101734263|NCT00730275|Hormones|hormones|mesh-ancestor
101734264|NCT00730275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101734265|NCT00730275|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101734266|NCT00730275|Protease Inhibitors|protease inhibitors|mesh-ancestor
101734267|NCT00730275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101734268|NCT00730275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734269|NCT04793711|Decanoic acid|decanoic acid|mesh-list
101734270|NCT04793711|Antifungal Agents|antifungal agents|mesh-ancestor
101734271|NCT04793711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101734272|NCT00729651|Cholecalciferol|cholecalciferol|mesh-list
101734273|NCT00729651|Vitamin D|vitamin d|mesh-list
101734274|NCT00729651|Alendronate|alendronate|mesh-list
101734275|NCT00729651|Calcium|calcium|mesh-list
101734276|NCT00729651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101734277|NCT00729651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734278|NCT00729651|Vitamins|vitamins|mesh-ancestor
101734279|NCT00729651|Micronutrients|micronutrients|mesh-ancestor
101734280|NCT00729651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101734281|NCT00729183|Calcium, Dietary|calcium, dietary|mesh-list
101391753|NCT04963296|Acetaminophen|acetaminophen|mesh-list
101734283|NCT00729183|Cholecalciferol|cholecalciferol|mesh-list
101734284|NCT00729183|Calcium Carbonate|calcium carbonate|mesh-list
101734285|NCT00729183|Calcium|calcium|mesh-list
101734286|NCT00729183|Vitamins|vitamins|mesh-ancestor
101734287|NCT00729183|Micronutrients|micronutrients|mesh-ancestor
101734288|NCT00729183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734289|NCT00729183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101734290|NCT00729183|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101734291|NCT00729183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734292|NCT00729183|Antacids|antacids|mesh-ancestor
101734293|NCT00729183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101734294|NCT00811733|Ofatumumab|ofatumumab|mesh-list
101734295|NCT00811733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101734296|NCT00728949|Tamoxifen|tamoxifen|mesh-list
101734297|NCT00728949|Letrozole|letrozole|mesh-list
101734298|NCT00728949|Fulvestrant|fulvestrant|mesh-list
101734299|NCT00728949|Anastrozole|anastrozole|mesh-list
101734300|NCT00728949|Exemestane|exemestane|mesh-list
101734301|NCT00728949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101734302|NCT00728949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101734303|NCT00728949|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101204155|NCT01421992|Dopamine Agents|dopamine agents|mesh-ancestor
101734304|NCT00728949|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101734305|NCT00728949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101734306|NCT00728949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734307|NCT00728949|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101734308|NCT00728949|Hormone Antagonists|hormone antagonists|mesh-ancestor
101734309|NCT00728949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101734310|NCT00728949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734311|NCT00728949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101734312|NCT00728949|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101734314|NCT00728949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101734315|NCT00728949|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101734316|NCT00728949|Immunologic Factors|immunologic factors|mesh-ancestor
101734317|NCT00918177|Levodopa|levodopa|mesh-list
101734318|NCT00918177|Carbidopa|carbidopa|mesh-list
101734319|NCT00918177|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101734320|NCT00918177|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101734321|NCT00918177|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101734322|NCT00918177|Dopamine Agents|dopamine agents|mesh-ancestor
101734323|NCT00918177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101734324|NCT00918177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734325|NCT00918177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734326|NCT00918177|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101734327|NCT00918177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101734328|NCT00918177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101734329|NCT00918177|Immunologic Factors|immunologic factors|mesh-ancestor
101734330|NCT00918177|Dopamine Agonists|dopamine agonists|mesh-ancestor
101734331|NCT00728481|Budesonide|budesonide|mesh-list
101734332|NCT00728481|Esomeprazole|esomeprazole|mesh-list
101734333|NCT00728481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101734334|NCT00728481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101734335|NCT00728481|Autonomic Agents|autonomic agents|mesh-ancestor
101734336|NCT00728481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101734337|NCT00728481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734338|NCT00728481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101734339|NCT00728481|Respiratory System Agents|respiratory system agents|mesh-ancestor
101734340|NCT00728481|Glucocorticoids|glucocorticoids|mesh-ancestor
101734341|NCT00728481|Hormones|hormones|mesh-ancestor
101734342|NCT00728481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101734343|NCT00728481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101734344|NCT00728481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101734345|NCT00728481|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101734346|NCT00728481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101734347|NCT00728481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734348|NCT02593227|Cyclophosphamide|cyclophosphamide|mesh-list
101734349|NCT02593227|Vaccines|vaccines|mesh-list
101734350|NCT02593227|Immunologic Factors|immunologic factors|mesh-ancestor
101734351|NCT02593227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734352|NCT02593227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101734353|NCT02593227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101734354|NCT02593227|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101734355|NCT02593227|Alkylating Agents|alkylating agents|mesh-ancestor
101734356|NCT02593227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734357|NCT02593227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101734358|NCT02593227|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101734359|NCT04030481|Anesthetics|anesthetics|mesh-list
101734360|NCT04030481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101734361|NCT04030481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734362|NCT02592915|Clonidine|clonidine|mesh-list
101734363|NCT02592915|Anesthetics|anesthetics|mesh-list
101734364|NCT02592915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101734365|NCT02592915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734366|NCT02592915|Analgesics|analgesics|mesh-ancestor
101734367|NCT02592915|Sensory System Agents|sensory system agents|mesh-ancestor
101734368|NCT02592915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101734369|NCT02592915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101734370|NCT02592915|Sympatholytics|sympatholytics|mesh-ancestor
101734371|NCT02592915|Autonomic Agents|autonomic agents|mesh-ancestor
101734372|NCT02592915|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101734373|NCT02592915|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101734374|NCT02592915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101734375|NCT02592915|Adrenergic Agents|adrenergic agents|mesh-ancestor
101734376|NCT02592915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101734377|NCT02592915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734378|NCT00727311|Ribavirin|ribavirin|mesh-list
101734379|NCT00727311|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101734380|NCT00727311|Interferon-alpha|interferon-alpha|mesh-list
101734381|NCT00727311|Antimetabolites|antimetabolites|mesh-ancestor
101734382|NCT00727311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734383|NCT00727311|Antiviral Agents|antiviral agents|mesh-ancestor
101734384|NCT00727311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101734385|NCT00727311|Immunologic Factors|immunologic factors|mesh-ancestor
101734386|NCT00727311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734387|NCT00726999|Morphine|morphine|mesh-list
101734388|NCT00726999|Gabapentin|gabapentin|mesh-list
101734389|NCT00726999|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101734390|NCT00726999|Narcotics|narcotics|mesh-ancestor
101734391|NCT00726999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101734392|NCT00726999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734393|NCT00726999|Analgesics|analgesics|mesh-ancestor
101734394|NCT00726999|Sensory System Agents|sensory system agents|mesh-ancestor
101734395|NCT00726999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101734396|NCT00726999|Anticonvulsants|anticonvulsants|mesh-ancestor
101734397|NCT00726999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101734398|NCT00726999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101734399|NCT00726999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101734400|NCT00726999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101734401|NCT00726999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101734402|NCT00726999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101204208|NCT01422291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734403|NCT00726999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734404|NCT00726999|Antimanic Agents|antimanic agents|mesh-ancestor
101734405|NCT00585351|Ranitidine|ranitidine|mesh-list
101734406|NCT00585351|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
101734407|NCT00585351|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101734408|NCT00585351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101734409|NCT00585351|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101734410|NCT00585351|Histamine Antagonists|histamine antagonists|mesh-ancestor
101734411|NCT00585351|Histamine Agents|histamine agents|mesh-ancestor
101734412|NCT00585351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101734413|NCT00585351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734414|NCT00585351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734415|NCT00726609|Posaconazole|posaconazole|mesh-list
101734416|NCT00726609|Antifungal Agents|antifungal agents|mesh-ancestor
101734417|NCT00726609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101734418|NCT00726609|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101734419|NCT00726609|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101734420|NCT00726609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101734421|NCT00726609|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101734422|NCT00726609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101734424|NCT00726609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734425|NCT00726609|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101734426|NCT00726609|Hormone Antagonists|hormone antagonists|mesh-ancestor
101734427|NCT00726609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101734428|NCT00726609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734429|NCT00808028|Vaccines|vaccines|mesh-list
101734430|NCT00808028|Immunologic Factors|immunologic factors|mesh-ancestor
101734431|NCT00808028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734433|NCT03466346|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101734434|NCT03466346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101734435|NCT03466346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101734436|NCT03466346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734437|NCT03466346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101734438|NCT03466346|Serotonin Agents|serotonin agents|mesh-ancestor
101734439|NCT03466346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734440|NCT03466346|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101734441|NCT03466346|Antidepressive Agents|antidepressive agents|mesh-ancestor
101734442|NCT03466346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101734443|NCT03466346|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101734444|NCT03466346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101734445|NCT03466346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101734446|NCT05754242|Ascorbic Acid|ascorbic acid|mesh-list
101734448|NCT05754242|Micronutrients|micronutrients|mesh-ancestor
101734449|NCT05754242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734450|NCT05754242|Antioxidants|antioxidants|mesh-ancestor
101734451|NCT05754242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734452|NCT05754242|Protective Agents|protective agents|mesh-ancestor
101734453|NCT00809783|Tanezumab|tanezumab|mesh-list
101734454|NCT00809783|Analgesics|analgesics|mesh-ancestor
101734455|NCT00809783|Sensory System Agents|sensory system agents|mesh-ancestor
101734456|NCT00809783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101734457|NCT00809783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734458|NCT05675462|Lenvatinib|lenvatinib|mesh-list
101734459|NCT05675462|Tislelizumab|tislelizumab|mesh-list
101734460|NCT05675462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101734461|NCT05675462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101734462|NCT05675462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101734463|NCT05675462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734464|NCT05675462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101734465|NCT02608658|Immunoglobulins|immunoglobulins|mesh-list
101734466|NCT02608658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101734467|NCT02608658|Antibodies|antibodies|mesh-list
101734468|NCT02608658|Immunologic Factors|immunologic factors|mesh-ancestor
101734469|NCT02608658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734470|NCT00807248|Gaboxadol|gaboxadol|mesh-list
101734471|NCT00807248|Dexetimide|dexetimide|mesh-list
101734472|NCT00807248|Citalopram|citalopram|mesh-list
101734473|NCT00807248|Escitalopram|escitalopram|mesh-list
101734474|NCT00807248|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101734475|NCT00807248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101734476|NCT00807248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101734477|NCT00807248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734478|NCT00807248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101734479|NCT00807248|Serotonin Agents|serotonin agents|mesh-ancestor
101734480|NCT00807248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734481|NCT00807248|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101734482|NCT00807248|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101734483|NCT00807248|Parasympatholytics|parasympatholytics|mesh-ancestor
101734484|NCT00807248|Autonomic Agents|autonomic agents|mesh-ancestor
101734485|NCT00807248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101734486|NCT00807248|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101734487|NCT00807248|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101734488|NCT00807248|Cholinergic Agents|cholinergic agents|mesh-ancestor
101734489|NCT00807248|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101734490|NCT00807248|Antidepressive Agents|antidepressive agents|mesh-ancestor
101734491|NCT00807248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101734492|NCT00807248|Analgesics|analgesics|mesh-ancestor
101734493|NCT00807248|Sensory System Agents|sensory system agents|mesh-ancestor
101734494|NCT00807248|Anticonvulsants|anticonvulsants|mesh-ancestor
101734496|NCT00807248|GABA Agents|gaba agents|mesh-ancestor
101734497|NCT02607332|Paclitaxel|paclitaxel|mesh-list
101734498|NCT02607332|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101734499|NCT02607332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101734500|NCT02607332|Tubulin Modulators|tubulin modulators|mesh-ancestor
101734501|NCT02607332|Antimitotic Agents|antimitotic agents|mesh-ancestor
101734502|NCT02607332|Mitosis Modulators|mitosis modulators|mesh-ancestor
101734503|NCT02607332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734504|NCT03356756|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101734505|NCT03356756|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101734506|NCT03356756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734507|NCT05297669|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
101734508|NCT05297669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101734509|NCT05297669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101734510|NCT05297669|Analgesics|analgesics|mesh-ancestor
101734511|NCT05297669|Sensory System Agents|sensory system agents|mesh-ancestor
101734512|NCT05297669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101734513|NCT05297669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734514|NCT05297669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101734515|NCT05297669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101734516|NCT00589628|Infliximab|infliximab|mesh-list
101734517|NCT00589628|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101734518|NCT00589628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101734519|NCT00589628|Dermatologic Agents|dermatologic agents|mesh-ancestor
101734520|NCT00589628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101734521|NCT00589628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101734522|NCT05754983|Immunomodulating Agents|immunomodulating agents|mesh-list
101734523|NCT05754983|Immunologic Factors|immunologic factors|mesh-ancestor
101734524|NCT05754983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734525|NCT00914576|Vitamins|vitamins|mesh-list
101734526|NCT00914576|Micronutrients|micronutrients|mesh-ancestor
101734527|NCT00914576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734528|NCT00914654|Formoterol Fumarate|formoterol fumarate|mesh-list
101734529|NCT00914654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101734530|NCT00914654|Autonomic Agents|autonomic agents|mesh-ancestor
101734531|NCT00914654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101734532|NCT00914654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734533|NCT00914654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101734534|NCT00914654|Respiratory System Agents|respiratory system agents|mesh-ancestor
101734535|NCT00914654|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101734536|NCT00914654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101734537|NCT00914654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101734538|NCT00914654|Adrenergic Agents|adrenergic agents|mesh-ancestor
101734539|NCT00914654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101734540|NCT00914654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734541|NCT02605772|Metformin|metformin|mesh-list
101734542|NCT02605772|Saxagliptin|saxagliptin|mesh-list
101734543|NCT02605772|Acarbose|acarbose|mesh-list
101734544|NCT02605772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101734545|NCT02605772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734546|NCT02605772|Incretins|incretins|mesh-ancestor
101734547|NCT02605772|Hormones|hormones|mesh-ancestor
101734548|NCT02605772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101734549|NCT02605772|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101734550|NCT02605772|Protease Inhibitors|protease inhibitors|mesh-ancestor
101734551|NCT02605772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101734552|NCT02605772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734553|NCT02605772|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101734554|NCT04115462|Morphine|morphine|mesh-list
101734555|NCT04115462|Histamine|histamine|mesh-list
101734556|NCT04115462|Histamine phosphate|histamine phosphate|mesh-list
101734557|NCT04115462|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101734558|NCT04115462|Narcotics|narcotics|mesh-ancestor
101734559|NCT04115462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101734560|NCT04115462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734561|NCT04115462|Analgesics|analgesics|mesh-ancestor
101734562|NCT04115462|Sensory System Agents|sensory system agents|mesh-ancestor
101734563|NCT04115462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101734564|NCT04115462|Histamine Agonists|histamine agonists|mesh-ancestor
101734565|NCT04115462|Histamine Agents|histamine agents|mesh-ancestor
101734566|NCT04115462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101734567|NCT04115462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734568|NCT02605460|Plerixafor|plerixafor|mesh-list
101734569|NCT02605460|Cyclophosphamide|cyclophosphamide|mesh-list
101734571|NCT02605460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101204330|NCT01422785|Dermatologic Agents|dermatologic agents|mesh-ancestor
101734573|NCT02605460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734574|NCT02605460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101734575|NCT02605460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101734576|NCT02605460|Alkylating Agents|alkylating agents|mesh-ancestor
101734577|NCT02605460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734578|NCT02605460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101734579|NCT02605460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101734580|NCT02605460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101734581|NCT02605460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101734582|NCT02605460|Antiviral Agents|antiviral agents|mesh-ancestor
101734583|NCT02605460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101734584|NCT00797108|Amoxicillin|amoxicillin|mesh-list
101734585|NCT00797108|Ceftriaxone|ceftriaxone|mesh-list
101734586|NCT00797108|Clavulanic Acid|clavulanic acid|mesh-list
101734587|NCT00797108|Clavulanic Acids|clavulanic acids|mesh-list
101734588|NCT00797108|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101734589|NCT00797108|Lactams|lactams|mesh-list
101734590|NCT00797108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101734591|NCT00797108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101734592|NCT00797108|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101734593|NCT00797108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101734594|NCT00797108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734595|NCT00742560|Dexamethasone|dexamethasone|mesh-list
101734596|NCT00742560|Dexamethasone acetate|dexamethasone acetate|mesh-list
101734597|NCT00742560|Lenalidomide|lenalidomide|mesh-list
101734598|NCT00742560|Elotuzumab|elotuzumab|mesh-list
101734599|NCT00742560|BB 1101|bb 1101|mesh-list
101734600|NCT00742560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101734601|NCT00742560|Antiemetics|antiemetics|mesh-ancestor
101734602|NCT00742560|Autonomic Agents|autonomic agents|mesh-ancestor
101734603|NCT00742560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101734604|NCT00742560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734605|NCT00742560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101734606|NCT00742560|Glucocorticoids|glucocorticoids|mesh-ancestor
101734607|NCT00742560|Hormones|hormones|mesh-ancestor
101734608|NCT00742560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101734609|NCT00742560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101734610|NCT00742560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101734611|NCT00742560|Protease Inhibitors|protease inhibitors|mesh-ancestor
101734612|NCT00742560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101734613|NCT00742560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734614|NCT00742560|Immunologic Factors|immunologic factors|mesh-ancestor
101734615|NCT00742560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101734616|NCT00742560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101734617|NCT00742560|Growth Substances|growth substances|mesh-ancestor
101734618|NCT00742560|Growth Inhibitors|growth inhibitors|mesh-ancestor
101734620|NCT02604914|Carbidopa|carbidopa|mesh-list
101734621|NCT02604914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101734622|NCT02604914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101734623|NCT02604914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101734624|NCT02604914|Dopamine Agents|dopamine agents|mesh-ancestor
101734625|NCT02604914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101734626|NCT02604914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734627|NCT02604914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734628|NCT02604914|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101734629|NCT02604914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101734630|NCT02604914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101734631|NCT02604914|Immunologic Factors|immunologic factors|mesh-ancestor
101734632|NCT02604914|Dopamine Agonists|dopamine agonists|mesh-ancestor
101734633|NCT00796718|Capecitabine|capecitabine|mesh-list
101734634|NCT00796718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101734635|NCT00796718|Antimetabolites|antimetabolites|mesh-ancestor
101734636|NCT00796718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734637|NCT00796718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101734638|NCT00745368|Raltegravir Potassium|raltegravir potassium|mesh-list
101734639|NCT00745368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101734640|NCT00745368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101734641|NCT00745368|Antiviral Agents|antiviral agents|mesh-ancestor
101734642|NCT00745368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101734643|NCT00745368|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101734644|NCT00745368|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101734645|NCT00745368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101734646|NCT00745368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734647|NCT04025840|Dexamethasone|dexamethasone|mesh-list
101734648|NCT04025840|Glucocorticoids|glucocorticoids|mesh-list
101734649|NCT04025840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101734650|NCT04025840|Antiemetics|antiemetics|mesh-ancestor
101734651|NCT04025840|Autonomic Agents|autonomic agents|mesh-ancestor
101734652|NCT04025840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101734653|NCT04025840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734654|NCT04025840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101734656|NCT04025840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101734657|NCT04025840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101734658|NCT04025840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101734659|NCT00589472|Vorinostat|vorinostat|mesh-list
101734660|NCT00589472|Leuprolide|leuprolide|mesh-list
101734661|NCT00589472|Goserelin|goserelin|mesh-list
101734662|NCT00589472|Bicalutamide|bicalutamide|mesh-list
101734663|NCT00589472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101734664|NCT00589472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101734665|NCT00589472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101734666|NCT00589472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734667|NCT00589472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101734668|NCT00589472|Fertility Agents|fertility agents|mesh-ancestor
101734669|NCT00589472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101734670|NCT00589472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734671|NCT00589472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101734672|NCT00589472|Androgen Antagonists|androgen antagonists|mesh-ancestor
101734673|NCT00589472|Hormone Antagonists|hormone antagonists|mesh-ancestor
101734674|NCT00589472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101734675|NCT02608931|Dronabinol|dronabinol|mesh-list
101734676|NCT02608931|Hallucinogens|hallucinogens|mesh-ancestor
101734677|NCT02608931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734679|NCT02608931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101734681|NCT02608931|Sensory System Agents|sensory system agents|mesh-ancestor
101734682|NCT02608931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101734683|NCT02608931|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101734684|NCT02608931|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101734686|NCT02608931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734687|NCT02608931|Hormones|hormones|mesh-ancestor
101734688|NCT02608931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101734689|NCT00744978|Varenicline|varenicline|mesh-list
101734690|NCT00744978|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101734691|NCT00744978|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101734692|NCT00744978|Cholinergic Agents|cholinergic agents|mesh-ancestor
101364667|NCT00148018|Dexamethasone|dexamethasone|mesh-list
101734693|NCT00744978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101734694|NCT00744978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734695|NCT00744978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734696|NCT02595606|Hyaluronic Acid|hyaluronic acid|mesh-list
101734697|NCT02595606|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101734698|NCT02595606|Immunologic Factors|immunologic factors|mesh-ancestor
101734699|NCT02595606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734700|NCT02595606|Viscosupplements|viscosupplements|mesh-ancestor
101734701|NCT02595606|Protective Agents|protective agents|mesh-ancestor
101734702|NCT02609945|Oxazolidinones|oxazolidinones|mesh-list
101734703|NCT02609945|Zolmitriptan|zolmitriptan|mesh-list
101734704|NCT02609945|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101734705|NCT02609945|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101734706|NCT02609945|Serotonin Agents|serotonin agents|mesh-ancestor
101734707|NCT02609945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101734708|NCT02609945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734709|NCT02609945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734710|NCT02609945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101734711|NCT02609945|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101734712|NCT02609945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101734713|NCT04570475|Vitamin D|vitamin d|mesh-list
101734714|NCT04570475|Vitamins|vitamins|mesh-ancestor
101734715|NCT04570475|Micronutrients|micronutrients|mesh-ancestor
101734716|NCT04570475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263256|NCT01760980|Exemestane|exemestane|mesh-list
101734717|NCT04570475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101734718|NCT02609165|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101734719|NCT02609165|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101734720|NCT00739596|Amlodipine|amlodipine|mesh-list
101734721|NCT00739596|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101734722|NCT00739596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101734723|NCT00739596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101734724|NCT00739596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101734725|NCT00739596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734726|NCT00739596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101734727|NCT00739596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734728|NCT00739596|Vasodilator Agents|vasodilator agents|mesh-ancestor
101734729|NCT00739596|Diuretics|diuretics|mesh-ancestor
101734730|NCT00739596|Natriuretic Agents|natriuretic agents|mesh-ancestor
101734731|NCT00739596|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101734732|NCT00742326|Pioglitazone|pioglitazone|mesh-list
101734733|NCT00742326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101734734|NCT00742326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734735|NCT02597868|Capecitabine|capecitabine|mesh-list
101734736|NCT02597868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101734737|NCT02597868|Antimetabolites|antimetabolites|mesh-ancestor
101734738|NCT02597868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734739|NCT02597868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101734740|NCT00811187|Lidocaine|lidocaine|mesh-list
101734741|NCT00811187|Anesthetics, Local|anesthetics, local|mesh-ancestor
101734742|NCT00811187|Anesthetics|anesthetics|mesh-ancestor
101734743|NCT00811187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101734744|NCT00811187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734745|NCT00811187|Sensory System Agents|sensory system agents|mesh-ancestor
101734746|NCT00811187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101734747|NCT00811187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101734748|NCT00811187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101734749|NCT00811187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101734750|NCT00811187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101734751|NCT00811187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734752|NCT00917748|Docetaxel|docetaxel|mesh-list
101734753|NCT00917748|Modafinil|modafinil|mesh-list
101734754|NCT00917748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101734755|NCT00917748|Tubulin Modulators|tubulin modulators|mesh-ancestor
101734756|NCT00917748|Antimitotic Agents|antimitotic agents|mesh-ancestor
101734757|NCT00917748|Mitosis Modulators|mitosis modulators|mesh-ancestor
101734758|NCT00917748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734759|NCT00917748|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101734760|NCT00917748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734761|NCT00917748|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101734762|NCT00917748|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101734763|NCT00917748|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101734764|NCT02595138|Zoledronic Acid|zoledronic acid|mesh-list
101734765|NCT02595138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101734766|NCT02595138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734768|NCT00591149|Oxaliplatin|oxaliplatin|mesh-list
101734769|NCT00591149|Cetuximab|cetuximab|mesh-list
101734770|NCT00591149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101734771|NCT00591149|Tubulin Modulators|tubulin modulators|mesh-ancestor
101734772|NCT00591149|Antimitotic Agents|antimitotic agents|mesh-ancestor
101734773|NCT00591149|Mitosis Modulators|mitosis modulators|mesh-ancestor
101734774|NCT00591149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734775|NCT00591149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101734776|NCT00735072|Maraviroc|maraviroc|mesh-list
101734777|NCT00735072|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101734778|NCT00735072|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101734779|NCT00735072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734780|NCT00735072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101734781|NCT00735072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101734782|NCT00735072|Antiviral Agents|antiviral agents|mesh-ancestor
101734783|NCT00735072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101734784|NCT00735072|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101734785|NCT00793598|Brincidofovir|brincidofovir|mesh-list
101734786|NCT00793598|Antiviral Agents|antiviral agents|mesh-ancestor
101734787|NCT00793598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101734788|NCT04115072|Praziquantel|praziquantel|mesh-list
101734789|NCT04115072|Anthelmintics|anthelmintics|mesh-ancestor
101734790|NCT04115072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101734791|NCT04115072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101734792|NCT00796562|Cyclophosphamide|cyclophosphamide|mesh-list
101734793|NCT00796562|Busulfan|busulfan|mesh-list
101734794|NCT00796562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101734795|NCT00796562|Immunologic Factors|immunologic factors|mesh-ancestor
101734796|NCT00796562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734797|NCT00796562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101734798|NCT00796562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101734799|NCT00796562|Alkylating Agents|alkylating agents|mesh-ancestor
101734800|NCT00796562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734801|NCT00796562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101734802|NCT00796562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101734803|NCT00801632|Prednisone|prednisone|mesh-list
101734804|NCT00801632|Methylprednisolone|methylprednisolone|mesh-list
101734805|NCT00801632|Cyclophosphamide|cyclophosphamide|mesh-list
101734806|NCT00801632|Rituximab|rituximab|mesh-list
101734807|NCT00801632|Tacrolimus|tacrolimus|mesh-list
101734808|NCT00801632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101734809|NCT00801632|Immunologic Factors|immunologic factors|mesh-ancestor
101734810|NCT00801632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734812|NCT00801632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101734813|NCT00801632|Alkylating Agents|alkylating agents|mesh-ancestor
101734814|NCT00801632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734815|NCT00801632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101734816|NCT00801632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101734817|NCT00801632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101734818|NCT00801632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101734819|NCT00801632|Glucocorticoids|glucocorticoids|mesh-ancestor
101734821|NCT00801632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101734822|NCT00801632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101734823|NCT00801632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101734824|NCT00801632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101734825|NCT00801632|Antiemetics|antiemetics|mesh-ancestor
101734826|NCT00801632|Autonomic Agents|autonomic agents|mesh-ancestor
101734827|NCT00801632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101734828|NCT00801632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101734829|NCT00801632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101734830|NCT00801632|Protective Agents|protective agents|mesh-ancestor
101734831|NCT04111484|Adrenomedullin|adrenomedullin|mesh-list
101734832|NCT04111484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101734833|NCT04111484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101734834|NCT04111484|Autonomic Agents|autonomic agents|mesh-ancestor
101734835|NCT04111484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101734836|NCT04111484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734837|NCT04111484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101734838|NCT04111484|Respiratory System Agents|respiratory system agents|mesh-ancestor
101734839|NCT04111484|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101734840|NCT04111484|Vasodilator Agents|vasodilator agents|mesh-ancestor
101734841|NCT04111484|Protective Agents|protective agents|mesh-ancestor
101734842|NCT04111328|Sufentanil|sufentanil|mesh-list
101734843|NCT04111328|Dexmedetomidine|dexmedetomidine|mesh-list
101734844|NCT04111328|Dsuvia|dsuvia|mesh-list
101734845|NCT04111328|Hydromorphone|hydromorphone|mesh-list
101734846|NCT04111328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101734847|NCT04111328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101734848|NCT04111328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734849|NCT04111328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101734850|NCT04111328|Analgesics|analgesics|mesh-ancestor
101734851|NCT04111328|Sensory System Agents|sensory system agents|mesh-ancestor
101734852|NCT04111328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101734853|NCT04111328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101734854|NCT04111328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101734855|NCT04111328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101734856|NCT04111328|Adrenergic Agents|adrenergic agents|mesh-ancestor
101734857|NCT04111328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101734858|NCT04111328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734859|NCT04111328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101734860|NCT04111328|Narcotics|narcotics|mesh-ancestor
101734861|NCT04111328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101734862|NCT04111328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101734863|NCT04111328|Anesthetics, General|anesthetics, general|mesh-ancestor
101734865|NCT00806819|Folic Acid|folic acid|mesh-list
101734866|NCT00806819|Vitamin B Complex|vitamin b complex|mesh-list
101734867|NCT00806819|Hydroxocobalamin|hydroxocobalamin|mesh-list
101734868|NCT00806819|Vitamin B 12|vitamin b 12|mesh-list
101734869|NCT00806819|Dexamethasone|dexamethasone|mesh-list
101734870|NCT00806819|Dexamethasone acetate|dexamethasone acetate|mesh-list
101734871|NCT00806819|Pemetrexed|pemetrexed|mesh-list
101734872|NCT00806819|Nintedanib|nintedanib|mesh-list
101734873|NCT00806819|BB 1101|bb 1101|mesh-list
101734874|NCT00806819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101734875|NCT00806819|Antiemetics|antiemetics|mesh-ancestor
101734876|NCT00806819|Autonomic Agents|autonomic agents|mesh-ancestor
101734877|NCT00806819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101734878|NCT00806819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734879|NCT00806819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101734880|NCT00806819|Glucocorticoids|glucocorticoids|mesh-ancestor
101734881|NCT00806819|Hormones|hormones|mesh-ancestor
101734882|NCT00806819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101734883|NCT00806819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101734884|NCT00806819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101734885|NCT00806819|Protease Inhibitors|protease inhibitors|mesh-ancestor
101734886|NCT00806819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101734887|NCT00806819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734888|NCT00806819|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101734889|NCT00806819|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101734891|NCT00806819|Vitamins|vitamins|mesh-ancestor
101734892|NCT00806819|Micronutrients|micronutrients|mesh-ancestor
101734893|NCT00806819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101734894|NCT04109534|Methacholine Chloride|methacholine chloride|mesh-list
101734895|NCT04109534|Miotics|miotics|mesh-ancestor
101734896|NCT04109534|Autonomic Agents|autonomic agents|mesh-ancestor
101734897|NCT04109534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101734898|NCT04109534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734899|NCT04109534|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101734900|NCT04109534|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
101734901|NCT04109534|Respiratory System Agents|respiratory system agents|mesh-ancestor
101734902|NCT04109534|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101734903|NCT04109534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101734904|NCT04109534|Cholinergic Agents|cholinergic agents|mesh-ancestor
101734905|NCT04109534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101734906|NCT04109534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734907|NCT05326139|Tranexamic Acid|tranexamic acid|mesh-list
101734908|NCT05326139|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101734909|NCT05326139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101734910|NCT05326139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734911|NCT05326139|Hemostatics|hemostatics|mesh-ancestor
101734912|NCT05326139|Coagulants|coagulants|mesh-ancestor
101734913|NCT02605694|Prednisone|prednisone|mesh-list
101734914|NCT02605694|Rituximab|rituximab|mesh-list
101734915|NCT02605694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101734916|NCT02605694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101734917|NCT02605694|Immunologic Factors|immunologic factors|mesh-ancestor
101734918|NCT02605694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734919|NCT02605694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101734920|NCT02605694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101734921|NCT02605694|Glucocorticoids|glucocorticoids|mesh-ancestor
101734922|NCT02605694|Hormones|hormones|mesh-ancestor
101734923|NCT02605694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101734924|NCT02605694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101734925|NCT02604134|Silver Nitrate|silver nitrate|mesh-list
101734928|NCT02604134|Cariostatic Agents|cariostatic agents|mesh-ancestor
101734929|NCT02604134|Protective Agents|protective agents|mesh-ancestor
101734930|NCT02604134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734931|NCT02604134|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101734932|NCT02604134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101734933|NCT00800540|Timolol|timolol|mesh-list
101734934|NCT00800540|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101734935|NCT00800540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101734937|NCT00800540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101734938|NCT00800540|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101734939|NCT00800540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101734940|NCT00800540|Adrenergic Agents|adrenergic agents|mesh-ancestor
101734941|NCT00800540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101734942|NCT00800540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734943|NCT00800540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734944|NCT00800540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101734945|NCT00800540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101734946|NCT00800540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101734947|NCT00800540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101734948|NCT00800540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101734949|NCT00800540|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101734950|NCT00800540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101734951|NCT00796328|Phenylephrine|phenylephrine|mesh-list
101734952|NCT00796328|Oxymetazoline|oxymetazoline|mesh-list
101734953|NCT00796328|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101734954|NCT00796328|Mydriatics|mydriatics|mesh-ancestor
101734955|NCT00796328|Autonomic Agents|autonomic agents|mesh-ancestor
101734956|NCT00796328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101734957|NCT00796328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734958|NCT00796328|Sympathomimetics|sympathomimetics|mesh-ancestor
101734959|NCT00796328|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101734960|NCT00796328|Nasal Decongestants|nasal decongestants|mesh-ancestor
101734961|NCT00796328|Respiratory System Agents|respiratory system agents|mesh-ancestor
101734962|NCT00796328|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101734963|NCT00796328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101734964|NCT00796328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101734965|NCT00796328|Adrenergic Agents|adrenergic agents|mesh-ancestor
101734966|NCT00796328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101734967|NCT00796328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734968|NCT00796328|Protective Agents|protective agents|mesh-ancestor
101734969|NCT02605382|Chlorhexidine|chlorhexidine|mesh-list
101734970|NCT02605382|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101734971|NCT02605382|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101734972|NCT02605382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101734973|NCT02605382|Disinfectants|disinfectants|mesh-ancestor
101734974|NCT02605382|Dermatologic Agents|dermatologic agents|mesh-ancestor
101734975|NCT04110860|Voriconazole|voriconazole|mesh-list
101734976|NCT04110860|Antifungal Agents|antifungal agents|mesh-ancestor
101734977|NCT04110860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101734978|NCT04110860|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101734979|NCT04110860|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101734980|NCT04110860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101734981|NCT04110860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101734982|NCT04110860|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101734983|NCT04110860|Hormone Antagonists|hormone antagonists|mesh-ancestor
101734984|NCT04110860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101734985|NCT04110860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734986|NCT04110860|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101734987|NCT02604836|Ibandronic Acid|ibandronic acid|mesh-list
101734988|NCT02604836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101734989|NCT02604836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734990|NCT04114526|Nicotine|nicotine|mesh-list
101734991|NCT04114526|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101734992|NCT04114526|Autonomic Agents|autonomic agents|mesh-ancestor
101734993|NCT04114526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101734994|NCT04114526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101734995|NCT04114526|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101734996|NCT04114526|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101734997|NCT04114526|Cholinergic Agents|cholinergic agents|mesh-ancestor
101734998|NCT04114526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101734999|NCT04114526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807838|NCT02976909|Cisplatin|cisplatin|mesh-list
101735000|NCT00915200|Acetylcysteine|acetylcysteine|mesh-list
101735001|NCT00915200|Silybin|silybin|mesh-list
101735002|NCT00915200|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101735003|NCT00915200|Antiviral Agents|antiviral agents|mesh-ancestor
101735004|NCT00915200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101735005|NCT00915200|Expectorants|expectorants|mesh-ancestor
101735006|NCT00915200|Respiratory System Agents|respiratory system agents|mesh-ancestor
101735007|NCT00915200|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101735008|NCT00915200|Antioxidants|antioxidants|mesh-ancestor
101735009|NCT00915200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735010|NCT00915200|Protective Agents|protective agents|mesh-ancestor
101735011|NCT00915200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735012|NCT00915200|Antidotes|antidotes|mesh-ancestor
101735013|NCT00915200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101735015|NCT00588146|Interferons|interferons|mesh-list
101735016|NCT00588146|Interferon-alpha|interferon-alpha|mesh-list
101735017|NCT00588146|Interferon alpha-2|interferon alpha-2|mesh-list
101735018|NCT00588146|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101735019|NCT00588146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101735020|NCT00588146|Antiviral Agents|antiviral agents|mesh-ancestor
101735021|NCT00588146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101735022|NCT00588146|Immunologic Factors|immunologic factors|mesh-ancestor
101735023|NCT00588146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735024|NCT00444457|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101735025|NCT00444457|Immunologic Factors|immunologic factors|mesh-ancestor
101735026|NCT00444457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735027|NCT00799058|Dapivirine|dapivirine|mesh-list
101735028|NCT00799058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101735029|NCT00799058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101735030|NCT00799058|Antiviral Agents|antiviral agents|mesh-ancestor
101735031|NCT00799058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101735032|NCT00725985|Cladribine|cladribine|mesh-list
101735033|NCT00725985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101735034|NCT00725985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101735035|NCT00725985|Immunologic Factors|immunologic factors|mesh-ancestor
101735036|NCT00725985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735037|NCT00793910|Gabapentin|gabapentin|mesh-list
101735038|NCT00793910|Analgesics|analgesics|mesh-ancestor
101735039|NCT00793910|Sensory System Agents|sensory system agents|mesh-ancestor
101735040|NCT00793910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101735041|NCT00793910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735042|NCT00793910|Anticonvulsants|anticonvulsants|mesh-ancestor
101735043|NCT00793910|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101735044|NCT00793910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101735045|NCT00793910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101735046|NCT00793910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101735047|NCT00793910|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101735048|NCT00793910|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101735049|NCT00793910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101735050|NCT00793910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735051|NCT00793910|Antimanic Agents|antimanic agents|mesh-ancestor
101735052|NCT01019941|Docetaxel|docetaxel|mesh-list
101735053|NCT01019941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101735054|NCT01019941|Tubulin Modulators|tubulin modulators|mesh-ancestor
101735055|NCT01019941|Antimitotic Agents|antimitotic agents|mesh-ancestor
101735056|NCT01019941|Mitosis Modulators|mitosis modulators|mesh-ancestor
101735057|NCT01019941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735058|NCT04113668|Diflunisal|diflunisal|mesh-list
101735059|NCT04113668|Deucravacitinib|deucravacitinib|mesh-list
101735060|NCT04113668|Dermatologic Agents|dermatologic agents|mesh-ancestor
101735061|NCT04113668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101735062|NCT04113668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101807846|NCT02976909|Antimetabolites|antimetabolites|mesh-ancestor
101735063|NCT04113668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735064|NCT04113668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101735067|NCT04113668|Sensory System Agents|sensory system agents|mesh-ancestor
101735068|NCT04113668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101735069|NCT04113668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735070|NCT04113668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101735071|NCT04113668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101735072|NCT04113668|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101735073|NCT00444145|Lansoprazole|lansoprazole|mesh-list
101735074|NCT00444145|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101735075|NCT00444145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101735076|NCT00444145|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101735077|NCT00444145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101735078|NCT00444145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735079|NCT04107896|Tamsulosin|tamsulosin|mesh-list
101735080|NCT04107896|Silodosin|silodosin|mesh-list
101735081|NCT04107896|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101735082|NCT04107896|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101735083|NCT04107896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101735084|NCT04107896|Adrenergic Agents|adrenergic agents|mesh-ancestor
101735085|NCT04107896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101735086|NCT04107896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735087|NCT04107896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735088|NCT04107896|Urological Agents|urological agents|mesh-ancestor
101735089|NCT01024777|Vitamin D|vitamin d|mesh-list
101735090|NCT01024777|Ergocalciferols|ergocalciferols|mesh-list
101735091|NCT01024777|Cholecalciferol|cholecalciferol|mesh-list
101735092|NCT01024777|Vitamins|vitamins|mesh-list
101735093|NCT01024777|Micronutrients|micronutrients|mesh-ancestor
101735094|NCT01024777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735095|NCT01024777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101735096|NCT01024777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101735097|NCT00789854|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101735098|NCT00789854|Lithium Carbonate|lithium carbonate|mesh-list
101735099|NCT00789854|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101735100|NCT00789854|Antidepressive Agents|antidepressive agents|mesh-ancestor
101735101|NCT00789854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101735102|NCT00789854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101735103|NCT00789854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101735104|NCT00789854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101735105|NCT00789854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735106|NCT00789854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101735107|NCT00789854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735108|NCT00789854|Antimanic Agents|antimanic agents|mesh-ancestor
101735109|NCT00789854|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101735110|NCT00789854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101735111|NCT00789854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101735112|NCT00789854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101735113|NCT00789854|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101735115|NCT00725205|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101735116|NCT00725205|Interferon-alpha|interferon-alpha|mesh-list
101735117|NCT00725205|Antimetabolites|antimetabolites|mesh-ancestor
101735118|NCT00725205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735119|NCT00725205|Antiviral Agents|antiviral agents|mesh-ancestor
101735120|NCT00725205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101735121|NCT00725205|Immunologic Factors|immunologic factors|mesh-ancestor
101735122|NCT00725205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735123|NCT00443755|Metformin|metformin|mesh-list
101735124|NCT00443755|Pioglitazone|pioglitazone|mesh-list
101735125|NCT00443755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101807858|NCT00093145|Carboplatin|carboplatin|mesh-list
101735126|NCT00443755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735128|NCT00724971|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
101735129|NCT00724971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101735130|NCT00724971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101735131|NCT00724971|Immunologic Factors|immunologic factors|mesh-ancestor
101735132|NCT00724971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735133|NCT00724971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101735134|NCT00724971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101735135|NCT00724971|Immunotoxins|immunotoxins|mesh-ancestor
101735136|NCT00724971|Immunoconjugates|immunoconjugates|mesh-ancestor
101735137|NCT00443599|Insulin|insulin|mesh-list
101735138|NCT00443599|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101735139|NCT00443599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101735140|NCT00443599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735141|NCT04107428|Somatostatin|somatostatin|mesh-list
101735142|NCT04107428|Hormones|hormones|mesh-ancestor
101735143|NCT04107428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101735144|NCT04107428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735145|NCT00455143|Dexmedetomidine|dexmedetomidine|mesh-list
101735146|NCT00455143|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101735147|NCT00455143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101735148|NCT00455143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735149|NCT00455143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101735150|NCT00455143|Analgesics|analgesics|mesh-ancestor
101735151|NCT00455143|Sensory System Agents|sensory system agents|mesh-ancestor
101735152|NCT00455143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101735153|NCT00455143|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101735154|NCT00455143|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101735155|NCT00455143|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101735156|NCT00455143|Adrenergic Agents|adrenergic agents|mesh-ancestor
101735157|NCT00455143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101735158|NCT00455143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735160|NCT00724893|Ribavirin|ribavirin|mesh-list
101735161|NCT00724893|Interferon-alpha|interferon-alpha|mesh-list
101735162|NCT00724893|Interferon alpha-2|interferon alpha-2|mesh-list
101735163|NCT00724893|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101735164|NCT00724893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101735165|NCT00724893|Antiviral Agents|antiviral agents|mesh-ancestor
101735166|NCT00724893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101735167|NCT00724893|Antimetabolites|antimetabolites|mesh-ancestor
101735168|NCT00724893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735169|NCT00724893|Immunologic Factors|immunologic factors|mesh-ancestor
101735170|NCT00724893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735171|NCT00789698|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101735172|NCT00789698|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
101735173|NCT00789698|Antidepressive Agents|antidepressive agents|mesh-ancestor
101735174|NCT00789698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101735175|NCT00789698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101735176|NCT00789698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101735177|NCT00789698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101735178|NCT00789698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735179|NCT00789698|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101735180|NCT00789698|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101735181|NCT00789698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101735182|NCT00789698|Adrenergic Agents|adrenergic agents|mesh-ancestor
101735183|NCT00789698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101392654|NCT04569747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101735184|NCT00789698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735186|NCT00789698|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101735187|NCT00789698|Serotonin Agents|serotonin agents|mesh-ancestor
101735188|NCT00789698|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101735189|NCT00789698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101735190|NCT00789698|Dopamine Agents|dopamine agents|mesh-ancestor
101735191|NCT00724815|Sumatriptan|sumatriptan|mesh-list
101735192|NCT00724815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101735193|NCT00724815|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101807869|NCT00965406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101735194|NCT00724815|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101735195|NCT00724815|Serotonin Agents|serotonin agents|mesh-ancestor
101735196|NCT00724815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101735197|NCT00724815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735198|NCT00724815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735199|NCT00798590|Glucagon|glucagon|mesh-list
101735200|NCT00798590|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101735201|NCT00798590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101735202|NCT00798590|Hormones|hormones|mesh-ancestor
101735203|NCT00798590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101735204|NCT00798590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735205|NCT00798590|Incretins|incretins|mesh-ancestor
101735206|NCT00481195|Modafinil|modafinil|mesh-list
101735207|NCT00481195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101735208|NCT00481195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735209|NCT00481195|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101735210|NCT00481195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101735211|NCT00481195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101735212|NCT00481195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735213|NCT03604549|Ethiodized Oil|ethiodized oil|mesh-list
101735214|NCT03604549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101735215|NCT01027429|Amoxicillin|amoxicillin|mesh-list
101735216|NCT01027429|Gentamicins|gentamicins|mesh-list
101735217|NCT01027429|Penicillins|penicillins|mesh-list
101735218|NCT01027429|Penicillin G Procaine|penicillin g procaine|mesh-list
101735219|NCT01027429|Penicillin G|penicillin g|mesh-list
101735220|NCT01027429|Penicillin G Benzathine|penicillin g benzathine|mesh-list
101735221|NCT01027429|Procaine|procaine|mesh-list
101735222|NCT01027429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101735223|NCT01027429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101735224|NCT01027429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101735225|NCT01027429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101735226|NCT01027429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735227|NCT01027429|Anesthetics, Local|anesthetics, local|mesh-ancestor
101735228|NCT01027429|Anesthetics|anesthetics|mesh-ancestor
101735229|NCT01027429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101735230|NCT01027429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735231|NCT01027429|Sensory System Agents|sensory system agents|mesh-ancestor
101735232|NCT01027429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101735233|NCT01020253|Alendronate|alendronate|mesh-list
101735234|NCT01020253|Alfacalcidol|alfacalcidol|mesh-list
101735235|NCT01020253|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
101735236|NCT01020253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101735237|NCT01020253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735239|NCT01020253|Micronutrients|micronutrients|mesh-ancestor
101735240|NCT00454207|Sildenafil Citrate|sildenafil citrate|mesh-list
101735241|NCT00454207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735242|NCT00454207|Vasodilator Agents|vasodilator agents|mesh-ancestor
101735243|NCT00454207|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101735244|NCT00454207|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101735245|NCT00454207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101735246|NCT00454207|Urological Agents|urological agents|mesh-ancestor
101735247|NCT01020331|Memantine|memantine|mesh-list
101735248|NCT01020331|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101735249|NCT01020331|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101735250|NCT01020331|Dopamine Agents|dopamine agents|mesh-ancestor
101735251|NCT01020331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101735252|NCT01020331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735253|NCT01020331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735254|NCT01020331|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101735255|NCT01020331|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101735257|NCT00738894|Clopidogrel|clopidogrel|mesh-list
101735258|NCT00738894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735259|NCT00738894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807877|NCT00960960|Paclitaxel|paclitaxel|mesh-list
101735260|NCT00738894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101735261|NCT00738894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101735262|NCT00738894|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101735263|NCT00738894|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101735264|NCT00738894|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101735265|NCT00738894|Purinergic Agents|purinergic agents|mesh-ancestor
101735266|NCT00738894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101735267|NCT00738894|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101735268|NCT00738894|Vasodilator Agents|vasodilator agents|mesh-ancestor
101735269|NCT00734994|Mitomycins|mitomycins|mesh-list
101735270|NCT00734994|Mitomycin|mitomycin|mesh-list
101735271|NCT00734994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101735272|NCT00734994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101735273|NCT00734994|Alkylating Agents|alkylating agents|mesh-ancestor
101735274|NCT00734994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735275|NCT00734994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101735276|NCT00734994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101735277|NCT02593734|Olanzapine|olanzapine|mesh-list
101735278|NCT02593734|Risperidone|risperidone|mesh-list
101735279|NCT02593734|Fluoxetine|fluoxetine|mesh-list
101735280|NCT02593734|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101735281|NCT02593734|Serotonin Agents|serotonin agents|mesh-ancestor
101735282|NCT02593734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101735283|NCT02593734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735284|NCT02593734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735285|NCT02593734|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101735286|NCT02593734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101735287|NCT02593734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101735288|NCT02593734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101735289|NCT02593734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101735290|NCT02593734|Dopamine Agents|dopamine agents|mesh-ancestor
101735291|NCT02593734|Antiemetics|antiemetics|mesh-ancestor
101735292|NCT02593734|Autonomic Agents|autonomic agents|mesh-ancestor
101735293|NCT02593734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101735294|NCT02593734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101735295|NCT02593734|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101735296|NCT02593734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101735297|NCT02593734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101735298|NCT02593734|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101735299|NCT02593734|Antidepressive Agents|antidepressive agents|mesh-ancestor
101735300|NCT02593734|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101735301|NCT02593734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101735302|NCT02593734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101735303|NCT00798434|Fesoterodine|fesoterodine|mesh-list
101735304|NCT00798434|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101735305|NCT00798434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101735306|NCT00798434|Cholinergic Agents|cholinergic agents|mesh-ancestor
101735307|NCT00798434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101735308|NCT00798434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735309|NCT00798434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735310|NCT00798434|Urological Agents|urological agents|mesh-ancestor
101735311|NCT04106804|Abatacept|abatacept|mesh-list
101735312|NCT04106804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101735313|NCT04106804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735314|NCT04106804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101735315|NCT04106804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101735316|NCT04106804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101735317|NCT04106804|Immunologic Factors|immunologic factors|mesh-ancestor
101735318|NCT04106804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735319|NCT04106804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101735320|NCT00791648|Atorvastatin|atorvastatin|mesh-list
101735322|NCT00791648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101735323|NCT00791648|Antimetabolites|antimetabolites|mesh-ancestor
101735324|NCT00791648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735325|NCT00791648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101735326|NCT00791648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101735327|NCT00791648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101735328|NCT05366595|Zinc Sulfate|zinc sulfate|mesh-list
101735329|NCT05366595|Astringents|astringents|mesh-ancestor
101735330|NCT05366595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735331|NCT05366595|Dermatologic Agents|dermatologic agents|mesh-ancestor
101735332|NCT04087239|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101735333|NCT04087239|Antiviral Agents|antiviral agents|mesh-ancestor
101735334|NCT04087239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101735335|NCT04017338|Ezetimibe|ezetimibe|mesh-list
101735336|NCT04017338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101735337|NCT04017338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101735338|NCT04017338|Antimetabolites|antimetabolites|mesh-ancestor
101735339|NCT04017338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735340|NCT04017338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101735341|NCT04106726|Ivermectin|ivermectin|mesh-list
101735342|NCT04106726|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101735343|NCT04106726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101735344|NCT03998774|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
101735345|NCT03998774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101735346|NCT03998774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101735347|NCT03998774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735348|NCT03998774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101735349|NCT00723957|Paclitaxel|paclitaxel|mesh-list
101735350|NCT00723957|Carboplatin|carboplatin|mesh-list
101735351|NCT00723957|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101735352|NCT00723957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101735353|NCT00723957|Tubulin Modulators|tubulin modulators|mesh-ancestor
101735354|NCT00723957|Antimitotic Agents|antimitotic agents|mesh-ancestor
101735355|NCT00723957|Mitosis Modulators|mitosis modulators|mesh-ancestor
101735356|NCT00723957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735357|NCT02603822|Indomethacin|indomethacin|mesh-list
101735358|NCT02603822|Mannitol|mannitol|mesh-list
101735359|NCT02603822|Lactulose|lactulose|mesh-list
101735360|NCT02603822|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101735361|NCT02603822|Diuretics|diuretics|mesh-ancestor
101735362|NCT02603822|Natriuretic Agents|natriuretic agents|mesh-ancestor
101735363|NCT02603822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735364|NCT02603822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101735365|NCT02603822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101735366|NCT02603822|Analgesics|analgesics|mesh-ancestor
101735367|NCT02603822|Sensory System Agents|sensory system agents|mesh-ancestor
101735368|NCT02603822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101735369|NCT02603822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101735370|NCT02603822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101735371|NCT02603822|Gout Suppressants|gout suppressants|mesh-ancestor
101735372|NCT02603822|Tocolytic Agents|tocolytic agents|mesh-ancestor
101735373|NCT02603822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101735374|NCT02603822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101735375|NCT02603822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101735376|NCT02603822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735377|NCT02603822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101735378|NCT02592057|Sofosbuvir|sofosbuvir|mesh-list
101735379|NCT02592057|Antiviral Agents|antiviral agents|mesh-ancestor
101735380|NCT02592057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101735381|NCT00723801|Losartan|losartan|mesh-list
101735382|NCT00723801|Atenolol|atenolol|mesh-list
101735383|NCT00723801|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101735384|NCT00723801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101735385|NCT00723801|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101735386|NCT00723801|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101735387|NCT00723801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735388|NCT00723801|Sympatholytics|sympatholytics|mesh-ancestor
101735389|NCT00723801|Autonomic Agents|autonomic agents|mesh-ancestor
101735390|NCT00723801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101735391|NCT00723801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735392|NCT00723801|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101735393|NCT00723801|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101735394|NCT00723801|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101735395|NCT00723801|Adrenergic Agents|adrenergic agents|mesh-ancestor
101735396|NCT00723801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101735397|NCT00797966|Fluoxetine|fluoxetine|mesh-list
101735398|NCT00797966|Paroxetine|paroxetine|mesh-list
101735399|NCT00797966|Sertraline|sertraline|mesh-list
101735400|NCT00797966|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101735401|NCT00797966|Escitalopram|escitalopram|mesh-list
101735402|NCT00797966|Brexpiprazole|brexpiprazole|mesh-list
101735403|NCT00797966|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101735404|NCT00797966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101735405|NCT00797966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101735406|NCT00797966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735407|NCT00797966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101735408|NCT00797966|Serotonin Agents|serotonin agents|mesh-ancestor
101735409|NCT00797966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735410|NCT00797966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101735411|NCT00797966|Antidepressive Agents|antidepressive agents|mesh-ancestor
101735412|NCT00797966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101735413|NCT00797966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101735414|NCT00797966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101735415|NCT00797966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101735416|NCT00797966|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101735417|NCT00797966|Dopamine Agonists|dopamine agonists|mesh-ancestor
101735418|NCT00797966|Dopamine Agents|dopamine agents|mesh-ancestor
101735419|NCT05361837|Dexmedetomidine|dexmedetomidine|mesh-list
101735420|NCT05361837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101735421|NCT05361837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101735422|NCT05361837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735423|NCT05361837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101735424|NCT05361837|Analgesics|analgesics|mesh-ancestor
101735425|NCT05361837|Sensory System Agents|sensory system agents|mesh-ancestor
101735426|NCT05361837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101735427|NCT05361837|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101735428|NCT05361837|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101735429|NCT05361837|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101735430|NCT05361837|Adrenergic Agents|adrenergic agents|mesh-ancestor
101735431|NCT05361837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101735432|NCT05361837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735433|NCT00723255|Sirolimus|sirolimus|mesh-list
101735434|NCT00723255|Bevacizumab|bevacizumab|mesh-list
101735435|NCT00723255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101735436|NCT00723255|Temsirolimus|temsirolimus|mesh-list
101735437|NCT00723255|MTOR Inhibitors|mtor inhibitors|mesh-list
101735438|NCT00723255|Antibodies|antibodies|mesh-list
101735439|NCT00723255|Immunoglobulins|immunoglobulins|mesh-list
101735440|NCT00723255|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101735441|NCT00723255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101735442|NCT00723255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101735443|NCT00723255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101735444|NCT00723255|Growth Substances|growth substances|mesh-ancestor
101735445|NCT00723255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735446|NCT00723255|Growth Inhibitors|growth inhibitors|mesh-ancestor
101735447|NCT00723255|Immunologic Factors|immunologic factors|mesh-ancestor
101735448|NCT00723255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101735449|NCT00723255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101735450|NCT00723255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735451|NCT00723255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101735452|NCT00723255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101735453|NCT00723255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101735454|NCT00723255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101735455|NCT00723255|Antifungal Agents|antifungal agents|mesh-ancestor
101735456|NCT00791258|Amlodipine|amlodipine|mesh-list
101735457|NCT00791258|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101735458|NCT00791258|Olmesartan|olmesartan|mesh-list
101735459|NCT00791258|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101735460|NCT00791258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101735461|NCT00791258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101735462|NCT00791258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101735463|NCT00791258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735464|NCT00791258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101735465|NCT00791258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735466|NCT00791258|Vasodilator Agents|vasodilator agents|mesh-ancestor
101735467|NCT00791258|Diuretics|diuretics|mesh-ancestor
101735468|NCT00791258|Natriuretic Agents|natriuretic agents|mesh-ancestor
101735469|NCT00791258|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101735470|NCT00791258|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101735471|NCT00791258|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101735472|NCT00808067|Dabigatran|dabigatran|mesh-list
101735473|NCT00808067|Antithrombins|antithrombins|mesh-ancestor
101735474|NCT00808067|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101735475|NCT00808067|Protease Inhibitors|protease inhibitors|mesh-ancestor
101735476|NCT00808067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101735477|NCT00808067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735478|NCT00808067|Anticoagulants|anticoagulants|mesh-ancestor
101735479|NCT00723021|Zileuton|zileuton|mesh-list
101735480|NCT00723021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101735481|NCT00723021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101735482|NCT00723021|Analgesics|analgesics|mesh-ancestor
101735483|NCT00723021|Sensory System Agents|sensory system agents|mesh-ancestor
101735484|NCT00723021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101735485|NCT00723021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735486|NCT00723021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101735487|NCT00723021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101735488|NCT00723021|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101735489|NCT00723021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101735490|NCT00723021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735491|NCT00723021|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101735492|NCT00723021|Hormone Antagonists|hormone antagonists|mesh-ancestor
101735493|NCT00723021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101735494|NCT04087317|Acetaminophen|acetaminophen|mesh-list
101735495|NCT04087317|Ibuprofen|ibuprofen|mesh-list
101735496|NCT04087317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101735497|NCT04087317|Analgesics|analgesics|mesh-ancestor
101807930|NCT05279586|Colistin|colistin|mesh-list
101735498|NCT04087317|Sensory System Agents|sensory system agents|mesh-ancestor
101735499|NCT04087317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101735500|NCT04087317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735501|NCT04087317|Antipyretics|antipyretics|mesh-ancestor
101735502|NCT04087317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101735503|NCT04087317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101735504|NCT04087317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101735505|NCT04087317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101735506|NCT04087317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101735507|NCT04087317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735508|NCT04309409|Nivolumab|nivolumab|mesh-list
101735509|NCT04309409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101735510|NCT04309409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101735511|NCT04309409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101735512|NCT04309409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735513|NCT04086537|Hepcidins|hepcidins|mesh-list
101735514|NCT04086537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101735515|NCT02608619|Choline|choline|mesh-list
101735516|NCT02608619|Lipotropic Agents|lipotropic agents|mesh-ancestor
101735517|NCT02608619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101735518|NCT02608619|Antimetabolites|antimetabolites|mesh-ancestor
101735519|NCT02608619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735520|NCT02608619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101735521|NCT02608619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101735522|NCT02608619|Nootropic Agents|nootropic agents|mesh-ancestor
101735523|NCT02591667|Bevacizumab|bevacizumab|mesh-list
101735524|NCT02591667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101735525|NCT02591667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101735526|NCT02591667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101735527|NCT02591667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101735528|NCT02591667|Growth Substances|growth substances|mesh-ancestor
101735529|NCT02591667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735530|NCT02591667|Growth Inhibitors|growth inhibitors|mesh-ancestor
101735531|NCT00807599|Dexamethasone|dexamethasone|mesh-list
101735532|NCT00807599|Dexamethasone acetate|dexamethasone acetate|mesh-list
101735533|NCT00807599|Lenalidomide|lenalidomide|mesh-list
101735534|NCT00807599|Melphalan|melphalan|mesh-list
101735535|NCT00807599|BB 1101|bb 1101|mesh-list
101735536|NCT00807599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101735537|NCT00807599|Antiemetics|antiemetics|mesh-ancestor
101735538|NCT00807599|Autonomic Agents|autonomic agents|mesh-ancestor
101735539|NCT00807599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101735540|NCT00807599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735541|NCT00807599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101735542|NCT00807599|Glucocorticoids|glucocorticoids|mesh-ancestor
101735543|NCT00807599|Hormones|hormones|mesh-ancestor
101735544|NCT00807599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101735545|NCT00807599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101735546|NCT00807599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101735547|NCT00807599|Protease Inhibitors|protease inhibitors|mesh-ancestor
101735548|NCT00807599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101735549|NCT00807599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735550|NCT00807599|Immunologic Factors|immunologic factors|mesh-ancestor
101735551|NCT00807599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101735552|NCT00807599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101735553|NCT00807599|Growth Substances|growth substances|mesh-ancestor
101735554|NCT00807599|Growth Inhibitors|growth inhibitors|mesh-ancestor
101735555|NCT00807599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101735556|NCT00807599|Alkylating Agents|alkylating agents|mesh-ancestor
101393027|NCT04246697|Antipyretics|antipyretics|mesh-ancestor
101735557|NCT00807599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101735558|NCT00807599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101735559|NCT00788372|Fentanyl|fentanyl|mesh-list
101735560|NCT00788372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101735561|NCT00788372|Narcotics|narcotics|mesh-ancestor
101735562|NCT00788372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101735563|NCT00788372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735564|NCT00788372|Analgesics|analgesics|mesh-ancestor
101735565|NCT00788372|Sensory System Agents|sensory system agents|mesh-ancestor
101735566|NCT00788372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101735567|NCT00788372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101735568|NCT00788372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101735569|NCT00788372|Anesthetics, General|anesthetics, general|mesh-ancestor
101735570|NCT00788372|Anesthetics|anesthetics|mesh-ancestor
101735571|NCT00738582|Pemetrexed|pemetrexed|mesh-list
101735572|NCT00738582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101735573|NCT00738582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101735574|NCT00738582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735575|NCT00738582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101735576|NCT00738582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101735577|NCT05753657|Pioglitazone|pioglitazone|mesh-list
101735578|NCT05753657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101735579|NCT05753657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735580|NCT00720759|Cycloserine|cycloserine|mesh-list
101735581|NCT00720759|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101735582|NCT00720759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101735583|NCT00720759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101735584|NCT00720759|Antitubercular Agents|antitubercular agents|mesh-ancestor
101735585|NCT00720759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101735586|NCT00720759|Antimetabolites|antimetabolites|mesh-ancestor
101735587|NCT00720759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735588|NCT00918411|Ramosetron|ramosetron|mesh-list
101735589|NCT00918411|Antiemetics|antiemetics|mesh-ancestor
101735590|NCT00918411|Autonomic Agents|autonomic agents|mesh-ancestor
101735591|NCT00918411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101735592|NCT00918411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735593|NCT00918411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101735594|NCT00918411|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101735595|NCT00918411|Serotonin Agents|serotonin agents|mesh-ancestor
101735596|NCT00918411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101735597|NCT00918411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735598|NCT00810407|Rifabutin|rifabutin|mesh-list
101735599|NCT00810407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101735600|NCT00810407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101735601|NCT00810407|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101735602|NCT00810407|Antitubercular Agents|antitubercular agents|mesh-ancestor
101735604|NCT00720057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101735605|NCT00720057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101735606|NCT00720057|Analgesics|analgesics|mesh-ancestor
101735607|NCT00720057|Sensory System Agents|sensory system agents|mesh-ancestor
101735608|NCT00720057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101735609|NCT00720057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735610|NCT00720057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101735611|NCT00720057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101735612|NCT00720057|Gout Suppressants|gout suppressants|mesh-ancestor
101735613|NCT00720057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101735614|NCT00720057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101735615|NCT00720057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735616|NCT00790868|Cycloserine|cycloserine|mesh-list
101735617|NCT00790868|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101735618|NCT00790868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101735619|NCT00790868|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101735620|NCT00790868|Antitubercular Agents|antitubercular agents|mesh-ancestor
101735621|NCT00790868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101735622|NCT00790868|Antimetabolites|antimetabolites|mesh-ancestor
101735623|NCT00790868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735624|NCT00719901|Bortezomib|bortezomib|mesh-list
101735625|NCT00719901|Obatoclax|obatoclax|mesh-list
101735626|NCT00719901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101735627|NCT00719901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101807947|NCT00415636|Pemetrexed|pemetrexed|mesh-list
101735628|NCT00719901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735629|NCT02603276|Red yeast rice|red yeast rice|mesh-list
101735630|NCT02603276|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101735631|NCT02603276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101735632|NCT02603276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101735633|NCT02603276|Antimetabolites|antimetabolites|mesh-ancestor
101735634|NCT02603276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735635|NCT02603276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101735636|NCT02603276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101735637|NCT02591277|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
101735638|NCT02591277|Antiviral Agents|antiviral agents|mesh-ancestor
101735639|NCT02591277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101735640|NCT00807365|Hormones|hormones|mesh-list
101735641|NCT00807365|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
101735642|NCT00807365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101735643|NCT00807365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735644|NCT02609711|Candesartan|candesartan|mesh-list
101735645|NCT02609711|Candesartan cilexetil|candesartan cilexetil|mesh-list
101735646|NCT02609711|Atorvastatin|atorvastatin|mesh-list
101735647|NCT02609711|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101735648|NCT02609711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101735649|NCT02609711|Antimetabolites|antimetabolites|mesh-ancestor
101735650|NCT02609711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735651|NCT02609711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101735652|NCT02609711|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101735653|NCT02609711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101735654|NCT02609711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101735655|NCT02609711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101735656|NCT02609711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101735657|NCT04016207|Guanfacine|guanfacine|mesh-list
101735658|NCT04016207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101735659|NCT04016207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101735660|NCT04016207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101735661|NCT04016207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101735662|NCT04016207|Adrenergic Agents|adrenergic agents|mesh-ancestor
101735663|NCT04016207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101735664|NCT04016207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735665|NCT04016207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735666|NCT04030091|Insulin|insulin|mesh-list
101735667|NCT04030091|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101735668|NCT04030091|Insulin, Isophane|insulin, isophane|mesh-list
101735669|NCT04030091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101735670|NCT04030091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735671|NCT00734604|Sildenafil Citrate|sildenafil citrate|mesh-list
101735672|NCT00734604|Tadalafil|tadalafil|mesh-list
101735673|NCT00734604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735674|NCT00734604|Vasodilator Agents|vasodilator agents|mesh-ancestor
101735675|NCT00734604|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101735676|NCT00734604|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101735677|NCT00734604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101735678|NCT00734604|Urological Agents|urological agents|mesh-ancestor
101735679|NCT00590681|Bevacizumab|bevacizumab|mesh-list
101735680|NCT00590681|Temozolomide|temozolomide|mesh-list
101735681|NCT00590681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101735682|NCT00590681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101735683|NCT00590681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101735684|NCT00590681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101735685|NCT00590681|Growth Substances|growth substances|mesh-ancestor
101735686|NCT00590681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735687|NCT00590681|Growth Inhibitors|growth inhibitors|mesh-ancestor
101735688|NCT00590681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101735689|NCT00590681|Alkylating Agents|alkylating agents|mesh-ancestor
101735690|NCT00590681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735691|NCT00727272|Quinine|quinine|mesh-list
101735693|NCT00727272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101735694|NCT00727272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101735695|NCT00727272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101735696|NCT00727272|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101735697|NCT00727272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735698|NCT00727272|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101735699|NCT00727272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101735700|NCT00727272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101735701|NCT00727272|Analgesics|analgesics|mesh-ancestor
101735702|NCT00727272|Sensory System Agents|sensory system agents|mesh-ancestor
101735703|NCT02609477|Phentermine|phentermine|mesh-list
101735704|NCT02609477|Istradefylline|istradefylline|mesh-list
101735705|NCT02609477|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101735706|NCT02609477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735707|NCT02609477|Appetite Depressants|appetite depressants|mesh-ancestor
101735708|NCT02609477|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101735709|NCT02609477|Sympathomimetics|sympathomimetics|mesh-ancestor
101735710|NCT02609477|Autonomic Agents|autonomic agents|mesh-ancestor
101735711|NCT02609477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101735712|NCT02609477|Adrenergic Agents|adrenergic agents|mesh-ancestor
101735713|NCT02609477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101735714|NCT02609477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735715|NCT02609477|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
101735716|NCT02609477|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101735717|NCT02609477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101735718|NCT02609477|Purinergic Agents|purinergic agents|mesh-ancestor
101735719|NCT02592720|Tenecteplase|tenecteplase|mesh-list
101735720|NCT02592720|Tirofiban|tirofiban|mesh-list
101735721|NCT02592720|Bivalirudin|bivalirudin|mesh-list
101735722|NCT02592720|Antithrombins|antithrombins|mesh-ancestor
101735723|NCT02592720|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101735724|NCT02592720|Protease Inhibitors|protease inhibitors|mesh-ancestor
101735725|NCT02592720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101735726|NCT02592720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735727|NCT02592720|Anticoagulants|anticoagulants|mesh-ancestor
101735728|NCT02592720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101735729|NCT02592720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101735730|NCT02592720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101735731|NCT02608073|Capecitabine|capecitabine|mesh-list
101735732|NCT02608073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101735733|NCT02608073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101735734|NCT02608073|Antimetabolites|antimetabolites|mesh-ancestor
101735735|NCT02608073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735736|NCT04041791|Amoxicillin|amoxicillin|mesh-list
101735737|NCT04041791|Gentamicins|gentamicins|mesh-list
101735738|NCT04041791|Ceftriaxone|ceftriaxone|mesh-list
101735739|NCT04041791|Clavulanic Acid|clavulanic acid|mesh-list
101735740|NCT04041791|Clavulanic Acids|clavulanic acids|mesh-list
101735741|NCT04041791|Penicillins|penicillins|mesh-list
101735742|NCT04041791|Ampicillin|ampicillin|mesh-list
101735743|NCT04041791|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101735744|NCT04041791|Penicillin G|penicillin g|mesh-list
101735745|NCT04041791|Penicillin G Benzathine|penicillin g benzathine|mesh-list
101735746|NCT04041791|Penicillin G Procaine|penicillin g procaine|mesh-list
101735763|NCT05571878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735764|NCT04088448|Metformin|metformin|mesh-list
101735765|NCT04088448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101735766|NCT04088448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735767|NCT00806351|Caspofungin|caspofungin|mesh-list
101735768|NCT00806351|Anidulafungin|anidulafungin|mesh-list
101735769|NCT00806351|Antifungal Agents|antifungal agents|mesh-ancestor
101735770|NCT00806351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101735771|NCT00806351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101735772|NCT00806351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101735773|NCT03995251|Testosterone|testosterone|mesh-list
101735774|NCT03995251|Androgens|androgens|mesh-ancestor
101735775|NCT03995251|Hormones|hormones|mesh-ancestor
101735776|NCT03995251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101735777|NCT03995251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735778|NCT01031017|Progesterone|progesterone|mesh-list
101735779|NCT01031017|Progestins|progestins|mesh-ancestor
101735780|NCT01031017|Hormones|hormones|mesh-ancestor
101393253|NCT04164069|Vitamins|vitamins|mesh-ancestor
101735781|NCT01031017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101735782|NCT01031017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101735783|NCT03742531|Oxytocin|oxytocin|mesh-list
101735784|NCT03742531|Oxytocics|oxytocics|mesh-ancestor
101796131|NCT00499252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796132|NCT01019590|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101796133|NCT01019590|Olmesartan|olmesartan|mesh-list
101796134|NCT01019590|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101796135|NCT01019590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101796136|NCT01019590|Diuretics|diuretics|mesh-ancestor
101796137|NCT01019590|Natriuretic Agents|natriuretic agents|mesh-ancestor
101796138|NCT01019590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796139|NCT01019590|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101796140|NCT01019590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101364710|NCT00399711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101796141|NCT01019590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796142|NCT01019590|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101796143|NCT01019590|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101796144|NCT03775421|Macitentan|macitentan|mesh-list
101796145|NCT03775421|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101796146|NCT03775421|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101796147|NCT03775421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796148|NCT03775421|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
101796149|NCT00532155|Dexamethasone|dexamethasone|mesh-list
101796150|NCT00532155|Docetaxel|docetaxel|mesh-list
101796151|NCT00532155|Aflibercept|aflibercept|mesh-list
101796152|NCT00532155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101796153|NCT00532155|Antiemetics|antiemetics|mesh-ancestor
101796154|NCT00532155|Autonomic Agents|autonomic agents|mesh-ancestor
101796155|NCT00532155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101796156|NCT00532155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796157|NCT00532155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101796158|NCT00532155|Glucocorticoids|glucocorticoids|mesh-ancestor
101796159|NCT00532155|Hormones|hormones|mesh-ancestor
101796160|NCT00532155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101796161|NCT00532155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101796162|NCT00532155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101796163|NCT00532155|Tubulin Modulators|tubulin modulators|mesh-ancestor
101796164|NCT00532155|Antimitotic Agents|antimitotic agents|mesh-ancestor
101796165|NCT00532155|Mitosis Modulators|mitosis modulators|mesh-ancestor
101796166|NCT00532155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796167|NCT00532155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101796168|NCT00532155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101796169|NCT00532155|Growth Substances|growth substances|mesh-ancestor
101796170|NCT00532155|Growth Inhibitors|growth inhibitors|mesh-ancestor
101796171|NCT01019668|Verteporfin|verteporfin|mesh-list
101796172|NCT01019668|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101796173|NCT01019668|Dermatologic Agents|dermatologic agents|mesh-ancestor
101796175|NCT01019746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101796176|NCT01019746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101796177|NCT01019746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796178|NCT01019746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101796179|NCT01019746|Anesthetics, General|anesthetics, general|mesh-ancestor
101796180|NCT01019746|Anesthetics|anesthetics|mesh-ancestor
101796181|NCT00205777|Bazedoxifene|bazedoxifene|mesh-list
101796182|NCT00205777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101796183|NCT00205777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101796184|NCT00205777|Hormone Antagonists|hormone antagonists|mesh-ancestor
101796185|NCT00205777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101796186|NCT00205777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796187|NCT00205777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101796188|NCT03762395|CXA-10|cxa-10|mesh-list
101796189|NCT03762395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101796190|NCT01004055|Anti-Infective Agents|anti-infective agents|mesh-list
101796191|NCT01004055|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101796192|NCT00483652|4-Aminopyridine|4-aminopyridine|mesh-list
101796193|NCT00483652|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101796194|NCT00483652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101796195|NCT00483652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796196|NCT00998283|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
101796197|NCT00998283|Immunologic Factors|immunologic factors|mesh-ancestor
101796198|NCT00998283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796200|NCT01014832|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101796201|NCT01014832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101796202|NCT01014832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796203|NCT03996473|Pembrolizumab|pembrolizumab|mesh-list
101796204|NCT03996473|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
101796205|NCT03996473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101796206|NCT03996473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101796207|NCT03996473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101796208|NCT03996473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796209|NCT01000545|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
101796210|NCT01000545|Anticoagulants|anticoagulants|mesh-ancestor
101796211|NCT01000545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101796212|NCT01000545|Antimetabolites|antimetabolites|mesh-ancestor
101796213|NCT01000545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796214|NCT01000545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101796215|NCT01000545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101796216|NCT01000545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101796217|NCT01000545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101796218|NCT01000545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796219|NCT03992729|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101796220|NCT03992729|Immunologic Factors|immunologic factors|mesh-ancestor
101796221|NCT03992729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796222|NCT00483574|Vaccines|vaccines|mesh-list
101796223|NCT00483574|Immunologic Factors|immunologic factors|mesh-ancestor
101796224|NCT00483574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796225|NCT01000623|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101796226|NCT01000623|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101796227|NCT01000623|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101796228|NCT01000623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101796229|NCT01000623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796230|NCT01000623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101796231|NCT01000623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796232|NCT01000623|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101796233|NCT01000623|Antidepressive Agents|antidepressive agents|mesh-ancestor
101796234|NCT01000623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101796235|NCT00998439|Paclitaxel|paclitaxel|mesh-list
101796236|NCT00998439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101796237|NCT00998439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101796238|NCT00998439|Tubulin Modulators|tubulin modulators|mesh-ancestor
101796239|NCT00998439|Antimitotic Agents|antimitotic agents|mesh-ancestor
101796240|NCT00998439|Mitosis Modulators|mitosis modulators|mesh-ancestor
101796241|NCT00998439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796242|NCT01000779|Propranolol|propranolol|mesh-list
101796243|NCT01000779|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101796244|NCT01000779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101796245|NCT01000779|Adrenergic Agents|adrenergic agents|mesh-ancestor
101796246|NCT01000779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101796247|NCT01000779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796248|NCT01000779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796249|NCT01000779|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101796250|NCT01000779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101796251|NCT01000779|Vasodilator Agents|vasodilator agents|mesh-ancestor
101796252|NCT01000857|Paroxetine|paroxetine|mesh-list
101796253|NCT01000857|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101796254|NCT01000857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101796255|NCT01000857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101796256|NCT01000857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796257|NCT01000857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101796258|NCT01000857|Serotonin Agents|serotonin agents|mesh-ancestor
101796259|NCT01000857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796260|NCT01000857|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101796261|NCT01000857|Antidepressive Agents|antidepressive agents|mesh-ancestor
101796262|NCT01000857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101796263|NCT01000857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101796264|NCT01000857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101796265|NCT01000857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101796266|NCT01004445|Amikacin|amikacin|mesh-list
101796267|NCT01004445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101796268|NCT01004445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101796269|NCT02580695|Hyaluronic Acid|hyaluronic acid|mesh-list
101796270|NCT02580695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101796271|NCT02580695|Immunologic Factors|immunologic factors|mesh-ancestor
101796272|NCT02580695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796273|NCT02580695|Viscosupplements|viscosupplements|mesh-ancestor
101796274|NCT02580695|Protective Agents|protective agents|mesh-ancestor
101796275|NCT02581553|Allopurinol|allopurinol|mesh-list
101796276|NCT02581553|Lesinurad|lesinurad|mesh-list
101796277|NCT02581553|Antimetabolites|antimetabolites|mesh-ancestor
101796278|NCT02581553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796279|NCT02581553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101796280|NCT02581553|Gout Suppressants|gout suppressants|mesh-ancestor
101796281|NCT02581553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101796282|NCT02581553|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101796283|NCT02581553|Antioxidants|antioxidants|mesh-ancestor
101796284|NCT02581553|Protective Agents|protective agents|mesh-ancestor
101796285|NCT02581553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796286|NCT02581553|Uricosuric Agents|uricosuric agents|mesh-ancestor
101796288|NCT03944915|Carboplatin|carboplatin|mesh-list
101796289|NCT03944915|Fluorouracil|fluorouracil|mesh-list
101796290|NCT03944915|Nivolumab|nivolumab|mesh-list
101796291|NCT03944915|Hydroxyurea|hydroxyurea|mesh-list
101796292|NCT03944915|Lenograstim|lenograstim|mesh-list
101796293|NCT03944915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101796294|NCT03944915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101796295|NCT03944915|Tubulin Modulators|tubulin modulators|mesh-ancestor
101796296|NCT03944915|Antimitotic Agents|antimitotic agents|mesh-ancestor
101796297|NCT03944915|Mitosis Modulators|mitosis modulators|mesh-ancestor
101796298|NCT03944915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796299|NCT03944915|Antimetabolites|antimetabolites|mesh-ancestor
101796300|NCT03944915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101796301|NCT03944915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101796302|NCT03944915|Immunologic Factors|immunologic factors|mesh-ancestor
101796303|NCT03944915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796304|NCT03944915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101796305|NCT03944915|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101796306|NCT03944915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101796307|NCT03944915|Antisickling Agents|antisickling agents|mesh-ancestor
101796308|NCT03944915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101796309|NCT03944915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101796311|NCT00482170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101796312|NCT00482170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101796313|NCT00482170|Analgesics|analgesics|mesh-ancestor
101796314|NCT00482170|Sensory System Agents|sensory system agents|mesh-ancestor
101796315|NCT00482170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101796316|NCT00482170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796317|NCT00482170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101796318|NCT00482170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101796319|NCT00482170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101796320|NCT00482170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101796321|NCT00482170|Immunologic Factors|immunologic factors|mesh-ancestor
101796322|NCT05228249|Cytarabine|cytarabine|mesh-list
101796323|NCT05228249|Etoposide|etoposide|mesh-list
101796324|NCT05228249|Podophyllotoxin|podophyllotoxin|mesh-list
101796325|NCT05228249|Etoposide phosphate|etoposide phosphate|mesh-list
101796326|NCT05228249|Melphalan|melphalan|mesh-list
101796327|NCT05228249|Mechlorethamine|mechlorethamine|mesh-list
101796328|NCT05228249|Carmustine|carmustine|mesh-list
101796329|NCT05228249|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
101796330|NCT05228249|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
101796331|NCT05228249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101796332|NCT05228249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101796333|NCT05228249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101796334|NCT05228249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101796335|NCT05228249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101796336|NCT05228249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796337|NCT05228249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101796339|NCT05228249|Antiviral Agents|antiviral agents|mesh-ancestor
101796340|NCT05228249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101796341|NCT05228249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101796342|NCT05228249|Immunologic Factors|immunologic factors|mesh-ancestor
101796343|NCT05228249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796344|NCT05228249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101796345|NCT05228249|Alkylating Agents|alkylating agents|mesh-ancestor
101796346|NCT05228249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101796347|NCT05228249|Keratolytic Agents|keratolytic agents|mesh-ancestor
101796348|NCT05228249|Dermatologic Agents|dermatologic agents|mesh-ancestor
101796349|NCT05228249|Tubulin Modulators|tubulin modulators|mesh-ancestor
101796350|NCT05228249|Antimitotic Agents|antimitotic agents|mesh-ancestor
101796351|NCT05228249|Mitosis Modulators|mitosis modulators|mesh-ancestor
101796352|NCT05228249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101796353|NCT02580227|Tranexamic Acid|tranexamic acid|mesh-list
101796354|NCT02580227|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101796355|NCT02580227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101796356|NCT02580227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796357|NCT02580227|Hemostatics|hemostatics|mesh-ancestor
101796358|NCT02580227|Coagulants|coagulants|mesh-ancestor
101796359|NCT04218695|Ceftriaxone|ceftriaxone|mesh-list
101796360|NCT04218695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101796361|NCT04218695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101796362|NCT01001013|Pioglitazone|pioglitazone|mesh-list
101796363|NCT01001013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101796364|NCT01001013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796365|NCT01004601|Docetaxel|docetaxel|mesh-list
101796366|NCT01004601|Pemetrexed|pemetrexed|mesh-list
101796367|NCT01004601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101796368|NCT01004601|Tubulin Modulators|tubulin modulators|mesh-ancestor
101796369|NCT01004601|Antimitotic Agents|antimitotic agents|mesh-ancestor
101796370|NCT01004601|Mitosis Modulators|mitosis modulators|mesh-ancestor
101796371|NCT01004601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796373|NCT01004601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101796374|NCT01004601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101796375|NCT01001247|Rilpivirine|rilpivirine|mesh-list
101796376|NCT01001247|Omeprazole|omeprazole|mesh-list
101796377|NCT01001247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101796378|NCT01001247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101796379|NCT01001247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101796380|NCT01001247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101796381|NCT01001247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796382|NCT01001247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101796383|NCT01001247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101796384|NCT01001247|Antiviral Agents|antiviral agents|mesh-ancestor
101796385|NCT01001247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101796386|NCT01001247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101796387|NCT01001247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101796388|NCT04205357|Sulfasalazine|sulfasalazine|mesh-list
101796389|NCT04205357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101796390|NCT04205357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101796391|NCT04205357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101796392|NCT04205357|Analgesics|analgesics|mesh-ancestor
101796393|NCT04205357|Sensory System Agents|sensory system agents|mesh-ancestor
101796394|NCT04205357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101796395|NCT04205357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796396|NCT04205357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101796397|NCT04205357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101796398|NCT04205357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101796399|NCT02580773|Tinzaparin|tinzaparin|mesh-list
101796400|NCT02580773|Anticoagulants|anticoagulants|mesh-ancestor
101796401|NCT02580773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101796402|NCT02580773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101796403|NCT02580773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796404|NCT01008813|Vaccines|vaccines|mesh-list
101796405|NCT01008813|Immunologic Factors|immunologic factors|mesh-ancestor
101796406|NCT01008813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796407|NCT01001637|Curcumin|curcumin|mesh-list
101796408|NCT01001637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101796409|NCT01001637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101796410|NCT01001637|Analgesics|analgesics|mesh-ancestor
101796411|NCT01001637|Sensory System Agents|sensory system agents|mesh-ancestor
101796412|NCT01001637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101796413|NCT01001637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796414|NCT01001637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101796415|NCT01001637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101796416|NCT01001637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101796417|NCT01001637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101796418|NCT01001637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796419|NCT01005147|Tranexamic Acid|tranexamic acid|mesh-list
101796420|NCT01005147|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101796421|NCT01005147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101796422|NCT01005147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796423|NCT01005147|Hemostatics|hemostatics|mesh-ancestor
101796424|NCT01005147|Coagulants|coagulants|mesh-ancestor
101796425|NCT01001871|Vitamins|vitamins|mesh-list
101796426|NCT01001871|Micronutrients|micronutrients|mesh-ancestor
101796427|NCT01001871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796428|NCT01005303|Vitamin D|vitamin d|mesh-list
101796429|NCT01005303|Cholecalciferol|cholecalciferol|mesh-list
101796430|NCT01005303|Vitamins|vitamins|mesh-ancestor
101796431|NCT01005303|Micronutrients|micronutrients|mesh-ancestor
101796432|NCT01005303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796433|NCT01005303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101310626|NCT00005959|Tubulin Modulators|tubulin modulators|mesh-ancestor
101796434|NCT01005303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101796435|NCT01005381|Calcium, Dietary|calcium, dietary|mesh-list
101796436|NCT01005381|Vitamin D|vitamin d|mesh-list
101796437|NCT01005381|Calcium Carbonate|calcium carbonate|mesh-list
101796438|NCT01005381|Calcium|calcium|mesh-list
101796439|NCT01005381|Vitamins|vitamins|mesh-ancestor
101796440|NCT01005381|Micronutrients|micronutrients|mesh-ancestor
101796441|NCT01005381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796442|NCT01005381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101796443|NCT01005381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101796444|NCT01005381|Antacids|antacids|mesh-ancestor
101796445|NCT01005381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796446|NCT01005381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101796447|NCT01002183|Fosmidomycin|fosmidomycin|mesh-list
101796448|NCT01002183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101796449|NCT01002183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101796450|NCT05154279|Terlipressin|terlipressin|mesh-list
101796451|NCT05154279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101796452|NCT05154279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101796453|NCT01005537|Aldesleukin|aldesleukin|mesh-list
101796454|NCT01005537|Cyclophosphamide|cyclophosphamide|mesh-list
101796455|NCT01005537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101796456|NCT01005537|Immunologic Factors|immunologic factors|mesh-ancestor
101796457|NCT01005537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796458|NCT01005537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101796459|NCT01005537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101796460|NCT01005537|Alkylating Agents|alkylating agents|mesh-ancestor
101796461|NCT01005537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796462|NCT01005537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101796463|NCT01005537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101796464|NCT01005537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101796465|NCT01005537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101796466|NCT01005537|Antiviral Agents|antiviral agents|mesh-ancestor
101796467|NCT01005537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101796468|NCT01005927|Calcium|calcium|mesh-list
101796469|NCT01005927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101796470|NCT01005927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796471|NCT03742713|Docetaxel|docetaxel|mesh-list
101796472|NCT03742713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101796473|NCT03742713|Tubulin Modulators|tubulin modulators|mesh-ancestor
101796474|NCT03742713|Antimitotic Agents|antimitotic agents|mesh-ancestor
101796475|NCT03742713|Mitosis Modulators|mitosis modulators|mesh-ancestor
101796476|NCT03742713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796477|NCT01002729|Oseltamivir|oseltamivir|mesh-list
101796478|NCT01002729|Antiviral Agents|antiviral agents|mesh-ancestor
101796479|NCT01002729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101796480|NCT01002729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101796481|NCT01002729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796482|NCT01002807|Metformin|metformin|mesh-list
101796483|NCT01002807|Dapagliflozin|dapagliflozin|mesh-list
101796484|NCT01002807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101796485|NCT01002807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796486|NCT01002807|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101796487|NCT01002807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796488|NCT05733117|Vitamin D|vitamin d|mesh-list
101796489|NCT05733117|Vitamins|vitamins|mesh-ancestor
101796490|NCT05733117|Micronutrients|micronutrients|mesh-ancestor
101796491|NCT05733117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796492|NCT05733117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101796493|NCT01006395|Zoledronic Acid|zoledronic acid|mesh-list
101796494|NCT01006395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101796495|NCT01006395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796496|NCT00615056|Leucovorin|leucovorin|mesh-list
101796497|NCT00615056|Bevacizumab|bevacizumab|mesh-list
101796498|NCT00615056|Fluorouracil|fluorouracil|mesh-list
101796499|NCT00615056|Oxaliplatin|oxaliplatin|mesh-list
101796501|NCT00615056|Axitinib|axitinib|mesh-list
101796502|NCT00615056|Levoleucovorin|levoleucovorin|mesh-list
101796503|NCT00615056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101796504|NCT00615056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101796505|NCT00615056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101796506|NCT00615056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101796507|NCT00615056|Growth Substances|growth substances|mesh-ancestor
101796508|NCT00615056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796509|NCT00615056|Growth Inhibitors|growth inhibitors|mesh-ancestor
101796511|NCT00615056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796512|NCT00615056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101796513|NCT00615056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101796514|NCT00615056|Immunologic Factors|immunologic factors|mesh-ancestor
101333740|NCT00040690|Leucovorin|leucovorin|mesh-list
101796515|NCT00615056|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101796516|NCT00615056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101796517|NCT00615056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101796518|NCT00615056|Antidotes|antidotes|mesh-ancestor
101796519|NCT00615056|Protective Agents|protective agents|mesh-ancestor
101796520|NCT00615056|Vitamin B Complex|vitamin b complex|mesh-ancestor
101796521|NCT00615056|Vitamins|vitamins|mesh-ancestor
101796522|NCT00615056|Micronutrients|micronutrients|mesh-ancestor
101796523|NCT00615056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101796524|NCT01006551|Ziprasidone|ziprasidone|mesh-list
101796525|NCT01006551|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101796526|NCT01006551|Serotonin Agents|serotonin agents|mesh-ancestor
101796527|NCT01006551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101796528|NCT01006551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796529|NCT01006551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796530|NCT01006551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101796531|NCT01006551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101796532|NCT01006551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101796533|NCT01006551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101796534|NCT01006551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101796535|NCT01006551|Dopamine Agents|dopamine agents|mesh-ancestor
101796536|NCT05732727|Antihypertensive Agents|antihypertensive agents|mesh-list
101796538|NCT00873626|Levofloxacin|levofloxacin|mesh-list
101796539|NCT00873626|Ofloxacin|ofloxacin|mesh-list
101796540|NCT00873626|Fluoroquinolones|fluoroquinolones|mesh-list
101796541|NCT00873626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101796542|NCT00873626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101796543|NCT00873626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101796544|NCT00873626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101796545|NCT00873626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101796546|NCT00873626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796547|NCT00873626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101796548|NCT00873626|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101796549|NCT00873626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101796550|NCT00873626|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101796551|NCT00873626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101796552|NCT00879242|Deferasirox|deferasirox|mesh-list
101796553|NCT00879242|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101796554|NCT00879242|Chelating Agents|chelating agents|mesh-ancestor
101796555|NCT00879242|Sequestering Agents|sequestering agents|mesh-ancestor
101796556|NCT00879242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796557|NCT05732493|Capecitabine|capecitabine|mesh-list
101796558|NCT05732493|Oxaliplatin|oxaliplatin|mesh-list
101796559|NCT05732493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101796560|NCT05732493|Antimetabolites|antimetabolites|mesh-ancestor
101796561|NCT05732493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796562|NCT05732493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101796563|NCT00868634|Bevacizumab|bevacizumab|mesh-list
101796564|NCT00868634|Capecitabine|capecitabine|mesh-list
101796565|NCT00868634|Vinorelbine|vinorelbine|mesh-list
101796566|NCT00868634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101796567|NCT00868634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101796568|NCT00868634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101796569|NCT00868634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101796570|NCT00868634|Growth Substances|growth substances|mesh-ancestor
101796571|NCT00868634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796572|NCT00868634|Growth Inhibitors|growth inhibitors|mesh-ancestor
101796573|NCT00868634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101796574|NCT00868634|Antimetabolites|antimetabolites|mesh-ancestor
101796575|NCT00868634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796576|NCT00868634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101796577|NCT00868634|Tubulin Modulators|tubulin modulators|mesh-ancestor
101796578|NCT00868634|Antimitotic Agents|antimitotic agents|mesh-ancestor
101796579|NCT00868634|Mitosis Modulators|mitosis modulators|mesh-ancestor
101796580|NCT05232357|Sodium thiosulfate|sodium thiosulfate|mesh-list
101796581|NCT05232357|Methylene Blue|methylene blue|mesh-list
101796582|NCT05232357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101796583|NCT05232357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796584|NCT05232357|Antidotes|antidotes|mesh-ancestor
101796585|NCT05232357|Protective Agents|protective agents|mesh-ancestor
101796586|NCT05232357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796587|NCT05232357|Antioxidants|antioxidants|mesh-ancestor
101796588|NCT05232357|Antitubercular Agents|antitubercular agents|mesh-ancestor
101796589|NCT05232357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101796590|NCT05232357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101796591|NCT05232357|Chelating Agents|chelating agents|mesh-ancestor
101796592|NCT05232357|Sequestering Agents|sequestering agents|mesh-ancestor
101796593|NCT00879476|Ramipril|ramipril|mesh-list
101796594|NCT00879476|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101796595|NCT00879476|Protease Inhibitors|protease inhibitors|mesh-ancestor
101796596|NCT00879476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101796597|NCT00879476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796598|NCT00879476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101796599|NCT00868946|Ribavirin|ribavirin|mesh-list
101796600|NCT00868946|Antimetabolites|antimetabolites|mesh-ancestor
101796601|NCT00868946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796602|NCT00868946|Antiviral Agents|antiviral agents|mesh-ancestor
101796603|NCT00868946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101796604|NCT00482014|Carboplatin|carboplatin|mesh-list
101796605|NCT00482014|Pemetrexed|pemetrexed|mesh-list
101796606|NCT00482014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101796607|NCT00482014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101796608|NCT00482014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796609|NCT00482014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101796610|NCT00482014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101796611|NCT00879788|Ramipril|ramipril|mesh-list
101796612|NCT00879788|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101796613|NCT00879788|Protease Inhibitors|protease inhibitors|mesh-ancestor
101796614|NCT00879788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101796615|NCT00879788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796616|NCT00879788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101796617|NCT03595553|Vancomycin|vancomycin|mesh-list
101796618|NCT03595553|Ridinilazole|ridinilazole|mesh-list
101796619|NCT03595553|Benzimidazole|benzimidazole|mesh-list
101796620|NCT03595553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101796621|NCT03595553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101796622|NCT03595553|Anthelmintics|anthelmintics|mesh-ancestor
101796623|NCT03595553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101796624|NCT00874172|Analgesics|analgesics|mesh-list
101796625|NCT00874172|Sensory System Agents|sensory system agents|mesh-ancestor
101796626|NCT00874172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101796627|NCT00874172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796628|NCT00614822|Bevacizumab|bevacizumab|mesh-list
101796629|NCT00614822|Carboplatin|carboplatin|mesh-list
101796630|NCT00614822|Pemetrexed|pemetrexed|mesh-list
101796631|NCT00614822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101796632|NCT00614822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101796633|NCT00614822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101796634|NCT00614822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101796635|NCT00614822|Growth Substances|growth substances|mesh-ancestor
101796636|NCT00614822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796637|NCT00614822|Growth Inhibitors|growth inhibitors|mesh-ancestor
101796638|NCT00614822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101796639|NCT00614822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796640|NCT00614822|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101796641|NCT00614822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101796642|NCT04861298|Quercetin|quercetin|mesh-list
101796643|NCT04861298|Antioxidants|antioxidants|mesh-ancestor
101453998|NCT00234234|Adalimumab|adalimumab|mesh-list
101796644|NCT04861298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796645|NCT04861298|Protective Agents|protective agents|mesh-ancestor
101796646|NCT04861298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796648|NCT03582917|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
101796649|NCT03582917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101796650|NCT03582917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796651|NCT03582917|Vitamins|vitamins|mesh-ancestor
101796652|NCT03582917|Micronutrients|micronutrients|mesh-ancestor
101796653|NCT05226728|Pembrolizumab|pembrolizumab|mesh-list
101796654|NCT05226728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101796655|NCT05226728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101796656|NCT05226728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101796657|NCT05226728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796658|NCT00869180|Diclofenac|diclofenac|mesh-list
101796659|NCT00869180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101796660|NCT00869180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101796662|NCT00869180|Sensory System Agents|sensory system agents|mesh-ancestor
101796663|NCT00869180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101796664|NCT00869180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796665|NCT00869180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101796666|NCT00869180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101796667|NCT00869180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101796668|NCT00869180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101796669|NCT00869180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796670|NCT00874328|Irinotecan|irinotecan|mesh-list
101796671|NCT00874328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101796672|NCT00874328|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101796673|NCT00874328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101796674|NCT00874328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101796675|NCT00874328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796676|NCT00874406|Leucovorin|leucovorin|mesh-list
101796677|NCT00874406|Fluorouracil|fluorouracil|mesh-list
101796678|NCT00874406|Oxaliplatin|oxaliplatin|mesh-list
101796679|NCT00874406|Antimetabolites|antimetabolites|mesh-ancestor
101796680|NCT00874406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796681|NCT00874406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101796682|NCT00874406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101796683|NCT00874406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101796684|NCT00874406|Immunologic Factors|immunologic factors|mesh-ancestor
101796685|NCT00874406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796686|NCT00874406|Antidotes|antidotes|mesh-ancestor
101796687|NCT00874406|Protective Agents|protective agents|mesh-ancestor
101796688|NCT00874406|Vitamin B Complex|vitamin b complex|mesh-ancestor
101796689|NCT00874406|Vitamins|vitamins|mesh-ancestor
101796690|NCT00874406|Micronutrients|micronutrients|mesh-ancestor
101796691|NCT04840628|Respiratory System Agents|respiratory system agents|mesh-list
101796693|NCT00880178|Niacinamide|niacinamide|mesh-list
101796694|NCT00880178|Nicotinic Acids|nicotinic acids|mesh-list
101796695|NCT00880178|Simvastatin|simvastatin|mesh-list
101796696|NCT00880178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101796697|NCT00880178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101796698|NCT00880178|Antimetabolites|antimetabolites|mesh-ancestor
101796699|NCT00880178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796700|NCT00880178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101796701|NCT00880178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101796702|NCT00880178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101796703|NCT00880178|Vasodilator Agents|vasodilator agents|mesh-ancestor
101796704|NCT00880178|Vitamin B Complex|vitamin b complex|mesh-ancestor
101796705|NCT00880178|Vitamins|vitamins|mesh-ancestor
101796706|NCT00880178|Micronutrients|micronutrients|mesh-ancestor
101796707|NCT00880178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796708|NCT04077125|Rifaximin|rifaximin|mesh-list
101796709|NCT04077125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101796710|NCT04077125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101796711|NCT04077125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101796712|NCT05172401|Triamcinolone|triamcinolone|mesh-list
101796713|NCT05172401|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101796714|NCT05172401|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101796715|NCT05172401|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101796716|NCT05172401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101796717|NCT05172401|Glucocorticoids|glucocorticoids|mesh-ancestor
101796718|NCT05172401|Hormones|hormones|mesh-ancestor
101796719|NCT05172401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101796720|NCT05172401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796722|NCT05172401|Immunologic Factors|immunologic factors|mesh-ancestor
101796723|NCT05172401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101796724|NCT05172401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796725|NCT00143455|Cisplatin|cisplatin|mesh-list
101796726|NCT00143455|Irinotecan|irinotecan|mesh-list
101796727|NCT00143455|Etoposide|etoposide|mesh-list
101796728|NCT00143455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101796729|NCT00143455|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101796730|NCT00143455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101796731|NCT00143455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101796732|NCT00143455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796733|NCT00143455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101796734|NCT00143455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101796735|NCT01006863|Phenylephrine|phenylephrine|mesh-list
101796736|NCT01006863|Oxymetazoline|oxymetazoline|mesh-list
101796737|NCT01006863|Ephedrine|ephedrine|mesh-list
101796738|NCT01006863|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101796739|NCT01006863|Mydriatics|mydriatics|mesh-ancestor
101796740|NCT01006863|Autonomic Agents|autonomic agents|mesh-ancestor
101796741|NCT01006863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101796742|NCT01006863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796743|NCT01006863|Sympathomimetics|sympathomimetics|mesh-ancestor
101796744|NCT01006863|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101796745|NCT01006863|Nasal Decongestants|nasal decongestants|mesh-ancestor
101796746|NCT01006863|Respiratory System Agents|respiratory system agents|mesh-ancestor
101796747|NCT01006863|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101796748|NCT01006863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101796749|NCT01006863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101808098|NCT04008888|Melphalan|melphalan|mesh-list
101796756|NCT03535727|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101796758|NCT03535727|Gemcitabine|gemcitabine|mesh-list
101796759|NCT03535727|Capecitabine|capecitabine|mesh-list
101796760|NCT03535727|Irinotecan|irinotecan|mesh-list
101796761|NCT03535727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101796762|NCT03535727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101796763|NCT03535727|Tubulin Modulators|tubulin modulators|mesh-ancestor
101796764|NCT03535727|Antimitotic Agents|antimitotic agents|mesh-ancestor
101796765|NCT03535727|Mitosis Modulators|mitosis modulators|mesh-ancestor
101796766|NCT03535727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796767|NCT03535727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101796768|NCT03535727|Antimetabolites|antimetabolites|mesh-ancestor
101796769|NCT03535727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101796770|NCT03535727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101796771|NCT03535727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101796772|NCT03529955|Apremilast|apremilast|mesh-list
101796773|NCT03529955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101796774|NCT03529955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101796775|NCT03529955|Analgesics|analgesics|mesh-ancestor
101796776|NCT03529955|Sensory System Agents|sensory system agents|mesh-ancestor
101796777|NCT03529955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101796778|NCT03529955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796779|NCT03529955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101796780|NCT03529955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101796781|NCT03529955|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101796782|NCT03529955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101796783|NCT03529955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101796784|NCT03529955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796785|NCT00142909|Lofexidine|lofexidine|mesh-list
101796786|NCT00142909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101796787|NCT00142909|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101796788|NCT00142909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796789|NCT00142909|Sensory System Agents|sensory system agents|mesh-ancestor
101796790|NCT00142909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101796791|NCT00142909|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101796792|NCT00142909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101796793|NCT00142909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101796794|NCT00142909|Adrenergic Agents|adrenergic agents|mesh-ancestor
101796795|NCT00142909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101796796|NCT00142909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796798|NCT01007019|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101796799|NCT01007019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101796800|NCT01007019|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101796801|NCT01007019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101796802|NCT01007019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796810|NCT03508739|Valsartan|valsartan|mesh-list
101796811|NCT03508739|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101796812|NCT03508739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101796813|NCT03508739|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101796814|NCT03508739|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101808100|NCT04008888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101796815|NCT03508739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796816|NCT00205699|Olanzapine|olanzapine|mesh-list
101796817|NCT00205699|Risperidone|risperidone|mesh-list
101796818|NCT00205699|Aripiprazole|aripiprazole|mesh-list
101796819|NCT00205699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101796820|NCT00205699|Serotonin Agents|serotonin agents|mesh-ancestor
101796821|NCT00205699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101796822|NCT00205699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796823|NCT00205699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796824|NCT00205699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101796825|NCT00205699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101796826|NCT00205699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101796827|NCT00205699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101796828|NCT00205699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101796829|NCT00205699|Dopamine Agents|dopamine agents|mesh-ancestor
101796830|NCT00205699|Antiemetics|antiemetics|mesh-ancestor
101796831|NCT00205699|Autonomic Agents|autonomic agents|mesh-ancestor
101796832|NCT00205699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101796833|NCT00205699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101796834|NCT00205699|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101796835|NCT00205699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101796836|NCT00205699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101796837|NCT00205699|Antidepressive Agents|antidepressive agents|mesh-ancestor
101796838|NCT00205699|Dopamine Agonists|dopamine agonists|mesh-ancestor
101796839|NCT00205699|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101796840|NCT00205699|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101796841|NCT00205699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101796842|NCT00205699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101796843|NCT03503513|Gentamicins|gentamicins|mesh-list
101796844|NCT03503513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101796845|NCT03503513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101796846|NCT03503513|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101796847|NCT03503513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101796848|NCT03503513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796849|NCT02580149|Clopidogrel|clopidogrel|mesh-list
101796850|NCT02580149|Ticagrelor|ticagrelor|mesh-list
101796851|NCT02580149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101796852|NCT02580149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101796853|NCT02580149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101796854|NCT02580149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101796855|NCT02580149|Purinergic Agents|purinergic agents|mesh-ancestor
101796856|NCT02580149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101796857|NCT02580149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796858|NCT02580149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796859|NCT04996017|Atezolizumab|atezolizumab|mesh-list
101796860|NCT04996017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101796861|NCT04996017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796862|NCT04996017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101796863|NCT04996017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101796865|NCT04994223|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101796866|NCT04994223|Antithrombins|antithrombins|mesh-ancestor
101796867|NCT04994223|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101796868|NCT04994223|Protease Inhibitors|protease inhibitors|mesh-ancestor
101796869|NCT04994223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101796870|NCT04994223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796871|NCT04994223|Anticoagulants|anticoagulants|mesh-ancestor
101796872|NCT01007565|Anesthetics|anesthetics|mesh-list
101796873|NCT01007565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101796874|NCT01007565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796875|NCT05229003|Irinotecan|irinotecan|mesh-list
101796876|NCT05229003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101796877|NCT05229003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101796878|NCT05229003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101796879|NCT05229003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796880|NCT05229003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101796881|NCT01016626|Mycophenolic Acid|mycophenolic acid|mesh-list
101796882|NCT01016626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101796883|NCT01016626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101796884|NCT01016626|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101796885|NCT01016626|Antitubercular Agents|antitubercular agents|mesh-ancestor
101796886|NCT01016626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101796887|NCT01016626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101796888|NCT01016626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101796889|NCT01016626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796890|NCT02798471|Heparin|heparin|mesh-list
101796891|NCT02798471|Enoxaparin|enoxaparin|mesh-list
101796892|NCT02798471|Warfarin|warfarin|mesh-list
101796893|NCT02798471|Edoxaban|edoxaban|mesh-list
101796894|NCT02798471|Fondaparinux|fondaparinux|mesh-list
101796895|NCT02798471|Anticoagulants|anticoagulants|mesh-ancestor
101796896|NCT02798471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101796897|NCT02798471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101796898|NCT02798471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796899|NCT02798471|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101796900|NCT02798471|Antithrombins|antithrombins|mesh-ancestor
101796901|NCT02798471|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101796902|NCT02798471|Protease Inhibitors|protease inhibitors|mesh-ancestor
101796903|NCT02798471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101796904|NCT03443765|Vitamin D|vitamin d|mesh-list
101796905|NCT03443765|Immunoglobulins|immunoglobulins|mesh-list
101796906|NCT03443765|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101796907|NCT03443765|Antibodies|antibodies|mesh-list
101796908|NCT03443765|Vitamins|vitamins|mesh-ancestor
101796909|NCT03443765|Micronutrients|micronutrients|mesh-ancestor
101796910|NCT03443765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796911|NCT03443765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101796912|NCT03443765|Immunologic Factors|immunologic factors|mesh-ancestor
101796913|NCT03441893|Nitazoxanide|nitazoxanide|mesh-list
101796914|NCT03441893|Mesalamine|mesalamine|mesh-list
101796915|NCT03441893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101796916|NCT03441893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101796917|NCT03441893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101796918|NCT03441893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101796919|NCT03441893|Analgesics|analgesics|mesh-ancestor
101796920|NCT03441893|Sensory System Agents|sensory system agents|mesh-ancestor
101796921|NCT03441893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101796922|NCT03441893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796923|NCT03441893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101796924|NCT03441893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101796925|NCT03440177|Ramipril|ramipril|mesh-list
101796926|NCT03440177|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101796927|NCT03440177|Protease Inhibitors|protease inhibitors|mesh-ancestor
101796928|NCT03440177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101796929|NCT03440177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796930|NCT03440177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101796931|NCT00489736|Amiodarone|amiodarone|mesh-list
101796932|NCT00489736|Dronedarone|dronedarone|mesh-list
101796933|NCT00489736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101796934|NCT00489736|Vasodilator Agents|vasodilator agents|mesh-ancestor
101796935|NCT00489736|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101796936|NCT00489736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101796937|NCT00489736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796938|NCT00489736|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101796939|NCT00489736|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101796940|NCT00489736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101796941|NCT00489736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101796942|NCT00489736|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101796943|NCT00489736|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101796944|NCT00489736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101796946|NCT00617084|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101796947|NCT00617084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101796948|NCT00617084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101796949|NCT00617084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796950|NCT00617084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101796951|NCT00617084|Immunologic Factors|immunologic factors|mesh-ancestor
101796952|NCT00617084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796953|NCT00617084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101796955|NCT02758847|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101796956|NCT02758847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101796957|NCT02758847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101796958|NCT02758847|Tubulin Modulators|tubulin modulators|mesh-ancestor
101796959|NCT02758847|Antimitotic Agents|antimitotic agents|mesh-ancestor
101796960|NCT02758847|Mitosis Modulators|mitosis modulators|mesh-ancestor
101796961|NCT02758847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796962|NCT01016860|Irinotecan|irinotecan|mesh-list
101796963|NCT01016860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101796964|NCT01016860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101796965|NCT01016860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101796966|NCT01016860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796967|NCT01016860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101796968|NCT00874484|Enoxaparin|enoxaparin|mesh-list
101796969|NCT00874484|Anticoagulants|anticoagulants|mesh-ancestor
101796970|NCT00874484|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101796971|NCT00874484|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101796972|NCT00874484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796973|NCT00869492|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101796974|NCT00869492|Dermatologic Agents|dermatologic agents|mesh-ancestor
101796975|NCT00489424|Acetaminophen|acetaminophen|mesh-list
101796976|NCT00489424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101796977|NCT00489424|Analgesics|analgesics|mesh-ancestor
101796978|NCT00489424|Sensory System Agents|sensory system agents|mesh-ancestor
101796979|NCT00489424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101796980|NCT00489424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796981|NCT00489424|Antipyretics|antipyretics|mesh-ancestor
101796982|NCT00869570|Capecitabine|capecitabine|mesh-list
101796983|NCT00869570|Sorafenib|sorafenib|mesh-list
101796984|NCT00869570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101796985|NCT00869570|Antimetabolites|antimetabolites|mesh-ancestor
101796986|NCT00869570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796987|NCT00869570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101796988|NCT00869570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101796989|NCT00869570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101796990|NCT05127304|Bromides|bromides|mesh-list
101796991|NCT05127304|Tiotropium Bromide|tiotropium bromide|mesh-list
101796992|NCT05127304|Olodaterol|olodaterol|mesh-list
101796993|NCT05127304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101796994|NCT05127304|Autonomic Agents|autonomic agents|mesh-ancestor
101796995|NCT05127304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101796996|NCT05127304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796997|NCT05127304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101796998|NCT05127304|Respiratory System Agents|respiratory system agents|mesh-ancestor
101796999|NCT05127304|Parasympatholytics|parasympatholytics|mesh-ancestor
101797000|NCT05127304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101797001|NCT05127304|Cholinergic Agents|cholinergic agents|mesh-ancestor
101797002|NCT05127304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101797003|NCT05127304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797004|NCT05127304|Anticonvulsants|anticonvulsants|mesh-ancestor
101797005|NCT00880412|Etazolate|etazolate|mesh-list
101797006|NCT00880412|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101797007|NCT00880412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101797008|NCT00880412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797009|NCT00880412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101797010|NCT00880412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101797011|NCT00880412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101797012|NCT00880412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797013|NCT00880412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101797014|NCT01020136|Axitinib|axitinib|mesh-list
101797015|NCT01020136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797016|NCT01020136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101797017|NCT01020136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101797018|NCT01020136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797019|NCT03412643|Paclitaxel|paclitaxel|mesh-list
101797020|NCT03412643|Cyclophosphamide|cyclophosphamide|mesh-list
101797021|NCT03412643|Doxorubicin|doxorubicin|mesh-list
101797022|NCT03412643|Trastuzumab|trastuzumab|mesh-list
101797023|NCT03412643|Pertuzumab|pertuzumab|mesh-list
101797024|NCT03412643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101797025|NCT03412643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797026|NCT03412643|Tubulin Modulators|tubulin modulators|mesh-ancestor
101797027|NCT03412643|Antimitotic Agents|antimitotic agents|mesh-ancestor
101797028|NCT03412643|Mitosis Modulators|mitosis modulators|mesh-ancestor
101797029|NCT03412643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797030|NCT03412643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101797031|NCT03412643|Immunologic Factors|immunologic factors|mesh-ancestor
101797032|NCT03412643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797033|NCT03412643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101797034|NCT03412643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101797036|NCT03412643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101797037|NCT03412643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101797038|NCT03412643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101797039|NCT03412643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101797040|NCT03412643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101797041|NCT03412643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101797042|NCT01017094|Silver Sulfadiazine|silver sulfadiazine|mesh-list
101797043|NCT01017094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101797044|NCT01017094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101797045|NCT01020214|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101797046|NCT01020214|Olmesartan|olmesartan|mesh-list
101797047|NCT01020214|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101797048|NCT01020214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101797049|NCT01020214|Diuretics|diuretics|mesh-ancestor
101797050|NCT01020214|Natriuretic Agents|natriuretic agents|mesh-ancestor
101797051|NCT01020214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184452|NCT03796182|Metformin|metformin|mesh-list
101797052|NCT01020214|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101797053|NCT01020214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101797054|NCT01020214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797055|NCT01020214|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101797056|NCT01020214|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101797057|NCT03970824|Adalimumab|adalimumab|mesh-list
101797058|NCT03970824|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101797059|NCT03970824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101797060|NCT03970824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101797061|NCT00933894|Escitalopram|escitalopram|mesh-list
101797062|NCT00933894|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101797063|NCT00933894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101797064|NCT00933894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101797065|NCT00933894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797066|NCT00933894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101797067|NCT00933894|Serotonin Agents|serotonin agents|mesh-ancestor
101797068|NCT00933894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797069|NCT00564486|Acetaminophen|acetaminophen|mesh-list
101797070|NCT00564486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101797071|NCT00564486|Analgesics|analgesics|mesh-ancestor
101797072|NCT00564486|Sensory System Agents|sensory system agents|mesh-ancestor
101797073|NCT00564486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101797074|NCT00564486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797076|NCT00481078|Paclitaxel|paclitaxel|mesh-list
101797077|NCT00481078|Carboplatin|carboplatin|mesh-list
101797078|NCT00481078|Vorinostat|vorinostat|mesh-list
101797079|NCT00481078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101797080|NCT00481078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797081|NCT00481078|Tubulin Modulators|tubulin modulators|mesh-ancestor
101797082|NCT00481078|Antimitotic Agents|antimitotic agents|mesh-ancestor
101797083|NCT00481078|Mitosis Modulators|mitosis modulators|mesh-ancestor
101797084|NCT00481078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797085|NCT00481078|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101797086|NCT00481078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101797087|NCT00480532|Doxycycline|doxycycline|mesh-list
101797088|NCT00480532|Levonorgestrel|levonorgestrel|mesh-list
101797089|NCT00480532|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101797090|NCT00480532|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
101797091|NCT00480532|Estradiol|estradiol|mesh-list
101797092|NCT00480532|Estrogens|estrogens|mesh-ancestor
101797093|NCT00480532|Hormones|hormones|mesh-ancestor
101797094|NCT00480532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101797095|NCT00480532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797096|NCT00480532|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101797097|NCT00480532|Contraceptive Agents|contraceptive agents|mesh-ancestor
101797098|NCT00480532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101797099|NCT00480532|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101797100|NCT00480532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101797101|NCT00480532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101797102|NCT00480532|Antimalarials|antimalarials|mesh-ancestor
101797103|NCT00480532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101797104|NCT00480532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101797105|NCT00480532|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101797106|NCT00480532|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101797107|NCT00480532|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101797108|NCT00480532|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101797109|NCT04013880|Decitabine|decitabine|mesh-list
101797110|NCT04013880|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
101797111|NCT04013880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101797112|NCT04013880|Antimetabolites|antimetabolites|mesh-ancestor
101797113|NCT04013880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797114|NCT04013880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797115|NCT04013880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101797116|NCT00934518|Cetuximab|cetuximab|mesh-list
101797117|NCT00934518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101797118|NCT00934518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797119|NCT00496366|Capecitabine|capecitabine|mesh-list
101797120|NCT00496366|Lapatinib|lapatinib|mesh-list
101797121|NCT00496366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101797122|NCT00496366|Antimetabolites|antimetabolites|mesh-ancestor
101797123|NCT00496366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797124|NCT00496366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797125|NCT00496366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101797126|NCT00496366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101797127|NCT00934752|Paclitaxel|paclitaxel|mesh-list
101797128|NCT00934752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101797129|NCT00934752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797130|NCT00934752|Tubulin Modulators|tubulin modulators|mesh-ancestor
101797131|NCT00934752|Antimitotic Agents|antimitotic agents|mesh-ancestor
101797132|NCT00934752|Mitosis Modulators|mitosis modulators|mesh-ancestor
101797133|NCT00934752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797134|NCT01020292|Nelfinavir|nelfinavir|mesh-list
101797135|NCT01020292|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101797136|NCT01020292|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101797137|NCT01020292|Protease Inhibitors|protease inhibitors|mesh-ancestor
101797138|NCT01020292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310670|NCT00005977|Leucovorin|leucovorin|mesh-list
101797139|NCT01020292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797140|NCT01020292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101797141|NCT01020292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101797142|NCT01020292|Antiviral Agents|antiviral agents|mesh-ancestor
101797143|NCT01020292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101797144|NCT00934830|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101797146|NCT00934830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101797147|NCT02575404|Pembrolizumab|pembrolizumab|mesh-list
101797148|NCT02575404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101797149|NCT02575404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797150|NCT02575404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101797151|NCT02575404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797152|NCT00564018|Insulin Detemir|insulin detemir|mesh-list
101797153|NCT00564018|Protamines|protamines|mesh-list
101797154|NCT00564018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101797155|NCT00564018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797156|NCT00564018|Heparin Antagonists|heparin antagonists|mesh-ancestor
101797157|NCT00564018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797158|NCT00564018|Coagulants|coagulants|mesh-ancestor
101797159|NCT00935298|Tacrolimus|tacrolimus|mesh-list
101797160|NCT00935298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101797161|NCT00935298|Immunologic Factors|immunologic factors|mesh-ancestor
101797162|NCT00935298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797164|NCT00935298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101797165|NCT00935298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797166|NCT04014192|Dapagliflozin|dapagliflozin|mesh-list
101797167|NCT04014192|Empagliflozin|empagliflozin|mesh-list
101454518|NCT00210509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101797168|NCT04014192|Canagliflozin|canagliflozin|mesh-list
101797169|NCT04014192|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101797170|NCT04014192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797171|NCT04014192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101797172|NCT04014192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797173|NCT00935610|Caseins|caseins|mesh-list
101797174|NCT00935610|Chelating Agents|chelating agents|mesh-ancestor
101797175|NCT00935610|Sequestering Agents|sequestering agents|mesh-ancestor
101797176|NCT00935610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797177|NCT04013646|Epoetin Alfa|epoetin alfa|mesh-list
101797178|NCT04013646|Hematinics|hematinics|mesh-ancestor
101797179|NCT04074473|Propranolol|propranolol|mesh-list
101797180|NCT04074473|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101797181|NCT04074473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101797182|NCT04074473|Adrenergic Agents|adrenergic agents|mesh-ancestor
101797183|NCT04074473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101797184|NCT04074473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797185|NCT04074473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797186|NCT04074473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101797187|NCT04074473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101797188|NCT04074473|Vasodilator Agents|vasodilator agents|mesh-ancestor
101797189|NCT03093480|Factor VIII|factor viii|mesh-list
101797190|NCT03093480|Coagulants|coagulants|mesh-ancestor
101797191|NCT02578511|Ixazomib|ixazomib|mesh-list
101797192|NCT02578511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797193|NCT02578511|Protease Inhibitors|protease inhibitors|mesh-ancestor
101797194|NCT02578511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101797195|NCT02578511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797196|NCT00563784|Paclitaxel|paclitaxel|mesh-list
101797197|NCT00563784|Carboplatin|carboplatin|mesh-list
101797198|NCT00563784|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101797199|NCT00563784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101797200|NCT00563784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797201|NCT00563784|Tubulin Modulators|tubulin modulators|mesh-ancestor
101797202|NCT00563784|Antimitotic Agents|antimitotic agents|mesh-ancestor
101797203|NCT00563784|Mitosis Modulators|mitosis modulators|mesh-ancestor
101808159|NCT01588912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101797204|NCT00563784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797205|NCT00563784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101797206|NCT00563784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101797207|NCT00203047|Prednisone|prednisone|mesh-list
101797208|NCT00203047|Glatiramer Acetate|glatiramer acetate|mesh-list
101797209|NCT00203047|(T,G)-A-L|(t,g)-a-l|mesh-list
101797210|NCT00203047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101797211|NCT00203047|Glucocorticoids|glucocorticoids|mesh-ancestor
101797212|NCT00203047|Hormones|hormones|mesh-ancestor
101797213|NCT00203047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101797214|NCT00203047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797215|NCT00203047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101797216|NCT00203047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797217|NCT00203047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101797218|NCT00203047|Immunologic Factors|immunologic factors|mesh-ancestor
101797219|NCT00203047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101797220|NCT00203047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101797221|NCT00870038|Paclitaxel|paclitaxel|mesh-list
101797222|NCT00870038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101797223|NCT00870038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797224|NCT00870038|Tubulin Modulators|tubulin modulators|mesh-ancestor
101797225|NCT00870038|Antimitotic Agents|antimitotic agents|mesh-ancestor
101797226|NCT00870038|Mitosis Modulators|mitosis modulators|mesh-ancestor
101797227|NCT00870038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797228|NCT04074551|Losartan|losartan|mesh-list
101797229|NCT04074551|Amlodipine|amlodipine|mesh-list
101797231|NCT04074551|Ezetimibe|ezetimibe|mesh-list
101797232|NCT04074551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101797233|NCT04074551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101797234|NCT04074551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101797235|NCT04074551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797236|NCT04074551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101797237|NCT04074551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797238|NCT04074551|Vasodilator Agents|vasodilator agents|mesh-ancestor
101797239|NCT04074551|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101797240|NCT04074551|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101797241|NCT04074551|Antimetabolites|antimetabolites|mesh-ancestor
101797242|NCT04074551|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101797243|NCT04074551|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101797244|NCT04074551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101797245|NCT04074551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101797246|NCT04074551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101797247|NCT04074551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101797248|NCT02608385|Pembrolizumab|pembrolizumab|mesh-list
101797249|NCT02608385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101797250|NCT02608385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797251|NCT02608385|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101797252|NCT02608385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797253|NCT00142519|Morphine|morphine|mesh-list
101797254|NCT00142519|Methadone|methadone|mesh-list
101797255|NCT00142519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101797256|NCT00142519|Narcotics|narcotics|mesh-ancestor
101797257|NCT00142519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101797258|NCT00142519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797259|NCT00142519|Analgesics|analgesics|mesh-ancestor
101797260|NCT00142519|Sensory System Agents|sensory system agents|mesh-ancestor
101364721|NCT00148291|Docetaxel|docetaxel|mesh-list
101797261|NCT00142519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101797262|NCT00142519|Antitussive Agents|antitussive agents|mesh-ancestor
101797263|NCT00142519|Respiratory System Agents|respiratory system agents|mesh-ancestor
101797264|NCT03713294|Dexamethasone|dexamethasone|mesh-list
101797265|NCT03713294|Dexamethasone acetate|dexamethasone acetate|mesh-list
101797266|NCT03713294|Pomalidomide|pomalidomide|mesh-list
101797267|NCT03713294|Elotuzumab|elotuzumab|mesh-list
101797268|NCT03713294|Ichthammol|ichthammol|mesh-list
101797269|NCT03713294|BB 1101|bb 1101|mesh-list
101808169|NCT01589068|Autonomic Agents|autonomic agents|mesh-ancestor
101797270|NCT03713294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101797271|NCT03713294|Antiemetics|antiemetics|mesh-ancestor
101797272|NCT03713294|Autonomic Agents|autonomic agents|mesh-ancestor
101797273|NCT03713294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101797274|NCT03713294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797275|NCT03713294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101797276|NCT03713294|Glucocorticoids|glucocorticoids|mesh-ancestor
101797277|NCT03713294|Hormones|hormones|mesh-ancestor
101797278|NCT03713294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101797279|NCT03713294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101797280|NCT03713294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797281|NCT03713294|Protease Inhibitors|protease inhibitors|mesh-ancestor
101797282|NCT03713294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101797283|NCT03713294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797284|NCT03713294|Immunologic Factors|immunologic factors|mesh-ancestor
101797285|NCT03713294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101797286|NCT03713294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101797287|NCT03713294|Growth Substances|growth substances|mesh-ancestor
101797288|NCT03713294|Growth Inhibitors|growth inhibitors|mesh-ancestor
101797289|NCT03713294|Dermatologic Agents|dermatologic agents|mesh-ancestor
101797290|NCT00141817|Pantoprazole|pantoprazole|mesh-list
101797291|NCT00141817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101797292|NCT00141817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101797293|NCT00141817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101797294|NCT00141817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101797295|NCT00141817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797296|NCT03967171|Oxytocin|oxytocin|mesh-list
101797297|NCT03967171|Oxytocics|oxytocics|mesh-ancestor
101797298|NCT03967171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101797299|NCT03967171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797300|NCT03967327|Morphine|morphine|mesh-list
101797301|NCT03967327|Buprenorphine|buprenorphine|mesh-list
101797302|NCT03967327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101797303|NCT03967327|Narcotics|narcotics|mesh-ancestor
101797304|NCT03967327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101797305|NCT03967327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797306|NCT03967327|Analgesics|analgesics|mesh-ancestor
101797307|NCT03967327|Sensory System Agents|sensory system agents|mesh-ancestor
101797308|NCT03967327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101797309|NCT03967327|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101797310|NCT01075945|Lumefantrine|lumefantrine|mesh-list
101797311|NCT01075945|Artemether|artemether|mesh-list
101797312|NCT01075945|Piperaquine|piperaquine|mesh-list
101797313|NCT01075945|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101797314|NCT01075945|Artenimol|artenimol|mesh-list
101797315|NCT01075945|Antimalarials|antimalarials|mesh-ancestor
101797316|NCT01075945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101797317|NCT01075945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101797318|NCT01075945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101797319|NCT00874562|Sirolimus|sirolimus|mesh-list
101797320|NCT00874562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101797321|NCT00874562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101797322|NCT00874562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101797323|NCT00874562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797324|NCT00874562|Antifungal Agents|antifungal agents|mesh-ancestor
101797325|NCT00874562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101797326|NCT00874562|Immunologic Factors|immunologic factors|mesh-ancestor
101797327|NCT00874562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797329|NCT00201643|Betamethasone|betamethasone|mesh-list
101797330|NCT00201643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101797331|NCT00201643|Antiemetics|antiemetics|mesh-ancestor
101797332|NCT00201643|Autonomic Agents|autonomic agents|mesh-ancestor
101797333|NCT00201643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101797334|NCT00201643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808177|NCT01589068|Progestins|progestins|mesh-ancestor
101797336|NCT00201643|Glucocorticoids|glucocorticoids|mesh-ancestor
101797337|NCT00201643|Hormones|hormones|mesh-ancestor
101797338|NCT00201643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101797339|NCT00201643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101797340|NCT00201643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797341|NCT00201643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101797342|NCT00201643|Respiratory System Agents|respiratory system agents|mesh-ancestor
101797343|NCT03798314|Nivolumab|nivolumab|mesh-list
101797344|NCT03798314|Pomalidomide|pomalidomide|mesh-list
101797345|NCT03798314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101797346|NCT03798314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797347|NCT03798314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101797348|NCT03798314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797349|NCT03798314|Immunologic Factors|immunologic factors|mesh-ancestor
101797350|NCT03798314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797351|NCT03798314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101797352|NCT03798314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101797353|NCT03798314|Growth Substances|growth substances|mesh-ancestor
101797354|NCT03798314|Growth Inhibitors|growth inhibitors|mesh-ancestor
101797355|NCT01077427|Gemcitabine|gemcitabine|mesh-list
101797356|NCT01077427|Capecitabine|capecitabine|mesh-list
101797357|NCT01077427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797358|NCT01077427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101797359|NCT01077427|Antimetabolites|antimetabolites|mesh-ancestor
101797360|NCT01077427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797361|NCT00883064|Lisinopril|lisinopril|mesh-list
101797362|NCT00883064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101797363|NCT00883064|Protease Inhibitors|protease inhibitors|mesh-ancestor
101797364|NCT00883064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101797365|NCT00883064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797366|NCT00883064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101797367|NCT00883064|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101797368|NCT00883064|Protective Agents|protective agents|mesh-ancestor
101797369|NCT00883064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797370|NCT01077505|Contraceptive Agents|contraceptive agents|mesh-list
101797371|NCT01077505|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
101797372|NCT01077505|Contraceptives, Oral|contraceptives, oral|mesh-list
101797373|NCT01077505|rGLP-1 protein|rglp-1 protein|mesh-list
101797374|NCT01077505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101797375|NCT01077505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797376|NCT01077505|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101797377|NCT01077505|Incretins|incretins|mesh-ancestor
101797378|NCT01077505|Hormones|hormones|mesh-ancestor
101797379|NCT01077505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101797380|NCT01077505|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101797381|NCT01077505|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101797382|NCT01077505|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101797383|NCT01077505|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
101797384|NCT01077505|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101797385|NCT01073995|Triamcinolone|triamcinolone|mesh-list
101797386|NCT01073995|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101797387|NCT01073995|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101797388|NCT01073995|Bupivacaine|bupivacaine|mesh-list
101797389|NCT01073995|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101797390|NCT01073995|Anesthetics, Local|anesthetics, local|mesh-ancestor
101797391|NCT01073995|Anesthetics|anesthetics|mesh-ancestor
101797392|NCT01073995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101797393|NCT01073995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797394|NCT01073995|Sensory System Agents|sensory system agents|mesh-ancestor
101797395|NCT01073995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101797396|NCT01073995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101797397|NCT01073995|Glucocorticoids|glucocorticoids|mesh-ancestor
101797398|NCT01073995|Hormones|hormones|mesh-ancestor
101797399|NCT01073995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101797400|NCT01073995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101797401|NCT01073995|Immunologic Factors|immunologic factors|mesh-ancestor
101797402|NCT01073995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101797403|NCT01073995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797404|NCT01074073|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
101797405|NCT01074073|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101797406|NCT01074073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101797407|NCT01074073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101797408|NCT01074073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797409|NCT01074073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101797410|NCT01074073|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101797411|NCT01074073|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101797412|NCT01074073|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101797413|NCT01074073|Adrenergic Agents|adrenergic agents|mesh-ancestor
101797414|NCT01074073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101797415|NCT01074073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797416|NCT01074073|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101797417|NCT01074073|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101797418|NCT01074073|Serotonin Agents|serotonin agents|mesh-ancestor
101797419|NCT01074073|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101797420|NCT01074073|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101797421|NCT01074073|Dopamine Agents|dopamine agents|mesh-ancestor
101797422|NCT00874874|Sorafenib|sorafenib|mesh-list
101797423|NCT00874874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797424|NCT00874874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101797425|NCT00874874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101797426|NCT00874874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797427|NCT04489628|Vitamin D|vitamin d|mesh-list
101797428|NCT04489628|Cholecalciferol|cholecalciferol|mesh-list
101797429|NCT04489628|Vitamins|vitamins|mesh-ancestor
101797430|NCT04489628|Micronutrients|micronutrients|mesh-ancestor
101797431|NCT04489628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797432|NCT04489628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101797433|NCT04489628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101797434|NCT00130039|Cilostazol|cilostazol|mesh-list
101797435|NCT00130039|Clopidogrel|clopidogrel|mesh-list
101797436|NCT00130039|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101797437|NCT00130039|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101797438|NCT00130039|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101797439|NCT00130039|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101797440|NCT00130039|Purinergic Agents|purinergic agents|mesh-ancestor
101797441|NCT00130039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101797442|NCT00130039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797443|NCT00130039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797444|NCT00130039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101797445|NCT00130039|Autonomic Agents|autonomic agents|mesh-ancestor
101797446|NCT00130039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101797447|NCT00130039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101797448|NCT00130039|Respiratory System Agents|respiratory system agents|mesh-ancestor
101797449|NCT00130039|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101797450|NCT00130039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101797451|NCT00130039|Vasodilator Agents|vasodilator agents|mesh-ancestor
101797452|NCT00130039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101797453|NCT00130039|Protective Agents|protective agents|mesh-ancestor
101797454|NCT00130039|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101797455|NCT00130039|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101797456|NCT00130039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101797458|NCT00875030|Antimalarials|antimalarials|mesh-ancestor
101797459|NCT00875030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101797460|NCT00875030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101797461|NCT00875030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101797462|NCT00875030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797463|NCT00875030|Antiviral Agents|antiviral agents|mesh-ancestor
101797464|NCT00875030|Schistosomicides|schistosomicides|mesh-ancestor
101797465|NCT00875030|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101797466|NCT00875030|Anthelmintics|anthelmintics|mesh-ancestor
101797467|NCT00883298|Bevacizumab|bevacizumab|mesh-list
101797468|NCT00883298|Temozolomide|temozolomide|mesh-list
101454831|NCT00238251|Gefitinib|gefitinib|mesh-list
101797469|NCT00883298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101797470|NCT00883298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797471|NCT00883298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101797472|NCT00883298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101797473|NCT00883298|Growth Substances|growth substances|mesh-ancestor
101797474|NCT00883298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797475|NCT00883298|Growth Inhibitors|growth inhibitors|mesh-ancestor
101797476|NCT00883298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101797477|NCT00883298|Alkylating Agents|alkylating agents|mesh-ancestor
101797478|NCT00883298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797479|NCT00881114|Cetuximab|cetuximab|mesh-list
101797480|NCT00881114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797481|NCT00881114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101797482|NCT00475852|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101797483|NCT00475852|Natriuretic Agents|natriuretic agents|mesh-ancestor
101797484|NCT00475852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797485|NCT00141271|Ziprasidone|ziprasidone|mesh-list
101797486|NCT00141271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101797487|NCT00141271|Serotonin Agents|serotonin agents|mesh-ancestor
101797488|NCT00141271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101797489|NCT00141271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797490|NCT00141271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797491|NCT00141271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101797492|NCT00141271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101797493|NCT00141271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101797494|NCT00141271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101797495|NCT00141271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101797497|NCT01017640|Mitomycins|mitomycins|mesh-list
101797498|NCT01017640|Mitomycin|mitomycin|mesh-list
101797499|NCT01017640|Veliparib|veliparib|mesh-list
101797500|NCT01017640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101797501|NCT01017640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797502|NCT01017640|Alkylating Agents|alkylating agents|mesh-ancestor
101797503|NCT01017640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797504|NCT01017640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101797505|NCT01017640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101797506|NCT01017640|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101797507|NCT00614120|Metformin|metformin|mesh-list
101797508|NCT00614120|Liraglutide|liraglutide|mesh-list
101797509|NCT00614120|Glimepiride|glimepiride|mesh-list
101797510|NCT00614120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101797511|NCT00614120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797512|NCT00614120|Incretins|incretins|mesh-ancestor
101797513|NCT00614120|Hormones|hormones|mesh-ancestor
101797514|NCT00614120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101797515|NCT00614120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101797516|NCT00614120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101797517|NCT00614120|Immunologic Factors|immunologic factors|mesh-ancestor
101797518|NCT00496054|Vaccines|vaccines|mesh-list
101797519|NCT00496054|Immunologic Factors|immunologic factors|mesh-ancestor
101797520|NCT00496054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797521|NCT00495820|Methylphenidate|methylphenidate|mesh-list
101797522|NCT00495820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101797523|NCT00495820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797524|NCT00495820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101797525|NCT00495820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101797526|NCT00495820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101797527|NCT00495820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797528|NCT00495820|Dopamine Agents|dopamine agents|mesh-ancestor
101797529|NCT00495820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101797531|NCT04387240|Artemisinins|artemisinins|mesh-list
101797532|NCT04387240|Artemisinin|artemisinin|mesh-list
101797533|NCT04387240|Antimalarials|antimalarials|mesh-ancestor
101797534|NCT04387240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101797535|NCT04387240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101797536|NCT04387240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101797537|NCT04387240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797538|NCT04387240|Antiviral Agents|antiviral agents|mesh-ancestor
101797539|NCT04387240|Schistosomicides|schistosomicides|mesh-ancestor
101797540|NCT04387240|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101797541|NCT04387240|Anthelmintics|anthelmintics|mesh-ancestor
101797542|NCT00495586|Amoxicillin|amoxicillin|mesh-list
101797543|NCT00495586|Clavulanic Acids|clavulanic acids|mesh-list
101797544|NCT00495586|Clavulanic Acid|clavulanic acid|mesh-list
101797545|NCT00495586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101797546|NCT00495586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101797547|NCT00495586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101797548|NCT00495586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797549|NCT00495586|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101797550|NCT00613730|Gemcitabine|gemcitabine|mesh-list
101797551|NCT00613730|Panitumumab|panitumumab|mesh-list
101797552|NCT00613730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101797553|NCT00613730|Antimetabolites|antimetabolites|mesh-ancestor
101797554|NCT00613730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797555|NCT00613730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797556|NCT00613730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101797557|NCT00613574|Bromides|bromides|mesh-list
101797558|NCT00613574|Tiotropium Bromide|tiotropium bromide|mesh-list
101797559|NCT00613574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101797560|NCT00613574|Autonomic Agents|autonomic agents|mesh-ancestor
101797561|NCT00613574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101797562|NCT00613574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797563|NCT00613574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101797564|NCT00613574|Respiratory System Agents|respiratory system agents|mesh-ancestor
101797565|NCT00613574|Parasympatholytics|parasympatholytics|mesh-ancestor
101797566|NCT00613574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101797567|NCT00613574|Cholinergic Agents|cholinergic agents|mesh-ancestor
101797568|NCT00613574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101797569|NCT00613574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797570|NCT00613574|Anticonvulsants|anticonvulsants|mesh-ancestor
101797571|NCT00881426|Cefprozil|cefprozil|mesh-list
101797572|NCT00881426|Cephalosporins|cephalosporins|mesh-list
101797573|NCT00881426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101797574|NCT00881426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101797575|NCT00883532|Budesonide|budesonide|mesh-list
101797576|NCT00883532|Pulmonary Surfactants|pulmonary surfactants|mesh-list
101797577|NCT00883532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101797578|NCT00883532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101797579|NCT00883532|Autonomic Agents|autonomic agents|mesh-ancestor
101797580|NCT00883532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101797581|NCT00883532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797582|NCT00883532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101797583|NCT00883532|Respiratory System Agents|respiratory system agents|mesh-ancestor
101797584|NCT00883532|Glucocorticoids|glucocorticoids|mesh-ancestor
101797585|NCT00883532|Hormones|hormones|mesh-ancestor
101808228|NCT01034410|Cytarabine|cytarabine|mesh-list
101797586|NCT00883532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101797587|NCT00881582|Interferons|interferons|mesh-list
101797588|NCT00881582|Interferon-alpha|interferon-alpha|mesh-list
101797589|NCT00881582|Interferon alpha-2|interferon alpha-2|mesh-list
101797590|NCT00881582|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101797591|NCT00881582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797592|NCT00881582|Antiviral Agents|antiviral agents|mesh-ancestor
101797593|NCT00881582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101797594|NCT00881582|Immunologic Factors|immunologic factors|mesh-ancestor
101797595|NCT00881582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797596|NCT00881738|Clarithromycin|clarithromycin|mesh-list
101797597|NCT00881738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101797598|NCT00881738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101797599|NCT00881738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101797600|NCT00881738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101797601|NCT00881738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797602|NCT00881738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101797603|NCT00881738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101797604|NCT00613106|Ibuprofen|ibuprofen|mesh-list
101797605|NCT00613106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101797606|NCT00613106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101797607|NCT00613106|Analgesics|analgesics|mesh-ancestor
101797608|NCT00613106|Sensory System Agents|sensory system agents|mesh-ancestor
101797609|NCT00613106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101797610|NCT00613106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797611|NCT00613106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101797612|NCT00613106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101797613|NCT00613106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101797614|NCT00613106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101797615|NCT00613106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797616|NCT00881816|Paclitaxel|paclitaxel|mesh-list
101797617|NCT00881816|Capecitabine|capecitabine|mesh-list
101797618|NCT00881816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101797619|NCT00881816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797620|NCT00881816|Tubulin Modulators|tubulin modulators|mesh-ancestor
101797621|NCT00881816|Antimitotic Agents|antimitotic agents|mesh-ancestor
101797622|NCT00881816|Mitosis Modulators|mitosis modulators|mesh-ancestor
101797623|NCT00881816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797624|NCT00881816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101797625|NCT00881816|Antimetabolites|antimetabolites|mesh-ancestor
101797627|NCT03712904|Endothelial Growth Factors|endothelial growth factors|mesh-list
101797628|NCT03712904|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101797629|NCT03712904|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101797630|NCT03712904|Growth Substances|growth substances|mesh-ancestor
101797631|NCT03712904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797632|NCT03712904|Growth Inhibitors|growth inhibitors|mesh-ancestor
101797633|NCT03712904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797634|NCT00875966|Azithromycin|azithromycin|mesh-list
101797635|NCT00875966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101797636|NCT00875966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101797637|NCT00141037|Mycophenolic Acid|mycophenolic acid|mesh-list
101797638|NCT00141037|Trimethoprim|trimethoprim|mesh-list
101797639|NCT00141037|Sulfamethoxazole|sulfamethoxazole|mesh-list
101797640|NCT00141037|Valganciclovir|valganciclovir|mesh-list
101797641|NCT00141037|Ganciclovir|ganciclovir|mesh-list
101797642|NCT00141037|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101797643|NCT00141037|Prednisone|prednisone|mesh-list
101797644|NCT00141037|Tacrolimus|tacrolimus|mesh-list
101797645|NCT00141037|Daclizumab|daclizumab|mesh-list
101797646|NCT00141037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101797648|NCT00141037|Hormones|hormones|mesh-ancestor
101808238|NCT00415168|Pemetrexed|pemetrexed|mesh-list
101797649|NCT00141037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101797650|NCT00141037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797651|NCT00141037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101797652|NCT00141037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797653|NCT00141037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101797654|NCT00141037|Immunologic Factors|immunologic factors|mesh-ancestor
101797655|NCT00141037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101797656|NCT00141037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101797657|NCT00141037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797658|NCT00141037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101797659|NCT00141037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101797660|NCT00141037|Antitubercular Agents|antitubercular agents|mesh-ancestor
101797661|NCT00141037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101797662|NCT00141037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101797663|NCT00141037|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101797664|NCT00141037|Antimalarials|antimalarials|mesh-ancestor
101797665|NCT00141037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101797666|NCT00141037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101797667|NCT00141037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101797668|NCT00141037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101797669|NCT00141037|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101797670|NCT00141037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101797671|NCT00141037|Antiviral Agents|antiviral agents|mesh-ancestor
101797672|NCT00141037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101797673|NCT01582555|Acetylcysteine|acetylcysteine|mesh-list
101797674|NCT01582555|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101797675|NCT01582555|Antidotes|antidotes|mesh-ancestor
101797676|NCT01582555|Protective Agents|protective agents|mesh-ancestor
101797677|NCT01582555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797678|NCT01582555|Antioxidants|antioxidants|mesh-ancestor
101797679|NCT01582555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797680|NCT01582555|Antiviral Agents|antiviral agents|mesh-ancestor
101797681|NCT01582555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101797682|NCT01582555|Expectorants|expectorants|mesh-ancestor
101797683|NCT01582555|Respiratory System Agents|respiratory system agents|mesh-ancestor
101797684|NCT01582555|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101797685|NCT00923390|Aldesleukin|aldesleukin|mesh-list
101797686|NCT00923390|Cyclophosphamide|cyclophosphamide|mesh-list
101797687|NCT00923390|Fludarabine|fludarabine|mesh-list
101797688|NCT00923390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101797689|NCT00923390|Immunologic Factors|immunologic factors|mesh-ancestor
101797690|NCT00923390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797691|NCT00923390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101808253|NCT00974766|Glucocorticoids|glucocorticoids|mesh-list
101797692|NCT00923390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101797693|NCT00923390|Alkylating Agents|alkylating agents|mesh-ancestor
101797694|NCT00923390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797695|NCT00923390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797696|NCT00923390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101797697|NCT00923390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101797698|NCT00923390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101797699|NCT00923390|Antiviral Agents|antiviral agents|mesh-ancestor
101797700|NCT00923390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101797701|NCT00885794|Ranibizumab|ranibizumab|mesh-list
101797702|NCT00885794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101797703|NCT00885794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101797704|NCT00885794|Growth Substances|growth substances|mesh-ancestor
101797705|NCT00885794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797706|NCT00885794|Growth Inhibitors|growth inhibitors|mesh-ancestor
101185112|NCT00571194|Pravastatin|pravastatin|mesh-list
101797707|NCT00885794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797708|NCT00888602|Psyllium|psyllium|mesh-list
101797709|NCT00888602|Calcium polycarbophil|calcium polycarbophil|mesh-list
101797710|NCT00888602|Cathartics|cathartics|mesh-ancestor
101797711|NCT00888602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101797712|NCT00888602|Antidiarrheals|antidiarrheals|mesh-ancestor
101797713|NCT00885872|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101797714|NCT00885872|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101797715|NCT00885872|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101797716|NCT00885872|Antimetabolites|antimetabolites|mesh-ancestor
101797717|NCT00885872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797718|NCT00885872|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101797719|NCT00885872|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101797722|NCT00888758|Umirolimus|umirolimus|mesh-list
101797723|NCT00888758|Everolimus|everolimus|mesh-list
101797724|NCT00888758|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101797725|NCT00888758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101797726|NCT00888758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101797727|NCT00888758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797728|NCT00888758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101797729|NCT00888758|Immunologic Factors|immunologic factors|mesh-ancestor
101797730|NCT00888758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797731|NCT00888758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797732|NCT00888758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101797733|NCT00888758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101797734|NCT00888758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101797735|NCT00888758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101797736|NCT00888758|Antifungal Agents|antifungal agents|mesh-ancestor
101797737|NCT00888836|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101797738|NCT00888836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797739|NCT04038320|Sofosbuvir|sofosbuvir|mesh-list
101797740|NCT04038320|Ledipasvir|ledipasvir|mesh-list
101797741|NCT04038320|Antiviral Agents|antiviral agents|mesh-ancestor
101797742|NCT04038320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101797743|NCT00563706|Risperidone|risperidone|mesh-list
101797744|NCT00563706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101797745|NCT00563706|Serotonin Agents|serotonin agents|mesh-ancestor
101797746|NCT00563706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101797747|NCT00563706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797748|NCT00563706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797749|NCT00563706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101797750|NCT00563706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101797751|NCT00563706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101797752|NCT00563706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101797753|NCT00563706|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101797754|NCT00563706|Dopamine Agents|dopamine agents|mesh-ancestor
101797755|NCT02543606|Esomeprazole|esomeprazole|mesh-list
101797756|NCT02543606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101797757|NCT02543606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101797758|NCT02543606|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101797759|NCT02543606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101808282|NCT00967512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101797760|NCT02543606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797762|NCT00939588|Telmisartan|telmisartan|mesh-list
101797763|NCT00939588|Ramipril|ramipril|mesh-list
101797764|NCT00939588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101797765|NCT00939588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101797766|NCT00939588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101797767|NCT00939588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797768|NCT00939588|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101797769|NCT00939588|Protease Inhibitors|protease inhibitors|mesh-ancestor
101797770|NCT00939588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101797771|NCT00889148|Gabapentin|gabapentin|mesh-list
101797772|NCT00889148|Analgesics|analgesics|mesh-ancestor
101797773|NCT00889148|Sensory System Agents|sensory system agents|mesh-ancestor
101797774|NCT00889148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101797775|NCT00889148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797776|NCT00889148|Anticonvulsants|anticonvulsants|mesh-ancestor
101797777|NCT00889148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101797778|NCT00889148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101797779|NCT00889148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101797780|NCT00889148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101797781|NCT00889148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101797782|NCT00889148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101185185|NCT04810572|Protective Agents|protective agents|mesh-ancestor
101797784|NCT00889148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797785|NCT00889148|Antimanic Agents|antimanic agents|mesh-ancestor
101797786|NCT00936156|Carboplatin|carboplatin|mesh-list
101797787|NCT00936156|Etoposide|etoposide|mesh-list
101797788|NCT00936156|Thiotepa|thiotepa|mesh-list
101797789|NCT00936156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797790|NCT00936156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101797791|NCT00936156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101797792|NCT00936156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101797793|NCT00936156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101797794|NCT00936156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797795|NCT00936156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101797796|NCT00936156|Alkylating Agents|alkylating agents|mesh-ancestor
101797797|NCT00936156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101797798|NCT00936156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101797799|NCT00936156|Immunologic Factors|immunologic factors|mesh-ancestor
101797800|NCT00936156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797801|NCT00129961|Cyclosporine|cyclosporine|mesh-list
101797802|NCT00129961|Sirolimus|sirolimus|mesh-list
101797803|NCT00129961|Tacrolimus|tacrolimus|mesh-list
101797804|NCT00129961|Cyclosporins|cyclosporins|mesh-list
101797805|NCT00129961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101797806|NCT00129961|Immunologic Factors|immunologic factors|mesh-ancestor
101797807|NCT00129961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797808|NCT00129961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101797809|NCT00129961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101797810|NCT00129961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797811|NCT00129961|Antifungal Agents|antifungal agents|mesh-ancestor
101797812|NCT00129961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101797813|NCT00129961|Dermatologic Agents|dermatologic agents|mesh-ancestor
101797814|NCT00129961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101797815|NCT00129961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101797816|NCT00129961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101797817|NCT00129961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797818|NCT00528567|Bevacizumab|bevacizumab|mesh-list
101797819|NCT00528567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101797820|NCT00528567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797821|NCT00528567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101797822|NCT00528567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101797823|NCT00528567|Growth Substances|growth substances|mesh-ancestor
101797824|NCT00528567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797825|NCT00528567|Growth Inhibitors|growth inhibitors|mesh-ancestor
101797826|NCT00936234|Vildagliptin|vildagliptin|mesh-list
101797827|NCT00936234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101797828|NCT00936234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797829|NCT00936234|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101797830|NCT00936234|Protease Inhibitors|protease inhibitors|mesh-ancestor
101797831|NCT00936234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101797832|NCT00936234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797833|NCT00886028|Doxorubicin|doxorubicin|mesh-list
101797834|NCT00886028|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101797835|NCT00886028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797836|NCT00886028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101797837|NCT00886028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101797838|NCT00886028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101797839|NCT00886028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101797840|NCT00886028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797841|NCT00936546|Rituximab|rituximab|mesh-list
101797842|NCT00936546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101797843|NCT00936546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797844|NCT00936546|Immunologic Factors|immunologic factors|mesh-ancestor
101797845|NCT00936546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797846|NCT00936546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101455196|NCT04668976|Irinotecan|irinotecan|mesh-list
101797847|NCT00936624|Montelukast|montelukast|mesh-list
101797848|NCT00936624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101797849|NCT00936624|Respiratory System Agents|respiratory system agents|mesh-ancestor
101797850|NCT00936624|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101797851|NCT00936624|Hormone Antagonists|hormone antagonists|mesh-ancestor
101310715|NCT00005977|Antidotes|antidotes|mesh-ancestor
101797852|NCT00936624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101797853|NCT00936624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797854|NCT00936624|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101797855|NCT00936624|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101797856|NCT00936624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797857|NCT00138151|Interferons|interferons|mesh-list
101797858|NCT00138151|Interferon-alpha|interferon-alpha|mesh-list
101797859|NCT00138151|Interferon alpha-2|interferon alpha-2|mesh-list
101797860|NCT00138151|Paclitaxel|paclitaxel|mesh-list
101797861|NCT00138151|Isotretinoin|isotretinoin|mesh-list
101797862|NCT00138151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101797863|NCT00138151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797864|NCT00138151|Tubulin Modulators|tubulin modulators|mesh-ancestor
101797865|NCT00138151|Antimitotic Agents|antimitotic agents|mesh-ancestor
101797866|NCT00138151|Mitosis Modulators|mitosis modulators|mesh-ancestor
101797867|NCT00138151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797868|NCT00138151|Antiviral Agents|antiviral agents|mesh-ancestor
101797869|NCT00138151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101797870|NCT00138151|Immunologic Factors|immunologic factors|mesh-ancestor
101797871|NCT00138151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797872|NCT00138151|Dermatologic Agents|dermatologic agents|mesh-ancestor
101797874|NCT02543060|Tin Fluorides|tin fluorides|mesh-list
101797875|NCT02543060|Cariostatic Agents|cariostatic agents|mesh-ancestor
101797876|NCT02543060|Protective Agents|protective agents|mesh-ancestor
101797877|NCT02543060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797878|NCT00889616|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101797879|NCT00889616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101797880|NCT00889616|Immunologic Factors|immunologic factors|mesh-ancestor
101797881|NCT00889616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797882|NCT00889616|Antacids|antacids|mesh-ancestor
101797883|NCT00889616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797884|NCT00889616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101797885|NCT02581631|Nivolumab|nivolumab|mesh-list
101797886|NCT02581631|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101797887|NCT02581631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101797888|NCT02581631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797889|NCT02581631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101797890|NCT02581631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797891|NCT02581631|Immunotoxins|immunotoxins|mesh-ancestor
101797892|NCT02581631|Immunoconjugates|immunoconjugates|mesh-ancestor
101797893|NCT02581631|Immunologic Factors|immunologic factors|mesh-ancestor
101797894|NCT02581631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797895|NCT00884546|Dexamethasone|dexamethasone|mesh-list
101797896|NCT00884546|Lenalidomide|lenalidomide|mesh-list
101797897|NCT00884546|Bortezomib|bortezomib|mesh-list
101797898|NCT00884546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101797899|NCT00884546|Antiemetics|antiemetics|mesh-ancestor
101797900|NCT00884546|Autonomic Agents|autonomic agents|mesh-ancestor
101797901|NCT00884546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101797902|NCT00884546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797903|NCT00884546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101797904|NCT00884546|Glucocorticoids|glucocorticoids|mesh-ancestor
101797905|NCT00884546|Hormones|hormones|mesh-ancestor
101797906|NCT00884546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101797907|NCT00884546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101797908|NCT00884546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797909|NCT00884546|Immunologic Factors|immunologic factors|mesh-ancestor
101797910|NCT00884546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101797911|NCT00884546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101797912|NCT00884546|Growth Substances|growth substances|mesh-ancestor
101797913|NCT00884546|Growth Inhibitors|growth inhibitors|mesh-ancestor
101797914|NCT00886106|Midazolam|midazolam|mesh-list
101797915|NCT00886106|Remifentanil|remifentanil|mesh-list
101797916|NCT00886106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101797917|NCT00886106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101797918|NCT00886106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101797919|NCT00886106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797920|NCT00886106|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101797921|NCT00886106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101797922|NCT00886106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101797923|NCT00886106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101797924|NCT00886106|Anesthetics, General|anesthetics, general|mesh-ancestor
101797925|NCT00886106|Anesthetics|anesthetics|mesh-ancestor
101797926|NCT00886106|GABA Modulators|gaba modulators|mesh-ancestor
101797927|NCT00886106|GABA Agents|gaba agents|mesh-ancestor
101797928|NCT00886106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101797929|NCT00886106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797930|NCT00886106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101797931|NCT00886106|Narcotics|narcotics|mesh-ancestor
101797932|NCT00886106|Analgesics|analgesics|mesh-ancestor
101797933|NCT00886106|Sensory System Agents|sensory system agents|mesh-ancestor
101797934|NCT00886106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101797935|NCT00889694|Sulfasalazine|sulfasalazine|mesh-list
101797936|NCT00889694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101797937|NCT00889694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101797938|NCT00889694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101797940|NCT00889694|Sensory System Agents|sensory system agents|mesh-ancestor
101797941|NCT00889694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101797942|NCT00889694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797943|NCT00889694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101797944|NCT00889694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101797945|NCT00889694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101797947|NCT00529035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101797948|NCT00529035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101797949|NCT00529035|Analgesics|analgesics|mesh-ancestor
101797950|NCT00529035|Sensory System Agents|sensory system agents|mesh-ancestor
101797951|NCT00529035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101797952|NCT00529035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797953|NCT04421664|Hydroxychloroquine|hydroxychloroquine|mesh-list
101797954|NCT04421664|Antimalarials|antimalarials|mesh-ancestor
101797955|NCT04421664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101797956|NCT04421664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101797957|NCT04421664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101797958|NCT04421664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101797959|NCT04421664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797960|NCT04421664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101797961|NCT02578043|Clindamycin|clindamycin|mesh-list
101797962|NCT02578043|Clindamycin palmitate|clindamycin palmitate|mesh-list
101797963|NCT02578043|Clindamycin phosphate|clindamycin phosphate|mesh-list
101797964|NCT02578043|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101797965|NCT02578043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101797966|NCT02578043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101797967|NCT02578043|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101797968|NCT02578043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101797969|NCT02578043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797970|NCT02578043|Dermatologic Agents|dermatologic agents|mesh-ancestor
101797971|NCT00889850|Esomeprazole|esomeprazole|mesh-list
101797972|NCT00889850|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101797973|NCT00889850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101797974|NCT00889850|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101797975|NCT00889850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101797976|NCT00889850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101797978|NCT04074317|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101797979|NCT04074317|Pramlintide|pramlintide|mesh-list
101797980|NCT04074317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101797981|NCT04074317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797982|NCT00941148|Insulin|insulin|mesh-list
101797983|NCT00941148|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101797984|NCT00941148|Metformin|metformin|mesh-list
101797985|NCT00941148|Insulin Detemir|insulin detemir|mesh-list
101797986|NCT00941148|Insulin, Isophane|insulin, isophane|mesh-list
101797987|NCT00941148|Isophane Insulin, Human|isophane insulin, human|mesh-list
101797988|NCT00941148|Isophane insulin, beef|isophane insulin, beef|mesh-list
101797989|NCT00941148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101797990|NCT00941148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101797991|NCT02541500|Minocycline|minocycline|mesh-list
101797992|NCT02541500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101797993|NCT02541500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101797994|NCT04073849|Epoetin Alfa|epoetin alfa|mesh-list
101797995|NCT04073849|Hematinics|hematinics|mesh-ancestor
101797996|NCT03263429|Irinotecan|irinotecan|mesh-list
101455348|NCT00212030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101797997|NCT03263429|Panitumumab|panitumumab|mesh-list
101797998|NCT03263429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101797999|NCT03263429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101798000|NCT03263429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101798001|NCT03263429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798002|NCT03263429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101798003|NCT03263429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101798004|NCT00609674|Fluticasone|fluticasone|mesh-list
101798005|NCT00609674|Xhance|xhance|mesh-list
101798006|NCT00609674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101808339|NCT00414466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101798007|NCT00609674|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101798008|NCT00609674|Autonomic Agents|autonomic agents|mesh-ancestor
101798009|NCT00609674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101798010|NCT00609674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798011|NCT00609674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101798012|NCT00609674|Respiratory System Agents|respiratory system agents|mesh-ancestor
101798013|NCT00609674|Dermatologic Agents|dermatologic agents|mesh-ancestor
101798014|NCT00609674|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101798015|NCT00941382|Metformin|metformin|mesh-list
101798016|NCT00941382|Sibutramine|sibutramine|mesh-list
101798017|NCT00941382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101798018|NCT00941382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798019|NCT00941382|Antidepressive Agents|antidepressive agents|mesh-ancestor
101798020|NCT00941382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101798021|NCT00941382|Appetite Depressants|appetite depressants|mesh-ancestor
101798022|NCT00941382|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101798023|NCT03253679|Adavosertib|adavosertib|mesh-list
101798024|NCT03253679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101798025|NCT03253679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798026|NCT00137839|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101798027|NCT00137839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101798028|NCT00137839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101798029|NCT00137839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101798030|NCT00137839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798031|NCT00941460|Temozolomide|temozolomide|mesh-list
101798032|NCT00941460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101798033|NCT00941460|Alkylating Agents|alkylating agents|mesh-ancestor
101798034|NCT00941460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798035|NCT00941460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101798036|NCT00890318|Ketoconazole|ketoconazole|mesh-list
101798037|NCT00890318|Antifungal Agents|antifungal agents|mesh-ancestor
101798038|NCT00890318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101798039|NCT00890318|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101798040|NCT00890318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101798041|NCT00890318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101798042|NCT00890318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798043|NCT00890318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101798044|NCT00890318|Hormone Antagonists|hormone antagonists|mesh-ancestor
101798045|NCT00890318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101798046|NCT00890318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798047|NCT00890318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101798048|NCT00563316|Irinotecan|irinotecan|mesh-list
101798049|NCT00563316|Panitumumab|panitumumab|mesh-list
101798050|NCT00563316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101798051|NCT00563316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101798052|NCT00563316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101798053|NCT00563316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798054|NCT00563316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101798055|NCT00563316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101798056|NCT04037774|Dexmedetomidine|dexmedetomidine|mesh-list
101798057|NCT04037774|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101798058|NCT04037774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101798059|NCT04037774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798060|NCT04037774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101798061|NCT04037774|Analgesics|analgesics|mesh-ancestor
101798062|NCT04037774|Sensory System Agents|sensory system agents|mesh-ancestor
101798063|NCT04037774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101798064|NCT04037774|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101798065|NCT04037774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101798067|NCT04037774|Adrenergic Agents|adrenergic agents|mesh-ancestor
101798068|NCT04037774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101798069|NCT04037774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798070|NCT02542748|Norepinephrine|norepinephrine|mesh-list
101798071|NCT02542748|Ephedrine|ephedrine|mesh-list
101798072|NCT02542748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101798073|NCT02542748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101798074|NCT02542748|Adrenergic Agents|adrenergic agents|mesh-ancestor
101798075|NCT02542748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101798076|NCT02542748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798077|NCT02542748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798078|NCT02542748|Sympathomimetics|sympathomimetics|mesh-ancestor
101798079|NCT02542748|Autonomic Agents|autonomic agents|mesh-ancestor
101798080|NCT02542748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101798081|NCT02542748|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101798082|NCT02542748|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101798083|NCT00941616|Factor VIII|factor viii|mesh-list
101798084|NCT00941616|Coagulants|coagulants|mesh-ancestor
101798085|NCT02542592|Methylprednisolone|methylprednisolone|mesh-list
101798086|NCT02542592|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101798087|NCT02542592|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101798088|NCT02542592|Prednisolone|prednisolone|mesh-list
101798089|NCT02542592|Prednisolone acetate|prednisolone acetate|mesh-list
101798090|NCT02542592|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101798091|NCT02542592|Prednisolone phosphate|prednisolone phosphate|mesh-list
101798092|NCT02542592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101798093|NCT02542592|Antiemetics|antiemetics|mesh-ancestor
101798094|NCT02542592|Autonomic Agents|autonomic agents|mesh-ancestor
101798095|NCT02542592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101798096|NCT02542592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798097|NCT02542592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101798098|NCT02542592|Glucocorticoids|glucocorticoids|mesh-ancestor
101798099|NCT02542592|Hormones|hormones|mesh-ancestor
101798100|NCT02542592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101798101|NCT02542592|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101798102|NCT02542592|Protective Agents|protective agents|mesh-ancestor
101798103|NCT02542592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101798104|NCT02542592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101798105|NCT03178487|Upadacitinib|upadacitinib|mesh-list
101798106|NCT03178487|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101798107|NCT03178487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101798108|NCT03178487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101798109|NCT03178487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798110|NCT03178487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101798111|NCT04430036|Cisplatin|cisplatin|mesh-list
101798112|NCT04430036|Gemcitabine|gemcitabine|mesh-list
101798113|NCT04430036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101798114|NCT04430036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101798116|NCT04430036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798117|NCT00528957|Tenofovir|tenofovir|mesh-list
101798118|NCT00528957|Zidovudine|zidovudine|mesh-list
101798119|NCT00528957|Stavudine|stavudine|mesh-list
101798120|NCT00528957|Antiviral Agents|antiviral agents|mesh-ancestor
101798121|NCT00528957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101798122|NCT00528957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101798123|NCT00528957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101798124|NCT00528957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101798125|NCT00528957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798126|NCT00528957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101798127|NCT00528957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101798128|NCT00528957|Antimetabolites|antimetabolites|mesh-ancestor
101798130|NCT00890630|Oxytocics|oxytocics|mesh-ancestor
101798131|NCT00890630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101798132|NCT00890630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798133|NCT00890708|Voriconazole|voriconazole|mesh-list
101798134|NCT00890708|Antifungal Agents|antifungal agents|mesh-ancestor
101798135|NCT00890708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101798136|NCT00890708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101798137|NCT00890708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101798138|NCT00890708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101798139|NCT00890708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798140|NCT00890708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101798141|NCT00890708|Hormone Antagonists|hormone antagonists|mesh-ancestor
101798142|NCT00890708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101798143|NCT00890708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798144|NCT00890708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101798145|NCT00890786|Bevacizumab|bevacizumab|mesh-list
101798146|NCT00890786|Irinotecan|irinotecan|mesh-list
101798147|NCT00890786|Temozolomide|temozolomide|mesh-list
101798148|NCT00890786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101798149|NCT00890786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101798150|NCT00890786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101798151|NCT00890786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101798152|NCT00890786|Growth Substances|growth substances|mesh-ancestor
101798153|NCT00890786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798154|NCT00890786|Growth Inhibitors|growth inhibitors|mesh-ancestor
101798155|NCT00890786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101798156|NCT00890786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101364729|NCT00148330|Triamcinolone|triamcinolone|mesh-list
101798157|NCT00890786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101798158|NCT00890786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798159|NCT00890786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101798160|NCT00890786|Alkylating Agents|alkylating agents|mesh-ancestor
101798161|NCT00560508|Pramipexole|pramipexole|mesh-list
101798162|NCT00560508|Antioxidants|antioxidants|mesh-ancestor
101798163|NCT00560508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798164|NCT00560508|Protective Agents|protective agents|mesh-ancestor
101798165|NCT00560508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798166|NCT00560508|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101798167|NCT00560508|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101798168|NCT00560508|Dopamine Agonists|dopamine agonists|mesh-ancestor
101798169|NCT00560508|Dopamine Agents|dopamine agents|mesh-ancestor
101798170|NCT00560508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101798171|NCT00890942|Naloxone|naloxone|mesh-list
101798172|NCT00890942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101798173|NCT00890942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798174|NCT00890942|Sensory System Agents|sensory system agents|mesh-ancestor
101798175|NCT00890942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101798176|NCT00942006|Doxycycline|doxycycline|mesh-list
101798177|NCT00942006|Ceftriaxone|ceftriaxone|mesh-list
101798178|NCT00942006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101798179|NCT00942006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101798180|NCT00942006|Antimalarials|antimalarials|mesh-ancestor
101798181|NCT00942006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101798182|NCT00942006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101798183|NCT02542124|Interleukin-12|interleukin-12|mesh-list
101798184|NCT02542124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101798185|NCT02542124|Immunologic Factors|immunologic factors|mesh-ancestor
101798186|NCT02542124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798187|NCT02542124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101798188|NCT02542124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101798190|NCT02542124|Growth Inhibitors|growth inhibitors|mesh-ancestor
101798191|NCT02542124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101798192|NCT00942318|Insulin|insulin|mesh-list
101798193|NCT00942318|Metformin|metformin|mesh-list
101798194|NCT00942318|Insulin Aspart|insulin aspart|mesh-list
101798195|NCT00942318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101798196|NCT00942318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798197|NCT04819269|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101798198|NCT04819269|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101798199|NCT05280054|Probenecid|probenecid|mesh-list
101798200|NCT05280054|Uricosuric Agents|uricosuric agents|mesh-ancestor
101798201|NCT05280054|Gout Suppressants|gout suppressants|mesh-ancestor
101798202|NCT05280054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101798203|NCT03999099|Suvorexant|suvorexant|mesh-list
101798204|NCT03999099|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101798205|NCT03999099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101798206|NCT03999099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101798207|NCT03999099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798208|NCT03999099|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
101798209|NCT03999099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101798210|NCT03999099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798211|NCT01007799|Vitamin D|vitamin d|mesh-list
101798212|NCT01007799|Ergocalciferols|ergocalciferols|mesh-list
101798213|NCT01007799|Cholecalciferol|cholecalciferol|mesh-list
101798214|NCT01007799|Vitamins|vitamins|mesh-list
101798215|NCT01007799|Micronutrients|micronutrients|mesh-ancestor
101798216|NCT01007799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798217|NCT01007799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101798218|NCT01007799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101798219|NCT00609518|Folic Acid|folic acid|mesh-list
101798220|NCT00609518|Vitamin B 12|vitamin b 12|mesh-list
101798221|NCT00609518|Vitamin B Complex|vitamin b complex|mesh-list
101798222|NCT00609518|Dexamethasone|dexamethasone|mesh-list
101798223|NCT00609518|Dexamethasone acetate|dexamethasone acetate|mesh-list
101798224|NCT00609518|Pemetrexed|pemetrexed|mesh-list
101798225|NCT00609518|BB 1101|bb 1101|mesh-list
101798226|NCT00609518|Vitamins|vitamins|mesh-ancestor
101798227|NCT00609518|Micronutrients|micronutrients|mesh-ancestor
101798228|NCT00609518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798229|NCT00609518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101798230|NCT00609518|Antiemetics|antiemetics|mesh-ancestor
101798231|NCT00609518|Autonomic Agents|autonomic agents|mesh-ancestor
101798232|NCT00609518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101798233|NCT00609518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101798234|NCT00609518|Glucocorticoids|glucocorticoids|mesh-ancestor
101798235|NCT00609518|Hormones|hormones|mesh-ancestor
101798236|NCT00609518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101798237|NCT00609518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101798238|NCT00609518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101798239|NCT00609518|Protease Inhibitors|protease inhibitors|mesh-ancestor
101798240|NCT00609518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101798241|NCT00609518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798242|NCT00609518|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101798243|NCT00609518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101798245|NCT01008111|Hydrogen Peroxide|hydrogen peroxide|mesh-list
101798246|NCT01008111|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101798247|NCT01008111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101798248|NCT00886496|Lectins|lectins|mesh-list
101798249|NCT00886496|Agglutinins|agglutinins|mesh-ancestor
101798250|NCT00886496|Immunologic Factors|immunologic factors|mesh-ancestor
101798251|NCT00886496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798252|NCT00886496|Coagulants|coagulants|mesh-ancestor
101798253|NCT00884858|Maraviroc|maraviroc|mesh-list
101798254|NCT00884858|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101798255|NCT00884858|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101798256|NCT00884858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798257|NCT00884858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101798258|NCT00884858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101798259|NCT00884858|Antiviral Agents|antiviral agents|mesh-ancestor
101798260|NCT00884858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101798261|NCT00884858|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101798262|NCT00891332|Leucovorin|leucovorin|mesh-list
101798263|NCT00891332|Antidotes|antidotes|mesh-ancestor
101798264|NCT00891332|Protective Agents|protective agents|mesh-ancestor
101798265|NCT00891332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798266|NCT00891332|Vitamin B Complex|vitamin b complex|mesh-ancestor
101798267|NCT00891332|Vitamins|vitamins|mesh-ancestor
101798268|NCT00891332|Micronutrients|micronutrients|mesh-ancestor
101798269|NCT00609362|Rosiglitazone|rosiglitazone|mesh-list
101798270|NCT00609362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101798271|NCT00609362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798272|NCT04038008|Fluconazole|fluconazole|mesh-list
101798273|NCT04038008|Antifungal Agents|antifungal agents|mesh-ancestor
101798274|NCT04038008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101798275|NCT04038008|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101798276|NCT04038008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101798277|NCT04038008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101798278|NCT04038008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798279|NCT04038008|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101798280|NCT04038008|Hormone Antagonists|hormone antagonists|mesh-ancestor
101798281|NCT04038008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101798282|NCT04038008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798283|NCT04038008|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101798284|NCT04038008|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101798285|NCT00886574|Aspirin|aspirin|mesh-list
101798286|NCT00886574|Cilostazol|cilostazol|mesh-list
101798287|NCT00886574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101798288|NCT00886574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101798289|NCT00886574|Analgesics|analgesics|mesh-ancestor
101798290|NCT00886574|Sensory System Agents|sensory system agents|mesh-ancestor
101798291|NCT00886574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101798292|NCT00886574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798293|NCT00886574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101798294|NCT00886574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101798295|NCT00886574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101798296|NCT00886574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101798297|NCT00886574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798298|NCT00886574|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101798299|NCT00886574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101798300|NCT00886574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101798301|NCT00886574|Antipyretics|antipyretics|mesh-ancestor
101798302|NCT00886574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101798304|NCT00886574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101798305|NCT00886574|Respiratory System Agents|respiratory system agents|mesh-ancestor
101798306|NCT00886574|Vasodilator Agents|vasodilator agents|mesh-ancestor
101798307|NCT00886574|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101798308|NCT00886574|Protective Agents|protective agents|mesh-ancestor
101798309|NCT00886574|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101798310|NCT00886574|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101798311|NCT00611858|Fluorouracil|fluorouracil|mesh-list
101798312|NCT00611858|Cetuximab|cetuximab|mesh-list
101798313|NCT00611858|Antimetabolites|antimetabolites|mesh-ancestor
101798314|NCT00611858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798315|NCT00611858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101798316|NCT00611858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101798317|NCT00611858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101798318|NCT00611858|Immunologic Factors|immunologic factors|mesh-ancestor
101798319|NCT00611858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798320|NCT00611858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101798321|NCT00137449|Sunitinib|sunitinib|mesh-list
101798322|NCT00137449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101798323|NCT00137449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101798324|NCT00137449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101798325|NCT00137449|Growth Substances|growth substances|mesh-ancestor
101798326|NCT00137449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798327|NCT00137449|Growth Inhibitors|growth inhibitors|mesh-ancestor
101798328|NCT00137449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101798329|NCT00137449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101798330|NCT00137449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798331|NCT00886886|Reboxetine|reboxetine|mesh-list
101798332|NCT00886886|Antidepressive Agents|antidepressive agents|mesh-ancestor
101798333|NCT00886886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101798334|NCT00886886|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101798335|NCT00886886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101798336|NCT00886886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101798337|NCT00886886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798338|NCT00886886|Adrenergic Agents|adrenergic agents|mesh-ancestor
101798339|NCT00886886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101798340|NCT00886886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798341|NCT00887042|Fludarabine|fludarabine|mesh-list
101798343|NCT00887042|Thymoglobulin|thymoglobulin|mesh-list
101798344|NCT00887042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101798345|NCT00887042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798346|NCT00887042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101798347|NCT00887042|Immunologic Factors|immunologic factors|mesh-ancestor
101798348|NCT00887042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798349|NCT00887042|Alkylating Agents|alkylating agents|mesh-ancestor
101798350|NCT00887042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101798351|NCT00887042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101798352|NCT00892112|Plasma Substitutes|plasma substitutes|mesh-list
101798353|NCT00892112|Immunoglobulins|immunoglobulins|mesh-list
101798354|NCT00892112|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101798356|NCT00892112|gamma-Globulins|gamma-globulins|mesh-list
101798357|NCT00892112|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101798358|NCT00892112|Immunologic Factors|immunologic factors|mesh-ancestor
101798359|NCT00892112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798360|NCT00892112|Blood Substitutes|blood substitutes|mesh-ancestor
101798361|NCT00887120|Ritonavir|ritonavir|mesh-list
101798362|NCT00887120|Lopinavir|lopinavir|mesh-list
101798363|NCT00887120|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101798364|NCT00887120|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101798365|NCT00887120|Protease Inhibitors|protease inhibitors|mesh-ancestor
101798366|NCT00887120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101798367|NCT00887120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798368|NCT00887120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101798369|NCT00887120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101798370|NCT00887120|Antiviral Agents|antiviral agents|mesh-ancestor
101798371|NCT00887120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101798372|NCT00887120|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101798373|NCT00887120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101798374|NCT00892190|Dasatinib|dasatinib|mesh-list
101798375|NCT00892190|Tretinoin|tretinoin|mesh-list
101798376|NCT00892190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101798377|NCT00892190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101798378|NCT00892190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101798379|NCT00892190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798380|NCT00892190|Keratolytic Agents|keratolytic agents|mesh-ancestor
101798381|NCT00892190|Dermatologic Agents|dermatologic agents|mesh-ancestor
101798382|NCT00887276|Amoxicillin|amoxicillin|mesh-list
101798383|NCT00887276|Moxifloxacin|moxifloxacin|mesh-list
101798384|NCT00887276|Ampicillin|ampicillin|mesh-list
101798385|NCT00887276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101798386|NCT00887276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101798387|NCT00887276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101798388|NCT00887276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101798389|NCT00887276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101798390|NCT00887276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798391|NCT00887276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101798392|NCT00528879|Metformin|metformin|mesh-list
101798393|NCT00528879|Dapagliflozin|dapagliflozin|mesh-list
101798394|NCT00528879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101798395|NCT00528879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798396|NCT00528879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101798397|NCT00528879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798398|NCT00608894|Prednisone|prednisone|mesh-list
101798399|NCT00608894|Azathioprine|azathioprine|mesh-list
101798400|NCT00608894|Tacrolimus|tacrolimus|mesh-list
101798401|NCT00608894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101798402|NCT00608894|Glucocorticoids|glucocorticoids|mesh-ancestor
101798403|NCT00608894|Hormones|hormones|mesh-ancestor
101798404|NCT00608894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101798405|NCT00608894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798406|NCT00608894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101798407|NCT00608894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101798408|NCT00608894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101798409|NCT00608894|Immunologic Factors|immunologic factors|mesh-ancestor
101798410|NCT00608894|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101798411|NCT00608894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101798412|NCT00608894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808459|NCT00545532|Oseltamivir|oseltamivir|mesh-list
101798413|NCT00608894|Antimetabolites|antimetabolites|mesh-ancestor
101798414|NCT00608894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101798415|NCT00608894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101798416|NCT00892346|Thalidomide|thalidomide|mesh-list
101798417|NCT00892346|Melphalan|melphalan|mesh-list
101798418|NCT00892346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101798419|NCT00892346|Alkylating Agents|alkylating agents|mesh-ancestor
101798420|NCT00892346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798421|NCT00892346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101798422|NCT00892346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101798423|NCT00892346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101798424|NCT00892346|Immunologic Factors|immunologic factors|mesh-ancestor
101798425|NCT00892346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798426|NCT00892346|Leprostatic Agents|leprostatic agents|mesh-ancestor
101798427|NCT00892346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101798428|NCT00892346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101798429|NCT00892346|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101798430|NCT00892346|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101798431|NCT00892346|Growth Substances|growth substances|mesh-ancestor
101798432|NCT00892346|Growth Inhibitors|growth inhibitors|mesh-ancestor
101798433|NCT00892424|Sorafenib|sorafenib|mesh-list
101798434|NCT00892424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101798435|NCT00892424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101798436|NCT00892424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101798437|NCT00892424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798438|NCT02541032|Minocycline|minocycline|mesh-list
101798439|NCT02541032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101798440|NCT02541032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101798441|NCT00892502|Bismuth|bismuth|mesh-list
101798442|NCT00892502|Antacids|antacids|mesh-ancestor
101798443|NCT00892502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798444|NCT00892502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101798445|NCT00885404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101798446|NCT00885404|Plasma-lyte 148|plasma-lyte 148|mesh-list
101798447|NCT00885404|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101798448|NCT00191113|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101798449|NCT00191113|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101798450|NCT00191113|Medroxyprogesterone|medroxyprogesterone|mesh-list
101798451|NCT00191113|Estradiol|estradiol|mesh-list
101798452|NCT00191113|Hormones|hormones|mesh-ancestor
101798453|NCT00191113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101455801|NCT00244023|Testosterone|testosterone|mesh-list
101798455|NCT00191113|Estrogens|estrogens|mesh-ancestor
101798456|NCT00191113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101798457|NCT00191113|Contraceptive Agents|contraceptive agents|mesh-ancestor
101798458|NCT00191113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101798459|NCT00191113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101798460|NCT00191113|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101798461|NCT00191113|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101798462|NCT00191113|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101798463|NCT00191113|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101798464|NCT00191113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101798465|NCT00191113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101798466|NCT03965052|Travoprost|travoprost|mesh-list
101798467|NCT03965052|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101798468|NCT03965052|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101798469|NCT03965052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101798471|NCT00892658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101798472|NCT00892658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101798473|NCT00892658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101798474|NCT00892658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798475|NCT00892736|Veliparib|veliparib|mesh-list
101798476|NCT00892736|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101798477|NCT00892736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101798478|NCT00892736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798479|NCT00892736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101798480|NCT03966235|Melatonin|melatonin|mesh-list
101798481|NCT03966235|Antioxidants|antioxidants|mesh-ancestor
101798482|NCT03966235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798483|NCT03966235|Protective Agents|protective agents|mesh-ancestor
101798484|NCT03966235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798485|NCT03966235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101798486|NCT01077661|Nebivolol|nebivolol|mesh-list
101798487|NCT01077661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101798488|NCT01077661|Vasodilator Agents|vasodilator agents|mesh-ancestor
101798489|NCT01077661|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101798490|NCT01077661|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101798491|NCT01077661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101798492|NCT01077661|Adrenergic Agents|adrenergic agents|mesh-ancestor
101798493|NCT01077661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101798494|NCT01077661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798495|NCT01077661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798497|NCT00606320|Antidepressive Agents|antidepressive agents|mesh-ancestor
101798498|NCT00606320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101798499|NCT00606320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101798500|NCT00606320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101798501|NCT00606320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101798502|NCT00606320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798503|NCT00606320|Dopamine Agonists|dopamine agonists|mesh-ancestor
101798504|NCT00606320|Dopamine Agents|dopamine agents|mesh-ancestor
101798505|NCT00606320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101798506|NCT00606320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798507|NCT00606320|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101798508|NCT00606320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101798509|NCT00606320|Serotonin Agents|serotonin agents|mesh-ancestor
101798510|NCT00606320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101798511|NCT00606320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101798512|NCT00606320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101798513|NCT00606320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101798515|NCT03966079|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101798516|NCT03966079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101798517|NCT03966079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101798518|NCT03966079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798519|NCT02540486|Insulin Glargine|insulin glargine|mesh-list
101798520|NCT02540486|Insulin, Long-Acting|insulin, long-acting|mesh-list
101798521|NCT02540486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101798522|NCT02540486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798523|NCT03966859|Atorvastatin|atorvastatin|mesh-list
101798524|NCT03966859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101798525|NCT03966859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101798526|NCT03966859|Antimetabolites|antimetabolites|mesh-ancestor
101798527|NCT03966859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798528|NCT03966859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101798529|NCT03966859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101798530|NCT03966859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101798531|NCT00528411|Aspirin|aspirin|mesh-list
101798532|NCT00528411|Clopidogrel|clopidogrel|mesh-list
101798533|NCT00528411|Ticagrelor|ticagrelor|mesh-list
101798534|NCT00528411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101798535|NCT00528411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101798536|NCT00528411|Analgesics|analgesics|mesh-ancestor
101798537|NCT00528411|Sensory System Agents|sensory system agents|mesh-ancestor
101798538|NCT00528411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101798539|NCT00528411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798540|NCT00528411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101798541|NCT00528411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101798542|NCT00528411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101798543|NCT00528411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101798544|NCT00528411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798545|NCT00528411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101798546|NCT00528411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101798547|NCT00528411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101798548|NCT00528411|Antipyretics|antipyretics|mesh-ancestor
101798549|NCT00528411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101798550|NCT00528411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101798551|NCT00528411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101798552|NCT00528411|Purinergic Agents|purinergic agents|mesh-ancestor
101798553|NCT00528411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101798554|NCT00895544|Vaccines|vaccines|mesh-list
101798555|NCT00895544|Immunologic Factors|immunologic factors|mesh-ancestor
101798556|NCT00895544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798557|NCT00895778|Rocuronium|rocuronium|mesh-list
101798558|NCT00895778|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101798559|NCT00895778|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101798560|NCT00895778|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101798561|NCT00895778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101798562|NCT00895778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798563|NCT00187135|Fentanyl|fentanyl|mesh-list
101798564|NCT00187135|Propofol|propofol|mesh-list
101798565|NCT00187135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101798566|NCT00187135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101798567|NCT00187135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798568|NCT00187135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101798569|NCT00187135|Anesthetics, General|anesthetics, general|mesh-ancestor
101808532|NCT00985374|Everolimus|everolimus|mesh-list
101798570|NCT00187135|Anesthetics|anesthetics|mesh-ancestor
101798571|NCT00187135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101798572|NCT00187135|Narcotics|narcotics|mesh-ancestor
101798573|NCT00187135|Analgesics|analgesics|mesh-ancestor
101798574|NCT00187135|Sensory System Agents|sensory system agents|mesh-ancestor
101798575|NCT00187135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101798576|NCT00187135|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101798577|NCT00896402|Iodine|iodine|mesh-list
101798578|NCT00896402|Chlorhexidine|chlorhexidine|mesh-list
101798579|NCT00896402|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101798580|NCT00896402|Povidone-Iodine|povidone-iodine|mesh-list
101798581|NCT00896402|Povidone|povidone|mesh-list
101798582|NCT00896402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101798583|NCT00896402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101798584|NCT00896402|Disinfectants|disinfectants|mesh-ancestor
101798585|NCT00896402|Dermatologic Agents|dermatologic agents|mesh-ancestor
101798586|NCT00896402|Trace Elements|trace elements|mesh-ancestor
101798587|NCT00896402|Micronutrients|micronutrients|mesh-ancestor
101798588|NCT00896402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798589|NCT00896402|Plasma Substitutes|plasma substitutes|mesh-ancestor
101798590|NCT00896402|Blood Substitutes|blood substitutes|mesh-ancestor
101798591|NCT00560352|Dexamethasone|dexamethasone|mesh-list
101798592|NCT00560352|Bortezomib|bortezomib|mesh-list
101798593|NCT00560352|Dasatinib|dasatinib|mesh-list
101798594|NCT00560352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101798595|NCT00560352|Antiemetics|antiemetics|mesh-ancestor
101798596|NCT00560352|Autonomic Agents|autonomic agents|mesh-ancestor
101798597|NCT00560352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101798598|NCT00560352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798599|NCT00560352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101310869|NCT00006025|Irinotecan|irinotecan|mesh-list
101798601|NCT00560352|Hormones|hormones|mesh-ancestor
101798602|NCT00560352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101798603|NCT00560352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101798604|NCT00560352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101798605|NCT00560352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101798606|NCT00560352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101798607|NCT00560352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798608|NCT00892892|Nitrendipine|nitrendipine|mesh-list
101798609|NCT00892892|Rilmenidine|rilmenidine|mesh-list
101798610|NCT00892892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101798611|NCT00892892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101798612|NCT00892892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101798613|NCT00892892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798614|NCT00892892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101798615|NCT00892892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798616|NCT00892892|Vasodilator Agents|vasodilator agents|mesh-ancestor
101798617|NCT00892892|Sympatholytics|sympatholytics|mesh-ancestor
101798618|NCT00892892|Autonomic Agents|autonomic agents|mesh-ancestor
101798619|NCT00892892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101798620|NCT00892892|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101798621|NCT00892892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101798622|NCT00892892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101798623|NCT00892892|Adrenergic Agents|adrenergic agents|mesh-ancestor
101798624|NCT00892892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101798626|NCT00944814|Trace Elements|trace elements|mesh-ancestor
101798627|NCT00944814|Micronutrients|micronutrients|mesh-ancestor
101798628|NCT00944814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798629|NCT00527787|Naproxen|naproxen|mesh-list
101798630|NCT00527787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101798631|NCT00527787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101798632|NCT00527787|Analgesics|analgesics|mesh-ancestor
101798633|NCT00527787|Sensory System Agents|sensory system agents|mesh-ancestor
101798634|NCT00527787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101798635|NCT00527787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798636|NCT00527787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101798637|NCT00527787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101798638|NCT00527787|Gout Suppressants|gout suppressants|mesh-ancestor
101798639|NCT00527787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101798640|NCT00527787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101798641|NCT00527787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798642|NCT00893048|Prednisone|prednisone|mesh-list
101798643|NCT00893048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101798644|NCT00893048|Glucocorticoids|glucocorticoids|mesh-ancestor
101798645|NCT00893048|Hormones|hormones|mesh-ancestor
101798646|NCT00893048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101798647|NCT00893048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798648|NCT00893048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101798649|NCT00893048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101798650|NCT00942864|Ranibizumab|ranibizumab|mesh-list
101798651|NCT00942864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101798652|NCT00942864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101798653|NCT00942864|Growth Substances|growth substances|mesh-ancestor
101798654|NCT00942864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310878|NCT00386659|Ritonavir|ritonavir|mesh-list
101798655|NCT00942864|Growth Inhibitors|growth inhibitors|mesh-ancestor
101798656|NCT00942864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101798657|NCT04036448|Lenalidomide|lenalidomide|mesh-list
101798658|NCT04036448|Immunologic Factors|immunologic factors|mesh-ancestor
101798659|NCT04036448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798660|NCT04036448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101798661|NCT04036448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101798662|NCT04036448|Growth Substances|growth substances|mesh-ancestor
101798663|NCT04036448|Growth Inhibitors|growth inhibitors|mesh-ancestor
101798664|NCT04036448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101798666|NCT00896558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101798667|NCT00896558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101798668|NCT00896558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101798669|NCT00896558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798670|NCT00896558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101798671|NCT00896558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101798672|NCT00896558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101798673|NCT00896558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101798674|NCT00896558|Anesthetics, General|anesthetics, general|mesh-ancestor
101798675|NCT00896558|Anesthetics|anesthetics|mesh-ancestor
101798676|NCT00896558|GABA Modulators|gaba modulators|mesh-ancestor
101798677|NCT00896558|GABA Agents|gaba agents|mesh-ancestor
101798678|NCT00896558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101798679|NCT00896558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798680|NCT00943176|Modafinil|modafinil|mesh-list
101798681|NCT00943176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101798682|NCT00943176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798683|NCT00943176|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101798684|NCT00943176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101808553|NCT00976092|Heparin|heparin|mesh-list
101798685|NCT00943176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101798686|NCT00943176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798687|NCT00129259|Iron|iron|mesh-list
101798688|NCT00129259|Trace Elements|trace elements|mesh-ancestor
101798689|NCT00129259|Micronutrients|micronutrients|mesh-ancestor
101798690|NCT00129259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798691|NCT00896714|Anesthetics|anesthetics|mesh-list
101798692|NCT00896714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101798693|NCT00896714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798694|NCT00940524|Cytarabine|cytarabine|mesh-list
101798695|NCT00940524|Cyclophosphamide|cyclophosphamide|mesh-list
101798696|NCT00940524|Methotrexate|methotrexate|mesh-list
101798697|NCT00940524|Etoposide|etoposide|mesh-list
101798698|NCT00940524|Asparaginase|asparaginase|mesh-list
101798699|NCT00940524|Dasatinib|dasatinib|mesh-list
101798700|NCT00940524|Mitoxantrone|mitoxantrone|mesh-list
101798701|NCT00940524|Pegaspargase|pegaspargase|mesh-list
101798702|NCT00940524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101798703|NCT00940524|Immunologic Factors|immunologic factors|mesh-ancestor
101798704|NCT00940524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798705|NCT00940524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101798706|NCT00940524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101798707|NCT00940524|Alkylating Agents|alkylating agents|mesh-ancestor
101798708|NCT00940524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798709|NCT00940524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101798710|NCT00940524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101798711|NCT00940524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101798712|NCT00940524|Abortifacient Agents|abortifacient agents|mesh-ancestor
101798713|NCT00940524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101798714|NCT00940524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101798715|NCT00940524|Antimetabolites|antimetabolites|mesh-ancestor
101798716|NCT00940524|Dermatologic Agents|dermatologic agents|mesh-ancestor
101798717|NCT00940524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101798718|NCT00940524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101798719|NCT00940524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101798720|NCT00940524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101798721|NCT00940524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101798722|NCT00940524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101798723|NCT00940524|Antiviral Agents|antiviral agents|mesh-ancestor
101798724|NCT00940524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101798725|NCT00940524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101798726|NCT00940524|Analgesics|analgesics|mesh-ancestor
101798727|NCT00940524|Sensory System Agents|sensory system agents|mesh-ancestor
101798728|NCT00940524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101798729|NCT00186901|Vitamin D|vitamin d|mesh-list
101798730|NCT00186901|Calcium Carbonate|calcium carbonate|mesh-list
101798731|NCT00186901|Calcium|calcium|mesh-list
101798732|NCT00186901|Vitamins|vitamins|mesh-ancestor
101798733|NCT00186901|Micronutrients|micronutrients|mesh-ancestor
101798734|NCT00186901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798735|NCT00186901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101798736|NCT00186901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101798737|NCT00186901|Antacids|antacids|mesh-ancestor
101798738|NCT00186901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798739|NCT00186901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101798740|NCT00943410|Trastuzumab|trastuzumab|mesh-list
101808580|NCT01323712|Vitamin D|vitamin d|mesh-list
101798741|NCT00943410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101798742|NCT00943410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101798743|NCT00896948|Antibodies|antibodies|mesh-list
101798744|NCT00896948|Immunologic Factors|immunologic factors|mesh-ancestor
101798745|NCT00896948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798746|NCT00186121|Anastrozole|anastrozole|mesh-list
101798747|NCT00186121|Goserelin|goserelin|mesh-list
101798748|NCT00186121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101798749|NCT00186121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101798750|NCT00186121|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101798751|NCT00186121|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101798752|NCT00186121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101456099|NCT04667299|Amoxicillin|amoxicillin|mesh-list
101798753|NCT00186121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798754|NCT00186121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101798755|NCT00186121|Hormone Antagonists|hormone antagonists|mesh-ancestor
101798756|NCT00186121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101798757|NCT00186121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798758|NCT00897026|Paclitaxel|paclitaxel|mesh-list
101798759|NCT00897026|Cyclophosphamide|cyclophosphamide|mesh-list
101798760|NCT00897026|Doxorubicin|doxorubicin|mesh-list
101798761|NCT00897026|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101798762|NCT00897026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101798763|NCT00897026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101798764|NCT00897026|Tubulin Modulators|tubulin modulators|mesh-ancestor
101798765|NCT00897026|Antimitotic Agents|antimitotic agents|mesh-ancestor
101798766|NCT00897026|Mitosis Modulators|mitosis modulators|mesh-ancestor
101798767|NCT00897026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798768|NCT00897026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101798769|NCT00897026|Immunologic Factors|immunologic factors|mesh-ancestor
101798770|NCT00897026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798771|NCT00897026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101798772|NCT00897026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101798773|NCT00897026|Alkylating Agents|alkylating agents|mesh-ancestor
101798774|NCT00897026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101798775|NCT00897026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101798776|NCT00897026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101798777|NCT00897026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101798778|NCT00897026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101798779|NCT00186043|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101798780|NCT00186043|Antidepressive Agents|antidepressive agents|mesh-ancestor
101798781|NCT00186043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101798782|NCT00186043|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101798783|NCT00186043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101798784|NCT00186043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101798785|NCT00186043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798787|NCT01076491|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101798788|NCT01076491|Diuretics|diuretics|mesh-ancestor
101798789|NCT01076491|Natriuretic Agents|natriuretic agents|mesh-ancestor
101798790|NCT01076491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798791|NCT00127933|Capecitabine|capecitabine|mesh-list
101798792|NCT00127933|Docetaxel|docetaxel|mesh-list
101798793|NCT00127933|Trastuzumab|trastuzumab|mesh-list
101798794|NCT00127933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101798795|NCT00127933|Antimetabolites|antimetabolites|mesh-ancestor
101798796|NCT00127933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798797|NCT00127933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101798798|NCT00127933|Tubulin Modulators|tubulin modulators|mesh-ancestor
101798799|NCT00127933|Antimitotic Agents|antimitotic agents|mesh-ancestor
101798800|NCT00127933|Mitosis Modulators|mitosis modulators|mesh-ancestor
101798801|NCT00127933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101798802|NCT03875313|Talazoparib|talazoparib|mesh-list
101798803|NCT03875313|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101798804|NCT03875313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101798805|NCT03875313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798806|NCT03875313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101798807|NCT01008345|Ezetimibe|ezetimibe|mesh-list
101798808|NCT01008345|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101798809|NCT01008345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101798810|NCT01008345|Antimetabolites|antimetabolites|mesh-ancestor
101798811|NCT01008345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798812|NCT01008345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101798813|NCT05239533|Nivolumab|nivolumab|mesh-list
101798814|NCT05239533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101798815|NCT05239533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101798816|NCT05239533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101798817|NCT05239533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101798818|NCT05239533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798819|NCT05239533|Immunologic Factors|immunologic factors|mesh-ancestor
101798820|NCT05239533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798821|NCT04828083|Lidocaine|lidocaine|mesh-list
101798822|NCT04828083|Anesthetics, Local|anesthetics, local|mesh-ancestor
101798823|NCT04828083|Anesthetics|anesthetics|mesh-ancestor
101798824|NCT04828083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101798825|NCT04828083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798826|NCT04828083|Sensory System Agents|sensory system agents|mesh-ancestor
101186243|NCT00001626|Cyclosporine|cyclosporine|mesh-list
101798827|NCT04828083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101456167|NCT00557011|Amphetamine|amphetamine|mesh-list
101798828|NCT04828083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101798829|NCT04828083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101798830|NCT04828083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101798831|NCT04828083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101798832|NCT04828083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798833|NCT05225961|Aspirin|aspirin|mesh-list
101798834|NCT05225961|Tirofiban|tirofiban|mesh-list
101798835|NCT05225961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101798836|NCT05225961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101798838|NCT05225961|Sensory System Agents|sensory system agents|mesh-ancestor
101798839|NCT05225961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101798840|NCT05225961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808619|NCT00982332|Hormones|hormones|mesh-ancestor
101798841|NCT05225961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101798842|NCT05225961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101798843|NCT05225961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101798844|NCT05225961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101798845|NCT05225961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798846|NCT05225961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101798847|NCT05225961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101798848|NCT05225961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101798849|NCT05225961|Antipyretics|antipyretics|mesh-ancestor
101798850|NCT00556998|Voriconazole|voriconazole|mesh-list
101798851|NCT00556998|Antifungal Agents|antifungal agents|mesh-ancestor
101798852|NCT00556998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101798853|NCT00556998|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101798854|NCT00556998|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101798855|NCT00556998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101798856|NCT00556998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798857|NCT00556998|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101798858|NCT00556998|Hormone Antagonists|hormone antagonists|mesh-ancestor
101798859|NCT00556998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101808675|NCT04008186|Metformin|metformin|mesh-list
101798860|NCT00556998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798861|NCT00556998|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101798862|NCT00945360|Letrozole|letrozole|mesh-list
101798863|NCT00945360|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101798864|NCT00945360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101798865|NCT00945360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101798866|NCT00945360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101798867|NCT00945360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798868|NCT00945360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101798869|NCT00945360|Hormone Antagonists|hormone antagonists|mesh-ancestor
101798870|NCT00945360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101798871|NCT00945360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798872|NCT00943566|Sufentanil|sufentanil|mesh-list
101798873|NCT00943566|Morphine|morphine|mesh-list
101798874|NCT00943566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101798875|NCT00943566|Narcotics|narcotics|mesh-ancestor
101798876|NCT00943566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101798877|NCT00943566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798878|NCT00943566|Analgesics|analgesics|mesh-ancestor
101798879|NCT00943566|Sensory System Agents|sensory system agents|mesh-ancestor
101798880|NCT00943566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101798881|NCT00943566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101798882|NCT00943566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101798883|NCT00943566|Anesthetics, General|anesthetics, general|mesh-ancestor
101798884|NCT00943566|Anesthetics|anesthetics|mesh-ancestor
101798885|NCT00940680|Losartan|losartan|mesh-list
101798886|NCT00940680|Amlodipine|amlodipine|mesh-list
101798887|NCT00940680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101798888|NCT00940680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101798889|NCT00940680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101798890|NCT00940680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798891|NCT00940680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101798892|NCT00940680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798893|NCT00940680|Vasodilator Agents|vasodilator agents|mesh-ancestor
101798894|NCT00940680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101798895|NCT00940680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101798896|NCT00940680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101798897|NCT00945438|Vaccines|vaccines|mesh-list
101798898|NCT00945438|Immunologic Factors|immunologic factors|mesh-ancestor
101798899|NCT00945438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798900|NCT00527397|Insulin|insulin|mesh-list
101798902|NCT00527397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798903|NCT00943956|Everolimus|everolimus|mesh-list
101798904|NCT00943956|Leuprolide|leuprolide|mesh-list
101798905|NCT00943956|Bicalutamide|bicalutamide|mesh-list
101798906|NCT00943956|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101798907|NCT00943956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101798908|NCT00943956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101798909|NCT00943956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798910|NCT00943956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101798911|NCT00943956|Immunologic Factors|immunologic factors|mesh-ancestor
101798912|NCT00943956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798913|NCT00943956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101798914|NCT00943956|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101798915|NCT00943956|Fertility Agents|fertility agents|mesh-ancestor
101798916|NCT00943956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101798917|NCT00943956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101798918|NCT00943956|Androgen Antagonists|androgen antagonists|mesh-ancestor
101798919|NCT00943956|Hormone Antagonists|hormone antagonists|mesh-ancestor
101798920|NCT00943956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101798921|NCT00944346|Metformin|metformin|mesh-list
101798922|NCT00944346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101798923|NCT00944346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798924|NCT04115319|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101798925|NCT04115319|Antidepressive Agents|antidepressive agents|mesh-ancestor
101798926|NCT04115319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101798927|NCT04115319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101798928|NCT04115319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101798929|NCT04115319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101798930|NCT04115319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798931|NCT00134719|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101798932|NCT00134719|Immunologic Factors|immunologic factors|mesh-ancestor
101798933|NCT00134719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798934|NCT00940836|Acetaminophen|acetaminophen|mesh-list
101798935|NCT00940836|Chlorpheniramine|chlorpheniramine|mesh-list
101798936|NCT00940836|Phenylephrine|phenylephrine|mesh-list
101798937|NCT00940836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101798938|NCT00940836|Analgesics|analgesics|mesh-ancestor
101798939|NCT00940836|Sensory System Agents|sensory system agents|mesh-ancestor
101798940|NCT00940836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101798941|NCT00940836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798942|NCT00940836|Antipyretics|antipyretics|mesh-ancestor
101798943|NCT00940836|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101798944|NCT00940836|Mydriatics|mydriatics|mesh-ancestor
101798945|NCT00940836|Autonomic Agents|autonomic agents|mesh-ancestor
101798946|NCT00940836|Sympathomimetics|sympathomimetics|mesh-ancestor
101798947|NCT00940836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101798948|NCT00940836|Nasal Decongestants|nasal decongestants|mesh-ancestor
101798949|NCT00940836|Respiratory System Agents|respiratory system agents|mesh-ancestor
101798950|NCT00940836|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101798951|NCT00940836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101798952|NCT00940836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101798953|NCT00940836|Adrenergic Agents|adrenergic agents|mesh-ancestor
101798954|NCT00940836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101798955|NCT00940836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798956|NCT00940836|Protective Agents|protective agents|mesh-ancestor
101798957|NCT00940836|Antipruritics|antipruritics|mesh-ancestor
101798958|NCT00940836|Dermatologic Agents|dermatologic agents|mesh-ancestor
101798959|NCT00940836|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101798960|NCT00940836|Histamine Antagonists|histamine antagonists|mesh-ancestor
101798961|NCT00940836|Histamine Agents|histamine agents|mesh-ancestor
101798962|NCT00940836|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101798963|NCT00940914|2beta-carbomethoxy-3beta-(4-iodophenyl)tropane|2beta-carbomethoxy-3beta-(4-iodophenyl)tropane|mesh-list
101798964|NCT00940914|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101798965|NCT00940914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798966|NCT00944424|Vitamin D|vitamin d|mesh-list
101798967|NCT00944424|Ergocalciferols|ergocalciferols|mesh-list
101798968|NCT00944424|Cholecalciferol|cholecalciferol|mesh-list
101798969|NCT00944424|Vitamins|vitamins|mesh-list
101798970|NCT00944424|Docetaxel|docetaxel|mesh-list
101798971|NCT00944424|Micronutrients|micronutrients|mesh-ancestor
101798972|NCT00944424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798973|NCT00944424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101798974|NCT00944424|Tubulin Modulators|tubulin modulators|mesh-ancestor
101798975|NCT00944424|Antimitotic Agents|antimitotic agents|mesh-ancestor
101798976|NCT00944424|Mitosis Modulators|mitosis modulators|mesh-ancestor
101798977|NCT00944424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101798978|NCT00944424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101798979|NCT00944424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101798980|NCT00944502|Dexamethasone|dexamethasone|mesh-list
101798981|NCT00944502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101798982|NCT00944502|Antiemetics|antiemetics|mesh-ancestor
101798983|NCT00944502|Autonomic Agents|autonomic agents|mesh-ancestor
101798984|NCT00944502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101798985|NCT00944502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798986|NCT00944502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101798987|NCT00944502|Glucocorticoids|glucocorticoids|mesh-ancestor
101798988|NCT00944502|Hormones|hormones|mesh-ancestor
101798989|NCT00944502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101798990|NCT00944502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101798991|NCT00944502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101798992|NCT00949962|Leuprolide|leuprolide|mesh-list
101808827|NCT00983268|Antimetabolites|antimetabolites|mesh-ancestor
101798994|NCT00949962|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101798995|NCT00949962|Fertility Agents|fertility agents|mesh-ancestor
101798996|NCT00949962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101798997|NCT00949962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101798998|NCT00949962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101798999|NCT00949962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799000|NCT00949962|Hormone Antagonists|hormone antagonists|mesh-ancestor
101799001|NCT00949962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101799002|NCT00946374|Cyclosporine|cyclosporine|mesh-list
101799003|NCT00946374|Doxorubicin|doxorubicin|mesh-list
101799004|NCT00946374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101799005|NCT00946374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799006|NCT00946374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101799007|NCT00946374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101799008|NCT00946374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101799009|NCT00946374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799010|NCT00946374|Immunologic Factors|immunologic factors|mesh-ancestor
101799011|NCT00946374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799012|NCT00946374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101799013|NCT00946374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101799014|NCT00946374|Antifungal Agents|antifungal agents|mesh-ancestor
101799015|NCT00946374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101799016|NCT00946374|Dermatologic Agents|dermatologic agents|mesh-ancestor
101799017|NCT00946374|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101799018|NCT00950196|Amantadine|amantadine|mesh-list
101799019|NCT00950196|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101799020|NCT00950196|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101799021|NCT00950196|Antiviral Agents|antiviral agents|mesh-ancestor
101799022|NCT00950196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101799023|NCT00950196|Dopamine Agents|dopamine agents|mesh-ancestor
101799024|NCT00950196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101799025|NCT00950196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799026|NCT00950196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799027|NCT00950196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101799028|NCT00950196|Analgesics|analgesics|mesh-ancestor
101799029|NCT00950196|Sensory System Agents|sensory system agents|mesh-ancestor
101799030|NCT00950196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101799031|NCT01565109|Docetaxel|docetaxel|mesh-list
101799032|NCT01565109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799033|NCT01565109|Tubulin Modulators|tubulin modulators|mesh-ancestor
101799034|NCT01565109|Antimitotic Agents|antimitotic agents|mesh-ancestor
101799035|NCT01565109|Mitosis Modulators|mitosis modulators|mesh-ancestor
101799036|NCT01565109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799037|NCT00525915|Fluorouracil|fluorouracil|mesh-list
101799038|NCT00525915|Oxaliplatin|oxaliplatin|mesh-list
101799039|NCT00525915|Antimetabolites|antimetabolites|mesh-ancestor
101799040|NCT00525915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799041|NCT00525915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101799042|NCT00525915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799043|NCT00525915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101799044|NCT00525915|Immunologic Factors|immunologic factors|mesh-ancestor
101799045|NCT00525915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799046|NCT00521001|Everolimus|everolimus|mesh-list
101799047|NCT00521001|Temozolomide|temozolomide|mesh-list
101799048|NCT00521001|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101799049|NCT00521001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101456385|NCT00216281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101799050|NCT00521001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101799051|NCT00521001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799052|NCT00521001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101799053|NCT00521001|Immunologic Factors|immunologic factors|mesh-ancestor
101799054|NCT00521001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799055|NCT00521001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799056|NCT00521001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101799057|NCT00521001|Alkylating Agents|alkylating agents|mesh-ancestor
101799058|NCT00134563|Teriflunomide|teriflunomide|mesh-list
101799059|NCT00134563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101799060|NCT00134563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101799061|NCT00134563|Analgesics|analgesics|mesh-ancestor
101799062|NCT00134563|Sensory System Agents|sensory system agents|mesh-ancestor
101799063|NCT00134563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101799064|NCT00134563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799065|NCT00134563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101799066|NCT00134563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101799067|NCT00134563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101799068|NCT00134563|Immunologic Factors|immunologic factors|mesh-ancestor
101799069|NCT03966547|Anesthetics|anesthetics|mesh-list
101799070|NCT03966547|Anesthetics, Local|anesthetics, local|mesh-list
101799071|NCT03966547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101799072|NCT03966547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799073|NCT03966547|Sensory System Agents|sensory system agents|mesh-ancestor
101799074|NCT03966547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101799075|NCT01326325|Ketamine|ketamine|mesh-list
101799076|NCT01326325|Analgesics|analgesics|mesh-ancestor
101799077|NCT01326325|Sensory System Agents|sensory system agents|mesh-ancestor
101799078|NCT01326325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101799079|NCT01326325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799080|NCT01326325|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101799081|NCT01326325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101799082|NCT01326325|Anesthetics, General|anesthetics, general|mesh-ancestor
101799083|NCT01326325|Anesthetics|anesthetics|mesh-ancestor
101799084|NCT01326325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101799085|NCT01326325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101799086|NCT01326325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101799087|NCT01326325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101799088|NCT01326325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799089|NCT01326403|Tranexamic Acid|tranexamic acid|mesh-list
101799090|NCT01326403|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101799091|NCT01326403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101799092|NCT01326403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799093|NCT01326403|Hemostatics|hemostatics|mesh-ancestor
101799094|NCT01326403|Coagulants|coagulants|mesh-ancestor
101799096|NCT00520845|Docetaxel|docetaxel|mesh-list
101799097|NCT00520845|Pemetrexed|pemetrexed|mesh-list
101799098|NCT00520845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799099|NCT00520845|Tubulin Modulators|tubulin modulators|mesh-ancestor
101799100|NCT00520845|Antimitotic Agents|antimitotic agents|mesh-ancestor
101799101|NCT00520845|Mitosis Modulators|mitosis modulators|mesh-ancestor
101799102|NCT00520845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799103|NCT00520845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101799104|NCT00520845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101799105|NCT00520845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101799106|NCT00520845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101799107|NCT00520845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101799108|NCT00520845|Analgesics|analgesics|mesh-ancestor
101799109|NCT00520845|Sensory System Agents|sensory system agents|mesh-ancestor
101799110|NCT00520845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101799111|NCT00520845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799112|NCT00520845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101799113|NCT00520845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101799114|NCT00520845|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101799115|NCT00520845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101799116|NCT00185731|Atorvastatin|atorvastatin|mesh-list
101799117|NCT00185731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101799118|NCT00185731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101799119|NCT00185731|Antimetabolites|antimetabolites|mesh-ancestor
101799120|NCT00185731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799121|NCT00185731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101799122|NCT00185731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101799123|NCT00185731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101456464|NCT00244998|Fulvestrant|fulvestrant|mesh-list
101799124|NCT00582491|Modafinil|modafinil|mesh-list
101799125|NCT00582491|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101799126|NCT00582491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799127|NCT00582491|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101799128|NCT00582491|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101799129|NCT00582491|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101799130|NCT00582491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799131|NCT00520767|Dexamethasone|dexamethasone|mesh-list
101799132|NCT00520767|Dexamethasone acetate|dexamethasone acetate|mesh-list
101799133|NCT00520767|Bortezomib|bortezomib|mesh-list
101799134|NCT00520767|Melphalan|melphalan|mesh-list
101799135|NCT00520767|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101799137|NCT00520767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101799138|NCT00520767|Antiemetics|antiemetics|mesh-ancestor
101799139|NCT00520767|Autonomic Agents|autonomic agents|mesh-ancestor
101799140|NCT00520767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101799141|NCT00520767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799142|NCT00520767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101799143|NCT00520767|Glucocorticoids|glucocorticoids|mesh-ancestor
101799144|NCT00520767|Hormones|hormones|mesh-ancestor
101799145|NCT00520767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101799146|NCT00520767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101799147|NCT00520767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799148|NCT00520767|Protease Inhibitors|protease inhibitors|mesh-ancestor
101799149|NCT00520767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101799150|NCT00520767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799151|NCT00520767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101799152|NCT00520767|Alkylating Agents|alkylating agents|mesh-ancestor
101799153|NCT00520767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101799154|NCT00520767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101799155|NCT00520767|Immunologic Factors|immunologic factors|mesh-ancestor
101799156|NCT03873987|Oritavancin|oritavancin|mesh-list
101799157|NCT03873987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101799158|NCT03873987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101799159|NCT02579681|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101799160|NCT02579681|Dermatologic Agents|dermatologic agents|mesh-ancestor
101799161|NCT02579681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101799162|NCT02579681|Immunologic Factors|immunologic factors|mesh-ancestor
101799163|NCT02579681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799164|NCT00528645|Saracatinib|saracatinib|mesh-list
101799165|NCT00528645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799166|NCT00528645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101799167|NCT00528645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799168|NCT01017796|Ascorbic Acid|ascorbic acid|mesh-list
101799169|NCT01017796|Acetylcysteine|acetylcysteine|mesh-list
101799170|NCT01017796|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101799171|NCT01017796|Antiviral Agents|antiviral agents|mesh-ancestor
101799172|NCT01017796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101799173|NCT01017796|Expectorants|expectorants|mesh-ancestor
101799174|NCT01017796|Respiratory System Agents|respiratory system agents|mesh-ancestor
101799175|NCT01017796|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101799176|NCT01017796|Antioxidants|antioxidants|mesh-ancestor
101799177|NCT01017796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799178|NCT01017796|Protective Agents|protective agents|mesh-ancestor
101799179|NCT01017796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799180|NCT01017796|Antidotes|antidotes|mesh-ancestor
101799181|NCT01017796|Vitamins|vitamins|mesh-ancestor
101799182|NCT01017796|Micronutrients|micronutrients|mesh-ancestor
101799183|NCT01783535|Cyclophosphamide|cyclophosphamide|mesh-list
101799184|NCT01783535|Carboplatin|carboplatin|mesh-list
101799185|NCT01783535|Doxorubicin|doxorubicin|mesh-list
101799186|NCT01783535|Etoposide|etoposide|mesh-list
101799187|NCT01783535|Vincristine|vincristine|mesh-list
101799188|NCT01783535|Topotecan|topotecan|mesh-list
101799189|NCT01783535|Lenograstim|lenograstim|mesh-list
101799190|NCT01783535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101799191|NCT01783535|Immunologic Factors|immunologic factors|mesh-ancestor
101799192|NCT01783535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799193|NCT01783535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101799194|NCT01783535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101799195|NCT01783535|Alkylating Agents|alkylating agents|mesh-ancestor
101799196|NCT01783535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799197|NCT01783535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799198|NCT01783535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101799199|NCT01783535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101799200|NCT01783535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101799201|NCT01783535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101799202|NCT01783535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101799203|NCT01783535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101799204|NCT01783535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101799205|NCT01783535|Tubulin Modulators|tubulin modulators|mesh-ancestor
101799206|NCT01783535|Antimitotic Agents|antimitotic agents|mesh-ancestor
101799207|NCT01783535|Mitosis Modulators|mitosis modulators|mesh-ancestor
101799208|NCT01783535|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101799210|NCT04073537|Carboplatin|carboplatin|mesh-list
101799211|NCT04073537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101799212|NCT04073537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799213|NCT04073537|Tubulin Modulators|tubulin modulators|mesh-ancestor
101799214|NCT04073537|Antimitotic Agents|antimitotic agents|mesh-ancestor
101799215|NCT04073537|Mitosis Modulators|mitosis modulators|mesh-ancestor
101799216|NCT04073537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799217|NCT01020994|Octenidine|octenidine|mesh-list
101799218|NCT01020994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101799219|NCT01020994|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101799220|NCT00494026|Carboplatin|carboplatin|mesh-list
101799221|NCT00494026|Pemetrexed|pemetrexed|mesh-list
101799222|NCT00494026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799223|NCT00494026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101799224|NCT00494026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799225|NCT00494026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101799226|NCT00494026|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101799227|NCT00524589|Calcitriol|calcitriol|mesh-list
101799228|NCT00524589|Dexamethasone|dexamethasone|mesh-list
101799229|NCT00524589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101799230|NCT00524589|Antiemetics|antiemetics|mesh-ancestor
101799231|NCT00524589|Autonomic Agents|autonomic agents|mesh-ancestor
101799232|NCT00524589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101799233|NCT00524589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799234|NCT00524589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101799235|NCT00524589|Glucocorticoids|glucocorticoids|mesh-ancestor
101799237|NCT00524589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101799238|NCT00524589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101808970|NCT00414310|Decitabine|decitabine|mesh-list
101799239|NCT00524589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799240|NCT00524589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101799241|NCT00524589|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101799242|NCT00524589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101799243|NCT00524589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799244|NCT00524589|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101799245|NCT00524589|Vitamins|vitamins|mesh-ancestor
101799246|NCT00524589|Micronutrients|micronutrients|mesh-ancestor
101799247|NCT00524589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101799248|NCT01015066|Naltrexone|naltrexone|mesh-list
101799249|NCT01015066|Buprenorphine|buprenorphine|mesh-list
101799250|NCT01015066|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101799251|NCT01015066|Naloxone|naloxone|mesh-list
101799252|NCT01015066|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101799253|NCT01015066|Narcotics|narcotics|mesh-ancestor
101799254|NCT01015066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101799255|NCT01015066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799256|NCT01015066|Analgesics|analgesics|mesh-ancestor
101799257|NCT01015066|Sensory System Agents|sensory system agents|mesh-ancestor
101799258|NCT01015066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101799259|NCT01015066|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101799260|NCT01015066|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101799261|NCT00472030|Omalizumab|omalizumab|mesh-list
101799262|NCT00472030|Prednisone|prednisone|mesh-list
101799263|NCT00472030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101799264|NCT00472030|Glucocorticoids|glucocorticoids|mesh-ancestor
101799265|NCT00472030|Hormones|hormones|mesh-ancestor
101799266|NCT00472030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101799267|NCT00472030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799268|NCT00472030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101799269|NCT00472030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799270|NCT00472030|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101186687|NCT00002208|Indinavir|indinavir|mesh-list
101799271|NCT00472030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101799272|NCT00472030|Respiratory System Agents|respiratory system agents|mesh-ancestor
101799273|NCT00127855|Vaccines|vaccines|mesh-list
101799274|NCT00127855|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101799275|NCT00127855|Immunologic Factors|immunologic factors|mesh-ancestor
101799276|NCT00127855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799277|NCT00493636|Gemcitabine|gemcitabine|mesh-list
101799278|NCT00493636|Capecitabine|capecitabine|mesh-list
101799279|NCT00493636|Sorafenib|sorafenib|mesh-list
101799280|NCT00493636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101799281|NCT00493636|Antimetabolites|antimetabolites|mesh-ancestor
101799282|NCT00493636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799283|NCT00493636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799284|NCT00493636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101799285|NCT00493636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101799286|NCT00524121|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101799287|NCT00524121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799288|NCT00524121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101799289|NCT00524121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101799290|NCT00524121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799291|NCT01018342|Nitrofurantoin|nitrofurantoin|mesh-list
101799292|NCT01018342|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101799293|NCT01018342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101799294|NCT01018342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101799295|NCT03965767|Tranexamic Acid|tranexamic acid|mesh-list
101799296|NCT03965767|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101799297|NCT03965767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101799298|NCT03965767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799299|NCT03965767|Hemostatics|hemostatics|mesh-ancestor
101799300|NCT03965767|Coagulants|coagulants|mesh-ancestor
101799301|NCT00133705|Mifepristone|mifepristone|mesh-list
101799302|NCT00133705|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101799304|NCT00133705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101799305|NCT00133705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799306|NCT00133705|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101799307|NCT00133705|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101799308|NCT00133705|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101799309|NCT00133705|Contraceptive Agents|contraceptive agents|mesh-ancestor
101799310|NCT00133705|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101799311|NCT00133705|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101799312|NCT00133705|Hormone Antagonists|hormone antagonists|mesh-ancestor
101799313|NCT00133705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101799314|NCT00133705|Luteolytic Agents|luteolytic agents|mesh-ancestor
101799315|NCT00133705|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101799316|NCT00133705|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101799317|NCT00132769|MK 0873|mk 0873|mesh-list
101799318|NCT00132769|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101799319|NCT00132769|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101799320|NCT00132769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101799321|NCT00132769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799322|NCT02478255|Xenon|xenon|mesh-list
101799323|NCT02478255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101799324|NCT02478255|Anesthetics, General|anesthetics, general|mesh-ancestor
101799325|NCT02478255|Anesthetics|anesthetics|mesh-ancestor
101799326|NCT02478255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101799327|NCT02478255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799328|NCT00132691|Cyclosporine|cyclosporine|mesh-list
101799329|NCT00132691|Mycophenolic Acid|mycophenolic acid|mesh-list
101799330|NCT00132691|Infliximab|infliximab|mesh-list
101799331|NCT00132691|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
101799332|NCT00132691|Cyclophosphamide|cyclophosphamide|mesh-list
101799333|NCT00132691|Chlorambucil|chlorambucil|mesh-list
101799334|NCT00132691|Methotrexate|methotrexate|mesh-list
101799335|NCT00132691|Azathioprine|azathioprine|mesh-list
101799336|NCT00132691|Tacrolimus|tacrolimus|mesh-list
101799337|NCT00132691|Cyclosporins|cyclosporins|mesh-list
101799338|NCT00132691|Daclizumab|daclizumab|mesh-list
101799339|NCT00132691|Immunosuppressive Agents|immunosuppressive agents|mesh-list
101799340|NCT00132691|Alkylating Agents|alkylating agents|mesh-list
101799341|NCT00132691|Immunologic Factors|immunologic factors|mesh-ancestor
101799342|NCT00132691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799343|NCT00132691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101799344|NCT00132691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101799345|NCT00132691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310953|NCT00006363|Aldesleukin|aldesleukin|mesh-list
101799346|NCT00132691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799347|NCT00132691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101799348|NCT00132691|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101799349|NCT00132691|Abortifacient Agents|abortifacient agents|mesh-ancestor
101799350|NCT00132691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101799351|NCT00132691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101799352|NCT00132691|Antimetabolites|antimetabolites|mesh-ancestor
101799354|NCT00132691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101799355|NCT00132691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101799356|NCT00132691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101799357|NCT00132691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101799358|NCT00132691|Antifungal Agents|antifungal agents|mesh-ancestor
101799359|NCT00132691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101799360|NCT00132691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101799361|NCT00132691|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101799362|NCT00132691|Antitubercular Agents|antitubercular agents|mesh-ancestor
101799363|NCT00132691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101799364|NCT00132691|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101799365|NCT00132691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101799366|NCT00132691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101799367|NCT00132691|Glucocorticoids|glucocorticoids|mesh-ancestor
101799368|NCT00132691|Hormones|hormones|mesh-ancestor
101799369|NCT00132691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101799370|NCT02390427|Paclitaxel|paclitaxel|mesh-list
101799371|NCT02390427|Maytansine|maytansine|mesh-list
101799372|NCT02390427|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101799373|NCT02390427|Trastuzumab|trastuzumab|mesh-list
101799374|NCT02390427|Pertuzumab|pertuzumab|mesh-list
101799375|NCT02390427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101799376|NCT02390427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799377|NCT02390427|Tubulin Modulators|tubulin modulators|mesh-ancestor
101799378|NCT02390427|Antimitotic Agents|antimitotic agents|mesh-ancestor
101799379|NCT02390427|Mitosis Modulators|mitosis modulators|mesh-ancestor
101799380|NCT02390427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799381|NCT02390427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101799382|NCT02390427|Immunotoxins|immunotoxins|mesh-ancestor
101799383|NCT02390427|Immunoconjugates|immunoconjugates|mesh-ancestor
101799384|NCT02390427|Immunologic Factors|immunologic factors|mesh-ancestor
101799385|NCT02390427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799386|NCT00125359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101799387|NCT00125359|Bexarotene|bexarotene|mesh-list
101799388|NCT00125359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799389|NCT00125359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101799390|NCT00125359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101799391|NCT00125359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799392|NCT00524043|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101799393|NCT00524043|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101799394|NCT00524043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101799395|NCT00524043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101799396|NCT00524043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799397|NCT00524043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101799398|NCT00524043|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101799399|NCT00524043|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101799400|NCT00524043|Serotonin Agents|serotonin agents|mesh-ancestor
101799401|NCT00524043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101799402|NCT00524043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799403|NCT00524043|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101799404|NCT00524043|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101799405|NCT00524043|Dopamine Agents|dopamine agents|mesh-ancestor
101799406|NCT01076803|Lanreotide|lanreotide|mesh-list
101799407|NCT01076803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799408|NCT00523419|Pemetrexed|pemetrexed|mesh-list
101799409|NCT00523419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799410|NCT00523419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101799411|NCT00523419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799412|NCT00523419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101799413|NCT00523419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101799414|NCT03868059|Methyltestosterone|methyltestosterone|mesh-list
101799415|NCT03868059|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101799416|NCT03868059|Testosterone|testosterone|mesh-list
101310957|NCT00006363|Busulfan|busulfan|mesh-list
101799417|NCT03868059|Testosterone undecanoate|testosterone undecanoate|mesh-list
101799418|NCT03868059|Testosterone enanthate|testosterone enanthate|mesh-list
101799419|NCT03868059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101799420|NCT03868059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799421|NCT03868059|Anabolic Agents|anabolic agents|mesh-ancestor
101799422|NCT03868059|Hormones|hormones|mesh-ancestor
101799423|NCT03868059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101799424|NCT03868059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799425|NCT03868059|Androgens|androgens|mesh-ancestor
101799426|NCT04028115|Ixazomib|ixazomib|mesh-list
101456765|NCT00241605|Metformin|metformin|mesh-list
101799427|NCT04028115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799428|NCT04028115|Protease Inhibitors|protease inhibitors|mesh-ancestor
101799429|NCT04028115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101799430|NCT04028115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799431|NCT03865407|Allopurinol|allopurinol|mesh-list
101799432|NCT03865407|Antimetabolites|antimetabolites|mesh-ancestor
101799433|NCT03865407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799434|NCT03865407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101799435|NCT03865407|Gout Suppressants|gout suppressants|mesh-ancestor
101799436|NCT03865407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101799437|NCT03865407|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101799438|NCT03865407|Antioxidants|antioxidants|mesh-ancestor
101799439|NCT03865407|Protective Agents|protective agents|mesh-ancestor
101799440|NCT03865407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799441|NCT00487942|Modafinil|modafinil|mesh-list
101799442|NCT00487942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101799443|NCT00487942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799444|NCT00487942|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101799445|NCT00487942|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101799446|NCT00487942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101799447|NCT00487942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799448|NCT00132301|Prednisone|prednisone|mesh-list
101799449|NCT00132301|Docetaxel|docetaxel|mesh-list
101799450|NCT00132301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799451|NCT00132301|Tubulin Modulators|tubulin modulators|mesh-ancestor
101799452|NCT00132301|Antimitotic Agents|antimitotic agents|mesh-ancestor
101809062|NCT00987636|Busulfan|busulfan|mesh-list
101799453|NCT00132301|Mitosis Modulators|mitosis modulators|mesh-ancestor
101799454|NCT00132301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799455|NCT00132301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101799456|NCT00132301|Glucocorticoids|glucocorticoids|mesh-ancestor
101799457|NCT00132301|Hormones|hormones|mesh-ancestor
101799458|NCT00132301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101799459|NCT00132301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799460|NCT00132301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101799461|NCT00519831|Cetuximab|cetuximab|mesh-list
101799462|NCT00519831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101799463|NCT00519831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799464|NCT04303845|Erenumab|erenumab|mesh-list
101799465|NCT04303845|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
101799466|NCT04303845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799467|NCT04303845|Analgesics|analgesics|mesh-ancestor
101799468|NCT04303845|Sensory System Agents|sensory system agents|mesh-ancestor
101799469|NCT04303845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101799470|NCT04303845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799471|NCT04187703|Azacitidine|azacitidine|mesh-list
101799472|NCT04187703|Decitabine|decitabine|mesh-list
101799473|NCT04187703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101799474|NCT04187703|Antimetabolites|antimetabolites|mesh-ancestor
101186905|NCT00002370|Itraconazole|itraconazole|mesh-list
101799475|NCT04187703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799476|NCT04187703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799477|NCT04187703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101799478|NCT00131911|Sorafenib|sorafenib|mesh-list
101799479|NCT00131911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799480|NCT00131911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101799481|NCT00131911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101799482|NCT00131911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799483|NCT00184093|Gemcitabine|gemcitabine|mesh-list
101799484|NCT00184093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101799485|NCT00184093|Antimetabolites|antimetabolites|mesh-ancestor
101799486|NCT00184093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799487|NCT00184093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799488|NCT01074619|Memantine|memantine|mesh-list
101799489|NCT01074619|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101799490|NCT01074619|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101799491|NCT01074619|Dopamine Agents|dopamine agents|mesh-ancestor
101799492|NCT01074619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101799493|NCT01074619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799494|NCT01074619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799495|NCT01074619|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101799496|NCT01074619|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101799497|NCT00183625|Olanzapine|olanzapine|mesh-list
101799498|NCT00183625|Risperidone|risperidone|mesh-list
101799499|NCT00183625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101799500|NCT00183625|Serotonin Agents|serotonin agents|mesh-ancestor
101799501|NCT00183625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101799502|NCT00183625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799503|NCT00183625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799504|NCT00183625|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101799505|NCT00183625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101799506|NCT00183625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101799507|NCT00183625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101799508|NCT00183625|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101799509|NCT00183625|Dopamine Agents|dopamine agents|mesh-ancestor
101799510|NCT00183625|Antiemetics|antiemetics|mesh-ancestor
101799511|NCT00183625|Autonomic Agents|autonomic agents|mesh-ancestor
101799512|NCT00183625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101799513|NCT00183625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101799514|NCT00183625|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101799515|NCT00183625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101799516|NCT00183625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101799517|NCT00511875|Doxycycline|doxycycline|mesh-list
101799518|NCT00511875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101799519|NCT00511875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101799520|NCT00511875|Antimalarials|antimalarials|mesh-ancestor
101799521|NCT00511875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101799522|NCT00511875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101799523|NCT02576327|Dexamethasone|dexamethasone|mesh-list
101799524|NCT02576327|Dexamethasone acetate|dexamethasone acetate|mesh-list
101799525|NCT02576327|Aprepitant|aprepitant|mesh-list
101799526|NCT02576327|Tropisetron|tropisetron|mesh-list
101799527|NCT02576327|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101799528|NCT02576327|BB 1101|bb 1101|mesh-list
101799529|NCT02576327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101799530|NCT02576327|Antiemetics|antiemetics|mesh-ancestor
101799531|NCT02576327|Autonomic Agents|autonomic agents|mesh-ancestor
101799532|NCT02576327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101799533|NCT02576327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799534|NCT02576327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101799535|NCT02576327|Glucocorticoids|glucocorticoids|mesh-ancestor
101799536|NCT02576327|Hormones|hormones|mesh-ancestor
101799537|NCT02576327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101799538|NCT02576327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101799539|NCT02576327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799540|NCT02576327|Protease Inhibitors|protease inhibitors|mesh-ancestor
101799541|NCT02576327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101799542|NCT02576327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799543|NCT02576327|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101799544|NCT02576327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101799545|NCT02576327|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101799546|NCT02576327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101799547|NCT02576327|Serotonin Agents|serotonin agents|mesh-ancestor
101799548|NCT00183391|Methylphenidate|methylphenidate|mesh-list
101799549|NCT00183391|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101799550|NCT00183391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101217461|NCT01487226|Cisplatin|cisplatin|mesh-list
101799551|NCT00183391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799552|NCT00183391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101799553|NCT00183391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101799554|NCT00183391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101799555|NCT00183391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799557|NCT00183391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101799558|NCT00183391|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101799559|NCT00183391|Adrenergic Agents|adrenergic agents|mesh-ancestor
101799560|NCT00493246|Acetaminophen|acetaminophen|mesh-list
101799561|NCT00493246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101799562|NCT00493246|Analgesics|analgesics|mesh-ancestor
101799563|NCT00493246|Sensory System Agents|sensory system agents|mesh-ancestor
101799564|NCT00493246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101799565|NCT00493246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799566|NCT00493246|Antipyretics|antipyretics|mesh-ancestor
101799567|NCT01021150|Cisplatin|cisplatin|mesh-list
101799568|NCT01021150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799569|NCT03997006|Atropine|atropine|mesh-list
101799570|NCT03997006|Aminophylline|aminophylline|mesh-list
101799571|NCT03997006|Neostigmine|neostigmine|mesh-list
101799572|NCT03997006|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101799573|NCT03997006|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101799574|NCT03997006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101799575|NCT03997006|Autonomic Agents|autonomic agents|mesh-ancestor
101456913|NCT04644484|Immunologic Factors|immunologic factors|mesh-ancestor
101799576|NCT03997006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101799577|NCT03997006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799578|NCT03997006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101799579|NCT03997006|Respiratory System Agents|respiratory system agents|mesh-ancestor
101799580|NCT03997006|Mydriatics|mydriatics|mesh-ancestor
101799581|NCT03997006|Parasympatholytics|parasympatholytics|mesh-ancestor
101799582|NCT03997006|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101799583|NCT03997006|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101799584|NCT03997006|Cholinergic Agents|cholinergic agents|mesh-ancestor
101799585|NCT03997006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101799586|NCT03997006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799587|NCT03997006|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101799588|NCT03997006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101799589|NCT03997006|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101799590|NCT03997006|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101799591|NCT03997006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101799592|NCT03997006|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101799593|NCT03997006|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101799594|NCT03997006|Purinergic Agents|purinergic agents|mesh-ancestor
101799595|NCT03997006|Protective Agents|protective agents|mesh-ancestor
101799596|NCT02281955|Cisplatin|cisplatin|mesh-list
101799597|NCT02281955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799599|NCT02272049|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101799600|NCT02272049|Anesthetics, General|anesthetics, general|mesh-ancestor
101799601|NCT02272049|Anesthetics|anesthetics|mesh-ancestor
101799602|NCT02272049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101799603|NCT02272049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799604|NCT03996538|Metformin|metformin|mesh-list
101799605|NCT03996538|Vaccines|vaccines|mesh-list
101799606|NCT03996538|Immunologic Factors|immunologic factors|mesh-ancestor
101799607|NCT03996538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799608|NCT03996538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101799609|NCT02576015|Lidocaine|lidocaine|mesh-list
101799610|NCT02576015|Ropivacaine|ropivacaine|mesh-list
101799611|NCT02576015|Anesthetics, Local|anesthetics, local|mesh-ancestor
101799612|NCT02576015|Anesthetics|anesthetics|mesh-ancestor
101799613|NCT02576015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101799614|NCT02576015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799615|NCT02576015|Sensory System Agents|sensory system agents|mesh-ancestor
101799616|NCT02576015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101799617|NCT02576015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101799618|NCT02576015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101799619|NCT02576015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101799620|NCT02576015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101799621|NCT02576015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799622|NCT02577965|Everolimus|everolimus|mesh-list
101799623|NCT02577965|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101799624|NCT02577965|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101799625|NCT02577965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101799626|NCT02577965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799627|NCT02577965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101799628|NCT02577965|Immunologic Factors|immunologic factors|mesh-ancestor
101799629|NCT02577965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799630|NCT02577965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799631|NCT00182689|Sorafenib|sorafenib|mesh-list
101799632|NCT00182689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799633|NCT00182689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101799634|NCT00182689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101799635|NCT00182689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799636|NCT02578121|Dexamethasone|dexamethasone|mesh-list
101799637|NCT02578121|Pomalidomide|pomalidomide|mesh-list
101799638|NCT02578121|Ixazomib|ixazomib|mesh-list
101799639|NCT02578121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101799640|NCT02578121|Antiemetics|antiemetics|mesh-ancestor
101799641|NCT02578121|Autonomic Agents|autonomic agents|mesh-ancestor
101799642|NCT02578121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101799643|NCT02578121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799644|NCT02578121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101799645|NCT02578121|Glucocorticoids|glucocorticoids|mesh-ancestor
101799646|NCT02578121|Hormones|hormones|mesh-ancestor
101799647|NCT02578121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101799648|NCT02578121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101799649|NCT02578121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101456989|NCT00218114|GABA Agents|gaba agents|mesh-ancestor
101799650|NCT02578121|Immunologic Factors|immunologic factors|mesh-ancestor
101799651|NCT02578121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101799652|NCT02578121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101799653|NCT02578121|Growth Substances|growth substances|mesh-ancestor
101799654|NCT02578121|Growth Inhibitors|growth inhibitors|mesh-ancestor
101799655|NCT02578121|Protease Inhibitors|protease inhibitors|mesh-ancestor
101799656|NCT02578121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101799657|NCT02578121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799658|NCT00487240|Insulin|insulin|mesh-list
101799659|NCT00487240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101799660|NCT00487240|Insulin Lispro|insulin lispro|mesh-list
101799661|NCT00487240|Insulin Detemir|insulin detemir|mesh-list
101799663|NCT00487240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101799664|NCT00487240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799665|NCT00487240|Heparin Antagonists|heparin antagonists|mesh-ancestor
101799666|NCT00487240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799667|NCT00487240|Coagulants|coagulants|mesh-ancestor
101799668|NCT02577809|Indomethacin|indomethacin|mesh-list
101799669|NCT02577809|Fentanyl|fentanyl|mesh-list
101799670|NCT02577809|Morphine|morphine|mesh-list
101799671|NCT02577809|Bupivacaine|bupivacaine|mesh-list
101799672|NCT02577809|Anesthetics, Local|anesthetics, local|mesh-ancestor
101799673|NCT02577809|Anesthetics|anesthetics|mesh-ancestor
101799674|NCT02577809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101799675|NCT02577809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799676|NCT02577809|Sensory System Agents|sensory system agents|mesh-ancestor
101799677|NCT02577809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101799678|NCT02577809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101799679|NCT02577809|Narcotics|narcotics|mesh-ancestor
101799680|NCT02577809|Analgesics|analgesics|mesh-ancestor
101799681|NCT02577809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101799682|NCT02577809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101799683|NCT02577809|Anesthetics, General|anesthetics, general|mesh-ancestor
101799684|NCT02577809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101799685|NCT02577809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101799686|NCT02577809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101799687|NCT02577809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101799688|NCT02577809|Gout Suppressants|gout suppressants|mesh-ancestor
101799689|NCT02577809|Tocolytic Agents|tocolytic agents|mesh-ancestor
101799690|NCT02577809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101799691|NCT02577809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101799692|NCT02577809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101799693|NCT02577809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799694|NCT02224391|Nicotine|nicotine|mesh-list
101799695|NCT02224391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101799696|NCT02224391|Autonomic Agents|autonomic agents|mesh-ancestor
101799697|NCT02224391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101799698|NCT02224391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799699|NCT02224391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101799700|NCT02224391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101799701|NCT02224391|Cholinergic Agents|cholinergic agents|mesh-ancestor
101799702|NCT02224391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101799703|NCT02224391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799704|NCT00487162|Insulin|insulin|mesh-list
101799705|NCT00487162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101799706|NCT00487162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799707|NCT03871959|Pembrolizumab|pembrolizumab|mesh-list
101799708|NCT03871959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101799709|NCT03871959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799710|NCT03871959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101799711|NCT03871959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799713|NCT00487084|Morphine|morphine|mesh-list
101799714|NCT00487084|Anesthetics, Local|anesthetics, local|mesh-ancestor
101799715|NCT00487084|Anesthetics|anesthetics|mesh-ancestor
101799716|NCT00487084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101799717|NCT00487084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799718|NCT00487084|Sensory System Agents|sensory system agents|mesh-ancestor
101799719|NCT00487084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101799720|NCT00487084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101799721|NCT00487084|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101799722|NCT00487084|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101799723|NCT00487084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101799724|NCT00487084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799725|NCT00487084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101799726|NCT00487084|Narcotics|narcotics|mesh-ancestor
101799727|NCT00487084|Analgesics|analgesics|mesh-ancestor
101799728|NCT00466726|Sargramostim|sargramostim|mesh-list
101799729|NCT00466726|Immunologic Factors|immunologic factors|mesh-ancestor
101799730|NCT00466726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799731|NCT01721291|Albuterol|albuterol|mesh-list
101799732|NCT01721291|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101799733|NCT01721291|Autonomic Agents|autonomic agents|mesh-ancestor
101799734|NCT01721291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101799735|NCT01721291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799736|NCT01721291|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101799737|NCT01721291|Respiratory System Agents|respiratory system agents|mesh-ancestor
101799738|NCT01721291|Tocolytic Agents|tocolytic agents|mesh-ancestor
101799739|NCT01721291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101799740|NCT01721291|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101799741|NCT01721291|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101799742|NCT01721291|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101799743|NCT01721291|Adrenergic Agents|adrenergic agents|mesh-ancestor
101799744|NCT01721291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101799745|NCT01721291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799746|NCT01021540|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101799747|NCT01021540|Hormones|hormones|mesh-ancestor
101799748|NCT01021540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101799749|NCT01021540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799750|NCT04840511|Lidocaine|lidocaine|mesh-list
101799751|NCT04840511|Anesthetics, Local|anesthetics, local|mesh-ancestor
101799752|NCT04840511|Anesthetics|anesthetics|mesh-ancestor
101799753|NCT04840511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101799754|NCT04840511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799755|NCT04840511|Sensory System Agents|sensory system agents|mesh-ancestor
101799756|NCT04840511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101799757|NCT04840511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101799758|NCT04840511|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101799759|NCT04840511|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101799760|NCT04840511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101799761|NCT04840511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799762|NCT02199665|Dexamethasone|dexamethasone|mesh-list
101799763|NCT02199665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101799764|NCT02199665|Antiemetics|antiemetics|mesh-ancestor
101799765|NCT02199665|Autonomic Agents|autonomic agents|mesh-ancestor
101799766|NCT02199665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101799767|NCT02199665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799768|NCT02199665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101799769|NCT02199665|Glucocorticoids|glucocorticoids|mesh-ancestor
101799771|NCT02199665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101799772|NCT02199665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101799773|NCT02199665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799774|NCT01021696|Acetaminophen|acetaminophen|mesh-list
101799775|NCT01021696|Pregabalin|pregabalin|mesh-list
101799776|NCT01021696|Morphine|morphine|mesh-list
101799777|NCT01021696|Buprenorphine|buprenorphine|mesh-list
101799778|NCT01021696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101799779|NCT01021696|Narcotics|narcotics|mesh-ancestor
101799780|NCT01021696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101799781|NCT01021696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799782|NCT01021696|Analgesics|analgesics|mesh-ancestor
101799783|NCT01021696|Sensory System Agents|sensory system agents|mesh-ancestor
101799784|NCT01021696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101799785|NCT01021696|Anticonvulsants|anticonvulsants|mesh-ancestor
101799786|NCT01021696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101799787|NCT01021696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101799788|NCT01021696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799789|NCT01021696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101799790|NCT01021696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101799791|NCT01021696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101799792|NCT01021696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101799793|NCT01021696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101799794|NCT01021696|Antipyretics|antipyretics|mesh-ancestor
101799795|NCT01021696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101799796|NCT02577575|Oxytocin|oxytocin|mesh-list
101799797|NCT02577575|Oxytocics|oxytocics|mesh-ancestor
101799798|NCT02577575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101799799|NCT02577575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799800|NCT00485758|Niacin|niacin|mesh-list
101799801|NCT00485758|Niacinamide|niacinamide|mesh-list
101799802|NCT00485758|Nicotinic Acids|nicotinic acids|mesh-list
101799803|NCT00485758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101799804|NCT00485758|Antimetabolites|antimetabolites|mesh-ancestor
101799805|NCT00485758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799806|NCT00485758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101799807|NCT00485758|Vasodilator Agents|vasodilator agents|mesh-ancestor
101799808|NCT00485758|Vitamin B Complex|vitamin b complex|mesh-ancestor
101799809|NCT00485758|Vitamins|vitamins|mesh-ancestor
101799810|NCT00485758|Micronutrients|micronutrients|mesh-ancestor
101799811|NCT00485758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799812|NCT02577341|Docetaxel|docetaxel|mesh-list
101799813|NCT02577341|Nimotuzumab|nimotuzumab|mesh-list
101799814|NCT02577341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799815|NCT02577341|Tubulin Modulators|tubulin modulators|mesh-ancestor
101799816|NCT02577341|Antimitotic Agents|antimitotic agents|mesh-ancestor
101799817|NCT02577341|Mitosis Modulators|mitosis modulators|mesh-ancestor
101799818|NCT02577341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799819|NCT02577341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101799820|NCT02577497|Fluticasone|fluticasone|mesh-list
101799821|NCT02577497|Beclomethasone|beclomethasone|mesh-list
101799822|NCT02577497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101799823|NCT02577497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101799824|NCT02577497|Autonomic Agents|autonomic agents|mesh-ancestor
101799825|NCT02577497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101799826|NCT02577497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799827|NCT02577497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101799828|NCT02577497|Respiratory System Agents|respiratory system agents|mesh-ancestor
101799829|NCT02577497|Dermatologic Agents|dermatologic agents|mesh-ancestor
101799830|NCT02577497|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101799831|NCT02577497|Glucocorticoids|glucocorticoids|mesh-ancestor
101799832|NCT02577497|Hormones|hormones|mesh-ancestor
101799833|NCT02577497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101799834|NCT02575859|Cisplatin|cisplatin|mesh-list
101799835|NCT02575859|Mitomycins|mitomycins|mesh-list
101799836|NCT02575859|Mitomycin|mitomycin|mesh-list
101799837|NCT02575859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799838|NCT02575859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101799839|NCT02575859|Alkylating Agents|alkylating agents|mesh-ancestor
101799840|NCT02575859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799841|NCT02575859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101799842|NCT02575859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101799843|NCT03850444|Paclitaxel|paclitaxel|mesh-list
101799844|NCT03850444|Carboplatin|carboplatin|mesh-list
101799845|NCT03850444|Pembrolizumab|pembrolizumab|mesh-list
101799846|NCT03850444|Pemetrexed|pemetrexed|mesh-list
101799847|NCT03850444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101799848|NCT03850444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799849|NCT03850444|Tubulin Modulators|tubulin modulators|mesh-ancestor
101799850|NCT03850444|Antimitotic Agents|antimitotic agents|mesh-ancestor
101799851|NCT03850444|Mitosis Modulators|mitosis modulators|mesh-ancestor
101799852|NCT03850444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799853|NCT03850444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101799854|NCT03850444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101799855|NCT03850444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101799856|NCT03850444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101799857|NCT03850444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101799858|NCT00469456|Memantine|memantine|mesh-list
101799859|NCT00469456|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101799860|NCT00469456|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101799861|NCT00469456|Dopamine Agents|dopamine agents|mesh-ancestor
101799862|NCT00469456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101799863|NCT00469456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799864|NCT00469456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799865|NCT00469456|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101799866|NCT00469456|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101799867|NCT00581555|Etanercept|etanercept|mesh-list
101799868|NCT00581555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101799869|NCT00581555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101799870|NCT00581555|Analgesics|analgesics|mesh-ancestor
101799871|NCT00581555|Sensory System Agents|sensory system agents|mesh-ancestor
101799872|NCT00581555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101799873|NCT00581555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799874|NCT00581555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101799875|NCT00581555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101799876|NCT00581555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101799877|NCT00581555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101799878|NCT00581555|Immunologic Factors|immunologic factors|mesh-ancestor
101799879|NCT00469144|Fludarabine|fludarabine|mesh-list
101799880|NCT00469144|Busulfan|busulfan|mesh-list
101799881|NCT00469144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799882|NCT00469144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799883|NCT00469144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101799884|NCT00469144|Immunologic Factors|immunologic factors|mesh-ancestor
101799885|NCT00469144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799886|NCT00469144|Alkylating Agents|alkylating agents|mesh-ancestor
101799887|NCT00469144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101799888|NCT00469144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101799889|NCT03987022|Acetaminophen|acetaminophen|mesh-list
101799890|NCT03987022|Ketorolac|ketorolac|mesh-list
101799891|NCT03987022|Oxycodone|oxycodone|mesh-list
101799892|NCT03987022|Hydromorphone|hydromorphone|mesh-list
101799893|NCT03987022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101799894|NCT03987022|Narcotics|narcotics|mesh-ancestor
101799895|NCT03987022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101799896|NCT03987022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799897|NCT03987022|Analgesics|analgesics|mesh-ancestor
101799898|NCT03987022|Sensory System Agents|sensory system agents|mesh-ancestor
101799899|NCT03987022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101809211|NCT00413920|Mycophenolic Acid|mycophenolic acid|mesh-list
101799900|NCT03987022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101799902|NCT03987022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101799903|NCT03987022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101799904|NCT03987022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101310989|NCT00006366|Irinotecan|irinotecan|mesh-list
101799905|NCT03987022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101799906|NCT03987022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799907|NCT03987022|Antipyretics|antipyretics|mesh-ancestor
101799908|NCT01025128|Vitamin D|vitamin d|mesh-list
101799909|NCT01025128|Vitamins|vitamins|mesh-ancestor
101799910|NCT01025128|Micronutrients|micronutrients|mesh-ancestor
101799911|NCT01025128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799912|NCT01025128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101799913|NCT00468910|Aspirin|aspirin|mesh-list
101799914|NCT00468910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101799915|NCT00468910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101799916|NCT00468910|Analgesics|analgesics|mesh-ancestor
101799917|NCT00468910|Sensory System Agents|sensory system agents|mesh-ancestor
101799918|NCT00468910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101799919|NCT00468910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799920|NCT00468910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101799921|NCT00468910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101799922|NCT00468910|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101799923|NCT00468910|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101799924|NCT00468910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799925|NCT00468910|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101799926|NCT00468910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101799927|NCT00468910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101799928|NCT00468910|Antipyretics|antipyretics|mesh-ancestor
101799929|NCT01412333|Interferons|interferons|mesh-list
101799930|NCT01412333|Interferon-beta|interferon-beta|mesh-list
101799931|NCT01412333|Interferon beta-1a|interferon beta-1a|mesh-list
101799932|NCT01412333|Ocrelizumab|ocrelizumab|mesh-list
101799933|NCT01412333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799934|NCT01412333|Antiviral Agents|antiviral agents|mesh-ancestor
101799935|NCT01412333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101799936|NCT01412333|Immunologic Factors|immunologic factors|mesh-ancestor
101799937|NCT01412333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799938|NCT01412333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101799939|NCT02577185|Botulinum Toxins|botulinum toxins|mesh-list
101799940|NCT02577185|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101799941|NCT02577185|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101799942|NCT02577185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101799943|NCT02577185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101799944|NCT02577185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799945|NCT02577185|Cholinergic Agents|cholinergic agents|mesh-ancestor
101799946|NCT02577185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101799947|NCT02577185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799948|NCT02577185|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101799949|NCT02577185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101799950|NCT00519285|Prednisone|prednisone|mesh-list
101799951|NCT00519285|Prednisolone|prednisolone|mesh-list
101799952|NCT00519285|Docetaxel|docetaxel|mesh-list
101799953|NCT00519285|Aflibercept|aflibercept|mesh-list
101799954|NCT00519285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799955|NCT00519285|Tubulin Modulators|tubulin modulators|mesh-ancestor
101799956|NCT00519285|Antimitotic Agents|antimitotic agents|mesh-ancestor
101799957|NCT00519285|Mitosis Modulators|mitosis modulators|mesh-ancestor
101799958|NCT00519285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799959|NCT00519285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101799960|NCT00519285|Glucocorticoids|glucocorticoids|mesh-ancestor
101799961|NCT00519285|Hormones|hormones|mesh-ancestor
101799962|NCT00519285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101799963|NCT00519285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799964|NCT00519285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101799965|NCT00519285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101799966|NCT00519285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101799968|NCT00519285|Growth Inhibitors|growth inhibitors|mesh-ancestor
101799969|NCT00464620|Dasatinib|dasatinib|mesh-list
101799970|NCT00464620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799971|NCT00464620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101799972|NCT00464620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101799973|NCT00464620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799974|NCT05212857|Leuprolide|leuprolide|mesh-list
101799975|NCT05212857|Goserelin|goserelin|mesh-list
101799976|NCT05212857|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101799977|NCT05212857|Abiraterone Acetate|abiraterone acetate|mesh-list
101799978|NCT05212857|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101799979|NCT05212857|Fertility Agents|fertility agents|mesh-ancestor
101799980|NCT05212857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101364787|NCT00148564|Olanzapine|olanzapine|mesh-list
101799981|NCT05212857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101799982|NCT05212857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101799983|NCT05212857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101799984|NCT05212857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101799985|NCT05212857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101799986|NCT05212857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799987|NCT05212857|Hormone Antagonists|hormone antagonists|mesh-ancestor
101799988|NCT05212857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101799989|NCT05212857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101799990|NCT05212857|Luteolytic Agents|luteolytic agents|mesh-ancestor
101799991|NCT05212857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101799992|NCT05212857|Contraceptive Agents|contraceptive agents|mesh-ancestor
101799993|NCT05212857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101799994|NCT02099123|Atorvastatin|atorvastatin|mesh-list
101799995|NCT02099123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101799996|NCT02099123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101799997|NCT02099123|Antimetabolites|antimetabolites|mesh-ancestor
101799998|NCT02099123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101799999|NCT02099123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101800000|NCT02099123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101800001|NCT02099123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800002|NCT00464542|Metronidazole|metronidazole|mesh-list
101800003|NCT00464542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101800004|NCT00464542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101800005|NCT00464542|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101800006|NCT00464542|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101800007|NCT02578823|Antipyretics|antipyretics|mesh-list
101800008|NCT02578823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800009|NCT01969643|Trastuzumab|trastuzumab|mesh-list
101800010|NCT01969643|SGN-LIV1A|sgn-liv1a|mesh-list
101800011|NCT01969643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101800012|NCT01969643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101800013|NCT01969643|Immunoconjugates|immunoconjugates|mesh-ancestor
101800014|NCT01969643|Immunologic Factors|immunologic factors|mesh-ancestor
101800015|NCT01969643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800016|NCT00464308|Esomeprazole|esomeprazole|mesh-list
101800017|NCT00464308|Rabeprazole|rabeprazole|mesh-list
101800018|NCT00464308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101800019|NCT00464308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101800020|NCT00464308|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101800021|NCT00464308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800022|NCT00464308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800023|NCT00463840|Fluorouracil|fluorouracil|mesh-list
101800024|NCT00463840|Oxaliplatin|oxaliplatin|mesh-list
101800025|NCT00463840|Antimetabolites|antimetabolites|mesh-ancestor
101800026|NCT00463840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800027|NCT00463840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101800028|NCT00463840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101800029|NCT00463840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101800030|NCT00463840|Immunologic Factors|immunologic factors|mesh-ancestor
101800031|NCT00463840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800032|NCT00129389|Paclitaxel|paclitaxel|mesh-list
101800033|NCT00129389|Cyclophosphamide|cyclophosphamide|mesh-list
101800034|NCT00129389|Doxorubicin|doxorubicin|mesh-list
101800035|NCT00129389|Fluorouracil|fluorouracil|mesh-list
101800036|NCT00129389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101800037|NCT00129389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101800038|NCT00129389|Tubulin Modulators|tubulin modulators|mesh-ancestor
101800039|NCT00129389|Antimitotic Agents|antimitotic agents|mesh-ancestor
101800040|NCT00129389|Mitosis Modulators|mitosis modulators|mesh-ancestor
101800041|NCT00129389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800042|NCT00129389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101800043|NCT00129389|Immunologic Factors|immunologic factors|mesh-ancestor
101800044|NCT00129389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800045|NCT00129389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101800046|NCT00129389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101800047|NCT00129389|Alkylating Agents|alkylating agents|mesh-ancestor
101800048|NCT00129389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101800049|NCT00129389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101800050|NCT00129389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101800051|NCT00129389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101800052|NCT00129389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800053|NCT00129389|Antimetabolites|antimetabolites|mesh-ancestor
101800054|NCT00129389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101800055|NCT00468052|Fentanyl|fentanyl|mesh-list
101800056|NCT00468052|Dexmedetomidine|dexmedetomidine|mesh-list
101800057|NCT00468052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101800058|NCT00468052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101800059|NCT00468052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800060|NCT00468052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101800061|NCT00468052|Analgesics|analgesics|mesh-ancestor
101800062|NCT00468052|Sensory System Agents|sensory system agents|mesh-ancestor
101800063|NCT00468052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101800064|NCT00468052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101800065|NCT00468052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101800066|NCT00468052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101800067|NCT00468052|Adrenergic Agents|adrenergic agents|mesh-ancestor
101800068|NCT00468052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101800069|NCT00468052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800070|NCT00468052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101800071|NCT00468052|Narcotics|narcotics|mesh-ancestor
101800072|NCT00468052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101800073|NCT00468052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101800074|NCT00468052|Anesthetics, General|anesthetics, general|mesh-ancestor
101800075|NCT00468052|Anesthetics|anesthetics|mesh-ancestor
101800076|NCT00453310|Sunitinib|sunitinib|mesh-list
101800077|NCT00453310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101800078|NCT00453310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101800079|NCT00453310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101800080|NCT00453310|Growth Substances|growth substances|mesh-ancestor
101800081|NCT00453310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800082|NCT00453310|Growth Inhibitors|growth inhibitors|mesh-ancestor
101800083|NCT00453310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101800084|NCT00453310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800085|NCT00453310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800086|NCT00128843|Anastrozole|anastrozole|mesh-list
101800087|NCT00128843|Exemestane|exemestane|mesh-list
101800088|NCT00128843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101800089|NCT00128843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101800090|NCT00128843|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101800091|NCT00128843|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101800092|NCT00128843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800093|NCT00128843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800094|NCT00128843|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101800095|NCT00128843|Hormone Antagonists|hormone antagonists|mesh-ancestor
101800096|NCT00128843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101800097|NCT00128843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800098|NCT04073927|Butyric Acid|butyric acid|mesh-list
101800099|NCT04073927|Histamine Antagonists|histamine antagonists|mesh-ancestor
101800100|NCT04073927|Histamine Agents|histamine agents|mesh-ancestor
101800101|NCT04073927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101800102|NCT04073927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457435|NCT00561964|Irbesartan|irbesartan|mesh-list
101800103|NCT04073927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800104|NCT00124657|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101800105|NCT00124657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101800106|NCT00124657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101800107|NCT00124657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800108|NCT00124657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800109|NCT02578277|BMS-955176|bms-955176|mesh-list
101800110|NCT02578277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101800111|NCT02578277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101800112|NCT02578277|Antiviral Agents|antiviral agents|mesh-ancestor
101800113|NCT02578277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101800114|NCT00555906|Dexamethasone|dexamethasone|mesh-list
101800115|NCT00555906|Bortezomib|bortezomib|mesh-list
101800116|NCT00555906|Palbociclib|palbociclib|mesh-list
101800117|NCT00555906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101800118|NCT00555906|Antiemetics|antiemetics|mesh-ancestor
101800119|NCT00555906|Autonomic Agents|autonomic agents|mesh-ancestor
101800120|NCT00555906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101800121|NCT00555906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800122|NCT00555906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101800123|NCT00555906|Glucocorticoids|glucocorticoids|mesh-ancestor
101800124|NCT00555906|Hormones|hormones|mesh-ancestor
101828152|NCT05923996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800125|NCT00555906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101800126|NCT00555906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101800127|NCT00555906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101800128|NCT00555906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101800129|NCT00555906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800130|NCT00555906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800131|NCT04071353|Interferons|interferons|mesh-list
101800132|NCT04071353|Ribavirin|ribavirin|mesh-list
101800133|NCT04071353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101800134|NCT04071353|Antiviral Agents|antiviral agents|mesh-ancestor
101800135|NCT04071353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101800136|NCT04071353|Antimetabolites|antimetabolites|mesh-ancestor
101800137|NCT04071353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800138|NCT00709475|Insulin Detemir|insulin detemir|mesh-list
101800139|NCT00709475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101800140|NCT00709475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800141|NCT00555672|Fluorouracil|fluorouracil|mesh-list
101800142|NCT00555672|Sunitinib|sunitinib|mesh-list
101800143|NCT00555672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101800144|NCT00555672|Antimetabolites|antimetabolites|mesh-ancestor
101800145|NCT00555672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800146|NCT00555672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101800147|NCT00555672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101800148|NCT00555672|Immunologic Factors|immunologic factors|mesh-ancestor
101800149|NCT00555672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800150|NCT00555672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101800151|NCT00555672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101800152|NCT00555672|Growth Substances|growth substances|mesh-ancestor
101800153|NCT00555672|Growth Inhibitors|growth inhibitors|mesh-ancestor
101800154|NCT00555672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101800155|NCT00555672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800156|NCT02575547|Docetaxel|docetaxel|mesh-list
101800157|NCT02575547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101800158|NCT02575547|Tubulin Modulators|tubulin modulators|mesh-ancestor
101800159|NCT02575547|Antimitotic Agents|antimitotic agents|mesh-ancestor
101800160|NCT02575547|Mitosis Modulators|mitosis modulators|mesh-ancestor
101800161|NCT02575547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800162|NCT01037387|Bronchodilator Agents|bronchodilator agents|mesh-list
101800163|NCT01037387|Autonomic Agents|autonomic agents|mesh-ancestor
101800164|NCT01037387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101800165|NCT01037387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800166|NCT01037387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101800167|NCT01037387|Respiratory System Agents|respiratory system agents|mesh-ancestor
101800168|NCT02574533|Pembrolizumab|pembrolizumab|mesh-list
101800169|NCT02574533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101800170|NCT02574533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101800171|NCT02574533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101800172|NCT02574533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800173|NCT04652375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101800174|NCT00709553|Midazolam|midazolam|mesh-list
101800175|NCT00709553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101800176|NCT00709553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101800177|NCT00709553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101800178|NCT00709553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800179|NCT00709553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101800180|NCT00709553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101800181|NCT00709553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101800182|NCT00709553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101800183|NCT00709553|Anesthetics, General|anesthetics, general|mesh-ancestor
101800184|NCT00709553|Anesthetics|anesthetics|mesh-ancestor
101800185|NCT00709553|GABA Modulators|gaba modulators|mesh-ancestor
101809307|NCT05919472|Iron|iron|mesh-list
101800186|NCT00709553|GABA Agents|gaba agents|mesh-ancestor
101800187|NCT00709553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101800188|NCT00709553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800189|NCT03958656|Cyclophosphamide|cyclophosphamide|mesh-list
101800190|NCT03958656|Fludarabine|fludarabine|mesh-list
101800191|NCT03958656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101800192|NCT03958656|Immunologic Factors|immunologic factors|mesh-ancestor
101800193|NCT03958656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800194|NCT03958656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101828153|NCT05923996|Cholinergic Agents|cholinergic agents|mesh-ancestor
101800195|NCT03958656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101800196|NCT03958656|Alkylating Agents|alkylating agents|mesh-ancestor
101800197|NCT03958656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800198|NCT03958656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101800199|NCT03958656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101800200|NCT00561912|Interferons|interferons|mesh-list
101800201|NCT00561912|Interferon-alpha|interferon-alpha|mesh-list
101800202|NCT00561912|Interferon alpha-2|interferon alpha-2|mesh-list
101800203|NCT00561912|Decitabine|decitabine|mesh-list
101800204|NCT00561912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101800205|NCT00561912|Antiviral Agents|antiviral agents|mesh-ancestor
101800206|NCT00561912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101800207|NCT00561912|Immunologic Factors|immunologic factors|mesh-ancestor
101800208|NCT00561912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800209|NCT00561912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101800210|NCT00561912|Antimetabolites|antimetabolites|mesh-ancestor
101800211|NCT00561912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800212|NCT00561912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800213|NCT00561678|Dexmedetomidine|dexmedetomidine|mesh-list
101800214|NCT00561678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101800215|NCT00561678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101800216|NCT00561678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800217|NCT00561678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101800218|NCT00561678|Analgesics|analgesics|mesh-ancestor
101800219|NCT00561678|Sensory System Agents|sensory system agents|mesh-ancestor
101800220|NCT00561678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101800221|NCT00561678|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101800222|NCT00561678|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101800223|NCT00561678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101800224|NCT00561678|Adrenergic Agents|adrenergic agents|mesh-ancestor
101800225|NCT00561678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101800226|NCT00561678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800227|NCT00946608|Loratadine|loratadine|mesh-list
101800228|NCT00946608|Antipruritics|antipruritics|mesh-ancestor
101800229|NCT00946608|Dermatologic Agents|dermatologic agents|mesh-ancestor
101800230|NCT00946608|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101800231|NCT00946608|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101800232|NCT00946608|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101800233|NCT00946608|Histamine Antagonists|histamine antagonists|mesh-ancestor
101800234|NCT00946608|Histamine Agents|histamine agents|mesh-ancestor
101800235|NCT00946608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101800236|NCT00946608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800237|NCT00946608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800238|NCT00463684|Vaccines|vaccines|mesh-list
101800239|NCT00463684|Immunologic Factors|immunologic factors|mesh-ancestor
101800240|NCT00463684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800241|NCT00463606|Calcium, Dietary|calcium, dietary|mesh-list
101800242|NCT00463606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101800243|NCT00463606|Fenofibric acid|fenofibric acid|mesh-list
101800244|NCT00463606|Calcium|calcium|mesh-list
101800245|NCT00463606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101800246|NCT00463606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800247|NCT00463606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101800249|NCT00463606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101800250|NCT00463606|Antimetabolites|antimetabolites|mesh-ancestor
101800251|NCT00463606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800252|NCT00463606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101800253|NCT00463606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101800254|NCT00463606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800255|NCT03961308|Vedolizumab|vedolizumab|mesh-list
101800256|NCT03961308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101800257|NCT00956436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101800259|NCT00956436|Liver Extracts|liver extracts|mesh-list
101800260|NCT00956436|Antibodies|antibodies|mesh-list
101800261|NCT00956436|Immunoglobulins|immunoglobulins|mesh-list
101800262|NCT00956436|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101800263|NCT00956436|Immunologic Factors|immunologic factors|mesh-ancestor
101800264|NCT00956436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800265|NCT00956436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101800266|NCT00956436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101800267|NCT00956436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800268|NCT00956436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800270|NCT00950586|Dextromethorphan|dextromethorphan|mesh-list
101800271|NCT00950586|Antitussive Agents|antitussive agents|mesh-ancestor
101800272|NCT00950586|Respiratory System Agents|respiratory system agents|mesh-ancestor
101800273|NCT00950586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101800274|NCT00950586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101800275|NCT00950586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101800276|NCT00950586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800277|NCT00950586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800278|NCT00467896|Iloprost|iloprost|mesh-list
101800279|NCT00467896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101800280|NCT00467896|Vasodilator Agents|vasodilator agents|mesh-ancestor
101800281|NCT00946686|Leflunomide|leflunomide|mesh-list
101800282|NCT00946686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800283|NCT00946686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800284|NCT00946686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101800285|NCT00946686|Immunologic Factors|immunologic factors|mesh-ancestor
101800286|NCT00946686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800287|NCT02531737|Docetaxel|docetaxel|mesh-list
101800288|NCT02531737|Nintedanib|nintedanib|mesh-list
101800289|NCT02531737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101800290|NCT02531737|Tubulin Modulators|tubulin modulators|mesh-ancestor
101800291|NCT02531737|Antimitotic Agents|antimitotic agents|mesh-ancestor
101800292|NCT02531737|Mitosis Modulators|mitosis modulators|mesh-ancestor
101800293|NCT02531737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800294|NCT02531737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101800295|NCT02531737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800296|NCT01326559|Docetaxel|docetaxel|mesh-list
101800297|NCT01326559|Cetuximab|cetuximab|mesh-list
101800298|NCT01326559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101800299|NCT01326559|Tubulin Modulators|tubulin modulators|mesh-ancestor
101800300|NCT01326559|Antimitotic Agents|antimitotic agents|mesh-ancestor
101809338|NCT05919017|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101809339|NCT05919017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809340|NCT05919017|Sensory System Agents|sensory system agents|mesh-ancestor
101809341|NCT05919017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101809342|NCT05918952|Antibodies|antibodies|mesh-list
101809343|NCT05918952|Immunologic Factors|immunologic factors|mesh-ancestor
101809344|NCT05918952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800302|NCT01326559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800303|NCT01326559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101800305|NCT04069949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101800306|NCT04069949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101800307|NCT04069949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800308|NCT04069949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800309|NCT02575235|Cetylpyridinium|cetylpyridinium|mesh-list
101800310|NCT02575235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101800311|NCT02575235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101800312|NCT00467740|Olodaterol|olodaterol|mesh-list
101800313|NCT00467740|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101800314|NCT00467740|Autonomic Agents|autonomic agents|mesh-ancestor
101800315|NCT00467740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101800316|NCT00467740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800317|NCT00467740|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101800318|NCT00467740|Respiratory System Agents|respiratory system agents|mesh-ancestor
101800319|NCT00710099|Sildenafil Citrate|sildenafil citrate|mesh-list
101800320|NCT00710099|Vasodilator Agents|vasodilator agents|mesh-ancestor
101800321|NCT00710099|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101800322|NCT00710099|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101800323|NCT00710099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800324|NCT00710099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800325|NCT00710099|Urological Agents|urological agents|mesh-ancestor
101800326|NCT03944044|Acetaminophen|acetaminophen|mesh-list
101800327|NCT03944044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101800328|NCT03944044|Analgesics|analgesics|mesh-ancestor
101800329|NCT03944044|Sensory System Agents|sensory system agents|mesh-ancestor
101800330|NCT03944044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101800331|NCT03944044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800333|NCT00714623|Sirolimus|sirolimus|mesh-list
101800334|NCT00714623|Temsirolimus|temsirolimus|mesh-list
101800335|NCT00714623|MTOR Inhibitors|mtor inhibitors|mesh-list
101800336|NCT00714623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101800337|NCT00714623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101800338|NCT00714623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101800339|NCT00714623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101800340|NCT00714623|Antifungal Agents|antifungal agents|mesh-ancestor
101800341|NCT00714623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101800342|NCT00714623|Immunologic Factors|immunologic factors|mesh-ancestor
101800343|NCT00714623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800344|NCT00714623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101800345|NCT00714623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800346|NCT00714623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800347|NCT01022476|Raltegravir Potassium|raltegravir potassium|mesh-list
101800348|NCT01022476|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101800349|NCT01022476|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101800350|NCT01022476|Antiviral Agents|antiviral agents|mesh-ancestor
101800351|NCT01022476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101800352|NCT01022476|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101800353|NCT01022476|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101800354|NCT01022476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800355|NCT01022476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800356|NCT02575001|Hydrocortisone|hydrocortisone|mesh-list
101800357|NCT02575001|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101800358|NCT02575001|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101800359|NCT02575001|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101800360|NCT02575001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101800361|NCT01021930|Sirolimus|sirolimus|mesh-list
101800362|NCT01021930|Paclitaxel|paclitaxel|mesh-list
101800363|NCT01021930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101800364|NCT01021930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101800365|NCT01021930|Tubulin Modulators|tubulin modulators|mesh-ancestor
101800366|NCT01021930|Antimitotic Agents|antimitotic agents|mesh-ancestor
101800367|NCT01021930|Mitosis Modulators|mitosis modulators|mesh-ancestor
101800368|NCT01021930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800369|NCT01021930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101800370|NCT01021930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101800371|NCT01021930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101800372|NCT01021930|Antifungal Agents|antifungal agents|mesh-ancestor
101800373|NCT01021930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101800374|NCT01021930|Immunologic Factors|immunologic factors|mesh-ancestor
101800375|NCT01021930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800376|NCT00946764|Imipramine|imipramine|mesh-list
101800377|NCT00946764|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101800378|NCT00946764|Antidepressive Agents|antidepressive agents|mesh-ancestor
101800379|NCT00946764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101800380|NCT00946764|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101800381|NCT00946764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101800382|NCT00946764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101800383|NCT00946764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800384|NCT00946764|Adrenergic Agents|adrenergic agents|mesh-ancestor
101800385|NCT00946764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101800386|NCT00946764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800387|NCT00950820|Capecitabine|capecitabine|mesh-list
101800388|NCT00950820|Oxaliplatin|oxaliplatin|mesh-list
101800389|NCT00950820|Panitumumab|panitumumab|mesh-list
101800390|NCT00950820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101800391|NCT00950820|Antimetabolites|antimetabolites|mesh-ancestor
101800392|NCT00950820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800393|NCT00950820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101800394|NCT00950820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101800395|NCT00950898|Caffeine|caffeine|mesh-list
101800396|NCT00950898|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101800397|NCT00950898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800398|NCT00950898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101800399|NCT00950898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800400|NCT00950898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800401|NCT00950898|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101800402|NCT00950898|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101800403|NCT00950898|Purinergic Agents|purinergic agents|mesh-ancestor
101800404|NCT00950898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101800406|NCT00168805|Dabigatran|dabigatran|mesh-list
101800407|NCT00168805|Anticoagulants|anticoagulants|mesh-ancestor
101800408|NCT00168805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101800409|NCT00168805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101800410|NCT00168805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800411|NCT00168805|Antithrombins|antithrombins|mesh-ancestor
101800412|NCT00168805|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101800413|NCT00168805|Protease Inhibitors|protease inhibitors|mesh-ancestor
101800414|NCT00168805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800415|NCT00467584|Aspirin|aspirin|mesh-list
101800416|NCT00467584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101800417|NCT00467584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101800418|NCT00467584|Analgesics|analgesics|mesh-ancestor
101800419|NCT00467584|Sensory System Agents|sensory system agents|mesh-ancestor
101800420|NCT00467584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101800421|NCT00467584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800422|NCT00467584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101800423|NCT00467584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101800424|NCT00467584|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101800425|NCT00467584|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101800426|NCT00467584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800427|NCT00467584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101800428|NCT00467584|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101800429|NCT00467584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800430|NCT00467584|Antipyretics|antipyretics|mesh-ancestor
101800431|NCT02574611|Glycopyrrolate|glycopyrrolate|mesh-list
101800432|NCT02574611|Neostigmine|neostigmine|mesh-list
101800433|NCT02574611|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101800434|NCT02574611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800435|NCT02574611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800436|NCT02574611|Cholinergic Agents|cholinergic agents|mesh-ancestor
101800437|NCT02574611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101800438|NCT02574611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800439|NCT02574611|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101800440|NCT02574611|Autonomic Agents|autonomic agents|mesh-ancestor
101800441|NCT02574611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101800442|NCT02574611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101800443|NCT02574611|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101800444|NCT02574611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101800445|NCT00714779|Fluoxetine|fluoxetine|mesh-list
101800446|NCT00714779|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101800447|NCT00714779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101800448|NCT00714779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101800449|NCT00714779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800450|NCT00714779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101800451|NCT00714779|Serotonin Agents|serotonin agents|mesh-ancestor
101800452|NCT00714779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800453|NCT00714779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101800454|NCT00714779|Antidepressive Agents|antidepressive agents|mesh-ancestor
101800455|NCT00714779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101800456|NCT00714779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101800457|NCT00714779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101800458|NCT00714779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800459|NCT00168103|Complement C1s|complement c1s|mesh-list
101800460|NCT00168103|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
101800461|NCT00168103|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
101800462|NCT00168103|Immunologic Factors|immunologic factors|mesh-ancestor
101800463|NCT00168103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800464|NCT00168103|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101800465|NCT00168103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101800466|NCT00463060|Sunitinib|sunitinib|mesh-list
101800467|NCT00463060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101800468|NCT00463060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101800469|NCT00463060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101800470|NCT00463060|Growth Substances|growth substances|mesh-ancestor
101800471|NCT00463060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800472|NCT00463060|Growth Inhibitors|growth inhibitors|mesh-ancestor
101800473|NCT00463060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101800474|NCT00463060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800475|NCT00463060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800476|NCT03964753|Paclitaxel|paclitaxel|mesh-list
101800477|NCT03964753|Cisplatin|cisplatin|mesh-list
101800478|NCT03964753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101800479|NCT03964753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101800480|NCT03964753|Tubulin Modulators|tubulin modulators|mesh-ancestor
101800481|NCT03964753|Antimitotic Agents|antimitotic agents|mesh-ancestor
101800482|NCT03964753|Mitosis Modulators|mitosis modulators|mesh-ancestor
101800483|NCT03964753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800484|NCT00956748|Acetylcysteine|acetylcysteine|mesh-list
101800485|NCT00956748|Ciprofloxacin|ciprofloxacin|mesh-list
101800486|NCT00956748|Dexamethasone|dexamethasone|mesh-list
101800487|NCT00956748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101800489|NCT00956748|Autonomic Agents|autonomic agents|mesh-ancestor
101800490|NCT00956748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101800491|NCT00956748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800492|NCT00956748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101800493|NCT00956748|Glucocorticoids|glucocorticoids|mesh-ancestor
101800494|NCT00956748|Hormones|hormones|mesh-ancestor
101800495|NCT00956748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101800496|NCT00956748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101800497|NCT00956748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101800498|NCT00956748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800499|NCT00956748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800500|NCT00956748|Antiviral Agents|antiviral agents|mesh-ancestor
101800501|NCT00956748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101800502|NCT00956748|Expectorants|expectorants|mesh-ancestor
101800503|NCT00956748|Respiratory System Agents|respiratory system agents|mesh-ancestor
101800504|NCT00956748|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101800506|NCT00956748|Protective Agents|protective agents|mesh-ancestor
101800507|NCT00956748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101800508|NCT00956748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101800509|NCT00956748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101800510|NCT00956748|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101800511|NCT00956748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101800512|NCT01079923|Vitamin D|vitamin d|mesh-list
101800513|NCT01079923|Ergocalciferols|ergocalciferols|mesh-list
101800514|NCT01079923|Cholecalciferol|cholecalciferol|mesh-list
101800515|NCT01079923|Vitamins|vitamins|mesh-list
101800516|NCT01079923|Micronutrients|micronutrients|mesh-ancestor
101800517|NCT01079923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800518|NCT01079923|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101800519|NCT01079923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101800520|NCT00947076|Fluoxetine|fluoxetine|mesh-list
101800521|NCT00947076|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101800522|NCT00947076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101800523|NCT00947076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101800524|NCT00947076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800525|NCT00947076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101800526|NCT00947076|Serotonin Agents|serotonin agents|mesh-ancestor
101800527|NCT00947076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800528|NCT00947076|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101800529|NCT00947076|Antidepressive Agents|antidepressive agents|mesh-ancestor
101800530|NCT00947076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101800531|NCT00947076|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101800532|NCT00947076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101800533|NCT00947076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800534|NCT00462982|Sunitinib|sunitinib|mesh-list
101800535|NCT00462982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101800536|NCT00462982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101800537|NCT00462982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101800538|NCT00462982|Growth Substances|growth substances|mesh-ancestor
101800539|NCT00462982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800540|NCT00462982|Growth Inhibitors|growth inhibitors|mesh-ancestor
101800541|NCT00462982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101800542|NCT00462982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800543|NCT00462982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800544|NCT02573597|Sufentanil|sufentanil|mesh-list
101800545|NCT02573597|Bupivacaine|bupivacaine|mesh-list
101800546|NCT02573597|Anesthetics, Local|anesthetics, local|mesh-ancestor
101800547|NCT02573597|Anesthetics|anesthetics|mesh-ancestor
101800548|NCT02573597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101800549|NCT02573597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800550|NCT02573597|Sensory System Agents|sensory system agents|mesh-ancestor
101800551|NCT02573597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101800552|NCT02573597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101800553|NCT02573597|Narcotics|narcotics|mesh-ancestor
101800554|NCT02573597|Analgesics|analgesics|mesh-ancestor
101800555|NCT02573597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101800556|NCT02573597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101800557|NCT02573597|Anesthetics, General|anesthetics, general|mesh-ancestor
101800559|NCT05300958|Siderophores|siderophores|mesh-ancestor
101800560|NCT05300958|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101800561|NCT05300958|Chelating Agents|chelating agents|mesh-ancestor
101800562|NCT05300958|Sequestering Agents|sequestering agents|mesh-ancestor
101800563|NCT05300958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800564|NCT04070729|Hyaluronic Acid|hyaluronic acid|mesh-list
101800565|NCT04070729|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101800566|NCT04070729|Immunologic Factors|immunologic factors|mesh-ancestor
101800567|NCT04070729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800568|NCT04070729|Viscosupplements|viscosupplements|mesh-ancestor
101800569|NCT04070729|Protective Agents|protective agents|mesh-ancestor
101800570|NCT00467272|Daptomycin|daptomycin|mesh-list
101800571|NCT00467272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101800572|NCT00467272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101800573|NCT00956982|Interferons|interferons|mesh-list
101800574|NCT00956982|Ribavirin|ribavirin|mesh-list
101800575|NCT00956982|Interferon-alpha|interferon-alpha|mesh-list
101800576|NCT00956982|Interferon alpha-2|interferon alpha-2|mesh-list
101800577|NCT00956982|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101800578|NCT00956982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101800579|NCT00956982|Antiviral Agents|antiviral agents|mesh-ancestor
101800580|NCT00956982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101800581|NCT00956982|Antimetabolites|antimetabolites|mesh-ancestor
101800582|NCT00956982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800583|NCT00956982|Immunologic Factors|immunologic factors|mesh-ancestor
101800584|NCT00956982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800585|NCT00714857|Dexmedetomidine|dexmedetomidine|mesh-list
101800586|NCT00714857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101800587|NCT00714857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101800588|NCT00714857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800589|NCT00714857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101800590|NCT00714857|Analgesics|analgesics|mesh-ancestor
101800591|NCT00714857|Sensory System Agents|sensory system agents|mesh-ancestor
101800592|NCT00714857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101800593|NCT00714857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101800594|NCT00714857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101800595|NCT00714857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101800596|NCT00714857|Adrenergic Agents|adrenergic agents|mesh-ancestor
101800597|NCT00714857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101800598|NCT00714857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800599|NCT00957060|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101800600|NCT00957060|Glimepiride|glimepiride|mesh-list
101800601|NCT00957060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101800602|NCT00957060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800603|NCT00957060|Incretins|incretins|mesh-ancestor
101800604|NCT00957060|Hormones|hormones|mesh-ancestor
101800605|NCT00957060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101800606|NCT00957060|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101800607|NCT00957060|Protease Inhibitors|protease inhibitors|mesh-ancestor
101800608|NCT00957060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800609|NCT00957060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800610|NCT00957060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101800611|NCT00957060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101800612|NCT00957060|Immunologic Factors|immunologic factors|mesh-ancestor
101800613|NCT02573519|Acetylcholine|acetylcholine|mesh-list
101800614|NCT02573519|Donepezil|donepezil|mesh-list
101800615|NCT02573519|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
101311030|NCT00006372|Mitosis Modulators|mitosis modulators|mesh-ancestor
101800616|NCT02573519|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101800617|NCT02573519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800618|NCT02573519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800619|NCT02573519|Cholinergic Agents|cholinergic agents|mesh-ancestor
101800620|NCT02573519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101800621|NCT02573519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800622|NCT02573519|Nootropic Agents|nootropic agents|mesh-ancestor
101800623|NCT02573519|Vasodilator Agents|vasodilator agents|mesh-ancestor
101800624|NCT02573519|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101800625|NCT02572583|Oseltamivir|oseltamivir|mesh-list
101800626|NCT02572583|Antiviral Agents|antiviral agents|mesh-ancestor
101800627|NCT02572583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101800628|NCT02572583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800629|NCT02572583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800630|NCT00951444|Carboplatin|carboplatin|mesh-list
101800631|NCT00951444|Gemcitabine|gemcitabine|mesh-list
101800632|NCT00951444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101800633|NCT00951444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101800634|NCT00951444|Antimetabolites|antimetabolites|mesh-ancestor
101800635|NCT00951444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800636|NCT00462826|Aflibercept|aflibercept|mesh-list
101800637|NCT00462826|Endothelial Growth Factors|endothelial growth factors|mesh-list
101800638|NCT00462826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101800639|NCT00462826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101800640|NCT00462826|Growth Substances|growth substances|mesh-ancestor
101809471|NCT05914506|Anesthetics|anesthetics|mesh-ancestor
101800641|NCT00462826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800642|NCT00462826|Growth Inhibitors|growth inhibitors|mesh-ancestor
101800643|NCT00462826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101800645|NCT00718601|Motesanib diphosphate|motesanib diphosphate|mesh-list
101800646|NCT00718601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800647|NCT00718601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800648|NCT00718601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101800649|NCT00947388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101800650|NCT00947388|Alemtuzumab|alemtuzumab|mesh-list
101800651|NCT00947388|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101800652|NCT00947388|Antibodies|antibodies|mesh-list
101800653|NCT00947388|Immunoglobulins|immunoglobulins|mesh-list
101800654|NCT00947388|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101800655|NCT00947388|Immunologic Factors|immunologic factors|mesh-ancestor
101800656|NCT00947388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800657|NCT00947388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101800658|NCT00947388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101800659|NCT00947388|Alkylating Agents|alkylating agents|mesh-ancestor
101800660|NCT00947388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800661|NCT00951600|Oxcarbazepine|oxcarbazepine|mesh-list
101800662|NCT00951600|Anticonvulsants|anticonvulsants|mesh-ancestor
101800663|NCT00951600|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101800664|NCT00951600|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101800665|NCT00951600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101800666|NCT00951600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800667|NCT00951600|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101800668|NCT00951600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101800669|NCT03910985|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
101800670|NCT03910985|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101800671|NCT03910985|Autonomic Agents|autonomic agents|mesh-ancestor
101800672|NCT03910985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101800673|NCT03910985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800674|NCT03910985|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101800675|NCT03910985|Respiratory System Agents|respiratory system agents|mesh-ancestor
101800676|NCT00957216|Ubiquinone|ubiquinone|mesh-list
101800677|NCT00957216|Coenzyme Q10|coenzyme q10|mesh-list
101800678|NCT00957216|Micronutrients|micronutrients|mesh-ancestor
101800679|NCT00957216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800680|NCT00957216|Vitamins|vitamins|mesh-ancestor
101800681|NCT00718757|Dexamethasone|dexamethasone|mesh-list
101800682|NCT00718757|Irinotecan|irinotecan|mesh-list
101800683|NCT00718757|Vincristine|vincristine|mesh-list
101800684|NCT00718757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101800685|NCT00718757|Antiemetics|antiemetics|mesh-ancestor
101800686|NCT00718757|Autonomic Agents|autonomic agents|mesh-ancestor
101800687|NCT00718757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101800688|NCT00718757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800689|NCT00718757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101800690|NCT00718757|Glucocorticoids|glucocorticoids|mesh-ancestor
101800692|NCT00718757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101800693|NCT00718757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101800694|NCT00718757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101800695|NCT00718757|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101800696|NCT00718757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101800697|NCT00718757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800698|NCT00718757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800699|NCT00718757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101800700|NCT00718757|Tubulin Modulators|tubulin modulators|mesh-ancestor
101800701|NCT00718757|Antimitotic Agents|antimitotic agents|mesh-ancestor
101800702|NCT00718757|Mitosis Modulators|mitosis modulators|mesh-ancestor
101800704|NCT00947466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101800705|NCT00947466|Narcotics|narcotics|mesh-ancestor
101800706|NCT00947466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101800707|NCT00947466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809474|NCT05913817|Adalimumab|adalimumab|mesh-list
101800708|NCT00947466|Analgesics|analgesics|mesh-ancestor
101800709|NCT00947466|Sensory System Agents|sensory system agents|mesh-ancestor
101800710|NCT00947466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101800711|NCT00947466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101800712|NCT00951834|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
101800713|NCT00951834|Antioxidants|antioxidants|mesh-ancestor
101800714|NCT00951834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800715|NCT00951834|Protective Agents|protective agents|mesh-ancestor
101800716|NCT00951834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800717|NCT00951834|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101800718|NCT00951834|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101800719|NCT00951834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101800720|NCT00951834|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101800721|NCT00715013|Epothilone B|epothilone b|mesh-list
101800722|NCT00715013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101800723|NCT00715013|Tubulin Modulators|tubulin modulators|mesh-ancestor
101800724|NCT00715013|Antimitotic Agents|antimitotic agents|mesh-ancestor
101800725|NCT00715013|Mitosis Modulators|mitosis modulators|mesh-ancestor
101800726|NCT00715013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800727|NCT00715091|Diclofenac|diclofenac|mesh-list
101800728|NCT00715091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101800729|NCT00715091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101800730|NCT00715091|Analgesics|analgesics|mesh-ancestor
101800731|NCT00715091|Sensory System Agents|sensory system agents|mesh-ancestor
101800732|NCT00715091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101800733|NCT00715091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800734|NCT00715091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101800735|NCT00715091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101800736|NCT00715091|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101800737|NCT00715091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800738|NCT00715091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800739|NCT00718913|Docetaxel|docetaxel|mesh-list
101800740|NCT00718913|Capecitabine|capecitabine|mesh-list
101800741|NCT00718913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101800742|NCT00718913|Tubulin Modulators|tubulin modulators|mesh-ancestor
101800743|NCT00718913|Antimitotic Agents|antimitotic agents|mesh-ancestor
101800744|NCT00718913|Mitosis Modulators|mitosis modulators|mesh-ancestor
101800745|NCT00718913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800746|NCT00718913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101800747|NCT00718913|Antimetabolites|antimetabolites|mesh-ancestor
101800748|NCT04011930|Vitamin D|vitamin d|mesh-list
101800749|NCT04011930|Cholecalciferol|cholecalciferol|mesh-list
101800750|NCT04011930|Calcitriol|calcitriol|mesh-list
101800751|NCT04011930|Vitamins|vitamins|mesh-ancestor
101800752|NCT04011930|Micronutrients|micronutrients|mesh-ancestor
101800753|NCT04011930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800754|NCT04011930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101800755|NCT04011930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101364803|NCT00148564|Serotonin Agents|serotonin agents|mesh-ancestor
101800756|NCT04011930|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101800757|NCT04011930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101800758|NCT04011930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800759|NCT04011930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101800760|NCT00551616|Levonorgestrel|levonorgestrel|mesh-list
101800761|NCT00551616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101800762|NCT00551616|Contraceptive Agents|contraceptive agents|mesh-ancestor
101800763|NCT00551616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101800764|NCT00551616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800765|NCT00551616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101800766|NCT00551616|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101800767|NCT00551616|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101800768|NCT02574221|Fluorides|fluorides|mesh-list
101800769|NCT02574221|Tin Fluorides|tin fluorides|mesh-list
101800770|NCT02574221|Cariostatic Agents|cariostatic agents|mesh-ancestor
101800771|NCT02574221|Protective Agents|protective agents|mesh-ancestor
101800772|NCT02574221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800773|NCT00452530|Enoxaparin|enoxaparin|mesh-list
101800774|NCT00452530|Enoxaparin sodium|enoxaparin sodium|mesh-list
101800775|NCT00452530|Apixaban|apixaban|mesh-list
101800776|NCT00452530|Anticoagulants|anticoagulants|mesh-ancestor
101800777|NCT00452530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101800778|NCT00452530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101800779|NCT00452530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800780|NCT00452530|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101800781|NCT00452530|Antithrombins|antithrombins|mesh-ancestor
101800782|NCT00452530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101800783|NCT00452530|Protease Inhibitors|protease inhibitors|mesh-ancestor
101800784|NCT00452530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800785|NCT00549198|Tenofovir|tenofovir|mesh-list
101800786|NCT00549198|Lamivudine|lamivudine|mesh-list
101800787|NCT00549198|Emtricitabine|emtricitabine|mesh-list
101800788|NCT00549198|Efavirenz|efavirenz|mesh-list
101800789|NCT00549198|Abacavir|abacavir|mesh-list
101800790|NCT00549198|Antiviral Agents|antiviral agents|mesh-ancestor
101800791|NCT00549198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101800792|NCT00549198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101800793|NCT00549198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101800794|NCT00549198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800795|NCT00549198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800796|NCT00549198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101800797|NCT00549198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101800798|NCT00549198|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101800799|NCT00549198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101800800|NCT00549198|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101800801|NCT00549198|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101800802|NCT00549198|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101800803|NCT00549198|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101800804|NCT00506415|Rivastigmine|rivastigmine|mesh-list
101800805|NCT00506415|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101800806|NCT00506415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800807|NCT00506415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800808|NCT00506415|Cholinergic Agents|cholinergic agents|mesh-ancestor
101800809|NCT00506415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101800810|NCT00506415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800811|NCT00506415|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101800812|NCT00506415|Protective Agents|protective agents|mesh-ancestor
101800813|NCT04036526|Vaccines|vaccines|mesh-list
101800814|NCT04036526|Immunologic Factors|immunologic factors|mesh-ancestor
101800815|NCT04036526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800816|NCT00452452|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101800817|NCT00452452|Immunologic Factors|immunologic factors|mesh-ancestor
101800818|NCT00452452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800819|NCT01009437|Ritonavir|ritonavir|mesh-list
101800820|NCT01009437|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101800821|NCT01009437|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101800822|NCT01009437|Protease Inhibitors|protease inhibitors|mesh-ancestor
101800823|NCT01009437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800824|NCT01009437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800825|NCT01009437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101800826|NCT01009437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101800827|NCT01009437|Antiviral Agents|antiviral agents|mesh-ancestor
101800828|NCT01009437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101800829|NCT01009437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101800830|NCT01009437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101800831|NCT00719381|Pioglitazone|pioglitazone|mesh-list
101800832|NCT00719381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101800833|NCT00719381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800834|NCT00510783|Phenytoin|phenytoin|mesh-list
101800835|NCT00510783|Fosphenytoin|fosphenytoin|mesh-list
101800836|NCT00510783|Levetiracetam|levetiracetam|mesh-list
101800837|NCT00510783|Anticonvulsants|anticonvulsants|mesh-ancestor
101800838|NCT00510783|Nootropic Agents|nootropic agents|mesh-ancestor
101800839|NCT00510783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101800840|NCT00510783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101800841|NCT00510783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101800842|NCT00510783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800843|NCT00510783|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101800844|NCT00510783|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101800845|NCT00952302|Iron|iron|mesh-list
101800846|NCT00952302|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101800847|NCT00952302|Trace Elements|trace elements|mesh-ancestor
101800848|NCT00952302|Micronutrients|micronutrients|mesh-ancestor
101800849|NCT00952302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800850|NCT00952302|Hematinics|hematinics|mesh-ancestor
101800851|NCT00518973|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101800852|NCT00518973|Antidepressive Agents|antidepressive agents|mesh-ancestor
101800853|NCT00518973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101800854|NCT00518973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101800855|NCT00518973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101800856|NCT00518973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101800857|NCT00518973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800858|NCT05300334|Adenosine|adenosine|mesh-list
101800859|NCT05300334|Analgesics|analgesics|mesh-ancestor
101800860|NCT05300334|Sensory System Agents|sensory system agents|mesh-ancestor
101800861|NCT05300334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101800862|NCT05300334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800863|NCT05300334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101800864|NCT05300334|Vasodilator Agents|vasodilator agents|mesh-ancestor
101800865|NCT05300334|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101800866|NCT05300334|Purinergic Agonists|purinergic agonists|mesh-ancestor
101800867|NCT05300334|Purinergic Agents|purinergic agents|mesh-ancestor
101800868|NCT05300334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101800869|NCT05300334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800870|NCT00897884|Metformin|metformin|mesh-list
101800871|NCT00897884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101800872|NCT00897884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800873|NCT01022164|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101800874|NCT01022164|Hemostatics|hemostatics|mesh-ancestor
101800875|NCT01022164|Coagulants|coagulants|mesh-ancestor
101800876|NCT01012479|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101800877|NCT01012479|Candesartan|candesartan|mesh-list
101800878|NCT01012479|Candesartan cilexetil|candesartan cilexetil|mesh-list
101800879|NCT01012479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101800880|NCT01012479|Diuretics|diuretics|mesh-ancestor
101800881|NCT01012479|Natriuretic Agents|natriuretic agents|mesh-ancestor
101800882|NCT01012479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800883|NCT01012479|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101800884|NCT01012479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101800885|NCT01012479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800886|NCT01012479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101800887|NCT01012479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101800888|NCT02541734|Exenatide|exenatide|mesh-list
101800889|NCT02541734|Polygeline|polygeline|mesh-list
101800890|NCT02541734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101800891|NCT02541734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800892|NCT02541734|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101800893|NCT02541734|Incretins|incretins|mesh-ancestor
101800894|NCT02541734|Hormones|hormones|mesh-ancestor
101800895|NCT02541734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101800896|NCT02541734|Plasma Substitutes|plasma substitutes|mesh-ancestor
101800897|NCT02541734|Blood Substitutes|blood substitutes|mesh-ancestor
101800898|NCT00462670|Tolvaptan|tolvaptan|mesh-list
101800899|NCT00462670|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101800900|NCT00462670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800901|NCT00462670|Natriuretic Agents|natriuretic agents|mesh-ancestor
101800902|NCT00462670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800903|NCT01009593|Sorafenib|sorafenib|mesh-list
101800904|NCT01009593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311042|NCT00006381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101800905|NCT01009593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101800906|NCT01009593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800907|NCT01009593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800908|NCT00719459|Iron|iron|mesh-list
101800909|NCT00719459|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101800910|NCT00719459|Trace Elements|trace elements|mesh-ancestor
101800911|NCT00719459|Micronutrients|micronutrients|mesh-ancestor
101800912|NCT00719459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800913|NCT00719459|Hematinics|hematinics|mesh-ancestor
101800914|NCT00711503|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101800915|NCT00711503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101800916|NCT00948168|Exenatide|exenatide|mesh-list
101800917|NCT00948168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101800918|NCT00948168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800919|NCT00948168|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101800920|NCT00948168|Incretins|incretins|mesh-ancestor
101800921|NCT00948168|Hormones|hormones|mesh-ancestor
101800922|NCT00948168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101800923|NCT00958386|Irinotecan|irinotecan|mesh-list
101800924|NCT00958386|Panitumumab|panitumumab|mesh-list
101800925|NCT00958386|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101800926|NCT00958386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101800927|NCT00958386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800928|NCT00958386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800929|NCT00958386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101800930|NCT00958386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101800932|NCT00719693|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101800933|NCT00719693|Fenofibric acid|fenofibric acid|mesh-list
101800934|NCT00719693|Fenofibrate|fenofibrate|mesh-list
101800935|NCT00719693|Calcium|calcium|mesh-list
101800936|NCT00719693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101800937|NCT00719693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800938|NCT00719693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101800939|NCT00719693|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101800940|NCT00719693|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101800941|NCT00719693|Antimetabolites|antimetabolites|mesh-ancestor
101800942|NCT00719693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800943|NCT00719693|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101800944|NCT00719693|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101800945|NCT00719693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800946|NCT00948402|Metformin|metformin|mesh-list
101800947|NCT00948402|Biguanides|biguanides|mesh-list
101800948|NCT00948402|Contraceptive Agents|contraceptive agents|mesh-list
101800949|NCT00948402|Contraceptives, Oral|contraceptives, oral|mesh-list
101800950|NCT00948402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101800951|NCT00948402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800952|NCT00948402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101800954|NCT05352126|Disinfectants|disinfectants|mesh-list
101800955|NCT05352126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101800956|NCT00948480|Sargramostim|sargramostim|mesh-list
101800957|NCT00948480|Immunologic Factors|immunologic factors|mesh-ancestor
101800958|NCT00948480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800959|NCT03753555|Calcium, Dietary|calcium, dietary|mesh-list
101800960|NCT03753555|Atorvastatin|atorvastatin|mesh-list
101800961|NCT03753555|Probucol|probucol|mesh-list
101800962|NCT03753555|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
101800963|NCT03753555|Calcium|calcium|mesh-list
101809522|NCT05882812|Diclofenac|diclofenac|mesh-list
101800964|NCT03753555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101800965|NCT03753555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800966|NCT03753555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101800967|NCT03753555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101800968|NCT03753555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101800969|NCT03753555|Antimetabolites|antimetabolites|mesh-ancestor
101800970|NCT03753555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800971|NCT03753555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101800972|NCT03753555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101800973|NCT03753555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101800974|NCT03753555|Antioxidants|antioxidants|mesh-ancestor
101800975|NCT03753555|Protective Agents|protective agents|mesh-ancestor
101800976|NCT03753555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101800977|NCT03753555|Protease Inhibitors|protease inhibitors|mesh-ancestor
101800978|NCT00606086|Interferons|interferons|mesh-list
101800979|NCT00606086|Ribavirin|ribavirin|mesh-list
101800980|NCT00606086|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101800981|NCT00606086|Interferon-alpha|interferon-alpha|mesh-list
101800982|NCT00606086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101800983|NCT00606086|Antiviral Agents|antiviral agents|mesh-ancestor
101800984|NCT00606086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101800985|NCT00606086|Antimetabolites|antimetabolites|mesh-ancestor
101800986|NCT00606086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800987|NCT00606086|Immunologic Factors|immunologic factors|mesh-ancestor
101333774|NCT00040690|Antidotes|antidotes|mesh-ancestor
101800988|NCT00606086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101800989|NCT02573363|Cytarabine|cytarabine|mesh-list
101800990|NCT02573363|Mitoxantrone|mitoxantrone|mesh-list
101800991|NCT02573363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101800992|NCT02573363|Antimetabolites|antimetabolites|mesh-ancestor
101800993|NCT02573363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101800994|NCT02573363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101800995|NCT02573363|Antiviral Agents|antiviral agents|mesh-ancestor
101800996|NCT02573363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101800997|NCT02573363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101800998|NCT02573363|Immunologic Factors|immunologic factors|mesh-ancestor
101800999|NCT02573363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801000|NCT02573363|Analgesics|analgesics|mesh-ancestor
101801001|NCT02573363|Sensory System Agents|sensory system agents|mesh-ancestor
101801002|NCT02573363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101801003|NCT02573363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101801004|NCT02573363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101801005|NCT02573363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801006|NCT00715637|Cytarabine|cytarabine|mesh-list
101801007|NCT00715637|Amonafide|amonafide|mesh-list
101801008|NCT00715637|Daunorubicin|daunorubicin|mesh-list
101801009|NCT00715637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101801010|NCT00715637|Antimetabolites|antimetabolites|mesh-ancestor
101801011|NCT00715637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801012|NCT00715637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101801013|NCT00715637|Antiviral Agents|antiviral agents|mesh-ancestor
101801014|NCT00715637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101801015|NCT00715637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101801016|NCT00715637|Immunologic Factors|immunologic factors|mesh-ancestor
101801017|NCT00715637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801018|NCT00715637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101809529|NCT05882812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101801019|NCT00715637|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101801020|NCT00715637|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101801021|NCT00715637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801022|NCT05300490|Prednisolone|prednisolone|mesh-list
101801023|NCT05300490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101801024|NCT05300490|Glucocorticoids|glucocorticoids|mesh-ancestor
101801025|NCT05300490|Hormones|hormones|mesh-ancestor
101801026|NCT05300490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101801027|NCT05300490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801028|NCT05300490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101801029|NCT05300490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101801030|NCT00893594|Naproxen|naproxen|mesh-list
101801031|NCT00893594|Sumatriptan|sumatriptan|mesh-list
101801032|NCT00893594|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101801033|NCT00893594|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101801034|NCT00893594|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101801035|NCT00893594|Serotonin Agents|serotonin agents|mesh-ancestor
101801036|NCT00893594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101801037|NCT00893594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801038|NCT00893594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801039|NCT00893594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101801040|NCT00893594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101801041|NCT00893594|Analgesics|analgesics|mesh-ancestor
101801042|NCT00893594|Sensory System Agents|sensory system agents|mesh-ancestor
101801043|NCT00893594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101801044|NCT00893594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101801045|NCT00893594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101801046|NCT00893594|Gout Suppressants|gout suppressants|mesh-ancestor
101801047|NCT00893594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101801048|NCT00893594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801049|NCT00715715|Prednisone|prednisone|mesh-list
101801050|NCT00715715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101801051|NCT00715715|Glucocorticoids|glucocorticoids|mesh-ancestor
101801052|NCT00715715|Hormones|hormones|mesh-ancestor
101311046|NCT00006381|Sensory System Agents|sensory system agents|mesh-ancestor
101801053|NCT00715715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101801054|NCT00715715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801055|NCT00715715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101801056|NCT00715715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101801057|NCT00953394|Octreotide|octreotide|mesh-list
101801058|NCT00953394|Fluorouracil|fluorouracil|mesh-list
101801059|NCT00953394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101801060|NCT00953394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101801061|NCT00953394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101801062|NCT00953394|Antimetabolites|antimetabolites|mesh-ancestor
101801063|NCT00953394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801064|NCT00953394|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101801065|NCT00953394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101801066|NCT00953394|Immunologic Factors|immunologic factors|mesh-ancestor
101801067|NCT00953394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801068|NCT00720161|Metformin|metformin|mesh-list
101801069|NCT00720161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101801070|NCT00720161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801071|NCT00898508|Antibodies|antibodies|mesh-list
101801072|NCT00898508|Immunologic Factors|immunologic factors|mesh-ancestor
101801073|NCT00898508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801074|NCT00609986|Insulin|insulin|mesh-list
101801075|NCT00609986|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101801076|NCT00609986|Insulin Glargine|insulin glargine|mesh-list
101801077|NCT00609986|Insulin, Isophane|insulin, isophane|mesh-list
101801078|NCT00609986|Isophane Insulin, Human|isophane insulin, human|mesh-list
101458406|NCT04612582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101801079|NCT00609986|Isophane insulin, beef|isophane insulin, beef|mesh-list
101801080|NCT00609986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101801081|NCT00609986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801082|NCT00715871|Nicotine|nicotine|mesh-list
101801083|NCT00715871|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101801084|NCT00715871|Autonomic Agents|autonomic agents|mesh-ancestor
101801085|NCT00715871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101801086|NCT00715871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801087|NCT00715871|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101801088|NCT00715871|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101801089|NCT00715871|Cholinergic Agents|cholinergic agents|mesh-ancestor
101801090|NCT00715871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101801091|NCT00715871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801092|NCT00712049|Nicotinic Acids|nicotinic acids|mesh-list
101801094|NCT00712049|Niacinamide|niacinamide|mesh-list
101801095|NCT00712049|Simvastatin|simvastatin|mesh-list
101801096|NCT00712049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101801097|NCT00712049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101801098|NCT00712049|Antimetabolites|antimetabolites|mesh-ancestor
101801099|NCT00712049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801100|NCT00712049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101801101|NCT00712049|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101801102|NCT00712049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801103|NCT00712049|Vitamin B Complex|vitamin b complex|mesh-ancestor
101801104|NCT00712049|Vitamins|vitamins|mesh-ancestor
101801105|NCT00712049|Micronutrients|micronutrients|mesh-ancestor
101801106|NCT00712049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801107|NCT00712049|Vasodilator Agents|vasodilator agents|mesh-ancestor
101801108|NCT00712205|Calcitriol|calcitriol|mesh-list
101828154|NCT05923996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101801109|NCT00712205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101801110|NCT00712205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801111|NCT00712205|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101801112|NCT00712205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101801113|NCT00712205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801114|NCT00712205|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101801115|NCT00712205|Vitamins|vitamins|mesh-ancestor
101801116|NCT00712205|Micronutrients|micronutrients|mesh-ancestor
101801117|NCT00712205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101801118|NCT00451906|Bevacizumab|bevacizumab|mesh-list
101801119|NCT00451906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101801120|NCT00451906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101801121|NCT00451906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101801122|NCT00451906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101801124|NCT00451906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801125|NCT00451906|Growth Inhibitors|growth inhibitors|mesh-ancestor
101801126|NCT04070495|Clarithromycin|clarithromycin|mesh-list
101801127|NCT04070495|Rifampin|rifampin|mesh-list
101801128|NCT04070495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101801129|NCT04070495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101801130|NCT04070495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101801131|NCT04070495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801132|NCT04070495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801133|NCT04070495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101801134|NCT04070495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101801135|NCT04070495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101801136|NCT04070495|Antitubercular Agents|antitubercular agents|mesh-ancestor
101801137|NCT04070495|Leprostatic Agents|leprostatic agents|mesh-ancestor
101801138|NCT04070495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101801139|NCT04070495|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101801140|NCT04070495|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101801141|NCT04070495|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101801142|NCT04070495|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101801143|NCT04070495|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101801144|NCT04070495|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101801148|NCT00712439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101801149|NCT00712439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801150|NCT00712439|Anticonvulsants|anticonvulsants|mesh-ancestor
101801151|NCT00712439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101801152|NCT00712439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101801153|NCT00712439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101801155|NCT00712439|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101801156|NCT00712439|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101801157|NCT00712439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101801158|NCT00712439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801159|NCT00712439|Antimanic Agents|antimanic agents|mesh-ancestor
101801160|NCT00716183|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101801161|NCT00716183|Amoxicillin|amoxicillin|mesh-list
101801162|NCT00716183|Clavulanic Acids|clavulanic acids|mesh-list
101801163|NCT00716183|Clavulanic Acid|clavulanic acid|mesh-list
101801164|NCT00716183|Lactams|lactams|mesh-list
101801165|NCT00716183|beta-Lactams|beta-lactams|mesh-list
101801166|NCT00716183|Cloxacillin|cloxacillin|mesh-list
101801167|NCT00716183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101801168|NCT00716183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801169|NCT00716183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801170|NCT00716183|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101801171|NCT00712517|Propofol|propofol|mesh-list
101801172|NCT00712517|Sevoflurane|sevoflurane|mesh-list
101801173|NCT00712517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101801174|NCT00712517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101801175|NCT00712517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801176|NCT00712517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101801177|NCT00712517|Anesthetics, General|anesthetics, general|mesh-ancestor
101801178|NCT00712517|Anesthetics|anesthetics|mesh-ancestor
101801179|NCT00712517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101801180|NCT00712517|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101801181|NCT00712595|Mifepristone|mifepristone|mesh-list
101801182|NCT00712595|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101801183|NCT00712595|Abortifacient Agents|abortifacient agents|mesh-ancestor
101801184|NCT00712595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101801185|NCT00712595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801186|NCT00712595|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101801187|NCT00712595|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101801188|NCT00712595|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101801189|NCT00712595|Contraceptive Agents|contraceptive agents|mesh-ancestor
101801190|NCT00712595|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101801191|NCT00712595|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101801192|NCT00712595|Hormone Antagonists|hormone antagonists|mesh-ancestor
101311055|NCT00006384|Interferons|interferons|mesh-list
101801193|NCT00712595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101801194|NCT00712595|Luteolytic Agents|luteolytic agents|mesh-ancestor
101801195|NCT00712595|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101801196|NCT00712595|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101801197|NCT00115765|Bevacizumab|bevacizumab|mesh-list
101801198|NCT00115765|Panitumumab|panitumumab|mesh-list
101801199|NCT00115765|Oxaliplatin|oxaliplatin|mesh-list
101801200|NCT00115765|Irinotecan|irinotecan|mesh-list
101801201|NCT00115765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101801202|NCT00115765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101801203|NCT00115765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101801204|NCT00115765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101801205|NCT00115765|Growth Substances|growth substances|mesh-ancestor
101801206|NCT00115765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801207|NCT00115765|Growth Inhibitors|growth inhibitors|mesh-ancestor
101801208|NCT00115765|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101801209|NCT00115765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101801210|NCT00115765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801211|NCT00115765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801212|NCT00606008|Sunitinib|sunitinib|mesh-list
101801213|NCT00606008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101801214|NCT00606008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101801215|NCT00606008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101801216|NCT00606008|Growth Substances|growth substances|mesh-ancestor
101801217|NCT00606008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801218|NCT00606008|Growth Inhibitors|growth inhibitors|mesh-ancestor
101801219|NCT00606008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101801220|NCT00606008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801221|NCT00606008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801222|NCT00461812|Mometasone Furoate|mometasone furoate|mesh-list
101801223|NCT00461812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101801224|NCT00461812|Dermatologic Agents|dermatologic agents|mesh-ancestor
101801225|NCT00461812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101801226|NCT00721331|Mometasone Furoate|mometasone furoate|mesh-list
101801227|NCT00721331|Loratadine|loratadine|mesh-list
101801228|NCT00721331|Nortriptyline|nortriptyline|mesh-list
101801229|NCT00721331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101801230|NCT00721331|Dermatologic Agents|dermatologic agents|mesh-ancestor
101801231|NCT00721331|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101801232|NCT00721331|Antipruritics|antipruritics|mesh-ancestor
101801233|NCT00721331|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101801234|NCT00721331|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101801235|NCT00721331|Histamine Antagonists|histamine antagonists|mesh-ancestor
101801236|NCT00721331|Histamine Agents|histamine agents|mesh-ancestor
101801237|NCT00721331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101801238|NCT00721331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801239|NCT00721331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801240|NCT00721331|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101801241|NCT00721331|Antidepressive Agents|antidepressive agents|mesh-ancestor
101801242|NCT00721331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101801243|NCT00721331|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101801244|NCT00721331|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101801245|NCT00721331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101801246|NCT00721331|Adrenergic Agents|adrenergic agents|mesh-ancestor
101801247|NCT00123955|Spironolactone|spironolactone|mesh-list
101801248|NCT00123955|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101801249|NCT00123955|Hormone Antagonists|hormone antagonists|mesh-ancestor
101801250|NCT00123955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101801251|NCT00123955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801252|NCT00123955|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101801253|NCT00123955|Diuretics|diuretics|mesh-ancestor
101801254|NCT00123955|Natriuretic Agents|natriuretic agents|mesh-ancestor
101801255|NCT01027546|Tranexamic Acid|tranexamic acid|mesh-list
101801256|NCT01027546|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101801257|NCT01027546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101801258|NCT01027546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801259|NCT01027546|Hemostatics|hemostatics|mesh-ancestor
101801260|NCT01027546|Coagulants|coagulants|mesh-ancestor
101801261|NCT00115063|Orlistat|orlistat|mesh-list
101801262|NCT00115063|Sibutramine|sibutramine|mesh-list
101801263|NCT00115063|Diethylpropion|diethylpropion|mesh-list
101801264|NCT00115063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801265|NCT00115063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801267|NCT00115063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101801268|NCT00115063|Antidepressive Agents|antidepressive agents|mesh-ancestor
101801269|NCT00115063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101801270|NCT00115063|Appetite Depressants|appetite depressants|mesh-ancestor
101801271|NCT01026064|Azithromycin|azithromycin|mesh-list
101801272|NCT01026064|Cantharidin|cantharidin|mesh-list
101801273|NCT01026064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101801274|NCT01026064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101801275|NCT01026064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801276|NCT01026064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801277|NCT02571959|Amoxicillin|amoxicillin|mesh-list
101801278|NCT02571959|Clavulanic Acids|clavulanic acids|mesh-list
101801279|NCT02571959|Clavulanic Acid|clavulanic acid|mesh-list
101801280|NCT02571959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101801281|NCT02571959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101801282|NCT02571959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801283|NCT02571959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801284|NCT02571959|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101801285|NCT00461500|Fluticasone|fluticasone|mesh-list
101801286|NCT00461500|Xhance|xhance|mesh-list
101801287|NCT00461500|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101801288|NCT00461500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101801289|NCT00461500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101801290|NCT00461500|Autonomic Agents|autonomic agents|mesh-ancestor
101801291|NCT00461500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101801292|NCT00461500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801293|NCT00461500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101801294|NCT00461500|Respiratory System Agents|respiratory system agents|mesh-ancestor
101801295|NCT00461500|Dermatologic Agents|dermatologic agents|mesh-ancestor
101801296|NCT00461500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101801297|NCT00461500|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101801298|NCT00461500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101801299|NCT00461500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101801300|NCT00461500|Adrenergic Agents|adrenergic agents|mesh-ancestor
101801301|NCT00461500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101801302|NCT00461500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801303|NCT00893906|Vaccines|vaccines|mesh-list
101801304|NCT00893906|Immunologic Factors|immunologic factors|mesh-ancestor
101801305|NCT00893906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801306|NCT00721487|Fluconazole|fluconazole|mesh-list
101801307|NCT00721487|Antifungal Agents|antifungal agents|mesh-ancestor
101801308|NCT00721487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101801309|NCT00721487|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101801310|NCT00721487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101801311|NCT00721487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801312|NCT00721487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801313|NCT00721487|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101801314|NCT00721487|Hormone Antagonists|hormone antagonists|mesh-ancestor
101801315|NCT00721487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101801316|NCT00721487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801317|NCT00721487|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101801318|NCT00721487|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101801319|NCT00167245|Topiramate|topiramate|mesh-list
101801320|NCT00167245|Anticonvulsants|anticonvulsants|mesh-ancestor
101801321|NCT00167245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101809610|NCT05525858|Bevacizumab|bevacizumab|mesh-list
101801323|NCT00894062|Everolimus|everolimus|mesh-list
101801324|NCT00894062|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101801325|NCT00894062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101801326|NCT00894062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801327|NCT00894062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801328|NCT00894062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101801329|NCT00894062|Immunologic Factors|immunologic factors|mesh-ancestor
101801330|NCT00894062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801331|NCT00894062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101801332|NCT00443560|Fentanyl|fentanyl|mesh-list
101801333|NCT00443560|Bupivacaine|bupivacaine|mesh-list
101801334|NCT00443560|Anesthetics, Local|anesthetics, local|mesh-ancestor
101801335|NCT00443560|Anesthetics|anesthetics|mesh-ancestor
101801336|NCT00443560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101801337|NCT00443560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801339|NCT00443560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101801340|NCT00443560|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101801341|NCT00443560|Narcotics|narcotics|mesh-ancestor
101801342|NCT00443560|Analgesics|analgesics|mesh-ancestor
101801343|NCT00443560|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101801344|NCT00443560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101801345|NCT00443560|Anesthetics, General|anesthetics, general|mesh-ancestor
101801346|NCT01022632|Curcumin|curcumin|mesh-list
101801347|NCT01022632|Fluoxetine|fluoxetine|mesh-list
101801348|NCT01022632|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101801349|NCT01022632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101801350|NCT01022632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101801351|NCT01022632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801352|NCT01022632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101801353|NCT01022632|Serotonin Agents|serotonin agents|mesh-ancestor
101801354|NCT01022632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801355|NCT01022632|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101801356|NCT01022632|Antidepressive Agents|antidepressive agents|mesh-ancestor
101801357|NCT01022632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101801358|NCT01022632|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101801359|NCT01022632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101801360|NCT01022632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801361|NCT01022632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101801362|NCT01022632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101801363|NCT01022632|Analgesics|analgesics|mesh-ancestor
101801364|NCT01022632|Sensory System Agents|sensory system agents|mesh-ancestor
101801367|NCT01022632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101801368|NCT01022632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101801369|NCT01026376|Decitabine|decitabine|mesh-list
101801370|NCT01026376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101801371|NCT01026376|Antimetabolites|antimetabolites|mesh-ancestor
101801372|NCT01026376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801373|NCT01026376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101801374|NCT01026376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801375|NCT00716573|Everolimus|everolimus|mesh-list
101801376|NCT00716573|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101801377|NCT00716573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101801378|NCT00716573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801379|NCT00716573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801380|NCT00716573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101801381|NCT00716573|Immunologic Factors|immunologic factors|mesh-ancestor
101801382|NCT00716573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801383|NCT00716573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101801385|NCT02539706|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101801386|NCT02539706|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101801387|NCT02539706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101801388|NCT02539706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101801389|NCT02539706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801390|NCT00451204|Glatiramer Acetate|glatiramer acetate|mesh-list
101801392|NCT00451204|(T,G)-A-L|(t,g)-a-l|mesh-list
101801393|NCT00451204|Hormones|hormones|mesh-ancestor
101801394|NCT00451204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101801395|NCT00451204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801396|NCT00451204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101801397|NCT00451204|Immunologic Factors|immunologic factors|mesh-ancestor
101801398|NCT00451204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101801399|NCT00451204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101801400|NCT00721877|Resveratrol|resveratrol|mesh-list
101801401|NCT00721877|Antioxidants|antioxidants|mesh-ancestor
101801402|NCT00721877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801403|NCT00721877|Protective Agents|protective agents|mesh-ancestor
101801404|NCT00721877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801405|NCT00721877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801406|NCT00721877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101801407|NCT03537586|Adenosine|adenosine|mesh-list
101801408|NCT03537586|Heparin|heparin|mesh-list
101801409|NCT03537586|Bivalirudin|bivalirudin|mesh-list
101801410|NCT03537586|Anticoagulants|anticoagulants|mesh-ancestor
101801411|NCT03537586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101801412|NCT03537586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101801413|NCT03537586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801414|NCT03537586|Analgesics|analgesics|mesh-ancestor
101801415|NCT03537586|Sensory System Agents|sensory system agents|mesh-ancestor
101801416|NCT03537586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101801417|NCT03537586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801418|NCT03537586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101801419|NCT03537586|Vasodilator Agents|vasodilator agents|mesh-ancestor
101801421|NCT03537586|Purinergic Agonists|purinergic agonists|mesh-ancestor
101801422|NCT03537586|Purinergic Agents|purinergic agents|mesh-ancestor
101801423|NCT03537586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101801424|NCT03537586|Antithrombins|antithrombins|mesh-ancestor
101801425|NCT03537586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101801426|NCT03537586|Protease Inhibitors|protease inhibitors|mesh-ancestor
101801429|NCT00722033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101801430|NCT00722033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101801432|NCT00722033|Sensory System Agents|sensory system agents|mesh-ancestor
101801433|NCT00722033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101801436|NCT00722033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101801437|NCT00722033|Gout Suppressants|gout suppressants|mesh-ancestor
101801438|NCT00722033|Tocolytic Agents|tocolytic agents|mesh-ancestor
101801439|NCT00722033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101801440|NCT00722033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101801441|NCT00722033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801442|NCT00722033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801444|NCT00894374|Antimalarials|antimalarials|mesh-ancestor
101801445|NCT00894374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101801446|NCT00894374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101801447|NCT00894374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101801448|NCT00894374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101801449|NCT00894374|Antiviral Agents|antiviral agents|mesh-ancestor
101801450|NCT00894374|Schistosomicides|schistosomicides|mesh-ancestor
101801451|NCT00894374|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101801452|NCT00894374|Anthelmintics|anthelmintics|mesh-ancestor
101801453|NCT04920149|Mesalamine|mesalamine|mesh-list
101801454|NCT04920149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101801456|NCT04920149|Analgesics|analgesics|mesh-ancestor
101801457|NCT04920149|Sensory System Agents|sensory system agents|mesh-ancestor
101801458|NCT04920149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101801459|NCT04920149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801460|NCT04920149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101801461|NCT04920149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101801462|NCT01026610|Entecavir|entecavir|mesh-list
101801463|NCT01026610|Antiviral Agents|antiviral agents|mesh-ancestor
101801464|NCT01026610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101801467|NCT00901550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101801468|NCT00901550|Abortifacient Agents|abortifacient agents|mesh-ancestor
101801469|NCT00901550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101801470|NCT00901550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801471|NCT00901550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101801472|NCT00901550|Antimetabolites|antimetabolites|mesh-ancestor
101801473|NCT00901550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801475|NCT00901550|Dermatologic Agents|dermatologic agents|mesh-ancestor
101801476|NCT00901550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801477|NCT00901550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101801478|NCT00901550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101801479|NCT00901550|Immunologic Factors|immunologic factors|mesh-ancestor
101801480|NCT00901550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101801481|NCT00901550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101801482|NCT00901550|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101801483|NCT00901550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101801484|NCT00901550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101801486|NCT02573051|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
101801488|NCT02573051|Misoprostol|misoprostol|mesh-list
101801489|NCT02573051|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101801490|NCT02573051|Abortifacient Agents|abortifacient agents|mesh-ancestor
101801491|NCT02573051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101801492|NCT02573051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801493|NCT02573051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101801494|NCT02573051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101801495|NCT02573051|Oxytocics|oxytocics|mesh-ancestor
101801496|NCT02573051|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101801497|NCT02573051|Diuretics|diuretics|mesh-ancestor
101801498|NCT02573051|Natriuretic Agents|natriuretic agents|mesh-ancestor
101801499|NCT02573051|Vasodilator Agents|vasodilator agents|mesh-ancestor
101801500|NCT02573051|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101801501|NCT02573051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801503|NCT02539940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101801505|NCT02539940|Tubulin Modulators|tubulin modulators|mesh-ancestor
101801506|NCT02539940|Antimitotic Agents|antimitotic agents|mesh-ancestor
101801507|NCT02539940|Mitosis Modulators|mitosis modulators|mesh-ancestor
101801508|NCT02539940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801509|NCT01028092|Cyclosporine|cyclosporine|mesh-list
101801510|NCT01028092|Everolimus|everolimus|mesh-list
101801511|NCT01028092|Interleukin-2|interleukin-2|mesh-list
101801512|NCT01028092|Cyclosporins|cyclosporins|mesh-list
101801513|NCT01028092|Thymoglobulin|thymoglobulin|mesh-list
101801514|NCT01028092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801515|NCT01028092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801516|NCT01028092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101801517|NCT01028092|Immunologic Factors|immunologic factors|mesh-ancestor
101801518|NCT01028092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801519|NCT01028092|Antifungal Agents|antifungal agents|mesh-ancestor
101801520|NCT01028092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101801523|NCT01028092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101801524|NCT01028092|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101801525|NCT01028092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101801526|NCT01028092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101801527|NCT01028092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101801528|NCT01028092|Analgesics|analgesics|mesh-ancestor
101801529|NCT01028092|Sensory System Agents|sensory system agents|mesh-ancestor
101801530|NCT01028092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101801531|NCT00605306|Mometasone Furoate|mometasone furoate|mesh-list
101801532|NCT00605306|Maleic acid|maleic acid|mesh-list
101801533|NCT00605306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801534|NCT00605306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801535|NCT00605306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101801536|NCT00605306|Dermatologic Agents|dermatologic agents|mesh-ancestor
101801537|NCT00605306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101801539|NCT00905918|Vitamins|vitamins|mesh-ancestor
101801540|NCT00905918|Micronutrients|micronutrients|mesh-ancestor
101801541|NCT00905918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801542|NCT00905918|Antioxidants|antioxidants|mesh-ancestor
101801543|NCT00905918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801544|NCT00905918|Protective Agents|protective agents|mesh-ancestor
101801545|NCT00894608|Letrozole|letrozole|mesh-list
101801546|NCT00894608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101801547|NCT00894608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101801548|NCT00894608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101801549|NCT00894608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801550|NCT00894608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801551|NCT00894608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101801552|NCT00894608|Hormone Antagonists|hormone antagonists|mesh-ancestor
101801553|NCT00894608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101801554|NCT00894608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801556|NCT00901784|Anticonvulsants|anticonvulsants|mesh-ancestor
101801557|NCT00901784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101801558|NCT00901784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801559|NCT00905996|Propranolol|propranolol|mesh-list
101801560|NCT00905996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101801561|NCT00905996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101801562|NCT00905996|Adrenergic Agents|adrenergic agents|mesh-ancestor
101801563|NCT00905996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101801564|NCT00905996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801568|NCT00905996|Vasodilator Agents|vasodilator agents|mesh-ancestor
101801569|NCT02539628|Ropivacaine|ropivacaine|mesh-list
101801570|NCT02539628|Anesthetics, Local|anesthetics, local|mesh-ancestor
101801571|NCT02539628|Anesthetics|anesthetics|mesh-ancestor
101801572|NCT02539628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101801573|NCT02539628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801574|NCT02539628|Sensory System Agents|sensory system agents|mesh-ancestor
101801575|NCT02539628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101801576|NCT02573987|Lidocaine|lidocaine|mesh-list
101801577|NCT02573987|Nitrous Oxide|nitrous oxide|mesh-list
101801579|NCT02573987|Anesthetics|anesthetics|mesh-ancestor
101801580|NCT02573987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101801581|NCT02573987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801582|NCT02573987|Sensory System Agents|sensory system agents|mesh-ancestor
101801583|NCT02573987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101801584|NCT02573987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101801585|NCT02573987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101801586|NCT02573987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101801587|NCT02573987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101801588|NCT02573987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801589|NCT02573987|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101801590|NCT02573987|Anesthetics, General|anesthetics, general|mesh-ancestor
101801591|NCT02573987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101801592|NCT02573987|Analgesics|analgesics|mesh-ancestor
101801593|NCT00906386|Varenicline|varenicline|mesh-list
101801594|NCT00906386|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101801595|NCT00906386|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101801596|NCT00906386|Cholinergic Agents|cholinergic agents|mesh-ancestor
101801597|NCT00906386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101801598|NCT00906386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801599|NCT00906386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801601|NCT00722579|Chromium|chromium|mesh-list
101801602|NCT00722579|Trace Elements|trace elements|mesh-ancestor
101801603|NCT00722579|Micronutrients|micronutrients|mesh-ancestor
101801604|NCT00722579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801605|NCT00713687|Gemcitabine|gemcitabine|mesh-list
101801606|NCT00713687|Oxaliplatin|oxaliplatin|mesh-list
101801607|NCT00713687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101801608|NCT00713687|Antimetabolites|antimetabolites|mesh-ancestor
101801609|NCT00713687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801610|NCT00713687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101801612|NCT02540876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101801613|NCT02540876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101801614|NCT02540876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801615|NCT02540876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801617|NCT00894920|Vitamin B Complex|vitamin b complex|mesh-ancestor
101801618|NCT00894920|Vitamins|vitamins|mesh-ancestor
101801619|NCT00894920|Micronutrients|micronutrients|mesh-ancestor
101801620|NCT00894920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801621|NCT00722735|Ciprofloxacin|ciprofloxacin|mesh-list
101801622|NCT00722735|Finafloxacin|finafloxacin|mesh-list
101801623|NCT00722735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101801624|NCT00722735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101801625|NCT00722735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101801626|NCT00722735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101801627|NCT00722735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801628|NCT00722735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801629|NCT00722735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101801630|NCT00722735|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101311068|NCT05679388|Ritonavir|ritonavir|mesh-list
101801631|NCT00722735|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101801632|NCT00722735|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101801633|NCT04067531|Clindamycin|clindamycin|mesh-list
101801634|NCT04067531|Clindamycin palmitate|clindamycin palmitate|mesh-list
101801635|NCT04067531|Clindamycin phosphate|clindamycin phosphate|mesh-list
101801636|NCT04067531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101801637|NCT04067531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101801638|NCT04067531|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101801639|NCT04067531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801640|NCT04067531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801641|NCT00713765|Donepezil|donepezil|mesh-list
101801642|NCT00713765|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101801643|NCT00713765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801644|NCT00713765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801645|NCT00713765|Cholinergic Agents|cholinergic agents|mesh-ancestor
101801646|NCT00713765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101801647|NCT00713765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801648|NCT00713765|Nootropic Agents|nootropic agents|mesh-ancestor
101801649|NCT00717587|Sunitinib|sunitinib|mesh-list
101801650|NCT00717587|Motexafin gadolinium|motexafin gadolinium|mesh-list
101801651|NCT00717587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101801652|NCT00717587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101801653|NCT00717587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101801654|NCT00717587|Growth Substances|growth substances|mesh-ancestor
101801655|NCT00717587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801656|NCT00717587|Growth Inhibitors|growth inhibitors|mesh-ancestor
101801657|NCT00717587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101801658|NCT00717587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801659|NCT00717587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801660|NCT00717587|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101801661|NCT00717587|Dermatologic Agents|dermatologic agents|mesh-ancestor
101801662|NCT00894998|Heparin|heparin|mesh-list
101801663|NCT00894998|Calcium heparin|calcium heparin|mesh-list
101801664|NCT00894998|Anticoagulants|anticoagulants|mesh-ancestor
101801665|NCT00894998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101801666|NCT00894998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101801667|NCT00894998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801668|NCT00713921|Fesoterodine|fesoterodine|mesh-list
101801669|NCT00713921|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101801671|NCT00713921|Cholinergic Agents|cholinergic agents|mesh-ancestor
101801672|NCT00713921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101801673|NCT00713921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801674|NCT00713921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801675|NCT00713921|Urological Agents|urological agents|mesh-ancestor
101801676|NCT00713999|Praziquantel|praziquantel|mesh-list
101801677|NCT00713999|Anthelmintics|anthelmintics|mesh-ancestor
101801678|NCT00713999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101801679|NCT00713999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101801680|NCT04072601|Atorvastatin|atorvastatin|mesh-list
101801683|NCT04072601|Antimetabolites|antimetabolites|mesh-ancestor
101801684|NCT04072601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801685|NCT04072601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101801686|NCT04072601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101801687|NCT04072601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801688|NCT00717821|Epoetin Alfa|epoetin alfa|mesh-list
101801689|NCT00717821|Darbepoetin alfa|darbepoetin alfa|mesh-list
101801690|NCT00717821|Hematinics|hematinics|mesh-ancestor
101801693|NCT03476369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101801694|NCT03476369|Narcotics|narcotics|mesh-ancestor
101801695|NCT03476369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101801696|NCT03476369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801697|NCT03476369|Analgesics|analgesics|mesh-ancestor
101801698|NCT03476369|Sensory System Agents|sensory system agents|mesh-ancestor
101801699|NCT03476369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101801700|NCT03476369|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101801701|NCT03476369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101801702|NCT03476369|Anesthetics, General|anesthetics, general|mesh-ancestor
101801703|NCT03476369|Anesthetics|anesthetics|mesh-ancestor
101801704|NCT03476369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101801705|NCT03476369|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101801708|NCT03476369|Purinergic Agents|purinergic agents|mesh-ancestor
101801709|NCT03476369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101801710|NCT03476369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801711|NCT00722969|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101801712|NCT00722969|Sorafenib|sorafenib|mesh-list
101801713|NCT00722969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101801714|NCT00722969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101801715|NCT00722969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801716|NCT00722969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801717|NCT04069325|Febuxostat|febuxostat|mesh-list
101801718|NCT04069325|Gout Suppressants|gout suppressants|mesh-ancestor
101801719|NCT04069325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101801720|NCT00723047|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101801744|NCT02571491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101801745|NCT02571491|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101801746|NCT02571491|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101801747|NCT02571491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101801748|NCT02571491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801749|NCT02571491|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101801751|NCT00723437|Acitretin|acitretin|mesh-list
101801752|NCT00723437|Keratolytic Agents|keratolytic agents|mesh-ancestor
101801753|NCT00723437|Dermatologic Agents|dermatologic agents|mesh-ancestor
101801754|NCT00723515|Listerine|listerine|mesh-list
101459078|NCT00565240|Progestins|progestins|mesh-ancestor
101801772|NCT00518115|rGLP-1 protein|rglp-1 protein|mesh-list
101801774|NCT00518115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801775|NCT00518115|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101801776|NCT00518115|Incretins|incretins|mesh-ancestor
101801777|NCT00518115|Hormones|hormones|mesh-ancestor
101801778|NCT00518115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101801779|NCT00723983|Sumatriptan|sumatriptan|mesh-list
101801780|NCT00723983|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101801781|NCT00723983|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101801782|NCT00723983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101801783|NCT00723983|Serotonin Agents|serotonin agents|mesh-ancestor
101801784|NCT00723983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101801785|NCT00723983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801786|NCT00723983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801787|NCT00450658|Ibuprofen|ibuprofen|mesh-list
101801789|NCT00450658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101801790|NCT00450658|Analgesics|analgesics|mesh-ancestor
101801791|NCT00450658|Sensory System Agents|sensory system agents|mesh-ancestor
101801792|NCT00450658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101801793|NCT00450658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801794|NCT00450658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101801795|NCT00450658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101801796|NCT00450658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101801797|NCT00450658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801798|NCT00450658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801799|NCT02572505|Tenofovir|tenofovir|mesh-list
101801800|NCT02572505|Emtricitabine|emtricitabine|mesh-list
101364946|NCT00149578|Leucovorin|leucovorin|mesh-list
101801801|NCT02572505|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101801803|NCT02572505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101801804|NCT02572505|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101801805|NCT02572505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101801806|NCT02572505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801807|NCT02572505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801808|NCT02572505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101801809|NCT02572505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101801810|NCT00517881|Epoetin Alfa|epoetin alfa|mesh-list
101801811|NCT00517881|Hematinics|hematinics|mesh-ancestor
101801812|NCT01010139|Codeine|codeine|mesh-list
101801813|NCT01010139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101801814|NCT01010139|Narcotics|narcotics|mesh-ancestor
101801816|NCT01010139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801817|NCT01010139|Analgesics|analgesics|mesh-ancestor
101801818|NCT01010139|Sensory System Agents|sensory system agents|mesh-ancestor
101801819|NCT01010139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101801820|NCT01010139|Antitussive Agents|antitussive agents|mesh-ancestor
101801821|NCT01010139|Respiratory System Agents|respiratory system agents|mesh-ancestor
101801822|NCT00724295|Ribavirin|ribavirin|mesh-list
101801823|NCT00724295|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101801824|NCT00724295|Antimetabolites|antimetabolites|mesh-ancestor
101801825|NCT00724295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801826|NCT00724295|Antiviral Agents|antiviral agents|mesh-ancestor
101801827|NCT00724295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101809701|NCT05428488|Abatacept|abatacept|mesh-list
101801828|NCT00718289|Dialysis Solutions|dialysis solutions|mesh-list
101801829|NCT00718289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101801830|NCT00517413|Epoetin Alfa|epoetin alfa|mesh-list
101801831|NCT00517413|Hematinics|hematinics|mesh-ancestor
101801833|NCT00724529|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101801834|NCT00724529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101801835|NCT00724529|Dermatologic Agents|dermatologic agents|mesh-ancestor
101801836|NCT00724529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101801837|NCT00724529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101801838|NCT01012869|Everolimus|everolimus|mesh-list
101801839|NCT01012869|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101801840|NCT01012869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101801841|NCT01012869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801842|NCT01012869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801843|NCT01012869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101801844|NCT01012869|Immunologic Factors|immunologic factors|mesh-ancestor
101801845|NCT01012869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801846|NCT01012869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101801847|NCT01010295|Doxycycline|doxycycline|mesh-list
101801848|NCT01010295|Tetracycline|tetracycline|mesh-list
101801849|NCT01010295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101801850|NCT01010295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101801851|NCT01010295|Antimalarials|antimalarials|mesh-ancestor
101801853|NCT01010295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101801854|NCT01010295|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101801855|NCT01010295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801856|NCT01010295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801857|NCT01010373|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
101801858|NCT01010373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101801859|NCT01010373|Immunologic Factors|immunologic factors|mesh-ancestor
101801860|NCT01010373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801861|NCT01010373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101801862|NCT01010373|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101801863|NCT01010373|Protective Agents|protective agents|mesh-ancestor
101801864|NCT01010373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101801865|NCT01010373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101801866|NCT01010373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101364957|NCT00149578|Vitamins|vitamins|mesh-ancestor
101801867|NCT01010373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801868|NCT01010373|Antiviral Agents|antiviral agents|mesh-ancestor
101801869|NCT01010373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101801870|NCT01010451|Anti-Infective Agents|anti-infective agents|mesh-list
101801873|NCT01010451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101801874|NCT01010451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801875|NCT02570789|Sunitinib|sunitinib|mesh-list
101801876|NCT02570789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101801877|NCT02570789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101801878|NCT02570789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101801879|NCT02570789|Growth Substances|growth substances|mesh-ancestor
101801880|NCT02570789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801881|NCT02570789|Growth Inhibitors|growth inhibitors|mesh-ancestor
101801882|NCT02570789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101801883|NCT02570789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801884|NCT02570789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801885|NCT00604214|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
101801887|NCT00450580|Ritonavir|ritonavir|mesh-list
101801888|NCT00450580|Fosamprenavir|fosamprenavir|mesh-list
101801889|NCT00450580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101801890|NCT00450580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101801891|NCT00450580|Protease Inhibitors|protease inhibitors|mesh-ancestor
101801892|NCT00450580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801893|NCT00450580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801895|NCT00450580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101801896|NCT00450580|Antiviral Agents|antiviral agents|mesh-ancestor
101801897|NCT00450580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101801898|NCT00450580|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101801899|NCT00450580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101801900|NCT00724685|Ropivacaine|ropivacaine|mesh-list
101801901|NCT00724685|Anesthetics, Local|anesthetics, local|mesh-ancestor
101801902|NCT00724685|Anesthetics|anesthetics|mesh-ancestor
101801903|NCT00724685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101801904|NCT00724685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459229|NCT05055128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801905|NCT00724685|Sensory System Agents|sensory system agents|mesh-ancestor
101801906|NCT00724685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101801907|NCT00123487|Dasatinib|dasatinib|mesh-list
101801908|NCT00123487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101801909|NCT00123487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101801910|NCT00123487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801911|NCT00123487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801912|NCT00509925|Insulin|insulin|mesh-list
101801913|NCT00509925|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101801914|NCT00509925|Insulin Aspart|insulin aspart|mesh-list
101801915|NCT00509925|Insulin Detemir|insulin detemir|mesh-list
101801916|NCT00509925|Isophane Insulin, Human|isophane insulin, human|mesh-list
101801926|NCT05277974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801927|NCT05277974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101801928|NCT05277974|Glucocorticoids|glucocorticoids|mesh-ancestor
101801929|NCT05277974|Hormones|hormones|mesh-ancestor
101801930|NCT05277974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101801931|NCT05277974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101801936|NCT00504777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101801937|NCT00504777|Immunologic Factors|immunologic factors|mesh-ancestor
101801938|NCT00504777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801939|NCT00504777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101801940|NCT00504777|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101801943|NCT00504777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101801945|NCT00504777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801946|NCT00504777|Dermatologic Agents|dermatologic agents|mesh-ancestor
101801947|NCT00504777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101801948|NCT00504777|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101801949|NCT00504777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101801954|NCT03968263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101801955|NCT03968263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801956|NCT03968263|Analgesics|analgesics|mesh-ancestor
101801957|NCT03968263|Sensory System Agents|sensory system agents|mesh-ancestor
101801958|NCT03968263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101801959|NCT03968263|Antitussive Agents|antitussive agents|mesh-ancestor
101801960|NCT03968263|Respiratory System Agents|respiratory system agents|mesh-ancestor
101801961|NCT00895076|Dexamethasone|dexamethasone|mesh-list
101801962|NCT00895076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101801963|NCT00895076|Antiemetics|antiemetics|mesh-ancestor
101801964|NCT00895076|Autonomic Agents|autonomic agents|mesh-ancestor
101801968|NCT00895076|Glucocorticoids|glucocorticoids|mesh-ancestor
101801969|NCT00895076|Hormones|hormones|mesh-ancestor
101801970|NCT00895076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101801971|NCT00895076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101801972|NCT00895076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101801974|NCT01078519|Anesthetics, Local|anesthetics, local|mesh-list
101801975|NCT01078519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101801976|NCT01078519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801977|NCT01078519|Sensory System Agents|sensory system agents|mesh-ancestor
101801978|NCT01078519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101801979|NCT02539316|SMOFlipid|smoflipid|mesh-list
101801980|NCT02539316|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101801981|NCT02539316|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101801983|NCT03968185|Analgesics|analgesics|mesh-list
101801984|NCT03968185|Sensory System Agents|sensory system agents|mesh-ancestor
101801985|NCT03968185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101801986|NCT03968185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101801987|NCT00509769|Trastuzumab|trastuzumab|mesh-list
101801988|NCT00509769|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101801989|NCT00509769|Maytansine|maytansine|mesh-list
101801990|NCT00509769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101801991|NCT00509769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101801992|NCT00509769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101801993|NCT00509769|Tubulin Modulators|tubulin modulators|mesh-ancestor
101801994|NCT00509769|Antimitotic Agents|antimitotic agents|mesh-ancestor
101801995|NCT00509769|Mitosis Modulators|mitosis modulators|mesh-ancestor
101801996|NCT00509769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101801997|NCT00509769|Immunotoxins|immunotoxins|mesh-ancestor
101801998|NCT00509769|Immunoconjugates|immunoconjugates|mesh-ancestor
101801999|NCT00509769|Immunologic Factors|immunologic factors|mesh-ancestor
101802000|NCT00509769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802001|NCT05206877|Insulin|insulin|mesh-list
101802002|NCT05206877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101802003|NCT05206877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101802004|NCT05206877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802005|NCT02977715|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
101802006|NCT02977715|Antiviral Agents|antiviral agents|mesh-ancestor
101802007|NCT02977715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101802008|NCT01074697|Dexamethasone|dexamethasone|mesh-list
101802009|NCT01074697|Palonosetron|palonosetron|mesh-list
101802010|NCT01074697|Fosaprepitant|fosaprepitant|mesh-list
101802011|NCT01074697|Aprepitant|aprepitant|mesh-list
101802012|NCT01074697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101802013|NCT01074697|Antiemetics|antiemetics|mesh-ancestor
101802014|NCT01074697|Autonomic Agents|autonomic agents|mesh-ancestor
101802015|NCT01074697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101802016|NCT01074697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802017|NCT01074697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101802018|NCT01074697|Glucocorticoids|glucocorticoids|mesh-ancestor
101802019|NCT01074697|Hormones|hormones|mesh-ancestor
101802020|NCT01074697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101802021|NCT01074697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101802022|NCT01074697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101802023|NCT01074697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802024|NCT01074697|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101809748|NCT05387187|Vasodilator Agents|vasodilator agents|mesh-ancestor
101802025|NCT01074697|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101802026|NCT01074697|Serotonin Agents|serotonin agents|mesh-ancestor
101802027|NCT01074697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101802028|NCT01074697|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101802029|NCT05124275|Pilocarpine|pilocarpine|mesh-list
101802030|NCT05124275|Miotics|miotics|mesh-ancestor
101802031|NCT05124275|Autonomic Agents|autonomic agents|mesh-ancestor
101802032|NCT05124275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101802033|NCT05124275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802034|NCT05124275|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101802035|NCT05124275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101802036|NCT05124275|Cholinergic Agents|cholinergic agents|mesh-ancestor
101802037|NCT05124275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101802038|NCT05124275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802039|NCT01080079|Terbinafine|terbinafine|mesh-list
101802040|NCT01080079|Antifungal Agents|antifungal agents|mesh-ancestor
101802041|NCT01080079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101802042|NCT01080079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101802043|NCT01080079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802044|NCT00725231|Alemtuzumab|alemtuzumab|mesh-list
101802045|NCT00725231|Doxorubicin|doxorubicin|mesh-list
101802046|NCT00725231|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101802047|NCT00725231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101802048|NCT00725231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101802049|NCT00725231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101802050|NCT00725231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101802051|NCT00725231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101802052|NCT00725231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101802053|NCT00725231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802054|NCT00114127|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101802055|NCT00114127|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101802056|NCT00114127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101802057|NCT00114127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101802058|NCT00114127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802059|NCT00114127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101802060|NCT00114127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802061|NCT00114127|Analgesics|analgesics|mesh-ancestor
101802062|NCT00114127|Sensory System Agents|sensory system agents|mesh-ancestor
101802063|NCT00114127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101802064|NCT00114127|Antidepressive Agents|antidepressive agents|mesh-ancestor
101802065|NCT00114127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101802066|NCT00114127|Dopamine Agents|dopamine agents|mesh-ancestor
101802068|NCT00902954|Anastrozole|anastrozole|mesh-list
101802069|NCT00902954|Exemestane|exemestane|mesh-list
101802070|NCT00902954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101802071|NCT00902954|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101802072|NCT00902954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101802073|NCT00902954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101802074|NCT00902954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802075|NCT00902954|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101802076|NCT00902954|Hormone Antagonists|hormone antagonists|mesh-ancestor
101802077|NCT00902954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101802078|NCT00902954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802079|NCT00902954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101802080|NCT02540720|Dexamethasone|dexamethasone|mesh-list
101802081|NCT02540720|gamma-Globulins|gamma-globulins|mesh-list
101467084|NCT04711824|Tubulin Modulators|tubulin modulators|mesh-ancestor
101802082|NCT02540720|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101802083|NCT02540720|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101802084|NCT02540720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101802085|NCT02540720|Antiemetics|antiemetics|mesh-ancestor
101802086|NCT02540720|Autonomic Agents|autonomic agents|mesh-ancestor
101802087|NCT02540720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101802088|NCT02540720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802089|NCT02540720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101802090|NCT02540720|Glucocorticoids|glucocorticoids|mesh-ancestor
101802091|NCT02540720|Hormones|hormones|mesh-ancestor
101333823|NCT00041236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101802092|NCT02540720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101802093|NCT02540720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101802094|NCT02540720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101802095|NCT02540720|Immunologic Factors|immunologic factors|mesh-ancestor
101802096|NCT02540642|Vitamin B 12|vitamin b 12|mesh-list
101802097|NCT02540642|Vitamins|vitamins|mesh-ancestor
101802098|NCT02540642|Micronutrients|micronutrients|mesh-ancestor
101802099|NCT02540642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802100|NCT02540642|Vitamin B Complex|vitamin b complex|mesh-ancestor
101802101|NCT00122317|Eculizumab|eculizumab|mesh-list
101802102|NCT00122317|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101802104|NCT00122317|Immunologic Factors|immunologic factors|mesh-ancestor
101802105|NCT00122317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802107|NCT00908336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101802108|NCT00908336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101802109|NCT00908336|Tubulin Modulators|tubulin modulators|mesh-ancestor
101802110|NCT00908336|Antimitotic Agents|antimitotic agents|mesh-ancestor
101802111|NCT00908336|Mitosis Modulators|mitosis modulators|mesh-ancestor
101802112|NCT00908336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802113|NCT00908336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101802114|NCT00908336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101802115|NCT00908414|TMC-310911|tmc-310911|mesh-list
101802116|NCT00908414|Protease Inhibitors|protease inhibitors|mesh-ancestor
101802117|NCT00908414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101802118|NCT00908414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802119|NCT01074853|Propranolol|propranolol|mesh-list
101802120|NCT01074853|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101802121|NCT01074853|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101802122|NCT01074853|Adrenergic Agents|adrenergic agents|mesh-ancestor
101802123|NCT01074853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101802124|NCT01074853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802125|NCT01074853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802126|NCT01074853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101802127|NCT01074853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101802128|NCT01074853|Vasodilator Agents|vasodilator agents|mesh-ancestor
101802129|NCT00725777|Lumefantrine|lumefantrine|mesh-list
101802131|NCT00725777|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101802132|NCT00725777|Antimalarials|antimalarials|mesh-ancestor
101802133|NCT00725777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101802134|NCT00725777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101802135|NCT00725777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101802136|NCT00165841|Rabeprazole|rabeprazole|mesh-list
101802137|NCT00165841|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101802138|NCT00165841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101802139|NCT00165841|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101802140|NCT00165841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101802141|NCT00165841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802142|NCT00907166|Gemcitabine|gemcitabine|mesh-list
101802143|NCT00907166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101802144|NCT00907166|Antimetabolites|antimetabolites|mesh-ancestor
101802145|NCT00907166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802147|NCT00460798|Sunitinib|sunitinib|mesh-list
101802148|NCT00460798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101802149|NCT00460798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101802150|NCT00460798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101802151|NCT00460798|Growth Substances|growth substances|mesh-ancestor
101802152|NCT00460798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802153|NCT00460798|Growth Inhibitors|growth inhibitors|mesh-ancestor
101802154|NCT00460798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101802155|NCT00460798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101802156|NCT00460798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802157|NCT03513406|Glycopyrrolate|glycopyrrolate|mesh-list
101802158|NCT03513406|Neostigmine|neostigmine|mesh-list
101802159|NCT03513406|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101802160|NCT03513406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101802161|NCT03513406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802162|NCT03513406|Cholinergic Agents|cholinergic agents|mesh-ancestor
101802163|NCT03513406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101802164|NCT03513406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802165|NCT03513406|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101802167|NCT03513406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101802168|NCT03513406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101802169|NCT03513406|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101802170|NCT03513406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101802171|NCT00726869|Elotuzumab|elotuzumab|mesh-list
101802172|NCT00726869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101802173|NCT01028248|Ranibizumab|ranibizumab|mesh-list
101802174|NCT01028248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101802175|NCT01028248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101802176|NCT01028248|Growth Substances|growth substances|mesh-ancestor
101802177|NCT01028248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802178|NCT01028248|Growth Inhibitors|growth inhibitors|mesh-ancestor
101802179|NCT01028248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101802180|NCT00726011|Tetrodotoxin|tetrodotoxin|mesh-list
101802181|NCT00726011|Anesthetics, Local|anesthetics, local|mesh-ancestor
101802182|NCT00726011|Anesthetics|anesthetics|mesh-ancestor
101802183|NCT00726011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101802184|NCT00726011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802185|NCT00726011|Sensory System Agents|sensory system agents|mesh-ancestor
101802186|NCT00726011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101802187|NCT00726011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101802188|NCT00726011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101802189|NCT00726011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802190|NCT00603980|Alprazolam|alprazolam|mesh-list
101802191|NCT00603980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101802192|NCT00603980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101802193|NCT00603980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802194|NCT00603980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101802195|NCT00603980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101802196|NCT00603980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101802197|NCT00603980|GABA Modulators|gaba modulators|mesh-ancestor
101802198|NCT00603980|GABA Agents|gaba agents|mesh-ancestor
101802199|NCT00603980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101802200|NCT00603980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802201|NCT01028404|Insulin|insulin|mesh-list
101802202|NCT01028404|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101802203|NCT01028404|Insulin Aspart|insulin aspart|mesh-list
101802204|NCT01028404|Insulin, Long-Acting|insulin, long-acting|mesh-list
101802205|NCT01028404|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101802206|NCT01028404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101802207|NCT01028404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802208|NCT00727103|Varenicline|varenicline|mesh-list
101802209|NCT00727103|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101802210|NCT00727103|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101802212|NCT00727103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101802213|NCT00727103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802214|NCT00727103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802216|NCT01028482|Antidepressive Agents|antidepressive agents|mesh-ancestor
101802217|NCT01028482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101802218|NCT01028482|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101802219|NCT01028482|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101802220|NCT01028482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101802221|NCT01028482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802222|NCT01028482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101802223|NCT01028482|Serotonin Agents|serotonin agents|mesh-ancestor
101802224|NCT01028482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802225|NCT00903188|Cyclosporine|cyclosporine|mesh-list
101802226|NCT00903188|Mycophenolic Acid|mycophenolic acid|mesh-list
101802227|NCT00903188|Methylprednisolone|methylprednisolone|mesh-list
101802228|NCT00903188|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101802229|NCT00903188|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101802230|NCT00903188|Prednisolone|prednisolone|mesh-list
101802231|NCT00903188|Prednisolone acetate|prednisolone acetate|mesh-list
101802232|NCT00903188|Everolimus|everolimus|mesh-list
101802233|NCT00903188|Cyclosporins|cyclosporins|mesh-list
101802234|NCT00903188|Basiliximab|basiliximab|mesh-list
101802235|NCT00903188|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101365047|NCT00405925|Lamivudine|lamivudine|mesh-list
101802236|NCT00903188|Prednisolone phosphate|prednisolone phosphate|mesh-list
101802237|NCT00903188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101802238|NCT00903188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802239|NCT00903188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101802240|NCT00903188|Immunologic Factors|immunologic factors|mesh-ancestor
101802241|NCT00903188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802242|NCT00903188|Antifungal Agents|antifungal agents|mesh-ancestor
101802243|NCT00903188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101802244|NCT00903188|Dermatologic Agents|dermatologic agents|mesh-ancestor
101802245|NCT00903188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101802246|NCT00903188|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101802247|NCT00903188|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101802248|NCT00903188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101802249|NCT00903188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101802250|NCT00903188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101802251|NCT00903188|Antiemetics|antiemetics|mesh-ancestor
101802252|NCT00903188|Autonomic Agents|autonomic agents|mesh-ancestor
101802253|NCT00903188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101802254|NCT00903188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101802255|NCT00903188|Glucocorticoids|glucocorticoids|mesh-ancestor
101802256|NCT00903188|Hormones|hormones|mesh-ancestor
101802257|NCT00903188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101802258|NCT00903188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101802259|NCT00903188|Protective Agents|protective agents|mesh-ancestor
101802260|NCT00903188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101802261|NCT00903188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101802262|NCT00903188|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101802263|NCT00903188|Antitubercular Agents|antitubercular agents|mesh-ancestor
101802264|NCT00903188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101802265|NCT00908726|Propofol|propofol|mesh-list
101802266|NCT00908726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101802267|NCT00908726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101802268|NCT00908726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802269|NCT00908726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101802270|NCT00908726|Anesthetics, General|anesthetics, general|mesh-ancestor
101802271|NCT00908726|Anesthetics|anesthetics|mesh-ancestor
101802272|NCT02948309|Viscum album peptide|viscum album peptide|mesh-list
101802273|NCT02948309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101802274|NCT02948309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101802275|NCT02948309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101802276|NCT02948309|Antiviral Agents|antiviral agents|mesh-ancestor
101459603|NCT04593706|Betamethasone acetate|betamethasone acetate|mesh-list
101802277|NCT02948309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101802279|NCT00449956|Dorzolamide|dorzolamide|mesh-list
101802280|NCT00449956|Maleic acid|maleic acid|mesh-list
101311097|NCT00006396|Zidovudine|zidovudine|mesh-list
101802281|NCT00449956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101802282|NCT00449956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802283|NCT00449956|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101802284|NCT00449956|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101802285|NCT00449956|Adrenergic Agents|adrenergic agents|mesh-ancestor
101802286|NCT00449956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101802287|NCT00449956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802288|NCT00449956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101802289|NCT00449956|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101802290|NCT00449956|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101802291|NCT00907400|Naproxen|naproxen|mesh-list
101802292|NCT00907400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101802293|NCT00907400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101802294|NCT00907400|Analgesics|analgesics|mesh-ancestor
101802295|NCT00907400|Sensory System Agents|sensory system agents|mesh-ancestor
101802296|NCT00907400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101802297|NCT00907400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802298|NCT00907400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101802299|NCT00907400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101802300|NCT00907400|Gout Suppressants|gout suppressants|mesh-ancestor
101802301|NCT00907400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101802302|NCT00907400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101802303|NCT00907400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802304|NCT00727493|Alendronate|alendronate|mesh-list
101802305|NCT00727493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101802306|NCT00727493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802307|NCT00727727|Piribedil|piribedil|mesh-list
101802308|NCT00727727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101802309|NCT00727727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101802310|NCT00727727|Dopamine Agonists|dopamine agonists|mesh-ancestor
101802311|NCT00727727|Dopamine Agents|dopamine agents|mesh-ancestor
101802312|NCT00727727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101802313|NCT00727727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802314|NCT00727727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802315|NCT00903656|Lapatinib|lapatinib|mesh-list
101802316|NCT00903656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101802317|NCT00903656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101802318|NCT00903656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101802319|NCT00903656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802320|NCT00730067|Sildenafil Citrate|sildenafil citrate|mesh-list
101802321|NCT00730067|Vasodilator Agents|vasodilator agents|mesh-ancestor
101802322|NCT00730067|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101802323|NCT00730067|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101802324|NCT00730067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101802325|NCT00730067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802327|NCT02538224|Doxycycline|doxycycline|mesh-list
101802328|NCT02538224|Ketoprofen|ketoprofen|mesh-list
101802329|NCT02538224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101802330|NCT02538224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101802331|NCT02538224|Antimalarials|antimalarials|mesh-ancestor
101802332|NCT02538224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101802333|NCT02538224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101802334|NCT02538224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101802335|NCT02538224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101802336|NCT02538224|Analgesics|analgesics|mesh-ancestor
101802337|NCT02538224|Sensory System Agents|sensory system agents|mesh-ancestor
101802338|NCT02538224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101802339|NCT02538224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802340|NCT02538224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101802341|NCT02538224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101802342|NCT02538224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101802343|NCT02538224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101802344|NCT02538224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802345|NCT02538302|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101802346|NCT02538302|Oxybutynin|oxybutynin|mesh-list
101802347|NCT02538302|Parasympatholytics|parasympatholytics|mesh-ancestor
101802348|NCT02538302|Autonomic Agents|autonomic agents|mesh-ancestor
101802349|NCT02538302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101802350|NCT02538302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459676|NCT00249483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101802351|NCT02538302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101802352|NCT02538302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101802353|NCT02538302|Cholinergic Agents|cholinergic agents|mesh-ancestor
101802354|NCT02538302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101802355|NCT02538302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802356|NCT02538302|Urological Agents|urological agents|mesh-ancestor
101802357|NCT02538302|Hemostatics|hemostatics|mesh-ancestor
101802358|NCT02538302|Coagulants|coagulants|mesh-ancestor
101802359|NCT02538302|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101802360|NCT02538302|Natriuretic Agents|natriuretic agents|mesh-ancestor
101802361|NCT00903734|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101802362|NCT00903734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101802363|NCT00903734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101802365|NCT00903734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802366|NCT00509067|Olanzapine|olanzapine|mesh-list
101802367|NCT00509067|Risperidone|risperidone|mesh-list
101802368|NCT00509067|Aripiprazole|aripiprazole|mesh-list
101802369|NCT00509067|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101802370|NCT00509067|Ziprasidone|ziprasidone|mesh-list
101802371|NCT00509067|Choline|choline|mesh-list
101802372|NCT00509067|Galantamine|galantamine|mesh-list
101802373|NCT00509067|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
101802374|NCT00509067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101802375|NCT00509067|Serotonin Agents|serotonin agents|mesh-ancestor
101802376|NCT00509067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101802377|NCT00509067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802378|NCT00509067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802379|NCT00509067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101802380|NCT00509067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101802381|NCT00509067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101802382|NCT00509067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101802383|NCT00509067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101802384|NCT00509067|Dopamine Agents|dopamine agents|mesh-ancestor
101802385|NCT00509067|Antiemetics|antiemetics|mesh-ancestor
101802387|NCT00509067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101802388|NCT00509067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101802389|NCT00509067|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101802390|NCT00509067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101802391|NCT00509067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101802392|NCT00509067|Antidepressive Agents|antidepressive agents|mesh-ancestor
101802393|NCT00509067|Dopamine Agonists|dopamine agonists|mesh-ancestor
101802394|NCT00509067|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101802395|NCT00509067|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101802396|NCT00509067|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101802397|NCT00509067|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101802398|NCT00509067|Lipotropic Agents|lipotropic agents|mesh-ancestor
101802399|NCT00509067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101802401|NCT00509067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101802402|NCT00509067|Nootropic Agents|nootropic agents|mesh-ancestor
101802403|NCT00509067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101802404|NCT00509067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101802405|NCT00509067|Cholinergic Agents|cholinergic agents|mesh-ancestor
101802406|NCT00509067|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101802407|NCT02538146|Acetylcarnitine|acetylcarnitine|mesh-list
101802408|NCT02538146|Vitamin B Complex|vitamin b complex|mesh-ancestor
101802409|NCT02538146|Vitamins|vitamins|mesh-ancestor
101802410|NCT02538146|Micronutrients|micronutrients|mesh-ancestor
101802411|NCT02538146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802412|NCT02538146|Nootropic Agents|nootropic agents|mesh-ancestor
101802413|NCT00908024|Cetuximab|cetuximab|mesh-list
101802414|NCT00908024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101802415|NCT00908024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101802416|NCT00730223|Efavirenz|efavirenz|mesh-list
101802417|NCT00730223|Nevirapine|nevirapine|mesh-list
101802418|NCT00730223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101802419|NCT00730223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101802420|NCT00730223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101802421|NCT00730223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802422|NCT00730223|Antiviral Agents|antiviral agents|mesh-ancestor
101802423|NCT00730223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101802424|NCT00730223|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101802425|NCT00730223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101459766|NCT04409873|Listerine|listerine|mesh-list
101802426|NCT00730223|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101802427|NCT00730223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101365085|NCT00150085|Cyclosporine|cyclosporine|mesh-list
101802428|NCT00730223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101802429|NCT00730223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101802430|NCT00730223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101802431|NCT00730223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101802432|NCT00908180|Cytarabine|cytarabine|mesh-list
101802433|NCT00908180|Cyclosporine|cyclosporine|mesh-list
101802434|NCT00908180|Etoposide|etoposide|mesh-list
101802435|NCT00908180|Melphalan|melphalan|mesh-list
101802436|NCT00908180|Alemtuzumab|alemtuzumab|mesh-list
101802437|NCT00908180|Carmustine|carmustine|mesh-list
101802438|NCT00908180|Cyclosporins|cyclosporins|mesh-list
101802439|NCT00908180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101802440|NCT00908180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101802441|NCT00908180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101802442|NCT00908180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101802443|NCT00908180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101802444|NCT00908180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802445|NCT00908180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101802446|NCT00908180|Antimetabolites|antimetabolites|mesh-ancestor
101802447|NCT00908180|Antiviral Agents|antiviral agents|mesh-ancestor
101802448|NCT00908180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101802451|NCT00908180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802452|NCT00908180|Antifungal Agents|antifungal agents|mesh-ancestor
101802453|NCT00908180|Dermatologic Agents|dermatologic agents|mesh-ancestor
101802454|NCT00908180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101802455|NCT00908180|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101802456|NCT00908180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101802457|NCT00908180|Alkylating Agents|alkylating agents|mesh-ancestor
101802458|NCT00908180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101802466|NCT04480463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101802468|NCT00909506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101802469|NCT00909506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802470|NCT03997539|Vinorelbine|vinorelbine|mesh-list
101802471|NCT03997539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101802472|NCT03997539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101802476|NCT03997539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802477|NCT02570243|Heparin|heparin|mesh-list
101802478|NCT02570243|Calcium heparin|calcium heparin|mesh-list
101802479|NCT02570243|Anticoagulants|anticoagulants|mesh-ancestor
101802480|NCT02570243|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101802481|NCT02570243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101802482|NCT02570243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802483|NCT00927212|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
101802484|NCT00927212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101802485|NCT00927212|Immunologic Factors|immunologic factors|mesh-ancestor
101802486|NCT00927212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802487|NCT00927212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101802488|NCT00927212|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101802489|NCT00927212|Protective Agents|protective agents|mesh-ancestor
101802490|NCT00927212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101802491|NCT00927212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101802492|NCT00927212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101802493|NCT00927212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802494|NCT00927212|Antiviral Agents|antiviral agents|mesh-ancestor
101802495|NCT00927212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101802496|NCT00927290|Pioglitazone|pioglitazone|mesh-list
101802497|NCT00927290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101802498|NCT00927290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802499|NCT00728195|Olanzapine|olanzapine|mesh-list
101802500|NCT00728195|N-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|n-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|mesh-list
101802501|NCT00728195|Antiemetics|antiemetics|mesh-ancestor
101802502|NCT00728195|Autonomic Agents|autonomic agents|mesh-ancestor
101802503|NCT00728195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101802504|NCT00728195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802505|NCT00728195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101802506|NCT00728195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101802507|NCT00728195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101802508|NCT00728195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101802509|NCT00728195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101802510|NCT00728195|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101802511|NCT00728195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101802512|NCT00728195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101802513|NCT00728195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802514|NCT00728195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101802515|NCT00728195|Serotonin Agents|serotonin agents|mesh-ancestor
101809873|NCT05050448|Diclofenac|diclofenac|mesh-list
101802516|NCT00728195|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101802517|NCT00728195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101802518|NCT00728195|Dopamine Agents|dopamine agents|mesh-ancestor
101802520|NCT00927524|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101802521|NCT00927524|Insulin glulisine|insulin glulisine|mesh-list
101802522|NCT00927524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101802523|NCT00927524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802528|NCT00927602|Fondaparinux|fondaparinux|mesh-list
101802529|NCT00927602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101802530|NCT00927602|Antithrombins|antithrombins|mesh-ancestor
101802531|NCT00927602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101802532|NCT00927602|Protease Inhibitors|protease inhibitors|mesh-ancestor
101802533|NCT00927602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101802534|NCT00927602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802535|NCT00927602|Anticoagulants|anticoagulants|mesh-ancestor
101802536|NCT00927602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101802537|NCT00927602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101802538|NCT04286867|Ethanol|ethanol|mesh-list
101802539|NCT04286867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101802540|NCT04286867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101802541|NCT04286867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101802545|NCT00730535|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101802546|NCT00730535|Cholinergic Agents|cholinergic agents|mesh-ancestor
101802547|NCT00730535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101802548|NCT00730535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802549|NCT00730535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802550|NCT00730535|Urological Agents|urological agents|mesh-ancestor
101802552|NCT00904202|Gabapentin|gabapentin|mesh-list
101802553|NCT00904202|Anesthetics, Local|anesthetics, local|mesh-ancestor
101802554|NCT00904202|Anesthetics|anesthetics|mesh-ancestor
101802555|NCT00904202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101802556|NCT00904202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802557|NCT00904202|Sensory System Agents|sensory system agents|mesh-ancestor
101802558|NCT00904202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101802559|NCT00904202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101802560|NCT00904202|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101802561|NCT00904202|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101802565|NCT00904202|Anticonvulsants|anticonvulsants|mesh-ancestor
101802566|NCT00904202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101802567|NCT00904202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101802568|NCT00904202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101802569|NCT00904202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101802570|NCT00904202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101802571|NCT00904202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101802572|NCT00904202|Antimanic Agents|antimanic agents|mesh-ancestor
101802573|NCT00927836|Lenograstim|lenograstim|mesh-list
101802574|NCT00927836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101802576|NCT00927836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802577|NCT00904280|Oxymorphone|oxymorphone|mesh-list
101802578|NCT00904280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101802579|NCT00904280|Narcotics|narcotics|mesh-ancestor
101802580|NCT00904280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101802581|NCT00904280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802582|NCT00904280|Analgesics|analgesics|mesh-ancestor
101802583|NCT00904280|Sensory System Agents|sensory system agents|mesh-ancestor
101802584|NCT00904280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101802585|NCT00904280|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101802586|NCT00928148|Amphetamine|amphetamine|mesh-list
101802587|NCT00928148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101802588|NCT00928148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802589|NCT00928148|Sympathomimetics|sympathomimetics|mesh-ancestor
101802590|NCT00928148|Autonomic Agents|autonomic agents|mesh-ancestor
101802591|NCT00928148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101802594|NCT00928148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802595|NCT00928148|Adrenergic Agents|adrenergic agents|mesh-ancestor
101802596|NCT00928148|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101802597|NCT00928148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101802598|NCT00928148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101802599|NCT00928148|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101802602|NCT02430077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101802603|NCT00904436|Ipratropium|ipratropium|mesh-list
101802604|NCT00904436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101802605|NCT00904436|Autonomic Agents|autonomic agents|mesh-ancestor
101802606|NCT00904436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101802607|NCT00904436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802608|NCT00904436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101802609|NCT00904436|Respiratory System Agents|respiratory system agents|mesh-ancestor
101802611|NCT00904436|Cholinergic Agents|cholinergic agents|mesh-ancestor
101802612|NCT00904436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101802613|NCT00904436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802615|NCT00728585|Mitosis Modulators|mitosis modulators|mesh-ancestor
101802616|NCT00728585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802617|NCT00730769|Valganciclovir|valganciclovir|mesh-list
101802621|NCT00730769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101802622|NCT00730769|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101802623|NCT00730769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101802624|NCT00730769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802625|NCT00728663|Docetaxel|docetaxel|mesh-list
101802626|NCT00728663|Cetuximab|cetuximab|mesh-list
101802627|NCT00728663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101802631|NCT00728663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802632|NCT00728663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101802633|NCT00731003|Tryptophan|tryptophan|mesh-list
101802634|NCT00731003|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
101802635|NCT00731003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101802636|NCT00731003|Antidepressive Agents|antidepressive agents|mesh-ancestor
101802637|NCT00731003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101802639|NCT00729131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101802640|NCT00729131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101802642|NCT00729131|Sensory System Agents|sensory system agents|mesh-ancestor
101802643|NCT00729131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101802644|NCT00729131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802645|NCT00729131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101802646|NCT00729131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101802647|NCT00729131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101802648|NCT00729131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101802649|NCT00729131|Immunologic Factors|immunologic factors|mesh-ancestor
101802650|NCT00729287|Selenium|selenium|mesh-list
101802651|NCT00729287|Antioxidants|antioxidants|mesh-ancestor
101802653|NCT00729287|Protective Agents|protective agents|mesh-ancestor
101802654|NCT00729287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802655|NCT00729287|Trace Elements|trace elements|mesh-ancestor
101802656|NCT00729287|Micronutrients|micronutrients|mesh-ancestor
101802657|NCT00731393|Vaccines|vaccines|mesh-list
101802658|NCT00731393|Immunologic Factors|immunologic factors|mesh-ancestor
101802659|NCT00731393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802660|NCT04390217|Tranexamic Acid|tranexamic acid|mesh-list
101802661|NCT04390217|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101802662|NCT04390217|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101802663|NCT04390217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802664|NCT04390217|Hemostatics|hemostatics|mesh-ancestor
101802665|NCT04390217|Coagulants|coagulants|mesh-ancestor
101802666|NCT02569463|Aldesleukin|aldesleukin|mesh-list
101802667|NCT02569463|Interleukin-2|interleukin-2|mesh-list
101802668|NCT02569463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101802669|NCT02569463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101802671|NCT02569463|Sensory System Agents|sensory system agents|mesh-ancestor
101802672|NCT02569463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101802673|NCT02569463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802674|NCT02569463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101802675|NCT02569463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101802676|NCT02569463|Antiviral Agents|antiviral agents|mesh-ancestor
101802677|NCT02569463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101802678|NCT00731627|Simvastatin|simvastatin|mesh-list
101802679|NCT00731627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101802680|NCT00731627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101802681|NCT00731627|Antimetabolites|antimetabolites|mesh-ancestor
101802682|NCT00731627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802683|NCT00731627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101802684|NCT00731627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101802685|NCT00731627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101802686|NCT00568178|Losartan|losartan|mesh-list
101802687|NCT00568178|Amlodipine|amlodipine|mesh-list
101802688|NCT00568178|Enalapril|enalapril|mesh-list
101802689|NCT00568178|Enalaprilat|enalaprilat|mesh-list
101802690|NCT00568178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101802691|NCT00568178|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101802692|NCT00568178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101802693|NCT00568178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802694|NCT00568178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101802695|NCT00568178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802696|NCT00568178|Vasodilator Agents|vasodilator agents|mesh-ancestor
101802697|NCT00568178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101802698|NCT00568178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101802699|NCT00568178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101802700|NCT00568178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101802701|NCT00568178|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101802702|NCT00568178|Protease Inhibitors|protease inhibitors|mesh-ancestor
101802703|NCT00577889|Gemcitabine|gemcitabine|mesh-list
101802704|NCT00577889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101802705|NCT00577889|Antimetabolites|antimetabolites|mesh-ancestor
101802706|NCT00577889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802707|NCT00577889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101802708|NCT00729599|Cetylpyridinium|cetylpyridinium|mesh-list
101802709|NCT00729599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101802710|NCT00729599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101802712|NCT02538926|Cortisone|cortisone|mesh-list
101809928|NCT04781088|Paclitaxel|paclitaxel|mesh-list
101802714|NCT02538926|Rituximab|rituximab|mesh-list
101802715|NCT02538926|Doxorubicin|doxorubicin|mesh-list
101802716|NCT02538926|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101802717|NCT02538926|Etoposide|etoposide|mesh-list
101802718|NCT02538926|Vincristine|vincristine|mesh-list
101802719|NCT02538926|Etoposide phosphate|etoposide phosphate|mesh-list
101802720|NCT02538926|Imatinib Mesylate|imatinib mesylate|mesh-list
101802721|NCT02538926|Asparaginase|asparaginase|mesh-list
101802722|NCT02538926|Podophyllotoxin|podophyllotoxin|mesh-list
101802723|NCT02538926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101802724|NCT02538926|Antibodies|antibodies|mesh-list
101802725|NCT02538926|Immunoglobulins|immunoglobulins|mesh-list
101802726|NCT02538926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101802727|NCT02538926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101802728|NCT02538926|Immunologic Factors|immunologic factors|mesh-ancestor
101802729|NCT02538926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802730|NCT02538926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101802731|NCT02538926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101802732|NCT02538926|Alkylating Agents|alkylating agents|mesh-ancestor
101802733|NCT02538926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802734|NCT02538926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101802735|NCT02538926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101802736|NCT02538926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101802737|NCT02538926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101802738|NCT02538926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101802739|NCT02538926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101802740|NCT02538926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101802741|NCT02538926|Glucocorticoids|glucocorticoids|mesh-ancestor
101802743|NCT02538926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101802744|NCT02538926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101802745|NCT02538926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101802746|NCT02538926|Tubulin Modulators|tubulin modulators|mesh-ancestor
101802747|NCT02538926|Antimitotic Agents|antimitotic agents|mesh-ancestor
101802748|NCT02538926|Mitosis Modulators|mitosis modulators|mesh-ancestor
101802749|NCT02538926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101802750|NCT02538926|Keratolytic Agents|keratolytic agents|mesh-ancestor
101802751|NCT02538926|Dermatologic Agents|dermatologic agents|mesh-ancestor
101802752|NCT00904904|Ketorolac|ketorolac|mesh-list
101802753|NCT00904904|Indomethacin|indomethacin|mesh-list
101802754|NCT00904904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101802755|NCT00904904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101802756|NCT00904904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101802757|NCT00904904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101802758|NCT00904904|Analgesics|analgesics|mesh-ancestor
101802759|NCT00904904|Sensory System Agents|sensory system agents|mesh-ancestor
101802760|NCT00904904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101802761|NCT00904904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802762|NCT00904904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101802763|NCT00904904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101802764|NCT00904904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101802765|NCT00904904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101802766|NCT00904904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802767|NCT00904904|Gout Suppressants|gout suppressants|mesh-ancestor
101802768|NCT00904904|Tocolytic Agents|tocolytic agents|mesh-ancestor
101802769|NCT00904904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101802770|NCT00731861|Paclitaxel|paclitaxel|mesh-list
101802771|NCT00731861|Vatalanib|vatalanib|mesh-list
101802772|NCT00731861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101802773|NCT00731861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101802774|NCT00731861|Tubulin Modulators|tubulin modulators|mesh-ancestor
101802775|NCT00731861|Antimitotic Agents|antimitotic agents|mesh-ancestor
101802776|NCT00731861|Mitosis Modulators|mitosis modulators|mesh-ancestor
101802777|NCT00731861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802778|NCT00731861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101802779|NCT00731861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101802780|NCT00567476|Omalizumab|omalizumab|mesh-list
101802781|NCT00567476|Terbutaline|terbutaline|mesh-list
101802782|NCT00567476|Adrenergic Agents|adrenergic agents|mesh-list
101802783|NCT00567476|Adrenergic Agonists|adrenergic agonists|mesh-list
101802784|NCT00567476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101802785|NCT00567476|Autonomic Agents|autonomic agents|mesh-ancestor
101802786|NCT00567476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101802787|NCT00567476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802788|NCT00567476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101802789|NCT00567476|Respiratory System Agents|respiratory system agents|mesh-ancestor
101802790|NCT00567476|Tocolytic Agents|tocolytic agents|mesh-ancestor
101802791|NCT00567476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101802792|NCT00567476|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101802793|NCT00567476|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101802794|NCT00567476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101802795|NCT00567476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802796|NCT00567476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101802797|NCT00567476|Sympathomimetics|sympathomimetics|mesh-ancestor
101802798|NCT00729911|Amiodarone|amiodarone|mesh-list
101802800|NCT00729911|Vasodilator Agents|vasodilator agents|mesh-ancestor
101802801|NCT00729911|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101802802|NCT00729911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101802803|NCT00729911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802804|NCT00729911|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101802805|NCT00729911|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101802806|NCT00729911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101802807|NCT00729911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101802808|NCT00729911|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101802809|NCT00729911|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101802810|NCT00729911|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101802812|NCT04018703|Dexmedetomidine|dexmedetomidine|mesh-list
101802813|NCT04018703|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101802814|NCT04018703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101802815|NCT04018703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802818|NCT04018703|Sensory System Agents|sensory system agents|mesh-ancestor
101802819|NCT04018703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101802820|NCT04018703|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101802821|NCT04018703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101802822|NCT04018703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101802823|NCT04018703|Adrenergic Agents|adrenergic agents|mesh-ancestor
101802824|NCT04018703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101802825|NCT04018703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802826|NCT04018703|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101802827|NCT04018703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101802828|NCT04018703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101802829|NCT04018703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101802830|NCT04018703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101802831|NCT04018703|Anesthetics, General|anesthetics, general|mesh-ancestor
101802833|NCT04018703|GABA Modulators|gaba modulators|mesh-ancestor
101802834|NCT04018703|GABA Agents|gaba agents|mesh-ancestor
101802835|NCT04629872|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101802836|NCT04629872|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101802837|NCT04629872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802838|NCT04629872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101802840|NCT04629872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802842|NCT04065581|Acarbose|acarbose|mesh-list
101802843|NCT04065581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101802844|NCT04065581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802845|NCT04065581|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101802846|NCT04065581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101802847|NCT04065581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802849|NCT00733889|Fluorouracil|fluorouracil|mesh-list
101802850|NCT00733889|Cetuximab|cetuximab|mesh-list
101802851|NCT00733889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101802852|NCT00733889|Tubulin Modulators|tubulin modulators|mesh-ancestor
101802853|NCT00733889|Antimitotic Agents|antimitotic agents|mesh-ancestor
101802854|NCT00733889|Mitosis Modulators|mitosis modulators|mesh-ancestor
101802855|NCT00733889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802856|NCT00733889|Antimetabolites|antimetabolites|mesh-ancestor
101802857|NCT00733889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101802858|NCT00733889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101802859|NCT00733889|Immunologic Factors|immunologic factors|mesh-ancestor
101802860|NCT00733889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802861|NCT00733889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101802863|NCT00733967|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101802864|NCT00733967|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101802865|NCT00733967|Cholinergic Agents|cholinergic agents|mesh-ancestor
101802866|NCT00733967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101802867|NCT00733967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802868|NCT00733967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802869|NCT04650243|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101802870|NCT04650243|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101802871|NCT04650243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101802872|NCT00738569|Raltegravir Potassium|raltegravir potassium|mesh-list
101802874|NCT00738569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101802875|NCT00738569|Antiviral Agents|antiviral agents|mesh-ancestor
101802876|NCT00738569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101802877|NCT00738569|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101802878|NCT00738569|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101802880|NCT00738569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802881|NCT04644627|Gentamicins|gentamicins|mesh-list
101802882|NCT04644627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101802883|NCT04644627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101802884|NCT04644627|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101802885|NCT04644627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101802886|NCT04644627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802887|NCT00732407|Losartan|losartan|mesh-list
101802888|NCT00732407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101802889|NCT00732407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101802890|NCT00732407|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101802891|NCT00732407|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101802892|NCT00732407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802893|NCT00507819|Sildenafil Citrate|sildenafil citrate|mesh-list
101802894|NCT00507819|Vasodilator Agents|vasodilator agents|mesh-ancestor
101802895|NCT00507819|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101802896|NCT00507819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101802897|NCT00507819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101802898|NCT00507819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802900|NCT02569307|Minocycline|minocycline|mesh-list
101333906|NCT00017433|Arsenic Trioxide|arsenic trioxide|mesh-list
101802901|NCT02569307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101802902|NCT02569307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101802903|NCT01013103|Atorvastatin|atorvastatin|mesh-list
101802904|NCT01013103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101802905|NCT01013103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101802906|NCT01013103|Antimetabolites|antimetabolites|mesh-ancestor
101802907|NCT01013103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802908|NCT01013103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101802909|NCT01013103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101802910|NCT01013103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101802911|NCT00732485|Fenofibrate|fenofibrate|mesh-list
101802912|NCT00732485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101802913|NCT00732485|Antimetabolites|antimetabolites|mesh-ancestor
101802914|NCT00732485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802915|NCT00732485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101802917|NCT02569073|Hallucinogens|hallucinogens|mesh-ancestor
101802918|NCT02569073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802919|NCT02569073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101802920|NCT02569073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101802921|NCT02569073|Analgesics|analgesics|mesh-ancestor
101802922|NCT02569073|Sensory System Agents|sensory system agents|mesh-ancestor
101802923|NCT02569073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101802924|NCT02569073|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101802925|NCT02569073|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101802926|NCT02569073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101802927|NCT02569073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802928|NCT02569073|Hormones|hormones|mesh-ancestor
101802929|NCT02569073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101802931|NCT00732563|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101802932|NCT00732563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802933|NCT00734123|Aspirin|aspirin|mesh-list
101802934|NCT00734123|Rimonabant|rimonabant|mesh-list
101802935|NCT00734123|Enalapril|enalapril|mesh-list
101802936|NCT00734123|Clopidogrel|clopidogrel|mesh-list
101802937|NCT00734123|Atorvastatin|atorvastatin|mesh-list
101802938|NCT00734123|Simvastatin|simvastatin|mesh-list
101802939|NCT00734123|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101802940|NCT00734123|Diuretics|diuretics|mesh-list
101802942|NCT00734123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101802943|NCT00734123|Analgesics|analgesics|mesh-ancestor
101802944|NCT00734123|Sensory System Agents|sensory system agents|mesh-ancestor
101802945|NCT00734123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101802946|NCT00734123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802947|NCT00734123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101802948|NCT00734123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101802949|NCT00734123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101802950|NCT00734123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101802951|NCT00734123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802952|NCT00734123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101802954|NCT00734123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101802956|NCT00734123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101802957|NCT00734123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101802958|NCT00734123|Antimetabolites|antimetabolites|mesh-ancestor
101802959|NCT00734123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101802960|NCT00734123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101802961|NCT00734123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101802962|NCT00734123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101802963|NCT00734123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101802964|NCT00734123|Purinergic Agents|purinergic agents|mesh-ancestor
101802965|NCT00734123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101802966|NCT00734123|Protease Inhibitors|protease inhibitors|mesh-ancestor
101802967|NCT00734123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101802968|NCT00734123|Natriuretic Agents|natriuretic agents|mesh-ancestor
101802969|NCT00734123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101802970|NCT00734123|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
101802971|NCT00734123|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101802972|NCT00734123|Hormones|hormones|mesh-ancestor
101802973|NCT00734123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101802977|NCT00734279|Fertility Agents|fertility agents|mesh-ancestor
101802978|NCT00734279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101802979|NCT00734279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802980|NCT00734279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101802981|NCT00734279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101802982|NCT00734279|Hormone Antagonists|hormone antagonists|mesh-ancestor
101802983|NCT00734279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101802984|NCT00442936|Oxazolidinones|oxazolidinones|mesh-list
101802985|NCT00442936|Zolmitriptan|zolmitriptan|mesh-list
101802986|NCT00442936|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101802987|NCT00442936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101802989|NCT00442936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101802990|NCT00442936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101802991|NCT00442936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101802992|NCT00442936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101802993|NCT00442936|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101802994|NCT00442936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101802996|NCT03410043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101802997|NCT03410043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101802998|NCT03410043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101802999|NCT03410043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803000|NCT00732953|Paclitaxel|paclitaxel|mesh-list
101803001|NCT00732953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101803002|NCT00732953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101803003|NCT00732953|Tubulin Modulators|tubulin modulators|mesh-ancestor
101803004|NCT00732953|Antimitotic Agents|antimitotic agents|mesh-ancestor
101803005|NCT00732953|Mitosis Modulators|mitosis modulators|mesh-ancestor
101803006|NCT00732953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803007|NCT00577655|Albuterol|albuterol|mesh-list
101803008|NCT00577655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101803009|NCT00577655|Autonomic Agents|autonomic agents|mesh-ancestor
101803010|NCT00577655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101803011|NCT00577655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803012|NCT00577655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101803013|NCT00577655|Respiratory System Agents|respiratory system agents|mesh-ancestor
101803014|NCT00577655|Tocolytic Agents|tocolytic agents|mesh-ancestor
101803015|NCT00577655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101803016|NCT00577655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101803017|NCT00577655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101803018|NCT00577655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101803019|NCT00577655|Adrenergic Agents|adrenergic agents|mesh-ancestor
101803020|NCT00577655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101803021|NCT00577655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803022|NCT00733031|Gemcitabine|gemcitabine|mesh-list
101803023|NCT00733031|Pemetrexed|pemetrexed|mesh-list
101803024|NCT00733031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101803025|NCT00733031|Antimetabolites|antimetabolites|mesh-ancestor
101803026|NCT00733031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803028|NCT00733031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101803029|NCT00733031|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101803030|NCT00733031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101803031|NCT00734669|Glyburide|glyburide|mesh-list
101803032|NCT00734669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101803033|NCT00734669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803034|NCT00113269|Mycophenolic Acid|mycophenolic acid|mesh-list
101803035|NCT00113269|Alemtuzumab|alemtuzumab|mesh-list
101803036|NCT00113269|Tacrolimus|tacrolimus|mesh-list
101803037|NCT00113269|Thymoglobulin|thymoglobulin|mesh-list
101803038|NCT00113269|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101803039|NCT00113269|Basiliximab|basiliximab|mesh-list
101803040|NCT00113269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101803041|NCT00113269|Immunologic Factors|immunologic factors|mesh-ancestor
101803042|NCT00113269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803043|NCT00113269|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101803044|NCT00113269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101803045|NCT00113269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803046|NCT00113269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101803047|NCT00113269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101803048|NCT00113269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101803049|NCT00113269|Antitubercular Agents|antitubercular agents|mesh-ancestor
101803050|NCT00113269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101803051|NCT00113269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101803052|NCT00113269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101803053|NCT04065269|Olaparib|olaparib|mesh-list
101803058|NCT00515619|Lacosamide|lacosamide|mesh-list
101803059|NCT00515619|Anticonvulsants|anticonvulsants|mesh-ancestor
101803060|NCT00515619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101803061|NCT00515619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101803063|NCT00515619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803067|NCT01815359|Antidotes|antidotes|mesh-ancestor
101803068|NCT01815359|Protective Agents|protective agents|mesh-ancestor
101803069|NCT01815359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803070|NCT01815359|Vitamin B Complex|vitamin b complex|mesh-ancestor
101803071|NCT01815359|Vitamins|vitamins|mesh-ancestor
101803072|NCT01815359|Micronutrients|micronutrients|mesh-ancestor
101803073|NCT01815359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101803074|NCT01815359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101803075|NCT01815359|Alkylating Agents|alkylating agents|mesh-ancestor
101803076|NCT01815359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803077|NCT01815359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101803078|NCT01815359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101803079|NCT00449644|Bedaquiline|bedaquiline|mesh-list
101803081|NCT00449644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101803082|NCT00449644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101803083|NCT00733265|Ticagrelor|ticagrelor|mesh-list
101803084|NCT00733265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101803085|NCT00733265|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101803086|NCT00733265|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101803087|NCT00733265|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101803088|NCT00733265|Purinergic Agents|purinergic agents|mesh-ancestor
101803089|NCT00733265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101803090|NCT00733265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803091|NCT00733265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803092|NCT00112489|Paclitaxel|paclitaxel|mesh-list
101803093|NCT00112489|Carboplatin|carboplatin|mesh-list
101803094|NCT00112489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101803095|NCT00112489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101803096|NCT00112489|Tubulin Modulators|tubulin modulators|mesh-ancestor
101803097|NCT00112489|Antimitotic Agents|antimitotic agents|mesh-ancestor
101803098|NCT00112489|Mitosis Modulators|mitosis modulators|mesh-ancestor
101803099|NCT00112489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803101|NCT01023100|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101311143|NCT00006399|Cholinergic Agents|cholinergic agents|mesh-ancestor
101803102|NCT01023100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101803103|NCT01023100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101803104|NCT01023100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803105|NCT00515463|Denosumab|denosumab|mesh-list
101803106|NCT00515463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101803107|NCT00515463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803108|NCT01082731|Artesunate|artesunate|mesh-list
101803109|NCT01082731|Lumefantrine|lumefantrine|mesh-list
101803110|NCT01082731|Artemether|artemether|mesh-list
101803111|NCT01082731|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101803112|NCT01082731|Mefloquine|mefloquine|mesh-list
101803113|NCT01082731|Antimalarials|antimalarials|mesh-ancestor
101803114|NCT01082731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101803115|NCT01082731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101803116|NCT01082731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101803117|NCT01082731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101803118|NCT01082731|Antiviral Agents|antiviral agents|mesh-ancestor
101803119|NCT01082731|Schistosomicides|schistosomicides|mesh-ancestor
101803120|NCT01082731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101803121|NCT01082731|Anthelmintics|anthelmintics|mesh-ancestor
101803122|NCT00739193|Amiodarone|amiodarone|mesh-list
101803123|NCT00739193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101803124|NCT00739193|Vasodilator Agents|vasodilator agents|mesh-ancestor
101803125|NCT00739193|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101803126|NCT00739193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101803127|NCT00739193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803129|NCT00739193|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101803130|NCT00739193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101803131|NCT00739193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101803132|NCT00739193|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101803133|NCT00739193|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101803134|NCT00739193|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101803135|NCT01011543|Dimercaprol|dimercaprol|mesh-list
101803136|NCT01011543|Chelating Agents|chelating agents|mesh-ancestor
101803137|NCT01011543|Sequestering Agents|sequestering agents|mesh-ancestor
101803138|NCT01011543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803139|NCT00733811|Deferiprone|deferiprone|mesh-list
101803140|NCT00733811|Deferoxamine|deferoxamine|mesh-list
101803141|NCT00733811|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101803142|NCT00733811|Chelating Agents|chelating agents|mesh-ancestor
101803143|NCT00733811|Sequestering Agents|sequestering agents|mesh-ancestor
101803144|NCT00733811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803145|NCT00733811|Siderophores|siderophores|mesh-ancestor
101803146|NCT00739505|Immunoglobulin G|immunoglobulin g|mesh-list
101803147|NCT00739505|Immunologic Factors|immunologic factors|mesh-ancestor
101803148|NCT00739505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803149|NCT00507507|Tenofovir|tenofovir|mesh-list
101803150|NCT00507507|Antiviral Agents|antiviral agents|mesh-ancestor
101803151|NCT00507507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101803152|NCT00507507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101803153|NCT00507507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101803154|NCT00507507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101803155|NCT00507507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803156|NCT00507507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101803157|NCT00507507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101803158|NCT00459706|Etanercept|etanercept|mesh-list
101803159|NCT00459706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101803160|NCT00459706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101803162|NCT00459706|Sensory System Agents|sensory system agents|mesh-ancestor
101803163|NCT00459706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101803164|NCT00459706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803165|NCT00459706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101803166|NCT00459706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101803167|NCT00459706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101803168|NCT00459706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101803169|NCT00459706|Immunologic Factors|immunologic factors|mesh-ancestor
101803170|NCT00735527|Lorazepam|lorazepam|mesh-list
101803171|NCT00735527|Anticonvulsants|anticonvulsants|mesh-ancestor
101803172|NCT00735527|Antiemetics|antiemetics|mesh-ancestor
101803173|NCT00735527|Autonomic Agents|autonomic agents|mesh-ancestor
101803174|NCT00735527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101460518|NCT00415116|Carboplatin|carboplatin|mesh-list
101803175|NCT00735527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803176|NCT00735527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101803177|NCT00735527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101803178|NCT00735527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101803179|NCT00735527|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101803180|NCT00735527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101803181|NCT00735527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101803182|NCT00735527|GABA Modulators|gaba modulators|mesh-ancestor
101803183|NCT00735527|GABA Agents|gaba agents|mesh-ancestor
101803184|NCT00735527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101803185|NCT00735527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803186|NCT00735761|Acyclovir|acyclovir|mesh-list
101803189|NCT00735761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101803190|NCT00735761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101803191|NCT00740285|Lidocaine|lidocaine|mesh-list
101803192|NCT00740285|Anesthetics, Local|anesthetics, local|mesh-ancestor
101803193|NCT00740285|Anesthetics|anesthetics|mesh-ancestor
101803194|NCT00740285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101803195|NCT00740285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803196|NCT00740285|Sensory System Agents|sensory system agents|mesh-ancestor
101803197|NCT00740285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101803198|NCT00740285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101803199|NCT00740285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101803200|NCT00740285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101803201|NCT00740285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101803202|NCT00740285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803203|NCT00507429|Paclitaxel|paclitaxel|mesh-list
101803204|NCT00507429|Fosbretabulin|fosbretabulin|mesh-list
101803205|NCT00507429|Combretastatin|combretastatin|mesh-list
101803206|NCT00507429|Carboplatin|carboplatin|mesh-list
101803207|NCT00507429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101803208|NCT00507429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101803209|NCT00507429|Tubulin Modulators|tubulin modulators|mesh-ancestor
101803210|NCT00507429|Antimitotic Agents|antimitotic agents|mesh-ancestor
101803211|NCT00507429|Mitosis Modulators|mitosis modulators|mesh-ancestor
101803212|NCT00507429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803213|NCT01011621|Prednisolone|prednisolone|mesh-list
101803214|NCT01011621|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101803215|NCT01011621|Methylprednisolone|methylprednisolone|mesh-list
101803216|NCT01011621|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101803217|NCT01011621|Prednisolone acetate|prednisolone acetate|mesh-list
101803218|NCT01011621|Betamethasone|betamethasone|mesh-list
101803220|NCT01011621|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101803221|NCT01011621|Betamethasone benzoate|betamethasone benzoate|mesh-list
101803222|NCT01011621|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101803223|NCT01011621|Prednisolone phosphate|prednisolone phosphate|mesh-list
101803224|NCT01011621|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101803225|NCT01011621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101803226|NCT01011621|Glucocorticoids|glucocorticoids|mesh-ancestor
101803227|NCT01011621|Hormones|hormones|mesh-ancestor
101803228|NCT01011621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101803229|NCT01011621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803230|NCT01011621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101803231|NCT01011621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101803232|NCT01011621|Antiemetics|antiemetics|mesh-ancestor
101803233|NCT01011621|Autonomic Agents|autonomic agents|mesh-ancestor
101803234|NCT01011621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101803235|NCT01011621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101803236|NCT01011621|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101803237|NCT01011621|Protective Agents|protective agents|mesh-ancestor
101803238|NCT01011621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101803239|NCT01011621|Respiratory System Agents|respiratory system agents|mesh-ancestor
101803240|NCT00449176|Oxycodone|oxycodone|mesh-list
101803241|NCT00449176|Tapentadol|tapentadol|mesh-list
101803242|NCT00449176|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101803243|NCT00449176|Narcotics|narcotics|mesh-ancestor
101803244|NCT00449176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101803245|NCT00449176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803246|NCT00449176|Analgesics|analgesics|mesh-ancestor
101803247|NCT00449176|Sensory System Agents|sensory system agents|mesh-ancestor
101803248|NCT00449176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101803249|NCT00449176|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101803250|NCT00449176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101803251|NCT00449176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101246500|NCT01666379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101803252|NCT00449176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803253|NCT00449176|Adrenergic Agents|adrenergic agents|mesh-ancestor
101803254|NCT00449176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101803255|NCT00515073|Diphenhydramine|diphenhydramine|mesh-list
101803256|NCT00515073|Promethazine|promethazine|mesh-list
101803257|NCT00515073|Dexamethasone|dexamethasone|mesh-list
101803259|NCT00515073|Cimetidine|cimetidine|mesh-list
101803260|NCT00515073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101803261|NCT00515073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101803262|NCT00515073|Tubulin Modulators|tubulin modulators|mesh-ancestor
101803263|NCT00515073|Antimitotic Agents|antimitotic agents|mesh-ancestor
101803264|NCT00515073|Mitosis Modulators|mitosis modulators|mesh-ancestor
101803265|NCT00515073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803266|NCT00515073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101803267|NCT00515073|Antiemetics|antiemetics|mesh-ancestor
101803268|NCT00515073|Autonomic Agents|autonomic agents|mesh-ancestor
101803269|NCT00515073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101803270|NCT00515073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803271|NCT00515073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101803272|NCT00515073|Glucocorticoids|glucocorticoids|mesh-ancestor
101803274|NCT00515073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101803275|NCT00515073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101803276|NCT00515073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101803277|NCT00515073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101246501|NCT01666379|Anesthetics, General|anesthetics, general|mesh-ancestor
101803278|NCT00515073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101803279|NCT00515073|Anesthetics, Local|anesthetics, local|mesh-ancestor
101803280|NCT00515073|Anesthetics|anesthetics|mesh-ancestor
101803281|NCT00515073|Sensory System Agents|sensory system agents|mesh-ancestor
101803282|NCT00515073|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101803283|NCT00515073|Histamine Antagonists|histamine antagonists|mesh-ancestor
101803284|NCT00515073|Histamine Agents|histamine agents|mesh-ancestor
101803285|NCT00515073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101803286|NCT00515073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101803287|NCT00515073|Antipruritics|antipruritics|mesh-ancestor
101803288|NCT00515073|Dermatologic Agents|dermatologic agents|mesh-ancestor
101803289|NCT00515073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101803290|NCT00515073|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101803291|NCT00515073|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101803292|NCT00515073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101803293|NCT00515073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101803294|NCT00710021|Vitamin D|vitamin d|mesh-list
101803295|NCT00710021|Ergocalciferols|ergocalciferols|mesh-list
101803296|NCT00710021|Cholecalciferol|cholecalciferol|mesh-list
101803297|NCT00710021|Vitamins|vitamins|mesh-list
101803298|NCT00710021|Micronutrients|micronutrients|mesh-ancestor
101803299|NCT00710021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803300|NCT00710021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101803301|NCT00710021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101803302|NCT00504153|Dasatinib|dasatinib|mesh-list
101803303|NCT00504153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101803304|NCT00504153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101803305|NCT00504153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101803306|NCT00504153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803307|NCT00740363|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101803308|NCT00740363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101803309|NCT00740363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803310|NCT00740363|Incretins|incretins|mesh-ancestor
101803311|NCT00740363|Hormones|hormones|mesh-ancestor
101803312|NCT00740363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101803313|NCT00740363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101803314|NCT00740363|Protease Inhibitors|protease inhibitors|mesh-ancestor
101803315|NCT00740363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101803316|NCT00740363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803317|NCT04065035|Sunscreening Agents|sunscreening agents|mesh-list
101803319|NCT04065035|Protective Agents|protective agents|mesh-ancestor
101803320|NCT04065035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803321|NCT04065035|Dermatologic Agents|dermatologic agents|mesh-ancestor
101803322|NCT00442702|Darbepoetin alfa|darbepoetin alfa|mesh-list
101803323|NCT00442702|Hematinics|hematinics|mesh-ancestor
101803324|NCT00740519|Insulin Detemir|insulin detemir|mesh-list
101460659|NCT00569920|Glucocorticoids|glucocorticoids|mesh-ancestor
101803325|NCT00740519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101803326|NCT00740519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803328|NCT00514917|Leuprolide|leuprolide|mesh-list
101803329|NCT00514917|Bicalutamide|bicalutamide|mesh-list
101803330|NCT00514917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101803331|NCT00514917|Tubulin Modulators|tubulin modulators|mesh-ancestor
101803332|NCT00514917|Antimitotic Agents|antimitotic agents|mesh-ancestor
101803333|NCT00514917|Mitosis Modulators|mitosis modulators|mesh-ancestor
101803335|NCT00514917|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101803336|NCT00514917|Fertility Agents|fertility agents|mesh-ancestor
101803337|NCT00514917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101803338|NCT00514917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803339|NCT00514917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101803340|NCT00514917|Androgen Antagonists|androgen antagonists|mesh-ancestor
101803341|NCT00514917|Hormone Antagonists|hormone antagonists|mesh-ancestor
101803342|NCT00514917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101803343|NCT01011699|Niacinamide|niacinamide|mesh-list
101803344|NCT01011699|Niacin|niacin|mesh-list
101803345|NCT01011699|Nicotinic Acids|nicotinic acids|mesh-list
101803346|NCT01011699|Sevelamer|sevelamer|mesh-list
101803347|NCT01011699|Cinacalcet|cinacalcet|mesh-list
101803348|NCT01011699|Vitamin B Complex|vitamin b complex|mesh-ancestor
101803349|NCT01011699|Vitamins|vitamins|mesh-ancestor
101803350|NCT01011699|Micronutrients|micronutrients|mesh-ancestor
101803351|NCT01011699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803352|NCT01011699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101803353|NCT01011699|Antimetabolites|antimetabolites|mesh-ancestor
101803354|NCT01011699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803355|NCT01011699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101803356|NCT01011699|Vasodilator Agents|vasodilator agents|mesh-ancestor
101803357|NCT01011699|Chelating Agents|chelating agents|mesh-ancestor
101803358|NCT01011699|Sequestering Agents|sequestering agents|mesh-ancestor
101803359|NCT01011699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101803360|NCT01011699|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101803361|NCT01011699|Hormone Antagonists|hormone antagonists|mesh-ancestor
101803362|NCT01011699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101803364|NCT00504075|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101803366|NCT00504075|gamma-Globulins|gamma-globulins|mesh-list
101803367|NCT00504075|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101803368|NCT00504075|Immunologic Factors|immunologic factors|mesh-ancestor
101803369|NCT00504075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803370|NCT00503997|Oxaliplatin|oxaliplatin|mesh-list
101803371|NCT00503997|Pemetrexed|pemetrexed|mesh-list
101803372|NCT00503997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101803373|NCT00503997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101803374|NCT00503997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803375|NCT00503997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101803376|NCT00503997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101803377|NCT00741143|Fe(III)-EDTA|fe(iii)-edta|mesh-list
101803378|NCT00741143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101803379|NCT00741143|Chelating Agents|chelating agents|mesh-ancestor
101803381|NCT00741143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803382|NCT00736463|Atorvastatin|atorvastatin|mesh-list
101803383|NCT00736463|Simvastatin|simvastatin|mesh-list
101803384|NCT00736463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101803385|NCT00736463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101803386|NCT00736463|Antimetabolites|antimetabolites|mesh-ancestor
101803387|NCT00736463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803388|NCT00736463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101803389|NCT00736463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101803390|NCT00736463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101803391|NCT00736541|Acetylcysteine|acetylcysteine|mesh-list
101803392|NCT00736541|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101803394|NCT00736541|Antiviral Agents|antiviral agents|mesh-ancestor
101803395|NCT00736541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101803396|NCT00736541|Expectorants|expectorants|mesh-ancestor
101803398|NCT00736541|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101803399|NCT00736541|Antioxidants|antioxidants|mesh-ancestor
101803400|NCT00736541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803401|NCT00736541|Protective Agents|protective agents|mesh-ancestor
101460732|NCT00570622|Pioglitazone|pioglitazone|mesh-list
101803402|NCT00736541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803403|NCT00736541|Antidotes|antidotes|mesh-ancestor
101803404|NCT00736541|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
101803405|NCT00736541|Protease Inhibitors|protease inhibitors|mesh-ancestor
101803406|NCT00736541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101803407|NCT00096265|Temozolomide|temozolomide|mesh-list
101803408|NCT00096265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101803409|NCT00096265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101803410|NCT00096265|Alkylating Agents|alkylating agents|mesh-ancestor
101803411|NCT00096265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803412|NCT00096265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101803413|NCT00096265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101803414|NCT00096265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101803416|NCT01082809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101803417|NCT01082809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101803418|NCT01082809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101803419|NCT01082809|Growth Substances|growth substances|mesh-ancestor
101803420|NCT01082809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803421|NCT01082809|Growth Inhibitors|growth inhibitors|mesh-ancestor
101803422|NCT01082809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101803423|NCT01082809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101803424|NCT01082809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803426|NCT01080469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101803427|NCT01080469|Immunologic Factors|immunologic factors|mesh-ancestor
101803428|NCT01080469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803429|NCT01080469|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101803430|NCT01080469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101803431|NCT01080469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803432|NCT01079065|Famotidine|famotidine|mesh-list
101803433|NCT01079065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101803434|NCT01079065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101803435|NCT01079065|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101810138|NCT04266795|Azacitidine|azacitidine|mesh-list
101803436|NCT01079065|Histamine Antagonists|histamine antagonists|mesh-ancestor
101803438|NCT01079065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101803439|NCT01079065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803440|NCT01079065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803442|NCT00711191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101803443|NCT00711191|Immunologic Factors|immunologic factors|mesh-ancestor
101803444|NCT00711191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803446|NCT00741221|Pemetrexed|pemetrexed|mesh-list
101803447|NCT00741221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101803448|NCT00741221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101803449|NCT00741221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101803450|NCT00741221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101803451|NCT00741221|Growth Substances|growth substances|mesh-ancestor
101803452|NCT00741221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803453|NCT00741221|Growth Inhibitors|growth inhibitors|mesh-ancestor
101803454|NCT00741221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101803455|NCT00741221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803456|NCT00741221|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101803457|NCT00741221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101803458|NCT00736619|Paclitaxel|paclitaxel|mesh-list
101803459|NCT00736619|Cetuximab|cetuximab|mesh-list
101803460|NCT00736619|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101803461|NCT00736619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101803462|NCT00736619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101803463|NCT00736619|Tubulin Modulators|tubulin modulators|mesh-ancestor
101803464|NCT00736619|Antimitotic Agents|antimitotic agents|mesh-ancestor
101803465|NCT00736619|Mitosis Modulators|mitosis modulators|mesh-ancestor
101803466|NCT00736619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803467|NCT00736619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101803468|NCT00741377|Zoledronic Acid|zoledronic acid|mesh-list
101803469|NCT00741377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101803470|NCT00741377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803471|NCT05742269|Atezolizumab|atezolizumab|mesh-list
101803472|NCT05742269|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101803473|NCT05742269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803474|NCT05742269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101803475|NCT05742269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101460806|NCT00254631|Oxycodone|oxycodone|mesh-list
101803477|NCT00448864|Analgesics|analgesics|mesh-ancestor
101803478|NCT00448864|Sensory System Agents|sensory system agents|mesh-ancestor
101803479|NCT00448864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101803480|NCT00448864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803481|NCT00448864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101803482|NCT00448864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101803483|NCT00448864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101803484|NCT00448864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101803485|NCT00567398|Icodextrin|icodextrin|mesh-list
101803486|NCT00567398|Dialysis Solutions|dialysis solutions|mesh-ancestor
101803487|NCT00567398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101803488|NCT00448708|Paclitaxel|paclitaxel|mesh-list
101803489|NCT00448708|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101803490|NCT00448708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101803491|NCT00448708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101803492|NCT00448708|Tubulin Modulators|tubulin modulators|mesh-ancestor
101803493|NCT00448708|Antimitotic Agents|antimitotic agents|mesh-ancestor
101803494|NCT00448708|Mitosis Modulators|mitosis modulators|mesh-ancestor
101803495|NCT00448708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803496|NCT00925028|Warfarin|warfarin|mesh-list
101803497|NCT00925028|Anticoagulants|anticoagulants|mesh-ancestor
101803498|NCT00905216|Heparin|heparin|mesh-list
101803499|NCT00905216|Calcium heparin|calcium heparin|mesh-list
101803500|NCT00905216|Anticoagulants|anticoagulants|mesh-ancestor
101803501|NCT00905216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101803502|NCT00905216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101803503|NCT00905216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803504|NCT00929630|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101803505|NCT00929630|Hemostatics|hemostatics|mesh-ancestor
101803506|NCT00929630|Coagulants|coagulants|mesh-ancestor
101803507|NCT00925106|Celecoxib|celecoxib|mesh-list
101803508|NCT00925106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101803509|NCT00925106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101803510|NCT00925106|Analgesics|analgesics|mesh-ancestor
101803511|NCT00925106|Sensory System Agents|sensory system agents|mesh-ancestor
101803512|NCT00925106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101803513|NCT00925106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803514|NCT00925106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101803515|NCT00925106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101803516|NCT00925106|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101803517|NCT00925106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101803518|NCT00925106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101803519|NCT00925106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803520|NCT00905528|Telmisartan|telmisartan|mesh-list
101803521|NCT00905528|Ramipril|ramipril|mesh-list
101803522|NCT00905528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101803523|NCT00905528|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101803524|NCT00905528|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101803525|NCT00905528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803526|NCT00905528|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101803527|NCT00905528|Protease Inhibitors|protease inhibitors|mesh-ancestor
101803528|NCT00905528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101803529|NCT00736697|Moxidectin|moxidectin|mesh-list
101803530|NCT00736697|Anthelmintics|anthelmintics|mesh-ancestor
101803531|NCT00736697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101803532|NCT00736697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101803533|NCT00736697|Antinematodal Agents|antinematodal agents|mesh-ancestor
101803534|NCT02568995|Ketorolac|ketorolac|mesh-list
101803535|NCT02568995|Epinephrine|epinephrine|mesh-list
101803536|NCT02568995|Racepinephrine|racepinephrine|mesh-list
101803537|NCT02568995|Ropivacaine|ropivacaine|mesh-list
101803538|NCT02568995|Epinephryl borate|epinephryl borate|mesh-list
101803539|NCT02568995|Anesthetics, Local|anesthetics, local|mesh-ancestor
101803540|NCT02568995|Anesthetics|anesthetics|mesh-ancestor
101803541|NCT02568995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101803542|NCT02568995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803543|NCT02568995|Sensory System Agents|sensory system agents|mesh-ancestor
101803544|NCT02568995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101803545|NCT02568995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101803546|NCT02568995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101803547|NCT02568995|Analgesics|analgesics|mesh-ancestor
101803548|NCT02568995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101803549|NCT02568995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101803550|NCT02568995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101803551|NCT02568995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101803552|NCT02568995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803553|NCT02568995|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101803554|NCT02568995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101803555|NCT02568995|Adrenergic Agents|adrenergic agents|mesh-ancestor
101803556|NCT02568995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101803557|NCT02568995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101803558|NCT02568995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101803559|NCT02568995|Autonomic Agents|autonomic agents|mesh-ancestor
101803560|NCT02568995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101803561|NCT02568995|Respiratory System Agents|respiratory system agents|mesh-ancestor
101803562|NCT02568995|Mydriatics|mydriatics|mesh-ancestor
101803563|NCT02568995|Sympathomimetics|sympathomimetics|mesh-ancestor
101803564|NCT02568995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101803565|NCT00930020|Minocycline|minocycline|mesh-list
101803566|NCT00930020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101803567|NCT00930020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101803568|NCT00930098|Clofarabine|clofarabine|mesh-list
101803569|NCT00930098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101803570|NCT00930098|Antimetabolites|antimetabolites|mesh-ancestor
101803571|NCT00930098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803572|NCT00930098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101803573|NCT00905684|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
101803574|NCT00905684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101803575|NCT00905684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803576|NCT00905762|Moxifloxacin|moxifloxacin|mesh-list
101803577|NCT00905762|Gatifloxacin|gatifloxacin|mesh-list
101803578|NCT00905762|Besifloxacin|besifloxacin|mesh-list
101803579|NCT00905762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101803580|NCT00905762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101803581|NCT00905762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101803582|NCT00905762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101803583|NCT00905762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101803584|NCT00905762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803585|NCT00905762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101803586|NCT00905762|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101803587|NCT00905762|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101803589|NCT02568839|Trastuzumab|trastuzumab|mesh-list
101803590|NCT02568839|Pertuzumab|pertuzumab|mesh-list
101803591|NCT02568839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101803592|NCT02568839|Tubulin Modulators|tubulin modulators|mesh-ancestor
101803593|NCT02568839|Antimitotic Agents|antimitotic agents|mesh-ancestor
101803594|NCT02568839|Mitosis Modulators|mitosis modulators|mesh-ancestor
101803595|NCT02568839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803596|NCT02568839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101803597|NCT00930488|Moxifloxacin|moxifloxacin|mesh-list
101803598|NCT00930488|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101803599|NCT00930488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101803600|NCT00930488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101803602|NCT00930488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101803603|NCT00930488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101803604|NCT00930488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803605|NCT00930488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101803606|NCT00930488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101803607|NCT00930488|Contraceptive Agents|contraceptive agents|mesh-ancestor
101803608|NCT00930488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101803609|NCT00930488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803610|NCT00930488|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101803611|NCT00930488|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101803612|NCT00930488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101803613|NCT00736931|Levetiracetam|levetiracetam|mesh-list
101803614|NCT00736931|Lorazepam|lorazepam|mesh-list
101803615|NCT00736931|Brivaracetam|brivaracetam|mesh-list
101803616|NCT00736931|Anticonvulsants|anticonvulsants|mesh-ancestor
101803617|NCT00736931|Nootropic Agents|nootropic agents|mesh-ancestor
101803619|NCT00736931|Autonomic Agents|autonomic agents|mesh-ancestor
101803620|NCT00736931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101803621|NCT00736931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803622|NCT00736931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101803623|NCT00736931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101803624|NCT00736931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101803626|NCT00736931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101803628|NCT00736931|GABA Modulators|gaba modulators|mesh-ancestor
101803629|NCT00736931|GABA Agents|gaba agents|mesh-ancestor
101803630|NCT00736931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101803631|NCT00736931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803632|NCT00567164|Drospirenone|drospirenone|mesh-list
101803633|NCT00567164|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101803634|NCT00567164|Hormone Antagonists|hormone antagonists|mesh-ancestor
101803635|NCT00567164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101810176|NCT04201561|Paclitaxel|paclitaxel|mesh-list
101803636|NCT00567164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803637|NCT00567164|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101803639|NCT00567164|Natriuretic Agents|natriuretic agents|mesh-ancestor
101803640|NCT00920933|Prednisolone|prednisolone|mesh-list
101803641|NCT00920933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101803642|NCT00920933|Glucocorticoids|glucocorticoids|mesh-ancestor
101803643|NCT00920933|Hormones|hormones|mesh-ancestor
101803644|NCT00920933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101803645|NCT00920933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803646|NCT00920933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101803647|NCT00920933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101803648|NCT00930566|Methoxsalen|methoxsalen|mesh-list
101803649|NCT00930566|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101803650|NCT00930566|Dermatologic Agents|dermatologic agents|mesh-ancestor
101803651|NCT00925730|Pimecrolimus|pimecrolimus|mesh-list
101803652|NCT00925730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101803653|NCT00925730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101803654|NCT00925730|Analgesics|analgesics|mesh-ancestor
101803655|NCT00925730|Sensory System Agents|sensory system agents|mesh-ancestor
101803656|NCT00925730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101803657|NCT00925730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803658|NCT00925730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101803659|NCT00925730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101803660|NCT00925730|Dermatologic Agents|dermatologic agents|mesh-ancestor
101803661|NCT00925730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101803662|NCT00925730|Immunologic Factors|immunologic factors|mesh-ancestor
101803663|NCT00925730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101803664|NCT00925730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101803665|NCT00925730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803666|NCT00713219|Docetaxel|docetaxel|mesh-list
101803667|NCT00713219|Cetuximab|cetuximab|mesh-list
101803668|NCT00713219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101803669|NCT00713219|Tubulin Modulators|tubulin modulators|mesh-ancestor
101803670|NCT00713219|Antimitotic Agents|antimitotic agents|mesh-ancestor
101803671|NCT00713219|Mitosis Modulators|mitosis modulators|mesh-ancestor
101803672|NCT00713219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803673|NCT00713219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101803674|NCT00931580|Vitamin D|vitamin d|mesh-list
101803675|NCT00931580|Cholecalciferol|cholecalciferol|mesh-list
101803676|NCT00931580|Vitamins|vitamins|mesh-ancestor
101803677|NCT00931580|Micronutrients|micronutrients|mesh-ancestor
101803678|NCT00931580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803679|NCT00931580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101803680|NCT00931580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101803681|NCT05661461|Sirolimus|sirolimus|mesh-list
101803683|NCT05661461|MTOR Inhibitors|mtor inhibitors|mesh-list
101803684|NCT05661461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101803685|NCT05661461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101803686|NCT05661461|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101803687|NCT05661461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101803688|NCT05661461|Antifungal Agents|antifungal agents|mesh-ancestor
101803689|NCT05661461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101803690|NCT05661461|Immunologic Factors|immunologic factors|mesh-ancestor
101803691|NCT05661461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803692|NCT05661461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101803693|NCT05661461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101803694|NCT05661461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803695|NCT00931736|Rifampin|rifampin|mesh-list
101803696|NCT00931736|Isoniazid|isoniazid|mesh-list
101803697|NCT00931736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101803698|NCT00931736|Antitubercular Agents|antitubercular agents|mesh-ancestor
101803699|NCT00931736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101803700|NCT00931736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101803701|NCT00931736|Leprostatic Agents|leprostatic agents|mesh-ancestor
101803703|NCT00931736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101803704|NCT00931736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803705|NCT00931736|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101803706|NCT00931736|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101803707|NCT00931736|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101803708|NCT00931736|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101803709|NCT00931736|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101803710|NCT00931736|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101803711|NCT00931736|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101803712|NCT00931736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101803713|NCT00931736|Antimetabolites|antimetabolites|mesh-ancestor
101803714|NCT00931736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101803715|NCT02567981|Vitamin A|vitamin a|mesh-list
101803716|NCT02567981|Micronutrients|micronutrients|mesh-list
101803717|NCT02567981|Trace Elements|trace elements|mesh-list
101803718|NCT02567981|Vitamins|vitamins|mesh-ancestor
101803719|NCT02567981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803720|NCT00737555|Tosedostat|tosedostat|mesh-list
101803721|NCT00737555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101803722|NCT00737555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803723|NCT00932048|Atorvastatin|atorvastatin|mesh-list
101803724|NCT00932048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101803725|NCT00932048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101803726|NCT00932048|Antimetabolites|antimetabolites|mesh-ancestor
101803727|NCT00932048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803728|NCT00932048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101803729|NCT00932048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101803730|NCT00932048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101803731|NCT04015778|Paclitaxel|paclitaxel|mesh-list
101803732|NCT04015778|Carboplatin|carboplatin|mesh-list
101803733|NCT04015778|Nivolumab|nivolumab|mesh-list
101803734|NCT04015778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101803735|NCT04015778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101803736|NCT04015778|Tubulin Modulators|tubulin modulators|mesh-ancestor
101803737|NCT04015778|Antimitotic Agents|antimitotic agents|mesh-ancestor
101803738|NCT04015778|Mitosis Modulators|mitosis modulators|mesh-ancestor
101828155|NCT05923996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803739|NCT04015778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803740|NCT04015778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101803741|NCT04015778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101803742|NCT00926354|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
101803743|NCT00926354|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101803744|NCT00926354|Immunologic Factors|immunologic factors|mesh-ancestor
101803745|NCT00926354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311209|NCT05470816|Tranexamic Acid|tranexamic acid|mesh-list
101803746|NCT00926354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101803747|NCT00926354|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101803748|NCT00926354|Protective Agents|protective agents|mesh-ancestor
101803749|NCT00926354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101803750|NCT00926354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101803751|NCT00926354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101803752|NCT00926354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803753|NCT00926354|Antiviral Agents|antiviral agents|mesh-ancestor
101803754|NCT00926354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101803755|NCT00712985|Zoledronic Acid|zoledronic acid|mesh-list
101803756|NCT00712985|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101803757|NCT00712985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803759|NCT00737789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101803760|NCT00737789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101803761|NCT00737789|Analgesics|analgesics|mesh-ancestor
101803762|NCT00737789|Sensory System Agents|sensory system agents|mesh-ancestor
101803763|NCT00737789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101803764|NCT00737789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803765|NCT00737789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101803766|NCT00737789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101803767|NCT00700115|Ritonavir|ritonavir|mesh-list
101803768|NCT00700115|Lopinavir|lopinavir|mesh-list
101803769|NCT00700115|Raltegravir Potassium|raltegravir potassium|mesh-list
101803770|NCT00700115|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101803771|NCT00700115|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101803772|NCT00700115|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101803773|NCT00700115|Protease Inhibitors|protease inhibitors|mesh-ancestor
101803774|NCT00700115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101803775|NCT00700115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803776|NCT00700115|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101803777|NCT00700115|Antiviral Agents|antiviral agents|mesh-ancestor
101803778|NCT00700115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101803779|NCT00700115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101803780|NCT00700115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101803781|NCT00700115|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101803782|NCT00700115|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101803783|NCT05556473|Tryptophan|tryptophan|mesh-list
101803784|NCT05556473|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101803785|NCT05556473|Antidepressive Agents|antidepressive agents|mesh-ancestor
101803786|NCT05556473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101803787|NCT00566852|Memantine|memantine|mesh-list
101803788|NCT00566852|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101803789|NCT00566852|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101803791|NCT00566852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101803792|NCT00566852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803793|NCT00566852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803794|NCT00566852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101803795|NCT00566852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101803796|NCT00936650|Cinacalcet|cinacalcet|mesh-list
101803797|NCT00936650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101803798|NCT00936650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803799|NCT00936650|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101803800|NCT00936650|Hormone Antagonists|hormone antagonists|mesh-ancestor
101803801|NCT00936650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101803802|NCT00442546|Pregabalin|pregabalin|mesh-list
101803803|NCT00442546|Analgesics|analgesics|mesh-ancestor
101803804|NCT00442546|Sensory System Agents|sensory system agents|mesh-ancestor
101803805|NCT00442546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101803806|NCT00442546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803807|NCT00442546|Anticonvulsants|anticonvulsants|mesh-ancestor
101803808|NCT00442546|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101803809|NCT00442546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101803810|NCT00442546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311210|NCT05470816|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101803811|NCT00442546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101803812|NCT00442546|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101803813|NCT00442546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101803815|NCT00442546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101803817|NCT00936962|Immunologic Factors|immunologic factors|mesh-ancestor
101803818|NCT00936962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803819|NCT00514683|Nintedanib|nintedanib|mesh-list
101803820|NCT00514683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101803821|NCT00514683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101803822|NCT00514683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101803823|NCT00514683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803825|NCT00566696|Cyclophosphamide|cyclophosphamide|mesh-list
101803826|NCT00566696|Melphalan|melphalan|mesh-list
101803827|NCT00566696|Mechlorethamine|mechlorethamine|mesh-list
101803828|NCT00566696|Thiotepa|thiotepa|mesh-list
101803829|NCT00566696|Rituximab|rituximab|mesh-list
101803830|NCT00566696|Fludarabine|fludarabine|mesh-list
101803831|NCT00566696|Alemtuzumab|alemtuzumab|mesh-list
101803832|NCT00566696|Thymoglobulin|thymoglobulin|mesh-list
101803833|NCT00566696|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101803834|NCT00566696|Muromonab-CD3|muromonab-cd3|mesh-list
101803835|NCT00566696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101803836|NCT00566696|Immunologic Factors|immunologic factors|mesh-ancestor
101803837|NCT00566696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803838|NCT00566696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101803839|NCT00566696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101803840|NCT00566696|Alkylating Agents|alkylating agents|mesh-ancestor
101803841|NCT00566696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803842|NCT00566696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101803843|NCT00566696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101246502|NCT01666379|Anesthetics|anesthetics|mesh-ancestor
101803844|NCT00566696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101803846|NCT00566696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101803847|NCT00566696|Antitubercular Agents|antitubercular agents|mesh-ancestor
101803848|NCT00566696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101803849|NCT00566696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101803850|NCT00566696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101803851|NCT00926666|Levobupivacaine|levobupivacaine|mesh-list
101803852|NCT00926666|Anesthetics, Local|anesthetics, local|mesh-ancestor
101803853|NCT00926666|Anesthetics|anesthetics|mesh-ancestor
101803854|NCT00926666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101803855|NCT00926666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803856|NCT00926666|Sensory System Agents|sensory system agents|mesh-ancestor
101803857|NCT00926666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101803858|NCT00926900|Cycloserine|cycloserine|mesh-list
101803859|NCT00926900|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101803860|NCT00926900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101803861|NCT00926900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101803862|NCT00926900|Antitubercular Agents|antitubercular agents|mesh-ancestor
101803863|NCT00926900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101803864|NCT00926900|Antimetabolites|antimetabolites|mesh-ancestor
101803865|NCT00926900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803866|NCT00503841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101803867|NCT00503841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101803868|NCT00503841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101803869|NCT00503841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101803870|NCT00503841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803871|NCT00937508|Varenicline|varenicline|mesh-list
101803872|NCT00937508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101803873|NCT00937508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101803874|NCT00937508|Cholinergic Agents|cholinergic agents|mesh-ancestor
101803875|NCT00937508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101803876|NCT00937508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803877|NCT00937508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803878|NCT00937664|Gemcitabine|gemcitabine|mesh-list
101803879|NCT00937664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101803880|NCT00937664|Antimetabolites|antimetabolites|mesh-ancestor
101803881|NCT00937664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803882|NCT00937664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101803883|NCT00937820|Darexaban|darexaban|mesh-list
101803884|NCT00937820|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101803885|NCT00937820|Antithrombins|antithrombins|mesh-ancestor
101803886|NCT00937820|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101803887|NCT00937820|Protease Inhibitors|protease inhibitors|mesh-ancestor
101803888|NCT00937820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101828156|NCT05923996|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101803889|NCT00937820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803890|NCT00937820|Anticoagulants|anticoagulants|mesh-ancestor
101803891|NCT00506883|Colchicine|colchicine|mesh-list
101803892|NCT00506883|Gout Suppressants|gout suppressants|mesh-ancestor
101803893|NCT00506883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101803894|NCT00506883|Tubulin Modulators|tubulin modulators|mesh-ancestor
101803895|NCT00506883|Antimitotic Agents|antimitotic agents|mesh-ancestor
101803896|NCT00506883|Mitosis Modulators|mitosis modulators|mesh-ancestor
101803897|NCT00506883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803898|NCT00506883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101803899|NCT01028638|Bevacizumab|bevacizumab|mesh-list
101803900|NCT01028638|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
101803901|NCT01028638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101803902|NCT01028638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101803903|NCT01028638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101803904|NCT01028638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101803905|NCT01028638|Growth Substances|growth substances|mesh-ancestor
101803906|NCT01028638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803907|NCT01028638|Growth Inhibitors|growth inhibitors|mesh-ancestor
101803908|NCT01028638|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101803909|NCT01028638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803911|NCT00938132|Anticoagulants|anticoagulants|mesh-ancestor
101803912|NCT01023334|Lidocaine|lidocaine|mesh-list
101803913|NCT01023334|Anesthetics|anesthetics|mesh-list
101803914|NCT01023334|Anesthetics, Local|anesthetics, local|mesh-ancestor
101803915|NCT01023334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101803916|NCT01023334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803917|NCT01023334|Sensory System Agents|sensory system agents|mesh-ancestor
101803918|NCT01023334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101803919|NCT01023334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101803920|NCT01023334|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101803921|NCT01023334|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101803922|NCT01023334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101803923|NCT01023334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803924|NCT00938522|Cilostazol|cilostazol|mesh-list
101803925|NCT00938522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101803926|NCT00938522|Autonomic Agents|autonomic agents|mesh-ancestor
101803927|NCT00938522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101803928|NCT00938522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803929|NCT00938522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101803930|NCT00938522|Respiratory System Agents|respiratory system agents|mesh-ancestor
101803931|NCT00938522|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101803932|NCT00938522|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101803933|NCT00938522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803934|NCT00938522|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101803935|NCT00938522|Vasodilator Agents|vasodilator agents|mesh-ancestor
101803936|NCT00938522|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101803937|NCT00938522|Protective Agents|protective agents|mesh-ancestor
101803938|NCT00938522|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101803939|NCT00938522|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101803940|NCT00938522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101803941|NCT00938600|Vitamin D|vitamin d|mesh-list
101803942|NCT00938600|Ergocalciferols|ergocalciferols|mesh-list
101803943|NCT00938600|Cholecalciferol|cholecalciferol|mesh-list
101803944|NCT00938600|Vitamins|vitamins|mesh-list
101803945|NCT00938600|Micronutrients|micronutrients|mesh-ancestor
101803946|NCT00938600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803947|NCT00938600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101803948|NCT00938600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101803949|NCT00503685|Cetuximab|cetuximab|mesh-list
101803950|NCT00503685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101803951|NCT00503685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101803952|NCT00712673|Metformin|metformin|mesh-list
101803953|NCT00712673|Lixisenatide|lixisenatide|mesh-list
101803954|NCT00712673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101803955|NCT00712673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803956|NCT01562990|Rituximab|rituximab|mesh-list
101803957|NCT01562990|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
101803958|NCT01562990|Gemcitabine|gemcitabine|mesh-list
101803959|NCT01562990|Oxaliplatin|oxaliplatin|mesh-list
101803960|NCT01562990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101803961|NCT01562990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101803962|NCT01562990|Immunologic Factors|immunologic factors|mesh-ancestor
101246503|NCT01666418|Paclitaxel|paclitaxel|mesh-list
101803964|NCT01562990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101803965|NCT01562990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101803967|NCT01562990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803968|NCT01562990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101803969|NCT01562990|Immunotoxins|immunotoxins|mesh-ancestor
101803970|NCT01562990|Immunoconjugates|immunoconjugates|mesh-ancestor
101803971|NCT00737867|Carboplatin|carboplatin|mesh-list
101803972|NCT00737867|Gemcitabine|gemcitabine|mesh-list
101803973|NCT00737867|Vinorelbine|vinorelbine|mesh-list
101803974|NCT00737867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101803975|NCT00737867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101803976|NCT00737867|Antimetabolites|antimetabolites|mesh-ancestor
101803977|NCT00737867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803978|NCT00737867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101803979|NCT00737867|Tubulin Modulators|tubulin modulators|mesh-ancestor
101803980|NCT00737867|Antimitotic Agents|antimitotic agents|mesh-ancestor
101803981|NCT00737867|Mitosis Modulators|mitosis modulators|mesh-ancestor
101803982|NCT03976466|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101803983|NCT03976466|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101803984|NCT03976466|Calcium|calcium|mesh-list
101803985|NCT03976466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101803986|NCT03976466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803987|NCT03976466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101803988|NCT03976466|Antitubercular Agents|antitubercular agents|mesh-ancestor
101803989|NCT02536755|Eliglustat|eliglustat|mesh-list
101803990|NCT02536755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101803991|NCT02536755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101803992|NCT02567279|Denosumab|denosumab|mesh-list
101803993|NCT02567279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101803994|NCT02567279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101803995|NCT00933374|Paclitaxel|paclitaxel|mesh-list
101803996|NCT00933374|Everolimus|everolimus|mesh-list
101803997|NCT00933374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101803998|NCT00933374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101804000|NCT00933374|Antimitotic Agents|antimitotic agents|mesh-ancestor
101804001|NCT00933374|Mitosis Modulators|mitosis modulators|mesh-ancestor
101804002|NCT00933374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804004|NCT00933374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101804005|NCT00933374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101804006|NCT00933374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101804007|NCT00933374|Immunologic Factors|immunologic factors|mesh-ancestor
101804008|NCT00933374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804009|NCT03303105|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101804010|NCT03303105|Immunologic Factors|immunologic factors|mesh-ancestor
101804011|NCT03303105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804012|NCT00933452|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101804013|NCT00933452|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101804014|NCT00933452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101804015|NCT00933452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101804016|NCT00933452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804017|NCT00933452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101804020|NCT00933452|Sensory System Agents|sensory system agents|mesh-ancestor
101804021|NCT00933452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101804022|NCT00933452|Antidepressive Agents|antidepressive agents|mesh-ancestor
101804023|NCT00933452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101804024|NCT00933452|Dopamine Agents|dopamine agents|mesh-ancestor
101804025|NCT00447694|Deferasirox|deferasirox|mesh-list
101804026|NCT00447694|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101804027|NCT00447694|Chelating Agents|chelating agents|mesh-ancestor
101804028|NCT00447694|Sequestering Agents|sequestering agents|mesh-ancestor
101804029|NCT00447694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804030|NCT00564278|Antidepressive Agents|antidepressive agents|mesh-list
101804031|NCT00564278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101804032|NCT00447382|Insulin|insulin|mesh-list
101804033|NCT00447382|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101804034|NCT00447382|Insulin Aspart|insulin aspart|mesh-list
101804035|NCT00447382|Insulin Detemir|insulin detemir|mesh-list
101804037|NCT00447382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804038|NCT00938990|Midazolam|midazolam|mesh-list
101804039|NCT00938990|Etomidate|etomidate|mesh-list
101804040|NCT00938990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101804041|NCT00938990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101804042|NCT00938990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101804043|NCT00938990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804044|NCT00938990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101804045|NCT00938990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101804046|NCT00938990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101804047|NCT00938990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101804048|NCT00938990|Anesthetics, General|anesthetics, general|mesh-ancestor
101804049|NCT00938990|Anesthetics|anesthetics|mesh-ancestor
101804050|NCT00938990|GABA Modulators|gaba modulators|mesh-ancestor
101804051|NCT00938990|GABA Agents|gaba agents|mesh-ancestor
101804052|NCT00938990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101804053|NCT00938990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804054|NCT00933998|Vitamin B 12|vitamin b 12|mesh-list
101804055|NCT00933998|Pyridoxal|pyridoxal|mesh-list
101804056|NCT00933998|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
101804057|NCT00933998|Vitamin B Complex|vitamin b complex|mesh-ancestor
101804059|NCT00933998|Micronutrients|micronutrients|mesh-ancestor
101804060|NCT00933998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804061|NCT00447226|Lapatinib|lapatinib|mesh-list
101804062|NCT00447226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101804063|NCT00447226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101804064|NCT00447226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101804065|NCT00447226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804066|NCT03360916|Atorvastatin|atorvastatin|mesh-list
101810268|NCT03937843|Etoposide|etoposide|mesh-list
101804067|NCT03360916|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101804068|NCT03360916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101804069|NCT03360916|Antimetabolites|antimetabolites|mesh-ancestor
101804070|NCT03360916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804071|NCT03360916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101804072|NCT03360916|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101804073|NCT03360916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101804074|NCT00446992|Olanzapine|olanzapine|mesh-list
101804075|NCT00446992|Antiemetics|antiemetics|mesh-ancestor
101804076|NCT00446992|Autonomic Agents|autonomic agents|mesh-ancestor
101461405|NCT04575064|Remdesivir|remdesivir|mesh-list
101804077|NCT00446992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101804078|NCT00446992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804079|NCT00446992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101804080|NCT00446992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101804081|NCT00446992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101804082|NCT00446992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101804083|NCT00446992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101804084|NCT00446992|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101804085|NCT00446992|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101804086|NCT00446992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101804087|NCT00446992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804088|NCT00446992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101804089|NCT00446992|Serotonin Agents|serotonin agents|mesh-ancestor
101804090|NCT00503139|Etanercept|etanercept|mesh-list
101804091|NCT00503139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101804092|NCT00503139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101804093|NCT00503139|Analgesics|analgesics|mesh-ancestor
101804094|NCT00503139|Sensory System Agents|sensory system agents|mesh-ancestor
101804095|NCT00503139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101804096|NCT00503139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804097|NCT00503139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101804098|NCT00503139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101804099|NCT00503139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101804100|NCT00503139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101804101|NCT00503139|Immunologic Factors|immunologic factors|mesh-ancestor
101804102|NCT00577031|Bevacizumab|bevacizumab|mesh-list
101804103|NCT00577031|Oxaliplatin|oxaliplatin|mesh-list
101804104|NCT00577031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101804106|NCT00577031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101804107|NCT00577031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101804108|NCT00577031|Growth Substances|growth substances|mesh-ancestor
101804109|NCT00577031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804110|NCT00577031|Growth Inhibitors|growth inhibitors|mesh-ancestor
101804112|NCT00565448|Fluorouracil|fluorouracil|mesh-list
101804113|NCT00565448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101804114|NCT00565448|Tubulin Modulators|tubulin modulators|mesh-ancestor
101804116|NCT00565448|Mitosis Modulators|mitosis modulators|mesh-ancestor
101828157|NCT05923996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101804117|NCT00565448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804118|NCT00565448|Antimetabolites|antimetabolites|mesh-ancestor
101804119|NCT00565448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101804120|NCT00565448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101804121|NCT00565448|Immunologic Factors|immunologic factors|mesh-ancestor
101804122|NCT00565448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804123|NCT01012011|Sorafenib|sorafenib|mesh-list
101804124|NCT01012011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101804125|NCT01012011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101804126|NCT01012011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101804127|NCT01012011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804128|NCT00934076|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101804129|NCT00934076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101804130|NCT00934076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101804131|NCT00934076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101804132|NCT00934076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804133|NCT00934154|Thalidomide|thalidomide|mesh-list
101804134|NCT00934154|Prednisolone|prednisolone|mesh-list
101804135|NCT00934154|Melphalan|melphalan|mesh-list
101804136|NCT00934154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101804137|NCT00934154|Alkylating Agents|alkylating agents|mesh-ancestor
101804138|NCT00934154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804139|NCT00934154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101804140|NCT00934154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101804141|NCT00934154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101804142|NCT00934154|Immunologic Factors|immunologic factors|mesh-ancestor
101804143|NCT00934154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804144|NCT00934154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101804146|NCT00934154|Hormones|hormones|mesh-ancestor
101804147|NCT00934154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101804148|NCT00934154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101804149|NCT00934154|Leprostatic Agents|leprostatic agents|mesh-ancestor
101804150|NCT00934154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101804151|NCT00934154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101804152|NCT00934154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101804153|NCT00934154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101804156|NCT00446446|Panitumumab|panitumumab|mesh-list
101804157|NCT00446446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101804158|NCT00446446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101804159|NCT05078255|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
101804160|NCT05078255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101804161|NCT05078255|Incretins|incretins|mesh-ancestor
101804162|NCT05078255|Hormones|hormones|mesh-ancestor
101804163|NCT05078255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101804164|NCT05078255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804165|NCT00939458|Lamotrigine|lamotrigine|mesh-list
101804166|NCT00939458|Anticonvulsants|anticonvulsants|mesh-ancestor
101804167|NCT00939458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101804168|NCT00939458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101804169|NCT00939458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804170|NCT00939458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101804171|NCT00939458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804173|NCT00939458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101804174|NCT00939458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101804175|NCT00939458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101804176|NCT00939458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101804177|NCT02566967|Tofacitinib|tofacitinib|mesh-list
101804178|NCT02566967|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101804179|NCT02566967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101804180|NCT02566967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101804181|NCT02566967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804182|NCT00939068|Telbivudine|telbivudine|mesh-list
101804183|NCT00939068|Antiviral Agents|antiviral agents|mesh-ancestor
101804184|NCT00939068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101804185|NCT00939068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101804186|NCT00939068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101804187|NCT00939068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804188|NCT00934232|Busulfan|busulfan|mesh-list
101804189|NCT00934232|Alkylating Agents|alkylating agents|mesh-ancestor
101804190|NCT00934232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804191|NCT00934232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101804192|NCT00934232|Immunologic Factors|immunologic factors|mesh-ancestor
101804193|NCT00934232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810305|NCT03743636|Niacin|niacin|mesh-list
101804195|NCT00934232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101804198|NCT01013571|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101804199|NCT01013571|Insulin Glargine|insulin glargine|mesh-list
101804200|NCT01013571|Insulin glulisine|insulin glulisine|mesh-list
101804201|NCT01013571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101804202|NCT01013571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804203|NCT00514449|Valacyclovir|valacyclovir|mesh-list
101804204|NCT00514449|Antiviral Agents|antiviral agents|mesh-ancestor
101804205|NCT00514449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101804206|NCT00492921|Cyclophosphamide|cyclophosphamide|mesh-list
101804207|NCT00492921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101804208|NCT00492921|Immunologic Factors|immunologic factors|mesh-ancestor
101804209|NCT00492921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804210|NCT00492921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101804211|NCT00492921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101804212|NCT00492921|Alkylating Agents|alkylating agents|mesh-ancestor
101804213|NCT00492921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804214|NCT00492921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101804215|NCT00492921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101804216|NCT00738257|Pamidronate|pamidronate|mesh-list
101804217|NCT00738257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101804218|NCT00738257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804219|NCT00738335|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101804220|NCT00738335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101804222|NCT00738335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101804223|NCT00738335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804224|NCT00502671|Capecitabine|capecitabine|mesh-list
101804225|NCT00502671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101804226|NCT00502671|Antimetabolites|antimetabolites|mesh-ancestor
101804227|NCT00502671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804228|NCT00502671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101804229|NCT00738413|Deferasirox|deferasirox|mesh-list
101804230|NCT00738413|Deferoxamine|deferoxamine|mesh-list
101804231|NCT00738413|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101804232|NCT00738413|Chelating Agents|chelating agents|mesh-ancestor
101804233|NCT00738413|Sequestering Agents|sequestering agents|mesh-ancestor
101804234|NCT00738413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804235|NCT00738413|Siderophores|siderophores|mesh-ancestor
101804236|NCT00697463|Teriparatide|teriparatide|mesh-list
101804237|NCT00697463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101804238|NCT00697463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804239|NCT00697463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101804240|NCT04409795|Metformin|metformin|mesh-list
101804241|NCT04409795|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101804242|NCT04409795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101804243|NCT04409795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804245|NCT04409795|Hormones|hormones|mesh-ancestor
101804246|NCT04409795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101804247|NCT04409795|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101804248|NCT04409795|Protease Inhibitors|protease inhibitors|mesh-ancestor
101804249|NCT04409795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101804250|NCT04409795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804251|NCT00492531|Sildenafil Citrate|sildenafil citrate|mesh-list
101804252|NCT00492531|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
101804253|NCT00492531|Vasodilator Agents|vasodilator agents|mesh-ancestor
101804254|NCT00492531|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101804255|NCT00492531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101804256|NCT00492531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804257|NCT00492531|Urological Agents|urological agents|mesh-ancestor
101804258|NCT01015209|Acetylcysteine|acetylcysteine|mesh-list
101804259|NCT01015209|Chitosan|chitosan|mesh-list
101804261|NCT01015209|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101804262|NCT01015209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101804263|NCT01015209|Antiviral Agents|antiviral agents|mesh-ancestor
101804264|NCT01015209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101804265|NCT01015209|Expectorants|expectorants|mesh-ancestor
101804266|NCT01015209|Respiratory System Agents|respiratory system agents|mesh-ancestor
101804267|NCT01015209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101804268|NCT01015209|Antioxidants|antioxidants|mesh-ancestor
101804269|NCT01015209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804270|NCT01015209|Protective Agents|protective agents|mesh-ancestor
101804271|NCT01015209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804272|NCT01015209|Antidotes|antidotes|mesh-ancestor
101804273|NCT01015209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101804276|NCT01015209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101804278|NCT01015209|Sequestering Agents|sequestering agents|mesh-ancestor
101804279|NCT01015209|Hemostatics|hemostatics|mesh-ancestor
101804280|NCT01015209|Coagulants|coagulants|mesh-ancestor
101804281|NCT04948463|Vancomycin|vancomycin|mesh-list
101804282|NCT04948463|Ciprofloxacin|ciprofloxacin|mesh-list
101804283|NCT04948463|Tazobactam|tazobactam|mesh-list
101804284|NCT04948463|Piperacillin|piperacillin|mesh-list
101804285|NCT04948463|Amikacin|amikacin|mesh-list
101804286|NCT04948463|Ceftazidime|ceftazidime|mesh-list
101804288|NCT04948463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101804289|NCT04948463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101804290|NCT04948463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101804291|NCT04948463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101804292|NCT04948463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101804293|NCT04948463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804294|NCT04948463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101804295|NCT04948463|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101804296|NCT04948463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101804298|NCT01080547|Capecitabine|capecitabine|mesh-list
101461633|NCT02277457|Crizotinib|crizotinib|mesh-list
101804299|NCT01080547|Oxaliplatin|oxaliplatin|mesh-list
101804300|NCT01080547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101804301|NCT01080547|Antimetabolites|antimetabolites|mesh-ancestor
101804302|NCT01080547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804303|NCT01080547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101804304|NCT04930991|Omeprazole|omeprazole|mesh-list
101804305|NCT04930991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101804306|NCT04930991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101804307|NCT04930991|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101804308|NCT04930991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101804309|NCT04930991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804311|NCT00111241|Anastrozole|anastrozole|mesh-list
101804312|NCT00111241|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101804313|NCT00111241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101804314|NCT00111241|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101804315|NCT00111241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101804316|NCT00111241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804318|NCT00111241|Hormone Antagonists|hormone antagonists|mesh-ancestor
101804319|NCT00111241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101804320|NCT00111241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804321|NCT00111241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101804323|NCT00492297|Dacarbazine|dacarbazine|mesh-list
101804324|NCT00492297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101804325|NCT00492297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101804326|NCT00492297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101804328|NCT00492297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101804329|NCT00492297|Alkylating Agents|alkylating agents|mesh-ancestor
101804330|NCT00446134|Ribavirin|ribavirin|mesh-list
101804331|NCT00446134|Taribavirin|taribavirin|mesh-list
101804332|NCT00446134|Antimetabolites|antimetabolites|mesh-ancestor
101804333|NCT00446134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804334|NCT00446134|Antiviral Agents|antiviral agents|mesh-ancestor
101804335|NCT00446134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101804336|NCT00934466|Dextromethorphan|dextromethorphan|mesh-list
101804337|NCT00934466|Antitussive Agents|antitussive agents|mesh-ancestor
101804338|NCT00934466|Respiratory System Agents|respiratory system agents|mesh-ancestor
101804339|NCT00934466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101804340|NCT00934466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101804342|NCT00934466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804343|NCT00934466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804344|NCT00921245|Darifenacin|darifenacin|mesh-list
101804345|NCT00921245|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101804346|NCT00921245|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101804347|NCT00921245|Cholinergic Agents|cholinergic agents|mesh-ancestor
101804348|NCT00921245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101804349|NCT00921245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804350|NCT00921245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804352|NCT00940238|Dexetimide|dexetimide|mesh-list
101804353|NCT00940238|Citalopram|citalopram|mesh-list
101804354|NCT00940238|Escitalopram|escitalopram|mesh-list
101804355|NCT00940238|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101804356|NCT00940238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101804357|NCT00940238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101804358|NCT00940238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804359|NCT00940238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101804360|NCT00940238|Serotonin Agents|serotonin agents|mesh-ancestor
101804362|NCT00940238|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101804363|NCT00940238|Antidepressive Agents|antidepressive agents|mesh-ancestor
101804364|NCT00940238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101804365|NCT00940238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101804366|NCT00940238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101804367|NCT00940238|Parasympatholytics|parasympatholytics|mesh-ancestor
101804368|NCT00940238|Autonomic Agents|autonomic agents|mesh-ancestor
101804370|NCT00940238|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101804371|NCT00940238|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101461699|NCT00226538|Leprostatic Agents|leprostatic agents|mesh-ancestor
101804372|NCT00940238|Cholinergic Agents|cholinergic agents|mesh-ancestor
101804373|NCT04013438|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101804374|NCT04013438|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101804375|NCT04013438|Saw palmetto extract|saw palmetto extract|mesh-list
101804376|NCT04013438|Estradiol|estradiol|mesh-list
101804377|NCT04013438|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101804378|NCT04013438|Estrogens|estrogens|mesh-ancestor
101804379|NCT04013438|Hormones|hormones|mesh-ancestor
101804380|NCT04013438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101804381|NCT04013438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804382|NCT04013438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101804383|NCT04013438|Contraceptive Agents|contraceptive agents|mesh-ancestor
101804384|NCT04013438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101804385|NCT04013438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101804386|NCT04013438|Urological Agents|urological agents|mesh-ancestor
101804388|NCT02565719|Tenofovir|tenofovir|mesh-list
101804389|NCT02565719|Interferon-alpha|interferon-alpha|mesh-list
101804390|NCT02565719|Interferon alpha-2|interferon alpha-2|mesh-list
101804391|NCT02565719|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101804393|NCT02565719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101804394|NCT02565719|Antiviral Agents|antiviral agents|mesh-ancestor
101804395|NCT02565719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101804396|NCT02565719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101804397|NCT02565719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101804398|NCT02565719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101804399|NCT02565719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804400|NCT02565719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101804401|NCT02565719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101804402|NCT02565719|Immunologic Factors|immunologic factors|mesh-ancestor
101804403|NCT02565719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804404|NCT00111007|Paclitaxel|paclitaxel|mesh-list
101804405|NCT00111007|Carboplatin|carboplatin|mesh-list
101804406|NCT00111007|Sorafenib|sorafenib|mesh-list
101804407|NCT00111007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101804408|NCT00111007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101804410|NCT00111007|Antimitotic Agents|antimitotic agents|mesh-ancestor
101804411|NCT00111007|Mitosis Modulators|mitosis modulators|mesh-ancestor
101804412|NCT00111007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804413|NCT00111007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101804414|NCT00111007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101804415|NCT00699335|Fentanyl|fentanyl|mesh-list
101804416|NCT00699335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101804417|NCT00699335|Narcotics|narcotics|mesh-ancestor
101804418|NCT00699335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101804419|NCT00699335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804420|NCT00699335|Analgesics|analgesics|mesh-ancestor
101804421|NCT00699335|Sensory System Agents|sensory system agents|mesh-ancestor
101804422|NCT00699335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101804424|NCT00699335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101804425|NCT00699335|Anesthetics, General|anesthetics, general|mesh-ancestor
101804427|NCT00939614|Lamotrigine|lamotrigine|mesh-list
101804428|NCT00939614|Anticonvulsants|anticonvulsants|mesh-ancestor
101804429|NCT00939614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101804430|NCT00939614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101804431|NCT00939614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804432|NCT00939614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101804433|NCT00939614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804434|NCT00939614|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101804435|NCT00939614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101804436|NCT00939614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101804437|NCT00939614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101804438|NCT00939614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101804439|NCT03962881|Vaccines|vaccines|mesh-list
101804440|NCT03962881|Immunologic Factors|immunologic factors|mesh-ancestor
101804441|NCT03962881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804442|NCT00935246|Dexetimide|dexetimide|mesh-list
101804444|NCT00935246|Escitalopram|escitalopram|mesh-list
101810361|NCT03559192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804445|NCT00935246|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101804446|NCT00935246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101804447|NCT00935246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101804448|NCT00935246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804449|NCT00935246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101804450|NCT00935246|Serotonin Agents|serotonin agents|mesh-ancestor
101804451|NCT00935246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804452|NCT00935246|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101804453|NCT00935246|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101804454|NCT00935246|Parasympatholytics|parasympatholytics|mesh-ancestor
101804455|NCT00935246|Autonomic Agents|autonomic agents|mesh-ancestor
101804456|NCT00935246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101804457|NCT00935246|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101804458|NCT00935246|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101804459|NCT00935246|Cholinergic Agents|cholinergic agents|mesh-ancestor
101804460|NCT00935246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101804461|NCT00935246|Antidepressive Agents|antidepressive agents|mesh-ancestor
101804462|NCT00935246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101804463|NCT00935480|Raltegravir Potassium|raltegravir potassium|mesh-list
101804464|NCT00935480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101804465|NCT00935480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101804466|NCT00935480|Antiviral Agents|antiviral agents|mesh-ancestor
101804467|NCT00935480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101804468|NCT00935480|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101804469|NCT00935480|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101804470|NCT00935480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101804471|NCT00935480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804472|NCT00939848|Cisplatin|cisplatin|mesh-list
101804473|NCT00939848|Gemcitabine|gemcitabine|mesh-list
101804474|NCT00939848|Cediranib|cediranib|mesh-list
101804475|NCT00939848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101804476|NCT00939848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101804477|NCT00939848|Antimetabolites|antimetabolites|mesh-ancestor
101804478|NCT00939848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804479|NCT00939848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101804480|NCT00939848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101804481|NCT04013048|Fluzoparib|fluzoparib|mesh-list
101804482|NCT04013048|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101804484|NCT04013048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804485|NCT04013048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101804486|NCT00935558|Interleukin-2|interleukin-2|mesh-list
101804487|NCT00935558|Exemestane|exemestane|mesh-list
101804488|NCT00935558|Anastrozole|anastrozole|mesh-list
101804489|NCT00935558|Letrozole|letrozole|mesh-list
101804490|NCT00935558|Lactitol|lactitol|mesh-list
101804491|NCT00935558|Vaccines|vaccines|mesh-list
101804492|NCT00935558|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101804493|NCT00935558|Immunologic Factors|immunologic factors|mesh-ancestor
101804494|NCT00935558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804495|NCT00935558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101804496|NCT00935558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101804497|NCT00935558|Analgesics|analgesics|mesh-ancestor
101804498|NCT00935558|Sensory System Agents|sensory system agents|mesh-ancestor
101804499|NCT00935558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101804500|NCT00935558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101804501|NCT00935558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101810374|NCT03552471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101804502|NCT00935558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804503|NCT00935558|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101804504|NCT00935558|Hormone Antagonists|hormone antagonists|mesh-ancestor
101804505|NCT00935558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101804506|NCT00935558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101804507|NCT00935558|Cathartics|cathartics|mesh-ancestor
101804508|NCT00935558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101804509|NCT05280236|Propofol|propofol|mesh-list
101804510|NCT05280236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101804511|NCT05280236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101804512|NCT05280236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804513|NCT05280236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101804514|NCT05280236|Anesthetics, General|anesthetics, general|mesh-ancestor
101804515|NCT05280236|Anesthetics|anesthetics|mesh-ancestor
101804516|NCT00940472|Metformin|metformin|mesh-list
101804517|NCT00940472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101804518|NCT00940472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804519|NCT00939926|Risperidone|risperidone|mesh-list
101804520|NCT00939926|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101804521|NCT00939926|Serotonin Agents|serotonin agents|mesh-ancestor
101804522|NCT00939926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101804523|NCT00939926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804524|NCT00939926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804525|NCT00939926|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101804526|NCT00939926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101804527|NCT00939926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101804528|NCT00939926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101804529|NCT00939926|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101804530|NCT00939926|Dopamine Agents|dopamine agents|mesh-ancestor
101804531|NCT00940550|Melatonin|melatonin|mesh-list
101804532|NCT00940550|Zolpidem|zolpidem|mesh-list
101804533|NCT00940550|Temazepam|temazepam|mesh-list
101804534|NCT00940550|Antioxidants|antioxidants|mesh-ancestor
101804535|NCT00940550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804536|NCT00940550|Protective Agents|protective agents|mesh-ancestor
101804537|NCT00940550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804538|NCT00940550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101804539|NCT00940550|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101804540|NCT00940550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101804541|NCT00940550|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101804542|NCT00940550|GABA Agonists|gaba agonists|mesh-ancestor
101804543|NCT00940550|GABA Agents|gaba agents|mesh-ancestor
101804544|NCT00940550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101804545|NCT00940550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101804546|NCT00940550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101804547|NCT00940550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101804549|NCT00940628|Orlistat|orlistat|mesh-list
101804550|NCT00940628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101804551|NCT00940628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804552|NCT00940628|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101804553|NCT00940628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101804554|NCT00936182|Fluconazole|fluconazole|mesh-list
101804555|NCT00936182|Antifungal Agents|antifungal agents|mesh-ancestor
101804556|NCT00936182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101804557|NCT00936182|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101804558|NCT00936182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101804559|NCT00936182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101804560|NCT00936182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804561|NCT00936182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101804562|NCT00936182|Hormone Antagonists|hormone antagonists|mesh-ancestor
101804563|NCT00936182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101804564|NCT00936182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804565|NCT00936182|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101804566|NCT00936182|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101804567|NCT00936260|Alendronate|alendronate|mesh-list
101804568|NCT00936260|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101804569|NCT00936260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804570|NCT00445978|Verapamil|verapamil|mesh-list
101804571|NCT00445978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101804572|NCT00445978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101804573|NCT00445978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101804574|NCT00445978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804575|NCT00445978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101804576|NCT00445978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804578|NCT02566733|Remifentanil|remifentanil|mesh-list
101804579|NCT02566733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101804580|NCT02566733|Narcotics|narcotics|mesh-ancestor
101804581|NCT02566733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101804582|NCT02566733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804583|NCT02566733|Analgesics|analgesics|mesh-ancestor
101804584|NCT02566733|Sensory System Agents|sensory system agents|mesh-ancestor
101804585|NCT02566733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101804586|NCT01028950|Darexaban|darexaban|mesh-list
101804587|NCT01028950|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101804588|NCT01028950|Antithrombins|antithrombins|mesh-ancestor
101804589|NCT01028950|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101804590|NCT01028950|Protease Inhibitors|protease inhibitors|mesh-ancestor
101804591|NCT01028950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101804592|NCT01028950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804593|NCT01028950|Anticoagulants|anticoagulants|mesh-ancestor
101804594|NCT00940784|Aspirin|aspirin|mesh-list
101804595|NCT00940784|Clopidogrel|clopidogrel|mesh-list
101804596|NCT00940784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101804597|NCT00940784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101804598|NCT00940784|Analgesics|analgesics|mesh-ancestor
101804599|NCT00940784|Sensory System Agents|sensory system agents|mesh-ancestor
101804600|NCT00940784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101804601|NCT00940784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804602|NCT00940784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101804603|NCT00940784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101804604|NCT00940784|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101804605|NCT00940784|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101804606|NCT00940784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804607|NCT00940784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101804608|NCT00940784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101804609|NCT00940784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101804610|NCT00940784|Antipyretics|antipyretics|mesh-ancestor
101804611|NCT00940784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101804613|NCT00940784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101804614|NCT00940784|Purinergic Agents|purinergic agents|mesh-ancestor
101804615|NCT00940784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101804617|NCT01023490|Vitamins|vitamins|mesh-ancestor
101804618|NCT01023490|Micronutrients|micronutrients|mesh-ancestor
101804619|NCT01023490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804620|NCT01023490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101804621|NCT00698009|Cyclophosphamide|cyclophosphamide|mesh-list
101804622|NCT00698009|Fludarabine|fludarabine|mesh-list
101804623|NCT00698009|Fludarabine phosphate|fludarabine phosphate|mesh-list
101804624|NCT00698009|Interleukin-2|interleukin-2|mesh-list
101804625|NCT00698009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101804626|NCT00698009|Immunologic Factors|immunologic factors|mesh-ancestor
101804627|NCT00698009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804628|NCT00698009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101804629|NCT00698009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101804630|NCT00698009|Alkylating Agents|alkylating agents|mesh-ancestor
101804631|NCT00698009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804632|NCT00698009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101804633|NCT00698009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101804634|NCT00698009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101804635|NCT00698009|Antimetabolites|antimetabolites|mesh-ancestor
101804636|NCT00698009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101804637|NCT00698009|Analgesics|analgesics|mesh-ancestor
101804638|NCT00698009|Sensory System Agents|sensory system agents|mesh-ancestor
101804639|NCT00698009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101804640|NCT04648631|Pulmonary Surfactants|pulmonary surfactants|mesh-list
101804641|NCT04648631|Respiratory System Agents|respiratory system agents|mesh-ancestor
101804642|NCT00944606|Vitamin D|vitamin d|mesh-list
101804643|NCT00944606|Vitamins|vitamins|mesh-ancestor
101804644|NCT00944606|Micronutrients|micronutrients|mesh-ancestor
101804645|NCT00944606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804646|NCT00944606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101804647|NCT05257655|Analgesics, Opioid|analgesics, opioid|mesh-list
101804648|NCT05257655|Narcotics|narcotics|mesh-ancestor
101804649|NCT05257655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101804650|NCT05257655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804651|NCT05257655|Analgesics|analgesics|mesh-ancestor
101804652|NCT05257655|Sensory System Agents|sensory system agents|mesh-ancestor
101804653|NCT05257655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101804654|NCT00944684|Ribavirin|ribavirin|mesh-list
101804655|NCT00944684|Antimetabolites|antimetabolites|mesh-ancestor
101804656|NCT00944684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804657|NCT00944684|Antiviral Agents|antiviral agents|mesh-ancestor
101804658|NCT00944684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101804659|NCT04061057|Lidocaine|lidocaine|mesh-list
101804660|NCT04061057|Anesthetics, Local|anesthetics, local|mesh-ancestor
101804661|NCT04061057|Anesthetics|anesthetics|mesh-ancestor
101804662|NCT04061057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101804664|NCT04061057|Sensory System Agents|sensory system agents|mesh-ancestor
101804665|NCT04061057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101804666|NCT04061057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101804667|NCT04061057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101804668|NCT04061057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101804669|NCT04061057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101804670|NCT04061057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804671|NCT00921167|Bevacizumab|bevacizumab|mesh-list
101804673|NCT00921167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101804674|NCT00921167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101461986|NCT00228020|Immunologic Factors|immunologic factors|mesh-ancestor
101804675|NCT00921167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101804676|NCT00921167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101804677|NCT00921167|Growth Substances|growth substances|mesh-ancestor
101804678|NCT00921167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804679|NCT00921167|Growth Inhibitors|growth inhibitors|mesh-ancestor
101804680|NCT00921167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101804681|NCT00921167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101804682|NCT00921167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101804683|NCT00921167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804684|NCT04061447|Clarithromycin|clarithromycin|mesh-list
101804685|NCT04061447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101804686|NCT04061447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101804687|NCT04061447|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101804688|NCT04061447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101804689|NCT04061447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804690|NCT04061447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101804691|NCT04061447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101804692|NCT03968978|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101804693|NCT03968978|Immunologic Factors|immunologic factors|mesh-ancestor
101804694|NCT03968978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804698|NCT05472779|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101804699|NCT05472779|Estrogens|estrogens|mesh-ancestor
101804700|NCT05472779|Hormones|hormones|mesh-ancestor
101804701|NCT05472779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101804702|NCT05472779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804703|NCT05472779|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101804704|NCT05472779|Contraceptive Agents|contraceptive agents|mesh-ancestor
101804706|NCT05472779|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101804707|NCT02565953|Paclitaxel|paclitaxel|mesh-list
101804708|NCT02565953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101804709|NCT02565953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101804710|NCT02565953|Tubulin Modulators|tubulin modulators|mesh-ancestor
101804711|NCT02565953|Antimitotic Agents|antimitotic agents|mesh-ancestor
101804712|NCT02565953|Mitosis Modulators|mitosis modulators|mesh-ancestor
101804713|NCT02565953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804714|NCT00562718|Capecitabine|capecitabine|mesh-list
101804715|NCT00562718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101804716|NCT00562718|Antimetabolites|antimetabolites|mesh-ancestor
101804717|NCT00562718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804718|NCT00562718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101804719|NCT05222165|Infigratinib|infigratinib|mesh-list
101804720|NCT05222165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101804721|NCT04555811|Rituximab|rituximab|mesh-list
101804722|NCT04555811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101804723|NCT04555811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101804724|NCT04555811|Immunologic Factors|immunologic factors|mesh-ancestor
101804725|NCT04555811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804726|NCT04555811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101804727|NCT00697619|Zoledronic Acid|zoledronic acid|mesh-list
101804728|NCT00697619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101804729|NCT00697619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804731|NCT02566187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101804732|NCT02566187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101804733|NCT02566187|Antimetabolites|antimetabolites|mesh-ancestor
101804734|NCT02566187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804735|NCT02566187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101804736|NCT02566187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101804737|NCT02566187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101804739|NCT05324891|Dexmedetomidine|dexmedetomidine|mesh-list
101804740|NCT05324891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101804741|NCT05324891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101804742|NCT05324891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804743|NCT05324891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101804744|NCT05324891|Analgesics|analgesics|mesh-ancestor
101804745|NCT05324891|Sensory System Agents|sensory system agents|mesh-ancestor
101804746|NCT05324891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101804747|NCT05324891|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101804748|NCT05324891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101804749|NCT05324891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101804752|NCT05324891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804753|NCT05324891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101804755|NCT05324891|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101804756|NCT05324891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101804757|NCT05324891|Anesthetics, General|anesthetics, general|mesh-ancestor
101804758|NCT05324891|Anesthetics|anesthetics|mesh-ancestor
101804759|NCT05451329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101804760|NCT05451329|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101804761|NCT00445432|Adalimumab|adalimumab|mesh-list
101804762|NCT00445432|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101804764|NCT00445432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101804765|NCT03370133|Ustekinumab|ustekinumab|mesh-list
101804766|NCT03370133|Dermatologic Agents|dermatologic agents|mesh-ancestor
101804767|NCT00696137|Fentanyl|fentanyl|mesh-list
101804768|NCT00696137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101804769|NCT00696137|Narcotics|narcotics|mesh-ancestor
101804770|NCT00696137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101804771|NCT00696137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804772|NCT00696137|Analgesics|analgesics|mesh-ancestor
101804773|NCT00696137|Sensory System Agents|sensory system agents|mesh-ancestor
101804774|NCT00696137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101804775|NCT00696137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101804776|NCT00696137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101804777|NCT00696137|Anesthetics, General|anesthetics, general|mesh-ancestor
101804778|NCT00696137|Anesthetics|anesthetics|mesh-ancestor
101804779|NCT02565641|Gemcitabine|gemcitabine|mesh-list
101804780|NCT02565641|Capecitabine|capecitabine|mesh-list
101804781|NCT02565641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101804782|NCT02565641|Antimetabolites|antimetabolites|mesh-ancestor
101804783|NCT02565641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804785|NCT04036721|Prednisone|prednisone|mesh-list
101804786|NCT04036721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101804787|NCT04036721|Glucocorticoids|glucocorticoids|mesh-ancestor
101804788|NCT04036721|Hormones|hormones|mesh-ancestor
101804789|NCT04036721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101804790|NCT04036721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804791|NCT04036721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101804792|NCT04036721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101804793|NCT00441142|Temozolomide|temozolomide|mesh-list
101804794|NCT00441142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101804795|NCT00441142|Alkylating Agents|alkylating agents|mesh-ancestor
101804796|NCT00441142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804797|NCT00441142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101804798|NCT03848416|Ixekizumab|ixekizumab|mesh-list
101804800|NCT01029418|Sorafenib|sorafenib|mesh-list
101804801|NCT01029418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101804802|NCT01029418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101804803|NCT01029418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101804804|NCT01029418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804805|NCT04060979|Nitric Oxide|nitric oxide|mesh-list
101804806|NCT04060979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101804807|NCT04060979|Autonomic Agents|autonomic agents|mesh-ancestor
101804808|NCT04060979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101804809|NCT04060979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804811|NCT04060979|Respiratory System Agents|respiratory system agents|mesh-ancestor
101804812|NCT04060979|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101804813|NCT04060979|Antioxidants|antioxidants|mesh-ancestor
101828159|NCT05919823|Trospium chloride|trospium chloride|mesh-list
101804814|NCT04060979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804815|NCT04060979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101804816|NCT04060979|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101804817|NCT04060979|Vasodilator Agents|vasodilator agents|mesh-ancestor
101804818|NCT04060979|Gasotransmitters|gasotransmitters|mesh-ancestor
101804819|NCT04060979|Protective Agents|protective agents|mesh-ancestor
101804821|NCT00458302|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101804822|NCT00458302|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101804823|NCT00458302|Protease Inhibitors|protease inhibitors|mesh-ancestor
101804824|NCT00458302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101804825|NCT00458302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804826|NCT00458302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101804827|NCT00458302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101804828|NCT00458302|Antiviral Agents|antiviral agents|mesh-ancestor
101804829|NCT00458302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101804830|NCT00444106|Artesunate|artesunate|mesh-list
101804831|NCT00444106|Lumefantrine|lumefantrine|mesh-list
101804832|NCT00444106|Artemether|artemether|mesh-list
101804833|NCT00444106|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101804834|NCT00444106|Mefloquine|mefloquine|mesh-list
101804835|NCT00444106|Atovaquone|atovaquone|mesh-list
101804836|NCT00444106|Proguanil|proguanil|mesh-list
101804837|NCT00444106|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
101804838|NCT00444106|Antimalarials|antimalarials|mesh-ancestor
101804839|NCT00444106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101804840|NCT00444106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101804841|NCT00444106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101804842|NCT00444106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101804843|NCT00444106|Antiviral Agents|antiviral agents|mesh-ancestor
101804844|NCT00444106|Schistosomicides|schistosomicides|mesh-ancestor
101804845|NCT00444106|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101804846|NCT00444106|Anthelmintics|anthelmintics|mesh-ancestor
101804847|NCT00444106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101804848|NCT00444106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804849|NCT00444106|Antimetabolites|antimetabolites|mesh-ancestor
101804850|NCT00561470|Leucovorin|leucovorin|mesh-list
101804851|NCT00561470|Fluorouracil|fluorouracil|mesh-list
101804852|NCT00561470|Irinotecan|irinotecan|mesh-list
101804853|NCT00561470|Aflibercept|aflibercept|mesh-list
101804854|NCT00561470|Levoleucovorin|levoleucovorin|mesh-list
101804855|NCT00561470|Antimetabolites|antimetabolites|mesh-ancestor
101804856|NCT00561470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804857|NCT00561470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101804858|NCT00561470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101804861|NCT00561470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804862|NCT00561470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101311859|NCT00006103|Leucovorin|leucovorin|mesh-list
101804863|NCT00561470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101804864|NCT00561470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101804866|NCT00561470|Protective Agents|protective agents|mesh-ancestor
101804867|NCT00561470|Vitamin B Complex|vitamin b complex|mesh-ancestor
101804868|NCT00561470|Vitamins|vitamins|mesh-ancestor
101804869|NCT00561470|Micronutrients|micronutrients|mesh-ancestor
101804870|NCT00561470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101804871|NCT00561470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101804872|NCT00561470|Growth Substances|growth substances|mesh-ancestor
101804873|NCT00561470|Growth Inhibitors|growth inhibitors|mesh-ancestor
101804874|NCT00443872|Selegiline|selegiline|mesh-list
101804875|NCT00443872|Antidepressive Agents|antidepressive agents|mesh-ancestor
101804876|NCT00443872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101804877|NCT00443872|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101804878|NCT00443872|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101804879|NCT00443872|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101804880|NCT00443872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101804881|NCT00443872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804882|NCT00443872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101804883|NCT00443872|Protective Agents|protective agents|mesh-ancestor
101804884|NCT00443872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804886|NCT01323244|Antiviral Agents|antiviral agents|mesh-ancestor
101804887|NCT01323244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101804888|NCT01323244|Protease Inhibitors|protease inhibitors|mesh-ancestor
101804889|NCT01323244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101804890|NCT01323244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804891|NCT03034642|Dimercaprol|dimercaprol|mesh-list
101804892|NCT03034642|Chelating Agents|chelating agents|mesh-ancestor
101804893|NCT03034642|Sequestering Agents|sequestering agents|mesh-ancestor
101804894|NCT03034642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828160|NCT05919823|Parasympatholytics|parasympatholytics|mesh-ancestor
101804897|NCT03840226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804898|NCT03840226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101804899|NCT03962738|Lasmiditan|lasmiditan|mesh-list
101804900|NCT03962738|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101804901|NCT03962738|Serotonin Agents|serotonin agents|mesh-ancestor
101804902|NCT03962738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101804903|NCT03962738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804904|NCT03962738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804906|NCT00561392|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101804907|NCT00561392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101804908|NCT00561392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804909|NCT00561392|Cholinergic Agents|cholinergic agents|mesh-ancestor
101804910|NCT00561392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101804911|NCT00561392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804912|NCT00561392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101804913|NCT00561392|Protective Agents|protective agents|mesh-ancestor
101804915|NCT00694109|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101804918|NCT00694109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804919|NCT00694109|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101804920|NCT03070301|Everolimus|everolimus|mesh-list
101804921|NCT03070301|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101804922|NCT03070301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101804923|NCT03070301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101804924|NCT03070301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804925|NCT03070301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101804926|NCT03070301|Immunologic Factors|immunologic factors|mesh-ancestor
101804927|NCT03070301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804928|NCT03070301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101804929|NCT00940862|Adalimumab|adalimumab|mesh-list
101804931|NCT00940862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101804932|NCT00940862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101804934|NCT03068741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101810490|NCT03073785|Imidazole|imidazole|mesh-list
101804935|NCT03068741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101804936|NCT00561080|Vaccines|vaccines|mesh-list
101804937|NCT00561080|Immunologic Factors|immunologic factors|mesh-ancestor
101804938|NCT00561080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804939|NCT01307306|Metformin|metformin|mesh-list
101804940|NCT01307306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101804941|NCT01307306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804942|NCT00941096|Timolol|timolol|mesh-list
101804943|NCT00941096|Bimatoprost|bimatoprost|mesh-list
101804944|NCT00941096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101804945|NCT00941096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101804946|NCT00941096|Adrenergic Agents|adrenergic agents|mesh-ancestor
101804947|NCT00941096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101804948|NCT00941096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804949|NCT00941096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804950|NCT00941096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101804951|NCT00941096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101804952|NCT04012424|Curcumin|curcumin|mesh-list
101804953|NCT04012424|Analgesics|analgesics|mesh-list
101804954|NCT04012424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101804955|NCT04012424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101804956|NCT04012424|Sensory System Agents|sensory system agents|mesh-ancestor
101804957|NCT04012424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101804958|NCT04012424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804959|NCT04012424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101804960|NCT04012424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101804961|NCT04012424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101804962|NCT04012424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101804963|NCT04012424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804964|NCT00562094|Pantoprazole|pantoprazole|mesh-list
101804965|NCT00562094|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101804966|NCT00562094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101804967|NCT00562094|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101804968|NCT00562094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101804969|NCT00562094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804970|NCT03817853|Prednisone|prednisone|mesh-list
101804971|NCT03817853|Methylprednisolone|methylprednisolone|mesh-list
101804972|NCT03817853|Prednisolone|prednisolone|mesh-list
101804973|NCT03817853|Cyclophosphamide|cyclophosphamide|mesh-list
101804974|NCT03817853|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101804975|NCT03817853|Doxorubicin|doxorubicin|mesh-list
101804976|NCT03817853|Vincristine|vincristine|mesh-list
101828161|NCT05919823|Autonomic Agents|autonomic agents|mesh-ancestor
101804978|NCT03817853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101804979|NCT03817853|Immunologic Factors|immunologic factors|mesh-ancestor
101804980|NCT03817853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101804981|NCT03817853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101804982|NCT03817853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101804983|NCT03817853|Alkylating Agents|alkylating agents|mesh-ancestor
101804984|NCT03817853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101804985|NCT03817853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101804986|NCT03817853|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101804987|NCT03817853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101804988|NCT03817853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101804989|NCT03817853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101804990|NCT03817853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101804991|NCT03817853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101804992|NCT03817853|Glucocorticoids|glucocorticoids|mesh-ancestor
101804993|NCT03817853|Hormones|hormones|mesh-ancestor
101804994|NCT03817853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101804995|NCT03817853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101810502|NCT03028103|Omeprazole|omeprazole|mesh-list
101804996|NCT03817853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101804997|NCT03817853|Tubulin Modulators|tubulin modulators|mesh-ancestor
101804998|NCT03817853|Antimitotic Agents|antimitotic agents|mesh-ancestor
101805000|NCT03817853|Antiemetics|antiemetics|mesh-ancestor
101805001|NCT03817853|Autonomic Agents|autonomic agents|mesh-ancestor
101805002|NCT03817853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101805003|NCT03817853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101805004|NCT03817853|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101805005|NCT03817853|Protective Agents|protective agents|mesh-ancestor
101805006|NCT03817853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101805007|NCT00944840|Amodiaquine|amodiaquine|mesh-list
101805008|NCT00944840|Antimalarials|antimalarials|mesh-ancestor
101805009|NCT00944840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101805011|NCT00944840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101805012|NCT00439270|Docetaxel|docetaxel|mesh-list
101805013|NCT00439270|Dasatinib|dasatinib|mesh-list
101805014|NCT00439270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101805015|NCT00439270|Tubulin Modulators|tubulin modulators|mesh-ancestor
101805016|NCT00439270|Antimitotic Agents|antimitotic agents|mesh-ancestor
101805017|NCT00439270|Mitosis Modulators|mitosis modulators|mesh-ancestor
101805018|NCT00439270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805019|NCT00439270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101805020|NCT00439270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101805021|NCT00944918|Fulvestrant|fulvestrant|mesh-list
101805022|NCT00944918|Anastrozole|anastrozole|mesh-list
101805023|NCT00944918|Exemestane|exemestane|mesh-list
101805025|NCT00944918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101805026|NCT00944918|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101805027|NCT00944918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101805028|NCT00944918|Hormone Antagonists|hormone antagonists|mesh-ancestor
101805029|NCT00944918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101805030|NCT00944918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805031|NCT00944918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101805032|NCT00944918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101805033|NCT00944918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101805034|NCT00944918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805035|NCT04012268|Aspirin|aspirin|mesh-list
101805036|NCT04012268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101805037|NCT04012268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101805038|NCT04012268|Analgesics|analgesics|mesh-ancestor
101805039|NCT04012268|Sensory System Agents|sensory system agents|mesh-ancestor
101805040|NCT04012268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101805041|NCT04012268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805042|NCT04012268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101805043|NCT04012268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101805044|NCT04012268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101805045|NCT04012268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101805046|NCT04012268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805047|NCT04012268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101805048|NCT04012268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101805049|NCT04012268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101805050|NCT04012268|Antipyretics|antipyretics|mesh-ancestor
101805051|NCT03995134|Remifentanil|remifentanil|mesh-list
101805052|NCT03995134|Propofol|propofol|mesh-list
101462367|NCT00236496|Topiramate|topiramate|mesh-list
101805053|NCT03995134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101805054|NCT03995134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101805055|NCT03995134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805057|NCT03995134|Anesthetics, General|anesthetics, general|mesh-ancestor
101805058|NCT03995134|Anesthetics|anesthetics|mesh-ancestor
101805059|NCT03995134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101805060|NCT03995134|Narcotics|narcotics|mesh-ancestor
101805061|NCT03995134|Analgesics|analgesics|mesh-ancestor
101805062|NCT03995134|Sensory System Agents|sensory system agents|mesh-ancestor
101805063|NCT03995134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101805064|NCT00553280|Pregabalin|pregabalin|mesh-list
101805065|NCT00553280|Analgesics|analgesics|mesh-ancestor
101805066|NCT00553280|Sensory System Agents|sensory system agents|mesh-ancestor
101805067|NCT00553280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101805068|NCT00553280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805069|NCT00553280|Anticonvulsants|anticonvulsants|mesh-ancestor
101805070|NCT00553280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101805071|NCT00553280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101805072|NCT00553280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805073|NCT00553280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101805074|NCT00553280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101805075|NCT00553280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101805076|NCT00553280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101805077|NCT00553280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101805079|NCT01024192|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101805080|NCT01024192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101805081|NCT01024192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101805082|NCT01024192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805083|NCT01024192|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101805084|NCT01024192|GABA Agonists|gaba agonists|mesh-ancestor
101805085|NCT01024192|GABA Agents|gaba agents|mesh-ancestor
101311289|NCT05147233|Dexamethasone|dexamethasone|mesh-list
101805086|NCT01024192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101805087|NCT01024192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805088|NCT01024270|Misoprostol|misoprostol|mesh-list
101805090|NCT01024270|Abortifacient Agents|abortifacient agents|mesh-ancestor
101805091|NCT01024270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101805092|NCT01024270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805093|NCT01024270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101805094|NCT01024270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101805095|NCT01024270|Oxytocics|oxytocics|mesh-ancestor
101805096|NCT00944996|Citalopram|citalopram|mesh-list
101805097|NCT00944996|Fluoxetine|fluoxetine|mesh-list
101805098|NCT00944996|Paroxetine|paroxetine|mesh-list
101805099|NCT00944996|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101805100|NCT00944996|Sertraline|sertraline|mesh-list
101805102|NCT00944996|Escitalopram|escitalopram|mesh-list
101805103|NCT00944996|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101805104|NCT00944996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101805105|NCT00944996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101805106|NCT00944996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805107|NCT00944996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101805108|NCT00944996|Serotonin Agents|serotonin agents|mesh-ancestor
101805110|NCT00944996|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101805111|NCT00944996|Antidepressive Agents|antidepressive agents|mesh-ancestor
101805112|NCT00944996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101805113|NCT00944996|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101805114|NCT00944996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101805115|NCT00944996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101805116|NCT00944996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101805117|NCT00944996|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101805118|NCT00950066|Amlodipine|amlodipine|mesh-list
101805119|NCT00950066|Irbesartan|irbesartan|mesh-list
101805120|NCT00950066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101805121|NCT00950066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101805122|NCT00950066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101805123|NCT00950066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805124|NCT00950066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101805125|NCT00950066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805126|NCT00950066|Vasodilator Agents|vasodilator agents|mesh-ancestor
101805127|NCT00950066|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101805128|NCT00950066|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101805129|NCT01031212|Acetic Acid|acetic acid|mesh-list
101805130|NCT01031212|Paclitaxel|paclitaxel|mesh-list
101805131|NCT01031212|Carboplatin|carboplatin|mesh-list
101805132|NCT01031212|Cetuximab|cetuximab|mesh-list
101805135|NCT01031212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101805136|NCT01031212|Tubulin Modulators|tubulin modulators|mesh-ancestor
101805137|NCT01031212|Antimitotic Agents|antimitotic agents|mesh-ancestor
101805138|NCT01031212|Mitosis Modulators|mitosis modulators|mesh-ancestor
101805139|NCT01031212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805140|NCT01031212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101805143|NCT01024348|Acetaminophen|acetaminophen|mesh-list
101805144|NCT01024348|Tramadol|tramadol|mesh-list
101805145|NCT01024348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101805146|NCT01024348|Analgesics|analgesics|mesh-ancestor
101805147|NCT01024348|Sensory System Agents|sensory system agents|mesh-ancestor
101805148|NCT01024348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101805149|NCT01024348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805150|NCT01024348|Antipyretics|antipyretics|mesh-ancestor
101805151|NCT01024348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101805152|NCT01024348|Narcotics|narcotics|mesh-ancestor
101805153|NCT01024348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101805154|NCT03994744|Metformin|metformin|mesh-list
101805155|NCT03994744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101805156|NCT03994744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101805157|NCT03994744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311292|NCT05147233|Autonomic Agents|autonomic agents|mesh-ancestor
101805158|NCT03994744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805159|NCT03994744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101805160|NCT03994744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101805162|NCT00950222|Amikacin|amikacin|mesh-list
101805163|NCT00950222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101805164|NCT00950222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101805165|NCT05301530|Docetaxel|docetaxel|mesh-list
101805166|NCT05301530|Trastuzumab|trastuzumab|mesh-list
101805167|NCT05301530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101805168|NCT05301530|Tubulin Modulators|tubulin modulators|mesh-ancestor
101805169|NCT05301530|Antimitotic Agents|antimitotic agents|mesh-ancestor
101805170|NCT05301530|Mitosis Modulators|mitosis modulators|mesh-ancestor
101805171|NCT05301530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805172|NCT05301530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101805176|NCT00941174|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101805177|NCT00941174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805178|NCT00941174|Antidotes|antidotes|mesh-ancestor
101805179|NCT00941174|Protective Agents|protective agents|mesh-ancestor
101805180|NCT00941174|Vitamin B Complex|vitamin b complex|mesh-ancestor
101805181|NCT00941174|Vitamins|vitamins|mesh-ancestor
101805184|NCT00440518|Anticonvulsants|anticonvulsants|mesh-ancestor
101805185|NCT00440518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101805186|NCT00440518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101805187|NCT00440518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101805188|NCT00440518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805189|NCT00950534|Insulin Glargine|insulin glargine|mesh-list
101810563|NCT02755272|Carboplatin|carboplatin|mesh-list
101805190|NCT00950534|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101805191|NCT00950534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805192|NCT00941252|Imiquimod|imiquimod|mesh-list
101805193|NCT00941252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101805194|NCT00941252|Immunologic Factors|immunologic factors|mesh-ancestor
101805195|NCT00941252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805196|NCT00941252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101805197|NCT00941252|Interferon Inducers|interferon inducers|mesh-ancestor
101805198|NCT01031368|Cytarabine|cytarabine|mesh-list
101805199|NCT01031368|Clofarabine|clofarabine|mesh-list
101805200|NCT01031368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101805201|NCT01031368|Antimetabolites|antimetabolites|mesh-ancestor
101805202|NCT01031368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805203|NCT01031368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101805205|NCT01031368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101805206|NCT01031368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101805207|NCT01031368|Immunologic Factors|immunologic factors|mesh-ancestor
101805208|NCT01031368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805210|NCT00945308|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101805211|NCT03172936|Spartalizumab|spartalizumab|mesh-list
101805212|NCT03172936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101805213|NCT03172936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805214|NCT03172936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101805215|NCT03172936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101805216|NCT01030042|Leucovorin|leucovorin|mesh-list
101805218|NCT01030042|Irinotecan|irinotecan|mesh-list
101805219|NCT01030042|Cetuximab|cetuximab|mesh-list
101805220|NCT01030042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101805221|NCT01030042|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101805222|NCT01030042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101805223|NCT01030042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101805224|NCT01030042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805225|NCT01030042|Antidotes|antidotes|mesh-ancestor
101805227|NCT01030042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805228|NCT01030042|Vitamin B Complex|vitamin b complex|mesh-ancestor
101805230|NCT01030042|Micronutrients|micronutrients|mesh-ancestor
101805231|NCT01030042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101805232|NCT01024504|Bevacizumab|bevacizumab|mesh-list
101805233|NCT01024504|Capecitabine|capecitabine|mesh-list
101805234|NCT01024504|Oxaliplatin|oxaliplatin|mesh-list
101805235|NCT01024504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101805236|NCT01024504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101805237|NCT01024504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101805238|NCT01024504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101805239|NCT01024504|Growth Substances|growth substances|mesh-ancestor
101805240|NCT01024504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805241|NCT01024504|Growth Inhibitors|growth inhibitors|mesh-ancestor
101805242|NCT01024504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101805243|NCT01024504|Antimetabolites|antimetabolites|mesh-ancestor
101805244|NCT01024504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805245|NCT01030120|Etanercept|etanercept|mesh-list
101805246|NCT01030120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101805248|NCT01030120|Analgesics|analgesics|mesh-ancestor
101805249|NCT01030120|Sensory System Agents|sensory system agents|mesh-ancestor
101805250|NCT01030120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101805251|NCT01030120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805252|NCT01030120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101805253|NCT01030120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101805254|NCT01030120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101810564|NCT02755272|Gemcitabine|gemcitabine|mesh-list
101805255|NCT01030120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101805256|NCT01030120|Immunologic Factors|immunologic factors|mesh-ancestor
101805257|NCT00951236|Cortisone|cortisone|mesh-list
101805258|NCT00951236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101805259|NCT00945542|Hemostatics|hemostatics|mesh-list
101805260|NCT00945542|Coagulants|coagulants|mesh-ancestor
101805261|NCT00438256|Capecitabine|capecitabine|mesh-list
101805262|NCT00438256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101805263|NCT00438256|Antimetabolites|antimetabolites|mesh-ancestor
101805264|NCT00438256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805265|NCT00438256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101805266|NCT01031524|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101805267|NCT01031524|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101805268|NCT01031524|Immunologic Factors|immunologic factors|mesh-ancestor
101805269|NCT01031524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805271|NCT00945620|Anesthetics, Local|anesthetics, local|mesh-ancestor
101805272|NCT00945620|Anesthetics|anesthetics|mesh-ancestor
101805273|NCT00945620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101805274|NCT00945620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805275|NCT00945620|Sensory System Agents|sensory system agents|mesh-ancestor
101805276|NCT00945620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101805277|NCT01565746|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
101805278|NCT01565746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101805279|NCT01030510|Rocuronium|rocuronium|mesh-list
101805280|NCT01030510|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101805281|NCT01030510|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101805282|NCT01030510|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101805283|NCT01030510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101805284|NCT01030510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805285|NCT04813822|Miconazole|miconazole|mesh-list
101805286|NCT04813822|Clotrimazole|clotrimazole|mesh-list
101805287|NCT04813822|Bromides|bromides|mesh-list
101805288|NCT04813822|Anticonvulsants|anticonvulsants|mesh-ancestor
101805289|NCT04813822|Antifungal Agents|antifungal agents|mesh-ancestor
101805290|NCT04813822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101805291|NCT04813822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101805292|NCT04813822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101805293|NCT04813822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101805294|NCT04813822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805295|NCT04813822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101805296|NCT04813822|Hormone Antagonists|hormone antagonists|mesh-ancestor
101805297|NCT04813822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101805298|NCT04813822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805299|NCT04813822|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101805300|NCT04813822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101805301|NCT04813822|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101805302|NCT02917564|Triamcinolone|triamcinolone|mesh-list
101805303|NCT02917564|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101204446|NCT01423500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101805304|NCT02917564|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101805305|NCT02917564|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101805306|NCT02917564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101805307|NCT02917564|Glucocorticoids|glucocorticoids|mesh-ancestor
101805308|NCT02917564|Hormones|hormones|mesh-ancestor
101805309|NCT02917564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101805310|NCT02917564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805311|NCT02917564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101805312|NCT02917564|Immunologic Factors|immunologic factors|mesh-ancestor
101805313|NCT02917564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101805314|NCT02917564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805315|NCT00952016|Methotrexate|methotrexate|mesh-list
101805316|NCT00952016|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101805317|NCT00952016|Abortifacient Agents|abortifacient agents|mesh-ancestor
101805318|NCT00952016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101805319|NCT00952016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805320|NCT00952016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101204519|NCT01423864|Prednisolone|prednisolone|mesh-list
101805321|NCT00952016|Antimetabolites|antimetabolites|mesh-ancestor
101805322|NCT00952016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805323|NCT00952016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101805324|NCT00952016|Dermatologic Agents|dermatologic agents|mesh-ancestor
101805325|NCT00952016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101805326|NCT00952016|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101805327|NCT00952016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101805328|NCT00952016|Immunologic Factors|immunologic factors|mesh-ancestor
101805329|NCT00952016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101805330|NCT00952016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101805331|NCT00952094|Cinacalcet|cinacalcet|mesh-list
101805332|NCT00952094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101805333|NCT00952094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805334|NCT00952094|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101805335|NCT00952094|Hormone Antagonists|hormone antagonists|mesh-ancestor
101805336|NCT00952094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101805338|NCT00942344|Amlodipine|amlodipine|mesh-list
101805339|NCT00942344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101805340|NCT00942344|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101805341|NCT00942344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101805342|NCT00942344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805343|NCT00942344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101805344|NCT00942344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805345|NCT00942344|Vasodilator Agents|vasodilator agents|mesh-ancestor
101805346|NCT00942344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101805347|NCT00942344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101805348|NCT00942344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101805349|NCT00946166|Simvastatin|simvastatin|mesh-list
101805350|NCT00946166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101805351|NCT00946166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101805352|NCT00946166|Antimetabolites|antimetabolites|mesh-ancestor
101805353|NCT00946166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805354|NCT00946166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101805355|NCT00946166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101805356|NCT00946166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101805357|NCT00952562|Cholecalciferol|cholecalciferol|mesh-list
101805358|NCT00952562|Vitamin D|vitamin d|mesh-list
101805359|NCT00952562|Vitamins|vitamins|mesh-ancestor
101805360|NCT00952562|Micronutrients|micronutrients|mesh-ancestor
101805361|NCT00952562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805362|NCT00952562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101805363|NCT00952562|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101805364|NCT00952640|Vitamin A|vitamin a|mesh-list
101805365|NCT00952640|Vitamins|vitamins|mesh-ancestor
101805366|NCT00952640|Micronutrients|micronutrients|mesh-ancestor
101805367|NCT00952640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805368|NCT00952796|Moxifloxacin|moxifloxacin|mesh-list
101805369|NCT00952796|Ampicillin|ampicillin|mesh-list
101805370|NCT00952796|Sulbactam|sulbactam|mesh-list
101805371|NCT00952796|Sultamicillin|sultamicillin|mesh-list
101805372|NCT00952796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101805373|NCT00952796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101805374|NCT00952796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101805375|NCT00952796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101805376|NCT00952796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101805377|NCT00952796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805378|NCT00952796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101805379|NCT00952796|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101805381|NCT00952952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101805382|NCT00952952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101805383|NCT00952952|Analgesics|analgesics|mesh-ancestor
101805384|NCT00952952|Sensory System Agents|sensory system agents|mesh-ancestor
101805385|NCT00952952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101805386|NCT00952952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805387|NCT00952952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101805388|NCT00952952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101805389|NCT00953108|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101805390|NCT00953108|Escitalopram|escitalopram|mesh-list
101805391|NCT00953108|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101805392|NCT00953108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101805393|NCT00953108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101805394|NCT00953108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805395|NCT00953108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101805396|NCT00953108|Serotonin Agents|serotonin agents|mesh-ancestor
101805397|NCT00953108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805398|NCT00953108|Antidepressive Agents|antidepressive agents|mesh-ancestor
101805399|NCT00953108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101805400|NCT00953108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101805401|NCT00953108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101805402|NCT00953108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101805403|NCT00953498|Pioglitazone|pioglitazone|mesh-list
101805404|NCT00953498|Rosiglitazone|rosiglitazone|mesh-list
101805405|NCT00953498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101805406|NCT00953498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805407|NCT00943358|Vaccines|vaccines|mesh-list
101805408|NCT00943358|Immunologic Factors|immunologic factors|mesh-ancestor
101805409|NCT00943358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805411|NCT00120289|Simvastatin|simvastatin|mesh-list
101805412|NCT00120289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101805413|NCT00120289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101805414|NCT00120289|Antimetabolites|antimetabolites|mesh-ancestor
101805415|NCT00120289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805416|NCT00120289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101805417|NCT00120289|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101805418|NCT00120289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101805419|NCT00120289|Vasodilator Agents|vasodilator agents|mesh-ancestor
101805420|NCT00120289|Vitamin B Complex|vitamin b complex|mesh-ancestor
101805421|NCT00120289|Vitamins|vitamins|mesh-ancestor
101805422|NCT00120289|Micronutrients|micronutrients|mesh-ancestor
101805423|NCT00120289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805424|NCT00946556|Valacyclovir|valacyclovir|mesh-list
101805425|NCT00946556|Antiviral Agents|antiviral agents|mesh-ancestor
101805426|NCT00946556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101805427|NCT00943748|Deferiprone|deferiprone|mesh-list
101805428|NCT00943748|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101805429|NCT00943748|Chelating Agents|chelating agents|mesh-ancestor
101805430|NCT00943748|Sequestering Agents|sequestering agents|mesh-ancestor
101805431|NCT00943748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805432|NCT00946790|Hydroxychloroquine|hydroxychloroquine|mesh-list
101805433|NCT00946790|Antimalarials|antimalarials|mesh-ancestor
101805434|NCT00946790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101805435|NCT00946790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101805436|NCT00946790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101805437|NCT00946790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101805438|NCT00946790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805439|NCT00946790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101805441|NCT00954200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101805442|NCT00954200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101805443|NCT00954200|Analgesics|analgesics|mesh-ancestor
101311304|NCT00006450|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
101805444|NCT00954200|Sensory System Agents|sensory system agents|mesh-ancestor
101805445|NCT00954200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101805446|NCT00954200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805447|NCT00954200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101805448|NCT00954200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101805449|NCT00954200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101805450|NCT00954200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101805451|NCT00954200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805452|NCT00954278|Sorafenib|sorafenib|mesh-list
101805453|NCT00954278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101805454|NCT00954278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101805455|NCT00954278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101805456|NCT00954278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805457|NCT00550446|Adalimumab|adalimumab|mesh-list
101805458|NCT00550446|Tofacitinib|tofacitinib|mesh-list
101805459|NCT00550446|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101805460|NCT00550446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101805461|NCT00550446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101805462|NCT00550446|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101805463|NCT00550446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101805464|NCT00550446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101805465|NCT00550446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805466|NCT00953472|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101805467|NCT00953472|Natriuretic Agents|natriuretic agents|mesh-ancestor
101805468|NCT00953472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805469|NCT00953550|Rocuronium|rocuronium|mesh-list
101805470|NCT00953550|Succinylcholine|succinylcholine|mesh-list
101805471|NCT00953550|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101805472|NCT00953550|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101805473|NCT00953550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101805474|NCT00953550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101805475|NCT00953550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805476|NCT00953550|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
101805477|NCT00953628|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101805478|NCT00953628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101204974|NCT05386121|Anesthetics|anesthetics|mesh-ancestor
101805479|NCT00953628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805480|NCT00949026|Sirolimus|sirolimus|mesh-list
101805481|NCT00949026|Temsirolimus|temsirolimus|mesh-list
101805482|NCT00949026|MTOR Inhibitors|mtor inhibitors|mesh-list
101805483|NCT00949026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101805484|NCT00949026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101805485|NCT00949026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805486|NCT00949026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101805487|NCT00949026|Immunologic Factors|immunologic factors|mesh-ancestor
101805488|NCT00949026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805489|NCT00949026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101805490|NCT00949026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101805491|NCT00949026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101805492|NCT00949026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101805493|NCT00949026|Antifungal Agents|antifungal agents|mesh-ancestor
101805494|NCT00436618|Everolimus|everolimus|mesh-list
101805495|NCT00436618|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101805496|NCT00436618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101805497|NCT00436618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101805498|NCT00436618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805499|NCT00436618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101805500|NCT00436618|Immunologic Factors|immunologic factors|mesh-ancestor
101462817|NCT00200525|Dopamine Agents|dopamine agents|mesh-ancestor
101805501|NCT00436618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805503|NCT01024660|Donepezil|donepezil|mesh-list
101805504|NCT01024660|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101805505|NCT01024660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101805506|NCT01024660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805507|NCT01024660|Cholinergic Agents|cholinergic agents|mesh-ancestor
101805508|NCT01024660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101805509|NCT01024660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805511|NCT01751126|Cyclosporine|cyclosporine|mesh-list
101805512|NCT01751126|Cyclosporins|cyclosporins|mesh-list
101805513|NCT01751126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101805514|NCT01751126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805515|NCT01751126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101205127|NCT04765371|Hormones|hormones|mesh-ancestor
101805516|NCT01751126|Immunologic Factors|immunologic factors|mesh-ancestor
101805517|NCT01751126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805518|NCT01751126|Antifungal Agents|antifungal agents|mesh-ancestor
101805519|NCT01751126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101805520|NCT01751126|Dermatologic Agents|dermatologic agents|mesh-ancestor
101805521|NCT01751126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101805522|NCT01751126|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101805523|NCT00943982|Interferons|interferons|mesh-list
101805524|NCT00943982|Interferon-gamma|interferon-gamma|mesh-list
101805525|NCT00943982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101805526|NCT00943982|Antiviral Agents|antiviral agents|mesh-ancestor
101805527|NCT00943982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101805528|NCT00548808|Insulin|insulin|mesh-list
101805529|NCT00548808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101805530|NCT00548808|Insulin Glargine|insulin glargine|mesh-list
101805531|NCT00548808|Insulin Lispro|insulin lispro|mesh-list
101805532|NCT00548808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101805533|NCT00548808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805534|NCT04011878|Mitomycins|mitomycins|mesh-list
101805535|NCT04011878|Mitomycin|mitomycin|mesh-list
101805536|NCT04011878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101205270|NCT03945084|Niraparib|niraparib|mesh-list
101805537|NCT04011878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101805538|NCT04011878|Alkylating Agents|alkylating agents|mesh-ancestor
101805539|NCT04011878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805540|NCT04011878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101805541|NCT04011878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101805542|NCT00954096|Nicotine|nicotine|mesh-list
101805543|NCT00954096|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101805544|NCT00954096|Autonomic Agents|autonomic agents|mesh-ancestor
101805545|NCT00954096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101805546|NCT00954096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805547|NCT00954096|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101805548|NCT00954096|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101805549|NCT00954096|Cholinergic Agents|cholinergic agents|mesh-ancestor
101805550|NCT00954096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101805551|NCT00954096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805552|NCT00954252|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
101805553|NCT00954252|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101805554|NCT00954252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101805555|NCT00954252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805556|NCT00110617|Deferasirox|deferasirox|mesh-list
101805557|NCT00110617|Deferoxamine|deferoxamine|mesh-list
101205333|NCT03444753|Nivolumab|nivolumab|mesh-list
101805558|NCT00110617|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101805559|NCT00110617|Chelating Agents|chelating agents|mesh-ancestor
101805560|NCT00110617|Sequestering Agents|sequestering agents|mesh-ancestor
101805561|NCT00110617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805562|NCT00110617|Siderophores|siderophores|mesh-ancestor
101805564|NCT00949494|Hyaluronic Acid|hyaluronic acid|mesh-list
101805565|NCT00949494|Viscosupplements|viscosupplements|mesh-ancestor
101805566|NCT00949494|Protective Agents|protective agents|mesh-ancestor
101805567|NCT00949494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805568|NCT00949494|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101805569|NCT00949494|Immunologic Factors|immunologic factors|mesh-ancestor
101805570|NCT00954486|Epoetin Alfa|epoetin alfa|mesh-list
101805571|NCT00954486|Hematinics|hematinics|mesh-ancestor
101805572|NCT00550238|Pimavanserin|pimavanserin|mesh-list
101805573|NCT00550238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101805574|NCT00550238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101805575|NCT00550238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101805576|NCT00550238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101805577|NCT00550238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101805578|NCT00550238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805579|NCT00550238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101805580|NCT00550238|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101805581|NCT00550238|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101805582|NCT00550238|Serotonin Agents|serotonin agents|mesh-ancestor
101805583|NCT00550238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101805584|NCT00550238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805585|NCT02903680|Dexamethasone|dexamethasone|mesh-list
101805586|NCT02903680|Dexamethasone acetate|dexamethasone acetate|mesh-list
101805587|NCT02903680|BB 1101|bb 1101|mesh-list
101805588|NCT02903680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101805589|NCT02903680|Antiemetics|antiemetics|mesh-ancestor
101805590|NCT02903680|Autonomic Agents|autonomic agents|mesh-ancestor
101805591|NCT02903680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101805592|NCT02903680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805593|NCT02903680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101805594|NCT02903680|Glucocorticoids|glucocorticoids|mesh-ancestor
101805596|NCT02903680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101805597|NCT02903680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101805598|NCT02903680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101805599|NCT02903680|Protease Inhibitors|protease inhibitors|mesh-ancestor
101805600|NCT02903680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101805601|NCT02903680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805602|NCT00946946|Mesalamine|mesalamine|mesh-list
101805603|NCT00946946|Azathioprine|azathioprine|mesh-list
101805604|NCT00946946|Antimetabolites|antimetabolites|mesh-ancestor
101805605|NCT00946946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805606|NCT00946946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101805607|NCT00946946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101805608|NCT00946946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101805609|NCT00946946|Immunologic Factors|immunologic factors|mesh-ancestor
101805610|NCT00946946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805611|NCT00946946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101805612|NCT00946946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101805613|NCT00946946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101805614|NCT00946946|Analgesics|analgesics|mesh-ancestor
101805615|NCT00946946|Sensory System Agents|sensory system agents|mesh-ancestor
101805616|NCT00946946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101805617|NCT00946946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101805618|NCT00947024|Glipizide|glipizide|mesh-list
101805619|NCT00947024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101805620|NCT00947024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805621|NCT00949572|Vaccines|vaccines|mesh-list
101805622|NCT00949572|Aluminum sulfate|aluminum sulfate|mesh-list
101805623|NCT00949572|Immunologic Factors|immunologic factors|mesh-ancestor
101805624|NCT00949572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810640|NCT01265030|Sirolimus|sirolimus|mesh-list
101805625|NCT00949572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101805626|NCT01031992|Tranexamic Acid|tranexamic acid|mesh-list
101805627|NCT01031992|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101805628|NCT01031992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101805629|NCT01031992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805630|NCT01031992|Hemostatics|hemostatics|mesh-ancestor
101805631|NCT01031992|Coagulants|coagulants|mesh-ancestor
101805632|NCT00954564|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101805633|NCT00954564|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101805634|NCT00954564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101805635|NCT00954564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805636|NCT00954564|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101805637|NCT00954564|Hormone Antagonists|hormone antagonists|mesh-ancestor
101805638|NCT00954564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101805639|NCT00954564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805640|NCT00949728|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101805641|NCT00949728|Hemostatics|hemostatics|mesh-ancestor
101805642|NCT00949728|Coagulants|coagulants|mesh-ancestor
101805643|NCT00954902|Antioxidants|antioxidants|mesh-list
101805644|NCT00954902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805645|NCT00954902|Protective Agents|protective agents|mesh-ancestor
101805646|NCT00954902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805647|NCT01034020|Nicotine|nicotine|mesh-list
101805648|NCT01034020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101805649|NCT01034020|Autonomic Agents|autonomic agents|mesh-ancestor
101805650|NCT01034020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101805651|NCT01034020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805652|NCT01034020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101805654|NCT01034020|Cholinergic Agents|cholinergic agents|mesh-ancestor
101805655|NCT01034020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101805656|NCT01034020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805657|NCT01032148|Panobinostat|panobinostat|mesh-list
101805658|NCT01032148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101805659|NCT01032148|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101805660|NCT01032148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101805661|NCT01032148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805663|NCT01032304|Expectorants|expectorants|mesh-ancestor
101805664|NCT01032304|Respiratory System Agents|respiratory system agents|mesh-ancestor
101805665|NCT00954642|Paclitaxel|paclitaxel|mesh-list
101805666|NCT00954642|Bevacizumab|bevacizumab|mesh-list
101805667|NCT00954642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101805668|NCT00954642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101805669|NCT00954642|Tubulin Modulators|tubulin modulators|mesh-ancestor
101805670|NCT00954642|Antimitotic Agents|antimitotic agents|mesh-ancestor
101805671|NCT00954642|Mitosis Modulators|mitosis modulators|mesh-ancestor
101805672|NCT00954642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805673|NCT00954642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101805674|NCT00954642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101805675|NCT00954642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101805676|NCT00954642|Growth Substances|growth substances|mesh-ancestor
101805677|NCT00954642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805678|NCT00954642|Growth Inhibitors|growth inhibitors|mesh-ancestor
101805679|NCT00954798|Vaccines|vaccines|mesh-list
101805680|NCT00954798|Immunologic Factors|immunologic factors|mesh-ancestor
101805681|NCT00954798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805682|NCT00110305|Efavirenz|efavirenz|mesh-list
101805683|NCT00110305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
101805684|NCT00110305|Rilpivirine|rilpivirine|mesh-list
101805685|NCT00110305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101805686|NCT00110305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101246504|NCT01666418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101805687|NCT00110305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805689|NCT00110305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101805690|NCT00110305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101805691|NCT00110305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101805692|NCT00110305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101805693|NCT00110305|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101805694|NCT00110305|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101805695|NCT00110305|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101805696|NCT00110305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101805697|NCT00110305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101805698|NCT00560066|Vaccines|vaccines|mesh-list
101805699|NCT00560066|Immunologic Factors|immunologic factors|mesh-ancestor
101805700|NCT00560066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805701|NCT00549900|Vaccines|vaccines|mesh-list
101805702|NCT00549900|Immunologic Factors|immunologic factors|mesh-ancestor
101805703|NCT00549900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805704|NCT00435994|Epinephrine|epinephrine|mesh-list
101805705|NCT00435994|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101805706|NCT00435994|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101805707|NCT00435994|Adrenergic Agents|adrenergic agents|mesh-ancestor
101805708|NCT00435994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101805709|NCT00435994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805710|NCT00435994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805711|NCT00435994|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101805712|NCT00435994|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101805713|NCT00435994|Autonomic Agents|autonomic agents|mesh-ancestor
101805714|NCT00435994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101805715|NCT00435994|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101805716|NCT00435994|Respiratory System Agents|respiratory system agents|mesh-ancestor
101805717|NCT00435994|Mydriatics|mydriatics|mesh-ancestor
101805718|NCT00435994|Sympathomimetics|sympathomimetics|mesh-ancestor
101805719|NCT00435994|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101805720|NCT01563120|Metformin|metformin|mesh-list
101805721|NCT01563120|Glyburide|glyburide|mesh-list
101805722|NCT01563120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101805723|NCT01563120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805724|NCT00435370|Tropisetron|tropisetron|mesh-list
101805725|NCT00435370|Risperidone|risperidone|mesh-list
101805726|NCT00435370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101805727|NCT00435370|Serotonin Agents|serotonin agents|mesh-ancestor
101805728|NCT00435370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101805729|NCT00435370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810690|NCT00098839|Cyclophosphamide|cyclophosphamide|mesh-list
101805730|NCT00435370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805731|NCT00435370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101805732|NCT00435370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101805733|NCT00435370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101805734|NCT00435370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101805735|NCT00435370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101805736|NCT00435370|Dopamine Agents|dopamine agents|mesh-ancestor
101805737|NCT00435370|Antiemetics|antiemetics|mesh-ancestor
101805738|NCT00435370|Autonomic Agents|autonomic agents|mesh-ancestor
101805739|NCT00435370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101805740|NCT00435370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101805741|NCT00435370|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101805742|NCT00096031|Cetuximab|cetuximab|mesh-list
101805743|NCT00096031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101805744|NCT00096031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101805745|NCT00118417|Clonazepam|clonazepam|mesh-list
101805746|NCT00118417|Sertraline|sertraline|mesh-list
101805747|NCT00118417|Antidepressive Agents|antidepressive agents|mesh-ancestor
101805748|NCT00118417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101805749|NCT00118417|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101805750|NCT00118417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101805751|NCT00118417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101805752|NCT00118417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805753|NCT00118417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101805754|NCT00118417|Serotonin Agents|serotonin agents|mesh-ancestor
101805755|NCT00118417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805756|NCT00118417|Anticonvulsants|anticonvulsants|mesh-ancestor
101805757|NCT00118417|GABA Modulators|gaba modulators|mesh-ancestor
101805758|NCT00118417|GABA Agents|gaba agents|mesh-ancestor
101805759|NCT04293744|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101805760|NCT01079455|Corticosterone|corticosterone|mesh-list
101805761|NCT01079455|Bupivacaine|bupivacaine|mesh-list
101805762|NCT01079455|Hyaluronic Acid|hyaluronic acid|mesh-list
101805763|NCT01079455|Anesthetics, Local|anesthetics, local|mesh-ancestor
101805764|NCT01079455|Anesthetics|anesthetics|mesh-ancestor
101805765|NCT01079455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101805766|NCT01079455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805767|NCT01079455|Sensory System Agents|sensory system agents|mesh-ancestor
101805768|NCT01079455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101805769|NCT01079455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101805770|NCT01079455|Immunologic Factors|immunologic factors|mesh-ancestor
101805771|NCT01079455|Viscosupplements|viscosupplements|mesh-ancestor
101805772|NCT01079455|Protective Agents|protective agents|mesh-ancestor
101805773|NCT01079455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101805774|NCT00549848|Cytarabine|cytarabine|mesh-list
101805775|NCT00549848|Dexamethasone|dexamethasone|mesh-list
101805776|NCT00549848|Dexamethasone acetate|dexamethasone acetate|mesh-list
101805777|NCT00549848|Prednisone|prednisone|mesh-list
101805778|NCT00549848|Prednisolone|prednisolone|mesh-list
101805779|NCT00549848|Cyclophosphamide|cyclophosphamide|mesh-list
101805780|NCT00549848|Doxorubicin|doxorubicin|mesh-list
101805781|NCT00549848|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101805782|NCT00549848|Methotrexate|methotrexate|mesh-list
101805783|NCT00549848|Etoposide|etoposide|mesh-list
101805784|NCT00549848|Etoposide phosphate|etoposide phosphate|mesh-list
101805785|NCT00549848|Vincristine|vincristine|mesh-list
101805786|NCT00549848|Daunorubicin|daunorubicin|mesh-list
101805787|NCT00549848|Asparaginase|asparaginase|mesh-list
101805788|NCT00549848|Dasatinib|dasatinib|mesh-list
101805789|NCT00549848|Mercaptopurine|mercaptopurine|mesh-list
101805790|NCT00549848|Clofarabine|clofarabine|mesh-list
101805791|NCT00549848|Pegaspargase|pegaspargase|mesh-list
101805792|NCT00549848|Thioguanine|thioguanine|mesh-list
101805793|NCT00549848|BB 1101|bb 1101|mesh-list
101805794|NCT00549848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101805795|NCT00549848|Immunologic Factors|immunologic factors|mesh-ancestor
101805796|NCT00549848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805797|NCT00549848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101805798|NCT00549848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101805799|NCT00549848|Alkylating Agents|alkylating agents|mesh-ancestor
101805800|NCT00549848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805801|NCT00549848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101805802|NCT00549848|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101805803|NCT00549848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101805805|NCT00549848|Autonomic Agents|autonomic agents|mesh-ancestor
101805806|NCT00549848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101805807|NCT00549848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101805808|NCT00549848|Glucocorticoids|glucocorticoids|mesh-ancestor
101805809|NCT00549848|Hormones|hormones|mesh-ancestor
101805810|NCT00549848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101805811|NCT00549848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101805812|NCT00549848|Protease Inhibitors|protease inhibitors|mesh-ancestor
101805813|NCT00549848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101805814|NCT00549848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101805815|NCT00549848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101805816|NCT00549848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101805817|NCT00549848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101805818|NCT00549848|Abortifacient Agents|abortifacient agents|mesh-ancestor
101805819|NCT00549848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101805820|NCT00549848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101805821|NCT00549848|Antimetabolites|antimetabolites|mesh-ancestor
101805822|NCT00549848|Dermatologic Agents|dermatologic agents|mesh-ancestor
101805823|NCT00549848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101805824|NCT00549848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101805825|NCT00549848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101805826|NCT00549848|Antiviral Agents|antiviral agents|mesh-ancestor
101805827|NCT00549848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101805828|NCT00549848|Tubulin Modulators|tubulin modulators|mesh-ancestor
101805829|NCT00549848|Antimitotic Agents|antimitotic agents|mesh-ancestor
101805830|NCT00549848|Mitosis Modulators|mitosis modulators|mesh-ancestor
101805831|NCT00549848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101805832|NCT01083589|Docetaxel|docetaxel|mesh-list
101805833|NCT01083589|Imatinib Mesylate|imatinib mesylate|mesh-list
101805834|NCT01083589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101805835|NCT01083589|Tubulin Modulators|tubulin modulators|mesh-ancestor
101805836|NCT01083589|Antimitotic Agents|antimitotic agents|mesh-ancestor
101805837|NCT01083589|Mitosis Modulators|mitosis modulators|mesh-ancestor
101805838|NCT01083589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805839|NCT01083589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101805840|NCT01083589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101805841|NCT00949182|Doxorubicin|doxorubicin|mesh-list
101805842|NCT00949182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101805843|NCT00949182|Mitomycins|mitomycins|mesh-list
101805844|NCT00949182|Mitomycin|mitomycin|mesh-list
101805845|NCT00949182|Sorafenib|sorafenib|mesh-list
101805846|NCT00949182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101805847|NCT00949182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101805848|NCT00949182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101805849|NCT00949182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101805850|NCT00949182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101805851|NCT00949182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805852|NCT00949182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101805853|NCT00949182|Alkylating Agents|alkylating agents|mesh-ancestor
101805854|NCT00949182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101805855|NCT00549770|Valsartan|valsartan|mesh-list
101805856|NCT00549770|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101805857|NCT00549770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101810722|NCT00098839|Abortifacient Agents|abortifacient agents|mesh-ancestor
101805858|NCT00549770|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101805859|NCT00549770|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101805860|NCT00549770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805861|NCT00548184|Trastuzumab|trastuzumab|mesh-list
101805862|NCT00548184|Lapatinib|lapatinib|mesh-list
101805863|NCT00548184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101805864|NCT00548184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101805865|NCT00548184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101805866|NCT00548184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101805867|NCT00548184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805869|NCT00454636|Docetaxel|docetaxel|mesh-list
101805870|NCT00454636|Capecitabine|capecitabine|mesh-list
101805871|NCT00454636|Oxaliplatin|oxaliplatin|mesh-list
101805872|NCT00454636|Epirubicin|epirubicin|mesh-list
101805873|NCT00454636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101805874|NCT00454636|Tubulin Modulators|tubulin modulators|mesh-ancestor
101805875|NCT00454636|Antimitotic Agents|antimitotic agents|mesh-ancestor
101805876|NCT00454636|Mitosis Modulators|mitosis modulators|mesh-ancestor
101805877|NCT00454636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805878|NCT00454636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101805879|NCT00454636|Antimetabolites|antimetabolites|mesh-ancestor
101805880|NCT00454636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101311320|NCT00006459|Paclitaxel|paclitaxel|mesh-list
101805881|NCT00454636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101805882|NCT00454636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101805883|NCT00454636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101805885|NCT00427960|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101805886|NCT00427960|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101805887|NCT00427960|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101805888|NCT00427960|Antimetabolites|antimetabolites|mesh-ancestor
101805889|NCT00427960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805890|NCT00427960|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101805891|NCT00427960|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101805892|NCT00427960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101805893|NCT04768686|Pembrolizumab|pembrolizumab|mesh-list
101805894|NCT04768686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101805895|NCT04768686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101805896|NCT04768686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101805897|NCT04768686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805898|NCT00955890|Dexrazoxane|dexrazoxane|mesh-list
101805899|NCT00955890|Razoxane|razoxane|mesh-list
101805900|NCT00955890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101805901|NCT00955890|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101805902|NCT00955890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101805903|NCT00955890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101805904|NCT00955890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101805905|NCT00955890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805906|NCT00955890|Protective Agents|protective agents|mesh-ancestor
101805907|NCT00955890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205899|NCT01428492|Hormones|hormones|mesh-ancestor
101805908|NCT00955890|Antimitotic Agents|antimitotic agents|mesh-ancestor
101805909|NCT00955890|Mitosis Modulators|mitosis modulators|mesh-ancestor
101805910|NCT00956046|Vaccines|vaccines|mesh-list
101805911|NCT00956046|Immunologic Factors|immunologic factors|mesh-ancestor
101805912|NCT00956046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805913|NCT00454246|Epoetin Alfa|epoetin alfa|mesh-list
101805914|NCT00454246|Darbepoetin alfa|darbepoetin alfa|mesh-list
101805915|NCT00454246|Hematinics|hematinics|mesh-ancestor
101805916|NCT00434590|Mycophenolic Acid|mycophenolic acid|mesh-list
101805917|NCT00434590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101805918|NCT00434590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101805919|NCT00434590|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101805920|NCT00434590|Antitubercular Agents|antitubercular agents|mesh-ancestor
101805921|NCT00434590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101805922|NCT00434590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101805923|NCT00434590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101805924|NCT00434590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805925|NCT00956202|Vaccines|vaccines|mesh-list
101805926|NCT00956202|Immunologic Factors|immunologic factors|mesh-ancestor
101805927|NCT00956202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805928|NCT00695903|Vancomycin|vancomycin|mesh-list
101805929|NCT00695903|Daptomycin|daptomycin|mesh-list
101805930|NCT00695903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101805931|NCT00695903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101805932|NCT02759861|Sofosbuvir|sofosbuvir|mesh-list
101805933|NCT02759861|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
101805934|NCT02759861|Ledipasvir|ledipasvir|mesh-list
101805935|NCT02759861|Antiviral Agents|antiviral agents|mesh-ancestor
101805936|NCT02759861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101805937|NCT00548262|Voriconazole|voriconazole|mesh-list
101805938|NCT00548262|Anidulafungin|anidulafungin|mesh-list
101805939|NCT00548262|Antifungal Agents|antifungal agents|mesh-ancestor
101805940|NCT00548262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101805941|NCT00548262|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101805942|NCT00548262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101805943|NCT00548262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101805944|NCT00548262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805945|NCT00548262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101805946|NCT00548262|Hormone Antagonists|hormone antagonists|mesh-ancestor
101805947|NCT00548262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101805948|NCT00548262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805949|NCT00548262|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101805950|NCT02565173|Timolol|timolol|mesh-list
101805951|NCT02565173|Adenosine|adenosine|mesh-list
101805952|NCT02565173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101805953|NCT02565173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101805954|NCT02565173|Adrenergic Agents|adrenergic agents|mesh-ancestor
101205927|NCT01428544|Fondaparinux|fondaparinux|mesh-list
101805955|NCT02565173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101805956|NCT02565173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805957|NCT02565173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805958|NCT02565173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101805959|NCT02565173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101805961|NCT02565173|Sensory System Agents|sensory system agents|mesh-ancestor
101805962|NCT02565173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101805963|NCT02565173|Vasodilator Agents|vasodilator agents|mesh-ancestor
101805964|NCT02565173|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101805965|NCT02565173|Purinergic Agonists|purinergic agonists|mesh-ancestor
101805966|NCT02565173|Purinergic Agents|purinergic agents|mesh-ancestor
101805967|NCT02730923|Anastrozole|anastrozole|mesh-list
101805968|NCT02730923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101805970|NCT02730923|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101805971|NCT02730923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101805972|NCT02730923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101805973|NCT02730923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805974|NCT02730923|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101805975|NCT02730923|Hormone Antagonists|hormone antagonists|mesh-ancestor
101805976|NCT02730923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101805977|NCT02730923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101805978|NCT04619082|Tenofovir|tenofovir|mesh-list
101805979|NCT04619082|Antiviral Agents|antiviral agents|mesh-ancestor
101805980|NCT04619082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101805981|NCT04619082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101805982|NCT04619082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101805983|NCT04619082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101805984|NCT04619082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805985|NCT04619082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101805986|NCT04619082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101805987|NCT03717623|Posaconazole|posaconazole|mesh-list
101805988|NCT03717623|Antifungal Agents|antifungal agents|mesh-ancestor
101805989|NCT03717623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101805990|NCT03717623|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101805991|NCT03717623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101805992|NCT03717623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101805993|NCT03717623|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101805994|NCT03717623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101805995|NCT03717623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101805996|NCT03717623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101805997|NCT03717623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101805998|NCT03717623|Hormone Antagonists|hormone antagonists|mesh-ancestor
101805999|NCT03717623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101806000|NCT03717623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806001|NCT00095173|Abatacept|abatacept|mesh-list
101806002|NCT00095173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101806003|NCT00095173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806004|NCT00095173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101806005|NCT00095173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101806006|NCT00095173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101806007|NCT00095173|Immunologic Factors|immunologic factors|mesh-ancestor
101806008|NCT00095173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806009|NCT00095173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101806010|NCT03704753|Ropivacaine|ropivacaine|mesh-list
101806011|NCT03704753|Anesthetics, Local|anesthetics, local|mesh-ancestor
101806012|NCT03704753|Anesthetics|anesthetics|mesh-ancestor
101806013|NCT03704753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101806014|NCT03704753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806015|NCT03704753|Sensory System Agents|sensory system agents|mesh-ancestor
101806016|NCT03704753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101806017|NCT00690443|Atorvastatin|atorvastatin|mesh-list
101806019|NCT00690443|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101806020|NCT00690443|Antimetabolites|antimetabolites|mesh-ancestor
101806021|NCT00690443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806022|NCT00690443|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101806023|NCT00690443|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101806024|NCT00690443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101806026|NCT03954834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101806027|NCT03954834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806028|NCT03954834|Incretins|incretins|mesh-ancestor
101806029|NCT03954834|Hormones|hormones|mesh-ancestor
101806030|NCT03954834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101806032|NCT00693017|Anticonvulsants|anticonvulsants|mesh-ancestor
101806033|NCT00693017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101806034|NCT00693017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101806035|NCT00693017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806036|NCT00693017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101806037|NCT00693017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806038|NCT05299554|Hydrocortisone|hydrocortisone|mesh-list
101806039|NCT05299554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101806040|NCT00692237|Sildenafil Citrate|sildenafil citrate|mesh-list
101806041|NCT00692237|Vasodilator Agents|vasodilator agents|mesh-ancestor
101806042|NCT00692237|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101806043|NCT00692237|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101806044|NCT00692237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101806045|NCT00692237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806046|NCT00692237|Urological Agents|urological agents|mesh-ancestor
101806047|NCT00110149|Rituximab|rituximab|mesh-list
101806048|NCT00110149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101806049|NCT00110149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101806050|NCT00110149|Immunologic Factors|immunologic factors|mesh-ancestor
101806051|NCT00110149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806052|NCT00110149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101806053|NCT01084057|Vorinostat|vorinostat|mesh-list
101806054|NCT01084057|Epothilone B|epothilone b|mesh-list
101806055|NCT01084057|Epothilones|epothilones|mesh-list
101806056|NCT01084057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101806057|NCT01084057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101806058|NCT01084057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101806059|NCT01084057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806060|NCT01084057|Tubulin Modulators|tubulin modulators|mesh-ancestor
101206037|NCT01429545|Atosiban|atosiban|mesh-list
101806062|NCT01084057|Mitosis Modulators|mitosis modulators|mesh-ancestor
101806063|NCT03954444|Phenylephrine|phenylephrine|mesh-list
101806064|NCT03954444|Oxymetazoline|oxymetazoline|mesh-list
101806065|NCT03954444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101806066|NCT03954444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101806067|NCT03954444|Adrenergic Agents|adrenergic agents|mesh-ancestor
101806068|NCT03954444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101806069|NCT03954444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806070|NCT03954444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806071|NCT03954444|Sympathomimetics|sympathomimetics|mesh-ancestor
101806072|NCT03954444|Autonomic Agents|autonomic agents|mesh-ancestor
101806073|NCT03954444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101806074|NCT03954444|Nasal Decongestants|nasal decongestants|mesh-ancestor
101806075|NCT03954444|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101806076|NCT03954444|Respiratory System Agents|respiratory system agents|mesh-ancestor
101806077|NCT03954444|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101806078|NCT03954444|Mydriatics|mydriatics|mesh-ancestor
101806079|NCT03954444|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101806080|NCT03954444|Protective Agents|protective agents|mesh-ancestor
101806081|NCT03953820|Diazepam|diazepam|mesh-list
101806082|NCT03953820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101806083|NCT03953820|Anticonvulsants|anticonvulsants|mesh-ancestor
101806084|NCT03953820|Antiemetics|antiemetics|mesh-ancestor
101806085|NCT03953820|Autonomic Agents|autonomic agents|mesh-ancestor
101806086|NCT03953820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101806087|NCT03953820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806088|NCT03953820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101806089|NCT03953820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101806090|NCT03953820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101806091|NCT03953820|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101806092|NCT03953820|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101806093|NCT03953820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101806094|NCT03953820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101806095|NCT03953820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101806096|NCT03953820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101806097|NCT03953820|Anesthetics, General|anesthetics, general|mesh-ancestor
101806098|NCT03953820|Anesthetics|anesthetics|mesh-ancestor
101806099|NCT03953820|GABA Modulators|gaba modulators|mesh-ancestor
101806100|NCT03953820|GABA Agents|gaba agents|mesh-ancestor
101806101|NCT03953820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101806102|NCT03953820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806103|NCT02611037|Gemcitabine|gemcitabine|mesh-list
101806104|NCT02611037|Methotrexate|methotrexate|mesh-list
101806105|NCT02611037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101806106|NCT02611037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101806107|NCT02611037|Antimetabolites|antimetabolites|mesh-ancestor
101806108|NCT02611037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806109|NCT02611037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101806110|NCT02611037|Abortifacient Agents|abortifacient agents|mesh-ancestor
101806111|NCT02611037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101806112|NCT02611037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806113|NCT02611037|Dermatologic Agents|dermatologic agents|mesh-ancestor
101806114|NCT02611037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101806115|NCT02611037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101806116|NCT02611037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101806117|NCT02611037|Immunologic Factors|immunologic factors|mesh-ancestor
101806118|NCT02611037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101806119|NCT02611037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101806120|NCT03678636|Anti-Infective Agents|anti-infective agents|mesh-list
101806121|NCT03678636|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101806122|NCT04492956|Ecopipam|ecopipam|mesh-list
101806123|NCT04492956|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101806124|NCT04492956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101806125|NCT04492956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101806126|NCT04492956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806127|NCT04492956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101806128|NCT04492956|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101806129|NCT04492956|Dopamine Agents|dopamine agents|mesh-ancestor
101806130|NCT04492956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101806131|NCT04492956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806132|NCT01084213|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101806133|NCT01084213|Antimalarials|antimalarials|mesh-ancestor
101806134|NCT01084213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101806135|NCT01084213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101806136|NCT01084213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101806137|NCT00742937|Vitamin A|vitamin a|mesh-list
101806138|NCT00742937|Vitamins|vitamins|mesh-ancestor
101806139|NCT00742937|Micronutrients|micronutrients|mesh-ancestor
101806140|NCT00742937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806141|NCT00692003|Zonisamide|zonisamide|mesh-list
101806142|NCT00692003|Anticonvulsants|anticonvulsants|mesh-ancestor
101806143|NCT00692003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101806144|NCT00692003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101806145|NCT00692003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810796|NCT00490971|Olanzapine|olanzapine|mesh-list
101806146|NCT00692003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101806147|NCT00692003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806148|NCT02564315|Nicotine|nicotine|mesh-list
101806149|NCT02564315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101806150|NCT02564315|Autonomic Agents|autonomic agents|mesh-ancestor
101806151|NCT02564315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101806152|NCT02564315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806153|NCT02564315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101806154|NCT02564315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101806155|NCT02564315|Cholinergic Agents|cholinergic agents|mesh-ancestor
101806156|NCT02564315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101806157|NCT02564315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806158|NCT02564237|Vaccines|vaccines|mesh-list
101806159|NCT02564237|Immunologic Factors|immunologic factors|mesh-ancestor
101806160|NCT02564237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806161|NCT00427648|Lidocaine|lidocaine|mesh-list
101806162|NCT00427648|Anesthetics, Local|anesthetics, local|mesh-ancestor
101806163|NCT00427648|Anesthetics|anesthetics|mesh-ancestor
101806164|NCT00427648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101806165|NCT00427648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806166|NCT00427648|Sensory System Agents|sensory system agents|mesh-ancestor
101806167|NCT00427648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101806168|NCT00427648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101206201|NCT01430260|Hormones|hormones|mesh-ancestor
101311332|NCT03876106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101806169|NCT00427648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101806170|NCT00427648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101806171|NCT00427648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101806172|NCT00427648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806173|NCT02153177|Acetaminophen|acetaminophen|mesh-list
101806174|NCT02153177|Ibuprofen|ibuprofen|mesh-list
101806175|NCT02153177|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
101806176|NCT02153177|Hydrocodone|hydrocodone|mesh-list
101806177|NCT02153177|Oxycodone|oxycodone|mesh-list
101806178|NCT02153177|Omeprazole|omeprazole|mesh-list
101806179|NCT02153177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101806180|NCT02153177|Analgesics|analgesics|mesh-ancestor
101806181|NCT02153177|Sensory System Agents|sensory system agents|mesh-ancestor
101806182|NCT02153177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101806183|NCT02153177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806184|NCT02153177|Antipyretics|antipyretics|mesh-ancestor
101806185|NCT02153177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101806186|NCT02153177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101806187|NCT02153177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101806188|NCT02153177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101806189|NCT02153177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101806190|NCT02153177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806191|NCT02153177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101806192|NCT02153177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101806193|NCT02153177|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101806194|NCT02153177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101806195|NCT02153177|Narcotics|narcotics|mesh-ancestor
101806196|NCT02153177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101806197|NCT02153177|Antitussive Agents|antitussive agents|mesh-ancestor
101806198|NCT02153177|Respiratory System Agents|respiratory system agents|mesh-ancestor
101806199|NCT00743327|Pioglitazone|pioglitazone|mesh-list
101806200|NCT00743327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101806201|NCT00743327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806202|NCT02564861|DS-1971a|ds-1971a|mesh-list
101806203|NCT02564861|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101806204|NCT02564861|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101806205|NCT02564861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101806206|NCT02564861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806207|NCT00416884|Fludarabine|fludarabine|mesh-list
101806208|NCT00416884|Alemtuzumab|alemtuzumab|mesh-list
101806209|NCT00416884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101806210|NCT00416884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101806211|NCT03507257|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101806212|NCT03507257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101806213|NCT03507257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806214|NCT00555620|Capecitabine|capecitabine|mesh-list
101806215|NCT00555620|Oxaliplatin|oxaliplatin|mesh-list
101806216|NCT00555620|Sunitinib|sunitinib|mesh-list
101806217|NCT00555620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101806218|NCT00555620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101806219|NCT00555620|Antimetabolites|antimetabolites|mesh-ancestor
101806220|NCT00555620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806221|NCT00555620|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101806222|NCT00555620|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101806223|NCT00555620|Growth Substances|growth substances|mesh-ancestor
101806224|NCT00555620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806225|NCT00555620|Growth Inhibitors|growth inhibitors|mesh-ancestor
101806226|NCT00555620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101806227|NCT00555620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101806228|NCT00433966|Paclitaxel|paclitaxel|mesh-list
101806229|NCT00433966|Heparin|heparin|mesh-list
101806230|NCT00433966|Calcium heparin|calcium heparin|mesh-list
101806231|NCT00433966|Bivalirudin|bivalirudin|mesh-list
101806232|NCT00433966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101806233|NCT00433966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101806234|NCT00433966|Tubulin Modulators|tubulin modulators|mesh-ancestor
101806235|NCT00433966|Antimitotic Agents|antimitotic agents|mesh-ancestor
101806236|NCT00433966|Mitosis Modulators|mitosis modulators|mesh-ancestor
101806237|NCT00433966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806238|NCT00433966|Anticoagulants|anticoagulants|mesh-ancestor
101806239|NCT00433966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101806240|NCT00433966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101206321|NCT01431326|Clozapine|clozapine|mesh-list
101206322|NCT01431326|Molindone|molindone|mesh-list
101806241|NCT00433966|Antithrombins|antithrombins|mesh-ancestor
101806242|NCT00433966|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101806243|NCT00433966|Protease Inhibitors|protease inhibitors|mesh-ancestor
101806244|NCT00433966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101806246|NCT03463265|Bevacizumab|bevacizumab|mesh-list
101806247|NCT03463265|Temozolomide|temozolomide|mesh-list
101806248|NCT03463265|Temsirolimus|temsirolimus|mesh-list
101806249|NCT03463265|Lomustine|lomustine|mesh-list
101806250|NCT03463265|MTOR Inhibitors|mtor inhibitors|mesh-list
101806251|NCT03463265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101806252|NCT03463265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101806253|NCT03463265|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101806254|NCT03463265|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101806255|NCT03463265|Growth Substances|growth substances|mesh-ancestor
101806256|NCT03463265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806257|NCT03463265|Growth Inhibitors|growth inhibitors|mesh-ancestor
101806258|NCT03463265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101806260|NCT03463265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806261|NCT03463265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101806262|NCT03463265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101806263|NCT03463265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101806264|NCT03463265|Antifungal Agents|antifungal agents|mesh-ancestor
101806265|NCT03463265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101806266|NCT03463265|Immunologic Factors|immunologic factors|mesh-ancestor
101806267|NCT03463265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101806268|NCT03463265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101806269|NCT00947336|Norfloxacin|norfloxacin|mesh-list
101806270|NCT00947336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101806271|NCT00947336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101806272|NCT00947336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101806273|NCT00947336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101806274|NCT00947336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101806275|NCT00947336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806276|NCT00947336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101806277|NCT00947336|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101806278|NCT00947336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101806280|NCT00955214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101806281|NCT00955214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101806282|NCT00955214|Tubulin Modulators|tubulin modulators|mesh-ancestor
101806283|NCT00955214|Antimitotic Agents|antimitotic agents|mesh-ancestor
101806284|NCT00955214|Mitosis Modulators|mitosis modulators|mesh-ancestor
101806285|NCT00955214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806286|NCT00956462|Dexamethasone|dexamethasone|mesh-list
101806287|NCT00956462|Ketorolac|ketorolac|mesh-list
101806288|NCT00956462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101806289|NCT00956462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101806290|NCT00956462|Antiemetics|antiemetics|mesh-ancestor
101806291|NCT00956462|Autonomic Agents|autonomic agents|mesh-ancestor
101806292|NCT00956462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101806293|NCT00956462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806294|NCT00956462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101806295|NCT00956462|Glucocorticoids|glucocorticoids|mesh-ancestor
101806296|NCT00956462|Hormones|hormones|mesh-ancestor
101806297|NCT00956462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101806298|NCT00956462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101806299|NCT00956462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101806300|NCT00956462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101806301|NCT00956462|Analgesics|analgesics|mesh-ancestor
101806302|NCT00956462|Sensory System Agents|sensory system agents|mesh-ancestor
101806303|NCT00956462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101806304|NCT00956462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101806305|NCT00956462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101806306|NCT00956462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806307|NCT05300360|Adenosine|adenosine|mesh-list
101806308|NCT05300360|Analgesics|analgesics|mesh-ancestor
101806309|NCT05300360|Sensory System Agents|sensory system agents|mesh-ancestor
101806310|NCT05300360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101806311|NCT05300360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806312|NCT05300360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101806313|NCT05300360|Vasodilator Agents|vasodilator agents|mesh-ancestor
101806314|NCT05300360|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101806315|NCT05300360|Purinergic Agonists|purinergic agonists|mesh-ancestor
101806316|NCT05300360|Purinergic Agents|purinergic agents|mesh-ancestor
101806317|NCT05300360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101806318|NCT05300360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806319|NCT00956696|Topiramate|topiramate|mesh-list
101806320|NCT00956696|Anticonvulsants|anticonvulsants|mesh-ancestor
101806321|NCT00956696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101806322|NCT00956696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806323|NCT03952650|Chloroquine|chloroquine|mesh-list
101806324|NCT03952650|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
101806325|NCT03952650|Pyrimethamine|pyrimethamine|mesh-list
101806326|NCT03952650|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101806327|NCT03952650|Ibuprofen|ibuprofen|mesh-list
101806328|NCT03952650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101806329|NCT03952650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101806330|NCT03952650|Analgesics|analgesics|mesh-ancestor
101463651|NCT00266838|Dexamethasone|dexamethasone|mesh-list
101806331|NCT03952650|Sensory System Agents|sensory system agents|mesh-ancestor
101806332|NCT03952650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101806333|NCT03952650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806334|NCT03952650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101806335|NCT03952650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101806336|NCT03952650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101806337|NCT03952650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101806338|NCT03952650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806339|NCT03952650|Amebicides|amebicides|mesh-ancestor
101806340|NCT03952650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101806341|NCT03952650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101806342|NCT03952650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101806343|NCT03952650|Antimalarials|antimalarials|mesh-ancestor
101806344|NCT03952650|Filaricides|filaricides|mesh-ancestor
101806345|NCT03952650|Antinematodal Agents|antinematodal agents|mesh-ancestor
101806346|NCT03952650|Anthelmintics|anthelmintics|mesh-ancestor
101806347|NCT03952650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101806348|NCT00955526|Istradefylline|istradefylline|mesh-list
101806349|NCT00955526|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
101806350|NCT00955526|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101806351|NCT00955526|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101806352|NCT00955526|Purinergic Agents|purinergic agents|mesh-ancestor
101806353|NCT00955526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101806354|NCT00955526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806355|NCT00955526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806356|NCT00955604|Rasagiline|rasagiline|mesh-list
101806357|NCT00955604|Antidepressive Agents|antidepressive agents|mesh-list
101806358|NCT00955604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101806359|NCT00955604|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101806360|NCT00955604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101806361|NCT00955604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806362|NCT00955604|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101806363|NCT00955604|Protective Agents|protective agents|mesh-ancestor
101206391|NCT01431326|Sequestering Agents|sequestering agents|mesh-ancestor
101806364|NCT00955604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806365|NCT03623646|Immunomodulating Agents|immunomodulating agents|mesh-list
101806367|NCT03623646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806368|NCT00962286|Furosemide|furosemide|mesh-list
101806369|NCT00962286|Diuretics|diuretics|mesh-ancestor
101806370|NCT00962286|Natriuretic Agents|natriuretic agents|mesh-ancestor
101806371|NCT00962286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806372|NCT00962286|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101806373|NCT00962286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101806374|NCT00962286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806375|NCT00691301|Pemetrexed|pemetrexed|mesh-list
101806376|NCT00691301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101806377|NCT00691301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101311345|NCT00388089|Bortezomib|bortezomib|mesh-list
101806378|NCT00691301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806379|NCT00691301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101806380|NCT00691301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101806381|NCT05277480|Apatinib|apatinib|mesh-list
101806382|NCT05277480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101806383|NCT05277480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101806384|NCT05277480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101806385|NCT05277480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806386|NCT00956072|Imatinib Mesylate|imatinib mesylate|mesh-list
101806387|NCT00956072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101806388|NCT00956072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101806389|NCT00956072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101806390|NCT00956072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806391|NCT02564003|Oxycodone|oxycodone|mesh-list
101806392|NCT02564003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101206506|NCT01431742|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101806394|NCT02564003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101806395|NCT02564003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806396|NCT02564003|Analgesics|analgesics|mesh-ancestor
101806397|NCT02564003|Sensory System Agents|sensory system agents|mesh-ancestor
101806398|NCT02564003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101806399|NCT00956150|Rifaximin|rifaximin|mesh-list
101806400|NCT00956150|Lactulose|lactulose|mesh-list
101806401|NCT00956150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101463720|NCT04558021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101806402|NCT00956150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101806403|NCT00956150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101806405|NCT00923663|Immunologic Factors|immunologic factors|mesh-ancestor
101206567|NCT01432080|Autonomic Agents|autonomic agents|mesh-ancestor
101806406|NCT00923663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806407|NCT00923663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101806408|NCT00923663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101806409|NCT00923663|Growth Substances|growth substances|mesh-ancestor
101806410|NCT00923663|Growth Inhibitors|growth inhibitors|mesh-ancestor
101806411|NCT00923663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101806412|NCT00743873|Mitogens|mitogens|mesh-list
101806413|NCT00743873|Mitosis Modulators|mitosis modulators|mesh-ancestor
101806414|NCT00743873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806415|NCT04011098|Fentanyl|fentanyl|mesh-list
101806416|NCT04011098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101806417|NCT04011098|Narcotics|narcotics|mesh-ancestor
101806418|NCT04011098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101806419|NCT04011098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806420|NCT04011098|Analgesics|analgesics|mesh-ancestor
101806421|NCT04011098|Sensory System Agents|sensory system agents|mesh-ancestor
101806422|NCT04011098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101806423|NCT04011098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101806424|NCT04011098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101806425|NCT04011098|Anesthetics, General|anesthetics, general|mesh-ancestor
101806426|NCT04011098|Anesthetics|anesthetics|mesh-ancestor
101806427|NCT00927563|Tolcapone|tolcapone|mesh-list
101806428|NCT00927563|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101806429|NCT00927563|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101806430|NCT00927563|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101806431|NCT00927563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101806432|NCT00927563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806433|NCT00956306|Udenafil|udenafil|mesh-list
101806434|NCT00956306|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101206686|NCT01432782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101806436|NCT00956306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101806437|NCT00956306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806438|NCT00775229|Naltrexone|naltrexone|mesh-list
101806439|NCT00775229|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101806440|NCT00775229|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101806441|NCT00775229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806442|NCT00775229|Sensory System Agents|sensory system agents|mesh-ancestor
101806443|NCT00775229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101806444|NCT00962442|Acetylcysteine|acetylcysteine|mesh-list
101806445|NCT00962442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101806446|NCT00962442|Antiviral Agents|antiviral agents|mesh-ancestor
101806447|NCT00962442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101806448|NCT00962442|Expectorants|expectorants|mesh-ancestor
101806449|NCT00962442|Respiratory System Agents|respiratory system agents|mesh-ancestor
101806450|NCT00962442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101806452|NCT00962442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806453|NCT00962442|Protective Agents|protective agents|mesh-ancestor
101806454|NCT00962442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806455|NCT00962442|Antidotes|antidotes|mesh-ancestor
101806456|NCT00957320|Sirolimus|sirolimus|mesh-list
101806457|NCT00957320|Asparaginase|asparaginase|mesh-list
101806458|NCT00957320|Pegaspargase|pegaspargase|mesh-list
101806459|NCT00957320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101806460|NCT00957320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101806461|NCT00957320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101806462|NCT00957320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101806463|NCT00957320|Antifungal Agents|antifungal agents|mesh-ancestor
101806464|NCT00957320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101806465|NCT00957320|Immunologic Factors|immunologic factors|mesh-ancestor
101806466|NCT00957320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806467|NCT00653159|Copper|copper|mesh-list
101806468|NCT00653159|Levonorgestrel|levonorgestrel|mesh-list
101806469|NCT00653159|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101806470|NCT00653159|Contraceptive Agents|contraceptive agents|mesh-ancestor
101806471|NCT00653159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101806472|NCT00653159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806473|NCT00653159|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101806474|NCT00653159|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101806475|NCT00653159|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101806476|NCT00653159|Trace Elements|trace elements|mesh-ancestor
101806477|NCT00653159|Micronutrients|micronutrients|mesh-ancestor
101806478|NCT03047070|Lidocaine|lidocaine|mesh-list
101806479|NCT03047070|Anesthetics, Local|anesthetics, local|mesh-ancestor
101806480|NCT03047070|Anesthetics|anesthetics|mesh-ancestor
101806481|NCT03047070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101806482|NCT03047070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806483|NCT03047070|Sensory System Agents|sensory system agents|mesh-ancestor
101206865|NCT01434134|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101806484|NCT03047070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101806485|NCT03047070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101806486|NCT03047070|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101806487|NCT03047070|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101806488|NCT03047070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101806489|NCT03047070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806491|NCT00948272|Immunologic Factors|immunologic factors|mesh-ancestor
101806492|NCT00948272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806493|NCT00957554|Amlodipine|amlodipine|mesh-list
101806494|NCT00957554|Irbesartan|irbesartan|mesh-list
101806495|NCT00957554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101806496|NCT00957554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101806497|NCT00957554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101806498|NCT00957554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806499|NCT00957554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101806500|NCT00957554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806501|NCT00957554|Vasodilator Agents|vasodilator agents|mesh-ancestor
101806502|NCT00957554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101806503|NCT00957554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101806504|NCT03024684|Atorvastatin|atorvastatin|mesh-list
101806505|NCT03024684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101806506|NCT03024684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101806507|NCT03024684|Antimetabolites|antimetabolites|mesh-ancestor
101806508|NCT03024684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806509|NCT03024684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101806510|NCT03024684|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101806511|NCT03024684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101806512|NCT00744107|Cobalt|cobalt|mesh-list
101806513|NCT00744107|Trace Elements|trace elements|mesh-ancestor
101207055|NCT01435213|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101806515|NCT00744107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806517|NCT00117637|Sorafenib|sorafenib|mesh-list
101806518|NCT00117637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101806519|NCT00117637|Antiviral Agents|antiviral agents|mesh-ancestor
101806520|NCT00117637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101806521|NCT00117637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101311352|NCT04742023|Insulin|insulin|mesh-list
101806522|NCT00117637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101806523|NCT00117637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806525|NCT00744185|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101806526|NCT00744185|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101806527|NCT00744185|Adrenergic Agents|adrenergic agents|mesh-ancestor
101806528|NCT00744185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101806529|NCT00744185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806530|NCT00744185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806531|NCT00744185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101806532|NCT00744185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101806533|NCT00744185|Vasodilator Agents|vasodilator agents|mesh-ancestor
101806534|NCT02897778|Entinostat|entinostat|mesh-list
101806535|NCT02897778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101806536|NCT02897778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101806537|NCT02897778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101806538|NCT02897778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806540|NCT01084291|Immunologic Factors|immunologic factors|mesh-ancestor
101806541|NCT01084291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806542|NCT00741767|Fluticasone|fluticasone|mesh-list
101806543|NCT00741767|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101806544|NCT00741767|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101806545|NCT00741767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101806546|NCT00741767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101806547|NCT00741767|Autonomic Agents|autonomic agents|mesh-ancestor
101806548|NCT00741767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101806549|NCT00741767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806550|NCT00741767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101806551|NCT00741767|Respiratory System Agents|respiratory system agents|mesh-ancestor
101806552|NCT00741767|Dermatologic Agents|dermatologic agents|mesh-ancestor
101463929|NCT04564456|Xhance|xhance|mesh-list
101806554|NCT00741767|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101806555|NCT00741767|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101806556|NCT00741767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101806557|NCT00741767|Adrenergic Agents|adrenergic agents|mesh-ancestor
101806558|NCT00741767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101806559|NCT00741767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806560|NCT00741767|Glucocorticoids|glucocorticoids|mesh-ancestor
101806561|NCT00741767|Hormones|hormones|mesh-ancestor
101806562|NCT00741767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101806563|NCT00741767|Sympathomimetics|sympathomimetics|mesh-ancestor
101806564|NCT00741845|Metronidazole|metronidazole|mesh-list
101806565|NCT00741845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101806566|NCT00741845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101806567|NCT00741845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101806568|NCT00741845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101806569|NCT00746447|Mesalamine|mesalamine|mesh-list
101806570|NCT00746447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101806571|NCT00746447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101806572|NCT00746447|Analgesics|analgesics|mesh-ancestor
101806573|NCT00746447|Sensory System Agents|sensory system agents|mesh-ancestor
101806574|NCT00746447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101806575|NCT00746447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806576|NCT00746447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101806577|NCT00746447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101806578|NCT00744419|Pantoprazole|pantoprazole|mesh-list
101806579|NCT00744419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101806580|NCT00744419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101810897|NCT00685685|Lovastatin|lovastatin|mesh-list
101806581|NCT00744419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101806582|NCT00744419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101806583|NCT00744419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806585|NCT00549302|Vasodilator Agents|vasodilator agents|mesh-ancestor
101806586|NCT00549302|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101806587|NCT00549302|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101806588|NCT00549302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101806589|NCT00549302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806590|NCT00549302|Urological Agents|urological agents|mesh-ancestor
101806591|NCT04277858|Cisplatin|cisplatin|mesh-list
101806592|NCT04277858|Docetaxel|docetaxel|mesh-list
101806593|NCT04277858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101806594|NCT04277858|Tubulin Modulators|tubulin modulators|mesh-ancestor
101806595|NCT04277858|Antimitotic Agents|antimitotic agents|mesh-ancestor
101806596|NCT04277858|Mitosis Modulators|mitosis modulators|mesh-ancestor
101806597|NCT04277858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806598|NCT00957866|Interferons|interferons|mesh-list
101806599|NCT00957866|Ribavirin|ribavirin|mesh-list
101806600|NCT00957866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101806601|NCT00957866|Antiviral Agents|antiviral agents|mesh-ancestor
101806602|NCT00957866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101207341|NCT01437293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806604|NCT00957866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806605|NCT00958022|Carboplatin|carboplatin|mesh-list
101806606|NCT00958022|Etoposide|etoposide|mesh-list
101806607|NCT00958022|Etoposide phosphate|etoposide phosphate|mesh-list
101806608|NCT00958022|Panobinostat|panobinostat|mesh-list
101806609|NCT00958022|Podophyllotoxin|podophyllotoxin|mesh-list
101806610|NCT00958022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101207405|NCT01437618|Growth Inhibitors|growth inhibitors|mesh-ancestor
101207421|NCT01437696|Vitamin D|vitamin d|mesh-list
101806611|NCT00958022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101806612|NCT00958022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101806613|NCT00958022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101806614|NCT00958022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101806615|NCT00958022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806616|NCT00958022|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101806617|NCT00958022|Keratolytic Agents|keratolytic agents|mesh-ancestor
101806618|NCT00958022|Dermatologic Agents|dermatologic agents|mesh-ancestor
101806619|NCT00958022|Tubulin Modulators|tubulin modulators|mesh-ancestor
101806620|NCT00958022|Antimitotic Agents|antimitotic agents|mesh-ancestor
101806621|NCT00958022|Mitosis Modulators|mitosis modulators|mesh-ancestor
101806622|NCT00958100|Tenofovir|tenofovir|mesh-list
101806623|NCT00958100|Lamivudine|lamivudine|mesh-list
101806624|NCT00958100|Emtricitabine|emtricitabine|mesh-list
101806625|NCT00958100|Raltegravir Potassium|raltegravir potassium|mesh-list
101806626|NCT00958100|Abacavir|abacavir|mesh-list
101806627|NCT00958100|Dideoxynucleosides|dideoxynucleosides|mesh-list
101806628|NCT00958100|Antiviral Agents|antiviral agents|mesh-ancestor
101806629|NCT00958100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101806630|NCT00958100|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101806631|NCT00958100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101333981|NCT00017589|Immunotoxins|immunotoxins|mesh-ancestor
101806632|NCT00958100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101806633|NCT00958100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806634|NCT00958100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101806635|NCT00958100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101806636|NCT00958100|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101806637|NCT00958100|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101207538|NCT05578859|Sotorasib|sotorasib|mesh-list
101806638|NCT00958100|Antimetabolites|antimetabolites|mesh-ancestor
101806639|NCT00948584|Insulin|insulin|mesh-list
101806640|NCT00948584|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101806641|NCT00948584|Insulin Glargine|insulin glargine|mesh-list
101806642|NCT00948584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101806643|NCT00948584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806644|NCT00948662|Ketoconazole|ketoconazole|mesh-list
101806645|NCT00948662|Antifungal Agents|antifungal agents|mesh-ancestor
101806646|NCT00948662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101806647|NCT00948662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101806648|NCT00948662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101806649|NCT00948662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101806650|NCT00948662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806651|NCT00948662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101806652|NCT00948662|Hormone Antagonists|hormone antagonists|mesh-ancestor
101806653|NCT00948662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101806654|NCT00948662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806655|NCT00948662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101806656|NCT00948740|Vitamin D|vitamin d|mesh-list
101806658|NCT00948740|Vitamins|vitamins|mesh-ancestor
101806659|NCT00948740|Micronutrients|micronutrients|mesh-ancestor
101806660|NCT00948740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311365|NCT00006462|Gemcitabine|gemcitabine|mesh-list
101806661|NCT00948740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101806662|NCT00948740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101806663|NCT00108433|Vancomycin|vancomycin|mesh-list
101806664|NCT00108433|Cefazolin|cefazolin|mesh-list
101806665|NCT00108433|Linezolid|linezolid|mesh-list
101806666|NCT00108433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101806667|NCT00108433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101806668|NCT00108433|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101806669|NCT00108433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101806670|NCT00108433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806671|NCT01084369|Methyltestosterone|methyltestosterone|mesh-list
101806672|NCT01084369|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101806673|NCT01084369|Testosterone|testosterone|mesh-list
101806674|NCT01084369|Testosterone undecanoate|testosterone undecanoate|mesh-list
101806675|NCT01084369|Testosterone enanthate|testosterone enanthate|mesh-list
101806676|NCT01084369|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101806677|NCT01084369|Androgens|androgens|mesh-ancestor
101806678|NCT01084369|Hormones|hormones|mesh-ancestor
101806679|NCT01084369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101806680|NCT01084369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806681|NCT01084369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101806682|NCT01084369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101806683|NCT01084369|Anabolic Agents|anabolic agents|mesh-ancestor
101806684|NCT01084369|Vasodilator Agents|vasodilator agents|mesh-ancestor
101806685|NCT01084369|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101806686|NCT01084369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101806687|NCT01084369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101806688|NCT01084369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806689|NCT01084369|Urological Agents|urological agents|mesh-ancestor
101806690|NCT00949130|Linezolid|linezolid|mesh-list
101806691|NCT00949130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101806692|NCT00949130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101806693|NCT00949130|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101806694|NCT00949130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101806695|NCT00949130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806696|NCT04010318|Anesthetics|anesthetics|mesh-list
101806697|NCT04010318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101806698|NCT04010318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806699|NCT00108355|Octreotide|octreotide|mesh-list
101806700|NCT00108355|Midodrine|midodrine|mesh-list
101806701|NCT00108355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101806702|NCT00108355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101806703|NCT00108355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464018|NCT00232856|Sirolimus|sirolimus|mesh-list
101806705|NCT00108355|Autonomic Agents|autonomic agents|mesh-ancestor
101806706|NCT00108355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101806707|NCT00108355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806708|NCT00108355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101806709|NCT00108355|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101806710|NCT00108355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101806711|NCT00108355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101806712|NCT00108355|Adrenergic Agents|adrenergic agents|mesh-ancestor
101806713|NCT00108355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101806714|NCT00108355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806715|NCT00963222|Vitamin A|vitamin a|mesh-list
101806716|NCT00963222|Vitamins|vitamins|mesh-ancestor
101806717|NCT00963222|Micronutrients|micronutrients|mesh-ancestor
101806718|NCT00963222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806719|NCT02703584|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101806720|NCT02703584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101806721|NCT02703584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806722|NCT00968682|Trastuzumab|trastuzumab|mesh-list
101806723|NCT00968682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101806724|NCT00968682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101806725|NCT00968760|Cytarabine|cytarabine|mesh-list
101806726|NCT00968760|Etoposide|etoposide|mesh-list
101806727|NCT00968760|Melphalan|melphalan|mesh-list
101806728|NCT00968760|Interleukin-2|interleukin-2|mesh-list
101806729|NCT00968760|Carmustine|carmustine|mesh-list
101806730|NCT00968760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101806731|NCT00968760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101806732|NCT00968760|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101207756|NCT04800692|Verapamil|verapamil|mesh-list
101806734|NCT00968760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101806735|NCT00968760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806736|NCT00968760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101806737|NCT00968760|Antimetabolites|antimetabolites|mesh-ancestor
101806738|NCT00968760|Antiviral Agents|antiviral agents|mesh-ancestor
101806739|NCT00968760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101806740|NCT00968760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101806741|NCT00968760|Immunologic Factors|immunologic factors|mesh-ancestor
101806742|NCT00968760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806743|NCT00968760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101806744|NCT00968760|Alkylating Agents|alkylating agents|mesh-ancestor
101806745|NCT00968760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101806746|NCT00968760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101806747|NCT00968760|Analgesics|analgesics|mesh-ancestor
101806748|NCT00968760|Sensory System Agents|sensory system agents|mesh-ancestor
101806749|NCT00968760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101806750|NCT02465138|Ketorolac|ketorolac|mesh-list
101806751|NCT02465138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101806752|NCT02465138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101806753|NCT02465138|Analgesics|analgesics|mesh-ancestor
101806754|NCT02465138|Sensory System Agents|sensory system agents|mesh-ancestor
101806755|NCT02465138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101806756|NCT02465138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806757|NCT02465138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101806758|NCT02465138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101806759|NCT02465138|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101806760|NCT02465138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101806761|NCT02465138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806762|NCT00968994|Petrolatum|petrolatum|mesh-list
101806763|NCT00968994|Emollients|emollients|mesh-ancestor
101806764|NCT00968994|Dermatologic Agents|dermatologic agents|mesh-ancestor
101806765|NCT00969072|Dutasteride|dutasteride|mesh-list
101806766|NCT00969072|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101806767|NCT00969072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101806768|NCT00969072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101806769|NCT00969072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806770|NCT00969072|Hormone Antagonists|hormone antagonists|mesh-ancestor
101207857|NCT04375202|Mitosis Modulators|mitosis modulators|mesh-ancestor
101806771|NCT00969072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101806772|NCT00969072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806773|NCT00094861|Paclitaxel|paclitaxel|mesh-list
101806774|NCT00094861|Carboplatin|carboplatin|mesh-list
101806775|NCT00094861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101806776|NCT00094861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464097|NCT00233051|Fluticasone|fluticasone|mesh-list
101806777|NCT00094861|Tubulin Modulators|tubulin modulators|mesh-ancestor
101806778|NCT00094861|Antimitotic Agents|antimitotic agents|mesh-ancestor
101207920|NCT03860077|Nicotine|nicotine|mesh-list
101806780|NCT00094861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806782|NCT00963534|Lenalidomide|lenalidomide|mesh-list
101806783|NCT00963534|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101806784|NCT00963534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101806785|NCT00963534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101806786|NCT00963534|Immunologic Factors|immunologic factors|mesh-ancestor
101806787|NCT00963534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806788|NCT00963534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101806789|NCT00963534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101806790|NCT00963534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101806791|NCT00963534|Growth Substances|growth substances|mesh-ancestor
101806792|NCT00963534|Growth Inhibitors|growth inhibitors|mesh-ancestor
101806793|NCT00963534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101806794|NCT00963534|Alkylating Agents|alkylating agents|mesh-ancestor
101806795|NCT00963534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806796|NCT00963690|Hemostatics|hemostatics|mesh-list
101806797|NCT00963690|Coagulants|coagulants|mesh-ancestor
101806798|NCT01079767|Sirolimus|sirolimus|mesh-list
101806799|NCT01079767|Temsirolimus|temsirolimus|mesh-list
101806800|NCT01079767|MTOR Inhibitors|mtor inhibitors|mesh-list
101806801|NCT01079767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101806802|NCT01079767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101806803|NCT01079767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806804|NCT01079767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101806805|NCT01079767|Immunologic Factors|immunologic factors|mesh-ancestor
101806806|NCT01079767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806807|NCT01079767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101806808|NCT01079767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101806809|NCT01079767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101806810|NCT01079767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101806811|NCT01079767|Antifungal Agents|antifungal agents|mesh-ancestor
101806812|NCT00969306|Chloroquine|chloroquine|mesh-list
101806813|NCT00969306|Amebicides|amebicides|mesh-ancestor
101806814|NCT00969306|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101806815|NCT00969306|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101806816|NCT00969306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101806817|NCT00969306|Antimalarials|antimalarials|mesh-ancestor
101806818|NCT00969306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101806819|NCT00963768|Canagliflozin|canagliflozin|mesh-list
101806820|NCT00963768|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101806821|NCT00963768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806822|NCT00963768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101806823|NCT00963768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806824|NCT00969462|Doxorubicin|doxorubicin|mesh-list
101806825|NCT00969462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101806826|NCT00969462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101806827|NCT00969462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101806828|NCT00969462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101806829|NCT00969462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101806830|NCT00969462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806831|NCT00963846|Huperzine A|huperzine a|mesh-list
101806832|NCT00963846|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101806833|NCT00963846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101806834|NCT00963846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806835|NCT00963846|Cholinergic Agents|cholinergic agents|mesh-ancestor
101806836|NCT00963846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101806837|NCT00963846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806838|NCT00963846|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101806839|NCT00963846|Protective Agents|protective agents|mesh-ancestor
101806840|NCT00969696|Galantamine|galantamine|mesh-list
101806841|NCT00969696|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101806842|NCT00969696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101806843|NCT00969696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806844|NCT00969696|Cholinergic Agents|cholinergic agents|mesh-ancestor
101806845|NCT00969696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101806847|NCT00969696|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101806848|NCT00969696|Autonomic Agents|autonomic agents|mesh-ancestor
101806849|NCT00969696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101806850|NCT00969696|Nootropic Agents|nootropic agents|mesh-ancestor
101806851|NCT00958854|Thalidomide|thalidomide|mesh-list
101464172|NCT00233558|Antimetabolites|antimetabolites|mesh-ancestor
101806852|NCT00958854|Cyclophosphamide|cyclophosphamide|mesh-list
101806853|NCT00958854|Fludarabine|fludarabine|mesh-list
101806854|NCT00958854|Fludarabine phosphate|fludarabine phosphate|mesh-list
101806855|NCT00958854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101806856|NCT00958854|Immunologic Factors|immunologic factors|mesh-ancestor
101806857|NCT00958854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208358|NCT01439399|Analgesics|analgesics|mesh-ancestor
101806858|NCT00958854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101806859|NCT00958854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101806860|NCT00958854|Alkylating Agents|alkylating agents|mesh-ancestor
101806861|NCT00958854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806862|NCT00958854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101806863|NCT00958854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101806864|NCT00958854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101806865|NCT00958854|Antimetabolites|antimetabolites|mesh-ancestor
101806866|NCT00958854|Leprostatic Agents|leprostatic agents|mesh-ancestor
101806867|NCT00958854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101806868|NCT00958854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101806869|NCT00958854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101806870|NCT00958854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101806871|NCT00958854|Growth Substances|growth substances|mesh-ancestor
101806872|NCT00958854|Growth Inhibitors|growth inhibitors|mesh-ancestor
101806874|NCT00964080|Fluorouracil|fluorouracil|mesh-list
101806875|NCT00964080|Oxaliplatin|oxaliplatin|mesh-list
101806876|NCT00964080|Antimetabolites|antimetabolites|mesh-ancestor
101806877|NCT00964080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806878|NCT00964080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101806879|NCT00964080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101806880|NCT00964080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101806881|NCT00964080|Immunologic Factors|immunologic factors|mesh-ancestor
101806882|NCT00964080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806884|NCT00964080|Protective Agents|protective agents|mesh-ancestor
101806885|NCT00964080|Vitamin B Complex|vitamin b complex|mesh-ancestor
101806886|NCT00964080|Vitamins|vitamins|mesh-ancestor
101806887|NCT00964080|Micronutrients|micronutrients|mesh-ancestor
101806888|NCT00969852|Sertraline|sertraline|mesh-list
101806889|NCT00969852|Antidepressive Agents|antidepressive agents|mesh-ancestor
101806890|NCT00969852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101806891|NCT00969852|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101806892|NCT00969852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101806893|NCT00969852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101806894|NCT00969852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806895|NCT00969852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101806896|NCT00969852|Serotonin Agents|serotonin agents|mesh-ancestor
101806897|NCT00969852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806898|NCT00426556|Paclitaxel|paclitaxel|mesh-list
101806899|NCT00426556|Trastuzumab|trastuzumab|mesh-list
101806900|NCT00426556|Everolimus|everolimus|mesh-list
101806901|NCT00426556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101806902|NCT00426556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101806903|NCT00426556|Tubulin Modulators|tubulin modulators|mesh-ancestor
101806904|NCT00426556|Antimitotic Agents|antimitotic agents|mesh-ancestor
101806905|NCT00426556|Mitosis Modulators|mitosis modulators|mesh-ancestor
101806906|NCT00426556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806907|NCT00426556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101806908|NCT00426556|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101806909|NCT00426556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101806910|NCT00426556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101806911|NCT00426556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101806912|NCT00426556|Immunologic Factors|immunologic factors|mesh-ancestor
101806913|NCT00426556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806914|NCT00107653|Ribavirin|ribavirin|mesh-list
101806915|NCT00107653|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101806916|NCT00107653|Interferon-alpha|interferon-alpha|mesh-list
101806917|NCT00107653|Antimetabolites|antimetabolites|mesh-ancestor
101806918|NCT00107653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806919|NCT00107653|Antiviral Agents|antiviral agents|mesh-ancestor
101806920|NCT00107653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101806921|NCT00107653|Immunologic Factors|immunologic factors|mesh-ancestor
101208731|NCT01441934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101806922|NCT00107653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806923|NCT03950856|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101806924|NCT03950856|Immunologic Factors|immunologic factors|mesh-ancestor
101806925|NCT03950856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806926|NCT00970008|CD59 Antigens|cd59 antigens|mesh-list
101806927|NCT00970008|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101464270|NCT00233792|Sirolimus|sirolimus|mesh-list
101806928|NCT00970008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101208804|NCT01442428|Analgesics|analgesics|mesh-ancestor
101806929|NCT00970008|Immunologic Factors|immunologic factors|mesh-ancestor
101806930|NCT00970008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806931|NCT00970086|Bupivacaine|bupivacaine|mesh-list
101806932|NCT00970086|Levobupivacaine|levobupivacaine|mesh-list
101806933|NCT00970086|Anesthetics, Local|anesthetics, local|mesh-ancestor
101806934|NCT00970086|Anesthetics|anesthetics|mesh-ancestor
101806935|NCT00970086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101806936|NCT00970086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806937|NCT00970086|Sensory System Agents|sensory system agents|mesh-ancestor
101208865|NCT01442701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101806938|NCT00970086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101806939|NCT00689351|Vaccines|vaccines|mesh-list
101806940|NCT00689351|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101806941|NCT00689351|Immunologic Factors|immunologic factors|mesh-ancestor
101806942|NCT00689351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806943|NCT03950622|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101806944|NCT03950622|Immunologic Factors|immunologic factors|mesh-ancestor
101208936|NCT01442974|Paclitaxel|paclitaxel|mesh-list
101806945|NCT03950622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806946|NCT02563847|Erythritol|erythritol|mesh-list
101806947|NCT02563847|Tryptophan|tryptophan|mesh-list
101806948|NCT02563847|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101806949|NCT02563847|Antidepressive Agents|antidepressive agents|mesh-ancestor
101806950|NCT02563847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101806951|NCT02563847|Vasodilator Agents|vasodilator agents|mesh-ancestor
101806952|NCT00746681|Pregabalin|pregabalin|mesh-list
101806953|NCT00746681|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101806954|NCT00746681|Analgesics|analgesics|mesh-ancestor
101806955|NCT00746681|Sensory System Agents|sensory system agents|mesh-ancestor
101209010|NCT01443195|Iron|iron|mesh-list
101806956|NCT00746681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101806957|NCT00746681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806959|NCT00746681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101806960|NCT00746681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101806961|NCT00746681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806962|NCT00746681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101806963|NCT00746681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101806964|NCT00746681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101806965|NCT00746681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101806966|NCT00746681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101806967|NCT00746681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101806968|NCT00746681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101806969|NCT00746681|Cholinergic Agents|cholinergic agents|mesh-ancestor
101806970|NCT00746681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101806971|NCT00746681|Urological Agents|urological agents|mesh-ancestor
101806972|NCT00746837|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
101806973|NCT00746837|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101806974|NCT00746837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101806975|NCT00746837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101806976|NCT00746837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101806977|NCT00746837|Antiviral Agents|antiviral agents|mesh-ancestor
101806978|NCT00746837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101806979|NCT00749099|Pancrelipase|pancrelipase|mesh-list
101806980|NCT00749099|Pancreatin|pancreatin|mesh-list
101806981|NCT00749099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101806982|NCT00959400|Fentanyl|fentanyl|mesh-list
101806983|NCT00959400|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101806984|NCT00959400|Narcotics|narcotics|mesh-ancestor
101806985|NCT00959400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101806986|NCT00959400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101806987|NCT00959400|Analgesics|analgesics|mesh-ancestor
101806988|NCT00959400|Sensory System Agents|sensory system agents|mesh-ancestor
101806989|NCT00959400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101806990|NCT00959400|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101806991|NCT00959400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101806992|NCT00959400|Anesthetics, General|anesthetics, general|mesh-ancestor
101806993|NCT00959400|Anesthetics|anesthetics|mesh-ancestor
101806994|NCT02563769|Clavulanic Acids|clavulanic acids|mesh-list
101806995|NCT02563769|Clavulanic Acid|clavulanic acid|mesh-list
101806996|NCT02563769|Cocaine|cocaine|mesh-list
101806997|NCT02563769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101806998|NCT02563769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101806999|NCT02563769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101209185|NCT01444521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101807000|NCT02563769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807001|NCT02563769|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101807002|NCT02563769|Anesthetics, Local|anesthetics, local|mesh-ancestor
101807003|NCT02563769|Anesthetics|anesthetics|mesh-ancestor
101807004|NCT02563769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101807005|NCT02563769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807006|NCT02563769|Sensory System Agents|sensory system agents|mesh-ancestor
101209257|NCT01444885|Amlodipine|amlodipine|mesh-list
101807007|NCT02563769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101807008|NCT02563769|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101807009|NCT02563769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101807010|NCT02563769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101807011|NCT02563769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101807012|NCT02563769|Dopamine Agents|dopamine agents|mesh-ancestor
101807013|NCT02563769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101807014|NCT00959478|Carbon Monoxide|carbon monoxide|mesh-list
101807015|NCT00959478|Antimetabolites|antimetabolites|mesh-ancestor
101807016|NCT00959478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807017|NCT00959478|Gasotransmitters|gasotransmitters|mesh-ancestor
101807018|NCT00959478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101209312|NCT01445223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101807019|NCT00959478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807020|NCT00964626|Paclitaxel|paclitaxel|mesh-list
101807021|NCT00964626|Cisplatin|cisplatin|mesh-list
101807022|NCT00964626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101807023|NCT00964626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807024|NCT00964626|Tubulin Modulators|tubulin modulators|mesh-ancestor
101807025|NCT00964626|Antimitotic Agents|antimitotic agents|mesh-ancestor
101807026|NCT00964626|Mitosis Modulators|mitosis modulators|mesh-ancestor
101807027|NCT00964626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807028|NCT02562287|Olanzapine|olanzapine|mesh-list
101807029|NCT02562287|Risperidone|risperidone|mesh-list
101209374|NCT01445522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101807030|NCT02562287|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101807031|NCT02562287|Clozapine|clozapine|mesh-list
101807032|NCT02562287|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101807033|NCT02562287|Serotonin Agents|serotonin agents|mesh-ancestor
101807034|NCT02562287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101807035|NCT02562287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807036|NCT02562287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807037|NCT02562287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101807038|NCT02562287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101209429|NCT01445860|Simvastatin|simvastatin|mesh-list
101807039|NCT02562287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101807040|NCT02562287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101807041|NCT02562287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101807042|NCT02562287|Dopamine Agents|dopamine agents|mesh-ancestor
101807043|NCT02562287|Antiemetics|antiemetics|mesh-ancestor
101807044|NCT02562287|Autonomic Agents|autonomic agents|mesh-ancestor
101807045|NCT02562287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101807046|NCT02562287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101807047|NCT02562287|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101807048|NCT02562287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101807049|NCT02562287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101807050|NCT02562287|Antidepressive Agents|antidepressive agents|mesh-ancestor
101807051|NCT02562287|GABA Antagonists|gaba antagonists|mesh-ancestor
101807052|NCT02562287|GABA Agents|gaba agents|mesh-ancestor
101807053|NCT02562053|Fluoxetine|fluoxetine|mesh-list
101807054|NCT02562053|Contraceptive Agents|contraceptive agents|mesh-list
101807055|NCT02562053|Contraceptives, Oral|contraceptives, oral|mesh-list
101807056|NCT02562053|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
101807057|NCT02562053|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101807058|NCT02562053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101807059|NCT02562053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101807060|NCT02562053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807061|NCT02562053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101807062|NCT02562053|Serotonin Agents|serotonin agents|mesh-ancestor
101807063|NCT02562053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807064|NCT02562053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101807065|NCT02562053|Antidepressive Agents|antidepressive agents|mesh-ancestor
101807066|NCT02562053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101807067|NCT02562053|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101807068|NCT02562053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101807069|NCT02562053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101807070|NCT02562053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101807071|NCT02562053|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101807072|NCT00746993|Contraceptive Agents|contraceptive agents|mesh-list
101807073|NCT00746993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101807074|NCT00746993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807075|NCT04060043|Goserelin|goserelin|mesh-list
101807076|NCT04060043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101807077|NCT04060043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807078|NCT00553358|Paclitaxel|paclitaxel|mesh-list
101807079|NCT00553358|Trastuzumab|trastuzumab|mesh-list
101807080|NCT00553358|Lapatinib|lapatinib|mesh-list
101807081|NCT00553358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101807082|NCT00553358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807083|NCT00553358|Tubulin Modulators|tubulin modulators|mesh-ancestor
101807084|NCT00553358|Antimitotic Agents|antimitotic agents|mesh-ancestor
101807085|NCT00553358|Mitosis Modulators|mitosis modulators|mesh-ancestor
101807086|NCT00553358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807087|NCT00553358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101807088|NCT00553358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101807089|NCT00553358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101807090|NCT00744809|Moxifloxacin|moxifloxacin|mesh-list
101807091|NCT00744809|Efavirenz|efavirenz|mesh-list
101807092|NCT00744809|Rilpivirine|rilpivirine|mesh-list
101807093|NCT00744809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101807094|NCT00744809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101807095|NCT00744809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101807096|NCT00744809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101209530|NCT01446328|Dopamine Agonists|dopamine agonists|mesh-ancestor
101807097|NCT00744809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101807098|NCT00744809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807099|NCT00744809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807100|NCT00744809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101807101|NCT00744809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101807102|NCT00744809|Antiviral Agents|antiviral agents|mesh-ancestor
101807103|NCT00744809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101807104|NCT00744809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101807105|NCT00744809|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101807106|NCT00744809|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101807107|NCT00744809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101807108|NCT00744809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101807109|NCT00744809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101807110|NCT00744809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101807112|NCT00744887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101807113|NCT00744887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101807114|NCT00744887|Protease Inhibitors|protease inhibitors|mesh-ancestor
101807115|NCT00744887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101807116|NCT00744887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807117|NCT00744887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101807118|NCT00744887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101807119|NCT00744887|Antiviral Agents|antiviral agents|mesh-ancestor
101807120|NCT00744887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101807121|NCT02286830|Zoledronic Acid|zoledronic acid|mesh-list
101807122|NCT02286830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101807123|NCT02286830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807124|NCT00749567|Bevacizumab|bevacizumab|mesh-list
101807125|NCT00749567|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101807126|NCT00749567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101807127|NCT00749567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101209656|NCT01447095|Tezosentan|tezosentan|mesh-list
101807128|NCT00749567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101807129|NCT00749567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101807130|NCT00749567|Growth Substances|growth substances|mesh-ancestor
101311417|NCT04201834|Risperidone|risperidone|mesh-list
101807131|NCT00749567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807132|NCT00749567|Growth Inhibitors|growth inhibitors|mesh-ancestor
101807133|NCT00749567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101807134|NCT00749567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101828162|NCT05919823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101807135|NCT00749567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807136|NCT04010942|Metformin|metformin|mesh-list
101807138|NCT04010942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101807139|NCT04010942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807140|NCT04010942|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101807141|NCT04010942|Hormone Antagonists|hormone antagonists|mesh-ancestor
101807142|NCT04010942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101807143|NCT04010942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101807144|NCT04010942|Fertility Agents|fertility agents|mesh-ancestor
101807145|NCT04010942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101807146|NCT04010942|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101807147|NCT04010942|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101807148|NCT00949364|Pomalidomide|pomalidomide|mesh-list
101807149|NCT00949364|Immunologic Factors|immunologic factors|mesh-ancestor
101807150|NCT00949364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807151|NCT00949364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101807152|NCT00949364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101807153|NCT00949364|Growth Substances|growth substances|mesh-ancestor
101807154|NCT00949364|Growth Inhibitors|growth inhibitors|mesh-ancestor
101807155|NCT00949364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807156|NCT00689117|Clindamycin|clindamycin|mesh-list
101807157|NCT00689117|Clindamycin palmitate|clindamycin palmitate|mesh-list
101807158|NCT00689117|Clindamycin phosphate|clindamycin phosphate|mesh-list
101807159|NCT00689117|Tretinoin|tretinoin|mesh-list
101807160|NCT00689117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101807161|NCT00689117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101807162|NCT00689117|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101807163|NCT00689117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101807164|NCT00689117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807165|NCT00689117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807166|NCT00689117|Keratolytic Agents|keratolytic agents|mesh-ancestor
101807167|NCT00689117|Dermatologic Agents|dermatologic agents|mesh-ancestor
101807168|NCT00949442|Insulin|insulin|mesh-list
101807169|NCT00949442|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101807170|NCT00949442|Insulin Glargine|insulin glargine|mesh-list
101807171|NCT00949442|Glimepiride|glimepiride|mesh-list
101807172|NCT00949442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101807173|NCT00949442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807174|NCT00949442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101807175|NCT00949442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101807176|NCT00949442|Immunologic Factors|immunologic factors|mesh-ancestor
101807177|NCT00749723|Carboplatin|carboplatin|mesh-list
101807178|NCT00749723|Etoposide|etoposide|mesh-list
101807179|NCT00749723|Etoposide phosphate|etoposide phosphate|mesh-list
101807180|NCT00749723|Temozolomide|temozolomide|mesh-list
101807181|NCT00749723|Thiotepa|thiotepa|mesh-list
101807182|NCT00749723|Trofosfamide|trofosfamide|mesh-list
101807183|NCT00749723|Cyclophosphamide|cyclophosphamide|mesh-list
101807184|NCT00749723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807185|NCT00749723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101807186|NCT00749723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101807187|NCT00749723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101807188|NCT00749723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101209952|NCT01448837|Bimatoprost|bimatoprost|mesh-list
101807189|NCT00749723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807190|NCT00749723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101807191|NCT00749723|Alkylating Agents|alkylating agents|mesh-ancestor
101807192|NCT00749723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101807193|NCT00749723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101807194|NCT00749723|Immunologic Factors|immunologic factors|mesh-ancestor
101807195|NCT00749723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807196|NCT00749723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101807198|NCT00547248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101807199|NCT00547248|Immunologic Factors|immunologic factors|mesh-ancestor
101807200|NCT00547248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807201|NCT00688103|Etanercept|etanercept|mesh-list
101807202|NCT00688103|Methotrexate|methotrexate|mesh-list
101807203|NCT00688103|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101807204|NCT00688103|Abortifacient Agents|abortifacient agents|mesh-ancestor
101807205|NCT00688103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101807206|NCT00688103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807207|NCT00688103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101807208|NCT00688103|Antimetabolites|antimetabolites|mesh-ancestor
101246505|NCT01666418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101210078|NCT01449448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101807209|NCT00688103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807210|NCT00688103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807211|NCT00688103|Dermatologic Agents|dermatologic agents|mesh-ancestor
101807212|NCT00688103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101807213|NCT00688103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101807214|NCT00688103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101807215|NCT00688103|Immunologic Factors|immunologic factors|mesh-ancestor
101807216|NCT00688103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101807217|NCT00688103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101246506|NCT01666418|Tubulin Modulators|tubulin modulators|mesh-ancestor
101807218|NCT00688103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101807219|NCT00688103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101807220|NCT00688103|Analgesics|analgesics|mesh-ancestor
101807221|NCT00688103|Sensory System Agents|sensory system agents|mesh-ancestor
101807222|NCT00688103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101807223|NCT00688103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101807224|NCT00688103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101807225|NCT00949598|Tamoxifen|tamoxifen|mesh-list
101807226|NCT00949598|Letrozole|letrozole|mesh-list
101807227|NCT00949598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807228|NCT00949598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807229|NCT00949598|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101807230|NCT00949598|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101807231|NCT00949598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101807232|NCT00949598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101807233|NCT00949598|Hormone Antagonists|hormone antagonists|mesh-ancestor
101807234|NCT00949598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101807235|NCT00949598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807236|NCT00949598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101807237|NCT00949598|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101807238|NCT00949598|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101807239|NCT00949598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101807241|NCT00964704|Trastuzumab|trastuzumab|mesh-list
101807242|NCT00964704|Docetaxel|docetaxel|mesh-list
101807243|NCT00964704|Capecitabine|capecitabine|mesh-list
101807244|NCT00964704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101807245|NCT00964704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807246|NCT00964704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101807247|NCT00964704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101807248|NCT00964704|Growth Substances|growth substances|mesh-ancestor
101807249|NCT00964704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807250|NCT00964704|Growth Inhibitors|growth inhibitors|mesh-ancestor
101807251|NCT00964704|Tubulin Modulators|tubulin modulators|mesh-ancestor
101807252|NCT00964704|Antimitotic Agents|antimitotic agents|mesh-ancestor
101807253|NCT00964704|Mitosis Modulators|mitosis modulators|mesh-ancestor
101807254|NCT00964704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807255|NCT00964704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101807256|NCT00964704|Antimetabolites|antimetabolites|mesh-ancestor
101807257|NCT00686855|Dexamethasone|dexamethasone|mesh-list
101807258|NCT00686855|Tacrolimus|tacrolimus|mesh-list
101807259|NCT00686855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101807260|NCT00686855|Antiemetics|antiemetics|mesh-ancestor
101807261|NCT00686855|Autonomic Agents|autonomic agents|mesh-ancestor
101807262|NCT00686855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101807263|NCT00686855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807264|NCT00686855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101807265|NCT00686855|Glucocorticoids|glucocorticoids|mesh-ancestor
101807266|NCT00686855|Hormones|hormones|mesh-ancestor
101807267|NCT00686855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101807268|NCT00686855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101807269|NCT00686855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807270|NCT00686855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101807271|NCT00686855|Immunologic Factors|immunologic factors|mesh-ancestor
101807272|NCT00686855|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101807273|NCT00686855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101807274|NCT00686855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807275|NCT00745043|Bronchodilator Agents|bronchodilator agents|mesh-list
101807276|NCT00745043|Autonomic Agents|autonomic agents|mesh-ancestor
101807277|NCT00745043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101807278|NCT00745043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807279|NCT00745043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101807280|NCT00745043|Respiratory System Agents|respiratory system agents|mesh-ancestor
101807281|NCT00949832|Calcium, Dietary|calcium, dietary|mesh-list
101807282|NCT00949832|Vitamin D|vitamin d|mesh-list
101807283|NCT00949832|Ergocalciferols|ergocalciferols|mesh-list
101807284|NCT00949832|Cholecalciferol|cholecalciferol|mesh-list
101807285|NCT00949832|Vitamins|vitamins|mesh-list
101807286|NCT00949832|Calcium|calcium|mesh-list
101807287|NCT00949832|Micronutrients|micronutrients|mesh-ancestor
101807288|NCT00949832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246507|NCT01666418|Antimitotic Agents|antimitotic agents|mesh-ancestor
101807289|NCT00949832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101807290|NCT00949832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101807291|NCT00745199|Cromolyn Sodium|cromolyn sodium|mesh-list
101807292|NCT00745199|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
101807293|NCT00745199|Immunologic Factors|immunologic factors|mesh-ancestor
101807294|NCT00745199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807295|NCT00745199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101807296|NCT00745199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101210514|NCT05962034|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101807297|NCT00745199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101807298|NCT00745199|Respiratory System Agents|respiratory system agents|mesh-ancestor
101807300|NCT00961844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101807301|NCT00961844|Alkylating Agents|alkylating agents|mesh-ancestor
101807302|NCT00961844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807303|NCT00961844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807304|NCT00686777|Interferons|interferons|mesh-list
101807305|NCT00686777|Ribavirin|ribavirin|mesh-list
101807306|NCT00686777|Interferon-alpha|interferon-alpha|mesh-list
101807307|NCT00686777|Interferon alpha-2|interferon alpha-2|mesh-list
101807308|NCT00686777|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101807309|NCT00686777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807311|NCT00686777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101807312|NCT00686777|Antimetabolites|antimetabolites|mesh-ancestor
101807313|NCT00686777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807314|NCT00686777|Immunologic Factors|immunologic factors|mesh-ancestor
101807315|NCT00686777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807316|NCT04009772|Metronidazole|metronidazole|mesh-list
101807317|NCT04009772|Cefepime|cefepime|mesh-list
101807318|NCT04009772|Cefuroxime|cefuroxime|mesh-list
101807319|NCT04009772|Cefuroxime axetil|cefuroxime axetil|mesh-list
101807320|NCT04009772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101807321|NCT04009772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101807322|NCT04009772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101807323|NCT04009772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101807324|NCT00959582|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101807325|NCT00959582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101807326|NCT00959582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210712|NCT05928611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101210713|NCT05928611|Glucocorticoids|glucocorticoids|mesh-ancestor
101210714|NCT05928611|Hormones|hormones|mesh-ancestor
101210715|NCT05928611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101210716|NCT05928611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101210717|NCT05928611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101210718|NCT05928611|Protease Inhibitors|protease inhibitors|mesh-ancestor
101210719|NCT05928611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101210721|NCT05917912|Amitriptyline|amitriptyline|mesh-list
101807327|NCT00962156|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
101807328|NCT00962156|Plasma Substitutes|plasma substitutes|mesh-ancestor
101807329|NCT00962156|Blood Substitutes|blood substitutes|mesh-ancestor
101807331|NCT01563068|Dermatologic Agents|dermatologic agents|mesh-ancestor
101807332|NCT00747305|Sunitinib|sunitinib|mesh-list
101807333|NCT00747305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807334|NCT00747305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101807335|NCT00747305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101807336|NCT00747305|Growth Substances|growth substances|mesh-ancestor
101807337|NCT00747305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807338|NCT00747305|Growth Inhibitors|growth inhibitors|mesh-ancestor
101807339|NCT00747305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101807340|NCT00747305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101807341|NCT00747305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807342|NCT05254106|Paclitaxel|paclitaxel|mesh-list
101210800|NCT05867550|Rifaximin|rifaximin|mesh-list
101210802|NCT05867550|Mebeverine|mebeverine|mesh-list
101210803|NCT05867550|Psyllium|psyllium|mesh-list
101807343|NCT05254106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101807344|NCT05254106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807345|NCT05254106|Tubulin Modulators|tubulin modulators|mesh-ancestor
101807346|NCT05254106|Antimitotic Agents|antimitotic agents|mesh-ancestor
101807347|NCT05254106|Mitosis Modulators|mitosis modulators|mesh-ancestor
101807348|NCT05254106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807349|NCT00747383|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101807350|NCT00747383|Glimepiride|glimepiride|mesh-list
101807351|NCT00747383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101807352|NCT00747383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807353|NCT00747383|Incretins|incretins|mesh-ancestor
101807354|NCT00747383|Hormones|hormones|mesh-ancestor
101807355|NCT00747383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101807356|NCT00747383|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101807357|NCT00747383|Protease Inhibitors|protease inhibitors|mesh-ancestor
101807358|NCT00747383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101807359|NCT00747383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807360|NCT00747383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101807361|NCT00747383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101807362|NCT00747383|Immunologic Factors|immunologic factors|mesh-ancestor
101807363|NCT00106639|Tacrolimus|tacrolimus|mesh-list
101807364|NCT00106639|Tofacitinib|tofacitinib|mesh-list
101807365|NCT00106639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101807366|NCT00106639|Immunologic Factors|immunologic factors|mesh-ancestor
101807367|NCT00106639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807368|NCT00106639|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101807369|NCT00106639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101807370|NCT00106639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807371|NCT00106639|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101807372|NCT00106639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101807373|NCT00747539|Interferons|interferons|mesh-list
101807374|NCT00747539|Ribavirin|ribavirin|mesh-list
101807375|NCT00747539|Interferon-alpha|interferon-alpha|mesh-list
101807376|NCT00747539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807377|NCT00747539|Antiviral Agents|antiviral agents|mesh-ancestor
101807378|NCT00747539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101807379|NCT00747539|Antimetabolites|antimetabolites|mesh-ancestor
101807380|NCT00747539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807381|NCT00747539|Immunologic Factors|immunologic factors|mesh-ancestor
101807382|NCT00747539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807383|NCT00745433|Metformin|metformin|mesh-list
101807384|NCT00745433|Repaglinide|repaglinide|mesh-list
101807385|NCT00745433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101807386|NCT00745433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807387|NCT00962234|Deuterium Oxide|deuterium oxide|mesh-list
101807388|NCT00962234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807389|NCT00962234|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101807390|NCT00962234|Protective Agents|protective agents|mesh-ancestor
101811106|NCT01019421|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101807391|NCT00962234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807393|NCT00747695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101807394|NCT00747695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101807395|NCT00747695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101807396|NCT00747695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101807397|NCT00747695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807398|NCT00959972|Nicotine|nicotine|mesh-list
101807399|NCT00959972|Varenicline|varenicline|mesh-list
101807400|NCT00959972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101807401|NCT00959972|Autonomic Agents|autonomic agents|mesh-ancestor
101807402|NCT00959972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101807403|NCT00959972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807404|NCT00959972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101807405|NCT00959972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101807406|NCT00959972|Cholinergic Agents|cholinergic agents|mesh-ancestor
101807407|NCT00959972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101807408|NCT00959972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807409|NCT04009616|Chlorhexidine|chlorhexidine|mesh-list
101807410|NCT04009616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101807411|NCT04009616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101807412|NCT04009616|Disinfectants|disinfectants|mesh-ancestor
101807413|NCT00960284|Gemcitabine|gemcitabine|mesh-list
101807414|NCT00960284|Fluorouracil|fluorouracil|mesh-list
101807415|NCT00960284|Capecitabine|capecitabine|mesh-list
101807416|NCT00960284|Epirubicin|epirubicin|mesh-list
101807417|NCT00960284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807418|NCT00960284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101807419|NCT00960284|Antimetabolites|antimetabolites|mesh-ancestor
101807420|NCT00960284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807421|NCT00960284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101807422|NCT00960284|Immunologic Factors|immunologic factors|mesh-ancestor
101807423|NCT00960284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807424|NCT00960284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101807425|NCT00960284|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101246508|NCT01666418|Mitosis Modulators|mitosis modulators|mesh-ancestor
101807426|NCT00960284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101807427|NCT00960284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101807429|NCT00105469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101807430|NCT00105469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101807431|NCT00962312|Capecitabine|capecitabine|mesh-list
101807432|NCT00962312|Lapatinib|lapatinib|mesh-list
101807433|NCT00962312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101807434|NCT00962312|Antimetabolites|antimetabolites|mesh-ancestor
101807435|NCT00962312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807436|NCT00962312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807437|NCT00962312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101807438|NCT00962312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101807439|NCT00960518|Adefovir|adefovir|mesh-list
101807440|NCT00960518|Antiviral Agents|antiviral agents|mesh-ancestor
101807441|NCT00960518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101807442|NCT00960518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101807443|NCT00960518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101807444|NCT00960518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101807445|NCT00960518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807446|NCT00960830|Mirtazapine|mirtazapine|mesh-list
101807447|NCT00960830|Antidepressive Agents|antidepressive agents|mesh-ancestor
101807448|NCT00960830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101807449|NCT00960830|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101807450|NCT00960830|Histamine Antagonists|histamine antagonists|mesh-ancestor
101807451|NCT00960830|Histamine Agents|histamine agents|mesh-ancestor
101807452|NCT00960830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101807453|NCT00960830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807454|NCT00960830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807455|NCT00960830|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101807456|NCT00960830|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101807458|NCT00960830|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101807459|NCT00960830|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101807460|NCT00960830|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101807461|NCT00960830|Adrenergic Agents|adrenergic agents|mesh-ancestor
101807462|NCT00960830|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101807463|NCT00960830|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101807464|NCT00960830|Serotonin Agents|serotonin agents|mesh-ancestor
101807465|NCT00960830|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101807466|NCT00962624|Vaccines|vaccines|mesh-list
101807467|NCT00962624|Immunologic Factors|immunologic factors|mesh-ancestor
101807468|NCT00962624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807469|NCT00105235|Cyclosporine|cyclosporine|mesh-list
101807470|NCT00105235|Mycophenolic Acid|mycophenolic acid|mesh-list
101807471|NCT00105235|Alemtuzumab|alemtuzumab|mesh-list
101807472|NCT00105235|Tacrolimus|tacrolimus|mesh-list
101807473|NCT00105235|Cyclosporins|cyclosporins|mesh-list
101807474|NCT00105235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101807475|NCT00105235|Immunologic Factors|immunologic factors|mesh-ancestor
101807476|NCT00105235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807477|NCT00105235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101807478|NCT00105235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101211257|NCT05523934|Dermatologic Agents|dermatologic agents|mesh-ancestor
101807479|NCT00105235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807481|NCT00105235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101807482|NCT00105235|Dermatologic Agents|dermatologic agents|mesh-ancestor
101807483|NCT00105235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101807484|NCT00105235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101807485|NCT00105235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807486|NCT00105235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101807487|NCT00105235|Antitubercular Agents|antitubercular agents|mesh-ancestor
101807488|NCT00105235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101807489|NCT00105235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101807491|NCT03962803|Immunologic Factors|immunologic factors|mesh-ancestor
101807492|NCT03962803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807493|NCT00547118|Rimonabant|rimonabant|mesh-list
101807494|NCT00547118|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101807495|NCT00547118|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
101807496|NCT00547118|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101807497|NCT00547118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101807498|NCT00547118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807499|NCT00547118|Hormones|hormones|mesh-ancestor
101211375|NCT05412173|Molnupiravir|molnupiravir|mesh-list
101807500|NCT00547118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101807501|NCT00547118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807502|NCT00962936|Pidilizumab|pidilizumab|mesh-list
101807503|NCT00962936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101807504|NCT00962936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807505|NCT01087099|Albendazole|albendazole|mesh-list
101807506|NCT01087099|Anthelmintics|anthelmintics|mesh-ancestor
101807507|NCT01087099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101807508|NCT01087099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101807509|NCT01087099|Anticestodal Agents|anticestodal agents|mesh-ancestor
101807510|NCT01087099|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101807511|NCT01087099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101807512|NCT01087099|Tubulin Modulators|tubulin modulators|mesh-ancestor
101807513|NCT01087099|Antimitotic Agents|antimitotic agents|mesh-ancestor
101807514|NCT01087099|Mitosis Modulators|mitosis modulators|mesh-ancestor
101807515|NCT01087099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807516|NCT01087099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807517|NCT00686543|Posaconazole|posaconazole|mesh-list
101807518|NCT00686543|Antifungal Agents|antifungal agents|mesh-ancestor
101807519|NCT00686543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101807520|NCT00686543|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101807521|NCT00686543|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101807522|NCT00686543|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101807523|NCT00686543|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101807524|NCT00686543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101807525|NCT00686543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101807526|NCT00686543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807527|NCT00686543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101464844|NCT04548700|Mitoxantrone|mitoxantrone|mesh-list
101807528|NCT00686543|Hormone Antagonists|hormone antagonists|mesh-ancestor
101807529|NCT00686543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101807530|NCT00686543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807531|NCT00750113|Telmisartan|telmisartan|mesh-list
101807532|NCT00750113|Nifedipine|nifedipine|mesh-list
101807533|NCT00750113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101807534|NCT00750113|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101807535|NCT00750113|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101807536|NCT00750113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211581|NCT05179512|Tiotropium Bromide|tiotropium bromide|mesh-list
101211603|NCT05179512|Hormones|hormones|mesh-ancestor
101807537|NCT00750113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101807538|NCT00750113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101807539|NCT00750113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101807540|NCT00750113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807541|NCT00750113|Vasodilator Agents|vasodilator agents|mesh-ancestor
101807542|NCT00750113|Tocolytic Agents|tocolytic agents|mesh-ancestor
101807543|NCT00750113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101807544|NCT00745511|Bevacizumab|bevacizumab|mesh-list
101807545|NCT00745511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101807546|NCT00745511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807547|NCT00745511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101211647|NCT05113745|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101807548|NCT00745511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101807549|NCT00745511|Growth Substances|growth substances|mesh-ancestor
101807550|NCT00745511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807551|NCT00745511|Growth Inhibitors|growth inhibitors|mesh-ancestor
101807553|NCT00545688|Trastuzumab|trastuzumab|mesh-list
101807554|NCT00545688|Pertuzumab|pertuzumab|mesh-list
101807555|NCT00545688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807556|NCT00545688|Tubulin Modulators|tubulin modulators|mesh-ancestor
101807557|NCT00545688|Antimitotic Agents|antimitotic agents|mesh-ancestor
101807558|NCT00545688|Mitosis Modulators|mitosis modulators|mesh-ancestor
101807559|NCT00545688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807560|NCT00545688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101807561|NCT00502203|Paclitaxel|paclitaxel|mesh-list
101807562|NCT00502203|Carboplatin|carboplatin|mesh-list
101807563|NCT00502203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101807564|NCT00502203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807565|NCT00502203|Tubulin Modulators|tubulin modulators|mesh-ancestor
101807566|NCT00502203|Antimitotic Agents|antimitotic agents|mesh-ancestor
101807567|NCT00502203|Mitosis Modulators|mitosis modulators|mesh-ancestor
101807568|NCT00502203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211708|NCT05083429|Tiotropium Bromide|tiotropium bromide|mesh-list
101807570|NCT00546078|Immunologic Factors|immunologic factors|mesh-ancestor
101807571|NCT00546078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807572|NCT00967772|Naftopidil|naftopidil|mesh-list
101807573|NCT00967772|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101807574|NCT00967772|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101807575|NCT00967772|Adrenergic Agents|adrenergic agents|mesh-ancestor
101807576|NCT00967772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101807577|NCT00967772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807578|NCT00967772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807579|NCT00967772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101807580|NCT00967772|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101807581|NCT00967772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101807582|NCT00967772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101807583|NCT00967772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101807584|NCT00967850|Verteporfin|verteporfin|mesh-list
101807585|NCT00967850|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101807586|NCT00967850|Dermatologic Agents|dermatologic agents|mesh-ancestor
101807587|NCT00967928|Everolimus|everolimus|mesh-list
101807588|NCT00967928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807589|NCT00967928|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101807590|NCT00967928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101807591|NCT00967928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101807592|NCT00967928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211823|NCT04979884|Cyclosporins|cyclosporins|mesh-list
101807593|NCT00967928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101807594|NCT00967928|Immunologic Factors|immunologic factors|mesh-ancestor
101807595|NCT00967928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807597|NCT00546000|Xhance|xhance|mesh-list
101807598|NCT00546000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101807599|NCT00546000|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101807600|NCT00546000|Autonomic Agents|autonomic agents|mesh-ancestor
101807601|NCT00546000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101211887|NCT04932980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807602|NCT00546000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807603|NCT00546000|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101807604|NCT00546000|Respiratory System Agents|respiratory system agents|mesh-ancestor
101807605|NCT00546000|Dermatologic Agents|dermatologic agents|mesh-ancestor
101807606|NCT00546000|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101807607|NCT00968006|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101807608|NCT00968006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101807609|NCT00968006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807610|NCT00968006|Incretins|incretins|mesh-ancestor
101807611|NCT00968006|Hormones|hormones|mesh-ancestor
101807612|NCT00968006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101807613|NCT00968006|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101807614|NCT00968006|Protease Inhibitors|protease inhibitors|mesh-ancestor
101807615|NCT00968006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101807616|NCT00968006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807618|NCT00968162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807619|NCT00968240|Bevacizumab|bevacizumab|mesh-list
101807620|NCT00968240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101807621|NCT00968240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807622|NCT00968240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101807623|NCT00968240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101807624|NCT00968240|Growth Substances|growth substances|mesh-ancestor
101807625|NCT00968240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807626|NCT00968240|Growth Inhibitors|growth inhibitors|mesh-ancestor
101807628|NCT00501969|Dopamine Agonists|dopamine agonists|mesh-ancestor
101807629|NCT00501969|Dopamine Agents|dopamine agents|mesh-ancestor
101807630|NCT00501969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101807631|NCT00501969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807632|NCT00501969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807634|NCT03942042|Dermatologic Agents|dermatologic agents|mesh-ancestor
101807635|NCT00968396|Melphalan|melphalan|mesh-list
101807636|NCT00968396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101807637|NCT00968396|Alkylating Agents|alkylating agents|mesh-ancestor
101807638|NCT00968396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807639|NCT00968396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212147|NCT04662944|Ranibizumab|ranibizumab|mesh-list
101807640|NCT00968396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101807641|NCT00968396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101807642|NCT00968396|Immunologic Factors|immunologic factors|mesh-ancestor
101807643|NCT00968396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807644|NCT04008732|Nitroglycerin|nitroglycerin|mesh-list
101807645|NCT04008732|Vasodilator Agents|vasodilator agents|mesh-ancestor
101807646|NCT01013727|Technetium Tc 99m bicisate|technetium tc 99m bicisate|mesh-list
101807647|NCT01013727|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101807648|NCT01013727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807649|NCT05299580|Trametinib|trametinib|mesh-list
101807650|NCT05299580|Dabrafenib|dabrafenib|mesh-list
101807651|NCT05299580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807652|NCT05299580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101807653|NCT05299580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101807654|NCT05299580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807655|NCT01013805|Leucovorin|leucovorin|mesh-list
101807656|NCT01013805|Fluorouracil|fluorouracil|mesh-list
101807657|NCT01013805|Oxaliplatin|oxaliplatin|mesh-list
101807658|NCT01013805|Antimetabolites|antimetabolites|mesh-ancestor
101807659|NCT01013805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807660|NCT01013805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101807661|NCT01013805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807662|NCT01013805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101807663|NCT01013805|Immunologic Factors|immunologic factors|mesh-ancestor
101807664|NCT01013805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807665|NCT01013805|Antidotes|antidotes|mesh-ancestor
101807666|NCT01013805|Protective Agents|protective agents|mesh-ancestor
101807667|NCT01013805|Vitamin B Complex|vitamin b complex|mesh-ancestor
101807668|NCT01013805|Vitamins|vitamins|mesh-ancestor
101807669|NCT01013805|Micronutrients|micronutrients|mesh-ancestor
101807670|NCT00104299|Prednisone|prednisone|mesh-list
101807671|NCT00104299|Methylprednisolone|methylprednisolone|mesh-list
101807672|NCT00104299|Cyclophosphamide|cyclophosphamide|mesh-list
101807673|NCT00104299|Rituximab|rituximab|mesh-list
101807674|NCT00104299|Azathioprine|azathioprine|mesh-list
101807675|NCT00104299|Glucocorticoids|glucocorticoids|mesh-list
101807676|NCT00104299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101807677|NCT00104299|Immunologic Factors|immunologic factors|mesh-ancestor
101807678|NCT00104299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807679|NCT00104299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101807680|NCT00104299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101807681|NCT00104299|Alkylating Agents|alkylating agents|mesh-ancestor
101807682|NCT00104299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807683|NCT00104299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807684|NCT00104299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101807685|NCT00104299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101807686|NCT00104299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101807687|NCT00104299|Hormones|hormones|mesh-ancestor
101807688|NCT00104299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101807689|NCT00104299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101807690|NCT00104299|Antiemetics|antiemetics|mesh-ancestor
101807691|NCT00104299|Autonomic Agents|autonomic agents|mesh-ancestor
101807692|NCT00104299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101807693|NCT00104299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101807694|NCT00104299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101807695|NCT00104299|Protective Agents|protective agents|mesh-ancestor
101807696|NCT00104299|Antimetabolites|antimetabolites|mesh-ancestor
101807697|NCT00104299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101807698|NCT05196308|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
101807699|NCT05196308|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101807700|NCT05196308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101807701|NCT05196308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807702|NCT05196308|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101807703|NCT05196308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101807704|NCT05196308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807705|NCT05196308|Cholinergic Agents|cholinergic agents|mesh-ancestor
101807706|NCT05196308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101807707|NCT00082381|Insulin Glargine|insulin glargine|mesh-list
101807708|NCT00082381|Exenatide|exenatide|mesh-list
101807709|NCT00082381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101212530|NCT03978598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101212538|NCT03975231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212540|NCT03972488|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
101212541|NCT03972488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101212542|NCT03972488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101212543|NCT03972488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212544|NCT03972488|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101212545|NCT03972488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212571|NCT03943537|Insulin|insulin|mesh-list
101212572|NCT03943537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101212573|NCT03943537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212574|NCT03937830|Bevacizumab|bevacizumab|mesh-list
101212575|NCT03937830|Durvalumab|durvalumab|mesh-list
101212576|NCT03937830|Doxorubicin|doxorubicin|mesh-list
101212577|NCT03937830|Tremelimumab|tremelimumab|mesh-list
101212578|NCT03937830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101807710|NCT00082381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807711|NCT00082381|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101807712|NCT00082381|Incretins|incretins|mesh-ancestor
101807713|NCT00082381|Hormones|hormones|mesh-ancestor
101807714|NCT00082381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101807715|NCT00964106|Rosiglitazone|rosiglitazone|mesh-list
101807716|NCT00964106|Rifampin|rifampin|mesh-list
101807717|NCT00964106|Fluconazole|fluconazole|mesh-list
101807718|NCT00964106|Ketoconazole|ketoconazole|mesh-list
101807719|NCT00964106|Flurbiprofen|flurbiprofen|mesh-list
101807720|NCT00964106|Midazolam|midazolam|mesh-list
101807721|NCT00964106|Dextromethorphan|dextromethorphan|mesh-list
101807722|NCT00964106|Caffeine|caffeine|mesh-list
101807723|NCT00964106|Omeprazole|omeprazole|mesh-list
101807724|NCT00964106|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101807725|NCT00964106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101811202|NCT00752375|Antimalarials|antimalarials|mesh-ancestor
101807726|NCT00964106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101807727|NCT00964106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101807728|NCT00964106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807729|NCT00964106|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101807730|NCT00964106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101807731|NCT00964106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101807732|NCT00964106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101807733|NCT00964106|Anesthetics, General|anesthetics, general|mesh-ancestor
101807734|NCT00964106|Anesthetics|anesthetics|mesh-ancestor
101807735|NCT00964106|GABA Modulators|gaba modulators|mesh-ancestor
101807736|NCT00964106|GABA Agents|gaba agents|mesh-ancestor
101807737|NCT00964106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101807738|NCT00964106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807739|NCT00964106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101807740|NCT00964106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101807741|NCT00964106|Antimetabolites|antimetabolites|mesh-ancestor
101807742|NCT00964106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101807743|NCT00964106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101807744|NCT00964106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101807745|NCT00964106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101807746|NCT00964106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101807747|NCT00964106|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101807748|NCT00964106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101807749|NCT00964106|Purinergic Agents|purinergic agents|mesh-ancestor
101807750|NCT00964106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101807751|NCT00964106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101807752|NCT00964106|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101807753|NCT00964106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101807754|NCT00964106|Antitubercular Agents|antitubercular agents|mesh-ancestor
101807755|NCT00964106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101807756|NCT00964106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101807757|NCT00964106|Leprostatic Agents|leprostatic agents|mesh-ancestor
101807758|NCT00964106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101807759|NCT00964106|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101807760|NCT00964106|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101807761|NCT00964106|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101807762|NCT00964106|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101807763|NCT00964106|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101807764|NCT00964106|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101807765|NCT00964106|Antifungal Agents|antifungal agents|mesh-ancestor
101807766|NCT00964106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101807767|NCT00964106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101807768|NCT00964106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101807769|NCT00964106|Hormone Antagonists|hormone antagonists|mesh-ancestor
101807770|NCT00964106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101807771|NCT00964106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101807772|NCT00964106|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101807773|NCT00964106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101807774|NCT00964106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101807775|NCT00964106|Antitussive Agents|antitussive agents|mesh-ancestor
101807776|NCT00964106|Respiratory System Agents|respiratory system agents|mesh-ancestor
101807777|NCT00964106|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101807778|NCT00964106|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101807779|NCT00964106|Analgesics|analgesics|mesh-ancestor
101811212|NCT00751517|Cyclophosphamide|cyclophosphamide|mesh-list
101807780|NCT00964106|Sensory System Agents|sensory system agents|mesh-ancestor
101807781|NCT00964106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101807782|NCT00964106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101807783|NCT00964106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101807784|NCT00964106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101311496|NCT03808480|Nivolumab|nivolumab|mesh-list
101807785|NCT00964106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101807786|NCT00964106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101807787|NCT00960336|Doxorubicin|doxorubicin|mesh-list
101807788|NCT00960336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101807789|NCT00960336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101807790|NCT00960336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807791|NCT00960336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101807792|NCT00960336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101807793|NCT00960336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101807794|NCT00960336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807795|NCT00965172|Calcium|calcium|mesh-list
101807796|NCT00965172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101212907|NCT03425643|Pemetrexed|pemetrexed|mesh-list
101807797|NCT00965172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807798|NCT01084837|Bortezomib|bortezomib|mesh-list
101807799|NCT01084837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807800|NCT00545844|Montelukast|montelukast|mesh-list
101807801|NCT00545844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101807802|NCT00545844|Respiratory System Agents|respiratory system agents|mesh-ancestor
101807803|NCT00545844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101807804|NCT00545844|Hormone Antagonists|hormone antagonists|mesh-ancestor
101212972|NCT03341078|Ibudilast|ibudilast|mesh-list
101807805|NCT00545844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101807806|NCT00545844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807807|NCT00545844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101807808|NCT00545844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101807809|NCT00545844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807810|NCT01084993|Heparin|heparin|mesh-list
101807811|NCT01084993|Bivalirudin|bivalirudin|mesh-list
101807812|NCT01084993|Anticoagulants|anticoagulants|mesh-ancestor
101807813|NCT01084993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101807814|NCT01084993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101807815|NCT01084993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213112|NCT02899052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807816|NCT01084993|Antithrombins|antithrombins|mesh-ancestor
101807817|NCT01084993|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101807818|NCT01084993|Protease Inhibitors|protease inhibitors|mesh-ancestor
101807819|NCT01084993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101807820|NCT00492063|Vaccines|vaccines|mesh-list
101807821|NCT00492063|Immunologic Factors|immunologic factors|mesh-ancestor
101807822|NCT00492063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807823|NCT00960492|Temozolomide|temozolomide|mesh-list
101807824|NCT00960492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101807825|NCT00960492|Alkylating Agents|alkylating agents|mesh-ancestor
101807826|NCT00960492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807827|NCT00960492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807828|NCT00971724|Prednisolone|prednisolone|mesh-list
101807829|NCT00971724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101807830|NCT00971724|Glucocorticoids|glucocorticoids|mesh-ancestor
101807831|NCT00971724|Hormones|hormones|mesh-ancestor
101807832|NCT00971724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101807833|NCT00971724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807834|NCT00971724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101807835|NCT00971724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807836|NCT02976909|Paclitaxel|paclitaxel|mesh-list
101213193|NCT02586831|Hormones|hormones|mesh-ancestor
101807837|NCT02976909|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101807839|NCT02976909|Fluorouracil|fluorouracil|mesh-list
101807840|NCT02976909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101807841|NCT02976909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807842|NCT02976909|Tubulin Modulators|tubulin modulators|mesh-ancestor
101807843|NCT02976909|Antimitotic Agents|antimitotic agents|mesh-ancestor
101807844|NCT02976909|Mitosis Modulators|mitosis modulators|mesh-ancestor
101807845|NCT02976909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807847|NCT02976909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101807848|NCT02976909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101807849|NCT02976909|Immunologic Factors|immunologic factors|mesh-ancestor
101807850|NCT02976909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807851|NCT02878083|Adalimumab|adalimumab|mesh-list
101807852|NCT02878083|Vedolizumab|vedolizumab|mesh-list
101807853|NCT02878083|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101807854|NCT02878083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101807855|NCT02878083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101807856|NCT02878083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101807857|NCT00093145|Paclitaxel|paclitaxel|mesh-list
101213306|NCT02220426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101807859|NCT00093145|Trastuzumab|trastuzumab|mesh-list
101807860|NCT00093145|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101807861|NCT00093145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101807862|NCT00093145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807863|NCT00093145|Tubulin Modulators|tubulin modulators|mesh-ancestor
101807864|NCT00093145|Antimitotic Agents|antimitotic agents|mesh-ancestor
101807865|NCT00093145|Mitosis Modulators|mitosis modulators|mesh-ancestor
101807866|NCT00093145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807867|NCT00093145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101807868|NCT00965406|Insulin|insulin|mesh-list
101807870|NCT00965406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807871|NCT00513357|Melatonin|melatonin|mesh-list
101807872|NCT00513357|Antioxidants|antioxidants|mesh-ancestor
101807873|NCT00513357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807874|NCT00513357|Protective Agents|protective agents|mesh-ancestor
101213440|NCT01728363|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101807875|NCT00513357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807876|NCT00513357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101807878|NCT00960960|Bevacizumab|bevacizumab|mesh-list
101807879|NCT00960960|Trastuzumab|trastuzumab|mesh-list
101807880|NCT00960960|Letrozole|letrozole|mesh-list
101807881|NCT00960960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101807882|NCT00960960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807883|NCT00960960|Tubulin Modulators|tubulin modulators|mesh-ancestor
101807884|NCT00960960|Antimitotic Agents|antimitotic agents|mesh-ancestor
101807885|NCT00960960|Mitosis Modulators|mitosis modulators|mesh-ancestor
101807886|NCT00960960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807887|NCT00960960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101807888|NCT00960960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101807889|NCT00960960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101807890|NCT00960960|Growth Substances|growth substances|mesh-ancestor
101807891|NCT00960960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807892|NCT00960960|Growth Inhibitors|growth inhibitors|mesh-ancestor
101807893|NCT00960960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101807894|NCT00960960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101807895|NCT00960960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101807896|NCT00960960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101807897|NCT00960960|Hormone Antagonists|hormone antagonists|mesh-ancestor
101807898|NCT00960960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101807899|NCT00965640|Botulinum Toxins|botulinum toxins|mesh-list
101807900|NCT00965640|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101807901|NCT00965640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101807902|NCT00965640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807903|NCT00965640|Cholinergic Agents|cholinergic agents|mesh-ancestor
101213638|NCT00544115|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101807904|NCT00965640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101807905|NCT00965640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807906|NCT00961038|Ciprofloxacin|ciprofloxacin|mesh-list
101807907|NCT00961038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101807908|NCT00961038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101807909|NCT00961038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101807910|NCT00961038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101807911|NCT00961038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101807912|NCT00961038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807913|NCT00961038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807914|NCT00961038|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101807915|NCT00961038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101807916|NCT00961194|Ketamine|ketamine|mesh-list
101807917|NCT00961194|Analgesics|analgesics|mesh-ancestor
101807918|NCT00961194|Sensory System Agents|sensory system agents|mesh-ancestor
101807919|NCT00961194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101213704|NCT01457508|Chelating Agents|chelating agents|mesh-ancestor
101807920|NCT00961194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807921|NCT00961194|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101807922|NCT00961194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101807923|NCT00961194|Anesthetics, General|anesthetics, general|mesh-ancestor
101807924|NCT00961194|Anesthetics|anesthetics|mesh-ancestor
101807925|NCT00961194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101807926|NCT00961194|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101807927|NCT00961194|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101807928|NCT00961194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101807929|NCT00961194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807931|NCT05279586|Lactulose|lactulose|mesh-list
101807932|NCT05279586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101807933|NCT05279586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101807934|NCT05279586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101807935|NCT00965796|Lidocaine|lidocaine|mesh-list
101807936|NCT00965796|Anesthetics, Local|anesthetics, local|mesh-ancestor
101807937|NCT00965796|Anesthetics|anesthetics|mesh-ancestor
101807938|NCT00965796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101807939|NCT00965796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807940|NCT00965796|Sensory System Agents|sensory system agents|mesh-ancestor
101807941|NCT00965796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101807942|NCT00965796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101807943|NCT00965796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101807944|NCT00965796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101807945|NCT00965796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101807946|NCT00965796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807948|NCT00415636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807949|NCT00415636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101807950|NCT00415636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807951|NCT00415636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101213887|NCT01461031|Sensory System Agents|sensory system agents|mesh-ancestor
101807952|NCT00415636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101807953|NCT00965874|Magnesium Sulfate|magnesium sulfate|mesh-list
101807954|NCT00965874|Analgesics|analgesics|mesh-ancestor
101807955|NCT00965874|Sensory System Agents|sensory system agents|mesh-ancestor
101807956|NCT00965874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101807957|NCT00965874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807959|NCT00965874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101807960|NCT00965874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101807961|NCT00965874|Anticonvulsants|anticonvulsants|mesh-ancestor
101807962|NCT00965874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101807963|NCT00965874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101807964|NCT00965874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807965|NCT00965874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101807966|NCT00965874|Tocolytic Agents|tocolytic agents|mesh-ancestor
101807967|NCT00965874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101807968|NCT00972426|Timolol|timolol|mesh-list
101807969|NCT00972426|Carteolol|carteolol|mesh-list
101807970|NCT00972426|Latanoprost|latanoprost|mesh-list
101807971|NCT00972426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101807972|NCT00972426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101807973|NCT00972426|Adrenergic Agents|adrenergic agents|mesh-ancestor
101807974|NCT00972426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101807975|NCT00972426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807976|NCT00972426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807977|NCT00972426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101807978|NCT00972426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101807980|NCT00972426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101807981|NCT00972426|Sympatholytics|sympatholytics|mesh-ancestor
101807982|NCT00972426|Autonomic Agents|autonomic agents|mesh-ancestor
101214022|NCT01463046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101807983|NCT00972426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101807984|NCT00972660|Cyclosporine|cyclosporine|mesh-list
101807985|NCT00972660|Mycophenolic Acid|mycophenolic acid|mesh-list
101807986|NCT00972660|Prednisone|prednisone|mesh-list
101807987|NCT00972660|Cyclosporins|cyclosporins|mesh-list
101807988|NCT00972660|Tacrolimus|tacrolimus|mesh-list
101807989|NCT00972660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101807990|NCT00972660|Glucocorticoids|glucocorticoids|mesh-ancestor
101807991|NCT00972660|Hormones|hormones|mesh-ancestor
101807992|NCT00972660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101807993|NCT00972660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101807994|NCT00972660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101807995|NCT00972660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101807996|NCT00972660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101807997|NCT00972660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101807998|NCT00972660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101807999|NCT00972660|Immunologic Factors|immunologic factors|mesh-ancestor
101808000|NCT00972660|Antifungal Agents|antifungal agents|mesh-ancestor
101808001|NCT00972660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101808002|NCT00972660|Dermatologic Agents|dermatologic agents|mesh-ancestor
101808003|NCT00972660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101808004|NCT00972660|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101808005|NCT00972660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101808006|NCT00972660|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101808007|NCT00972660|Antitubercular Agents|antitubercular agents|mesh-ancestor
101808008|NCT00972660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101808009|NCT04008966|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101214206|NCT01464242|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101808010|NCT04008966|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101808011|NCT04008966|Cetrorelix|cetrorelix|mesh-list
101808012|NCT04008966|Progesterone|progesterone|mesh-list
101808013|NCT04008966|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101808014|NCT04008966|Progestins|progestins|mesh-ancestor
101808015|NCT04008966|Hormones|hormones|mesh-ancestor
101808016|NCT04008966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101808017|NCT04008966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214277|NCT01466712|Hormones|hormones|mesh-ancestor
101808018|NCT04008966|Luteolytic Agents|luteolytic agents|mesh-ancestor
101808019|NCT04008966|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101808020|NCT04008966|Contraceptive Agents|contraceptive agents|mesh-ancestor
101808021|NCT04008966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101808022|NCT04008966|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101808023|NCT04008966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101808024|NCT04008966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101808025|NCT04008966|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101808026|NCT04008966|Fertility Agents|fertility agents|mesh-ancestor
101808027|NCT04008966|Hormone Antagonists|hormone antagonists|mesh-ancestor
101808028|NCT00425854|Afatinib|afatinib|mesh-list
101808029|NCT00425854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101808030|NCT00425854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101808031|NCT00425854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101808032|NCT00425854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808033|NCT00425698|Epoetin Alfa|epoetin alfa|mesh-list
101808034|NCT00425698|Hematinics|hematinics|mesh-ancestor
101808035|NCT01037530|Ramipril|ramipril|mesh-list
101808036|NCT01037530|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101808037|NCT01037530|Protease Inhibitors|protease inhibitors|mesh-ancestor
101808038|NCT01037530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101808039|NCT01037530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808040|NCT01037530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101808041|NCT00973050|Bicalutamide|bicalutamide|mesh-list
101808042|NCT00973050|Androgen Antagonists|androgen antagonists|mesh-ancestor
101808043|NCT00973050|Hormone Antagonists|hormone antagonists|mesh-ancestor
101808044|NCT00973050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101808045|NCT00973050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808046|NCT00973050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101808047|NCT00973128|Meglumine Antimoniate|meglumine antimoniate|mesh-list
101808048|NCT00973128|Sargramostim|sargramostim|mesh-list
101808049|NCT00973128|Immunologic Factors|immunologic factors|mesh-ancestor
101808050|NCT00973128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808051|NCT00973128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101808052|NCT00973128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101808053|NCT00973128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101808054|NCT00973986|Atorvastatin|atorvastatin|mesh-list
101808055|NCT00973986|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101808056|NCT00973986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101808057|NCT00973986|Antimetabolites|antimetabolites|mesh-ancestor
101808058|NCT00973986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808059|NCT00973986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101808060|NCT00973986|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101811294|NCT00423670|Ribavirin|ribavirin|mesh-list
101808061|NCT00973986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101808062|NCT00966576|Timolol|timolol|mesh-list
101808063|NCT00966576|Brinzolamide|brinzolamide|mesh-list
101808064|NCT00966576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101808065|NCT00966576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808066|NCT00966576|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101808067|NCT00966576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101808068|NCT00966576|Adrenergic Agents|adrenergic agents|mesh-ancestor
101808069|NCT00966576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101808070|NCT00966576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808071|NCT00966576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101808072|NCT00966576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101808073|NCT00966576|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101808074|NCT00425308|Cyclosporine|cyclosporine|mesh-list
101808075|NCT00425308|Mycophenolic Acid|mycophenolic acid|mesh-list
101808076|NCT00425308|Everolimus|everolimus|mesh-list
101808077|NCT00425308|Cyclosporins|cyclosporins|mesh-list
101808078|NCT00425308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101808079|NCT00425308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808080|NCT00425308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101808081|NCT00425308|Immunologic Factors|immunologic factors|mesh-ancestor
101808082|NCT00425308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808083|NCT00425308|Antifungal Agents|antifungal agents|mesh-ancestor
101808084|NCT00425308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101808085|NCT00425308|Dermatologic Agents|dermatologic agents|mesh-ancestor
101808086|NCT00425308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101808087|NCT00425308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101808088|NCT00425308|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101808089|NCT00425308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101808090|NCT00425308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101808091|NCT00425308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101808092|NCT00425308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101808093|NCT00425308|Antitubercular Agents|antitubercular agents|mesh-ancestor
101808094|NCT00425308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101808095|NCT04008888|Dexamethasone|dexamethasone|mesh-list
101808096|NCT04008888|Dexamethasone acetate|dexamethasone acetate|mesh-list
101808097|NCT04008888|Fludarabine|fludarabine|mesh-list
101808099|NCT04008888|BB 1101|bb 1101|mesh-list
101214647|NCT01468740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101808101|NCT04008888|Antiemetics|antiemetics|mesh-ancestor
101808102|NCT04008888|Autonomic Agents|autonomic agents|mesh-ancestor
101808103|NCT04008888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101808104|NCT04008888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808105|NCT04008888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101808106|NCT04008888|Glucocorticoids|glucocorticoids|mesh-ancestor
101808107|NCT04008888|Hormones|hormones|mesh-ancestor
101214708|NCT01469468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101808108|NCT04008888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101808109|NCT04008888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101808110|NCT04008888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101808111|NCT04008888|Protease Inhibitors|protease inhibitors|mesh-ancestor
101808112|NCT04008888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101808113|NCT04008888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808114|NCT04008888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101311552|NCT00006519|Capravirine|capravirine|mesh-list
101808115|NCT04008888|Immunologic Factors|immunologic factors|mesh-ancestor
101808116|NCT04008888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101808117|NCT04008888|Alkylating Agents|alkylating agents|mesh-ancestor
101808118|NCT04008888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101808120|NCT01033084|Antidepressive Agents|antidepressive agents|mesh-ancestor
101808121|NCT01033084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101808122|NCT01033084|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101465443|NCT00261729|Prazosin|prazosin|mesh-list
101808123|NCT01033084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101808124|NCT01033084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101808125|NCT01033084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808126|NCT01033084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101808127|NCT01033084|Serotonin Agents|serotonin agents|mesh-ancestor
101808128|NCT01033084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808129|NCT00979758|Atorvastatin|atorvastatin|mesh-list
101808130|NCT00979758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101808131|NCT00979758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101808132|NCT00979758|Antimetabolites|antimetabolites|mesh-ancestor
101808133|NCT00979758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808134|NCT00979758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101214899|NCT01470339|Antidepressive Agents|antidepressive agents|mesh-ancestor
101214900|NCT01470339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101808135|NCT00979758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101808136|NCT00979758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101808137|NCT00545064|Timolol|timolol|mesh-list
101808138|NCT00545064|Dorzolamide|dorzolamide|mesh-list
101808139|NCT00545064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101808140|NCT00545064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808141|NCT00545064|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101808142|NCT00545064|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101808143|NCT00545064|Adrenergic Agents|adrenergic agents|mesh-ancestor
101808144|NCT00545064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101808145|NCT00545064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808146|NCT00545064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101808147|NCT00545064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101808148|NCT00545064|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101808149|NCT00979836|Calcium Dobesilate|calcium dobesilate|mesh-list
101808150|NCT00979836|Calcium|calcium|mesh-list
101808151|NCT00979836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101808152|NCT00979836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808153|NCT00979836|Hemostatics|hemostatics|mesh-ancestor
101808154|NCT00979836|Coagulants|coagulants|mesh-ancestor
101808155|NCT01588912|Tenofovir|tenofovir|mesh-list
101808156|NCT01588912|Entecavir|entecavir|mesh-list
101808157|NCT01588912|Telbivudine|telbivudine|mesh-list
101808158|NCT01588912|Antiviral Agents|antiviral agents|mesh-ancestor
101808160|NCT01588912|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101808161|NCT01588912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101808162|NCT01588912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101808163|NCT01588912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808164|NCT01588912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101808165|NCT01588912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101808166|NCT01589068|Nicotine|nicotine|mesh-list
101808167|NCT01589068|Progesterone|progesterone|mesh-list
101808168|NCT01589068|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101808170|NCT01589068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101808171|NCT01589068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808172|NCT01589068|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101808173|NCT01589068|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101808174|NCT01589068|Cholinergic Agents|cholinergic agents|mesh-ancestor
101808175|NCT01589068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101808176|NCT01589068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215158|NCT01472016|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101808178|NCT01589068|Hormones|hormones|mesh-ancestor
101808179|NCT01589068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101808180|NCT00432562|Vinorelbine|vinorelbine|mesh-list
101808181|NCT00432562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101808182|NCT00432562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101808183|NCT00432562|Tubulin Modulators|tubulin modulators|mesh-ancestor
101808184|NCT00432562|Antimitotic Agents|antimitotic agents|mesh-ancestor
101808185|NCT00432562|Mitosis Modulators|mitosis modulators|mesh-ancestor
101808186|NCT00432562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808187|NCT00966966|Gemfibrozil|gemfibrozil|mesh-list
101808188|NCT00966966|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101808189|NCT00966966|Antimetabolites|antimetabolites|mesh-ancestor
101808190|NCT00966966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808191|NCT00966966|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101808192|NCT00966966|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101808193|NCT00966966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101808194|NCT00966966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101808195|NCT00974532|Calcium, Dietary|calcium, dietary|mesh-list
101808196|NCT00974532|Calcium|calcium|mesh-list
101808197|NCT00974532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101808198|NCT00974532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465514|NCT04545463|Psyllium|psyllium|mesh-list
101808199|NCT00974532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101808200|NCT00432172|Cyclophosphamide|cyclophosphamide|mesh-list
101808201|NCT00432172|Carboplatin|carboplatin|mesh-list
101808203|NCT00432172|Epirubicin|epirubicin|mesh-list
101808204|NCT00432172|Exemestane|exemestane|mesh-list
101808205|NCT00432172|Goserelin|goserelin|mesh-list
101215295|NCT01473147|Exenatide|exenatide|mesh-list
101808206|NCT00432172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101808207|NCT00432172|Immunologic Factors|immunologic factors|mesh-ancestor
101808208|NCT00432172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808209|NCT00432172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101808210|NCT00432172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101808211|NCT00432172|Alkylating Agents|alkylating agents|mesh-ancestor
101808212|NCT00432172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808213|NCT00432172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101808214|NCT00432172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101808215|NCT00432172|Tubulin Modulators|tubulin modulators|mesh-ancestor
101808216|NCT00432172|Antimitotic Agents|antimitotic agents|mesh-ancestor
101808217|NCT00432172|Mitosis Modulators|mitosis modulators|mesh-ancestor
101215348|NCT01473303|Immunologic Factors|immunologic factors|mesh-ancestor
101808218|NCT00432172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101808219|NCT00432172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101808220|NCT00432172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101808221|NCT00432172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101808222|NCT00432172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101808223|NCT00432172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101808224|NCT00432172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101808225|NCT00432172|Hormone Antagonists|hormone antagonists|mesh-ancestor
101808226|NCT00432172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101808227|NCT00432172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101808229|NCT01034410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101808230|NCT01034410|Antimetabolites|antimetabolites|mesh-ancestor
101808231|NCT01034410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808232|NCT01034410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101808233|NCT01034410|Antiviral Agents|antiviral agents|mesh-ancestor
101808234|NCT01034410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101808235|NCT01034410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101808236|NCT01034410|Immunologic Factors|immunologic factors|mesh-ancestor
101808237|NCT01034410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808239|NCT00415168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101808240|NCT00415168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101808241|NCT00415168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808242|NCT00415168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101808243|NCT00415168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101808244|NCT00424762|Rosiglitazone|rosiglitazone|mesh-list
101808245|NCT00424762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101808246|NCT00424762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808247|NCT00980304|Rituximab|rituximab|mesh-list
101808248|NCT00980304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101808249|NCT00980304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101808250|NCT00980304|Immunologic Factors|immunologic factors|mesh-ancestor
101215539|NCT01475318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101808251|NCT00980304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808252|NCT00980304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101808254|NCT00974766|Hormones|hormones|mesh-ancestor
101808255|NCT00974766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101808256|NCT00974766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808257|NCT00980382|Docetaxel|docetaxel|mesh-list
101808258|NCT00980382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101808259|NCT00980382|Tubulin Modulators|tubulin modulators|mesh-ancestor
101808260|NCT00980382|Antimitotic Agents|antimitotic agents|mesh-ancestor
101808261|NCT00980382|Mitosis Modulators|mitosis modulators|mesh-ancestor
101808262|NCT00980382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808263|NCT00967434|Atorvastatin|atorvastatin|mesh-list
101808264|NCT00967434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101808265|NCT00967434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101808266|NCT00967434|Antimetabolites|antimetabolites|mesh-ancestor
101808267|NCT00967434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808268|NCT00967434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101808269|NCT00967434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101808270|NCT00967434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101808271|NCT00967512|Cytarabine|cytarabine|mesh-list
101808272|NCT00967512|Idarubicin|idarubicin|mesh-list
101808273|NCT00967512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101808274|NCT00967512|Antimetabolites|antimetabolites|mesh-ancestor
101808275|NCT00967512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808276|NCT00967512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101808277|NCT00967512|Antiviral Agents|antiviral agents|mesh-ancestor
101808278|NCT00967512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101808279|NCT00967512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101808280|NCT00967512|Immunologic Factors|immunologic factors|mesh-ancestor
101215599|NCT01475708|Antimalarials|antimalarials|mesh-ancestor
101808281|NCT00967512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808283|NCT00967512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101808284|NCT00967512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101808285|NCT00967512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101808288|NCT04082910|Metoprolol|metoprolol|mesh-list
101808289|NCT04082910|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101808290|NCT04082910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101808291|NCT04082910|Dermatologic Agents|dermatologic agents|mesh-ancestor
101808292|NCT04082910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101808293|NCT04082910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101808294|NCT04082910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101808295|NCT04082910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101808296|NCT04082910|Analgesics|analgesics|mesh-ancestor
101808297|NCT04082910|Sensory System Agents|sensory system agents|mesh-ancestor
101808298|NCT04082910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101808299|NCT04082910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808300|NCT04082910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101808301|NCT04082910|Immunologic Factors|immunologic factors|mesh-ancestor
101808302|NCT04082910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101808303|NCT04082910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101808304|NCT04082910|Sympatholytics|sympatholytics|mesh-ancestor
101808305|NCT04082910|Autonomic Agents|autonomic agents|mesh-ancestor
101808306|NCT04082910|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101808307|NCT04082910|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101808308|NCT04082910|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101808309|NCT04082910|Adrenergic Agents|adrenergic agents|mesh-ancestor
101808310|NCT04082910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101808311|NCT04082910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808312|NCT00975078|Prednisone|prednisone|mesh-list
101808313|NCT00975078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101808314|NCT00975078|Glucocorticoids|glucocorticoids|mesh-ancestor
101808315|NCT00975078|Hormones|hormones|mesh-ancestor
101808316|NCT00975078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101808317|NCT00975078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808318|NCT00975078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101808319|NCT00975078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101808320|NCT00980616|Ropivacaine|ropivacaine|mesh-list
101808321|NCT00980616|Anesthetics, Local|anesthetics, local|mesh-ancestor
101808322|NCT00980616|Anesthetics|anesthetics|mesh-ancestor
101808323|NCT00980616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101808324|NCT00980616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808325|NCT00980616|Sensory System Agents|sensory system agents|mesh-ancestor
101808326|NCT00980616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101808327|NCT00980850|Vaccines|vaccines|mesh-list
101808328|NCT00980850|Immunologic Factors|immunologic factors|mesh-ancestor
101808329|NCT00980850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808330|NCT00414466|Gabapentin|gabapentin|mesh-list
101808331|NCT00414466|Analgesics|analgesics|mesh-ancestor
101808332|NCT00414466|Sensory System Agents|sensory system agents|mesh-ancestor
101808333|NCT00414466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101808334|NCT00414466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808335|NCT00414466|Anticonvulsants|anticonvulsants|mesh-ancestor
101808336|NCT00414466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101808337|NCT00414466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101808338|NCT00414466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101808340|NCT00414466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101808341|NCT00414466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101808342|NCT00414466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101808343|NCT00414466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808344|NCT00414466|Antimanic Agents|antimanic agents|mesh-ancestor
101808345|NCT00984750|Acetylcarnitine|acetylcarnitine|mesh-list
101808346|NCT00984750|Simvastatin|simvastatin|mesh-list
101808347|NCT00984750|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101808348|NCT00984750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101808349|NCT00984750|Antimetabolites|antimetabolites|mesh-ancestor
101828163|NCT05919823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808350|NCT00984750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808351|NCT00984750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101808352|NCT00984750|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101808353|NCT00984750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101808354|NCT00984750|Vitamin B Complex|vitamin b complex|mesh-ancestor
101808355|NCT00984750|Vitamins|vitamins|mesh-ancestor
101808356|NCT00984750|Micronutrients|micronutrients|mesh-ancestor
101808357|NCT00984750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808358|NCT00984750|Nootropic Agents|nootropic agents|mesh-ancestor
101808359|NCT00975312|Tretinoin|tretinoin|mesh-list
101808360|NCT00975312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311608|NCT00006669|Hormones|hormones|mesh-ancestor
101808361|NCT00975312|Keratolytic Agents|keratolytic agents|mesh-ancestor
101808362|NCT00975312|Dermatologic Agents|dermatologic agents|mesh-ancestor
101808363|NCT00424528|Tiotropium Bromide|tiotropium bromide|mesh-list
101808364|NCT00424528|Formoterol Fumarate|formoterol fumarate|mesh-list
101808365|NCT00424528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101808366|NCT00424528|Autonomic Agents|autonomic agents|mesh-ancestor
101808367|NCT00424528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101808368|NCT00424528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808369|NCT00424528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101808370|NCT00424528|Respiratory System Agents|respiratory system agents|mesh-ancestor
101808371|NCT00424528|Parasympatholytics|parasympatholytics|mesh-ancestor
101808372|NCT00424528|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101808373|NCT00424528|Cholinergic Agents|cholinergic agents|mesh-ancestor
101216015|NCT01478165|Antiemetics|antiemetics|mesh-ancestor
101808374|NCT00424528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101808375|NCT00424528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808376|NCT00424528|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101808377|NCT00424528|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101808378|NCT00424528|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101808379|NCT00424528|Adrenergic Agents|adrenergic agents|mesh-ancestor
101808380|NCT04974996|Prednisone|prednisone|mesh-list
101808381|NCT04974996|Cyclophosphamide|cyclophosphamide|mesh-list
101808382|NCT04974996|Rituximab|rituximab|mesh-list
101808383|NCT04974996|Doxorubicin|doxorubicin|mesh-list
101808384|NCT04974996|Vincristine|vincristine|mesh-list
101808385|NCT04974996|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
101808386|NCT04974996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101808387|NCT04974996|Immunologic Factors|immunologic factors|mesh-ancestor
101808388|NCT04974996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808389|NCT04974996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101808390|NCT04974996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101808391|NCT04974996|Alkylating Agents|alkylating agents|mesh-ancestor
101808392|NCT04974996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808393|NCT04974996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101808394|NCT04974996|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101808395|NCT04974996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101808396|NCT04974996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101808397|NCT04974996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101808398|NCT04974996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101808399|NCT04974996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101808400|NCT04974996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101808401|NCT04974996|Glucocorticoids|glucocorticoids|mesh-ancestor
101808402|NCT04974996|Hormones|hormones|mesh-ancestor
101808403|NCT04974996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101808404|NCT04974996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101808405|NCT04974996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101808406|NCT04974996|Tubulin Modulators|tubulin modulators|mesh-ancestor
101808407|NCT04974996|Antimitotic Agents|antimitotic agents|mesh-ancestor
101216135|NCT01478685|Carboplatin|carboplatin|mesh-list
101808408|NCT04974996|Mitosis Modulators|mitosis modulators|mesh-ancestor
101808409|NCT00981006|Mitogens|mitogens|mesh-list
101808410|NCT00981006|Mitosis Modulators|mitosis modulators|mesh-ancestor
101808411|NCT00981006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808412|NCT00975390|Caffeine|caffeine|mesh-list
101808413|NCT00975390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101808414|NCT00975390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808415|NCT00975390|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101808416|NCT00975390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101808417|NCT00975390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808418|NCT00975390|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101808419|NCT00975390|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101808420|NCT00975390|Purinergic Agents|purinergic agents|mesh-ancestor
101808421|NCT00975390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101808422|NCT00981318|Ritonavir|ritonavir|mesh-list
101808423|NCT00981318|Lopinavir|lopinavir|mesh-list
101808425|NCT00981318|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101808426|NCT00981318|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101808427|NCT00981318|Protease Inhibitors|protease inhibitors|mesh-ancestor
101808428|NCT00981318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101808429|NCT00981318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808430|NCT00981318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101808431|NCT00981318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101808432|NCT00981318|Antiviral Agents|antiviral agents|mesh-ancestor
101808433|NCT00981318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101808434|NCT00981318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101811505|NCT00482391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808435|NCT00981318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101808436|NCT00981318|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101808437|NCT00981318|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101808438|NCT00981318|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101808439|NCT00984984|Methylprednisolone|methylprednisolone|mesh-list
101808440|NCT00984984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101808441|NCT00984984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101808442|NCT00984984|Prednisolone|prednisolone|mesh-list
101808443|NCT00984984|Prednisolone acetate|prednisolone acetate|mesh-list
101808444|NCT00984984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101808445|NCT00984984|Prednisolone phosphate|prednisolone phosphate|mesh-list
101808446|NCT00984984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101808447|NCT00984984|Antiemetics|antiemetics|mesh-ancestor
101808448|NCT00984984|Autonomic Agents|autonomic agents|mesh-ancestor
101808449|NCT00984984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101808450|NCT00984984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808451|NCT00984984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101808452|NCT00984984|Glucocorticoids|glucocorticoids|mesh-ancestor
101808454|NCT00984984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101808455|NCT00984984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101808456|NCT00984984|Protective Agents|protective agents|mesh-ancestor
101808457|NCT00984984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101808458|NCT00984984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101808460|NCT00545532|Antiviral Agents|antiviral agents|mesh-ancestor
101808461|NCT00545532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101808462|NCT00545532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101808463|NCT00545532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808464|NCT00544440|Prednisone|prednisone|mesh-list
101808465|NCT00544440|Abiraterone Acetate|abiraterone acetate|mesh-list
101808466|NCT00544440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101808467|NCT00544440|Glucocorticoids|glucocorticoids|mesh-ancestor
101808468|NCT00544440|Hormones|hormones|mesh-ancestor
101808469|NCT00544440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101808470|NCT00544440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808471|NCT00544440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101808472|NCT00544440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101808473|NCT00544440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101808474|NCT00544440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101808475|NCT00544440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808476|NCT00544440|Hormone Antagonists|hormone antagonists|mesh-ancestor
101808477|NCT00544440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101808478|NCT00981708|Dexamethasone|dexamethasone|mesh-list
101808479|NCT00981708|Dexamethasone acetate|dexamethasone acetate|mesh-list
101808480|NCT00981708|Cyclophosphamide|cyclophosphamide|mesh-list
101808481|NCT00981708|Lenalidomide|lenalidomide|mesh-list
101808482|NCT00981708|BB 1101|bb 1101|mesh-list
101808483|NCT00981708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101808484|NCT00981708|Immunologic Factors|immunologic factors|mesh-ancestor
101808485|NCT00981708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808486|NCT00981708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101808487|NCT00981708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101808488|NCT00981708|Alkylating Agents|alkylating agents|mesh-ancestor
101808489|NCT00981708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216359|NCT01480141|Afatinib|afatinib|mesh-list
101808490|NCT00981708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101808491|NCT00981708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101808492|NCT00981708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101808493|NCT00981708|Antiemetics|antiemetics|mesh-ancestor
101808494|NCT00981708|Autonomic Agents|autonomic agents|mesh-ancestor
101808495|NCT00981708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101808496|NCT00981708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101808497|NCT00981708|Glucocorticoids|glucocorticoids|mesh-ancestor
101808498|NCT00981708|Hormones|hormones|mesh-ancestor
101808499|NCT00981708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101808500|NCT00981708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101808501|NCT00981708|Protease Inhibitors|protease inhibitors|mesh-ancestor
101808502|NCT00981708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101808503|NCT00981708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101808504|NCT00981708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101808505|NCT00981708|Growth Substances|growth substances|mesh-ancestor
101808506|NCT00981708|Growth Inhibitors|growth inhibitors|mesh-ancestor
101808508|NCT00981786|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101808510|NCT00981786|Brinzolamide|brinzolamide|mesh-list
101808511|NCT00981786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101216410|NCT01480687|Ciprofibrate|ciprofibrate|mesh-list
101808512|NCT00981786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101808513|NCT00981786|Adrenergic Agents|adrenergic agents|mesh-ancestor
101808514|NCT00981786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101808515|NCT00981786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808516|NCT00981786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808517|NCT00981786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101808518|NCT00981786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101808519|NCT00981786|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101808520|NCT00981786|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101808521|NCT00981786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101808522|NCT00981786|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101808523|NCT00981786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101808524|NCT04007562|Hydroxychloroquine|hydroxychloroquine|mesh-list
101808525|NCT04007562|Antimalarials|antimalarials|mesh-ancestor
101808526|NCT04007562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101808527|NCT04007562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101808528|NCT04007562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101808529|NCT04007562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101808530|NCT04007562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808531|NCT04007562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101808533|NCT00985374|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101808534|NCT00985374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101808535|NCT00985374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101808536|NCT00985374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808537|NCT00985374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101808538|NCT00985374|Immunologic Factors|immunologic factors|mesh-ancestor
101216470|NCT01480791|Diuretics|diuretics|mesh-ancestor
101808539|NCT00985374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808540|NCT00985374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101808541|NCT00975936|Ketoconazole|ketoconazole|mesh-list
101808542|NCT00975936|Antifungal Agents|antifungal agents|mesh-ancestor
101808543|NCT00975936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101808544|NCT00975936|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101808545|NCT00975936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101808546|NCT00975936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101808547|NCT00975936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808548|NCT00975936|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101808549|NCT00975936|Hormone Antagonists|hormone antagonists|mesh-ancestor
101808550|NCT00975936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101808551|NCT00975936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808552|NCT00975936|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101808554|NCT00976092|Calcium heparin|calcium heparin|mesh-list
101808555|NCT00976092|Bivalirudin|bivalirudin|mesh-list
101808556|NCT00976092|Clopidogrel|clopidogrel|mesh-list
101808557|NCT00976092|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101808558|NCT00976092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101808559|NCT00976092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101808560|NCT00976092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101808561|NCT00976092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101808562|NCT00976092|Purinergic Agents|purinergic agents|mesh-ancestor
101808563|NCT00976092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101808564|NCT00976092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808565|NCT00976092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808566|NCT00976092|Anticoagulants|anticoagulants|mesh-ancestor
101808567|NCT00976092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101808568|NCT00976092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101808569|NCT00976092|Antithrombins|antithrombins|mesh-ancestor
101808570|NCT00976092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101808571|NCT00976092|Protease Inhibitors|protease inhibitors|mesh-ancestor
101808572|NCT00976092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101808573|NCT00985530|Arsenic Trioxide|arsenic trioxide|mesh-list
101808574|NCT00985530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101808576|NCT04006470|Tin Fluorides|tin fluorides|mesh-list
101808577|NCT04006470|Cariostatic Agents|cariostatic agents|mesh-ancestor
101808578|NCT04006470|Protective Agents|protective agents|mesh-ancestor
101808579|NCT04006470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808581|NCT01323712|Cholecalciferol|cholecalciferol|mesh-list
101808582|NCT01323712|Vitamins|vitamins|mesh-ancestor
101808583|NCT01323712|Micronutrients|micronutrients|mesh-ancestor
101808584|NCT01323712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808585|NCT01323712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101808586|NCT01323712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101808587|NCT00981942|Imatinib Mesylate|imatinib mesylate|mesh-list
101808588|NCT00981942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101808589|NCT00981942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101808590|NCT00981942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101808591|NCT00981942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808592|NCT03927144|Erenumab|erenumab|mesh-list
101808593|NCT03927144|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
101808594|NCT03927144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808595|NCT03927144|Analgesics|analgesics|mesh-ancestor
101808596|NCT03927144|Sensory System Agents|sensory system agents|mesh-ancestor
101808597|NCT03927144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101808598|NCT03927144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808599|NCT00976170|Sorafenib|sorafenib|mesh-list
101808600|NCT00976170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101808601|NCT00976170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101808602|NCT00976170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101808603|NCT00976170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808604|NCT00982254|Insulin|insulin|mesh-list
101808605|NCT00982254|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101808606|NCT00982254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101808607|NCT00982254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808608|NCT00985608|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101808609|NCT00985608|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101808610|NCT00985608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101808611|NCT00985608|Antitubercular Agents|antitubercular agents|mesh-ancestor
101808612|NCT00976326|Insulin|insulin|mesh-list
101808613|NCT00976326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101808614|NCT00976326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808615|NCT00982332|Betamethasone|betamethasone|mesh-list
101808616|NCT00982332|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
101808617|NCT00982332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101808618|NCT00982332|Glucocorticoids|glucocorticoids|mesh-ancestor
101808620|NCT00982332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101808621|NCT00982332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808622|NCT00982332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101808623|NCT00982332|Respiratory System Agents|respiratory system agents|mesh-ancestor
101808624|NCT04007328|Methylprednisolone|methylprednisolone|mesh-list
101808625|NCT04007328|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101808626|NCT04007328|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101808627|NCT04007328|Prednisolone|prednisolone|mesh-list
101808628|NCT04007328|Prednisolone acetate|prednisolone acetate|mesh-list
101808629|NCT04007328|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101808630|NCT04007328|Prednisolone phosphate|prednisolone phosphate|mesh-list
101808631|NCT04007328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101808632|NCT04007328|Antiemetics|antiemetics|mesh-ancestor
101808633|NCT04007328|Autonomic Agents|autonomic agents|mesh-ancestor
101808634|NCT04007328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101808635|NCT04007328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808636|NCT04007328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101808637|NCT04007328|Glucocorticoids|glucocorticoids|mesh-ancestor
101808639|NCT04007328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101808640|NCT04007328|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101808641|NCT04007328|Protective Agents|protective agents|mesh-ancestor
101808642|NCT04007328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101216744|NCT01482338|Hormones|hormones|mesh-ancestor
101808643|NCT04007328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101808644|NCT00985920|Tranexamic Acid|tranexamic acid|mesh-list
101808645|NCT00985920|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101808646|NCT00985920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101808647|NCT00985920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808648|NCT00985920|Hemostatics|hemostatics|mesh-ancestor
101808649|NCT00985920|Coagulants|coagulants|mesh-ancestor
101808650|NCT00976794|Carbamazepine|carbamazepine|mesh-list
101808651|NCT00976794|Valproic Acid|valproic acid|mesh-list
101808652|NCT00976794|Lithium Carbonate|lithium carbonate|mesh-list
101808653|NCT00976794|Antidepressive Agents|antidepressive agents|mesh-ancestor
101808654|NCT00976794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101808655|NCT00976794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101808656|NCT00976794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808657|NCT00976794|Antimanic Agents|antimanic agents|mesh-ancestor
101808658|NCT00976794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101808659|NCT00976794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101808660|NCT00976794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808661|NCT00976794|Anticonvulsants|anticonvulsants|mesh-ancestor
101808662|NCT00976794|GABA Agents|gaba agents|mesh-ancestor
101808663|NCT00976794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101808664|NCT00976794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101808665|NCT00976794|Analgesics|analgesics|mesh-ancestor
101808666|NCT00976794|Sensory System Agents|sensory system agents|mesh-ancestor
101808667|NCT00976794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101808668|NCT00976794|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101808669|NCT00976794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101808670|NCT00976794|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101808671|NCT00976794|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101808672|NCT00985998|Nimotuzumab|nimotuzumab|mesh-list
101808673|NCT00985998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101808674|NCT00985998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101808676|NCT04008186|Repaglinide|repaglinide|mesh-list
101808677|NCT04008186|Itraconazole|itraconazole|mesh-list
101808678|NCT04008186|Digoxin|digoxin|mesh-list
101808679|NCT04008186|Verapamil|verapamil|mesh-list
101808680|NCT04008186|Midazolam|midazolam|mesh-list
101808681|NCT04008186|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101808682|NCT04008186|Gemfibrozil|gemfibrozil|mesh-list
101808683|NCT04008186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101808684|NCT04008186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808685|NCT04008186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101808686|NCT04008186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101808687|NCT04008186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101808688|NCT04008186|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101808689|NCT04008186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101808690|NCT04008186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101808691|NCT04008186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101808692|NCT04008186|Anesthetics, General|anesthetics, general|mesh-ancestor
101808693|NCT04008186|Anesthetics|anesthetics|mesh-ancestor
101808694|NCT04008186|GABA Modulators|gaba modulators|mesh-ancestor
101808695|NCT04008186|GABA Agents|gaba agents|mesh-ancestor
101808696|NCT04008186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101808697|NCT04008186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808698|NCT04008186|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101808699|NCT04008186|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101808700|NCT04008186|Antimetabolites|antimetabolites|mesh-ancestor
101808701|NCT04008186|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101808702|NCT04008186|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101808703|NCT04008186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101808704|NCT04008186|Antifungal Agents|antifungal agents|mesh-ancestor
101808705|NCT04008186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101808706|NCT04008186|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101808707|NCT04008186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101808708|NCT04008186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101808709|NCT04008186|Hormone Antagonists|hormone antagonists|mesh-ancestor
101808710|NCT04008186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101808711|NCT04008186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101808712|NCT04008186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101808713|NCT04008186|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101808714|NCT04008186|Protective Agents|protective agents|mesh-ancestor
101808715|NCT04008186|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101808716|NCT04008186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101808717|NCT04008186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101808718|NCT04008186|Vasodilator Agents|vasodilator agents|mesh-ancestor
101808719|NCT04008186|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101466039|NCT00270036|Epoetin Alfa|epoetin alfa|mesh-list
101466076|NCT00238004|Niacin|niacin|mesh-list
101808720|NCT00982566|Navitoclax|navitoclax|mesh-list
101808721|NCT00982566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101808722|NCT00977028|Lidocaine|lidocaine|mesh-list
101808723|NCT00977028|Epinephrine|epinephrine|mesh-list
101808724|NCT00977028|Racepinephrine|racepinephrine|mesh-list
101808725|NCT00977028|Anesthetics|anesthetics|mesh-list
101808726|NCT00977028|Epinephryl borate|epinephryl borate|mesh-list
101808727|NCT00977028|Anesthetics, Local|anesthetics, local|mesh-ancestor
101808728|NCT00977028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101808729|NCT00977028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808730|NCT00977028|Sensory System Agents|sensory system agents|mesh-ancestor
101808731|NCT00977028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101808732|NCT00977028|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101808733|NCT00977028|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101808734|NCT00977028|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101808735|NCT00977028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101808736|NCT00977028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808737|NCT00977028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101808738|NCT00977028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101808739|NCT00977028|Adrenergic Agents|adrenergic agents|mesh-ancestor
101808740|NCT00977028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101808741|NCT00977028|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101808742|NCT00977028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101808743|NCT00977028|Autonomic Agents|autonomic agents|mesh-ancestor
101808744|NCT00977028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101216802|NCT01482897|Methylprednisolone|methylprednisolone|mesh-list
101808745|NCT00977028|Respiratory System Agents|respiratory system agents|mesh-ancestor
101808746|NCT00977028|Mydriatics|mydriatics|mesh-ancestor
101808747|NCT00977028|Sympathomimetics|sympathomimetics|mesh-ancestor
101808748|NCT00977028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101808749|NCT00982722|Calcium, Dietary|calcium, dietary|mesh-list
101808750|NCT00982722|Cholecalciferol|cholecalciferol|mesh-list
101808751|NCT00982722|Vitamin D|vitamin d|mesh-list
101808752|NCT00982722|Calcium Carbonate|calcium carbonate|mesh-list
101808753|NCT00982722|Calcium|calcium|mesh-list
101808754|NCT00982722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101808755|NCT00982722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808756|NCT00982722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101808758|NCT00982722|Micronutrients|micronutrients|mesh-ancestor
101808759|NCT00982722|Antacids|antacids|mesh-ancestor
101808760|NCT00982722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808761|NCT00982722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101808762|NCT00982800|Gabapentin|gabapentin|mesh-list
101808763|NCT00982800|Analgesics|analgesics|mesh-ancestor
101808764|NCT00982800|Sensory System Agents|sensory system agents|mesh-ancestor
101808765|NCT00982800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101808766|NCT00982800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808767|NCT00982800|Anticonvulsants|anticonvulsants|mesh-ancestor
101808768|NCT00982800|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101808769|NCT00982800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101808770|NCT00982800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101808771|NCT00982800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101808772|NCT00982800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101808773|NCT00982800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101808774|NCT00982800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101808775|NCT00982800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808776|NCT00982800|Antimanic Agents|antimanic agents|mesh-ancestor
101808777|NCT00986076|Enoxaparin|enoxaparin|mesh-list
101808778|NCT00986076|Anticoagulants|anticoagulants|mesh-ancestor
101808779|NCT00986076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101808780|NCT00986076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101808781|NCT00986076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808782|NCT00984828|Bortezomib|bortezomib|mesh-list
101808783|NCT00984828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101808784|NCT00983034|Amoxicillin|amoxicillin|mesh-list
101808785|NCT00983034|Clarithromycin|clarithromycin|mesh-list
101808786|NCT00983034|Lansoprazole|lansoprazole|mesh-list
101808787|NCT00983034|Dexlansoprazole|dexlansoprazole|mesh-list
101808788|NCT00983034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101808789|NCT00983034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101808790|NCT00983034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101808791|NCT00983034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101808792|NCT00983034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808793|NCT00983034|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101808794|NCT00983034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101808795|NCT00983034|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101466123|NCT04536961|Famotidine|famotidine|mesh-list
101808796|NCT00983034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101808797|NCT00983034|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101808798|NCT00983112|Thrombin|thrombin|mesh-list
101808799|NCT00983112|Hemostatics|hemostatics|mesh-ancestor
101808800|NCT00983112|Coagulants|coagulants|mesh-ancestor
101808801|NCT00986466|Vitamin D|vitamin d|mesh-list
101808802|NCT00986466|Ergocalciferols|ergocalciferols|mesh-list
101808803|NCT00986466|Cholecalciferol|cholecalciferol|mesh-list
101808804|NCT00986466|Vitamins|vitamins|mesh-list
101808805|NCT00986466|Micronutrients|micronutrients|mesh-ancestor
101808806|NCT00986466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808807|NCT00986466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101808808|NCT00986466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101808809|NCT00545298|Nitric Oxide|nitric oxide|mesh-list
101808810|NCT00545298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101808811|NCT00545298|Autonomic Agents|autonomic agents|mesh-ancestor
101808812|NCT00545298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101808813|NCT00545298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808815|NCT00545298|Respiratory System Agents|respiratory system agents|mesh-ancestor
101808816|NCT00545298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101808817|NCT00545298|Antioxidants|antioxidants|mesh-ancestor
101808818|NCT00545298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808819|NCT00545298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101808820|NCT00545298|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101808821|NCT00545298|Vasodilator Agents|vasodilator agents|mesh-ancestor
101808822|NCT00545298|Gasotransmitters|gasotransmitters|mesh-ancestor
101808823|NCT00545298|Protective Agents|protective agents|mesh-ancestor
101808824|NCT00983268|Capecitabine|capecitabine|mesh-list
101808825|NCT00983268|Vorinostat|vorinostat|mesh-list
101808826|NCT00983268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101808828|NCT00983268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808829|NCT00983268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101808830|NCT00983268|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101808831|NCT00983268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101808833|NCT00977964|Chelating Agents|chelating agents|mesh-ancestor
101808834|NCT00977964|Sequestering Agents|sequestering agents|mesh-ancestor
101808835|NCT00977964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808836|NCT00983424|Cyclosporine|cyclosporine|mesh-list
101808837|NCT00983424|Paclitaxel|paclitaxel|mesh-list
101808838|NCT00983424|Cyclosporins|cyclosporins|mesh-list
101808839|NCT00983424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101808840|NCT00983424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101808841|NCT00983424|Tubulin Modulators|tubulin modulators|mesh-ancestor
101808842|NCT00983424|Antimitotic Agents|antimitotic agents|mesh-ancestor
101808843|NCT00983424|Mitosis Modulators|mitosis modulators|mesh-ancestor
101808844|NCT00983424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808845|NCT00983424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101808846|NCT00983424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101808847|NCT00983424|Immunologic Factors|immunologic factors|mesh-ancestor
101808848|NCT00983424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808849|NCT00983424|Antifungal Agents|antifungal agents|mesh-ancestor
101808850|NCT00983424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101808851|NCT00983424|Dermatologic Agents|dermatologic agents|mesh-ancestor
101808852|NCT00983424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101808853|NCT00983424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101808854|NCT00983736|Tramadol|tramadol|mesh-list
101808855|NCT00983736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101808856|NCT00983736|Narcotics|narcotics|mesh-ancestor
101808857|NCT00983736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101808858|NCT00983736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808859|NCT00983736|Analgesics|analgesics|mesh-ancestor
101808860|NCT00983736|Sensory System Agents|sensory system agents|mesh-ancestor
101808861|NCT00983736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101808862|NCT00986778|Lamivudine|lamivudine|mesh-list
101808863|NCT00986778|Adefovir|adefovir|mesh-list
101808864|NCT00986778|Entecavir|entecavir|mesh-list
101808865|NCT00986778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101808866|NCT00986778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101808867|NCT00986778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101808868|NCT00986778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808869|NCT00986778|Antiviral Agents|antiviral agents|mesh-ancestor
101808870|NCT00986778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101808871|NCT00986778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101808872|NCT00986778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101808873|NCT00429364|Losartan|losartan|mesh-list
101808874|NCT00429364|Atenolol|atenolol|mesh-list
101466187|NCT00262587|Sympathomimetics|sympathomimetics|mesh-ancestor
101808875|NCT00429364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101808876|NCT00429364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101808877|NCT00429364|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101808878|NCT00429364|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101808879|NCT00429364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808880|NCT00429364|Sympatholytics|sympatholytics|mesh-ancestor
101808881|NCT00429364|Autonomic Agents|autonomic agents|mesh-ancestor
101808882|NCT00429364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101808883|NCT00429364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808884|NCT00429364|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101808885|NCT00429364|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101808886|NCT00429364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101808887|NCT00429364|Adrenergic Agents|adrenergic agents|mesh-ancestor
101808888|NCT00429364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101808889|NCT00978354|Furosemide|furosemide|mesh-list
101808890|NCT00978354|Diuretics|diuretics|mesh-ancestor
101808891|NCT00978354|Natriuretic Agents|natriuretic agents|mesh-ancestor
101808892|NCT00978354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808893|NCT00978354|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101808894|NCT00978354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101808895|NCT00978354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808896|NCT00984360|Naltrexone|naltrexone|mesh-list
101808897|NCT00984360|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101808898|NCT00984360|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101808899|NCT00984360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808900|NCT00984360|Sensory System Agents|sensory system agents|mesh-ancestor
101808901|NCT00984360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101808902|NCT00414388|Sorafenib|sorafenib|mesh-list
101808903|NCT00414388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101808904|NCT00414388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101808905|NCT00414388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101808906|NCT00414388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808907|NCT00978588|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
101808908|NCT00978588|Plasma Substitutes|plasma substitutes|mesh-ancestor
101808909|NCT00978588|Blood Substitutes|blood substitutes|mesh-ancestor
101808910|NCT01037608|Nabiximols|nabiximols|mesh-list
101808911|NCT01037608|Analgesics|analgesics|mesh-ancestor
101808912|NCT01037608|Sensory System Agents|sensory system agents|mesh-ancestor
101808913|NCT01037608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101808914|NCT01037608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808915|NCT04006080|Vedolizumab|vedolizumab|mesh-list
101808916|NCT04006080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101808917|NCT00984438|Bevacizumab|bevacizumab|mesh-list
101808918|NCT00984438|Irinotecan|irinotecan|mesh-list
101808919|NCT00984438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101808920|NCT00984438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101808921|NCT00984438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101808922|NCT00984438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101808923|NCT00984438|Growth Substances|growth substances|mesh-ancestor
101808924|NCT00984438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808925|NCT00984438|Growth Inhibitors|growth inhibitors|mesh-ancestor
101808926|NCT00984438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101808927|NCT00984438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101808928|NCT00984438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101808929|NCT00984438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808930|NCT00424372|Pregabalin|pregabalin|mesh-list
101808931|NCT00424372|Analgesics|analgesics|mesh-ancestor
101808932|NCT00424372|Sensory System Agents|sensory system agents|mesh-ancestor
101808933|NCT00424372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101808934|NCT00424372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808935|NCT00424372|Anticonvulsants|anticonvulsants|mesh-ancestor
101808936|NCT00424372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101808937|NCT00424372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101808938|NCT00424372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808939|NCT00424372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101808940|NCT00424372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101808941|NCT00424372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101808942|NCT00424372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101808943|NCT00424372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101808944|NCT00987168|Octreotide|octreotide|mesh-list
101808945|NCT00987168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101808946|NCT00987168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101808947|NCT00987168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101808948|NCT00978978|Fentanyl|fentanyl|mesh-list
101808949|NCT00978978|Midazolam|midazolam|mesh-list
101808950|NCT00978978|Propofol|propofol|mesh-list
101808951|NCT00978978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101808952|NCT00978978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101808953|NCT00978978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808954|NCT00978978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101808955|NCT00978978|Anesthetics, General|anesthetics, general|mesh-ancestor
101808956|NCT00978978|Anesthetics|anesthetics|mesh-ancestor
101808957|NCT00978978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101808958|NCT00978978|Narcotics|narcotics|mesh-ancestor
101808959|NCT00978978|Analgesics|analgesics|mesh-ancestor
101808960|NCT00978978|Sensory System Agents|sensory system agents|mesh-ancestor
101808961|NCT00978978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101808962|NCT00978978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101808963|NCT00978978|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101808964|NCT00978978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101808965|NCT00978978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101808966|NCT00978978|GABA Modulators|gaba modulators|mesh-ancestor
101808967|NCT00978978|GABA Agents|gaba agents|mesh-ancestor
101808968|NCT00978978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101808969|NCT00978978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808971|NCT00414310|Valproic Acid|valproic acid|mesh-list
101808972|NCT00414310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101808973|NCT00414310|Antimetabolites|antimetabolites|mesh-ancestor
101808974|NCT00414310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101808975|NCT00414310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101808976|NCT00414310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101808977|NCT00414310|Anticonvulsants|anticonvulsants|mesh-ancestor
101808978|NCT00414310|GABA Agents|gaba agents|mesh-ancestor
101808979|NCT00414310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101808980|NCT00414310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808981|NCT00414310|Antimanic Agents|antimanic agents|mesh-ancestor
101808982|NCT00414310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101808983|NCT00414310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101808984|NCT00414310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101808985|NCT00542880|Fluticasone|fluticasone|mesh-list
101808986|NCT00542880|Budesonide|budesonide|mesh-list
101808987|NCT00542880|Formoterol Fumarate|formoterol fumarate|mesh-list
101808988|NCT00542880|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101808989|NCT00542880|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101808990|NCT00542880|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101808991|NCT00542880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101808992|NCT00542880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101808993|NCT00542880|Autonomic Agents|autonomic agents|mesh-ancestor
101808994|NCT00542880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101808995|NCT00542880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101808996|NCT00542880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101808997|NCT00542880|Respiratory System Agents|respiratory system agents|mesh-ancestor
101808998|NCT00542880|Dermatologic Agents|dermatologic agents|mesh-ancestor
101808999|NCT00542880|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101809000|NCT00542880|Glucocorticoids|glucocorticoids|mesh-ancestor
101809001|NCT00542880|Hormones|hormones|mesh-ancestor
101809002|NCT00542880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101809003|NCT00542880|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101809004|NCT00542880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101809005|NCT00542880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101809006|NCT00542880|Adrenergic Agents|adrenergic agents|mesh-ancestor
101809007|NCT00542880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101809008|NCT00542880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809009|NCT00542880|Sympathomimetics|sympathomimetics|mesh-ancestor
101809010|NCT00414076|Letrozole|letrozole|mesh-list
101809011|NCT00414076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101217183|NCT01485744|Irinotecan|irinotecan|mesh-list
101809012|NCT00414076|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101809013|NCT00414076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101809014|NCT00414076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101809015|NCT00414076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809016|NCT00414076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101809017|NCT00414076|Hormone Antagonists|hormone antagonists|mesh-ancestor
101809018|NCT00414076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101809019|NCT00414076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809020|NCT01033318|Losartan|losartan|mesh-list
101809021|NCT01033318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101809022|NCT01033318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101466343|NCT00262977|Aspirin|aspirin|mesh-list
101809023|NCT01033318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101809024|NCT01033318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101809025|NCT01033318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809026|NCT01033396|Fexofenadine|fexofenadine|mesh-list
101809027|NCT01033396|Terfenadine|terfenadine|mesh-list
101809028|NCT01033396|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101809029|NCT01033396|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101809030|NCT01033396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101809031|NCT01033396|Histamine Antagonists|histamine antagonists|mesh-ancestor
101809032|NCT01033396|Histamine Agents|histamine agents|mesh-ancestor
101809033|NCT01033396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101809034|NCT01033396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809035|NCT01033396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809036|NCT00979056|Rifaximin|rifaximin|mesh-list
101809037|NCT00979056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101809038|NCT00979056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101809039|NCT00979056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101809040|NCT00092677|Simvastatin|simvastatin|mesh-list
101809041|NCT00092677|Ezetimibe|ezetimibe|mesh-list
101809042|NCT00092677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101809043|NCT00092677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101809044|NCT00092677|Antimetabolites|antimetabolites|mesh-ancestor
101809045|NCT00092677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809046|NCT00092677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101809047|NCT00092677|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101809048|NCT00092677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101809049|NCT00542178|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101809050|NCT00542178|Simvastatin|simvastatin|mesh-list
101809051|NCT00542178|Fenofibrate|fenofibrate|mesh-list
101809052|NCT00542178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101809053|NCT00542178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101809054|NCT00542178|Antimetabolites|antimetabolites|mesh-ancestor
101809055|NCT00542178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809056|NCT00542178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101809057|NCT00542178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101809058|NCT00542178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101809059|NCT00542178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809060|NCT00987636|Zoledronic Acid|zoledronic acid|mesh-list
101809061|NCT00987636|Diphosphonates|diphosphonates|mesh-list
101809063|NCT00987636|Treosulfan|treosulfan|mesh-list
101809064|NCT00987636|Alkylating Agents|alkylating agents|mesh-ancestor
101809065|NCT00987636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809066|NCT00987636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101809067|NCT00987636|Immunologic Factors|immunologic factors|mesh-ancestor
101809068|NCT00987636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809069|NCT00987636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101809070|NCT00987636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101809071|NCT00987636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101809072|NCT00987636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101809073|NCT00424294|Celecoxib|celecoxib|mesh-list
101809074|NCT00424294|Methotrexate|methotrexate|mesh-list
101809075|NCT00424294|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101809076|NCT00424294|Abortifacient Agents|abortifacient agents|mesh-ancestor
101809077|NCT00424294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101809078|NCT00424294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809079|NCT00424294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101809080|NCT00424294|Antimetabolites|antimetabolites|mesh-ancestor
101809081|NCT00424294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809082|NCT00424294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101809083|NCT00424294|Dermatologic Agents|dermatologic agents|mesh-ancestor
101809084|NCT00424294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101809085|NCT00424294|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101809086|NCT00424294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101809087|NCT00424294|Immunologic Factors|immunologic factors|mesh-ancestor
101809088|NCT00424294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101809089|NCT00424294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101809090|NCT00424294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101809091|NCT00424294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101809092|NCT00424294|Analgesics|analgesics|mesh-ancestor
101809093|NCT00424294|Sensory System Agents|sensory system agents|mesh-ancestor
101466419|NCT04534231|Nicotine|nicotine|mesh-list
101809094|NCT00424294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101809095|NCT00424294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101809097|NCT00424294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101809098|NCT00988728|Olanzapine|olanzapine|mesh-list
101809099|NCT00988728|Antiemetics|antiemetics|mesh-ancestor
101809100|NCT00988728|Autonomic Agents|autonomic agents|mesh-ancestor
101809101|NCT00988728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101809102|NCT00988728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809103|NCT00988728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101809104|NCT00988728|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101809105|NCT00988728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101311683|NCT00006786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101809106|NCT00988728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101809107|NCT00988728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101809108|NCT00988728|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101809109|NCT00988728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101809110|NCT00988728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101809111|NCT00988728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809112|NCT00988728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101809113|NCT00988728|Serotonin Agents|serotonin agents|mesh-ancestor
101809114|NCT00988806|Simendan|simendan|mesh-list
101809115|NCT00988806|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101809116|NCT00988806|Vasodilator Agents|vasodilator agents|mesh-ancestor
101809117|NCT00988806|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101809118|NCT00988806|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101809119|NCT00988806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101809120|NCT00988806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809121|NCT00988806|Protective Agents|protective agents|mesh-ancestor
101809122|NCT00988806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809123|NCT04005768|Hydroxychloroquine|hydroxychloroquine|mesh-list
101809124|NCT04005768|Antimalarials|antimalarials|mesh-ancestor
101809125|NCT04005768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101809126|NCT04005768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101809127|NCT04005768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101809128|NCT04005768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101809129|NCT04005768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809130|NCT04005768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101809131|NCT00987792|Moxifloxacin|moxifloxacin|mesh-list
101809132|NCT00987792|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101809133|NCT00987792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101809134|NCT00987792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101809135|NCT00987792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101809136|NCT00987792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101809137|NCT00987792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101809138|NCT00987792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809139|NCT00987792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101809140|NCT00987792|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101809141|NCT00987792|Contraceptive Agents|contraceptive agents|mesh-ancestor
101809142|NCT00987792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101809143|NCT00987792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809144|NCT00987792|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101809145|NCT00987792|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101809146|NCT00987792|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101809147|NCT00987870|Betamethasone|betamethasone|mesh-list
101809148|NCT00987870|Calcipotriene|calcipotriene|mesh-list
101809149|NCT00987870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101809150|NCT00987870|Glucocorticoids|glucocorticoids|mesh-ancestor
101809151|NCT00987870|Hormones|hormones|mesh-ancestor
101809152|NCT00987870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101809153|NCT00987870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809154|NCT00987870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101809155|NCT00987870|Respiratory System Agents|respiratory system agents|mesh-ancestor
101809156|NCT00987870|Dermatologic Agents|dermatologic agents|mesh-ancestor
101809157|NCT00988026|Minocycline|minocycline|mesh-list
101809158|NCT00988026|Lymecycline|lymecycline|mesh-list
101809159|NCT00988026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101809160|NCT00988026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101809161|NCT05578170|Pembrolizumab|pembrolizumab|mesh-list
101809162|NCT05578170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101809163|NCT05578170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101809164|NCT05578170|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101809165|NCT05578170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809166|NCT00989274|Vaccines|vaccines|mesh-list
101809167|NCT00989274|Immunologic Factors|immunologic factors|mesh-ancestor
101466488|NCT00238940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101809168|NCT00989274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809169|NCT03310944|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
101809170|NCT03310944|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101809171|NCT03310944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809172|NCT03310944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101809173|NCT03310944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809174|NCT05712642|Bevacizumab|bevacizumab|mesh-list
101809175|NCT05712642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101809176|NCT05712642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101809177|NCT05712642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101217612|NCT01488266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101809178|NCT05712642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101809179|NCT05712642|Growth Substances|growth substances|mesh-ancestor
101809180|NCT05712642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809181|NCT05712642|Growth Inhibitors|growth inhibitors|mesh-ancestor
101809182|NCT05492682|Cyclophosphamide|cyclophosphamide|mesh-list
101809183|NCT05492682|Pembrolizumab|pembrolizumab|mesh-list
101809184|NCT05492682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101809185|NCT05492682|Immunologic Factors|immunologic factors|mesh-ancestor
101809186|NCT05492682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809187|NCT05492682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101809188|NCT05492682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101809189|NCT05492682|Alkylating Agents|alkylating agents|mesh-ancestor
101809190|NCT05492682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809191|NCT05492682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101809192|NCT05492682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101809193|NCT05492682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101809194|NCT05492682|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101217685|NCT01488656|Vitamin D|vitamin d|mesh-list
101809195|NCT01085149|Simvastatin|simvastatin|mesh-list
101811635|NCT00754403|Metformin|metformin|mesh-list
101809196|NCT01085149|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101809197|NCT01085149|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101809198|NCT01085149|Antimetabolites|antimetabolites|mesh-ancestor
101809199|NCT01085149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809200|NCT01085149|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101809201|NCT01085149|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101809202|NCT01085149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101809203|NCT04005612|Vitamin D|vitamin d|mesh-list
101809204|NCT04005612|Ergocalciferols|ergocalciferols|mesh-list
101809205|NCT04005612|Cholecalciferol|cholecalciferol|mesh-list
101809206|NCT04005612|Vitamins|vitamins|mesh-list
101809207|NCT04005612|Micronutrients|micronutrients|mesh-ancestor
101809208|NCT04005612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809209|NCT04005612|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101809210|NCT04005612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101809212|NCT00413920|Prednisone|prednisone|mesh-list
101809213|NCT00413920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101809214|NCT00413920|Glucocorticoids|glucocorticoids|mesh-ancestor
101809215|NCT00413920|Hormones|hormones|mesh-ancestor
101809216|NCT00413920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101809217|NCT00413920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809218|NCT00413920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101809219|NCT00413920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101809220|NCT00413920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101809221|NCT00413920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101809222|NCT00413920|Antitubercular Agents|antitubercular agents|mesh-ancestor
101809223|NCT00413920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101809224|NCT00413920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101809225|NCT00413920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101809226|NCT00413920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809228|NCT00091819|Telavancin|telavancin|mesh-list
101809229|NCT00091819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101809230|NCT00091819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101809231|NCT01326871|Gemcitabine|gemcitabine|mesh-list
101809232|NCT01326871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101809233|NCT01326871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101809234|NCT01326871|Antimetabolites|antimetabolites|mesh-ancestor
101809235|NCT01326871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809236|NCT01081561|Riboflavin|riboflavin|mesh-list
101809237|NCT01081561|Vitamin B Complex|vitamin b complex|mesh-ancestor
101809238|NCT01081561|Vitamins|vitamins|mesh-ancestor
101809239|NCT01081561|Micronutrients|micronutrients|mesh-ancestor
101466561|NCT05897372|Pentoxifylline|pentoxifylline|mesh-list
101809240|NCT01081561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809241|NCT01081561|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101809242|NCT01081561|Dermatologic Agents|dermatologic agents|mesh-ancestor
101809244|NCT04004754|Antifungal Agents|antifungal agents|mesh-ancestor
101809245|NCT04004754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101217847|NCT01489592|Antioxidants|antioxidants|mesh-ancestor
101809246|NCT04004754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101809247|NCT04004754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101809248|NCT04004754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101809249|NCT05919797|Naltrexone|naltrexone|mesh-list
101809250|NCT05919797|Bupropion|bupropion|mesh-list
101809251|NCT05919797|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101809252|NCT05919797|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101809253|NCT05919797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809254|NCT05919797|Sensory System Agents|sensory system agents|mesh-ancestor
101809255|NCT05919797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101809256|NCT05919797|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101809257|NCT05919797|Antidepressive Agents|antidepressive agents|mesh-ancestor
101217915|NCT01489852|Estradiol|estradiol|mesh-list
101809258|NCT05919797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101809259|NCT05919797|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101809260|NCT05919797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101809261|NCT05919797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101809262|NCT05919797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809263|NCT05919797|Dopamine Agents|dopamine agents|mesh-ancestor
101809264|NCT05919797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101809265|NCT05919797|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101809266|NCT05919797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101809267|NCT05919797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101809268|NCT05919732|Epinephrine|epinephrine|mesh-list
101809269|NCT05919732|Bupivacaine|bupivacaine|mesh-list
101809270|NCT05919732|Anesthetics, Local|anesthetics, local|mesh-ancestor
101809271|NCT05919732|Anesthetics|anesthetics|mesh-ancestor
101809272|NCT05919732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101809273|NCT05919732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809274|NCT05919732|Sensory System Agents|sensory system agents|mesh-ancestor
101809275|NCT05919732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101809276|NCT05919732|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101809277|NCT05919732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101809278|NCT05919732|Adrenergic Agents|adrenergic agents|mesh-ancestor
101809279|NCT05919732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101809280|NCT05919732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809281|NCT05919732|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101809282|NCT05919732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101809283|NCT05919732|Autonomic Agents|autonomic agents|mesh-ancestor
101809284|NCT05919732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101809285|NCT05919732|Respiratory System Agents|respiratory system agents|mesh-ancestor
101809286|NCT05919732|Mydriatics|mydriatics|mesh-ancestor
101809287|NCT05919732|Sympathomimetics|sympathomimetics|mesh-ancestor
101809288|NCT05919732|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101809289|NCT05919615|Tranexamic Acid|tranexamic acid|mesh-list
101809290|NCT05919615|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101809291|NCT05919615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101809292|NCT05919615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809293|NCT05919615|Hemostatics|hemostatics|mesh-ancestor
101809294|NCT05919615|Coagulants|coagulants|mesh-ancestor
101809296|NCT05919550|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101809297|NCT05919550|Serotonin Agents|serotonin agents|mesh-ancestor
101809298|NCT05919550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101809299|NCT05919550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809300|NCT05919550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809301|NCT05919550|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101809302|NCT05919550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101809303|NCT05919550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101809304|NCT05919550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101809305|NCT05919550|GABA Antagonists|gaba antagonists|mesh-ancestor
101809306|NCT05919550|GABA Agents|gaba agents|mesh-ancestor
101809308|NCT05919472|Vaccines|vaccines|mesh-list
101809309|NCT05919472|Immunologic Factors|immunologic factors|mesh-ancestor
101809310|NCT05919472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809311|NCT05919472|Trace Elements|trace elements|mesh-ancestor
101809312|NCT05919472|Micronutrients|micronutrients|mesh-ancestor
101809313|NCT05919407|Amifampridine|amifampridine|mesh-list
101809314|NCT05919407|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
101809315|NCT05919407|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101809316|NCT05919407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101809317|NCT05919407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809318|NCT05919407|Cholinergic Agents|cholinergic agents|mesh-ancestor
101809319|NCT05919407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101809320|NCT05919407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809321|NCT05919407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101809322|NCT05919407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101809323|NCT05919407|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101809324|NCT05919407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101809325|NCT05919277|Antibodies|antibodies|mesh-list
101809326|NCT05919277|Immunoglobulins|immunoglobulins|mesh-list
101809327|NCT05919277|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101809328|NCT05919277|Immunoglobulin G|immunoglobulin g|mesh-list
101809329|NCT05919277|Immunologic Factors|immunologic factors|mesh-ancestor
101809330|NCT05919277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809331|NCT05919121|Hydrocortisone|hydrocortisone|mesh-list
101809332|NCT05919121|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101809333|NCT05919121|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101809334|NCT05919121|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101809335|NCT05919121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101809336|NCT05919017|Naltrexone|naltrexone|mesh-list
101809337|NCT05919017|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101809345|NCT05918861|Dalcetrapib|dalcetrapib|mesh-list
101809346|NCT05918861|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101809347|NCT05918861|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101809348|NCT05918861|Antimetabolites|antimetabolites|mesh-ancestor
101809349|NCT05918861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809350|NCT05918861|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101809360|NCT05918718|Methotrexate|methotrexate|mesh-list
101809361|NCT05918718|Letrozole|letrozole|mesh-list
101809362|NCT05918718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101809363|NCT05918718|Abortifacient Agents|abortifacient agents|mesh-ancestor
101809364|NCT05918718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101809365|NCT05918718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809366|NCT05918718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101809367|NCT05918718|Antimetabolites|antimetabolites|mesh-ancestor
101809368|NCT05918718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809369|NCT05918718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101809370|NCT05918718|Dermatologic Agents|dermatologic agents|mesh-ancestor
101809371|NCT05918718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101809372|NCT05918718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101809373|NCT05918718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101809374|NCT05918718|Immunologic Factors|immunologic factors|mesh-ancestor
101809375|NCT05918718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101809376|NCT05918718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101809377|NCT05918718|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101809378|NCT05918718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101809379|NCT05918718|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101809380|NCT05918718|Hormone Antagonists|hormone antagonists|mesh-ancestor
101809381|NCT05918718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101809382|NCT05918627|Belumosudil|belumosudil|mesh-list
101809383|NCT05918627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101809384|NCT05918627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101809385|NCT05918627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809386|NCT05918614|Belumosudil|belumosudil|mesh-list
101809387|NCT05918614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101809388|NCT05918614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101809389|NCT05918614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809390|NCT05918588|Belumosudil|belumosudil|mesh-list
101809391|NCT05918588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101809392|NCT05918588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101809393|NCT05918588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809394|NCT05918341|Piracetam|piracetam|mesh-list
101809395|NCT05918341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101809396|NCT05918341|Protective Agents|protective agents|mesh-ancestor
101809397|NCT05918341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809398|NCT05918341|Nootropic Agents|nootropic agents|mesh-ancestor
101809399|NCT05918328|Paclitaxel|paclitaxel|mesh-list
101809400|NCT05918328|Docetaxel|docetaxel|mesh-list
101809401|NCT05918328|Carboplatin|carboplatin|mesh-list
101809402|NCT05918328|Trastuzumab|trastuzumab|mesh-list
101809403|NCT05918328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101809404|NCT05918328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101809405|NCT05918328|Tubulin Modulators|tubulin modulators|mesh-ancestor
101809406|NCT05918328|Antimitotic Agents|antimitotic agents|mesh-ancestor
101809407|NCT05918328|Mitosis Modulators|mitosis modulators|mesh-ancestor
101809408|NCT05918328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809409|NCT05918328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101809410|NCT05918302|Everolimus|everolimus|mesh-list
101809411|NCT05918302|Edotreotide|edotreotide|mesh-list
101809412|NCT05918302|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
101809413|NCT05918302|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101809414|NCT05918302|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101809415|NCT05918302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101809416|NCT05918302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809417|NCT05918302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101809418|NCT05918302|Immunologic Factors|immunologic factors|mesh-ancestor
101809419|NCT05918302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809420|NCT05918302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101809421|NCT05918302|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101809423|NCT05918211|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101809424|NCT05918211|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101809425|NCT05918211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101809426|NCT05918211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809427|NCT05918198|Venetoclax|venetoclax|mesh-list
101218368|NCT01492205|Insulin|insulin|mesh-list
101809428|NCT05918198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101809429|NCT05918094|Fluorouracil|fluorouracil|mesh-list
101809430|NCT05918094|Antimetabolites|antimetabolites|mesh-ancestor
101809431|NCT05918094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809432|NCT05918094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101809433|NCT05918094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101809434|NCT05918094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101809435|NCT05918094|Immunologic Factors|immunologic factors|mesh-ancestor
101809436|NCT05918094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809437|NCT05918068|Vitamin B 6|vitamin b 6|mesh-list
101809438|NCT05918068|Pyridoxal|pyridoxal|mesh-list
101809439|NCT05918068|Pyridoxine|pyridoxine|mesh-list
101809440|NCT05918068|Metformin|metformin|mesh-list
101809441|NCT05918068|Vitamins|vitamins|mesh-ancestor
101809442|NCT05918068|Micronutrients|micronutrients|mesh-ancestor
101809443|NCT05918068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809444|NCT05918068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101809445|NCT05918068|Vitamin B Complex|vitamin b complex|mesh-ancestor
101809446|NCT05918029|Potassium Citrate|potassium citrate|mesh-list
101809447|NCT05918029|Diuretics|diuretics|mesh-ancestor
101809448|NCT05918029|Natriuretic Agents|natriuretic agents|mesh-ancestor
101809449|NCT05918029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809450|NCT05918029|Expectorants|expectorants|mesh-ancestor
101809451|NCT05918029|Respiratory System Agents|respiratory system agents|mesh-ancestor
101809452|NCT05917691|Anesthetics|anesthetics|mesh-list
101809453|NCT05917691|Anesthetics, General|anesthetics, general|mesh-list
101809454|NCT05917691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101809455|NCT05917691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809456|NCT05917587|Metformin|metformin|mesh-list
101218432|NCT01492881|Bortezomib|bortezomib|mesh-list
101809457|NCT05917587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101809458|NCT05917587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809459|NCT05917522|Abatacept|abatacept|mesh-list
101809460|NCT05917522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101809461|NCT05917522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809462|NCT05917522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101334053|NCT00017628|Glucocorticoids|glucocorticoids|mesh-ancestor
101809463|NCT05917522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101809464|NCT05917522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101809465|NCT05917522|Immunologic Factors|immunologic factors|mesh-ancestor
101809466|NCT05917522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809467|NCT05917522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101809469|NCT05914506|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101809470|NCT05914506|Anesthetics, General|anesthetics, general|mesh-ancestor
101809472|NCT05914506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101809473|NCT05914506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809475|NCT05913817|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101809476|NCT05913817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101809477|NCT05913817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101809478|NCT05912244|Nivolumab|nivolumab|mesh-list
101809479|NCT05912244|Relatlimab|relatlimab|mesh-list
101809480|NCT05912244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101809481|NCT05912244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101809482|NCT05912244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101809483|NCT05912244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809484|NCT05909683|Anti-Infective Agents|anti-infective agents|mesh-list
101809485|NCT05909683|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101809486|NCT05907993|Ibuprofen|ibuprofen|mesh-list
101809487|NCT05907993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101809488|NCT05907993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101809489|NCT05907993|Analgesics|analgesics|mesh-ancestor
101809490|NCT05907993|Sensory System Agents|sensory system agents|mesh-ancestor
101809491|NCT05907993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101809492|NCT05907993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809493|NCT05907993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101809494|NCT05907993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101809495|NCT05907993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101809496|NCT05907993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101809497|NCT05907993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809498|NCT05900427|Bupivacaine|bupivacaine|mesh-list
101809499|NCT05900427|Anesthetics, Local|anesthetics, local|mesh-ancestor
101809500|NCT05900427|Anesthetics|anesthetics|mesh-ancestor
101809501|NCT05900427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101809502|NCT05900427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809503|NCT05900427|Sensory System Agents|sensory system agents|mesh-ancestor
101809504|NCT05900427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101218731|NCT01494597|Cyclosporine|cyclosporine|mesh-list
101809505|NCT05888831|Nivolumab|nivolumab|mesh-list
101809506|NCT05888831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101809507|NCT05888831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101809508|NCT05888831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101809509|NCT05888831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809510|NCT05883241|Diclofenac|diclofenac|mesh-list
101809511|NCT05883241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101809512|NCT05883241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101809513|NCT05883241|Analgesics|analgesics|mesh-ancestor
101809514|NCT05883241|Sensory System Agents|sensory system agents|mesh-ancestor
101809515|NCT05883241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101809516|NCT05883241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809517|NCT05883241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101809518|NCT05883241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101809519|NCT05883241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101809520|NCT05883241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101809521|NCT05883241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809523|NCT05882812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101809524|NCT05882812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101809525|NCT05882812|Analgesics|analgesics|mesh-ancestor
101809526|NCT05882812|Sensory System Agents|sensory system agents|mesh-ancestor
101809527|NCT05882812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101809528|NCT05882812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809530|NCT05882812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101809531|NCT05882812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101809532|NCT05882812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101809533|NCT05882812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809534|NCT05879107|Vaccines|vaccines|mesh-list
101311774|NCT00006055|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101809535|NCT05879107|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101809537|NCT05879107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809538|NCT05874245|Midazolam|midazolam|mesh-list
101809539|NCT05874245|Dexmedetomidine|dexmedetomidine|mesh-list
101809540|NCT05874245|Ketamine|ketamine|mesh-list
101809541|NCT05874245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101809542|NCT05874245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101809543|NCT05874245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809544|NCT05874245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101809545|NCT05874245|Analgesics|analgesics|mesh-ancestor
101218923|NCT01495468|Hormones|hormones|mesh-list
101809546|NCT05874245|Sensory System Agents|sensory system agents|mesh-ancestor
101809547|NCT05874245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101809548|NCT05874245|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101809549|NCT05874245|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101809550|NCT05874245|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101809551|NCT05874245|Adrenergic Agents|adrenergic agents|mesh-ancestor
101809552|NCT05874245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101809553|NCT05874245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809554|NCT05874245|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101809555|NCT05874245|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101809556|NCT05874245|Anesthetics, General|anesthetics, general|mesh-ancestor
101809557|NCT05874245|Anesthetics|anesthetics|mesh-ancestor
101809558|NCT05874245|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101809559|NCT05874245|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101809560|NCT05874245|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101809561|NCT05874245|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101809562|NCT05874245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101809563|NCT05874245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101809564|NCT05874245|GABA Modulators|gaba modulators|mesh-ancestor
101809565|NCT05874245|GABA Agents|gaba agents|mesh-ancestor
101809566|NCT05824351|Propolis|propolis|mesh-list
101809567|NCT05824351|Pycnogenols|pycnogenols|mesh-list
101809568|NCT05824351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101809569|NCT05824351|Immunologic Factors|immunologic factors|mesh-ancestor
101809570|NCT05824351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809571|NCT05824351|Antioxidants|antioxidants|mesh-ancestor
101809572|NCT05824351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809573|NCT05824351|Protective Agents|protective agents|mesh-ancestor
101809574|NCT05824351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101809575|NCT05824351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101809576|NCT05824143|Carbamazepine|carbamazepine|mesh-list
101809577|NCT05824143|Anticonvulsants|anticonvulsants|mesh-ancestor
101219023|NCT01496196|Hemostatics|hemostatics|mesh-ancestor
101809578|NCT05824143|Antimanic Agents|antimanic agents|mesh-ancestor
101809579|NCT05824143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101809580|NCT05824143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101809581|NCT05824143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809582|NCT05824143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101809583|NCT05824143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101809584|NCT05824143|Analgesics|analgesics|mesh-ancestor
101809585|NCT05824143|Sensory System Agents|sensory system agents|mesh-ancestor
101809586|NCT05824143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101809587|NCT05824143|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101809588|NCT05824143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101809589|NCT05824143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809590|NCT05824143|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101809591|NCT05824143|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101809592|NCT05730712|Trastuzumab|trastuzumab|mesh-list
101809593|NCT05730712|Pertuzumab|pertuzumab|mesh-list
101809594|NCT05730712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101809595|NCT05730712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101809596|NCT05687136|Peposertib|peposertib|mesh-list
101809597|NCT05687136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101809598|NCT05687136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101809599|NCT05687136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809600|NCT05664568|Amoxicillin|amoxicillin|mesh-list
101809601|NCT05664568|Clavulanic Acid|clavulanic acid|mesh-list
101809602|NCT05664568|Clavulanic Acids|clavulanic acids|mesh-list
101809603|NCT05664568|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101809604|NCT05664568|Cephalexin|cephalexin|mesh-list
101809605|NCT05664568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101809606|NCT05664568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101809607|NCT05664568|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101809608|NCT05664568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101809609|NCT05664568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809611|NCT05525858|Trastuzumab|trastuzumab|mesh-list
101809612|NCT05525858|Atezolizumab|atezolizumab|mesh-list
101809613|NCT05525858|Pertuzumab|pertuzumab|mesh-list
101809614|NCT05525858|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101809615|NCT05525858|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101809616|NCT05525858|Vemurafenib|vemurafenib|mesh-list
101219210|NCT01497327|Sofosbuvir|sofosbuvir|mesh-list
101809618|NCT05525858|Pralsetinib|pralsetinib|mesh-list
101809619|NCT05525858|Entrectinib|entrectinib|mesh-list
101809620|NCT05525858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101809621|NCT05525858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101809622|NCT05525858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101809623|NCT05525858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101809624|NCT05525858|Growth Substances|growth substances|mesh-ancestor
101809625|NCT05525858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809626|NCT05525858|Growth Inhibitors|growth inhibitors|mesh-ancestor
101809627|NCT05525858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101809628|NCT05525858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101809629|NCT05525858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809630|NCT05525858|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101809631|NCT05525858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101809632|NCT05525858|Tubulin Modulators|tubulin modulators|mesh-ancestor
101809633|NCT05525858|Antimitotic Agents|antimitotic agents|mesh-ancestor
101809634|NCT05525858|Mitosis Modulators|mitosis modulators|mesh-ancestor
101809635|NCT05525858|Immunotoxins|immunotoxins|mesh-ancestor
101809636|NCT05525858|Immunoconjugates|immunoconjugates|mesh-ancestor
101809637|NCT05525858|Immunologic Factors|immunologic factors|mesh-ancestor
101809638|NCT05524584|Fulvestrant|fulvestrant|mesh-list
101809639|NCT05524584|Anastrozole|anastrozole|mesh-list
101809640|NCT05524584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101809641|NCT05524584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101809642|NCT05524584|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101809643|NCT05524584|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101809644|NCT05524584|Hormone Antagonists|hormone antagonists|mesh-ancestor
101809645|NCT05524584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101809646|NCT05524584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809647|NCT05524584|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101219339|NCT01497990|Ertapenem|ertapenem|mesh-list
101809648|NCT05524584|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101809649|NCT05524584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101809650|NCT05524584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809651|NCT05507541|Pembrolizumab|pembrolizumab|mesh-list
101809652|NCT05507541|Immunoglobulin G|immunoglobulin g|mesh-list
101809653|NCT05507541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101809654|NCT05507541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101809655|NCT05507541|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101809656|NCT05507541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809657|NCT05507541|Immunologic Factors|immunologic factors|mesh-ancestor
101809658|NCT05507541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809659|NCT05498220|Dexamethasone|dexamethasone|mesh-list
101809660|NCT05498220|Rituximab|rituximab|mesh-list
101809661|NCT05498220|Gemcitabine|gemcitabine|mesh-list
101809662|NCT05498220|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
101809663|NCT05498220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101809664|NCT05498220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101809665|NCT05498220|Immunologic Factors|immunologic factors|mesh-ancestor
101809666|NCT05498220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809667|NCT05498220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101809668|NCT05498220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101809669|NCT05498220|Antiemetics|antiemetics|mesh-ancestor
101809670|NCT05498220|Autonomic Agents|autonomic agents|mesh-ancestor
101809671|NCT05498220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101809672|NCT05498220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101809673|NCT05498220|Glucocorticoids|glucocorticoids|mesh-ancestor
101809674|NCT05498220|Hormones|hormones|mesh-ancestor
101809675|NCT05498220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101809676|NCT05498220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101809677|NCT05498220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101811713|NCT01038388|Hormones|hormones|mesh-ancestor
101809679|NCT05498220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809680|NCT05498220|Immunoconjugates|immunoconjugates|mesh-ancestor
101809681|NCT05494437|Gabapentin|gabapentin|mesh-list
101809682|NCT05494437|Nabilone|nabilone|mesh-list
101809683|NCT05494437|Analgesics|analgesics|mesh-ancestor
101809684|NCT05494437|Sensory System Agents|sensory system agents|mesh-ancestor
101809685|NCT05494437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101809686|NCT05494437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809687|NCT05494437|Anticonvulsants|anticonvulsants|mesh-ancestor
101809688|NCT05494437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101809689|NCT05494437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101809690|NCT05494437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101809691|NCT05494437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101809692|NCT05494437|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101809693|NCT05494437|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101809694|NCT05494437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101809695|NCT05494437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809696|NCT05494437|Antimanic Agents|antimanic agents|mesh-ancestor
101809697|NCT05494437|Antiemetics|antiemetics|mesh-ancestor
101809698|NCT05494437|Autonomic Agents|autonomic agents|mesh-ancestor
101809699|NCT05494437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101219588|NCT01499693|Pantoprazole|pantoprazole|mesh-list
101809700|NCT05428488|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
101809702|NCT05428488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101809703|NCT05428488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809704|NCT05428488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101809705|NCT05428488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101809706|NCT05428488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101809707|NCT05428488|Immunologic Factors|immunologic factors|mesh-ancestor
101809708|NCT05428488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809709|NCT05428488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101809710|NCT05428488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101809711|NCT05414201|Adalimumab|adalimumab|mesh-list
101809712|NCT05414201|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101809713|NCT05414201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101809714|NCT05414201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101809715|NCT05412004|Tirzepatide|tirzepatide|mesh-list
101809716|NCT05412004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101809717|NCT05412004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809718|NCT05412004|Incretins|incretins|mesh-ancestor
101809719|NCT05412004|Hormones|hormones|mesh-ancestor
101809720|NCT05412004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101809721|NCT05405751|Tenofovir|tenofovir|mesh-list
101809722|NCT05405751|Emtricitabine|emtricitabine|mesh-list
101809723|NCT05405751|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
101809724|NCT05405751|Antiviral Agents|antiviral agents|mesh-ancestor
101809725|NCT05405751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101809726|NCT05405751|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101809727|NCT05405751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101809728|NCT05405751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101809729|NCT05405751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219715|NCT01500590|Ramipril|ramipril|mesh-list
101809730|NCT05405751|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101809731|NCT05405751|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101809732|NCT05405309|Olaparib|olaparib|mesh-list
101809733|NCT05405309|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101809734|NCT05405309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101809735|NCT05405309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809736|NCT05405309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101809737|NCT05392452|Insulin|insulin|mesh-list
101809738|NCT05392452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101809739|NCT05392452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809740|NCT05387187|Pentoxifylline|pentoxifylline|mesh-list
101809741|NCT05387187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101809742|NCT05387187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101809743|NCT05387187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809744|NCT05387187|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101809745|NCT05387187|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101809746|NCT05387187|Protective Agents|protective agents|mesh-ancestor
101219771|NCT01500850|Insulin|insulin|mesh-list
101809747|NCT05387187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809749|NCT05387187|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101809750|NCT05387187|Antioxidants|antioxidants|mesh-ancestor
101809751|NCT05365893|Hydroxychloroquine|hydroxychloroquine|mesh-list
101809752|NCT05365893|Losartan|losartan|mesh-list
101809753|NCT05365893|Antimalarials|antimalarials|mesh-ancestor
101809754|NCT05365893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101809755|NCT05365893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101809756|NCT05365893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101809757|NCT05365893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101809758|NCT05365893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809759|NCT05365893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101809760|NCT05365893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101809761|NCT05365893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101809762|NCT05365893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101809763|NCT05365893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101809764|NCT05364073|Aflutinib|aflutinib|mesh-list
101809765|NCT05364073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101809766|NCT05364073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101809767|NCT05364073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809768|NCT05312671|Cisplatin|cisplatin|mesh-list
101809769|NCT05312671|Carboplatin|carboplatin|mesh-list
101809770|NCT05312671|Etoposide|etoposide|mesh-list
101809771|NCT05312671|Atezolizumab|atezolizumab|mesh-list
101809772|NCT05312671|Podophyllotoxin|podophyllotoxin|mesh-list
101809773|NCT05312671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101809774|NCT05312671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101809775|NCT05312671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101809776|NCT05312671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101809777|NCT05312671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101809778|NCT05312671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809779|NCT05312671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101809780|NCT05312671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101809781|NCT05312671|Keratolytic Agents|keratolytic agents|mesh-ancestor
101809782|NCT05312671|Dermatologic Agents|dermatologic agents|mesh-ancestor
101809783|NCT05312671|Tubulin Modulators|tubulin modulators|mesh-ancestor
101809784|NCT05312671|Antimitotic Agents|antimitotic agents|mesh-ancestor
101809785|NCT05312671|Mitosis Modulators|mitosis modulators|mesh-ancestor
101809786|NCT05254574|Diclofenac|diclofenac|mesh-list
101809787|NCT05254574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101809788|NCT05254574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101809789|NCT05254574|Analgesics|analgesics|mesh-ancestor
101809790|NCT05254574|Sensory System Agents|sensory system agents|mesh-ancestor
101809791|NCT05254574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101809792|NCT05254574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809793|NCT05254574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101809794|NCT05254574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101809795|NCT05254574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101809796|NCT05254574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101219957|NCT01501396|Megestrol|megestrol|mesh-list
101809797|NCT05254574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809798|NCT05219929|Tetracycline|tetracycline|mesh-list
101809799|NCT05219929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101809800|NCT05219929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101809801|NCT05219929|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101809802|NCT05219929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101809803|NCT05219929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809804|NCT05205382|Nicotine|nicotine|mesh-list
101809805|NCT05205382|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101809806|NCT05205382|Autonomic Agents|autonomic agents|mesh-ancestor
101809807|NCT05205382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101809808|NCT05205382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809809|NCT05205382|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101809810|NCT05205382|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101809811|NCT05205382|Cholinergic Agents|cholinergic agents|mesh-ancestor
101809812|NCT05205382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101809813|NCT05205382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809814|NCT05198843|Dasatinib|dasatinib|mesh-list
101809815|NCT05198843|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
101809816|NCT05198843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101809817|NCT05198843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101809818|NCT05198843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101809819|NCT05198843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809820|NCT05198843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101809821|NCT05198843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101809822|NCT05139225|Daratumumab|daratumumab|mesh-list
101809823|NCT05139225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101809824|NCT05132829|Azithromycin|azithromycin|mesh-list
101809825|NCT05132829|Cefazolin|cefazolin|mesh-list
101809826|NCT05132829|Indomethacin|indomethacin|mesh-list
101809827|NCT05132829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101809828|NCT05132829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101809829|NCT05132829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101809830|NCT05132829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101809831|NCT05132829|Analgesics|analgesics|mesh-ancestor
101809832|NCT05132829|Sensory System Agents|sensory system agents|mesh-ancestor
101809833|NCT05132829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101809834|NCT05132829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809835|NCT05132829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101809836|NCT05132829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101809837|NCT05132829|Gout Suppressants|gout suppressants|mesh-ancestor
101809838|NCT05132829|Tocolytic Agents|tocolytic agents|mesh-ancestor
101809839|NCT05132829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101809840|NCT05132829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101467161|NCT04381143|Aspirin|aspirin|mesh-list
101809841|NCT05132829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101220132|NCT01501786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101809842|NCT05132829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809843|NCT05117450|Heparin|heparin|mesh-list
101809844|NCT05117450|Anticoagulants|anticoagulants|mesh-ancestor
101809845|NCT05117450|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101809846|NCT05117450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101809847|NCT05117450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809848|NCT05102669|Antibodies|antibodies|mesh-list
101809849|NCT05102669|Immunologic Factors|immunologic factors|mesh-ancestor
101809850|NCT05102669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220184|NCT01502020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101809879|NCT05050448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809880|NCT05050448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101809881|NCT05050448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101809882|NCT05050448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101809883|NCT05050448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101809884|NCT05050448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809885|NCT04899388|Fentanyl|fentanyl|mesh-list
101809886|NCT04899388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101809887|NCT04899388|Narcotics|narcotics|mesh-ancestor
101809888|NCT04899388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101311803|NCT00006070|Analgesics|analgesics|mesh-ancestor
101809889|NCT04899388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809890|NCT04899388|Analgesics|analgesics|mesh-ancestor
101809891|NCT04899388|Sensory System Agents|sensory system agents|mesh-ancestor
101809892|NCT04899388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101809893|NCT04899388|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101809894|NCT04899388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101809895|NCT04899388|Anesthetics, General|anesthetics, general|mesh-ancestor
101809896|NCT04899388|Anesthetics|anesthetics|mesh-ancestor
101809897|NCT04880785|Lamivudine|lamivudine|mesh-list
101809898|NCT04880785|Dolutegravir|dolutegravir|mesh-list
101809899|NCT04880785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101809900|NCT04880785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101809901|NCT04880785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101809902|NCT04880785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809903|NCT04880785|Antiviral Agents|antiviral agents|mesh-ancestor
101809904|NCT04880785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101809905|NCT04880785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101809906|NCT04880785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101809907|NCT04880785|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101809908|NCT04880785|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101809909|NCT04874246|Vasopressins|vasopressins|mesh-list
101809910|NCT04874246|Arginine Vasopressin|arginine vasopressin|mesh-list
101809911|NCT04874246|Hemostatics|hemostatics|mesh-ancestor
101809912|NCT04874246|Coagulants|coagulants|mesh-ancestor
101809913|NCT04874246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101809914|NCT04874246|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101809915|NCT04874246|Natriuretic Agents|natriuretic agents|mesh-ancestor
101809916|NCT04874246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809918|NCT04865731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101809919|NCT04865731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101809920|NCT04865731|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101809921|NCT04865731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101809922|NCT04865731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809923|NCT04847466|Pembrolizumab|pembrolizumab|mesh-list
101809924|NCT04847466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101809925|NCT04847466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101809926|NCT04847466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101809927|NCT04847466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809930|NCT04781088|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101809931|NCT04781088|Lenvatinib|lenvatinib|mesh-list
101809932|NCT04781088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101809933|NCT04781088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101809934|NCT04781088|Tubulin Modulators|tubulin modulators|mesh-ancestor
101809935|NCT04781088|Antimitotic Agents|antimitotic agents|mesh-ancestor
101809936|NCT04781088|Mitosis Modulators|mitosis modulators|mesh-ancestor
101809937|NCT04781088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809938|NCT04781088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101220487|NCT01503671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101809939|NCT04781088|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101809940|NCT04781088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101809941|NCT04781088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101809942|NCT04777006|Amitriptyline|amitriptyline|mesh-list
101809943|NCT04777006|Fluoxetine|fluoxetine|mesh-list
101809944|NCT04777006|Antidepressive Agents|antidepressive agents|mesh-list
101809945|NCT04777006|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101809946|NCT04777006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101809947|NCT04777006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101809948|NCT04777006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809949|NCT04777006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101809950|NCT04777006|Serotonin Agents|serotonin agents|mesh-ancestor
101809951|NCT04777006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220538|NCT01503905|Immunologic Factors|immunologic factors|mesh-ancestor
101809952|NCT04777006|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101809953|NCT04777006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101809954|NCT04777006|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101809955|NCT04777006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101809956|NCT04777006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101809957|NCT04777006|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101809958|NCT04777006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101809959|NCT04777006|Analgesics|analgesics|mesh-ancestor
101809960|NCT04777006|Sensory System Agents|sensory system agents|mesh-ancestor
101809961|NCT04777006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101809962|NCT04777006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101809963|NCT04777006|Adrenergic Agents|adrenergic agents|mesh-ancestor
101809964|NCT04766086|Vaccines|vaccines|mesh-list
101809965|NCT04766086|Immunologic Factors|immunologic factors|mesh-ancestor
101809966|NCT04766086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809967|NCT04733547|Furosemide|furosemide|mesh-list
101809968|NCT04733547|Diuretics|diuretics|mesh-ancestor
101809969|NCT04733547|Natriuretic Agents|natriuretic agents|mesh-ancestor
101809970|NCT04733547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809971|NCT04733547|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101809972|NCT04733547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101809973|NCT04733547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809974|NCT04717986|Dapagliflozin|dapagliflozin|mesh-list
101809975|NCT04717986|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101809976|NCT04717986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809977|NCT04717986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101811774|NCT00496197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101809978|NCT04717986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809980|NCT04680910|Anesthetics|anesthetics|mesh-list
101809981|NCT04680910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101809982|NCT04680910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101809983|NCT04680910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809984|NCT04680910|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101809985|NCT04680910|Anesthetics, General|anesthetics, general|mesh-ancestor
101809986|NCT04678102|PHI-101|phi-101|mesh-list
101809987|NCT04678102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101220660|NCT01504282|Mitomycins|mitomycins|mesh-list
101809988|NCT04678102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101809989|NCT04678102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101809990|NCT04678102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101809992|NCT04653246|Lenalidomide|lenalidomide|mesh-list
101809993|NCT04653246|Bortezomib|bortezomib|mesh-list
101809994|NCT04653246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101809995|NCT04653246|Antiemetics|antiemetics|mesh-ancestor
101809996|NCT04653246|Autonomic Agents|autonomic agents|mesh-ancestor
101809997|NCT04653246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101809998|NCT04653246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101809999|NCT04653246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101810000|NCT04653246|Glucocorticoids|glucocorticoids|mesh-ancestor
101810001|NCT04653246|Hormones|hormones|mesh-ancestor
101810002|NCT04653246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101810003|NCT04653246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101810004|NCT04653246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101810005|NCT04653246|Immunologic Factors|immunologic factors|mesh-ancestor
101810006|NCT04653246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101810007|NCT04653246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101810008|NCT04653246|Growth Substances|growth substances|mesh-ancestor
101810009|NCT04653246|Growth Inhibitors|growth inhibitors|mesh-ancestor
101810010|NCT04643106|Hemostatics|hemostatics|mesh-list
101810011|NCT04643106|Coagulants|coagulants|mesh-ancestor
101810012|NCT04636437|Tenofovir|tenofovir|mesh-list
101810013|NCT04636437|Lamivudine|lamivudine|mesh-list
101810014|NCT04636437|Emtricitabine|emtricitabine|mesh-list
101810015|NCT04636437|Integrase Inhibitors|integrase inhibitors|mesh-list
101810016|NCT04636437|Antiviral Agents|antiviral agents|mesh-ancestor
101810017|NCT04636437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101810018|NCT04636437|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101810019|NCT04636437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101810020|NCT04636437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101810021|NCT04636437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810022|NCT04636437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101220776|NCT01504906|Purinergic Agents|purinergic agents|mesh-ancestor
101810023|NCT04636437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101810024|NCT04606914|Maytansine|maytansine|mesh-list
101810025|NCT04606914|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
101810026|NCT04606914|Immunoconjugates|immunoconjugates|mesh-ancestor
101810027|NCT04606914|Immunologic Factors|immunologic factors|mesh-ancestor
101810028|NCT04606914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810029|NCT04606914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101810030|NCT04606914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101810039|NCT04564885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101810040|NCT04564885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101220831|NCT01505127|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101810042|NCT04564885|Sensory System Agents|sensory system agents|mesh-ancestor
101810043|NCT04564885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101810044|NCT04564885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810045|NCT04564885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101810046|NCT04564885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101810047|NCT04564885|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101810048|NCT04564885|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101810049|NCT04564885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101810050|NCT04564885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810051|NCT04564157|Paclitaxel|paclitaxel|mesh-list
101810052|NCT04564157|Carboplatin|carboplatin|mesh-list
101810053|NCT04564157|Nivolumab|nivolumab|mesh-list
101810054|NCT04564157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101810055|NCT04564157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101220887|NCT01505426|Metformin|metformin|mesh-list
101810056|NCT04564157|Tubulin Modulators|tubulin modulators|mesh-ancestor
101810057|NCT04564157|Antimitotic Agents|antimitotic agents|mesh-ancestor
101810058|NCT04564157|Mitosis Modulators|mitosis modulators|mesh-ancestor
101810059|NCT04564157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810060|NCT04564157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101810061|NCT04564157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101810070|NCT04509791|Immunoglobulins|immunoglobulins|mesh-list
101810071|NCT04509791|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101810072|NCT04509791|Antibodies|antibodies|mesh-list
101810073|NCT04509791|Thymoglobulin|thymoglobulin|mesh-list
101810074|NCT04509791|Immunologic Factors|immunologic factors|mesh-ancestor
101810075|NCT04509791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810076|NCT04509791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101810077|NCT04504812|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101810078|NCT04504812|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101810079|NCT04504812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101810080|NCT04504812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101810081|NCT04504812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810082|NCT04504812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101810083|NCT04504812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810084|NCT04504812|Analgesics|analgesics|mesh-ancestor
101810085|NCT04504812|Sensory System Agents|sensory system agents|mesh-ancestor
101810086|NCT04504812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101810087|NCT04504812|Antidepressive Agents|antidepressive agents|mesh-ancestor
101810088|NCT04504812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101810089|NCT04504812|Dopamine Agents|dopamine agents|mesh-ancestor
101810090|NCT04497584|Prednisone|prednisone|mesh-list
101810091|NCT04497584|Afatinib|afatinib|mesh-list
101810092|NCT04497584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101810093|NCT04497584|Glucocorticoids|glucocorticoids|mesh-ancestor
101810094|NCT04497584|Hormones|hormones|mesh-ancestor
101810095|NCT04497584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101810096|NCT04497584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810097|NCT04497584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101810098|NCT04497584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101810099|NCT04497584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101810100|NCT04497584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101810101|NCT04497584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810103|NCT04484623|Bortezomib|bortezomib|mesh-list
101810104|NCT04484623|Pomalidomide|pomalidomide|mesh-list
101810105|NCT04484623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101810106|NCT04484623|Antiemetics|antiemetics|mesh-ancestor
101810107|NCT04484623|Autonomic Agents|autonomic agents|mesh-ancestor
101810108|NCT04484623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101810109|NCT04484623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810110|NCT04484623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101810111|NCT04484623|Glucocorticoids|glucocorticoids|mesh-ancestor
101810112|NCT04484623|Hormones|hormones|mesh-ancestor
101810113|NCT04484623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101810114|NCT04484623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101810115|NCT04484623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101810116|NCT04484623|Immunologic Factors|immunologic factors|mesh-ancestor
101810117|NCT04484623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101810118|NCT04484623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101810119|NCT04484623|Growth Substances|growth substances|mesh-ancestor
101810120|NCT04484623|Growth Inhibitors|growth inhibitors|mesh-ancestor
101810121|NCT04469595|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
101810122|NCT04469595|Aflibercept|aflibercept|mesh-list
101810123|NCT04469595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101810124|NCT04469595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101810125|NCT04469595|Growth Substances|growth substances|mesh-ancestor
101810126|NCT04469595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810127|NCT04469595|Growth Inhibitors|growth inhibitors|mesh-ancestor
101810128|NCT04469595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101810129|NCT04469595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101810130|NCT04469595|Glucocorticoids|glucocorticoids|mesh-ancestor
101810131|NCT04469595|Hormones|hormones|mesh-ancestor
101810132|NCT04469595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101810133|NCT04374877|Pembrolizumab|pembrolizumab|mesh-list
101810134|NCT04374877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101810135|NCT04374877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101810136|NCT04374877|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101810137|NCT04374877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810139|NCT04266795|Venetoclax|venetoclax|mesh-list
101810140|NCT04266795|Pevonedistat|pevonedistat|mesh-list
101810141|NCT04266795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101810142|NCT04266795|Antimetabolites|antimetabolites|mesh-ancestor
101810143|NCT04266795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810144|NCT04266795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101810145|NCT04266795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101810146|NCT04250636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101810147|NCT04250636|Antibodies|antibodies|mesh-list
101810148|NCT04250636|Immunoglobulins|immunoglobulins|mesh-list
101810149|NCT04250636|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101221164|NCT01506713|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101810150|NCT04250636|Immunologic Factors|immunologic factors|mesh-ancestor
101810151|NCT04250636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810152|NCT04250636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101810153|NCT04233749|Tranexamic Acid|tranexamic acid|mesh-list
101810154|NCT04233749|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101810155|NCT04233749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101810156|NCT04233749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810157|NCT04233749|Hemostatics|hemostatics|mesh-ancestor
101810158|NCT04233749|Coagulants|coagulants|mesh-ancestor
101810159|NCT04231851|Cytarabine|cytarabine|mesh-list
101810160|NCT04231851|Daunorubicin|daunorubicin|mesh-list
101810161|NCT04231851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101810162|NCT04231851|Antimetabolites|antimetabolites|mesh-ancestor
101810163|NCT04231851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810164|NCT04231851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101810165|NCT04231851|Antiviral Agents|antiviral agents|mesh-ancestor
101810166|NCT04231851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101810167|NCT04231851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101810168|NCT04231851|Immunologic Factors|immunologic factors|mesh-ancestor
101456539|NCT00245115|Cyclophosphamide|cyclophosphamide|mesh-list
101810169|NCT04231851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810170|NCT04231851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101810171|NCT04231851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101810172|NCT04231851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101810173|NCT04231851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101810175|NCT04201561|Sodium Selenite|sodium selenite|mesh-list
101810177|NCT04201561|Carboplatin|carboplatin|mesh-list
101810178|NCT04201561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101810179|NCT04201561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101810180|NCT04201561|Tubulin Modulators|tubulin modulators|mesh-ancestor
101810181|NCT04201561|Antimitotic Agents|antimitotic agents|mesh-ancestor
101810182|NCT04201561|Mitosis Modulators|mitosis modulators|mesh-ancestor
101810183|NCT04201561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810184|NCT04201561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810185|NCT04201561|Trace Elements|trace elements|mesh-ancestor
101810186|NCT04201561|Micronutrients|micronutrients|mesh-ancestor
101810187|NCT04184609|Albuterol|albuterol|mesh-list
101810188|NCT04184609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101810189|NCT04184609|Autonomic Agents|autonomic agents|mesh-ancestor
101810190|NCT04184609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101810191|NCT04184609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810192|NCT04184609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101810193|NCT04184609|Respiratory System Agents|respiratory system agents|mesh-ancestor
101810194|NCT04184609|Tocolytic Agents|tocolytic agents|mesh-ancestor
101810195|NCT04184609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101810196|NCT04184609|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101810197|NCT04184609|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101810198|NCT04184609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101810199|NCT04184609|Adrenergic Agents|adrenergic agents|mesh-ancestor
101810200|NCT04184609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101810201|NCT04184609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810202|NCT04162873|Celecoxib|celecoxib|mesh-list
101810203|NCT04162873|Benzenesulfonamide|benzenesulfonamide|mesh-list
101810204|NCT04162873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101810205|NCT04162873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101810206|NCT04162873|Analgesics|analgesics|mesh-ancestor
101810207|NCT04162873|Sensory System Agents|sensory system agents|mesh-ancestor
101810208|NCT04162873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101810209|NCT04162873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810210|NCT04162873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101810211|NCT04162873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101810212|NCT04162873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101810213|NCT04162873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101810214|NCT04162873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101810215|NCT04162873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810216|NCT04162873|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101810218|NCT04100018|Docetaxel|docetaxel|mesh-list
101810219|NCT04100018|Nivolumab|nivolumab|mesh-list
101810220|NCT04100018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101810221|NCT04100018|Tubulin Modulators|tubulin modulators|mesh-ancestor
101810222|NCT04100018|Antimitotic Agents|antimitotic agents|mesh-ancestor
101810223|NCT04100018|Mitosis Modulators|mitosis modulators|mesh-ancestor
101810224|NCT04100018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810225|NCT04100018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101810226|NCT04100018|Glucocorticoids|glucocorticoids|mesh-ancestor
101810227|NCT04100018|Hormones|hormones|mesh-ancestor
101810228|NCT04100018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101810229|NCT04100018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810230|NCT04100018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101810231|NCT04100018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101810232|NCT04100018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101810233|NCT04061421|Decitabine|decitabine|mesh-list
101810234|NCT04061421|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
101810235|NCT04061421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101810236|NCT04061421|Antimetabolites|antimetabolites|mesh-ancestor
101810237|NCT04061421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810238|NCT04061421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101810239|NCT04061421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101810240|NCT04046900|Metronidazole|metronidazole|mesh-list
101221623|NCT01508611|Fluorides|fluorides|mesh-list
101810241|NCT04046900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101810242|NCT04046900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101810243|NCT04046900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101810244|NCT04046900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101810245|NCT03989115|Osimertinib|osimertinib|mesh-list
101810246|NCT03989115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101810247|NCT03989115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101810248|NCT03989115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101810249|NCT03989115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810250|NCT03971071|Erenumab|erenumab|mesh-list
101810251|NCT03971071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101810252|NCT03971071|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
101810253|NCT03971071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810254|NCT03971071|Analgesics|analgesics|mesh-ancestor
101810255|NCT03971071|Sensory System Agents|sensory system agents|mesh-ancestor
101810256|NCT03971071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101221661|NCT01508845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810257|NCT03971071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810258|NCT03971071|Immunologic Factors|immunologic factors|mesh-ancestor
101810259|NCT03939897|Fulvestrant|fulvestrant|mesh-list
101810260|NCT03939897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101810261|NCT03939897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101810262|NCT03939897|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101810263|NCT03939897|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101810264|NCT03939897|Hormone Antagonists|hormone antagonists|mesh-ancestor
101810265|NCT03939897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101810266|NCT03939897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810267|NCT03937843|Carboplatin|carboplatin|mesh-list
101810269|NCT03937843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101810270|NCT03937843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101810271|NCT03937843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101810272|NCT03937843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101810273|NCT03937843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101810274|NCT03937843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810275|NCT03839823|Paclitaxel|paclitaxel|mesh-list
101810276|NCT03839823|Vinorelbine|vinorelbine|mesh-list
101810277|NCT03839823|Docetaxel|docetaxel|mesh-list
101810278|NCT03839823|Gemcitabine|gemcitabine|mesh-list
101810279|NCT03839823|Capecitabine|capecitabine|mesh-list
101810280|NCT03839823|Letrozole|letrozole|mesh-list
101810281|NCT03839823|Anastrozole|anastrozole|mesh-list
101810282|NCT03839823|Goserelin|goserelin|mesh-list
101810283|NCT03839823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101810284|NCT03839823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101810285|NCT03839823|Tubulin Modulators|tubulin modulators|mesh-ancestor
101810286|NCT03839823|Antimitotic Agents|antimitotic agents|mesh-ancestor
101810287|NCT03839823|Mitosis Modulators|mitosis modulators|mesh-ancestor
101810288|NCT03839823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810289|NCT03839823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101810290|NCT03839823|Antimetabolites|antimetabolites|mesh-ancestor
101810291|NCT03839823|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101810292|NCT03839823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101810293|NCT03839823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101810294|NCT03839823|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101810295|NCT03839823|Hormone Antagonists|hormone antagonists|mesh-ancestor
101810296|NCT03839823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101810297|NCT03839823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810298|NCT03839823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101810299|NCT03787680|Olaparib|olaparib|mesh-list
101810300|NCT03787680|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101810301|NCT03787680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101810302|NCT03787680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810303|NCT03787680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101810304|NCT03743636|Niacinamide|niacinamide|mesh-list
101810306|NCT03743636|Nicotinic Acids|nicotinic acids|mesh-list
101810307|NCT03743636|Resveratrol|resveratrol|mesh-list
101810308|NCT03743636|Antioxidants|antioxidants|mesh-ancestor
101311832|NCT00006088|Mitosis Modulators|mitosis modulators|mesh-ancestor
101810309|NCT03743636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810310|NCT03743636|Protective Agents|protective agents|mesh-ancestor
101810311|NCT03743636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810312|NCT03743636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101810313|NCT03743636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101810314|NCT03743636|Vitamin B Complex|vitamin b complex|mesh-ancestor
101810315|NCT03743636|Vitamins|vitamins|mesh-ancestor
101810316|NCT03743636|Micronutrients|micronutrients|mesh-ancestor
101810317|NCT03743636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101810318|NCT03743636|Antimetabolites|antimetabolites|mesh-ancestor
101810319|NCT03743636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101810320|NCT03743636|Vasodilator Agents|vasodilator agents|mesh-ancestor
101810321|NCT03726775|Durvalumab|durvalumab|mesh-list
101810322|NCT03726775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101810323|NCT03726775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101810324|NCT03718039|Aprepitant|aprepitant|mesh-list
101810325|NCT03718039|Antiemetics|antiemetics|mesh-ancestor
101810326|NCT03718039|Autonomic Agents|autonomic agents|mesh-ancestor
101810327|NCT03718039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101810328|NCT03718039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810329|NCT03718039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101810330|NCT03718039|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101810331|NCT03718039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101810332|NCT03718039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810333|NCT03672292|Voriconazole|voriconazole|mesh-list
101810334|NCT03672292|Ibrexafungerp|ibrexafungerp|mesh-list
101810335|NCT03672292|Antifungal Agents|antifungal agents|mesh-ancestor
101810336|NCT03672292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101810337|NCT03672292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101810338|NCT03672292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101810339|NCT03672292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101810340|NCT03672292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810341|NCT03672292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101810342|NCT03672292|Hormone Antagonists|hormone antagonists|mesh-ancestor
101810343|NCT03672292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101810344|NCT03672292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810345|NCT03672292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101810346|NCT03635164|Durvalumab|durvalumab|mesh-list
101810347|NCT03635164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101810348|NCT03635164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101810349|NCT03602014|Droxidopa|droxidopa|mesh-list
101810350|NCT03602014|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101810351|NCT03602014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101810352|NCT03559868|Digoxin|digoxin|mesh-list
101810353|NCT03559868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101810354|NCT03559868|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101810355|NCT03559868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101810356|NCT03559868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810357|NCT03559868|Protective Agents|protective agents|mesh-ancestor
101810358|NCT03559868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810359|NCT03559192|Aticaprant|aticaprant|mesh-list
101810360|NCT03559192|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101467686|NCT04531423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101810362|NCT03559192|Sensory System Agents|sensory system agents|mesh-ancestor
101810363|NCT03559192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101810365|NCT03552471|Maytansine|maytansine|mesh-list
101810366|NCT03552471|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
101810367|NCT03552471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101810368|NCT03552471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101810369|NCT03552471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810370|NCT03552471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101810371|NCT03552471|Immunoconjugates|immunoconjugates|mesh-ancestor
101810372|NCT03552471|Immunologic Factors|immunologic factors|mesh-ancestor
101810373|NCT03552471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810375|NCT03552471|Tubulin Modulators|tubulin modulators|mesh-ancestor
101810376|NCT03552471|Antimitotic Agents|antimitotic agents|mesh-ancestor
101810377|NCT03552471|Mitosis Modulators|mitosis modulators|mesh-ancestor
101810378|NCT03533946|Rucaparib|rucaparib|mesh-list
101810379|NCT03533946|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101810380|NCT03533946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101810381|NCT03533946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810382|NCT03533946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101810383|NCT03523585|Capecitabine|capecitabine|mesh-list
101810384|NCT03523585|Trastuzumab|trastuzumab|mesh-list
101810385|NCT03523585|Lapatinib|lapatinib|mesh-list
101810386|NCT03523585|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
101810387|NCT03523585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101810388|NCT03523585|Antimetabolites|antimetabolites|mesh-ancestor
101810389|NCT03523585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810390|NCT03523585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101810391|NCT03523585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101810392|NCT03523585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101810393|NCT03523585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101810394|NCT03523585|Immunoconjugates|immunoconjugates|mesh-ancestor
101810395|NCT03523585|Immunologic Factors|immunologic factors|mesh-ancestor
101810396|NCT03523585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810397|NCT03485911|Berotralstat|berotralstat|mesh-list
101810398|NCT03485911|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101810399|NCT03485911|Protease Inhibitors|protease inhibitors|mesh-ancestor
101810400|NCT03485911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101810401|NCT03485911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810402|NCT03435250|Paclitaxel|paclitaxel|mesh-list
101810403|NCT03435250|Docetaxel|docetaxel|mesh-list
101810404|NCT03435250|Gemcitabine|gemcitabine|mesh-list
101810405|NCT03435250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101810406|NCT03435250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101810407|NCT03435250|Tubulin Modulators|tubulin modulators|mesh-ancestor
101810408|NCT03435250|Antimitotic Agents|antimitotic agents|mesh-ancestor
101810409|NCT03435250|Mitosis Modulators|mitosis modulators|mesh-ancestor
101810410|NCT03435250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810411|NCT03435250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101810412|NCT03435250|Antimetabolites|antimetabolites|mesh-ancestor
101810413|NCT03416153|Paclitaxel|paclitaxel|mesh-list
101810414|NCT03416153|Carboplatin|carboplatin|mesh-list
101810415|NCT03416153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101810416|NCT03416153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101810417|NCT03416153|Tubulin Modulators|tubulin modulators|mesh-ancestor
101810418|NCT03416153|Antimitotic Agents|antimitotic agents|mesh-ancestor
101810419|NCT03416153|Mitosis Modulators|mitosis modulators|mesh-ancestor
101810420|NCT03416153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810421|NCT03409718|Cimetidine|cimetidine|mesh-list
101810422|NCT03409718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101810423|NCT03409718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101810424|NCT03409718|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101810425|NCT03409718|Histamine Antagonists|histamine antagonists|mesh-ancestor
101810426|NCT03409718|Histamine Agents|histamine agents|mesh-ancestor
101810427|NCT03409718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101810428|NCT03409718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810429|NCT03409718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810430|NCT03409718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101810431|NCT03409718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101810432|NCT03409718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101810433|NCT03395314|Midazolam|midazolam|mesh-list
101810434|NCT03395314|Ketamine|ketamine|mesh-list
101810435|NCT03395314|Analgesics|analgesics|mesh-ancestor
101810436|NCT03395314|Sensory System Agents|sensory system agents|mesh-ancestor
101810437|NCT03395314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101810438|NCT03395314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810439|NCT03395314|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101810440|NCT03395314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101810441|NCT03395314|Anesthetics, General|anesthetics, general|mesh-ancestor
101810442|NCT03395314|Anesthetics|anesthetics|mesh-ancestor
101810443|NCT03395314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101810444|NCT03395314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101810445|NCT03395314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101810446|NCT03395314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101810447|NCT03395314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810448|NCT03395314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101810449|NCT03395314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101810450|NCT03395314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101810451|NCT03395314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101810452|NCT03395314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101810453|NCT03395314|GABA Modulators|gaba modulators|mesh-ancestor
101810454|NCT03395314|GABA Agents|gaba agents|mesh-ancestor
101810455|NCT03386500|Manganese|manganese|mesh-list
101810456|NCT03386500|Trace Elements|trace elements|mesh-ancestor
101810457|NCT03386500|Micronutrients|micronutrients|mesh-ancestor
101810458|NCT03386500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810459|NCT03293680|Pembrolizumab|pembrolizumab|mesh-list
101810460|NCT03293680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101810461|NCT03293680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101810462|NCT03293680|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101810463|NCT03293680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810464|NCT03239340|Osimertinib|osimertinib|mesh-list
101810465|NCT03239340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101810466|NCT03239340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101810467|NCT03239340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101810468|NCT03239340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810469|NCT03172975|Albendazole|albendazole|mesh-list
101810470|NCT03172975|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101810471|NCT03172975|Anthelmintics|anthelmintics|mesh-ancestor
101810472|NCT03172975|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101810473|NCT03172975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101810474|NCT03172975|Anticestodal Agents|anticestodal agents|mesh-ancestor
101810475|NCT03172975|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101810476|NCT03172975|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101810477|NCT03172975|Tubulin Modulators|tubulin modulators|mesh-ancestor
101810478|NCT03172975|Antimitotic Agents|antimitotic agents|mesh-ancestor
101810479|NCT03172975|Mitosis Modulators|mitosis modulators|mesh-ancestor
101810480|NCT03172975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810481|NCT03172975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101810482|NCT03172975|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101810483|NCT03172975|Immunologic Factors|immunologic factors|mesh-ancestor
101810484|NCT03172975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810486|NCT03172975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101810487|NCT03073785|Zoledronic Acid|zoledronic acid|mesh-list
101810488|NCT03073785|Fluorouracil|fluorouracil|mesh-list
101810489|NCT03073785|Capecitabine|capecitabine|mesh-list
101810491|NCT03073785|Antimetabolites|antimetabolites|mesh-ancestor
101810492|NCT03073785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810493|NCT03073785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101810494|NCT03073785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101810495|NCT03073785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101810496|NCT03073785|Immunologic Factors|immunologic factors|mesh-ancestor
101810497|NCT03073785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810498|NCT03073785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101810499|NCT03073785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101810500|NCT03028103|Repaglinide|repaglinide|mesh-list
101810501|NCT03028103|Fluconazole|fluconazole|mesh-list
101810503|NCT03028103|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101810504|NCT03028103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101810505|NCT03028103|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101810506|NCT03028103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101810507|NCT03028103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810508|NCT03028103|Antifungal Agents|antifungal agents|mesh-ancestor
101810509|NCT03028103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101810510|NCT03028103|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101810511|NCT03028103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101810512|NCT03028103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101810513|NCT03028103|Hormone Antagonists|hormone antagonists|mesh-ancestor
101810514|NCT03028103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101810516|NCT03028103|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101810517|NCT03028103|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101810518|NCT03028103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101810519|NCT03020589|Tacrolimus|tacrolimus|mesh-list
101810520|NCT03020589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101810521|NCT03020589|Immunologic Factors|immunologic factors|mesh-ancestor
101810522|NCT03020589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810523|NCT03020589|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101810524|NCT03020589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101810525|NCT03020589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810526|NCT02932475|Metformin|metformin|mesh-list
101810527|NCT02932475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101810528|NCT02932475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810530|NCT02919917|Sympathomimetics|sympathomimetics|mesh-ancestor
101810531|NCT02919917|Autonomic Agents|autonomic agents|mesh-ancestor
101810532|NCT02919917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101810533|NCT02919917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810534|NCT02919917|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101810535|NCT02919917|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101810536|NCT02919917|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101810537|NCT02919917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101810538|NCT02919917|Adrenergic Agents|adrenergic agents|mesh-ancestor
101810539|NCT02919917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101810540|NCT02919917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810541|NCT02893553|Midodrine|midodrine|mesh-list
101810542|NCT02893553|Bromides|bromides|mesh-list
101810543|NCT02893553|Mirabegron|mirabegron|mesh-list
101810544|NCT02893553|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
101810545|NCT02893553|Anticonvulsants|anticonvulsants|mesh-ancestor
101810546|NCT02893553|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101810547|NCT02893553|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101810548|NCT02893553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101810549|NCT02893553|Adrenergic Agents|adrenergic agents|mesh-ancestor
101810550|NCT02893553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101810551|NCT02893553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810552|NCT02893553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810553|NCT02893553|Urological Agents|urological agents|mesh-ancestor
101810554|NCT02893553|Sympathomimetics|sympathomimetics|mesh-ancestor
101810555|NCT02893553|Autonomic Agents|autonomic agents|mesh-ancestor
101810556|NCT02893553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101810557|NCT02893553|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101810558|NCT02893553|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101810559|NCT02893553|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101810560|NCT02893553|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101810561|NCT02893553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101810562|NCT02893553|Cholinergic Agents|cholinergic agents|mesh-ancestor
101810565|NCT02755272|Pembrolizumab|pembrolizumab|mesh-list
101810566|NCT02755272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101810567|NCT02755272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101810568|NCT02755272|Antimetabolites|antimetabolites|mesh-ancestor
101810569|NCT02755272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810570|NCT02755272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101810571|NCT02755272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101810572|NCT02542293|Paclitaxel|paclitaxel|mesh-list
101810573|NCT02542293|Cisplatin|cisplatin|mesh-list
101810574|NCT02542293|Carboplatin|carboplatin|mesh-list
101810575|NCT02542293|Gemcitabine|gemcitabine|mesh-list
101810576|NCT02542293|Pemetrexed|pemetrexed|mesh-list
101810577|NCT02542293|Durvalumab|durvalumab|mesh-list
101810578|NCT02542293|Tremelimumab|tremelimumab|mesh-list
101810579|NCT02542293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101810580|NCT02542293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101810581|NCT02542293|Tubulin Modulators|tubulin modulators|mesh-ancestor
101810582|NCT02542293|Antimitotic Agents|antimitotic agents|mesh-ancestor
101810583|NCT02542293|Mitosis Modulators|mitosis modulators|mesh-ancestor
101810584|NCT02542293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810585|NCT02542293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101810586|NCT02542293|Antimetabolites|antimetabolites|mesh-ancestor
101810587|NCT02542293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101810588|NCT02542293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101810589|NCT02542293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101311909|NCT00006112|Alkylating Agents|alkylating agents|mesh-ancestor
101810590|NCT02542293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101810592|NCT02507687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101810593|NCT02321501|Everolimus|everolimus|mesh-list
101810594|NCT02321501|Ceritinib|ceritinib|mesh-list
101810595|NCT02321501|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101810596|NCT02321501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101810597|NCT02321501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101810598|NCT02321501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810599|NCT02321501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101810600|NCT02321501|Immunologic Factors|immunologic factors|mesh-ancestor
101810601|NCT02321501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810602|NCT02321501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101810603|NCT02242942|Venetoclax|venetoclax|mesh-list
101810604|NCT02242942|Obinutuzumab|obinutuzumab|mesh-list
101810605|NCT02242942|Chlorambucil|chlorambucil|mesh-list
101810606|NCT02242942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101810607|NCT02242942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101810608|NCT02242942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101810609|NCT02242942|Alkylating Agents|alkylating agents|mesh-ancestor
101810610|NCT02242942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810611|NCT02237079|Bazedoxifene|bazedoxifene|mesh-list
101810612|NCT02237079|Estrogens|estrogens|mesh-list
101810613|NCT02237079|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101810614|NCT02237079|Hormones|hormones|mesh-ancestor
101810615|NCT02237079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101810616|NCT02237079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810617|NCT02237079|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101810618|NCT02237079|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101810619|NCT02237079|Hormone Antagonists|hormone antagonists|mesh-ancestor
101810620|NCT02237079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101810621|NCT01992861|Deoxyglucose|deoxyglucose|mesh-list
101810622|NCT01992861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101810623|NCT01992861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101810624|NCT01992861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810625|NCT01992861|Antimetabolites|antimetabolites|mesh-ancestor
101810626|NCT01992861|Antiviral Agents|antiviral agents|mesh-ancestor
101810627|NCT01992861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101810628|NCT01267448|Metformin|metformin|mesh-list
101810629|NCT01267448|Saxagliptin|saxagliptin|mesh-list
101810630|NCT01267448|Glipizide|glipizide|mesh-list
101810631|NCT01267448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101810632|NCT01267448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810633|NCT01267448|Incretins|incretins|mesh-ancestor
101810634|NCT01267448|Hormones|hormones|mesh-ancestor
101810635|NCT01267448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101810636|NCT01267448|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101810637|NCT01267448|Protease Inhibitors|protease inhibitors|mesh-ancestor
101810638|NCT01267448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101810639|NCT01267448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810641|NCT01265030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101810642|NCT01265030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101810643|NCT01265030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101810644|NCT01265030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101810645|NCT01265030|Antifungal Agents|antifungal agents|mesh-ancestor
101810646|NCT01265030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101810647|NCT01265030|Immunologic Factors|immunologic factors|mesh-ancestor
101810648|NCT01265030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810650|NCT00901511|Immunologic Factors|immunologic factors|mesh-ancestor
101810651|NCT00901511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810652|NCT00775476|Acetylcysteine|acetylcysteine|mesh-list
101810653|NCT00775476|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101810654|NCT00775476|Antiviral Agents|antiviral agents|mesh-ancestor
101810655|NCT00775476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101810656|NCT00775476|Expectorants|expectorants|mesh-ancestor
101810657|NCT00775476|Respiratory System Agents|respiratory system agents|mesh-ancestor
101810658|NCT00775476|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101810659|NCT00775476|Antioxidants|antioxidants|mesh-ancestor
101810660|NCT00775476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810661|NCT00775476|Protective Agents|protective agents|mesh-ancestor
101810662|NCT00775476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810664|NCT00202813|Anti-Infective Agents|anti-infective agents|mesh-list
101810666|NCT00004180|Rosiglitazone|rosiglitazone|mesh-list
101810667|NCT00004180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101810668|NCT00004180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810669|NCT00988494|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101810670|NCT00988494|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101810671|NCT00539994|Retapamulin|retapamulin|mesh-list
101810672|NCT00539994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101810673|NCT00539994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101810674|NCT04005222|Selenium|selenium|mesh-list
101810675|NCT04005222|Melatonin|melatonin|mesh-list
101810676|NCT04005222|Antioxidants|antioxidants|mesh-ancestor
101810677|NCT04005222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810678|NCT04005222|Protective Agents|protective agents|mesh-ancestor
101810679|NCT04005222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810680|NCT04005222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101810681|NCT04005222|Trace Elements|trace elements|mesh-ancestor
101810682|NCT04005222|Micronutrients|micronutrients|mesh-ancestor
101810683|NCT00098839|Leucovorin|leucovorin|mesh-list
101810684|NCT00098839|Cytarabine|cytarabine|mesh-list
101810685|NCT00098839|Prednisone|prednisone|mesh-list
101810686|NCT00098839|Hydrocortisone|hydrocortisone|mesh-list
101810687|NCT00098839|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101810688|NCT00098839|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101810689|NCT00098839|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101810691|NCT00098839|Doxorubicin|doxorubicin|mesh-list
101810692|NCT00098839|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101810693|NCT00098839|Methotrexate|methotrexate|mesh-list
101810694|NCT00098839|Etoposide|etoposide|mesh-list
101810695|NCT00098839|Vincristine|vincristine|mesh-list
101810696|NCT00098839|Etoposide phosphate|etoposide phosphate|mesh-list
101810697|NCT00098839|Asparaginase|asparaginase|mesh-list
101810698|NCT00098839|Pegaspargase|pegaspargase|mesh-list
101810699|NCT00098839|Epratuzumab|epratuzumab|mesh-list
101810700|NCT00098839|Dexrazoxane|dexrazoxane|mesh-list
101810701|NCT00098839|Razoxane|razoxane|mesh-list
101810702|NCT00098839|Levoleucovorin|levoleucovorin|mesh-list
101810703|NCT00098839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101810704|NCT00098839|Immunologic Factors|immunologic factors|mesh-ancestor
101810705|NCT00098839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810706|NCT00098839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101810707|NCT00098839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101810708|NCT00098839|Alkylating Agents|alkylating agents|mesh-ancestor
101810709|NCT00098839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810711|NCT00098839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101810712|NCT00098839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101810713|NCT00098839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101810714|NCT00098839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101810715|NCT00098839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101810716|NCT00098839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101810717|NCT00098839|Glucocorticoids|glucocorticoids|mesh-ancestor
101810718|NCT00098839|Hormones|hormones|mesh-ancestor
101810719|NCT00098839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101810720|NCT00098839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101810721|NCT00098839|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101810723|NCT00098839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101810724|NCT00098839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101810725|NCT00098839|Antimetabolites|antimetabolites|mesh-ancestor
101810726|NCT00098839|Dermatologic Agents|dermatologic agents|mesh-ancestor
101810727|NCT00098839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101810728|NCT00098839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101810729|NCT00098839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101810730|NCT00098839|Antiviral Agents|antiviral agents|mesh-ancestor
101810731|NCT00098839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101810732|NCT00098839|Antidotes|antidotes|mesh-ancestor
101810733|NCT00098839|Protective Agents|protective agents|mesh-ancestor
101810734|NCT00098839|Vitamin B Complex|vitamin b complex|mesh-ancestor
101810735|NCT00098839|Vitamins|vitamins|mesh-ancestor
101810736|NCT00098839|Micronutrients|micronutrients|mesh-ancestor
101810737|NCT00098839|Tubulin Modulators|tubulin modulators|mesh-ancestor
101311935|NCT00006118|Gemcitabine|gemcitabine|mesh-list
101810738|NCT00098839|Antimitotic Agents|antimitotic agents|mesh-ancestor
101810739|NCT00098839|Mitosis Modulators|mitosis modulators|mesh-ancestor
101810740|NCT00098839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101810741|NCT00098839|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101810742|NCT05268744|Micronutrients|micronutrients|mesh-list
101810743|NCT05268744|Trace Elements|trace elements|mesh-list
101810744|NCT05268744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810745|NCT02531191|Peficitinib|peficitinib|mesh-list
101810746|NCT02531191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101810747|NCT02531191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810748|NCT02531191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101810749|NCT02531191|Immunologic Factors|immunologic factors|mesh-ancestor
101810750|NCT02531191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810751|NCT01081639|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101810752|NCT01081639|Hormones|hormones|mesh-ancestor
101810753|NCT01081639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101810754|NCT01081639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810755|NCT01081717|Golimumab|golimumab|mesh-list
101810756|NCT01081717|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101810757|NCT01081717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101810758|NCT01081717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101810759|NCT01081717|Immunologic Factors|immunologic factors|mesh-ancestor
101810760|NCT01081717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810761|NCT01085383|Aripiprazole|aripiprazole|mesh-list
101810762|NCT01085383|Antidepressive Agents|antidepressive agents|mesh-ancestor
101810763|NCT01085383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101810764|NCT01085383|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101810765|NCT01085383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101810766|NCT01085383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101810767|NCT01085383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810768|NCT01085383|Dopamine Agonists|dopamine agonists|mesh-ancestor
101810769|NCT01085383|Dopamine Agents|dopamine agents|mesh-ancestor
101810770|NCT01085383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101810771|NCT01085383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810772|NCT01085383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101810773|NCT01085383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101810774|NCT01085383|Serotonin Agents|serotonin agents|mesh-ancestor
101810775|NCT01085383|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101810776|NCT01085383|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101810777|NCT01085383|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101810778|NCT01085383|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101810779|NCT00485589|Methotrexate|methotrexate|mesh-list
101810780|NCT00485589|Ocrelizumab|ocrelizumab|mesh-list
101810781|NCT00485589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101810782|NCT00485589|Abortifacient Agents|abortifacient agents|mesh-ancestor
101810783|NCT00485589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101810784|NCT00485589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810785|NCT00485589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101810786|NCT00485589|Antimetabolites|antimetabolites|mesh-ancestor
101810787|NCT00485589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810788|NCT00485589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101810789|NCT00485589|Dermatologic Agents|dermatologic agents|mesh-ancestor
101810790|NCT00485589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101810791|NCT00485589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101810792|NCT00485589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101810793|NCT00485589|Immunologic Factors|immunologic factors|mesh-ancestor
101810794|NCT00485589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101810795|NCT00485589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101810797|NCT00490971|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101810798|NCT00490971|Antiemetics|antiemetics|mesh-ancestor
101810799|NCT00490971|Autonomic Agents|autonomic agents|mesh-ancestor
101810800|NCT00490971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101810801|NCT00490971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810802|NCT00490971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101810803|NCT00490971|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101810804|NCT00490971|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101810805|NCT00490971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101810806|NCT00490971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101810807|NCT00490971|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101311940|NCT00006118|Mitosis Modulators|mitosis modulators|mesh-ancestor
101810808|NCT00490971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101810809|NCT00490971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101810810|NCT00490971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810811|NCT00490971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101810812|NCT00490971|Serotonin Agents|serotonin agents|mesh-ancestor
101810813|NCT00490971|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101810814|NCT00490971|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101810815|NCT00490971|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101468134|NCT01645774|Sympathomimetics|sympathomimetics|mesh-ancestor
101810817|NCT00490971|Dopamine Agents|dopamine agents|mesh-ancestor
101810818|NCT04286295|Nicotine|nicotine|mesh-list
101810819|NCT04286295|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101810820|NCT04286295|Autonomic Agents|autonomic agents|mesh-ancestor
101810821|NCT04286295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101810822|NCT04286295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810823|NCT04286295|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101810824|NCT04286295|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101810825|NCT04286295|Cholinergic Agents|cholinergic agents|mesh-ancestor
101810826|NCT04286295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101810827|NCT04286295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810828|NCT00750347|Acetaminophen|acetaminophen|mesh-list
101810829|NCT00750347|Rimonabant|rimonabant|mesh-list
101810830|NCT00750347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101810831|NCT00750347|Analgesics|analgesics|mesh-ancestor
101810832|NCT00750347|Sensory System Agents|sensory system agents|mesh-ancestor
101810833|NCT00750347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101810834|NCT00750347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810835|NCT00750347|Antipyretics|antipyretics|mesh-ancestor
101810836|NCT00750347|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101810837|NCT00750347|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
101810838|NCT00750347|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101810839|NCT00750347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101810840|NCT00750347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810841|NCT00750347|Hormones|hormones|mesh-ancestor
101246509|NCT01666418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810842|NCT00750347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101810843|NCT00750425|Cediranib|cediranib|mesh-list
101810844|NCT00750425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101810845|NCT00750425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101810846|NCT00750425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101810847|NCT00750425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810848|NCT00745589|Sevelamer|sevelamer|mesh-list
101810849|NCT00745589|Chelating Agents|chelating agents|mesh-ancestor
101810850|NCT00745589|Sequestering Agents|sequestering agents|mesh-ancestor
101810851|NCT00745589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810852|NCT00750581|Indomethacin|indomethacin|mesh-list
101810853|NCT00750581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101810854|NCT00750581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101810855|NCT00750581|Analgesics|analgesics|mesh-ancestor
101810856|NCT00750581|Sensory System Agents|sensory system agents|mesh-ancestor
101810857|NCT00750581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101810858|NCT00750581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810859|NCT00750581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101810860|NCT00750581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101810861|NCT00750581|Gout Suppressants|gout suppressants|mesh-ancestor
101810862|NCT00750581|Tocolytic Agents|tocolytic agents|mesh-ancestor
101810863|NCT00750581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101810864|NCT00750581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101810865|NCT00750581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101810866|NCT00750581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810867|NCT00685763|Gemcitabine|gemcitabine|mesh-list
101810868|NCT00685763|Capecitabine|capecitabine|mesh-list
101810869|NCT00685763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101810870|NCT00685763|Antimetabolites|antimetabolites|mesh-ancestor
101810871|NCT00685763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810872|NCT00685763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101810873|NCT00098293|Lamivudine|lamivudine|mesh-list
101810874|NCT00098293|Zidovudine|zidovudine|mesh-list
101810875|NCT00098293|Efavirenz|efavirenz|mesh-list
101810876|NCT00098293|Maraviroc|maraviroc|mesh-list
101810877|NCT00098293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101810878|NCT00098293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101810879|NCT00098293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101810880|NCT00098293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810881|NCT00098293|Antiviral Agents|antiviral agents|mesh-ancestor
101810882|NCT00098293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101810883|NCT00098293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101810884|NCT00098293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101810885|NCT00098293|Antimetabolites|antimetabolites|mesh-ancestor
101810886|NCT00098293|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101810887|NCT00098293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101810888|NCT00098293|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101810889|NCT00098293|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101810890|NCT00098293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101810891|NCT00098293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101810892|NCT00098293|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101810893|NCT00098293|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101810894|NCT00098293|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101810895|NCT00923741|Talactoferrin alfa|talactoferrin alfa|mesh-list
101810896|NCT00923741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101810898|NCT00685685|L 647318|l 647318|mesh-list
101810899|NCT00685685|Dihydromevinolin|dihydromevinolin|mesh-list
101810900|NCT00685685|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101810901|NCT00685685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101810902|NCT00685685|Antimetabolites|antimetabolites|mesh-ancestor
101810903|NCT00685685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810904|NCT00685685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101810905|NCT00685685|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101810906|NCT00685685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101810907|NCT01087567|Insulin|insulin|mesh-list
101810908|NCT01087567|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101810909|NCT01087567|Metformin|metformin|mesh-list
101810910|NCT01087567|Pioglitazone|pioglitazone|mesh-list
101810911|NCT01087567|Glimepiride|glimepiride|mesh-list
101810912|NCT01087567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101810913|NCT01087567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810914|NCT01087567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101810915|NCT01087567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101810916|NCT01087567|Immunologic Factors|immunologic factors|mesh-ancestor
101810917|NCT00751049|Timolol|timolol|mesh-list
101810918|NCT00751049|Latanoprost|latanoprost|mesh-list
101810919|NCT00751049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101810920|NCT00751049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101810921|NCT00751049|Adrenergic Agents|adrenergic agents|mesh-ancestor
101810922|NCT00751049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101810923|NCT00751049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810924|NCT00751049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810925|NCT00751049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101810926|NCT00751049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101810927|NCT00751049|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101810928|NCT00751049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101810929|NCT00500331|Pioglitazone|pioglitazone|mesh-list
101810930|NCT00500331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101810931|NCT00500331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810932|NCT01019109|Cobalt|cobalt|mesh-list
101810933|NCT01019109|Trace Elements|trace elements|mesh-ancestor
101810934|NCT01019109|Micronutrients|micronutrients|mesh-ancestor
101810935|NCT01019109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810936|NCT00499863|Methylphenidate|methylphenidate|mesh-list
101810937|NCT00499863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101810938|NCT00499863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810939|NCT00499863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101810940|NCT00499863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101810941|NCT00499863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101810942|NCT00499863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810943|NCT00499863|Dopamine Agents|dopamine agents|mesh-ancestor
101810944|NCT00499863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101810945|NCT04475835|Heparin|heparin|mesh-list
101810946|NCT04475835|Bivalirudin|bivalirudin|mesh-list
101810947|NCT04475835|Anticoagulants|anticoagulants|mesh-ancestor
101810948|NCT04475835|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101810949|NCT04475835|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101810950|NCT04475835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101810951|NCT04475835|Antithrombins|antithrombins|mesh-ancestor
101810952|NCT04475835|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101810953|NCT04475835|Protease Inhibitors|protease inhibitors|mesh-ancestor
101810954|NCT04475835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101810955|NCT01014507|Goserelin|goserelin|mesh-list
101810956|NCT01014507|Contraceptive Agents|contraceptive agents|mesh-list
101810957|NCT01014507|Contraceptives, Oral|contraceptives, oral|mesh-list
101810958|NCT01014507|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101810959|NCT01014507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810960|NCT01014507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101810961|NCT01014507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101810962|NCT01014507|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101810963|NCT00097981|Thalidomide|thalidomide|mesh-list
101810964|NCT00097981|Dexamethasone|dexamethasone|mesh-list
101810965|NCT00097981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101810966|NCT00097981|Antiemetics|antiemetics|mesh-ancestor
101810967|NCT00097981|Autonomic Agents|autonomic agents|mesh-ancestor
101810968|NCT00097981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101810969|NCT00097981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810970|NCT00097981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101810971|NCT00097981|Glucocorticoids|glucocorticoids|mesh-ancestor
101810973|NCT00097981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101810974|NCT00097981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101810975|NCT00097981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101810976|NCT00097981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101810977|NCT00097981|Immunologic Factors|immunologic factors|mesh-ancestor
101810978|NCT00097981|Leprostatic Agents|leprostatic agents|mesh-ancestor
101810979|NCT00097981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101810980|NCT00097981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101810981|NCT00097981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101810982|NCT00097981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101810983|NCT00097981|Growth Substances|growth substances|mesh-ancestor
101810984|NCT00097981|Growth Inhibitors|growth inhibitors|mesh-ancestor
101810985|NCT01016145|Antipsychotic Agents|antipsychotic agents|mesh-list
101810986|NCT01016145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101810987|NCT01016145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101810988|NCT01016145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101810989|NCT01016145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810990|NCT01016223|Beclomethasone|beclomethasone|mesh-list
101810991|NCT01016223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101810992|NCT01016223|Glucocorticoids|glucocorticoids|mesh-ancestor
101810993|NCT01016223|Hormones|hormones|mesh-ancestor
101810994|NCT01016223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101810995|NCT01016223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101810996|NCT01016223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101810997|NCT01016223|Respiratory System Agents|respiratory system agents|mesh-ancestor
101810998|NCT04151017|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101810999|NCT04151017|Hemostatics|hemostatics|mesh-ancestor
101811000|NCT04151017|Coagulants|coagulants|mesh-ancestor
101811001|NCT01019265|Buprenorphine|buprenorphine|mesh-list
101811002|NCT01019265|Tramadol|tramadol|mesh-list
101811003|NCT01019265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101811004|NCT01019265|Narcotics|narcotics|mesh-ancestor
101811005|NCT01019265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101811006|NCT01019265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811007|NCT01019265|Analgesics|analgesics|mesh-ancestor
101811008|NCT01019265|Sensory System Agents|sensory system agents|mesh-ancestor
101811009|NCT01019265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101811010|NCT01019265|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101811011|NCT01085617|Cytarabine|cytarabine|mesh-list
101811012|NCT01085617|Cyclophosphamide|cyclophosphamide|mesh-list
101811013|NCT01085617|Melphalan|melphalan|mesh-list
101811014|NCT01085617|Rituximab|rituximab|mesh-list
101811015|NCT01085617|Methotrexate|methotrexate|mesh-list
101811016|NCT01085617|Fludarabine|fludarabine|mesh-list
101811017|NCT01085617|Fludarabine phosphate|fludarabine phosphate|mesh-list
101811018|NCT01085617|Etoposide|etoposide|mesh-list
101811019|NCT01085617|Vincristine|vincristine|mesh-list
101811020|NCT01085617|Imatinib Mesylate|imatinib mesylate|mesh-list
101811021|NCT01085617|Daunorubicin|daunorubicin|mesh-list
101811022|NCT01085617|Mercaptopurine|mercaptopurine|mesh-list
101811023|NCT01085617|Pegaspargase|pegaspargase|mesh-list
101811024|NCT01085617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101811025|NCT01085617|Immunologic Factors|immunologic factors|mesh-ancestor
101811026|NCT01085617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811027|NCT01085617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101456540|NCT00245115|Busulfan|busulfan|mesh-list
101811028|NCT01085617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101811029|NCT01085617|Alkylating Agents|alkylating agents|mesh-ancestor
101811030|NCT01085617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811031|NCT01085617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101811033|NCT01085617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101811034|NCT01085617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101811035|NCT01085617|Abortifacient Agents|abortifacient agents|mesh-ancestor
101811036|NCT01085617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101811037|NCT01085617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101811038|NCT01085617|Antimetabolites|antimetabolites|mesh-ancestor
101811039|NCT01085617|Dermatologic Agents|dermatologic agents|mesh-ancestor
101811040|NCT01085617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101811041|NCT01085617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101811042|NCT01085617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101811043|NCT01085617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101246510|NCT01666431|Lapatinib|lapatinib|mesh-list
101811044|NCT01085617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101811045|NCT01085617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101811046|NCT01085617|Antiviral Agents|antiviral agents|mesh-ancestor
101811047|NCT01085617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101811048|NCT01085617|Tubulin Modulators|tubulin modulators|mesh-ancestor
101811049|NCT01085617|Antimitotic Agents|antimitotic agents|mesh-ancestor
101811050|NCT01085617|Mitosis Modulators|mitosis modulators|mesh-ancestor
101811051|NCT01085617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101811052|NCT01085617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101811053|NCT00499083|Tamoxifen|tamoxifen|mesh-list
101811054|NCT00499083|Paclitaxel|paclitaxel|mesh-list
101811055|NCT00499083|Cyclophosphamide|cyclophosphamide|mesh-list
101811056|NCT00499083|Doxorubicin|doxorubicin|mesh-list
101811057|NCT00499083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101811058|NCT00499083|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101811059|NCT00499083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101811060|NCT00499083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101811061|NCT00499083|Tubulin Modulators|tubulin modulators|mesh-ancestor
101811062|NCT00499083|Antimitotic Agents|antimitotic agents|mesh-ancestor
101811063|NCT00499083|Mitosis Modulators|mitosis modulators|mesh-ancestor
101811064|NCT00499083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811065|NCT00499083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101811066|NCT00499083|Immunologic Factors|immunologic factors|mesh-ancestor
101811067|NCT00499083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811068|NCT00499083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101811069|NCT00499083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101811070|NCT00499083|Alkylating Agents|alkylating agents|mesh-ancestor
101811071|NCT00499083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101811072|NCT00499083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101811073|NCT00499083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101811074|NCT00499083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101811075|NCT00499083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101811076|NCT00499083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101811077|NCT00499083|Hormone Antagonists|hormone antagonists|mesh-ancestor
101811078|NCT00499083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101811079|NCT00499083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101811080|NCT00499083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101811081|NCT00499083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101811082|NCT00499083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101811083|NCT00499083|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101811084|NCT01087879|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101811085|NCT01087879|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101811086|NCT01087879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101811087|NCT01087879|Etonogestrel|etonogestrel|mesh-list
101811088|NCT01087879|Desogestrel|desogestrel|mesh-list
101811089|NCT01087879|NuvaRing|nuvaring|mesh-list
101811090|NCT01087879|Norelgestromin|norelgestromin|mesh-list
101811091|NCT01087879|Contraceptive Agents|contraceptive agents|mesh-list
101811092|NCT01087879|Estradiol|estradiol|mesh-list
101811093|NCT01087879|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101811094|NCT01087879|Estrogens|estrogens|mesh-ancestor
101811095|NCT01087879|Hormones|hormones|mesh-ancestor
101811096|NCT01087879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101311953|NCT00006124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101811097|NCT01087879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811098|NCT01087879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101811099|NCT01087879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101811100|NCT01087879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101811101|NCT01087879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101811102|NCT01087879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101811103|NCT01087879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101811104|NCT01087879|Progestins|progestins|mesh-ancestor
101811105|NCT01019421|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
101811107|NCT01019421|Serotonin Agents|serotonin agents|mesh-ancestor
101811108|NCT01019421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101811109|NCT01019421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811110|NCT01019421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811111|NCT01085695|Rabeprazole|rabeprazole|mesh-list
101811112|NCT01085695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101811113|NCT01085695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101811114|NCT01085695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101811115|NCT01085695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101811116|NCT01085695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468440|NCT00250536|Nandrolone|nandrolone|mesh-list
101811117|NCT01088035|Carboplatin|carboplatin|mesh-list
101811118|NCT01088035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101811119|NCT01085851|Chlorpheniramine|chlorpheniramine|mesh-list
101811120|NCT01085851|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
101811121|NCT01085851|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101811122|NCT01085851|Histamine Antagonists|histamine antagonists|mesh-ancestor
101811123|NCT01085851|Histamine Agents|histamine agents|mesh-ancestor
101811124|NCT01085851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101811125|NCT01085851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811126|NCT01085851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811127|NCT01085851|Antipruritics|antipruritics|mesh-ancestor
101811128|NCT01085851|Dermatologic Agents|dermatologic agents|mesh-ancestor
101811129|NCT01085851|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101811131|NCT00751127|Latanoprost|latanoprost|mesh-list
101811132|NCT00751127|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101811133|NCT00751127|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101811134|NCT00751127|Adrenergic Agents|adrenergic agents|mesh-ancestor
101811135|NCT00751127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101811136|NCT00751127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811137|NCT00751127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811138|NCT00751127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101811139|NCT00751127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101811140|NCT00751127|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101811141|NCT00751127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101811142|NCT00751205|Acetylcarnitine|acetylcarnitine|mesh-list
101811143|NCT00751205|Prednisone|prednisone|mesh-list
101811144|NCT00751205|Prednisolone|prednisolone|mesh-list
101811145|NCT00751205|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101811146|NCT00751205|Methylprednisolone|methylprednisolone|mesh-list
101811147|NCT00751205|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101811148|NCT00751205|Prednisolone acetate|prednisolone acetate|mesh-list
101811149|NCT00751205|Sagopilone|sagopilone|mesh-list
101811150|NCT00751205|Epothilones|epothilones|mesh-list
101811151|NCT00751205|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101811152|NCT00751205|Prednisolone phosphate|prednisolone phosphate|mesh-list
101811153|NCT00751205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101811154|NCT00751205|Glucocorticoids|glucocorticoids|mesh-ancestor
101811155|NCT00751205|Hormones|hormones|mesh-ancestor
101812003|NCT01082263|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101811156|NCT00751205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101811157|NCT00751205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811158|NCT00751205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101811159|NCT00751205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101811161|NCT00751205|Autonomic Agents|autonomic agents|mesh-ancestor
101311959|NCT00006127|Amifostine|amifostine|mesh-list
101811162|NCT00751205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101811163|NCT00751205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101811164|NCT00751205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101811165|NCT00751205|Protective Agents|protective agents|mesh-ancestor
101811166|NCT00751205|Vitamin B Complex|vitamin b complex|mesh-ancestor
101811168|NCT00751205|Micronutrients|micronutrients|mesh-ancestor
101811169|NCT00751205|Nootropic Agents|nootropic agents|mesh-ancestor
101811170|NCT00751205|Tubulin Modulators|tubulin modulators|mesh-ancestor
101811171|NCT00751205|Antimitotic Agents|antimitotic agents|mesh-ancestor
101811172|NCT00751205|Mitosis Modulators|mitosis modulators|mesh-ancestor
101811173|NCT00751205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811174|NCT00752063|Capecitabine|capecitabine|mesh-list
101811175|NCT00752063|Oxaliplatin|oxaliplatin|mesh-list
101811176|NCT00752063|Sorafenib|sorafenib|mesh-list
101811177|NCT00752063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101811178|NCT00752063|Antimetabolites|antimetabolites|mesh-ancestor
101811179|NCT00752063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811180|NCT00752063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101811181|NCT00752063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101811182|NCT00752063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101811183|NCT00752141|Mandelic Acids|mandelic acids|mesh-list
101811184|NCT00752141|Oxybutynin|oxybutynin|mesh-list
101811185|NCT00752141|Parasympatholytics|parasympatholytics|mesh-ancestor
101811186|NCT00752141|Autonomic Agents|autonomic agents|mesh-ancestor
101811187|NCT00752141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101811188|NCT00752141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811189|NCT00752141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101811190|NCT00752141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101811191|NCT00752141|Cholinergic Agents|cholinergic agents|mesh-ancestor
101811192|NCT00752141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101811193|NCT00752141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811194|NCT00752141|Urological Agents|urological agents|mesh-ancestor
101811195|NCT00752141|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101811196|NCT00752141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101811197|NCT00752375|Trimethoprim|trimethoprim|mesh-list
101811198|NCT00752375|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101811199|NCT00752375|Sulfamethoxazole|sulfamethoxazole|mesh-list
101811200|NCT00752375|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101811201|NCT00752375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101811203|NCT00752375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101811204|NCT00752375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101811205|NCT00752375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101811206|NCT00752375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101811207|NCT00752375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811208|NCT00752375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101811209|NCT00752375|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101811210|NCT00752375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101811211|NCT00752375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101811213|NCT00751517|Methotrexate|methotrexate|mesh-list
101811214|NCT00751517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101811215|NCT00751517|Immunologic Factors|immunologic factors|mesh-ancestor
101811216|NCT00751517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811217|NCT00751517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101811218|NCT00751517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101811219|NCT00751517|Alkylating Agents|alkylating agents|mesh-ancestor
101811220|NCT00751517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811221|NCT00751517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101811222|NCT00751517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101811223|NCT00751517|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101811224|NCT00751517|Abortifacient Agents|abortifacient agents|mesh-ancestor
101811225|NCT00751517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101811226|NCT00751517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101811227|NCT00751517|Antimetabolites|antimetabolites|mesh-ancestor
101811228|NCT00751517|Dermatologic Agents|dermatologic agents|mesh-ancestor
101811229|NCT00751517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101811230|NCT00751517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101811231|NCT00751517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101811232|NCT02561117|Metronidazole|metronidazole|mesh-list
101811233|NCT02561117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101811234|NCT02561117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101811235|NCT02561117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101811236|NCT02561117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101811237|NCT00684515|Aspirin|aspirin|mesh-list
101811238|NCT00684515|Vorapaxar|vorapaxar|mesh-list
101811239|NCT00684515|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101811240|NCT00684515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101811241|NCT00684515|Analgesics|analgesics|mesh-ancestor
101811242|NCT00684515|Sensory System Agents|sensory system agents|mesh-ancestor
101811243|NCT00684515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101811244|NCT00684515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811245|NCT00684515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101811246|NCT00684515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101811247|NCT00684515|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101811248|NCT00684515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101811249|NCT00684515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811250|NCT00684515|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101811251|NCT00684515|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101811252|NCT00684515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101811253|NCT00684515|Antipyretics|antipyretics|mesh-ancestor
101811254|NCT00751751|Losartan|losartan|mesh-list
101811255|NCT00751751|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101811256|NCT00751751|Olmesartan|olmesartan|mesh-list
101811257|NCT00751751|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101811258|NCT00751751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101811259|NCT00751751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101811260|NCT00751751|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101811261|NCT00751751|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101811262|NCT00751751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811263|NCT00751751|Diuretics|diuretics|mesh-ancestor
101811264|NCT00751751|Natriuretic Agents|natriuretic agents|mesh-ancestor
101811265|NCT00751751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811266|NCT00751751|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101811267|NCT00751751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101811268|NCT00490815|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
101811269|NCT00490815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101811270|NCT00490815|Glucocorticoids|glucocorticoids|mesh-ancestor
101811272|NCT00490815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101811273|NCT00490815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811274|NCT04453137|Adalimumab|adalimumab|mesh-list
101811275|NCT04453137|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101811276|NCT04453137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101811277|NCT04453137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101811278|NCT03855189|Mometasone Furoate|mometasone furoate|mesh-list
101811279|NCT03855189|Beclomethasone|beclomethasone|mesh-list
101811280|NCT03855189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101811281|NCT03855189|Dermatologic Agents|dermatologic agents|mesh-ancestor
101811282|NCT03855189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101811283|NCT03855189|Glucocorticoids|glucocorticoids|mesh-ancestor
101811284|NCT03855189|Hormones|hormones|mesh-ancestor
101811285|NCT03855189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101811286|NCT03855189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811287|NCT03855189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101812024|NCT01017159|Antibodies|antibodies|mesh-list
101811288|NCT03855189|Respiratory System Agents|respiratory system agents|mesh-ancestor
101811289|NCT03853551|Osimertinib|osimertinib|mesh-list
101811290|NCT03853551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101811291|NCT03853551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101811292|NCT03853551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101811293|NCT03853551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811295|NCT00423670|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101811296|NCT00423670|Antimetabolites|antimetabolites|mesh-ancestor
101811297|NCT00423670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811298|NCT00423670|Antiviral Agents|antiviral agents|mesh-ancestor
101811299|NCT00423670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101811300|NCT01019655|Nadroparin|nadroparin|mesh-list
101811301|NCT01019655|Calcium|calcium|mesh-list
101811302|NCT01019655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101811303|NCT01019655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811304|NCT01019655|Anticoagulants|anticoagulants|mesh-ancestor
101811305|NCT01019655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101811306|NCT01019655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101311972|NCT00006133|Estrogens|estrogens|mesh-ancestor
101811307|NCT01019655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811308|NCT00483717|Ketorolac|ketorolac|mesh-list
101811309|NCT00483717|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101811310|NCT00483717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101811311|NCT00483717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101811312|NCT00483717|Analgesics|analgesics|mesh-ancestor
101811313|NCT00483717|Sensory System Agents|sensory system agents|mesh-ancestor
101811314|NCT00483717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101811315|NCT00483717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811316|NCT00483717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101811317|NCT00483717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101811318|NCT00483717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101811319|NCT00483717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101811320|NCT00483717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811321|NCT00406354|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101811322|NCT00406354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101811323|NCT00406354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101811324|NCT00406354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101811325|NCT00406354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811326|NCT00406354|Adrenergic Agents|adrenergic agents|mesh-ancestor
101811327|NCT00406354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101811328|NCT00406354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811329|NCT01037842|Mitiglinide|mitiglinide|mesh-list
101811330|NCT01037842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101811331|NCT01037842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811332|NCT00483405|Capecitabine|capecitabine|mesh-list
101811333|NCT00483405|Oxaliplatin|oxaliplatin|mesh-list
101811334|NCT00483405|Cetuximab|cetuximab|mesh-list
101811335|NCT00483405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101811336|NCT00483405|Antimetabolites|antimetabolites|mesh-ancestor
101811337|NCT00483405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811338|NCT00483405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101811339|NCT00483405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101811340|NCT00483327|Megestrol|megestrol|mesh-list
101811341|NCT00483327|Megestrol Acetate|megestrol acetate|mesh-list
101811342|NCT00483327|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101811343|NCT00483327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101811344|NCT00483327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101811345|NCT00483327|Contraceptive Agents|contraceptive agents|mesh-ancestor
101811346|NCT00483327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101811347|NCT00483327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811348|NCT00483327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101811349|NCT00483327|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101811350|NCT00483327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101811351|NCT00483327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101811352|NCT00483327|Appetite Stimulants|appetite stimulants|mesh-ancestor
101812028|NCT00494013|Protamines|protamines|mesh-list
101811353|NCT00483327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101811355|NCT00684203|Clopidogrel|clopidogrel|mesh-list
101811356|NCT00684203|Vorapaxar|vorapaxar|mesh-list
101811357|NCT00684203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101811358|NCT00684203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101811359|NCT00684203|Analgesics|analgesics|mesh-ancestor
101811360|NCT00684203|Sensory System Agents|sensory system agents|mesh-ancestor
101811361|NCT00684203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101811362|NCT00684203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811363|NCT00684203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101811364|NCT00684203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101811365|NCT00684203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101811366|NCT00684203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101811367|NCT00684203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811368|NCT00684203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101811369|NCT00684203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101811370|NCT00684203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101811371|NCT00684203|Antipyretics|antipyretics|mesh-ancestor
101811372|NCT00684203|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101311973|NCT00006133|Hormones|hormones|mesh-ancestor
101811373|NCT00684203|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101811374|NCT00684203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101811375|NCT00684203|Purinergic Agents|purinergic agents|mesh-ancestor
101811376|NCT00684203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101811377|NCT00423592|Ambrisentan|ambrisentan|mesh-list
101811378|NCT00423592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101811379|NCT01037998|Gefitinib|gefitinib|mesh-list
101811380|NCT01037998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101811381|NCT01037998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101811382|NCT01037998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101811383|NCT01037998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811384|NCT00751907|Atorvastatin|atorvastatin|mesh-list
101811385|NCT00751907|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101811386|NCT00751907|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101811387|NCT00751907|Antimetabolites|antimetabolites|mesh-ancestor
101811388|NCT00751907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811389|NCT00751907|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101811390|NCT00751907|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101811391|NCT00751907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101811392|NCT00752843|Mifepristone|mifepristone|mesh-list
101811393|NCT00752843|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101811394|NCT00752843|Abortifacient Agents|abortifacient agents|mesh-ancestor
101811395|NCT00752843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101811396|NCT00752843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811397|NCT00752843|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101811398|NCT00752843|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101811399|NCT00752843|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101811400|NCT00752843|Contraceptive Agents|contraceptive agents|mesh-ancestor
101811401|NCT00752843|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101811402|NCT00752843|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101811403|NCT00752843|Hormone Antagonists|hormone antagonists|mesh-ancestor
101811404|NCT00752843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101811405|NCT00752843|Luteolytic Agents|luteolytic agents|mesh-ancestor
101811406|NCT00752843|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101811407|NCT00752843|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101811408|NCT00752921|Etoricoxib|etoricoxib|mesh-list
101811409|NCT00752921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101811410|NCT00752921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101811411|NCT00752921|Analgesics|analgesics|mesh-ancestor
101811412|NCT00752921|Sensory System Agents|sensory system agents|mesh-ancestor
101811413|NCT00752921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101812033|NCT00494013|Coagulants|coagulants|mesh-ancestor
101811414|NCT00752921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811415|NCT00752921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101811416|NCT00752921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101811417|NCT00752921|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101811418|NCT00752921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101811419|NCT00752921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101811420|NCT00752921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811421|NCT00683657|Saxagliptin|saxagliptin|mesh-list
101811422|NCT00683657|Incretins|incretins|mesh-ancestor
101811424|NCT00683657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101811425|NCT00683657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811426|NCT00683657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101811427|NCT00683657|Protease Inhibitors|protease inhibitors|mesh-ancestor
101811428|NCT00683657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101811429|NCT00683657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811430|NCT00683657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101811431|NCT00755885|Abiraterone Acetate|abiraterone acetate|mesh-list
101811432|NCT00755885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101811433|NCT00755885|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101811434|NCT00755885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101811435|NCT00755885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811436|NCT00755885|Hormone Antagonists|hormone antagonists|mesh-ancestor
101811437|NCT00755885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101811438|NCT00755885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811439|NCT00755885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101811440|NCT00755963|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101811441|NCT00755963|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101811442|NCT00755963|Estradiol|estradiol|mesh-list
101811443|NCT00755963|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101811444|NCT00755963|Progesterone|progesterone|mesh-list
101811445|NCT00755963|Estrogens|estrogens|mesh-ancestor
101811446|NCT00755963|Hormones|hormones|mesh-ancestor
101811447|NCT00755963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101811448|NCT00755963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811449|NCT00755963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101811450|NCT00755963|Contraceptive Agents|contraceptive agents|mesh-ancestor
101811451|NCT00755963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101811452|NCT00755963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101811453|NCT00755963|Progestins|progestins|mesh-ancestor
101811454|NCT00753311|Rizatriptan|rizatriptan|mesh-list
101811455|NCT00753311|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101811456|NCT00753311|Serotonin Agents|serotonin agents|mesh-ancestor
101811457|NCT00753311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101811458|NCT00753311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811459|NCT00753311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811460|NCT00753389|Anesthetics|anesthetics|mesh-list
101811461|NCT00753389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101811462|NCT00753389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811463|NCT00753467|Interferons|interferons|mesh-list
101811464|NCT00753467|Adefovir|adefovir|mesh-list
101811465|NCT00753467|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101811466|NCT00753467|Interferon-gamma|interferon-gamma|mesh-list
101811467|NCT00753467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101811468|NCT00753467|Antiviral Agents|antiviral agents|mesh-ancestor
101811469|NCT00753467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101811470|NCT00753467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101811471|NCT00753467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101811472|NCT00753467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101811473|NCT00753467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811474|NCT00482703|Dasatinib|dasatinib|mesh-list
101811475|NCT00482703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101811476|NCT00482703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101811477|NCT00482703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101811478|NCT00482703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811479|NCT04052867|Lidocaine|lidocaine|mesh-list
101811480|NCT04052867|Anesthetics, Local|anesthetics, local|mesh-ancestor
101811481|NCT04052867|Anesthetics|anesthetics|mesh-ancestor
101811482|NCT04052867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101811483|NCT04052867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811484|NCT04052867|Sensory System Agents|sensory system agents|mesh-ancestor
101811485|NCT04052867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101811486|NCT04052867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101811487|NCT04052867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101468803|NCT02218762|Sympathomimetics|sympathomimetics|mesh-ancestor
101811488|NCT04052867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101811489|NCT04052867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101811490|NCT04052867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811492|NCT00482391|Cyclophosphamide|cyclophosphamide|mesh-list
101811493|NCT00482391|Doxorubicin|doxorubicin|mesh-list
101811494|NCT00482391|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101811495|NCT00482391|Trastuzumab|trastuzumab|mesh-list
101811496|NCT00482391|Lapatinib|lapatinib|mesh-list
101811497|NCT00482391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101811498|NCT00482391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101811499|NCT00482391|Tubulin Modulators|tubulin modulators|mesh-ancestor
101811500|NCT00482391|Antimitotic Agents|antimitotic agents|mesh-ancestor
101811501|NCT00482391|Mitosis Modulators|mitosis modulators|mesh-ancestor
101811502|NCT00482391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811503|NCT00482391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101811504|NCT00482391|Immunologic Factors|immunologic factors|mesh-ancestor
101811506|NCT00482391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101811507|NCT00482391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101811508|NCT00482391|Alkylating Agents|alkylating agents|mesh-ancestor
101811509|NCT00482391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101811510|NCT00482391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101811511|NCT00482391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101811512|NCT00482391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101811513|NCT00482391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101811514|NCT00482391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101811515|NCT00482391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101811516|NCT00753779|Simvastatin|simvastatin|mesh-list
101811517|NCT00753779|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
101811518|NCT00753779|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101811519|NCT00753779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101811520|NCT00753779|Antimetabolites|antimetabolites|mesh-ancestor
101811521|NCT00753779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811522|NCT00753779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101811523|NCT00753779|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101811524|NCT00753779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101811525|NCT00757523|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
101811526|NCT00757523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101811527|NCT00757523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101811528|NCT00757523|Analgesics|analgesics|mesh-ancestor
101811529|NCT00757523|Sensory System Agents|sensory system agents|mesh-ancestor
101811530|NCT00757523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101811531|NCT00757523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811532|NCT00757523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101811533|NCT00757523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101811534|NCT00757523|Dermatologic Agents|dermatologic agents|mesh-ancestor
101811535|NCT00757679|Milnacipran|milnacipran|mesh-list
101811536|NCT00757679|Levomilnacipran|levomilnacipran|mesh-list
101812055|NCT00493467|Rituximab|rituximab|mesh-list
101811537|NCT00757679|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101811538|NCT00757679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101811539|NCT00757679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101811540|NCT00757679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811541|NCT00757679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101811542|NCT00757679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811543|NCT00757679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101811545|NCT00757679|Sensory System Agents|sensory system agents|mesh-ancestor
101811546|NCT00757679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101811547|NCT00757679|Antidepressive Agents|antidepressive agents|mesh-ancestor
101811548|NCT00757679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101811549|NCT00496587|Bevacizumab|bevacizumab|mesh-list
101811550|NCT00496587|Gemcitabine|gemcitabine|mesh-list
101811551|NCT00496587|Capecitabine|capecitabine|mesh-list
101811552|NCT00496587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101811553|NCT00496587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101811554|NCT00496587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101811555|NCT00496587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101811556|NCT00496587|Growth Substances|growth substances|mesh-ancestor
101811557|NCT00496587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811558|NCT00496587|Growth Inhibitors|growth inhibitors|mesh-ancestor
101811559|NCT00496587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101468877|NCT02219737|Carboplatin|carboplatin|mesh-list
101811560|NCT00496587|Antimetabolites|antimetabolites|mesh-ancestor
101811561|NCT00496587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811562|NCT00757835|Timolol|timolol|mesh-list
101811563|NCT00757835|Latanoprost|latanoprost|mesh-list
101811564|NCT00757835|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101811565|NCT00757835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101811566|NCT00757835|Adrenergic Agents|adrenergic agents|mesh-ancestor
101811567|NCT00757835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101811568|NCT00757835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811569|NCT00757835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811570|NCT00757835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101811571|NCT00757835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101811572|NCT00757835|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101811573|NCT00757835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101811574|NCT01038154|Pravastatin|pravastatin|mesh-list
101811575|NCT01038154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101811576|NCT01038154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101811577|NCT01038154|Antimetabolites|antimetabolites|mesh-ancestor
101811578|NCT01038154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811579|NCT01038154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101811580|NCT01038154|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101811581|NCT01038154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101811582|NCT00405652|Mycophenolic Acid|mycophenolic acid|mesh-list
101811583|NCT00405652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101811584|NCT00405652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101811585|NCT00405652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101811586|NCT00405652|Antitubercular Agents|antitubercular agents|mesh-ancestor
101811587|NCT00405652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101811588|NCT00405652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101811589|NCT00405652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101811590|NCT00405652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811592|NCT01324180|Dexamethasone|dexamethasone|mesh-list
101811593|NCT01324180|Doxorubicin|doxorubicin|mesh-list
101811594|NCT01324180|Vincristine|vincristine|mesh-list
101811595|NCT01324180|Asparaginase|asparaginase|mesh-list
101811596|NCT01324180|Pegaspargase|pegaspargase|mesh-list
101811597|NCT01324180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101811598|NCT01324180|Antiemetics|antiemetics|mesh-ancestor
101811599|NCT01324180|Autonomic Agents|autonomic agents|mesh-ancestor
101811600|NCT01324180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101811601|NCT01324180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811602|NCT01324180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101811604|NCT01324180|Hormones|hormones|mesh-ancestor
101811605|NCT01324180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101811606|NCT01324180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101811607|NCT01324180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101811608|NCT01324180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101811609|NCT01324180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101811610|NCT01324180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101811611|NCT01324180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101811612|NCT01324180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101811613|NCT01324180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811614|NCT01324180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101811615|NCT01324180|Tubulin Modulators|tubulin modulators|mesh-ancestor
101811616|NCT01324180|Antimitotic Agents|antimitotic agents|mesh-ancestor
101811617|NCT01324180|Mitosis Modulators|mitosis modulators|mesh-ancestor
101811618|NCT02560649|Tenofovir|tenofovir|mesh-list
101811619|NCT02560649|Lamivudine|lamivudine|mesh-list
101811620|NCT02560649|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101811621|NCT02560649|Interferon-alpha|interferon-alpha|mesh-list
101811622|NCT02560649|Entecavir|entecavir|mesh-list
101811623|NCT02560649|Adefovir|adefovir|mesh-list
101811624|NCT02560649|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101811625|NCT02560649|Antiviral Agents|antiviral agents|mesh-ancestor
101811626|NCT02560649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101811627|NCT02560649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101811628|NCT02560649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101811629|NCT02560649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101811630|NCT02560649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811631|NCT02560649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101811632|NCT02560649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101811633|NCT02560649|Immunologic Factors|immunologic factors|mesh-ancestor
101811634|NCT02560649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811636|NCT00754403|Pioglitazone|pioglitazone|mesh-list
101811637|NCT00754403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101811638|NCT00754403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811639|NCT00758225|Idebenone|idebenone|mesh-list
101811640|NCT00758225|Antioxidants|antioxidants|mesh-ancestor
101811641|NCT00758225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811642|NCT00758225|Protective Agents|protective agents|mesh-ancestor
101811643|NCT00758225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811644|NCT02561039|Ibandronic Acid|ibandronic acid|mesh-list
101811645|NCT02561039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101811646|NCT02561039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811647|NCT00422734|Tadalafil|tadalafil|mesh-list
101811648|NCT00422734|Vasodilator Agents|vasodilator agents|mesh-ancestor
101811649|NCT00422734|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101811650|NCT00422734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101811651|NCT00422734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101811652|NCT00422734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811653|NCT00422734|Urological Agents|urological agents|mesh-ancestor
101811654|NCT00422422|Brivaracetam|brivaracetam|mesh-list
101811655|NCT00422422|Anticonvulsants|anticonvulsants|mesh-ancestor
101811656|NCT00413374|Enoxaparin|enoxaparin|mesh-list
101811657|NCT00413374|Anticoagulants|anticoagulants|mesh-ancestor
101811658|NCT00413374|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101811659|NCT00413374|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101811660|NCT00413374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811661|NCT00682643|Fluticasone|fluticasone|mesh-list
101811662|NCT00682643|Xhance|xhance|mesh-list
101811663|NCT00682643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101811664|NCT00682643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101812074|NCT04221750|Metformin|metformin|mesh-list
101811665|NCT00682643|Autonomic Agents|autonomic agents|mesh-ancestor
101811666|NCT00682643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101811667|NCT00682643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811668|NCT00682643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101811669|NCT00682643|Respiratory System Agents|respiratory system agents|mesh-ancestor
101811670|NCT00682643|Dermatologic Agents|dermatologic agents|mesh-ancestor
101811671|NCT00682643|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101811672|NCT00758381|Sorafenib|sorafenib|mesh-list
101811673|NCT00758381|Cisplatin|cisplatin|mesh-list
101811674|NCT00758381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101811675|NCT00758381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101811676|NCT00758381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101811677|NCT00758381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811678|NCT00754871|Dienogest|dienogest|mesh-list
101811679|NCT00754871|Nandrolone|nandrolone|mesh-list
101811680|NCT00754871|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101811681|NCT00754871|Contraceptive Agents|contraceptive agents|mesh-ancestor
101811682|NCT00754871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101811683|NCT00754871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811684|NCT00754871|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101811685|NCT00754871|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101811686|NCT00754871|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101811687|NCT00754871|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101811688|NCT00754871|Hormone Antagonists|hormone antagonists|mesh-ancestor
101811689|NCT00754871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101811690|NCT00754871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101811691|NCT00754871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101811692|NCT00754871|Androgens|androgens|mesh-ancestor
101811693|NCT00754871|Hormones|hormones|mesh-ancestor
101811694|NCT00754871|Anabolic Agents|anabolic agents|mesh-ancestor
101811695|NCT00755027|Rasagiline|rasagiline|mesh-list
101811696|NCT00755027|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101811697|NCT00755027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101811698|NCT00755027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811699|NCT00755027|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101811700|NCT00755027|Protective Agents|protective agents|mesh-ancestor
101811701|NCT00755027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811702|NCT01038388|Dexamethasone|dexamethasone|mesh-list
101811703|NCT01038388|Lenalidomide|lenalidomide|mesh-list
101811704|NCT01038388|Bortezomib|bortezomib|mesh-list
101811705|NCT01038388|Vorinostat|vorinostat|mesh-list
101811706|NCT01038388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101811707|NCT01038388|Antiemetics|antiemetics|mesh-ancestor
101811708|NCT01038388|Autonomic Agents|autonomic agents|mesh-ancestor
101811709|NCT01038388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101811710|NCT01038388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811711|NCT01038388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101811712|NCT01038388|Glucocorticoids|glucocorticoids|mesh-ancestor
101811714|NCT01038388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101811715|NCT01038388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101811717|NCT01038388|Immunologic Factors|immunologic factors|mesh-ancestor
101811718|NCT01038388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101811719|NCT01038388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101811720|NCT01038388|Growth Substances|growth substances|mesh-ancestor
101811721|NCT01038388|Growth Inhibitors|growth inhibitors|mesh-ancestor
101811722|NCT01038388|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101811723|NCT01038388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101811724|NCT01038388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811725|NCT04050059|Lidocaine|lidocaine|mesh-list
101811726|NCT04050059|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
101811727|NCT04050059|Anesthetics, Local|anesthetics, local|mesh-ancestor
101811728|NCT04050059|Anesthetics|anesthetics|mesh-ancestor
101811729|NCT04050059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101811730|NCT04050059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811731|NCT04050059|Sensory System Agents|sensory system agents|mesh-ancestor
101811732|NCT04050059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101811733|NCT04050059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101811734|NCT04050059|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101811735|NCT04050059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101811736|NCT04050059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101811737|NCT04050059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811738|NCT04050059|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
101811739|NCT00482001|Donepezil|donepezil|mesh-list
101811740|NCT00482001|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101811741|NCT00482001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101811742|NCT00482001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811743|NCT00482001|Cholinergic Agents|cholinergic agents|mesh-ancestor
101811744|NCT00482001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101811745|NCT00482001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811746|NCT00482001|Nootropic Agents|nootropic agents|mesh-ancestor
101811747|NCT00490035|Brivaracetam|brivaracetam|mesh-list
101811748|NCT00490035|Anticonvulsants|anticonvulsants|mesh-ancestor
101811749|NCT00421174|Methylprednisolone|methylprednisolone|mesh-list
101811750|NCT00421174|Etanercept|etanercept|mesh-list
101811751|NCT00421174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101811752|NCT00421174|Antiemetics|antiemetics|mesh-ancestor
101811753|NCT00421174|Autonomic Agents|autonomic agents|mesh-ancestor
101811754|NCT00421174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101811755|NCT00421174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811756|NCT00421174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101811757|NCT00421174|Glucocorticoids|glucocorticoids|mesh-ancestor
101811758|NCT00421174|Hormones|hormones|mesh-ancestor
101811759|NCT00421174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101811760|NCT00421174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101811761|NCT00421174|Protective Agents|protective agents|mesh-ancestor
101811762|NCT00421174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101811763|NCT00421174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101811764|NCT00421174|Analgesics|analgesics|mesh-ancestor
101811765|NCT00421174|Sensory System Agents|sensory system agents|mesh-ancestor
101811766|NCT00421174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101811767|NCT00421174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101811768|NCT00421174|Immunologic Factors|immunologic factors|mesh-ancestor
101811769|NCT00496197|Fluconazole|fluconazole|mesh-list
101811770|NCT00496197|Voriconazole|voriconazole|mesh-list
101811771|NCT00496197|Anidulafungin|anidulafungin|mesh-list
101811772|NCT00496197|Antifungal Agents|antifungal agents|mesh-ancestor
101811773|NCT00496197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101811775|NCT00496197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101811776|NCT00496197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101811777|NCT00496197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811778|NCT00496197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101811779|NCT00496197|Hormone Antagonists|hormone antagonists|mesh-ancestor
101811780|NCT00496197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101811781|NCT00496197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811782|NCT00496197|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101811783|NCT00496197|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101312011|NCT00006154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101811784|NCT00496197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101811785|NCT03996993|Bicalutamide|bicalutamide|mesh-list
101811786|NCT03996993|Androgen Antagonists|androgen antagonists|mesh-ancestor
101811788|NCT03996993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101811789|NCT03996993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811790|NCT03996993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101811791|NCT01015053|Ropivacaine|ropivacaine|mesh-list
101811792|NCT01015053|Anesthetics, Local|anesthetics, local|mesh-ancestor
101811794|NCT01015053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101811795|NCT01015053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811796|NCT01015053|Sensory System Agents|sensory system agents|mesh-ancestor
101811797|NCT01015053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101811798|NCT00404092|Caspofungin|caspofungin|mesh-list
101811799|NCT00404092|Antifungal Agents|antifungal agents|mesh-ancestor
101811800|NCT00404092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101811801|NCT00404092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101811802|NCT00404092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811803|NCT00481767|Vaccines|vaccines|mesh-list
101811804|NCT00481767|Immunologic Factors|immunologic factors|mesh-ancestor
101811805|NCT00481767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811806|NCT00489489|Interferons|interferons|mesh-list
101811807|NCT00489489|Interferon-beta|interferon-beta|mesh-list
101811808|NCT00489489|Teriflunomide|teriflunomide|mesh-list
101811809|NCT00489489|Interferon beta-1b|interferon beta-1b|mesh-list
101811810|NCT00489489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101811811|NCT00489489|Antiviral Agents|antiviral agents|mesh-ancestor
101811812|NCT00489489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101811813|NCT00489489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101811814|NCT00489489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101811815|NCT00489489|Analgesics|analgesics|mesh-ancestor
101811816|NCT00489489|Sensory System Agents|sensory system agents|mesh-ancestor
101811817|NCT00489489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101811818|NCT00489489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811819|NCT00489489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101811820|NCT00489489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101811821|NCT00489489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101811822|NCT00489489|Immunologic Factors|immunologic factors|mesh-ancestor
101811823|NCT00489489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101811824|NCT00489411|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101811825|NCT00489411|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101811826|NCT00489411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101811827|NCT00489411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101811828|NCT00489411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811829|NCT00489411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101811830|NCT00489411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811831|NCT00489411|Analgesics|analgesics|mesh-ancestor
101811832|NCT00489411|Sensory System Agents|sensory system agents|mesh-ancestor
101811833|NCT00489411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101811834|NCT00489411|Antidepressive Agents|antidepressive agents|mesh-ancestor
101811835|NCT00489411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101811836|NCT00489411|Dopamine Agents|dopamine agents|mesh-ancestor
101811837|NCT00420784|Interferons|interferons|mesh-list
101811838|NCT00420784|Ribavirin|ribavirin|mesh-list
101811839|NCT00420784|Interferon-alpha|interferon-alpha|mesh-list
101811840|NCT00420784|Interferon alpha-2|interferon alpha-2|mesh-list
101811841|NCT00420784|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101811842|NCT00420784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101811843|NCT00420784|Antiviral Agents|antiviral agents|mesh-ancestor
101811844|NCT00420784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101811845|NCT00420784|Antimetabolites|antimetabolites|mesh-ancestor
101811846|NCT00420784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811847|NCT00420784|Immunologic Factors|immunologic factors|mesh-ancestor
101811848|NCT00420784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811849|NCT00420628|Loteprednol Etabonate|loteprednol etabonate|mesh-list
101811850|NCT00420628|Tobramycin|tobramycin|mesh-list
101811851|NCT00420628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101811852|NCT00420628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101811853|NCT00420628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101811854|NCT00413218|Voriconazole|voriconazole|mesh-list
101811855|NCT00413218|Caspofungin|caspofungin|mesh-list
101811856|NCT00413218|Isavuconazole|isavuconazole|mesh-list
101811857|NCT00413218|Antifungal Agents|antifungal agents|mesh-ancestor
101811859|NCT00413218|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101811860|NCT00413218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101811861|NCT00413218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101811862|NCT00413218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811863|NCT00413218|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101811864|NCT00413218|Hormone Antagonists|hormone antagonists|mesh-ancestor
101811865|NCT00413218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101811866|NCT00413218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811867|NCT00413218|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101811868|NCT00494871|Warfarin|warfarin|mesh-list
101811869|NCT00494871|Rivaroxaban|rivaroxaban|mesh-list
101811870|NCT00494871|Anticoagulants|anticoagulants|mesh-ancestor
101811871|NCT00494871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101811872|NCT00494871|Antithrombins|antithrombins|mesh-ancestor
101811873|NCT00494871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101811874|NCT00494871|Protease Inhibitors|protease inhibitors|mesh-ancestor
101811875|NCT00494871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101811876|NCT00494871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811877|NCT00420238|Etanercept|etanercept|mesh-list
101811878|NCT00420238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101811879|NCT00420238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101811880|NCT00420238|Analgesics|analgesics|mesh-ancestor
101811881|NCT00420238|Sensory System Agents|sensory system agents|mesh-ancestor
101811882|NCT00420238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101811883|NCT00420238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811884|NCT00420238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101811885|NCT00420238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101811886|NCT00420238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101811887|NCT00420238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101811888|NCT00420238|Immunologic Factors|immunologic factors|mesh-ancestor
101811889|NCT00420004|Escitalopram|escitalopram|mesh-list
101811890|NCT00420004|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101811891|NCT00420004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101811892|NCT00420004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101811893|NCT00420004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811894|NCT00420004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101811895|NCT00420004|Serotonin Agents|serotonin agents|mesh-ancestor
101811896|NCT00420004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811897|NCT00494481|Docetaxel|docetaxel|mesh-list
101811898|NCT00494481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101811899|NCT00494481|Tubulin Modulators|tubulin modulators|mesh-ancestor
101811900|NCT00494481|Antimitotic Agents|antimitotic agents|mesh-ancestor
101811901|NCT00494481|Mitosis Modulators|mitosis modulators|mesh-ancestor
101811902|NCT00494481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811903|NCT00097591|Clopidogrel|clopidogrel|mesh-list
101811904|NCT00097591|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101811905|NCT00097591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101811906|NCT00097591|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101811907|NCT00097591|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101811908|NCT00097591|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101811909|NCT00097591|Purinergic Agents|purinergic agents|mesh-ancestor
101811910|NCT00097591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101811911|NCT00097591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811912|NCT00097591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811913|NCT01082029|Lansoprazole|lansoprazole|mesh-list
101811914|NCT01082029|Dexlansoprazole|dexlansoprazole|mesh-list
101811915|NCT01082029|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101811916|NCT01082029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101811917|NCT01082029|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101811918|NCT01082029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101811919|NCT01082029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811920|NCT00419926|Cyclosporine|cyclosporine|mesh-list
101811921|NCT00419926|Mycophenolic Acid|mycophenolic acid|mesh-list
101811922|NCT00419926|Prednisone|prednisone|mesh-list
101811923|NCT00419926|Cyclosporins|cyclosporins|mesh-list
101811925|NCT00419926|Glucocorticoids|glucocorticoids|mesh-ancestor
101811926|NCT00419926|Hormones|hormones|mesh-ancestor
101811927|NCT00419926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101811928|NCT00419926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811929|NCT00419926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101811930|NCT00419926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101811931|NCT00419926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101811932|NCT00419926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811933|NCT00419926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101811934|NCT00419926|Immunologic Factors|immunologic factors|mesh-ancestor
101811935|NCT00419926|Antifungal Agents|antifungal agents|mesh-ancestor
101811936|NCT00419926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101811937|NCT00419926|Dermatologic Agents|dermatologic agents|mesh-ancestor
101811938|NCT00419926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101811939|NCT00419926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101811940|NCT00419926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101811941|NCT00419926|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101811942|NCT00419926|Antitubercular Agents|antitubercular agents|mesh-ancestor
101811943|NCT00419926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101811944|NCT00419770|Amphotericin B|amphotericin b|mesh-list
101811945|NCT00419770|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101811946|NCT00419770|Deferasirox|deferasirox|mesh-list
101811947|NCT00419770|Amebicides|amebicides|mesh-ancestor
101811948|NCT00419770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101811949|NCT00419770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101811950|NCT00419770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101811951|NCT00419770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101811952|NCT00419770|Antifungal Agents|antifungal agents|mesh-ancestor
101811953|NCT00419770|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101811954|NCT00419770|Chelating Agents|chelating agents|mesh-ancestor
101811955|NCT00419770|Sequestering Agents|sequestering agents|mesh-ancestor
101811956|NCT00419770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811957|NCT00080119|Isoniazid|isoniazid|mesh-list
101811958|NCT00080119|Trimethoprim|trimethoprim|mesh-list
101811959|NCT00080119|Sulfamethoxazole|sulfamethoxazole|mesh-list
101811960|NCT00080119|Antitubercular Agents|antitubercular agents|mesh-ancestor
101811961|NCT00080119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101811962|NCT00080119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101811963|NCT00080119|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101811964|NCT00080119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101811965|NCT00080119|Antimetabolites|antimetabolites|mesh-ancestor
101811966|NCT00080119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811967|NCT00080119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101811968|NCT00080119|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101811969|NCT00080119|Antimalarials|antimalarials|mesh-ancestor
101811970|NCT00080119|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101811971|NCT00080119|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101811972|NCT00080119|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101811973|NCT00080119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101811974|NCT00080119|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101811975|NCT00080119|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101811976|NCT00080119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101811977|NCT01034878|Sunitinib|sunitinib|mesh-list
101811978|NCT01034878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101811979|NCT01034878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101811980|NCT01034878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101811981|NCT01034878|Growth Substances|growth substances|mesh-ancestor
101811982|NCT01034878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811983|NCT01034878|Growth Inhibitors|growth inhibitors|mesh-ancestor
101811984|NCT01034878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101811985|NCT01034878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101811986|NCT01034878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811987|NCT01082263|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
101811988|NCT01082263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101811989|NCT01082263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101811990|NCT01082263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101811991|NCT01082263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101811992|NCT01082263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101811993|NCT01082263|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101811994|NCT01082263|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101811995|NCT01082263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101811996|NCT01082263|Adrenergic Agents|adrenergic agents|mesh-ancestor
101811997|NCT01082263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101811998|NCT01082263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101811999|NCT01082263|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101812000|NCT01082263|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101812001|NCT01082263|Serotonin Agents|serotonin agents|mesh-ancestor
101812002|NCT01082263|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101812004|NCT01082263|Dopamine Agents|dopamine agents|mesh-ancestor
101812005|NCT02208544|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101812006|NCT02208544|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101812007|NCT02208544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812009|NCT00494091|Temsirolimus|temsirolimus|mesh-list
101812010|NCT00494091|MTOR Inhibitors|mtor inhibitors|mesh-list
101812011|NCT00494091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101812012|NCT00494091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101812013|NCT00494091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812014|NCT00494091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101812015|NCT00494091|Immunologic Factors|immunologic factors|mesh-ancestor
101812016|NCT00494091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812017|NCT00494091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101812018|NCT00494091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101812019|NCT00494091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101812020|NCT00494091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101812021|NCT00494091|Antifungal Agents|antifungal agents|mesh-ancestor
101812022|NCT01017159|Immunoglobulins|immunoglobulins|mesh-list
101812023|NCT01017159|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101812025|NCT01017159|Immunologic Factors|immunologic factors|mesh-ancestor
101812026|NCT01017159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812027|NCT00494013|Insulin Lispro|insulin lispro|mesh-list
101812029|NCT00494013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101812030|NCT00494013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812031|NCT00494013|Heparin Antagonists|heparin antagonists|mesh-ancestor
101812032|NCT00494013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812034|NCT00079339|Tipifarnib|tipifarnib|mesh-list
101812035|NCT00079339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101812036|NCT01088191|Hyaluronic Acid|hyaluronic acid|mesh-list
101812037|NCT01088191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101812038|NCT01088191|Immunologic Factors|immunologic factors|mesh-ancestor
101812039|NCT01088191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812040|NCT01088191|Viscosupplements|viscosupplements|mesh-ancestor
101812041|NCT01088191|Protective Agents|protective agents|mesh-ancestor
101812042|NCT01082341|Vaccines|vaccines|mesh-list
101812043|NCT01082341|Immunologic Factors|immunologic factors|mesh-ancestor
101812139|NCT00681863|Dopamine Agents|dopamine agents|mesh-ancestor
101812044|NCT01082341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812045|NCT00541866|Cytarabine|cytarabine|mesh-list
101812046|NCT00541866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101812047|NCT00541866|Antimetabolites|antimetabolites|mesh-ancestor
101812048|NCT00541866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812049|NCT00541866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101812050|NCT00541866|Antiviral Agents|antiviral agents|mesh-ancestor
101812051|NCT00541866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101812052|NCT00541866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101812053|NCT00541866|Immunologic Factors|immunologic factors|mesh-ancestor
101812054|NCT00541866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812056|NCT00493467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101812057|NCT00493467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101812058|NCT00493467|Immunologic Factors|immunologic factors|mesh-ancestor
101812059|NCT00493467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812060|NCT00493467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101812061|NCT00090493|Immunomodulating Agents|immunomodulating agents|mesh-list
101812062|NCT00090493|Immunologic Factors|immunologic factors|mesh-ancestor
101812063|NCT00090493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812064|NCT01088347|Mapatumumab|mapatumumab|mesh-list
101812065|NCT01088347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101812066|NCT04221828|Paclitaxel|paclitaxel|mesh-list
101812067|NCT04221828|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101812068|NCT04221828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101812069|NCT04221828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101812070|NCT04221828|Tubulin Modulators|tubulin modulators|mesh-ancestor
101812071|NCT04221828|Antimitotic Agents|antimitotic agents|mesh-ancestor
101812072|NCT04221828|Mitosis Modulators|mitosis modulators|mesh-ancestor
101812073|NCT04221828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812075|NCT04221750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101812076|NCT04221750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812077|NCT04198428|Analgesics, Opioid|analgesics, opioid|mesh-list
101812078|NCT04198428|Narcotics|narcotics|mesh-ancestor
101812079|NCT04198428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101812080|NCT04198428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812081|NCT04198428|Analgesics|analgesics|mesh-ancestor
101812082|NCT04198428|Sensory System Agents|sensory system agents|mesh-ancestor
101812083|NCT04198428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101812084|NCT00481065|MF59 oil emulsion|mf59 oil emulsion|mesh-list
101812085|NCT00481065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101812086|NCT00481065|Immunologic Factors|immunologic factors|mesh-ancestor
101812087|NCT00481065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812088|NCT01017393|Ketamine|ketamine|mesh-list
101812089|NCT01017393|Analgesics|analgesics|mesh-ancestor
101812090|NCT01017393|Sensory System Agents|sensory system agents|mesh-ancestor
101812091|NCT01017393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101812092|NCT01017393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812093|NCT01017393|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101812094|NCT01017393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101812095|NCT01017393|Anesthetics, General|anesthetics, general|mesh-ancestor
101812096|NCT01017393|Anesthetics|anesthetics|mesh-ancestor
101812097|NCT01017393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101812098|NCT01017393|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101812099|NCT01017393|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101812100|NCT01017393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101812101|NCT01017393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812102|NCT00493311|Acetaminophen|acetaminophen|mesh-list
101812103|NCT00493311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101812104|NCT00493311|Analgesics|analgesics|mesh-ancestor
101812105|NCT00493311|Sensory System Agents|sensory system agents|mesh-ancestor
101812106|NCT00493311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101812107|NCT00493311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812108|NCT00493311|Antipyretics|antipyretics|mesh-ancestor
101812110|NCT00571649|Rivaroxaban|rivaroxaban|mesh-list
101812111|NCT00571649|Enoxaparin sodium|enoxaparin sodium|mesh-list
101812112|NCT00571649|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101812113|NCT00571649|Antithrombins|antithrombins|mesh-ancestor
101812114|NCT00571649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101812115|NCT00571649|Protease Inhibitors|protease inhibitors|mesh-ancestor
101812116|NCT00571649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101812117|NCT00571649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812118|NCT00571649|Anticoagulants|anticoagulants|mesh-ancestor
101812119|NCT00571649|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101812120|NCT00571649|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101812121|NCT00546572|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101812122|NCT00546572|Immunologic Factors|immunologic factors|mesh-ancestor
101812123|NCT00546572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812124|NCT03917472|Aflibercept|aflibercept|mesh-list
101812125|NCT03917472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101812126|NCT03917472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101812127|NCT03917472|Growth Substances|growth substances|mesh-ancestor
101812128|NCT03917472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812129|NCT03917472|Growth Inhibitors|growth inhibitors|mesh-ancestor
101812130|NCT03917472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101812131|NCT00681863|Pramipexole|pramipexole|mesh-list
101812132|NCT00681863|Antioxidants|antioxidants|mesh-ancestor
101812133|NCT00681863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812134|NCT00681863|Protective Agents|protective agents|mesh-ancestor
101812135|NCT00681863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812136|NCT00681863|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101312029|NCT00006157|Adrenergic Agents|adrenergic agents|mesh-ancestor
101812137|NCT00681863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101812138|NCT00681863|Dopamine Agonists|dopamine agonists|mesh-ancestor
101812140|NCT00681863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101812142|NCT02559791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101812143|NCT02559791|Respiratory System Agents|respiratory system agents|mesh-ancestor
101812144|NCT05677620|Propofol|propofol|mesh-list
101812145|NCT05677620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101812146|NCT05677620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101812147|NCT05677620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812148|NCT05677620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101812149|NCT05677620|Anesthetics, General|anesthetics, general|mesh-ancestor
101812150|NCT05677620|Anesthetics|anesthetics|mesh-ancestor
101812151|NCT00681629|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101812152|NCT00681629|Antidepressive Agents|antidepressive agents|mesh-ancestor
101812153|NCT00681629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101812154|NCT00681629|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101812155|NCT00681629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101812156|NCT00681629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101812157|NCT00681629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812158|NCT00969176|Acetaminophen|acetaminophen|mesh-list
101812159|NCT00969176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101812160|NCT00969176|Analgesics|analgesics|mesh-ancestor
101812161|NCT00969176|Sensory System Agents|sensory system agents|mesh-ancestor
101812162|NCT00969176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101812163|NCT00969176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812165|NCT04503252|Cefazolin|cefazolin|mesh-list
101812166|NCT04503252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101812167|NCT04503252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101812168|NCT00679367|Dexamethasone|dexamethasone|mesh-list
101812169|NCT00679367|Lenalidomide|lenalidomide|mesh-list
101812170|NCT00679367|Melphalan|melphalan|mesh-list
101812341|NCT00964808|Oxycodone|oxycodone|mesh-list
101812342|NCT00964808|Buprenorphine|buprenorphine|mesh-list
101812343|NCT00964808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101812344|NCT00964808|Narcotics|narcotics|mesh-ancestor
101812345|NCT00964808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101812346|NCT00964808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812347|NCT00964808|Analgesics|analgesics|mesh-ancestor
101812171|NCT00679367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101812172|NCT00679367|Antiemetics|antiemetics|mesh-ancestor
101812173|NCT00679367|Autonomic Agents|autonomic agents|mesh-ancestor
101812174|NCT00679367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101812175|NCT00679367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812176|NCT00679367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101812177|NCT00679367|Glucocorticoids|glucocorticoids|mesh-ancestor
101812178|NCT00679367|Hormones|hormones|mesh-ancestor
101812179|NCT00679367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101812348|NCT00964808|Sensory System Agents|sensory system agents|mesh-ancestor
101812349|NCT00964808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101812350|NCT00964808|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101812351|NCT00970970|Bevacizumab|bevacizumab|mesh-list
101812352|NCT00970970|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
101812353|NCT00970970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101812354|NCT00970970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101812355|NCT00970970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101812356|NCT00970970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101812357|NCT00970970|Growth Substances|growth substances|mesh-ancestor
101812358|NCT00970970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812359|NCT00970970|Growth Inhibitors|growth inhibitors|mesh-ancestor
101812360|NCT00970970|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101812361|NCT00970970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812362|NCT03765450|Infliximab|infliximab|mesh-list
101812363|NCT03765450|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101812364|NCT03765450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101812365|NCT03765450|Dermatologic Agents|dermatologic agents|mesh-ancestor
101812366|NCT03765450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101812367|NCT03765450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101812368|NCT00971126|Thalidomide|thalidomide|mesh-list
101812369|NCT00971126|Sorafenib|sorafenib|mesh-list
101812370|NCT00971126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101812439|NCT00974792|Antimitotic Agents|antimitotic agents|mesh-ancestor
101812440|NCT00974792|Mitosis Modulators|mitosis modulators|mesh-ancestor
101812441|NCT00965120|Bradykinin|bradykinin|mesh-list
101812765|NCT05590572|Isophosphamide mustard|isophosphamide mustard|mesh-list
101812766|NCT05590572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101812767|NCT05590572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101812768|NCT05590572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101812769|NCT05590572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101812770|NCT05590572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101812771|NCT05590572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812772|NCT05590572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101812773|NCT05590572|Alkylating Agents|alkylating agents|mesh-ancestor
101812774|NCT03069378|Pembrolizumab|pembrolizumab|mesh-list
101812775|NCT03069378|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
101812776|NCT03069378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101812777|NCT03069378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101812778|NCT03069378|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101812779|NCT03069378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812781|NCT05590416|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101812782|NCT05590416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101812783|NCT05590416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101812784|NCT00990444|Insulin|insulin|mesh-list
101812785|NCT00990444|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101812786|NCT00990444|Dextrans|dextrans|mesh-list
101812787|NCT00990444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101812788|NCT00990444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812789|NCT00990444|Anticoagulants|anticoagulants|mesh-ancestor
101812790|NCT00990444|Plasma Substitutes|plasma substitutes|mesh-ancestor
101812791|NCT00990444|Blood Substitutes|blood substitutes|mesh-ancestor
101812792|NCT00990600|Tenofovir|tenofovir|mesh-list
101812793|NCT00990600|Emtricitabine|emtricitabine|mesh-list
101812794|NCT00990600|Efavirenz|efavirenz|mesh-list
101812795|NCT00990600|Antiviral Agents|antiviral agents|mesh-ancestor
101812796|NCT00990600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101312085|NCT00006208|Stavudine|stavudine|mesh-list
101812180|NCT00679367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101812181|NCT00679367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101812182|NCT00679367|Immunologic Factors|immunologic factors|mesh-ancestor
101812183|NCT00679367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101812184|NCT00679367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101812185|NCT00679367|Growth Substances|growth substances|mesh-ancestor
101812186|NCT00679367|Growth Inhibitors|growth inhibitors|mesh-ancestor
101812187|NCT00679367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101813268|NCT00967538|Analgesics|analgesics|mesh-ancestor
101813269|NCT00967538|Sensory System Agents|sensory system agents|mesh-ancestor
101813270|NCT00967538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101813271|NCT00967538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814453|NCT01041508|Mycophenolic Acid|mycophenolic acid|mesh-list
101814454|NCT01041508|Clofarabine|clofarabine|mesh-list
101814455|NCT01041508|Cyclosporins|cyclosporins|mesh-list
101814456|NCT01041508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101814457|NCT01041508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814458|NCT01041508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101814459|NCT01041508|Immunologic Factors|immunologic factors|mesh-ancestor
101814460|NCT01041508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814461|NCT01041508|Antifungal Agents|antifungal agents|mesh-ancestor
101814462|NCT01041508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101814463|NCT01041508|Dermatologic Agents|dermatologic agents|mesh-ancestor
101814464|NCT01041508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101814465|NCT01041508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101814466|NCT01041508|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101814467|NCT01041508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101814468|NCT01041508|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101814469|NCT01041508|Antitubercular Agents|antitubercular agents|mesh-ancestor
101814470|NCT01041508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101814471|NCT01041508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101814472|NCT01041508|Antimetabolites|antimetabolites|mesh-ancestor
101814473|NCT00766025|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101814474|NCT00766025|Calcium|calcium|mesh-list
101814475|NCT00766025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101814476|NCT00766025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814477|NCT00766025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101814478|NCT00766025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101814479|NCT00766025|Antimetabolites|antimetabolites|mesh-ancestor
101814480|NCT00766025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814481|NCT00766025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101814543|NCT00991562|Mitosis Modulators|mitosis modulators|mesh-ancestor
101814544|NCT00991562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814545|NCT00762671|Ebselen|ebselen|mesh-list
101814546|NCT00762671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101814547|NCT00762671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101814548|NCT00762671|Analgesics|analgesics|mesh-ancestor
101814549|NCT00762671|Sensory System Agents|sensory system agents|mesh-ancestor
101814550|NCT00762671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101814551|NCT00762671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814610|NCT00403546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814611|NCT00403546|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101814612|NCT00403546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101814613|NCT00403546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101814614|NCT00403546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101814615|NCT00403546|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101814616|NCT00403546|Dopamine Agents|dopamine agents|mesh-ancestor
101814617|NCT00767117|Ritonavir|ritonavir|mesh-list
101814618|NCT00767117|Lopinavir|lopinavir|mesh-list
101814619|NCT00767117|Etravirine|etravirine|mesh-list
101814772|NCT00768209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814774|NCT00401752|Ranitidine|ranitidine|mesh-list
101814775|NCT00401752|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
101814776|NCT00401752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101814777|NCT00401752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101812188|NCT00679367|Alkylating Agents|alkylating agents|mesh-ancestor
101812189|NCT00679367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812190|NCT00679367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101812191|NCT00679367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101812193|NCT00969566|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101812194|NCT00969566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101812195|NCT00969566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812196|NCT00969566|Incretins|incretins|mesh-ancestor
101812197|NCT00969566|Hormones|hormones|mesh-ancestor
101812198|NCT00969566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101814778|NCT00401752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101814779|NCT00401752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101814780|NCT00401752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814781|NCT00401752|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101814782|NCT00401752|Histamine Antagonists|histamine antagonists|mesh-ancestor
101814783|NCT00401752|Histamine Agents|histamine agents|mesh-ancestor
101814784|NCT00401752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101814785|NCT00401752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814786|NCT00770471|Temozolomide|temozolomide|mesh-list
101814787|NCT00770471|Veliparib|veliparib|mesh-list
101814788|NCT00770471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101814789|NCT00770471|Alkylating Agents|alkylating agents|mesh-ancestor
101814790|NCT00770471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814791|NCT00770471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101814859|NCT00763685|Analgesics|analgesics|mesh-ancestor
101814860|NCT00763685|Sensory System Agents|sensory system agents|mesh-ancestor
101814861|NCT00763685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101814892|NCT05408936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814894|NCT02558153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101814895|NCT02558153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101814896|NCT02558153|Tubulin Modulators|tubulin modulators|mesh-ancestor
101814897|NCT02558153|Antimitotic Agents|antimitotic agents|mesh-ancestor
101814898|NCT02558153|Mitosis Modulators|mitosis modulators|mesh-ancestor
101814899|NCT02558153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814900|NCT00763763|Interferons|interferons|mesh-list
101814901|NCT00763763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101814902|NCT00763763|Interferon-alpha|interferon-alpha|mesh-list
101814903|NCT00763763|Dexamethasone|dexamethasone|mesh-list
101814904|NCT00763763|Vincristine|vincristine|mesh-list
101814942|NCT05357456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814943|NCT05357456|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101814944|NCT05357456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101814967|NCT00069121|Micronutrients|micronutrients|mesh-ancestor
101814968|NCT00768911|Temozolomide|temozolomide|mesh-list
101814969|NCT00768911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101814970|NCT00768911|Alkylating Agents|alkylating agents|mesh-ancestor
101814971|NCT00768911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814972|NCT00768911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101814973|NCT00769145|Ranibizumab|ranibizumab|mesh-list
101814974|NCT00769145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101814975|NCT00769145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101814976|NCT00769145|Growth Substances|growth substances|mesh-ancestor
101814977|NCT00769145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814978|NCT00769145|Growth Inhibitors|growth inhibitors|mesh-ancestor
101814979|NCT00769145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101814980|NCT00763997|Acetaminophen|acetaminophen|mesh-list
101814981|NCT00763997|Dipyrone|dipyrone|mesh-list
101814982|NCT00763997|Ibuprofen|ibuprofen|mesh-list
101814983|NCT00763997|Parecoxib|parecoxib|mesh-list
101814984|NCT00763997|Valdecoxib|valdecoxib|mesh-list
101814985|NCT00763997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101814986|NCT00763997|Analgesics|analgesics|mesh-ancestor
101814987|NCT00763997|Sensory System Agents|sensory system agents|mesh-ancestor
101812199|NCT00969566|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101812200|NCT00969566|Protease Inhibitors|protease inhibitors|mesh-ancestor
101812201|NCT00969566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101812202|NCT00969566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812204|NCT00755495|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101812205|NCT00755495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101812206|NCT00755495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101812207|NCT00755495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812208|NCT00755495|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101812209|NCT00755495|Antidepressive Agents|antidepressive agents|mesh-ancestor
101812210|NCT00755495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101814988|NCT00763997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101814989|NCT00763997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814990|NCT00763997|Antipyretics|antipyretics|mesh-ancestor
101814991|NCT00763997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101814992|NCT00763997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101814993|NCT00763997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101814994|NCT00763997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101814995|NCT00763997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101814996|NCT00763997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814997|NCT00763997|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101814998|NCT00771251|Golimumab|golimumab|mesh-list
101814999|NCT00771251|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101815000|NCT00771251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101815093|NCT01415882|Protease Inhibitors|protease inhibitors|mesh-ancestor
101815094|NCT01415882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101815095|NCT01415882|Dermatologic Agents|dermatologic agents|mesh-ancestor
101815096|NCT01415882|Glycine Agents|glycine agents|mesh-ancestor
101815097|NCT01415882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101815098|NCT00068419|Tamoxifen|tamoxifen|mesh-list
101815099|NCT00068419|Sulindac|sulindac|mesh-list
101815100|NCT00068419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815101|NCT00068419|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101815102|NCT00068419|Hormone Antagonists|hormone antagonists|mesh-ancestor
101815103|NCT00068419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101815104|NCT00068419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815141|NCT01086631|Rituximab|rituximab|mesh-list
101815142|NCT01086631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101815143|NCT01086631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101815144|NCT01086631|Immunologic Factors|immunologic factors|mesh-ancestor
101815211|NCT01589146|Heparin|heparin|mesh-list
101815212|NCT01589146|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101815213|NCT01589146|Tinzaparin|tinzaparin|mesh-list
101815214|NCT01589146|Dalteparin|dalteparin|mesh-list
101815215|NCT01589146|Anticoagulants|anticoagulants|mesh-ancestor
101815216|NCT01589146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101815217|NCT01589146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101815506|NCT00772499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101815507|NCT00772499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101815635|NCT03961087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101815636|NCT03961087|Protective Agents|protective agents|mesh-ancestor
101815637|NCT03961087|Nootropic Agents|nootropic agents|mesh-ancestor
101815638|NCT03960775|Dexmedetomidine|dexmedetomidine|mesh-list
101815639|NCT03960775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101815640|NCT03960775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101816231|NCT00778505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101816233|NCT00778505|Anesthetics|anesthetics|mesh-ancestor
101816234|NCT00778505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101812211|NCT00755495|Histamine Antagonists|histamine antagonists|mesh-ancestor
101312033|NCT00006190|Efavirenz|efavirenz|mesh-list
101812212|NCT00755495|Histamine Agents|histamine agents|mesh-ancestor
101812213|NCT00755495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101812214|NCT00755495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812215|NCT00964184|Metformin|metformin|mesh-list
101812216|NCT00964184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101812217|NCT00964184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812218|NCT00969800|Chlorine dioxide|chlorine dioxide|mesh-list
101812219|NCT00969800|Dental Disinfectants|dental disinfectants|mesh-ancestor
101812220|NCT00969800|Disinfectants|disinfectants|mesh-ancestor
101812221|NCT00969800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101812222|NCT00964262|Exenatide|exenatide|mesh-list
101816235|NCT00778505|Narcotics|narcotics|mesh-ancestor
101816236|NCT00778505|Analgesics|analgesics|mesh-ancestor
101816237|NCT00778505|Sensory System Agents|sensory system agents|mesh-ancestor
101816238|NCT00778505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101816239|NCT00532844|Vitamins|vitamins|mesh-list
101816240|NCT00532844|Ascorbic Acid|ascorbic acid|mesh-list
101816241|NCT00532844|Verapamil|verapamil|mesh-list
101816242|NCT00532844|Micronutrients|micronutrients|mesh-ancestor
101816243|NCT00532844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816250|NCT00532844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101816251|NCT00532844|Vasodilator Agents|vasodilator agents|mesh-ancestor
101816253|NCT00778583|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101816254|NCT00778583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101816255|NCT00778583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101816256|NCT00778661|Amoxicillin|amoxicillin|mesh-list
101816257|NCT00778661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101816258|NCT00778661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101816259|NCT00993356|Lanreotide|lanreotide|mesh-list
101816260|NCT00993356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101816261|NCT00781547|Hormones|hormones|mesh-list
101816262|NCT00781547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101816263|NCT00781547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816264|NCT00778739|Cefprozil|cefprozil|mesh-list
101816265|NCT00778739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101816266|NCT00778739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101816267|NCT00781625|Methenamine hippurate|methenamine hippurate|mesh-list
101816268|NCT00781625|Methenamine|methenamine|mesh-list
101816269|NCT00781625|Methenamine mandelate|methenamine mandelate|mesh-list
101816270|NCT00781625|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101816271|NCT00781625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101816272|NCT00781625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101816273|NCT00781781|Alemtuzumab|alemtuzumab|mesh-list
101816274|NCT00781781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101816275|NCT00781781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101816276|NCT00666263|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101816277|NCT00666263|Immunoglobulins|immunoglobulins|mesh-list
101816278|NCT00666263|Antibodies|antibodies|mesh-list
101816279|NCT00666263|gamma-Globulins|gamma-globulins|mesh-list
101816280|NCT00666263|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101816281|NCT00666263|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101816282|NCT00666263|Immunologic Factors|immunologic factors|mesh-ancestor
101816283|NCT00666263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816284|NCT00667277|Bevacizumab|bevacizumab|mesh-list
101816285|NCT00667277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101816286|NCT00667277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101816287|NCT00667277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101816288|NCT00667277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101816289|NCT00667277|Growth Substances|growth substances|mesh-ancestor
101816290|NCT00667277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816291|NCT00667277|Growth Inhibitors|growth inhibitors|mesh-ancestor
101816292|NCT00774527|Cyclophosphamide|cyclophosphamide|mesh-list
101816293|NCT00774527|Fludarabine|fludarabine|mesh-list
101816294|NCT00774527|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101812223|NCT00964262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101812224|NCT00964262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812225|NCT00964262|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101812226|NCT00964262|Incretins|incretins|mesh-ancestor
101812227|NCT00964262|Hormones|hormones|mesh-ancestor
101812228|NCT00964262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101812229|NCT00973778|Capecitabine|capecitabine|mesh-list
101812230|NCT00973778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101812231|NCT00973778|Antimetabolites|antimetabolites|mesh-ancestor
101816295|NCT00774527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101816296|NCT00774527|Immunologic Factors|immunologic factors|mesh-ancestor
101816297|NCT00774527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816298|NCT00774527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101816299|NCT00774527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101816300|NCT00774527|Alkylating Agents|alkylating agents|mesh-ancestor
101816301|NCT00774527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816302|NCT00774527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101816303|NCT00774527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101816305|NCT00778973|Antidepressive Agents|antidepressive agents|mesh-ancestor
101816306|NCT00778973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101816307|NCT00778973|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101816308|NCT00778973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101816309|NCT00778973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101816310|NCT00778973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816311|NCT00778973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101816312|NCT00778973|Serotonin Agents|serotonin agents|mesh-ancestor
101816316|NCT00774605|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101816317|NCT00774605|Cholinergic Agents|cholinergic agents|mesh-ancestor
101816318|NCT00774605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101816319|NCT00774605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816320|NCT00774605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816321|NCT00779051|Zolpidem|zolpidem|mesh-list
101816322|NCT00779051|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101816323|NCT00779051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101816324|NCT00779051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101816325|NCT00779051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816326|NCT00779051|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101816327|NCT00779051|GABA Agonists|gaba agonists|mesh-ancestor
101816328|NCT00779051|GABA Agents|gaba agents|mesh-ancestor
101816329|NCT00779051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101816330|NCT00779051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816331|NCT00774683|Raltegravir Potassium|raltegravir potassium|mesh-list
101816332|NCT00774683|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101816333|NCT00774683|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101816334|NCT00774683|Antiviral Agents|antiviral agents|mesh-ancestor
101816335|NCT00774683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101816336|NCT00774683|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101816337|NCT00774683|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101816338|NCT00774683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101816339|NCT00774683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816340|NCT00782093|Volociximab|volociximab|mesh-list
101816341|NCT00782093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101816342|NCT00782093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101816343|NCT00782093|Growth Substances|growth substances|mesh-ancestor
101816344|NCT00782093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816345|NCT00782093|Growth Inhibitors|growth inhibitors|mesh-ancestor
101816346|NCT00782093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101816347|NCT00784511|Vitamin D|vitamin d|mesh-list
101816348|NCT00784511|Ergocalciferols|ergocalciferols|mesh-list
101816349|NCT00784511|Cholecalciferol|cholecalciferol|mesh-list
101816350|NCT00784511|Vitamins|vitamins|mesh-list
101816351|NCT00784511|Micronutrients|micronutrients|mesh-ancestor
101812232|NCT00973778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812233|NCT00973778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101812234|NCT05623410|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
101812235|NCT05623410|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101812236|NCT05623410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101812238|NCT05623410|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101812239|NCT05623410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101816352|NCT00784511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816353|NCT00784511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101816354|NCT00784511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101816355|NCT00784589|Rituximab|rituximab|mesh-list
101816356|NCT00784589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101816357|NCT00784589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101816358|NCT00784589|Immunologic Factors|immunologic factors|mesh-ancestor
101816359|NCT00784589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816360|NCT00784589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101816361|NCT00784667|Cetuximab|cetuximab|mesh-list
101816362|NCT00784667|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101816363|NCT00784667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101816364|NCT00784667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101816365|NCT00784667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101816366|NCT00784667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101816367|NCT00784667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816368|NCT00784745|Dexamethasone|dexamethasone|mesh-list
101816369|NCT00784745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101816370|NCT00784745|Antiemetics|antiemetics|mesh-ancestor
101816371|NCT00784745|Autonomic Agents|autonomic agents|mesh-ancestor
101816372|NCT00784745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101816373|NCT00784745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816374|NCT00784745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101816375|NCT00784745|Glucocorticoids|glucocorticoids|mesh-ancestor
101816376|NCT00784745|Hormones|hormones|mesh-ancestor
101816377|NCT00784745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101816378|NCT00784745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101816379|NCT00784745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101816380|NCT00993512|Bleomycin|bleomycin|mesh-list
101816381|NCT00993512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101816382|NCT00993512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101816383|NCT00662129|Paclitaxel|paclitaxel|mesh-list
101816384|NCT00662129|Bevacizumab|bevacizumab|mesh-list
101816385|NCT00662129|Gemcitabine|gemcitabine|mesh-list
101816398|NCT00662129|Growth Inhibitors|growth inhibitors|mesh-ancestor
101816399|NCT00662129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101816400|NCT00662129|Antimetabolites|antimetabolites|mesh-ancestor
101816401|NCT00993746|Lidocaine|lidocaine|mesh-list
101816402|NCT00993746|Bupivacaine|bupivacaine|mesh-list
101816403|NCT00993746|Anesthetics, Local|anesthetics, local|mesh-ancestor
101816404|NCT00993746|Anesthetics|anesthetics|mesh-ancestor
101816405|NCT00993746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101816406|NCT00993746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816407|NCT00993746|Sensory System Agents|sensory system agents|mesh-ancestor
101816408|NCT00993746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101816409|NCT00993746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101816410|NCT00993746|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101816411|NCT00993746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101816412|NCT00993746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101816413|NCT00993746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816414|NCT00789971|Triamcinolone|triamcinolone|mesh-list
101816415|NCT00789971|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101816416|NCT00789971|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101816417|NCT00789971|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101816418|NCT00789971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101816419|NCT00789971|Glucocorticoids|glucocorticoids|mesh-ancestor
101816420|NCT00789971|Hormones|hormones|mesh-ancestor
101816421|NCT00789971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101812240|NCT05623410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812241|NCT05623410|Cholinergic Agents|cholinergic agents|mesh-ancestor
101812242|NCT05623410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101812243|NCT00964418|Insulin|insulin|mesh-list
101812244|NCT00964418|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101812245|NCT00964418|Insulin Glargine|insulin glargine|mesh-list
101812246|NCT00964418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101812247|NCT00964418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812248|NCT00974012|Valproic Acid|valproic acid|mesh-list
101812249|NCT00974012|Anticonvulsants|anticonvulsants|mesh-ancestor
101816422|NCT00789971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816423|NCT00789971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101816424|NCT00789971|Immunologic Factors|immunologic factors|mesh-ancestor
101816425|NCT00789971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101816426|NCT00789971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816427|NCT00782405|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101816428|NCT00782405|Mirtazapine|mirtazapine|mesh-list
101816429|NCT00782405|Antidepressive Agents|antidepressive agents|mesh-ancestor
101816430|NCT00782405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101816431|NCT00782405|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101816432|NCT00782405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101816433|NCT00782405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101816434|NCT00782405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816435|NCT00782405|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101816436|NCT00782405|Histamine Antagonists|histamine antagonists|mesh-ancestor
101816437|NCT00782405|Histamine Agents|histamine agents|mesh-ancestor
101816438|NCT00782405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101816439|NCT00782405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816440|NCT00782405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101816441|NCT00782405|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101816443|NCT00782405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101816444|NCT00782405|Adrenergic Agents|adrenergic agents|mesh-ancestor
101816445|NCT00782405|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101816446|NCT00782405|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101816475|NCT00996788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101816476|NCT01564550|Insulin|insulin|mesh-list
101816477|NCT01564550|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101816478|NCT01564550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101816479|NCT01564550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816480|NCT00790439|Cyclosporine|cyclosporine|mesh-list
101816481|NCT00790439|Sirolimus|sirolimus|mesh-list
101816482|NCT00790439|Mycophenolic Acid|mycophenolic acid|mesh-list
101816483|NCT00790439|Heparin|heparin|mesh-list
101816484|NCT00790439|Calcium heparin|calcium heparin|mesh-list
101816485|NCT00790439|Dextrans|dextrans|mesh-list
101816486|NCT00790439|Tacrolimus|tacrolimus|mesh-list
101816487|NCT00790439|Cyclosporins|cyclosporins|mesh-list
101816488|NCT00790439|Basiliximab|basiliximab|mesh-list
101816489|NCT00790439|Daclizumab|daclizumab|mesh-list
101816490|NCT00790439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101816491|NCT00790439|Immunologic Factors|immunologic factors|mesh-ancestor
101816492|NCT00790439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816493|NCT00790439|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101816494|NCT00790439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101816495|NCT00790439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817241|NCT00387088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101817242|NCT00387088|Autonomic Agents|autonomic agents|mesh-ancestor
101817243|NCT00387088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101817244|NCT00387088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817245|NCT00387088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101817246|NCT00387088|Respiratory System Agents|respiratory system agents|mesh-ancestor
101817247|NCT00387088|Parasympatholytics|parasympatholytics|mesh-ancestor
101817248|NCT00387088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101812250|NCT00974012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101812251|NCT00974012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812252|NCT00974012|GABA Agents|gaba agents|mesh-ancestor
101812253|NCT00974012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101812254|NCT00974012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812255|NCT00974012|Antimanic Agents|antimanic agents|mesh-ancestor
101812256|NCT00974012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101812257|NCT00974012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101822209|NCT05843708|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101822210|NCT05843708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101822212|NCT05805826|Immunologic Factors|immunologic factors|mesh-ancestor
101822213|NCT05805826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822214|NCT05779020|Vaccines|vaccines|mesh-list
101822215|NCT05779020|Immunologic Factors|immunologic factors|mesh-ancestor
101822216|NCT05779020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822217|NCT05774899|Venetoclax|venetoclax|mesh-list
101822218|NCT05774899|Lenvatinib|lenvatinib|mesh-list
101822219|NCT05774899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101822220|NCT05774899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101822221|NCT05774899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101822222|NCT05774899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822223|NCT05743946|Ivacaftor|ivacaftor|mesh-list
101822224|NCT05743946|Elexacaftor|elexacaftor|mesh-list
101822225|NCT05743946|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101822591|NCT04682158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101822593|NCT04682158|Tubulin Modulators|tubulin modulators|mesh-ancestor
101822594|NCT04682158|Antimitotic Agents|antimitotic agents|mesh-ancestor
101822595|NCT04682158|Mitosis Modulators|mitosis modulators|mesh-ancestor
101822690|NCT04416269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822694|NCT04374461|Acetylcysteine|acetylcysteine|mesh-list
101822695|NCT04374461|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101822696|NCT04374461|Antiviral Agents|antiviral agents|mesh-ancestor
101822697|NCT04374461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101822698|NCT04374461|Expectorants|expectorants|mesh-ancestor
101822699|NCT04374461|Respiratory System Agents|respiratory system agents|mesh-ancestor
101822700|NCT04374461|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101822701|NCT04374461|Antioxidants|antioxidants|mesh-ancestor
101822702|NCT04374461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822703|NCT04374461|Protective Agents|protective agents|mesh-ancestor
101822704|NCT04374461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822705|NCT04374461|Antidotes|antidotes|mesh-ancestor
101822706|NCT04344860|Tranexamic Acid|tranexamic acid|mesh-list
101822707|NCT04344860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101822708|NCT04344860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101822709|NCT04344860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822710|NCT04344860|Hemostatics|hemostatics|mesh-ancestor
101822711|NCT04344860|Coagulants|coagulants|mesh-ancestor
101822712|NCT04333420|Vilobelimab|vilobelimab|mesh-list
101822713|NCT04333420|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101822714|NCT04333420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101822715|NCT04333420|Immunologic Factors|immunologic factors|mesh-ancestor
101822716|NCT04333420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822718|NCT04317534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101822719|NCT04317534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101822720|NCT04317534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101812258|NCT00974012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101812259|NCT00964574|Insulin|insulin|mesh-list
101812260|NCT00964574|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101812261|NCT00964574|Insulin Glargine|insulin glargine|mesh-list
101812262|NCT00964574|Insulin glulisine|insulin glulisine|mesh-list
101812263|NCT00964574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101812264|NCT00964574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812265|NCT00970580|Paclitaxel|paclitaxel|mesh-list
101812266|NCT00970580|Carboplatin|carboplatin|mesh-list
101812267|NCT00970580|Alkylating Agents|alkylating agents|mesh-list
101812268|NCT00970580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101812269|NCT00970580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101812270|NCT00970580|Tubulin Modulators|tubulin modulators|mesh-ancestor
101812271|NCT00970580|Antimitotic Agents|antimitotic agents|mesh-ancestor
101822721|NCT04317534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822722|NCT04247165|Paclitaxel|paclitaxel|mesh-list
101822723|NCT04247165|Gemcitabine|gemcitabine|mesh-list
101822724|NCT04247165|Nivolumab|nivolumab|mesh-list
101822725|NCT04247165|Ipilimumab|ipilimumab|mesh-list
101822726|NCT04247165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101822727|NCT04247165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101822728|NCT04247165|Tubulin Modulators|tubulin modulators|mesh-ancestor
101822729|NCT04247165|Antimitotic Agents|antimitotic agents|mesh-ancestor
101822730|NCT04247165|Mitosis Modulators|mitosis modulators|mesh-ancestor
101822731|NCT04247165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822732|NCT04247165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101822733|NCT04247165|Antimetabolites|antimetabolites|mesh-ancestor
101822734|NCT04247165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101822735|NCT04247165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101822736|NCT04245865|Leucovorin|leucovorin|mesh-list
101822737|NCT04245865|Tocotrienols|tocotrienols|mesh-list
101822738|NCT04245865|Vitamin E|vitamin e|mesh-list
101822739|NCT04245865|Tocopherols|tocopherols|mesh-list
101822740|NCT04245865|Bevacizumab|bevacizumab|mesh-list
101822741|NCT04245865|Fluorouracil|fluorouracil|mesh-list
101822742|NCT04245865|Capecitabine|capecitabine|mesh-list
101822743|NCT04245865|Oxaliplatin|oxaliplatin|mesh-list
101822744|NCT04245865|Levoleucovorin|levoleucovorin|mesh-list
101822745|NCT04245865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101822746|NCT04245865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101822747|NCT04245865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101822748|NCT04245865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101822749|NCT04245865|Growth Substances|growth substances|mesh-ancestor
101822750|NCT04245865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822751|NCT04245865|Growth Inhibitors|growth inhibitors|mesh-ancestor
101822752|NCT04245865|Antimetabolites|antimetabolites|mesh-ancestor
101822753|NCT04245865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822754|NCT04245865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101822755|NCT04245865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101822756|NCT04245865|Immunologic Factors|immunologic factors|mesh-ancestor
101822757|NCT04245865|Antidotes|antidotes|mesh-ancestor
101822758|NCT04245865|Protective Agents|protective agents|mesh-ancestor
101822759|NCT04245865|Vitamin B Complex|vitamin b complex|mesh-ancestor
101822760|NCT04245865|Vitamins|vitamins|mesh-ancestor
101822761|NCT04245865|Micronutrients|micronutrients|mesh-ancestor
101822762|NCT04245865|Antioxidants|antioxidants|mesh-ancestor
101822763|NCT04234867|Dapagliflozin|dapagliflozin|mesh-list
101822764|NCT04234867|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101822765|NCT04234867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822766|NCT04234867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101822767|NCT04234867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812272|NCT00970580|Mitosis Modulators|mitosis modulators|mesh-ancestor
101812273|NCT00970580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812274|NCT00974324|Endostar protein|endostar protein|mesh-list
101812275|NCT00974324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101812276|NCT00974324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101812277|NCT00974324|Growth Substances|growth substances|mesh-ancestor
101822768|NCT04234048|Fenretinide|fenretinide|mesh-list
101822770|NCT04234048|Tretinoin|tretinoin|mesh-list
101822771|NCT04234048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101822772|NCT04234048|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101822773|NCT04234048|Protective Agents|protective agents|mesh-ancestor
101822774|NCT04234048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822775|NCT04234048|Keratolytic Agents|keratolytic agents|mesh-ancestor
101822776|NCT04234048|Dermatologic Agents|dermatologic agents|mesh-ancestor
101822777|NCT04219280|Methylphenidate|methylphenidate|mesh-list
101822778|NCT04219280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101822779|NCT04219280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822780|NCT04219280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101822781|NCT04219280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101822783|NCT04219280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822784|NCT04219280|Dopamine Agents|dopamine agents|mesh-ancestor
101822785|NCT04219280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101822786|NCT04191096|Pembrolizumab|pembrolizumab|mesh-list
101822787|NCT04191096|Androgens|androgens|mesh-list
101822788|NCT04191096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101822789|NCT04191096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101822790|NCT04191096|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101822791|NCT04191096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822793|NCT04191096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101822794|NCT04191096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822795|NCT04177693|Letrozole|letrozole|mesh-list
101822796|NCT04177693|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
101822797|NCT04177693|Clomiphene|clomiphene|mesh-list
101822798|NCT04177693|Enclomiphene|enclomiphene|mesh-list
101822799|NCT04177693|Zuclomiphene|zuclomiphene|mesh-list
101822800|NCT04177693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822801|NCT04177693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101822802|NCT04177693|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101822803|NCT04177693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101822804|NCT04177693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101822805|NCT04177693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101822806|NCT04177693|Hormone Antagonists|hormone antagonists|mesh-ancestor
101822807|NCT04177693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101822808|NCT04177693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822809|NCT04177693|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101822810|NCT04177693|Fertility Agents|fertility agents|mesh-ancestor
101822811|NCT04177693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101822812|NCT04177693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101822813|NCT04177693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101822814|NCT04177693|Antioxidants|antioxidants|mesh-ancestor
101822815|NCT04177693|Protective Agents|protective agents|mesh-ancestor
101822816|NCT04177693|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101822817|NCT04177693|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101822818|NCT04177693|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101822819|NCT04118387|Acetazolamide|acetazolamide|mesh-list
101822820|NCT04118387|Zolpidem|zolpidem|mesh-list
101822821|NCT04118387|Buspirone|buspirone|mesh-list
101822822|NCT04118387|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101822823|NCT04118387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101822824|NCT04118387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101822825|NCT04118387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822826|NCT04118387|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101822827|NCT04118387|GABA Agonists|gaba agonists|mesh-ancestor
101822828|NCT04118387|GABA Agents|gaba agents|mesh-ancestor
101822829|NCT04118387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101812278|NCT00974324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812279|NCT00974324|Growth Inhibitors|growth inhibitors|mesh-ancestor
101812280|NCT00974324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101812281|NCT00545714|Cyclophosphamide|cyclophosphamide|mesh-list
101812282|NCT00545714|Rituximab|rituximab|mesh-list
101812283|NCT00545714|Fludarabine|fludarabine|mesh-list
101312035|NCT00006190|Nelfinavir|nelfinavir|mesh-list
101812284|NCT00545714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101812285|NCT00545714|Immunologic Factors|immunologic factors|mesh-ancestor
101812286|NCT00545714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822830|NCT04118387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822831|NCT04118387|Anticonvulsants|anticonvulsants|mesh-ancestor
101822832|NCT04118387|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101822833|NCT04118387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101822834|NCT04118387|Diuretics|diuretics|mesh-ancestor
101822835|NCT04118387|Natriuretic Agents|natriuretic agents|mesh-ancestor
101822836|NCT04118387|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101822837|NCT04118387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101822838|NCT04118387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101822839|NCT04118387|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101822840|NCT04118387|Serotonin Agents|serotonin agents|mesh-ancestor
101822841|NCT04105335|Pembrolizumab|pembrolizumab|mesh-list
101822842|NCT04105335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101822843|NCT04105335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101822844|NCT04105335|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101822845|NCT04105335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822846|NCT04072952|Palbociclib|palbociclib|mesh-list
101822847|NCT04072952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101822848|NCT04072952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101822849|NCT04072952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101822850|NCT04072952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822851|NCT04068194|Avelumab|avelumab|mesh-list
101822852|NCT04068194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101822853|NCT04068194|Peposertib|peposertib|mesh-list
101822854|NCT04068194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101822856|NCT04068194|Immunologic Factors|immunologic factors|mesh-ancestor
101822857|NCT04068194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822858|NCT04068194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101822859|NCT04068194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101822860|NCT04068194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822861|NCT04032418|Pembrolizumab|pembrolizumab|mesh-list
101822862|NCT04032418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101822863|NCT04032418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101822864|NCT04032418|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101822865|NCT04032418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822867|NCT04026412|Ipilimumab|ipilimumab|mesh-list
101822868|NCT04026412|Durvalumab|durvalumab|mesh-list
101822869|NCT04026412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101822870|NCT04026412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101822871|NCT04026412|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101822872|NCT04026412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822873|NCT04006522|Atezolizumab|atezolizumab|mesh-list
101822874|NCT04006522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101822875|NCT04006522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822876|NCT04006522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101822877|NCT04006522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101822878|NCT03971734|Regadenoson|regadenoson|mesh-list
101822879|NCT03971734|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
101822880|NCT03971734|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101822881|NCT03971734|Purinergic Agonists|purinergic agonists|mesh-ancestor
101822882|NCT03971734|Purinergic Agents|purinergic agents|mesh-ancestor
101822883|NCT03971734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101822884|NCT03971734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812287|NCT00545714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101812288|NCT00545714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101822885|NCT03971734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822886|NCT03922048|Bupivacaine|bupivacaine|mesh-list
101822887|NCT03922048|Anesthetics, Local|anesthetics, local|mesh-ancestor
101822889|NCT03922048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101822890|NCT03922048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822891|NCT03922048|Sensory System Agents|sensory system agents|mesh-ancestor
101822892|NCT03922048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101822893|NCT03914742|Temozolomide|temozolomide|mesh-list
101822894|NCT03914742|Pamiparib|pamiparib|mesh-list
101822895|NCT03914742|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
101822896|NCT03914742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101822897|NCT03914742|Alkylating Agents|alkylating agents|mesh-ancestor
101822898|NCT03914742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822899|NCT03914742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101822900|NCT03914742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101822901|NCT03891667|Disulfiram|disulfiram|mesh-list
101822902|NCT03891667|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101822903|NCT03891667|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
101822904|NCT03891667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101822905|NCT03891667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822907|NCT03866174|Psilocybin|psilocybin|mesh-list
101822908|NCT03866174|Vitamins|vitamins|mesh-ancestor
101822909|NCT03866174|Micronutrients|micronutrients|mesh-ancestor
101822910|NCT03866174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822911|NCT03866174|Vitamin B Complex|vitamin b complex|mesh-ancestor
101822912|NCT03866174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101822913|NCT03866174|Antimetabolites|antimetabolites|mesh-ancestor
101822914|NCT03866174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822915|NCT03866174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101822916|NCT03866174|Vasodilator Agents|vasodilator agents|mesh-ancestor
101822917|NCT03866174|Hallucinogens|hallucinogens|mesh-ancestor
101822918|NCT03866174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101822920|NCT03859869|Pancreatin|pancreatin|mesh-list
101822921|NCT03859869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101822922|NCT03764098|Guanfacine|guanfacine|mesh-list
101822923|NCT03764098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101822924|NCT03764098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101822925|NCT03764098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101822926|NCT03764098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101822927|NCT03764098|Adrenergic Agents|adrenergic agents|mesh-ancestor
101822928|NCT03764098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101822929|NCT03764098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822930|NCT03764098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822931|NCT03740204|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101822932|NCT03740204|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101822934|NCT03740204|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101822935|NCT03740204|Progesterone|progesterone|mesh-list
101822936|NCT03740204|Estrogens|estrogens|mesh-ancestor
101822937|NCT03740204|Hormones|hormones|mesh-ancestor
101822938|NCT03740204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101822939|NCT03740204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822940|NCT03740204|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101822941|NCT03740204|Contraceptive Agents|contraceptive agents|mesh-ancestor
101822942|NCT03740204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101822943|NCT03740204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101822944|NCT03740204|Progestins|progestins|mesh-ancestor
101822945|NCT03735563|Fentanyl|fentanyl|mesh-list
101822946|NCT03735563|Ketamine|ketamine|mesh-list
101822947|NCT03735563|Analgesics|analgesics|mesh-ancestor
101822948|NCT03735563|Sensory System Agents|sensory system agents|mesh-ancestor
101822949|NCT03735563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101822950|NCT03735563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822951|NCT03735563|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101822952|NCT03735563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101822953|NCT03735563|Anesthetics, General|anesthetics, general|mesh-ancestor
101822955|NCT03735563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101822956|NCT03735563|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101822957|NCT03735563|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101812289|NCT00545714|Alkylating Agents|alkylating agents|mesh-ancestor
101812290|NCT00545714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812291|NCT00545714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101812292|NCT00545714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101812293|NCT00545714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101812295|NCT00964730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101812296|NCT00964730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101812297|NCT00964730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101822958|NCT03735563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101822959|NCT03735563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822960|NCT03735563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101822962|NCT03735563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101822963|NCT03735095|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
101822964|NCT03735095|Trioxsalen|trioxsalen|mesh-list
101822965|NCT03735095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101822966|NCT03735095|Dermatologic Agents|dermatologic agents|mesh-ancestor
101822967|NCT03735095|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101822968|NCT03715153|Bumetanide|bumetanide|mesh-list
101822969|NCT03715153|Diuretics|diuretics|mesh-ancestor
101822970|NCT03715153|Natriuretic Agents|natriuretic agents|mesh-ancestor
101822971|NCT03715153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822972|NCT03715153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101822973|NCT03715153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101822974|NCT03715153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822975|NCT03685773|Niacin|niacin|mesh-list
101822976|NCT03685773|Nicotinic Acids|nicotinic acids|mesh-list
101822977|NCT03685773|Niacinamide|niacinamide|mesh-list
101822978|NCT03685773|Diazoxide|diazoxide|mesh-list
101822979|NCT03685773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101822980|NCT03685773|Antimetabolites|antimetabolites|mesh-ancestor
101822981|NCT03685773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822982|NCT03685773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101822984|NCT03685773|Vitamin B Complex|vitamin b complex|mesh-ancestor
101822985|NCT03685773|Vitamins|vitamins|mesh-ancestor
101822986|NCT03685773|Micronutrients|micronutrients|mesh-ancestor
101822987|NCT03685773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822988|NCT03685773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101822989|NCT03683277|Dexamethasone|dexamethasone|mesh-list
101822990|NCT03683277|Pomalidomide|pomalidomide|mesh-list
101822991|NCT03683277|Ixazomib|ixazomib|mesh-list
101822992|NCT03683277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101822993|NCT03683277|Antiemetics|antiemetics|mesh-ancestor
101822994|NCT03683277|Autonomic Agents|autonomic agents|mesh-ancestor
101822995|NCT03683277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101822996|NCT03683277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822997|NCT03683277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101822998|NCT03683277|Glucocorticoids|glucocorticoids|mesh-ancestor
101822999|NCT03683277|Hormones|hormones|mesh-ancestor
101823000|NCT03683277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101823001|NCT03683277|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101823002|NCT03683277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101823003|NCT03683277|Immunologic Factors|immunologic factors|mesh-ancestor
101823004|NCT03683277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101823005|NCT03683277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101823006|NCT03683277|Growth Substances|growth substances|mesh-ancestor
101823007|NCT03683277|Growth Inhibitors|growth inhibitors|mesh-ancestor
101823008|NCT03683277|Protease Inhibitors|protease inhibitors|mesh-ancestor
101823009|NCT03683277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101823010|NCT03683277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823011|NCT03665207|Insulin|insulin|mesh-list
101823012|NCT03665207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101823013|NCT03665207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823014|NCT03660683|Dapagliflozin|dapagliflozin|mesh-list
101823015|NCT03660683|Saxagliptin|saxagliptin|mesh-list
101812298|NCT00964730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101812299|NCT00964730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101812300|NCT00964730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812301|NCT00964730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101812302|NCT00539838|Mycophenolic Acid|mycophenolic acid|mesh-list
101812303|NCT00539838|Prednisone|prednisone|mesh-list
101812304|NCT00539838|Methylprednisolone|methylprednisolone|mesh-list
101812305|NCT00539838|Methotrexate|methotrexate|mesh-list
101812306|NCT00539838|Azathioprine|azathioprine|mesh-list
101812307|NCT00539838|Immunosuppressive Agents|immunosuppressive agents|mesh-list
101812308|NCT00539838|Ocrelizumab|ocrelizumab|mesh-list
101812309|NCT00539838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101823016|NCT03660683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101823017|NCT03660683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823018|NCT03660683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101823019|NCT03660683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823020|NCT03660683|Incretins|incretins|mesh-ancestor
101823021|NCT03660683|Hormones|hormones|mesh-ancestor
101823022|NCT03660683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101823023|NCT03660683|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101823024|NCT03660683|Protease Inhibitors|protease inhibitors|mesh-ancestor
101823025|NCT03660683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101823026|NCT03569293|Upadacitinib|upadacitinib|mesh-list
101823027|NCT03569293|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101823028|NCT03569293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101823029|NCT03569293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101823030|NCT03569293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823031|NCT03569293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101823032|NCT03566511|Diazoxide|diazoxide|mesh-list
101823033|NCT03566511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101823034|NCT03566511|Vasodilator Agents|vasodilator agents|mesh-ancestor
101823035|NCT03464136|Adalimumab|adalimumab|mesh-list
101823036|NCT03464136|Ustekinumab|ustekinumab|mesh-list
101823037|NCT03464136|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101823038|NCT03464136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101823039|NCT03464136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101823040|NCT03464136|Dermatologic Agents|dermatologic agents|mesh-ancestor
101823042|NCT03397706|Antiviral Agents|antiviral agents|mesh-ancestor
101823043|NCT03397706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101823044|NCT03382587|Aflibercept|aflibercept|mesh-list
101823045|NCT03382587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101823046|NCT03382587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101823047|NCT03382587|Growth Substances|growth substances|mesh-ancestor
101334088|NCT00042718|Clavulanic Acid|clavulanic acid|mesh-list
101823048|NCT03382587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823049|NCT03382587|Growth Inhibitors|growth inhibitors|mesh-ancestor
101823050|NCT03382587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101823051|NCT03325972|Dexmedetomidine|dexmedetomidine|mesh-list
101823052|NCT03325972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101823053|NCT03325972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101823054|NCT03325972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823055|NCT03325972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101823056|NCT03325972|Analgesics|analgesics|mesh-ancestor
101823057|NCT03325972|Sensory System Agents|sensory system agents|mesh-ancestor
101823058|NCT03325972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101823059|NCT03325972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101823060|NCT03325972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101823061|NCT03325972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101823062|NCT03325972|Adrenergic Agents|adrenergic agents|mesh-ancestor
101823063|NCT03325972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101823064|NCT03325972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823096|NCT03247712|Nivolumab|nivolumab|mesh-list
101823097|NCT03247712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101823098|NCT03247712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101812310|NCT00539838|Glucocorticoids|glucocorticoids|mesh-ancestor
101812311|NCT00539838|Hormones|hormones|mesh-ancestor
101469618|NCT00245141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101812312|NCT00539838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101812313|NCT00539838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812314|NCT00539838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101812315|NCT00539838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101812316|NCT00539838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101812317|NCT00539838|Abortifacient Agents|abortifacient agents|mesh-ancestor
101823099|NCT03247712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101823100|NCT03247712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823101|NCT03198026|Obinutuzumab|obinutuzumab|mesh-list
101823102|NCT03198026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101823103|NCT03198026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101823104|NCT03125642|Cytarabine|cytarabine|mesh-list
101823105|NCT03125642|Cyclophosphamide|cyclophosphamide|mesh-list
101823106|NCT03125642|Melphalan|melphalan|mesh-list
101823107|NCT03125642|Carmustine|carmustine|mesh-list
101823108|NCT03125642|Etoposide|etoposide|mesh-list
101823109|NCT03125642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101823110|NCT03125642|Immunologic Factors|immunologic factors|mesh-ancestor
101823111|NCT03125642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823112|NCT03125642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101823113|NCT03125642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101823114|NCT03125642|Alkylating Agents|alkylating agents|mesh-ancestor
101823115|NCT03125642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823116|NCT03125642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101823117|NCT03125642|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101823118|NCT03125642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101823119|NCT03125642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101823120|NCT03125642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101823121|NCT03125642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101823122|NCT03125642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101823123|NCT03125642|Antimetabolites|antimetabolites|mesh-ancestor
101823124|NCT03125642|Antiviral Agents|antiviral agents|mesh-ancestor
101823125|NCT03125642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101823126|NCT03048825|Colchicine|colchicine|mesh-list
101823127|NCT03048825|Spironolactone|spironolactone|mesh-list
101823128|NCT03048825|Gout Suppressants|gout suppressants|mesh-ancestor
101823129|NCT03048825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101823130|NCT03048825|Tubulin Modulators|tubulin modulators|mesh-ancestor
101823131|NCT03048825|Antimitotic Agents|antimitotic agents|mesh-ancestor
101823132|NCT03048825|Mitosis Modulators|mitosis modulators|mesh-ancestor
101823133|NCT03048825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823134|NCT03048825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101823135|NCT03048825|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101823136|NCT03048825|Hormone Antagonists|hormone antagonists|mesh-ancestor
101823137|NCT03048825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101823138|NCT03048825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823139|NCT03048825|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101823140|NCT03048825|Diuretics|diuretics|mesh-ancestor
101823141|NCT03048825|Natriuretic Agents|natriuretic agents|mesh-ancestor
101823143|NCT03039413|Trace Elements|trace elements|mesh-ancestor
101823144|NCT03039413|Micronutrients|micronutrients|mesh-ancestor
101823145|NCT03039413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823146|NCT03026790|Buprenorphine|buprenorphine|mesh-list
101823147|NCT03026790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101823148|NCT03026790|Naloxone|naloxone|mesh-list
101823149|NCT03026790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101823150|NCT03026790|Narcotics|narcotics|mesh-ancestor
101823151|NCT03026790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101823152|NCT03026790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823153|NCT03026790|Analgesics|analgesics|mesh-ancestor
101823154|NCT03026790|Sensory System Agents|sensory system agents|mesh-ancestor
101823155|NCT03026790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101812318|NCT00539838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101812319|NCT00539838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101812320|NCT00539838|Antimetabolites|antimetabolites|mesh-ancestor
101812321|NCT00539838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812322|NCT00539838|Dermatologic Agents|dermatologic agents|mesh-ancestor
101812323|NCT00539838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101812324|NCT00539838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101812325|NCT00539838|Immunologic Factors|immunologic factors|mesh-ancestor
101812326|NCT00539838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101812327|NCT00539838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101812328|NCT00539838|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101812329|NCT00539838|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101812330|NCT00539838|Antitubercular Agents|antitubercular agents|mesh-ancestor
101812331|NCT00539838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101812332|NCT00539838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101812333|NCT00539838|Antiemetics|antiemetics|mesh-ancestor
101812334|NCT00539838|Autonomic Agents|autonomic agents|mesh-ancestor
101812335|NCT00539838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101812336|NCT00539838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101812337|NCT00539838|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101812338|NCT00539838|Protective Agents|protective agents|mesh-ancestor
101812339|NCT00970892|Warfarin|warfarin|mesh-list
101812340|NCT00970892|Anticoagulants|anticoagulants|mesh-ancestor
101812371|NCT00971126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101812372|NCT00971126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101812373|NCT00971126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812374|NCT00971126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101812375|NCT00971126|Immunologic Factors|immunologic factors|mesh-ancestor
101812376|NCT00971126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812377|NCT00971126|Leprostatic Agents|leprostatic agents|mesh-ancestor
101812378|NCT00971126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101812379|NCT00971126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101812380|NCT00971126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101812381|NCT00971126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101812382|NCT00971126|Growth Substances|growth substances|mesh-ancestor
101812383|NCT00971126|Growth Inhibitors|growth inhibitors|mesh-ancestor
101469715|NCT00245609|Pregabalin|pregabalin|mesh-list
101812384|NCT00964964|Insulin|insulin|mesh-list
101812385|NCT00964964|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101812386|NCT00964964|Insulin, Long-Acting|insulin, long-acting|mesh-list
101812388|NCT00964964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812389|NCT00965042|Ceftobiprole|ceftobiprole|mesh-list
101823156|NCT03026790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101823158|NCT02974725|Naporafenib|naporafenib|mesh-list
101823159|NCT02974725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101823160|NCT02974725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101823161|NCT02974725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101823162|NCT02974725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823163|NCT02955290|Pembrolizumab|pembrolizumab|mesh-list
101823164|NCT02955290|Nivolumab|nivolumab|mesh-list
101823165|NCT02955290|Vaccines|vaccines|mesh-list
101823166|NCT02955290|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101823167|NCT02955290|Mitogens|mitogens|mesh-list
101823168|NCT02955290|Immunologic Factors|immunologic factors|mesh-ancestor
101823169|NCT02955290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823170|NCT02955290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101823171|NCT02955290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101823172|NCT02955290|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101823173|NCT02955290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823174|NCT02955290|Mitosis Modulators|mitosis modulators|mesh-ancestor
101823175|NCT02955290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101823176|NCT02735707|Aspirin|aspirin|mesh-list
101823177|NCT02735707|Vitamins|vitamins|mesh-list
101823178|NCT02735707|Ascorbic Acid|ascorbic acid|mesh-list
101823179|NCT02735707|Interferons|interferons|mesh-list
101823180|NCT02735707|Ritonavir|ritonavir|mesh-list
101823181|NCT02735707|Lopinavir|lopinavir|mesh-list
101823182|NCT02735707|Interferon-beta|interferon-beta|mesh-list
101823183|NCT02735707|Oseltamivir|oseltamivir|mesh-list
101823184|NCT02735707|Interferon beta-1a|interferon beta-1a|mesh-list
101823185|NCT02735707|Antiviral Agents|antiviral agents|mesh-list
101823186|NCT02735707|Baloxavir|baloxavir|mesh-list
101823187|NCT02735707|Amoxicillin|amoxicillin|mesh-list
101823188|NCT02735707|Moxifloxacin|moxifloxacin|mesh-list
101823189|NCT02735707|Hydroxychloroquine|hydroxychloroquine|mesh-list
101823190|NCT02735707|Levofloxacin|levofloxacin|mesh-list
101823191|NCT02735707|Ivermectin|ivermectin|mesh-list
101823192|NCT02735707|Ceftriaxone|ceftriaxone|mesh-list
101823193|NCT02735707|Tazobactam|tazobactam|mesh-list
101823194|NCT02735707|Piperacillin|piperacillin|mesh-list
101823195|NCT02735707|Clavulanic Acid|clavulanic acid|mesh-list
101823196|NCT02735707|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101812390|NCT00965042|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
101812391|NCT00965042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101812392|NCT00965042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101812393|NCT03676764|Azithromycin|azithromycin|mesh-list
101812394|NCT03676764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101812395|NCT03676764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101812396|NCT00974792|Leucovorin|leucovorin|mesh-list
101812397|NCT00974792|Cytarabine|cytarabine|mesh-list
101812398|NCT00974792|Cyclophosphamide|cyclophosphamide|mesh-list
101812399|NCT00974792|Ifosfamide|ifosfamide|mesh-list
101812400|NCT00974792|Rituximab|rituximab|mesh-list
101812401|NCT00974792|Doxorubicin|doxorubicin|mesh-list
101823197|NCT02735707|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101823198|NCT02735707|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
101823199|NCT02735707|Dexamethasone|dexamethasone|mesh-list
101823200|NCT02735707|Hydrocortisone|hydrocortisone|mesh-list
101823201|NCT02735707|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101823202|NCT02735707|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101823203|NCT02735707|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101823204|NCT02735707|Apremilast|apremilast|mesh-list
101823205|NCT02735707|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101823206|NCT02735707|Losartan|losartan|mesh-list
101823207|NCT02735707|Valsartan|valsartan|mesh-list
101823208|NCT02735707|Telmisartan|telmisartan|mesh-list
101823209|NCT02735707|Candesartan|candesartan|mesh-list
101823210|NCT02735707|Ramipril|ramipril|mesh-list
101823211|NCT02735707|Olmesartan|olmesartan|mesh-list
101823212|NCT02735707|Enalapril|enalapril|mesh-list
101823213|NCT02735707|Lisinopril|lisinopril|mesh-list
101823214|NCT02735707|Irbesartan|irbesartan|mesh-list
101823215|NCT02735707|Perindopril|perindopril|mesh-list
101823216|NCT02735707|Captopril|captopril|mesh-list
101823217|NCT02735707|Trandolapril|trandolapril|mesh-list
101823218|NCT02735707|Clopidogrel|clopidogrel|mesh-list
101823219|NCT02735707|Ticagrelor|ticagrelor|mesh-list
101823220|NCT02735707|Simvastatin|simvastatin|mesh-list
101823221|NCT02735707|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101823222|NCT02735707|Immunoglobulins|immunoglobulins|mesh-list
101823223|NCT02735707|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
101823224|NCT02735707|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101823225|NCT02735707|Cysteamine|cysteamine|mesh-list
101823226|NCT02735707|Micronutrients|micronutrients|mesh-ancestor
101823227|NCT02735707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823228|NCT02735707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101823229|NCT02735707|Antiemetics|antiemetics|mesh-ancestor
101823230|NCT02735707|Autonomic Agents|autonomic agents|mesh-ancestor
101823231|NCT02735707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101823232|NCT02735707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101823233|NCT02735707|Glucocorticoids|glucocorticoids|mesh-ancestor
101823234|NCT02735707|Hormones|hormones|mesh-ancestor
101823235|NCT02735707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101823236|NCT02735707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101823237|NCT02735707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101823238|NCT02735707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101823239|NCT02735707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101823240|NCT02735707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101823241|NCT02735707|Analgesics|analgesics|mesh-ancestor
101823242|NCT02735707|Sensory System Agents|sensory system agents|mesh-ancestor
101823243|NCT02735707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101823244|NCT02735707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101823245|NCT02735707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101823246|NCT02735707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823247|NCT02735707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101823248|NCT02735707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101823249|NCT02735707|Antipyretics|antipyretics|mesh-ancestor
101823250|NCT02735707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101823251|NCT02735707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101823252|NCT02735707|Protease Inhibitors|protease inhibitors|mesh-ancestor
101823253|NCT02735707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101812402|NCT00974792|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101812403|NCT00974792|Methotrexate|methotrexate|mesh-list
101812404|NCT00974792|Etoposide|etoposide|mesh-list
101812405|NCT00974792|Vincristine|vincristine|mesh-list
101812406|NCT00974792|Etoposide phosphate|etoposide phosphate|mesh-list
101812407|NCT00974792|Levoleucovorin|levoleucovorin|mesh-list
101812408|NCT00974792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101812409|NCT00974792|Immunologic Factors|immunologic factors|mesh-ancestor
101812410|NCT00974792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812411|NCT00974792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101812412|NCT00974792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101812413|NCT00974792|Alkylating Agents|alkylating agents|mesh-ancestor
101812414|NCT00974792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812415|NCT00974792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101812416|NCT00974792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101812417|NCT00974792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101812418|NCT00974792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101812419|NCT00974792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101812420|NCT00974792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101812421|NCT00974792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101812422|NCT00974792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101812423|NCT00974792|Abortifacient Agents|abortifacient agents|mesh-ancestor
101812424|NCT00974792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101812425|NCT00974792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101812426|NCT00974792|Antimetabolites|antimetabolites|mesh-ancestor
101812427|NCT00974792|Dermatologic Agents|dermatologic agents|mesh-ancestor
101812428|NCT00974792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101812429|NCT00974792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101812430|NCT00974792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101812431|NCT00974792|Antiviral Agents|antiviral agents|mesh-ancestor
101812432|NCT00974792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101812433|NCT00974792|Antidotes|antidotes|mesh-ancestor
101812434|NCT00974792|Protective Agents|protective agents|mesh-ancestor
101812435|NCT00974792|Vitamin B Complex|vitamin b complex|mesh-ancestor
101812436|NCT00974792|Vitamins|vitamins|mesh-ancestor
101812437|NCT00974792|Micronutrients|micronutrients|mesh-ancestor
101812438|NCT00974792|Tubulin Modulators|tubulin modulators|mesh-ancestor
101812442|NCT00965120|Kininogens|kininogens|mesh-list
101812443|NCT00965120|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-list
101812444|NCT00965120|Vasodilator Agents|vasodilator agents|mesh-ancestor
101812445|NCT00965120|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
101812446|NCT00965120|Protease Inhibitors|protease inhibitors|mesh-ancestor
101812447|NCT00965120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101812448|NCT00965120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812449|NCT00679289|Interferons|interferons|mesh-list
101812450|NCT00679289|Ecromeximab|ecromeximab|mesh-list
101812451|NCT00679289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101812452|NCT00679289|Antiviral Agents|antiviral agents|mesh-ancestor
101812453|NCT00679289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101812454|NCT00679289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101812455|NCT00679211|Trastuzumab|trastuzumab|mesh-list
101812456|NCT00679211|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101823254|NCT02735707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101823255|NCT02735707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101823256|NCT02735707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101823257|NCT02735707|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101823258|NCT02735707|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101823259|NCT02735707|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101823260|NCT02735707|Purinergic Agents|purinergic agents|mesh-ancestor
101823261|NCT02735707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101823262|NCT02735707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101823263|NCT02735707|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101823264|NCT02735707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101823265|NCT02735707|Antimetabolites|antimetabolites|mesh-ancestor
101823266|NCT02735707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101823267|NCT02735707|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101823268|NCT02735707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101823269|NCT02735707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101823270|NCT02735707|Immunologic Factors|immunologic factors|mesh-ancestor
101823271|NCT02735707|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101823272|NCT02735707|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101823273|NCT02735707|Antimalarials|antimalarials|mesh-ancestor
101823274|NCT02735707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101823275|NCT02735707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101823276|NCT02735707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101823277|NCT02735707|Antioxidants|antioxidants|mesh-ancestor
101823278|NCT02735707|Protective Agents|protective agents|mesh-ancestor
101823279|NCT02735707|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101823280|NCT02735707|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101823281|NCT02735707|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101823282|NCT02735707|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101823283|NCT02735707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101823284|NCT02735707|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101823285|NCT02735707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101823286|NCT02735707|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
101823287|NCT02697448|Propofol|propofol|mesh-list
101823288|NCT02697448|Sevoflurane|sevoflurane|mesh-list
101823289|NCT02697448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101823290|NCT02697448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101823291|NCT02697448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480579|NCT00292721|Celecoxib|celecoxib|mesh-list
101823292|NCT02697448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101823293|NCT02697448|Anesthetics, General|anesthetics, general|mesh-ancestor
101823294|NCT02697448|Anesthetics|anesthetics|mesh-ancestor
101823295|NCT02697448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101823296|NCT02697448|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101823297|NCT02647203|Fluorides|fluorides|mesh-list
101812457|NCT00679211|Maytansine|maytansine|mesh-list
101812458|NCT00679211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101812459|NCT00679211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101469767|NCT00274677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101812460|NCT00679211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101812461|NCT00679211|Tubulin Modulators|tubulin modulators|mesh-ancestor
101812462|NCT00679211|Antimitotic Agents|antimitotic agents|mesh-ancestor
101812463|NCT00679211|Mitosis Modulators|mitosis modulators|mesh-ancestor
101823298|NCT02647203|Cariostatic Agents|cariostatic agents|mesh-ancestor
101823299|NCT02647203|Protective Agents|protective agents|mesh-ancestor
101823300|NCT02647203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823301|NCT02637973|Empagliflozin|empagliflozin|mesh-list
101823302|NCT02637973|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101823303|NCT02637973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823304|NCT02637973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101823305|NCT02637973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823306|NCT02575794|Masoprocol|masoprocol|mesh-list
101823307|NCT02575794|Antioxidants|antioxidants|mesh-ancestor
101823308|NCT02575794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823309|NCT02575794|Protective Agents|protective agents|mesh-ancestor
101823310|NCT02575794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823311|NCT02575794|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101823312|NCT02575794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101823313|NCT02575794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101823314|NCT02575794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101823315|NCT02575794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101823316|NCT02575794|Analgesics|analgesics|mesh-ancestor
101823317|NCT02575794|Sensory System Agents|sensory system agents|mesh-ancestor
101823318|NCT02575794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101823319|NCT02575794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101823320|NCT02575794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101823321|NCT02546921|Immunoglobulin E|immunoglobulin e|mesh-list
101823322|NCT02546921|Immunologic Factors|immunologic factors|mesh-ancestor
101823323|NCT02546921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823324|NCT02527681|Ceftobiprole|ceftobiprole|mesh-list
101823325|NCT02527681|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
101823326|NCT02527681|Cephalosporins|cephalosporins|mesh-list
101823327|NCT02527681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101823328|NCT02527681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101823329|NCT02516696|Clarithromycin|clarithromycin|mesh-list
101823330|NCT02516696|Dexamethasone|dexamethasone|mesh-list
101823331|NCT02516696|Lenalidomide|lenalidomide|mesh-list
101823332|NCT02516696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101823333|NCT02516696|Antiemetics|antiemetics|mesh-ancestor
101823334|NCT02516696|Autonomic Agents|autonomic agents|mesh-ancestor
101823335|NCT02516696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101823336|NCT02516696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823337|NCT02516696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101823338|NCT02516696|Glucocorticoids|glucocorticoids|mesh-ancestor
101823339|NCT02516696|Hormones|hormones|mesh-ancestor
101823340|NCT02516696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101823341|NCT02516696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101823342|NCT02516696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101823343|NCT02516696|Immunologic Factors|immunologic factors|mesh-ancestor
101823344|NCT02516696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101823345|NCT02516696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101823346|NCT02516696|Growth Substances|growth substances|mesh-ancestor
101823347|NCT02516696|Growth Inhibitors|growth inhibitors|mesh-ancestor
101823348|NCT02516696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101823350|NCT02516696|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101823351|NCT02516696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101823352|NCT02516696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823353|NCT02516696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101823354|NCT02516696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101823355|NCT02513329|Bupivacaine|bupivacaine|mesh-list
101823356|NCT02513329|Anesthetics, Local|anesthetics, local|mesh-ancestor
101812464|NCT00679211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812466|NCT00679211|Immunoconjugates|immunoconjugates|mesh-ancestor
101812467|NCT00679211|Immunologic Factors|immunologic factors|mesh-ancestor
101812468|NCT00679211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812469|NCT00545948|Cisplatin|cisplatin|mesh-list
101812470|NCT00545948|Pemetrexed|pemetrexed|mesh-list
101812471|NCT00545948|Vinorelbine|vinorelbine|mesh-list
101812472|NCT00545948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101812473|NCT00545948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101812474|NCT00545948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812475|NCT00545948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101812476|NCT00545948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101812477|NCT00545948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101812478|NCT00545948|Tubulin Modulators|tubulin modulators|mesh-ancestor
101823357|NCT02513329|Anesthetics|anesthetics|mesh-ancestor
101823358|NCT02513329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101823359|NCT02513329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823360|NCT02513329|Sensory System Agents|sensory system agents|mesh-ancestor
101823361|NCT02513329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101823362|NCT02425826|Thalidomide|thalidomide|mesh-list
101823363|NCT02425826|Apremilast|apremilast|mesh-list
101823364|NCT02425826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101823365|NCT02425826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101823366|NCT02425826|Analgesics|analgesics|mesh-ancestor
101823367|NCT02425826|Sensory System Agents|sensory system agents|mesh-ancestor
101823368|NCT02425826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101823369|NCT02425826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823370|NCT02425826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101823371|NCT02425826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101823372|NCT02425826|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101823373|NCT02425826|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101823374|NCT02425826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101823375|NCT02425826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823376|NCT02425826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101823377|NCT02425826|Immunologic Factors|immunologic factors|mesh-ancestor
101823378|NCT02425826|Leprostatic Agents|leprostatic agents|mesh-ancestor
101823379|NCT02425826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101823380|NCT02425826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101823381|NCT02425826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101823382|NCT02425826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101823383|NCT02425826|Growth Substances|growth substances|mesh-ancestor
101823384|NCT02425826|Growth Inhibitors|growth inhibitors|mesh-ancestor
101823385|NCT02425826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101823387|NCT02386774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101823388|NCT02386774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101823389|NCT02386774|Anesthetics, Local|anesthetics, local|mesh-ancestor
101823390|NCT02386774|Anesthetics|anesthetics|mesh-ancestor
101823391|NCT02386774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101823392|NCT02386774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823393|NCT02386774|Sensory System Agents|sensory system agents|mesh-ancestor
101823394|NCT02386774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101823396|NCT02278120|Letrozole|letrozole|mesh-list
101823397|NCT02278120|Anastrozole|anastrozole|mesh-list
101823398|NCT02278120|Goserelin|goserelin|mesh-list
101823399|NCT02278120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101823400|NCT02278120|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101823401|NCT02278120|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101823402|NCT02278120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101812479|NCT00545948|Antimitotic Agents|antimitotic agents|mesh-ancestor
101812480|NCT00545948|Mitosis Modulators|mitosis modulators|mesh-ancestor
101812481|NCT00755573|Pregabalin|pregabalin|mesh-list
101812482|NCT00755573|Analgesics|analgesics|mesh-ancestor
101812483|NCT00755573|Sensory System Agents|sensory system agents|mesh-ancestor
101812484|NCT00755573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101812485|NCT00755573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812486|NCT00755573|Anticonvulsants|anticonvulsants|mesh-ancestor
101812487|NCT00755573|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101812488|NCT00755573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101812489|NCT00755573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812490|NCT00755573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101812491|NCT00755573|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101812492|NCT00755573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101812493|NCT00755573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101812494|NCT00755573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101812495|NCT00975104|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
101812496|NCT00975104|Immunologic Factors|immunologic factors|mesh-ancestor
101812497|NCT00975104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812498|NCT04008290|Liraglutide|liraglutide|mesh-list
101812499|NCT04008290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101823403|NCT02278120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823404|NCT02278120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101823405|NCT02278120|Hormone Antagonists|hormone antagonists|mesh-ancestor
101823406|NCT02278120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101823407|NCT02278120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823408|NCT02278120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101823409|NCT02278120|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101823410|NCT02278120|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101823411|NCT02278120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101823412|NCT02274155|Antibodies|antibodies|mesh-list
101823413|NCT02274155|Immunologic Factors|immunologic factors|mesh-ancestor
101823414|NCT02274155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823415|NCT02255357|Oxytocin|oxytocin|mesh-list
101823416|NCT02255357|Oxytocics|oxytocics|mesh-ancestor
101823417|NCT02255357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101823418|NCT02255357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823419|NCT02211131|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
101823420|NCT02211131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101823421|NCT02211131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101823422|NCT02155647|Avelumab|avelumab|mesh-list
101823423|NCT02155647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101823424|NCT02155647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101823425|NCT02057107|Docetaxel|docetaxel|mesh-list
101823426|NCT02057107|Cetuximab|cetuximab|mesh-list
101823427|NCT02057107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101823428|NCT02057107|Tubulin Modulators|tubulin modulators|mesh-ancestor
101823429|NCT02057107|Antimitotic Agents|antimitotic agents|mesh-ancestor
101823430|NCT02057107|Mitosis Modulators|mitosis modulators|mesh-ancestor
101823431|NCT02057107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823432|NCT02057107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101823433|NCT01479075|Insulin|insulin|mesh-list
101812500|NCT04008290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812501|NCT04008290|Incretins|incretins|mesh-ancestor
101812502|NCT04008290|Hormones|hormones|mesh-ancestor
101812503|NCT04008290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101812504|NCT02559167|Cannabidiol|cannabidiol|mesh-list
101812505|NCT02559167|Anticonvulsants|anticonvulsants|mesh-ancestor
101812506|NCT00975182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101812507|NCT00975182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101812508|NCT00975182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101812509|NCT00975182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101812510|NCT00975182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823434|NCT01479075|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101823435|NCT01479075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101823436|NCT01479075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823437|NCT01082679|Buprenorphine|buprenorphine|mesh-list
101823438|NCT01082679|Methadone|methadone|mesh-list
101823439|NCT01082679|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101823440|NCT01082679|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101823441|NCT01082679|Narcotics|narcotics|mesh-ancestor
101823442|NCT01082679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101823444|NCT01082679|Analgesics|analgesics|mesh-ancestor
101823445|NCT01082679|Sensory System Agents|sensory system agents|mesh-ancestor
101823446|NCT01082679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101823447|NCT01082679|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101823448|NCT01082679|Antitussive Agents|antitussive agents|mesh-ancestor
101823449|NCT01082679|Respiratory System Agents|respiratory system agents|mesh-ancestor
101823450|NCT00976963|Fosfomycin|fosfomycin|mesh-list
101823451|NCT00976963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101823452|NCT00976963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101823454|NCT00958633|Escitalopram|escitalopram|mesh-list
101823455|NCT00958633|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101823456|NCT00958633|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101823457|NCT00958633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101823458|NCT00958633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823459|NCT00958633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101823460|NCT00958633|Serotonin Agents|serotonin agents|mesh-ancestor
101823461|NCT00958633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823462|NCT00958633|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101823463|NCT00958633|Antidepressive Agents|antidepressive agents|mesh-ancestor
101823464|NCT00958633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101823465|NCT00958633|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101823466|NCT00958633|Dopamine Agents|dopamine agents|mesh-ancestor
101823467|NCT00958633|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101823468|NCT00958633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101823469|NCT00958633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101823471|NCT00393783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101823472|NCT00393783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101823473|NCT00074269|Cyclosporine|cyclosporine|mesh-list
101823474|NCT00074269|Methotrexate|methotrexate|mesh-list
101823475|NCT00074269|Fludarabine phosphate|fludarabine phosphate|mesh-list
101823476|NCT00074269|Fludarabine|fludarabine|mesh-list
101823477|NCT00074269|Melphalan|melphalan|mesh-list
101823478|NCT00074269|Cyclosporins|cyclosporins|mesh-list
101823479|NCT00074269|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101823480|NCT00074269|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101823481|NCT00074269|Abortifacient Agents|abortifacient agents|mesh-ancestor
101823482|NCT00074269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101823483|NCT00074269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823484|NCT00074269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101823485|NCT00074269|Antimetabolites|antimetabolites|mesh-ancestor
101823486|NCT00074269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812511|NCT05271071|Lidocaine|lidocaine|mesh-list
101812512|NCT05271071|Anesthetics, Local|anesthetics, local|mesh-ancestor
101812513|NCT05271071|Anesthetics|anesthetics|mesh-ancestor
101812514|NCT05271071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101812515|NCT05271071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812516|NCT05271071|Sensory System Agents|sensory system agents|mesh-ancestor
101812517|NCT05271071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101812518|NCT05271071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101823487|NCT00074269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101823488|NCT00074269|Dermatologic Agents|dermatologic agents|mesh-ancestor
101823489|NCT00074269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101823490|NCT00074269|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101823491|NCT00074269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101823492|NCT00074269|Immunologic Factors|immunologic factors|mesh-ancestor
101823493|NCT00074269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101823494|NCT00074269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101823495|NCT00074269|Antifungal Agents|antifungal agents|mesh-ancestor
101823496|NCT00074269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101823497|NCT00074269|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101823498|NCT00074269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101823499|NCT00074269|Alkylating Agents|alkylating agents|mesh-ancestor
101823500|NCT00074269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101823502|NCT00423735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101823503|NCT00423735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101823504|NCT00423735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101823505|NCT00423735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823507|NCT01032213|Analgesics|analgesics|mesh-ancestor
101823508|NCT01032213|Sensory System Agents|sensory system agents|mesh-ancestor
101823509|NCT01032213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101823510|NCT01032213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823511|NCT01032213|Anesthetics|anesthetics|mesh-ancestor
101823512|NCT01032213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101823513|NCT01032213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101823514|NCT01032213|Anticonvulsants|anticonvulsants|mesh-ancestor
101823515|NCT01032213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101823516|NCT01032213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101823517|NCT01032213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823518|NCT01032213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101823519|NCT01032213|Tocolytic Agents|tocolytic agents|mesh-ancestor
101823520|NCT01032213|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101823521|NCT00357994|Levodopa|levodopa|mesh-list
101823522|NCT00357994|Carbidopa|carbidopa|mesh-list
101823523|NCT00357994|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101823524|NCT00357994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101823525|NCT00357994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101823526|NCT00357994|Dopamine Agents|dopamine agents|mesh-ancestor
101823527|NCT00357994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101823528|NCT00357994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823529|NCT00357994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823530|NCT00357994|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101823531|NCT00357994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101823532|NCT00357994|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101823533|NCT00357994|Immunologic Factors|immunologic factors|mesh-ancestor
101823534|NCT00357994|Dopamine Agonists|dopamine agonists|mesh-ancestor
101823535|NCT00823433|Penicillins|penicillins|mesh-list
101823536|NCT00823433|Penicillin V|penicillin v|mesh-list
101823537|NCT00823433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101823538|NCT00823433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101823539|NCT00423657|Vancomycin|vancomycin|mesh-list
101823540|NCT00423657|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
101823541|NCT00423657|Aztreonam|aztreonam|mesh-list
101823542|NCT00423657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101812519|NCT05271071|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101812520|NCT05271071|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101812521|NCT05271071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101812522|NCT05271071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812524|NCT00972140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101812525|NCT00972140|Autonomic Agents|autonomic agents|mesh-ancestor
101812526|NCT00972140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101812527|NCT00972140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812528|NCT00972140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101812529|NCT00972140|Respiratory System Agents|respiratory system agents|mesh-ancestor
101812530|NCT00972140|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101812531|NCT00972140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101812532|NCT00972140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101812533|NCT00972140|Adrenergic Agents|adrenergic agents|mesh-ancestor
101812534|NCT00972140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101812535|NCT00972140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812536|NCT00972218|Adalimumab|adalimumab|mesh-list
101812537|NCT00972218|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101812538|NCT00972218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101812539|NCT00972218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101812540|NCT05230901|Dihydralazine|dihydralazine|mesh-list
101812541|NCT05230901|Spironolactone|spironolactone|mesh-list
101812542|NCT05230901|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101812543|NCT05230901|Hormone Antagonists|hormone antagonists|mesh-ancestor
101812544|NCT05230901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101823543|NCT00423657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101823544|NCT00831155|Nicotine|nicotine|mesh-list
101823545|NCT00831155|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101823546|NCT00831155|Autonomic Agents|autonomic agents|mesh-ancestor
101823547|NCT00831155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101823548|NCT00831155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823549|NCT00831155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101823550|NCT00831155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101823551|NCT00831155|Cholinergic Agents|cholinergic agents|mesh-ancestor
101823552|NCT00831155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101823553|NCT00831155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823554|NCT00827021|Epoetin Alfa|epoetin alfa|mesh-list
101823555|NCT00827021|Hematinics|hematinics|mesh-list
101823556|NCT01050712|Carbon Monoxide|carbon monoxide|mesh-list
101823557|NCT01050712|Antimetabolites|antimetabolites|mesh-ancestor
101823558|NCT01050712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823559|NCT01050712|Gasotransmitters|gasotransmitters|mesh-ancestor
101823560|NCT01050712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101812545|NCT05230901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812546|NCT05230901|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101812547|NCT05230901|Diuretics|diuretics|mesh-ancestor
101812548|NCT05230901|Natriuretic Agents|natriuretic agents|mesh-ancestor
101812549|NCT05230901|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101812550|NCT00972296|Carbon Fiber|carbon fiber|mesh-list
101812551|NCT00972296|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101812552|NCT00972296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101812553|NCT03927950|Bupropion|bupropion|mesh-list
101812554|NCT03927950|Escitalopram|escitalopram|mesh-list
101812555|NCT03927950|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101812556|NCT03927950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101812557|NCT03927950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101823561|NCT01050712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823562|NCT02550119|Dexamethasone|dexamethasone|mesh-list
101823563|NCT02550119|Dexamethasone acetate|dexamethasone acetate|mesh-list
101823564|NCT02550119|Aprepitant|aprepitant|mesh-list
101823565|NCT02550119|Dolasetron|dolasetron|mesh-list
101823566|NCT02550119|Ichthammol|ichthammol|mesh-list
101823567|NCT02550119|BB 1101|bb 1101|mesh-list
101823568|NCT02550119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101823569|NCT02550119|Antiemetics|antiemetics|mesh-ancestor
101823570|NCT02550119|Autonomic Agents|autonomic agents|mesh-ancestor
101823571|NCT02550119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101823572|NCT02550119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823573|NCT02550119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101823574|NCT02550119|Glucocorticoids|glucocorticoids|mesh-ancestor
101823576|NCT02550119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101823577|NCT02550119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101823578|NCT02550119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101823579|NCT02550119|Protease Inhibitors|protease inhibitors|mesh-ancestor
101823580|NCT02550119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101823581|NCT02550119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823582|NCT02550119|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101823583|NCT02550119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101823584|NCT02550119|Dermatologic Agents|dermatologic agents|mesh-ancestor
101823585|NCT02550119|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101823586|NCT02550119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101823589|NCT02548403|Antifoaming Agents|antifoaming agents|mesh-ancestor
101823590|NCT02548403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823591|NCT02548403|Emollients|emollients|mesh-ancestor
101823592|NCT02548403|Dermatologic Agents|dermatologic agents|mesh-ancestor
101823593|NCT00367432|Levetiracetam|levetiracetam|mesh-list
101823594|NCT00367432|Anticonvulsants|anticonvulsants|mesh-ancestor
101823595|NCT00367432|Nootropic Agents|nootropic agents|mesh-ancestor
101823596|NCT00623363|Piclozotan|piclozotan|mesh-list
101823597|NCT00623363|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101823598|NCT00623363|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101823599|NCT00623363|Serotonin Agents|serotonin agents|mesh-ancestor
101823600|NCT00623363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101823601|NCT00623363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823602|NCT00623363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823603|NCT00827177|Sorafenib|sorafenib|mesh-list
101823604|NCT00827177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101823605|NCT00827177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101823606|NCT00827177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101823607|NCT00827177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823608|NCT00423267|Fluconazole|fluconazole|mesh-list
101823609|NCT00423267|Posaconazole|posaconazole|mesh-list
101823610|NCT00423267|Antifungal Agents|antifungal agents|mesh-ancestor
101812558|NCT03927950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812559|NCT03927950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101812560|NCT03927950|Serotonin Agents|serotonin agents|mesh-ancestor
101812561|NCT03927950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812562|NCT03927950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101812563|NCT03927950|Antidepressive Agents|antidepressive agents|mesh-ancestor
101812564|NCT03927950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101823611|NCT00423267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101823612|NCT00423267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101823613|NCT00423267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101823614|NCT00423267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101823615|NCT00423267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823616|NCT00423267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101823617|NCT00423267|Hormone Antagonists|hormone antagonists|mesh-ancestor
101823618|NCT00423267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101823619|NCT00423267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823620|NCT00423267|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101313090|NCT00007891|Antibodies|antibodies|mesh-list
101823621|NCT00423267|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101823622|NCT00423267|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101823623|NCT00423267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101823624|NCT00423267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101823625|NCT02549261|Etoposide|etoposide|mesh-list
101823626|NCT02549261|Nimotuzumab|nimotuzumab|mesh-list
101823627|NCT02549261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101823628|NCT02549261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101823629|NCT02549261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101823630|NCT02549261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101823631|NCT02549261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101823632|NCT02549261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823633|NCT02549261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101823634|NCT00357760|Aflibercept|aflibercept|mesh-list
101823635|NCT00357760|Endothelial Growth Factors|endothelial growth factors|mesh-list
101823636|NCT00357760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101823637|NCT00357760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101823638|NCT00357760|Growth Substances|growth substances|mesh-ancestor
101823639|NCT00357760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823640|NCT00357760|Growth Inhibitors|growth inhibitors|mesh-ancestor
101823641|NCT00357760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101823643|NCT00622739|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101823644|NCT00622739|Serotonin Agents|serotonin agents|mesh-ancestor
101823645|NCT00622739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101823646|NCT00622739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823647|NCT00622739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823648|NCT00622739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101823649|NCT00622739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101823650|NCT00622739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101823651|NCT00622739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101823652|NCT00622739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101823653|NCT00622739|Dopamine Agents|dopamine agents|mesh-ancestor
101823654|NCT03742336|Dabigatran|dabigatran|mesh-list
101823655|NCT03742336|Abrocitinib|abrocitinib|mesh-list
101823656|NCT03742336|Antithrombins|antithrombins|mesh-ancestor
101823657|NCT03742336|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101823658|NCT03742336|Protease Inhibitors|protease inhibitors|mesh-ancestor
101823659|NCT03742336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101823660|NCT03742336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823661|NCT03742336|Anticoagulants|anticoagulants|mesh-ancestor
101823662|NCT03742336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101823663|NCT00435825|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101823664|NCT00435825|Antiviral Agents|antiviral agents|mesh-ancestor
101823665|NCT00435825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101823667|NCT00824057|Caffeine|caffeine|mesh-list
101812565|NCT03927950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101812567|NCT03927950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101812568|NCT03927950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101812569|NCT03927950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101812571|NCT00972842|Vorinostat|vorinostat|mesh-list
101812572|NCT00972842|Immunologic Factors|immunologic factors|mesh-ancestor
101812573|NCT00972842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823668|NCT00824057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101823669|NCT00824057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101823670|NCT00824057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101823671|NCT00824057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823672|NCT00824057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101823673|NCT00824057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101823674|NCT00824057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101823675|NCT00824057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101823676|NCT00824057|Anesthetics, General|anesthetics, general|mesh-ancestor
101823678|NCT00824057|GABA Modulators|gaba modulators|mesh-ancestor
101823679|NCT00824057|GABA Agents|gaba agents|mesh-ancestor
101823680|NCT00824057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101823681|NCT00824057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823682|NCT00824057|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101823683|NCT00824057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101823684|NCT00824057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101823685|NCT00824057|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101823686|NCT00824057|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101823687|NCT00824057|Purinergic Agents|purinergic agents|mesh-ancestor
101823688|NCT01053208|Diphenhydramine|diphenhydramine|mesh-list
101823689|NCT01053208|Promethazine|promethazine|mesh-list
101823690|NCT01053208|Ibuprofen|ibuprofen|mesh-list
101313103|NCT00008008|Cyclophosphamide|cyclophosphamide|mesh-list
101823691|NCT01053208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823692|NCT01053208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101823693|NCT01053208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101823694|NCT01053208|Analgesics|analgesics|mesh-ancestor
101823695|NCT01053208|Sensory System Agents|sensory system agents|mesh-ancestor
101823696|NCT01053208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101823697|NCT01053208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823698|NCT01053208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101823699|NCT01053208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101823700|NCT01053208|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101823701|NCT01053208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101823702|NCT01053208|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101823703|NCT01053208|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101823704|NCT01053208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101823705|NCT01053208|Anesthetics, Local|anesthetics, local|mesh-ancestor
101823706|NCT01053208|Anesthetics|anesthetics|mesh-ancestor
101823707|NCT01053208|Antiemetics|antiemetics|mesh-ancestor
101823708|NCT01053208|Autonomic Agents|autonomic agents|mesh-ancestor
101823709|NCT01053208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101823710|NCT01053208|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101823711|NCT01053208|Histamine Antagonists|histamine antagonists|mesh-ancestor
101823712|NCT01053208|Histamine Agents|histamine agents|mesh-ancestor
101823713|NCT01053208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101823714|NCT01053208|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101823715|NCT01053208|Antipruritics|antipruritics|mesh-ancestor
101823716|NCT01053208|Dermatologic Agents|dermatologic agents|mesh-ancestor
101823717|NCT00423189|Ranibizumab|ranibizumab|mesh-list
101823718|NCT00423189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101823719|NCT00423189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101823720|NCT00423189|Growth Substances|growth substances|mesh-ancestor
101823721|NCT00423189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823722|NCT00423189|Growth Inhibitors|growth inhibitors|mesh-ancestor
101812575|NCT00972842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101812577|NCT00972842|Growth Inhibitors|growth inhibitors|mesh-ancestor
101812578|NCT00972842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101812579|NCT00972842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101812580|NCT00972842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101812581|NCT00972842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823723|NCT00423189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101823724|NCT00831545|Temozolomide|temozolomide|mesh-list
101823725|NCT00831545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101823726|NCT00831545|Alkylating Agents|alkylating agents|mesh-ancestor
101823727|NCT00831545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823728|NCT00831545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101823729|NCT00824135|Mycophenolic Acid|mycophenolic acid|mesh-list
101823732|NCT00824135|Thiotepa|thiotepa|mesh-list
101823733|NCT00824135|Clofarabine|clofarabine|mesh-list
101823734|NCT00824135|Muromonab-CD3|muromonab-cd3|mesh-list
101823735|NCT00824135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101823736|NCT00824135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101823737|NCT00824135|Immunologic Factors|immunologic factors|mesh-ancestor
101823738|NCT00824135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823739|NCT00824135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101823740|NCT00824135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101823741|NCT00824135|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101823742|NCT00824135|Antitubercular Agents|antitubercular agents|mesh-ancestor
101823743|NCT00824135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101481018|NCT00326352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101823744|NCT00824135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101823745|NCT00824135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101823746|NCT00824135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823747|NCT00824135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101823748|NCT00824135|Alkylating Agents|alkylating agents|mesh-ancestor
101823749|NCT00824135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101823750|NCT00824135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101823751|NCT00824135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101823752|NCT00824135|Antimetabolites|antimetabolites|mesh-ancestor
101823753|NCT00422799|Rituximab|rituximab|mesh-list
101823754|NCT00422799|Bortezomib|bortezomib|mesh-list
101823755|NCT00422799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101823756|NCT00422799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101823757|NCT00422799|Immunologic Factors|immunologic factors|mesh-ancestor
101823758|NCT00422799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823759|NCT00422799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101823760|NCT00827411|Aspirin|aspirin|mesh-list
101823761|NCT00827411|Clopidogrel|clopidogrel|mesh-list
101823762|NCT00827411|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101823763|NCT00827411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101823764|NCT00827411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101823765|NCT00827411|Analgesics|analgesics|mesh-ancestor
101823766|NCT00827411|Sensory System Agents|sensory system agents|mesh-ancestor
101823767|NCT00827411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101823768|NCT00827411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823769|NCT00827411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101823770|NCT00827411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101823771|NCT00827411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101823772|NCT00827411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101823773|NCT00827411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823774|NCT00827411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101823775|NCT00827411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101823776|NCT00827411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101823777|NCT00827411|Antipyretics|antipyretics|mesh-ancestor
101823778|NCT00827411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101823779|NCT00827411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101823780|NCT00827411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101812584|NCT00975494|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101812585|NCT00975494|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101812587|NCT00975494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812588|NCT00975494|Urological Agents|urological agents|mesh-ancestor
101812589|NCT00975572|Vaccines|vaccines|mesh-list
101812590|NCT00975572|Immunologic Factors|immunologic factors|mesh-ancestor
101812591|NCT00975572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812592|NCT00965666|Etanercept|etanercept|mesh-list
101823781|NCT00827411|Purinergic Agents|purinergic agents|mesh-ancestor
101823782|NCT00827411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101823783|NCT00435045|Atorvastatin|atorvastatin|mesh-list
101823784|NCT00435045|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101823785|NCT00435045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101823786|NCT00435045|Antimetabolites|antimetabolites|mesh-ancestor
101823787|NCT00435045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823788|NCT00435045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101823789|NCT00435045|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101823790|NCT00435045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101823791|NCT00441129|Insulin|insulin|mesh-list
101823792|NCT00441129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101823793|NCT00441129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823794|NCT00622505|Zoledronic Acid|zoledronic acid|mesh-list
101823795|NCT00622505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101823812|NCT00832013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101823813|NCT00832013|Anesthetics, General|anesthetics, general|mesh-ancestor
101823814|NCT00832013|Anesthetics|anesthetics|mesh-ancestor
101823815|NCT00832481|Metformin|metformin|mesh-list
101823816|NCT00832481|Repaglinide|repaglinide|mesh-list
101823817|NCT00832481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101823818|NCT00832481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313115|NCT00008047|Paclitaxel|paclitaxel|mesh-list
101823840|NCT04044287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101823841|NCT04044287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823842|NCT04044287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101823843|NCT04044287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101823844|NCT04044287|Oxytocics|oxytocics|mesh-ancestor
101823845|NCT00357370|Dapagliflozin|dapagliflozin|mesh-list
101823846|NCT00357370|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101823847|NCT00357370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823848|NCT00357370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101823849|NCT00357370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823850|NCT00825071|Dexamethasone|dexamethasone|mesh-list
101823851|NCT00825071|Ondansetron|ondansetron|mesh-list
101823852|NCT00825071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101823853|NCT00825071|Antiemetics|antiemetics|mesh-ancestor
101823854|NCT00825071|Autonomic Agents|autonomic agents|mesh-ancestor
101823855|NCT00825071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101823856|NCT00825071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823857|NCT00825071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101823858|NCT00825071|Glucocorticoids|glucocorticoids|mesh-ancestor
101823859|NCT00825071|Hormones|hormones|mesh-ancestor
101823860|NCT00825071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101823861|NCT00825071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101823862|NCT00825071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101823863|NCT00825071|Antipruritics|antipruritics|mesh-ancestor
101823864|NCT00825071|Dermatologic Agents|dermatologic agents|mesh-ancestor
101823865|NCT00825071|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101823866|NCT00825071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101812594|NCT00965666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101812595|NCT00965666|Analgesics|analgesics|mesh-ancestor
101812596|NCT00965666|Sensory System Agents|sensory system agents|mesh-ancestor
101812597|NCT00965666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101812598|NCT00965666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812599|NCT00965666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101812600|NCT00965666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101812601|NCT00965666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101812602|NCT00965666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101823867|NCT00825071|Serotonin Agents|serotonin agents|mesh-ancestor
101823868|NCT00825071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101823869|NCT00825071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823870|NCT00574847|Escitalopram|escitalopram|mesh-list
101823871|NCT00574847|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101823872|NCT00574847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101823873|NCT00574847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101823874|NCT00574847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823875|NCT00574847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101823876|NCT00574847|Serotonin Agents|serotonin agents|mesh-ancestor
101823877|NCT00574847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823878|NCT00348790|Vatalanib|vatalanib|mesh-list
101823879|NCT00348790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101823880|NCT00348790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101823881|NCT00348790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823882|NCT00825149|Prednisone|prednisone|mesh-list
101823883|NCT00825149|Cyclophosphamide|cyclophosphamide|mesh-list
101823884|NCT00825149|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101823885|NCT00825149|Doxorubicin|doxorubicin|mesh-list
101823886|NCT00825149|Fludarabine|fludarabine|mesh-list
101823887|NCT00825149|Vincristine|vincristine|mesh-list
101823888|NCT00825149|Obinutuzumab|obinutuzumab|mesh-list
101823889|NCT00825149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101823890|NCT00825149|Immunologic Factors|immunologic factors|mesh-ancestor
101823891|NCT00825149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823892|NCT00825149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101481180|NCT00296309|Tacrolimus|tacrolimus|mesh-list
101823893|NCT00825149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101823895|NCT00825149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823896|NCT00825149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101823897|NCT00825149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101823898|NCT00825149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101823899|NCT00825149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101823900|NCT00825149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101823901|NCT00825149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101823902|NCT00825149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101823903|NCT00825149|Glucocorticoids|glucocorticoids|mesh-ancestor
101823904|NCT00825149|Hormones|hormones|mesh-ancestor
101823905|NCT00825149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101823906|NCT00825149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101823907|NCT00825149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101823908|NCT00825149|Tubulin Modulators|tubulin modulators|mesh-ancestor
101823909|NCT00825149|Antimitotic Agents|antimitotic agents|mesh-ancestor
101823910|NCT00825149|Mitosis Modulators|mitosis modulators|mesh-ancestor
101823911|NCT00825149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101823912|NCT00360490|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101823913|NCT00360490|Levonorgestrel|levonorgestrel|mesh-list
101823914|NCT00360490|Medroxyprogesterone|medroxyprogesterone|mesh-list
101823915|NCT00360490|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101823916|NCT00360490|Contraceptive Agents|contraceptive agents|mesh-ancestor
101823917|NCT00360490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101823918|NCT00360490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812605|NCT00975728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812607|NCT00975728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812608|NCT04049747|Bicalutamide|bicalutamide|mesh-list
101812609|NCT04049747|Finasteride|finasteride|mesh-list
101469917|NCT00246467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101812610|NCT04049747|Androgen Antagonists|androgen antagonists|mesh-ancestor
101812611|NCT04049747|Hormone Antagonists|hormone antagonists|mesh-ancestor
101812612|NCT04049747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101812613|NCT04049747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812614|NCT04049747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101812615|NCT04049747|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101812616|NCT04049747|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101823919|NCT00360490|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101823920|NCT00360490|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101823921|NCT00360490|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101823922|NCT00360490|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101823923|NCT00360490|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101823924|NCT00360490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101823925|NCT00360490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101823926|NCT02549105|Lidocaine|lidocaine|mesh-list
101823927|NCT02549105|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
101823928|NCT02549105|Anesthetics, Local|anesthetics, local|mesh-ancestor
101823929|NCT02549105|Anesthetics|anesthetics|mesh-ancestor
101823930|NCT02549105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101823931|NCT02549105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823932|NCT02549105|Sensory System Agents|sensory system agents|mesh-ancestor
101823933|NCT02549105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101823934|NCT02549105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101823935|NCT02549105|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101823936|NCT02549105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101823937|NCT02549105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101823938|NCT02549105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823939|NCT02549105|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
101823940|NCT00624377|Tiotropium Bromide|tiotropium bromide|mesh-list
101823941|NCT00624377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101823942|NCT00624377|Autonomic Agents|autonomic agents|mesh-ancestor
101823943|NCT00624377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101823944|NCT00624377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823945|NCT00624377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101823946|NCT00624377|Respiratory System Agents|respiratory system agents|mesh-ancestor
101823947|NCT00624377|Parasympatholytics|parasympatholytics|mesh-ancestor
101823948|NCT00624377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101823950|NCT00624377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101823951|NCT00624377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823952|NCT02549963|Rivaroxaban|rivaroxaban|mesh-list
101823953|NCT02549963|Anticoagulants|anticoagulants|mesh-list
101823954|NCT02549963|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101823955|NCT02549963|Antithrombins|antithrombins|mesh-ancestor
101823956|NCT02549963|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101823957|NCT02549963|Protease Inhibitors|protease inhibitors|mesh-ancestor
101823958|NCT02549963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101823959|NCT02549963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823960|NCT00624065|Carvedilol|carvedilol|mesh-list
101812617|NCT04049747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101812618|NCT04049747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812619|NCT04049747|Urological Agents|urological agents|mesh-ancestor
101812621|NCT00973154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101812622|NCT00973154|Glucocorticoids|glucocorticoids|mesh-ancestor
101812623|NCT00973154|Hormones|hormones|mesh-ancestor
101812624|NCT00973154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101812625|NCT00973154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812626|NCT00973154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101812627|NCT00973154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101812628|NCT00965900|Propranolol|propranolol|mesh-list
101812629|NCT00965900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101812630|NCT00965900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101812631|NCT00965900|Adrenergic Agents|adrenergic agents|mesh-ancestor
101812632|NCT00965900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101823961|NCT00624065|Lisinopril|lisinopril|mesh-list
101823962|NCT00624065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101823963|NCT00624065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101823964|NCT00624065|Adrenergic Agents|adrenergic agents|mesh-ancestor
101823965|NCT00624065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101823966|NCT00624065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823967|NCT00624065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823968|NCT00624065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101823969|NCT00624065|Antioxidants|antioxidants|mesh-ancestor
101823970|NCT00624065|Protective Agents|protective agents|mesh-ancestor
101823971|NCT00624065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101823972|NCT00624065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101823973|NCT00624065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101823974|NCT00624065|Vasodilator Agents|vasodilator agents|mesh-ancestor
101823975|NCT00624065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101823976|NCT00624065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101823977|NCT00624065|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101823978|NCT00624065|Protease Inhibitors|protease inhibitors|mesh-ancestor
101823979|NCT00624065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101823980|NCT00624065|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101823982|NCT00833339|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101823983|NCT00833339|Abortifacient Agents|abortifacient agents|mesh-ancestor
101823984|NCT00833339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101823985|NCT00833339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823986|NCT00833339|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101823987|NCT00833339|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101823988|NCT00833339|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101823989|NCT00833339|Contraceptive Agents|contraceptive agents|mesh-ancestor
101823990|NCT00833339|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101823991|NCT00833339|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101823992|NCT00833339|Hormone Antagonists|hormone antagonists|mesh-ancestor
101823993|NCT00833339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101823994|NCT00833339|Luteolytic Agents|luteolytic agents|mesh-ancestor
101823995|NCT00833339|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101823996|NCT00833339|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101823997|NCT00825617|Hormones|hormones|mesh-list
101823998|NCT00825617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101823999|NCT00825617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824000|NCT00360334|Insulin Glargine|insulin glargine|mesh-list
101824003|NCT00360334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824004|NCT00360334|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101824005|NCT00360334|Incretins|incretins|mesh-ancestor
101824006|NCT00360334|Hormones|hormones|mesh-ancestor
101824007|NCT00360334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101824008|NCT00422097|Epothilones|epothilones|mesh-list
101824009|NCT00422097|Famotidine|famotidine|mesh-list
101824010|NCT00422097|Tubulin Modulators|tubulin modulators|mesh-ancestor
101824011|NCT00422097|Antimitotic Agents|antimitotic agents|mesh-ancestor
101824012|NCT00422097|Mitosis Modulators|mitosis modulators|mesh-ancestor
101824013|NCT00422097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824014|NCT00422097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101824015|NCT00422097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101824016|NCT00422097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101824017|NCT00422097|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101824018|NCT00422097|Histamine Antagonists|histamine antagonists|mesh-ancestor
101824019|NCT00422097|Histamine Agents|histamine agents|mesh-ancestor
101824020|NCT00422097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101824021|NCT00422097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824022|NCT01051102|Insulin|insulin|mesh-list
101824023|NCT01051102|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101824024|NCT01051102|Insulin Aspart|insulin aspart|mesh-list
101824025|NCT01051102|Insulin, Long-Acting|insulin, long-acting|mesh-list
101824026|NCT01051102|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101824027|NCT01051102|Biphasic Insulins|biphasic insulins|mesh-list
101824028|NCT01051102|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101824029|NCT01051102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101824030|NCT01051102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824031|NCT00348556|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101824032|NCT00348556|Natriuretic Agents|natriuretic agents|mesh-ancestor
101824033|NCT00348556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824034|NCT00434967|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101824035|NCT00434967|Candesartan|candesartan|mesh-list
101824036|NCT00434967|Candesartan cilexetil|candesartan cilexetil|mesh-list
101824037|NCT00434967|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101481316|NCT00327093|Cetuximab|cetuximab|mesh-list
101824039|NCT00434967|Natriuretic Agents|natriuretic agents|mesh-ancestor
101824040|NCT00434967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824041|NCT00434967|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101824042|NCT00434967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101824043|NCT00434967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824044|NCT00434967|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101812647|NCT00973232|Sensory System Agents|sensory system agents|mesh-ancestor
101812648|NCT00973232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101812649|NCT00973232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812650|NCT00973232|Antipyretics|antipyretics|mesh-ancestor
101812651|NCT00973232|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101812652|NCT00973232|Narcotics|narcotics|mesh-ancestor
101812653|NCT00973232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101812654|NCT00973310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101812655|NCT00973310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101812656|NCT00973310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101812657|NCT00973310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101812658|NCT00973310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812659|NCT00973388|Moxifloxacin|moxifloxacin|mesh-list
101812660|NCT00973388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101812661|NCT00973388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101824045|NCT00434967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101824047|NCT00833729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101824048|NCT00833729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101824049|NCT00833729|Analgesics|analgesics|mesh-ancestor
101824050|NCT00833729|Sensory System Agents|sensory system agents|mesh-ancestor
101824051|NCT00833729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101824052|NCT00833729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824053|NCT00833729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101824054|NCT00833729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101824055|NCT00833729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101824056|NCT00833729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101824057|NCT00833729|Immunologic Factors|immunologic factors|mesh-ancestor
101824058|NCT00837239|Gemcitabine|gemcitabine|mesh-list
101824059|NCT00837239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101824060|NCT00837239|Antimetabolites|antimetabolites|mesh-ancestor
101824061|NCT00837239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824062|NCT00837239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101824063|NCT00833807|Paclitaxel|paclitaxel|mesh-list
101824064|NCT00833807|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101824065|NCT00833807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101824066|NCT00833807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101824067|NCT00833807|Tubulin Modulators|tubulin modulators|mesh-ancestor
101824068|NCT00833807|Antimitotic Agents|antimitotic agents|mesh-ancestor
101824069|NCT00833807|Mitosis Modulators|mitosis modulators|mesh-ancestor
101824070|NCT00833807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824071|NCT00833963|Trastuzumab|trastuzumab|mesh-list
101824073|NCT00833963|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101824074|NCT00833963|Maytansine|maytansine|mesh-list
101824075|NCT00833963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101824076|NCT00833963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101824077|NCT00833963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101824078|NCT00833963|Tubulin Modulators|tubulin modulators|mesh-ancestor
101824079|NCT00833963|Antimitotic Agents|antimitotic agents|mesh-ancestor
101824080|NCT00833963|Mitosis Modulators|mitosis modulators|mesh-ancestor
101824081|NCT00833963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824082|NCT00833963|Immunotoxins|immunotoxins|mesh-ancestor
101824083|NCT00833963|Immunoconjugates|immunoconjugates|mesh-ancestor
101824084|NCT00833963|Immunologic Factors|immunologic factors|mesh-ancestor
101812663|NCT00973388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101812664|NCT00973388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101812665|NCT00973388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812666|NCT00973388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101812667|NCT00975962|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101812668|NCT00975962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101812669|NCT00975962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101812670|NCT00975962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812671|NCT00966056|Mitomycins|mitomycins|mesh-list
101812672|NCT00966056|Mitomycin|mitomycin|mesh-list
101812673|NCT00966056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101812674|NCT00966056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101812675|NCT00966056|Alkylating Agents|alkylating agents|mesh-ancestor
101812676|NCT00966056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812677|NCT00966056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101812678|NCT00966056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101812679|NCT00976040|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101812680|NCT00976040|Antiviral Agents|antiviral agents|mesh-ancestor
101812681|NCT00976040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101812682|NCT03523728|Venglustat|venglustat|mesh-list
101812683|NCT03523728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101812684|NCT03523728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812685|NCT00979706|Cyclosporine|cyclosporine|mesh-list
101824085|NCT00833963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824086|NCT00837317|Phenol|phenol|mesh-list
101824087|NCT00837317|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101824088|NCT00837317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101824089|NCT00837317|Disinfectants|disinfectants|mesh-ancestor
101824090|NCT00837317|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
101824091|NCT00837317|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101824092|NCT04043897|Rifaximin|rifaximin|mesh-list
101824093|NCT04043897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101824094|NCT04043897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101824095|NCT04043897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101824096|NCT00356590|Etanercept|etanercept|mesh-list
101824097|NCT00356590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101824098|NCT00356590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101824099|NCT00356590|Analgesics|analgesics|mesh-ancestor
101824100|NCT00356590|Sensory System Agents|sensory system agents|mesh-ancestor
101824101|NCT00356590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101824102|NCT00356590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824103|NCT00356590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101824104|NCT00356590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101824105|NCT00356590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101824106|NCT00356590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101824107|NCT00356590|Immunologic Factors|immunologic factors|mesh-ancestor
101824108|NCT00828503|Valganciclovir|valganciclovir|mesh-list
101824109|NCT00828503|Everolimus|everolimus|mesh-list
101824111|NCT00828503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101812689|NCT00979706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812691|NCT00979706|Immunologic Factors|immunologic factors|mesh-ancestor
101812692|NCT00979706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812693|NCT00979706|Antifungal Agents|antifungal agents|mesh-ancestor
101812694|NCT00979706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101812695|NCT00979706|Dermatologic Agents|dermatologic agents|mesh-ancestor
101824112|NCT00828503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101824113|NCT00828503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824114|NCT00828503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101824116|NCT00828503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824117|NCT00828503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101824118|NCT00828503|Antiviral Agents|antiviral agents|mesh-ancestor
101824119|NCT00828503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101824120|NCT00834665|Molgramostim|molgramostim|mesh-list
101824121|NCT00834665|Sargramostim|sargramostim|mesh-list
101824122|NCT00834665|Immunologic Factors|immunologic factors|mesh-ancestor
101824123|NCT00834665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824124|NCT00834665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101824125|NCT00837707|Aripiprazole|aripiprazole|mesh-list
101824126|NCT00837707|Antidepressive Agents|antidepressive agents|mesh-ancestor
101824127|NCT00837707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101824128|NCT00837707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101824129|NCT00837707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101824130|NCT00837707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101824131|NCT00837707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824132|NCT00837707|Dopamine Agonists|dopamine agonists|mesh-ancestor
101824133|NCT00837707|Dopamine Agents|dopamine agents|mesh-ancestor
101824134|NCT00837707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101824135|NCT00837707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824136|NCT00837707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101824137|NCT00837707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101824138|NCT00837707|Serotonin Agents|serotonin agents|mesh-ancestor
101824139|NCT00837707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101824140|NCT00837707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101824141|NCT00837707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101824142|NCT00837707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101824143|NCT01055938|Valproic Acid|valproic acid|mesh-list
101824144|NCT01055938|Anticonvulsants|anticonvulsants|mesh-ancestor
101824145|NCT01055938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101824146|NCT01055938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824147|NCT01055938|GABA Agents|gaba agents|mesh-ancestor
101824148|NCT01055938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101824149|NCT01055938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824150|NCT01055938|Antimanic Agents|antimanic agents|mesh-ancestor
101824151|NCT01055938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101824152|NCT01055938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101824153|NCT01055938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101824154|NCT00837785|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101824155|NCT00837785|Dermatologic Agents|dermatologic agents|mesh-ancestor
101824156|NCT00837785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101824157|NCT00837785|Immunologic Factors|immunologic factors|mesh-ancestor
101824158|NCT00837785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824159|NCT00356278|Cycloserine|cycloserine|mesh-list
101824161|NCT00356278|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101824163|NCT00356278|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101812699|NCT00979706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101812700|NCT00979706|Analgesics|analgesics|mesh-ancestor
101812701|NCT00979706|Sensory System Agents|sensory system agents|mesh-ancestor
101812702|NCT00979706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101812703|NCT00979862|Cediranib|cediranib|mesh-list
101812704|NCT00979862|Maleic acid|maleic acid|mesh-list
101812705|NCT00979862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101812706|NCT00979862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812707|NCT00979862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101812708|NCT00979862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101812709|NCT00966290|Warfarin|warfarin|mesh-list
101812710|NCT00966290|Anticoagulants|anticoagulants|mesh-list
101812711|NCT00966290|Acenocoumarol|acenocoumarol|mesh-list
101812712|NCT00966290|Fluindione|fluindione|mesh-list
101812713|NCT00966290|Phenindione|phenindione|mesh-list
101812714|NCT00966368|Insulin|insulin|mesh-list
101812715|NCT00966368|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101824164|NCT00356278|Antitubercular Agents|antitubercular agents|mesh-ancestor
101824165|NCT00356278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101824166|NCT00356278|Antimetabolites|antimetabolites|mesh-ancestor
101824167|NCT00356278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824168|NCT00356278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101824169|NCT00356278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101824170|NCT00356278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824171|NCT00356278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101824172|NCT00356278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101824173|NCT00356278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101824174|NCT00356278|GABA Modulators|gaba modulators|mesh-ancestor
101824176|NCT00356278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101824177|NCT03991780|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101824178|NCT03991780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101824179|NCT03991780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101824180|NCT03991780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824181|NCT00837941|Diphenhydramine|diphenhydramine|mesh-list
101824182|NCT00837941|Promethazine|promethazine|mesh-list
101824184|NCT00837941|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101824185|NCT00837941|Analgesics|analgesics|mesh-ancestor
101824186|NCT00837941|Sensory System Agents|sensory system agents|mesh-ancestor
101824187|NCT00837941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101824188|NCT00837941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824189|NCT00837941|Anticonvulsants|anticonvulsants|mesh-ancestor
101824190|NCT00837941|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101824191|NCT00837941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101824192|NCT00837941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824193|NCT00837941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101824194|NCT00837941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101824195|NCT00837941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101824196|NCT00837941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101824197|NCT00837941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101812719|NCT00980408|Cycloserine|cycloserine|mesh-list
101812720|NCT00980408|Memantine|memantine|mesh-list
101812721|NCT00980408|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101812722|NCT00980408|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101812723|NCT00980408|Dopamine Agents|dopamine agents|mesh-ancestor
101812724|NCT00980408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101812725|NCT00980408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812726|NCT00980408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812727|NCT00980408|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101812728|NCT00980408|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101812729|NCT00980408|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101812730|NCT00980408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101812731|NCT00980408|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101812732|NCT00980408|Antitubercular Agents|antitubercular agents|mesh-ancestor
101824198|NCT00837941|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101824199|NCT00837941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101824200|NCT00837941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101824201|NCT00837941|Antidepressive Agents|antidepressive agents|mesh-ancestor
101824202|NCT00837941|Dopamine Agents|dopamine agents|mesh-ancestor
101824203|NCT00837941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101824204|NCT00837941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101824205|NCT00837941|Anesthetics, Local|anesthetics, local|mesh-ancestor
101824207|NCT00837941|Antiemetics|antiemetics|mesh-ancestor
101824208|NCT00837941|Autonomic Agents|autonomic agents|mesh-ancestor
101824209|NCT00837941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101824210|NCT00837941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101824211|NCT00837941|Histamine Antagonists|histamine antagonists|mesh-ancestor
101824212|NCT00837941|Histamine Agents|histamine agents|mesh-ancestor
101824213|NCT00837941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101824214|NCT00837941|Antipruritics|antipruritics|mesh-ancestor
101824215|NCT00837941|Dermatologic Agents|dermatologic agents|mesh-ancestor
101824216|NCT01053442|Fe(III)-EDTA|fe(iii)-edta|mesh-list
101824217|NCT01053442|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101824218|NCT01053442|Chelating Agents|chelating agents|mesh-ancestor
101824219|NCT01053442|Sequestering Agents|sequestering agents|mesh-ancestor
101824220|NCT01053442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824221|NCT00356200|Fluphenazine|fluphenazine|mesh-list
101824222|NCT00356200|Fluphenazine depot|fluphenazine depot|mesh-list
101824223|NCT00356200|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
101824224|NCT00356200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101824225|NCT00356200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101824226|NCT00356200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101824227|NCT00356200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824228|NCT00356200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101824229|NCT00356200|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101824230|NCT00356200|Dopamine Agents|dopamine agents|mesh-ancestor
101824231|NCT00356200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101824232|NCT00356200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824233|NCT00356122|Bevacizumab|bevacizumab|mesh-list
101824235|NCT00356122|Oxaliplatin|oxaliplatin|mesh-list
101824236|NCT00356122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101824237|NCT00356122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101812735|NCT00980876|Ciprofloxacin|ciprofloxacin|mesh-list
101812736|NCT00980876|Hydrocortisone|hydrocortisone|mesh-list
101812737|NCT00980876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101812738|NCT00980876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101812739|NCT00980876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101812740|NCT00980876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101812741|NCT00980876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101812742|NCT00980876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101246511|NCT01666431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101824238|NCT00356122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101824239|NCT00356122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101824240|NCT00356122|Growth Substances|growth substances|mesh-ancestor
101824241|NCT00356122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824242|NCT00356122|Growth Inhibitors|growth inhibitors|mesh-ancestor
101824243|NCT00356122|Tubulin Modulators|tubulin modulators|mesh-ancestor
101824244|NCT00356122|Antimitotic Agents|antimitotic agents|mesh-ancestor
101824245|NCT00356122|Mitosis Modulators|mitosis modulators|mesh-ancestor
101824246|NCT00356122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824248|NCT00828815|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101824249|NCT00828815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101824250|NCT00828815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101824251|NCT00828815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824252|NCT00828815|Antiviral Agents|antiviral agents|mesh-ancestor
101824253|NCT00828815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101824254|NCT01053520|Navitoclax|navitoclax|mesh-list
101824255|NCT01053520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101824256|NCT00347932|Besifloxacin|besifloxacin|mesh-list
101824257|NCT00347932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101824258|NCT00347932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101824259|NCT00347932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101824260|NCT00347932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101824261|NCT00347932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101824262|NCT00347932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824263|NCT00347932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101824265|NCT00828971|Moxifloxacin|moxifloxacin|mesh-list
101824266|NCT00828971|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101824267|NCT00828971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101824268|NCT00828971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101824269|NCT00828971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101824270|NCT00828971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101824271|NCT00828971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101824272|NCT00828971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824273|NCT00828971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101824274|NCT00828971|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101824275|NCT00828971|Contraceptive Agents|contraceptive agents|mesh-ancestor
101824276|NCT00828971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101824277|NCT00828971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824278|NCT00828971|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101824279|NCT00828971|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101824280|NCT00828971|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101824281|NCT00528996|Bromides|bromides|mesh-list
101824282|NCT00528996|Tiotropium Bromide|tiotropium bromide|mesh-list
101824283|NCT00528996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101824284|NCT00528996|Autonomic Agents|autonomic agents|mesh-ancestor
101824285|NCT00528996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101824286|NCT00528996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824287|NCT00528996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101824288|NCT00528996|Respiratory System Agents|respiratory system agents|mesh-ancestor
101824289|NCT00528996|Parasympatholytics|parasympatholytics|mesh-ancestor
101812743|NCT00980876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812745|NCT00980876|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101812746|NCT00980876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101812747|NCT05279040|Ivacaftor|ivacaftor|mesh-list
101812748|NCT05279040|Elexacaftor|elexacaftor|mesh-list
101812749|NCT05279040|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101812750|NCT05279040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101812751|NCT05279040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812752|NCT00989898|Insulin|insulin|mesh-list
101812753|NCT00989898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101812754|NCT00989898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812755|NCT00990054|Plerixafor|plerixafor|mesh-list
101812756|NCT00990054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101812757|NCT00990054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101812758|NCT00990054|Antiviral Agents|antiviral agents|mesh-ancestor
101812759|NCT00990054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101812760|NCT05361408|Zoledronic Acid|zoledronic acid|mesh-list
101812761|NCT05361408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101312068|NCT00006205|Antiemetics|antiemetics|mesh-ancestor
101812762|NCT05361408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812764|NCT05590572|Ifosfamide|ifosfamide|mesh-list
101812780|NCT05590416|Adalimumab|adalimumab|mesh-list
101812797|NCT00990600|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101812798|NCT00990600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101812799|NCT00990600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101812800|NCT00990600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812801|NCT00990600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101812802|NCT00990600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101812803|NCT00990600|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101812804|NCT00990600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101812805|NCT00990600|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101812806|NCT00990600|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101812807|NCT00990600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101812808|NCT00990600|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101812809|NCT02897076|Betamethasone|betamethasone|mesh-list
101812810|NCT02897076|Betamethasone Valerate|betamethasone valerate|mesh-list
101812811|NCT02897076|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101812812|NCT02897076|Betamethasone benzoate|betamethasone benzoate|mesh-list
101812813|NCT02897076|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101812814|NCT02897076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101812815|NCT02897076|Glucocorticoids|glucocorticoids|mesh-ancestor
101812816|NCT02897076|Hormones|hormones|mesh-ancestor
101812817|NCT02897076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101812818|NCT02897076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812819|NCT02897076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101812820|NCT02897076|Respiratory System Agents|respiratory system agents|mesh-ancestor
101812821|NCT02797548|Aspirin|aspirin|mesh-list
101812822|NCT02797548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101812823|NCT02797548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101812824|NCT02797548|Analgesics|analgesics|mesh-ancestor
101812825|NCT02797548|Sensory System Agents|sensory system agents|mesh-ancestor
101812826|NCT02797548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101812827|NCT02797548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812828|NCT02797548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101812829|NCT02797548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101812830|NCT02797548|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101812831|NCT02797548|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101470140|NCT00247715|Pantoprazole|pantoprazole|mesh-list
101812833|NCT02797548|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101812834|NCT02797548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101812835|NCT02797548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101812836|NCT02797548|Antipyretics|antipyretics|mesh-ancestor
101812837|NCT00990678|Vitamin D|vitamin d|mesh-list
101812838|NCT00990678|Calcitriol|calcitriol|mesh-list
101812839|NCT00990678|Calcium|calcium|mesh-list
101812840|NCT00990678|Vitamins|vitamins|mesh-ancestor
101812841|NCT00990678|Micronutrients|micronutrients|mesh-ancestor
101812842|NCT00990678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824290|NCT00528996|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101824291|NCT00528996|Cholinergic Agents|cholinergic agents|mesh-ancestor
101824292|NCT00528996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101824293|NCT00528996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824294|NCT00528996|Anticonvulsants|anticonvulsants|mesh-ancestor
101824295|NCT00359788|Albuterol|albuterol|mesh-list
101824296|NCT00359788|Tiotropium Bromide|tiotropium bromide|mesh-list
101824297|NCT00359788|Ipratropium|ipratropium|mesh-list
101824298|NCT00359788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101824299|NCT00359788|Autonomic Agents|autonomic agents|mesh-ancestor
101824300|NCT00359788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101824301|NCT00359788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824302|NCT00359788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101824303|NCT00359788|Respiratory System Agents|respiratory system agents|mesh-ancestor
101824304|NCT00359788|Parasympatholytics|parasympatholytics|mesh-ancestor
101824305|NCT00359788|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101824306|NCT00359788|Cholinergic Agents|cholinergic agents|mesh-ancestor
101824307|NCT00359788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101824308|NCT00359788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824309|NCT00359788|Tocolytic Agents|tocolytic agents|mesh-ancestor
101824310|NCT00359788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101824311|NCT00359788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101824312|NCT00359788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101824313|NCT00359788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101824314|NCT00359788|Adrenergic Agents|adrenergic agents|mesh-ancestor
101824316|NCT05416476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101824317|NCT05416476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101824319|NCT05416476|Sensory System Agents|sensory system agents|mesh-ancestor
101824320|NCT05416476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101824321|NCT05416476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824322|NCT05416476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101824323|NCT05416476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101824324|NCT05416476|Parasympatholytics|parasympatholytics|mesh-ancestor
101824325|NCT05416476|Autonomic Agents|autonomic agents|mesh-ancestor
101824326|NCT00623597|Ritonavir|ritonavir|mesh-list
101824327|NCT00623597|Saquinavir|saquinavir|mesh-list
101824328|NCT00623597|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101824329|NCT00623597|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101824330|NCT00623597|Protease Inhibitors|protease inhibitors|mesh-ancestor
101824331|NCT00623597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101824332|NCT00623597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824333|NCT00623597|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101824334|NCT00623597|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101824335|NCT00623597|Antiviral Agents|antiviral agents|mesh-ancestor
101481616|NCT00299858|Vasodilator Agents|vasodilator agents|mesh-ancestor
101824336|NCT00623597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101824337|NCT00623597|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101824338|NCT00623597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101824340|NCT01056172|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101824341|NCT01056172|Interferon-alpha|interferon-alpha|mesh-list
101824342|NCT01056172|Antimetabolites|antimetabolites|mesh-ancestor
101812846|NCT00990678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101812847|NCT00990678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812848|NCT00990678|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101812849|NCT00538590|Mitomycins|mitomycins|mesh-list
101812850|NCT00538590|Mitomycin|mitomycin|mesh-list
101824343|NCT01056172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824344|NCT01056172|Antiviral Agents|antiviral agents|mesh-ancestor
101824345|NCT01056172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101824346|NCT01056172|Immunologic Factors|immunologic factors|mesh-ancestor
101824347|NCT01056172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824348|NCT00838955|Sirolimus|sirolimus|mesh-list
101824349|NCT00838955|Temsirolimus|temsirolimus|mesh-list
101824350|NCT00838955|MTOR Inhibitors|mtor inhibitors|mesh-list
101824351|NCT00838955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101824352|NCT00838955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101824353|NCT00838955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824354|NCT00838955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101824355|NCT00838955|Immunologic Factors|immunologic factors|mesh-ancestor
101824356|NCT00838955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824357|NCT00838955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101824358|NCT00838955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101824359|NCT00838955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101824360|NCT00838955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101824361|NCT00838955|Antifungal Agents|antifungal agents|mesh-ancestor
101824362|NCT00347776|Azithromycin|azithromycin|mesh-list
101824363|NCT00347776|Tetracycline|tetracycline|mesh-list
101824364|NCT00347776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101824365|NCT00347776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101824366|NCT00347776|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101824367|NCT00347776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101824368|NCT00347776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824369|NCT04452136|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101824370|NCT04452136|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101824371|NCT04452136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824372|NCT00829205|Rituximab|rituximab|mesh-list
101824373|NCT00829205|Carboplatin|carboplatin|mesh-list
101824374|NCT00829205|Etoposide|etoposide|mesh-list
101824375|NCT00829205|Ifosfamide|ifosfamide|mesh-list
101824376|NCT00829205|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
101824377|NCT00829205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101824378|NCT00829205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101824379|NCT00829205|Immunologic Factors|immunologic factors|mesh-ancestor
101824380|NCT00829205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824381|NCT00829205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101824382|NCT00829205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101824383|NCT00829205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101824384|NCT00829205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101824385|NCT00829205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101824386|NCT00829205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824387|NCT00829205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101824388|NCT00829205|Alkylating Agents|alkylating agents|mesh-ancestor
101824389|NCT00829205|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101824390|NCT00829205|Protective Agents|protective agents|mesh-ancestor
101824391|NCT04944888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101824393|NCT04944888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824394|NCT04944888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101824395|NCT04944888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101824396|NCT04944888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101824397|NCT00839111|Irinotecan|irinotecan|mesh-list
101824398|NCT00839111|Sorafenib|sorafenib|mesh-list
101812852|NCT00538590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101812853|NCT00538590|Alkylating Agents|alkylating agents|mesh-ancestor
101812854|NCT00538590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812855|NCT00538590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101812856|NCT00538590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101812857|NCT00990834|Simvastatin|simvastatin|mesh-list
101812858|NCT00990834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101812859|NCT00990834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101812860|NCT00990834|Antimetabolites|antimetabolites|mesh-ancestor
101824399|NCT00839111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101824400|NCT00839111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101824401|NCT00839111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101824402|NCT00839111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824403|NCT00839111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101824404|NCT00839111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101824405|NCT00836381|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101824406|NCT00836381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101824407|NCT00836381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101824408|NCT00836381|Cholinergic Agents|cholinergic agents|mesh-ancestor
101824409|NCT00836381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101824410|NCT00836381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824411|NCT00836381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824412|NCT00836381|Urological Agents|urological agents|mesh-ancestor
101824413|NCT02533336|Abamectin|abamectin|mesh-list
101824414|NCT02533336|Anthelmintics|anthelmintics|mesh-ancestor
101824415|NCT02533336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101824416|NCT02533336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101824418|NCT05367960|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101824419|NCT05367960|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101824420|NCT05367960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101824421|NCT05367960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824422|NCT01053910|Ramipril|ramipril|mesh-list
101824423|NCT01053910|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101824424|NCT01053910|Protease Inhibitors|protease inhibitors|mesh-ancestor
101824425|NCT01053910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101824426|NCT01053910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824428|NCT00829595|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101824429|NCT00829595|Immunologic Factors|immunologic factors|mesh-ancestor
101824430|NCT00829595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824431|NCT01008384|Vitamin D|vitamin d|mesh-list
101824432|NCT01008384|Cholecalciferol|cholecalciferol|mesh-list
101824433|NCT01008384|Vitamins|vitamins|mesh-ancestor
101824434|NCT01008384|Micronutrients|micronutrients|mesh-ancestor
101824435|NCT01008384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824436|NCT01008384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101824437|NCT01008384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101824438|NCT02547155|Anesthetics|anesthetics|mesh-list
101824439|NCT02547155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101824440|NCT02547155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824441|NCT00836849|Sertraline|sertraline|mesh-list
101824442|NCT00836849|Antidepressive Agents|antidepressive agents|mesh-ancestor
101824443|NCT00836849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101824444|NCT00836849|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101824445|NCT00836849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101824446|NCT00836849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101824447|NCT00836849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824448|NCT00836849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101824449|NCT00836849|Serotonin Agents|serotonin agents|mesh-ancestor
101824450|NCT00836849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812863|NCT00990834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101812865|NCT00990990|Linezolid|linezolid|mesh-list
101812866|NCT00990990|Oxazolidinones|oxazolidinones|mesh-list
101812867|NCT00990990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101812868|NCT00990990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101812869|NCT00990990|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101812870|NCT00990990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101812871|NCT00990990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812872|NCT05589402|Lidocaine|lidocaine|mesh-list
101812873|NCT05589402|Anesthetics, Local|anesthetics, local|mesh-ancestor
101812874|NCT05589402|Anesthetics|anesthetics|mesh-ancestor
101812875|NCT05589402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101812876|NCT05589402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824452|NCT00839345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101824453|NCT00839345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101824454|NCT00839345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101824455|NCT00839345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101824456|NCT00839345|Purinergic Agents|purinergic agents|mesh-ancestor
101824457|NCT00839345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101824458|NCT00839345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824459|NCT00839345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824460|NCT00839501|Acetazolamide|acetazolamide|mesh-list
101824461|NCT00839501|Anticonvulsants|anticonvulsants|mesh-ancestor
101824462|NCT00839501|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101824463|NCT00839501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101824464|NCT00839501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824465|NCT00839501|Diuretics|diuretics|mesh-ancestor
101824466|NCT00839501|Natriuretic Agents|natriuretic agents|mesh-ancestor
101824467|NCT00839501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824468|NCT00529542|Atorvastatin|atorvastatin|mesh-list
101313143|NCT00008086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101824469|NCT00529542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101824470|NCT00529542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101824471|NCT00529542|Antimetabolites|antimetabolites|mesh-ancestor
101824472|NCT00529542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824473|NCT00529542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101824474|NCT00529542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101824475|NCT00529542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101824477|NCT04043741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101824478|NCT00621959|Levocetirizine|levocetirizine|mesh-list
101824479|NCT00621959|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101824480|NCT00621959|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101824481|NCT00621959|Histamine Antagonists|histamine antagonists|mesh-ancestor
101824482|NCT00621959|Histamine Agents|histamine agents|mesh-ancestor
101824483|NCT00621959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101824484|NCT00621959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824485|NCT00621959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824486|NCT00839657|Warfarin|warfarin|mesh-list
101824487|NCT00839657|Anticoagulants|anticoagulants|mesh-ancestor
101812877|NCT05589402|Sensory System Agents|sensory system agents|mesh-ancestor
101812878|NCT05589402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101812879|NCT05589402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101812880|NCT05589402|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101812881|NCT05589402|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101812882|NCT05589402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101812883|NCT05589402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812885|NCT00466947|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101812886|NCT00466947|Immunologic Factors|immunologic factors|mesh-ancestor
101812887|NCT00466947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824488|NCT05259696|Cemiplimab|cemiplimab|mesh-list
101824489|NCT05259696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101824490|NCT05259696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101824491|NCT00830297|Isophane Insulin, Human|isophane insulin, human|mesh-list
101824492|NCT00830297|Insulin, Isophane|insulin, isophane|mesh-list
101824493|NCT00830297|Isophane insulin, beef|isophane insulin, beef|mesh-list
101824494|NCT00830297|Insulin, Long-Acting|insulin, long-acting|mesh-list
101824495|NCT00830297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101824496|NCT00830297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824497|NCT03877224|Dapagliflozin|dapagliflozin|mesh-list
101824498|NCT03877224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101824499|NCT03877224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824500|NCT03877224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101824501|NCT03877224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824502|NCT00840125|Docetaxel|docetaxel|mesh-list
101824503|NCT00840125|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101824504|NCT00840125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101824505|NCT00840125|Tubulin Modulators|tubulin modulators|mesh-ancestor
101824506|NCT00840125|Antimitotic Agents|antimitotic agents|mesh-ancestor
101824507|NCT00840125|Mitosis Modulators|mitosis modulators|mesh-ancestor
101824508|NCT00840125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824509|NCT00840125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101824510|NCT00840125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101824511|NCT00830531|Bumetanide|bumetanide|mesh-list
101824512|NCT00830531|Diuretics|diuretics|mesh-ancestor
101824513|NCT00830531|Natriuretic Agents|natriuretic agents|mesh-ancestor
101824514|NCT00830531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824515|NCT00830531|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101824516|NCT00830531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101824517|NCT00830531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824518|NCT05014542|Analgesics|analgesics|mesh-list
101824519|NCT05014542|Sensory System Agents|sensory system agents|mesh-ancestor
101824520|NCT05014542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101824521|NCT05014542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824523|NCT04926324|Dostarlimab|dostarlimab|mesh-list
101824524|NCT04926324|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101824525|NCT04926324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101824526|NCT04926324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824527|NCT04926324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101824528|NCT00621257|Vitamin D|vitamin d|mesh-list
101824529|NCT00621257|Ergocalciferols|ergocalciferols|mesh-list
101824530|NCT00621257|Cholecalciferol|cholecalciferol|mesh-list
101824531|NCT00621257|Vitamins|vitamins|mesh-list
101824532|NCT00621257|Micronutrients|micronutrients|mesh-ancestor
101824533|NCT00621257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824534|NCT00621257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101824535|NCT00621257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101824536|NCT00840671|Cerebrolysin|cerebrolysin|mesh-list
101824537|NCT00840671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101824539|NCT00840671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812894|NCT01829568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101812895|NCT01829568|Lenalidomide|lenalidomide|mesh-list
101812896|NCT01829568|Antibodies|antibodies|mesh-list
101812897|NCT01829568|Immunoglobulins|immunoglobulins|mesh-list
101812898|NCT01829568|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101812899|NCT01829568|Immunologic Factors|immunologic factors|mesh-ancestor
101824540|NCT00840671|Nootropic Agents|nootropic agents|mesh-ancestor
101824541|NCT02546531|Gemcitabine|gemcitabine|mesh-list
101824542|NCT02546531|Pembrolizumab|pembrolizumab|mesh-list
101824543|NCT02546531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101824544|NCT02546531|Antimetabolites|antimetabolites|mesh-ancestor
101824545|NCT02546531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824546|NCT02546531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101824547|NCT02546531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101824548|NCT02546531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101824549|NCT05205720|Ropivacaine|ropivacaine|mesh-list
101824550|NCT05205720|Anesthetics, Local|anesthetics, local|mesh-ancestor
101824551|NCT05205720|Anesthetics|anesthetics|mesh-ancestor
101824552|NCT05205720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101824553|NCT05205720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824554|NCT05205720|Sensory System Agents|sensory system agents|mesh-ancestor
101824555|NCT05205720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101824556|NCT00841061|Ferrous fumarate|ferrous fumarate|mesh-list
101824557|NCT00841061|Trace Elements|trace elements|mesh-ancestor
101824558|NCT00841061|Micronutrients|micronutrients|mesh-ancestor
101824559|NCT00841061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824561|NCT04042805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101824562|NCT04042805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101824563|NCT04042805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101824564|NCT04042805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824565|NCT05643846|Bupivacaine|bupivacaine|mesh-list
101824566|NCT05643846|Anesthetics, Local|anesthetics, local|mesh-list
101824567|NCT05643846|Anesthetics|anesthetics|mesh-list
101824568|NCT05643846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101824569|NCT05643846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824570|NCT05643846|Sensory System Agents|sensory system agents|mesh-ancestor
101824571|NCT05643846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101824573|NCT00841139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101334144|NCT00042874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101824574|NCT00841139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101824575|NCT00841139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824576|NCT00841139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101824577|NCT00841139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824578|NCT00841139|Vasodilator Agents|vasodilator agents|mesh-ancestor
101824580|NCT00844337|Gentamicins|gentamicins|mesh-list
101824581|NCT00844337|Penicillins|penicillins|mesh-list
101824582|NCT00844337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101824583|NCT00844337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101824584|NCT00844337|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101824585|NCT00844337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101824586|NCT00844337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824587|NCT00841373|Ranibizumab|ranibizumab|mesh-list
101824588|NCT00841373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101812902|NCT01829568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101812903|NCT01829568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101812904|NCT01829568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101812905|NCT01829568|Growth Substances|growth substances|mesh-ancestor
101812906|NCT01829568|Growth Inhibitors|growth inhibitors|mesh-ancestor
101470214|NCT00248144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101812908|NCT00848328|Lenalidomide|lenalidomide|mesh-list
101812909|NCT00848328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101812910|NCT00848328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101812911|NCT00848328|Immunologic Factors|immunologic factors|mesh-ancestor
101812912|NCT00848328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812913|NCT00848328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101812914|NCT00848328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101812915|NCT00848328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101812916|NCT00848328|Growth Substances|growth substances|mesh-ancestor
101812917|NCT00848328|Growth Inhibitors|growth inhibitors|mesh-ancestor
101812918|NCT00989352|Rituximab|rituximab|mesh-list
101812919|NCT00989352|Methotrexate|methotrexate|mesh-list
101812920|NCT00989352|Lomustine|lomustine|mesh-list
101812921|NCT00989352|Procarbazine|procarbazine|mesh-list
101824589|NCT00841373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101824590|NCT00841373|Growth Substances|growth substances|mesh-ancestor
101824591|NCT00841373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824592|NCT00841373|Growth Inhibitors|growth inhibitors|mesh-ancestor
101824593|NCT00841373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101824595|NCT00851513|Anesthetics, Local|anesthetics, local|mesh-ancestor
101824596|NCT00851513|Anesthetics|anesthetics|mesh-ancestor
101824597|NCT00851513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101824598|NCT00851513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824599|NCT00851513|Sensory System Agents|sensory system agents|mesh-ancestor
101824600|NCT00851513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101824601|NCT00851513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101824602|NCT00851513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101824603|NCT00851513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101824604|NCT00851513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101824605|NCT00851513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824606|NCT00841841|Acetaminophen|acetaminophen|mesh-list
101824607|NCT00841841|Dipyrone|dipyrone|mesh-list
101824608|NCT00841841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101824609|NCT00841841|Analgesics|analgesics|mesh-ancestor
101824610|NCT00841841|Sensory System Agents|sensory system agents|mesh-ancestor
101824611|NCT00841841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101824612|NCT00841841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824614|NCT00841841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101824615|NCT00841841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101824616|NCT00841841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101812926|NCT00989352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101812927|NCT00989352|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101812928|NCT00989352|Abortifacient Agents|abortifacient agents|mesh-ancestor
101812929|NCT00989352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101812930|NCT00989352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101812931|NCT00989352|Antimetabolites|antimetabolites|mesh-ancestor
101824617|NCT02545751|Thymalfasin|thymalfasin|mesh-list
101824618|NCT02545751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101824619|NCT02545751|Immunologic Factors|immunologic factors|mesh-ancestor
101334150|NCT00042874|Growth Inhibitors|growth inhibitors|mesh-ancestor
101824620|NCT02545751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824622|NCT00841919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101824623|NCT00841919|Insulin Glargine|insulin glargine|mesh-list
101824624|NCT00841919|Insulin, Isophane|insulin, isophane|mesh-list
101824625|NCT00841919|Isophane Insulin, Human|isophane insulin, human|mesh-list
101824626|NCT00841919|Isophane insulin, beef|isophane insulin, beef|mesh-list
101824627|NCT00841919|Insulin Lispro|insulin lispro|mesh-list
101824628|NCT00841919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101824629|NCT00841919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824630|NCT00852059|Methylphenidate|methylphenidate|mesh-list
101824631|NCT00852059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101824632|NCT00852059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824633|NCT00852059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101824634|NCT00852059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101824635|NCT00852059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101824636|NCT00852059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824637|NCT00852059|Dopamine Agents|dopamine agents|mesh-ancestor
101824638|NCT00852059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101824639|NCT00844727|Rofecoxib|rofecoxib|mesh-list
101824640|NCT00844727|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101824641|NCT00844727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101824642|NCT00844727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101824643|NCT00844727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824644|NCT00844727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101824645|NCT00844727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101824646|NCT00844727|Analgesics|analgesics|mesh-ancestor
101824647|NCT00844727|Sensory System Agents|sensory system agents|mesh-ancestor
101824648|NCT00844727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101824649|NCT00844727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824650|NCT00844727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101824651|NCT00844727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101824652|NCT00528528|Ribavirin|ribavirin|mesh-list
101824653|NCT00528528|Interferon-alpha|interferon-alpha|mesh-list
101824655|NCT00528528|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
101824656|NCT00528528|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101824657|NCT00528528|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101824658|NCT00528528|Antimetabolites|antimetabolites|mesh-ancestor
101824659|NCT00528528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824660|NCT00528528|Antiviral Agents|antiviral agents|mesh-ancestor
101824661|NCT00528528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101824662|NCT00528528|Immunologic Factors|immunologic factors|mesh-ancestor
101824663|NCT00528528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824664|NCT00528528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101824665|NCT00620555|Gabapentin|gabapentin|mesh-list
101824666|NCT00620555|Analgesics|analgesics|mesh-ancestor
101824667|NCT00620555|Sensory System Agents|sensory system agents|mesh-ancestor
101812941|NCT05566626|Mydriatics|mydriatics|mesh-ancestor
101812942|NCT05566626|Autonomic Agents|autonomic agents|mesh-ancestor
101824668|NCT00620555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101824669|NCT00620555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824670|NCT00620555|Anticonvulsants|anticonvulsants|mesh-ancestor
101824671|NCT00620555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101824672|NCT00620555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101824673|NCT00620555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101824674|NCT00620555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101824675|NCT00620555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101824676|NCT00620555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101824677|NCT00620555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101824678|NCT00620555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824679|NCT00620555|Antimanic Agents|antimanic agents|mesh-ancestor
101824680|NCT00845351|Bexarotene|bexarotene|mesh-list
101824681|NCT00845351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101824683|NCT02546141|Chelating Agents|chelating agents|mesh-ancestor
101824684|NCT02546141|Sequestering Agents|sequestering agents|mesh-ancestor
101824685|NCT02546141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824686|NCT00845819|Iodine|iodine|mesh-list
101824687|NCT00845819|Chlorhexidine|chlorhexidine|mesh-list
101824688|NCT00845819|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101824689|NCT00845819|Cadexomer iodine|cadexomer iodine|mesh-list
101824690|NCT00845819|Povidone-Iodine|povidone-iodine|mesh-list
101824691|NCT00845819|Nystatin|nystatin|mesh-list
101824692|NCT00845819|Povidone|povidone|mesh-list
101824693|NCT00845819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101824694|NCT00845819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101824695|NCT00845819|Disinfectants|disinfectants|mesh-ancestor
101824696|NCT00845819|Dermatologic Agents|dermatologic agents|mesh-ancestor
101824697|NCT00845819|Trace Elements|trace elements|mesh-ancestor
101824698|NCT00845819|Micronutrients|micronutrients|mesh-ancestor
101824699|NCT00845819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824700|NCT00845819|Plasma Substitutes|plasma substitutes|mesh-ancestor
101824701|NCT00845819|Blood Substitutes|blood substitutes|mesh-ancestor
101824702|NCT00845819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101824703|NCT00845819|Antifungal Agents|antifungal agents|mesh-ancestor
101824704|NCT00845819|Ionophores|ionophores|mesh-ancestor
101824705|NCT00845819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101824706|NCT00845819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824707|NCT02546843|Rocuronium|rocuronium|mesh-list
101824708|NCT02546843|Atracurium|atracurium|mesh-list
101824709|NCT02546843|Cisatracurium|cisatracurium|mesh-list
101824710|NCT02546843|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101824711|NCT02546843|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101824712|NCT02546843|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101824713|NCT02546843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101812944|NCT05566626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812945|NCT05566626|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101812946|NCT05566626|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101812947|NCT05566626|Cholinergic Agents|cholinergic agents|mesh-ancestor
101812948|NCT05566626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101812949|NCT05566626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812950|NCT00989508|Perhexiline|perhexiline|mesh-list
101812951|NCT00989508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101812952|NCT00989508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101812953|NCT00989508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812954|NCT00989508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101812955|NCT00989508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812956|NCT00989508|Vasodilator Agents|vasodilator agents|mesh-ancestor
101812957|NCT05360394|Paclitaxel|paclitaxel|mesh-list
101812958|NCT05360394|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101812959|NCT05360394|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101812960|NCT05360394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101824714|NCT02546843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824715|NCT02546843|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101824716|NCT02546843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101824717|NCT02546843|Cholinergic Agents|cholinergic agents|mesh-ancestor
101824718|NCT02546843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101824719|NCT02546843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824720|NCT03998982|Dexamethasone|dexamethasone|mesh-list
101824721|NCT03998982|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
101824722|NCT03998982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101824723|NCT03998982|Antiemetics|antiemetics|mesh-ancestor
101824724|NCT03998982|Autonomic Agents|autonomic agents|mesh-ancestor
101824725|NCT03998982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101824726|NCT03998982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824727|NCT03998982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101824728|NCT03998982|Glucocorticoids|glucocorticoids|mesh-ancestor
101824730|NCT03998982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101824731|NCT03998982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101824732|NCT03998982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101824733|NCT00620321|Cytarabine|cytarabine|mesh-list
101824734|NCT00620321|Idarubicin|idarubicin|mesh-list
101824735|NCT00620321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101824736|NCT00620321|Antimetabolites|antimetabolites|mesh-ancestor
101824737|NCT00620321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824738|NCT00620321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101824739|NCT00620321|Antiviral Agents|antiviral agents|mesh-ancestor
101824740|NCT00620321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101824741|NCT00620321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101824742|NCT00620321|Immunologic Factors|immunologic factors|mesh-ancestor
101824743|NCT00620321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824744|NCT00620321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101824745|NCT00620321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101824746|NCT00620321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101824747|NCT00620321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101824749|NCT00621023|Decitabine|decitabine|mesh-list
101824750|NCT00621023|Arsenic Trioxide|arsenic trioxide|mesh-list
101812970|NCT00090259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812972|NCT00079183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101824751|NCT00621023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101313158|NCT00008203|Cyclophosphamide|cyclophosphamide|mesh-list
101824753|NCT00621023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824754|NCT00621023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101824755|NCT00621023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101824756|NCT00621023|Antioxidants|antioxidants|mesh-ancestor
101824757|NCT00621023|Protective Agents|protective agents|mesh-ancestor
101824758|NCT00621023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824759|NCT00621023|Vitamins|vitamins|mesh-ancestor
101824760|NCT00621023|Micronutrients|micronutrients|mesh-ancestor
101824761|NCT00848861|Midazolam|midazolam|mesh-list
101824762|NCT00848861|Meperidine|meperidine|mesh-list
101824763|NCT00848861|Propofol|propofol|mesh-list
101824764|NCT00848861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101824765|NCT00848861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101824766|NCT00848861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824767|NCT00848861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101824768|NCT00848861|Anesthetics, General|anesthetics, general|mesh-ancestor
101824769|NCT00848861|Anesthetics|anesthetics|mesh-ancestor
101824770|NCT00848861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101824771|NCT00848861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101824772|NCT00848861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101824773|NCT00848861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101824774|NCT00848861|GABA Modulators|gaba modulators|mesh-ancestor
101824775|NCT00848861|GABA Agents|gaba agents|mesh-ancestor
101824776|NCT00848861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101824777|NCT00848861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824778|NCT00848861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101824779|NCT00848861|Narcotics|narcotics|mesh-ancestor
101824780|NCT00848861|Analgesics|analgesics|mesh-ancestor
101824781|NCT00848861|Sensory System Agents|sensory system agents|mesh-ancestor
101824782|NCT00848861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101824783|NCT00852371|Pyrimethamine|pyrimethamine|mesh-list
101824784|NCT00852371|Piperaquine|piperaquine|mesh-list
101824785|NCT00852371|Sulfadoxine|sulfadoxine|mesh-list
101824786|NCT00852371|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101824787|NCT00852371|Amodiaquine|amodiaquine|mesh-list
101824788|NCT00852371|Artenimol|artenimol|mesh-list
101824789|NCT00852371|Antimalarials|antimalarials|mesh-ancestor
101824790|NCT00852371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101824791|NCT00852371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101824792|NCT00852371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101470302|NCT00278421|Hormones|hormones|mesh-ancestor
101812981|NCT01086085|Interferon-alpha|interferon-alpha|mesh-list
101812982|NCT01086085|Adefovir|adefovir|mesh-list
101812983|NCT01086085|Antiviral Agents|antiviral agents|mesh-ancestor
101812984|NCT01086085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101824793|NCT00852371|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101824794|NCT00852371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101824795|NCT00852371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824796|NCT00852371|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101824797|NCT00528372|Metformin|metformin|mesh-list
101824798|NCT00528372|Dapagliflozin|dapagliflozin|mesh-list
101824799|NCT00528372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101824800|NCT00528372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824801|NCT00528372|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101824802|NCT00528372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824803|NCT01564680|Acetaminophen|acetaminophen|mesh-list
101824804|NCT01564680|Lornoxicam|lornoxicam|mesh-list
101824805|NCT01564680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101824806|NCT01564680|Analgesics|analgesics|mesh-ancestor
101824807|NCT01564680|Sensory System Agents|sensory system agents|mesh-ancestor
101824808|NCT01564680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101824809|NCT01564680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824811|NCT01564680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101824812|NCT01564680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101824813|NCT01564680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101824814|NCT01564836|Imatinib Mesylate|imatinib mesylate|mesh-list
101824815|NCT01564836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101824816|NCT01564836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101824817|NCT01564836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101824818|NCT01564836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824819|NCT00527982|Celecoxib|celecoxib|mesh-list
101824820|NCT00527982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101824821|NCT00527982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101824822|NCT00527982|Analgesics|analgesics|mesh-ancestor
101824823|NCT00527982|Sensory System Agents|sensory system agents|mesh-ancestor
101824824|NCT00527982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101824825|NCT00527982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824826|NCT00527982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101824827|NCT00527982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101824828|NCT00527982|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101824829|NCT00527982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101824830|NCT00527982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101824831|NCT00527982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824832|NCT00527904|Naproxen|naproxen|mesh-list
101824833|NCT00527904|Esomeprazole|esomeprazole|mesh-list
101824834|NCT00527904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101824835|NCT00527904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101812986|NCT01086085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101812987|NCT01086085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101812988|NCT01086085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101812989|NCT01086085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101812990|NCT01086085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812992|NCT01589419|Veliparib|veliparib|mesh-list
101812993|NCT01589419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101812994|NCT01589419|Antimetabolites|antimetabolites|mesh-ancestor
101812995|NCT01589419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101812996|NCT01589419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101812997|NCT01589419|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101812998|NCT01589419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101812999|NCT00676403|Pregabalin|pregabalin|mesh-list
101824836|NCT00527904|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101824837|NCT00527904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101824838|NCT00527904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824839|NCT00527904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101824840|NCT00527904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101824841|NCT00527904|Analgesics|analgesics|mesh-ancestor
101824842|NCT00527904|Sensory System Agents|sensory system agents|mesh-ancestor
101824843|NCT00527904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101824844|NCT00527904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824845|NCT00527904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101824846|NCT00527904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101824847|NCT00527904|Gout Suppressants|gout suppressants|mesh-ancestor
101824848|NCT00527904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101824849|NCT00619619|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101824850|NCT00619619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101824851|NCT00619619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101824852|NCT00619619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101824853|NCT00619619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824854|NCT00619619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101824855|NCT00619619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824856|NCT00619619|Antidepressive Agents|antidepressive agents|mesh-ancestor
101824857|NCT00619619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101824858|NCT00848939|Treprostinil|treprostinil|mesh-list
101824859|NCT00848939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101824860|NCT00842933|Prednisone|prednisone|mesh-list
101824861|NCT00842933|Methylprednisolone|methylprednisolone|mesh-list
101824862|NCT00842933|Hydrocortisone|hydrocortisone|mesh-list
101824863|NCT00842933|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101824865|NCT00842933|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101824866|NCT00842933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101824867|NCT00842933|Glucocorticoids|glucocorticoids|mesh-ancestor
101824868|NCT00842933|Hormones|hormones|mesh-ancestor
101824869|NCT00842933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101824870|NCT00842933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824871|NCT00842933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101824872|NCT00842933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101824873|NCT00842933|Antiemetics|antiemetics|mesh-ancestor
101824874|NCT00842933|Autonomic Agents|autonomic agents|mesh-ancestor
101824875|NCT00842933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101824876|NCT00842933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101813001|NCT00676403|Sensory System Agents|sensory system agents|mesh-ancestor
101813002|NCT00676403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101813003|NCT00676403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813005|NCT00676403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101813006|NCT00676403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101813007|NCT00676403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813008|NCT00676403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101813009|NCT00676403|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101813010|NCT00676403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101813011|NCT00676403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101813012|NCT00676403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101813013|NCT00078325|Modafinil|modafinil|mesh-list
101813014|NCT00078325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101813015|NCT00078325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813016|NCT00078325|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101813017|NCT00078325|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101813018|NCT00078325|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101813019|NCT00078325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813020|NCT03963193|Cisplatin|cisplatin|mesh-list
101813021|NCT03963193|Irinotecan|irinotecan|mesh-list
101813022|NCT03963193|Etoposide|etoposide|mesh-list
101813023|NCT03963193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101813024|NCT03963193|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101813025|NCT03963193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101813026|NCT03963193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101813027|NCT03963193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813028|NCT03963193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101813029|NCT03963193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101813030|NCT03961867|Docetaxel|docetaxel|mesh-list
101813031|NCT03961867|Oxaliplatin|oxaliplatin|mesh-list
101813032|NCT03961867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101813033|NCT03961867|Tubulin Modulators|tubulin modulators|mesh-ancestor
101824877|NCT00842933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101824878|NCT00842933|Protective Agents|protective agents|mesh-ancestor
101824880|NCT00849095|Terbutaline|terbutaline|mesh-list
101824881|NCT00849095|Formoterol Fumarate|formoterol fumarate|mesh-list
101813036|NCT03961867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813037|NCT00077857|Docetaxel|docetaxel|mesh-list
101813038|NCT00077857|Capecitabine|capecitabine|mesh-list
101813039|NCT00077857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101813040|NCT00077857|Tubulin Modulators|tubulin modulators|mesh-ancestor
101813041|NCT00077857|Antimitotic Agents|antimitotic agents|mesh-ancestor
101813042|NCT00077857|Mitosis Modulators|mitosis modulators|mesh-ancestor
101813043|NCT00077857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813044|NCT00077857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101813045|NCT00077857|Antimetabolites|antimetabolites|mesh-ancestor
101813046|NCT00545402|Mycophenolic Acid|mycophenolic acid|mesh-list
101813047|NCT00545402|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101813048|NCT00545402|Tacrolimus|tacrolimus|mesh-list
101813049|NCT00545402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101813050|NCT00545402|Immunologic Factors|immunologic factors|mesh-ancestor
101813051|NCT00545402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813052|NCT00545402|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101824882|NCT00849095|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101824883|NCT00849095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101824884|NCT00849095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101824885|NCT00849095|Autonomic Agents|autonomic agents|mesh-ancestor
101824886|NCT00849095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101824887|NCT00849095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824888|NCT00849095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101824889|NCT00849095|Respiratory System Agents|respiratory system agents|mesh-ancestor
101824890|NCT00849095|Glucocorticoids|glucocorticoids|mesh-ancestor
101824891|NCT00849095|Hormones|hormones|mesh-ancestor
101824892|NCT00849095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101824893|NCT00849095|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101824894|NCT00849095|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101824895|NCT00849095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101824896|NCT00849095|Adrenergic Agents|adrenergic agents|mesh-ancestor
101824897|NCT00849095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101824898|NCT00849095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824899|NCT00849095|Sympathomimetics|sympathomimetics|mesh-ancestor
101824900|NCT00849095|Tocolytic Agents|tocolytic agents|mesh-ancestor
101824901|NCT00849095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101824902|NCT00527826|Fluticasone|fluticasone|mesh-list
101824903|NCT00527826|Xhance|xhance|mesh-list
101824904|NCT00527826|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101824905|NCT00527826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101824906|NCT00527826|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101824907|NCT00527826|Autonomic Agents|autonomic agents|mesh-ancestor
101824908|NCT00527826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101824909|NCT00527826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824910|NCT00527826|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101824911|NCT00527826|Respiratory System Agents|respiratory system agents|mesh-ancestor
101824912|NCT00527826|Dermatologic Agents|dermatologic agents|mesh-ancestor
101824913|NCT00527826|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101824914|NCT00527826|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101813054|NCT00545402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813055|NCT00545402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101813056|NCT00545402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101813057|NCT00545402|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101813058|NCT00545402|Antitubercular Agents|antitubercular agents|mesh-ancestor
101813059|NCT00545402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101813060|NCT00545402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101813061|NCT00545402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101813062|NCT00545402|Glucocorticoids|glucocorticoids|mesh-ancestor
101813063|NCT00545402|Hormones|hormones|mesh-ancestor
101813064|NCT00545402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101813065|NCT00545402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101813066|NCT00545402|Protective Agents|protective agents|mesh-ancestor
101813067|NCT00545402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101813068|NCT03963115|Epinephrine|epinephrine|mesh-list
101813069|NCT03963115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101813070|NCT03963115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101813071|NCT03963115|Adrenergic Agents|adrenergic agents|mesh-ancestor
101813072|NCT03963115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101813073|NCT03963115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813074|NCT03963115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813075|NCT03963115|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101813076|NCT03963115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101813077|NCT03963115|Autonomic Agents|autonomic agents|mesh-ancestor
101824915|NCT00527826|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101824916|NCT00527826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101824917|NCT00527826|Adrenergic Agents|adrenergic agents|mesh-ancestor
101824918|NCT00527826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101824919|NCT00527826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824920|NCT00849329|Lapatinib|lapatinib|mesh-list
101824921|NCT00849329|Esomeprazole|esomeprazole|mesh-list
101824922|NCT00849329|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101824923|NCT00849329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101824924|NCT00849329|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101824925|NCT00849329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101824926|NCT00849329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824927|NCT00849329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101824928|NCT00849329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101824929|NCT03998670|Methamphetamine|methamphetamine|mesh-list
101824930|NCT03998670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101824931|NCT03998670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824932|NCT03998670|Sympathomimetics|sympathomimetics|mesh-ancestor
101824933|NCT03998670|Autonomic Agents|autonomic agents|mesh-ancestor
101824934|NCT03998670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101824935|NCT03998670|Dopamine Agents|dopamine agents|mesh-ancestor
101824936|NCT03998670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101813079|NCT03963115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101813080|NCT03963115|Respiratory System Agents|respiratory system agents|mesh-ancestor
101813081|NCT03963115|Mydriatics|mydriatics|mesh-ancestor
101813082|NCT03963115|Sympathomimetics|sympathomimetics|mesh-ancestor
101813083|NCT03963115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101813084|NCT01583023|Bupropion|bupropion|mesh-list
101824937|NCT03998670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824938|NCT03998670|Adrenergic Agents|adrenergic agents|mesh-ancestor
101824939|NCT03998670|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101824940|NCT03998670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101824941|NCT03998670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101824942|NCT03998670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101824943|NCT00852683|Pregabalin|pregabalin|mesh-list
101824944|NCT00852683|Analgesics|analgesics|mesh-ancestor
101824945|NCT00852683|Sensory System Agents|sensory system agents|mesh-ancestor
101824946|NCT00852683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101824947|NCT00852683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824948|NCT00852683|Anticonvulsants|anticonvulsants|mesh-ancestor
101824949|NCT00852683|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101824950|NCT00852683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101824951|NCT00852683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824952|NCT00852683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101824953|NCT00852683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101824954|NCT00852683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101824955|NCT00852683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101824956|NCT00852683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101824957|NCT00619307|Interferon beta-1a|interferon beta-1a|mesh-list
101824958|NCT00619307|Ibuprofen|ibuprofen|mesh-list
101824959|NCT00619307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101824960|NCT00619307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101824961|NCT00619307|Analgesics|analgesics|mesh-ancestor
101824962|NCT00619307|Sensory System Agents|sensory system agents|mesh-ancestor
101824963|NCT00619307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101824964|NCT00619307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824965|NCT00619307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101824966|NCT00619307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101824967|NCT00619307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101824968|NCT00619307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101824969|NCT00619307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824970|NCT00619307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101824971|NCT00619307|Immunologic Factors|immunologic factors|mesh-ancestor
101824972|NCT00619307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101824973|NCT00619307|Antiviral Agents|antiviral agents|mesh-ancestor
101824974|NCT00619307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101824975|NCT00855881|Tegafur|tegafur|mesh-list
101824976|NCT00855881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101824977|NCT00855881|Antimetabolites|antimetabolites|mesh-ancestor
101824978|NCT00855881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824979|NCT00855881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101824980|NCT00619229|Alprostadil|alprostadil|mesh-list
101824981|NCT00619229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101824982|NCT00619229|Vasodilator Agents|vasodilator agents|mesh-ancestor
101824983|NCT00619229|Urological Agents|urological agents|mesh-ancestor
101824984|NCT02546297|Budesonide|budesonide|mesh-list
101824985|NCT02546297|Bromides|bromides|mesh-list
101824986|NCT02546297|Formoterol Fumarate|formoterol fumarate|mesh-list
101824987|NCT02546297|Tiotropium Bromide|tiotropium bromide|mesh-list
101824988|NCT02546297|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101824989|NCT02546297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101824990|NCT02546297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101824991|NCT02546297|Autonomic Agents|autonomic agents|mesh-ancestor
101824992|NCT02546297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101824993|NCT02546297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824994|NCT02546297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101824995|NCT02546297|Respiratory System Agents|respiratory system agents|mesh-ancestor
101813086|NCT01583023|Antidepressive Agents|antidepressive agents|mesh-ancestor
101813087|NCT01583023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101813088|NCT01583023|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101813089|NCT01583023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101813090|NCT01583023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101813091|NCT01583023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813092|NCT01583023|Dopamine Agents|dopamine agents|mesh-ancestor
101813093|NCT01583023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101824996|NCT02546297|Glucocorticoids|glucocorticoids|mesh-ancestor
101824997|NCT02546297|Hormones|hormones|mesh-ancestor
101824998|NCT02546297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101824999|NCT02546297|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101825000|NCT02546297|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101825001|NCT02546297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101825002|NCT02546297|Adrenergic Agents|adrenergic agents|mesh-ancestor
101825003|NCT02546297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101825004|NCT02546297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825005|NCT02546297|Parasympatholytics|parasympatholytics|mesh-ancestor
101825006|NCT02546297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101825007|NCT02546297|Cholinergic Agents|cholinergic agents|mesh-ancestor
101825008|NCT02546297|Anticonvulsants|anticonvulsants|mesh-ancestor
101825009|NCT00618995|Niacin|niacin|mesh-list
101825010|NCT00618995|Niacinamide|niacinamide|mesh-list
101825011|NCT00618995|Nicotinic Acids|nicotinic acids|mesh-list
101825012|NCT00618995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101825013|NCT00618995|Antimetabolites|antimetabolites|mesh-ancestor
101825014|NCT00618995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825015|NCT00618995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101825016|NCT00618995|Vasodilator Agents|vasodilator agents|mesh-ancestor
101825017|NCT00618995|Vitamin B Complex|vitamin b complex|mesh-ancestor
101825018|NCT00618995|Vitamins|vitamins|mesh-ancestor
101825019|NCT00618995|Micronutrients|micronutrients|mesh-ancestor
101825020|NCT00618995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825021|NCT03685344|Durvalumab|durvalumab|mesh-list
101825022|NCT03685344|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
101825023|NCT03685344|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101825024|NCT03685344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101825025|NCT03685344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101825026|NCT03685344|Immunologic Factors|immunologic factors|mesh-ancestor
101825027|NCT03685344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825029|NCT00856037|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101825030|NCT00856037|Topotecan|topotecan|mesh-list
101825031|NCT00856037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101825032|NCT00856037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101825033|NCT00856037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101825034|NCT00856037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101825035|NCT00856037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101825036|NCT00856037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825037|NCT00856037|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101825038|NCT00856271|Losartan|losartan|mesh-list
101825039|NCT00856271|Olmesartan|olmesartan|mesh-list
101825040|NCT00856271|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101825041|NCT00856271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101825042|NCT00856271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101825043|NCT00856271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101825044|NCT00856271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101176834|NCT01835262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101825045|NCT00856271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825046|NCT00856505|Mycophenolic Acid|mycophenolic acid|mesh-list
101825047|NCT00856505|Everolimus|everolimus|mesh-list
101825048|NCT00856505|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101825049|NCT00856505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101813094|NCT01583023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813095|NCT01583023|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101813096|NCT01583023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101813097|NCT01583023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101813098|NCT00976976|Cisplatin|cisplatin|mesh-list
101813099|NCT00976976|Docetaxel|docetaxel|mesh-list
101813100|NCT00976976|Capecitabine|capecitabine|mesh-list
101813101|NCT00976976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101813102|NCT00976976|Tubulin Modulators|tubulin modulators|mesh-ancestor
101813103|NCT00976976|Antimitotic Agents|antimitotic agents|mesh-ancestor
101813104|NCT00976976|Mitosis Modulators|mitosis modulators|mesh-ancestor
101813105|NCT00976976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813106|NCT00976976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101813107|NCT00976976|Antimetabolites|antimetabolites|mesh-ancestor
101813108|NCT00977054|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101813109|NCT00977054|Interferon-alpha|interferon-alpha|mesh-list
101825050|NCT00856505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101825051|NCT00856505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825052|NCT00856505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101176896|NCT01809054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101825053|NCT00856505|Immunologic Factors|immunologic factors|mesh-ancestor
101825054|NCT00856505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825055|NCT00856505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101825056|NCT00856505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101825057|NCT00856505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101825058|NCT00856505|Antitubercular Agents|antitubercular agents|mesh-ancestor
101825059|NCT00856505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101825060|NCT00856505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101825061|NCT02544893|Dexmedetomidine|dexmedetomidine|mesh-list
101825062|NCT02544893|Bupivacaine|bupivacaine|mesh-list
101176963|NCT01845636|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101825063|NCT02544893|Anesthetics, Local|anesthetics, local|mesh-ancestor
101825064|NCT02544893|Anesthetics|anesthetics|mesh-ancestor
101825065|NCT02544893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101825066|NCT02544893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825067|NCT02544893|Sensory System Agents|sensory system agents|mesh-ancestor
101825068|NCT02544893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101825069|NCT02544893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101825070|NCT02544893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101825072|NCT02544893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101825073|NCT02544893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101825074|NCT02544893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101825075|NCT02544893|Adrenergic Agents|adrenergic agents|mesh-ancestor
101825076|NCT02544893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101825077|NCT02544893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825078|NCT00520572|Etanercept|etanercept|mesh-list
101825079|NCT00520572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101825080|NCT00520572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101825081|NCT00520572|Analgesics|analgesics|mesh-ancestor
101825082|NCT00520572|Sensory System Agents|sensory system agents|mesh-ancestor
101825083|NCT00520572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101482360|NCT00304655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101825084|NCT00520572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825085|NCT00520572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101825086|NCT00520572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101825087|NCT00520572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101825088|NCT00520572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101825089|NCT00520572|Immunologic Factors|immunologic factors|mesh-ancestor
101825090|NCT00853697|Methyltestosterone|methyltestosterone|mesh-list
101813111|NCT00977054|Interferon alpha-2|interferon alpha-2|mesh-list
101813112|NCT00977054|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
101813113|NCT00977054|Antiviral Agents|antiviral agents|mesh-ancestor
101813114|NCT00977054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101813115|NCT00977054|Immunologic Factors|immunologic factors|mesh-ancestor
101813116|NCT00977054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813117|NCT00977054|Antimetabolites|antimetabolites|mesh-ancestor
101813118|NCT00977054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813119|NCT00977054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101813120|NCT00977132|Lenalidomide|lenalidomide|mesh-list
101813121|NCT00977132|Immunologic Factors|immunologic factors|mesh-ancestor
101813122|NCT00977132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825092|NCT00853697|Testosterone undecanoate|testosterone undecanoate|mesh-list
101825093|NCT00853697|Testosterone enanthate|testosterone enanthate|mesh-list
101825094|NCT00853697|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101825095|NCT00853697|Dutasteride|dutasteride|mesh-list
101825096|NCT00853697|Androgens|androgens|mesh-ancestor
101825097|NCT00853697|Hormones|hormones|mesh-ancestor
101825098|NCT00853697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101825099|NCT00853697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825100|NCT00853697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101825101|NCT00853697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101825102|NCT00853697|Anabolic Agents|anabolic agents|mesh-ancestor
101825103|NCT00853697|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101825104|NCT00853697|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101825105|NCT00853697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101825106|NCT00853697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825107|NCT00853697|Hormone Antagonists|hormone antagonists|mesh-ancestor
101825108|NCT00861419|Niacinamide|niacinamide|mesh-list
101825109|NCT00861419|Bevacizumab|bevacizumab|mesh-list
101825110|NCT00861419|Sunitinib|sunitinib|mesh-list
101825111|NCT00861419|Trebananib|trebananib|mesh-list
101825112|NCT00861419|Sorafenib|sorafenib|mesh-list
101825113|NCT00861419|Motesanib diphosphate|motesanib diphosphate|mesh-list
101825114|NCT00861419|Imetelstat|imetelstat|mesh-list
101825115|NCT00861419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101825116|NCT00861419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101825117|NCT00861419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101825118|NCT00861419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101825119|NCT00861419|Growth Substances|growth substances|mesh-ancestor
101825120|NCT00861419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177215|NCT05606718|Dapagliflozin|dapagliflozin|mesh-list
101825121|NCT00861419|Growth Inhibitors|growth inhibitors|mesh-ancestor
101825122|NCT00861419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101825123|NCT00861419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101825124|NCT00861419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825125|NCT00861419|Vitamin B Complex|vitamin b complex|mesh-ancestor
101825126|NCT00861419|Vitamins|vitamins|mesh-ancestor
101825127|NCT00861419|Micronutrients|micronutrients|mesh-ancestor
101825128|NCT00527514|Amlodipine|amlodipine|mesh-list
101825129|NCT00527514|Olmesartan|olmesartan|mesh-list
101825130|NCT00527514|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101825131|NCT00527514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101825132|NCT00527514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101825133|NCT00527514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101825134|NCT00527514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825135|NCT00527514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101825136|NCT00527514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825137|NCT00527514|Vasodilator Agents|vasodilator agents|mesh-ancestor
101825138|NCT00527514|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101825139|NCT00527514|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101825140|NCT03998826|Piroxicam|piroxicam|mesh-list
101825141|NCT03998826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101813123|NCT00977132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101813124|NCT00977132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101813125|NCT00977132|Growth Substances|growth substances|mesh-ancestor
101813126|NCT00977132|Growth Inhibitors|growth inhibitors|mesh-ancestor
101813127|NCT00977132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101813128|NCT00545792|Bevacizumab|bevacizumab|mesh-list
101825142|NCT03998826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101825143|NCT03998826|Analgesics|analgesics|mesh-ancestor
101177333|NCT04337814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101825144|NCT03998826|Sensory System Agents|sensory system agents|mesh-ancestor
101825145|NCT03998826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101825146|NCT03998826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825147|NCT03998826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101825148|NCT03998826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101825149|NCT03998826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101825150|NCT03998826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101825151|NCT03998826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825152|NCT00853931|Panitumumab|panitumumab|mesh-list
101825153|NCT00853931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101825154|NCT00853931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101177397|NCT01430442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177398|NCT01420926|Bortezomib|bortezomib|mesh-list
101825156|NCT00854009|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101825158|NCT00854009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825159|NCT00854009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101825160|NCT00854009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101825161|NCT03998592|Vaccines|vaccines|mesh-list
101825162|NCT03998592|Immunologic Factors|immunologic factors|mesh-ancestor
101825163|NCT03998592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825164|NCT00861731|Simvastatin|simvastatin|mesh-list
101825165|NCT00861731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101825166|NCT00861731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101825167|NCT00861731|Antimetabolites|antimetabolites|mesh-ancestor
101825168|NCT00861731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825169|NCT00861731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101825170|NCT00861731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101825171|NCT00861731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101825172|NCT02544659|Pamidronate|pamidronate|mesh-list
101825173|NCT02544659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101825174|NCT02544659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825175|NCT00861887|Vancomycin|vancomycin|mesh-list
101825176|NCT00861887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101825177|NCT00861887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101825178|NCT00857519|Carboplatin|carboplatin|mesh-list
101825179|NCT00857519|Melphalan|melphalan|mesh-list
101825180|NCT00857519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101825181|NCT00857519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101825182|NCT00857519|Alkylating Agents|alkylating agents|mesh-ancestor
101825183|NCT00857519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825184|NCT00857519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101825185|NCT00857519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101825186|NCT00857519|Immunologic Factors|immunologic factors|mesh-ancestor
101825187|NCT00857519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825188|NCT00618449|Azithromycin|azithromycin|mesh-list
101825189|NCT00618449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101825190|NCT00618449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101825191|NCT00857597|Esomeprazole|esomeprazole|mesh-list
101177547|NCT01920282|Nebivolol|nebivolol|mesh-list
101825192|NCT00857597|Omeprazole|omeprazole|mesh-list
101825193|NCT00857597|Rabeprazole|rabeprazole|mesh-list
101825194|NCT00857597|Pantoprazole|pantoprazole|mesh-list
101825195|NCT00857597|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101825196|NCT00857597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101334169|NCT00043069|Vitamins|vitamins|mesh-ancestor
101825197|NCT00857597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101825198|NCT00857597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101825199|NCT00857597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825200|NCT00857753|Fentanyl|fentanyl|mesh-list
101825201|NCT00857753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101825202|NCT00857753|Narcotics|narcotics|mesh-ancestor
101813129|NCT00545792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101813130|NCT00545792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101813131|NCT00545792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101813132|NCT00545792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101813133|NCT00545792|Growth Substances|growth substances|mesh-ancestor
101813134|NCT00545792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813135|NCT00545792|Growth Inhibitors|growth inhibitors|mesh-ancestor
101813136|NCT00977288|Atorvastatin|atorvastatin|mesh-list
101177574|NCT01929642|Immunologic Factors|immunologic factors|mesh-ancestor
101825203|NCT00857753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101825204|NCT00857753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825205|NCT00857753|Analgesics|analgesics|mesh-ancestor
101825206|NCT00857753|Sensory System Agents|sensory system agents|mesh-ancestor
101825207|NCT00857753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101825208|NCT00857753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101825209|NCT00857753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101825210|NCT00857753|Anesthetics, General|anesthetics, general|mesh-ancestor
101825211|NCT00857753|Anesthetics|anesthetics|mesh-ancestor
101825212|NCT00854321|Rituximab|rituximab|mesh-list
101825213|NCT00854321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101825214|NCT00854321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101825215|NCT00854321|Immunologic Factors|immunologic factors|mesh-ancestor
101825216|NCT00854321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825217|NCT00854321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101825218|NCT03684642|Metformin|metformin|mesh-list
101825219|NCT03684642|Dulaglutide|dulaglutide|mesh-list
101177640|NCT01949844|Regadenoson|regadenoson|mesh-list
101825221|NCT03684642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101825222|NCT03684642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825223|NCT00857831|Vitamin D|vitamin d|mesh-list
101825224|NCT00857831|Calcium|calcium|mesh-list
101825225|NCT00857831|Vitamins|vitamins|mesh-ancestor
101825226|NCT00857831|Micronutrients|micronutrients|mesh-ancestor
101825227|NCT00857831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825228|NCT00857831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101825229|NCT00857831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101825230|NCT00862043|Sildenafil Citrate|sildenafil citrate|mesh-list
101177697|NCT01957410|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101825231|NCT00862043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825232|NCT00862043|Vasodilator Agents|vasodilator agents|mesh-ancestor
101825233|NCT00862043|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101825234|NCT00862043|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101825235|NCT00862043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101825236|NCT00862043|Urological Agents|urological agents|mesh-ancestor
101825237|NCT00519636|Fluticasone|fluticasone|mesh-list
101825239|NCT00519636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101825240|NCT00519636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101825241|NCT00519636|Autonomic Agents|autonomic agents|mesh-ancestor
101825242|NCT00519636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101825243|NCT00519636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825244|NCT00519636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101825245|NCT00519636|Respiratory System Agents|respiratory system agents|mesh-ancestor
101825246|NCT00519636|Dermatologic Agents|dermatologic agents|mesh-ancestor
101825247|NCT00519636|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101825248|NCT00857909|Amiloride|amiloride|mesh-list
101825249|NCT00857909|Spironolactone|spironolactone|mesh-list
101825250|NCT00857909|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101825251|NCT00857909|Hormone Antagonists|hormone antagonists|mesh-ancestor
101177760|NCT05737680|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101825252|NCT00857909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101825253|NCT00857909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825254|NCT00857909|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101825255|NCT00857909|Diuretics|diuretics|mesh-ancestor
101825256|NCT00857909|Natriuretic Agents|natriuretic agents|mesh-ancestor
101825257|NCT00857909|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
101825258|NCT00857909|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101825259|NCT00857909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101813137|NCT00977288|Anacetrapib|anacetrapib|mesh-list
101813138|NCT00977288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101813139|NCT00977288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101813140|NCT00977288|Antimetabolites|antimetabolites|mesh-ancestor
101813141|NCT00977288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813142|NCT00977288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101813143|NCT00977288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101813144|NCT00977288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101813145|NCT00966602|Ivacaftor|ivacaftor|mesh-list
101813146|NCT00966602|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101813147|NCT00966602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101813148|NCT00966602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825260|NCT00857909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825261|NCT00857909|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101825262|NCT00857987|Expectorants|expectorants|mesh-list
101825263|NCT00857987|Respiratory System Agents|respiratory system agents|mesh-ancestor
101825264|NCT00854477|Capecitabine|capecitabine|mesh-list
101825265|NCT00854477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101177816|NCT05721144|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101825266|NCT00854477|Antimetabolites|antimetabolites|mesh-ancestor
101825267|NCT00854477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825268|NCT00854477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101825269|NCT00854633|Lactoferrin|lactoferrin|mesh-list
101825270|NCT00854633|Talactoferrin alfa|talactoferrin alfa|mesh-list
101825271|NCT00854633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101177877|NCT05242692|Dexmedetomidine|dexmedetomidine|mesh-list
101825273|NCT00618371|Raltegravir Potassium|raltegravir potassium|mesh-list
101825274|NCT00618371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101825275|NCT00618371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101825276|NCT00618371|Antiviral Agents|antiviral agents|mesh-ancestor
101825277|NCT00618371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101825278|NCT00618371|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101825279|NCT00618371|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101825280|NCT00618371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101825281|NCT00618371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177948|NCT03616236|Naloxone|naloxone|mesh-list
101825283|NCT00858299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101825284|NCT00858299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101825285|NCT00858299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101825286|NCT00858299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825287|NCT00526890|Selenium|selenium|mesh-list
101825288|NCT00526890|Paclitaxel|paclitaxel|mesh-list
101825289|NCT00526890|Carboplatin|carboplatin|mesh-list
101825290|NCT00526890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101825291|NCT00526890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101825292|NCT00526890|Tubulin Modulators|tubulin modulators|mesh-ancestor
101825293|NCT00526890|Antimitotic Agents|antimitotic agents|mesh-ancestor
101825294|NCT00526890|Mitosis Modulators|mitosis modulators|mesh-ancestor
101825295|NCT00526890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825296|NCT00526890|Antioxidants|antioxidants|mesh-ancestor
101825297|NCT00526890|Protective Agents|protective agents|mesh-ancestor
101825298|NCT00526890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825299|NCT00526890|Trace Elements|trace elements|mesh-ancestor
101825300|NCT00526890|Micronutrients|micronutrients|mesh-ancestor
101825301|NCT04041167|Thioctic Acid|thioctic acid|mesh-list
101825302|NCT04041167|Antioxidants|antioxidants|mesh-ancestor
101825303|NCT04041167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825304|NCT04041167|Protective Agents|protective agents|mesh-ancestor
101825305|NCT04041167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813149|NCT00966680|Anesthetics|anesthetics|mesh-list
101813150|NCT00966680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101813151|NCT00966680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813152|NCT00977444|Prednisolone|prednisolone|mesh-list
101813153|NCT00977444|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101813154|NCT00977444|Methylprednisolone|methylprednisolone|mesh-list
101813155|NCT00977444|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101813156|NCT00977444|Prednisolone acetate|prednisolone acetate|mesh-list
101813157|NCT00977444|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101825306|NCT04041167|Vitamin B Complex|vitamin b complex|mesh-ancestor
101825307|NCT04041167|Vitamins|vitamins|mesh-ancestor
101825308|NCT04041167|Micronutrients|micronutrients|mesh-ancestor
101825309|NCT00858377|Complement Factor H|complement factor h|mesh-list
101825310|NCT00858377|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101178072|NCT01239030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101825312|NCT00858377|Immunologic Factors|immunologic factors|mesh-ancestor
101825314|NCT00854711|Nitric Oxide|nitric oxide|mesh-list
101825315|NCT00854711|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101825316|NCT00854711|Autonomic Agents|autonomic agents|mesh-ancestor
101825317|NCT00854711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101178133|NCT01965756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101825319|NCT00854711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101825320|NCT00854711|Respiratory System Agents|respiratory system agents|mesh-ancestor
101825321|NCT00854711|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101825322|NCT00854711|Antioxidants|antioxidants|mesh-ancestor
101825323|NCT00854711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825324|NCT00854711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101825325|NCT00854711|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101825326|NCT00854711|Vasodilator Agents|vasodilator agents|mesh-ancestor
101825327|NCT00854711|Gasotransmitters|gasotransmitters|mesh-ancestor
101825328|NCT00854711|Protective Agents|protective agents|mesh-ancestor
101825329|NCT00858455|Dolutegravir|dolutegravir|mesh-list
101825330|NCT00858455|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101825331|NCT00858455|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101825332|NCT00858455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101825333|NCT00858455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825334|NCT00858455|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101825335|NCT00858455|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101825336|NCT00858455|Antiviral Agents|antiviral agents|mesh-ancestor
101178264|NCT02004366|Linagliptin|linagliptin|mesh-list
101825337|NCT00858455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101825338|NCT02544737|Apatinib|apatinib|mesh-list
101825339|NCT02544737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101825340|NCT02544737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101825341|NCT02544737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101825342|NCT02544737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825343|NCT00526656|Sunitinib|sunitinib|mesh-list
101825344|NCT00526656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101825345|NCT00526656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101825346|NCT00526656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101825347|NCT00526656|Growth Substances|growth substances|mesh-ancestor
101825348|NCT00526656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178328|NCT02025426|Phenylephrine|phenylephrine|mesh-list
101178329|NCT02025426|Oxymetazoline|oxymetazoline|mesh-list
101825349|NCT00526656|Growth Inhibitors|growth inhibitors|mesh-ancestor
101825350|NCT00526656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101825351|NCT00526656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101825352|NCT00526656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825353|NCT00858767|Vitamin K 2|vitamin k 2|mesh-list
101825354|NCT00858767|Vitamin K|vitamin k|mesh-list
101825355|NCT00858767|Menaquinone 7|menaquinone 7|mesh-list
101825356|NCT00858767|Caseins|caseins|mesh-list
101825357|NCT00858767|Chelating Agents|chelating agents|mesh-ancestor
101825358|NCT00858767|Sequestering Agents|sequestering agents|mesh-ancestor
101825359|NCT00858767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813158|NCT00977444|Prednisolone phosphate|prednisolone phosphate|mesh-list
101813159|NCT00977444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101813160|NCT00977444|Glucocorticoids|glucocorticoids|mesh-ancestor
101813161|NCT00977444|Hormones|hormones|mesh-ancestor
101813162|NCT00977444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101813163|NCT00977444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813164|NCT00977444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101813165|NCT00977444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101813166|NCT00977444|Antiemetics|antiemetics|mesh-ancestor
101825360|NCT00858767|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101825361|NCT00858767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101825362|NCT00858767|Hemostatics|hemostatics|mesh-ancestor
101825363|NCT00858767|Coagulants|coagulants|mesh-ancestor
101825364|NCT00858767|Vitamins|vitamins|mesh-ancestor
101825365|NCT00858767|Micronutrients|micronutrients|mesh-ancestor
101825366|NCT00858767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825367|NCT00617903|Azelaic acid|azelaic acid|mesh-list
101825368|NCT00617903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101825369|NCT00617903|Dermatologic Agents|dermatologic agents|mesh-ancestor
101825370|NCT00526110|Docetaxel|docetaxel|mesh-list
101825371|NCT00526110|Fluorouracil|fluorouracil|mesh-list
101825372|NCT00526110|Oxaliplatin|oxaliplatin|mesh-list
101825373|NCT00526110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101825374|NCT00526110|Tubulin Modulators|tubulin modulators|mesh-ancestor
101825375|NCT00526110|Antimitotic Agents|antimitotic agents|mesh-ancestor
101825376|NCT00526110|Mitosis Modulators|mitosis modulators|mesh-ancestor
101178458|NCT02057640|Dexamethasone|dexamethasone|mesh-list
101825377|NCT00526110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825378|NCT00526110|Antimetabolites|antimetabolites|mesh-ancestor
101825379|NCT00526110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101825380|NCT00526110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101825381|NCT00526110|Immunologic Factors|immunologic factors|mesh-ancestor
101825382|NCT00526110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825383|NCT00859079|Insulin|insulin|mesh-list
101178515|NCT02062710|Dextromethorphan|dextromethorphan|mesh-list
101178516|NCT02062710|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101825384|NCT00859079|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101825385|NCT00859079|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101825386|NCT00859079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101825387|NCT00859079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825388|NCT00859079|Incretins|incretins|mesh-ancestor
101825389|NCT00859079|Hormones|hormones|mesh-ancestor
101825390|NCT00859079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101825391|NCT02544425|Dexamethasone|dexamethasone|mesh-list
101825392|NCT02544425|Etoposide|etoposide|mesh-list
101825393|NCT02544425|Melphalan|melphalan|mesh-list
101825394|NCT02544425|Busulfan|busulfan|mesh-list
101825395|NCT02544425|Asparaginase|asparaginase|mesh-list
101825396|NCT02544425|Ifosfamide|ifosfamide|mesh-list
101825397|NCT02544425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101825398|NCT02544425|Antiemetics|antiemetics|mesh-ancestor
101825399|NCT02544425|Autonomic Agents|autonomic agents|mesh-ancestor
101825400|NCT02544425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101825401|NCT02544425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825402|NCT02544425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101825403|NCT02544425|Glucocorticoids|glucocorticoids|mesh-ancestor
101825404|NCT02544425|Hormones|hormones|mesh-ancestor
101825405|NCT02544425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101825406|NCT02544425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101825407|NCT02544425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101825408|NCT02544425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101825409|NCT02544425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101825410|NCT02544425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101825411|NCT02544425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101825412|NCT02544425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825413|NCT02544425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101825414|NCT02544425|Alkylating Agents|alkylating agents|mesh-ancestor
101825415|NCT02544425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101825416|NCT02544425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101813167|NCT00977444|Autonomic Agents|autonomic agents|mesh-ancestor
101813168|NCT00977444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101813169|NCT00977444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101813170|NCT00977444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101813171|NCT00977444|Protective Agents|protective agents|mesh-ancestor
101813172|NCT00977600|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
101813173|NCT00977600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101813174|NCT00966836|Mycophenolic Acid|mycophenolic acid|mesh-list
101813176|NCT00966836|Everolimus|everolimus|mesh-list
101813177|NCT00966836|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101813178|NCT00966836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101813179|NCT00966836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101813180|NCT00966836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825417|NCT02544425|Immunologic Factors|immunologic factors|mesh-ancestor
101825418|NCT00859235|Chlorhexidine|chlorhexidine|mesh-list
101825419|NCT00859235|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101825420|NCT00859235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101825421|NCT00859235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101825422|NCT00859235|Disinfectants|disinfectants|mesh-ancestor
101825423|NCT00859235|Dermatologic Agents|dermatologic agents|mesh-ancestor
101825424|NCT04523688|Temozolomide|temozolomide|mesh-list
101825425|NCT04523688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101825426|NCT04523688|Alkylating Agents|alkylating agents|mesh-ancestor
101825427|NCT04523688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825428|NCT04523688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101825429|NCT00511836|Naltrexone|naltrexone|mesh-list
101825430|NCT00511836|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101825431|NCT00511836|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101825432|NCT00511836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825433|NCT00511836|Sensory System Agents|sensory system agents|mesh-ancestor
101825434|NCT00511836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101825435|NCT00859703|Risedronic Acid|risedronic acid|mesh-list
101825436|NCT00859703|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101825437|NCT00859703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101825438|NCT00859703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825439|NCT00859703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101825440|NCT00859703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825441|NCT00859703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101825442|NCT03998436|Esmolol|esmolol|mesh-list
101825443|NCT03998436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101825444|NCT03998436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101825445|NCT03998436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101825446|NCT03998436|Adrenergic Agents|adrenergic agents|mesh-ancestor
101825447|NCT03998436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101825448|NCT03998436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825449|NCT03998436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825450|NCT00855101|Voriconazole|voriconazole|mesh-list
101825451|NCT00855101|Antifungal Agents|antifungal agents|mesh-ancestor
101825452|NCT00855101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101178673|NCT02160288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101825453|NCT00855101|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101825454|NCT00855101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101825455|NCT00855101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101825456|NCT00855101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825457|NCT00855101|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101825458|NCT00855101|Hormone Antagonists|hormone antagonists|mesh-ancestor
101825459|NCT00855101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101813181|NCT00966836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101813182|NCT00966836|Immunologic Factors|immunologic factors|mesh-ancestor
101813183|NCT00966836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813184|NCT00966836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101813185|NCT00966836|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101813186|NCT00966836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101825460|NCT00855101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825461|NCT00855101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101825464|NCT00573755|Anastrozole|anastrozole|mesh-list
101825465|NCT00573755|Exemestane|exemestane|mesh-list
101825466|NCT00573755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101825467|NCT00573755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101825468|NCT00573755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101825469|NCT00573755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825470|NCT00573755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101825471|NCT00573755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101825472|NCT00573755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101825473|NCT00573755|Hormone Antagonists|hormone antagonists|mesh-ancestor
101178735|NCT02181426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101825474|NCT00573755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101825475|NCT00573755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825476|NCT00573755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101825477|NCT02544191|Goserelin|goserelin|mesh-list
101825478|NCT02544191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101825479|NCT02544191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101825480|NCT00524316|Doxorubicin|doxorubicin|mesh-list
101825481|NCT00524316|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101825482|NCT00524316|Sunitinib|sunitinib|mesh-list
101825483|NCT00524316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101825484|NCT00524316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101825485|NCT00524316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101825486|NCT00524316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101825487|NCT00524316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101825488|NCT00524316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825489|NCT00524316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101825490|NCT00524316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101825491|NCT00524316|Growth Substances|growth substances|mesh-ancestor
101825492|NCT00524316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825493|NCT00524316|Growth Inhibitors|growth inhibitors|mesh-ancestor
101825494|NCT00524316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101825495|NCT03861936|Botulinum Toxins|botulinum toxins|mesh-list
101825496|NCT03861936|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101178852|NCT02223702|Amoxicillin|amoxicillin|mesh-list
101825497|NCT03861936|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101825498|NCT03861936|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101825499|NCT03861936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101825500|NCT03861936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825501|NCT03861936|Cholinergic Agents|cholinergic agents|mesh-ancestor
101825502|NCT03861936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101825503|NCT03861936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825504|NCT03861936|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101825505|NCT03861936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101825506|NCT02544269|Bupivacaine|bupivacaine|mesh-list
101825507|NCT02544269|Ropivacaine|ropivacaine|mesh-list
101825508|NCT02544269|Anesthetics, Local|anesthetics, local|mesh-ancestor
101178918|NCT02241486|Fentanyl|fentanyl|mesh-list
101825509|NCT02544269|Anesthetics|anesthetics|mesh-ancestor
101825510|NCT02544269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101825511|NCT02544269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825512|NCT02544269|Sensory System Agents|sensory system agents|mesh-ancestor
101825513|NCT02544269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101825514|NCT00434577|Vaccines|vaccines|mesh-list
101825515|NCT00434577|Immunologic Factors|immunologic factors|mesh-ancestor
101825516|NCT00434577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825517|NCT00865085|Dexetimide|dexetimide|mesh-list
101813187|NCT00966836|Antitubercular Agents|antitubercular agents|mesh-ancestor
101813188|NCT00966836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101813189|NCT00966836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101813190|NCT00966836|Antiviral Agents|antiviral agents|mesh-ancestor
101813191|NCT00967070|Nicotine|nicotine|mesh-list
101813192|NCT00967070|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101813193|NCT00967070|Autonomic Agents|autonomic agents|mesh-ancestor
101813194|NCT00967070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101813195|NCT00967070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813196|NCT00967070|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101813197|NCT00967070|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101825519|NCT00865085|Escitalopram|escitalopram|mesh-list
101825520|NCT00865085|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101825521|NCT00865085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101825522|NCT00865085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101825523|NCT00865085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825524|NCT00865085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101825525|NCT00865085|Serotonin Agents|serotonin agents|mesh-ancestor
101825526|NCT00865085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825527|NCT00865085|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101825528|NCT00865085|Antidepressive Agents|antidepressive agents|mesh-ancestor
101825529|NCT00865085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101825530|NCT00865085|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101825531|NCT00865085|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101825532|NCT00865085|Parasympatholytics|parasympatholytics|mesh-ancestor
101825533|NCT00865085|Autonomic Agents|autonomic agents|mesh-ancestor
101825534|NCT00865085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101825535|NCT00865085|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101825536|NCT00865085|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101825538|NCT00796068|Cyclosporine|cyclosporine|mesh-list
101825539|NCT00796068|Mycophenolic Acid|mycophenolic acid|mesh-list
101825540|NCT00796068|Fludarabine|fludarabine|mesh-list
101825541|NCT00796068|Fludarabine phosphate|fludarabine phosphate|mesh-list
101825542|NCT00796068|Treosulfan|treosulfan|mesh-list
101825543|NCT00796068|Busulfan|busulfan|mesh-list
101825544|NCT00796068|Cyclosporins|cyclosporins|mesh-list
101825545|NCT00796068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101825546|NCT00796068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101825547|NCT00796068|Antimetabolites|antimetabolites|mesh-ancestor
101825548|NCT00796068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825549|NCT00796068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101825550|NCT00796068|Immunologic Factors|immunologic factors|mesh-ancestor
101825551|NCT00796068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825552|NCT00796068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101825553|NCT00796068|Antifungal Agents|antifungal agents|mesh-ancestor
101825554|NCT00796068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101825555|NCT00796068|Dermatologic Agents|dermatologic agents|mesh-ancestor
101825556|NCT00796068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101825557|NCT00796068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101825558|NCT00796068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101825559|NCT00796068|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101825560|NCT00796068|Antitubercular Agents|antitubercular agents|mesh-ancestor
101825561|NCT00796068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101825562|NCT00796068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101825563|NCT00796068|Alkylating Agents|alkylating agents|mesh-ancestor
101825564|NCT00796068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101825565|NCT04732182|Donepezil|donepezil|mesh-list
101825566|NCT04732182|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101825567|NCT04732182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101179228|NCT02297100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101825568|NCT04732182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825569|NCT04732182|Cholinergic Agents|cholinergic agents|mesh-ancestor
101825570|NCT04732182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101813198|NCT00967070|Cholinergic Agents|cholinergic agents|mesh-ancestor
101813199|NCT00967070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101813200|NCT00967070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813201|NCT00977756|Ritonavir|ritonavir|mesh-list
101813202|NCT00977756|Lopinavir|lopinavir|mesh-list
101813203|NCT00977756|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101813204|NCT00977756|Darunavir|darunavir|mesh-list
101813205|NCT00977756|Tenofovir|tenofovir|mesh-list
101813206|NCT00977756|Raltegravir Potassium|raltegravir potassium|mesh-list
101813207|NCT00977756|Maraviroc|maraviroc|mesh-list
101813208|NCT00977756|Etravirine|etravirine|mesh-list
101813209|NCT00977756|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101813210|NCT00977756|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101813211|NCT00977756|Protease Inhibitors|protease inhibitors|mesh-ancestor
101825571|NCT04732182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825573|NCT03783078|Pembrolizumab|pembrolizumab|mesh-list
101825574|NCT03783078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101825575|NCT03783078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101825576|NCT03783078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101825577|NCT03783078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825578|NCT01009476|Nicergoline|nicergoline|mesh-list
101825579|NCT01009476|Piracetam|piracetam|mesh-list
101825580|NCT01009476|Galantamine|galantamine|mesh-list
101825581|NCT01009476|Nootropic Agents|nootropic agents|mesh-list
101825582|NCT01009476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101825583|NCT01009476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101825584|NCT01009476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825585|NCT01009476|Cholinergic Agents|cholinergic agents|mesh-ancestor
101825586|NCT01009476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101825587|NCT01009476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825588|NCT01009476|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101825589|NCT01009476|Autonomic Agents|autonomic agents|mesh-ancestor
101825590|NCT01009476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101825591|NCT01009476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101825592|NCT01009476|Protective Agents|protective agents|mesh-ancestor
101825593|NCT01009476|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101825594|NCT01009476|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101825595|NCT01009476|Adrenergic Agents|adrenergic agents|mesh-ancestor
101825596|NCT01009476|Vasodilator Agents|vasodilator agents|mesh-ancestor
101825597|NCT00517296|Adalimumab|adalimumab|mesh-list
101825598|NCT00517296|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101825599|NCT00517296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101179419|NCT02374398|Tranexamic Acid|tranexamic acid|mesh-list
101825600|NCT00517296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101825601|NCT00516906|Chlorhexidine|chlorhexidine|mesh-list
101825602|NCT00516906|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101825603|NCT00516906|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101825604|NCT00516906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101825605|NCT00516906|Disinfectants|disinfectants|mesh-ancestor
101825606|NCT00516906|Dermatologic Agents|dermatologic agents|mesh-ancestor
101825607|NCT00523848|Thalidomide|thalidomide|mesh-list
101825608|NCT00523848|Doxorubicin|doxorubicin|mesh-list
101825609|NCT00523848|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101825610|NCT00523848|Bortezomib|bortezomib|mesh-list
101825611|NCT00523848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101825612|NCT00523848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101825613|NCT00523848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101825614|NCT00523848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101825615|NCT00523848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101825616|NCT00523848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825617|NCT00523848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101179559|NCT05718492|Vitamins|vitamins|mesh-ancestor
101825619|NCT00523848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825620|NCT00523848|Leprostatic Agents|leprostatic agents|mesh-ancestor
101825621|NCT00523848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101825622|NCT00523848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101813212|NCT00977756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101813213|NCT00977756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813214|NCT00977756|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101813215|NCT00977756|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101813216|NCT00977756|Antiviral Agents|antiviral agents|mesh-ancestor
101813217|NCT00977756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101813218|NCT00977756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101813219|NCT00977756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101813220|NCT00977756|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101813221|NCT00977756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101813222|NCT00977756|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101813223|NCT00977756|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101813224|NCT00977756|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101825623|NCT00523848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101825624|NCT00523848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101825625|NCT00523848|Growth Substances|growth substances|mesh-ancestor
101825626|NCT00523848|Growth Inhibitors|growth inhibitors|mesh-ancestor
101825628|NCT00617669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101179615|NCT05495568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101825629|NCT00617669|Tubulin Modulators|tubulin modulators|mesh-ancestor
101825630|NCT00617669|Antimitotic Agents|antimitotic agents|mesh-ancestor
101825631|NCT00617669|Mitosis Modulators|mitosis modulators|mesh-ancestor
101825632|NCT00617669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825633|NCT04018157|Dexmedetomidine|dexmedetomidine|mesh-list
101825635|NCT04018157|Propofol|propofol|mesh-list
101825636|NCT04018157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101825637|NCT04018157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101825638|NCT04018157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179686|NCT04547790|Psyllium|psyllium|mesh-list
101825639|NCT04018157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101825640|NCT04018157|Analgesics|analgesics|mesh-ancestor
101825641|NCT04018157|Sensory System Agents|sensory system agents|mesh-ancestor
101825642|NCT04018157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101825643|NCT04018157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101825644|NCT04018157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101825645|NCT04018157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101825646|NCT04018157|Adrenergic Agents|adrenergic agents|mesh-ancestor
101825647|NCT04018157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101825648|NCT04018157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179748|NCT02834052|Poly ICLC|poly iclc|mesh-list
101825649|NCT04018157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101825650|NCT04018157|Anesthetics, General|anesthetics, general|mesh-ancestor
101825651|NCT04018157|Anesthetics|anesthetics|mesh-ancestor
101825652|NCT04018157|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101825653|NCT04018157|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101825654|NCT04018157|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101825655|NCT00865241|Metformin|metformin|mesh-list
101825656|NCT00865241|Glyburide|glyburide|mesh-list
101825657|NCT00865241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101825658|NCT00865241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825659|NCT00863213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
101825660|NCT00860639|Gemtuzumab|gemtuzumab|mesh-list
101825661|NCT00860639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101825662|NCT00860639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101825663|NCT00860639|Immunotoxins|immunotoxins|mesh-ancestor
101825664|NCT00860639|Immunoconjugates|immunoconjugates|mesh-ancestor
101179813|NCT05722002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825665|NCT00860639|Immunologic Factors|immunologic factors|mesh-ancestor
101825666|NCT00860639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825667|NCT00863291|Buprenorphine|buprenorphine|mesh-list
101825668|NCT00863291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101813225|NCT00977756|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101813226|NCT00977756|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101813227|NCT00967148|Tinzaparin|tinzaparin|mesh-list
101813228|NCT00967148|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101813229|NCT00967148|Dalteparin|dalteparin|mesh-list
101813230|NCT00967148|Anticoagulants|anticoagulants|mesh-ancestor
101813231|NCT00967148|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101813232|NCT00967148|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101825669|NCT00863291|Narcotics|narcotics|mesh-ancestor
101825670|NCT00863291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101825671|NCT00863291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825672|NCT00863291|Analgesics|analgesics|mesh-ancestor
101825673|NCT00863291|Sensory System Agents|sensory system agents|mesh-ancestor
101334181|NCT00043147|Methylprednisolone|methylprednisolone|mesh-list
101825674|NCT00863291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101825675|NCT00863291|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101825676|NCT00865319|Deoxyglucose|deoxyglucose|mesh-list
101825677|NCT00865319|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101825678|NCT00865319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101179872|NCT05715840|Bevacizumab|bevacizumab|mesh-list
101825679|NCT00865319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825680|NCT00865319|Antimetabolites|antimetabolites|mesh-ancestor
101825681|NCT00865319|Antiviral Agents|antiviral agents|mesh-ancestor
101825682|NCT00865319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101825684|NCT03639714|Ipilimumab|ipilimumab|mesh-list
101825685|NCT03639714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101825686|NCT03639714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101825687|NCT03639714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101825688|NCT03639714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825689|NCT00861029|Moxifloxacin|moxifloxacin|mesh-list
101825690|NCT00861029|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101825691|NCT00861029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101825692|NCT00861029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101825693|NCT00861029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101825694|NCT00861029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101180003|NCT05312892|Vasodilator Agents|vasodilator agents|mesh-ancestor
101825696|NCT00861029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825697|NCT00861029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101825698|NCT00861029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101825699|NCT00861029|Contraceptive Agents|contraceptive agents|mesh-ancestor
101825700|NCT00861029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101825701|NCT00861029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825702|NCT00861029|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101825703|NCT00861029|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101825704|NCT00861029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101825705|NCT00865397|Insulin Detemir|insulin detemir|mesh-list
101825706|NCT00865397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101825707|NCT00865397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825708|NCT00861107|Vaccines|vaccines|mesh-list
101825709|NCT00861107|Immunologic Factors|immunologic factors|mesh-ancestor
101180068|NCT04988646|Acyclovir|acyclovir|mesh-list
101180071|NCT04924062|Cisplatin|cisplatin|mesh-list
101825710|NCT00861107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825711|NCT00510510|Glycopyrrolate|glycopyrrolate|mesh-list
101825712|NCT00510510|Bromides|bromides|mesh-list
101825713|NCT00510510|Anticonvulsants|anticonvulsants|mesh-ancestor
101825714|NCT00510510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101825715|NCT00510510|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101825716|NCT00510510|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101825717|NCT00510510|Cholinergic Agents|cholinergic agents|mesh-ancestor
101825718|NCT00510510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101180137|NCT04509414|Midazolam|midazolam|mesh-list
101825719|NCT00510510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825720|NCT00510510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825721|NCT04685694|Misoprostol|misoprostol|mesh-list
101825722|NCT04685694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101825723|NCT04685694|Abortifacient Agents|abortifacient agents|mesh-ancestor
101825724|NCT04685694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101825725|NCT04685694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813233|NCT00967148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813234|NCT04007588|Nivolumab|nivolumab|mesh-list
101813235|NCT04007588|Ipilimumab|ipilimumab|mesh-list
101813236|NCT04007588|Linrodostat|linrodostat|mesh-list
101813237|NCT04007588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101813238|NCT04007588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101813239|NCT04007588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101813240|NCT04007588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813241|NCT04007588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101813242|NCT00978146|Hydroxyurea|hydroxyurea|mesh-list
101813243|NCT00978146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101813244|NCT00978146|Antisickling Agents|antisickling agents|mesh-ancestor
101813245|NCT00978146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101813246|NCT00978146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813247|NCT00978146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101813248|NCT00981968|Sitaxsentan|sitaxsentan|mesh-list
101813249|NCT00981968|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101813250|NCT00981968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813251|NCT00982046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101813252|NCT00967382|Dalteparin|dalteparin|mesh-list
101813253|NCT00967382|Tinzaparin|tinzaparin|mesh-list
101813254|NCT00967382|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101813255|NCT00967382|Anticoagulants|anticoagulants|mesh-ancestor
101813256|NCT00967382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101813257|NCT00967382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101813258|NCT00967382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813259|NCT00982124|Zoledronic Acid|zoledronic acid|mesh-list
101813260|NCT00982124|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101813261|NCT00982124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813262|NCT00982202|Pioglitazone|pioglitazone|mesh-list
101813263|NCT00982202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101813264|NCT00982202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813265|NCT00967538|Etanercept|etanercept|mesh-list
101813266|NCT00967538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101813267|NCT00967538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101813272|NCT00967538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101813273|NCT00967538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101813274|NCT00967538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101813275|NCT00967538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101813276|NCT00967538|Immunologic Factors|immunologic factors|mesh-ancestor
101813277|NCT00982358|Valsartan|valsartan|mesh-list
101813278|NCT00982358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101813279|NCT00982358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101813280|NCT00982358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101813281|NCT00982358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825726|NCT04685694|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101825727|NCT04685694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101825728|NCT04685694|Oxytocics|oxytocics|mesh-ancestor
101825730|NCT00870311|Antidepressive Agents|antidepressive agents|mesh-ancestor
101825731|NCT00870311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101825732|NCT00870311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101825733|NCT00870311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825734|NCT00870311|Antimanic Agents|antimanic agents|mesh-ancestor
101825735|NCT00870311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101825736|NCT00870311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101825737|NCT00870311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825738|NCT00865631|Gabapentin|gabapentin|mesh-list
101825739|NCT00865631|Analgesics|analgesics|mesh-ancestor
101825740|NCT00865631|Sensory System Agents|sensory system agents|mesh-ancestor
101825741|NCT00865631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101825742|NCT00865631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825743|NCT00865631|Anticonvulsants|anticonvulsants|mesh-ancestor
101825744|NCT00865631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101825745|NCT00865631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101825746|NCT00865631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101825747|NCT00865631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101825748|NCT00865631|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101825749|NCT00865631|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101180260|NCT03778944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101180261|NCT03778944|Dopamine Agents|dopamine agents|mesh-ancestor
101180262|NCT03778944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101180263|NCT03778944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180264|NCT03778944|Protective Agents|protective agents|mesh-ancestor
101180265|NCT03653052|Durvalumab|durvalumab|mesh-list
101825750|NCT00865631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101825751|NCT00865631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825752|NCT00865631|Antimanic Agents|antimanic agents|mesh-ancestor
101825753|NCT00863837|Terlipressin|terlipressin|mesh-list
101825754|NCT00863837|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
101825755|NCT00863837|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101825756|NCT00863837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101825757|NCT00863837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825758|NCT00863837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101825759|NCT00863915|Ramipril|ramipril|mesh-list
101825760|NCT00863915|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101825761|NCT00863915|Protease Inhibitors|protease inhibitors|mesh-ancestor
101825762|NCT00863915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101825763|NCT00863915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825764|NCT00863915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101825766|NCT01009944|Lisinopril|lisinopril|mesh-list
101825767|NCT01009944|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101825768|NCT01009944|Protease Inhibitors|protease inhibitors|mesh-ancestor
101825769|NCT01009944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101825770|NCT01009944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825771|NCT01009944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101825772|NCT01009944|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101825773|NCT01009944|Protective Agents|protective agents|mesh-ancestor
101825774|NCT01009944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813282|NCT00982436|Carboplatin|carboplatin|mesh-list
101813283|NCT00982436|Docetaxel|docetaxel|mesh-list
101813284|NCT00982436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101813285|NCT00982436|Tubulin Modulators|tubulin modulators|mesh-ancestor
101813286|NCT00982436|Antimitotic Agents|antimitotic agents|mesh-ancestor
101813287|NCT00982436|Mitosis Modulators|mitosis modulators|mesh-ancestor
101813288|NCT00982436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813289|NCT00545168|Permethrin|permethrin|mesh-list
101813290|NCT00545168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101813291|NCT00545168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813292|NCT00984932|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101825775|NCT01009944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101825776|NCT01009944|Sympatholytics|sympatholytics|mesh-ancestor
101825777|NCT01009944|Autonomic Agents|autonomic agents|mesh-ancestor
101825778|NCT01009944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101180368|NCT03122262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825779|NCT01009944|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101825780|NCT01009944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101825781|NCT01009944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101825782|NCT01009944|Adrenergic Agents|adrenergic agents|mesh-ancestor
101825783|NCT01009944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101825784|NCT01010022|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
101825785|NCT01010022|Plasma Substitutes|plasma substitutes|mesh-ancestor
101825786|NCT01010022|Blood Substitutes|blood substitutes|mesh-ancestor
101825788|NCT00864071|Antifungal Agents|antifungal agents|mesh-ancestor
101825789|NCT00864071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101825790|NCT04264026|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
101825791|NCT04264026|Hallucinogens|hallucinogens|mesh-ancestor
101825792|NCT04264026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825793|NCT04264026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101825794|NCT04264026|Serotonin Agents|serotonin agents|mesh-ancestor
101825795|NCT04264026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101825796|NCT04264026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825797|NCT04264026|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101825798|NCT04264026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101825799|NCT04264026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101825800|NCT04264026|Adrenergic Agents|adrenergic agents|mesh-ancestor
101825801|NCT00864149|Carvedilol|carvedilol|mesh-list
101825802|NCT00864149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101825803|NCT00864149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101825804|NCT00864149|Adrenergic Agents|adrenergic agents|mesh-ancestor
101825805|NCT00864149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101825806|NCT00864149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825807|NCT00864149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825808|NCT00864149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101825810|NCT00864149|Protective Agents|protective agents|mesh-ancestor
101825811|NCT00864149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101825812|NCT00864149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101825813|NCT00864149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101825814|NCT00864149|Vasodilator Agents|vasodilator agents|mesh-ancestor
101180502|NCT00596154|Vincristine|vincristine|mesh-list
101825815|NCT00864149|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101825816|NCT00864149|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101825817|NCT01010100|Acarbose|acarbose|mesh-list
101825818|NCT01010100|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101825819|NCT01010100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101825820|NCT01010100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825821|NCT01010100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101825822|NCT01010100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825823|NCT00870779|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101825824|NCT00870779|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101825825|NCT00870779|Dermatologic Agents|dermatologic agents|mesh-ancestor
101825826|NCT01010178|Theophylline|theophylline|mesh-list
101813293|NCT00984932|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101813294|NCT00984932|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101813295|NCT00984932|Antimetabolites|antimetabolites|mesh-ancestor
101813296|NCT00984932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813297|NCT00984932|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101813298|NCT00984932|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101813299|NCT00984932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101813300|NCT00983138|Asparaginase|asparaginase|mesh-list
101813301|NCT00983138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101813302|NCT00544544|Riluzole|riluzole|mesh-list
101813303|NCT00544544|Anticonvulsants|anticonvulsants|mesh-ancestor
101813304|NCT00544544|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101180571|NCT02422290|Anesthetics|anesthetics|mesh-ancestor
101825827|NCT01010178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101825828|NCT01010178|Autonomic Agents|autonomic agents|mesh-ancestor
101825829|NCT01010178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101825830|NCT01010178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825831|NCT01010178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101825832|NCT01010178|Respiratory System Agents|respiratory system agents|mesh-ancestor
101825833|NCT01010178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101825834|NCT01010178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101825835|NCT01010178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825836|NCT01010178|Vasodilator Agents|vasodilator agents|mesh-ancestor
101825837|NCT01010178|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101825838|NCT01010178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101825839|NCT01010178|Purinergic Agents|purinergic agents|mesh-ancestor
101825840|NCT01010178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101825841|NCT00617591|Dexamethasone|dexamethasone|mesh-list
101825842|NCT00617591|Doxorubicin|doxorubicin|mesh-list
101825843|NCT00617591|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101825844|NCT00617591|Lenalidomide|lenalidomide|mesh-list
101825845|NCT00617591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101825846|NCT00617591|Antiemetics|antiemetics|mesh-ancestor
101825847|NCT00617591|Autonomic Agents|autonomic agents|mesh-ancestor
101825848|NCT00617591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101825849|NCT00617591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825850|NCT00617591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101825851|NCT00617591|Glucocorticoids|glucocorticoids|mesh-ancestor
101825852|NCT00617591|Hormones|hormones|mesh-ancestor
101825853|NCT00617591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101825854|NCT00617591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101825855|NCT00617591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101825856|NCT00617591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101825857|NCT00617591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101825858|NCT00617591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101825859|NCT00617591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101180682|NCT02464176|Hormones|hormones|mesh-ancestor
101825860|NCT00617591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825861|NCT00617591|Immunologic Factors|immunologic factors|mesh-ancestor
101825862|NCT00617591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101825863|NCT00617591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101825864|NCT00617591|Growth Substances|growth substances|mesh-ancestor
101825865|NCT00617591|Growth Inhibitors|growth inhibitors|mesh-ancestor
101825866|NCT00864305|Gabapentin|gabapentin|mesh-list
101825867|NCT00864305|Analgesics|analgesics|mesh-ancestor
101825868|NCT00864305|Sensory System Agents|sensory system agents|mesh-ancestor
101825869|NCT00864305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101825870|NCT00864305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825871|NCT00864305|Anticonvulsants|anticonvulsants|mesh-ancestor
101825872|NCT00864305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101825873|NCT00864305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101825874|NCT00864305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101825875|NCT00864305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101813305|NCT00544544|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101813306|NCT00544544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101813307|NCT00544544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813308|NCT00544544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813309|NCT00544544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101813310|NCT00544544|Protective Agents|protective agents|mesh-ancestor
101813311|NCT00979160|Dasatinib|dasatinib|mesh-list
101813312|NCT00979160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101825876|NCT00864305|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101180816|NCT02500602|Doxazosin|doxazosin|mesh-list
101825878|NCT00864305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101825879|NCT00864305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825880|NCT00864305|Antimanic Agents|antimanic agents|mesh-ancestor
101825881|NCT00510276|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101825882|NCT00510276|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101825883|NCT00510276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101825884|NCT00510276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101313231|NCT00008359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101825885|NCT00510276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825886|NCT00510276|Adrenergic Agents|adrenergic agents|mesh-ancestor
101825887|NCT00510276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101825888|NCT00510276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180948|NCT02530554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101825890|NCT00864617|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101825891|NCT00864617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101825892|NCT00864617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825893|NCT00864617|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101825894|NCT00864617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825895|NCT00864617|Vasodilator Agents|vasodilator agents|mesh-ancestor
101825896|NCT00864617|Tocolytic Agents|tocolytic agents|mesh-ancestor
101825897|NCT00864617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101825898|NCT00865943|Dexetimide|dexetimide|mesh-list
101825899|NCT00865943|Citalopram|citalopram|mesh-list
101825900|NCT00865943|Escitalopram|escitalopram|mesh-list
101825901|NCT00865943|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101825902|NCT00865943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101825903|NCT00865943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101825904|NCT00865943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825905|NCT00865943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101825906|NCT00865943|Serotonin Agents|serotonin agents|mesh-ancestor
101825907|NCT00865943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825908|NCT00865943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101483191|NCT00452660|Deferasirox|deferasirox|mesh-list
101825909|NCT00865943|Antidepressive Agents|antidepressive agents|mesh-ancestor
101825910|NCT00865943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101825911|NCT00865943|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101825912|NCT00865943|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101825913|NCT00865943|Parasympatholytics|parasympatholytics|mesh-ancestor
101825914|NCT00865943|Autonomic Agents|autonomic agents|mesh-ancestor
101825915|NCT00865943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101825916|NCT00865943|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101825917|NCT00865943|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101825918|NCT00865943|Cholinergic Agents|cholinergic agents|mesh-ancestor
101825919|NCT00866021|Ritonavir|ritonavir|mesh-list
101825920|NCT00866021|Lopinavir|lopinavir|mesh-list
101825921|NCT00866021|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101825922|NCT00866021|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101825923|NCT00866021|Protease Inhibitors|protease inhibitors|mesh-ancestor
101825924|NCT00866021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101181211|NCT05132166|Sirolimus|sirolimus|mesh-list
101181212|NCT05132166|Everolimus|everolimus|mesh-list
101825925|NCT00866021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825926|NCT00866021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101813313|NCT00979160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101813314|NCT00979160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101813315|NCT00979160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813316|NCT00979316|Moxifloxacin|moxifloxacin|mesh-list
101813317|NCT00979316|BMS 708163|bms 708163|mesh-list
101813318|NCT00979316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101813319|NCT00979316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101813320|NCT00979316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101813321|NCT00979316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101813322|NCT00979316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101813323|NCT00979316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813324|NCT00979316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101813325|NCT00979316|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101825927|NCT00866021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101825928|NCT00866021|Antiviral Agents|antiviral agents|mesh-ancestor
101825929|NCT00866021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101825930|NCT00866021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101825931|NCT00866021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101825932|NCT00871247|Finasteride|finasteride|mesh-list
101181278|NCT02056236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101825933|NCT00871247|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101825934|NCT00871247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101825935|NCT00871247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101825936|NCT00871247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825937|NCT00871247|Hormone Antagonists|hormone antagonists|mesh-ancestor
101825938|NCT00871247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101825939|NCT00871247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825940|NCT00871247|Urological Agents|urological agents|mesh-ancestor
101825942|NCT04137120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101825943|NCT04137120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101825944|NCT04137120|Growth Substances|growth substances|mesh-ancestor
101181345|NCT03376698|Gout Suppressants|gout suppressants|mesh-ancestor
101825945|NCT04137120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825946|NCT04137120|Growth Inhibitors|growth inhibitors|mesh-ancestor
101825947|NCT04137120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101825948|NCT00616655|Eszopiclone|eszopiclone|mesh-list
101825949|NCT00616655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101825950|NCT00616655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101825951|NCT00616655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825953|NCT00864773|Growth Substances|growth substances|mesh-ancestor
101825954|NCT00864773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825955|NCT01010490|Dipivefrin|dipivefrin|mesh-list
101825956|NCT01010490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101181405|NCT05730738|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101181406|NCT05730738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101181407|NCT05730738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181409|NCT05730660|Antioxidants|antioxidants|mesh-ancestor
101181410|NCT05730660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181411|NCT05730660|Protective Agents|protective agents|mesh-ancestor
101181412|NCT05730660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181426|NCT05419674|Amoxicillin|amoxicillin|mesh-list
101181427|NCT05419674|Clarithromycin|clarithromycin|mesh-list
101181428|NCT05419674|Rabeprazole|rabeprazole|mesh-list
101181429|NCT05419674|Bismuth|bismuth|mesh-list
101181430|NCT05419674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101181431|NCT05419674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101181433|NCT05419674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101825957|NCT01010490|Adrenergic Agents|adrenergic agents|mesh-ancestor
101813326|NCT00983450|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101813327|NCT00983450|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
101813329|NCT00983450|Hormones|hormones|mesh-ancestor
101813330|NCT00983450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101813331|NCT00983450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813332|NCT00983450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101825958|NCT01010490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101825959|NCT01010490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825960|NCT01010490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825962|NCT00516048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101825963|NCT00516048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825964|NCT00516048|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101825965|NCT00516048|Incretins|incretins|mesh-ancestor
101825966|NCT00516048|Hormones|hormones|mesh-ancestor
101825967|NCT00516048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101825968|NCT00871949|Oxazolidinones|oxazolidinones|mesh-list
101825969|NCT00871949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101334208|NCT00043264|Rifampin|rifampin|mesh-list
101825970|NCT00871949|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101825971|NCT00871949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101825972|NCT00871949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825973|NCT00865007|Ritonavir|ritonavir|mesh-list
101825974|NCT00865007|Lopinavir|lopinavir|mesh-list
101825975|NCT00865007|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101825976|NCT00865007|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101825977|NCT00865007|Protease Inhibitors|protease inhibitors|mesh-ancestor
101825978|NCT00865007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101825979|NCT00865007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825980|NCT00865007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101825981|NCT00865007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101825982|NCT00865007|Antiviral Agents|antiviral agents|mesh-ancestor
101483275|NCT00335205|Ropinirole|ropinirole|mesh-list
101825983|NCT00865007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101181471|NCT04355130|Vitamin B 12|vitamin b 12|mesh-list
101825984|NCT00865007|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101825985|NCT00865007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101825986|NCT00872417|Lamivudine|lamivudine|mesh-list
101825987|NCT00872417|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101825988|NCT00872417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101825989|NCT00872417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101825990|NCT00872417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181522|NCT02960646|Melphalan|melphalan|mesh-list
101825991|NCT00872417|Antiviral Agents|antiviral agents|mesh-ancestor
101825992|NCT00872417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101825993|NCT00872417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101825994|NCT00872417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101825995|NCT00876317|Etoricoxib|etoricoxib|mesh-list
101825996|NCT00876317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101825997|NCT00876317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101825998|NCT00876317|Analgesics|analgesics|mesh-ancestor
101825999|NCT00876317|Sensory System Agents|sensory system agents|mesh-ancestor
101826000|NCT00876317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101826001|NCT00876317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826002|NCT00876317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101826003|NCT00876317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101826004|NCT00876317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101826005|NCT00876317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101826006|NCT00876317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101826007|NCT00876317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826008|NCT00866645|Haloperidol|haloperidol|mesh-list
101181652|NCT02634684|Adrenergic Agents|adrenergic agents|mesh-ancestor
101826009|NCT00866645|Haloperidol decanoate|haloperidol decanoate|mesh-list
101826011|NCT00866645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101826012|NCT00866645|Antiemetics|antiemetics|mesh-ancestor
101826013|NCT00866645|Autonomic Agents|autonomic agents|mesh-ancestor
101813333|NCT00983450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813334|NCT00983996|Alendronate|alendronate|mesh-list
101813335|NCT00983996|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101813336|NCT00983996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813337|NCT00985244|Azithromycin|azithromycin|mesh-list
101813338|NCT00985244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101813339|NCT00985244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101826014|NCT00866645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101826015|NCT00866645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826016|NCT00866645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101826017|NCT00866645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101826018|NCT00866645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101826019|NCT00866645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101826020|NCT00866645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101826021|NCT00866645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101826022|NCT00866645|Dopamine Agents|dopamine agents|mesh-ancestor
101826023|NCT00866645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101826024|NCT00866645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826025|NCT00866645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101826026|NCT00866645|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101826027|NCT00866645|Antidepressive Agents|antidepressive agents|mesh-ancestor
101826028|NCT00872651|Timolol|timolol|mesh-list
101826029|NCT00872651|Travoprost|travoprost|mesh-list
101826030|NCT00872651|Latanoprost|latanoprost|mesh-list
101826031|NCT00872651|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101826032|NCT00872651|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101826033|NCT00872651|Adrenergic Agents|adrenergic agents|mesh-ancestor
101826034|NCT00872651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101826035|NCT00872651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826036|NCT00872651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826037|NCT00872651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101826038|NCT00872651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101826039|NCT00872651|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101826040|NCT00872651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101826042|NCT00872963|Immunologic Factors|immunologic factors|mesh-ancestor
101181993|NCT02695290|Afatinib|afatinib|mesh-list
101826043|NCT00872963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826044|NCT00873197|Granisetron|granisetron|mesh-list
101826045|NCT00873197|Antiemetics|antiemetics|mesh-ancestor
101826046|NCT00873197|Autonomic Agents|autonomic agents|mesh-ancestor
101826047|NCT00873197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101826048|NCT00873197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826049|NCT00873197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101826050|NCT00873197|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101826051|NCT00873197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101826052|NCT00873197|Serotonin Agents|serotonin agents|mesh-ancestor
101826053|NCT00873197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101826054|NCT00873197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826055|NCT00873353|Capecitabine|capecitabine|mesh-list
101826056|NCT00873353|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101826057|NCT00873353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101826058|NCT00873353|Antimetabolites|antimetabolites|mesh-ancestor
101826059|NCT00873353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826060|NCT00873353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101826061|NCT00873353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101826062|NCT00873353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101826063|NCT00877097|Clodronic Acid|clodronic acid|mesh-list
101826064|NCT00877097|Trisequens|trisequens|mesh-list
101826065|NCT00877097|Norethindrone|norethindrone|mesh-list
101182120|NCT05444088|Bevacizumab|bevacizumab|mesh-list
101826066|NCT00877097|Estradiol|estradiol|mesh-list
101826067|NCT00877097|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101826068|NCT00877097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826069|NCT00877097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101813340|NCT00979472|Solifenacin Succinate|solifenacin succinate|mesh-list
101813341|NCT00979472|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101813342|NCT00979472|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101813343|NCT00979472|Cholinergic Agents|cholinergic agents|mesh-ancestor
101813344|NCT00979472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101813345|NCT00979472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813346|NCT00979472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813347|NCT00979472|Urological Agents|urological agents|mesh-ancestor
101813348|NCT00984152|Efavirenz|efavirenz|mesh-list
101813349|NCT00984152|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101813350|NCT00984152|Raltegravir Potassium|raltegravir potassium|mesh-list
101826070|NCT00877097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101826071|NCT00877097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101826072|NCT00877097|Contraceptive Agents|contraceptive agents|mesh-ancestor
101826073|NCT00877097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101826074|NCT00877097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101826075|NCT00877097|Estrogens|estrogens|mesh-ancestor
101826076|NCT00877097|Hormones|hormones|mesh-ancestor
101826077|NCT00877097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101826078|NCT00877097|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101826079|NCT00877175|Phenylephrine|phenylephrine|mesh-list
101826080|NCT00877175|Oxymetazoline|oxymetazoline|mesh-list
101826081|NCT00877175|Tropicamide|tropicamide|mesh-list
101826082|NCT00877175|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101826083|NCT00877175|Mydriatics|mydriatics|mesh-ancestor
101826084|NCT00877175|Autonomic Agents|autonomic agents|mesh-ancestor
101826085|NCT00877175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101182244|NCT04495608|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101182248|NCT03770130|Dexmedetomidine|dexmedetomidine|mesh-list
101182249|NCT03770130|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101826086|NCT00877175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826087|NCT00877175|Sympathomimetics|sympathomimetics|mesh-ancestor
101826088|NCT00877175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101826089|NCT00877175|Nasal Decongestants|nasal decongestants|mesh-ancestor
101313252|NCT00008554|Lamivudine|lamivudine|mesh-list
101826090|NCT00877175|Respiratory System Agents|respiratory system agents|mesh-ancestor
101826091|NCT00877175|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101826092|NCT00877175|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101826094|NCT00877175|Adrenergic Agents|adrenergic agents|mesh-ancestor
101826095|NCT00877175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101826096|NCT00877175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826097|NCT00877175|Protective Agents|protective agents|mesh-ancestor
101826098|NCT00877175|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101826099|NCT00877175|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101826100|NCT00877175|Cholinergic Agents|cholinergic agents|mesh-ancestor
101826102|NCT00420927|Methotrexate|methotrexate|mesh-list
101826103|NCT00420927|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101826104|NCT00420927|Abortifacient Agents|abortifacient agents|mesh-ancestor
101826105|NCT00420927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101826106|NCT00420927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826107|NCT00420927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101826108|NCT00420927|Antimetabolites|antimetabolites|mesh-ancestor
101826109|NCT00420927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826110|NCT00420927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101826111|NCT00420927|Dermatologic Agents|dermatologic agents|mesh-ancestor
101826112|NCT00420927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101826113|NCT00420927|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101826114|NCT00420927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101826115|NCT00420927|Immunologic Factors|immunologic factors|mesh-ancestor
101826116|NCT00420927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101826117|NCT00420927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101826118|NCT00420927|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101813351|NCT00984152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101813352|NCT00984152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101813354|NCT00984152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813356|NCT00984152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101813357|NCT00984152|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101826119|NCT00420927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101826120|NCT00573443|Quinidine|quinidine|mesh-list
101826121|NCT00573443|Quinidine gluconate|quinidine gluconate|mesh-list
101182506|NCT03341676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101826123|NCT00573443|Antitussive Agents|antitussive agents|mesh-ancestor
101826124|NCT00573443|Respiratory System Agents|respiratory system agents|mesh-ancestor
101826125|NCT00573443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101826126|NCT00573443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101826127|NCT00573443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101826128|NCT00573443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826129|NCT00573443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826130|NCT00573443|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101826131|NCT00573443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101826132|NCT00573443|Adrenergic Agents|adrenergic agents|mesh-ancestor
101826133|NCT00573443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101826134|NCT00573443|Antimalarials|antimalarials|mesh-ancestor
101826135|NCT00573443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101826136|NCT00573443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101826137|NCT00573443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101826138|NCT00573443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101826139|NCT00573443|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101826140|NCT00573443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101826141|NCT00573443|Cholinergic Agents|cholinergic agents|mesh-ancestor
101826142|NCT00573443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101826143|NCT00573443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101826144|NCT00573443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101826145|NCT00573443|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101826146|NCT00573443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101826147|NCT05225831|Cyclophosphamide|cyclophosphamide|mesh-list
101826149|NCT05225831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101826150|NCT05225831|Immunologic Factors|immunologic factors|mesh-ancestor
101826151|NCT05225831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826152|NCT05225831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101826153|NCT05225831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101826154|NCT05225831|Alkylating Agents|alkylating agents|mesh-ancestor
101826155|NCT05225831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826156|NCT05225831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101826157|NCT05225831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101826158|NCT00873509|Buspirone|buspirone|mesh-list
101826159|NCT00873509|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101826160|NCT00873509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101826161|NCT00873509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101826162|NCT00873509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826163|NCT00873509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101826164|NCT00873509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101826165|NCT00873509|Serotonin Agents|serotonin agents|mesh-ancestor
101826166|NCT00873509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101826167|NCT00873509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826168|NCT00877253|Carboplatin|carboplatin|mesh-list
101826169|NCT00877253|genexol-PM|genexol-pm|mesh-list
101826170|NCT00877253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101826171|NCT00877253|Tubulin Modulators|tubulin modulators|mesh-ancestor
101826173|NCT00877253|Mitosis Modulators|mitosis modulators|mesh-ancestor
101826174|NCT00877253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826175|NCT05225753|Chrysarobin|chrysarobin|mesh-list
101826176|NCT05225753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101826177|NCT05225753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101826178|NCT05225753|Analgesics|analgesics|mesh-ancestor
101813358|NCT00984152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101813359|NCT00984152|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101813360|NCT00984152|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101813361|NCT00984152|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101813362|NCT00984152|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101813363|NCT00984152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101813364|NCT00984152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101813365|NCT00984152|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101813366|NCT00984152|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101813367|NCT00985322|Ramipril|ramipril|mesh-list
101813368|NCT00985322|Antihypertensive Agents|antihypertensive agents|mesh-list
101813369|NCT00985322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101813370|NCT00985322|Protease Inhibitors|protease inhibitors|mesh-ancestor
101813371|NCT00985322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101813372|NCT00985322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813373|NCT00984230|Lactoferrin|lactoferrin|mesh-list
101826179|NCT05225753|Sensory System Agents|sensory system agents|mesh-ancestor
101826180|NCT05225753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101182827|NCT04040790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826181|NCT05225753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826182|NCT05225753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101826183|NCT05225753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101826184|NCT00877409|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101826185|NCT00877409|Dermatologic Agents|dermatologic agents|mesh-ancestor
101826186|NCT00874133|Domperidone|domperidone|mesh-list
101826187|NCT00874133|Antiemetics|antiemetics|mesh-ancestor
101826188|NCT00874133|Autonomic Agents|autonomic agents|mesh-ancestor
101826189|NCT00874133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101826190|NCT00874133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826191|NCT00874133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101826192|NCT00874133|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101826193|NCT00874133|Dopamine Agents|dopamine agents|mesh-ancestor
101826194|NCT00874133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101826195|NCT00874133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826196|NCT00867737|Fluticasone|fluticasone|mesh-list
101826197|NCT00867737|Budesonide|budesonide|mesh-list
101182904|NCT02796144|Metformin|metformin|mesh-list
101826198|NCT00867737|Formoterol Fumarate|formoterol fumarate|mesh-list
101826199|NCT00867737|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101826200|NCT00867737|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101826201|NCT00867737|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101826202|NCT00867737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101826203|NCT00867737|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101826204|NCT00867737|Autonomic Agents|autonomic agents|mesh-ancestor
101182952|NCT02835846|Estrogens|estrogens|mesh-list
101826205|NCT00867737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101826206|NCT00867737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826207|NCT00867737|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101826209|NCT00867737|Dermatologic Agents|dermatologic agents|mesh-ancestor
101826210|NCT00867737|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101826211|NCT00867737|Glucocorticoids|glucocorticoids|mesh-ancestor
101826213|NCT00867737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101826214|NCT00867737|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101826215|NCT00867737|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101183016|NCT02864706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101826216|NCT00867737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101826217|NCT00867737|Adrenergic Agents|adrenergic agents|mesh-ancestor
101813374|NCT00984230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101813375|NCT00984386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101813376|NCT00984386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101813377|NCT00984386|Estradiol|estradiol|mesh-list
101813378|NCT00984386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101813379|NCT00984386|Estrogens|estrogens|mesh-ancestor
101813380|NCT00984386|Hormones|hormones|mesh-ancestor
101813381|NCT00984386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101813382|NCT00984386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813383|NCT00984386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101826218|NCT00867737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101826219|NCT00867737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826220|NCT00867737|Sympathomimetics|sympathomimetics|mesh-ancestor
101826221|NCT04551677|Vaccines|vaccines|mesh-list
101826222|NCT04551677|Immunologic Factors|immunologic factors|mesh-ancestor
101826223|NCT04551677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826224|NCT04040465|Aspirin|aspirin|mesh-list
101826225|NCT04040465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101826226|NCT04040465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101826227|NCT04040465|Analgesics|analgesics|mesh-ancestor
101826228|NCT04040465|Sensory System Agents|sensory system agents|mesh-ancestor
101826229|NCT04040465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101826230|NCT04040465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826232|NCT04040465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101826233|NCT04040465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101826234|NCT04040465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101826235|NCT04040465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826236|NCT04040465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101826237|NCT04040465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101826238|NCT04040465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101826239|NCT04040465|Antipyretics|antipyretics|mesh-ancestor
101826240|NCT00420849|Dexamethasone|dexamethasone|mesh-list
101826241|NCT00420849|Lenalidomide|lenalidomide|mesh-list
101826242|NCT00420849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101826243|NCT00420849|Antiemetics|antiemetics|mesh-ancestor
101826244|NCT00420849|Autonomic Agents|autonomic agents|mesh-ancestor
101826245|NCT00420849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101826246|NCT00420849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826247|NCT00420849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101826248|NCT00420849|Glucocorticoids|glucocorticoids|mesh-ancestor
101826249|NCT00420849|Hormones|hormones|mesh-ancestor
101826250|NCT00420849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101826251|NCT00420849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101826252|NCT00420849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101826253|NCT00420849|Immunologic Factors|immunologic factors|mesh-ancestor
101826254|NCT00420849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101826255|NCT00420849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101826256|NCT00420849|Growth Substances|growth substances|mesh-ancestor
101826257|NCT00420849|Growth Inhibitors|growth inhibitors|mesh-ancestor
101826258|NCT00874523|Raltegravir Potassium|raltegravir potassium|mesh-list
101826259|NCT00874523|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101826260|NCT00874523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101826262|NCT00874523|Antiviral Agents|antiviral agents|mesh-ancestor
101826263|NCT00874523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101826264|NCT00874523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101826265|NCT00874523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101826266|NCT00874523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101826267|NCT00874523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826268|NCT00874523|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101826269|NCT00874523|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101826270|NCT00874523|Protease Inhibitors|protease inhibitors|mesh-ancestor
101826271|NCT00874601|Valsartan|valsartan|mesh-list
101826272|NCT00874601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101826273|NCT00874601|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101826274|NCT00874601|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101813384|NCT00984386|Contraceptive Agents|contraceptive agents|mesh-ancestor
101813385|NCT00984386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101813386|NCT00984386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101813388|NCT00984464|Carboplatin|carboplatin|mesh-list
101813389|NCT00984464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101813390|NCT00984464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101813391|NCT00984464|Tubulin Modulators|tubulin modulators|mesh-ancestor
101813392|NCT00984464|Antimitotic Agents|antimitotic agents|mesh-ancestor
101813393|NCT00984464|Mitosis Modulators|mitosis modulators|mesh-ancestor
101813394|NCT00984464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813395|NCT00985556|Capecitabine|capecitabine|mesh-list
101813396|NCT00985556|Tegafur|tegafur|mesh-list
101813397|NCT00985556|Oxaliplatin|oxaliplatin|mesh-list
101813398|NCT00985556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101813399|NCT00985556|Antimetabolites|antimetabolites|mesh-ancestor
101813400|NCT00985556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813401|NCT00985556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101813402|NCT04445246|Iloprost|iloprost|mesh-list
101813403|NCT04445246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101826275|NCT00874601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826276|NCT00874679|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101826277|NCT00874679|Vasodilator Agents|vasodilator agents|mesh-ancestor
101826278|NCT00874679|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101826279|NCT00874679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101826280|NCT00874679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101483552|NCT00336960|Celecoxib|celecoxib|mesh-list
101826281|NCT00874679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826282|NCT00874679|Urological Agents|urological agents|mesh-ancestor
101826283|NCT00617201|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101826284|NCT00617201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101826285|NCT00617201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101313264|NCT00008554|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101826286|NCT00617201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101183261|NCT02956122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101826287|NCT00617201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826288|NCT00617201|Adrenergic Agents|adrenergic agents|mesh-ancestor
101826289|NCT00617201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101826290|NCT00617201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826292|NCT00420303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101826293|NCT00420303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101826295|NCT00420303|Sensory System Agents|sensory system agents|mesh-ancestor
101826296|NCT00420303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101826297|NCT00420303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826298|NCT00420303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101826299|NCT00420303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101826300|NCT00420303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101826301|NCT00420303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101826302|NCT00420303|Immunologic Factors|immunologic factors|mesh-ancestor
101826303|NCT00617123|Vorapaxar|vorapaxar|mesh-list
101826304|NCT00617123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101826305|NCT00877955|Alprazolam|alprazolam|mesh-list
101826306|NCT00877955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101813405|NCT00541346|Methylphenidate|methylphenidate|mesh-list
101813406|NCT00541346|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101813407|NCT00541346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813408|NCT00541346|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101813409|NCT00541346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101813410|NCT00541346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101813411|NCT00541346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813412|NCT00541346|Dopamine Agents|dopamine agents|mesh-ancestor
101813413|NCT00541346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101826307|NCT00877955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101826308|NCT00877955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826309|NCT00877955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101183307|NCT02970552|Progesterone|progesterone|mesh-list
101826310|NCT00877955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101826311|NCT00877955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101826312|NCT00877955|GABA Modulators|gaba modulators|mesh-ancestor
101826313|NCT00877955|GABA Agents|gaba agents|mesh-ancestor
101826314|NCT00877955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101826315|NCT00877955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826316|NCT00419757|Budesonide|budesonide|mesh-list
101826317|NCT00419757|Formoterol Fumarate|formoterol fumarate|mesh-list
101826318|NCT00419757|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101826319|NCT00419757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101826320|NCT00419757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101826321|NCT00419757|Autonomic Agents|autonomic agents|mesh-ancestor
101826322|NCT00419757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101826323|NCT00419757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826324|NCT00419757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101826325|NCT00419757|Respiratory System Agents|respiratory system agents|mesh-ancestor
101826326|NCT00419757|Glucocorticoids|glucocorticoids|mesh-ancestor
101826327|NCT00419757|Hormones|hormones|mesh-ancestor
101826328|NCT00419757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101826329|NCT00419757|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101826330|NCT00419757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101826331|NCT00419757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101826332|NCT00419757|Adrenergic Agents|adrenergic agents|mesh-ancestor
101183358|NCT03017508|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101826333|NCT00419757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101826334|NCT00419757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826335|NCT00434109|Sunitinib|sunitinib|mesh-list
101826336|NCT00434109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101826337|NCT00434109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101826338|NCT00434109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101826339|NCT00434109|Growth Substances|growth substances|mesh-ancestor
101826340|NCT00434109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826341|NCT00434109|Growth Inhibitors|growth inhibitors|mesh-ancestor
101826342|NCT00434109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101826343|NCT00434109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101826344|NCT00434109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826345|NCT00875069|Ethanol|ethanol|mesh-list
101826346|NCT00875069|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101826347|NCT00875069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101826348|NCT00875069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101826349|NCT00875069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826350|NCT01029639|Insulin|insulin|mesh-list
101826351|NCT01029639|Insulin Aspart|insulin aspart|mesh-list
101826352|NCT01029639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101826353|NCT01029639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101183477|NCT03061812|Glucocorticoids|glucocorticoids|mesh-ancestor
101813414|NCT00988520|Bromides|bromides|mesh-list
101813415|NCT00988520|Propofol|propofol|mesh-list
101813416|NCT00988520|Sevoflurane|sevoflurane|mesh-list
101813417|NCT00988520|Rocuronium|rocuronium|mesh-list
101813418|NCT00988520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101813419|NCT00988520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101813420|NCT00988520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813421|NCT00988520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101813422|NCT00988520|Anesthetics, General|anesthetics, general|mesh-ancestor
101813423|NCT00988520|Anesthetics|anesthetics|mesh-ancestor
101813424|NCT00988520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101813425|NCT00988520|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101813426|NCT00988520|Anticonvulsants|anticonvulsants|mesh-ancestor
101813427|NCT00988520|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101826354|NCT01029639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826355|NCT00875147|Bevacizumab|bevacizumab|mesh-list
101313283|NCT05636566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101826356|NCT00875147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101826357|NCT00875147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101826358|NCT00875147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101826359|NCT00875147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101183545|NCT03096444|Lidocaine|lidocaine|mesh-list
101826360|NCT00875147|Growth Substances|growth substances|mesh-ancestor
101826361|NCT00875147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826362|NCT00875147|Growth Inhibitors|growth inhibitors|mesh-ancestor
101826364|NCT00433329|Sildenafil Citrate|sildenafil citrate|mesh-list
101826365|NCT00433329|Vasodilator Agents|vasodilator agents|mesh-ancestor
101826366|NCT00433329|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101826367|NCT00433329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101826368|NCT00433329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101826369|NCT00433329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826370|NCT00433329|Urological Agents|urological agents|mesh-ancestor
101826371|NCT00433329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101826372|NCT00433329|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101826373|NCT01035021|Rocuronium|rocuronium|mesh-list
101826374|NCT01035021|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101826375|NCT01035021|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101183605|NCT03177798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101826376|NCT01035021|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101826377|NCT01035021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101826378|NCT01035021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826379|NCT00878345|Pentobarbital|pentobarbital|mesh-list
101826380|NCT00878345|Dexmedetomidine|dexmedetomidine|mesh-list
101826381|NCT00878345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101826382|NCT00878345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101826383|NCT00878345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826384|NCT00878345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101826385|NCT00878345|Analgesics|analgesics|mesh-ancestor
101183662|NCT04601532|Coccidiostats|coccidiostats|mesh-ancestor
101826387|NCT00878345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101826388|NCT00878345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101826389|NCT00878345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101826390|NCT00878345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101826391|NCT00878345|Adrenergic Agents|adrenergic agents|mesh-ancestor
101826392|NCT00878345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101826393|NCT00878345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826394|NCT00878345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101826395|NCT00878345|GABA Modulators|gaba modulators|mesh-ancestor
101826396|NCT00878345|GABA Agents|gaba agents|mesh-ancestor
101826397|NCT00433017|Ranibizumab|ranibizumab|mesh-list
101826398|NCT00433017|Verteporfin|verteporfin|mesh-list
101813428|NCT00988520|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101813429|NCT00988520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101813430|NCT00988520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101813432|NCT05498090|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101813433|NCT05498090|Antimetabolites|antimetabolites|mesh-ancestor
101813434|NCT05498090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813435|NCT05498090|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101813436|NCT00077623|Epoetin Alfa|epoetin alfa|mesh-list
101813437|NCT00077623|Hematinics|hematinics|mesh-ancestor
101813438|NCT00541034|Cyclophosphamide|cyclophosphamide|mesh-list
101813439|NCT00541034|Rituximab|rituximab|mesh-list
101813440|NCT00541034|Pentostatin|pentostatin|mesh-list
101813441|NCT00541034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101813442|NCT00541034|Immunologic Factors|immunologic factors|mesh-ancestor
101813443|NCT00541034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826399|NCT00433017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101826400|NCT00433017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101826401|NCT00433017|Growth Substances|growth substances|mesh-ancestor
101826402|NCT00433017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826403|NCT00433017|Growth Inhibitors|growth inhibitors|mesh-ancestor
101826404|NCT00433017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101826405|NCT00433017|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101826406|NCT00433017|Dermatologic Agents|dermatologic agents|mesh-ancestor
101826407|NCT03726671|Choline|choline|mesh-list
101826408|NCT03726671|Lipotropic Agents|lipotropic agents|mesh-ancestor
101826409|NCT03726671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101826410|NCT03726671|Antimetabolites|antimetabolites|mesh-ancestor
101826411|NCT03726671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826412|NCT03726671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101826413|NCT03726671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101826414|NCT03726671|Nootropic Agents|nootropic agents|mesh-ancestor
101826415|NCT00868283|Cerebrolysin|cerebrolysin|mesh-list
101826416|NCT00868283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101826417|NCT00868283|Protective Agents|protective agents|mesh-ancestor
101826418|NCT00868283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826419|NCT00868283|Nootropic Agents|nootropic agents|mesh-ancestor
101826420|NCT04039373|Mycophenolic Acid|mycophenolic acid|mesh-list
101826421|NCT04039373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101826422|NCT04039373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101826423|NCT04039373|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101826424|NCT04039373|Antitubercular Agents|antitubercular agents|mesh-ancestor
101826425|NCT04039373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101826426|NCT04039373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101826427|NCT04039373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101826428|NCT04039373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826430|NCT00875537|Antipruritics|antipruritics|mesh-ancestor
101826431|NCT00875537|Dermatologic Agents|dermatologic agents|mesh-ancestor
101826432|NCT00875537|Sensory System Agents|sensory system agents|mesh-ancestor
101826433|NCT00875537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101826434|NCT00875537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826435|NCT00875771|Bevacizumab|bevacizumab|mesh-list
101826436|NCT00875771|Capecitabine|capecitabine|mesh-list
101826437|NCT00875771|Irinotecan|irinotecan|mesh-list
101826438|NCT00875771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101826439|NCT00875771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101826440|NCT00875771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101826441|NCT00875771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101826442|NCT00875771|Growth Substances|growth substances|mesh-ancestor
101813444|NCT00541034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101813445|NCT00541034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101813446|NCT00541034|Alkylating Agents|alkylating agents|mesh-ancestor
101813447|NCT00541034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813448|NCT00541034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101813449|NCT00541034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101813450|NCT00541034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101813451|NCT00541034|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
101813452|NCT00541034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101813454|NCT00540644|Cyclophosphamide|cyclophosphamide|mesh-list
101813455|NCT00540644|Lenalidomide|lenalidomide|mesh-list
101813456|NCT00540644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101813457|NCT00540644|Immunologic Factors|immunologic factors|mesh-ancestor
101813458|NCT00540644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813459|NCT00540644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101813460|NCT00540644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101813461|NCT00540644|Alkylating Agents|alkylating agents|mesh-ancestor
101813462|NCT00540644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813463|NCT00540644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101813464|NCT00540644|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101813465|NCT00540644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101813466|NCT00540644|Glucocorticoids|glucocorticoids|mesh-ancestor
101813467|NCT00540644|Hormones|hormones|mesh-ancestor
101813468|NCT00540644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101826443|NCT00875771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826444|NCT00875771|Growth Inhibitors|growth inhibitors|mesh-ancestor
101826445|NCT00875771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101826446|NCT00875771|Antimetabolites|antimetabolites|mesh-ancestor
101826447|NCT00875771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826448|NCT00875771|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101826449|NCT00875771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101826450|NCT00875771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101826452|NCT00875849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101826453|NCT00875849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101826454|NCT00875927|Zinc|zinc|mesh-list
101826455|NCT00875927|Propolis|propolis|mesh-list
101826456|NCT00875927|Trace Elements|trace elements|mesh-ancestor
101826457|NCT00875927|Micronutrients|micronutrients|mesh-ancestor
101826458|NCT00875927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826459|NCT00875927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101826460|NCT00878657|Gemcitabine|gemcitabine|mesh-list
101826461|NCT00878657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101826462|NCT00878657|Antimetabolites|antimetabolites|mesh-ancestor
101826463|NCT00878657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826464|NCT00878657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101826465|NCT00868829|Chromium|chromium|mesh-list
101826466|NCT00868829|Sirolimus|sirolimus|mesh-list
101826467|NCT00868829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101813469|NCT00540644|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101813470|NCT00540644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101813471|NCT00540644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101813472|NCT00540644|Growth Substances|growth substances|mesh-ancestor
101813473|NCT00540644|Growth Inhibitors|growth inhibitors|mesh-ancestor
101813474|NCT05470400|Vaccines|vaccines|mesh-list
101813475|NCT05470400|Immunologic Factors|immunologic factors|mesh-ancestor
101813476|NCT05470400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813477|NCT05450900|Biotin|biotin|mesh-list
101813478|NCT05450900|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101813479|NCT05450900|Vitamins|vitamins|mesh-ancestor
101813480|NCT05450900|Micronutrients|micronutrients|mesh-ancestor
101826468|NCT00868829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101826469|NCT00868829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101826470|NCT00868829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101826471|NCT00868829|Antifungal Agents|antifungal agents|mesh-ancestor
101826472|NCT00868829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101826473|NCT00868829|Immunologic Factors|immunologic factors|mesh-ancestor
101826474|NCT00868829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826475|NCT00868829|Trace Elements|trace elements|mesh-ancestor
101826476|NCT00868829|Micronutrients|micronutrients|mesh-ancestor
101826477|NCT00868907|Risedronic Acid|risedronic acid|mesh-list
101826478|NCT00868907|Etidronic Acid|etidronic acid|mesh-list
101183953|NCT03375294|Nitrous Oxide|nitrous oxide|mesh-list
101826479|NCT00868907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101826480|NCT00868907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101826481|NCT00868907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826482|NCT00868907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101826483|NCT00868907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826484|NCT00868907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101826485|NCT00868985|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101826486|NCT00868985|Laxatives|laxatives|mesh-ancestor
101826487|NCT00868985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101826488|NCT00869063|Diclofenac|diclofenac|mesh-list
101826489|NCT00869063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101826490|NCT00869063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101826491|NCT00869063|Analgesics|analgesics|mesh-ancestor
101826492|NCT00869063|Sensory System Agents|sensory system agents|mesh-ancestor
101313297|NCT05637073|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101826493|NCT00869063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101826494|NCT00869063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826495|NCT00869063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101826496|NCT00869063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101184076|NCT03503292|Serotonin Agents|serotonin agents|mesh-ancestor
101826497|NCT00869063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101826498|NCT00869063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101826499|NCT00869063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826500|NCT00869219|Nepafenac|nepafenac|mesh-list
101826501|NCT00869219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101826502|NCT00869219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101826503|NCT00869219|Analgesics|analgesics|mesh-ancestor
101826504|NCT00869219|Sensory System Agents|sensory system agents|mesh-ancestor
101826505|NCT00869219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101184138|NCT03574818|Gemcitabine|gemcitabine|mesh-list
101184139|NCT03574818|Necitumumab|necitumumab|mesh-list
101826506|NCT00869219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826507|NCT00869219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101826508|NCT00869219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101826510|NCT03994965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101826511|NCT03994965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101826512|NCT03994965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101826513|NCT03994965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101826514|NCT03994965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101826515|NCT03994965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813481|NCT05450900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813482|NCT05450900|Vitamin B Complex|vitamin b complex|mesh-ancestor
101813483|NCT05450900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101813484|NCT00988910|Contraceptive Agents|contraceptive agents|mesh-list
101813485|NCT00988910|Contraceptives, Oral|contraceptives, oral|mesh-list
101813486|NCT00988910|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
101813487|NCT00988910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101813488|NCT00988910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813489|NCT00988910|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101813491|NCT00986336|Risperidone|risperidone|mesh-list
101826516|NCT03994965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101826517|NCT03994965|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101826518|NCT03994965|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101826519|NCT03994965|Serotonin Agents|serotonin agents|mesh-ancestor
101826520|NCT03994965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101826521|NCT03994965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826522|NCT00531284|Dexamethasone|dexamethasone|mesh-list
101826523|NCT00531284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101826524|NCT00531284|Antiemetics|antiemetics|mesh-ancestor
101826526|NCT00531284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101826527|NCT00531284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826528|NCT00531284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101826529|NCT00531284|Glucocorticoids|glucocorticoids|mesh-ancestor
101826530|NCT00531284|Hormones|hormones|mesh-ancestor
101826531|NCT00531284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101826532|NCT00531284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101826533|NCT00531284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101826534|NCT00531206|Ritonavir|ritonavir|mesh-list
101826535|NCT00531206|Tipranavir|tipranavir|mesh-list
101826536|NCT00531206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101826537|NCT00531206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101826538|NCT00531206|Protease Inhibitors|protease inhibitors|mesh-ancestor
101826539|NCT00531206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101826540|NCT00531206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826541|NCT00531206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101826542|NCT00531206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101826543|NCT00531206|Antiviral Agents|antiviral agents|mesh-ancestor
101826544|NCT00531206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101826545|NCT00531206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101826546|NCT00531206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101826547|NCT00994994|Tranylcypromine|tranylcypromine|mesh-list
101826548|NCT00994994|Tranexamic Acid|tranexamic acid|mesh-list
101826549|NCT00994994|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
101826550|NCT00994994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101826551|NCT00994994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826552|NCT00994994|Hemostatics|hemostatics|mesh-ancestor
101826553|NCT00994994|Coagulants|coagulants|mesh-ancestor
101826554|NCT00994994|Antidepressive Agents|antidepressive agents|mesh-ancestor
101826555|NCT00994994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101826556|NCT00994994|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101826557|NCT00994994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101826558|NCT00994994|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101826559|NCT00994994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101826560|NCT00994994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101184395|NCT03933618|Fertility Agents|fertility agents|mesh-ancestor
101826561|NCT00994994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826562|NCT00999752|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101826563|NCT00999752|Nebivolol|nebivolol|mesh-list
101826564|NCT00999752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101826565|NCT00999752|Diuretics|diuretics|mesh-ancestor
101826566|NCT00999752|Natriuretic Agents|natriuretic agents|mesh-ancestor
101826567|NCT00999752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826568|NCT00999752|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101813492|NCT00986336|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101813493|NCT00986336|Serotonin Agents|serotonin agents|mesh-ancestor
101813494|NCT00986336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101813495|NCT00986336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813496|NCT00986336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813497|NCT00986336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101813498|NCT00986336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101813499|NCT00986336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101813500|NCT00986336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101813501|NCT00986336|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101813502|NCT00986336|Dopamine Agents|dopamine agents|mesh-ancestor
101813503|NCT00986336|Anticonvulsants|anticonvulsants|mesh-ancestor
101813504|NCT00986336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101813505|NCT00989300|Omeprazole|omeprazole|mesh-list
101813506|NCT00989300|Rabeprazole|rabeprazole|mesh-list
101813507|NCT00989300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101826569|NCT00999752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101826570|NCT00999752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826571|NCT00999752|Vasodilator Agents|vasodilator agents|mesh-ancestor
101826572|NCT00999752|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101826573|NCT00999752|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101826574|NCT00999752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101826575|NCT00999752|Adrenergic Agents|adrenergic agents|mesh-ancestor
101184525|NCT02974686|Everolimus|everolimus|mesh-list
101826576|NCT00999752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101826578|NCT01005758|Dexamethasone|dexamethasone|mesh-list
101826579|NCT01005758|Prednisone|prednisone|mesh-list
101826580|NCT01005758|Methylprednisolone|methylprednisolone|mesh-list
101826581|NCT01005758|Prednisolone|prednisolone|mesh-list
101826582|NCT01005758|Hydrocortisone|hydrocortisone|mesh-list
101826583|NCT01005758|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101826584|NCT01005758|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101826585|NCT01005758|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101826586|NCT01005758|Cyclophosphamide|cyclophosphamide|mesh-list
101826587|NCT01005758|Doxorubicin|doxorubicin|mesh-list
101826588|NCT01005758|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101826589|NCT01005758|Methotrexate|methotrexate|mesh-list
101826591|NCT01005758|Vincristine|vincristine|mesh-list
101826592|NCT01005758|Imatinib Mesylate|imatinib mesylate|mesh-list
101826593|NCT01005758|Mercaptopurine|mercaptopurine|mesh-list
101826594|NCT01005758|Pegaspargase|pegaspargase|mesh-list
101826595|NCT01005758|Etoposide phosphate|etoposide phosphate|mesh-list
101826596|NCT01005758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101826597|NCT01005758|Immunologic Factors|immunologic factors|mesh-ancestor
101826598|NCT01005758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826599|NCT01005758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101826600|NCT01005758|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101826601|NCT01005758|Alkylating Agents|alkylating agents|mesh-ancestor
101826602|NCT01005758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826603|NCT01005758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101826604|NCT01005758|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101826605|NCT01005758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101184658|NCT02133534|Antimetabolites|antimetabolites|mesh-ancestor
101184660|NCT02133534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101826607|NCT01005758|Autonomic Agents|autonomic agents|mesh-ancestor
101826608|NCT01005758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101826609|NCT01005758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101826610|NCT01005758|Glucocorticoids|glucocorticoids|mesh-ancestor
101826611|NCT01005758|Hormones|hormones|mesh-ancestor
101826612|NCT01005758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101826613|NCT01005758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101826614|NCT01005758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101813508|NCT00989300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101813509|NCT00989300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101813510|NCT00989300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101813511|NCT00989300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813512|NCT01563614|Cytarabine|cytarabine|mesh-list
101813513|NCT01563614|Lomustine|lomustine|mesh-list
101813514|NCT01563614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101813515|NCT01563614|Antimetabolites|antimetabolites|mesh-ancestor
101813516|NCT01563614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813517|NCT01563614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101813518|NCT01563614|Antiviral Agents|antiviral agents|mesh-ancestor
101813519|NCT01563614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101813520|NCT01563614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101826615|NCT01005758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101826616|NCT01005758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101826617|NCT01005758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101826618|NCT01005758|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101826619|NCT01005758|Abortifacient Agents|abortifacient agents|mesh-ancestor
101826620|NCT01005758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101826621|NCT01005758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101184710|NCT01851174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101826622|NCT01005758|Antimetabolites|antimetabolites|mesh-ancestor
101826623|NCT01005758|Dermatologic Agents|dermatologic agents|mesh-ancestor
101826624|NCT01005758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101826625|NCT01005758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101826626|NCT01005758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101826627|NCT01005758|Antiviral Agents|antiviral agents|mesh-ancestor
101826628|NCT01005758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101826629|NCT01005758|Tubulin Modulators|tubulin modulators|mesh-ancestor
101826630|NCT01005758|Antimitotic Agents|antimitotic agents|mesh-ancestor
101826631|NCT01005758|Mitosis Modulators|mitosis modulators|mesh-ancestor
101826632|NCT01005758|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101826633|NCT01005758|Protective Agents|protective agents|mesh-ancestor
101826634|NCT01005758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101826635|NCT00879047|Ethanol|ethanol|mesh-list
101826636|NCT00879047|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101826637|NCT00879047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101184843|NCT01350258|Fludarabine|fludarabine|mesh-list
101826638|NCT00879047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101826639|NCT00879047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826640|NCT00999986|Cyclophosphamide|cyclophosphamide|mesh-list
101826641|NCT00999986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101826642|NCT00999986|Immunologic Factors|immunologic factors|mesh-ancestor
101826643|NCT00999986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826644|NCT00999986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101826645|NCT00999986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101826646|NCT00999986|Alkylating Agents|alkylating agents|mesh-ancestor
101826647|NCT00999986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826648|NCT00999986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101826649|NCT00999986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101826651|NCT01000220|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101826652|NCT01000220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101826653|NCT01000220|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101826654|NCT01000220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101826655|NCT01000220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826656|NCT01006694|Antidepressive Agents|antidepressive agents|mesh-list
101826657|NCT01006694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101826658|NCT01000298|Amoxicillin|amoxicillin|mesh-list
101826659|NCT01000298|Cefdinir|cefdinir|mesh-list
101813521|NCT01563614|Immunologic Factors|immunologic factors|mesh-ancestor
101813522|NCT01563614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813523|NCT01563614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101813524|NCT01563614|Alkylating Agents|alkylating agents|mesh-ancestor
101813525|NCT00543296|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
101813526|NCT00543296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101813527|NCT00543296|Glucocorticoids|glucocorticoids|mesh-ancestor
101813528|NCT00543296|Hormones|hormones|mesh-ancestor
101813529|NCT00543296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101813530|NCT00543296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184963|NCT00907218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101826660|NCT01000298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101826661|NCT01000298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101826662|NCT00614939|Saxagliptin|saxagliptin|mesh-list
101826663|NCT00614939|Incretins|incretins|mesh-ancestor
101826664|NCT00614939|Hormones|hormones|mesh-ancestor
101826665|NCT00614939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101826666|NCT00614939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826667|NCT00614939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101826668|NCT00614939|Protease Inhibitors|protease inhibitors|mesh-ancestor
101826669|NCT00614939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101826670|NCT00614939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826671|NCT00614939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101826672|NCT05176964|Capecitabine|capecitabine|mesh-list
101826673|NCT05176964|Oxaliplatin|oxaliplatin|mesh-list
101826674|NCT05176964|Tislelizumab|tislelizumab|mesh-list
101826675|NCT05176964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101826676|NCT05176964|Antimetabolites|antimetabolites|mesh-ancestor
101826677|NCT05176964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826678|NCT05176964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101826679|NCT05176964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101185035|NCT00726180|Trastuzumab|trastuzumab|mesh-list
101826680|NCT00879827|PENTA|penta|mesh-list
101826681|NCT00879827|Anticoagulants|anticoagulants|mesh-ancestor
101826682|NCT00879827|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101826683|NCT00879827|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101826684|NCT00879827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826685|NCT01007084|Propranolol|propranolol|mesh-list
101826686|NCT01007084|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101826687|NCT01007084|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101185078|NCT00676026|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101826688|NCT01007084|Adrenergic Agents|adrenergic agents|mesh-ancestor
101826689|NCT01007084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101826690|NCT01007084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826691|NCT01007084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826692|NCT01007084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101826693|NCT01007084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101826694|NCT01007084|Vasodilator Agents|vasodilator agents|mesh-ancestor
101826695|NCT04040309|Lidocaine|lidocaine|mesh-list
101185178|NCT04954638|Eusol|eusol|mesh-list
101826696|NCT04040309|Anesthetics, Local|anesthetics, local|mesh-ancestor
101826697|NCT04040309|Anesthetics|anesthetics|mesh-ancestor
101826698|NCT04040309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101826699|NCT04040309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826700|NCT04040309|Sensory System Agents|sensory system agents|mesh-ancestor
101826701|NCT04040309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101826702|NCT04040309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101826703|NCT04040309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101826704|NCT04040309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101185215|NCT03472872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101826705|NCT04040309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101826706|NCT04040309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826707|NCT01000688|Vildagliptin|vildagliptin|mesh-list
101826708|NCT01000688|Acarbose|acarbose|mesh-list
101813531|NCT00543062|Moxifloxacin|moxifloxacin|mesh-list
101813532|NCT00543062|Prochlorperazine|prochlorperazine|mesh-list
101813534|NCT00543062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101813535|NCT00543062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101813536|NCT00543062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101813537|NCT00543062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101813538|NCT00543062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101813539|NCT00543062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813540|NCT00543062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101813541|NCT00543062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813542|NCT00543062|Antiemetics|antiemetics|mesh-ancestor
101826709|NCT01000688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101826710|NCT01000688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826711|NCT01000688|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101826712|NCT01000688|Protease Inhibitors|protease inhibitors|mesh-ancestor
101826713|NCT01000688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101826714|NCT01000688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826715|NCT01000688|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101826716|NCT00879983|Azithromycin|azithromycin|mesh-list
101826717|NCT00879983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101826718|NCT00879983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101826720|NCT00880061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101826721|NCT00869765|Cycloserine|cycloserine|mesh-list
101826722|NCT00869765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101826723|NCT00869765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101826724|NCT00869765|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101826725|NCT00869765|Antitubercular Agents|antitubercular agents|mesh-ancestor
101826726|NCT00869765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101826727|NCT00869765|Antimetabolites|antimetabolites|mesh-ancestor
101826728|NCT00869765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826729|NCT00880373|Ibuprofen|ibuprofen|mesh-list
101826730|NCT00880373|Morphine|morphine|mesh-list
101826731|NCT00880373|Heroin|heroin|mesh-list
101826732|NCT00880373|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101826733|NCT00880373|Narcotics|narcotics|mesh-ancestor
101826734|NCT00880373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101826735|NCT00880373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826736|NCT00880373|Analgesics|analgesics|mesh-ancestor
101826737|NCT00880373|Sensory System Agents|sensory system agents|mesh-ancestor
101826738|NCT00880373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101826739|NCT00880373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101826740|NCT00880373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101826741|NCT00880373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101185408|NCT00000132|Betaxolol|betaxolol|mesh-list
101826742|NCT00880373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101826743|NCT00880373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101826744|NCT00880373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101826745|NCT00880373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826746|NCT01007630|Rasagiline|rasagiline|mesh-list
101826747|NCT01007630|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101826748|NCT01007630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101826749|NCT01007630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826750|NCT01007630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101826751|NCT01007630|Protective Agents|protective agents|mesh-ancestor
101185467|NCT00000198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826752|NCT01007630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826753|NCT05883384|Caseins|caseins|mesh-list
101826754|NCT05883384|Chelating Agents|chelating agents|mesh-ancestor
101826755|NCT05883384|Sequestering Agents|sequestering agents|mesh-ancestor
101826756|NCT05883384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826757|NCT05883358|Clonidine|clonidine|mesh-list
101826758|NCT05883358|Buprenorphine|buprenorphine|mesh-list
101826759|NCT05883358|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101813543|NCT00543062|Autonomic Agents|autonomic agents|mesh-ancestor
101813544|NCT00543062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101813545|NCT00543062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101813546|NCT00543062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101813547|NCT00543062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101813548|NCT00543062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101813549|NCT00543062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101813550|NCT00543062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101826760|NCT05883358|Narcotics|narcotics|mesh-ancestor
101826761|NCT05883358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101826762|NCT05883358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826763|NCT05883358|Analgesics|analgesics|mesh-ancestor
101826764|NCT05883358|Sensory System Agents|sensory system agents|mesh-ancestor
101826765|NCT05883358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101826766|NCT05883358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101826767|NCT05883358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101826768|NCT05883358|Sympatholytics|sympatholytics|mesh-ancestor
101826769|NCT05883358|Autonomic Agents|autonomic agents|mesh-ancestor
101826770|NCT05883358|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101826771|NCT05883358|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101826772|NCT05883358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101826773|NCT05883358|Adrenergic Agents|adrenergic agents|mesh-ancestor
101826774|NCT05883358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101826775|NCT05883358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826776|NCT05883345|Immunoglobulins|immunoglobulins|mesh-list
101826777|NCT05883345|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101826779|NCT05883345|Immunoglobulin G|immunoglobulin g|mesh-list
101826780|NCT05883345|Gastrins|gastrins|mesh-list
101826781|NCT05883345|Immunologic Factors|immunologic factors|mesh-ancestor
101826782|NCT05883345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826783|NCT05883345|Hormones|hormones|mesh-ancestor
101826784|NCT05883345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101826785|NCT05883332|Nitrous Oxide|nitrous oxide|mesh-list
101826786|NCT05883332|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101826787|NCT05883332|Anesthetics, General|anesthetics, general|mesh-ancestor
101826788|NCT05883332|Anesthetics|anesthetics|mesh-ancestor
101826789|NCT05883332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101826790|NCT05883332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826791|NCT05883332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101826792|NCT05883332|Analgesics|analgesics|mesh-ancestor
101826793|NCT05883332|Sensory System Agents|sensory system agents|mesh-ancestor
101826794|NCT05883332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101826795|NCT05883176|Bevacizumab|bevacizumab|mesh-list
101826796|NCT05883176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101185656|NCT00000354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826797|NCT05883176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101826798|NCT05883176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101826799|NCT05883176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101826800|NCT05883176|Growth Substances|growth substances|mesh-ancestor
101826801|NCT05883176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826802|NCT05883176|Growth Inhibitors|growth inhibitors|mesh-ancestor
101826803|NCT05883150|Midazolam|midazolam|mesh-list
101826804|NCT05883150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101826805|NCT05883150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101826806|NCT05883150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101826807|NCT05883150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826808|NCT05883150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101826809|NCT05883150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101826810|NCT05883150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101826811|NCT05883150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101185713|NCT00000444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101826812|NCT05883150|Anesthetics, General|anesthetics, general|mesh-ancestor
101826813|NCT05883150|Anesthetics|anesthetics|mesh-ancestor
101826814|NCT05883150|GABA Modulators|gaba modulators|mesh-ancestor
101826815|NCT05883150|GABA Agents|gaba agents|mesh-ancestor
101826816|NCT05883150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101826817|NCT05883150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813551|NCT00543062|Dopamine Agents|dopamine agents|mesh-ancestor
101813552|NCT00543062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101813553|NCT00986804|Decitabine|decitabine|mesh-list
101813554|NCT00986804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101813555|NCT00986804|Antimetabolites|antimetabolites|mesh-ancestor
101813556|NCT00986804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813557|NCT00986804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101813558|NCT00986804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101813559|NCT00676091|Vaccines|vaccines|mesh-list
101813560|NCT00676091|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101826818|NCT05883124|Rivastigmine|rivastigmine|mesh-list
101826819|NCT05883124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101826820|NCT05883124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101826821|NCT05883124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826822|NCT05883124|Cholinergic Agents|cholinergic agents|mesh-ancestor
101826823|NCT05883124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101826824|NCT05883124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826825|NCT05883124|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101826826|NCT05883124|Protective Agents|protective agents|mesh-ancestor
101826827|NCT05883046|Performance-Enhancing Substances|performance-enhancing substances|mesh-list
101185842|NCT00000732|Antimalarials|antimalarials|mesh-ancestor
101826851|NCT05882864|Immunologic Factors|immunologic factors|mesh-ancestor
101826852|NCT05882864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101826853|NCT05882864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826854|NCT05882734|Cemiplimab|cemiplimab|mesh-list
101826855|NCT05882734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101826856|NCT05882734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101826857|NCT05882630|Carboplatin|carboplatin|mesh-list
101826858|NCT05882630|Etoposide|etoposide|mesh-list
101826859|NCT05882630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101826860|NCT05882630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101826861|NCT05882630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101826862|NCT05882630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101826863|NCT05882630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101826864|NCT05882630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826866|NCT05882604|Protective Agents|protective agents|mesh-ancestor
101826867|NCT05882604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826868|NCT05881980|Itraconazole|itraconazole|mesh-list
101826869|NCT05881980|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
101826870|NCT05881980|Terbinafine|terbinafine|mesh-list
101826871|NCT05881980|Antifungal Agents|antifungal agents|mesh-ancestor
101826872|NCT05881980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101826873|NCT05881980|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101826874|NCT05881980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101826875|NCT05881980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101826876|NCT05881980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826877|NCT05881980|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101826878|NCT05881980|Hormone Antagonists|hormone antagonists|mesh-ancestor
101826879|NCT05881980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101826880|NCT05881980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826881|NCT05881980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101826882|NCT05881915|Phenylephrine|phenylephrine|mesh-list
101826883|NCT05881915|Epinephrine|epinephrine|mesh-list
101826884|NCT05881915|Oxymetazoline|oxymetazoline|mesh-list
101826885|NCT05881915|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101826886|NCT05881915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101826887|NCT05881915|Adrenergic Agents|adrenergic agents|mesh-ancestor
101826888|NCT05881915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101826889|NCT05881915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826890|NCT05881915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826891|NCT05881915|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101826892|NCT05881915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101826893|NCT05881915|Autonomic Agents|autonomic agents|mesh-ancestor
101826894|NCT05881915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101813561|NCT00676091|Immunologic Factors|immunologic factors|mesh-ancestor
101813562|NCT00676091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813563|NCT02558933|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
101813564|NCT02558933|Antioxidants|antioxidants|mesh-ancestor
101813565|NCT02558933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813566|NCT02558933|Protective Agents|protective agents|mesh-ancestor
101813567|NCT02558933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813568|NCT02558933|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101813569|NCT02558933|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101813570|NCT02558933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101813571|NCT02558933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101826895|NCT05881915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101826896|NCT05881915|Respiratory System Agents|respiratory system agents|mesh-ancestor
101826897|NCT05881915|Mydriatics|mydriatics|mesh-ancestor
101826898|NCT05881915|Sympathomimetics|sympathomimetics|mesh-ancestor
101186078|NCT00000954|Antiviral Agents|antiviral agents|mesh-ancestor
101186079|NCT00000954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101826899|NCT05881915|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101826901|NCT05881915|Nasal Decongestants|nasal decongestants|mesh-ancestor
101826902|NCT05881915|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101826903|NCT05881915|Protective Agents|protective agents|mesh-ancestor
101826904|NCT05881746|Liver Extracts|liver extracts|mesh-list
101826905|NCT05881746|Hematinics|hematinics|mesh-ancestor
101826906|NCT05881525|Paclitaxel|paclitaxel|mesh-list
101186139|NCT00001080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186140|NCT00001080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186142|NCT00001080|Antiviral Agents|antiviral agents|mesh-ancestor
101826907|NCT05881525|Cyclophosphamide|cyclophosphamide|mesh-list
101826908|NCT05881525|Fludarabine|fludarabine|mesh-list
101826909|NCT05881525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101826910|NCT05881525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101826911|NCT05881525|Tubulin Modulators|tubulin modulators|mesh-ancestor
101826912|NCT05881525|Antimitotic Agents|antimitotic agents|mesh-ancestor
101826913|NCT05881525|Mitosis Modulators|mitosis modulators|mesh-ancestor
101826914|NCT05881525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826915|NCT05881525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101826916|NCT05881525|Immunologic Factors|immunologic factors|mesh-ancestor
101826917|NCT05881525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826918|NCT05881525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101826919|NCT05881525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101826920|NCT05881525|Alkylating Agents|alkylating agents|mesh-ancestor
101826921|NCT05881525|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101826923|NCT05881187|Antifungal Agents|antifungal agents|mesh-list
101826924|NCT05881187|Clotrimazole|clotrimazole|mesh-list
101826925|NCT05881187|Miconazole|miconazole|mesh-list
101826926|NCT05881187|Vitamin B Complex|vitamin b complex|mesh-ancestor
101826927|NCT05881187|Vitamins|vitamins|mesh-ancestor
101826928|NCT05881187|Micronutrients|micronutrients|mesh-ancestor
101826929|NCT05881187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826930|NCT05881187|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101826931|NCT05881187|Dermatologic Agents|dermatologic agents|mesh-ancestor
101826932|NCT05881187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101826933|NCT05881187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101826934|NCT05881187|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101826935|NCT05881187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101826936|NCT05881187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101826937|NCT05881187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826938|NCT05881187|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101826939|NCT05881187|Hormone Antagonists|hormone antagonists|mesh-ancestor
101826940|NCT05881187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101826941|NCT05881187|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101826942|NCT05881187|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101813577|NCT03903822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101813578|NCT03903822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101813579|NCT03903822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813580|NCT04003350|Acetaminophen|acetaminophen|mesh-list
101813581|NCT04003350|Meloxicam|meloxicam|mesh-list
101813582|NCT04003350|Oxycodone|oxycodone|mesh-list
101813583|NCT04003350|Tramadol|tramadol|mesh-list
101813584|NCT04003350|Gabapentin|gabapentin|mesh-list
101813585|NCT04003350|Esomeprazole|esomeprazole|mesh-list
101813586|NCT04003350|Metaxalone|metaxalone|mesh-list
101813587|NCT04003350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101813588|NCT04003350|Narcotics|narcotics|mesh-ancestor
101813589|NCT04003350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101813590|NCT04003350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813591|NCT04003350|Analgesics|analgesics|mesh-ancestor
101813592|NCT04003350|Sensory System Agents|sensory system agents|mesh-ancestor
101826944|NCT05881135|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
101186330|NCT00001848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101826945|NCT05881135|Lipotropic Agents|lipotropic agents|mesh-ancestor
101826946|NCT05881135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101334249|NCT00043342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101826948|NCT05881135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826949|NCT05881135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101826950|NCT05881135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101826951|NCT05881135|Nootropic Agents|nootropic agents|mesh-ancestor
101826952|NCT05880732|Magnesium Sulfate|magnesium sulfate|mesh-list
101826953|NCT05880732|Analgesics|analgesics|mesh-ancestor
101826954|NCT05880732|Sensory System Agents|sensory system agents|mesh-ancestor
101826955|NCT05880732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101826956|NCT05880732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826958|NCT05880732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101826959|NCT05880732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101826960|NCT05880732|Anticonvulsants|anticonvulsants|mesh-ancestor
101826961|NCT05880732|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101826962|NCT05880732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101826963|NCT05880732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826964|NCT05880732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101826965|NCT05880732|Tocolytic Agents|tocolytic agents|mesh-ancestor
101186461|NCT00002070|Ganciclovir|ganciclovir|mesh-list
101826966|NCT05880732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101826972|NCT05880693|Magnesium Sulfate|magnesium sulfate|mesh-list
101826973|NCT05880693|Dexmedetomidine|dexmedetomidine|mesh-list
101826974|NCT05880693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101826975|NCT05880693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101826976|NCT05880693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826977|NCT05880693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101826978|NCT05880693|Analgesics|analgesics|mesh-ancestor
101813593|NCT04003350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101813595|NCT04003350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101813596|NCT04003350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101813597|NCT04003350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101813598|NCT04003350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101813599|NCT04003350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101826979|NCT05880693|Sensory System Agents|sensory system agents|mesh-ancestor
101826980|NCT05880693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101826981|NCT05880693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101826982|NCT05880693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101826983|NCT05880693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101826984|NCT05880693|Adrenergic Agents|adrenergic agents|mesh-ancestor
101826986|NCT05880693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101826987|NCT05880693|Anesthetics|anesthetics|mesh-ancestor
101826988|NCT05880693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101826989|NCT05880693|Anticonvulsants|anticonvulsants|mesh-ancestor
101826990|NCT05880693|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101826991|NCT05880693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101826992|NCT05880693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101186577|NCT00002154|Selegiline|selegiline|mesh-list
101826993|NCT05880693|Tocolytic Agents|tocolytic agents|mesh-ancestor
101826994|NCT05880693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101826995|NCT05880355|Dapansutrile|dapansutrile|mesh-list
101826996|NCT05880355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101826997|NCT05880342|Methylphenidate|methylphenidate|mesh-list
101826998|NCT05880342|Reboxetine|reboxetine|mesh-list
101826999|NCT05880342|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101827000|NCT05880342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827001|NCT05880342|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101827002|NCT05880342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101827003|NCT05880342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101827004|NCT05880342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827005|NCT05880342|Dopamine Agents|dopamine agents|mesh-ancestor
101827006|NCT05880342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101827007|NCT05880342|Antidepressive Agents|antidepressive agents|mesh-ancestor
101186712|NCT00002220|Indinavir|indinavir|mesh-list
101827009|NCT05880342|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101827010|NCT05880342|Adrenergic Agents|adrenergic agents|mesh-ancestor
101827011|NCT05880186|Caffeine|caffeine|mesh-list
101827012|NCT05880186|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101827013|NCT05880186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827014|NCT05880186|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101827015|NCT05880186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101827016|NCT05880186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827017|NCT05880186|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101827018|NCT05880186|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101827019|NCT05880186|Purinergic Agents|purinergic agents|mesh-ancestor
101827020|NCT05880186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101827021|NCT05880082|Cisplatin|cisplatin|mesh-list
101827022|NCT05880082|Carboplatin|carboplatin|mesh-list
101827023|NCT05880082|Tislelizumab|tislelizumab|mesh-list
101827024|NCT05880082|Nedaplatin|nedaplatin|mesh-list
101827025|NCT05880082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827026|NCT05880082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101827027|NCT05880030|Vitamin D|vitamin d|mesh-list
101827028|NCT05880030|Cholecalciferol|cholecalciferol|mesh-list
101827029|NCT05880030|Vitamins|vitamins|mesh-ancestor
101827030|NCT05880030|Micronutrients|micronutrients|mesh-ancestor
101827031|NCT05880030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101186838|NCT00002322|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101827032|NCT05880030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101827033|NCT05880030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101827034|NCT05880017|Morphine|morphine|mesh-list
101827035|NCT05880017|Bupivacaine|bupivacaine|mesh-list
101827036|NCT05880017|Anesthetics, Local|anesthetics, local|mesh-ancestor
101827037|NCT05880017|Anesthetics|anesthetics|mesh-ancestor
101827038|NCT05880017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101813600|NCT04003350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101813601|NCT04003350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813602|NCT04003350|Antimanic Agents|antimanic agents|mesh-ancestor
101813603|NCT04003350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101813604|NCT04003350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101813605|NCT04003350|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101813606|NCT04003350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101813607|NCT04003350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101813608|NCT04003350|Antipyretics|antipyretics|mesh-ancestor
101813609|NCT04003350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101813610|NCT04003350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101827039|NCT05880017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827040|NCT05880017|Sensory System Agents|sensory system agents|mesh-ancestor
101827041|NCT05880017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101827042|NCT05880017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101827043|NCT05880017|Narcotics|narcotics|mesh-ancestor
101827044|NCT05880017|Analgesics|analgesics|mesh-ancestor
101827045|NCT05879926|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101827046|NCT05879926|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101827047|NCT05879926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186901|NCT00002364|Antiviral Agents|antiviral agents|mesh-ancestor
101827048|NCT05879926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827050|NCT05879926|Hormone Antagonists|hormone antagonists|mesh-ancestor
101827051|NCT05879926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101827052|NCT05879926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827053|NCT05879796|Cisplatin|cisplatin|mesh-list
101827054|NCT05879796|Endostatins|endostatins|mesh-list
101827055|NCT05879796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827056|NCT05879796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101827057|NCT05879796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101827058|NCT05879796|Growth Substances|growth substances|mesh-ancestor
101827059|NCT05879796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827060|NCT05879796|Growth Inhibitors|growth inhibitors|mesh-ancestor
101827062|NCT05879653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101827063|NCT05879653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827064|NCT05879653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101827065|NCT05879653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827066|NCT05879627|Exatecan|exatecan|mesh-list
101827067|NCT05879627|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101827068|NCT05879627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101827069|NCT05879627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101827070|NCT05879627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827071|NCT05879627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827072|NCT05879536|Tramadol|tramadol|mesh-list
101827073|NCT05879536|Ondansetron|ondansetron|mesh-list
101827074|NCT05879536|Ropivacaine|ropivacaine|mesh-list
101827075|NCT05879536|Anesthetics, Local|anesthetics, local|mesh-ancestor
101827076|NCT05879536|Anesthetics|anesthetics|mesh-ancestor
101827077|NCT05879536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101827078|NCT05879536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827080|NCT05879536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101827081|NCT05879536|Antiemetics|antiemetics|mesh-ancestor
101827082|NCT05879536|Autonomic Agents|autonomic agents|mesh-ancestor
101827083|NCT05879536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101827084|NCT05879536|Antipruritics|antipruritics|mesh-ancestor
101827085|NCT05879536|Dermatologic Agents|dermatologic agents|mesh-ancestor
101827086|NCT05879536|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101827087|NCT05879536|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101827088|NCT05879536|Serotonin Agents|serotonin agents|mesh-ancestor
101827089|NCT05879536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101827090|NCT05879536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813611|NCT04003350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101813612|NCT04003350|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101813613|NCT04003350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101813614|NCT04003350|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101813616|NCT00748007|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
101813617|NCT00748007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101813618|NCT00748007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813619|NCT00748007|Cholinergic Agents|cholinergic agents|mesh-ancestor
101813620|NCT00748007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101813621|NCT00748007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827091|NCT05879536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101827092|NCT05879536|Narcotics|narcotics|mesh-ancestor
101827093|NCT05879536|Analgesics|analgesics|mesh-ancestor
101827094|NCT05879367|Eflornithine|eflornithine|mesh-list
101827095|NCT05879367|Temozolomide|temozolomide|mesh-list
101827096|NCT05879367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101827097|NCT05879367|Alkylating Agents|alkylating agents|mesh-ancestor
101827098|NCT05879367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827099|NCT05879367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827100|NCT05879367|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101827101|NCT05879367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101827102|NCT05879367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101827103|NCT05879367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101827104|NCT05879367|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
101827105|NCT05879367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101827107|NCT05879276|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101827108|NCT05879276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827109|NCT05879276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101827110|NCT05879276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827111|NCT05879237|Vitamin D|vitamin d|mesh-list
101827112|NCT05879237|Cholecalciferol|cholecalciferol|mesh-list
101827113|NCT05879237|Vitamins|vitamins|mesh-ancestor
101827114|NCT05879237|Micronutrients|micronutrients|mesh-ancestor
101827115|NCT05879237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187211|NCT00002532|Daunorubicin|daunorubicin|mesh-list
101827116|NCT05879237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101827117|NCT05879237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101827118|NCT05879146|Nirogacestat|nirogacestat|mesh-list
101827119|NCT05879146|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101827120|NCT05879146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101827121|NCT05879146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827123|NCT05879068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101827124|NCT05879068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827125|NCT05879068|Tubulin Modulators|tubulin modulators|mesh-ancestor
101827126|NCT05879068|Antimitotic Agents|antimitotic agents|mesh-ancestor
101827127|NCT05879068|Mitosis Modulators|mitosis modulators|mesh-ancestor
101187276|NCT00002550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101827128|NCT05879068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827130|NCT05879029|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101827131|NCT05879029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101827132|NCT05879029|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101827133|NCT05879029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101827134|NCT05879029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827135|NCT05878977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101827136|NCT05878977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827137|NCT05878977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101187337|NCT00002580|Leuprolide|leuprolide|mesh-list
101827138|NCT05878977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827139|NCT05878964|Mitogens|mitogens|mesh-list
101827140|NCT05878964|Mitosis Modulators|mitosis modulators|mesh-ancestor
101827141|NCT05878964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813622|NCT00748007|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101813623|NCT00748007|Protective Agents|protective agents|mesh-ancestor
101813625|NCT00748163|Sunitinib|sunitinib|mesh-list
101813626|NCT00748163|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101813627|NCT00748163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101813628|NCT00748163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101813629|NCT00748163|Tubulin Modulators|tubulin modulators|mesh-ancestor
101813630|NCT00748163|Antimitotic Agents|antimitotic agents|mesh-ancestor
101827142|NCT05878951|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101827143|NCT05878951|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101827144|NCT05878951|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101827145|NCT05878951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101827146|NCT05878951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827147|NCT05878951|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101827148|NCT05878951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101187403|NCT00002598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101827149|NCT05878951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827150|NCT05878951|Cholinergic Agents|cholinergic agents|mesh-ancestor
101827151|NCT05878951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101827152|NCT05878535|Metformin|metformin|mesh-list
101827153|NCT05878535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101827154|NCT05878535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827155|NCT05876806|Trametinib|trametinib|mesh-list
101827156|NCT05876806|Dabrafenib|dabrafenib|mesh-list
101827157|NCT05876806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827158|NCT05876806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101827159|NCT05876806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101187480|NCT00002634|Cobalt|cobalt|mesh-list
101827160|NCT05876806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827162|NCT05876273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101827163|NCT05875506|Doxycycline|doxycycline|mesh-list
101827164|NCT05875506|Chitosan|chitosan|mesh-list
101827165|NCT05875506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101827166|NCT05875506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101827167|NCT05875506|Antimalarials|antimalarials|mesh-ancestor
101187535|NCT00002658|Thioguanine|thioguanine|mesh-list
101827168|NCT05875506|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101827169|NCT05875506|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101827170|NCT05875506|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101827171|NCT05875506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101827172|NCT05875506|Antimetabolites|antimetabolites|mesh-ancestor
101827173|NCT05875506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827175|NCT05875506|Chelating Agents|chelating agents|mesh-ancestor
101827176|NCT05875506|Sequestering Agents|sequestering agents|mesh-ancestor
101827177|NCT05875506|Hemostatics|hemostatics|mesh-ancestor
101187604|NCT00002676|Antimetabolites|antimetabolites|mesh-ancestor
101827179|NCT05875350|Anesthetics|anesthetics|mesh-list
101484523|NCT00312533|Hylan|hylan|mesh-list
101827180|NCT05875350|Anesthetics, Local|anesthetics, local|mesh-list
101827181|NCT05875350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101827182|NCT05875350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827183|NCT05875350|Sensory System Agents|sensory system agents|mesh-ancestor
101827184|NCT05875350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101827185|NCT05871086|Ubiquinone|ubiquinone|mesh-list
101827186|NCT05871086|Coenzyme Q10|coenzyme q10|mesh-list
101827187|NCT05871086|Micronutrients|micronutrients|mesh-ancestor
101827188|NCT05871086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827189|NCT05871086|Vitamins|vitamins|mesh-ancestor
101187675|NCT00002700|Mercaptopurine|mercaptopurine|mesh-list
101187676|NCT00002700|Levoleucovorin|levoleucovorin|mesh-list
101827190|NCT05868837|Rituximab|rituximab|mesh-list
101827191|NCT05868837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101827192|NCT05868837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827193|NCT05868837|Immunologic Factors|immunologic factors|mesh-ancestor
101827194|NCT05868837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827195|NCT05868837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101813631|NCT00748163|Mitosis Modulators|mitosis modulators|mesh-ancestor
101813632|NCT00748163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813633|NCT00748163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101813634|NCT00748163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101813635|NCT00748163|Growth Substances|growth substances|mesh-ancestor
101813636|NCT00748163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813637|NCT00748163|Growth Inhibitors|growth inhibitors|mesh-ancestor
101813638|NCT00748163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101813639|NCT00748163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101827197|NCT05864755|Durvalumab|durvalumab|mesh-list
101827198|NCT05864755|Tremelimumab|tremelimumab|mesh-list
101827199|NCT05864755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101827200|NCT05864755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827201|NCT05864755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101187748|NCT00002730|Melphalan|melphalan|mesh-list
101827202|NCT05864755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101827203|NCT05864755|Growth Substances|growth substances|mesh-ancestor
101827204|NCT05864755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827205|NCT05864755|Growth Inhibitors|growth inhibitors|mesh-ancestor
101827207|NCT05864404|Remifentanil|remifentanil|mesh-list
101827208|NCT05864404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101827209|NCT05864404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101827210|NCT05864404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827211|NCT05864404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101827212|NCT05864404|Analgesics|analgesics|mesh-ancestor
101827213|NCT05864404|Sensory System Agents|sensory system agents|mesh-ancestor
101827214|NCT05864404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101827215|NCT05864404|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101827216|NCT05864404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101827217|NCT05864404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101827218|NCT05864404|Adrenergic Agents|adrenergic agents|mesh-ancestor
101827219|NCT05864404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101827220|NCT05864404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827221|NCT05864404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101827222|NCT05864404|Narcotics|narcotics|mesh-ancestor
101827223|NCT05856981|Pembrolizumab|pembrolizumab|mesh-list
101827224|NCT05856981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101827225|NCT05856981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827226|NCT05856981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101827227|NCT05856981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827228|NCT05856357|Pyrimethamine|pyrimethamine|mesh-list
101827229|NCT05856357|Sulfadoxine|sulfadoxine|mesh-list
101187860|NCT00002784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101187881|NCT00002790|Sirolimus|sirolimus|mesh-list
101827230|NCT05856357|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101827231|NCT05856357|Antimalarials|antimalarials|mesh-ancestor
101827232|NCT05856357|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101827233|NCT05856357|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101827234|NCT05856357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101827235|NCT05856357|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101827236|NCT05856357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101827237|NCT05856357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827238|NCT05856357|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101827239|NCT05846906|Sildenafil Citrate|sildenafil citrate|mesh-list
101827240|NCT05846906|Citric Acid|citric acid|mesh-list
101827241|NCT05846906|Sodium Citrate|sodium citrate|mesh-list
101827242|NCT05846906|Clomiphene|clomiphene|mesh-list
101827243|NCT05846906|Enclomiphene|enclomiphene|mesh-list
101827244|NCT05846906|Zuclomiphene|zuclomiphene|mesh-list
101827245|NCT05846906|Anticoagulants|anticoagulants|mesh-ancestor
101827246|NCT05846906|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101827247|NCT05846906|Chelating Agents|chelating agents|mesh-ancestor
101827248|NCT05846906|Sequestering Agents|sequestering agents|mesh-ancestor
101827249|NCT05846906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827250|NCT05846906|Vasodilator Agents|vasodilator agents|mesh-ancestor
101813640|NCT00687401|Infliximab|infliximab|mesh-list
101813641|NCT00687401|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101813642|NCT00687401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101813643|NCT00687401|Dermatologic Agents|dermatologic agents|mesh-ancestor
101813644|NCT00687401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101813645|NCT00687401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101813646|NCT00485693|Epinephrine|epinephrine|mesh-list
101813647|NCT00485693|Bupivacaine|bupivacaine|mesh-list
101813648|NCT00485693|Anesthetics, Local|anesthetics, local|mesh-ancestor
101813649|NCT00485693|Anesthetics|anesthetics|mesh-ancestor
101813650|NCT00485693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101813651|NCT00485693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813652|NCT00485693|Sensory System Agents|sensory system agents|mesh-ancestor
101827251|NCT05846906|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101827252|NCT05846906|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101827253|NCT05846906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101187982|NCT05588388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101187987|NCT05516628|Bevacizumab|bevacizumab|mesh-list
101827254|NCT05846906|Urological Agents|urological agents|mesh-ancestor
101827255|NCT05846906|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101827256|NCT05846906|Hormone Antagonists|hormone antagonists|mesh-ancestor
101828164|NCT05919823|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101827257|NCT05846906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101827258|NCT05846906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827259|NCT05846906|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101827261|NCT05846906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101827262|NCT05846906|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101827263|NCT05846906|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101827264|NCT05844462|Tadalafil|tadalafil|mesh-list
101827265|NCT05844462|Vasodilator Agents|vasodilator agents|mesh-ancestor
101827266|NCT05844462|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101827267|NCT05844462|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101827268|NCT05844462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101827269|NCT05844462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827270|NCT05844462|Urological Agents|urological agents|mesh-ancestor
101827271|NCT05835245|Lenvatinib|lenvatinib|mesh-list
101188046|NCT05218668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101827272|NCT05835245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827273|NCT05835245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101827274|NCT05835245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101827275|NCT05835245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827276|NCT05832255|Psilocybin|psilocybin|mesh-list
101827277|NCT05832255|Hallucinogens|hallucinogens|mesh-ancestor
101827278|NCT05832255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827279|NCT05832255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101827280|NCT05826327|Sufentanil|sufentanil|mesh-list
101827281|NCT05826327|Esketamine|esketamine|mesh-list
101827282|NCT05826327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101827283|NCT05826327|Narcotics|narcotics|mesh-ancestor
101827284|NCT05826327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101827285|NCT05826327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827286|NCT05826327|Analgesics|analgesics|mesh-ancestor
101827287|NCT05826327|Sensory System Agents|sensory system agents|mesh-ancestor
101827288|NCT05826327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101827289|NCT05826327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101827290|NCT05826327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101827291|NCT05826327|Anesthetics, General|anesthetics, general|mesh-ancestor
101827292|NCT05826327|Anesthetics|anesthetics|mesh-ancestor
101827293|NCT05826327|Antidepressive Agents|antidepressive agents|mesh-ancestor
101827294|NCT05826327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101827295|NCT05823116|Vancomycin|vancomycin|mesh-list
101827296|NCT05823116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101827297|NCT05823116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101827298|NCT05817721|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101470979|NCT05140096|Fluconazole|fluconazole|mesh-list
101813653|NCT00485693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101813654|NCT00485693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101813655|NCT00485693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101813656|NCT00485693|Adrenergic Agents|adrenergic agents|mesh-ancestor
101813657|NCT00485693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101813658|NCT00485693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813659|NCT00485693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101813660|NCT00485693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101813661|NCT00485693|Autonomic Agents|autonomic agents|mesh-ancestor
101813662|NCT00485693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101813663|NCT00485693|Respiratory System Agents|respiratory system agents|mesh-ancestor
101813664|NCT00485693|Mydriatics|mydriatics|mesh-ancestor
101813665|NCT00485693|Sympathomimetics|sympathomimetics|mesh-ancestor
101813666|NCT00485693|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101813667|NCT00538902|Adalimumab|adalimumab|mesh-list
101813668|NCT00538902|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101827299|NCT05817721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101827300|NCT05817721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827301|NCT05814991|Nitroglycerin|nitroglycerin|mesh-list
101827302|NCT05814991|Vasodilator Agents|vasodilator agents|mesh-ancestor
101827303|NCT05814367|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101827304|NCT05814367|Lubricant Eye Drops|lubricant eye drops|mesh-list
101827305|NCT05814367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101827306|NCT05809011|Dexamethasone|dexamethasone|mesh-list
101827307|NCT05809011|Prednisone|prednisone|mesh-list
101827308|NCT05809011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101827309|NCT05809011|Antiemetics|antiemetics|mesh-ancestor
101827310|NCT05809011|Autonomic Agents|autonomic agents|mesh-ancestor
101827311|NCT05809011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101827312|NCT05809011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827313|NCT05809011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101827314|NCT05809011|Glucocorticoids|glucocorticoids|mesh-ancestor
101827315|NCT05809011|Hormones|hormones|mesh-ancestor
101828165|NCT05919823|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101827316|NCT05809011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101827317|NCT05809011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101827318|NCT05809011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827319|NCT05801757|Propofol|propofol|mesh-list
101827320|NCT05801757|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101827321|NCT05801757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101827322|NCT05801757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827323|NCT05801757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101827324|NCT05801757|Anesthetics, General|anesthetics, general|mesh-ancestor
101827325|NCT05801757|Anesthetics|anesthetics|mesh-ancestor
101827326|NCT05801146|Botulinum Toxins|botulinum toxins|mesh-list
101827327|NCT05801146|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101827328|NCT05801146|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101827329|NCT05801146|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101827330|NCT05801146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101827331|NCT05801146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827332|NCT05801146|Cholinergic Agents|cholinergic agents|mesh-ancestor
101827333|NCT05801146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101827334|NCT05801146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827335|NCT05801146|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101827336|NCT05801146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101827339|NCT05795647|Tocotrienols|tocotrienols|mesh-list
101827340|NCT05795647|alpha-Tocopherol|alpha-tocopherol|mesh-list
101827341|NCT05795647|Pentoxifylline|pentoxifylline|mesh-list
101827342|NCT05795647|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101813669|NCT00538902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101813670|NCT00538902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101813671|NCT00541970|Vaccines|vaccines|mesh-list
101813672|NCT00541970|Immunologic Factors|immunologic factors|mesh-ancestor
101813673|NCT00541970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813674|NCT00687323|Temozolomide|temozolomide|mesh-list
101813675|NCT00687323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101827343|NCT05795647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101188196|NCT03787602|Avelumab|avelumab|mesh-list
101827344|NCT05795647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827345|NCT05795647|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101827346|NCT05795647|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101827347|NCT05795647|Protective Agents|protective agents|mesh-ancestor
101827348|NCT05795647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827349|NCT05795647|Vasodilator Agents|vasodilator agents|mesh-ancestor
101827350|NCT05795647|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101827351|NCT05795647|Antioxidants|antioxidants|mesh-ancestor
101827352|NCT05795647|Vitamins|vitamins|mesh-ancestor
101827353|NCT05795647|Micronutrients|micronutrients|mesh-ancestor
101827354|NCT05794399|Warfarin|warfarin|mesh-list
101827355|NCT05794399|Rivaroxaban|rivaroxaban|mesh-list
101827356|NCT05794399|Anticoagulants|anticoagulants|mesh-ancestor
101827357|NCT05794399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101827358|NCT05794399|Antithrombins|antithrombins|mesh-ancestor
101827359|NCT05794399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101827360|NCT05794399|Protease Inhibitors|protease inhibitors|mesh-ancestor
101827361|NCT05794399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101827362|NCT05794399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827363|NCT05788510|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101827364|NCT05788510|Immunologic Factors|immunologic factors|mesh-ancestor
101827365|NCT05788510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827380|NCT05771480|Paclitaxel|paclitaxel|mesh-list
101827381|NCT05771480|Cisplatin|cisplatin|mesh-list
101827382|NCT05771480|Carboplatin|carboplatin|mesh-list
101827383|NCT05771480|Gemcitabine|gemcitabine|mesh-list
101827384|NCT05771480|Oxaliplatin|oxaliplatin|mesh-list
101827385|NCT05771480|Durvalumab|durvalumab|mesh-list
101827386|NCT05771480|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101188299|NCT01096368|Etoposide phosphate|etoposide phosphate|mesh-list
101188300|NCT01096368|Podophyllotoxin|podophyllotoxin|mesh-list
101827388|NCT05771480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827389|NCT05771480|Tubulin Modulators|tubulin modulators|mesh-ancestor
101827391|NCT05771480|Mitosis Modulators|mitosis modulators|mesh-ancestor
101827392|NCT05771480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827393|NCT05771480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101827394|NCT05771480|Antimetabolites|antimetabolites|mesh-ancestor
101827395|NCT05771480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101827396|NCT05764395|Pembrolizumab|pembrolizumab|mesh-list
101827397|NCT05764395|ON 01910|on 01910|mesh-list
101827398|NCT05764395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101827399|NCT05764395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827400|NCT05764395|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101827401|NCT05764395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827402|NCT05764395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101827403|NCT05764395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101827404|NCT05746546|Nicotine|nicotine|mesh-list
101813676|NCT00687323|Alkylating Agents|alkylating agents|mesh-ancestor
101813677|NCT00687323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813678|NCT00687323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101813679|NCT00989742|Doxycycline|doxycycline|mesh-list
101813680|NCT00989742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101813681|NCT00989742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101827405|NCT05746546|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101827407|NCT05746546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101827408|NCT05746546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827409|NCT05746546|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101827410|NCT05746546|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101827411|NCT05746546|Cholinergic Agents|cholinergic agents|mesh-ancestor
101827412|NCT05746546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101827413|NCT05746546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827415|NCT05727371|Viscosupplements|viscosupplements|mesh-ancestor
101827417|NCT05727371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827418|NCT05714306|Cyclophosphamide|cyclophosphamide|mesh-list
101827419|NCT05714306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101827420|NCT05714306|Immunologic Factors|immunologic factors|mesh-ancestor
101827421|NCT05714306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827422|NCT05714306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101827423|NCT05714306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101827424|NCT05714306|Alkylating Agents|alkylating agents|mesh-ancestor
101827425|NCT05714306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827426|NCT05714306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827427|NCT05714306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101827429|NCT05706259|Ergocalciferols|ergocalciferols|mesh-list
101827430|NCT05706259|Cholecalciferol|cholecalciferol|mesh-list
101827431|NCT05706259|Vitamins|vitamins|mesh-list
101827432|NCT05706259|Micronutrients|micronutrients|mesh-ancestor
101827433|NCT05706259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827434|NCT05706259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101827435|NCT05706259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101827436|NCT05704374|Pregabalin|pregabalin|mesh-list
101827437|NCT05704374|Analgesics|analgesics|mesh-ancestor
101827438|NCT05704374|Sensory System Agents|sensory system agents|mesh-ancestor
101827439|NCT05704374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101827440|NCT05704374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827441|NCT05704374|Anticonvulsants|anticonvulsants|mesh-ancestor
101827442|NCT05704374|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101827443|NCT05704374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101827444|NCT05704374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827445|NCT05704374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101827446|NCT05704374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101827447|NCT05704374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101827448|NCT05704374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101827449|NCT05704374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101827450|NCT05704166|Pirfenidone|pirfenidone|mesh-list
101827451|NCT05704166|Analgesics|analgesics|mesh-ancestor
101827452|NCT05704166|Sensory System Agents|sensory system agents|mesh-ancestor
101313384|NCT00000115|Acetazolamide|acetazolamide|mesh-list
101827453|NCT05704166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101827454|NCT05704166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827455|NCT05704166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101827456|NCT05704166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101827457|NCT05704166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101827458|NCT05704166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101827459|NCT05704166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827461|NCT05680558|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101827462|NCT05680558|Dermatologic Agents|dermatologic agents|mesh-ancestor
101827463|NCT05667324|Dexamethasone|dexamethasone|mesh-list
101827464|NCT05667324|Ropivacaine|ropivacaine|mesh-list
101827465|NCT05667324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101827466|NCT05667324|Antiemetics|antiemetics|mesh-ancestor
101827467|NCT05667324|Autonomic Agents|autonomic agents|mesh-ancestor
101827468|NCT05667324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101827469|NCT05667324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827470|NCT05667324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101813682|NCT00989742|Antimalarials|antimalarials|mesh-ancestor
101813683|NCT00989742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101813684|NCT00989742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101813685|NCT05408208|Triamcinolone|triamcinolone|mesh-list
101813686|NCT05408208|Methotrexate|methotrexate|mesh-list
101813687|NCT05408208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101813688|NCT05408208|Abortifacient Agents|abortifacient agents|mesh-ancestor
101813689|NCT05408208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101813690|NCT05408208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813691|NCT05408208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101813692|NCT05408208|Antimetabolites|antimetabolites|mesh-ancestor
101827471|NCT05667324|Glucocorticoids|glucocorticoids|mesh-ancestor
101827473|NCT05667324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101827474|NCT05667324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101827475|NCT05667324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827476|NCT05667324|Anesthetics, Local|anesthetics, local|mesh-ancestor
101827477|NCT05667324|Anesthetics|anesthetics|mesh-ancestor
101827478|NCT05667324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101827479|NCT05667324|Sensory System Agents|sensory system agents|mesh-ancestor
101827480|NCT05663242|Anesthetics|anesthetics|mesh-list
101827482|NCT05663242|Sevoflurane|sevoflurane|mesh-list
101827485|NCT05663242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101827486|NCT05663242|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101827488|NCT05663242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101827489|NCT05663242|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101827490|NCT05661851|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101827492|NCT05661851|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101827494|NCT05656521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101827495|NCT05656521|Antiemetics|antiemetics|mesh-ancestor
101827496|NCT05656521|Autonomic Agents|autonomic agents|mesh-ancestor
101827497|NCT05656521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101827498|NCT05656521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827499|NCT05656521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101827500|NCT05656521|Glucocorticoids|glucocorticoids|mesh-ancestor
101827502|NCT05656521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101827503|NCT05656521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101827504|NCT05656521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827505|NCT05655013|Zoledronic Acid|zoledronic acid|mesh-list
101827506|NCT05655013|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101827507|NCT05655013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827508|NCT05653271|Cyclophosphamide|cyclophosphamide|mesh-list
101827509|NCT05653271|Fludarabine|fludarabine|mesh-list
101827510|NCT05653271|Obinutuzumab|obinutuzumab|mesh-list
101827511|NCT05653271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101827512|NCT05653271|Immunologic Factors|immunologic factors|mesh-ancestor
101827513|NCT05653271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827514|NCT05653271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101827515|NCT05653271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101827516|NCT05653271|Alkylating Agents|alkylating agents|mesh-ancestor
101827517|NCT05653271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827518|NCT05653271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827519|NCT05653271|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101827520|NCT05653271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101827521|NCT05644184|Vaccines|vaccines|mesh-list
101827522|NCT05644184|Immunologic Factors|immunologic factors|mesh-ancestor
101827523|NCT05644184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827526|NCT05644041|Antimetabolites|antimetabolites|mesh-ancestor
101827527|NCT05644041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827528|NCT05644041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827529|NCT05633992|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101827530|NCT05633992|Immunologic Factors|immunologic factors|mesh-ancestor
101827531|NCT05633992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827533|NCT05628623|Azacitidine|azacitidine|mesh-list
101813693|NCT05408208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813694|NCT05408208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101813695|NCT05408208|Dermatologic Agents|dermatologic agents|mesh-ancestor
101813696|NCT05408208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101813697|NCT05408208|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101813698|NCT05408208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101813699|NCT05408208|Immunologic Factors|immunologic factors|mesh-ancestor
101813700|NCT05408208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101813701|NCT05408208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101813702|NCT05408208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101827534|NCT05628623|Daunorubicin|daunorubicin|mesh-list
101827535|NCT05628623|Venetoclax|venetoclax|mesh-list
101827536|NCT05628623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101827537|NCT05628623|Antimetabolites|antimetabolites|mesh-ancestor
101827538|NCT05628623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827539|NCT05628623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827540|NCT05628623|Antiviral Agents|antiviral agents|mesh-ancestor
101827541|NCT05628623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101827542|NCT05628623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101827543|NCT05628623|Immunologic Factors|immunologic factors|mesh-ancestor
101827544|NCT05628623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827545|NCT05628623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101827546|NCT05628623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101827547|NCT05628623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101827548|NCT05628623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101827550|NCT05616923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827551|NCT05616923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101827552|NCT05616923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101827553|NCT05616923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827554|NCT05616013|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101827555|NCT05616013|Antibodies, Blocking|antibodies, blocking|mesh-list
101827556|NCT05616013|Immunologic Factors|immunologic factors|mesh-ancestor
101827557|NCT05616013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827558|NCT05608200|Lenvatinib|lenvatinib|mesh-list
101827559|NCT05608200|Chlorotrianisene|chlorotrianisene|mesh-list
101827560|NCT05608200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827561|NCT05608200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101827562|NCT05608200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101827563|NCT05608200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827564|NCT05608200|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101827565|NCT05608200|Estrogens|estrogens|mesh-ancestor
101827566|NCT05608200|Hormones|hormones|mesh-ancestor
101827567|NCT05608200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101827568|NCT05608200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827569|NCT05608200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101827570|NCT05606692|Propofol|propofol|mesh-list
101827571|NCT05606692|Sevoflurane|sevoflurane|mesh-list
101827572|NCT05606692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101827573|NCT05606692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101827574|NCT05606692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827575|NCT05606692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101827576|NCT05606692|Anesthetics, General|anesthetics, general|mesh-ancestor
101827577|NCT05606692|Anesthetics|anesthetics|mesh-ancestor
101827578|NCT05606692|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101827579|NCT05606692|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101827580|NCT05601336|Metformin|metformin|mesh-list
101827581|NCT05601336|Dapagliflozin|dapagliflozin|mesh-list
101827584|NCT05601336|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101827585|NCT05601336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827586|NCT05599243|Dutasteride|dutasteride|mesh-list
101827587|NCT05599243|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101827588|NCT05599243|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101827589|NCT05599243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101813703|NCT05408208|Glucocorticoids|glucocorticoids|mesh-ancestor
101813704|NCT05408208|Hormones|hormones|mesh-ancestor
101813705|NCT05408208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101813706|NCT00758693|Rituximab|rituximab|mesh-list
101813707|NCT00758693|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101813708|NCT00758693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101813709|NCT00758693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101813710|NCT00758693|Immunologic Factors|immunologic factors|mesh-ancestor
101813711|NCT00758693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813712|NCT00758693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101813713|NCT00758693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101813714|NCT00758693|Alkylating Agents|alkylating agents|mesh-ancestor
101246512|NCT01666431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101827590|NCT05599243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827591|NCT05599243|Hormone Antagonists|hormone antagonists|mesh-ancestor
101827592|NCT05599243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101827593|NCT05599243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827594|NCT05595083|Dexmedetomidine|dexmedetomidine|mesh-list
101827595|NCT05595083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101827596|NCT05595083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101827597|NCT05595083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827598|NCT05595083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101827599|NCT05595083|Analgesics|analgesics|mesh-ancestor
101827600|NCT05595083|Sensory System Agents|sensory system agents|mesh-ancestor
101827601|NCT05595083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101827602|NCT05595083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101827603|NCT05595083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101827604|NCT05595083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101827605|NCT05595083|Adrenergic Agents|adrenergic agents|mesh-ancestor
101827606|NCT05595083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101827607|NCT05595083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827608|NCT05580666|Azithromycin|azithromycin|mesh-list
101827609|NCT05580666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101827610|NCT05580666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101827612|NCT05557110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827613|NCT05556889|Iodine|iodine|mesh-list
101827614|NCT05556889|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101827615|NCT05556889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101827616|NCT05556889|Trace Elements|trace elements|mesh-ancestor
101827617|NCT05556889|Micronutrients|micronutrients|mesh-ancestor
101827618|NCT05556889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827619|NCT05544136|Carboplatin|carboplatin|mesh-list
101827620|NCT05544136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827621|NCT05541471|Digoxin|digoxin|mesh-list
101827622|NCT05541471|Midazolam|midazolam|mesh-list
101827623|NCT05541471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101827624|NCT05541471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101827625|NCT05541471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101827626|NCT05541471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827627|NCT05541471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101827628|NCT05541471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101827629|NCT05541471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101827630|NCT05541471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101827631|NCT05541471|Anesthetics, General|anesthetics, general|mesh-ancestor
101827632|NCT05541471|Anesthetics|anesthetics|mesh-ancestor
101827633|NCT05541471|GABA Modulators|gaba modulators|mesh-ancestor
101827634|NCT05541471|GABA Agents|gaba agents|mesh-ancestor
101827636|NCT05541471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827637|NCT05541471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101827638|NCT05541471|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101827639|NCT05541471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101813715|NCT00758693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813716|NCT00989820|Coal Tar|coal tar|mesh-list
101813717|NCT00989820|Keratolytic Agents|keratolytic agents|mesh-ancestor
101813718|NCT00989820|Dermatologic Agents|dermatologic agents|mesh-ancestor
101813719|NCT05357820|Itraconazole|itraconazole|mesh-list
101813720|NCT05357820|Rifampin|rifampin|mesh-list
101813721|NCT05357820|Antifungal Agents|antifungal agents|mesh-ancestor
101813722|NCT05357820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101813723|NCT05357820|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101827640|NCT05541471|Protective Agents|protective agents|mesh-ancestor
101827641|NCT05516914|Cisplatin|cisplatin|mesh-list
101827642|NCT05516914|Gemcitabine|gemcitabine|mesh-list
101827643|NCT05516914|Docetaxel|docetaxel|mesh-list
101827644|NCT05516914|Tislelizumab|tislelizumab|mesh-list
101827645|NCT05516914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827646|NCT05516914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101827647|NCT05516914|Antimetabolites|antimetabolites|mesh-ancestor
101827648|NCT05516914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827649|NCT05516914|Tubulin Modulators|tubulin modulators|mesh-ancestor
101827650|NCT05516914|Antimitotic Agents|antimitotic agents|mesh-ancestor
101827651|NCT05516914|Mitosis Modulators|mitosis modulators|mesh-ancestor
101827652|NCT05516914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101827653|NCT05504278|Carboplatin|carboplatin|mesh-list
101827654|NCT05504278|Pemetrexed|pemetrexed|mesh-list
101827655|NCT05504278|Cisplatin|cisplatin|mesh-list
101827656|NCT05504278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827657|NCT05504278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101827658|NCT05504278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827659|NCT05504278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101827660|NCT05504278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101827661|NCT05498792|Nivolumab|nivolumab|mesh-list
101827662|NCT05498792|Ipilimumab|ipilimumab|mesh-list
101827663|NCT05498792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101827664|NCT05498792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827665|NCT05498792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101827666|NCT05498792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827667|NCT05490134|Naloxone|naloxone|mesh-list
101827668|NCT05490134|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101827669|NCT05490134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827670|NCT05490134|Sensory System Agents|sensory system agents|mesh-ancestor
101827671|NCT05490134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101827672|NCT05479812|Pembrolizumab|pembrolizumab|mesh-list
101827673|NCT05479812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101827675|NCT05479812|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101827676|NCT05479812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827677|NCT05475613|Immunomodulating Agents|immunomodulating agents|mesh-list
101827678|NCT05475613|Immunologic Factors|immunologic factors|mesh-ancestor
101827679|NCT05475613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827680|NCT05453968|Berotralstat|berotralstat|mesh-list
101827681|NCT05453968|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101827682|NCT05453968|Protease Inhibitors|protease inhibitors|mesh-ancestor
101827683|NCT05453968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101827684|NCT05453968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827685|NCT05443035|Anti-Infective Agents|anti-infective agents|mesh-list
101827688|NCT05440201|Anticoagulants|anticoagulants|mesh-list
101827689|NCT05440201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101827690|NCT05440201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101827691|NCT05440201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827692|NCT05422885|Dasatinib|dasatinib|mesh-list
101827693|NCT05422885|Quercetin|quercetin|mesh-list
101827694|NCT05422885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827695|NCT05422885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101827696|NCT05422885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101827697|NCT05422885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827698|NCT05422885|Antioxidants|antioxidants|mesh-ancestor
101827699|NCT05422885|Protective Agents|protective agents|mesh-ancestor
101813724|NCT05357820|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101813725|NCT05357820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101813726|NCT05357820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813727|NCT05357820|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101813728|NCT05357820|Hormone Antagonists|hormone antagonists|mesh-ancestor
101813729|NCT05357820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101813730|NCT05357820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813731|NCT05357820|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101813732|NCT05357820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101813733|NCT05357820|Antitubercular Agents|antitubercular agents|mesh-ancestor
101813734|NCT05357820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101813735|NCT05357820|Leprostatic Agents|leprostatic agents|mesh-ancestor
101827700|NCT05422885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827701|NCT05418049|Memantine|memantine|mesh-list
101827702|NCT05418049|Baclofen|baclofen|mesh-list
101827703|NCT05418049|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101827704|NCT05418049|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101827705|NCT05418049|Dopamine Agents|dopamine agents|mesh-ancestor
101827706|NCT05418049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101827707|NCT05418049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827708|NCT05418049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827709|NCT05418049|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101827710|NCT05418049|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101827711|NCT05418049|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101827712|NCT05418049|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101827713|NCT05418049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101827714|NCT05418049|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101827715|NCT05418049|GABA Agonists|gaba agonists|mesh-ancestor
101827716|NCT05418049|GABA Agents|gaba agents|mesh-ancestor
101827717|NCT05414500|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101827718|NCT05414500|Mogamulizumab|mogamulizumab|mesh-list
101827719|NCT05414500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101827720|NCT05414500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827721|NCT05414500|Immunotoxins|immunotoxins|mesh-ancestor
101827722|NCT05414500|Immunoconjugates|immunoconjugates|mesh-ancestor
101827723|NCT05414500|Immunologic Factors|immunologic factors|mesh-ancestor
101827724|NCT05414500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827725|NCT05411484|Doxycycline|doxycycline|mesh-list
101313435|NCT00000157|Aspirin|aspirin|mesh-list
101827726|NCT05411484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101827727|NCT05411484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101827728|NCT05411484|Antimalarials|antimalarials|mesh-ancestor
101827729|NCT05411484|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101827731|NCT05403450|Decitabine|decitabine|mesh-list
101827732|NCT05403450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101827733|NCT05403450|Antimetabolites|antimetabolites|mesh-ancestor
101827734|NCT05403450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313412|NCT00000145|Zinc|zinc|mesh-list
101827735|NCT05403450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827736|NCT05403450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101827737|NCT05369676|Ritonavir|ritonavir|mesh-list
101827738|NCT05369676|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101827739|NCT05369676|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101827740|NCT05369676|Protease Inhibitors|protease inhibitors|mesh-ancestor
101827742|NCT05369676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827744|NCT05369676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101827745|NCT05369676|Antiviral Agents|antiviral agents|mesh-ancestor
101827746|NCT05369676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101827747|NCT05369676|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101827748|NCT05369676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101827749|NCT06014983|Ferrous fumarate|ferrous fumarate|mesh-list
101827750|NCT06014983|Trace Elements|trace elements|mesh-ancestor
101813738|NCT05357820|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101813739|NCT05357820|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101813740|NCT05357820|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101813741|NCT05357820|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101813742|NCT05357820|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101813743|NCT00748787|Psyllium|psyllium|mesh-list
101827751|NCT06014983|Micronutrients|micronutrients|mesh-ancestor
101827752|NCT06014983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827753|NCT06014957|Anesthetics|anesthetics|mesh-list
101827754|NCT06014957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101827760|NCT06014853|Abiraterone Acetate|abiraterone acetate|mesh-list
101827761|NCT06014853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827762|NCT06014853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101827764|NCT06014853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827765|NCT06014853|Hormone Antagonists|hormone antagonists|mesh-ancestor
101827766|NCT06014853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101827767|NCT06014853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827768|NCT06014853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101827769|NCT06014827|Osimertinib|osimertinib|mesh-list
101827770|NCT06014827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827771|NCT06014827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101827772|NCT06014827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101827773|NCT06014827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827774|NCT06014801|Dialysis Solutions|dialysis solutions|mesh-list
101827775|NCT06014801|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101827776|NCT06014775|Antibodies|antibodies|mesh-list
101827777|NCT06014775|Immunologic Factors|immunologic factors|mesh-ancestor
101827778|NCT06014775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827779|NCT06014749|Anesthetics|anesthetics|mesh-list
101827780|NCT06014749|Anesthetics, Local|anesthetics, local|mesh-list
101827781|NCT06014749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101827782|NCT06014749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827783|NCT06014749|Sensory System Agents|sensory system agents|mesh-ancestor
101827784|NCT06014749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101827786|NCT06014658|Immunoconjugates|immunoconjugates|mesh-list
101827787|NCT06014658|Immunologic Factors|immunologic factors|mesh-ancestor
101827792|NCT06014606|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101827793|NCT06014606|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101827794|NCT06014606|Adrenergic Agents|adrenergic agents|mesh-ancestor
101827795|NCT06014606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101827796|NCT06014606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827797|NCT06014606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827798|NCT06014606|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101827799|NCT06014606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101313419|NCT00000151|Aspirin|aspirin|mesh-list
101827802|NCT06014606|Autonomic Agents|autonomic agents|mesh-ancestor
101827803|NCT06014606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101827804|NCT06014606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101827805|NCT06014606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101827806|NCT06014606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101827807|NCT06014606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101827808|NCT06014606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101827809|NCT06014606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101827810|NCT06014606|Dopamine Agents|dopamine agents|mesh-ancestor
101827811|NCT06014606|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101827812|NCT06014528|Doxorubicin|doxorubicin|mesh-list
101813754|NCT00986960|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101813755|NCT00986960|Hormones|hormones|mesh-ancestor
101813756|NCT00986960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101813757|NCT00986960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827813|NCT06014528|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101827814|NCT06014528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101827815|NCT06014528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827816|NCT06014528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101827817|NCT06014528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101827818|NCT06014528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101827819|NCT06014528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827820|NCT06014515|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101827821|NCT06014515|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101827822|NCT06014515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827823|NCT06014489|Cobicistat|cobicistat|mesh-list
101827824|NCT06014489|Azacitidine|azacitidine|mesh-list
101827825|NCT06014489|Venetoclax|venetoclax|mesh-list
101827826|NCT06014489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101827827|NCT06014489|Antimetabolites|antimetabolites|mesh-ancestor
101827828|NCT06014489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827829|NCT06014489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827830|NCT06014489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101827831|NCT06014489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101827832|NCT06014489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101827833|NCT06014489|Antiviral Agents|antiviral agents|mesh-ancestor
101827834|NCT06014489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101827835|NCT06014489|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101827836|NCT06014489|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101827837|NCT06014385|Scopolamine|scopolamine|mesh-list
101827838|NCT06014385|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101827839|NCT06014385|LSN3172176|lsn3172176|mesh-list
101827840|NCT06014385|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101827841|NCT06014385|Antiemetics|antiemetics|mesh-ancestor
101827842|NCT06014385|Autonomic Agents|autonomic agents|mesh-ancestor
101827843|NCT06014385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101827844|NCT06014385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827846|NCT06014385|Mydriatics|mydriatics|mesh-ancestor
101827847|NCT06014385|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101827848|NCT06014385|Cholinergic Agents|cholinergic agents|mesh-ancestor
101827849|NCT06014385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101827850|NCT06014385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827851|NCT06014385|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101827852|NCT06014385|Parasympatholytics|parasympatholytics|mesh-ancestor
101827853|NCT06014385|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101813758|NCT05711966|Pulmonary Surfactants|pulmonary surfactants|mesh-list
101813759|NCT05711966|Respiratory System Agents|respiratory system agents|mesh-ancestor
101813760|NCT00759005|Hydrocortisone|hydrocortisone|mesh-list
101813761|NCT00759005|Propranolol|propranolol|mesh-list
101813762|NCT00759005|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101813763|NCT00759005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101813764|NCT00759005|Adrenergic Agents|adrenergic agents|mesh-ancestor
101813765|NCT00759005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101827868|NCT06014138|Propofol|propofol|mesh-list
101827869|NCT06014138|Isoflurane|isoflurane|mesh-list
101827870|NCT06014138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101827871|NCT06014138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101827872|NCT06014138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827874|NCT06014138|Anesthetics, General|anesthetics, general|mesh-ancestor
101827875|NCT06014138|Anesthetics|anesthetics|mesh-ancestor
101827876|NCT06014138|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101827877|NCT06014073|Cyclophosphamide|cyclophosphamide|mesh-list
101827878|NCT06014073|Fludarabine|fludarabine|mesh-list
101827879|NCT06014073|Fludarabine phosphate|fludarabine phosphate|mesh-list
101827880|NCT06014073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101827881|NCT06014073|Immunologic Factors|immunologic factors|mesh-ancestor
101827884|NCT06014073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101827885|NCT06014073|Alkylating Agents|alkylating agents|mesh-ancestor
101827886|NCT06014073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827887|NCT06014073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827888|NCT06014073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101827889|NCT06014073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101827890|NCT06014073|Antimetabolites|antimetabolites|mesh-ancestor
101827891|NCT06013956|Levodopa|levodopa|mesh-list
101827892|NCT06013956|Carbidopa|carbidopa|mesh-list
101827893|NCT06013956|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101827894|NCT06013956|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101827896|NCT06013956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101827897|NCT06013956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827898|NCT06013956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827899|NCT06013956|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101827900|NCT06013956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101827901|NCT06013865|Empagliflozin|empagliflozin|mesh-list
101827902|NCT06013865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101827903|NCT06013865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827904|NCT06013865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101827905|NCT06013865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827906|NCT06013839|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
101827907|NCT06013839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101827908|NCT06013839|Vasodilator Agents|vasodilator agents|mesh-ancestor
101827909|NCT06013735|Listerine|listerine|mesh-list
101827910|NCT06013735|Fluorides|fluorides|mesh-list
101827911|NCT06013735|Sodium Fluoride|sodium fluoride|mesh-list
101827912|NCT06013735|Cariostatic Agents|cariostatic agents|mesh-ancestor
101827913|NCT06013735|Protective Agents|protective agents|mesh-ancestor
101827914|NCT06013735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827915|NCT06013735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101827916|NCT06013735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101827917|NCT06013618|Irinotecan|irinotecan|mesh-list
101827918|NCT06013618|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
101827919|NCT06013618|Temozolomide|temozolomide|mesh-list
101827920|NCT06013618|Molgramostim|molgramostim|mesh-list
101827921|NCT06013618|Sargramostim|sargramostim|mesh-list
101827922|NCT06013618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101827923|NCT06013618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101827924|NCT06013618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827925|NCT06013618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827926|NCT06013618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101827927|NCT06013618|Alkylating Agents|alkylating agents|mesh-ancestor
101813766|NCT00759005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813767|NCT00759005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813768|NCT00759005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101813769|NCT00759005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101813770|NCT00759005|Vasodilator Agents|vasodilator agents|mesh-ancestor
101813771|NCT00759005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101813772|NCT04360070|Ketamine|ketamine|mesh-list
101813773|NCT04360070|Analgesics|analgesics|mesh-ancestor
101813774|NCT04360070|Sensory System Agents|sensory system agents|mesh-ancestor
101813775|NCT04360070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101827928|NCT06013618|Immunologic Factors|immunologic factors|mesh-ancestor
101827929|NCT06013618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827930|NCT06013540|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
101827931|NCT06013540|Tretinoin|tretinoin|mesh-list
101827932|NCT06013540|Hydroquinone|hydroquinone|mesh-list
101827933|NCT06013540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827934|NCT06013540|Antioxidants|antioxidants|mesh-ancestor
101827935|NCT06013540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485206|NCT00349362|Hormones|hormones|mesh-ancestor
101827936|NCT06013540|Protective Agents|protective agents|mesh-ancestor
101827937|NCT06013540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827938|NCT06013540|Keratolytic Agents|keratolytic agents|mesh-ancestor
101827939|NCT06013540|Dermatologic Agents|dermatologic agents|mesh-ancestor
101827940|NCT06013540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101827941|NCT06013540|Glucocorticoids|glucocorticoids|mesh-ancestor
101827942|NCT06013540|Hormones|hormones|mesh-ancestor
101827943|NCT06013540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101827944|NCT06013540|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101827945|NCT06013436|Cyclosporine|cyclosporine|mesh-list
101827946|NCT06013436|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101827947|NCT06013436|Cyclosporins|cyclosporins|mesh-list
101827948|NCT06013436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101827949|NCT06013436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827950|NCT06013436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101827951|NCT06013436|Immunologic Factors|immunologic factors|mesh-ancestor
101827952|NCT06013436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827953|NCT06013436|Antifungal Agents|antifungal agents|mesh-ancestor
101827954|NCT06013436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101827955|NCT06013436|Dermatologic Agents|dermatologic agents|mesh-ancestor
101827956|NCT06013436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101827957|NCT06013436|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101827958|NCT06013436|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101827959|NCT06013423|Cyclosporine|cyclosporine|mesh-list
101827960|NCT06013423|Mycophenolic Acid|mycophenolic acid|mesh-list
101827961|NCT06013423|Cyclophosphamide|cyclophosphamide|mesh-list
101827962|NCT06013423|Thiotepa|thiotepa|mesh-list
101827964|NCT06013423|Fludarabine phosphate|fludarabine phosphate|mesh-list
101827965|NCT06013423|Cyclosporins|cyclosporins|mesh-list
101827966|NCT06013423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101827967|NCT06013423|Immunologic Factors|immunologic factors|mesh-ancestor
101827968|NCT06013423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827969|NCT06013423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101827970|NCT06013423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101827971|NCT06013423|Alkylating Agents|alkylating agents|mesh-ancestor
101827972|NCT06013423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827973|NCT06013423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827974|NCT06013423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101827975|NCT06013423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101827976|NCT06013423|Antimetabolites|antimetabolites|mesh-ancestor
101827977|NCT06013423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101827978|NCT06013423|Antifungal Agents|antifungal agents|mesh-ancestor
101827979|NCT06013423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101827980|NCT06013423|Dermatologic Agents|dermatologic agents|mesh-ancestor
101827981|NCT06013423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101827982|NCT06013423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101827983|NCT06013423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101813776|NCT04360070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813777|NCT04360070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101813778|NCT04360070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101813779|NCT04360070|Anesthetics, General|anesthetics, general|mesh-ancestor
101813780|NCT04360070|Anesthetics|anesthetics|mesh-ancestor
101813781|NCT04360070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101813782|NCT04360070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101827984|NCT06013423|Antitubercular Agents|antitubercular agents|mesh-ancestor
101827985|NCT06013423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101827986|NCT06013345|Propofol|propofol|mesh-list
101827987|NCT06013345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101827988|NCT06013345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101827989|NCT06013345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827990|NCT06013345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101827991|NCT06013345|Anesthetics, General|anesthetics, general|mesh-ancestor
101827992|NCT06013345|Anesthetics|anesthetics|mesh-ancestor
101827993|NCT06013319|Esmolol|esmolol|mesh-list
101827994|NCT06013319|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101827995|NCT06013319|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101827996|NCT06013319|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101827997|NCT06013319|Adrenergic Agents|adrenergic agents|mesh-ancestor
101827998|NCT06013319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101827999|NCT06013319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828000|NCT06013319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101828001|NCT06013293|Zinc Oxide|zinc oxide|mesh-list
101828002|NCT06013293|Dermatologic Agents|dermatologic agents|mesh-ancestor
101828003|NCT06013293|Sunscreening Agents|sunscreening agents|mesh-ancestor
101828004|NCT06013293|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101828005|NCT06013293|Protective Agents|protective agents|mesh-ancestor
101828006|NCT06013293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101828007|NCT06013241|Mometasone Furoate|mometasone furoate|mesh-list
101828008|NCT06013241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101828009|NCT06013241|Dermatologic Agents|dermatologic agents|mesh-ancestor
101828010|NCT06013241|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101828011|NCT06013163|Orlistat|orlistat|mesh-list
101828012|NCT06013163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101828013|NCT06013163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828014|NCT06013163|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101828015|NCT06013163|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101828017|NCT06013150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101828018|NCT06013150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101828019|NCT06013150|Adrenergic Agents|adrenergic agents|mesh-ancestor
101828020|NCT06013150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101828021|NCT06013150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828023|NCT06013150|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101828024|NCT06013150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101828026|NCT06013150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101828027|NCT06013150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101828028|NCT06013150|Respiratory System Agents|respiratory system agents|mesh-ancestor
101828029|NCT06013150|Mydriatics|mydriatics|mesh-ancestor
101828031|NCT06013150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101828032|NCT06013111|Cyclophosphamide|cyclophosphamide|mesh-list
101828033|NCT06013111|Fludarabine|fludarabine|mesh-list
101828034|NCT06013111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101828035|NCT06013111|Immunologic Factors|immunologic factors|mesh-ancestor
101828036|NCT06013111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101828037|NCT06013111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101828038|NCT06013111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101828039|NCT06013111|Alkylating Agents|alkylating agents|mesh-ancestor
101828040|NCT06013111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828041|NCT06013111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101828042|NCT06013111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101828043|NCT06013020|Aspirin|aspirin|mesh-list
101828044|NCT06013020|Rivaroxaban|rivaroxaban|mesh-list
101828045|NCT06013020|Clopidogrel|clopidogrel|mesh-list
101828046|NCT06013020|Ticagrelor|ticagrelor|mesh-list
101813783|NCT04360070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101813784|NCT04360070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101813785|NCT04360070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813786|NCT00748943|Chlorine dioxide|chlorine dioxide|mesh-list
101813787|NCT00748943|Dental Disinfectants|dental disinfectants|mesh-ancestor
101813788|NCT00748943|Disinfectants|disinfectants|mesh-ancestor
101813789|NCT00748943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101813790|NCT00749021|Ranibizumab|ranibizumab|mesh-list
101813791|NCT00749021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101813792|NCT00749021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101828047|NCT06013020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101828049|NCT06013020|Analgesics|analgesics|mesh-ancestor
101828050|NCT06013020|Sensory System Agents|sensory system agents|mesh-ancestor
101828051|NCT06013020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101828052|NCT06013020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101828053|NCT06013020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101828054|NCT06013020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101828055|NCT06013020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101828056|NCT06013020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101828057|NCT06013020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828058|NCT06013020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101828059|NCT06013020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101828060|NCT06013020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101828061|NCT06013020|Antipyretics|antipyretics|mesh-ancestor
101828062|NCT06013020|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101828063|NCT06013020|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101828065|NCT06013020|Purinergic Agents|purinergic agents|mesh-ancestor
101828066|NCT06013020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101828067|NCT06013020|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101828068|NCT06013020|Antithrombins|antithrombins|mesh-ancestor
101828069|NCT06013020|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101828070|NCT06013020|Protease Inhibitors|protease inhibitors|mesh-ancestor
101828071|NCT06013020|Anticoagulants|anticoagulants|mesh-ancestor
101828072|NCT06012929|TIC10 compound|tic10 compound|mesh-list
101828073|NCT06012929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101828074|NCT06012916|Esketamine|esketamine|mesh-list
101828075|NCT06012916|Antidepressive Agents|antidepressive agents|mesh-ancestor
101828076|NCT06012916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101828077|NCT06008860|Azelastine|azelastine|mesh-list
101828078|NCT06008860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101828079|NCT06008860|Autonomic Agents|autonomic agents|mesh-ancestor
101828080|NCT06008860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101828081|NCT06008860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101828082|NCT06008860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101828083|NCT06008860|Respiratory System Agents|respiratory system agents|mesh-ancestor
101828084|NCT06008860|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101828085|NCT06008860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101828086|NCT06008860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828087|NCT06008860|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101828088|NCT06008860|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101828089|NCT06008860|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101828090|NCT06008860|Histamine Antagonists|histamine antagonists|mesh-ancestor
101828092|NCT06008860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101828093|NCT05997004|Glycopyrrolate|glycopyrrolate|mesh-list
101828280|NCT05815160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828307|NCT05784246|Analgesics|analgesics|mesh-ancestor
101828308|NCT05784246|Sensory System Agents|sensory system agents|mesh-ancestor
101828309|NCT05784246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101828310|NCT05784246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813805|NCT00987038|Midazolam|midazolam|mesh-list
101813806|NCT00987038|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101813807|NCT00987038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101813808|NCT00987038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101813809|NCT00987038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813810|NCT00987038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101813811|NCT00987038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101813812|NCT00987038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101813813|NCT00987038|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101813814|NCT00987038|Anesthetics, General|anesthetics, general|mesh-ancestor
101813815|NCT00987038|Anesthetics|anesthetics|mesh-ancestor
101828311|NCT05784246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101828312|NCT05784246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101828313|NCT05784246|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101828314|NCT05784246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101828315|NCT05782881|Glucagon|glucagon|mesh-list
101828316|NCT05782881|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101828317|NCT05782881|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101828318|NCT05782881|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101828319|NCT05782881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101828320|NCT05782881|Hormones|hormones|mesh-ancestor
101828321|NCT05782881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101828322|NCT05782881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101828323|NCT05782881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828324|NCT05782881|Incretins|incretins|mesh-ancestor
101828325|NCT05782881|Protease Inhibitors|protease inhibitors|mesh-ancestor
101828335|NCT05765812|Temozolomide|temozolomide|mesh-list
101828338|NCT05765812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828339|NCT05765812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101828340|NCT05759442|Metformin|metformin|mesh-list
101828341|NCT05759442|Acetic Acid|acetic acid|mesh-list
101828342|NCT05759442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101828343|NCT05759442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101828344|NCT05759442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101828345|NCT05759442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101828346|NCT05730218|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101828347|NCT05730218|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101828349|NCT05728346|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101828350|NCT05728346|Immunologic Factors|immunologic factors|mesh-ancestor
101828351|NCT05728346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101828352|NCT05728346|Viscosupplements|viscosupplements|mesh-ancestor
101828353|NCT05728346|Protective Agents|protective agents|mesh-ancestor
101828354|NCT05722015|Paclitaxel|paclitaxel|mesh-list
101828355|NCT05722015|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101828358|NCT05722015|Pemetrexed|pemetrexed|mesh-list
101828359|NCT05722015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101828360|NCT05722015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101828361|NCT05722015|Tubulin Modulators|tubulin modulators|mesh-ancestor
101828362|NCT05722015|Antimitotic Agents|antimitotic agents|mesh-ancestor
101828363|NCT05722015|Mitosis Modulators|mitosis modulators|mesh-ancestor
101828364|NCT05722015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828365|NCT05722015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101828366|NCT05722015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101828367|NCT05722015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101828368|NCT05722015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101828369|NCT05722015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101828370|NCT05718843|BI 425809|bi 425809|mesh-list
101828371|NCT05718843|Nootropic Agents|nootropic agents|mesh-ancestor
101828446|NCT05631899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101828447|NCT05631899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101828448|NCT05631899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101828449|NCT05631899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101828450|NCT05631899|Tubulin Modulators|tubulin modulators|mesh-ancestor
101828451|NCT05631899|Antimitotic Agents|antimitotic agents|mesh-ancestor
101828452|NCT05631899|Mitosis Modulators|mitosis modulators|mesh-ancestor
101813817|NCT00987038|GABA Agents|gaba agents|mesh-ancestor
101813818|NCT00987038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101813819|NCT00987038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813820|NCT05711810|Ubiquinone|ubiquinone|mesh-list
101813821|NCT05711810|Coenzyme Q10|coenzyme q10|mesh-list
101813822|NCT05711810|Tocopherols|tocopherols|mesh-list
101813823|NCT05711810|Vitamin E|vitamin e|mesh-list
101813824|NCT05711810|alpha-Tocopherol|alpha-tocopherol|mesh-list
101813825|NCT05711810|Metoprolol|metoprolol|mesh-list
101813826|NCT05711810|Enalapril|enalapril|mesh-list
101813827|NCT05711810|Enalaprilat|enalaprilat|mesh-list
101828453|NCT05631886|Cyclophosphamide|cyclophosphamide|mesh-list
101828454|NCT05631886|Ipilimumab|ipilimumab|mesh-list
101828455|NCT05631886|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101828456|NCT05631886|Paclitaxel|paclitaxel|mesh-list
101828457|NCT05631886|Antibodies|antibodies|mesh-list
101828458|NCT05631886|Immunoglobulins|immunoglobulins|mesh-list
101828459|NCT05631886|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101828462|NCT05631886|Immunologic Factors|immunologic factors|mesh-ancestor
101828463|NCT05631886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101828464|NCT05631886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101828465|NCT05631886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101828466|NCT05631886|Alkylating Agents|alkylating agents|mesh-ancestor
101828467|NCT05631886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828468|NCT05631886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101828470|NCT05631886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101828471|NCT05631886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101828472|NCT05631886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101828473|NCT05631886|Tubulin Modulators|tubulin modulators|mesh-ancestor
101828474|NCT05631886|Antimitotic Agents|antimitotic agents|mesh-ancestor
101828475|NCT05631886|Mitosis Modulators|mitosis modulators|mesh-ancestor
101828476|NCT05613088|Paclitaxel|paclitaxel|mesh-list
101828477|NCT05613088|Doxorubicin|doxorubicin|mesh-list
101828478|NCT05613088|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101828479|NCT05613088|Topotecan|topotecan|mesh-list
101828481|NCT05613088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101828482|NCT05613088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101828483|NCT05613088|Tubulin Modulators|tubulin modulators|mesh-ancestor
101828484|NCT05613088|Antimitotic Agents|antimitotic agents|mesh-ancestor
101828485|NCT05613088|Mitosis Modulators|mitosis modulators|mesh-ancestor
101828486|NCT05613088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828487|NCT05613088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101828488|NCT05613088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101828489|NCT05613088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101828490|NCT05613088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101828491|NCT05613088|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101828500|NCT05601752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101828501|NCT05601752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101828502|NCT05601752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828503|NCT05600426|Cyclosporine|cyclosporine|mesh-list
101828504|NCT05600426|Cyclophosphamide|cyclophosphamide|mesh-list
101828505|NCT05600426|Methotrexate|methotrexate|mesh-list
101828506|NCT05600426|Fludarabine|fludarabine|mesh-list
101828507|NCT05600426|Cyclosporins|cyclosporins|mesh-list
101828508|NCT05600426|Thymoglobulin|thymoglobulin|mesh-list
101828509|NCT05600426|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101828510|NCT05600426|Immunosuppressive Agents|immunosuppressive agents|mesh-list
101828512|NCT05600426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101828513|NCT05600426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101828514|NCT05600426|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101828515|NCT05600426|Alkylating Agents|alkylating agents|mesh-ancestor
101828516|NCT05600426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828517|NCT05600426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101828518|NCT05600426|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101828519|NCT05600426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101828520|NCT05600426|Abortifacient Agents|abortifacient agents|mesh-ancestor
101828522|NCT05600426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101813828|NCT05711810|Nifedipine|nifedipine|mesh-list
101813829|NCT05711810|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101813830|NCT05711810|Lansoprazole|lansoprazole|mesh-list
101813831|NCT05711810|Superoxide Dismutase|superoxide dismutase|mesh-list
101813832|NCT05711810|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101813833|NCT05711810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101813834|NCT05711810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101246513|NCT01666431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101828524|NCT05600426|Dermatologic Agents|dermatologic agents|mesh-ancestor
101828525|NCT05600426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101828526|NCT05600426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101828527|NCT05600426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101828528|NCT05600426|Antifungal Agents|antifungal agents|mesh-ancestor
101828529|NCT05600426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101828530|NCT05600426|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101828589|NCT05556681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101828603|NCT05552976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101828604|NCT05552976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101828607|NCT05552976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101828608|NCT05552976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101828620|NCT05537740|Pembrolizumab|pembrolizumab|mesh-list
101828621|NCT05537740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101828622|NCT05537740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101828623|NCT05537740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101828624|NCT05537740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828625|NCT05534529|Rezafungin|rezafungin|mesh-list
101828626|NCT05534529|Antifungal Agents|antifungal agents|mesh-ancestor
101828627|NCT05534529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101828639|NCT05501054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828641|NCT05483010|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101828642|NCT05483010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101828643|NCT05483010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101828644|NCT05483010|Antimetabolites|antimetabolites|mesh-ancestor
101828645|NCT05483010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828646|NCT05483010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101828647|NCT05483010|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101828648|NCT05483010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101828671|NCT05368207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101828672|NCT05368207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101828673|NCT05368207|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101828674|NCT05368207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828675|NCT05364944|Octreotide|octreotide|mesh-list
101828676|NCT05364944|Lanreotide|lanreotide|mesh-list
101828677|NCT05364944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101828678|NCT05364944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101828679|NCT05364944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101828681|NCT05350774|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101828683|NCT05350774|gamma-Globulins|gamma-globulins|mesh-list
101828684|NCT05350774|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101828685|NCT05350774|Immunologic Factors|immunologic factors|mesh-ancestor
101828686|NCT05350774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101828687|NCT05350202|Empagliflozin|empagliflozin|mesh-list
101828688|NCT05350202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101828689|NCT05350202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828690|NCT05350202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101828691|NCT05350202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101828692|NCT05341115|Leuprolide|leuprolide|mesh-list
101828694|NCT05341115|Fertility Agents|fertility agents|mesh-ancestor
101828695|NCT05341115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101828696|NCT05341115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101828697|NCT05341115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101828698|NCT05341115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101828699|NCT05330429|Leucovorin|leucovorin|mesh-list
101828700|NCT05330429|Bevacizumab|bevacizumab|mesh-list
101828701|NCT05330429|Magrolimab|magrolimab|mesh-list
101813835|NCT05711810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813836|NCT05711810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101813837|NCT05711810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813838|NCT05711810|Analgesics|analgesics|mesh-ancestor
101813839|NCT05711810|Sensory System Agents|sensory system agents|mesh-ancestor
101813840|NCT05711810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101828702|NCT05330429|Fluorouracil|fluorouracil|mesh-list
101828703|NCT05330429|Irinotecan|irinotecan|mesh-list
101828704|NCT05330429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101828705|NCT05330429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101828706|NCT05330429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101828707|NCT05330429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101828708|NCT05330429|Growth Substances|growth substances|mesh-ancestor
101828709|NCT05330429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101828710|NCT05330429|Growth Inhibitors|growth inhibitors|mesh-ancestor
101828711|NCT05330429|Antimetabolites|antimetabolites|mesh-ancestor
101828712|NCT05330429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828713|NCT05330429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101828714|NCT05330429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101828715|NCT05330429|Immunologic Factors|immunologic factors|mesh-ancestor
101828716|NCT05330429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101828717|NCT05330429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101828718|NCT05330429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101828719|NCT05330429|Antidotes|antidotes|mesh-ancestor
101828720|NCT05330429|Protective Agents|protective agents|mesh-ancestor
101828721|NCT05330429|Vitamin B Complex|vitamin b complex|mesh-ancestor
101828722|NCT05330429|Vitamins|vitamins|mesh-ancestor
101828723|NCT05330429|Micronutrients|micronutrients|mesh-ancestor
101828724|NCT05328908|Trifluridine|trifluridine|mesh-list
101828725|NCT05328908|Nivolumab|nivolumab|mesh-list
101828726|NCT05328908|Relatlimab|relatlimab|mesh-list
101828727|NCT05328908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101828728|NCT05328908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101828729|NCT05328908|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101828730|NCT05328908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828731|NCT05328908|Antimetabolites|antimetabolites|mesh-ancestor
101828748|NCT05319730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101828749|NCT05319730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101828750|NCT05319730|Immunologic Factors|immunologic factors|mesh-ancestor
101828751|NCT05319730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101828752|NCT05319730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101828753|NCT05308446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101828754|NCT05308446|Nivolumab|nivolumab|mesh-list
101828755|NCT05308446|Cetuximab|cetuximab|mesh-list
101828756|NCT05308446|Antibodies|antibodies|mesh-list
101828757|NCT05308446|Immunoglobulins|immunoglobulins|mesh-list
101828758|NCT05308446|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101486033|NCT00320723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101828759|NCT05308446|Immunologic Factors|immunologic factors|mesh-ancestor
101828760|NCT05308446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101828761|NCT05308446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101828763|NCT05308446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828779|NCT05285917|Hydroxyurea|hydroxyurea|mesh-list
101828780|NCT05285917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101828781|NCT05285917|Antisickling Agents|antisickling agents|mesh-ancestor
101828782|NCT05285917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101828783|NCT05285917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828784|NCT05285917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101828785|NCT05280704|Lidocaine|lidocaine|mesh-list
101828786|NCT05280704|Anesthetics, Local|anesthetics, local|mesh-ancestor
101828787|NCT05280704|Anesthetics|anesthetics|mesh-ancestor
101828788|NCT05280704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101828789|NCT05280704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101828791|NCT05280704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101828792|NCT05280704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101828793|NCT05280704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101828794|NCT05280704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101828795|NCT05280704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101813841|NCT05711810|Antidepressive Agents|antidepressive agents|mesh-ancestor
101813842|NCT05711810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101813844|NCT05711810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101813845|NCT05711810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101813846|NCT05711810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101813847|NCT05711810|Sympatholytics|sympatholytics|mesh-ancestor
101813848|NCT05711810|Autonomic Agents|autonomic agents|mesh-ancestor
101813849|NCT05711810|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101813850|NCT05711810|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101828796|NCT05280704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828805|NCT05271318|Pembrolizumab|pembrolizumab|mesh-list
101828806|NCT05271318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101828807|NCT05271318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101828808|NCT05271318|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101828809|NCT05271318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828810|NCT05263908|Ritonavir|ritonavir|mesh-list
101828811|NCT05263908|Nirmatrelvir|nirmatrelvir|mesh-list
101828812|NCT05263908|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
101828813|NCT05263908|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101828814|NCT05263908|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101828815|NCT05263908|Protease Inhibitors|protease inhibitors|mesh-ancestor
101828816|NCT05263908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101828817|NCT05263908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828818|NCT05263908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101828819|NCT05263908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101828820|NCT05263908|Antiviral Agents|antiviral agents|mesh-ancestor
101828821|NCT05263908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101828822|NCT05263908|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101828823|NCT05263908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101828824|NCT05262855|FAPI-46|fapi-46|mesh-list
101828825|NCT05262855|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101828826|NCT05262855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828827|NCT05257408|Paclitaxel|paclitaxel|mesh-list
101828828|NCT05257408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101828829|NCT05257408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101828830|NCT05257408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101828831|NCT05257408|Tubulin Modulators|tubulin modulators|mesh-ancestor
101828832|NCT05257408|Antimitotic Agents|antimitotic agents|mesh-ancestor
101828833|NCT05257408|Mitosis Modulators|mitosis modulators|mesh-ancestor
101828834|NCT05257408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828862|NCT05253573|Nicotine|nicotine|mesh-list
101828864|NCT05253573|Autonomic Agents|autonomic agents|mesh-ancestor
101828865|NCT05253573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101828866|NCT05253573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101828867|NCT05253573|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101828868|NCT05253573|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101828869|NCT05253573|Cholinergic Agents|cholinergic agents|mesh-ancestor
101828870|NCT05253573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101828871|NCT05253573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828873|NCT05236673|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101313474|NCT00000187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101828874|NCT05236673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828875|NCT05236673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101828876|NCT05236673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101828877|NCT05233228|Nicotine|nicotine|mesh-list
101828878|NCT05233228|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101828879|NCT05233228|Autonomic Agents|autonomic agents|mesh-ancestor
101828880|NCT05233228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101828881|NCT05233228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101828882|NCT05233228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101828883|NCT05233228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101828884|NCT05233228|Cholinergic Agents|cholinergic agents|mesh-ancestor
101813851|NCT05711810|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101813852|NCT05711810|Adrenergic Agents|adrenergic agents|mesh-ancestor
101813853|NCT05711810|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101813854|NCT05711810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101813855|NCT05711810|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101813856|NCT05711810|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101813857|NCT05711810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101813858|NCT05711810|Vasodilator Agents|vasodilator agents|mesh-ancestor
101813859|NCT05711810|Tocolytic Agents|tocolytic agents|mesh-ancestor
101813860|NCT05711810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101813861|NCT05711810|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101813862|NCT05711810|Protease Inhibitors|protease inhibitors|mesh-ancestor
101813863|NCT05711810|Micronutrients|micronutrients|mesh-ancestor
101813864|NCT05711810|Vitamins|vitamins|mesh-ancestor
101813865|NCT05711810|Antioxidants|antioxidants|mesh-ancestor
101813866|NCT05711810|Protective Agents|protective agents|mesh-ancestor
101813867|NCT05711810|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101813868|NCT00759083|Bivalirudin|bivalirudin|mesh-list
101828885|NCT05233228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101828886|NCT05233228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828888|NCT05220046|Hallucinogens|hallucinogens|mesh-ancestor
101828889|NCT05220046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101828890|NCT05220046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101828891|NCT05183035|Cytarabine|cytarabine|mesh-list
101828892|NCT05183035|Fludarabine|fludarabine|mesh-list
101828893|NCT05183035|Azacitidine|azacitidine|mesh-list
101828894|NCT05183035|Venetoclax|venetoclax|mesh-list
101828895|NCT05183035|Gemtuzumab|gemtuzumab|mesh-list
101828896|NCT05183035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101828897|NCT05183035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101828898|NCT05183035|Antimetabolites|antimetabolites|mesh-ancestor
101828899|NCT05183035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828900|NCT05183035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101828901|NCT05183035|Immunologic Factors|immunologic factors|mesh-ancestor
101828902|NCT05183035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101828903|NCT05183035|Antiviral Agents|antiviral agents|mesh-ancestor
101828904|NCT05183035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101828905|NCT05183035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101828906|NCT05183035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101828907|NCT05183035|Immunotoxins|immunotoxins|mesh-ancestor
101828908|NCT05183035|Immunoconjugates|immunoconjugates|mesh-ancestor
101828909|NCT05176951|Treprostinil|treprostinil|mesh-list
101828910|NCT05176951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101828911|NCT05173987|Paclitaxel|paclitaxel|mesh-list
101828913|NCT05173987|Carboplatin|carboplatin|mesh-list
101828914|NCT05173987|Pembrolizumab|pembrolizumab|mesh-list
101828915|NCT05173987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101828916|NCT05173987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101828917|NCT05173987|Tubulin Modulators|tubulin modulators|mesh-ancestor
101828918|NCT05173987|Antimitotic Agents|antimitotic agents|mesh-ancestor
101828919|NCT05173987|Mitosis Modulators|mitosis modulators|mesh-ancestor
101828920|NCT05173987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828921|NCT05173987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101828922|NCT05173987|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101828923|NCT05151640|Nintedanib|nintedanib|mesh-list
101828924|NCT05151640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101828925|NCT05151640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101828926|NCT05151640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101828927|NCT05151640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828928|NCT05119712|Terbinafine|terbinafine|mesh-list
101813869|NCT00759083|Antithrombins|antithrombins|mesh-ancestor
101813870|NCT00759083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101813871|NCT00759083|Protease Inhibitors|protease inhibitors|mesh-ancestor
101813872|NCT00759083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101813873|NCT00759083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813874|NCT00759083|Anticoagulants|anticoagulants|mesh-ancestor
101813875|NCT00759239|Timolol|timolol|mesh-list
101813876|NCT00759239|Travoprost|travoprost|mesh-list
101813877|NCT00759239|Maleic acid|maleic acid|mesh-list
101813878|NCT00759239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101813879|NCT00759239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813880|NCT00759239|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101813881|NCT00759239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101813882|NCT00759239|Adrenergic Agents|adrenergic agents|mesh-ancestor
101813883|NCT00759239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101813884|NCT00759239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101828929|NCT05119712|Antifungal Agents|antifungal agents|mesh-ancestor
101828930|NCT05119712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101828931|NCT05119712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101828932|NCT05119712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828933|NCT05115630|Mycophenolic Acid|mycophenolic acid|mesh-list
101828934|NCT05115630|Cyclophosphamide|cyclophosphamide|mesh-list
101828935|NCT05115630|Melphalan|melphalan|mesh-list
101828936|NCT05115630|Fludarabine|fludarabine|mesh-list
101828937|NCT05115630|Fludarabine phosphate|fludarabine phosphate|mesh-list
101828938|NCT05115630|Tacrolimus|tacrolimus|mesh-list
101828939|NCT05115630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101828941|NCT05115630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101828942|NCT05115630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101828943|NCT05115630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101828944|NCT05115630|Alkylating Agents|alkylating agents|mesh-ancestor
101828945|NCT05115630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828946|NCT05115630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101828947|NCT05115630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101828948|NCT05115630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101828952|NCT05115630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101828953|NCT05115630|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101828954|NCT05115630|Antitubercular Agents|antitubercular agents|mesh-ancestor
101828955|NCT05115630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101828956|NCT05115630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101828957|NCT05104047|Lobeline|lobeline|mesh-list
101828958|NCT05104047|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101828959|NCT05104047|Autonomic Agents|autonomic agents|mesh-ancestor
101828960|NCT05104047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101828961|NCT05104047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101828962|NCT05104047|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101828963|NCT05104047|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101828965|NCT05104047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101828966|NCT05104047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828967|NCT05104047|Respiratory System Agents|respiratory system agents|mesh-ancestor
101828968|NCT05101629|Pembrolizumab|pembrolizumab|mesh-list
101828969|NCT05101629|Lenvatinib|lenvatinib|mesh-list
101828970|NCT05101629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101828971|NCT05101629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101828972|NCT05101629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101828973|NCT05101629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828974|NCT05101629|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101828975|NCT05101629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101828977|NCT05081479|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101813885|NCT00759239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101813886|NCT00759239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101813887|NCT03742908|Clindamycin|clindamycin|mesh-list
101828978|NCT05081479|Antiviral Agents|antiviral agents|mesh-ancestor
101828979|NCT05081479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101828980|NCT05081479|Expectorants|expectorants|mesh-ancestor
101828981|NCT05081479|Respiratory System Agents|respiratory system agents|mesh-ancestor
101828982|NCT05081479|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101828983|NCT05081479|Antioxidants|antioxidants|mesh-ancestor
101828984|NCT05081479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828985|NCT05081479|Protective Agents|protective agents|mesh-ancestor
101828986|NCT05081479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101828987|NCT05081479|Antidotes|antidotes|mesh-ancestor
101828989|NCT05059626|Simvastatin|simvastatin|mesh-list
101828990|NCT05059626|Estrogens|estrogens|mesh-list
101828991|NCT05059626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101828992|NCT05059626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101828993|NCT05059626|Antimetabolites|antimetabolites|mesh-ancestor
101828994|NCT05059626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828995|NCT05059626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101828996|NCT05059626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101828997|NCT05059626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101828998|NCT05059626|Hormones|hormones|mesh-ancestor
101828999|NCT05059626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101829000|NCT05059626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829001|NCT05059626|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101829002|NCT05059626|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101829004|NCT05059626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101829005|NCT05053867|Tranexamic Acid|tranexamic acid|mesh-list
101829006|NCT05053867|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101829007|NCT05053867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101829008|NCT05053867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829009|NCT05053867|Hemostatics|hemostatics|mesh-ancestor
101829010|NCT05053867|Coagulants|coagulants|mesh-ancestor
101829011|NCT05042609|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101829012|NCT05042609|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101829013|NCT04985344|Propranolol|propranolol|mesh-list
101829014|NCT04985344|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101829016|NCT04985344|Adrenergic Agents|adrenergic agents|mesh-ancestor
101829020|NCT04985344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101829021|NCT04985344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101829022|NCT04985344|Vasodilator Agents|vasodilator agents|mesh-ancestor
101829023|NCT04974970|Immunomodulating Agents|immunomodulating agents|mesh-list
101829024|NCT04974970|Immunologic Factors|immunologic factors|mesh-ancestor
101829025|NCT04974970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829026|NCT04946370|Pembrolizumab|pembrolizumab|mesh-list
101829027|NCT04946370|Androgens|androgens|mesh-list
101829028|NCT04946370|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101829029|NCT04946370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101829030|NCT04946370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829031|NCT04946370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101829032|NCT04946370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829033|NCT04946370|Hormones|hormones|mesh-ancestor
101829034|NCT04946370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101829035|NCT04946370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829036|NCT04946370|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101829037|NCT04920695|Nitric Oxide|nitric oxide|mesh-list
101829038|NCT04920695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101829039|NCT04920695|Autonomic Agents|autonomic agents|mesh-ancestor
101829040|NCT04920695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101829041|NCT04920695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829042|NCT04920695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101829044|NCT04920695|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101829045|NCT04920695|Antioxidants|antioxidants|mesh-ancestor
101829046|NCT04920695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829047|NCT04920695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101829048|NCT04920695|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101829049|NCT04920695|Vasodilator Agents|vasodilator agents|mesh-ancestor
101829050|NCT04920695|Gasotransmitters|gasotransmitters|mesh-ancestor
101829051|NCT04920695|Protective Agents|protective agents|mesh-ancestor
101829052|NCT04915612|Cytarabine|cytarabine|mesh-list
101829053|NCT04915612|Daunorubicin|daunorubicin|mesh-list
101813888|NCT03742908|Clindamycin palmitate|clindamycin palmitate|mesh-list
101813889|NCT03742908|Clindamycin phosphate|clindamycin phosphate|mesh-list
101813891|NCT03742908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101813892|NCT03742908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101813893|NCT03742908|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101813894|NCT03742908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101813895|NCT03742908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813896|NCT05357196|Gemcitabine|gemcitabine|mesh-list
101813897|NCT05357196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101813898|NCT05357196|Antimetabolites|antimetabolites|mesh-ancestor
101813899|NCT05357196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813900|NCT05357196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101813901|NCT05232630|Fenfluramine|fenfluramine|mesh-list
101813902|NCT05232630|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101829054|NCT04915612|Gemtuzumab|gemtuzumab|mesh-list
101829056|NCT04915612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101829057|NCT04915612|Antimetabolites|antimetabolites|mesh-ancestor
101829058|NCT04915612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829059|NCT04915612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829060|NCT04915612|Antiviral Agents|antiviral agents|mesh-ancestor
101829061|NCT04915612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101829062|NCT04915612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101829063|NCT04915612|Immunologic Factors|immunologic factors|mesh-ancestor
101829064|NCT04915612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829065|NCT04915612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101829066|NCT04915612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101829067|NCT04915612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101829068|NCT04915612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101829069|NCT04915612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101829070|NCT04915612|Immunotoxins|immunotoxins|mesh-ancestor
101829071|NCT04915612|Immunoconjugates|immunoconjugates|mesh-ancestor
101829084|NCT04895358|Paclitaxel|paclitaxel|mesh-list
101829085|NCT04895358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101829086|NCT04895358|Doxorubicin|doxorubicin|mesh-list
101829087|NCT04895358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101829088|NCT04895358|Pembrolizumab|pembrolizumab|mesh-list
101829089|NCT04895358|Capecitabine|capecitabine|mesh-list
101829090|NCT04895358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101829091|NCT04895358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829092|NCT04895358|Tubulin Modulators|tubulin modulators|mesh-ancestor
101829093|NCT04895358|Antimitotic Agents|antimitotic agents|mesh-ancestor
101829094|NCT04895358|Mitosis Modulators|mitosis modulators|mesh-ancestor
101829095|NCT04895358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829096|NCT04895358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101829097|NCT04895358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101829098|NCT04895358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101829099|NCT04895358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101829100|NCT04895358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101829101|NCT04895358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101829102|NCT04895358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101829114|NCT04874480|Decitabine|decitabine|mesh-list
101829115|NCT04874480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101829116|NCT04874480|Antimetabolites|antimetabolites|mesh-ancestor
101829117|NCT04874480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829118|NCT04874480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829119|NCT04874480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101829120|NCT04865419|Voriconazole|voriconazole|mesh-list
101829121|NCT04865419|Antifungal Agents|antifungal agents|mesh-ancestor
101829123|NCT04865419|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101829124|NCT04865419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101813903|NCT05232630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101813904|NCT05232630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101813905|NCT05232630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813906|NCT05232630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101813907|NCT05232630|Serotonin Agents|serotonin agents|mesh-ancestor
101813908|NCT05232630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813910|NCT03902574|Serotonin Agents|serotonin agents|mesh-ancestor
101813911|NCT03902574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101813912|NCT03902574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813913|NCT03902574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813914|NCT03902574|Dopamine Agonists|dopamine agonists|mesh-ancestor
101813915|NCT03902574|Dopamine Agents|dopamine agents|mesh-ancestor
101829125|NCT04865419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101829126|NCT04865419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829127|NCT04865419|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101829128|NCT04865419|Hormone Antagonists|hormone antagonists|mesh-ancestor
101829129|NCT04865419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101829130|NCT04865419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829131|NCT04865419|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101829132|NCT04808505|Miglustat|miglustat|mesh-list
101829133|NCT04808505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101829134|NCT04808505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486404|NCT00331695|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
101829135|NCT04808505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101829136|NCT04808505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101829137|NCT04808505|Antiviral Agents|antiviral agents|mesh-ancestor
101829138|NCT04808505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101829139|NCT04808505|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101829140|NCT04808505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101829141|NCT04808505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829142|NCT04777357|Cariprazine|cariprazine|mesh-list
101829143|NCT04777357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101829144|NCT04777357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101829145|NCT04777357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101829146|NCT04777357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829147|NCT04777357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101829148|NCT04767594|Palbociclib|palbociclib|mesh-list
101829150|NCT04767594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101829151|NCT04767594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101829152|NCT04767594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829153|NCT04749108|Folfirinox|folfirinox|mesh-list
101829154|NCT04749108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829155|NCT04739800|Paclitaxel|paclitaxel|mesh-list
101829156|NCT04739800|Doxorubicin|doxorubicin|mesh-list
101829157|NCT04739800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101829158|NCT04739800|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101829159|NCT04739800|Durvalumab|durvalumab|mesh-list
101829168|NCT04739800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829169|NCT04739800|Tubulin Modulators|tubulin modulators|mesh-ancestor
101829170|NCT04739800|Antimitotic Agents|antimitotic agents|mesh-ancestor
101829171|NCT04739800|Mitosis Modulators|mitosis modulators|mesh-ancestor
101829172|NCT04739800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829173|NCT04739800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101829174|NCT04739800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101829175|NCT04739800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101829177|NCT04739800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101829178|NCT04739800|Immunologic Factors|immunologic factors|mesh-ancestor
101813917|NCT01004874|Temozolomide|temozolomide|mesh-list
101813918|NCT01004874|Topotecan|topotecan|mesh-list
101813919|NCT01004874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101813920|NCT01004874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101813921|NCT01004874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101813922|NCT01004874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101813923|NCT01004874|Growth Substances|growth substances|mesh-ancestor
101813924|NCT01004874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813925|NCT01004874|Growth Inhibitors|growth inhibitors|mesh-ancestor
101813926|NCT01004874|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101813927|NCT01004874|Alkylating Agents|alkylating agents|mesh-ancestor
101813928|NCT01004874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813929|NCT01004874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101813930|NCT01004874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101813931|NCT01004874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101813932|NCT00987116|Prednisone|prednisone|mesh-list
101813933|NCT00987116|Azathioprine|azathioprine|mesh-list
101813934|NCT00987116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101813935|NCT00987116|Glucocorticoids|glucocorticoids|mesh-ancestor
101813936|NCT00987116|Hormones|hormones|mesh-ancestor
101813937|NCT00987116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101813938|NCT00987116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829179|NCT04739800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829180|NCT04739800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101829181|NCT04739800|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101829182|NCT04739800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101829183|NCT04711343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101829184|NCT04711343|Immunologic Factors|immunologic factors|mesh-ancestor
101829185|NCT04711343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829186|NCT04704154|Nivolumab|nivolumab|mesh-list
101829187|NCT04704154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101829188|NCT04704154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829189|NCT04704154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101829190|NCT04704154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829192|NCT04700124|Gemcitabine|gemcitabine|mesh-list
101829193|NCT04700124|Pembrolizumab|pembrolizumab|mesh-list
101829194|NCT04700124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829195|NCT04700124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101829196|NCT04700124|Antimetabolites|antimetabolites|mesh-ancestor
101829197|NCT04700124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829198|NCT04700124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101829199|NCT04700124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101829207|NCT04646707|Lidocaine|lidocaine|mesh-list
101829208|NCT04646707|Bupivacaine|bupivacaine|mesh-list
101829209|NCT04646707|Anesthetics, Local|anesthetics, local|mesh-ancestor
101486478|NCT00331851|Incretins|incretins|mesh-ancestor
101829210|NCT04646707|Anesthetics|anesthetics|mesh-ancestor
101829211|NCT04646707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101813939|NCT00987116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101813940|NCT00987116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101813941|NCT00987116|Antimetabolites|antimetabolites|mesh-ancestor
101813942|NCT00987116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813943|NCT00987116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101829212|NCT04646707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829214|NCT04646707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101829215|NCT04646707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101829216|NCT04646707|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101829217|NCT04646707|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101829218|NCT04646707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101829219|NCT04646707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829220|NCT04646694|Ketamine|ketamine|mesh-list
101829221|NCT04646694|Analgesics|analgesics|mesh-ancestor
101829222|NCT04646694|Sensory System Agents|sensory system agents|mesh-ancestor
101829223|NCT04646694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101829224|NCT04646694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829225|NCT04646694|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101829226|NCT04646694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101829227|NCT04646694|Anesthetics, General|anesthetics, general|mesh-ancestor
101829231|NCT04646694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101829232|NCT04646694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101829233|NCT04646694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829234|NCT04645160|Tivozanib|tivozanib|mesh-list
101829235|NCT04645160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101829237|NCT04645160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829238|NCT04626518|Pembrolizumab|pembrolizumab|mesh-list
101829239|NCT04626518|Lenvatinib|lenvatinib|mesh-list
101829240|NCT04626518|Belzutifan|belzutifan|mesh-list
101829241|NCT04626518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101829242|NCT04626518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829243|NCT04626518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101829244|NCT04626518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829246|NCT04626518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101829247|NCT04626479|Pembrolizumab|pembrolizumab|mesh-list
101829248|NCT04626479|Lenvatinib|lenvatinib|mesh-list
101829249|NCT04626479|Belzutifan|belzutifan|mesh-list
101829250|NCT04626479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101829251|NCT04626479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829252|NCT04626479|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101829253|NCT04626479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829255|NCT04626479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101829256|NCT04616183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101829257|NCT04616183|Cetuximab|cetuximab|mesh-list
101829258|NCT04616183|Antibodies|antibodies|mesh-list
101829259|NCT04616183|Immunoglobulins|immunoglobulins|mesh-list
101829260|NCT04616183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101829261|NCT04616183|Immunologic Factors|immunologic factors|mesh-ancestor
101829262|NCT04616183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829263|NCT04616183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829264|NCT04595370|Dapagliflozin|dapagliflozin|mesh-list
101829265|NCT04595370|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101829269|NCT04555837|Pembrolizumab|pembrolizumab|mesh-list
101829270|NCT04555837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101829271|NCT04555837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829272|NCT04555837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101829273|NCT04555837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829287|NCT04534153|Fexofenadine|fexofenadine|mesh-list
101829288|NCT04534153|Terfenadine|terfenadine|mesh-list
101829290|NCT04534153|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101829291|NCT04534153|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101829292|NCT04534153|Histamine Antagonists|histamine antagonists|mesh-ancestor
101829293|NCT04534153|Histamine Agents|histamine agents|mesh-ancestor
101829294|NCT04534153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101829295|NCT04534153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829296|NCT04534153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829297|NCT04530565|Cytarabine|cytarabine|mesh-list
101829298|NCT04530565|Dexamethasone|dexamethasone|mesh-list
101813944|NCT00987116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101813946|NCT00987116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101813947|NCT05711732|Busulfan|busulfan|mesh-list
101813948|NCT05711732|Alkylating Agents|alkylating agents|mesh-ancestor
101813949|NCT05711732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813950|NCT05711732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101813951|NCT05711732|Immunologic Factors|immunologic factors|mesh-ancestor
101813952|NCT05711732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829299|NCT04530565|Dexamethasone acetate|dexamethasone acetate|mesh-list
101829300|NCT04530565|Prednisone|prednisone|mesh-list
101829301|NCT04530565|Cortisone|cortisone|mesh-list
101829302|NCT04530565|Cyclophosphamide|cyclophosphamide|mesh-list
101829303|NCT04530565|Doxorubicin|doxorubicin|mesh-list
101829304|NCT04530565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101829305|NCT04530565|Methotrexate|methotrexate|mesh-list
101829306|NCT04530565|Vincristine|vincristine|mesh-list
101829307|NCT04530565|Dasatinib|dasatinib|mesh-list
101829308|NCT04530565|Blinatumomab|blinatumomab|mesh-list
101829309|NCT04530565|Ponatinib|ponatinib|mesh-list
101829310|NCT04530565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101829311|NCT04530565|Muromonab-CD3|muromonab-cd3|mesh-list
101829312|NCT04530565|Antibodies|antibodies|mesh-list
101829313|NCT04530565|Immunoglobulins|immunoglobulins|mesh-list
101829314|NCT04530565|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101829315|NCT04530565|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101829316|NCT04530565|BB 1101|bb 1101|mesh-list
101829319|NCT04530565|Immunologic Factors|immunologic factors|mesh-ancestor
101829320|NCT04530565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829321|NCT04530565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101829322|NCT04530565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101829323|NCT04530565|Alkylating Agents|alkylating agents|mesh-ancestor
101829324|NCT04530565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829325|NCT04530565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829326|NCT04530565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101829327|NCT04530565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101829328|NCT04530565|Antiemetics|antiemetics|mesh-ancestor
101829329|NCT04530565|Autonomic Agents|autonomic agents|mesh-ancestor
101829330|NCT04530565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101829331|NCT04530565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101829332|NCT04530565|Glucocorticoids|glucocorticoids|mesh-ancestor
101829333|NCT04530565|Hormones|hormones|mesh-ancestor
101829334|NCT04530565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101829335|NCT04530565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101829336|NCT04530565|Protease Inhibitors|protease inhibitors|mesh-ancestor
101829337|NCT04530565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101829338|NCT04530565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101829340|NCT04530565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101829341|NCT04530565|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101829342|NCT04530565|Abortifacient Agents|abortifacient agents|mesh-ancestor
101829343|NCT04530565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101829344|NCT04530565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101829345|NCT04530565|Antimetabolites|antimetabolites|mesh-ancestor
101829346|NCT04530565|Dermatologic Agents|dermatologic agents|mesh-ancestor
101829347|NCT04530565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101829348|NCT04530565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101829349|NCT04530565|Antiviral Agents|antiviral agents|mesh-ancestor
101829350|NCT04530565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101326199|NCT00115726|Diuretics|diuretics|mesh-ancestor
101829351|NCT04530565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101829352|NCT04530565|Tubulin Modulators|tubulin modulators|mesh-ancestor
101829353|NCT04530565|Antimitotic Agents|antimitotic agents|mesh-ancestor
101829354|NCT04530565|Mitosis Modulators|mitosis modulators|mesh-ancestor
101829355|NCT04530565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101829356|NCT04530565|Protective Agents|protective agents|mesh-ancestor
101829357|NCT04526795|Cytarabine|cytarabine|mesh-list
101829358|NCT04526795|Fludarabine|fludarabine|mesh-list
101829359|NCT04526795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829360|NCT04526795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101312158|NCT00006232|Glucocorticoids|glucocorticoids|mesh-ancestor
101813953|NCT05711732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101813954|NCT05711732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101813955|NCT05711732|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101813956|NCT04004702|Levetiracetam|levetiracetam|mesh-list
101813957|NCT04004702|Anticonvulsants|anticonvulsants|mesh-ancestor
101813958|NCT04004702|Nootropic Agents|nootropic agents|mesh-ancestor
101813959|NCT00542828|Immunoglobulins|immunoglobulins|mesh-list
101813960|NCT00542828|Thymoglobulin|thymoglobulin|mesh-list
101813961|NCT00542828|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101829361|NCT04526795|Antimetabolites|antimetabolites|mesh-ancestor
101829362|NCT04526795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829363|NCT04526795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101829364|NCT04526795|Immunologic Factors|immunologic factors|mesh-ancestor
101829365|NCT04526795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829366|NCT04526795|Antiviral Agents|antiviral agents|mesh-ancestor
101829367|NCT04526795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101829368|NCT04519619|Aflibercept|aflibercept|mesh-list
101829369|NCT04519619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101829370|NCT04519619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101829371|NCT04519619|Growth Substances|growth substances|mesh-ancestor
101829372|NCT04519619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829373|NCT04519619|Growth Inhibitors|growth inhibitors|mesh-ancestor
101829374|NCT04519619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829375|NCT04514497|Irinotecan|irinotecan|mesh-list
101829376|NCT04514497|Topotecan|topotecan|mesh-list
101829377|NCT04514497|Camptothecin|camptothecin|mesh-list
101829378|NCT04514497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101829379|NCT04514497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101829380|NCT04514497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101829381|NCT04514497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829382|NCT04514497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829383|NCT04514497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101829384|NCT04506567|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101829385|NCT04506567|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101829386|NCT04506567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829401|NCT04361708|Leucovorin|leucovorin|mesh-list
101829402|NCT04361708|Docetaxel|docetaxel|mesh-list
101829403|NCT04361708|Fluorouracil|fluorouracil|mesh-list
101829404|NCT04361708|Oxaliplatin|oxaliplatin|mesh-list
101829405|NCT04361708|Irinotecan|irinotecan|mesh-list
101829406|NCT04361708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829407|NCT04361708|Tubulin Modulators|tubulin modulators|mesh-ancestor
101829408|NCT04361708|Antimitotic Agents|antimitotic agents|mesh-ancestor
101829409|NCT04361708|Mitosis Modulators|mitosis modulators|mesh-ancestor
101829410|NCT04361708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829411|NCT04361708|Antimetabolites|antimetabolites|mesh-ancestor
101829412|NCT04361708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101829413|NCT04361708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101829414|NCT04361708|Immunologic Factors|immunologic factors|mesh-ancestor
101829415|NCT04361708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829416|NCT04361708|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101829417|NCT04361708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101829418|NCT04361708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101829419|NCT04361708|Antidotes|antidotes|mesh-ancestor
101829420|NCT04361708|Protective Agents|protective agents|mesh-ancestor
101829421|NCT04361708|Vitamin B Complex|vitamin b complex|mesh-ancestor
101829433|NCT04345146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101829434|NCT04345146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101829435|NCT04345146|Growth Substances|growth substances|mesh-ancestor
101829436|NCT04345146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829437|NCT04345146|Growth Inhibitors|growth inhibitors|mesh-ancestor
101829445|NCT04336098|Pembrolizumab|pembrolizumab|mesh-list
101829446|NCT04336098|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101813962|NCT00542828|Immunologic Factors|immunologic factors|mesh-ancestor
101813963|NCT00542828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813964|NCT00542828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101813965|NCT04731974|Melatonin|melatonin|mesh-list
101813966|NCT04731974|Antioxidants|antioxidants|mesh-ancestor
101829447|NCT04336098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101829448|NCT04336098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829449|NCT04336098|Tubulin Modulators|tubulin modulators|mesh-ancestor
101829450|NCT04336098|Antimitotic Agents|antimitotic agents|mesh-ancestor
101829451|NCT04336098|Mitosis Modulators|mitosis modulators|mesh-ancestor
101829452|NCT04336098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829453|NCT04336098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101829454|NCT04336098|Antimetabolites|antimetabolites|mesh-ancestor
101829456|NCT04336098|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101829457|NCT04316494|Hydroxychloroquine|hydroxychloroquine|mesh-list
101829458|NCT04316494|Antimalarials|antimalarials|mesh-ancestor
101829459|NCT04316494|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101829460|NCT04316494|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101829461|NCT04316494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101829462|NCT04316494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101829463|NCT04316494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829464|NCT04316494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101829465|NCT04310020|Atezolizumab|atezolizumab|mesh-list
101829466|NCT04310020|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101829468|NCT04310020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829469|NCT04310020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101829470|NCT04310020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829471|NCT04310020|Immunologic Factors|immunologic factors|mesh-ancestor
101829472|NCT04310020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829473|NCT04298567|Aspirin|aspirin|mesh-list
101829474|NCT04298567|Rivaroxaban|rivaroxaban|mesh-list
101829475|NCT04298567|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101829476|NCT04298567|Antithrombins|antithrombins|mesh-ancestor
101829477|NCT04298567|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101829478|NCT04298567|Protease Inhibitors|protease inhibitors|mesh-ancestor
101829479|NCT04298567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101829480|NCT04298567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829481|NCT04298567|Anticoagulants|anticoagulants|mesh-ancestor
101829482|NCT04298567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101829485|NCT04298567|Sensory System Agents|sensory system agents|mesh-ancestor
101829486|NCT04298567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101829487|NCT04298567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829488|NCT04298567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101829489|NCT04298567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101829490|NCT04298567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101829520|NCT04169737|Venetoclax|venetoclax|mesh-list
101829522|NCT04169737|Acalabrutinib|acalabrutinib|mesh-list
101829523|NCT04169737|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101829524|NCT04169737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829525|NCT04169737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101829526|NCT04169737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101829527|NCT04169737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101829528|NCT04169737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829529|NCT04165070|Paclitaxel|paclitaxel|mesh-list
101829530|NCT04165070|Carboplatin|carboplatin|mesh-list
101829531|NCT04165070|Pembrolizumab|pembrolizumab|mesh-list
101829532|NCT04165070|Pemetrexed|pemetrexed|mesh-list
101829533|NCT04165070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101829534|NCT04165070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829535|NCT04165070|Tubulin Modulators|tubulin modulators|mesh-ancestor
101829536|NCT04165070|Antimitotic Agents|antimitotic agents|mesh-ancestor
101829537|NCT04165070|Mitosis Modulators|mitosis modulators|mesh-ancestor
101829538|NCT04165070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829539|NCT04165070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101829540|NCT04165070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101829541|NCT04165070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101829542|NCT04165070|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101829543|NCT04165070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101829544|NCT04145115|Nivolumab|nivolumab|mesh-list
101813967|NCT04731974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813968|NCT04731974|Protective Agents|protective agents|mesh-ancestor
101813969|NCT04731974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813970|NCT04731974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101813972|NCT00987662|Irbesartan|irbesartan|mesh-list
101813973|NCT00987662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101326200|NCT00115726|Natriuretic Agents|natriuretic agents|mesh-ancestor
101813974|NCT00987662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101813975|NCT00987662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101813976|NCT00987662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813977|NCT00987662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101813978|NCT00987662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813979|NCT00987662|Vasodilator Agents|vasodilator agents|mesh-ancestor
101813980|NCT00987662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101813981|NCT00987662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101813982|NCT04430426|Glycolic acid|glycolic acid|mesh-list
101813983|NCT04430426|Keratolytic Agents|keratolytic agents|mesh-ancestor
101813984|NCT04430426|Dermatologic Agents|dermatologic agents|mesh-ancestor
101813985|NCT00090103|Tamsulosin|tamsulosin|mesh-list
101813986|NCT00090103|Dutasteride|dutasteride|mesh-list
101813987|NCT00090103|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101813988|NCT00090103|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101813989|NCT00090103|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101813990|NCT00090103|Adrenergic Agents|adrenergic agents|mesh-ancestor
101829545|NCT04145115|Ipilimumab|ipilimumab|mesh-list
101829546|NCT04145115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101829547|NCT04145115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829548|NCT04145115|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101829549|NCT04145115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829550|NCT04138277|Miglustat|miglustat|mesh-list
101829551|NCT04138277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101829552|NCT04138277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829553|NCT04138277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101829554|NCT04138277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101829555|NCT04138277|Antiviral Agents|antiviral agents|mesh-ancestor
101829556|NCT04138277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101829557|NCT04138277|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101829558|NCT04138277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101829559|NCT04138277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829561|NCT04129515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101829562|NCT04129515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101313537|NCT00000457|Bupropion|bupropion|mesh-list
101829563|NCT04129515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101829564|NCT04129515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829565|NCT04128501|Azacitidine|azacitidine|mesh-list
101829566|NCT04128501|Venetoclax|venetoclax|mesh-list
101829567|NCT04128501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101829568|NCT04128501|Antimetabolites|antimetabolites|mesh-ancestor
101813991|NCT00090103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101813992|NCT00090103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813993|NCT00090103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101813994|NCT00090103|Urological Agents|urological agents|mesh-ancestor
101813995|NCT00090103|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101813996|NCT00090103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101813997|NCT00090103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101829569|NCT04128501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829570|NCT04128501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829571|NCT04128501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101486852|NCT00426621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101829589|NCT04069052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101829590|NCT04069052|Autonomic Agents|autonomic agents|mesh-ancestor
101829591|NCT04069052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101829592|NCT04069052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829593|NCT04069052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101829594|NCT04069052|Respiratory System Agents|respiratory system agents|mesh-ancestor
101829595|NCT04069052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101829605|NCT04062266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101829606|NCT04062266|Antimetabolites|antimetabolites|mesh-ancestor
101829607|NCT04062266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829608|NCT04062266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829610|NCT04029480|Metformin|metformin|mesh-list
101829611|NCT04029480|Ertugliflozin|ertugliflozin|mesh-list
101829612|NCT04029480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101829613|NCT04029480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829614|NCT04029480|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101829615|NCT04029480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829616|NCT03986034|Venetoclax|venetoclax|mesh-list
101829617|NCT03986034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829618|NCT03968653|Carboplatin|carboplatin|mesh-list
101829619|NCT03968653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829620|NCT03963414|Carboplatin|carboplatin|mesh-list
101829621|NCT03963414|Etoposide|etoposide|mesh-list
101829622|NCT03963414|Etoposide phosphate|etoposide phosphate|mesh-list
101829623|NCT03963414|Durvalumab|durvalumab|mesh-list
101829624|NCT03963414|Tremelimumab|tremelimumab|mesh-list
101829625|NCT03963414|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101829626|NCT03963414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829627|NCT03963414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101829628|NCT03963414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101829629|NCT03963414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101829630|NCT03963414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101829631|NCT03963414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829632|NCT03963414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101829633|NCT03963414|Immunologic Factors|immunologic factors|mesh-ancestor
101829634|NCT03963414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829635|NCT03953898|Olaparib|olaparib|mesh-list
101829636|NCT03953898|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
101829637|NCT03953898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101829638|NCT03953898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829640|NCT03949855|Rituximab|rituximab|mesh-list
101829641|NCT03949855|Belimumab|belimumab|mesh-list
101829642|NCT03949855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101829643|NCT03949855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829644|NCT03949855|Immunologic Factors|immunologic factors|mesh-ancestor
101829645|NCT03949855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829646|NCT03949855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101829647|NCT03949855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101829648|NCT03932201|Factor VIII|factor viii|mesh-list
101829649|NCT03932201|Coagulants|coagulants|mesh-ancestor
101829650|NCT03896269|Cytarabine|cytarabine|mesh-list
101829651|NCT03896269|Daunorubicin|daunorubicin|mesh-list
101829652|NCT03896269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101829653|NCT03896269|Antimetabolites|antimetabolites|mesh-ancestor
101829654|NCT03896269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101813998|NCT00090103|Hormone Antagonists|hormone antagonists|mesh-ancestor
101813999|NCT00090103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101814000|NCT01088659|Tenofovir|tenofovir|mesh-list
101814001|NCT01088659|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101814002|NCT01088659|Antiviral Agents|antiviral agents|mesh-ancestor
101814003|NCT01088659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101814004|NCT01088659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101814005|NCT01088659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101814006|NCT01088659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101829655|NCT03896269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829656|NCT03896269|Antiviral Agents|antiviral agents|mesh-ancestor
101829657|NCT03896269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101829658|NCT03896269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101829660|NCT03896269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829661|NCT03896269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101829662|NCT03896269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101829663|NCT03896269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101829664|NCT03896269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101829665|NCT03861390|Prednisone|prednisone|mesh-list
101829666|NCT03861390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101829667|NCT03861390|Glucocorticoids|glucocorticoids|mesh-ancestor
101829668|NCT03861390|Hormones|hormones|mesh-ancestor
101829669|NCT03861390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101829670|NCT03861390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829671|NCT03861390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101829672|NCT03861390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829673|NCT03829683|Ascorbic Acid|ascorbic acid|mesh-list
101829686|NCT03776487|Fluorouracil|fluorouracil|mesh-list
101829687|NCT03776487|Oxaliplatin|oxaliplatin|mesh-list
101829688|NCT03776487|Nivolumab|nivolumab|mesh-list
101829689|NCT03776487|Ipilimumab|ipilimumab|mesh-list
101829690|NCT03776487|Antimetabolites|antimetabolites|mesh-ancestor
101829691|NCT03776487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829692|NCT03776487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101829693|NCT03776487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829694|NCT03776487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101829695|NCT03776487|Immunologic Factors|immunologic factors|mesh-ancestor
101829696|NCT03776487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829697|NCT03776487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101829698|NCT03776487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101829708|NCT03723551|Afabicin|afabicin|mesh-list
101829709|NCT03723551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101829710|NCT03723551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101829711|NCT03711032|Pembrolizumab|pembrolizumab|mesh-list
101829712|NCT03711032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101829713|NCT03711032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829714|NCT03711032|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101829715|NCT03711032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829716|NCT03672539|Cytarabine|cytarabine|mesh-list
101829717|NCT03672539|Daunorubicin|daunorubicin|mesh-list
101829718|NCT03672539|Gemtuzumab|gemtuzumab|mesh-list
101829719|NCT03672539|Calicheamicins|calicheamicins|mesh-list
101829720|NCT03672539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101829721|NCT03672539|Antimetabolites|antimetabolites|mesh-ancestor
101829723|NCT03672539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829724|NCT03672539|Antiviral Agents|antiviral agents|mesh-ancestor
101829725|NCT03672539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101829726|NCT03672539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101829727|NCT03672539|Immunologic Factors|immunologic factors|mesh-ancestor
101829728|NCT03672539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829729|NCT03672539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101829730|NCT03672539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101829732|NCT03672539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101829733|NCT03672539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101829735|NCT03672539|Immunoconjugates|immunoconjugates|mesh-ancestor
101829736|NCT03629171|Cytarabine|cytarabine|mesh-list
101829737|NCT03629171|Daunorubicin|daunorubicin|mesh-list
101814007|NCT01088659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814008|NCT01088659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101814009|NCT01088659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101814010|NCT00087607|Ribavirin|ribavirin|mesh-list
101814011|NCT00087607|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101814012|NCT00087607|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101814013|NCT00087607|Antimetabolites|antimetabolites|mesh-ancestor
101814014|NCT00087607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829739|NCT03629171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101829741|NCT03629171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829742|NCT03629171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829743|NCT03629171|Antiviral Agents|antiviral agents|mesh-ancestor
101829744|NCT03629171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101829745|NCT03629171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101829746|NCT03629171|Immunologic Factors|immunologic factors|mesh-ancestor
101829747|NCT03629171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829748|NCT03629171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101829749|NCT03629171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101829750|NCT03629171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101829751|NCT03629171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101829752|NCT03616587|Everolimus|everolimus|mesh-list
101829753|NCT03616587|Palbociclib|palbociclib|mesh-list
101829754|NCT03616587|Anastrozole|anastrozole|mesh-list
101829755|NCT03616587|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101829756|NCT03616587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101829757|NCT03616587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101829758|NCT03616587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829759|NCT03616587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101829760|NCT03616587|Immunologic Factors|immunologic factors|mesh-ancestor
101829761|NCT03616587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829762|NCT03616587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829763|NCT03616587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101829764|NCT03616587|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101829765|NCT03616587|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101829766|NCT03616587|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101829767|NCT03616587|Hormone Antagonists|hormone antagonists|mesh-ancestor
101829768|NCT03616587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101829769|NCT03609580|Tamsulosin|tamsulosin|mesh-list
101829770|NCT03609580|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101829771|NCT03609580|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101829772|NCT03609580|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101829774|NCT03609580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101829775|NCT03609580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829776|NCT03609580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829777|NCT03609580|Urological Agents|urological agents|mesh-ancestor
101829778|NCT03605342|Buprenorphine|buprenorphine|mesh-list
101829779|NCT03605342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101829780|NCT03605342|Narcotics|narcotics|mesh-ancestor
101829781|NCT03605342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101829782|NCT03605342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829784|NCT03605342|Sensory System Agents|sensory system agents|mesh-ancestor
101829785|NCT03605342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101829786|NCT03605342|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101829787|NCT03604978|Nivolumab|nivolumab|mesh-list
101829788|NCT03604978|Ipilimumab|ipilimumab|mesh-list
101829789|NCT03604978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101829790|NCT03604978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829791|NCT03604978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101829792|NCT03604978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829793|NCT03598608|Pembrolizumab|pembrolizumab|mesh-list
101829805|NCT03530696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101829806|NCT03530696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101829807|NCT03530696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829808|NCT03522961|Nitrofurantoin|nitrofurantoin|mesh-list
101829809|NCT03522961|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101814015|NCT00087607|Antiviral Agents|antiviral agents|mesh-ancestor
101814016|NCT00087607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101814017|NCT01088737|Imiquimod|imiquimod|mesh-list
101814018|NCT01088737|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101814019|NCT01088737|Immunologic Factors|immunologic factors|mesh-ancestor
101814020|NCT01088737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814021|NCT01088737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101814022|NCT01088737|Interferon Inducers|interferon inducers|mesh-ancestor
101814023|NCT00069823|Esomeprazole|esomeprazole|mesh-list
101814024|NCT00069823|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101814025|NCT00069823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101814026|NCT00069823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101814027|NCT00069823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101814028|NCT00069823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814029|NCT01088815|Paclitaxel|paclitaxel|mesh-list
101814030|NCT01088815|Gemcitabine|gemcitabine|mesh-list
101829810|NCT03522961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101829811|NCT03522961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101829812|NCT03520686|Paclitaxel|paclitaxel|mesh-list
101829813|NCT03520686|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101829814|NCT03520686|Cisplatin|cisplatin|mesh-list
101829815|NCT03520686|Carboplatin|carboplatin|mesh-list
101829816|NCT03520686|Pembrolizumab|pembrolizumab|mesh-list
101829817|NCT03520686|Pemetrexed|pemetrexed|mesh-list
101829818|NCT03520686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101829819|NCT03520686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829820|NCT03520686|Tubulin Modulators|tubulin modulators|mesh-ancestor
101829821|NCT03520686|Antimitotic Agents|antimitotic agents|mesh-ancestor
101829822|NCT03520686|Mitosis Modulators|mitosis modulators|mesh-ancestor
101829823|NCT03520686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829825|NCT03520686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101829826|NCT03520686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101829827|NCT03520686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101829828|NCT03520686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101829830|NCT03486873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101829831|NCT03486873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829832|NCT03486873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101829833|NCT03486873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829834|NCT03452332|Durvalumab|durvalumab|mesh-list
101829835|NCT03452332|Ipilimumab|ipilimumab|mesh-list
101829836|NCT03452332|Tremelimumab|tremelimumab|mesh-list
101829837|NCT03452332|Immunoglobulins|immunoglobulins|mesh-list
101829838|NCT03452332|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101829839|NCT03452332|Immunoglobulin G|immunoglobulin g|mesh-list
101829841|NCT03452332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829842|NCT03452332|Immunologic Factors|immunologic factors|mesh-ancestor
101829843|NCT03452332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829844|NCT03452332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101829845|NCT03452332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829846|NCT03450057|Dexamethasone|dexamethasone|mesh-list
101829847|NCT03450057|Daratumumab|daratumumab|mesh-list
101829848|NCT03450057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101829849|NCT03450057|Antiemetics|antiemetics|mesh-ancestor
101829850|NCT03450057|Autonomic Agents|autonomic agents|mesh-ancestor
101829853|NCT03450057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101829855|NCT03450057|Hormones|hormones|mesh-ancestor
101829856|NCT03450057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101829857|NCT03450057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101829858|NCT03450057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829859|NCT03391869|Nivolumab|nivolumab|mesh-list
101829860|NCT03391869|Ipilimumab|ipilimumab|mesh-list
101814031|NCT01088815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101814032|NCT01088815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101814033|NCT01088815|Tubulin Modulators|tubulin modulators|mesh-ancestor
101814034|NCT01088815|Antimitotic Agents|antimitotic agents|mesh-ancestor
101814035|NCT01088815|Mitosis Modulators|mitosis modulators|mesh-ancestor
101814036|NCT01088815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829861|NCT03391869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101829862|NCT03391869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829863|NCT03391869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101829864|NCT03391869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829865|NCT03375307|Olaparib|olaparib|mesh-list
101829866|NCT03375307|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
101829867|NCT03375307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101829868|NCT03375307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829869|NCT03375307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829871|NCT03335839|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101829872|NCT03335839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101829873|NCT03335839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101829874|NCT03335839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829875|NCT03317392|Olaparib|olaparib|mesh-list
101829876|NCT03317392|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
101829877|NCT03317392|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
101829879|NCT03317392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829880|NCT03317392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829881|NCT03270059|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
101829882|NCT03270059|Hematinics|hematinics|mesh-ancestor
101829883|NCT03270059|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101829884|NCT03270059|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101829885|NCT03214562|Cytarabine|cytarabine|mesh-list
101829886|NCT03214562|Fludarabine|fludarabine|mesh-list
101829888|NCT03214562|Idarubicin|idarubicin|mesh-list
101829889|NCT03214562|Lenograstim|lenograstim|mesh-list
101829890|NCT03214562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829891|NCT03214562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101829892|NCT03214562|Antimetabolites|antimetabolites|mesh-ancestor
101829893|NCT03214562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829894|NCT03214562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101829895|NCT03214562|Immunologic Factors|immunologic factors|mesh-ancestor
101829897|NCT03214562|Antiviral Agents|antiviral agents|mesh-ancestor
101829898|NCT03214562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101829899|NCT03214562|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101829900|NCT03214562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101829901|NCT03214562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101829902|NCT03214562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101829903|NCT03214562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101829904|NCT03213652|Ensartinib|ensartinib|mesh-list
101829905|NCT03213652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829906|NCT03213652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101829907|NCT03213652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101829908|NCT03213652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829909|NCT03198351|Teriflunomide|teriflunomide|mesh-list
101829910|NCT03198351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101829911|NCT03198351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101829912|NCT03198351|Analgesics|analgesics|mesh-ancestor
101829913|NCT03198351|Sensory System Agents|sensory system agents|mesh-ancestor
101829914|NCT03198351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101829915|NCT03198351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829916|NCT03198351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101829917|NCT03198351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101829918|NCT03198351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101829919|NCT03198351|Immunologic Factors|immunologic factors|mesh-ancestor
101829920|NCT03190265|Cyclophosphamide|cyclophosphamide|mesh-list
101829921|NCT03190265|Nivolumab|nivolumab|mesh-list
101829922|NCT03190265|Ipilimumab|ipilimumab|mesh-list
101829923|NCT03190265|Pancrelipase|pancrelipase|mesh-list
101829924|NCT03190265|Vaccines|vaccines|mesh-list
101829925|NCT03190265|Immunologic Factors|immunologic factors|mesh-ancestor
101829926|NCT03190265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814037|NCT01088815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101814038|NCT01088815|Antimetabolites|antimetabolites|mesh-ancestor
101814039|NCT00086515|Metformin|metformin|mesh-list
101814040|NCT00086515|Pioglitazone|pioglitazone|mesh-list
101814041|NCT00086515|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101814042|NCT00086515|Glipizide|glipizide|mesh-list
101814043|NCT00086515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101814044|NCT00086515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814045|NCT00086515|Incretins|incretins|mesh-ancestor
101814046|NCT00086515|Hormones|hormones|mesh-ancestor
101829927|NCT03190265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101829928|NCT03190265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101829929|NCT03190265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101829930|NCT03190265|Alkylating Agents|alkylating agents|mesh-ancestor
101829931|NCT03190265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829932|NCT03190265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829933|NCT03190265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101829934|NCT03190265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101829935|NCT03190265|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101829936|NCT03190265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101829939|NCT03173950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829940|NCT03173950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101829941|NCT03173950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829942|NCT03160040|Minocycline|minocycline|mesh-list
101829943|NCT03160040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101829944|NCT03160040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101829955|NCT03137407|Botulinum Toxins|botulinum toxins|mesh-list
101829956|NCT03137407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101829957|NCT03137407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101829958|NCT03137407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101829959|NCT03137407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101487223|NCT00427362|Adalimumab|adalimumab|mesh-list
101829960|NCT03137407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829961|NCT03137407|Cholinergic Agents|cholinergic agents|mesh-ancestor
101829963|NCT03137407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829964|NCT03137407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101829965|NCT03137407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101829966|NCT03107182|Diphenhydramine|diphenhydramine|mesh-list
101829967|NCT03107182|Promethazine|promethazine|mesh-list
101829968|NCT03107182|Dexamethasone|dexamethasone|mesh-list
101829969|NCT03107182|Paclitaxel|paclitaxel|mesh-list
101829970|NCT03107182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101829971|NCT03107182|Carboplatin|carboplatin|mesh-list
101829972|NCT03107182|Nivolumab|nivolumab|mesh-list
101829973|NCT03107182|Hydroxyurea|hydroxyurea|mesh-list
101829974|NCT03107182|Famotidine|famotidine|mesh-list
101829975|NCT03107182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101829976|NCT03107182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829977|NCT03107182|Tubulin Modulators|tubulin modulators|mesh-ancestor
101829978|NCT03107182|Antimitotic Agents|antimitotic agents|mesh-ancestor
101829979|NCT03107182|Mitosis Modulators|mitosis modulators|mesh-ancestor
101829980|NCT03107182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829981|NCT03107182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101829982|NCT03107182|Antiemetics|antiemetics|mesh-ancestor
101829983|NCT03107182|Autonomic Agents|autonomic agents|mesh-ancestor
101829984|NCT03107182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101829986|NCT03107182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101829988|NCT03107182|Hormones|hormones|mesh-ancestor
101829989|NCT03107182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101829990|NCT03107182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101407796|NCT00441961|Antimetabolites|antimetabolites|mesh-ancestor
101829991|NCT03107182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101829992|NCT03107182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101829993|NCT03107182|Antisickling Agents|antisickling agents|mesh-ancestor
101829994|NCT03107182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101829995|NCT03107182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101829996|NCT03107182|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101829997|NCT03107182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101814047|NCT00086515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101814048|NCT00086515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101814049|NCT00086515|Protease Inhibitors|protease inhibitors|mesh-ancestor
101814050|NCT00086515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101814051|NCT00086515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829998|NCT03107182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101829999|NCT03107182|Anesthetics, Local|anesthetics, local|mesh-ancestor
101830000|NCT03107182|Anesthetics|anesthetics|mesh-ancestor
101830001|NCT03107182|Sensory System Agents|sensory system agents|mesh-ancestor
101830002|NCT03107182|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101830003|NCT03107182|Histamine Antagonists|histamine antagonists|mesh-ancestor
101830004|NCT03107182|Histamine Agents|histamine agents|mesh-ancestor
101830005|NCT03107182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101830006|NCT03107182|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101830007|NCT03107182|Antipruritics|antipruritics|mesh-ancestor
101830009|NCT03107182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101830010|NCT03107182|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101830011|NCT03037385|Pralsetinib|pralsetinib|mesh-list
101830012|NCT03037385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830041|NCT02960555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101830042|NCT02960555|Immunologic Factors|immunologic factors|mesh-ancestor
101830043|NCT02960555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830044|NCT02941783|Factor VIII|factor viii|mesh-list
101830045|NCT02941783|Coagulants|coagulants|mesh-ancestor
101830046|NCT02927769|Nivolumab|nivolumab|mesh-list
101830047|NCT02927769|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101830048|NCT02927769|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101830049|NCT02927769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101830050|NCT02927769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830051|NCT02927769|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101830052|NCT02927769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830053|NCT02927769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101830055|NCT02927769|Immunotoxins|immunotoxins|mesh-ancestor
101830056|NCT02927769|Immunoconjugates|immunoconjugates|mesh-ancestor
101830057|NCT02927769|Immunologic Factors|immunologic factors|mesh-ancestor
101830058|NCT02927769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830059|NCT02915198|Metformin|metformin|mesh-list
101830060|NCT02915198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101830061|NCT02915198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830062|NCT02879318|Paclitaxel|paclitaxel|mesh-list
101830063|NCT02879318|Gemcitabine|gemcitabine|mesh-list
101830064|NCT02879318|Durvalumab|durvalumab|mesh-list
101830065|NCT02879318|Tremelimumab|tremelimumab|mesh-list
101830066|NCT02879318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101830067|NCT02879318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830068|NCT02879318|Tubulin Modulators|tubulin modulators|mesh-ancestor
101830069|NCT02879318|Antimitotic Agents|antimitotic agents|mesh-ancestor
101830070|NCT02879318|Mitosis Modulators|mitosis modulators|mesh-ancestor
101830071|NCT02879318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830072|NCT02879318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101830073|NCT02879318|Antimetabolites|antimetabolites|mesh-ancestor
101830074|NCT02879318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101830076|NCT02873195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101830077|NCT02873195|Atezolizumab|atezolizumab|mesh-list
101830078|NCT02873195|Capecitabine|capecitabine|mesh-list
101830079|NCT02873195|Endothelial Growth Factors|endothelial growth factors|mesh-list
101830080|NCT02873195|Antibodies|antibodies|mesh-list
101830081|NCT02873195|Immunoglobulins|immunoglobulins|mesh-list
101830082|NCT02873195|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101830083|NCT02873195|Immunoglobulin G|immunoglobulin g|mesh-list
101830084|NCT02873195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830085|NCT02873195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101830086|NCT02873195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101830087|NCT02873195|Growth Substances|growth substances|mesh-ancestor
101830088|NCT02873195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830089|NCT02873195|Growth Inhibitors|growth inhibitors|mesh-ancestor
101830090|NCT02873195|Immunologic Factors|immunologic factors|mesh-ancestor
101830091|NCT02873195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101830092|NCT02873195|Antimetabolites|antimetabolites|mesh-ancestor
101814053|NCT00541658|Etidronic Acid|etidronic acid|mesh-list
101814054|NCT00541658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101814055|NCT00541658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101814056|NCT00541658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814057|NCT00541658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101814058|NCT00541658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814059|NCT00541658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101814060|NCT04334174|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101814061|NCT04334174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101814062|NCT04334174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101814063|NCT04334174|Immunotoxins|immunotoxins|mesh-ancestor
101814064|NCT04334174|Immunoconjugates|immunoconjugates|mesh-ancestor
101814065|NCT04334174|Immunologic Factors|immunologic factors|mesh-ancestor
101830093|NCT02873195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830094|NCT02873195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101830095|NCT02833701|Vitamins|vitamins|mesh-list
101830096|NCT02833701|Ascorbic Acid|ascorbic acid|mesh-list
101830097|NCT02833701|Bevacizumab|bevacizumab|mesh-list
101830098|NCT02833701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101830099|NCT02833701|Endothelial Growth Factors|endothelial growth factors|mesh-list
101830100|NCT02833701|Antibodies|antibodies|mesh-list
101830101|NCT02833701|Immunoglobulins|immunoglobulins|mesh-list
101830103|NCT02833701|Immunoglobulin G|immunoglobulin g|mesh-list
101830104|NCT02833701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830105|NCT02833701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101830106|NCT02833701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101830107|NCT02833701|Growth Substances|growth substances|mesh-ancestor
101830108|NCT02833701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830109|NCT02833701|Growth Inhibitors|growth inhibitors|mesh-ancestor
101830110|NCT02833701|Micronutrients|micronutrients|mesh-ancestor
101830111|NCT02833701|Immunologic Factors|immunologic factors|mesh-ancestor
101830112|NCT02833701|Antioxidants|antioxidants|mesh-ancestor
101830113|NCT02833701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830115|NCT02815995|Durvalumab|durvalumab|mesh-list
101830116|NCT02815995|Tremelimumab|tremelimumab|mesh-list
101830117|NCT02815995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101830118|NCT02815995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830119|NCT02767999|Fluoxetine|fluoxetine|mesh-list
101830120|NCT02767999|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101830121|NCT02767999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101830122|NCT02767999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101830123|NCT02767999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830124|NCT02767999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101830125|NCT02767999|Serotonin Agents|serotonin agents|mesh-ancestor
101830126|NCT02767999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830127|NCT02767999|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101830128|NCT02767999|Antidepressive Agents|antidepressive agents|mesh-ancestor
101830129|NCT02767999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101830130|NCT02767999|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101830131|NCT02767999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101830132|NCT02767999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101830133|NCT02675465|Miglustat|miglustat|mesh-list
101830134|NCT02675465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101830135|NCT02675465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830136|NCT02675465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101830138|NCT02675465|Antiviral Agents|antiviral agents|mesh-ancestor
101830139|NCT02675465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101830140|NCT02675465|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101814066|NCT04334174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814067|NCT04333706|Capecitabine|capecitabine|mesh-list
101814068|NCT04333706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101814069|NCT04333706|Antimetabolites|antimetabolites|mesh-ancestor
101814070|NCT04333706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814071|NCT04333706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101814072|NCT00987974|Atorvastatin|atorvastatin|mesh-list
101830141|NCT02675465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101830142|NCT02675465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830143|NCT02670707|Cytarabine|cytarabine|mesh-list
101830144|NCT02670707|Prednisone|prednisone|mesh-list
101830145|NCT02670707|Vinblastine|vinblastine|mesh-list
101830146|NCT02670707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101830147|NCT02670707|Glucocorticoids|glucocorticoids|mesh-ancestor
101830148|NCT02670707|Hormones|hormones|mesh-ancestor
101830149|NCT02670707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101830150|NCT02670707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830151|NCT02670707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101830152|NCT02670707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830153|NCT02670707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101830154|NCT02670707|Antimetabolites|antimetabolites|mesh-ancestor
101830155|NCT02670707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830156|NCT02670707|Antiviral Agents|antiviral agents|mesh-ancestor
101830157|NCT02670707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101830158|NCT02670707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101830159|NCT02670707|Immunologic Factors|immunologic factors|mesh-ancestor
101830160|NCT02670707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101830161|NCT02670707|Tubulin Modulators|tubulin modulators|mesh-ancestor
101830162|NCT02670707|Antimitotic Agents|antimitotic agents|mesh-ancestor
101830163|NCT02670707|Mitosis Modulators|mitosis modulators|mesh-ancestor
101830165|NCT02658890|Ipilimumab|ipilimumab|mesh-list
101830166|NCT02658890|Linrodostat|linrodostat|mesh-list
101830167|NCT02658890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101830168|NCT02658890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830169|NCT02658890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101830171|NCT02658890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101830172|NCT02597062|Dexamethasone|dexamethasone|mesh-list
101830173|NCT02597062|Cyclophosphamide|cyclophosphamide|mesh-list
101830174|NCT02597062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101830175|NCT02597062|Immunologic Factors|immunologic factors|mesh-ancestor
101830176|NCT02597062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830178|NCT02597062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101830179|NCT02597062|Alkylating Agents|alkylating agents|mesh-ancestor
101830180|NCT02597062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830181|NCT02597062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830182|NCT02597062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101830183|NCT02597062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101830184|NCT02597062|Antiemetics|antiemetics|mesh-ancestor
101830185|NCT02597062|Autonomic Agents|autonomic agents|mesh-ancestor
101830186|NCT02597062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101830187|NCT02597062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101830188|NCT02597062|Glucocorticoids|glucocorticoids|mesh-ancestor
101830189|NCT02597062|Hormones|hormones|mesh-ancestor
101830190|NCT02597062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101830191|NCT02597062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101830192|NCT02530463|Nivolumab|nivolumab|mesh-list
101830193|NCT02530463|Ipilimumab|ipilimumab|mesh-list
101830194|NCT02530463|Azacitidine|azacitidine|mesh-list
101830195|NCT02530463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101830196|NCT02530463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830197|NCT02530463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101830198|NCT02530463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830199|NCT02530463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101830200|NCT02530463|Antimetabolites|antimetabolites|mesh-ancestor
101830201|NCT02530463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101830202|NCT02458014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101830204|NCT02458014|Antibodies|antibodies|mesh-list
101830205|NCT02458014|Immunoglobulins|immunoglobulins|mesh-list
101830217|NCT02451982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101830218|NCT02451982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101830219|NCT02451982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101830220|NCT02451982|Alkylating Agents|alkylating agents|mesh-ancestor
101830221|NCT02451982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830222|NCT02451982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830223|NCT02451982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101830224|NCT02451982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101830225|NCT02451982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101830227|NCT02444741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101830228|NCT02444741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830229|NCT02444741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101830230|NCT02444741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830255|NCT02185560|Sorafenib|sorafenib|mesh-list
101830256|NCT02185560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830257|NCT02185560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101830258|NCT02185560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101814093|NCT03905642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101814094|NCT04126538|Pirfenidone|pirfenidone|mesh-list
101814095|NCT04126538|Analgesics|analgesics|mesh-ancestor
101814096|NCT04126538|Sensory System Agents|sensory system agents|mesh-ancestor
101814097|NCT04126538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101814098|NCT04126538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814099|NCT04126538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101814100|NCT04126538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101814101|NCT04126538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101814103|NCT04126538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101814104|NCT04004234|Manganese|manganese|mesh-list
101830259|NCT02185560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830260|NCT02122185|Metformin|metformin|mesh-list
101830261|NCT02122185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101830262|NCT02122185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830263|NCT01955460|Aldesleukin|aldesleukin|mesh-list
101830264|NCT01955460|Cyclophosphamide|cyclophosphamide|mesh-list
101830265|NCT01955460|Fludarabine|fludarabine|mesh-list
101830266|NCT01955460|Fludarabine phosphate|fludarabine phosphate|mesh-list
101830267|NCT01955460|Interleukin-2|interleukin-2|mesh-list
101830268|NCT01955460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101830269|NCT01955460|Immunologic Factors|immunologic factors|mesh-ancestor
101830270|NCT01955460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830271|NCT01955460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101830272|NCT01955460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101830273|NCT01955460|Alkylating Agents|alkylating agents|mesh-ancestor
101313581|NCT00000466|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101830274|NCT01955460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830275|NCT01955460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830276|NCT01955460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101830277|NCT01955460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101830278|NCT01955460|Antimetabolites|antimetabolites|mesh-ancestor
101830279|NCT01955460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101830280|NCT01955460|Analgesics|analgesics|mesh-ancestor
101830281|NCT01955460|Sensory System Agents|sensory system agents|mesh-ancestor
101830282|NCT01955460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101830283|NCT01955460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101830284|NCT01955460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101830285|NCT01955460|Antiviral Agents|antiviral agents|mesh-ancestor
101830286|NCT01955460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101830287|NCT01919619|Lenalidomide|lenalidomide|mesh-list
101830288|NCT01919619|Ipilimumab|ipilimumab|mesh-list
101830289|NCT01919619|Immunologic Factors|immunologic factors|mesh-ancestor
101830290|NCT01919619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830291|NCT01919619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101830292|NCT01919619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101830293|NCT01919619|Growth Substances|growth substances|mesh-ancestor
101830294|NCT01919619|Growth Inhibitors|growth inhibitors|mesh-ancestor
101830295|NCT01919619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830296|NCT01919619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101830297|NCT01919619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101830298|NCT01919619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830299|NCT01528852|Chlorhexidine|chlorhexidine|mesh-list
101830300|NCT01528852|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101830301|NCT01528852|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101830302|NCT01528852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101830304|NCT01528852|Dermatologic Agents|dermatologic agents|mesh-ancestor
101830305|NCT01248585|Dexamethasone|dexamethasone|mesh-list
101830306|NCT01248585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101814105|NCT04004234|Paclitaxel|paclitaxel|mesh-list
101471418|NCT00252707|Gefitinib|gefitinib|mesh-list
101814106|NCT04004234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101814107|NCT04004234|Gemcitabine|gemcitabine|mesh-list
101814108|NCT04004234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101814109|NCT04004234|Antibodies|antibodies|mesh-list
101814110|NCT04004234|Immunoglobulins|immunoglobulins|mesh-list
101814111|NCT04004234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101814112|NCT04004234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830307|NCT01248585|Antiemetics|antiemetics|mesh-ancestor
101830308|NCT01248585|Autonomic Agents|autonomic agents|mesh-ancestor
101830309|NCT01248585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101830310|NCT01248585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101830311|NCT01248585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101830312|NCT01248585|Glucocorticoids|glucocorticoids|mesh-ancestor
101830313|NCT01248585|Hormones|hormones|mesh-ancestor
101830314|NCT01248585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101830315|NCT01248585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101830316|NCT01248585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830317|NCT00993655|Paclitaxel|paclitaxel|mesh-list
101830319|NCT00993655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101830320|NCT00993655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101830321|NCT00993655|Tubulin Modulators|tubulin modulators|mesh-ancestor
101830322|NCT00993655|Antimitotic Agents|antimitotic agents|mesh-ancestor
101830323|NCT00993655|Mitosis Modulators|mitosis modulators|mesh-ancestor
101830324|NCT00993655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101830325|NCT00168701|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101830326|NCT00168701|Dermatologic Agents|dermatologic agents|mesh-ancestor
101830327|NCT00168701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101830328|NCT00168701|Immunologic Factors|immunologic factors|mesh-ancestor
101830329|NCT00168701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488186|NCT00434382|Fentanyl|fentanyl|mesh-list
101488486|NCT00435279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101488566|NCT00435435|Disulfiram|disulfiram|mesh-list
101488782|NCT00432081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101488855|NCT00420563|Contraceptive Agents|contraceptive agents|mesh-ancestor
101489307|NCT00437814|Ketamine|ketamine|mesh-list
101489537|NCT00337298|Amlodipine|amlodipine|mesh-list
101490198|NCT00343226|Basiliximab|basiliximab|mesh-list
101490576|NCT00448305|Paclitaxel|paclitaxel|mesh-list
101490957|NCT00449202|Estrone|estrone|mesh-list
101491022|NCT00449280|Sirolimus|sirolimus|mesh-list
101491997|NCT00425906|Nicotine|nicotine|mesh-list
101492070|NCT00426140|Antimitotic Agents|antimitotic agents|mesh-ancestor
101493559|NCT00433784|Purinergic Agents|purinergic agents|mesh-ancestor
101494745|NCT00476424|Efavirenz|efavirenz|mesh-list
101495045|NCT00438945|Eprosartan|eprosartan|mesh-list
101495418|NCT00440739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101495568|NCT02957279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101496178|NCT00456560|Serotonin Agents|serotonin agents|mesh-ancestor
101496393|NCT00443937|Everolimus|everolimus|mesh-list
101496468|NCT00488163|Adrenergic Agents|adrenergic agents|mesh-ancestor
101497145|NCT00466154|Antipyretics|antipyretics|mesh-ancestor
101497518|NCT02893384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497598|NCT00491634|Treosulfan|treosulfan|mesh-list
101498270|NCT00493077|Interferons|interferons|mesh-list
101498341|NCT00493116|Methylprednisolone|methylprednisolone|mesh-list
101498443|NCT00500253|Miotics|miotics|mesh-ancestor
101498790|NCT00469937|Antimanic Agents|antimanic agents|mesh-ancestor
101498946|NCT00600301|Glucocorticoids|glucocorticoids|mesh-ancestor
101499530|NCT01324999|Tadalafil|tadalafil|mesh-list
101499829|NCT05645302|Lidocaine|lidocaine|mesh-list
101500291|NCT00479609|Testosterone|testosterone|mesh-list
101500427|NCT01248858|Trametinib|trametinib|mesh-list
101500580|NCT01313221|Etanercept|etanercept|mesh-list
101500730|NCT04518735|Anticoagulants|anticoagulants|mesh-list
101500815|NCT01310803|Valrubicin|valrubicin|mesh-list
101500893|NCT00480935|Sunitinib|sunitinib|mesh-list
101501097|NCT00482963|Efavirenz|efavirenz|mesh-list
101502135|NCT00485771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101502351|NCT00486213|Pyridoxine|pyridoxine|mesh-list
101502721|NCT01300351|Fulvestrant|fulvestrant|mesh-list
101503174|NCT00495872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101503395|NCT01296568|Antimetabolites|antimetabolites|mesh-ancestor
101503699|NCT05148546|Nivolumab|nivolumab|mesh-list
101265358|NCT01773044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101814113|NCT04004234|Tubulin Modulators|tubulin modulators|mesh-ancestor
101814114|NCT04004234|Antimitotic Agents|antimitotic agents|mesh-ancestor
101814115|NCT04004234|Mitosis Modulators|mitosis modulators|mesh-ancestor
101814116|NCT04004234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814117|NCT04004234|Immunologic Factors|immunologic factors|mesh-ancestor
101814118|NCT04004234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814119|NCT04004234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101265361|NCT01773044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101265362|NCT01773044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101265363|NCT01773044|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101265364|NCT01773044|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101265365|NCT01773044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101265366|NCT01773044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265367|NCT01773096|Methylnaltrexone|methylnaltrexone|mesh-list
101265369|NCT01773096|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101265370|NCT01773096|Magnesium Hydroxide|magnesium hydroxide|mesh-list
101265371|NCT01773096|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
101265372|NCT01773096|Cathartics|cathartics|mesh-ancestor
101265373|NCT01773096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101265374|NCT01773096|Laxatives|laxatives|mesh-ancestor
101265375|NCT01773096|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101265376|NCT01773096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265377|NCT01773096|Sensory System Agents|sensory system agents|mesh-ancestor
101265378|NCT01773096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101265379|NCT01773096|Antacids|antacids|mesh-ancestor
101265380|NCT01773096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265381|NCT01773096|Antidiarrheals|antidiarrheals|mesh-ancestor
101265382|NCT01773174|Dabigatran|dabigatran|mesh-list
101265383|NCT01773174|Antithrombins|antithrombins|mesh-ancestor
101265384|NCT01773174|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101265385|NCT01773174|Protease Inhibitors|protease inhibitors|mesh-ancestor
101265386|NCT01773174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101265387|NCT01773174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265388|NCT01773174|Anticoagulants|anticoagulants|mesh-ancestor
101265389|NCT01773408|Cytarabine|cytarabine|mesh-list
101265391|NCT01773408|Idarubicin|idarubicin|mesh-list
101265392|NCT01773408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101265393|NCT01773408|Antimetabolites|antimetabolites|mesh-ancestor
101265394|NCT01773408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265395|NCT01773408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101265396|NCT01773408|Antiviral Agents|antiviral agents|mesh-ancestor
101265397|NCT01773408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101265399|NCT01773408|Immunologic Factors|immunologic factors|mesh-ancestor
101265400|NCT01773408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265401|NCT01773408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101265402|NCT01773408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101265403|NCT01773408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101265404|NCT01773408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101265405|NCT01773460|Everolimus|everolimus|mesh-list
101265406|NCT01773460|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101265407|NCT01773460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101265408|NCT01773460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101265409|NCT01773460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265410|NCT01773460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101265411|NCT01773460|Immunologic Factors|immunologic factors|mesh-ancestor
101265412|NCT01773460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265413|NCT01773460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101265414|NCT01773512|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101265415|NCT01773512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101265417|NCT01773512|Antimetabolites|antimetabolites|mesh-ancestor
101265418|NCT01773512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265419|NCT01773512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101265420|NCT01773512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101265421|NCT01773512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101265422|NCT01773538|Rifaximin|rifaximin|mesh-list
101265423|NCT01773538|Lactulose|lactulose|mesh-list
101265424|NCT01773538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101814120|NCT04004234|Antimetabolites|antimetabolites|mesh-ancestor
101814121|NCT04004234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101814122|NCT04004234|Trace Elements|trace elements|mesh-ancestor
101814123|NCT04004234|Micronutrients|micronutrients|mesh-ancestor
101814124|NCT00990158|Vitamin K|vitamin k|mesh-list
101814125|NCT00990158|Vitamin K 1|vitamin k 1|mesh-list
101814126|NCT00990158|Vitamins|vitamins|mesh-ancestor
101814127|NCT00990158|Micronutrients|micronutrients|mesh-ancestor
101814128|NCT00990158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814129|NCT00990158|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101814130|NCT00990158|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101814131|NCT00990158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814132|NCT00990158|Hemostatics|hemostatics|mesh-ancestor
101814133|NCT00990158|Coagulants|coagulants|mesh-ancestor
101814134|NCT00412984|Warfarin|warfarin|mesh-list
101814135|NCT00412984|Apixaban|apixaban|mesh-list
101814136|NCT00412984|Anticoagulants|anticoagulants|mesh-ancestor
101814137|NCT00412984|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101814138|NCT00412984|Antithrombins|antithrombins|mesh-ancestor
101814139|NCT00412984|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101265425|NCT01773538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101265426|NCT01773538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101265427|NCT01773616|Mycophenolic Acid|mycophenolic acid|mesh-list
101265428|NCT01773616|Prednisolone|prednisolone|mesh-list
101265429|NCT01773616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101265430|NCT01773616|Methylprednisolone|methylprednisolone|mesh-list
101265431|NCT01773616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101265432|NCT01773616|Prednisolone acetate|prednisolone acetate|mesh-list
101265435|NCT01773616|Prednisolone phosphate|prednisolone phosphate|mesh-list
101265436|NCT01773616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101265437|NCT01773616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101265438|NCT01773616|Immunologic Factors|immunologic factors|mesh-ancestor
101265439|NCT01773616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265440|NCT01773616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101265441|NCT01773616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101265443|NCT01773616|Antitubercular Agents|antitubercular agents|mesh-ancestor
101265444|NCT01773616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101265445|NCT01773616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101265446|NCT01773616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101265447|NCT01773616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265448|NCT01773616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101265450|NCT01773616|Hormones|hormones|mesh-ancestor
101265451|NCT01773616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101265452|NCT01773616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101265453|NCT01773616|Antiemetics|antiemetics|mesh-ancestor
101265454|NCT01773616|Autonomic Agents|autonomic agents|mesh-ancestor
101265455|NCT01773616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101265456|NCT01773616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101265457|NCT01773616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101265458|NCT01773616|Protective Agents|protective agents|mesh-ancestor
101265459|NCT01773681|Certolizumab Pegol|certolizumab pegol|mesh-list
101265460|NCT01773681|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101265461|NCT01773681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101265462|NCT01773681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101265463|NCT01773681|Immunologic Factors|immunologic factors|mesh-ancestor
101265464|NCT01773681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265465|NCT01773681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101814140|NCT00412984|Protease Inhibitors|protease inhibitors|mesh-ancestor
101814141|NCT00412984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101814142|NCT00412984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814144|NCT00539864|Agglutinins|agglutinins|mesh-ancestor
101814145|NCT00539864|Immunologic Factors|immunologic factors|mesh-ancestor
101814146|NCT00539864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814147|NCT00539864|Coagulants|coagulants|mesh-ancestor
101814148|NCT04003376|Vitamin D|vitamin d|mesh-list
101814149|NCT04003376|Triamcinolone|triamcinolone|mesh-list
101814150|NCT04003376|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101265466|NCT01773772|Progesterone|progesterone|mesh-list
101265467|NCT01773772|Progestins|progestins|mesh-ancestor
101265468|NCT01773772|Hormones|hormones|mesh-ancestor
101265469|NCT01773772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101265470|NCT01773772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265471|NCT01773798|Insulin|insulin|mesh-list
101265472|NCT01773798|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101265473|NCT01773798|Insulin Aspart|insulin aspart|mesh-list
101265475|NCT01773798|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101265476|NCT01773798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101265477|NCT01773798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265478|NCT01773824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101265479|NCT01773824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101265480|NCT01773837|Methylphenidate|methylphenidate|mesh-list
101265481|NCT01773837|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101265482|NCT01773837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265483|NCT01773837|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101265484|NCT01773837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101265485|NCT01773837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101265486|NCT01773837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265487|NCT01773837|Dopamine Agents|dopamine agents|mesh-ancestor
101265490|NCT01773876|Antifungal Agents|antifungal agents|mesh-ancestor
101265491|NCT01773876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101265492|NCT01774370|Dabigatran|dabigatran|mesh-list
101265493|NCT01774370|Antithrombins|antithrombins|mesh-ancestor
101265494|NCT01774370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101265495|NCT01774370|Protease Inhibitors|protease inhibitors|mesh-ancestor
101265496|NCT01774370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101265497|NCT01774370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265499|NCT01774396|Lidocaine|lidocaine|mesh-list
101265500|NCT01774396|Anesthetics, Local|anesthetics, local|mesh-ancestor
101265501|NCT01774396|Anesthetics|anesthetics|mesh-ancestor
101265502|NCT01774396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101265503|NCT01774396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265504|NCT01774396|Sensory System Agents|sensory system agents|mesh-ancestor
101265505|NCT01774396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101265506|NCT01774396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101265507|NCT01774396|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101265510|NCT01774396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265511|NCT01774474|Dexamethasone|dexamethasone|mesh-list
101265512|NCT01774474|Dexamethasone acetate|dexamethasone acetate|mesh-list
101265513|NCT01774474|Triamcinolone|triamcinolone|mesh-list
101265514|NCT01774474|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101265515|NCT01774474|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101265516|NCT01774474|Bromfenac|bromfenac|mesh-list
101265517|NCT01774474|Bevacizumab|bevacizumab|mesh-list
101265518|NCT01774474|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101265519|NCT01774474|BB 1101|bb 1101|mesh-list
101265520|NCT01774474|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101265522|NCT01774474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101265523|NCT01774474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101265524|NCT01774474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101265525|NCT01774474|Growth Substances|growth substances|mesh-ancestor
101265526|NCT01774474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814151|NCT04003376|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101814152|NCT04003376|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101814154|NCT04003376|Micronutrients|micronutrients|mesh-ancestor
101814155|NCT04003376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814156|NCT04003376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101814157|NCT04003376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101814158|NCT04003376|Glucocorticoids|glucocorticoids|mesh-ancestor
101814159|NCT04003376|Hormones|hormones|mesh-ancestor
101265527|NCT01774474|Growth Inhibitors|growth inhibitors|mesh-ancestor
101265528|NCT01774474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101265529|NCT01774474|Antiemetics|antiemetics|mesh-ancestor
101265530|NCT01774474|Autonomic Agents|autonomic agents|mesh-ancestor
101265531|NCT01774474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101265532|NCT01774474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101265533|NCT01774474|Glucocorticoids|glucocorticoids|mesh-ancestor
101265534|NCT01774474|Hormones|hormones|mesh-ancestor
101265535|NCT01774474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101265536|NCT01774474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101265537|NCT01774474|Protease Inhibitors|protease inhibitors|mesh-ancestor
101265538|NCT01774474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101265539|NCT01774474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265540|NCT01774474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101265541|NCT01774474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101265542|NCT01774474|Immunologic Factors|immunologic factors|mesh-ancestor
101265543|NCT01774474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101265544|NCT01774474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101265545|NCT01774474|Analgesics|analgesics|mesh-ancestor
101265546|NCT01774474|Sensory System Agents|sensory system agents|mesh-ancestor
101265547|NCT01774474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101265548|NCT01774565|Insulin|insulin|mesh-list
101265549|NCT01774565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101265550|NCT01774565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101265551|NCT01774565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265552|NCT01774812|Ergocalciferols|ergocalciferols|mesh-list
101265553|NCT01774812|Vitamin D|vitamin d|mesh-list
101265554|NCT01774812|Alfacalcidol|alfacalcidol|mesh-list
101265555|NCT01774812|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
101265556|NCT01774812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101265557|NCT01774812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265558|NCT01774812|Vitamins|vitamins|mesh-ancestor
101265559|NCT01774812|Micronutrients|micronutrients|mesh-ancestor
101265560|NCT01774812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101265561|NCT01774838|Clopidogrel|clopidogrel|mesh-list
101265562|NCT01774838|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101265563|NCT01774838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101265564|NCT01774838|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101265565|NCT01774838|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101265566|NCT01774838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101265567|NCT01774838|Purinergic Agents|purinergic agents|mesh-ancestor
101265568|NCT01774838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101265569|NCT01774838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265570|NCT01774838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265572|NCT01774864|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101265573|NCT01774864|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101265574|NCT01774864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101265575|NCT01774864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265576|NCT01774877|Leflunomide|leflunomide|mesh-list
101265578|NCT01774877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265579|NCT01774877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101265581|NCT01774877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265582|NCT01775098|Allopurinol|allopurinol|mesh-list
101265583|NCT01775098|Antimetabolites|antimetabolites|mesh-ancestor
101265584|NCT01775098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814160|NCT04003376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101814161|NCT04003376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101814162|NCT04003376|Immunologic Factors|immunologic factors|mesh-ancestor
101814163|NCT04003376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101814164|NCT04003376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814165|NCT04086212|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101814166|NCT04086212|Icodextrin|icodextrin|mesh-list
101814167|NCT04086212|Dialysis Solutions|dialysis solutions|mesh-list
101265585|NCT01775098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101265586|NCT01775098|Gout Suppressants|gout suppressants|mesh-ancestor
101265587|NCT01775098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101265588|NCT01775098|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101265589|NCT01775098|Antioxidants|antioxidants|mesh-ancestor
101265590|NCT01775098|Protective Agents|protective agents|mesh-ancestor
101265591|NCT01775098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265592|NCT01775215|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101265593|NCT01775215|Natriuretic Agents|natriuretic agents|mesh-ancestor
101265594|NCT01775215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265595|NCT01775397|Vancomycin|vancomycin|mesh-list
101265596|NCT01775397|Fidaxomicin|fidaxomicin|mesh-list
101265597|NCT01775397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101265598|NCT01775397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101265600|NCT01775540|Lubricant Eye Drops|lubricant eye drops|mesh-list
101265601|NCT01775540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101265602|NCT01775540|Antiemetics|antiemetics|mesh-ancestor
101265603|NCT01775540|Autonomic Agents|autonomic agents|mesh-ancestor
101265604|NCT01775540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101265605|NCT01775540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265606|NCT01775540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101265607|NCT01775540|Glucocorticoids|glucocorticoids|mesh-ancestor
101265608|NCT01775540|Hormones|hormones|mesh-ancestor
101265609|NCT01775540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101265610|NCT01775540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101265611|NCT01775540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101265612|NCT01775540|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101265613|NCT01775540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101265614|NCT01775579|Metformin|metformin|mesh-list
101265615|NCT01775579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101265616|NCT01775579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101265617|NCT01775579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265618|NCT01775579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101265619|NCT01775579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101265621|NCT01775579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265622|NCT01775579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101265623|NCT01775579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101265624|NCT01775579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101265625|NCT01775618|Factor VIII|factor viii|mesh-list
101265626|NCT01775618|Coagulants|coagulants|mesh-ancestor
101265627|NCT01775631|Rituximab|rituximab|mesh-list
101265628|NCT01775631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101265629|NCT01775631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101265630|NCT01775631|Immunologic Factors|immunologic factors|mesh-ancestor
101265631|NCT01775631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265632|NCT01775631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101265633|NCT01775761|Moxifloxacin|moxifloxacin|mesh-list
101265634|NCT01775761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101265635|NCT01775761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101265636|NCT01775761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101265637|NCT01775761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101265638|NCT01775761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101265639|NCT01775761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265640|NCT01775761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101265641|NCT01775839|Aspirin|aspirin|mesh-list
101265642|NCT01775839|Digoxin|digoxin|mesh-list
101265643|NCT01775839|Clopidogrel|clopidogrel|mesh-list
101265644|NCT01775839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101265646|NCT01775839|Analgesics|analgesics|mesh-ancestor
101265647|NCT01775839|Sensory System Agents|sensory system agents|mesh-ancestor
101814168|NCT05404490|Bupivacaine|bupivacaine|mesh-list
101814169|NCT05404490|Anesthetics, Local|anesthetics, local|mesh-ancestor
101814170|NCT05404490|Anesthetics|anesthetics|mesh-ancestor
101814171|NCT05404490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101814172|NCT05404490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814173|NCT05404490|Sensory System Agents|sensory system agents|mesh-ancestor
101814174|NCT05404490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101814176|NCT05359874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101814177|NCT05359874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101814178|NCT05359874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101265648|NCT01775839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101265649|NCT01775839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265650|NCT01775839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101265651|NCT01775839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101265652|NCT01775839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101265653|NCT01775839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101265654|NCT01775839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265655|NCT01775839|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101265656|NCT01775839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101265657|NCT01775839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101265659|NCT01775839|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101265660|NCT01775839|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101265661|NCT01775839|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101265662|NCT01775839|Purinergic Agents|purinergic agents|mesh-ancestor
101265663|NCT01775839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101265664|NCT01775839|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101265665|NCT01775839|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101265666|NCT01775839|Protective Agents|protective agents|mesh-ancestor
101265668|NCT01775891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
101265669|NCT01775891|Propafenone|propafenone|mesh-list
101265670|NCT01775891|Pilsicainide|pilsicainide|mesh-list
101265671|NCT01775891|Lidocaine|lidocaine|mesh-list
101265672|NCT01775891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101265673|NCT01775891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101265674|NCT01775891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101265675|NCT01775891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265676|NCT01775891|Anesthetics, Local|anesthetics, local|mesh-ancestor
101265677|NCT01775891|Anesthetics|anesthetics|mesh-ancestor
101265678|NCT01775891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101265679|NCT01775891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265680|NCT01775891|Sensory System Agents|sensory system agents|mesh-ancestor
101265681|NCT01775891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101265682|NCT01776047|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
101265683|NCT01776047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101265684|NCT01776203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101265685|NCT01776203|Medroxyprogesterone|medroxyprogesterone|mesh-list
101265686|NCT01776203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101265687|NCT01776203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101265688|NCT01776203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101265689|NCT01776203|Contraceptive Agents|contraceptive agents|mesh-ancestor
101265690|NCT01776203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101265691|NCT01776203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265692|NCT01776203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101265693|NCT01776203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101265694|NCT01776203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101265695|NCT01776203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101265697|NCT01776320|Alprostadil|alprostadil|mesh-list
101265698|NCT01776320|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101265699|NCT01776320|Vasodilator Agents|vasodilator agents|mesh-ancestor
101265700|NCT01776320|Urological Agents|urological agents|mesh-ancestor
101265701|NCT01776437|Talazoparib|talazoparib|mesh-list
101814179|NCT05359874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101814180|NCT05359874|Growth Substances|growth substances|mesh-ancestor
101814181|NCT05359874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814182|NCT05359874|Growth Inhibitors|growth inhibitors|mesh-ancestor
101814183|NCT00990392|Polymyxins|polymyxins|mesh-list
101814184|NCT00990392|Bacitracin|bacitracin|mesh-list
101814185|NCT00990392|Polymyxin B|polymyxin b|mesh-list
101265702|NCT01776437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101265703|NCT01776437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101265704|NCT01776437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265705|NCT01776437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101265706|NCT01776515|Acetaminophen|acetaminophen|mesh-list
101265707|NCT01776515|Tramadol|tramadol|mesh-list
101265708|NCT01776515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101265709|NCT01776515|Analgesics|analgesics|mesh-ancestor
101265710|NCT01776515|Sensory System Agents|sensory system agents|mesh-ancestor
101265711|NCT01776515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101265712|NCT01776515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265713|NCT01776515|Antipyretics|antipyretics|mesh-ancestor
101265714|NCT01776515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101265715|NCT01776515|Narcotics|narcotics|mesh-ancestor
101265716|NCT01776515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101265717|NCT01776567|Everolimus|everolimus|mesh-list
101265718|NCT01776567|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101265719|NCT01776567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101265720|NCT01776567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101265721|NCT01776567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265722|NCT01776567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101265723|NCT01776567|Immunologic Factors|immunologic factors|mesh-ancestor
101265724|NCT01776567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265725|NCT01776567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101265726|NCT01776671|Gabapentin|gabapentin|mesh-list
101265727|NCT01776671|Analgesics|analgesics|mesh-ancestor
101265728|NCT01776671|Sensory System Agents|sensory system agents|mesh-ancestor
101265729|NCT01776671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101265730|NCT01776671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265731|NCT01776671|Anticonvulsants|anticonvulsants|mesh-ancestor
101265732|NCT01776671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101265733|NCT01776671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101265734|NCT01776671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101265735|NCT01776671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101265736|NCT01776671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101265737|NCT01776671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101265738|NCT01776671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101265739|NCT01776671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265740|NCT01776671|Antimanic Agents|antimanic agents|mesh-ancestor
101265741|NCT01776684|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101265742|NCT01776684|Gefitinib|gefitinib|mesh-list
101265743|NCT01776684|Afatinib|afatinib|mesh-list
101265745|NCT01776684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101265746|NCT01776684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101265747|NCT01776684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265748|NCT01776788|Insulin|insulin|mesh-list
101265749|NCT01776788|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101265750|NCT01776788|Exenatide|exenatide|mesh-list
101265751|NCT01776788|Insulin Lispro|insulin lispro|mesh-list
101265752|NCT01776788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101265753|NCT01776788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265754|NCT01776788|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101265755|NCT01776788|Incretins|incretins|mesh-ancestor
101265756|NCT01776788|Hormones|hormones|mesh-ancestor
101265757|NCT01776788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101265758|NCT01776853|Levan|levan|mesh-list
101265759|NCT01776853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101265760|NCT01776970|Nabiximols|nabiximols|mesh-list
101265761|NCT01776970|Analgesics|analgesics|mesh-ancestor
101265762|NCT01776970|Sensory System Agents|sensory system agents|mesh-ancestor
101265763|NCT01776970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101814186|NCT00990392|Gramicidin|gramicidin|mesh-list
101814187|NCT00990392|Petrolatum|petrolatum|mesh-list
101814188|NCT00990392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101814189|NCT00990392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101814190|NCT00990392|Emollients|emollients|mesh-ancestor
101814191|NCT00990392|Dermatologic Agents|dermatologic agents|mesh-ancestor
101814192|NCT00990392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101265764|NCT01776970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265765|NCT01777087|Capsaicin|capsaicin|mesh-list
101265766|NCT01777087|Antipruritics|antipruritics|mesh-ancestor
101265767|NCT01777087|Dermatologic Agents|dermatologic agents|mesh-ancestor
101265768|NCT01777087|Sensory System Agents|sensory system agents|mesh-ancestor
101265769|NCT01777087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101265770|NCT01777087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265771|NCT01777100|Sufentanil|sufentanil|mesh-list
101265772|NCT01777100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101265773|NCT01777100|Narcotics|narcotics|mesh-ancestor
101265774|NCT01777100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101265775|NCT01777100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265776|NCT01777100|Analgesics|analgesics|mesh-ancestor
101265777|NCT01777100|Sensory System Agents|sensory system agents|mesh-ancestor
101265778|NCT01777100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101265779|NCT01777100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101265780|NCT01777100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101265781|NCT01777100|Anesthetics, General|anesthetics, general|mesh-ancestor
101265782|NCT01777100|Anesthetics|anesthetics|mesh-ancestor
101265783|NCT01777347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101265784|NCT01777464|Histamine|histamine|mesh-list
101265785|NCT01777464|Histamine Agonists|histamine agonists|mesh-ancestor
101265786|NCT01777464|Histamine Agents|histamine agents|mesh-ancestor
101265787|NCT01777464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101265788|NCT01777464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265789|NCT01777464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265790|NCT01777477|Chloroquine|chloroquine|mesh-list
101265791|NCT01777477|Gemcitabine|gemcitabine|mesh-list
101265792|NCT01777477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101265793|NCT01777477|Antimetabolites|antimetabolites|mesh-ancestor
101265794|NCT01777477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265795|NCT01777477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101265796|NCT01777477|Amebicides|amebicides|mesh-ancestor
101265797|NCT01777477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101265798|NCT01777477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101265799|NCT01777477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101265800|NCT01777477|Antimalarials|antimalarials|mesh-ancestor
101265801|NCT01777477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101265802|NCT01777503|Clopidogrel|clopidogrel|mesh-list
101265803|NCT01777503|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101265804|NCT01777503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101265805|NCT01777503|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101265806|NCT01777503|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101265807|NCT01777503|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101265808|NCT01777503|Purinergic Agents|purinergic agents|mesh-ancestor
101265809|NCT01777503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101265810|NCT01777503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265811|NCT01777503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265813|NCT01777685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101265814|NCT01777685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101265815|NCT01777685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101265816|NCT01777685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265817|NCT01777685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101265818|NCT01777685|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101265819|NCT01777685|Dopamine Agents|dopamine agents|mesh-ancestor
101265820|NCT01777685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101265821|NCT01777685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265822|NCT01777685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101265823|NCT01777685|Antidepressive Agents|antidepressive agents|mesh-ancestor
101265824|NCT01777737|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101265825|NCT01777737|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101265826|NCT01777737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101814193|NCT03367754|Pembrolizumab|pembrolizumab|mesh-list
101814194|NCT03367754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101814195|NCT03367754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101814196|NCT03367754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101814197|NCT03367754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814198|NCT03335072|Azithromycin|azithromycin|mesh-list
101814199|NCT03335072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101814200|NCT03335072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101265827|NCT01777737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101265828|NCT01777737|Antimalarials|antimalarials|mesh-ancestor
101265829|NCT01777737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101265830|NCT01777737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101265831|NCT01777867|Methacholine Chloride|methacholine chloride|mesh-list
101265832|NCT01777867|Miotics|miotics|mesh-ancestor
101265833|NCT01777867|Autonomic Agents|autonomic agents|mesh-ancestor
101265834|NCT01777867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101265835|NCT01777867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265836|NCT01777867|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101265837|NCT01777867|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
101265838|NCT01777867|Respiratory System Agents|respiratory system agents|mesh-ancestor
101265839|NCT01777867|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101265840|NCT01777867|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101265841|NCT01777867|Cholinergic Agents|cholinergic agents|mesh-ancestor
101265842|NCT01777867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101265843|NCT01777867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265844|NCT01777919|Copper|copper|mesh-list
101265845|NCT01777919|Temozolomide|temozolomide|mesh-list
101265846|NCT01777919|Disulfiram|disulfiram|mesh-list
101265847|NCT01777919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101265848|NCT01777919|Alkylating Agents|alkylating agents|mesh-ancestor
101265849|NCT01777919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265850|NCT01777919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101265851|NCT01777919|Trace Elements|trace elements|mesh-ancestor
101265852|NCT01777919|Micronutrients|micronutrients|mesh-ancestor
101265853|NCT01777919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265854|NCT01777919|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101265855|NCT01777919|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
101265856|NCT01777919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101265857|NCT01778075|Acetaminophen|acetaminophen|mesh-list
101265858|NCT01778075|Tramadol|tramadol|mesh-list
101265859|NCT01778075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101265860|NCT01778075|Analgesics|analgesics|mesh-ancestor
101265861|NCT01778075|Sensory System Agents|sensory system agents|mesh-ancestor
101265862|NCT01778075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101265863|NCT01778075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265864|NCT01778075|Antipyretics|antipyretics|mesh-ancestor
101265865|NCT01778075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101265867|NCT01778075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101265868|NCT01778101|Lansoprazole|lansoprazole|mesh-list
101265869|NCT01778101|Dexlansoprazole|dexlansoprazole|mesh-list
101265870|NCT01778101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101265871|NCT01778101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101265872|NCT01778101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101265873|NCT01778101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101265874|NCT01778101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265875|NCT01778114|Vitamin D|vitamin d|mesh-list
101265876|NCT01778114|Ergocalciferols|ergocalciferols|mesh-list
101265877|NCT01778114|Cholecalciferol|cholecalciferol|mesh-list
101265878|NCT01778114|Vitamins|vitamins|mesh-list
101265879|NCT01778114|Micronutrients|micronutrients|mesh-ancestor
101265880|NCT01778114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265881|NCT01778114|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101265882|NCT01778114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101265883|NCT01778192|Magnesium citrate|magnesium citrate|mesh-list
101265884|NCT01778192|Picosulfate sodium|picosulfate sodium|mesh-list
101265885|NCT01778192|Citric Acid|citric acid|mesh-list
101265886|NCT01778192|Sodium Citrate|sodium citrate|mesh-list
101265887|NCT01778192|Anticoagulants|anticoagulants|mesh-ancestor
101265888|NCT01778192|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101814201|NCT01034956|Calcium|calcium|mesh-list
101814202|NCT01034956|Hyaluronic Acid|hyaluronic acid|mesh-list
101814203|NCT01034956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101814204|NCT01034956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814205|NCT01034956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101814206|NCT01034956|Immunologic Factors|immunologic factors|mesh-ancestor
101814207|NCT01034956|Viscosupplements|viscosupplements|mesh-ancestor
101814208|NCT01034956|Protective Agents|protective agents|mesh-ancestor
101814209|NCT01580878|Butenafine|butenafine|mesh-list
101814210|NCT01580878|Clotrimazole|clotrimazole|mesh-list
101265889|NCT01778192|Chelating Agents|chelating agents|mesh-ancestor
101265890|NCT01778192|Sequestering Agents|sequestering agents|mesh-ancestor
101265891|NCT01778192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265892|NCT01778192|Cathartics|cathartics|mesh-ancestor
101265893|NCT01778192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101265894|NCT01778218|Deoxyglucose|deoxyglucose|mesh-list
101265895|NCT01778218|Antimetabolites|antimetabolites|mesh-ancestor
101265896|NCT01778218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265897|NCT01778218|Antiviral Agents|antiviral agents|mesh-ancestor
101265898|NCT01778218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101265899|NCT01778244|Metformin|metformin|mesh-list
101265900|NCT01778244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101265901|NCT01778244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265902|NCT01778283|Dialysis Solutions|dialysis solutions|mesh-list
101265903|NCT01778283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101265904|NCT01778309|Acetylcysteine|acetylcysteine|mesh-list
101265905|NCT01778309|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101265906|NCT01778309|Antiviral Agents|antiviral agents|mesh-ancestor
101265907|NCT01778309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101265908|NCT01778309|Expectorants|expectorants|mesh-ancestor
101265909|NCT01778309|Respiratory System Agents|respiratory system agents|mesh-ancestor
101265910|NCT01778309|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101265911|NCT01778309|Antioxidants|antioxidants|mesh-ancestor
101265912|NCT01778309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265913|NCT01778309|Protective Agents|protective agents|mesh-ancestor
101265914|NCT01778309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265915|NCT01778309|Antidotes|antidotes|mesh-ancestor
101265916|NCT01778400|Ethanol|ethanol|mesh-list
101265917|NCT01778400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101265918|NCT01778400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101265919|NCT01778400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101265920|NCT01778400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265921|NCT01778413|Tenofovir|tenofovir|mesh-list
101265922|NCT01778413|Emtricitabine|emtricitabine|mesh-list
101265923|NCT01778413|Efavirenz|efavirenz|mesh-list
101265924|NCT01778413|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101265925|NCT01778413|Antiviral Agents|antiviral agents|mesh-ancestor
101265926|NCT01778413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101265927|NCT01778413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101265928|NCT01778413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101265929|NCT01778413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101265930|NCT01778413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265931|NCT01778413|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101265932|NCT01778413|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101265933|NCT01778413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101265934|NCT01778413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101265935|NCT01778413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101265936|NCT01778413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101265937|NCT01778413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101265938|NCT01778413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101265939|NCT01778647|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
101265940|NCT01778647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265941|NCT01778686|Pindolol|pindolol|mesh-list
101265942|NCT01778686|Citalopram|citalopram|mesh-list
101265943|NCT01778686|Tryptophan|tryptophan|mesh-list
101265944|NCT01778686|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101814211|NCT01580878|Antifungal Agents|antifungal agents|mesh-ancestor
101814212|NCT01580878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101814213|NCT01580878|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101814214|NCT01580878|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101814215|NCT01580878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101814216|NCT01580878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101814217|NCT01580878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814218|NCT01580878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101814219|NCT01580878|Hormone Antagonists|hormone antagonists|mesh-ancestor
101814220|NCT01580878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101814221|NCT01580878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814222|NCT05589974|Verteporfin|verteporfin|mesh-list
101265945|NCT01778686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101265946|NCT01778686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101265947|NCT01778686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265948|NCT01778686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101265949|NCT01778686|Serotonin Agents|serotonin agents|mesh-ancestor
101265950|NCT01778686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528331|NCT04628676|Tranylcypromine|tranylcypromine|mesh-list
101265951|NCT01778686|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101265952|NCT01778686|Antidepressive Agents|antidepressive agents|mesh-ancestor
101265953|NCT01778686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101265954|NCT01778686|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101265955|NCT01778686|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101265956|NCT01778686|Adrenergic Agents|adrenergic agents|mesh-ancestor
101265957|NCT01778686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101265958|NCT01778686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101265959|NCT01778686|Vasodilator Agents|vasodilator agents|mesh-ancestor
101265961|NCT01778803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101265962|NCT01778803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101265963|NCT01778803|Tubulin Modulators|tubulin modulators|mesh-ancestor
101265964|NCT01778803|Antimitotic Agents|antimitotic agents|mesh-ancestor
101265965|NCT01778803|Mitosis Modulators|mitosis modulators|mesh-ancestor
101265966|NCT01778803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265967|NCT01778842|Clopidogrel|clopidogrel|mesh-list
101265968|NCT01778842|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101265969|NCT01778842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101265970|NCT01778842|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101265971|NCT01778842|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101265972|NCT01778842|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101265973|NCT01778842|Purinergic Agents|purinergic agents|mesh-ancestor
101265974|NCT01778842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101265975|NCT01778842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265976|NCT01778842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265977|NCT01779089|Minocycline|minocycline|mesh-list
101265978|NCT01779089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101265979|NCT01779089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101265981|NCT01779232|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101265982|NCT01779232|Hormone Antagonists|hormone antagonists|mesh-ancestor
101265983|NCT01779232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101265984|NCT01779232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265985|NCT01779245|Calcium|calcium|mesh-list
101265986|NCT01779245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101265987|NCT01779245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265988|NCT01779258|Desonide|desonide|mesh-list
101265989|NCT01779258|Glycerol|glycerol|mesh-list
101265990|NCT01779258|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101814223|NCT05589974|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101814224|NCT05589974|Dermatologic Agents|dermatologic agents|mesh-ancestor
101814225|NCT05589896|Mycophenolic Acid|mycophenolic acid|mesh-list
101814226|NCT05589896|Cyclophosphamide|cyclophosphamide|mesh-list
101814227|NCT05589896|Busulfan|busulfan|mesh-list
101814228|NCT05589896|Fludarabine|fludarabine|mesh-list
101814229|NCT05589896|Tacrolimus|tacrolimus|mesh-list
101814230|NCT05589896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101265991|NCT01779258|Protective Agents|protective agents|mesh-ancestor
101265992|NCT01779258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265993|NCT01779258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101265994|NCT01779271|Loxoprofen|loxoprofen|mesh-list
101265995|NCT01779271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101265996|NCT01779271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101265997|NCT01779271|Analgesics|analgesics|mesh-ancestor
101265998|NCT01779271|Sensory System Agents|sensory system agents|mesh-ancestor
101265999|NCT01779271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101266000|NCT01779271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266001|NCT01779271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101266002|NCT01779271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101266003|NCT01779284|Timolol|timolol|mesh-list
101266004|NCT01779284|Travoprost|travoprost|mesh-list
101266005|NCT01779284|Latanoprost|latanoprost|mesh-list
101266006|NCT01779284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101266007|NCT01779284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101266008|NCT01779284|Adrenergic Agents|adrenergic agents|mesh-ancestor
101266009|NCT01779284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101266010|NCT01779284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266011|NCT01779284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266012|NCT01779284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101266013|NCT01779284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101266014|NCT01779284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101266015|NCT01779284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101266016|NCT01779362|Metformin|metformin|mesh-list
101266017|NCT01779362|Insulin Glargine|insulin glargine|mesh-list
101266018|NCT01779362|Liraglutide|liraglutide|mesh-list
101266019|NCT01779362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101266020|NCT01779362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266021|NCT01779362|Incretins|incretins|mesh-ancestor
101266022|NCT01779362|Hormones|hormones|mesh-ancestor
101266023|NCT01779362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101266024|NCT01779401|Aspirin|aspirin|mesh-list
101266025|NCT01779401|Cilostazol|cilostazol|mesh-list
101266026|NCT01779401|Clopidogrel|clopidogrel|mesh-list
101266027|NCT01779401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101266028|NCT01779401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101266029|NCT01779401|Analgesics|analgesics|mesh-ancestor
101266030|NCT01779401|Sensory System Agents|sensory system agents|mesh-ancestor
101266031|NCT01779401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101266032|NCT01779401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266033|NCT01779401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101266034|NCT01779401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101266035|NCT01779401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101266036|NCT01779401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101266037|NCT01779401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266038|NCT01779401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101266039|NCT01779401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101266040|NCT01779401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101266041|NCT01779401|Antipyretics|antipyretics|mesh-ancestor
101266042|NCT01779401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101266043|NCT01779401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101266044|NCT01779401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101266045|NCT01779401|Purinergic Agents|purinergic agents|mesh-ancestor
101266046|NCT01779401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101266047|NCT01779401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101266048|NCT01779401|Autonomic Agents|autonomic agents|mesh-ancestor
101266049|NCT01779401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101266050|NCT01779401|Respiratory System Agents|respiratory system agents|mesh-ancestor
101266051|NCT01779401|Vasodilator Agents|vasodilator agents|mesh-ancestor
101266052|NCT01779401|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101814231|NCT05589896|Immunologic Factors|immunologic factors|mesh-ancestor
101814232|NCT05589896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814233|NCT05589896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101814234|NCT05589896|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101814235|NCT05589896|Alkylating Agents|alkylating agents|mesh-ancestor
101814236|NCT05589896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814237|NCT05589896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101266053|NCT01779401|Protective Agents|protective agents|mesh-ancestor
101266054|NCT01779401|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101266055|NCT01779401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101266056|NCT01779466|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101266057|NCT01779466|Hemostatics|hemostatics|mesh-ancestor
101266058|NCT01779466|Coagulants|coagulants|mesh-ancestor
101266059|NCT01779466|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101266060|NCT01779466|Natriuretic Agents|natriuretic agents|mesh-ancestor
101266061|NCT01779466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266062|NCT01779479|Paclitaxel|paclitaxel|mesh-list
101266063|NCT01779479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101266064|NCT01779479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101266065|NCT01779479|Tubulin Modulators|tubulin modulators|mesh-ancestor
101266066|NCT01779479|Antimitotic Agents|antimitotic agents|mesh-ancestor
101266067|NCT01779479|Mitosis Modulators|mitosis modulators|mesh-ancestor
101266068|NCT01779479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266069|NCT01779492|Oxycodone|oxycodone|mesh-list
101266070|NCT01779492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101266071|NCT01779492|Narcotics|narcotics|mesh-ancestor
101266072|NCT01779492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101266073|NCT01779492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266074|NCT01779492|Analgesics|analgesics|mesh-ancestor
101266075|NCT01779492|Sensory System Agents|sensory system agents|mesh-ancestor
101266076|NCT01779492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101266077|NCT01779518|Interferons|interferons|mesh-list
101266078|NCT01779518|Ribavirin|ribavirin|mesh-list
101266079|NCT01779518|Sofosbuvir|sofosbuvir|mesh-list
101266080|NCT01779518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101266081|NCT01779518|Antiviral Agents|antiviral agents|mesh-ancestor
101266082|NCT01779518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101266083|NCT01779518|Antimetabolites|antimetabolites|mesh-ancestor
101266084|NCT01779518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266085|NCT01779596|Bosentan|bosentan|mesh-list
101266086|NCT01779596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101266087|NCT01779596|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101266088|NCT01779596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266089|NCT01779609|Bosentan|bosentan|mesh-list
101266091|NCT01779609|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101266092|NCT01779609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266093|NCT01779687|Raltegravir Potassium|raltegravir potassium|mesh-list
101266095|NCT01779687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101266096|NCT01779687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101266097|NCT01779687|Antimetabolites|antimetabolites|mesh-ancestor
101266098|NCT01779687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266099|NCT01779687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101266100|NCT01779687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101266101|NCT01779687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101266102|NCT01779687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101266103|NCT01779687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101266104|NCT01779687|Antiviral Agents|antiviral agents|mesh-ancestor
101266105|NCT01779687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101266106|NCT01779687|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101266107|NCT01779687|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101266109|NCT01779830|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101266110|NCT01779830|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101266111|NCT01779830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101266112|NCT01779830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266113|NCT01779830|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101266114|NCT01779830|GABA Agonists|gaba agonists|mesh-ancestor
101266115|NCT01779830|GABA Agents|gaba agents|mesh-ancestor
101814238|NCT05589896|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101814239|NCT05589896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101814240|NCT05589896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101814241|NCT05589896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101814242|NCT05589896|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101814243|NCT05589896|Antitubercular Agents|antitubercular agents|mesh-ancestor
101814244|NCT05589896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101814245|NCT05589896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101814246|NCT00673049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101266116|NCT01779830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101266117|NCT01779830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266119|NCT01779843|Idarubicin|idarubicin|mesh-list
101266120|NCT01779843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101266121|NCT01779843|Antimetabolites|antimetabolites|mesh-ancestor
101266122|NCT01779843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266123|NCT01779843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101266124|NCT01779843|Antiviral Agents|antiviral agents|mesh-ancestor
101266125|NCT01779843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101266126|NCT01779843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101266127|NCT01779843|Immunologic Factors|immunologic factors|mesh-ancestor
101266128|NCT01779843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266129|NCT01779843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101266130|NCT01779843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101266131|NCT01779843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101266132|NCT01779843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101266133|NCT01779882|Cyclophosphamide|cyclophosphamide|mesh-list
101266134|NCT01779882|Busulfan|busulfan|mesh-list
101266135|NCT01779882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101266136|NCT01779882|Immunologic Factors|immunologic factors|mesh-ancestor
101266137|NCT01779882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266138|NCT01779882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101266139|NCT01779882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101266140|NCT01779882|Alkylating Agents|alkylating agents|mesh-ancestor
101266141|NCT01779882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266142|NCT01779882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101266143|NCT01779882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101266144|NCT01779908|Vitamin D|vitamin d|mesh-list
101266145|NCT01779908|Vitamins|vitamins|mesh-ancestor
101266146|NCT01779908|Micronutrients|micronutrients|mesh-ancestor
101266147|NCT01779908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266148|NCT01779908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101266149|NCT01779921|Thrombin|thrombin|mesh-list
101266150|NCT01779921|Hemostatics|hemostatics|mesh-ancestor
101266151|NCT01779921|Coagulants|coagulants|mesh-ancestor
101266152|NCT01780051|Metformin|metformin|mesh-list
101266153|NCT01780051|Repaglinide|repaglinide|mesh-list
101266154|NCT01780051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101266155|NCT01780051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266156|NCT01780181|Gemcitabine|gemcitabine|mesh-list
101266157|NCT01780181|Docetaxel|docetaxel|mesh-list
101266158|NCT01780181|Vinorelbine|vinorelbine|mesh-list
101266159|NCT01780181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101266160|NCT01780181|Antimetabolites|antimetabolites|mesh-ancestor
101266161|NCT01780181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266162|NCT01780181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101266163|NCT01780181|Tubulin Modulators|tubulin modulators|mesh-ancestor
101266164|NCT01780181|Antimitotic Agents|antimitotic agents|mesh-ancestor
101266165|NCT01780181|Mitosis Modulators|mitosis modulators|mesh-ancestor
101266166|NCT01780181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101266167|NCT01780233|Fentanyl|fentanyl|mesh-list
101266168|NCT01780233|Naltrexone|naltrexone|mesh-list
101266170|NCT01780233|Sodium Citrate|sodium citrate|mesh-list
101266171|NCT01780233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101266172|NCT01780233|Narcotics|narcotics|mesh-ancestor
101266173|NCT01780233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101266174|NCT01780233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266175|NCT01780233|Analgesics|analgesics|mesh-ancestor
101814247|NCT00673049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101814248|NCT00673049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101814249|NCT00673049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101814250|NCT00673049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814251|NCT04003844|Aspirin|aspirin|mesh-list
101814252|NCT04003844|Immunoglobulins|immunoglobulins|mesh-list
101814253|NCT04003844|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101814254|NCT04003844|Antibodies|antibodies|mesh-list
101814255|NCT04003844|Immunoglobulin G|immunoglobulin g|mesh-list
101814256|NCT04003844|Immunologic Factors|immunologic factors|mesh-ancestor
101814257|NCT04003844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266176|NCT01780233|Sensory System Agents|sensory system agents|mesh-ancestor
101266177|NCT01780233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101266178|NCT01780233|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101266179|NCT01780233|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101266180|NCT01780233|Anesthetics, General|anesthetics, general|mesh-ancestor
101266181|NCT01780233|Anesthetics|anesthetics|mesh-ancestor
101266182|NCT01780233|Anticoagulants|anticoagulants|mesh-ancestor
101266183|NCT01780233|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101266184|NCT01780233|Chelating Agents|chelating agents|mesh-ancestor
101266185|NCT01780233|Sequestering Agents|sequestering agents|mesh-ancestor
101266186|NCT01780233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266187|NCT01780233|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101266188|NCT01780233|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101266189|NCT01780259|Triazolam|triazolam|mesh-list
101266190|NCT01780259|Esketamine|esketamine|mesh-list
101266191|NCT01780259|Antidepressive Agents|antidepressive agents|mesh-ancestor
101266192|NCT01780259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101266193|NCT01780259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101266194|NCT01780259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101266195|NCT01780259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101266196|NCT01780259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101266197|NCT01780259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266198|NCT01780259|GABA Modulators|gaba modulators|mesh-ancestor
101266199|NCT01780259|GABA Agents|gaba agents|mesh-ancestor
101266200|NCT01780259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101266201|NCT01780259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266202|NCT01780311|Sotalol|sotalol|mesh-list
101266203|NCT01780311|Flecainide|flecainide|mesh-list
101266204|NCT01780311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
101266205|NCT01780311|Propafenone|propafenone|mesh-list
101266206|NCT01780311|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101266207|NCT01780311|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101266208|NCT01780311|Adrenergic Agents|adrenergic agents|mesh-ancestor
101266209|NCT01780311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101266210|NCT01780311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266211|NCT01780311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266212|NCT01780311|Sympatholytics|sympatholytics|mesh-ancestor
101266213|NCT01780311|Autonomic Agents|autonomic agents|mesh-ancestor
101266214|NCT01780311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101266215|NCT01780311|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101266216|NCT01780311|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101266217|NCT01780311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101266218|NCT01780467|Dopamine|dopamine|mesh-list
101266219|NCT01780467|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101266220|NCT01780467|Sympathomimetics|sympathomimetics|mesh-ancestor
101266221|NCT01780467|Autonomic Agents|autonomic agents|mesh-ancestor
101266222|NCT01780467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101266223|NCT01780467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266224|NCT01780467|Dopamine Agents|dopamine agents|mesh-ancestor
101266225|NCT01780467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101266226|NCT01780467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266227|NCT01780467|Protective Agents|protective agents|mesh-ancestor
101266228|NCT01780519|Lorazepam|lorazepam|mesh-list
101814258|NCT04003844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101814259|NCT04003844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101814260|NCT04003844|Analgesics|analgesics|mesh-ancestor
101814261|NCT04003844|Sensory System Agents|sensory system agents|mesh-ancestor
101814262|NCT04003844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101814263|NCT04003844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101266229|NCT01780519|Anticonvulsants|anticonvulsants|mesh-ancestor
101266230|NCT01780519|Antiemetics|antiemetics|mesh-ancestor
101266231|NCT01780519|Autonomic Agents|autonomic agents|mesh-ancestor
101266232|NCT01780519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101266233|NCT01780519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266234|NCT01780519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101266235|NCT01780519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101266236|NCT01780519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101266237|NCT01780519|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101266238|NCT01780519|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101266239|NCT01780519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101266240|NCT01780519|GABA Modulators|gaba modulators|mesh-ancestor
101266241|NCT01780519|GABA Agents|gaba agents|mesh-ancestor
101266242|NCT01780519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101266243|NCT01780519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266244|NCT01780558|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101266245|NCT01780558|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101266246|NCT01780558|Hormones|hormones|mesh-list
101266247|NCT01780558|Estradiol|estradiol|mesh-list
101266248|NCT01780558|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101266249|NCT01780558|Progesterone|progesterone|mesh-list
101266250|NCT01780558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101266251|NCT01780558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266252|NCT01780558|Estrogens|estrogens|mesh-ancestor
101266253|NCT01780558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101266254|NCT01780558|Contraceptive Agents|contraceptive agents|mesh-ancestor
101266255|NCT01780558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101266256|NCT01780558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101266257|NCT01780558|Progestins|progestins|mesh-ancestor
101266258|NCT01780610|Letrozole|letrozole|mesh-list
101266259|NCT01780610|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101266260|NCT01780610|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101266261|NCT01780610|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101266262|NCT01780610|Hormones|hormones|mesh-list
101266263|NCT01780610|Estradiol|estradiol|mesh-list
101266264|NCT01780610|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101266265|NCT01780610|Progesterone|progesterone|mesh-list
101266266|NCT01780610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101266267|NCT01780610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266268|NCT01780610|Estrogens|estrogens|mesh-ancestor
101266269|NCT01780610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101266270|NCT01780610|Contraceptive Agents|contraceptive agents|mesh-ancestor
101266271|NCT01780610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101266272|NCT01780610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101266273|NCT01780610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101266274|NCT01780610|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101266275|NCT01780610|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101266276|NCT01780610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101266277|NCT01780610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266278|NCT01780610|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101266279|NCT01780610|Hormone Antagonists|hormone antagonists|mesh-ancestor
101266280|NCT01780610|Progestins|progestins|mesh-ancestor
101266281|NCT01780740|Atorvastatin|atorvastatin|mesh-list
101266282|NCT01780740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101266283|NCT01780740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101266284|NCT01780740|Antimetabolites|antimetabolites|mesh-ancestor
101266285|NCT01780740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266286|NCT01780740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101266287|NCT01780740|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101266288|NCT01780740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101266289|NCT01780753|Primaquine|primaquine|mesh-list
101266290|NCT01780753|Antimalarials|antimalarials|mesh-ancestor
101814264|NCT04003844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101814265|NCT04003844|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101814266|NCT04003844|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101814267|NCT04003844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814268|NCT04003844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101814269|NCT04003844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101814270|NCT04003844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101266291|NCT01780753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101266292|NCT01780753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101266293|NCT01780753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101266294|NCT01780909|Paromomycin|paromomycin|mesh-list
101266295|NCT01780909|Domperidone|domperidone|mesh-list
101266296|NCT01780909|Loperamide|loperamide|mesh-list
101266297|NCT01780909|Antidiarrheals|antidiarrheals|mesh-list
101266298|NCT01780909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101266299|NCT01780909|Antiemetics|antiemetics|mesh-ancestor
101266300|NCT01780909|Autonomic Agents|autonomic agents|mesh-ancestor
101266301|NCT01780909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101266302|NCT01780909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266303|NCT01780909|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101266305|NCT01780909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101266306|NCT01780909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266307|NCT01780909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101266308|NCT01780909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101266309|NCT01780909|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101266310|NCT01780909|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101266311|NCT01780948|Everolimus|everolimus|mesh-list
101266312|NCT01780948|Atorvastatin|atorvastatin|mesh-list
101266313|NCT01780948|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101266314|NCT01780948|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101266315|NCT01780948|Antimetabolites|antimetabolites|mesh-ancestor
101266316|NCT01780948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266317|NCT01780948|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101266318|NCT01780948|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101266319|NCT01780948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101266320|NCT01780948|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101266321|NCT01780948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101266322|NCT01780948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101266323|NCT01780948|Immunologic Factors|immunologic factors|mesh-ancestor
101266324|NCT01780948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266325|NCT01780948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101266327|NCT01781052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101266328|NCT01781052|Vasodilator Agents|vasodilator agents|mesh-ancestor
101266329|NCT01781273|Ethanol|ethanol|mesh-list
101266330|NCT01781273|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101266331|NCT01781273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101266332|NCT01781273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101266333|NCT01781273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266334|NCT01781377|Metoclopramide|metoclopramide|mesh-list
101266336|NCT01781377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101266337|NCT01781377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101266338|NCT01781377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266339|NCT01781377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101266340|NCT01781377|Anesthetics, General|anesthetics, general|mesh-ancestor
101266341|NCT01781377|Anesthetics|anesthetics|mesh-ancestor
101266342|NCT01781377|Antiemetics|antiemetics|mesh-ancestor
101266343|NCT01781377|Autonomic Agents|autonomic agents|mesh-ancestor
101266344|NCT01781377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101266345|NCT01781377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101266346|NCT01781377|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101266347|NCT01781377|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101266348|NCT01781377|Dopamine Agents|dopamine agents|mesh-ancestor
101266349|NCT01781377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101266350|NCT01781377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266351|NCT01781442|Sirolimus|sirolimus|mesh-list
101266352|NCT01781442|Temsirolimus|temsirolimus|mesh-list
101814271|NCT04003844|Antipyretics|antipyretics|mesh-ancestor
101814272|NCT05589584|Acetylcysteine|acetylcysteine|mesh-list
101814273|NCT05589584|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101814274|NCT05589584|Antiviral Agents|antiviral agents|mesh-ancestor
101814275|NCT05589584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101814276|NCT05589584|Expectorants|expectorants|mesh-ancestor
101814277|NCT05589584|Respiratory System Agents|respiratory system agents|mesh-ancestor
101814278|NCT05589584|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101814279|NCT05589584|Antioxidants|antioxidants|mesh-ancestor
101814280|NCT05589584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814281|NCT05589584|Protective Agents|protective agents|mesh-ancestor
101814282|NCT05589584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814283|NCT05589584|Antidotes|antidotes|mesh-ancestor
101266353|NCT01781442|MTOR Inhibitors|mtor inhibitors|mesh-list
101266354|NCT01781442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101266355|NCT01781442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101266356|NCT01781442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266357|NCT01781442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101266358|NCT01781442|Immunologic Factors|immunologic factors|mesh-ancestor
101266359|NCT01781442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266360|NCT01781442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101266361|NCT01781442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101266362|NCT01781442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101266363|NCT01781442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101266364|NCT01781442|Antifungal Agents|antifungal agents|mesh-ancestor
101266365|NCT01781507|Cetirizine|cetirizine|mesh-list
101266366|NCT01781507|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101266367|NCT01781507|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101313688|NCT00000514|Atenolol|atenolol|mesh-list
101266368|NCT01781507|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101266369|NCT01781507|Histamine Antagonists|histamine antagonists|mesh-ancestor
101266370|NCT01781507|Histamine Agents|histamine agents|mesh-ancestor
101266372|NCT01781507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266373|NCT01781507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266374|NCT01781663|Petrolatum|petrolatum|mesh-list
101266375|NCT01781663|Emollients|emollients|mesh-ancestor
101266376|NCT01781663|Dermatologic Agents|dermatologic agents|mesh-ancestor
101266377|NCT01781702|Celecoxib|celecoxib|mesh-list
101266378|NCT01781702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101266379|NCT01781702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101266380|NCT01781702|Analgesics|analgesics|mesh-ancestor
101266381|NCT01781702|Sensory System Agents|sensory system agents|mesh-ancestor
101266382|NCT01781702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101266383|NCT01781702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266384|NCT01781702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101266385|NCT01781702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101266386|NCT01781702|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101266387|NCT01781702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101266388|NCT01781702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101266389|NCT01781702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266390|NCT01781871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101266391|NCT01781871|Immunologic Factors|immunologic factors|mesh-ancestor
101266392|NCT01781871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266393|NCT01781884|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
101266394|NCT01781884|GABA Agents|gaba agents|mesh-ancestor
101266395|NCT01781884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101266396|NCT01781884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266397|NCT01781884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266398|NCT01781897|Mosapride|mosapride|mesh-list
101266399|NCT01781897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101266400|NCT01781897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101266401|NCT01781897|Serotonin Agents|serotonin agents|mesh-ancestor
101266402|NCT01781897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101814284|NCT00412750|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101814285|NCT00412750|Telbivudine|telbivudine|mesh-list
101814286|NCT00412750|Antiviral Agents|antiviral agents|mesh-ancestor
101814287|NCT00412750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101814288|NCT00412750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101814289|NCT00412750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101814290|NCT00412750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814291|NCT05361278|Chlorhexidine|chlorhexidine|mesh-list
101814292|NCT05361278|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101814293|NCT05361278|Sodium Hypochlorite|sodium hypochlorite|mesh-list
101814295|NCT05361278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101814296|NCT05361278|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101814297|NCT05361278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101814298|NCT05361278|Disinfectants|disinfectants|mesh-ancestor
101814299|NCT05361278|Dermatologic Agents|dermatologic agents|mesh-ancestor
101266403|NCT01781897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266404|NCT01781897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266405|NCT01781936|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
101266406|NCT01781936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101266407|NCT01781936|Glucocorticoids|glucocorticoids|mesh-ancestor
101266408|NCT01781936|Hormones|hormones|mesh-ancestor
101266409|NCT01781936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101266410|NCT01781936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266411|NCT01781988|Carboplatin|carboplatin|mesh-list
101266412|NCT01781988|Gemcitabine|gemcitabine|mesh-list
101266413|NCT01781988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101266414|NCT01781988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101266415|NCT01781988|Antimetabolites|antimetabolites|mesh-ancestor
101266416|NCT01781988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266417|NCT01782001|Vitamins|vitamins|mesh-list
101266418|NCT01782001|Vitamin A|vitamin a|mesh-list
101266419|NCT01782001|Retinol palmitate|retinol palmitate|mesh-list
101266420|NCT01782001|Micronutrients|micronutrients|mesh-ancestor
101266421|NCT01782001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266422|NCT01782001|Antioxidants|antioxidants|mesh-ancestor
101266423|NCT01782001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266424|NCT01782001|Protective Agents|protective agents|mesh-ancestor
101266425|NCT01782001|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101266426|NCT01782001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101266427|NCT01782261|Liraglutide|liraglutide|mesh-list
101266428|NCT01782261|Saxagliptin|saxagliptin|mesh-list
101266429|NCT01782261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101266430|NCT01782261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266431|NCT01782261|Incretins|incretins|mesh-ancestor
101266432|NCT01782261|Hormones|hormones|mesh-ancestor
101266433|NCT01782261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101266434|NCT01782261|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101266435|NCT01782261|Protease Inhibitors|protease inhibitors|mesh-ancestor
101266436|NCT01782261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101266437|NCT01782261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266438|NCT01782274|Vaccines|vaccines|mesh-list
101266439|NCT01782274|Immunologic Factors|immunologic factors|mesh-ancestor
101266440|NCT01782274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266441|NCT01782287|Vaccines|vaccines|mesh-list
101266442|NCT01782287|Immunologic Factors|immunologic factors|mesh-ancestor
101266443|NCT01782287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266444|NCT01782300|Vaccines|vaccines|mesh-list
101266445|NCT01782300|Immunologic Factors|immunologic factors|mesh-ancestor
101266446|NCT01782300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266447|NCT01782404|Chlorhexidine|chlorhexidine|mesh-list
101266448|NCT01782404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101814301|NCT00764855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101814302|NCT00764855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101814303|NCT00764855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814304|NCT00764855|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101814305|NCT00764855|Anesthetics, General|anesthetics, general|mesh-ancestor
101814306|NCT00764855|Anesthetics|anesthetics|mesh-ancestor
101814307|NCT00759317|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101814308|NCT00759317|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101266449|NCT01782404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101266450|NCT01782404|Disinfectants|disinfectants|mesh-ancestor
101266451|NCT01782508|Interferons|interferons|mesh-list
101266452|NCT01782508|Imatinib Mesylate|imatinib mesylate|mesh-list
101266453|NCT01782508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101266454|NCT01782508|Antiviral Agents|antiviral agents|mesh-ancestor
101266455|NCT01782508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101266456|NCT01782508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101266457|NCT01782508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101266458|NCT01782508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266459|NCT01782560|Omeprazole|omeprazole|mesh-list
101266460|NCT01782560|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101266461|NCT01782560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101266462|NCT01782560|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101266463|NCT01782560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101266464|NCT01782560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266465|NCT01782573|Chlorhexidine|chlorhexidine|mesh-list
101266466|NCT01782573|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101266467|NCT01782573|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101266468|NCT01782573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101266469|NCT01782573|Disinfectants|disinfectants|mesh-ancestor
101266470|NCT01782573|Dermatologic Agents|dermatologic agents|mesh-ancestor
101266471|NCT01782599|Nicotine|nicotine|mesh-list
101266472|NCT01782599|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101266473|NCT01782599|Autonomic Agents|autonomic agents|mesh-ancestor
101266474|NCT01782599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101266475|NCT01782599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266476|NCT01782599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101266477|NCT01782599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101266478|NCT01782599|Cholinergic Agents|cholinergic agents|mesh-ancestor
101266479|NCT01782599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101266480|NCT01782599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266481|NCT01782612|Analgesics|analgesics|mesh-list
101266482|NCT01782612|Sensory System Agents|sensory system agents|mesh-ancestor
101266483|NCT01782612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101266484|NCT01782612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266485|NCT01782651|Capecitabine|capecitabine|mesh-list
101266486|NCT01782651|Lapatinib|lapatinib|mesh-list
101266487|NCT01782651|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101266488|NCT01782651|Antimetabolites|antimetabolites|mesh-ancestor
101266489|NCT01782651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266490|NCT01782651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101266491|NCT01782651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101266492|NCT01782651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101266493|NCT01782781|Epinephrine|epinephrine|mesh-list
101266494|NCT01782781|Ropivacaine|ropivacaine|mesh-list
101266495|NCT01782781|Anesthetics, Local|anesthetics, local|mesh-ancestor
101266496|NCT01782781|Anesthetics|anesthetics|mesh-ancestor
101266497|NCT01782781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101266498|NCT01782781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266499|NCT01782781|Sensory System Agents|sensory system agents|mesh-ancestor
101266500|NCT01782781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101266501|NCT01782781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101266502|NCT01782781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101266503|NCT01782781|Adrenergic Agents|adrenergic agents|mesh-ancestor
101266504|NCT01782781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101814309|NCT00759317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101814310|NCT00759317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101814311|NCT00759317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814312|NCT00759317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101814313|NCT00759317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814314|NCT00759317|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101814315|NCT00759317|Antidepressive Agents|antidepressive agents|mesh-ancestor
101814316|NCT00759317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101814317|NCT00076999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101814318|NCT01041040|Gemtuzumab|gemtuzumab|mesh-list
101814319|NCT01041040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101814320|NCT01041040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101814321|NCT01041040|Immunotoxins|immunotoxins|mesh-ancestor
101814322|NCT01041040|Immunoconjugates|immunoconjugates|mesh-ancestor
101266505|NCT01782781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266506|NCT01782781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101266507|NCT01782781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101266508|NCT01782781|Autonomic Agents|autonomic agents|mesh-ancestor
101266509|NCT01782781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101266510|NCT01782781|Respiratory System Agents|respiratory system agents|mesh-ancestor
101266511|NCT01782781|Mydriatics|mydriatics|mesh-ancestor
101266512|NCT01782781|Sympathomimetics|sympathomimetics|mesh-ancestor
101266513|NCT01782781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101266514|NCT01782846|Codeine|codeine|mesh-list
101266515|NCT01782846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101266516|NCT01782846|Narcotics|narcotics|mesh-ancestor
101266517|NCT01782846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101266518|NCT01782846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266519|NCT01782846|Analgesics|analgesics|mesh-ancestor
101266520|NCT01782846|Sensory System Agents|sensory system agents|mesh-ancestor
101266521|NCT01782846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101266522|NCT01782846|Antitussive Agents|antitussive agents|mesh-ancestor
101266523|NCT01782846|Respiratory System Agents|respiratory system agents|mesh-ancestor
101266524|NCT01782911|Resveratrol|resveratrol|mesh-list
101266525|NCT01782911|Antioxidants|antioxidants|mesh-ancestor
101266526|NCT01782911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266527|NCT01782911|Protective Agents|protective agents|mesh-ancestor
101266528|NCT01782911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266529|NCT01782911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101266530|NCT01782911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101266531|NCT01782924|Brodalumab|brodalumab|mesh-list
101266532|NCT01782924|Dermatologic Agents|dermatologic agents|mesh-ancestor
101266533|NCT01782937|Brodalumab|brodalumab|mesh-list
101266534|NCT01782937|Dermatologic Agents|dermatologic agents|mesh-ancestor
101266535|NCT01782950|Rifampin|rifampin|mesh-list
101266536|NCT01782950|Isoniazid|isoniazid|mesh-list
101266537|NCT01782950|Pyrazinamide|pyrazinamide|mesh-list
101266538|NCT01782950|Ethambutol|ethambutol|mesh-list
101266539|NCT01782950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101266540|NCT01782950|Antitubercular Agents|antitubercular agents|mesh-ancestor
101266541|NCT01782950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101266542|NCT01782950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101266543|NCT01782950|Leprostatic Agents|leprostatic agents|mesh-ancestor
101266544|NCT01782950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101266545|NCT01782950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101266546|NCT01782950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266547|NCT01782950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101266549|NCT01782950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101266550|NCT01782950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101266551|NCT01782950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101814324|NCT01041040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814325|NCT00765011|Cetuximab|cetuximab|mesh-list
101814326|NCT00765011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101814327|NCT00765011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101814328|NCT00765167|Chlorhexidine|chlorhexidine|mesh-list
101814329|NCT00765167|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101814330|NCT00765167|Triclosan|triclosan|mesh-list
101814331|NCT00765167|Fluorides|fluorides|mesh-list
101814332|NCT00765167|Cariostatic Agents|cariostatic agents|mesh-ancestor
101814333|NCT00765167|Protective Agents|protective agents|mesh-ancestor
101814334|NCT00765167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471647|NCT00287664|Terlipressin|terlipressin|mesh-list
101266552|NCT01782950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101266553|NCT01782950|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101266554|NCT01782950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101266555|NCT01782950|Antimetabolites|antimetabolites|mesh-ancestor
101266556|NCT01782950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101266557|NCT01782976|Bevacizumab|bevacizumab|mesh-list
101266558|NCT01782976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101266559|NCT01782976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101266560|NCT01782976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101266561|NCT01782976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101266562|NCT01782976|Growth Substances|growth substances|mesh-ancestor
101266563|NCT01782976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266564|NCT01782976|Growth Inhibitors|growth inhibitors|mesh-ancestor
101266565|NCT01783002|Carbon-11 methionine|carbon-11 methionine|mesh-list
101266566|NCT01783002|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101266567|NCT01783002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266569|NCT01783106|Doxycycline|doxycycline|mesh-list
101266570|NCT01783106|Ciprofloxacin|ciprofloxacin|mesh-list
101266572|NCT01783106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101266573|NCT01783106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101266575|NCT01783106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101266576|NCT01783106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266577|NCT01783106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101266578|NCT01783106|Respiratory System Agents|respiratory system agents|mesh-ancestor
101266579|NCT01783106|Glucocorticoids|glucocorticoids|mesh-ancestor
101266580|NCT01783106|Hormones|hormones|mesh-ancestor
101266581|NCT01783106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101266582|NCT01783106|Antimalarials|antimalarials|mesh-ancestor
101266583|NCT01783106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101266584|NCT01783106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101266585|NCT01783106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101266586|NCT01783106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101266587|NCT01783106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266588|NCT01783106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101266589|NCT01783106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101266590|NCT01783106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101266591|NCT01783106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101266592|NCT01783106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101266593|NCT01783106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101266594|NCT01783106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101266595|NCT01783340|Azithromycin|azithromycin|mesh-list
101266596|NCT01783340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101266597|NCT01783340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101266598|NCT01783379|Micafungin|micafungin|mesh-list
101266599|NCT01783379|Antifungal Agents|antifungal agents|mesh-ancestor
101266600|NCT01783379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101266601|NCT01783431|Poly ICLC|poly iclc|mesh-list
101266602|NCT01783431|Interferon Inducers|interferon inducers|mesh-ancestor
101266603|NCT01783431|Immunologic Factors|immunologic factors|mesh-ancestor
101266604|NCT01783431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266605|NCT01783587|Docetaxel|docetaxel|mesh-list
101814336|NCT00765167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101814337|NCT00765167|Disinfectants|disinfectants|mesh-ancestor
101814338|NCT00765167|Dermatologic Agents|dermatologic agents|mesh-ancestor
101814339|NCT00765167|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101814340|NCT00765167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101814341|NCT00765167|Antimetabolites|antimetabolites|mesh-ancestor
101814342|NCT00765167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814343|NCT00765167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101814344|NCT00759551|Olmesartan|olmesartan|mesh-list
101814345|NCT00759551|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
101814346|NCT00759551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101814347|NCT00759551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101814348|NCT00759551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101814349|NCT00759551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814350|NCT03905096|Donepezil|donepezil|mesh-list
101814351|NCT03905096|BI 425809|bi 425809|mesh-list
101814352|NCT03905096|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101814353|NCT03905096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101814354|NCT03905096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814355|NCT03905096|Cholinergic Agents|cholinergic agents|mesh-ancestor
101814356|NCT03905096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101814357|NCT03905096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814358|NCT03905096|Nootropic Agents|nootropic agents|mesh-ancestor
101814359|NCT00412360|Cyclosporine|cyclosporine|mesh-list
101814360|NCT00412360|Mycophenolic Acid|mycophenolic acid|mesh-list
101814361|NCT00412360|Cyclophosphamide|cyclophosphamide|mesh-list
101814362|NCT00412360|Fludarabine|fludarabine|mesh-list
101814363|NCT00412360|Cyclosporins|cyclosporins|mesh-list
101814364|NCT00412360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101814365|NCT00412360|Immunologic Factors|immunologic factors|mesh-ancestor
101814366|NCT00412360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814367|NCT00412360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101814368|NCT00412360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101266606|NCT01783587|Afatinib|afatinib|mesh-list
101266607|NCT01783587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101266608|NCT01783587|Tubulin Modulators|tubulin modulators|mesh-ancestor
101266609|NCT01783587|Antimitotic Agents|antimitotic agents|mesh-ancestor
101266610|NCT01783587|Mitosis Modulators|mitosis modulators|mesh-ancestor
101266611|NCT01783587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266612|NCT01783587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101266613|NCT01783587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101814369|NCT00412360|Alkylating Agents|alkylating agents|mesh-ancestor
101814370|NCT00412360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814371|NCT00412360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101814372|NCT00412360|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101814373|NCT00412360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101814374|NCT00412360|Antifungal Agents|antifungal agents|mesh-ancestor
101814375|NCT00412360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101814376|NCT00412360|Dermatologic Agents|dermatologic agents|mesh-ancestor
101814377|NCT00412360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101814378|NCT00412360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101814379|NCT00412360|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101814380|NCT00412360|Antitubercular Agents|antitubercular agents|mesh-ancestor
101814381|NCT00412360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101814383|NCT00761501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101814384|NCT00761501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101814385|NCT00761501|Analgesics|analgesics|mesh-ancestor
101814386|NCT00761501|Sensory System Agents|sensory system agents|mesh-ancestor
101814387|NCT00761501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101814388|NCT00761501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814389|NCT00761501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101814390|NCT00761501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101814391|NCT00761501|Gout Suppressants|gout suppressants|mesh-ancestor
101814392|NCT00761501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101814393|NCT00761501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101814394|NCT00761501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814395|NCT01088893|Everolimus|everolimus|mesh-list
101814396|NCT01088893|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101814397|NCT01088893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101814398|NCT01088893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101814399|NCT01088893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814400|NCT01088893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101266614|NCT01783717|Exenatide|exenatide|mesh-list
101266615|NCT01783717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101266616|NCT01783717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266617|NCT01783717|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101266618|NCT01783717|Incretins|incretins|mesh-ancestor
101266619|NCT01783717|Hormones|hormones|mesh-ancestor
101266620|NCT01783717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101266621|NCT01783756|Capecitabine|capecitabine|mesh-list
101266622|NCT01783756|Everolimus|everolimus|mesh-list
101814401|NCT01088893|Immunologic Factors|immunologic factors|mesh-ancestor
101814402|NCT01088893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814403|NCT01088893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101814404|NCT03026036|Raclopride|raclopride|mesh-list
101814405|NCT03026036|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101814406|NCT03026036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101814407|NCT03026036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101814408|NCT03026036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814409|NCT03026036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101814410|NCT03026036|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101814412|NCT03026036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101814413|NCT03026036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814414|NCT00990860|Doxorubicin|doxorubicin|mesh-list
101814415|NCT00990860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101814416|NCT00990860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101814417|NCT00990860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101814418|NCT00990860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101814419|NCT00990860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101814420|NCT00990860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814421|NCT01035190|Budesonide|budesonide|mesh-list
101814422|NCT01035190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101814423|NCT01035190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101814424|NCT01035190|Autonomic Agents|autonomic agents|mesh-ancestor
101814425|NCT01035190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101814426|NCT01035190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814427|NCT01035190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101814428|NCT01035190|Respiratory System Agents|respiratory system agents|mesh-ancestor
101266623|NCT01783756|Lapatinib|lapatinib|mesh-list
101266624|NCT01783756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101266625|NCT01783756|Antimetabolites|antimetabolites|mesh-ancestor
101266626|NCT01783756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266627|NCT01783756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101266628|NCT01783756|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101266629|NCT01783756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101266630|NCT01783756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101266631|NCT01783756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101266632|NCT01783756|Immunologic Factors|immunologic factors|mesh-ancestor
101266633|NCT01783756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266635|NCT01783834|Gefitinib|gefitinib|mesh-list
101266636|NCT01783834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101266637|NCT01783834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101266638|NCT01783834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266639|NCT01783834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101266640|NCT01783834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101266641|NCT01783834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101266642|NCT01783925|Aflibercept|aflibercept|mesh-list
101266643|NCT01783925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101814430|NCT01035190|Hormones|hormones|mesh-ancestor
101814431|NCT01035190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101814432|NCT00571103|Acamprosate|acamprosate|mesh-list
101814433|NCT00571103|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101814434|NCT00084799|Antibodies|antibodies|mesh-list
101814435|NCT00084799|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101814436|NCT00084799|Immunologic Factors|immunologic factors|mesh-ancestor
101814437|NCT00084799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814438|NCT00765557|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101814439|NCT00765557|Laxatives|laxatives|mesh-ancestor
101814440|NCT00765557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101814441|NCT01086553|Budesonide|budesonide|mesh-list
101814442|NCT01086553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101814443|NCT01086553|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101814444|NCT01086553|Autonomic Agents|autonomic agents|mesh-ancestor
101814445|NCT01086553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101814446|NCT01086553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814447|NCT01086553|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101814448|NCT01086553|Respiratory System Agents|respiratory system agents|mesh-ancestor
101814449|NCT01086553|Glucocorticoids|glucocorticoids|mesh-ancestor
101814450|NCT01086553|Hormones|hormones|mesh-ancestor
101814451|NCT01086553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101814452|NCT01041508|Cyclosporine|cyclosporine|mesh-list
101814482|NCT00766025|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101814484|NCT00766181|Lidocaine|lidocaine|mesh-list
101814485|NCT00766181|Anesthetics, Local|anesthetics, local|mesh-ancestor
101814486|NCT00766181|Anesthetics|anesthetics|mesh-ancestor
101814487|NCT00766181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101814488|NCT00766181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814489|NCT00766181|Sensory System Agents|sensory system agents|mesh-ancestor
101814490|NCT00766181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101814491|NCT00766181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101814492|NCT00766181|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101814493|NCT00766181|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101814494|NCT00766181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101814495|NCT00766181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814496|NCT04048577|Natalizumab|natalizumab|mesh-list
101814497|NCT04048577|Immunologic Factors|immunologic factors|mesh-ancestor
101814498|NCT04048577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814499|NCT00991250|Temozolomide|temozolomide|mesh-list
101814500|NCT00991250|Dacarbazine|dacarbazine|mesh-list
101814501|NCT00991250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101814502|NCT00991250|Alkylating Agents|alkylating agents|mesh-ancestor
101814503|NCT00991250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814504|NCT00991250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101814505|NCT00418522|Insulin|insulin|mesh-list
101814506|NCT00418522|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101814507|NCT00418522|Insulin Glargine|insulin glargine|mesh-list
101814508|NCT00418522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101814509|NCT00418522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266644|NCT01783925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101266645|NCT01783925|Growth Substances|growth substances|mesh-ancestor
101266646|NCT01783925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266647|NCT01783925|Growth Inhibitors|growth inhibitors|mesh-ancestor
101266648|NCT01783925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101266649|NCT01783951|Cisplatin|cisplatin|mesh-list
101266650|NCT01783951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101266651|NCT01783964|Cytarabine|cytarabine|mesh-list
101266652|NCT01783964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101266653|NCT01783964|Antimetabolites|antimetabolites|mesh-ancestor
101266654|NCT01783964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266655|NCT01783964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101266656|NCT01783964|Antiviral Agents|antiviral agents|mesh-ancestor
101266657|NCT01783964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101266658|NCT01783964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101266659|NCT01783964|Immunologic Factors|immunologic factors|mesh-ancestor
101266660|NCT01783964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266661|NCT01783977|Vaccines|vaccines|mesh-list
101814510|NCT00760175|Vaccines|vaccines|mesh-list
101814511|NCT00760175|Immunologic Factors|immunologic factors|mesh-ancestor
101814512|NCT00760175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814513|NCT00766337|Sirolimus|sirolimus|mesh-list
101814514|NCT00766337|Temsirolimus|temsirolimus|mesh-list
101814515|NCT00766337|Ranibizumab|ranibizumab|mesh-list
101814516|NCT00766337|MTOR Inhibitors|mtor inhibitors|mesh-list
101814517|NCT00766337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101814518|NCT00766337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101814519|NCT00766337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101814520|NCT00766337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101814521|NCT00766337|Antifungal Agents|antifungal agents|mesh-ancestor
101814522|NCT00766337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101814523|NCT00766337|Immunologic Factors|immunologic factors|mesh-ancestor
101814524|NCT00766337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814525|NCT00766337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101814526|NCT00766337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101814527|NCT00766337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814528|NCT00766337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101814529|NCT00766337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101814530|NCT00766337|Growth Substances|growth substances|mesh-ancestor
101814531|NCT00766337|Growth Inhibitors|growth inhibitors|mesh-ancestor
101814532|NCT00991562|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
101814533|NCT00991562|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101814534|NCT00991562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101814535|NCT00991562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101814536|NCT00991562|Immunotoxins|immunotoxins|mesh-ancestor
101814537|NCT00991562|Immunoconjugates|immunoconjugates|mesh-ancestor
101814538|NCT00991562|Immunologic Factors|immunologic factors|mesh-ancestor
101814539|NCT00991562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814540|NCT00991562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101814541|NCT00991562|Tubulin Modulators|tubulin modulators|mesh-ancestor
101814542|NCT00991562|Antimitotic Agents|antimitotic agents|mesh-ancestor
101814552|NCT00762671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101814553|NCT00762671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101814554|NCT00762671|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101814555|NCT00762671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101814556|NCT00762671|Antioxidants|antioxidants|mesh-ancestor
101814557|NCT00762671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814558|NCT00762671|Protective Agents|protective agents|mesh-ancestor
101471889|NCT01685125|Prednisone|prednisone|mesh-list
101814559|NCT00762671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101814560|NCT00762671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101814561|NCT00762671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101814563|NCT02558387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101814564|NCT02558387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101814565|NCT02558387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101814566|NCT02558387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814567|NCT00766805|Propranolol|propranolol|mesh-list
101814568|NCT00766805|Isosorbide|isosorbide|mesh-list
101814569|NCT00766805|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
101814570|NCT00766805|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
101814571|NCT00766805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101814572|NCT00766805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101814573|NCT00766805|Adrenergic Agents|adrenergic agents|mesh-ancestor
101814574|NCT00766805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101814575|NCT00766805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266662|NCT01783977|Immunologic Factors|immunologic factors|mesh-ancestor
101266663|NCT01783977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266664|NCT01784107|Ifosfamide|ifosfamide|mesh-list
101266665|NCT01784107|Belotecan|belotecan|mesh-list
101266666|NCT01784107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101266667|NCT01784107|Alkylating Agents|alkylating agents|mesh-ancestor
101266668|NCT01784107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266669|NCT01784107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101266670|NCT01784107|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101266671|NCT01784107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101266672|NCT01784107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101266673|NCT01784120|Doxorubicin|doxorubicin|mesh-list
101266674|NCT01784120|genexol-PM|genexol-pm|mesh-list
101266675|NCT01784120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101266676|NCT01784120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101266677|NCT01784120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101266678|NCT01784120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101266679|NCT01784120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101266680|NCT01784120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266681|NCT01784120|Tubulin Modulators|tubulin modulators|mesh-ancestor
101266682|NCT01784120|Antimitotic Agents|antimitotic agents|mesh-ancestor
101266683|NCT01784120|Mitosis Modulators|mitosis modulators|mesh-ancestor
101266684|NCT01784250|Propranolol|propranolol|mesh-list
101266685|NCT01784250|Clonidine|clonidine|mesh-list
101266686|NCT01784250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101266687|NCT01784250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101266688|NCT01784250|Adrenergic Agents|adrenergic agents|mesh-ancestor
101266689|NCT01784250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101814576|NCT00766805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814578|NCT00766805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101814579|NCT00766805|Vasodilator Agents|vasodilator agents|mesh-ancestor
101814580|NCT00766805|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101814581|NCT00766805|Diuretics|diuretics|mesh-ancestor
101814582|NCT00766805|Natriuretic Agents|natriuretic agents|mesh-ancestor
101814583|NCT00766805|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101814584|NCT00762749|Diphenhydramine|diphenhydramine|mesh-list
101814585|NCT00762749|Promethazine|promethazine|mesh-list
101814586|NCT00762749|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101814587|NCT00762749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101814588|NCT00762749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101814589|NCT00762749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814590|NCT00762749|Anesthetics, Local|anesthetics, local|mesh-ancestor
101814591|NCT00762749|Anesthetics|anesthetics|mesh-ancestor
101814592|NCT00762749|Sensory System Agents|sensory system agents|mesh-ancestor
101814593|NCT00762749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101814594|NCT00762749|Antiemetics|antiemetics|mesh-ancestor
101814595|NCT00762749|Autonomic Agents|autonomic agents|mesh-ancestor
101814596|NCT00762749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101814597|NCT00762749|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101814598|NCT00762749|Histamine Antagonists|histamine antagonists|mesh-ancestor
101814599|NCT00762749|Histamine Agents|histamine agents|mesh-ancestor
101814600|NCT00762749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101814601|NCT00762749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814602|NCT00762749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101814603|NCT00762749|Antipruritics|antipruritics|mesh-ancestor
101814604|NCT00762749|Dermatologic Agents|dermatologic agents|mesh-ancestor
101814605|NCT00403546|Ziprasidone|ziprasidone|mesh-list
101814606|NCT00403546|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101814607|NCT00403546|Serotonin Agents|serotonin agents|mesh-ancestor
101814608|NCT00403546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101814609|NCT00403546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814620|NCT00767117|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101814621|NCT00767117|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101814622|NCT00767117|Protease Inhibitors|protease inhibitors|mesh-ancestor
101814623|NCT00767117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101814624|NCT00767117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814625|NCT00767117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101814626|NCT00767117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101814627|NCT00767117|Antiviral Agents|antiviral agents|mesh-ancestor
101814628|NCT00767117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101814629|NCT00767117|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101814630|NCT00767117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101814631|NCT00767117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101814632|NCT00767117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101814633|NCT00762983|Loratadine|loratadine|mesh-list
101814634|NCT00762983|Antipruritics|antipruritics|mesh-ancestor
101814635|NCT00762983|Dermatologic Agents|dermatologic agents|mesh-ancestor
101814636|NCT00762983|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101814637|NCT00762983|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101814638|NCT00762983|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101814639|NCT00762983|Histamine Antagonists|histamine antagonists|mesh-ancestor
101814640|NCT00762983|Histamine Agents|histamine agents|mesh-ancestor
101814641|NCT00762983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101814642|NCT00762983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814643|NCT00762983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814644|NCT00403234|Buprenorphine|buprenorphine|mesh-list
101814645|NCT00403234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101814646|NCT00403234|Narcotics|narcotics|mesh-ancestor
101814647|NCT00403234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101814648|NCT00403234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814649|NCT00403234|Analgesics|analgesics|mesh-ancestor
101814650|NCT00403234|Sensory System Agents|sensory system agents|mesh-ancestor
101814651|NCT00403234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101266690|NCT01784250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266691|NCT01784250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266692|NCT01784250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101266693|NCT01784250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101266694|NCT01784250|Vasodilator Agents|vasodilator agents|mesh-ancestor
101266695|NCT01784250|Analgesics|analgesics|mesh-ancestor
101266696|NCT01784250|Sensory System Agents|sensory system agents|mesh-ancestor
101814652|NCT00403234|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101814653|NCT04049201|Midazolam|midazolam|mesh-list
101814654|NCT04049201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101814655|NCT04049201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101814656|NCT04049201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101814657|NCT04049201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814658|NCT04049201|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101814659|NCT04049201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101814660|NCT04049201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101814661|NCT04049201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101814662|NCT04049201|Anesthetics, General|anesthetics, general|mesh-ancestor
101814663|NCT04049201|Anesthetics|anesthetics|mesh-ancestor
101814664|NCT04049201|GABA Modulators|gaba modulators|mesh-ancestor
101814665|NCT04049201|GABA Agents|gaba agents|mesh-ancestor
101814666|NCT04049201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101814667|NCT04049201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814668|NCT00767663|Dipyridamole|dipyridamole|mesh-list
101814669|NCT00767663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101814670|NCT00767663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101814671|NCT00767663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814672|NCT00767663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101814673|NCT00767663|Vasodilator Agents|vasodilator agents|mesh-ancestor
101814674|NCT00402688|Levofloxacin|levofloxacin|mesh-list
101814675|NCT00402688|Ofloxacin|ofloxacin|mesh-list
101312186|NCT00006247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101814676|NCT00402688|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101814677|NCT00402688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101814678|NCT00402688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101814679|NCT00402688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101814680|NCT00402688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101814681|NCT00402688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101266697|NCT01784250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101266698|NCT01784250|Sympatholytics|sympatholytics|mesh-ancestor
101266699|NCT01784250|Autonomic Agents|autonomic agents|mesh-ancestor
101266700|NCT01784250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101266701|NCT01784250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101266702|NCT01784250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101266703|NCT01784302|Raltegravir Potassium|raltegravir potassium|mesh-list
101266704|NCT01784302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101266705|NCT01784302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101266706|NCT01784302|Antiviral Agents|antiviral agents|mesh-ancestor
101266707|NCT01784302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101266708|NCT01784302|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101266709|NCT01784302|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101266710|NCT01784302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101814682|NCT00402688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814683|NCT00402688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101814684|NCT00402688|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101814685|NCT00402688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101814687|NCT04049045|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101814688|NCT04049045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814689|NCT04049045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101814690|NCT04049045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814691|NCT00763373|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101814692|NCT00763373|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101266711|NCT01784302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266712|NCT01784315|Chloroquine|chloroquine|mesh-list
101266713|NCT01784315|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
101266714|NCT01784315|Primaquine|primaquine|mesh-list
101266715|NCT01784315|Artemisinins|artemisinins|mesh-list
101266716|NCT01784315|Artemisinin|artemisinin|mesh-list
101266717|NCT01784315|Amebicides|amebicides|mesh-ancestor
101266718|NCT01784315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101266719|NCT01784315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101266720|NCT01784315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101266721|NCT01784315|Antimalarials|antimalarials|mesh-ancestor
101266722|NCT01784315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101266723|NCT01784315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101266724|NCT01784315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101266725|NCT01784315|Analgesics|analgesics|mesh-ancestor
101266726|NCT01784315|Sensory System Agents|sensory system agents|mesh-ancestor
101266727|NCT01784315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101266728|NCT01784315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266729|NCT01784315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101266730|NCT01784315|Filaricides|filaricides|mesh-ancestor
101266731|NCT01784315|Antinematodal Agents|antinematodal agents|mesh-ancestor
101266732|NCT01784315|Anthelmintics|anthelmintics|mesh-ancestor
101266733|NCT01784380|Metformin|metformin|mesh-list
101266734|NCT01784380|Clomiphene|clomiphene|mesh-list
101266735|NCT01784380|Enclomiphene|enclomiphene|mesh-list
101266736|NCT01784380|Zuclomiphene|zuclomiphene|mesh-list
101266737|NCT01784380|Menotropins|menotropins|mesh-list
101266738|NCT01784380|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
101266739|NCT01784380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101266740|NCT01784380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266741|NCT01784380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101266742|NCT01784380|Hormone Antagonists|hormone antagonists|mesh-ancestor
101266743|NCT01784380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101266744|NCT01784380|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101266745|NCT01784380|Fertility Agents|fertility agents|mesh-ancestor
101266746|NCT01784380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101266747|NCT01784380|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101266748|NCT01784380|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101266749|NCT01784380|Androgen Antagonists|androgen antagonists|mesh-ancestor
101266750|NCT01784445|Ceftazidime|ceftazidime|mesh-list
101266751|NCT01784445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101266752|NCT01784445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101266753|NCT01784536|Oritavancin|oritavancin|mesh-list
101266754|NCT01784536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101266755|NCT01784536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101266756|NCT01784549|Gemcitabine|gemcitabine|mesh-list
101266757|NCT01784549|Docetaxel|docetaxel|mesh-list
101266758|NCT01784549|Pemetrexed|pemetrexed|mesh-list
101266759|NCT01784549|Vinorelbine|vinorelbine|mesh-list
101266760|NCT01784549|Gefitinib|gefitinib|mesh-list
101266761|NCT01784549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101266763|NCT01784549|Antimetabolites|antimetabolites|mesh-ancestor
101266764|NCT01784549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266765|NCT01784549|Tubulin Modulators|tubulin modulators|mesh-ancestor
101814693|NCT00763373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101814694|NCT00763373|Antitubercular Agents|antitubercular agents|mesh-ancestor
101814695|NCT01035580|Curcumin|curcumin|mesh-list
101814696|NCT01035580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101814697|NCT01035580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101814698|NCT01035580|Analgesics|analgesics|mesh-ancestor
101814699|NCT01035580|Sensory System Agents|sensory system agents|mesh-ancestor
101814700|NCT01035580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101814701|NCT01035580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814702|NCT01035580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101814703|NCT01035580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101814704|NCT01035580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101814705|NCT01035580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101814706|NCT01035580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814707|NCT00671879|Carisoprodol|carisoprodol|mesh-list
101814708|NCT00671879|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101814709|NCT00671879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266766|NCT01784549|Antimitotic Agents|antimitotic agents|mesh-ancestor
101266767|NCT01784549|Mitosis Modulators|mitosis modulators|mesh-ancestor
101266768|NCT01784549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101266769|NCT01784549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101266770|NCT01784549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101266771|NCT01784549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101266772|NCT01784549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101266773|NCT01784562|Riociguat|riociguat|mesh-list
101266774|NCT01784562|Enzyme Activators|enzyme activators|mesh-ancestor
101266775|NCT01784562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266776|NCT01784640|Pemetrexed|pemetrexed|mesh-list
101266777|NCT01784640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101266778|NCT01784640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101266779|NCT01784640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266780|NCT01784640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101266781|NCT01784640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101266782|NCT01784718|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
101266783|NCT01784718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101266784|NCT01784900|Catumaxomab|catumaxomab|mesh-list
101266785|NCT01784900|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101266786|NCT01784900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101266787|NCT01784900|Immunologic Factors|immunologic factors|mesh-ancestor
101528332|NCT04628676|Tranexamic Acid|tranexamic acid|mesh-list
101266788|NCT01784900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266790|NCT01784913|Immunologic Factors|immunologic factors|mesh-ancestor
101266791|NCT01784913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266792|NCT01784978|Everolimus|everolimus|mesh-list
101266793|NCT01784978|Sunitinib|sunitinib|mesh-list
101266794|NCT01784978|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101266795|NCT01784978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101266796|NCT01784978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101266797|NCT01784978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266798|NCT01784978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101266799|NCT01784978|Immunologic Factors|immunologic factors|mesh-ancestor
101266800|NCT01784978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266801|NCT01784978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101266802|NCT01784978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101266803|NCT01784978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101266804|NCT01784978|Growth Substances|growth substances|mesh-ancestor
101266805|NCT01784978|Growth Inhibitors|growth inhibitors|mesh-ancestor
101266806|NCT01785004|Vitamin D|vitamin d|mesh-list
101814711|NCT00671879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101814712|NCT00402298|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
101814713|NCT00402298|Hallucinogens|hallucinogens|mesh-ancestor
101814714|NCT00402298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814715|NCT00402298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101814716|NCT00402298|Serotonin Agents|serotonin agents|mesh-ancestor
101814717|NCT00402298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101814718|NCT00402298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814719|NCT00402298|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101814720|NCT00402298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101814721|NCT00402298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101814722|NCT00402298|Adrenergic Agents|adrenergic agents|mesh-ancestor
101266807|NCT01785004|Cholecalciferol|cholecalciferol|mesh-list
101266809|NCT01785004|Micronutrients|micronutrients|mesh-ancestor
101266810|NCT01785004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266811|NCT01785004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101266812|NCT01785004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101266813|NCT01785030|Nitrous Oxide|nitrous oxide|mesh-list
101266814|NCT01785030|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101266815|NCT01785030|Anesthetics, General|anesthetics, general|mesh-ancestor
101266816|NCT01785030|Anesthetics|anesthetics|mesh-ancestor
101266817|NCT01785030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101266818|NCT01785030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266819|NCT01785030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101266820|NCT01785030|Analgesics|analgesics|mesh-ancestor
101266821|NCT01785030|Sensory System Agents|sensory system agents|mesh-ancestor
101266822|NCT01785030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101266823|NCT01785043|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101266825|NCT01785043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101266826|NCT01785043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266827|NCT01785043|Incretins|incretins|mesh-ancestor
101266828|NCT01785043|Hormones|hormones|mesh-ancestor
101266829|NCT01785043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101266830|NCT01785043|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101266831|NCT01785043|Protease Inhibitors|protease inhibitors|mesh-ancestor
101266832|NCT01785043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101266833|NCT01785043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266834|NCT01785056|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101266835|NCT01785056|Immunologic Factors|immunologic factors|mesh-ancestor
101266836|NCT01785056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266837|NCT01785108|Vitamin D|vitamin d|mesh-list
101266838|NCT01785108|Ibuprofen|ibuprofen|mesh-list
101266839|NCT01785108|Aluminum sulfate|aluminum sulfate|mesh-list
101266840|NCT01785108|Vitamins|vitamins|mesh-ancestor
101266841|NCT01785108|Micronutrients|micronutrients|mesh-ancestor
101266842|NCT01785108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266843|NCT01785108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101266844|NCT01785108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101266845|NCT01785108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101266846|NCT01785108|Analgesics|analgesics|mesh-ancestor
101266847|NCT01785108|Sensory System Agents|sensory system agents|mesh-ancestor
101266848|NCT01785108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101266849|NCT01785108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101266851|NCT01785108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101266852|NCT01785108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101266853|NCT01785108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266854|NCT01785108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101266855|NCT01785108|Immunologic Factors|immunologic factors|mesh-ancestor
101266856|NCT01785290|Haloperidol|haloperidol|mesh-list
101266857|NCT01785290|Haloperidol decanoate|haloperidol decanoate|mesh-list
101266858|NCT01785290|Antiemetics|antiemetics|mesh-ancestor
101814724|NCT00767975|Isoniazid|isoniazid|mesh-list
101814725|NCT00767975|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101814726|NCT00767975|Antitubercular Agents|antitubercular agents|mesh-ancestor
101814727|NCT00767975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101814728|NCT00767975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101814729|NCT00767975|Leprostatic Agents|leprostatic agents|mesh-ancestor
101814730|NCT00767975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101814731|NCT00767975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101814732|NCT00767975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814733|NCT00767975|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101814734|NCT00767975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101814735|NCT00767975|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101814736|NCT00767975|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101814737|NCT00767975|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101814738|NCT00767975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101814739|NCT00767975|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101814740|NCT00767975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101814741|NCT00767975|Antimetabolites|antimetabolites|mesh-ancestor
101814742|NCT00767975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101814743|NCT00768131|Paclitaxel|paclitaxel|mesh-list
101814744|NCT00768131|Carboplatin|carboplatin|mesh-list
101266859|NCT01785290|Autonomic Agents|autonomic agents|mesh-ancestor
101266860|NCT01785290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101266861|NCT01785290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266862|NCT01785290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101266863|NCT01785290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101266864|NCT01785290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101266865|NCT01785290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101266866|NCT01785290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101266867|NCT01785290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101266868|NCT01785290|Dopamine Agents|dopamine agents|mesh-ancestor
101266869|NCT01785290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101266870|NCT01785290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266871|NCT01785290|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101266872|NCT01785329|Alirocumab|alirocumab|mesh-list
101266873|NCT01785329|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101266874|NCT01785329|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101266875|NCT01785329|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101266876|NCT01785329|Antimetabolites|antimetabolites|mesh-ancestor
101266877|NCT01785329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266878|NCT01785329|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101266879|NCT01785329|Protease Inhibitors|protease inhibitors|mesh-ancestor
101266880|NCT01785329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101266881|NCT01785329|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101266882|NCT01785446|Sufentanil|sufentanil|mesh-list
101266883|NCT01785446|Dexmedetomidine|dexmedetomidine|mesh-list
101266884|NCT01785446|Dsuvia|dsuvia|mesh-list
101266885|NCT01785446|Atracurium|atracurium|mesh-list
101266886|NCT01785446|Cisatracurium|cisatracurium|mesh-list
101266887|NCT01785446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101266888|NCT01785446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101266889|NCT01785446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814745|NCT00768131|Cetuximab|cetuximab|mesh-list
101814746|NCT00768131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101814747|NCT00768131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101814748|NCT00768131|Tubulin Modulators|tubulin modulators|mesh-ancestor
101814749|NCT00768131|Antimitotic Agents|antimitotic agents|mesh-ancestor
101814750|NCT00768131|Mitosis Modulators|mitosis modulators|mesh-ancestor
101814751|NCT00768131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814752|NCT00768131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101814753|NCT00401830|Lacosamide|lacosamide|mesh-list
101814754|NCT00401830|Anticonvulsants|anticonvulsants|mesh-ancestor
101814755|NCT00401830|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101814756|NCT00401830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101814757|NCT00401830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101814758|NCT00401830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814759|NCT00768209|Topiramate|topiramate|mesh-list
101814760|NCT00768209|Phentermine|phentermine|mesh-list
101814761|NCT00768209|Anticonvulsants|anticonvulsants|mesh-ancestor
101814762|NCT00768209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101814763|NCT00768209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814764|NCT00768209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101814765|NCT00768209|Appetite Depressants|appetite depressants|mesh-ancestor
101814766|NCT00768209|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101814767|NCT00768209|Sympathomimetics|sympathomimetics|mesh-ancestor
101814768|NCT00768209|Autonomic Agents|autonomic agents|mesh-ancestor
101814769|NCT00768209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101814770|NCT00768209|Adrenergic Agents|adrenergic agents|mesh-ancestor
101814771|NCT00768209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101814773|NCT00401752|Esomeprazole|esomeprazole|mesh-list
101814792|NCT00770471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101814793|NCT00770471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101814794|NCT00539240|Antidepressive Agents|antidepressive agents|mesh-list
101814795|NCT00539240|Nortriptyline|nortriptyline|mesh-list
101814796|NCT00539240|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
101814797|NCT00539240|Rabeprazole|rabeprazole|mesh-list
101814798|NCT00539240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101814799|NCT00539240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101814800|NCT00539240|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101814801|NCT00539240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101814802|NCT00539240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814803|NCT00539240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101814804|NCT00539240|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101814805|NCT00539240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101814806|NCT00539240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101814807|NCT00539240|Adrenergic Agents|adrenergic agents|mesh-ancestor
101814808|NCT00539240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101814809|NCT00539240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814810|NCT00417976|Bevacizumab|bevacizumab|mesh-list
101814811|NCT00417976|Gemcitabine|gemcitabine|mesh-list
101814812|NCT00417976|Fluorouracil|fluorouracil|mesh-list
101814813|NCT00417976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101814814|NCT00417976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101814815|NCT00417976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101814816|NCT00417976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101814817|NCT00417976|Growth Substances|growth substances|mesh-ancestor
101814818|NCT00417976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814819|NCT00417976|Growth Inhibitors|growth inhibitors|mesh-ancestor
101814820|NCT00417976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101814821|NCT00417976|Antimetabolites|antimetabolites|mesh-ancestor
101814822|NCT00417976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814823|NCT00417976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101266890|NCT01785446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101266891|NCT01785446|Analgesics|analgesics|mesh-ancestor
101266892|NCT01785446|Sensory System Agents|sensory system agents|mesh-ancestor
101266893|NCT01785446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101266894|NCT01785446|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101266895|NCT01785446|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101266896|NCT01785446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101266897|NCT01785446|Adrenergic Agents|adrenergic agents|mesh-ancestor
101814824|NCT00417976|Immunologic Factors|immunologic factors|mesh-ancestor
101814825|NCT00770705|Phenoxybenzamine|phenoxybenzamine|mesh-list
101814826|NCT00770705|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101814827|NCT00770705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101814828|NCT00770705|Adrenergic Agents|adrenergic agents|mesh-ancestor
101814829|NCT00770705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101814830|NCT00770705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814831|NCT00770705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814832|NCT00770705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101814833|NCT00770705|Vasodilator Agents|vasodilator agents|mesh-ancestor
101814834|NCT00991796|Paclitaxel|paclitaxel|mesh-list
101814835|NCT00991796|Carboplatin|carboplatin|mesh-list
101814836|NCT00991796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101814837|NCT00991796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101814838|NCT00991796|Tubulin Modulators|tubulin modulators|mesh-ancestor
101814839|NCT00991796|Antimitotic Agents|antimitotic agents|mesh-ancestor
101814840|NCT00991796|Mitosis Modulators|mitosis modulators|mesh-ancestor
101814841|NCT00991796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814842|NCT00673673|Bevacizumab|bevacizumab|mesh-list
101814843|NCT00673673|Fluorouracil|fluorouracil|mesh-list
101814844|NCT00673673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101814845|NCT00673673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101814846|NCT00673673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101814847|NCT00673673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101814848|NCT00673673|Growth Substances|growth substances|mesh-ancestor
101814849|NCT00673673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814850|NCT00673673|Growth Inhibitors|growth inhibitors|mesh-ancestor
101814851|NCT00673673|Antimetabolites|antimetabolites|mesh-ancestor
101814852|NCT00673673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814853|NCT00673673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101814854|NCT00673673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101814855|NCT00673673|Immunologic Factors|immunologic factors|mesh-ancestor
101814856|NCT00763685|Etoricoxib|etoricoxib|mesh-list
101814857|NCT00763685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101814858|NCT00763685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101814862|NCT00763685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814863|NCT00763685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101814864|NCT00763685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101814865|NCT00763685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101814866|NCT00763685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101814867|NCT00763685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101814868|NCT00763685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814869|NCT04048655|Neostigmine|neostigmine|mesh-list
101814870|NCT04048655|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101814871|NCT04048655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101814872|NCT04048655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814873|NCT04048655|Cholinergic Agents|cholinergic agents|mesh-ancestor
101814874|NCT04048655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101814875|NCT04048655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814876|NCT04048655|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101814877|NCT04048655|Autonomic Agents|autonomic agents|mesh-ancestor
101814878|NCT04048655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101814879|NCT00768677|Topiramate|topiramate|mesh-list
101814880|NCT00768677|Anticonvulsants|anticonvulsants|mesh-ancestor
101814881|NCT00768677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101814882|NCT00768677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814883|NCT02557451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
101814884|NCT02557451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101814885|NCT02557451|Growth Substances|growth substances|mesh-ancestor
101814886|NCT02557451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814887|NCT02557451|Growth Inhibitors|growth inhibitors|mesh-ancestor
101814888|NCT02557451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101814889|NCT05408936|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
101814890|NCT05408936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814891|NCT05408936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101814893|NCT02558153|Paclitaxel|paclitaxel|mesh-list
101814905|NCT00763763|Imatinib Mesylate|imatinib mesylate|mesh-list
101814906|NCT00763763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101814907|NCT00763763|Antiemetics|antiemetics|mesh-ancestor
101814908|NCT00763763|Autonomic Agents|autonomic agents|mesh-ancestor
101814909|NCT00763763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101814910|NCT00763763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814911|NCT00763763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101814912|NCT00763763|Glucocorticoids|glucocorticoids|mesh-ancestor
101814913|NCT00763763|Hormones|hormones|mesh-ancestor
101814914|NCT00763763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101814915|NCT00763763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101814916|NCT00763763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101814917|NCT00763763|Antiviral Agents|antiviral agents|mesh-ancestor
101814918|NCT00763763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101814919|NCT00763763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101814920|NCT00763763|Tubulin Modulators|tubulin modulators|mesh-ancestor
101814921|NCT00763763|Antimitotic Agents|antimitotic agents|mesh-ancestor
101814922|NCT00763763|Mitosis Modulators|mitosis modulators|mesh-ancestor
101814923|NCT00763763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814924|NCT00763763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101814925|NCT00763763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101814926|NCT00763763|Immunologic Factors|immunologic factors|mesh-ancestor
101814927|NCT01037140|Vitamin D|vitamin d|mesh-list
101814928|NCT01037140|Cholecalciferol|cholecalciferol|mesh-list
101814929|NCT01037140|Vitamins|vitamins|mesh-ancestor
101814930|NCT01037140|Micronutrients|micronutrients|mesh-ancestor
101814931|NCT01037140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814932|NCT01037140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101814933|NCT01037140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101814935|NCT05357456|Racepinephrine|racepinephrine|mesh-list
101814936|NCT05357456|Epinephryl borate|epinephryl borate|mesh-list
101814937|NCT05357456|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101814938|NCT05357456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101814939|NCT05357456|Adrenergic Agents|adrenergic agents|mesh-ancestor
101814940|NCT05357456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101814941|NCT05357456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814945|NCT05357456|Autonomic Agents|autonomic agents|mesh-ancestor
101814946|NCT05357456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101814947|NCT05357456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101814948|NCT05357456|Respiratory System Agents|respiratory system agents|mesh-ancestor
101814949|NCT05357456|Mydriatics|mydriatics|mesh-ancestor
101814950|NCT05357456|Sympathomimetics|sympathomimetics|mesh-ancestor
101814951|NCT05357456|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101814952|NCT00069121|Leucovorin|leucovorin|mesh-list
101814953|NCT00069121|Fluorouracil|fluorouracil|mesh-list
101814954|NCT00069121|Capecitabine|capecitabine|mesh-list
101814955|NCT00069121|Oxaliplatin|oxaliplatin|mesh-list
101814956|NCT00069121|Antimetabolites|antimetabolites|mesh-ancestor
101312205|NCT00006250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101814957|NCT00069121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101814958|NCT00069121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101814959|NCT00069121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101814960|NCT00069121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101814961|NCT00069121|Immunologic Factors|immunologic factors|mesh-ancestor
101814962|NCT00069121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101814964|NCT00069121|Protective Agents|protective agents|mesh-ancestor
101814965|NCT00069121|Vitamin B Complex|vitamin b complex|mesh-ancestor
101814966|NCT00069121|Vitamins|vitamins|mesh-ancestor
101815001|NCT00771251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101815002|NCT00771251|Immunologic Factors|immunologic factors|mesh-ancestor
101815003|NCT00771251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815004|NCT01420250|Bicalutamide|bicalutamide|mesh-list
101815005|NCT01420250|Hormones|hormones|mesh-list
101815006|NCT01420250|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101815007|NCT01420250|Androgens|androgens|mesh-list
101815008|NCT01420250|Androgen Antagonists|androgen antagonists|mesh-list
101815009|NCT01420250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101815010|NCT01420250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815011|NCT01420250|Hormone Antagonists|hormone antagonists|mesh-ancestor
101815012|NCT01420250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101815014|NCT00399568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101815015|NCT00399568|Analgesics|analgesics|mesh-ancestor
101815016|NCT00399568|Sensory System Agents|sensory system agents|mesh-ancestor
101815017|NCT00399568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101815018|NCT00399568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815019|NCT00399568|Antipyretics|antipyretics|mesh-ancestor
101815020|NCT05088356|Plerixafor|plerixafor|mesh-list
101815021|NCT05088356|Cyclophosphamide|cyclophosphamide|mesh-list
101815022|NCT05088356|Melphalan|melphalan|mesh-list
101815023|NCT05088356|Fludarabine|fludarabine|mesh-list
101815024|NCT05088356|Fludarabine phosphate|fludarabine phosphate|mesh-list
101815025|NCT05088356|Tacrolimus|tacrolimus|mesh-list
101815026|NCT05088356|Alkylating Agents|alkylating agents|mesh-list
101815027|NCT05088356|Lenograstim|lenograstim|mesh-list
101815028|NCT05088356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101815029|NCT05088356|Immunologic Factors|immunologic factors|mesh-ancestor
101815030|NCT05088356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815031|NCT05088356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101815032|NCT05088356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101815033|NCT05088356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266898|NCT01785446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101266899|NCT01785446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266900|NCT01785446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101266901|NCT01785446|Narcotics|narcotics|mesh-ancestor
101266902|NCT01785446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101266903|NCT01785446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101266904|NCT01785446|Anesthetics, General|anesthetics, general|mesh-ancestor
101266905|NCT01785446|Anesthetics|anesthetics|mesh-ancestor
101266906|NCT01785446|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101266907|NCT01785446|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101266908|NCT01785446|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101266909|NCT01785446|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101266910|NCT01785446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101815034|NCT05088356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101815035|NCT05088356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101815036|NCT05088356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101815037|NCT05088356|Antimetabolites|antimetabolites|mesh-ancestor
101815038|NCT05088356|Antiviral Agents|antiviral agents|mesh-ancestor
101815039|NCT05088356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101815040|NCT05088356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101815041|NCT05088356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101815042|NCT05088356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101815043|NCT05088356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101815044|NCT05088356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101815045|NCT01039558|Ecabet|ecabet|mesh-list
101815046|NCT01039558|Lansoprazole|lansoprazole|mesh-list
101815047|NCT01039558|Dexlansoprazole|dexlansoprazole|mesh-list
101815048|NCT01039558|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101815049|NCT01039558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101815050|NCT01039558|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101815051|NCT01039558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101815052|NCT01039558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815053|NCT01039558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101815054|NCT01039558|Protease Inhibitors|protease inhibitors|mesh-ancestor
101815055|NCT01039558|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101815056|NCT01039558|Protective Agents|protective agents|mesh-ancestor
101815057|NCT01039558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815058|NCT01039558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101815059|NCT01324258|Gemcitabine|gemcitabine|mesh-list
101266911|NCT01785446|Cholinergic Agents|cholinergic agents|mesh-ancestor
101266912|NCT01785589|Adenosine|adenosine|mesh-list
101266913|NCT01785589|Analgesics|analgesics|mesh-ancestor
101266914|NCT01785589|Sensory System Agents|sensory system agents|mesh-ancestor
101266915|NCT01785589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101266916|NCT01785589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266917|NCT01785589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101266918|NCT01785589|Vasodilator Agents|vasodilator agents|mesh-ancestor
101266919|NCT01785589|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101266920|NCT01785589|Purinergic Agonists|purinergic agonists|mesh-ancestor
101266921|NCT01785589|Purinergic Agents|purinergic agents|mesh-ancestor
101266922|NCT01785589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101266923|NCT01785589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266924|NCT01785641|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101266926|NCT01785641|Gentamicins|gentamicins|mesh-list
101266927|NCT01785641|Cefazolin|cefazolin|mesh-list
101266928|NCT01785641|Ceftazidime|ceftazidime|mesh-list
101266929|NCT01785641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101266930|NCT01785641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101266931|NCT01785641|Antitubercular Agents|antitubercular agents|mesh-ancestor
101266932|NCT01785641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101266933|NCT01785641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101266934|NCT01785641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101266935|NCT01785641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266936|NCT01785641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101815060|NCT01324258|Trametinib|trametinib|mesh-list
101815061|NCT01324258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101815062|NCT01324258|Antimetabolites|antimetabolites|mesh-ancestor
101815063|NCT01324258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815064|NCT01324258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101815065|NCT01324258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101815066|NCT01324258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101815067|NCT01415882|Dexamethasone|dexamethasone|mesh-list
101815068|NCT01415882|Dexamethasone acetate|dexamethasone acetate|mesh-list
101815069|NCT01415882|Cyclophosphamide|cyclophosphamide|mesh-list
101815070|NCT01415882|Daratumumab|daratumumab|mesh-list
101815071|NCT01415882|Ixazomib|ixazomib|mesh-list
101815072|NCT01415882|Ichthammol|ichthammol|mesh-list
101815073|NCT01415882|BB 1101|bb 1101|mesh-list
101815074|NCT01415882|Glycine|glycine|mesh-list
101815075|NCT01415882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101815076|NCT01415882|Immunologic Factors|immunologic factors|mesh-ancestor
101815077|NCT01415882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815078|NCT01415882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101815079|NCT01415882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101815080|NCT01415882|Alkylating Agents|alkylating agents|mesh-ancestor
101815081|NCT01415882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815082|NCT01415882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101815083|NCT01415882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101815084|NCT01415882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101815085|NCT01415882|Antiemetics|antiemetics|mesh-ancestor
101815086|NCT01415882|Autonomic Agents|autonomic agents|mesh-ancestor
101815087|NCT01415882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101815088|NCT01415882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101815089|NCT01415882|Glucocorticoids|glucocorticoids|mesh-ancestor
101815091|NCT01415882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101815092|NCT01415882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101815105|NCT00068419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101815106|NCT00068419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101815107|NCT00068419|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101815108|NCT00068419|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101815109|NCT00068419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101815110|NCT00068419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101815111|NCT00068419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101815112|NCT00068419|Analgesics|analgesics|mesh-ancestor
101815113|NCT00068419|Sensory System Agents|sensory system agents|mesh-ancestor
101815114|NCT00068419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101815115|NCT00068419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101815116|NCT00068419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101815117|NCT00068419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101815118|NCT00068419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101815119|NCT02557373|Vitamins|vitamins|mesh-list
101815120|NCT02557373|Vitamin A|vitamin a|mesh-list
101815121|NCT02557373|Retinol palmitate|retinol palmitate|mesh-list
101815122|NCT02557373|Micronutrients|micronutrients|mesh-ancestor
101815123|NCT02557373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815124|NCT02557373|Antioxidants|antioxidants|mesh-ancestor
101815125|NCT02557373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815126|NCT02557373|Protective Agents|protective agents|mesh-ancestor
101815127|NCT02557373|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101815128|NCT02557373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101815129|NCT01757626|Molgramostim|molgramostim|mesh-list
101815130|NCT01757626|Sargramostim|sargramostim|mesh-list
101815131|NCT01757626|Immunologic Factors|immunologic factors|mesh-ancestor
101815132|NCT01757626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815133|NCT01757626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101815134|NCT04048811|Propofol|propofol|mesh-list
101815135|NCT04048811|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101815136|NCT04048811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101815137|NCT04048811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815138|NCT04048811|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101815139|NCT04048811|Anesthetics, General|anesthetics, general|mesh-ancestor
101815140|NCT04048811|Anesthetics|anesthetics|mesh-ancestor
101815145|NCT01086631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815146|NCT01086631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101815147|NCT00399490|Tanezumab|tanezumab|mesh-list
101815148|NCT00399490|Analgesics|analgesics|mesh-ancestor
101815149|NCT00399490|Sensory System Agents|sensory system agents|mesh-ancestor
101815150|NCT00399490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101815151|NCT00399490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815152|NCT00398866|Triamcinolone|triamcinolone|mesh-list
101815153|NCT00398866|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101815154|NCT00398866|Bupivacaine|bupivacaine|mesh-list
101815155|NCT00398866|Hyaluronic Acid|hyaluronic acid|mesh-list
101815156|NCT00398866|Hylan|hylan|mesh-list
101815157|NCT00398866|Anesthetics, Local|anesthetics, local|mesh-ancestor
101815158|NCT00398866|Anesthetics|anesthetics|mesh-ancestor
101815159|NCT00398866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101815160|NCT00398866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815161|NCT00398866|Sensory System Agents|sensory system agents|mesh-ancestor
101815162|NCT00398866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101815163|NCT00398866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101815164|NCT00398866|Glucocorticoids|glucocorticoids|mesh-ancestor
101815165|NCT00398866|Hormones|hormones|mesh-ancestor
101815166|NCT00398866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101815167|NCT00398866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101815168|NCT00398866|Immunologic Factors|immunologic factors|mesh-ancestor
101815169|NCT00398866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101815170|NCT00398866|Viscosupplements|viscosupplements|mesh-ancestor
101815171|NCT00398866|Protective Agents|protective agents|mesh-ancestor
101815172|NCT00771563|Cisplatin|cisplatin|mesh-list
101815173|NCT00771563|Docetaxel|docetaxel|mesh-list
101815174|NCT00771563|Enoxaparin|enoxaparin|mesh-list
101815175|NCT00771563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101815176|NCT00771563|Tubulin Modulators|tubulin modulators|mesh-ancestor
101266937|NCT01785641|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101266938|NCT01785641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101266939|NCT01785641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101266941|NCT01785693|Levobupivacaine|levobupivacaine|mesh-list
101266942|NCT01785693|Analgesics|analgesics|mesh-ancestor
101266943|NCT01785693|Sensory System Agents|sensory system agents|mesh-ancestor
101266944|NCT01785693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101266945|NCT01785693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266946|NCT01785693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101266947|NCT01785693|Sympatholytics|sympatholytics|mesh-ancestor
101266948|NCT01785693|Autonomic Agents|autonomic agents|mesh-ancestor
101266949|NCT01785693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101407866|NCT00442390|Hydrocortisone|hydrocortisone|mesh-list
101266950|NCT01785693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101266951|NCT01785693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101266952|NCT01785693|Adrenergic Agents|adrenergic agents|mesh-ancestor
101815177|NCT00771563|Antimitotic Agents|antimitotic agents|mesh-ancestor
101815178|NCT00771563|Mitosis Modulators|mitosis modulators|mesh-ancestor
101815179|NCT00771563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815180|NCT00771563|Anticoagulants|anticoagulants|mesh-ancestor
101815181|NCT00771563|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101815182|NCT00771563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101815185|NCT00775073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101815186|NCT00775073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101815187|NCT00775073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101815188|NCT00775073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101815189|NCT00775073|Growth Substances|growth substances|mesh-ancestor
101815190|NCT00775073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815191|NCT00775073|Growth Inhibitors|growth inhibitors|mesh-ancestor
101815192|NCT00775073|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101815193|NCT00775073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101815194|NCT00775073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101815195|NCT00775073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815196|NCT00775073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101815197|NCT00775073|Immunologic Factors|immunologic factors|mesh-ancestor
101815198|NCT00398632|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101815199|NCT00398632|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101815200|NCT00398632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101815201|NCT00398632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101815202|NCT00398632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815203|NCT00398632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101815204|NCT00398632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815205|NCT00398632|Analgesics|analgesics|mesh-ancestor
101815206|NCT00398632|Sensory System Agents|sensory system agents|mesh-ancestor
101815207|NCT00398632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101815208|NCT00398632|Antidepressive Agents|antidepressive agents|mesh-ancestor
101815209|NCT00398632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101815210|NCT00398632|Dopamine Agents|dopamine agents|mesh-ancestor
101815218|NCT01589146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815220|NCT00775151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101815221|NCT00775151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101815222|NCT00775151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101815223|NCT00775151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815224|NCT00775151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101815225|NCT00775151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815226|NCT00775151|Vasodilator Agents|vasodilator agents|mesh-ancestor
101815227|NCT04694300|Acetaminophen|acetaminophen|mesh-list
101815228|NCT04694300|Naproxen|naproxen|mesh-list
101815229|NCT04694300|Tramadol|tramadol|mesh-list
101815230|NCT04694300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101815231|NCT04694300|Analgesics|analgesics|mesh-ancestor
101815232|NCT04694300|Sensory System Agents|sensory system agents|mesh-ancestor
101815233|NCT04694300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101815234|NCT04694300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815235|NCT04694300|Antipyretics|antipyretics|mesh-ancestor
101815236|NCT04694300|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101815237|NCT04694300|Narcotics|narcotics|mesh-ancestor
101815238|NCT04694300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101815239|NCT04694300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101815240|NCT04694300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101815242|NCT04694300|Gout Suppressants|gout suppressants|mesh-ancestor
101815243|NCT04694300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101815244|NCT04694300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101815245|NCT04694300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815246|NCT04642820|Methamphetamine|methamphetamine|mesh-list
101312222|NCT00006250|Alkylating Agents|alkylating agents|mesh-ancestor
101815247|NCT04642820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101815248|NCT04642820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815249|NCT04642820|Sympathomimetics|sympathomimetics|mesh-ancestor
101815250|NCT04642820|Autonomic Agents|autonomic agents|mesh-ancestor
101266953|NCT01785693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101266954|NCT01785693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266955|NCT01785693|Anesthetics, Local|anesthetics, local|mesh-ancestor
101266956|NCT01785693|Anesthetics|anesthetics|mesh-ancestor
101266957|NCT01785693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101266958|NCT01785797|Silicon|silicon|mesh-list
101266959|NCT01785797|Trace Elements|trace elements|mesh-ancestor
101815251|NCT04642820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101815252|NCT04642820|Dopamine Agents|dopamine agents|mesh-ancestor
101815253|NCT04642820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101815254|NCT04642820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815255|NCT04642820|Adrenergic Agents|adrenergic agents|mesh-ancestor
101815256|NCT04642820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101815257|NCT04642820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101815258|NCT04642820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101815259|NCT04642820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101815260|NCT00771641|Cobalt|cobalt|mesh-list
101815261|NCT00771641|Trace Elements|trace elements|mesh-ancestor
101815262|NCT00771641|Micronutrients|micronutrients|mesh-ancestor
101815263|NCT00771641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815264|NCT05408000|Propofol|propofol|mesh-list
101815265|NCT05408000|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101815266|NCT05408000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101815267|NCT05408000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815268|NCT05408000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101815269|NCT05408000|Anesthetics, General|anesthetics, general|mesh-ancestor
101815270|NCT05408000|Anesthetics|anesthetics|mesh-ancestor
101815271|NCT00771719|Ceftobiprole|ceftobiprole|mesh-list
101815272|NCT00771719|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
101815273|NCT00771719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101815274|NCT00771719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101815275|NCT00673361|Temozolomide|temozolomide|mesh-list
101815276|NCT00673361|Sorafenib|sorafenib|mesh-list
101815277|NCT00673361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101815278|NCT00673361|Alkylating Agents|alkylating agents|mesh-ancestor
101815279|NCT00673361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815280|NCT00673361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101815281|NCT00673361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101815282|NCT00673361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101815283|NCT00393718|Liraglutide|liraglutide|mesh-list
101815284|NCT00393718|Glyburide|glyburide|mesh-list
101266960|NCT01785797|Micronutrients|micronutrients|mesh-ancestor
101266961|NCT01785797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266962|NCT01785836|Dapsone|dapsone|mesh-list
101266963|NCT01785836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101266964|NCT01785836|Antimalarials|antimalarials|mesh-ancestor
101266965|NCT01785836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101266966|NCT01785836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101266967|NCT01785836|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101266968|NCT01785836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101815285|NCT00393718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101815286|NCT00393718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815287|NCT00393718|Incretins|incretins|mesh-ancestor
101815288|NCT00393718|Hormones|hormones|mesh-ancestor
101815289|NCT00393718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101815290|NCT00669071|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
101815291|NCT00669071|Tretinoin|tretinoin|mesh-list
101815292|NCT00669071|Hydroquinone|hydroquinone|mesh-list
101815293|NCT00669071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101815294|NCT00669071|Keratolytic Agents|keratolytic agents|mesh-ancestor
101815295|NCT00669071|Dermatologic Agents|dermatologic agents|mesh-ancestor
101815296|NCT00669071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101815297|NCT00669071|Glucocorticoids|glucocorticoids|mesh-ancestor
101815298|NCT00669071|Hormones|hormones|mesh-ancestor
101815299|NCT00669071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101815300|NCT00669071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815301|NCT00669071|Antioxidants|antioxidants|mesh-ancestor
101815302|NCT00669071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815303|NCT00669071|Protective Agents|protective agents|mesh-ancestor
101815304|NCT00669071|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101815305|NCT00398320|Bevacizumab|bevacizumab|mesh-list
101815306|NCT00398320|Capecitabine|capecitabine|mesh-list
101815307|NCT00398320|Oxaliplatin|oxaliplatin|mesh-list
101815308|NCT00398320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101815309|NCT00398320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101815310|NCT00398320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101815311|NCT00398320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101815312|NCT00398320|Growth Substances|growth substances|mesh-ancestor
101815313|NCT00398320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815314|NCT00398320|Growth Inhibitors|growth inhibitors|mesh-ancestor
101815315|NCT00398320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101815316|NCT00398320|Antimetabolites|antimetabolites|mesh-ancestor
101815317|NCT00398320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815318|NCT00670007|Protease Inhibitors|protease inhibitors|mesh-list
101815319|NCT00670007|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
101266969|NCT01785836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266970|NCT01785836|Leprostatic Agents|leprostatic agents|mesh-ancestor
101266971|NCT01785836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101815320|NCT00670007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101815321|NCT00670007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815322|NCT00670007|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101815323|NCT00670007|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101815324|NCT04003688|Magnesium Sulfate|magnesium sulfate|mesh-list
101815325|NCT04003688|Analgesics|analgesics|mesh-ancestor
101815326|NCT04003688|Sensory System Agents|sensory system agents|mesh-ancestor
101815327|NCT04003688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101815328|NCT04003688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815329|NCT04003688|Anesthetics|anesthetics|mesh-ancestor
101815330|NCT04003688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101815331|NCT04003688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101815332|NCT04003688|Anticonvulsants|anticonvulsants|mesh-ancestor
101815333|NCT04003688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101815334|NCT04003688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101815335|NCT04003688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815336|NCT04003688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101815337|NCT04003688|Tocolytic Agents|tocolytic agents|mesh-ancestor
101815338|NCT04003688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101815339|NCT00779129|Cyclophosphamide|cyclophosphamide|mesh-list
101815340|NCT00779129|Doxorubicin|doxorubicin|mesh-list
101815341|NCT00779129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101815342|NCT00779129|Immunologic Factors|immunologic factors|mesh-ancestor
101815343|NCT00779129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815344|NCT00779129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101815345|NCT00779129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101815346|NCT00779129|Alkylating Agents|alkylating agents|mesh-ancestor
101815347|NCT00779129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266973|NCT01785862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101266974|NCT01785862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101266975|NCT01785862|Analgesics|analgesics|mesh-ancestor
101266976|NCT01785862|Sensory System Agents|sensory system agents|mesh-ancestor
101266977|NCT01785862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101266978|NCT01785862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266979|NCT01785862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101266980|NCT01785862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101266981|NCT01785862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101266982|NCT01785862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101266983|NCT01785862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101266984|NCT01785979|Chloroquine|chloroquine|mesh-list
101266985|NCT01785979|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
101266986|NCT01785979|Prednisone|prednisone|mesh-list
101266987|NCT01785979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101266988|NCT01785979|Glucocorticoids|glucocorticoids|mesh-ancestor
101815348|NCT00779129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101815349|NCT00779129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101815350|NCT00779129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101815351|NCT00779129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101815352|NCT00779129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101815353|NCT00779129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101815356|NCT00772187|Anesthetics|anesthetics|mesh-ancestor
101815357|NCT00772187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101815358|NCT00772187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815359|NCT00772187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101815360|NCT00772187|Narcotics|narcotics|mesh-ancestor
101815361|NCT00772187|Analgesics|analgesics|mesh-ancestor
101815362|NCT00772187|Sensory System Agents|sensory system agents|mesh-ancestor
101815363|NCT00772187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101815364|NCT00772187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101815365|NCT00772187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101815366|NCT00772187|Anesthetics, General|anesthetics, general|mesh-ancestor
101815367|NCT00772265|Insulin|insulin|mesh-list
101815368|NCT00772265|Isophane Insulin, Human|isophane insulin, human|mesh-list
101815369|NCT00772265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101815370|NCT00772265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815371|NCT00779441|Zolpidem|zolpidem|mesh-list
101815372|NCT00779441|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101266989|NCT01785979|Hormones|hormones|mesh-ancestor
101266990|NCT01785979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101266991|NCT01785979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101266992|NCT01785979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101266993|NCT01785979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101266994|NCT01785979|Amebicides|amebicides|mesh-ancestor
101266995|NCT01785979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101266996|NCT01785979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101266997|NCT01785979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101266998|NCT01785979|Antimalarials|antimalarials|mesh-ancestor
101266999|NCT01785979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101267000|NCT01785979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101267001|NCT01785979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101267002|NCT01785979|Analgesics|analgesics|mesh-ancestor
101267003|NCT01785979|Sensory System Agents|sensory system agents|mesh-ancestor
101267004|NCT01785979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101267005|NCT01785979|Filaricides|filaricides|mesh-ancestor
101267006|NCT01785979|Antinematodal Agents|antinematodal agents|mesh-ancestor
101267007|NCT01785979|Anthelmintics|anthelmintics|mesh-ancestor
101267008|NCT01786018|Cyclosporine|cyclosporine|mesh-list
101267009|NCT01786018|Methotrexate|methotrexate|mesh-list
101267010|NCT01786018|Busulfan|busulfan|mesh-list
101267011|NCT01786018|Thiotepa|thiotepa|mesh-list
101267012|NCT01786018|Cyclosporins|cyclosporins|mesh-list
101267013|NCT01786018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101267014|NCT01786018|Abortifacient Agents|abortifacient agents|mesh-ancestor
101267015|NCT01786018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101267016|NCT01786018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267017|NCT01786018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101267018|NCT01786018|Antimetabolites|antimetabolites|mesh-ancestor
101267019|NCT01786018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815373|NCT00779441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101815374|NCT00779441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101815375|NCT00779441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815376|NCT00779441|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101815377|NCT00779441|GABA Agonists|gaba agonists|mesh-ancestor
101815378|NCT00779441|GABA Agents|gaba agents|mesh-ancestor
101815379|NCT00779441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101815380|NCT00779441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815381|NCT02556437|Immunoglobulins|immunoglobulins|mesh-list
101815382|NCT02556437|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101815383|NCT02556437|Antibodies|antibodies|mesh-list
101815384|NCT02556437|Immunologic Factors|immunologic factors|mesh-ancestor
101815385|NCT02556437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815386|NCT04946006|Oxytocin|oxytocin|mesh-list
101815387|NCT04946006|Oxytocics|oxytocics|mesh-ancestor
101815388|NCT04946006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101815389|NCT04946006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815390|NCT00775619|Carvedilol|carvedilol|mesh-list
101815391|NCT00775619|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101815392|NCT00775619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101815393|NCT00775619|Adrenergic Agents|adrenergic agents|mesh-ancestor
101815394|NCT00775619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101815395|NCT00775619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815396|NCT00775619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815397|NCT00775619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101815398|NCT00775619|Antioxidants|antioxidants|mesh-ancestor
101815399|NCT00775619|Protective Agents|protective agents|mesh-ancestor
101815400|NCT00775619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101815401|NCT00775619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101815402|NCT00775619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101815403|NCT00775619|Vasodilator Agents|vasodilator agents|mesh-ancestor
101815404|NCT00775619|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101815405|NCT00775619|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101815406|NCT00775697|Montelukast|montelukast|mesh-list
101815407|NCT00775697|Leukotriene Antagonists|leukotriene antagonists|mesh-list
101267020|NCT01786018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101267021|NCT01786018|Dermatologic Agents|dermatologic agents|mesh-ancestor
101267022|NCT01786018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101267023|NCT01786018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101267024|NCT01786018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101815408|NCT00775697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101815409|NCT00775697|Respiratory System Agents|respiratory system agents|mesh-ancestor
101815410|NCT00775697|Hormone Antagonists|hormone antagonists|mesh-ancestor
101815411|NCT00775697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101815412|NCT00775697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815413|NCT00775697|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101815414|NCT00775697|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101815415|NCT00775697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815417|NCT05357066|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101815418|NCT05357066|Anesthetics, General|anesthetics, general|mesh-ancestor
101815419|NCT05357066|Anesthetics|anesthetics|mesh-ancestor
101815420|NCT05357066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101815421|NCT05357066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815422|NCT05357066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101815423|NCT05357066|Analgesics|analgesics|mesh-ancestor
101815424|NCT05357066|Sensory System Agents|sensory system agents|mesh-ancestor
101815425|NCT05357066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101815426|NCT02556905|Dexamethasone|dexamethasone|mesh-list
101815427|NCT02556905|Lenalidomide|lenalidomide|mesh-list
101815428|NCT02556905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101815429|NCT02556905|Antiemetics|antiemetics|mesh-ancestor
101815430|NCT02556905|Autonomic Agents|autonomic agents|mesh-ancestor
101815431|NCT02556905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101815432|NCT02556905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815433|NCT02556905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101815434|NCT02556905|Glucocorticoids|glucocorticoids|mesh-ancestor
101815435|NCT02556905|Hormones|hormones|mesh-ancestor
101815436|NCT02556905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101267025|NCT01786018|Immunologic Factors|immunologic factors|mesh-ancestor
101267026|NCT01786018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101267027|NCT01786018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101267028|NCT01786018|Antifungal Agents|antifungal agents|mesh-ancestor
101267029|NCT01786018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101267030|NCT01786018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101267031|NCT01786018|Alkylating Agents|alkylating agents|mesh-ancestor
101267032|NCT01786018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101267033|NCT01786018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101267034|NCT01786070|Budesonide|budesonide|mesh-list
101267035|NCT01786070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101267036|NCT01786070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101267037|NCT01786070|Autonomic Agents|autonomic agents|mesh-ancestor
101267038|NCT01786070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101267039|NCT01786070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815437|NCT02556905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101815438|NCT02556905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101815439|NCT02556905|Immunologic Factors|immunologic factors|mesh-ancestor
101815440|NCT02556905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101815441|NCT02556905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101815442|NCT02556905|Growth Substances|growth substances|mesh-ancestor
101815443|NCT02556905|Growth Inhibitors|growth inhibitors|mesh-ancestor
101815444|NCT00539006|Fluticasone|fluticasone|mesh-list
101815445|NCT00539006|Xhance|xhance|mesh-list
101815446|NCT00539006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101815447|NCT00539006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101815448|NCT00539006|Autonomic Agents|autonomic agents|mesh-ancestor
101815449|NCT00539006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101815450|NCT00539006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815451|NCT00539006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101815452|NCT00539006|Respiratory System Agents|respiratory system agents|mesh-ancestor
101815453|NCT00539006|Dermatologic Agents|dermatologic agents|mesh-ancestor
101815454|NCT00539006|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101815455|NCT04047329|Anesthetics|anesthetics|mesh-list
101815456|NCT04047329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101815457|NCT04047329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815458|NCT00779753|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
101815459|NCT00779753|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101312232|NCT00006265|Immunologic Factors|immunologic factors|mesh-ancestor
101815460|NCT00779753|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101815461|NCT00537056|Sunitinib|sunitinib|mesh-list
101815463|NCT00537056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101815464|NCT00537056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101815465|NCT00537056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101815466|NCT00537056|Growth Substances|growth substances|mesh-ancestor
101815467|NCT00537056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815468|NCT00537056|Growth Inhibitors|growth inhibitors|mesh-ancestor
101267040|NCT01786070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101267041|NCT01786070|Respiratory System Agents|respiratory system agents|mesh-ancestor
101267042|NCT01786070|Glucocorticoids|glucocorticoids|mesh-ancestor
101267043|NCT01786070|Hormones|hormones|mesh-ancestor
101267044|NCT01786070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101267045|NCT01786200|Aspirin|aspirin|mesh-list
101267046|NCT01786200|Ibuprofen|ibuprofen|mesh-list
101267047|NCT01786200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101267048|NCT01786200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101267049|NCT01786200|Analgesics|analgesics|mesh-ancestor
101815469|NCT00537056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101815470|NCT00537056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101815471|NCT00537056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815472|NCT00537056|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101815473|NCT00779831|Pseudoephedrine|pseudoephedrine|mesh-list
101815475|NCT00779831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101815476|NCT00779831|Autonomic Agents|autonomic agents|mesh-ancestor
101815477|NCT00779831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101815478|NCT00779831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815479|NCT00779831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101815480|NCT00779831|Respiratory System Agents|respiratory system agents|mesh-ancestor
101815481|NCT00779831|Nasal Decongestants|nasal decongestants|mesh-ancestor
101815482|NCT00779831|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101815483|NCT00779831|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101815484|NCT00779831|Sympathomimetics|sympathomimetics|mesh-ancestor
101815485|NCT00779831|Adrenergic Agents|adrenergic agents|mesh-ancestor
101815486|NCT00779831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101815487|NCT00779831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815488|NCT00535262|Selegiline|selegiline|mesh-list
101815489|NCT00535262|Antidepressive Agents|antidepressive agents|mesh-ancestor
101815490|NCT00535262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101815491|NCT00535262|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101815492|NCT00535262|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101815493|NCT00535262|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101815494|NCT00535262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101815495|NCT00535262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815496|NCT00535262|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101815497|NCT00535262|Protective Agents|protective agents|mesh-ancestor
101815498|NCT00535262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815499|NCT00772499|Atenolol|atenolol|mesh-list
101815500|NCT00772499|Amlodipine|amlodipine|mesh-list
101815501|NCT00772499|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101815502|NCT00772499|Olmesartan|olmesartan|mesh-list
101815503|NCT00772499|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101815504|NCT00772499|Hydralazine|hydralazine|mesh-list
101815505|NCT00772499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101815508|NCT00772499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815509|NCT00772499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101815510|NCT00772499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815511|NCT00772499|Vasodilator Agents|vasodilator agents|mesh-ancestor
101815512|NCT00772499|Diuretics|diuretics|mesh-ancestor
101815513|NCT00772499|Natriuretic Agents|natriuretic agents|mesh-ancestor
101815514|NCT00772499|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101815515|NCT00772499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101815516|NCT00772499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101815517|NCT00772499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101815518|NCT00772499|Sympatholytics|sympatholytics|mesh-ancestor
101815519|NCT00772499|Autonomic Agents|autonomic agents|mesh-ancestor
101815520|NCT00772499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101815521|NCT00772499|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101815522|NCT00772499|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101815523|NCT00772499|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101815524|NCT00772499|Adrenergic Agents|adrenergic agents|mesh-ancestor
101312235|NCT00006265|Immunotoxins|immunotoxins|mesh-ancestor
101815525|NCT00772499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101815526|NCT00989690|Docetaxel|docetaxel|mesh-list
101815527|NCT00989690|Pemetrexed|pemetrexed|mesh-list
101815528|NCT00989690|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101815529|NCT00989690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101815530|NCT00989690|Tubulin Modulators|tubulin modulators|mesh-ancestor
101815531|NCT00989690|Antimitotic Agents|antimitotic agents|mesh-ancestor
101815532|NCT00989690|Mitosis Modulators|mitosis modulators|mesh-ancestor
101815533|NCT00989690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815534|NCT00989690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101815535|NCT00989690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101815536|NCT00989690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101815537|NCT00989690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101815538|NCT00074581|Ritonavir|ritonavir|mesh-list
101815539|NCT00074581|Lopinavir|lopinavir|mesh-list
101815540|NCT00074581|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101815541|NCT00074581|Tenofovir|tenofovir|mesh-list
101815542|NCT00074581|Lamivudine|lamivudine|mesh-list
101815543|NCT00074581|Emtricitabine|emtricitabine|mesh-list
101815544|NCT00074581|Zidovudine|zidovudine|mesh-list
101267050|NCT01786200|Sensory System Agents|sensory system agents|mesh-ancestor
101815545|NCT00074581|Nevirapine|nevirapine|mesh-list
101815546|NCT00074581|Didanosine|didanosine|mesh-list
101815547|NCT00074581|Stavudine|stavudine|mesh-list
101815548|NCT00074581|Efavirenz|efavirenz|mesh-list
101815549|NCT00074581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101815550|NCT00074581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101815551|NCT00074581|Protease Inhibitors|protease inhibitors|mesh-ancestor
101815552|NCT00074581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101815553|NCT00074581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815554|NCT00074581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101815555|NCT00074581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101815556|NCT00074581|Antiviral Agents|antiviral agents|mesh-ancestor
101815557|NCT00074581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101815558|NCT00074581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101815559|NCT00074581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101815560|NCT00074581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101815561|NCT00074581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101815562|NCT00074581|Antimetabolites|antimetabolites|mesh-ancestor
101815563|NCT00074581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101815564|NCT00074581|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101815565|NCT00074581|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101815566|NCT00074581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101815567|NCT00074581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101815568|NCT00776477|Aspirin|aspirin|mesh-list
101815569|NCT00776477|Clopidogrel|clopidogrel|mesh-list
101815570|NCT00776477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101815571|NCT00776477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101267051|NCT01786200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101267052|NCT01786200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267053|NCT01786200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101267054|NCT01786200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101267055|NCT01786200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101267056|NCT01786200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101267057|NCT01786200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267058|NCT01786200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101267059|NCT01786200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101267060|NCT01786200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101267061|NCT01786200|Antipyretics|antipyretics|mesh-ancestor
101267062|NCT01786226|Mifepristone|mifepristone|mesh-list
101267063|NCT01786226|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101267064|NCT01786226|Abortifacient Agents|abortifacient agents|mesh-ancestor
101267065|NCT01786226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101267066|NCT01786226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267067|NCT01786226|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101267068|NCT01786226|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101267069|NCT01786226|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101267070|NCT01786226|Contraceptive Agents|contraceptive agents|mesh-ancestor
101815572|NCT00776477|Analgesics|analgesics|mesh-ancestor
101815573|NCT00776477|Sensory System Agents|sensory system agents|mesh-ancestor
101815574|NCT00776477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101815575|NCT00776477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815576|NCT00776477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101815577|NCT00776477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101815578|NCT00776477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101815579|NCT00776477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101815580|NCT00776477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815581|NCT00776477|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101815582|NCT00776477|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101815583|NCT00776477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101815584|NCT00776477|Antipyretics|antipyretics|mesh-ancestor
101815585|NCT00776477|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101815586|NCT00776477|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101815587|NCT00776477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101815588|NCT00776477|Purinergic Agents|purinergic agents|mesh-ancestor
101815589|NCT00776477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101815590|NCT00772655|Rituximab|rituximab|mesh-list
101815591|NCT00772655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101815592|NCT00772655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101815593|NCT00772655|Immunologic Factors|immunologic factors|mesh-ancestor
101815594|NCT00772655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815595|NCT00772655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101815596|NCT00776633|Aspirin|aspirin|mesh-list
101815597|NCT00776633|Clopidogrel|clopidogrel|mesh-list
101815598|NCT00776633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101815599|NCT00776633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101815600|NCT00776633|Analgesics|analgesics|mesh-ancestor
101815601|NCT00776633|Sensory System Agents|sensory system agents|mesh-ancestor
101815602|NCT00776633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101267071|NCT01786226|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101267072|NCT01786226|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101267073|NCT01786226|Hormone Antagonists|hormone antagonists|mesh-ancestor
101267074|NCT01786226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101267075|NCT01786226|Luteolytic Agents|luteolytic agents|mesh-ancestor
101267076|NCT01786226|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101267077|NCT01786226|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101267079|NCT01786382|Omeprazole|omeprazole|mesh-list
101267080|NCT01786382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101267081|NCT01786382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101267082|NCT01786382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101815603|NCT00776633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815604|NCT00776633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101815605|NCT00776633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101815606|NCT00776633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101815607|NCT00776633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101815608|NCT00776633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815609|NCT00776633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101815610|NCT00776633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101815611|NCT00776633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101815612|NCT00776633|Antipyretics|antipyretics|mesh-ancestor
101815613|NCT00776633|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101815614|NCT00776633|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101815615|NCT00776633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101815616|NCT00776633|Purinergic Agents|purinergic agents|mesh-ancestor
101815617|NCT00776633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101815618|NCT01093963|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101815619|NCT01093963|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101815620|NCT01093963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815621|NCT01093963|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101815622|NCT01093963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101815623|NCT01093963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101815624|NCT01093963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815625|NCT01093963|Dopamine Agents|dopamine agents|mesh-ancestor
101815626|NCT01093963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101815627|NCT04256018|Mogamulizumab|mogamulizumab|mesh-list
101815628|NCT04256018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101815629|NCT03961087|Ubiquinone|ubiquinone|mesh-list
101815630|NCT03961087|Coenzyme Q10|coenzyme q10|mesh-list
101815631|NCT03961087|Meclofenoxate|meclofenoxate|mesh-list
101815632|NCT03961087|Micronutrients|micronutrients|mesh-ancestor
101815633|NCT03961087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815634|NCT03961087|Vitamins|vitamins|mesh-ancestor
101815641|NCT03960775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815642|NCT03960775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101815643|NCT03960775|Analgesics|analgesics|mesh-ancestor
101815644|NCT03960775|Sensory System Agents|sensory system agents|mesh-ancestor
101815645|NCT03960775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101815646|NCT03960775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101815647|NCT03960775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101815648|NCT03960775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101815649|NCT03960775|Adrenergic Agents|adrenergic agents|mesh-ancestor
101815650|NCT03960775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101815651|NCT03960775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815652|NCT00536978|Cytarabine|cytarabine|mesh-list
101815653|NCT00536978|Cyclophosphamide|cyclophosphamide|mesh-list
101815654|NCT00536978|Melphalan|melphalan|mesh-list
101815655|NCT00536978|Carmustine|carmustine|mesh-list
101815656|NCT00536978|Rituximab|rituximab|mesh-list
101815657|NCT00536978|Methotrexate|methotrexate|mesh-list
101815658|NCT00536978|Fludarabine|fludarabine|mesh-list
101815659|NCT00536978|Fludarabine phosphate|fludarabine phosphate|mesh-list
101815660|NCT00536978|Etoposide|etoposide|mesh-list
101815661|NCT00536978|Alemtuzumab|alemtuzumab|mesh-list
101815662|NCT00536978|Tacrolimus|tacrolimus|mesh-list
101815663|NCT00536978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101815664|NCT00536978|Immunologic Factors|immunologic factors|mesh-ancestor
101815665|NCT00536978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815666|NCT00536978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101815667|NCT00536978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101815668|NCT00536978|Alkylating Agents|alkylating agents|mesh-ancestor
101312250|NCT00006286|Fluoxetine|fluoxetine|mesh-list
101815669|NCT00536978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815670|NCT00536978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101815671|NCT00536978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101815672|NCT00536978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101815673|NCT00536978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101815674|NCT00536978|Abortifacient Agents|abortifacient agents|mesh-ancestor
101815675|NCT00536978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101815676|NCT00536978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101815677|NCT00536978|Antimetabolites|antimetabolites|mesh-ancestor
101267083|NCT01786382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267084|NCT01786382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101815678|NCT00536978|Dermatologic Agents|dermatologic agents|mesh-ancestor
101815679|NCT00536978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101815680|NCT00536978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101815681|NCT00536978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101815682|NCT00536978|Antiviral Agents|antiviral agents|mesh-ancestor
101815683|NCT00536978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101815684|NCT00536978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101815685|NCT00536978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101815686|NCT00536978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101267085|NCT01786382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101267086|NCT01786382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101267087|NCT01786382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101267088|NCT01786382|Anesthetics, General|anesthetics, general|mesh-ancestor
101267090|NCT01786382|GABA Modulators|gaba modulators|mesh-ancestor
101267091|NCT01786382|GABA Agents|gaba agents|mesh-ancestor
101267092|NCT01786382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101267093|NCT01786382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267094|NCT01786382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101267095|NCT01786382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101267096|NCT01786382|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101267097|NCT01786382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101267098|NCT01786395|Isopropyl unoprostone|isopropyl unoprostone|mesh-list
101267099|NCT01786395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101267100|NCT01786538|Leucovorin|leucovorin|mesh-list
101267101|NCT01786538|Fluorouracil|fluorouracil|mesh-list
101267102|NCT01786538|Oxaliplatin|oxaliplatin|mesh-list
101267103|NCT01786538|Antimetabolites|antimetabolites|mesh-ancestor
101267104|NCT01786538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267105|NCT01786538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101267106|NCT01786538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101267107|NCT01786538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101267108|NCT01786538|Immunologic Factors|immunologic factors|mesh-ancestor
101267109|NCT01786538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267110|NCT01786538|Antidotes|antidotes|mesh-ancestor
101267111|NCT01786538|Protective Agents|protective agents|mesh-ancestor
101267112|NCT01786538|Vitamin B Complex|vitamin b complex|mesh-ancestor
101267113|NCT01786538|Vitamins|vitamins|mesh-ancestor
101267114|NCT01786538|Micronutrients|micronutrients|mesh-ancestor
101267115|NCT01786616|Formoterol Fumarate|formoterol fumarate|mesh-list
101267116|NCT01786616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101267117|NCT01786616|Autonomic Agents|autonomic agents|mesh-ancestor
101267118|NCT01786616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101267119|NCT01786616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267120|NCT01786616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101267121|NCT01786616|Respiratory System Agents|respiratory system agents|mesh-ancestor
101267122|NCT01786616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101815687|NCT00536978|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101815689|NCT03809611|Lipotropic Agents|lipotropic agents|mesh-ancestor
101815690|NCT03809611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101815691|NCT03809611|Antimetabolites|antimetabolites|mesh-ancestor
101815692|NCT03809611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815693|NCT03809611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101815694|NCT03809611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101815695|NCT03809611|Nootropic Agents|nootropic agents|mesh-ancestor
101267123|NCT01786616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101267124|NCT01786616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101267125|NCT01786616|Adrenergic Agents|adrenergic agents|mesh-ancestor
101267126|NCT01786616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101267127|NCT01786616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267128|NCT01786655|Epinephrine|epinephrine|mesh-list
101267129|NCT01786655|Bupivacaine|bupivacaine|mesh-list
101267130|NCT01786655|Neosaxitoxin|neosaxitoxin|mesh-list
101267131|NCT01786655|Anesthetics, Local|anesthetics, local|mesh-ancestor
101267132|NCT01786655|Anesthetics|anesthetics|mesh-ancestor
101267133|NCT01786655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101267134|NCT01786655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267135|NCT01786655|Sensory System Agents|sensory system agents|mesh-ancestor
101267136|NCT01786655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101267137|NCT01786655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101267138|NCT01786655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101267139|NCT01786655|Adrenergic Agents|adrenergic agents|mesh-ancestor
101267140|NCT01786655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101267141|NCT01786655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267142|NCT01786655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101267143|NCT01786655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101267144|NCT01786655|Autonomic Agents|autonomic agents|mesh-ancestor
101267145|NCT01786655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101267146|NCT01786655|Respiratory System Agents|respiratory system agents|mesh-ancestor
101267147|NCT01786655|Mydriatics|mydriatics|mesh-ancestor
101267148|NCT01786655|Sympathomimetics|sympathomimetics|mesh-ancestor
101267149|NCT01786655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101267150|NCT01786655|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101267152|NCT01786759|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101267153|NCT01786759|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101267154|NCT01786759|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101267155|NCT01786759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101267156|NCT01787123|Cerebrolysin|cerebrolysin|mesh-list
101267157|NCT01787123|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101267158|NCT01787123|Protective Agents|protective agents|mesh-ancestor
101267159|NCT01787123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267160|NCT01787123|Nootropic Agents|nootropic agents|mesh-ancestor
101267161|NCT01787136|Dextromethorphan|dextromethorphan|mesh-list
101267162|NCT01787136|Antitussive Agents|antitussive agents|mesh-ancestor
101267163|NCT01787136|Respiratory System Agents|respiratory system agents|mesh-ancestor
101267164|NCT01787136|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101267165|NCT01787136|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101267166|NCT01787136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101267167|NCT01787136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267168|NCT01787136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267170|NCT01787344|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101267171|NCT01787344|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101267172|NCT01787344|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101267173|NCT01787344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101267174|NCT01787344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267175|NCT01787344|Cholinergic Agents|cholinergic agents|mesh-ancestor
101267176|NCT01787344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101267177|NCT01787344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267178|NCT01787344|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101267179|NCT01787344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101815696|NCT05360342|Vitamins|vitamins|mesh-list
101815697|NCT05360342|Vitamin K|vitamin k|mesh-list
101815698|NCT05360342|Vitamin K 1|vitamin k 1|mesh-list
101815699|NCT05360342|Micronutrients|micronutrients|mesh-ancestor
101815700|NCT05360342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815701|NCT05360342|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101815702|NCT05360342|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101815703|NCT05360342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267180|NCT01787357|Canagliflozin|canagliflozin|mesh-list
101267181|NCT01787357|Moxifloxacin|moxifloxacin|mesh-list
101267182|NCT01787357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101267183|NCT01787357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101267184|NCT01787357|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101267185|NCT01787357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101267186|NCT01787357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101267187|NCT01787357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267188|NCT01787357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101267189|NCT01787357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267190|NCT01787357|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101267191|NCT01787357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101267192|NCT01787396|Metformin|metformin|mesh-list
101267193|NCT01787396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101267194|NCT01787396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267195|NCT01787474|Cytarabine|cytarabine|mesh-list
101267196|NCT01787474|Fludarabine|fludarabine|mesh-list
101267197|NCT01787474|Fludarabine phosphate|fludarabine phosphate|mesh-list
101267198|NCT01787474|Lenograstim|lenograstim|mesh-list
101267199|NCT01787474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101267200|NCT01787474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101267201|NCT01787474|Antimetabolites|antimetabolites|mesh-ancestor
101267202|NCT01787474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267203|NCT01787474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101267204|NCT01787474|Immunologic Factors|immunologic factors|mesh-ancestor
101267205|NCT01787474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267206|NCT01787474|Antiviral Agents|antiviral agents|mesh-ancestor
101267207|NCT01787474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101267208|NCT01787474|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101267209|NCT01787630|Hyaluronic Acid|hyaluronic acid|mesh-list
101267210|NCT01787630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101267211|NCT01787630|Immunologic Factors|immunologic factors|mesh-ancestor
101267212|NCT01787630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267213|NCT01787630|Viscosupplements|viscosupplements|mesh-ancestor
101267214|NCT01787630|Protective Agents|protective agents|mesh-ancestor
101267215|NCT01787669|Dexamethasone|dexamethasone|mesh-list
101267216|NCT01787669|Bevacizumab|bevacizumab|mesh-list
101267217|NCT01787669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101267218|NCT01787669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101267219|NCT01787669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101267220|NCT01787669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101267221|NCT01787669|Growth Substances|growth substances|mesh-ancestor
101267222|NCT01787669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267223|NCT01787669|Growth Inhibitors|growth inhibitors|mesh-ancestor
101267224|NCT01787669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101267225|NCT01787669|Antiemetics|antiemetics|mesh-ancestor
101267226|NCT01787669|Autonomic Agents|autonomic agents|mesh-ancestor
101267227|NCT01787669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101267228|NCT01787669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101267229|NCT01787669|Glucocorticoids|glucocorticoids|mesh-ancestor
101267231|NCT01787669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101267232|NCT01787669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101267233|NCT01788007|Imiquimod|imiquimod|mesh-list
101267234|NCT01788007|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101267235|NCT01788007|Immunologic Factors|immunologic factors|mesh-ancestor
101267236|NCT01788007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267237|NCT01788007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101267238|NCT01788007|Interferon Inducers|interferon inducers|mesh-ancestor
101267239|NCT01788072|Oxytocin|oxytocin|mesh-list
101815704|NCT05360342|Hemostatics|hemostatics|mesh-ancestor
101815705|NCT05360342|Coagulants|coagulants|mesh-ancestor
101815706|NCT05290220|Lenvatinib|lenvatinib|mesh-list
101815707|NCT05290220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101815708|NCT05290220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101815709|NCT05290220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101815710|NCT05290220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815711|NCT04026230|Atorvastatin|atorvastatin|mesh-list
101815712|NCT04026230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101815713|NCT04026230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101815714|NCT04026230|Antimetabolites|antimetabolites|mesh-ancestor
101267240|NCT01788072|Oxytocics|oxytocics|mesh-ancestor
101267241|NCT01788072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101267242|NCT01788072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267243|NCT01788176|Zoledronic Acid|zoledronic acid|mesh-list
101267244|NCT01788176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101267245|NCT01788176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267246|NCT01788189|Lenalidomide|lenalidomide|mesh-list
101267247|NCT01788189|Immunologic Factors|immunologic factors|mesh-ancestor
101267248|NCT01788189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267249|NCT01788189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101267250|NCT01788189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101267251|NCT01788189|Growth Substances|growth substances|mesh-ancestor
101267252|NCT01788189|Growth Inhibitors|growth inhibitors|mesh-ancestor
101267253|NCT01788189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101267254|NCT01788254|Talinolol|talinolol|mesh-list
101267255|NCT01788254|Torsemide|torsemide|mesh-list
101267256|NCT01788254|Midazolam|midazolam|mesh-list
101267257|NCT01788254|Codeine|codeine|mesh-list
101267258|NCT01788254|Pravastatin|pravastatin|mesh-list
101267259|NCT01788254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101267260|NCT01788254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101267261|NCT01788254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101267262|NCT01788254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267263|NCT01788254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101267264|NCT01788254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101267265|NCT01788254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101267266|NCT01788254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101267267|NCT01788254|Anesthetics, General|anesthetics, general|mesh-ancestor
101267268|NCT01788254|Anesthetics|anesthetics|mesh-ancestor
101267269|NCT01788254|GABA Modulators|gaba modulators|mesh-ancestor
101267270|NCT01788254|GABA Agents|gaba agents|mesh-ancestor
101267271|NCT01788254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101267272|NCT01788254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267273|NCT01788254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101267274|NCT01788254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101267275|NCT01788254|Antimetabolites|antimetabolites|mesh-ancestor
101267276|NCT01788254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101267277|NCT01788254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101267278|NCT01788254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101267279|NCT01788254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101267280|NCT01788254|Narcotics|narcotics|mesh-ancestor
101267281|NCT01788254|Analgesics|analgesics|mesh-ancestor
101267282|NCT01788254|Sensory System Agents|sensory system agents|mesh-ancestor
101267283|NCT01788254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101267284|NCT01788254|Antitussive Agents|antitussive agents|mesh-ancestor
101267285|NCT01788254|Respiratory System Agents|respiratory system agents|mesh-ancestor
101267286|NCT01788254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101267287|NCT01788254|Diuretics|diuretics|mesh-ancestor
101267288|NCT01788254|Natriuretic Agents|natriuretic agents|mesh-ancestor
101267289|NCT01788254|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101267290|NCT01788254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101267291|NCT01788254|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101267292|NCT01788254|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101267293|NCT01788254|Adrenergic Agents|adrenergic agents|mesh-ancestor
101267294|NCT01788254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101815715|NCT04026230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815716|NCT04026230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101815717|NCT04026230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101815718|NCT04026230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101815719|NCT00536510|Niacin|niacin|mesh-list
101815720|NCT00536510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101815721|NCT00536510|Antimetabolites|antimetabolites|mesh-ancestor
101815722|NCT00536510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267295|NCT01788280|Bevacizumab|bevacizumab|mesh-list
101267296|NCT01788280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101267297|NCT01788280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101267298|NCT01788280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101267299|NCT01788280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101267300|NCT01788280|Growth Substances|growth substances|mesh-ancestor
101267302|NCT01788280|Growth Inhibitors|growth inhibitors|mesh-ancestor
101267304|NCT01788332|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101267305|NCT01788332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101267306|NCT01788332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267307|NCT01788332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101267308|NCT01788371|Lamivudine|lamivudine|mesh-list
101267309|NCT01788371|Telbivudine|telbivudine|mesh-list
101267310|NCT01788371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101267311|NCT01788371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101267312|NCT01788371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101267313|NCT01788371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267314|NCT01788371|Antiviral Agents|antiviral agents|mesh-ancestor
101267315|NCT01788371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101267317|NCT01788371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101267318|NCT01788384|Clindamycin|clindamycin|mesh-list
101267320|NCT01788384|Clindamycin phosphate|clindamycin phosphate|mesh-list
101267322|NCT01788384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101267323|NCT01788384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101267324|NCT01788384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101267325|NCT01788384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101267326|NCT01788384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267327|NCT01788384|Dermatologic Agents|dermatologic agents|mesh-ancestor
101267328|NCT01788462|Tesamorelin|tesamorelin|mesh-list
101267329|NCT01788462|Growth Substances|growth substances|mesh-ancestor
101267330|NCT01788462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267331|NCT01788501|Cyclosporine|cyclosporine|mesh-list
101267332|NCT01788501|Methotrexate|methotrexate|mesh-list
101267333|NCT01788501|Tacrolimus|tacrolimus|mesh-list
101267334|NCT01788501|Cyclosporins|cyclosporins|mesh-list
101267335|NCT01788501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101267336|NCT01788501|Abortifacient Agents|abortifacient agents|mesh-ancestor
101267337|NCT01788501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101267338|NCT01788501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267339|NCT01788501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101267340|NCT01788501|Antimetabolites|antimetabolites|mesh-ancestor
101267341|NCT01788501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267342|NCT01788501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101267343|NCT01788501|Dermatologic Agents|dermatologic agents|mesh-ancestor
101267344|NCT01788501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101267345|NCT01788501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101267346|NCT01788501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101267347|NCT01788501|Immunologic Factors|immunologic factors|mesh-ancestor
101267348|NCT01788501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101267349|NCT01788501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101267350|NCT01788501|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101267351|NCT01788501|Antifungal Agents|antifungal agents|mesh-ancestor
101267352|NCT01788501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101267353|NCT01788540|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101815723|NCT00536510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101815724|NCT00536510|Vasodilator Agents|vasodilator agents|mesh-ancestor
101815725|NCT00536510|Vitamin B Complex|vitamin b complex|mesh-ancestor
101815726|NCT00536510|Vitamins|vitamins|mesh-ancestor
101815727|NCT00536510|Micronutrients|micronutrients|mesh-ancestor
101815728|NCT00536510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815729|NCT04424264|Tenofovir|tenofovir|mesh-list
101815730|NCT04424264|Lamivudine|lamivudine|mesh-list
101815731|NCT04424264|Emtricitabine|emtricitabine|mesh-list
101267354|NCT01788540|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101267355|NCT01788540|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101267356|NCT01788540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101267357|NCT01788605|Ramosetron|ramosetron|mesh-list
101267358|NCT01788605|Antiemetics|antiemetics|mesh-ancestor
101267359|NCT01788605|Autonomic Agents|autonomic agents|mesh-ancestor
101267360|NCT01788605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101267361|NCT01788605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267362|NCT01788605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101267363|NCT01788605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101267364|NCT01788605|Serotonin Agents|serotonin agents|mesh-ancestor
101267365|NCT01788605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101267366|NCT01788605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267367|NCT01788670|Ethanol|ethanol|mesh-list
101267368|NCT01788670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101267369|NCT01788670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101267370|NCT01788670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101267371|NCT01788670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267372|NCT01788722|Dienogest|dienogest|mesh-list
101267373|NCT01788722|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101267374|NCT01788722|Contraceptive Agents|contraceptive agents|mesh-ancestor
101267375|NCT01788722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101267376|NCT01788722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267377|NCT01788722|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101267379|NCT01788722|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101267380|NCT01788722|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101267381|NCT01788722|Hormone Antagonists|hormone antagonists|mesh-ancestor
101267382|NCT01788722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101267383|NCT01788722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101267384|NCT01788722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101267385|NCT01788774|Risperidone|risperidone|mesh-list
101267386|NCT01788774|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101267387|NCT01788774|Serotonin Agents|serotonin agents|mesh-ancestor
101267388|NCT01788774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101267389|NCT01788774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267390|NCT01788774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267391|NCT01788774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101267392|NCT01788774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101267393|NCT01788774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101267394|NCT01788774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101267395|NCT01788774|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101267396|NCT01788774|Dopamine Agents|dopamine agents|mesh-ancestor
101267397|NCT01788969|Escitalopram|escitalopram|mesh-list
101267398|NCT01788969|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101267399|NCT01788969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101267400|NCT01788969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101267401|NCT01788969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267402|NCT01788969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101267403|NCT01788969|Serotonin Agents|serotonin agents|mesh-ancestor
101267404|NCT01788969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267405|NCT01788982|Nintedanib|nintedanib|mesh-list
101267406|NCT01788982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101267407|NCT01788982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101267408|NCT01788982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101267409|NCT01788982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267410|NCT01789086|Liraglutide|liraglutide|mesh-list
101267411|NCT01789086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101815733|NCT04424264|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101815734|NCT04424264|Rifampin|rifampin|mesh-list
101815735|NCT04424264|Isoniazid|isoniazid|mesh-list
101815736|NCT04424264|Antiviral Agents|antiviral agents|mesh-ancestor
101815737|NCT04424264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101815738|NCT04424264|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101815739|NCT04424264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101312256|NCT00006286|Serotonin Agents|serotonin agents|mesh-ancestor
101815740|NCT04424264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101267412|NCT01789086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267413|NCT01789086|Incretins|incretins|mesh-ancestor
101267414|NCT01789086|Hormones|hormones|mesh-ancestor
101267415|NCT01789086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101267416|NCT01789099|Sargramostim|sargramostim|mesh-list
101267417|NCT01789099|Immunologic Factors|immunologic factors|mesh-ancestor
101267418|NCT01789099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267419|NCT01789125|Nicotine|nicotine|mesh-list
101267420|NCT01789125|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101267421|NCT01789125|Autonomic Agents|autonomic agents|mesh-ancestor
101267422|NCT01789125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101267423|NCT01789125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267424|NCT01789125|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101267425|NCT01789125|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101267426|NCT01789125|Cholinergic Agents|cholinergic agents|mesh-ancestor
101267427|NCT01789125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101267428|NCT01789125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267429|NCT01789216|Ketorolac|ketorolac|mesh-list
101267430|NCT01789216|Meloxicam|meloxicam|mesh-list
101267431|NCT01789216|Pregabalin|pregabalin|mesh-list
101267432|NCT01789216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101267433|NCT01789216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101267434|NCT01789216|Analgesics|analgesics|mesh-ancestor
101267435|NCT01789216|Sensory System Agents|sensory system agents|mesh-ancestor
101267436|NCT01789216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101267437|NCT01789216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267438|NCT01789216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101267439|NCT01789216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101267440|NCT01789216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101267441|NCT01789216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101267442|NCT01789216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267443|NCT01789216|Anticonvulsants|anticonvulsants|mesh-ancestor
101267444|NCT01789216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101267445|NCT01789216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101267446|NCT01789216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101267447|NCT01789216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101267448|NCT01789216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101267449|NCT01789216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101267450|NCT01789216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101267451|NCT01789216|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101267452|NCT01789242|Dexamethasone|dexamethasone|mesh-list
101267453|NCT01789242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101267454|NCT01789242|Antiemetics|antiemetics|mesh-ancestor
101267455|NCT01789242|Autonomic Agents|autonomic agents|mesh-ancestor
101267456|NCT01789242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101267457|NCT01789242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267458|NCT01789242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101267459|NCT01789242|Glucocorticoids|glucocorticoids|mesh-ancestor
101267460|NCT01789242|Hormones|hormones|mesh-ancestor
101267461|NCT01789242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101267462|NCT01789242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101267463|NCT01789242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101267465|NCT01789294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101815741|NCT04424264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815742|NCT04424264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101815743|NCT04424264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101815744|NCT04424264|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101815745|NCT04424264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101815746|NCT04424264|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101815747|NCT04424264|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101267466|NCT01789294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101267467|NCT01789294|Analgesics|analgesics|mesh-ancestor
101267468|NCT01789294|Sensory System Agents|sensory system agents|mesh-ancestor
101267469|NCT01789294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101267470|NCT01789294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267471|NCT01789294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101267472|NCT01789294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101267473|NCT01789385|Dexmedetomidine|dexmedetomidine|mesh-list
101267474|NCT01789385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101267475|NCT01789385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101267476|NCT01789385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267477|NCT01789385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101267478|NCT01789385|Analgesics|analgesics|mesh-ancestor
101267479|NCT01789385|Sensory System Agents|sensory system agents|mesh-ancestor
101267480|NCT01789385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101267481|NCT01789385|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101267482|NCT01789385|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101267483|NCT01789385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101267484|NCT01789385|Adrenergic Agents|adrenergic agents|mesh-ancestor
101267485|NCT01789385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101267486|NCT01789385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267487|NCT01789437|Dexamethasone|dexamethasone|mesh-list
101267488|NCT01789437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101267489|NCT01789437|Antiemetics|antiemetics|mesh-ancestor
101267490|NCT01789437|Autonomic Agents|autonomic agents|mesh-ancestor
101267491|NCT01789437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101267492|NCT01789437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267493|NCT01789437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101267494|NCT01789437|Glucocorticoids|glucocorticoids|mesh-ancestor
101267496|NCT01789437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101267497|NCT01789437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101267498|NCT01789437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101267499|NCT01789619|Tacrolimus|tacrolimus|mesh-list
101267500|NCT01789619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101267501|NCT01789619|Immunologic Factors|immunologic factors|mesh-ancestor
101267502|NCT01789619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267503|NCT01789619|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101267504|NCT01789619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101267505|NCT01789619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267506|NCT01789710|Bupropion|bupropion|mesh-list
101267507|NCT01789710|Nicotine|nicotine|mesh-list
101267508|NCT01789710|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101267509|NCT01789710|Autonomic Agents|autonomic agents|mesh-ancestor
101267510|NCT01789710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101267511|NCT01789710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267512|NCT01789710|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101267513|NCT01789710|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101267514|NCT01789710|Cholinergic Agents|cholinergic agents|mesh-ancestor
101267515|NCT01789710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101313749|NCT00000529|Tamoxifen|tamoxifen|mesh-list
101267516|NCT01789710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267517|NCT01789710|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101267518|NCT01789710|Antidepressive Agents|antidepressive agents|mesh-ancestor
101267519|NCT01789710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101267520|NCT01789710|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101815748|NCT04424264|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101815749|NCT04424264|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101815750|NCT04424264|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101815751|NCT04424264|Antitubercular Agents|antitubercular agents|mesh-ancestor
101815752|NCT04424264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101815753|NCT04424264|Leprostatic Agents|leprostatic agents|mesh-ancestor
101815754|NCT04424264|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101815755|NCT04424264|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101815756|NCT04424264|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101267521|NCT01789710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101267522|NCT01789710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101267523|NCT01789710|Dopamine Agents|dopamine agents|mesh-ancestor
101267524|NCT01789710|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101267525|NCT01789710|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101267526|NCT01789710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101267527|NCT01789723|Leucovorin|leucovorin|mesh-list
101267528|NCT01789723|Levoleucovorin|levoleucovorin|mesh-list
101267529|NCT01789723|Antidotes|antidotes|mesh-ancestor
101267530|NCT01789723|Protective Agents|protective agents|mesh-ancestor
101267531|NCT01789723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267532|NCT01789723|Vitamin B Complex|vitamin b complex|mesh-ancestor
101267533|NCT01789723|Vitamins|vitamins|mesh-ancestor
101267534|NCT01789723|Micronutrients|micronutrients|mesh-ancestor
101267535|NCT01789827|Interleukin-2|interleukin-2|mesh-list
101267536|NCT01789827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101267537|NCT01789827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101267538|NCT01789827|Analgesics|analgesics|mesh-ancestor
101267539|NCT01789827|Sensory System Agents|sensory system agents|mesh-ancestor
101267541|NCT01789827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267542|NCT01789879|Efavirenz|efavirenz|mesh-list
101267543|NCT01789879|Nevirapine|nevirapine|mesh-list
101267544|NCT01789879|Levonorgestrel|levonorgestrel|mesh-list
101267545|NCT01789879|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101267546|NCT01789879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101267547|NCT01789879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101267548|NCT01789879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267549|NCT01789879|Antiviral Agents|antiviral agents|mesh-ancestor
101267550|NCT01789879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101267551|NCT01789879|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101267552|NCT01789879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101267553|NCT01789879|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101267554|NCT01789879|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101267555|NCT01789879|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101267556|NCT01789879|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101267557|NCT01789879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101267558|NCT01789879|Contraceptive Agents|contraceptive agents|mesh-ancestor
101267559|NCT01789879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101267560|NCT01789879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267561|NCT01789879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101267562|NCT01789879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101267563|NCT01789879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101267564|NCT01789879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101267565|NCT01789879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101267566|NCT01789892|Methylprednisolone|methylprednisolone|mesh-list
101267567|NCT01789892|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101267568|NCT01789892|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101267569|NCT01789892|Prednisolone|prednisolone|mesh-list
101267570|NCT01789892|Prednisolone acetate|prednisolone acetate|mesh-list
101267571|NCT01789892|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101267572|NCT01789892|Prednisolone phosphate|prednisolone phosphate|mesh-list
101267573|NCT01789892|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101267574|NCT01789892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101267575|NCT01789892|Antiemetics|antiemetics|mesh-ancestor
101267576|NCT01789892|Autonomic Agents|autonomic agents|mesh-ancestor
101267577|NCT01789892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101815758|NCT04424264|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101815759|NCT04424264|Antimetabolites|antimetabolites|mesh-ancestor
101815760|NCT04424264|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101815761|NCT00398086|Paclitaxel|paclitaxel|mesh-list
101815762|NCT00398086|Gemcitabine|gemcitabine|mesh-list
101815763|NCT00398086|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101267578|NCT01789892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267579|NCT01789892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101267580|NCT01789892|Glucocorticoids|glucocorticoids|mesh-ancestor
101267581|NCT01789892|Hormones|hormones|mesh-ancestor
101267582|NCT01789892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101267583|NCT01789892|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101267584|NCT01789892|Protective Agents|protective agents|mesh-ancestor
101267585|NCT01789892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101267586|NCT01789892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101267587|NCT01789892|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101267588|NCT01789892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267589|NCT01789957|Exenatide|exenatide|mesh-list
101267590|NCT01789957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101267591|NCT01789957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267592|NCT01789957|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101267593|NCT01789957|Incretins|incretins|mesh-ancestor
101267594|NCT01789957|Hormones|hormones|mesh-ancestor
101267595|NCT01789957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101267596|NCT01790854|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101267597|NCT01790854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101267598|NCT01792063|Sevoflurane|sevoflurane|mesh-list
101267599|NCT01792063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101267600|NCT01792063|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101267601|NCT01792063|Anesthetics, General|anesthetics, general|mesh-ancestor
101267602|NCT01792063|Anesthetics|anesthetics|mesh-ancestor
101267603|NCT01792063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101267604|NCT01792063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267605|NCT01792570|Darunavir|darunavir|mesh-list
101267606|NCT01792570|Rilpivirine|rilpivirine|mesh-list
101267607|NCT01792570|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101267608|NCT01792570|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101267609|NCT01792570|Protease Inhibitors|protease inhibitors|mesh-ancestor
101267610|NCT01792570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101267611|NCT01792570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267612|NCT01792570|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101267613|NCT01792570|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101267615|NCT01792570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101267616|NCT01792570|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101267617|NCT01792570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101267618|NCT01792804|Vancomycin|vancomycin|mesh-list
101267619|NCT01792804|Clindamycin|clindamycin|mesh-list
101267620|NCT01792804|Cefazolin|cefazolin|mesh-list
101267621|NCT01792804|Linezolid|linezolid|mesh-list
101267622|NCT01792804|Daptomycin|daptomycin|mesh-list
101267623|NCT01792804|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101267624|NCT01792804|Floxacillin|floxacillin|mesh-list
101267625|NCT01792804|Cloxacillin|cloxacillin|mesh-list
101267626|NCT01792804|Trimethoprim|trimethoprim|mesh-list
101267627|NCT01792804|Sulfamethoxazole|sulfamethoxazole|mesh-list
101267628|NCT01792804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101267629|NCT01792804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101267630|NCT01792804|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101267631|NCT01792804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101267632|NCT01792804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267633|NCT01792804|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101267634|NCT01792804|Antimalarials|antimalarials|mesh-ancestor
101267635|NCT01792804|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101267636|NCT01792804|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101267637|NCT01792804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101267638|NCT01792804|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101267639|NCT01792804|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101267640|NCT01792804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101267641|NCT01793038|Clomiphene|clomiphene|mesh-list
101815764|NCT00398086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101815765|NCT00398086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101815767|NCT00398086|Antimitotic Agents|antimitotic agents|mesh-ancestor
101815768|NCT00398086|Mitosis Modulators|mitosis modulators|mesh-ancestor
101815769|NCT00398086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815770|NCT00398086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101815771|NCT00398086|Antimetabolites|antimetabolites|mesh-ancestor
101815772|NCT04364360|Sulforaphane|sulforaphane|mesh-list
101267642|NCT01793038|Enclomiphene|enclomiphene|mesh-list
101267643|NCT01793038|Zuclomiphene|zuclomiphene|mesh-list
101267644|NCT01793038|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101267645|NCT01793038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267646|NCT01793038|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101267647|NCT01793038|Hormone Antagonists|hormone antagonists|mesh-ancestor
101267648|NCT01793038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101267649|NCT01793038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267650|NCT01793038|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101267651|NCT01793038|Fertility Agents|fertility agents|mesh-ancestor
101267652|NCT01793038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101267653|NCT01793038|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101267654|NCT01793038|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101267655|NCT01793038|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101267656|NCT01793038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101267657|NCT01794182|Glyburide|glyburide|mesh-list
101267658|NCT01794182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101267659|NCT01794182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267660|NCT01794208|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101267661|NCT01794208|Hormones|hormones|mesh-ancestor
101267662|NCT01794208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101267664|NCT01794247|Lidocaine|lidocaine|mesh-list
101267665|NCT01794247|Magnesium Sulfate|magnesium sulfate|mesh-list
101267666|NCT01794247|Fentanyl|fentanyl|mesh-list
101267667|NCT01794247|Anesthetics, Local|anesthetics, local|mesh-ancestor
101267668|NCT01794247|Anesthetics|anesthetics|mesh-ancestor
101267669|NCT01794247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101267670|NCT01794247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267671|NCT01794247|Sensory System Agents|sensory system agents|mesh-ancestor
101267672|NCT01794247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101267673|NCT01794247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101267674|NCT01794247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101267675|NCT01794247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101267676|NCT01794247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101267677|NCT01794247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267678|NCT01794247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101267679|NCT01794247|Narcotics|narcotics|mesh-ancestor
101267680|NCT01794247|Analgesics|analgesics|mesh-ancestor
101267681|NCT01794247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101267682|NCT01794247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101267683|NCT01794247|Anesthetics, General|anesthetics, general|mesh-ancestor
101267684|NCT01794247|Anticonvulsants|anticonvulsants|mesh-ancestor
101267685|NCT01794247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101267686|NCT01794247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101267687|NCT01794247|Tocolytic Agents|tocolytic agents|mesh-ancestor
101267688|NCT01794247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101267689|NCT01794429|Exenatide|exenatide|mesh-list
101267690|NCT01794429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101267691|NCT01794429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267692|NCT01794429|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101267693|NCT01794429|Incretins|incretins|mesh-ancestor
101267694|NCT01794429|Hormones|hormones|mesh-ancestor
101267695|NCT01794429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101267696|NCT01795248|Liraglutide|liraglutide|mesh-list
101267697|NCT01795248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101267698|NCT01795248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815773|NCT04364360|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101815774|NCT04364360|Protective Agents|protective agents|mesh-ancestor
101815775|NCT04364360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815776|NCT04364360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101815778|NCT00536198|Antidepressive Agents|antidepressive agents|mesh-ancestor
101815779|NCT00536198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101815780|NCT00536198|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101815781|NCT00536198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101815782|NCT00536198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101267700|NCT01795248|Hormones|hormones|mesh-ancestor
101267701|NCT01795248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101267702|NCT01796132|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101267703|NCT01796132|Fluvoxamine|fluvoxamine|mesh-list
101267704|NCT01796132|Citalopram|citalopram|mesh-list
101267705|NCT01796132|Fluoxetine|fluoxetine|mesh-list
101267706|NCT01796132|Paroxetine|paroxetine|mesh-list
101267707|NCT01796132|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101267708|NCT01796132|Sertraline|sertraline|mesh-list
101267709|NCT01796132|Escitalopram|escitalopram|mesh-list
101267710|NCT01796132|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101267711|NCT01796132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101267712|NCT01796132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101267713|NCT01796132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267714|NCT01796132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101267715|NCT01796132|Serotonin Agents|serotonin agents|mesh-ancestor
101267716|NCT01796132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267717|NCT01796132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101267718|NCT01796132|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101267719|NCT01796132|Antidepressive Agents|antidepressive agents|mesh-ancestor
101267720|NCT01796132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101267721|NCT01796132|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101267722|NCT01796132|Analgesics|analgesics|mesh-ancestor
101267723|NCT01796132|Sensory System Agents|sensory system agents|mesh-ancestor
101267724|NCT01796132|Dopamine Agents|dopamine agents|mesh-ancestor
101267725|NCT01796132|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101267726|NCT01796132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101267727|NCT01796132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101267728|NCT01796132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101267729|NCT01796132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101267730|NCT01796132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101267731|NCT01796132|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101267732|NCT01796132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101267733|NCT01796418|Beraprost|beraprost|mesh-list
101267734|NCT01796418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101267735|NCT01796418|Vasodilator Agents|vasodilator agents|mesh-ancestor
101267737|NCT01796522|Progesterone|progesterone|mesh-list
101267738|NCT01796522|Progestins|progestins|mesh-ancestor
101267739|NCT01796522|Hormones|hormones|mesh-ancestor
101267740|NCT01796522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101267741|NCT01796522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267742|NCT01796522|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101267743|NCT01796522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101267744|NCT01796522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267745|NCT01796522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101267746|NCT01796522|Vasodilator Agents|vasodilator agents|mesh-ancestor
101267747|NCT01796522|Tocolytic Agents|tocolytic agents|mesh-ancestor
101267748|NCT01796522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101267749|NCT01796730|Bambuterol|bambuterol|mesh-list
101267750|NCT01796730|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101267751|NCT01796730|Autonomic Agents|autonomic agents|mesh-ancestor
101267752|NCT01796730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101815783|NCT00536198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815784|NCT00536198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101815785|NCT00536198|Serotonin Agents|serotonin agents|mesh-ancestor
101815786|NCT00536198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815787|NCT00393484|Lamivudine|lamivudine|mesh-list
101815788|NCT00393484|Entecavir|entecavir|mesh-list
101815789|NCT00393484|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101815790|NCT00393484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101815791|NCT00393484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101815792|NCT00393484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815793|NCT00393484|Antiviral Agents|antiviral agents|mesh-ancestor
101815794|NCT00393484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101815795|NCT00393484|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101815796|NCT00393484|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101815797|NCT00667823|Macitentan|macitentan|mesh-list
101815798|NCT00667823|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101267753|NCT01796730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267754|NCT01796730|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101267755|NCT01796730|Respiratory System Agents|respiratory system agents|mesh-ancestor
101267756|NCT01796808|Lidocaine|lidocaine|mesh-list
101267757|NCT01796808|Epinephrine|epinephrine|mesh-list
101267758|NCT01796808|Anesthetics, Local|anesthetics, local|mesh-list
101267759|NCT01796808|Anesthetics|anesthetics|mesh-list
101267760|NCT01796808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101267761|NCT01796808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267762|NCT01796808|Sensory System Agents|sensory system agents|mesh-ancestor
101267763|NCT01796808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101267764|NCT01796808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101267765|NCT01796808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101267766|NCT01796808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101267767|NCT01796808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101267768|NCT01796808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267769|NCT01796808|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101267770|NCT01796808|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101267771|NCT01796808|Adrenergic Agents|adrenergic agents|mesh-ancestor
101267772|NCT01796808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101267773|NCT01796808|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101267774|NCT01796808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101267775|NCT01796808|Autonomic Agents|autonomic agents|mesh-ancestor
101267776|NCT01796808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101267777|NCT01796808|Respiratory System Agents|respiratory system agents|mesh-ancestor
101267778|NCT01796808|Mydriatics|mydriatics|mesh-ancestor
101267779|NCT01796808|Sympathomimetics|sympathomimetics|mesh-ancestor
101267780|NCT01796808|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101267781|NCT01797289|Fibrin fragment D|fibrin fragment d|mesh-list
101267782|NCT01797289|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101267783|NCT01797289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101267784|NCT01797289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267785|NCT01797289|Hemostatics|hemostatics|mesh-ancestor
101267786|NCT01797289|Coagulants|coagulants|mesh-ancestor
101267787|NCT01797718|Letrozole|letrozole|mesh-list
101267788|NCT01797718|Testosterone|testosterone|mesh-list
101267789|NCT01797718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101267790|NCT01797718|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101267791|NCT01797718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101267792|NCT01797718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101267793|NCT01797718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267794|NCT01797718|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101815799|NCT00667823|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101815800|NCT00667823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815801|NCT00667823|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
101815802|NCT00536120|Natalizumab|natalizumab|mesh-list
101815803|NCT00536120|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
101815804|NCT00536120|Immunologic Factors|immunologic factors|mesh-ancestor
101815805|NCT00536120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815806|NCT00536120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101815807|NCT00057811|Leucovorin|leucovorin|mesh-list
101815808|NCT00057811|Cytarabine|cytarabine|mesh-list
101815809|NCT00057811|Prednisone|prednisone|mesh-list
101815810|NCT00057811|Methylprednisolone|methylprednisolone|mesh-list
101815811|NCT00057811|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101267795|NCT01797718|Hormone Antagonists|hormone antagonists|mesh-ancestor
101267796|NCT01797718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101267797|NCT01797718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267798|NCT01797718|Androgens|androgens|mesh-ancestor
101267800|NCT01797796|Capsaicin|capsaicin|mesh-list
101267801|NCT01797796|Antipruritics|antipruritics|mesh-ancestor
101267802|NCT01797796|Dermatologic Agents|dermatologic agents|mesh-ancestor
101267803|NCT01797796|Sensory System Agents|sensory system agents|mesh-ancestor
101267804|NCT01797796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101267805|NCT01797796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267806|NCT01798108|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
101267807|NCT01798108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101267808|NCT01798446|Axitinib|axitinib|mesh-list
101267809|NCT01798446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101267810|NCT01798446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101267811|NCT01798446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101267812|NCT01798446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267813|NCT01798680|Vitamin D|vitamin d|mesh-list
101267814|NCT01798680|Cholecalciferol|cholecalciferol|mesh-list
101267815|NCT01798680|Vitamins|vitamins|mesh-ancestor
101267816|NCT01798680|Micronutrients|micronutrients|mesh-ancestor
101267817|NCT01798680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267818|NCT01798680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101267819|NCT01798680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101267820|NCT01798836|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101267821|NCT01798836|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101267822|NCT01798836|Estradiol|estradiol|mesh-list
101267823|NCT01798836|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101267824|NCT01798836|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101267825|NCT01798836|Estrogens|estrogens|mesh-ancestor
101267826|NCT01798836|Hormones|hormones|mesh-ancestor
101267827|NCT01798836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101267828|NCT01798836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267829|NCT01798836|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101267830|NCT01798836|Contraceptive Agents|contraceptive agents|mesh-ancestor
101267831|NCT01798836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101267832|NCT01798836|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101267833|NCT01798901|Decitabine|decitabine|mesh-list
101267834|NCT01798901|Azacitidine|azacitidine|mesh-list
101267835|NCT01798901|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
101267836|NCT01798901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101267837|NCT01798901|Antimetabolites|antimetabolites|mesh-ancestor
101267838|NCT01798901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267839|NCT01798901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101267840|NCT01798901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101267841|NCT01799863|Ketorolac|ketorolac|mesh-list
101267842|NCT01799863|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101267843|NCT01799863|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101815812|NCT00057811|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101815814|NCT00057811|Prednisolone acetate|prednisolone acetate|mesh-list
101815815|NCT00057811|Hydrocortisone|hydrocortisone|mesh-list
101815816|NCT00057811|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101815817|NCT00057811|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101815818|NCT00057811|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101815819|NCT00057811|Cyclophosphamide|cyclophosphamide|mesh-list
101815820|NCT00057811|Rituximab|rituximab|mesh-list
101815821|NCT00057811|Doxorubicin|doxorubicin|mesh-list
101815822|NCT00057811|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101815823|NCT00057811|Methotrexate|methotrexate|mesh-list
101267844|NCT01799863|Lubricant Eye Drops|lubricant eye drops|mesh-list
101267845|NCT01799863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101267846|NCT01799863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101267847|NCT01799863|Analgesics|analgesics|mesh-ancestor
101267848|NCT01799863|Sensory System Agents|sensory system agents|mesh-ancestor
101267849|NCT01799863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101267850|NCT01799863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267851|NCT01799863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101267852|NCT01799863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101267853|NCT01799863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101267854|NCT01799863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101267855|NCT01799863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267856|NCT01799863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101267857|NCT01799863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101267858|NCT01799863|Laxatives|laxatives|mesh-ancestor
101267859|NCT01799863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101267860|NCT01800006|Rivaroxaban|rivaroxaban|mesh-list
101267861|NCT01800006|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101267862|NCT01800006|Antithrombins|antithrombins|mesh-ancestor
101267863|NCT01800006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101267864|NCT01800006|Protease Inhibitors|protease inhibitors|mesh-ancestor
101267865|NCT01800006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101267866|NCT01800006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267867|NCT01800006|Anticoagulants|anticoagulants|mesh-ancestor
101267869|NCT01800019|Varenicline|varenicline|mesh-list
101313771|NCT00000553|Vitamins|vitamins|mesh-ancestor
101267870|NCT01800019|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101267871|NCT01800019|Autonomic Agents|autonomic agents|mesh-ancestor
101267872|NCT01800019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101267873|NCT01800019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267874|NCT01800019|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101267875|NCT01800019|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101267876|NCT01800019|Cholinergic Agents|cholinergic agents|mesh-ancestor
101267877|NCT01800019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101267878|NCT01800019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267879|NCT01800097|Modafinil|modafinil|mesh-list
101267880|NCT01800097|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101267881|NCT01800097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267882|NCT01800097|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101267883|NCT01800097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101267884|NCT01800097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101267885|NCT01800097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267886|NCT01800227|Metformin|metformin|mesh-list
101267887|NCT01800227|Pioglitazone|pioglitazone|mesh-list
101267888|NCT01800227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101267889|NCT01800227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267890|NCT01800240|Metformin|metformin|mesh-list
101267891|NCT01800240|Pioglitazone|pioglitazone|mesh-list
101267892|NCT01800240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101267893|NCT01800240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267894|NCT01800292|Sildenafil Citrate|sildenafil citrate|mesh-list
101267895|NCT01800292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267896|NCT01800292|Vasodilator Agents|vasodilator agents|mesh-ancestor
101815825|NCT00057811|Vincristine|vincristine|mesh-list
101815826|NCT00057811|Etoposide phosphate|etoposide phosphate|mesh-list
101815827|NCT00057811|Rasburicase|rasburicase|mesh-list
101815828|NCT00057811|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101815829|NCT00057811|Prednisolone phosphate|prednisolone phosphate|mesh-list
101815830|NCT00057811|Levoleucovorin|levoleucovorin|mesh-list
101815831|NCT00057811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101815832|NCT00057811|Immunologic Factors|immunologic factors|mesh-ancestor
101267897|NCT01800292|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101267898|NCT01800292|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101267899|NCT01800292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101267900|NCT01800292|Urological Agents|urological agents|mesh-ancestor
101267901|NCT01800357|Aspirin|aspirin|mesh-list
101267902|NCT01800357|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
101267903|NCT01800357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101267904|NCT01800357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101267905|NCT01800357|Analgesics|analgesics|mesh-ancestor
101267906|NCT01800357|Sensory System Agents|sensory system agents|mesh-ancestor
101267907|NCT01800357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101267908|NCT01800357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267909|NCT01800357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101267910|NCT01800357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101267911|NCT01800357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101267912|NCT01800357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101267913|NCT01800357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267914|NCT01800357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101267915|NCT01800357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101267916|NCT01800357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101267917|NCT01800357|Antipyretics|antipyretics|mesh-ancestor
101267918|NCT01800357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101267920|NCT01800396|Caseins|caseins|mesh-list
101267921|NCT01800396|Chelating Agents|chelating agents|mesh-ancestor
101267922|NCT01800396|Sequestering Agents|sequestering agents|mesh-ancestor
101267923|NCT01800396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267924|NCT01800422|Progesterone|progesterone|mesh-list
101267925|NCT01800422|Progestins|progestins|mesh-ancestor
101267926|NCT01800422|Hormones|hormones|mesh-ancestor
101267927|NCT01800422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101267928|NCT01800422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267929|NCT01800435|Tranexamic Acid|tranexamic acid|mesh-list
101267930|NCT01800435|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
101267931|NCT01800435|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101267932|NCT01800435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101267933|NCT01800435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267934|NCT01800435|Hemostatics|hemostatics|mesh-ancestor
101267935|NCT01800435|Coagulants|coagulants|mesh-ancestor
101267936|NCT01800487|Silymarin|silymarin|mesh-list
101267937|NCT01800487|Antioxidants|antioxidants|mesh-ancestor
101267938|NCT01800487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267939|NCT01800487|Protective Agents|protective agents|mesh-ancestor
101267940|NCT01800487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267942|NCT01800526|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101267943|NCT01800526|Antiviral Agents|antiviral agents|mesh-ancestor
101267944|NCT01800526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101267945|NCT01800526|Expectorants|expectorants|mesh-ancestor
101267946|NCT01800526|Respiratory System Agents|respiratory system agents|mesh-ancestor
101267947|NCT01800526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101267948|NCT01800526|Antioxidants|antioxidants|mesh-ancestor
101267949|NCT01800526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267950|NCT01800526|Protective Agents|protective agents|mesh-ancestor
101267951|NCT01800526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267952|NCT01800526|Antidotes|antidotes|mesh-ancestor
101267953|NCT01800630|Gemcitabine|gemcitabine|mesh-list
101267954|NCT01800630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101267955|NCT01800630|Antimetabolites|antimetabolites|mesh-ancestor
101267956|NCT01800630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267957|NCT01800630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101815833|NCT00057811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815834|NCT00057811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101815835|NCT00057811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101815836|NCT00057811|Alkylating Agents|alkylating agents|mesh-ancestor
101815837|NCT00057811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815838|NCT00057811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101815839|NCT00057811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101815840|NCT00057811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101815841|NCT00057811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101815842|NCT00057811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101815843|NCT00057811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101815844|NCT00057811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101815845|NCT00057811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101267958|NCT01800643|Busulfan|busulfan|mesh-list
101267959|NCT01800643|Alkylating Agents|alkylating agents|mesh-ancestor
101267960|NCT01800643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267961|NCT01800643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101267962|NCT01800643|Immunologic Factors|immunologic factors|mesh-ancestor
101267963|NCT01800643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267964|NCT01800643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101267965|NCT01800643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101267967|NCT01800695|Temozolomide|temozolomide|mesh-list
101267968|NCT01800695|ABT-414|abt-414|mesh-list
101267969|NCT01800695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101267970|NCT01800695|Alkylating Agents|alkylating agents|mesh-ancestor
101267971|NCT01800695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267972|NCT01800695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101267973|NCT01800695|Immunoconjugates|immunoconjugates|mesh-ancestor
101267974|NCT01800695|Immunologic Factors|immunologic factors|mesh-ancestor
101267975|NCT01800695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267976|NCT01800708|Prednisolone|prednisolone|mesh-list
101267977|NCT01800708|Triamcinolone|triamcinolone|mesh-list
101267978|NCT01800708|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101267979|NCT01800708|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101267980|NCT01800708|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101267981|NCT01800708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101267982|NCT01800708|Glucocorticoids|glucocorticoids|mesh-ancestor
101267983|NCT01800708|Hormones|hormones|mesh-ancestor
101267984|NCT01800708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101267985|NCT01800708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267986|NCT01800708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101267987|NCT01800708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101267988|NCT01800708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101267989|NCT01800708|Immunologic Factors|immunologic factors|mesh-ancestor
101267990|NCT01800708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101267991|NCT01800708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267992|NCT01800747|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101267993|NCT01800747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101267994|NCT01800799|Anti-Infective Agents|anti-infective agents|mesh-list
101267996|NCT01800799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101267997|NCT01800799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101267998|NCT01800799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101267999|NCT01800799|Analgesics|analgesics|mesh-ancestor
101268000|NCT01800799|Sensory System Agents|sensory system agents|mesh-ancestor
101268001|NCT01800799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101268002|NCT01800799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268003|NCT01800799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101268004|NCT01800799|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101268005|NCT01800799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101815846|NCT00057811|Glucocorticoids|glucocorticoids|mesh-ancestor
101815847|NCT00057811|Hormones|hormones|mesh-ancestor
101815848|NCT00057811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101815849|NCT00057811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101815850|NCT00057811|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101815851|NCT00057811|Abortifacient Agents|abortifacient agents|mesh-ancestor
101815852|NCT00057811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101815853|NCT00057811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101815854|NCT00057811|Antimetabolites|antimetabolites|mesh-ancestor
101815855|NCT00057811|Dermatologic Agents|dermatologic agents|mesh-ancestor
101815856|NCT00057811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101268006|NCT01800799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101268007|NCT01800799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268008|NCT01800825|Clindamycin|clindamycin|mesh-list
101268009|NCT01800825|Clindamycin palmitate|clindamycin palmitate|mesh-list
101268010|NCT01800825|Clindamycin phosphate|clindamycin phosphate|mesh-list
101268011|NCT01800825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101268012|NCT01800825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101268013|NCT01800825|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101268014|NCT01800825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101268015|NCT01800825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268016|NCT01800942|Azithromycin|azithromycin|mesh-list
101268017|NCT01800942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101268018|NCT01800942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101268019|NCT01801046|Cytarabine|cytarabine|mesh-list
101268020|NCT01801046|Mitoxantrone|mitoxantrone|mesh-list
101268021|NCT01801046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101268022|NCT01801046|Antimetabolites|antimetabolites|mesh-ancestor
101268023|NCT01801046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268024|NCT01801046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101268025|NCT01801046|Antiviral Agents|antiviral agents|mesh-ancestor
101268026|NCT01801046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101268027|NCT01801046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101268028|NCT01801046|Immunologic Factors|immunologic factors|mesh-ancestor
101268029|NCT01801046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268030|NCT01801046|Analgesics|analgesics|mesh-ancestor
101268031|NCT01801046|Sensory System Agents|sensory system agents|mesh-ancestor
101268032|NCT01801046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101268033|NCT01801046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101268034|NCT01801046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101268035|NCT01801046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101268036|NCT01801137|Everolimus|everolimus|mesh-list
101268037|NCT01801137|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101268038|NCT01801137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101268039|NCT01801137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101268040|NCT01801137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268041|NCT01801137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101268042|NCT01801137|Immunologic Factors|immunologic factors|mesh-ancestor
101268043|NCT01801137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268044|NCT01801137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101268045|NCT01801163|Sorafenib|sorafenib|mesh-list
101268046|NCT01801163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101268047|NCT01801163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101268048|NCT01801163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101268049|NCT01801163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268050|NCT01801228|Eplerenone|eplerenone|mesh-list
101268051|NCT01801228|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101268052|NCT01801228|Hormone Antagonists|hormone antagonists|mesh-ancestor
101268053|NCT01801228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101268054|NCT01801228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815857|NCT00057811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101815858|NCT00057811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101815859|NCT00057811|Antiviral Agents|antiviral agents|mesh-ancestor
101815860|NCT00057811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101815861|NCT00057811|Antidotes|antidotes|mesh-ancestor
101815862|NCT00057811|Protective Agents|protective agents|mesh-ancestor
101815863|NCT00057811|Vitamin B Complex|vitamin b complex|mesh-ancestor
101815864|NCT00057811|Vitamins|vitamins|mesh-ancestor
101815865|NCT00057811|Micronutrients|micronutrients|mesh-ancestor
101815866|NCT00057811|Tubulin Modulators|tubulin modulators|mesh-ancestor
101815867|NCT00057811|Antimitotic Agents|antimitotic agents|mesh-ancestor
101815868|NCT00057811|Mitosis Modulators|mitosis modulators|mesh-ancestor
101815869|NCT00057811|Antiemetics|antiemetics|mesh-ancestor
101815870|NCT00057811|Autonomic Agents|autonomic agents|mesh-ancestor
101815871|NCT00057811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101815872|NCT00057811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101312264|NCT00007605|Amiodarone|amiodarone|mesh-list
101815873|NCT00057811|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101268055|NCT01801228|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101268056|NCT01801228|Diuretics|diuretics|mesh-ancestor
101268057|NCT01801228|Natriuretic Agents|natriuretic agents|mesh-ancestor
101268058|NCT01801228|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101268059|NCT01801410|Misoprostol|misoprostol|mesh-list
101268060|NCT01801410|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101268061|NCT01801410|Abortifacient Agents|abortifacient agents|mesh-ancestor
101268062|NCT01801410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101268063|NCT01801410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268064|NCT01801410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101268065|NCT01801410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101268066|NCT01801410|Oxytocics|oxytocics|mesh-ancestor
101268067|NCT01801423|Hydroxyurea|hydroxyurea|mesh-list
101268068|NCT01801423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101268069|NCT01801423|Antisickling Agents|antisickling agents|mesh-ancestor
101268070|NCT01801423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101268071|NCT01801423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268072|NCT01801423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101268074|NCT01801644|Gemcitabine|gemcitabine|mesh-list
101268075|NCT01801644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101268076|NCT01801644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101268077|NCT01801644|Antimetabolites|antimetabolites|mesh-ancestor
101268078|NCT01801644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268079|NCT01801774|Triamcinolone|triamcinolone|mesh-list
101268080|NCT01801774|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101268081|NCT01801774|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101268082|NCT01801774|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101268083|NCT01801774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101313778|NCT00000556|Verapamil|verapamil|mesh-list
101268085|NCT01801774|Hormones|hormones|mesh-ancestor
101268086|NCT01801774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101268087|NCT01801774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268088|NCT01801774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101268089|NCT01801774|Immunologic Factors|immunologic factors|mesh-ancestor
101268090|NCT01801774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101268091|NCT01801774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268092|NCT01802255|Midazolam|midazolam|mesh-list
101268093|NCT01802255|Sevoflurane|sevoflurane|mesh-list
101268094|NCT01802255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101268095|NCT01802255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101268096|NCT01802255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101815874|NCT00057811|Gout Suppressants|gout suppressants|mesh-ancestor
101815875|NCT03502148|Cisplatin|cisplatin|mesh-list
101815876|NCT03502148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101815877|NCT02530801|Bevacizumab|bevacizumab|mesh-list
101815878|NCT02530801|Fluorouracil|fluorouracil|mesh-list
101815879|NCT02530801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101815880|NCT02530801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101815881|NCT02530801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101815882|NCT02530801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101815883|NCT02530801|Growth Substances|growth substances|mesh-ancestor
101815884|NCT02530801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268097|NCT01802255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268098|NCT01802255|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101268099|NCT01802255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101268102|NCT01802255|Anesthetics, General|anesthetics, general|mesh-ancestor
101268103|NCT01802255|Anesthetics|anesthetics|mesh-ancestor
101268104|NCT01802255|GABA Modulators|gaba modulators|mesh-ancestor
101268105|NCT01802255|GABA Agents|gaba agents|mesh-ancestor
101268106|NCT01802255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101268107|NCT01802255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268108|NCT01802255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101268109|NCT01802255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101268110|NCT01802268|Sirolimus|sirolimus|mesh-list
101268111|NCT01802268|Tacrolimus|tacrolimus|mesh-list
101268112|NCT01802268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101268113|NCT01802268|Immunologic Factors|immunologic factors|mesh-ancestor
101268114|NCT01802268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268115|NCT01802268|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101268116|NCT01802268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101268117|NCT01802268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268118|NCT01802268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101268119|NCT01802268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101268120|NCT01802268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101268121|NCT01802268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101268122|NCT01802268|Antifungal Agents|antifungal agents|mesh-ancestor
101268123|NCT01802450|Dasatinib|dasatinib|mesh-list
101268124|NCT01802450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101268125|NCT01802450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101268126|NCT01802450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101268127|NCT01802450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268128|NCT01802476|Palbociclib|palbociclib|mesh-list
101268129|NCT01802476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101268130|NCT01802476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101268131|NCT01802476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101268132|NCT01802476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268133|NCT01802489|Amiloride|amiloride|mesh-list
101268134|NCT01802489|Diuretics|diuretics|mesh-ancestor
101268135|NCT01802489|Natriuretic Agents|natriuretic agents|mesh-ancestor
101268136|NCT01802489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268137|NCT01802489|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
101268138|NCT01802489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101268139|NCT01802489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101268140|NCT01802489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268141|NCT01802489|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101268142|NCT01802489|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101268143|NCT01802502|Rifampin|rifampin|mesh-list
101268144|NCT01802502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101268145|NCT01802502|Antitubercular Agents|antitubercular agents|mesh-ancestor
101268146|NCT01802502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101268147|NCT01802502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101268148|NCT01802502|Leprostatic Agents|leprostatic agents|mesh-ancestor
101268149|NCT01802502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101268150|NCT01802502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101268151|NCT01802502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815885|NCT02530801|Growth Inhibitors|growth inhibitors|mesh-ancestor
101815886|NCT02530801|Antimetabolites|antimetabolites|mesh-ancestor
101815887|NCT02530801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815888|NCT02530801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101815889|NCT02530801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101815890|NCT02530801|Immunologic Factors|immunologic factors|mesh-ancestor
101815891|NCT01091077|Naringenin|naringenin|mesh-list
101815892|NCT01091077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101815893|NCT01091077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101815894|NCT01091077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101815895|NCT01091077|Hormone Antagonists|hormone antagonists|mesh-ancestor
101815896|NCT01091077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101815897|NCT01091077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815898|NCT01094275|Omeprazole|omeprazole|mesh-list
101815899|NCT01094275|Clopidogrel|clopidogrel|mesh-list
101815900|NCT01094275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101815901|NCT01094275|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101815902|NCT01094275|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101815903|NCT01094275|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101815904|NCT01094275|Purinergic Agents|purinergic agents|mesh-ancestor
101815905|NCT01094275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101815906|NCT01094275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815907|NCT01094275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815908|NCT01094275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101815909|NCT01094275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101815910|NCT01094275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101815911|NCT01094275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101815912|NCT01089205|Metformin|metformin|mesh-list
101815913|NCT01089205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101815914|NCT01089205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815915|NCT02866682|Tacrolimus|tacrolimus|mesh-list
101815916|NCT02866682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101815917|NCT02866682|Immunologic Factors|immunologic factors|mesh-ancestor
101815918|NCT02866682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815919|NCT02866682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101815920|NCT02866682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101815921|NCT02866682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815922|NCT01089439|Nitric Oxide|nitric oxide|mesh-list
101815923|NCT01089439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101815924|NCT01089439|Autonomic Agents|autonomic agents|mesh-ancestor
101815925|NCT01089439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101815926|NCT01089439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815927|NCT01089439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101815928|NCT01089439|Respiratory System Agents|respiratory system agents|mesh-ancestor
101815929|NCT01089439|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101815930|NCT01089439|Antioxidants|antioxidants|mesh-ancestor
101815931|NCT01089439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815932|NCT01089439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101815933|NCT01089439|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101815934|NCT01089439|Vasodilator Agents|vasodilator agents|mesh-ancestor
101815935|NCT01089439|Gasotransmitters|gasotransmitters|mesh-ancestor
101815936|NCT01089439|Protective Agents|protective agents|mesh-ancestor
101313784|NCT00000556|Disopyramide|disopyramide|mesh-list
101268152|NCT01802502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101268153|NCT01802502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101268154|NCT01802502|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101268155|NCT01802502|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101268156|NCT01802502|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101268157|NCT01802502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101268158|NCT01802593|Methotrexate|methotrexate|mesh-list
101268159|NCT01802593|Mercaptopurine|mercaptopurine|mesh-list
101268160|NCT01802593|Azathioprine|azathioprine|mesh-list
101268161|NCT01802593|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101268162|NCT01802593|Abortifacient Agents|abortifacient agents|mesh-ancestor
101268163|NCT01802593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101268164|NCT01802593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268165|NCT01802593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101268166|NCT01802593|Antimetabolites|antimetabolites|mesh-ancestor
101268167|NCT01802593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268168|NCT01802593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101268169|NCT01802593|Dermatologic Agents|dermatologic agents|mesh-ancestor
101268170|NCT01802593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101268171|NCT01802593|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101268172|NCT01802593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101268173|NCT01802593|Immunologic Factors|immunologic factors|mesh-ancestor
101268174|NCT01802593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101268175|NCT01802593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101268176|NCT01802619|Nitric Oxide|nitric oxide|mesh-list
101268177|NCT01802619|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101268178|NCT01802619|Autonomic Agents|autonomic agents|mesh-ancestor
101268179|NCT01802619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101268180|NCT01802619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268181|NCT01802619|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101268182|NCT01802619|Respiratory System Agents|respiratory system agents|mesh-ancestor
101268183|NCT01802619|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101268184|NCT01802619|Antioxidants|antioxidants|mesh-ancestor
101268185|NCT01802619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268186|NCT01802619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101268187|NCT01802619|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101268188|NCT01802619|Vasodilator Agents|vasodilator agents|mesh-ancestor
101268189|NCT01802619|Gasotransmitters|gasotransmitters|mesh-ancestor
101815938|NCT00992030|Doxorubicin|doxorubicin|mesh-list
101815939|NCT00992030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101815940|NCT00992030|Dacarbazine|dacarbazine|mesh-list
101815941|NCT00992030|Bleomycin|bleomycin|mesh-list
101815942|NCT00992030|Vinblastine|vinblastine|mesh-list
101815943|NCT00992030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101815944|NCT00992030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101815945|NCT00992030|Immunologic Factors|immunologic factors|mesh-ancestor
101815946|NCT00992030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815947|NCT00992030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101815948|NCT00992030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101815949|NCT00992030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101815950|NCT00992030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101815951|NCT00992030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101815952|NCT00992030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815953|NCT00992030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101268190|NCT01802619|Protective Agents|protective agents|mesh-ancestor
101268191|NCT01802645|Leucovorin|leucovorin|mesh-list
101268192|NCT01802645|Folic Acid|folic acid|mesh-list
101268193|NCT01802645|Bevacizumab|bevacizumab|mesh-list
101268194|NCT01802645|Cetuximab|cetuximab|mesh-list
101268195|NCT01802645|Fluorouracil|fluorouracil|mesh-list
101268196|NCT01802645|Oxaliplatin|oxaliplatin|mesh-list
101268197|NCT01802645|Irinotecan|irinotecan|mesh-list
101268198|NCT01802645|Levoleucovorin|levoleucovorin|mesh-list
101268199|NCT01802645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101268200|NCT01802645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101268201|NCT01802645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101268202|NCT01802645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101268203|NCT01802645|Growth Substances|growth substances|mesh-ancestor
101268204|NCT01802645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268205|NCT01802645|Growth Inhibitors|growth inhibitors|mesh-ancestor
101268206|NCT01802645|Antimetabolites|antimetabolites|mesh-ancestor
101268207|NCT01802645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268208|NCT01802645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101268209|NCT01802645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101268210|NCT01802645|Immunologic Factors|immunologic factors|mesh-ancestor
101268211|NCT01802645|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101268212|NCT01802645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101268213|NCT01802645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101268214|NCT01802645|Antidotes|antidotes|mesh-ancestor
101268215|NCT01802645|Protective Agents|protective agents|mesh-ancestor
101268216|NCT01802645|Vitamin B Complex|vitamin b complex|mesh-ancestor
101268217|NCT01802645|Vitamins|vitamins|mesh-ancestor
101268218|NCT01802645|Micronutrients|micronutrients|mesh-ancestor
101268219|NCT01802645|Hematinics|hematinics|mesh-ancestor
101268220|NCT01802658|Zoledronic Acid|zoledronic acid|mesh-list
101268221|NCT01802658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101268222|NCT01802658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268223|NCT01802684|Aflibercept|aflibercept|mesh-list
101268224|NCT01802684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101268225|NCT01802684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101268226|NCT01802684|Growth Substances|growth substances|mesh-ancestor
101268227|NCT01802684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268228|NCT01802684|Growth Inhibitors|growth inhibitors|mesh-ancestor
101268229|NCT01802684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101268231|NCT01802814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101268232|NCT01802814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101268233|NCT01802892|Plerixafor|plerixafor|mesh-list
101268234|NCT01802892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101815954|NCT00992030|Alkylating Agents|alkylating agents|mesh-ancestor
101815955|NCT00992030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101815956|NCT00992030|Tubulin Modulators|tubulin modulators|mesh-ancestor
101815957|NCT00992030|Antimitotic Agents|antimitotic agents|mesh-ancestor
101815958|NCT00992030|Mitosis Modulators|mitosis modulators|mesh-ancestor
101815959|NCT01976390|Sirolimus|sirolimus|mesh-list
101815960|NCT01976390|Everolimus|everolimus|mesh-list
101815961|NCT01976390|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101268235|NCT01802892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101268236|NCT01802892|Antiviral Agents|antiviral agents|mesh-ancestor
101268237|NCT01802892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101268238|NCT01802918|Ritonavir|ritonavir|mesh-list
101268239|NCT01802918|GSK-2838232|gsk-2838232|mesh-list
101268240|NCT01802918|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101268241|NCT01802918|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101268242|NCT01802918|Protease Inhibitors|protease inhibitors|mesh-ancestor
101268243|NCT01802918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101268244|NCT01802918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268245|NCT01802918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101268246|NCT01802918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101268247|NCT01802918|Antiviral Agents|antiviral agents|mesh-ancestor
101268248|NCT01802918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101268249|NCT01802918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101268250|NCT01802918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101268251|NCT01802931|Ketoconazole|ketoconazole|mesh-list
101268252|NCT01802931|Antifungal Agents|antifungal agents|mesh-ancestor
101268253|NCT01802931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101268254|NCT01802931|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101268255|NCT01802931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101268256|NCT01802931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101268257|NCT01802931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268258|NCT01802931|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101268259|NCT01802931|Hormone Antagonists|hormone antagonists|mesh-ancestor
101268260|NCT01802931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101268261|NCT01802931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268262|NCT01802931|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101268263|NCT01802944|Insulin|insulin|mesh-list
101268264|NCT01802944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101268265|NCT01802944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268266|NCT01802970|Paclitaxel|paclitaxel|mesh-list
101268267|NCT01802970|Vinorelbine|vinorelbine|mesh-list
101268268|NCT01802970|Capecitabine|capecitabine|mesh-list
101268269|NCT01802970|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101268270|NCT01802970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101268271|NCT01802970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101268272|NCT01802970|Tubulin Modulators|tubulin modulators|mesh-ancestor
101268273|NCT01802970|Antimitotic Agents|antimitotic agents|mesh-ancestor
101268274|NCT01802970|Mitosis Modulators|mitosis modulators|mesh-ancestor
101268275|NCT01802970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268276|NCT01802970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101268277|NCT01802970|Antimetabolites|antimetabolites|mesh-ancestor
101268278|NCT01802970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101268279|NCT01803087|Formoterol Fumarate|formoterol fumarate|mesh-list
101268280|NCT01803087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101268281|NCT01803087|Autonomic Agents|autonomic agents|mesh-ancestor
101268282|NCT01803087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101268283|NCT01803087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268284|NCT01803087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101268285|NCT01803087|Respiratory System Agents|respiratory system agents|mesh-ancestor
101268286|NCT01803087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101268287|NCT01803087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101268288|NCT01803087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101268289|NCT01803087|Adrenergic Agents|adrenergic agents|mesh-ancestor
101268290|NCT01803087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101268291|NCT01803087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815962|NCT01976390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101815963|NCT01976390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101815964|NCT01976390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815965|NCT01976390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101815966|NCT01976390|Immunologic Factors|immunologic factors|mesh-ancestor
101815967|NCT01976390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815968|NCT01976390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101815969|NCT01976390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101815970|NCT01976390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101815971|NCT01976390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101815972|NCT01976390|Antifungal Agents|antifungal agents|mesh-ancestor
101815973|NCT00570713|Gemcitabine|gemcitabine|mesh-list
101815974|NCT00570713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101815975|NCT00570713|Antimetabolites|antimetabolites|mesh-ancestor
101815976|NCT00570713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815977|NCT00570713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101815978|NCT04002440|Candesartan cilexetil|candesartan cilexetil|mesh-list
101268292|NCT01803191|Ciprofloxacin|ciprofloxacin|mesh-list
101268293|NCT01803191|Fosfomycin|fosfomycin|mesh-list
101268294|NCT01803191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101268295|NCT01803191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101268296|NCT01803191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101268297|NCT01803191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101268298|NCT01803191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101268299|NCT01803191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268300|NCT01803191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101268301|NCT01803191|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101268302|NCT01803191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101268303|NCT01803321|Rilonacept|rilonacept|mesh-list
101268304|NCT01803321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101268305|NCT01803347|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101268306|NCT01803347|Hemostatics|hemostatics|mesh-ancestor
101268307|NCT01803347|Coagulants|coagulants|mesh-ancestor
101268308|NCT01803399|Moxifloxacin|moxifloxacin|mesh-list
101268309|NCT01803399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101268310|NCT01803399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101268311|NCT01803399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101268312|NCT01803399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101268313|NCT01803399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101268314|NCT01803399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268315|NCT01803399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101268316|NCT01803438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
101268317|NCT01803503|Docetaxel|docetaxel|mesh-list
101268318|NCT01803503|Sunitinib|sunitinib|mesh-list
101268319|NCT01803503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101268320|NCT01803503|Tubulin Modulators|tubulin modulators|mesh-ancestor
101268321|NCT01803503|Antimitotic Agents|antimitotic agents|mesh-ancestor
101268322|NCT01803503|Mitosis Modulators|mitosis modulators|mesh-ancestor
101268323|NCT01803503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268324|NCT01803503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101268325|NCT01803503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101268326|NCT01803503|Growth Substances|growth substances|mesh-ancestor
101268327|NCT01803503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268328|NCT01803503|Growth Inhibitors|growth inhibitors|mesh-ancestor
101268329|NCT01803503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101268330|NCT01803503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101815979|NCT04002440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101815980|NCT04002440|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101815981|NCT04002440|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101815982|NCT04002440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815983|NCT00780377|Bradykinin|bradykinin|mesh-list
101815984|NCT00780377|Kininogens|kininogens|mesh-list
101815985|NCT00780377|Vasodilator Agents|vasodilator agents|mesh-ancestor
101815986|NCT00780377|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
101815987|NCT00780377|Protease Inhibitors|protease inhibitors|mesh-ancestor
101815988|NCT00780377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101815989|NCT00780377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101815990|NCT05219942|Insulin|insulin|mesh-list
101815991|NCT05219942|Insulin Glargine|insulin glargine|mesh-list
101815992|NCT05219942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101815993|NCT05219942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101815994|NCT00669617|Fluticasone|fluticasone|mesh-list
101815995|NCT00669617|Xhance|xhance|mesh-list
101815996|NCT00669617|Albuterol|albuterol|mesh-list
101815997|NCT00669617|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101815998|NCT00669617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101815999|NCT00669617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101816000|NCT00669617|Autonomic Agents|autonomic agents|mesh-ancestor
101268332|NCT01803659|Retinol palmitate|retinol palmitate|mesh-list
101268333|NCT01803659|Carotenoids|carotenoids|mesh-list
101268334|NCT01803659|Antioxidants|antioxidants|mesh-ancestor
101268335|NCT01803659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268336|NCT01803659|Protective Agents|protective agents|mesh-ancestor
101268337|NCT01803659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268338|NCT01803659|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101268339|NCT01803659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101268340|NCT01803659|Vitamins|vitamins|mesh-ancestor
101268341|NCT01803659|Micronutrients|micronutrients|mesh-ancestor
101268342|NCT01803763|Omalizumab|omalizumab|mesh-list
101268343|NCT01803763|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101268344|NCT01803763|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101268345|NCT01803763|Respiratory System Agents|respiratory system agents|mesh-ancestor
101268346|NCT01803828|Tadalafil|tadalafil|mesh-list
101268347|NCT01803828|Vasodilator Agents|vasodilator agents|mesh-ancestor
101268348|NCT01803828|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101268349|NCT01803828|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101268350|NCT01803828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101268351|NCT01803828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268352|NCT01803828|Urological Agents|urological agents|mesh-ancestor
101268353|NCT01804127|Rituximab|rituximab|mesh-list
101268354|NCT01804127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101268355|NCT01804127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101268356|NCT01804127|Immunologic Factors|immunologic factors|mesh-ancestor
101268357|NCT01804127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268358|NCT01804127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101268359|NCT01804205|Magnesium Sulfate|magnesium sulfate|mesh-list
101268360|NCT01804205|Analgesics|analgesics|mesh-ancestor
101268361|NCT01804205|Sensory System Agents|sensory system agents|mesh-ancestor
101816001|NCT00669617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101816002|NCT00669617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816003|NCT00669617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101816004|NCT00669617|Respiratory System Agents|respiratory system agents|mesh-ancestor
101816006|NCT00669617|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101816007|NCT00669617|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101268362|NCT01804205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101268363|NCT01804205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268364|NCT01804205|Anesthetics|anesthetics|mesh-ancestor
101268365|NCT01804205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101268366|NCT01804205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101268367|NCT01804205|Anticonvulsants|anticonvulsants|mesh-ancestor
101268368|NCT01804205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101268370|NCT01804205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326201|NCT00115726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268371|NCT01804205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101268372|NCT01804205|Tocolytic Agents|tocolytic agents|mesh-ancestor
101268373|NCT01804205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101268374|NCT01804218|Nadolol|nadolol|mesh-list
101268375|NCT01804218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101268376|NCT01804218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101268377|NCT01804218|Adrenergic Agents|adrenergic agents|mesh-ancestor
101268378|NCT01804218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101268379|NCT01804218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268380|NCT01804218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268381|NCT01804218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101268382|NCT01804218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101268383|NCT01804218|Sympatholytics|sympatholytics|mesh-ancestor
101268384|NCT01804218|Autonomic Agents|autonomic agents|mesh-ancestor
101268385|NCT01804218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101268386|NCT01804244|Rilpivirine|rilpivirine|mesh-list
101268387|NCT01804244|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101268388|NCT01804244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101268389|NCT01804244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101268390|NCT01804244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268391|NCT01804244|Antiviral Agents|antiviral agents|mesh-ancestor
101268392|NCT01804244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101268393|NCT01804244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101268394|NCT01804244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101268395|NCT01804335|Trifarotene|trifarotene|mesh-list
101268396|NCT01804335|Dermatologic Agents|dermatologic agents|mesh-ancestor
101268397|NCT01804361|Cyclosporine|cyclosporine|mesh-list
101268398|NCT01804361|Cyclosporins|cyclosporins|mesh-list
101268399|NCT01804361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101268400|NCT01804361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268401|NCT01804361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101268402|NCT01804361|Immunologic Factors|immunologic factors|mesh-ancestor
101268403|NCT01804361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268404|NCT01804361|Antifungal Agents|antifungal agents|mesh-ancestor
101268405|NCT01804361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101268406|NCT01804361|Dermatologic Agents|dermatologic agents|mesh-ancestor
101268407|NCT01804361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101268410|NCT01804374|Sorafenib|sorafenib|mesh-list
101268411|NCT01804374|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101268412|NCT01804374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101268413|NCT01804374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101268414|NCT01804374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268415|NCT01804374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101268416|NCT01804374|Immunologic Factors|immunologic factors|mesh-ancestor
101268417|NCT01804374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268418|NCT01804374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101268419|NCT01804387|Lamivudine|lamivudine|mesh-list
101268420|NCT01804387|Adefovir|adefovir|mesh-list
101268421|NCT01804387|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101268422|NCT01804387|Telbivudine|telbivudine|mesh-list
101268423|NCT01804387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101816008|NCT00669617|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101816009|NCT00669617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101816010|NCT00669617|Adrenergic Agents|adrenergic agents|mesh-ancestor
101816011|NCT00669617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101816012|NCT00669617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816013|NCT00669617|Tocolytic Agents|tocolytic agents|mesh-ancestor
101816014|NCT00669617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101816015|NCT03979352|Empagliflozin|empagliflozin|mesh-list
101816016|NCT03979352|Pancrelipase|pancrelipase|mesh-list
101816017|NCT03979352|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101816018|NCT03979352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816019|NCT03979352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101816020|NCT03979352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816021|NCT03979352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101816023|NCT00773201|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101816024|NCT00773201|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101816025|NCT00773201|Adrenergic Agents|adrenergic agents|mesh-ancestor
101268424|NCT01804387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101268425|NCT01804387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101268426|NCT01804387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268427|NCT01804387|Antiviral Agents|antiviral agents|mesh-ancestor
101268428|NCT01804387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101268430|NCT01804387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101268431|NCT01804400|Montelukast|montelukast|mesh-list
101268432|NCT01804400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101268433|NCT01804400|Respiratory System Agents|respiratory system agents|mesh-ancestor
101268434|NCT01804400|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101268435|NCT01804400|Hormone Antagonists|hormone antagonists|mesh-ancestor
101268436|NCT01804400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101268437|NCT01804400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268438|NCT01804400|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101268439|NCT01804400|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101268440|NCT01804400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268441|NCT01804413|Insulin|insulin|mesh-list
101268442|NCT01804413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101268443|NCT01804413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101268444|NCT01804413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268445|NCT01804543|Ranolazine|ranolazine|mesh-list
101268446|NCT01804543|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101268447|NCT01804543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101268448|NCT01804543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268449|NCT01804595|Sunscreening Agents|sunscreening agents|mesh-list
101268450|NCT01804595|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101268451|NCT01804595|Protective Agents|protective agents|mesh-ancestor
101268452|NCT01804595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268453|NCT01804595|Dermatologic Agents|dermatologic agents|mesh-ancestor
101268454|NCT01804712|Rituximab|rituximab|mesh-list
101268455|NCT01804712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101268456|NCT01804712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101268457|NCT01804712|Immunologic Factors|immunologic factors|mesh-ancestor
101268458|NCT01804712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268459|NCT01804712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101268460|NCT01804777|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101268461|NCT01804777|Amiloride|amiloride|mesh-list
101268462|NCT01804777|Diuretics|diuretics|mesh-ancestor
101268463|NCT01804777|Natriuretic Agents|natriuretic agents|mesh-ancestor
101816026|NCT00773201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101816027|NCT00773201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816028|NCT00773201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816029|NCT00773201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101816030|NCT00773201|Sympatholytics|sympatholytics|mesh-ancestor
101816031|NCT00773201|Autonomic Agents|autonomic agents|mesh-ancestor
101816032|NCT00773201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101816033|NCT00777413|Minocycline|minocycline|mesh-list
101816034|NCT00777413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101816035|NCT00777413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101816036|NCT05162690|Dapagliflozin|dapagliflozin|mesh-list
101816037|NCT05162690|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101816038|NCT05162690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816039|NCT05162690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101816040|NCT05162690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268464|NCT01804777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268465|NCT01804777|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
101268466|NCT01804777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101268467|NCT01804777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101268468|NCT01804777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268469|NCT01804777|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101268470|NCT01804777|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101268471|NCT01804777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101268472|NCT01804777|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101268475|NCT01804985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101268476|NCT01804985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101268477|NCT01804985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101268478|NCT01804985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268479|NCT01805115|Misoprostol|misoprostol|mesh-list
101268480|NCT01805115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101268481|NCT01805115|Abortifacient Agents|abortifacient agents|mesh-ancestor
101268482|NCT01805115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101268483|NCT01805115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268484|NCT01805115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101268485|NCT01805115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101268486|NCT01805115|Oxytocics|oxytocics|mesh-ancestor
101268487|NCT01805232|Artesunate|artesunate|mesh-list
101268488|NCT01805232|Quinine|quinine|mesh-list
101268489|NCT01805232|Antimalarials|antimalarials|mesh-ancestor
101268490|NCT01805232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101268491|NCT01805232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101268492|NCT01805232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101268493|NCT01805232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101268494|NCT01805232|Antiviral Agents|antiviral agents|mesh-ancestor
101268495|NCT01805232|Schistosomicides|schistosomicides|mesh-ancestor
101268496|NCT01805232|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101268497|NCT01805232|Anthelmintics|anthelmintics|mesh-ancestor
101268498|NCT01805232|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101268499|NCT01805232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268500|NCT01805232|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101268501|NCT01805232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101268502|NCT01805232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101268503|NCT01805232|Analgesics|analgesics|mesh-ancestor
101268504|NCT01805232|Sensory System Agents|sensory system agents|mesh-ancestor
101268505|NCT01805258|Efavirenz|efavirenz|mesh-list
101268506|NCT01805258|Nevirapine|nevirapine|mesh-list
101268507|NCT01805258|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101268508|NCT01805258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101816041|NCT00992576|Hydromorphone|hydromorphone|mesh-list
101816042|NCT00992576|Naloxone|naloxone|mesh-list
101816043|NCT00992576|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101816044|NCT00992576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816045|NCT00992576|Sensory System Agents|sensory system agents|mesh-ancestor
101816046|NCT00992576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101816047|NCT00992576|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101816048|NCT00992576|Narcotics|narcotics|mesh-ancestor
101816049|NCT00992576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101268509|NCT01805258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101268510|NCT01805258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268511|NCT01805258|Antiviral Agents|antiviral agents|mesh-ancestor
101268512|NCT01805258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101268513|NCT01805258|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101268514|NCT01805258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101268515|NCT01805258|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101268516|NCT01805258|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101268517|NCT01805258|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101268518|NCT01805258|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101268519|NCT01805258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101268520|NCT01805258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101268521|NCT01805310|Magnesium citrate|magnesium citrate|mesh-list
101268522|NCT01805310|Cathartics|cathartics|mesh-ancestor
101268523|NCT01805310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101268524|NCT01805388|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101268525|NCT01805388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101268527|NCT01807741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101268528|NCT01807741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101268529|NCT01807741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101268530|NCT01807741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268531|NCT01807741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101268535|NCT01807767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101268536|NCT01807767|Immunologic Factors|immunologic factors|mesh-ancestor
101268537|NCT01807767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268538|NCT01807767|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101268539|NCT01807767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101268540|NCT01807767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268541|NCT01807767|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101268542|NCT01807767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101268543|NCT01807767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101268544|NCT01807767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101268545|NCT01807767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101268546|NCT01807767|Antitubercular Agents|antitubercular agents|mesh-ancestor
101268547|NCT01807767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101268548|NCT01807767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101268549|NCT01807832|Capsaicin|capsaicin|mesh-list
101268550|NCT01807832|Antipruritics|antipruritics|mesh-ancestor
101268551|NCT01807832|Dermatologic Agents|dermatologic agents|mesh-ancestor
101268552|NCT01807832|Sensory System Agents|sensory system agents|mesh-ancestor
101268553|NCT01807832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101268554|NCT01807832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268555|NCT01807910|Choline|choline|mesh-list
101268556|NCT01807910|Lipotropic Agents|lipotropic agents|mesh-ancestor
101268557|NCT01807910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101268558|NCT01807910|Antimetabolites|antimetabolites|mesh-ancestor
101268559|NCT01807910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268560|NCT01807910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101268561|NCT01807910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101268562|NCT01807910|Nootropic Agents|nootropic agents|mesh-ancestor
101268563|NCT01807962|Lidocaine|lidocaine|mesh-list
101268564|NCT01807962|Anesthetics, Local|anesthetics, local|mesh-ancestor
101268565|NCT01807962|Anesthetics|anesthetics|mesh-ancestor
101268566|NCT01807962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101268567|NCT01807962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816051|NCT00777569|Nicotine|nicotine|mesh-list
101816052|NCT00777569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101816053|NCT00777569|Autonomic Agents|autonomic agents|mesh-ancestor
101816054|NCT00777569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101816055|NCT00777569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816056|NCT00777569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101816057|NCT00777569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101816058|NCT00777569|Cholinergic Agents|cholinergic agents|mesh-ancestor
101816059|NCT00777569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101816060|NCT00777569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816061|NCT02556593|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101816062|NCT02556593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101816063|NCT02556593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101816065|NCT02556593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268568|NCT01807962|Sensory System Agents|sensory system agents|mesh-ancestor
101268569|NCT01807962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101268570|NCT01807962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101268571|NCT01807962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101268572|NCT01807962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101268573|NCT01807962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101268574|NCT01807962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268575|NCT01808014|Nefopam|nefopam|mesh-list
101268576|NCT01808014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101268577|NCT01808014|Analgesics|analgesics|mesh-ancestor
101268578|NCT01808014|Sensory System Agents|sensory system agents|mesh-ancestor
101268579|NCT01808014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101268580|NCT01808014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268581|NCT01808131|Lesinurad|lesinurad|mesh-list
101268582|NCT01808131|Gout Suppressants|gout suppressants|mesh-ancestor
101268583|NCT01808131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101268584|NCT01808131|Uricosuric Agents|uricosuric agents|mesh-ancestor
101268585|NCT01808300|Thioctic Acid|thioctic acid|mesh-list
101268586|NCT01808300|Pregabalin|pregabalin|mesh-list
101268587|NCT01808300|Analgesics|analgesics|mesh-ancestor
101268588|NCT01808300|Sensory System Agents|sensory system agents|mesh-ancestor
101268589|NCT01808300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101268590|NCT01808300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268591|NCT01808300|Anticonvulsants|anticonvulsants|mesh-ancestor
101268592|NCT01808300|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101268593|NCT01808300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101268595|NCT01808300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101268596|NCT01808300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101268597|NCT01808300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101268598|NCT01808300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101268599|NCT01808300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101268600|NCT01808300|Antioxidants|antioxidants|mesh-ancestor
101268601|NCT01808300|Protective Agents|protective agents|mesh-ancestor
101268602|NCT01808300|Vitamin B Complex|vitamin b complex|mesh-ancestor
101268603|NCT01808300|Vitamins|vitamins|mesh-ancestor
101268604|NCT01808300|Micronutrients|micronutrients|mesh-ancestor
101268605|NCT01808469|Antibodies|antibodies|mesh-list
101268606|NCT01808469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101268607|NCT01808469|Immunologic Factors|immunologic factors|mesh-ancestor
101268608|NCT01808469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268609|NCT01808495|Mitomycins|mitomycins|mesh-list
101268610|NCT01808495|Mitomycin|mitomycin|mesh-list
101268611|NCT01808495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101268612|NCT01808495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101816066|NCT00535730|Vaccines|vaccines|mesh-list
101816067|NCT00535730|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101816068|NCT00535730|Immunologic Factors|immunologic factors|mesh-ancestor
101816069|NCT00535730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816070|NCT00992654|Maraviroc|maraviroc|mesh-list
101816071|NCT00992654|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101816072|NCT00992654|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101816073|NCT00992654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816074|NCT00992654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101816075|NCT00992654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101816076|NCT00992654|Antiviral Agents|antiviral agents|mesh-ancestor
101816077|NCT00992654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101816078|NCT00992654|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101816079|NCT00773591|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101816080|NCT00773591|Botulinum Toxins|botulinum toxins|mesh-list
101816081|NCT00773591|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101816082|NCT00773591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101816083|NCT00773591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101816084|NCT00773591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268613|NCT01808495|Alkylating Agents|alkylating agents|mesh-ancestor
101268614|NCT01808495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268615|NCT01808495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101268616|NCT01808495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101268617|NCT01808521|Acetylcysteine|acetylcysteine|mesh-list
101268618|NCT01808521|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101268619|NCT01808521|Antiviral Agents|antiviral agents|mesh-ancestor
101268620|NCT01808521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101268621|NCT01808521|Expectorants|expectorants|mesh-ancestor
101268622|NCT01808521|Respiratory System Agents|respiratory system agents|mesh-ancestor
101268623|NCT01808521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101268624|NCT01808521|Antioxidants|antioxidants|mesh-ancestor
101268625|NCT01808521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268626|NCT01808521|Protective Agents|protective agents|mesh-ancestor
101268627|NCT01808521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268628|NCT01808521|Antidotes|antidotes|mesh-ancestor
101268629|NCT01808586|Dexamethasone|dexamethasone|mesh-list
101268630|NCT01808586|Betamethasone|betamethasone|mesh-list
101268631|NCT01808586|Lidocaine|lidocaine|mesh-list
101268632|NCT01808586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101268633|NCT01808586|Antiemetics|antiemetics|mesh-ancestor
101268634|NCT01808586|Autonomic Agents|autonomic agents|mesh-ancestor
101268635|NCT01808586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101268636|NCT01808586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268637|NCT01808586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101268638|NCT01808586|Glucocorticoids|glucocorticoids|mesh-ancestor
101268639|NCT01808586|Hormones|hormones|mesh-ancestor
101268640|NCT01808586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101268641|NCT01808586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101268642|NCT01808586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101268643|NCT01808586|Anesthetics, Local|anesthetics, local|mesh-ancestor
101268644|NCT01808586|Anesthetics|anesthetics|mesh-ancestor
101268645|NCT01808586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101268646|NCT01808586|Sensory System Agents|sensory system agents|mesh-ancestor
101268647|NCT01808586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101268648|NCT01808586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101268649|NCT01808586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101816085|NCT00773591|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101816086|NCT00773591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101816087|NCT00773591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816088|NCT00773591|Cholinergic Agents|cholinergic agents|mesh-ancestor
101816089|NCT00773591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101816091|NCT00995306|Antipruritics|antipruritics|mesh-ancestor
101816092|NCT00995306|Dermatologic Agents|dermatologic agents|mesh-ancestor
101816093|NCT00995306|Sensory System Agents|sensory system agents|mesh-ancestor
101816094|NCT00995306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101816095|NCT00995306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816096|NCT00666965|Rotigotine|rotigotine|mesh-list
101816097|NCT00666965|Dopamine Agonists|dopamine agonists|mesh-ancestor
101268650|NCT01808586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101268651|NCT01808586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268652|NCT01808586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101268653|NCT01808586|Respiratory System Agents|respiratory system agents|mesh-ancestor
101268655|NCT01808638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101268656|NCT01808638|Antimetabolites|antimetabolites|mesh-ancestor
101268657|NCT01808638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268658|NCT01808638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101268660|NCT01808768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101268661|NCT01808768|Histamine Antagonists|histamine antagonists|mesh-ancestor
101268662|NCT01808768|Histamine Agents|histamine agents|mesh-ancestor
101268663|NCT01808768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101268664|NCT01808768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268665|NCT01808768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268666|NCT01808898|Bupivacaine|bupivacaine|mesh-list
101268667|NCT01808898|Anesthetics, Local|anesthetics, local|mesh-list
101268668|NCT01808898|Mepivacaine|mepivacaine|mesh-list
101268669|NCT01808898|Anesthetics|anesthetics|mesh-list
101268670|NCT01808898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101268671|NCT01808898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268672|NCT01808898|Sensory System Agents|sensory system agents|mesh-ancestor
101268673|NCT01808898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101268674|NCT01808911|Cyclophosphamide|cyclophosphamide|mesh-list
101268676|NCT01808911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101268677|NCT01808911|Immunologic Factors|immunologic factors|mesh-ancestor
101268678|NCT01808911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268679|NCT01808911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101268680|NCT01808911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101268681|NCT01808911|Alkylating Agents|alkylating agents|mesh-ancestor
101268682|NCT01808911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268683|NCT01808911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101268684|NCT01808911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101268685|NCT01808911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101268686|NCT01809158|Minocycline|minocycline|mesh-list
101268687|NCT01809158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101268688|NCT01809158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101268689|NCT01809171|Vitamin D|vitamin d|mesh-list
101268690|NCT01809171|Cholecalciferol|cholecalciferol|mesh-list
101268691|NCT01809171|Vitamins|vitamins|mesh-ancestor
101268692|NCT01809171|Micronutrients|micronutrients|mesh-ancestor
101268693|NCT01809171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268694|NCT01809171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101268695|NCT01809171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101268696|NCT01809184|Insulin|insulin|mesh-list
101268697|NCT01809184|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101268698|NCT01809184|Insulin Glargine|insulin glargine|mesh-list
101268699|NCT01809184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101268700|NCT01809184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816098|NCT00666965|Dopamine Agents|dopamine agents|mesh-ancestor
101816099|NCT00666965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101816100|NCT00666965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816101|NCT00666965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816102|NCT00781157|Phenylephrine|phenylephrine|mesh-list
101816103|NCT00781157|Oxymetazoline|oxymetazoline|mesh-list
101816104|NCT00781157|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101816105|NCT00781157|Mydriatics|mydriatics|mesh-ancestor
101816106|NCT00781157|Autonomic Agents|autonomic agents|mesh-ancestor
101816107|NCT00781157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101268701|NCT01809301|Niacin|niacin|mesh-list
101268702|NCT01809301|Nicotinic Acids|nicotinic acids|mesh-list
101268703|NCT01809301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101268704|NCT01809301|Antimetabolites|antimetabolites|mesh-ancestor
101268705|NCT01809301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268706|NCT01809301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101268708|NCT01809301|Vitamin B Complex|vitamin b complex|mesh-ancestor
101268709|NCT01809301|Vitamins|vitamins|mesh-ancestor
101268710|NCT01809301|Micronutrients|micronutrients|mesh-ancestor
101268711|NCT01809301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268712|NCT01809340|Minocycline|minocycline|mesh-list
101268713|NCT01809340|Ketamine|ketamine|mesh-list
101268714|NCT01809340|Analgesics|analgesics|mesh-ancestor
101268715|NCT01809340|Sensory System Agents|sensory system agents|mesh-ancestor
101268716|NCT01809340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101268717|NCT01809340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268718|NCT01809340|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101268719|NCT01809340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101268720|NCT01809340|Anesthetics, General|anesthetics, general|mesh-ancestor
101268721|NCT01809340|Anesthetics|anesthetics|mesh-ancestor
101268722|NCT01809340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101268723|NCT01809340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101268724|NCT01809340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101268725|NCT01809340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101268726|NCT01809340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268727|NCT01809340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101268728|NCT01809340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101268729|NCT01809392|Decitabine|decitabine|mesh-list
101268730|NCT01809392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101268731|NCT01809392|Antimetabolites|antimetabolites|mesh-ancestor
101268732|NCT01809392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268733|NCT01809392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101268734|NCT01809392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101268735|NCT01809444|Doxycycline|doxycycline|mesh-list
101268737|NCT01809444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101268738|NCT01809444|Glucocorticoids|glucocorticoids|mesh-ancestor
101268739|NCT01809444|Hormones|hormones|mesh-ancestor
101268740|NCT01809444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101268741|NCT01809444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268742|NCT01809444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101268743|NCT01809444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101268744|NCT01809444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101268745|NCT01809444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101268746|NCT01809444|Antimalarials|antimalarials|mesh-ancestor
101268747|NCT01809444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101268748|NCT01809444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101268749|NCT01809626|Zolpidem|zolpidem|mesh-list
101268750|NCT01809626|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101268751|NCT01809626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101268752|NCT01809626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101268753|NCT01809626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268754|NCT01809626|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101268755|NCT01809626|GABA Agonists|gaba agonists|mesh-ancestor
101268756|NCT01809626|GABA Agents|gaba agents|mesh-ancestor
101268757|NCT01809626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101268758|NCT01809626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816108|NCT00781157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816109|NCT00781157|Sympathomimetics|sympathomimetics|mesh-ancestor
101816110|NCT00781157|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101816111|NCT00781157|Nasal Decongestants|nasal decongestants|mesh-ancestor
101816112|NCT00781157|Respiratory System Agents|respiratory system agents|mesh-ancestor
101816113|NCT00781157|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101816114|NCT00781157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101816115|NCT00781157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101816116|NCT00781157|Adrenergic Agents|adrenergic agents|mesh-ancestor
101268759|NCT01809743|Adenosine|adenosine|mesh-list
101268760|NCT01809743|Regadenoson|regadenoson|mesh-list
101268761|NCT01809743|Analgesics|analgesics|mesh-ancestor
101268762|NCT01809743|Sensory System Agents|sensory system agents|mesh-ancestor
101268763|NCT01809743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101268764|NCT01809743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268765|NCT01809743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101268766|NCT01809743|Vasodilator Agents|vasodilator agents|mesh-ancestor
101268767|NCT01809743|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101268768|NCT01809743|Purinergic Agonists|purinergic agonists|mesh-ancestor
101268769|NCT01809743|Purinergic Agents|purinergic agents|mesh-ancestor
101268770|NCT01809743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101268771|NCT01809743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268772|NCT01809743|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
101268773|NCT01809847|Ofatumumab|ofatumumab|mesh-list
101268774|NCT01809847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101268775|NCT01809860|Sirolimus|sirolimus|mesh-list
101268776|NCT01809860|Isavuconazole|isavuconazole|mesh-list
101268777|NCT01809860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101268778|NCT01809860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101268779|NCT01809860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101268780|NCT01809860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101268781|NCT01809860|Antifungal Agents|antifungal agents|mesh-ancestor
101268782|NCT01809860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101268783|NCT01809860|Immunologic Factors|immunologic factors|mesh-ancestor
101268784|NCT01809860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268785|NCT01809886|Neostigmine|neostigmine|mesh-list
101268786|NCT01809886|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101268787|NCT01809886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101268788|NCT01809886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268789|NCT01809886|Cholinergic Agents|cholinergic agents|mesh-ancestor
101268790|NCT01809886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101407916|NCT00108251|Eplerenone|eplerenone|mesh-list
101268791|NCT01809886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268792|NCT01809886|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101268793|NCT01809886|Autonomic Agents|autonomic agents|mesh-ancestor
101268794|NCT01809886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101268795|NCT01809925|Psyllium|psyllium|mesh-list
101268796|NCT01809925|Calcium polycarbophil|calcium polycarbophil|mesh-list
101268797|NCT01809925|Cathartics|cathartics|mesh-ancestor
101268798|NCT01809925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101268799|NCT01809925|Antidiarrheals|antidiarrheals|mesh-ancestor
101268800|NCT01810185|Naltrexone|naltrexone|mesh-list
101268801|NCT01810185|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101268802|NCT01810185|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101268803|NCT01810185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268804|NCT01810185|Sensory System Agents|sensory system agents|mesh-ancestor
101313889|NCT00000640|Clindamycin|clindamycin|mesh-list
101268805|NCT01810185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101268806|NCT01810237|Dabigatran|dabigatran|mesh-list
101268807|NCT01810237|Antithrombins|antithrombins|mesh-ancestor
101268808|NCT01810237|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101268809|NCT01810237|Protease Inhibitors|protease inhibitors|mesh-ancestor
101268810|NCT01810237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101268811|NCT01810237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268812|NCT01810237|Anticoagulants|anticoagulants|mesh-ancestor
101268813|NCT01810315|Estradiol|estradiol|mesh-list
101268814|NCT01810315|Estrogens|estrogens|mesh-ancestor
101268815|NCT01810315|Hormones|hormones|mesh-ancestor
101816117|NCT00781157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101816118|NCT00781157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816119|NCT00781157|Protective Agents|protective agents|mesh-ancestor
101816120|NCT00777959|Sirolimus|sirolimus|mesh-list
101816121|NCT00777959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101816122|NCT00777959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101816123|NCT00777959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101816124|NCT00777959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101816125|NCT00777959|Antifungal Agents|antifungal agents|mesh-ancestor
101816126|NCT00777959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101816127|NCT00777959|Immunologic Factors|immunologic factors|mesh-ancestor
101268816|NCT01810315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101268817|NCT01810315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268818|NCT01810354|Cefazolin|cefazolin|mesh-list
101268819|NCT01810354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101268820|NCT01810354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101268821|NCT01810367|Cisplatin|cisplatin|mesh-list
101268822|NCT01810367|Gemcitabine|gemcitabine|mesh-list
101268823|NCT01810367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101268824|NCT01810367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101268825|NCT01810367|Antimetabolites|antimetabolites|mesh-ancestor
101268826|NCT01810367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268827|NCT01810393|Trastuzumab|trastuzumab|mesh-list
101268828|NCT01810393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101268829|NCT01810393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101268830|NCT01810458|Acetaminophen|acetaminophen|mesh-list
101268831|NCT01810458|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
101268832|NCT01810458|Lidocaine|lidocaine|mesh-list
101268833|NCT01810458|Fentanyl|fentanyl|mesh-list
101268834|NCT01810458|Midazolam|midazolam|mesh-list
101268835|NCT01810458|Oxycodone|oxycodone|mesh-list
101268836|NCT01810458|Lorazepam|lorazepam|mesh-list
101268837|NCT01810458|Ondansetron|ondansetron|mesh-list
101268838|NCT01810458|Liver Extracts|liver extracts|mesh-list
101268839|NCT01810458|Anesthetics, Local|anesthetics, local|mesh-ancestor
101268840|NCT01810458|Anesthetics|anesthetics|mesh-ancestor
101268841|NCT01810458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101268842|NCT01810458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268843|NCT01810458|Sensory System Agents|sensory system agents|mesh-ancestor
101268844|NCT01810458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101268845|NCT01810458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101268846|NCT01810458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101268847|NCT01810458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101268848|NCT01810458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101268849|NCT01810458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268850|NCT01810458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101268851|NCT01810458|Narcotics|narcotics|mesh-ancestor
101268852|NCT01810458|Analgesics|analgesics|mesh-ancestor
101268853|NCT01810458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101268854|NCT01810458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101268855|NCT01810458|Anesthetics, General|anesthetics, general|mesh-ancestor
101268856|NCT01810458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101268857|NCT01810458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101268858|NCT01810458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101268859|NCT01810458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101268860|NCT01810458|GABA Modulators|gaba modulators|mesh-ancestor
101268861|NCT01810458|GABA Agents|gaba agents|mesh-ancestor
101268862|NCT01810458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101268863|NCT01810458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101268864|NCT01810458|Antipyretics|antipyretics|mesh-ancestor
101268865|NCT01810458|Hematinics|hematinics|mesh-ancestor
101268866|NCT01810458|Antiemetics|antiemetics|mesh-ancestor
101268867|NCT01810458|Autonomic Agents|autonomic agents|mesh-ancestor
101268868|NCT01810458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101268869|NCT01810458|Antipruritics|antipruritics|mesh-ancestor
101268870|NCT01810458|Dermatologic Agents|dermatologic agents|mesh-ancestor
101816128|NCT00777959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816129|NCT00778037|Cyclobenzaprine|cyclobenzaprine|mesh-list
101816130|NCT00778037|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101816131|NCT00778037|Antidepressive Agents|antidepressive agents|mesh-ancestor
101816132|NCT00778037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101816133|NCT00778037|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101816134|NCT00778037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816135|NCT00778037|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101816136|NCT00778037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101816137|NCT00778037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101816138|NCT00778037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101816139|NCT00778115|Simethicone|simethicone|mesh-list
101816140|NCT00778115|Loperamide|loperamide|mesh-list
101816141|NCT00778115|Antidiarrheals|antidiarrheals|mesh-list
101816142|NCT00778115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101816143|NCT00778115|Antifoaming Agents|antifoaming agents|mesh-ancestor
101816144|NCT00778115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816145|NCT00778115|Emollients|emollients|mesh-ancestor
101816146|NCT00778115|Dermatologic Agents|dermatologic agents|mesh-ancestor
101816147|NCT00993122|Ribavirin|ribavirin|mesh-list
101816148|NCT00993122|Antimetabolites|antimetabolites|mesh-ancestor
101268871|NCT01810458|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101268872|NCT01810458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101268873|NCT01810458|Serotonin Agents|serotonin agents|mesh-ancestor
101268874|NCT01810458|Anticonvulsants|anticonvulsants|mesh-ancestor
101268875|NCT01810458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101268876|NCT01810458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101268877|NCT01810458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101268878|NCT01810549|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101268879|NCT01810549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101268880|NCT01810601|Progesterone|progesterone|mesh-list
101268881|NCT01810601|Progestins|progestins|mesh-ancestor
101268882|NCT01810601|Hormones|hormones|mesh-ancestor
101268883|NCT01810601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101268884|NCT01810601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268885|NCT01810640|Liver Extracts|liver extracts|mesh-list
101268886|NCT01810640|Hematinics|hematinics|mesh-ancestor
101268887|NCT01810731|Vaccines|vaccines|mesh-list
101268888|NCT01810731|Immunologic Factors|immunologic factors|mesh-ancestor
101268890|NCT01810770|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
101268891|NCT01810770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101268892|NCT01810796|Ranolazine|ranolazine|mesh-list
101268893|NCT01810796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101268894|NCT01810796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101268895|NCT01810796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268897|NCT01810809|Hyaluronic Acid|hyaluronic acid|mesh-list
101268898|NCT01810809|Viscosupplements|viscosupplements|mesh-ancestor
101268899|NCT01810809|Protective Agents|protective agents|mesh-ancestor
101268900|NCT01810809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268901|NCT01810809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101268902|NCT01810809|Immunologic Factors|immunologic factors|mesh-ancestor
101268903|NCT01810848|Hyaluronic Acid|hyaluronic acid|mesh-list
101268905|NCT01810848|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101816149|NCT00993122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816150|NCT00993122|Antiviral Agents|antiviral agents|mesh-ancestor
101816151|NCT00993122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101816152|NCT00778193|Aspirin|aspirin|mesh-list
101816153|NCT00778193|Celecoxib|celecoxib|mesh-list
101816154|NCT00778193|Naproxen|naproxen|mesh-list
101816155|NCT00778193|Clopidogrel|clopidogrel|mesh-list
101816156|NCT00778193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101268907|NCT01810848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268909|NCT01810848|Protective Agents|protective agents|mesh-ancestor
101268910|NCT01810887|Ritonavir|ritonavir|mesh-list
101268911|NCT01810887|Darunavir|darunavir|mesh-list
101268912|NCT01810887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101268913|NCT01810887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101268914|NCT01810887|Protease Inhibitors|protease inhibitors|mesh-ancestor
101268915|NCT01810887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101268916|NCT01810887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268917|NCT01810887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101268918|NCT01810887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101268919|NCT01810887|Antiviral Agents|antiviral agents|mesh-ancestor
101268920|NCT01810887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101268921|NCT01810887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101268922|NCT01810887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101268923|NCT01810926|Cyclosporine|cyclosporine|mesh-list
101268924|NCT01810926|Rituximab|rituximab|mesh-list
101268925|NCT01810926|Methotrexate|methotrexate|mesh-list
101268926|NCT01810926|Fludarabine|fludarabine|mesh-list
101268927|NCT01810926|Thiotepa|thiotepa|mesh-list
101268929|NCT01810926|Antibodies|antibodies|mesh-list
101268930|NCT01810926|Cyclosporins|cyclosporins|mesh-list
101268931|NCT01810926|Immunologic Factors|immunologic factors|mesh-ancestor
101268932|NCT01810926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268933|NCT01810926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101268934|NCT01810926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101268935|NCT01810926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101268936|NCT01810926|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101268937|NCT01810926|Abortifacient Agents|abortifacient agents|mesh-ancestor
101268938|NCT01810926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101268939|NCT01810926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101268940|NCT01810926|Antimetabolites|antimetabolites|mesh-ancestor
101268941|NCT01810926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268942|NCT01810926|Dermatologic Agents|dermatologic agents|mesh-ancestor
101268943|NCT01810926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101268944|NCT01810926|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101268945|NCT01810926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101268946|NCT01810926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101268947|NCT01810926|Antifungal Agents|antifungal agents|mesh-ancestor
101268948|NCT01810926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101268949|NCT01810926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101268950|NCT01810926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101268951|NCT01810926|Alkylating Agents|alkylating agents|mesh-ancestor
101268952|NCT01810926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101268953|NCT01811056|Mifepristone|mifepristone|mesh-list
101268954|NCT01811056|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101268955|NCT01811056|Abortifacient Agents|abortifacient agents|mesh-ancestor
101268956|NCT01811056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101268957|NCT01811056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268958|NCT01811056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101268959|NCT01811056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101268960|NCT01811056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101268961|NCT01811056|Contraceptive Agents|contraceptive agents|mesh-ancestor
101268963|NCT01811056|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101268964|NCT01811056|Hormone Antagonists|hormone antagonists|mesh-ancestor
101268965|NCT01811056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101268966|NCT01811056|Luteolytic Agents|luteolytic agents|mesh-ancestor
101268967|NCT01811056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101816157|NCT00778193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101816158|NCT00778193|Analgesics|analgesics|mesh-ancestor
101312286|NCT00006292|Infliximab|infliximab|mesh-list
101816159|NCT00778193|Sensory System Agents|sensory system agents|mesh-ancestor
101816160|NCT00778193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101816161|NCT00778193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816162|NCT00778193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101816163|NCT00778193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101816164|NCT00778193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101816165|NCT00778193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101816166|NCT00778193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816167|NCT00778193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101268968|NCT01811056|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101268969|NCT01811160|Melatonin|melatonin|mesh-list
101268970|NCT01811160|Antioxidants|antioxidants|mesh-ancestor
101268971|NCT01811160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268972|NCT01811160|Protective Agents|protective agents|mesh-ancestor
101268973|NCT01811160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268974|NCT01811160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101268975|NCT01811251|Dexamethasone|dexamethasone|mesh-list
101268976|NCT01811251|Pregabalin|pregabalin|mesh-list
101268977|NCT01811251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101268978|NCT01811251|Antiemetics|antiemetics|mesh-ancestor
101268979|NCT01811251|Autonomic Agents|autonomic agents|mesh-ancestor
101268980|NCT01811251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101268981|NCT01811251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101268982|NCT01811251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101268983|NCT01811251|Glucocorticoids|glucocorticoids|mesh-ancestor
101268984|NCT01811251|Hormones|hormones|mesh-ancestor
101268985|NCT01811251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101268986|NCT01811251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101268987|NCT01811251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101268988|NCT01811251|Analgesics|analgesics|mesh-ancestor
101268989|NCT01811251|Sensory System Agents|sensory system agents|mesh-ancestor
101268990|NCT01811251|Anticonvulsants|anticonvulsants|mesh-ancestor
101268991|NCT01811251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101268992|NCT01811251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101268993|NCT01811251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268994|NCT01811251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101268995|NCT01811251|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101268996|NCT01811251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101268997|NCT01811251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101268998|NCT01811251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101268999|NCT01811277|Oxaliplatin|oxaliplatin|mesh-list
101269000|NCT01811277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101269002|NCT01811381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101269003|NCT01811381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101269004|NCT01811381|Analgesics|analgesics|mesh-ancestor
101269005|NCT01811381|Sensory System Agents|sensory system agents|mesh-ancestor
101269006|NCT01811381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101269007|NCT01811381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269008|NCT01811381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101269009|NCT01811381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101269010|NCT01811381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101269011|NCT01811381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101269012|NCT01811381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269013|NCT01811459|Haloperidol|haloperidol|mesh-list
101269014|NCT01811459|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101816168|NCT00778193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101816169|NCT00778193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101816170|NCT00778193|Antipyretics|antipyretics|mesh-ancestor
101816171|NCT00778193|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101816172|NCT00778193|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101816173|NCT00778193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101816174|NCT00778193|Purinergic Agents|purinergic agents|mesh-ancestor
101816175|NCT00778193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101816176|NCT00778193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101816177|NCT00778193|Gout Suppressants|gout suppressants|mesh-ancestor
101269015|NCT01811459|Haloperidol decanoate|haloperidol decanoate|mesh-list
101269016|NCT01811459|Antidepressive Agents|antidepressive agents|mesh-ancestor
101269017|NCT01811459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101269018|NCT01811459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101269019|NCT01811459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101269020|NCT01811459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101269021|NCT01811459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269022|NCT01811459|Antiemetics|antiemetics|mesh-ancestor
101269024|NCT01811459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101269025|NCT01811459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101269026|NCT01811459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101269027|NCT01811459|Dopamine Agents|dopamine agents|mesh-ancestor
101269028|NCT01811459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101269029|NCT01811459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269030|NCT01811459|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101269031|NCT01811615|Ethanol|ethanol|mesh-list
101269032|NCT01811615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101269033|NCT01811615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101269034|NCT01811615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101269035|NCT01811615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269036|NCT01811667|Sirolimus|sirolimus|mesh-list
101269037|NCT01811667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101269038|NCT01811667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101269039|NCT01811667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101269040|NCT01811667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101269041|NCT01811667|Antifungal Agents|antifungal agents|mesh-ancestor
101269042|NCT01811667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101269043|NCT01811667|Immunologic Factors|immunologic factors|mesh-ancestor
101269044|NCT01811667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269045|NCT01811810|Androgens|androgens|mesh-list
101269046|NCT01811810|Hormones|hormones|mesh-ancestor
101269047|NCT01811810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101269048|NCT01811810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269050|NCT01811836|Trace Elements|trace elements|mesh-ancestor
101269051|NCT01811836|Micronutrients|micronutrients|mesh-ancestor
101269052|NCT01811836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269053|NCT01811849|Insulin|insulin|mesh-list
101269054|NCT01811849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101269055|NCT01811849|Insulin Lispro|insulin lispro|mesh-list
101269056|NCT01811849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101269057|NCT01811849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269058|NCT01812018|Gemcitabine|gemcitabine|mesh-list
101269059|NCT01812018|Docetaxel|docetaxel|mesh-list
101269060|NCT01812018|Endostar protein|endostar protein|mesh-list
101269061|NCT01812018|Endostatins|endostatins|mesh-list
101269062|NCT01812018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101269063|NCT01812018|Antimetabolites|antimetabolites|mesh-ancestor
101269064|NCT01812018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269065|NCT01812018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101269066|NCT01812018|Tubulin Modulators|tubulin modulators|mesh-ancestor
101269067|NCT01812018|Antimitotic Agents|antimitotic agents|mesh-ancestor
101269068|NCT01812018|Mitosis Modulators|mitosis modulators|mesh-ancestor
101269069|NCT01812018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101816179|NCT00778271|Analgesics|analgesics|mesh-ancestor
101816180|NCT00778271|Sensory System Agents|sensory system agents|mesh-ancestor
101816181|NCT00778271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101816182|NCT00778271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816183|NCT00778271|Anticonvulsants|anticonvulsants|mesh-ancestor
101816184|NCT00778271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101816185|NCT00778271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101816186|NCT00778271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101269070|NCT01812018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101269071|NCT01812018|Growth Substances|growth substances|mesh-ancestor
101269072|NCT01812018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269073|NCT01812018|Growth Inhibitors|growth inhibitors|mesh-ancestor
101269074|NCT01812096|Bortezomib|bortezomib|mesh-list
101269075|NCT01812096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101269076|NCT01812122|Glimepiride|glimepiride|mesh-list
101269077|NCT01812122|Vildagliptin|vildagliptin|mesh-list
101269078|NCT01812122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101269079|NCT01812122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101269080|NCT01812122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269081|NCT01812122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101269082|NCT01812122|Immunologic Factors|immunologic factors|mesh-ancestor
101269083|NCT01812122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101269084|NCT01812122|Protease Inhibitors|protease inhibitors|mesh-ancestor
101269085|NCT01812122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101269086|NCT01812122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269087|NCT01812135|Vaccines|vaccines|mesh-list
101269088|NCT01812135|Immunologic Factors|immunologic factors|mesh-ancestor
101269089|NCT01812135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269090|NCT01812200|Rivaroxaban|rivaroxaban|mesh-list
101269091|NCT01812200|Dabigatran|dabigatran|mesh-list
101269093|NCT01812200|Ticagrelor|ticagrelor|mesh-list
101269094|NCT01812200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101269095|NCT01812200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101313904|NCT00000640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101269096|NCT01812200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101269097|NCT01812200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101269098|NCT01812200|Purinergic Agents|purinergic agents|mesh-ancestor
101269099|NCT01812200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101269100|NCT01812200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269101|NCT01812200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269102|NCT01812200|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101269103|NCT01812200|Antithrombins|antithrombins|mesh-ancestor
101269104|NCT01812200|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101269105|NCT01812200|Protease Inhibitors|protease inhibitors|mesh-ancestor
101269106|NCT01812200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101269107|NCT01812200|Anticoagulants|anticoagulants|mesh-ancestor
101269108|NCT01812239|Progesterone|progesterone|mesh-list
101269109|NCT01812239|Progestins|progestins|mesh-list
101269110|NCT01812239|Hormones|hormones|mesh-ancestor
101269111|NCT01812239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101269112|NCT01812239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269113|NCT01812330|Clopidogrel|clopidogrel|mesh-list
101269114|NCT01812330|Ticagrelor|ticagrelor|mesh-list
101269115|NCT01812330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101269116|NCT01812330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101269117|NCT01812330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101269119|NCT01812330|Purinergic Agents|purinergic agents|mesh-ancestor
101269120|NCT01812330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101269121|NCT01812330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269122|NCT01812330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269123|NCT01812356|Nitrous Oxide|nitrous oxide|mesh-list
101269124|NCT01812356|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101269125|NCT01812356|Anesthetics, General|anesthetics, general|mesh-ancestor
101269126|NCT01812356|Anesthetics|anesthetics|mesh-ancestor
101816187|NCT00778271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101816188|NCT00778271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101816189|NCT00778271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101816190|NCT00778271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101816191|NCT00778271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816192|NCT00778271|Antimanic Agents|antimanic agents|mesh-ancestor
101816193|NCT00778349|Metformin|metformin|mesh-list
101816194|NCT00778349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101816195|NCT00778349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816196|NCT00995618|Tranilast|tranilast|mesh-list
101816197|NCT00995618|Febuxostat|febuxostat|mesh-list
101816198|NCT00995618|Gout Suppressants|gout suppressants|mesh-ancestor
101269127|NCT01812356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101269128|NCT01812356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269129|NCT01812356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101269130|NCT01812356|Analgesics|analgesics|mesh-ancestor
101269131|NCT01812356|Sensory System Agents|sensory system agents|mesh-ancestor
101269132|NCT01812356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101269133|NCT01812369|Gemcitabine|gemcitabine|mesh-list
101269134|NCT01812369|Doxorubicin|doxorubicin|mesh-list
101269135|NCT01812369|Vinblastine|vinblastine|mesh-list
101269136|NCT01812369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101269137|NCT01812369|Antimetabolites|antimetabolites|mesh-ancestor
101269138|NCT01812369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269139|NCT01812369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101269140|NCT01812369|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101269141|NCT01812369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101269142|NCT01812369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101269143|NCT01812369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101269144|NCT01812369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101269145|NCT01812369|Tubulin Modulators|tubulin modulators|mesh-ancestor
101269146|NCT01812369|Antimitotic Agents|antimitotic agents|mesh-ancestor
101269147|NCT01812369|Mitosis Modulators|mitosis modulators|mesh-ancestor
101269148|NCT01812382|Retapamulin|retapamulin|mesh-list
101269149|NCT01812382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101269150|NCT01812382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101269151|NCT01812434|Sildenafil Citrate|sildenafil citrate|mesh-list
101269152|NCT01812434|Vasodilator Agents|vasodilator agents|mesh-ancestor
101269153|NCT01812434|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101269154|NCT01812434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101269155|NCT01812434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101269156|NCT01812434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269157|NCT01812434|Urological Agents|urological agents|mesh-ancestor
101269159|NCT01812538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101269160|NCT01812538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101269161|NCT01812538|Analgesics|analgesics|mesh-ancestor
101269162|NCT01812538|Sensory System Agents|sensory system agents|mesh-ancestor
101269163|NCT01812538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101269164|NCT01812538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269165|NCT01812538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101269166|NCT01812538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101269167|NCT01812538|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101269168|NCT01812538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101269169|NCT01812538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269171|NCT01812551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101269172|NCT01812551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269173|NCT01812642|N-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|n-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|mesh-list
101269174|NCT01812642|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101269175|NCT01812642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101816199|NCT00995618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101816200|NCT00995618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101816201|NCT00995618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101816202|NCT00995618|Analgesics|analgesics|mesh-ancestor
101816203|NCT00995618|Sensory System Agents|sensory system agents|mesh-ancestor
101816204|NCT00995618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101816205|NCT00995618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816206|NCT00995618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101816207|NCT00995618|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101816208|NCT00995618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101816209|NCT00995618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816210|NCT00995618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101816211|NCT00995618|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101816212|NCT00995618|Histamine Antagonists|histamine antagonists|mesh-ancestor
101816213|NCT00995618|Histamine Agents|histamine agents|mesh-ancestor
101816214|NCT00995618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101816215|NCT00995618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101816216|NCT00995618|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101816217|NCT00778427|Metformin|metformin|mesh-list
101816218|NCT00778427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101816219|NCT00778427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816220|NCT03889886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101816221|NCT03889886|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101816222|NCT00667355|Adalimumab|adalimumab|mesh-list
101816223|NCT00667355|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101816224|NCT00667355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101816225|NCT00667355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101816226|NCT00778505|Remifentanil|remifentanil|mesh-list
101816227|NCT00778505|Propofol|propofol|mesh-list
101816228|NCT00778505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101816229|NCT00778505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101816230|NCT00778505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816244|NCT00532844|Antioxidants|antioxidants|mesh-ancestor
101816245|NCT00532844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816246|NCT00532844|Protective Agents|protective agents|mesh-ancestor
101816247|NCT00532844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101816248|NCT00532844|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101816249|NCT00532844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101816252|NCT00778583|Nitrofurantoin|nitrofurantoin|mesh-list
101816313|NCT00778973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816315|NCT00774605|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101816386|NCT00662129|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101816387|NCT00662129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101816388|NCT00662129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101816389|NCT00662129|Tubulin Modulators|tubulin modulators|mesh-ancestor
101816390|NCT00662129|Antimitotic Agents|antimitotic agents|mesh-ancestor
101816391|NCT00662129|Mitosis Modulators|mitosis modulators|mesh-ancestor
101816392|NCT00662129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816393|NCT00662129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101816394|NCT00662129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101816395|NCT00662129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101816396|NCT00662129|Growth Substances|growth substances|mesh-ancestor
101816397|NCT00662129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816447|NCT00782405|Serotonin Agents|serotonin agents|mesh-ancestor
101816448|NCT00782405|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101816449|NCT05343260|Propofol|propofol|mesh-list
101816450|NCT05343260|Sevoflurane|sevoflurane|mesh-list
101816451|NCT05343260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101816452|NCT05343260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101816453|NCT05343260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816454|NCT05343260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101816455|NCT05343260|Anesthetics, General|anesthetics, general|mesh-ancestor
101816456|NCT05343260|Anesthetics|anesthetics|mesh-ancestor
101816457|NCT05343260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101816458|NCT05343260|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101816459|NCT00664859|Atorvastatin|atorvastatin|mesh-list
101816460|NCT00664859|Fenofibrate|fenofibrate|mesh-list
101816461|NCT00664859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101816462|NCT00664859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101816463|NCT00664859|Antimetabolites|antimetabolites|mesh-ancestor
101816464|NCT00664859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816465|NCT00664859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101816466|NCT00664859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101816467|NCT00664859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101816468|NCT00996788|Rebamipide|rebamipide|mesh-list
101816469|NCT00996788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101816470|NCT00996788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101816471|NCT00996788|Antioxidants|antioxidants|mesh-ancestor
101816472|NCT00996788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816473|NCT00996788|Protective Agents|protective agents|mesh-ancestor
101816474|NCT00996788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816496|NCT00790439|Antifungal Agents|antifungal agents|mesh-ancestor
101816497|NCT00790439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101816498|NCT00790439|Dermatologic Agents|dermatologic agents|mesh-ancestor
101816499|NCT00790439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101816500|NCT00790439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101816501|NCT00790439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101816502|NCT00790439|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101816503|NCT00790439|Antitubercular Agents|antitubercular agents|mesh-ancestor
101816504|NCT00790439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101816505|NCT00790439|Anticoagulants|anticoagulants|mesh-ancestor
101816506|NCT00790439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101816507|NCT00790439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101816508|NCT00790439|Plasma Substitutes|plasma substitutes|mesh-ancestor
101816509|NCT00790439|Blood Substitutes|blood substitutes|mesh-ancestor
101816510|NCT00785603|Tramadol|tramadol|mesh-list
101816511|NCT00785603|Paroxetine|paroxetine|mesh-list
101816512|NCT00785603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101816513|NCT00785603|Narcotics|narcotics|mesh-ancestor
101816514|NCT00785603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101816515|NCT00785603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816516|NCT00785603|Analgesics|analgesics|mesh-ancestor
101816517|NCT00785603|Sensory System Agents|sensory system agents|mesh-ancestor
101473839|NCT01604629|Adalimumab|adalimumab|mesh-list
101816518|NCT00785603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101816519|NCT00785603|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101816520|NCT00785603|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101816521|NCT00785603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101816522|NCT00785603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816523|NCT00785603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101816524|NCT00785603|Serotonin Agents|serotonin agents|mesh-ancestor
101816525|NCT00785603|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101816526|NCT00785603|Antidepressive Agents|antidepressive agents|mesh-ancestor
101816527|NCT00785603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101816528|NCT00785603|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101816529|NCT00785603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101816530|NCT00785603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101816531|NCT00570401|Dasatinib|dasatinib|mesh-list
101816532|NCT00570401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101816533|NCT00570401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101816534|NCT00570401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101816535|NCT00570401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816536|NCT00532298|Vaccines|vaccines|mesh-list
101816537|NCT00532298|Immunologic Factors|immunologic factors|mesh-ancestor
101816538|NCT00532298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816539|NCT04047017|Apatinib|apatinib|mesh-list
101816540|NCT04047017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101816541|NCT04047017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101816542|NCT04047017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101816543|NCT04047017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816544|NCT00997022|Sorafenib|sorafenib|mesh-list
101269176|NCT01812642|Dopamine Agents|dopamine agents|mesh-ancestor
101269177|NCT01812642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101269178|NCT01812642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269179|NCT01812642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269180|NCT01812720|Dexamethasone|dexamethasone|mesh-list
101269181|NCT01812720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101269182|NCT01812720|Antiemetics|antiemetics|mesh-ancestor
101269183|NCT01812720|Autonomic Agents|autonomic agents|mesh-ancestor
101269184|NCT01812720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101269185|NCT01812720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269186|NCT01812720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101269187|NCT01812720|Glucocorticoids|glucocorticoids|mesh-ancestor
101269188|NCT01812720|Hormones|hormones|mesh-ancestor
101269189|NCT01812720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101269190|NCT01812720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101269191|NCT01812720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101269192|NCT01812889|TOL-463|tol-463|mesh-list
101269193|NCT01812889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101269194|NCT01812928|Diclofenac|diclofenac|mesh-list
101269195|NCT01812928|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101269196|NCT01812928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101269197|NCT01812928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101269198|NCT01812928|Analgesics|analgesics|mesh-ancestor
101269199|NCT01812928|Sensory System Agents|sensory system agents|mesh-ancestor
101269200|NCT01812928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101269201|NCT01812928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269202|NCT01812928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101269203|NCT01812928|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101269204|NCT01812928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101269205|NCT01812928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269206|NCT01812954|Cyclosporine|cyclosporine|mesh-list
101269207|NCT01812954|Adalimumab|adalimumab|mesh-list
101269208|NCT01812954|Infliximab|infliximab|mesh-list
101269209|NCT01812954|Etanercept|etanercept|mesh-list
101269211|NCT01812954|Ustekinumab|ustekinumab|mesh-list
101269212|NCT01812954|Acitretin|acitretin|mesh-list
101269213|NCT01812954|Cyclosporins|cyclosporins|mesh-list
101269214|NCT01812954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101269215|NCT01812954|Abortifacient Agents|abortifacient agents|mesh-ancestor
101269216|NCT01812954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101269217|NCT01812954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269218|NCT01812954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101269219|NCT01812954|Antimetabolites|antimetabolites|mesh-ancestor
101269220|NCT01812954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269221|NCT01812954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101269222|NCT01812954|Dermatologic Agents|dermatologic agents|mesh-ancestor
101269223|NCT01812954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101269224|NCT01812954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101269225|NCT01812954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101816545|NCT00997022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101816546|NCT00997022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101816548|NCT00997022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816549|NCT00786149|Varenicline|varenicline|mesh-list
101816550|NCT00786149|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101816551|NCT00786149|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101816552|NCT00786149|Cholinergic Agents|cholinergic agents|mesh-ancestor
101269226|NCT01812954|Immunologic Factors|immunologic factors|mesh-ancestor
101269227|NCT01812954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101269228|NCT01812954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101269229|NCT01812954|Antifungal Agents|antifungal agents|mesh-ancestor
101269230|NCT01812954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101269231|NCT01812954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101269232|NCT01812954|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101269233|NCT01812954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101269234|NCT01812954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101269235|NCT01812954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101269236|NCT01812954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101269237|NCT01812954|Analgesics|analgesics|mesh-ancestor
101269238|NCT01812954|Sensory System Agents|sensory system agents|mesh-ancestor
101269239|NCT01812954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101269240|NCT01812954|Keratolytic Agents|keratolytic agents|mesh-ancestor
101269241|NCT01812967|Caseins|caseins|mesh-list
101269242|NCT01812967|Chelating Agents|chelating agents|mesh-ancestor
101269243|NCT01812967|Sequestering Agents|sequestering agents|mesh-ancestor
101269244|NCT01812967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269245|NCT01813162|Tenofovir|tenofovir|mesh-list
101269246|NCT01813162|Metronidazole|metronidazole|mesh-list
101269247|NCT01813162|Terconazole|terconazole|mesh-list
101269248|NCT01813162|Contraceptive Agents|contraceptive agents|mesh-list
101269249|NCT01813162|Antiviral Agents|antiviral agents|mesh-ancestor
101269250|NCT01813162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101269251|NCT01813162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101269252|NCT01813162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101269253|NCT01813162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101269254|NCT01813162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269255|NCT01813162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101269256|NCT01813162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101269257|NCT01813162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101269258|NCT01813162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101269259|NCT01813162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101269260|NCT01813162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101269261|NCT01813162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269262|NCT01813162|Antifungal Agents|antifungal agents|mesh-ancestor
101269263|NCT01813201|Methyltestosterone|methyltestosterone|mesh-list
101269264|NCT01813201|Testosterone|testosterone|mesh-list
101269265|NCT01813201|Testosterone undecanoate|testosterone undecanoate|mesh-list
101269266|NCT01813201|Testosterone enanthate|testosterone enanthate|mesh-list
101269267|NCT01813201|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101269268|NCT01813201|Androgens|androgens|mesh-ancestor
101269270|NCT01813201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101269271|NCT01813201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269272|NCT01813201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101269273|NCT01813201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101269274|NCT01813201|Anabolic Agents|anabolic agents|mesh-ancestor
101269275|NCT01813240|Minocycline|minocycline|mesh-list
101269276|NCT01813240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101269277|NCT01813240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101269278|NCT01813253|Irinotecan|irinotecan|mesh-list
101269279|NCT01813253|Nimotuzumab|nimotuzumab|mesh-list
101269280|NCT01813253|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101269281|NCT01813253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101269282|NCT01813253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101269283|NCT01813253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816553|NCT00786149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101816554|NCT00786149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816555|NCT00786149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816556|NCT00410410|Abatacept|abatacept|mesh-list
101816557|NCT00410410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101816558|NCT00410410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816559|NCT00410410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101816560|NCT00410410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101816561|NCT00410410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101816562|NCT00410410|Immunologic Factors|immunologic factors|mesh-ancestor
101269284|NCT01813253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101269285|NCT01813253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101269286|NCT01813318|Acamprosate|acamprosate|mesh-list
101269287|NCT01813318|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101269288|NCT01813448|Fidaxomicin|fidaxomicin|mesh-list
101269289|NCT01813448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101269290|NCT01813448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101269291|NCT01813461|Isavuconazole|isavuconazole|mesh-list
101269292|NCT01813461|Antifungal Agents|antifungal agents|mesh-ancestor
101269293|NCT01813461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101269294|NCT01813487|Entecavir|entecavir|mesh-list
101269295|NCT01813487|Antiviral Agents|antiviral agents|mesh-ancestor
101269296|NCT01813487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101269297|NCT01813513|Simeprevir|simeprevir|mesh-list
101269298|NCT01813513|Antiviral Agents|antiviral agents|mesh-ancestor
101269299|NCT01813513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101269301|NCT01813513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101269302|NCT01813513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269303|NCT01813552|Ritonavir|ritonavir|mesh-list
101269304|NCT01813552|Omeprazole|omeprazole|mesh-list
101269305|NCT01813552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101269306|NCT01813552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101269307|NCT01813552|Protease Inhibitors|protease inhibitors|mesh-ancestor
101269308|NCT01813552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101269309|NCT01813552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269311|NCT01813552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101269312|NCT01813552|Antiviral Agents|antiviral agents|mesh-ancestor
101269313|NCT01813552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101269314|NCT01813552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101269315|NCT01813552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101269316|NCT01813552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101269317|NCT01813552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101269318|NCT01813552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101269319|NCT01813565|Hyaluronic Acid|hyaluronic acid|mesh-list
101269320|NCT01813565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101269321|NCT01813565|Immunologic Factors|immunologic factors|mesh-ancestor
101269322|NCT01813565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269323|NCT01813565|Viscosupplements|viscosupplements|mesh-ancestor
101269324|NCT01813565|Protective Agents|protective agents|mesh-ancestor
101269325|NCT01813591|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101269326|NCT01813591|Hormones|hormones|mesh-ancestor
101269327|NCT01813591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101269328|NCT01813591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269329|NCT01813604|Vaccines|vaccines|mesh-list
101269330|NCT01813604|Immunologic Factors|immunologic factors|mesh-ancestor
101269331|NCT01813604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269332|NCT01813617|Prednisone|prednisone|mesh-list
101269333|NCT01813617|Methotrexate|methotrexate|mesh-list
101269334|NCT01813617|Azathioprine|azathioprine|mesh-list
101269335|NCT01813617|Immunosuppressive Agents|immunosuppressive agents|mesh-list
101269336|NCT01813617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101269337|NCT01813617|Glucocorticoids|glucocorticoids|mesh-ancestor
101269338|NCT01813617|Hormones|hormones|mesh-ancestor
101269339|NCT01813617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101269340|NCT01813617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816563|NCT00410410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816564|NCT00410410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101816566|NCT00782951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101816567|NCT00782951|Narcotics|narcotics|mesh-ancestor
101816568|NCT00782951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101816569|NCT00782951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816570|NCT00782951|Analgesics|analgesics|mesh-ancestor
101816571|NCT00782951|Sensory System Agents|sensory system agents|mesh-ancestor
101816572|NCT00782951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101816573|NCT02555813|Paclitaxel|paclitaxel|mesh-list
101816574|NCT02555813|Gemcitabine|gemcitabine|mesh-list
101816575|NCT02555813|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101816576|NCT02555813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101816577|NCT02555813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101816578|NCT02555813|Tubulin Modulators|tubulin modulators|mesh-ancestor
101816579|NCT02555813|Antimitotic Agents|antimitotic agents|mesh-ancestor
101816580|NCT02555813|Mitosis Modulators|mitosis modulators|mesh-ancestor
101269341|NCT01813617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101269342|NCT01813617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101269343|NCT01813617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101269344|NCT01813617|Abortifacient Agents|abortifacient agents|mesh-ancestor
101269345|NCT01813617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101269346|NCT01813617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101269347|NCT01813617|Antimetabolites|antimetabolites|mesh-ancestor
101269349|NCT01813617|Dermatologic Agents|dermatologic agents|mesh-ancestor
101269350|NCT01813617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101269351|NCT01813617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101269352|NCT01813617|Immunologic Factors|immunologic factors|mesh-ancestor
101269353|NCT01813617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101269354|NCT01813617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101269355|NCT01813643|Risperidone|risperidone|mesh-list
101269356|NCT01813643|Aripiprazole|aripiprazole|mesh-list
101269357|NCT01813643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101269358|NCT01813643|Serotonin Agents|serotonin agents|mesh-ancestor
101269359|NCT01813643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101269360|NCT01813643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269361|NCT01813643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269362|NCT01813643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101269363|NCT01813643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101269364|NCT01813643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101269365|NCT01813643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101269366|NCT01813643|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101269367|NCT01813643|Dopamine Agents|dopamine agents|mesh-ancestor
101269368|NCT01813643|Antidepressive Agents|antidepressive agents|mesh-ancestor
101269369|NCT01813643|Dopamine Agonists|dopamine agonists|mesh-ancestor
101269370|NCT01813643|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101269371|NCT01813643|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101269372|NCT01813643|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101269373|NCT01813643|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101269375|NCT01813656|Antidepressive Agents|antidepressive agents|mesh-ancestor
101269376|NCT01813656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101269377|NCT01813656|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101269378|NCT01813656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101269379|NCT01813656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101816581|NCT02555813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816582|NCT02555813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101816583|NCT02555813|Antimetabolites|antimetabolites|mesh-ancestor
101816584|NCT00997412|Mycophenolic Acid|mycophenolic acid|mesh-list
101816585|NCT00997412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101816586|NCT00997412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101816587|NCT00997412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101816588|NCT00997412|Antitubercular Agents|antitubercular agents|mesh-ancestor
101816589|NCT00997412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101816590|NCT00997412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101816591|NCT00997412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101269380|NCT01813656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269381|NCT01813656|Dopamine Agonists|dopamine agonists|mesh-ancestor
101269382|NCT01813656|Dopamine Agents|dopamine agents|mesh-ancestor
101269383|NCT01813656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101269384|NCT01813656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269385|NCT01813656|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101269386|NCT01813656|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101269387|NCT01813656|Serotonin Agents|serotonin agents|mesh-ancestor
101269388|NCT01813656|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101269389|NCT01813656|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101269390|NCT01813656|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101269391|NCT01813656|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101269392|NCT01813773|Aflibercept|aflibercept|mesh-list
101269393|NCT01813773|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101269394|NCT01813773|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101269395|NCT01813773|Growth Substances|growth substances|mesh-ancestor
101269396|NCT01813773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269397|NCT01813773|Growth Inhibitors|growth inhibitors|mesh-ancestor
101269398|NCT01813773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101269400|NCT01813812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101269401|NCT01813812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101269402|NCT01813812|Antioxidants|antioxidants|mesh-ancestor
101269403|NCT01813812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269404|NCT01813812|Protective Agents|protective agents|mesh-ancestor
101269405|NCT01813812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269406|NCT01813812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101269407|NCT01813955|Papaverine|papaverine|mesh-list
101269408|NCT01813955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101269409|NCT01813955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101269411|NCT01813955|Vasodilator Agents|vasodilator agents|mesh-ancestor
101269412|NCT01813955|Urological Agents|urological agents|mesh-ancestor
101269413|NCT01813981|Caffeine|caffeine|mesh-list
101269414|NCT01813981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101269415|NCT01813981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269416|NCT01813981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101269417|NCT01813981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101269418|NCT01813981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269419|NCT01813981|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101269420|NCT01813981|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101269421|NCT01813981|Purinergic Agents|purinergic agents|mesh-ancestor
101269422|NCT01813981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101269423|NCT01813994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
101269424|NCT01813994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101269425|NCT01813994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101269426|NCT01813994|Antimetabolites|antimetabolites|mesh-ancestor
101269427|NCT01813994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269428|NCT01813994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101269429|NCT01813994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101269431|NCT01814059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101269432|NCT01814059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101269433|NCT01814059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101816592|NCT00997412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816595|NCT00783107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101816596|NCT00783107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816597|NCT00783107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101816598|NCT00783107|Immunologic Factors|immunologic factors|mesh-ancestor
101816599|NCT00783107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816600|NCT00783107|Antifungal Agents|antifungal agents|mesh-ancestor
101816601|NCT00783107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101816602|NCT00783107|Dermatologic Agents|dermatologic agents|mesh-ancestor
101816603|NCT00783107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101816604|NCT00783107|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101816605|NCT00534404|Nicotine|nicotine|mesh-list
101816606|NCT00534404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101816607|NCT00534404|Autonomic Agents|autonomic agents|mesh-ancestor
101816608|NCT00534404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101816609|NCT00534404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816610|NCT00534404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101816611|NCT00534404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101816612|NCT00534404|Cholinergic Agents|cholinergic agents|mesh-ancestor
101816613|NCT00534404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101816614|NCT00534404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816615|NCT00393094|Bevacizumab|bevacizumab|mesh-list
101816616|NCT00393094|Irinotecan|irinotecan|mesh-list
101816617|NCT00393094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101816618|NCT00393094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101269434|NCT01814059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101269435|NCT01814059|Antifungal Agents|antifungal agents|mesh-ancestor
101269436|NCT01814059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101269437|NCT01814059|Immunologic Factors|immunologic factors|mesh-ancestor
101269438|NCT01814059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269439|NCT01814085|Escitalopram|escitalopram|mesh-list
101269440|NCT01814085|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101269441|NCT01814085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101269442|NCT01814085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101269443|NCT01814085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269444|NCT01814085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101269446|NCT01814085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269447|NCT01814098|Escitalopram|escitalopram|mesh-list
101269448|NCT01814098|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101269449|NCT01814098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101269450|NCT01814098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101269451|NCT01814098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269452|NCT01814098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101269453|NCT01814098|Serotonin Agents|serotonin agents|mesh-ancestor
101816619|NCT00393094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101816620|NCT00393094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101816621|NCT00393094|Growth Substances|growth substances|mesh-ancestor
101816622|NCT00393094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816623|NCT00393094|Growth Inhibitors|growth inhibitors|mesh-ancestor
101816624|NCT00393094|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101816625|NCT00393094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101816626|NCT00393094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101816627|NCT00393094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816628|NCT00783653|Sunitinib|sunitinib|mesh-list
101816629|NCT00783653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101816630|NCT00783653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101816631|NCT00783653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101816632|NCT00783653|Growth Substances|growth substances|mesh-ancestor
101816633|NCT00783653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816634|NCT00783653|Growth Inhibitors|growth inhibitors|mesh-ancestor
101816635|NCT00783653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101816636|NCT00783653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101816637|NCT00783653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816638|NCT00786305|Amikacin|amikacin|mesh-list
101816639|NCT00786305|Ceftazidime|ceftazidime|mesh-list
101816640|NCT00786305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101816641|NCT00786305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101816642|NCT01044004|Modafinil|modafinil|mesh-list
101816643|NCT01044004|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101269454|NCT01814098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269455|NCT01814163|Paclitaxel|paclitaxel|mesh-list
101269456|NCT01814163|Bevacizumab|bevacizumab|mesh-list
101269457|NCT01814163|Carboplatin|carboplatin|mesh-list
101269458|NCT01814163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101269459|NCT01814163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101269460|NCT01814163|Tubulin Modulators|tubulin modulators|mesh-ancestor
101269461|NCT01814163|Antimitotic Agents|antimitotic agents|mesh-ancestor
101269462|NCT01814163|Mitosis Modulators|mitosis modulators|mesh-ancestor
101269463|NCT01814163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269464|NCT01814163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101269465|NCT01814163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101269466|NCT01814163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101269467|NCT01814163|Growth Substances|growth substances|mesh-ancestor
101269468|NCT01814163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269469|NCT01814163|Growth Inhibitors|growth inhibitors|mesh-ancestor
101269470|NCT01814189|Promethazine|promethazine|mesh-list
101269471|NCT01814189|Diphenhydramine|diphenhydramine|mesh-list
101269472|NCT01814189|Sumatriptan|sumatriptan|mesh-list
101269473|NCT01814189|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101269474|NCT01814189|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101816644|NCT01044004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816645|NCT01044004|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101816646|NCT01044004|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101816647|NCT01044004|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101816648|NCT01044004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816649|NCT00786383|Ramucirumab|ramucirumab|mesh-list
101816650|NCT00786383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101816651|NCT00790595|Sunitinib|sunitinib|mesh-list
101816652|NCT00790595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101269475|NCT01814189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101269476|NCT01814189|Serotonin Agents|serotonin agents|mesh-ancestor
101269477|NCT01814189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101269478|NCT01814189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269479|NCT01814189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269480|NCT01814189|Antipruritics|antipruritics|mesh-ancestor
101269481|NCT01814189|Dermatologic Agents|dermatologic agents|mesh-ancestor
101269482|NCT01814189|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101269483|NCT01814189|Histamine Antagonists|histamine antagonists|mesh-ancestor
101269484|NCT01814189|Histamine Agents|histamine agents|mesh-ancestor
101269485|NCT01814189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101269486|NCT01814189|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101269487|NCT01814189|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101269488|NCT01814189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101269489|NCT01814189|Anesthetics, Local|anesthetics, local|mesh-ancestor
101269490|NCT01814189|Anesthetics|anesthetics|mesh-ancestor
101269491|NCT01814189|Sensory System Agents|sensory system agents|mesh-ancestor
101269492|NCT01814189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101269493|NCT01814189|Antiemetics|antiemetics|mesh-ancestor
101269494|NCT01814189|Autonomic Agents|autonomic agents|mesh-ancestor
101269495|NCT01814189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101269496|NCT01814319|Probenecid|probenecid|mesh-list
101269497|NCT01814319|Uricosuric Agents|uricosuric agents|mesh-ancestor
101269498|NCT01814319|Gout Suppressants|gout suppressants|mesh-ancestor
101269499|NCT01814319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101269500|NCT01814410|Ethanol|ethanol|mesh-list
101269501|NCT01814410|Nicotine|nicotine|mesh-list
101269502|NCT01814410|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101269503|NCT01814410|Autonomic Agents|autonomic agents|mesh-ancestor
101269504|NCT01814410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101269505|NCT01814410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269506|NCT01814410|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101269507|NCT01814410|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101269508|NCT01814410|Cholinergic Agents|cholinergic agents|mesh-ancestor
101269509|NCT01814410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101269510|NCT01814410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269511|NCT01814410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101269512|NCT01814410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101269513|NCT01814410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101269514|NCT01814423|Chloroquine|chloroquine|mesh-list
101269515|NCT01814423|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
101269516|NCT01814423|Amebicides|amebicides|mesh-ancestor
101269517|NCT01814423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101269518|NCT01814423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101269519|NCT01814423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101269520|NCT01814423|Antimalarials|antimalarials|mesh-ancestor
101269521|NCT01814423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101269522|NCT01814423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101269523|NCT01814423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101269524|NCT01814423|Analgesics|analgesics|mesh-ancestor
101269525|NCT01814423|Sensory System Agents|sensory system agents|mesh-ancestor
101269526|NCT01814423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101269527|NCT01814423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269528|NCT01814423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101269529|NCT01814423|Filaricides|filaricides|mesh-ancestor
101269530|NCT01814423|Antinematodal Agents|antinematodal agents|mesh-ancestor
101816654|NCT00790595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101816655|NCT00790595|Growth Substances|growth substances|mesh-ancestor
101816656|NCT00790595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816657|NCT00790595|Growth Inhibitors|growth inhibitors|mesh-ancestor
101816658|NCT00790595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101816659|NCT00790595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101816660|NCT00790595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816661|NCT00783731|Midazolam|midazolam|mesh-list
101816662|NCT00783731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101816663|NCT00783731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101816664|NCT00783731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101816665|NCT00783731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816666|NCT00783731|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101816667|NCT00783731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101816668|NCT00783731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101816669|NCT00783731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101816670|NCT00783731|Anesthetics, General|anesthetics, general|mesh-ancestor
101816672|NCT00783731|GABA Modulators|gaba modulators|mesh-ancestor
101816673|NCT00783731|GABA Agents|gaba agents|mesh-ancestor
101816674|NCT00783731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101269531|NCT01814423|Anthelmintics|anthelmintics|mesh-ancestor
101269532|NCT01814449|Letrozole|letrozole|mesh-list
101269533|NCT01814449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101269534|NCT01814449|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101269535|NCT01814449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101269536|NCT01814449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101269537|NCT01814449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269538|NCT01814449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101269539|NCT01814449|Hormone Antagonists|hormone antagonists|mesh-ancestor
101269540|NCT01814449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101269541|NCT01814449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269542|NCT01814475|Vidarabine|vidarabine|mesh-list
101269543|NCT01814475|Fludarabine|fludarabine|mesh-list
101269544|NCT01814475|Fludarabine phosphate|fludarabine phosphate|mesh-list
101269545|NCT01814475|Busulfan|busulfan|mesh-list
101269546|NCT01814475|Thiotepa|thiotepa|mesh-list
101269547|NCT01814475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101269548|NCT01814475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101269549|NCT01814475|Antimetabolites|antimetabolites|mesh-ancestor
101269550|NCT01814475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269551|NCT01814475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101269552|NCT01814475|Immunologic Factors|immunologic factors|mesh-ancestor
101269553|NCT01814475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269554|NCT01814475|Antiviral Agents|antiviral agents|mesh-ancestor
101269555|NCT01814475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101269556|NCT01814475|Alkylating Agents|alkylating agents|mesh-ancestor
101269557|NCT01814475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101269558|NCT01814475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101269559|NCT01814501|Leucovorin|leucovorin|mesh-list
101269560|NCT01814501|Fluorouracil|fluorouracil|mesh-list
101269561|NCT01814501|Irinotecan|irinotecan|mesh-list
101816675|NCT00783731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816676|NCT00409708|Methylphenidate|methylphenidate|mesh-list
101816677|NCT00409708|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101816678|NCT00409708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816679|NCT00409708|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101816680|NCT00409708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101816681|NCT00409708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101816682|NCT00409708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816683|NCT00409708|Dopamine Agents|dopamine agents|mesh-ancestor
101816684|NCT00409708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101269562|NCT01814501|Panitumumab|panitumumab|mesh-list
101269563|NCT01814501|Calcium|calcium|mesh-list
101269565|NCT01814501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101269566|NCT01814501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269567|NCT01814501|Antimetabolites|antimetabolites|mesh-ancestor
101269568|NCT01814501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269569|NCT01814501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101269570|NCT01814501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101269571|NCT01814501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101269572|NCT01814501|Immunologic Factors|immunologic factors|mesh-ancestor
101269573|NCT01814501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101534678|NCT00568880|Antimalarials|antimalarials|mesh-ancestor
101269574|NCT01814501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101269575|NCT01814501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101269576|NCT01814501|Antidotes|antidotes|mesh-ancestor
101269577|NCT01814501|Protective Agents|protective agents|mesh-ancestor
101269578|NCT01814501|Vitamin B Complex|vitamin b complex|mesh-ancestor
101269579|NCT01814501|Vitamins|vitamins|mesh-ancestor
101269580|NCT01814501|Micronutrients|micronutrients|mesh-ancestor
101269581|NCT01814501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101269582|NCT01814514|Timolol|timolol|mesh-list
101269583|NCT01814514|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101269584|NCT01814514|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101269585|NCT01814514|Adrenergic Agents|adrenergic agents|mesh-ancestor
101269586|NCT01814514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101269587|NCT01814514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269588|NCT01814514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269589|NCT01814514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101269590|NCT01814514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101269591|NCT01814618|Budesonide|budesonide|mesh-list
101269592|NCT01814618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101269593|NCT01814618|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101269594|NCT01814618|Autonomic Agents|autonomic agents|mesh-ancestor
101269595|NCT01814618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101269596|NCT01814618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269597|NCT01814618|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101269598|NCT01814618|Respiratory System Agents|respiratory system agents|mesh-ancestor
101269599|NCT01814618|Glucocorticoids|glucocorticoids|mesh-ancestor
101269600|NCT01814618|Hormones|hormones|mesh-ancestor
101269601|NCT01814618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101269602|NCT01814683|Primaquine|primaquine|mesh-list
101269603|NCT01814683|Antimalarials|antimalarials|mesh-ancestor
101269604|NCT01814683|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101269605|NCT01814683|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101269606|NCT01814683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101269607|NCT01814709|Itraconazole|itraconazole|mesh-list
101269608|NCT01814709|Rifampin|rifampin|mesh-list
101269609|NCT01814709|Antifungal Agents|antifungal agents|mesh-ancestor
101269610|NCT01814709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101269611|NCT01814709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101269612|NCT01814709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101269613|NCT01814709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101269614|NCT01814709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816685|NCT00790985|Naproxen|naproxen|mesh-list
101816686|NCT00790985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101816687|NCT00790985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101816688|NCT00790985|Analgesics|analgesics|mesh-ancestor
101816689|NCT00790985|Sensory System Agents|sensory system agents|mesh-ancestor
101816690|NCT00790985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101816691|NCT00790985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816692|NCT00790985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101816693|NCT00790985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101816694|NCT00790985|Gout Suppressants|gout suppressants|mesh-ancestor
101816695|NCT00790985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101816696|NCT00790985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101269615|NCT01814709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101269616|NCT01814709|Hormone Antagonists|hormone antagonists|mesh-ancestor
101269617|NCT01814709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101269618|NCT01814709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269619|NCT01814709|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101269620|NCT01814709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101269621|NCT01814709|Antitubercular Agents|antitubercular agents|mesh-ancestor
101269622|NCT01814709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101269623|NCT01814709|Leprostatic Agents|leprostatic agents|mesh-ancestor
101269624|NCT01814709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101269625|NCT01814709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101269626|NCT01814709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101269627|NCT01814709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101269628|NCT01814709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101269629|NCT01814709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101269630|NCT01814709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101269631|NCT01814826|Azacitidine|azacitidine|mesh-list
101269632|NCT01814826|Pevonedistat|pevonedistat|mesh-list
101269633|NCT01814826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101269634|NCT01814826|Antimetabolites|antimetabolites|mesh-ancestor
101269635|NCT01814826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269636|NCT01814826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101269637|NCT01814826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101269639|NCT01814865|Anastrozole|anastrozole|mesh-list
101269640|NCT01814865|Abiraterone Acetate|abiraterone acetate|mesh-list
101269641|NCT01814865|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101269642|NCT01814865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101269643|NCT01814865|Glucocorticoids|glucocorticoids|mesh-ancestor
101269644|NCT01814865|Hormones|hormones|mesh-ancestor
101269645|NCT01814865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101269646|NCT01814865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269647|NCT01814865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101269648|NCT01814865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101269649|NCT01814865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101269650|NCT01814865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101269651|NCT01814865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269652|NCT01814865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101269653|NCT01814865|Hormone Antagonists|hormone antagonists|mesh-ancestor
101269654|NCT01814865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101269655|NCT01814891|Vitamin A|vitamin a|mesh-list
101269656|NCT01814891|Vitamins|vitamins|mesh-ancestor
101269657|NCT01814891|Micronutrients|micronutrients|mesh-ancestor
101269658|NCT01814891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269659|NCT01814904|Bile Acids and Salts|bile acids and salts|mesh-list
101269660|NCT01814904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101269661|NCT01814930|Contraceptive Agents|contraceptive agents|mesh-list
101816697|NCT00790985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816698|NCT01324336|Mercaptopurine|mercaptopurine|mesh-list
101816699|NCT01324336|Antimetabolites|antimetabolites|mesh-ancestor
101816700|NCT01324336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816701|NCT01324336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101816702|NCT01324336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101816703|NCT01324336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101816704|NCT01324336|Immunologic Factors|immunologic factors|mesh-ancestor
101816705|NCT01324336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816706|NCT01324336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101816707|NCT01324336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101816708|NCT01324492|Everolimus|everolimus|mesh-list
101816709|NCT01324492|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101816710|NCT01324492|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101269662|NCT01814930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101269664|NCT01815021|Calcium, Dietary|calcium, dietary|mesh-list
101269665|NCT01815021|Calcium Carbonate|calcium carbonate|mesh-list
101269666|NCT01815021|Calcium|calcium|mesh-list
101269667|NCT01815021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101269668|NCT01815021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269669|NCT01815021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101269670|NCT01815021|Antacids|antacids|mesh-ancestor
101269671|NCT01815021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269672|NCT01815021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101269673|NCT01815047|Vitamin D|vitamin d|mesh-list
101269674|NCT01815047|Cholecalciferol|cholecalciferol|mesh-list
101269675|NCT01815047|Vitamins|vitamins|mesh-ancestor
101269676|NCT01815047|Micronutrients|micronutrients|mesh-ancestor
101269677|NCT01815047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269678|NCT01815047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101269679|NCT01815047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101269680|NCT01815073|Vaccines|vaccines|mesh-list
101269681|NCT01815073|Immunologic Factors|immunologic factors|mesh-ancestor
101269682|NCT01815073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269683|NCT01815125|Ondansetron|ondansetron|mesh-list
101269684|NCT01815125|Antiemetics|antiemetics|mesh-ancestor
101269685|NCT01815125|Autonomic Agents|autonomic agents|mesh-ancestor
101269686|NCT01815125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101269687|NCT01815125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269688|NCT01815125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101269689|NCT01815125|Antipruritics|antipruritics|mesh-ancestor
101269690|NCT01815125|Dermatologic Agents|dermatologic agents|mesh-ancestor
101269691|NCT01815125|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101269692|NCT01815125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101269693|NCT01815125|Serotonin Agents|serotonin agents|mesh-ancestor
101269694|NCT01815125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101269695|NCT01815125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269696|NCT01815203|Caffeine|caffeine|mesh-list
101269697|NCT01815203|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101269698|NCT01815203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269699|NCT01815203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101269700|NCT01815203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101269701|NCT01815203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269702|NCT01815203|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101269703|NCT01815203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101269704|NCT01815203|Purinergic Agents|purinergic agents|mesh-ancestor
101269705|NCT01815203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101816711|NCT01324492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101816712|NCT01324492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816713|NCT01324492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101816714|NCT01324492|Immunologic Factors|immunologic factors|mesh-ancestor
101816715|NCT01324492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816716|NCT01324492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101816717|NCT01039948|Gefitinib|gefitinib|mesh-list
101816718|NCT01039948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101816719|NCT01039948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101816720|NCT01039948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101269706|NCT01815255|Tenofovir|tenofovir|mesh-list
101269707|NCT01815255|Antiviral Agents|antiviral agents|mesh-ancestor
101269708|NCT01815255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101269709|NCT01815255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101269710|NCT01815255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101269711|NCT01815255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101269712|NCT01815255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269713|NCT01815255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101269714|NCT01815255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101269715|NCT01815268|Vaccines|vaccines|mesh-list
101269716|NCT01815268|Immunologic Factors|immunologic factors|mesh-ancestor
101269717|NCT01815268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269718|NCT01815294|Doxorubicin|doxorubicin|mesh-list
101269719|NCT01815294|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101269720|NCT01815294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101269721|NCT01815294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101269722|NCT01815294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101269723|NCT01815294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101269724|NCT01815294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101269725|NCT01815294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269726|NCT01815307|Gemcitabine|gemcitabine|mesh-list
101269727|NCT01815307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101269728|NCT01815307|Antimetabolites|antimetabolites|mesh-ancestor
101269729|NCT01815307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269730|NCT01815307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101269731|NCT01815437|Vitamin D|vitamin d|mesh-list
101269732|NCT01815437|Ergocalciferols|ergocalciferols|mesh-list
101269733|NCT01815437|Cholecalciferol|cholecalciferol|mesh-list
101269734|NCT01815437|Vitamins|vitamins|mesh-list
101269735|NCT01815437|Micronutrients|micronutrients|mesh-ancestor
101269736|NCT01815437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269737|NCT01815437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101269738|NCT01815437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101269739|NCT01815528|Catumaxomab|catumaxomab|mesh-list
101269740|NCT01815528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101269741|NCT01815541|Teicoplanin|teicoplanin|mesh-list
101269742|NCT01815541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101269743|NCT01815541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101269744|NCT01815658|Carbon Fiber|carbon fiber|mesh-list
101269745|NCT01815658|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101269746|NCT01815658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101269747|NCT01815723|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101269748|NCT01815723|Dermatologic Agents|dermatologic agents|mesh-ancestor
101269749|NCT01815723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101269750|NCT01815723|Immunologic Factors|immunologic factors|mesh-ancestor
101269751|NCT01815723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269752|NCT01815892|Furosemide|furosemide|mesh-list
101269753|NCT01815892|Diuretics|diuretics|mesh-ancestor
101269754|NCT01815892|Natriuretic Agents|natriuretic agents|mesh-ancestor
101269755|NCT01815892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269756|NCT01815892|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101269757|NCT01815892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101269758|NCT01815892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269759|NCT01815944|Ropivacaine|ropivacaine|mesh-list
101269760|NCT01815944|Anesthetics, Local|anesthetics, local|mesh-ancestor
101269761|NCT01815944|Anesthetics|anesthetics|mesh-ancestor
101816721|NCT01039948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816722|NCT00391846|Metoprolol|metoprolol|mesh-list
101816723|NCT00391846|Valsartan|valsartan|mesh-list
101816724|NCT00391846|Carvedilol|carvedilol|mesh-list
101816725|NCT00391846|Candesartan|candesartan|mesh-list
101816726|NCT00391846|Ramipril|ramipril|mesh-list
101816728|NCT00391846|Lisinopril|lisinopril|mesh-list
101816729|NCT00391846|Eplerenone|eplerenone|mesh-list
101816730|NCT00391846|Bisoprolol|bisoprolol|mesh-list
101816731|NCT00391846|Captopril|captopril|mesh-list
101816732|NCT00391846|Trandolapril|trandolapril|mesh-list
101816733|NCT00391846|Spironolactone|spironolactone|mesh-list
101816734|NCT00391846|Diuretics|diuretics|mesh-list
101816735|NCT00391846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101816736|NCT00391846|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101816737|NCT00391846|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101269762|NCT01815944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101269763|NCT01815944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269764|NCT01815944|Sensory System Agents|sensory system agents|mesh-ancestor
101269765|NCT01815944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101269766|NCT01816009|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101269767|NCT01816009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101269768|NCT01816035|Trastuzumab|trastuzumab|mesh-list
101269769|NCT01816035|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101269770|NCT01816035|Maytansine|maytansine|mesh-list
101269771|NCT01816035|Immunoconjugates|immunoconjugates|mesh-list
101269772|NCT01816035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101269773|NCT01816035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101269774|NCT01816035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101269775|NCT01816035|Tubulin Modulators|tubulin modulators|mesh-ancestor
101269776|NCT01816035|Antimitotic Agents|antimitotic agents|mesh-ancestor
101269777|NCT01816035|Mitosis Modulators|mitosis modulators|mesh-ancestor
101269778|NCT01816035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269779|NCT01816035|Immunotoxins|immunotoxins|mesh-ancestor
101269780|NCT01816035|Immunologic Factors|immunologic factors|mesh-ancestor
101269781|NCT01816035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269782|NCT01816191|Diltiazem|diltiazem|mesh-list
101269783|NCT01816191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101269784|NCT01816191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101269785|NCT01816191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101269786|NCT01816191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269787|NCT01816191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101269788|NCT01816191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269789|NCT01816191|Vasodilator Agents|vasodilator agents|mesh-ancestor
101269791|NCT01816321|Hormone Antagonists|hormone antagonists|mesh-ancestor
101269792|NCT01816321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101269793|NCT01816321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269794|NCT01816334|Methylprednisolone|methylprednisolone|mesh-list
101269795|NCT01816334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101269796|NCT01816334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101269797|NCT01816334|Prednisolone|prednisolone|mesh-list
101269798|NCT01816334|Prednisolone acetate|prednisolone acetate|mesh-list
101269799|NCT01816334|Ketoprofen|ketoprofen|mesh-list
101269800|NCT01816334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101269801|NCT01816334|Prednisolone phosphate|prednisolone phosphate|mesh-list
101269802|NCT01816334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101269803|NCT01816334|Antiemetics|antiemetics|mesh-ancestor
101269804|NCT01816334|Autonomic Agents|autonomic agents|mesh-ancestor
101269805|NCT01816334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101269806|NCT01816334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816738|NCT00391846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816739|NCT00391846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101474054|NCT00291408|Gasotransmitters|gasotransmitters|mesh-ancestor
101816740|NCT00391846|Sympatholytics|sympatholytics|mesh-ancestor
101816741|NCT00391846|Autonomic Agents|autonomic agents|mesh-ancestor
101816742|NCT00391846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101816743|NCT00391846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816744|NCT00391846|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101816745|NCT00391846|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101816746|NCT00391846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101816747|NCT00391846|Adrenergic Agents|adrenergic agents|mesh-ancestor
101816748|NCT00391846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101816749|NCT00391846|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101816750|NCT00391846|Hormone Antagonists|hormone antagonists|mesh-ancestor
101269807|NCT01816334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101269808|NCT01816334|Glucocorticoids|glucocorticoids|mesh-ancestor
101269809|NCT01816334|Hormones|hormones|mesh-ancestor
101269810|NCT01816334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101269811|NCT01816334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101269812|NCT01816334|Protective Agents|protective agents|mesh-ancestor
101269813|NCT01816334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101269814|NCT01816334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101269815|NCT01816334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101269816|NCT01816334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101269817|NCT01816334|Analgesics|analgesics|mesh-ancestor
101269818|NCT01816334|Sensory System Agents|sensory system agents|mesh-ancestor
101269819|NCT01816334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101269820|NCT01816334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101269821|NCT01816334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101269822|NCT01816334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269823|NCT01816412|Paclitaxel|paclitaxel|mesh-list
101269824|NCT01816412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101269825|NCT01816412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101269826|NCT01816412|Tubulin Modulators|tubulin modulators|mesh-ancestor
101269827|NCT01816412|Antimitotic Agents|antimitotic agents|mesh-ancestor
101269828|NCT01816412|Mitosis Modulators|mitosis modulators|mesh-ancestor
101269829|NCT01816412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269830|NCT01816490|Silybin|silybin|mesh-list
101269831|NCT01816490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101269832|NCT01816490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101269833|NCT01816490|Protective Agents|protective agents|mesh-ancestor
101269834|NCT01816490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269835|NCT01816529|Diltiazem|diltiazem|mesh-list
101269836|NCT01816529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101269837|NCT01816529|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101269838|NCT01816529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101269839|NCT01816529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269840|NCT01816529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101269841|NCT01816529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269842|NCT01816529|Vasodilator Agents|vasodilator agents|mesh-ancestor
101269843|NCT01816555|Vitamin D|vitamin d|mesh-list
101269844|NCT01816555|Vitamins|vitamins|mesh-ancestor
101269845|NCT01816555|Micronutrients|micronutrients|mesh-ancestor
101269847|NCT01816555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101269848|NCT01816581|Morphine|morphine|mesh-list
101269849|NCT01816581|Naloxone|naloxone|mesh-list
101269850|NCT01816581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101269851|NCT01816581|Narcotics|narcotics|mesh-ancestor
101269852|NCT01816581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101816751|NCT00391846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101816752|NCT00391846|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101816753|NCT00391846|Natriuretic Agents|natriuretic agents|mesh-ancestor
101816754|NCT00391846|Antioxidants|antioxidants|mesh-ancestor
101816755|NCT00391846|Protective Agents|protective agents|mesh-ancestor
101816756|NCT00391846|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101816757|NCT00391846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101816758|NCT00391846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101816759|NCT00391846|Vasodilator Agents|vasodilator agents|mesh-ancestor
101816760|NCT00391846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101816761|NCT00391846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101269853|NCT01816581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269854|NCT01816581|Analgesics|analgesics|mesh-ancestor
101269855|NCT01816581|Sensory System Agents|sensory system agents|mesh-ancestor
101269856|NCT01816581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101269857|NCT01816581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101269858|NCT01816620|Dexamethasone|dexamethasone|mesh-list
101269859|NCT01816620|Lenalidomide|lenalidomide|mesh-list
101269860|NCT01816620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101269862|NCT01816620|Autonomic Agents|autonomic agents|mesh-ancestor
101269863|NCT01816620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101269864|NCT01816620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269865|NCT01816620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101269866|NCT01816620|Glucocorticoids|glucocorticoids|mesh-ancestor
101269868|NCT01816620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101269869|NCT01816620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101269870|NCT01816620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101269871|NCT01816620|Immunologic Factors|immunologic factors|mesh-ancestor
101269872|NCT01816620|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101269873|NCT01816620|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101269874|NCT01816620|Growth Substances|growth substances|mesh-ancestor
101269875|NCT01816620|Growth Inhibitors|growth inhibitors|mesh-ancestor
101269876|NCT01816646|Cidofovir|cidofovir|mesh-list
101269877|NCT01816646|Probenecid|probenecid|mesh-list
101269878|NCT01816646|Uricosuric Agents|uricosuric agents|mesh-ancestor
101269879|NCT01816646|Gout Suppressants|gout suppressants|mesh-ancestor
101269880|NCT01816646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101269881|NCT01816646|Antiviral Agents|antiviral agents|mesh-ancestor
101269882|NCT01816646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101269883|NCT01816646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101269884|NCT01816646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269885|NCT01816659|Metformin|metformin|mesh-list
101269886|NCT01816659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101269887|NCT01816659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269888|NCT01816789|Buserelin|buserelin|mesh-list
101269889|NCT01816789|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101269891|NCT01816789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101269892|NCT01816789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269893|NCT01816958|Ketamine|ketamine|mesh-list
101269894|NCT01816958|Analgesics|analgesics|mesh-ancestor
101269895|NCT01816958|Sensory System Agents|sensory system agents|mesh-ancestor
101269896|NCT01816958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101269897|NCT01816958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269898|NCT01816958|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101269899|NCT01816958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101269900|NCT01816958|Anesthetics, General|anesthetics, general|mesh-ancestor
101269901|NCT01816958|Anesthetics|anesthetics|mesh-ancestor
101269902|NCT01816958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101269903|NCT01816958|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101816762|NCT00391846|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101816763|NCT00391846|Protease Inhibitors|protease inhibitors|mesh-ancestor
101816764|NCT00391846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101816765|NCT00391846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101816766|NCT00391768|Oseltamivir|oseltamivir|mesh-list
101816767|NCT00391768|Antiviral Agents|antiviral agents|mesh-ancestor
101269904|NCT01816958|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101269905|NCT01816958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101269906|NCT01816958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269907|NCT01816997|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101269908|NCT01816997|Pravastatin|pravastatin|mesh-list
101269909|NCT01816997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101269910|NCT01816997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101269911|NCT01816997|Antimetabolites|antimetabolites|mesh-ancestor
101269912|NCT01816997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269913|NCT01816997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101269914|NCT01816997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101269915|NCT01816997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101269917|NCT01817023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101269918|NCT01817036|Vitamin D|vitamin d|mesh-list
101269919|NCT01817036|Vitamins|vitamins|mesh-ancestor
101269920|NCT01817036|Micronutrients|micronutrients|mesh-ancestor
101269921|NCT01817036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269922|NCT01817036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101269923|NCT01817153|Hydrocortisone|hydrocortisone|mesh-list
101269924|NCT01817153|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101269925|NCT01817153|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101269926|NCT01817153|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101269927|NCT01817153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101269928|NCT01817218|Anti-Infective Agents|anti-infective agents|mesh-list
101269929|NCT01817218|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101269930|NCT01817257|Heparin|heparin|mesh-list
101269931|NCT01817257|Enoxaparin|enoxaparin|mesh-list
101269932|NCT01817257|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101269933|NCT01817257|Tinzaparin|tinzaparin|mesh-list
101269934|NCT01817257|Dalteparin|dalteparin|mesh-list
101269935|NCT01817257|Anticoagulants|anticoagulants|mesh-ancestor
101269936|NCT01817257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101269937|NCT01817257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101269938|NCT01817257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269939|NCT01817283|Triptolide|triptolide|mesh-list
101269940|NCT01817283|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
101269941|NCT01817283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269942|NCT01817283|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101269943|NCT01817283|Contraceptive Agents|contraceptive agents|mesh-ancestor
101269944|NCT01817283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101269945|NCT01817283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101269946|NCT01817283|Immunologic Factors|immunologic factors|mesh-ancestor
101269947|NCT01817283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101269948|NCT01817283|Alkylating Agents|alkylating agents|mesh-ancestor
101269949|NCT01817283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269950|NCT01817283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101269951|NCT01817322|Mycophenolic Acid|mycophenolic acid|mesh-list
101269952|NCT01817322|Methylprednisolone|methylprednisolone|mesh-list
101269953|NCT01817322|Prednisolone|prednisolone|mesh-list
101269954|NCT01817322|Deflazacort|deflazacort|mesh-list
101269955|NCT01817322|Basiliximab|basiliximab|mesh-list
101269956|NCT01817322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101269957|NCT01817322|Antiemetics|antiemetics|mesh-ancestor
101269958|NCT01817322|Autonomic Agents|autonomic agents|mesh-ancestor
101269959|NCT01817322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101269960|NCT01817322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269961|NCT01817322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101269962|NCT01817322|Glucocorticoids|glucocorticoids|mesh-ancestor
101269963|NCT01817322|Hormones|hormones|mesh-ancestor
101269964|NCT01817322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101269966|NCT01817322|Protective Agents|protective agents|mesh-ancestor
101269967|NCT01817322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101269968|NCT01817322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101269969|NCT01817322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101816768|NCT00391768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101816769|NCT00391768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101816770|NCT00391768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816772|NCT00391222|Risperidone|risperidone|mesh-list
101816773|NCT00391222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101816774|NCT00391222|Serotonin Agents|serotonin agents|mesh-ancestor
101816775|NCT00391222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101816776|NCT00391222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816777|NCT00391222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816778|NCT00391222|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101816779|NCT00391222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101816780|NCT00391222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101269970|NCT01817322|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101269971|NCT01817322|Antitubercular Agents|antitubercular agents|mesh-ancestor
101269972|NCT01817322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101269973|NCT01817322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101269974|NCT01817322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101269975|NCT01817322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269977|NCT01817322|Immunologic Factors|immunologic factors|mesh-ancestor
101269978|NCT01817348|Lidocaine|lidocaine|mesh-list
101269979|NCT01817348|Anesthetics, Local|anesthetics, local|mesh-ancestor
101269980|NCT01817348|Anesthetics|anesthetics|mesh-ancestor
101269981|NCT01817348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101269982|NCT01817348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269983|NCT01817348|Sensory System Agents|sensory system agents|mesh-ancestor
101269984|NCT01817348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101269985|NCT01817348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101269986|NCT01817348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101269987|NCT01817348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101269988|NCT01817348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101269989|NCT01817348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101269990|NCT01817400|Aspirin|aspirin|mesh-list
101269991|NCT01817400|Pioglitazone|pioglitazone|mesh-list
101269992|NCT01817400|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
101269993|NCT01817400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101269994|NCT01817400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101269995|NCT01817400|Analgesics|analgesics|mesh-ancestor
101269996|NCT01817400|Sensory System Agents|sensory system agents|mesh-ancestor
101269997|NCT01817400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101269998|NCT01817400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101269999|NCT01817400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101270000|NCT01817400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101270001|NCT01817400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101270002|NCT01817400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101270003|NCT01817400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270004|NCT01817400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101270005|NCT01817400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101270006|NCT01817400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101270007|NCT01817400|Antipyretics|antipyretics|mesh-ancestor
101270008|NCT01817400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101270009|NCT01817400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101270010|NCT01817439|Amiodarone|amiodarone|mesh-list
101270011|NCT01817439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101270012|NCT01817439|Vasodilator Agents|vasodilator agents|mesh-ancestor
101816781|NCT00391222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101816782|NCT00391222|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101816783|NCT00391222|Dopamine Agents|dopamine agents|mesh-ancestor
101816785|NCT00391222|Autonomic Agents|autonomic agents|mesh-ancestor
101816786|NCT00391222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101816787|NCT00391222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101816788|NCT00391222|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101270013|NCT01817439|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101270014|NCT01817439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101270015|NCT01817439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270016|NCT01817439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101270017|NCT01817439|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101270018|NCT01817439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101270019|NCT01817439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101270020|NCT01817439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101270021|NCT01817439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101270022|NCT01817439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101270023|NCT01817699|Vitamin D|vitamin d|mesh-list
101270024|NCT01817699|Cholecalciferol|cholecalciferol|mesh-list
101270025|NCT01817699|Vitamins|vitamins|mesh-ancestor
101270026|NCT01817699|Micronutrients|micronutrients|mesh-ancestor
101270027|NCT01817699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270028|NCT01817699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101270029|NCT01817699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101270030|NCT01817803|Metolazone|metolazone|mesh-list
101270031|NCT01817803|Furosemide|furosemide|mesh-list
101270032|NCT01817803|Spironolactone|spironolactone|mesh-list
101270033|NCT01817803|Diuretics|diuretics|mesh-ancestor
101270034|NCT01817803|Natriuretic Agents|natriuretic agents|mesh-ancestor
101270035|NCT01817803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270036|NCT01817803|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101270037|NCT01817803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101270038|NCT01817803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270039|NCT01817803|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101270041|NCT01817803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101270042|NCT01817803|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101270043|NCT01817803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101270044|NCT01817803|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101270045|NCT01817816|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101270046|NCT01817816|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101270047|NCT01817816|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101270048|NCT01817816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101270049|NCT01817816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270050|NCT01817816|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101270051|NCT01817816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101270052|NCT01817816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270053|NCT01817816|Cholinergic Agents|cholinergic agents|mesh-ancestor
101270054|NCT01817816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101270055|NCT01817829|Acetaminophen|acetaminophen|mesh-list
101270056|NCT01817829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101270057|NCT01817829|Analgesics|analgesics|mesh-ancestor
101270058|NCT01817829|Sensory System Agents|sensory system agents|mesh-ancestor
101270059|NCT01817829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101270060|NCT01817829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270061|NCT01817829|Antipyretics|antipyretics|mesh-ancestor
101270062|NCT01817868|Factor VIII|factor viii|mesh-list
101270063|NCT01817868|Coagulants|coagulants|mesh-ancestor
101270064|NCT01817894|Eflornithine|eflornithine|mesh-list
101270065|NCT01817894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101270066|NCT01817894|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101270067|NCT01817894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101270068|NCT01817894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101270069|NCT01817894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101816789|NCT00391222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101816790|NCT00391222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101816792|NCT00409006|Gefitinib|gefitinib|mesh-list
101816793|NCT00409006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101270070|NCT01817894|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
101270071|NCT01817894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101270072|NCT01817894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270073|NCT01817972|Certolizumab Pegol|certolizumab pegol|mesh-list
101270074|NCT01817972|Azathioprine|azathioprine|mesh-list
101270075|NCT01817972|Antimetabolites|antimetabolites|mesh-ancestor
101270076|NCT01817972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270077|NCT01817972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101270078|NCT01817972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101270079|NCT01817972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101270080|NCT01817972|Immunologic Factors|immunologic factors|mesh-ancestor
101270081|NCT01817972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270083|NCT01817972|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101270084|NCT01817972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101270085|NCT01817985|Velpatasvir|velpatasvir|mesh-list
101270086|NCT01817985|Antiviral Agents|antiviral agents|mesh-ancestor
101270087|NCT01817985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101270088|NCT01818024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101270089|NCT01818024|Immunologic Factors|immunologic factors|mesh-ancestor
101270090|NCT01818024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270091|NCT01818232|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
101270092|NCT01818232|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101270093|NCT01818232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270094|NCT01818232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101270095|NCT01818232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270097|NCT01818648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101270098|NCT01818648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270099|NCT01818648|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101270100|NCT01818648|Incretins|incretins|mesh-ancestor
101270101|NCT01818648|Hormones|hormones|mesh-ancestor
101270102|NCT01818648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101270103|NCT01818713|Doxorubicin|doxorubicin|mesh-list
101270104|NCT01818713|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101270105|NCT01818713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101270106|NCT01818713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101270107|NCT01818713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101270108|NCT01818713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101270109|NCT01818713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101270110|NCT01818713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270111|NCT01818843|Carbon Monoxide|carbon monoxide|mesh-list
101270112|NCT01818843|Antimetabolites|antimetabolites|mesh-ancestor
101270113|NCT01818843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270114|NCT01818843|Gasotransmitters|gasotransmitters|mesh-ancestor
101270115|NCT01818843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101270116|NCT01818843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270117|NCT01818856|Ritonavir|ritonavir|mesh-list
101270118|NCT01818856|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101270119|NCT01818856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101270120|NCT01818856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101270121|NCT01818856|Protease Inhibitors|protease inhibitors|mesh-ancestor
101270122|NCT01818856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101270123|NCT01818856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270124|NCT01818856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101270125|NCT01818856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101270126|NCT01818856|Antiviral Agents|antiviral agents|mesh-ancestor
101270127|NCT01818856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101270128|NCT01818856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101270129|NCT01818856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101270130|NCT01818869|Adenosine|adenosine|mesh-list
101270131|NCT01818869|Analgesics|analgesics|mesh-ancestor
101270132|NCT01818869|Sensory System Agents|sensory system agents|mesh-ancestor
101270133|NCT01818869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101816795|NCT00409006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816796|NCT00409006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101816797|NCT00409006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101816798|NCT00409006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101816799|NCT00997880|Calcium, Dietary|calcium, dietary|mesh-list
101816800|NCT00997880|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101816801|NCT00997880|Calcium|calcium|mesh-list
101816802|NCT00997880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101816803|NCT00997880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816804|NCT00997880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101816805|NCT00997880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101816806|NCT00997880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101816807|NCT00997880|Antimetabolites|antimetabolites|mesh-ancestor
101816808|NCT00997880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816809|NCT00997880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101816810|NCT00997880|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101816811|NCT00997880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101816812|NCT00408928|Bortezomib|bortezomib|mesh-list
101816813|NCT00408928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101816814|NCT00997958|Mycophenolic Acid|mycophenolic acid|mesh-list
101816815|NCT00997958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101816816|NCT00997958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101816817|NCT00997958|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101816818|NCT00997958|Antitubercular Agents|antitubercular agents|mesh-ancestor
101816819|NCT00997958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101816820|NCT00997958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101270134|NCT01818869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270135|NCT01818869|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101270136|NCT01818869|Vasodilator Agents|vasodilator agents|mesh-ancestor
101270137|NCT01818869|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101270138|NCT01818869|Purinergic Agonists|purinergic agonists|mesh-ancestor
101270139|NCT01818869|Purinergic Agents|purinergic agents|mesh-ancestor
101270140|NCT01818869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101270141|NCT01818869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270142|NCT01818908|Prednisone|prednisone|mesh-list
101270143|NCT01818908|Cyclophosphamide|cyclophosphamide|mesh-list
101270144|NCT01818908|Doxorubicin|doxorubicin|mesh-list
101270145|NCT01818908|Etoposide|etoposide|mesh-list
101270146|NCT01818908|Vincristine|vincristine|mesh-list
101270147|NCT01818908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101270148|NCT01818908|Immunologic Factors|immunologic factors|mesh-ancestor
101270149|NCT01818908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270150|NCT01818908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101270151|NCT01818908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101270152|NCT01818908|Alkylating Agents|alkylating agents|mesh-ancestor
101816821|NCT00997958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101816822|NCT00997958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816823|NCT00998036|Sirolimus|sirolimus|mesh-list
101816824|NCT00998036|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101816825|NCT00998036|Temsirolimus|temsirolimus|mesh-list
101270153|NCT01818908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270154|NCT01818908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101270155|NCT01818908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101270156|NCT01818908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101270157|NCT01818908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101270159|NCT01818908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101270160|NCT01818908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101270161|NCT01818908|Glucocorticoids|glucocorticoids|mesh-ancestor
101270163|NCT01818908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101270164|NCT01818908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101270165|NCT01818908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101270166|NCT01818908|Tubulin Modulators|tubulin modulators|mesh-ancestor
101270167|NCT01818908|Antimitotic Agents|antimitotic agents|mesh-ancestor
101270168|NCT01818908|Mitosis Modulators|mitosis modulators|mesh-ancestor
101270169|NCT01818973|Bevacizumab|bevacizumab|mesh-list
101270170|NCT01818973|Capecitabine|capecitabine|mesh-list
101270171|NCT01818973|Oxaliplatin|oxaliplatin|mesh-list
101270172|NCT01818973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101270173|NCT01818973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101270174|NCT01818973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101270175|NCT01818973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101270176|NCT01818973|Growth Substances|growth substances|mesh-ancestor
101270177|NCT01818973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270178|NCT01818973|Growth Inhibitors|growth inhibitors|mesh-ancestor
101270179|NCT01818973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101270180|NCT01818973|Antimetabolites|antimetabolites|mesh-ancestor
101270181|NCT01818973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270182|NCT01819012|Isoflurane|isoflurane|mesh-list
101270183|NCT01819012|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101270184|NCT01819012|Anesthetics, General|anesthetics, general|mesh-ancestor
101270185|NCT01819012|Anesthetics|anesthetics|mesh-ancestor
101270186|NCT01819012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101270187|NCT01819012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270188|NCT01819051|Anti-Infective Agents|anti-infective agents|mesh-list
101270189|NCT01819051|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101270190|NCT01819155|Vaccines|vaccines|mesh-list
101270191|NCT01819155|Immunologic Factors|immunologic factors|mesh-ancestor
101270192|NCT01819155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270193|NCT01819220|Amlodipine|amlodipine|mesh-list
101270194|NCT01819220|Valsartan|valsartan|mesh-list
101270195|NCT01819220|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101270196|NCT01819220|Telmisartan|telmisartan|mesh-list
101270197|NCT01819220|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
101270198|NCT01819220|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
101270199|NCT01819220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101270200|NCT01819220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101270201|NCT01819220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101270202|NCT01819220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270203|NCT01819220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101270204|NCT01819220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270205|NCT01819220|Vasodilator Agents|vasodilator agents|mesh-ancestor
101270206|NCT01819220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101270207|NCT01819220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101270208|NCT01819220|Diuretics|diuretics|mesh-ancestor
101270209|NCT01819220|Natriuretic Agents|natriuretic agents|mesh-ancestor
101270210|NCT01819220|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101270211|NCT01819259|Nicotine|nicotine|mesh-list
101270212|NCT01819259|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101270213|NCT01819259|Autonomic Agents|autonomic agents|mesh-ancestor
101270214|NCT01819259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101270215|NCT01819259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270216|NCT01819259|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101270217|NCT01819259|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101270218|NCT01819259|Cholinergic Agents|cholinergic agents|mesh-ancestor
101816826|NCT00998036|MTOR Inhibitors|mtor inhibitors|mesh-list
101816827|NCT00998036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101816828|NCT00998036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101816829|NCT00998036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101816830|NCT00998036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816831|NCT00998036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101816832|NCT00998036|Immunologic Factors|immunologic factors|mesh-ancestor
101816833|NCT00998036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816834|NCT00998036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101816835|NCT00998036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101816836|NCT00998036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101816837|NCT00998036|Antifungal Agents|antifungal agents|mesh-ancestor
101816838|NCT05254808|Fosfomycin|fosfomycin|mesh-list
101270219|NCT01819259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101270220|NCT01819259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270223|NCT01819285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101270224|NCT01819285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270226|NCT01819389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101270227|NCT01819389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101270228|NCT01819389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101313964|NCT00000676|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101270229|NCT01819389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270231|NCT01819402|Glimepiride|glimepiride|mesh-list
101270232|NCT01819402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101270233|NCT01819402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270234|NCT01819402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101270235|NCT01819402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101270236|NCT01819402|Immunologic Factors|immunologic factors|mesh-ancestor
101270237|NCT01819441|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101270238|NCT01819441|Perindopril|perindopril|mesh-list
101270239|NCT01819441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101270240|NCT01819441|Diuretics|diuretics|mesh-ancestor
101270241|NCT01819441|Natriuretic Agents|natriuretic agents|mesh-ancestor
101270242|NCT01819441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270243|NCT01819441|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101270244|NCT01819441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101270245|NCT01819441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270246|NCT01819441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101270247|NCT01819441|Protease Inhibitors|protease inhibitors|mesh-ancestor
101270248|NCT01819441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101270249|NCT01819610|Ketorolac|ketorolac|mesh-list
101270250|NCT01819610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101270251|NCT01819610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101270252|NCT01819610|Analgesics|analgesics|mesh-ancestor
101270253|NCT01819610|Sensory System Agents|sensory system agents|mesh-ancestor
101270254|NCT01819610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101270255|NCT01819610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270257|NCT01819610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101270258|NCT01819610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101270259|NCT01819610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101270260|NCT01819610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270261|NCT01819649|Selenium|selenium|mesh-list
101270262|NCT01819649|Antioxidants|antioxidants|mesh-ancestor
101270263|NCT01819649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270264|NCT01819649|Protective Agents|protective agents|mesh-ancestor
101270265|NCT01819649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270266|NCT01819649|Trace Elements|trace elements|mesh-ancestor
101270267|NCT01819649|Micronutrients|micronutrients|mesh-ancestor
101270268|NCT01819701|Ubiquinone|ubiquinone|mesh-list
101270269|NCT01819701|Coenzyme Q10|coenzyme q10|mesh-list
101816840|NCT05254808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101816841|NCT05254808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101816842|NCT05254808|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101816843|NCT02275286|Trabectedin|trabectedin|mesh-list
101816844|NCT02275286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101816845|NCT02275286|Alkylating Agents|alkylating agents|mesh-ancestor
101816846|NCT02275286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270270|NCT01819701|Micronutrients|micronutrients|mesh-ancestor
101270271|NCT01819701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270272|NCT01819701|Vitamins|vitamins|mesh-ancestor
101270273|NCT01819779|Amlodipine|amlodipine|mesh-list
101270274|NCT01819779|Valsartan|valsartan|mesh-list
101270275|NCT01819779|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
101270276|NCT01819779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101270277|NCT01819779|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101270278|NCT01819779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101270279|NCT01819779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270280|NCT01819779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101270281|NCT01819779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270282|NCT01819779|Vasodilator Agents|vasodilator agents|mesh-ancestor
101270283|NCT01819779|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101270284|NCT01819779|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101270285|NCT01819857|Ondansetron|ondansetron|mesh-list
101270286|NCT01819857|Antiemetics|antiemetics|mesh-ancestor
101270287|NCT01819857|Autonomic Agents|autonomic agents|mesh-ancestor
101313976|NCT00000682|Zidovudine|zidovudine|mesh-list
101270288|NCT01819857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101270289|NCT01819857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270290|NCT01819857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101270291|NCT01819857|Antipruritics|antipruritics|mesh-ancestor
101270292|NCT01819857|Dermatologic Agents|dermatologic agents|mesh-ancestor
101270293|NCT01819857|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101270294|NCT01819857|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101270295|NCT01819857|Serotonin Agents|serotonin agents|mesh-ancestor
101270296|NCT01819857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101270297|NCT01819857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270298|NCT01819870|Carvedilol|carvedilol|mesh-list
101270299|NCT01819870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101270300|NCT01819870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101270301|NCT01819870|Adrenergic Agents|adrenergic agents|mesh-ancestor
101270302|NCT01819870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101270303|NCT01819870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270304|NCT01819870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270305|NCT01819870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101270306|NCT01819870|Antioxidants|antioxidants|mesh-ancestor
101270307|NCT01819870|Protective Agents|protective agents|mesh-ancestor
101270308|NCT01819870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101270309|NCT01819870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101270310|NCT01819870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101270311|NCT01819870|Vasodilator Agents|vasodilator agents|mesh-ancestor
101270312|NCT01819870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101270313|NCT01819870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101270314|NCT01819961|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101270315|NCT01819961|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101270316|NCT01819961|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101270317|NCT01819961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101270318|NCT01820026|Amoxicillin|amoxicillin|mesh-list
101270319|NCT01820026|Azithromycin|azithromycin|mesh-list
101270320|NCT01820026|Vancomycin|vancomycin|mesh-list
101270321|NCT01820026|Imipenem|imipenem|mesh-list
101270322|NCT01820026|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101270323|NCT01820026|Cefotaxime|cefotaxime|mesh-list
101270324|NCT01820026|Cefoxitin|cefoxitin|mesh-list
101270325|NCT01820026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101816847|NCT02275286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101816848|NCT00998192|Paclitaxel|paclitaxel|mesh-list
101816849|NCT00998192|Carboplatin|carboplatin|mesh-list
101816850|NCT00998192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101816851|NCT00998192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101816852|NCT00998192|Tubulin Modulators|tubulin modulators|mesh-ancestor
101816853|NCT00998192|Antimitotic Agents|antimitotic agents|mesh-ancestor
101816854|NCT00998192|Mitosis Modulators|mitosis modulators|mesh-ancestor
101816855|NCT00998192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816856|NCT00994526|Vitamin E|vitamin e|mesh-list
101816857|NCT00994526|Calcium|calcium|mesh-list
101816858|NCT00994526|Vitamins|vitamins|mesh-ancestor
101816859|NCT00994526|Micronutrients|micronutrients|mesh-ancestor
101816860|NCT00994526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816861|NCT00994526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101816862|NCT00994526|Antioxidants|antioxidants|mesh-ancestor
101816863|NCT00994526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816864|NCT00994526|Protective Agents|protective agents|mesh-ancestor
101816865|NCT00998504|Resveratrol|resveratrol|mesh-list
101816866|NCT00998504|Antioxidants|antioxidants|mesh-ancestor
101270326|NCT01820026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101270327|NCT01820026|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101270328|NCT01820026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101270329|NCT01820026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270330|NCT01820091|Levoleucovorin|levoleucovorin|mesh-list
101270331|NCT01820091|Antidotes|antidotes|mesh-ancestor
101270332|NCT01820091|Protective Agents|protective agents|mesh-ancestor
101270333|NCT01820091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270334|NCT01820104|Lansoprazole|lansoprazole|mesh-list
101270335|NCT01820104|Dexlansoprazole|dexlansoprazole|mesh-list
101270336|NCT01820104|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101270337|NCT01820104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101270338|NCT01820104|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101270339|NCT01820104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101270340|NCT01820104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270341|NCT01820143|Esomeprazole|esomeprazole|mesh-list
101270343|NCT01820143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101270344|NCT01820143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101270345|NCT01820143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101270346|NCT01820143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270347|NCT01820299|Vitamin D|vitamin d|mesh-list
101270348|NCT01820299|Grape Seed Extract|grape seed extract|mesh-list
101270349|NCT01820299|Vitamins|vitamins|mesh-ancestor
101270350|NCT01820299|Micronutrients|micronutrients|mesh-ancestor
101270351|NCT01820299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270352|NCT01820299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101270353|NCT01820299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101270354|NCT01820299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101270355|NCT01820299|Antioxidants|antioxidants|mesh-ancestor
101270356|NCT01820299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270357|NCT01820299|Protective Agents|protective agents|mesh-ancestor
101270358|NCT01820312|Paclitaxel|paclitaxel|mesh-list
101270359|NCT01820312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101270360|NCT01820312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101270361|NCT01820312|Tubulin Modulators|tubulin modulators|mesh-ancestor
101816867|NCT00998504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816868|NCT00998504|Protective Agents|protective agents|mesh-ancestor
101816869|NCT00998504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816870|NCT00998504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101816871|NCT00998504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101816872|NCT00788684|Rituximab|rituximab|mesh-list
101816873|NCT00788684|Navitoclax|navitoclax|mesh-list
101816874|NCT00788684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101816875|NCT00788684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101816876|NCT00788684|Immunologic Factors|immunologic factors|mesh-ancestor
101270362|NCT01820312|Antimitotic Agents|antimitotic agents|mesh-ancestor
101270363|NCT01820312|Mitosis Modulators|mitosis modulators|mesh-ancestor
101270364|NCT01820312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270366|NCT01820325|Carboplatin|carboplatin|mesh-list
101270367|NCT01820325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101270368|NCT01820325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101270369|NCT01820325|Tubulin Modulators|tubulin modulators|mesh-ancestor
101270370|NCT01820325|Antimitotic Agents|antimitotic agents|mesh-ancestor
101270371|NCT01820325|Mitosis Modulators|mitosis modulators|mesh-ancestor
101270372|NCT01820325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270373|NCT01820442|Lofexidine|lofexidine|mesh-list
101270374|NCT01820442|Clonidine|clonidine|mesh-list
101270375|NCT01820442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101270376|NCT01820442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101270377|NCT01820442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270378|NCT01820442|Sensory System Agents|sensory system agents|mesh-ancestor
101270379|NCT01820442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101270380|NCT01820442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101270381|NCT01820442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101270382|NCT01820442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101270383|NCT01820442|Adrenergic Agents|adrenergic agents|mesh-ancestor
101270384|NCT01820442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101270385|NCT01820442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270386|NCT01820442|Analgesics|analgesics|mesh-ancestor
101270387|NCT01820442|Sympatholytics|sympatholytics|mesh-ancestor
101270388|NCT01820442|Autonomic Agents|autonomic agents|mesh-ancestor
101270389|NCT01820455|Chlorhexidine|chlorhexidine|mesh-list
101270390|NCT01820455|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101270391|NCT01820455|Mupirocin|mupirocin|mesh-list
101270392|NCT01820455|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101270393|NCT01820455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101270394|NCT01820455|Disinfectants|disinfectants|mesh-ancestor
101270395|NCT01820455|Dermatologic Agents|dermatologic agents|mesh-ancestor
101270396|NCT01820455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101270397|NCT01820455|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101270398|NCT01820455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101270399|NCT01820455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270400|NCT01820624|Tretinoin|tretinoin|mesh-list
101270401|NCT01820624|Lithium Carbonate|lithium carbonate|mesh-list
101270402|NCT01820624|Antidepressive Agents|antidepressive agents|mesh-ancestor
101270403|NCT01820624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101270404|NCT01820624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101270405|NCT01820624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270406|NCT01820624|Antimanic Agents|antimanic agents|mesh-ancestor
101270407|NCT01820624|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101270408|NCT01820624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101270409|NCT01820624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270412|NCT01820624|Dermatologic Agents|dermatologic agents|mesh-ancestor
101270413|NCT01820767|Ergocalciferols|ergocalciferols|mesh-list
101270414|NCT01820767|Atorvastatin|atorvastatin|mesh-list
101270415|NCT01820767|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101270416|NCT01820767|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101270417|NCT01820767|Antimetabolites|antimetabolites|mesh-ancestor
101270418|NCT01820767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816877|NCT00788684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816878|NCT00788684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101816879|NCT00998972|Acetylcysteine|acetylcysteine|mesh-list
101816880|NCT00998972|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101816881|NCT00998972|Antiviral Agents|antiviral agents|mesh-ancestor
101816882|NCT00998972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101816883|NCT00998972|Expectorants|expectorants|mesh-ancestor
101816884|NCT00998972|Respiratory System Agents|respiratory system agents|mesh-ancestor
101816885|NCT00998972|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101816886|NCT00998972|Antioxidants|antioxidants|mesh-ancestor
101816887|NCT00998972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816888|NCT00998972|Protective Agents|protective agents|mesh-ancestor
101816890|NCT00998972|Antidotes|antidotes|mesh-ancestor
101270419|NCT01820767|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101270420|NCT01820767|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101270421|NCT01820767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101270422|NCT01820767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101270423|NCT01820767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270424|NCT01820767|Vitamins|vitamins|mesh-ancestor
101270425|NCT01820767|Micronutrients|micronutrients|mesh-ancestor
101270426|NCT01820767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101270427|NCT01820793|Cefoxitin|cefoxitin|mesh-list
101270428|NCT01820793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101270429|NCT01820793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101270430|NCT01820832|Cholecalciferol|cholecalciferol|mesh-list
101270431|NCT01820832|Calcitriol|calcitriol|mesh-list
101270432|NCT01820832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101270433|NCT01820832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270435|NCT01820832|Micronutrients|micronutrients|mesh-ancestor
101270436|NCT01820832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101270437|NCT01820832|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101270438|NCT01820832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101270439|NCT01820832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270440|NCT01820832|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101270441|NCT01820897|Trimethoprim|trimethoprim|mesh-list
101270442|NCT01820897|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101270443|NCT01820897|Sulfamethoxazole|sulfamethoxazole|mesh-list
101270444|NCT01820897|Fosfomycin|fosfomycin|mesh-list
101270445|NCT01820897|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101270446|NCT01820897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101270447|NCT01820897|Antimalarials|antimalarials|mesh-ancestor
101270448|NCT01820897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101270449|NCT01820897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101270450|NCT01820897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101270451|NCT01820897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101270452|NCT01820897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270453|NCT01820897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101270454|NCT01820897|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101270455|NCT01820897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101270456|NCT01820897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101270457|NCT01820962|Heparin|heparin|mesh-list
101270458|NCT01820962|Anticoagulants|anticoagulants|mesh-ancestor
101270459|NCT01820962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270460|NCT01820962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101270461|NCT01820962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101270462|NCT01821001|Bromocriptine|bromocriptine|mesh-list
101270463|NCT01821001|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101270464|NCT01821001|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101270465|NCT01821001|Hormone Antagonists|hormone antagonists|mesh-ancestor
101816891|NCT00390910|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101816892|NCT00390910|Immunologic Factors|immunologic factors|mesh-ancestor
101816893|NCT00390910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816894|NCT00998816|Pregabalin|pregabalin|mesh-list
101816895|NCT00998816|Analgesics|analgesics|mesh-ancestor
101816896|NCT00998816|Sensory System Agents|sensory system agents|mesh-ancestor
101816897|NCT00998816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101816898|NCT00998816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816899|NCT00998816|Anticonvulsants|anticonvulsants|mesh-ancestor
101816900|NCT00998816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101816901|NCT00998816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101816902|NCT00998816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816903|NCT00998816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101816904|NCT00998816|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101816905|NCT00998816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101270466|NCT01821001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101270467|NCT01821001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270468|NCT01821001|Dopamine Agonists|dopamine agonists|mesh-ancestor
101270469|NCT01821001|Dopamine Agents|dopamine agents|mesh-ancestor
101270470|NCT01821001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101270471|NCT01821001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270472|NCT01821027|Canagliflozin|canagliflozin|mesh-list
101270473|NCT01821027|Simvastatin|simvastatin|mesh-list
101270474|NCT01821027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101270475|NCT01821027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101270476|NCT01821027|Antimetabolites|antimetabolites|mesh-ancestor
101270477|NCT01821027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270478|NCT01821027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101270479|NCT01821027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101270480|NCT01821027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101270481|NCT01821027|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101270482|NCT01821027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101270483|NCT01821027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270484|NCT01821040|Prednisone|prednisone|mesh-list
101270485|NCT01821040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101270486|NCT01821040|Glucocorticoids|glucocorticoids|mesh-ancestor
101270487|NCT01821040|Hormones|hormones|mesh-ancestor
101270488|NCT01821040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101270489|NCT01821040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270490|NCT01821040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101270491|NCT01821040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101270492|NCT01821066|Tamoxifen|tamoxifen|mesh-list
101270493|NCT01821066|Palbociclib|palbociclib|mesh-list
101270494|NCT01821066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101270495|NCT01821066|Hormone Antagonists|hormone antagonists|mesh-ancestor
101270496|NCT01821066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101270497|NCT01821066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270498|NCT01821066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101270499|NCT01821066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101270500|NCT01821066|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101270501|NCT01821066|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101270502|NCT01821066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101270503|NCT01821066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101270504|NCT01821066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101816906|NCT00998816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101816907|NCT00998816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101816909|NCT00533702|Ramucirumab|ramucirumab|mesh-list
101816910|NCT00533702|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101816911|NCT00533702|Imidazole|imidazole|mesh-list
101816912|NCT00533702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101816913|NCT00533702|Alkylating Agents|alkylating agents|mesh-ancestor
101816914|NCT00533702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816915|NCT00533702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101816916|NCT00533702|Immunologic Factors|immunologic factors|mesh-ancestor
101816917|NCT00533702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816918|NCT00533702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101816919|NCT00408694|Bevacizumab|bevacizumab|mesh-list
101816920|NCT00408694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101816921|NCT00408694|Cisplatin|cisplatin|mesh-list
101816922|NCT00408694|Fluorouracil|fluorouracil|mesh-list
101816923|NCT00408694|Endothelial Growth Factors|endothelial growth factors|mesh-list
101816924|NCT00408694|Antibodies|antibodies|mesh-list
101816925|NCT00408694|Immunoglobulins|immunoglobulins|mesh-list
101816926|NCT00408694|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101816927|NCT00408694|Immunoglobulin G|immunoglobulin g|mesh-list
101816928|NCT00408694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101816929|NCT00408694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101816930|NCT00408694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101270505|NCT01821066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270506|NCT01821170|Methylphenidate|methylphenidate|mesh-list
101270507|NCT01821170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101270508|NCT01821170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270509|NCT01821170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101270510|NCT01821170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101270511|NCT01821170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101270512|NCT01821170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270513|NCT01821170|Dopamine Agents|dopamine agents|mesh-ancestor
101270514|NCT01821170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101270515|NCT01821235|Gabapentin|gabapentin|mesh-list
101270516|NCT01821235|Analgesics|analgesics|mesh-ancestor
101270517|NCT01821235|Sensory System Agents|sensory system agents|mesh-ancestor
101270518|NCT01821235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101270519|NCT01821235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270520|NCT01821235|Anticonvulsants|anticonvulsants|mesh-ancestor
101270521|NCT01821235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101270522|NCT01821235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101270523|NCT01821235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101270524|NCT01821235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101270525|NCT01821235|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101270526|NCT01821235|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101270527|NCT01821235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101816931|NCT00408694|Growth Substances|growth substances|mesh-ancestor
101816932|NCT00408694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816933|NCT00408694|Growth Inhibitors|growth inhibitors|mesh-ancestor
101816934|NCT00408694|Immunologic Factors|immunologic factors|mesh-ancestor
101816936|NCT00408694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816937|NCT00408694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101816938|NCT00408694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101816939|NCT00999128|Rabeprazole|rabeprazole|mesh-list
101270528|NCT01821235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270531|NCT01821248|Gemcitabine|gemcitabine|mesh-list
101270532|NCT01821248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101270533|NCT01821248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101270534|NCT01821248|Antimetabolites|antimetabolites|mesh-ancestor
101270535|NCT01821248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270536|NCT01821261|Chlorhexidine|chlorhexidine|mesh-list
101270538|NCT01821261|Cariostatic Agents|cariostatic agents|mesh-ancestor
101270539|NCT01821261|Protective Agents|protective agents|mesh-ancestor
101270540|NCT01821261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270541|NCT01821261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101270542|NCT01821261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101270543|NCT01821261|Disinfectants|disinfectants|mesh-ancestor
101270544|NCT01821274|Diltiazem|diltiazem|mesh-list
101270545|NCT01821274|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101270546|NCT01821274|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101270547|NCT01821274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101270548|NCT01821274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270549|NCT01821274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101270550|NCT01821274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270552|NCT01821404|Atorvastatin|atorvastatin|mesh-list
101270553|NCT01821404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101270554|NCT01821404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101270555|NCT01821404|Antimetabolites|antimetabolites|mesh-ancestor
101270556|NCT01821404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270557|NCT01821404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101270558|NCT01821404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101270559|NCT01821404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101270560|NCT01821430|Pregabalin|pregabalin|mesh-list
101270561|NCT01821430|Analgesics|analgesics|mesh-ancestor
101270562|NCT01821430|Sensory System Agents|sensory system agents|mesh-ancestor
101270563|NCT01821430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101270564|NCT01821430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270565|NCT01821430|Anticonvulsants|anticonvulsants|mesh-ancestor
101270566|NCT01821430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101270567|NCT01821430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101270568|NCT01821430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270569|NCT01821430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101270570|NCT01821430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101270571|NCT01821430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101270572|NCT01821430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101270573|NCT01821430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101270574|NCT01821456|Antiviral Agents|antiviral agents|mesh-list
101270575|NCT01821456|Anti-Infective Agents|anti-infective agents|mesh-list
101270576|NCT01821573|Botulinum Toxins|botulinum toxins|mesh-list
101270577|NCT01821573|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101270578|NCT01821573|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101270579|NCT01821573|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101270580|NCT01821573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101270581|NCT01821573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270582|NCT01821573|Cholinergic Agents|cholinergic agents|mesh-ancestor
101270583|NCT01821573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101270584|NCT01821573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270585|NCT01821573|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101816940|NCT00999128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101816941|NCT00999128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101816942|NCT00999128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101816943|NCT00999128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101816944|NCT00999128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816946|NCT00999206|Immunologic Factors|immunologic factors|mesh-ancestor
101816947|NCT00999206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816948|NCT01043224|Clobetasol|clobetasol|mesh-list
101816949|NCT01043224|Calcipotriene|calcipotriene|mesh-list
101816950|NCT01043224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101816951|NCT01043224|Glucocorticoids|glucocorticoids|mesh-ancestor
101816952|NCT01043224|Hormones|hormones|mesh-ancestor
101816953|NCT01043224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101816954|NCT01043224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270586|NCT01821573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101270587|NCT01821612|Leucovorin|leucovorin|mesh-list
101270588|NCT01821612|Gemcitabine|gemcitabine|mesh-list
101270589|NCT01821612|Fluorouracil|fluorouracil|mesh-list
101270590|NCT01821612|Capecitabine|capecitabine|mesh-list
101270591|NCT01821612|Oxaliplatin|oxaliplatin|mesh-list
101270592|NCT01821612|Irinotecan|irinotecan|mesh-list
101270593|NCT01821612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101270594|NCT01821612|Antimetabolites|antimetabolites|mesh-ancestor
101270595|NCT01821612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270596|NCT01821612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101270597|NCT01821612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101270598|NCT01821612|Immunologic Factors|immunologic factors|mesh-ancestor
101270599|NCT01821612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270600|NCT01821612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101270601|NCT01821612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101270602|NCT01821612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101270603|NCT01821612|Antidotes|antidotes|mesh-ancestor
101270604|NCT01821612|Protective Agents|protective agents|mesh-ancestor
101270605|NCT01821612|Vitamin B Complex|vitamin b complex|mesh-ancestor
101270606|NCT01821612|Vitamins|vitamins|mesh-ancestor
101270607|NCT01821612|Micronutrients|micronutrients|mesh-ancestor
101270608|NCT01821664|Heparin|heparin|mesh-list
101270609|NCT01821664|Anticoagulants|anticoagulants|mesh-ancestor
101270610|NCT01821664|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101270611|NCT01821664|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101270612|NCT01821664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270613|NCT01821703|Spironolactone|spironolactone|mesh-list
101270614|NCT01821703|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101270615|NCT01821703|Hormone Antagonists|hormone antagonists|mesh-ancestor
101270616|NCT01821703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101270617|NCT01821703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270618|NCT01821703|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101270619|NCT01821703|Diuretics|diuretics|mesh-ancestor
101270620|NCT01821703|Natriuretic Agents|natriuretic agents|mesh-ancestor
101270621|NCT01821846|Liraglutide|liraglutide|mesh-list
101270622|NCT01821846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101270623|NCT01821846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270624|NCT01821846|Incretins|incretins|mesh-ancestor
101270625|NCT01821846|Hormones|hormones|mesh-ancestor
101270626|NCT01821846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101270627|NCT01821872|Acetaminophen|acetaminophen|mesh-list
101270628|NCT01821872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101270629|NCT01821872|Analgesics|analgesics|mesh-ancestor
101270630|NCT01821872|Sensory System Agents|sensory system agents|mesh-ancestor
101270631|NCT01821872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101270632|NCT01821872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816955|NCT01043224|Dermatologic Agents|dermatologic agents|mesh-ancestor
101816956|NCT01044238|Methylphenidate|methylphenidate|mesh-list
101816957|NCT01044238|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101816958|NCT01044238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816959|NCT01044238|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101816960|NCT01044238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101816961|NCT01044238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101474277|NCT04718376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101270633|NCT01821872|Antipyretics|antipyretics|mesh-ancestor
101270634|NCT01821989|Lactoferrin|lactoferrin|mesh-list
101270635|NCT01821989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101270636|NCT01822028|Miglustat|miglustat|mesh-list
101270637|NCT01822028|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
101270638|NCT01822028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101270639|NCT01822028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270640|NCT01822028|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101270641|NCT01822028|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101270642|NCT01822028|Antiviral Agents|antiviral agents|mesh-ancestor
101270643|NCT01822028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101270644|NCT01822028|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101270645|NCT01822028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101270646|NCT01822028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270647|NCT01822080|Dienogest|dienogest|mesh-list
101270648|NCT01822080|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101270649|NCT01822080|Contraceptive Agents|contraceptive agents|mesh-ancestor
101270650|NCT01822080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101270651|NCT01822080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270652|NCT01822080|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101270653|NCT01822080|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101270654|NCT01822080|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101270655|NCT01822080|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101270656|NCT01822080|Hormone Antagonists|hormone antagonists|mesh-ancestor
101270657|NCT01822080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101270658|NCT01822080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101270659|NCT01822080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101270660|NCT01822210|Botulinum Toxins|botulinum toxins|mesh-list
101270661|NCT01822210|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101270662|NCT01822210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101270663|NCT01822210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270664|NCT01822210|Cholinergic Agents|cholinergic agents|mesh-ancestor
101270665|NCT01822210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101270666|NCT01822210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270668|NCT01822405|Vitamin E|vitamin e|mesh-list
101270669|NCT01822405|Tocotrienols|tocotrienols|mesh-list
101270670|NCT01822405|alpha-Tocopherol|alpha-tocopherol|mesh-list
101270671|NCT01822405|Pentoxifylline|pentoxifylline|mesh-list
101270672|NCT01822405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101270673|NCT01822405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101270674|NCT01822405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270675|NCT01822405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101270676|NCT01822405|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101270677|NCT01822405|Protective Agents|protective agents|mesh-ancestor
101270678|NCT01822405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270679|NCT01822405|Vasodilator Agents|vasodilator agents|mesh-ancestor
101270680|NCT01822405|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101270681|NCT01822405|Antioxidants|antioxidants|mesh-ancestor
101270683|NCT01822405|Micronutrients|micronutrients|mesh-ancestor
101270684|NCT01822418|Agomelatine|agomelatine|mesh-list
101270685|NCT01822418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101270686|NCT01822418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101270687|NCT01822418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270688|NCT01822431|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
101816962|NCT01044238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816963|NCT01044238|Dopamine Agents|dopamine agents|mesh-ancestor
101816964|NCT01044238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101816965|NCT01043380|Atorvastatin|atorvastatin|mesh-list
101816966|NCT01043380|Ezetimibe|ezetimibe|mesh-list
101816967|NCT01043380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101816968|NCT01043380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101816969|NCT01043380|Antimetabolites|antimetabolites|mesh-ancestor
101816970|NCT01043380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816971|NCT01043380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101816972|NCT01043380|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101816973|NCT01043380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101816974|NCT01044394|Bisacodyl|bisacodyl|mesh-list
101816975|NCT01044394|Cathartics|cathartics|mesh-ancestor
101816976|NCT01044394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101816977|NCT01044394|Laxatives|laxatives|mesh-ancestor
101816978|NCT03474094|Atezolizumab|atezolizumab|mesh-list
101816979|NCT03474094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101816980|NCT03474094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101816981|NCT03474094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816982|NCT03474094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101816983|NCT03474094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101816984|NCT03474094|Immunologic Factors|immunologic factors|mesh-ancestor
101816985|NCT03474094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101816986|NCT01043536|Temozolomide|temozolomide|mesh-list
101816987|NCT01043536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101816988|NCT01043536|Alkylating Agents|alkylating agents|mesh-ancestor
101816989|NCT01043536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816990|NCT01043536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101816991|NCT01004198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101270689|NCT01822431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101270690|NCT01822431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101270691|NCT01822431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270692|NCT01822431|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101270693|NCT01822483|Mycophenolic Acid|mycophenolic acid|mesh-list
101270694|NCT01822483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101270695|NCT01822483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101270696|NCT01822483|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101270697|NCT01822483|Antitubercular Agents|antitubercular agents|mesh-ancestor
101270698|NCT01822483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101270699|NCT01822483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101270700|NCT01822483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101270701|NCT01822483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270702|NCT01822600|Omeprazole|omeprazole|mesh-list
101816992|NCT00056407|Dutasteride|dutasteride|mesh-list
101816993|NCT00056407|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101816994|NCT00056407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101816995|NCT00056407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101816996|NCT00056407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101816997|NCT00056407|Hormone Antagonists|hormone antagonists|mesh-ancestor
101816998|NCT00056407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101816999|NCT00056407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817000|NCT00387790|Motexafin gadolinium|motexafin gadolinium|mesh-list
101817001|NCT00387790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101817002|NCT00387790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101270703|NCT01822600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101270704|NCT01822600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101270705|NCT01822600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101270706|NCT01822600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101270707|NCT01822600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270708|NCT01822613|Paclitaxel|paclitaxel|mesh-list
101270709|NCT01822613|Docetaxel|docetaxel|mesh-list
101270710|NCT01822613|Irinotecan|irinotecan|mesh-list
101270711|NCT01822613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101314082|NCT00000751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101270712|NCT01822613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101270714|NCT01822613|Antimitotic Agents|antimitotic agents|mesh-ancestor
101270715|NCT01822613|Mitosis Modulators|mitosis modulators|mesh-ancestor
101270716|NCT01822613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270717|NCT01822613|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101270718|NCT01822613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101270719|NCT01822613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101270720|NCT01822639|Amlodipine|amlodipine|mesh-list
101270721|NCT01822639|Enalapril|enalapril|mesh-list
101270722|NCT01822639|Enalaprilat|enalaprilat|mesh-list
101270723|NCT01822639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101270724|NCT01822639|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101270725|NCT01822639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101270726|NCT01822639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270728|NCT01822639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270729|NCT01822639|Vasodilator Agents|vasodilator agents|mesh-ancestor
101270730|NCT01822639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101270731|NCT01822639|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101270732|NCT01822639|Protease Inhibitors|protease inhibitors|mesh-ancestor
101270733|NCT01822730|Risperidone|risperidone|mesh-list
101270734|NCT01822730|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101270735|NCT01822730|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101270736|NCT01822730|Serotonin Agents|serotonin agents|mesh-ancestor
101270737|NCT01822730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101270738|NCT01822730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270739|NCT01822730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270740|NCT01822730|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101270741|NCT01822730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101270742|NCT01822730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101270743|NCT01822730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101270744|NCT01822730|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101270745|NCT01822730|Dopamine Agents|dopamine agents|mesh-ancestor
101270746|NCT01822730|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101270747|NCT01822730|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101270748|NCT01822808|Hydralazine|hydralazine|mesh-list
101270749|NCT01822808|Isosorbide|isosorbide|mesh-list
101270750|NCT01822808|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
101270751|NCT01822808|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
101270752|NCT01822808|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101817003|NCT00387790|Dermatologic Agents|dermatologic agents|mesh-ancestor
101817004|NCT00073021|Mesalamine|mesalamine|mesh-list
101817005|NCT00073021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101817006|NCT00073021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101817007|NCT00073021|Analgesics|analgesics|mesh-ancestor
101817008|NCT00073021|Sensory System Agents|sensory system agents|mesh-ancestor
101817009|NCT00073021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101270753|NCT01822808|Diuretics|diuretics|mesh-ancestor
101270754|NCT01822808|Natriuretic Agents|natriuretic agents|mesh-ancestor
101270755|NCT01822808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270756|NCT01822808|Vasodilator Agents|vasodilator agents|mesh-ancestor
101270757|NCT01822808|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101270758|NCT01822808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270759|NCT01822808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101270760|NCT01822860|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101270761|NCT01822860|Chlorthalidone|chlorthalidone|mesh-list
101270762|NCT01822860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101270763|NCT01822860|Diuretics|diuretics|mesh-ancestor
101270764|NCT01822860|Natriuretic Agents|natriuretic agents|mesh-ancestor
101270765|NCT01822860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270766|NCT01822860|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101270767|NCT01822860|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101270768|NCT01822860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270769|NCT01822951|Cerebrolysin|cerebrolysin|mesh-list
101270771|NCT01822951|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101270772|NCT01822951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101270773|NCT01822951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270774|NCT01822951|Cholinergic Agents|cholinergic agents|mesh-ancestor
101270775|NCT01822951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101270776|NCT01822951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270777|NCT01822951|Nootropic Agents|nootropic agents|mesh-ancestor
101270778|NCT01822951|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101270779|NCT01822951|Protective Agents|protective agents|mesh-ancestor
101270780|NCT01822977|Omeprazole|omeprazole|mesh-list
101270781|NCT01822977|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101270782|NCT01822977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101270783|NCT01822977|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101270784|NCT01822977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101270785|NCT01822977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270786|NCT01823029|Epoetin Alfa|epoetin alfa|mesh-list
101270787|NCT01823029|Hematinics|hematinics|mesh-ancestor
101270788|NCT01822509|Nivolumab|nivolumab|mesh-list
101270789|NCT01822509|Ipilimumab|ipilimumab|mesh-list
101270790|NCT01822509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101270791|NCT01822509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101270792|NCT01822509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101270793|NCT01822509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270794|NCT01823042|Azathioprine|azathioprine|mesh-list
101270795|NCT01823042|Antimetabolites|antimetabolites|mesh-ancestor
101270796|NCT01823042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270797|NCT01823042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101270798|NCT01823042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101270799|NCT01823042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101270800|NCT01823042|Immunologic Factors|immunologic factors|mesh-ancestor
101270801|NCT01823042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270802|NCT01823042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101270803|NCT01823081|Bevacizumab|bevacizumab|mesh-list
101270804|NCT01823081|Fasudil|fasudil|mesh-list
101270805|NCT01823081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101270806|NCT01823081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101270807|NCT01823081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101270808|NCT01823081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101270809|NCT01823081|Growth Substances|growth substances|mesh-ancestor
101270810|NCT01823081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270811|NCT01823081|Growth Inhibitors|growth inhibitors|mesh-ancestor
101270812|NCT01823081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101270813|NCT01823081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101817010|NCT00073021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817011|NCT00073021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101817012|NCT00073021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101817013|NCT01584115|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
101817014|NCT01584115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101817015|NCT01584115|Immunologic Factors|immunologic factors|mesh-ancestor
101817016|NCT01584115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817017|NCT00395746|Liraglutide|liraglutide|mesh-list
101817018|NCT00395746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101817019|NCT00395746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817020|NCT00395746|Incretins|incretins|mesh-ancestor
101817021|NCT00395746|Hormones|hormones|mesh-ancestor
101817022|NCT00395746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101817023|NCT01004900|Timolol|timolol|mesh-list
101817024|NCT01004900|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101270814|NCT01823081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270815|NCT01823081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101270816|NCT01823081|Vasodilator Agents|vasodilator agents|mesh-ancestor
101270817|NCT01823081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101270818|NCT01823081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101270819|NCT01823133|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101270820|NCT01823133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101270821|NCT01823133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101270822|NCT01823133|Antimetabolites|antimetabolites|mesh-ancestor
101270823|NCT01823133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270824|NCT01823133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101270825|NCT01823133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101270826|NCT01823133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101270827|NCT01823159|Ezogabine|ezogabine|mesh-list
101270828|NCT01823159|Anticonvulsants|anticonvulsants|mesh-ancestor
101270829|NCT01823159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101270830|NCT01823159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270831|NCT01823172|Methylene Blue|methylene blue|mesh-list
101270832|NCT01823172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101270833|NCT01823172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270834|NCT01823185|Clopidogrel|clopidogrel|mesh-list
101270835|NCT01823185|Ticagrelor|ticagrelor|mesh-list
101270836|NCT01823185|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101270837|NCT01823185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101270838|NCT01823185|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101270839|NCT01823185|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101270840|NCT01823185|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101270841|NCT01823185|Purinergic Agents|purinergic agents|mesh-ancestor
101270842|NCT01823185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101270843|NCT01823185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270844|NCT01823185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270846|NCT01823393|Calcium heparin|calcium heparin|mesh-list
101270847|NCT01823393|Anticoagulants|anticoagulants|mesh-ancestor
101270848|NCT01823393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101270849|NCT01823393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101270850|NCT01823393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270851|NCT01823523|Clindamycin|clindamycin|mesh-list
101270852|NCT01823523|Clindamycin palmitate|clindamycin palmitate|mesh-list
101270853|NCT01823523|Clindamycin phosphate|clindamycin phosphate|mesh-list
101270854|NCT01823523|Cefazolin|cefazolin|mesh-list
101270855|NCT01823523|Cephalexin|cephalexin|mesh-list
101270856|NCT01823523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101270857|NCT01823523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101270858|NCT01823523|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101270859|NCT01823523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101817025|NCT01004900|Travoprost|travoprost|mesh-list
101817026|NCT01004900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101817027|NCT01004900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101817028|NCT01004900|Adrenergic Agents|adrenergic agents|mesh-ancestor
101817029|NCT01004900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101817030|NCT01004900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817031|NCT01004900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817032|NCT01004900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101817033|NCT01004900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101817034|NCT01004900|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101817035|NCT01004900|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101817037|NCT04001348|Diazepam|diazepam|mesh-list
101817038|NCT04001348|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101817039|NCT04001348|Anticonvulsants|anticonvulsants|mesh-ancestor
101817040|NCT04001348|Antiemetics|antiemetics|mesh-ancestor
101817041|NCT04001348|Autonomic Agents|autonomic agents|mesh-ancestor
101817042|NCT04001348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101817043|NCT04001348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270860|NCT01823523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270861|NCT01823744|Micronutrients|micronutrients|mesh-list
101270862|NCT01823744|Trace Elements|trace elements|mesh-list
101270863|NCT01823744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270864|NCT01823770|Rotigotine|rotigotine|mesh-list
101270865|NCT01823770|Dopamine Agonists|dopamine agonists|mesh-ancestor
101270866|NCT01823770|Dopamine Agents|dopamine agents|mesh-ancestor
101270867|NCT01823770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101270868|NCT01823770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270869|NCT01823770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270870|NCT01823809|Adenosine|adenosine|mesh-list
101270871|NCT01823809|Analgesics|analgesics|mesh-ancestor
101270872|NCT01823809|Sensory System Agents|sensory system agents|mesh-ancestor
101270873|NCT01823809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101270874|NCT01823809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270875|NCT01823809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101270876|NCT01823809|Vasodilator Agents|vasodilator agents|mesh-ancestor
101270877|NCT01823809|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101270878|NCT01823809|Purinergic Agonists|purinergic agonists|mesh-ancestor
101270879|NCT01823809|Purinergic Agents|purinergic agents|mesh-ancestor
101270880|NCT01823809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101270881|NCT01823809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270882|NCT01823848|Mineral Oil|mineral oil|mesh-list
101270883|NCT01823848|Emollients|emollients|mesh-ancestor
101270884|NCT01823848|Dermatologic Agents|dermatologic agents|mesh-ancestor
101270885|NCT01823965|Ranibizumab|ranibizumab|mesh-list
101270886|NCT01823965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101270887|NCT01823965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101270888|NCT01823965|Growth Substances|growth substances|mesh-ancestor
101270889|NCT01823965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270890|NCT01823965|Growth Inhibitors|growth inhibitors|mesh-ancestor
101270891|NCT01823965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101270892|NCT01824056|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101270893|NCT01824056|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101270894|NCT01824056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270895|NCT01824199|Omeprazole|omeprazole|mesh-list
101270896|NCT01824199|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101817044|NCT04001348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101817045|NCT04001348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101817046|NCT04001348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101817047|NCT04001348|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101817048|NCT04001348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101817049|NCT04001348|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101817050|NCT04001348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101817051|NCT04001348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101817052|NCT04001348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101817053|NCT04001348|Anesthetics, General|anesthetics, general|mesh-ancestor
101270897|NCT01824199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101270898|NCT01824199|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101270900|NCT01824199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270901|NCT01824225|Aflibercept|aflibercept|mesh-list
101270902|NCT01824225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101270903|NCT01824225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101270904|NCT01824225|Growth Substances|growth substances|mesh-ancestor
101270905|NCT01824225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270906|NCT01824225|Growth Inhibitors|growth inhibitors|mesh-ancestor
101270907|NCT01824225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101270909|NCT01824238|Anacetrapib|anacetrapib|mesh-list
101270910|NCT01824238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101270911|NCT01824238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101270912|NCT01824238|Antimetabolites|antimetabolites|mesh-ancestor
101270913|NCT01824238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270914|NCT01824238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101270915|NCT01824238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101270916|NCT01824238|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101270917|NCT01824238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101270918|NCT01824251|Immunoglobulins|immunoglobulins|mesh-list
101270919|NCT01824251|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101270920|NCT01824251|gamma-Globulins|gamma-globulins|mesh-list
101270921|NCT01824251|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101270922|NCT01824251|Immunologic Factors|immunologic factors|mesh-ancestor
101270923|NCT01824251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270924|NCT01824264|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101270925|NCT01824264|Licogliflozin|licogliflozin|mesh-list
101270926|NCT01824264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101270927|NCT01824264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270928|NCT01824264|Incretins|incretins|mesh-ancestor
101270929|NCT01824264|Hormones|hormones|mesh-ancestor
101270930|NCT01824264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101270931|NCT01824264|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101270932|NCT01824264|Protease Inhibitors|protease inhibitors|mesh-ancestor
101270933|NCT01824264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101270934|NCT01824264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270935|NCT01824264|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101270936|NCT01824420|Mandelic Acids|mandelic acids|mesh-list
101270937|NCT01824420|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101270938|NCT01824420|Oxybutynin|oxybutynin|mesh-list
101270939|NCT01824420|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101270940|NCT01824420|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101270941|NCT01824420|Cholinergic Agents|cholinergic agents|mesh-ancestor
101270942|NCT01824420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101270943|NCT01824420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270944|NCT01824420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270945|NCT01824420|Urological Agents|urological agents|mesh-ancestor
101270946|NCT01824420|Parasympatholytics|parasympatholytics|mesh-ancestor
101270947|NCT01824420|Autonomic Agents|autonomic agents|mesh-ancestor
101270948|NCT01824420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101270949|NCT01824420|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101270950|NCT01824420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101270951|NCT01824433|Fluoxetine|fluoxetine|mesh-list
101270952|NCT01824433|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101817054|NCT04001348|Anesthetics|anesthetics|mesh-ancestor
101817055|NCT04001348|GABA Modulators|gaba modulators|mesh-ancestor
101817056|NCT04001348|GABA Agents|gaba agents|mesh-ancestor
101817057|NCT04001348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101817058|NCT04001348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817059|NCT00395512|Pioglitazone|pioglitazone|mesh-list
101817060|NCT00395512|Alogliptin|alogliptin|mesh-list
101817061|NCT00395512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101817062|NCT00395512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817063|NCT00395512|Incretins|incretins|mesh-ancestor
101817064|NCT00395512|Hormones|hormones|mesh-ancestor
101817065|NCT00395512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101817066|NCT00395512|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101817067|NCT00395512|Protease Inhibitors|protease inhibitors|mesh-ancestor
101817068|NCT00395512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101817069|NCT00395512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817070|NCT03956017|Ubiquinone|ubiquinone|mesh-list
101817071|NCT03956017|Coenzyme Q10|coenzyme q10|mesh-list
101817072|NCT03956017|Micronutrients|micronutrients|mesh-ancestor
101817073|NCT03956017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817074|NCT03956017|Vitamins|vitamins|mesh-ancestor
101817075|NCT00994916|Amifampridine|amifampridine|mesh-list
101270953|NCT01824433|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101270954|NCT01824433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101270955|NCT01824433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101270956|NCT01824433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270957|NCT01824433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101270958|NCT01824433|Serotonin Agents|serotonin agents|mesh-ancestor
101270959|NCT01824433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270960|NCT01824433|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101270961|NCT01824433|Antidepressive Agents|antidepressive agents|mesh-ancestor
101270962|NCT01824433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101270963|NCT01824433|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101270964|NCT01824433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101270965|NCT01824433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101270966|NCT01824433|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101270967|NCT01824459|Oxaliplatin|oxaliplatin|mesh-list
101270968|NCT01824459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101270969|NCT01824524|Hydromorphone|hydromorphone|mesh-list
101270970|NCT01824524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101270972|NCT01824524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101270973|NCT01824524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270975|NCT01824524|Sensory System Agents|sensory system agents|mesh-ancestor
101270976|NCT01824524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101270977|NCT01824615|Sunitinib|sunitinib|mesh-list
101270978|NCT01824615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101270979|NCT01824615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101270980|NCT01824615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101270981|NCT01824615|Growth Substances|growth substances|mesh-ancestor
101270982|NCT01824615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270983|NCT01824615|Growth Inhibitors|growth inhibitors|mesh-ancestor
101270984|NCT01824615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101270985|NCT01824615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101817076|NCT00994916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101817077|NCT00994916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101817078|NCT00994916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817079|NCT00994916|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101817080|NCT00994916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101817081|NCT00994916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817082|NCT00999440|Methadone|methadone|mesh-list
101817083|NCT00999440|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101817084|NCT00999440|Narcotics|narcotics|mesh-ancestor
101314106|NCT00000760|Zidovudine|zidovudine|mesh-list
101270986|NCT01824615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101270987|NCT01824758|Lidocaine|lidocaine|mesh-list
101270988|NCT01824758|Rocuronium|rocuronium|mesh-list
101270989|NCT01824758|Esmolol|esmolol|mesh-list
101270990|NCT01824758|Anesthetics, Local|anesthetics, local|mesh-ancestor
101270991|NCT01824758|Anesthetics|anesthetics|mesh-ancestor
101270992|NCT01824758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101270993|NCT01824758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101270994|NCT01824758|Sensory System Agents|sensory system agents|mesh-ancestor
101270995|NCT01824758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101270996|NCT01824758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101270997|NCT01824758|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101270998|NCT01824758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101270999|NCT01824758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101271000|NCT01824758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271001|NCT01824758|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101271002|NCT01824758|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101271003|NCT01824758|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101271004|NCT01824758|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101271005|NCT01824758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101271006|NCT01824758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101271007|NCT01824758|Adrenergic Agents|adrenergic agents|mesh-ancestor
101271008|NCT01824758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101271009|NCT01824888|Anti-Infective Agents|anti-infective agents|mesh-list
101271010|NCT01824888|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101271011|NCT01824927|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101271012|NCT01824927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101271013|NCT01824992|Interferons|interferons|mesh-list
101271014|NCT01824992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101271015|NCT01824992|Antiviral Agents|antiviral agents|mesh-ancestor
101271016|NCT01824992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101271017|NCT01825031|Azithromycin|azithromycin|mesh-list
101271018|NCT01825031|Isoniazid|isoniazid|mesh-list
101271019|NCT01825031|Raltegravir Potassium|raltegravir potassium|mesh-list
101271020|NCT01825031|Fluconazole|fluconazole|mesh-list
101271021|NCT01825031|Albendazole|albendazole|mesh-list
101271022|NCT01825031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101271023|NCT01825031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101271024|NCT01825031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101271025|NCT01825031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101271026|NCT01825031|Antiviral Agents|antiviral agents|mesh-ancestor
101271027|NCT01825031|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101271028|NCT01825031|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101271029|NCT01825031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101271030|NCT01825031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271031|NCT01825031|Antifungal Agents|antifungal agents|mesh-ancestor
101271032|NCT01825031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101271033|NCT01825031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101271034|NCT01825031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101271035|NCT01825031|Hormone Antagonists|hormone antagonists|mesh-ancestor
101271037|NCT01825031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817085|NCT00999440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101817086|NCT00999440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817087|NCT00999440|Analgesics|analgesics|mesh-ancestor
101817088|NCT00999440|Sensory System Agents|sensory system agents|mesh-ancestor
101817089|NCT00999440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101817090|NCT00999440|Antitussive Agents|antitussive agents|mesh-ancestor
101817091|NCT00999440|Respiratory System Agents|respiratory system agents|mesh-ancestor
101817093|NCT00054691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101817094|NCT00054691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101817095|NCT00054691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101271038|NCT01825031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101271039|NCT01825031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101271040|NCT01825031|Antitubercular Agents|antitubercular agents|mesh-ancestor
101271041|NCT01825031|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101271042|NCT01825031|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101271043|NCT01825031|Antimetabolites|antimetabolites|mesh-ancestor
101271044|NCT01825031|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101271045|NCT01825031|Anthelmintics|anthelmintics|mesh-ancestor
101271046|NCT01825031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101271047|NCT01825031|Anticestodal Agents|anticestodal agents|mesh-ancestor
101271048|NCT01825031|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101271049|NCT01825031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101271050|NCT01825031|Tubulin Modulators|tubulin modulators|mesh-ancestor
101271051|NCT01825031|Antimitotic Agents|antimitotic agents|mesh-ancestor
101271052|NCT01825031|Mitosis Modulators|mitosis modulators|mesh-ancestor
101271053|NCT01825031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101271055|NCT01825044|Cyclosporins|cyclosporins|mesh-list
101271056|NCT01825044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101271057|NCT01825044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271058|NCT01825044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101271059|NCT01825044|Immunologic Factors|immunologic factors|mesh-ancestor
101271060|NCT01825044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271061|NCT01825044|Antifungal Agents|antifungal agents|mesh-ancestor
101271062|NCT01825044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101271063|NCT01825044|Dermatologic Agents|dermatologic agents|mesh-ancestor
101271064|NCT01825044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101271065|NCT01825044|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101271066|NCT01825083|Ketamine|ketamine|mesh-list
101271067|NCT01825083|Analgesics|analgesics|mesh-ancestor
101271068|NCT01825083|Sensory System Agents|sensory system agents|mesh-ancestor
101271069|NCT01825083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101271070|NCT01825083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271071|NCT01825083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101271072|NCT01825083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101271073|NCT01825083|Anesthetics, General|anesthetics, general|mesh-ancestor
101271074|NCT01825083|Anesthetics|anesthetics|mesh-ancestor
101271075|NCT01825083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101271076|NCT01825083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101271077|NCT01825083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101271078|NCT01825083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101271079|NCT01825083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271080|NCT01825109|Vaccines|vaccines|mesh-list
101271081|NCT01825109|Immunologic Factors|immunologic factors|mesh-ancestor
101271082|NCT01825109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271083|NCT01825395|Amifampridine|amifampridine|mesh-list
101271084|NCT01825395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101271085|NCT01825395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101271086|NCT01825395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271087|NCT01825395|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101271088|NCT01825395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101271089|NCT01825395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271090|NCT01825421|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101817096|NCT00054691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817097|NCT02530879|Esomeprazole|esomeprazole|mesh-list
101817098|NCT02530879|Omeprazole|omeprazole|mesh-list
101817099|NCT02530879|Lansoprazole|lansoprazole|mesh-list
101817100|NCT02530879|Dexlansoprazole|dexlansoprazole|mesh-list
101817101|NCT02530879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101817102|NCT02530879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101817103|NCT02530879|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101817104|NCT02530879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101817105|NCT02530879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817106|NCT03957499|Dexamethasone|dexamethasone|mesh-list
101271091|NCT01825421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101271092|NCT01825447|Naltrexone|naltrexone|mesh-list
101271093|NCT01825447|Oxycodone|oxycodone|mesh-list
101271094|NCT01825447|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101271095|NCT01825447|Narcotics|narcotics|mesh-ancestor
101271096|NCT01825447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101271097|NCT01825447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271098|NCT01825447|Analgesics|analgesics|mesh-ancestor
101271099|NCT01825447|Sensory System Agents|sensory system agents|mesh-ancestor
101271100|NCT01825447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101271101|NCT01825447|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101271102|NCT01825447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101271103|NCT01825473|Erythromycin|erythromycin|mesh-list
101271104|NCT01825473|Erythromycin Estolate|erythromycin estolate|mesh-list
101271105|NCT01825473|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101271106|NCT01825473|Erythromycin stearate|erythromycin stearate|mesh-list
101271107|NCT01825473|Phenobarbital|phenobarbital|mesh-list
101271108|NCT01825473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101271109|NCT01825473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101271110|NCT01825473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101271111|NCT01825473|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101271112|NCT01825473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101271113|NCT01825473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271114|NCT01825473|Anticonvulsants|anticonvulsants|mesh-ancestor
101271115|NCT01825473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101271116|NCT01825473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101271117|NCT01825473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271118|NCT01825473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101271119|NCT01825473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101271120|NCT01825473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101271121|NCT01825473|GABA Modulators|gaba modulators|mesh-ancestor
101271122|NCT01825473|GABA Agents|gaba agents|mesh-ancestor
101271123|NCT01825473|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101271124|NCT01825473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101271125|NCT01825473|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101271126|NCT01824043|Ranibizumab|ranibizumab|mesh-list
101271127|NCT01824043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101271128|NCT01824043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101271129|NCT01824043|Growth Substances|growth substances|mesh-ancestor
101271130|NCT01824043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271131|NCT01824043|Growth Inhibitors|growth inhibitors|mesh-ancestor
101271132|NCT01824043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101271134|NCT01825551|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101271135|NCT01825551|Immunologic Factors|immunologic factors|mesh-ancestor
101271136|NCT01825551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271137|NCT01825590|Dialysis Solutions|dialysis solutions|mesh-list
101271138|NCT01825590|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101271139|NCT01825603|Cisplatin|cisplatin|mesh-list
101271140|NCT01825603|Gemcitabine|gemcitabine|mesh-list
101271141|NCT01825603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101271142|NCT01825603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101271143|NCT01825603|Antimetabolites|antimetabolites|mesh-ancestor
101817107|NCT03957499|Magnesium Sulfate|magnesium sulfate|mesh-list
101817108|NCT03957499|Bupivacaine|bupivacaine|mesh-list
101817109|NCT03957499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101817110|NCT03957499|Antiemetics|antiemetics|mesh-ancestor
101817111|NCT03957499|Autonomic Agents|autonomic agents|mesh-ancestor
101817112|NCT03957499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101817113|NCT03957499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817114|NCT03957499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101817115|NCT03957499|Glucocorticoids|glucocorticoids|mesh-ancestor
101817116|NCT03957499|Hormones|hormones|mesh-ancestor
101271144|NCT01825603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271145|NCT01825616|Vitamin D|vitamin d|mesh-list
101271146|NCT01825616|Ergocalciferols|ergocalciferols|mesh-list
101271147|NCT01825616|Vitamins|vitamins|mesh-ancestor
101271148|NCT01825616|Micronutrients|micronutrients|mesh-ancestor
101271149|NCT01825616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271150|NCT01825616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101271151|NCT01825616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101271152|NCT01825720|Insulin|insulin|mesh-list
101271153|NCT01825720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101271154|NCT01825720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271155|NCT01825733|Palonosetron|palonosetron|mesh-list
101271156|NCT01825733|Ramosetron|ramosetron|mesh-list
101271157|NCT01825733|Antiemetics|antiemetics|mesh-ancestor
101271158|NCT01825733|Autonomic Agents|autonomic agents|mesh-ancestor
101271159|NCT01825733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101271160|NCT01825733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271161|NCT01825733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101271162|NCT01825733|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101271163|NCT01825733|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101271164|NCT01825733|Serotonin Agents|serotonin agents|mesh-ancestor
101271165|NCT01825733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101271166|NCT01825733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271168|NCT01825850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101271169|NCT01825850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101271170|NCT01825850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101271171|NCT01825850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271172|NCT01825863|Ropivacaine|ropivacaine|mesh-list
101271173|NCT01825863|Anesthetics, Local|anesthetics, local|mesh-ancestor
101271174|NCT01825863|Anesthetics|anesthetics|mesh-ancestor
101271175|NCT01825863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101271176|NCT01825863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271177|NCT01825863|Sensory System Agents|sensory system agents|mesh-ancestor
101271178|NCT01825863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101271179|NCT01825902|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101271180|NCT01825902|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101271181|NCT01825902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271182|NCT01825928|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101271183|NCT01825928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101271184|NCT01825928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101271185|NCT01825928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101271186|NCT01825928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271187|NCT01825928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101271188|NCT01825928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101271189|NCT01825928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101271190|NCT01825928|Serotonin Agents|serotonin agents|mesh-ancestor
101271191|NCT01825928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101271192|NCT01825928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271193|NCT01825928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101271194|NCT01825928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101271195|NCT01825928|Dopamine Agents|dopamine agents|mesh-ancestor
101817117|NCT03957499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101817118|NCT03957499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101817119|NCT03957499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101817120|NCT03957499|Anesthetics, Local|anesthetics, local|mesh-ancestor
101817121|NCT03957499|Anesthetics|anesthetics|mesh-ancestor
101817122|NCT03957499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101817123|NCT03957499|Sensory System Agents|sensory system agents|mesh-ancestor
101817124|NCT03957499|Analgesics|analgesics|mesh-ancestor
101817125|NCT03957499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101817126|NCT03957499|Anticonvulsants|anticonvulsants|mesh-ancestor
101817127|NCT03957499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101817128|NCT03957499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101817129|NCT03957499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271196|NCT01825993|Morphine|morphine|mesh-list
101271197|NCT01825993|Bupivacaine|bupivacaine|mesh-list
101271199|NCT01825993|Anesthetics|anesthetics|mesh-ancestor
101271200|NCT01825993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101271201|NCT01825993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271202|NCT01825993|Sensory System Agents|sensory system agents|mesh-ancestor
101271203|NCT01825993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101271204|NCT01825993|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101271205|NCT01825993|Narcotics|narcotics|mesh-ancestor
101271206|NCT01825993|Analgesics|analgesics|mesh-ancestor
101271207|NCT01826149|Propofol|propofol|mesh-list
101271208|NCT01826149|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101271209|NCT01826149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101271210|NCT01826149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271211|NCT01826149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101271212|NCT01826149|Anesthetics, General|anesthetics, general|mesh-ancestor
101271213|NCT01826149|Anesthetics|anesthetics|mesh-ancestor
101271214|NCT01826175|Clopidogrel|clopidogrel|mesh-list
101271215|NCT01826175|Ticagrelor|ticagrelor|mesh-list
101271216|NCT01826175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101271217|NCT01826175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101271218|NCT01826175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101271219|NCT01826175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101271220|NCT01826175|Purinergic Agents|purinergic agents|mesh-ancestor
101271221|NCT01826175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101271222|NCT01826175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271223|NCT01826175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271224|NCT01826253|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
101271226|NCT01826253|Blood Substitutes|blood substitutes|mesh-ancestor
101271227|NCT01826279|Resveratrol|resveratrol|mesh-list
101271228|NCT01826279|Antioxidants|antioxidants|mesh-ancestor
101271229|NCT01826279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271230|NCT01826279|Protective Agents|protective agents|mesh-ancestor
101271231|NCT01826279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271232|NCT01826279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101271233|NCT01826279|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101271234|NCT01826396|Irinotecan|irinotecan|mesh-list
101271235|NCT01826396|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101271236|NCT01826396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101271237|NCT01826396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101271238|NCT01826396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271239|NCT01826396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101271240|NCT01826526|Taurolidine|taurolidine|mesh-list
101271241|NCT01826526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101271242|NCT01826526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101271243|NCT01826526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101817130|NCT03957499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101817131|NCT03957499|Tocolytic Agents|tocolytic agents|mesh-ancestor
101817132|NCT03957499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101817133|NCT01040338|Nicotine|nicotine|mesh-list
101817134|NCT01040338|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101817135|NCT01040338|Autonomic Agents|autonomic agents|mesh-ancestor
101817136|NCT01040338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101817137|NCT01040338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817138|NCT01040338|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101817139|NCT01040338|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101271244|NCT01826747|Progesterone|progesterone|mesh-list
101271245|NCT01826747|Progestins|progestins|mesh-ancestor
101271246|NCT01826747|Hormones|hormones|mesh-ancestor
101271247|NCT01826747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101271248|NCT01826747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271249|NCT01826773|Palmitic Acid|palmitic acid|mesh-list
101271250|NCT01826773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101271251|NCT01826773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271252|NCT01826786|JNJ-42165279|jnj-42165279|mesh-list
101271253|NCT01826786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101271254|NCT01826786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271255|NCT01826864|Sargramostim|sargramostim|mesh-list
101271256|NCT01826864|Immunologic Factors|immunologic factors|mesh-ancestor
101271257|NCT01826864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271258|NCT01826916|Ecallantide|ecallantide|mesh-list
101271259|NCT01826916|Analgesics|analgesics|mesh-ancestor
101271260|NCT01826916|Sensory System Agents|sensory system agents|mesh-ancestor
101271261|NCT01826916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101271262|NCT01826916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271263|NCT01826916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101271264|NCT01826916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101271265|NCT01826916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101271266|NCT01826916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101271267|NCT01827007|Polygeline|polygeline|mesh-list
101271268|NCT01827007|Plasma Substitutes|plasma substitutes|mesh-ancestor
101271269|NCT01827007|Blood Substitutes|blood substitutes|mesh-ancestor
101271270|NCT01827020|Lidocaine|lidocaine|mesh-list
101271271|NCT01827020|Ketamine|ketamine|mesh-list
101271272|NCT01827020|Anesthetics, Local|anesthetics, local|mesh-ancestor
101271273|NCT01827020|Anesthetics|anesthetics|mesh-ancestor
101271274|NCT01827020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101271275|NCT01827020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271276|NCT01827020|Sensory System Agents|sensory system agents|mesh-ancestor
101271277|NCT01827020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101271278|NCT01827020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101271279|NCT01827020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101271280|NCT01827020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101271281|NCT01827020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101271282|NCT01827020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271283|NCT01827020|Analgesics|analgesics|mesh-ancestor
101271284|NCT01827020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101271285|NCT01827020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101271286|NCT01827020|Anesthetics, General|anesthetics, general|mesh-ancestor
101271287|NCT01827020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101271288|NCT01827020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101271289|NCT01827020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101271291|NCT01827059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101271292|NCT01827059|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101271293|NCT01827059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271294|NCT01827072|Immunoglobulins|immunoglobulins|mesh-list
101271295|NCT01827072|Immunologic Factors|immunologic factors|mesh-ancestor
101271296|NCT01827072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271297|NCT01827124|Oxytocin|oxytocin|mesh-list
101271298|NCT01827124|Carbetocin|carbetocin|mesh-list
101817140|NCT01040338|Cholinergic Agents|cholinergic agents|mesh-ancestor
101817141|NCT01040338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101817142|NCT01040338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817143|NCT00066703|Tamoxifen|tamoxifen|mesh-list
101817144|NCT00066703|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101817145|NCT00066703|Exemestane|exemestane|mesh-list
101817146|NCT00066703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101817147|NCT00066703|Hormone Antagonists|hormone antagonists|mesh-ancestor
101817148|NCT00066703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101817149|NCT00066703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817150|NCT00066703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101817151|NCT00066703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101817152|NCT00066703|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101817153|NCT00066703|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101271299|NCT01827124|Oxytocics|oxytocics|mesh-ancestor
101271300|NCT01827124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101271301|NCT01827124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271302|NCT01827137|Lenalidomide|lenalidomide|mesh-list
101271303|NCT01827137|Molgramostim|molgramostim|mesh-list
101271304|NCT01827137|Sargramostim|sargramostim|mesh-list
101271305|NCT01827137|Immunologic Factors|immunologic factors|mesh-ancestor
101271306|NCT01827137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271307|NCT01827137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101271308|NCT01827137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101271309|NCT01827137|Growth Substances|growth substances|mesh-ancestor
101271310|NCT01827137|Growth Inhibitors|growth inhibitors|mesh-ancestor
101271311|NCT01827137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101271312|NCT01827202|Candesartan|candesartan|mesh-list
101271313|NCT01827202|Candesartan cilexetil|candesartan cilexetil|mesh-list
101271314|NCT01827202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101271315|NCT01827202|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101271316|NCT01827202|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101271317|NCT01827202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271318|NCT01827228|HIV Antibodies|hiv antibodies|mesh-list
101271319|NCT01827228|Immunologic Factors|immunologic factors|mesh-ancestor
101271320|NCT01827228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271321|NCT01827280|Vildagliptin|vildagliptin|mesh-list
101271322|NCT01827280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101271323|NCT01827280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271324|NCT01827280|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101271325|NCT01827280|Protease Inhibitors|protease inhibitors|mesh-ancestor
101271326|NCT01827280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101271327|NCT01827280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271328|NCT01827293|Promethazine|promethazine|mesh-list
101271329|NCT01827293|Diphenhydramine|diphenhydramine|mesh-list
101271330|NCT01827293|Lorazepam|lorazepam|mesh-list
101271331|NCT01827293|Anticonvulsants|anticonvulsants|mesh-ancestor
101271332|NCT01827293|Antiemetics|antiemetics|mesh-ancestor
101271333|NCT01827293|Autonomic Agents|autonomic agents|mesh-ancestor
101271334|NCT01827293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101271335|NCT01827293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271336|NCT01827293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101271337|NCT01827293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101271338|NCT01827293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101271339|NCT01827293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101271340|NCT01827293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101271341|NCT01827293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101817154|NCT00066703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101817155|NCT00066703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101817156|NCT00066703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101817157|NCT00066703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101817158|NCT00066703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817159|NCT00066703|Luteolytic Agents|luteolytic agents|mesh-ancestor
101817160|NCT00066703|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101817161|NCT00066703|Contraceptive Agents|contraceptive agents|mesh-ancestor
101271342|NCT01827293|GABA Modulators|gaba modulators|mesh-ancestor
101271343|NCT01827293|GABA Agents|gaba agents|mesh-ancestor
101271344|NCT01827293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101271345|NCT01827293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271346|NCT01827293|Antipruritics|antipruritics|mesh-ancestor
101271347|NCT01827293|Dermatologic Agents|dermatologic agents|mesh-ancestor
101271348|NCT01827293|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101271349|NCT01827293|Histamine Antagonists|histamine antagonists|mesh-ancestor
101271351|NCT01827293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101271352|NCT01827293|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101271353|NCT01827293|Anesthetics, Local|anesthetics, local|mesh-ancestor
101271354|NCT01827293|Anesthetics|anesthetics|mesh-ancestor
101271355|NCT01827293|Sensory System Agents|sensory system agents|mesh-ancestor
101271356|NCT01827345|Vitamin D|vitamin d|mesh-list
101271357|NCT01827345|Vitamins|vitamins|mesh-ancestor
101271358|NCT01827345|Micronutrients|micronutrients|mesh-ancestor
101271359|NCT01827345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271360|NCT01827345|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101271361|NCT01827397|Vaccines|vaccines|mesh-list
101271362|NCT01827397|Immunologic Factors|immunologic factors|mesh-ancestor
101271363|NCT01827397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271364|NCT01827540|Dolutegravir|dolutegravir|mesh-list
101271365|NCT01827540|Cenicriviroc|cenicriviroc|mesh-list
101271366|NCT01827540|Midazolam|midazolam|mesh-list
101271367|NCT01827540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101271368|NCT01827540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101271369|NCT01827540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101271370|NCT01827540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271371|NCT01827540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101271372|NCT01827540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101271373|NCT01827540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101271374|NCT01827540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101271375|NCT01827540|Anesthetics, General|anesthetics, general|mesh-ancestor
101271376|NCT01827540|Anesthetics|anesthetics|mesh-ancestor
101271377|NCT01827540|GABA Modulators|gaba modulators|mesh-ancestor
101271378|NCT01827540|GABA Agents|gaba agents|mesh-ancestor
101271379|NCT01827540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101271380|NCT01827540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271381|NCT01827540|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101271382|NCT01827540|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101271383|NCT01827540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101271384|NCT01827540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101271385|NCT01827540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101271386|NCT01827540|Antiviral Agents|antiviral agents|mesh-ancestor
101271387|NCT01827540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101271388|NCT01827540|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101271389|NCT01827618|Sirolimus|sirolimus|mesh-list
101271390|NCT01827618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101271391|NCT01827618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101271392|NCT01827618|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101271393|NCT01827618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101271394|NCT01827618|Antifungal Agents|antifungal agents|mesh-ancestor
101271395|NCT01827618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101271396|NCT01827618|Immunologic Factors|immunologic factors|mesh-ancestor
101271397|NCT01827618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271398|NCT01827722|Dexamethasone|dexamethasone|mesh-list
101271399|NCT01827722|Dexamethasone acetate|dexamethasone acetate|mesh-list
101271400|NCT01827722|Ranibizumab|ranibizumab|mesh-list
101271401|NCT01827722|BB 1101|bb 1101|mesh-list
101271402|NCT01827722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101271403|NCT01827722|Antiemetics|antiemetics|mesh-ancestor
101271404|NCT01827722|Autonomic Agents|autonomic agents|mesh-ancestor
101817162|NCT00066703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101817163|NCT00066703|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101817164|NCT03955939|Midazolam|midazolam|mesh-list
101817165|NCT03955939|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101817166|NCT03955939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101817167|NCT03955939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101817168|NCT03955939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817169|NCT03955939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101817170|NCT03955939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101817171|NCT03955939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101817172|NCT03955939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101817173|NCT03955939|Anesthetics, General|anesthetics, general|mesh-ancestor
101817174|NCT03955939|Anesthetics|anesthetics|mesh-ancestor
101817175|NCT03955939|GABA Modulators|gaba modulators|mesh-ancestor
101271405|NCT01827722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101271406|NCT01827722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271407|NCT01827722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101271408|NCT01827722|Glucocorticoids|glucocorticoids|mesh-ancestor
101271409|NCT01827722|Hormones|hormones|mesh-ancestor
101271410|NCT01827722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101271411|NCT01827722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101314129|NCT00000793|Mexiletine|mexiletine|mesh-list
101271412|NCT01827722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101271413|NCT01827722|Protease Inhibitors|protease inhibitors|mesh-ancestor
101271414|NCT01827722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101271415|NCT01827722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271416|NCT01827722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101271417|NCT01827722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101271418|NCT01827722|Growth Substances|growth substances|mesh-ancestor
101271419|NCT01827722|Growth Inhibitors|growth inhibitors|mesh-ancestor
101271420|NCT01827735|Aldesleukin|aldesleukin|mesh-list
101271421|NCT01827735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101271422|NCT01827735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101271423|NCT01827735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101271424|NCT01827735|Antiviral Agents|antiviral agents|mesh-ancestor
101271425|NCT01827735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101271427|NCT01827865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101271428|NCT01827865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101271429|NCT01827865|Analgesics|analgesics|mesh-ancestor
101271430|NCT01827865|Sensory System Agents|sensory system agents|mesh-ancestor
101271431|NCT01827865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101271432|NCT01827865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271433|NCT01827865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101271434|NCT01827865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101271435|NCT01827865|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101271436|NCT01827865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101271437|NCT01827865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101271438|NCT01827865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271439|NCT01827878|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101271440|NCT01827878|Lisinopril|lisinopril|mesh-list
101271441|NCT01827878|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
101271442|NCT01827878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101271443|NCT01827878|Diuretics|diuretics|mesh-ancestor
101271444|NCT01827878|Natriuretic Agents|natriuretic agents|mesh-ancestor
101271445|NCT01827878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271446|NCT01827878|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101271447|NCT01827878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101271448|NCT01827878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817176|NCT03955939|GABA Agents|gaba agents|mesh-ancestor
101817177|NCT03955939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101817178|NCT03955939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817179|NCT01094821|ATI 7505|ati 7505|mesh-list
101817180|NCT01094821|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101817181|NCT01094821|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101817182|NCT01094821|Serotonin Agents|serotonin agents|mesh-ancestor
101817183|NCT01094821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101817184|NCT01094821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817185|NCT01094821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817186|NCT00072475|Vatalanib|vatalanib|mesh-list
101271449|NCT01827878|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101271450|NCT01827878|Protease Inhibitors|protease inhibitors|mesh-ancestor
101271451|NCT01827878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101271452|NCT01827878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101271453|NCT01827878|Protective Agents|protective agents|mesh-ancestor
101271454|NCT01828125|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101271455|NCT01828125|Glucagon|glucagon|mesh-list
101271456|NCT01828125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101271457|NCT01828125|Hormones|hormones|mesh-ancestor
101271458|NCT01828125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101271459|NCT01828125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271460|NCT01828203|Minocycline|minocycline|mesh-list
101271461|NCT01828203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101271462|NCT01828203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101271463|NCT01828294|Immunoglobulins|immunoglobulins|mesh-list
101271464|NCT01828294|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101271465|NCT01828294|Antibodies|antibodies|mesh-list
101271466|NCT01828294|Immunologic Factors|immunologic factors|mesh-ancestor
101271467|NCT01828294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271468|NCT01828346|Azacitidine|azacitidine|mesh-list
101271469|NCT01828346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101271470|NCT01828346|Antimetabolites|antimetabolites|mesh-ancestor
101271471|NCT01828346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271472|NCT01828346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101271473|NCT01828346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101271474|NCT01828359|Losartan|losartan|mesh-list
101271475|NCT01828359|Amlodipine|amlodipine|mesh-list
101271476|NCT01828359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101271477|NCT01828359|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101271478|NCT01828359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101271479|NCT01828359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271480|NCT01828359|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101271481|NCT01828359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271482|NCT01828359|Vasodilator Agents|vasodilator agents|mesh-ancestor
101271483|NCT01828359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101271484|NCT01828359|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101271485|NCT01828359|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101271486|NCT01828385|Magnesium Sulfate|magnesium sulfate|mesh-list
101271488|NCT01828385|Sensory System Agents|sensory system agents|mesh-ancestor
101271489|NCT01828385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101271490|NCT01828385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271491|NCT01828385|Anesthetics|anesthetics|mesh-ancestor
101271492|NCT01828385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101271493|NCT01828385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101271494|NCT01828385|Anticonvulsants|anticonvulsants|mesh-ancestor
101271495|NCT01828385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101271496|NCT01828385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101817187|NCT00072475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101817189|NCT00072475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817190|NCT01091701|Plasma-lyte 148|plasma-lyte 148|mesh-list
101817191|NCT01091701|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101817192|NCT01091701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101817193|NCT00066469|Prednisone|prednisone|mesh-list
101817194|NCT00066469|Methylprednisolone|methylprednisolone|mesh-list
101817195|NCT00066469|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101271497|NCT01828385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271498|NCT01828385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101271499|NCT01828385|Tocolytic Agents|tocolytic agents|mesh-ancestor
101271500|NCT01828385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101271501|NCT01828437|Pyridoxine|pyridoxine|mesh-list
101271502|NCT01828437|Prednisolone|prednisolone|mesh-list
101271503|NCT01828437|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101271504|NCT01828437|Methylprednisolone|methylprednisolone|mesh-list
101271505|NCT01828437|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101271506|NCT01828437|Prednisolone acetate|prednisolone acetate|mesh-list
101271507|NCT01828437|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101271508|NCT01828437|Prednisolone phosphate|prednisolone phosphate|mesh-list
101271509|NCT01828437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101271510|NCT01828437|Glucocorticoids|glucocorticoids|mesh-ancestor
101271511|NCT01828437|Hormones|hormones|mesh-ancestor
101271512|NCT01828437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101271513|NCT01828437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271514|NCT01828437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101271515|NCT01828437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101271516|NCT01828437|Antiemetics|antiemetics|mesh-ancestor
101271517|NCT01828437|Autonomic Agents|autonomic agents|mesh-ancestor
101271518|NCT01828437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101271519|NCT01828437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101271520|NCT01828437|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101271521|NCT01828437|Protective Agents|protective agents|mesh-ancestor
101271522|NCT01828437|Vitamin B Complex|vitamin b complex|mesh-ancestor
101271523|NCT01828437|Vitamins|vitamins|mesh-ancestor
101271524|NCT01828437|Micronutrients|micronutrients|mesh-ancestor
101271525|NCT01828463|Nitisinone|nitisinone|mesh-list
101271526|NCT01828463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101271527|NCT01828463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271528|NCT01828489|Mitoxantrone|mitoxantrone|mesh-list
101271529|NCT01828489|Analgesics|analgesics|mesh-ancestor
101271530|NCT01828489|Sensory System Agents|sensory system agents|mesh-ancestor
101271531|NCT01828489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101271532|NCT01828489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271533|NCT01828489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101271534|NCT01828489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101271535|NCT01828489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101271536|NCT01828489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101271537|NCT01828489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271538|NCT01828606|Monensin|monensin|mesh-list
101271539|NCT01828606|Antifungal Agents|antifungal agents|mesh-ancestor
101271540|NCT01828606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101271541|NCT01828606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101271542|NCT01828606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101271543|NCT01828606|Coccidiostats|coccidiostats|mesh-ancestor
101271544|NCT01828606|Proton Ionophores|proton ionophores|mesh-ancestor
101271545|NCT01828606|Uncoupling Agents|uncoupling agents|mesh-ancestor
101271546|NCT01828606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101271547|NCT01828606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271548|NCT01828606|Ionophores|ionophores|mesh-ancestor
101271549|NCT01828606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101271551|NCT01828736|Cisplatin|cisplatin|mesh-list
101271552|NCT01828736|Carboplatin|carboplatin|mesh-list
101271553|NCT01828736|Gemcitabine|gemcitabine|mesh-list
101271554|NCT01828736|Trastuzumab|trastuzumab|mesh-list
101271555|NCT01828736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101271556|NCT01828736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101817196|NCT00066469|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101817197|NCT00066469|Prednisolone|prednisolone|mesh-list
101817198|NCT00066469|Prednisolone acetate|prednisolone acetate|mesh-list
101817199|NCT00066469|Cyclophosphamide|cyclophosphamide|mesh-list
101817201|NCT00066469|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101817202|NCT00066469|Prednisolone phosphate|prednisolone phosphate|mesh-list
101817203|NCT00066469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101817204|NCT00066469|Immunologic Factors|immunologic factors|mesh-ancestor
101817205|NCT00066469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817206|NCT00066469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101817207|NCT00066469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101817208|NCT00066469|Alkylating Agents|alkylating agents|mesh-ancestor
101271557|NCT01828736|Antimetabolites|antimetabolites|mesh-ancestor
101271558|NCT01828736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271559|NCT01828736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101271560|NCT01828788|Ropivacaine|ropivacaine|mesh-list
101271561|NCT01828788|Anesthetics, Local|anesthetics, local|mesh-ancestor
101271562|NCT01828788|Anesthetics|anesthetics|mesh-ancestor
101271563|NCT01828788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101271564|NCT01828788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271565|NCT01828788|Sensory System Agents|sensory system agents|mesh-ancestor
101271566|NCT01828788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101271567|NCT01828879|Tacrolimus|tacrolimus|mesh-list
101271568|NCT01828879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101271569|NCT01828879|Immunologic Factors|immunologic factors|mesh-ancestor
101271570|NCT01828879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271571|NCT01828879|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101271572|NCT01828879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101271573|NCT01828879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271574|NCT01828892|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101271575|NCT01828892|Vancomycin|vancomycin|mesh-list
101271576|NCT01828892|Meropenem|meropenem|mesh-list
101271577|NCT01828892|Ceftazidime|ceftazidime|mesh-list
101271578|NCT01828892|Cefotaxime|cefotaxime|mesh-list
101271579|NCT01828892|Cefoxitin|cefoxitin|mesh-list
101271580|NCT01828892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101271581|NCT01828970|Insulin Aspart|insulin aspart|mesh-list
101271582|NCT01828970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101271583|NCT01828970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271584|NCT01829178|Cisplatin|cisplatin|mesh-list
101271585|NCT01829178|Docetaxel|docetaxel|mesh-list
101271586|NCT01829178|Fluorouracil|fluorouracil|mesh-list
101271587|NCT01829178|Silymarin|silymarin|mesh-list
101271588|NCT01829178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101271589|NCT01829178|Tubulin Modulators|tubulin modulators|mesh-ancestor
101271590|NCT01829178|Antimitotic Agents|antimitotic agents|mesh-ancestor
101271591|NCT01829178|Mitosis Modulators|mitosis modulators|mesh-ancestor
101271592|NCT01829178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271593|NCT01829178|Antimetabolites|antimetabolites|mesh-ancestor
101271594|NCT01829178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101271595|NCT01829178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101271596|NCT01829178|Immunologic Factors|immunologic factors|mesh-ancestor
101271597|NCT01829178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271599|NCT01829178|Protective Agents|protective agents|mesh-ancestor
101271600|NCT01829334|Listerine|listerine|mesh-list
101271601|NCT01829334|Fluorides|fluorides|mesh-list
101271602|NCT01829334|Sodium Fluoride|sodium fluoride|mesh-list
101271603|NCT01829334|Fluorides, Topical|fluorides, topical|mesh-list
101271604|NCT01829334|Cariostatic Agents|cariostatic agents|mesh-ancestor
101271605|NCT01829334|Protective Agents|protective agents|mesh-ancestor
101271606|NCT01829334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271607|NCT01829334|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101271608|NCT01829334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101271609|NCT01829451|Hyaluronic Acid|hyaluronic acid|mesh-list
101817209|NCT00066469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817210|NCT00066469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101817211|NCT00066469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101817212|NCT00066469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101817213|NCT00066469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101817214|NCT00066469|Glucocorticoids|glucocorticoids|mesh-ancestor
101271610|NCT01829451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101271611|NCT01829451|Immunologic Factors|immunologic factors|mesh-ancestor
101271612|NCT01829451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271613|NCT01829451|Viscosupplements|viscosupplements|mesh-ancestor
101271614|NCT01829451|Protective Agents|protective agents|mesh-ancestor
101271615|NCT01829529|Amoxicillin|amoxicillin|mesh-list
101271616|NCT01829529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101271617|NCT01829529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101271618|NCT01829659|Ticagrelor|ticagrelor|mesh-list
101271620|NCT01829659|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101271621|NCT01829659|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101271622|NCT01829659|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101271623|NCT01829659|Purinergic Agents|purinergic agents|mesh-ancestor
101271624|NCT01829659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101271625|NCT01829659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271626|NCT01829659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271627|NCT01829685|Entecavir|entecavir|mesh-list
101271628|NCT01829685|Adefovir|adefovir|mesh-list
101271629|NCT01829685|Antiviral Agents|antiviral agents|mesh-ancestor
101271630|NCT01829685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101271631|NCT01829685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101271632|NCT01829685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101271633|NCT01829685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101271634|NCT01829685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271635|NCT01829698|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101271636|NCT01829698|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101271637|NCT01829698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101271638|NCT01829711|Immunotoxin HA22|immunotoxin ha22|mesh-list
101271639|NCT01829711|Protective Agents|protective agents|mesh-list
101271640|NCT01829711|Immunotoxins|immunotoxins|mesh-ancestor
101271641|NCT01829711|Immunoconjugates|immunoconjugates|mesh-ancestor
101271642|NCT01829711|Immunologic Factors|immunologic factors|mesh-ancestor
101271643|NCT01829711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271644|NCT01829711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101271645|NCT01829802|Ritonavir|ritonavir|mesh-list
101271646|NCT01829802|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101271647|NCT01829802|Raltegravir Potassium|raltegravir potassium|mesh-list
101271648|NCT01829802|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101271649|NCT01829802|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101271650|NCT01829802|Protease Inhibitors|protease inhibitors|mesh-ancestor
101271651|NCT01829802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101271652|NCT01829802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271654|NCT01829802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101271655|NCT01829802|Antiviral Agents|antiviral agents|mesh-ancestor
101271656|NCT01829802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101271657|NCT01829802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101271658|NCT01829802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101271659|NCT01829802|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101271660|NCT01829802|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101271661|NCT01829841|Sunitinib|sunitinib|mesh-list
101271662|NCT01829841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101271663|NCT01829841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101271664|NCT01829841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101271665|NCT01829841|Growth Substances|growth substances|mesh-ancestor
101271666|NCT01829841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271668|NCT01829841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101271669|NCT01829841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101271670|NCT01829841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271672|NCT01829893|Finasteride|finasteride|mesh-list
101271673|NCT01829893|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101271674|NCT01829893|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101271675|NCT01829893|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101817215|NCT00066469|Hormones|hormones|mesh-ancestor
101817216|NCT00066469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101817217|NCT00066469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101817218|NCT00066469|Antiemetics|antiemetics|mesh-ancestor
101817219|NCT00066469|Autonomic Agents|autonomic agents|mesh-ancestor
101817220|NCT00066469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101817221|NCT00066469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101817222|NCT00066469|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101817223|NCT00066469|Protective Agents|protective agents|mesh-ancestor
101817224|NCT01094977|Tranexamic Acid|tranexamic acid|mesh-list
101817225|NCT01094977|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101817226|NCT01094977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101817227|NCT01094977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817228|NCT01094977|Hemostatics|hemostatics|mesh-ancestor
101817229|NCT01094977|Coagulants|coagulants|mesh-ancestor
101817230|NCT01095133|Amiloride|amiloride|mesh-list
101817231|NCT01095133|Diuretics|diuretics|mesh-ancestor
101817232|NCT01095133|Natriuretic Agents|natriuretic agents|mesh-ancestor
101817233|NCT01095133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817234|NCT01095133|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
101817235|NCT01095133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101817236|NCT01095133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101817237|NCT01095133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817238|NCT01095133|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101817239|NCT01095133|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101817240|NCT00387088|Tiotropium Bromide|tiotropium bromide|mesh-list
101817249|NCT00387088|Cholinergic Agents|cholinergic agents|mesh-ancestor
101817250|NCT00387088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101817251|NCT00387088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817252|NCT01095211|Vitamin B Complex|vitamin b complex|mesh-list
101817254|NCT01095211|Micronutrients|micronutrients|mesh-ancestor
101817255|NCT01095211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817256|NCT01089985|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101271676|NCT01829893|Adrenergic Agents|adrenergic agents|mesh-ancestor
101271677|NCT01829893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101271678|NCT01829893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271679|NCT01829893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271680|NCT01829893|Urological Agents|urological agents|mesh-ancestor
101271681|NCT01829893|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101271682|NCT01829893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101271683|NCT01829893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101271684|NCT01829893|Hormone Antagonists|hormone antagonists|mesh-ancestor
101271685|NCT01829893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101271686|NCT01830153|Everolimus|everolimus|mesh-list
101271687|NCT01830153|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101271688|NCT01830153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101271689|NCT01830153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101271690|NCT01830153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271691|NCT01830153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101271692|NCT01830153|Immunologic Factors|immunologic factors|mesh-ancestor
101271693|NCT01830153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271694|NCT01830153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101271695|NCT01830244|Paclitaxel|paclitaxel|mesh-list
101271696|NCT01830244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101271697|NCT01830244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101271698|NCT01830244|Tubulin Modulators|tubulin modulators|mesh-ancestor
101271699|NCT01830244|Antimitotic Agents|antimitotic agents|mesh-ancestor
101271700|NCT01830244|Mitosis Modulators|mitosis modulators|mesh-ancestor
101271701|NCT01830244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271703|NCT01830270|Epirubicin|epirubicin|mesh-list
101271704|NCT01830270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101271705|NCT01830270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101271706|NCT01830270|Tubulin Modulators|tubulin modulators|mesh-ancestor
101271707|NCT01830270|Antimitotic Agents|antimitotic agents|mesh-ancestor
101271708|NCT01830270|Mitosis Modulators|mitosis modulators|mesh-ancestor
101271709|NCT01830270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271710|NCT01830270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101271711|NCT01830270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101271712|NCT01830270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101271713|NCT01830270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101271714|NCT01830530|Telmisartan|telmisartan|mesh-list
101271715|NCT01830530|Nifedipine|nifedipine|mesh-list
101271716|NCT01830530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101271717|NCT01830530|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101271718|NCT01830530|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101271719|NCT01830530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271720|NCT01830530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101271721|NCT01830530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101271722|NCT01830530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101271723|NCT01830530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271724|NCT01830530|Vasodilator Agents|vasodilator agents|mesh-ancestor
101271725|NCT01830530|Tocolytic Agents|tocolytic agents|mesh-ancestor
101271726|NCT01830530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101271727|NCT01830907|Vitamins|vitamins|mesh-list
101271729|NCT01830907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271730|NCT01831050|Vaccines|vaccines|mesh-list
101271731|NCT01831050|Immunologic Factors|immunologic factors|mesh-ancestor
101271732|NCT01831050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271733|NCT01831440|Antidepressive Agents|antidepressive agents|mesh-list
101271734|NCT01831440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101817258|NCT00053365|Irofulven|irofulven|mesh-list
101817259|NCT00053365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101474607|NCT00293163|Hylan|hylan|mesh-list
101817260|NCT00053365|Alkylating Agents|alkylating agents|mesh-ancestor
101817261|NCT00053365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817262|NCT00053365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101817263|NCT00387010|Fentanyl|fentanyl|mesh-list
101817264|NCT00387010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101817265|NCT00387010|Narcotics|narcotics|mesh-ancestor
101817266|NCT00387010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101817267|NCT00387010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271735|NCT01832311|Ketorolac|ketorolac|mesh-list
101271736|NCT01832311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101271737|NCT01832311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101271738|NCT01832311|Analgesics|analgesics|mesh-ancestor
101271739|NCT01832311|Sensory System Agents|sensory system agents|mesh-ancestor
101271740|NCT01832311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101271741|NCT01832311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271742|NCT01832311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101271743|NCT01832311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101271744|NCT01832311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101271745|NCT01832311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101271746|NCT01832311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271747|NCT01832350|Quinidine|quinidine|mesh-list
101271748|NCT01832350|Dextromethorphan|dextromethorphan|mesh-list
101271749|NCT01832350|Antitussive Agents|antitussive agents|mesh-ancestor
101271750|NCT01832350|Respiratory System Agents|respiratory system agents|mesh-ancestor
101271751|NCT01832350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101271752|NCT01832350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101271753|NCT01832350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101271754|NCT01832350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271755|NCT01832350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271756|NCT01832350|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101271757|NCT01832350|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101271758|NCT01832350|Adrenergic Agents|adrenergic agents|mesh-ancestor
101271759|NCT01832350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101271760|NCT01832350|Antimalarials|antimalarials|mesh-ancestor
101271761|NCT01832350|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101271762|NCT01832350|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101271763|NCT01832350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101271764|NCT01832350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101271765|NCT01832350|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101271766|NCT01832350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101271767|NCT01832350|Cholinergic Agents|cholinergic agents|mesh-ancestor
101271768|NCT01832350|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101271769|NCT01832350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101271773|NCT01833221|Lidocaine|lidocaine|mesh-list
101271774|NCT01833221|Anesthetics, Local|anesthetics, local|mesh-ancestor
101271775|NCT01833221|Anesthetics|anesthetics|mesh-ancestor
101271776|NCT01833221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101271777|NCT01833221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271778|NCT01833221|Sensory System Agents|sensory system agents|mesh-ancestor
101271779|NCT01833221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101271780|NCT01833221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101271781|NCT01833221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101271782|NCT01833221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101271783|NCT01833221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101271784|NCT01833221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271785|NCT01834820|Dexamethasone|dexamethasone|mesh-list
101271786|NCT01834820|Epinephrine|epinephrine|mesh-list
101271787|NCT01834820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101271788|NCT01834820|Antiemetics|antiemetics|mesh-ancestor
101817269|NCT00387010|Sensory System Agents|sensory system agents|mesh-ancestor
101817270|NCT00387010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101817271|NCT00387010|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101817272|NCT00387010|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101817273|NCT00387010|Anesthetics, General|anesthetics, general|mesh-ancestor
101817274|NCT00387010|Anesthetics|anesthetics|mesh-ancestor
101817275|NCT01092091|BCT-100|bct-100|mesh-list
101817276|NCT01092091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101817277|NCT00065065|Rosiglitazone|rosiglitazone|mesh-list
101817278|NCT00065065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101817279|NCT00065065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271789|NCT01834820|Autonomic Agents|autonomic agents|mesh-ancestor
101271792|NCT01834820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101271793|NCT01834820|Glucocorticoids|glucocorticoids|mesh-ancestor
101271794|NCT01834820|Hormones|hormones|mesh-ancestor
101271795|NCT01834820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101271796|NCT01834820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101271797|NCT01834820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101271798|NCT01834820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101271799|NCT01834820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101271800|NCT01834820|Adrenergic Agents|adrenergic agents|mesh-ancestor
101271801|NCT01834820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101271802|NCT01834820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271803|NCT01834820|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101271804|NCT01834820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101271811|NCT01835197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101271812|NCT01835197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101271813|NCT01835197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271815|NCT01835418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101271816|NCT01835418|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101271817|NCT01835418|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101271818|NCT01835418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271820|NCT01835418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271822|NCT01835678|Linagliptin|linagliptin|mesh-list
101271823|NCT01835678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101271824|NCT01835678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271825|NCT01835678|Incretins|incretins|mesh-ancestor
101271826|NCT01835678|Hormones|hormones|mesh-ancestor
101817280|NCT00386308|Tranexamic Acid|tranexamic acid|mesh-list
101817281|NCT00386308|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101817282|NCT00386308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101271827|NCT01835678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101271828|NCT01835678|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101271829|NCT01835678|Protease Inhibitors|protease inhibitors|mesh-ancestor
101271830|NCT01835678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101271833|NCT01836614|Anesthetics, Local|anesthetics, local|mesh-ancestor
101271834|NCT01836614|Anesthetics|anesthetics|mesh-ancestor
101314156|NCT00000793|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101271835|NCT01836614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101271836|NCT01836614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271838|NCT01836614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101271839|NCT01836614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101271840|NCT01836614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101271841|NCT01836614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101271842|NCT01836614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101271843|NCT01836614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271844|NCT01837251|Bevacizumab|bevacizumab|mesh-list
101271845|NCT01837251|Carboplatin|carboplatin|mesh-list
101271846|NCT01837251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101271847|NCT01837251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101271848|NCT01837251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101271849|NCT01837251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101271850|NCT01837251|Growth Substances|growth substances|mesh-ancestor
101271851|NCT01837251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271852|NCT01837251|Growth Inhibitors|growth inhibitors|mesh-ancestor
101271853|NCT01837290|Midazolam|midazolam|mesh-list
101271854|NCT01837290|Dexmedetomidine|dexmedetomidine|mesh-list
101271855|NCT01837290|Bupivacaine|bupivacaine|mesh-list
101271856|NCT01837290|Anesthetics, Local|anesthetics, local|mesh-ancestor
101271857|NCT01837290|Anesthetics|anesthetics|mesh-ancestor
101271858|NCT01837290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101271859|NCT01837290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271862|NCT01837290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101271863|NCT01837290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101271864|NCT01837290|Analgesics|analgesics|mesh-ancestor
101271865|NCT01837290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101271866|NCT01837290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101271867|NCT01837290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101271868|NCT01837290|Adrenergic Agents|adrenergic agents|mesh-ancestor
101271869|NCT01837290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101271870|NCT01837290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271871|NCT01837290|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101271872|NCT01837290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101271873|NCT01837290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101271874|NCT01837290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101271875|NCT01837290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101271876|NCT01837290|Anesthetics, General|anesthetics, general|mesh-ancestor
101271877|NCT01837290|GABA Modulators|gaba modulators|mesh-ancestor
101271878|NCT01837290|GABA Agents|gaba agents|mesh-ancestor
101271879|NCT01837433|Prednisone|prednisone|mesh-list
101271880|NCT01837433|Glucocorticoids|glucocorticoids|mesh-list
101271881|NCT01837433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101271882|NCT01837433|Hormones|hormones|mesh-ancestor
101271884|NCT01837433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271885|NCT01837433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101271886|NCT01837433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101271887|NCT01837446|Diphenhydramine|diphenhydramine|mesh-list
101271888|NCT01837446|Promethazine|promethazine|mesh-list
101271889|NCT01837446|Lidocaine|lidocaine|mesh-list
101271890|NCT01837446|Morphine|morphine|mesh-list
101271891|NCT01837446|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101271892|NCT01837446|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
101271893|NCT01837446|Anesthetics, Local|anesthetics, local|mesh-ancestor
101271894|NCT01837446|Anesthetics|anesthetics|mesh-ancestor
101271895|NCT01837446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101271896|NCT01837446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271897|NCT01837446|Sensory System Agents|sensory system agents|mesh-ancestor
101817283|NCT00386308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817284|NCT00386308|Hemostatics|hemostatics|mesh-ancestor
101817285|NCT00386308|Coagulants|coagulants|mesh-ancestor
101817286|NCT00064987|Hormones|hormones|mesh-list
101817287|NCT00064987|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101817288|NCT00064987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101817289|NCT00064987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817290|NCT00374140|Everolimus|everolimus|mesh-list
101817291|NCT00374140|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101817292|NCT00374140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101817293|NCT00374140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101817294|NCT00374140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271900|NCT01837446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101271901|NCT01837446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101271902|NCT01837446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101271903|NCT01837446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271906|NCT01837446|Analgesics|analgesics|mesh-ancestor
101271907|NCT01837446|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101271908|NCT01837446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101271909|NCT01837446|Antiemetics|antiemetics|mesh-ancestor
101271910|NCT01837446|Autonomic Agents|autonomic agents|mesh-ancestor
101271912|NCT01837446|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101271913|NCT01837446|Histamine Antagonists|histamine antagonists|mesh-ancestor
101271914|NCT01837446|Histamine Agents|histamine agents|mesh-ancestor
101271915|NCT01837446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101271916|NCT01837446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101271917|NCT01837446|Antipruritics|antipruritics|mesh-ancestor
101271918|NCT01837446|Dermatologic Agents|dermatologic agents|mesh-ancestor
101271919|NCT01837446|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101271920|NCT01837446|Immunologic Factors|immunologic factors|mesh-ancestor
101271922|NCT01838850|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101271923|NCT01838850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101271924|NCT01838850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101271925|NCT01838850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101271926|NCT01838850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271927|NCT01839344|Acarbose|acarbose|mesh-list
101271928|NCT01839344|Quercetin|quercetin|mesh-list
101271929|NCT01839344|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101271930|NCT01839344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101271933|NCT01839344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271934|NCT01839344|Antioxidants|antioxidants|mesh-ancestor
101271935|NCT01839344|Protective Agents|protective agents|mesh-ancestor
101271936|NCT01839578|Heparin|heparin|mesh-list
101271937|NCT01839578|Calcium heparin|calcium heparin|mesh-list
101271938|NCT01839578|Anticoagulants|anticoagulants|mesh-ancestor
101271939|NCT01839578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271940|NCT01839578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101271941|NCT01839578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101271942|NCT01839994|Androgens|androgens|mesh-list
101271943|NCT01839994|Hormones|hormones|mesh-ancestor
101271944|NCT01839994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101271945|NCT01839994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271946|NCT01840189|Hydrocortisone|hydrocortisone|mesh-list
101271949|NCT01840189|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101271950|NCT01840189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101271951|NCT01840254|Dexmedetomidine|dexmedetomidine|mesh-list
101271952|NCT01840254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101271953|NCT01840254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101271954|NCT01840254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271955|NCT01840254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101817295|NCT00374140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101817296|NCT00374140|Immunologic Factors|immunologic factors|mesh-ancestor
101817297|NCT00374140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817298|NCT00374140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101817299|NCT00665561|Maraviroc|maraviroc|mesh-list
101817300|NCT00665561|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101817301|NCT00665561|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101817302|NCT00665561|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101817303|NCT00665561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817304|NCT00665561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101817305|NCT00665561|Antiviral Agents|antiviral agents|mesh-ancestor
101817306|NCT00665561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101817307|NCT00665561|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101271956|NCT01840254|Analgesics|analgesics|mesh-ancestor
101271957|NCT01840254|Sensory System Agents|sensory system agents|mesh-ancestor
101271958|NCT01840254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101271959|NCT01840254|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101271960|NCT01840254|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101271961|NCT01840254|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101271962|NCT01840254|Adrenergic Agents|adrenergic agents|mesh-ancestor
101271963|NCT01840254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101271964|NCT01840254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271965|NCT01840384|Micronutrients|micronutrients|mesh-list
101271966|NCT01840384|Trace Elements|trace elements|mesh-list
101271967|NCT01840384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271968|NCT01840423|Levodopa|levodopa|mesh-list
101271969|NCT01840423|Carbidopa|carbidopa|mesh-list
101271970|NCT01840423|Entacapone|entacapone|mesh-list
101271971|NCT01840423|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101271972|NCT01840423|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101271973|NCT01840423|Dopamine Agents|dopamine agents|mesh-ancestor
101271974|NCT01840423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101271975|NCT01840423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271976|NCT01840423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271979|NCT01840423|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101271980|NCT01840449|Lanreotide|lanreotide|mesh-list
101271981|NCT01840449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101271982|NCT01840683|Heparin|heparin|mesh-list
101271983|NCT01840683|Anticoagulants|anticoagulants|mesh-ancestor
101271984|NCT01840683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101271985|NCT01840683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101271986|NCT01840683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271987|NCT01840696|Regadenoson|regadenoson|mesh-list
101271988|NCT01840696|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
101271989|NCT01840696|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101271990|NCT01840696|Purinergic Agonists|purinergic agonists|mesh-ancestor
101271991|NCT01840696|Purinergic Agents|purinergic agents|mesh-ancestor
101271992|NCT01840696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101271993|NCT01840696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271994|NCT01840696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271995|NCT01840774|Ketamine|ketamine|mesh-list
101271996|NCT01840774|Analgesics|analgesics|mesh-list
101271997|NCT01840774|Sensory System Agents|sensory system agents|mesh-ancestor
101271998|NCT01840774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101271999|NCT01840774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272000|NCT01840774|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101272001|NCT01840774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101272002|NCT01840774|Anesthetics, General|anesthetics, general|mesh-ancestor
101272003|NCT01840774|Anesthetics|anesthetics|mesh-ancestor
101272004|NCT01840774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101817309|NCT03955705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101817310|NCT03955705|Analgesics|analgesics|mesh-ancestor
101817311|NCT03955705|Sensory System Agents|sensory system agents|mesh-ancestor
101817312|NCT03955705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101817313|NCT03955705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817314|NCT00786461|Silver Nitrate|silver nitrate|mesh-list
101817315|NCT00786461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101272005|NCT01840774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101272006|NCT01840774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101272007|NCT01840774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101272008|NCT01840774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272009|NCT01840800|Ropivacaine|ropivacaine|mesh-list
101272010|NCT01840800|Anesthetics, Local|anesthetics, local|mesh-ancestor
101272011|NCT01840800|Anesthetics|anesthetics|mesh-ancestor
101272012|NCT01840800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101272013|NCT01840800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272014|NCT01840800|Sensory System Agents|sensory system agents|mesh-ancestor
101272015|NCT01840800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101272016|NCT01840813|Misoprostol|misoprostol|mesh-list
101272017|NCT01840813|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101272018|NCT01840813|Abortifacient Agents|abortifacient agents|mesh-ancestor
101272019|NCT01840813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101272020|NCT01840813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272021|NCT01840813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101272022|NCT01840813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101272024|NCT01841008|Tacrolimus|tacrolimus|mesh-list
101272025|NCT01841008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101272026|NCT01841008|Immunologic Factors|immunologic factors|mesh-ancestor
101272027|NCT01841008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272028|NCT01841008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101272029|NCT01841008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101272030|NCT01841008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272031|NCT01841099|Mesalamine|mesalamine|mesh-list
101272032|NCT01841099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101222103|NCT01511302|RNS60|rns60|mesh-list
101272033|NCT01841099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101272034|NCT01841099|Analgesics|analgesics|mesh-ancestor
101272035|NCT01841099|Sensory System Agents|sensory system agents|mesh-ancestor
101272036|NCT01841099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101272037|NCT01841099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272038|NCT01841099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101272039|NCT01841099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101272040|NCT01841112|BI 409306|bi 409306|mesh-list
101272041|NCT01841112|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101272042|NCT01841112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101272043|NCT01841112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272044|NCT01841125|Escitalopram|escitalopram|mesh-list
101272045|NCT01841125|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101314167|NCT00000817|Amitriptyline|amitriptyline|mesh-list
101272046|NCT01841125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101272047|NCT01841125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101272048|NCT01841125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272049|NCT01841125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101272050|NCT01841125|Serotonin Agents|serotonin agents|mesh-ancestor
101272051|NCT01841125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272052|NCT01841164|Montelukast|montelukast|mesh-list
101272053|NCT01841164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101272054|NCT01841164|Respiratory System Agents|respiratory system agents|mesh-ancestor
101272055|NCT01841164|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101272056|NCT01841164|Hormone Antagonists|hormone antagonists|mesh-ancestor
101272057|NCT01841164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101817316|NCT00786461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101817317|NCT00786695|Esomeprazole|esomeprazole|mesh-list
101817318|NCT00786695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101817319|NCT00786695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101817320|NCT00786695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101817321|NCT00786695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101817322|NCT00786695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817323|NCT00786851|Lenalidomide|lenalidomide|mesh-list
101817324|NCT00786851|Immunologic Factors|immunologic factors|mesh-ancestor
101817325|NCT00786851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272058|NCT01841164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272059|NCT01841164|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101272060|NCT01841164|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101272061|NCT01841164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272062|NCT01841242|Chlorhexidine|chlorhexidine|mesh-list
101272063|NCT01841242|Povidone-Iodine|povidone-iodine|mesh-list
101272065|NCT01841242|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101272066|NCT01841242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101272067|NCT01841242|Disinfectants|disinfectants|mesh-ancestor
101272068|NCT01841242|Plasma Substitutes|plasma substitutes|mesh-ancestor
101272069|NCT01841242|Blood Substitutes|blood substitutes|mesh-ancestor
101272070|NCT01841294|Lidocaine|lidocaine|mesh-list
101272071|NCT01841294|Anesthetics, Local|anesthetics, local|mesh-ancestor
101272072|NCT01841294|Anesthetics|anesthetics|mesh-ancestor
101272073|NCT01841294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101272074|NCT01841294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272075|NCT01841294|Sensory System Agents|sensory system agents|mesh-ancestor
101272076|NCT01841294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101272077|NCT01841294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101272078|NCT01841294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101272079|NCT01841294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101272080|NCT01841294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101272081|NCT01841294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272082|NCT01841307|Cromolyn Sodium|cromolyn sodium|mesh-list
101272083|NCT01841307|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
101272084|NCT01841307|Immunologic Factors|immunologic factors|mesh-ancestor
101272085|NCT01841307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272086|NCT01841307|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101272087|NCT01841307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101272088|NCT01841307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101272089|NCT01841307|Respiratory System Agents|respiratory system agents|mesh-ancestor
101272090|NCT01841320|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101272091|NCT01841320|Methadone|methadone|mesh-list
101272092|NCT01841320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101272093|NCT01841320|Narcotics|narcotics|mesh-ancestor
101272094|NCT01841320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101272095|NCT01841320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272096|NCT01841320|Analgesics|analgesics|mesh-ancestor
101272097|NCT01841320|Sensory System Agents|sensory system agents|mesh-ancestor
101272098|NCT01841320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101272099|NCT01841320|Antitussive Agents|antitussive agents|mesh-ancestor
101272100|NCT01841320|Respiratory System Agents|respiratory system agents|mesh-ancestor
101272101|NCT01841320|Antiviral Agents|antiviral agents|mesh-ancestor
101272102|NCT01841320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101272103|NCT01841411|Metronidazole|metronidazole|mesh-list
101272104|NCT01841411|Acetylcysteine|acetylcysteine|mesh-list
101272105|NCT01841411|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101272106|NCT01841411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101272107|NCT01841411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101272108|NCT01841411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101272109|NCT01841411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101272110|NCT01841411|Antiviral Agents|antiviral agents|mesh-ancestor
101272111|NCT01841411|Expectorants|expectorants|mesh-ancestor
101272112|NCT01841411|Respiratory System Agents|respiratory system agents|mesh-ancestor
101817326|NCT00786851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101817327|NCT00786851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101817328|NCT00786851|Growth Substances|growth substances|mesh-ancestor
101817329|NCT00786851|Growth Inhibitors|growth inhibitors|mesh-ancestor
101817330|NCT00786851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101817332|NCT00787007|Phytoestrogens|phytoestrogens|mesh-ancestor
101817333|NCT00787007|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101817334|NCT00787007|Estrogens|estrogens|mesh-ancestor
101817335|NCT00787007|Hormones|hormones|mesh-ancestor
101817336|NCT00787007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101817337|NCT00787007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817338|NCT00791141|Cetuximab|cetuximab|mesh-list
101817339|NCT00791141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101817340|NCT00791141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101817341|NCT00386152|Epoetin Alfa|epoetin alfa|mesh-list
101817342|NCT00386152|Darbepoetin alfa|darbepoetin alfa|mesh-list
101817343|NCT00386152|Hematinics|hematinics|mesh-ancestor
101817344|NCT00787553|Cefazolin|cefazolin|mesh-list
101817345|NCT00787553|Tinidazole|tinidazole|mesh-list
101817346|NCT00787553|Imidazole|imidazole|mesh-list
101817347|NCT00787553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101817348|NCT00787553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101817349|NCT00787553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101817350|NCT00787553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817351|NCT00787553|Alkylating Agents|alkylating agents|mesh-ancestor
101817352|NCT00787553|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
101817353|NCT00787553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101817354|NCT00787553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101817355|NCT00795353|Alefacept|alefacept|mesh-list
101817356|NCT00795353|Dermatologic Agents|dermatologic agents|mesh-ancestor
101817357|NCT00795353|Immunologic Factors|immunologic factors|mesh-ancestor
101272113|NCT01841411|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101272114|NCT01841411|Antioxidants|antioxidants|mesh-ancestor
101272115|NCT01841411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272116|NCT01841411|Protective Agents|protective agents|mesh-ancestor
101272117|NCT01841411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272119|NCT01841424|Benzocaine|benzocaine|mesh-list
101272120|NCT01841424|Anesthetics, Local|anesthetics, local|mesh-ancestor
101272121|NCT01841424|Anesthetics|anesthetics|mesh-ancestor
101272122|NCT01841424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101272123|NCT01841424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272124|NCT01841424|Sensory System Agents|sensory system agents|mesh-ancestor
101272125|NCT01841424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101272126|NCT01841463|Vemurafenib|vemurafenib|mesh-list
101272127|NCT01841463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101272128|NCT01841463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101272129|NCT01841463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101817358|NCT00795353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817359|NCT00791297|Ulipristal acetate|ulipristal acetate|mesh-list
101312360|NCT00006340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101817360|NCT00791297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101817361|NCT00791297|Contraceptive Agents|contraceptive agents|mesh-ancestor
101817362|NCT00791297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101817363|NCT00791297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222885|NCT01515397|Polygeline|polygeline|mesh-list
101817364|NCT00791297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101817365|NCT01045876|Dexamethasone|dexamethasone|mesh-list
101817366|NCT01045876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101817367|NCT01045876|Antiemetics|antiemetics|mesh-ancestor
101817368|NCT01045876|Autonomic Agents|autonomic agents|mesh-ancestor
101817369|NCT01045876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101817370|NCT01045876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817371|NCT01045876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101817372|NCT01045876|Glucocorticoids|glucocorticoids|mesh-ancestor
101817373|NCT01045876|Hormones|hormones|mesh-ancestor
101817374|NCT01045876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101817375|NCT01045876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101817376|NCT01045876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101272130|NCT01841463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272131|NCT01841502|Paroxetine|paroxetine|mesh-list
101272132|NCT01841502|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101272133|NCT01841502|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101272134|NCT01841502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101272135|NCT01841502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272136|NCT01841502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101272137|NCT01841502|Serotonin Agents|serotonin agents|mesh-ancestor
101272138|NCT01841502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272139|NCT01841502|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101272140|NCT01841502|Antidepressive Agents|antidepressive agents|mesh-ancestor
101272141|NCT01841502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101272142|NCT01841502|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101272143|NCT01841502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101272144|NCT01841502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101272145|NCT01841515|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101272146|NCT01841515|Hemostatics|hemostatics|mesh-ancestor
101272147|NCT01841515|Coagulants|coagulants|mesh-ancestor
101272148|NCT01841515|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101272149|NCT01841515|Natriuretic Agents|natriuretic agents|mesh-ancestor
101272150|NCT01841515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272151|NCT01841658|Folic Acid|folic acid|mesh-list
101272152|NCT01841658|Hematinics|hematinics|mesh-ancestor
101272153|NCT01841658|Vitamin B Complex|vitamin b complex|mesh-ancestor
101272154|NCT01841658|Vitamins|vitamins|mesh-ancestor
101272155|NCT01841658|Micronutrients|micronutrients|mesh-ancestor
101272156|NCT01841658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272157|NCT01841684|Anacetrapib|anacetrapib|mesh-list
101272158|NCT01841684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101272159|NCT01841684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101272160|NCT01841684|Antimetabolites|antimetabolites|mesh-ancestor
101272161|NCT01841684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817378|NCT00385762|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
101817379|NCT00385762|Serotonin|serotonin|mesh-list
101817380|NCT00385762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101817381|NCT00385762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101817382|NCT00385762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817383|NCT00385762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101817384|NCT00385762|Serotonin Agents|serotonin agents|mesh-ancestor
101272162|NCT01841684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101272163|NCT01841775|Interferons|interferons|mesh-list
101272164|NCT01841775|Ribavirin|ribavirin|mesh-list
101272166|NCT01841775|Antiviral Agents|antiviral agents|mesh-ancestor
101272167|NCT01841775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101272168|NCT01841775|Antimetabolites|antimetabolites|mesh-ancestor
101272169|NCT01841775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272170|NCT01841827|Cilostazol|cilostazol|mesh-list
101272171|NCT01841827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101272172|NCT01841827|Autonomic Agents|autonomic agents|mesh-ancestor
101272173|NCT01841827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101272174|NCT01841827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272175|NCT01841827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101272176|NCT01841827|Respiratory System Agents|respiratory system agents|mesh-ancestor
101272177|NCT01841827|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101272178|NCT01841827|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101272179|NCT01841827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408017|NCT00108446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101272180|NCT01841827|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101272181|NCT01841827|Vasodilator Agents|vasodilator agents|mesh-ancestor
101272182|NCT01841827|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101272183|NCT01841827|Protective Agents|protective agents|mesh-ancestor
101272184|NCT01841827|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101272185|NCT01841827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101272186|NCT01841827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101272187|NCT01841996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101272188|NCT01842074|Bortezomib|bortezomib|mesh-list
101272189|NCT01842074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101272190|NCT01842087|Iproplatin|iproplatin|mesh-list
101272191|NCT01842087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101272192|NCT01842100|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101272193|NCT01842100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101272194|NCT01842113|Rifaximin|rifaximin|mesh-list
101272195|NCT01842113|Lactulose|lactulose|mesh-list
101272196|NCT01842113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101272197|NCT01842113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101272198|NCT01842113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101272199|NCT01842139|Poly I-C|poly i-c|mesh-list
101272200|NCT01842139|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101272201|NCT01842139|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101272202|NCT01842139|Poly ICLC|poly iclc|mesh-list
101272203|NCT01842139|Basiliximab|basiliximab|mesh-list
101272204|NCT01842139|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101272205|NCT01842139|Immunologic Factors|immunologic factors|mesh-ancestor
101272206|NCT01842139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272207|NCT01842139|Interferon Inducers|interferon inducers|mesh-ancestor
101272208|NCT01842139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101272209|NCT01842139|Laxatives|laxatives|mesh-ancestor
101272210|NCT01842139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101272211|NCT01842139|Antiviral Agents|antiviral agents|mesh-ancestor
101272212|NCT01842139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101272213|NCT01842230|Niacin|niacin|mesh-list
101272214|NCT01842230|Amlodipine|amlodipine|mesh-list
101272215|NCT01842230|Telmisartan|telmisartan|mesh-list
101272216|NCT01842230|Atorvastatin|atorvastatin|mesh-list
101272217|NCT01842230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101272218|NCT01842230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101272219|NCT01842230|Antimetabolites|antimetabolites|mesh-ancestor
101272220|NCT01842230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817385|NCT00385762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817386|NCT00385762|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101817387|NCT00385762|Antidepressive Agents|antidepressive agents|mesh-ancestor
101817388|NCT00385762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101817389|NCT00385762|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101817390|NCT00385762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101817391|NCT00385762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101817392|NCT00385762|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101272221|NCT01842230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101272222|NCT01842230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101272223|NCT01842230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101272224|NCT01842230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101272226|NCT01842230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101272227|NCT01842230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101272228|NCT01842230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272229|NCT01842230|Vasodilator Agents|vasodilator agents|mesh-ancestor
101272230|NCT01842230|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101272231|NCT01842230|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101272232|NCT01842230|Vitamin B Complex|vitamin b complex|mesh-ancestor
101272233|NCT01842230|Vitamins|vitamins|mesh-ancestor
101272234|NCT01842230|Micronutrients|micronutrients|mesh-ancestor
101272235|NCT01842256|Amlodipine|amlodipine|mesh-list
101272236|NCT01842256|Telmisartan|telmisartan|mesh-list
101272237|NCT01842256|Atorvastatin|atorvastatin|mesh-list
101272238|NCT01842256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101272239|NCT01842256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101272240|NCT01842256|Antimetabolites|antimetabolites|mesh-ancestor
101272241|NCT01842256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272242|NCT01842256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101272243|NCT01842256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101272244|NCT01842256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101272245|NCT01842256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101272246|NCT01842256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101272247|NCT01842256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101272248|NCT01842256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101272249|NCT01842256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272250|NCT01842256|Vasodilator Agents|vasodilator agents|mesh-ancestor
101272251|NCT01842256|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101272252|NCT01842256|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101272253|NCT01842269|Mycophenolic Acid|mycophenolic acid|mesh-list
101272254|NCT01842269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101272255|NCT01842269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101272256|NCT01842269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101272257|NCT01842269|Antitubercular Agents|antitubercular agents|mesh-ancestor
101272258|NCT01842269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101272259|NCT01842269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101272260|NCT01842269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101272261|NCT01842269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272262|NCT01842321|Abiraterone Acetate|abiraterone acetate|mesh-list
101272263|NCT01842321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101272264|NCT01842321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101272265|NCT01842321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101272266|NCT01842321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272267|NCT01842321|Hormone Antagonists|hormone antagonists|mesh-ancestor
101272268|NCT01842321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101272269|NCT01842321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272270|NCT01842321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101272271|NCT01842373|Lidocaine|lidocaine|mesh-list
101817394|NCT00385684|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
101817395|NCT00385684|Hydrocodone|hydrocodone|mesh-list
101817396|NCT00385684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101817397|NCT00385684|Narcotics|narcotics|mesh-ancestor
101817398|NCT00385684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101817399|NCT00385684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817400|NCT00385684|Analgesics|analgesics|mesh-ancestor
101817401|NCT00385684|Sensory System Agents|sensory system agents|mesh-ancestor
101272272|NCT01842373|Tetracaine|tetracaine|mesh-list
101272273|NCT01842373|Benzocaine|benzocaine|mesh-list
101272274|NCT01842373|Anesthetics, Local|anesthetics, local|mesh-ancestor
101272275|NCT01842373|Anesthetics|anesthetics|mesh-ancestor
101272276|NCT01842373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101272277|NCT01842373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272278|NCT01842373|Sensory System Agents|sensory system agents|mesh-ancestor
101272279|NCT01842373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101272280|NCT01842373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101272281|NCT01842373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101272282|NCT01842373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101272284|NCT01842373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272285|NCT01842516|Delpazolid|delpazolid|mesh-list
101272286|NCT01842516|Oxazolidinones|oxazolidinones|mesh-list
101272287|NCT01842516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101272288|NCT01842516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101272289|NCT01842516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101272290|NCT01842516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101272291|NCT01842516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272292|NCT01842529|Botulinum Toxins|botulinum toxins|mesh-list
101272293|NCT01842529|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101272294|NCT01842529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101272295|NCT01842529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272296|NCT01842529|Cholinergic Agents|cholinergic agents|mesh-ancestor
101272297|NCT01842529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101272298|NCT01842529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272299|NCT01842893|Fentanyl|fentanyl|mesh-list
101272300|NCT01842893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101272301|NCT01842893|Narcotics|narcotics|mesh-ancestor
101272302|NCT01842893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101272303|NCT01842893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272304|NCT01842893|Analgesics|analgesics|mesh-ancestor
101272305|NCT01842893|Sensory System Agents|sensory system agents|mesh-ancestor
101272306|NCT01842893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101272307|NCT01842893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101272308|NCT01842893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101272309|NCT01842893|Anesthetics, General|anesthetics, general|mesh-ancestor
101272310|NCT01842893|Anesthetics|anesthetics|mesh-ancestor
101272311|NCT01842932|Bromides|bromides|mesh-list
101272312|NCT01842932|Cholinergic Antagonists|cholinergic antagonists|mesh-list
101272313|NCT01842932|Cimetropium|cimetropium|mesh-list
101272314|NCT01842932|Anticonvulsants|anticonvulsants|mesh-ancestor
101272315|NCT01842932|Cholinergic Agents|cholinergic agents|mesh-ancestor
101272316|NCT01842932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101272317|NCT01842932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272318|NCT01842932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272319|NCT01842932|Parasympatholytics|parasympatholytics|mesh-ancestor
101272320|NCT01842932|Autonomic Agents|autonomic agents|mesh-ancestor
101272321|NCT01842932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101272322|NCT01843010|Parecoxib|parecoxib|mesh-list
101272323|NCT01843010|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101272324|NCT01843010|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101272325|NCT01843010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101272326|NCT01843010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272327|NCT01843010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101272328|NCT01843010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101272329|NCT01843010|Analgesics|analgesics|mesh-ancestor
101817402|NCT00385684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101817403|NCT00385684|Antitussive Agents|antitussive agents|mesh-ancestor
101817404|NCT00385684|Respiratory System Agents|respiratory system agents|mesh-ancestor
101817405|NCT00385684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101817406|NCT00385684|Antipyretics|antipyretics|mesh-ancestor
101817407|NCT00385684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101272330|NCT01843010|Sensory System Agents|sensory system agents|mesh-ancestor
101272331|NCT01843010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101272332|NCT01843010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272333|NCT01843010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101272334|NCT01843010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101272335|NCT01843075|Liraglutide|liraglutide|mesh-list
101272336|NCT01843075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101272337|NCT01843075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272338|NCT01843075|Incretins|incretins|mesh-ancestor
101272340|NCT01843075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101272341|NCT01843088|Mannitol|mannitol|mesh-list
101272342|NCT01843088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101272343|NCT01843088|Diuretics|diuretics|mesh-ancestor
101272344|NCT01843088|Natriuretic Agents|natriuretic agents|mesh-ancestor
101272345|NCT01843088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272346|NCT01843127|Exenatide|exenatide|mesh-list
101272347|NCT01843127|Ranolazine|ranolazine|mesh-list
101272348|NCT01843127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101272349|NCT01843127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272350|NCT01843127|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101272351|NCT01843127|Incretins|incretins|mesh-ancestor
101272353|NCT01843127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101272354|NCT01843127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101272355|NCT01843127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101272356|NCT01843127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272357|NCT01843153|Ropivacaine|ropivacaine|mesh-list
101272358|NCT01843153|Anesthetics, Local|anesthetics, local|mesh-ancestor
101272359|NCT01843153|Anesthetics|anesthetics|mesh-ancestor
101272360|NCT01843153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101272361|NCT01843153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272362|NCT01843153|Sensory System Agents|sensory system agents|mesh-ancestor
101272363|NCT01843153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101272364|NCT01843166|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101272365|NCT01843166|Estrogens|estrogens|mesh-ancestor
101272366|NCT01843166|Hormones|hormones|mesh-ancestor
101272367|NCT01843166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101272368|NCT01843166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272369|NCT01843179|Cytarabine|cytarabine|mesh-list
101272370|NCT01843179|Sulindac|sulindac|mesh-list
101272371|NCT01843179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101272372|NCT01843179|Antimetabolites|antimetabolites|mesh-ancestor
101272373|NCT01843179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272374|NCT01843179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101272375|NCT01843179|Antiviral Agents|antiviral agents|mesh-ancestor
101272376|NCT01843179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101272377|NCT01843179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101272378|NCT01843179|Immunologic Factors|immunologic factors|mesh-ancestor
101272379|NCT01843179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272380|NCT01843179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101272381|NCT01843179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101272382|NCT01843179|Analgesics|analgesics|mesh-ancestor
101272383|NCT01843179|Sensory System Agents|sensory system agents|mesh-ancestor
101272384|NCT01843179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101272385|NCT01843179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101272386|NCT01843179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101272387|NCT01843179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101272388|NCT01843179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101272389|NCT01843257|Ethanol|ethanol|mesh-list
101272390|NCT01843257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101272391|NCT01843257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101272392|NCT01843257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101272393|NCT01843257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817408|NCT00385684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101817409|NCT00385684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101817410|NCT00661661|Tofacitinib|tofacitinib|mesh-list
101817411|NCT00661661|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101817412|NCT00661661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101817413|NCT00661661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101272394|NCT01843296|Magnesium Sulfate|magnesium sulfate|mesh-list
101272395|NCT01843296|Fentanyl|fentanyl|mesh-list
101272396|NCT01843296|Bupivacaine|bupivacaine|mesh-list
101314188|NCT00000826|Clarithromycin|clarithromycin|mesh-list
101272397|NCT01843296|Anesthetics, Local|anesthetics, local|mesh-ancestor
101272398|NCT01843296|Anesthetics|anesthetics|mesh-ancestor
101272399|NCT01843296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101272400|NCT01843296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272401|NCT01843296|Sensory System Agents|sensory system agents|mesh-ancestor
101272402|NCT01843296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101272403|NCT01843296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101272404|NCT01843296|Narcotics|narcotics|mesh-ancestor
101272405|NCT01843296|Analgesics|analgesics|mesh-ancestor
101272406|NCT01843296|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101272407|NCT01843296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101272408|NCT01843296|Anesthetics, General|anesthetics, general|mesh-ancestor
101272409|NCT01843296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101272410|NCT01843296|Anticonvulsants|anticonvulsants|mesh-ancestor
101272411|NCT01843296|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101272412|NCT01843296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101272413|NCT01843296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272414|NCT01843296|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101272415|NCT01843296|Tocolytic Agents|tocolytic agents|mesh-ancestor
101272416|NCT01843296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101272417|NCT01843309|Spironolactone|spironolactone|mesh-list
101272418|NCT01843309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101272419|NCT01843309|Hormone Antagonists|hormone antagonists|mesh-ancestor
101272420|NCT01843309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101272421|NCT01843309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272422|NCT01843309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101272423|NCT01843309|Diuretics|diuretics|mesh-ancestor
101272424|NCT01843309|Natriuretic Agents|natriuretic agents|mesh-ancestor
101272425|NCT01843439|Pyridoxine|pyridoxine|mesh-list
101272426|NCT01843439|Vitamin B Complex|vitamin b complex|mesh-ancestor
101272427|NCT01843439|Vitamins|vitamins|mesh-ancestor
101272428|NCT01843439|Micronutrients|micronutrients|mesh-ancestor
101272429|NCT01843439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272430|NCT01843452|Capecitabine|capecitabine|mesh-list
101272431|NCT01843452|Mitomycins|mitomycins|mesh-list
101272432|NCT01843452|Mitomycin|mitomycin|mesh-list
101272433|NCT01843452|Panitumumab|panitumumab|mesh-list
101272434|NCT01843452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101272435|NCT01843452|Antimetabolites|antimetabolites|mesh-ancestor
101272436|NCT01843452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272437|NCT01843452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101272438|NCT01843452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101272439|NCT01843452|Alkylating Agents|alkylating agents|mesh-ancestor
101272440|NCT01843452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101272441|NCT01843452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101272442|NCT01843452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101272443|NCT01843530|Cortisone|cortisone|mesh-list
101272444|NCT01843530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101272445|NCT01843647|Cisplatin|cisplatin|mesh-list
101272446|NCT01843647|Vinorelbine|vinorelbine|mesh-list
101272447|NCT01843647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101272448|NCT01843647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101272449|NCT01843647|Tubulin Modulators|tubulin modulators|mesh-ancestor
101272450|NCT01843647|Antimitotic Agents|antimitotic agents|mesh-ancestor
101272451|NCT01843647|Mitosis Modulators|mitosis modulators|mesh-ancestor
101272452|NCT01843647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272453|NCT01843699|Topiramate|topiramate|mesh-list
101272454|NCT01843699|Anticonvulsants|anticonvulsants|mesh-ancestor
101272455|NCT01843699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101817414|NCT00661661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817415|NCT00038467|Tamoxifen|tamoxifen|mesh-list
101817416|NCT00038467|Exemestane|exemestane|mesh-list
101817417|NCT00038467|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101817418|NCT00038467|Hormone Antagonists|hormone antagonists|mesh-ancestor
101817419|NCT00038467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101817420|NCT00038467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272456|NCT01843699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272457|NCT01843725|Capecitabine|capecitabine|mesh-list
101272458|NCT01843725|Aflibercept|aflibercept|mesh-list
101272459|NCT01843725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101272460|NCT01843725|Antimetabolites|antimetabolites|mesh-ancestor
101272461|NCT01843725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272462|NCT01843725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101272463|NCT01843725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101272464|NCT01843725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101272465|NCT01843725|Growth Substances|growth substances|mesh-ancestor
101272466|NCT01843725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272467|NCT01843725|Growth Inhibitors|growth inhibitors|mesh-ancestor
101272469|NCT01843738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101272470|NCT01843738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101272471|NCT01843738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101272472|NCT01843738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272474|NCT01843829|Carboplatin|carboplatin|mesh-list
101272475|NCT01843829|Capecitabine|capecitabine|mesh-list
101272476|NCT01843829|Oxaliplatin|oxaliplatin|mesh-list
101272477|NCT01843829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101272478|NCT01843829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101272479|NCT01843829|Tubulin Modulators|tubulin modulators|mesh-ancestor
101272481|NCT01843829|Mitosis Modulators|mitosis modulators|mesh-ancestor
101272482|NCT01843829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272483|NCT01843829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101272484|NCT01843829|Antimetabolites|antimetabolites|mesh-ancestor
101272486|NCT01843868|Cyclophosphamide|cyclophosphamide|mesh-list
101272487|NCT01843868|Doxorubicin|doxorubicin|mesh-list
101272488|NCT01843868|Vincristine|vincristine|mesh-list
101272489|NCT01843868|Lorazepam|lorazepam|mesh-list
101272490|NCT01843868|Ondansetron|ondansetron|mesh-list
101272491|NCT01843868|Aprepitant|aprepitant|mesh-list
101272492|NCT01843868|Metoclopramide|metoclopramide|mesh-list
101272493|NCT01843868|Palonosetron|palonosetron|mesh-list
101272494|NCT01843868|Granisetron|granisetron|mesh-list
101272495|NCT01843868|Prochlorperazine|prochlorperazine|mesh-list
101272496|NCT01843868|Tropisetron|tropisetron|mesh-list
101272497|NCT01843868|Antiemetics|antiemetics|mesh-list
101272498|NCT01843868|Emetics|emetics|mesh-list
101272499|NCT01843868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101272500|NCT01843868|Immunologic Factors|immunologic factors|mesh-ancestor
101272501|NCT01843868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272502|NCT01843868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101272503|NCT01843868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101272504|NCT01843868|Alkylating Agents|alkylating agents|mesh-ancestor
101272505|NCT01843868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272506|NCT01843868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101272507|NCT01843868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101272508|NCT01843868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101272509|NCT01843868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101272510|NCT01843868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101272511|NCT01843868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101272512|NCT01843868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101272513|NCT01843868|Tubulin Modulators|tubulin modulators|mesh-ancestor
101272514|NCT01843868|Antimitotic Agents|antimitotic agents|mesh-ancestor
101272515|NCT01843868|Mitosis Modulators|mitosis modulators|mesh-ancestor
101272516|NCT01843868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101272517|NCT01843868|Glucocorticoids|glucocorticoids|mesh-ancestor
101272518|NCT01843868|Hormones|hormones|mesh-ancestor
101272519|NCT01843868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101272520|NCT01843868|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101272521|NCT01843868|Autonomic Agents|autonomic agents|mesh-ancestor
101817421|NCT00038467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101817422|NCT00038467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101817423|NCT00038467|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101817424|NCT00038467|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101817425|NCT00038467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101817426|NCT00038467|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101817427|NCT00038467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101817428|NCT00038467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101272522|NCT01843868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101272523|NCT01843868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101272524|NCT01843868|Antipruritics|antipruritics|mesh-ancestor
101272525|NCT01843868|Dermatologic Agents|dermatologic agents|mesh-ancestor
101272526|NCT01843868|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101272527|NCT01843868|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101272528|NCT01843868|Serotonin Agents|serotonin agents|mesh-ancestor
101272529|NCT01843868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101272530|NCT01843868|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101272531|NCT01843868|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101272532|NCT01843868|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101272533|NCT01843868|Dopamine Agents|dopamine agents|mesh-ancestor
101272534|NCT01843868|Anticonvulsants|anticonvulsants|mesh-ancestor
101272535|NCT01843868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101272536|NCT01843868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101272537|NCT01843868|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101272538|NCT01843868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101272539|NCT01843868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101272540|NCT01843868|GABA Modulators|gaba modulators|mesh-ancestor
101272541|NCT01843868|GABA Agents|gaba agents|mesh-ancestor
101272542|NCT01843868|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101272544|NCT01843998|Temsirolimus|temsirolimus|mesh-list
101272545|NCT01843998|MTOR Inhibitors|mtor inhibitors|mesh-list
101272546|NCT01843998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101272547|NCT01843998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101272549|NCT01843998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101272550|NCT01843998|Antifungal Agents|antifungal agents|mesh-ancestor
101272551|NCT01843998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101272552|NCT01843998|Immunologic Factors|immunologic factors|mesh-ancestor
101272553|NCT01843998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272554|NCT01843998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101272555|NCT01843998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101272556|NCT01843998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272558|NCT01844024|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101272559|NCT01844024|Abortifacient Agents|abortifacient agents|mesh-ancestor
101272560|NCT01844024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101272561|NCT01844024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272562|NCT01844024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101272563|NCT01844024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101272564|NCT01844024|Oxytocics|oxytocics|mesh-ancestor
101272565|NCT01844063|Antiviral Agents|antiviral agents|mesh-list
101272566|NCT01844063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101272568|NCT01844141|Chlorhexidine|chlorhexidine|mesh-list
101272569|NCT01844141|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101272570|NCT01844141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101272571|NCT01844141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101272572|NCT01844141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101272573|NCT01844141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272574|NCT01844141|Disinfectants|disinfectants|mesh-ancestor
101272575|NCT01844141|Dermatologic Agents|dermatologic agents|mesh-ancestor
101272576|NCT01844323|Palbociclib|palbociclib|mesh-list
101272577|NCT01844323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101272578|NCT01844323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101817429|NCT00038467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817430|NCT01095445|Ribavirin|ribavirin|mesh-list
101817431|NCT01095445|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101817432|NCT01095445|Antimetabolites|antimetabolites|mesh-ancestor
101817433|NCT01095445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817434|NCT01095445|Antiviral Agents|antiviral agents|mesh-ancestor
101817435|NCT01095445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101817436|NCT00660179|Macitentan|macitentan|mesh-list
101817437|NCT00660179|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101817438|NCT00660179|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101817439|NCT00660179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817440|NCT00660179|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
101817441|NCT00050167|Paclitaxel|paclitaxel|mesh-list
101272579|NCT01844323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101272580|NCT01844323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272581|NCT01844401|Albuterol|albuterol|mesh-list
101272582|NCT01844401|Procaterol|procaterol|mesh-list
101272583|NCT01844401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101272584|NCT01844401|Autonomic Agents|autonomic agents|mesh-ancestor
101272585|NCT01844401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101272588|NCT01844401|Respiratory System Agents|respiratory system agents|mesh-ancestor
101272589|NCT01844401|Tocolytic Agents|tocolytic agents|mesh-ancestor
101272590|NCT01844401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101272591|NCT01844401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101272592|NCT01844401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101272593|NCT01844401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101272594|NCT01844401|Adrenergic Agents|adrenergic agents|mesh-ancestor
101272595|NCT01844401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101272596|NCT01844401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272597|NCT01844401|Sympathomimetics|sympathomimetics|mesh-ancestor
101272601|NCT01844427|Dopamine Agents|dopamine agents|mesh-ancestor
101272602|NCT01844427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101272603|NCT01844427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272604|NCT01844427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272605|NCT01844427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101272606|NCT01844427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101272607|NCT01844622|Domperidone|domperidone|mesh-list
101272608|NCT01844622|Antiemetics|antiemetics|mesh-ancestor
101272609|NCT01844622|Autonomic Agents|autonomic agents|mesh-ancestor
101272610|NCT01844622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101272611|NCT01844622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272612|NCT01844622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101272613|NCT01844622|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101272614|NCT01844622|Dopamine Agents|dopamine agents|mesh-ancestor
101272615|NCT01844622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101272616|NCT01844622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272618|NCT01844635|Immunologic Factors|immunologic factors|mesh-ancestor
101272619|NCT01844635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272620|NCT01844635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101272622|NCT01844648|Mydriatics|mydriatics|mesh-ancestor
101272623|NCT01844648|Autonomic Agents|autonomic agents|mesh-ancestor
101272624|NCT01844648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101272625|NCT01844648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272626|NCT01844648|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101272627|NCT01844648|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101272628|NCT01844648|Cholinergic Agents|cholinergic agents|mesh-ancestor
101817442|NCT00050167|Docetaxel|docetaxel|mesh-list
101817443|NCT00050167|Capecitabine|capecitabine|mesh-list
101817444|NCT00050167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101817445|NCT00050167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101817446|NCT00050167|Tubulin Modulators|tubulin modulators|mesh-ancestor
101817447|NCT00050167|Antimitotic Agents|antimitotic agents|mesh-ancestor
101817448|NCT00050167|Mitosis Modulators|mitosis modulators|mesh-ancestor
101817449|NCT00050167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817450|NCT00050167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101817451|NCT00050167|Antimetabolites|antimetabolites|mesh-ancestor
101817452|NCT01096927|Amoxicillin|amoxicillin|mesh-list
101817453|NCT01096927|Clavulanic Acids|clavulanic acids|mesh-list
101272629|NCT01844648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101272631|NCT01844674|Vemurafenib|vemurafenib|mesh-list
101272632|NCT01844674|Tizanidine|tizanidine|mesh-list
101272633|NCT01844674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101272634|NCT01844674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101272635|NCT01844674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101272636|NCT01844674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272637|NCT01844674|Analgesics|analgesics|mesh-ancestor
101272638|NCT01844674|Sensory System Agents|sensory system agents|mesh-ancestor
101272639|NCT01844674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101272640|NCT01844674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272641|NCT01844674|Anticonvulsants|anticonvulsants|mesh-ancestor
101272642|NCT01844674|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101272643|NCT01844674|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101272644|NCT01844674|Parasympatholytics|parasympatholytics|mesh-ancestor
101272645|NCT01844674|Autonomic Agents|autonomic agents|mesh-ancestor
101272646|NCT01844674|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101272647|NCT01844674|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101272648|NCT01844674|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101272649|NCT01844674|Adrenergic Agents|adrenergic agents|mesh-ancestor
101272650|NCT01844674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101272651|NCT01844791|Pentamidine|pentamidine|mesh-list
101272652|NCT01844791|Gemcitabine|gemcitabine|mesh-list
101272653|NCT01844791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101272654|NCT01844791|Antimetabolites|antimetabolites|mesh-ancestor
101272655|NCT01844791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272656|NCT01844791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101272657|NCT01844791|Antifungal Agents|antifungal agents|mesh-ancestor
101272658|NCT01844791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101272659|NCT01844791|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101272660|NCT01844791|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101272661|NCT01844791|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101272662|NCT01844804|Infliximab|infliximab|mesh-list
101272663|NCT01844804|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101272664|NCT01844804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101272665|NCT01844804|Dermatologic Agents|dermatologic agents|mesh-ancestor
101272666|NCT01844804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101272667|NCT01844804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101272668|NCT01844869|Homoharringtonine|homoharringtonine|mesh-list
101272669|NCT01844869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101272670|NCT01844869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101272671|NCT01844869|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101272672|NCT01844869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101272673|NCT01844869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272674|NCT01844947|Sorafenib|sorafenib|mesh-list
101272675|NCT01844947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101272676|NCT01844947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101272677|NCT01844947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101272678|NCT01844947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272679|NCT01845012|Dialysis Solutions|dialysis solutions|mesh-list
101272680|NCT01845012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101272681|NCT01845038|Timolol|timolol|mesh-list
101817455|NCT01096927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101817456|NCT01096927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101817457|NCT01096927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101817458|NCT01096927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817459|NCT01096927|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101817460|NCT00660023|Epoetin Alfa|epoetin alfa|mesh-list
101817461|NCT00660023|Hematinics|hematinics|mesh-ancestor
101817462|NCT02554955|Mycophenolic Acid|mycophenolic acid|mesh-list
101272682|NCT01845038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272683|NCT01845038|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101272684|NCT01845038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101272685|NCT01845038|Adrenergic Agents|adrenergic agents|mesh-ancestor
101272686|NCT01845038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101272687|NCT01845038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272688|NCT01845038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101272689|NCT01845038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101272690|NCT01845064|Kallikreins|kallikreins|mesh-list
101272691|NCT01845064|Coagulants|coagulants|mesh-ancestor
101272692|NCT01845064|Fertility Agents, Male|fertility agents, male|mesh-ancestor
101272693|NCT01845064|Fertility Agents|fertility agents|mesh-ancestor
101272694|NCT01845064|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101272695|NCT01845064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272696|NCT01845090|Calcium Carbonate|calcium carbonate|mesh-list
101272697|NCT01845090|Calcium|calcium|mesh-list
101272698|NCT01845090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101272699|NCT01845090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272700|NCT01845090|Antacids|antacids|mesh-ancestor
101272701|NCT01845090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272702|NCT01845090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101272703|NCT01845142|Vitamin D|vitamin d|mesh-list
101272704|NCT01845142|Cholecalciferol|cholecalciferol|mesh-list
101272705|NCT01845142|Vitamins|vitamins|mesh-ancestor
101272706|NCT01845142|Micronutrients|micronutrients|mesh-ancestor
101272707|NCT01845142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272708|NCT01845142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101272709|NCT01845142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101272710|NCT01845194|Metoprolol|metoprolol|mesh-list
101272711|NCT01845194|Talinolol|talinolol|mesh-list
101272712|NCT01845194|Torsemide|torsemide|mesh-list
101272713|NCT01845194|Midazolam|midazolam|mesh-list
101272714|NCT01845194|Codeine|codeine|mesh-list
101272715|NCT01845194|Caffeine|caffeine|mesh-list
101272716|NCT01845194|Pravastatin|pravastatin|mesh-list
101272717|NCT01845194|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101272718|NCT01845194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101272719|NCT01845194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101272720|NCT01845194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272721|NCT01845194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101272722|NCT01845194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101272723|NCT01845194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101272724|NCT01845194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101272725|NCT01845194|Anesthetics, General|anesthetics, general|mesh-ancestor
101272726|NCT01845194|Anesthetics|anesthetics|mesh-ancestor
101272727|NCT01845194|GABA Modulators|gaba modulators|mesh-ancestor
101272728|NCT01845194|GABA Agents|gaba agents|mesh-ancestor
101272729|NCT01845194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101272730|NCT01845194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272731|NCT01845194|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101272732|NCT01845194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101272733|NCT01845194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101272734|NCT01845194|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101272735|NCT01845194|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101272736|NCT01845194|Purinergic Agents|purinergic agents|mesh-ancestor
101272737|NCT01845194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101272738|NCT01845194|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101272739|NCT01845194|Sympatholytics|sympatholytics|mesh-ancestor
101817463|NCT02554955|Daclizumab|daclizumab|mesh-list
101817464|NCT02554955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101817465|NCT02554955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101817466|NCT02554955|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101817467|NCT02554955|Antitubercular Agents|antitubercular agents|mesh-ancestor
101817468|NCT02554955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101817469|NCT02554955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101817470|NCT02554955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101817471|NCT02554955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817472|NCT02554955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101272740|NCT01845194|Autonomic Agents|autonomic agents|mesh-ancestor
101272741|NCT01845194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101272742|NCT01845194|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101272743|NCT01845194|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101272744|NCT01845194|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101272745|NCT01845194|Adrenergic Agents|adrenergic agents|mesh-ancestor
101272747|NCT01845194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101272748|NCT01845194|Antimetabolites|antimetabolites|mesh-ancestor
101272749|NCT01845194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101272750|NCT01845194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101272751|NCT01845194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101272752|NCT01845194|Narcotics|narcotics|mesh-ancestor
101272753|NCT01845194|Analgesics|analgesics|mesh-ancestor
101272754|NCT01845194|Sensory System Agents|sensory system agents|mesh-ancestor
101272755|NCT01845194|Antitussive Agents|antitussive agents|mesh-ancestor
101272756|NCT01845194|Respiratory System Agents|respiratory system agents|mesh-ancestor
101272757|NCT01845194|Diuretics|diuretics|mesh-ancestor
101272758|NCT01845194|Natriuretic Agents|natriuretic agents|mesh-ancestor
101272759|NCT01845194|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101272760|NCT01845194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101272761|NCT01845246|Colistin|colistin|mesh-list
101272762|NCT01845246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101272763|NCT01845246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101272764|NCT01845259|Liraglutide|liraglutide|mesh-list
101272765|NCT01845259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101272766|NCT01845259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272767|NCT01845259|Incretins|incretins|mesh-ancestor
101272768|NCT01845259|Hormones|hormones|mesh-ancestor
101272769|NCT01845259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101272770|NCT01845272|Amlodipine|amlodipine|mesh-list
101272771|NCT01845272|Candesartan|candesartan|mesh-list
101272772|NCT01845272|Candesartan cilexetil|candesartan cilexetil|mesh-list
101272773|NCT01845272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101272774|NCT01845272|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101272775|NCT01845272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101272776|NCT01845272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272777|NCT01845272|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101272778|NCT01845272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272780|NCT01845272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101272781|NCT01845272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101272783|NCT01845298|Rifamycins|rifamycins|mesh-list
101272784|NCT01845298|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101272785|NCT01845298|Antitubercular Agents|antitubercular agents|mesh-ancestor
101272786|NCT01845298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101272787|NCT01845298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101272788|NCT01845298|Leprostatic Agents|leprostatic agents|mesh-ancestor
101272789|NCT01845298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101272790|NCT01845298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101272791|NCT01845298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272792|NCT01845298|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101272793|NCT01845298|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101272794|NCT01845298|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101817473|NCT02554955|Immunologic Factors|immunologic factors|mesh-ancestor
101817474|NCT02554955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817475|NCT00062647|Vancomycin|vancomycin|mesh-list
101817476|NCT00062647|Cloxacillin|cloxacillin|mesh-list
101817477|NCT00062647|Oxacillin|oxacillin|mesh-list
101817478|NCT00062647|Nafcillin|nafcillin|mesh-list
101817479|NCT00062647|Telavancin|telavancin|mesh-list
101817480|NCT00062647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101817481|NCT00062647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101817482|NCT00570323|Fulvestrant|fulvestrant|mesh-list
101817483|NCT00570323|Anastrozole|anastrozole|mesh-list
101817484|NCT00570323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101272795|NCT01845298|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101272796|NCT01845298|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101272797|NCT01845298|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101272798|NCT01845363|Anti-Infective Agents|anti-infective agents|mesh-list
101272799|NCT01845363|Cefazolin|cefazolin|mesh-list
101272800|NCT01845363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101272801|NCT01845376|Anesthetics|anesthetics|mesh-list
101272802|NCT01845376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101272803|NCT01845376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272804|NCT01845428|Pravastatin|pravastatin|mesh-list
101272805|NCT01845428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101272806|NCT01845428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101272807|NCT01845428|Antimetabolites|antimetabolites|mesh-ancestor
101272808|NCT01845428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272809|NCT01845428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101272810|NCT01845428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101272811|NCT01845428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101272812|NCT01845493|Sulforaphane|sulforaphane|mesh-list
101272813|NCT01845493|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101272814|NCT01845493|Protective Agents|protective agents|mesh-ancestor
101272815|NCT01845493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272816|NCT01845493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101272817|NCT01845532|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
101272818|NCT01845532|Anesthetics, Local|anesthetics, local|mesh-ancestor
101272819|NCT01845532|Anesthetics|anesthetics|mesh-ancestor
101272820|NCT01845532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101272821|NCT01845532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272822|NCT01845532|Sensory System Agents|sensory system agents|mesh-ancestor
101272823|NCT01845532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101272824|NCT01845532|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
101272825|NCT01845558|Wobenzym|wobenzym|mesh-list
101272826|NCT01845558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101272827|NCT01845558|Immunologic Factors|immunologic factors|mesh-ancestor
101272828|NCT01845558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272829|NCT01845584|Immunoglobulins|immunoglobulins|mesh-list
101272830|NCT01845584|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101272831|NCT01845584|gamma-Globulins|gamma-globulins|mesh-list
101272832|NCT01845584|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101272833|NCT01845584|Immunologic Factors|immunologic factors|mesh-ancestor
101272835|NCT01845610|Manganese|manganese|mesh-list
101272836|NCT01845610|Trace Elements|trace elements|mesh-ancestor
101272837|NCT01845610|Micronutrients|micronutrients|mesh-ancestor
101272838|NCT01845610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272839|NCT01845675|Temozolomide|temozolomide|mesh-list
101272840|NCT01845675|Dacarbazine|dacarbazine|mesh-list
101272841|NCT01845675|Endostatins|endostatins|mesh-list
101272842|NCT01845675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101272843|NCT01845675|Alkylating Agents|alkylating agents|mesh-ancestor
101272844|NCT01845675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272845|NCT01845675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101272846|NCT01845675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101272847|NCT01845675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101272848|NCT01845675|Growth Substances|growth substances|mesh-ancestor
101817485|NCT00570323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101817486|NCT00570323|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101817487|NCT00570323|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101817488|NCT00570323|Hormone Antagonists|hormone antagonists|mesh-ancestor
101817489|NCT00570323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101817490|NCT00570323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272849|NCT01845675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272851|NCT01845701|Artesunate|artesunate|mesh-list
101272852|NCT01845701|Lumefantrine|lumefantrine|mesh-list
101272853|NCT01845701|Artemether|artemether|mesh-list
101272854|NCT01845701|Piperaquine|piperaquine|mesh-list
101272855|NCT01845701|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101272856|NCT01845701|Amodiaquine|amodiaquine|mesh-list
101272857|NCT01845701|Artenimol|artenimol|mesh-list
101272858|NCT01845701|Antimalarials|antimalarials|mesh-ancestor
101272859|NCT01845701|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101272860|NCT01845701|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101272861|NCT01845701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101272862|NCT01845701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101272863|NCT01845701|Antiviral Agents|antiviral agents|mesh-ancestor
101272864|NCT01845701|Schistosomicides|schistosomicides|mesh-ancestor
101272865|NCT01845701|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101272866|NCT01845701|Anthelmintics|anthelmintics|mesh-ancestor
101272867|NCT01845727|Amphotericin B|amphotericin b|mesh-list
101272868|NCT01845727|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101272869|NCT01845727|Amebicides|amebicides|mesh-ancestor
101272870|NCT01845727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101272871|NCT01845727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101272872|NCT01845727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101272873|NCT01845727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101272874|NCT01845727|Antifungal Agents|antifungal agents|mesh-ancestor
101272875|NCT01845844|Ranibizumab|ranibizumab|mesh-list
101272876|NCT01845844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101272877|NCT01845844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101272878|NCT01845844|Growth Substances|growth substances|mesh-ancestor
101272879|NCT01845844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272880|NCT01845844|Growth Inhibitors|growth inhibitors|mesh-ancestor
101272881|NCT01845844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101272882|NCT01846026|Vitamin D|vitamin d|mesh-list
101272883|NCT01846026|Cholecalciferol|cholecalciferol|mesh-list
101272884|NCT01846026|Vitamins|vitamins|mesh-ancestor
101272885|NCT01846026|Micronutrients|micronutrients|mesh-ancestor
101272886|NCT01846026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272887|NCT01846026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101272888|NCT01846026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101272889|NCT01846117|Vitamin D|vitamin d|mesh-list
101272890|NCT01846117|Secoisolariciresinol|secoisolariciresinol|mesh-list
101272891|NCT01846117|Vitamins|vitamins|mesh-ancestor
101272892|NCT01846117|Micronutrients|micronutrients|mesh-ancestor
101272893|NCT01846117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272894|NCT01846117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101272895|NCT01846117|Phytoestrogens|phytoestrogens|mesh-ancestor
101272896|NCT01846117|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101272897|NCT01846117|Estrogens|estrogens|mesh-ancestor
101272898|NCT01846117|Hormones|hormones|mesh-ancestor
101272899|NCT01846117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101272900|NCT01846143|Poly ICLC|poly iclc|mesh-list
101272901|NCT01846143|Immunologic Factors|immunologic factors|mesh-ancestor
101272902|NCT01846143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272903|NCT01846143|Interferon Inducers|interferon inducers|mesh-ancestor
101272904|NCT01846273|Ranibizumab|ranibizumab|mesh-list
101272905|NCT01846273|Verteporfin|verteporfin|mesh-list
101272906|NCT01846273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101272907|NCT01846273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101272908|NCT01846273|Growth Substances|growth substances|mesh-ancestor
101272909|NCT01846273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272910|NCT01846273|Growth Inhibitors|growth inhibitors|mesh-ancestor
101272911|NCT01846273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101272912|NCT01846273|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101272914|NCT01846325|Vitamin E|vitamin e|mesh-list
101272915|NCT01846325|Vitamins|vitamins|mesh-ancestor
101272916|NCT01846325|Micronutrients|micronutrients|mesh-ancestor
101817492|NCT00570323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101817493|NCT00570323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101817494|NCT00570323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817495|NCT00791531|Methotrexate|methotrexate|mesh-list
101817496|NCT00791531|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101817497|NCT00791531|Abortifacient Agents|abortifacient agents|mesh-ancestor
101817498|NCT00791531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101817499|NCT00791531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817500|NCT00791531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101272917|NCT01846325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272918|NCT01846325|Antioxidants|antioxidants|mesh-ancestor
101272919|NCT01846325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272920|NCT01846325|Protective Agents|protective agents|mesh-ancestor
101272921|NCT01846364|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
101272922|NCT01846364|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101272923|NCT01846364|Protective Agents|protective agents|mesh-ancestor
101272924|NCT01846364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272925|NCT01846364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101272926|NCT01846559|Clopidogrel|clopidogrel|mesh-list
101272927|NCT01846559|Ticagrelor|ticagrelor|mesh-list
101272928|NCT01846559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101272929|NCT01846559|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101272930|NCT01846559|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101272931|NCT01846559|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101272932|NCT01846559|Purinergic Agents|purinergic agents|mesh-ancestor
101272933|NCT01846559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101272934|NCT01846559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272935|NCT01846559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272936|NCT01846650|Capecitabine|capecitabine|mesh-list
101272937|NCT01846650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101272938|NCT01846650|Antimetabolites|antimetabolites|mesh-ancestor
101272940|NCT01846650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101272941|NCT01846806|Rifaximin|rifaximin|mesh-list
101272942|NCT01846806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101272943|NCT01846806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101272944|NCT01846806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101272945|NCT01846832|Interferons|interferons|mesh-list
101272946|NCT01846832|Ribavirin|ribavirin|mesh-list
101272947|NCT01846832|Interferon-alpha|interferon-alpha|mesh-list
101272948|NCT01846832|Interferon alpha-2|interferon alpha-2|mesh-list
101272949|NCT01846832|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101272950|NCT01846832|Simeprevir|simeprevir|mesh-list
101272951|NCT01846832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101272952|NCT01846832|Antiviral Agents|antiviral agents|mesh-ancestor
101272953|NCT01846832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101272954|NCT01846832|Antimetabolites|antimetabolites|mesh-ancestor
101272955|NCT01846832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272956|NCT01846832|Immunologic Factors|immunologic factors|mesh-ancestor
101272957|NCT01846832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272958|NCT01846832|Protease Inhibitors|protease inhibitors|mesh-ancestor
101272959|NCT01846832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101272960|NCT01846962|Fluticasone|fluticasone|mesh-list
101272961|NCT01846962|Budesonide|budesonide|mesh-list
101272962|NCT01846962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101272963|NCT01846962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101272964|NCT01846962|Autonomic Agents|autonomic agents|mesh-ancestor
101272965|NCT01846962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101272966|NCT01846962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272967|NCT01846962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101272968|NCT01846962|Respiratory System Agents|respiratory system agents|mesh-ancestor
101272969|NCT01846962|Dermatologic Agents|dermatologic agents|mesh-ancestor
101272970|NCT01846962|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101272971|NCT01846962|Glucocorticoids|glucocorticoids|mesh-ancestor
101272972|NCT01846962|Hormones|hormones|mesh-ancestor
101817501|NCT00791531|Antimetabolites|antimetabolites|mesh-ancestor
101817502|NCT00791531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817503|NCT00791531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101817504|NCT00791531|Dermatologic Agents|dermatologic agents|mesh-ancestor
101817505|NCT00791531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101817506|NCT00791531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101817507|NCT00791531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101817508|NCT00791531|Immunologic Factors|immunologic factors|mesh-ancestor
101817509|NCT00791531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101817510|NCT00791531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101817511|NCT00788099|Gemcitabine|gemcitabine|mesh-list
101272973|NCT01846962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101272974|NCT01846975|Abatacept|abatacept|mesh-list
101272975|NCT01846975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101534693|NCT00569465|Acetylcysteine|acetylcysteine|mesh-list
101272976|NCT01846975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272977|NCT01846975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101272978|NCT01846975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101272979|NCT01846975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101272980|NCT01846975|Immunologic Factors|immunologic factors|mesh-ancestor
101272981|NCT01846975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272982|NCT01846975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101272983|NCT01847144|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101272984|NCT01847144|Gliclazide|gliclazide|mesh-list
101272985|NCT01847144|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
101272986|NCT01847144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101272987|NCT01847144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272988|NCT01847144|Incretins|incretins|mesh-ancestor
101272989|NCT01847144|Hormones|hormones|mesh-ancestor
101272990|NCT01847144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101272991|NCT01847144|Protease Inhibitors|protease inhibitors|mesh-ancestor
101272992|NCT01847144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101272993|NCT01847144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272994|NCT01847157|Anesthetics|anesthetics|mesh-list
101272995|NCT01847157|Prilocaine|prilocaine|mesh-list
101272996|NCT01847157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101272997|NCT01847157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101272998|NCT01847157|Anesthetics, Local|anesthetics, local|mesh-ancestor
101272999|NCT01847157|Sensory System Agents|sensory system agents|mesh-ancestor
101273000|NCT01847157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101273001|NCT01847235|Temozolomide|temozolomide|mesh-list
101273002|NCT01847235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101273003|NCT01847235|Alkylating Agents|alkylating agents|mesh-ancestor
101273004|NCT01847235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273005|NCT01847235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101273006|NCT01847339|Bupivacaine|bupivacaine|mesh-list
101273007|NCT01847339|Anesthetics, Local|anesthetics, local|mesh-ancestor
101273008|NCT01847339|Anesthetics|anesthetics|mesh-ancestor
101273009|NCT01847339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101273010|NCT01847339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273011|NCT01847339|Sensory System Agents|sensory system agents|mesh-ancestor
101273012|NCT01847339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101273013|NCT01847404|Pantoprazole|pantoprazole|mesh-list
101273014|NCT01847404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273015|NCT01847404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101273016|NCT01847404|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101273017|NCT01847404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101273018|NCT01847404|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101273019|NCT01847417|Pantoprazole|pantoprazole|mesh-list
101273020|NCT01847417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101273021|NCT01847417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101273022|NCT01847417|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101273023|NCT01847417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101817512|NCT00788099|Sorafenib|sorafenib|mesh-list
101817513|NCT00788099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101817514|NCT00788099|Antimetabolites|antimetabolites|mesh-ancestor
101817515|NCT00788099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817516|NCT00788099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101817517|NCT00788099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101817518|NCT00788099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101817519|NCT00795587|Mannitol|mannitol|mesh-list
101817520|NCT00795587|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101817521|NCT00795587|Diuretics|diuretics|mesh-ancestor
101273024|NCT01847417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273025|NCT01847456|Insulin|insulin|mesh-list
101273026|NCT01847456|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101273027|NCT01847456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101273028|NCT01847456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273029|NCT01847495|Irinotecan|irinotecan|mesh-list
101273030|NCT01847495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101273031|NCT01847495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101273032|NCT01847495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101273033|NCT01847495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273034|NCT01847495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101273035|NCT01847521|Quercetin|quercetin|mesh-list
101273036|NCT01847521|Antioxidants|antioxidants|mesh-ancestor
101273037|NCT01847521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273038|NCT01847521|Protective Agents|protective agents|mesh-ancestor
101273039|NCT01847521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273040|NCT01847599|Capecitabine|capecitabine|mesh-list
101273041|NCT01847599|Lapatinib|lapatinib|mesh-list
101273042|NCT01847599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101273043|NCT01847599|Antimetabolites|antimetabolites|mesh-ancestor
101273044|NCT01847599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273045|NCT01847599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101273046|NCT01847599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101273047|NCT01847599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101273048|NCT01847612|Methylene Blue|methylene blue|mesh-list
101273049|NCT01847612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101273050|NCT01847612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273051|NCT01847664|Rifamycins|rifamycins|mesh-list
101273052|NCT01847664|Rifamycin SV|rifamycin sv|mesh-list
101273053|NCT01847664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101273054|NCT01847664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101273055|NCT01847664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101273056|NCT01847677|Paclitaxel|paclitaxel|mesh-list
101273057|NCT01847677|Bevacizumab|bevacizumab|mesh-list
101273058|NCT01847677|Carboplatin|carboplatin|mesh-list
101273059|NCT01847677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101273060|NCT01847677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101273061|NCT01847677|Tubulin Modulators|tubulin modulators|mesh-ancestor
101273062|NCT01847677|Antimitotic Agents|antimitotic agents|mesh-ancestor
101273063|NCT01847677|Mitosis Modulators|mitosis modulators|mesh-ancestor
101273064|NCT01847677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273065|NCT01847677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101273066|NCT01847677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101273067|NCT01847677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101273068|NCT01847677|Growth Substances|growth substances|mesh-ancestor
101273069|NCT01847677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273070|NCT01847677|Growth Inhibitors|growth inhibitors|mesh-ancestor
101273071|NCT01847690|Hydrocortisone|hydrocortisone|mesh-list
101273072|NCT01847690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101273073|NCT01847768|Methacholine Chloride|methacholine chloride|mesh-list
101273074|NCT01847768|Dimercaprol|dimercaprol|mesh-list
101273075|NCT01847768|Chelating Agents|chelating agents|mesh-ancestor
101273076|NCT01847768|Sequestering Agents|sequestering agents|mesh-ancestor
101273077|NCT01847768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273078|NCT01847768|Miotics|miotics|mesh-ancestor
101273079|NCT01847768|Autonomic Agents|autonomic agents|mesh-ancestor
101273080|NCT01847768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101817523|NCT00795587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817524|NCT00661505|Epoetin Alfa|epoetin alfa|mesh-list
101817525|NCT00661505|Hematinics|hematinics|mesh-ancestor
101817526|NCT00788333|Trastuzumab|trastuzumab|mesh-list
101817527|NCT00788333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101817528|NCT00788333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101817529|NCT00795899|Paclitaxel|paclitaxel|mesh-list
101817530|NCT00795899|Cyclophosphamide|cyclophosphamide|mesh-list
101817531|NCT00795899|Trastuzumab|trastuzumab|mesh-list
101273081|NCT01847768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273082|NCT01847768|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101273083|NCT01847768|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
101273084|NCT01847768|Respiratory System Agents|respiratory system agents|mesh-ancestor
101273085|NCT01847768|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101273086|NCT01847768|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101273087|NCT01847768|Cholinergic Agents|cholinergic agents|mesh-ancestor
101273088|NCT01847768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101273089|NCT01847781|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101273090|NCT01847781|Immunologic Factors|immunologic factors|mesh-ancestor
101273091|NCT01847781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273092|NCT01847872|Vaccines|vaccines|mesh-list
101273093|NCT01847872|Immunologic Factors|immunologic factors|mesh-ancestor
101273094|NCT01847872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273095|NCT01847976|Doxycycline|doxycycline|mesh-list
101273096|NCT01847976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101273097|NCT01847976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101273098|NCT01847976|Antimalarials|antimalarials|mesh-ancestor
101273099|NCT01847976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101273100|NCT01847976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101273101|NCT01848106|Bivalirudin|bivalirudin|mesh-list
101273102|NCT01848106|Antithrombins|antithrombins|mesh-ancestor
101273103|NCT01848106|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101273104|NCT01848106|Protease Inhibitors|protease inhibitors|mesh-ancestor
101273105|NCT01848106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101273106|NCT01848106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273107|NCT01848106|Anticoagulants|anticoagulants|mesh-ancestor
101273108|NCT01848119|Gabapentin|gabapentin|mesh-list
101273109|NCT01848119|Analgesics|analgesics|mesh-ancestor
101273110|NCT01848119|Sensory System Agents|sensory system agents|mesh-ancestor
101273111|NCT01848119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101273112|NCT01848119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273113|NCT01848119|Anticonvulsants|anticonvulsants|mesh-ancestor
101273114|NCT01848119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101273115|NCT01848119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101273116|NCT01848119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101273117|NCT01848119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101273118|NCT01848119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101273119|NCT01848119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101273120|NCT01848119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101273121|NCT01848119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273122|NCT01848119|Antimanic Agents|antimanic agents|mesh-ancestor
101273123|NCT01848132|Prednisone|prednisone|mesh-list
101273124|NCT01848132|Cyclophosphamide|cyclophosphamide|mesh-list
101273127|NCT01848132|Vincristine|vincristine|mesh-list
101273128|NCT01848132|Bortezomib|bortezomib|mesh-list
101273129|NCT01848132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101273130|NCT01848132|Immunologic Factors|immunologic factors|mesh-ancestor
101273131|NCT01848132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273132|NCT01848132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101273133|NCT01848132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101273134|NCT01848132|Alkylating Agents|alkylating agents|mesh-ancestor
101273135|NCT01848132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273136|NCT01848132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101273137|NCT01848132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101273138|NCT01848132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101817533|NCT00795899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101817534|NCT00795899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101817535|NCT00795899|Tubulin Modulators|tubulin modulators|mesh-ancestor
101817536|NCT00795899|Antimitotic Agents|antimitotic agents|mesh-ancestor
101817537|NCT00795899|Mitosis Modulators|mitosis modulators|mesh-ancestor
101817538|NCT00795899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817539|NCT00795899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101817540|NCT00795899|Immunologic Factors|immunologic factors|mesh-ancestor
101273139|NCT01848132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101273140|NCT01848132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101273141|NCT01848132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101273142|NCT01848132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101273143|NCT01848132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101273144|NCT01848132|Glucocorticoids|glucocorticoids|mesh-ancestor
101273145|NCT01848132|Hormones|hormones|mesh-ancestor
101273146|NCT01848132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101273147|NCT01848132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101273148|NCT01848132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101273149|NCT01848132|Tubulin Modulators|tubulin modulators|mesh-ancestor
101273150|NCT01848132|Antimitotic Agents|antimitotic agents|mesh-ancestor
101273151|NCT01848132|Mitosis Modulators|mitosis modulators|mesh-ancestor
101273152|NCT01848197|Paclitaxel|paclitaxel|mesh-list
101273153|NCT01848197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101273154|NCT01848197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101273155|NCT01848197|Tubulin Modulators|tubulin modulators|mesh-ancestor
101273156|NCT01848197|Antimitotic Agents|antimitotic agents|mesh-ancestor
101273157|NCT01848197|Mitosis Modulators|mitosis modulators|mesh-ancestor
101273158|NCT01848197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273160|NCT01848236|Ergocalciferols|ergocalciferols|mesh-list
101273161|NCT01848236|Cholecalciferol|cholecalciferol|mesh-list
101273162|NCT01848236|Vitamins|vitamins|mesh-list
101273163|NCT01848236|Micronutrients|micronutrients|mesh-ancestor
101273164|NCT01848236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273165|NCT01848236|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101273166|NCT01848236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101273167|NCT01848262|Pulmonary Surfactants|pulmonary surfactants|mesh-list
101273168|NCT01848262|Respiratory System Agents|respiratory system agents|mesh-ancestor
101273169|NCT01848301|Acetylcholine|acetylcholine|mesh-list
101273170|NCT01848301|Vasodilator Agents|vasodilator agents|mesh-ancestor
101273171|NCT01848301|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101273172|NCT01848301|Cholinergic Agents|cholinergic agents|mesh-ancestor
101273173|NCT01848301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101273174|NCT01848301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273175|NCT01848301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273176|NCT01848340|Cabotegravir|cabotegravir|mesh-list
101273177|NCT01848340|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101273178|NCT01848340|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101273179|NCT01848340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101273180|NCT01848340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273181|NCT01848340|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101273182|NCT01848340|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101273183|NCT01848340|Antiviral Agents|antiviral agents|mesh-ancestor
101273185|NCT01848379|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101273186|NCT01848379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273187|NCT01848613|Vinorelbine|vinorelbine|mesh-list
101273188|NCT01848613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101273189|NCT01848613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101273190|NCT01848613|Tubulin Modulators|tubulin modulators|mesh-ancestor
101273191|NCT01848613|Antimitotic Agents|antimitotic agents|mesh-ancestor
101273192|NCT01848613|Mitosis Modulators|mitosis modulators|mesh-ancestor
101273193|NCT01848613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273194|NCT01848652|Doxorubicin|doxorubicin|mesh-list
101273195|NCT01848652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101817541|NCT00795899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817542|NCT00795899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101817543|NCT00795899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101817544|NCT00795899|Alkylating Agents|alkylating agents|mesh-ancestor
101817545|NCT00795899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101817546|NCT00795899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101817547|NCT00795899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101817548|NCT00795899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101817549|NCT00795899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101273196|NCT01848652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101273197|NCT01848652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101273198|NCT01848652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101273200|NCT01848652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273201|NCT01848665|Indomethacin|indomethacin|mesh-list
101273202|NCT01848665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101273203|NCT01848665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101273204|NCT01848665|Analgesics|analgesics|mesh-ancestor
101273205|NCT01848665|Sensory System Agents|sensory system agents|mesh-ancestor
101273206|NCT01848665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101273207|NCT01848665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273208|NCT01848665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101273209|NCT01848665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101273210|NCT01848665|Gout Suppressants|gout suppressants|mesh-ancestor
101273211|NCT01848665|Tocolytic Agents|tocolytic agents|mesh-ancestor
101273212|NCT01848665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101273213|NCT01848665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101273214|NCT01848665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101273215|NCT01848665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273216|NCT01848691|Carbon Monoxide|carbon monoxide|mesh-list
101273217|NCT01848691|Antimetabolites|antimetabolites|mesh-ancestor
101273218|NCT01848691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273219|NCT01848691|Gasotransmitters|gasotransmitters|mesh-ancestor
101273220|NCT01848691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101273221|NCT01848691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273222|NCT01848743|Tenofovir|tenofovir|mesh-list
101273223|NCT01848743|Lamivudine|lamivudine|mesh-list
101273224|NCT01848743|Antiviral Agents|antiviral agents|mesh-ancestor
101273225|NCT01848743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101273226|NCT01848743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101273227|NCT01848743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101273228|NCT01848743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101273229|NCT01848743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273230|NCT01848743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101273231|NCT01848743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101273232|NCT01848769|Beclomethasone|beclomethasone|mesh-list
101273233|NCT01848769|Formoterol Fumarate|formoterol fumarate|mesh-list
101273234|NCT01848769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101273235|NCT01848769|Autonomic Agents|autonomic agents|mesh-ancestor
101273236|NCT01848769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101273237|NCT01848769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273238|NCT01848769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101273239|NCT01848769|Respiratory System Agents|respiratory system agents|mesh-ancestor
101273240|NCT01848769|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101273241|NCT01848769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101273242|NCT01848769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101273243|NCT01848769|Adrenergic Agents|adrenergic agents|mesh-ancestor
101273244|NCT01848769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101273245|NCT01848769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273246|NCT01848769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101273247|NCT01848769|Glucocorticoids|glucocorticoids|mesh-ancestor
101273248|NCT01848769|Hormones|hormones|mesh-ancestor
101273250|NCT01848808|Wobenzym|wobenzym|mesh-list
101817551|NCT00795977|Picibanil|picibanil|mesh-list
101817552|NCT00795977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101817553|NCT00796211|Nortriptyline|nortriptyline|mesh-list
101817554|NCT00796211|Calcipotriene|calcipotriene|mesh-list
101817555|NCT00796211|Dermatologic Agents|dermatologic agents|mesh-ancestor
101817556|NCT00796211|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101817557|NCT00796211|Antidepressive Agents|antidepressive agents|mesh-ancestor
101817558|NCT00796211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101817559|NCT00796211|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101273251|NCT01848808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101273252|NCT01848808|Immunologic Factors|immunologic factors|mesh-ancestor
101273253|NCT01848808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273254|NCT01848873|Amlodipine|amlodipine|mesh-list
101273255|NCT01848873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101273256|NCT01848873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101273257|NCT01848873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101273258|NCT01848873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273259|NCT01848873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101273260|NCT01848873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273261|NCT01848873|Vasodilator Agents|vasodilator agents|mesh-ancestor
101273262|NCT01848925|Hydroxyurea|hydroxyurea|mesh-list
101273263|NCT01848925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101273264|NCT01848925|Antisickling Agents|antisickling agents|mesh-ancestor
101273265|NCT01848925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101273266|NCT01848925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273267|NCT01848925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101273268|NCT01849016|Acetylcysteine|acetylcysteine|mesh-list
101273269|NCT01849016|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101273270|NCT01849016|Antiviral Agents|antiviral agents|mesh-ancestor
101273271|NCT01849016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101273272|NCT01849016|Expectorants|expectorants|mesh-ancestor
101273273|NCT01849016|Respiratory System Agents|respiratory system agents|mesh-ancestor
101273274|NCT01849016|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101273275|NCT01849016|Antioxidants|antioxidants|mesh-ancestor
101273276|NCT01849016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273277|NCT01849016|Protective Agents|protective agents|mesh-ancestor
101273278|NCT01849016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273279|NCT01849016|Antidotes|antidotes|mesh-ancestor
101273280|NCT01849042|Donepezil|donepezil|mesh-list
101273281|NCT01849042|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101273282|NCT01849042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101273283|NCT01849042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273284|NCT01849042|Cholinergic Agents|cholinergic agents|mesh-ancestor
101273285|NCT01849042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101273286|NCT01849042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273287|NCT01849042|Nootropic Agents|nootropic agents|mesh-ancestor
101273288|NCT01849094|Milrinone|milrinone|mesh-list
101273289|NCT01849094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101273290|NCT01849094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101273291|NCT01849094|Vasodilator Agents|vasodilator agents|mesh-ancestor
101273292|NCT01849094|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101273293|NCT01849094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101273294|NCT01849094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101273295|NCT01849094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273296|NCT01849094|Protective Agents|protective agents|mesh-ancestor
101273297|NCT01849094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273298|NCT01849211|Rocuronium|rocuronium|mesh-list
101273299|NCT01849211|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101273300|NCT01849211|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101273302|NCT01849211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101273303|NCT01849211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273304|NCT01849406|Budesonide|budesonide|mesh-list
101273305|NCT01849406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101273306|NCT01849406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101817560|NCT00796211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101817561|NCT00796211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101817562|NCT00796211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817563|NCT00796211|Adrenergic Agents|adrenergic agents|mesh-ancestor
101817564|NCT00796211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101817565|NCT00796211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817566|NCT00788567|Mycophenolic Acid|mycophenolic acid|mesh-list
101817567|NCT00788567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101817568|NCT00788567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101817569|NCT00788567|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101817570|NCT00788567|Antitubercular Agents|antitubercular agents|mesh-ancestor
101817571|NCT00788567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101817572|NCT00788567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101817573|NCT00788567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101817574|NCT00788567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273308|NCT01849406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101273309|NCT01849406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273310|NCT01849406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101273311|NCT01849406|Respiratory System Agents|respiratory system agents|mesh-ancestor
101273312|NCT01849406|Glucocorticoids|glucocorticoids|mesh-ancestor
101273313|NCT01849406|Hormones|hormones|mesh-ancestor
101273314|NCT01849406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101273315|NCT01849640|Piperaquine|piperaquine|mesh-list
101273316|NCT01849640|Primaquine|primaquine|mesh-list
101273317|NCT01849640|Antimalarials|antimalarials|mesh-ancestor
101273318|NCT01849640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101273319|NCT01849640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101273320|NCT01849640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101273321|NCT01849666|Vemurafenib|vemurafenib|mesh-list
101273322|NCT01849666|Phenprocoumon|phenprocoumon|mesh-list
101273323|NCT01849666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101273324|NCT01849666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101273325|NCT01849666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101273326|NCT01849666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273327|NCT01849666|Anticoagulants|anticoagulants|mesh-ancestor
101273328|NCT01849757|Plasma-lyte 148|plasma-lyte 148|mesh-list
101273329|NCT01849757|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101273330|NCT01849757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101273331|NCT01849835|Menthol|menthol|mesh-list
101273332|NCT01849835|Antipruritics|antipruritics|mesh-ancestor
101273333|NCT01849835|Dermatologic Agents|dermatologic agents|mesh-ancestor
101273334|NCT01849861|Methimazole|methimazole|mesh-list
101273335|NCT01849861|Antithyroid Agents|antithyroid agents|mesh-ancestor
101273336|NCT01849861|Hormone Antagonists|hormone antagonists|mesh-ancestor
101273337|NCT01849861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101273338|NCT01849861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273339|NCT01849926|Amdinocillin|amdinocillin|mesh-list
101273340|NCT01849926|Ibuprofen|ibuprofen|mesh-list
101273341|NCT01849926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101273342|NCT01849926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101273343|NCT01849926|Analgesics|analgesics|mesh-ancestor
101273344|NCT01849926|Sensory System Agents|sensory system agents|mesh-ancestor
101273345|NCT01849926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101273346|NCT01849926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273347|NCT01849926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101273348|NCT01849926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101273349|NCT01849926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101273350|NCT01849926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101817575|NCT00662909|Mirabegron|mirabegron|mesh-list
101817576|NCT00662909|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101817577|NCT00662909|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101817578|NCT00662909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101817579|NCT00662909|Adrenergic Agents|adrenergic agents|mesh-ancestor
101817580|NCT00662909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101817581|NCT00662909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817582|NCT00662909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817583|NCT00662909|Urological Agents|urological agents|mesh-ancestor
101817584|NCT00050011|Zoledronic Acid|zoledronic acid|mesh-list
101273351|NCT01849926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273352|NCT01849926|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101273353|NCT01849926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101273354|NCT01849926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101273355|NCT01849939|Immunosuppressive Agents|immunosuppressive agents|mesh-list
101273356|NCT01849939|Immunologic Factors|immunologic factors|mesh-ancestor
101273357|NCT01849939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273358|NCT01850017|Dexmedetomidine|dexmedetomidine|mesh-list
101273359|NCT01850017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101273360|NCT01850017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101273361|NCT01850017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273362|NCT01850017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101273363|NCT01850017|Analgesics|analgesics|mesh-ancestor
101273364|NCT01850017|Sensory System Agents|sensory system agents|mesh-ancestor
101273365|NCT01850017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101273366|NCT01850017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101273367|NCT01850017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101273368|NCT01850017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101273369|NCT01850017|Adrenergic Agents|adrenergic agents|mesh-ancestor
101273370|NCT01850017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101273371|NCT01850017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273372|NCT01850095|Azelaic acid|azelaic acid|mesh-list
101273373|NCT01850095|Estradiol|estradiol|mesh-list
101273374|NCT01850095|Estrogens|estrogens|mesh-ancestor
101273375|NCT01850095|Hormones|hormones|mesh-ancestor
101273376|NCT01850095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101273377|NCT01850095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273378|NCT01850095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101273379|NCT01850095|Dermatologic Agents|dermatologic agents|mesh-ancestor
101273381|NCT01850121|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101273382|NCT01850121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101273383|NCT01850121|Dermatologic Agents|dermatologic agents|mesh-ancestor
101273384|NCT01850121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101273385|NCT01850121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101273386|NCT01850147|Sunitinib|sunitinib|mesh-list
101273387|NCT01850147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101273388|NCT01850147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101273389|NCT01850147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101273390|NCT01850147|Growth Substances|growth substances|mesh-ancestor
101273391|NCT01850147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273392|NCT01850147|Growth Inhibitors|growth inhibitors|mesh-ancestor
101273393|NCT01850147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101273394|NCT01850147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101273395|NCT01850147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273396|NCT01850160|Valsartan|valsartan|mesh-list
101273397|NCT01850160|Antihypertensive Agents|antihypertensive agents|mesh-list
101273398|NCT01850160|Chlorthalidone|chlorthalidone|mesh-list
101273399|NCT01850160|Angiotensin II|angiotensin ii|mesh-list
101273400|NCT01850160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
101273401|NCT01850160|Diuretics|diuretics|mesh-list
101273402|NCT01850160|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
101273403|NCT01850160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101273404|NCT01850160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817586|NCT00050011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101817587|NCT00050011|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101817588|NCT00050011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101817589|NCT00050011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101817590|NCT00050011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817591|NCT00050011|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101817592|NCT00050011|Hormone Antagonists|hormone antagonists|mesh-ancestor
101817593|NCT00050011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101273405|NCT01850160|Natriuretic Agents|natriuretic agents|mesh-ancestor
101314238|NCT00000877|Protease Inhibitors|protease inhibitors|mesh-ancestor
101273406|NCT01850160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273407|NCT01850160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101273408|NCT01850160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101273410|NCT01850251|Vitamins|vitamins|mesh-ancestor
101273411|NCT01850251|Micronutrients|micronutrients|mesh-ancestor
101273412|NCT01850251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273413|NCT01850251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101273414|NCT01850277|Amiodarone|amiodarone|mesh-list
101273415|NCT01850277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273416|NCT01850277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101273417|NCT01850277|Vasodilator Agents|vasodilator agents|mesh-ancestor
101273418|NCT01850277|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101273419|NCT01850277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101273420|NCT01850277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101273421|NCT01850277|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101273422|NCT01850277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101273423|NCT01850277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101273424|NCT01850277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101273425|NCT01850277|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101273426|NCT01850277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101273427|NCT01850511|Phenylephrine|phenylephrine|mesh-list
101273428|NCT01850511|Oxymetazoline|oxymetazoline|mesh-list
101273429|NCT01850511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101273430|NCT01850511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101273431|NCT01850511|Adrenergic Agents|adrenergic agents|mesh-ancestor
101273432|NCT01850511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101273433|NCT01850511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273434|NCT01850511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273435|NCT01850511|Sympathomimetics|sympathomimetics|mesh-ancestor
101273436|NCT01850511|Autonomic Agents|autonomic agents|mesh-ancestor
101273437|NCT01850511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101273438|NCT01850511|Nasal Decongestants|nasal decongestants|mesh-ancestor
101273439|NCT01850511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101273440|NCT01850511|Respiratory System Agents|respiratory system agents|mesh-ancestor
101273441|NCT01850511|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101273442|NCT01850511|Mydriatics|mydriatics|mesh-ancestor
101273443|NCT01850511|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101273444|NCT01850511|Protective Agents|protective agents|mesh-ancestor
101273445|NCT01850628|Paclitaxel|paclitaxel|mesh-list
101273446|NCT01850628|Trastuzumab|trastuzumab|mesh-list
101273447|NCT01850628|Pertuzumab|pertuzumab|mesh-list
101273448|NCT01850628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101273449|NCT01850628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101273450|NCT01850628|Tubulin Modulators|tubulin modulators|mesh-ancestor
101273451|NCT01850628|Antimitotic Agents|antimitotic agents|mesh-ancestor
101273452|NCT01850628|Mitosis Modulators|mitosis modulators|mesh-ancestor
101273453|NCT01850628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273454|NCT01850628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101273455|NCT01850680|Folic Acid|folic acid|mesh-list
101273456|NCT01850680|Methotrexate|methotrexate|mesh-list
101273457|NCT01850680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101273458|NCT01850680|Abortifacient Agents|abortifacient agents|mesh-ancestor
101273459|NCT01850680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101817594|NCT00050011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817595|NCT00050011|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101817596|NCT00661427|Cetuximab|cetuximab|mesh-list
101817597|NCT00661427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101817598|NCT00661427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101817599|NCT00049543|Gefitinib|gefitinib|mesh-list
101817600|NCT00049543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101817601|NCT00049543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101273460|NCT01850680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273461|NCT01850680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101273462|NCT01850680|Antimetabolites|antimetabolites|mesh-ancestor
101273463|NCT01850680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273464|NCT01850680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101273465|NCT01850680|Dermatologic Agents|dermatologic agents|mesh-ancestor
101273466|NCT01850680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101273467|NCT01850680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101273468|NCT01850680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101273469|NCT01850680|Immunologic Factors|immunologic factors|mesh-ancestor
101273470|NCT01850680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101273471|NCT01850680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101273472|NCT01850680|Hematinics|hematinics|mesh-ancestor
101273473|NCT01850680|Vitamin B Complex|vitamin b complex|mesh-ancestor
101273474|NCT01850680|Vitamins|vitamins|mesh-ancestor
101273475|NCT01850680|Micronutrients|micronutrients|mesh-ancestor
101273476|NCT01850940|Tolvaptan|tolvaptan|mesh-list
101314241|NCT00000877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101273477|NCT01850940|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101273478|NCT01850940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273479|NCT01850940|Natriuretic Agents|natriuretic agents|mesh-ancestor
101273480|NCT01850940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273481|NCT01850953|Varenicline|varenicline|mesh-list
101273482|NCT01850953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101273483|NCT01850953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101273484|NCT01850953|Cholinergic Agents|cholinergic agents|mesh-ancestor
101273485|NCT01850953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101273486|NCT01850953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273487|NCT01850953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273488|NCT01850979|Tacrolimus|tacrolimus|mesh-list
101273489|NCT01850979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101273490|NCT01850979|Immunologic Factors|immunologic factors|mesh-ancestor
101273491|NCT01850979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273492|NCT01850979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101273493|NCT01850979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101273494|NCT01850979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273495|NCT01851005|Dexmedetomidine|dexmedetomidine|mesh-list
101273496|NCT01851005|Remifentanil|remifentanil|mesh-list
101273497|NCT01851005|Anesthetics|anesthetics|mesh-list
101273498|NCT01851005|Propofol|propofol|mesh-list
101273499|NCT01851005|Sevoflurane|sevoflurane|mesh-list
101273500|NCT01851005|Rocuronium|rocuronium|mesh-list
101273501|NCT01851005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101273502|NCT01851005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273503|NCT01851005|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101273504|NCT01851005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101273505|NCT01851005|Analgesics|analgesics|mesh-ancestor
101273506|NCT01851005|Sensory System Agents|sensory system agents|mesh-ancestor
101273507|NCT01851005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101273508|NCT01851005|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101273509|NCT01851005|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101273510|NCT01851005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101273511|NCT01851005|Adrenergic Agents|adrenergic agents|mesh-ancestor
101273512|NCT01851005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101273513|NCT01851005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273514|NCT01851005|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101273515|NCT01851005|Anesthetics, General|anesthetics, general|mesh-ancestor
101273516|NCT01851005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101273517|NCT01851005|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101817602|NCT00049543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101817603|NCT00049543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817604|NCT03955393|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
101817605|NCT03955393|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101817606|NCT03955393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817608|NCT01092481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101273518|NCT01851005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101273519|NCT01851005|Narcotics|narcotics|mesh-ancestor
101273520|NCT01851005|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101273521|NCT01851005|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101273522|NCT01851005|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101273523|NCT01851148|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
101273524|NCT01851148|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101273525|NCT01851148|Serotonin Agents|serotonin agents|mesh-ancestor
101273526|NCT01851148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101273527|NCT01851148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273528|NCT01851148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273529|NCT01851200|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101273530|NCT01851200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101273531|NCT01851200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101273532|NCT01851200|Immunotoxins|immunotoxins|mesh-ancestor
101273533|NCT01851200|Immunoconjugates|immunoconjugates|mesh-ancestor
101273534|NCT01851200|Immunologic Factors|immunologic factors|mesh-ancestor
101273535|NCT01851200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273536|NCT01851265|Olaparib|olaparib|mesh-list
101273537|NCT01851265|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101273538|NCT01851265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101273539|NCT01851265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273540|NCT01851265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101273541|NCT01851278|Triamcinolone|triamcinolone|mesh-list
101273542|NCT01851278|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101273543|NCT01851278|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101273544|NCT01851278|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101273545|NCT01851278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101273546|NCT01851278|Glucocorticoids|glucocorticoids|mesh-ancestor
101273547|NCT01851278|Hormones|hormones|mesh-ancestor
101273548|NCT01851278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101273549|NCT01851278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273550|NCT01851278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101273551|NCT01851278|Immunologic Factors|immunologic factors|mesh-ancestor
101273552|NCT01851278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101273553|NCT01851278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273554|NCT01851408|Sirolimus|sirolimus|mesh-list
101273555|NCT01851408|Sorafenib|sorafenib|mesh-list
101273556|NCT01851408|Temsirolimus|temsirolimus|mesh-list
101273557|NCT01851408|MTOR Inhibitors|mtor inhibitors|mesh-list
101273558|NCT01851408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101273559|NCT01851408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101273560|NCT01851408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101273561|NCT01851408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273562|NCT01851408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101273563|NCT01851408|Immunologic Factors|immunologic factors|mesh-ancestor
101273564|NCT01851408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273565|NCT01851408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101273566|NCT01851408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101273567|NCT01851408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101273568|NCT01851408|Antifungal Agents|antifungal agents|mesh-ancestor
101273569|NCT01851473|Quinine|quinine|mesh-list
101273570|NCT01851473|Acetazolamide|acetazolamide|mesh-list
101273571|NCT01851473|Cocaine|cocaine|mesh-list
101273572|NCT01851473|Anticonvulsants|anticonvulsants|mesh-ancestor
101273573|NCT01851473|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101273575|NCT01851473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273576|NCT01851473|Diuretics|diuretics|mesh-ancestor
101273577|NCT01851473|Natriuretic Agents|natriuretic agents|mesh-ancestor
101817610|NCT00035815|Mitosis Modulators|mitosis modulators|mesh-ancestor
101817611|NCT00035815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817612|NCT00662831|Dalteparin|dalteparin|mesh-list
101817613|NCT00662831|Tinzaparin|tinzaparin|mesh-list
101817614|NCT00662831|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101817615|NCT00662831|Anticoagulants|anticoagulants|mesh-ancestor
101817616|NCT00662831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101817617|NCT00662831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101817618|NCT00662831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273578|NCT01851473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273579|NCT01851473|Anesthetics, Local|anesthetics, local|mesh-ancestor
101273580|NCT01851473|Anesthetics|anesthetics|mesh-ancestor
101273581|NCT01851473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101273582|NCT01851473|Sensory System Agents|sensory system agents|mesh-ancestor
101273583|NCT01851473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101273584|NCT01851473|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101273585|NCT01851473|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101273586|NCT01851473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101273587|NCT01851473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101273588|NCT01851473|Dopamine Agents|dopamine agents|mesh-ancestor
101273589|NCT01851473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101273590|NCT01851473|Antimalarials|antimalarials|mesh-ancestor
101273591|NCT01851473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101273592|NCT01851473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101273593|NCT01851473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101273594|NCT01851473|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101273595|NCT01851473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101273596|NCT01851473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101273597|NCT01851473|Analgesics|analgesics|mesh-ancestor
101273598|NCT01851486|Clonidine|clonidine|mesh-list
101273599|NCT01851486|Naloxone|naloxone|mesh-list
101273600|NCT01851486|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101273601|NCT01851486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273602|NCT01851486|Sensory System Agents|sensory system agents|mesh-ancestor
101273603|NCT01851486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101273604|NCT01851486|Analgesics|analgesics|mesh-ancestor
101273605|NCT01851486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101273606|NCT01851486|Sympatholytics|sympatholytics|mesh-ancestor
101273607|NCT01851486|Autonomic Agents|autonomic agents|mesh-ancestor
101273608|NCT01851486|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101273609|NCT01851486|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101273610|NCT01851486|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101273611|NCT01851486|Adrenergic Agents|adrenergic agents|mesh-ancestor
101273612|NCT01851486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101273613|NCT01851486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273614|NCT01851512|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101273615|NCT01851512|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101273616|NCT01851512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273617|NCT01851551|Rituximab|rituximab|mesh-list
101273618|NCT01851551|Vincristine|vincristine|mesh-list
101273619|NCT01851551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101273620|NCT01851551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101273621|NCT01851551|Immunologic Factors|immunologic factors|mesh-ancestor
101273622|NCT01851551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273623|NCT01851551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101273624|NCT01851551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101273625|NCT01851551|Tubulin Modulators|tubulin modulators|mesh-ancestor
101273626|NCT01851551|Antimitotic Agents|antimitotic agents|mesh-ancestor
101273627|NCT01851551|Mitosis Modulators|mitosis modulators|mesh-ancestor
101273628|NCT01851551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273629|NCT01851681|Amoxicillin|amoxicillin|mesh-list
101273630|NCT01851681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101273631|NCT01851681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101273632|NCT01851733|Doxorubicin|doxorubicin|mesh-list
101273633|NCT01851733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101817620|NCT02555423|Levobupivacaine|levobupivacaine|mesh-list
101817621|NCT02555423|Anesthetics, Local|anesthetics, local|mesh-list
101817622|NCT02555423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101817623|NCT02555423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817624|NCT02555423|Sensory System Agents|sensory system agents|mesh-ancestor
101817625|NCT02555423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101817626|NCT00792779|Propofol|propofol|mesh-list
101817627|NCT00792779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101817628|NCT00792779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101817629|NCT00792779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273634|NCT01851733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101273635|NCT01851733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101273636|NCT01851733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101273637|NCT01851733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101273638|NCT01851733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273640|NCT01851759|Vasodilator Agents|vasodilator agents|mesh-ancestor
101273641|NCT01851824|Vemurafenib|vemurafenib|mesh-list
101273642|NCT01851824|Acenocoumarol|acenocoumarol|mesh-list
101273643|NCT01851824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101273644|NCT01851824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101273645|NCT01851824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101273646|NCT01851824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273647|NCT01851824|Anticoagulants|anticoagulants|mesh-ancestor
101273648|NCT01851850|Opicapone|opicapone|mesh-list
101273649|NCT01851850|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101273650|NCT01851850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101273651|NCT01851850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273652|NCT01851850|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101273653|NCT01851850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101273654|NCT01851941|Leucovorin|leucovorin|mesh-list
101273655|NCT01851941|Folic Acid|folic acid|mesh-list
101273656|NCT01851941|Fluorouracil|fluorouracil|mesh-list
101273657|NCT01851941|Oxaliplatin|oxaliplatin|mesh-list
101273658|NCT01851941|Levoleucovorin|levoleucovorin|mesh-list
101273659|NCT01851941|Antimetabolites|antimetabolites|mesh-ancestor
101273660|NCT01851941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273661|NCT01851941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101273662|NCT01851941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101273663|NCT01851941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101273664|NCT01851941|Immunologic Factors|immunologic factors|mesh-ancestor
101273665|NCT01851941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273666|NCT01851941|Antidotes|antidotes|mesh-ancestor
101273667|NCT01851941|Protective Agents|protective agents|mesh-ancestor
101273668|NCT01851941|Vitamin B Complex|vitamin b complex|mesh-ancestor
101273669|NCT01851941|Vitamins|vitamins|mesh-ancestor
101273670|NCT01851941|Micronutrients|micronutrients|mesh-ancestor
101273671|NCT01851941|Hematinics|hematinics|mesh-ancestor
101273672|NCT01851954|Clarithromycin|clarithromycin|mesh-list
101273673|NCT01851954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101273674|NCT01851954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101273675|NCT01851954|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101273676|NCT01851954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101273677|NCT01851954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273678|NCT01851954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101273679|NCT01851954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101273680|NCT01851980|Furosemide|furosemide|mesh-list
101273681|NCT01851980|Diuretics|diuretics|mesh-ancestor
101273682|NCT01851980|Natriuretic Agents|natriuretic agents|mesh-ancestor
101273683|NCT01851980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273684|NCT01851980|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101273685|NCT01851980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101273686|NCT01851980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817630|NCT00792779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101817631|NCT00792779|Anesthetics, General|anesthetics, general|mesh-ancestor
101817632|NCT00792779|Anesthetics|anesthetics|mesh-ancestor
101817633|NCT00662363|Lubiprostone|lubiprostone|mesh-list
101817634|NCT00662363|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101817635|NCT00662363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101817636|NCT00662363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817637|NCT00796835|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101817639|NCT00796835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101817640|NCT00796835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101273687|NCT01851993|Ondansetron|ondansetron|mesh-list
101273688|NCT01851993|Antiemetics|antiemetics|mesh-ancestor
101273689|NCT01851993|Autonomic Agents|autonomic agents|mesh-ancestor
101273690|NCT01851993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101273691|NCT01851993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273692|NCT01851993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101273693|NCT01851993|Antipruritics|antipruritics|mesh-ancestor
101273695|NCT01851993|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101273696|NCT01851993|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101273697|NCT01851993|Serotonin Agents|serotonin agents|mesh-ancestor
101273698|NCT01851993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101273699|NCT01851993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273700|NCT01852253|Chlorhexidine|chlorhexidine|mesh-list
101273701|NCT01852253|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101273702|NCT01852253|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101273703|NCT01852253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101273704|NCT01852253|Disinfectants|disinfectants|mesh-ancestor
101273705|NCT01852253|Dermatologic Agents|dermatologic agents|mesh-ancestor
101273706|NCT01852266|Vaccines|vaccines|mesh-list
101273707|NCT01852266|Immunologic Factors|immunologic factors|mesh-ancestor
101273708|NCT01852266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273709|NCT01852318|Fexofenadine|fexofenadine|mesh-list
101273710|NCT01852318|Pregabalin|pregabalin|mesh-list
101273711|NCT01852318|Analgesics|analgesics|mesh-ancestor
101273712|NCT01852318|Sensory System Agents|sensory system agents|mesh-ancestor
101273713|NCT01852318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101273714|NCT01852318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273715|NCT01852318|Anticonvulsants|anticonvulsants|mesh-ancestor
101273716|NCT01852318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101273717|NCT01852318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101273718|NCT01852318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273719|NCT01852318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101273720|NCT01852318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101273721|NCT01852318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101273722|NCT01852318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101273723|NCT01852318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101273724|NCT01852318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101273725|NCT01852318|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101273726|NCT01852318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101273727|NCT01852318|Histamine Antagonists|histamine antagonists|mesh-ancestor
101273728|NCT01852318|Histamine Agents|histamine agents|mesh-ancestor
101273729|NCT01852318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101273730|NCT01852409|Bevacizumab|bevacizumab|mesh-list
101273731|NCT01852409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101273732|NCT01852409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101273733|NCT01852409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101273734|NCT01852409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101273735|NCT01852409|Growth Substances|growth substances|mesh-ancestor
101273736|NCT01852409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273737|NCT01852409|Growth Inhibitors|growth inhibitors|mesh-ancestor
101273738|NCT01852461|Poractant alfa|poractant alfa|mesh-list
101817641|NCT00796835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817642|NCT00796835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101817643|NCT00796835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101817644|NCT00796835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101817645|NCT00796835|Serotonin Agents|serotonin agents|mesh-ancestor
101817646|NCT00796835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101817647|NCT00796835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273739|NCT01852461|Beractant|beractant|mesh-list
101273740|NCT01852461|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
101273741|NCT01852461|Respiratory System Agents|respiratory system agents|mesh-ancestor
101273742|NCT01852539|Dexmedetomidine|dexmedetomidine|mesh-list
101273743|NCT01852539|Propofol|propofol|mesh-list
101273744|NCT01852539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101273745|NCT01852539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101273746|NCT01852539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273747|NCT01852539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101273748|NCT01852539|Analgesics|analgesics|mesh-ancestor
101273749|NCT01852539|Sensory System Agents|sensory system agents|mesh-ancestor
101273750|NCT01852539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101273751|NCT01852539|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101273752|NCT01852539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101273753|NCT01852539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101273754|NCT01852539|Adrenergic Agents|adrenergic agents|mesh-ancestor
101273755|NCT01852539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101273756|NCT01852539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273757|NCT01852539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101273758|NCT01852539|Anesthetics, General|anesthetics, general|mesh-ancestor
101273759|NCT01852539|Anesthetics|anesthetics|mesh-ancestor
101273760|NCT01852565|Diltiazem|diltiazem|mesh-list
101273761|NCT01852565|Darapladib|darapladib|mesh-list
101273762|NCT01852565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101273764|NCT01852565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101273765|NCT01852565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273766|NCT01852565|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101273767|NCT01852565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273768|NCT01852565|Vasodilator Agents|vasodilator agents|mesh-ancestor
101273769|NCT01852565|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
101273770|NCT01852565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101273771|NCT01852604|Interferons|interferons|mesh-list
101273772|NCT01852604|Ritonavir|ritonavir|mesh-list
101273773|NCT01852604|Ribavirin|ribavirin|mesh-list
101273774|NCT01852604|Simeprevir|simeprevir|mesh-list
101273775|NCT01852604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101273776|NCT01852604|Antiviral Agents|antiviral agents|mesh-ancestor
101273777|NCT01852604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101273778|NCT01852604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101273779|NCT01852604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101273780|NCT01852604|Protease Inhibitors|protease inhibitors|mesh-ancestor
101273781|NCT01852604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101273782|NCT01852604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273783|NCT01852604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101273784|NCT01852604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101273785|NCT01852604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101273786|NCT01852604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101273787|NCT01852604|Antimetabolites|antimetabolites|mesh-ancestor
101273788|NCT01852630|Imipenem|imipenem|mesh-list
101273789|NCT01852630|Cefepime|cefepime|mesh-list
101273790|NCT01852630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101273791|NCT01852630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101273792|NCT01852786|Contraceptive Agents|contraceptive agents|mesh-list
101273793|NCT01852786|Contraceptives, Oral|contraceptives, oral|mesh-list
101273794|NCT01852786|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
101273795|NCT01852786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101273796|NCT01852786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273797|NCT01852786|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101817648|NCT00796835|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101817649|NCT00796835|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101817650|NCT00796835|Dopamine Agents|dopamine agents|mesh-ancestor
101817651|NCT00792857|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
101817653|NCT00792857|Micronutrients|micronutrients|mesh-ancestor
101817654|NCT00792857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817655|NCT00792857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101817656|NCT02554175|Propofol|propofol|mesh-list
101817657|NCT02554175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101817658|NCT02554175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101817659|NCT02554175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273798|NCT01852903|Vitamins|vitamins|mesh-list
101273799|NCT01852903|Ascorbic Acid|ascorbic acid|mesh-list
101273800|NCT01852903|Calcium ascorbate|calcium ascorbate|mesh-list
101273801|NCT01852903|Calcium|calcium|mesh-list
101273802|NCT01852903|Micronutrients|micronutrients|mesh-ancestor
101273803|NCT01852903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534698|NCT00569465|Respiratory System Agents|respiratory system agents|mesh-ancestor
101273804|NCT01852903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101273805|NCT01852903|Antioxidants|antioxidants|mesh-ancestor
101273806|NCT01852903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273807|NCT01852903|Protective Agents|protective agents|mesh-ancestor
101273808|NCT01852994|Methyltestosterone|methyltestosterone|mesh-list
101273809|NCT01852994|Testosterone|testosterone|mesh-list
101273810|NCT01852994|Testosterone undecanoate|testosterone undecanoate|mesh-list
101273811|NCT01852994|Testosterone enanthate|testosterone enanthate|mesh-list
101273812|NCT01852994|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101273813|NCT01852994|Androgens|androgens|mesh-ancestor
101273814|NCT01852994|Hormones|hormones|mesh-ancestor
101273815|NCT01852994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101273816|NCT01852994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273817|NCT01852994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101273818|NCT01852994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101273819|NCT01852994|Anabolic Agents|anabolic agents|mesh-ancestor
101273820|NCT01853111|Aldesleukin|aldesleukin|mesh-list
101273821|NCT01853111|Interleukin-2|interleukin-2|mesh-list
101273822|NCT01853111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101273823|NCT01853111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101273824|NCT01853111|Analgesics|analgesics|mesh-ancestor
101273825|NCT01853111|Sensory System Agents|sensory system agents|mesh-ancestor
101273826|NCT01853111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101273827|NCT01853111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273828|NCT01853111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101273829|NCT01853111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101273830|NCT01853111|Antiviral Agents|antiviral agents|mesh-ancestor
101273831|NCT01853111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101273832|NCT01853306|Veliparib|veliparib|mesh-list
101273833|NCT01853306|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101273834|NCT01853306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314257|NCT00000892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101273835|NCT01853306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273836|NCT01853306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101273837|NCT01853423|Sirolimus|sirolimus|mesh-list
101273838|NCT01853423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101273839|NCT01853423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101273840|NCT01853423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101273841|NCT01853423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101273842|NCT01853423|Antifungal Agents|antifungal agents|mesh-ancestor
101273843|NCT01853423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101273844|NCT01853423|Immunologic Factors|immunologic factors|mesh-ancestor
101273845|NCT01853423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273846|NCT01853449|Fentanyl|fentanyl|mesh-list
101273847|NCT01853449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101273848|NCT01853449|Narcotics|narcotics|mesh-ancestor
101817660|NCT02554175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101817661|NCT02554175|Anesthetics, General|anesthetics, general|mesh-ancestor
101817662|NCT02554175|Anesthetics|anesthetics|mesh-ancestor
101817663|NCT00793091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101273849|NCT01853449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101273850|NCT01853449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273851|NCT01853449|Analgesics|analgesics|mesh-ancestor
101273852|NCT01853449|Sensory System Agents|sensory system agents|mesh-ancestor
101273853|NCT01853449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101273854|NCT01853449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101273855|NCT01853449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101273856|NCT01853449|Anesthetics, General|anesthetics, general|mesh-ancestor
101273857|NCT01853449|Anesthetics|anesthetics|mesh-ancestor
101273858|NCT01853540|Sildenafil Citrate|sildenafil citrate|mesh-list
101273859|NCT01853540|Vasodilator Agents|vasodilator agents|mesh-ancestor
101273860|NCT01853540|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101273861|NCT01853540|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101273862|NCT01853540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101273863|NCT01853540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273864|NCT01853540|Urological Agents|urological agents|mesh-ancestor
101273865|NCT01853566|Hormones|hormones|mesh-list
101273866|NCT01853566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101273867|NCT01853566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273868|NCT01853709|Bisacodyl|bisacodyl|mesh-list
101273869|NCT01853709|Cathartics|cathartics|mesh-ancestor
101273870|NCT01853709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101273871|NCT01853709|Laxatives|laxatives|mesh-ancestor
101273872|NCT01853787|Formoterol Fumarate|formoterol fumarate|mesh-list
101273873|NCT01853787|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101273874|NCT01853787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101273875|NCT01853787|Autonomic Agents|autonomic agents|mesh-ancestor
101273876|NCT01853787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101273877|NCT01853787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273878|NCT01853787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101273879|NCT01853787|Respiratory System Agents|respiratory system agents|mesh-ancestor
101273880|NCT01853787|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101273881|NCT01853787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101273882|NCT01853787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101273883|NCT01853787|Adrenergic Agents|adrenergic agents|mesh-ancestor
101273884|NCT01853787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101273885|NCT01853787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273886|NCT01853800|Rivaroxaban|rivaroxaban|mesh-list
101273887|NCT01853800|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101273888|NCT01853800|Antithrombins|antithrombins|mesh-ancestor
101273889|NCT01853800|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101273890|NCT01853800|Protease Inhibitors|protease inhibitors|mesh-ancestor
101273891|NCT01853800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101273892|NCT01853800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273893|NCT01853800|Anticoagulants|anticoagulants|mesh-ancestor
101273894|NCT01853813|Bevacizumab|bevacizumab|mesh-list
101273895|NCT01853813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101273896|NCT01853813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101273897|NCT01853813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101273898|NCT01853813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101273899|NCT01853813|Growth Substances|growth substances|mesh-ancestor
101273900|NCT01853813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273901|NCT01853813|Growth Inhibitors|growth inhibitors|mesh-ancestor
101273902|NCT01853852|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
101273903|NCT01853852|Antiviral Agents|antiviral agents|mesh-ancestor
101273904|NCT01853852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101273905|NCT01853852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101273906|NCT01853852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273908|NCT01853956|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101273909|NCT01853956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101273910|NCT01853956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273911|NCT01853956|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101273912|NCT01853956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101273913|NCT01853956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101273914|NCT01853956|GABA Modulators|gaba modulators|mesh-ancestor
101273915|NCT01853956|GABA Agents|gaba agents|mesh-ancestor
101273916|NCT01853956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101817664|NCT00793091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101817666|NCT00789503|Cholecalciferol|cholecalciferol|mesh-list
101817667|NCT00789503|Calcium|calcium|mesh-list
101817668|NCT00789503|Vitamins|vitamins|mesh-ancestor
101817669|NCT00789503|Micronutrients|micronutrients|mesh-ancestor
101817670|NCT00789503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817671|NCT00789503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101817672|NCT00789503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101817673|NCT00797303|Bevacizumab|bevacizumab|mesh-list
101273917|NCT01853956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273918|NCT01854021|Anesthetics|anesthetics|mesh-list
101273919|NCT01854021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101273920|NCT01854021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273921|NCT01854073|Scopolamine|scopolamine|mesh-list
101273922|NCT01854073|Bromides|bromides|mesh-list
101273923|NCT01854073|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101273924|NCT01854073|Anticonvulsants|anticonvulsants|mesh-ancestor
101273925|NCT01854073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101273926|NCT01854073|Antiemetics|antiemetics|mesh-ancestor
101273927|NCT01854073|Autonomic Agents|autonomic agents|mesh-ancestor
101273928|NCT01854073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101273929|NCT01854073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273930|NCT01854073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101273931|NCT01854073|Mydriatics|mydriatics|mesh-ancestor
101408044|NCT00443521|Hormones|hormones|mesh-ancestor
101273932|NCT01854073|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101273933|NCT01854073|Cholinergic Agents|cholinergic agents|mesh-ancestor
101273934|NCT01854073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101273935|NCT01854073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273936|NCT01854073|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101273937|NCT01854073|Parasympatholytics|parasympatholytics|mesh-ancestor
101273938|NCT01854086|Diphosphonates|diphosphonates|mesh-list
101273939|NCT01854086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101273940|NCT01854086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273941|NCT01854203|Cisplatin|cisplatin|mesh-list
101273942|NCT01854203|Gemcitabine|gemcitabine|mesh-list
101273943|NCT01854203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101273944|NCT01854203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101273945|NCT01854203|Antimetabolites|antimetabolites|mesh-ancestor
101273946|NCT01854203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273947|NCT01854216|Rotigotine|rotigotine|mesh-list
101273948|NCT01854216|Dopamine Agonists|dopamine agonists|mesh-ancestor
101273949|NCT01854216|Dopamine Agents|dopamine agents|mesh-ancestor
101273950|NCT01854216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101273951|NCT01854216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273952|NCT01854216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273953|NCT01854411|Analgesics|analgesics|mesh-list
101273954|NCT01854411|Sensory System Agents|sensory system agents|mesh-ancestor
101273955|NCT01854411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101273956|NCT01854411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273957|NCT01854424|Dimercaprol|dimercaprol|mesh-list
101273958|NCT01854424|Chelating Agents|chelating agents|mesh-ancestor
101273959|NCT01854424|Sequestering Agents|sequestering agents|mesh-ancestor
101273960|NCT01854424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273962|NCT01854463|Cholecalciferol|cholecalciferol|mesh-list
101273963|NCT01854463|Vitamins|vitamins|mesh-ancestor
101273964|NCT01854463|Micronutrients|micronutrients|mesh-ancestor
101273965|NCT01854463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273966|NCT01854463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101273967|NCT01854463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101273968|NCT01854476|Tranexamic Acid|tranexamic acid|mesh-list
101273969|NCT01854476|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101273970|NCT01854476|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101273971|NCT01854476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273972|NCT01854476|Hemostatics|hemostatics|mesh-ancestor
101817674|NCT00797303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101817675|NCT00797303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101817676|NCT00797303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101817677|NCT00797303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101817678|NCT00797303|Growth Substances|growth substances|mesh-ancestor
101817679|NCT00797303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817680|NCT00797303|Growth Inhibitors|growth inhibitors|mesh-ancestor
101817681|NCT00661193|Paclitaxel|paclitaxel|mesh-list
101273973|NCT01854476|Coagulants|coagulants|mesh-ancestor
101273974|NCT01854489|Rifampin|rifampin|mesh-list
101273975|NCT01854489|Buprenorphine|buprenorphine|mesh-list
101273976|NCT01854489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101273977|NCT01854489|Narcotics|narcotics|mesh-ancestor
101273978|NCT01854489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101273979|NCT01854489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101273980|NCT01854489|Analgesics|analgesics|mesh-ancestor
101273981|NCT01854489|Sensory System Agents|sensory system agents|mesh-ancestor
101273982|NCT01854489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101273984|NCT01854489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101273985|NCT01854489|Antitubercular Agents|antitubercular agents|mesh-ancestor
101273986|NCT01854489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101273987|NCT01854489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101273988|NCT01854489|Leprostatic Agents|leprostatic agents|mesh-ancestor
101273989|NCT01854489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101273990|NCT01854489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101273991|NCT01854489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273992|NCT01854489|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101273993|NCT01854489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101273994|NCT01854489|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101273995|NCT01854489|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101273996|NCT01854489|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101273997|NCT01854489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101273998|NCT01854502|Fluorides|fluorides|mesh-list
101273999|NCT01854502|Cariostatic Agents|cariostatic agents|mesh-ancestor
101274000|NCT01854502|Protective Agents|protective agents|mesh-ancestor
101274001|NCT01854502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274002|NCT01854515|Dexamethasone|dexamethasone|mesh-list
101274003|NCT01854515|Budesonide|budesonide|mesh-list
101274004|NCT01854515|Dexamethasone acetate|dexamethasone acetate|mesh-list
101274005|NCT01854515|BB 1101|bb 1101|mesh-list
101274006|NCT01854515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101274007|NCT01854515|Antiemetics|antiemetics|mesh-ancestor
101274008|NCT01854515|Autonomic Agents|autonomic agents|mesh-ancestor
101274009|NCT01854515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101274010|NCT01854515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274011|NCT01854515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101274012|NCT01854515|Glucocorticoids|glucocorticoids|mesh-ancestor
101274013|NCT01854515|Hormones|hormones|mesh-ancestor
101274014|NCT01854515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101274015|NCT01854515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101274016|NCT01854515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101274017|NCT01854515|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101274018|NCT01854515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101274019|NCT01854515|Respiratory System Agents|respiratory system agents|mesh-ancestor
101274020|NCT01854515|Protease Inhibitors|protease inhibitors|mesh-ancestor
101274021|NCT01854515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101274022|NCT01854515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274023|NCT01854606|Everolimus|everolimus|mesh-list
101274024|NCT01854606|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101274026|NCT01854606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101274027|NCT01854606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274028|NCT01854606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101274029|NCT01854606|Immunologic Factors|immunologic factors|mesh-ancestor
101817683|NCT00661193|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101817684|NCT00661193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101817685|NCT00661193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101817686|NCT00661193|Tubulin Modulators|tubulin modulators|mesh-ancestor
101817687|NCT00661193|Antimitotic Agents|antimitotic agents|mesh-ancestor
101817688|NCT00661193|Mitosis Modulators|mitosis modulators|mesh-ancestor
101817689|NCT00661193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817690|NCT00661193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101817691|NCT00661193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101817692|NCT00801047|Remifentanil|remifentanil|mesh-list
101274030|NCT01854606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274031|NCT01854606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101274032|NCT01854619|Anti-Infective Agents|anti-infective agents|mesh-list
101274033|NCT01854619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101274035|NCT01854723|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101274036|NCT01854723|Insulin Glargine|insulin glargine|mesh-list
101274037|NCT01854723|Insulin, Isophane|insulin, isophane|mesh-list
101274038|NCT01854723|Isophane Insulin, Human|isophane insulin, human|mesh-list
101274039|NCT01854723|Isophane insulin, beef|isophane insulin, beef|mesh-list
101274040|NCT01854723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101274041|NCT01854723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274043|NCT01854749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101274044|NCT01854762|Ritonavir|ritonavir|mesh-list
101274045|NCT01854762|Lopinavir|lopinavir|mesh-list
101274046|NCT01854762|Raltegravir Potassium|raltegravir potassium|mesh-list
101274047|NCT01854762|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101274048|NCT01854762|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101274049|NCT01854762|Protease Inhibitors|protease inhibitors|mesh-ancestor
101274050|NCT01854762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101274051|NCT01854762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274052|NCT01854762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101274053|NCT01854762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101274054|NCT01854762|Antiviral Agents|antiviral agents|mesh-ancestor
101274055|NCT01854762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101274056|NCT01854762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101274057|NCT01854762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101274058|NCT01854762|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101274059|NCT01854762|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101274060|NCT01854970|Esomeprazole|esomeprazole|mesh-list
101274061|NCT01854970|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101274062|NCT01854970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101274063|NCT01854970|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101274064|NCT01854970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101274065|NCT01854970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274066|NCT01855009|Calcium, Dietary|calcium, dietary|mesh-list
101274067|NCT01855009|Vitamin D|vitamin d|mesh-list
101274068|NCT01855009|Cholecalciferol|cholecalciferol|mesh-list
101274069|NCT01855009|Calcium Carbonate|calcium carbonate|mesh-list
101274070|NCT01855009|Calcium|calcium|mesh-list
101274071|NCT01855009|Vitamins|vitamins|mesh-ancestor
101274072|NCT01855009|Micronutrients|micronutrients|mesh-ancestor
101274073|NCT01855009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274074|NCT01855009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101274075|NCT01855009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101274076|NCT01855009|Antacids|antacids|mesh-ancestor
101274077|NCT01855009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274078|NCT01855009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101274079|NCT01855061|Midazolam|midazolam|mesh-list
101274080|NCT01855061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101274081|NCT01855061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101274082|NCT01855061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101274083|NCT01855061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274084|NCT01855061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101817694|NCT00801047|Anesthetics, Local|anesthetics, local|mesh-ancestor
101817695|NCT00801047|Anesthetics|anesthetics|mesh-ancestor
101817696|NCT00801047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101817697|NCT00801047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817698|NCT00801047|Sensory System Agents|sensory system agents|mesh-ancestor
101817699|NCT00801047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101817700|NCT00801047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101817701|NCT00801047|Narcotics|narcotics|mesh-ancestor
101274085|NCT01855061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101274086|NCT01855061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101274087|NCT01855061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101274088|NCT01855061|Anesthetics, General|anesthetics, general|mesh-ancestor
101274089|NCT01855061|Anesthetics|anesthetics|mesh-ancestor
101274090|NCT01855061|GABA Modulators|gaba modulators|mesh-ancestor
101274091|NCT01855061|GABA Agents|gaba agents|mesh-ancestor
101274092|NCT01855061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101274093|NCT01855061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274095|NCT01855100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101274096|NCT01855100|Antithrombins|antithrombins|mesh-ancestor
101274097|NCT01855100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101274098|NCT01855100|Protease Inhibitors|protease inhibitors|mesh-ancestor
101274099|NCT01855100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101274100|NCT01855100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274101|NCT01855100|Anticoagulants|anticoagulants|mesh-ancestor
101274102|NCT01855139|Rivaroxaban|rivaroxaban|mesh-list
101274103|NCT01855139|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101274104|NCT01855139|Antithrombins|antithrombins|mesh-ancestor
101274105|NCT01855139|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101274106|NCT01855139|Protease Inhibitors|protease inhibitors|mesh-ancestor
101274107|NCT01855139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101274108|NCT01855139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274109|NCT01855139|Anticoagulants|anticoagulants|mesh-ancestor
101274110|NCT01855256|Oxybutynin|oxybutynin|mesh-list
101274111|NCT01855256|Parasympatholytics|parasympatholytics|mesh-ancestor
101274112|NCT01855256|Autonomic Agents|autonomic agents|mesh-ancestor
101274113|NCT01855256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101274114|NCT01855256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274115|NCT01855256|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101274116|NCT01855256|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101274117|NCT01855256|Cholinergic Agents|cholinergic agents|mesh-ancestor
101274118|NCT01855256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101274119|NCT01855256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274120|NCT01855256|Urological Agents|urological agents|mesh-ancestor
101274122|NCT01855321|Cholecalciferol|cholecalciferol|mesh-list
101274123|NCT01855321|Vitamins|vitamins|mesh-ancestor
101274124|NCT01855321|Micronutrients|micronutrients|mesh-ancestor
101274125|NCT01855321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274126|NCT01855321|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101274127|NCT01855321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101274128|NCT01855334|Spironolactone|spironolactone|mesh-list
101274129|NCT01855334|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101274130|NCT01855334|Hormone Antagonists|hormone antagonists|mesh-ancestor
101274131|NCT01855334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101274132|NCT01855334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274133|NCT01855334|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101274134|NCT01855334|Diuretics|diuretics|mesh-ancestor
101274135|NCT01855334|Natriuretic Agents|natriuretic agents|mesh-ancestor
101274136|NCT01855386|Liver Extracts|liver extracts|mesh-list
101274137|NCT01855386|Hematinics|hematinics|mesh-ancestor
101274138|NCT01855490|Exenatide|exenatide|mesh-list
101274139|NCT01855490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101274140|NCT01855490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274141|NCT01855490|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101274142|NCT01855490|Incretins|incretins|mesh-ancestor
101274143|NCT01855490|Hormones|hormones|mesh-ancestor
101274144|NCT01855490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101274145|NCT01855516|Heparin|heparin|mesh-list
101817702|NCT00801047|Analgesics|analgesics|mesh-ancestor
101817703|NCT00801125|Natalizumab|natalizumab|mesh-list
101817704|NCT00801125|Immunologic Factors|immunologic factors|mesh-ancestor
101817705|NCT00801125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817706|NCT00801281|Prednisone|prednisone|mesh-list
101817707|NCT00801281|Cyclophosphamide|cyclophosphamide|mesh-list
101817708|NCT00801281|Rituximab|rituximab|mesh-list
101817709|NCT00801281|Doxorubicin|doxorubicin|mesh-list
101817710|NCT00801281|Vincristine|vincristine|mesh-list
101817711|NCT00801281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101817712|NCT00801281|Immunologic Factors|immunologic factors|mesh-ancestor
101817713|NCT00801281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817714|NCT00801281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101274146|NCT01855516|Anticoagulants|anticoagulants|mesh-ancestor
101274147|NCT01855516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101274148|NCT01855516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101274149|NCT01855516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274150|NCT01855529|Ropivacaine|ropivacaine|mesh-list
101274151|NCT01855529|Anesthetics, Local|anesthetics, local|mesh-ancestor
101274153|NCT01855529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101274154|NCT01855529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274155|NCT01855529|Sensory System Agents|sensory system agents|mesh-ancestor
101274156|NCT01855529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101274157|NCT01855542|Plasma-lyte 148|plasma-lyte 148|mesh-list
101274158|NCT01855542|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101274159|NCT01855542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101274160|NCT01855555|Propofol|propofol|mesh-list
101274161|NCT01855555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101274162|NCT01855555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101274163|NCT01855555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274164|NCT01855555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101274165|NCT01855555|Anesthetics, General|anesthetics, general|mesh-ancestor
101274166|NCT01855555|Anesthetics|anesthetics|mesh-ancestor
101274167|NCT01855568|Methotrexate|methotrexate|mesh-list
101274168|NCT01855568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101274169|NCT01855568|Abortifacient Agents|abortifacient agents|mesh-ancestor
101274170|NCT01855568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101274171|NCT01855568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274172|NCT01855568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101274173|NCT01855568|Antimetabolites|antimetabolites|mesh-ancestor
101274174|NCT01855568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274175|NCT01855568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101274176|NCT01855568|Dermatologic Agents|dermatologic agents|mesh-ancestor
101274177|NCT01855568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101274178|NCT01855568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101274179|NCT01855568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101274180|NCT01855568|Immunologic Factors|immunologic factors|mesh-ancestor
101274181|NCT01855568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101274182|NCT01855568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101274184|NCT01855581|Propofol|propofol|mesh-list
101274185|NCT01855581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101274186|NCT01855581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101274187|NCT01855581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274188|NCT01855581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101274189|NCT01855581|Anesthetics, General|anesthetics, general|mesh-ancestor
101274190|NCT01855581|Anesthetics|anesthetics|mesh-ancestor
101274191|NCT01855581|Analgesics|analgesics|mesh-ancestor
101274192|NCT01855581|Sensory System Agents|sensory system agents|mesh-ancestor
101274193|NCT01855581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101274194|NCT01855581|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101274195|NCT01855581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101274196|NCT01855581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101274197|NCT01855581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101817715|NCT00801281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101817716|NCT00801281|Alkylating Agents|alkylating agents|mesh-ancestor
101817717|NCT00801281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817719|NCT00801281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101817720|NCT00801281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101817721|NCT00801281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101817722|NCT00801281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101274198|NCT01855581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274199|NCT01855594|Lithium Carbonate|lithium carbonate|mesh-list
101274200|NCT01855594|Antidepressive Agents|antidepressive agents|mesh-ancestor
101274201|NCT01855594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101274202|NCT01855594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101274203|NCT01855594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274204|NCT01855594|Antimanic Agents|antimanic agents|mesh-ancestor
101274205|NCT01855594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101274206|NCT01855594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101274207|NCT01855594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274208|NCT01855711|Alosetron|alosetron|mesh-list
101274209|NCT01855711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101274210|NCT01855711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101274211|NCT01855711|Serotonin Agents|serotonin agents|mesh-ancestor
101274212|NCT01855711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101274213|NCT01855711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274214|NCT01855711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274215|NCT01855724|Gemcitabine|gemcitabine|mesh-list
101274216|NCT01855724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101274217|NCT01855724|Antimetabolites|antimetabolites|mesh-ancestor
101274218|NCT01855724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274219|NCT01855724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101274220|NCT01855737|Warfarin|warfarin|mesh-list
101274221|NCT01855737|Anticoagulants|anticoagulants|mesh-ancestor
101274222|NCT01855763|Insulin|insulin|mesh-list
101274223|NCT01855763|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101274224|NCT01855763|Metformin|metformin|mesh-list
101274225|NCT01855763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101274226|NCT01855763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274227|NCT01855971|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
101274228|NCT01855971|Antioxidants|antioxidants|mesh-ancestor
101274229|NCT01855971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274230|NCT01855971|Protective Agents|protective agents|mesh-ancestor
101274231|NCT01855971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274232|NCT01855971|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101274233|NCT01855971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101274234|NCT01855971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101274235|NCT01855971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101274236|NCT01855984|Tocotrienols|tocotrienols|mesh-list
101274237|NCT01855984|Vitamin E|vitamin e|mesh-list
101274238|NCT01855984|Tocopherols|tocopherols|mesh-list
101274239|NCT01855984|Tocovid|tocovid|mesh-list
101274240|NCT01855984|Antioxidants|antioxidants|mesh-ancestor
101274241|NCT01855984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274242|NCT01855984|Protective Agents|protective agents|mesh-ancestor
101274243|NCT01855984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274244|NCT01855984|Vitamins|vitamins|mesh-ancestor
101274245|NCT01855984|Micronutrients|micronutrients|mesh-ancestor
101274246|NCT01856023|Aldesleukin|aldesleukin|mesh-list
101274247|NCT01856023|Ipilimumab|ipilimumab|mesh-list
101274248|NCT01856023|Interleukin-2|interleukin-2|mesh-list
101274249|NCT01856023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101274250|NCT01856023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101274251|NCT01856023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101274252|NCT01856023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274253|NCT01856023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101274254|NCT01856023|Analgesics|analgesics|mesh-ancestor
101274255|NCT01856023|Sensory System Agents|sensory system agents|mesh-ancestor
101274256|NCT01856023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101817723|NCT00801281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101817724|NCT00801281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101817725|NCT00801281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101817726|NCT00801281|Glucocorticoids|glucocorticoids|mesh-ancestor
101817727|NCT00801281|Hormones|hormones|mesh-ancestor
101817728|NCT00801281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101817729|NCT00801281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101817730|NCT00801281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101817731|NCT00801281|Tubulin Modulators|tubulin modulators|mesh-ancestor
101817732|NCT00801281|Antimitotic Agents|antimitotic agents|mesh-ancestor
101817733|NCT00801281|Mitosis Modulators|mitosis modulators|mesh-ancestor
101817734|NCT00801359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101274257|NCT01856023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274258|NCT01856023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101274259|NCT01856023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101274260|NCT01856023|Antiviral Agents|antiviral agents|mesh-ancestor
101274261|NCT01856023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101274262|NCT01856062|Dexamethasone|dexamethasone|mesh-list
101274263|NCT01856062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101274264|NCT01856062|Antiemetics|antiemetics|mesh-ancestor
101274265|NCT01856062|Autonomic Agents|autonomic agents|mesh-ancestor
101274266|NCT01856062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101274267|NCT01856062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274268|NCT01856062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101274269|NCT01856062|Glucocorticoids|glucocorticoids|mesh-ancestor
101274270|NCT01856062|Hormones|hormones|mesh-ancestor
101274271|NCT01856062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101274273|NCT01856062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101274274|NCT01856101|Dactolisib|dactolisib|mesh-list
101274275|NCT01856101|MTOR Inhibitors|mtor inhibitors|mesh-list
101274276|NCT01856101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101274277|NCT01856101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101274278|NCT01856101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101274279|NCT01856101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274280|NCT01856101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101274281|NCT01856101|Immunologic Factors|immunologic factors|mesh-ancestor
101274282|NCT01856101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274283|NCT01856127|Sertraline|sertraline|mesh-list
101274284|NCT01856127|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
101274285|NCT01856127|Antidepressive Agents|antidepressive agents|mesh-ancestor
101274286|NCT01856127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101274287|NCT01856127|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101274288|NCT01856127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101274289|NCT01856127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101274290|NCT01856127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274291|NCT01856127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101274293|NCT01856127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274294|NCT01856127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101274295|NCT01856127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101274296|NCT01856166|Sufentanil|sufentanil|mesh-list
101274297|NCT01856166|Levobupivacaine|levobupivacaine|mesh-list
101274298|NCT01856166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101274299|NCT01856166|Narcotics|narcotics|mesh-ancestor
101274300|NCT01856166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101274301|NCT01856166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274302|NCT01856166|Analgesics|analgesics|mesh-ancestor
101274303|NCT01856166|Sensory System Agents|sensory system agents|mesh-ancestor
101274304|NCT01856166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101274305|NCT01856166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101274306|NCT01856166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101274307|NCT01856166|Anesthetics, General|anesthetics, general|mesh-ancestor
101274308|NCT01856166|Anesthetics|anesthetics|mesh-ancestor
101274309|NCT01856166|Anesthetics, Local|anesthetics, local|mesh-ancestor
101817735|NCT00801515|Maraviroc|maraviroc|mesh-list
101817736|NCT00801515|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101817737|NCT00801515|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101817738|NCT00801515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817739|NCT00801515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101817740|NCT00801515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101817741|NCT00801515|Antiviral Agents|antiviral agents|mesh-ancestor
101817742|NCT00801515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101817743|NCT00801515|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101817744|NCT00797693|Misoprostol|misoprostol|mesh-list
101817745|NCT00797693|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101274310|NCT01856205|Immunoglobulins|immunoglobulins|mesh-list
101274311|NCT01856205|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101274312|NCT01856205|Antibodies|antibodies|mesh-list
101274313|NCT01856205|gamma-Globulins|gamma-globulins|mesh-list
101314303|NCT00389233|Antioxidants|antioxidants|mesh-ancestor
101274314|NCT01856205|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101274315|NCT01856205|Immunologic Factors|immunologic factors|mesh-ancestor
101274316|NCT01856205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274317|NCT01856348|Vitamin D|vitamin d|mesh-list
101274318|NCT01856348|Vitamins|vitamins|mesh-ancestor
101274319|NCT01856348|Micronutrients|micronutrients|mesh-ancestor
101274320|NCT01856348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274321|NCT01856348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101274322|NCT01856374|Sirolimus|sirolimus|mesh-list
101274323|NCT01856374|Everolimus|everolimus|mesh-list
101274324|NCT01856374|Atorvastatin|atorvastatin|mesh-list
101274325|NCT01856374|Pravastatin|pravastatin|mesh-list
101274326|NCT01856374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101274327|NCT01856374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101274328|NCT01856374|Antimetabolites|antimetabolites|mesh-ancestor
101274329|NCT01856374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274330|NCT01856374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101274331|NCT01856374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101274332|NCT01856374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101274333|NCT01856374|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101274334|NCT01856374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101274335|NCT01856374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101274336|NCT01856374|Immunologic Factors|immunologic factors|mesh-ancestor
101274337|NCT01856374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274338|NCT01856374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101274339|NCT01856374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101274340|NCT01856374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101274341|NCT01856374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101274342|NCT01856374|Antifungal Agents|antifungal agents|mesh-ancestor
101274344|NCT01856413|Immunologic Factors|immunologic factors|mesh-ancestor
101274345|NCT01856413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274346|NCT01856517|Clonidine|clonidine|mesh-list
101274347|NCT01856517|Analgesics|analgesics|mesh-ancestor
101274349|NCT01856517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101274350|NCT01856517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274351|NCT01856517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101274352|NCT01856517|Sympatholytics|sympatholytics|mesh-ancestor
101274353|NCT01856517|Autonomic Agents|autonomic agents|mesh-ancestor
101274354|NCT01856517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101274355|NCT01856517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101274356|NCT01856517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101274357|NCT01856517|Adrenergic Agents|adrenergic agents|mesh-ancestor
101274358|NCT01856517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101274359|NCT01856517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274360|NCT01856556|Glycine|glycine|mesh-list
101274361|NCT01856556|Glycine Agents|glycine agents|mesh-ancestor
101274362|NCT01856556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101274363|NCT01856556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274364|NCT01856556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817746|NCT00797693|Abortifacient Agents|abortifacient agents|mesh-ancestor
101817747|NCT00797693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101817748|NCT00797693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817749|NCT00797693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101817750|NCT00797693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101817751|NCT00797693|Oxytocics|oxytocics|mesh-ancestor
101817752|NCT00797771|Insulin|insulin|mesh-list
101817753|NCT00797771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101817754|NCT00797771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817755|NCT00793559|Terlipressin|terlipressin|mesh-list
101817756|NCT00793559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101817757|NCT00793559|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101817758|NCT00797927|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101274365|NCT01856621|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101274366|NCT01856621|Charcoal|charcoal|mesh-list
101274367|NCT01856621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101274368|NCT01856621|Autonomic Agents|autonomic agents|mesh-ancestor
101274369|NCT01856621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101274370|NCT01856621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274371|NCT01856621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101274372|NCT01856621|Respiratory System Agents|respiratory system agents|mesh-ancestor
101274373|NCT01856621|Glucocorticoids|glucocorticoids|mesh-ancestor
101274374|NCT01856621|Hormones|hormones|mesh-ancestor
101274375|NCT01856621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101274376|NCT01856621|Sympathomimetics|sympathomimetics|mesh-ancestor
101274377|NCT01856621|Antidotes|antidotes|mesh-ancestor
101274378|NCT01856621|Protective Agents|protective agents|mesh-ancestor
101274379|NCT01856738|Rivastigmine|rivastigmine|mesh-list
101274380|NCT01856738|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101274381|NCT01856738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101274382|NCT01856738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274383|NCT01856738|Cholinergic Agents|cholinergic agents|mesh-ancestor
101274384|NCT01856738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101274385|NCT01856738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274386|NCT01856738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101274387|NCT01856738|Protective Agents|protective agents|mesh-ancestor
101274388|NCT01856803|Thymoglobulin|thymoglobulin|mesh-list
101274389|NCT01856803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101274390|NCT01856803|Immunologic Factors|immunologic factors|mesh-ancestor
101274391|NCT01856803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274392|NCT01856803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101274394|NCT01856946|Cholecalciferol|cholecalciferol|mesh-list
101274395|NCT01856946|Vitamins|vitamins|mesh-ancestor
101274396|NCT01856946|Micronutrients|micronutrients|mesh-ancestor
101274397|NCT01856946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274398|NCT01856946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101274399|NCT01856946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101274400|NCT01856959|Magnesium Sulfate|magnesium sulfate|mesh-list
101274401|NCT01856959|Albuterol|albuterol|mesh-list
101274402|NCT01856959|Analgesics|analgesics|mesh-ancestor
101274403|NCT01856959|Sensory System Agents|sensory system agents|mesh-ancestor
101274404|NCT01856959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101274405|NCT01856959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274406|NCT01856959|Anesthetics|anesthetics|mesh-ancestor
101274407|NCT01856959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101274408|NCT01856959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101274409|NCT01856959|Anticonvulsants|anticonvulsants|mesh-ancestor
101274410|NCT01856959|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101274411|NCT01856959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101274412|NCT01856959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274413|NCT01856959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101817760|NCT00797927|Antidepressive Agents|antidepressive agents|mesh-ancestor
101817761|NCT00797927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101817762|NCT00797927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101817763|NCT00797927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101817764|NCT00797927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817765|NCT00798083|Lidocaine|lidocaine|mesh-list
101817766|NCT00798083|Ketamine|ketamine|mesh-list
101817767|NCT00798083|Amitriptyline|amitriptyline|mesh-list
101274414|NCT01856959|Tocolytic Agents|tocolytic agents|mesh-ancestor
101274415|NCT01856959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101274416|NCT01856959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101274417|NCT01856959|Autonomic Agents|autonomic agents|mesh-ancestor
101274418|NCT01856959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101274419|NCT01856959|Respiratory System Agents|respiratory system agents|mesh-ancestor
101274420|NCT01856959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101274421|NCT01856959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101274422|NCT01856959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101274423|NCT01856959|Adrenergic Agents|adrenergic agents|mesh-ancestor
101274424|NCT01856959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101274425|NCT01856985|Misoprostol|misoprostol|mesh-list
101274426|NCT01856985|Mifepristone|mifepristone|mesh-list
101274427|NCT01856985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101274428|NCT01856985|Abortifacient Agents|abortifacient agents|mesh-ancestor
101274429|NCT01856985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101274430|NCT01856985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274431|NCT01856985|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101274432|NCT01856985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101274433|NCT01856985|Oxytocics|oxytocics|mesh-ancestor
101274434|NCT01856985|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101274435|NCT01856985|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101274436|NCT01856985|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101274437|NCT01856985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101274438|NCT01856985|Contraceptive Agents|contraceptive agents|mesh-ancestor
101274439|NCT01856985|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101274440|NCT01856985|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101274441|NCT01856985|Hormone Antagonists|hormone antagonists|mesh-ancestor
101274442|NCT01856985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101274443|NCT01856985|Luteolytic Agents|luteolytic agents|mesh-ancestor
101274444|NCT01856985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101274445|NCT01856985|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101274446|NCT01856998|Propofol|propofol|mesh-list
101274447|NCT01856998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101274448|NCT01856998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101274449|NCT01856998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274450|NCT01856998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101274451|NCT01856998|Anesthetics, General|anesthetics, general|mesh-ancestor
101274452|NCT01856998|Anesthetics|anesthetics|mesh-ancestor
101274453|NCT01857011|Iron|iron|mesh-list
101274454|NCT01857011|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101274455|NCT01857011|Teferrol|teferrol|mesh-list
101274456|NCT01857011|Ferric Compounds|ferric compounds|mesh-list
101274457|NCT01857011|Trace Elements|trace elements|mesh-ancestor
101274458|NCT01857011|Micronutrients|micronutrients|mesh-ancestor
101274459|NCT01857011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274460|NCT01857011|Hematinics|hematinics|mesh-ancestor
101274461|NCT01857024|Sevelamer|sevelamer|mesh-list
101274462|NCT01857024|Chelating Agents|chelating agents|mesh-ancestor
101274463|NCT01857024|Sequestering Agents|sequestering agents|mesh-ancestor
101274464|NCT01857024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274465|NCT01857141|Dexmedetomidine|dexmedetomidine|mesh-list
101274466|NCT01857141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101274467|NCT01857141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101274468|NCT01857141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274469|NCT01857141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101274470|NCT01857141|Analgesics|analgesics|mesh-ancestor
101817768|NCT00798083|Anesthetics, Local|anesthetics, local|mesh-ancestor
101817769|NCT00798083|Anesthetics|anesthetics|mesh-ancestor
101817770|NCT00798083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101817771|NCT00798083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817772|NCT00798083|Sensory System Agents|sensory system agents|mesh-ancestor
101817773|NCT00798083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101274471|NCT01857141|Sensory System Agents|sensory system agents|mesh-ancestor
101274472|NCT01857141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101274473|NCT01857141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101274474|NCT01857141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101274475|NCT01857141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101274476|NCT01857141|Adrenergic Agents|adrenergic agents|mesh-ancestor
101274477|NCT01857141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101274478|NCT01857141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274479|NCT01857154|Calcium, Dietary|calcium, dietary|mesh-list
101274480|NCT01857154|Vitamin D|vitamin d|mesh-list
101274481|NCT01857154|Cholecalciferol|cholecalciferol|mesh-list
101274482|NCT01857154|Calcium Carbonate|calcium carbonate|mesh-list
101274483|NCT01857154|Calcium|calcium|mesh-list
101274484|NCT01857154|Vitamins|vitamins|mesh-ancestor
101274485|NCT01857154|Micronutrients|micronutrients|mesh-ancestor
101274486|NCT01857154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274487|NCT01857154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101274488|NCT01857154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101274489|NCT01857154|Antacids|antacids|mesh-ancestor
101274490|NCT01857154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274491|NCT01857154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101274492|NCT01857193|Everolimus|everolimus|mesh-list
101274493|NCT01857193|Exemestane|exemestane|mesh-list
101274494|NCT01857193|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101274495|NCT01857193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101274496|NCT01857193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101274497|NCT01857193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274498|NCT01857193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101274499|NCT01857193|Immunologic Factors|immunologic factors|mesh-ancestor
101274500|NCT01857193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274501|NCT01857193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101274502|NCT01857193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101274503|NCT01857193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101274504|NCT01857193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101274505|NCT01857193|Hormone Antagonists|hormone antagonists|mesh-ancestor
101274506|NCT01857193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101274507|NCT01857284|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
101274508|NCT01857284|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101274509|NCT01857284|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101274510|NCT01857284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101274511|NCT01857284|Antiviral Agents|antiviral agents|mesh-ancestor
101274512|NCT01857284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101274513|NCT01857349|Ethanol|ethanol|mesh-list
101274514|NCT01857349|Chlorhexidine|chlorhexidine|mesh-list
101274515|NCT01857349|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101274516|NCT01857349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101274517|NCT01857349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101274518|NCT01857349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101274519|NCT01857349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274520|NCT01857349|Disinfectants|disinfectants|mesh-ancestor
101274521|NCT01857349|Dermatologic Agents|dermatologic agents|mesh-ancestor
101274522|NCT01857375|Insulin|insulin|mesh-list
101274523|NCT01857375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101274524|NCT01857375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274525|NCT01857453|Etoposide|etoposide|mesh-list
101274526|NCT01857453|Carboplatin|carboplatin|mesh-list
101274527|NCT01857453|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101274528|NCT01857453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101274529|NCT01857453|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101274530|NCT01857453|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101274531|NCT01857453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101274532|NCT01857453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817774|NCT00798083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101817775|NCT00798083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101817776|NCT00798083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101817777|NCT00798083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101817778|NCT00798083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817779|NCT00798083|Analgesics|analgesics|mesh-ancestor
101274533|NCT01857479|Amphotericin B|amphotericin b|mesh-list
101274534|NCT01857479|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101274535|NCT01857479|Budesonide|budesonide|mesh-list
101274536|NCT01857479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101274537|NCT01857479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101274538|NCT01857479|Autonomic Agents|autonomic agents|mesh-ancestor
101274539|NCT01857479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101274540|NCT01857479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274541|NCT01857479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101274542|NCT01857479|Respiratory System Agents|respiratory system agents|mesh-ancestor
101274543|NCT01857479|Glucocorticoids|glucocorticoids|mesh-ancestor
101274544|NCT01857479|Hormones|hormones|mesh-ancestor
101274545|NCT01857479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101274546|NCT01857479|Amebicides|amebicides|mesh-ancestor
101274547|NCT01857479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101274548|NCT01857479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101274549|NCT01857479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101274550|NCT01857479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101274551|NCT01857479|Antifungal Agents|antifungal agents|mesh-ancestor
101274552|NCT01857544|Aflibercept|aflibercept|mesh-list
101274553|NCT01857544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101274554|NCT01857544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101274555|NCT01857544|Growth Substances|growth substances|mesh-ancestor
101274556|NCT01857544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274557|NCT01857544|Growth Inhibitors|growth inhibitors|mesh-ancestor
101274558|NCT01857544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101274560|NCT01857596|Bupropion|bupropion|mesh-list
101274561|NCT01857596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101274562|NCT01857596|Antidepressive Agents|antidepressive agents|mesh-ancestor
101274563|NCT01857596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101274564|NCT01857596|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101274565|NCT01857596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101274566|NCT01857596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101274567|NCT01857596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274568|NCT01857596|Dopamine Agents|dopamine agents|mesh-ancestor
101274569|NCT01857596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101274570|NCT01857596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274571|NCT01857596|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101274572|NCT01857596|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101274573|NCT01857596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101274574|NCT01857596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101274575|NCT01857596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101274576|NCT01857596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101274577|NCT01857596|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101274578|NCT01857596|Serotonin Agents|serotonin agents|mesh-ancestor
101274579|NCT01857609|Metformin|metformin|mesh-list
101274580|NCT01857609|Rabeprazole|rabeprazole|mesh-list
101274581|NCT01857609|Pantoprazole|pantoprazole|mesh-list
101274582|NCT01857609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101274583|NCT01857609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274584|NCT01857609|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101274585|NCT01857609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101274586|NCT01857609|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101274587|NCT01857609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101274588|NCT01857609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274590|NCT01857726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101274591|NCT01857726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101274592|NCT01857726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101274593|NCT01857726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101274594|NCT01857726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101817780|NCT00798083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101817781|NCT00798083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101817783|NCT00798083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101817784|NCT00798083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101274595|NCT01857726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274596|NCT01857752|Temozolomide|temozolomide|mesh-list
101274597|NCT01857752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101274598|NCT01857752|Alkylating Agents|alkylating agents|mesh-ancestor
101274599|NCT01857752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274600|NCT01857752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101274601|NCT01857804|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101274602|NCT01857804|Amoxicillin|amoxicillin|mesh-list
101274603|NCT01857804|Chlorhexidine|chlorhexidine|mesh-list
101274604|NCT01857804|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101274605|NCT01857804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101274606|NCT01857804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101274607|NCT01857804|Disinfectants|disinfectants|mesh-ancestor
101274608|NCT01857804|Dermatologic Agents|dermatologic agents|mesh-ancestor
101274610|NCT01857817|Propranolol|propranolol|mesh-list
101274611|NCT01857817|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101274612|NCT01857817|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101274613|NCT01857817|Adrenergic Agents|adrenergic agents|mesh-ancestor
101274614|NCT01857817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101274615|NCT01857817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274616|NCT01857817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274617|NCT01857817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101274618|NCT01857817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101274619|NCT01857817|Vasodilator Agents|vasodilator agents|mesh-ancestor
101274620|NCT01857817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101274621|NCT01857817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101274622|NCT01857817|Analgesics|analgesics|mesh-ancestor
101274623|NCT01857817|Sensory System Agents|sensory system agents|mesh-ancestor
101274624|NCT01857817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101274625|NCT01857817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101274626|NCT01857817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101274627|NCT01857817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101274628|NCT01857817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101274629|NCT01857817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101274630|NCT01857843|Everolimus|everolimus|mesh-list
101274631|NCT01857843|Simvastatin|simvastatin|mesh-list
101274632|NCT01857843|Ezetimibe|ezetimibe|mesh-list
101274633|NCT01857843|Pravastatin|pravastatin|mesh-list
101274634|NCT01857843|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101274635|NCT01857843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101274636|NCT01857843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101274637|NCT01857843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274638|NCT01857843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101274639|NCT01857843|Immunologic Factors|immunologic factors|mesh-ancestor
101274640|NCT01857843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274641|NCT01857843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101274642|NCT01857843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101274643|NCT01857843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101274644|NCT01857843|Antimetabolites|antimetabolites|mesh-ancestor
101274645|NCT01857843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101274646|NCT01857843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101274647|NCT01857856|Eplerenone|eplerenone|mesh-list
101274648|NCT01857856|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101274649|NCT01857856|Hormone Antagonists|hormone antagonists|mesh-ancestor
101274650|NCT01857856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101274651|NCT01857856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274652|NCT01857856|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101274653|NCT01857856|Diuretics|diuretics|mesh-ancestor
101274654|NCT01857856|Natriuretic Agents|natriuretic agents|mesh-ancestor
101274655|NCT01857856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101274656|NCT01857895|Exenatide|exenatide|mesh-list
101274657|NCT01857895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101274658|NCT01857895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312384|NCT00387868|Etoposide|etoposide|mesh-list
101817786|NCT00798083|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101817787|NCT00798083|Antidepressive Agents|antidepressive agents|mesh-ancestor
101817788|NCT00798083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101817790|NCT00798083|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101817791|NCT00798083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101817792|NCT00798083|Adrenergic Agents|adrenergic agents|mesh-ancestor
101817793|NCT00798395|Zopiclone|zopiclone|mesh-list
101817794|NCT00798395|Mirtazapine|mirtazapine|mesh-list
101817795|NCT00798395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101817796|NCT00798395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101817797|NCT00798395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817798|NCT00798395|Antidepressive Agents|antidepressive agents|mesh-ancestor
101817799|NCT00798395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101817800|NCT00798395|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101274659|NCT01857895|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101274660|NCT01857895|Incretins|incretins|mesh-ancestor
101274661|NCT01857895|Hormones|hormones|mesh-ancestor
101274662|NCT01857895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101274664|NCT01857921|Atorvastatin|atorvastatin|mesh-list
101274665|NCT01857921|Pravastatin|pravastatin|mesh-list
101274666|NCT01857921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101274667|NCT01857921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101274668|NCT01857921|Antimetabolites|antimetabolites|mesh-ancestor
101274669|NCT01857921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274670|NCT01857921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101274671|NCT01857921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101274672|NCT01857921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101274673|NCT01857921|Vasodilator Agents|vasodilator agents|mesh-ancestor
101274674|NCT01857999|Losartan|losartan|mesh-list
101274675|NCT01857999|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101274676|NCT01857999|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101274677|NCT01857999|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101274678|NCT01857999|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101274679|NCT01857999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274680|NCT01858025|Fluorouracil|fluorouracil|mesh-list
101274682|NCT01858025|Mitomycin|mitomycin|mesh-list
101274683|NCT01858025|Antimetabolites|antimetabolites|mesh-ancestor
101274684|NCT01858025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274685|NCT01858025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101274686|NCT01858025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101274687|NCT01858025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101274688|NCT01858025|Immunologic Factors|immunologic factors|mesh-ancestor
101274689|NCT01858025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274690|NCT01858025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101274691|NCT01858025|Alkylating Agents|alkylating agents|mesh-ancestor
101274692|NCT01858025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101274693|NCT01858025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101274694|NCT01858051|Cholecalciferol|cholecalciferol|mesh-list
101274695|NCT01858051|Vitamin D|vitamin d|mesh-list
101274696|NCT01858051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101274697|NCT01858051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274698|NCT01858051|Vitamins|vitamins|mesh-ancestor
101274699|NCT01858051|Micronutrients|micronutrients|mesh-ancestor
101274700|NCT01858051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101274701|NCT01858077|Everolimus|everolimus|mesh-list
101274702|NCT01858077|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101274703|NCT01858077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101817801|NCT00798395|Histamine Antagonists|histamine antagonists|mesh-ancestor
101817802|NCT00798395|Histamine Agents|histamine agents|mesh-ancestor
101817803|NCT00798395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101817804|NCT00798395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817805|NCT00798395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101817806|NCT00798395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101817807|NCT00798395|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101817808|NCT00798395|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101817809|NCT00798395|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101817810|NCT00798395|Adrenergic Agents|adrenergic agents|mesh-ancestor
101817811|NCT00798395|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101817812|NCT00798395|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101817813|NCT00798395|Serotonin Agents|serotonin agents|mesh-ancestor
101817814|NCT00798395|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101817815|NCT00801905|Nepafenac|nepafenac|mesh-list
101817816|NCT00801905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101817817|NCT00801905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101274704|NCT01858077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101274705|NCT01858077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274706|NCT01858077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101274707|NCT01858077|Immunologic Factors|immunologic factors|mesh-ancestor
101274708|NCT01858077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274709|NCT01858077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101274710|NCT01858090|Diphenhydramine|diphenhydramine|mesh-list
101274711|NCT01858090|Promethazine|promethazine|mesh-list
101274712|NCT01858090|Diclofenac|diclofenac|mesh-list
101274713|NCT01858090|Atropine|atropine|mesh-list
101274714|NCT01858090|Ephedrine|ephedrine|mesh-list
101274715|NCT01858090|Fentanyl|fentanyl|mesh-list
101274716|NCT01858090|Sufentanil|sufentanil|mesh-list
101274717|NCT01858090|Meperidine|meperidine|mesh-list
101274718|NCT01858090|Metoclopramide|metoclopramide|mesh-list
101274719|NCT01858090|Propofol|propofol|mesh-list
101274720|NCT01858090|Levobupivacaine|levobupivacaine|mesh-list
101274721|NCT01858090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101274722|NCT01858090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101274723|NCT01858090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274724|NCT01858090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101274725|NCT01858090|Anesthetics, General|anesthetics, general|mesh-ancestor
101274726|NCT01858090|Anesthetics|anesthetics|mesh-ancestor
101274727|NCT01858090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101274728|NCT01858090|Narcotics|narcotics|mesh-ancestor
101274729|NCT01858090|Analgesics|analgesics|mesh-ancestor
101274730|NCT01858090|Sensory System Agents|sensory system agents|mesh-ancestor
101274731|NCT01858090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101274732|NCT01858090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101274733|NCT01858090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101274734|NCT01858090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101274735|NCT01858090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101274736|NCT01858090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101274737|NCT01858090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101274738|NCT01858090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101274739|NCT01858090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274740|NCT01858090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101274741|NCT01858090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101274743|NCT01858090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101274744|NCT01858090|Respiratory System Agents|respiratory system agents|mesh-ancestor
101274745|NCT01858090|Mydriatics|mydriatics|mesh-ancestor
101274746|NCT01858090|Parasympatholytics|parasympatholytics|mesh-ancestor
101817819|NCT00801905|Sensory System Agents|sensory system agents|mesh-ancestor
101817820|NCT00801905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101817821|NCT00801905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817822|NCT00801905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101817823|NCT00801905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101817824|NCT00658541|Zolpidem|zolpidem|mesh-list
101817825|NCT00658541|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101817826|NCT00658541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101817827|NCT00658541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101817828|NCT00658541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817829|NCT00658541|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101817830|NCT00658541|GABA Agonists|gaba agonists|mesh-ancestor
101817831|NCT00658541|GABA Agents|gaba agents|mesh-ancestor
101817832|NCT00658541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101817833|NCT00658541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817834|NCT00048061|Vitamin D|vitamin d|mesh-list
101817835|NCT00048061|Ibandronic Acid|ibandronic acid|mesh-list
101817836|NCT00048061|Calcium|calcium|mesh-list
101817837|NCT00048061|Vitamins|vitamins|mesh-ancestor
101817838|NCT00048061|Micronutrients|micronutrients|mesh-ancestor
101817839|NCT00048061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274747|NCT01858090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101274748|NCT01858090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101274749|NCT01858090|Cholinergic Agents|cholinergic agents|mesh-ancestor
101274750|NCT01858090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101274751|NCT01858090|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101274752|NCT01858090|Anesthetics, Local|anesthetics, local|mesh-ancestor
101274753|NCT01858090|Antiemetics|antiemetics|mesh-ancestor
101274754|NCT01858090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101274755|NCT01858090|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101274756|NCT01858090|Histamine Antagonists|histamine antagonists|mesh-ancestor
101274757|NCT01858090|Histamine Agents|histamine agents|mesh-ancestor
101274758|NCT01858090|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101274759|NCT01858090|Antipruritics|antipruritics|mesh-ancestor
101274760|NCT01858090|Dermatologic Agents|dermatologic agents|mesh-ancestor
101274761|NCT01858090|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101274762|NCT01858090|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101274763|NCT01858090|Dopamine Agents|dopamine agents|mesh-ancestor
101274764|NCT01858090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101274765|NCT01858090|Sympathomimetics|sympathomimetics|mesh-ancestor
101274766|NCT01858090|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101274767|NCT01858090|Adrenergic Agents|adrenergic agents|mesh-ancestor
101274768|NCT01858155|Melatonin|melatonin|mesh-list
101274769|NCT01858155|Antioxidants|antioxidants|mesh-ancestor
101274770|NCT01858155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274771|NCT01858155|Protective Agents|protective agents|mesh-ancestor
101274772|NCT01858155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274773|NCT01858155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101274774|NCT01858168|Irinotecan|irinotecan|mesh-list
101274775|NCT01858168|Temozolomide|temozolomide|mesh-list
101274776|NCT01858168|Olaparib|olaparib|mesh-list
101274777|NCT01858168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101274778|NCT01858168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101274779|NCT01858168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101817840|NCT00048061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101817841|NCT00048061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101817843|NCT00802139|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101817844|NCT00802139|Trace Elements|trace elements|mesh-ancestor
101817845|NCT00802139|Micronutrients|micronutrients|mesh-ancestor
101817846|NCT00802139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817847|NCT00802139|Hematinics|hematinics|mesh-ancestor
101817849|NCT00802217|Antipruritics|antipruritics|mesh-ancestor
101817850|NCT00802217|Dermatologic Agents|dermatologic agents|mesh-ancestor
101817851|NCT00802217|Sensory System Agents|sensory system agents|mesh-ancestor
101817852|NCT00802217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101817853|NCT00802217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817854|NCT00802373|Solifenacin Succinate|solifenacin succinate|mesh-list
101817855|NCT00802373|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101817856|NCT00802373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101817857|NCT00802373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101817858|NCT00802373|Cholinergic Agents|cholinergic agents|mesh-ancestor
101817859|NCT00802373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101817860|NCT00802373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817861|NCT00802373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817863|NCT03957109|Anesthetics|anesthetics|mesh-list
101817864|NCT03957109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101817865|NCT03957109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817866|NCT00802451|Mesalamine|mesalamine|mesh-list
101817867|NCT00802451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101817868|NCT00802451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101817869|NCT00802451|Analgesics|analgesics|mesh-ancestor
101274780|NCT01858168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274781|NCT01858168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101274782|NCT01858168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101274783|NCT01858168|Alkylating Agents|alkylating agents|mesh-ancestor
101274784|NCT01858168|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101274786|NCT01858207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101274787|NCT01858207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101274788|NCT01858207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101274789|NCT01858207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101274790|NCT01858207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101274791|NCT01858207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274792|NCT01858311|Tocotrienols|tocotrienols|mesh-list
101274793|NCT01858311|Vitamin E|vitamin e|mesh-list
101274794|NCT01858311|Tocopherols|tocopherols|mesh-list
101274795|NCT01858311|Antioxidants|antioxidants|mesh-ancestor
101817870|NCT00802451|Sensory System Agents|sensory system agents|mesh-ancestor
101817871|NCT00802451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101817872|NCT00802451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817873|NCT00802451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101817874|NCT00802451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101817875|NCT03956953|Deucravacitinib|deucravacitinib|mesh-list
101817876|NCT03956953|Dermatologic Agents|dermatologic agents|mesh-ancestor
101817877|NCT03956953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101274796|NCT01858311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274797|NCT01858311|Protective Agents|protective agents|mesh-ancestor
101274798|NCT01858311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274799|NCT01858311|Vitamins|vitamins|mesh-ancestor
101274800|NCT01858311|Micronutrients|micronutrients|mesh-ancestor
101274801|NCT01858402|Acetaminophen|acetaminophen|mesh-list
101274802|NCT01858402|Dipyrone|dipyrone|mesh-list
101274803|NCT01858402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101274804|NCT01858402|Analgesics|analgesics|mesh-ancestor
101274805|NCT01858402|Sensory System Agents|sensory system agents|mesh-ancestor
101274806|NCT01858402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101274807|NCT01858402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274808|NCT01858402|Antipyretics|antipyretics|mesh-ancestor
101274809|NCT01858402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101274810|NCT01858402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101274811|NCT01858402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101274812|NCT01858441|Abiraterone Acetate|abiraterone acetate|mesh-list
101274813|NCT01858441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101274814|NCT01858441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101274815|NCT01858441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101274816|NCT01858441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274817|NCT01858441|Hormone Antagonists|hormone antagonists|mesh-ancestor
101274818|NCT01858441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101274819|NCT01858441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274820|NCT01858441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101274821|NCT01858571|Thalidomide|thalidomide|mesh-list
101274823|NCT01858571|Cyclophosphamide|cyclophosphamide|mesh-list
101274824|NCT01858571|Etoposide|etoposide|mesh-list
101274825|NCT01858571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101274826|NCT01858571|Immunologic Factors|immunologic factors|mesh-ancestor
101274827|NCT01858571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274828|NCT01858571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101274829|NCT01858571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101274830|NCT01858571|Alkylating Agents|alkylating agents|mesh-ancestor
101274831|NCT01858571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274832|NCT01858571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101274833|NCT01858571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101274834|NCT01858571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101274835|NCT01858571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101274836|NCT01858571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101274837|NCT01858571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101274838|NCT01858571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101274839|NCT01858571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101274840|NCT01858571|Analgesics|analgesics|mesh-ancestor
101274841|NCT01858571|Sensory System Agents|sensory system agents|mesh-ancestor
101274842|NCT01858571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101274843|NCT01858571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101274844|NCT01858571|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101274845|NCT01858571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101274846|NCT01858571|Leprostatic Agents|leprostatic agents|mesh-ancestor
101274847|NCT01858571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101274848|NCT01858571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101274849|NCT01858571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101274850|NCT01858571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101274851|NCT01858571|Growth Substances|growth substances|mesh-ancestor
101274852|NCT01858571|Growth Inhibitors|growth inhibitors|mesh-ancestor
101817878|NCT03956953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101817879|NCT03956953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817880|NCT00798473|Zoledronic Acid|zoledronic acid|mesh-list
101817881|NCT00798473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101274853|NCT01858610|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101274854|NCT01858610|Irbesartan|irbesartan|mesh-list
101274855|NCT01858610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101274856|NCT01858610|Diuretics|diuretics|mesh-ancestor
101274857|NCT01858610|Natriuretic Agents|natriuretic agents|mesh-ancestor
101274858|NCT01858610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274859|NCT01858610|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101274860|NCT01858610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101274861|NCT01858610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274862|NCT01858610|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101274863|NCT01858610|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101274865|NCT01858623|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101274866|NCT01858623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101274867|NCT01858623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101274868|NCT01858623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101274869|NCT01858623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101274870|NCT01858623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274871|NCT01858623|Diuretics|diuretics|mesh-ancestor
101274872|NCT01858623|Natriuretic Agents|natriuretic agents|mesh-ancestor
101274873|NCT01858623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274874|NCT01858623|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101274875|NCT01858623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101274876|NCT01858649|Bevacizumab|bevacizumab|mesh-list
101274877|NCT01858649|Oxaliplatin|oxaliplatin|mesh-list
101274879|NCT01858649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101274880|NCT01858649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101274881|NCT01858649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101274882|NCT01858649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101274883|NCT01858649|Growth Substances|growth substances|mesh-ancestor
101274884|NCT01858649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274885|NCT01858649|Growth Inhibitors|growth inhibitors|mesh-ancestor
101274886|NCT01858649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101274887|NCT01858649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101274888|NCT01858649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101274889|NCT01858649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274890|NCT01858662|Leucovorin|leucovorin|mesh-list
101274891|NCT01858662|Oxaliplatin|oxaliplatin|mesh-list
101274892|NCT01858662|Irinotecan|irinotecan|mesh-list
101274893|NCT01858662|Cetuximab|cetuximab|mesh-list
101274894|NCT01858662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101274895|NCT01858662|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101274896|NCT01858662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101274897|NCT01858662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101274898|NCT01858662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274899|NCT01858662|Antidotes|antidotes|mesh-ancestor
101274900|NCT01858662|Protective Agents|protective agents|mesh-ancestor
101274901|NCT01858662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274902|NCT01858662|Vitamin B Complex|vitamin b complex|mesh-ancestor
101274903|NCT01858662|Vitamins|vitamins|mesh-ancestor
101274904|NCT01858662|Micronutrients|micronutrients|mesh-ancestor
101274905|NCT01858662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101274906|NCT01858792|Belimumab|belimumab|mesh-list
101274907|NCT01858792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101274908|NCT01858792|Immunologic Factors|immunologic factors|mesh-ancestor
101274909|NCT01858792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274910|NCT01858831|Atovaquone|atovaquone|mesh-list
101274911|NCT01858831|Proguanil|proguanil|mesh-list
101274912|NCT01858831|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
101274913|NCT01858831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101274914|NCT01858831|Antimalarials|antimalarials|mesh-ancestor
101274915|NCT01858831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101274916|NCT01858831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101274917|NCT01858831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101274918|NCT01858831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274919|NCT01858831|Antimetabolites|antimetabolites|mesh-ancestor
101274920|NCT01858870|Lacosamide|lacosamide|mesh-list
101817882|NCT00798473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817883|NCT04045769|Moxifloxacin|moxifloxacin|mesh-list
101817884|NCT04045769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101817885|NCT04045769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101817886|NCT04045769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101817887|NCT04045769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101817888|NCT04045769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101274921|NCT01858870|Anticonvulsants|anticonvulsants|mesh-ancestor
101274922|NCT01858870|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101274923|NCT01858870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101274924|NCT01858870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101274925|NCT01858870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274926|NCT01858909|Melatonin|melatonin|mesh-list
101274927|NCT01858909|Antioxidants|antioxidants|mesh-ancestor
101274928|NCT01858909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274929|NCT01858909|Protective Agents|protective agents|mesh-ancestor
101274930|NCT01858909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274931|NCT01858909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101274932|NCT01858961|Interferons|interferons|mesh-list
101274933|NCT01858961|Ribavirin|ribavirin|mesh-list
101274934|NCT01858961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101274935|NCT01858961|Antiviral Agents|antiviral agents|mesh-ancestor
101274936|NCT01858961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101274937|NCT01858961|Antimetabolites|antimetabolites|mesh-ancestor
101274938|NCT01858961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274939|NCT01859234|Bevacizumab|bevacizumab|mesh-list
101274940|NCT01859234|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
101274941|NCT01859234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101274942|NCT01859234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101274944|NCT01859234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101274945|NCT01859234|Growth Substances|growth substances|mesh-ancestor
101274946|NCT01859234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274947|NCT01859234|Growth Inhibitors|growth inhibitors|mesh-ancestor
101274948|NCT01859234|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101274949|NCT01859234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274951|NCT01859377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101274952|NCT01859377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101274953|NCT01859377|Analgesics|analgesics|mesh-ancestor
101274954|NCT01859377|Sensory System Agents|sensory system agents|mesh-ancestor
101274955|NCT01859377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101274956|NCT01859377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274957|NCT01859377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101274958|NCT01859377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101274959|NCT01859377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101274960|NCT01859377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101274961|NCT01859377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274962|NCT01859455|Atorvastatin|atorvastatin|mesh-list
101274963|NCT01859455|Simvastatin|simvastatin|mesh-list
101274964|NCT01859455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101274965|NCT01859455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101274966|NCT01859455|Antimetabolites|antimetabolites|mesh-ancestor
101274967|NCT01859455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274968|NCT01859455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101274969|NCT01859455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101274970|NCT01859455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101274971|NCT01859468|Calcium Carbonate|calcium carbonate|mesh-list
101274972|NCT01859468|Calcium|calcium|mesh-list
101274973|NCT01859468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101274974|NCT01859468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274976|NCT01859468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274977|NCT01859468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101274978|NCT01859481|Eletriptan|eletriptan|mesh-list
101274979|NCT01859481|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101274980|NCT01859481|Serotonin Agents|serotonin agents|mesh-ancestor
101274981|NCT01859481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101817889|NCT04045769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817890|NCT04045769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101817891|NCT01097317|Carboplatin|carboplatin|mesh-list
101817892|NCT01097317|Vinorelbine|vinorelbine|mesh-list
101817893|NCT01097317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101817894|NCT01097317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101817895|NCT01097317|Tubulin Modulators|tubulin modulators|mesh-ancestor
101817896|NCT01097317|Antimitotic Agents|antimitotic agents|mesh-ancestor
101817897|NCT01097317|Mitosis Modulators|mitosis modulators|mesh-ancestor
101817898|NCT01097317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817899|NCT01095679|Baclofen|baclofen|mesh-list
101817900|NCT01095679|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101817901|NCT01095679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817902|NCT01095679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101817903|NCT01095679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101817904|NCT01095679|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101817905|NCT01095679|GABA Agonists|gaba agonists|mesh-ancestor
101817906|NCT01095679|GABA Agents|gaba agents|mesh-ancestor
101274982|NCT01859481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274983|NCT01859481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274984|NCT01859585|Ketorolac|ketorolac|mesh-list
101274985|NCT01859585|Parecoxib|parecoxib|mesh-list
101274986|NCT01859585|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101274987|NCT01859585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101274988|NCT01859585|Analgesics|analgesics|mesh-ancestor
101274990|NCT01859585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101274991|NCT01859585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101274993|NCT01859585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101274994|NCT01859585|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101274995|NCT01859585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101274996|NCT01859585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101274997|NCT01859585|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101274998|NCT01859624|Albuterol|albuterol|mesh-list
101274999|NCT01859624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101275000|NCT01859624|Autonomic Agents|autonomic agents|mesh-ancestor
101275001|NCT01859624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101275002|NCT01859624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275003|NCT01859624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101275004|NCT01859624|Respiratory System Agents|respiratory system agents|mesh-ancestor
101275005|NCT01859624|Tocolytic Agents|tocolytic agents|mesh-ancestor
101275006|NCT01859624|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101275007|NCT01859624|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101275008|NCT01859624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101275009|NCT01859624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101275010|NCT01859624|Adrenergic Agents|adrenergic agents|mesh-ancestor
101275011|NCT01859624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101275012|NCT01859624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275014|NCT01859728|Gemcitabine|gemcitabine|mesh-list
101275016|NCT01859728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101275017|NCT01859728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101275018|NCT01859728|Antimetabolites|antimetabolites|mesh-ancestor
101275021|NCT01859728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101275022|NCT01859728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101817907|NCT01095679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101817908|NCT01095679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817909|NCT00794261|Lenograstim|lenograstim|mesh-list
101817910|NCT00794261|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101817911|NCT00794261|Immunologic Factors|immunologic factors|mesh-ancestor
101817912|NCT00794261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817913|NCT03953287|Acetaminophen|acetaminophen|mesh-list
101817914|NCT03953287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101817915|NCT03953287|Analgesics|analgesics|mesh-ancestor
101817916|NCT03953287|Sensory System Agents|sensory system agents|mesh-ancestor
101817917|NCT03953287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101817918|NCT03953287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817919|NCT03953287|Antipyretics|antipyretics|mesh-ancestor
101817920|NCT01097551|Phenylephrine|phenylephrine|mesh-list
101275024|NCT01859754|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101275025|NCT01859754|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101275026|NCT01859754|Immunologic Factors|immunologic factors|mesh-ancestor
101275027|NCT01859754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275028|NCT01859858|Curcumin|curcumin|mesh-list
101275029|NCT01859858|Irinotecan|irinotecan|mesh-list
101275030|NCT01859858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101275031|NCT01859858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101275032|NCT01859858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101275033|NCT01859858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275034|NCT01859858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101275035|NCT01859858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101275037|NCT01859858|Analgesics|analgesics|mesh-ancestor
101275038|NCT01859858|Sensory System Agents|sensory system agents|mesh-ancestor
101275039|NCT01859858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101275040|NCT01859858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275041|NCT01859858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101275042|NCT01859858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101275043|NCT01860014|Poractant alfa|poractant alfa|mesh-list
101275044|NCT01860014|Beractant|beractant|mesh-list
101275045|NCT01860014|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
101275046|NCT01860014|Respiratory System Agents|respiratory system agents|mesh-ancestor
101275047|NCT01860066|Fluticasone|fluticasone|mesh-list
101275048|NCT01860066|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101275049|NCT01860066|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101275050|NCT01860066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101275051|NCT01860066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101275052|NCT01860066|Autonomic Agents|autonomic agents|mesh-ancestor
101275054|NCT01860066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275055|NCT01860066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101275056|NCT01860066|Respiratory System Agents|respiratory system agents|mesh-ancestor
101275057|NCT01860066|Dermatologic Agents|dermatologic agents|mesh-ancestor
101275058|NCT01860066|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101275059|NCT01860066|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101275060|NCT01860066|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101275061|NCT01860066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101275062|NCT01860066|Adrenergic Agents|adrenergic agents|mesh-ancestor
101275063|NCT01860066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101275064|NCT01860066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275066|NCT01860066|Hormones|hormones|mesh-ancestor
101275067|NCT01860066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101275068|NCT01860066|Sympathomimetics|sympathomimetics|mesh-ancestor
101275069|NCT01860105|Clopidogrel|clopidogrel|mesh-list
101275070|NCT01860105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101275071|NCT01860105|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101275072|NCT01860105|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101275073|NCT01860105|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101817921|NCT01097551|Acetylcholine|acetylcholine|mesh-list
101817922|NCT01097551|Nitroglycerin|nitroglycerin|mesh-list
101817923|NCT01097551|Vasodilator Agents|vasodilator agents|mesh-ancestor
101817924|NCT01097551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101817925|NCT01097551|Cholinergic Agents|cholinergic agents|mesh-ancestor
101817926|NCT01097551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101817927|NCT01097551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275074|NCT01860105|Purinergic Agents|purinergic agents|mesh-ancestor
101275075|NCT01860105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101275076|NCT01860105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275077|NCT01860105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275078|NCT01860144|Bevacizumab|bevacizumab|mesh-list
101275079|NCT01860144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101275080|NCT01860144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101275081|NCT01860144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101275082|NCT01860144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101275083|NCT01860144|Growth Substances|growth substances|mesh-ancestor
101275084|NCT01860144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275085|NCT01860144|Growth Inhibitors|growth inhibitors|mesh-ancestor
101275086|NCT01860183|Mycophenolic Acid|mycophenolic acid|mesh-list
101275087|NCT01860183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101275088|NCT01860183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101275089|NCT01860183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101275090|NCT01860183|Antitubercular Agents|antitubercular agents|mesh-ancestor
101275093|NCT01860183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101275094|NCT01860183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275095|NCT01860196|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101275096|NCT01860196|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101275097|NCT01860196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101275098|NCT01860196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275099|NCT01860196|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101275102|NCT01860196|Cholinergic Agents|cholinergic agents|mesh-ancestor
101275103|NCT01860196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101275104|NCT01860235|Anesthetics|anesthetics|mesh-list
101275105|NCT01860235|Benzocaine|benzocaine|mesh-list
101275106|NCT01860235|Anesthetics, Local|anesthetics, local|mesh-list
101275107|NCT01860235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101275108|NCT01860235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275109|NCT01860235|Sensory System Agents|sensory system agents|mesh-ancestor
101275110|NCT01860235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101275111|NCT01860300|Amoxicillin|amoxicillin|mesh-list
101275112|NCT01860300|Clavulanic Acid|clavulanic acid|mesh-list
101275113|NCT01860300|Clavulanic Acids|clavulanic acids|mesh-list
101275114|NCT01860300|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101275115|NCT01860300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101275116|NCT01860300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101275117|NCT01860300|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101275118|NCT01860300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101275119|NCT01860300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275120|NCT01860391|Fluorides|fluorides|mesh-list
101275121|NCT01860391|Cariostatic Agents|cariostatic agents|mesh-ancestor
101275122|NCT01860391|Protective Agents|protective agents|mesh-ancestor
101275123|NCT01860391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275124|NCT01860417|Mepivacaine|mepivacaine|mesh-list
101275125|NCT01860417|Anesthetics, Local|anesthetics, local|mesh-ancestor
101275126|NCT01860417|Anesthetics|anesthetics|mesh-ancestor
101275127|NCT01860417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101275128|NCT01860417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275129|NCT01860417|Sensory System Agents|sensory system agents|mesh-ancestor
101275130|NCT01860417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101275131|NCT01860469|Vancomycin|vancomycin|mesh-list
101275132|NCT01860469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101275133|NCT01860469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101275134|NCT01860482|Rabeprazole|rabeprazole|mesh-list
101275135|NCT01860482|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101275136|NCT01860482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101817928|NCT01097551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817929|NCT01097551|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101275137|NCT01860482|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101275138|NCT01860482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101275139|NCT01860482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275140|NCT01860508|Carboplatin|carboplatin|mesh-list
101275141|NCT01860508|Pemetrexed|pemetrexed|mesh-list
101275142|NCT01860508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101275143|NCT01860508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101275144|NCT01860508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275145|NCT01860508|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101275146|NCT01860508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101275147|NCT01860625|Donepezil|donepezil|mesh-list
101275148|NCT01860625|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101275149|NCT01860625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101275150|NCT01860625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275151|NCT01860625|Cholinergic Agents|cholinergic agents|mesh-ancestor
101275152|NCT01860625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101275153|NCT01860625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275154|NCT01860625|Nootropic Agents|nootropic agents|mesh-ancestor
101275155|NCT01860638|Bevacizumab|bevacizumab|mesh-list
101275156|NCT01860638|Temozolomide|temozolomide|mesh-list
101275157|NCT01860638|Lomustine|lomustine|mesh-list
101275158|NCT01860638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101275159|NCT01860638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101275160|NCT01860638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101275161|NCT01860638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101275162|NCT01860638|Growth Substances|growth substances|mesh-ancestor
101275163|NCT01860638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275164|NCT01860638|Growth Inhibitors|growth inhibitors|mesh-ancestor
101275165|NCT01860638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101275166|NCT01860638|Alkylating Agents|alkylating agents|mesh-ancestor
101275167|NCT01860638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275168|NCT01860664|Hydrocortisone|hydrocortisone|mesh-list
101275169|NCT01860664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101275170|NCT01860690|Methotrexate|methotrexate|mesh-list
101275171|NCT01860690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101275172|NCT01860690|Abortifacient Agents|abortifacient agents|mesh-ancestor
101275173|NCT01860690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101275174|NCT01860690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275175|NCT01860690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101275176|NCT01860690|Antimetabolites|antimetabolites|mesh-ancestor
101275177|NCT01860690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275180|NCT01860690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101275181|NCT01860690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101275182|NCT01860690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101275183|NCT01860690|Immunologic Factors|immunologic factors|mesh-ancestor
101275184|NCT01860690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101275185|NCT01860690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101275186|NCT01860716|Melatonin|melatonin|mesh-list
101275187|NCT01860716|Antioxidants|antioxidants|mesh-ancestor
101275188|NCT01860716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275189|NCT01860716|Protective Agents|protective agents|mesh-ancestor
101275190|NCT01860716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275191|NCT01860716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101275192|NCT01860729|Anacetrapib|anacetrapib|mesh-list
101275193|NCT01860729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101275194|NCT01860729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101275195|NCT01860729|Antimetabolites|antimetabolites|mesh-ancestor
101275196|NCT01860729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275197|NCT01860729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101275198|NCT01860742|Interferons|interferons|mesh-list
101275199|NCT01860742|Interferon-alpha|interferon-alpha|mesh-list
101275200|NCT01860742|Interferon alpha-2|interferon alpha-2|mesh-list
101275201|NCT01860742|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
101275202|NCT01860742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101275203|NCT01860742|Antiviral Agents|antiviral agents|mesh-ancestor
101275204|NCT01860742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101275205|NCT01860742|Immunologic Factors|immunologic factors|mesh-ancestor
101275206|NCT01860742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275207|NCT01860742|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101817931|NCT01097551|Autonomic Agents|autonomic agents|mesh-ancestor
101817932|NCT01097551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101817933|NCT01097551|Sympathomimetics|sympathomimetics|mesh-ancestor
101817934|NCT01097551|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101817935|NCT01097551|Nasal Decongestants|nasal decongestants|mesh-ancestor
101817936|NCT01097551|Respiratory System Agents|respiratory system agents|mesh-ancestor
101817937|NCT01097551|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101817938|NCT01097551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101817939|NCT01097551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101817940|NCT01097551|Adrenergic Agents|adrenergic agents|mesh-ancestor
101817941|NCT01097551|Protective Agents|protective agents|mesh-ancestor
101817942|NCT00803309|Interferons|interferons|mesh-list
101817943|NCT00803309|Ribavirin|ribavirin|mesh-list
101817944|NCT00803309|Interferon-alpha|interferon-alpha|mesh-list
101275208|NCT01860742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275209|NCT01860781|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101275210|NCT01860781|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101275211|NCT01860781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101275212|NCT01860781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101275213|NCT01860781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275214|NCT01860781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101275215|NCT01860781|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101275216|NCT01860781|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101275217|NCT01860781|Serotonin Agents|serotonin agents|mesh-ancestor
101275218|NCT01860781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101275219|NCT01860781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275220|NCT01860781|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101275221|NCT01860781|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101275222|NCT01860781|Dopamine Agents|dopamine agents|mesh-ancestor
101275225|NCT01860833|Diclofenac|diclofenac|mesh-list
101275226|NCT01860833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101275227|NCT01860833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101275228|NCT01860833|Analgesics|analgesics|mesh-ancestor
101275229|NCT01860833|Sensory System Agents|sensory system agents|mesh-ancestor
101275230|NCT01860833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101275231|NCT01860833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275232|NCT01860833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101275233|NCT01860833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101275234|NCT01860833|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101275235|NCT01860833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101275236|NCT01860833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275237|NCT01860833|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101275238|NCT01860911|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
101275239|NCT01860911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101275240|NCT01860911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275241|NCT01861015|Vasopressins|vasopressins|mesh-list
101275242|NCT01861015|Arginine Vasopressin|arginine vasopressin|mesh-list
101275243|NCT01861015|Epinephrine|epinephrine|mesh-list
101275244|NCT01861015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101275245|NCT01861015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101275246|NCT01861015|Adrenergic Agents|adrenergic agents|mesh-ancestor
101275249|NCT01861015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275250|NCT01861015|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101275251|NCT01861015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101275252|NCT01861015|Autonomic Agents|autonomic agents|mesh-ancestor
101275253|NCT01861015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101275254|NCT01861015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101275255|NCT01861015|Respiratory System Agents|respiratory system agents|mesh-ancestor
101275256|NCT01861015|Mydriatics|mydriatics|mesh-ancestor
101275257|NCT01861015|Sympathomimetics|sympathomimetics|mesh-ancestor
101817945|NCT00803309|Interferon alpha-2|interferon alpha-2|mesh-list
101817946|NCT00803309|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101817947|NCT00803309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101817948|NCT00803309|Antiviral Agents|antiviral agents|mesh-ancestor
101817949|NCT00803309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101817950|NCT00803309|Antimetabolites|antimetabolites|mesh-ancestor
101817951|NCT00803309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275258|NCT01861015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101275259|NCT01861015|Hemostatics|hemostatics|mesh-ancestor
101275260|NCT01861015|Coagulants|coagulants|mesh-ancestor
101275261|NCT01861015|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101275262|NCT01861015|Natriuretic Agents|natriuretic agents|mesh-ancestor
101275264|NCT01861041|Anesthetics, Local|anesthetics, local|mesh-ancestor
101275265|NCT01861041|Anesthetics|anesthetics|mesh-ancestor
101275266|NCT01861041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101275267|NCT01861041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275268|NCT01861041|Sensory System Agents|sensory system agents|mesh-ancestor
101275269|NCT01861041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101275270|NCT01861145|Mometasone Furoate|mometasone furoate|mesh-list
101275274|NCT01861223|Afatinib|afatinib|mesh-list
101314406|NCT00000943|Vaccines|vaccines|mesh-list
101275275|NCT01861223|Nimotuzumab|nimotuzumab|mesh-list
101275276|NCT01861223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101275277|NCT01861223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101275278|NCT01861223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101275279|NCT01861223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275280|NCT01861223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101275281|NCT01861340|Dexamethasone|dexamethasone|mesh-list
101275282|NCT01861340|Lenalidomide|lenalidomide|mesh-list
101275283|NCT01861340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101275284|NCT01861340|Antiemetics|antiemetics|mesh-ancestor
101275285|NCT01861340|Autonomic Agents|autonomic agents|mesh-ancestor
101275286|NCT01861340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101275287|NCT01861340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275288|NCT01861340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101275289|NCT01861340|Glucocorticoids|glucocorticoids|mesh-ancestor
101275290|NCT01861340|Hormones|hormones|mesh-ancestor
101275291|NCT01861340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101275292|NCT01861340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101275293|NCT01861340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101275297|NCT01861340|Growth Substances|growth substances|mesh-ancestor
101275298|NCT01861340|Growth Inhibitors|growth inhibitors|mesh-ancestor
101275300|NCT01861535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101275301|NCT01861535|Immunologic Factors|immunologic factors|mesh-ancestor
101275302|NCT01861535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275303|NCT01861535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101275304|NCT01861535|Interferon Inducers|interferon inducers|mesh-ancestor
101275305|NCT01861561|Cyclophosphamide|cyclophosphamide|mesh-list
101275306|NCT01861561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101275307|NCT01861561|Immunologic Factors|immunologic factors|mesh-ancestor
101275308|NCT01861561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275309|NCT01861561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101275310|NCT01861561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101275311|NCT01861561|Alkylating Agents|alkylating agents|mesh-ancestor
101275312|NCT01861561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275313|NCT01861561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101275314|NCT01861561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101275315|NCT01861626|Isotretinoin|isotretinoin|mesh-list
101275316|NCT01861626|Dermatologic Agents|dermatologic agents|mesh-ancestor
101275317|NCT01861912|Arsenic Trioxide|arsenic trioxide|mesh-list
101275318|NCT01861912|Ethiodized Oil|ethiodized oil|mesh-list
101275319|NCT01861912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101275320|NCT01861951|Doxorubicin|doxorubicin|mesh-list
101275321|NCT01861951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101275322|NCT01861951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101275323|NCT01861951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101275324|NCT01861951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101275325|NCT01861951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101275326|NCT01861951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817952|NCT00803309|Immunologic Factors|immunologic factors|mesh-ancestor
101817953|NCT00803309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817955|NCT03953209|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101817956|NCT03953209|Hormone Antagonists|hormone antagonists|mesh-ancestor
101817957|NCT03953209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101817958|NCT03953209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817959|NCT03953209|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101817960|NCT03953209|Diuretics|diuretics|mesh-ancestor
101817961|NCT03953209|Natriuretic Agents|natriuretic agents|mesh-ancestor
101817962|NCT01583959|Folic Acid|folic acid|mesh-list
101817963|NCT01583959|Hematinics|hematinics|mesh-ancestor
101817964|NCT01583959|Vitamin B Complex|vitamin b complex|mesh-ancestor
101817965|NCT01583959|Vitamins|vitamins|mesh-ancestor
101817966|NCT01583959|Micronutrients|micronutrients|mesh-ancestor
101817967|NCT01583959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275327|NCT01861990|Valproic Acid|valproic acid|mesh-list
101275328|NCT01861990|Anticonvulsants|anticonvulsants|mesh-ancestor
101275329|NCT01861990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101275330|NCT01861990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275331|NCT01861990|GABA Agents|gaba agents|mesh-ancestor
101275332|NCT01861990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101275333|NCT01861990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275334|NCT01861990|Antimanic Agents|antimanic agents|mesh-ancestor
101275335|NCT01861990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101275336|NCT01861990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101275337|NCT01861990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101275339|NCT01862003|Folic Acid|folic acid|mesh-list
101275340|NCT01862003|Fluorouracil|fluorouracil|mesh-list
101275341|NCT01862003|Irinotecan|irinotecan|mesh-list
101275342|NCT01862003|Levoleucovorin|levoleucovorin|mesh-list
101275343|NCT01862003|Antimetabolites|antimetabolites|mesh-ancestor
101314417|NCT00000952|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101275345|NCT01862003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101275346|NCT01862003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101275347|NCT01862003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101275348|NCT01862003|Immunologic Factors|immunologic factors|mesh-ancestor
101275349|NCT01862003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275350|NCT01862003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101275351|NCT01862003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101275352|NCT01862003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101275353|NCT01862003|Antidotes|antidotes|mesh-ancestor
101275354|NCT01862003|Protective Agents|protective agents|mesh-ancestor
101275355|NCT01862003|Vitamin B Complex|vitamin b complex|mesh-ancestor
101275356|NCT01862003|Vitamins|vitamins|mesh-ancestor
101275357|NCT01862003|Micronutrients|micronutrients|mesh-ancestor
101275358|NCT01862003|Hematinics|hematinics|mesh-ancestor
101275359|NCT01862081|Paclitaxel|paclitaxel|mesh-list
101275360|NCT01862081|Docetaxel|docetaxel|mesh-list
101275361|NCT01862081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101275364|NCT01862081|Antimitotic Agents|antimitotic agents|mesh-ancestor
101275365|NCT01862081|Mitosis Modulators|mitosis modulators|mesh-ancestor
101275366|NCT01862081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275367|NCT01862120|Interleukin-2|interleukin-2|mesh-list
101275368|NCT01862120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101275369|NCT01862120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101275370|NCT01862120|Analgesics|analgesics|mesh-ancestor
101275371|NCT01862120|Sensory System Agents|sensory system agents|mesh-ancestor
101275372|NCT01862120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101817969|NCT00803387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101817970|NCT02553551|Vitamins|vitamins|mesh-list
101817971|NCT02553551|Micronutrients|micronutrients|mesh-ancestor
101817972|NCT02553551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817973|NCT00803465|Fluticasone|fluticasone|mesh-list
101817975|NCT00803465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101817976|NCT00803465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101817977|NCT00803465|Autonomic Agents|autonomic agents|mesh-ancestor
101817978|NCT00803465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101817979|NCT00803465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817980|NCT00803465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101817981|NCT00803465|Respiratory System Agents|respiratory system agents|mesh-ancestor
101817982|NCT00803465|Dermatologic Agents|dermatologic agents|mesh-ancestor
101817983|NCT00803465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101817984|NCT00803699|Selenium|selenium|mesh-list
101817985|NCT00803699|Antioxidants|antioxidants|mesh-ancestor
101275373|NCT01862120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275375|NCT01862263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101275376|NCT01862263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275377|NCT01862263|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101275378|NCT01862263|Protease Inhibitors|protease inhibitors|mesh-ancestor
101275379|NCT01862263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101275380|NCT01862263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275381|NCT01862302|Haloperidol|haloperidol|mesh-list
101275382|NCT01862302|Haloperidol decanoate|haloperidol decanoate|mesh-list
101275383|NCT01862302|Antiemetics|antiemetics|mesh-ancestor
101275384|NCT01862302|Autonomic Agents|autonomic agents|mesh-ancestor
101275385|NCT01862302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101275388|NCT01862302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101275389|NCT01862302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101275390|NCT01862302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101275391|NCT01862302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101275392|NCT01862302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101275393|NCT01862302|Dopamine Agents|dopamine agents|mesh-ancestor
101275394|NCT01862302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101275395|NCT01862302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275396|NCT01862302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101275397|NCT01862354|Anesthetics|anesthetics|mesh-list
101275398|NCT01862354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101275399|NCT01862354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275400|NCT01862497|Carvedilol|carvedilol|mesh-list
101275401|NCT01862497|Prazosin|prazosin|mesh-list
101275402|NCT01862497|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101275403|NCT01862497|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101275404|NCT01862497|Adrenergic Agents|adrenergic agents|mesh-ancestor
101275405|NCT01862497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101275406|NCT01862497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275407|NCT01862497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275408|NCT01862497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101275409|NCT01862497|Antioxidants|antioxidants|mesh-ancestor
101275410|NCT01862497|Protective Agents|protective agents|mesh-ancestor
101275411|NCT01862497|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101275412|NCT01862497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101275413|NCT01862497|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101275415|NCT01862497|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101275416|NCT01862497|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101817986|NCT00803699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101817987|NCT00803699|Protective Agents|protective agents|mesh-ancestor
101817988|NCT00803699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817989|NCT00803699|Trace Elements|trace elements|mesh-ancestor
101817990|NCT00803699|Micronutrients|micronutrients|mesh-ancestor
101817991|NCT00798785|Rituximab|rituximab|mesh-list
101817992|NCT00798785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101817993|NCT00798785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101817994|NCT00798785|Immunologic Factors|immunologic factors|mesh-ancestor
101817995|NCT00798785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101817996|NCT00798785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101817997|NCT01095991|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101817998|NCT01095991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101817999|NCT01095991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818000|NCT01095991|Incretins|incretins|mesh-ancestor
101818001|NCT01095991|Hormones|hormones|mesh-ancestor
101818002|NCT01095991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101818003|NCT01095991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101818004|NCT01095991|Protease Inhibitors|protease inhibitors|mesh-ancestor
101818005|NCT01095991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101818006|NCT01095991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818007|NCT00794807|Alefacept|alefacept|mesh-list
101818008|NCT00794807|Dermatologic Agents|dermatologic agents|mesh-ancestor
101818009|NCT00794807|Immunologic Factors|immunologic factors|mesh-ancestor
101818010|NCT00794807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818011|NCT00794885|Folic Acid|folic acid|mesh-list
101818012|NCT00794885|Vitamin B Complex|vitamin b complex|mesh-list
101475326|NCT00264953|Vincristine|vincristine|mesh-list
101275417|NCT01862523|Capsaicin|capsaicin|mesh-list
101275418|NCT01862523|Antipruritics|antipruritics|mesh-ancestor
101275419|NCT01862523|Dermatologic Agents|dermatologic agents|mesh-ancestor
101275420|NCT01862523|Sensory System Agents|sensory system agents|mesh-ancestor
101275421|NCT01862523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101275422|NCT01862523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275423|NCT01862835|Anastrozole|anastrozole|mesh-list
101275424|NCT01862835|Testosterone|testosterone|mesh-list
101275425|NCT01862835|Estrogens|estrogens|mesh-list
101275426|NCT01862835|Androgens|androgens|mesh-ancestor
101275427|NCT01862835|Hormones|hormones|mesh-ancestor
101275428|NCT01862835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101275429|NCT01862835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275430|NCT01862835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101275431|NCT01862835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101275432|NCT01862835|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101275433|NCT01862835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101275434|NCT01862835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101275435|NCT01862835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275436|NCT01862835|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101818013|NCT00794885|Enalapril|enalapril|mesh-list
101818014|NCT00794885|Enalaprilat|enalaprilat|mesh-list
101818015|NCT00794885|Maleic acid|maleic acid|mesh-list
101818016|NCT00794885|Hematinics|hematinics|mesh-ancestor
101818017|NCT00794885|Vitamins|vitamins|mesh-ancestor
101818018|NCT00794885|Micronutrients|micronutrients|mesh-ancestor
101818019|NCT00794885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818020|NCT00794885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101818021|NCT00794885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818022|NCT00794885|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101818023|NCT00794885|Protease Inhibitors|protease inhibitors|mesh-ancestor
101275437|NCT01862835|Hormone Antagonists|hormone antagonists|mesh-ancestor
101275441|NCT01862887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101275442|NCT01862887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101275443|NCT01862887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101275444|NCT01862887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275445|NCT01862887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101275446|NCT01862926|Cyclophosphamide|cyclophosphamide|mesh-list
101275447|NCT01862926|Rituximab|rituximab|mesh-list
101275448|NCT01862926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101275449|NCT01862926|Immunologic Factors|immunologic factors|mesh-ancestor
101275450|NCT01862926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275451|NCT01862926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101275452|NCT01862926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101275453|NCT01862926|Alkylating Agents|alkylating agents|mesh-ancestor
101275454|NCT01862926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275455|NCT01862926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101275456|NCT01862926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101275457|NCT01862926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101275458|NCT01862978|Heparin|heparin|mesh-list
101275459|NCT01862978|Nadroparin|nadroparin|mesh-list
101275460|NCT01862978|Anticoagulants|anticoagulants|mesh-ancestor
101275461|NCT01862978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101275462|NCT01862978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101275463|NCT01862978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275464|NCT01863004|Bortezomib|bortezomib|mesh-list
101275465|NCT01863004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101275466|NCT01863069|Interferons|interferons|mesh-list
101275467|NCT01863069|Interferon-beta|interferon-beta|mesh-list
101275468|NCT01863069|Interferon beta-1a|interferon beta-1a|mesh-list
101275469|NCT01863069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101275471|NCT01863069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101275472|NCT01863069|Immunologic Factors|immunologic factors|mesh-ancestor
101275473|NCT01863069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275474|NCT01863069|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101275475|NCT01863147|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101275476|NCT01863147|Acarbose|acarbose|mesh-list
101275481|NCT01863147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101275482|NCT01863147|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101275483|NCT01863147|Protease Inhibitors|protease inhibitors|mesh-ancestor
101275484|NCT01863147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101275485|NCT01863147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275486|NCT01863147|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101275487|NCT01863173|Metoprolol|metoprolol|mesh-list
101275488|NCT01863173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101275489|NCT01863173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101275490|NCT01863173|Sympatholytics|sympatholytics|mesh-ancestor
101275491|NCT01863173|Autonomic Agents|autonomic agents|mesh-ancestor
101275492|NCT01863173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101275493|NCT01863173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275494|NCT01863173|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101275495|NCT01863173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101275496|NCT01863173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101275497|NCT01863173|Adrenergic Agents|adrenergic agents|mesh-ancestor
101818024|NCT00794885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101818025|NCT00803933|Pentamidine|pentamidine|mesh-list
101818026|NCT00803933|Pafuramidine|pafuramidine|mesh-list
101818027|NCT00803933|Antifungal Agents|antifungal agents|mesh-ancestor
101818028|NCT00803933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101818029|NCT00803933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101818030|NCT00803933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101818031|NCT00803933|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101818032|NCT02553707|Ibandronic Acid|ibandronic acid|mesh-list
101818033|NCT02553707|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101818034|NCT02553707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818035|NCT00799175|Ketorolac|ketorolac|mesh-list
101818036|NCT00799175|Epinephrine|epinephrine|mesh-list
101818037|NCT00799175|Ropivacaine|ropivacaine|mesh-list
101818038|NCT00799175|Anesthetics, Local|anesthetics, local|mesh-ancestor
101818039|NCT00799175|Anesthetics|anesthetics|mesh-ancestor
101818040|NCT00799175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101818041|NCT00799175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818042|NCT00799175|Sensory System Agents|sensory system agents|mesh-ancestor
101818043|NCT00799175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101818044|NCT00799175|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101818045|NCT00799175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101818046|NCT00799175|Adrenergic Agents|adrenergic agents|mesh-ancestor
101818047|NCT00799175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101818048|NCT00799175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818049|NCT00799175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101818050|NCT00799175|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101818051|NCT00799175|Autonomic Agents|autonomic agents|mesh-ancestor
101818052|NCT00799175|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101818053|NCT00799175|Respiratory System Agents|respiratory system agents|mesh-ancestor
101275498|NCT01863173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101275499|NCT01863173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275500|NCT01863199|Ranibizumab|ranibizumab|mesh-list
101275501|NCT01863199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101275502|NCT01863199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101275503|NCT01863199|Growth Substances|growth substances|mesh-ancestor
101275504|NCT01863199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275505|NCT01863199|Growth Inhibitors|growth inhibitors|mesh-ancestor
101275506|NCT01863199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101275508|NCT01863225|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101275509|NCT01863225|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101275510|NCT01863225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101275511|NCT01863225|Antimetabolites|antimetabolites|mesh-ancestor
101275512|NCT01863225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275513|NCT01863225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101275514|NCT01863225|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101818054|NCT00799175|Mydriatics|mydriatics|mesh-ancestor
101818055|NCT00799175|Sympathomimetics|sympathomimetics|mesh-ancestor
101818056|NCT00799175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101818057|NCT00799175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101818058|NCT00799175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101818059|NCT00799175|Analgesics|analgesics|mesh-ancestor
101818060|NCT00799175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101818061|NCT00799175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101818062|NCT00799175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101818063|NCT00799175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101818064|NCT00656513|Pilocarpine|pilocarpine|mesh-list
101818065|NCT00656513|Miotics|miotics|mesh-ancestor
101818066|NCT00656513|Autonomic Agents|autonomic agents|mesh-ancestor
101818067|NCT00656513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101818068|NCT00656513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818069|NCT00656513|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101818070|NCT00656513|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101818071|NCT00656513|Cholinergic Agents|cholinergic agents|mesh-ancestor
101818072|NCT00656513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101818073|NCT00656513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818074|NCT04017221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
101275515|NCT01863225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101275516|NCT01863238|Ivacaftor|ivacaftor|mesh-list
101275517|NCT01863238|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101275518|NCT01863238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101275519|NCT01863238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275521|NCT01863251|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101275522|NCT01863251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101275523|NCT01863251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101275524|NCT01863251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275525|NCT01863251|Adrenergic Agents|adrenergic agents|mesh-ancestor
101275526|NCT01863251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101275527|NCT01863251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275528|NCT01863277|Melatonin|melatonin|mesh-list
101275529|NCT01863277|Antioxidants|antioxidants|mesh-ancestor
101275530|NCT01863277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275531|NCT01863277|Protective Agents|protective agents|mesh-ancestor
101275532|NCT01863277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275533|NCT01863277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101275535|NCT01863355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101275536|NCT01863355|Narcotics|narcotics|mesh-ancestor
101275537|NCT01863355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101275538|NCT01863355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275539|NCT01863355|Analgesics|analgesics|mesh-ancestor
101275540|NCT01863355|Sensory System Agents|sensory system agents|mesh-ancestor
101275541|NCT01863355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101275542|NCT01863355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101275543|NCT01863355|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101275544|NCT01863355|Anesthetics, General|anesthetics, general|mesh-ancestor
101275545|NCT01863355|Anesthetics|anesthetics|mesh-ancestor
101275548|NCT01863407|Allantoin|allantoin|mesh-list
101275549|NCT01863407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101275550|NCT01863407|Antiemetics|antiemetics|mesh-ancestor
101818075|NCT04017221|Protease Inhibitors|protease inhibitors|mesh-ancestor
101818076|NCT04017221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101818077|NCT04017221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818078|NCT04017221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101818079|NCT04017221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818081|NCT00804245|Lipotropic Agents|lipotropic agents|mesh-ancestor
101818082|NCT00804245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101818083|NCT00804245|Antimetabolites|antimetabolites|mesh-ancestor
101818084|NCT00804245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818085|NCT00804245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101275551|NCT01863407|Autonomic Agents|autonomic agents|mesh-ancestor
101275552|NCT01863407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101275553|NCT01863407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275554|NCT01863407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101275555|NCT01863407|Glucocorticoids|glucocorticoids|mesh-ancestor
101275556|NCT01863407|Hormones|hormones|mesh-ancestor
101275557|NCT01863407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101275558|NCT01863407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101275559|NCT01863407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101275560|NCT01863407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101275561|NCT01863407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101275562|NCT01863407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101275563|NCT01863407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101275564|NCT01863407|Dermatologic Agents|dermatologic agents|mesh-ancestor
101275565|NCT01863459|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101275566|NCT01863459|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101275567|NCT01863459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275568|NCT01863459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101275569|NCT01863459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101275570|NCT01863459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101275571|NCT01863459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275572|NCT01863459|Dopamine Agents|dopamine agents|mesh-ancestor
101275573|NCT01863459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101275574|NCT01863485|Vorolanib|vorolanib|mesh-list
101275575|NCT01863485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101275576|NCT01863485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101275577|NCT01863485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275578|NCT01863511|Tolvaptan|tolvaptan|mesh-list
101275579|NCT01863511|Diuretics|diuretics|mesh-list
101275580|NCT01863511|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
101275581|NCT01863511|Natriuretic Agents|natriuretic agents|mesh-ancestor
101275582|NCT01863511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275583|NCT01863511|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101275584|NCT01863511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275585|NCT01863511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101275586|NCT01863589|Adefovir|adefovir|mesh-list
101275587|NCT01863589|Antiviral Agents|antiviral agents|mesh-ancestor
101275588|NCT01863589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101275589|NCT01863589|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101275590|NCT01863589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101275591|NCT01863589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101275592|NCT01863589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275593|NCT01863602|Lamotrigine|lamotrigine|mesh-list
101275594|NCT01863602|Anticonvulsants|anticonvulsants|mesh-ancestor
101275595|NCT01863602|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101275596|NCT01863602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101275597|NCT01863602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275598|NCT01863602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101275599|NCT01863602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818086|NCT00804245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101818087|NCT00804245|Nootropic Agents|nootropic agents|mesh-ancestor
101818088|NCT00804401|Naproxen|naproxen|mesh-list
101818089|NCT00804401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101818090|NCT00804401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101818091|NCT00804401|Analgesics|analgesics|mesh-ancestor
101818092|NCT00804401|Sensory System Agents|sensory system agents|mesh-ancestor
101818093|NCT00804401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101818094|NCT00804401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818095|NCT00804401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101818096|NCT00804401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101818097|NCT00804401|Gout Suppressants|gout suppressants|mesh-ancestor
101818098|NCT00804401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101818099|NCT00804401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101275600|NCT01863602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101275601|NCT01863602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101275602|NCT01863602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101275603|NCT01863602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101314455|NCT00000973|Zidovudine|zidovudine|mesh-list
101275604|NCT01863602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101275605|NCT01863615|Isotretinoin|isotretinoin|mesh-list
101275606|NCT01863615|Dermatologic Agents|dermatologic agents|mesh-ancestor
101275607|NCT01863641|Calcitriol|calcitriol|mesh-list
101275608|NCT01863641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101275609|NCT01863641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275610|NCT01863641|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101275611|NCT01863641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101275612|NCT01863641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275613|NCT01863641|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101275614|NCT01863641|Vitamins|vitamins|mesh-ancestor
101275615|NCT01863641|Micronutrients|micronutrients|mesh-ancestor
101275616|NCT01863641|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101275617|NCT01863654|Montelukast|montelukast|mesh-list
101275618|NCT01863654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101275619|NCT01863654|Respiratory System Agents|respiratory system agents|mesh-ancestor
101275620|NCT01863654|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101275621|NCT01863654|Hormone Antagonists|hormone antagonists|mesh-ancestor
101275622|NCT01863654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101275623|NCT01863654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275624|NCT01863654|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101275625|NCT01863654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101275626|NCT01863654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275627|NCT01863706|Misoprostol|misoprostol|mesh-list
101275628|NCT01863706|Oxytocin|oxytocin|mesh-list
101275629|NCT01863706|Oxytocics|oxytocics|mesh-ancestor
101275630|NCT01863706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101275631|NCT01863706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275632|NCT01863706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101275633|NCT01863706|Abortifacient Agents|abortifacient agents|mesh-ancestor
101275634|NCT01863706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101275635|NCT01863706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101275636|NCT01863719|Colistin|colistin|mesh-list
101275637|NCT01863719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101275638|NCT01863719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101275639|NCT01863810|Pregabalin|pregabalin|mesh-list
101275640|NCT01863810|Analgesics|analgesics|mesh-ancestor
101275641|NCT01863810|Sensory System Agents|sensory system agents|mesh-ancestor
101275642|NCT01863810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101275645|NCT01863810|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101275646|NCT01863810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101818100|NCT00804401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818101|NCT00804791|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101818102|NCT00804791|Lubricant Eye Drops|lubricant eye drops|mesh-list
101818103|NCT00804791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101818104|NCT02553083|Amoxicillin|amoxicillin|mesh-list
101818105|NCT02553083|Doxycycline|doxycycline|mesh-list
101818106|NCT02553083|Esomeprazole|esomeprazole|mesh-list
101818107|NCT02553083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101818108|NCT02553083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101818109|NCT02553083|Antimalarials|antimalarials|mesh-ancestor
101818110|NCT02553083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101818111|NCT02553083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101818112|NCT02553083|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101818113|NCT02553083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101818114|NCT02553083|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101818115|NCT02553083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101275647|NCT01863810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275648|NCT01863810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101275649|NCT01863810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101275650|NCT01863810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101275651|NCT01863810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101275652|NCT01863810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101275653|NCT01863823|Amoxicillin|amoxicillin|mesh-list
101275654|NCT01863823|Tetracycline|tetracycline|mesh-list
101275655|NCT01863823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101275656|NCT01863823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101275657|NCT01863823|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101275658|NCT01863823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101275659|NCT01863823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275660|NCT01863888|Teriflunomide|teriflunomide|mesh-list
101275661|NCT01863888|Cholestyramine Resin|cholestyramine resin|mesh-list
101275662|NCT01863888|Charcoal|charcoal|mesh-list
101275663|NCT01863888|Antidotes|antidotes|mesh-ancestor
101275664|NCT01863888|Protective Agents|protective agents|mesh-ancestor
101275665|NCT01863888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275666|NCT01863888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101275667|NCT01863888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101275668|NCT01863888|Analgesics|analgesics|mesh-ancestor
101275669|NCT01863888|Sensory System Agents|sensory system agents|mesh-ancestor
101275670|NCT01863888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101275671|NCT01863888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101275672|NCT01863888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101275673|NCT01863888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101275674|NCT01863888|Immunologic Factors|immunologic factors|mesh-ancestor
101275675|NCT01863888|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101275676|NCT01863888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101275677|NCT01863888|Antimetabolites|antimetabolites|mesh-ancestor
101275678|NCT01863888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275679|NCT01863888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101275680|NCT01863914|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101275681|NCT01863914|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101275682|NCT01863914|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101275683|NCT01863914|Antimetabolites|antimetabolites|mesh-ancestor
101275684|NCT01863914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275685|NCT01863914|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101275686|NCT01863914|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101275687|NCT01863914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101275688|NCT01864057|Thiamine|thiamine|mesh-list
101818116|NCT02553083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818118|NCT00804947|Busulfan|busulfan|mesh-list
101818119|NCT00804947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101818120|NCT00804947|Alkylating Agents|alkylating agents|mesh-ancestor
101818121|NCT00804947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818122|NCT00804947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101818123|NCT00804947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101818124|NCT00804947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101818125|NCT00804947|Immunologic Factors|immunologic factors|mesh-ancestor
101818126|NCT00804947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818127|NCT00806663|Sunitinib|sunitinib|mesh-list
101818128|NCT00806663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101818129|NCT00806663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101818130|NCT00806663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101818131|NCT00806663|Growth Substances|growth substances|mesh-ancestor
101818132|NCT00806663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818133|NCT00806663|Growth Inhibitors|growth inhibitors|mesh-ancestor
101818134|NCT00806663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101818135|NCT00806663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101818136|NCT00806663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818137|NCT00806741|Phenylephrine|phenylephrine|mesh-list
101818138|NCT00806741|Oxymetazoline|oxymetazoline|mesh-list
101818139|NCT00806741|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
101275689|NCT01864057|Vitamin B Complex|vitamin b complex|mesh-ancestor
101275690|NCT01864057|Vitamins|vitamins|mesh-ancestor
101275691|NCT01864057|Micronutrients|micronutrients|mesh-ancestor
101275692|NCT01864057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275693|NCT01864070|Everolimus|everolimus|mesh-list
101275694|NCT01864070|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101275695|NCT01864070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101275696|NCT01864070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101275697|NCT01864070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275698|NCT01864070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101275699|NCT01864070|Immunologic Factors|immunologic factors|mesh-ancestor
101275700|NCT01864070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275701|NCT01864070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101275702|NCT01864083|Fluorides|fluorides|mesh-list
101275703|NCT01864083|Cariostatic Agents|cariostatic agents|mesh-ancestor
101275704|NCT01864083|Protective Agents|protective agents|mesh-ancestor
101275707|NCT01864096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101275708|NCT01864096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275710|NCT01864161|Trace Elements|trace elements|mesh-ancestor
101275711|NCT01864161|Micronutrients|micronutrients|mesh-ancestor
101275712|NCT01864161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275713|NCT01864187|Dexmedetomidine|dexmedetomidine|mesh-list
101275714|NCT01864187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101275715|NCT01864187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101275716|NCT01864187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275717|NCT01864187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101275718|NCT01864187|Analgesics|analgesics|mesh-ancestor
101314493|NCT00001003|Zidovudine|zidovudine|mesh-list
101818140|NCT00806741|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101818141|NCT00806741|Mydriatics|mydriatics|mesh-ancestor
101818142|NCT00806741|Autonomic Agents|autonomic agents|mesh-ancestor
101818143|NCT00806741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101818144|NCT00806741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818145|NCT00806741|Sympathomimetics|sympathomimetics|mesh-ancestor
101818146|NCT00806741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101818147|NCT00806741|Nasal Decongestants|nasal decongestants|mesh-ancestor
101818148|NCT00806741|Respiratory System Agents|respiratory system agents|mesh-ancestor
101818149|NCT00806741|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101818150|NCT00806741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101818152|NCT00806741|Adrenergic Agents|adrenergic agents|mesh-ancestor
101818153|NCT00806741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101275719|NCT01864187|Sensory System Agents|sensory system agents|mesh-ancestor
101275720|NCT01864187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101275721|NCT01864187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101275722|NCT01864187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101275723|NCT01864187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101275724|NCT01864187|Adrenergic Agents|adrenergic agents|mesh-ancestor
101275725|NCT01864187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101275726|NCT01864187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275727|NCT01864213|Tetracaine|tetracaine|mesh-list
101275728|NCT01864213|Anesthetics, Local|anesthetics, local|mesh-ancestor
101275729|NCT01864213|Anesthetics|anesthetics|mesh-ancestor
101275730|NCT01864213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101275731|NCT01864213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275732|NCT01864213|Sensory System Agents|sensory system agents|mesh-ancestor
101275733|NCT01864213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101275734|NCT01864252|Nitroglycerin|nitroglycerin|mesh-list
101275735|NCT01864252|Vasodilator Agents|vasodilator agents|mesh-ancestor
101275736|NCT01864265|Certolizumab Pegol|certolizumab pegol|mesh-list
101275737|NCT01864265|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101275738|NCT01864265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101275740|NCT01864265|Immunologic Factors|immunologic factors|mesh-ancestor
101275741|NCT01864265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275742|NCT01864265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101275743|NCT01864551|Lamotrigine|lamotrigine|mesh-list
101275744|NCT01864551|Olanzapine|olanzapine|mesh-list
101275745|NCT01864551|Antiemetics|antiemetics|mesh-ancestor
101275746|NCT01864551|Autonomic Agents|autonomic agents|mesh-ancestor
101275747|NCT01864551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101275748|NCT01864551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275749|NCT01864551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101275750|NCT01864551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101275751|NCT01864551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101275752|NCT01864551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101275753|NCT01864551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101275754|NCT01864551|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101275755|NCT01864551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101275756|NCT01864551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101275757|NCT01864551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275758|NCT01864551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101275759|NCT01864551|Serotonin Agents|serotonin agents|mesh-ancestor
101275760|NCT01864551|Anticonvulsants|anticonvulsants|mesh-ancestor
101275761|NCT01864551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101275762|NCT01864551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101275763|NCT01864551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101275764|NCT01864616|Vitamin D|vitamin d|mesh-list
101275765|NCT01864616|Cholecalciferol|cholecalciferol|mesh-list
101275766|NCT01864616|Vitamins|vitamins|mesh-ancestor
101275767|NCT01864616|Micronutrients|micronutrients|mesh-ancestor
101818154|NCT00806741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818155|NCT00806741|Protective Agents|protective agents|mesh-ancestor
101818156|NCT00806741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101818157|NCT00806897|Insulin Detemir|insulin detemir|mesh-list
101818158|NCT00806897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101818159|NCT00806897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818160|NCT00805649|Dexamethasone|dexamethasone|mesh-list
101818161|NCT00805649|Bevacizumab|bevacizumab|mesh-list
101818162|NCT00805649|Temazepam|temazepam|mesh-list
101818163|NCT00805649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101818164|NCT00805649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101818165|NCT00805649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101275768|NCT01864616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275769|NCT01864616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101275770|NCT01864616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101275771|NCT01864655|Saracatinib|saracatinib|mesh-list
101275772|NCT01864655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101275773|NCT01864655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101275774|NCT01864655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275775|NCT01864681|Metformin|metformin|mesh-list
101275776|NCT01864681|Gefitinib|gefitinib|mesh-list
101275777|NCT01864681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101275778|NCT01864681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275779|NCT01864681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101275780|NCT01864681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101275781|NCT01864681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101275782|NCT01864681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275783|NCT01864798|Denosumab|denosumab|mesh-list
101275784|NCT01864798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101275785|NCT01864798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275786|NCT01864824|Vitamins|vitamins|mesh-list
101275787|NCT01864824|Folic Acid|folic acid|mesh-list
101275788|NCT01864824|Vitamin B 12|vitamin b 12|mesh-list
101275789|NCT01864824|Vitamin B 6|vitamin b 6|mesh-list
101275790|NCT01864824|Vitamin B Complex|vitamin b complex|mesh-list
101275791|NCT01864824|Micronutrients|micronutrients|mesh-ancestor
101275792|NCT01864824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275793|NCT01864824|Hematinics|hematinics|mesh-ancestor
101275794|NCT01864863|Bosentan|bosentan|mesh-list
101275795|NCT01864863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101275796|NCT01864863|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101275797|NCT01864863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275798|NCT01864915|Prucalopride|prucalopride|mesh-list
101275799|NCT01864915|Laxatives|laxatives|mesh-ancestor
101275800|NCT01864915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101275801|NCT01864915|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101275802|NCT01864915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101275803|NCT01864915|Serotonin Agents|serotonin agents|mesh-ancestor
101275804|NCT01864915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101275805|NCT01864915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275806|NCT01864915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275807|NCT01865175|Iron|iron|mesh-list
101275808|NCT01865175|Trace Elements|trace elements|mesh-ancestor
101275809|NCT01865175|Micronutrients|micronutrients|mesh-ancestor
101275810|NCT01865175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275811|NCT01865188|Amlodipine|amlodipine|mesh-list
101275812|NCT01865188|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101275813|NCT01865188|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101275814|NCT01865188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101275815|NCT01865188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101275816|NCT01865188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275817|NCT01865188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101275818|NCT01865188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475474|NCT00301002|Immunologic Factors|immunologic factors|mesh-ancestor
101818166|NCT00805649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101818167|NCT00805649|Growth Substances|growth substances|mesh-ancestor
101818168|NCT00805649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818169|NCT00805649|Growth Inhibitors|growth inhibitors|mesh-ancestor
101818170|NCT00805649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101818171|NCT00805649|Antiemetics|antiemetics|mesh-ancestor
101818172|NCT00805649|Autonomic Agents|autonomic agents|mesh-ancestor
101818173|NCT00805649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101818174|NCT00805649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101818175|NCT00805649|Glucocorticoids|glucocorticoids|mesh-ancestor
101818176|NCT00805649|Hormones|hormones|mesh-ancestor
101818177|NCT00805649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101818178|NCT00805649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101818179|NCT00805649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101275819|NCT01865188|Vasodilator Agents|vasodilator agents|mesh-ancestor
101275820|NCT01865188|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101275821|NCT01865201|Mannitol|mannitol|mesh-list
101275822|NCT01865201|Edaravone|edaravone|mesh-list
101275823|NCT01865201|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101275824|NCT01865201|Diuretics|diuretics|mesh-ancestor
101275825|NCT01865201|Natriuretic Agents|natriuretic agents|mesh-ancestor
101275826|NCT01865201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275827|NCT01865201|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101275828|NCT01865201|Antioxidants|antioxidants|mesh-ancestor
101275829|NCT01865201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275830|NCT01865201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101275831|NCT01865201|Protective Agents|protective agents|mesh-ancestor
101275832|NCT01865279|Insulin|insulin|mesh-list
101275833|NCT01865279|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101275834|NCT01865279|Insulin, Long-Acting|insulin, long-acting|mesh-list
101275835|NCT01865279|Isophane Insulin, Human|isophane insulin, human|mesh-list
101275836|NCT01865279|Insulin, Isophane|insulin, isophane|mesh-list
101275837|NCT01865279|Isophane insulin, beef|isophane insulin, beef|mesh-list
101275838|NCT01865279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101275839|NCT01865279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275840|NCT01865292|Insulin|insulin|mesh-list
101275841|NCT01865292|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101275842|NCT01865292|Insulin Glargine|insulin glargine|mesh-list
101275843|NCT01865292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101275844|NCT01865292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275845|NCT01865305|Insulin|insulin|mesh-list
101275846|NCT01865305|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101275847|NCT01865305|Insulin Aspart|insulin aspart|mesh-list
101275848|NCT01865305|Insulin, Long-Acting|insulin, long-acting|mesh-list
101275849|NCT01865305|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101275850|NCT01865305|Biphasic Insulins|biphasic insulins|mesh-list
101275851|NCT01865305|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101275852|NCT01865305|Insulin, Isophane|insulin, isophane|mesh-list
101275853|NCT01865305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101275854|NCT01865305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275855|NCT01865318|Insulin|insulin|mesh-list
101275856|NCT01865318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101275857|NCT01865318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275858|NCT01865331|Insulin|insulin|mesh-list
101275859|NCT01865331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101275860|NCT01865331|Insulin Aspart|insulin aspart|mesh-list
101818180|NCT00805649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101818181|NCT00805649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101818182|NCT00805649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101818183|NCT00805649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101818184|NCT00805649|GABA Modulators|gaba modulators|mesh-ancestor
101818185|NCT00805649|GABA Agents|gaba agents|mesh-ancestor
101818186|NCT00805649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101818187|NCT00805649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818188|NCT00807053|Ciclesonide|ciclesonide|mesh-list
101818189|NCT00807053|Glucocorticoids|glucocorticoids|mesh-ancestor
101818191|NCT00807053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101818192|NCT00807053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818193|NCT00807053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101818194|NCT00809393|Tranexamic Acid|tranexamic acid|mesh-list
101275861|NCT01865331|Insulin, Long-Acting|insulin, long-acting|mesh-list
101275862|NCT01865331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101275863|NCT01865331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275864|NCT01865500|Prednisolone|prednisolone|mesh-list
101275865|NCT01865500|Budesonide|budesonide|mesh-list
101275866|NCT01865500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101275867|NCT01865500|Glucocorticoids|glucocorticoids|mesh-ancestor
101275868|NCT01865500|Hormones|hormones|mesh-ancestor
101275869|NCT01865500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101275870|NCT01865500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275871|NCT01865500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101275872|NCT01865500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101275873|NCT01865500|Autonomic Agents|autonomic agents|mesh-ancestor
101275874|NCT01865500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101275875|NCT01865500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101275876|NCT01865500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101275877|NCT01865500|Respiratory System Agents|respiratory system agents|mesh-ancestor
101275878|NCT01865630|Etanercept|etanercept|mesh-list
101275879|NCT01865630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101275880|NCT01865630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101275881|NCT01865630|Analgesics|analgesics|mesh-ancestor
101275882|NCT01865630|Sensory System Agents|sensory system agents|mesh-ancestor
101275883|NCT01865630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101275884|NCT01865630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275885|NCT01865630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101275886|NCT01865630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101275887|NCT01865630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101275888|NCT01865630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101275889|NCT01865630|Immunologic Factors|immunologic factors|mesh-ancestor
101275890|NCT01865669|Oxytocin|oxytocin|mesh-list
101275891|NCT01865669|Oxytocics|oxytocics|mesh-ancestor
101275892|NCT01865669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101275893|NCT01865669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275894|NCT01865721|Entonox|entonox|mesh-list
101275895|NCT01865721|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
101275896|NCT01865721|Anesthetics|anesthetics|mesh-ancestor
101275897|NCT01865721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101275898|NCT01865721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275899|NCT01865760|Octreotide|octreotide|mesh-list
101275900|NCT01865760|Somatostatin|somatostatin|mesh-list
101275901|NCT01865760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101275902|NCT01865760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101275903|NCT01865760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101275904|NCT01865760|Hormones|hormones|mesh-ancestor
101818195|NCT00809393|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101818196|NCT00809393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101818197|NCT00809393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818198|NCT00809393|Hemostatics|hemostatics|mesh-ancestor
101818199|NCT00809393|Coagulants|coagulants|mesh-ancestor
101818200|NCT00658775|Esomeprazole|esomeprazole|mesh-list
101818201|NCT00658775|Rabeprazole|rabeprazole|mesh-list
101818202|NCT00658775|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101275905|NCT01865760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101275906|NCT01865760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275907|NCT01865916|Ascorbic Acid|ascorbic acid|mesh-list
101275908|NCT01865916|Bisacodyl|bisacodyl|mesh-list
101275909|NCT01865916|Antioxidants|antioxidants|mesh-ancestor
101275910|NCT01865916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275911|NCT01865916|Protective Agents|protective agents|mesh-ancestor
101275912|NCT01865916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275913|NCT01865916|Vitamins|vitamins|mesh-ancestor
101275914|NCT01865916|Micronutrients|micronutrients|mesh-ancestor
101275915|NCT01865916|Cathartics|cathartics|mesh-ancestor
101275916|NCT01865916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101275917|NCT01865916|Laxatives|laxatives|mesh-ancestor
101275918|NCT01865968|Vaccines|vaccines|mesh-list
101275919|NCT01865968|Immunologic Factors|immunologic factors|mesh-ancestor
101275920|NCT01865968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275921|NCT01866007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101275922|NCT01866007|Immunologic Factors|immunologic factors|mesh-ancestor
101275923|NCT01866007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275924|NCT01866059|Methamphetamine|methamphetamine|mesh-list
101275925|NCT01866059|Calcium|calcium|mesh-list
101275926|NCT01866059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101275927|NCT01866059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275928|NCT01866059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101275929|NCT01866059|Sympathomimetics|sympathomimetics|mesh-ancestor
101275930|NCT01866059|Autonomic Agents|autonomic agents|mesh-ancestor
101275931|NCT01866059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101275932|NCT01866059|Dopamine Agents|dopamine agents|mesh-ancestor
101275933|NCT01866059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101275934|NCT01866059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275935|NCT01866059|Adrenergic Agents|adrenergic agents|mesh-ancestor
101275936|NCT01866059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101275937|NCT01866059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101275938|NCT01866059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101275939|NCT01866059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101275940|NCT01866241|Misoprostol|misoprostol|mesh-list
101275941|NCT01866241|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101275942|NCT01866241|Abortifacient Agents|abortifacient agents|mesh-ancestor
101275943|NCT01866241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101275944|NCT01866241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275945|NCT01866241|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101275946|NCT01866241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101275947|NCT01866241|Oxytocics|oxytocics|mesh-ancestor
101275949|NCT01866254|Hydromorphone|hydromorphone|mesh-list
101275950|NCT01866254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101275951|NCT01866254|Narcotics|narcotics|mesh-ancestor
101275952|NCT01866254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101275953|NCT01866254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275954|NCT01866254|Analgesics|analgesics|mesh-ancestor
101275955|NCT01866254|Sensory System Agents|sensory system agents|mesh-ancestor
101275956|NCT01866254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101275957|NCT01866267|Maraviroc|maraviroc|mesh-list
101275958|NCT01866267|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101275959|NCT01866267|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101275960|NCT01866267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275961|NCT01866267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101275962|NCT01866267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101275963|NCT01866267|Antiviral Agents|antiviral agents|mesh-ancestor
101275964|NCT01866267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101275965|NCT01866267|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101275966|NCT01866397|Cidofovir|cidofovir|mesh-list
101818204|NCT00658775|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101818205|NCT00658775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101818206|NCT00658775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818207|NCT00488631|Golimumab|golimumab|mesh-list
101818208|NCT00488631|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101275967|NCT01866397|Antiviral Agents|antiviral agents|mesh-ancestor
101275968|NCT01866397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101275969|NCT01866397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101275970|NCT01866397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275971|NCT01866488|Misoprostol|misoprostol|mesh-list
101275972|NCT01866488|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101275973|NCT01866488|Abortifacient Agents|abortifacient agents|mesh-ancestor
101275974|NCT01866488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101275975|NCT01866488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275976|NCT01866488|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101275977|NCT01866488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101275978|NCT01866488|Oxytocics|oxytocics|mesh-ancestor
101275979|NCT01866514|Lidocaine|lidocaine|mesh-list
101275980|NCT01866514|Anesthetics, Local|anesthetics, local|mesh-ancestor
101275981|NCT01866514|Anesthetics|anesthetics|mesh-ancestor
101275982|NCT01866514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101275983|NCT01866514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275984|NCT01866514|Sensory System Agents|sensory system agents|mesh-ancestor
101275985|NCT01866514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101275986|NCT01866514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101275987|NCT01866514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101275988|NCT01866514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101275989|NCT01866514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101275990|NCT01866514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275991|NCT01866553|Interferons|interferons|mesh-list
101275992|NCT01866553|Interferon-alpha|interferon-alpha|mesh-list
101275993|NCT01866553|Interferon alpha-2|interferon alpha-2|mesh-list
101275994|NCT01866553|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101275995|NCT01866553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101275996|NCT01866553|Antiviral Agents|antiviral agents|mesh-ancestor
101275997|NCT01866553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101275998|NCT01866553|Immunologic Factors|immunologic factors|mesh-ancestor
101275999|NCT01866553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276000|NCT01866605|Midazolam|midazolam|mesh-list
101276001|NCT01866605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101276002|NCT01866605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101276003|NCT01866605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101276004|NCT01866605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276006|NCT01866605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101276007|NCT01866605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101276008|NCT01866605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101276009|NCT01866605|Anesthetics, General|anesthetics, general|mesh-ancestor
101276010|NCT01866605|Anesthetics|anesthetics|mesh-ancestor
101276011|NCT01866605|GABA Modulators|gaba modulators|mesh-ancestor
101276012|NCT01866605|GABA Agents|gaba agents|mesh-ancestor
101276013|NCT01866605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101276014|NCT01866605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276016|NCT01866644|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101276017|NCT01866644|Antiviral Agents|antiviral agents|mesh-ancestor
101276018|NCT01866644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101276019|NCT01866644|Expectorants|expectorants|mesh-ancestor
101276020|NCT01866644|Respiratory System Agents|respiratory system agents|mesh-ancestor
101276021|NCT01866644|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101276022|NCT01866644|Antioxidants|antioxidants|mesh-ancestor
101276023|NCT01866644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276024|NCT01866644|Protective Agents|protective agents|mesh-ancestor
101276025|NCT01866644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276026|NCT01866644|Antidotes|antidotes|mesh-ancestor
101276027|NCT01867138|Vancomycin|vancomycin|mesh-list
101276028|NCT01867138|Cefazolin|cefazolin|mesh-list
101276029|NCT01867138|Amikacin|amikacin|mesh-list
101276030|NCT01867138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101276031|NCT01867138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101818209|NCT00488631|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101818210|NCT00488631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101818211|NCT00488631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101818212|NCT00488631|Immunologic Factors|immunologic factors|mesh-ancestor
101818213|NCT00488631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818214|NCT00809549|Lenograstim|lenograstim|mesh-list
101818215|NCT00809549|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101818216|NCT00809549|Immunologic Factors|immunologic factors|mesh-ancestor
101818217|NCT00809549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818218|NCT00809627|Caffeine|caffeine|mesh-list
101818219|NCT00809627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101818220|NCT00809627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818221|NCT00809627|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101276032|NCT01867255|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101276033|NCT01867255|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101276034|NCT01867255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101276035|NCT01867255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101276036|NCT01867255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276037|NCT01867255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101276038|NCT01867255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276039|NCT01867255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101276040|NCT01867255|Antidepressive Agents|antidepressive agents|mesh-ancestor
101276041|NCT01867255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101276043|NCT01867268|Anticonvulsants|anticonvulsants|mesh-ancestor
101276044|NCT01867268|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101276045|NCT01867268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101276046|NCT01867268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276047|NCT01867268|Diuretics|diuretics|mesh-ancestor
101276048|NCT01867268|Natriuretic Agents|natriuretic agents|mesh-ancestor
101276049|NCT01867268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276050|NCT01867281|Aspirin|aspirin|mesh-list
101276051|NCT01867281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101276052|NCT01867281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101276053|NCT01867281|Analgesics|analgesics|mesh-ancestor
101276054|NCT01867281|Sensory System Agents|sensory system agents|mesh-ancestor
101276055|NCT01867281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101276056|NCT01867281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276057|NCT01867281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101276058|NCT01867281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101276059|NCT01867281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101276060|NCT01867281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101276061|NCT01867281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276062|NCT01867281|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101276063|NCT01867281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101276064|NCT01867281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101276065|NCT01867281|Antipyretics|antipyretics|mesh-ancestor
101276066|NCT01867463|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101276067|NCT01867463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101276068|NCT01867463|Immunologic Factors|immunologic factors|mesh-ancestor
101276069|NCT01867463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276070|NCT01867463|Antacids|antacids|mesh-ancestor
101276071|NCT01867463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276072|NCT01867463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101276073|NCT01867502|Metformin|metformin|mesh-list
101276074|NCT01867502|Vildagliptin|vildagliptin|mesh-list
101276075|NCT01867502|Glyburide|glyburide|mesh-list
101276076|NCT01867502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101276077|NCT01867502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276078|NCT01867502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101276079|NCT01867502|Protease Inhibitors|protease inhibitors|mesh-ancestor
101312400|NCT00006349|Vitamins|vitamins|mesh-ancestor
101818222|NCT00809627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101818223|NCT00809627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818224|NCT00809627|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101818225|NCT00809627|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101818226|NCT00809627|Purinergic Agents|purinergic agents|mesh-ancestor
101818227|NCT00809627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101276080|NCT01867502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101276081|NCT01867502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276082|NCT01867593|Carbon-11 methionine|carbon-11 methionine|mesh-list
101276083|NCT01867593|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101276084|NCT01867593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276085|NCT01867645|Immunoglobulins|immunoglobulins|mesh-list
101276086|NCT01867645|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101276087|NCT01867645|Antibodies|antibodies|mesh-list
101276088|NCT01867645|gamma-Globulins|gamma-globulins|mesh-list
101276089|NCT01867645|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101276090|NCT01867645|Immunologic Factors|immunologic factors|mesh-ancestor
101276091|NCT01867645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276092|NCT01867697|Leucovorin|leucovorin|mesh-list
101276093|NCT01867697|Folic Acid|folic acid|mesh-list
101276094|NCT01867697|Oxaliplatin|oxaliplatin|mesh-list
101276095|NCT01867697|Irinotecan|irinotecan|mesh-list
101276096|NCT01867697|Cetuximab|cetuximab|mesh-list
101276097|NCT01867697|Calcium Carbonate|calcium carbonate|mesh-list
101276098|NCT01867697|Levoleucovorin|levoleucovorin|mesh-list
101276099|NCT01867697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276100|NCT01867697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101276101|NCT01867697|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101276102|NCT01867697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101276103|NCT01867697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101276104|NCT01867697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276105|NCT01867697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101276106|NCT01867697|Antidotes|antidotes|mesh-ancestor
101276107|NCT01867697|Protective Agents|protective agents|mesh-ancestor
101276108|NCT01867697|Vitamin B Complex|vitamin b complex|mesh-ancestor
101276109|NCT01867697|Vitamins|vitamins|mesh-ancestor
101276110|NCT01867697|Micronutrients|micronutrients|mesh-ancestor
101276111|NCT01867697|Hematinics|hematinics|mesh-ancestor
101276112|NCT01867697|Antacids|antacids|mesh-ancestor
101276113|NCT01867697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101276114|NCT01867775|Mirtazapine|mirtazapine|mesh-list
101276115|NCT01867775|Antidepressive Agents|antidepressive agents|mesh-ancestor
101276116|NCT01867775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101276117|NCT01867775|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101276118|NCT01867775|Histamine Antagonists|histamine antagonists|mesh-ancestor
101276119|NCT01867775|Histamine Agents|histamine agents|mesh-ancestor
101276120|NCT01867775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101276121|NCT01867775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276123|NCT01867775|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101276124|NCT01867775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101276125|NCT01867775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101276126|NCT01867775|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101276127|NCT01867775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101276128|NCT01867775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101276129|NCT01867775|Adrenergic Agents|adrenergic agents|mesh-ancestor
101276130|NCT01867775|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101276131|NCT01867775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101276132|NCT01867775|Serotonin Agents|serotonin agents|mesh-ancestor
101276133|NCT01867775|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101276134|NCT01867866|Trifluridine|trifluridine|mesh-list
101276135|NCT01867866|Antimetabolites|antimetabolites|mesh-ancestor
101276136|NCT01867866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276137|NCT01867866|Antiviral Agents|antiviral agents|mesh-ancestor
101276138|NCT01867866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101276139|NCT01867892|Leucovorin|leucovorin|mesh-list
101276140|NCT01867892|Gemcitabine|gemcitabine|mesh-list
101276141|NCT01867892|Fluorouracil|fluorouracil|mesh-list
101276142|NCT01867892|Irinotecan|irinotecan|mesh-list
101276143|NCT01867892|Levoleucovorin|levoleucovorin|mesh-list
101818228|NCT00809705|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101818229|NCT00809705|Incretins|incretins|mesh-ancestor
101818230|NCT00809705|Hormones|hormones|mesh-ancestor
101818231|NCT00809705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101818232|NCT00809705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818233|NCT00655499|Irinotecan|irinotecan|mesh-list
101818234|NCT00655499|Panitumumab|panitumumab|mesh-list
101818235|NCT00655499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101818236|NCT00655499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101818237|NCT00655499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101818238|NCT00655499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276144|NCT01867892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101276145|NCT01867892|Antimetabolites|antimetabolites|mesh-ancestor
101276146|NCT01867892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276147|NCT01867892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101276148|NCT01867892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101276149|NCT01867892|Immunologic Factors|immunologic factors|mesh-ancestor
101276150|NCT01867892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276151|NCT01867892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101276152|NCT01867892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101276153|NCT01867892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101276154|NCT01867892|Antidotes|antidotes|mesh-ancestor
101276155|NCT01867892|Protective Agents|protective agents|mesh-ancestor
101276156|NCT01867892|Vitamin B Complex|vitamin b complex|mesh-ancestor
101276158|NCT01867892|Micronutrients|micronutrients|mesh-ancestor
101276159|NCT01868048|Nabiximols|nabiximols|mesh-list
101276160|NCT01868048|Analgesics|analgesics|mesh-ancestor
101276161|NCT01868048|Sensory System Agents|sensory system agents|mesh-ancestor
101276162|NCT01868048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101276163|NCT01868048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276164|NCT01868113|Fluticasone|fluticasone|mesh-list
101276166|NCT01868113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101276167|NCT01868113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101276168|NCT01868113|Autonomic Agents|autonomic agents|mesh-ancestor
101276169|NCT01868113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101276170|NCT01868113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276171|NCT01868113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101276172|NCT01868113|Respiratory System Agents|respiratory system agents|mesh-ancestor
101276173|NCT01868113|Dermatologic Agents|dermatologic agents|mesh-ancestor
101276174|NCT01868113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101276175|NCT01868126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101276176|NCT01868126|Latanoprost|latanoprost|mesh-list
101276177|NCT01868126|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101276178|NCT01868191|Thiamine|thiamine|mesh-list
101276179|NCT01868191|Benphothiamine|benphothiamine|mesh-list
101276180|NCT01868191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101276181|NCT01868191|Immunologic Factors|immunologic factors|mesh-ancestor
101276182|NCT01868191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276183|NCT01868191|Chelating Agents|chelating agents|mesh-ancestor
101276184|NCT01868191|Sequestering Agents|sequestering agents|mesh-ancestor
101276185|NCT01868191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276186|NCT01868191|Vitamin B Complex|vitamin b complex|mesh-ancestor
101276187|NCT01868191|Vitamins|vitamins|mesh-ancestor
101276188|NCT01868191|Micronutrients|micronutrients|mesh-ancestor
101276189|NCT01868360|Aflibercept|aflibercept|mesh-list
101276190|NCT01868360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101276191|NCT01868360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101276192|NCT01868360|Growth Substances|growth substances|mesh-ancestor
101276193|NCT01868360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276194|NCT01868360|Growth Inhibitors|growth inhibitors|mesh-ancestor
101276195|NCT01868360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101276197|NCT01868438|Pyronaridine|pyronaridine|mesh-list
101818239|NCT00655499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101818240|NCT00655499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101818241|NCT00800267|Timolol|timolol|mesh-list
101818242|NCT00800267|Latanoprost|latanoprost|mesh-list
101818243|NCT00800267|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101818244|NCT00800267|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101276198|NCT01868438|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
101276199|NCT01868438|Antimalarials|antimalarials|mesh-ancestor
101276200|NCT01868438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101276201|NCT01868438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101276202|NCT01868438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101276203|NCT01868438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101276204|NCT01868438|Antiviral Agents|antiviral agents|mesh-ancestor
101276205|NCT01868438|Schistosomicides|schistosomicides|mesh-ancestor
101276206|NCT01868438|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101276207|NCT01868438|Anthelmintics|anthelmintics|mesh-ancestor
101276208|NCT01868464|BCG Vaccine|bcg vaccine|mesh-list
101276209|NCT01868464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101276210|NCT01868464|Immunologic Factors|immunologic factors|mesh-ancestor
101276211|NCT01868464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276212|NCT01868529|Insulin|insulin|mesh-list
101276213|NCT01868529|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101276214|NCT01868529|Insulin Glargine|insulin glargine|mesh-list
101276215|NCT01868529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101276216|NCT01868529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276217|NCT01868555|Insulin|insulin|mesh-list
101276218|NCT01868555|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101276219|NCT01868555|Insulin Aspart|insulin aspart|mesh-list
101276220|NCT01868555|Insulin, Long-Acting|insulin, long-acting|mesh-list
101276221|NCT01868555|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101276222|NCT01868555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101276223|NCT01868555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276224|NCT01868568|Insulin|insulin|mesh-list
101276225|NCT01868568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101276226|NCT01868568|Insulin Aspart|insulin aspart|mesh-list
101276227|NCT01868568|Insulin, Long-Acting|insulin, long-acting|mesh-list
101276228|NCT01868568|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101276229|NCT01868568|Biphasic Insulins|biphasic insulins|mesh-list
101276230|NCT01868568|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101276231|NCT01868568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101276232|NCT01868568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276233|NCT01868581|Insulin|insulin|mesh-list
101276234|NCT01868581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101276235|NCT01868581|Insulin Aspart|insulin aspart|mesh-list
101276236|NCT01868581|Insulin, Long-Acting|insulin, long-acting|mesh-list
101276237|NCT01868581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101276238|NCT01868581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276239|NCT01868750|Calcitriol|calcitriol|mesh-list
101276241|NCT01868750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276242|NCT01868750|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101276243|NCT01868750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101276244|NCT01868750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276245|NCT01868750|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101276246|NCT01868750|Vitamins|vitamins|mesh-ancestor
101276247|NCT01868750|Micronutrients|micronutrients|mesh-ancestor
101276248|NCT01868750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101276249|NCT01868802|Ketamine|ketamine|mesh-list
101276250|NCT01868802|Analgesics|analgesics|mesh-ancestor
101276251|NCT01868802|Sensory System Agents|sensory system agents|mesh-ancestor
101276252|NCT01868802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101276253|NCT01868802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276254|NCT01868802|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101276255|NCT01868802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101276256|NCT01868802|Anesthetics, General|anesthetics, general|mesh-ancestor
101276257|NCT01868802|Anesthetics|anesthetics|mesh-ancestor
101408102|NCT00443716|Hormones|hormones|mesh-ancestor
101276258|NCT01868802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101276259|NCT01868802|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101276260|NCT01868802|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101276261|NCT01868802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101818245|NCT00800267|Adrenergic Agents|adrenergic agents|mesh-ancestor
101818246|NCT00800267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101818247|NCT00800267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818248|NCT00800267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818249|NCT00800267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101818250|NCT00800267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101818251|NCT00800267|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101818252|NCT00800267|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101818253|NCT00809939|Progesterone|progesterone|mesh-list
101818254|NCT00809939|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
101818255|NCT00809939|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
101818256|NCT00809939|Progestins|progestins|mesh-ancestor
101818257|NCT00809939|Hormones|hormones|mesh-ancestor
101818258|NCT00809939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101818259|NCT00809939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276262|NCT01868802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276263|NCT01868906|Temozolomide|temozolomide|mesh-list
101276264|NCT01868906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101276265|NCT01868906|Alkylating Agents|alkylating agents|mesh-ancestor
101276266|NCT01868906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276267|NCT01868906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101276268|NCT01868945|Vitamin D|vitamin d|mesh-list
101276269|NCT01868945|Cholecalciferol|cholecalciferol|mesh-list
101276270|NCT01868945|Calcifediol|calcifediol|mesh-list
101276271|NCT01868945|Vitamins|vitamins|mesh-ancestor
101276272|NCT01868945|Micronutrients|micronutrients|mesh-ancestor
101276273|NCT01868945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276274|NCT01868945|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101276275|NCT01868945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101276276|NCT01868984|Paclitaxel|paclitaxel|mesh-list
101276277|NCT01868984|Heparin|heparin|mesh-list
101276278|NCT01868984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101276279|NCT01868984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101276280|NCT01868984|Tubulin Modulators|tubulin modulators|mesh-ancestor
101276281|NCT01868984|Antimitotic Agents|antimitotic agents|mesh-ancestor
101276282|NCT01868984|Mitosis Modulators|mitosis modulators|mesh-ancestor
101276283|NCT01868984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276284|NCT01868984|Anticoagulants|anticoagulants|mesh-ancestor
101276285|NCT01868984|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101276286|NCT01868984|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101276287|NCT01869010|Tenofovir|tenofovir|mesh-list
101276288|NCT01869010|Antiviral Agents|antiviral agents|mesh-ancestor
101276289|NCT01869010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101276290|NCT01869010|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101276291|NCT01869010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101276292|NCT01869010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101276293|NCT01869010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276294|NCT01869010|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101276295|NCT01869010|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101276296|NCT01869023|Gemcitabine|gemcitabine|mesh-list
101276297|NCT01869023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101276298|NCT01869023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101276299|NCT01869023|Antimetabolites|antimetabolites|mesh-ancestor
101276300|NCT01869023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276301|NCT01869036|Morphine|morphine|mesh-list
101276302|NCT01869036|Anesthetics|anesthetics|mesh-list
101276303|NCT01869036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101818260|NCT00809939|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101818261|NCT00809939|Hormone Antagonists|hormone antagonists|mesh-ancestor
101818262|NCT00807443|Raltegravir Potassium|raltegravir potassium|mesh-list
101818263|NCT00807443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101818264|NCT00807443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101818265|NCT00807443|Antiviral Agents|antiviral agents|mesh-ancestor
101818266|NCT00807443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101818267|NCT00807443|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101276304|NCT01869036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276306|NCT01869036|Narcotics|narcotics|mesh-ancestor
101276307|NCT01869036|Analgesics|analgesics|mesh-ancestor
101276308|NCT01869036|Sensory System Agents|sensory system agents|mesh-ancestor
101276309|NCT01869036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101276310|NCT01869205|Ivermectin|ivermectin|mesh-list
101276311|NCT01869205|Abamectin|abamectin|mesh-list
101276312|NCT01869205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101276313|NCT01869205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101276314|NCT01869205|Anthelmintics|anthelmintics|mesh-ancestor
101276315|NCT01869257|Triclosan|triclosan|mesh-list
101276316|NCT01869257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101276317|NCT01869257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101276318|NCT01869257|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101276319|NCT01869257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101276320|NCT01869257|Antimetabolites|antimetabolites|mesh-ancestor
101276321|NCT01869257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276322|NCT01869257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101276323|NCT01869309|Ticagrelor|ticagrelor|mesh-list
101276324|NCT01869309|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101276325|NCT01869309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101276326|NCT01869309|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101276327|NCT01869309|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101276328|NCT01869309|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101276329|NCT01869309|Purinergic Agents|purinergic agents|mesh-ancestor
101276330|NCT01869309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101276331|NCT01869309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276332|NCT01869309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276333|NCT01869491|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
101276334|NCT01869491|Antacids|antacids|mesh-ancestor
101276335|NCT01869491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276336|NCT01869491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101276337|NCT01869556|Oxytocin|oxytocin|mesh-list
101276338|NCT01869556|Carboprost|carboprost|mesh-list
101314555|NCT00001033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101276339|NCT01869556|Carboprost tromethamine|carboprost tromethamine|mesh-list
101276341|NCT01869556|Oxytocics|oxytocics|mesh-ancestor
101276342|NCT01869556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101276343|NCT01869556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276344|NCT01869556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101276347|NCT01869569|Analgesics|analgesics|mesh-ancestor
101276348|NCT01869569|Sensory System Agents|sensory system agents|mesh-ancestor
101276349|NCT01869569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101276350|NCT01869569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276351|NCT01869569|Anticonvulsants|anticonvulsants|mesh-ancestor
101276352|NCT01869569|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101276353|NCT01869569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101276354|NCT01869569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276355|NCT01869569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101276356|NCT01869569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101276357|NCT01869569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101276358|NCT01869569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101276359|NCT01869569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101276360|NCT01869621|Metformin|metformin|mesh-list
101276361|NCT01869621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101276362|NCT01869621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276363|NCT01869673|Anesthetics|anesthetics|mesh-list
101276364|NCT01869673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101818268|NCT00807443|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101818269|NCT00807443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101818270|NCT00807443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818271|NCT00807521|Dexamethasone|dexamethasone|mesh-list
101818272|NCT00807521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101818273|NCT00807521|Antiemetics|antiemetics|mesh-ancestor
101818274|NCT00807521|Autonomic Agents|autonomic agents|mesh-ancestor
101818275|NCT00807521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101818276|NCT00807521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818277|NCT00807521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101818278|NCT00807521|Glucocorticoids|glucocorticoids|mesh-ancestor
101818279|NCT00807521|Hormones|hormones|mesh-ancestor
101818280|NCT00807521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101818281|NCT00807521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101818282|NCT00807521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101818283|NCT00800423|Timolol|timolol|mesh-list
101276365|NCT01869673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276366|NCT01869751|Prucalopride|prucalopride|mesh-list
101276367|NCT01869751|Laxatives|laxatives|mesh-ancestor
101276368|NCT01869751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101276369|NCT01869751|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101276370|NCT01869751|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101276371|NCT01869751|Serotonin Agents|serotonin agents|mesh-ancestor
101276372|NCT01869751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101276373|NCT01869751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276374|NCT01869751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276375|NCT01869803|Gemtuzumab|gemtuzumab|mesh-list
101276376|NCT01869803|Calicheamicins|calicheamicins|mesh-list
101276377|NCT01869803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101276378|NCT01869803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101276379|NCT01869803|Immunotoxins|immunotoxins|mesh-ancestor
101276380|NCT01869803|Immunoconjugates|immunoconjugates|mesh-ancestor
101276381|NCT01869803|Immunologic Factors|immunologic factors|mesh-ancestor
101276382|NCT01869803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276383|NCT01869803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101276384|NCT01869881|Sarpogrelate|sarpogrelate|mesh-list
101276385|NCT01869881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101276386|NCT01869881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101276387|NCT01869881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276388|NCT01869881|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101276389|NCT01869881|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101276390|NCT01869881|Serotonin Agents|serotonin agents|mesh-ancestor
101276391|NCT01869881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101276392|NCT01869881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276394|NCT01869907|Amitriptyline|amitriptyline|mesh-list
101276395|NCT01869907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101276396|NCT01869907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101276397|NCT01869907|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101276398|NCT01869907|Antidepressive Agents|antidepressive agents|mesh-ancestor
101276399|NCT01869907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101276400|NCT01869907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101276401|NCT01869907|Analgesics|analgesics|mesh-ancestor
101276402|NCT01869907|Sensory System Agents|sensory system agents|mesh-ancestor
101276403|NCT01869907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101276404|NCT01869907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276405|NCT01869907|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101276406|NCT01869907|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101276407|NCT01869907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101818284|NCT00800423|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101818285|NCT00800423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818286|NCT00800423|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101818287|NCT00800423|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101818288|NCT00800423|Adrenergic Agents|adrenergic agents|mesh-ancestor
101818289|NCT00800423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101818290|NCT00800423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818291|NCT00800423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101818292|NCT00800423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101818293|NCT00800423|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101818294|NCT00800423|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101818295|NCT00800423|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101818296|NCT00651755|Prednisone|prednisone|mesh-list
101276408|NCT01869907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276409|NCT01869907|Adrenergic Agents|adrenergic agents|mesh-ancestor
101276410|NCT01869907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101276411|NCT01869946|Ropivacaine|ropivacaine|mesh-list
101276412|NCT01869946|Anesthetics, Local|anesthetics, local|mesh-ancestor
101276413|NCT01869946|Anesthetics|anesthetics|mesh-ancestor
101276414|NCT01869946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101276415|NCT01869946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276416|NCT01869946|Sensory System Agents|sensory system agents|mesh-ancestor
101276417|NCT01869946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101276418|NCT01870011|Anesthetics|anesthetics|mesh-list
101276419|NCT01870011|Propofol|propofol|mesh-list
101276420|NCT01870011|Desflurane|desflurane|mesh-list
101276421|NCT01870011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101276422|NCT01870011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276423|NCT01870011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101276424|NCT01870011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101276425|NCT01870011|Anesthetics, General|anesthetics, general|mesh-ancestor
101276426|NCT01870011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101276427|NCT01870024|Fosphenytoin|fosphenytoin|mesh-list
101276428|NCT01870024|Lorazepam|lorazepam|mesh-list
101276429|NCT01870024|Clonazepam|clonazepam|mesh-list
101276430|NCT01870024|Anticonvulsants|anticonvulsants|mesh-ancestor
101276431|NCT01870024|Antiemetics|antiemetics|mesh-ancestor
101276432|NCT01870024|Autonomic Agents|autonomic agents|mesh-ancestor
101276433|NCT01870024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101276434|NCT01870024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276435|NCT01870024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101276436|NCT01870024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101276437|NCT01870024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101276438|NCT01870024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101276439|NCT01870024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101276440|NCT01870024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101276441|NCT01870024|GABA Modulators|gaba modulators|mesh-ancestor
101276442|NCT01870024|GABA Agents|gaba agents|mesh-ancestor
101276443|NCT01870024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101276444|NCT01870024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276445|NCT01870024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101276446|NCT01870024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101276447|NCT01870050|Dapsone|dapsone|mesh-list
101276448|NCT01870050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101276450|NCT01870050|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101276451|NCT01870050|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101276452|NCT01870050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101276453|NCT01870050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101276454|NCT01870050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276455|NCT01870050|Leprostatic Agents|leprostatic agents|mesh-ancestor
101276456|NCT01870050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101818297|NCT00651755|Cyclophosphamide|cyclophosphamide|mesh-list
101818298|NCT00651755|Rituximab|rituximab|mesh-list
101818299|NCT00651755|Doxorubicin|doxorubicin|mesh-list
101818300|NCT00651755|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101818301|NCT00651755|Vincristine|vincristine|mesh-list
101818302|NCT00651755|Ondansetron|ondansetron|mesh-list
101818303|NCT00651755|Aprepitant|aprepitant|mesh-list
101818304|NCT00651755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101818305|NCT00651755|Immunologic Factors|immunologic factors|mesh-ancestor
101276457|NCT01870115|Vitamin D|vitamin d|mesh-list
101276458|NCT01870115|Cholecalciferol|cholecalciferol|mesh-list
101276459|NCT01870115|Melatonin|melatonin|mesh-list
101276460|NCT01870115|Vitamins|vitamins|mesh-ancestor
101276461|NCT01870115|Micronutrients|micronutrients|mesh-ancestor
101276462|NCT01870115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276463|NCT01870115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101276464|NCT01870115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276465|NCT01870115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101276466|NCT01870115|Antioxidants|antioxidants|mesh-ancestor
101276467|NCT01870115|Protective Agents|protective agents|mesh-ancestor
101276468|NCT01870115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101276469|NCT01870128|Hydroxychloroquine|hydroxychloroquine|mesh-list
101276470|NCT01870128|Sulfasalazine|sulfasalazine|mesh-list
101276471|NCT01870128|Methylprednisolone|methylprednisolone|mesh-list
101276472|NCT01870128|Methotrexate|methotrexate|mesh-list
101276473|NCT01870128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101276474|NCT01870128|Abortifacient Agents|abortifacient agents|mesh-ancestor
101276475|NCT01870128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101276476|NCT01870128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276477|NCT01870128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101276478|NCT01870128|Antimetabolites|antimetabolites|mesh-ancestor
101276479|NCT01870128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276480|NCT01870128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101276481|NCT01870128|Dermatologic Agents|dermatologic agents|mesh-ancestor
101276482|NCT01870128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101276483|NCT01870128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101276484|NCT01870128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101276485|NCT01870128|Immunologic Factors|immunologic factors|mesh-ancestor
101276486|NCT01870128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101276487|NCT01870128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101276488|NCT01870128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101276489|NCT01870128|Antiemetics|antiemetics|mesh-ancestor
101276490|NCT01870128|Autonomic Agents|autonomic agents|mesh-ancestor
101276491|NCT01870128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101276492|NCT01870128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101276493|NCT01870128|Glucocorticoids|glucocorticoids|mesh-ancestor
101276494|NCT01870128|Hormones|hormones|mesh-ancestor
101276495|NCT01870128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101276496|NCT01870128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101276497|NCT01870128|Protective Agents|protective agents|mesh-ancestor
101276498|NCT01870128|Antimalarials|antimalarials|mesh-ancestor
101276499|NCT01870128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101276500|NCT01870128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101276501|NCT01870128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101276502|NCT01870128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101276503|NCT01870128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101276504|NCT01870128|Analgesics|analgesics|mesh-ancestor
101276505|NCT01870128|Sensory System Agents|sensory system agents|mesh-ancestor
101276506|NCT01870167|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101276507|NCT01870167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101276509|NCT01870167|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101276510|NCT01870167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101276511|NCT01870167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276512|NCT01870219|Ketamine|ketamine|mesh-list
101276513|NCT01870219|Anesthetics|anesthetics|mesh-list
101276514|NCT01870219|Sevoflurane|sevoflurane|mesh-list
101818306|NCT00651755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818308|NCT00651755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101818309|NCT00651755|Alkylating Agents|alkylating agents|mesh-ancestor
101818310|NCT00651755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818311|NCT00651755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101818312|NCT00651755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101818313|NCT00651755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101276515|NCT01870219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
101276516|NCT01870219|Analgesics|analgesics|mesh-ancestor
101276517|NCT01870219|Sensory System Agents|sensory system agents|mesh-ancestor
101276518|NCT01870219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101276519|NCT01870219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276520|NCT01870219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101276521|NCT01870219|Anesthetics, General|anesthetics, general|mesh-ancestor
101276522|NCT01870219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101276523|NCT01870219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101276524|NCT01870219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101276525|NCT01870219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101276526|NCT01870219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276527|NCT01870219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101276528|NCT01870219|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101276529|NCT01870284|Adalimumab|adalimumab|mesh-list
101276530|NCT01870284|Ixekizumab|ixekizumab|mesh-list
101276531|NCT01870284|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101276532|NCT01870284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101276533|NCT01870284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101276534|NCT01870284|Dermatologic Agents|dermatologic agents|mesh-ancestor
101276535|NCT01870427|Aflibercept|aflibercept|mesh-list
101276536|NCT01870427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101276537|NCT01870427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101276538|NCT01870427|Growth Substances|growth substances|mesh-ancestor
101276539|NCT01870427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276540|NCT01870427|Growth Inhibitors|growth inhibitors|mesh-ancestor
101276541|NCT01870427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101276542|NCT01868880|Bisoprolol|bisoprolol|mesh-list
101276543|NCT01868880|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101276544|NCT01868880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101276545|NCT01868880|Adrenergic Agents|adrenergic agents|mesh-ancestor
101276546|NCT01868880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101276547|NCT01868880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276548|NCT01868880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276549|NCT01868880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101276550|NCT01868880|Sympatholytics|sympatholytics|mesh-ancestor
101276551|NCT01868880|Autonomic Agents|autonomic agents|mesh-ancestor
101276552|NCT01868880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101276553|NCT01868880|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101276555|NCT01870440|Dexamethasone acetate|dexamethasone acetate|mesh-list
101276556|NCT01870440|BB 1101|bb 1101|mesh-list
101276557|NCT01870440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101276558|NCT01870440|Antiemetics|antiemetics|mesh-ancestor
101276559|NCT01870440|Autonomic Agents|autonomic agents|mesh-ancestor
101276560|NCT01870440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101276561|NCT01870440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276562|NCT01870440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101276563|NCT01870440|Glucocorticoids|glucocorticoids|mesh-ancestor
101276564|NCT01870440|Hormones|hormones|mesh-ancestor
101276565|NCT01870440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101276566|NCT01870440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101276567|NCT01870440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101276568|NCT01870440|Protease Inhibitors|protease inhibitors|mesh-ancestor
101818314|NCT00651755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101818315|NCT00651755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101818316|NCT00651755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101818317|NCT00651755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101818318|NCT00651755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101818320|NCT00651755|Hormones|hormones|mesh-ancestor
101276569|NCT01870440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101276570|NCT01870440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276571|NCT01870466|Cilostazol|cilostazol|mesh-list
101276572|NCT01870466|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101276573|NCT01870466|Simvastatin|simvastatin|mesh-list
101276574|NCT01870466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101276577|NCT01870466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276578|NCT01870466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101276579|NCT01870466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101276580|NCT01870466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101276581|NCT01870466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101276582|NCT01870466|Autonomic Agents|autonomic agents|mesh-ancestor
101276583|NCT01870466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101276584|NCT01870466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276585|NCT01870466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101276586|NCT01870466|Respiratory System Agents|respiratory system agents|mesh-ancestor
101276587|NCT01870466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101276588|NCT01870466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101276589|NCT01870466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101276590|NCT01870466|Vasodilator Agents|vasodilator agents|mesh-ancestor
101276591|NCT01870466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101276592|NCT01870466|Protective Agents|protective agents|mesh-ancestor
101276593|NCT01870466|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101276594|NCT01870466|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101276595|NCT01870492|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101276596|NCT01870492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101276597|NCT01870492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101276598|NCT01870492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276599|NCT01870635|Ondansetron|ondansetron|mesh-list
101276600|NCT01870635|Antiemetics|antiemetics|mesh-ancestor
101276601|NCT01870635|Autonomic Agents|autonomic agents|mesh-ancestor
101276602|NCT01870635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101276603|NCT01870635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276604|NCT01870635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101276605|NCT01870635|Antipruritics|antipruritics|mesh-ancestor
101276606|NCT01870635|Dermatologic Agents|dermatologic agents|mesh-ancestor
101276607|NCT01870635|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101276608|NCT01870635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101276609|NCT01870635|Serotonin Agents|serotonin agents|mesh-ancestor
101276610|NCT01870635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101276611|NCT01870635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276612|NCT01870648|Ondansetron|ondansetron|mesh-list
101276613|NCT01870648|Antiemetics|antiemetics|mesh-ancestor
101276614|NCT01870648|Autonomic Agents|autonomic agents|mesh-ancestor
101276615|NCT01870648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101276616|NCT01870648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276618|NCT01870648|Antipruritics|antipruritics|mesh-ancestor
101276619|NCT01870648|Dermatologic Agents|dermatologic agents|mesh-ancestor
101276620|NCT01870648|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101276621|NCT01870648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101276622|NCT01870648|Serotonin Agents|serotonin agents|mesh-ancestor
101276623|NCT01870648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101314571|NCT00001036|Antimetabolites|antimetabolites|mesh-ancestor
101276624|NCT01870648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276625|NCT01870674|Prucalopride|prucalopride|mesh-list
101276627|NCT01870674|Laxatives|laxatives|mesh-ancestor
101276628|NCT01870674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101276629|NCT01870674|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101276630|NCT01870674|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101818321|NCT00651755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101818322|NCT00651755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101818323|NCT00651755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101818325|NCT00651755|Antimitotic Agents|antimitotic agents|mesh-ancestor
101818326|NCT00651755|Mitosis Modulators|mitosis modulators|mesh-ancestor
101818327|NCT00651755|Antiemetics|antiemetics|mesh-ancestor
101818328|NCT00651755|Autonomic Agents|autonomic agents|mesh-ancestor
101818329|NCT00651755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101276631|NCT01870674|Serotonin Agents|serotonin agents|mesh-ancestor
101276632|NCT01870674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101276633|NCT01870674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276634|NCT01870674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276635|NCT01870804|Atorvastatin|atorvastatin|mesh-list
101276636|NCT01870804|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101276638|NCT01870804|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101276639|NCT01870804|Antimetabolites|antimetabolites|mesh-ancestor
101408169|NCT00444184|Travoprost|travoprost|mesh-list
101276640|NCT01870804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276641|NCT01870804|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101276642|NCT01870804|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101276643|NCT01870804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101276644|NCT01870895|Ramosetron|ramosetron|mesh-list
101276645|NCT01870895|Antiemetics|antiemetics|mesh-ancestor
101276646|NCT01870895|Autonomic Agents|autonomic agents|mesh-ancestor
101276647|NCT01870895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101276648|NCT01870895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276649|NCT01870895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101276650|NCT01870895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101276651|NCT01870895|Serotonin Agents|serotonin agents|mesh-ancestor
101276652|NCT01870895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101276653|NCT01870895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276654|NCT01870908|Tacrolimus|tacrolimus|mesh-list
101276655|NCT01870908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101276656|NCT01870908|Immunologic Factors|immunologic factors|mesh-ancestor
101276657|NCT01870908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276658|NCT01870908|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101276659|NCT01870908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101276660|NCT01870908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276661|NCT01870986|Adalimumab|adalimumab|mesh-list
101276662|NCT01870986|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101276663|NCT01870986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101276664|NCT01870986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101276665|NCT01871129|Dexmedetomidine|dexmedetomidine|mesh-list
101276666|NCT01871129|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101276667|NCT01871129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101276668|NCT01871129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276669|NCT01871129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101276670|NCT01871129|Analgesics|analgesics|mesh-ancestor
101276671|NCT01871129|Sensory System Agents|sensory system agents|mesh-ancestor
101276672|NCT01871129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101276673|NCT01871129|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101276674|NCT01871129|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101276675|NCT01871129|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101276676|NCT01871129|Adrenergic Agents|adrenergic agents|mesh-ancestor
101276677|NCT01871129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101276678|NCT01871129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276679|NCT01871363|Capecitabine|capecitabine|mesh-list
101276680|NCT01871363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101276681|NCT01871363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101276682|NCT01871363|Antimetabolites|antimetabolites|mesh-ancestor
101276683|NCT01871363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276684|NCT01871376|Aflibercept|aflibercept|mesh-list
101818330|NCT00651755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101818331|NCT00651755|Antipruritics|antipruritics|mesh-ancestor
101818332|NCT00651755|Dermatologic Agents|dermatologic agents|mesh-ancestor
101818333|NCT00651755|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101818334|NCT00651755|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101818335|NCT00651755|Serotonin Agents|serotonin agents|mesh-ancestor
101818336|NCT00651755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101276685|NCT01871376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101276686|NCT01871376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101276687|NCT01871376|Growth Substances|growth substances|mesh-ancestor
101276688|NCT01871376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276689|NCT01871376|Growth Inhibitors|growth inhibitors|mesh-ancestor
101276690|NCT01871376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101276691|NCT01871454|Pentoxifylline|pentoxifylline|mesh-list
101276693|NCT01871454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101276694|NCT01871454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276695|NCT01871454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101276696|NCT01871454|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101408178|NCT00444223|Fluorides|fluorides|mesh-list
101276697|NCT01871454|Protective Agents|protective agents|mesh-ancestor
101276698|NCT01871454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276700|NCT01871454|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101276701|NCT01871454|Antioxidants|antioxidants|mesh-ancestor
101276702|NCT01871467|Sargramostim|sargramostim|mesh-list
101276703|NCT01871467|Immunologic Factors|immunologic factors|mesh-ancestor
101276704|NCT01871467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276705|NCT01871480|Gefitinib|gefitinib|mesh-list
101276706|NCT01871480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101276707|NCT01871480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101276708|NCT01871480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101276709|NCT01871480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276710|NCT01871493|Insulin Lispro|insulin lispro|mesh-list
101276711|NCT01871493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101276712|NCT01871493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276713|NCT01871649|Golimumab|golimumab|mesh-list
101276714|NCT01871649|Methotrexate|methotrexate|mesh-list
101276715|NCT01871649|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101276716|NCT01871649|Abortifacient Agents|abortifacient agents|mesh-ancestor
101276717|NCT01871649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101276718|NCT01871649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276719|NCT01871649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101276720|NCT01871649|Antimetabolites|antimetabolites|mesh-ancestor
101276721|NCT01871649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276722|NCT01871649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101276723|NCT01871649|Dermatologic Agents|dermatologic agents|mesh-ancestor
101276724|NCT01871649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101276725|NCT01871649|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101276726|NCT01871649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101276727|NCT01871649|Immunologic Factors|immunologic factors|mesh-ancestor
101276728|NCT01871649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101276729|NCT01871649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101276730|NCT01871649|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101276731|NCT01871649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101276732|NCT01871662|Interferons|interferons|mesh-list
101276733|NCT01871662|Ribavirin|ribavirin|mesh-list
101276734|NCT01871662|Interferon-alpha|interferon-alpha|mesh-list
101276735|NCT01871662|Interferon alpha-2|interferon alpha-2|mesh-list
101276736|NCT01871662|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101276737|NCT01871662|Silybin|silybin|mesh-list
101276738|NCT01871662|Silymarin|silymarin|mesh-list
101276739|NCT01871662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101276740|NCT01871662|Antiviral Agents|antiviral agents|mesh-ancestor
101276741|NCT01871662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101276742|NCT01871662|Antimetabolites|antimetabolites|mesh-ancestor
101276743|NCT01871662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276744|NCT01871662|Immunologic Factors|immunologic factors|mesh-ancestor
101276745|NCT01871662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276746|NCT01871662|Antioxidants|antioxidants|mesh-ancestor
101276747|NCT01871662|Protective Agents|protective agents|mesh-ancestor
101818337|NCT00651755|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101818339|NCT00807755|Etoposide|etoposide|mesh-list
101818340|NCT00807755|Everolimus|everolimus|mesh-list
101818341|NCT00807755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101818342|NCT00807755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101818343|NCT00807755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101818344|NCT00807755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101818345|NCT00807755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101276748|NCT01871662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101276749|NCT01871675|Rituximab|rituximab|mesh-list
101276750|NCT01871675|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101276751|NCT01871675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101276752|NCT01871675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101276753|NCT01871675|Immunologic Factors|immunologic factors|mesh-ancestor
101408180|NCT00444223|Protective Agents|protective agents|mesh-ancestor
101276754|NCT01871675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276755|NCT01871675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101276756|NCT01871675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101276757|NCT01871675|Alkylating Agents|alkylating agents|mesh-ancestor
101276758|NCT01871675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276759|NCT01871701|Moxifloxacin|moxifloxacin|mesh-list
101276760|NCT01871701|Dexetimide|dexetimide|mesh-list
101276761|NCT01871701|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101276762|NCT01871701|Citalopram|citalopram|mesh-list
101276763|NCT01871701|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101276764|NCT01871701|Escitalopram|escitalopram|mesh-list
101276765|NCT01871701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101276766|NCT01871701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101276767|NCT01871701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101276768|NCT01871701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101276770|NCT01871701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276772|NCT01871701|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101276773|NCT01871701|Contraceptive Agents|contraceptive agents|mesh-ancestor
101276774|NCT01871701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101276775|NCT01871701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276776|NCT01871701|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101276778|NCT01871701|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101276779|NCT01871701|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101276780|NCT01871701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101276781|NCT01871701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101276782|NCT01871701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101276783|NCT01871701|Serotonin Agents|serotonin agents|mesh-ancestor
101276784|NCT01871701|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101276785|NCT01871701|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101276786|NCT01871701|Parasympatholytics|parasympatholytics|mesh-ancestor
101276787|NCT01871701|Autonomic Agents|autonomic agents|mesh-ancestor
101276788|NCT01871701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101276789|NCT01871701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101276790|NCT01871701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101276791|NCT01871701|Cholinergic Agents|cholinergic agents|mesh-ancestor
101276792|NCT01871701|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101276793|NCT01871701|Antidepressive Agents|antidepressive agents|mesh-ancestor
101276794|NCT01871701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101276795|NCT01871701|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101276796|NCT01871701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101276797|NCT01871701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101276798|NCT01871740|Folic Acid|folic acid|mesh-list
101276799|NCT01871740|Enalapril|enalapril|mesh-list
101276800|NCT01871740|Enalaprilat|enalaprilat|mesh-list
101276801|NCT01871740|Maleic acid|maleic acid|mesh-list
101276802|NCT01871740|Hematinics|hematinics|mesh-ancestor
101276803|NCT01871740|Vitamin B Complex|vitamin b complex|mesh-ancestor
101276804|NCT01871740|Vitamins|vitamins|mesh-ancestor
101818346|NCT00807755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818347|NCT00807755|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101818348|NCT00807755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101818349|NCT00807755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101818350|NCT00807755|Immunologic Factors|immunologic factors|mesh-ancestor
101818351|NCT00807755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818352|NCT00813527|Fenofibrate|fenofibrate|mesh-list
101818353|NCT00813527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101818354|NCT00813527|Antimetabolites|antimetabolites|mesh-ancestor
101818355|NCT00813527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818356|NCT00813527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101276805|NCT01871740|Micronutrients|micronutrients|mesh-ancestor
101276806|NCT01871740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276807|NCT01871740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101276808|NCT01871740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276809|NCT01871740|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101276810|NCT01871740|Protease Inhibitors|protease inhibitors|mesh-ancestor
101408194|NCT04698772|Ketamine|ketamine|mesh-list
101276811|NCT01871740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101276812|NCT01871753|Anti-Infective Agents|anti-infective agents|mesh-list
101276813|NCT01871792|Pitavastatin|pitavastatin|mesh-list
101276814|NCT01871792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101276815|NCT01871792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101276816|NCT01871792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101276817|NCT01871792|Antimetabolites|antimetabolites|mesh-ancestor
101276818|NCT01871792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276819|NCT01871792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101276820|NCT01871792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101276821|NCT01871844|Octreotide|octreotide|mesh-list
101276823|NCT01871844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101276824|NCT01871844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101276825|NCT01871844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101276827|NCT01871844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101276828|NCT01871844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276829|NCT01871857|Epinephrine|epinephrine|mesh-list
101276830|NCT01871857|Racepinephrine|racepinephrine|mesh-list
101276831|NCT01871857|Epinephryl borate|epinephryl borate|mesh-list
101276832|NCT01871857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101276833|NCT01871857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101276834|NCT01871857|Adrenergic Agents|adrenergic agents|mesh-ancestor
101276835|NCT01871857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101276836|NCT01871857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276837|NCT01871857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276838|NCT01871857|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101276839|NCT01871857|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101276840|NCT01871857|Autonomic Agents|autonomic agents|mesh-ancestor
101276841|NCT01871857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101276842|NCT01871857|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101276843|NCT01871857|Respiratory System Agents|respiratory system agents|mesh-ancestor
101276844|NCT01871857|Mydriatics|mydriatics|mesh-ancestor
101276845|NCT01871857|Sympathomimetics|sympathomimetics|mesh-ancestor
101276846|NCT01871857|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101276847|NCT01871922|Atropine|atropine|mesh-list
101276848|NCT01871922|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101276849|NCT01871922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101276850|NCT01871922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101276851|NCT01871922|Autonomic Agents|autonomic agents|mesh-ancestor
101276852|NCT01871922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101276853|NCT01871922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276854|NCT01871922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101276855|NCT01871922|Respiratory System Agents|respiratory system agents|mesh-ancestor
101276857|NCT01871922|Parasympatholytics|parasympatholytics|mesh-ancestor
101818357|NCT00810563|Bupivacaine|bupivacaine|mesh-list
101818358|NCT00810563|Anesthetics, Local|anesthetics, local|mesh-ancestor
101818359|NCT00810563|Anesthetics|anesthetics|mesh-ancestor
101818360|NCT00810563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101818361|NCT00810563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818362|NCT00810563|Sensory System Agents|sensory system agents|mesh-ancestor
101818363|NCT00810563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101818364|NCT00808145|Cisplatin|cisplatin|mesh-list
101818365|NCT00808145|Gemcitabine|gemcitabine|mesh-list
101818366|NCT00808145|Sorafenib|sorafenib|mesh-list
101818367|NCT00808145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101818368|NCT00808145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101818369|NCT00808145|Antimetabolites|antimetabolites|mesh-ancestor
101818370|NCT00808145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818371|NCT00808145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101818372|NCT00808145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101818373|NCT02552459|Sufentanil|sufentanil|mesh-list
101818374|NCT02552459|Dexmedetomidine|dexmedetomidine|mesh-list
101818375|NCT02552459|Dsuvia|dsuvia|mesh-list
101818376|NCT02552459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101818377|NCT02552459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101818378|NCT02552459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818379|NCT02552459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101818380|NCT02552459|Analgesics|analgesics|mesh-ancestor
101818381|NCT02552459|Sensory System Agents|sensory system agents|mesh-ancestor
101818382|NCT02552459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101818383|NCT02552459|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101818384|NCT02552459|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101818385|NCT02552459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101818386|NCT02552459|Adrenergic Agents|adrenergic agents|mesh-ancestor
101818387|NCT02552459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101276858|NCT01871922|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101276859|NCT01871922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101276860|NCT01871922|Cholinergic Agents|cholinergic agents|mesh-ancestor
101276861|NCT01871922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101276862|NCT01871922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276863|NCT01871935|Sufentanil|sufentanil|mesh-list
101276864|NCT01871935|Remifentanil|remifentanil|mesh-list
101276865|NCT01871935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101276866|NCT01871935|Narcotics|narcotics|mesh-ancestor
101276867|NCT01871935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101276868|NCT01871935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276869|NCT01871935|Analgesics|analgesics|mesh-ancestor
101276870|NCT01871935|Sensory System Agents|sensory system agents|mesh-ancestor
101818388|NCT02552459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818389|NCT02552459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101818390|NCT02552459|Narcotics|narcotics|mesh-ancestor
101818391|NCT02552459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101818392|NCT02552459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101276871|NCT01871935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101276872|NCT01871935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101276873|NCT01871935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101276874|NCT01871935|Anesthetics, General|anesthetics, general|mesh-ancestor
101276875|NCT01871935|Anesthetics|anesthetics|mesh-ancestor
101276876|NCT01871961|Methotrexate|methotrexate|mesh-list
101276877|NCT01871961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101276878|NCT01871961|Abortifacient Agents|abortifacient agents|mesh-ancestor
101276879|NCT01871961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101276880|NCT01871961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276881|NCT01871961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101276882|NCT01871961|Antimetabolites|antimetabolites|mesh-ancestor
101276883|NCT01871961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276884|NCT01871961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101276885|NCT01871961|Dermatologic Agents|dermatologic agents|mesh-ancestor
101276886|NCT01871961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101276887|NCT01871961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101276888|NCT01871961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101276889|NCT01871961|Immunologic Factors|immunologic factors|mesh-ancestor
101276890|NCT01871961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101276891|NCT01871961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101276892|NCT01871974|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101276893|NCT01871974|Antidepressive Agents|antidepressive agents|mesh-ancestor
101276894|NCT01871974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101276895|NCT01871974|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101276896|NCT01871974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101276897|NCT01871974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101276898|NCT01871974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276899|NCT01871987|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101276900|NCT01871987|Antidepressive Agents|antidepressive agents|mesh-ancestor
101276901|NCT01871987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101276902|NCT01871987|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101276903|NCT01871987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101276904|NCT01871987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101276905|NCT01871987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276907|NCT01872013|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101276908|NCT01872013|Hormone Antagonists|hormone antagonists|mesh-ancestor
101276909|NCT01872013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101276910|NCT01872013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276911|NCT01872026|ASP7991|asp7991|mesh-list
101276912|NCT01872026|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101276913|NCT01872026|Hormone Antagonists|hormone antagonists|mesh-ancestor
101528333|NCT04628676|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101276914|NCT01872026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101276915|NCT01872026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276916|NCT01872039|Nicardipine|nicardipine|mesh-list
101276917|NCT01872039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101276918|NCT01872039|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101276919|NCT01872039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101276920|NCT01872039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276921|NCT01872039|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101276922|NCT01872039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276923|NCT01872039|Vasodilator Agents|vasodilator agents|mesh-ancestor
101276924|NCT01871311|Cetuximab|cetuximab|mesh-list
101276925|NCT01871311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101276926|NCT01871311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101276927|NCT01872351|Thioctic Acid|thioctic acid|mesh-list
101276928|NCT01872351|Acetylcarnitine|acetylcarnitine|mesh-list
101276929|NCT01872351|Antioxidants|antioxidants|mesh-ancestor
101276930|NCT01872351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276931|NCT01872351|Protective Agents|protective agents|mesh-ancestor
101818393|NCT02552459|Anesthetics, General|anesthetics, general|mesh-ancestor
101818394|NCT02552459|Anesthetics|anesthetics|mesh-ancestor
101818395|NCT00810953|Pentamidine|pentamidine|mesh-list
101818396|NCT00810953|Antifungal Agents|antifungal agents|mesh-ancestor
101818397|NCT00810953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101818398|NCT00810953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101818399|NCT00810953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101818400|NCT00810953|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101818401|NCT00811031|Prednisone|prednisone|mesh-list
101818402|NCT00811031|Docetaxel|docetaxel|mesh-list
101818403|NCT00811031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101818404|NCT00811031|Tubulin Modulators|tubulin modulators|mesh-ancestor
101276932|NCT01872351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276933|NCT01872351|Vitamin B Complex|vitamin b complex|mesh-ancestor
101276934|NCT01872351|Vitamins|vitamins|mesh-ancestor
101276935|NCT01872351|Micronutrients|micronutrients|mesh-ancestor
101276936|NCT01872351|Nootropic Agents|nootropic agents|mesh-ancestor
101276937|NCT01872403|Paclitaxel|paclitaxel|mesh-list
101276938|NCT01872403|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101276939|NCT01872403|Carboplatin|carboplatin|mesh-list
101276940|NCT01872403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101276941|NCT01872403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101276942|NCT01872403|Tubulin Modulators|tubulin modulators|mesh-ancestor
101276943|NCT01872403|Antimitotic Agents|antimitotic agents|mesh-ancestor
101276944|NCT01872403|Mitosis Modulators|mitosis modulators|mesh-ancestor
101276945|NCT01872403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276946|NCT01872416|Doxorubicin|doxorubicin|mesh-list
101276947|NCT01872416|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101276948|NCT01872416|Ifosfamide|ifosfamide|mesh-list
101276950|NCT01872416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101276951|NCT01872416|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101276952|NCT01872416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101276953|NCT01872416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101276954|NCT01872416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276955|NCT01872416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101276956|NCT01872416|Alkylating Agents|alkylating agents|mesh-ancestor
101276957|NCT01872442|Interferons|interferons|mesh-list
101276958|NCT01872442|Interferon-alpha|interferon-alpha|mesh-list
101276959|NCT01872442|Interferon alpha-2|interferon alpha-2|mesh-list
101276960|NCT01872442|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101276961|NCT01872442|Dasatinib|dasatinib|mesh-list
101276962|NCT01872442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101276963|NCT01872442|Antiviral Agents|antiviral agents|mesh-ancestor
101276964|NCT01872442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101276965|NCT01872442|Immunologic Factors|immunologic factors|mesh-ancestor
101276966|NCT01872442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276967|NCT01872442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101276968|NCT01872442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101276969|NCT01872442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276970|NCT01872494|Flurbiprofen|flurbiprofen|mesh-list
101276971|NCT01872494|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
101276972|NCT01872494|Pentazocine|pentazocine|mesh-list
101276973|NCT01872494|Palonosetron|palonosetron|mesh-list
101276974|NCT01872494|Ropivacaine|ropivacaine|mesh-list
101276975|NCT01872494|Anesthetics, Local|anesthetics, local|mesh-ancestor
101276976|NCT01872494|Anesthetics|anesthetics|mesh-ancestor
101276977|NCT01872494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101276978|NCT01872494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276979|NCT01872494|Sensory System Agents|sensory system agents|mesh-ancestor
101276980|NCT01872494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101276981|NCT01872494|Antiemetics|antiemetics|mesh-ancestor
101276982|NCT01872494|Autonomic Agents|autonomic agents|mesh-ancestor
101276983|NCT01872494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101276984|NCT01872494|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101276985|NCT01872494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101276986|NCT01872494|Serotonin Agents|serotonin agents|mesh-ancestor
101276987|NCT01872494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101276988|NCT01872494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818405|NCT00811031|Antimitotic Agents|antimitotic agents|mesh-ancestor
101818406|NCT00811031|Mitosis Modulators|mitosis modulators|mesh-ancestor
101818407|NCT00811031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818408|NCT00811031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101818409|NCT00811031|Glucocorticoids|glucocorticoids|mesh-ancestor
101818410|NCT00811031|Hormones|hormones|mesh-ancestor
101818411|NCT00811031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101818412|NCT00811031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818413|NCT00811031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101818414|NCT02552537|Mannitol|mannitol|mesh-list
101818415|NCT02552537|Omeprazole|omeprazole|mesh-list
101818416|NCT02552537|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101276989|NCT01872494|Analgesics|analgesics|mesh-ancestor
101276990|NCT01872494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101276991|NCT01872494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101276992|NCT01872494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101276993|NCT01872494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101276994|NCT01872494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101276995|NCT01872494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101276996|NCT01872494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101276997|NCT01872494|Narcotics|narcotics|mesh-ancestor
101276998|NCT01872494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101276999|NCT01872494|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101277000|NCT01872546|Adalimumab|adalimumab|mesh-list
101277001|NCT01872546|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101277002|NCT01872546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101277003|NCT01872546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101277004|NCT01872702|Piperaquine|piperaquine|mesh-list
101277005|NCT01872702|Primaquine|primaquine|mesh-list
101277006|NCT01872702|Artenimol|artenimol|mesh-list
101277007|NCT01872702|Antimalarials|antimalarials|mesh-ancestor
101277008|NCT01872702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101277009|NCT01872702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101277010|NCT01872702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101277011|NCT01872728|Anesthetics|anesthetics|mesh-list
101277012|NCT01872728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101277013|NCT01872728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277014|NCT01872754|Remifentanil|remifentanil|mesh-list
101277015|NCT01872754|Propofol|propofol|mesh-list
101277016|NCT01872754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101277017|NCT01872754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101277018|NCT01872754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277019|NCT01872754|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101277020|NCT01872754|Anesthetics, General|anesthetics, general|mesh-ancestor
101277021|NCT01872754|Anesthetics|anesthetics|mesh-ancestor
101277022|NCT01872754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101277023|NCT01872754|Narcotics|narcotics|mesh-ancestor
101277024|NCT01872754|Analgesics|analgesics|mesh-ancestor
101277025|NCT01872754|Sensory System Agents|sensory system agents|mesh-ancestor
101277026|NCT01872754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101277027|NCT01872780|Rosiglitazone|rosiglitazone|mesh-list
101277028|NCT01872780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101277029|NCT01872780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277030|NCT01872832|Verinurad|verinurad|mesh-list
101277031|NCT01872832|Gout Suppressants|gout suppressants|mesh-ancestor
101277032|NCT01872832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101277033|NCT01872845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101277034|NCT01872845|Pravastatin|pravastatin|mesh-list
101277035|NCT01872845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101277036|NCT01872845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101277037|NCT01872845|Antimetabolites|antimetabolites|mesh-ancestor
101277038|NCT01872845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277039|NCT01872845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101277040|NCT01872845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101818417|NCT02552537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101818418|NCT02552537|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101818419|NCT02552537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101818420|NCT02552537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818421|NCT02552537|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101818422|NCT02552537|Diuretics|diuretics|mesh-ancestor
101818423|NCT02552537|Natriuretic Agents|natriuretic agents|mesh-ancestor
101818424|NCT02552537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818425|NCT00808223|Alefacept|alefacept|mesh-list
101818426|NCT00808223|Dermatologic Agents|dermatologic agents|mesh-ancestor
101818427|NCT00808223|Immunologic Factors|immunologic factors|mesh-ancestor
101277041|NCT01872845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101277042|NCT01872858|Aspirin|aspirin|mesh-list
101277043|NCT01872858|Cilostazol|cilostazol|mesh-list
101277044|NCT01872858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101314604|NCT00001048|Antiviral Agents|antiviral agents|mesh-ancestor
101277045|NCT01872858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101277046|NCT01872858|Analgesics|analgesics|mesh-ancestor
101277047|NCT01872858|Sensory System Agents|sensory system agents|mesh-ancestor
101277048|NCT01872858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101277049|NCT01872858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277050|NCT01872858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101277051|NCT01872858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101277052|NCT01872858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101277053|NCT01872858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101277054|NCT01872858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277055|NCT01872858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101277056|NCT01872858|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101277057|NCT01872858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101277058|NCT01872858|Antipyretics|antipyretics|mesh-ancestor
101277059|NCT01872858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101277060|NCT01872858|Autonomic Agents|autonomic agents|mesh-ancestor
101277061|NCT01872858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101277062|NCT01872858|Respiratory System Agents|respiratory system agents|mesh-ancestor
101277063|NCT01872858|Vasodilator Agents|vasodilator agents|mesh-ancestor
101277064|NCT01872858|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101277065|NCT01872858|Protective Agents|protective agents|mesh-ancestor
101277066|NCT01872858|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101277067|NCT01872858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101277068|NCT01872871|Acetaminophen|acetaminophen|mesh-list
101277069|NCT01872871|Anesthetics|anesthetics|mesh-list
101277070|NCT01872871|Anesthetics, Local|anesthetics, local|mesh-list
101277071|NCT01872871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101277072|NCT01872871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277073|NCT01872871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101277075|NCT01872871|Sensory System Agents|sensory system agents|mesh-ancestor
101277076|NCT01872871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101277077|NCT01872871|Antipyretics|antipyretics|mesh-ancestor
101277078|NCT01872884|Remifentanil|remifentanil|mesh-list
101277079|NCT01872884|Sevoflurane|sevoflurane|mesh-list
101277080|NCT01872884|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101277081|NCT01872884|Narcotics|narcotics|mesh-ancestor
101277082|NCT01872884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101277083|NCT01872884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277084|NCT01872884|Analgesics|analgesics|mesh-ancestor
101277085|NCT01872884|Sensory System Agents|sensory system agents|mesh-ancestor
101277086|NCT01872884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101277087|NCT01872884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101277088|NCT01872884|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101277089|NCT01872884|Anesthetics, General|anesthetics, general|mesh-ancestor
101277090|NCT01872884|Anesthetics|anesthetics|mesh-ancestor
101277091|NCT01872897|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
101277092|NCT01872897|Antacids|antacids|mesh-ancestor
101818429|NCT00811421|Pyrimethamine|pyrimethamine|mesh-list
101818430|NCT00811421|Sulfadoxine|sulfadoxine|mesh-list
101818431|NCT00811421|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101818432|NCT00811421|Mefloquine|mefloquine|mesh-list
101277093|NCT01872897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277094|NCT01872897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101277095|NCT01872923|Bleomycin|bleomycin|mesh-list
101277096|NCT01872923|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101277097|NCT01872923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101277098|NCT01872936|Ribavirin|ribavirin|mesh-list
101277099|NCT01872936|Antimetabolites|antimetabolites|mesh-ancestor
101277100|NCT01872936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277101|NCT01872936|Antiviral Agents|antiviral agents|mesh-ancestor
101277102|NCT01872936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101277103|NCT01872962|Cisplatin|cisplatin|mesh-list
101277104|NCT01872962|Gemcitabine|gemcitabine|mesh-list
101277105|NCT01872962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101277106|NCT01872962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101277107|NCT01872962|Antimetabolites|antimetabolites|mesh-ancestor
101277108|NCT01872962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277109|NCT01872988|Tenofovir|tenofovir|mesh-list
101277110|NCT01872988|Antiviral Agents|antiviral agents|mesh-ancestor
101277111|NCT01872988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101277112|NCT01872988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101277113|NCT01872988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101277114|NCT01872988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101277115|NCT01872988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277116|NCT01872988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101277117|NCT01872988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101277118|NCT01873001|Pioglitazone|pioglitazone|mesh-list
101277119|NCT01873001|Abiraterone Acetate|abiraterone acetate|mesh-list
101277120|NCT01873001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101408275|NCT00451828|Simvastatin|simvastatin|mesh-list
101277121|NCT01873001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277122|NCT01873001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101277123|NCT01873001|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101277124|NCT01873001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101277125|NCT01873001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277126|NCT01873001|Hormone Antagonists|hormone antagonists|mesh-ancestor
101277127|NCT01873001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101277128|NCT01873001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101277129|NCT01873027|Sirolimus|sirolimus|mesh-list
101277130|NCT01873027|Umirolimus|umirolimus|mesh-list
101277131|NCT01873027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101277132|NCT01873027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101277133|NCT01873027|Immunologic Factors|immunologic factors|mesh-ancestor
101277134|NCT01873027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277135|NCT01873027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101277136|NCT01873027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101277137|NCT01873027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101277138|NCT01873027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101277139|NCT01873027|Antifungal Agents|antifungal agents|mesh-ancestor
101277140|NCT01873079|Esomeprazole|esomeprazole|mesh-list
101277141|NCT01873079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101277142|NCT01873079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101277143|NCT01873079|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101277144|NCT01873079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101277145|NCT01873079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277147|NCT05855746|Gout Suppressants|gout suppressants|mesh-ancestor
101277148|NCT05855746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101277149|NCT05855746|Tubulin Modulators|tubulin modulators|mesh-ancestor
101277150|NCT05855746|Antimitotic Agents|antimitotic agents|mesh-ancestor
101277151|NCT05855746|Mitosis Modulators|mitosis modulators|mesh-ancestor
101277152|NCT05855746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277153|NCT05855746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101277154|NCT05855629|Inositol|inositol|mesh-list
101277155|NCT05855629|Adapalene|adapalene|mesh-list
101277156|NCT05855629|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101277157|NCT05855629|Dermatologic Agents|dermatologic agents|mesh-ancestor
101277158|NCT05855629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101277159|NCT05855629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101818433|NCT00811421|Antimalarials|antimalarials|mesh-ancestor
101818434|NCT00811421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101818435|NCT00811421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101818436|NCT00811421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101818437|NCT00811421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101818438|NCT00811421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101818439|NCT00811421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818440|NCT00811421|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101818442|NCT00569777|Antipruritics|antipruritics|mesh-ancestor
101818443|NCT00569777|Dermatologic Agents|dermatologic agents|mesh-ancestor
101818444|NCT00569777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101818445|NCT00569777|Histamine Antagonists|histamine antagonists|mesh-ancestor
101818446|NCT00569777|Histamine Agents|histamine agents|mesh-ancestor
101818447|NCT00569777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101818448|NCT00569777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818449|NCT00569777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277160|NCT05855629|Analgesics|analgesics|mesh-ancestor
101277161|NCT05855629|Sensory System Agents|sensory system agents|mesh-ancestor
101277162|NCT05855629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101277163|NCT05855629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277164|NCT05855629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101277165|NCT05855629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101277166|NCT05855629|Vitamin B Complex|vitamin b complex|mesh-ancestor
101277167|NCT05855629|Vitamins|vitamins|mesh-ancestor
101277168|NCT05855629|Micronutrients|micronutrients|mesh-ancestor
101277169|NCT05855616|Chlorhexidine|chlorhexidine|mesh-list
101277170|NCT05855616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101277171|NCT05855616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101277172|NCT05855616|Disinfectants|disinfectants|mesh-ancestor
101277173|NCT05855590|Tranexamic Acid|tranexamic acid|mesh-list
101277174|NCT05855590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101277175|NCT05855590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101277176|NCT05855590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277177|NCT05855590|Hemostatics|hemostatics|mesh-ancestor
101277178|NCT05855590|Coagulants|coagulants|mesh-ancestor
101277179|NCT05855577|Terazosin|terazosin|mesh-list
101277180|NCT05855577|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101277181|NCT05855577|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101277182|NCT05855577|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101277183|NCT05855577|Adrenergic Agents|adrenergic agents|mesh-ancestor
101277184|NCT05855577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101277185|NCT05855577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277186|NCT05855577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277187|NCT05855577|Urological Agents|urological agents|mesh-ancestor
101277188|NCT05855486|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101277189|NCT05855486|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101277191|NCT05855187|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101277192|NCT05855187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277193|NCT05855187|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101277194|NCT05855187|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101277195|NCT05855187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101277196|NCT05855187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277197|NCT05855070|Verapamil|verapamil|mesh-list
101277198|NCT05855070|Hyaluronic Acid|hyaluronic acid|mesh-list
101277199|NCT05855070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101277200|NCT05855070|Immunologic Factors|immunologic factors|mesh-ancestor
101818450|NCT00569777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101818451|NCT00654095|Atorvastatin|atorvastatin|mesh-list
101818452|NCT00654095|Ezetimibe|ezetimibe|mesh-list
101818453|NCT00654095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101818454|NCT00654095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101818455|NCT00654095|Antimetabolites|antimetabolites|mesh-ancestor
101277201|NCT05855070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277203|NCT05855070|Protective Agents|protective agents|mesh-ancestor
101277204|NCT05855070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101277205|NCT05855070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101277206|NCT05855070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101277207|NCT05855070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277208|NCT05855070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101277209|NCT05855070|Vasodilator Agents|vasodilator agents|mesh-ancestor
101277211|NCT05855018|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101277212|NCT05855018|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101277213|NCT05855018|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101277214|NCT05855018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101277215|NCT05855018|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101277216|NCT05855018|Autonomic Agents|autonomic agents|mesh-ancestor
101277217|NCT05855018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101277218|NCT05855018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277219|NCT05855018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101277220|NCT05855018|Respiratory System Agents|respiratory system agents|mesh-ancestor
101277221|NCT05855018|Mydriatics|mydriatics|mesh-ancestor
101277222|NCT05855018|Parasympatholytics|parasympatholytics|mesh-ancestor
101277223|NCT05855018|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101277224|NCT05855018|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101277225|NCT05855018|Cholinergic Agents|cholinergic agents|mesh-ancestor
101277226|NCT05855018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101277227|NCT05855018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277228|NCT05854992|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
101277229|NCT05854992|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101277230|NCT05854992|Serotonin Agents|serotonin agents|mesh-ancestor
101277231|NCT05854992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101277232|NCT05854992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277233|NCT05854992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277234|NCT05854849|Gemcitabine|gemcitabine|mesh-list
101277235|NCT05854849|Apatinib|apatinib|mesh-list
101277236|NCT05854849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101277237|NCT05854849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101277238|NCT05854849|Antimetabolites|antimetabolites|mesh-ancestor
101277239|NCT05854849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277240|NCT05854849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101277241|NCT05854849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101277242|NCT05854667|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101277243|NCT05854667|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101277244|NCT05854667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277245|NCT05854667|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101277246|NCT05854667|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101277247|NCT05854667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101277248|NCT05854667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277249|NCT05854667|Dopamine Agents|dopamine agents|mesh-ancestor
101277250|NCT05854667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101277251|NCT05854537|Lidocaine|lidocaine|mesh-list
101277252|NCT05854537|Bupivacaine|bupivacaine|mesh-list
101277253|NCT05854537|Anesthetics, Local|anesthetics, local|mesh-ancestor
101277254|NCT05854537|Anesthetics|anesthetics|mesh-ancestor
101277255|NCT05854537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101277256|NCT05854537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277257|NCT05854537|Sensory System Agents|sensory system agents|mesh-ancestor
101277258|NCT05854537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101277259|NCT05854537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101277260|NCT05854537|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101277262|NCT05854537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101277263|NCT05854537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818456|NCT00654095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818457|NCT00654095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101818458|NCT00654095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101818459|NCT00654095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101818461|NCT00811967|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101818462|NCT00811967|Interferon-alpha|interferon-alpha|mesh-list
101818463|NCT00811967|Antimetabolites|antimetabolites|mesh-ancestor
101818464|NCT00811967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818465|NCT00811967|Antiviral Agents|antiviral agents|mesh-ancestor
101818466|NCT00811967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101818467|NCT00811967|Immunologic Factors|immunologic factors|mesh-ancestor
101818468|NCT00811967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818469|NCT04046159|Tamoxifen|tamoxifen|mesh-list
101818470|NCT04046159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101818471|NCT04046159|Hormone Antagonists|hormone antagonists|mesh-ancestor
101818472|NCT04046159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101277264|NCT05854511|Sofosbuvir|sofosbuvir|mesh-list
101277265|NCT05854511|Antiviral Agents|antiviral agents|mesh-ancestor
101277266|NCT05854511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101277267|NCT05854342|Calcium|calcium|mesh-list
101277268|NCT05854342|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101277269|NCT05854342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277270|NCT05854225|Thiotepa|thiotepa|mesh-list
101277271|NCT05854225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101277272|NCT05854225|Alkylating Agents|alkylating agents|mesh-ancestor
101277273|NCT05854225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277274|NCT05854225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101277275|NCT05854225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101277276|NCT05854225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101277277|NCT05854225|Immunologic Factors|immunologic factors|mesh-ancestor
101277278|NCT05854225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277279|NCT05854082|Lidocaine|lidocaine|mesh-list
101277280|NCT05854082|Anesthetics, Local|anesthetics, local|mesh-ancestor
101277281|NCT05854082|Anesthetics|anesthetics|mesh-ancestor
101277282|NCT05854082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101277283|NCT05854082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277284|NCT05854082|Sensory System Agents|sensory system agents|mesh-ancestor
101277285|NCT05854082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101277286|NCT05854082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101277287|NCT05854082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101277288|NCT05854082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101277289|NCT05854082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101277290|NCT05854082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277292|NCT05853965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101277293|NCT05853718|Tenofovir|tenofovir|mesh-list
101277294|NCT05853718|Antiviral Agents|antiviral agents|mesh-ancestor
101277295|NCT05853718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101277296|NCT05853718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101277297|NCT05853718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101277298|NCT05853718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101277299|NCT05853718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277300|NCT05853718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101277301|NCT05853718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101277302|NCT05853627|Propranolol|propranolol|mesh-list
101818473|NCT04046159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818474|NCT04046159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101818476|NCT04046159|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101818477|NCT04046159|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101818478|NCT04046159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101818479|NCT00653939|Paclitaxel|paclitaxel|mesh-list
101818480|NCT00653939|Fosbretabulin|fosbretabulin|mesh-list
101818481|NCT00653939|Combretastatin|combretastatin|mesh-list
101818482|NCT00653939|Bevacizumab|bevacizumab|mesh-list
101818483|NCT00653939|Carboplatin|carboplatin|mesh-list
101818484|NCT00653939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101818485|NCT00653939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101818486|NCT00653939|Tubulin Modulators|tubulin modulators|mesh-ancestor
101818487|NCT00653939|Antimitotic Agents|antimitotic agents|mesh-ancestor
101818488|NCT00653939|Mitosis Modulators|mitosis modulators|mesh-ancestor
101277303|NCT05853627|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101277304|NCT05853627|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101277305|NCT05853627|Adrenergic Agents|adrenergic agents|mesh-ancestor
101277306|NCT05853627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101277307|NCT05853627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277308|NCT05853627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277309|NCT05853627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101277310|NCT05853627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101277311|NCT05853627|Vasodilator Agents|vasodilator agents|mesh-ancestor
101277312|NCT05853601|Theophylline|theophylline|mesh-list
101277313|NCT05853601|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101277314|NCT05853601|Autonomic Agents|autonomic agents|mesh-ancestor
101277315|NCT05853601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101277316|NCT05853601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277317|NCT05853601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101277318|NCT05853601|Respiratory System Agents|respiratory system agents|mesh-ancestor
101277319|NCT05853601|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101277320|NCT05853601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101277321|NCT05853601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277322|NCT05853601|Vasodilator Agents|vasodilator agents|mesh-ancestor
101277323|NCT05853601|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101277324|NCT05853601|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101277325|NCT05853601|Purinergic Agents|purinergic agents|mesh-ancestor
101277326|NCT05853601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101277327|NCT05852730|Promethazine|promethazine|mesh-list
101277328|NCT05852730|Diphenhydramine|diphenhydramine|mesh-list
101277329|NCT05852730|Meclizine|meclizine|mesh-list
101277330|NCT05852730|Scopolamine|scopolamine|mesh-list
101277331|NCT05852730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101277332|NCT05852730|Antiemetics|antiemetics|mesh-ancestor
101277333|NCT05852730|Autonomic Agents|autonomic agents|mesh-ancestor
101277334|NCT05852730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101277335|NCT05852730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277336|NCT05852730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101277337|NCT05852730|Mydriatics|mydriatics|mesh-ancestor
101277338|NCT05852730|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101277339|NCT05852730|Cholinergic Agents|cholinergic agents|mesh-ancestor
101277340|NCT05852730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101534741|NCT00570050|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101277341|NCT05852730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277342|NCT05852730|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101277343|NCT05852730|Antipruritics|antipruritics|mesh-ancestor
101277344|NCT05852730|Dermatologic Agents|dermatologic agents|mesh-ancestor
101277345|NCT05852730|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101277346|NCT05852730|Histamine Antagonists|histamine antagonists|mesh-ancestor
101818489|NCT00653939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818490|NCT00653939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101818491|NCT00653939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101818492|NCT00653939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101818493|NCT00653939|Growth Substances|growth substances|mesh-ancestor
101818494|NCT00653939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818495|NCT00653939|Growth Inhibitors|growth inhibitors|mesh-ancestor
101818496|NCT00812123|Cyclosporine|cyclosporine|mesh-list
101818497|NCT00812123|Sirolimus|sirolimus|mesh-list
101818498|NCT00812123|Mycophenolic Acid|mycophenolic acid|mesh-list
101818499|NCT00812123|Prednisone|prednisone|mesh-list
101277347|NCT05852730|Histamine Agents|histamine agents|mesh-ancestor
101277348|NCT05852730|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101277349|NCT05852730|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101277350|NCT05852730|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101277351|NCT05852730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101277352|NCT05852730|Anesthetics, Local|anesthetics, local|mesh-ancestor
101277353|NCT05852730|Anesthetics|anesthetics|mesh-ancestor
101277354|NCT05852730|Sensory System Agents|sensory system agents|mesh-ancestor
101277355|NCT05852041|Fluorides|fluorides|mesh-list
101277356|NCT05852041|Cariostatic Agents|cariostatic agents|mesh-ancestor
101277357|NCT05852041|Protective Agents|protective agents|mesh-ancestor
101277358|NCT05852041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277359|NCT05845489|Anticoagulants|anticoagulants|mesh-list
101277360|NCT05845489|Clopidogrel|clopidogrel|mesh-list
101277361|NCT05845489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101277362|NCT05845489|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101277363|NCT05845489|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101277364|NCT05845489|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101277365|NCT05845489|Purinergic Agents|purinergic agents|mesh-ancestor
101277366|NCT05845489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101277367|NCT05845489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277368|NCT05845489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277369|NCT05826873|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101277370|NCT05826873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101277371|NCT05823532|Infliximab|infliximab|mesh-list
101277372|NCT05823532|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101277373|NCT05823532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101277374|NCT05823532|Dermatologic Agents|dermatologic agents|mesh-ancestor
101277375|NCT05823532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101277376|NCT05823532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101277377|NCT05815602|Mebeverine|mebeverine|mesh-list
101277378|NCT05815602|Ebastine|ebastine|mesh-list
101277379|NCT05815602|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101277380|NCT05815602|Histamine Antagonists|histamine antagonists|mesh-ancestor
101277381|NCT05815602|Histamine Agents|histamine agents|mesh-ancestor
101277382|NCT05815602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101277383|NCT05815602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277384|NCT05815602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277385|NCT05815602|Anticonvulsants|anticonvulsants|mesh-ancestor
101277386|NCT05815602|Parasympatholytics|parasympatholytics|mesh-ancestor
101277387|NCT05815602|Autonomic Agents|autonomic agents|mesh-ancestor
101277388|NCT05815602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101277389|NCT05755737|Ondansetron|ondansetron|mesh-list
101277390|NCT05755737|Antiemetics|antiemetics|mesh-ancestor
101277391|NCT05755737|Autonomic Agents|autonomic agents|mesh-ancestor
101277392|NCT05755737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101277393|NCT05755737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277394|NCT05755737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101277395|NCT05755737|Antipruritics|antipruritics|mesh-ancestor
101277396|NCT05755737|Dermatologic Agents|dermatologic agents|mesh-ancestor
101277397|NCT05755737|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101277398|NCT05755737|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101277399|NCT05755737|Serotonin Agents|serotonin agents|mesh-ancestor
101277400|NCT05755737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101818500|NCT00812123|Cyclosporins|cyclosporins|mesh-list
101818501|NCT00812123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101818502|NCT00812123|Glucocorticoids|glucocorticoids|mesh-ancestor
101818503|NCT00812123|Hormones|hormones|mesh-ancestor
101818504|NCT00812123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101818505|NCT00812123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277401|NCT05755737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277402|NCT05739292|Vaccines|vaccines|mesh-list
101277403|NCT05739292|Immunologic Factors|immunologic factors|mesh-ancestor
101277404|NCT05739292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277405|NCT05736952|Topotecan|topotecan|mesh-list
101277406|NCT05736952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101277407|NCT05736952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101277408|NCT05736952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101277409|NCT05736952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277410|NCT05736952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101277411|NCT05732506|Edoxaban|edoxaban|mesh-list
101277412|NCT05732506|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101277413|NCT05732506|Antithrombins|antithrombins|mesh-ancestor
101277414|NCT05732506|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101277415|NCT05732506|Protease Inhibitors|protease inhibitors|mesh-ancestor
101277416|NCT05732506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101277417|NCT05732506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277418|NCT05732506|Anticoagulants|anticoagulants|mesh-ancestor
101277419|NCT05674656|Dolutegravir|dolutegravir|mesh-list
101277420|NCT05674656|Rilpivirine|rilpivirine|mesh-list
101277421|NCT05674656|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
101277422|NCT05674656|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101277423|NCT05674656|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101277424|NCT05674656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101277425|NCT05674656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277426|NCT05674656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101277427|NCT05674656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101277428|NCT05674656|Antiviral Agents|antiviral agents|mesh-ancestor
101277429|NCT05674656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101277430|NCT05674656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101277431|NCT05674656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101277432|NCT05664789|Acetylcysteine|acetylcysteine|mesh-list
101277433|NCT05664789|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101277434|NCT05664789|Antiviral Agents|antiviral agents|mesh-ancestor
101277435|NCT05664789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101277436|NCT05664789|Expectorants|expectorants|mesh-ancestor
101277437|NCT05664789|Respiratory System Agents|respiratory system agents|mesh-ancestor
101277438|NCT05664789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101277439|NCT05664789|Antioxidants|antioxidants|mesh-ancestor
101277440|NCT05664789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277441|NCT05664789|Protective Agents|protective agents|mesh-ancestor
101277442|NCT05664789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277443|NCT05664789|Antidotes|antidotes|mesh-ancestor
101277444|NCT05656443|Ritonavir|ritonavir|mesh-list
101277445|NCT05656443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101277446|NCT05656443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101277447|NCT05656443|Protease Inhibitors|protease inhibitors|mesh-ancestor
101277448|NCT05656443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101277449|NCT05656443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277450|NCT05656443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101534744|NCT00570245|Nitric Oxide|nitric oxide|mesh-list
101277451|NCT05656443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101277452|NCT05656443|Antiviral Agents|antiviral agents|mesh-ancestor
101277453|NCT05656443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101277454|NCT05656443|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101314631|NCT00001075|Protease Inhibitors|protease inhibitors|mesh-ancestor
101277455|NCT05656443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101277457|NCT05651633|Anesthetics, Local|anesthetics, local|mesh-ancestor
101277458|NCT05651633|Anesthetics|anesthetics|mesh-ancestor
101277459|NCT05651633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101277460|NCT05651633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277461|NCT05651633|Sensory System Agents|sensory system agents|mesh-ancestor
101818506|NCT00812123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101312417|NCT00007878|Leucovorin|leucovorin|mesh-list
101818508|NCT00812123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101818509|NCT00812123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818510|NCT00812123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101818511|NCT00812123|Immunologic Factors|immunologic factors|mesh-ancestor
101277462|NCT05651633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101277463|NCT05651633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101277464|NCT05651633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101277465|NCT05651633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101277466|NCT05651633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101277467|NCT05651633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277468|NCT05648448|Oseltamivir|oseltamivir|mesh-list
101277469|NCT05648448|Favipiravir|favipiravir|mesh-list
101277470|NCT05648448|Zanamivir|zanamivir|mesh-list
101277471|NCT05648448|Molnupiravir|molnupiravir|mesh-list
101277472|NCT05648448|Peramivir|peramivir|mesh-list
101277473|NCT05648448|Baloxavir|baloxavir|mesh-list
101277474|NCT05648448|Laninamivir|laninamivir|mesh-list
101277475|NCT05648448|Antiviral Agents|antiviral agents|mesh-ancestor
101277476|NCT05648448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101277477|NCT05648448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101277478|NCT05648448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277479|NCT05641064|Dexmedetomidine|dexmedetomidine|mesh-list
101277480|NCT05641064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101277481|NCT05641064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101277482|NCT05641064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277483|NCT05641064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101277484|NCT05641064|Analgesics|analgesics|mesh-ancestor
101277485|NCT05641064|Sensory System Agents|sensory system agents|mesh-ancestor
101277486|NCT05641064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101277487|NCT05641064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101277488|NCT05641064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101277489|NCT05641064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101277490|NCT05641064|Adrenergic Agents|adrenergic agents|mesh-ancestor
101277491|NCT05641064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101277492|NCT05641064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277493|NCT05634967|Ofatumumab|ofatumumab|mesh-list
101277494|NCT05634967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101277495|NCT05625776|Capsaicin|capsaicin|mesh-list
101277496|NCT05625776|Antipruritics|antipruritics|mesh-ancestor
101277497|NCT05625776|Dermatologic Agents|dermatologic agents|mesh-ancestor
101277498|NCT05625776|Sensory System Agents|sensory system agents|mesh-ancestor
101277499|NCT05625776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101277500|NCT05625776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277501|NCT05563558|Carboplatin|carboplatin|mesh-list
101277502|NCT05563558|Pembrolizumab|pembrolizumab|mesh-list
101277503|NCT05563558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101277504|NCT05563558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101277505|NCT05563558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101277506|NCT05563558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277507|NCT05557838|Durvalumab|durvalumab|mesh-list
101277508|NCT05557838|Tremelimumab|tremelimumab|mesh-list
101277509|NCT05557838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101277510|NCT05557838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101277511|NCT05545735|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101277512|NCT05545735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101277513|NCT05531994|Montelukast|montelukast|mesh-list
101277514|NCT05531994|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101408333|NCT00143130|Pregabalin|pregabalin|mesh-list
101277515|NCT05531994|Respiratory System Agents|respiratory system agents|mesh-ancestor
101277517|NCT05531994|Hormone Antagonists|hormone antagonists|mesh-ancestor
101277518|NCT05531994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101277519|NCT05531994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314645|NCT00001084|Stavudine|stavudine|mesh-list
101277520|NCT05531994|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101818512|NCT00812123|Antifungal Agents|antifungal agents|mesh-ancestor
101818513|NCT00812123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101818514|NCT00812123|Dermatologic Agents|dermatologic agents|mesh-ancestor
101818515|NCT00812123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101818516|NCT00812123|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101818517|NCT00812123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101277521|NCT05531994|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101277522|NCT05531994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277524|NCT05528718|Nitrous Oxide|nitrous oxide|mesh-list
101277525|NCT05528718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101277526|NCT05528718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101277527|NCT05528718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101277528|NCT05528718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277529|NCT05528718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101277530|NCT05528718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101277531|NCT05528718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101277532|NCT05528718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101277533|NCT05528718|Anesthetics, General|anesthetics, general|mesh-ancestor
101277534|NCT05528718|Anesthetics|anesthetics|mesh-ancestor
101277535|NCT05528718|GABA Modulators|gaba modulators|mesh-ancestor
101277536|NCT05528718|GABA Agents|gaba agents|mesh-ancestor
101277537|NCT05528718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101277538|NCT05528718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277539|NCT05528718|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101277540|NCT05528718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101277541|NCT05528718|Analgesics|analgesics|mesh-ancestor
101277542|NCT05528718|Sensory System Agents|sensory system agents|mesh-ancestor
101277543|NCT05528718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101277544|NCT05528198|Montelukast|montelukast|mesh-list
101277545|NCT05528198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101277546|NCT05528198|Respiratory System Agents|respiratory system agents|mesh-ancestor
101277547|NCT05528198|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101277548|NCT05528198|Hormone Antagonists|hormone antagonists|mesh-ancestor
101277549|NCT05528198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101277550|NCT05528198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277551|NCT05528198|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101277552|NCT05528198|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101277553|NCT05528198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277554|NCT05514899|Dronabinol|dronabinol|mesh-list
101277555|NCT05514899|Cannabidiol|cannabidiol|mesh-list
101277556|NCT05514899|Anticonvulsants|anticonvulsants|mesh-ancestor
101277557|NCT05514899|Hallucinogens|hallucinogens|mesh-ancestor
101277558|NCT05514899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277559|NCT05514899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101277560|NCT05514899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101277561|NCT05514899|Analgesics|analgesics|mesh-ancestor
101277562|NCT05514899|Sensory System Agents|sensory system agents|mesh-ancestor
101277563|NCT05514899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101277564|NCT05514899|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101277565|NCT05514899|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101277566|NCT05514899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101277567|NCT05514899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277568|NCT05514899|Hormones|hormones|mesh-ancestor
101277569|NCT05514899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101277570|NCT05458401|Trastuzumab|trastuzumab|mesh-list
101277571|NCT05458401|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
101277572|NCT05458401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101277573|NCT05458401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101277574|NCT05458401|Immunoconjugates|immunoconjugates|mesh-ancestor
101277575|NCT05458401|Immunologic Factors|immunologic factors|mesh-ancestor
101277576|NCT05458401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277577|NCT05458375|Estradiol|estradiol|mesh-list
101277578|NCT05458375|Estrogens|estrogens|mesh-ancestor
101277579|NCT05458375|Hormones|hormones|mesh-ancestor
101277580|NCT05458375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101277582|NCT05420584|Tislelizumab|tislelizumab|mesh-list
101314656|NCT00001084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101818518|NCT00812123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101818519|NCT00812123|Antitubercular Agents|antitubercular agents|mesh-ancestor
101818520|NCT00812123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101818521|NCT00646451|Pregabalin|pregabalin|mesh-list
101818522|NCT00646451|Analgesics|analgesics|mesh-ancestor
101818523|NCT00646451|Sensory System Agents|sensory system agents|mesh-ancestor
101818524|NCT00646451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101818525|NCT00646451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277583|NCT05420584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101277584|NCT05420584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101277585|NCT05416580|Metformin|metformin|mesh-list
101277586|NCT05416580|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101277587|NCT05416580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101277588|NCT05416580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277589|NCT05416580|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101277590|NCT05416580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101277591|NCT05413980|Moxifloxacin|moxifloxacin|mesh-list
101277592|NCT05413980|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101277593|NCT05413980|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101277594|NCT05413980|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101277595|NCT05413980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101277596|NCT05413980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101277597|NCT05413980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101277598|NCT05413980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101277599|NCT05413980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101277600|NCT05413980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277601|NCT05413980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101277602|NCT05413980|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101277603|NCT05413980|Contraceptive Agents|contraceptive agents|mesh-ancestor
101277604|NCT05413980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101277605|NCT05413980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277606|NCT05413980|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101277607|NCT05413980|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101277608|NCT05413980|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101277609|NCT05413551|Isoniazid|isoniazid|mesh-list
101277610|NCT05413551|Antitubercular Agents|antitubercular agents|mesh-ancestor
101277611|NCT05413551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101277612|NCT05413551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101277613|NCT05413551|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101277614|NCT05413551|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101277615|NCT05413551|Antimetabolites|antimetabolites|mesh-ancestor
101277616|NCT05413551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277617|NCT05413551|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101277618|NCT05385406|Acetic Acid|acetic acid|mesh-list
101277619|NCT05385406|Retinol acetate|retinol acetate|mesh-list
101277620|NCT05385406|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101277621|NCT05385406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101277622|NCT05385406|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101277623|NCT05385406|Immunologic Factors|immunologic factors|mesh-ancestor
101277624|NCT05385406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277625|NCT05385406|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101277626|NCT05385406|Protective Agents|protective agents|mesh-ancestor
101277627|NCT05385406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101277628|NCT05375760|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
101277629|NCT05375760|Antiviral Agents|antiviral agents|mesh-ancestor
101277630|NCT05375760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101277631|NCT05357547|Buspirone|buspirone|mesh-list
101277632|NCT05357547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101277633|NCT05357547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101277634|NCT05357547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101277635|NCT05357547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277636|NCT05357547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101277637|NCT05357547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101277638|NCT05357547|Serotonin Agents|serotonin agents|mesh-ancestor
101277639|NCT05357547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101277640|NCT05357547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818526|NCT00646451|Anticonvulsants|anticonvulsants|mesh-ancestor
101818527|NCT00646451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101818528|NCT00646451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101818529|NCT00646451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818530|NCT00646451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101818531|NCT00646451|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101818532|NCT00646451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101818533|NCT00646451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101818534|NCT00646451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101277641|NCT05344833|Lenalidomide|lenalidomide|mesh-list
101277642|NCT05344833|Immunologic Factors|immunologic factors|mesh-ancestor
101277643|NCT05344833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277644|NCT05344833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101277645|NCT05344833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101277646|NCT05344833|Growth Substances|growth substances|mesh-ancestor
101277647|NCT05344833|Growth Inhibitors|growth inhibitors|mesh-ancestor
101277648|NCT05344833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101277649|NCT05323838|Complement System Proteins|complement system proteins|mesh-list
101277650|NCT05323838|Immunologic Factors|immunologic factors|mesh-ancestor
101277651|NCT05323838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277653|NCT05302999|Analgesics|analgesics|mesh-ancestor
101277654|NCT05302999|Sensory System Agents|sensory system agents|mesh-ancestor
101277655|NCT05302999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101277656|NCT05302999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277657|NCT05302999|Anticonvulsants|anticonvulsants|mesh-ancestor
101277658|NCT05302999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101277659|NCT05302999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101277660|NCT05302999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101277661|NCT05302999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101277662|NCT05302999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101277663|NCT05302999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101277664|NCT05302999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101277665|NCT05302999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277668|NCT05294965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101277669|NCT05294965|Autonomic Agents|autonomic agents|mesh-ancestor
101277670|NCT05294965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101277671|NCT05294965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277672|NCT05294965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101277673|NCT05294965|Respiratory System Agents|respiratory system agents|mesh-ancestor
101277674|NCT05294965|Sympathomimetics|sympathomimetics|mesh-ancestor
101277675|NCT05294965|Tocolytic Agents|tocolytic agents|mesh-ancestor
101277676|NCT05294965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101277677|NCT05294965|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101277678|NCT05294965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101277679|NCT05294965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101277680|NCT05294965|Adrenergic Agents|adrenergic agents|mesh-ancestor
101277681|NCT05294965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101277682|NCT05294965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277683|NCT05265806|Oxytocin|oxytocin|mesh-list
101277684|NCT05265806|Oxytocics|oxytocics|mesh-ancestor
101534746|NCT00570245|Autonomic Agents|autonomic agents|mesh-ancestor
101277685|NCT05265806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101277686|NCT05265806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277687|NCT05252585|Everolimus|everolimus|mesh-list
101277688|NCT05252585|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101277689|NCT05252585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101277690|NCT05252585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101277691|NCT05252585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277692|NCT05252585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101277693|NCT05252585|Immunologic Factors|immunologic factors|mesh-ancestor
101277694|NCT05252585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277695|NCT05252585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101277696|NCT05242419|Huperzine A|huperzine a|mesh-list
101277697|NCT05242419|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101818536|NCT00809237|Gefitinib|gefitinib|mesh-list
101818537|NCT00809237|Antimalarials|antimalarials|mesh-ancestor
101818538|NCT00809237|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101818539|NCT00809237|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101818540|NCT00809237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101818541|NCT00809237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101818542|NCT00809237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818543|NCT00809237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101818544|NCT00809237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101818545|NCT00809237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101818546|NCT00817583|Docetaxel|docetaxel|mesh-list
101818547|NCT00817583|Fluorouracil|fluorouracil|mesh-list
101818548|NCT00817583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101818549|NCT00817583|Tubulin Modulators|tubulin modulators|mesh-ancestor
101818550|NCT00817583|Antimitotic Agents|antimitotic agents|mesh-ancestor
101818551|NCT00817583|Mitosis Modulators|mitosis modulators|mesh-ancestor
101277698|NCT05242419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101277699|NCT05242419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277700|NCT05242419|Cholinergic Agents|cholinergic agents|mesh-ancestor
101277701|NCT05242419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101277702|NCT05242419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277703|NCT05242419|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101277704|NCT05242419|Protective Agents|protective agents|mesh-ancestor
101277705|NCT05232227|Primaquine|primaquine|mesh-list
101277706|NCT05232227|Antimalarials|antimalarials|mesh-ancestor
101277707|NCT05232227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101277709|NCT05232227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101277710|NCT05225363|Cyclophosphamide|cyclophosphamide|mesh-list
101277711|NCT05225363|Fludarabine|fludarabine|mesh-list
101277712|NCT05225363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101277713|NCT05225363|Immunologic Factors|immunologic factors|mesh-ancestor
101277714|NCT05225363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277715|NCT05225363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101277716|NCT05225363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101277717|NCT05225363|Alkylating Agents|alkylating agents|mesh-ancestor
101277718|NCT05225363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277719|NCT05225363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101277720|NCT05225363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101277721|NCT05221229|Liraglutide|liraglutide|mesh-list
101277722|NCT05221229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101277723|NCT05221229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277724|NCT05221229|Incretins|incretins|mesh-ancestor
101277725|NCT05221229|Hormones|hormones|mesh-ancestor
101277726|NCT05221229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101277727|NCT05216432|Fulvestrant|fulvestrant|mesh-list
101277728|NCT05216432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101277729|NCT05216432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101277730|NCT05216432|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101277731|NCT05216432|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101277732|NCT05216432|Hormone Antagonists|hormone antagonists|mesh-ancestor
101277733|NCT05216432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101277734|NCT05216432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277735|NCT05184842|Decitabine|decitabine|mesh-list
101277736|NCT05184842|Venetoclax|venetoclax|mesh-list
101277737|NCT05184842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101277738|NCT05184842|Antimetabolites|antimetabolites|mesh-ancestor
101277739|NCT05184842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408367|NCT00143169|Analgesics|analgesics|mesh-ancestor
101818552|NCT00817583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818553|NCT00817583|Antimetabolites|antimetabolites|mesh-ancestor
101818554|NCT00817583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101818555|NCT00817583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101818556|NCT00817583|Immunologic Factors|immunologic factors|mesh-ancestor
101818557|NCT00817583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277740|NCT05184842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101277741|NCT05184842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101277743|NCT05139420|Phentermine|phentermine|mesh-list
101277744|NCT05139420|Anticonvulsants|anticonvulsants|mesh-ancestor
101277745|NCT05139420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101277746|NCT05139420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277747|NCT05139420|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101277748|NCT05139420|Appetite Depressants|appetite depressants|mesh-ancestor
101277749|NCT05139420|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101277750|NCT05139420|Sympathomimetics|sympathomimetics|mesh-ancestor
101277751|NCT05139420|Autonomic Agents|autonomic agents|mesh-ancestor
101277752|NCT05139420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101277753|NCT05139420|Adrenergic Agents|adrenergic agents|mesh-ancestor
101277754|NCT05139420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101277755|NCT05139420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277756|NCT05135650|Sotrovimab|sotrovimab|mesh-list
101277757|NCT05135650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101277758|NCT05135650|Antibodies|antibodies|mesh-list
101277759|NCT05135650|Immunoglobulins|immunoglobulins|mesh-list
101277760|NCT05135650|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101277761|NCT05135650|Immunologic Factors|immunologic factors|mesh-ancestor
101277762|NCT05135650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277763|NCT05135650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101277764|NCT05135650|Antiviral Agents|antiviral agents|mesh-ancestor
101277765|NCT05135650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101277766|NCT05073822|Mycophenolic Acid|mycophenolic acid|mesh-list
101277767|NCT05073822|Tacrolimus|tacrolimus|mesh-list
101277768|NCT05073822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101277769|NCT05073822|Immunologic Factors|immunologic factors|mesh-ancestor
101277770|NCT05073822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277771|NCT05073822|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101277772|NCT05073822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101277773|NCT05073822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277774|NCT05073822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101277776|NCT05073822|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101277777|NCT05073822|Antitubercular Agents|antitubercular agents|mesh-ancestor
101277778|NCT05073822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101277779|NCT05073822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101277780|NCT05047952|Vortioxetine|vortioxetine|mesh-list
101277781|NCT05047952|Antidepressive Agents|antidepressive agents|mesh-ancestor
101277782|NCT05047952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101277783|NCT05047952|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101277784|NCT05047952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101277785|NCT05047952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101277786|NCT05047952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277787|NCT05047952|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101277788|NCT05047952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101277789|NCT05047952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101277790|NCT05047952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277791|NCT05047952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101277792|NCT05047952|Serotonin Agents|serotonin agents|mesh-ancestor
101277793|NCT05047952|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101277794|NCT05047952|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101277795|NCT05047952|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101277796|NCT05047952|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101277797|NCT05001828|Azacitidine|azacitidine|mesh-list
101277798|NCT05001828|Venetoclax|venetoclax|mesh-list
101277799|NCT05001828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101818560|NCT00817661|Micronutrients|micronutrients|mesh-ancestor
101818561|NCT00817661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818562|NCT00642707|Leronlimab|leronlimab|mesh-list
101818563|NCT00642707|Antibodies|antibodies|mesh-list
101818564|NCT00642707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101818565|NCT00642707|Immunologic Factors|immunologic factors|mesh-ancestor
101277800|NCT05001828|Antimetabolites|antimetabolites|mesh-ancestor
101277801|NCT05001828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277802|NCT05001828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101277803|NCT05001828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101277805|NCT04965454|Lipotropic Agents|lipotropic agents|mesh-ancestor
101277806|NCT04965454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101277807|NCT04965454|Antimetabolites|antimetabolites|mesh-ancestor
101277808|NCT04965454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277809|NCT04965454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101277810|NCT04965454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101277811|NCT04965454|Nootropic Agents|nootropic agents|mesh-ancestor
101277812|NCT04957615|Nivolumab|nivolumab|mesh-list
101277813|NCT04957615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101277814|NCT04957615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101277815|NCT04957615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101277816|NCT04957615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277817|NCT04933552|Siponimod|siponimod|mesh-list
101277818|NCT04933552|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101277819|NCT04933552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277820|NCT04933552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101277821|NCT04933552|Immunologic Factors|immunologic factors|mesh-ancestor
101277822|NCT04933552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277823|NCT04917484|Octreotide|octreotide|mesh-list
101277824|NCT04917484|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
101277825|NCT04917484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101277826|NCT04917484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101277827|NCT04917484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101277828|NCT04917484|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101277829|NCT04917484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277830|NCT04916613|Androgens|androgens|mesh-list
101277831|NCT04916613|Hormones|hormones|mesh-ancestor
101277832|NCT04916613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101277833|NCT04916613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277834|NCT04893525|Buprenorphine|buprenorphine|mesh-list
101277835|NCT04893525|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101277836|NCT04893525|Naloxone|naloxone|mesh-list
101277837|NCT04893525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101277838|NCT04893525|Narcotics|narcotics|mesh-ancestor
101277839|NCT04893525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101277840|NCT04893525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277842|NCT04893525|Sensory System Agents|sensory system agents|mesh-ancestor
101277843|NCT04893525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101277844|NCT04893525|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101277845|NCT04865848|Anesthetics|anesthetics|mesh-list
101277846|NCT04865848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101277847|NCT04865848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277848|NCT04859322|Glucagon|glucagon|mesh-list
101277849|NCT04859322|Somatostatin|somatostatin|mesh-list
101277850|NCT04859322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277851|NCT04859322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101277852|NCT04859322|Hormones|hormones|mesh-ancestor
101277853|NCT04859322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101277854|NCT04839666|Propofol|propofol|mesh-list
101277855|NCT04839666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101277856|NCT04839666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101277857|NCT04839666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277858|NCT04839666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101277859|NCT04839666|Anesthetics, General|anesthetics, general|mesh-ancestor
101277860|NCT04839666|Anesthetics|anesthetics|mesh-ancestor
101277861|NCT04804007|Etoposide|etoposide|mesh-list
101277862|NCT04804007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101277863|NCT04804007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101277864|NCT04804007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101818566|NCT00642707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818567|NCT00642707|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101818568|NCT00642707|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101818569|NCT00642707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818570|NCT00642707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101818571|NCT00642707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101818572|NCT00642707|Antiviral Agents|antiviral agents|mesh-ancestor
101818573|NCT00642707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101818574|NCT02551523|Dolutegravir|dolutegravir|mesh-list
101818575|NCT02551523|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101818576|NCT02551523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101277865|NCT04804007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101277866|NCT04804007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101277867|NCT04804007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277869|NCT04788667|Botulinum Toxins|botulinum toxins|mesh-list
101277870|NCT04788667|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101277871|NCT04788667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101277872|NCT04788667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277873|NCT04788667|Cholinergic Agents|cholinergic agents|mesh-ancestor
101277874|NCT04788667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101277875|NCT04788667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277876|NCT04788667|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
101277877|NCT04788667|Analgesics|analgesics|mesh-ancestor
101277878|NCT04788667|Sensory System Agents|sensory system agents|mesh-ancestor
101277879|NCT04788667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101277880|NCT04782180|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
101277881|NCT04782180|Antiviral Agents|antiviral agents|mesh-ancestor
101277882|NCT04782180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101277883|NCT04782180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101277884|NCT04782180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101277885|NCT04782180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101277886|NCT04782180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277887|NCT04782180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101277888|NCT04782180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101277889|NCT04757584|Propranolol|propranolol|mesh-list
101277890|NCT04757584|Metoprolol|metoprolol|mesh-list
101277891|NCT04757584|Atenolol|atenolol|mesh-list
101277892|NCT04757584|Sotalol|sotalol|mesh-list
101277893|NCT04757584|Nadolol|nadolol|mesh-list
101277894|NCT04757584|Acebutolol|acebutolol|mesh-list
101277895|NCT04757584|Carvedilol|carvedilol|mesh-list
101277896|NCT04757584|Nebivolol|nebivolol|mesh-list
101277897|NCT04757584|Bisoprolol|bisoprolol|mesh-list
101277898|NCT04757584|Labetalol|labetalol|mesh-list
101277899|NCT04757584|Pindolol|pindolol|mesh-list
101277900|NCT04757584|Betaxolol|betaxolol|mesh-list
101277901|NCT04757584|Penbutolol|penbutolol|mesh-list
101277902|NCT04757584|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101277903|NCT04757584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101277904|NCT04757584|Adrenergic Agents|adrenergic agents|mesh-ancestor
101277906|NCT04757584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277907|NCT04757584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277908|NCT04757584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101277909|NCT04757584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101277910|NCT04757584|Vasodilator Agents|vasodilator agents|mesh-ancestor
101277911|NCT04757584|Sympatholytics|sympatholytics|mesh-ancestor
101277912|NCT04757584|Autonomic Agents|autonomic agents|mesh-ancestor
101277913|NCT04757584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101277914|NCT04757584|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101277915|NCT04757584|Antioxidants|antioxidants|mesh-ancestor
101277916|NCT04757584|Protective Agents|protective agents|mesh-ancestor
101277917|NCT04757584|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101818577|NCT02551523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101818578|NCT02551523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101818579|NCT02551523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818580|NCT02551523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101818581|NCT02551523|Antiviral Agents|antiviral agents|mesh-ancestor
101818582|NCT02551523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101818583|NCT00817739|Leuprolide|leuprolide|mesh-list
101818584|NCT00817739|Flutamide|flutamide|mesh-list
101818585|NCT00817739|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101818586|NCT00817739|Fertility Agents|fertility agents|mesh-ancestor
101818587|NCT00817739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101818588|NCT00817739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277918|NCT04757584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101277919|NCT04757584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101277920|NCT04757584|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101277921|NCT04757584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101277922|NCT04757584|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101277923|NCT04757584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101277924|NCT04757584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101277925|NCT04757584|Sympathomimetics|sympathomimetics|mesh-ancestor
101277926|NCT04757584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101277927|NCT04757584|Serotonin Agents|serotonin agents|mesh-ancestor
101277928|NCT04756791|Anesthetics|anesthetics|mesh-list
101277929|NCT04756791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101277930|NCT04756791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277931|NCT04752475|Furosemide|furosemide|mesh-list
101277932|NCT04752475|Diuretics|diuretics|mesh-ancestor
101277933|NCT04752475|Natriuretic Agents|natriuretic agents|mesh-ancestor
101277934|NCT04752475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277935|NCT04752475|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101277936|NCT04752475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101277937|NCT04752475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277938|NCT04720326|Tacrolimus|tacrolimus|mesh-list
101277939|NCT04720326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101277940|NCT04720326|Immunologic Factors|immunologic factors|mesh-ancestor
101277941|NCT04720326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277942|NCT04720326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101277943|NCT04720326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101277944|NCT04720326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277945|NCT04717362|Methyltestosterone|methyltestosterone|mesh-list
101277946|NCT04717362|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101277947|NCT04717362|Testosterone|testosterone|mesh-list
101277948|NCT04717362|Testosterone undecanoate|testosterone undecanoate|mesh-list
101277949|NCT04717362|Testosterone enanthate|testosterone enanthate|mesh-list
101277950|NCT04717362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101277951|NCT04717362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101277952|NCT04717362|Anabolic Agents|anabolic agents|mesh-ancestor
101277954|NCT04717362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101277955|NCT04717362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277956|NCT04717362|Androgens|androgens|mesh-ancestor
101277957|NCT04708054|Fludarabine|fludarabine|mesh-list
101277958|NCT04708054|Fludarabine phosphate|fludarabine phosphate|mesh-list
101277959|NCT04708054|Busulfan|busulfan|mesh-list
101277960|NCT04708054|Venetoclax|venetoclax|mesh-list
101277961|NCT04708054|Thiotepa|thiotepa|mesh-list
101277962|NCT04708054|Cladribine|cladribine|mesh-list
101277963|NCT04708054|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
101277964|NCT04708054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101277965|NCT04708054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101277966|NCT04708054|Antimetabolites|antimetabolites|mesh-ancestor
101277967|NCT04708054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818589|NCT00817739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101818590|NCT00817739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101818591|NCT00817739|Androgen Antagonists|androgen antagonists|mesh-ancestor
101818592|NCT00817739|Hormone Antagonists|hormone antagonists|mesh-ancestor
101818593|NCT00817739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101818594|NCT00817895|Cisplatin|cisplatin|mesh-list
101818595|NCT00817895|Fluorouracil|fluorouracil|mesh-list
101818596|NCT00817895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101818597|NCT00817895|Antimetabolites|antimetabolites|mesh-ancestor
101277968|NCT04708054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101277970|NCT04708054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277971|NCT04708054|Alkylating Agents|alkylating agents|mesh-ancestor
101277972|NCT04708054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101277973|NCT04708054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101277974|NCT04700826|Rivaroxaban|rivaroxaban|mesh-list
101277975|NCT04700826|Apixaban|apixaban|mesh-list
101277976|NCT04700826|Edoxaban|edoxaban|mesh-list
101277977|NCT04700826|Dabigatran|dabigatran|mesh-list
101277978|NCT04700826|Anticoagulants|anticoagulants|mesh-list
101277979|NCT04700826|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101277980|NCT04700826|Antithrombins|antithrombins|mesh-ancestor
101277981|NCT04700826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101277982|NCT04700826|Protease Inhibitors|protease inhibitors|mesh-ancestor
101277983|NCT04700826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101277984|NCT04700826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277985|NCT04648033|Atovaquone|atovaquone|mesh-list
101277986|NCT04648033|Cisplatin|cisplatin|mesh-list
101277987|NCT04648033|Vinorelbine|vinorelbine|mesh-list
101277988|NCT04648033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101277989|NCT04648033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101277990|NCT04648033|Tubulin Modulators|tubulin modulators|mesh-ancestor
101277991|NCT04648033|Antimitotic Agents|antimitotic agents|mesh-ancestor
101277992|NCT04648033|Mitosis Modulators|mitosis modulators|mesh-ancestor
101277993|NCT04648033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277994|NCT04648033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101277995|NCT04648033|Antimalarials|antimalarials|mesh-ancestor
101277996|NCT04648033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101408373|NCT00109109|Vorinostat|vorinostat|mesh-list
101277997|NCT04648033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101277998|NCT04648033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101277999|NCT04604782|Regadenoson|regadenoson|mesh-list
101278000|NCT04604782|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
101278001|NCT04604782|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101278002|NCT04604782|Purinergic Agonists|purinergic agonists|mesh-ancestor
101278003|NCT04604782|Purinergic Agents|purinergic agents|mesh-ancestor
101278004|NCT04604782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101278005|NCT04604782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278006|NCT04604782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278007|NCT04549207|Denosumab|denosumab|mesh-list
101278008|NCT04549207|Zoledronic Acid|zoledronic acid|mesh-list
101278009|NCT04549207|Pamidronate|pamidronate|mesh-list
101278010|NCT04549207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101278011|NCT04549207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278012|NCT04319328|Ciprofloxacin|ciprofloxacin|mesh-list
101278013|NCT04319328|Cefazolin|cefazolin|mesh-list
101278014|NCT04319328|Ceftazidime|ceftazidime|mesh-list
101278015|NCT04319328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101278016|NCT04319328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101278017|NCT04319328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101278018|NCT04319328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101278019|NCT04319328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101278020|NCT04319328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278021|NCT04319328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278022|NCT04319328|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101278023|NCT04319328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101278024|NCT04306315|Brodalumab|brodalumab|mesh-list
101278025|NCT04306315|Dermatologic Agents|dermatologic agents|mesh-ancestor
101278026|NCT04267926|Ubiquinone|ubiquinone|mesh-list
101818598|NCT00817895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818599|NCT00817895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101818600|NCT00817895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101818601|NCT00817895|Immunologic Factors|immunologic factors|mesh-ancestor
101818602|NCT00817895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818603|NCT00814229|Vaccines|vaccines|mesh-list
101818604|NCT00814229|Aluminum sulfate|aluminum sulfate|mesh-list
101818605|NCT00814229|Immunologic Factors|immunologic factors|mesh-ancestor
101278027|NCT04267926|Micronutrients|micronutrients|mesh-ancestor
101278028|NCT04267926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278030|NCT04255160|Estrogens|estrogens|mesh-ancestor
101278031|NCT04255160|Hormones|hormones|mesh-ancestor
101278033|NCT04255160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278034|NCT04141501|Psilocybin|psilocybin|mesh-list
101278035|NCT04141501|Hallucinogens|hallucinogens|mesh-ancestor
101278036|NCT04141501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278037|NCT04141501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101278038|NCT04098718|Prednisolone|prednisolone|mesh-list
101278039|NCT04098718|Benralizumab|benralizumab|mesh-list
101278040|NCT04098718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101278041|NCT04098718|Glucocorticoids|glucocorticoids|mesh-ancestor
101278042|NCT04098718|Hormones|hormones|mesh-ancestor
101278043|NCT04098718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101278044|NCT04098718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278045|NCT04098718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101278046|NCT04098718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278047|NCT04098718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101278048|NCT04098718|Respiratory System Agents|respiratory system agents|mesh-ancestor
101278049|NCT04097730|Riboflavin|riboflavin|mesh-list
101278050|NCT04097730|Moxifloxacin|moxifloxacin|mesh-list
101278051|NCT04097730|Difluprednate|difluprednate|mesh-list
101278052|NCT04097730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101278053|NCT04097730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101278054|NCT04097730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101278055|NCT04097730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101278056|NCT04097730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101278057|NCT04097730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278058|NCT04097730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278059|NCT04097730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278060|NCT04097730|Vitamin B Complex|vitamin b complex|mesh-ancestor
101278061|NCT04097730|Vitamins|vitamins|mesh-ancestor
101278062|NCT04097730|Micronutrients|micronutrients|mesh-ancestor
101278063|NCT04097730|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101278064|NCT04097730|Dermatologic Agents|dermatologic agents|mesh-ancestor
101278065|NCT04097730|Glucocorticoids|glucocorticoids|mesh-ancestor
101278066|NCT04097730|Hormones|hormones|mesh-ancestor
101278067|NCT04097730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101278068|NCT04092387|Nicotine|nicotine|mesh-list
101278069|NCT04092387|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101278070|NCT04092387|Autonomic Agents|autonomic agents|mesh-ancestor
101278071|NCT04092387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101278072|NCT04092387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278073|NCT04092387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101278074|NCT04092387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101278075|NCT04092387|Cholinergic Agents|cholinergic agents|mesh-ancestor
101278076|NCT04092387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101278077|NCT04092387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278078|NCT04074330|Rituximab|rituximab|mesh-list
101278079|NCT04074330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101278080|NCT04074330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278081|NCT04074330|Immunologic Factors|immunologic factors|mesh-ancestor
101278082|NCT04074330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278083|NCT04074330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101278084|NCT04062656|Leucovorin|leucovorin|mesh-list
101278085|NCT04062656|Folic Acid|folic acid|mesh-list
101278086|NCT04062656|Docetaxel|docetaxel|mesh-list
101278087|NCT04062656|Fluorouracil|fluorouracil|mesh-list
101818606|NCT00814229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818607|NCT00814229|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101818608|NCT00568685|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101818609|NCT00568685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101818610|NCT00568685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101818611|NCT00568685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101818612|NCT00568685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818613|NCT00568685|Adrenergic Agents|adrenergic agents|mesh-ancestor
101818614|NCT00568685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101818615|NCT00568685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818617|NCT00061945|Cytarabine|cytarabine|mesh-list
101818618|NCT00061945|Acyclovir|acyclovir|mesh-list
101818619|NCT00061945|Trimethoprim|trimethoprim|mesh-list
101475922|NCT04718649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101278088|NCT04062656|Oxaliplatin|oxaliplatin|mesh-list
101278089|NCT04062656|Nivolumab|nivolumab|mesh-list
101278090|NCT04062656|Relatlimab|relatlimab|mesh-list
101278092|NCT04062656|Tubulin Modulators|tubulin modulators|mesh-ancestor
101278093|NCT04062656|Antimitotic Agents|antimitotic agents|mesh-ancestor
101278094|NCT04062656|Mitosis Modulators|mitosis modulators|mesh-ancestor
101278095|NCT04062656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278096|NCT04062656|Antimetabolites|antimetabolites|mesh-ancestor
101278097|NCT04062656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101278098|NCT04062656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101278099|NCT04062656|Immunologic Factors|immunologic factors|mesh-ancestor
101278100|NCT04062656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278101|NCT04062656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101278102|NCT04062656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101278103|NCT04062656|Antidotes|antidotes|mesh-ancestor
101278104|NCT04062656|Protective Agents|protective agents|mesh-ancestor
101278105|NCT04062656|Vitamin B Complex|vitamin b complex|mesh-ancestor
101278106|NCT04062656|Vitamins|vitamins|mesh-ancestor
101278107|NCT04062656|Micronutrients|micronutrients|mesh-ancestor
101278108|NCT04062656|Hematinics|hematinics|mesh-ancestor
101278109|NCT04041050|Celecoxib|celecoxib|mesh-list
101278110|NCT04041050|Navitoclax|navitoclax|mesh-list
101278111|NCT04041050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101278112|NCT04041050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101278113|NCT04041050|Analgesics|analgesics|mesh-ancestor
101278114|NCT04041050|Sensory System Agents|sensory system agents|mesh-ancestor
101278115|NCT04041050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101278116|NCT04041050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278117|NCT04041050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101278118|NCT04041050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101278119|NCT04041050|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101278120|NCT04041050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101278121|NCT04041050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101278122|NCT04041050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278123|NCT04041050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278125|NCT04018313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101278126|NCT04018313|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101278127|NCT04018313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101278128|NCT04018313|Respiratory System Agents|respiratory system agents|mesh-ancestor
101278129|NCT04018313|Immunologic Factors|immunologic factors|mesh-ancestor
101278130|NCT04018313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278131|NCT03976518|Atezolizumab|atezolizumab|mesh-list
101278132|NCT03976518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101278133|NCT03976518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818620|NCT00061945|Sulfamethoxazole|sulfamethoxazole|mesh-list
101818621|NCT00061945|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101818623|NCT00061945|Cyclophosphamide|cyclophosphamide|mesh-list
101818624|NCT00061945|Methotrexate|methotrexate|mesh-list
101818625|NCT00061945|Vincristine|vincristine|mesh-list
101818626|NCT00061945|Imatinib Mesylate|imatinib mesylate|mesh-list
101818627|NCT00061945|Daunorubicin|daunorubicin|mesh-list
101818628|NCT00061945|Asparaginase|asparaginase|mesh-list
101818629|NCT00061945|Mercaptopurine|mercaptopurine|mesh-list
101818630|NCT00061945|Alemtuzumab|alemtuzumab|mesh-list
101818631|NCT00061945|Allopurinol|allopurinol|mesh-list
101818632|NCT00061945|Levoleucovorin|levoleucovorin|mesh-list
101818633|NCT00061945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101818634|NCT00061945|Immunologic Factors|immunologic factors|mesh-ancestor
101818635|NCT00061945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818636|NCT00061945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101818637|NCT00061945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101818638|NCT00061945|Alkylating Agents|alkylating agents|mesh-ancestor
101818639|NCT00061945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818640|NCT00061945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101818641|NCT00061945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101818642|NCT00061945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101818643|NCT00061945|Antiemetics|antiemetics|mesh-ancestor
101818644|NCT00061945|Autonomic Agents|autonomic agents|mesh-ancestor
101278134|NCT03976518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101278135|NCT03976518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278136|NCT03973203|Niacin|niacin|mesh-list
101278137|NCT03973203|Nicotinic Acids|nicotinic acids|mesh-list
101278138|NCT03973203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101278139|NCT03973203|Antimetabolites|antimetabolites|mesh-ancestor
101278140|NCT03973203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278141|NCT03973203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101278142|NCT03973203|Vasodilator Agents|vasodilator agents|mesh-ancestor
101278143|NCT03973203|Vitamin B Complex|vitamin b complex|mesh-ancestor
101278144|NCT03973203|Vitamins|vitamins|mesh-ancestor
101278145|NCT03973203|Micronutrients|micronutrients|mesh-ancestor
101278146|NCT03973203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278147|NCT03916926|Fluorides|fluorides|mesh-list
101278148|NCT03916926|Fluorides, Topical|fluorides, topical|mesh-list
101278149|NCT03916926|Cariostatic Agents|cariostatic agents|mesh-ancestor
101278150|NCT03916926|Protective Agents|protective agents|mesh-ancestor
101278151|NCT03916926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278152|NCT03899857|Pembrolizumab|pembrolizumab|mesh-list
101278153|NCT03899857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101278154|NCT03899857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278155|NCT03899857|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101278156|NCT03899857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278158|NCT03879694|Sargramostim|sargramostim|mesh-list
101278159|NCT03879694|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101278160|NCT03879694|Freund's Adjuvant|freund's adjuvant|mesh-list
101278161|NCT03879694|Immunologic Factors|immunologic factors|mesh-ancestor
101278162|NCT03879694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278163|NCT03879694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101818645|NCT00061945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101818646|NCT00061945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101818647|NCT00061945|Glucocorticoids|glucocorticoids|mesh-ancestor
101818648|NCT00061945|Hormones|hormones|mesh-ancestor
101818649|NCT00061945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101818650|NCT00061945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101818651|NCT00061945|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101278164|NCT03879694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101278165|NCT03879694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101278166|NCT03879694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101278167|NCT03871491|Azithromycin|azithromycin|mesh-list
101278168|NCT03871491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101278169|NCT03871491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101278170|NCT03840967|Niraparib|niraparib|mesh-list
101278171|NCT03840967|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101278172|NCT03840967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101278173|NCT03840967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278174|NCT03840967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278175|NCT03839914|Vancomycin|vancomycin|mesh-list
101278176|NCT03839914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101278177|NCT03839914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101278178|NCT03838263|Cisplatin|cisplatin|mesh-list
101278179|NCT03838263|Nivolumab|nivolumab|mesh-list
101278180|NCT03838263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278181|NCT03838263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101278182|NCT03838263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101278183|NCT03838263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278184|NCT03801642|Dapagliflozin|dapagliflozin|mesh-list
101278185|NCT03801642|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101278186|NCT03801642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278187|NCT03801642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101278188|NCT03801642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278189|NCT03792490|Fasudil|fasudil|mesh-list
101278190|NCT03792490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101278191|NCT03792490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101278192|NCT03792490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278193|NCT03792490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101278194|NCT03792490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278195|NCT03792490|Vasodilator Agents|vasodilator agents|mesh-ancestor
101278196|NCT03792490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101278197|NCT03792490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101278198|NCT03783429|Digoxin|digoxin|mesh-list
101278199|NCT03783429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101278200|NCT03783429|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101278201|NCT03783429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101278202|NCT03783429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278203|NCT03783429|Protective Agents|protective agents|mesh-ancestor
101278204|NCT03783429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278205|NCT03770338|Teriparatide|teriparatide|mesh-list
101278209|NCT03721653|Leucovorin|leucovorin|mesh-list
101278210|NCT03721653|Bevacizumab|bevacizumab|mesh-list
101278211|NCT03721653|Atezolizumab|atezolizumab|mesh-list
101278212|NCT03721653|Fluorouracil|fluorouracil|mesh-list
101278213|NCT03721653|Oxaliplatin|oxaliplatin|mesh-list
101278214|NCT03721653|Irinotecan|irinotecan|mesh-list
101278215|NCT03721653|Levoleucovorin|levoleucovorin|mesh-list
101278216|NCT03721653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101278217|NCT03721653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278218|NCT03721653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101278219|NCT03721653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101278220|NCT03721653|Growth Substances|growth substances|mesh-ancestor
101278221|NCT03721653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278222|NCT03721653|Growth Inhibitors|growth inhibitors|mesh-ancestor
101278223|NCT03721653|Antimetabolites|antimetabolites|mesh-ancestor
101818652|NCT00061945|Abortifacient Agents|abortifacient agents|mesh-ancestor
101818653|NCT00061945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101818654|NCT00061945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101818655|NCT00061945|Antimetabolites|antimetabolites|mesh-ancestor
101818656|NCT00061945|Dermatologic Agents|dermatologic agents|mesh-ancestor
101818657|NCT00061945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101818658|NCT00061945|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101818659|NCT00061945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101818660|NCT00061945|Antiviral Agents|antiviral agents|mesh-ancestor
101818661|NCT00061945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101278224|NCT03721653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278225|NCT03721653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101278226|NCT03721653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101278227|NCT03721653|Immunologic Factors|immunologic factors|mesh-ancestor
101278228|NCT03721653|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101278229|NCT03721653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101278230|NCT03721653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101278231|NCT03721653|Antidotes|antidotes|mesh-ancestor
101278232|NCT03721653|Protective Agents|protective agents|mesh-ancestor
101278233|NCT03721653|Vitamin B Complex|vitamin b complex|mesh-ancestor
101278234|NCT03721653|Vitamins|vitamins|mesh-ancestor
101278235|NCT03721653|Micronutrients|micronutrients|mesh-ancestor
101278236|NCT03721653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101278237|NCT03713645|Tacrolimus|tacrolimus|mesh-list
101278238|NCT03713645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101278239|NCT03713645|Immunologic Factors|immunologic factors|mesh-ancestor
101278240|NCT03713645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278241|NCT03713645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101278242|NCT03713645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101278243|NCT03713645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278244|NCT03705507|Dexamethasone|dexamethasone|mesh-list
101278245|NCT03705507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101278246|NCT03705507|Antiemetics|antiemetics|mesh-ancestor
101278247|NCT03705507|Autonomic Agents|autonomic agents|mesh-ancestor
101278248|NCT03705507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101278249|NCT03705507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278250|NCT03705507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101278251|NCT03705507|Glucocorticoids|glucocorticoids|mesh-ancestor
101278252|NCT03705507|Hormones|hormones|mesh-ancestor
101278253|NCT03705507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101278254|NCT03705507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101278255|NCT03705507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278256|NCT03664687|Zoledronic Acid|zoledronic acid|mesh-list
101278257|NCT03664687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101278258|NCT03664687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278259|NCT03663504|Metronidazole|metronidazole|mesh-list
101278260|NCT03663504|Neomycin|neomycin|mesh-list
101278261|NCT03663504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101278262|NCT03663504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101278263|NCT03663504|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101278264|NCT03663504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101278265|NCT03663504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101278266|NCT03663504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101278267|NCT03663504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278268|NCT03654066|Botulinum Toxins|botulinum toxins|mesh-list
101278269|NCT03654066|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101278270|NCT03654066|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101278271|NCT03654066|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101278272|NCT03654066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101278273|NCT03654066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278274|NCT03654066|Cholinergic Agents|cholinergic agents|mesh-ancestor
101278275|NCT03654066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101278276|NCT03654066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818669|NCT00061945|Antimitotic Agents|antimitotic agents|mesh-ancestor
101818670|NCT00061945|Mitosis Modulators|mitosis modulators|mesh-ancestor
101818671|NCT00061945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101818672|NCT00061945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101818673|NCT00061945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101278277|NCT03654066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101278278|NCT03654066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101278280|NCT03582488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101278281|NCT03553810|Valsartan|valsartan|mesh-list
101278282|NCT03553810|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101278283|NCT03553810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101278284|NCT03553810|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101278285|NCT03553810|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101278286|NCT03553810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278294|NCT03404596|Nicotine|nicotine|mesh-list
101314843|NCT00388557|Hormone Antagonists|hormone antagonists|mesh-ancestor
101278295|NCT03404596|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101278296|NCT03404596|Autonomic Agents|autonomic agents|mesh-ancestor
101278297|NCT03404596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101278298|NCT03404596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278299|NCT03404596|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101278300|NCT03404596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101278301|NCT03404596|Cholinergic Agents|cholinergic agents|mesh-ancestor
101278302|NCT03404596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101278303|NCT03404596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278304|NCT03340220|Itraconazole|itraconazole|mesh-list
101278305|NCT03340220|Antifungal Agents|antifungal agents|mesh-ancestor
101278306|NCT03340220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101278307|NCT03340220|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101278308|NCT03340220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101278309|NCT03340220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101278310|NCT03340220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278311|NCT03340220|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101278312|NCT03340220|Hormone Antagonists|hormone antagonists|mesh-ancestor
101278313|NCT03340220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101278314|NCT03340220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278315|NCT03340220|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101278316|NCT03334253|Atropine|atropine|mesh-list
101278317|NCT03334253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101278318|NCT03334253|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101278319|NCT03334253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101278320|NCT03334253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101278321|NCT03334253|Autonomic Agents|autonomic agents|mesh-ancestor
101278322|NCT03334253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101278323|NCT03334253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278324|NCT03334253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101278325|NCT03334253|Respiratory System Agents|respiratory system agents|mesh-ancestor
101818675|NCT00061945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101818676|NCT00061945|Gout Suppressants|gout suppressants|mesh-ancestor
101818677|NCT00061945|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101818678|NCT00061945|Antioxidants|antioxidants|mesh-ancestor
101818679|NCT00061945|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101818680|NCT00061945|Antimalarials|antimalarials|mesh-ancestor
101818681|NCT00061945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101278326|NCT03334253|Mydriatics|mydriatics|mesh-ancestor
101278327|NCT03334253|Parasympatholytics|parasympatholytics|mesh-ancestor
101278328|NCT03334253|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101278329|NCT03334253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101278330|NCT03334253|Cholinergic Agents|cholinergic agents|mesh-ancestor
101278331|NCT03334253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101278332|NCT03334253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278333|NCT03334253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101278334|NCT03317158|Gemcitabine|gemcitabine|mesh-list
101278335|NCT03317158|Docetaxel|docetaxel|mesh-list
101278336|NCT03317158|Durvalumab|durvalumab|mesh-list
101278337|NCT03317158|Tremelimumab|tremelimumab|mesh-list
101278338|NCT03317158|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101278339|NCT03317158|BCG Vaccine|bcg vaccine|mesh-list
101278340|NCT03317158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101278342|NCT03317158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278343|NCT03317158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278344|NCT03317158|Tubulin Modulators|tubulin modulators|mesh-ancestor
101278345|NCT03317158|Antimitotic Agents|antimitotic agents|mesh-ancestor
101278346|NCT03317158|Mitosis Modulators|mitosis modulators|mesh-ancestor
101278347|NCT03317158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101278348|NCT03317158|Immunologic Factors|immunologic factors|mesh-ancestor
101278349|NCT03317158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278350|NCT03317158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101278351|NCT03202316|Atezolizumab|atezolizumab|mesh-list
101278352|NCT03202316|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101278353|NCT03202316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101278354|NCT03202316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278355|NCT03202316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101278356|NCT03202316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278357|NCT03202316|Immunologic Factors|immunologic factors|mesh-ancestor
101278358|NCT03202316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278359|NCT03147859|Vedolizumab|vedolizumab|mesh-list
101278360|NCT03147859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101278361|NCT03131219|Ravulizumab|ravulizumab|mesh-list
101278362|NCT03131219|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101278363|NCT03131219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101278364|NCT03131219|Immunologic Factors|immunologic factors|mesh-ancestor
101278365|NCT03131219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278366|NCT02914613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101278367|NCT02914613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101278369|NCT02783092|Anticonvulsants|anticonvulsants|mesh-ancestor
101278370|NCT02713945|Simvastatin|simvastatin|mesh-list
101278371|NCT02713945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101278372|NCT02713945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101278373|NCT02713945|Antimetabolites|antimetabolites|mesh-ancestor
101278374|NCT02713945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278375|NCT02713945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101278376|NCT02713945|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101278377|NCT02713945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101278378|NCT02685605|Temozolomide|temozolomide|mesh-list
101278379|NCT02685605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101278380|NCT02685605|Alkylating Agents|alkylating agents|mesh-ancestor
101278381|NCT02685605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278382|NCT02685605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278383|NCT02664935|Docetaxel|docetaxel|mesh-list
101278384|NCT02664935|Durvalumab|durvalumab|mesh-list
101818682|NCT00061945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101818683|NCT00061945|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101818684|NCT00061945|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101818685|NCT00061945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101818686|NCT00061945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101818687|NCT00817973|Caseins|caseins|mesh-list
101818688|NCT00817973|Chelating Agents|chelating agents|mesh-ancestor
101818689|NCT00817973|Sequestering Agents|sequestering agents|mesh-ancestor
101818690|NCT00817973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818691|NCT01097941|Vaccines|vaccines|mesh-list
101818692|NCT01097941|Immunologic Factors|immunologic factors|mesh-ancestor
101818693|NCT01097941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818694|NCT00642473|Metronidazole|metronidazole|mesh-list
101818695|NCT00642473|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101818696|NCT00642473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101818697|NCT00642473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101818698|NCT00642473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101818699|NCT00642473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818700|NCT00642473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101818701|NCT00642473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101278385|NCT02664935|Palbociclib|palbociclib|mesh-list
101278386|NCT02664935|Osimertinib|osimertinib|mesh-list
101278387|NCT02664935|Crizotinib|crizotinib|mesh-list
101278388|NCT02664935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278389|NCT02664935|Tubulin Modulators|tubulin modulators|mesh-ancestor
101278390|NCT02664935|Antimitotic Agents|antimitotic agents|mesh-ancestor
101278391|NCT02664935|Mitosis Modulators|mitosis modulators|mesh-ancestor
101278392|NCT02664935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278393|NCT02664935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101278394|NCT02664935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101278395|NCT02664935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101278396|NCT02586207|Cisplatin|cisplatin|mesh-list
101278397|NCT02586207|Pembrolizumab|pembrolizumab|mesh-list
101278398|NCT02586207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278399|NCT02586207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101278400|NCT02586207|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101278401|NCT02586207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278402|NCT02573324|Temozolomide|temozolomide|mesh-list
101278403|NCT02573324|ABT-414|abt-414|mesh-list
101278404|NCT02573324|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101278405|NCT02573324|Alkylating Agents|alkylating agents|mesh-ancestor
101278406|NCT02573324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278407|NCT02573324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278408|NCT02573324|Immunoconjugates|immunoconjugates|mesh-ancestor
101278409|NCT02573324|Immunologic Factors|immunologic factors|mesh-ancestor
101278410|NCT02573324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278411|NCT02553642|Nivolumab|nivolumab|mesh-list
101278412|NCT02553642|Ipilimumab|ipilimumab|mesh-list
101278413|NCT02553642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101278414|NCT02553642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278415|NCT02553642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101278416|NCT02553642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818702|NCT00642473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101818703|NCT00642473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101818704|NCT00645671|Loteprednol Etabonate|loteprednol etabonate|mesh-list
101818705|NCT00645671|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101818706|NCT00366340|Vaccines|vaccines|mesh-list
101818707|NCT00366340|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101818708|NCT00366340|Immunologic Factors|immunologic factors|mesh-ancestor
101818709|NCT00366340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818710|NCT03992326|Cyclophosphamide|cyclophosphamide|mesh-list
101278417|NCT02523092|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101278418|NCT02523092|Hormones|hormones|mesh-ancestor
101278419|NCT02523092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101278420|NCT02523092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278421|NCT02450773|Furosemide|furosemide|mesh-list
101278422|NCT02450773|Diuretics|diuretics|mesh-ancestor
101278423|NCT02450773|Natriuretic Agents|natriuretic agents|mesh-ancestor
101278424|NCT02450773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278425|NCT02450773|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101278426|NCT02450773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101278427|NCT02450773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278428|NCT02445248|Tisagenlecleucel|tisagenlecleucel|mesh-list
101278429|NCT02445248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101278430|NCT02445248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278431|NCT02412566|SMOFlipid|smoflipid|mesh-list
101278432|NCT02412566|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101278433|NCT02412566|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101278434|NCT02412566|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101278435|NCT02397226|Anesthetics|anesthetics|mesh-list
101278436|NCT02397226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101278437|NCT02397226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278438|NCT02296684|Cisplatin|cisplatin|mesh-list
101278439|NCT02296684|Pembrolizumab|pembrolizumab|mesh-list
101278440|NCT02296684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278441|NCT02296684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101278442|NCT02296684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101278443|NCT02296684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278444|NCT01939275|Copper|copper|mesh-list
101278445|NCT01939275|Trastuzumab|trastuzumab|mesh-list
101278446|NCT01939275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101278447|NCT01939275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278448|NCT01939275|Trace Elements|trace elements|mesh-ancestor
101278449|NCT01939275|Micronutrients|micronutrients|mesh-ancestor
101278450|NCT01939275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278451|NCT01900574|Golimumab|golimumab|mesh-list
101278452|NCT01900574|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101278453|NCT01900574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101278454|NCT01900574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101278455|NCT01900574|Immunologic Factors|immunologic factors|mesh-ancestor
101278456|NCT01900574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278457|NCT01342367|Bicalutamide|bicalutamide|mesh-list
101278458|NCT01342367|Finasteride|finasteride|mesh-list
101278459|NCT01342367|Dutasteride|dutasteride|mesh-list
101278460|NCT01342367|Androgen Antagonists|androgen antagonists|mesh-ancestor
101278461|NCT01342367|Hormone Antagonists|hormone antagonists|mesh-ancestor
101278462|NCT01342367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101278463|NCT01342367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278464|NCT01342367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278465|NCT01342367|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101278466|NCT01342367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101278467|NCT01342367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101818711|NCT03992326|Fludarabine|fludarabine|mesh-list
101818712|NCT03992326|Interleukin-2|interleukin-2|mesh-list
101818713|NCT03992326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101818714|NCT03992326|Immunologic Factors|immunologic factors|mesh-ancestor
101818715|NCT03992326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818716|NCT03992326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101278468|NCT01342367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278469|NCT01342367|Urological Agents|urological agents|mesh-ancestor
101278470|NCT01185171|Gefitinib|gefitinib|mesh-list
101278471|NCT01185171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278472|NCT01185171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101278473|NCT01185171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101278474|NCT01185171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278475|NCT00896493|Cyclosporine|cyclosporine|mesh-list
101278476|NCT00896493|Cyclosporins|cyclosporins|mesh-list
101278477|NCT00896493|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101278478|NCT00896493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101278479|NCT00896493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278480|NCT00896493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101278481|NCT00896493|Immunologic Factors|immunologic factors|mesh-ancestor
101278482|NCT00896493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278483|NCT00896493|Antifungal Agents|antifungal agents|mesh-ancestor
101278484|NCT00896493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101278485|NCT00896493|Dermatologic Agents|dermatologic agents|mesh-ancestor
101278486|NCT00896493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101278487|NCT00896493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101278488|NCT00790010|Bevacizumab|bevacizumab|mesh-list
101278489|NCT00790010|Ipilimumab|ipilimumab|mesh-list
101278490|NCT00790010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101278491|NCT00790010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278492|NCT00790010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101278493|NCT00790010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101278494|NCT00790010|Growth Substances|growth substances|mesh-ancestor
101278495|NCT00790010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278496|NCT00790010|Growth Inhibitors|growth inhibitors|mesh-ancestor
101278497|NCT00790010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101278498|NCT00790010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278499|NCT00444093|Antidiarrheals|antidiarrheals|mesh-list
101278500|NCT00444093|Loperamide|loperamide|mesh-list
101278501|NCT00444093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101278502|NCT00408005|Calcium, Dietary|calcium, dietary|mesh-list
101278503|NCT00408005|Leucovorin|leucovorin|mesh-list
101278504|NCT00408005|Folic Acid|folic acid|mesh-list
101278505|NCT00408005|Cytarabine|cytarabine|mesh-list
101278506|NCT00408005|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
101278507|NCT00408005|Dexamethasone|dexamethasone|mesh-list
101278508|NCT00408005|Dexamethasone acetate|dexamethasone acetate|mesh-list
101278509|NCT00408005|Prednisone|prednisone|mesh-list
101278510|NCT00408005|Cortisone|cortisone|mesh-list
101278511|NCT00408005|Cyclophosphamide|cyclophosphamide|mesh-list
101278512|NCT00408005|Doxorubicin|doxorubicin|mesh-list
101278513|NCT00408005|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101278514|NCT00408005|Methotrexate|methotrexate|mesh-list
101278515|NCT00408005|Vincristine|vincristine|mesh-list
101278516|NCT00408005|Daunorubicin|daunorubicin|mesh-list
101278517|NCT00408005|Asparaginase|asparaginase|mesh-list
101278518|NCT00408005|Mercaptopurine|mercaptopurine|mesh-list
101278519|NCT00408005|Pegaspargase|pegaspargase|mesh-list
101278520|NCT00408005|Thioguanine|thioguanine|mesh-list
101278521|NCT00408005|BB 1101|bb 1101|mesh-list
101278522|NCT00408005|Calcium|calcium|mesh-list
101278523|NCT00408005|2-Aminopurine|2-aminopurine|mesh-list
101278524|NCT00408005|Levoleucovorin|levoleucovorin|mesh-list
101278525|NCT00408005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101278526|NCT00408005|Immunologic Factors|immunologic factors|mesh-ancestor
101278528|NCT00408005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101278529|NCT00408005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101278530|NCT00408005|Alkylating Agents|alkylating agents|mesh-ancestor
101278531|NCT00408005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278532|NCT00408005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278533|NCT00408005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101278534|NCT00408005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101818717|NCT03992326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101818718|NCT03992326|Alkylating Agents|alkylating agents|mesh-ancestor
101818719|NCT03992326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818720|NCT03992326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101818721|NCT03992326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101818722|NCT03992326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101818723|NCT03992326|Analgesics|analgesics|mesh-ancestor
101278535|NCT00408005|Antiemetics|antiemetics|mesh-ancestor
101278536|NCT00408005|Autonomic Agents|autonomic agents|mesh-ancestor
101278537|NCT00408005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101278538|NCT00408005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101278539|NCT00408005|Glucocorticoids|glucocorticoids|mesh-ancestor
101278540|NCT00408005|Hormones|hormones|mesh-ancestor
101278541|NCT00408005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101278542|NCT00408005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101278543|NCT00408005|Protease Inhibitors|protease inhibitors|mesh-ancestor
101278544|NCT00408005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101278545|NCT00408005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101278546|NCT00408005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101278547|NCT00408005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101278548|NCT00408005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101278549|NCT00408005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101278550|NCT00408005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101278551|NCT00408005|Abortifacient Agents|abortifacient agents|mesh-ancestor
101278552|NCT00408005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101278553|NCT00408005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101278554|NCT00408005|Antimetabolites|antimetabolites|mesh-ancestor
101278555|NCT00408005|Dermatologic Agents|dermatologic agents|mesh-ancestor
101278556|NCT00408005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101278557|NCT00408005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101278558|NCT00408005|Antiviral Agents|antiviral agents|mesh-ancestor
101278559|NCT00408005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101278560|NCT00408005|Antidotes|antidotes|mesh-ancestor
101278561|NCT00408005|Protective Agents|protective agents|mesh-ancestor
101278562|NCT00408005|Vitamin B Complex|vitamin b complex|mesh-ancestor
101278563|NCT00408005|Vitamins|vitamins|mesh-ancestor
101278564|NCT00408005|Micronutrients|micronutrients|mesh-ancestor
101278565|NCT00408005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101278566|NCT00408005|Tubulin Modulators|tubulin modulators|mesh-ancestor
101278567|NCT00408005|Antimitotic Agents|antimitotic agents|mesh-ancestor
101278568|NCT00408005|Mitosis Modulators|mitosis modulators|mesh-ancestor
101278569|NCT00408005|Hematinics|hematinics|mesh-ancestor
101278570|NCT00003042|Tamoxifen|tamoxifen|mesh-list
101278571|NCT00003042|Paclitaxel|paclitaxel|mesh-list
101278572|NCT00003042|Cyclophosphamide|cyclophosphamide|mesh-list
101278573|NCT00003042|Doxorubicin|doxorubicin|mesh-list
101278574|NCT00003042|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101278575|NCT00003042|Melphalan|melphalan|mesh-list
101278576|NCT00003042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101278577|NCT00003042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278578|NCT00003042|Tubulin Modulators|tubulin modulators|mesh-ancestor
101278579|NCT00003042|Antimitotic Agents|antimitotic agents|mesh-ancestor
101278580|NCT00003042|Mitosis Modulators|mitosis modulators|mesh-ancestor
101278581|NCT00003042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278582|NCT00003042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101278583|NCT00003042|Immunologic Factors|immunologic factors|mesh-ancestor
101278584|NCT00003042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278585|NCT00003042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101278586|NCT00003042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101278587|NCT00003042|Alkylating Agents|alkylating agents|mesh-ancestor
101278588|NCT00003042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101278589|NCT00003042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101278590|NCT00003042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101278591|NCT00003042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101278592|NCT00003042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101278593|NCT00003042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101278594|NCT00003042|Hormone Antagonists|hormone antagonists|mesh-ancestor
101818724|NCT03992326|Sensory System Agents|sensory system agents|mesh-ancestor
101818725|NCT03992326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101818726|NCT01045954|Insulin|insulin|mesh-list
101818727|NCT01045954|Insulin Glargine|insulin glargine|mesh-list
101818728|NCT01045954|Insulin Lispro|insulin lispro|mesh-list
101818729|NCT01045954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101818730|NCT01045954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818731|NCT01046032|Metformin|metformin|mesh-list
101818732|NCT01046032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101818733|NCT01046032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818734|NCT00061633|Vancomycin|vancomycin|mesh-list
101818735|NCT00061633|Penicillins|penicillins|mesh-list
101818736|NCT00061633|Telavancin|telavancin|mesh-list
101818737|NCT00061633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101818738|NCT00061633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101818739|NCT00645593|Gemcitabine|gemcitabine|mesh-list
101818740|NCT00645593|Cetuximab|cetuximab|mesh-list
101818741|NCT00645593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101818742|NCT00645593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101818743|NCT00645593|Antimetabolites|antimetabolites|mesh-ancestor
101818744|NCT00645593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278595|NCT00003042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101278596|NCT00003042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101278597|NCT00003042|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101278598|NCT00003042|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101278599|NCT00003042|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101278600|NCT01873144|Epinephrine|epinephrine|mesh-list
101278601|NCT01873144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101278602|NCT01873144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101278603|NCT01873144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101278604|NCT01873144|Adrenergic Agents|adrenergic agents|mesh-ancestor
101278605|NCT01873144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101278606|NCT01873144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278607|NCT01873144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278608|NCT01873144|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101278609|NCT01873144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101278610|NCT01873144|Autonomic Agents|autonomic agents|mesh-ancestor
101278611|NCT01873144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101278612|NCT01873144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101278613|NCT01873144|Respiratory System Agents|respiratory system agents|mesh-ancestor
101278614|NCT01873144|Mydriatics|mydriatics|mesh-ancestor
101278615|NCT01873144|Sympathomimetics|sympathomimetics|mesh-ancestor
101278616|NCT01873144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101278617|NCT01873157|Bortezomib|bortezomib|mesh-list
101278618|NCT01873157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278619|NCT01873222|Sirolimus|sirolimus|mesh-list
101278620|NCT01873222|Umirolimus|umirolimus|mesh-list
101278621|NCT01873222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101278622|NCT01873222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101278623|NCT01873222|Immunologic Factors|immunologic factors|mesh-ancestor
101278624|NCT01873222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278625|NCT01873222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101278626|NCT01873222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101278627|NCT01873222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101278628|NCT01873222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278629|NCT01873222|Antifungal Agents|antifungal agents|mesh-ancestor
101278630|NCT01873313|Ropivacaine|ropivacaine|mesh-list
101818745|NCT00645593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101818747|NCT01093261|Fludrocortisone|fludrocortisone|mesh-list
101818748|NCT01093261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101818749|NCT02550977|Gestodene|gestodene|mesh-list
101818750|NCT02550977|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101818751|NCT02550977|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101818752|NCT02550977|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101818753|NCT02550977|Contraceptive Agents|contraceptive agents|mesh-ancestor
101278631|NCT01873313|Anesthetics, Local|anesthetics, local|mesh-ancestor
101278632|NCT01873313|Anesthetics|anesthetics|mesh-ancestor
101278633|NCT01873313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101278634|NCT01873313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278635|NCT01873313|Sensory System Agents|sensory system agents|mesh-ancestor
101278636|NCT01873313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101278637|NCT01873339|Midazolam|midazolam|mesh-list
101278638|NCT01873339|Darapladib|darapladib|mesh-list
101278639|NCT01873339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101278640|NCT01873339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101278641|NCT01873339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101278642|NCT01873339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278643|NCT01873339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101278644|NCT01873339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101278645|NCT01873339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101278646|NCT01873339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101278647|NCT01873339|Anesthetics, General|anesthetics, general|mesh-ancestor
101278648|NCT01873339|Anesthetics|anesthetics|mesh-ancestor
101278649|NCT01873339|GABA Modulators|gaba modulators|mesh-ancestor
101278650|NCT01873339|GABA Agents|gaba agents|mesh-ancestor
101278652|NCT01873339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278653|NCT01873339|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
101278654|NCT01873339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101278655|NCT01873378|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101278656|NCT01873378|Luteolytic Agents|luteolytic agents|mesh-ancestor
101278657|NCT01873378|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101278658|NCT01873378|Contraceptive Agents|contraceptive agents|mesh-ancestor
101278659|NCT01873378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101278660|NCT01873378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278661|NCT01873378|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101278662|NCT01873378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101278663|NCT01873378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278664|NCT01873430|Melatonin|melatonin|mesh-list
101278665|NCT01873430|Antioxidants|antioxidants|mesh-ancestor
101278666|NCT01873430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278667|NCT01873430|Protective Agents|protective agents|mesh-ancestor
101278668|NCT01873430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278669|NCT01873430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101278670|NCT01873443|Folic Acid|folic acid|mesh-list
101278671|NCT01873443|Rituximab|rituximab|mesh-list
101278672|NCT01873443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101278673|NCT01873443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278674|NCT01873443|Immunologic Factors|immunologic factors|mesh-ancestor
101278675|NCT01873443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278676|NCT01873443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101278677|NCT01873443|Hematinics|hematinics|mesh-ancestor
101278678|NCT01873443|Vitamin B Complex|vitamin b complex|mesh-ancestor
101278679|NCT01873443|Vitamins|vitamins|mesh-ancestor
101278680|NCT01873443|Micronutrients|micronutrients|mesh-ancestor
101278681|NCT01873573|Triamcinolone|triamcinolone|mesh-list
101278682|NCT01873573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101278683|NCT01873573|Glucocorticoids|glucocorticoids|mesh-ancestor
101278684|NCT01873573|Hormones|hormones|mesh-ancestor
101278685|NCT01873573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101278686|NCT01873573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278687|NCT01873690|Ciprofloxacin|ciprofloxacin|mesh-list
101278688|NCT01873690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101278689|NCT01873690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101278690|NCT01873690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101818754|NCT02550977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101818755|NCT02550977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818756|NCT02550977|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101818757|NCT02550977|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101818759|NCT02550977|Hormones|hormones|mesh-ancestor
101818760|NCT02550977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101278691|NCT01873690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101278692|NCT01873690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101278693|NCT01873690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278694|NCT01873690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278695|NCT01873690|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101278696|NCT01873690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101278697|NCT01873768|Tranexamic Acid|tranexamic acid|mesh-list
101278698|NCT01873768|Aminocaproic Acid|aminocaproic acid|mesh-list
101278699|NCT01873768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101278700|NCT01873768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101278701|NCT01873768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278702|NCT01873768|Hemostatics|hemostatics|mesh-ancestor
101278703|NCT01873768|Coagulants|coagulants|mesh-ancestor
101278704|NCT01873807|Cyclophosphamide|cyclophosphamide|mesh-list
101278705|NCT01873807|Etoposide|etoposide|mesh-list
101278706|NCT01873807|Idarubicin|idarubicin|mesh-list
101278707|NCT01873807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101278708|NCT01873807|Immunologic Factors|immunologic factors|mesh-ancestor
101278709|NCT01873807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278710|NCT01873807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101278711|NCT01873807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101278712|NCT01873807|Alkylating Agents|alkylating agents|mesh-ancestor
101278713|NCT01873807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278714|NCT01873807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278715|NCT01873807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101278716|NCT01873807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101278717|NCT01873807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101278718|NCT01873807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101278719|NCT01873807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101278720|NCT01873807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101278721|NCT01873820|Ascorbic Acid|ascorbic acid|mesh-list
101278722|NCT01873820|Calcium ascorbate|calcium ascorbate|mesh-list
101278723|NCT01873820|Calcium|calcium|mesh-list
101278724|NCT01873820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101278725|NCT01873820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278726|NCT01873820|Antioxidants|antioxidants|mesh-ancestor
101278727|NCT01873820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278728|NCT01873820|Protective Agents|protective agents|mesh-ancestor
101278729|NCT01873820|Vitamins|vitamins|mesh-ancestor
101278730|NCT01873820|Micronutrients|micronutrients|mesh-ancestor
101278731|NCT01873833|Cyclophosphamide|cyclophosphamide|mesh-list
101278732|NCT01873833|Capecitabine|capecitabine|mesh-list
101278733|NCT01873833|Trastuzumab|trastuzumab|mesh-list
101278734|NCT01873833|Lapatinib|lapatinib|mesh-list
101278735|NCT01873833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101278736|NCT01873833|Immunologic Factors|immunologic factors|mesh-ancestor
101278737|NCT01873833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278738|NCT01873833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101278739|NCT01873833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101278740|NCT01873833|Alkylating Agents|alkylating agents|mesh-ancestor
101278741|NCT01873833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278742|NCT01873833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278743|NCT01873833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101278744|NCT01873833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101278745|NCT01873833|Antimetabolites|antimetabolites|mesh-ancestor
101278746|NCT01873833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101278747|NCT01873833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101278748|NCT01873833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101818761|NCT01045018|Mesalamine|mesalamine|mesh-list
101818762|NCT01045018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101818763|NCT01045018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101818764|NCT01045018|Analgesics|analgesics|mesh-ancestor
101818765|NCT01045018|Sensory System Agents|sensory system agents|mesh-ancestor
101818766|NCT01045018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101818767|NCT01045018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818768|NCT01045018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101818769|NCT01045018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101818770|NCT01049464|Magnesium Sulfate|magnesium sulfate|mesh-list
101476072|NCT00268151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278749|NCT01873885|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
101278750|NCT01873885|Vasodilator Agents|vasodilator agents|mesh-ancestor
101278751|NCT01874002|Sirolimus|sirolimus|mesh-list
101278752|NCT01874002|Temsirolimus|temsirolimus|mesh-list
101278753|NCT01874002|MTOR Inhibitors|mtor inhibitors|mesh-list
101278754|NCT01874002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101278755|NCT01874002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101278756|NCT01874002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101278757|NCT01874002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278758|NCT01874002|Antifungal Agents|antifungal agents|mesh-ancestor
101278759|NCT01874002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101278760|NCT01874002|Immunologic Factors|immunologic factors|mesh-ancestor
101278761|NCT01874002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278762|NCT01874002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101278763|NCT01874002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101278764|NCT01874002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278766|NCT01874028|Chelating Agents|chelating agents|mesh-ancestor
101278767|NCT01874028|Sequestering Agents|sequestering agents|mesh-ancestor
101278768|NCT01874028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278769|NCT01874041|Salicylic Acid|salicylic acid|mesh-list
101278770|NCT01874041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101278771|NCT01874041|Antifungal Agents|antifungal agents|mesh-ancestor
101278772|NCT01874041|Keratolytic Agents|keratolytic agents|mesh-ancestor
101278773|NCT01874041|Dermatologic Agents|dermatologic agents|mesh-ancestor
101278774|NCT01874080|Metformin|metformin|mesh-list
101278775|NCT01874080|Saxagliptin|saxagliptin|mesh-list
101278776|NCT01874080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101278777|NCT01874080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278778|NCT01874080|Incretins|incretins|mesh-ancestor
101278779|NCT01874080|Hormones|hormones|mesh-ancestor
101278780|NCT01874080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101278781|NCT01874080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101278782|NCT01874080|Protease Inhibitors|protease inhibitors|mesh-ancestor
101278783|NCT01874080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101278784|NCT01874080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278785|NCT01874171|Cetuximab|cetuximab|mesh-list
101278786|NCT01874171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278787|NCT01874171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101278788|NCT01874236|Bupivacaine|bupivacaine|mesh-list
101278789|NCT01874236|Anesthetics, Local|anesthetics, local|mesh-ancestor
101278790|NCT01874236|Anesthetics|anesthetics|mesh-ancestor
101278791|NCT01874236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101278792|NCT01874236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278793|NCT01874236|Sensory System Agents|sensory system agents|mesh-ancestor
101278794|NCT01874236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101278795|NCT01874314|Moxifloxacin|moxifloxacin|mesh-list
101278796|NCT01874314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101818771|NCT01049464|Analgesics|analgesics|mesh-ancestor
101818772|NCT01049464|Sensory System Agents|sensory system agents|mesh-ancestor
101818773|NCT01049464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101818774|NCT01049464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818776|NCT01049464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101818777|NCT01049464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101278797|NCT01874314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101278798|NCT01874314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101278799|NCT01874314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101278800|NCT01874314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101278801|NCT01874314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278802|NCT01874314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278803|NCT01874470|Antihypertensive Agents|antihypertensive agents|mesh-list
101278804|NCT01874470|Diuretics|diuretics|mesh-list
101278805|NCT01874470|Natriuretic Agents|natriuretic agents|mesh-ancestor
101278806|NCT01874470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278807|NCT01874561|Moxifloxacin|moxifloxacin|mesh-list
101278808|NCT01874561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101278809|NCT01874561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101278810|NCT01874561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101278811|NCT01874561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101278812|NCT01874561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101278813|NCT01874561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278814|NCT01874561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278815|NCT01874574|Triamcinolone|triamcinolone|mesh-list
101278816|NCT01874574|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101278817|NCT01874574|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101278818|NCT01874574|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101278820|NCT01874574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101278821|NCT01874574|Glucocorticoids|glucocorticoids|mesh-ancestor
101278822|NCT01874574|Hormones|hormones|mesh-ancestor
101278823|NCT01874574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101278824|NCT01874574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314928|NCT00000147|Prednisolone|prednisolone|mesh-list
101278825|NCT01874574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101278826|NCT01874574|Immunologic Factors|immunologic factors|mesh-ancestor
101278827|NCT01874574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101278828|NCT01874574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278829|NCT01874574|Viscosupplements|viscosupplements|mesh-ancestor
101278830|NCT01874574|Protective Agents|protective agents|mesh-ancestor
101278831|NCT01874639|Hemostatics|hemostatics|mesh-list
101278832|NCT01874639|Coagulants|coagulants|mesh-ancestor
101278833|NCT01874678|Cisplatin|cisplatin|mesh-list
101278834|NCT01874678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278835|NCT01874717|Midazolam|midazolam|mesh-list
101278836|NCT01874717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101278837|NCT01874717|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101278838|NCT01874717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101278839|NCT01874717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278840|NCT01874717|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101278841|NCT01874717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101278842|NCT01874717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101278843|NCT01874717|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101278844|NCT01874717|Anesthetics, General|anesthetics, general|mesh-ancestor
101278845|NCT01874717|Anesthetics|anesthetics|mesh-ancestor
101278846|NCT01874717|GABA Modulators|gaba modulators|mesh-ancestor
101278847|NCT01874717|GABA Agents|gaba agents|mesh-ancestor
101278848|NCT01874717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101278849|NCT01874717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278851|NCT01874730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101278852|NCT01874730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278853|NCT01874743|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101278854|NCT01874743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101278855|NCT01874743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101278856|NCT01874743|Antimetabolites|antimetabolites|mesh-ancestor
101278857|NCT01874743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278858|NCT01874743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101278859|NCT01874743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101818778|NCT01049464|Anticonvulsants|anticonvulsants|mesh-ancestor
101818779|NCT01049464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101818780|NCT01049464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101818781|NCT01049464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818782|NCT01049464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101818783|NCT01049464|Tocolytic Agents|tocolytic agents|mesh-ancestor
101818784|NCT01049464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101818785|NCT01046266|Cetuximab|cetuximab|mesh-list
101818786|NCT01046266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101818787|NCT01046266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278860|NCT01874743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101278862|NCT01874847|Antioxidants|antioxidants|mesh-ancestor
101278863|NCT01874847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278864|NCT01874847|Protective Agents|protective agents|mesh-ancestor
101278865|NCT01874847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278866|NCT01874847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101278867|NCT01874964|Methadone|methadone|mesh-list
101278868|NCT01874964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101278869|NCT01874964|Narcotics|narcotics|mesh-ancestor
101278870|NCT01874964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101278871|NCT01874964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278872|NCT01874964|Analgesics|analgesics|mesh-ancestor
101278873|NCT01874964|Sensory System Agents|sensory system agents|mesh-ancestor
101278874|NCT01874964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101278875|NCT01874964|Antitussive Agents|antitussive agents|mesh-ancestor
101278876|NCT01874964|Respiratory System Agents|respiratory system agents|mesh-ancestor
101278877|NCT01875107|Insulin|insulin|mesh-list
101278878|NCT01875107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101278879|NCT01875107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278880|NCT01875172|Bupropion|bupropion|mesh-list
101278881|NCT01875172|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101278882|NCT01875172|Antidepressive Agents|antidepressive agents|mesh-ancestor
101278883|NCT01875172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101278884|NCT01875172|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101278885|NCT01875172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101278886|NCT01875172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101278887|NCT01875172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278888|NCT01875172|Dopamine Agents|dopamine agents|mesh-ancestor
101278889|NCT01875172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101278890|NCT01875172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278891|NCT01875172|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101278892|NCT01875172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101278893|NCT01875172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101278894|NCT01875185|Aspirin|aspirin|mesh-list
101314933|NCT00000147|Glucocorticoids|glucocorticoids|mesh-ancestor
101278895|NCT01875185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101278897|NCT01875185|Analgesics|analgesics|mesh-ancestor
101278898|NCT01875185|Sensory System Agents|sensory system agents|mesh-ancestor
101278899|NCT01875185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101278900|NCT01875185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278901|NCT01875185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101278903|NCT01875185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101278904|NCT01875185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101278905|NCT01875185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278906|NCT01875185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101278907|NCT01875185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101278908|NCT01875185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101278910|NCT01875224|Abatacept|abatacept|mesh-list
101278911|NCT01875224|Tacrolimus|tacrolimus|mesh-list
101278912|NCT01875224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101278913|NCT01875224|Immunologic Factors|immunologic factors|mesh-ancestor
101818788|NCT00365794|Testosterone|testosterone|mesh-list
101818789|NCT00365794|Androgens|androgens|mesh-ancestor
101818790|NCT00365794|Hormones|hormones|mesh-ancestor
101818791|NCT00365794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101818792|NCT00365794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818793|NCT01098019|Botulinum Toxins|botulinum toxins|mesh-list
101818794|NCT01098019|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101818795|NCT01098019|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
101278914|NCT01875224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278915|NCT01875224|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101278916|NCT01875224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101278917|NCT01875224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278918|NCT01875224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101278919|NCT01875224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101278920|NCT01875224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278921|NCT01875224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101278922|NCT01875263|Levofloxacin|levofloxacin|mesh-list
101278923|NCT01875263|Cloxacillin|cloxacillin|mesh-list
101278924|NCT01875263|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101278925|NCT01875263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101278926|NCT01875263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101278927|NCT01875263|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101278928|NCT01875263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101278929|NCT01875263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101278930|NCT01875263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278931|NCT01875263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278932|NCT01875263|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101278933|NCT01875263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101278934|NCT01875653|Molgramostim|molgramostim|mesh-list
101278935|NCT01875653|Sargramostim|sargramostim|mesh-list
101278936|NCT01875653|Immunologic Factors|immunologic factors|mesh-ancestor
101278937|NCT01875653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278938|NCT01875653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278939|NCT01875666|Trastuzumab|trastuzumab|mesh-list
101278940|NCT01875666|Pertuzumab|pertuzumab|mesh-list
101278941|NCT01875666|Lapatinib|lapatinib|mesh-list
101278942|NCT01875666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101278943|NCT01875666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278944|NCT01875666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101278945|NCT01875666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101278946|NCT01875666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278947|NCT01875705|Ravoxertinib|ravoxertinib|mesh-list
101278948|NCT01875705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278949|NCT01875705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101278950|NCT01875705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101278951|NCT01875705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278952|NCT01875757|Vitamin D|vitamin d|mesh-list
101278953|NCT01875757|Cholecalciferol|cholecalciferol|mesh-list
101278954|NCT01875757|Vitamins|vitamins|mesh-ancestor
101278955|NCT01875757|Micronutrients|micronutrients|mesh-ancestor
101278956|NCT01875757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278957|NCT01875757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101278958|NCT01875757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101278960|NCT01875822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101278961|NCT01875822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101278962|NCT01875822|Analgesics|analgesics|mesh-ancestor
101278963|NCT01875822|Sensory System Agents|sensory system agents|mesh-ancestor
101278964|NCT01875822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101278965|NCT01875822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278966|NCT01875822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101278967|NCT01875822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101278968|NCT01875822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278969|NCT01875822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101278970|NCT01875822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278971|NCT01875926|Gontivimab|gontivimab|mesh-list
101278972|NCT01875926|Antiviral Agents|antiviral agents|mesh-ancestor
101818796|NCT01098019|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101818797|NCT01098019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101818798|NCT01098019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818799|NCT01098019|Cholinergic Agents|cholinergic agents|mesh-ancestor
101278973|NCT01875926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101278974|NCT01875939|Levonadifloxacin|levonadifloxacin|mesh-list
101278975|NCT01875939|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101278976|NCT01875939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101278977|NCT01875939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278978|NCT01875939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101278979|NCT01875939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101278980|NCT01875952|Isoniazid|isoniazid|mesh-list
101278981|NCT01875952|Antitubercular Agents|antitubercular agents|mesh-ancestor
101278982|NCT01875952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101278983|NCT01875952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101278984|NCT01875952|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101278985|NCT01875952|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101278986|NCT01875952|Antimetabolites|antimetabolites|mesh-ancestor
101278987|NCT01875952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278988|NCT01875952|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101278989|NCT01876004|Methotrexate|methotrexate|mesh-list
101278990|NCT01876004|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101278991|NCT01876004|Abortifacient Agents|abortifacient agents|mesh-ancestor
101278992|NCT01876004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101278993|NCT01876004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101278994|NCT01876004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101278995|NCT01876004|Antimetabolites|antimetabolites|mesh-ancestor
101278996|NCT01876004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101278997|NCT01876004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101278998|NCT01876004|Dermatologic Agents|dermatologic agents|mesh-ancestor
101278999|NCT01876004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101279000|NCT01876004|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101279001|NCT01876004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101279002|NCT01876004|Immunologic Factors|immunologic factors|mesh-ancestor
101279003|NCT01876004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101279004|NCT01876004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101279005|NCT01876108|Amoxicillin|amoxicillin|mesh-list
101279006|NCT01876108|Azithromycin|azithromycin|mesh-list
101279007|NCT01876108|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
101279008|NCT01876108|Omeprazole|omeprazole|mesh-list
101279009|NCT01876108|Bismuth|bismuth|mesh-list
101279010|NCT01876108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101279011|NCT01876108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101279012|NCT01876108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101279013|NCT01876108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101279014|NCT01876108|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101279015|NCT01876108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314947|NCT00001624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279016|NCT01876108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279018|NCT01876121|Celecoxib|celecoxib|mesh-list
101279019|NCT01876121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101279020|NCT01876121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101279021|NCT01876121|Analgesics|analgesics|mesh-ancestor
101279022|NCT01876121|Sensory System Agents|sensory system agents|mesh-ancestor
101279023|NCT01876121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101279024|NCT01876121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279025|NCT01876121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101279026|NCT01876121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101279027|NCT01876121|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101279028|NCT01876121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101279030|NCT01876121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279031|NCT01876186|Solifenacin Succinate|solifenacin succinate|mesh-list
101279032|NCT01876186|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101279033|NCT01876186|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101279034|NCT01876186|Cholinergic Agents|cholinergic agents|mesh-ancestor
101279035|NCT01876186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101279036|NCT01876186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279037|NCT01876186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818800|NCT01098019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101818801|NCT01098019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818802|NCT01098019|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101818803|NCT01098019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101818804|NCT00365716|Vaccines|vaccines|mesh-list
101818805|NCT00365716|Immunologic Factors|immunologic factors|mesh-ancestor
101818806|NCT00365716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818807|NCT01049542|Astressin|astressin|mesh-list
101818808|NCT01049542|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101818809|NCT01049542|Protective Agents|protective agents|mesh-ancestor
101818810|NCT01049542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279038|NCT01876186|Urological Agents|urological agents|mesh-ancestor
101279039|NCT01876290|Dexamethasone|dexamethasone|mesh-list
101279040|NCT01876290|Ondansetron|ondansetron|mesh-list
101279041|NCT01876290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101279042|NCT01876290|Antiemetics|antiemetics|mesh-ancestor
101279043|NCT01876290|Autonomic Agents|autonomic agents|mesh-ancestor
101279044|NCT01876290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101279045|NCT01876290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279046|NCT01876290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101279047|NCT01876290|Glucocorticoids|glucocorticoids|mesh-ancestor
101279048|NCT01876290|Hormones|hormones|mesh-ancestor
101279049|NCT01876290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101279050|NCT01876290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101279051|NCT01876290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101279052|NCT01876290|Antipruritics|antipruritics|mesh-ancestor
101279053|NCT01876290|Dermatologic Agents|dermatologic agents|mesh-ancestor
101279054|NCT01876290|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101279055|NCT01876290|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101279056|NCT01876290|Serotonin Agents|serotonin agents|mesh-ancestor
101279057|NCT01876290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101279058|NCT01876290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279059|NCT01876316|Moxifloxacin|moxifloxacin|mesh-list
101279060|NCT01876316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101279061|NCT01876316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101279062|NCT01876316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101279063|NCT01876316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101279064|NCT01876316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101279065|NCT01876316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279066|NCT01876316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101279067|NCT01876433|Mirabegron|mirabegron|mesh-list
101279068|NCT01876433|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101279069|NCT01876433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101279070|NCT01876433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101279071|NCT01876433|Adrenergic Agents|adrenergic agents|mesh-ancestor
101279072|NCT01876433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101279073|NCT01876433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279074|NCT01876433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279075|NCT01876433|Urological Agents|urological agents|mesh-ancestor
101279076|NCT01876550|Mupirocin|mupirocin|mesh-list
101279077|NCT01876550|Calcium|calcium|mesh-list
101279078|NCT01876550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101279079|NCT01876550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279080|NCT01876550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101279081|NCT01876550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101279082|NCT01876550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101279083|NCT01876550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314965|NCT00001693|Celecoxib|celecoxib|mesh-list
101279084|NCT01876550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279085|NCT01876563|Vitamin D|vitamin d|mesh-list
101279086|NCT01876563|Vitamins|vitamins|mesh-ancestor
101279087|NCT01876563|Micronutrients|micronutrients|mesh-ancestor
101279088|NCT01876563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818812|NCT01049620|Oxaliplatin|oxaliplatin|mesh-list
101818813|NCT01049620|Everolimus|everolimus|mesh-list
101818814|NCT01049620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101818815|NCT01049620|Antimetabolites|antimetabolites|mesh-ancestor
101818816|NCT01049620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818817|NCT01049620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101818818|NCT01049620|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101818819|NCT01049620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101818820|NCT01049620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101818821|NCT01049620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101818822|NCT01049620|Immunologic Factors|immunologic factors|mesh-ancestor
101818823|NCT01049620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279089|NCT01876563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101279090|NCT01876615|Diclofenac|diclofenac|mesh-list
101279091|NCT01876615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101279092|NCT01876615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101279093|NCT01876615|Analgesics|analgesics|mesh-ancestor
101279096|NCT01876615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279097|NCT01876615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101279098|NCT01876615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101279099|NCT01876615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101279100|NCT01876615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101279101|NCT01876615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279103|NCT01876641|Vemurafenib|vemurafenib|mesh-list
101279104|NCT01876641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101279105|NCT01876641|Antimetabolites|antimetabolites|mesh-ancestor
101279106|NCT01876641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279107|NCT01876641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101279108|NCT01876641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101279109|NCT01876641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101279110|NCT01876797|Ticagrelor|ticagrelor|mesh-list
101279111|NCT01876797|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101279112|NCT01876797|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101279113|NCT01876797|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101279114|NCT01876797|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101279115|NCT01876797|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101279116|NCT01876797|Purinergic Agents|purinergic agents|mesh-ancestor
101279117|NCT01876797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101279118|NCT01876797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279119|NCT01876797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279120|NCT01876849|Exenatide|exenatide|mesh-list
101279121|NCT01876849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101279122|NCT01876849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279123|NCT01876849|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101279124|NCT01876849|Incretins|incretins|mesh-ancestor
101279125|NCT01876849|Hormones|hormones|mesh-ancestor
101279126|NCT01876849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101279127|NCT01876862|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101279128|NCT01876862|Antiviral Agents|antiviral agents|mesh-ancestor
101279129|NCT01876862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101279130|NCT01876966|Ritonavir|ritonavir|mesh-list
101279131|NCT01876966|Darunavir|darunavir|mesh-list
101279132|NCT01876966|Lumefantrine|lumefantrine|mesh-list
101279133|NCT01876966|Artemether|artemether|mesh-list
101279134|NCT01876966|Etravirine|etravirine|mesh-list
101279135|NCT01876966|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101279136|NCT01876966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101279137|NCT01876966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101279138|NCT01876966|Protease Inhibitors|protease inhibitors|mesh-ancestor
101279139|NCT01876966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101818824|NCT00059839|Prednisone|prednisone|mesh-list
101818825|NCT00059839|Doxorubicin|doxorubicin|mesh-list
101818826|NCT00059839|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101818827|NCT00059839|Methotrexate|methotrexate|mesh-list
101818828|NCT00059839|Vincristine|vincristine|mesh-list
101818829|NCT00059839|Mercaptopurine|mercaptopurine|mesh-list
101818830|NCT00059839|Vinblastine|vinblastine|mesh-list
101818831|NCT00059839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101818832|NCT00059839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101818833|NCT00059839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101279140|NCT01876966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279141|NCT01876966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101279142|NCT01876966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101279143|NCT01876966|Antiviral Agents|antiviral agents|mesh-ancestor
101279144|NCT01876966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101279145|NCT01876966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101279146|NCT01876966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101279147|NCT01876966|Antimalarials|antimalarials|mesh-ancestor
101279148|NCT01876966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101279149|NCT01876966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101279150|NCT01876966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101279151|NCT01876966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101279152|NCT01877122|Ibuprofen|ibuprofen|mesh-list
101279153|NCT01877122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101279154|NCT01877122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101279155|NCT01877122|Analgesics|analgesics|mesh-ancestor
101279156|NCT01877122|Sensory System Agents|sensory system agents|mesh-ancestor
101279157|NCT01877122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101279158|NCT01877122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279159|NCT01877122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101279160|NCT01877122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101279161|NCT01877122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101279162|NCT01877122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101279163|NCT01877122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279164|NCT01877226|Tapentadol|tapentadol|mesh-list
101279165|NCT01877226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101279166|NCT01877226|Narcotics|narcotics|mesh-ancestor
101279167|NCT01877226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101279168|NCT01877226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279169|NCT01877226|Analgesics|analgesics|mesh-ancestor
101279170|NCT01877226|Sensory System Agents|sensory system agents|mesh-ancestor
101279171|NCT01877226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101279172|NCT01877226|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101279173|NCT01877226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101279174|NCT01877226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101279175|NCT01877226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279176|NCT01877226|Adrenergic Agents|adrenergic agents|mesh-ancestor
101279177|NCT01877226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101279178|NCT01877356|Anesthetics|anesthetics|mesh-list
101279179|NCT01877356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101279180|NCT01877356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279181|NCT01877512|Hormones|hormones|mesh-list
101279182|NCT01877512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101279183|NCT01877512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279184|NCT01877577|Vitamin D|vitamin d|mesh-list
101279185|NCT01877577|Ergocalciferols|ergocalciferols|mesh-list
101279186|NCT01877577|Cholecalciferol|cholecalciferol|mesh-list
101279187|NCT01877577|Vitamins|vitamins|mesh-list
101279188|NCT01877577|Micronutrients|micronutrients|mesh-ancestor
101279189|NCT01877577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279190|NCT01877577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101279191|NCT01877577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101279192|NCT01877590|Thioctic Acid|thioctic acid|mesh-list
101279193|NCT01877590|Antioxidants|antioxidants|mesh-ancestor
101818834|NCT00059839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101818835|NCT00059839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101818836|NCT00059839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818837|NCT00059839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101818838|NCT00059839|Glucocorticoids|glucocorticoids|mesh-ancestor
101818839|NCT00059839|Hormones|hormones|mesh-ancestor
101818840|NCT00059839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101818841|NCT00059839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279194|NCT01877590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279195|NCT01877590|Protective Agents|protective agents|mesh-ancestor
101279196|NCT01877590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279197|NCT01877590|Vitamin B Complex|vitamin b complex|mesh-ancestor
101279198|NCT01877590|Vitamins|vitamins|mesh-ancestor
101279199|NCT01877590|Micronutrients|micronutrients|mesh-ancestor
101279200|NCT01877746|Prednisone|prednisone|mesh-list
101279201|NCT01877746|Azathioprine|azathioprine|mesh-list
101279202|NCT01877746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101279203|NCT01877746|Glucocorticoids|glucocorticoids|mesh-ancestor
101279204|NCT01877746|Hormones|hormones|mesh-ancestor
101314986|NCT00001696|Phytoestrogens|phytoestrogens|mesh-ancestor
101279205|NCT01877746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101279206|NCT01877746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279207|NCT01877746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101279208|NCT01877746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101279209|NCT01877746|Antimetabolites|antimetabolites|mesh-ancestor
101279210|NCT01877746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279211|NCT01877746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101279212|NCT01877746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101279213|NCT01877746|Immunologic Factors|immunologic factors|mesh-ancestor
101279214|NCT01877746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101279215|NCT01877811|Agerafenib|agerafenib|mesh-list
101279216|NCT01877811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101279217|NCT01877811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101279218|NCT01877811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279219|NCT01877889|Dapagliflozin|dapagliflozin|mesh-list
101279220|NCT01877889|Canagliflozin|canagliflozin|mesh-list
101279221|NCT01877889|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101279222|NCT01877889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279223|NCT01877889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101279224|NCT01877889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279225|NCT01877954|Fluticasone|fluticasone|mesh-list
101279226|NCT01877954|Xhance|xhance|mesh-list
101279227|NCT01877954|Beclomethasone|beclomethasone|mesh-list
101279228|NCT01877954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101279229|NCT01877954|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101279230|NCT01877954|Autonomic Agents|autonomic agents|mesh-ancestor
101279231|NCT01877954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101279232|NCT01877954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279233|NCT01877954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101279234|NCT01877954|Respiratory System Agents|respiratory system agents|mesh-ancestor
101279235|NCT01877954|Dermatologic Agents|dermatologic agents|mesh-ancestor
101279236|NCT01877954|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101279237|NCT01877954|Glucocorticoids|glucocorticoids|mesh-ancestor
101279238|NCT01877954|Hormones|hormones|mesh-ancestor
101279239|NCT01877954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101279240|NCT01878136|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101279241|NCT01878136|Plasminogen|plasminogen|mesh-list
101279242|NCT01878136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101279243|NCT01878136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101279244|NCT01878136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279245|NCT01878188|BCG Vaccine|bcg vaccine|mesh-list
101818842|NCT00059839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101818843|NCT00059839|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101818844|NCT00059839|Abortifacient Agents|abortifacient agents|mesh-ancestor
101818845|NCT00059839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101818846|NCT00059839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101818847|NCT00059839|Antimetabolites|antimetabolites|mesh-ancestor
101818848|NCT00059839|Dermatologic Agents|dermatologic agents|mesh-ancestor
101476146|NCT00268697|Ezetimibe|ezetimibe|mesh-list
101818849|NCT00059839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101818850|NCT00059839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101818851|NCT00059839|Immunologic Factors|immunologic factors|mesh-ancestor
101818852|NCT00059839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101818853|NCT00059839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101818854|NCT00059839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101818855|NCT00059839|Tubulin Modulators|tubulin modulators|mesh-ancestor
101818856|NCT00059839|Antimitotic Agents|antimitotic agents|mesh-ancestor
101818857|NCT00059839|Mitosis Modulators|mitosis modulators|mesh-ancestor
101818858|NCT00059215|Clopidogrel|clopidogrel|mesh-list
101818859|NCT00059215|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101818860|NCT00059215|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101818861|NCT00059215|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101279246|NCT01878188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101279247|NCT01878188|Immunologic Factors|immunologic factors|mesh-ancestor
101279248|NCT01878188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279249|NCT01878201|Valsartan|valsartan|mesh-list
101279250|NCT01878201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101279251|NCT01878201|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101279252|NCT01878201|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101279253|NCT01878201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279254|NCT01878227|Fenofibrate|fenofibrate|mesh-list
101279255|NCT01878227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101279256|NCT01878227|Antimetabolites|antimetabolites|mesh-ancestor
101279257|NCT01878227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279258|NCT01878227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101279259|NCT01878318|Methotrexate|methotrexate|mesh-list
101279260|NCT01878318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101279261|NCT01878318|Abortifacient Agents|abortifacient agents|mesh-ancestor
101279262|NCT01878318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101279263|NCT01878318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279264|NCT01878318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101279265|NCT01878318|Antimetabolites|antimetabolites|mesh-ancestor
101279266|NCT01878318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279267|NCT01878318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101279268|NCT01878318|Dermatologic Agents|dermatologic agents|mesh-ancestor
101279269|NCT01878318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101279270|NCT01878318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101279271|NCT01878318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101279272|NCT01878318|Immunologic Factors|immunologic factors|mesh-ancestor
101279273|NCT01878318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101279274|NCT01878318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101279275|NCT01878357|Piperaquine|piperaquine|mesh-list
101818862|NCT00059215|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101818863|NCT00059215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101818864|NCT00059215|Purinergic Agents|purinergic agents|mesh-ancestor
101818865|NCT00059215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101818866|NCT00059215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818867|NCT00059215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818869|NCT00058825|Fludarabine|fludarabine|mesh-list
101818870|NCT00058825|Alemtuzumab|alemtuzumab|mesh-list
101818871|NCT00058825|Tacrolimus|tacrolimus|mesh-list
101818872|NCT00058825|Cyclosporins|cyclosporins|mesh-list
101818873|NCT00058825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101279276|NCT01878357|Primaquine|primaquine|mesh-list
101279278|NCT01878357|Antimalarials|antimalarials|mesh-ancestor
101279279|NCT01878357|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101279280|NCT01878357|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101279281|NCT01878357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101279282|NCT01878422|Leucovorin|leucovorin|mesh-list
101279283|NCT01878422|Bevacizumab|bevacizumab|mesh-list
101279284|NCT01878422|Cetuximab|cetuximab|mesh-list
101279285|NCT01878422|Fluorouracil|fluorouracil|mesh-list
101279286|NCT01878422|Oxaliplatin|oxaliplatin|mesh-list
101279287|NCT01878422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101279288|NCT01878422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101279289|NCT01878422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101279290|NCT01878422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101279291|NCT01878422|Growth Substances|growth substances|mesh-ancestor
101279292|NCT01878422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279293|NCT01878422|Growth Inhibitors|growth inhibitors|mesh-ancestor
101279294|NCT01878422|Antimetabolites|antimetabolites|mesh-ancestor
101279295|NCT01878422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279296|NCT01878422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101279297|NCT01878422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101279298|NCT01878422|Immunologic Factors|immunologic factors|mesh-ancestor
101279299|NCT01878422|Antidotes|antidotes|mesh-ancestor
101279300|NCT01878422|Protective Agents|protective agents|mesh-ancestor
101279301|NCT01878422|Vitamin B Complex|vitamin b complex|mesh-ancestor
101279302|NCT01878422|Vitamins|vitamins|mesh-ancestor
101279303|NCT01878422|Micronutrients|micronutrients|mesh-ancestor
101279304|NCT01878513|Risperidone|risperidone|mesh-list
101279305|NCT01878513|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101279306|NCT01878513|Serotonin Agents|serotonin agents|mesh-ancestor
101279307|NCT01878513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101279308|NCT01878513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279309|NCT01878513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279310|NCT01878513|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101279311|NCT01878513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101279312|NCT01878513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101279313|NCT01878513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101279314|NCT01878513|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101279315|NCT01878513|Dopamine Agents|dopamine agents|mesh-ancestor
101279316|NCT01878539|Anticoagulants|anticoagulants|mesh-list
101279317|NCT01878578|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
101279318|NCT01878578|Phenytoin|phenytoin|mesh-list
101279319|NCT01878578|Anticonvulsants|anticonvulsants|mesh-ancestor
101279320|NCT01878578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101279321|NCT01878578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101279322|NCT01878578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101279323|NCT01878578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279324|NCT01878578|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101279325|NCT01878578|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101279326|NCT01878643|Vancomycin|vancomycin|mesh-list
101279327|NCT01878643|Gentamicins|gentamicins|mesh-list
101279328|NCT01878643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101818874|NCT00058825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818875|NCT00058825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101818876|NCT00058825|Immunologic Factors|immunologic factors|mesh-ancestor
101818877|NCT00058825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818878|NCT00058825|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101818879|NCT00058825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101279329|NCT01878643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101279330|NCT01878643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101279331|NCT01878643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101279332|NCT01878643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279334|NCT01878695|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101279335|NCT01878695|Antiviral Agents|antiviral agents|mesh-ancestor
101279336|NCT01878695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101279337|NCT01878695|Expectorants|expectorants|mesh-ancestor
101279338|NCT01878695|Respiratory System Agents|respiratory system agents|mesh-ancestor
101279339|NCT01878695|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101279340|NCT01878695|Antioxidants|antioxidants|mesh-ancestor
101279341|NCT01878695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279342|NCT01878695|Protective Agents|protective agents|mesh-ancestor
101279343|NCT01878695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279344|NCT01878695|Antidotes|antidotes|mesh-ancestor
101279345|NCT01878708|Dexamethasone|dexamethasone|mesh-list
101279346|NCT01878708|Dexamethasone acetate|dexamethasone acetate|mesh-list
101279347|NCT01878708|Asparaginase|asparaginase|mesh-list
101279348|NCT01878708|Pegaspargase|pegaspargase|mesh-list
101279349|NCT01878708|BB 1101|bb 1101|mesh-list
101279350|NCT01878708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101279351|NCT01878708|Antiemetics|antiemetics|mesh-ancestor
101279352|NCT01878708|Autonomic Agents|autonomic agents|mesh-ancestor
101279353|NCT01878708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101279354|NCT01878708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279355|NCT01878708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101279356|NCT01878708|Glucocorticoids|glucocorticoids|mesh-ancestor
101279357|NCT01878708|Hormones|hormones|mesh-ancestor
101279358|NCT01878708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101279359|NCT01878708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101279360|NCT01878708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101279361|NCT01878708|Protease Inhibitors|protease inhibitors|mesh-ancestor
101279362|NCT01878708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101279363|NCT01878708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279364|NCT01878734|Micronutrients|micronutrients|mesh-list
101279365|NCT01878734|Trace Elements|trace elements|mesh-list
101279366|NCT01878734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279367|NCT01878864|Lidocaine|lidocaine|mesh-list
101279368|NCT01878864|Bupivacaine|bupivacaine|mesh-list
101279369|NCT01878864|Anesthetics, Local|anesthetics, local|mesh-ancestor
101279370|NCT01878864|Anesthetics|anesthetics|mesh-ancestor
101279371|NCT01878864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101279372|NCT01878864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279373|NCT01878864|Sensory System Agents|sensory system agents|mesh-ancestor
101279374|NCT01878864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101279375|NCT01878864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101279376|NCT01878864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101279377|NCT01878864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101279378|NCT01878864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101279379|NCT01878864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279380|NCT01878942|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
101279381|NCT01878942|Hallucinogens|hallucinogens|mesh-ancestor
101279382|NCT01878942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279383|NCT01878942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101279384|NCT01878942|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101279385|NCT01878942|Serotonin Agents|serotonin agents|mesh-ancestor
101279386|NCT01878942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101279387|NCT01878942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279388|NCT01878942|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101279389|NCT01879007|Gemifloxacin|gemifloxacin|mesh-list
101279390|NCT01879007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101818880|NCT00058825|Antifungal Agents|antifungal agents|mesh-ancestor
101818881|NCT00058825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101818882|NCT00058825|Dermatologic Agents|dermatologic agents|mesh-ancestor
101818883|NCT00058825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101818884|NCT00058825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101818885|NCT02535052|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101818886|NCT02535052|Immunologic Factors|immunologic factors|mesh-ancestor
101818887|NCT02535052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279391|NCT01879007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101279392|NCT01879007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101279393|NCT01879007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101279394|NCT01879007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101279395|NCT01879007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279396|NCT01879007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101279397|NCT01879033|Insulin|insulin|mesh-list
101279398|NCT01879033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101279399|NCT01879033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279400|NCT01879202|Methylphenidate|methylphenidate|mesh-list
101279401|NCT01879202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101279402|NCT01879202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279403|NCT01879202|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101279404|NCT01879202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101279405|NCT01879202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101279406|NCT01879202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279407|NCT01879202|Dopamine Agents|dopamine agents|mesh-ancestor
101279408|NCT01879202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101279409|NCT01879293|Metformin|metformin|mesh-list
101279410|NCT01879293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101279411|NCT01879293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279412|NCT01879358|Sirolimus|sirolimus|mesh-list
101279413|NCT01879358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101279414|NCT01879358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101279415|NCT01879358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101279416|NCT01879358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101279417|NCT01879358|Antifungal Agents|antifungal agents|mesh-ancestor
101279418|NCT01879358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101279419|NCT01879358|Immunologic Factors|immunologic factors|mesh-ancestor
101279420|NCT01879358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279421|NCT01879423|Lamotrigine|lamotrigine|mesh-list
101279422|NCT01879423|Anticonvulsants|anticonvulsants|mesh-list
101279423|NCT01879423|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101279424|NCT01879423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101279425|NCT01879423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279426|NCT01879423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101279427|NCT01879423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279428|NCT01879423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101279429|NCT01879423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101279430|NCT01879423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101279431|NCT01879423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101279432|NCT01879423|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101279433|NCT01879488|Edetic Acid|edetic acid|mesh-list
101279434|NCT01879488|Pentetic Acid|pentetic acid|mesh-list
101279435|NCT01879488|Antidotes|antidotes|mesh-ancestor
101279436|NCT01879488|Protective Agents|protective agents|mesh-ancestor
101279437|NCT01879488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279438|NCT01879488|Chelating Agents|chelating agents|mesh-ancestor
101279439|NCT01879488|Sequestering Agents|sequestering agents|mesh-ancestor
101279440|NCT01879488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279441|NCT01879488|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101279442|NCT01879488|Anticoagulants|anticoagulants|mesh-ancestor
101279443|NCT01879488|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101818889|NCT03953989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101818890|NCT03953989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101818891|NCT03953989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818892|NCT01096225|Vaccines|vaccines|mesh-list
101279445|NCT01879514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101279446|NCT01879514|Glucocorticoids|glucocorticoids|mesh-ancestor
101279448|NCT01879514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101279449|NCT01879514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279450|NCT01879514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101279451|NCT01879514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101279453|NCT01879527|Amiloride|amiloride|mesh-list
101279454|NCT01879527|Amiloride, hydrochlorothiazide drug combination|amiloride, hydrochlorothiazide drug combination|mesh-list
101279455|NCT01879527|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101279456|NCT01879527|Diuretics|diuretics|mesh-ancestor
101279457|NCT01879527|Natriuretic Agents|natriuretic agents|mesh-ancestor
101279458|NCT01879527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279459|NCT01879527|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101279460|NCT01879527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101279461|NCT01879527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279462|NCT01879527|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
101279463|NCT01879527|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101279464|NCT01879527|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101279465|NCT01879527|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101279466|NCT01879605|Bisacodyl|bisacodyl|mesh-list
101279467|NCT01879605|Sorbitol|sorbitol|mesh-list
101279468|NCT01879605|Cathartics|cathartics|mesh-ancestor
101279469|NCT01879605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101279470|NCT01879605|Laxatives|laxatives|mesh-ancestor
101279471|NCT01879748|Rasagiline|rasagiline|mesh-list
101279472|NCT01879748|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101279473|NCT01879748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101279474|NCT01879748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279475|NCT01879748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101279476|NCT01879748|Protective Agents|protective agents|mesh-ancestor
101279477|NCT01879748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279478|NCT01879917|Liraglutide|liraglutide|mesh-list
101279479|NCT01879917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101279480|NCT01879917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279481|NCT01879917|Incretins|incretins|mesh-ancestor
101279482|NCT01879917|Hormones|hormones|mesh-ancestor
101279483|NCT01879917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101279484|NCT01879930|Doxycycline|doxycycline|mesh-list
101279485|NCT01879930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101279486|NCT01879930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101279487|NCT01879930|Antimalarials|antimalarials|mesh-ancestor
101279488|NCT01879930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101279489|NCT01879930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101279490|NCT01880112|Cefazolin|cefazolin|mesh-list
101279491|NCT01880112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101279492|NCT01880112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101279493|NCT01880125|Acetaminophen|acetaminophen|mesh-list
101279494|NCT01880125|Tramadol|tramadol|mesh-list
101279495|NCT01880125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101279496|NCT01880125|Analgesics|analgesics|mesh-ancestor
101279497|NCT01880125|Sensory System Agents|sensory system agents|mesh-ancestor
101279498|NCT01880125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101279499|NCT01880125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279500|NCT01880125|Antipyretics|antipyretics|mesh-ancestor
101279501|NCT01880125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101279502|NCT01880125|Narcotics|narcotics|mesh-ancestor
101279503|NCT01880125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101279504|NCT01880138|Anesthetics|anesthetics|mesh-list
101279505|NCT01880138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101279506|NCT01880138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279508|NCT01880216|Enoxaparin sodium|enoxaparin sodium|mesh-list
101279509|NCT01880216|Bemiparin|bemiparin|mesh-list
101279510|NCT01880216|Anticoagulants|anticoagulants|mesh-ancestor
101279511|NCT01880216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101279512|NCT01880216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101279513|NCT01880216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279514|NCT01880307|Prednisolone|prednisolone|mesh-list
101818893|NCT01096225|Immunologic Factors|immunologic factors|mesh-ancestor
101818894|NCT01096225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818895|NCT02535130|Amikacin|amikacin|mesh-list
101818896|NCT02535130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101818897|NCT02535130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101818898|NCT01046500|Inositol|inositol|mesh-list
101818899|NCT01046500|Metformin|metformin|mesh-list
101818900|NCT01046500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101279515|NCT01880307|Infliximab|infliximab|mesh-list
101279516|NCT01880307|Azathioprine|azathioprine|mesh-list
101279517|NCT01880307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101279518|NCT01880307|Glucocorticoids|glucocorticoids|mesh-ancestor
101279519|NCT01880307|Hormones|hormones|mesh-ancestor
101279520|NCT01880307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101279521|NCT01880307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279522|NCT01880307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101279523|NCT01880307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101279524|NCT01880307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101279525|NCT01880307|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101279526|NCT01880307|Dermatologic Agents|dermatologic agents|mesh-ancestor
101279527|NCT01880307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101279528|NCT01880307|Antimetabolites|antimetabolites|mesh-ancestor
101279529|NCT01880307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279530|NCT01880307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101279531|NCT01880307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101279532|NCT01880307|Immunologic Factors|immunologic factors|mesh-ancestor
101279533|NCT01880346|Vitamin D|vitamin d|mesh-list
101279534|NCT01880346|Ergocalciferols|ergocalciferols|mesh-list
101279535|NCT01880346|Cholecalciferol|cholecalciferol|mesh-list
101279536|NCT01880346|Vitamins|vitamins|mesh-list
101279537|NCT01880346|Micronutrients|micronutrients|mesh-ancestor
101279538|NCT01880346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279539|NCT01880346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101279540|NCT01880346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101279541|NCT01880372|Thioctic Acid|thioctic acid|mesh-list
101279542|NCT01880372|Antioxidants|antioxidants|mesh-ancestor
101279543|NCT01880372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279544|NCT01880372|Protective Agents|protective agents|mesh-ancestor
101279545|NCT01880372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279546|NCT01880372|Vitamin B Complex|vitamin b complex|mesh-ancestor
101279547|NCT01880372|Vitamins|vitamins|mesh-ancestor
101279548|NCT01880372|Micronutrients|micronutrients|mesh-ancestor
101279549|NCT01880385|Cyclophosphamide|cyclophosphamide|mesh-list
101279550|NCT01880385|Bevacizumab|bevacizumab|mesh-list
101279551|NCT01880385|Docetaxel|docetaxel|mesh-list
101279552|NCT01880385|Fluorouracil|fluorouracil|mesh-list
101279553|NCT01880385|Trastuzumab|trastuzumab|mesh-list
101279554|NCT01880385|Epirubicin|epirubicin|mesh-list
101279555|NCT01880385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101279556|NCT01880385|Immunologic Factors|immunologic factors|mesh-ancestor
101279557|NCT01880385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279558|NCT01880385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101279559|NCT01880385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101279560|NCT01880385|Alkylating Agents|alkylating agents|mesh-ancestor
101279561|NCT01880385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279562|NCT01880385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101279563|NCT01880385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101279564|NCT01880385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101279566|NCT01880385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101279567|NCT01880385|Growth Substances|growth substances|mesh-ancestor
101279568|NCT01880385|Growth Inhibitors|growth inhibitors|mesh-ancestor
101279569|NCT01880385|Tubulin Modulators|tubulin modulators|mesh-ancestor
101279570|NCT01880385|Antimitotic Agents|antimitotic agents|mesh-ancestor
101279571|NCT01880385|Mitosis Modulators|mitosis modulators|mesh-ancestor
101279572|NCT01880385|Antimetabolites|antimetabolites|mesh-ancestor
101279573|NCT01880385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101279574|NCT01880385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101279575|NCT01880385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101279576|NCT01880385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101279577|NCT01880385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101279578|NCT01880463|Vitamin D|vitamin d|mesh-list
101818901|NCT01046500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818902|NCT01046500|Vitamin B Complex|vitamin b complex|mesh-ancestor
101818903|NCT01046500|Vitamins|vitamins|mesh-ancestor
101818904|NCT01046500|Micronutrients|micronutrients|mesh-ancestor
101818905|NCT01046578|Letrozole|letrozole|mesh-list
101818906|NCT01046578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101818907|NCT01046578|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101818908|NCT01046578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101818909|NCT01046578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101818910|NCT01046578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279579|NCT01880463|Ergocalciferols|ergocalciferols|mesh-list
101279580|NCT01880463|Cholecalciferol|cholecalciferol|mesh-list
101279581|NCT01880463|Vitamins|vitamins|mesh-list
101279582|NCT01880463|Micronutrients|micronutrients|mesh-ancestor
101279583|NCT01880463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279584|NCT01880463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101279585|NCT01880463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101279586|NCT01880619|Tamsulosin|tamsulosin|mesh-list
101279587|NCT01880619|Solifenacin Succinate|solifenacin succinate|mesh-list
101279588|NCT01880619|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101279589|NCT01880619|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101315058|NCT00000216|Analgesics|analgesics|mesh-ancestor
101279590|NCT01880619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101279591|NCT01880619|Adrenergic Agents|adrenergic agents|mesh-ancestor
101279592|NCT01880619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101279593|NCT01880619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279594|NCT01880619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279595|NCT01880619|Urological Agents|urological agents|mesh-ancestor
101279596|NCT01880619|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101279597|NCT01880619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101279598|NCT01880619|Cholinergic Agents|cholinergic agents|mesh-ancestor
101279599|NCT01880658|Capecitabine|capecitabine|mesh-list
101279600|NCT01880658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101279601|NCT01880658|Antimetabolites|antimetabolites|mesh-ancestor
101279602|NCT01880658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279603|NCT01880658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101279604|NCT01880749|Everolimus|everolimus|mesh-list
101279605|NCT01880749|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101279606|NCT01880749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101279607|NCT01880749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101279608|NCT01880749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279609|NCT01880749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101279610|NCT01880749|Immunologic Factors|immunologic factors|mesh-ancestor
101279611|NCT01880749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279612|NCT01880749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101279613|NCT01880775|Bupivacaine|bupivacaine|mesh-list
101279614|NCT01880775|Prilocaine|prilocaine|mesh-list
101279615|NCT01880775|Anesthetics, Local|anesthetics, local|mesh-ancestor
101279616|NCT01880775|Anesthetics|anesthetics|mesh-ancestor
101279617|NCT01880775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101279618|NCT01880775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279619|NCT01880775|Sensory System Agents|sensory system agents|mesh-ancestor
101279620|NCT01880775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101279621|NCT01879241|Rasagiline|rasagiline|mesh-list
101279622|NCT01879241|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101279623|NCT01879241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101279624|NCT01879241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279625|NCT01879241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101279626|NCT01879241|Protective Agents|protective agents|mesh-ancestor
101279627|NCT01879241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279629|NCT01880931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101279630|NCT01880931|Narcotics|narcotics|mesh-ancestor
101279631|NCT01880931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101818911|NCT01046578|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101818912|NCT01046578|Hormone Antagonists|hormone antagonists|mesh-ancestor
101818913|NCT01046578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101818914|NCT01046578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818915|NCT00372424|Docetaxel|docetaxel|mesh-list
101818916|NCT00372424|Trastuzumab|trastuzumab|mesh-list
101818917|NCT00372424|Sunitinib|sunitinib|mesh-list
101818918|NCT00372424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101818919|NCT00372424|Tubulin Modulators|tubulin modulators|mesh-ancestor
101818920|NCT00372424|Antimitotic Agents|antimitotic agents|mesh-ancestor
101279632|NCT01880931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279633|NCT01880931|Analgesics|analgesics|mesh-ancestor
101279634|NCT01880931|Sensory System Agents|sensory system agents|mesh-ancestor
101279635|NCT01880931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101279636|NCT01881074|Listerine|listerine|mesh-list
101279637|NCT01881074|Triclosan|triclosan|mesh-list
101279638|NCT01881074|Sodium Fluoride|sodium fluoride|mesh-list
101279639|NCT01881074|Cariostatic Agents|cariostatic agents|mesh-ancestor
101279640|NCT01881074|Protective Agents|protective agents|mesh-ancestor
101279641|NCT01881074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279642|NCT01881074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101279643|NCT01881074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101279644|NCT01881074|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101279645|NCT01881074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101279646|NCT01881074|Antimetabolites|antimetabolites|mesh-ancestor
101279647|NCT01881074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279648|NCT01881074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101279649|NCT01881100|Listerine|listerine|mesh-list
101279650|NCT01881100|Fluorides|fluorides|mesh-list
101279651|NCT01881100|Fluorides, Topical|fluorides, topical|mesh-list
101279652|NCT01881100|Sodium Fluoride|sodium fluoride|mesh-list
101279653|NCT01881100|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
101279654|NCT01881100|Cariostatic Agents|cariostatic agents|mesh-ancestor
101279655|NCT01881100|Protective Agents|protective agents|mesh-ancestor
101279656|NCT01881100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279657|NCT01881100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101279658|NCT01881100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101279659|NCT01881347|Resveratrol|resveratrol|mesh-list
101279660|NCT01881347|Antioxidants|antioxidants|mesh-ancestor
101279661|NCT01881347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279662|NCT01881347|Protective Agents|protective agents|mesh-ancestor
101279663|NCT01881347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279664|NCT01881347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101279665|NCT01881347|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101279666|NCT01881464|Adalimumab|adalimumab|mesh-list
101279667|NCT01881464|Infliximab|infliximab|mesh-list
101279668|NCT01881464|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101279669|NCT01881464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101279670|NCT01881464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101279671|NCT01881464|Dermatologic Agents|dermatologic agents|mesh-ancestor
101279672|NCT01881464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101279673|NCT01881503|HBOC 201|hboc 201|mesh-list
101279674|NCT01881503|Blood Substitutes|blood substitutes|mesh-ancestor
101279675|NCT01881568|Tranexamic Acid|tranexamic acid|mesh-list
101279676|NCT01881568|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101279677|NCT01881568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101279678|NCT01881568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279679|NCT01881568|Hemostatics|hemostatics|mesh-ancestor
101279680|NCT01881568|Coagulants|coagulants|mesh-ancestor
101279681|NCT01881919|Quercetin|quercetin|mesh-list
101279682|NCT01881919|Antioxidants|antioxidants|mesh-ancestor
101279683|NCT01881919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279684|NCT01881919|Protective Agents|protective agents|mesh-ancestor
101279685|NCT01881919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279686|NCT01881971|Calcium|calcium|mesh-list
101279687|NCT01881971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101279688|NCT01881971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279689|NCT01881997|Fentanyl|fentanyl|mesh-list
101818921|NCT00372424|Mitosis Modulators|mitosis modulators|mesh-ancestor
101818922|NCT00372424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818923|NCT00372424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101818924|NCT00372424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101818925|NCT00372424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101818926|NCT00372424|Growth Substances|growth substances|mesh-ancestor
101818927|NCT00372424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818928|NCT00372424|Growth Inhibitors|growth inhibitors|mesh-ancestor
101818929|NCT00372424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101818930|NCT00372424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101818931|NCT02530411|Fulvestrant|fulvestrant|mesh-list
101818932|NCT02530411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101818933|NCT02530411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101818934|NCT02530411|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101818935|NCT02530411|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101818936|NCT02530411|Hormone Antagonists|hormone antagonists|mesh-ancestor
101279690|NCT01881997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101279692|NCT01881997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101279693|NCT01881997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279695|NCT01881997|Sensory System Agents|sensory system agents|mesh-ancestor
101279696|NCT01881997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101279697|NCT01881997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101279698|NCT01881997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101279699|NCT01881997|Anesthetics, General|anesthetics, general|mesh-ancestor
101279700|NCT01881997|Anesthetics|anesthetics|mesh-ancestor
101279701|NCT01882010|Sargramostim|sargramostim|mesh-list
101279702|NCT01882010|Immunologic Factors|immunologic factors|mesh-ancestor
101279703|NCT01882010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279704|NCT01882075|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
101279705|NCT01882075|Plasma Substitutes|plasma substitutes|mesh-ancestor
101279706|NCT01882075|Blood Substitutes|blood substitutes|mesh-ancestor
101279707|NCT01882127|Dexamethasone|dexamethasone|mesh-list
101279708|NCT01882127|Tretinoin|tretinoin|mesh-list
101279709|NCT01882127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101279710|NCT01882127|Antiemetics|antiemetics|mesh-ancestor
101279711|NCT01882127|Autonomic Agents|autonomic agents|mesh-ancestor
101279712|NCT01882127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101279713|NCT01882127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279714|NCT01882127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101279715|NCT01882127|Glucocorticoids|glucocorticoids|mesh-ancestor
101279716|NCT01882127|Hormones|hormones|mesh-ancestor
101279717|NCT01882127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101279718|NCT01882127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101279719|NCT01882127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101279720|NCT01882127|Keratolytic Agents|keratolytic agents|mesh-ancestor
101279721|NCT01882127|Dermatologic Agents|dermatologic agents|mesh-ancestor
101279722|NCT01882179|Canrenoic Acid|canrenoic acid|mesh-list
101279723|NCT01882179|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
101279724|NCT01882179|Mineralocorticoids|mineralocorticoids|mesh-list
101279725|NCT01882179|Hormone Antagonists|hormone antagonists|mesh-ancestor
101279726|NCT01882179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101279727|NCT01882179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279728|NCT01882179|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101279729|NCT01882179|Diuretics|diuretics|mesh-ancestor
101279730|NCT01882179|Natriuretic Agents|natriuretic agents|mesh-ancestor
101279731|NCT01882179|Hormones|hormones|mesh-ancestor
101279732|NCT01882296|Pantoprazole|pantoprazole|mesh-list
101818937|NCT02530411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101818938|NCT02530411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818939|NCT01327027|Vasopressins|vasopressins|mesh-list
101818940|NCT01327027|Arginine Vasopressin|arginine vasopressin|mesh-list
101818941|NCT01327027|Hemostatics|hemostatics|mesh-ancestor
101818942|NCT01327027|Coagulants|coagulants|mesh-ancestor
101818943|NCT01327027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101818944|NCT01327027|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101818945|NCT01327027|Natriuretic Agents|natriuretic agents|mesh-ancestor
101279733|NCT01882296|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101279734|NCT01882296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101279735|NCT01882296|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101279736|NCT01882296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101279737|NCT01882296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279738|NCT01882322|Tacrolimus|tacrolimus|mesh-list
101279739|NCT01882322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101279740|NCT01882322|Immunologic Factors|immunologic factors|mesh-ancestor
101279741|NCT01882322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279742|NCT01882322|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101279743|NCT01882322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101279744|NCT01882322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279745|NCT01882361|Naltrexone|naltrexone|mesh-list
101279746|NCT01882361|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101279747|NCT01882361|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101279748|NCT01882361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279749|NCT01882361|Sensory System Agents|sensory system agents|mesh-ancestor
101279750|NCT01882361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101279751|NCT01882374|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
101279752|NCT01882374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101279753|NCT01882374|Vasodilator Agents|vasodilator agents|mesh-ancestor
101279754|NCT01882387|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
101279756|NCT01882387|Vasodilator Agents|vasodilator agents|mesh-ancestor
101279757|NCT01882400|Alendronate|alendronate|mesh-list
101279758|NCT01882400|Risedronic Acid|risedronic acid|mesh-list
101279759|NCT01882400|Diphosphonates|diphosphonates|mesh-list
101279760|NCT01882400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101279761|NCT01882400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279762|NCT01882400|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101279763|NCT01882400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101279764|NCT01882400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279765|NCT01882400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101279766|NCT01882530|Acetaminophen|acetaminophen|mesh-list
101279767|NCT01882530|Ketoprofen|ketoprofen|mesh-list
101279768|NCT01882530|Morphine|morphine|mesh-list
101279769|NCT01882530|Nefopam|nefopam|mesh-list
101279770|NCT01882530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101279771|NCT01882530|Narcotics|narcotics|mesh-ancestor
101279772|NCT01882530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101279773|NCT01882530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279774|NCT01882530|Analgesics|analgesics|mesh-ancestor
101279775|NCT01882530|Sensory System Agents|sensory system agents|mesh-ancestor
101279776|NCT01882530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101279777|NCT01882530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101279778|NCT01882530|Antipyretics|antipyretics|mesh-ancestor
101279779|NCT01882530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101279780|NCT01882530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101279781|NCT01882530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101279782|NCT01882530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101279783|NCT01882530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101279784|NCT01882530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279785|NCT01882556|Botulinum Toxins|botulinum toxins|mesh-list
101279786|NCT01882556|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101279787|NCT01882556|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101279788|NCT01882556|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101279789|NCT01882556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101818946|NCT01327027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818948|NCT01093807|Enalaprilat|enalaprilat|mesh-list
101818949|NCT01093807|Lercanidipine|lercanidipine|mesh-list
101818950|NCT01093807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101818951|NCT01093807|Protease Inhibitors|protease inhibitors|mesh-ancestor
101818952|NCT01093807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101279790|NCT01882556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279791|NCT01882556|Cholinergic Agents|cholinergic agents|mesh-ancestor
101279792|NCT01882556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101279793|NCT01882556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279794|NCT01882556|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101279795|NCT01882556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101279796|NCT01882920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101279797|NCT01883011|Piracetam|piracetam|mesh-list
101279798|NCT01883011|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101279799|NCT01883011|Protective Agents|protective agents|mesh-ancestor
101279800|NCT01883011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279803|NCT01883102|Antipruritics|antipruritics|mesh-ancestor
101279804|NCT01883102|Dermatologic Agents|dermatologic agents|mesh-ancestor
101279805|NCT01883102|Sensory System Agents|sensory system agents|mesh-ancestor
101279806|NCT01883102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101279807|NCT01883102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279808|NCT01883167|Febuxostat|febuxostat|mesh-list
101279809|NCT01883167|Verinurad|verinurad|mesh-list
101279810|NCT01883167|Gout Suppressants|gout suppressants|mesh-ancestor
101279811|NCT01883167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101279812|NCT01883193|Micronutrients|micronutrients|mesh-list
101279813|NCT01883193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279814|NCT01883232|Lidocaine|lidocaine|mesh-list
101279815|NCT01883232|Epinephrine|epinephrine|mesh-list
101279816|NCT01883232|Anesthetics, Local|anesthetics, local|mesh-ancestor
101279817|NCT01883232|Anesthetics|anesthetics|mesh-ancestor
101279818|NCT01883232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101279819|NCT01883232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279820|NCT01883232|Sensory System Agents|sensory system agents|mesh-ancestor
101279821|NCT01883232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101279823|NCT01883232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101279824|NCT01883232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101279825|NCT01883232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101279826|NCT01883232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279827|NCT01883232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101279828|NCT01883232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101279829|NCT01883232|Adrenergic Agents|adrenergic agents|mesh-ancestor
101279830|NCT01883232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101279831|NCT01883232|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101279832|NCT01883232|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101279833|NCT01883232|Autonomic Agents|autonomic agents|mesh-ancestor
101279834|NCT01883232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101279835|NCT01883232|Respiratory System Agents|respiratory system agents|mesh-ancestor
101279836|NCT01883232|Mydriatics|mydriatics|mesh-ancestor
101279837|NCT01883232|Sympathomimetics|sympathomimetics|mesh-ancestor
101279838|NCT01883232|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101279839|NCT01883323|Aldesleukin|aldesleukin|mesh-list
101279840|NCT01883323|Cyclophosphamide|cyclophosphamide|mesh-list
101279841|NCT01883323|Fludarabine|fludarabine|mesh-list
101279842|NCT01883323|Interleukin-2|interleukin-2|mesh-list
101279843|NCT01883323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101279844|NCT01883323|Immunologic Factors|immunologic factors|mesh-ancestor
101279845|NCT01883323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279846|NCT01883323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101279847|NCT01883323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101279848|NCT01883323|Alkylating Agents|alkylating agents|mesh-ancestor
101279849|NCT01883323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279850|NCT01883323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101279851|NCT01883323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101279852|NCT01883323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101279853|NCT01883323|Analgesics|analgesics|mesh-ancestor
101818953|NCT01093807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818954|NCT01093807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101818955|NCT01093807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101818956|NCT01093807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101818957|NCT01093807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101818958|NCT01093807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818960|NCT00044083|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101279854|NCT01883323|Sensory System Agents|sensory system agents|mesh-ancestor
101279855|NCT01883323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101279856|NCT01883323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101279857|NCT01883323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101279858|NCT01883323|Antiviral Agents|antiviral agents|mesh-ancestor
101279859|NCT01883323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101279860|NCT01883505|Levodopa|levodopa|mesh-list
101279861|NCT01883505|Carbidopa|carbidopa|mesh-list
101279862|NCT01883505|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101279863|NCT01883505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101279864|NCT01883505|Dopamine Agents|dopamine agents|mesh-ancestor
101279865|NCT01883505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101279866|NCT01883505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279867|NCT01883505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279868|NCT01883505|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101279869|NCT01883505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101279870|NCT01883518|Vaccines|vaccines|mesh-list
101279871|NCT01883518|Immunologic Factors|immunologic factors|mesh-ancestor
101279872|NCT01883518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279873|NCT01883531|Mannitol|mannitol|mesh-list
101279874|NCT01883531|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101279875|NCT01883531|Diuretics|diuretics|mesh-ancestor
101279876|NCT01883531|Natriuretic Agents|natriuretic agents|mesh-ancestor
101279877|NCT01883531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279878|NCT01883596|Chlorhexidine|chlorhexidine|mesh-list
101279879|NCT01883596|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101279880|NCT01883596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101279881|NCT01883596|Disinfectants|disinfectants|mesh-ancestor
101279883|NCT01883869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101279884|NCT01883869|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101279885|NCT01883869|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101279886|NCT01883869|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101279887|NCT01883869|Purinergic Agents|purinergic agents|mesh-ancestor
101279888|NCT01883869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101279889|NCT01883869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279890|NCT01883869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279891|NCT01883882|Analgesics, Opioid|analgesics, opioid|mesh-list
101279892|NCT01883882|Narcotics|narcotics|mesh-ancestor
101279893|NCT01883882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101279894|NCT01883882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279895|NCT01883882|Analgesics|analgesics|mesh-ancestor
101279896|NCT01883882|Sensory System Agents|sensory system agents|mesh-ancestor
101279897|NCT01883882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101279898|NCT01883921|Immunoglobulins|immunoglobulins|mesh-list
101279899|NCT01883921|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101279900|NCT01883921|Antibodies|antibodies|mesh-list
101279901|NCT01883921|Immunologic Factors|immunologic factors|mesh-ancestor
101279902|NCT01883921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279903|NCT01884038|Treprostinil|treprostinil|mesh-list
101279904|NCT01884038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101279905|NCT01884116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101279906|NCT01884116|Capsaicin|capsaicin|mesh-list
101279907|NCT01884116|Antipruritics|antipruritics|mesh-ancestor
101279908|NCT01884116|Dermatologic Agents|dermatologic agents|mesh-ancestor
101279909|NCT01884116|Sensory System Agents|sensory system agents|mesh-ancestor
101279910|NCT01884116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101279911|NCT01884116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279912|NCT01884116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101818961|NCT00044083|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101818962|NCT00044083|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101818963|NCT00044083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101279913|NCT01884116|Analgesics|analgesics|mesh-ancestor
101279914|NCT01884116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101279915|NCT01884116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101279916|NCT01884168|Immunomodulating Agents|immunomodulating agents|mesh-list
101279917|NCT01884168|Immunologic Factors|immunologic factors|mesh-ancestor
101279918|NCT01884168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279919|NCT01884272|Naproxen|naproxen|mesh-list
101279920|NCT01884272|Indomethacin|indomethacin|mesh-list
101279921|NCT01884272|Lesinurad|lesinurad|mesh-list
101279922|NCT01884272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101279923|NCT01884272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101279924|NCT01884272|Analgesics|analgesics|mesh-ancestor
101279925|NCT01884272|Sensory System Agents|sensory system agents|mesh-ancestor
101279926|NCT01884272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101279927|NCT01884272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279928|NCT01884272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101279929|NCT01884272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101279930|NCT01884272|Gout Suppressants|gout suppressants|mesh-ancestor
101279931|NCT01884272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101279932|NCT01884272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101279933|NCT01884272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279934|NCT01884272|Tocolytic Agents|tocolytic agents|mesh-ancestor
101279935|NCT01884272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101279936|NCT01884272|Uricosuric Agents|uricosuric agents|mesh-ancestor
101279937|NCT01884285|Abiraterone Acetate|abiraterone acetate|mesh-list
101279938|NCT01884285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101279939|NCT01884285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101279940|NCT01884285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101279941|NCT01884285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279942|NCT01884285|Hormone Antagonists|hormone antagonists|mesh-ancestor
101279943|NCT01884285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101279944|NCT01884285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279945|NCT01884285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101279948|NCT01884298|Anesthetics, Local|anesthetics, local|mesh-ancestor
101279949|NCT01884298|Anesthetics|anesthetics|mesh-ancestor
101279950|NCT01884298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101279951|NCT01884298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279952|NCT01884298|Sensory System Agents|sensory system agents|mesh-ancestor
101279953|NCT01884298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101279954|NCT01884298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101279955|NCT01884298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101279956|NCT01884298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101279957|NCT01884298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101279958|NCT01884298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279959|NCT01884298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101279960|NCT01884298|Narcotics|narcotics|mesh-ancestor
101279961|NCT01884298|Analgesics|analgesics|mesh-ancestor
101279962|NCT01884402|Ribavirin|ribavirin|mesh-list
101279963|NCT01884402|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101279964|NCT01884402|Antimetabolites|antimetabolites|mesh-ancestor
101279965|NCT01884402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279966|NCT01884402|Antiviral Agents|antiviral agents|mesh-ancestor
101279967|NCT01884402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101279968|NCT01884415|Vaccines|vaccines|mesh-list
101279969|NCT01884415|Immunologic Factors|immunologic factors|mesh-ancestor
101279970|NCT01884415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279971|NCT01884428|Prednisolone|prednisolone|mesh-list
101279972|NCT01884428|Gemcitabine|gemcitabine|mesh-list
101279973|NCT01884428|Vinorelbine|vinorelbine|mesh-list
101279974|NCT01884428|Ifosfamide|ifosfamide|mesh-list
101279975|NCT01884428|Panobinostat|panobinostat|mesh-list
101279976|NCT01884428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101279977|NCT01884428|Antimetabolites|antimetabolites|mesh-ancestor
101279978|NCT01884428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101279979|NCT01884428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101279980|NCT01884428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101818964|NCT00044083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818965|NCT00058123|Poly ICLC|poly iclc|mesh-list
101818966|NCT00058123|Interferon Inducers|interferon inducers|mesh-ancestor
101818967|NCT00058123|Immunologic Factors|immunologic factors|mesh-ancestor
101818968|NCT00058123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101818969|NCT00022633|Paclitaxel|paclitaxel|mesh-list
101818970|NCT00022633|Gemcitabine|gemcitabine|mesh-list
101818971|NCT00022633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101818972|NCT00022633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101279981|NCT01884428|Glucocorticoids|glucocorticoids|mesh-ancestor
101279982|NCT01884428|Hormones|hormones|mesh-ancestor
101279983|NCT01884428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101279984|NCT01884428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101279985|NCT01884428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101279986|NCT01884428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101279987|NCT01884428|Tubulin Modulators|tubulin modulators|mesh-ancestor
101279988|NCT01884428|Antimitotic Agents|antimitotic agents|mesh-ancestor
101279989|NCT01884428|Mitosis Modulators|mitosis modulators|mesh-ancestor
101279990|NCT01884428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101279991|NCT01884428|Alkylating Agents|alkylating agents|mesh-ancestor
101279992|NCT01884428|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101279993|NCT01884428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101279994|NCT01884441|Gemcitabine|gemcitabine|mesh-list
101279995|NCT01884441|Vinorelbine|vinorelbine|mesh-list
101279996|NCT01884441|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101279997|NCT01884441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101279998|NCT01884441|Antimetabolites|antimetabolites|mesh-ancestor
101279999|NCT01884441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280000|NCT01884441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101280001|NCT01884441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101280002|NCT01884441|Tubulin Modulators|tubulin modulators|mesh-ancestor
101280003|NCT01884441|Antimitotic Agents|antimitotic agents|mesh-ancestor
101280004|NCT01884441|Mitosis Modulators|mitosis modulators|mesh-ancestor
101280005|NCT01884441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101280006|NCT01884441|Alkylating Agents|alkylating agents|mesh-ancestor
101280007|NCT01884467|Gentamicins|gentamicins|mesh-list
101280008|NCT01884467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101280009|NCT01884467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101280011|NCT01884467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101280012|NCT01884467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280014|NCT01884506|Ascorbic Acid|ascorbic acid|mesh-list
101280015|NCT01884506|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101280016|NCT01884506|Trace Elements|trace elements|mesh-ancestor
101280017|NCT01884506|Micronutrients|micronutrients|mesh-ancestor
101280018|NCT01884506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280019|NCT01884506|Antioxidants|antioxidants|mesh-ancestor
101280020|NCT01884506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280021|NCT01884506|Protective Agents|protective agents|mesh-ancestor
101280022|NCT01884506|Vitamins|vitamins|mesh-ancestor
101280023|NCT01884558|Metformin|metformin|mesh-list
101280024|NCT01884558|Isavuconazole|isavuconazole|mesh-list
101280025|NCT01884558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101280026|NCT01884558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280027|NCT01884558|Antifungal Agents|antifungal agents|mesh-ancestor
101280028|NCT01884558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101280029|NCT01884623|Methotrexate|methotrexate|mesh-list
101280030|NCT01884623|Cetuximab|cetuximab|mesh-list
101280031|NCT01884623|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101280032|NCT01884623|Abortifacient Agents|abortifacient agents|mesh-ancestor
101280033|NCT01884623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101280034|NCT01884623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280035|NCT01884623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101280036|NCT01884623|Antimetabolites|antimetabolites|mesh-ancestor
101280037|NCT01884623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818973|NCT00022633|Tubulin Modulators|tubulin modulators|mesh-ancestor
101818974|NCT00022633|Antimitotic Agents|antimitotic agents|mesh-ancestor
101818975|NCT00022633|Mitosis Modulators|mitosis modulators|mesh-ancestor
101818976|NCT00022633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818977|NCT00022633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101818978|NCT00022633|Antimetabolites|antimetabolites|mesh-ancestor
101818979|NCT00021541|Tipifarnib|tipifarnib|mesh-list
101280038|NCT01884623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101280039|NCT01884623|Dermatologic Agents|dermatologic agents|mesh-ancestor
101280040|NCT01884623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101280041|NCT01884623|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101280042|NCT01884623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101280043|NCT01884623|Immunologic Factors|immunologic factors|mesh-ancestor
101280044|NCT01884623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101280045|NCT01884623|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101280046|NCT01884623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101280047|NCT01884636|Isavuconazole|isavuconazole|mesh-list
101280048|NCT01884636|Methotrexate|methotrexate|mesh-list
101280049|NCT01884636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101280050|NCT01884636|Abortifacient Agents|abortifacient agents|mesh-ancestor
101280051|NCT01884636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101280052|NCT01884636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280053|NCT01884636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101280054|NCT01884636|Antimetabolites|antimetabolites|mesh-ancestor
101280055|NCT01884636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280056|NCT01884636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101280057|NCT01884636|Dermatologic Agents|dermatologic agents|mesh-ancestor
101280058|NCT01884636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101280059|NCT01884636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101280060|NCT01884636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101280061|NCT01884636|Immunologic Factors|immunologic factors|mesh-ancestor
101280062|NCT01884636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101280063|NCT01884636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101280064|NCT01884636|Antifungal Agents|antifungal agents|mesh-ancestor
101280065|NCT01884636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101280066|NCT01884857|Metoprolol|metoprolol|mesh-list
101280067|NCT01884857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101280068|NCT01884857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101280069|NCT01884857|Sympatholytics|sympatholytics|mesh-ancestor
101280070|NCT01884857|Autonomic Agents|autonomic agents|mesh-ancestor
101280071|NCT01884857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101280072|NCT01884857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280073|NCT01884857|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101280074|NCT01884857|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101280075|NCT01884857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101280076|NCT01884857|Adrenergic Agents|adrenergic agents|mesh-ancestor
101280078|NCT01884857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280079|NCT01884896|Metoprolol|metoprolol|mesh-list
101280080|NCT01884896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101280081|NCT01884896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101280082|NCT01884896|Sympatholytics|sympatholytics|mesh-ancestor
101280083|NCT01884896|Autonomic Agents|autonomic agents|mesh-ancestor
101280084|NCT01884896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101280085|NCT01884896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280086|NCT01884896|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101280087|NCT01884896|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101280088|NCT01884896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101280089|NCT01884896|Adrenergic Agents|adrenergic agents|mesh-ancestor
101280090|NCT01884896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101280091|NCT01884896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280092|NCT01884909|Metoprolol|metoprolol|mesh-list
101280093|NCT01884909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101280094|NCT01884909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101280095|NCT01884909|Sympatholytics|sympatholytics|mesh-ancestor
101280096|NCT01884909|Autonomic Agents|autonomic agents|mesh-ancestor
101818980|NCT00021541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101818981|NCT00021229|Imatinib Mesylate|imatinib mesylate|mesh-list
101818982|NCT00021229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101818983|NCT00021229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101818984|NCT00021229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101818985|NCT00021229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101818986|NCT02688790|Dalbavancin|dalbavancin|mesh-list
101280097|NCT01884909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101280098|NCT01884909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280099|NCT01884909|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101280100|NCT01884909|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101280101|NCT01884909|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101280102|NCT01884909|Adrenergic Agents|adrenergic agents|mesh-ancestor
101280103|NCT01884909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101280104|NCT01884909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280105|NCT01884935|Natalizumab|natalizumab|mesh-list
101280106|NCT01884935|Immunologic Factors|immunologic factors|mesh-ancestor
101280107|NCT01884935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280108|NCT01885013|Metformin|metformin|mesh-list
101280109|NCT01885013|Cyclophosphamide|cyclophosphamide|mesh-list
101280110|NCT01885013|Doxorubicin|doxorubicin|mesh-list
101280111|NCT01885013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101280112|NCT01885013|Immunologic Factors|immunologic factors|mesh-ancestor
101280113|NCT01885013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280114|NCT01885013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101280115|NCT01885013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101280116|NCT01885013|Alkylating Agents|alkylating agents|mesh-ancestor
101280117|NCT01885013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280118|NCT01885013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101280119|NCT01885013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101280120|NCT01885013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101280121|NCT01885013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101280122|NCT01885013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101280123|NCT01885013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101280124|NCT01885013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101280125|NCT01885091|Kinetin|kinetin|mesh-list
101280126|NCT01885091|Plant Growth Regulators|plant growth regulators|mesh-ancestor
101280127|NCT01885091|Growth Substances|growth substances|mesh-ancestor
101280128|NCT01885091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280129|NCT01885338|Acetylcysteine|acetylcysteine|mesh-list
101280130|NCT01885338|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101280131|NCT01885338|Antiviral Agents|antiviral agents|mesh-ancestor
101280132|NCT01885338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101280134|NCT01885338|Respiratory System Agents|respiratory system agents|mesh-ancestor
101280135|NCT01885338|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101280136|NCT01885338|Antioxidants|antioxidants|mesh-ancestor
101280137|NCT01885338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280138|NCT01885338|Protective Agents|protective agents|mesh-ancestor
101280139|NCT01885338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280140|NCT01885338|Antidotes|antidotes|mesh-ancestor
101280141|NCT01885364|Remifentanil|remifentanil|mesh-list
101280142|NCT01885364|Propofol|propofol|mesh-list
101280143|NCT01885364|Esmolol|esmolol|mesh-list
101280144|NCT01885364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101280145|NCT01885364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101280146|NCT01885364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280147|NCT01885364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101280148|NCT01885364|Anesthetics, General|anesthetics, general|mesh-ancestor
101280149|NCT01885364|Anesthetics|anesthetics|mesh-ancestor
101280150|NCT01885364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101280151|NCT01885364|Narcotics|narcotics|mesh-ancestor
101280152|NCT01885364|Analgesics|analgesics|mesh-ancestor
101280153|NCT01885364|Sensory System Agents|sensory system agents|mesh-ancestor
101280154|NCT01885364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101280155|NCT01885364|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101280156|NCT01885364|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101280157|NCT01885364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101280158|NCT01885364|Adrenergic Agents|adrenergic agents|mesh-ancestor
101818988|NCT02688790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101818989|NCT00488475|Etanercept|etanercept|mesh-list
101818990|NCT00488475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101818991|NCT00488475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101818992|NCT00488475|Analgesics|analgesics|mesh-ancestor
101818993|NCT00488475|Sensory System Agents|sensory system agents|mesh-ancestor
101534754|NCT00570245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101818994|NCT00488475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101818995|NCT00488475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280159|NCT01885364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101280160|NCT01885364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280161|NCT01885481|Dexamethasone|dexamethasone|mesh-list
101280162|NCT01885481|Dexamethasone acetate|dexamethasone acetate|mesh-list
101280163|NCT01885481|Betamethasone|betamethasone|mesh-list
101280164|NCT01885481|Betamethasone Valerate|betamethasone valerate|mesh-list
101280165|NCT01885481|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101280166|NCT01885481|Betamethasone benzoate|betamethasone benzoate|mesh-list
101280167|NCT01885481|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101280168|NCT01885481|BB 1101|bb 1101|mesh-list
101280169|NCT01885481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101280170|NCT01885481|Antiemetics|antiemetics|mesh-ancestor
101280171|NCT01885481|Autonomic Agents|autonomic agents|mesh-ancestor
101280172|NCT01885481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101280173|NCT01885481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280174|NCT01885481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101280175|NCT01885481|Glucocorticoids|glucocorticoids|mesh-ancestor
101280176|NCT01885481|Hormones|hormones|mesh-ancestor
101280177|NCT01885481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101280178|NCT01885481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101280179|NCT01885481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101280180|NCT01885481|Protease Inhibitors|protease inhibitors|mesh-ancestor
101280181|NCT01885481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101280182|NCT01885481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280184|NCT01885481|Respiratory System Agents|respiratory system agents|mesh-ancestor
101280185|NCT01885585|Apixaban|apixaban|mesh-list
101280186|NCT01885585|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101280187|NCT01885585|Antithrombins|antithrombins|mesh-ancestor
101280188|NCT01885585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101280189|NCT01885585|Protease Inhibitors|protease inhibitors|mesh-ancestor
101280190|NCT01885585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101280191|NCT01885585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280192|NCT01885585|Anticoagulants|anticoagulants|mesh-ancestor
101280193|NCT01885598|Apixaban|apixaban|mesh-list
101280194|NCT01885598|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101280195|NCT01885598|Antithrombins|antithrombins|mesh-ancestor
101280196|NCT01885598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101280197|NCT01885598|Protease Inhibitors|protease inhibitors|mesh-ancestor
101280198|NCT01885598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101280199|NCT01885598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280200|NCT01885598|Anticoagulants|anticoagulants|mesh-ancestor
101280201|NCT01885715|Neostigmine|neostigmine|mesh-list
101280202|NCT01885715|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101280203|NCT01885715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101280204|NCT01885715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280205|NCT01885715|Cholinergic Agents|cholinergic agents|mesh-ancestor
101280206|NCT01885715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101280207|NCT01885715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280208|NCT01885715|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101280209|NCT01885715|Autonomic Agents|autonomic agents|mesh-ancestor
101280210|NCT01885715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101280211|NCT01885988|Nebivolol|nebivolol|mesh-list
101280212|NCT01885988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101280213|NCT01885988|Vasodilator Agents|vasodilator agents|mesh-ancestor
101280214|NCT01885988|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101818996|NCT00488475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101818997|NCT00488475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101818998|NCT00488475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101818999|NCT00488475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101819000|NCT00488475|Immunologic Factors|immunologic factors|mesh-ancestor
101819001|NCT01020279|Celecoxib|celecoxib|mesh-list
101819002|NCT01020279|Ketoprofen|ketoprofen|mesh-list
101819003|NCT01020279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101819004|NCT01020279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101819005|NCT01020279|Analgesics|analgesics|mesh-ancestor
101819006|NCT01020279|Sensory System Agents|sensory system agents|mesh-ancestor
101819007|NCT01020279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101819008|NCT01020279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819009|NCT01020279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101819010|NCT01020279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101280215|NCT01885988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101280216|NCT01885988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101280217|NCT01885988|Adrenergic Agents|adrenergic agents|mesh-ancestor
101280218|NCT01885988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101280219|NCT01885988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280220|NCT01885988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280221|NCT01886001|Chlorhexidine|chlorhexidine|mesh-list
101280222|NCT01886001|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101280223|NCT01886001|Povidone-Iodine|povidone-iodine|mesh-list
101280224|NCT01886001|Povidone|povidone|mesh-list
101280225|NCT01886001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101280226|NCT01886001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101280227|NCT01886001|Disinfectants|disinfectants|mesh-ancestor
101280228|NCT01886001|Dermatologic Agents|dermatologic agents|mesh-ancestor
101280229|NCT01886001|Plasma Substitutes|plasma substitutes|mesh-ancestor
101280230|NCT01886001|Blood Substitutes|blood substitutes|mesh-ancestor
101280231|NCT01886014|Oxytocin|oxytocin|mesh-list
101280232|NCT01886014|Oxytocics|oxytocics|mesh-ancestor
101280233|NCT01886014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101280234|NCT01886014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280235|NCT01886053|Ertapenem|ertapenem|mesh-list
101280236|NCT01886053|beta-Lactams|beta-lactams|mesh-list
101280237|NCT01886053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101280238|NCT01886053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101280239|NCT01886079|Dexmedetomidine|dexmedetomidine|mesh-list
101280240|NCT01886079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101280241|NCT01886079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101280242|NCT01886079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280243|NCT01886079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101280244|NCT01886079|Analgesics|analgesics|mesh-ancestor
101280245|NCT01886079|Sensory System Agents|sensory system agents|mesh-ancestor
101280246|NCT01886079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101280247|NCT01886079|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101280248|NCT01886079|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101280249|NCT01886079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101280251|NCT01886079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101280252|NCT01886079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280254|NCT01886196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101280255|NCT01886196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101280256|NCT01886196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101280257|NCT01886196|Analgesics|analgesics|mesh-ancestor
101819011|NCT01020279|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101819012|NCT01020279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101819013|NCT01020279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101819014|NCT01020279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819015|NCT01020357|Caffeine|caffeine|mesh-list
101819016|NCT01020357|Caffeine citrate|caffeine citrate|mesh-list
101819017|NCT01020357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819018|NCT01020357|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101819019|NCT01020357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819020|NCT01020357|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101819021|NCT01020357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101819022|NCT01020357|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101819023|NCT01020357|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101819024|NCT01020357|Purinergic Agents|purinergic agents|mesh-ancestor
101819025|NCT01020357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101819026|NCT00042991|Gefitinib|gefitinib|mesh-list
101819027|NCT00042991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101280258|NCT01886196|Sensory System Agents|sensory system agents|mesh-ancestor
101280259|NCT01886196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101280260|NCT01886196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280261|NCT01886196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101280262|NCT01886196|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101280263|NCT01886196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101280264|NCT01886196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280265|NCT01886209|Prednisone|prednisone|mesh-list
101280266|NCT01886209|Methylprednisolone|methylprednisolone|mesh-list
101280267|NCT01886209|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101280268|NCT01886209|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101280269|NCT01886209|Prednisolone|prednisolone|mesh-list
101280270|NCT01886209|Prednisolone acetate|prednisolone acetate|mesh-list
101280271|NCT01886209|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101280272|NCT01886209|Prednisolone phosphate|prednisolone phosphate|mesh-list
101280273|NCT01886209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101280274|NCT01886209|Glucocorticoids|glucocorticoids|mesh-ancestor
101280275|NCT01886209|Hormones|hormones|mesh-ancestor
101280276|NCT01886209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101280277|NCT01886209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280278|NCT01886209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101280279|NCT01886209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101315119|NCT00389584|Irinotecan|irinotecan|mesh-list
101280280|NCT01886209|Antiemetics|antiemetics|mesh-ancestor
101280281|NCT01886209|Autonomic Agents|autonomic agents|mesh-ancestor
101280282|NCT01886209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101280283|NCT01886209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101280284|NCT01886209|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101280285|NCT01886209|Protective Agents|protective agents|mesh-ancestor
101280286|NCT01886248|Antithrombins|antithrombins|mesh-list
101280287|NCT01886248|Antithrombin III|antithrombin iii|mesh-list
101280288|NCT01886248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101280289|NCT01886248|Protease Inhibitors|protease inhibitors|mesh-ancestor
101280290|NCT01886248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101280291|NCT01886248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280292|NCT01886248|Anticoagulants|anticoagulants|mesh-ancestor
101280293|NCT01886352|Levobupivacaine|levobupivacaine|mesh-list
101280294|NCT01886352|Anesthetics, Local|anesthetics, local|mesh-ancestor
101280295|NCT01886352|Anesthetics|anesthetics|mesh-ancestor
101819028|NCT00042991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101819029|NCT00042991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101819030|NCT00042991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819031|NCT00466167|Pramipexole|pramipexole|mesh-list
101819032|NCT00466167|Antioxidants|antioxidants|mesh-ancestor
101819033|NCT00466167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819034|NCT00466167|Protective Agents|protective agents|mesh-ancestor
101819035|NCT00466167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819036|NCT00466167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101819037|NCT00466167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101819038|NCT00466167|Dopamine Agonists|dopamine agonists|mesh-ancestor
101819039|NCT00466167|Dopamine Agents|dopamine agents|mesh-ancestor
101819040|NCT00466167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101819041|NCT01017939|Prednisone|prednisone|mesh-list
101819042|NCT01017939|Abiraterone Acetate|abiraterone acetate|mesh-list
101819043|NCT01017939|Theophylline|theophylline|mesh-list
101819044|NCT01017939|Dextromethorphan|dextromethorphan|mesh-list
101280296|NCT01886352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101280297|NCT01886352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280298|NCT01886352|Sensory System Agents|sensory system agents|mesh-ancestor
101280299|NCT01886352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101280300|NCT01886365|Insulin|insulin|mesh-list
101280301|NCT01886365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101280302|NCT01886365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280303|NCT01886404|Efavirenz|efavirenz|mesh-list
101280304|NCT01886404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101280305|NCT01886404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101280306|NCT01886404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101280307|NCT01886404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280308|NCT01886404|Antiviral Agents|antiviral agents|mesh-ancestor
101280309|NCT01886404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101280310|NCT01886404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101280311|NCT01886404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101280312|NCT01886404|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101280313|NCT01886404|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101280314|NCT01886404|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101280315|NCT01886404|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101280316|NCT01886443|Tocopherols|tocopherols|mesh-list
101280318|NCT01886443|alpha-Tocopherol|alpha-tocopherol|mesh-list
101280319|NCT01886443|Infliximab|infliximab|mesh-list
101280320|NCT01886443|Epoprostenol|epoprostenol|mesh-list
101280321|NCT01886443|Tezosentan|tezosentan|mesh-list
101280322|NCT01886443|Melatonin|melatonin|mesh-list
101280323|NCT01886443|Antithrombins|antithrombins|mesh-list
101280324|NCT01886443|Antithrombin III|antithrombin iii|mesh-list
101280325|NCT01886443|Epoetin Alfa|epoetin alfa|mesh-list
101280326|NCT01886443|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
101280327|NCT01886443|Antioxidants|antioxidants|mesh-ancestor
101280328|NCT01886443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280329|NCT01886443|Protective Agents|protective agents|mesh-ancestor
101280330|NCT01886443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280331|NCT01886443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101280332|NCT01886443|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101280333|NCT01886443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101280334|NCT01886443|Dermatologic Agents|dermatologic agents|mesh-ancestor
101280335|NCT01886443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101280336|NCT01886443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101280337|NCT01886443|Hematinics|hematinics|mesh-ancestor
101819045|NCT01017939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101819046|NCT01017939|Glucocorticoids|glucocorticoids|mesh-ancestor
101819047|NCT01017939|Hormones|hormones|mesh-ancestor
101819048|NCT01017939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101819049|NCT01017939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819050|NCT01017939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101819051|NCT01017939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101819052|NCT01017939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101819053|NCT01017939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101819054|NCT01017939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819055|NCT01017939|Hormone Antagonists|hormone antagonists|mesh-ancestor
101819056|NCT01017939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101280338|NCT01886443|Vitamins|vitamins|mesh-ancestor
101280339|NCT01886443|Micronutrients|micronutrients|mesh-ancestor
101280340|NCT01886443|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101280341|NCT01886443|Protease Inhibitors|protease inhibitors|mesh-ancestor
101280342|NCT01886443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101280343|NCT01886443|Anticoagulants|anticoagulants|mesh-ancestor
101280344|NCT01886443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101280345|NCT01886443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101280346|NCT01886443|Vasodilator Agents|vasodilator agents|mesh-ancestor
101280347|NCT01886443|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101280348|NCT01886443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101315125|NCT00000324|Tryptophan|tryptophan|mesh-list
101280349|NCT01886443|Immunologic Factors|immunologic factors|mesh-ancestor
101280350|NCT01886534|Diuretics|diuretics|mesh-list
101280351|NCT01886534|Natriuretic Agents|natriuretic agents|mesh-ancestor
101280352|NCT01886534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280353|NCT01886560|Doxycycline|doxycycline|mesh-list
101280354|NCT01886560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101280355|NCT01886560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101280356|NCT01886560|Antimalarials|antimalarials|mesh-ancestor
101280357|NCT01886560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101280358|NCT01886560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101280359|NCT01886573|Azacitidine|azacitidine|mesh-list
101280360|NCT01886573|Entinostat|entinostat|mesh-list
101280361|NCT01886573|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
101280362|NCT01886573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101280363|NCT01886573|Antimetabolites|antimetabolites|mesh-ancestor
101280364|NCT01886573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280365|NCT01886573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101280366|NCT01886573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101280367|NCT01886599|Asunaprevir|asunaprevir|mesh-list
101280368|NCT01886599|Protease Inhibitors|protease inhibitors|mesh-ancestor
101280369|NCT01886599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101280370|NCT01886599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280371|NCT01886638|Abacavir|abacavir|mesh-list
101280372|NCT01886638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101280373|NCT01886638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101280374|NCT01886638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101280375|NCT01886638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280376|NCT01886638|Antiviral Agents|antiviral agents|mesh-ancestor
101280377|NCT01886638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101280378|NCT01886638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101280379|NCT01886638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101280380|NCT01886664|Sevoflurane|sevoflurane|mesh-list
101280381|NCT01886664|Desflurane|desflurane|mesh-list
101280382|NCT01886664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101280383|NCT01886664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101280384|NCT01886664|Anesthetics, General|anesthetics, general|mesh-ancestor
101280385|NCT01886664|Anesthetics|anesthetics|mesh-ancestor
101280386|NCT01886664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101280387|NCT01886664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819057|NCT01017939|Antitussive Agents|antitussive agents|mesh-ancestor
101819058|NCT01017939|Respiratory System Agents|respiratory system agents|mesh-ancestor
101819059|NCT01017939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101819060|NCT01017939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101819061|NCT01017939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101819062|NCT01017939|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101819063|NCT01017939|Autonomic Agents|autonomic agents|mesh-ancestor
101280388|NCT01886768|Anesthetics|anesthetics|mesh-list
101280389|NCT01886768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101280390|NCT01886768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280391|NCT01887119|Eplerenone|eplerenone|mesh-list
101280392|NCT01887119|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101280393|NCT01887119|Hormone Antagonists|hormone antagonists|mesh-ancestor
101280394|NCT01887119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101280395|NCT01887119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280396|NCT01887119|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101280398|NCT01887119|Natriuretic Agents|natriuretic agents|mesh-ancestor
101280399|NCT01887119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101280400|NCT01887158|Bisacodyl|bisacodyl|mesh-list
101280401|NCT01887158|Cathartics|cathartics|mesh-ancestor
101280402|NCT01887158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101280403|NCT01887158|Laxatives|laxatives|mesh-ancestor
101280404|NCT01887184|Dexmedetomidine|dexmedetomidine|mesh-list
101280405|NCT01887184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101280406|NCT01887184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101280407|NCT01887184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280408|NCT01887184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101280409|NCT01887184|Analgesics|analgesics|mesh-ancestor
101280410|NCT01887184|Sensory System Agents|sensory system agents|mesh-ancestor
101280411|NCT01887184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101280412|NCT01887184|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101280413|NCT01887184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101280414|NCT01887184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101280415|NCT01887184|Adrenergic Agents|adrenergic agents|mesh-ancestor
101280416|NCT01887184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101280417|NCT01887184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280418|NCT01887197|Mannitol|mannitol|mesh-list
101280419|NCT01887197|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101280420|NCT01887197|Diuretics|diuretics|mesh-ancestor
101280421|NCT01887197|Natriuretic Agents|natriuretic agents|mesh-ancestor
101280422|NCT01887197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280424|NCT01887223|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101280425|NCT01887223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101280426|NCT01887223|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101280427|NCT01887223|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101280428|NCT01887223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101280429|NCT01887223|Adrenergic Agents|adrenergic agents|mesh-ancestor
101280430|NCT01887223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101280431|NCT01887223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280432|NCT01887223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280433|NCT01887223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101280434|NCT01887223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101280435|NCT01887223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101280436|NCT01887249|Metronidazole|metronidazole|mesh-list
101280437|NCT01887249|Clarithromycin|clarithromycin|mesh-list
101280438|NCT01887249|Esomeprazole|esomeprazole|mesh-list
101280442|NCT01887249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101280443|NCT01887249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101280444|NCT01887249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101280445|NCT01887249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101280446|NCT01887249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101280447|NCT01887249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280448|NCT01887249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101280449|NCT01887249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101280450|NCT01887249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101280451|NCT01887275|Interferons|interferons|mesh-list
101280452|NCT01887275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101819064|NCT01017939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101819065|NCT01017939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101819066|NCT01017939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101819067|NCT01017939|Vasodilator Agents|vasodilator agents|mesh-ancestor
101819068|NCT01017939|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101819069|NCT01017939|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101280453|NCT01887275|Antiviral Agents|antiviral agents|mesh-ancestor
101280454|NCT01887275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101280455|NCT01887340|Carboplatin|carboplatin|mesh-list
101280456|NCT01887340|Etoposide|etoposide|mesh-list
101280457|NCT01887340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101280458|NCT01887340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101280459|NCT01887340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101280460|NCT01887340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101280461|NCT01887340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101280462|NCT01887340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280463|NCT01887379|Furosemide|furosemide|mesh-list
101280464|NCT01887379|Diuretics|diuretics|mesh-ancestor
101280465|NCT01887379|Natriuretic Agents|natriuretic agents|mesh-ancestor
101280466|NCT01887379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280467|NCT01887379|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101280468|NCT01887379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101280469|NCT01887379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280470|NCT01887405|Epinephrine|epinephrine|mesh-list
101280471|NCT01887405|Racepinephrine|racepinephrine|mesh-list
101280472|NCT01887405|Epinephryl borate|epinephryl borate|mesh-list
101280473|NCT01887405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101280474|NCT01887405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101280475|NCT01887405|Adrenergic Agents|adrenergic agents|mesh-ancestor
101280476|NCT01887405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101280477|NCT01887405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280478|NCT01887405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280479|NCT01887405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101280480|NCT01887405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101280481|NCT01887405|Autonomic Agents|autonomic agents|mesh-ancestor
101280482|NCT01887405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101280483|NCT01887405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101280484|NCT01887405|Respiratory System Agents|respiratory system agents|mesh-ancestor
101280485|NCT01887405|Mydriatics|mydriatics|mesh-ancestor
101280486|NCT01887405|Sympathomimetics|sympathomimetics|mesh-ancestor
101280487|NCT01887405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101280488|NCT01887457|Voriconazole|voriconazole|mesh-list
101280489|NCT01887457|Antifungal Agents|antifungal agents|mesh-ancestor
101280490|NCT01887457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101280491|NCT01887457|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101280492|NCT01887457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101280493|NCT01887457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101280494|NCT01887457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280495|NCT01887457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101280496|NCT01887457|Hormone Antagonists|hormone antagonists|mesh-ancestor
101280497|NCT01887457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101280498|NCT01887457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280499|NCT01887457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101280501|NCT01887561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101280502|NCT01887561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101280503|NCT01887561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101280504|NCT01887561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280505|NCT01887613|Gabapentin|gabapentin|mesh-list
101280506|NCT01887613|Analgesics|analgesics|mesh-ancestor
101280507|NCT01887613|Sensory System Agents|sensory system agents|mesh-ancestor
101280508|NCT01887613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101280509|NCT01887613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280510|NCT01887613|Anticonvulsants|anticonvulsants|mesh-ancestor
101280511|NCT01887613|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101280512|NCT01887613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101280513|NCT01887613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101280514|NCT01887613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101819070|NCT01017939|Purinergic Agents|purinergic agents|mesh-ancestor
101819071|NCT00480441|Dronabinol|dronabinol|mesh-list
101819072|NCT00480441|Hallucinogens|hallucinogens|mesh-ancestor
101819073|NCT00480441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819074|NCT00480441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101819075|NCT00480441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101819076|NCT00480441|Analgesics|analgesics|mesh-ancestor
101280515|NCT01887613|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101280516|NCT01887613|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101280517|NCT01887613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101280518|NCT01887613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280519|NCT01887613|Antimanic Agents|antimanic agents|mesh-ancestor
101280520|NCT01887626|Ticagrelor|ticagrelor|mesh-list
101280521|NCT01887626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101280522|NCT01887626|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101280523|NCT01887626|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101280524|NCT01887626|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101280525|NCT01887626|Purinergic Agents|purinergic agents|mesh-ancestor
101280526|NCT01887626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101280527|NCT01887626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280528|NCT01887626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280530|NCT01887691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101280531|NCT01887691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101280532|NCT01887691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280533|NCT01887704|Aspirin|aspirin|mesh-list
101280534|NCT01887704|Sirolimus|sirolimus|mesh-list
101280535|NCT01887704|Paclitaxel|paclitaxel|mesh-list
101280536|NCT01887704|Everolimus|everolimus|mesh-list
101280537|NCT01887704|Clopidogrel|clopidogrel|mesh-list
101280538|NCT01887704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101280539|NCT01887704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101280540|NCT01887704|Tubulin Modulators|tubulin modulators|mesh-ancestor
101280541|NCT01887704|Antimitotic Agents|antimitotic agents|mesh-ancestor
101280542|NCT01887704|Mitosis Modulators|mitosis modulators|mesh-ancestor
101280543|NCT01887704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280544|NCT01887704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101280546|NCT01887704|Analgesics|analgesics|mesh-ancestor
101280547|NCT01887704|Sensory System Agents|sensory system agents|mesh-ancestor
101280548|NCT01887704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101280549|NCT01887704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280550|NCT01887704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101280551|NCT01887704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101280552|NCT01887704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101280553|NCT01887704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101280554|NCT01887704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101280555|NCT01887704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101280556|NCT01887704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101280557|NCT01887704|Antipyretics|antipyretics|mesh-ancestor
101280559|NCT01887704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101280560|NCT01887704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101280561|NCT01887704|Immunologic Factors|immunologic factors|mesh-ancestor
101280562|NCT01887704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101280563|NCT01887704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101280564|NCT01887704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101280565|NCT01887704|Purinergic Agents|purinergic agents|mesh-ancestor
101280566|NCT01887704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101280567|NCT01887704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101280568|NCT01887704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101280569|NCT01887704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101280570|NCT01887704|Antifungal Agents|antifungal agents|mesh-ancestor
101280571|NCT01887743|Pantoprazole|pantoprazole|mesh-list
101280572|NCT01887743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101280573|NCT01887743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101280574|NCT01887743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101280575|NCT01887743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101280576|NCT01887743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280577|NCT01887795|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101819077|NCT00480441|Sensory System Agents|sensory system agents|mesh-ancestor
101819078|NCT00480441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101819079|NCT00480441|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101819080|NCT00480441|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101819081|NCT00480441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101819082|NCT00480441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819083|NCT00480441|Hormones|hormones|mesh-ancestor
101280578|NCT01887795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101280579|NCT01887795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101280580|NCT01887795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101280581|NCT01887795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280582|NCT01887821|Chloroquine|chloroquine|mesh-list
101280583|NCT01887821|Piperaquine|piperaquine|mesh-list
101280584|NCT01887821|Artenimol|artenimol|mesh-list
101280585|NCT01887821|Amebicides|amebicides|mesh-ancestor
101280586|NCT01887821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101280587|NCT01887821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101280588|NCT01887821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101280589|NCT01887821|Antimalarials|antimalarials|mesh-ancestor
101280590|NCT01887821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101280591|NCT01887847|Nicotine|nicotine|mesh-list
101280592|NCT01887847|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101280593|NCT01887847|Autonomic Agents|autonomic agents|mesh-ancestor
101280594|NCT01887847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101280595|NCT01887847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280596|NCT01887847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101280597|NCT01887847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101280598|NCT01887847|Cholinergic Agents|cholinergic agents|mesh-ancestor
101280599|NCT01887847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101280600|NCT01887847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280601|NCT01887873|Hyaluronic Acid|hyaluronic acid|mesh-list
101280602|NCT01887873|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101280603|NCT01887873|Immunologic Factors|immunologic factors|mesh-ancestor
101280604|NCT01887873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280606|NCT01887873|Protective Agents|protective agents|mesh-ancestor
101280608|NCT01887951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101280609|NCT01887951|Narcotics|narcotics|mesh-ancestor
101280610|NCT01887951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101280611|NCT01887951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280612|NCT01887951|Analgesics|analgesics|mesh-ancestor
101280613|NCT01887951|Sensory System Agents|sensory system agents|mesh-ancestor
101280614|NCT01887951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101280615|NCT01888042|Everolimus|everolimus|mesh-list
101280616|NCT01888042|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101280617|NCT01888042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101280618|NCT01888042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101280619|NCT01888042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280620|NCT01888042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101280621|NCT01888042|Immunologic Factors|immunologic factors|mesh-ancestor
101280622|NCT01888042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280623|NCT01888042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101280624|NCT01888107|Risperidone|risperidone|mesh-list
101280625|NCT01888107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101280626|NCT01888107|Serotonin Agents|serotonin agents|mesh-ancestor
101280627|NCT01888107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101280628|NCT01888107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280629|NCT01888107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280630|NCT01888107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101280631|NCT01888107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101280632|NCT01888107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101280633|NCT01888107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101280634|NCT01888107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101280635|NCT01888107|Dopamine Agents|dopamine agents|mesh-ancestor
101280636|NCT01888120|Ziconotide|ziconotide|mesh-list
101280637|NCT01888120|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101280638|NCT01888120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101819084|NCT00480441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101819085|NCT01022463|Atenolol|atenolol|mesh-list
101819086|NCT01022463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101819087|NCT01022463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101819088|NCT01022463|Sympatholytics|sympatholytics|mesh-ancestor
101819089|NCT01022463|Autonomic Agents|autonomic agents|mesh-ancestor
101819090|NCT01022463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101280639|NCT01888120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280640|NCT01888120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101280641|NCT01888120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280642|NCT01888120|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101280643|NCT01888120|Protective Agents|protective agents|mesh-ancestor
101280644|NCT01888120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101280645|NCT01888120|Analgesics|analgesics|mesh-ancestor
101280646|NCT01888120|Sensory System Agents|sensory system agents|mesh-ancestor
101280647|NCT01888120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101280648|NCT01888224|Isotretinoin|isotretinoin|mesh-list
101280649|NCT01888224|Dermatologic Agents|dermatologic agents|mesh-ancestor
101280650|NCT01888250|Lamotrigine|lamotrigine|mesh-list
101280651|NCT01888250|Anticonvulsants|anticonvulsants|mesh-ancestor
101280652|NCT01888250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101280653|NCT01888250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101280654|NCT01888250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280655|NCT01888250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101280656|NCT01888250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280657|NCT01888250|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101280658|NCT01888250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101280659|NCT01888250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101280660|NCT01888250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101280661|NCT01888250|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101280662|NCT01888263|Lamotrigine|lamotrigine|mesh-list
101280663|NCT01888263|Anticonvulsants|anticonvulsants|mesh-ancestor
101280664|NCT01888263|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101280665|NCT01888263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101280666|NCT01888263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280667|NCT01888263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101280668|NCT01888263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280670|NCT01888263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101280671|NCT01888263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101280672|NCT01888263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101280673|NCT01888263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101280674|NCT01888289|Isotretinoin|isotretinoin|mesh-list
101280675|NCT01888289|Dermatologic Agents|dermatologic agents|mesh-ancestor
101280676|NCT01888302|Sirolimus|sirolimus|mesh-list
101280677|NCT01888302|Cisplatin|cisplatin|mesh-list
101280678|NCT01888302|Gemcitabine|gemcitabine|mesh-list
101280679|NCT01888302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101280680|NCT01888302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101280681|NCT01888302|Antimetabolites|antimetabolites|mesh-ancestor
101280682|NCT01888302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280683|NCT01888302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101280684|NCT01888302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101280685|NCT01888302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101280686|NCT01888302|Antifungal Agents|antifungal agents|mesh-ancestor
101280687|NCT01888302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101280688|NCT01888302|Immunologic Factors|immunologic factors|mesh-ancestor
101280689|NCT01888302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280690|NCT01888328|Isotretinoin|isotretinoin|mesh-list
101280691|NCT01888328|Dermatologic Agents|dermatologic agents|mesh-ancestor
101280692|NCT01888341|Isotretinoin|isotretinoin|mesh-list
101280693|NCT01888341|Dermatologic Agents|dermatologic agents|mesh-ancestor
101280694|NCT01888354|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101280695|NCT01888354|Hormones|hormones|mesh-ancestor
101280696|NCT01888354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101280697|NCT01888354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819091|NCT01022463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819092|NCT01022463|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101819093|NCT01022463|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101819094|NCT01022463|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101819095|NCT01022463|Adrenergic Agents|adrenergic agents|mesh-ancestor
101819096|NCT01022463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101819097|NCT01022463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315149|NCT00000369|Lithium Carbonate|lithium carbonate|mesh-list
101280699|NCT01888393|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101280700|NCT01888393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101280701|NCT01888393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280702|NCT01888445|Darbepoetin alfa|darbepoetin alfa|mesh-list
101280703|NCT01888445|Hematinics|hematinics|mesh-ancestor
101280704|NCT01888458|Micafungin|micafungin|mesh-list
101280705|NCT01888458|Antifungal Agents|antifungal agents|mesh-ancestor
101280706|NCT01888458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101280707|NCT01888536|Pregabalin|pregabalin|mesh-list
101280708|NCT01888536|Alprostadil|alprostadil|mesh-list
101280709|NCT01888536|Analgesics|analgesics|mesh-ancestor
101280710|NCT01888536|Sensory System Agents|sensory system agents|mesh-ancestor
101280711|NCT01888536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101280712|NCT01888536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280713|NCT01888536|Anticonvulsants|anticonvulsants|mesh-ancestor
101280714|NCT01888536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101280715|NCT01888536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101280716|NCT01888536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280717|NCT01888536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101280718|NCT01888536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101280719|NCT01888536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101280720|NCT01888536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101280721|NCT01888536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101280722|NCT01888536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101280723|NCT01888536|Vasodilator Agents|vasodilator agents|mesh-ancestor
101280724|NCT01888536|Urological Agents|urological agents|mesh-ancestor
101280725|NCT01888562|Ponatinib|ponatinib|mesh-list
101280726|NCT01888562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101280727|NCT01888562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101280728|NCT01888562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101280729|NCT01888562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280730|NCT01888575|Aspirin|aspirin|mesh-list
101280731|NCT01888575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101280732|NCT01888575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101280733|NCT01888575|Analgesics|analgesics|mesh-ancestor
101280734|NCT01888575|Sensory System Agents|sensory system agents|mesh-ancestor
101280735|NCT01888575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101280736|NCT01888575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280737|NCT01888575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101280738|NCT01888575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101280739|NCT01888575|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101280740|NCT01888575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101280741|NCT01888575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280742|NCT01888575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101280743|NCT01888575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101280744|NCT01888575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101280745|NCT01888575|Antipyretics|antipyretics|mesh-ancestor
101280746|NCT01888718|Fexofenadine|fexofenadine|mesh-list
101280747|NCT01888718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101280748|NCT01888718|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101280749|NCT01888718|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101280750|NCT01888718|Histamine Antagonists|histamine antagonists|mesh-ancestor
101280751|NCT01888718|Histamine Agents|histamine agents|mesh-ancestor
101280752|NCT01888718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101280753|NCT01888718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280754|NCT01888718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280755|NCT01888731|Lamotrigine|lamotrigine|mesh-list
101819098|NCT00488319|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101819099|NCT00488319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101819100|NCT00488319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101819101|NCT00488319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101819102|NCT00488319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819103|NCT00488319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101819104|NCT00488319|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101280756|NCT01888731|Anticonvulsants|anticonvulsants|mesh-ancestor
101280757|NCT01888731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101280758|NCT01888731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101280759|NCT01888731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280760|NCT01888731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101280761|NCT01888731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280762|NCT01888731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101280763|NCT01888731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101280764|NCT01888731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101280765|NCT01888731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101280766|NCT01888731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101280767|NCT01888744|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101280768|NCT01888744|Cetrorelix|cetrorelix|mesh-list
101280769|NCT01888744|Progesterone|progesterone|mesh-list
101280770|NCT01888744|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101280771|NCT01888744|Ganirelix|ganirelix|mesh-list
101280772|NCT01888744|Progestins|progestins|mesh-ancestor
101280773|NCT01888744|Hormones|hormones|mesh-ancestor
101280774|NCT01888744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101280775|NCT01888744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280776|NCT01888744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101280777|NCT01888744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101280778|NCT01888744|Fertility Agents|fertility agents|mesh-ancestor
101280779|NCT01888744|Hormone Antagonists|hormone antagonists|mesh-ancestor
101280780|NCT01888757|Lamotrigine|lamotrigine|mesh-list
101280781|NCT01888757|Anticonvulsants|anticonvulsants|mesh-ancestor
101280782|NCT01888757|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101280783|NCT01888757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101280784|NCT01888757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280785|NCT01888757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101280786|NCT01888757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280787|NCT01888757|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101280788|NCT01888757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101280789|NCT01888757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101280790|NCT01888757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101280791|NCT01888757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101280792|NCT01888796|Linagliptin|linagliptin|mesh-list
101280793|NCT01888796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101280794|NCT01888796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280795|NCT01888796|Incretins|incretins|mesh-ancestor
101280796|NCT01888796|Hormones|hormones|mesh-ancestor
101280797|NCT01888796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101280798|NCT01888796|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101280799|NCT01888796|Protease Inhibitors|protease inhibitors|mesh-ancestor
101280800|NCT01888796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101280801|NCT01888796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280802|NCT01888822|Ciprofloxacin|ciprofloxacin|mesh-list
101280803|NCT01888822|Ampicillin|ampicillin|mesh-list
101280804|NCT01888822|Sulbactam|sulbactam|mesh-list
101280805|NCT01888822|Sultamicillin|sultamicillin|mesh-list
101280806|NCT01888822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101280807|NCT01888822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101280808|NCT01888822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101280809|NCT01888822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101280810|NCT01888822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101280811|NCT01888822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280812|NCT01888822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101819105|NCT00488319|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101819106|NCT00488319|Serotonin Agents|serotonin agents|mesh-ancestor
101819107|NCT00488319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101819108|NCT00488319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819109|NCT00488319|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101280813|NCT01888822|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101280814|NCT01888822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101280815|NCT01888822|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101280816|NCT01888835|Mirtazapine|mirtazapine|mesh-list
101280817|NCT01888835|Antidepressive Agents|antidepressive agents|mesh-ancestor
101280818|NCT01888835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101280819|NCT01888835|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101280820|NCT01888835|Histamine Antagonists|histamine antagonists|mesh-ancestor
101280821|NCT01888835|Histamine Agents|histamine agents|mesh-ancestor
101280822|NCT01888835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101280823|NCT01888835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280824|NCT01888835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280825|NCT01888835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101280826|NCT01888835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101280827|NCT01888835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101280828|NCT01888835|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101280829|NCT01888835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101280830|NCT01888835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101280831|NCT01888835|Adrenergic Agents|adrenergic agents|mesh-ancestor
101280832|NCT01888835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101280833|NCT01888835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101280834|NCT01888835|Serotonin Agents|serotonin agents|mesh-ancestor
101280835|NCT01888835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101280836|NCT01888861|Thioctic Acid|thioctic acid|mesh-list
101280837|NCT01888861|Antioxidants|antioxidants|mesh-ancestor
101280838|NCT01888861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280839|NCT01888861|Protective Agents|protective agents|mesh-ancestor
101280840|NCT01888861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280841|NCT01888861|Vitamin B Complex|vitamin b complex|mesh-ancestor
101280842|NCT01888861|Vitamins|vitamins|mesh-ancestor
101280843|NCT01888861|Micronutrients|micronutrients|mesh-ancestor
101280844|NCT01888978|Leucovorin|leucovorin|mesh-list
101280845|NCT01888978|Gemcitabine|gemcitabine|mesh-list
101280846|NCT01888978|Fluorouracil|fluorouracil|mesh-list
101280847|NCT01888978|Docetaxel|docetaxel|mesh-list
101280848|NCT01888978|Oxaliplatin|oxaliplatin|mesh-list
101280849|NCT01888978|Irinotecan|irinotecan|mesh-list
101280850|NCT01888978|Levoleucovorin|levoleucovorin|mesh-list
101280851|NCT01888978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101280852|NCT01888978|Antimetabolites|antimetabolites|mesh-ancestor
101280853|NCT01888978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280854|NCT01888978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101280855|NCT01888978|Tubulin Modulators|tubulin modulators|mesh-ancestor
101280856|NCT01888978|Antimitotic Agents|antimitotic agents|mesh-ancestor
101280857|NCT01888978|Mitosis Modulators|mitosis modulators|mesh-ancestor
101280858|NCT01888978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101280861|NCT01888978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101280862|NCT01888978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101280863|NCT01888978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101280864|NCT01888978|Antidotes|antidotes|mesh-ancestor
101280865|NCT01888978|Protective Agents|protective agents|mesh-ancestor
101280866|NCT01888978|Vitamin B Complex|vitamin b complex|mesh-ancestor
101280867|NCT01888978|Vitamins|vitamins|mesh-ancestor
101280868|NCT01888978|Micronutrients|micronutrients|mesh-ancestor
101280869|NCT01889004|Dexmedetomidine|dexmedetomidine|mesh-list
101280870|NCT01889004|Propofol|propofol|mesh-list
101280871|NCT01889004|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101280872|NCT01889004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101280873|NCT01889004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280874|NCT01889004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101280875|NCT01889004|Analgesics|analgesics|mesh-ancestor
101280876|NCT01889004|Sensory System Agents|sensory system agents|mesh-ancestor
101280877|NCT01889004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101280878|NCT01889004|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101280879|NCT01889004|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101819110|NCT00488319|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101819111|NCT00488319|Dopamine Agents|dopamine agents|mesh-ancestor
101819112|NCT01018251|Alovudine|alovudine|mesh-list
101819113|NCT01018251|Antiviral Agents|antiviral agents|mesh-ancestor
101819114|NCT01018251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101819115|NCT00463047|Fentanyl|fentanyl|mesh-list
101819116|NCT00463047|Oxycodone|oxycodone|mesh-list
101819117|NCT00463047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101819118|NCT00463047|Narcotics|narcotics|mesh-ancestor
101819119|NCT00463047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101280880|NCT01889004|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101280881|NCT01889004|Adrenergic Agents|adrenergic agents|mesh-ancestor
101280882|NCT01889004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101280883|NCT01889004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280884|NCT01889004|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101280885|NCT01889004|Anesthetics, General|anesthetics, general|mesh-ancestor
101280886|NCT01889004|Anesthetics|anesthetics|mesh-ancestor
101280887|NCT01889056|Epoetin Alfa|epoetin alfa|mesh-list
101280888|NCT01889056|Hematinics|hematinics|mesh-ancestor
101280889|NCT01889095|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101280890|NCT01889095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101280891|NCT01889095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280892|NCT01889134|Alendronate|alendronate|mesh-list
101280893|NCT01889134|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101280894|NCT01889134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280895|NCT01889173|Cyclobenzaprine|cyclobenzaprine|mesh-list
101280896|NCT01889173|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101280897|NCT01889173|Antidepressive Agents|antidepressive agents|mesh-ancestor
101280898|NCT01889173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101280899|NCT01889173|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101280900|NCT01889173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280901|NCT01889173|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101280902|NCT01889173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101280903|NCT01889173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101280904|NCT01889173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101280905|NCT01889212|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101280906|NCT01889212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101280907|NCT01889212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101280908|NCT01889212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101280909|NCT01889212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280911|NCT01889290|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101280912|NCT01889290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280913|NCT01889290|Sensory System Agents|sensory system agents|mesh-ancestor
101280915|NCT01889368|Grape Seed Extract|grape seed extract|mesh-list
101280916|NCT01889368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101280917|NCT01889368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101280919|NCT01889368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280920|NCT01889368|Protective Agents|protective agents|mesh-ancestor
101280921|NCT01889368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280922|NCT01889407|Idarubicin|idarubicin|mesh-list
101280923|NCT01889407|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101280924|NCT01889407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101280925|NCT01889407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101280926|NCT01889407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101280927|NCT01889407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101280928|NCT01889407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280929|NCT01889433|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101280930|NCT01889433|Antiviral Agents|antiviral agents|mesh-ancestor
101280931|NCT01889433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101280932|NCT01889446|Calcium|calcium|mesh-list
101280933|NCT01889446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101280934|NCT01889446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280935|NCT01889498|Acetazolamide|acetazolamide|mesh-list
101280936|NCT01889498|Anticonvulsants|anticonvulsants|mesh-ancestor
101819120|NCT00463047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819121|NCT00463047|Analgesics|analgesics|mesh-ancestor
101819122|NCT00463047|Sensory System Agents|sensory system agents|mesh-ancestor
101819123|NCT00463047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101819124|NCT00463047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101819125|NCT00463047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101819126|NCT00463047|Anesthetics, General|anesthetics, general|mesh-ancestor
101819127|NCT00463047|Anesthetics|anesthetics|mesh-ancestor
101819128|NCT00487539|Golimumab|golimumab|mesh-list
101819129|NCT00487539|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101819130|NCT00487539|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101819131|NCT00487539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101819132|NCT00487539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101819133|NCT00487539|Immunologic Factors|immunologic factors|mesh-ancestor
101819134|NCT00487539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280937|NCT01889498|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101280938|NCT01889498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101280939|NCT01889498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280940|NCT01889498|Diuretics|diuretics|mesh-ancestor
101280941|NCT01889498|Natriuretic Agents|natriuretic agents|mesh-ancestor
101280942|NCT01889498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280943|NCT01889576|Magnesium Oxide|magnesium oxide|mesh-list
101280944|NCT01889576|Antacids|antacids|mesh-ancestor
101280945|NCT01889576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280946|NCT01889576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101280947|NCT01889680|Leucovorin|leucovorin|mesh-list
101280948|NCT01889680|Fluorouracil|fluorouracil|mesh-list
101280949|NCT01889680|Oxaliplatin|oxaliplatin|mesh-list
101280950|NCT01889680|Aflibercept|aflibercept|mesh-list
101280951|NCT01889680|Levoleucovorin|levoleucovorin|mesh-list
101280952|NCT01889680|Antimetabolites|antimetabolites|mesh-ancestor
101280953|NCT01889680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280954|NCT01889680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101280955|NCT01889680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101280956|NCT01889680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101280957|NCT01889680|Immunologic Factors|immunologic factors|mesh-ancestor
101280958|NCT01889680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280959|NCT01889680|Antidotes|antidotes|mesh-ancestor
101280960|NCT01889680|Protective Agents|protective agents|mesh-ancestor
101280961|NCT01889680|Vitamin B Complex|vitamin b complex|mesh-ancestor
101280962|NCT01889680|Vitamins|vitamins|mesh-ancestor
101280963|NCT01889680|Micronutrients|micronutrients|mesh-ancestor
101280964|NCT01889680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101280965|NCT01889680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101280966|NCT01889680|Growth Substances|growth substances|mesh-ancestor
101280967|NCT01889680|Growth Inhibitors|growth inhibitors|mesh-ancestor
101280968|NCT01889758|Tacrolimus|tacrolimus|mesh-list
101280969|NCT01889758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101280970|NCT01889758|Immunologic Factors|immunologic factors|mesh-ancestor
101280971|NCT01889758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280972|NCT01889758|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101280974|NCT01889758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280975|NCT01889771|Nicotine|nicotine|mesh-list
101280976|NCT01889771|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101280977|NCT01889771|Autonomic Agents|autonomic agents|mesh-ancestor
101280978|NCT01889771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101280979|NCT01889771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280980|NCT01889771|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101280981|NCT01889771|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101280982|NCT01889771|Cholinergic Agents|cholinergic agents|mesh-ancestor
101280983|NCT01889771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101280984|NCT01889771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819136|NCT00486837|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
101819137|NCT00486837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101408454|NCT00109226|Growth Substances|growth substances|mesh-ancestor
101819138|NCT00486837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819139|NCT00486837|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101819140|NCT00486837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101819141|NCT00486759|Bevacizumab|bevacizumab|mesh-list
101819142|NCT00486759|Rituximab|rituximab|mesh-list
101280985|NCT01889849|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101280986|NCT01889849|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101280987|NCT01889849|Antiviral Agents|antiviral agents|mesh-ancestor
101280988|NCT01889849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101280989|NCT01889914|Insulin|insulin|mesh-list
101280990|NCT01889914|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101280991|NCT01889914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101280992|NCT01889914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101280993|NCT01889966|Sildenafil Citrate|sildenafil citrate|mesh-list
101280994|NCT01889966|Vasodilator Agents|vasodilator agents|mesh-ancestor
101280995|NCT01889966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101280996|NCT01889966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101280997|NCT01889966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101280998|NCT01889966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280999|NCT01889966|Urological Agents|urological agents|mesh-ancestor
101281000|NCT01889979|Tramadol|tramadol|mesh-list
101281001|NCT01889979|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101281002|NCT01889979|Narcotics|narcotics|mesh-ancestor
101281003|NCT01889979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101281004|NCT01889979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281005|NCT01889979|Analgesics|analgesics|mesh-ancestor
101281006|NCT01889979|Sensory System Agents|sensory system agents|mesh-ancestor
101281007|NCT01889979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101281008|NCT01890538|Dimenhydrinate|dimenhydrinate|mesh-list
101281009|NCT01890538|Piracetam|piracetam|mesh-list
101281010|NCT01890538|Antiemetics|antiemetics|mesh-ancestor
101281011|NCT01890538|Autonomic Agents|autonomic agents|mesh-ancestor
101281012|NCT01890538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101281013|NCT01890538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281014|NCT01890538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101281015|NCT01890538|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101281016|NCT01890538|Histamine Antagonists|histamine antagonists|mesh-ancestor
101281017|NCT01890538|Histamine Agents|histamine agents|mesh-ancestor
101281018|NCT01890538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101281019|NCT01890538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281020|NCT01890538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101281021|NCT01890538|Protective Agents|protective agents|mesh-ancestor
101281022|NCT01890538|Nootropic Agents|nootropic agents|mesh-ancestor
101281023|NCT01891292|Acetylcysteine|acetylcysteine|mesh-list
101281024|NCT01891292|Enalapril|enalapril|mesh-list
101281025|NCT01891292|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101281026|NCT01891292|Antiviral Agents|antiviral agents|mesh-ancestor
101281027|NCT01891292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101281028|NCT01891292|Expectorants|expectorants|mesh-ancestor
101281029|NCT01891292|Respiratory System Agents|respiratory system agents|mesh-ancestor
101281030|NCT01891292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101281031|NCT01891292|Antioxidants|antioxidants|mesh-ancestor
101281032|NCT01891292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281033|NCT01891292|Protective Agents|protective agents|mesh-ancestor
101281034|NCT01891292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281035|NCT01891292|Antidotes|antidotes|mesh-ancestor
101281036|NCT01891292|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101281037|NCT01891292|Protease Inhibitors|protease inhibitors|mesh-ancestor
101281038|NCT01891292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101281039|NCT01891292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101281040|NCT01891487|Bimatoprost|bimatoprost|mesh-list
101281041|NCT01891487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101281043|NCT01891981|Immunotoxins|immunotoxins|mesh-ancestor
101281044|NCT01891981|Immunoconjugates|immunoconjugates|mesh-ancestor
101281045|NCT01891981|Immunologic Factors|immunologic factors|mesh-ancestor
101281046|NCT01891981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281047|NCT01891981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101819143|NCT00486759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101819144|NCT00486759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101819145|NCT00486759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101281048|NCT01892319|Insulin Detemir|insulin detemir|mesh-list
101281049|NCT01892319|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101281050|NCT01892319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281051|NCT01893229|Oxcarbazepine|oxcarbazepine|mesh-list
101281052|NCT01893229|Valproic Acid|valproic acid|mesh-list
101281053|NCT01893229|Olanzapine|olanzapine|mesh-list
101281054|NCT01893229|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101281055|NCT01893229|Ziprasidone|ziprasidone|mesh-list
101281056|NCT01893229|Lithium Carbonate|lithium carbonate|mesh-list
101281057|NCT01893229|Antiemetics|antiemetics|mesh-ancestor
101281058|NCT01893229|Autonomic Agents|autonomic agents|mesh-ancestor
101281059|NCT01893229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101281060|NCT01893229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281061|NCT01893229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101281062|NCT01893229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101281063|NCT01893229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101281064|NCT01893229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101281065|NCT01893229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101281066|NCT01893229|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101281067|NCT01893229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101281068|NCT01893229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101281069|NCT01893229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281070|NCT01893229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101281071|NCT01893229|Serotonin Agents|serotonin agents|mesh-ancestor
101281072|NCT01893229|Antidepressive Agents|antidepressive agents|mesh-ancestor
101281073|NCT01893229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101281074|NCT01893229|Antimanic Agents|antimanic agents|mesh-ancestor
101281075|NCT01893229|Anticonvulsants|anticonvulsants|mesh-ancestor
101281076|NCT01893229|GABA Agents|gaba agents|mesh-ancestor
101281077|NCT01893229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101281078|NCT01893229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101281079|NCT01893229|Dopamine Agents|dopamine agents|mesh-ancestor
101281080|NCT01893229|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101281081|NCT01893229|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101281082|NCT01893229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101281083|NCT01893229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101281085|NCT01894269|Entecavir|entecavir|mesh-list
101281086|NCT01894269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101281087|NCT01894269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101281088|NCT01894269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101281089|NCT01894269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281090|NCT01894269|Antiviral Agents|antiviral agents|mesh-ancestor
101281091|NCT01894269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101281092|NCT01894269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101281093|NCT01894269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101281094|NCT01894789|Clopidogrel|clopidogrel|mesh-list
101281095|NCT01894789|Ticagrelor|ticagrelor|mesh-list
101281096|NCT01894789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101281097|NCT01894789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101281098|NCT01894789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101281099|NCT01894789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101281100|NCT01894789|Purinergic Agents|purinergic agents|mesh-ancestor
101281101|NCT01894789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101281102|NCT01894789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281103|NCT01894789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281104|NCT01894815|Dexetimide|dexetimide|mesh-list
101281105|NCT01894815|Citalopram|citalopram|mesh-list
101281106|NCT01894815|Escitalopram|escitalopram|mesh-list
101281107|NCT01894815|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101281108|NCT01894815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101281109|NCT01894815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101281110|NCT01894815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281111|NCT01894815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101281112|NCT01894815|Serotonin Agents|serotonin agents|mesh-ancestor
101281113|NCT01894815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281114|NCT01894815|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101281115|NCT01894815|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101281116|NCT01894815|Parasympatholytics|parasympatholytics|mesh-ancestor
101281117|NCT01894815|Autonomic Agents|autonomic agents|mesh-ancestor
101819146|NCT00486759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101819147|NCT00486759|Growth Substances|growth substances|mesh-ancestor
101819148|NCT00486759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819149|NCT00486759|Growth Inhibitors|growth inhibitors|mesh-ancestor
101819150|NCT00486759|Immunologic Factors|immunologic factors|mesh-ancestor
101819151|NCT00486759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101819152|NCT00486603|Hydroxychloroquine|hydroxychloroquine|mesh-list
101819153|NCT00486603|Temozolomide|temozolomide|mesh-list
101819154|NCT00486603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101281118|NCT01894815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101281119|NCT01894815|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101281120|NCT01894815|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101281121|NCT01894815|Cholinergic Agents|cholinergic agents|mesh-ancestor
101281122|NCT01894815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101281123|NCT01894815|Antidepressive Agents|antidepressive agents|mesh-ancestor
101281124|NCT01894815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101281125|NCT01895049|Mycophenolic Acid|mycophenolic acid|mesh-list
101281127|NCT01895049|Everolimus|everolimus|mesh-list
101281129|NCT01895049|Thymoglobulin|thymoglobulin|mesh-list
101281130|NCT01895049|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101281131|NCT01895049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101281132|NCT01895049|Glucocorticoids|glucocorticoids|mesh-ancestor
101281133|NCT01895049|Hormones|hormones|mesh-ancestor
101281134|NCT01895049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101281135|NCT01895049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281136|NCT01895049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101281137|NCT01895049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101281138|NCT01895049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101281139|NCT01895049|Immunologic Factors|immunologic factors|mesh-ancestor
101281140|NCT01895049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101281141|NCT01895049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101281142|NCT01895049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281143|NCT01895049|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101281144|NCT01895049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101281145|NCT01895049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101281146|NCT01895049|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101281147|NCT01895049|Antitubercular Agents|antitubercular agents|mesh-ancestor
101281148|NCT01895049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101281149|NCT01895049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101281150|NCT01896622|Ritonavir|ritonavir|mesh-list
101281151|NCT01896622|Cobicistat|cobicistat|mesh-list
101281152|NCT01896622|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101281153|NCT01896622|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101281154|NCT01896622|Protease Inhibitors|protease inhibitors|mesh-ancestor
101281155|NCT01896622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101281156|NCT01896622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281157|NCT01896622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101281158|NCT01896622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101281159|NCT01896622|Antiviral Agents|antiviral agents|mesh-ancestor
101281160|NCT01896622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101281161|NCT01896622|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101281162|NCT01896622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101281163|NCT01897051|Rifaximin|rifaximin|mesh-list
101281164|NCT01897051|Propranolol|propranolol|mesh-list
101281165|NCT01897051|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101281166|NCT01897051|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101281167|NCT01897051|Adrenergic Agents|adrenergic agents|mesh-ancestor
101281168|NCT01897051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101281169|NCT01897051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281170|NCT01897051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281171|NCT01897051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101281172|NCT01897051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101281173|NCT01897051|Vasodilator Agents|vasodilator agents|mesh-ancestor
101281174|NCT01897051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101819155|NCT00486603|Alkylating Agents|alkylating agents|mesh-ancestor
101819156|NCT00486603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819157|NCT00486603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101819158|NCT00486603|Antimalarials|antimalarials|mesh-ancestor
101819159|NCT00486603|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101819160|NCT00486603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101819161|NCT00486603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101819162|NCT00486603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101819163|NCT00486603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101819164|NCT00474045|Insulin|insulin|mesh-list
101819165|NCT00474045|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101819166|NCT00474045|Insulin Aspart|insulin aspart|mesh-list
101819167|NCT00474045|Insulin Detemir|insulin detemir|mesh-list
101819168|NCT00474045|Insulin, Isophane|insulin, isophane|mesh-list
101819169|NCT00474045|Isophane Insulin, Human|isophane insulin, human|mesh-list
101819170|NCT00474045|Isophane insulin, beef|isophane insulin, beef|mesh-list
101819171|NCT00474045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101819172|NCT00474045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819173|NCT01020825|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101819174|NCT01020825|Hemostatics|hemostatics|mesh-ancestor
101819175|NCT01020825|Coagulants|coagulants|mesh-ancestor
101819176|NCT01018485|Botulinum Toxins|botulinum toxins|mesh-list
101819177|NCT01018485|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101819178|NCT01018485|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101819179|NCT01018485|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101819180|NCT01018485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101819181|NCT01018485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281175|NCT01897051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101281176|NCT01897051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101281177|NCT01897740|Sildenafil Citrate|sildenafil citrate|mesh-list
101281178|NCT01897740|Vasodilator Agents|vasodilator agents|mesh-ancestor
101281180|NCT01897740|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101281181|NCT01897740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101281182|NCT01897740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281183|NCT01897740|Urological Agents|urological agents|mesh-ancestor
101281184|NCT01897753|Hormones|hormones|mesh-list
101281185|NCT01897753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101281186|NCT01897753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281187|NCT01898065|Misonidazole|misonidazole|mesh-list
101281188|NCT01898065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101281189|NCT01898065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101281190|NCT01898065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101281191|NCT01898065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101281192|NCT01898221|Ethanol|ethanol|mesh-list
101281193|NCT01898221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101281194|NCT01898221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101281195|NCT01898221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101281196|NCT01898221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281197|NCT01898338|Daptomycin|daptomycin|mesh-list
101281198|NCT01898338|Fosfomycin|fosfomycin|mesh-list
101819182|NCT01018485|Cholinergic Agents|cholinergic agents|mesh-ancestor
101819183|NCT01018485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101819184|NCT01018485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819185|NCT01018485|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101819186|NCT01018485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101819187|NCT00462501|Leucovorin|leucovorin|mesh-list
101819188|NCT00462501|Bevacizumab|bevacizumab|mesh-list
101819189|NCT00462501|Fluorouracil|fluorouracil|mesh-list
101819190|NCT00462501|Oxaliplatin|oxaliplatin|mesh-list
101819191|NCT00462501|Calcium|calcium|mesh-list
101819192|NCT00462501|Levoleucovorin|levoleucovorin|mesh-list
101819193|NCT00462501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101819194|NCT00462501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101819195|NCT00462501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101819196|NCT00462501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101819197|NCT00462501|Growth Substances|growth substances|mesh-ancestor
101281199|NCT01898338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101281200|NCT01898338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101281201|NCT01899105|Ivacaftor|ivacaftor|mesh-list
101281202|NCT01899105|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101281203|NCT01899105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101281204|NCT01899105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281205|NCT01900015|Efavirenz|efavirenz|mesh-list
101281206|NCT01900015|Raltegravir Potassium|raltegravir potassium|mesh-list
101281207|NCT01900015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101281208|NCT01900015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101281209|NCT01900015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101281210|NCT01900015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281211|NCT01900015|Antiviral Agents|antiviral agents|mesh-ancestor
101281212|NCT01900015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101281213|NCT01900015|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101281214|NCT01900015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101281215|NCT01900015|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101281216|NCT01900015|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101281217|NCT01900015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101281219|NCT01900015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101281220|NCT01900015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101281221|NCT01900015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101281222|NCT01900015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101281223|NCT01900028|Itraconazole|itraconazole|mesh-list
101281224|NCT01900028|Olaparib|olaparib|mesh-list
101281225|NCT01900028|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101281226|NCT01900028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101281227|NCT01900028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281228|NCT01900028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101281229|NCT01900028|Antifungal Agents|antifungal agents|mesh-ancestor
101281230|NCT01900028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101281231|NCT01900028|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101281232|NCT01900028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101281233|NCT01900028|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101281234|NCT01900028|Hormone Antagonists|hormone antagonists|mesh-ancestor
101281235|NCT01900028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101281236|NCT01900028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281237|NCT01900028|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101281238|NCT01900041|Minoxidil|minoxidil|mesh-list
101281239|NCT01900041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101281240|NCT01900041|Vasodilator Agents|vasodilator agents|mesh-ancestor
101281241|NCT01900093|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101281242|NCT01900093|Hormones|hormones|mesh-ancestor
101819198|NCT00462501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819199|NCT00462501|Growth Inhibitors|growth inhibitors|mesh-ancestor
101819200|NCT00462501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101819202|NCT00462501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819203|NCT00462501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101819204|NCT00462501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101819205|NCT00462501|Immunologic Factors|immunologic factors|mesh-ancestor
101281243|NCT01900093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101281244|NCT01900093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281245|NCT01900106|Ritonavir|ritonavir|mesh-list
101281246|NCT01900106|Darunavir|darunavir|mesh-list
101281247|NCT01900106|Lamivudine|lamivudine|mesh-list
101281248|NCT01900106|Raltegravir Potassium|raltegravir potassium|mesh-list
101281249|NCT01900106|Abacavir|abacavir|mesh-list
101281250|NCT01900106|Dideoxynucleosides|dideoxynucleosides|mesh-list
101281251|NCT01900106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101281252|NCT01900106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101281253|NCT01900106|Protease Inhibitors|protease inhibitors|mesh-ancestor
101281254|NCT01900106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101281255|NCT01900106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281256|NCT01900106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101281257|NCT01900106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101281258|NCT01900106|Antiviral Agents|antiviral agents|mesh-ancestor
101281259|NCT01900106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101281260|NCT01900106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101281261|NCT01900106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101281262|NCT01900106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101281263|NCT01900106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101281264|NCT01900106|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101281265|NCT01900106|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101281266|NCT01900106|Antimetabolites|antimetabolites|mesh-ancestor
101281267|NCT01900158|Cisplatin|cisplatin|mesh-list
101281268|NCT01900158|Gemcitabine|gemcitabine|mesh-list
101281269|NCT01900158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101315176|NCT05639959|Mometasone Furoate|mometasone furoate|mesh-list
101281270|NCT01900158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101281271|NCT01900158|Antimetabolites|antimetabolites|mesh-ancestor
101281272|NCT01900158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281273|NCT01900197|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
101281274|NCT01900197|Hematinics|hematinics|mesh-ancestor
101281276|NCT01900301|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101281277|NCT01900301|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101281278|NCT01900301|Antiemetics|antiemetics|mesh-ancestor
101281280|NCT01900301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101281281|NCT01900301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281282|NCT01900301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101281283|NCT01900301|Mydriatics|mydriatics|mesh-ancestor
101281284|NCT01900301|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101281285|NCT01900301|Cholinergic Agents|cholinergic agents|mesh-ancestor
101281286|NCT01900301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101281287|NCT01900301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281288|NCT01900301|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101281289|NCT01900301|Parasympatholytics|parasympatholytics|mesh-ancestor
101281291|NCT01900327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101281292|NCT01900327|Antimetabolites|antimetabolites|mesh-ancestor
101281293|NCT01900327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281294|NCT01900327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101281295|NCT01900405|Dexmedetomidine|dexmedetomidine|mesh-list
101281296|NCT01900405|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101281297|NCT01900405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101281298|NCT01900405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819206|NCT00462501|Antidotes|antidotes|mesh-ancestor
101819207|NCT00462501|Protective Agents|protective agents|mesh-ancestor
101819208|NCT00462501|Vitamin B Complex|vitamin b complex|mesh-ancestor
101819210|NCT00462501|Micronutrients|micronutrients|mesh-ancestor
101819211|NCT03996603|Estrogens|estrogens|mesh-list
101819212|NCT03996603|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101819213|NCT03996603|Hormones|hormones|mesh-ancestor
101281299|NCT01900405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101281300|NCT01900405|Analgesics|analgesics|mesh-ancestor
101281301|NCT01900405|Sensory System Agents|sensory system agents|mesh-ancestor
101281302|NCT01900405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101281303|NCT01900405|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101281304|NCT01900405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101281305|NCT01900405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101281306|NCT01900405|Adrenergic Agents|adrenergic agents|mesh-ancestor
101281307|NCT01900405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101281308|NCT01900405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281310|NCT01900496|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101281311|NCT01900496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101281312|NCT01900496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101281313|NCT01900496|Immunologic Factors|immunologic factors|mesh-ancestor
101281314|NCT01900496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281315|NCT01900496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101281316|NCT01900496|Immunotoxins|immunotoxins|mesh-ancestor
101281317|NCT01900496|Immunoconjugates|immunoconjugates|mesh-ancestor
101281318|NCT01900509|Dexamethasone|dexamethasone|mesh-list
101281319|NCT01900509|Etoposide|etoposide|mesh-list
101281320|NCT01900509|Etoposide phosphate|etoposide phosphate|mesh-list
101281321|NCT01900509|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101281322|NCT01900509|Clofarabine|clofarabine|mesh-list
101281323|NCT01900509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101281324|NCT01900509|Antiemetics|antiemetics|mesh-ancestor
101281325|NCT01900509|Autonomic Agents|autonomic agents|mesh-ancestor
101281326|NCT01900509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101281327|NCT01900509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281328|NCT01900509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101281329|NCT01900509|Glucocorticoids|glucocorticoids|mesh-ancestor
101281330|NCT01900509|Hormones|hormones|mesh-ancestor
101281331|NCT01900509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101281332|NCT01900509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101281333|NCT01900509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101281334|NCT01900509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101281335|NCT01900509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101281336|NCT01900509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101281337|NCT01900509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101281338|NCT01900509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281339|NCT01900509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101281340|NCT01900509|Alkylating Agents|alkylating agents|mesh-ancestor
101281341|NCT01900509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101281342|NCT01900509|Antimetabolites|antimetabolites|mesh-ancestor
101281343|NCT01900587|Tapentadol|tapentadol|mesh-list
101281344|NCT01900587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101281345|NCT01900587|Narcotics|narcotics|mesh-ancestor
101281346|NCT01900587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101281347|NCT01900587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281348|NCT01900587|Analgesics|analgesics|mesh-ancestor
101281349|NCT01900587|Sensory System Agents|sensory system agents|mesh-ancestor
101281350|NCT01900587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101281352|NCT01900587|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101281353|NCT01900587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101281354|NCT01900587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281355|NCT01900587|Adrenergic Agents|adrenergic agents|mesh-ancestor
101281356|NCT01900587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101281358|NCT01900639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101281359|NCT01900639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101281360|NCT01900639|Analgesics|analgesics|mesh-ancestor
101281361|NCT01900639|Sensory System Agents|sensory system agents|mesh-ancestor
101819214|NCT03996603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101819215|NCT03996603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819216|NCT00462345|Rituximab|rituximab|mesh-list
101819217|NCT00462345|Methotrexate|methotrexate|mesh-list
101819218|NCT00462345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101819219|NCT00462345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101819220|NCT00462345|Immunologic Factors|immunologic factors|mesh-ancestor
101819221|NCT00462345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819222|NCT00462345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101819223|NCT00462345|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101476520|NCT00297804|Tubulin Modulators|tubulin modulators|mesh-ancestor
101819224|NCT00462345|Abortifacient Agents|abortifacient agents|mesh-ancestor
101819225|NCT00462345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101819226|NCT00462345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101819228|NCT00462345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819229|NCT00462345|Dermatologic Agents|dermatologic agents|mesh-ancestor
101281362|NCT01900639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101281363|NCT01900639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281364|NCT01900639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101281365|NCT01900639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101281366|NCT01900639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101281367|NCT01900639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101281368|NCT01900639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281369|NCT01900639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101281370|NCT01900639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101281371|NCT01900639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101281372|NCT01900639|Antipyretics|antipyretics|mesh-ancestor
101281373|NCT01900717|Leucovorin|leucovorin|mesh-list
101281374|NCT01900717|Bevacizumab|bevacizumab|mesh-list
101281375|NCT01900717|Fluorouracil|fluorouracil|mesh-list
101281376|NCT01900717|Oxaliplatin|oxaliplatin|mesh-list
101281377|NCT01900717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101281378|NCT01900717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101281379|NCT01900717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101281380|NCT01900717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101281381|NCT01900717|Growth Substances|growth substances|mesh-ancestor
101281382|NCT01900717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281383|NCT01900717|Growth Inhibitors|growth inhibitors|mesh-ancestor
101281384|NCT01900717|Antimetabolites|antimetabolites|mesh-ancestor
101281385|NCT01900717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281386|NCT01900717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101281387|NCT01900717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101281388|NCT01900717|Immunologic Factors|immunologic factors|mesh-ancestor
101281389|NCT01900717|Antidotes|antidotes|mesh-ancestor
101281390|NCT01900717|Protective Agents|protective agents|mesh-ancestor
101281391|NCT01900717|Vitamin B Complex|vitamin b complex|mesh-ancestor
101281392|NCT01900717|Vitamins|vitamins|mesh-ancestor
101281393|NCT01900717|Micronutrients|micronutrients|mesh-ancestor
101281394|NCT01900795|Ibuprofen|ibuprofen|mesh-list
101281395|NCT01900795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101281396|NCT01900795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101281397|NCT01900795|Analgesics|analgesics|mesh-ancestor
101281398|NCT01900795|Sensory System Agents|sensory system agents|mesh-ancestor
101281399|NCT01900795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101281400|NCT01900795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819230|NCT00462345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101819231|NCT00462345|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101819232|NCT00462345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101819233|NCT00462345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101819234|NCT01022541|Bevacizumab|bevacizumab|mesh-list
101819235|NCT01022541|Capecitabine|capecitabine|mesh-list
101281401|NCT01900795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101281402|NCT01900795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101281403|NCT01900795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101281404|NCT01900795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101281405|NCT01900795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281406|NCT01900860|Vitamin D|vitamin d|mesh-list
101281407|NCT01900860|Ergocalciferols|ergocalciferols|mesh-list
101281408|NCT01900860|Cholecalciferol|cholecalciferol|mesh-list
101281409|NCT01900860|Vitamins|vitamins|mesh-list
101281410|NCT01900860|Micronutrients|micronutrients|mesh-ancestor
101281411|NCT01900860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281412|NCT01900860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101281413|NCT01900860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101281414|NCT01900886|Ribavirin|ribavirin|mesh-list
101281415|NCT01900886|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101281416|NCT01900886|Antimetabolites|antimetabolites|mesh-ancestor
101281417|NCT01900886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281418|NCT01900886|Antiviral Agents|antiviral agents|mesh-ancestor
101281419|NCT01900886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101281421|NCT01900938|Propofol|propofol|mesh-list
101281422|NCT01900938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101281423|NCT01900938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101281424|NCT01900938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281425|NCT01900938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101281426|NCT01900938|Anesthetics, General|anesthetics, general|mesh-ancestor
101281427|NCT01900938|Anesthetics|anesthetics|mesh-ancestor
101281428|NCT01900938|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101281429|NCT01900938|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101281430|NCT01900938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101281431|NCT01900938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101281432|NCT01900938|GABA Modulators|gaba modulators|mesh-ancestor
101281433|NCT01900938|GABA Agents|gaba agents|mesh-ancestor
101281434|NCT01900938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101281435|NCT01900938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281436|NCT01900951|Temozolomide|temozolomide|mesh-list
101281437|NCT01900951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101281438|NCT01900951|Alkylating Agents|alkylating agents|mesh-ancestor
101281439|NCT01900951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281440|NCT01900951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101281442|NCT01901003|Anticonvulsants|anticonvulsants|mesh-ancestor
101281443|NCT01901003|Antiemetics|antiemetics|mesh-ancestor
101281444|NCT01901003|Autonomic Agents|autonomic agents|mesh-ancestor
101281445|NCT01901003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101281446|NCT01901003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281447|NCT01901003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101281448|NCT01901003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101281449|NCT01901003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101281450|NCT01901003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101281451|NCT01901003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101281452|NCT01901003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101281453|NCT01901003|GABA Modulators|gaba modulators|mesh-ancestor
101281454|NCT01901003|GABA Agents|gaba agents|mesh-ancestor
101281455|NCT01901003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101281456|NCT01901003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281457|NCT01901120|Mirabegron|mirabegron|mesh-list
101281458|NCT01901120|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101281459|NCT01901120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101281460|NCT01901120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101281461|NCT01901120|Adrenergic Agents|adrenergic agents|mesh-ancestor
101281462|NCT01901120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101281463|NCT01901120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281464|NCT01901120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281465|NCT01901120|Urological Agents|urological agents|mesh-ancestor
101281466|NCT01901172|Posaconazole|posaconazole|mesh-list
101819236|NCT01022541|Oxaliplatin|oxaliplatin|mesh-list
101819237|NCT01022541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101819238|NCT01022541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101819239|NCT01022541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101819240|NCT01022541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101819241|NCT01022541|Growth Substances|growth substances|mesh-ancestor
101819242|NCT01022541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819243|NCT01022541|Growth Inhibitors|growth inhibitors|mesh-ancestor
101819244|NCT01022541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101819245|NCT01022541|Antimetabolites|antimetabolites|mesh-ancestor
101281467|NCT01901172|Antifungal Agents|antifungal agents|mesh-ancestor
101281468|NCT01901172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101281469|NCT01901172|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101281470|NCT01901172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101281471|NCT01901172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101281472|NCT01901172|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101281473|NCT01901172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101281474|NCT01901172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101281475|NCT01901172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281476|NCT01901172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101281477|NCT01901172|Hormone Antagonists|hormone antagonists|mesh-ancestor
101281478|NCT01901172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101281479|NCT01901172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281480|NCT01901198|Interferons|interferons|mesh-list
101281481|NCT01901198|Interferon-alpha|interferon-alpha|mesh-list
101281482|NCT01901198|Interferon alpha-2|interferon alpha-2|mesh-list
101281483|NCT01901198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101281484|NCT01901198|Antiviral Agents|antiviral agents|mesh-ancestor
101281485|NCT01901198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101281486|NCT01901198|Immunologic Factors|immunologic factors|mesh-ancestor
101281487|NCT01901198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281488|NCT01901276|Omeprazole|omeprazole|mesh-list
101281489|NCT01901276|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101281490|NCT01901276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101281491|NCT01901276|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101281492|NCT01901276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101281493|NCT01901276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281494|NCT01901380|Caseins|caseins|mesh-list
101281495|NCT01901380|Chelating Agents|chelating agents|mesh-ancestor
101281496|NCT01901380|Sequestering Agents|sequestering agents|mesh-ancestor
101281497|NCT01901380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281498|NCT01901432|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
101281499|NCT01901432|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101281500|NCT01901432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528334|NCT04628676|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101281501|NCT01901432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281502|NCT01901471|Cyclosporine|cyclosporine|mesh-list
101281503|NCT01901471|Cyclosporins|cyclosporins|mesh-list
101281504|NCT01901471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101281505|NCT01901471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281506|NCT01901471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101281507|NCT01901471|Immunologic Factors|immunologic factors|mesh-ancestor
101281508|NCT01901471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281509|NCT01901471|Antifungal Agents|antifungal agents|mesh-ancestor
101281510|NCT01901471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101281511|NCT01901471|Dermatologic Agents|dermatologic agents|mesh-ancestor
101281512|NCT01901471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101281513|NCT01901471|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101819246|NCT01022541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819248|NCT01047202|Immunologic Factors|immunologic factors|mesh-ancestor
101819249|NCT01047202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819250|NCT01049854|Vidarabine|vidarabine|mesh-list
101819251|NCT01049854|Cyclophosphamide|cyclophosphamide|mesh-list
101819252|NCT01049854|Thiotepa|thiotepa|mesh-list
101819253|NCT01049854|Busulfan|busulfan|mesh-list
101281514|NCT01901484|Praziquantel|praziquantel|mesh-list
101281515|NCT01901484|Anthelmintics|anthelmintics|mesh-ancestor
101281516|NCT01901484|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101281517|NCT01901484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101281518|NCT01901549|Metoprolol|metoprolol|mesh-list
101281519|NCT01901549|Lisinopril|lisinopril|mesh-list
101281520|NCT01901549|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101281521|NCT01901549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101281522|NCT01901549|Sympatholytics|sympatholytics|mesh-ancestor
101281523|NCT01901549|Autonomic Agents|autonomic agents|mesh-ancestor
101281524|NCT01901549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101281525|NCT01901549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281526|NCT01901549|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101281527|NCT01901549|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101281528|NCT01901549|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101281529|NCT01901549|Adrenergic Agents|adrenergic agents|mesh-ancestor
101281530|NCT01901549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101281531|NCT01901549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281532|NCT01901549|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101281533|NCT01901549|Protease Inhibitors|protease inhibitors|mesh-ancestor
101281534|NCT01901549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101281535|NCT01901549|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101281536|NCT01901549|Protective Agents|protective agents|mesh-ancestor
101281537|NCT01901601|Anesthetics|anesthetics|mesh-list
101281538|NCT01901601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101281539|NCT01901601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281540|NCT01901640|Udenafil|udenafil|mesh-list
101281541|NCT01901640|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101281542|NCT01901640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101281543|NCT01901640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101281544|NCT01901640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281545|NCT01901666|Hormones|hormones|mesh-list
101281546|NCT01901666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101281547|NCT01901666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281548|NCT01901692|Sorafenib|sorafenib|mesh-list
101281549|NCT01901692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101281550|NCT01901692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101281551|NCT01901692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101281552|NCT01901692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281553|NCT01902017|Ketotifen|ketotifen|mesh-list
101281554|NCT01902017|Antipruritics|antipruritics|mesh-ancestor
101281555|NCT01902017|Dermatologic Agents|dermatologic agents|mesh-ancestor
101281556|NCT01902017|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101281557|NCT01902017|Histamine Antagonists|histamine antagonists|mesh-ancestor
101281558|NCT01902017|Histamine Agents|histamine agents|mesh-ancestor
101281559|NCT01902017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101281560|NCT01902017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281561|NCT01902017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281562|NCT01902017|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101281563|NCT01902108|Clonidine|clonidine|mesh-list
101281564|NCT01902108|Bupivacaine|bupivacaine|mesh-list
101281565|NCT01902108|Anesthetics, Local|anesthetics, local|mesh-ancestor
101281566|NCT01902108|Anesthetics|anesthetics|mesh-ancestor
101281567|NCT01902108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101281568|NCT01902108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281569|NCT01902108|Sensory System Agents|sensory system agents|mesh-ancestor
101281570|NCT01902108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101281571|NCT01902108|Analgesics|analgesics|mesh-ancestor
101281572|NCT01902108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101819254|NCT01049854|Fludarabine phosphate|fludarabine phosphate|mesh-list
101819255|NCT01049854|Fludarabine|fludarabine|mesh-list
101819256|NCT01049854|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101819257|NCT01049854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101819258|NCT01049854|Immunologic Factors|immunologic factors|mesh-ancestor
101819259|NCT01049854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819260|NCT01049854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101819261|NCT01049854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101819262|NCT01049854|Alkylating Agents|alkylating agents|mesh-ancestor
101281573|NCT01902108|Sympatholytics|sympatholytics|mesh-ancestor
101281574|NCT01902108|Autonomic Agents|autonomic agents|mesh-ancestor
101281575|NCT01902108|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101281576|NCT01902108|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101281577|NCT01902108|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101281578|NCT01902108|Adrenergic Agents|adrenergic agents|mesh-ancestor
101281579|NCT01902108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101281580|NCT01902108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281581|NCT01902121|Insulin|insulin|mesh-list
101281582|NCT01902121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101281583|NCT01902121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101281584|NCT01902121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281585|NCT01902160|Sirolimus|sirolimus|mesh-list
101281586|NCT01902160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101281587|NCT01902160|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101281588|NCT01902160|Temsirolimus|temsirolimus|mesh-list
101281589|NCT01902160|MTOR Inhibitors|mtor inhibitors|mesh-list
101281590|NCT01902160|Antibodies|antibodies|mesh-list
101281591|NCT01902160|Immunoglobulins|immunoglobulins|mesh-list
101281592|NCT01902160|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101281593|NCT01902160|Immunoconjugates|immunoconjugates|mesh-list
101281594|NCT01902160|Immunologic Factors|immunologic factors|mesh-ancestor
101281595|NCT01902160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281596|NCT01902160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101281597|NCT01902160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101281598|NCT01902160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101281599|NCT01902160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101281600|NCT01902160|Antifungal Agents|antifungal agents|mesh-ancestor
101281601|NCT01902160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101281602|NCT01902160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101281603|NCT01902160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101281604|NCT01902160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281605|NCT01902160|Immunotoxins|immunotoxins|mesh-ancestor
101281606|NCT01902186|Ritonavir|ritonavir|mesh-list
101281607|NCT01902186|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101281608|NCT01902186|Tenofovir|tenofovir|mesh-list
101281609|NCT01902186|Emtricitabine|emtricitabine|mesh-list
101281610|NCT01902186|Raltegravir Potassium|raltegravir potassium|mesh-list
101281611|NCT01902186|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101281612|NCT01902186|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101281613|NCT01902186|Protease Inhibitors|protease inhibitors|mesh-ancestor
101281614|NCT01902186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101281615|NCT01902186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281616|NCT01902186|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101281617|NCT01902186|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101281618|NCT01902186|Antiviral Agents|antiviral agents|mesh-ancestor
101281619|NCT01902186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101281620|NCT01902186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101281621|NCT01902186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101281623|NCT01902186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101281624|NCT01902186|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101281625|NCT01902186|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101281626|NCT01901861|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101281627|NCT01901861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101281628|NCT01901861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819263|NCT01049854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819264|NCT01049854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101819265|NCT01049854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101819266|NCT01049854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101819267|NCT01049854|Antimetabolites|antimetabolites|mesh-ancestor
101281629|NCT01901861|Incretins|incretins|mesh-ancestor
101281630|NCT01901861|Hormones|hormones|mesh-ancestor
101281631|NCT01901861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101281632|NCT01901861|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101281634|NCT01901861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101281635|NCT01901861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281636|NCT01902225|Doxorubicin|doxorubicin|mesh-list
101281637|NCT01902225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101281638|NCT01902225|Romidepsin|romidepsin|mesh-list
101281639|NCT01902225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101281640|NCT01902225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101281641|NCT01902225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101281642|NCT01902225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101281644|NCT01902225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281645|NCT01902225|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101281646|NCT01902238|Ethanol|ethanol|mesh-list
101281647|NCT01902238|Ethiodized Oil|ethiodized oil|mesh-list
101281648|NCT01902238|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101281649|NCT01902238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101281650|NCT01902238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101281651|NCT01902238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281652|NCT01902238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101281653|NCT01902342|Oseltamivir|oseltamivir|mesh-list
101281654|NCT01902342|Antiviral Agents|antiviral agents|mesh-ancestor
101281655|NCT01902342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101281656|NCT01902342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101281657|NCT01902342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281658|NCT01902446|Chlorhexidine|chlorhexidine|mesh-list
101281659|NCT01902446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101281660|NCT01902446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101281661|NCT01902446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101281662|NCT01902446|Disinfectants|disinfectants|mesh-ancestor
101281663|NCT01902446|Dermatologic Agents|dermatologic agents|mesh-ancestor
101281664|NCT01902485|Contraceptive Agents|contraceptive agents|mesh-list
101281665|NCT01902485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101281666|NCT01902485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281667|NCT01902498|Aspirin|aspirin|mesh-list
101281668|NCT01902498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101281669|NCT01902498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101281670|NCT01902498|Analgesics|analgesics|mesh-ancestor
101281671|NCT01902498|Sensory System Agents|sensory system agents|mesh-ancestor
101281672|NCT01902498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101281673|NCT01902498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281674|NCT01902498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101281675|NCT01902498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101281676|NCT01902498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101281677|NCT01902498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101281678|NCT01902498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281679|NCT01902498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101281680|NCT01902498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101281681|NCT01902498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101281682|NCT01902498|Antipyretics|antipyretics|mesh-ancestor
101281683|NCT01902511|Epoetin Alfa|epoetin alfa|mesh-list
101281685|NCT01902511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101281686|NCT01902511|Immunologic Factors|immunologic factors|mesh-ancestor
101281687|NCT01902511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281688|NCT01902511|Hematinics|hematinics|mesh-ancestor
101281689|NCT01902524|Fentanyl|fentanyl|mesh-list
101281690|NCT01902524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101281691|NCT01902524|Narcotics|narcotics|mesh-ancestor
101281692|NCT01902524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101281693|NCT01902524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281694|NCT01902524|Analgesics|analgesics|mesh-ancestor
101819268|NCT01049854|Antiviral Agents|antiviral agents|mesh-ancestor
101819269|NCT01049854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101819270|NCT00453999|Oseltamivir|oseltamivir|mesh-list
101819271|NCT00453999|Peramivir|peramivir|mesh-list
101819272|NCT00453999|Antiviral Agents|antiviral agents|mesh-ancestor
101819273|NCT00453999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101819274|NCT00453999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101819275|NCT00453999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819276|NCT00453921|Methylphenidate|methylphenidate|mesh-list
101819277|NCT00453921|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101819278|NCT00453921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281695|NCT01902524|Sensory System Agents|sensory system agents|mesh-ancestor
101281696|NCT01902524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101281697|NCT01902524|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101281698|NCT01902524|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101281699|NCT01902524|Anesthetics, General|anesthetics, general|mesh-ancestor
101281700|NCT01902524|Anesthetics|anesthetics|mesh-ancestor
101281701|NCT01902537|Prucalopride|prucalopride|mesh-list
101281702|NCT01902537|Laxatives|laxatives|mesh-ancestor
101281703|NCT01902537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101281704|NCT01902537|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101281705|NCT01902537|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101281706|NCT01902537|Serotonin Agents|serotonin agents|mesh-ancestor
101281707|NCT01902537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101281708|NCT01902537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281709|NCT01902537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281710|NCT01902550|Metoprolol|metoprolol|mesh-list
101281711|NCT01902550|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101281712|NCT01902550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101281713|NCT01902550|Sympatholytics|sympatholytics|mesh-ancestor
101281714|NCT01902550|Autonomic Agents|autonomic agents|mesh-ancestor
101281715|NCT01902550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101281716|NCT01902550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281717|NCT01902550|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101281718|NCT01902550|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101281719|NCT01902550|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101281720|NCT01902550|Adrenergic Agents|adrenergic agents|mesh-ancestor
101281721|NCT01902550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101281722|NCT01902550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281723|NCT01902641|Rocuronium|rocuronium|mesh-list
101281724|NCT01902641|Succinylcholine|succinylcholine|mesh-list
101281725|NCT01902641|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101281726|NCT01902641|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101281727|NCT01902641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101281728|NCT01902641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101281729|NCT01902641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281730|NCT01902641|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
101281731|NCT01902771|Imiquimod|imiquimod|mesh-list
101281732|NCT01902771|Vaccines|vaccines|mesh-list
101281733|NCT01902771|Immunologic Factors|immunologic factors|mesh-ancestor
101281734|NCT01902771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281735|NCT01902771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101281736|NCT01902771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101281737|NCT01902771|Interferon Inducers|interferon inducers|mesh-ancestor
101281739|NCT01902810|Metoprolol|metoprolol|mesh-list
101281740|NCT01902810|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101281741|NCT01902810|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101281742|NCT01902810|Adrenergic Agents|adrenergic agents|mesh-ancestor
101281743|NCT01902810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101281744|NCT01902810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281745|NCT01902810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819279|NCT00453921|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101819280|NCT00453921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101819281|NCT00453921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101819282|NCT00453921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819283|NCT00453921|Dopamine Agents|dopamine agents|mesh-ancestor
101819284|NCT00453921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101819285|NCT00382720|Docetaxel|docetaxel|mesh-list
101819286|NCT00382720|Capecitabine|capecitabine|mesh-list
101819287|NCT00382720|Oxaliplatin|oxaliplatin|mesh-list
101819288|NCT00382720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101819289|NCT00382720|Tubulin Modulators|tubulin modulators|mesh-ancestor
101819290|NCT00382720|Antimitotic Agents|antimitotic agents|mesh-ancestor
101819291|NCT00382720|Mitosis Modulators|mitosis modulators|mesh-ancestor
101819292|NCT00382720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819293|NCT00382720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101819294|NCT00382720|Antimetabolites|antimetabolites|mesh-ancestor
101819295|NCT01025349|Bevacizumab|bevacizumab|mesh-list
101281746|NCT01902810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101281747|NCT01902810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101281748|NCT01902810|Vasodilator Agents|vasodilator agents|mesh-ancestor
101281749|NCT01902810|Sympatholytics|sympatholytics|mesh-ancestor
101281750|NCT01902810|Autonomic Agents|autonomic agents|mesh-ancestor
101281751|NCT01902810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101281752|NCT01902810|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101281753|NCT01902862|Rituximab|rituximab|mesh-list
101281754|NCT01902862|Bortezomib|bortezomib|mesh-list
101281755|NCT01902862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101281756|NCT01902862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101281757|NCT01902862|Immunologic Factors|immunologic factors|mesh-ancestor
101281758|NCT01902862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281759|NCT01902862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101281760|NCT01902875|Paclitaxel|paclitaxel|mesh-list
101281761|NCT01902875|Cisplatin|cisplatin|mesh-list
101281762|NCT01902875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101281763|NCT01902875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101281764|NCT01902875|Tubulin Modulators|tubulin modulators|mesh-ancestor
101281765|NCT01902875|Antimitotic Agents|antimitotic agents|mesh-ancestor
101281766|NCT01902875|Mitosis Modulators|mitosis modulators|mesh-ancestor
101281767|NCT01902875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281768|NCT01903018|Cisplatin|cisplatin|mesh-list
101281769|NCT01903018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101281770|NCT01903057|Azithromycin|azithromycin|mesh-list
101281771|NCT01903057|Ivermectin|ivermectin|mesh-list
101281772|NCT01903057|Albendazole|albendazole|mesh-list
101281773|NCT01903057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101281774|NCT01903057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101281775|NCT01903057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101281776|NCT01903057|Anthelmintics|anthelmintics|mesh-ancestor
101281777|NCT01903057|Anticestodal Agents|anticestodal agents|mesh-ancestor
101281778|NCT01903057|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101281779|NCT01903057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101281780|NCT01903057|Tubulin Modulators|tubulin modulators|mesh-ancestor
101281781|NCT01903057|Antimitotic Agents|antimitotic agents|mesh-ancestor
101281782|NCT01903057|Mitosis Modulators|mitosis modulators|mesh-ancestor
101281783|NCT01903057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281784|NCT01903057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101281785|NCT01903070|Linagliptin|linagliptin|mesh-list
101281786|NCT01903070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101819296|NCT01025349|Docetaxel|docetaxel|mesh-list
101819297|NCT01025349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101819298|NCT01025349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101476596|NCT00418587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101819299|NCT01025349|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101819300|NCT01025349|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101819301|NCT01025349|Growth Substances|growth substances|mesh-ancestor
101819302|NCT01025349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819303|NCT01025349|Growth Inhibitors|growth inhibitors|mesh-ancestor
101281787|NCT01903070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281788|NCT01903070|Incretins|incretins|mesh-ancestor
101281789|NCT01903070|Hormones|hormones|mesh-ancestor
101281790|NCT01903070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101281791|NCT01903070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101281793|NCT01903070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101281794|NCT01903070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281795|NCT01903083|Gemcitabine|gemcitabine|mesh-list
101281796|NCT01903083|Tadalafil|tadalafil|mesh-list
101281797|NCT01903083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101281798|NCT01903083|Antimetabolites|antimetabolites|mesh-ancestor
101281799|NCT01903083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281800|NCT01903083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101281801|NCT01903083|Vasodilator Agents|vasodilator agents|mesh-ancestor
101281802|NCT01903083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101281803|NCT01903083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101281804|NCT01903083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101281805|NCT01903083|Urological Agents|urological agents|mesh-ancestor
101281806|NCT01903096|Antidepressive Agents|antidepressive agents|mesh-list
101281807|NCT01903096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101281808|NCT01903109|Cevimeline|cevimeline|mesh-list
101281809|NCT01903109|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101281810|NCT01903109|Autonomic Agents|autonomic agents|mesh-ancestor
101281811|NCT01903109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101281812|NCT01903109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281813|NCT01903109|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101281814|NCT01903109|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101281815|NCT01903109|Cholinergic Agents|cholinergic agents|mesh-ancestor
101281816|NCT01903109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101281817|NCT01903109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281818|NCT01903122|Cevimeline|cevimeline|mesh-list
101281819|NCT01903122|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101281820|NCT01903122|Autonomic Agents|autonomic agents|mesh-ancestor
101281821|NCT01903122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101281822|NCT01903122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281823|NCT01903122|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101281824|NCT01903122|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101281825|NCT01903122|Cholinergic Agents|cholinergic agents|mesh-ancestor
101281826|NCT01903122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101281827|NCT01903122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281828|NCT01903200|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101281829|NCT01903200|Antidepressive Agents|antidepressive agents|mesh-ancestor
101281830|NCT01903200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101281831|NCT01903200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101281832|NCT01903200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101281833|NCT01903200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101281834|NCT01903200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281835|NCT01903278|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101281836|NCT01903278|Antiviral Agents|antiviral agents|mesh-ancestor
101281837|NCT01903278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101281838|NCT01903291|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101281839|NCT01903291|Dermatologic Agents|dermatologic agents|mesh-ancestor
101281840|NCT01903291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101281841|NCT01903291|Immunologic Factors|immunologic factors|mesh-ancestor
101281842|NCT01903291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281843|NCT01903681|Melatonin|melatonin|mesh-list
101281844|NCT01903681|Antioxidants|antioxidants|mesh-ancestor
101819304|NCT01025349|Tubulin Modulators|tubulin modulators|mesh-ancestor
101819305|NCT01025349|Antimitotic Agents|antimitotic agents|mesh-ancestor
101819306|NCT01025349|Mitosis Modulators|mitosis modulators|mesh-ancestor
101281845|NCT01903681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281846|NCT01903681|Protective Agents|protective agents|mesh-ancestor
101281847|NCT01903681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281848|NCT01903681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101281850|NCT01903694|Pravastatin|pravastatin|mesh-list
101281851|NCT01903694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101281852|NCT01903694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101281853|NCT01903694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101281854|NCT01903694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281855|NCT01903694|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101281856|NCT01903694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101281857|NCT01903694|Antimetabolites|antimetabolites|mesh-ancestor
101281858|NCT01903694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101281859|NCT01903694|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101281860|NCT01903785|Albuterol|albuterol|mesh-list
101281861|NCT01903785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101281862|NCT01903785|Autonomic Agents|autonomic agents|mesh-ancestor
101281863|NCT01903785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101281865|NCT01903785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101281866|NCT01903785|Respiratory System Agents|respiratory system agents|mesh-ancestor
101281867|NCT01903785|Tocolytic Agents|tocolytic agents|mesh-ancestor
101281868|NCT01903785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101281869|NCT01903785|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101281870|NCT01903785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101281871|NCT01903785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101281872|NCT01903785|Adrenergic Agents|adrenergic agents|mesh-ancestor
101281873|NCT01903785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101281874|NCT01903785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281875|NCT01903824|Modafinil|modafinil|mesh-list
101281876|NCT01903824|Donepezil|donepezil|mesh-list
101281877|NCT01903824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101281878|NCT01903824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101281879|NCT01903824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281880|NCT01903824|Cholinergic Agents|cholinergic agents|mesh-ancestor
101281881|NCT01903824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101281882|NCT01903824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281883|NCT01903824|Nootropic Agents|nootropic agents|mesh-ancestor
101281884|NCT01903824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101281885|NCT01903824|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101281886|NCT01903824|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101281887|NCT01903824|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101281888|NCT01904045|Tacrolimus|tacrolimus|mesh-list
101281889|NCT01904045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101281890|NCT01904045|Immunologic Factors|immunologic factors|mesh-ancestor
101281891|NCT01904045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281892|NCT01904045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101281893|NCT01904045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101281894|NCT01904045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281895|NCT01904097|Pregabalin|pregabalin|mesh-list
101281896|NCT01904097|Analgesics|analgesics|mesh-ancestor
101281897|NCT01904097|Sensory System Agents|sensory system agents|mesh-ancestor
101281898|NCT01904097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101281899|NCT01904097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281900|NCT01904097|Anticonvulsants|anticonvulsants|mesh-ancestor
101281901|NCT01904097|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101281902|NCT01904097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101281903|NCT01904097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281904|NCT01904097|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101281905|NCT01904097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101281906|NCT01904097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101281907|NCT01904097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101281908|NCT01904097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101281909|NCT01904110|Cholecalciferol|cholecalciferol|mesh-list
101281910|NCT01904110|Vitamin D|vitamin d|mesh-list
101281911|NCT01904110|Risedronic Acid|risedronic acid|mesh-list
101281912|NCT01904110|Etidronic Acid|etidronic acid|mesh-list
101819307|NCT01025349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819308|NCT02473276|Morphine|morphine|mesh-list
101819309|NCT02473276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101819310|NCT02473276|Narcotics|narcotics|mesh-ancestor
101819311|NCT02473276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101819312|NCT02473276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819313|NCT02473276|Analgesics|analgesics|mesh-ancestor
101819314|NCT02473276|Sensory System Agents|sensory system agents|mesh-ancestor
101819315|NCT02473276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101819316|NCT00453063|Mometasone Furoate|mometasone furoate|mesh-list
101281914|NCT01904110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281915|NCT01904110|Vitamins|vitamins|mesh-ancestor
101281916|NCT01904110|Micronutrients|micronutrients|mesh-ancestor
101315281|NCT05519683|Serotonin Agents|serotonin agents|mesh-ancestor
101281917|NCT01904110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101281918|NCT01904110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101281919|NCT01904110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101281920|NCT01904110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281921|NCT01904162|Finafloxacin|finafloxacin|mesh-list
101281922|NCT01904162|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101281923|NCT01904162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101281924|NCT01904162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101281925|NCT01904162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101281926|NCT01904162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101281927|NCT01904162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101281928|NCT01904162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281929|NCT01904162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101281930|NCT01904214|Siponimod|siponimod|mesh-list
101281931|NCT01904214|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101281932|NCT01904214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281933|NCT01904214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101281934|NCT01904214|Immunologic Factors|immunologic factors|mesh-ancestor
101281935|NCT01904214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281937|NCT01904253|Amrubicin|amrubicin|mesh-list
101281938|NCT01904253|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101281939|NCT01904253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101281940|NCT01904253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101281941|NCT01904253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281942|NCT01904253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101281943|NCT01904357|Cefazolin|cefazolin|mesh-list
101281944|NCT01904357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101281945|NCT01904357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101281946|NCT01904487|Tiagabine|tiagabine|mesh-list
101281947|NCT01904487|Flumazenil|flumazenil|mesh-list
101281948|NCT01904487|Antidotes|antidotes|mesh-ancestor
101281949|NCT01904487|Protective Agents|protective agents|mesh-ancestor
101281950|NCT01904487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281951|NCT01904487|GABA Modulators|gaba modulators|mesh-ancestor
101281952|NCT01904487|GABA Agents|gaba agents|mesh-ancestor
101281953|NCT01904487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101281954|NCT01904487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281955|NCT01904487|Anticonvulsants|anticonvulsants|mesh-ancestor
101281956|NCT01904487|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
101281957|NCT01904487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101281958|NCT01904487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101281959|NCT01904500|Cefazolin|cefazolin|mesh-list
101281960|NCT01904500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101281961|NCT01904500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101281962|NCT01904539|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
101281963|NCT01904539|Cathartics|cathartics|mesh-ancestor
101281964|NCT01904539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101281965|NCT01904591|Vitamin E|vitamin e|mesh-list
101281966|NCT01904591|Selenium|selenium|mesh-list
101281967|NCT01904591|Vitamins|vitamins|mesh-ancestor
101819317|NCT00453063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101819318|NCT00453063|Dermatologic Agents|dermatologic agents|mesh-ancestor
101819319|NCT00453063|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101819321|NCT00371566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101819322|NCT00371566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101819323|NCT00371566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101281968|NCT01904591|Micronutrients|micronutrients|mesh-ancestor
101281969|NCT01904591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281970|NCT01904591|Antioxidants|antioxidants|mesh-ancestor
101281971|NCT01904591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281972|NCT01904591|Protective Agents|protective agents|mesh-ancestor
101281973|NCT01904591|Trace Elements|trace elements|mesh-ancestor
101281974|NCT01904643|Cytarabine|cytarabine|mesh-list
101281975|NCT01904643|Etoposide|etoposide|mesh-list
101281976|NCT01904643|Mitoxantrone|mitoxantrone|mesh-list
101281977|NCT01904643|Lenalidomide|lenalidomide|mesh-list
101281978|NCT01904643|Etoposide phosphate|etoposide phosphate|mesh-list
101281979|NCT01904643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101281980|NCT01904643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101281981|NCT01904643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101281982|NCT01904643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101281983|NCT01904643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101281984|NCT01904643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281985|NCT01904643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101281986|NCT01904643|Antimetabolites|antimetabolites|mesh-ancestor
101281987|NCT01904643|Antiviral Agents|antiviral agents|mesh-ancestor
101281988|NCT01904643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101281989|NCT01904643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101281990|NCT01904643|Immunologic Factors|immunologic factors|mesh-ancestor
101315283|NCT05442268|Acetaminophen|acetaminophen|mesh-list
101281991|NCT01904643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281992|NCT01904643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101281993|NCT01904643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101281994|NCT01904643|Growth Substances|growth substances|mesh-ancestor
101281995|NCT01904643|Growth Inhibitors|growth inhibitors|mesh-ancestor
101281996|NCT01904643|Analgesics|analgesics|mesh-ancestor
101281997|NCT01904643|Sensory System Agents|sensory system agents|mesh-ancestor
101281998|NCT01904643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101281999|NCT01904682|ON 01910|on 01910|mesh-list
101282000|NCT01904682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101282001|NCT01904682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101282002|NCT01904682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101282003|NCT01904682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282004|NCT01904695|Antihypertensive Agents|antihypertensive agents|mesh-list
101282005|NCT01904695|Diuretics|diuretics|mesh-list
101282006|NCT01904695|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101282007|NCT01904695|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
101282008|NCT01904695|Natriuretic Agents|natriuretic agents|mesh-ancestor
101282009|NCT01904695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282010|NCT01904695|Protease Inhibitors|protease inhibitors|mesh-ancestor
101282011|NCT01904695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101282012|NCT01904695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282013|NCT01904695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101282015|NCT01904734|Enclomiphene|enclomiphene|mesh-list
101282016|NCT01904734|Zuclomiphene|zuclomiphene|mesh-list
101282017|NCT01904734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101282018|NCT01904734|Hormone Antagonists|hormone antagonists|mesh-ancestor
101282019|NCT01904734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101282020|NCT01904734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282021|NCT01904734|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101282022|NCT01904734|Fertility Agents|fertility agents|mesh-ancestor
101282023|NCT01904734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101282024|NCT01904734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101282025|NCT01904734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101282026|NCT01904747|Palbociclib|palbociclib|mesh-list
101282027|NCT01904747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101282028|NCT01904747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101819324|NCT00371566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819325|NCT00371254|Dasatinib|dasatinib|mesh-list
101819326|NCT00371254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101819327|NCT00371254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101819328|NCT00371254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101282029|NCT01904747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101282030|NCT01904747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282031|NCT01904786|Melatonin|melatonin|mesh-list
101282032|NCT01904786|Antioxidants|antioxidants|mesh-ancestor
101282033|NCT01904786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282034|NCT01904786|Protective Agents|protective agents|mesh-ancestor
101282035|NCT01904786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282036|NCT01904786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101282038|NCT01904981|Valsartan|valsartan|mesh-list
101282039|NCT01904981|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
101282040|NCT01904981|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101282041|NCT01904981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101282042|NCT01904981|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101282043|NCT01904981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282044|NCT01904981|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101282045|NCT01904981|Adrenergic Agents|adrenergic agents|mesh-ancestor
101282046|NCT01904981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101282047|NCT01904981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282048|NCT01904981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101282049|NCT01904981|Sympatholytics|sympatholytics|mesh-ancestor
101282050|NCT01904981|Autonomic Agents|autonomic agents|mesh-ancestor
101282051|NCT01904981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101282052|NCT01904981|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101282053|NCT01904994|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101282054|NCT01904994|Antiviral Agents|antiviral agents|mesh-ancestor
101282055|NCT01904994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101282056|NCT01905059|Lamivudine|lamivudine|mesh-list
101282057|NCT01905059|Lopinavir|lopinavir|mesh-list
101282058|NCT01905059|Darunavir|darunavir|mesh-list
101282059|NCT01905059|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
101282060|NCT01905059|Protease Inhibitors|protease inhibitors|mesh-list
101282061|NCT01905059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101282062|NCT01905059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101282063|NCT01905059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101282064|NCT01905059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282065|NCT01905059|Antiviral Agents|antiviral agents|mesh-ancestor
101282066|NCT01905059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101282067|NCT01905059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101282068|NCT01905059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101282069|NCT01905059|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101282070|NCT01905059|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101282071|NCT01905059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101282072|NCT01905137|Botulinum Toxins|botulinum toxins|mesh-list
101282073|NCT01905137|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101282074|NCT01905137|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101282075|NCT01905137|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101282076|NCT01905137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101282077|NCT01905137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282078|NCT01905137|Cholinergic Agents|cholinergic agents|mesh-ancestor
101282079|NCT01905137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101282080|NCT01905137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282081|NCT01905137|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101282082|NCT01905137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101282084|NCT01905150|Ascorbic Acid|ascorbic acid|mesh-list
101282085|NCT01905150|Gemcitabine|gemcitabine|mesh-list
101282086|NCT01905150|Fluorouracil|fluorouracil|mesh-list
101282087|NCT01905150|Docetaxel|docetaxel|mesh-list
101282088|NCT01905150|Oxaliplatin|oxaliplatin|mesh-list
101282089|NCT01905150|Irinotecan|irinotecan|mesh-list
101282090|NCT01905150|Mitomycins|mitomycins|mesh-list
101282091|NCT01905150|Mitomycin|mitomycin|mesh-list
101282092|NCT01905150|Levoleucovorin|levoleucovorin|mesh-list
101282093|NCT01905150|Vitamins|vitamins|mesh-ancestor
101282094|NCT01905150|Micronutrients|micronutrients|mesh-ancestor
101819329|NCT00371254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819330|NCT00452673|Capecitabine|capecitabine|mesh-list
101819331|NCT00452673|Dasatinib|dasatinib|mesh-list
101819332|NCT00452673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101819333|NCT00452673|Antimetabolites|antimetabolites|mesh-ancestor
101282095|NCT01905150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282096|NCT01905150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101282097|NCT01905150|Antimetabolites|antimetabolites|mesh-ancestor
101282098|NCT01905150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282099|NCT01905150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101282103|NCT01905150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101282104|NCT01905150|Immunologic Factors|immunologic factors|mesh-ancestor
101282105|NCT01905150|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101282106|NCT01905150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101282107|NCT01905150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101282109|NCT01905150|Protective Agents|protective agents|mesh-ancestor
101282110|NCT01905150|Vitamin B Complex|vitamin b complex|mesh-ancestor
101282111|NCT01905150|Antioxidants|antioxidants|mesh-ancestor
101282112|NCT01905150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101282113|NCT01905150|Alkylating Agents|alkylating agents|mesh-ancestor
101282114|NCT01905150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101282115|NCT01905215|Vaccines|vaccines|mesh-list
101282116|NCT01905215|Immunologic Factors|immunologic factors|mesh-ancestor
101282117|NCT01905215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282118|NCT01905371|Amphetamine|amphetamine|mesh-list
101282119|NCT01905371|Dextroamphetamine|dextroamphetamine|mesh-list
101282120|NCT01905371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101282121|NCT01905371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282122|NCT01905371|Sympathomimetics|sympathomimetics|mesh-ancestor
101282123|NCT01905371|Autonomic Agents|autonomic agents|mesh-ancestor
101282124|NCT01905371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101282125|NCT01905371|Dopamine Agents|dopamine agents|mesh-ancestor
101282126|NCT01905371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101282127|NCT01905371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282128|NCT01905371|Adrenergic Agents|adrenergic agents|mesh-ancestor
101282129|NCT01905371|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101282130|NCT01905371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101282131|NCT01905371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101282132|NCT01905371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101282133|NCT01905501|Anesthetics|anesthetics|mesh-list
101282134|NCT01905501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101282135|NCT01905501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282136|NCT01905566|Clopidogrel|clopidogrel|mesh-list
101282138|NCT01905566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101282139|NCT01905566|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101282140|NCT01905566|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101282141|NCT01905566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101282142|NCT01905566|Purinergic Agents|purinergic agents|mesh-ancestor
101282143|NCT01905566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101282144|NCT01905566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282145|NCT01905566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282146|NCT01905618|Nicotine|nicotine|mesh-list
101282147|NCT01905618|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101282148|NCT01905618|Autonomic Agents|autonomic agents|mesh-ancestor
101282149|NCT01905618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101282150|NCT01905618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282151|NCT01905618|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101282152|NCT01905618|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101282153|NCT01905618|Cholinergic Agents|cholinergic agents|mesh-ancestor
101282154|NCT01905618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101282155|NCT01905618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282156|NCT01905696|Acetylcysteine|acetylcysteine|mesh-list
101282157|NCT01905696|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101282158|NCT01905696|Antiviral Agents|antiviral agents|mesh-ancestor
101282159|NCT01905696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101282161|NCT01905696|Respiratory System Agents|respiratory system agents|mesh-ancestor
101282162|NCT01905696|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101819334|NCT00452673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819335|NCT00452673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101819336|NCT00452673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101819337|NCT00452673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101819338|NCT00461253|Copper|copper|mesh-list
101819339|NCT00461253|Levonorgestrel|levonorgestrel|mesh-list
101819340|NCT00461253|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101819341|NCT00461253|Contraceptive Agents|contraceptive agents|mesh-ancestor
101819342|NCT00461253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101819343|NCT00461253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819344|NCT00461253|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101819345|NCT00461253|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101819346|NCT00461253|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101819347|NCT00461253|Trace Elements|trace elements|mesh-ancestor
101819348|NCT00461253|Micronutrients|micronutrients|mesh-ancestor
101819349|NCT00469833|Insulin|insulin|mesh-list
101819350|NCT00469833|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101282163|NCT01905696|Antioxidants|antioxidants|mesh-ancestor
101282164|NCT01905696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282166|NCT01905696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282168|NCT01905774|Deferasirox|deferasirox|mesh-list
101282169|NCT01905774|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101282170|NCT01905774|Chelating Agents|chelating agents|mesh-ancestor
101282171|NCT01905774|Sequestering Agents|sequestering agents|mesh-ancestor
101282172|NCT01905774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282173|NCT01905904|Sevoflurane|sevoflurane|mesh-list
101282174|NCT01905904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101282175|NCT01905904|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101282176|NCT01905904|Anesthetics, General|anesthetics, general|mesh-ancestor
101282177|NCT01905904|Anesthetics|anesthetics|mesh-ancestor
101282178|NCT01905904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101282179|NCT01905904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282180|NCT01906073|Fentanyl|fentanyl|mesh-list
101282181|NCT01906073|Morphine|morphine|mesh-list
101282182|NCT01906073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101282183|NCT01906073|Narcotics|narcotics|mesh-ancestor
101282184|NCT01906073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101282185|NCT01906073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282186|NCT01906073|Analgesics|analgesics|mesh-ancestor
101282187|NCT01906073|Sensory System Agents|sensory system agents|mesh-ancestor
101282188|NCT01906073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101282189|NCT01906073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101282190|NCT01906073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101282191|NCT01906073|Anesthetics, General|anesthetics, general|mesh-ancestor
101282192|NCT01906073|Anesthetics|anesthetics|mesh-ancestor
101282193|NCT01906125|Palbociclib|palbociclib|mesh-list
101282194|NCT01906125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101282195|NCT01906125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101282196|NCT01906125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101282197|NCT01906125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282198|NCT01906216|Sorafenib|sorafenib|mesh-list
101282199|NCT01906216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101282200|NCT01906216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101282201|NCT01906216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101282202|NCT01906216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282203|NCT01906242|Chlorhexidine|chlorhexidine|mesh-list
101282204|NCT01906242|Sodium Hypochlorite|sodium hypochlorite|mesh-list
101819352|NCT00469833|Insulin, Long-Acting|insulin, long-acting|mesh-list
101819353|NCT00469833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101819354|NCT00469833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819355|NCT00641537|Cladribine|cladribine|mesh-list
101819356|NCT00641537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101819357|NCT00641537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101819358|NCT00641537|Immunologic Factors|immunologic factors|mesh-ancestor
101819359|NCT00641537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282206|NCT01906242|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101282207|NCT01906242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101282208|NCT01906242|Disinfectants|disinfectants|mesh-ancestor
101282209|NCT01906294|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101282210|NCT01906294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282211|NCT01906307|Angiotensin II|angiotensin ii|mesh-list
101282212|NCT01906307|Giapreza|giapreza|mesh-list
101282213|NCT01906307|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101282214|NCT01906411|Dopamine|dopamine|mesh-list
101282215|NCT01906411|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101282216|NCT01906411|Sympathomimetics|sympathomimetics|mesh-ancestor
101282217|NCT01906411|Autonomic Agents|autonomic agents|mesh-ancestor
101282218|NCT01906411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101282219|NCT01906411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282220|NCT01906411|Dopamine Agents|dopamine agents|mesh-ancestor
101282221|NCT01906411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101282222|NCT01906411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282223|NCT01906411|Protective Agents|protective agents|mesh-ancestor
101282224|NCT01906450|Azithromycin|azithromycin|mesh-list
101282225|NCT01906450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101282226|NCT01906450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101282227|NCT01906528|Mivacurium|mivacurium|mesh-list
101282228|NCT01906528|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101282229|NCT01906528|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101282230|NCT01906528|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101282231|NCT01906528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101282232|NCT01906528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282233|NCT01906580|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101282234|NCT01906580|Entecavir|entecavir|mesh-list
101282235|NCT01906580|Antiviral Agents|antiviral agents|mesh-ancestor
101282236|NCT01906580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101282237|NCT01906632|Immunomodulating Agents|immunomodulating agents|mesh-list
101282238|NCT01906632|Immunologic Factors|immunologic factors|mesh-ancestor
101282239|NCT01906632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282240|NCT01906671|Mercaptopurine|mercaptopurine|mesh-list
101282241|NCT01906671|Antimetabolites|antimetabolites|mesh-ancestor
101282242|NCT01906671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282243|NCT01906671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101282244|NCT01906671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101282245|NCT01906671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101282246|NCT01906671|Immunologic Factors|immunologic factors|mesh-ancestor
101282247|NCT01906671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282248|NCT01906671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101282249|NCT01906671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101282250|NCT01906749|Colchicine|colchicine|mesh-list
101282251|NCT01906749|Gout Suppressants|gout suppressants|mesh-ancestor
101282252|NCT01906749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101282253|NCT01906749|Tubulin Modulators|tubulin modulators|mesh-ancestor
101282254|NCT01906749|Antimitotic Agents|antimitotic agents|mesh-ancestor
101282255|NCT01906749|Mitosis Modulators|mitosis modulators|mesh-ancestor
101282256|NCT01906749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282257|NCT01906749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101282258|NCT01906762|Acetaminophen|acetaminophen|mesh-list
101282259|NCT01906762|Morphine|morphine|mesh-list
101282260|NCT01906762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101282261|NCT01906762|Narcotics|narcotics|mesh-ancestor
101282262|NCT01906762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101819360|NCT01025583|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101819361|NCT00814541|Dexamethasone|dexamethasone|mesh-list
101819362|NCT00814541|Doxorubicin|doxorubicin|mesh-list
101819363|NCT00814541|Bortezomib|bortezomib|mesh-list
101819364|NCT00814541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101819365|NCT00814541|Antiemetics|antiemetics|mesh-ancestor
101819366|NCT00814541|Autonomic Agents|autonomic agents|mesh-ancestor
101282263|NCT01906762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282265|NCT01906762|Sensory System Agents|sensory system agents|mesh-ancestor
101282266|NCT01906762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101282267|NCT01906762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101282268|NCT01906762|Antipyretics|antipyretics|mesh-ancestor
101282269|NCT01906788|Lumefantrine|lumefantrine|mesh-list
101282270|NCT01906788|Artemether|artemether|mesh-list
101282271|NCT01906788|Primaquine|primaquine|mesh-list
101282272|NCT01906788|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101282273|NCT01906788|Antimalarials|antimalarials|mesh-ancestor
101282274|NCT01906788|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101282275|NCT01906788|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101282276|NCT01906788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101282277|NCT01906801|Diacerein|diacerein|mesh-list
101282278|NCT01906801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101282279|NCT01906879|Bismuth|bismuth|mesh-list
101282280|NCT01906879|Antacids|antacids|mesh-ancestor
101282281|NCT01906879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282282|NCT01906879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101282283|NCT01906944|Triamcinolone|triamcinolone|mesh-list
101282284|NCT01906944|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101282285|NCT01906944|Bupivacaine|bupivacaine|mesh-list
101282286|NCT01906944|Anesthetics, Local|anesthetics, local|mesh-ancestor
101282287|NCT01906944|Anesthetics|anesthetics|mesh-ancestor
101282288|NCT01906944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101282289|NCT01906944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282290|NCT01906944|Sensory System Agents|sensory system agents|mesh-ancestor
101282291|NCT01906944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101282292|NCT01906944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101282293|NCT01906944|Glucocorticoids|glucocorticoids|mesh-ancestor
101282294|NCT01906944|Hormones|hormones|mesh-ancestor
101282295|NCT01906944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101282296|NCT01906944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101282297|NCT01906944|Immunologic Factors|immunologic factors|mesh-ancestor
101282298|NCT01907048|Rivaroxaban|rivaroxaban|mesh-list
101282299|NCT01907048|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101282300|NCT01907048|Antithrombins|antithrombins|mesh-ancestor
101282301|NCT01907048|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101282302|NCT01907048|Protease Inhibitors|protease inhibitors|mesh-ancestor
101282303|NCT01907048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101282304|NCT01907048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282305|NCT01907048|Anticoagulants|anticoagulants|mesh-ancestor
101282306|NCT01907061|Acetylcysteine|acetylcysteine|mesh-list
101282308|NCT01907061|Antiviral Agents|antiviral agents|mesh-ancestor
101282309|NCT01907061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101282311|NCT01907061|Respiratory System Agents|respiratory system agents|mesh-ancestor
101282312|NCT01907061|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101282313|NCT01907061|Antioxidants|antioxidants|mesh-ancestor
101282314|NCT01907061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282315|NCT01907061|Protective Agents|protective agents|mesh-ancestor
101282316|NCT01907061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282317|NCT01907061|Antidotes|antidotes|mesh-ancestor
101282318|NCT01907074|Cholic Acids|cholic acids|mesh-list
101282319|NCT01907074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101282321|NCT01907165|Temozolomide|temozolomide|mesh-list
101282322|NCT01907165|Disulfiram|disulfiram|mesh-list
101282323|NCT01907165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101282324|NCT01907165|Alkylating Agents|alkylating agents|mesh-ancestor
101282325|NCT01907165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282326|NCT01907165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101282327|NCT01907165|Trace Elements|trace elements|mesh-ancestor
101282328|NCT01907165|Micronutrients|micronutrients|mesh-ancestor
101282329|NCT01907165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282330|NCT01907165|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101819367|NCT00814541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101312465|NCT00006364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101819368|NCT00814541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819369|NCT00814541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101819370|NCT00814541|Glucocorticoids|glucocorticoids|mesh-ancestor
101282331|NCT01907165|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
101282332|NCT01907165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101282333|NCT01907204|Methylprednisolone|methylprednisolone|mesh-list
101282334|NCT01907204|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101282335|NCT01907204|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101282336|NCT01907204|Prednisolone|prednisolone|mesh-list
101282337|NCT01907204|Prednisolone acetate|prednisolone acetate|mesh-list
101282338|NCT01907204|Budesonide|budesonide|mesh-list
101282339|NCT01907204|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101282340|NCT01907204|Prednisolone phosphate|prednisolone phosphate|mesh-list
101282341|NCT01907204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101282342|NCT01907204|Antiemetics|antiemetics|mesh-ancestor
101282343|NCT01907204|Autonomic Agents|autonomic agents|mesh-ancestor
101282344|NCT01907204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101282345|NCT01907204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282346|NCT01907204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101282347|NCT01907204|Glucocorticoids|glucocorticoids|mesh-ancestor
101282348|NCT01907204|Hormones|hormones|mesh-ancestor
101282349|NCT01907204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101282350|NCT01907204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101282351|NCT01907204|Protective Agents|protective agents|mesh-ancestor
101282352|NCT01907204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101282353|NCT01907204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101282354|NCT01907204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101282355|NCT01907204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101282356|NCT01907204|Respiratory System Agents|respiratory system agents|mesh-ancestor
101282357|NCT01907230|Entecavir|entecavir|mesh-list
101282358|NCT01907230|Antiviral Agents|antiviral agents|mesh-ancestor
101282359|NCT01907230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101282360|NCT01907308|Docetaxel|docetaxel|mesh-list
101282361|NCT01907308|Trebananib|trebananib|mesh-list
101282362|NCT01907308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101282363|NCT01907308|Tubulin Modulators|tubulin modulators|mesh-ancestor
101282364|NCT01907308|Antimitotic Agents|antimitotic agents|mesh-ancestor
101282365|NCT01907308|Mitosis Modulators|mitosis modulators|mesh-ancestor
101282366|NCT01907308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282367|NCT01907308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101282368|NCT01907308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101282369|NCT01907308|Growth Substances|growth substances|mesh-ancestor
101282370|NCT01907308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282371|NCT01907308|Growth Inhibitors|growth inhibitors|mesh-ancestor
101282372|NCT01907373|Probenecid|probenecid|mesh-list
101282373|NCT01907373|Olmesartan|olmesartan|mesh-list
101282374|NCT01907373|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101282375|NCT01907373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101282376|NCT01907373|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101282377|NCT01907373|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101282378|NCT01907373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282379|NCT01907373|Uricosuric Agents|uricosuric agents|mesh-ancestor
101282380|NCT01907373|Gout Suppressants|gout suppressants|mesh-ancestor
101282381|NCT01907373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101282382|NCT01907529|Cyclophosphamide|cyclophosphamide|mesh-list
101282383|NCT01907529|Docetaxel|docetaxel|mesh-list
101282384|NCT01907529|Epirubicin|epirubicin|mesh-list
101282385|NCT01907529|Endostar protein|endostar protein|mesh-list
101282386|NCT01907529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101282387|NCT01907529|Immunologic Factors|immunologic factors|mesh-ancestor
101282388|NCT01907529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282389|NCT01907529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101282390|NCT01907529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101282391|NCT01907529|Alkylating Agents|alkylating agents|mesh-ancestor
101282392|NCT01907529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819372|NCT00814541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101476671|NCT00271349|Budesonide|budesonide|mesh-list
101819373|NCT00814541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101819374|NCT00814541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101819375|NCT00814541|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101819376|NCT00814541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101819377|NCT00814541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101819378|NCT00814541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101819379|NCT00814541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282393|NCT01907529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101282394|NCT01907529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101282395|NCT01907529|Tubulin Modulators|tubulin modulators|mesh-ancestor
101282396|NCT01907529|Antimitotic Agents|antimitotic agents|mesh-ancestor
101282397|NCT01907529|Mitosis Modulators|mitosis modulators|mesh-ancestor
101282398|NCT01907529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101282399|NCT01907529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101282400|NCT01907529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101282401|NCT01907529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101282402|NCT01907529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101282403|NCT01907529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101282404|NCT01907529|Growth Substances|growth substances|mesh-ancestor
101282405|NCT01907529|Growth Inhibitors|growth inhibitors|mesh-ancestor
101282406|NCT01907594|Cycloserine|cycloserine|mesh-list
101282408|NCT01907594|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101282409|NCT01907594|Autonomic Agents|autonomic agents|mesh-ancestor
101282410|NCT01907594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101282411|NCT01907594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282412|NCT01907594|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101282413|NCT01907594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101282414|NCT01907594|Cholinergic Agents|cholinergic agents|mesh-ancestor
101282415|NCT01907594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101282416|NCT01907594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282417|NCT01907594|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101282418|NCT01907594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101282419|NCT01907594|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101282420|NCT01907594|Antitubercular Agents|antitubercular agents|mesh-ancestor
101282421|NCT01907594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101282422|NCT01907594|Antimetabolites|antimetabolites|mesh-ancestor
101282424|NCT01907633|Antiemetics|antiemetics|mesh-ancestor
101282425|NCT01907633|Autonomic Agents|autonomic agents|mesh-ancestor
101282426|NCT01907633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101282427|NCT01907633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282428|NCT01907633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101282429|NCT01907633|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101282430|NCT01907633|Dopamine Agents|dopamine agents|mesh-ancestor
101282431|NCT01907633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101282432|NCT01907633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282433|NCT01907685|Docetaxel|docetaxel|mesh-list
101282434|NCT01907685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101282435|NCT01907685|Tubulin Modulators|tubulin modulators|mesh-ancestor
101282436|NCT01907685|Antimitotic Agents|antimitotic agents|mesh-ancestor
101282437|NCT01907685|Mitosis Modulators|mitosis modulators|mesh-ancestor
101282438|NCT01907685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282439|NCT01907724|Simeprevir|simeprevir|mesh-list
101282440|NCT01907724|Antiviral Agents|antiviral agents|mesh-ancestor
101282441|NCT01907724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101282442|NCT01907724|Protease Inhibitors|protease inhibitors|mesh-ancestor
101282443|NCT01907724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101282444|NCT01907724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282445|NCT01907776|Arbekacin|arbekacin|mesh-list
101282446|NCT01907776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101282447|NCT01907776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101282448|NCT01907776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101282449|NCT01907802|Dabrafenib|dabrafenib|mesh-list
101819381|NCT00814619|Panitumumab|panitumumab|mesh-list
101819382|NCT00814619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101819383|NCT00814619|Antimetabolites|antimetabolites|mesh-ancestor
101819384|NCT00814619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819385|NCT00814619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101819386|NCT00814619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101819387|NCT00641147|Curcumin|curcumin|mesh-list
101819388|NCT00641147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101819389|NCT00641147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101819390|NCT00641147|Analgesics|analgesics|mesh-ancestor
101819391|NCT00641147|Sensory System Agents|sensory system agents|mesh-ancestor
101819392|NCT00641147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101819393|NCT00641147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819394|NCT00641147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101819395|NCT00641147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101819396|NCT00641147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101282450|NCT01907802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101282451|NCT01907802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101282452|NCT01907802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101282453|NCT01907802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282454|NCT01907867|Finafloxacin|finafloxacin|mesh-list
101282455|NCT01907867|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101282456|NCT01907867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101282457|NCT01907867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101282458|NCT01907867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101282459|NCT01907867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101282460|NCT01907867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101282461|NCT01907867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282462|NCT01907867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101282463|NCT01907880|Zoledronic Acid|zoledronic acid|mesh-list
101282464|NCT01907880|Pamidronate|pamidronate|mesh-list
101282465|NCT01907880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101282466|NCT01907880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282468|NCT01907984|Midazolam|midazolam|mesh-list
101282469|NCT01907984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101282470|NCT01907984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101282471|NCT01907984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101282472|NCT01907984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282473|NCT01907984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101282474|NCT01907984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101282475|NCT01907984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101282476|NCT01907984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101282477|NCT01907984|Anesthetics, General|anesthetics, general|mesh-ancestor
101282478|NCT01907984|Anesthetics|anesthetics|mesh-ancestor
101282479|NCT01907984|GABA Modulators|gaba modulators|mesh-ancestor
101282480|NCT01907984|GABA Agents|gaba agents|mesh-ancestor
101282481|NCT01907984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101282482|NCT01907984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282483|NCT01907984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101282485|NCT01907984|Analgesics|analgesics|mesh-ancestor
101282486|NCT01907984|Sensory System Agents|sensory system agents|mesh-ancestor
101282487|NCT01907984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101282488|NCT01907984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101282489|NCT01907984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101282490|NCT01907984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101819397|NCT00641147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101819398|NCT00641147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819400|NCT00460239|Buprenorphine|buprenorphine|mesh-list
101819401|NCT00460239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101819402|NCT00460239|Narcotics|narcotics|mesh-ancestor
101819403|NCT00460239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101282491|NCT01907984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101282492|NCT01907997|Lidocaine|lidocaine|mesh-list
101282493|NCT01907997|Anesthetics, Local|anesthetics, local|mesh-ancestor
101282494|NCT01907997|Anesthetics|anesthetics|mesh-ancestor
101282495|NCT01907997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101282496|NCT01907997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282497|NCT01907997|Sensory System Agents|sensory system agents|mesh-ancestor
101282498|NCT01907997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101282499|NCT01907997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101282500|NCT01907997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101282501|NCT01907997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101282502|NCT01907997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101282503|NCT01907997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282504|NCT01908075|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101282505|NCT01908075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101282506|NCT01908075|Autonomic Agents|autonomic agents|mesh-ancestor
101282507|NCT01908075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101282508|NCT01908075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282509|NCT01908075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101282510|NCT01908075|Respiratory System Agents|respiratory system agents|mesh-ancestor
101282511|NCT01908075|Glucocorticoids|glucocorticoids|mesh-ancestor
101282512|NCT01908075|Hormones|hormones|mesh-ancestor
101282513|NCT01908075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101282514|NCT01908075|Sympathomimetics|sympathomimetics|mesh-ancestor
101282515|NCT01908114|Vaccines|vaccines|mesh-list
101282516|NCT01908114|Immunologic Factors|immunologic factors|mesh-ancestor
101282517|NCT01908114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282518|NCT01908257|Lesinurad|lesinurad|mesh-list
101282519|NCT01908257|Ranitidine|ranitidine|mesh-list
101282520|NCT01908257|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
101282521|NCT01908257|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101282522|NCT01908257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101282523|NCT01908257|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101282524|NCT01908257|Histamine Antagonists|histamine antagonists|mesh-ancestor
101282525|NCT01908257|Histamine Agents|histamine agents|mesh-ancestor
101282526|NCT01908257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101282527|NCT01908257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282528|NCT01908257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282529|NCT01908257|Gout Suppressants|gout suppressants|mesh-ancestor
101282530|NCT01908257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101282531|NCT01908257|Uricosuric Agents|uricosuric agents|mesh-ancestor
101282532|NCT01908283|Vaccines|vaccines|mesh-list
101282533|NCT01908283|Immunologic Factors|immunologic factors|mesh-ancestor
101282534|NCT01908283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282535|NCT01908296|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101282536|NCT01908296|Fluvoxamine|fluvoxamine|mesh-list
101282537|NCT01908296|Antidepressive Agents|antidepressive agents|mesh-ancestor
101282538|NCT01908296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101282539|NCT01908296|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101282540|NCT01908296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101282541|NCT01908296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101282542|NCT01908296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282543|NCT01908296|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101282544|NCT01908296|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101282545|NCT01908296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101282546|NCT01908296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101282547|NCT01908296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282548|NCT01908296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101282549|NCT01908296|Serotonin Agents|serotonin agents|mesh-ancestor
101282550|NCT01908296|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101819404|NCT00460239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819405|NCT00460239|Analgesics|analgesics|mesh-ancestor
101819406|NCT00460239|Sensory System Agents|sensory system agents|mesh-ancestor
101819407|NCT00460239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101819408|NCT00460239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101819409|NCT00640835|Buprenorphine|buprenorphine|mesh-list
101819410|NCT00640835|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101819411|NCT00640835|Naloxone|naloxone|mesh-list
101282551|NCT01908296|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101282552|NCT01908296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101282553|NCT01908296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101282554|NCT01908296|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101282555|NCT01908322|Sorafenib|sorafenib|mesh-list
101282556|NCT01908322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101282557|NCT01908322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101282558|NCT01908322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101282559|NCT01908322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282560|NCT01908335|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101282562|NCT01908335|Antiviral Agents|antiviral agents|mesh-ancestor
101282563|NCT01908335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101282564|NCT01908335|Immunologic Factors|immunologic factors|mesh-ancestor
101282565|NCT01908335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282566|NCT01908348|Erythritol|erythritol|mesh-list
101282567|NCT01908348|Vasodilator Agents|vasodilator agents|mesh-ancestor
101282569|NCT01908387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101282570|NCT01908387|Antimetabolites|antimetabolites|mesh-ancestor
101282571|NCT01908387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282572|NCT01908387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101282573|NCT01908387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101282574|NCT01908452|Pyridoxine|pyridoxine|mesh-list
101282575|NCT01908452|Vitamin B Complex|vitamin b complex|mesh-ancestor
101282576|NCT01908452|Vitamins|vitamins|mesh-ancestor
101282577|NCT01908452|Micronutrients|micronutrients|mesh-ancestor
101282578|NCT01908452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282579|NCT01908478|Gemcitabine|gemcitabine|mesh-list
101282580|NCT01908478|Veliparib|veliparib|mesh-list
101282581|NCT01908478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101282582|NCT01908478|Antimetabolites|antimetabolites|mesh-ancestor
101282583|NCT01908478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282584|NCT01908478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101282585|NCT01908478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101282586|NCT01908478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101282587|NCT01908556|Letrozole|letrozole|mesh-list
101282588|NCT01908556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101282589|NCT01908556|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101282590|NCT01908556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101282591|NCT01908556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101282592|NCT01908556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282593|NCT01908556|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101282594|NCT01908556|Hormone Antagonists|hormone antagonists|mesh-ancestor
101282595|NCT01908556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101282596|NCT01908556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282597|NCT01908621|Cytarabine|cytarabine|mesh-list
101282598|NCT01908621|Lenograstim|lenograstim|mesh-list
101282599|NCT01908621|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101282600|NCT01908621|Immunologic Factors|immunologic factors|mesh-ancestor
101282601|NCT01908621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282602|NCT01908621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101282603|NCT01908621|Antimetabolites|antimetabolites|mesh-ancestor
101282604|NCT01908621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282605|NCT01908621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101282606|NCT01908621|Antiviral Agents|antiviral agents|mesh-ancestor
101282607|NCT01908621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101282608|NCT01908621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101282609|NCT01908660|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101282610|NCT01908660|Antiviral Agents|antiviral agents|mesh-ancestor
101282611|NCT01908660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101819412|NCT00640835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101819413|NCT00640835|Narcotics|narcotics|mesh-ancestor
101819414|NCT00640835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101819415|NCT00640835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819416|NCT00640835|Analgesics|analgesics|mesh-ancestor
101819417|NCT00640835|Sensory System Agents|sensory system agents|mesh-ancestor
101819418|NCT00640835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101819419|NCT00640835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101819420|NCT03839355|Warfarin|warfarin|mesh-list
101819421|NCT03839355|Apixaban|apixaban|mesh-list
101819422|NCT03839355|Anticoagulants|anticoagulants|mesh-ancestor
101819423|NCT03839355|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101819424|NCT03839355|Antithrombins|antithrombins|mesh-ancestor
101819425|NCT03839355|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101282612|NCT01908894|Insulin Lispro|insulin lispro|mesh-list
101282613|NCT01908894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101282614|NCT01908894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282615|NCT01909037|Curcumin|curcumin|mesh-list
101282616|NCT01909037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101282617|NCT01909037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101282618|NCT01909037|Analgesics|analgesics|mesh-ancestor
101282619|NCT01909037|Sensory System Agents|sensory system agents|mesh-ancestor
101282620|NCT01909037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101282621|NCT01909037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282622|NCT01909037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101282623|NCT01909037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101282624|NCT01909037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101282625|NCT01909037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101282626|NCT01909037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282627|NCT01909063|Vitamin D|vitamin d|mesh-list
101282628|NCT01909063|Ergocalciferols|ergocalciferols|mesh-list
101282629|NCT01909063|Cholecalciferol|cholecalciferol|mesh-list
101282630|NCT01909063|Vitamins|vitamins|mesh-list
101282633|NCT01909063|Micronutrients|micronutrients|mesh-ancestor
101282634|NCT01909063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282635|NCT01909063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101282636|NCT01909063|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101282637|NCT01909063|Antioxidants|antioxidants|mesh-ancestor
101282638|NCT01909063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282639|NCT01909063|Protective Agents|protective agents|mesh-ancestor
101282641|NCT01909115|Ergocalciferols|ergocalciferols|mesh-list
101282642|NCT01909115|Cholecalciferol|cholecalciferol|mesh-list
101282643|NCT01909115|Vitamins|vitamins|mesh-list
101282644|NCT01909115|Micronutrients|micronutrients|mesh-ancestor
101282645|NCT01909115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282646|NCT01909115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101282647|NCT01909115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101282648|NCT01909219|Magnesium citrate|magnesium citrate|mesh-list
101282649|NCT01909219|Picosulfate sodium|picosulfate sodium|mesh-list
101282650|NCT01909219|Cathartics|cathartics|mesh-ancestor
101282651|NCT01909219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101282652|NCT01909557|Acetylcarnitine|acetylcarnitine|mesh-list
101282653|NCT01909557|Vitamin B Complex|vitamin b complex|mesh-ancestor
101282654|NCT01909557|Vitamins|vitamins|mesh-ancestor
101282655|NCT01909557|Micronutrients|micronutrients|mesh-ancestor
101282656|NCT01909557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282657|NCT01909557|Nootropic Agents|nootropic agents|mesh-ancestor
101282658|NCT01909622|Vitamin D|vitamin d|mesh-list
101282659|NCT01909622|Ergocalciferols|ergocalciferols|mesh-list
101282660|NCT01909622|Cholecalciferol|cholecalciferol|mesh-list
101282661|NCT01909622|Vitamins|vitamins|mesh-list
101282662|NCT01909622|Micronutrients|micronutrients|mesh-ancestor
101282663|NCT01909622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282664|NCT01909622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101819426|NCT03839355|Protease Inhibitors|protease inhibitors|mesh-ancestor
101819427|NCT03839355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101819428|NCT03839355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282665|NCT01909622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101282666|NCT01909661|Caseins|caseins|mesh-list
101282667|NCT01909661|Chelating Agents|chelating agents|mesh-ancestor
101282668|NCT01909661|Sequestering Agents|sequestering agents|mesh-ancestor
101282669|NCT01909661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282670|NCT01909752|Cyclophosphamide|cyclophosphamide|mesh-list
101282671|NCT01909752|Imiquimod|imiquimod|mesh-list
101282672|NCT01909752|Vaccines|vaccines|mesh-list
101282673|NCT01909752|Immunologic Factors|immunologic factors|mesh-ancestor
101282674|NCT01909752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282675|NCT01909752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101282676|NCT01909752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101282677|NCT01909752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101282678|NCT01909752|Alkylating Agents|alkylating agents|mesh-ancestor
101282679|NCT01909752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282680|NCT01909752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101282681|NCT01909752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101282682|NCT01909752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101282683|NCT01909752|Interferon Inducers|interferon inducers|mesh-ancestor
101282684|NCT01909830|Gemcitabine|gemcitabine|mesh-list
101282685|NCT01909830|Pemetrexed|pemetrexed|mesh-list
101282686|NCT01909830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101282687|NCT01909830|Antimetabolites|antimetabolites|mesh-ancestor
101282688|NCT01909830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282689|NCT01909830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101282690|NCT01909830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101282691|NCT01909830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101282692|NCT01909830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101282693|NCT01909843|Gontivimab|gontivimab|mesh-list
101282694|NCT01909843|Antiviral Agents|antiviral agents|mesh-ancestor
101282695|NCT01909843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101282698|NCT01909856|Granisetron|granisetron|mesh-list
101282699|NCT01909856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101282700|NCT01909856|Antiemetics|antiemetics|mesh-ancestor
101282701|NCT01909856|Autonomic Agents|autonomic agents|mesh-ancestor
101282702|NCT01909856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101282703|NCT01909856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282704|NCT01909856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101282706|NCT01909856|Hormones|hormones|mesh-ancestor
101282707|NCT01909856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101282708|NCT01909856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101282709|NCT01909856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101282710|NCT01909856|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101282711|NCT01909856|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101282713|NCT01909856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101282714|NCT01909856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282715|NCT01910077|Tacrolimus|tacrolimus|mesh-list
101282716|NCT01910077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101282717|NCT01910077|Immunologic Factors|immunologic factors|mesh-ancestor
101282718|NCT01910077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282719|NCT01910077|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101282720|NCT01910077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101282721|NCT01910077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282722|NCT01910090|Flurbiprofen|flurbiprofen|mesh-list
101282723|NCT01910090|Famotidine|famotidine|mesh-list
101282724|NCT01910090|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101282725|NCT01910090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101282726|NCT01910090|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101282727|NCT01910090|Histamine Antagonists|histamine antagonists|mesh-ancestor
101282728|NCT01910090|Histamine Agents|histamine agents|mesh-ancestor
101282729|NCT01910090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101282730|NCT01910090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282731|NCT01910090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282732|NCT01910090|Analgesics|analgesics|mesh-ancestor
101282733|NCT01910090|Sensory System Agents|sensory system agents|mesh-ancestor
101282734|NCT01910090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101282735|NCT01910090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101282736|NCT01910090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101819429|NCT00640601|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101819430|NCT00640601|Antidepressive Agents|antidepressive agents|mesh-ancestor
101819431|NCT00640601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101819432|NCT00640601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101819433|NCT00640601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101819434|NCT00640601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101819435|NCT00640601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819436|NCT02551133|Dexamethasone|dexamethasone|mesh-list
101819437|NCT02551133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101819438|NCT02551133|Antiemetics|antiemetics|mesh-ancestor
101282737|NCT01910090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101282738|NCT01910090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101282739|NCT01910090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101282740|NCT01910090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101282741|NCT01910142|Vitamin K|vitamin k|mesh-list
101282742|NCT01910142|Calcium|calcium|mesh-list
101282743|NCT01910142|Vitamins|vitamins|mesh-ancestor
101282744|NCT01910142|Micronutrients|micronutrients|mesh-ancestor
101282745|NCT01910142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282746|NCT01910142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101282747|NCT01910142|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101282748|NCT01910142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101282749|NCT01910142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282750|NCT01910142|Hemostatics|hemostatics|mesh-ancestor
101282751|NCT01910142|Coagulants|coagulants|mesh-ancestor
101282752|NCT01910155|Ciprofloxacin|ciprofloxacin|mesh-list
101282753|NCT01910155|Dexamethasone|dexamethasone|mesh-list
101282754|NCT01910155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101282755|NCT01910155|Antiemetics|antiemetics|mesh-ancestor
101282756|NCT01910155|Autonomic Agents|autonomic agents|mesh-ancestor
101282757|NCT01910155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101282758|NCT01910155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282759|NCT01910155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101282760|NCT01910155|Glucocorticoids|glucocorticoids|mesh-ancestor
101282761|NCT01910155|Hormones|hormones|mesh-ancestor
101282762|NCT01910155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101282763|NCT01910155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101282764|NCT01910155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101282765|NCT01910155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101282766|NCT01910155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101282767|NCT01910155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101282768|NCT01910155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101282769|NCT01910155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101282770|NCT01910155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282771|NCT01910155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101282772|NCT01910155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101282773|NCT01910194|Insulin Glargine|insulin glargine|mesh-list
101282774|NCT01910194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101282775|NCT01910194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282777|NCT01910246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101282778|NCT01910246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282779|NCT01910259|Amiloride|amiloride|mesh-list
101282780|NCT01910259|Riluzole|riluzole|mesh-list
101282781|NCT01910259|Fluoxetine|fluoxetine|mesh-list
101282782|NCT01910259|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101282783|NCT01910259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101282784|NCT01910259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101282785|NCT01910259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282786|NCT01910259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101282787|NCT01910259|Serotonin Agents|serotonin agents|mesh-ancestor
101282788|NCT01910259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282789|NCT01910259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101282790|NCT01910259|Antidepressive Agents|antidepressive agents|mesh-ancestor
101282791|NCT01910259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101282792|NCT01910259|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101819440|NCT02551133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101819441|NCT02551133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819442|NCT02551133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101819443|NCT02551133|Glucocorticoids|glucocorticoids|mesh-ancestor
101819444|NCT02551133|Hormones|hormones|mesh-ancestor
101819445|NCT02551133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101819446|NCT02551133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101819447|NCT02551133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101819448|NCT00818285|Psychotropic Drugs|psychotropic drugs|mesh-list
101819449|NCT00452439|Vitamin D|vitamin d|mesh-list
101819450|NCT00452439|Risedronic Acid|risedronic acid|mesh-list
101819451|NCT00452439|Etidronic Acid|etidronic acid|mesh-list
101819452|NCT00452439|Calcium|calcium|mesh-list
101819453|NCT00452439|Vitamins|vitamins|mesh-ancestor
101282793|NCT01910259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101282794|NCT01910259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101282795|NCT01910259|Anticonvulsants|anticonvulsants|mesh-ancestor
101282796|NCT01910259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101282797|NCT01910259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101282798|NCT01910259|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101282799|NCT01910259|Protective Agents|protective agents|mesh-ancestor
101282800|NCT01910259|Diuretics|diuretics|mesh-ancestor
101282801|NCT01910259|Natriuretic Agents|natriuretic agents|mesh-ancestor
101282802|NCT01910259|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
101282803|NCT01910259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101282804|NCT01910259|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101282805|NCT01910259|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101282806|NCT01910285|Sufentanil|sufentanil|mesh-list
101282807|NCT01910285|Dsuvia|dsuvia|mesh-list
101282808|NCT01910285|Remifentanil|remifentanil|mesh-list
101282809|NCT01910285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101282810|NCT01910285|Narcotics|narcotics|mesh-ancestor
101282811|NCT01910285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101282812|NCT01910285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282813|NCT01910285|Analgesics|analgesics|mesh-ancestor
101282814|NCT01910285|Sensory System Agents|sensory system agents|mesh-ancestor
101282815|NCT01910285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101282816|NCT01910285|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101282817|NCT01910285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101282818|NCT01910285|Anesthetics, General|anesthetics, general|mesh-ancestor
101282819|NCT01910285|Anesthetics|anesthetics|mesh-ancestor
101282820|NCT01910363|Botulinum Toxins|botulinum toxins|mesh-list
101282821|NCT01910363|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101282822|NCT01910363|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101282823|NCT01910363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101282824|NCT01910363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101282825|NCT01910363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282826|NCT01910363|Cholinergic Agents|cholinergic agents|mesh-ancestor
101282828|NCT01910363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282829|NCT01910363|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101282830|NCT01910363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101282831|NCT01910415|Moxifloxacin|moxifloxacin|mesh-list
101282832|NCT01910415|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101282833|NCT01910415|Ivacaftor|ivacaftor|mesh-list
101282835|NCT01910415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101282836|NCT01910415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101282837|NCT01910415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101282838|NCT01910415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101282839|NCT01910415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819454|NCT00452439|Micronutrients|micronutrients|mesh-ancestor
101819455|NCT00452439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819456|NCT00452439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101819457|NCT00452439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101819458|NCT00452439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101819459|NCT00452439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101819460|NCT00452439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819461|NCT01023087|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101819463|NCT01023087|Polymyxins|polymyxins|mesh-list
101819464|NCT01023087|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101819465|NCT01023087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101819466|NCT01023087|Antitubercular Agents|antitubercular agents|mesh-ancestor
101819467|NCT00381940|Bortezomib|bortezomib|mesh-list
101819468|NCT00381940|Vinorelbine|vinorelbine|mesh-list
101819469|NCT00381940|Ifosfamide|ifosfamide|mesh-list
101282840|NCT01910415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101282841|NCT01910415|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101282842|NCT01910415|Contraceptive Agents|contraceptive agents|mesh-ancestor
101282843|NCT01910415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101282844|NCT01910415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282845|NCT01910415|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101282846|NCT01910415|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101282847|NCT01910415|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101282848|NCT01910415|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101282849|NCT01910415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101282850|NCT01910428|Asparaginase|asparaginase|mesh-list
101282851|NCT01910428|Eryaspase|eryaspase|mesh-list
101282852|NCT01910428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101282853|NCT01910480|Ketoconazole|ketoconazole|mesh-list
101282854|NCT01910480|Antifungal Agents|antifungal agents|mesh-ancestor
101282855|NCT01910480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101282856|NCT01910480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101282857|NCT01910480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101282858|NCT01910480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101282859|NCT01910480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282860|NCT01910480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101282861|NCT01910480|Hormone Antagonists|hormone antagonists|mesh-ancestor
101282862|NCT01910480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101282863|NCT01910480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282864|NCT01910480|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101282866|NCT01910506|Gout Suppressants|gout suppressants|mesh-ancestor
101282867|NCT01910506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101282868|NCT01910532|Clevidipine|clevidipine|mesh-list
101282869|NCT01910532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101282870|NCT01910532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101282871|NCT01910532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282872|NCT01910532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101282873|NCT01910532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282874|NCT01910545|OTS167|ots167|mesh-list
101282875|NCT01910545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101282876|NCT01910545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101282877|NCT01910545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282878|NCT01910610|Bevacizumab|bevacizumab|mesh-list
101282879|NCT01910610|Cetuximab|cetuximab|mesh-list
101819470|NCT00381940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101819471|NCT00381940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101819472|NCT00381940|Tubulin Modulators|tubulin modulators|mesh-ancestor
101819473|NCT00381940|Antimitotic Agents|antimitotic agents|mesh-ancestor
101819474|NCT00381940|Mitosis Modulators|mitosis modulators|mesh-ancestor
101819475|NCT00381940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819476|NCT00381940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101282880|NCT01910610|Panitumumab|panitumumab|mesh-list
101282881|NCT01910610|Irinotecan|irinotecan|mesh-list
101282882|NCT01910610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101282883|NCT01910610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101282884|NCT01910610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101282885|NCT01910610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101282886|NCT01910610|Growth Substances|growth substances|mesh-ancestor
101282887|NCT01910610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282888|NCT01910610|Growth Inhibitors|growth inhibitors|mesh-ancestor
101282889|NCT01910610|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101282890|NCT01910610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101282891|NCT01910610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101282892|NCT01910610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282894|NCT01910766|Coenzyme Q10|coenzyme q10|mesh-list
101282895|NCT01910766|Clomiphene|clomiphene|mesh-list
101282896|NCT01910766|Enclomiphene|enclomiphene|mesh-list
101282897|NCT01910766|Zuclomiphene|zuclomiphene|mesh-list
101282898|NCT01910766|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101282899|NCT01910766|Hormone Antagonists|hormone antagonists|mesh-ancestor
101282900|NCT01910766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101282901|NCT01910766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282902|NCT01910766|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101282904|NCT01910766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101282905|NCT01910766|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101282906|NCT01910766|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101282907|NCT01910766|Micronutrients|micronutrients|mesh-ancestor
101282909|NCT01910844|Cyclophosphamide|cyclophosphamide|mesh-list
101282910|NCT01910844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101282911|NCT01910844|Immunologic Factors|immunologic factors|mesh-ancestor
101282912|NCT01910844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282913|NCT01910844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101282914|NCT01910844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101282915|NCT01910844|Alkylating Agents|alkylating agents|mesh-ancestor
101282916|NCT01910844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282917|NCT01910844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101282918|NCT01910844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101282919|NCT01910870|Cyclophosphamide|cyclophosphamide|mesh-list
101282920|NCT01910870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101282921|NCT01910870|Immunologic Factors|immunologic factors|mesh-ancestor
101282922|NCT01910870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282923|NCT01910870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101282924|NCT01910870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101282925|NCT01910870|Alkylating Agents|alkylating agents|mesh-ancestor
101282926|NCT01910870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282927|NCT01910870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101282928|NCT01910870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101282929|NCT01910883|Finafloxacin|finafloxacin|mesh-list
101282930|NCT01910883|Fluoroquinolones|fluoroquinolones|mesh-list
101282932|NCT01910883|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101282933|NCT01910883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101282934|NCT01910883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101282935|NCT01910883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101282936|NCT01910883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101282937|NCT01910883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101282938|NCT01910883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282939|NCT01910883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101282940|NCT01910883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101819477|NCT00381940|Alkylating Agents|alkylating agents|mesh-ancestor
101819478|NCT00818675|Sirolimus|sirolimus|mesh-list
101819479|NCT00818675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101819480|NCT00818675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101819481|NCT00818675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101819482|NCT00818675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101819483|NCT00818675|Antifungal Agents|antifungal agents|mesh-ancestor
101819484|NCT00818675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101819485|NCT00818675|Immunologic Factors|immunologic factors|mesh-ancestor
101819486|NCT00818675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282941|NCT01910987|Dexamethasone|dexamethasone|mesh-list
101282942|NCT01910987|Dexamethasone acetate|dexamethasone acetate|mesh-list
101282943|NCT01910987|Bortezomib|bortezomib|mesh-list
101282944|NCT01910987|BB 1101|bb 1101|mesh-list
101282945|NCT01910987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101282946|NCT01910987|Antiemetics|antiemetics|mesh-ancestor
101282947|NCT01910987|Autonomic Agents|autonomic agents|mesh-ancestor
101282948|NCT01910987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101282949|NCT01910987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282950|NCT01910987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101282951|NCT01910987|Glucocorticoids|glucocorticoids|mesh-ancestor
101282952|NCT01910987|Hormones|hormones|mesh-ancestor
101282953|NCT01910987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101282954|NCT01910987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101282955|NCT01910987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101282956|NCT01910987|Protease Inhibitors|protease inhibitors|mesh-ancestor
101282957|NCT01910987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101282958|NCT01910987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282959|NCT01911195|Isoflurane|isoflurane|mesh-list
101282960|NCT01911195|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101282961|NCT01911195|Anesthetics, General|anesthetics, general|mesh-ancestor
101282962|NCT01911195|Anesthetics|anesthetics|mesh-ancestor
101282963|NCT01911195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101282964|NCT01911195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282965|NCT01911234|Freund's Adjuvant|freund's adjuvant|mesh-list
101282966|NCT01911234|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101282967|NCT01911234|Immunologic Factors|immunologic factors|mesh-ancestor
101282968|NCT01911234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282969|NCT01911247|Metformin|metformin|mesh-list
101282970|NCT01911247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101282971|NCT01911247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282972|NCT01911299|Choline|choline|mesh-list
101282973|NCT01911299|Glycerol|glycerol|mesh-list
101282974|NCT01911299|Lipotropic Agents|lipotropic agents|mesh-ancestor
101282976|NCT01911299|Antimetabolites|antimetabolites|mesh-ancestor
101282977|NCT01911299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282978|NCT01911299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101282979|NCT01911299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101282980|NCT01911299|Nootropic Agents|nootropic agents|mesh-ancestor
101282981|NCT01911299|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101282982|NCT01911299|Protective Agents|protective agents|mesh-ancestor
101282983|NCT01911299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282984|NCT01911325|Docetaxel|docetaxel|mesh-list
101282985|NCT01911325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101282986|NCT01911325|Tubulin Modulators|tubulin modulators|mesh-ancestor
101282987|NCT01911325|Antimitotic Agents|antimitotic agents|mesh-ancestor
101282988|NCT01911325|Mitosis Modulators|mitosis modulators|mesh-ancestor
101282989|NCT01911325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282990|NCT01911364|Tiotropium Bromide|tiotropium bromide|mesh-list
101282991|NCT01911364|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101282992|NCT01911364|Autonomic Agents|autonomic agents|mesh-ancestor
101282993|NCT01911364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101282994|NCT01911364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282995|NCT01911364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101282996|NCT01911364|Respiratory System Agents|respiratory system agents|mesh-ancestor
101282997|NCT01911364|Parasympatholytics|parasympatholytics|mesh-ancestor
101282998|NCT01911364|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101819487|NCT00364156|Nicotine|nicotine|mesh-list
101819488|NCT00364156|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101819489|NCT00364156|Autonomic Agents|autonomic agents|mesh-ancestor
101819490|NCT00364156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101819491|NCT00364156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819492|NCT00364156|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101819493|NCT00364156|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101819494|NCT00364156|Cholinergic Agents|cholinergic agents|mesh-ancestor
101819495|NCT00364156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101819496|NCT00364156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282999|NCT01911364|Cholinergic Agents|cholinergic agents|mesh-ancestor
101283000|NCT01911364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101283001|NCT01911364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283002|NCT01911377|Botulinum Toxins|botulinum toxins|mesh-list
101283003|NCT01911377|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101283004|NCT01911377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101283005|NCT01911377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101283006|NCT01911377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101283007|NCT01911377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283008|NCT01911377|Cholinergic Agents|cholinergic agents|mesh-ancestor
101283009|NCT01911377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101283010|NCT01911377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283011|NCT01911377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101283012|NCT01911377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101283013|NCT01911455|Acamprosate|acamprosate|mesh-list
101283018|NCT01911468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101283019|NCT01911468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283020|NCT01911468|Incretins|incretins|mesh-ancestor
101283021|NCT01911468|Hormones|hormones|mesh-ancestor
101283022|NCT01911468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101283023|NCT01911494|Magnesium Sulfate|magnesium sulfate|mesh-list
101283024|NCT01911494|Methyldopa|methyldopa|mesh-list
101283025|NCT01911494|Analgesics|analgesics|mesh-ancestor
101283026|NCT01911494|Sensory System Agents|sensory system agents|mesh-ancestor
101283027|NCT01911494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101283028|NCT01911494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283029|NCT01911494|Anesthetics|anesthetics|mesh-ancestor
101283030|NCT01911494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101283031|NCT01911494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101283032|NCT01911494|Anticonvulsants|anticonvulsants|mesh-ancestor
101283033|NCT01911494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101283034|NCT01911494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101283035|NCT01911494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283036|NCT01911494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101283037|NCT01911494|Tocolytic Agents|tocolytic agents|mesh-ancestor
101283038|NCT01911494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101283039|NCT01911494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101283040|NCT01911494|Sympatholytics|sympatholytics|mesh-ancestor
101283041|NCT01911494|Autonomic Agents|autonomic agents|mesh-ancestor
101283042|NCT01911494|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101283043|NCT01911494|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101283044|NCT01911494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101283045|NCT01911494|Adrenergic Agents|adrenergic agents|mesh-ancestor
101283046|NCT01911494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101283047|NCT01911507|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101283048|NCT01911507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101283049|NCT01911507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101283050|NCT01911507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101283051|NCT01911507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283052|NCT01911598|Paclitaxel|paclitaxel|mesh-list
101819497|NCT00452361|Cyclosporine|cyclosporine|mesh-list
101819498|NCT00452361|Sirolimus|sirolimus|mesh-list
101819499|NCT00452361|Tacrolimus|tacrolimus|mesh-list
101819500|NCT00452361|Cyclosporins|cyclosporins|mesh-list
101819501|NCT00452361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
101819502|NCT00452361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101819503|NCT00452361|Immunologic Factors|immunologic factors|mesh-ancestor
101819504|NCT00452361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819505|NCT00452361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101283053|NCT01911598|Carboplatin|carboplatin|mesh-list
101283054|NCT01911598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101283055|NCT01911598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101283056|NCT01911598|Tubulin Modulators|tubulin modulators|mesh-ancestor
101283057|NCT01911598|Antimitotic Agents|antimitotic agents|mesh-ancestor
101283058|NCT01911598|Mitosis Modulators|mitosis modulators|mesh-ancestor
101283059|NCT01911598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283060|NCT01911624|Enoxaparin|enoxaparin|mesh-list
101283061|NCT01911624|Dabigatran|dabigatran|mesh-list
101283062|NCT01911624|Argatroban|argatroban|mesh-list
101283063|NCT01911624|Thrombin|thrombin|mesh-list
101283064|NCT01911624|Anticoagulants|anticoagulants|mesh-ancestor
101283065|NCT01911624|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101283066|NCT01911624|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101283067|NCT01911624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283068|NCT01911624|Antithrombins|antithrombins|mesh-ancestor
101283069|NCT01911624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101283070|NCT01911624|Protease Inhibitors|protease inhibitors|mesh-ancestor
101283071|NCT01911624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101283072|NCT01911624|Hemostatics|hemostatics|mesh-ancestor
101283073|NCT01911624|Coagulants|coagulants|mesh-ancestor
101283074|NCT01911624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101283075|NCT01911728|Pioglitazone|pioglitazone|mesh-list
101283076|NCT01911728|Midazolam|midazolam|mesh-list
101283077|NCT01911728|Omeprazole|omeprazole|mesh-list
101283078|NCT01911728|Warfarin|warfarin|mesh-list
101283079|NCT01911728|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101283080|NCT01911728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101283081|NCT01911728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101283082|NCT01911728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283083|NCT01911728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101283084|NCT01911728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101283085|NCT01911728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101283086|NCT01911728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101283087|NCT01911728|Anesthetics, General|anesthetics, general|mesh-ancestor
101283088|NCT01911728|Anesthetics|anesthetics|mesh-ancestor
101283089|NCT01911728|GABA Modulators|gaba modulators|mesh-ancestor
101283090|NCT01911728|GABA Agents|gaba agents|mesh-ancestor
101283091|NCT01911728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101283092|NCT01911728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283093|NCT01911728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101283094|NCT01911728|Anticoagulants|anticoagulants|mesh-ancestor
101315371|NCT05305456|Vitamins|vitamins|mesh-list
101283095|NCT01911728|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101283096|NCT01911728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101283097|NCT01911728|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101283098|NCT01911728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101283099|NCT01911949|Epinephrine|epinephrine|mesh-list
101283100|NCT01911949|Bupivacaine|bupivacaine|mesh-list
101283101|NCT01911949|Anesthetics, Local|anesthetics, local|mesh-ancestor
101283102|NCT01911949|Anesthetics|anesthetics|mesh-ancestor
101283103|NCT01911949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101283104|NCT01911949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283105|NCT01911949|Sensory System Agents|sensory system agents|mesh-ancestor
101283106|NCT01911949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101283107|NCT01911949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101283108|NCT01911949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101283109|NCT01911949|Adrenergic Agents|adrenergic agents|mesh-ancestor
101283110|NCT01911949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101819506|NCT00452361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819507|NCT00452361|Antifungal Agents|antifungal agents|mesh-ancestor
101819508|NCT00452361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101819509|NCT00452361|Dermatologic Agents|dermatologic agents|mesh-ancestor
101819510|NCT00452361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101819511|NCT00452361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101283111|NCT01911949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283112|NCT01911949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101283113|NCT01911949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101283114|NCT01911949|Autonomic Agents|autonomic agents|mesh-ancestor
101283115|NCT01911949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101283116|NCT01911949|Respiratory System Agents|respiratory system agents|mesh-ancestor
101283117|NCT01911949|Mydriatics|mydriatics|mesh-ancestor
101283118|NCT01911949|Sympathomimetics|sympathomimetics|mesh-ancestor
101283119|NCT01911949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101283121|NCT01911975|Anticonvulsants|anticonvulsants|mesh-ancestor
101283122|NCT01911975|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101283123|NCT01911975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101283124|NCT01911975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101408497|NCT00109382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101283125|NCT01911975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283126|NCT01912053|Gemcitabine|gemcitabine|mesh-list
101283127|NCT01912053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101283128|NCT01912053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101283129|NCT01912053|Antimetabolites|antimetabolites|mesh-ancestor
101283130|NCT01912053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283131|NCT01912066|Aceclofenac|aceclofenac|mesh-list
101283132|NCT01912066|Misoprostol|misoprostol|mesh-list
101283133|NCT01912066|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101283134|NCT01912066|Abortifacient Agents|abortifacient agents|mesh-ancestor
101283135|NCT01912066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101283136|NCT01912066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283137|NCT01912066|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101283138|NCT01912066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101283139|NCT01912066|Oxytocics|oxytocics|mesh-ancestor
101283140|NCT01912066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101283141|NCT01912066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101283142|NCT01912066|Analgesics|analgesics|mesh-ancestor
101283143|NCT01912066|Sensory System Agents|sensory system agents|mesh-ancestor
101283144|NCT01912066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101283145|NCT01912066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101283146|NCT01912066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101283147|NCT01912118|Remifentanil|remifentanil|mesh-list
101283148|NCT01912118|Propofol|propofol|mesh-list
101283149|NCT01912118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101283150|NCT01912118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101283151|NCT01912118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283152|NCT01912118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101283153|NCT01912118|Anesthetics, General|anesthetics, general|mesh-ancestor
101283154|NCT01912118|Anesthetics|anesthetics|mesh-ancestor
101283155|NCT01912118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101283156|NCT01912118|Narcotics|narcotics|mesh-ancestor
101283157|NCT01912118|Analgesics|analgesics|mesh-ancestor
101283158|NCT01912118|Sensory System Agents|sensory system agents|mesh-ancestor
101283159|NCT01912118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101283160|NCT01912261|Iron|iron|mesh-list
101283161|NCT01912261|Trace Elements|trace elements|mesh-ancestor
101283162|NCT01912261|Micronutrients|micronutrients|mesh-ancestor
101283163|NCT01912261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283164|NCT01912378|Oxytocin|oxytocin|mesh-list
101283165|NCT01912378|Oxytocics|oxytocics|mesh-ancestor
101283166|NCT01912378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101283167|NCT01912378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283168|NCT01912391|Selegiline|selegiline|mesh-list
101283169|NCT01912391|Antidepressive Agents|antidepressive agents|mesh-ancestor
101283170|NCT01912391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101283171|NCT01912391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101283172|NCT01912391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101283173|NCT01912391|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101283175|NCT01912391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283176|NCT01912391|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101819512|NCT00452361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101819513|NCT00452361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101819514|NCT03334318|Allopurinol|allopurinol|mesh-list
101819515|NCT03334318|Antimetabolites|antimetabolites|mesh-ancestor
101819516|NCT03334318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819517|NCT03334318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101819518|NCT03334318|Gout Suppressants|gout suppressants|mesh-ancestor
101283177|NCT01912391|Protective Agents|protective agents|mesh-ancestor
101283178|NCT01912391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283179|NCT01912443|Bevacizumab|bevacizumab|mesh-list
101283180|NCT01912443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101283181|NCT01912443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101283182|NCT01912443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101283183|NCT01912443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101283184|NCT01912443|Growth Substances|growth substances|mesh-ancestor
101283185|NCT01912443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283186|NCT01912443|Growth Inhibitors|growth inhibitors|mesh-ancestor
101283188|NCT01912534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101283189|NCT01912534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101283190|NCT01912534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101283191|NCT01912534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283192|NCT01912573|Naloxone|naloxone|mesh-list
101283193|NCT01912573|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101283194|NCT01912573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283195|NCT01912573|Sensory System Agents|sensory system agents|mesh-ancestor
101283196|NCT01912573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101283197|NCT01912586|Sildenafil Citrate|sildenafil citrate|mesh-list
101283198|NCT01912586|Vasodilator Agents|vasodilator agents|mesh-ancestor
101283199|NCT01912586|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101283200|NCT01912586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101283202|NCT01912586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283203|NCT01912586|Urological Agents|urological agents|mesh-ancestor
101283204|NCT01912638|Hyaluronic Acid|hyaluronic acid|mesh-list
101283205|NCT01912638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101283206|NCT01912638|Immunologic Factors|immunologic factors|mesh-ancestor
101283207|NCT01912638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283208|NCT01912638|Viscosupplements|viscosupplements|mesh-ancestor
101283209|NCT01912638|Protective Agents|protective agents|mesh-ancestor
101283210|NCT01912677|Labetalol|labetalol|mesh-list
101283211|NCT01912677|Methyldopa|methyldopa|mesh-list
101283212|NCT01912677|Nifedipine|nifedipine|mesh-list
101283213|NCT01912677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101283214|NCT01912677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101283215|NCT01912677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283216|NCT01912677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101283217|NCT01912677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283218|NCT01912677|Vasodilator Agents|vasodilator agents|mesh-ancestor
101283219|NCT01912677|Tocolytic Agents|tocolytic agents|mesh-ancestor
101283220|NCT01912677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101283221|NCT01912677|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101283222|NCT01912677|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101283223|NCT01912677|Adrenergic Agents|adrenergic agents|mesh-ancestor
101283224|NCT01912677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101283225|NCT01912677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101283226|NCT01912677|Sympathomimetics|sympathomimetics|mesh-ancestor
101283227|NCT01912677|Autonomic Agents|autonomic agents|mesh-ancestor
101283228|NCT01912677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101283229|NCT01912677|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101283230|NCT01912677|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101283231|NCT01912677|Sympatholytics|sympatholytics|mesh-ancestor
101283232|NCT01912677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101283233|NCT01912677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101283235|NCT01912755|Lidocaine|lidocaine|mesh-list
101283236|NCT01912755|Epinephrine|epinephrine|mesh-list
101819519|NCT03334318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101819520|NCT03334318|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101819521|NCT03334318|Antioxidants|antioxidants|mesh-ancestor
101819522|NCT03334318|Protective Agents|protective agents|mesh-ancestor
101819523|NCT03334318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819524|NCT00640289|Fibrinolysin|fibrinolysin|mesh-list
101819525|NCT00640289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101819526|NCT00640289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101819527|NCT00640289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819528|NCT03877809|Sirolimus|sirolimus|mesh-list
101283237|NCT01912755|Racepinephrine|racepinephrine|mesh-list
101283238|NCT01912755|Carticaine|carticaine|mesh-list
101283239|NCT01912755|Epinephryl borate|epinephryl borate|mesh-list
101283240|NCT01912755|Anesthetics, Local|anesthetics, local|mesh-ancestor
101283241|NCT01912755|Anesthetics|anesthetics|mesh-ancestor
101283242|NCT01912755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101283243|NCT01912755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283244|NCT01912755|Sensory System Agents|sensory system agents|mesh-ancestor
101283245|NCT01912755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101283246|NCT01912755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101283247|NCT01912755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101283248|NCT01912755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101283249|NCT01912755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101283250|NCT01912755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283251|NCT01912755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101283252|NCT01912755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101283253|NCT01912755|Adrenergic Agents|adrenergic agents|mesh-ancestor
101283254|NCT01912755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101283255|NCT01912755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101283256|NCT01912755|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101283257|NCT01912755|Autonomic Agents|autonomic agents|mesh-ancestor
101283258|NCT01912755|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101283259|NCT01912755|Respiratory System Agents|respiratory system agents|mesh-ancestor
101283260|NCT01912755|Mydriatics|mydriatics|mesh-ancestor
101283261|NCT01912755|Sympathomimetics|sympathomimetics|mesh-ancestor
101283262|NCT01912755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101283263|NCT01912820|Quercetin|quercetin|mesh-list
101283264|NCT01912820|Antioxidants|antioxidants|mesh-ancestor
101283265|NCT01912820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283266|NCT01912820|Protective Agents|protective agents|mesh-ancestor
101283267|NCT01912820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283268|NCT01912898|Vitamin D|vitamin d|mesh-list
101283269|NCT01912898|Ergocalciferols|ergocalciferols|mesh-list
101283270|NCT01912898|Cholecalciferol|cholecalciferol|mesh-list
101283271|NCT01912898|Vitamins|vitamins|mesh-list
101283272|NCT01912898|Micronutrients|micronutrients|mesh-ancestor
101283273|NCT01912898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283274|NCT01912898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101283275|NCT01912898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101283276|NCT01912976|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
101283277|NCT01912976|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101283278|NCT01912976|Dermatologic Agents|dermatologic agents|mesh-ancestor
101283279|NCT01913002|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
101283280|NCT01913002|Moxifloxacin|moxifloxacin|mesh-list
101283281|NCT01913002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101283282|NCT01913002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101283283|NCT01913002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101283284|NCT01913002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101283285|NCT01913002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101283286|NCT01913002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283288|NCT01913002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283289|NCT01913002|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101283290|NCT01913002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101283291|NCT01913015|Abiraterone Acetate|abiraterone acetate|mesh-list
101819529|NCT03877809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101819530|NCT03877809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101819531|NCT03877809|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101819532|NCT03877809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101819533|NCT03877809|Antifungal Agents|antifungal agents|mesh-ancestor
101819534|NCT03877809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101819535|NCT03877809|Immunologic Factors|immunologic factors|mesh-ancestor
101819536|NCT03877809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819538|NCT01049932|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101819539|NCT01049932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101283292|NCT01913015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101283293|NCT01913015|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101283294|NCT01913015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101283295|NCT01913015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283296|NCT01913015|Hormone Antagonists|hormone antagonists|mesh-ancestor
101283297|NCT01913015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101283298|NCT01913015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283299|NCT01913015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101283300|NCT01913054|Fentanyl|fentanyl|mesh-list
101283301|NCT01913054|Propofol|propofol|mesh-list
101283302|NCT01913054|Etomidate|etomidate|mesh-list
101283303|NCT01913054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101283304|NCT01913054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101283305|NCT01913054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283306|NCT01913054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101283307|NCT01913054|Anesthetics, General|anesthetics, general|mesh-ancestor
101283308|NCT01913054|Anesthetics|anesthetics|mesh-ancestor
101283309|NCT01913054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101283310|NCT01913054|Narcotics|narcotics|mesh-ancestor
101283311|NCT01913054|Analgesics|analgesics|mesh-ancestor
101283312|NCT01913054|Sensory System Agents|sensory system agents|mesh-ancestor
101283313|NCT01913054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101283314|NCT01913054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101283315|NCT01913106|Valacyclovir|valacyclovir|mesh-list
101283316|NCT01913106|Antiviral Agents|antiviral agents|mesh-ancestor
101283317|NCT01913106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101283318|NCT01913119|Romidepsin|romidepsin|mesh-list
101283319|NCT01913119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101283320|NCT01913119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101283321|NCT01913119|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101283322|NCT01913119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101283323|NCT01913119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283324|NCT01913379|Itraconazole|itraconazole|mesh-list
101283325|NCT01913379|Gemfibrozil|gemfibrozil|mesh-list
101283326|NCT01913379|Antifungal Agents|antifungal agents|mesh-ancestor
101283327|NCT01913379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101283328|NCT01913379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101283329|NCT01913379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101283330|NCT01913379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101283331|NCT01913379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283332|NCT01913379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101283334|NCT01913379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101283335|NCT01913379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283336|NCT01913379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101283337|NCT01913379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101283338|NCT01913379|Antimetabolites|antimetabolites|mesh-ancestor
101283339|NCT01913379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101283340|NCT01913379|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101283341|NCT01913431|Entecavir|entecavir|mesh-list
101283342|NCT01913431|Antiviral Agents|antiviral agents|mesh-ancestor
101283343|NCT01913431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101283344|NCT01913444|Antithrombins|antithrombins|mesh-list
101819540|NCT01049932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101819541|NCT01049932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819542|NCT01049932|Antiviral Agents|antiviral agents|mesh-ancestor
101819543|NCT01049932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101819544|NCT01049932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101819545|NCT01049932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101283345|NCT01913444|Antithrombin III|antithrombin iii|mesh-list
101283346|NCT01913444|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101283347|NCT01913444|Protease Inhibitors|protease inhibitors|mesh-ancestor
101283349|NCT01913444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283350|NCT01913444|Anticoagulants|anticoagulants|mesh-ancestor
101283351|NCT01913691|Ipilimumab|ipilimumab|mesh-list
101283352|NCT01913691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101283353|NCT01913691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101283354|NCT01913691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101283355|NCT01913691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283356|NCT01913808|Iron|iron|mesh-list
101283357|NCT01913808|Glycine|glycine|mesh-list
101283358|NCT01913808|Trace Elements|trace elements|mesh-ancestor
101283359|NCT01913808|Micronutrients|micronutrients|mesh-ancestor
101283360|NCT01913808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283361|NCT01913808|Glycine Agents|glycine agents|mesh-ancestor
101283362|NCT01913808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101283363|NCT01913808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283364|NCT01913834|Teriparatide|teriparatide|mesh-list
101283365|NCT01913834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101283366|NCT01913834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283367|NCT01913834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101283368|NCT01913847|Sildenafil Citrate|sildenafil citrate|mesh-list
101283369|NCT01913847|Vasodilator Agents|vasodilator agents|mesh-ancestor
101283370|NCT01913847|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101283371|NCT01913847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101283372|NCT01913847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101283373|NCT01913847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283374|NCT01913847|Urological Agents|urological agents|mesh-ancestor
101283375|NCT01913860|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101283376|NCT01913860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101283377|NCT01913964|Acetylcarnitine|acetylcarnitine|mesh-list
101283378|NCT01913964|Vitamin B Complex|vitamin b complex|mesh-ancestor
101283379|NCT01913964|Vitamins|vitamins|mesh-ancestor
101283380|NCT01913964|Micronutrients|micronutrients|mesh-ancestor
101283381|NCT01913964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283382|NCT01913964|Nootropic Agents|nootropic agents|mesh-ancestor
101283383|NCT01913990|Dexamethasone|dexamethasone|mesh-list
101283384|NCT01913990|Ondansetron|ondansetron|mesh-list
101283385|NCT01913990|Aprepitant|aprepitant|mesh-list
101283386|NCT01913990|Antiemetics|antiemetics|mesh-list
101283387|NCT01913990|Emetics|emetics|mesh-list
101283388|NCT01913990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101283389|NCT01913990|Autonomic Agents|autonomic agents|mesh-ancestor
101283390|NCT01913990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101283391|NCT01913990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283392|NCT01913990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101283393|NCT01913990|Glucocorticoids|glucocorticoids|mesh-ancestor
101408499|NCT00109382|Analgesics|analgesics|mesh-ancestor
101283395|NCT01913990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101283396|NCT01913990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101283397|NCT01913990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101283398|NCT01913990|Antipruritics|antipruritics|mesh-ancestor
101283399|NCT01913990|Dermatologic Agents|dermatologic agents|mesh-ancestor
101283400|NCT01913990|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101283401|NCT01913990|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101283402|NCT01913990|Serotonin Agents|serotonin agents|mesh-ancestor
101283403|NCT01913990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101283404|NCT01913990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283405|NCT01913990|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101283406|NCT01914042|Morphine|morphine|mesh-list
101283407|NCT01914042|Milnacipran|milnacipran|mesh-list
101283408|NCT01914042|Levomilnacipran|levomilnacipran|mesh-list
101283409|NCT01914042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101283410|NCT01914042|Narcotics|narcotics|mesh-ancestor
101819546|NCT01047670|Hydrocortisone|hydrocortisone|mesh-list
101819547|NCT01047670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101819548|NCT00819065|Botulinum Toxins|botulinum toxins|mesh-list
101819549|NCT00819065|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101819550|NCT00819065|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101819551|NCT00819065|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101819552|NCT00819065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101819553|NCT00819065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819554|NCT00819065|Cholinergic Agents|cholinergic agents|mesh-ancestor
101819555|NCT00819065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101819556|NCT00819065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819557|NCT00819065|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101819558|NCT00819065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101819559|NCT01047748|Digoxin|digoxin|mesh-list
101819560|NCT01047748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101819561|NCT01047748|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101819562|NCT01047748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101819563|NCT01047748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819564|NCT01047748|Protective Agents|protective agents|mesh-ancestor
101819565|NCT01047748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819566|NCT00568451|Paclitaxel|paclitaxel|mesh-list
101819567|NCT00568451|Carboplatin|carboplatin|mesh-list
101819568|NCT00568451|Temozolomide|temozolomide|mesh-list
101819569|NCT00568451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101819570|NCT00568451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101819571|NCT00568451|Tubulin Modulators|tubulin modulators|mesh-ancestor
101819572|NCT00568451|Antimitotic Agents|antimitotic agents|mesh-ancestor
101819573|NCT00568451|Mitosis Modulators|mitosis modulators|mesh-ancestor
101283411|NCT01914042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101283412|NCT01914042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283413|NCT01914042|Analgesics|analgesics|mesh-ancestor
101283414|NCT01914042|Sensory System Agents|sensory system agents|mesh-ancestor
101283415|NCT01914042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101283416|NCT01914042|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101283417|NCT01914042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101283418|NCT01914042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101283419|NCT01914042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283420|NCT01914042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101283421|NCT01914042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101283422|NCT01914042|Antidepressive Agents|antidepressive agents|mesh-ancestor
101283424|NCT01914081|Resveratrol|resveratrol|mesh-list
101283425|NCT01914081|Antioxidants|antioxidants|mesh-ancestor
101283426|NCT01914081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819574|NCT00568451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819575|NCT00568451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101819576|NCT00568451|Alkylating Agents|alkylating agents|mesh-ancestor
101819577|NCT00459537|Terbinafine|terbinafine|mesh-list
101819578|NCT00459537|Amorolfine|amorolfine|mesh-list
101819579|NCT00459537|Antifungal Agents|antifungal agents|mesh-ancestor
101283427|NCT01914081|Protective Agents|protective agents|mesh-ancestor
101283428|NCT01914081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283429|NCT01914081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101283430|NCT01914081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101283431|NCT01914133|Acarbose|acarbose|mesh-list
101283432|NCT01914133|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
101283433|NCT01914133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101283434|NCT01914133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283435|NCT01914133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101283436|NCT01914133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283437|NCT01914146|Insulin|insulin|mesh-list
101283438|NCT01914146|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101283439|NCT01914146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101283440|NCT01914146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283441|NCT01914211|Tranexamic Acid|tranexamic acid|mesh-list
101283442|NCT01914211|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101283443|NCT01914211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101283444|NCT01914211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283445|NCT01914211|Hemostatics|hemostatics|mesh-ancestor
101283446|NCT01914211|Coagulants|coagulants|mesh-ancestor
101283447|NCT01914237|Castor Oil|castor oil|mesh-list
101283448|NCT01914237|Cathartics|cathartics|mesh-ancestor
101283449|NCT01914237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101283452|NCT01914250|Sensory System Agents|sensory system agents|mesh-ancestor
101283453|NCT01914250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101283454|NCT01914250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283455|NCT01914250|Anesthetics, Local|anesthetics, local|mesh-ancestor
101283457|NCT01914250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101283458|NCT01914380|Aflibercept|aflibercept|mesh-list
101283459|NCT01914380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101283460|NCT01914380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101283461|NCT01914380|Growth Substances|growth substances|mesh-ancestor
101283462|NCT01914380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283463|NCT01914380|Growth Inhibitors|growth inhibitors|mesh-ancestor
101283464|NCT01914380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101283465|NCT01914419|Oxytocin|oxytocin|mesh-list
101283466|NCT01914419|Oxytocics|oxytocics|mesh-ancestor
101283467|NCT01914419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101283468|NCT01914419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283469|NCT01914432|Telmisartan|telmisartan|mesh-list
101283470|NCT01914432|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101283471|NCT01914432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101283472|NCT01914432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101283473|NCT01914432|Antimetabolites|antimetabolites|mesh-ancestor
101283474|NCT01914432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283475|NCT01914432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101283476|NCT01914432|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101283477|NCT01914432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101283478|NCT01914432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101283479|NCT01914432|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101283480|NCT01914432|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101283481|NCT01914562|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
101283482|NCT01914562|Cathartics|cathartics|mesh-ancestor
101283483|NCT01914562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101283484|NCT01914627|Salicylic Acid|salicylic acid|mesh-list
101283485|NCT01914627|Salicylates|salicylates|mesh-list
101283486|NCT01914627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101283487|NCT01914627|Antifungal Agents|antifungal agents|mesh-ancestor
101283488|NCT01914627|Keratolytic Agents|keratolytic agents|mesh-ancestor
101283489|NCT01914627|Dermatologic Agents|dermatologic agents|mesh-ancestor
101283490|NCT01914627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101283491|NCT01914627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101819580|NCT00459537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101819581|NCT00459537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101819582|NCT00459537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819583|NCT03866421|Liver Extracts|liver extracts|mesh-list
101819584|NCT03866421|Hematinics|hematinics|mesh-ancestor
101819585|NCT00819377|Milrinone|milrinone|mesh-list
101819586|NCT00819377|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101283492|NCT01914627|Analgesics|analgesics|mesh-ancestor
101283493|NCT01914627|Sensory System Agents|sensory system agents|mesh-ancestor
101283494|NCT01914627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101283495|NCT01914627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283496|NCT01914627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101283497|NCT01914627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101283498|NCT01914627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101283499|NCT01914627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101283500|NCT01914627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283502|NCT01914692|Hormones|hormones|mesh-ancestor
101283503|NCT01914692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101283504|NCT01914692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283505|NCT01914718|Rituximab|rituximab|mesh-list
101283506|NCT01914718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101283507|NCT01914718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101283508|NCT01914718|Immunologic Factors|immunologic factors|mesh-ancestor
101283509|NCT01914718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283510|NCT01914718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101283511|NCT01914744|Lamivudine|lamivudine|mesh-list
101283512|NCT01914744|Entecavir|entecavir|mesh-list
101283513|NCT01914744|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101283514|NCT01914744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101283515|NCT01914744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101283516|NCT01914744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283517|NCT01914744|Antiviral Agents|antiviral agents|mesh-ancestor
101283518|NCT01914744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101283519|NCT01914744|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101283520|NCT01914744|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101283521|NCT01914770|Belimumab|belimumab|mesh-list
101283522|NCT01914770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101283523|NCT01914770|Immunologic Factors|immunologic factors|mesh-ancestor
101283524|NCT01914770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283525|NCT01914822|Methylphenidate|methylphenidate|mesh-list
101283526|NCT01914822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101283527|NCT01914822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283528|NCT01914822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101283529|NCT01914822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101283530|NCT01914822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101283531|NCT01914822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283532|NCT01914822|Dopamine Agents|dopamine agents|mesh-ancestor
101283533|NCT01914822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101283534|NCT01914900|Docetaxel|docetaxel|mesh-list
101283535|NCT01914900|Fluorouracil|fluorouracil|mesh-list
101283536|NCT01914900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101283537|NCT01914900|Tubulin Modulators|tubulin modulators|mesh-ancestor
101283538|NCT01914900|Antimitotic Agents|antimitotic agents|mesh-ancestor
101283539|NCT01914900|Mitosis Modulators|mitosis modulators|mesh-ancestor
101283540|NCT01914900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283541|NCT01914900|Antimetabolites|antimetabolites|mesh-ancestor
101283542|NCT01914900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101283543|NCT01914900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101283544|NCT01914900|Immunologic Factors|immunologic factors|mesh-ancestor
101283545|NCT01914900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283546|NCT01914939|Oxytocin|oxytocin|mesh-list
101283547|NCT01914939|Oxytocics|oxytocics|mesh-ancestor
101283548|NCT01914939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101283549|NCT01914939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283550|NCT01914965|Bupropion|bupropion|mesh-list
101283551|NCT01914965|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101819587|NCT00819377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101819588|NCT00819377|Vasodilator Agents|vasodilator agents|mesh-ancestor
101819589|NCT00819377|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101819590|NCT00819377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101819591|NCT00819377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101819592|NCT00819377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819593|NCT00819377|Protective Agents|protective agents|mesh-ancestor
101819594|NCT00819377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283552|NCT01914965|Antidepressive Agents|antidepressive agents|mesh-ancestor
101283553|NCT01914965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101283554|NCT01914965|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101283555|NCT01914965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101283556|NCT01914965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101283557|NCT01914965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283558|NCT01914965|Dopamine Agents|dopamine agents|mesh-ancestor
101283559|NCT01914965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101283560|NCT01914965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315430|NCT00389935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101283561|NCT01914965|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101283562|NCT01914965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101283563|NCT01914965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101283565|NCT01915069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101283566|NCT01915069|Autonomic Agents|autonomic agents|mesh-ancestor
101283567|NCT01915069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101283568|NCT01915069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283569|NCT01915069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101283570|NCT01915069|Respiratory System Agents|respiratory system agents|mesh-ancestor
101283571|NCT01915069|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101283572|NCT01915069|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101283573|NCT01915069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283574|NCT01915069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101283575|NCT01915069|Vasodilator Agents|vasodilator agents|mesh-ancestor
101283576|NCT01915069|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101283577|NCT01915069|Protective Agents|protective agents|mesh-ancestor
101283578|NCT01915069|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101283579|NCT01915069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101283580|NCT01915069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101283581|NCT01915082|Azithromycin|azithromycin|mesh-list
101283582|NCT01915082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101283583|NCT01915082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101283584|NCT01915134|Cisplatin|cisplatin|mesh-list
101283585|NCT01915134|Gemcitabine|gemcitabine|mesh-list
101283586|NCT01915134|Endostatins|endostatins|mesh-list
101283587|NCT01915134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101283588|NCT01915134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101283589|NCT01915134|Antimetabolites|antimetabolites|mesh-ancestor
101283590|NCT01915134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283591|NCT01915134|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101283592|NCT01915134|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101283593|NCT01915134|Growth Substances|growth substances|mesh-ancestor
101283594|NCT01915134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283595|NCT01915134|Growth Inhibitors|growth inhibitors|mesh-ancestor
101283596|NCT01915186|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101283597|NCT01915186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101283598|NCT01915186|Immunologic Factors|immunologic factors|mesh-ancestor
101283599|NCT01915186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283600|NCT01915264|Metformin|metformin|mesh-list
101283601|NCT01915264|Acarbose|acarbose|mesh-list
101283602|NCT01915264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101283603|NCT01915264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283604|NCT01915264|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101283605|NCT01915264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101283606|NCT01915264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283607|NCT01915277|Dexmedetomidine|dexmedetomidine|mesh-list
101819595|NCT01023165|Insulin Lispro|insulin lispro|mesh-list
101819596|NCT01023165|Insulin Aspart|insulin aspart|mesh-list
101819597|NCT01023165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101819598|NCT01023165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819599|NCT01023243|Aspirin|aspirin|mesh-list
101819600|NCT01023243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101819601|NCT01023243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101819602|NCT01023243|Analgesics|analgesics|mesh-ancestor
101819603|NCT01023243|Sensory System Agents|sensory system agents|mesh-ancestor
101819604|NCT01023243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101819605|NCT01023243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819606|NCT01023243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101819607|NCT01023243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101819608|NCT01023243|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101819609|NCT01023243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101283609|NCT01915277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101283610|NCT01915277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283611|NCT01915277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101283612|NCT01915277|Analgesics|analgesics|mesh-ancestor
101283613|NCT01915277|Sensory System Agents|sensory system agents|mesh-ancestor
101283614|NCT01915277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101283615|NCT01915277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101283616|NCT01915277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101283617|NCT01915277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101283618|NCT01915277|Adrenergic Agents|adrenergic agents|mesh-ancestor
101283619|NCT01915277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101283620|NCT01915277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283621|NCT01915459|Botulinum Toxins|botulinum toxins|mesh-list
101283622|NCT01915459|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101283623|NCT01915459|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101283624|NCT01915459|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101283625|NCT01915459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101283626|NCT01915459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283627|NCT01915459|Cholinergic Agents|cholinergic agents|mesh-ancestor
101283628|NCT01915459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101283629|NCT01915459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283630|NCT01915459|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101283631|NCT01915459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101283632|NCT01915472|Irinotecan|irinotecan|mesh-list
101283633|NCT01915472|Labetuzumab|labetuzumab|mesh-list
101283634|NCT01915472|Immunoconjugates|immunoconjugates|mesh-list
101283635|NCT01915472|Immunologic Factors|immunologic factors|mesh-ancestor
101283636|NCT01915472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283637|NCT01915472|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101283638|NCT01915472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101283639|NCT01915472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101283640|NCT01915472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283641|NCT01915472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101283642|NCT01915472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101283643|NCT01915537|Infliximab|infliximab|mesh-list
101283644|NCT01915537|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101283645|NCT01915537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101283646|NCT01915537|Dermatologic Agents|dermatologic agents|mesh-ancestor
101283647|NCT01915537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101283648|NCT01915537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101283649|NCT01915550|Insulin|insulin|mesh-list
101283651|NCT01915550|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101283652|NCT01915550|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
101283653|NCT01915550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101819610|NCT01023243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819611|NCT01023243|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101819612|NCT01023243|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101819613|NCT01023243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101283654|NCT01915550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283655|NCT01915602|Sorafenib|sorafenib|mesh-list
101283656|NCT01915602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101283657|NCT01915602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101283658|NCT01915602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101283659|NCT01915602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283660|NCT01915758|Clindamycin|clindamycin|mesh-list
101283661|NCT01915758|Clindamycin palmitate|clindamycin palmitate|mesh-list
101283662|NCT01915758|Clindamycin phosphate|clindamycin phosphate|mesh-list
101283663|NCT01915758|Tretinoin|tretinoin|mesh-list
101283664|NCT01915758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101283665|NCT01915758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101283666|NCT01915758|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101283667|NCT01915758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101283668|NCT01915758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283669|NCT01915758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101283670|NCT01915758|Keratolytic Agents|keratolytic agents|mesh-ancestor
101283671|NCT01915758|Dermatologic Agents|dermatologic agents|mesh-ancestor
101283672|NCT01915901|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101283673|NCT01915901|Bismuth|bismuth|mesh-list
101283674|NCT01915901|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
101283675|NCT01915901|Antacids|antacids|mesh-ancestor
101283676|NCT01915901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283677|NCT01915901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101283678|NCT01915901|Dermatologic Agents|dermatologic agents|mesh-ancestor
101283679|NCT01915901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101283680|NCT01915901|Immunologic Factors|immunologic factors|mesh-ancestor
101283681|NCT01915901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283682|NCT01915901|Antidiarrheals|antidiarrheals|mesh-ancestor
101283683|NCT01915979|Betamethasone|betamethasone|mesh-list
101283684|NCT01915979|Mitogens|mitogens|mesh-list
101283685|NCT01915979|Mitosis Modulators|mitosis modulators|mesh-ancestor
101283686|NCT01915979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283687|NCT01915979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101283688|NCT01915979|Glucocorticoids|glucocorticoids|mesh-ancestor
101283689|NCT01915979|Hormones|hormones|mesh-ancestor
101283690|NCT01915979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101283691|NCT01915979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283692|NCT01915979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101283693|NCT01915979|Respiratory System Agents|respiratory system agents|mesh-ancestor
101283694|NCT01916057|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101283695|NCT01916057|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101283696|NCT01916057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283697|NCT01916174|Insulin|insulin|mesh-list
101283698|NCT01916174|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101283699|NCT01916174|Liraglutide|liraglutide|mesh-list
101283700|NCT01916174|Insulin, Long-Acting|insulin, long-acting|mesh-list
101283701|NCT01916174|Xultophy|xultophy|mesh-list
101283702|NCT01916174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101283703|NCT01916174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283705|NCT01916174|Hormones|hormones|mesh-ancestor
101283706|NCT01916174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101283707|NCT01916187|Imetelstat|imetelstat|mesh-list
101283708|NCT01916187|Motesanib diphosphate|motesanib diphosphate|mesh-list
101283709|NCT01916187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101283710|NCT01916187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283711|NCT01916187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101283712|NCT01916200|Paroxetine|paroxetine|mesh-list
101283713|NCT01916200|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101283714|NCT01916200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101283716|NCT01916200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283718|NCT01916200|Serotonin Agents|serotonin agents|mesh-ancestor
101283719|NCT01916200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283720|NCT01916200|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101819616|NCT03762915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101819617|NCT03762915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101819618|NCT00469209|Ascorbic Acid|ascorbic acid|mesh-list
101819619|NCT00469209|Bortezomib|bortezomib|mesh-list
101819620|NCT00469209|Melphalan|melphalan|mesh-list
101819621|NCT00469209|Arsenic Trioxide|arsenic trioxide|mesh-list
101819622|NCT00469209|Vitamins|vitamins|mesh-ancestor
101819623|NCT00469209|Micronutrients|micronutrients|mesh-ancestor
101283721|NCT01916200|Antidepressive Agents|antidepressive agents|mesh-ancestor
101283722|NCT01916200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101283723|NCT01916200|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101283724|NCT01916200|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101283725|NCT01916200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101283726|NCT01916213|Hyaluronic Acid|hyaluronic acid|mesh-list
101283727|NCT01916213|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101283728|NCT01916213|Immunologic Factors|immunologic factors|mesh-ancestor
101283729|NCT01916213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283730|NCT01916213|Viscosupplements|viscosupplements|mesh-ancestor
101283731|NCT01916213|Protective Agents|protective agents|mesh-ancestor
101283732|NCT01916252|Dexamethasone|dexamethasone|mesh-list
101283733|NCT01916252|Dexamethasone acetate|dexamethasone acetate|mesh-list
101283734|NCT01916252|Lenalidomide|lenalidomide|mesh-list
101283735|NCT01916252|Bortezomib|bortezomib|mesh-list
101283736|NCT01916252|Melphalan|melphalan|mesh-list
101283737|NCT01916252|Busulfan|busulfan|mesh-list
101283738|NCT01916252|BB 1101|bb 1101|mesh-list
101283739|NCT01916252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101283740|NCT01916252|Antiemetics|antiemetics|mesh-ancestor
101283741|NCT01916252|Autonomic Agents|autonomic agents|mesh-ancestor
101283742|NCT01916252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101283743|NCT01916252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283744|NCT01916252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101283745|NCT01916252|Glucocorticoids|glucocorticoids|mesh-ancestor
101283746|NCT01916252|Hormones|hormones|mesh-ancestor
101283747|NCT01916252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101283748|NCT01916252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101283749|NCT01916252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101283750|NCT01916252|Immunologic Factors|immunologic factors|mesh-ancestor
101283751|NCT01916252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101283752|NCT01916252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101283753|NCT01916252|Growth Substances|growth substances|mesh-ancestor
101283754|NCT01916252|Growth Inhibitors|growth inhibitors|mesh-ancestor
101283755|NCT01916252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101283756|NCT01916252|Alkylating Agents|alkylating agents|mesh-ancestor
101283757|NCT01916252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283758|NCT01916252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101283759|NCT01916252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101283760|NCT01916252|Protease Inhibitors|protease inhibitors|mesh-ancestor
101283761|NCT01916252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101283762|NCT01916265|Glucagon|glucagon|mesh-list
101283763|NCT01916265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101283764|NCT01916265|Hormones|hormones|mesh-ancestor
101283765|NCT01916265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101283767|NCT01916382|Nitisinone|nitisinone|mesh-list
101283768|NCT01916382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101283769|NCT01916382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283770|NCT01916395|Sumatriptan|sumatriptan|mesh-list
101283771|NCT01916395|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101283772|NCT01916395|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101283773|NCT01916395|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101283774|NCT01916395|Serotonin Agents|serotonin agents|mesh-ancestor
101315455|NCT05116930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101283775|NCT01916395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101283776|NCT01916395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283777|NCT01916395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283778|NCT01916408|Wobenzym|wobenzym|mesh-list
101283779|NCT01916408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101819624|NCT00469209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819625|NCT00469209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101819626|NCT00469209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101819627|NCT00469209|Alkylating Agents|alkylating agents|mesh-ancestor
101819628|NCT00469209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819629|NCT00469209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101819630|NCT00469209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101819631|NCT00469209|Immunologic Factors|immunologic factors|mesh-ancestor
101819632|NCT00469209|Antioxidants|antioxidants|mesh-ancestor
101819633|NCT00469209|Protective Agents|protective agents|mesh-ancestor
101819634|NCT00635219|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101283780|NCT01916408|Immunologic Factors|immunologic factors|mesh-ancestor
101283781|NCT01916408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283782|NCT01916447|Bevacizumab|bevacizumab|mesh-list
101283783|NCT01916447|Irinotecan|irinotecan|mesh-list
101283784|NCT01916447|Camptothecin|camptothecin|mesh-list
101283785|NCT01916447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101283786|NCT01916447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101283787|NCT01916447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101283788|NCT01916447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101283789|NCT01916447|Growth Substances|growth substances|mesh-ancestor
101283790|NCT01916447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283791|NCT01916447|Growth Inhibitors|growth inhibitors|mesh-ancestor
101283792|NCT01916447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101283793|NCT01916447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101283794|NCT01916447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101283795|NCT01916447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283796|NCT01916447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101283797|NCT01916577|Plerixafor|plerixafor|mesh-list
101283798|NCT01916577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101283799|NCT01916577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101283800|NCT01916577|Antiviral Agents|antiviral agents|mesh-ancestor
101283801|NCT01916577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101283802|NCT01916642|Lidocaine|lidocaine|mesh-list
101283803|NCT01916642|Etomidate|etomidate|mesh-list
101283804|NCT01916642|Anesthetics, Local|anesthetics, local|mesh-ancestor
101283805|NCT01916642|Anesthetics|anesthetics|mesh-ancestor
101283806|NCT01916642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101283807|NCT01916642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283808|NCT01916642|Sensory System Agents|sensory system agents|mesh-ancestor
101283809|NCT01916642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101283811|NCT01916642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101283812|NCT01916642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101283813|NCT01916642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101283814|NCT01916642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283815|NCT01916642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101283816|NCT01916642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101283817|NCT01916642|Anesthetics, General|anesthetics, general|mesh-ancestor
101283818|NCT01916707|Enoxaparin|enoxaparin|mesh-list
101283819|NCT01916707|Anticoagulants|anticoagulants|mesh-ancestor
101283820|NCT01916707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101283821|NCT01916707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101283822|NCT01916707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283823|NCT01916720|Darapladib|darapladib|mesh-list
101283824|NCT01916720|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
101283825|NCT01916720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101283826|NCT01916720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283827|NCT01916733|Insulin|insulin|mesh-list
101283828|NCT01916733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101283829|NCT01916733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283830|NCT01916785|Dasatinib|dasatinib|mesh-list
101283831|NCT01916785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101283832|NCT01916785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101819635|NCT00635219|Vortioxetine|vortioxetine|mesh-list
101819636|NCT00635219|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101819637|NCT00635219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101819638|NCT00635219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101819639|NCT00635219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819640|NCT00635219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101819641|NCT00635219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819642|NCT00635219|Analgesics|analgesics|mesh-ancestor
101819643|NCT00635219|Sensory System Agents|sensory system agents|mesh-ancestor
101819644|NCT00635219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101819645|NCT00635219|Antidepressive Agents|antidepressive agents|mesh-ancestor
101819646|NCT00635219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101819647|NCT00635219|Dopamine Agents|dopamine agents|mesh-ancestor
101819648|NCT00635219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101819649|NCT00635219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101819650|NCT00635219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101819651|NCT00635219|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101283833|NCT01916785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101283834|NCT01916785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283835|NCT01916798|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101283836|NCT01916798|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101283837|NCT01916798|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101283838|NCT01916798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101283839|NCT01916850|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
101283840|NCT01916850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101283841|NCT01916850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283842|NCT01916850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101283843|NCT01916850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283844|NCT01916863|Canagliflozin|canagliflozin|mesh-list
101283845|NCT01916863|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
101283846|NCT01916863|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101283847|NCT01916863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283848|NCT01916863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101283849|NCT01916863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283850|NCT01916902|Ticagrelor|ticagrelor|mesh-list
101283851|NCT01916902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101283852|NCT01916902|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101283853|NCT01916902|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101283854|NCT01916902|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101283855|NCT01916902|Purinergic Agents|purinergic agents|mesh-ancestor
101283856|NCT01916902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101283857|NCT01916902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283858|NCT01916902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283859|NCT01916915|Tramadol|tramadol|mesh-list
101283860|NCT01916915|Levobupivacaine|levobupivacaine|mesh-list
101283861|NCT01916915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101283862|NCT01916915|Narcotics|narcotics|mesh-ancestor
101283863|NCT01916915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101283864|NCT01916915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283865|NCT01916915|Analgesics|analgesics|mesh-ancestor
101819652|NCT00635219|Serotonin Agents|serotonin agents|mesh-ancestor
101819653|NCT00635219|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101819654|NCT00635219|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101819655|NCT00635219|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101819656|NCT00635219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101819658|NCT01026129|Remifentanil|remifentanil|mesh-list
101819659|NCT01026129|Anesthetics, Local|anesthetics, local|mesh-ancestor
101819660|NCT01026129|Anesthetics|anesthetics|mesh-ancestor
101283866|NCT01916915|Sensory System Agents|sensory system agents|mesh-ancestor
101283867|NCT01916915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101283868|NCT01916915|Anesthetics, Local|anesthetics, local|mesh-ancestor
101283869|NCT01916915|Anesthetics|anesthetics|mesh-ancestor
101283870|NCT01916954|Lumefantrine|lumefantrine|mesh-list
101283872|NCT01916954|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101283873|NCT01916954|Antimalarials|antimalarials|mesh-ancestor
101283874|NCT01916954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101283875|NCT01916954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101283876|NCT01916954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101283877|NCT01917019|4-Aminopyridine|4-aminopyridine|mesh-list
101283878|NCT01917019|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101283879|NCT01917019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101283880|NCT01917019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283881|NCT01917032|Folic Acid|folic acid|mesh-list
101283882|NCT01917032|Vitamin A|vitamin a|mesh-list
101283883|NCT01917032|Micronutrients|micronutrients|mesh-list
101283884|NCT01917032|Trace Elements|trace elements|mesh-list
101283885|NCT01917032|Tretinoin|tretinoin|mesh-list
101283886|NCT01917032|Vitamins|vitamins|mesh-ancestor
101283887|NCT01917032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283888|NCT01917032|Hematinics|hematinics|mesh-ancestor
101283889|NCT01917032|Vitamin B Complex|vitamin b complex|mesh-ancestor
101283890|NCT01917032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101283891|NCT01917032|Keratolytic Agents|keratolytic agents|mesh-ancestor
101283892|NCT01917032|Dermatologic Agents|dermatologic agents|mesh-ancestor
101283893|NCT01917045|Sufentanil|sufentanil|mesh-list
101283894|NCT01917045|Morphine|morphine|mesh-list
101283896|NCT01917045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101283897|NCT01917045|Narcotics|narcotics|mesh-ancestor
101283898|NCT01917045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101283899|NCT01917045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283900|NCT01917045|Analgesics|analgesics|mesh-ancestor
101283901|NCT01917045|Sensory System Agents|sensory system agents|mesh-ancestor
101283902|NCT01917045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101283903|NCT01917045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101283904|NCT01917045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101283905|NCT01917045|Anesthetics, General|anesthetics, general|mesh-ancestor
101283907|NCT01917058|Abatacept|abatacept|mesh-list
101283908|NCT01917058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101283909|NCT01917058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283910|NCT01917058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101283911|NCT01917058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101283912|NCT01917058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101283913|NCT01917058|Immunologic Factors|immunologic factors|mesh-ancestor
101283914|NCT01917058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283915|NCT01917058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101283917|NCT01917097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101283918|NCT01917097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101283919|NCT01917097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283920|NCT01917097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101283921|NCT01917097|Analgesics|analgesics|mesh-ancestor
101283922|NCT01917097|Sensory System Agents|sensory system agents|mesh-ancestor
101283923|NCT01917097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101283924|NCT01917097|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101819661|NCT01026129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101819662|NCT01026129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819663|NCT01026129|Sensory System Agents|sensory system agents|mesh-ancestor
101819664|NCT01026129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101819665|NCT01026129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101819666|NCT01026129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101819667|NCT01026129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101819668|NCT01026129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101819669|NCT01026129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819670|NCT01026129|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101819671|NCT01026129|Narcotics|narcotics|mesh-ancestor
101819672|NCT01026129|Analgesics|analgesics|mesh-ancestor
101819673|NCT01026285|Risperidone|risperidone|mesh-list
101819674|NCT01026285|Antipsychotic Agents|antipsychotic agents|mesh-list
101819675|NCT01026285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101819676|NCT01026285|Serotonin Agents|serotonin agents|mesh-ancestor
101283925|NCT01917097|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101283926|NCT01917097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101283927|NCT01917097|Adrenergic Agents|adrenergic agents|mesh-ancestor
101283928|NCT01917097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101283929|NCT01917097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283930|NCT01917149|Metoprolol|metoprolol|mesh-list
101283931|NCT01917149|Valsartan|valsartan|mesh-list
101283932|NCT01917149|Benazepril|benazepril|mesh-list
101283933|NCT01917149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101283934|NCT01917149|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101283935|NCT01917149|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101283936|NCT01917149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283937|NCT01917149|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101283938|NCT01917149|Sympatholytics|sympatholytics|mesh-ancestor
101283939|NCT01917149|Autonomic Agents|autonomic agents|mesh-ancestor
101283940|NCT01917149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101283941|NCT01917149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283942|NCT01917149|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101283943|NCT01917149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101283944|NCT01917149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101283945|NCT01917149|Adrenergic Agents|adrenergic agents|mesh-ancestor
101283946|NCT01917149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101283947|NCT01917149|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101283948|NCT01917149|Protease Inhibitors|protease inhibitors|mesh-ancestor
101283949|NCT01917149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101283950|NCT01917279|Docetaxel|docetaxel|mesh-list
101283951|NCT01917279|Capecitabine|capecitabine|mesh-list
101283952|NCT01917279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101283953|NCT01917279|Tubulin Modulators|tubulin modulators|mesh-ancestor
101283954|NCT01917279|Antimitotic Agents|antimitotic agents|mesh-ancestor
101283955|NCT01917279|Mitosis Modulators|mitosis modulators|mesh-ancestor
101283956|NCT01917279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283957|NCT01917279|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101283958|NCT01917279|Antimetabolites|antimetabolites|mesh-ancestor
101283959|NCT01917318|Iloperidone|iloperidone|mesh-list
101283960|NCT01917318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101283961|NCT01917318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101283962|NCT01917318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101283963|NCT01917318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283964|NCT01917318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101819677|NCT01026285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101819678|NCT01026285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819679|NCT01026285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819680|NCT01026285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101819681|NCT01026285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101819682|NCT01026285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101819683|NCT01026285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101819684|NCT01026285|Dopamine Agents|dopamine agents|mesh-ancestor
101819685|NCT01026363|Vitamin D|vitamin d|mesh-list
101819686|NCT01026363|Ergocalciferols|ergocalciferols|mesh-list
101819687|NCT01026363|Cholecalciferol|cholecalciferol|mesh-list
101819688|NCT01026363|Calcitriol|calcitriol|mesh-list
101819689|NCT01026363|Vitamins|vitamins|mesh-list
101283965|NCT01917331|Beclomethasone|beclomethasone|mesh-list
101283966|NCT01917331|Glycopyrrolate|glycopyrrolate|mesh-list
101283967|NCT01917331|Formoterol Fumarate|formoterol fumarate|mesh-list
101283968|NCT01917331|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101283969|NCT01917331|Autonomic Agents|autonomic agents|mesh-ancestor
101283970|NCT01917331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101283971|NCT01917331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283972|NCT01917331|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101283973|NCT01917331|Respiratory System Agents|respiratory system agents|mesh-ancestor
101283974|NCT01917331|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101283975|NCT01917331|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101283976|NCT01917331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101283977|NCT01917331|Adrenergic Agents|adrenergic agents|mesh-ancestor
101283978|NCT01917331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101283979|NCT01917331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101283980|NCT01917331|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101283981|NCT01917331|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101283982|NCT01917331|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101283983|NCT01917331|Cholinergic Agents|cholinergic agents|mesh-ancestor
101283984|NCT01917331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101283985|NCT01917331|Glucocorticoids|glucocorticoids|mesh-ancestor
101283987|NCT01917331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101283988|NCT01917448|Morphine|morphine|mesh-list
101283989|NCT01917448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101283990|NCT01917448|Narcotics|narcotics|mesh-ancestor
101283991|NCT01917448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101283992|NCT01917448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101283993|NCT01917448|Analgesics|analgesics|mesh-ancestor
101283994|NCT01917448|Sensory System Agents|sensory system agents|mesh-ancestor
101283995|NCT01917448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101283996|NCT01917578|Paclitaxel|paclitaxel|mesh-list
101283997|NCT01917578|Docetaxel|docetaxel|mesh-list
101283998|NCT01917578|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101283999|NCT01917578|Cyclophosphamide|cyclophosphamide|mesh-list
101284000|NCT01917578|Carboplatin|carboplatin|mesh-list
101284001|NCT01917578|Doxorubicin|doxorubicin|mesh-list
101284002|NCT01917578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101284003|NCT01917578|Fluorouracil|fluorouracil|mesh-list
101284004|NCT01917578|Trastuzumab|trastuzumab|mesh-list
101284005|NCT01917578|Epirubicin|epirubicin|mesh-list
101284006|NCT01917578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101284007|NCT01917578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101284008|NCT01917578|Tubulin Modulators|tubulin modulators|mesh-ancestor
101284009|NCT01917578|Antimitotic Agents|antimitotic agents|mesh-ancestor
101284010|NCT01917578|Mitosis Modulators|mitosis modulators|mesh-ancestor
101284011|NCT01917578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284012|NCT01917578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101284013|NCT01917578|Immunologic Factors|immunologic factors|mesh-ancestor
101284014|NCT01917578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284015|NCT01917578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101819690|NCT01026363|Micronutrients|micronutrients|mesh-ancestor
101819691|NCT01026363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819692|NCT01026363|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101819693|NCT01026363|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101819694|NCT01026363|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101284016|NCT01917578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101284017|NCT01917578|Alkylating Agents|alkylating agents|mesh-ancestor
101284018|NCT01917578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101284019|NCT01917578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101284020|NCT01917578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101284021|NCT01917578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101284022|NCT01917578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101284023|NCT01917578|Antimetabolites|antimetabolites|mesh-ancestor
101284024|NCT01917578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101284025|NCT01917578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101284026|NCT01917617|Cisplatin|cisplatin|mesh-list
101284027|NCT01917617|Gemcitabine|gemcitabine|mesh-list
101284028|NCT01917617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101284029|NCT01917617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101284030|NCT01917617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101284031|NCT01917617|Antimetabolites|antimetabolites|mesh-ancestor
101284032|NCT01917617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284033|NCT01917708|Abatacept|abatacept|mesh-list
101284034|NCT01917708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101284035|NCT01917708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284036|NCT01917708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101284037|NCT01917708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101284038|NCT01917708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101284039|NCT01917708|Immunologic Factors|immunologic factors|mesh-ancestor
101284040|NCT01917708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284041|NCT01917708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101284042|NCT01917721|Doxycycline|doxycycline|mesh-list
101284043|NCT01917721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101284044|NCT01917721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101284045|NCT01917721|Antimalarials|antimalarials|mesh-ancestor
101284046|NCT01917721|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101284047|NCT01917721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101284048|NCT01917799|Aspirin|aspirin|mesh-list
101284049|NCT01917799|Heparin|heparin|mesh-list
101284050|NCT01917799|Enoxaparin|enoxaparin|mesh-list
101284051|NCT01917799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101284052|NCT01917799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101284053|NCT01917799|Analgesics|analgesics|mesh-ancestor
101284054|NCT01917799|Sensory System Agents|sensory system agents|mesh-ancestor
101284055|NCT01917799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101284056|NCT01917799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284057|NCT01917799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101284058|NCT01917799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101284059|NCT01917799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101284060|NCT01917799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101284061|NCT01917799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284062|NCT01917799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101284064|NCT01917799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101284065|NCT01917799|Antipyretics|antipyretics|mesh-ancestor
101284066|NCT01917799|Anticoagulants|anticoagulants|mesh-ancestor
101284067|NCT01917890|Curcumin|curcumin|mesh-list
101284068|NCT01917890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101284069|NCT01917890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101284070|NCT01917890|Analgesics|analgesics|mesh-ancestor
101284071|NCT01917890|Sensory System Agents|sensory system agents|mesh-ancestor
101284072|NCT01917890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101284073|NCT01917890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284074|NCT01917890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101284075|NCT01917890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101284076|NCT01917890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101284077|NCT01917890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101284078|NCT01917890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284079|NCT01918098|Oxycodone|oxycodone|mesh-list
101819695|NCT01026363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101819696|NCT01026363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819697|NCT01026363|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101819698|NCT01023399|Artesunate|artesunate|mesh-list
101819699|NCT01023399|Amodiaquine|amodiaquine|mesh-list
101819700|NCT01023399|Antimalarials|antimalarials|mesh-ancestor
101819701|NCT01023399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101284080|NCT01918098|Naloxone|naloxone|mesh-list
101284081|NCT01918098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101284082|NCT01918098|Narcotics|narcotics|mesh-ancestor
101284083|NCT01918098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101284084|NCT01918098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284085|NCT01918098|Analgesics|analgesics|mesh-ancestor
101284086|NCT01918098|Sensory System Agents|sensory system agents|mesh-ancestor
101284087|NCT01918098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101284089|NCT01918111|Adenosine|adenosine|mesh-list
101284090|NCT01918111|Analgesics|analgesics|mesh-ancestor
101284091|NCT01918111|Sensory System Agents|sensory system agents|mesh-ancestor
101284092|NCT01918111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101284093|NCT01918111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284094|NCT01918111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101284095|NCT01918111|Vasodilator Agents|vasodilator agents|mesh-ancestor
101284096|NCT01918111|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101284097|NCT01918111|Purinergic Agonists|purinergic agonists|mesh-ancestor
101284098|NCT01918111|Purinergic Agents|purinergic agents|mesh-ancestor
101284099|NCT01918111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101284100|NCT01918111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284101|NCT01918124|Paclitaxel|paclitaxel|mesh-list
101284102|NCT01918124|Cyclophosphamide|cyclophosphamide|mesh-list
101284103|NCT01918124|Cisplatin|cisplatin|mesh-list
101284104|NCT01918124|Carboplatin|carboplatin|mesh-list
101284105|NCT01918124|Doxorubicin|doxorubicin|mesh-list
101284106|NCT01918124|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101284107|NCT01918124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101284108|NCT01918124|Tubulin Modulators|tubulin modulators|mesh-ancestor
101284109|NCT01918124|Antimitotic Agents|antimitotic agents|mesh-ancestor
101284110|NCT01918124|Mitosis Modulators|mitosis modulators|mesh-ancestor
101284111|NCT01918124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284112|NCT01918124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101284113|NCT01918124|Immunologic Factors|immunologic factors|mesh-ancestor
101284114|NCT01918124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284115|NCT01918124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101284116|NCT01918124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101284117|NCT01918124|Alkylating Agents|alkylating agents|mesh-ancestor
101284118|NCT01918124|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101284119|NCT01918124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101284120|NCT01918124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101284121|NCT01918124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101284122|NCT01918124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101284123|NCT01918150|Cobalt|cobalt|mesh-list
101284124|NCT01918150|Chromium|chromium|mesh-list
101284125|NCT01918150|Trace Elements|trace elements|mesh-ancestor
101284126|NCT01918150|Micronutrients|micronutrients|mesh-ancestor
101284127|NCT01918150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284128|NCT01918176|Palbociclib|palbociclib|mesh-list
101284129|NCT01918176|Rabeprazole|rabeprazole|mesh-list
101284130|NCT01918176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101284131|NCT01918176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101284132|NCT01918176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101284133|NCT01918176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284135|NCT01918176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101284136|NCT01918176|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101284137|NCT01918241|Lenograstim|lenograstim|mesh-list
101284138|NCT01918241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101284139|NCT01918241|Immunologic Factors|immunologic factors|mesh-ancestor
101284140|NCT01918241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284142|NCT01918254|Pertuzumab|pertuzumab|mesh-list
101284143|NCT01918254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101284144|NCT01918254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101284145|NCT01918254|Tubulin Modulators|tubulin modulators|mesh-ancestor
101819703|NCT01023399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101819704|NCT01023399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101819705|NCT01023399|Antiviral Agents|antiviral agents|mesh-ancestor
101819706|NCT01023399|Schistosomicides|schistosomicides|mesh-ancestor
101819707|NCT01023399|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101819708|NCT01023399|Anthelmintics|anthelmintics|mesh-ancestor
101819709|NCT00451191|Botulinum Toxins|botulinum toxins|mesh-list
101284146|NCT01918254|Antimitotic Agents|antimitotic agents|mesh-ancestor
101284147|NCT01918254|Mitosis Modulators|mitosis modulators|mesh-ancestor
101284148|NCT01918254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284149|NCT01918254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101284150|NCT01918358|Valsartan|valsartan|mesh-list
101284151|NCT01918358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101284152|NCT01918358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101284153|NCT01918358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101284154|NCT01918358|Antimetabolites|antimetabolites|mesh-ancestor
101284155|NCT01918358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284156|NCT01918358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101284157|NCT01918358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101284158|NCT01918358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101284159|NCT01918358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101284160|NCT01918358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101284161|NCT01918358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101284163|NCT01918384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101284164|NCT01918384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101284165|NCT01918475|Carbetocin|carbetocin|mesh-list
101284166|NCT01918475|Oxytocics|oxytocics|mesh-ancestor
101284167|NCT01918475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101284168|NCT01918475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284169|NCT01918488|Amiloride|amiloride|mesh-list
101284170|NCT01918488|Triamterene|triamterene|mesh-list
101284171|NCT01918488|Diuretics|diuretics|mesh-ancestor
101284172|NCT01918488|Natriuretic Agents|natriuretic agents|mesh-ancestor
101284173|NCT01918488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284174|NCT01918488|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
101284175|NCT01918488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101284176|NCT01918488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101284177|NCT01918488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284178|NCT01918488|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101284179|NCT01918488|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101284180|NCT01918514|Magnesium Sulfate|magnesium sulfate|mesh-list
101284181|NCT01918514|Analgesics|analgesics|mesh-ancestor
101284182|NCT01918514|Sensory System Agents|sensory system agents|mesh-ancestor
101284184|NCT01918514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284186|NCT01918514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101284187|NCT01918514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101284188|NCT01918514|Anticonvulsants|anticonvulsants|mesh-ancestor
101284189|NCT01918514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101284190|NCT01918514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101284191|NCT01918514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284192|NCT01918514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101284193|NCT01918514|Tocolytic Agents|tocolytic agents|mesh-ancestor
101284194|NCT01918514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101284195|NCT01918631|Tenofovir|tenofovir|mesh-list
101284196|NCT01918631|Entecavir|entecavir|mesh-list
101284197|NCT01918631|Antiviral Agents|antiviral agents|mesh-ancestor
101284198|NCT01918631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101284199|NCT01918631|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101284200|NCT01918631|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101284201|NCT01918631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101284202|NCT01918631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284203|NCT01918631|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101284204|NCT01918631|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101284205|NCT01918709|Valsartan|valsartan|mesh-list
101819710|NCT00451191|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101819711|NCT00451191|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101819712|NCT00451191|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101819713|NCT00451191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101819714|NCT00451191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819715|NCT00451191|Cholinergic Agents|cholinergic agents|mesh-ancestor
101819716|NCT00451191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101819717|NCT00451191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284206|NCT01918709|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101284207|NCT01918709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101284208|NCT01918709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101284209|NCT01918709|Antimetabolites|antimetabolites|mesh-ancestor
101284210|NCT01918709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284211|NCT01918709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101284212|NCT01918709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101284213|NCT01918709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101284214|NCT01918709|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101284215|NCT01918709|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101284216|NCT01918709|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101284217|NCT01918813|Vancomycin|vancomycin|mesh-list
101284218|NCT01918813|Mupirocin|mupirocin|mesh-list
101284219|NCT01918813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101284220|NCT01918813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101284221|NCT01918813|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101284222|NCT01918813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101284223|NCT01918813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284224|NCT01918852|Bevacizumab|bevacizumab|mesh-list
101284225|NCT01918852|Capecitabine|capecitabine|mesh-list
101284226|NCT01918852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101284227|NCT01918852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101284228|NCT01918852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101284229|NCT01918852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101284230|NCT01918852|Growth Substances|growth substances|mesh-ancestor
101284231|NCT01918852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284232|NCT01918852|Growth Inhibitors|growth inhibitors|mesh-ancestor
101284233|NCT01918852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101284234|NCT01918852|Antimetabolites|antimetabolites|mesh-ancestor
101284235|NCT01918852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284237|NCT01918865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101284238|NCT01918865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284239|NCT01918878|Aflibercept|aflibercept|mesh-list
101284240|NCT01918878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101284241|NCT01918878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101284242|NCT01918878|Growth Substances|growth substances|mesh-ancestor
101284243|NCT01918878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284244|NCT01918878|Growth Inhibitors|growth inhibitors|mesh-ancestor
101284245|NCT01918878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101284246|NCT01918904|Sodium thiosulfate|sodium thiosulfate|mesh-list
101284247|NCT01918904|Antidotes|antidotes|mesh-ancestor
101284248|NCT01918904|Protective Agents|protective agents|mesh-ancestor
101284249|NCT01918904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284250|NCT01918904|Antioxidants|antioxidants|mesh-ancestor
101284251|NCT01918904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284252|NCT01918904|Antitubercular Agents|antitubercular agents|mesh-ancestor
101284253|NCT01918904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101284254|NCT01918904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101284255|NCT01918904|Chelating Agents|chelating agents|mesh-ancestor
101284256|NCT01918904|Sequestering Agents|sequestering agents|mesh-ancestor
101284257|NCT01918917|Dexmedetomidine|dexmedetomidine|mesh-list
101284258|NCT01918917|Morphine|morphine|mesh-list
101284259|NCT01918917|Levobupivacaine|levobupivacaine|mesh-list
101284260|NCT01918917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101284261|NCT01918917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101284262|NCT01918917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819718|NCT00451191|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101819719|NCT00451191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101819720|NCT00451035|Panobinostat|panobinostat|mesh-list
101819721|NCT00451035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101284263|NCT01918917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101284264|NCT01918917|Analgesics|analgesics|mesh-ancestor
101284265|NCT01918917|Sensory System Agents|sensory system agents|mesh-ancestor
101284266|NCT01918917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101284267|NCT01918917|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101408518|NCT00109382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101284268|NCT01918917|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101284269|NCT01918917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101284270|NCT01918917|Adrenergic Agents|adrenergic agents|mesh-ancestor
101284271|NCT01918917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101284272|NCT01918917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284273|NCT01918917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101284274|NCT01918917|Narcotics|narcotics|mesh-ancestor
101284275|NCT01918917|Anesthetics, Local|anesthetics, local|mesh-ancestor
101284276|NCT01918917|Anesthetics|anesthetics|mesh-ancestor
101284277|NCT01918995|Regadenoson|regadenoson|mesh-list
101284278|NCT01918995|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
101284279|NCT01918995|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101284280|NCT01918995|Purinergic Agonists|purinergic agonists|mesh-ancestor
101284281|NCT01918995|Purinergic Agents|purinergic agents|mesh-ancestor
101284282|NCT01918995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101284283|NCT01918995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284284|NCT01918995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284285|NCT01919008|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101284286|NCT01919008|Antidepressive Agents|antidepressive agents|mesh-ancestor
101284287|NCT01919008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101284288|NCT01919008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101284289|NCT01919008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101284290|NCT01919008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101284291|NCT01919008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284292|NCT01919047|Mirabegron|mirabegron|mesh-list
101284293|NCT01919047|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101284294|NCT01919047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101284295|NCT01919047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101284296|NCT01919047|Adrenergic Agents|adrenergic agents|mesh-ancestor
101284297|NCT01919047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101284298|NCT01919047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284299|NCT01919047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284300|NCT01919047|Urological Agents|urological agents|mesh-ancestor
101284301|NCT01919203|Remifentanil|remifentanil|mesh-list
101284302|NCT01919203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101284303|NCT01919203|Narcotics|narcotics|mesh-ancestor
101284304|NCT01919203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101284305|NCT01919203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284306|NCT01919203|Analgesics|analgesics|mesh-ancestor
101284307|NCT01919203|Sensory System Agents|sensory system agents|mesh-ancestor
101284308|NCT01919203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101284309|NCT01919255|Picosulfate sodium|picosulfate sodium|mesh-list
101284310|NCT01919255|Sodium sulfate|sodium sulfate|mesh-list
101284311|NCT01919255|Magnesium Oxide|magnesium oxide|mesh-list
101284312|NCT01919255|Sodium Citrate|sodium citrate|mesh-list
101284313|NCT01919255|Citric Acid|citric acid|mesh-list
101284314|NCT01919255|Anticoagulants|anticoagulants|mesh-ancestor
101284315|NCT01919255|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101284316|NCT01919255|Chelating Agents|chelating agents|mesh-ancestor
101284317|NCT01919255|Sequestering Agents|sequestering agents|mesh-ancestor
101284318|NCT01919255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284319|NCT01919255|Cathartics|cathartics|mesh-ancestor
101284320|NCT01919255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101284321|NCT01919255|Antacids|antacids|mesh-ancestor
101284322|NCT01919294|Methyltestosterone|methyltestosterone|mesh-list
101284323|NCT01919294|Testosterone|testosterone|mesh-list
101284324|NCT01919294|Testosterone undecanoate|testosterone undecanoate|mesh-list
101284325|NCT01919294|Testosterone enanthate|testosterone enanthate|mesh-list
101284326|NCT01919294|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101284327|NCT01919294|Androgens|androgens|mesh-ancestor
101284328|NCT01919294|Hormones|hormones|mesh-ancestor
101284329|NCT01919294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101819722|NCT00451035|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101819723|NCT00451035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101819724|NCT00451035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819725|NCT00468585|Bevacizumab|bevacizumab|mesh-list
101284330|NCT01919294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284331|NCT01919294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101284332|NCT01919294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101284333|NCT01919294|Anabolic Agents|anabolic agents|mesh-ancestor
101284334|NCT01919346|Eculizumab|eculizumab|mesh-list
101284335|NCT01919346|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101284336|NCT01919346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101284337|NCT01919346|Immunologic Factors|immunologic factors|mesh-ancestor
101284338|NCT01919346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284339|NCT01919424|Methacholine Chloride|methacholine chloride|mesh-list
101284340|NCT01919424|Miotics|miotics|mesh-ancestor
101284341|NCT01919424|Autonomic Agents|autonomic agents|mesh-ancestor
101284342|NCT01919424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101284343|NCT01919424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284344|NCT01919424|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101284345|NCT01919424|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
101284346|NCT01919424|Respiratory System Agents|respiratory system agents|mesh-ancestor
101284347|NCT01919424|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101284348|NCT01919424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101284349|NCT01919424|Cholinergic Agents|cholinergic agents|mesh-ancestor
101284350|NCT01919424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101284351|NCT01919424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284352|NCT01919593|Chlorhexidine|chlorhexidine|mesh-list
101284353|NCT01919593|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101284354|NCT01919593|Povidone-Iodine|povidone-iodine|mesh-list
101284355|NCT01919593|Povidone|povidone|mesh-list
101284356|NCT01919593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101284357|NCT01919593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101284359|NCT01919593|Dermatologic Agents|dermatologic agents|mesh-ancestor
101284360|NCT01919593|Plasma Substitutes|plasma substitutes|mesh-ancestor
101284361|NCT01919593|Blood Substitutes|blood substitutes|mesh-ancestor
101284362|NCT01919788|Insulin|insulin|mesh-list
101284363|NCT01919788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101284364|NCT01919788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284365|NCT01919879|Cetuximab|cetuximab|mesh-list
101284366|NCT01919879|Afatinib|afatinib|mesh-list
101284367|NCT01919879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101284368|NCT01919879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101284369|NCT01919879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101284370|NCT01919879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101284371|NCT01919879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284372|NCT01919892|Lithium Carbonate|lithium carbonate|mesh-list
101284373|NCT01919892|Antidepressive Agents|antidepressive agents|mesh-ancestor
101284374|NCT01919892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101284375|NCT01919892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101284376|NCT01919892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284377|NCT01919892|Antimanic Agents|antimanic agents|mesh-ancestor
101284378|NCT01919892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101284379|NCT01919892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101284380|NCT01919892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284381|NCT01919905|Vitamin D|vitamin d|mesh-list
101284382|NCT01919905|Vitamins|vitamins|mesh-ancestor
101284383|NCT01919905|Micronutrients|micronutrients|mesh-ancestor
101284384|NCT01919905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284385|NCT01919905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101284386|NCT01919918|Adenosine|adenosine|mesh-list
101284387|NCT01919918|Analgesics|analgesics|mesh-ancestor
101284388|NCT01919918|Sensory System Agents|sensory system agents|mesh-ancestor
101284389|NCT01919918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101284390|NCT01919918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284391|NCT01919918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101284392|NCT01919918|Vasodilator Agents|vasodilator agents|mesh-ancestor
101284393|NCT01919918|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101284394|NCT01919918|Purinergic Agonists|purinergic agonists|mesh-ancestor
101284395|NCT01919918|Purinergic Agents|purinergic agents|mesh-ancestor
101284396|NCT01919918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101284397|NCT01919918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819726|NCT00468585|Capecitabine|capecitabine|mesh-list
101819727|NCT00468585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101819728|NCT00468585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101819729|NCT00468585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101819730|NCT00468585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101819731|NCT00468585|Growth Substances|growth substances|mesh-ancestor
101819732|NCT00468585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819733|NCT00468585|Growth Inhibitors|growth inhibitors|mesh-ancestor
101819734|NCT00468585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101819735|NCT00468585|Antimetabolites|antimetabolites|mesh-ancestor
101819736|NCT00468585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819737|NCT01026597|Alirocumab|alirocumab|mesh-list
101819738|NCT01026597|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101284398|NCT01920022|Contraceptive Agents|contraceptive agents|mesh-list
101284399|NCT01920022|Mifepristone|mifepristone|mesh-list
101284400|NCT01920022|Etonogestrel|etonogestrel|mesh-list
101284401|NCT01920022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101284402|NCT01920022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284403|NCT01920022|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101284404|NCT01920022|Abortifacient Agents|abortifacient agents|mesh-ancestor
101284405|NCT01920022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101284406|NCT01920022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101284407|NCT01920022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101284408|NCT01920022|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101284409|NCT01920022|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101284410|NCT01920022|Hormone Antagonists|hormone antagonists|mesh-ancestor
101284411|NCT01920022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101284412|NCT01920022|Luteolytic Agents|luteolytic agents|mesh-ancestor
101284413|NCT01920022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101284414|NCT01920022|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101284415|NCT01920074|Nitroglycerin|nitroglycerin|mesh-list
101284416|NCT01920074|Vasodilator Agents|vasodilator agents|mesh-ancestor
101284417|NCT01920516|Melphalan|melphalan|mesh-list
101284418|NCT01920516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101284419|NCT01920516|Alkylating Agents|alkylating agents|mesh-ancestor
101284420|NCT01920516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284421|NCT01920516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101284422|NCT01920516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101284423|NCT01920516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101284424|NCT01920516|Immunologic Factors|immunologic factors|mesh-ancestor
101284425|NCT01920516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284426|NCT01920984|Bevacizumab|bevacizumab|mesh-list
101284427|NCT01920984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101284428|NCT01920984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101284429|NCT01920984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101284430|NCT01920984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101284431|NCT01920984|Growth Substances|growth substances|mesh-ancestor
101284432|NCT01920984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284433|NCT01920984|Growth Inhibitors|growth inhibitors|mesh-ancestor
101284435|NCT01921374|Interferons|interferons|mesh-list
101284436|NCT01921374|Interferon-gamma|interferon-gamma|mesh-list
101284437|NCT01921374|Interleukin-2|interleukin-2|mesh-list
101284438|NCT01921374|Interleukin-4|interleukin-4|mesh-list
101284439|NCT01921374|Dinoprostone|dinoprostone|mesh-list
101284440|NCT01921374|Hormones|hormones|mesh-list
101284441|NCT01921374|Estradiol|estradiol|mesh-list
101284442|NCT01921374|Testosterone|testosterone|mesh-list
101284443|NCT01921374|Progesterone|progesterone|mesh-list
101284444|NCT01921374|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101284445|NCT01921374|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101284446|NCT01921374|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
101284447|NCT01921374|Immunoglobulins|immunoglobulins|mesh-list
101284448|NCT01921374|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101819739|NCT01026597|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101819740|NCT01026597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101819741|NCT01026597|Antimetabolites|antimetabolites|mesh-ancestor
101819742|NCT01026597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819743|NCT01026597|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101284449|NCT01921374|Antibodies|antibodies|mesh-list
101284450|NCT01921374|Immunoglobulin G|immunoglobulin g|mesh-list
101284451|NCT01921374|Complement System Proteins|complement system proteins|mesh-list
101284452|NCT01921374|Immunoglobulin A|immunoglobulin a|mesh-list
101284453|NCT01921374|Immunoglobulin M|immunoglobulin m|mesh-list
101284454|NCT01921374|beta-Endorphin|beta-endorphin|mesh-list
101284455|NCT01921374|Uric Acid|uric acid|mesh-list
101284456|NCT01921374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284457|NCT01921374|Vitamins|vitamins|mesh-ancestor
101284458|NCT01921374|Micronutrients|micronutrients|mesh-ancestor
101284459|NCT01921374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101284461|NCT01921374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101284462|NCT01921374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101284464|NCT01921374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101284465|NCT01921374|Immunologic Factors|immunologic factors|mesh-ancestor
101284466|NCT01921374|Androgens|androgens|mesh-ancestor
101284467|NCT01921374|Progestins|progestins|mesh-ancestor
101284468|NCT01921374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101284469|NCT01921374|Analgesics|analgesics|mesh-ancestor
101284470|NCT01921374|Sensory System Agents|sensory system agents|mesh-ancestor
101284471|NCT01921374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101284472|NCT01921374|Vitamin B Complex|vitamin b complex|mesh-ancestor
101284473|NCT01921374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101284474|NCT01921374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284475|NCT01921374|Antioxidants|antioxidants|mesh-ancestor
101284476|NCT01921374|Protective Agents|protective agents|mesh-ancestor
101284477|NCT01921374|Oxytocics|oxytocics|mesh-ancestor
101284478|NCT01921374|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101284479|NCT01921374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101284480|NCT01921972|Memantine|memantine|mesh-list
101284481|NCT01921972|Galantamine|galantamine|mesh-list
101284482|NCT01921972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101284483|NCT01921972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101284484|NCT01921972|Dopamine Agents|dopamine agents|mesh-ancestor
101284485|NCT01921972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101284486|NCT01921972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284487|NCT01921972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284488|NCT01921972|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101284489|NCT01921972|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101284490|NCT01921972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101284491|NCT01921972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101315495|NCT03126799|Bevacizumab|bevacizumab|mesh-list
101284492|NCT01921972|Cholinergic Agents|cholinergic agents|mesh-ancestor
101284493|NCT01921972|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101284494|NCT01921972|Autonomic Agents|autonomic agents|mesh-ancestor
101284495|NCT01921972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101284496|NCT01921972|Nootropic Agents|nootropic agents|mesh-ancestor
101284497|NCT01923454|Acetazolamide|acetazolamide|mesh-list
101284498|NCT01923454|Anticonvulsants|anticonvulsants|mesh-ancestor
101284499|NCT01923454|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101284500|NCT01923454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101284501|NCT01923454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284502|NCT01923454|Diuretics|diuretics|mesh-ancestor
101284503|NCT01923454|Natriuretic Agents|natriuretic agents|mesh-ancestor
101284504|NCT01923454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284505|NCT01923935|Melphalan|melphalan|mesh-list
101284506|NCT01923935|Busulfan|busulfan|mesh-list
101284507|NCT01923935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101284508|NCT01923935|Alkylating Agents|alkylating agents|mesh-ancestor
101284509|NCT01923935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284510|NCT01923935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101284511|NCT01923935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101284512|NCT01923935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101284513|NCT01923935|Immunologic Factors|immunologic factors|mesh-ancestor
101284514|NCT01923935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284515|NCT01923974|Melatonin|melatonin|mesh-list
101284516|NCT01923974|Antioxidants|antioxidants|mesh-ancestor
101819744|NCT01026597|Protease Inhibitors|protease inhibitors|mesh-ancestor
101819745|NCT01026597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101819746|NCT01026597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101819747|NCT00450801|Leucovorin|leucovorin|mesh-list
101819748|NCT00450801|Cytarabine|cytarabine|mesh-list
101819749|NCT00450801|Thalidomide|thalidomide|mesh-list
101819750|NCT00450801|Cyclophosphamide|cyclophosphamide|mesh-list
101819751|NCT00450801|Ifosfamide|ifosfamide|mesh-list
101819752|NCT00450801|Rituximab|rituximab|mesh-list
101819753|NCT00450801|Doxorubicin|doxorubicin|mesh-list
101819754|NCT00450801|Methotrexate|methotrexate|mesh-list
101819755|NCT00450801|Etoposide|etoposide|mesh-list
101284517|NCT01923974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284518|NCT01923974|Protective Agents|protective agents|mesh-ancestor
101284519|NCT01923974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284520|NCT01923974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101284521|NCT01924013|Vitamin D|vitamin d|mesh-list
101284522|NCT01924013|Cholecalciferol|cholecalciferol|mesh-list
101284523|NCT01924013|Vitamins|vitamins|mesh-ancestor
101284524|NCT01924013|Micronutrients|micronutrients|mesh-ancestor
101284525|NCT01924013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284526|NCT01924013|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101284527|NCT01924013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101284529|NCT01924676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101284530|NCT01924676|Narcotics|narcotics|mesh-ancestor
101284531|NCT01924676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101284532|NCT01924676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284533|NCT01924676|Analgesics|analgesics|mesh-ancestor
101284534|NCT01924676|Sensory System Agents|sensory system agents|mesh-ancestor
101284535|NCT01924676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101284536|NCT01925066|Vancomycin|vancomycin|mesh-list
101284537|NCT01925066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101284538|NCT01925066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101284540|NCT01927640|Dexmedetomidine|dexmedetomidine|mesh-list
101284541|NCT01927640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101284542|NCT01927640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101284543|NCT01927640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284544|NCT01927640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101284545|NCT01927640|Analgesics|analgesics|mesh-ancestor
101284546|NCT01927640|Sensory System Agents|sensory system agents|mesh-ancestor
101284547|NCT01927640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101284548|NCT01927640|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101284549|NCT01927640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101284550|NCT01927640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101284551|NCT01927640|Adrenergic Agents|adrenergic agents|mesh-ancestor
101284552|NCT01927640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101284553|NCT01927640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284554|NCT01927640|Anesthetics, Local|anesthetics, local|mesh-ancestor
101284555|NCT01927640|Anesthetics|anesthetics|mesh-ancestor
101284556|NCT01927640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101284557|NCT01927640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101284558|NCT01927640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101284559|NCT01927640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101284560|NCT01927640|Dopamine Agents|dopamine agents|mesh-ancestor
101284561|NCT01927679|Vitamin E|vitamin e|mesh-list
101284562|NCT01927679|Antioxidants|antioxidants|mesh-list
101284563|NCT01927679|Vitamins|vitamins|mesh-ancestor
101284564|NCT01927679|Micronutrients|micronutrients|mesh-ancestor
101284565|NCT01927679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284566|NCT01927679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284568|NCT01927965|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
101284569|NCT01927965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101284570|NCT01927965|Alkylating Agents|alkylating agents|mesh-ancestor
101284571|NCT01927965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284572|NCT01927965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101284573|NCT01928407|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101284574|NCT01928407|Darunavir|darunavir|mesh-list
101819756|NCT00450801|Vincristine|vincristine|mesh-list
101819758|NCT00450801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101819759|NCT00450801|Immunologic Factors|immunologic factors|mesh-ancestor
101819760|NCT00450801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819761|NCT00450801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101284575|NCT01928407|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101284576|NCT01928407|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101284577|NCT01928407|Protease Inhibitors|protease inhibitors|mesh-ancestor
101284578|NCT01928407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101284579|NCT01928407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284580|NCT01928407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101284581|NCT01928407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101284582|NCT01928407|Antiviral Agents|antiviral agents|mesh-ancestor
101284583|NCT01928407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101284584|NCT01928875|Anesthetics|anesthetics|mesh-list
101284585|NCT01928875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101284586|NCT01928875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284587|NCT01929486|Mogamulizumab|mogamulizumab|mesh-list
101284588|NCT01929486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101284589|NCT01929590|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101284590|NCT01929590|Laxatives|laxatives|mesh-ancestor
101284591|NCT01929590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101284592|NCT01930019|Thiopental|thiopental|mesh-list
101284593|NCT01930019|Etomidate|etomidate|mesh-list
101284594|NCT01930019|Anesthetics|anesthetics|mesh-ancestor
101284595|NCT01930019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101284596|NCT01930019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284597|NCT01930019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101284598|NCT01930019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101284599|NCT01930019|Anesthetics, General|anesthetics, general|mesh-ancestor
101284602|NCT01930019|GABA Agents|gaba agents|mesh-ancestor
101284603|NCT01930019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101284604|NCT01930019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284605|NCT01930201|Anesthetics|anesthetics|mesh-list
101284606|NCT01930201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101284607|NCT01930201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284608|NCT01930292|Paclitaxel|paclitaxel|mesh-list
101284609|NCT01930292|Carboplatin|carboplatin|mesh-list
101284610|NCT01930292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101284611|NCT01930292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101284612|NCT01930292|Tubulin Modulators|tubulin modulators|mesh-ancestor
101284613|NCT01930292|Antimitotic Agents|antimitotic agents|mesh-ancestor
101284615|NCT01930292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284616|NCT01930318|Parecoxib|parecoxib|mesh-list
101284617|NCT01930318|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101284618|NCT01930318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101284619|NCT01930318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101284620|NCT01930318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284621|NCT01930318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101284622|NCT01930318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101284623|NCT01930318|Analgesics|analgesics|mesh-ancestor
101284624|NCT01930318|Sensory System Agents|sensory system agents|mesh-ancestor
101284625|NCT01930318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101284626|NCT01930318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284627|NCT01930318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101284628|NCT01930318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101284629|NCT01930331|Piperaquine|piperaquine|mesh-list
101284630|NCT01930331|Artenimol|artenimol|mesh-list
101284631|NCT01930331|Artemisinins|artemisinins|mesh-list
101284632|NCT01930331|Artemisinin|artemisinin|mesh-list
101284633|NCT01930331|Antimalarials|antimalarials|mesh-ancestor
101284634|NCT01930331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101284635|NCT01930331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101284636|NCT01930331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101284637|NCT01930370|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101284639|NCT01930370|Dialysis Solutions|dialysis solutions|mesh-ancestor
101284640|NCT01930396|Heparin|heparin|mesh-list
101284641|NCT01930396|Calcium heparin|calcium heparin|mesh-list
101284642|NCT01930396|Tinzaparin|tinzaparin|mesh-list
101284643|NCT01930396|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101284644|NCT01930396|Dalteparin|dalteparin|mesh-list
101284645|NCT01930396|Anticoagulants|anticoagulants|mesh-ancestor
101284646|NCT01930396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101819762|NCT00450801|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101819763|NCT00450801|Alkylating Agents|alkylating agents|mesh-ancestor
101819764|NCT00450801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819765|NCT00450801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101819766|NCT00450801|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101819767|NCT00450801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101819768|NCT00450801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101819769|NCT00450801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101284647|NCT01930396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101284648|NCT01930396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284649|NCT01930461|Immunomodulating Agents|immunomodulating agents|mesh-list
101284650|NCT01930461|Immunologic Factors|immunologic factors|mesh-list
101284651|NCT01930461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284652|NCT01930552|Leucovorin|leucovorin|mesh-list
101284653|NCT01930552|Fluorouracil|fluorouracil|mesh-list
101284654|NCT01930552|Irinotecan|irinotecan|mesh-list
101284655|NCT01930552|Aflibercept|aflibercept|mesh-list
101284656|NCT01930552|Antimetabolites|antimetabolites|mesh-ancestor
101284657|NCT01930552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284658|NCT01930552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101284659|NCT01930552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101284660|NCT01930552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101284661|NCT01930552|Immunologic Factors|immunologic factors|mesh-ancestor
101284662|NCT01930552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284665|NCT01930552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101284666|NCT01930552|Antidotes|antidotes|mesh-ancestor
101284667|NCT01930552|Protective Agents|protective agents|mesh-ancestor
101284668|NCT01930552|Vitamin B Complex|vitamin b complex|mesh-ancestor
101284669|NCT01930552|Vitamins|vitamins|mesh-ancestor
101284670|NCT01930552|Micronutrients|micronutrients|mesh-ancestor
101284671|NCT01930552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101284672|NCT01930552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101284673|NCT01930552|Growth Substances|growth substances|mesh-ancestor
101284674|NCT01930552|Growth Inhibitors|growth inhibitors|mesh-ancestor
101284675|NCT01930591|Clopidogrel|clopidogrel|mesh-list
101284676|NCT01930591|Ticagrelor|ticagrelor|mesh-list
101284677|NCT01930591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101284678|NCT01930591|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101284679|NCT01930591|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101284680|NCT01930591|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101284681|NCT01930591|Purinergic Agents|purinergic agents|mesh-ancestor
101284682|NCT01930591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101284683|NCT01930591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284684|NCT01930591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284685|NCT01930604|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
101284686|NCT01930604|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101284687|NCT01930604|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101284688|NCT01930604|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101284689|NCT01930604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101284690|NCT01930604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284691|NCT01930604|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101284692|NCT01930604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101284693|NCT01930604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284694|NCT01930604|Cholinergic Agents|cholinergic agents|mesh-ancestor
101284695|NCT01930604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101284696|NCT01930604|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101284697|NCT01930682|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101284698|NCT01930682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101284699|NCT01930682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101284700|NCT01930682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284701|NCT01930708|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101284702|NCT01930708|Dermatologic Agents|dermatologic agents|mesh-ancestor
101284703|NCT01930708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101819770|NCT00450801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101819771|NCT00450801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101819772|NCT00450801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101819773|NCT00450801|Abortifacient Agents|abortifacient agents|mesh-ancestor
101819774|NCT00450801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101819775|NCT00450801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101819776|NCT00450801|Antimetabolites|antimetabolites|mesh-ancestor
101284704|NCT01930708|Immunologic Factors|immunologic factors|mesh-ancestor
101284705|NCT01930708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284706|NCT01930734|Dobutamine|dobutamine|mesh-list
101284707|NCT01930734|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101284709|NCT01930734|Autonomic Agents|autonomic agents|mesh-ancestor
101284710|NCT01930734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101284711|NCT01930734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284712|NCT01930734|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101284713|NCT01930734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101284714|NCT01930734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101284715|NCT01930734|Adrenergic Agents|adrenergic agents|mesh-ancestor
101284716|NCT01930734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101284717|NCT01930734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284718|NCT01930734|Protective Agents|protective agents|mesh-ancestor
101284719|NCT01930773|Clopidogrel|clopidogrel|mesh-list
101284720|NCT01930773|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101284721|NCT01930773|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101284722|NCT01930773|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101284723|NCT01930773|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101284724|NCT01930773|Purinergic Agents|purinergic agents|mesh-ancestor
101284725|NCT01930773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101284726|NCT01930773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284727|NCT01930773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284728|NCT01930786|Botulinum Toxins|botulinum toxins|mesh-list
101284729|NCT01930786|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101284730|NCT01930786|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101284731|NCT01930786|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101284732|NCT01930786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101284733|NCT01930786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284734|NCT01930786|Cholinergic Agents|cholinergic agents|mesh-ancestor
101284735|NCT01930786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101284736|NCT01930786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284737|NCT01930786|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101284738|NCT01930786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101284739|NCT01930812|Listerine|listerine|mesh-list
101284740|NCT01930812|Fluorides|fluorides|mesh-list
101284741|NCT01930812|Sodium Fluoride|sodium fluoride|mesh-list
101284742|NCT01930812|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
101284743|NCT01930812|Cariostatic Agents|cariostatic agents|mesh-ancestor
101284744|NCT01930812|Protective Agents|protective agents|mesh-ancestor
101284745|NCT01930812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284746|NCT01930812|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101284747|NCT01930812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101284748|NCT01930812|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101284749|NCT01930812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284750|NCT01930864|Metformin|metformin|mesh-list
101284751|NCT01930864|Irinotecan|irinotecan|mesh-list
101284752|NCT01930864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101284753|NCT01930864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284754|NCT01930864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101284755|NCT01930864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101284756|NCT01930864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101284757|NCT01930864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284758|NCT01930864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101284759|NCT01930877|Lidocaine|lidocaine|mesh-list
101284760|NCT01930877|Anesthetics, Local|anesthetics, local|mesh-ancestor
101284761|NCT01930877|Anesthetics|anesthetics|mesh-ancestor
101284762|NCT01930877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101284763|NCT01930877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284764|NCT01930877|Sensory System Agents|sensory system agents|mesh-ancestor
101819777|NCT00450801|Dermatologic Agents|dermatologic agents|mesh-ancestor
101819778|NCT00450801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101819779|NCT00450801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101819780|NCT00450801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101819781|NCT00450801|Antiviral Agents|antiviral agents|mesh-ancestor
101819782|NCT00450801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101819783|NCT00450801|Antidotes|antidotes|mesh-ancestor
101819784|NCT00450801|Protective Agents|protective agents|mesh-ancestor
101819785|NCT00450801|Vitamin B Complex|vitamin b complex|mesh-ancestor
101284765|NCT01930877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101284766|NCT01930877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101284767|NCT01930877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101284768|NCT01930877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101284769|NCT01930877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101284770|NCT01930877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284771|NCT01930916|Anticoagulants|anticoagulants|mesh-list
101284772|NCT01930916|Antibodies|antibodies|mesh-list
101284773|NCT01930916|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
101284774|NCT01930916|Lupus Coagulation Inhibitor|lupus coagulation inhibitor|mesh-list
101284775|NCT01930916|Immunologic Factors|immunologic factors|mesh-ancestor
101284776|NCT01930916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284777|NCT01931085|Triclabendazole|triclabendazole|mesh-list
101284778|NCT01931085|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101284779|NCT01931085|Anthelmintics|anthelmintics|mesh-ancestor
101284780|NCT01931085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101284781|NCT01931085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101284782|NCT01931098|Topotecan|topotecan|mesh-list
101284783|NCT01931098|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101284784|NCT01931098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101284785|NCT01931098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101284786|NCT01931098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284787|NCT01931098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101284788|NCT01931137|Insulin|insulin|mesh-list
101284789|NCT01931137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101284790|NCT01931137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284791|NCT01931189|Infliximab|infliximab|mesh-list
101284792|NCT01931189|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101284793|NCT01931189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101284794|NCT01931189|Dermatologic Agents|dermatologic agents|mesh-ancestor
101284795|NCT01931189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101284796|NCT01931189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101284797|NCT01931215|Clonidine|clonidine|mesh-list
101284798|NCT01931215|Morphine|morphine|mesh-list
101284799|NCT01931215|Ropivacaine|ropivacaine|mesh-list
101284800|NCT01931215|Anesthetics|anesthetics|mesh-ancestor
101284801|NCT01931215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101284802|NCT01931215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284803|NCT01931215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101284804|NCT01931215|Narcotics|narcotics|mesh-ancestor
101284805|NCT01931215|Analgesics|analgesics|mesh-ancestor
101408542|NCT00143481|Urological Agents|urological agents|mesh-ancestor
101284806|NCT01931215|Sensory System Agents|sensory system agents|mesh-ancestor
101284807|NCT01931215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101284808|NCT01931215|Anesthetics, Local|anesthetics, local|mesh-ancestor
101284809|NCT01931215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101284810|NCT01931215|Sympatholytics|sympatholytics|mesh-ancestor
101284811|NCT01931215|Autonomic Agents|autonomic agents|mesh-ancestor
101284812|NCT01931215|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101284813|NCT01931215|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101284814|NCT01931215|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101284815|NCT01931215|Adrenergic Agents|adrenergic agents|mesh-ancestor
101284816|NCT01931215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101284817|NCT01931215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284818|NCT01931293|Folic Acid|folic acid|mesh-list
101284819|NCT01931293|Vitamin B Complex|vitamin b complex|mesh-list
101284820|NCT01931293|Vitamins|vitamins|mesh-ancestor
101284821|NCT01931293|Micronutrients|micronutrients|mesh-ancestor
101284822|NCT01931293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819786|NCT00450801|Vitamins|vitamins|mesh-ancestor
101819787|NCT00450801|Micronutrients|micronutrients|mesh-ancestor
101819788|NCT00450801|Tubulin Modulators|tubulin modulators|mesh-ancestor
101819789|NCT00450801|Antimitotic Agents|antimitotic agents|mesh-ancestor
101819790|NCT00450801|Mitosis Modulators|mitosis modulators|mesh-ancestor
101819791|NCT00450801|Antiemetics|antiemetics|mesh-ancestor
101819792|NCT00450801|Autonomic Agents|autonomic agents|mesh-ancestor
101819793|NCT00450801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101819794|NCT00450801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101819795|NCT00450801|Leprostatic Agents|leprostatic agents|mesh-ancestor
101284823|NCT01931293|Hematinics|hematinics|mesh-ancestor
101284824|NCT01931306|Afatinib|afatinib|mesh-list
101284825|NCT01931306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101284826|NCT01931306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101284827|NCT01931306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101284828|NCT01931306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284829|NCT01931319|Baclofen|baclofen|mesh-list
101284830|NCT01931319|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101284831|NCT01931319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284832|NCT01931319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101284833|NCT01931319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101284834|NCT01931319|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101284835|NCT01931319|GABA Agonists|gaba agonists|mesh-ancestor
101284836|NCT01931319|GABA Agents|gaba agents|mesh-ancestor
101284837|NCT01931319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101284838|NCT01931319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284839|NCT01931332|Heroin|heroin|mesh-list
101284840|NCT01931332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101284841|NCT01931332|Narcotics|narcotics|mesh-ancestor
101284842|NCT01931332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101284843|NCT01931332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284844|NCT01931332|Analgesics|analgesics|mesh-ancestor
101284845|NCT01931332|Sensory System Agents|sensory system agents|mesh-ancestor
101284846|NCT01931332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101284847|NCT01931384|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101284848|NCT01931384|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101284849|NCT01931384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284850|NCT01931410|Misoprostol|misoprostol|mesh-list
101284851|NCT01931410|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101284852|NCT01931410|Abortifacient Agents|abortifacient agents|mesh-ancestor
101284853|NCT01931410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101284854|NCT01931410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284855|NCT01931410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101284856|NCT01931410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101284857|NCT01931410|Oxytocics|oxytocics|mesh-ancestor
101284858|NCT01931501|Montelukast|montelukast|mesh-list
101284859|NCT01931501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101284860|NCT01931501|Respiratory System Agents|respiratory system agents|mesh-ancestor
101284861|NCT01931501|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101284862|NCT01931501|Hormone Antagonists|hormone antagonists|mesh-ancestor
101284863|NCT01931501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101284864|NCT01931501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284865|NCT01931501|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101284866|NCT01931501|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101284867|NCT01931501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284868|NCT01931514|Montelukast|montelukast|mesh-list
101284869|NCT01931514|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101284870|NCT01931514|Respiratory System Agents|respiratory system agents|mesh-ancestor
101284871|NCT01931514|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101284872|NCT01931514|Hormone Antagonists|hormone antagonists|mesh-ancestor
101284873|NCT01931514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101284874|NCT01931514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284875|NCT01931514|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101284876|NCT01931514|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101284877|NCT01931514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819796|NCT00450801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101819797|NCT00450801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101819798|NCT00450801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101819799|NCT00450801|Growth Substances|growth substances|mesh-ancestor
101819800|NCT00450801|Growth Inhibitors|growth inhibitors|mesh-ancestor
101312487|NCT00006367|Antiviral Agents|antiviral agents|mesh-ancestor
101819801|NCT00450801|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101284878|NCT01931592|Gentamicins|gentamicins|mesh-list
101284879|NCT01931592|Colistin|colistin|mesh-list
101284880|NCT01931592|Fosfomycin|fosfomycin|mesh-list
101284881|NCT01931592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101284882|NCT01931592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101284883|NCT01931592|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101284884|NCT01931592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101284885|NCT01931592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284886|NCT01931657|Mifepristone|mifepristone|mesh-list
101284887|NCT01931657|Levonorgestrel|levonorgestrel|mesh-list
101284888|NCT01931657|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101284889|NCT01931657|Abortifacient Agents|abortifacient agents|mesh-ancestor
101284890|NCT01931657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101284891|NCT01931657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284892|NCT01931657|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101284893|NCT01931657|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101284894|NCT01931657|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101284895|NCT01931657|Contraceptive Agents|contraceptive agents|mesh-ancestor
101284896|NCT01931657|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101284897|NCT01931657|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101284898|NCT01931657|Hormone Antagonists|hormone antagonists|mesh-ancestor
101284899|NCT01931657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101284900|NCT01931657|Luteolytic Agents|luteolytic agents|mesh-ancestor
101284901|NCT01931657|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101284902|NCT01931657|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101284903|NCT01931683|Remifentanil|remifentanil|mesh-list
101284904|NCT01931683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101284905|NCT01931683|Narcotics|narcotics|mesh-ancestor
101284906|NCT01931683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101284907|NCT01931683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284909|NCT01931683|Sensory System Agents|sensory system agents|mesh-ancestor
101284910|NCT01931683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101284911|NCT01931787|Thioctic Acid|thioctic acid|mesh-list
101284912|NCT01931787|Antioxidants|antioxidants|mesh-ancestor
101284913|NCT01931787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284914|NCT01931787|Protective Agents|protective agents|mesh-ancestor
101284915|NCT01931787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284916|NCT01931787|Vitamin B Complex|vitamin b complex|mesh-ancestor
101284917|NCT01931787|Vitamins|vitamins|mesh-ancestor
101284918|NCT01931787|Micronutrients|micronutrients|mesh-ancestor
101284919|NCT01931982|Liraglutide|liraglutide|mesh-list
101284920|NCT01931982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101284921|NCT01931982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284922|NCT01931982|Incretins|incretins|mesh-ancestor
101284923|NCT01931982|Hormones|hormones|mesh-ancestor
101284924|NCT01931982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101284925|NCT01932151|Terlipressin|terlipressin|mesh-list
101284926|NCT01932151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101284927|NCT01932151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101284928|NCT01932177|Everolimus|everolimus|mesh-list
101284929|NCT01932177|Sorafenib|sorafenib|mesh-list
101284930|NCT01932177|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101284931|NCT01932177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101284932|NCT01932177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101284933|NCT01932177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284934|NCT01932177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101284935|NCT01932177|Immunologic Factors|immunologic factors|mesh-ancestor
101284936|NCT01932177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284937|NCT01932177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101284938|NCT01932203|Aspirin|aspirin|mesh-list
101284939|NCT01932203|Cilostazol|cilostazol|mesh-list
101819802|NCT00450801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101819804|NCT00450801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101819805|NCT01023633|Oxaliplatin|oxaliplatin|mesh-list
101819806|NCT01023633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101819807|NCT00458211|Ziprasidone|ziprasidone|mesh-list
101819808|NCT00458211|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101819809|NCT00458211|Serotonin Agents|serotonin agents|mesh-ancestor
101284940|NCT01932203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101284941|NCT01932203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101284942|NCT01932203|Analgesics|analgesics|mesh-ancestor
101284943|NCT01932203|Sensory System Agents|sensory system agents|mesh-ancestor
101284944|NCT01932203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101284945|NCT01932203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101284946|NCT01932203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101284947|NCT01932203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101284948|NCT01932203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101284949|NCT01932203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101284950|NCT01932203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284951|NCT01932203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101284952|NCT01932203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101284953|NCT01932203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101284954|NCT01932203|Antipyretics|antipyretics|mesh-ancestor
101284955|NCT01932203|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101284956|NCT01932203|Autonomic Agents|autonomic agents|mesh-ancestor
101284957|NCT01932203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101284958|NCT01932203|Respiratory System Agents|respiratory system agents|mesh-ancestor
101284959|NCT01932203|Vasodilator Agents|vasodilator agents|mesh-ancestor
101284960|NCT01932203|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101284961|NCT01932203|Protective Agents|protective agents|mesh-ancestor
101284962|NCT01932203|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101284963|NCT01932203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101284965|NCT01932229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101284966|NCT01932229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101284967|NCT01932229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101284968|NCT01932229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284969|NCT01932268|Rifampin|rifampin|mesh-list
101284970|NCT01932268|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101284971|NCT01932268|Antitubercular Agents|antitubercular agents|mesh-ancestor
101284972|NCT01932268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101284973|NCT01932268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101284974|NCT01932268|Leprostatic Agents|leprostatic agents|mesh-ancestor
101284975|NCT01932268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101284976|NCT01932268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101284977|NCT01932268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284978|NCT01932268|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101284979|NCT01932268|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101284980|NCT01932268|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101284981|NCT01932268|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101284982|NCT01932268|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101284983|NCT01932268|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101284984|NCT01932320|Ketoconazole|ketoconazole|mesh-list
101284985|NCT01932320|Antifungal Agents|antifungal agents|mesh-ancestor
101284986|NCT01932320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101284987|NCT01932320|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101284988|NCT01932320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101284989|NCT01932320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101284990|NCT01932320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101284991|NCT01932320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101284992|NCT01932320|Hormone Antagonists|hormone antagonists|mesh-ancestor
101284993|NCT01932320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101284994|NCT01932320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819810|NCT00458211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101819811|NCT00458211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819812|NCT00458211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819813|NCT00458211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101819814|NCT00458211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101819815|NCT00458211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101819816|NCT00458211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101284995|NCT01932320|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101284996|NCT01932372|Etanercept|etanercept|mesh-list
101284997|NCT01932372|Antirheumatic Agents|antirheumatic agents|mesh-list
101284998|NCT01932372|Tofacitinib|tofacitinib|mesh-list
101284999|NCT01932372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101285000|NCT01932372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101285001|NCT01932372|Analgesics|analgesics|mesh-ancestor
101285002|NCT01932372|Sensory System Agents|sensory system agents|mesh-ancestor
101285003|NCT01932372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101285004|NCT01932372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285005|NCT01932372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101285006|NCT01932372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101285007|NCT01932372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101285008|NCT01932372|Immunologic Factors|immunologic factors|mesh-ancestor
101285009|NCT01932372|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101285010|NCT01932372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101285011|NCT01932372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101285012|NCT01932372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285013|NCT01932385|Sorafenib|sorafenib|mesh-list
101285014|NCT01932385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101285015|NCT01932385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101285016|NCT01932385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101285017|NCT01932385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285018|NCT01932424|Propofol|propofol|mesh-list
101285019|NCT01932424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101285020|NCT01932424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101285021|NCT01932424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285022|NCT01932424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101285023|NCT01932424|Anesthetics, General|anesthetics, general|mesh-ancestor
101285024|NCT01932424|Anesthetics|anesthetics|mesh-ancestor
101285027|NCT01932502|Anticonvulsants|anticonvulsants|mesh-ancestor
101285028|NCT01932502|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101285029|NCT01932502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101285030|NCT01932502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101285031|NCT01932502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285032|NCT01932502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101285033|NCT01932502|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101285034|NCT01932502|GABA Agonists|gaba agonists|mesh-ancestor
101285035|NCT01932502|GABA Agents|gaba agents|mesh-ancestor
101285036|NCT01932502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101285037|NCT01932502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285038|NCT01932541|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
101285039|NCT01932541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101285040|NCT01932541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101285041|NCT01932541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101285042|NCT01932541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285043|NCT01932541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101285044|NCT01932541|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101315537|NCT00000531|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101285046|NCT01932541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101285047|NCT01932541|Adrenergic Agents|adrenergic agents|mesh-ancestor
101285048|NCT01932541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101285049|NCT01932541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285050|NCT01932541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101285051|NCT01932541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101285052|NCT01932541|Serotonin Agents|serotonin agents|mesh-ancestor
101285053|NCT01932541|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101819818|NCT00458211|Dopamine Agents|dopamine agents|mesh-ancestor
101819819|NCT00450723|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
101819820|NCT00450723|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101819821|NCT00450723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819822|NCT00457821|Ivacaftor|ivacaftor|mesh-list
101819823|NCT00457821|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101819824|NCT00457821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101819825|NCT00457821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819826|NCT00633893|Apixaban|apixaban|mesh-list
101285054|NCT01932541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101285055|NCT01932541|Dopamine Agents|dopamine agents|mesh-ancestor
101285056|NCT01932554|Ibuprofen|ibuprofen|mesh-list
101285057|NCT01932554|Fentanyl|fentanyl|mesh-list
101285058|NCT01932554|Morphine|morphine|mesh-list
101285059|NCT01932554|Hydromorphone|hydromorphone|mesh-list
101285060|NCT01932554|Narcotics|narcotics|mesh-list
101285061|NCT01932554|Abciximab|abciximab|mesh-list
101285062|NCT01932554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101285063|NCT01932554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101285064|NCT01932554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285065|NCT01932554|Analgesics|analgesics|mesh-ancestor
101285066|NCT01932554|Sensory System Agents|sensory system agents|mesh-ancestor
101285067|NCT01932554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101285068|NCT01932554|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101285069|NCT01932554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101285070|NCT01932554|Anesthetics, General|anesthetics, general|mesh-ancestor
101285071|NCT01932554|Anesthetics|anesthetics|mesh-ancestor
101285072|NCT01932554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101285073|NCT01932554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101285074|NCT01932554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101285075|NCT01932554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101285076|NCT01932554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101285077|NCT01932554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101285078|NCT01932554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285079|NCT01932554|Anticoagulants|anticoagulants|mesh-ancestor
101285080|NCT01932554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101285081|NCT01932580|Docetaxel|docetaxel|mesh-list
101285082|NCT01932580|Fluorouracil|fluorouracil|mesh-list
101285083|NCT01932580|Oxaliplatin|oxaliplatin|mesh-list
101285084|NCT01932580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101285085|NCT01932580|Tubulin Modulators|tubulin modulators|mesh-ancestor
101285086|NCT01932580|Antimitotic Agents|antimitotic agents|mesh-ancestor
101285087|NCT01932580|Mitosis Modulators|mitosis modulators|mesh-ancestor
101285088|NCT01932580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285089|NCT01932580|Antimetabolites|antimetabolites|mesh-ancestor
101285090|NCT01932580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101285091|NCT01932580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101285093|NCT01932580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285094|NCT01932918|Ketorolac|ketorolac|mesh-list
101285095|NCT01932918|Morphine|morphine|mesh-list
101285096|NCT01932918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101285097|NCT01932918|Narcotics|narcotics|mesh-ancestor
101285098|NCT01932918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101285099|NCT01932918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285100|NCT01932918|Analgesics|analgesics|mesh-ancestor
101285101|NCT01932918|Sensory System Agents|sensory system agents|mesh-ancestor
101285102|NCT01932918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101285103|NCT01932918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101285104|NCT01932918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101285105|NCT01932918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101285106|NCT01932918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101285107|NCT01932918|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101285108|NCT01932918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101285109|NCT01932918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285111|NCT01932931|Cholecalciferol|cholecalciferol|mesh-list
101819827|NCT00633893|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101819828|NCT00633893|Antithrombins|antithrombins|mesh-ancestor
101819829|NCT00633893|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101819830|NCT00633893|Protease Inhibitors|protease inhibitors|mesh-ancestor
101477122|NCT00273338|Calcitriol|calcitriol|mesh-list
101819831|NCT00633893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101819832|NCT00633893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819833|NCT00633893|Anticoagulants|anticoagulants|mesh-ancestor
101819834|NCT02550665|Donepezil|donepezil|mesh-list
101285112|NCT01932931|Vitamins|vitamins|mesh-ancestor
101285113|NCT01932931|Micronutrients|micronutrients|mesh-ancestor
101285114|NCT01932931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285115|NCT01932931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101285116|NCT01932931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101285117|NCT01933022|Leuprolide|leuprolide|mesh-list
101285118|NCT01933022|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101285119|NCT01933022|Fertility Agents|fertility agents|mesh-ancestor
101285120|NCT01933022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101315538|NCT00000531|Adrenergic Agents|adrenergic agents|mesh-ancestor
101285121|NCT01933022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285122|NCT01933022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101285123|NCT01933022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101285124|NCT01933061|Paclitaxel|paclitaxel|mesh-list
101285125|NCT01933061|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101285126|NCT01933061|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101285127|NCT01933061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101285128|NCT01933061|Tubulin Modulators|tubulin modulators|mesh-ancestor
101285129|NCT01933061|Antimitotic Agents|antimitotic agents|mesh-ancestor
101285130|NCT01933061|Mitosis Modulators|mitosis modulators|mesh-ancestor
101285131|NCT01933061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285132|NCT01933152|Ranibizumab|ranibizumab|mesh-list
101285133|NCT01933152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101285134|NCT01933152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101285135|NCT01933152|Growth Substances|growth substances|mesh-ancestor
101285136|NCT01933152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285137|NCT01933152|Growth Inhibitors|growth inhibitors|mesh-ancestor
101285138|NCT01933152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101285139|NCT01933347|Gefitinib|gefitinib|mesh-list
101285140|NCT01933347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101285141|NCT01933347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101285142|NCT01933347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101285143|NCT01933347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285144|NCT01933360|Misoprostol|misoprostol|mesh-list
101285145|NCT01933360|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101285146|NCT01933360|Abortifacient Agents|abortifacient agents|mesh-ancestor
101285147|NCT01933360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101285148|NCT01933360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285149|NCT01933360|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101285150|NCT01933360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101285151|NCT01933360|Oxytocics|oxytocics|mesh-ancestor
101285152|NCT01933412|Vaccines|vaccines|mesh-list
101285153|NCT01933412|Immunologic Factors|immunologic factors|mesh-ancestor
101285154|NCT01933412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285155|NCT01933490|Insulin Aspart|insulin aspart|mesh-list
101285156|NCT01933490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101285157|NCT01933490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285158|NCT01933503|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
101285159|NCT01933503|Cathartics|cathartics|mesh-ancestor
101285160|NCT01933503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101285161|NCT01933516|Rituximab|rituximab|mesh-list
101285162|NCT01933516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101285163|NCT01933516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101285164|NCT01933516|Immunologic Factors|immunologic factors|mesh-ancestor
101285165|NCT01933516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285166|NCT01933516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101285167|NCT01933542|Morphine|morphine|mesh-list
101819835|NCT02550665|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101819836|NCT02550665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101819837|NCT02550665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819838|NCT02550665|Cholinergic Agents|cholinergic agents|mesh-ancestor
101819839|NCT02550665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101819840|NCT02550665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819841|NCT02550665|Nootropic Agents|nootropic agents|mesh-ancestor
101819842|NCT00819845|Carvedilol|carvedilol|mesh-list
101819843|NCT00819845|Ramipril|ramipril|mesh-list
101285168|NCT01933542|Chlorzoxazone|chlorzoxazone|mesh-list
101285169|NCT01933542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101285170|NCT01933542|Narcotics|narcotics|mesh-ancestor
101285171|NCT01933542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101285172|NCT01933542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285173|NCT01933542|Analgesics|analgesics|mesh-ancestor
101285174|NCT01933542|Sensory System Agents|sensory system agents|mesh-ancestor
101285175|NCT01933542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101285176|NCT01933542|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101285177|NCT01933542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101285178|NCT01933568|Cisplatin|cisplatin|mesh-list
101285179|NCT01933568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101285180|NCT01933698|Amoxicillin|amoxicillin|mesh-list
101285181|NCT01933698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101285182|NCT01933698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101285183|NCT01933711|Rituximab|rituximab|mesh-list
101285184|NCT01933711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101285185|NCT01933711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101285186|NCT01933711|Immunologic Factors|immunologic factors|mesh-ancestor
101285187|NCT01933711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285188|NCT01933711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101285189|NCT01933906|Interferons|interferons|mesh-list
101285190|NCT01933906|Interferon-alpha|interferon-alpha|mesh-list
101285191|NCT01933906|Interferon alpha-2|interferon alpha-2|mesh-list
101285192|NCT01933906|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101285193|NCT01933906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101285194|NCT01933906|Antiviral Agents|antiviral agents|mesh-ancestor
101285195|NCT01933906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101285196|NCT01933906|Immunologic Factors|immunologic factors|mesh-ancestor
101285197|NCT01933906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285198|NCT01933945|Sorafenib|sorafenib|mesh-list
101285199|NCT01933945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101285200|NCT01933945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101285201|NCT01933945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101285202|NCT01933945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285203|NCT01933971|Lenograstim|lenograstim|mesh-list
101285204|NCT01933971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101285205|NCT01933971|Immunologic Factors|immunologic factors|mesh-ancestor
101285206|NCT01933971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285208|NCT01933997|Metadoxine|metadoxine|mesh-list
101285209|NCT01933997|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101285210|NCT01933997|Vitamin B Complex|vitamin b complex|mesh-ancestor
101285211|NCT01933997|Vitamins|vitamins|mesh-ancestor
101285212|NCT01933997|Micronutrients|micronutrients|mesh-ancestor
101285213|NCT01933997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285214|NCT01934023|Varenicline|varenicline|mesh-list
101285215|NCT01934023|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101285216|NCT01934023|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101285217|NCT01934023|Cholinergic Agents|cholinergic agents|mesh-ancestor
101285218|NCT01934023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101285219|NCT01934023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285220|NCT01934023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285221|NCT01934049|Anesthetics|anesthetics|mesh-list
101285222|NCT01934049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101285223|NCT01934049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285224|NCT01934088|Fentanyl|fentanyl|mesh-list
101285225|NCT01934088|Midazolam|midazolam|mesh-list
101819844|NCT00819845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101819845|NCT00819845|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101819846|NCT00819845|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101819847|NCT00819845|Adrenergic Agents|adrenergic agents|mesh-ancestor
101819848|NCT00819845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101819849|NCT00819845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285226|NCT01934088|Propofol|propofol|mesh-list
101285227|NCT01934088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101285228|NCT01934088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101285229|NCT01934088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285230|NCT01934088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101285231|NCT01934088|Anesthetics, General|anesthetics, general|mesh-ancestor
101285232|NCT01934088|Anesthetics|anesthetics|mesh-ancestor
101285233|NCT01934088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101285234|NCT01934088|Narcotics|narcotics|mesh-ancestor
101285235|NCT01934088|Analgesics|analgesics|mesh-ancestor
101315572|NCT04888858|Fentanyl|fentanyl|mesh-list
101285236|NCT01934088|Sensory System Agents|sensory system agents|mesh-ancestor
101285237|NCT01934088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101285238|NCT01934088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101285239|NCT01934088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101285240|NCT01934088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101285241|NCT01934088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101285242|NCT01934088|GABA Modulators|gaba modulators|mesh-ancestor
101285243|NCT01934088|GABA Agents|gaba agents|mesh-ancestor
101285244|NCT01934088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101285245|NCT01934088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285246|NCT01934127|Vaccines|vaccines|mesh-list
101285247|NCT01934127|Immunologic Factors|immunologic factors|mesh-ancestor
101285248|NCT01934127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285249|NCT01934166|Nalmefene|nalmefene|mesh-list
101285250|NCT01934166|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101285251|NCT01934166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285252|NCT01934166|Sensory System Agents|sensory system agents|mesh-ancestor
101285253|NCT01934166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101285254|NCT01934205|Gepotidacin|gepotidacin|mesh-list
101285255|NCT01934205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101285256|NCT01934205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101285257|NCT01934205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285258|NCT01934205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101285259|NCT01934361|Carboplatin|carboplatin|mesh-list
101285260|NCT01934361|Lomustine|lomustine|mesh-list
101285261|NCT01934361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101285262|NCT01934361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101285263|NCT01934361|Alkylating Agents|alkylating agents|mesh-ancestor
101285264|NCT01934361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285265|NCT01934569|Losartan|losartan|mesh-list
101285266|NCT01934569|Midazolam|midazolam|mesh-list
101285267|NCT01934569|Caffeine|caffeine|mesh-list
101285268|NCT01934569|Omeprazole|omeprazole|mesh-list
101285269|NCT01934569|Pravastatin|pravastatin|mesh-list
101285270|NCT01934569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101285271|NCT01934569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101285272|NCT01934569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101285273|NCT01934569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285274|NCT01934569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101285275|NCT01934569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101285277|NCT01934569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101285278|NCT01934569|Anesthetics, General|anesthetics, general|mesh-ancestor
101285279|NCT01934569|Anesthetics|anesthetics|mesh-ancestor
101285280|NCT01934569|GABA Modulators|gaba modulators|mesh-ancestor
101285281|NCT01934569|GABA Agents|gaba agents|mesh-ancestor
101285282|NCT01934569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101285283|NCT01934569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285284|NCT01934569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101285285|NCT01934569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101285286|NCT01934569|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101285287|NCT01934569|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101819850|NCT00819845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819851|NCT00819845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101819852|NCT00819845|Antioxidants|antioxidants|mesh-ancestor
101819853|NCT00819845|Protective Agents|protective agents|mesh-ancestor
101819854|NCT00819845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101819855|NCT00819845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101819856|NCT00819845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101819857|NCT00819845|Vasodilator Agents|vasodilator agents|mesh-ancestor
101819858|NCT00819845|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101819859|NCT00819845|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101819860|NCT00819845|Protease Inhibitors|protease inhibitors|mesh-ancestor
101819861|NCT00819845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101285288|NCT01934569|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101285289|NCT01934569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101285290|NCT01934569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101285291|NCT01934569|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101285292|NCT01934569|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101285293|NCT01934569|Purinergic Agents|purinergic agents|mesh-ancestor
101285294|NCT01934569|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101285295|NCT01934569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101285296|NCT01934569|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101285297|NCT01934569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101285298|NCT01934569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101285300|NCT01934569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101285301|NCT01934569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101285302|NCT01934634|Paclitaxel|paclitaxel|mesh-list
101285303|NCT01934634|Gemcitabine|gemcitabine|mesh-list
101285304|NCT01934634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101285305|NCT01934634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101285306|NCT01934634|Tubulin Modulators|tubulin modulators|mesh-ancestor
101285307|NCT01934634|Antimitotic Agents|antimitotic agents|mesh-ancestor
101285308|NCT01934634|Mitosis Modulators|mitosis modulators|mesh-ancestor
101285309|NCT01934634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285310|NCT01934634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101285311|NCT01934634|Antimetabolites|antimetabolites|mesh-ancestor
101285312|NCT01934712|Insulin|insulin|mesh-list
101285313|NCT01934712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101285314|NCT01934712|Insulin Aspart|insulin aspart|mesh-list
101285315|NCT01934712|Insulin, Long-Acting|insulin, long-acting|mesh-list
101285316|NCT01934712|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101285317|NCT01934712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101285318|NCT01934712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285319|NCT01934777|Vitamin E|vitamin e|mesh-list
101285320|NCT01934777|Choline|choline|mesh-list
101285321|NCT01934777|Vitamins|vitamins|mesh-ancestor
101285322|NCT01934777|Micronutrients|micronutrients|mesh-ancestor
101285323|NCT01934777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285324|NCT01934777|Antioxidants|antioxidants|mesh-ancestor
101285325|NCT01934777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285326|NCT01934777|Protective Agents|protective agents|mesh-ancestor
101285327|NCT01934777|Lipotropic Agents|lipotropic agents|mesh-ancestor
101285328|NCT01934777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101285329|NCT01934777|Antimetabolites|antimetabolites|mesh-ancestor
101285330|NCT01934777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101285331|NCT01934777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101285332|NCT01934777|Nootropic Agents|nootropic agents|mesh-ancestor
101285333|NCT01934816|Liraglutide|liraglutide|mesh-list
101285334|NCT01934816|Exenatide|exenatide|mesh-list
101285335|NCT01934816|Glucagon|glucagon|mesh-list
101285336|NCT01934816|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101285337|NCT01934816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101285338|NCT01934816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285339|NCT01934816|Incretins|incretins|mesh-ancestor
101819862|NCT00457743|Sunitinib|sunitinib|mesh-list
101819863|NCT00457743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101819864|NCT00457743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101819865|NCT00457743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101819866|NCT00457743|Growth Substances|growth substances|mesh-ancestor
101819867|NCT00457743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285341|NCT01934816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101285342|NCT01934816|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101285343|NCT01934816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101285344|NCT01934829|Sorafenib|sorafenib|mesh-list
101285345|NCT01934829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101285346|NCT01934829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101285347|NCT01934829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101285348|NCT01934829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285349|NCT01934933|Celecoxib|celecoxib|mesh-list
101285350|NCT01934933|Etanercept|etanercept|mesh-list
101285351|NCT01934933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101285352|NCT01934933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101285353|NCT01934933|Analgesics|analgesics|mesh-ancestor
101285354|NCT01934933|Sensory System Agents|sensory system agents|mesh-ancestor
101285355|NCT01934933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101285356|NCT01934933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285358|NCT01934933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101285359|NCT01934933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101285360|NCT01934933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101315603|NCT04802746|Alprazolam|alprazolam|mesh-list
101285361|NCT01934933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101285362|NCT01934933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285363|NCT01934933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101285364|NCT01934933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101285365|NCT01934933|Immunologic Factors|immunologic factors|mesh-ancestor
101285366|NCT01935063|Lidocaine|lidocaine|mesh-list
101285367|NCT01935063|Anesthetics, Local|anesthetics, local|mesh-ancestor
101285368|NCT01935063|Anesthetics|anesthetics|mesh-ancestor
101285369|NCT01935063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101285370|NCT01935063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285371|NCT01935063|Sensory System Agents|sensory system agents|mesh-ancestor
101285372|NCT01935063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101285373|NCT01935063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101285374|NCT01935063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101285375|NCT01935063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101285376|NCT01935063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101285377|NCT01935063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285378|NCT01935115|Ketamine|ketamine|mesh-list
101285379|NCT01935115|Propofol|propofol|mesh-list
101285380|NCT01935115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101285381|NCT01935115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101285382|NCT01935115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285383|NCT01935115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101285384|NCT01935115|Anesthetics, General|anesthetics, general|mesh-ancestor
101285385|NCT01935115|Anesthetics|anesthetics|mesh-ancestor
101285386|NCT01935115|Analgesics|analgesics|mesh-ancestor
101285387|NCT01935115|Sensory System Agents|sensory system agents|mesh-ancestor
101285388|NCT01935115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101285389|NCT01935115|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101285390|NCT01935115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101285391|NCT01935115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101285392|NCT01935115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101285393|NCT01935115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285394|NCT01935141|Triiodobenzoic Acids|triiodobenzoic acids|mesh-list
101285395|NCT01935141|Plant Growth Regulators|plant growth regulators|mesh-ancestor
101285396|NCT01935141|Growth Substances|growth substances|mesh-ancestor
101285397|NCT01935141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285398|NCT01935193|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
101285399|NCT01935193|Analgesics|analgesics|mesh-ancestor
101285400|NCT01935193|Sensory System Agents|sensory system agents|mesh-ancestor
101285401|NCT01935193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101285402|NCT01935193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819868|NCT00457743|Growth Inhibitors|growth inhibitors|mesh-ancestor
101819869|NCT00457743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101819870|NCT00457743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101819871|NCT00457743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819873|NCT01023867|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101819874|NCT01023867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101819875|NCT01023867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819876|NCT01023867|Cholinergic Agents|cholinergic agents|mesh-ancestor
101285403|NCT01935193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101285404|NCT01935193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101285406|NCT01935193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101285407|NCT01935193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101285408|NCT01935193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101285409|NCT01935193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101285410|NCT01935193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285411|NCT01935206|Naloxone|naloxone|mesh-list
101285412|NCT01935206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101285413|NCT01935206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285414|NCT01935206|Sensory System Agents|sensory system agents|mesh-ancestor
101315611|NCT04802746|GABA Agents|gaba agents|mesh-ancestor
101285415|NCT01935206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101285417|NCT01935310|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101285418|NCT01935310|Immunologic Factors|immunologic factors|mesh-ancestor
101285419|NCT01935310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285420|NCT01935310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101285421|NCT01935310|Interferon Inducers|interferon inducers|mesh-ancestor
101285422|NCT01935492|Paclitaxel|paclitaxel|mesh-list
101285423|NCT01935492|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101285424|NCT01935492|Bevacizumab|bevacizumab|mesh-list
101285425|NCT01935492|Doxorubicin|doxorubicin|mesh-list
101285426|NCT01935492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101285427|NCT01935492|Capecitabine|capecitabine|mesh-list
101285428|NCT01935492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101285429|NCT01935492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101285430|NCT01935492|Tubulin Modulators|tubulin modulators|mesh-ancestor
101285431|NCT01935492|Antimitotic Agents|antimitotic agents|mesh-ancestor
101285432|NCT01935492|Mitosis Modulators|mitosis modulators|mesh-ancestor
101285433|NCT01935492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285434|NCT01935492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101285435|NCT01935492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101285436|NCT01935492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101285437|NCT01935492|Growth Substances|growth substances|mesh-ancestor
101285438|NCT01935492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285439|NCT01935492|Growth Inhibitors|growth inhibitors|mesh-ancestor
101285440|NCT01935492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101285441|NCT01935492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101285442|NCT01935492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101285443|NCT01935492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101285444|NCT01935492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101285445|NCT01935492|Antimetabolites|antimetabolites|mesh-ancestor
101285448|NCT01935505|Varenicline|varenicline|mesh-list
101285449|NCT01935505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101285450|NCT01935505|Autonomic Agents|autonomic agents|mesh-ancestor
101285451|NCT01935505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101285452|NCT01935505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285453|NCT01935505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101285454|NCT01935505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101285455|NCT01935505|Cholinergic Agents|cholinergic agents|mesh-ancestor
101285456|NCT01935505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101285457|NCT01935505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285458|NCT01935505|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101285459|NCT01935505|Antidepressive Agents|antidepressive agents|mesh-ancestor
101285460|NCT01935505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101819877|NCT01023867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101819878|NCT01023867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819879|NCT01023867|Nootropic Agents|nootropic agents|mesh-ancestor
101819880|NCT00820469|Rituximab|rituximab|mesh-list
101819881|NCT00820469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101819882|NCT00820469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101819883|NCT00820469|Immunologic Factors|immunologic factors|mesh-ancestor
101819884|NCT00820469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819885|NCT00820469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101819886|NCT00815399|Metformin|metformin|mesh-list
101819887|NCT00815399|Pioglitazone|pioglitazone|mesh-list
101819888|NCT00815399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101819889|NCT00815399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819890|NCT00644969|Varenicline|varenicline|mesh-list
101819891|NCT00644969|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101819892|NCT00644969|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101819893|NCT00644969|Cholinergic Agents|cholinergic agents|mesh-ancestor
101285461|NCT01935505|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101285462|NCT01935505|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101285463|NCT01935505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101285464|NCT01935505|Dopamine Agents|dopamine agents|mesh-ancestor
101285465|NCT01935505|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101285466|NCT01935505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101285467|NCT01935505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101285468|NCT01935518|Fasudil|fasudil|mesh-list
101285469|NCT01935518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101285471|NCT01935518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285472|NCT01935518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101285473|NCT01935518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285475|NCT01935518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101285476|NCT01935518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101285478|NCT01935531|Hyaluronic Acid|hyaluronic acid|mesh-list
101285479|NCT01935531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101285480|NCT01935531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101285481|NCT01935531|Analgesics|analgesics|mesh-ancestor
101285482|NCT01935531|Sensory System Agents|sensory system agents|mesh-ancestor
101285483|NCT01935531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101285484|NCT01935531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285485|NCT01935531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101285486|NCT01935531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101285487|NCT01935531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101285488|NCT01935531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101285489|NCT01935531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285490|NCT01935531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101285492|NCT01935531|Viscosupplements|viscosupplements|mesh-ancestor
101285493|NCT01935531|Protective Agents|protective agents|mesh-ancestor
101285494|NCT01935544|Botulinum Toxins|botulinum toxins|mesh-list
101285495|NCT01935544|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101285496|NCT01935544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101819894|NCT00644969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101819895|NCT00644969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819896|NCT00644969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819897|NCT00812435|Eptifibatide|eptifibatide|mesh-list
101819898|NCT00812435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101819899|NCT00812513|Becaplermin|becaplermin|mesh-list
101819900|NCT00812513|Anticoagulants|anticoagulants|mesh-ancestor
101819901|NCT00812513|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
101819902|NCT00812513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101819903|NCT00812513|Growth Substances|growth substances|mesh-ancestor
101285497|NCT01935544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285498|NCT01935544|Cholinergic Agents|cholinergic agents|mesh-ancestor
101285499|NCT01935544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101285500|NCT01935544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285501|NCT01935557|Heparin|heparin|mesh-list
101285502|NCT01935557|Calcium heparin|calcium heparin|mesh-list
101285503|NCT01935557|Anticoagulants|anticoagulants|mesh-ancestor
101285505|NCT01935557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101285506|NCT01935557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285507|NCT01935596|Ropivacaine|ropivacaine|mesh-list
101285508|NCT01935596|Levobupivacaine|levobupivacaine|mesh-list
101285509|NCT01935596|Anesthetics, Local|anesthetics, local|mesh-ancestor
101285510|NCT01935596|Anesthetics|anesthetics|mesh-ancestor
101285511|NCT01935596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101285512|NCT01935596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285513|NCT01935596|Sensory System Agents|sensory system agents|mesh-ancestor
101285514|NCT01935596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101285515|NCT01935648|Ropivacaine|ropivacaine|mesh-list
101285516|NCT01935648|Anesthetics, Local|anesthetics, local|mesh-ancestor
101285517|NCT01935648|Anesthetics|anesthetics|mesh-ancestor
101285518|NCT01935648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101285519|NCT01935648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285520|NCT01935648|Sensory System Agents|sensory system agents|mesh-ancestor
101285521|NCT01935648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101285522|NCT01935674|Ritonavir|ritonavir|mesh-list
101285523|NCT01935674|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101285524|NCT01935674|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101285525|NCT01935674|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101285526|NCT01935674|Protease Inhibitors|protease inhibitors|mesh-ancestor
101285527|NCT01935674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101285528|NCT01935674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285529|NCT01935674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101285530|NCT01935674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101285531|NCT01935674|Antiviral Agents|antiviral agents|mesh-ancestor
101285532|NCT01935674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101285533|NCT01935674|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101285534|NCT01935674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101285535|NCT01935674|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101285536|NCT01935674|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101285537|NCT01935674|Antimetabolites|antimetabolites|mesh-ancestor
101285538|NCT01935674|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101285539|NCT01935674|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101285540|NCT01935713|Nicotine|nicotine|mesh-list
101285541|NCT01935713|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101285542|NCT01935713|Autonomic Agents|autonomic agents|mesh-ancestor
101285543|NCT01935713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101285544|NCT01935713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285545|NCT01935713|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101285546|NCT01935713|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101285547|NCT01935713|Cholinergic Agents|cholinergic agents|mesh-ancestor
101285548|NCT01935713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101285549|NCT01935713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285550|NCT01935804|Metformin|metformin|mesh-list
101285551|NCT01935804|Pioglitazone|pioglitazone|mesh-list
101819904|NCT00812513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819905|NCT00820547|Cyclophosphamide|cyclophosphamide|mesh-list
101819906|NCT00820547|Bevacizumab|bevacizumab|mesh-list
101819907|NCT00820547|Docetaxel|docetaxel|mesh-list
101819908|NCT00820547|Fluorouracil|fluorouracil|mesh-list
101819909|NCT00820547|Epirubicin|epirubicin|mesh-list
101819910|NCT00820547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101819911|NCT00820547|Immunologic Factors|immunologic factors|mesh-ancestor
101819912|NCT00820547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285552|NCT01935804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101285553|NCT01935804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285554|NCT01935817|Vitamin E|vitamin e|mesh-list
101285555|NCT01935817|Silybin|silybin|mesh-list
101285556|NCT01935817|Vitamins|vitamins|mesh-ancestor
101285557|NCT01935817|Micronutrients|micronutrients|mesh-ancestor
101285558|NCT01935817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285559|NCT01935817|Antioxidants|antioxidants|mesh-ancestor
101285560|NCT01935817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285561|NCT01935817|Protective Agents|protective agents|mesh-ancestor
101285562|NCT01935817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101285563|NCT01935817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101285564|NCT01935830|Ritonavir|ritonavir|mesh-list
101285565|NCT01935830|Efavirenz|efavirenz|mesh-list
101285566|NCT01935830|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101285567|NCT01935830|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101285568|NCT01935830|Protease Inhibitors|protease inhibitors|mesh-ancestor
101285569|NCT01935830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101285570|NCT01935830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285571|NCT01935830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101285572|NCT01935830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101285573|NCT01935830|Antiviral Agents|antiviral agents|mesh-ancestor
101285574|NCT01935830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101285575|NCT01935830|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101285576|NCT01935830|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101285577|NCT01935830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101285578|NCT01935830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101285579|NCT01935830|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101285580|NCT01935830|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101285581|NCT01935830|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101285582|NCT01935830|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101285583|NCT01935830|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101285584|NCT01935869|Petrolatum|petrolatum|mesh-list
101285585|NCT01935869|Emollients|emollients|mesh-ancestor
101285586|NCT01935869|Dermatologic Agents|dermatologic agents|mesh-ancestor
101285587|NCT01935882|Lumefantrine|lumefantrine|mesh-list
101285588|NCT01935882|Artemether|artemether|mesh-list
101285589|NCT01935882|Primaquine|primaquine|mesh-list
101285590|NCT01935882|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101285591|NCT01935882|Antimalarials|antimalarials|mesh-ancestor
101315733|NCT04544683|Protease Inhibitors|protease inhibitors|mesh-ancestor
101285594|NCT01935882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101285596|NCT01935908|Anticonvulsants|anticonvulsants|mesh-ancestor
101285597|NCT01935908|Nootropic Agents|nootropic agents|mesh-ancestor
101285598|NCT01935973|Trametinib|trametinib|mesh-list
101285599|NCT01935973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101285600|NCT01935973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101285601|NCT01935973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101285602|NCT01935973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285603|NCT01936012|Lisinopril|lisinopril|mesh-list
101285604|NCT01936012|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101285605|NCT01936012|Protease Inhibitors|protease inhibitors|mesh-ancestor
101285606|NCT01936012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101285607|NCT01936012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285608|NCT01936012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101285609|NCT01936012|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101285610|NCT01936012|Protective Agents|protective agents|mesh-ancestor
101819913|NCT00820547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101819914|NCT00820547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101819915|NCT00820547|Alkylating Agents|alkylating agents|mesh-ancestor
101819916|NCT00820547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819917|NCT00820547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101819918|NCT00820547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101819919|NCT00820547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101819920|NCT00820547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101285611|NCT01936012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285612|NCT01936025|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101285613|NCT01936025|Dextromethorphan|dextromethorphan|mesh-list
101285614|NCT01936025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101285615|NCT01936025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285616|NCT01936025|Incretins|incretins|mesh-ancestor
101285618|NCT01936025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101285619|NCT01936025|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101285620|NCT01936025|Protease Inhibitors|protease inhibitors|mesh-ancestor
101285621|NCT01936025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101285622|NCT01936025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285623|NCT01936025|Antitussive Agents|antitussive agents|mesh-ancestor
101285624|NCT01936025|Respiratory System Agents|respiratory system agents|mesh-ancestor
101285625|NCT01936025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101285626|NCT01936025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101285627|NCT01936025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101285628|NCT01936064|Cyclophosphamide|cyclophosphamide|mesh-list
101285629|NCT01936064|Epirubicin|epirubicin|mesh-list
101285630|NCT01936064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101285631|NCT01936064|Immunologic Factors|immunologic factors|mesh-ancestor
101285632|NCT01936064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285633|NCT01936064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101285634|NCT01936064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101285635|NCT01936064|Alkylating Agents|alkylating agents|mesh-ancestor
101285636|NCT01936064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285637|NCT01936064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101285638|NCT01936064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101285639|NCT01936064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101285640|NCT01936064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101285641|NCT01936064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101285642|NCT01936064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101285643|NCT01936090|Bortezomib|bortezomib|mesh-list
101285644|NCT01936090|Melphalan|melphalan|mesh-list
101285645|NCT01936090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101285646|NCT01936090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101285647|NCT01936090|Alkylating Agents|alkylating agents|mesh-ancestor
101285648|NCT01936090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285649|NCT01936090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101285650|NCT01936090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101285651|NCT01936090|Immunologic Factors|immunologic factors|mesh-ancestor
101285652|NCT01936090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285653|NCT01936103|Atorvastatin|atorvastatin|mesh-list
101285654|NCT01936103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101285655|NCT01936103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101285656|NCT01936103|Antimetabolites|antimetabolites|mesh-ancestor
101285657|NCT01936103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285658|NCT01936103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101285659|NCT01936103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101285660|NCT01936103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101285661|NCT01936129|Glatiramer Acetate|glatiramer acetate|mesh-list
101285662|NCT01936129|(T,G)-A-L|(t,g)-a-l|mesh-list
101285663|NCT01936129|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101285664|NCT01936129|Immunologic Factors|immunologic factors|mesh-ancestor
101285665|NCT01936129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285666|NCT01936129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101285667|NCT01936129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101819921|NCT00820547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101819922|NCT00820547|Growth Substances|growth substances|mesh-ancestor
101819923|NCT00820547|Growth Inhibitors|growth inhibitors|mesh-ancestor
101819924|NCT00820547|Tubulin Modulators|tubulin modulators|mesh-ancestor
101819925|NCT00820547|Antimitotic Agents|antimitotic agents|mesh-ancestor
101819926|NCT00820547|Mitosis Modulators|mitosis modulators|mesh-ancestor
101819927|NCT00820547|Antimetabolites|antimetabolites|mesh-ancestor
101819928|NCT00820547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101819929|NCT00820547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101819930|NCT00820547|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101819931|NCT00820547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101819932|NCT00820547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101819933|NCT00815867|Epoetin Alfa|epoetin alfa|mesh-list
101819934|NCT00815867|Hematinics|hematinics|mesh-ancestor
101285668|NCT01936220|Antipsychotic Agents|antipsychotic agents|mesh-list
101285669|NCT01936220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101285670|NCT01936220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101285671|NCT01936220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285672|NCT01936220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101285673|NCT01936233|Aspirin|aspirin|mesh-list
101285674|NCT01936233|Lamivudine|lamivudine|mesh-list
101285675|NCT01936233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101285676|NCT01936233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101285677|NCT01936233|Analgesics|analgesics|mesh-ancestor
101285678|NCT01936233|Sensory System Agents|sensory system agents|mesh-ancestor
101285679|NCT01936233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101285680|NCT01936233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285681|NCT01936233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101285682|NCT01936233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101285683|NCT01936233|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101285684|NCT01936233|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101285685|NCT01936233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285686|NCT01936233|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101285687|NCT01936233|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101285688|NCT01936233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101285689|NCT01936233|Antipyretics|antipyretics|mesh-ancestor
101285690|NCT01936233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101285691|NCT01936233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101285692|NCT01936233|Antiviral Agents|antiviral agents|mesh-ancestor
101285693|NCT01936233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101285694|NCT01936233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101285695|NCT01936233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101285696|NCT01936285|Colchicine|colchicine|mesh-list
101285697|NCT01936285|Gout Suppressants|gout suppressants|mesh-ancestor
101285698|NCT01936285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101285699|NCT01936285|Tubulin Modulators|tubulin modulators|mesh-ancestor
101285700|NCT01936285|Antimitotic Agents|antimitotic agents|mesh-ancestor
101285701|NCT01936285|Mitosis Modulators|mitosis modulators|mesh-ancestor
101285702|NCT01936285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285703|NCT01936285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101285704|NCT01936350|Sildenafil Citrate|sildenafil citrate|mesh-list
101285705|NCT01936350|Vasodilator Agents|vasodilator agents|mesh-ancestor
101285706|NCT01936350|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101285707|NCT01936350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101285708|NCT01936350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101285709|NCT01936350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285710|NCT01936350|Urological Agents|urological agents|mesh-ancestor
101285711|NCT01936545|Propofol|propofol|mesh-list
101285712|NCT01936545|Desflurane|desflurane|mesh-list
101285713|NCT01936545|Liver Extracts|liver extracts|mesh-list
101819935|NCT00815945|Carboplatin|carboplatin|mesh-list
101819936|NCT00815945|Doxorubicin|doxorubicin|mesh-list
101819937|NCT00815945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101819938|NCT00815945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101819939|NCT00815945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101819940|NCT00815945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101819941|NCT00815945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312495|NCT00006367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101819942|NCT00815945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819943|NCT00812825|Prednisolone|prednisolone|mesh-list
101819944|NCT00812825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101819945|NCT00812825|Glucocorticoids|glucocorticoids|mesh-ancestor
101819946|NCT00812825|Hormones|hormones|mesh-ancestor
101285714|NCT01936545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101285715|NCT01936545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101285716|NCT01936545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285718|NCT01936545|Anesthetics, General|anesthetics, general|mesh-ancestor
101285719|NCT01936545|Anesthetics|anesthetics|mesh-ancestor
101285720|NCT01936545|Hematinics|hematinics|mesh-ancestor
101285721|NCT01936545|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101285722|NCT01936636|Fentanyl|fentanyl|mesh-list
101285723|NCT01936636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101285724|NCT01936636|Narcotics|narcotics|mesh-ancestor
101285725|NCT01936636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101285726|NCT01936636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285727|NCT01936636|Analgesics|analgesics|mesh-ancestor
101285728|NCT01936636|Sensory System Agents|sensory system agents|mesh-ancestor
101285729|NCT01936636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101285730|NCT01936636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101285731|NCT01936636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101285732|NCT01936636|Anesthetics, General|anesthetics, general|mesh-ancestor
101285733|NCT01936636|Anesthetics|anesthetics|mesh-ancestor
101285734|NCT01936805|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101285735|NCT01936805|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101285736|NCT01936805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101285737|NCT01936805|Antimetabolites|antimetabolites|mesh-ancestor
101285738|NCT01936805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285739|NCT01936805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101285740|NCT01936805|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101285741|NCT01936805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101285742|NCT01936961|Antibodies|antibodies|mesh-list
101285743|NCT01936961|Immunologic Factors|immunologic factors|mesh-ancestor
101285744|NCT01936961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285745|NCT01937013|Oxytocin|oxytocin|mesh-list
101285746|NCT01937013|Oxytocics|oxytocics|mesh-ancestor
101285747|NCT01937013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101285748|NCT01937013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285749|NCT01937078|Famotidine|famotidine|mesh-list
101285750|NCT01937078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101285751|NCT01937078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101285752|NCT01937078|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101285753|NCT01937078|Histamine Antagonists|histamine antagonists|mesh-ancestor
101285754|NCT01937078|Histamine Agents|histamine agents|mesh-ancestor
101285755|NCT01937078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101285756|NCT01937078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285757|NCT01937078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285758|NCT01937104|Remifentanil|remifentanil|mesh-list
101285759|NCT01937104|Desflurane|desflurane|mesh-list
101285760|NCT01937104|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101285761|NCT01937104|Narcotics|narcotics|mesh-ancestor
101285762|NCT01937104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101285763|NCT01937104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285764|NCT01937104|Analgesics|analgesics|mesh-ancestor
101819947|NCT00812825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101819948|NCT00812825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819949|NCT00812825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101819950|NCT00812825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101819951|NCT00628355|Lidocaine|lidocaine|mesh-list
101819952|NCT00628355|Anesthetics, Local|anesthetics, local|mesh-ancestor
101819953|NCT00628355|Anesthetics|anesthetics|mesh-ancestor
101819954|NCT00628355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101819955|NCT00628355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819956|NCT00628355|Sensory System Agents|sensory system agents|mesh-ancestor
101819957|NCT00628355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101819958|NCT00628355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101819959|NCT00628355|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101819960|NCT00628355|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101285765|NCT01937104|Sensory System Agents|sensory system agents|mesh-ancestor
101285766|NCT01937104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101285767|NCT01937104|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101285768|NCT01937104|Anesthetics, General|anesthetics, general|mesh-ancestor
101285769|NCT01937104|Anesthetics|anesthetics|mesh-ancestor
101285770|NCT01937169|Levodopa|levodopa|mesh-list
101285771|NCT01937169|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101285772|NCT01937169|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101285773|NCT01937169|Dopamine Agents|dopamine agents|mesh-ancestor
101285774|NCT01937169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101285775|NCT01937169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285776|NCT01937169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285778|NCT01937182|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
101285779|NCT01937182|Serotonin|serotonin|mesh-list
101315785|NCT00390208|Dexamethasone|dexamethasone|mesh-list
101285780|NCT01937182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101285781|NCT01937182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101285782|NCT01937182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285783|NCT01937182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101285784|NCT01937182|Serotonin Agents|serotonin agents|mesh-ancestor
101285785|NCT01937182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285786|NCT01937182|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101285787|NCT01937182|Antidepressive Agents|antidepressive agents|mesh-ancestor
101285788|NCT01937182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101285789|NCT01937182|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101285790|NCT01937234|Metoclopramide|metoclopramide|mesh-list
101285791|NCT01937234|Antiemetics|antiemetics|mesh-ancestor
101285792|NCT01937234|Autonomic Agents|autonomic agents|mesh-ancestor
101285793|NCT01937234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101285794|NCT01937234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285795|NCT01937234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101285796|NCT01937234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101285797|NCT01937234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101285798|NCT01937234|Dopamine Agents|dopamine agents|mesh-ancestor
101285799|NCT01937234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101285800|NCT01937234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285802|NCT01937325|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101285803|NCT01937325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101285804|NCT01937325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285806|NCT01937338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101285807|NCT01937338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101285808|NCT01937338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819961|NCT00628355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101819962|NCT00628355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819963|NCT00647699|Riboflavin|riboflavin|mesh-list
101819964|NCT00647699|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101819965|NCT00647699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101819966|NCT00647699|Vitamin B Complex|vitamin b complex|mesh-ancestor
101819967|NCT00647699|Vitamins|vitamins|mesh-ancestor
101819968|NCT00647699|Micronutrients|micronutrients|mesh-ancestor
101819969|NCT00647699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285809|NCT01937442|Thalidomide|thalidomide|mesh-list
101285810|NCT01937442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101285811|NCT01937442|Immunologic Factors|immunologic factors|mesh-ancestor
101285812|NCT01937442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285813|NCT01937442|Leprostatic Agents|leprostatic agents|mesh-ancestor
101285814|NCT01937442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101285815|NCT01937442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101285816|NCT01937442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101285817|NCT01937442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101285818|NCT01937442|Growth Substances|growth substances|mesh-ancestor
101285819|NCT01937442|Growth Inhibitors|growth inhibitors|mesh-ancestor
101285820|NCT01937442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101285821|NCT01937494|Benzyl Alcohol|benzyl alcohol|mesh-list
101285822|NCT01937494|Histamine|histamine|mesh-list
101285823|NCT01937494|Histamine Agonists|histamine agonists|mesh-ancestor
101285824|NCT01937494|Histamine Agents|histamine agents|mesh-ancestor
101285825|NCT01937494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101285826|NCT01937494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285827|NCT01937494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285828|NCT01937494|Anesthetics, Local|anesthetics, local|mesh-ancestor
101285829|NCT01937494|Anesthetics|anesthetics|mesh-ancestor
101285830|NCT01937494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101285831|NCT01937494|Sensory System Agents|sensory system agents|mesh-ancestor
101285832|NCT01937494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101285834|NCT01937611|Dexmedetomidine|dexmedetomidine|mesh-list
101285835|NCT01937611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101285836|NCT01937611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101285837|NCT01937611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285838|NCT01937611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101285839|NCT01937611|Analgesics|analgesics|mesh-ancestor
101285840|NCT01937611|Sensory System Agents|sensory system agents|mesh-ancestor
101285841|NCT01937611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101285842|NCT01937611|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101285843|NCT01937611|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101285844|NCT01937611|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101285845|NCT01937611|Adrenergic Agents|adrenergic agents|mesh-ancestor
101285846|NCT01937611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101285847|NCT01937611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285848|NCT01937611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101315789|NCT00390208|Antiemetics|antiemetics|mesh-ancestor
101285849|NCT01937611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101285850|NCT01937611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101285851|NCT01937611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101285852|NCT01937611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101285853|NCT01937611|Anesthetics, General|anesthetics, general|mesh-ancestor
101285854|NCT01937611|Anesthetics|anesthetics|mesh-ancestor
101285855|NCT01937611|GABA Modulators|gaba modulators|mesh-ancestor
101285856|NCT01937611|GABA Agents|gaba agents|mesh-ancestor
101285857|NCT01937650|Metronidazole|metronidazole|mesh-list
101285858|NCT01937650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101285859|NCT01937650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101285860|NCT01937650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101285861|NCT01937650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101285863|NCT01937728|Ribavirin|ribavirin|mesh-list
101285864|NCT01937728|Interferon-alpha|interferon-alpha|mesh-list
101285865|NCT01937728|Interferon alpha-2|interferon alpha-2|mesh-list
101285866|NCT01937728|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101819970|NCT00647699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101819971|NCT00647699|Dermatologic Agents|dermatologic agents|mesh-ancestor
101819972|NCT00813059|Bevacizumab|bevacizumab|mesh-list
101819973|NCT00813059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101819974|NCT00813059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101819975|NCT00813059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101819976|NCT00813059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101819977|NCT00813059|Growth Substances|growth substances|mesh-ancestor
101819978|NCT00813059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819979|NCT00813059|Growth Inhibitors|growth inhibitors|mesh-ancestor
101819981|NCT00467649|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101819983|NCT00467649|Insulin Aspart|insulin aspart|mesh-list
101819984|NCT00467649|Insulin Lispro|insulin lispro|mesh-list
101819985|NCT00467649|Insulin Detemir|insulin detemir|mesh-list
101819986|NCT00467649|Insulin glulisine|insulin glulisine|mesh-list
101819987|NCT00467649|Pramlintide|pramlintide|mesh-list
101819988|NCT00467649|Insulin, Short-Acting|insulin, short-acting|mesh-list
101819989|NCT00467649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101819990|NCT00467649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819991|NCT01023945|Ipragliflozin|ipragliflozin|mesh-list
101819992|NCT01023945|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101819993|NCT01023945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101819994|NCT01023945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101285867|NCT01937728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101285868|NCT01937728|Antiviral Agents|antiviral agents|mesh-ancestor
101285869|NCT01937728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101285870|NCT01937728|Antimetabolites|antimetabolites|mesh-ancestor
101285871|NCT01937728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285872|NCT01937728|Immunologic Factors|immunologic factors|mesh-ancestor
101285873|NCT01937728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285874|NCT01937754|Nitric Oxide|nitric oxide|mesh-list
101285875|NCT01937754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101285876|NCT01937754|Autonomic Agents|autonomic agents|mesh-ancestor
101285877|NCT01937754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101285878|NCT01937754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285879|NCT01937754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101285880|NCT01937754|Respiratory System Agents|respiratory system agents|mesh-ancestor
101285881|NCT01937754|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101285882|NCT01937754|Antioxidants|antioxidants|mesh-ancestor
101285883|NCT01937754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285884|NCT01937754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101285885|NCT01937754|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101285886|NCT01937754|Vasodilator Agents|vasodilator agents|mesh-ancestor
101285887|NCT01937754|Gasotransmitters|gasotransmitters|mesh-ancestor
101285888|NCT01937754|Protective Agents|protective agents|mesh-ancestor
101285890|NCT01937767|Remifentanil|remifentanil|mesh-list
101285891|NCT01937767|Propofol|propofol|mesh-list
101285892|NCT01937767|Sevoflurane|sevoflurane|mesh-list
101285893|NCT01937767|Rocuronium|rocuronium|mesh-list
101285894|NCT01937767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101285895|NCT01937767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101285896|NCT01937767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819995|NCT01023945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101819996|NCT00450333|Epoetin Alfa|epoetin alfa|mesh-list
101819997|NCT00450333|Hematinics|hematinics|mesh-ancestor
101819998|NCT00643565|Bevacizumab|bevacizumab|mesh-list
101819999|NCT00643565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101285897|NCT01937767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101285898|NCT01937767|Anesthetics, General|anesthetics, general|mesh-ancestor
101285899|NCT01937767|Anesthetics|anesthetics|mesh-ancestor
101285900|NCT01937767|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101285901|NCT01937767|Narcotics|narcotics|mesh-ancestor
101285903|NCT01937767|Sensory System Agents|sensory system agents|mesh-ancestor
101285904|NCT01937767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101285905|NCT01937767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101285906|NCT01937767|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101285907|NCT01937767|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101285908|NCT01937767|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101285909|NCT01937767|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101285910|NCT01937767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101285911|NCT01937806|Tenofovir|tenofovir|mesh-list
101285913|NCT01937806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101285914|NCT01937806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101285915|NCT01937806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101285916|NCT01937806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101285917|NCT01937806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285918|NCT01937806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101285919|NCT01937806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101285920|NCT01937832|Ertapenem|ertapenem|mesh-list
101285921|NCT01937832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101285922|NCT01937832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101285923|NCT01938092|Diazepam|diazepam|mesh-list
101285924|NCT01938092|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101285925|NCT01938092|Anticonvulsants|anticonvulsants|mesh-ancestor
101285926|NCT01938092|Antiemetics|antiemetics|mesh-ancestor
101285927|NCT01938092|Autonomic Agents|autonomic agents|mesh-ancestor
101285928|NCT01938092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101285929|NCT01938092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285930|NCT01938092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101285931|NCT01938092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101285932|NCT01938092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101285933|NCT01938092|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101285934|NCT01938092|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101285935|NCT01938092|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101285936|NCT01938092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101285937|NCT01938092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101285938|NCT01938092|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101285939|NCT01938092|Anesthetics, General|anesthetics, general|mesh-ancestor
101285940|NCT01938092|Anesthetics|anesthetics|mesh-ancestor
101285941|NCT01938092|GABA Modulators|gaba modulators|mesh-ancestor
101285942|NCT01938092|GABA Agents|gaba agents|mesh-ancestor
101285943|NCT01938092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101285944|NCT01938092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285945|NCT01938105|Nimotuzumab|nimotuzumab|mesh-list
101285946|NCT01938105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101285947|NCT01938105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101285948|NCT01938144|Acetaminophen|acetaminophen|mesh-list
101285949|NCT01938144|Ibuprofen|ibuprofen|mesh-list
101285950|NCT01938144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101285951|NCT01938144|Analgesics|analgesics|mesh-ancestor
101285952|NCT01938144|Sensory System Agents|sensory system agents|mesh-ancestor
101285953|NCT01938144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101285954|NCT01938144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285955|NCT01938144|Antipyretics|antipyretics|mesh-ancestor
101285956|NCT01938144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101285957|NCT01938144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101285958|NCT01938144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101285959|NCT01938144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101285960|NCT01938144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101285961|NCT01938144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285962|NCT01938183|Metronidazole|metronidazole|mesh-list
101285963|NCT01938183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101820000|NCT00643565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101820001|NCT00643565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101820002|NCT00643565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101820003|NCT00643565|Growth Substances|growth substances|mesh-ancestor
101820004|NCT00643565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820005|NCT00643565|Growth Inhibitors|growth inhibitors|mesh-ancestor
101285964|NCT01938183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101285965|NCT01938183|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101285966|NCT01938183|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101285967|NCT01938235|Exenatide|exenatide|mesh-list
101285968|NCT01938235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101285969|NCT01938235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285970|NCT01938235|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101285971|NCT01938235|Incretins|incretins|mesh-ancestor
101285972|NCT01938235|Hormones|hormones|mesh-ancestor
101285973|NCT01938235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101285974|NCT01938300|Magnesium Sulfate|magnesium sulfate|mesh-list
101285975|NCT01938300|Analgesics|analgesics|mesh-ancestor
101285976|NCT01938300|Sensory System Agents|sensory system agents|mesh-ancestor
101285977|NCT01938300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101285978|NCT01938300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101285979|NCT01938300|Anesthetics|anesthetics|mesh-ancestor
101285980|NCT01938300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101285981|NCT01938300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101285982|NCT01938300|Anticonvulsants|anticonvulsants|mesh-ancestor
101285983|NCT01938300|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101285984|NCT01938300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101285985|NCT01938300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285986|NCT01938300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101285987|NCT01938300|Tocolytic Agents|tocolytic agents|mesh-ancestor
101285988|NCT01938300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101285989|NCT01938417|Tobramycin|tobramycin|mesh-list
101285990|NCT01938417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101285991|NCT01938417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101285992|NCT01938443|Trametinib|trametinib|mesh-list
101285993|NCT01938443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101285994|NCT01938443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101285995|NCT01938443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101285996|NCT01938443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285997|NCT01938456|Docetaxel|docetaxel|mesh-list
101285998|NCT01938456|Trametinib|trametinib|mesh-list
101285999|NCT01938456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101286000|NCT01938456|Tubulin Modulators|tubulin modulators|mesh-ancestor
101286001|NCT01938456|Antimitotic Agents|antimitotic agents|mesh-ancestor
101286002|NCT01938456|Mitosis Modulators|mitosis modulators|mesh-ancestor
101286003|NCT01938456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286004|NCT01938456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101286005|NCT01938456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101286006|NCT01938508|Minocycline|minocycline|mesh-list
101286007|NCT01938508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101286008|NCT01938508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101286009|NCT01938612|Durvalumab|durvalumab|mesh-list
101286010|NCT01938612|Tremelimumab|tremelimumab|mesh-list
101286011|NCT01938612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101286012|NCT01938612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101286013|NCT01938729|Dexamethasone|dexamethasone|mesh-list
101286014|NCT01938729|Gemcitabine|gemcitabine|mesh-list
101286015|NCT01938729|Floxuridine|floxuridine|mesh-list
101286016|NCT01938729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101286017|NCT01938729|Antiemetics|antiemetics|mesh-ancestor
101286018|NCT01938729|Autonomic Agents|autonomic agents|mesh-ancestor
101286019|NCT01938729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101286020|NCT01938729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286021|NCT01938729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101286022|NCT01938729|Glucocorticoids|glucocorticoids|mesh-ancestor
101286023|NCT01938729|Hormones|hormones|mesh-ancestor
101286024|NCT01938729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101286025|NCT01938729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101286026|NCT01938729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101820006|NCT00450255|Aflibercept|aflibercept|mesh-list
101820007|NCT00450255|Endothelial Growth Factors|endothelial growth factors|mesh-list
101820008|NCT00450255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101820009|NCT00450255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101820010|NCT00450255|Growth Substances|growth substances|mesh-ancestor
101312499|NCT00006370|Edotreotide|edotreotide|mesh-list
101286027|NCT01938729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101286028|NCT01938729|Antimetabolites|antimetabolites|mesh-ancestor
101286029|NCT01938729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286030|NCT01938755|Levobupivacaine|levobupivacaine|mesh-list
101286031|NCT01938755|Anesthetics, Local|anesthetics, local|mesh-ancestor
101286032|NCT01938755|Anesthetics|anesthetics|mesh-ancestor
101286033|NCT01938755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101286034|NCT01938755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286035|NCT01938755|Sensory System Agents|sensory system agents|mesh-ancestor
101286036|NCT01938755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101286037|NCT01938781|Entecavir|entecavir|mesh-list
101286038|NCT01938781|Antiviral Agents|antiviral agents|mesh-ancestor
101286039|NCT01938781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101286040|NCT01938820|Entecavir|entecavir|mesh-list
101286041|NCT01938820|Antiviral Agents|antiviral agents|mesh-ancestor
101286042|NCT01938820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101286043|NCT01938859|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101286045|NCT01938859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101286046|NCT01938859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101286047|NCT01938859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101286048|NCT01938859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101286049|NCT01938859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286050|NCT01938872|Paclitaxel|paclitaxel|mesh-list
101286051|NCT01938872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101286052|NCT01938872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101286053|NCT01938872|Tubulin Modulators|tubulin modulators|mesh-ancestor
101286054|NCT01938872|Antimitotic Agents|antimitotic agents|mesh-ancestor
101286055|NCT01938872|Mitosis Modulators|mitosis modulators|mesh-ancestor
101286056|NCT01938872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286057|NCT01938911|Oxytocin|oxytocin|mesh-list
101286058|NCT01938911|Oxytocics|oxytocics|mesh-ancestor
101286059|NCT01938911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101286060|NCT01938911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286061|NCT01939054|Docetaxel|docetaxel|mesh-list
101286062|NCT01939054|Capecitabine|capecitabine|mesh-list
101286063|NCT01939054|Nimotuzumab|nimotuzumab|mesh-list
101286064|NCT01939054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101286065|NCT01939054|Tubulin Modulators|tubulin modulators|mesh-ancestor
101286066|NCT01939054|Antimitotic Agents|antimitotic agents|mesh-ancestor
101286067|NCT01939054|Mitosis Modulators|mitosis modulators|mesh-ancestor
101286068|NCT01939054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286069|NCT01939054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101286070|NCT01939054|Antimetabolites|antimetabolites|mesh-ancestor
101286071|NCT01939054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101286072|NCT01939093|Thiamine|thiamine|mesh-list
101286073|NCT01939093|Cinnarizine|cinnarizine|mesh-list
101286074|NCT01939093|Diazepam|diazepam|mesh-list
101286075|NCT01939093|Vitamins|vitamins|mesh-ancestor
101286076|NCT01939093|Micronutrients|micronutrients|mesh-ancestor
101286077|NCT01939093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286078|NCT01939093|Vitamin B Complex|vitamin b complex|mesh-ancestor
101286079|NCT01939093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101286080|NCT01939093|Anticonvulsants|anticonvulsants|mesh-ancestor
101286081|NCT01939093|Antiemetics|antiemetics|mesh-ancestor
101286082|NCT01939093|Autonomic Agents|autonomic agents|mesh-ancestor
101286083|NCT01939093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101286084|NCT01939093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101286085|NCT01939093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101286086|NCT01939093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101286087|NCT01939093|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101286088|NCT01939093|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101286089|NCT01939093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101315904|NCT00000681|Zidovudine|zidovudine|mesh-list
101286090|NCT01939093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101286091|NCT01939093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101820011|NCT00450255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820013|NCT00450255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101820014|NCT00816335|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101820015|NCT00816335|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101820016|NCT00816335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820017|NCT00813137|Endostar protein|endostar protein|mesh-list
101286092|NCT01939093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101286093|NCT01939093|Anesthetics, General|anesthetics, general|mesh-ancestor
101286094|NCT01939093|Anesthetics|anesthetics|mesh-ancestor
101286095|NCT01939093|GABA Modulators|gaba modulators|mesh-ancestor
101286096|NCT01939093|GABA Agents|gaba agents|mesh-ancestor
101286097|NCT01939093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101286098|NCT01939093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286099|NCT01939093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101286100|NCT01939093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101286101|NCT01939093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101286102|NCT01939093|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101286103|NCT01939093|Histamine Antagonists|histamine antagonists|mesh-ancestor
101286105|NCT01939171|Thymoglobulin|thymoglobulin|mesh-list
101286106|NCT01939171|Immunologic Factors|immunologic factors|mesh-ancestor
101286107|NCT01939171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286108|NCT01939171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101286109|NCT01939327|Rituximab|rituximab|mesh-list
101286110|NCT01939327|Lenalidomide|lenalidomide|mesh-list
101286111|NCT01939327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101286112|NCT01939327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101286113|NCT01939327|Immunologic Factors|immunologic factors|mesh-ancestor
101286114|NCT01939327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286115|NCT01939327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101286116|NCT01939327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101286117|NCT01939327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101286118|NCT01939327|Growth Substances|growth substances|mesh-ancestor
101286119|NCT01939327|Growth Inhibitors|growth inhibitors|mesh-ancestor
101286120|NCT01939379|Acetaminophen|acetaminophen|mesh-list
101286121|NCT01939379|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
101286122|NCT01939379|Morphine|morphine|mesh-list
101286123|NCT01939379|Oxycodone|oxycodone|mesh-list
101286124|NCT01939379|Analgesics|analgesics|mesh-list
101286125|NCT01939379|Ropivacaine|ropivacaine|mesh-list
101286126|NCT01939379|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101286127|NCT01939379|Narcotics|narcotics|mesh-ancestor
101286128|NCT01939379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101286129|NCT01939379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286130|NCT01939379|Sensory System Agents|sensory system agents|mesh-ancestor
101286131|NCT01939379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101286132|NCT01939379|Anesthetics, Local|anesthetics, local|mesh-ancestor
101286133|NCT01939379|Anesthetics|anesthetics|mesh-ancestor
101286134|NCT01939379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101286135|NCT01939379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101286136|NCT01939379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101286137|NCT01939379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101286138|NCT01939379|Antipyretics|antipyretics|mesh-ancestor
101286139|NCT01939418|Gemcitabine|gemcitabine|mesh-list
101286140|NCT01939418|Everolimus|everolimus|mesh-list
101286141|NCT01939418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101286142|NCT01939418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101286143|NCT01939418|Antimetabolites|antimetabolites|mesh-ancestor
101286144|NCT01939418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286145|NCT01939418|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101286146|NCT01939418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101286147|NCT01939418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101286148|NCT01939418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101286149|NCT01939418|Immunologic Factors|immunologic factors|mesh-ancestor
101286150|NCT01939418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286151|NCT01939444|Naloxone|naloxone|mesh-list
101286152|NCT01939444|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101286153|NCT01939444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286154|NCT01939444|Sensory System Agents|sensory system agents|mesh-ancestor
101820019|NCT00813137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101820020|NCT00813137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101820021|NCT00813137|Growth Substances|growth substances|mesh-ancestor
101820022|NCT00813137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820023|NCT00813137|Growth Inhibitors|growth inhibitors|mesh-ancestor
101820024|NCT00813137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101820026|NCT01024179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101820027|NCT01024179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101286155|NCT01939444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101286156|NCT01939457|Misoprostol|misoprostol|mesh-list
101286157|NCT01939457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101286158|NCT01939457|Abortifacient Agents|abortifacient agents|mesh-ancestor
101286159|NCT01939457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101286160|NCT01939457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286161|NCT01939457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101286162|NCT01939457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101286163|NCT01939457|Oxytocics|oxytocics|mesh-ancestor
101286164|NCT01939483|Irinotecan|irinotecan|mesh-list
101286167|NCT01939483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101286168|NCT01939483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101286169|NCT01939483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286170|NCT01939483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101286171|NCT01939483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101286172|NCT01939509|Atenolol|atenolol|mesh-list
101286174|NCT01939509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101286175|NCT01939509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101286176|NCT01939509|Sympatholytics|sympatholytics|mesh-ancestor
101286177|NCT01939509|Autonomic Agents|autonomic agents|mesh-ancestor
101286178|NCT01939509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101286179|NCT01939509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286180|NCT01939509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101286181|NCT01939509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101286182|NCT01939509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101286183|NCT01939509|Adrenergic Agents|adrenergic agents|mesh-ancestor
101286184|NCT01939509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101286185|NCT01939509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286186|NCT01939522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101286187|NCT01939522|Immunologic Factors|immunologic factors|mesh-ancestor
101286188|NCT01939522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286189|NCT01939561|Lamotrigine|lamotrigine|mesh-list
101286190|NCT01939561|Anticonvulsants|anticonvulsants|mesh-ancestor
101286191|NCT01939561|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101286192|NCT01939561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101286193|NCT01939561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286194|NCT01939561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101286195|NCT01939561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286196|NCT01939561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101286197|NCT01939561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101286198|NCT01939561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101286199|NCT01939561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101286200|NCT01939561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101286202|NCT01939574|Temozolomide|temozolomide|mesh-list
101286203|NCT01939574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101286204|NCT01939574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101286205|NCT01939574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101286206|NCT01939574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101286207|NCT01939574|Growth Substances|growth substances|mesh-ancestor
101286208|NCT01939574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286209|NCT01939574|Growth Inhibitors|growth inhibitors|mesh-ancestor
101286210|NCT01939574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101286211|NCT01939574|Alkylating Agents|alkylating agents|mesh-ancestor
101286212|NCT01939574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820028|NCT01024179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101820029|NCT01024179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101820030|NCT01024179|Antifungal Agents|antifungal agents|mesh-ancestor
101820031|NCT01024179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101286213|NCT01939639|Oxytocin|oxytocin|mesh-list
101286214|NCT01939639|Oxytocics|oxytocics|mesh-ancestor
101286215|NCT01939639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101286216|NCT01939639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286217|NCT01939691|Prednisolone|prednisolone|mesh-list
101286218|NCT01939691|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101286219|NCT01939691|Methylprednisolone|methylprednisolone|mesh-list
101286220|NCT01939691|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101286221|NCT01939691|Prednisolone acetate|prednisolone acetate|mesh-list
101286222|NCT01939691|Nepafenac|nepafenac|mesh-list
101286223|NCT01939691|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101286224|NCT01939691|Prednisolone phosphate|prednisolone phosphate|mesh-list
101286225|NCT01939691|Difluprednate|difluprednate|mesh-list
101286226|NCT01939691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101286227|NCT01939691|Glucocorticoids|glucocorticoids|mesh-ancestor
101286228|NCT01939691|Hormones|hormones|mesh-ancestor
101286229|NCT01939691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101286230|NCT01939691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286231|NCT01939691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101286232|NCT01939691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101286233|NCT01939691|Antiemetics|antiemetics|mesh-ancestor
101286234|NCT01939691|Autonomic Agents|autonomic agents|mesh-ancestor
101286235|NCT01939691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101286236|NCT01939691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101286237|NCT01939691|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101286238|NCT01939691|Protective Agents|protective agents|mesh-ancestor
101286239|NCT01939691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101286240|NCT01939691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101286241|NCT01939691|Analgesics|analgesics|mesh-ancestor
101286242|NCT01939691|Sensory System Agents|sensory system agents|mesh-ancestor
101286243|NCT01939691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101286244|NCT01939730|Rituximab|rituximab|mesh-list
101286245|NCT01939730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101286246|NCT01939730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101286247|NCT01939730|Immunologic Factors|immunologic factors|mesh-ancestor
101286248|NCT01939730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286249|NCT01939730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101286250|NCT01939743|Diclofenac|diclofenac|mesh-list
101286251|NCT01939743|Lidocaine|lidocaine|mesh-list
101286252|NCT01939743|Anesthetics, Local|anesthetics, local|mesh-ancestor
101286253|NCT01939743|Anesthetics|anesthetics|mesh-ancestor
101286254|NCT01939743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101286255|NCT01939743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286256|NCT01939743|Sensory System Agents|sensory system agents|mesh-ancestor
101286257|NCT01939743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101286258|NCT01939743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101286259|NCT01939743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101286260|NCT01939743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101286261|NCT01939743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101316109|NCT04020172|Dobutamine|dobutamine|mesh-list
101286262|NCT01939743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286263|NCT01939743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101286264|NCT01939743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101286265|NCT01939743|Analgesics|analgesics|mesh-ancestor
101286266|NCT01939743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101286267|NCT01939743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101286268|NCT01939743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101286269|NCT01939743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101286270|NCT01939834|Insulin|insulin|mesh-list
101286271|NCT01939834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101286272|NCT01939834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286273|NCT01939886|Artesunate|artesunate|mesh-list
101286274|NCT01939886|Lumefantrine|lumefantrine|mesh-list
101286275|NCT01939886|Artemether|artemether|mesh-list
101286276|NCT01939886|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101286277|NCT01939886|Mefloquine|mefloquine|mesh-list
101286278|NCT01939886|Antimalarials|antimalarials|mesh-ancestor
101286279|NCT01939886|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101286280|NCT01939886|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101820032|NCT01024179|Immunologic Factors|immunologic factors|mesh-ancestor
101820033|NCT01024179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820034|NCT00821483|Frovatriptan|frovatriptan|mesh-list
101820035|NCT00821483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101820036|NCT00821483|Serotonin Agents|serotonin agents|mesh-ancestor
101286281|NCT01939886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101286282|NCT01939886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101286283|NCT01939886|Antiviral Agents|antiviral agents|mesh-ancestor
101286284|NCT01939886|Schistosomicides|schistosomicides|mesh-ancestor
101286285|NCT01939886|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101286286|NCT01939886|Anthelmintics|anthelmintics|mesh-ancestor
101286287|NCT01939912|Adenosine|adenosine|mesh-list
101286288|NCT01939912|Analgesics|analgesics|mesh-ancestor
101286289|NCT01939912|Sensory System Agents|sensory system agents|mesh-ancestor
101286290|NCT01939912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101286291|NCT01939912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286292|NCT01939912|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101286293|NCT01939912|Vasodilator Agents|vasodilator agents|mesh-ancestor
101286294|NCT01939912|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101286295|NCT01939912|Purinergic Agonists|purinergic agonists|mesh-ancestor
101286296|NCT01939912|Purinergic Agents|purinergic agents|mesh-ancestor
101286297|NCT01939912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101286298|NCT01939912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286299|NCT01939990|Nebivolol|nebivolol|mesh-list
101286300|NCT01939990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101286301|NCT01939990|Vasodilator Agents|vasodilator agents|mesh-ancestor
101286302|NCT01939990|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101286303|NCT01939990|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101286304|NCT01939990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101286305|NCT01939990|Adrenergic Agents|adrenergic agents|mesh-ancestor
101286306|NCT01939990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101286307|NCT01939990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286308|NCT01939990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286309|NCT01940081|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
101286310|NCT01940081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101286311|NCT01940081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101286312|NCT01940081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286313|NCT01940081|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101286314|NCT01940172|Conatumumab|conatumumab|mesh-list
101286315|NCT01940172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101286316|NCT01940172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101286317|NCT01940224|Pregabalin|pregabalin|mesh-list
101286318|NCT01940224|Morphine|morphine|mesh-list
101286319|NCT01940224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101286320|NCT01940224|Narcotics|narcotics|mesh-ancestor
101286321|NCT01940224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101286322|NCT01940224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286323|NCT01940224|Analgesics|analgesics|mesh-ancestor
101286324|NCT01940224|Sensory System Agents|sensory system agents|mesh-ancestor
101286325|NCT01940224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101286326|NCT01940224|Anticonvulsants|anticonvulsants|mesh-ancestor
101286327|NCT01940224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101286328|NCT01940224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101286329|NCT01940224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286330|NCT01940224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101286331|NCT01940224|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101286332|NCT01940224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101286333|NCT01940224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101286334|NCT01940250|Magnesium Sulfate|magnesium sulfate|mesh-list
101286335|NCT01940250|Analgesics|analgesics|mesh-ancestor
101286336|NCT01940250|Sensory System Agents|sensory system agents|mesh-ancestor
101286337|NCT01940250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101286338|NCT01940250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286339|NCT01940250|Anesthetics|anesthetics|mesh-ancestor
101286340|NCT01940250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101286341|NCT01940250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101286342|NCT01940250|Anticonvulsants|anticonvulsants|mesh-ancestor
101286343|NCT01940250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101286344|NCT01940250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101286345|NCT01940250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820037|NCT00821483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101820038|NCT00821483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820039|NCT00821483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820040|NCT02551367|Letrozole|letrozole|mesh-list
101820041|NCT02551367|Clomiphene|clomiphene|mesh-list
101820042|NCT02551367|Enclomiphene|enclomiphene|mesh-list
101820043|NCT02551367|Zuclomiphene|zuclomiphene|mesh-list
101820044|NCT02551367|Hormones|hormones|mesh-list
101286346|NCT01940250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101286347|NCT01940250|Tocolytic Agents|tocolytic agents|mesh-ancestor
101286348|NCT01940250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101286349|NCT01940393|Cetirizine|cetirizine|mesh-list
101286350|NCT01940393|Fexofenadine|fexofenadine|mesh-list
101286351|NCT01940393|Desloratadine|desloratadine|mesh-list
101286352|NCT01940393|Ebastine|ebastine|mesh-list
101286353|NCT01940393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101286354|NCT01940393|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101286355|NCT01940393|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101286356|NCT01940393|Histamine Antagonists|histamine antagonists|mesh-ancestor
101286357|NCT01940393|Histamine Agents|histamine agents|mesh-ancestor
101286358|NCT01940393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101286359|NCT01940393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286360|NCT01940393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286361|NCT01940393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101286362|NCT01940393|Cholinergic Agents|cholinergic agents|mesh-ancestor
101286363|NCT01940419|Tranexamic Acid|tranexamic acid|mesh-list
101286364|NCT01940419|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101286365|NCT01940419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101286367|NCT01940419|Hemostatics|hemostatics|mesh-ancestor
101286368|NCT01940419|Coagulants|coagulants|mesh-ancestor
101286369|NCT01940536|Tranexamic Acid|tranexamic acid|mesh-list
101286370|NCT01940536|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101286371|NCT01940536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101286372|NCT01940536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286373|NCT01940536|Hemostatics|hemostatics|mesh-ancestor
101286374|NCT01940536|Coagulants|coagulants|mesh-ancestor
101286375|NCT01940601|Lenograstim|lenograstim|mesh-list
101286376|NCT01940601|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101286377|NCT01940601|Immunologic Factors|immunologic factors|mesh-ancestor
101286378|NCT01940601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286380|NCT01940627|Coenzyme Q10|coenzyme q10|mesh-list
101286381|NCT01940627|Micronutrients|micronutrients|mesh-ancestor
101286382|NCT01940627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286383|NCT01940627|Vitamins|vitamins|mesh-ancestor
101286384|NCT01940653|Estradiol|estradiol|mesh-list
101286385|NCT01940653|Progesterone|progesterone|mesh-list
101286386|NCT01940653|Estrogens|estrogens|mesh-ancestor
101286387|NCT01940653|Hormones|hormones|mesh-ancestor
101286388|NCT01940653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101286389|NCT01940653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286391|NCT01940692|Tranexamic Acid|tranexamic acid|mesh-list
101286392|NCT01940692|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101286393|NCT01940692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101286394|NCT01940692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286395|NCT01940692|Hemostatics|hemostatics|mesh-ancestor
101286396|NCT01940692|Coagulants|coagulants|mesh-ancestor
101286397|NCT01940718|Methyltestosterone|methyltestosterone|mesh-list
101286398|NCT01940718|Testosterone|testosterone|mesh-list
101286399|NCT01940718|Testosterone undecanoate|testosterone undecanoate|mesh-list
101286401|NCT01940718|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101286402|NCT01940718|Androgens|androgens|mesh-ancestor
101286404|NCT01940718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101286405|NCT01940718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286406|NCT01940718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101286407|NCT01940718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101286408|NCT01940718|Anabolic Agents|anabolic agents|mesh-ancestor
101286409|NCT01940796|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101286410|NCT01940796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101286411|NCT01940796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101820045|NCT02551367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820046|NCT02551367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101820047|NCT02551367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820048|NCT02551367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101820049|NCT02551367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101286412|NCT01940796|Immunotoxins|immunotoxins|mesh-ancestor
101286413|NCT01940796|Immunoconjugates|immunoconjugates|mesh-ancestor
101286414|NCT01940796|Immunologic Factors|immunologic factors|mesh-ancestor
101286415|NCT01940796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286416|NCT01940952|Donepezil|donepezil|mesh-list
101286417|NCT01940952|Udenafil|udenafil|mesh-list
101286418|NCT01940952|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101286419|NCT01940952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101286420|NCT01940952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286421|NCT01940952|Cholinergic Agents|cholinergic agents|mesh-ancestor
101286422|NCT01940952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101286424|NCT01940952|Nootropic Agents|nootropic agents|mesh-ancestor
101286425|NCT01940952|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101286426|NCT01940952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101286427|NCT01940965|Lixisenatide|lixisenatide|mesh-list
101286428|NCT01940965|Biguanides|biguanides|mesh-list
101286429|NCT01940965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101286430|NCT01940965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286431|NCT01940978|Cyproheptadine|cyproheptadine|mesh-list
101286432|NCT01940978|Methylphenidate|methylphenidate|mesh-list
101286433|NCT01940978|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101286434|NCT01940978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286435|NCT01940978|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101286436|NCT01940978|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101286437|NCT01940978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101286438|NCT01940978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286439|NCT01940978|Dopamine Agents|dopamine agents|mesh-ancestor
101286440|NCT01940978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101286441|NCT01940978|Antipruritics|antipruritics|mesh-ancestor
101286442|NCT01940978|Dermatologic Agents|dermatologic agents|mesh-ancestor
101286443|NCT01940978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101286444|NCT01940978|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101286445|NCT01940978|Histamine Antagonists|histamine antagonists|mesh-ancestor
101286446|NCT01940978|Histamine Agents|histamine agents|mesh-ancestor
101286447|NCT01940978|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101286448|NCT01940978|Serotonin Agents|serotonin agents|mesh-ancestor
101286449|NCT01940978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101286450|NCT01941004|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101286451|NCT01941004|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101286452|NCT01941004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286453|NCT01941004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101286454|NCT01941004|Immunologic Factors|immunologic factors|mesh-ancestor
101286455|NCT01941004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286456|NCT01941056|Vaccines|vaccines|mesh-list
101286457|NCT01941056|Immunologic Factors|immunologic factors|mesh-ancestor
101286458|NCT01941056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286459|NCT01941134|Levonorgestrel|levonorgestrel|mesh-list
101286460|NCT01941134|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101286461|NCT01941134|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
101286462|NCT01941134|Contraceptive Agents|contraceptive agents|mesh-list
101286463|NCT01941134|Contraceptives, Oral|contraceptives, oral|mesh-list
101286464|NCT01941134|Estradiol|estradiol|mesh-list
101286465|NCT01941134|Estrogens|estrogens|mesh-ancestor
101286466|NCT01941134|Hormones|hormones|mesh-ancestor
101286467|NCT01941134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101286468|NCT01941134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286469|NCT01941134|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101286470|NCT01941134|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101286471|NCT01941134|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101286472|NCT01941134|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101286473|NCT01941134|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101286474|NCT01941134|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101820050|NCT02551367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101820051|NCT02551367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101820052|NCT02551367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101820053|NCT02551367|Hormone Antagonists|hormone antagonists|mesh-ancestor
101820054|NCT02551367|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101820056|NCT02551367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101477347|NCT00274235|Mefloquine|mefloquine|mesh-list
101286475|NCT01941173|Leucovorin|leucovorin|mesh-list
101286476|NCT01941173|Fluorouracil|fluorouracil|mesh-list
101286477|NCT01941173|Irinotecan|irinotecan|mesh-list
101286478|NCT01941173|Aflibercept|aflibercept|mesh-list
101286479|NCT01941173|Calcium|calcium|mesh-list
101286480|NCT01941173|Levoleucovorin|levoleucovorin|mesh-list
101286481|NCT01941173|Endothelial Growth Factors|endothelial growth factors|mesh-list
101286482|NCT01941173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101286483|NCT01941173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286484|NCT01941173|Antimetabolites|antimetabolites|mesh-ancestor
101286485|NCT01941173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286486|NCT01941173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101286487|NCT01941173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101286488|NCT01941173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101286489|NCT01941173|Immunologic Factors|immunologic factors|mesh-ancestor
101286490|NCT01941173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101286491|NCT01941173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101286492|NCT01941173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101286493|NCT01941173|Antidotes|antidotes|mesh-ancestor
101286494|NCT01941173|Protective Agents|protective agents|mesh-ancestor
101286495|NCT01941173|Vitamin B Complex|vitamin b complex|mesh-ancestor
101286496|NCT01941173|Vitamins|vitamins|mesh-ancestor
101286497|NCT01941173|Micronutrients|micronutrients|mesh-ancestor
101286498|NCT01941173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101286499|NCT01941173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101286500|NCT01941173|Growth Substances|growth substances|mesh-ancestor
101286501|NCT01941173|Growth Inhibitors|growth inhibitors|mesh-ancestor
101286502|NCT01941199|Metformin|metformin|mesh-list
101286503|NCT01941199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101286504|NCT01941199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286505|NCT01941225|Iloprost|iloprost|mesh-list
101286506|NCT01941225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101286507|NCT01941225|Vasodilator Agents|vasodilator agents|mesh-ancestor
101286508|NCT01941264|Lumefantrine|lumefantrine|mesh-list
101286509|NCT01941264|Artemether|artemether|mesh-list
101286510|NCT01941264|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101286511|NCT01941264|Antimalarials|antimalarials|mesh-ancestor
101286512|NCT01941264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101286513|NCT01941264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101286514|NCT01941264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101286515|NCT01941316|Irinotecan|irinotecan|mesh-list
101286516|NCT01941316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101286517|NCT01941316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101286518|NCT01941316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101286519|NCT01941316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286520|NCT01941316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101286521|NCT01941329|Ranibizumab|ranibizumab|mesh-list
101286522|NCT01941329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101286523|NCT01941329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101286524|NCT01941329|Growth Substances|growth substances|mesh-ancestor
101286525|NCT01941329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286526|NCT01941329|Growth Inhibitors|growth inhibitors|mesh-ancestor
101286527|NCT01941329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101286528|NCT01941407|Bevacizumab|bevacizumab|mesh-list
101286529|NCT01941407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101286530|NCT01941407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101286531|NCT01941407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101286532|NCT01941407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101286533|NCT01941407|Growth Substances|growth substances|mesh-ancestor
101286534|NCT01941407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286535|NCT01941407|Growth Inhibitors|growth inhibitors|mesh-ancestor
101286536|NCT01941524|Poractant alfa|poractant alfa|mesh-list
101820057|NCT02551367|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101820058|NCT02551367|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101820059|NCT00813449|Dacarbazine|dacarbazine|mesh-list
101820060|NCT00813449|Endostar protein|endostar protein|mesh-list
101820061|NCT00813449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101820062|NCT00813449|Alkylating Agents|alkylating agents|mesh-ancestor
101820063|NCT00813449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286537|NCT01941524|Beractant|beractant|mesh-list
101286538|NCT01941524|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
101286539|NCT01941524|Respiratory System Agents|respiratory system agents|mesh-ancestor
101286540|NCT01941576|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101286541|NCT01941576|Natriuretic Agents|natriuretic agents|mesh-ancestor
101286542|NCT01941576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286544|NCT01941602|Anticoagulants|anticoagulants|mesh-ancestor
101286545|NCT01941602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101286546|NCT01941602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101286547|NCT01941602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286548|NCT01941732|Sildenafil Citrate|sildenafil citrate|mesh-list
101286549|NCT01941732|Vasodilator Agents|vasodilator agents|mesh-ancestor
101286550|NCT01941732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101286551|NCT01941732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101286552|NCT01941732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101286553|NCT01941732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286554|NCT01941732|Urological Agents|urological agents|mesh-ancestor
101286556|NCT01941758|Immunologic Factors|immunologic factors|mesh-ancestor
101286557|NCT01941758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286558|NCT01941771|Capecitabine|capecitabine|mesh-list
101286559|NCT01941771|Vinorelbine|vinorelbine|mesh-list
101286560|NCT01941771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101286561|NCT01941771|Antimetabolites|antimetabolites|mesh-ancestor
101286562|NCT01941771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286563|NCT01941771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101286564|NCT01941771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101286565|NCT01941771|Tubulin Modulators|tubulin modulators|mesh-ancestor
101286566|NCT01941771|Antimitotic Agents|antimitotic agents|mesh-ancestor
101286567|NCT01941771|Mitosis Modulators|mitosis modulators|mesh-ancestor
101286568|NCT01941810|Lactoferrin|lactoferrin|mesh-list
101286569|NCT01941810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101286570|NCT01941888|Midazolam|midazolam|mesh-list
101286571|NCT01941888|Propofol|propofol|mesh-list
101286572|NCT01941888|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101286573|NCT01941888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101286574|NCT01941888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286575|NCT01941888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101286576|NCT01941888|Anesthetics, General|anesthetics, general|mesh-ancestor
101286577|NCT01941888|Anesthetics|anesthetics|mesh-ancestor
101286578|NCT01941888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101286579|NCT01941888|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101286580|NCT01941888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101286581|NCT01941888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101286582|NCT01941888|GABA Modulators|gaba modulators|mesh-ancestor
101286583|NCT01941888|GABA Agents|gaba agents|mesh-ancestor
101286584|NCT01941888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101286585|NCT01941888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286586|NCT01941901|Calcium, Dietary|calcium, dietary|mesh-list
101286587|NCT01941901|Bleomycin|bleomycin|mesh-list
101286588|NCT01941901|Calcium|calcium|mesh-list
101286589|NCT01941901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101286590|NCT01941901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286591|NCT01941901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101286592|NCT01941901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101286593|NCT01941901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101286594|NCT01941914|Calcium, Dietary|calcium, dietary|mesh-list
101286595|NCT01941914|Calcium|calcium|mesh-list
101286596|NCT01941914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101286597|NCT01941914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820065|NCT00813449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101820066|NCT00813449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101820067|NCT00813449|Growth Substances|growth substances|mesh-ancestor
101820068|NCT00813449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820069|NCT00813449|Growth Inhibitors|growth inhibitors|mesh-ancestor
101820070|NCT00822029|Alendronate|alendronate|mesh-list
101820071|NCT00822029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101820072|NCT00822029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820073|NCT00467259|Testosterone|testosterone|mesh-list
101820074|NCT00467259|Androgens|androgens|mesh-ancestor
101820076|NCT00467259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101820077|NCT00467259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820078|NCT01022151|Aminophylline|aminophylline|mesh-list
101820079|NCT01022151|Doxapram|doxapram|mesh-list
101820080|NCT01022151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101820081|NCT01022151|Autonomic Agents|autonomic agents|mesh-ancestor
101286598|NCT01941914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101286599|NCT01941953|Metformin|metformin|mesh-list
101286600|NCT01941953|Fluorouracil|fluorouracil|mesh-list
101286601|NCT01941953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101286602|NCT01941953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286603|NCT01941953|Antimetabolites|antimetabolites|mesh-ancestor
101408603|NCT03274765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286604|NCT01941953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286605|NCT01941953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101286606|NCT01941953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101286607|NCT01941953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101286608|NCT01941953|Immunologic Factors|immunologic factors|mesh-ancestor
101286609|NCT01941966|Capecitabine|capecitabine|mesh-list
101286610|NCT01941966|Mitomycins|mitomycins|mesh-list
101286612|NCT01941966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101286614|NCT01941966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286615|NCT01941966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101286616|NCT01941966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101286617|NCT01941966|Alkylating Agents|alkylating agents|mesh-ancestor
101286618|NCT01941966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101286619|NCT01941966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101286622|NCT01941979|Oxaliplatin|oxaliplatin|mesh-list
101286623|NCT01941979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101286624|NCT01941979|Antimetabolites|antimetabolites|mesh-ancestor
101286625|NCT01941979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820082|NCT01022151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101820083|NCT01022151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820084|NCT01022151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101820085|NCT01022151|Respiratory System Agents|respiratory system agents|mesh-ancestor
101820086|NCT01022151|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101286626|NCT01941979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101286627|NCT01941979|Antidotes|antidotes|mesh-ancestor
101286628|NCT01941979|Protective Agents|protective agents|mesh-ancestor
101286629|NCT01941979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286630|NCT01941979|Vitamin B Complex|vitamin b complex|mesh-ancestor
101286631|NCT01941979|Vitamins|vitamins|mesh-ancestor
101286632|NCT01941979|Micronutrients|micronutrients|mesh-ancestor
101286633|NCT01942070|Everolimus|everolimus|mesh-list
101286634|NCT01942070|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101286635|NCT01942070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101286636|NCT01942070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101286637|NCT01942070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286638|NCT01942070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101286639|NCT01942070|Immunologic Factors|immunologic factors|mesh-ancestor
101286640|NCT01942070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286641|NCT01942070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101286642|NCT01942109|Torsemide|torsemide|mesh-list
101286643|NCT01942109|Furosemide|furosemide|mesh-list
101286644|NCT01942109|Diuretics|diuretics|mesh-ancestor
101286645|NCT01942109|Natriuretic Agents|natriuretic agents|mesh-ancestor
101286646|NCT01942109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286647|NCT01942109|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101286648|NCT01942109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101286649|NCT01942109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286650|NCT01942109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101286651|NCT01942174|Methotrexate|methotrexate|mesh-list
101286652|NCT01942174|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101286653|NCT01942174|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101286654|NCT01942174|Abortifacient Agents|abortifacient agents|mesh-ancestor
101286655|NCT01942174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101286656|NCT01942174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286657|NCT01942174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101286658|NCT01942174|Antimetabolites|antimetabolites|mesh-ancestor
101286659|NCT01942174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286660|NCT01942174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101286661|NCT01942174|Dermatologic Agents|dermatologic agents|mesh-ancestor
101286662|NCT01942174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101286663|NCT01942174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101286664|NCT01942174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101286665|NCT01942174|Immunologic Factors|immunologic factors|mesh-ancestor
101286666|NCT01942174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101286667|NCT01942174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101286668|NCT01942187|Aripiprazole|aripiprazole|mesh-list
101286669|NCT01942187|Bupropion|bupropion|mesh-list
101286670|NCT01942187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101286671|NCT01942187|Antidepressive Agents|antidepressive agents|mesh-ancestor
101286672|NCT01942187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101286673|NCT01942187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101286674|NCT01942187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101286675|NCT01942187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101286676|NCT01942187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286677|NCT01942187|Dopamine Agents|dopamine agents|mesh-ancestor
101286678|NCT01942187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101286679|NCT01942187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286680|NCT01942187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101286681|NCT01942187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101286682|NCT01942187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101286683|NCT01942187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101286684|NCT01942187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101286685|NCT01942187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101286686|NCT01942187|Dopamine Agonists|dopamine agonists|mesh-ancestor
101286687|NCT01942187|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101820087|NCT01022151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101820088|NCT01022151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101820089|NCT01022151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820090|NCT01022151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101820091|NCT01022151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101820092|NCT01022151|Purinergic Agents|purinergic agents|mesh-ancestor
101286688|NCT01942187|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101286689|NCT01942187|Serotonin Agents|serotonin agents|mesh-ancestor
101286690|NCT01942187|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101286691|NCT01942187|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101286692|NCT01942187|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101286693|NCT01942187|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101286695|NCT01942291|Nicotinic Acids|nicotinic acids|mesh-list
101286696|NCT01942291|Vitamins|vitamins|mesh-ancestor
101286697|NCT01942291|Micronutrients|micronutrients|mesh-ancestor
101286698|NCT01942291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286699|NCT01942291|Vitamin B Complex|vitamin b complex|mesh-ancestor
101286700|NCT01942291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101286701|NCT01942291|Antimetabolites|antimetabolites|mesh-ancestor
101286702|NCT01942291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286703|NCT01942291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101286704|NCT01942291|Vasodilator Agents|vasodilator agents|mesh-ancestor
101286705|NCT01942304|Calcium|calcium|mesh-list
101286706|NCT01942304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101286707|NCT01942304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286708|NCT01942343|Droperidol|droperidol|mesh-list
101286709|NCT01942343|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101286710|NCT01942343|Antiemetics|antiemetics|mesh-ancestor
101286711|NCT01942343|Autonomic Agents|autonomic agents|mesh-ancestor
101286712|NCT01942343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101286713|NCT01942343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286714|NCT01942343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101286715|NCT01942343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101286716|NCT01942343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101286717|NCT01942343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101286718|NCT01942343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101286719|NCT01942343|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101286720|NCT01942343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101286721|NCT01942343|Dopamine Agents|dopamine agents|mesh-ancestor
101286722|NCT01942343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101286723|NCT01942343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286724|NCT01942369|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101286725|NCT01942369|Luteolytic Agents|luteolytic agents|mesh-ancestor
101286726|NCT01942369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101286727|NCT01942369|Contraceptive Agents|contraceptive agents|mesh-ancestor
101286728|NCT01942369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101286729|NCT01942369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286730|NCT01942369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101286731|NCT01942369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101286732|NCT01942369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101286733|NCT01942382|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101286734|NCT01942382|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101286735|NCT01942382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101286736|NCT01942382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101286737|NCT01942382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286738|NCT01942382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101286739|NCT01942382|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101286740|NCT01942382|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101286741|NCT01942382|Serotonin Agents|serotonin agents|mesh-ancestor
101286742|NCT01942382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101286743|NCT01942382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286744|NCT01942382|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101286745|NCT01942382|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101286746|NCT01942382|Dopamine Agents|dopamine agents|mesh-ancestor
101286747|NCT01942447|Vancomycin|vancomycin|mesh-list
101286748|NCT01942447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101286749|NCT01942447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101820093|NCT01022151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101820094|NCT01022151|Protective Agents|protective agents|mesh-ancestor
101820095|NCT01022151|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101820096|NCT01022229|Vitamins|vitamins|mesh-list
101820097|NCT01022229|Vitamin B 6|vitamin b 6|mesh-list
101820098|NCT01022229|Micronutrients|micronutrients|mesh-ancestor
101820099|NCT01022229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820100|NCT01022229|Vitamin B Complex|vitamin b complex|mesh-ancestor
101820101|NCT00449787|Naproxen|naproxen|mesh-list
101820102|NCT00449787|Sumatriptan|sumatriptan|mesh-list
101820103|NCT00449787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101820104|NCT00449787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101820105|NCT00449787|Analgesics|analgesics|mesh-ancestor
101820106|NCT00449787|Sensory System Agents|sensory system agents|mesh-ancestor
101820107|NCT00449787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101820108|NCT00449787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820109|NCT00449787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101820110|NCT00449787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101820111|NCT00449787|Gout Suppressants|gout suppressants|mesh-ancestor
101820112|NCT00449787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101820113|NCT00449787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101820114|NCT00449787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820115|NCT00449787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101820116|NCT00449787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101820117|NCT00449787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101286750|NCT01942460|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
101286751|NCT01942460|Hematinics|hematinics|mesh-ancestor
101286752|NCT01942460|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101286753|NCT01942460|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101286754|NCT01942551|Tadalafil|tadalafil|mesh-list
101286755|NCT01942551|Dutasteride|dutasteride|mesh-list
101286756|NCT01942551|Vasodilator Agents|vasodilator agents|mesh-ancestor
101286757|NCT01942551|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101286758|NCT01942551|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101286759|NCT01942551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101286760|NCT01942551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286761|NCT01942551|Urological Agents|urological agents|mesh-ancestor
101286762|NCT01942551|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101286763|NCT01942551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101286764|NCT01942551|Hormone Antagonists|hormone antagonists|mesh-ancestor
101286765|NCT01942551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101286766|NCT01942551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286767|NCT01942577|Protective Agents|protective agents|mesh-list
101286768|NCT01942577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286769|NCT01942681|Propiverine|propiverine|mesh-list
101286770|NCT01942681|Parasympatholytics|parasympatholytics|mesh-ancestor
101286771|NCT01942681|Autonomic Agents|autonomic agents|mesh-ancestor
101286772|NCT01942681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101286773|NCT01942681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286774|NCT01942681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101820119|NCT00449787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101820120|NCT01566201|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101820121|NCT01566201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101820122|NCT01566279|Everolimus|everolimus|mesh-list
101820123|NCT01566279|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101820124|NCT01566279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101820125|NCT01566279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101286775|NCT01942681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101286776|NCT01942681|Cholinergic Agents|cholinergic agents|mesh-ancestor
101286777|NCT01942681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101286778|NCT01942681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286779|NCT01942681|Urological Agents|urological agents|mesh-ancestor
101286780|NCT01942889|Antioxidants|antioxidants|mesh-list
101286781|NCT01942889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286782|NCT01942889|Protective Agents|protective agents|mesh-ancestor
101286783|NCT01942889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286784|NCT01943019|Linagliptin|linagliptin|mesh-list
101286785|NCT01943019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101286786|NCT01943019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286787|NCT01943019|Incretins|incretins|mesh-ancestor
101286788|NCT01943019|Hormones|hormones|mesh-ancestor
101286789|NCT01943019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101286790|NCT01943019|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101286791|NCT01943019|Protease Inhibitors|protease inhibitors|mesh-ancestor
101286792|NCT01943019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101286793|NCT01943019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286794|NCT01943058|Megestrol|megestrol|mesh-list
101286795|NCT01943058|Megestrol Acetate|megestrol acetate|mesh-list
101286797|NCT01943058|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101286798|NCT01943058|Contraceptive Agents|contraceptive agents|mesh-ancestor
101286799|NCT01943058|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101286800|NCT01943058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286801|NCT01943058|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101286802|NCT01943058|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101286803|NCT01943058|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101286804|NCT01943058|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101286805|NCT01943058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101286806|NCT01943058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101286807|NCT01943058|Appetite Stimulants|appetite stimulants|mesh-ancestor
101286808|NCT01943058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101286809|NCT01943136|Mupirocin|mupirocin|mesh-list
101286810|NCT01943136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101286811|NCT01943136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101286812|NCT01943136|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101286813|NCT01943136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101286814|NCT01943136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286815|NCT01943188|Cyclophosphamide|cyclophosphamide|mesh-list
101286816|NCT01943188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101286817|NCT01943188|Immunologic Factors|immunologic factors|mesh-ancestor
101316182|NCT03937609|Infliximab|infliximab|mesh-list
101286818|NCT01943188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286819|NCT01943188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101286820|NCT01943188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101286821|NCT01943188|Alkylating Agents|alkylating agents|mesh-ancestor
101286822|NCT01943188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286823|NCT01943188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101286824|NCT01943188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101286825|NCT01943240|Ropivacaine|ropivacaine|mesh-list
101286826|NCT01943240|Anesthetics, Local|anesthetics, local|mesh-ancestor
101286827|NCT01943240|Anesthetics|anesthetics|mesh-ancestor
101286828|NCT01943240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101286829|NCT01943240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286830|NCT01943240|Sensory System Agents|sensory system agents|mesh-ancestor
101286831|NCT01943240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101820126|NCT01566279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820127|NCT01566279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101820128|NCT01566279|Immunologic Factors|immunologic factors|mesh-ancestor
101820129|NCT01566279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477424|NCT00274430|Hormones|hormones|mesh-ancestor
101820130|NCT01566279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101820131|NCT00449163|Leucovorin|leucovorin|mesh-list
101820132|NCT00449163|Bevacizumab|bevacizumab|mesh-list
101820133|NCT00449163|Irinotecan|irinotecan|mesh-list
101820134|NCT00449163|Floxuridine|floxuridine|mesh-list
101820135|NCT00449163|Levoleucovorin|levoleucovorin|mesh-list
101820136|NCT00449163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101820137|NCT00449163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101820138|NCT00449163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101820139|NCT00449163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101820140|NCT00449163|Growth Substances|growth substances|mesh-ancestor
101820141|NCT00449163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820142|NCT00449163|Growth Inhibitors|growth inhibitors|mesh-ancestor
101820143|NCT00449163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101820144|NCT00449163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101820145|NCT00449163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101820146|NCT00449163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820147|NCT00449163|Antidotes|antidotes|mesh-ancestor
101820148|NCT00449163|Protective Agents|protective agents|mesh-ancestor
101820149|NCT00449163|Vitamin B Complex|vitamin b complex|mesh-ancestor
101820150|NCT00449163|Vitamins|vitamins|mesh-ancestor
101820151|NCT00449163|Micronutrients|micronutrients|mesh-ancestor
101820152|NCT00449163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101820153|NCT00449163|Antimetabolites|antimetabolites|mesh-ancestor
101820154|NCT01026987|Plerixafor|plerixafor|mesh-list
101820155|NCT01026987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101820156|NCT01026987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101820157|NCT01026987|Antiviral Agents|antiviral agents|mesh-ancestor
101820158|NCT01026987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101820159|NCT00448539|Rufinamide|rufinamide|mesh-list
101820160|NCT00448539|Anticonvulsants|anticonvulsants|mesh-ancestor
101286832|NCT01943305|Vaccines|vaccines|mesh-list
101286833|NCT01943305|Immunologic Factors|immunologic factors|mesh-ancestor
101286834|NCT01943305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286835|NCT01943409|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101820161|NCT00448539|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101820162|NCT00448539|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101820163|NCT00448539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101820164|NCT00448539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820166|NCT00457665|Nelfinavir|nelfinavir|mesh-list
101820167|NCT00457665|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101820168|NCT00457665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101820169|NCT00457665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101820170|NCT00457665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820171|NCT00457665|Antiviral Agents|antiviral agents|mesh-ancestor
101286836|NCT01943409|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101286837|NCT01943409|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101286838|NCT01943409|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101286839|NCT01943422|Interferons|interferons|mesh-list
101286840|NCT01943422|Interferon-alpha|interferon-alpha|mesh-list
101286841|NCT01943422|Interferon alpha-2|interferon alpha-2|mesh-list
101286842|NCT01943422|Vemurafenib|vemurafenib|mesh-list
101286843|NCT01943422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101286844|NCT01943422|Antiviral Agents|antiviral agents|mesh-ancestor
101286845|NCT01943422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101286846|NCT01943422|Immunologic Factors|immunologic factors|mesh-ancestor
101286847|NCT01943422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286848|NCT01943422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101286849|NCT01943422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101286850|NCT01943422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286851|NCT01943487|Verapamil|verapamil|mesh-list
101286852|NCT01943487|Tamsulosin|tamsulosin|mesh-list
101286853|NCT01943487|Solifenacin Succinate|solifenacin succinate|mesh-list
101286854|NCT01943487|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101286855|NCT01943487|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101286856|NCT01943487|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101286857|NCT01943487|Adrenergic Agents|adrenergic agents|mesh-ancestor
101286858|NCT01943487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101286859|NCT01943487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286860|NCT01943487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286861|NCT01943487|Urological Agents|urological agents|mesh-ancestor
101286862|NCT01943487|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101286863|NCT01943487|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101286864|NCT01943487|Cholinergic Agents|cholinergic agents|mesh-ancestor
101286865|NCT01943487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101286866|NCT01943487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101286867|NCT01943487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101286868|NCT01943487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101286869|NCT01943487|Vasodilator Agents|vasodilator agents|mesh-ancestor
101286870|NCT01943526|Natalizumab|natalizumab|mesh-list
101286871|NCT01943526|Immunologic Factors|immunologic factors|mesh-ancestor
101286872|NCT01943526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286873|NCT01943617|Entecavir|entecavir|mesh-list
101286874|NCT01943617|Antiviral Agents|antiviral agents|mesh-ancestor
101286875|NCT01943617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101286876|NCT01943630|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
101286877|NCT01943630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101286878|NCT01943630|Immunologic Factors|immunologic factors|mesh-ancestor
101286879|NCT01943630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286880|NCT01943630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101286881|NCT01943630|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101286882|NCT01943630|Protective Agents|protective agents|mesh-ancestor
101286883|NCT01943630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101286884|NCT01943630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101286885|NCT01943630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101820172|NCT00457665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101820173|NCT00457665|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101820174|NCT00457665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101820175|NCT00457665|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101820176|NCT00457665|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101820177|NCT00457665|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101820178|NCT00457665|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101820179|NCT00457665|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101820180|NCT00457665|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101820181|NCT00457665|Protease Inhibitors|protease inhibitors|mesh-ancestor
101820183|NCT00457665|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101820184|NCT00447603|Losartan|losartan|mesh-list
101820185|NCT00447603|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101820186|NCT00447603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101820187|NCT00447603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101820188|NCT00447603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101820189|NCT00447603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101820190|NCT00447603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820191|NCT00447603|Diuretics|diuretics|mesh-ancestor
101286886|NCT01943630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286888|NCT01943630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101286889|NCT01943760|Tramadol|tramadol|mesh-list
101286890|NCT01943760|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101286891|NCT01943760|Narcotics|narcotics|mesh-ancestor
101286892|NCT01943760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101286893|NCT01943760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286894|NCT01943760|Analgesics|analgesics|mesh-ancestor
101286895|NCT01943760|Sensory System Agents|sensory system agents|mesh-ancestor
101286896|NCT01943760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101286897|NCT01943786|Cetuximab|cetuximab|mesh-list
101286898|NCT01943786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101286899|NCT01943786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101286900|NCT01943812|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101286901|NCT01943812|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101286902|NCT01943812|Estradiol|estradiol|mesh-list
101286903|NCT01943812|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101286904|NCT01943812|Progesterone|progesterone|mesh-list
101286905|NCT01943812|Estrogens|estrogens|mesh-ancestor
101286906|NCT01943812|Hormones|hormones|mesh-ancestor
101286907|NCT01943812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101286908|NCT01943812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286909|NCT01943812|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101286910|NCT01943812|Contraceptive Agents|contraceptive agents|mesh-ancestor
101286911|NCT01943812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101286912|NCT01943812|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101286913|NCT01943812|Progestins|progestins|mesh-ancestor
101286914|NCT01943877|Propolis|propolis|mesh-list
101286915|NCT01943877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101286916|NCT01943942|Montelukast|montelukast|mesh-list
101286917|NCT01943942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101286918|NCT01943942|Respiratory System Agents|respiratory system agents|mesh-ancestor
101286919|NCT01943942|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101820192|NCT00447603|Natriuretic Agents|natriuretic agents|mesh-ancestor
101820193|NCT00447603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820194|NCT00447603|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101820195|NCT00447603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101820196|NCT00447057|Pemetrexed|pemetrexed|mesh-list
101820197|NCT00447057|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101820198|NCT00447057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101820199|NCT00447057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101286920|NCT01943942|Hormone Antagonists|hormone antagonists|mesh-ancestor
101286921|NCT01943942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101286922|NCT01943942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286923|NCT01943942|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101286924|NCT01943942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101286925|NCT01943942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286927|NCT01944033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101286928|NCT01944033|Autonomic Agents|autonomic agents|mesh-ancestor
101286929|NCT01944033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101286930|NCT01944033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286931|NCT01944033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101286932|NCT01944033|Respiratory System Agents|respiratory system agents|mesh-ancestor
101286933|NCT01944033|Sympathomimetics|sympathomimetics|mesh-ancestor
101286934|NCT01944033|Tocolytic Agents|tocolytic agents|mesh-ancestor
101286935|NCT01944033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101286936|NCT01944033|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101286937|NCT01944033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101286938|NCT01944033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101286939|NCT01944033|Adrenergic Agents|adrenergic agents|mesh-ancestor
101286940|NCT01944033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101286941|NCT01944033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286942|NCT01944085|Acetaminophen|acetaminophen|mesh-list
101286943|NCT01944085|Ascorbic Acid|ascorbic acid|mesh-list
101286944|NCT01944085|Ibuprofen|ibuprofen|mesh-list
101286945|NCT01944085|Vitamins|vitamins|mesh-ancestor
101286946|NCT01944085|Micronutrients|micronutrients|mesh-ancestor
101286947|NCT01944085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286948|NCT01944085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101286949|NCT01944085|Analgesics|analgesics|mesh-ancestor
101286950|NCT01944085|Sensory System Agents|sensory system agents|mesh-ancestor
101286951|NCT01944085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101286952|NCT01944085|Antipyretics|antipyretics|mesh-ancestor
101286953|NCT01944085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101286954|NCT01944085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101286955|NCT01944085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101286956|NCT01944085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101286957|NCT01944085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101286958|NCT01944085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286959|NCT01944085|Antioxidants|antioxidants|mesh-ancestor
101286960|NCT01944085|Protective Agents|protective agents|mesh-ancestor
101286961|NCT01944176|Simvastatin|simvastatin|mesh-list
101286962|NCT01944176|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101286963|NCT01944176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101286964|NCT01944176|Antimetabolites|antimetabolites|mesh-ancestor
101286965|NCT01944176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286966|NCT01944176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101286967|NCT01944176|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101286968|NCT01944176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101286969|NCT01944189|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101286970|NCT01944189|Antimalarials|antimalarials|mesh-ancestor
101286971|NCT01944189|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101286972|NCT01944189|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101286973|NCT01944189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101286974|NCT01944215|Caffeine|caffeine|mesh-list
101286975|NCT01944215|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101820200|NCT00447057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820201|NCT00447057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101820202|NCT00447057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101477491|NCT00274820|Antiemetics|antiemetics|mesh-ancestor
101286976|NCT01944215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286977|NCT01944215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101286978|NCT01944215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101286979|NCT01944215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286980|NCT01944215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101286981|NCT01944215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101286983|NCT01944215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101286984|NCT01944384|Spironolactone|spironolactone|mesh-list
101286985|NCT01944384|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101286986|NCT01944384|Hormone Antagonists|hormone antagonists|mesh-ancestor
101286987|NCT01944384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101286988|NCT01944384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101286989|NCT01944384|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101286990|NCT01944384|Diuretics|diuretics|mesh-ancestor
101286991|NCT01944384|Natriuretic Agents|natriuretic agents|mesh-ancestor
101286993|NCT01944410|Mitosis Modulators|mitosis modulators|mesh-ancestor
101286994|NCT01944410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286995|NCT01944436|Rivastigmine|rivastigmine|mesh-list
101286996|NCT01944436|Donepezil|donepezil|mesh-list
101286997|NCT01944436|Galantamine|galantamine|mesh-list
101286998|NCT01944436|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
101286999|NCT01944436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101287000|NCT01944436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287001|NCT01944436|Cholinergic Agents|cholinergic agents|mesh-ancestor
101287002|NCT01944436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101287003|NCT01944436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287004|NCT01944436|Nootropic Agents|nootropic agents|mesh-ancestor
101287005|NCT01944436|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101287006|NCT01944436|Autonomic Agents|autonomic agents|mesh-ancestor
101287007|NCT01944436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101287008|NCT01944436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101287009|NCT01944436|Protective Agents|protective agents|mesh-ancestor
101287010|NCT01944618|Dapagliflozin|dapagliflozin|mesh-list
101287011|NCT01944618|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101287012|NCT01944618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287013|NCT01944618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101287014|NCT01944618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287015|NCT01944657|Antidepressive Agents|antidepressive agents|mesh-list
101287016|NCT01944657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101287017|NCT01944683|Midazolam|midazolam|mesh-list
101287018|NCT01944683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101287019|NCT01944683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101287020|NCT01944683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101287021|NCT01944683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287022|NCT01944683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101287023|NCT01944683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101287024|NCT01944683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101287025|NCT01944683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101287026|NCT01944683|Anesthetics, General|anesthetics, general|mesh-ancestor
101287027|NCT01944683|Anesthetics|anesthetics|mesh-ancestor
101287028|NCT01944683|GABA Modulators|gaba modulators|mesh-ancestor
101287029|NCT01944683|GABA Agents|gaba agents|mesh-ancestor
101287030|NCT01944683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101287031|NCT01944683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287032|NCT01944735|Mannitol|mannitol|mesh-list
101287033|NCT01944735|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101287034|NCT01944735|Diuretics|diuretics|mesh-ancestor
101287035|NCT01944735|Natriuretic Agents|natriuretic agents|mesh-ancestor
101287036|NCT01944735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287037|NCT01944852|Icodextrin|icodextrin|mesh-list
101287038|NCT01944852|Dialysis Solutions|dialysis solutions|mesh-ancestor
101287039|NCT01944852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101287040|NCT01945021|Crizotinib|crizotinib|mesh-list
101287041|NCT01945021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101820203|NCT00447057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101820204|NCT01027611|Lidocaine|lidocaine|mesh-list
101820205|NCT01027611|Proxymetacaine|proxymetacaine|mesh-list
101820206|NCT01027611|Propoxycaine|propoxycaine|mesh-list
101820207|NCT01027611|Anesthetics, Local|anesthetics, local|mesh-ancestor
101820208|NCT01027611|Anesthetics|anesthetics|mesh-ancestor
101820209|NCT01027611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101820210|NCT01027611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820211|NCT01027611|Sensory System Agents|sensory system agents|mesh-ancestor
101820212|NCT01027611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101820213|NCT01027611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101287044|NCT01945021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287045|NCT01945047|Midazolam|midazolam|mesh-list
101287046|NCT01945047|Ketamine|ketamine|mesh-list
101287047|NCT01945047|Analgesics|analgesics|mesh-ancestor
101287048|NCT01945047|Sensory System Agents|sensory system agents|mesh-ancestor
101287049|NCT01945047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101287050|NCT01945047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287051|NCT01945047|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101287052|NCT01945047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101287053|NCT01945047|Anesthetics, General|anesthetics, general|mesh-ancestor
101287054|NCT01945047|Anesthetics|anesthetics|mesh-ancestor
101287055|NCT01945047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101287056|NCT01945047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101287057|NCT01945047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101287058|NCT01945047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101287059|NCT01945047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287060|NCT01945047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101287061|NCT01945047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101287062|NCT01945047|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101287063|NCT01945047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101287064|NCT01945047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101287065|NCT01945047|GABA Modulators|gaba modulators|mesh-ancestor
101287066|NCT01945047|GABA Agents|gaba agents|mesh-ancestor
101287067|NCT01945099|Insulin|insulin|mesh-list
101287068|NCT01945099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101287069|NCT01945099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287070|NCT01945268|Vaccines|vaccines|mesh-list
101287071|NCT01945268|Immunologic Factors|immunologic factors|mesh-ancestor
101287072|NCT01945268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287073|NCT01945437|Magnesium Sulfate|magnesium sulfate|mesh-list
101287075|NCT01945437|Sensory System Agents|sensory system agents|mesh-ancestor
101287076|NCT01945437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101287077|NCT01945437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287078|NCT01945437|Anesthetics|anesthetics|mesh-ancestor
101287079|NCT01945437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101287080|NCT01945437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101287081|NCT01945437|Anticonvulsants|anticonvulsants|mesh-ancestor
101287082|NCT01945437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101287083|NCT01945437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101287084|NCT01945437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287085|NCT01945437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101287086|NCT01945437|Tocolytic Agents|tocolytic agents|mesh-ancestor
101287087|NCT01945437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101287088|NCT01945450|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101287089|NCT01945450|Clindamycin|clindamycin|mesh-list
101287090|NCT01945450|Clindamycin palmitate|clindamycin palmitate|mesh-list
101287091|NCT01945450|Clindamycin phosphate|clindamycin phosphate|mesh-list
101287092|NCT01945450|Gentamicins|gentamicins|mesh-list
101287093|NCT01945450|Ampicillin|ampicillin|mesh-list
101287094|NCT01945450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101287095|NCT01945450|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101287096|NCT01945450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101287097|NCT01945450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820214|NCT01027611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101820215|NCT01027611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101820216|NCT01027611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101820217|NCT01027611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820218|NCT01024413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101820219|NCT01024413|Gefitinib|gefitinib|mesh-list
101820220|NCT01024413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101287098|NCT01945476|Midazolam|midazolam|mesh-list
101287099|NCT01945476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101287100|NCT01945476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101316199|NCT00000813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101287101|NCT01945476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101287102|NCT01945476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287103|NCT01945476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101287104|NCT01945476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101287105|NCT01945476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101287106|NCT01945476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101287107|NCT01945476|Anesthetics, General|anesthetics, general|mesh-ancestor
101287108|NCT01945476|Anesthetics|anesthetics|mesh-ancestor
101287109|NCT01945476|GABA Modulators|gaba modulators|mesh-ancestor
101287110|NCT01945476|GABA Agents|gaba agents|mesh-ancestor
101287111|NCT01945476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101287112|NCT01945476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287113|NCT01945528|Lidocaine|lidocaine|mesh-list
101287114|NCT01945528|Anesthetics, Local|anesthetics, local|mesh-list
101287115|NCT01945528|Anesthetics|anesthetics|mesh-list
101287116|NCT01945528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101287117|NCT01945528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287118|NCT01945528|Sensory System Agents|sensory system agents|mesh-ancestor
101287119|NCT01945528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101287120|NCT01945528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101287121|NCT01945528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101287122|NCT01945528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101287123|NCT01945528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101287124|NCT01945528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287125|NCT01945554|Bupivacaine|bupivacaine|mesh-list
101287127|NCT01945554|Anesthetics|anesthetics|mesh-ancestor
101287128|NCT01945554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101287129|NCT01945554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287130|NCT01945554|Sensory System Agents|sensory system agents|mesh-ancestor
101287131|NCT01945554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101287132|NCT01945684|Botulinum Toxins|botulinum toxins|mesh-list
101287133|NCT01945684|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101287134|NCT01945684|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101408613|NCT00143676|Atorvastatin|atorvastatin|mesh-list
101287135|NCT01945684|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101287136|NCT01945684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101287137|NCT01945684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287138|NCT01945684|Cholinergic Agents|cholinergic agents|mesh-ancestor
101287139|NCT01945684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101287140|NCT01945684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287141|NCT01945684|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101287142|NCT01945684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101287143|NCT01945736|Methadone|methadone|mesh-list
101287144|NCT01945736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101287145|NCT01945736|Narcotics|narcotics|mesh-ancestor
101287146|NCT01945736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101287147|NCT01945736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287148|NCT01945736|Analgesics|analgesics|mesh-ancestor
101287149|NCT01945736|Sensory System Agents|sensory system agents|mesh-ancestor
101287150|NCT01945736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101287151|NCT01945736|Antitussive Agents|antitussive agents|mesh-ancestor
101287152|NCT01945736|Respiratory System Agents|respiratory system agents|mesh-ancestor
101287153|NCT01945788|Teriparatide|teriparatide|mesh-list
101287154|NCT01945788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101287155|NCT01945788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820221|NCT01024413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101820222|NCT01024413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101820223|NCT01024413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820224|NCT00446511|Valsartan|valsartan|mesh-list
101820225|NCT00446511|Enalapril|enalapril|mesh-list
101820226|NCT00446511|Enalaprilat|enalaprilat|mesh-list
101820227|NCT00446511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101820228|NCT00446511|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101287156|NCT01945788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101287157|NCT01945801|Furosemide|furosemide|mesh-list
101287158|NCT01945801|Spironolactone|spironolactone|mesh-list
101287159|NCT01945801|Diuretics|diuretics|mesh-ancestor
101287160|NCT01945801|Natriuretic Agents|natriuretic agents|mesh-ancestor
101287161|NCT01945801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287162|NCT01945801|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101287163|NCT01945801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101287164|NCT01945801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287165|NCT01945801|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101287166|NCT01945801|Hormone Antagonists|hormone antagonists|mesh-ancestor
101316203|NCT00000813|Interferon Inducers|interferon inducers|mesh-ancestor
101287167|NCT01945801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101287168|NCT01945801|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101287169|NCT05410626|Methylphenidate|methylphenidate|mesh-list
101287170|NCT05410626|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101287171|NCT05410626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287172|NCT05410626|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101287173|NCT05410626|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101287174|NCT05410626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101287175|NCT05410626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287176|NCT05410626|Dopamine Agents|dopamine agents|mesh-ancestor
101287177|NCT05410626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101287178|NCT05410535|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101287179|NCT05410535|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101287180|NCT05410535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101287182|NCT05410483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101287183|NCT05410483|Tubulin Modulators|tubulin modulators|mesh-ancestor
101287184|NCT05410483|Antimitotic Agents|antimitotic agents|mesh-ancestor
101287185|NCT05410483|Mitosis Modulators|mitosis modulators|mesh-ancestor
101287186|NCT05410483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287187|NCT05410314|Inositol|inositol|mesh-list
101287189|NCT05410314|Vitamins|vitamins|mesh-ancestor
101287190|NCT05410314|Micronutrients|micronutrients|mesh-ancestor
101287191|NCT05410314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287192|NCT05410275|Rivaroxaban|rivaroxaban|mesh-list
101287193|NCT05410275|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101287194|NCT05410275|Antithrombins|antithrombins|mesh-ancestor
101287195|NCT05410275|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101287196|NCT05410275|Protease Inhibitors|protease inhibitors|mesh-ancestor
101287197|NCT05410275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101287198|NCT05410275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287199|NCT05410275|Anticoagulants|anticoagulants|mesh-ancestor
101287200|NCT05410093|Vitamin E|vitamin e|mesh-list
101287201|NCT05410093|Tocopherols|tocopherols|mesh-list
101287202|NCT05410093|Resveratrol|resveratrol|mesh-list
101287203|NCT05410093|Vitamins|vitamins|mesh-ancestor
101287204|NCT05410093|Micronutrients|micronutrients|mesh-ancestor
101287205|NCT05410093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287207|NCT05410093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287208|NCT05410093|Protective Agents|protective agents|mesh-ancestor
101287209|NCT05410093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101287210|NCT05410093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101287211|NCT05409820|Anesthetics|anesthetics|mesh-list
101287212|NCT05409820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101287213|NCT05409820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287214|NCT05409339|Mannitol|mannitol|mesh-list
101287215|NCT05409339|Caffeine|caffeine|mesh-list
101820229|NCT00446511|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101820230|NCT00446511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820231|NCT00446511|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101287216|NCT05409339|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101287217|NCT05409339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287218|NCT05409339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101287219|NCT05409339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101287220|NCT05409339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287221|NCT05409339|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101287222|NCT05409339|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101287223|NCT05409339|Purinergic Agents|purinergic agents|mesh-ancestor
101287224|NCT05409339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101287225|NCT05409339|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101287226|NCT05409339|Diuretics|diuretics|mesh-ancestor
101287227|NCT05409339|Natriuretic Agents|natriuretic agents|mesh-ancestor
101287229|NCT05155527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101287230|NCT05155527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101287231|NCT05151146|Metformin|metformin|mesh-list
101287232|NCT05151146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101287233|NCT05151146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287234|NCT05068063|Bupivacaine|bupivacaine|mesh-list
101287235|NCT05068063|Anesthetics, Local|anesthetics, local|mesh-ancestor
101287236|NCT05068063|Anesthetics|anesthetics|mesh-ancestor
101287237|NCT05068063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101287238|NCT05068063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287239|NCT05068063|Sensory System Agents|sensory system agents|mesh-ancestor
101287240|NCT05068063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101287241|NCT04967378|Psychotropic Drugs|psychotropic drugs|mesh-list
101287242|NCT04946396|Dexmedetomidine|dexmedetomidine|mesh-list
101287243|NCT04946396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101287244|NCT04946396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101287245|NCT04946396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287246|NCT04946396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101287247|NCT04946396|Analgesics|analgesics|mesh-ancestor
101287248|NCT04946396|Sensory System Agents|sensory system agents|mesh-ancestor
101287249|NCT04946396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101287250|NCT04946396|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101287251|NCT04946396|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101287252|NCT04946396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101287253|NCT04946396|Adrenergic Agents|adrenergic agents|mesh-ancestor
101287254|NCT04946396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101287255|NCT04946396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287256|NCT04908657|Sildenafil Citrate|sildenafil citrate|mesh-list
101287257|NCT04908657|Vasodilator Agents|vasodilator agents|mesh-ancestor
101287258|NCT04908657|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101287259|NCT04908657|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101287260|NCT04908657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101287261|NCT04908657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287262|NCT04908657|Urological Agents|urological agents|mesh-ancestor
101287263|NCT04887389|Listerine|listerine|mesh-list
101287264|NCT04887389|Fluorides|fluorides|mesh-list
101287265|NCT04887389|Sodium Fluoride|sodium fluoride|mesh-list
101287266|NCT04887389|Fluorides, Topical|fluorides, topical|mesh-list
101287267|NCT04887389|Cariostatic Agents|cariostatic agents|mesh-ancestor
101287268|NCT04887389|Protective Agents|protective agents|mesh-ancestor
101287269|NCT04887389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287270|NCT04887389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101287271|NCT04887389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101287272|NCT04773392|Mycophenolic Acid|mycophenolic acid|mesh-list
101287273|NCT04773392|Prednisone|prednisone|mesh-list
101287274|NCT04773392|Methylprednisolone|methylprednisolone|mesh-list
101287275|NCT04773392|Azathioprine|azathioprine|mesh-list
101287276|NCT04773392|Tacrolimus|tacrolimus|mesh-list
101287277|NCT04773392|Thymoglobulin|thymoglobulin|mesh-list
101287278|NCT04773392|Basiliximab|basiliximab|mesh-list
101287279|NCT04773392|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101287280|NCT04773392|Antimetabolites|antimetabolites|mesh-list
101287281|NCT04773392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101287282|NCT04773392|Glucocorticoids|glucocorticoids|mesh-ancestor
101287284|NCT04773392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101820232|NCT00446511|Protease Inhibitors|protease inhibitors|mesh-ancestor
101820233|NCT00446511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101820234|NCT01024491|Paroxetine|paroxetine|mesh-list
101820235|NCT01024491|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101820236|NCT01024491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101820237|NCT01024491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101820238|NCT01024491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820239|NCT01024491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101287285|NCT04773392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287286|NCT04773392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101287287|NCT04773392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101287288|NCT04773392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101287289|NCT04773392|Immunologic Factors|immunologic factors|mesh-ancestor
101287290|NCT04773392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101287291|NCT04773392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101287292|NCT04773392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287293|NCT04773392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101287294|NCT04773392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101287295|NCT04773392|Antitubercular Agents|antitubercular agents|mesh-ancestor
101287296|NCT04773392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101287297|NCT04773392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101287298|NCT04773392|Antiemetics|antiemetics|mesh-ancestor
101287299|NCT04773392|Autonomic Agents|autonomic agents|mesh-ancestor
101287300|NCT04773392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101287301|NCT04773392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101287302|NCT04773392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101287303|NCT04773392|Protective Agents|protective agents|mesh-ancestor
101287304|NCT04773392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101287305|NCT04773392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101287306|NCT04724655|Mineral Oil|mineral oil|mesh-list
101287308|NCT04724655|Dermatologic Agents|dermatologic agents|mesh-ancestor
101287309|NCT04722835|Albuterol|albuterol|mesh-list
101287310|NCT04722835|Dimercaprol|dimercaprol|mesh-list
101287311|NCT04722835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101287312|NCT04722835|Autonomic Agents|autonomic agents|mesh-ancestor
101287313|NCT04722835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101287314|NCT04722835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287315|NCT04722835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101287316|NCT04722835|Respiratory System Agents|respiratory system agents|mesh-ancestor
101287317|NCT04722835|Tocolytic Agents|tocolytic agents|mesh-ancestor
101287318|NCT04722835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101287319|NCT04722835|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101287320|NCT04722835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101287321|NCT04722835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101287322|NCT04722835|Adrenergic Agents|adrenergic agents|mesh-ancestor
101287323|NCT04722835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101287324|NCT04722835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287325|NCT04722835|Chelating Agents|chelating agents|mesh-ancestor
101287326|NCT04722835|Sequestering Agents|sequestering agents|mesh-ancestor
101287327|NCT04487990|Heparin|heparin|mesh-list
101287328|NCT04487990|Calcium heparin|calcium heparin|mesh-list
101287329|NCT04487990|Anticoagulants|anticoagulants|mesh-ancestor
101287330|NCT04487990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101287331|NCT04487990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101287332|NCT04487990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287333|NCT04476979|Dexamethasone|dexamethasone|mesh-list
101287334|NCT04476979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101287335|NCT04476979|Antiemetics|antiemetics|mesh-ancestor
101287336|NCT04476979|Autonomic Agents|autonomic agents|mesh-ancestor
101287337|NCT04476979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101287338|NCT04476979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287339|NCT04476979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101287340|NCT04476979|Glucocorticoids|glucocorticoids|mesh-ancestor
101287341|NCT04476979|Hormones|hormones|mesh-ancestor
101820240|NCT01024491|Serotonin Agents|serotonin agents|mesh-ancestor
101820241|NCT01024491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820242|NCT01024491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101820243|NCT01024491|Antidepressive Agents|antidepressive agents|mesh-ancestor
101820244|NCT01024491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101820245|NCT01024491|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101287342|NCT04476979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101287343|NCT04476979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101287344|NCT04476979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101287345|NCT04411953|Haloperidol|haloperidol|mesh-list
101287346|NCT04411953|Benztropine|benztropine|mesh-list
101287347|NCT04411953|Haloperidol decanoate|haloperidol decanoate|mesh-list
101287348|NCT04411953|Antiemetics|antiemetics|mesh-ancestor
101287349|NCT04411953|Autonomic Agents|autonomic agents|mesh-ancestor
101287350|NCT04411953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101287351|NCT04411953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287352|NCT04411953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101287353|NCT04411953|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101287354|NCT04411953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101287355|NCT04411953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101287356|NCT04411953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101287357|NCT04411953|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101287358|NCT04411953|Dopamine Agents|dopamine agents|mesh-ancestor
101287359|NCT04411953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101287360|NCT04411953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287361|NCT04411953|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101287362|NCT04411953|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101287363|NCT04411953|Parasympatholytics|parasympatholytics|mesh-ancestor
101287364|NCT04411953|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101287365|NCT04411953|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101287366|NCT04411953|Cholinergic Agents|cholinergic agents|mesh-ancestor
101287367|NCT04411953|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101287368|NCT04411953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101287369|NCT04411953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101287370|NCT04411940|Haloperidol|haloperidol|mesh-list
101287371|NCT04411940|Benztropine|benztropine|mesh-list
101287372|NCT04411940|Haloperidol decanoate|haloperidol decanoate|mesh-list
101287373|NCT04411940|Antiemetics|antiemetics|mesh-ancestor
101287375|NCT04411940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101287376|NCT04411940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287377|NCT04411940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101287379|NCT04411940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101287380|NCT04411940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101287381|NCT04411940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101287382|NCT04411940|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101287384|NCT04411940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101287385|NCT04411940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287386|NCT04411940|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101287387|NCT04411940|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101287388|NCT04411940|Parasympatholytics|parasympatholytics|mesh-ancestor
101287389|NCT04411940|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101287390|NCT04411940|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101287391|NCT04411940|Cholinergic Agents|cholinergic agents|mesh-ancestor
101287392|NCT04411940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101287393|NCT04411940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101287394|NCT04411940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101287395|NCT04035109|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101287396|NCT04035109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101287398|NCT04030429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101287399|NCT04030429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101287400|NCT04030429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101287401|NCT04030429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287402|NCT03970694|Capecitabine|capecitabine|mesh-list
101287403|NCT03970694|Oxaliplatin|oxaliplatin|mesh-list
101287404|NCT03970694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101287405|NCT03970694|Antimetabolites|antimetabolites|mesh-ancestor
101287406|NCT03970694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820246|NCT01024491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101820247|NCT01024491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101820248|NCT00446199|Drospirenone|drospirenone|mesh-list
101820249|NCT00446199|Estradiol|estradiol|mesh-list
101820250|NCT00446199|Estrogens|estrogens|mesh-ancestor
101820251|NCT00446199|Hormones|hormones|mesh-ancestor
101820252|NCT00446199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101820253|NCT00446199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820254|NCT00446199|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101287407|NCT03970694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101287408|NCT03941132|Ustekinumab|ustekinumab|mesh-list
101287409|NCT03941132|Dermatologic Agents|dermatologic agents|mesh-ancestor
101287410|NCT03873246|Varenicline|varenicline|mesh-list
101287411|NCT03873246|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101287412|NCT03873246|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101287413|NCT03873246|Cholinergic Agents|cholinergic agents|mesh-ancestor
101287414|NCT03873246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101287415|NCT03873246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287416|NCT03873246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287417|NCT03714880|Mifepristone|mifepristone|mesh-list
101287418|NCT03714880|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101287419|NCT03714880|Abortifacient Agents|abortifacient agents|mesh-ancestor
101287420|NCT03714880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101287421|NCT03714880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287422|NCT03714880|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101287423|NCT03714880|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101287424|NCT03714880|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101287425|NCT03714880|Contraceptive Agents|contraceptive agents|mesh-ancestor
101287426|NCT03714880|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101287427|NCT03714880|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101287428|NCT03714880|Hormone Antagonists|hormone antagonists|mesh-ancestor
101287429|NCT03714880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101287431|NCT03714880|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101287432|NCT03714880|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101287433|NCT03619850|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
101287434|NCT03619850|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101287435|NCT03619850|Hematinics|hematinics|mesh-ancestor
101287436|NCT03619850|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101287437|NCT03619850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101287438|NCT03559686|Certolizumab Pegol|certolizumab pegol|mesh-list
101287439|NCT03559686|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101287440|NCT03559686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101287441|NCT03559686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101287442|NCT03559686|Immunologic Factors|immunologic factors|mesh-ancestor
101287443|NCT03559686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287444|NCT03559686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101287445|NCT03559660|Certolizumab Pegol|certolizumab pegol|mesh-list
101287446|NCT03559660|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101287447|NCT03559660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101287448|NCT03559660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101287450|NCT03559660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287451|NCT03559660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101287452|NCT03532516|Brivaracetam|brivaracetam|mesh-list
101287454|NCT03333005|Antifungal Agents|antifungal agents|mesh-list
101287455|NCT03333005|Clotrimazole|clotrimazole|mesh-list
101287456|NCT03333005|Miconazole|miconazole|mesh-list
101287457|NCT03333005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101287458|NCT03333005|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101287459|NCT03333005|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101287460|NCT03333005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101287461|NCT03333005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101287462|NCT03333005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287463|NCT03333005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101287464|NCT03333005|Hormone Antagonists|hormone antagonists|mesh-ancestor
101820255|NCT00446199|Hormone Antagonists|hormone antagonists|mesh-ancestor
101820256|NCT00446199|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101820257|NCT00446199|Diuretics|diuretics|mesh-ancestor
101820258|NCT00446199|Natriuretic Agents|natriuretic agents|mesh-ancestor
101820259|NCT01027689|Alprazolam|alprazolam|mesh-list
101820260|NCT01027689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101287465|NCT03333005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101287466|NCT03333005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287467|NCT03333005|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101287468|NCT03333005|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101287469|NCT03148366|Levofloxacin|levofloxacin|mesh-list
101287470|NCT03148366|Bismuth|bismuth|mesh-list
101287471|NCT03148366|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101287472|NCT03148366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101287473|NCT03148366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101287474|NCT03148366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101287475|NCT03148366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101287476|NCT03148366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101287477|NCT03148366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287478|NCT03148366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101287479|NCT03148366|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101287480|NCT03148366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101287481|NCT03148366|Antacids|antacids|mesh-ancestor
101287482|NCT03148366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101287483|NCT03122496|Durvalumab|durvalumab|mesh-list
101287484|NCT03122496|Tremelimumab|tremelimumab|mesh-list
101287485|NCT03122496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101287486|NCT03122496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101287487|NCT03073694|Melphalan|melphalan|mesh-list
101287488|NCT03073694|Mitomycins|mitomycins|mesh-list
101287489|NCT03073694|Mitomycin|mitomycin|mesh-list
101287490|NCT03073694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101287491|NCT03073694|Alkylating Agents|alkylating agents|mesh-ancestor
101287492|NCT03073694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287493|NCT03073694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101287495|NCT03073694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101287496|NCT03073694|Immunologic Factors|immunologic factors|mesh-ancestor
101287497|NCT03073694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287498|NCT03073694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101287499|NCT03073694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101287500|NCT03073694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101287502|NCT03069703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101287503|NCT03069703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101287504|NCT03069703|Immunologic Factors|immunologic factors|mesh-ancestor
101287505|NCT03069703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287506|NCT03069703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101287510|NCT02862548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101287511|NCT02818738|Levamisole|levamisole|mesh-list
101287512|NCT02818738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101287513|NCT02818738|Immunologic Factors|immunologic factors|mesh-ancestor
101287514|NCT02818738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287515|NCT02818738|Antinematodal Agents|antinematodal agents|mesh-ancestor
101287516|NCT02818738|Anthelmintics|anthelmintics|mesh-ancestor
101287517|NCT02818738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101287518|NCT02818738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101287519|NCT02818738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101287520|NCT02335099|Ticagrelor|ticagrelor|mesh-list
101287521|NCT02335099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101287522|NCT02335099|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101287523|NCT02335099|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101287524|NCT02335099|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101287525|NCT02335099|Purinergic Agents|purinergic agents|mesh-ancestor
101287526|NCT02335099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101287527|NCT02335099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287528|NCT02335099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287529|NCT02330562|Bevacizumab|bevacizumab|mesh-list
101287530|NCT02330562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101820261|NCT01027689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101820262|NCT01027689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820263|NCT01027689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101820264|NCT01027689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101820265|NCT01027689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101820266|NCT01027689|GABA Modulators|gaba modulators|mesh-ancestor
101820267|NCT01027689|GABA Agents|gaba agents|mesh-ancestor
101820268|NCT01027689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101820269|NCT01027689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820270|NCT01024647|Certolizumab Pegol|certolizumab pegol|mesh-list
101820271|NCT01024647|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101820272|NCT01024647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101820273|NCT01024647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101287531|NCT02330562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101287532|NCT02330562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101287533|NCT02330562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101287534|NCT02330562|Growth Substances|growth substances|mesh-ancestor
101287535|NCT02330562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287536|NCT02330562|Growth Inhibitors|growth inhibitors|mesh-ancestor
101287537|NCT02053363|Tranexamic Acid|tranexamic acid|mesh-list
101287538|NCT02053363|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101287539|NCT02053363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101287540|NCT02053363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287541|NCT02053363|Hemostatics|hemostatics|mesh-ancestor
101287542|NCT02053363|Coagulants|coagulants|mesh-ancestor
101287543|NCT01100775|Galantamine|galantamine|mesh-list
101287544|NCT01100775|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101287545|NCT01100775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101287546|NCT01100775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287547|NCT01100775|Cholinergic Agents|cholinergic agents|mesh-ancestor
101287548|NCT01100775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101287549|NCT01100775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287550|NCT01100775|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101287551|NCT01100775|Autonomic Agents|autonomic agents|mesh-ancestor
101287552|NCT01100775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101287553|NCT01100775|Nootropic Agents|nootropic agents|mesh-ancestor
101287554|NCT00504712|Testosterone|testosterone|mesh-list
101287555|NCT00504712|Androgens|androgens|mesh-ancestor
101287556|NCT00504712|Hormones|hormones|mesh-ancestor
101287557|NCT00504712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101287558|NCT00504712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287559|NCT05413200|Isotretinoin|isotretinoin|mesh-list
101287560|NCT05413200|Dermatologic Agents|dermatologic agents|mesh-ancestor
101287562|NCT05412589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101287563|NCT05412589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101287564|NCT05412589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101287565|NCT05412589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287566|NCT05412576|Lidocaine|lidocaine|mesh-list
101287567|NCT05412576|Anesthetics, Local|anesthetics, local|mesh-ancestor
101287568|NCT05412576|Anesthetics|anesthetics|mesh-ancestor
101287569|NCT05412576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101287570|NCT05412576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287571|NCT05412576|Sensory System Agents|sensory system agents|mesh-ancestor
101287572|NCT05412576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101287573|NCT05412576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101287574|NCT05412576|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101287575|NCT05412576|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101287576|NCT05412576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101287577|NCT05412576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820274|NCT01024647|Immunologic Factors|immunologic factors|mesh-ancestor
101820275|NCT01024647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820276|NCT01024647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101820277|NCT01027923|Cytarabine|cytarabine|mesh-list
101820278|NCT01027923|Plerixafor|plerixafor|mesh-list
101820279|NCT01027923|Etoposide|etoposide|mesh-list
101820280|NCT01027923|Mitoxantrone|mitoxantrone|mesh-list
101820281|NCT01027923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101820282|NCT01027923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101820283|NCT01027923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101820284|NCT01027923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101820285|NCT01027923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101287578|NCT05412472|Avasopasem manganese|avasopasem manganese|mesh-list
101287579|NCT05412472|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101287580|NCT05412472|Antioxidants|antioxidants|mesh-ancestor
101287581|NCT05412472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287582|NCT05412472|Protective Agents|protective agents|mesh-ancestor
101287583|NCT05412472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287584|NCT05412394|Prednisolone|prednisolone|mesh-list
101287585|NCT05412394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101287586|NCT05412394|Glucocorticoids|glucocorticoids|mesh-ancestor
101287587|NCT05412394|Hormones|hormones|mesh-ancestor
101287588|NCT05412394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101287589|NCT05412394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287590|NCT05412394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101287591|NCT05412394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101287592|NCT05412147|Vitamins|vitamins|mesh-list
101287593|NCT05412147|Micronutrients|micronutrients|mesh-ancestor
101287594|NCT05412147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287595|NCT05411900|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
101287596|NCT05411900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101287597|NCT05411900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101287598|NCT05411900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287599|NCT05411900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101287600|NCT05411900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101287601|NCT05411900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287602|NCT05411900|Cholinergic Agents|cholinergic agents|mesh-ancestor
101287603|NCT05411900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101287604|NCT05411757|Bevacizumab|bevacizumab|mesh-list
101287606|NCT05411757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101287607|NCT05411757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101287608|NCT05411757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101287609|NCT05411757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101287610|NCT05411757|Growth Substances|growth substances|mesh-ancestor
101287611|NCT05411757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287612|NCT05411757|Growth Inhibitors|growth inhibitors|mesh-ancestor
101287613|NCT05411757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101287614|NCT05411757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101287615|NCT05411757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287616|NCT05411666|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101287617|NCT05411276|Maleic acid|maleic acid|mesh-list
101287618|NCT05411276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101287619|NCT05411276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287620|NCT05396781|Proflavine|proflavine|mesh-list
101287621|NCT05396781|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101287622|NCT05396781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101287624|NCT05384951|Cholecalciferol|cholecalciferol|mesh-list
101287625|NCT05384951|Vitamins|vitamins|mesh-ancestor
101287626|NCT05384951|Micronutrients|micronutrients|mesh-ancestor
101287627|NCT05384951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287628|NCT05384951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101287629|NCT05384951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101287630|NCT05303038|Bevacizumab|bevacizumab|mesh-list
101820286|NCT01027923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820287|NCT01027923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101820288|NCT01027923|Antimetabolites|antimetabolites|mesh-ancestor
101820289|NCT01027923|Antiviral Agents|antiviral agents|mesh-ancestor
101820290|NCT01027923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101820291|NCT01027923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101820292|NCT01027923|Immunologic Factors|immunologic factors|mesh-ancestor
101287631|NCT05303038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101287632|NCT05303038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101287634|NCT05303038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101287635|NCT05303038|Growth Substances|growth substances|mesh-ancestor
101287636|NCT05303038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287637|NCT05303038|Growth Inhibitors|growth inhibitors|mesh-ancestor
101287638|NCT05275894|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101287639|NCT05275894|Metronidazole|metronidazole|mesh-list
101287640|NCT05275894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101287641|NCT05275894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101287642|NCT05275894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101287644|NCT05077800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101287645|NCT05077800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101287646|NCT05077800|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101287647|NCT05077800|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101287648|NCT05077800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287649|NCT05062902|Botulinum Toxins|botulinum toxins|mesh-list
101287650|NCT05062902|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101287651|NCT05062902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101287652|NCT05062902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287653|NCT05062902|Cholinergic Agents|cholinergic agents|mesh-ancestor
101287654|NCT05062902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101287655|NCT05062902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287656|NCT05042674|Ergothioneine|ergothioneine|mesh-list
101287657|NCT05042674|Antioxidants|antioxidants|mesh-ancestor
101287658|NCT05042674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287659|NCT05042674|Protective Agents|protective agents|mesh-ancestor
101287660|NCT05042674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287661|NCT04927585|Vaccines|vaccines|mesh-list
101287662|NCT04927585|Immunologic Factors|immunologic factors|mesh-ancestor
101287663|NCT04927585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287664|NCT04917055|Dexamethasone|dexamethasone|mesh-list
101287665|NCT04917055|Epinephrine|epinephrine|mesh-list
101287666|NCT04917055|Ropivacaine|ropivacaine|mesh-list
101287667|NCT04917055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101287669|NCT04917055|Autonomic Agents|autonomic agents|mesh-ancestor
101287670|NCT04917055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101287671|NCT04917055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287672|NCT04917055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101287673|NCT04917055|Glucocorticoids|glucocorticoids|mesh-ancestor
101287674|NCT04917055|Hormones|hormones|mesh-ancestor
101287675|NCT04917055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101287676|NCT04917055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101287677|NCT04917055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101287678|NCT04917055|Anesthetics, Local|anesthetics, local|mesh-ancestor
101287679|NCT04917055|Anesthetics|anesthetics|mesh-ancestor
101287680|NCT04917055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101287681|NCT04917055|Sensory System Agents|sensory system agents|mesh-ancestor
101287682|NCT04917055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101287683|NCT04917055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101287684|NCT04917055|Adrenergic Agents|adrenergic agents|mesh-ancestor
101287685|NCT04917055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101287686|NCT04917055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287687|NCT04917055|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101287688|NCT04917055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101287689|NCT04917055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101287690|NCT04917055|Respiratory System Agents|respiratory system agents|mesh-ancestor
101287691|NCT04917055|Mydriatics|mydriatics|mesh-ancestor
101287692|NCT04917055|Sympathomimetics|sympathomimetics|mesh-ancestor
101820293|NCT01027923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820294|NCT01027923|Analgesics|analgesics|mesh-ancestor
101820295|NCT01027923|Sensory System Agents|sensory system agents|mesh-ancestor
101820296|NCT01027923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101820297|NCT01027923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101820298|NCT01027923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101820299|NCT01565733|Insulin Aspart|insulin aspart|mesh-list
101820300|NCT01565733|Biphasic Insulins|biphasic insulins|mesh-list
101820301|NCT01565733|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101287693|NCT04917055|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101287694|NCT04898478|Analgesics, Opioid|analgesics, opioid|mesh-list
101287695|NCT04898478|Narcotics|narcotics|mesh-ancestor
101287696|NCT04898478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101287697|NCT04898478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287698|NCT04898478|Analgesics|analgesics|mesh-ancestor
101287699|NCT04898478|Sensory System Agents|sensory system agents|mesh-ancestor
101287700|NCT04898478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101287701|NCT04725864|Progesterone|progesterone|mesh-list
101287702|NCT04725864|Progestins|progestins|mesh-ancestor
101287703|NCT04725864|Hormones|hormones|mesh-ancestor
101287704|NCT04725864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101287705|NCT04725864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287706|NCT04721821|Tofacitinib|tofacitinib|mesh-list
101287707|NCT04721821|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101287708|NCT04721821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101287709|NCT04721821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101287710|NCT04721821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287711|NCT04655391|Decitabine|decitabine|mesh-list
101287712|NCT04655391|Venetoclax|venetoclax|mesh-list
101287713|NCT04655391|Ivosidenib|ivosidenib|mesh-list
101287714|NCT04655391|Maleic acid|maleic acid|mesh-list
101287715|NCT04655391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101287716|NCT04655391|Antimetabolites|antimetabolites|mesh-ancestor
101287717|NCT04655391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287718|NCT04655391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101287719|NCT04655391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101287720|NCT04609098|Piperaquine|piperaquine|mesh-list
101287721|NCT04609098|Artenimol|artenimol|mesh-list
101287722|NCT04609098|Tafenoquine|tafenoquine|mesh-list
101287723|NCT04609098|Antimalarials|antimalarials|mesh-ancestor
101287724|NCT04609098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101287725|NCT04609098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101287726|NCT04609098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101287727|NCT04605614|Copper|copper|mesh-list
101287728|NCT04605614|Pembrolizumab|pembrolizumab|mesh-list
101287729|NCT04605614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101287730|NCT04605614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101287731|NCT04605614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101408620|NCT00143676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101287732|NCT04605614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287733|NCT04605614|Trace Elements|trace elements|mesh-ancestor
101287734|NCT04605614|Micronutrients|micronutrients|mesh-ancestor
101287735|NCT04605614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287736|NCT04475016|Paclitaxel|paclitaxel|mesh-list
101287737|NCT04475016|Ifosfamide|ifosfamide|mesh-list
101287738|NCT04475016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101287739|NCT04475016|Nimotuzumab|nimotuzumab|mesh-list
101287740|NCT04475016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101287741|NCT04475016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101287742|NCT04475016|Tubulin Modulators|tubulin modulators|mesh-ancestor
101287743|NCT04475016|Antimitotic Agents|antimitotic agents|mesh-ancestor
101287744|NCT04475016|Mitosis Modulators|mitosis modulators|mesh-ancestor
101287745|NCT04475016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287746|NCT04475016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101287747|NCT04475016|Alkylating Agents|alkylating agents|mesh-ancestor
101287748|NCT04475016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101287750|NCT04321551|Methyltestosterone|methyltestosterone|mesh-list
101820302|NCT01565733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101820303|NCT01565733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820305|NCT01027065|Entecavir|entecavir|mesh-list
101820306|NCT01027065|Antiviral Agents|antiviral agents|mesh-ancestor
101820307|NCT01027065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101820308|NCT01027065|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101820309|NCT01027065|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101820310|NCT01027065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101820311|NCT01027065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287751|NCT04321551|Testosterone|testosterone|mesh-list
101287752|NCT04321551|Testosterone undecanoate|testosterone undecanoate|mesh-list
101287753|NCT04321551|Testosterone enanthate|testosterone enanthate|mesh-list
101287754|NCT04321551|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101287755|NCT04321551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101287756|NCT04321551|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101287757|NCT04321551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101287758|NCT04321551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101287759|NCT04321551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287760|NCT04321551|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101287761|NCT04321551|Hormone Antagonists|hormone antagonists|mesh-ancestor
101287762|NCT04321551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101287763|NCT04321551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287764|NCT04321551|Androgens|androgens|mesh-ancestor
101287765|NCT04321551|Hormones|hormones|mesh-ancestor
101287766|NCT04321551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101287767|NCT04321551|Anabolic Agents|anabolic agents|mesh-ancestor
101287768|NCT04174781|Immunomodulating Agents|immunomodulating agents|mesh-list
101287769|NCT04174781|Immunologic Factors|immunologic factors|mesh-ancestor
101287770|NCT04174781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287771|NCT04074460|Propofol|propofol|mesh-list
101287772|NCT04074460|Sevoflurane|sevoflurane|mesh-list
101287773|NCT04074460|Desflurane|desflurane|mesh-list
101287774|NCT04074460|Isoflurane|isoflurane|mesh-list
101287775|NCT04074460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101287776|NCT04074460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101287777|NCT04074460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287778|NCT04074460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101287779|NCT04074460|Anesthetics, General|anesthetics, general|mesh-ancestor
101287780|NCT04074460|Anesthetics|anesthetics|mesh-ancestor
101287781|NCT04074460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101287782|NCT04074460|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101287783|NCT03817125|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101287784|NCT03817125|Vancomycin|vancomycin|mesh-list
101287785|NCT03817125|Nivolumab|nivolumab|mesh-list
101287786|NCT03817125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101287787|NCT03817125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101287788|NCT03817125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101287789|NCT03817125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287790|NCT03817125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101287791|NCT03703102|KHK4083|khk4083|mesh-list
101287792|NCT03703102|Dermatologic Agents|dermatologic agents|mesh-ancestor
101287793|NCT03581370|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
101287794|NCT03581370|Cephalosporins|cephalosporins|mesh-list
101287795|NCT03581370|Penicillanic Acid|penicillanic acid|mesh-list
101287796|NCT03581370|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101287798|NCT03581370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101287799|NCT03581370|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101287800|NCT03581370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101287801|NCT03581370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287802|NCT03568604|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101287803|NCT03568604|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101287804|NCT03568604|Immunologic Factors|immunologic factors|mesh-ancestor
101287805|NCT03568604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287806|NCT03539055|Dabigatran|dabigatran|mesh-list
101287807|NCT03539055|Antithrombins|antithrombins|mesh-ancestor
101820312|NCT01027065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101820313|NCT01027065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101820314|NCT00456495|Ranibizumab|ranibizumab|mesh-list
101820315|NCT00456495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101820316|NCT00456495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101820317|NCT00456495|Growth Substances|growth substances|mesh-ancestor
101820318|NCT00456495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287808|NCT03539055|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101287809|NCT03539055|Protease Inhibitors|protease inhibitors|mesh-ancestor
101287811|NCT03539055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287812|NCT03539055|Anticoagulants|anticoagulants|mesh-ancestor
101287813|NCT03485534|Tenofovir|tenofovir|mesh-list
101287814|NCT03485534|Antiviral Agents|antiviral agents|mesh-ancestor
101287815|NCT03485534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101287816|NCT03485534|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101287817|NCT03485534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101287819|NCT03485534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287820|NCT03485534|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101287821|NCT03485534|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101287822|NCT03427736|Ketorolac|ketorolac|mesh-list
101287823|NCT03427736|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101287824|NCT03427736|Ketamine|ketamine|mesh-list
101287825|NCT03427736|Morphine|morphine|mesh-list
101287826|NCT03427736|Oxycodone|oxycodone|mesh-list
101287827|NCT03427736|Hydromorphone|hydromorphone|mesh-list
101287828|NCT03427736|Analgesics|analgesics|mesh-ancestor
101287829|NCT03427736|Sensory System Agents|sensory system agents|mesh-ancestor
101287830|NCT03427736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101287831|NCT03427736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287832|NCT03427736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101287833|NCT03427736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101287834|NCT03427736|Anesthetics, General|anesthetics, general|mesh-ancestor
101287835|NCT03427736|Anesthetics|anesthetics|mesh-ancestor
101287836|NCT03427736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101287837|NCT03427736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101287838|NCT03427736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101287839|NCT03427736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101287840|NCT03427736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287841|NCT03427736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101287842|NCT03427736|Narcotics|narcotics|mesh-ancestor
101316277|NCT03797560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101287843|NCT03427736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101287844|NCT03427736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101287845|NCT03427736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101287846|NCT03427736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101287847|NCT03427736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101287848|NCT03427736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101287849|NCT03395704|Hepcidins|hepcidins|mesh-list
101287850|NCT03395704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101287851|NCT03246503|Bilirubin|bilirubin|mesh-list
101287852|NCT03246503|Antioxidants|antioxidants|mesh-ancestor
101287853|NCT03246503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287854|NCT03246503|Protective Agents|protective agents|mesh-ancestor
101287855|NCT03246503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287856|NCT03091881|Granisetron|granisetron|mesh-list
101287857|NCT03091881|Antiemetics|antiemetics|mesh-ancestor
101287858|NCT03091881|Autonomic Agents|autonomic agents|mesh-ancestor
101287859|NCT03091881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101287860|NCT03091881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287861|NCT03091881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101287862|NCT03091881|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101287863|NCT03091881|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101287864|NCT03091881|Serotonin Agents|serotonin agents|mesh-ancestor
101287865|NCT03091881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101287866|NCT03091881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287867|NCT02864368|Temozolomide|temozolomide|mesh-list
101287868|NCT02864368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101287869|NCT02864368|Alkylating Agents|alkylating agents|mesh-ancestor
101820319|NCT00456495|Growth Inhibitors|growth inhibitors|mesh-ancestor
101820320|NCT00456495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101820321|NCT00445341|Alvocidib|alvocidib|mesh-list
101820322|NCT00445341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101820323|NCT00445341|Growth Inhibitors|growth inhibitors|mesh-ancestor
101820324|NCT00445341|Growth Substances|growth substances|mesh-ancestor
101820325|NCT00445341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820326|NCT00445341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101820327|NCT00445341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101287870|NCT02864368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287871|NCT02864368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101287872|NCT02856698|Midazolam|midazolam|mesh-list
101287873|NCT02856698|Morphine|morphine|mesh-list
101287874|NCT02856698|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101287875|NCT02856698|Narcotics|narcotics|mesh-ancestor
101287876|NCT02856698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101287877|NCT02856698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287878|NCT02856698|Analgesics|analgesics|mesh-ancestor
101287879|NCT02856698|Sensory System Agents|sensory system agents|mesh-ancestor
101287880|NCT02856698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101287881|NCT02856698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101287882|NCT02856698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101287883|NCT02856698|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101287884|NCT02856698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101287885|NCT02856698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101287886|NCT02856698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101287887|NCT02856698|Anesthetics, General|anesthetics, general|mesh-ancestor
101287888|NCT02856698|Anesthetics|anesthetics|mesh-ancestor
101287889|NCT02856698|GABA Modulators|gaba modulators|mesh-ancestor
101287890|NCT02856698|GABA Agents|gaba agents|mesh-ancestor
101287891|NCT02856698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101287892|NCT02856698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287893|NCT02793375|Montelukast|montelukast|mesh-list
101287894|NCT02793375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101287895|NCT02793375|Respiratory System Agents|respiratory system agents|mesh-ancestor
101287896|NCT02793375|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101287897|NCT02793375|Hormone Antagonists|hormone antagonists|mesh-ancestor
101287898|NCT02793375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101287899|NCT02793375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287900|NCT02793375|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101287901|NCT02793375|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101534820|NCT04580342|Vasodilator Agents|vasodilator agents|mesh-ancestor
101287902|NCT02793375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287904|NCT02625610|Fluorouracil|fluorouracil|mesh-list
101287905|NCT02625610|Capecitabine|capecitabine|mesh-list
101287906|NCT02625610|Oxaliplatin|oxaliplatin|mesh-list
101287907|NCT02625610|Avelumab|avelumab|mesh-list
101287908|NCT02625610|Levoleucovorin|levoleucovorin|mesh-list
101287909|NCT02625610|Antimetabolites|antimetabolites|mesh-ancestor
101287910|NCT02625610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287911|NCT02625610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101287912|NCT02625610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101287913|NCT02625610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101287914|NCT02625610|Immunologic Factors|immunologic factors|mesh-ancestor
101287915|NCT02625610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287916|NCT02625610|Antidotes|antidotes|mesh-ancestor
101287917|NCT02625610|Protective Agents|protective agents|mesh-ancestor
101287918|NCT02625610|Vitamin B Complex|vitamin b complex|mesh-ancestor
101287919|NCT02625610|Vitamins|vitamins|mesh-ancestor
101287920|NCT02625610|Micronutrients|micronutrients|mesh-ancestor
101287921|NCT02625610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101287922|NCT02515591|Dimercaprol|dimercaprol|mesh-list
101287923|NCT02515591|Chelating Agents|chelating agents|mesh-ancestor
101287924|NCT02515591|Sequestering Agents|sequestering agents|mesh-ancestor
101287925|NCT02515591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287926|NCT02514447|Topotecan|topotecan|mesh-list
101287927|NCT02514447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101287928|NCT02514447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101820328|NCT00445341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820329|NCT03846453|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101820330|NCT03846453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101820331|NCT00444951|Vaccines|vaccines|mesh-list
101820332|NCT00444951|Immunologic Factors|immunologic factors|mesh-ancestor
101820333|NCT00444951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820334|NCT00444795|Sunitinib|sunitinib|mesh-list
101287929|NCT02514447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101287930|NCT02514447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287931|NCT02514447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101287932|NCT02257346|Lidocaine|lidocaine|mesh-list
101287933|NCT02257346|Anesthetics, Local|anesthetics, local|mesh-ancestor
101287934|NCT02257346|Anesthetics|anesthetics|mesh-ancestor
101287935|NCT02257346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101287936|NCT02257346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287937|NCT02257346|Sensory System Agents|sensory system agents|mesh-ancestor
101287939|NCT02257346|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101287940|NCT02257346|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101287941|NCT02257346|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101287942|NCT02257346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101287943|NCT02257346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287944|NCT02167477|Pyrithione zinc|pyrithione zinc|mesh-list
101287945|NCT02167477|Keratolytic Agents|keratolytic agents|mesh-ancestor
101287946|NCT02167477|Dermatologic Agents|dermatologic agents|mesh-ancestor
101287948|NCT00712322|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101287949|NCT00712322|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101287950|NCT00712322|Cholinergic Agents|cholinergic agents|mesh-ancestor
101287951|NCT00712322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101287952|NCT00712322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287953|NCT00712322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287954|NCT00712322|Urological Agents|urological agents|mesh-ancestor
101287955|NCT00323856|Factor VIII|factor viii|mesh-list
101287956|NCT00323856|Coagulants|coagulants|mesh-ancestor
101287957|NCT05415150|Fibrinolytic Agents|fibrinolytic agents|mesh-list
101287958|NCT05415150|Eptifibatide|eptifibatide|mesh-list
101287959|NCT05415150|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101287960|NCT05415150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101287961|NCT05415150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287962|NCT05414942|Analgesics, Opioid|analgesics, opioid|mesh-list
101287963|NCT05414942|Narcotics|narcotics|mesh-ancestor
101408626|NCT00454480|Busulfan|busulfan|mesh-list
101287964|NCT05414942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101287965|NCT05414942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287967|NCT05414942|Sensory System Agents|sensory system agents|mesh-ancestor
101287968|NCT05414942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101287969|NCT05414721|Anesthetics|anesthetics|mesh-list
101287970|NCT05414721|Desflurane|desflurane|mesh-list
101287971|NCT05414721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101287972|NCT05414721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287973|NCT05414721|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101287974|NCT05414721|Anesthetics, General|anesthetics, general|mesh-ancestor
101287975|NCT05414669|Allopurinol|allopurinol|mesh-list
101287976|NCT05414669|Antimetabolites|antimetabolites|mesh-ancestor
101287977|NCT05414669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287978|NCT05414669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101287979|NCT05414669|Gout Suppressants|gout suppressants|mesh-ancestor
101287980|NCT05414669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101287981|NCT05414669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101287982|NCT05414669|Antioxidants|antioxidants|mesh-ancestor
101287983|NCT05414669|Protective Agents|protective agents|mesh-ancestor
101287984|NCT05414669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287985|NCT05414474|Ascorbic Acid|ascorbic acid|mesh-list
101287986|NCT05414474|Antioxidants|antioxidants|mesh-ancestor
101287987|NCT05414474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101287988|NCT05414474|Protective Agents|protective agents|mesh-ancestor
101287989|NCT05414474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287990|NCT05414474|Vitamins|vitamins|mesh-ancestor
101287991|NCT05414474|Micronutrients|micronutrients|mesh-ancestor
101820335|NCT00444795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101820336|NCT00444795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101820337|NCT00444795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101820338|NCT00444795|Growth Substances|growth substances|mesh-ancestor
101820339|NCT00444795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820340|NCT00444795|Growth Inhibitors|growth inhibitors|mesh-ancestor
101820341|NCT00444795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101820342|NCT00444795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101820343|NCT00444795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820344|NCT03846219|Calcium, Dietary|calcium, dietary|mesh-list
101820345|NCT03846219|Calcium|calcium|mesh-list
101287992|NCT05414292|Sirolimus|sirolimus|mesh-list
101287993|NCT05414292|Temsirolimus|temsirolimus|mesh-list
101287994|NCT05414292|MTOR Inhibitors|mtor inhibitors|mesh-list
101287995|NCT05414292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101287996|NCT05414292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101287997|NCT05414292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101287998|NCT05414292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101287999|NCT05414292|Antifungal Agents|antifungal agents|mesh-ancestor
101288000|NCT05414292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101288001|NCT05414292|Immunologic Factors|immunologic factors|mesh-ancestor
101288002|NCT05414292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288003|NCT05414292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101288004|NCT05414292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101288005|NCT05414292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288006|NCT05414149|Ranibizumab|ranibizumab|mesh-list
101288007|NCT05414149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101288008|NCT05414149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101288010|NCT05414149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288012|NCT05414149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101288013|NCT05413902|Acetaminophen|acetaminophen|mesh-list
101288014|NCT05413902|Methylprednisolone|methylprednisolone|mesh-list
101288015|NCT05413902|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101288016|NCT05413902|Lidocaine|lidocaine|mesh-list
101288017|NCT05413902|Epinephrine|epinephrine|mesh-list
101288018|NCT05413902|Morphine|morphine|mesh-list
101288019|NCT05413902|Narcotics|narcotics|mesh-list
101288020|NCT05413902|Gabapentin|gabapentin|mesh-list
101288021|NCT05413902|Orphenadrine|orphenadrine|mesh-list
101288022|NCT05413902|Bupivacaine|bupivacaine|mesh-list
101288023|NCT05413902|Anesthetics, Local|anesthetics, local|mesh-ancestor
101288024|NCT05413902|Anesthetics|anesthetics|mesh-ancestor
101288025|NCT05413902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101288026|NCT05413902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288027|NCT05413902|Sensory System Agents|sensory system agents|mesh-ancestor
101288028|NCT05413902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101288029|NCT05413902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101288030|NCT05413902|Analgesics|analgesics|mesh-ancestor
101288031|NCT05413902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101288032|NCT05413902|Antipyretics|antipyretics|mesh-ancestor
101288033|NCT05413902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101288034|NCT05413902|Antiemetics|antiemetics|mesh-ancestor
101288035|NCT05413902|Autonomic Agents|autonomic agents|mesh-ancestor
101288036|NCT05413902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101288037|NCT05413902|Glucocorticoids|glucocorticoids|mesh-ancestor
101288038|NCT05413902|Hormones|hormones|mesh-ancestor
101288039|NCT05413902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101288040|NCT05413902|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101288041|NCT05413902|Protective Agents|protective agents|mesh-ancestor
101288042|NCT05413902|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101288043|NCT05413902|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101288044|NCT05413902|Adrenergic Agents|adrenergic agents|mesh-ancestor
101288045|NCT05413902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101288046|NCT05413902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288047|NCT05413902|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101288048|NCT05413902|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101820346|NCT03846219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101820347|NCT03846219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820348|NCT03846219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101820349|NCT00455325|Chloroquine|chloroquine|mesh-list
101820350|NCT00455325|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
101288049|NCT05413902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101288050|NCT05413902|Respiratory System Agents|respiratory system agents|mesh-ancestor
101288052|NCT05413902|Sympathomimetics|sympathomimetics|mesh-ancestor
101288053|NCT05413902|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101288054|NCT05413902|Anticonvulsants|anticonvulsants|mesh-ancestor
101288055|NCT05413902|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101288056|NCT05413902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101288057|NCT05413902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101288058|NCT05413902|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101288059|NCT05413902|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101288060|NCT05413902|Antimanic Agents|antimanic agents|mesh-ancestor
101288061|NCT05413902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101288062|NCT05413902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101288063|NCT05413902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101288064|NCT05413902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101288065|NCT05413902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101288066|NCT05413902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101288067|NCT05413902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101288068|NCT05413902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101288069|NCT05413902|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101288070|NCT05413902|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101288071|NCT05413902|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101288072|NCT05413902|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101288073|NCT05413902|Parasympatholytics|parasympatholytics|mesh-ancestor
101288074|NCT05413902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101288075|NCT05413902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101288076|NCT05413902|Cholinergic Agents|cholinergic agents|mesh-ancestor
101288077|NCT05413902|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
101288078|NCT05413902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101288079|NCT05413746|Antioxidants|antioxidants|mesh-list
101288080|NCT05413746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288081|NCT05413746|Protective Agents|protective agents|mesh-ancestor
101288082|NCT05413746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288084|NCT05409365|Immunoglobulins|immunoglobulins|mesh-list
101288085|NCT05409365|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101288086|NCT05409365|Immunologic Factors|immunologic factors|mesh-ancestor
101288087|NCT05409365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288088|NCT05397587|Vaccines|vaccines|mesh-list
101288089|NCT05397587|Immunologic Factors|immunologic factors|mesh-ancestor
101288090|NCT05397587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288091|NCT05378880|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101288092|NCT05378880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101288093|NCT05352178|Ascorbic Acid|ascorbic acid|mesh-list
101288094|NCT05352178|Methyltestosterone|methyltestosterone|mesh-list
101288095|NCT05352178|Androgens|androgens|mesh-list
101288096|NCT05352178|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101288098|NCT05352178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101288099|NCT05352178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288100|NCT05352178|Antioxidants|antioxidants|mesh-ancestor
101288101|NCT05352178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288102|NCT05352178|Protective Agents|protective agents|mesh-ancestor
101288103|NCT05352178|Vitamins|vitamins|mesh-ancestor
101288104|NCT05352178|Micronutrients|micronutrients|mesh-ancestor
101288105|NCT05352178|Estrogens|estrogens|mesh-ancestor
101288106|NCT05352178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101288107|NCT05352178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101288108|NCT05352178|Anabolic Agents|anabolic agents|mesh-ancestor
101288109|NCT05328141|Ascorbic Acid|ascorbic acid|mesh-list
101288110|NCT05328141|Antioxidants|antioxidants|mesh-ancestor
101288111|NCT05328141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288112|NCT05328141|Protective Agents|protective agents|mesh-ancestor
101288113|NCT05328141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288114|NCT05328141|Vitamins|vitamins|mesh-ancestor
101288115|NCT05328141|Micronutrients|micronutrients|mesh-ancestor
101820351|NCT00455325|Amebicides|amebicides|mesh-ancestor
101820352|NCT00455325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101477647|NCT00315276|Modafinil|modafinil|mesh-list
101820353|NCT00455325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101820354|NCT00455325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101288116|NCT05310916|Dapagliflozin|dapagliflozin|mesh-list
101288117|NCT05310916|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101288118|NCT05310916|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101288119|NCT05310916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288121|NCT05251493|Iron|iron|mesh-list
101288122|NCT05251493|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101288123|NCT05251493|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
101288124|NCT05251493|Trace Elements|trace elements|mesh-ancestor
101288125|NCT05251493|Micronutrients|micronutrients|mesh-ancestor
101288126|NCT05251493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288127|NCT05251493|Hematinics|hematinics|mesh-ancestor
101288128|NCT05233709|Fesoterodine|fesoterodine|mesh-list
101288129|NCT05233709|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101288130|NCT05233709|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101288131|NCT05233709|Cholinergic Agents|cholinergic agents|mesh-ancestor
101288132|NCT05233709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101288133|NCT05233709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288134|NCT05233709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288135|NCT05233709|Urological Agents|urological agents|mesh-ancestor
101288136|NCT05173896|Tadalafil|tadalafil|mesh-list
101288137|NCT05173896|Vasodilator Agents|vasodilator agents|mesh-ancestor
101288138|NCT05173896|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101288139|NCT05173896|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101288140|NCT05173896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101288141|NCT05173896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288142|NCT05173896|Urological Agents|urological agents|mesh-ancestor
101288143|NCT05150236|Nivolumab|nivolumab|mesh-list
101288144|NCT05150236|Ipilimumab|ipilimumab|mesh-list
101288145|NCT05150236|177Lu-PSMA-617|177lu-psma-617|mesh-list
101288146|NCT05150236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101288147|NCT05150236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101288148|NCT05150236|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101288149|NCT05150236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288150|NCT05150236|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101288151|NCT05111821|Deferiprone|deferiprone|mesh-list
101288152|NCT05111821|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101288153|NCT05111821|Chelating Agents|chelating agents|mesh-ancestor
101288154|NCT05111821|Sequestering Agents|sequestering agents|mesh-ancestor
101288155|NCT05111821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288156|NCT05105282|Anesthetics|anesthetics|mesh-list
101288157|NCT05105282|Anesthetics, Local|anesthetics, local|mesh-list
101288158|NCT05105282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101288159|NCT05105282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288160|NCT05105282|Sensory System Agents|sensory system agents|mesh-ancestor
101288161|NCT05105282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101288162|NCT05005455|Bevacizumab|bevacizumab|mesh-list
101288163|NCT05005455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101288164|NCT05005455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101288165|NCT05005455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101288166|NCT05005455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101288167|NCT05005455|Growth Substances|growth substances|mesh-ancestor
101288168|NCT05005455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288169|NCT05005455|Growth Inhibitors|growth inhibitors|mesh-ancestor
101288170|NCT04742010|Zoledronic Acid|zoledronic acid|mesh-list
101288171|NCT04742010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101288172|NCT04742010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288174|NCT04641234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101288175|NCT04641234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101288176|NCT04641234|Growth Substances|growth substances|mesh-ancestor
101288177|NCT04641234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288178|NCT04641234|Growth Inhibitors|growth inhibitors|mesh-ancestor
101288179|NCT04641234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101288180|NCT04636034|Anesthetics|anesthetics|mesh-list
101288181|NCT04636034|Anesthetics, Local|anesthetics, local|mesh-list
101288182|NCT04636034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101820355|NCT00455325|Antimalarials|antimalarials|mesh-ancestor
101820356|NCT00455325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101820357|NCT00455325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101820358|NCT00455325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101820359|NCT00455325|Analgesics|analgesics|mesh-ancestor
101820360|NCT00455325|Sensory System Agents|sensory system agents|mesh-ancestor
101288183|NCT04636034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288184|NCT04636034|Sensory System Agents|sensory system agents|mesh-ancestor
101288185|NCT04636034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101288186|NCT04524663|Camostat|camostat|mesh-list
101288187|NCT04524663|Protease Inhibitors|protease inhibitors|mesh-ancestor
101288188|NCT04524663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101288189|NCT04524663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288190|NCT04524663|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101288191|NCT04524663|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101288192|NCT04435795|Ciclesonide|ciclesonide|mesh-list
101288193|NCT04435795|Glucocorticoids|glucocorticoids|mesh-ancestor
101288194|NCT04435795|Hormones|hormones|mesh-ancestor
101288195|NCT04435795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101288196|NCT04435795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288197|NCT04435795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101288198|NCT04350593|Dapagliflozin|dapagliflozin|mesh-list
101288199|NCT04350593|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101288200|NCT04350593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288201|NCT04350593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101288202|NCT04350593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288203|NCT04222283|Emtricitabine|emtricitabine|mesh-list
101288204|NCT04222283|Antiviral Agents|antiviral agents|mesh-ancestor
101288205|NCT04222283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101288206|NCT04222283|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101288207|NCT04222283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101288208|NCT04222283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101288209|NCT04222283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288211|NCT04222283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101288219|NCT04070352|Fidaxomicin|fidaxomicin|mesh-list
101288220|NCT04070352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101288221|NCT04070352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101288222|NCT04065152|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
101288223|NCT04065152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101288224|NCT04065152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101288225|NCT03962998|Lactulose|lactulose|mesh-list
101288226|NCT03962998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101288227|NCT03859635|Bupivacaine|bupivacaine|mesh-list
101288228|NCT03859635|Anesthetics, Local|anesthetics, local|mesh-ancestor
101288229|NCT03859635|Anesthetics|anesthetics|mesh-ancestor
101288230|NCT03859635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101288231|NCT03859635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288232|NCT03859635|Sensory System Agents|sensory system agents|mesh-ancestor
101288233|NCT03859635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101288234|NCT03783013|Lycopene|lycopene|mesh-list
101288235|NCT03783013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101288236|NCT03783013|Antioxidants|antioxidants|mesh-ancestor
101288237|NCT03783013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288238|NCT03783013|Protective Agents|protective agents|mesh-ancestor
101288239|NCT03783013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288240|NCT03783013|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101288241|NCT03783013|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101288242|NCT03783013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101288243|NCT03726229|Cholic Acids|cholic acids|mesh-list
101288244|NCT03726229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101288245|NCT03712228|Antibodies|antibodies|mesh-list
101820361|NCT00455325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101820362|NCT00455325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820363|NCT00455325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101820364|NCT00455325|Filaricides|filaricides|mesh-ancestor
101820365|NCT00455325|Antinematodal Agents|antinematodal agents|mesh-ancestor
101820366|NCT00455325|Anthelmintics|anthelmintics|mesh-ancestor
101820367|NCT01028079|Aspirin|aspirin|mesh-list
101820368|NCT01028079|Ibuprofen|ibuprofen|mesh-list
101288246|NCT03712228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101288247|NCT03712228|Immunologic Factors|immunologic factors|mesh-ancestor
101288248|NCT03712228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288249|NCT03626922|Folic Acid|folic acid|mesh-list
101288250|NCT03626922|Vitamin B 12|vitamin b 12|mesh-list
101288251|NCT03626922|Dexamethasone|dexamethasone|mesh-list
101288252|NCT03626922|Pembrolizumab|pembrolizumab|mesh-list
101288253|NCT03626922|Oxaliplatin|oxaliplatin|mesh-list
101288254|NCT03626922|Pemetrexed|pemetrexed|mesh-list
101288255|NCT03626922|Vitamins|vitamins|mesh-ancestor
101288256|NCT03626922|Micronutrients|micronutrients|mesh-ancestor
101288257|NCT03626922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288258|NCT03626922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101288259|NCT03626922|Antiemetics|antiemetics|mesh-ancestor
101288260|NCT03626922|Autonomic Agents|autonomic agents|mesh-ancestor
101288261|NCT03626922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101288262|NCT03626922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101288263|NCT03626922|Glucocorticoids|glucocorticoids|mesh-ancestor
101288265|NCT03626922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101288266|NCT03626922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101288267|NCT03626922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101288268|NCT03626922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101288269|NCT03626922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101288270|NCT03626922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288272|NCT03626922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101288273|NCT03626922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101288274|NCT03626922|Hematinics|hematinics|mesh-ancestor
101288275|NCT03626922|Vitamin B Complex|vitamin b complex|mesh-ancestor
101288276|NCT03600818|Prednisone|prednisone|mesh-list
101288277|NCT03600818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101288278|NCT03600818|Glucocorticoids|glucocorticoids|mesh-ancestor
101288279|NCT03600818|Hormones|hormones|mesh-ancestor
101288280|NCT03600818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101288281|NCT03600818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288282|NCT03600818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101288283|NCT03600818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101288284|NCT03578276|Gatifloxacin|gatifloxacin|mesh-list
101288285|NCT03578276|Prednisolone|prednisolone|mesh-list
101288286|NCT03578276|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101288287|NCT03578276|Methylprednisolone|methylprednisolone|mesh-list
101288288|NCT03578276|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101288289|NCT03578276|Prednisolone acetate|prednisolone acetate|mesh-list
101288290|NCT03578276|Bromfenac|bromfenac|mesh-list
101288291|NCT03578276|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101288292|NCT03578276|Prednisolone phosphate|prednisolone phosphate|mesh-list
101288293|NCT03578276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101288294|NCT03578276|Glucocorticoids|glucocorticoids|mesh-ancestor
101288295|NCT03578276|Hormones|hormones|mesh-ancestor
101288296|NCT03578276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101288297|NCT03578276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288298|NCT03578276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101288299|NCT03578276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101288300|NCT03578276|Antiemetics|antiemetics|mesh-ancestor
101288301|NCT03578276|Autonomic Agents|autonomic agents|mesh-ancestor
101288302|NCT03578276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101288303|NCT03578276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101288304|NCT03578276|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101288305|NCT03578276|Protective Agents|protective agents|mesh-ancestor
101288306|NCT03578276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101820369|NCT01028079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101820371|NCT01028079|Analgesics|analgesics|mesh-ancestor
101820372|NCT01028079|Sensory System Agents|sensory system agents|mesh-ancestor
101820373|NCT01028079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101820374|NCT01028079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820375|NCT01028079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101288307|NCT03578276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101288308|NCT03578276|Analgesics|analgesics|mesh-ancestor
101288309|NCT03578276|Sensory System Agents|sensory system agents|mesh-ancestor
101288310|NCT03578276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101288311|NCT03578276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101288312|NCT03578276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101288313|NCT03578276|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101288314|NCT03578276|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101288315|NCT03578276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101288316|NCT03578276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101288317|NCT03578276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101288318|NCT03578276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288319|NCT03491267|Tretinoin|tretinoin|mesh-list
101288320|NCT03491267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101288321|NCT03491267|Keratolytic Agents|keratolytic agents|mesh-ancestor
101288322|NCT03491267|Dermatologic Agents|dermatologic agents|mesh-ancestor
101288323|NCT03174184|Amoxicillin|amoxicillin|mesh-list
101288324|NCT03174184|Rifampin|rifampin|mesh-list
101288325|NCT03174184|Meropenem|meropenem|mesh-list
101288326|NCT03174184|Clavulanic Acid|clavulanic acid|mesh-list
101288327|NCT03174184|Clavulanic Acids|clavulanic acids|mesh-list
101288328|NCT03174184|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101288329|NCT03174184|Rifamycins|rifamycins|mesh-list
101288330|NCT03174184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101288331|NCT03174184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101288332|NCT03174184|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101288333|NCT03174184|Antitubercular Agents|antitubercular agents|mesh-ancestor
101288334|NCT03174184|Leprostatic Agents|leprostatic agents|mesh-ancestor
101288335|NCT03174184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101288336|NCT03174184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101288337|NCT03174184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288338|NCT03174184|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101288339|NCT03174184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101288340|NCT03174184|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101288341|NCT03174184|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101288342|NCT03174184|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101288343|NCT03174184|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101288344|NCT03174184|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101288345|NCT03052933|Gemcitabine|gemcitabine|mesh-list
101288346|NCT03052933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101288347|NCT03052933|Antimetabolites|antimetabolites|mesh-ancestor
101288348|NCT03052933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288349|NCT03052933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101288350|NCT02959697|Lidocaine|lidocaine|mesh-list
101288351|NCT02959697|Anesthetics, Local|anesthetics, local|mesh-ancestor
101288352|NCT02959697|Anesthetics|anesthetics|mesh-ancestor
101288353|NCT02959697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101288354|NCT02959697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288355|NCT02959697|Sensory System Agents|sensory system agents|mesh-ancestor
101288356|NCT02959697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101288357|NCT02959697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101288358|NCT02959697|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101288359|NCT02959697|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101288360|NCT02959697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101288361|NCT02959697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288363|NCT02900560|Azacitidine|azacitidine|mesh-list
101288364|NCT02900560|Cc-486|cc-486|mesh-list
101288365|NCT02900560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101288366|NCT02900560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101820376|NCT01028079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101820377|NCT01028079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101820378|NCT01028079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101820379|NCT01028079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820380|NCT01028079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101288367|NCT02900560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101288368|NCT02900560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288369|NCT02900560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101288370|NCT02900560|Antimetabolites|antimetabolites|mesh-ancestor
101288371|NCT02900560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101288372|NCT02877550|Venetoclax|venetoclax|mesh-list
101288373|NCT02877550|Obinutuzumab|obinutuzumab|mesh-list
101288374|NCT02877550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101288375|NCT02877550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101288376|NCT02775812|Pembrolizumab|pembrolizumab|mesh-list
101288377|NCT02775812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101288378|NCT02775812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101288379|NCT02775812|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101288380|NCT02775812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288381|NCT02679170|Crizotinib|crizotinib|mesh-list
101288382|NCT02679170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101288383|NCT02679170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101288384|NCT02679170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101288385|NCT02679170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288386|NCT02518009|Estrogens|estrogens|mesh-list
101288387|NCT02518009|Androgens|androgens|mesh-list
101288388|NCT02518009|Hormones|hormones|mesh-ancestor
101288389|NCT02518009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101288390|NCT02518009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288391|NCT02238496|Sirolimus|sirolimus|mesh-list
101288392|NCT02238496|Temsirolimus|temsirolimus|mesh-list
101288393|NCT02238496|MTOR Inhibitors|mtor inhibitors|mesh-list
101288394|NCT02238496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101288395|NCT02238496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101288396|NCT02238496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288397|NCT02238496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101288399|NCT02238496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288400|NCT02238496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101288401|NCT02238496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101288402|NCT02238496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101288403|NCT02238496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101288404|NCT02238496|Antifungal Agents|antifungal agents|mesh-ancestor
101288405|NCT02034110|Trametinib|trametinib|mesh-list
101288406|NCT02034110|Dabrafenib|dabrafenib|mesh-list
101288407|NCT02034110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101288408|NCT02034110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101288409|NCT02034110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101288410|NCT02034110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288411|NCT01968213|Rucaparib|rucaparib|mesh-list
101288412|NCT01968213|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101288413|NCT01968213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101288414|NCT01968213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288415|NCT01968213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101316312|NCT00000831|Stavudine|stavudine|mesh-list
101288426|NCT01498458|Capecitabine|capecitabine|mesh-list
101288427|NCT01498458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101288428|NCT01498458|Antimetabolites|antimetabolites|mesh-ancestor
101820382|NCT01028079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101820383|NCT01028079|Antipyretics|antipyretics|mesh-ancestor
101820384|NCT00443781|Anesthetics|anesthetics|mesh-list
101820385|NCT00443781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101820386|NCT00443781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820387|NCT00443703|Ritonavir|ritonavir|mesh-list
101820388|NCT00443703|Lopinavir|lopinavir|mesh-list
101820389|NCT00443703|Raltegravir Potassium|raltegravir potassium|mesh-list
101288429|NCT01498458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288430|NCT01498458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101288431|NCT01427712|Pancrelipase|pancrelipase|mesh-list
101288432|NCT01427712|Pancreatin|pancreatin|mesh-list
101288433|NCT01427712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101288434|NCT01369147|Clevidipine|clevidipine|mesh-list
101288435|NCT01369147|Propofol|propofol|mesh-list
101288436|NCT01369147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101288437|NCT01369147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101288438|NCT01369147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288439|NCT01369147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101288440|NCT01369147|Anesthetics, General|anesthetics, general|mesh-ancestor
101288441|NCT01369147|Anesthetics|anesthetics|mesh-ancestor
101288442|NCT01369147|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101288443|NCT01369147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101288444|NCT01369147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288445|NCT01369147|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101288446|NCT01197066|Certolizumab Pegol|certolizumab pegol|mesh-list
101288447|NCT01197066|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101288448|NCT01197066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101288449|NCT01197066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101288450|NCT01197066|Immunologic Factors|immunologic factors|mesh-ancestor
101288451|NCT01197066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288452|NCT01197066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101288453|NCT01945840|Hormones|hormones|mesh-list
101288454|NCT01945840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101288455|NCT01945840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288456|NCT01945879|Heparin|heparin|mesh-list
101288457|NCT01945879|Enoxaparin|enoxaparin|mesh-list
101288458|NCT01945879|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101288459|NCT01945879|Tinzaparin|tinzaparin|mesh-list
101288460|NCT01945879|Dalteparin|dalteparin|mesh-list
101288461|NCT01945879|Anticoagulants|anticoagulants|mesh-ancestor
101288462|NCT01945879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101288463|NCT01945879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101288464|NCT01945879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288465|NCT01945892|Dexamethasone|dexamethasone|mesh-list
101288466|NCT01945892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101288467|NCT01945892|Antiemetics|antiemetics|mesh-ancestor
101288468|NCT01945892|Autonomic Agents|autonomic agents|mesh-ancestor
101288469|NCT01945892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101288470|NCT01945892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288471|NCT01945892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101288472|NCT01945892|Glucocorticoids|glucocorticoids|mesh-ancestor
101288473|NCT01945892|Hormones|hormones|mesh-ancestor
101288474|NCT01945892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101288475|NCT01945892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101288476|NCT01945892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101288477|NCT01945957|Oxytocin|oxytocin|mesh-list
101288478|NCT01945957|Oxytocics|oxytocics|mesh-ancestor
101288479|NCT01945957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101288480|NCT01945957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288481|NCT01945983|Norepinephrine|norepinephrine|mesh-list
101288482|NCT01945983|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101288483|NCT01945983|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101288484|NCT01945983|Adrenergic Agents|adrenergic agents|mesh-ancestor
101820390|NCT00443703|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101820391|NCT00443703|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101820392|NCT00443703|Protease Inhibitors|protease inhibitors|mesh-ancestor
101820393|NCT00443703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101820394|NCT00443703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820395|NCT00443703|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101820396|NCT00443703|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101288485|NCT01945983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101288487|NCT01945983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288488|NCT01945983|Sympathomimetics|sympathomimetics|mesh-ancestor
101288489|NCT01945983|Autonomic Agents|autonomic agents|mesh-ancestor
101288490|NCT01945983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101288491|NCT01945983|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101288492|NCT01946009|Cidofovir|cidofovir|mesh-list
101288493|NCT01946009|Antiviral Agents|antiviral agents|mesh-ancestor
101288494|NCT01946009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101288495|NCT01946009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101288496|NCT01946009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288498|NCT01946035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101288499|NCT01946035|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101288500|NCT01946035|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101288501|NCT01946035|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101288502|NCT01946035|Adrenergic Agents|adrenergic agents|mesh-ancestor
101288503|NCT01946035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101288504|NCT01946035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288505|NCT01946035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288506|NCT01946061|Oxaliplatin|oxaliplatin|mesh-list
101288507|NCT01946061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101288508|NCT01946256|Amoxicillin|amoxicillin|mesh-list
101288509|NCT01946256|Erythromycin|erythromycin|mesh-list
101288510|NCT01946256|Erythromycin Estolate|erythromycin estolate|mesh-list
101288511|NCT01946256|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101288512|NCT01946256|Erythromycin stearate|erythromycin stearate|mesh-list
101288513|NCT01946256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101288514|NCT01946256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101288515|NCT01946256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101288516|NCT01946256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101288517|NCT01946256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101288518|NCT01946256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288519|NCT01946295|Famotidine|famotidine|mesh-list
101288520|NCT01946295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101288521|NCT01946295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101288522|NCT01946295|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101288523|NCT01946295|Histamine Antagonists|histamine antagonists|mesh-ancestor
101288524|NCT01946295|Histamine Agents|histamine agents|mesh-ancestor
101288525|NCT01946295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101288526|NCT01946295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288527|NCT01946295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288528|NCT01946386|Betamethasone|betamethasone|mesh-list
101288529|NCT01946386|Betamethasone Valerate|betamethasone valerate|mesh-list
101288530|NCT01946386|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101288531|NCT01946386|Betamethasone benzoate|betamethasone benzoate|mesh-list
101288532|NCT01946386|Clobetasol|clobetasol|mesh-list
101288533|NCT01946386|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101288534|NCT01946386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101288535|NCT01946386|Glucocorticoids|glucocorticoids|mesh-ancestor
101288536|NCT01946386|Hormones|hormones|mesh-ancestor
101288537|NCT01946386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101288538|NCT01946386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288539|NCT01946386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101288540|NCT01946386|Respiratory System Agents|respiratory system agents|mesh-ancestor
101288541|NCT01946399|Dexamethasone|dexamethasone|mesh-list
101288542|NCT01946399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101288543|NCT01946399|Antiemetics|antiemetics|mesh-ancestor
101288544|NCT01946399|Autonomic Agents|autonomic agents|mesh-ancestor
101288545|NCT01946399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101288546|NCT01946399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288548|NCT01946399|Glucocorticoids|glucocorticoids|mesh-ancestor
101820398|NCT00443703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101820399|NCT00443703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101820400|NCT00443703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101820401|NCT00443703|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101820402|NCT00443703|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101820403|NCT00381706|Leucovorin|leucovorin|mesh-list
101820404|NCT00381706|Cisplatin|cisplatin|mesh-list
101820405|NCT00381706|Fluorouracil|fluorouracil|mesh-list
101820406|NCT00381706|Oxaliplatin|oxaliplatin|mesh-list
101820407|NCT00381706|Irinotecan|irinotecan|mesh-list
101820408|NCT00381706|Cetuximab|cetuximab|mesh-list
101820409|NCT00381706|Epirubicin|epirubicin|mesh-list
101820410|NCT00381706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101820411|NCT00381706|Antimetabolites|antimetabolites|mesh-ancestor
101820412|NCT00381706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820413|NCT00381706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101820414|NCT00381706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101288549|NCT01946399|Hormones|hormones|mesh-ancestor
101288550|NCT01946399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101288551|NCT01946399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101288552|NCT01946399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101288553|NCT01946555|Fentanyl|fentanyl|mesh-list
101288554|NCT01946555|Morphine|morphine|mesh-list
101288555|NCT01946555|Oxycodone|oxycodone|mesh-list
101288556|NCT01946555|Buprenorphine|buprenorphine|mesh-list
101288557|NCT01946555|Methadone|methadone|mesh-list
101288558|NCT01946555|Hydromorphone|hydromorphone|mesh-list
101288559|NCT01946555|Tapentadol|tapentadol|mesh-list
101288560|NCT01946555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101288561|NCT01946555|Narcotics|narcotics|mesh-ancestor
101288562|NCT01946555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101288563|NCT01946555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288564|NCT01946555|Analgesics|analgesics|mesh-ancestor
101288565|NCT01946555|Sensory System Agents|sensory system agents|mesh-ancestor
101288566|NCT01946555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101288567|NCT01946555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101288568|NCT01946555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101288569|NCT01946555|Anesthetics, General|anesthetics, general|mesh-ancestor
101288570|NCT01946555|Anesthetics|anesthetics|mesh-ancestor
101288571|NCT01946555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101288572|NCT01946555|Antitussive Agents|antitussive agents|mesh-ancestor
101288573|NCT01946555|Respiratory System Agents|respiratory system agents|mesh-ancestor
101288574|NCT01946555|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101288575|NCT01946555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101288576|NCT01946555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101288577|NCT01946555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288578|NCT01946555|Adrenergic Agents|adrenergic agents|mesh-ancestor
101288579|NCT01946555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101288580|NCT01946568|Dalbavancin|dalbavancin|mesh-list
101288581|NCT01946568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101288582|NCT01946568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101288583|NCT01946594|Acetaminophen|acetaminophen|mesh-list
101288584|NCT01946594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101288585|NCT01946594|Analgesics|analgesics|mesh-ancestor
101288586|NCT01946594|Sensory System Agents|sensory system agents|mesh-ancestor
101288587|NCT01946594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101288588|NCT01946594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288589|NCT01946594|Antipyretics|antipyretics|mesh-ancestor
101288591|NCT01946607|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101288592|NCT01946607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101820415|NCT00381706|Immunologic Factors|immunologic factors|mesh-ancestor
101820416|NCT00381706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820417|NCT00381706|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101820418|NCT00381706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101820419|NCT00381706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101288593|NCT01946607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101288594|NCT01946607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288595|NCT01946607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101288596|NCT01946607|Serotonin Agents|serotonin agents|mesh-ancestor
101288597|NCT01946607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288598|NCT01946607|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101288599|NCT01946607|Antidepressive Agents|antidepressive agents|mesh-ancestor
101288600|NCT01946607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101288601|NCT01946620|Formoterol Fumarate|formoterol fumarate|mesh-list
101288602|NCT01946620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101288603|NCT01946620|Autonomic Agents|autonomic agents|mesh-ancestor
101288604|NCT01946620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101288605|NCT01946620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288606|NCT01946620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101288607|NCT01946620|Respiratory System Agents|respiratory system agents|mesh-ancestor
101288608|NCT01946620|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101288609|NCT01946620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101288610|NCT01946620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101288611|NCT01946620|Adrenergic Agents|adrenergic agents|mesh-ancestor
101288612|NCT01946620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101288613|NCT01946620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288614|NCT01946906|Rifaximin|rifaximin|mesh-list
101288615|NCT01946906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101288616|NCT01946906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101288617|NCT01946906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101288618|NCT01946971|Lansoprazole|lansoprazole|mesh-list
101288619|NCT01946971|Dexlansoprazole|dexlansoprazole|mesh-list
101288620|NCT01946971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101288621|NCT01946971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101288622|NCT01946971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101288623|NCT01946971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101288624|NCT01946971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288626|NCT01946984|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
101288627|NCT01946984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101288628|NCT01946984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101288629|NCT01946984|Analgesics|analgesics|mesh-ancestor
101288630|NCT01946984|Sensory System Agents|sensory system agents|mesh-ancestor
101288631|NCT01946984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101288632|NCT01946984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288633|NCT01946984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101288634|NCT01946984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101288635|NCT01946984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101288636|NCT01946984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101288637|NCT01946984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288638|NCT01947010|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101288639|NCT01947010|Immunologic Factors|immunologic factors|mesh-ancestor
101288640|NCT01947010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288641|NCT01947062|Cyclophosphamide|cyclophosphamide|mesh-list
101288642|NCT01947062|Cisplatin|cisplatin|mesh-list
101288643|NCT01947062|Etoposide|etoposide|mesh-list
101288644|NCT01947062|Etoposide phosphate|etoposide phosphate|mesh-list
101288645|NCT01947062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101288646|NCT01947062|Immunologic Factors|immunologic factors|mesh-ancestor
101288647|NCT01947062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288648|NCT01947062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101288649|NCT01947062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101288650|NCT01947062|Alkylating Agents|alkylating agents|mesh-ancestor
101288651|NCT01947062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288652|NCT01947062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101288653|NCT01947062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101820421|NCT00381706|Protective Agents|protective agents|mesh-ancestor
101820422|NCT00381706|Vitamin B Complex|vitamin b complex|mesh-ancestor
101820423|NCT00381706|Vitamins|vitamins|mesh-ancestor
101820424|NCT00381706|Micronutrients|micronutrients|mesh-ancestor
101820425|NCT00381706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101820426|NCT00381706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101820427|NCT00381706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101820428|NCT01045642|Omeprazole|omeprazole|mesh-list
101820429|NCT01045642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101820430|NCT01045642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101820431|NCT01045642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101820432|NCT01045642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101820433|NCT01045642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820434|NCT05357430|Propofol|propofol|mesh-list
101820435|NCT05357430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101820436|NCT05357430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101288654|NCT01947062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101288655|NCT01947062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101288656|NCT01947062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101288657|NCT01947062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101288658|NCT01947114|Ketamine|ketamine|mesh-list
101288659|NCT01947114|Remifentanil|remifentanil|mesh-list
101288660|NCT01947114|Propofol|propofol|mesh-list
101288661|NCT01947114|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101288662|NCT01947114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101288663|NCT01947114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288664|NCT01947114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101288665|NCT01947114|Anesthetics, General|anesthetics, general|mesh-ancestor
101288666|NCT01947114|Anesthetics|anesthetics|mesh-ancestor
101288667|NCT01947114|Analgesics|analgesics|mesh-ancestor
101288668|NCT01947114|Sensory System Agents|sensory system agents|mesh-ancestor
101288669|NCT01947114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101288670|NCT01947114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101288671|NCT01947114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101288672|NCT01947114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101288673|NCT01947114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101288674|NCT01947114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288675|NCT01947114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101288676|NCT01947114|Narcotics|narcotics|mesh-ancestor
101288677|NCT01947192|Chlorhexidine|chlorhexidine|mesh-list
101288678|NCT01947192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101288679|NCT01947192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101288680|NCT01947192|Disinfectants|disinfectants|mesh-ancestor
101288681|NCT01947205|Acetaminophen|acetaminophen|mesh-list
101288682|NCT01947205|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
101288683|NCT01947205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101288684|NCT01947205|Analgesics|analgesics|mesh-ancestor
101288685|NCT01947205|Sensory System Agents|sensory system agents|mesh-ancestor
101288686|NCT01947205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101288689|NCT01947205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101288690|NCT01947205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101288691|NCT01947205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101288692|NCT01947309|Lenalidomide|lenalidomide|mesh-list
101288693|NCT01947309|Immunologic Factors|immunologic factors|mesh-ancestor
101288694|NCT01947309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288695|NCT01947309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101288696|NCT01947309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101288697|NCT01947309|Growth Substances|growth substances|mesh-ancestor
101288698|NCT01947309|Growth Inhibitors|growth inhibitors|mesh-ancestor
101820437|NCT05357430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820438|NCT05357430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101820439|NCT05357430|Anesthetics, General|anesthetics, general|mesh-ancestor
101820440|NCT05357430|Anesthetics|anesthetics|mesh-ancestor
101820441|NCT00370552|Paclitaxel|paclitaxel|mesh-list
101820442|NCT00370552|Epothilones|epothilones|mesh-list
101820443|NCT00370552|Bevacizumab|bevacizumab|mesh-list
101288699|NCT01947309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101288700|NCT01947465|Vaccines|vaccines|mesh-list
101288701|NCT01947465|Immunologic Factors|immunologic factors|mesh-ancestor
101288702|NCT01947465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288703|NCT01947556|Insulin Aspart|insulin aspart|mesh-list
101288704|NCT01947556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101288705|NCT01947556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288706|NCT01947608|Ceritinib|ceritinib|mesh-list
101288707|NCT01947608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101288708|NCT01947608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101288709|NCT01947608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316324|NCT00000849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101288710|NCT01947608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288711|NCT01947660|Anesthetics|anesthetics|mesh-list
101288712|NCT01947660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101288713|NCT01947660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288714|NCT01947699|Glyburide|glyburide|mesh-list
101288715|NCT01947699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101288716|NCT01947699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288717|NCT01947777|Rifampin|rifampin|mesh-list
101288718|NCT01947777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101288719|NCT01947777|Antitubercular Agents|antitubercular agents|mesh-ancestor
101288720|NCT01947777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101288721|NCT01947777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101288722|NCT01947777|Leprostatic Agents|leprostatic agents|mesh-ancestor
101288723|NCT01947777|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101288724|NCT01947777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101288725|NCT01947777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288726|NCT01947777|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101288727|NCT01947777|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101288728|NCT01947777|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101288729|NCT01947777|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101288730|NCT01947777|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101288731|NCT01947777|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101288732|NCT01947790|Metformin|metformin|mesh-list
101288733|NCT01947790|Pioglitazone|pioglitazone|mesh-list
101288734|NCT01947790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101288735|NCT01947790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288736|NCT01947803|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101288737|NCT01947803|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101288738|NCT01947803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101288739|NCT01947803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101288740|NCT01947803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288741|NCT01947803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101288742|NCT01947803|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101288743|NCT01947803|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101288744|NCT01947803|Serotonin Agents|serotonin agents|mesh-ancestor
101288745|NCT01947803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101288746|NCT01947803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288748|NCT01947803|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101288749|NCT01947803|Dopamine Agents|dopamine agents|mesh-ancestor
101288750|NCT01947920|Tramadol|tramadol|mesh-list
101288751|NCT01947920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101288752|NCT01947920|Narcotics|narcotics|mesh-ancestor
101288753|NCT01947920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101288754|NCT01947920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288755|NCT01947920|Analgesics|analgesics|mesh-ancestor
101288756|NCT01947920|Sensory System Agents|sensory system agents|mesh-ancestor
101288757|NCT01947920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101288758|NCT01947933|Mirikizumab|mirikizumab|mesh-list
101820444|NCT00370552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101820445|NCT00370552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101820447|NCT00370552|Antimitotic Agents|antimitotic agents|mesh-ancestor
101820448|NCT00370552|Mitosis Modulators|mitosis modulators|mesh-ancestor
101820449|NCT00370552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820450|NCT00370552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101820451|NCT00370552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101820452|NCT00370552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101288759|NCT01947933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101288760|NCT01947933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101288761|NCT01947933|Analgesics|analgesics|mesh-ancestor
101288762|NCT01947933|Sensory System Agents|sensory system agents|mesh-ancestor
101288763|NCT01947933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101288764|NCT01947933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288765|NCT01947933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101288766|NCT01947933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101288767|NCT01947933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101288768|NCT01947933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101288769|NCT01947959|Rivaroxaban|rivaroxaban|mesh-list
101288770|NCT01947959|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101288771|NCT01947959|Antithrombins|antithrombins|mesh-ancestor
101288772|NCT01947959|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101288773|NCT01947959|Protease Inhibitors|protease inhibitors|mesh-ancestor
101288774|NCT01947959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101288775|NCT01947959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288776|NCT01947959|Anticoagulants|anticoagulants|mesh-ancestor
101288777|NCT01947985|Rivaroxaban|rivaroxaban|mesh-list
101288778|NCT01947985|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101288779|NCT01947985|Antithrombins|antithrombins|mesh-ancestor
101288780|NCT01947985|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101288781|NCT01947985|Protease Inhibitors|protease inhibitors|mesh-ancestor
101288782|NCT01947985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101288783|NCT01947985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288784|NCT01947985|Anticoagulants|anticoagulants|mesh-ancestor
101288786|NCT01947998|Rivaroxaban|rivaroxaban|mesh-list
101288787|NCT01947998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
101288788|NCT01947998|Anticoagulants|anticoagulants|mesh-ancestor
101288789|NCT01947998|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101288790|NCT01947998|Antithrombins|antithrombins|mesh-ancestor
101288791|NCT01947998|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101288792|NCT01947998|Protease Inhibitors|protease inhibitors|mesh-ancestor
101288793|NCT01947998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101288794|NCT01947998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288795|NCT01948011|Racecadotril|racecadotril|mesh-list
101288796|NCT01948011|Thiorphan|thiorphan|mesh-list
101288797|NCT01948011|Antidiarrheals|antidiarrheals|mesh-ancestor
101288798|NCT01948011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101288799|NCT01948011|Protease Inhibitors|protease inhibitors|mesh-ancestor
101288800|NCT01948011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101288801|NCT01948011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288802|NCT01948024|Asenapine|asenapine|mesh-list
101288803|NCT01948024|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101288804|NCT01948024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101288805|NCT01948024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101288806|NCT01948024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288807|NCT01948024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101288808|NCT01948115|Nitrous Oxide|nitrous oxide|mesh-list
101288809|NCT01948115|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101288810|NCT01948115|Anesthetics, General|anesthetics, general|mesh-ancestor
101288811|NCT01948115|Anesthetics|anesthetics|mesh-ancestor
101288812|NCT01948115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101288813|NCT01948115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288814|NCT01948115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101288815|NCT01948115|Analgesics|analgesics|mesh-ancestor
101820453|NCT00370552|Growth Substances|growth substances|mesh-ancestor
101820454|NCT00370552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820455|NCT00370552|Growth Inhibitors|growth inhibitors|mesh-ancestor
101288816|NCT01948115|Sensory System Agents|sensory system agents|mesh-ancestor
101288817|NCT01948115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101288818|NCT01948128|Vitamin D|vitamin d|mesh-list
101288819|NCT01948128|Ergocalciferols|ergocalciferols|mesh-list
101288820|NCT01948128|Cholecalciferol|cholecalciferol|mesh-list
101288821|NCT01948128|Vitamins|vitamins|mesh-list
101288822|NCT01948128|Micronutrients|micronutrients|mesh-ancestor
101288823|NCT01948128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288824|NCT01948128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101288825|NCT01948128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101288826|NCT01948232|Perindopril|perindopril|mesh-list
101288827|NCT01948232|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101288828|NCT01948232|Protease Inhibitors|protease inhibitors|mesh-ancestor
101288829|NCT01948232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101288830|NCT01948232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288831|NCT01948232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101288832|NCT01948336|Dexmedetomidine|dexmedetomidine|mesh-list
101288833|NCT01948336|Ketamine|ketamine|mesh-list
101288834|NCT01948336|Propofol|propofol|mesh-list
101288835|NCT01948336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101288836|NCT01948336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101288837|NCT01948336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288838|NCT01948336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101288839|NCT01948336|Analgesics|analgesics|mesh-ancestor
101288840|NCT01948336|Sensory System Agents|sensory system agents|mesh-ancestor
101288841|NCT01948336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101288842|NCT01948336|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101288843|NCT01948336|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101288845|NCT01948336|Adrenergic Agents|adrenergic agents|mesh-ancestor
101288846|NCT01948336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101288847|NCT01948336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288848|NCT01948336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101288849|NCT01948336|Anesthetics, General|anesthetics, general|mesh-ancestor
101288850|NCT01948336|Anesthetics|anesthetics|mesh-ancestor
101288851|NCT01948336|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101288852|NCT01948336|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101288853|NCT01948336|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101288854|NCT01948362|Sulforaphane|sulforaphane|mesh-list
101288855|NCT01948362|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101288856|NCT01948362|Protective Agents|protective agents|mesh-ancestor
101288857|NCT01948362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288858|NCT01948362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101288859|NCT01948401|Prednisolone|prednisolone|mesh-list
101288860|NCT01948401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101288861|NCT01948401|Glucocorticoids|glucocorticoids|mesh-ancestor
101288862|NCT01948401|Hormones|hormones|mesh-ancestor
101288863|NCT01948401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101288864|NCT01948401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288865|NCT01948401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101288866|NCT01948401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101288867|NCT01948583|Hyaluronic Acid|hyaluronic acid|mesh-list
101288868|NCT01948583|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101288869|NCT01948583|Immunologic Factors|immunologic factors|mesh-ancestor
101288870|NCT01948583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288871|NCT01948583|Viscosupplements|viscosupplements|mesh-ancestor
101288872|NCT01948583|Protective Agents|protective agents|mesh-ancestor
101288874|NCT01948648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101288875|NCT01948648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101288876|NCT01948648|Antimetabolites|antimetabolites|mesh-ancestor
101288877|NCT01948648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288878|NCT01948648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101288879|NCT01948765|Propofol|propofol|mesh-list
101288880|NCT01948765|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101288881|NCT01948765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101288882|NCT01948765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288883|NCT01948765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101288884|NCT01948765|Anesthetics, General|anesthetics, general|mesh-ancestor
101288885|NCT01948765|Anesthetics|anesthetics|mesh-ancestor
101288886|NCT01948804|Letrozole|letrozole|mesh-list
101288887|NCT01948804|Clomiphene|clomiphene|mesh-list
101820456|NCT00537030|Asparaginase|asparaginase|mesh-list
101820457|NCT00537030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101820458|NCT00381238|Rosiglitazone|rosiglitazone|mesh-list
101820459|NCT00381238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101820460|NCT00381238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288888|NCT01948804|Cetrorelix|cetrorelix|mesh-list
101288889|NCT01948804|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101288890|NCT01948804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101288891|NCT01948804|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101288892|NCT01948804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101288893|NCT01948804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101288894|NCT01948804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288895|NCT01948804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101288896|NCT01948804|Hormone Antagonists|hormone antagonists|mesh-ancestor
101288897|NCT01948804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101288898|NCT01948804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288899|NCT01948804|Hormones|hormones|mesh-ancestor
101288900|NCT01948804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101288901|NCT01948804|Fertility Agents|fertility agents|mesh-ancestor
101288902|NCT01948804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101288903|NCT01948804|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101288904|NCT01948804|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101288905|NCT01948817|Deferasirox|deferasirox|mesh-list
101288906|NCT01948817|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101288907|NCT01948817|Chelating Agents|chelating agents|mesh-ancestor
101288908|NCT01948817|Sequestering Agents|sequestering agents|mesh-ancestor
101288909|NCT01948817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288910|NCT01948895|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101288911|NCT01948895|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101288912|NCT01948895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101288913|NCT01948895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101288914|NCT01948895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288915|NCT01948895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101288916|NCT01948895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288917|NCT01948895|Antidepressive Agents|antidepressive agents|mesh-ancestor
101288918|NCT01948895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101288919|NCT01948921|Meperidine|meperidine|mesh-list
101288920|NCT01948921|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101288921|NCT01948921|Narcotics|narcotics|mesh-ancestor
101288922|NCT01948921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101288923|NCT01948921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288924|NCT01948921|Analgesics|analgesics|mesh-ancestor
101288925|NCT01948921|Sensory System Agents|sensory system agents|mesh-ancestor
101288926|NCT01948921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101288927|NCT01948921|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101288928|NCT01948960|Everolimus|everolimus|mesh-list
101288929|NCT01948960|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101288930|NCT01948960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101288931|NCT01948960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101288932|NCT01948960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288933|NCT01948960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101288934|NCT01948960|Immunologic Factors|immunologic factors|mesh-ancestor
101288935|NCT01948960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288936|NCT01948960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101288937|NCT01948999|Anesthetics|anesthetics|mesh-list
101288938|NCT01948999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101288939|NCT01948999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288940|NCT01949038|Alprazolam|alprazolam|mesh-list
101288941|NCT01949038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101288942|NCT01949038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101288943|NCT01949038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288944|NCT01949038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101288945|NCT01949038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101288946|NCT01949038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101288947|NCT01949038|GABA Modulators|gaba modulators|mesh-ancestor
101288948|NCT01949038|GABA Agents|gaba agents|mesh-ancestor
101312547|NCT00007995|Cyclophosphamide|cyclophosphamide|mesh-list
101820468|NCT04928820|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101820469|NCT04928820|Chelating Agents|chelating agents|mesh-ancestor
101820470|NCT04928820|Sequestering Agents|sequestering agents|mesh-ancestor
101820471|NCT04928820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820472|NCT04928820|Anticoagulants|anticoagulants|mesh-ancestor
101820473|NCT04928820|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101820474|NCT04928820|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101820475|NCT04429152|Tenofovir|tenofovir|mesh-list
101288949|NCT01949038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101288950|NCT01949038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288951|NCT01949064|Salicylic Acid|salicylic acid|mesh-list
101288952|NCT01949064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101288953|NCT01949064|Antifungal Agents|antifungal agents|mesh-ancestor
101288954|NCT01949064|Keratolytic Agents|keratolytic agents|mesh-ancestor
101288955|NCT01949064|Dermatologic Agents|dermatologic agents|mesh-ancestor
101288956|NCT01949129|Cyclophosphamide|cyclophosphamide|mesh-list
101288957|NCT01949129|Busulfan|busulfan|mesh-list
101288958|NCT01949129|Thiotepa|thiotepa|mesh-list
101288959|NCT01949129|Treosulfan|treosulfan|mesh-list
101288960|NCT01949129|Fludarabine|fludarabine|mesh-list
101288961|NCT01949129|Etoposide|etoposide|mesh-list
101288962|NCT01949129|Thymoglobulin|thymoglobulin|mesh-list
101288963|NCT01949129|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101288964|NCT01949129|Immunoglobulins|immunoglobulins|mesh-list
101288965|NCT01949129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101288966|NCT01949129|Immunologic Factors|immunologic factors|mesh-ancestor
101288967|NCT01949129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288968|NCT01949129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101288969|NCT01949129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101288970|NCT01949129|Alkylating Agents|alkylating agents|mesh-ancestor
101288971|NCT01949129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288972|NCT01949129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101288973|NCT01949129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101288974|NCT01949129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101288975|NCT01949129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101288976|NCT01949129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101288977|NCT01949129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101288978|NCT01949168|Ribavirin|ribavirin|mesh-list
101288979|NCT01949168|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101288980|NCT01949168|Antimetabolites|antimetabolites|mesh-ancestor
101288981|NCT01949168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288982|NCT01949168|Antiviral Agents|antiviral agents|mesh-ancestor
101288983|NCT01949168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101288984|NCT01949233|Doxycycline|doxycycline|mesh-list
101288985|NCT01949233|Irbesartan|irbesartan|mesh-list
101288986|NCT01949233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101288987|NCT01949233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101288988|NCT01949233|Antimalarials|antimalarials|mesh-ancestor
101288989|NCT01949233|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101288990|NCT01949233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101288991|NCT01949233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101288992|NCT01949233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101288993|NCT01949233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101288994|NCT01949233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101288995|NCT01949363|Cefixime|cefixime|mesh-list
101288996|NCT01949363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101288997|NCT01949363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101288998|NCT01949454|Fluorometholone|fluorometholone|mesh-list
101288999|NCT01949454|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101289000|NCT01949454|Lubricant Eye Drops|lubricant eye drops|mesh-list
101289001|NCT01949454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101289002|NCT01949454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101289003|NCT01949454|Glucocorticoids|glucocorticoids|mesh-ancestor
101289004|NCT01949454|Hormones|hormones|mesh-ancestor
101289005|NCT01949454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101820476|NCT04429152|Lamivudine|lamivudine|mesh-list
101820477|NCT04429152|Antiviral Agents|antiviral agents|mesh-ancestor
101820478|NCT04429152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101820479|NCT04429152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101820480|NCT04429152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101820481|NCT04429152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101820482|NCT04429152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820483|NCT04429152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101289006|NCT01949454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289007|NCT01949454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101289008|NCT01949519|Lycopene|lycopene|mesh-list
101289009|NCT01949519|Docetaxel|docetaxel|mesh-list
101289010|NCT01949519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101289011|NCT01949519|Tubulin Modulators|tubulin modulators|mesh-ancestor
101289012|NCT01949519|Antimitotic Agents|antimitotic agents|mesh-ancestor
101289013|NCT01949519|Mitosis Modulators|mitosis modulators|mesh-ancestor
101289014|NCT01949519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289015|NCT01949519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101289016|NCT01949519|Antioxidants|antioxidants|mesh-ancestor
101289017|NCT01949519|Protective Agents|protective agents|mesh-ancestor
101289018|NCT01949519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289019|NCT01949519|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101289020|NCT01949519|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101289021|NCT01949571|Mirtazapine|mirtazapine|mesh-list
101289022|NCT01949571|Antidepressive Agents|antidepressive agents|mesh-ancestor
101289023|NCT01949571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101289024|NCT01949571|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101289025|NCT01949571|Histamine Antagonists|histamine antagonists|mesh-ancestor
101289026|NCT01949571|Histamine Agents|histamine agents|mesh-ancestor
101289027|NCT01949571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101289028|NCT01949571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289029|NCT01949571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289030|NCT01949571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101289031|NCT01949571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101289032|NCT01949571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101289033|NCT01949571|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101289034|NCT01949571|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101289035|NCT01949571|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101289036|NCT01949571|Adrenergic Agents|adrenergic agents|mesh-ancestor
101289037|NCT01949571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101289038|NCT01949571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101289039|NCT01949571|Serotonin Agents|serotonin agents|mesh-ancestor
101289040|NCT01949571|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101289041|NCT01949675|Vaccines|vaccines|mesh-list
101289042|NCT01949675|Immunologic Factors|immunologic factors|mesh-ancestor
101289043|NCT01949675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289044|NCT01949766|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
101289045|NCT01949766|Glycerol|glycerol|mesh-list
101289046|NCT01949766|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101289047|NCT01949766|Protective Agents|protective agents|mesh-ancestor
101289048|NCT01949766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289049|NCT01949766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101289050|NCT01948245|Taurolidine|taurolidine|mesh-list
101289051|NCT01948245|Heparin|heparin|mesh-list
101289052|NCT01948245|Calcium heparin|calcium heparin|mesh-list
101289053|NCT01948245|Anticoagulants|anticoagulants|mesh-ancestor
101289054|NCT01948245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289055|NCT01948245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101289056|NCT01948245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101289057|NCT01948245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101289058|NCT01948245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101289059|NCT01948245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101289060|NCT01949805|Interferon alpha-2|interferon alpha-2|mesh-list
101289061|NCT01949805|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101820484|NCT04429152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101820485|NCT04001400|Rabeprazole|rabeprazole|mesh-list
101820486|NCT04001400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101820487|NCT04001400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101820488|NCT04001400|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101289062|NCT01949805|Hydroxyurea|hydroxyurea|mesh-list
101289063|NCT01949805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101289064|NCT01949805|Antisickling Agents|antisickling agents|mesh-ancestor
101289065|NCT01949805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101289066|NCT01949805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289067|NCT01949805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101289068|NCT01949805|Antiviral Agents|antiviral agents|mesh-ancestor
101289069|NCT01949805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101289070|NCT01949818|Prednisone|prednisone|mesh-list
101289071|NCT01949818|Prednisolone|prednisolone|mesh-list
101289072|NCT01949818|Cyclophosphamide|cyclophosphamide|mesh-list
101289073|NCT01949818|Doxorubicin|doxorubicin|mesh-list
101289074|NCT01949818|Vincristine|vincristine|mesh-list
101289075|NCT01949818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101289076|NCT01949818|Immunologic Factors|immunologic factors|mesh-ancestor
101289077|NCT01949818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289078|NCT01949818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101289079|NCT01949818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101289080|NCT01949818|Alkylating Agents|alkylating agents|mesh-ancestor
101289081|NCT01949818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289082|NCT01949818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101289083|NCT01949818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101289084|NCT01949818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101289085|NCT01949818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101289086|NCT01949818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101289087|NCT01949818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101289088|NCT01949818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101289089|NCT01949818|Glucocorticoids|glucocorticoids|mesh-ancestor
101289090|NCT01949818|Hormones|hormones|mesh-ancestor
101289091|NCT01949818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101289092|NCT01949818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101289093|NCT01949818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101289094|NCT01949818|Tubulin Modulators|tubulin modulators|mesh-ancestor
101289095|NCT01949818|Antimitotic Agents|antimitotic agents|mesh-ancestor
101289096|NCT01949818|Mitosis Modulators|mitosis modulators|mesh-ancestor
101289097|NCT01949857|Vaccines|vaccines|mesh-list
101289098|NCT01949857|Immunologic Factors|immunologic factors|mesh-ancestor
101289099|NCT01949857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289100|NCT01949909|Aluminum sulfate|aluminum sulfate|mesh-list
101289101|NCT01949909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101289102|NCT01949909|Immunologic Factors|immunologic factors|mesh-ancestor
101289103|NCT01949909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289104|NCT01949935|Mupirocin|mupirocin|mesh-list
101289105|NCT01949935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101289106|NCT01949935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101289107|NCT01949935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101289108|NCT01949935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101289109|NCT01949935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289110|NCT01949948|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101289111|NCT01949948|Tenecteplase|tenecteplase|mesh-list
101289112|NCT01949948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101289113|NCT01949948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101289114|NCT01949948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289115|NCT01950000|Fentanyl|fentanyl|mesh-list
101289116|NCT01950000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101289117|NCT01950000|Narcotics|narcotics|mesh-ancestor
101289118|NCT01950000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101289119|NCT01950000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289120|NCT01950000|Analgesics|analgesics|mesh-ancestor
101289121|NCT01950000|Sensory System Agents|sensory system agents|mesh-ancestor
101289122|NCT01950000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101289123|NCT01950000|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101289124|NCT01950000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101289125|NCT01950000|Anesthetics, General|anesthetics, general|mesh-ancestor
101289126|NCT01950000|Anesthetics|anesthetics|mesh-ancestor
101820489|NCT04001400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101820490|NCT04001400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820491|NCT00380692|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101820492|NCT00380692|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101820493|NCT00380692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101820494|NCT00380692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101820495|NCT00380692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289127|NCT01950182|Tamoxifen|tamoxifen|mesh-list
101289128|NCT01950182|Gemcitabine|gemcitabine|mesh-list
101289129|NCT01950182|Capecitabine|capecitabine|mesh-list
101289130|NCT01950182|Trastuzumab|trastuzumab|mesh-list
101289131|NCT01950182|Vinorelbine|vinorelbine|mesh-list
101289132|NCT01950182|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101289133|NCT01950182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101289134|NCT01950182|Antimetabolites|antimetabolites|mesh-ancestor
101289135|NCT01950182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289136|NCT01950182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101289137|NCT01950182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101289138|NCT01950182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101289139|NCT01950182|Tubulin Modulators|tubulin modulators|mesh-ancestor
101289140|NCT01950182|Antimitotic Agents|antimitotic agents|mesh-ancestor
101289142|NCT01950182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101289143|NCT01950182|Hormone Antagonists|hormone antagonists|mesh-ancestor
101289144|NCT01950182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101289145|NCT01950182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289146|NCT01950182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101289147|NCT01950182|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101289148|NCT01950182|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101289149|NCT01950182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101289150|NCT01950182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101289151|NCT01950182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101289152|NCT01950195|Ipilimumab|ipilimumab|mesh-list
101289153|NCT01950195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101289154|NCT01950195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101289155|NCT01950195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101289156|NCT01950195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289157|NCT01950416|Clopidogrel|clopidogrel|mesh-list
101289158|NCT01950416|Ticagrelor|ticagrelor|mesh-list
101289159|NCT01950416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101289160|NCT01950416|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101289161|NCT01950416|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101289162|NCT01950416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101289163|NCT01950416|Purinergic Agents|purinergic agents|mesh-ancestor
101289164|NCT01950416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101289165|NCT01950416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289166|NCT01950416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289167|NCT01950481|Ceritinib|ceritinib|mesh-list
101289168|NCT01950481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101289169|NCT01950481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101289170|NCT01950481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101289171|NCT01950481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289172|NCT01950494|Hand Sanitizers|hand sanitizers|mesh-list
101289173|NCT01950494|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101289174|NCT01950494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101289175|NCT01950494|Disinfectants|disinfectants|mesh-ancestor
101289176|NCT01950507|Fluconazole|fluconazole|mesh-list
101289177|NCT01950507|Voriconazole|voriconazole|mesh-list
101289178|NCT01950507|Micafungin|micafungin|mesh-list
101289179|NCT01950507|Budesonide|budesonide|mesh-list
101289180|NCT01950507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101289181|NCT01950507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101289182|NCT01950507|Autonomic Agents|autonomic agents|mesh-ancestor
101289183|NCT01950507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101289184|NCT01950507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820496|NCT00380692|Adrenergic Agents|adrenergic agents|mesh-ancestor
101820497|NCT00380692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101820498|NCT00380692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820500|NCT04285866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101820501|NCT04285866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101820503|NCT01047982|Inositol|inositol|mesh-list
101820504|NCT01047982|Hematinics|hematinics|mesh-ancestor
101820505|NCT01047982|Vitamin B Complex|vitamin b complex|mesh-ancestor
101820506|NCT01047982|Vitamins|vitamins|mesh-ancestor
101820507|NCT01047982|Micronutrients|micronutrients|mesh-ancestor
101820508|NCT01047982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820509|NCT00536874|Gemcitabine|gemcitabine|mesh-list
101289185|NCT01950507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101289186|NCT01950507|Respiratory System Agents|respiratory system agents|mesh-ancestor
101289187|NCT01950507|Glucocorticoids|glucocorticoids|mesh-ancestor
101289188|NCT01950507|Hormones|hormones|mesh-ancestor
101289189|NCT01950507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101289190|NCT01950507|Antifungal Agents|antifungal agents|mesh-ancestor
101289191|NCT01950507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101289192|NCT01950507|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101289193|NCT01950507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101289194|NCT01950507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101289195|NCT01950507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289196|NCT01950507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101289197|NCT01950507|Hormone Antagonists|hormone antagonists|mesh-ancestor
101289198|NCT01950507|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101289199|NCT01950507|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101289200|NCT01950507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101289201|NCT01950546|Fluorides|fluorides|mesh-list
101289202|NCT01950546|Cariostatic Agents|cariostatic agents|mesh-ancestor
101289203|NCT01950546|Protective Agents|protective agents|mesh-ancestor
101289204|NCT01950546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289205|NCT01950585|Hydroxyurea|hydroxyurea|mesh-list
101289206|NCT01950585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101289207|NCT01950585|Antisickling Agents|antisickling agents|mesh-ancestor
101289208|NCT01950585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101289209|NCT01950585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289210|NCT01950585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101289211|NCT01950611|Bortezomib|bortezomib|mesh-list
101289212|NCT01950611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101289213|NCT01950689|Nimorazole|nimorazole|mesh-list
101289214|NCT01950689|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
101289215|NCT01950689|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101289216|NCT01950689|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101289217|NCT01950689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101289218|NCT01950793|Triamcinolone|triamcinolone|mesh-list
101289219|NCT01950793|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101289220|NCT01950793|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101289221|NCT01950793|Hyaluronic Acid|hyaluronic acid|mesh-list
101289222|NCT01950793|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101289223|NCT01950793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101289224|NCT01950793|Glucocorticoids|glucocorticoids|mesh-ancestor
101289225|NCT01950793|Hormones|hormones|mesh-ancestor
101289226|NCT01950793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101289227|NCT01950793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289228|NCT01950793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101289229|NCT01950793|Immunologic Factors|immunologic factors|mesh-ancestor
101289230|NCT01950793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101289231|NCT01950793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289232|NCT01950793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101289233|NCT01950793|Viscosupplements|viscosupplements|mesh-ancestor
101289234|NCT01950793|Protective Agents|protective agents|mesh-ancestor
101289235|NCT01950884|Ezetimibe|ezetimibe|mesh-list
101820510|NCT00536874|Oxaliplatin|oxaliplatin|mesh-list
101820511|NCT00536874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101820512|NCT00536874|Antimetabolites|antimetabolites|mesh-ancestor
101820513|NCT00536874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820514|NCT00536874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101820515|NCT00991848|Lidocaine|lidocaine|mesh-list
101289236|NCT01950884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101289237|NCT01950884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101289238|NCT01950884|Antimetabolites|antimetabolites|mesh-ancestor
101289239|NCT01950884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289240|NCT01950884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101289241|NCT01950923|Sildenafil Citrate|sildenafil citrate|mesh-list
101289242|NCT01950923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289243|NCT01950923|Vasodilator Agents|vasodilator agents|mesh-ancestor
101289244|NCT01950923|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101289245|NCT01950923|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101289246|NCT01950923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101289247|NCT01950923|Urological Agents|urological agents|mesh-ancestor
101289248|NCT01950949|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
101289249|NCT01950949|Plasma Substitutes|plasma substitutes|mesh-ancestor
101289250|NCT01950949|Blood Substitutes|blood substitutes|mesh-ancestor
101289251|NCT01951001|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101289252|NCT01951001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101289253|NCT01951027|Lenograstim|lenograstim|mesh-list
101289254|NCT01951027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101289255|NCT01951027|Immunologic Factors|immunologic factors|mesh-ancestor
101289256|NCT01951027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289257|NCT01951053|Citalopram|citalopram|mesh-list
101289258|NCT01951053|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101289259|NCT01951053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101289260|NCT01951053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101289261|NCT01951053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289262|NCT01951053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101289263|NCT01951053|Serotonin Agents|serotonin agents|mesh-ancestor
101289264|NCT01951053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289265|NCT01951053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101289266|NCT01951053|Antidepressive Agents|antidepressive agents|mesh-ancestor
101289267|NCT01951053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101289268|NCT01951079|Digoxin|digoxin|mesh-list
101289269|NCT01951079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101289270|NCT01951079|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101289271|NCT01951079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101289272|NCT01951079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289273|NCT01951079|Protective Agents|protective agents|mesh-ancestor
101289275|NCT01951144|Lorazepam|lorazepam|mesh-list
101289276|NCT01951144|PF-06372865|pf-06372865|mesh-list
101289277|NCT01951144|Anticonvulsants|anticonvulsants|mesh-ancestor
101289278|NCT01951144|Antiemetics|antiemetics|mesh-ancestor
101289279|NCT01951144|Autonomic Agents|autonomic agents|mesh-ancestor
101289280|NCT01951144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101289281|NCT01951144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289283|NCT01951144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101289284|NCT01951144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101289285|NCT01951144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101289286|NCT01951144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101289287|NCT01951144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101289288|NCT01951144|GABA Modulators|gaba modulators|mesh-ancestor
101289289|NCT01951144|GABA Agents|gaba agents|mesh-ancestor
101289290|NCT01951144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101289291|NCT01951144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289293|NCT01951209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101289294|NCT01951209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101289295|NCT01951209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101289296|NCT01951404|Allopurinol|allopurinol|mesh-list
101289297|NCT01951404|Antimetabolites|antimetabolites|mesh-ancestor
101289298|NCT01951404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289299|NCT01951404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101289300|NCT01951404|Gout Suppressants|gout suppressants|mesh-ancestor
101289301|NCT01951404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101820516|NCT00991848|Anesthetics, Local|anesthetics, local|mesh-ancestor
101820517|NCT00991848|Anesthetics|anesthetics|mesh-ancestor
101289302|NCT01951404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101289303|NCT01951404|Antioxidants|antioxidants|mesh-ancestor
101289304|NCT01951404|Protective Agents|protective agents|mesh-ancestor
101289305|NCT01951404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289306|NCT01951430|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101289307|NCT01951430|Cephalosporins|cephalosporins|mesh-list
101289308|NCT01951430|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101289309|NCT01951430|Itraconazole|itraconazole|mesh-list
101289310|NCT01951430|Fluconazole|fluconazole|mesh-list
101289311|NCT01951430|Posaconazole|posaconazole|mesh-list
101289312|NCT01951430|Antifungal Agents|antifungal agents|mesh-list
101289313|NCT01951430|Clotrimazole|clotrimazole|mesh-list
101289314|NCT01951430|Miconazole|miconazole|mesh-list
101289315|NCT01951430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101289316|NCT01951430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101289317|NCT01951430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101289318|NCT01951430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101289319|NCT01951430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289320|NCT01951430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101289321|NCT01951430|Hormone Antagonists|hormone antagonists|mesh-ancestor
101289322|NCT01951430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101289323|NCT01951430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289324|NCT01951430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101289325|NCT01951430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101289326|NCT01951430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101289327|NCT01951430|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101289328|NCT01951430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101289329|NCT01951430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101289330|NCT01951430|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101289331|NCT01951430|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101289332|NCT01951430|Antimalarials|antimalarials|mesh-ancestor
101289333|NCT01951482|Bevacizumab|bevacizumab|mesh-list
101289334|NCT01951482|Cisplatin|cisplatin|mesh-list
101289335|NCT01951482|Pemetrexed|pemetrexed|mesh-list
101289336|NCT01951482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101289337|NCT01951482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101289338|NCT01951482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101289339|NCT01951482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101289340|NCT01951482|Growth Substances|growth substances|mesh-ancestor
101289341|NCT01951482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289342|NCT01951482|Growth Inhibitors|growth inhibitors|mesh-ancestor
101289343|NCT01951482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101289344|NCT01951482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289345|NCT01951482|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101289346|NCT01951482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101289347|NCT01951508|Methylphenidate|methylphenidate|mesh-list
101289348|NCT01951508|Modafinil|modafinil|mesh-list
101289349|NCT01951508|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101289350|NCT01951508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289351|NCT01951508|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101289352|NCT01951508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101289353|NCT01951508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101289354|NCT01951508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289355|NCT01951508|Dopamine Agents|dopamine agents|mesh-ancestor
101289356|NCT01951508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101289357|NCT01951508|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101289358|NCT01951508|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101289359|NCT01951508|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101289361|NCT01951560|Anticonvulsants|anticonvulsants|mesh-ancestor
101289362|NCT01951560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101289363|NCT01951560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289364|NCT01951560|GABA Agents|gaba agents|mesh-ancestor
101289365|NCT01951560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101289366|NCT01951560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289367|NCT01951560|Antimanic Agents|antimanic agents|mesh-ancestor
101289368|NCT01951560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101289369|NCT01951560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101820518|NCT00991848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101820519|NCT00991848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820520|NCT00991848|Sensory System Agents|sensory system agents|mesh-ancestor
101820521|NCT00991848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101820522|NCT00991848|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101820523|NCT00991848|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101820524|NCT00991848|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101289370|NCT01951560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101289371|NCT01951599|Osimertinib|osimertinib|mesh-list
101289372|NCT01951599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101289373|NCT01951599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101289374|NCT01951599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101289375|NCT01951599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289376|NCT01951677|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101289377|NCT01951677|Immunologic Factors|immunologic factors|mesh-ancestor
101289378|NCT01951677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289379|NCT01951677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101289380|NCT01951677|Antacids|antacids|mesh-ancestor
101289381|NCT01951677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289382|NCT01951677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101289383|NCT01951729|Atropine|atropine|mesh-list
101289384|NCT01951729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101289385|NCT01951729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101289386|NCT01951729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101289387|NCT01951729|Autonomic Agents|autonomic agents|mesh-ancestor
101289388|NCT01951729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101289389|NCT01951729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289390|NCT01951729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101289391|NCT01951729|Respiratory System Agents|respiratory system agents|mesh-ancestor
101289392|NCT01951729|Mydriatics|mydriatics|mesh-ancestor
101289393|NCT01951729|Parasympatholytics|parasympatholytics|mesh-ancestor
101289394|NCT01951729|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101289395|NCT01951729|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101289396|NCT01951729|Cholinergic Agents|cholinergic agents|mesh-ancestor
101289397|NCT01951729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101289398|NCT01951729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289399|NCT01951846|Nintedanib|nintedanib|mesh-list
101289400|NCT01951846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101289401|NCT01951846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101289402|NCT01951846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101289403|NCT01951846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289404|NCT01951872|Caffeine|caffeine|mesh-list
101289406|NCT01951872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289407|NCT01951872|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101289408|NCT01951872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101289409|NCT01951872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289410|NCT01951872|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101289411|NCT01951872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101289412|NCT01951872|Purinergic Agents|purinergic agents|mesh-ancestor
101289413|NCT01951872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101289414|NCT01951898|Montelukast|montelukast|mesh-list
101289415|NCT01951898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101289416|NCT01951898|Respiratory System Agents|respiratory system agents|mesh-ancestor
101289417|NCT01951898|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101289418|NCT01951898|Hormone Antagonists|hormone antagonists|mesh-ancestor
101289419|NCT01951898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101289420|NCT01951898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289421|NCT01951898|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101289422|NCT01951898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101289423|NCT01951898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289425|NCT01951911|Analgesics|analgesics|mesh-ancestor
101289426|NCT01951911|Sensory System Agents|sensory system agents|mesh-ancestor
101289427|NCT01951911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101820525|NCT00991848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101820526|NCT00991848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820527|NCT05281068|Danazol|danazol|mesh-list
101820528|NCT05281068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101820529|NCT05281068|Hormone Antagonists|hormone antagonists|mesh-ancestor
101289428|NCT01951911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289429|NCT01951911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101289430|NCT01951911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101289431|NCT01951911|Anesthetics, General|anesthetics, general|mesh-ancestor
101289432|NCT01951911|Anesthetics|anesthetics|mesh-ancestor
101289433|NCT01951911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101289434|NCT01951911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101289435|NCT01951911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101289436|NCT01951911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101289437|NCT01951911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289438|NCT01951924|Immunoglobulins|immunoglobulins|mesh-list
101289439|NCT01951924|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101289440|NCT01951924|Antibodies|antibodies|mesh-list
101289441|NCT01951924|Immunoglobulin G|immunoglobulin g|mesh-list
101289442|NCT01951924|Immunologic Factors|immunologic factors|mesh-ancestor
101289443|NCT01951924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289444|NCT01952314|Naftopidil|naftopidil|mesh-list
101289445|NCT01952314|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101289446|NCT01952314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101289447|NCT01952314|Adrenergic Agents|adrenergic agents|mesh-ancestor
101289448|NCT01952314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101289449|NCT01952314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289450|NCT01952314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289451|NCT01952314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101289452|NCT01952314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101289453|NCT01952314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101289454|NCT01952314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101289455|NCT01952314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101289456|NCT01952561|Dapivirine|dapivirine|mesh-list
101289457|NCT01952561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101289458|NCT01952561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101289459|NCT01952561|Antiviral Agents|antiviral agents|mesh-ancestor
101289460|NCT01952561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101289461|NCT01952626|Ondansetron|ondansetron|mesh-list
101289462|NCT01952626|Palonosetron|palonosetron|mesh-list
101289463|NCT01952626|Antiemetics|antiemetics|mesh-ancestor
101289464|NCT01952626|Autonomic Agents|autonomic agents|mesh-ancestor
101289465|NCT01952626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101289466|NCT01952626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289467|NCT01952626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101289469|NCT01952626|Dermatologic Agents|dermatologic agents|mesh-ancestor
101289470|NCT01952626|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101289471|NCT01952626|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101289472|NCT01952626|Serotonin Agents|serotonin agents|mesh-ancestor
101289473|NCT01952626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101289474|NCT01952626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289475|NCT01952652|Naproxen|naproxen|mesh-list
101289476|NCT01952652|Codeine|codeine|mesh-list
101289477|NCT01952652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101289478|NCT01952652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101289479|NCT01952652|Analgesics|analgesics|mesh-ancestor
101289480|NCT01952652|Sensory System Agents|sensory system agents|mesh-ancestor
101289481|NCT01952652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101289482|NCT01952652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289483|NCT01952652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101289484|NCT01952652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101289485|NCT01952652|Gout Suppressants|gout suppressants|mesh-ancestor
101289486|NCT01952652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101289487|NCT01952652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101289488|NCT01952652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289489|NCT01952652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101289491|NCT01952652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101289492|NCT01952652|Antitussive Agents|antitussive agents|mesh-ancestor
101820530|NCT05281068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101820531|NCT05281068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820532|NCT00380068|Ambrisentan|ambrisentan|mesh-list
101820533|NCT00380068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101820534|NCT00991926|Orlistat|orlistat|mesh-list
101820535|NCT00991926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101820536|NCT00991926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820537|NCT00991926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101820538|NCT00991926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101820539|NCT04230954|Pembrolizumab|pembrolizumab|mesh-list
101820540|NCT04230954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101820541|NCT04230954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101289493|NCT01952652|Respiratory System Agents|respiratory system agents|mesh-ancestor
101289494|NCT01952756|Cilostazol|cilostazol|mesh-list
101289495|NCT01952756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101289496|NCT01952756|Autonomic Agents|autonomic agents|mesh-ancestor
101289497|NCT01952756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101289498|NCT01952756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289499|NCT01952756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101289500|NCT01952756|Respiratory System Agents|respiratory system agents|mesh-ancestor
101289501|NCT01952756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101289502|NCT01952756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101289503|NCT01952756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289504|NCT01952756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101289505|NCT01952756|Vasodilator Agents|vasodilator agents|mesh-ancestor
101289506|NCT01952756|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101289507|NCT01952756|Protective Agents|protective agents|mesh-ancestor
101289508|NCT01952756|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101289509|NCT01952756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101289510|NCT01952756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101289511|NCT01952769|Pidilizumab|pidilizumab|mesh-list
101289512|NCT01952769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101289513|NCT01952769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101289514|NCT05876598|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101289515|NCT05876598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101289516|NCT05876585|Ondansetron|ondansetron|mesh-list
101289517|NCT05876585|Metoclopramide|metoclopramide|mesh-list
101289518|NCT05876585|Antiemetics|antiemetics|mesh-ancestor
101289519|NCT05876585|Autonomic Agents|autonomic agents|mesh-ancestor
101289520|NCT05876585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101289521|NCT05876585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289522|NCT05876585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101289523|NCT05876585|Antipruritics|antipruritics|mesh-ancestor
101289524|NCT05876585|Dermatologic Agents|dermatologic agents|mesh-ancestor
101289525|NCT05876585|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101289526|NCT05876585|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101289527|NCT05876585|Serotonin Agents|serotonin agents|mesh-ancestor
101289528|NCT05876585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101289529|NCT05876585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289530|NCT05876585|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101289531|NCT05876585|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101289532|NCT05876585|Dopamine Agents|dopamine agents|mesh-ancestor
101289533|NCT05876481|Psilocybin|psilocybin|mesh-list
101289534|NCT05876481|Hallucinogens|hallucinogens|mesh-ancestor
101289535|NCT05876481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289536|NCT05876481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101289537|NCT05876390|Acetaminophen|acetaminophen|mesh-list
101289538|NCT05876390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101289539|NCT05876390|Analgesics|analgesics|mesh-ancestor
101289540|NCT05876390|Sensory System Agents|sensory system agents|mesh-ancestor
101820542|NCT04230954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101820543|NCT04230954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820544|NCT00536484|Fesoterodine|fesoterodine|mesh-list
101820545|NCT00536484|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101820546|NCT00536484|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101820547|NCT00536484|Cholinergic Agents|cholinergic agents|mesh-ancestor
101820548|NCT00536484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101820549|NCT00536484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820550|NCT00536484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820551|NCT00536484|Urological Agents|urological agents|mesh-ancestor
101289541|NCT05876390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101289542|NCT05876390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289543|NCT05876390|Antipyretics|antipyretics|mesh-ancestor
101289544|NCT05876377|Vaccines|vaccines|mesh-list
101289545|NCT05876377|Immunologic Factors|immunologic factors|mesh-ancestor
101289546|NCT05876377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289547|NCT05876195|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101289548|NCT05876195|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101289549|NCT05876195|Freund's Adjuvant|freund's adjuvant|mesh-list
101289550|NCT05876195|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
101289551|NCT05876195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101289552|NCT05876195|Immunologic Factors|immunologic factors|mesh-ancestor
101289553|NCT05876195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289554|NCT05876195|Antacids|antacids|mesh-ancestor
101289555|NCT05876195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289556|NCT05876195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101289557|NCT05876169|Salicylic Acid|salicylic acid|mesh-list
101289558|NCT05876169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101289559|NCT05876169|Antifungal Agents|antifungal agents|mesh-ancestor
101289560|NCT05876169|Keratolytic Agents|keratolytic agents|mesh-ancestor
101289561|NCT05876169|Dermatologic Agents|dermatologic agents|mesh-ancestor
101289562|NCT05876039|Remifentanil|remifentanil|mesh-list
101289563|NCT05876039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101289564|NCT05876039|Narcotics|narcotics|mesh-ancestor
101289565|NCT05876039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101289566|NCT05876039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289567|NCT05876039|Analgesics|analgesics|mesh-ancestor
101289568|NCT05876039|Sensory System Agents|sensory system agents|mesh-ancestor
101289569|NCT05876039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101289570|NCT05875948|Terlipressin|terlipressin|mesh-list
101289571|NCT05875948|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101289572|NCT05875948|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101289573|NCT05875714|Apremilast|apremilast|mesh-list
101289574|NCT05875714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101289575|NCT05875714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101289576|NCT05875714|Analgesics|analgesics|mesh-ancestor
101289577|NCT05875714|Sensory System Agents|sensory system agents|mesh-ancestor
101289578|NCT05875714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101289579|NCT05875714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289580|NCT05875714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101289581|NCT05875714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101289582|NCT05875714|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101289583|NCT05875714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101289584|NCT05875714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101289585|NCT05875714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289586|NCT05875701|Vaccines|vaccines|mesh-list
101289587|NCT05875701|Immunologic Factors|immunologic factors|mesh-ancestor
101289588|NCT05875701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289591|NCT05875675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289592|NCT05875610|Gabapentin|gabapentin|mesh-list
101289593|NCT05875610|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101289594|NCT05875610|Analgesics|analgesics|mesh-ancestor
101289595|NCT05875610|Sensory System Agents|sensory system agents|mesh-ancestor
101820552|NCT00370396|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101820553|NCT00370396|Immunologic Factors|immunologic factors|mesh-ancestor
101820554|NCT00370396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820556|NCT00992004|Antioxidants|antioxidants|mesh-ancestor
101312617|NCT00006397|Protease Inhibitors|protease inhibitors|mesh-ancestor
101820557|NCT00992004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820558|NCT00992004|Protective Agents|protective agents|mesh-ancestor
101820559|NCT00992004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289596|NCT05875610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101289597|NCT05875610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289598|NCT05875610|Anticonvulsants|anticonvulsants|mesh-ancestor
101289599|NCT05875610|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101289600|NCT05875610|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101289601|NCT05875610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101289602|NCT05875610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101289603|NCT05875610|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101289604|NCT05875610|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101289605|NCT05875610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101289606|NCT05875610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289607|NCT05875610|Antimanic Agents|antimanic agents|mesh-ancestor
101289608|NCT05875610|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101289609|NCT05875610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101289610|NCT05875610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101289611|NCT05875610|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101289612|NCT05875610|Antidepressive Agents|antidepressive agents|mesh-ancestor
101289613|NCT05875571|Ketorolac|ketorolac|mesh-list
101289614|NCT05875571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101289615|NCT05875571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101289616|NCT05875571|Analgesics|analgesics|mesh-ancestor
101289617|NCT05875571|Sensory System Agents|sensory system agents|mesh-ancestor
101289618|NCT05875571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101289619|NCT05875571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289620|NCT05875571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101289621|NCT05875571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101289622|NCT05875571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101289623|NCT05875571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316380|NCT00390871|Fentanyl|fentanyl|mesh-list
101289624|NCT05875571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289627|NCT05875519|Anesthetics|anesthetics|mesh-ancestor
101289628|NCT05875519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101289629|NCT05875519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289630|NCT05875519|Anesthetics, Local|anesthetics, local|mesh-ancestor
101289631|NCT05875519|Sensory System Agents|sensory system agents|mesh-ancestor
101289632|NCT05875519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101289633|NCT05875519|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101289634|NCT05875428|Mitoxantrone|mitoxantrone|mesh-list
101289635|NCT05875428|Analgesics|analgesics|mesh-ancestor
101289636|NCT05875428|Sensory System Agents|sensory system agents|mesh-ancestor
101289637|NCT05875428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101289638|NCT05875428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289639|NCT05875428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101289640|NCT05875428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101289641|NCT05875428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101289642|NCT05875428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101289643|NCT05875428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289644|NCT05875285|Methotrexate|methotrexate|mesh-list
101289645|NCT05875285|Coal Tar|coal tar|mesh-list
101289646|NCT05875285|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101289647|NCT05875285|Abortifacient Agents|abortifacient agents|mesh-ancestor
101289648|NCT05875285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101289649|NCT05875285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289650|NCT05875285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101289657|NCT05875285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101289658|NCT05875285|Immunologic Factors|immunologic factors|mesh-ancestor
101289659|NCT05875285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101289660|NCT05875285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101289661|NCT05875285|Keratolytic Agents|keratolytic agents|mesh-ancestor
101289680|NCT05875025|Norflurane|norflurane|mesh-list
101289681|NCT05875025|Anesthetics|anesthetics|mesh-ancestor
101289682|NCT05875025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101289683|NCT05875025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289684|NCT05874921|Mitomycins|mitomycins|mesh-list
101289685|NCT05874921|Mitomycin|mitomycin|mesh-list
101289686|NCT05874921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101289687|NCT05874921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101289688|NCT05874921|Alkylating Agents|alkylating agents|mesh-ancestor
101289689|NCT05874921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289690|NCT05874921|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101289691|NCT05874921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101289692|NCT05874882|Chlorhexidine|chlorhexidine|mesh-list
101289693|NCT05874882|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101289694|NCT05874882|Resveratrol|resveratrol|mesh-list
101289695|NCT05874882|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101289696|NCT05874882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101289697|NCT05874882|Disinfectants|disinfectants|mesh-ancestor
101289698|NCT05874882|Dermatologic Agents|dermatologic agents|mesh-ancestor
101289699|NCT05874882|Antioxidants|antioxidants|mesh-ancestor
101289700|NCT05874882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289701|NCT05874882|Protective Agents|protective agents|mesh-ancestor
101289702|NCT05874882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289703|NCT05874882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101820573|NCT00992082|Morphine|morphine|mesh-list
101820574|NCT00992082|Ropivacaine|ropivacaine|mesh-list
101820575|NCT00992082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101820576|NCT00992082|Narcotics|narcotics|mesh-ancestor
101820577|NCT00992082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101820578|NCT00992082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820579|NCT00992082|Analgesics|analgesics|mesh-ancestor
101289704|NCT05874882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101289705|NCT05874778|Prednisone|prednisone|mesh-list
101289706|NCT05874778|Cyclophosphamide|cyclophosphamide|mesh-list
101289707|NCT05874778|Vincristine|vincristine|mesh-list
101289708|NCT05874778|Rituximab|rituximab|mesh-list
101289709|NCT05874778|Doxorubicin|doxorubicin|mesh-list
101289710|NCT05874778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101289711|NCT05874778|Immunologic Factors|immunologic factors|mesh-ancestor
101289712|NCT05874778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289713|NCT05874778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101289714|NCT05874778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101289715|NCT05874778|Alkylating Agents|alkylating agents|mesh-ancestor
101289716|NCT05874778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289717|NCT05874778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101289718|NCT05874778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101289719|NCT05874778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101289720|NCT05874778|Glucocorticoids|glucocorticoids|mesh-ancestor
101289721|NCT05874778|Hormones|hormones|mesh-ancestor
101289722|NCT05874778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101289723|NCT05874778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101289724|NCT05874778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101289725|NCT05874778|Tubulin Modulators|tubulin modulators|mesh-ancestor
101289726|NCT05874778|Antimitotic Agents|antimitotic agents|mesh-ancestor
101289727|NCT05874778|Mitosis Modulators|mitosis modulators|mesh-ancestor
101289728|NCT05874778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101289729|NCT05874778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101289730|NCT05874778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101289731|NCT05874778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101289732|NCT05874778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101289733|NCT05874700|Sivelestat|sivelestat|mesh-list
101289734|NCT05874700|Glycine|glycine|mesh-list
101289735|NCT05874700|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101289736|NCT05874700|Protease Inhibitors|protease inhibitors|mesh-ancestor
101289737|NCT05874700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101289738|NCT05874700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289739|NCT05874700|Glycine Agents|glycine agents|mesh-ancestor
101289740|NCT05874700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101289741|NCT05874700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289742|NCT05874674|Nafamostat|nafamostat|mesh-list
101289743|NCT05874674|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101289744|NCT05874674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101289745|NCT05874674|Analgesics|analgesics|mesh-ancestor
101289746|NCT05874674|Sensory System Agents|sensory system agents|mesh-ancestor
101289747|NCT05874674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101289748|NCT05874674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289749|NCT05874674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101289750|NCT05874674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101289751|NCT05874674|Anticoagulants|anticoagulants|mesh-ancestor
101289752|NCT05874674|Protease Inhibitors|protease inhibitors|mesh-ancestor
101289753|NCT05874674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101289754|NCT05874674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289755|NCT05874674|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101289756|NCT05874674|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101289757|NCT05874674|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101289758|NCT05874674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101289759|NCT05874674|Immunologic Factors|immunologic factors|mesh-ancestor
101289760|NCT05874583|Tranexamic Acid|tranexamic acid|mesh-list
101289761|NCT05874583|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101289762|NCT05874583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101289763|NCT05874583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289764|NCT05874583|Hemostatics|hemostatics|mesh-ancestor
101820580|NCT00992082|Sensory System Agents|sensory system agents|mesh-ancestor
101820581|NCT00992082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101820582|NCT00992082|Anesthetics, Local|anesthetics, local|mesh-ancestor
101820583|NCT00992082|Anesthetics|anesthetics|mesh-ancestor
101820584|NCT00992082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101820585|NCT00992082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101820586|NCT00992082|Adrenergic Agents|adrenergic agents|mesh-ancestor
101820587|NCT00992082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101289766|NCT05874544|Amoxicillin|amoxicillin|mesh-list
101289767|NCT05874544|Metronidazole|metronidazole|mesh-list
101289768|NCT05874544|Tetracycline|tetracycline|mesh-list
101289769|NCT05874544|Rifabutin|rifabutin|mesh-list
101289770|NCT05874544|Potassium Citrate|potassium citrate|mesh-list
101289771|NCT05874544|Bismuth|bismuth|mesh-list
101289772|NCT05874544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289773|NCT05874544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101289774|NCT05874544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101289775|NCT05874544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101289776|NCT05874544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101289777|NCT05874544|Antacids|antacids|mesh-ancestor
101289778|NCT05874544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101289779|NCT05874544|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101289780|NCT05874544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101289781|NCT05874544|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101289782|NCT05874544|Antitubercular Agents|antitubercular agents|mesh-ancestor
101289783|NCT05874544|Diuretics|diuretics|mesh-ancestor
101289784|NCT05874544|Natriuretic Agents|natriuretic agents|mesh-ancestor
101289785|NCT05874544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289786|NCT05874544|Expectorants|expectorants|mesh-ancestor
101289787|NCT05874544|Respiratory System Agents|respiratory system agents|mesh-ancestor
101289788|NCT05874518|Letrozole|letrozole|mesh-list
101289789|NCT05874518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101289790|NCT05874518|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101289791|NCT05874518|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101289792|NCT05874518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101289793|NCT05874518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289794|NCT05874518|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101289795|NCT05874518|Hormone Antagonists|hormone antagonists|mesh-ancestor
101289796|NCT05874518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101289797|NCT05874518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289798|NCT05874505|Adalimumab|adalimumab|mesh-list
101289799|NCT05874505|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101289800|NCT05874505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101289801|NCT05874505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101289802|NCT05872789|Diazepam|diazepam|mesh-list
101289803|NCT05872789|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101289804|NCT05872789|Anticonvulsants|anticonvulsants|mesh-ancestor
101289805|NCT05872789|Antiemetics|antiemetics|mesh-ancestor
101289806|NCT05872789|Autonomic Agents|autonomic agents|mesh-ancestor
101289807|NCT05872789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101289808|NCT05872789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289809|NCT05872789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101289810|NCT05872789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101289811|NCT05872789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101289812|NCT05872789|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101289813|NCT05872789|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101289814|NCT05872789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101289815|NCT05872789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101289816|NCT05872789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101289817|NCT05872789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101289818|NCT05872789|Anesthetics, General|anesthetics, general|mesh-ancestor
101289819|NCT05872789|Anesthetics|anesthetics|mesh-ancestor
101289820|NCT05872789|GABA Modulators|gaba modulators|mesh-ancestor
101289821|NCT05872789|GABA Agents|gaba agents|mesh-ancestor
101289822|NCT05872789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101289823|NCT05872789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820588|NCT00992082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820589|NCT00992082|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101820590|NCT00992082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101820591|NCT00992082|Autonomic Agents|autonomic agents|mesh-ancestor
101820592|NCT00992082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101820593|NCT00992082|Respiratory System Agents|respiratory system agents|mesh-ancestor
101820594|NCT00992082|Mydriatics|mydriatics|mesh-ancestor
101820595|NCT00992082|Sympathomimetics|sympathomimetics|mesh-ancestor
101820596|NCT00992082|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101820597|NCT00992082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101820598|NCT00992082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101820599|NCT00992082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101820600|NCT00992082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101820601|NCT00992082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101820602|NCT00992082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101820603|NCT00455013|Mycophenolic Acid|mycophenolic acid|mesh-list
101820604|NCT00455013|Sirolimus|sirolimus|mesh-list
101820605|NCT00455013|Abatacept|abatacept|mesh-list
101820606|NCT00455013|Tacrolimus|tacrolimus|mesh-list
101820607|NCT00455013|Thymoglobulin|thymoglobulin|mesh-list
101289824|NCT05872412|Paclitaxel|paclitaxel|mesh-list
101289825|NCT05872412|Cyclophosphamide|cyclophosphamide|mesh-list
101289826|NCT05872412|Carboplatin|carboplatin|mesh-list
101289827|NCT05872412|Doxorubicin|doxorubicin|mesh-list
101289828|NCT05872412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101289829|NCT05872412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101289830|NCT05872412|Tubulin Modulators|tubulin modulators|mesh-ancestor
101289831|NCT05872412|Antimitotic Agents|antimitotic agents|mesh-ancestor
101820608|NCT00455013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101820609|NCT00455013|Immunologic Factors|immunologic factors|mesh-ancestor
101820610|NCT00455013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820611|NCT00455013|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101820612|NCT00455013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101820613|NCT00455013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820614|NCT00455013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101820615|NCT00455013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101820616|NCT00455013|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101820617|NCT00455013|Antitubercular Agents|antitubercular agents|mesh-ancestor
101289832|NCT05872412|Mitosis Modulators|mitosis modulators|mesh-ancestor
101289833|NCT05872412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289834|NCT05872412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101289835|NCT05872412|Immunologic Factors|immunologic factors|mesh-ancestor
101289836|NCT05872412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289838|NCT05872412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101289839|NCT05872412|Alkylating Agents|alkylating agents|mesh-ancestor
101289840|NCT05872412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101289841|NCT05872412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101289842|NCT05872412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101289843|NCT05872412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101289845|NCT05871476|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101289846|NCT05871476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101289848|NCT05864144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101289849|NCT05864144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101289850|NCT05860439|Polidocanol|polidocanol|mesh-list
101289851|NCT05860439|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
101289852|NCT05860439|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101289853|NCT05849610|Dexamethasone|dexamethasone|mesh-list
101289854|NCT05849610|Lenalidomide|lenalidomide|mesh-list
101289855|NCT05849610|Bortezomib|bortezomib|mesh-list
101289856|NCT05849610|Daratumumab|daratumumab|mesh-list
101289857|NCT05849610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101289858|NCT05849610|Antiemetics|antiemetics|mesh-ancestor
101289859|NCT05849610|Autonomic Agents|autonomic agents|mesh-ancestor
101289860|NCT05849610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101289861|NCT05849610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289862|NCT05849610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101289863|NCT05849610|Glucocorticoids|glucocorticoids|mesh-ancestor
101289864|NCT05849610|Hormones|hormones|mesh-ancestor
101289865|NCT05849610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101289866|NCT05849610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101289867|NCT05849610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101289868|NCT05849610|Immunologic Factors|immunologic factors|mesh-ancestor
101289869|NCT05849610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101289870|NCT05849610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101289871|NCT05849610|Growth Substances|growth substances|mesh-ancestor
101289872|NCT05849610|Growth Inhibitors|growth inhibitors|mesh-ancestor
101289873|NCT05823675|Methylprednisolone|methylprednisolone|mesh-list
101289874|NCT05823675|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101289875|NCT05823675|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101289876|NCT05823675|Prednisolone|prednisolone|mesh-list
101289877|NCT05823675|Prednisolone acetate|prednisolone acetate|mesh-list
101289878|NCT05823675|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101289879|NCT05823675|Prednisolone phosphate|prednisolone phosphate|mesh-list
101289880|NCT05823675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101289881|NCT05823675|Antiemetics|antiemetics|mesh-ancestor
101289882|NCT05823675|Autonomic Agents|autonomic agents|mesh-ancestor
101289883|NCT05823675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101289884|NCT05823675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289885|NCT05823675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101289886|NCT05823675|Glucocorticoids|glucocorticoids|mesh-ancestor
101289887|NCT05823675|Hormones|hormones|mesh-ancestor
101289888|NCT05823675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101820618|NCT00455013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101820619|NCT00455013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101820620|NCT00455013|Antifungal Agents|antifungal agents|mesh-ancestor
101820621|NCT00455013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101820622|NCT00455013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101820623|NCT00455013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101820624|NCT00363298|Caffeine|caffeine|mesh-list
101820625|NCT00363298|Amphetamine|amphetamine|mesh-list
101820626|NCT00363298|Dextroamphetamine|dextroamphetamine|mesh-list
101820627|NCT00363298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101820628|NCT00363298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289889|NCT05823675|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101289890|NCT05823675|Protective Agents|protective agents|mesh-ancestor
101289891|NCT05823675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101289892|NCT05823675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101289894|NCT05874869|Artenimol|artenimol|mesh-list
101289895|NCT05874869|Antimalarials|antimalarials|mesh-ancestor
101289896|NCT05874869|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101289897|NCT05874869|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101289898|NCT05874869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101289899|NCT05818735|Escitalopram|escitalopram|mesh-list
101289900|NCT05818735|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101289901|NCT05818735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101289902|NCT05818735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101289903|NCT05818735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289904|NCT05818735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101289905|NCT05818735|Serotonin Agents|serotonin agents|mesh-ancestor
101289906|NCT05818735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289907|NCT05799820|Bevacizumab|bevacizumab|mesh-list
101289908|NCT05799820|Capecitabine|capecitabine|mesh-list
101289909|NCT05799820|Oxaliplatin|oxaliplatin|mesh-list
101289910|NCT05799820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101289911|NCT05799820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101289912|NCT05799820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101289913|NCT05799820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101289914|NCT05799820|Growth Substances|growth substances|mesh-ancestor
101289915|NCT05799820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289916|NCT05799820|Growth Inhibitors|growth inhibitors|mesh-ancestor
101289917|NCT05799820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101289918|NCT05799820|Antimetabolites|antimetabolites|mesh-ancestor
101289919|NCT05799820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289920|NCT05790161|Caffeine|caffeine|mesh-list
101289921|NCT05790161|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101289922|NCT05790161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289923|NCT05790161|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101289925|NCT05790161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289926|NCT05790161|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101289927|NCT05790161|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101289928|NCT05790161|Purinergic Agents|purinergic agents|mesh-ancestor
101289931|NCT05786040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101289932|NCT05786040|Antibodies|antibodies|mesh-list
101289933|NCT05786040|Immunoglobulins|immunoglobulins|mesh-list
101289934|NCT05786040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101289935|NCT05786040|Immunologic Factors|immunologic factors|mesh-ancestor
101289936|NCT05786040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289937|NCT05786040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101289939|NCT05775809|Serotonin|serotonin|mesh-list
101289940|NCT05775809|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
101289941|NCT05775809|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101289942|NCT05775809|Serotonin Agents|serotonin agents|mesh-ancestor
101289943|NCT05775809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101289944|NCT05775809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289945|NCT05775809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820629|NCT00363298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101820630|NCT00363298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101820631|NCT00363298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820632|NCT00363298|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101820633|NCT00363298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101820634|NCT00363298|Purinergic Agents|purinergic agents|mesh-ancestor
101820635|NCT00363298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101820636|NCT00363298|Sympathomimetics|sympathomimetics|mesh-ancestor
101820637|NCT00363298|Autonomic Agents|autonomic agents|mesh-ancestor
101820638|NCT00363298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101820639|NCT00363298|Dopamine Agents|dopamine agents|mesh-ancestor
101820640|NCT00363298|Adrenergic Agents|adrenergic agents|mesh-ancestor
101820641|NCT00363298|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101820642|NCT00363298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101289946|NCT05775809|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101289947|NCT05775809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101289948|NCT05723601|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101289949|NCT05723601|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101289950|NCT05723601|Estradiol|estradiol|mesh-list
101289951|NCT05723601|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101289952|NCT05723601|Estrogens|estrogens|mesh-ancestor
101289953|NCT05723601|Hormones|hormones|mesh-ancestor
101289954|NCT05723601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101289955|NCT05723601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289956|NCT05723601|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101289957|NCT05723601|Contraceptive Agents|contraceptive agents|mesh-ancestor
101289958|NCT05723601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101289959|NCT05723601|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101289960|NCT05701527|Pembrolizumab|pembrolizumab|mesh-list
101289961|NCT05701527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101289962|NCT05701527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101289963|NCT05701527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101289964|NCT05701527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289965|NCT05698407|Sufentanil|sufentanil|mesh-list
101289966|NCT05698407|Dexmedetomidine|dexmedetomidine|mesh-list
101289967|NCT05698407|Dsuvia|dsuvia|mesh-list
101289968|NCT05698407|Ropivacaine|ropivacaine|mesh-list
101289969|NCT05698407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101289970|NCT05698407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101289971|NCT05698407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289972|NCT05698407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101289973|NCT05698407|Analgesics|analgesics|mesh-ancestor
101289974|NCT05698407|Sensory System Agents|sensory system agents|mesh-ancestor
101289975|NCT05698407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101289976|NCT05698407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101289977|NCT05698407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101289978|NCT05698407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101289979|NCT05698407|Adrenergic Agents|adrenergic agents|mesh-ancestor
101289980|NCT05698407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101289981|NCT05698407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101289982|NCT05698407|Anesthetics, Local|anesthetics, local|mesh-ancestor
101289983|NCT05698407|Anesthetics|anesthetics|mesh-ancestor
101289987|NCT05698407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101289988|NCT05698407|Anesthetics, General|anesthetics, general|mesh-ancestor
101289989|NCT05696236|Tin Fluorides|tin fluorides|mesh-list
101289990|NCT05696236|Cariostatic Agents|cariostatic agents|mesh-ancestor
101289991|NCT05696236|Protective Agents|protective agents|mesh-ancestor
101289992|NCT05696236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820645|NCT05254548|Flurbiprofen|flurbiprofen|mesh-list
101820646|NCT05254548|Midazolam|midazolam|mesh-list
101820647|NCT05254548|Omeprazole|omeprazole|mesh-list
101820648|NCT05254548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101820649|NCT05254548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101820650|NCT05254548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101289993|NCT05671315|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101289994|NCT05671315|Antiviral Agents|antiviral agents|mesh-ancestor
101289995|NCT05671315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101289996|NCT05641467|Methamphetamine|methamphetamine|mesh-list
101289997|NCT05641467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101289998|NCT05641467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101289999|NCT05641467|Sympathomimetics|sympathomimetics|mesh-ancestor
101290000|NCT05641467|Autonomic Agents|autonomic agents|mesh-ancestor
101290001|NCT05641467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101290002|NCT05641467|Dopamine Agents|dopamine agents|mesh-ancestor
101290003|NCT05641467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101290004|NCT05641467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290005|NCT05641467|Adrenergic Agents|adrenergic agents|mesh-ancestor
101290006|NCT05641467|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101290007|NCT05641467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101290008|NCT05641467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101290009|NCT05641467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101290010|NCT05627245|Belinostat|belinostat|mesh-list
101290011|NCT05627245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290012|NCT05627245|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101290013|NCT05627245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101290014|NCT05627245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290017|NCT05574712|Leuprolide|leuprolide|mesh-list
101290018|NCT05574712|Abiraterone Acetate|abiraterone acetate|mesh-list
101290019|NCT05574712|Belzutifan|belzutifan|mesh-list
101290020|NCT05574712|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101290021|NCT05574712|Fertility Agents|fertility agents|mesh-ancestor
101290022|NCT05574712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101290023|NCT05574712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290024|NCT05574712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101290025|NCT05574712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290026|NCT05574712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101290027|NCT05574712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101290028|NCT05574712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290029|NCT05574712|Hormone Antagonists|hormone antagonists|mesh-ancestor
101290030|NCT05574712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101290031|NCT05574712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101290032|NCT05510063|Adalimumab|adalimumab|mesh-list
101290033|NCT05510063|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101290034|NCT05510063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101290035|NCT05510063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101290036|NCT05508815|Methotrexate|methotrexate|mesh-list
101290037|NCT05508815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101290038|NCT05508815|Abortifacient Agents|abortifacient agents|mesh-ancestor
101290039|NCT05508815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101290040|NCT05508815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290041|NCT05508815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101290042|NCT05508815|Antimetabolites|antimetabolites|mesh-ancestor
101290043|NCT05508815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290044|NCT05508815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290045|NCT05508815|Dermatologic Agents|dermatologic agents|mesh-ancestor
101820651|NCT05254548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820652|NCT05254548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101820653|NCT05254548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101820654|NCT05254548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101820655|NCT05254548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101820656|NCT05254548|Anesthetics, General|anesthetics, general|mesh-ancestor
101820657|NCT05254548|Anesthetics|anesthetics|mesh-ancestor
101477961|NCT00279461|Vitamin D|vitamin d|mesh-list
101820658|NCT05254548|GABA Modulators|gaba modulators|mesh-ancestor
101290046|NCT05508815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101290047|NCT05508815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101290048|NCT05508815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101290049|NCT05508815|Immunologic Factors|immunologic factors|mesh-ancestor
101290050|NCT05508815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101290051|NCT05508815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101290052|NCT05500508|Eflornithine|eflornithine|mesh-list
101290053|NCT05500508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290054|NCT05500508|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101290055|NCT05500508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101290056|NCT05500508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101290057|NCT05500508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101290058|NCT05500508|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
101290059|NCT05500508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101290060|NCT05500508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290061|NCT05463861|Lemborexant|lemborexant|mesh-list
101290062|NCT05463861|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
101290063|NCT05463861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101290064|NCT05463861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290065|NCT05463861|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101290066|NCT05463861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101290067|NCT05463861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101290068|NCT05463861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290069|NCT05346588|Propofol|propofol|mesh-list
101290070|NCT05346588|Anesthetics|anesthetics|mesh-list
101290071|NCT05346588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101290072|NCT05346588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101290073|NCT05346588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290074|NCT05346588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101290075|NCT05346588|Anesthetics, General|anesthetics, general|mesh-ancestor
101290077|NCT05327530|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
101290078|NCT05327530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101290079|NCT05327530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290080|NCT05327530|Immunoconjugates|immunoconjugates|mesh-ancestor
101290081|NCT05327530|Immunologic Factors|immunologic factors|mesh-ancestor
101290082|NCT05327530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290083|NCT05323708|Denosumab|denosumab|mesh-list
101290084|NCT05323708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101290085|NCT05323708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290086|NCT05312645|Diclofenac|diclofenac|mesh-list
101290087|NCT05312645|Petrolatum|petrolatum|mesh-list
101290088|NCT05312645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101290089|NCT05312645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101290090|NCT05312645|Analgesics|analgesics|mesh-ancestor
101290091|NCT05312645|Sensory System Agents|sensory system agents|mesh-ancestor
101290092|NCT05312645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101290093|NCT05312645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290094|NCT05312645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101290095|NCT05312645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101820660|NCT05254548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101820661|NCT05254548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820662|NCT05254548|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101820663|NCT05254548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101820664|NCT05254548|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101820665|NCT05254548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101820666|NCT05254548|Analgesics|analgesics|mesh-ancestor
101820667|NCT05254548|Sensory System Agents|sensory system agents|mesh-ancestor
101820668|NCT05254548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101290096|NCT05312645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101290097|NCT05312645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101290098|NCT05312645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290099|NCT05312645|Emollients|emollients|mesh-ancestor
101290100|NCT05312645|Dermatologic Agents|dermatologic agents|mesh-ancestor
101290101|NCT05285566|Lidocaine|lidocaine|mesh-list
101290102|NCT05285566|Bupivacaine|bupivacaine|mesh-list
101290103|NCT05285566|Anesthetics, Local|anesthetics, local|mesh-ancestor
101290104|NCT05285566|Anesthetics|anesthetics|mesh-ancestor
101290105|NCT05285566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101290106|NCT05285566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290107|NCT05285566|Sensory System Agents|sensory system agents|mesh-ancestor
101290108|NCT05285566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101290109|NCT05285566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101290110|NCT05285566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101290111|NCT05285566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101290112|NCT05285566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101290113|NCT05285566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290114|NCT05184712|Carboplatin|carboplatin|mesh-list
101290115|NCT05184712|Pemetrexed|pemetrexed|mesh-list
101290116|NCT05184712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290117|NCT05184712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101290118|NCT05184712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290119|NCT05184712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101290120|NCT05184712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101290121|NCT05129722|Empagliflozin|empagliflozin|mesh-list
101290122|NCT05129722|Eplerenone|eplerenone|mesh-list
101290123|NCT05129722|Bumetanide|bumetanide|mesh-list
101290124|NCT05129722|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101290125|NCT05129722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290126|NCT05129722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101290127|NCT05129722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290128|NCT05129722|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101290129|NCT05129722|Hormone Antagonists|hormone antagonists|mesh-ancestor
101290130|NCT05129722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101290131|NCT05129722|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101290132|NCT05129722|Diuretics|diuretics|mesh-ancestor
101290133|NCT05129722|Natriuretic Agents|natriuretic agents|mesh-ancestor
101290134|NCT05129722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101290135|NCT05129722|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101290136|NCT05129722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101290137|NCT05044962|Rilpivirine|rilpivirine|mesh-list
101290138|NCT05044962|Cabotegravir|cabotegravir|mesh-list
101290139|NCT05044962|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101290140|NCT05044962|Levonorgestrel|levonorgestrel|mesh-list
101290141|NCT05044962|Medroxyprogesterone|medroxyprogesterone|mesh-list
101290143|NCT05044962|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101290144|NCT05044962|Contraceptive Agents|contraceptive agents|mesh-ancestor
101290145|NCT05044962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101290147|NCT05044962|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101290148|NCT05044962|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101290149|NCT05044962|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101290150|NCT05044962|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101290151|NCT05044962|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101290152|NCT05044962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101820669|NCT05254548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101820670|NCT05254548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101820671|NCT05254548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101820673|NCT05254548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101820674|NCT00363142|Ritonavir|ritonavir|mesh-list
101820675|NCT00363142|Fosamprenavir|fosamprenavir|mesh-list
101290153|NCT05044962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290154|NCT05044962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101290155|NCT05044962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101290156|NCT05044962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101290157|NCT05044962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290158|NCT05044962|Antiviral Agents|antiviral agents|mesh-ancestor
101290159|NCT05044962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101290160|NCT05044962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101290161|NCT05044962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101290162|NCT05044962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101290163|NCT05044962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101290164|NCT05041101|Halichondrin B|halichondrin b|mesh-list
101290165|NCT05041101|Tubulin Modulators|tubulin modulators|mesh-ancestor
101290166|NCT05041101|Antimitotic Agents|antimitotic agents|mesh-ancestor
101290167|NCT05041101|Mitosis Modulators|mitosis modulators|mesh-ancestor
101290168|NCT05041101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290169|NCT05041101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290170|NCT05027919|Lofexidine|lofexidine|mesh-list
101290171|NCT05027919|Clonidine|clonidine|mesh-list
101290172|NCT05027919|Morphine|morphine|mesh-list
101290173|NCT05027919|Naloxone|naloxone|mesh-list
101290174|NCT05027919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101290175|NCT05027919|Narcotics|narcotics|mesh-ancestor
101290176|NCT05027919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101290177|NCT05027919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290178|NCT05027919|Analgesics|analgesics|mesh-ancestor
101290179|NCT05027919|Sensory System Agents|sensory system agents|mesh-ancestor
101290180|NCT05027919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101290181|NCT05027919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101290182|NCT05027919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101290183|NCT05027919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101290184|NCT05027919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101290185|NCT05027919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101290186|NCT05027919|Adrenergic Agents|adrenergic agents|mesh-ancestor
101290187|NCT05027919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101290188|NCT05027919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290190|NCT05027919|Autonomic Agents|autonomic agents|mesh-ancestor
101290191|NCT04994431|Tamsulosin|tamsulosin|mesh-list
101290192|NCT04994431|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101290193|NCT04994431|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101290194|NCT04994431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101290195|NCT04994431|Adrenergic Agents|adrenergic agents|mesh-ancestor
101290196|NCT04994431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101290197|NCT04994431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290198|NCT04994431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290199|NCT04994431|Urological Agents|urological agents|mesh-ancestor
101290200|NCT04985760|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101290203|NCT04985760|Immunologic Factors|immunologic factors|mesh-ancestor
101290204|NCT04985760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290205|NCT04985760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101290206|NCT04985760|Antacids|antacids|mesh-ancestor
101290207|NCT04985760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290208|NCT04985760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101290209|NCT04966546|Memantine|memantine|mesh-list
101290210|NCT04966546|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101290211|NCT04966546|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101290212|NCT04966546|Dopamine Agents|dopamine agents|mesh-ancestor
101290213|NCT04966546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101290214|NCT04966546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290215|NCT04966546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290216|NCT04966546|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101290217|NCT04966546|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101820676|NCT00363142|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101820677|NCT00363142|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101820678|NCT00363142|Protease Inhibitors|protease inhibitors|mesh-ancestor
101820679|NCT00363142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101820680|NCT00363142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820681|NCT00363142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101820682|NCT00363142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101290218|NCT04912063|Azacitidine|azacitidine|mesh-list
101290219|NCT04912063|Venetoclax|venetoclax|mesh-list
101290220|NCT04912063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101290221|NCT04912063|Antimetabolites|antimetabolites|mesh-ancestor
101290222|NCT04912063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290223|NCT04912063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290224|NCT04912063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101290225|NCT04853446|Dexamethasone|dexamethasone|mesh-list
101290226|NCT04853446|Dexamethasone acetate|dexamethasone acetate|mesh-list
101290227|NCT04853446|BB 1101|bb 1101|mesh-list
101290228|NCT04853446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101290229|NCT04853446|Antiemetics|antiemetics|mesh-ancestor
101290230|NCT04853446|Autonomic Agents|autonomic agents|mesh-ancestor
101290231|NCT04853446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101290232|NCT04853446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290233|NCT04853446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101290234|NCT04853446|Glucocorticoids|glucocorticoids|mesh-ancestor
101290235|NCT04853446|Hormones|hormones|mesh-ancestor
101290236|NCT04853446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101290237|NCT04853446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101290238|NCT04853446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290239|NCT04853446|Protease Inhibitors|protease inhibitors|mesh-ancestor
101290240|NCT04853446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101290241|NCT04853446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290242|NCT04846231|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101290243|NCT04846231|Red yeast rice|red yeast rice|mesh-list
101290244|NCT04846231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101290245|NCT04846231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101290246|NCT04846231|Antimetabolites|antimetabolites|mesh-ancestor
101290247|NCT04846231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290248|NCT04846231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101316432|NCT00000882|Protease Inhibitors|protease inhibitors|mesh-ancestor
101290249|NCT04846231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101290250|NCT04846231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101290251|NCT04756401|Dexamethasone|dexamethasone|mesh-list
101290252|NCT04756401|Dexamethasone acetate|dexamethasone acetate|mesh-list
101290253|NCT04756401|Daratumumab|daratumumab|mesh-list
101290254|NCT04756401|Ichthammol|ichthammol|mesh-list
101290255|NCT04756401|BB 1101|bb 1101|mesh-list
101290256|NCT04756401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101290257|NCT04756401|Antiemetics|antiemetics|mesh-ancestor
101290258|NCT04756401|Autonomic Agents|autonomic agents|mesh-ancestor
101290259|NCT04756401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101290260|NCT04756401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290261|NCT04756401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101290263|NCT04756401|Hormones|hormones|mesh-ancestor
101290264|NCT04756401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101290265|NCT04756401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101290266|NCT04756401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290267|NCT04756401|Protease Inhibitors|protease inhibitors|mesh-ancestor
101290268|NCT04756401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101290269|NCT04756401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290270|NCT04756401|Dermatologic Agents|dermatologic agents|mesh-ancestor
101290271|NCT04705428|Fluorides|fluorides|mesh-list
101290272|NCT04705428|Cariostatic Agents|cariostatic agents|mesh-ancestor
101290273|NCT04705428|Protective Agents|protective agents|mesh-ancestor
101290274|NCT04705428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290275|NCT04664933|Neuroprotective Agents|neuroprotective agents|mesh-list
101290276|NCT04664933|Protective Agents|protective agents|mesh-ancestor
101290277|NCT04664933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290278|NCT04660760|Trifluridine|trifluridine|mesh-list
101290279|NCT04660760|Paclitaxel|paclitaxel|mesh-list
101820683|NCT00363142|Antiviral Agents|antiviral agents|mesh-ancestor
101820684|NCT00363142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101820685|NCT00363142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101820686|NCT00363142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101820687|NCT05246982|Capecitabine|capecitabine|mesh-list
101290280|NCT04660760|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101290281|NCT04660760|Ramucirumab|ramucirumab|mesh-list
101290282|NCT04660760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101290283|NCT04660760|Antibodies|antibodies|mesh-list
101290284|NCT04660760|Immunoglobulins|immunoglobulins|mesh-list
101290285|NCT04660760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101290286|NCT04660760|Lexatumumab|lexatumumab|mesh-list
101290287|NCT04660760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101290288|NCT04660760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290289|NCT04660760|Tubulin Modulators|tubulin modulators|mesh-ancestor
101290290|NCT04660760|Antimitotic Agents|antimitotic agents|mesh-ancestor
101290291|NCT04660760|Mitosis Modulators|mitosis modulators|mesh-ancestor
101290292|NCT04660760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290293|NCT04660760|Immunologic Factors|immunologic factors|mesh-ancestor
101290294|NCT04660760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290295|NCT04660760|Antimetabolites|antimetabolites|mesh-ancestor
101290296|NCT04660760|Antiviral Agents|antiviral agents|mesh-ancestor
101290297|NCT04660760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101290298|NCT04650698|Tranexamic Acid|tranexamic acid|mesh-list
101290299|NCT04650698|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101290300|NCT04650698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101290301|NCT04650698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290303|NCT04650698|Coagulants|coagulants|mesh-ancestor
101290304|NCT04507217|Carboplatin|carboplatin|mesh-list
101290305|NCT04507217|Pemetrexed|pemetrexed|mesh-list
101290306|NCT04507217|Tislelizumab|tislelizumab|mesh-list
101290307|NCT04507217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290308|NCT04507217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101290309|NCT04507217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290324|NCT04495452|Anesthetics|anesthetics|mesh-ancestor
101290325|NCT04447846|Cannabidiol|cannabidiol|mesh-list
101290326|NCT04447846|Anticonvulsants|anticonvulsants|mesh-ancestor
101290327|NCT04405245|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101290328|NCT04405245|Latanoprost|latanoprost|mesh-list
101290329|NCT04405245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101290330|NCT04335968|Melatonin|melatonin|mesh-list
101290331|NCT04335968|Antioxidants|antioxidants|mesh-ancestor
101290332|NCT04335968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290333|NCT04335968|Protective Agents|protective agents|mesh-ancestor
101290334|NCT04335968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290335|NCT04335968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101290349|NCT04262024|Cabergoline|cabergoline|mesh-list
101290350|NCT04262024|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101290351|NCT04262024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101290352|NCT04262024|Dopamine Agonists|dopamine agonists|mesh-ancestor
101290353|NCT04262024|Dopamine Agents|dopamine agents|mesh-ancestor
101290354|NCT04262024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101290355|NCT04262024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290356|NCT04262024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290357|NCT04237103|Methotrexate|methotrexate|mesh-list
101290358|NCT04237103|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101290359|NCT04237103|Abortifacient Agents|abortifacient agents|mesh-ancestor
101290360|NCT04237103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101290361|NCT04237103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290362|NCT04237103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101290363|NCT04237103|Antimetabolites|antimetabolites|mesh-ancestor
101290364|NCT04237103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290365|NCT04237103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290366|NCT04237103|Dermatologic Agents|dermatologic agents|mesh-ancestor
101290367|NCT04237103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101290368|NCT04237103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101290369|NCT04237103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101290370|NCT04237103|Immunologic Factors|immunologic factors|mesh-ancestor
101290371|NCT04237103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101290372|NCT04237103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101290374|NCT04226690|Hallucinogens|hallucinogens|mesh-ancestor
101820688|NCT05246982|Oxaliplatin|oxaliplatin|mesh-list
101820689|NCT05246982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101820690|NCT05246982|Antimetabolites|antimetabolites|mesh-ancestor
101820691|NCT05246982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820692|NCT05246982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290375|NCT04226690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290376|NCT04226690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101290377|NCT04226690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101290378|NCT04226690|Analgesics|analgesics|mesh-ancestor
101290379|NCT04226690|Sensory System Agents|sensory system agents|mesh-ancestor
101290380|NCT04226690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101290381|NCT04226690|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101290382|NCT04226690|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101290383|NCT04226690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101534946|NCT04573803|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101290384|NCT04226690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290385|NCT04226690|Hormones|hormones|mesh-ancestor
101290386|NCT04226690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101290387|NCT04201964|Tenecteplase|tenecteplase|mesh-list
101290388|NCT04201964|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101290389|NCT04201964|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101290390|NCT04201964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290391|NCT04198805|Vitamins|vitamins|mesh-list
101290392|NCT04198805|Vitamin E|vitamin e|mesh-list
101290393|NCT04198805|Tocopherols|tocopherols|mesh-list
101290394|NCT04198805|Tocotrienols|tocotrienols|mesh-list
101290395|NCT04198805|alpha-Tocopherol|alpha-tocopherol|mesh-list
101290396|NCT04198805|Micronutrients|micronutrients|mesh-ancestor
101290397|NCT04198805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290398|NCT04198805|Antioxidants|antioxidants|mesh-ancestor
101290399|NCT04198805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290400|NCT04198805|Protective Agents|protective agents|mesh-ancestor
101290401|NCT04179890|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101290402|NCT04179890|Gefitinib|gefitinib|mesh-list
101290403|NCT04179890|Osimertinib|osimertinib|mesh-list
101290404|NCT04179890|Afatinib|afatinib|mesh-list
101290405|NCT04179890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290406|NCT04179890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101290407|NCT04179890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101290408|NCT04179890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290409|NCT04166331|Dobutamine|dobutamine|mesh-list
101290410|NCT04166331|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101290412|NCT04166331|Autonomic Agents|autonomic agents|mesh-ancestor
101290413|NCT04166331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101290414|NCT04166331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290415|NCT04166331|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101290416|NCT04166331|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101290417|NCT04166331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101290418|NCT04166331|Adrenergic Agents|adrenergic agents|mesh-ancestor
101290419|NCT04166331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101290420|NCT04166331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290421|NCT04166331|Protective Agents|protective agents|mesh-ancestor
101290422|NCT04084210|Nicotine|nicotine|mesh-list
101290423|NCT04084210|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101290424|NCT04084210|Autonomic Agents|autonomic agents|mesh-ancestor
101290425|NCT04084210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101290426|NCT04084210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290427|NCT04084210|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101290428|NCT04084210|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101290429|NCT04084210|Cholinergic Agents|cholinergic agents|mesh-ancestor
101290430|NCT04084210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101290431|NCT04084210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290432|NCT04030026|Nalbuphine|nalbuphine|mesh-list
101290433|NCT04030026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101290434|NCT04030026|Narcotics|narcotics|mesh-ancestor
101290435|NCT04030026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101290436|NCT04030026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290437|NCT04030026|Analgesics|analgesics|mesh-ancestor
101290438|NCT04030026|Sensory System Agents|sensory system agents|mesh-ancestor
101290439|NCT04030026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101290440|NCT04006210|Levodopa|levodopa|mesh-list
101820694|NCT04002024|Salicylates|salicylates|mesh-list
101820695|NCT04002024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101820696|NCT04002024|Antifungal Agents|antifungal agents|mesh-ancestor
101820697|NCT04002024|Keratolytic Agents|keratolytic agents|mesh-ancestor
101820698|NCT04002024|Dermatologic Agents|dermatologic agents|mesh-ancestor
101820699|NCT04002024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101820700|NCT04002024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101820701|NCT04002024|Analgesics|analgesics|mesh-ancestor
101290442|NCT04006210|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101534950|NCT00584688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101290443|NCT04006210|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101290445|NCT04006210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101290446|NCT04006210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290447|NCT04006210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290448|NCT04006210|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101290449|NCT04006210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101290450|NCT03927274|Topotecan|topotecan|mesh-list
101290451|NCT03927274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101290452|NCT03927274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101290453|NCT03927274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101290454|NCT03927274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290455|NCT03927274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290456|NCT03923699|Anesthetics|anesthetics|mesh-list
101290457|NCT03923699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101290458|NCT03923699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290459|NCT03883880|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
101290460|NCT03883880|Capsaicin|capsaicin|mesh-list
101290461|NCT03883880|Antipruritics|antipruritics|mesh-ancestor
101290462|NCT03883880|Dermatologic Agents|dermatologic agents|mesh-ancestor
101290463|NCT03883880|Sensory System Agents|sensory system agents|mesh-ancestor
101290464|NCT03883880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101290465|NCT03883880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290466|NCT03883880|Antioxidants|antioxidants|mesh-ancestor
101290467|NCT03883880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290470|NCT03883880|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101290471|NCT03883880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290472|NCT03883880|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101290473|NCT03853798|Mitapivat|mitapivat|mesh-list
101290474|NCT03853798|Enzyme Activators|enzyme activators|mesh-ancestor
101290475|NCT03853798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290476|NCT03801369|Durvalumab|durvalumab|mesh-list
101290477|NCT03801369|Olaparib|olaparib|mesh-list
101290478|NCT03801369|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
101290479|NCT03801369|Immunoglobulins|immunoglobulins|mesh-list
101290480|NCT03801369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101290481|NCT03801369|Immunoglobulin G|immunoglobulin g|mesh-list
101290482|NCT03801369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101290483|NCT03801369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290484|NCT03801369|Immunologic Factors|immunologic factors|mesh-ancestor
101290485|NCT03801369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290486|NCT03801369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101290487|NCT03801369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290488|NCT03649659|Fluorides|fluorides|mesh-list
101290489|NCT03649659|Cariostatic Agents|cariostatic agents|mesh-ancestor
101290490|NCT03649659|Protective Agents|protective agents|mesh-ancestor
101290491|NCT03649659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290492|NCT03620981|Brexpiprazole|brexpiprazole|mesh-list
101290493|NCT03620981|Serotonin Agents|serotonin agents|mesh-ancestor
101290494|NCT03620981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101290495|NCT03620981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290496|NCT03620981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290497|NCT03620981|Dopamine Agonists|dopamine agonists|mesh-ancestor
101290498|NCT03620981|Dopamine Agents|dopamine agents|mesh-ancestor
101290499|NCT03563716|Atezolizumab|atezolizumab|mesh-list
101290500|NCT03563716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101820702|NCT04002024|Sensory System Agents|sensory system agents|mesh-ancestor
101820703|NCT04002024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101820704|NCT04002024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820705|NCT04002024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101820706|NCT04002024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101820707|NCT04002024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101820708|NCT04002024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101820709|NCT04002024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820710|NCT01028313|Methylprednisolone|methylprednisolone|mesh-list
101820711|NCT01028313|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101290501|NCT03563716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290502|NCT03563716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101290503|NCT03563716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290504|NCT03543969|Nivolumab|nivolumab|mesh-list
101290505|NCT03543969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101290506|NCT03543969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290507|NCT03543969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101290508|NCT03543969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290509|NCT03493048|Leucovorin|leucovorin|mesh-list
101290510|NCT03493048|Fluorouracil|fluorouracil|mesh-list
101290511|NCT03493048|Oxaliplatin|oxaliplatin|mesh-list
101290512|NCT03493048|Irinotecan|irinotecan|mesh-list
101290513|NCT03493048|Cetuximab|cetuximab|mesh-list
101290514|NCT03493048|Antimetabolites|antimetabolites|mesh-ancestor
101290515|NCT03493048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290516|NCT03493048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101290517|NCT03493048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290518|NCT03493048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101290519|NCT03493048|Immunologic Factors|immunologic factors|mesh-ancestor
101290520|NCT03493048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290521|NCT03493048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101290522|NCT03493048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101290523|NCT03493048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101290524|NCT03493048|Antidotes|antidotes|mesh-ancestor
101290525|NCT03493048|Protective Agents|protective agents|mesh-ancestor
101290526|NCT03493048|Vitamin B Complex|vitamin b complex|mesh-ancestor
101290527|NCT03493048|Vitamins|vitamins|mesh-ancestor
101290528|NCT03493048|Micronutrients|micronutrients|mesh-ancestor
101290529|NCT03493048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101290530|NCT03486106|Propofol|propofol|mesh-list
101290531|NCT03486106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101290532|NCT03486106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101290533|NCT03486106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290534|NCT03486106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101290535|NCT03486106|Anesthetics, General|anesthetics, general|mesh-ancestor
101290536|NCT03486106|Anesthetics|anesthetics|mesh-ancestor
101290537|NCT03434275|Meloxicam|meloxicam|mesh-list
101290538|NCT03434275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101290540|NCT03434275|Analgesics|analgesics|mesh-ancestor
101290541|NCT03434275|Sensory System Agents|sensory system agents|mesh-ancestor
101290542|NCT03434275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101290543|NCT03434275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290544|NCT03434275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101290545|NCT03434275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101290546|NCT03434275|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101290547|NCT03434275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101290548|NCT03434275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101290549|NCT03434275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290550|NCT03354013|Calcium|calcium|mesh-list
101290551|NCT03354013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101290552|NCT03354013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290553|NCT03348423|Fentanyl|fentanyl|mesh-list
101290554|NCT03348423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101290555|NCT03348423|Narcotics|narcotics|mesh-ancestor
101820712|NCT01028313|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101820713|NCT01028313|Prednisolone|prednisolone|mesh-list
101820714|NCT01028313|Prednisolone acetate|prednisolone acetate|mesh-list
101820715|NCT01028313|Panobinostat|panobinostat|mesh-list
101820716|NCT01028313|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101290556|NCT03348423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101290557|NCT03348423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290558|NCT03348423|Analgesics|analgesics|mesh-ancestor
101290559|NCT03348423|Sensory System Agents|sensory system agents|mesh-ancestor
101290560|NCT03348423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101290561|NCT03348423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101290562|NCT03348423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101290563|NCT03348423|Anesthetics, General|anesthetics, general|mesh-ancestor
101290564|NCT03348423|Anesthetics|anesthetics|mesh-ancestor
101290565|NCT03337087|Calcium, Dietary|calcium, dietary|mesh-list
101290566|NCT03337087|Leucovorin|leucovorin|mesh-list
101290567|NCT03337087|Folic Acid|folic acid|mesh-list
101290568|NCT03337087|Fluorouracil|fluorouracil|mesh-list
101290569|NCT03337087|Irinotecan|irinotecan|mesh-list
101290570|NCT03337087|Rucaparib|rucaparib|mesh-list
101290571|NCT03337087|Calcium|calcium|mesh-list
101290572|NCT03337087|Levoleucovorin|levoleucovorin|mesh-list
101290573|NCT03337087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101290574|NCT03337087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290575|NCT03337087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101290576|NCT03337087|Antimetabolites|antimetabolites|mesh-ancestor
101290577|NCT03337087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290578|NCT03337087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101290579|NCT03337087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290580|NCT03337087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101290581|NCT03337087|Immunologic Factors|immunologic factors|mesh-ancestor
101290582|NCT03337087|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101290583|NCT03337087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101290584|NCT03337087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101290585|NCT03337087|Antidotes|antidotes|mesh-ancestor
101290586|NCT03337087|Protective Agents|protective agents|mesh-ancestor
101290587|NCT03337087|Vitamin B Complex|vitamin b complex|mesh-ancestor
101290589|NCT03337087|Micronutrients|micronutrients|mesh-ancestor
101290590|NCT03337087|Hematinics|hematinics|mesh-ancestor
101290591|NCT03337087|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101290592|NCT03262935|Capecitabine|capecitabine|mesh-list
101290593|NCT03262935|Trastuzumab|trastuzumab|mesh-list
101290594|NCT03262935|Vinorelbine|vinorelbine|mesh-list
101290595|NCT03262935|Lapatinib|lapatinib|mesh-list
101290596|NCT03262935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101290597|NCT03262935|Antimetabolites|antimetabolites|mesh-ancestor
101290598|NCT03262935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290599|NCT03262935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290600|NCT03262935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101290601|NCT03262935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101290602|NCT03262935|Tubulin Modulators|tubulin modulators|mesh-ancestor
101290603|NCT03262935|Antimitotic Agents|antimitotic agents|mesh-ancestor
101290604|NCT03262935|Mitosis Modulators|mitosis modulators|mesh-ancestor
101290605|NCT03262935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101290606|NCT03262935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101290607|NCT03262142|Ciprofloxacin|ciprofloxacin|mesh-list
101290608|NCT03262142|Tazobactam|tazobactam|mesh-list
101290609|NCT03262142|Piperacillin|piperacillin|mesh-list
101290610|NCT03262142|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101290611|NCT03262142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101290612|NCT03262142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101290613|NCT03262142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101290614|NCT03262142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101290615|NCT03262142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101290616|NCT03262142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290617|NCT03262142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290618|NCT03262142|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101290619|NCT03262142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101290620|NCT03262142|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101290621|NCT03150810|Temozolomide|temozolomide|mesh-list
101290622|NCT03150810|Pamiparib|pamiparib|mesh-list
101290623|NCT03150810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101290624|NCT03150810|Alkylating Agents|alkylating agents|mesh-ancestor
101820717|NCT01028313|Prednisolone phosphate|prednisolone phosphate|mesh-list
101820718|NCT01028313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101820719|NCT01028313|Antiemetics|antiemetics|mesh-ancestor
101820720|NCT01028313|Autonomic Agents|autonomic agents|mesh-ancestor
101820721|NCT01028313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101290625|NCT03150810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290626|NCT03150810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290627|NCT03150810|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101290628|NCT03150810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101290629|NCT03117998|Volagidemab|volagidemab|mesh-list
101290630|NCT03117998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101290631|NCT03117998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290632|NCT03117751|Cytarabine|cytarabine|mesh-list
101290633|NCT03117751|Dexamethasone|dexamethasone|mesh-list
101290634|NCT03117751|Prednisone|prednisone|mesh-list
101290635|NCT03117751|Prednisolone|prednisolone|mesh-list
101290636|NCT03117751|Cyclophosphamide|cyclophosphamide|mesh-list
101290637|NCT03117751|Doxorubicin|doxorubicin|mesh-list
101290638|NCT03117751|Methotrexate|methotrexate|mesh-list
101290639|NCT03117751|Etoposide|etoposide|mesh-list
101290640|NCT03117751|Etoposide phosphate|etoposide phosphate|mesh-list
101290641|NCT03117751|Vincristine|vincristine|mesh-list
101290642|NCT03117751|Bortezomib|bortezomib|mesh-list
101290643|NCT03117751|Daunorubicin|daunorubicin|mesh-list
101290644|NCT03117751|Asparaginase|asparaginase|mesh-list
101290645|NCT03117751|Dasatinib|dasatinib|mesh-list
101290646|NCT03117751|Mercaptopurine|mercaptopurine|mesh-list
101290647|NCT03117751|Vorinostat|vorinostat|mesh-list
101290648|NCT03117751|Idarubicin|idarubicin|mesh-list
101290649|NCT03117751|Clofarabine|clofarabine|mesh-list
101290650|NCT03117751|Pegaspargase|pegaspargase|mesh-list
101290651|NCT03117751|Thioguanine|thioguanine|mesh-list
101290652|NCT03117751|Blinatumomab|blinatumomab|mesh-list
101290653|NCT03117751|Asparaginase erwinia chrysanthemi, recombinant-rywn|asparaginase erwinia chrysanthemi, recombinant-rywn|mesh-list
101290654|NCT03117751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101290655|NCT03117751|Immunologic Factors|immunologic factors|mesh-ancestor
101290656|NCT03117751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290657|NCT03117751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101290658|NCT03117751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101290659|NCT03117751|Alkylating Agents|alkylating agents|mesh-ancestor
101290660|NCT03117751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290661|NCT03117751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290662|NCT03117751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101290663|NCT03117751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101290664|NCT03117751|Antiemetics|antiemetics|mesh-ancestor
101290665|NCT03117751|Autonomic Agents|autonomic agents|mesh-ancestor
101290666|NCT03117751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101290667|NCT03117751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101290668|NCT03117751|Glucocorticoids|glucocorticoids|mesh-ancestor
101290669|NCT03117751|Hormones|hormones|mesh-ancestor
101290670|NCT03117751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101290671|NCT03117751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101290672|NCT03117751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101290673|NCT03117751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101290674|NCT03117751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101290675|NCT03117751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101290676|NCT03117751|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101290677|NCT03117751|Abortifacient Agents|abortifacient agents|mesh-ancestor
101290678|NCT03117751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101290679|NCT03117751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101290680|NCT03117751|Antimetabolites|antimetabolites|mesh-ancestor
101290681|NCT03117751|Dermatologic Agents|dermatologic agents|mesh-ancestor
101290682|NCT03117751|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101290683|NCT03117751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101290684|NCT03117751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101290685|NCT03117751|Antiviral Agents|antiviral agents|mesh-ancestor
101290686|NCT03117751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101290687|NCT03117751|Tubulin Modulators|tubulin modulators|mesh-ancestor
101290688|NCT03117751|Antimitotic Agents|antimitotic agents|mesh-ancestor
101290689|NCT03117751|Mitosis Modulators|mitosis modulators|mesh-ancestor
101290690|NCT03117751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101290691|NCT03117751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101290693|NCT03114865|Blinatumomab|blinatumomab|mesh-list
101290694|NCT03114865|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101820722|NCT01028313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820723|NCT01028313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101820724|NCT01028313|Glucocorticoids|glucocorticoids|mesh-ancestor
101820725|NCT01028313|Hormones|hormones|mesh-ancestor
101820726|NCT01028313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101820727|NCT01028313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101290695|NCT03114865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101290696|NCT03114865|Antiemetics|antiemetics|mesh-ancestor
101290697|NCT03114865|Autonomic Agents|autonomic agents|mesh-ancestor
101290698|NCT03114865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101290699|NCT03114865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290700|NCT03114865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101290701|NCT03114865|Glucocorticoids|glucocorticoids|mesh-ancestor
101290702|NCT03114865|Hormones|hormones|mesh-ancestor
101290703|NCT03114865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101290704|NCT03114865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101290705|NCT03114865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290706|NCT03114865|Immunologic Factors|immunologic factors|mesh-ancestor
101290707|NCT02920008|Guadecitabine|guadecitabine|mesh-list
101290708|NCT02920008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290710|NCT02866747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101290711|NCT02866747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290712|NCT02766335|Docetaxel|docetaxel|mesh-list
101290713|NCT02766335|Durvalumab|durvalumab|mesh-list
101290714|NCT02766335|Immunoglobulins|immunoglobulins|mesh-list
101290715|NCT02766335|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101290716|NCT02766335|Immunoglobulin G|immunoglobulin g|mesh-list
101290717|NCT02766335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290718|NCT02766335|Tubulin Modulators|tubulin modulators|mesh-ancestor
101290719|NCT02766335|Antimitotic Agents|antimitotic agents|mesh-ancestor
101290720|NCT02766335|Mitosis Modulators|mitosis modulators|mesh-ancestor
101290721|NCT02766335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290722|NCT02766335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101290723|NCT02766335|Immunologic Factors|immunologic factors|mesh-ancestor
101290724|NCT02766335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290725|NCT02739711|polysaccharide-K|polysaccharide-k|mesh-list
101290726|NCT02739711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101290727|NCT02739711|Immunologic Factors|immunologic factors|mesh-ancestor
101290728|NCT02739711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290729|NCT02739711|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101290730|NCT02739711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290731|NCT02739711|Antiviral Agents|antiviral agents|mesh-ancestor
101290732|NCT02739711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101290733|NCT02739711|Interferon Inducers|interferon inducers|mesh-ancestor
101290734|NCT02739711|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101290735|NCT02739711|Protective Agents|protective agents|mesh-ancestor
101290736|NCT02607423|Deoxyglucose|deoxyglucose|mesh-list
101290737|NCT02607423|Cisplatin|cisplatin|mesh-list
101290738|NCT02607423|Gemcitabine|gemcitabine|mesh-list
101290739|NCT02607423|Docetaxel|docetaxel|mesh-list
101290740|NCT02607423|Pemetrexed|pemetrexed|mesh-list
101290741|NCT02607423|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101290742|NCT02607423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290743|NCT02607423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101290744|NCT02607423|Antimetabolites|antimetabolites|mesh-ancestor
101290745|NCT02607423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290746|NCT02607423|Tubulin Modulators|tubulin modulators|mesh-ancestor
101290747|NCT02607423|Antimitotic Agents|antimitotic agents|mesh-ancestor
101290748|NCT02607423|Mitosis Modulators|mitosis modulators|mesh-ancestor
101290749|NCT02607423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101290750|NCT02607423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101290751|NCT02607423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101290752|NCT02607423|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101290753|NCT02607423|Antiviral Agents|antiviral agents|mesh-ancestor
101290754|NCT02607423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101290755|NCT02577523|Levodopa|levodopa|mesh-list
101290756|NCT02577523|Carbidopa|carbidopa|mesh-list
101290757|NCT02577523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101290758|NCT02577523|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101290759|NCT02577523|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101820728|NCT01028313|Protective Agents|protective agents|mesh-ancestor
101820729|NCT01028313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101820730|NCT01028313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101820731|NCT01028313|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101820732|NCT01028313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101820733|NCT01028313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820734|NCT04001712|Caffeine|caffeine|mesh-list
101820735|NCT04001712|Caffeine citrate|caffeine citrate|mesh-list
101290760|NCT02577523|Dopamine Agents|dopamine agents|mesh-ancestor
101290761|NCT02577523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101290762|NCT02577523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290763|NCT02577523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290764|NCT02577523|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101290765|NCT02577523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101290766|NCT02516241|Carboplatin|carboplatin|mesh-list
101290767|NCT02516241|Gemcitabine|gemcitabine|mesh-list
101290768|NCT02516241|Durvalumab|durvalumab|mesh-list
101290769|NCT02516241|Tremelimumab|tremelimumab|mesh-list
101290770|NCT02516241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290771|NCT02516241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101290772|NCT02516241|Antimetabolites|antimetabolites|mesh-ancestor
101290773|NCT02516241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290774|NCT02516241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101290775|NCT02499328|Durvalumab|durvalumab|mesh-list
101290776|NCT02499328|Tremelimumab|tremelimumab|mesh-list
101534975|NCT02883595|Thymalfasin|thymalfasin|mesh-list
101290777|NCT02499328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101290778|NCT02499328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290779|NCT02388906|Nivolumab|nivolumab|mesh-list
101290780|NCT02388906|Ipilimumab|ipilimumab|mesh-list
101290781|NCT02388906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101290782|NCT02388906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290783|NCT02388906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101290784|NCT02388906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290785|NCT02344810|Leucovorin|leucovorin|mesh-list
101290786|NCT02344810|Fluorouracil|fluorouracil|mesh-list
101290787|NCT02344810|Oxaliplatin|oxaliplatin|mesh-list
101290788|NCT02344810|Calcium|calcium|mesh-list
101290789|NCT02344810|Levoleucovorin|levoleucovorin|mesh-list
101290790|NCT02344810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101290791|NCT02344810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290792|NCT02344810|Antimetabolites|antimetabolites|mesh-ancestor
101290793|NCT02344810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290794|NCT02344810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101290795|NCT02344810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290796|NCT02344810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101290797|NCT02344810|Immunologic Factors|immunologic factors|mesh-ancestor
101290798|NCT02344810|Antidotes|antidotes|mesh-ancestor
101290799|NCT02344810|Protective Agents|protective agents|mesh-ancestor
101290800|NCT02344810|Vitamin B Complex|vitamin b complex|mesh-ancestor
101290801|NCT02344810|Vitamins|vitamins|mesh-ancestor
101290802|NCT02344810|Micronutrients|micronutrients|mesh-ancestor
101290803|NCT02333565|Everolimus|everolimus|mesh-list
101290804|NCT02333565|Octreotide|octreotide|mesh-list
101290805|NCT02333565|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101290806|NCT02333565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101290807|NCT02333565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101290808|NCT02333565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290809|NCT02333565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101290810|NCT02333565|Immunologic Factors|immunologic factors|mesh-ancestor
101290811|NCT02333565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290812|NCT02333565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290813|NCT02333565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101290814|NCT02333565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101290815|NCT02278185|Leuprolide|leuprolide|mesh-list
101290816|NCT02278185|Goserelin|goserelin|mesh-list
101290817|NCT02278185|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101290818|NCT02278185|Tryptophan|tryptophan|mesh-list
101290819|NCT02278185|Androgens|androgens|mesh-list
101290820|NCT02278185|Hormones|hormones|mesh-ancestor
101316553|NCT00000966|Antidotes|antidotes|mesh-ancestor
101820736|NCT04001712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820737|NCT04001712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101820738|NCT04001712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820739|NCT04001712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101820741|NCT04001712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101820742|NCT04001712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101290821|NCT02278185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101290822|NCT02278185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290823|NCT02278185|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101290824|NCT02278185|Fertility Agents|fertility agents|mesh-ancestor
101290825|NCT02278185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101290826|NCT02278185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101290827|NCT02278185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290828|NCT02278185|Luteolytic Agents|luteolytic agents|mesh-ancestor
101290829|NCT02278185|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101290830|NCT02278185|Contraceptive Agents|contraceptive agents|mesh-ancestor
101290831|NCT02278185|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101290832|NCT02278185|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101290833|NCT02278185|Antidepressive Agents|antidepressive agents|mesh-ancestor
101290834|NCT02278185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101290835|NCT02177695|Gemcitabine|gemcitabine|mesh-list
101290836|NCT02177695|Doxorubicin|doxorubicin|mesh-list
101290837|NCT02177695|Methotrexate|methotrexate|mesh-list
101290838|NCT02177695|Vinblastine|vinblastine|mesh-list
101290839|NCT02177695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290840|NCT02177695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101290841|NCT02177695|Antimetabolites|antimetabolites|mesh-ancestor
101290842|NCT02177695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290843|NCT02177695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101290844|NCT02177695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101290845|NCT02177695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101290846|NCT02177695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101290847|NCT02177695|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101290848|NCT02177695|Abortifacient Agents|abortifacient agents|mesh-ancestor
101290849|NCT02177695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101290850|NCT02177695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290851|NCT02177695|Dermatologic Agents|dermatologic agents|mesh-ancestor
101290852|NCT02177695|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101290853|NCT02177695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101290854|NCT02177695|Immunologic Factors|immunologic factors|mesh-ancestor
101290855|NCT02177695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101290856|NCT02177695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101290857|NCT02177695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101290858|NCT02177695|Tubulin Modulators|tubulin modulators|mesh-ancestor
101290859|NCT02177695|Antimitotic Agents|antimitotic agents|mesh-ancestor
101290860|NCT02177695|Mitosis Modulators|mitosis modulators|mesh-ancestor
101290863|NCT02106572|Mitomycin|mitomycin|mesh-list
101290864|NCT02106572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101290865|NCT02106572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290866|NCT02106572|Alkylating Agents|alkylating agents|mesh-ancestor
101290867|NCT02106572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290868|NCT02106572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101290869|NCT02106572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101290870|NCT02106572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101290871|NCT02106572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101290872|NCT02106572|Antiviral Agents|antiviral agents|mesh-ancestor
101290873|NCT02106572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101290874|NCT02096601|Levodopa|levodopa|mesh-list
101290875|NCT02096601|Carbidopa|carbidopa|mesh-list
101290876|NCT02096601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101290877|NCT02096601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101290878|NCT02096601|Dopamine Agents|dopamine agents|mesh-ancestor
101290879|NCT02096601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101820743|NCT04001712|Purinergic Agents|purinergic agents|mesh-ancestor
101820744|NCT04001712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101820746|NCT01027377|Coagulants|coagulants|mesh-ancestor
101820747|NCT00992160|Vestipitant|vestipitant|mesh-list
101820748|NCT00992160|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101820749|NCT00992160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101290880|NCT02096601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290881|NCT02096601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290882|NCT02096601|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101290883|NCT02096601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101290884|NCT01840566|Cytarabine|cytarabine|mesh-list
101290885|NCT01840566|Etoposide|etoposide|mesh-list
101290886|NCT01840566|Melphalan|melphalan|mesh-list
101290887|NCT01840566|Carmustine|carmustine|mesh-list
101290888|NCT01840566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101290889|NCT01840566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290890|NCT01840566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101290891|NCT01840566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101290892|NCT01840566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101290893|NCT01840566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290894|NCT01840566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101290895|NCT01840566|Antimetabolites|antimetabolites|mesh-ancestor
101290896|NCT01840566|Antiviral Agents|antiviral agents|mesh-ancestor
101290897|NCT01840566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101290898|NCT01840566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101290899|NCT01840566|Immunologic Factors|immunologic factors|mesh-ancestor
101290900|NCT01840566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290901|NCT01840566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101290902|NCT01840566|Alkylating Agents|alkylating agents|mesh-ancestor
101290903|NCT01840566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101290904|NCT01725802|Levodopa|levodopa|mesh-list
101290905|NCT01725802|Carbidopa|carbidopa|mesh-list
101290906|NCT01725802|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101290907|NCT01725802|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101290908|NCT01725802|Dopamine Agents|dopamine agents|mesh-ancestor
101290909|NCT01725802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101290910|NCT01725802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290911|NCT01725802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290912|NCT01725802|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101290913|NCT01725802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101290914|NCT01719237|Ropivacaine|ropivacaine|mesh-list
101290915|NCT01719237|Chloroprocaine|chloroprocaine|mesh-list
101290916|NCT01719237|Anesthetics, Local|anesthetics, local|mesh-ancestor
101290917|NCT01719237|Anesthetics|anesthetics|mesh-ancestor
101290918|NCT01719237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101290919|NCT01719237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290920|NCT01719237|Sensory System Agents|sensory system agents|mesh-ancestor
101290921|NCT01719237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101290922|NCT01257594|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101290923|NCT01257594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290924|NCT01257594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101290925|NCT01257594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101290926|NCT01257594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290927|NCT01004731|Carboplatin|carboplatin|mesh-list
101290928|NCT01004731|Gemcitabine|gemcitabine|mesh-list
101290929|NCT01004731|Cetuximab|cetuximab|mesh-list
101290930|NCT01004731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290931|NCT01004731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101290932|NCT01004731|Antimetabolites|antimetabolites|mesh-ancestor
101290933|NCT01004731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290934|NCT01004731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101290935|NCT00771017|Leuprolide|leuprolide|mesh-list
101290936|NCT00771017|Goserelin|goserelin|mesh-list
101290937|NCT00771017|Bicalutamide|bicalutamide|mesh-list
101290938|NCT00771017|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101290939|NCT00771017|Fertility Agents|fertility agents|mesh-ancestor
101290940|NCT00771017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101290941|NCT00771017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290942|NCT00771017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101820750|NCT00992160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820751|NCT00992160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820752|NCT00379912|Azacitidine|azacitidine|mesh-list
101820753|NCT00379912|Epoetin Alfa|epoetin alfa|mesh-list
101820754|NCT00379912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101820755|NCT00379912|Antimetabolites|antimetabolites|mesh-ancestor
101820756|NCT00379912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820757|NCT00379912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101820758|NCT00379912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101820759|NCT00379912|Hematinics|hematinics|mesh-ancestor
101820760|NCT00379834|Timolol|timolol|mesh-list
101290943|NCT00771017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290944|NCT00771017|Androgen Antagonists|androgen antagonists|mesh-ancestor
101290945|NCT00771017|Hormone Antagonists|hormone antagonists|mesh-ancestor
101290946|NCT00771017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101290947|NCT00707473|Cisplatin|cisplatin|mesh-list
101290948|NCT00707473|Carboplatin|carboplatin|mesh-list
101290949|NCT00707473|Docetaxel|docetaxel|mesh-list
101290950|NCT00707473|Fluorouracil|fluorouracil|mesh-list
101290951|NCT00707473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290952|NCT00707473|Tubulin Modulators|tubulin modulators|mesh-ancestor
101290953|NCT00707473|Antimitotic Agents|antimitotic agents|mesh-ancestor
101290954|NCT00707473|Mitosis Modulators|mitosis modulators|mesh-ancestor
101290955|NCT00707473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290956|NCT00707473|Antimetabolites|antimetabolites|mesh-ancestor
101290957|NCT00707473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101290958|NCT00707473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101290959|NCT00707473|Immunologic Factors|immunologic factors|mesh-ancestor
101290960|NCT00707473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290961|NCT00499291|Paclitaxel|paclitaxel|mesh-list
101290962|NCT00499291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101290963|NCT00499291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101290964|NCT00499291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290965|NCT00499291|Tubulin Modulators|tubulin modulators|mesh-ancestor
101290966|NCT00499291|Antimitotic Agents|antimitotic agents|mesh-ancestor
101290967|NCT00499291|Mitosis Modulators|mitosis modulators|mesh-ancestor
101290968|NCT00499291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290969|NCT00318903|Docetaxel|docetaxel|mesh-list
101290970|NCT00318903|Irinotecan|irinotecan|mesh-list
101290971|NCT00318903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290972|NCT00318903|Tubulin Modulators|tubulin modulators|mesh-ancestor
101290973|NCT00318903|Antimitotic Agents|antimitotic agents|mesh-ancestor
101290974|NCT00318903|Mitosis Modulators|mitosis modulators|mesh-ancestor
101290975|NCT00318903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290976|NCT00318903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101290977|NCT00318903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101290978|NCT00318903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101290979|NCT00129090|Rituximab|rituximab|mesh-list
101290980|NCT00129090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101290981|NCT00129090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101290982|NCT00129090|Immunologic Factors|immunologic factors|mesh-ancestor
101290983|NCT00129090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290984|NCT00129090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101290985|NCT01952886|Ondansetron|ondansetron|mesh-list
101290986|NCT01952886|Granisetron|granisetron|mesh-list
101290987|NCT01952886|Antiemetics|antiemetics|mesh-ancestor
101290988|NCT01952886|Autonomic Agents|autonomic agents|mesh-ancestor
101290989|NCT01952886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101290990|NCT01952886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290991|NCT01952886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101290993|NCT01952886|Dermatologic Agents|dermatologic agents|mesh-ancestor
101290994|NCT01952886|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101290995|NCT01952886|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101290996|NCT01952886|Serotonin Agents|serotonin agents|mesh-ancestor
101290997|NCT01952886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101820761|NCT00379834|Dorzolamide|dorzolamide|mesh-list
101820762|NCT00379834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101820763|NCT00379834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101820764|NCT00379834|Adrenergic Agents|adrenergic agents|mesh-ancestor
101290998|NCT01952886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101290999|NCT01952951|Fluorouracil|fluorouracil|mesh-list
101291000|NCT01952951|Capecitabine|capecitabine|mesh-list
101291001|NCT01952951|Oxaliplatin|oxaliplatin|mesh-list
101291002|NCT01952951|Antimetabolites|antimetabolites|mesh-ancestor
101291003|NCT01952951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291004|NCT01952951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101291005|NCT01952951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101291006|NCT01952951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101291007|NCT01952951|Immunologic Factors|immunologic factors|mesh-ancestor
101291008|NCT01952951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291009|NCT01953107|Ferrous fumarate|ferrous fumarate|mesh-list
101291010|NCT01953107|Trace Elements|trace elements|mesh-ancestor
101291011|NCT01953107|Micronutrients|micronutrients|mesh-ancestor
101291012|NCT01953107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291013|NCT01953172|Tocotrienols|tocotrienols|mesh-list
101291014|NCT01953172|Tocotrienol, alpha|tocotrienol, alpha|mesh-list
101291015|NCT01953172|Antioxidants|antioxidants|mesh-ancestor
101291016|NCT01953172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291017|NCT01953172|Protective Agents|protective agents|mesh-ancestor
101291018|NCT01953172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291019|NCT01953172|Vitamins|vitamins|mesh-ancestor
101291020|NCT01953172|Micronutrients|micronutrients|mesh-ancestor
101291021|NCT01953367|Tobramycin|tobramycin|mesh-list
101291022|NCT01953367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101291023|NCT01953367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101291024|NCT01953406|Fluorouracil|fluorouracil|mesh-list
101291025|NCT01953406|Mitomycins|mitomycins|mesh-list
101291026|NCT01953406|Mitomycin|mitomycin|mesh-list
101291027|NCT01953406|Antimetabolites|antimetabolites|mesh-ancestor
101291028|NCT01953406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291029|NCT01953406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101291030|NCT01953406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101291031|NCT01953406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101291032|NCT01953406|Immunologic Factors|immunologic factors|mesh-ancestor
101291033|NCT01953406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291034|NCT01953406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101291035|NCT01953406|Alkylating Agents|alkylating agents|mesh-ancestor
101291036|NCT01953406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101291037|NCT01953406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101291039|NCT01953419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101291040|NCT01953419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101291041|NCT01953419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291042|NCT01953419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101291043|NCT01953419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101291044|NCT01953445|Paclitaxel|paclitaxel|mesh-list
101291045|NCT01953445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101291046|NCT01953445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101291047|NCT01953445|Tubulin Modulators|tubulin modulators|mesh-ancestor
101291048|NCT01953445|Antimitotic Agents|antimitotic agents|mesh-ancestor
101291049|NCT01953445|Mitosis Modulators|mitosis modulators|mesh-ancestor
101291051|NCT01953536|Folic Acid|folic acid|mesh-list
101291052|NCT01953536|Paclitaxel|paclitaxel|mesh-list
101291053|NCT01953536|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101291054|NCT01953536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101291055|NCT01953536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101291056|NCT01953536|Tubulin Modulators|tubulin modulators|mesh-ancestor
101291057|NCT01953536|Antimitotic Agents|antimitotic agents|mesh-ancestor
101291058|NCT01953536|Mitosis Modulators|mitosis modulators|mesh-ancestor
101291059|NCT01953536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291060|NCT01953536|Hematinics|hematinics|mesh-ancestor
101291061|NCT01953536|Vitamin B Complex|vitamin b complex|mesh-ancestor
101291062|NCT01953536|Vitamins|vitamins|mesh-ancestor
101291063|NCT01953536|Micronutrients|micronutrients|mesh-ancestor
101291064|NCT01953536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291065|NCT01953679|Ulipristal acetate|ulipristal acetate|mesh-list
101291066|NCT01953679|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101291067|NCT01953679|Contraceptive Agents|contraceptive agents|mesh-ancestor
101820765|NCT00379834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101820766|NCT00379834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820767|NCT00379834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820768|NCT00379834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101820769|NCT00379834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101291068|NCT01953679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101291069|NCT01953679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291070|NCT01953679|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101291071|NCT01953731|Rifampin|rifampin|mesh-list
101291072|NCT01953731|Palbociclib|palbociclib|mesh-list
101291073|NCT01953731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101291074|NCT01953731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101291075|NCT01953731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101291076|NCT01953731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291077|NCT01953731|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101291078|NCT01953731|Antitubercular Agents|antitubercular agents|mesh-ancestor
101291079|NCT01953731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101291080|NCT01953731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101291081|NCT01953731|Leprostatic Agents|leprostatic agents|mesh-ancestor
101291082|NCT01953731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101291083|NCT01953731|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101291084|NCT01953731|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101291085|NCT01953731|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101291086|NCT01953731|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101291087|NCT01953731|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101291088|NCT01953731|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101291089|NCT01953744|Fluconazole|fluconazole|mesh-list
101291090|NCT01953744|Meglumine Antimoniate|meglumine antimoniate|mesh-list
101291091|NCT01953744|Antifungal Agents|antifungal agents|mesh-ancestor
101291092|NCT01953744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101291093|NCT01953744|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101291094|NCT01953744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101291095|NCT01953744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101291096|NCT01953744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291097|NCT01953744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101291098|NCT01953744|Hormone Antagonists|hormone antagonists|mesh-ancestor
101326202|NCT00115726|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101291099|NCT01953744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101291100|NCT01953744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291101|NCT01953744|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101291102|NCT01953744|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101291103|NCT01953744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101291104|NCT01953744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101291105|NCT01953757|Vitamins|vitamins|mesh-list
101291106|NCT01953757|Hydroxocobalamin|hydroxocobalamin|mesh-list
101291107|NCT01953757|Vitamin B 12|vitamin b 12|mesh-list
101291108|NCT01953757|Vitamin B Complex|vitamin b complex|mesh-list
101291110|NCT01953757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291111|NCT01953757|Hematinics|hematinics|mesh-ancestor
101291112|NCT01953770|Cytarabine|cytarabine|mesh-list
101291113|NCT01953770|Prednisone|prednisone|mesh-list
101291114|NCT01953770|Methotrexate|methotrexate|mesh-list
101291115|NCT01953770|Daunorubicin|daunorubicin|mesh-list
101291116|NCT01953770|Asparaginase|asparaginase|mesh-list
101291117|NCT01953770|Pegaspargase|pegaspargase|mesh-list
101291118|NCT01953770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101291119|NCT01953770|Glucocorticoids|glucocorticoids|mesh-ancestor
101291120|NCT01953770|Hormones|hormones|mesh-ancestor
101291121|NCT01953770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101291122|NCT01953770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291123|NCT01953770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101291124|NCT01953770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101291125|NCT01953770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101291126|NCT01953770|Abortifacient Agents|abortifacient agents|mesh-ancestor
101291127|NCT01953770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101291128|NCT01953770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101291129|NCT01953770|Antimetabolites|antimetabolites|mesh-ancestor
101820770|NCT00379834|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101820771|NCT00379834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101820772|NCT02292706|Sofosbuvir|sofosbuvir|mesh-list
101820773|NCT02292706|Antiviral Agents|antiviral agents|mesh-ancestor
101820774|NCT02292706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101820775|NCT00992472|Prochlorperazine|prochlorperazine|mesh-list
101291130|NCT01953770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291131|NCT01953770|Dermatologic Agents|dermatologic agents|mesh-ancestor
101291132|NCT01953770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101291133|NCT01953770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101291134|NCT01953770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101291135|NCT01953770|Immunologic Factors|immunologic factors|mesh-ancestor
101291136|NCT01953770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101291137|NCT01953770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101291138|NCT01953770|Antiviral Agents|antiviral agents|mesh-ancestor
101291139|NCT01953770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101291140|NCT01953770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101291141|NCT01953770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101291142|NCT01953770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101291143|NCT01953796|Clomiphene|clomiphene|mesh-list
101291144|NCT01953796|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101291145|NCT01953796|Hormone Antagonists|hormone antagonists|mesh-ancestor
101291146|NCT01953796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101291147|NCT01953796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291148|NCT01953796|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101291149|NCT01953796|Fertility Agents|fertility agents|mesh-ancestor
101291150|NCT01953796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101291151|NCT01953796|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101291152|NCT01953796|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101291153|NCT01953835|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101291154|NCT01953835|Simvastatin|simvastatin|mesh-list
101291155|NCT01953835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101291157|NCT01953835|Antimetabolites|antimetabolites|mesh-ancestor
101291158|NCT01953835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291159|NCT01953835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101291160|NCT01953835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101291161|NCT01953835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101291162|NCT01953848|Tamsulosin|tamsulosin|mesh-list
101291163|NCT01953848|Solifenacin Succinate|solifenacin succinate|mesh-list
101291164|NCT01953848|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101291165|NCT01953848|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101291166|NCT01953848|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101291167|NCT01953848|Adrenergic Agents|adrenergic agents|mesh-ancestor
101291168|NCT01953848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101291169|NCT01953848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291170|NCT01953848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291171|NCT01953848|Urological Agents|urological agents|mesh-ancestor
101291172|NCT01953848|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101291173|NCT01953848|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101291174|NCT01953848|Cholinergic Agents|cholinergic agents|mesh-ancestor
101291176|NCT01953887|Solifenacin Succinate|solifenacin succinate|mesh-list
101291177|NCT01953887|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101291178|NCT01953887|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101291179|NCT01953887|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101291180|NCT01953887|Adrenergic Agents|adrenergic agents|mesh-ancestor
101291181|NCT01953887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101291182|NCT01953887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291183|NCT01953887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291184|NCT01953887|Urological Agents|urological agents|mesh-ancestor
101291185|NCT01953887|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101291186|NCT01953887|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101291187|NCT01953887|Cholinergic Agents|cholinergic agents|mesh-ancestor
101291188|NCT01953952|Cisplatin|cisplatin|mesh-list
101291189|NCT01953952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101291190|NCT01953978|Acetaminophen|acetaminophen|mesh-list
101291191|NCT01953978|Dexamethasone|dexamethasone|mesh-list
101291192|NCT01953978|Ibuprofen|ibuprofen|mesh-list
101291193|NCT01953978|Morphine|morphine|mesh-list
101291194|NCT01953978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101820776|NCT00992472|Antiemetics|antiemetics|mesh-ancestor
101820777|NCT00992472|Autonomic Agents|autonomic agents|mesh-ancestor
101820778|NCT00992472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101820779|NCT00992472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820780|NCT00992472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101820781|NCT00992472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101291195|NCT01953978|Antiemetics|antiemetics|mesh-ancestor
101291196|NCT01953978|Autonomic Agents|autonomic agents|mesh-ancestor
101291197|NCT01953978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101291198|NCT01953978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291199|NCT01953978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101291200|NCT01953978|Glucocorticoids|glucocorticoids|mesh-ancestor
101291201|NCT01953978|Hormones|hormones|mesh-ancestor
101291202|NCT01953978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101291203|NCT01953978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101291204|NCT01953978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101291205|NCT01953978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101291207|NCT01953978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101291208|NCT01953978|Analgesics|analgesics|mesh-ancestor
101291209|NCT01953978|Sensory System Agents|sensory system agents|mesh-ancestor
101291210|NCT01953978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101291211|NCT01953978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101291212|NCT01953978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101291213|NCT01953978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101291214|NCT01953978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101291215|NCT01953978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291216|NCT01953978|Antipyretics|antipyretics|mesh-ancestor
101291217|NCT01954030|Bevacizumab|bevacizumab|mesh-list
101291218|NCT01954030|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
101291219|NCT01954030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101291220|NCT01954030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101291221|NCT01954030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101291222|NCT01954030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101291223|NCT01954030|Growth Substances|growth substances|mesh-ancestor
101291225|NCT01954030|Growth Inhibitors|growth inhibitors|mesh-ancestor
101291226|NCT01954030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101291227|NCT01954030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101291228|NCT01954030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291229|NCT01954030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101291231|NCT01954043|Dabrafenib|dabrafenib|mesh-list
101291232|NCT01954043|Rabeprazole|rabeprazole|mesh-list
101291233|NCT01954043|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101291234|NCT01954043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101291235|NCT01954043|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101291236|NCT01954043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101291237|NCT01954043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291238|NCT01954043|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101291239|NCT01954043|Antitubercular Agents|antitubercular agents|mesh-ancestor
101291240|NCT01954043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101291241|NCT01954043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101291242|NCT01954043|Leprostatic Agents|leprostatic agents|mesh-ancestor
101291243|NCT01954043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101291244|NCT01954043|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101291245|NCT01954043|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101291246|NCT01954043|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101291247|NCT01954043|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101291248|NCT01954043|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101291249|NCT01954043|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101291250|NCT01954043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101291251|NCT01954043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101291252|NCT01954108|Hyaluronic Acid|hyaluronic acid|mesh-list
101291253|NCT01954108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101291254|NCT01954108|Immunologic Factors|immunologic factors|mesh-ancestor
101291255|NCT01954108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291256|NCT01954108|Viscosupplements|viscosupplements|mesh-ancestor
101291257|NCT01954108|Protective Agents|protective agents|mesh-ancestor
101291258|NCT01954186|Oxytocin|oxytocin|mesh-list
101291259|NCT01954186|Oxytocics|oxytocics|mesh-ancestor
101820782|NCT00992472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101820783|NCT00992472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101820784|NCT00992472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101820785|NCT00992472|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101820786|NCT00992472|Dopamine Agents|dopamine agents|mesh-ancestor
101291260|NCT01954186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101291261|NCT01954186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291262|NCT01954238|Rivaroxaban|rivaroxaban|mesh-list
101291263|NCT01954238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101291264|NCT01954238|Antithrombins|antithrombins|mesh-ancestor
101291265|NCT01954238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101291266|NCT01954238|Protease Inhibitors|protease inhibitors|mesh-ancestor
101291267|NCT01954238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101291268|NCT01954238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291269|NCT01954238|Anticoagulants|anticoagulants|mesh-ancestor
101291270|NCT01954290|Mannitol|mannitol|mesh-list
101291271|NCT01954290|Conivaptan|conivaptan|mesh-list
101291272|NCT01954290|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101291273|NCT01954290|Diuretics|diuretics|mesh-ancestor
101291274|NCT01954290|Natriuretic Agents|natriuretic agents|mesh-ancestor
101291275|NCT01954290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291276|NCT01954290|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101291277|NCT01954290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291278|NCT01954355|Paclitaxel|paclitaxel|mesh-list
101291279|NCT01954355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101291280|NCT01954355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101291281|NCT01954355|Tubulin Modulators|tubulin modulators|mesh-ancestor
101291282|NCT01954355|Antimitotic Agents|antimitotic agents|mesh-ancestor
101291283|NCT01954355|Mitosis Modulators|mitosis modulators|mesh-ancestor
101291284|NCT01954355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291287|NCT01954368|Narcotics|narcotics|mesh-ancestor
101291288|NCT01954368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101291289|NCT01954368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291290|NCT01954368|Analgesics|analgesics|mesh-ancestor
101291291|NCT01954368|Sensory System Agents|sensory system agents|mesh-ancestor
101291292|NCT01954368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101291293|NCT01954368|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101291294|NCT01954368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101291295|NCT01954368|Anesthetics, General|anesthetics, general|mesh-ancestor
101291296|NCT01954368|Anesthetics|anesthetics|mesh-ancestor
101291297|NCT01954693|Everolimus|everolimus|mesh-list
101291298|NCT01954693|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101291299|NCT01954693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101291300|NCT01954693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101291301|NCT01954693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291302|NCT01954693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101291303|NCT01954693|Immunologic Factors|immunologic factors|mesh-ancestor
101291304|NCT01954693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291305|NCT01954693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101291306|NCT01954732|Metformin|metformin|mesh-list
101291307|NCT01954732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101291308|NCT01954732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291309|NCT01954784|Cyclosporine|cyclosporine|mesh-list
101291310|NCT01954784|Mycophenolic Acid|mycophenolic acid|mesh-list
101291311|NCT01954784|Fludarabine|fludarabine|mesh-list
101291312|NCT01954784|Fludarabine phosphate|fludarabine phosphate|mesh-list
101291313|NCT01954784|Lenalidomide|lenalidomide|mesh-list
101291314|NCT01954784|Bortezomib|bortezomib|mesh-list
101291315|NCT01954784|Cyclosporins|cyclosporins|mesh-list
101291316|NCT01954784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101291317|NCT01954784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101291318|NCT01954784|Antimetabolites|antimetabolites|mesh-ancestor
101291319|NCT01954784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291320|NCT01954784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101291321|NCT01954784|Immunologic Factors|immunologic factors|mesh-ancestor
101291322|NCT01954784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291323|NCT01954784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101291324|NCT01954784|Antifungal Agents|antifungal agents|mesh-ancestor
101291325|NCT01954784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101291326|NCT01954784|Dermatologic Agents|dermatologic agents|mesh-ancestor
101291327|NCT01954784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101820787|NCT00992472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101820788|NCT00992472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820790|NCT03453840|Artemether|artemether|mesh-list
101820791|NCT03453840|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101820792|NCT03453840|Antimalarials|antimalarials|mesh-ancestor
101820793|NCT03453840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101820794|NCT03453840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101820795|NCT03453840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101820796|NCT03439254|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
101291328|NCT01954784|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101291329|NCT01954784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101291330|NCT01954784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101291331|NCT01954784|Growth Substances|growth substances|mesh-ancestor
101291332|NCT01954784|Growth Inhibitors|growth inhibitors|mesh-ancestor
101291333|NCT01954784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101291334|NCT01954784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101291335|NCT01954784|Antitubercular Agents|antitubercular agents|mesh-ancestor
101291336|NCT01954784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101291337|NCT01954914|Plerixafor|plerixafor|mesh-list
101291338|NCT01954914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101291339|NCT01954914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101291340|NCT01954914|Antiviral Agents|antiviral agents|mesh-ancestor
101291341|NCT01954914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101291342|NCT01954992|Fluorouracil|fluorouracil|mesh-list
101291343|NCT01954992|Antimetabolites|antimetabolites|mesh-ancestor
101291344|NCT01954992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291345|NCT01954992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101291346|NCT01954992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101291347|NCT01954992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101291348|NCT01954992|Immunologic Factors|immunologic factors|mesh-ancestor
101291349|NCT01954992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291350|NCT01955057|Carbon Monoxide|carbon monoxide|mesh-list
101291351|NCT01955057|Antimetabolites|antimetabolites|mesh-ancestor
101291352|NCT01955057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291354|NCT01955057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101291355|NCT01955057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291356|NCT01955070|Ketamine|ketamine|mesh-list
101291357|NCT01955070|Analgesics|analgesics|mesh-ancestor
101291358|NCT01955070|Sensory System Agents|sensory system agents|mesh-ancestor
101291359|NCT01955070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101291360|NCT01955070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291361|NCT01955070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101291362|NCT01955070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101291363|NCT01955070|Anesthetics, General|anesthetics, general|mesh-ancestor
101291364|NCT01955070|Anesthetics|anesthetics|mesh-ancestor
101291365|NCT01955070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101291366|NCT01955070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101291367|NCT01955070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101291368|NCT01955070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101291369|NCT01955070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291370|NCT01955135|Ketamine|ketamine|mesh-list
101291371|NCT01955135|Propofol|propofol|mesh-list
101291372|NCT01955135|Sevoflurane|sevoflurane|mesh-list
101291373|NCT01955135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101291374|NCT01955135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101291375|NCT01955135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291376|NCT01955135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101291377|NCT01955135|Anesthetics, General|anesthetics, general|mesh-ancestor
101291378|NCT01955135|Anesthetics|anesthetics|mesh-ancestor
101291379|NCT01955135|Analgesics|analgesics|mesh-ancestor
101291380|NCT01955135|Sensory System Agents|sensory system agents|mesh-ancestor
101291381|NCT01955135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101291382|NCT01955135|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101820797|NCT03439254|Cathartics|cathartics|mesh-ancestor
101820799|NCT05354700|Carboplatin|carboplatin|mesh-list
101820800|NCT05354700|Etoposide|etoposide|mesh-list
101820801|NCT05354700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101820802|NCT05354700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101820803|NCT05354700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101820804|NCT05354700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101820805|NCT05354700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101291383|NCT01955135|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101291384|NCT01955135|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101291385|NCT01955135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101291386|NCT01955135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316582|NCT00000975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101291387|NCT01955135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101291388|NCT01955135|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101291390|NCT01955174|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101291391|NCT01955174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101291392|NCT01955174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291393|NCT01955174|Cholinergic Agents|cholinergic agents|mesh-ancestor
101291394|NCT01955174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101291395|NCT01955174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291396|NCT01955187|Methylprednisolone|methylprednisolone|mesh-list
101291397|NCT01955187|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101291398|NCT01955187|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101291399|NCT01955187|Prednisolone|prednisolone|mesh-list
101291400|NCT01955187|Prednisolone acetate|prednisolone acetate|mesh-list
101291401|NCT01955187|Cyclophosphamide|cyclophosphamide|mesh-list
101291402|NCT01955187|Rituximab|rituximab|mesh-list
101291403|NCT01955187|Tacrolimus|tacrolimus|mesh-list
101291404|NCT01955187|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101291405|NCT01955187|Prednisolone phosphate|prednisolone phosphate|mesh-list
101291406|NCT01955187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101291407|NCT01955187|Immunologic Factors|immunologic factors|mesh-ancestor
101291408|NCT01955187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291409|NCT01955187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101291410|NCT01955187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101291411|NCT01955187|Alkylating Agents|alkylating agents|mesh-ancestor
101291412|NCT01955187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291413|NCT01955187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101291414|NCT01955187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101291416|NCT01955187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101291417|NCT01955187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101291418|NCT01955187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101291420|NCT01955187|Autonomic Agents|autonomic agents|mesh-ancestor
101291421|NCT01955187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101291422|NCT01955187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101291423|NCT01955187|Glucocorticoids|glucocorticoids|mesh-ancestor
101291424|NCT01955187|Hormones|hormones|mesh-ancestor
101291425|NCT01955187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101291426|NCT01955187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101291427|NCT01955187|Protective Agents|protective agents|mesh-ancestor
101291428|NCT01955187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101291429|NCT01955200|Cilostazol|cilostazol|mesh-list
101291430|NCT01955200|Clopidogrel|clopidogrel|mesh-list
101291431|NCT01955200|Ticagrelor|ticagrelor|mesh-list
101291432|NCT01955200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101291433|NCT01955200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101291434|NCT01955200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101291435|NCT01955200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101291436|NCT01955200|Purinergic Agents|purinergic agents|mesh-ancestor
101291437|NCT01955200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101291438|NCT01955200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291439|NCT01955200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820806|NCT05354700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820807|NCT03339258|Doxazosin|doxazosin|mesh-list
101820808|NCT03339258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101820809|NCT03339258|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101820810|NCT03339258|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101820811|NCT03339258|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101820812|NCT03339258|Adrenergic Agents|adrenergic agents|mesh-ancestor
101820813|NCT03339258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101820814|NCT03339258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820815|NCT03339258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291440|NCT01955200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101291441|NCT01955200|Autonomic Agents|autonomic agents|mesh-ancestor
101291442|NCT01955200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101291443|NCT01955200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101291444|NCT01955200|Respiratory System Agents|respiratory system agents|mesh-ancestor
101291445|NCT01955200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101291446|NCT01955200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101291447|NCT01955200|Vasodilator Agents|vasodilator agents|mesh-ancestor
101291448|NCT01955200|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101291449|NCT01955200|Protective Agents|protective agents|mesh-ancestor
101291450|NCT01955200|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101291451|NCT01955200|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101291452|NCT01955200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101291453|NCT01955213|Methylnaltrexone|methylnaltrexone|mesh-list
101291454|NCT01955213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101291455|NCT01955213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291456|NCT01955213|Sensory System Agents|sensory system agents|mesh-ancestor
101291457|NCT01955213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101291458|NCT01955252|Azithromycin|azithromycin|mesh-list
101291459|NCT01955252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101291460|NCT01955252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101291461|NCT01955317|Chlorhexidine|chlorhexidine|mesh-list
101291462|NCT01955317|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101291463|NCT01955317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101291464|NCT01955317|Disinfectants|disinfectants|mesh-ancestor
101291465|NCT01955408|Cholinergic Antagonists|cholinergic antagonists|mesh-list
101291466|NCT01955408|Cholinergic Agents|cholinergic agents|mesh-ancestor
101291467|NCT01955408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101291468|NCT01955408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291469|NCT01955408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291470|NCT01955421|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101291472|NCT01955421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101291473|NCT01955421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101291474|NCT01955421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101291475|NCT01955421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291476|NCT01955577|Vitamin D|vitamin d|mesh-list
101291477|NCT01955577|Cholecalciferol|cholecalciferol|mesh-list
101291478|NCT01955577|Vitamins|vitamins|mesh-ancestor
101291479|NCT01955577|Micronutrients|micronutrients|mesh-ancestor
101291480|NCT01955577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291481|NCT01955577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101291482|NCT01955577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101291483|NCT01955642|Clopidogrel|clopidogrel|mesh-list
101291484|NCT01955642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101291485|NCT01955642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101291486|NCT01955642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101291487|NCT01955642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101291488|NCT01955642|Purinergic Agents|purinergic agents|mesh-ancestor
101291489|NCT01955642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101291490|NCT01955642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291491|NCT01955642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291492|NCT01955655|Baclofen|baclofen|mesh-list
101820816|NCT00992706|Doxorubicin|doxorubicin|mesh-list
101820817|NCT00992706|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101820818|NCT00992706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101820819|NCT00992706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101820820|NCT00992706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101820821|NCT00992706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101820822|NCT00992706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101820823|NCT00992706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820824|NCT00454779|Cisplatin|cisplatin|mesh-list
101820825|NCT00454779|Docetaxel|docetaxel|mesh-list
101820826|NCT00454779|Panitumumab|panitumumab|mesh-list
101820827|NCT00454779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101820828|NCT00454779|Tubulin Modulators|tubulin modulators|mesh-ancestor
101820829|NCT00454779|Antimitotic Agents|antimitotic agents|mesh-ancestor
101820830|NCT00454779|Mitosis Modulators|mitosis modulators|mesh-ancestor
101291493|NCT01955655|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101291494|NCT01955655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291495|NCT01955655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101291496|NCT01955655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101291497|NCT01955655|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101291498|NCT01955655|GABA Agonists|gaba agonists|mesh-ancestor
101291499|NCT01955655|GABA Agents|gaba agents|mesh-ancestor
101291500|NCT01955655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101291501|NCT01955655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291503|NCT01955694|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101291504|NCT01955694|Hormone Antagonists|hormone antagonists|mesh-ancestor
101291505|NCT01955694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101291506|NCT01955694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291507|NCT01955694|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101291508|NCT01955694|Diuretics|diuretics|mesh-ancestor
101291509|NCT01955694|Natriuretic Agents|natriuretic agents|mesh-ancestor
101291510|NCT01955694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101291511|NCT01955759|Amiodarone|amiodarone|mesh-list
101291512|NCT01955759|Bisoprolol|bisoprolol|mesh-list
101291513|NCT01955759|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101291514|NCT01955759|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101291515|NCT01955759|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101291516|NCT01955759|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101291517|NCT01955759|Antimetabolites|antimetabolites|mesh-ancestor
101291518|NCT01955759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291519|NCT01955759|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101291520|NCT01955759|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101291521|NCT01955759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101291522|NCT01955759|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101291523|NCT01955759|Adrenergic Agents|adrenergic agents|mesh-ancestor
101291524|NCT01955759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101291525|NCT01955759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291526|NCT01955759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101291527|NCT01955759|Vasodilator Agents|vasodilator agents|mesh-ancestor
101291528|NCT01955759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101291529|NCT01955759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101291530|NCT01955759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101291531|NCT01955759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101291532|NCT01955759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101291533|NCT01955759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101291534|NCT01955759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101291535|NCT01955759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101291536|NCT01955759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101291538|NCT01955759|Autonomic Agents|autonomic agents|mesh-ancestor
101820831|NCT00454779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820832|NCT00454779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101820833|NCT00992862|Moexipril|moexipril|mesh-list
101408712|NCT00143715|Micronutrients|micronutrients|mesh-ancestor
101820834|NCT00992862|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101820835|NCT00992862|Protease Inhibitors|protease inhibitors|mesh-ancestor
101820836|NCT00992862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101291539|NCT01955759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101291540|NCT01955759|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101291541|NCT01955824|Lidocaine|lidocaine|mesh-list
101291542|NCT01955824|Anesthetics, Local|anesthetics, local|mesh-ancestor
101291543|NCT01955824|Anesthetics|anesthetics|mesh-ancestor
101291544|NCT01955824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101291545|NCT01955824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291546|NCT01955824|Sensory System Agents|sensory system agents|mesh-ancestor
101291547|NCT01955824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101291548|NCT01955824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101291549|NCT01955824|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101291550|NCT01955824|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101291551|NCT01955824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101291552|NCT01955824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291553|NCT01955967|Lidocaine|lidocaine|mesh-list
101291554|NCT01955967|Anesthetics, Local|anesthetics, local|mesh-ancestor
101291555|NCT01955967|Anesthetics|anesthetics|mesh-ancestor
101291556|NCT01955967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101291557|NCT01955967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291558|NCT01955967|Sensory System Agents|sensory system agents|mesh-ancestor
101291559|NCT01955967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101291560|NCT01955967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101291561|NCT01955967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101291562|NCT01955967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101291563|NCT01955967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101291564|NCT01955967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291565|NCT01956006|Milrinone|milrinone|mesh-list
101291566|NCT01956006|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101291567|NCT01956006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101291568|NCT01956006|Vasodilator Agents|vasodilator agents|mesh-ancestor
101291569|NCT01956006|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101291570|NCT01956006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101291571|NCT01956006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101291572|NCT01956006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291573|NCT01956006|Protective Agents|protective agents|mesh-ancestor
101291574|NCT01956006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291575|NCT01956201|Atorvastatin|atorvastatin|mesh-list
101291576|NCT01956201|Fenofibrate|fenofibrate|mesh-list
101291577|NCT01956201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101291578|NCT01956201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101291579|NCT01956201|Antimetabolites|antimetabolites|mesh-ancestor
101291580|NCT01956201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291581|NCT01956201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101291582|NCT01956201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101291583|NCT01956201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101291584|NCT01956305|Metformin|metformin|mesh-list
101291585|NCT01956305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101291586|NCT01956305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291587|NCT01956474|Riboflavin|riboflavin|mesh-list
101291588|NCT01956474|Vitamin B Complex|vitamin b complex|mesh-ancestor
101291589|NCT01956474|Vitamins|vitamins|mesh-ancestor
101291590|NCT01956474|Micronutrients|micronutrients|mesh-ancestor
101291591|NCT01956474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291592|NCT01956474|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101291593|NCT01956474|Dermatologic Agents|dermatologic agents|mesh-ancestor
101291594|NCT01956487|Propafenone|propafenone|mesh-list
101291595|NCT01956487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101291596|NCT01956487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101291597|NCT01956487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101291598|NCT01956487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101820837|NCT00992862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820838|NCT00992862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101820839|NCT00993096|Insulin|insulin|mesh-list
101820840|NCT00993096|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101820841|NCT00993096|Insulin Aspart|insulin aspart|mesh-list
101820842|NCT00993096|Insulin, Long-Acting|insulin, long-acting|mesh-list
101820843|NCT00993096|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101820844|NCT00993096|Biphasic Insulins|biphasic insulins|mesh-list
101291599|NCT01956487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291601|NCT01956591|Parasympatholytics|parasympatholytics|mesh-ancestor
101291602|NCT01956591|Autonomic Agents|autonomic agents|mesh-ancestor
101291603|NCT01956591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101291604|NCT01956591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291606|NCT01956591|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101291607|NCT01956591|Cholinergic Agents|cholinergic agents|mesh-ancestor
101291608|NCT01956591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101291609|NCT01956591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291610|NCT01956591|Urological Agents|urological agents|mesh-ancestor
101291611|NCT01956604|Clonidine|clonidine|mesh-list
101291612|NCT01956604|Analgesics|analgesics|mesh-ancestor
101291613|NCT01956604|Sensory System Agents|sensory system agents|mesh-ancestor
101291614|NCT01956604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101291615|NCT01956604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291616|NCT01956604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101291617|NCT01956604|Sympatholytics|sympatholytics|mesh-ancestor
101291618|NCT01956604|Autonomic Agents|autonomic agents|mesh-ancestor
101291619|NCT01956604|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101291620|NCT01956604|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101291621|NCT01956604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101291622|NCT01956604|Adrenergic Agents|adrenergic agents|mesh-ancestor
101291623|NCT01956604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101291624|NCT01956604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291625|NCT01956695|Rituximab|rituximab|mesh-list
101291626|NCT01956695|Lenalidomide|lenalidomide|mesh-list
101291627|NCT01956695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101291628|NCT01956695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101291629|NCT01956695|Immunologic Factors|immunologic factors|mesh-ancestor
101291630|NCT01956695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291631|NCT01956695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101291632|NCT01956695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101291633|NCT01956695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101291634|NCT01956695|Growth Substances|growth substances|mesh-ancestor
101291635|NCT01956695|Growth Inhibitors|growth inhibitors|mesh-ancestor
101291636|NCT01956734|Temozolomide|temozolomide|mesh-list
101291637|NCT01956734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101291638|NCT01956734|Alkylating Agents|alkylating agents|mesh-ancestor
101291639|NCT01956734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291640|NCT01956734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101291641|NCT01956786|Amlodipine|amlodipine|mesh-list
101291642|NCT01956786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101291643|NCT01956786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101291644|NCT01956786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101291645|NCT01956786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291646|NCT01956786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101291647|NCT01956786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291649|NCT01956864|Vitamin D|vitamin d|mesh-list
101291650|NCT01956864|Vitamins|vitamins|mesh-ancestor
101291651|NCT01956864|Micronutrients|micronutrients|mesh-ancestor
101291652|NCT01956864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291653|NCT01956864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101291654|NCT01956929|Metformin|metformin|mesh-list
101291655|NCT01956929|Lactulose|lactulose|mesh-list
101291656|NCT01956929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101291657|NCT01956929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820845|NCT00993096|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101820847|NCT00993096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101820848|NCT00993096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820849|NCT00439569|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
101820850|NCT00439569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101291658|NCT01956929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101291659|NCT01956955|Heparin|heparin|mesh-list
101291660|NCT01956955|Enoxaparin|enoxaparin|mesh-list
101291661|NCT01956955|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101291662|NCT01956955|Calcium heparin|calcium heparin|mesh-list
101291664|NCT01956955|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101291665|NCT01956955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101291666|NCT01956955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291667|NCT01956981|Magnesium Sulfate|magnesium sulfate|mesh-list
101291668|NCT01956981|Dexmedetomidine|dexmedetomidine|mesh-list
101291669|NCT01956981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101291670|NCT01956981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101291672|NCT01956981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101291673|NCT01956981|Analgesics|analgesics|mesh-ancestor
101291674|NCT01956981|Sensory System Agents|sensory system agents|mesh-ancestor
101291675|NCT01956981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101291676|NCT01956981|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101291677|NCT01956981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101291678|NCT01956981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101291679|NCT01956981|Adrenergic Agents|adrenergic agents|mesh-ancestor
101291680|NCT01956981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101291681|NCT01956981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291682|NCT01956981|Anesthetics|anesthetics|mesh-ancestor
101291683|NCT01956981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101291684|NCT01956981|Anticonvulsants|anticonvulsants|mesh-ancestor
101291685|NCT01956981|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101291686|NCT01956981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101291687|NCT01956981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101291688|NCT01956981|Tocolytic Agents|tocolytic agents|mesh-ancestor
101291689|NCT01956981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101291690|NCT01957007|Docetaxel|docetaxel|mesh-list
101291691|NCT01957007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101291692|NCT01957007|Tubulin Modulators|tubulin modulators|mesh-ancestor
101291693|NCT01957007|Antimitotic Agents|antimitotic agents|mesh-ancestor
101291694|NCT01957007|Mitosis Modulators|mitosis modulators|mesh-ancestor
101291695|NCT01957007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291696|NCT01957046|Laxatives|laxatives|mesh-list
101291697|NCT01957046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101291698|NCT01957189|Tamsulosin|tamsulosin|mesh-list
101291699|NCT01957189|Dutasteride|dutasteride|mesh-list
101291700|NCT01957189|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101291701|NCT01957189|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101291702|NCT01957189|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101291703|NCT01957189|Adrenergic Agents|adrenergic agents|mesh-ancestor
101291704|NCT01957189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101291705|NCT01957189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291706|NCT01957189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291707|NCT01957189|Urological Agents|urological agents|mesh-ancestor
101291708|NCT01957189|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101291709|NCT01957189|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101291710|NCT01957189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101291711|NCT01957189|Hormone Antagonists|hormone antagonists|mesh-ancestor
101291712|NCT01957189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101291713|NCT01957293|Albuterol|albuterol|mesh-list
101291714|NCT01957293|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101291715|NCT01957293|Autonomic Agents|autonomic agents|mesh-ancestor
101291716|NCT01957293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101291717|NCT01957293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291718|NCT01957293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101291719|NCT01957293|Respiratory System Agents|respiratory system agents|mesh-ancestor
101291720|NCT01957293|Tocolytic Agents|tocolytic agents|mesh-ancestor
101820851|NCT03994107|Paclitaxel|paclitaxel|mesh-list
101820852|NCT03994107|Doxorubicin|doxorubicin|mesh-list
101820853|NCT03994107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101820854|NCT03994107|Trastuzumab|trastuzumab|mesh-list
101820855|NCT03994107|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101820856|NCT03994107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101820857|NCT03994107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101820858|NCT03994107|Tubulin Modulators|tubulin modulators|mesh-ancestor
101820859|NCT03994107|Antimitotic Agents|antimitotic agents|mesh-ancestor
101291721|NCT01957293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101291722|NCT01957293|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101291723|NCT01957293|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101291724|NCT01957293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101291726|NCT01957293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101291727|NCT01957293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291728|NCT01957319|Vitamin E|vitamin e|mesh-list
101291729|NCT01957319|Silybin|silybin|mesh-list
101291730|NCT01957319|Vitamins|vitamins|mesh-ancestor
101291731|NCT01957319|Micronutrients|micronutrients|mesh-ancestor
101291732|NCT01957319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291733|NCT01957319|Antioxidants|antioxidants|mesh-ancestor
101291734|NCT01957319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291735|NCT01957319|Protective Agents|protective agents|mesh-ancestor
101291736|NCT01957319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101291737|NCT01957319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101291738|NCT01957436|Docetaxel|docetaxel|mesh-list
101291739|NCT01957436|Abiraterone Acetate|abiraterone acetate|mesh-list
101291740|NCT01957436|Androgens|androgens|mesh-list
101291741|NCT01957436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101291742|NCT01957436|Tubulin Modulators|tubulin modulators|mesh-ancestor
101291743|NCT01957436|Antimitotic Agents|antimitotic agents|mesh-ancestor
101291745|NCT01957436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291746|NCT01957436|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101291747|NCT01957436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101291748|NCT01957436|Hormone Antagonists|hormone antagonists|mesh-ancestor
101291749|NCT01957436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101291750|NCT01957436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291751|NCT01957436|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101291752|NCT01957436|Hormones|hormones|mesh-ancestor
101291753|NCT01957449|Propranolol|propranolol|mesh-list
101291754|NCT01957449|Metoprolol|metoprolol|mesh-list
101291755|NCT01957449|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101291756|NCT01957449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101291757|NCT01957449|Adrenergic Agents|adrenergic agents|mesh-ancestor
101291758|NCT01957449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101291759|NCT01957449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291760|NCT01957449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291761|NCT01957449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101291762|NCT01957449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101291763|NCT01957449|Vasodilator Agents|vasodilator agents|mesh-ancestor
101291764|NCT01957449|Sympatholytics|sympatholytics|mesh-ancestor
101291765|NCT01957449|Autonomic Agents|autonomic agents|mesh-ancestor
101291767|NCT01957449|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101291768|NCT01957540|Ticagrelor|ticagrelor|mesh-list
101291769|NCT01957540|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101291770|NCT01957540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101291771|NCT01957540|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101291772|NCT01957540|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101291773|NCT01957540|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101291774|NCT01957540|Purinergic Agents|purinergic agents|mesh-ancestor
101291775|NCT01957540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101291776|NCT01957540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291777|NCT01957540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291778|NCT01957631|Methylprednisolone|methylprednisolone|mesh-list
101291779|NCT01957631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101820860|NCT03994107|Mitosis Modulators|mitosis modulators|mesh-ancestor
101820861|NCT03994107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820862|NCT03994107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101820863|NCT03994107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101820864|NCT03994107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101820865|NCT03994107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101820866|NCT03994107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101820868|NCT03469713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101820869|NCT03469713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101820870|NCT03469713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101820871|NCT03469713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820872|NCT00427635|Esomeprazole|esomeprazole|mesh-list
101820873|NCT00427635|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101820874|NCT00427635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101820875|NCT00427635|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101820876|NCT00427635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101820877|NCT00427635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820878|NCT00993642|Panobinostat|panobinostat|mesh-list
101820879|NCT00993642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101820880|NCT00993642|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101820881|NCT00993642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478178|NCT00280358|Xhance|xhance|mesh-list
101820882|NCT00993642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820883|NCT01028547|Dexamethasone|dexamethasone|mesh-list
101820884|NCT01028547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101820885|NCT01028547|Antiemetics|antiemetics|mesh-ancestor
101820886|NCT01028547|Autonomic Agents|autonomic agents|mesh-ancestor
101820887|NCT01028547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101291780|NCT01957631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101291781|NCT01957631|Prednisolone|prednisolone|mesh-list
101291782|NCT01957631|Prednisolone acetate|prednisolone acetate|mesh-list
101291783|NCT01957631|Bupivacaine|bupivacaine|mesh-list
101291784|NCT01957631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101291785|NCT01957631|Prednisolone phosphate|prednisolone phosphate|mesh-list
101291786|NCT01957631|Anesthetics, Local|anesthetics, local|mesh-ancestor
101291787|NCT01957631|Anesthetics|anesthetics|mesh-ancestor
101291788|NCT01957631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101291789|NCT01957631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291790|NCT01957631|Sensory System Agents|sensory system agents|mesh-ancestor
101291791|NCT01957631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101291792|NCT01957631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101291793|NCT01957631|Antiemetics|antiemetics|mesh-ancestor
101820888|NCT01028547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820889|NCT01028547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101820890|NCT01028547|Glucocorticoids|glucocorticoids|mesh-ancestor
101820891|NCT01028547|Hormones|hormones|mesh-ancestor
101820892|NCT01028547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101820893|NCT01028547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101820894|NCT01028547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101820895|NCT01031355|Calcium, Dietary|calcium, dietary|mesh-list
101820896|NCT01031355|Tetrahydrofolates|tetrahydrofolates|mesh-list
101291794|NCT01957631|Autonomic Agents|autonomic agents|mesh-ancestor
101291795|NCT01957631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101291796|NCT01957631|Glucocorticoids|glucocorticoids|mesh-ancestor
101291797|NCT01957631|Hormones|hormones|mesh-ancestor
101316614|NCT00001002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291798|NCT01957631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101291799|NCT01957631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101291800|NCT01957631|Protective Agents|protective agents|mesh-ancestor
101291801|NCT01957631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101291802|NCT01957631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101291803|NCT01957839|Cabergoline|cabergoline|mesh-list
101291804|NCT01957839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101291805|NCT01957839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101291806|NCT01957839|Dopamine Agonists|dopamine agonists|mesh-ancestor
101291807|NCT01957839|Dopamine Agents|dopamine agents|mesh-ancestor
101291808|NCT01957839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101291809|NCT01957839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291810|NCT01957839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291811|NCT01957852|Thrombin|thrombin|mesh-list
101291812|NCT01957852|Hemostatics|hemostatics|mesh-ancestor
101291813|NCT01957852|Coagulants|coagulants|mesh-ancestor
101291814|NCT01957943|SMOFlipid|smoflipid|mesh-list
101291815|NCT01957943|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101291816|NCT01957943|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101291817|NCT01957943|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101291818|NCT01957995|Docetaxel|docetaxel|mesh-list
101408727|NCT00454831|Hemostatics|hemostatics|mesh-ancestor
101291819|NCT01957995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101291820|NCT01957995|Tubulin Modulators|tubulin modulators|mesh-ancestor
101291821|NCT01957995|Antimitotic Agents|antimitotic agents|mesh-ancestor
101291822|NCT01957995|Mitosis Modulators|mitosis modulators|mesh-ancestor
101291823|NCT01957995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291824|NCT01958138|Propofol|propofol|mesh-list
101291825|NCT01958138|Isoflurane|isoflurane|mesh-list
101291826|NCT01958138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101291828|NCT01958138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291829|NCT01958138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101291830|NCT01958138|Anesthetics, General|anesthetics, general|mesh-ancestor
101291831|NCT01958138|Anesthetics|anesthetics|mesh-ancestor
101291832|NCT01958138|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101291833|NCT01958216|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101291834|NCT01958216|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101291835|NCT01958216|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101291836|NCT01958216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101291837|NCT01958372|Etoposide|etoposide|mesh-list
101291838|NCT01958372|Pemetrexed|pemetrexed|mesh-list
101291839|NCT01958372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101291840|NCT01958372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101291841|NCT01958372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101291842|NCT01958372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101291843|NCT01958372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101291844|NCT01958372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291845|NCT01958372|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101291846|NCT01958372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101291847|NCT01958580|Gemcitabine|gemcitabine|mesh-list
101291848|NCT01958580|Docetaxel|docetaxel|mesh-list
101820897|NCT01031355|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101820898|NCT01031355|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101820899|NCT01031355|Calcium|calcium|mesh-list
101820900|NCT01031355|Estradiol|estradiol|mesh-list
101820901|NCT01031355|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101820902|NCT01031355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101820903|NCT01031355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820904|NCT01031355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101291849|NCT01958580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101291850|NCT01958580|Antimetabolites|antimetabolites|mesh-ancestor
101291851|NCT01958580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291852|NCT01958580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101291853|NCT01958580|Tubulin Modulators|tubulin modulators|mesh-ancestor
101291854|NCT01958580|Antimitotic Agents|antimitotic agents|mesh-ancestor
101291855|NCT01958580|Mitosis Modulators|mitosis modulators|mesh-ancestor
101291857|NCT01958684|Levonorgestrel|levonorgestrel|mesh-list
101291858|NCT01958684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101291859|NCT01958684|Contraceptive Agents|contraceptive agents|mesh-ancestor
101291860|NCT01958684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101291861|NCT01958684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291862|NCT01958684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101291863|NCT01958684|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101291864|NCT01958684|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101291865|NCT01958684|Trace Elements|trace elements|mesh-ancestor
101291866|NCT01958684|Micronutrients|micronutrients|mesh-ancestor
101291867|NCT01958775|Glucagon|glucagon|mesh-list
101291868|NCT01958775|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101291869|NCT01958775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101291870|NCT01958775|Hormones|hormones|mesh-ancestor
101291871|NCT01958775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101291872|NCT01958775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291874|NCT01958814|Albuterol|albuterol|mesh-list
101291875|NCT01958814|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101291876|NCT01958814|Autonomic Agents|autonomic agents|mesh-ancestor
101291877|NCT01958814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101291878|NCT01958814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291879|NCT01958814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101291880|NCT01958814|Respiratory System Agents|respiratory system agents|mesh-ancestor
101291881|NCT01958814|Tocolytic Agents|tocolytic agents|mesh-ancestor
101291882|NCT01958814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101291883|NCT01958814|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101291884|NCT01958814|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101291885|NCT01958814|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101291886|NCT01958814|Adrenergic Agents|adrenergic agents|mesh-ancestor
101291887|NCT01958814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101291888|NCT01958814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291889|NCT01958866|Acetaminophen|acetaminophen|mesh-list
101291890|NCT01958866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101291891|NCT01958866|Analgesics|analgesics|mesh-ancestor
101291892|NCT01958866|Sensory System Agents|sensory system agents|mesh-ancestor
101291893|NCT01958866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101291894|NCT01958866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291895|NCT01958866|Antipyretics|antipyretics|mesh-ancestor
101291896|NCT01958905|Lumefantrine|lumefantrine|mesh-list
101291897|NCT01958905|Artemether|artemether|mesh-list
101291898|NCT01958905|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101291899|NCT01958905|Antimalarials|antimalarials|mesh-ancestor
101291900|NCT01958905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101291901|NCT01958905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101291902|NCT01958905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101291903|NCT01958944|Nitric Oxide|nitric oxide|mesh-list
101291904|NCT01958944|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101291905|NCT01958944|Autonomic Agents|autonomic agents|mesh-ancestor
101291906|NCT01958944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101291907|NCT01958944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291908|NCT01958944|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101291909|NCT01958944|Respiratory System Agents|respiratory system agents|mesh-ancestor
101820905|NCT01031355|Estrogens|estrogens|mesh-ancestor
101820906|NCT01031355|Hormones|hormones|mesh-ancestor
101820907|NCT01031355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101820908|NCT01031355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101820909|NCT01031355|Contraceptive Agents|contraceptive agents|mesh-ancestor
101820910|NCT01031355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101820911|NCT01031355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101820912|NCT01031355|Vitamin B Complex|vitamin b complex|mesh-ancestor
101820913|NCT01031355|Vitamins|vitamins|mesh-ancestor
101820914|NCT01031355|Micronutrients|micronutrients|mesh-ancestor
101820915|NCT00993720|Liraglutide|liraglutide|mesh-list
101820916|NCT00993720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101820917|NCT00993720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291910|NCT01958944|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101291911|NCT01958944|Antioxidants|antioxidants|mesh-ancestor
101291912|NCT01958944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291913|NCT01958944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101291914|NCT01958944|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101291915|NCT01958944|Vasodilator Agents|vasodilator agents|mesh-ancestor
101291916|NCT01958944|Gasotransmitters|gasotransmitters|mesh-ancestor
101291917|NCT01958944|Protective Agents|protective agents|mesh-ancestor
101291918|NCT01958996|Idarubicin|idarubicin|mesh-list
101291919|NCT01958996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101291920|NCT01958996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101291921|NCT01958996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101291922|NCT01958996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101291923|NCT01958996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101291924|NCT01958996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291925|NCT01959022|Doxazosin|doxazosin|mesh-list
101291926|NCT01959022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101291927|NCT01959022|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101291928|NCT01959022|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101291929|NCT01959022|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101291931|NCT01959022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101291932|NCT01959022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291933|NCT01959022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291935|NCT01959061|Ethiodized Oil|ethiodized oil|mesh-list
101291936|NCT01959061|Raltitrexed|raltitrexed|mesh-list
101291937|NCT01959061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101291938|NCT01959061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101291939|NCT01959061|Antimetabolites|antimetabolites|mesh-ancestor
101291940|NCT01959061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291941|NCT01959061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101291942|NCT01959061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101291943|NCT01959074|Aceclofenac|aceclofenac|mesh-list
101291944|NCT01959074|Naftopidil|naftopidil|mesh-list
101291945|NCT01959074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101291946|NCT01959074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101291947|NCT01959074|Analgesics|analgesics|mesh-ancestor
101291948|NCT01959074|Sensory System Agents|sensory system agents|mesh-ancestor
101291949|NCT01959074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101291950|NCT01959074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291951|NCT01959074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101291952|NCT01959074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101291953|NCT01959074|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101291954|NCT01959074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101291955|NCT01959074|Adrenergic Agents|adrenergic agents|mesh-ancestor
101291956|NCT01959074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101291957|NCT01959074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291958|NCT01959074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101291959|NCT01959074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101820918|NCT00993720|Incretins|incretins|mesh-ancestor
101820919|NCT00993720|Hormones|hormones|mesh-ancestor
101820920|NCT00993720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101820921|NCT03891264|Cannabidiol|cannabidiol|mesh-list
101820922|NCT03891264|Anticonvulsants|anticonvulsants|mesh-ancestor
101820923|NCT00425607|Lonafarnib|lonafarnib|mesh-list
101820924|NCT00425607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101820925|NCT00425607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820926|NCT00437073|Capecitabine|capecitabine|mesh-list
101820927|NCT00437073|Topotecan|topotecan|mesh-list
101820928|NCT00437073|Lapatinib|lapatinib|mesh-list
101820929|NCT00437073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101820930|NCT00437073|Antimetabolites|antimetabolites|mesh-ancestor
101291960|NCT01959074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101291961|NCT01959074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101291962|NCT01959074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101291964|NCT01959100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101291965|NCT01959100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101291967|NCT01959152|Cholinergic Agents|cholinergic agents|mesh-ancestor
101291968|NCT01959152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101291969|NCT01959152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291970|NCT01959152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291971|NCT01959191|Aspirin|aspirin|mesh-list
101291972|NCT01959191|Clopidogrel|clopidogrel|mesh-list
101291973|NCT01959191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101291974|NCT01959191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101291975|NCT01959191|Analgesics|analgesics|mesh-ancestor
101291976|NCT01959191|Sensory System Agents|sensory system agents|mesh-ancestor
101291977|NCT01959191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101291978|NCT01959191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291979|NCT01959191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101291980|NCT01959191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101291981|NCT01959191|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101291982|NCT01959191|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101291983|NCT01959191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291984|NCT01959191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101291985|NCT01959191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101291986|NCT01959191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101291988|NCT01959191|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101291989|NCT01959191|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101291990|NCT01959191|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101291991|NCT01959191|Purinergic Agents|purinergic agents|mesh-ancestor
101291992|NCT01959191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101291993|NCT01959386|Trastuzumab|trastuzumab|mesh-list
101291994|NCT01959386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101291995|NCT01959386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101291996|NCT01959399|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101291997|NCT01959399|Peficitinib|peficitinib|mesh-list
101291998|NCT01959399|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101291999|NCT01959399|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101292000|NCT01959399|Antimetabolites|antimetabolites|mesh-ancestor
101292001|NCT01959399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292002|NCT01959399|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101292003|NCT01959399|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101292004|NCT01959399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101292005|NCT01959399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101292006|NCT01959399|Immunologic Factors|immunologic factors|mesh-ancestor
101292007|NCT01959399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292008|NCT01959438|Selenious Acid|selenious acid|mesh-list
101292009|NCT01959438|Sodium Selenite|sodium selenite|mesh-list
101292010|NCT01959438|Trace Elements|trace elements|mesh-ancestor
101820931|NCT00437073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820932|NCT00437073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101820933|NCT00437073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101820934|NCT00437073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101820935|NCT00437073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101820936|NCT00437073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101820937|NCT00425373|Amlodipine|amlodipine|mesh-list
101820938|NCT00425373|Valsartan|valsartan|mesh-list
101820939|NCT00425373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101820940|NCT00425373|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101820941|NCT00425373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101820942|NCT00425373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820943|NCT00425373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101820944|NCT00425373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820945|NCT00425373|Vasodilator Agents|vasodilator agents|mesh-ancestor
101292011|NCT01959438|Micronutrients|micronutrients|mesh-ancestor
101292012|NCT01959438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292013|NCT01959451|Clopidogrel|clopidogrel|mesh-list
101292014|NCT01959451|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101292015|NCT01959451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101292016|NCT01959451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101292017|NCT01959451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101292018|NCT01959451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101292019|NCT01959451|Purinergic Agents|purinergic agents|mesh-ancestor
101292020|NCT01959451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101292021|NCT01959451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292022|NCT01959451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292023|NCT01959477|Cyclophosphamide|cyclophosphamide|mesh-list
101292024|NCT01959477|Busulfan|busulfan|mesh-list
101292025|NCT01959477|Etoposide|etoposide|mesh-list
101292026|NCT01959477|Etoposide phosphate|etoposide phosphate|mesh-list
101292027|NCT01959477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101292028|NCT01959477|Immunologic Factors|immunologic factors|mesh-ancestor
101292029|NCT01959477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292030|NCT01959477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101292031|NCT01959477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101292032|NCT01959477|Alkylating Agents|alkylating agents|mesh-ancestor
101292033|NCT01959477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292035|NCT01959477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101292036|NCT01959477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101292038|NCT01959477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101292039|NCT01959477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101292040|NCT01959828|Nitric Oxide|nitric oxide|mesh-list
101292041|NCT01959828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101292042|NCT01959828|Autonomic Agents|autonomic agents|mesh-ancestor
101292043|NCT01959828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101292044|NCT01959828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292045|NCT01959828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101292046|NCT01959828|Respiratory System Agents|respiratory system agents|mesh-ancestor
101292047|NCT01959828|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101292048|NCT01959828|Antioxidants|antioxidants|mesh-ancestor
101292049|NCT01959828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292050|NCT01959828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101292051|NCT01959828|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101820946|NCT00425373|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101820947|NCT00425373|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101820949|NCT01031589|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101820950|NCT01031589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101820951|NCT01031589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101820952|NCT01031589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292052|NCT01959828|Vasodilator Agents|vasodilator agents|mesh-ancestor
101292053|NCT01959828|Gasotransmitters|gasotransmitters|mesh-ancestor
101292054|NCT01959828|Protective Agents|protective agents|mesh-ancestor
101292055|NCT01959854|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101292056|NCT01959854|Laxatives|laxatives|mesh-ancestor
101292057|NCT01959854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101292058|NCT01959971|Alirocumab|alirocumab|mesh-list
101292059|NCT01959971|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101292060|NCT01959971|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101292061|NCT01959971|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101292062|NCT01959971|Antimetabolites|antimetabolites|mesh-ancestor
101292063|NCT01959971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292064|NCT01959971|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101292065|NCT01959971|Protease Inhibitors|protease inhibitors|mesh-ancestor
101292066|NCT01959971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101292067|NCT01959971|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101292068|NCT01960023|Cetuximab|cetuximab|mesh-list
101292069|NCT01960023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101292070|NCT01960023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101292071|NCT01960049|Ropivacaine|ropivacaine|mesh-list
101292072|NCT01960049|Anesthetics, Local|anesthetics, local|mesh-ancestor
101292073|NCT01960049|Anesthetics|anesthetics|mesh-ancestor
101292074|NCT01960049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101292075|NCT01960049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292076|NCT01960049|Sensory System Agents|sensory system agents|mesh-ancestor
101292077|NCT01960049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101292078|NCT01960153|Tadalafil|tadalafil|mesh-list
101292079|NCT01960153|Vasodilator Agents|vasodilator agents|mesh-ancestor
101292080|NCT01960153|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101292081|NCT01960153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101292082|NCT01960153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101292083|NCT01960153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292084|NCT01960153|Urological Agents|urological agents|mesh-ancestor
101292085|NCT01960179|Lixisenatide|lixisenatide|mesh-list
101292086|NCT01960179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101292087|NCT01960179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292088|NCT01960205|Metformin|metformin|mesh-list
101292089|NCT01960205|Saxagliptin|saxagliptin|mesh-list
101292090|NCT01960205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101292091|NCT01960205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292092|NCT01960205|Incretins|incretins|mesh-ancestor
101292093|NCT01960205|Hormones|hormones|mesh-ancestor
101292094|NCT01960205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101292095|NCT01960205|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101292097|NCT01960205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101292098|NCT01960205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292099|NCT01960283|Methotrexate|methotrexate|mesh-list
101292100|NCT01960283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101292101|NCT01960283|Abortifacient Agents|abortifacient agents|mesh-ancestor
101292102|NCT01960283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101292103|NCT01960283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292104|NCT01960283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101292105|NCT01960283|Antimetabolites|antimetabolites|mesh-ancestor
101292106|NCT01960283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292107|NCT01960283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101292108|NCT01960283|Dermatologic Agents|dermatologic agents|mesh-ancestor
101292109|NCT01960283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101292110|NCT01960283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101292111|NCT01960283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101820953|NCT01031589|Antiviral Agents|antiviral agents|mesh-ancestor
101820954|NCT01031589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101820955|NCT01031589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101478260|NCT00280787|Paclitaxel|paclitaxel|mesh-list
101820956|NCT01031589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101820957|NCT03894540|Paclitaxel|paclitaxel|mesh-list
101820958|NCT03894540|Pembrolizumab|pembrolizumab|mesh-list
101820959|NCT03894540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101292112|NCT01960283|Immunologic Factors|immunologic factors|mesh-ancestor
101292113|NCT01960283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101292114|NCT01960283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101292116|NCT01960426|Infliximab|infliximab|mesh-list
101292117|NCT01960426|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101292118|NCT01960426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101292119|NCT01960426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101292120|NCT01960426|Dermatologic Agents|dermatologic agents|mesh-ancestor
101292121|NCT01960426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101292122|NCT01960543|Fentanyl|fentanyl|mesh-list
101292123|NCT01960543|Bupivacaine|bupivacaine|mesh-list
101292124|NCT01960543|Levobupivacaine|levobupivacaine|mesh-list
101292125|NCT01960543|Anesthetics, Local|anesthetics, local|mesh-ancestor
101292126|NCT01960543|Anesthetics|anesthetics|mesh-ancestor
101292127|NCT01960543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101292128|NCT01960543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292129|NCT01960543|Sensory System Agents|sensory system agents|mesh-ancestor
101292130|NCT01960543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101292131|NCT01960543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101292132|NCT01960543|Narcotics|narcotics|mesh-ancestor
101292133|NCT01960543|Analgesics|analgesics|mesh-ancestor
101292134|NCT01960543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101292135|NCT01960543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101292136|NCT01960543|Anesthetics, General|anesthetics, general|mesh-ancestor
101292137|NCT01960569|Hirudins|hirudins|mesh-list
101292138|NCT01960569|Antithrombins|antithrombins|mesh-ancestor
101292139|NCT01960569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101292140|NCT01960569|Protease Inhibitors|protease inhibitors|mesh-ancestor
101292141|NCT01960569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101292142|NCT01960569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292143|NCT01960569|Anticoagulants|anticoagulants|mesh-ancestor
101292144|NCT01960569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101292145|NCT01960569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101292146|NCT01960595|Fentanyl|fentanyl|mesh-list
101292147|NCT01960595|Bupivacaine|bupivacaine|mesh-list
101292148|NCT01960595|Anesthetics, Local|anesthetics, local|mesh-ancestor
101292149|NCT01960595|Anesthetics|anesthetics|mesh-ancestor
101292150|NCT01960595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101292151|NCT01960595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292152|NCT01960595|Sensory System Agents|sensory system agents|mesh-ancestor
101292153|NCT01960595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101292154|NCT01960595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101292155|NCT01960595|Narcotics|narcotics|mesh-ancestor
101292156|NCT01960595|Analgesics|analgesics|mesh-ancestor
101292157|NCT01960595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101292158|NCT01960595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101292159|NCT01960595|Anesthetics, General|anesthetics, general|mesh-ancestor
101292160|NCT01960647|Paclitaxel|paclitaxel|mesh-list
101292161|NCT01960647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101292162|NCT01960647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101292163|NCT01960647|Tubulin Modulators|tubulin modulators|mesh-ancestor
101292164|NCT01960647|Antimitotic Agents|antimitotic agents|mesh-ancestor
101292165|NCT01960647|Mitosis Modulators|mitosis modulators|mesh-ancestor
101292166|NCT01960647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292167|NCT01960764|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101292168|NCT01960764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101292169|NCT01960829|Everolimus|everolimus|mesh-list
101292170|NCT01960829|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101292171|NCT01960829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101292172|NCT01960829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101292173|NCT01960829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292174|NCT01960829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101292175|NCT01960829|Immunologic Factors|immunologic factors|mesh-ancestor
101820960|NCT03894540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101820961|NCT03894540|Tubulin Modulators|tubulin modulators|mesh-ancestor
101820962|NCT03894540|Antimitotic Agents|antimitotic agents|mesh-ancestor
101820963|NCT03894540|Mitosis Modulators|mitosis modulators|mesh-ancestor
101820964|NCT03894540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101820965|NCT03894540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101820966|NCT03894540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101820968|NCT00993876|Reboxetine|reboxetine|mesh-list
101820969|NCT00993876|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101820970|NCT00993876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101820971|NCT00993876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101820972|NCT00993876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292176|NCT01960829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292177|NCT01960829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101292178|NCT01961154|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101292179|NCT01961154|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101292180|NCT01961154|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101292181|NCT01961154|Respiratory System Agents|respiratory system agents|mesh-ancestor
101292182|NCT01961154|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101292183|NCT01961154|Autonomic Agents|autonomic agents|mesh-ancestor
101292184|NCT01961154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101292185|NCT01961154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292186|NCT01961154|Glucocorticoids|glucocorticoids|mesh-ancestor
101292187|NCT01961154|Hormones|hormones|mesh-ancestor
101292188|NCT01961154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101292189|NCT01961154|Sympathomimetics|sympathomimetics|mesh-ancestor
101292190|NCT01961180|Escitalopram|escitalopram|mesh-list
101292191|NCT01961180|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101292192|NCT01961180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101292193|NCT01961180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101292194|NCT01961180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292195|NCT01961180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101292196|NCT01961180|Serotonin Agents|serotonin agents|mesh-ancestor
101292197|NCT01961180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292198|NCT01961193|Silicon|silicon|mesh-list
101292199|NCT01961193|Trace Elements|trace elements|mesh-ancestor
101292200|NCT01961193|Micronutrients|micronutrients|mesh-ancestor
101292201|NCT01961193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292202|NCT01961219|Anesthetics|anesthetics|mesh-list
101292203|NCT01961219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101292204|NCT01961219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292205|NCT01961336|Testosterone|testosterone|mesh-list
101292206|NCT01961336|Androgens|androgens|mesh-ancestor
101292207|NCT01961336|Hormones|hormones|mesh-ancestor
101292208|NCT01961336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101292209|NCT01961336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292210|NCT01961388|Metformin|metformin|mesh-list
101292211|NCT01961388|Acarbose|acarbose|mesh-list
101292212|NCT01961388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101292213|NCT01961388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292214|NCT01961388|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101292215|NCT01961388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101292216|NCT01961388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292217|NCT01961414|Aflibercept|aflibercept|mesh-list
101292218|NCT01961414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101292219|NCT01961414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101820973|NCT00993876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101820974|NCT00993876|Serotonin Agents|serotonin agents|mesh-ancestor
101820975|NCT00993876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820976|NCT00993876|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101820977|NCT00993876|Antidepressive Agents|antidepressive agents|mesh-ancestor
101820978|NCT00993876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101820979|NCT00993876|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101820980|NCT00993876|Adrenergic Agents|adrenergic agents|mesh-ancestor
101820981|NCT01646814|Aspirin|aspirin|mesh-list
101820982|NCT01646814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101820983|NCT01646814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101292220|NCT01961414|Growth Substances|growth substances|mesh-ancestor
101292221|NCT01961414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292222|NCT01961414|Growth Inhibitors|growth inhibitors|mesh-ancestor
101292223|NCT01961414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101292224|NCT01961453|Isosorbide|isosorbide|mesh-list
101292225|NCT01961453|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
101292226|NCT01961453|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
101292227|NCT01961453|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101292228|NCT01961453|Diuretics|diuretics|mesh-ancestor
101292229|NCT01961453|Natriuretic Agents|natriuretic agents|mesh-ancestor
101292230|NCT01961453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292231|NCT01961453|Vasodilator Agents|vasodilator agents|mesh-ancestor
101292232|NCT01961453|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101292233|NCT01961453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292234|NCT01961635|Cimetidine|cimetidine|mesh-list
101292235|NCT01961635|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101292236|NCT01961635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101292237|NCT01961635|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101292238|NCT01961635|Histamine Antagonists|histamine antagonists|mesh-ancestor
101292239|NCT01961635|Histamine Agents|histamine agents|mesh-ancestor
101292240|NCT01961635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101292241|NCT01961635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292242|NCT01961635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292243|NCT01961635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101292244|NCT01961635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101292245|NCT01961635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101292246|NCT01961739|Lidocaine|lidocaine|mesh-list
101292247|NCT01961739|Anesthetics, Local|anesthetics, local|mesh-ancestor
101292248|NCT01961739|Anesthetics|anesthetics|mesh-ancestor
101292249|NCT01961739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101292250|NCT01961739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292251|NCT01961739|Sensory System Agents|sensory system agents|mesh-ancestor
101292252|NCT01961739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101292253|NCT01961739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101292254|NCT01961739|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101292255|NCT01961739|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101292256|NCT01961739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101292257|NCT01961739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292258|NCT01961752|Triamcinolone|triamcinolone|mesh-list
101292259|NCT01961752|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101292260|NCT01961752|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101292261|NCT01961752|Bupivacaine|bupivacaine|mesh-list
101292262|NCT01961752|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101292263|NCT01961752|Anesthetics, Local|anesthetics, local|mesh-ancestor
101292264|NCT01961752|Anesthetics|anesthetics|mesh-ancestor
101292265|NCT01961752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101292266|NCT01961752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292267|NCT01961752|Sensory System Agents|sensory system agents|mesh-ancestor
101292268|NCT01961752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101292269|NCT01961752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101292270|NCT01961752|Glucocorticoids|glucocorticoids|mesh-ancestor
101292271|NCT01961752|Hormones|hormones|mesh-ancestor
101820984|NCT01646814|Analgesics|analgesics|mesh-ancestor
101820985|NCT01646814|Sensory System Agents|sensory system agents|mesh-ancestor
101820986|NCT01646814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101820987|NCT01646814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101820988|NCT01646814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101820989|NCT01646814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101820990|NCT01646814|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101820991|NCT01646814|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101820992|NCT01646814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292272|NCT01961752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101292273|NCT01961752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101292274|NCT01961752|Immunologic Factors|immunologic factors|mesh-ancestor
101292275|NCT01961752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101292276|NCT01961752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292277|NCT01961830|Arbekacin|arbekacin|mesh-list
101292278|NCT01961830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101292279|NCT01961830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101292280|NCT01961843|Prednisone|prednisone|mesh-list
101292281|NCT01961843|Abiraterone Acetate|abiraterone acetate|mesh-list
101292282|NCT01961843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101292283|NCT01961843|Glucocorticoids|glucocorticoids|mesh-ancestor
101292284|NCT01961843|Hormones|hormones|mesh-ancestor
101292285|NCT01961843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101292286|NCT01961843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292287|NCT01961843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101292288|NCT01961843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101292289|NCT01961843|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101292290|NCT01961843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101292291|NCT01961843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292292|NCT01961843|Hormone Antagonists|hormone antagonists|mesh-ancestor
101292293|NCT01961843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101292294|NCT01961856|Clopidogrel|clopidogrel|mesh-list
101292295|NCT01961856|Ticagrelor|ticagrelor|mesh-list
101292296|NCT01961856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101292297|NCT01961856|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101292298|NCT01961856|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101292299|NCT01961856|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101292300|NCT01961856|Purinergic Agents|purinergic agents|mesh-ancestor
101292301|NCT01961856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101292302|NCT01961856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292303|NCT01961856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292304|NCT01961947|Vaccines|vaccines|mesh-list
101292305|NCT01961947|Immunologic Factors|immunologic factors|mesh-ancestor
101292306|NCT01961947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292307|NCT01962116|Heparin|heparin|mesh-list
101292308|NCT01962116|Calcium heparin|calcium heparin|mesh-list
101292309|NCT01962116|Anticoagulants|anticoagulants|mesh-ancestor
101292310|NCT01962116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292311|NCT01962116|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101292312|NCT01962116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101292313|NCT01962181|Methylphenidate|methylphenidate|mesh-list
101292314|NCT01962181|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101292315|NCT01962181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292316|NCT01962181|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101292317|NCT01962181|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101292318|NCT01962181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101292319|NCT01962181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292321|NCT01962181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101292322|NCT01962285|Propofol|propofol|mesh-list
101292323|NCT01962285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101292324|NCT01962285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101820993|NCT01646814|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101820994|NCT01646814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101820995|NCT01646814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101820997|NCT00994344|Ritonavir|ritonavir|mesh-list
101292325|NCT01962285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292326|NCT01962285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101292327|NCT01962285|Anesthetics, General|anesthetics, general|mesh-ancestor
101292328|NCT01962285|Anesthetics|anesthetics|mesh-ancestor
101292329|NCT01962363|Tocotrienols|tocotrienols|mesh-list
101292330|NCT01962363|Tocotrienol, alpha|tocotrienol, alpha|mesh-list
101292331|NCT01962363|Antioxidants|antioxidants|mesh-ancestor
101292332|NCT01962363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292334|NCT01962363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292335|NCT01962363|Vitamins|vitamins|mesh-ancestor
101292336|NCT01962363|Micronutrients|micronutrients|mesh-ancestor
101292337|NCT01962376|Bevacizumab|bevacizumab|mesh-list
101292338|NCT01962376|Capecitabine|capecitabine|mesh-list
101292339|NCT01962376|Oxaliplatin|oxaliplatin|mesh-list
101292340|NCT01962376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101292341|NCT01962376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101292342|NCT01962376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101292343|NCT01962376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101292344|NCT01962376|Growth Substances|growth substances|mesh-ancestor
101292345|NCT01962376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292346|NCT01962376|Growth Inhibitors|growth inhibitors|mesh-ancestor
101292347|NCT01962376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101292349|NCT01962376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292350|NCT01962454|Methyltestosterone|methyltestosterone|mesh-list
101292351|NCT01962454|Testosterone|testosterone|mesh-list
101292352|NCT01962454|Testosterone undecanoate|testosterone undecanoate|mesh-list
101292353|NCT01962454|Testosterone enanthate|testosterone enanthate|mesh-list
101292354|NCT01962454|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101292355|NCT01962454|Androgens|androgens|mesh-ancestor
101292357|NCT01962454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101292358|NCT01962454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292359|NCT01962454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101292360|NCT01962454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101292361|NCT01962454|Anabolic Agents|anabolic agents|mesh-ancestor
101292362|NCT01962571|Epoetin Alfa|epoetin alfa|mesh-list
101292363|NCT01962571|Hematinics|hematinics|mesh-ancestor
101292364|NCT01962831|Dinoprostone|dinoprostone|mesh-list
101292365|NCT01962831|Oxytocics|oxytocics|mesh-ancestor
101292366|NCT01962831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101292367|NCT01962831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292368|NCT01963039|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
101292369|NCT01963039|Vasodilator Agents|vasodilator agents|mesh-ancestor
101292370|NCT01963039|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101292371|NCT01963039|Protective Agents|protective agents|mesh-ancestor
101292372|NCT01963039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292373|NCT01963182|Irinotecan|irinotecan|mesh-list
101292374|NCT01963182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101292375|NCT01963182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101292376|NCT01963182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101292377|NCT01963182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292378|NCT01963182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101292379|NCT01963221|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101292380|NCT01963221|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101292381|NCT01963221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292382|NCT01963299|Clonidine|clonidine|mesh-list
101292383|NCT01963299|Ropivacaine|ropivacaine|mesh-list
101292384|NCT01963299|Anesthetics, Local|anesthetics, local|mesh-ancestor
101292385|NCT01963299|Anesthetics|anesthetics|mesh-ancestor
101292386|NCT01963299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101292387|NCT01963299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292388|NCT01963299|Sensory System Agents|sensory system agents|mesh-ancestor
101292389|NCT01963299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101292390|NCT01963299|Analgesics|analgesics|mesh-ancestor
101292391|NCT01963299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101292392|NCT01963299|Sympatholytics|sympatholytics|mesh-ancestor
101292393|NCT01963299|Autonomic Agents|autonomic agents|mesh-ancestor
101292394|NCT01963299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101820998|NCT00994344|Lopinavir|lopinavir|mesh-list
101820999|NCT00994344|Darunavir|darunavir|mesh-list
101821000|NCT00994344|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101821001|NCT00994344|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101821002|NCT00994344|Protease Inhibitors|protease inhibitors|mesh-ancestor
101821003|NCT00994344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101821004|NCT00994344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821005|NCT00994344|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101821006|NCT00994344|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101821007|NCT00994344|Antiviral Agents|antiviral agents|mesh-ancestor
101292395|NCT01963299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101292396|NCT01963299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101292397|NCT01963299|Adrenergic Agents|adrenergic agents|mesh-ancestor
101292398|NCT01963299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101292399|NCT01963299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292400|NCT01963325|Paclitaxel|paclitaxel|mesh-list
101292401|NCT01963325|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101292402|NCT01963325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101292403|NCT01963325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101292404|NCT01963325|Tubulin Modulators|tubulin modulators|mesh-ancestor
101292405|NCT01963325|Antimitotic Agents|antimitotic agents|mesh-ancestor
101292406|NCT01963325|Mitosis Modulators|mitosis modulators|mesh-ancestor
101292407|NCT01963325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292408|NCT01963390|Testosterone|testosterone|mesh-list
101292409|NCT01963390|Androgens|androgens|mesh-ancestor
101292410|NCT01963390|Hormones|hormones|mesh-ancestor
101292411|NCT01963390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101292412|NCT01963390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292413|NCT01963416|Micronutrients|micronutrients|mesh-list
101292414|NCT01963416|Trace Elements|trace elements|mesh-list
101292415|NCT01963416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292416|NCT01963442|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101292419|NCT01963442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101292420|NCT01963442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101292421|NCT01963442|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101292422|NCT01963442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101292423|NCT01963442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292424|NCT01963546|Dexmedetomidine|dexmedetomidine|mesh-list
101316662|NCT00391144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101292425|NCT01963546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101292426|NCT01963546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292427|NCT01963546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101292428|NCT01963546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101292429|NCT01963546|Analgesics|analgesics|mesh-ancestor
101292430|NCT01963546|Sensory System Agents|sensory system agents|mesh-ancestor
101292431|NCT01963546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101292432|NCT01963546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101292433|NCT01963546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101292434|NCT01963546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101292435|NCT01963546|Adrenergic Agents|adrenergic agents|mesh-ancestor
101292436|NCT01963546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101292437|NCT01963546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292439|NCT01963559|Prilocaine|prilocaine|mesh-list
101292440|NCT01963559|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
101292441|NCT01963559|Anesthetics, Local|anesthetics, local|mesh-ancestor
101292442|NCT01963559|Anesthetics|anesthetics|mesh-ancestor
101292443|NCT01963559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101292444|NCT01963559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292445|NCT01963559|Sensory System Agents|sensory system agents|mesh-ancestor
101292446|NCT01963559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101292447|NCT01963559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101292448|NCT01963559|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101292449|NCT01963559|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101292450|NCT01963559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101821008|NCT00994344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101821009|NCT00994344|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101292451|NCT01963559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292452|NCT01963559|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
101292453|NCT01963663|Metformin|metformin|mesh-list
101292454|NCT01963663|Pioglitazone|pioglitazone|mesh-list
101292455|NCT01963663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101292456|NCT01963663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292457|NCT01963702|Capecitabine|capecitabine|mesh-list
101292458|NCT01963702|Oxaliplatin|oxaliplatin|mesh-list
101292459|NCT01963702|Docetaxel|docetaxel|mesh-list
101292460|NCT01963702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101292461|NCT01963702|Antimetabolites|antimetabolites|mesh-ancestor
101292462|NCT01963702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292463|NCT01963702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101292464|NCT01963702|Tubulin Modulators|tubulin modulators|mesh-ancestor
101292465|NCT01963702|Antimitotic Agents|antimitotic agents|mesh-ancestor
101292466|NCT01963702|Mitosis Modulators|mitosis modulators|mesh-ancestor
101292467|NCT01963741|Histamine|histamine|mesh-list
101292468|NCT01963741|Histamine Agonists|histamine agonists|mesh-ancestor
101292469|NCT01963741|Histamine Agents|histamine agents|mesh-ancestor
101292470|NCT01963741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101292471|NCT01963741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292472|NCT01963741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292473|NCT01963754|Epinephrine|epinephrine|mesh-list
101292474|NCT01963754|Racepinephrine|racepinephrine|mesh-list
101292475|NCT01963754|Anesthetics|anesthetics|mesh-list
101292476|NCT01963754|Carticaine|carticaine|mesh-list
101292477|NCT01963754|Epinephryl borate|epinephryl borate|mesh-list
101292478|NCT01963754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101292480|NCT01963754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101292482|NCT01963754|Adrenergic Agents|adrenergic agents|mesh-ancestor
101292483|NCT01963754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101292484|NCT01963754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292486|NCT01963754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101292487|NCT01963754|Autonomic Agents|autonomic agents|mesh-ancestor
101292488|NCT01963754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101292489|NCT01963754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101292490|NCT01963754|Respiratory System Agents|respiratory system agents|mesh-ancestor
101292491|NCT01963754|Mydriatics|mydriatics|mesh-ancestor
101292492|NCT01963754|Sympathomimetics|sympathomimetics|mesh-ancestor
101292493|NCT01963754|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101292494|NCT01963754|Anesthetics, Local|anesthetics, local|mesh-ancestor
101292495|NCT01963754|Sensory System Agents|sensory system agents|mesh-ancestor
101292496|NCT01963832|Fluoxetine|fluoxetine|mesh-list
101292497|NCT01963832|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101292498|NCT01963832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101292499|NCT01963832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101292500|NCT01963832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292501|NCT01963832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101292502|NCT01963832|Serotonin Agents|serotonin agents|mesh-ancestor
101292503|NCT01963832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292504|NCT01963832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101292505|NCT01963832|Antidepressive Agents|antidepressive agents|mesh-ancestor
101292506|NCT01963832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101292507|NCT01963832|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101292508|NCT01963832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101292509|NCT01963832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101292510|NCT01963910|Mannitol|mannitol|mesh-list
101292511|NCT01963910|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101292512|NCT01963910|Diuretics|diuretics|mesh-ancestor
101292513|NCT01963910|Natriuretic Agents|natriuretic agents|mesh-ancestor
101292514|NCT01963910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292516|NCT01963962|Levonorgestrel|levonorgestrel|mesh-list
101292517|NCT01963962|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101292518|NCT01963962|Contraceptive Agents|contraceptive agents|mesh-ancestor
101292519|NCT01963962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101292520|NCT01963962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292521|NCT01963962|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101292522|NCT01963962|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101821010|NCT00994344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101821011|NCT00994500|Bortezomib|bortezomib|mesh-list
101821012|NCT00994500|Vorinostat|vorinostat|mesh-list
101821013|NCT00994500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821014|NCT00994500|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101821015|NCT00994500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101821016|NCT00994500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292523|NCT01963962|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101292524|NCT01963962|Trace Elements|trace elements|mesh-ancestor
101292525|NCT01963962|Micronutrients|micronutrients|mesh-ancestor
101292526|NCT01964001|Vitamins|vitamins|mesh-list
101292527|NCT01964001|Coenzyme Q10|coenzyme q10|mesh-list
101292528|NCT01964001|Vitamin B 6|vitamin b 6|mesh-list
101292529|NCT01964001|Pyridoxal|pyridoxal|mesh-list
101292530|NCT01964001|Pyridoxine|pyridoxine|mesh-list
101292531|NCT01964001|Vitamin B Complex|vitamin b complex|mesh-list
101292532|NCT01964001|Ubiquinone|ubiquinone|mesh-list
101292533|NCT01964001|Micronutrients|micronutrients|mesh-ancestor
101292534|NCT01964001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292535|NCT01964027|Irinotecan|irinotecan|mesh-list
101292536|NCT01964027|Epirubicin|epirubicin|mesh-list
101292537|NCT01964027|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101292538|NCT01964027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101292539|NCT01964027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101292540|NCT01964027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292541|NCT01964027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101292542|NCT01964027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101292543|NCT01964027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101292544|NCT01964040|Dexmedetomidine|dexmedetomidine|mesh-list
101292545|NCT01964040|Bupivacaine|bupivacaine|mesh-list
101292546|NCT01964040|Anesthetics, Local|anesthetics, local|mesh-ancestor
101292548|NCT01964040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101292549|NCT01964040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292550|NCT01964040|Sensory System Agents|sensory system agents|mesh-ancestor
101292551|NCT01964040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101292554|NCT01964040|Analgesics|analgesics|mesh-ancestor
101292555|NCT01964040|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101292556|NCT01964040|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101292557|NCT01964040|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101292558|NCT01964040|Adrenergic Agents|adrenergic agents|mesh-ancestor
101292559|NCT01964040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101292560|NCT01964040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292561|NCT01964079|Losartan|losartan|mesh-list
101292562|NCT01964079|Amlodipine|amlodipine|mesh-list
101292563|NCT01964079|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101292564|NCT01964079|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101292565|NCT01964079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101292566|NCT01964079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292567|NCT01964079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101292568|NCT01964079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292569|NCT01964079|Vasodilator Agents|vasodilator agents|mesh-ancestor
101292570|NCT01964079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101292571|NCT01964079|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101292572|NCT01964079|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101292573|NCT01964157|Ceritinib|ceritinib|mesh-list
101292574|NCT01964157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101292575|NCT01964157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101292576|NCT01964157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101292577|NCT01964157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292578|NCT01964170|Goserelin|goserelin|mesh-list
101292579|NCT01964170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101292580|NCT01964170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101292581|NCT01964183|Mirabegron|mirabegron|mesh-list
101292582|NCT01964183|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101292583|NCT01964183|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101292584|NCT01964183|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101292585|NCT01964183|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101292586|NCT01964183|Adrenergic Agents|adrenergic agents|mesh-ancestor
101292587|NCT01964183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101821018|NCT01416636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101821019|NCT00999180|Botulinum Toxins|botulinum toxins|mesh-list
101821020|NCT00999180|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101821021|NCT00999180|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101821022|NCT00999180|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101821023|NCT00999180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101821024|NCT00999180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292588|NCT01964183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292589|NCT01964183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292590|NCT01964183|Urological Agents|urological agents|mesh-ancestor
101292591|NCT01964183|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101292592|NCT01964183|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101292593|NCT01964183|Cholinergic Agents|cholinergic agents|mesh-ancestor
101292594|NCT01964248|Lidocaine|lidocaine|mesh-list
101292595|NCT01964248|Prilocaine|prilocaine|mesh-list
101292596|NCT01964248|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
101292597|NCT01964248|Anesthetics, Local|anesthetics, local|mesh-ancestor
101292598|NCT01964248|Anesthetics|anesthetics|mesh-ancestor
101292599|NCT01964248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101292600|NCT01964248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292601|NCT01964248|Sensory System Agents|sensory system agents|mesh-ancestor
101292602|NCT01964248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101292603|NCT01964248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101292604|NCT01964248|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101292605|NCT01964248|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101292606|NCT01964248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101292607|NCT01964248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292608|NCT01964248|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
101292609|NCT01964287|Leucovorin|leucovorin|mesh-list
101292610|NCT01964287|Paclitaxel|paclitaxel|mesh-list
101292611|NCT01964287|Gemcitabine|gemcitabine|mesh-list
101292612|NCT01964287|Oxaliplatin|oxaliplatin|mesh-list
101292613|NCT01964287|Irinotecan|irinotecan|mesh-list
101292614|NCT01964287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101292615|NCT01964287|Folfirinox|folfirinox|mesh-list
101292616|NCT01964287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101292619|NCT01964287|Antimitotic Agents|antimitotic agents|mesh-ancestor
101292620|NCT01964287|Mitosis Modulators|mitosis modulators|mesh-ancestor
101292621|NCT01964287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292622|NCT01964287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101292624|NCT01964287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101292625|NCT01964287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101292626|NCT01964287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101292627|NCT01964287|Antidotes|antidotes|mesh-ancestor
101292628|NCT01964287|Protective Agents|protective agents|mesh-ancestor
101292629|NCT01964287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292630|NCT01964287|Vitamin B Complex|vitamin b complex|mesh-ancestor
101292631|NCT01964287|Vitamins|vitamins|mesh-ancestor
101292632|NCT01964287|Micronutrients|micronutrients|mesh-ancestor
101292633|NCT01964365|Fenofibric acid|fenofibric acid|mesh-list
101292634|NCT01964365|Fenofibrate|fenofibrate|mesh-list
101292635|NCT01964365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101292636|NCT01964365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101292637|NCT01964365|Antimetabolites|antimetabolites|mesh-ancestor
101292638|NCT01964365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292639|NCT01964365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101292640|NCT01964391|Paclitaxel|paclitaxel|mesh-list
101292641|NCT01964391|Docetaxel|docetaxel|mesh-list
101292642|NCT01964391|Cyclophosphamide|cyclophosphamide|mesh-list
101292643|NCT01964391|Carboplatin|carboplatin|mesh-list
101292644|NCT01964391|Doxorubicin|doxorubicin|mesh-list
101292645|NCT01964391|Trastuzumab|trastuzumab|mesh-list
101292646|NCT01964391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101292647|NCT01964391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101292648|NCT01964391|Tubulin Modulators|tubulin modulators|mesh-ancestor
101292649|NCT01964391|Antimitotic Agents|antimitotic agents|mesh-ancestor
101292650|NCT01964391|Mitosis Modulators|mitosis modulators|mesh-ancestor
101821025|NCT00999180|Cholinergic Agents|cholinergic agents|mesh-ancestor
101821026|NCT00999180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101821027|NCT00999180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821028|NCT00999180|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101821029|NCT00999180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101821030|NCT00999258|Sirolimus|sirolimus|mesh-list
101821031|NCT00999258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101821032|NCT00999258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101821033|NCT00999258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101821034|NCT00999258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101292651|NCT01964391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292652|NCT01964391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101292653|NCT01964391|Immunologic Factors|immunologic factors|mesh-ancestor
101292654|NCT01964391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292655|NCT01964391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101292656|NCT01964391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101292657|NCT01964391|Alkylating Agents|alkylating agents|mesh-ancestor
101292658|NCT01964391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101292659|NCT01964391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101292660|NCT01964391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101292661|NCT01964391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101292662|NCT01964391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101292663|NCT01964391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101292664|NCT01964404|Dronabinol|dronabinol|mesh-list
101292665|NCT01964404|Hallucinogens|hallucinogens|mesh-ancestor
101292666|NCT01964404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292667|NCT01964404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101292668|NCT01964404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101292669|NCT01964404|Analgesics|analgesics|mesh-ancestor
101292670|NCT01964404|Sensory System Agents|sensory system agents|mesh-ancestor
101292671|NCT01964404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101292672|NCT01964404|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101292673|NCT01964404|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101292674|NCT01964404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101292675|NCT01964404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292676|NCT01964404|Hormones|hormones|mesh-ancestor
101292677|NCT01964404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101292678|NCT01964534|Gemcitabine|gemcitabine|mesh-list
101292679|NCT01964534|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101292680|NCT01964534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101292682|NCT01964534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292683|NCT01964534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101292684|NCT01964573|Rotigotine|rotigotine|mesh-list
101292685|NCT01964573|Dopamine Agonists|dopamine agonists|mesh-ancestor
101292686|NCT01964573|Dopamine Agents|dopamine agents|mesh-ancestor
101292687|NCT01964573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101292688|NCT01964573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292689|NCT01964573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292690|NCT01964586|Lidocaine|lidocaine|mesh-list
101292691|NCT01964586|Epinephrine|epinephrine|mesh-list
101292692|NCT01964586|Racepinephrine|racepinephrine|mesh-list
101292693|NCT01964586|Dexmedetomidine|dexmedetomidine|mesh-list
101292694|NCT01964586|Epinephryl borate|epinephryl borate|mesh-list
101292695|NCT01964586|Anesthetics, Local|anesthetics, local|mesh-ancestor
101292696|NCT01964586|Anesthetics|anesthetics|mesh-ancestor
101292697|NCT01964586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101292698|NCT01964586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292699|NCT01964586|Sensory System Agents|sensory system agents|mesh-ancestor
101292700|NCT01964586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101292701|NCT01964586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101292702|NCT01964586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101292703|NCT01964586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101821035|NCT00999258|Antifungal Agents|antifungal agents|mesh-ancestor
101821036|NCT00999258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101821037|NCT00999258|Immunologic Factors|immunologic factors|mesh-ancestor
101821038|NCT00999258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821039|NCT00994734|Mifepristone|mifepristone|mesh-list
101821040|NCT00994734|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101821041|NCT00994734|Abortifacient Agents|abortifacient agents|mesh-ancestor
101821042|NCT00994734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101821043|NCT00994734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821044|NCT00994734|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101821045|NCT00994734|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101292704|NCT01964586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101292705|NCT01964586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292706|NCT01964586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101292707|NCT01964586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101292708|NCT01964586|Analgesics|analgesics|mesh-ancestor
101292709|NCT01964586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101292710|NCT01964586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101292711|NCT01964586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101292712|NCT01964586|Adrenergic Agents|adrenergic agents|mesh-ancestor
101292713|NCT01964586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101292714|NCT01964586|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101292715|NCT01964586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101292716|NCT01964586|Autonomic Agents|autonomic agents|mesh-ancestor
101292717|NCT01964586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101292718|NCT01964586|Respiratory System Agents|respiratory system agents|mesh-ancestor
101292719|NCT01964586|Mydriatics|mydriatics|mesh-ancestor
101292720|NCT01964586|Sympathomimetics|sympathomimetics|mesh-ancestor
101292721|NCT01964586|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101292722|NCT01964651|JNJ-42165279|jnj-42165279|mesh-list
101292723|NCT01964651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101292724|NCT01964651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292725|NCT01964781|Epinephrine|epinephrine|mesh-list
101292726|NCT01964781|Racepinephrine|racepinephrine|mesh-list
101292727|NCT01964781|Bupivacaine|bupivacaine|mesh-list
101292728|NCT01964781|Tranexamic Acid|tranexamic acid|mesh-list
101292729|NCT01964781|Epinephryl borate|epinephryl borate|mesh-list
101292730|NCT01964781|Anesthetics, Local|anesthetics, local|mesh-ancestor
101292731|NCT01964781|Anesthetics|anesthetics|mesh-ancestor
101292732|NCT01964781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101292733|NCT01964781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292734|NCT01964781|Sensory System Agents|sensory system agents|mesh-ancestor
101292735|NCT01964781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101292736|NCT01964781|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101292737|NCT01964781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101292738|NCT01964781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292739|NCT01964781|Hemostatics|hemostatics|mesh-ancestor
101292740|NCT01964781|Coagulants|coagulants|mesh-ancestor
101292743|NCT01964781|Adrenergic Agents|adrenergic agents|mesh-ancestor
101292744|NCT01964781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101292745|NCT01964781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101292746|NCT01964781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101292747|NCT01964781|Autonomic Agents|autonomic agents|mesh-ancestor
101292748|NCT01964781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101292749|NCT01964781|Respiratory System Agents|respiratory system agents|mesh-ancestor
101292750|NCT01964781|Mydriatics|mydriatics|mesh-ancestor
101292751|NCT01964781|Sympathomimetics|sympathomimetics|mesh-ancestor
101292752|NCT01964781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101292753|NCT01964846|Curcumin|curcumin|mesh-list
101292754|NCT01964846|Resveratrol|resveratrol|mesh-list
101292755|NCT01964846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101292756|NCT01964846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101292757|NCT01964846|Analgesics|analgesics|mesh-ancestor
101292758|NCT01964846|Sensory System Agents|sensory system agents|mesh-ancestor
101292759|NCT01964846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101821046|NCT00994734|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101821048|NCT00994734|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101821049|NCT00994734|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101821050|NCT00994734|Hormone Antagonists|hormone antagonists|mesh-ancestor
101246514|NCT01666431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292760|NCT01964846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292761|NCT01964846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101292762|NCT01964846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101292763|NCT01964846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101292764|NCT01964846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101292765|NCT01964846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292766|NCT01964846|Antioxidants|antioxidants|mesh-ancestor
101292767|NCT01964846|Protective Agents|protective agents|mesh-ancestor
101292768|NCT01964846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101292769|NCT01964911|Ropivacaine|ropivacaine|mesh-list
101292770|NCT01964911|Anesthetics, Local|anesthetics, local|mesh-ancestor
101292771|NCT01964911|Anesthetics|anesthetics|mesh-ancestor
101292772|NCT01964911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101292773|NCT01964911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292774|NCT01964911|Sensory System Agents|sensory system agents|mesh-ancestor
101292775|NCT01964911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101292777|NCT01965041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101292778|NCT01965041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101292780|NCT01965041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292781|NCT01965041|Growth Inhibitors|growth inhibitors|mesh-ancestor
101292782|NCT01965041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101292783|NCT01965080|Exemestane|exemestane|mesh-list
101292784|NCT01965080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101292785|NCT01965080|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101292786|NCT01965080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101292787|NCT01965080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101292788|NCT01965080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292789|NCT01965080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101292790|NCT01965080|Hormone Antagonists|hormone antagonists|mesh-ancestor
101292791|NCT01965080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101292792|NCT01965080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292793|NCT01965275|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101292794|NCT01965275|Gefitinib|gefitinib|mesh-list
101292795|NCT01965275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101292796|NCT01965275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101292797|NCT01965275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101292798|NCT01965275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292799|NCT01965301|Diphenhydramine|diphenhydramine|mesh-list
101292800|NCT01965301|Promethazine|promethazine|mesh-list
101292801|NCT01965301|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101292802|NCT01965301|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101292803|NCT01965301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101292804|NCT01965301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292805|NCT01965301|Anesthetics, Local|anesthetics, local|mesh-ancestor
101292806|NCT01965301|Anesthetics|anesthetics|mesh-ancestor
101292807|NCT01965301|Sensory System Agents|sensory system agents|mesh-ancestor
101292808|NCT01965301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101292809|NCT01965301|Antiemetics|antiemetics|mesh-ancestor
101292810|NCT01965301|Autonomic Agents|autonomic agents|mesh-ancestor
101292811|NCT01965301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101292812|NCT01965301|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101292813|NCT01965301|Histamine Antagonists|histamine antagonists|mesh-ancestor
101292814|NCT01965301|Histamine Agents|histamine agents|mesh-ancestor
101292815|NCT01965301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101292816|NCT01965301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292817|NCT01965301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101292818|NCT01965301|Antipruritics|antipruritics|mesh-ancestor
101292819|NCT01965301|Dermatologic Agents|dermatologic agents|mesh-ancestor
101292820|NCT01965353|Dexamethasone|dexamethasone|mesh-list
101292821|NCT01965353|Lenalidomide|lenalidomide|mesh-list
101292822|NCT01965353|Bortezomib|bortezomib|mesh-list
101292823|NCT01965353|Panobinostat|panobinostat|mesh-list
101821051|NCT00994734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101821052|NCT00994734|Luteolytic Agents|luteolytic agents|mesh-ancestor
101821053|NCT00994734|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101821054|NCT00994734|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101821055|NCT00995826|Laninamivir|laninamivir|mesh-list
101821056|NCT00995826|Antiviral Agents|antiviral agents|mesh-ancestor
101821057|NCT00995826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101821058|NCT00994812|Metformin|metformin|mesh-list
101821059|NCT00994812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101821060|NCT00994812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535081|NCT00572819|Oxytocics|oxytocics|mesh-ancestor
101292824|NCT01965353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101292825|NCT01965353|Antiemetics|antiemetics|mesh-ancestor
101292826|NCT01965353|Autonomic Agents|autonomic agents|mesh-ancestor
101292827|NCT01965353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101292828|NCT01965353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292829|NCT01965353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101292830|NCT01965353|Glucocorticoids|glucocorticoids|mesh-ancestor
101292831|NCT01965353|Hormones|hormones|mesh-ancestor
101292832|NCT01965353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101292833|NCT01965353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101292834|NCT01965353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101292835|NCT01965353|Immunologic Factors|immunologic factors|mesh-ancestor
101292836|NCT01965353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101292837|NCT01965353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101292838|NCT01965353|Growth Substances|growth substances|mesh-ancestor
101292839|NCT01965353|Growth Inhibitors|growth inhibitors|mesh-ancestor
101292840|NCT01965353|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101292841|NCT01965353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101292842|NCT01965353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292843|NCT01965522|Vitamin D|vitamin d|mesh-list
101292844|NCT01965522|Ergocalciferols|ergocalciferols|mesh-list
101292845|NCT01965522|Cholecalciferol|cholecalciferol|mesh-list
101292846|NCT01965522|Vitamins|vitamins|mesh-list
101292847|NCT01965522|Melatonin|melatonin|mesh-list
101292848|NCT01965522|Micronutrients|micronutrients|mesh-ancestor
101292849|NCT01965522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292850|NCT01965522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101292851|NCT01965522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101292852|NCT01965522|Antioxidants|antioxidants|mesh-ancestor
101292853|NCT01965522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292854|NCT01965522|Protective Agents|protective agents|mesh-ancestor
101292855|NCT01965522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101292856|NCT01965587|Levonorgestrel|levonorgestrel|mesh-list
101292857|NCT01965587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101292858|NCT01965587|Contraceptive Agents|contraceptive agents|mesh-ancestor
101292859|NCT01965587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101292860|NCT01965587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292861|NCT01965587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101292862|NCT01965587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101292863|NCT01965587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101292864|NCT01965626|Oseltamivir|oseltamivir|mesh-list
101292865|NCT01965626|Dexamethasone|dexamethasone|mesh-list
101292866|NCT01965626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101292867|NCT01965626|Antiemetics|antiemetics|mesh-ancestor
101292868|NCT01965626|Autonomic Agents|autonomic agents|mesh-ancestor
101292869|NCT01965626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101292870|NCT01965626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292871|NCT01965626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101292872|NCT01965626|Glucocorticoids|glucocorticoids|mesh-ancestor
101292873|NCT01965626|Hormones|hormones|mesh-ancestor
101292874|NCT01965626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101292875|NCT01965626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101292876|NCT01965626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821062|NCT00994968|Docetaxel|docetaxel|mesh-list
101821063|NCT00994968|Doxorubicin|doxorubicin|mesh-list
101821064|NCT00994968|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101821065|NCT00994968|Tegafur|tegafur|mesh-list
101821066|NCT00994968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101821067|NCT00994968|Immunologic Factors|immunologic factors|mesh-ancestor
101821068|NCT00994968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821069|NCT00994968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101821070|NCT00994968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101821071|NCT00994968|Alkylating Agents|alkylating agents|mesh-ancestor
101821072|NCT00994968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821073|NCT00994968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821074|NCT00994968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101821075|NCT00994968|Tubulin Modulators|tubulin modulators|mesh-ancestor
101821076|NCT00994968|Antimitotic Agents|antimitotic agents|mesh-ancestor
101292877|NCT01965626|Antiviral Agents|antiviral agents|mesh-ancestor
101292878|NCT01965626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101292879|NCT01965626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101292880|NCT01965626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292881|NCT01965730|Aminocaproic Acid|aminocaproic acid|mesh-list
101292882|NCT01965730|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101292883|NCT01965730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101292884|NCT01965730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292885|NCT01965730|Hemostatics|hemostatics|mesh-ancestor
101292886|NCT01965730|Coagulants|coagulants|mesh-ancestor
101292888|NCT01965405|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101292889|NCT01965405|Antidepressive Agents|antidepressive agents|mesh-ancestor
101292890|NCT01965405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101292891|NCT01965405|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101292892|NCT01965405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101292893|NCT01965405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101292894|NCT01965405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292895|NCT01965405|Dopamine Agents|dopamine agents|mesh-ancestor
101292896|NCT01965405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101292897|NCT01965405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292898|NCT01965405|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101292899|NCT01965405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101292900|NCT01965405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101292901|NCT01965925|Modafinil|modafinil|mesh-list
101292902|NCT01965925|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101292903|NCT01965925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292904|NCT01965925|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101292905|NCT01965925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101292906|NCT01965925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101292907|NCT01965925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292908|NCT01965977|Bortezomib|bortezomib|mesh-list
101292909|NCT01965977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101292910|NCT01966055|Solithromycin|solithromycin|mesh-list
101292911|NCT01966055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101292912|NCT01966055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101292913|NCT01966133|Doxorubicin|doxorubicin|mesh-list
101292914|NCT01966133|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101292915|NCT01966133|Ethiodized Oil|ethiodized oil|mesh-list
101292916|NCT01966133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101292917|NCT01966133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101292918|NCT01966133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101292919|NCT01966133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101292920|NCT01966133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101821077|NCT00994968|Mitosis Modulators|mitosis modulators|mesh-ancestor
101821078|NCT00994968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101821079|NCT00994968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101821080|NCT00994968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101821081|NCT00994968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101821082|NCT00994968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101821083|NCT00994968|Antimetabolites|antimetabolites|mesh-ancestor
101821084|NCT03887442|Paclitaxel|paclitaxel|mesh-list
101821085|NCT03887442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101821086|NCT03887442|Cetuximab|cetuximab|mesh-list
101246515|NCT01666522|Vitamin D|vitamin d|mesh-list
101292921|NCT01966133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292922|NCT01966172|Acetaminophen|acetaminophen|mesh-list
101292923|NCT01966172|Ibuprofen|ibuprofen|mesh-list
101292924|NCT01966172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101292925|NCT01966172|Morphine|morphine|mesh-list
101292926|NCT01966172|Gabapentin|gabapentin|mesh-list
101292927|NCT01966172|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101292928|NCT01966172|Narcotics|narcotics|mesh-ancestor
101292929|NCT01966172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101292930|NCT01966172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292931|NCT01966172|Analgesics|analgesics|mesh-ancestor
101292932|NCT01966172|Sensory System Agents|sensory system agents|mesh-ancestor
101292933|NCT01966172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101292934|NCT01966172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101292935|NCT01966172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101292936|NCT01966172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101292937|NCT01966172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101292938|NCT01966172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101292939|NCT01966172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292940|NCT01966172|Antipyretics|antipyretics|mesh-ancestor
101292941|NCT01966172|Anticonvulsants|anticonvulsants|mesh-ancestor
101292942|NCT01966172|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101292943|NCT01966172|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101292944|NCT01966172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101292945|NCT01966172|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101292946|NCT01966172|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101292947|NCT01966172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101292948|NCT01966172|Antimanic Agents|antimanic agents|mesh-ancestor
101292949|NCT01966276|Methylphenidate|methylphenidate|mesh-list
101292950|NCT01966276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101292951|NCT01966276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292952|NCT01966276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101292953|NCT01966276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101292954|NCT01966276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101292955|NCT01966276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292956|NCT01966276|Dopamine Agents|dopamine agents|mesh-ancestor
101292957|NCT01966276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101292958|NCT01966289|Cyclophosphamide|cyclophosphamide|mesh-list
101292959|NCT01966289|Guadecitabine|guadecitabine|mesh-list
101292960|NCT01966289|Immunologic Factors|immunologic factors|mesh-ancestor
101292961|NCT01966289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292962|NCT01966289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101292963|NCT01966289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101292964|NCT01966289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101292965|NCT01966289|Alkylating Agents|alkylating agents|mesh-ancestor
101292966|NCT01966289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292967|NCT01966289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101292968|NCT01966289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101292969|NCT01966302|Beraprost|beraprost|mesh-list
101292970|NCT01966302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101292971|NCT01966302|Vasodilator Agents|vasodilator agents|mesh-ancestor
101292972|NCT01966341|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101292973|NCT01966341|Laxatives|laxatives|mesh-list
101292974|NCT01966341|Parasympatholytics|parasympatholytics|mesh-list
101292975|NCT01966341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101821087|NCT03887442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101821088|NCT03887442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821089|NCT03887442|Tubulin Modulators|tubulin modulators|mesh-ancestor
101821090|NCT03887442|Antimitotic Agents|antimitotic agents|mesh-ancestor
101821091|NCT03887442|Mitosis Modulators|mitosis modulators|mesh-ancestor
101821092|NCT03887442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821093|NCT03887442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101292976|NCT01966341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101292977|NCT01966341|Autonomic Agents|autonomic agents|mesh-ancestor
101292978|NCT01966341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101292979|NCT01966341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292980|NCT01966484|Succinylcholine|succinylcholine|mesh-list
101292981|NCT01966484|Mivacurium|mivacurium|mesh-list
101292982|NCT01966484|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
101292983|NCT01966484|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101292984|NCT01966484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101292985|NCT01966484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101292986|NCT01966484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292987|NCT01966484|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101292988|NCT01966575|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101292989|NCT01966575|Medroxyprogesterone|medroxyprogesterone|mesh-list
101292990|NCT01966575|Progestins|progestins|mesh-list
101292991|NCT01966575|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101292992|NCT01966575|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101292993|NCT01966575|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101292994|NCT01966575|Contraceptive Agents|contraceptive agents|mesh-ancestor
101292996|NCT01966575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292997|NCT01966575|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101292998|NCT01966575|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101293000|NCT01966575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101293001|NCT01966575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101293002|NCT01966575|Hormones|hormones|mesh-ancestor
101293003|NCT01966575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101293004|NCT01966627|Liver Extracts|liver extracts|mesh-list
101293005|NCT01966627|Hematinics|hematinics|mesh-ancestor
101293006|NCT01966653|Fosfomycin|fosfomycin|mesh-list
101293007|NCT01966653|Nitrofurantoin|nitrofurantoin|mesh-list
101293008|NCT01966653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101293009|NCT01966653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316793|NCT00005834|Glucocorticoids|glucocorticoids|mesh-ancestor
101293010|NCT01966653|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101293011|NCT01966692|Fluticasone|fluticasone|mesh-list
101293012|NCT01966692|Xhance|xhance|mesh-list
101293013|NCT01966692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101293014|NCT01966692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101293015|NCT01966692|Autonomic Agents|autonomic agents|mesh-ancestor
101293016|NCT01966692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101293017|NCT01966692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293018|NCT01966692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101293019|NCT01966692|Respiratory System Agents|respiratory system agents|mesh-ancestor
101293020|NCT01966692|Dermatologic Agents|dermatologic agents|mesh-ancestor
101293021|NCT01966692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101293022|NCT01966783|Budesonide|budesonide|mesh-list
101293023|NCT01966783|Mesalamine|mesalamine|mesh-list
101293024|NCT01966783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101293025|NCT01966783|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101293026|NCT01966783|Autonomic Agents|autonomic agents|mesh-ancestor
101293027|NCT01966783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101293028|NCT01966783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293029|NCT01966783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101293030|NCT01966783|Respiratory System Agents|respiratory system agents|mesh-ancestor
101293031|NCT01966783|Glucocorticoids|glucocorticoids|mesh-ancestor
101293032|NCT01966783|Hormones|hormones|mesh-ancestor
101293033|NCT01966783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101293034|NCT01966783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101821094|NCT00996060|Hydralazine|hydralazine|mesh-list
101821095|NCT00996060|Valproic Acid|valproic acid|mesh-list
101821096|NCT00996060|Anticonvulsants|anticonvulsants|mesh-ancestor
101821097|NCT00996060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101821098|NCT00996060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821099|NCT00996060|GABA Agents|gaba agents|mesh-ancestor
101821100|NCT00996060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101293035|NCT01966783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101293036|NCT01966783|Analgesics|analgesics|mesh-ancestor
101293037|NCT01966783|Sensory System Agents|sensory system agents|mesh-ancestor
101293038|NCT01966783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101293039|NCT01966822|Ritonavir|ritonavir|mesh-list
101293040|NCT01966822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
101293041|NCT01966822|Dolutegravir|dolutegravir|mesh-list
101293042|NCT01966822|Protease Inhibitors|protease inhibitors|mesh-list
101293043|NCT01966822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101293044|NCT01966822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101293045|NCT01966822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293046|NCT01966822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101293047|NCT01966822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101293048|NCT01966822|Antiviral Agents|antiviral agents|mesh-ancestor
101293050|NCT01966822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101293051|NCT01966822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101293052|NCT01966822|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101293053|NCT01966822|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101293054|NCT01966913|Bevacizumab|bevacizumab|mesh-list
101293055|NCT01966913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101293056|NCT01966913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101293057|NCT01966913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101293058|NCT01966913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101293059|NCT01966913|Growth Substances|growth substances|mesh-ancestor
101293060|NCT01966913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293061|NCT01966913|Growth Inhibitors|growth inhibitors|mesh-ancestor
101293063|NCT01967017|Anesthetics, Local|anesthetics, local|mesh-ancestor
101293064|NCT01967017|Anesthetics|anesthetics|mesh-ancestor
101293065|NCT01967017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101293066|NCT01967017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316837|NCT00005840|Paclitaxel|paclitaxel|mesh-list
101293067|NCT01967017|Sensory System Agents|sensory system agents|mesh-ancestor
101293068|NCT01967017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101293069|NCT01967017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101293070|NCT01967017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101293071|NCT01967017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101293072|NCT01967017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101293073|NCT01967017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293075|NCT01967095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101293076|NCT01967095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101293077|NCT01967095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101293078|NCT01967095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293079|NCT01967199|Paclitaxel|paclitaxel|mesh-list
101293080|NCT01967199|Everolimus|everolimus|mesh-list
101293081|NCT01967199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101293082|NCT01967199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101293083|NCT01967199|Tubulin Modulators|tubulin modulators|mesh-ancestor
101293084|NCT01967199|Antimitotic Agents|antimitotic agents|mesh-ancestor
101293085|NCT01967199|Mitosis Modulators|mitosis modulators|mesh-ancestor
101293086|NCT01967199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293087|NCT01967199|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101293090|NCT01967199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101293091|NCT01967199|Immunologic Factors|immunologic factors|mesh-ancestor
101293092|NCT01967199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293093|NCT01967251|Udenafil|udenafil|mesh-list
101293094|NCT01967251|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101293095|NCT01967251|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101293096|NCT01967251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101293097|NCT01967251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293098|NCT01967264|Udenafil|udenafil|mesh-list
101293099|NCT01967264|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101821101|NCT00996060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821102|NCT00996060|Antimanic Agents|antimanic agents|mesh-ancestor
101821103|NCT00996060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101821104|NCT00996060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101478395|NCT00417053|Melphalan|melphalan|mesh-list
101821105|NCT00996060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101821106|NCT00996060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101821107|NCT00996060|Vasodilator Agents|vasodilator agents|mesh-ancestor
101821108|NCT00995046|Factor VIII|factor viii|mesh-list
101821109|NCT00995046|Coagulants|coagulants|mesh-ancestor
101821110|NCT00995124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101293100|NCT01967264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101293101|NCT01967264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101293102|NCT01967264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293103|NCT01967368|Vaccines|vaccines|mesh-list
101293104|NCT01967368|Immunologic Factors|immunologic factors|mesh-ancestor
101293105|NCT01967368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293106|NCT01967381|Methamphetamine|methamphetamine|mesh-list
101293107|NCT01967381|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101293108|NCT01967381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293109|NCT01967381|Sympathomimetics|sympathomimetics|mesh-ancestor
101293110|NCT01967381|Autonomic Agents|autonomic agents|mesh-ancestor
101293111|NCT01967381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101293112|NCT01967381|Dopamine Agents|dopamine agents|mesh-ancestor
101293113|NCT01967381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101293114|NCT01967381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293115|NCT01967381|Adrenergic Agents|adrenergic agents|mesh-ancestor
101293116|NCT01967381|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101293117|NCT01967381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101293118|NCT01967381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101293119|NCT01967381|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101293120|NCT01967459|Cholecalciferol|cholecalciferol|mesh-list
101293121|NCT01967459|Vitamin D|vitamin d|mesh-list
101293122|NCT01967459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101293123|NCT01967459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293124|NCT01967459|Vitamins|vitamins|mesh-ancestor
101293125|NCT01967459|Micronutrients|micronutrients|mesh-ancestor
101293126|NCT01967459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101293127|NCT01967472|Artesunate|artesunate|mesh-list
101293128|NCT01967472|Lumefantrine|lumefantrine|mesh-list
101293129|NCT01967472|Artemether|artemether|mesh-list
101293130|NCT01967472|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101293131|NCT01967472|Amodiaquine|amodiaquine|mesh-list
101293132|NCT01967472|Antimalarials|antimalarials|mesh-ancestor
101293133|NCT01967472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101293134|NCT01967472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101293135|NCT01967472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101293136|NCT01967472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101293137|NCT01967472|Antiviral Agents|antiviral agents|mesh-ancestor
101293138|NCT01967472|Schistosomicides|schistosomicides|mesh-ancestor
101293139|NCT01967472|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101293140|NCT01967472|Anthelmintics|anthelmintics|mesh-ancestor
101293141|NCT01967498|Montelukast|montelukast|mesh-list
101293142|NCT01967498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101293143|NCT01967498|Respiratory System Agents|respiratory system agents|mesh-ancestor
101293144|NCT01967498|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101293145|NCT01967498|Hormone Antagonists|hormone antagonists|mesh-ancestor
101293146|NCT01967498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101293147|NCT01967498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293148|NCT01967498|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101293149|NCT01967498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101293150|NCT01967498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293152|NCT01967524|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101293153|NCT01967524|Botulinum Toxins|botulinum toxins|mesh-list
101293154|NCT01967524|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101821111|NCT04000932|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
101821113|NCT04000932|Glucocorticoids|glucocorticoids|mesh-ancestor
101821114|NCT04000932|Hormones|hormones|mesh-ancestor
101821115|NCT04000932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101821116|NCT04000932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293155|NCT01967524|Anesthetics, Local|anesthetics, local|mesh-ancestor
101293156|NCT01967524|Anesthetics|anesthetics|mesh-ancestor
101293157|NCT01967524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101293158|NCT01967524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293159|NCT01967524|Sensory System Agents|sensory system agents|mesh-ancestor
101293160|NCT01967524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101293161|NCT01967524|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101293162|NCT01967524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101293163|NCT01967524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293164|NCT01967524|Cholinergic Agents|cholinergic agents|mesh-ancestor
101293165|NCT01967524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101293166|NCT01967524|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101293167|NCT01967758|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101293168|NCT01967758|Amoxicillin|amoxicillin|mesh-list
101293169|NCT01967758|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101293170|NCT01967758|Trimethoprim|trimethoprim|mesh-list
101293171|NCT01967758|Sulfamethoxazole|sulfamethoxazole|mesh-list
101293172|NCT01967758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101293173|NCT01967758|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101293174|NCT01967758|Antimalarials|antimalarials|mesh-ancestor
101293175|NCT01967758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101293177|NCT01967758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101293178|NCT01967758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101293179|NCT01967758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293180|NCT01967758|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101293181|NCT01967758|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101293182|NCT01967758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101293183|NCT01967758|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101293184|NCT01967823|Aldesleukin|aldesleukin|mesh-list
101293185|NCT01967823|Cyclophosphamide|cyclophosphamide|mesh-list
101293186|NCT01967823|Fludarabine|fludarabine|mesh-list
101293187|NCT01967823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101293188|NCT01967823|Immunologic Factors|immunologic factors|mesh-ancestor
101293189|NCT01967823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293190|NCT01967823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101293191|NCT01967823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101293192|NCT01967823|Alkylating Agents|alkylating agents|mesh-ancestor
101293193|NCT01967823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293194|NCT01967823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101293195|NCT01967823|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101293196|NCT01967823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101293197|NCT01967823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101293198|NCT01967823|Antiviral Agents|antiviral agents|mesh-ancestor
101293199|NCT01967823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101293200|NCT01967875|Docetaxel|docetaxel|mesh-list
101293201|NCT01967875|Capecitabine|capecitabine|mesh-list
101293202|NCT01967875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101293203|NCT01967875|Tubulin Modulators|tubulin modulators|mesh-ancestor
101293204|NCT01967875|Antimitotic Agents|antimitotic agents|mesh-ancestor
101293205|NCT01967875|Mitosis Modulators|mitosis modulators|mesh-ancestor
101293206|NCT01967875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293207|NCT01967875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101293208|NCT01967875|Antimetabolites|antimetabolites|mesh-ancestor
101293210|NCT01967927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101293211|NCT01967927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293212|NCT01967979|Itraconazole|itraconazole|mesh-list
101293213|NCT01967979|Fluoxetine|fluoxetine|mesh-list
101293214|NCT01967979|Antifungal Agents|antifungal agents|mesh-ancestor
101293215|NCT01967979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101293216|NCT01967979|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101821117|NCT05170230|Terlipressin|terlipressin|mesh-list
101821118|NCT05170230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101821119|NCT05170230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101821120|NCT01000116|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101821121|NCT01000116|Hemostatics|hemostatics|mesh-ancestor
101821122|NCT01000116|Coagulants|coagulants|mesh-ancestor
101821123|NCT00996684|Plasminogen|plasminogen|mesh-list
101821124|NCT00996684|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101821125|NCT00996684|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101821126|NCT00996684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821127|NCT00996762|Lapatinib|lapatinib|mesh-list
101293217|NCT01967979|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101293218|NCT01967979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101293219|NCT01967979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293220|NCT01967979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101293221|NCT01967979|Hormone Antagonists|hormone antagonists|mesh-ancestor
101293222|NCT01967979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101293223|NCT01967979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293224|NCT01967979|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101293225|NCT01967979|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101293226|NCT01967979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101293227|NCT01967979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101293228|NCT01967979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101293229|NCT01967979|Serotonin Agents|serotonin agents|mesh-ancestor
101293230|NCT01967979|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101293231|NCT01967979|Antidepressive Agents|antidepressive agents|mesh-ancestor
101293232|NCT01967979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101293233|NCT01967979|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101293235|NCT01968005|Lidocaine|lidocaine|mesh-list
101293236|NCT01968005|Anesthetics, Local|anesthetics, local|mesh-ancestor
101293237|NCT01968005|Anesthetics|anesthetics|mesh-ancestor
101293238|NCT01968005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101293239|NCT01968005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293240|NCT01968005|Sensory System Agents|sensory system agents|mesh-ancestor
101293241|NCT01968005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101293242|NCT01968005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101293243|NCT01968005|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101293244|NCT01968005|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101293245|NCT01968005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101293246|NCT01968005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293247|NCT01968005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101293248|NCT01968005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101821128|NCT00996762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821129|NCT00996762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101821130|NCT00996762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101821131|NCT00996762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821132|NCT05162196|Niraparib|niraparib|mesh-list
101821133|NCT05162196|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101821134|NCT05162196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101821135|NCT05162196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821136|NCT05162196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821137|NCT00997074|Ibuprofen|ibuprofen|mesh-list
101821138|NCT00997074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101821139|NCT00997074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101821140|NCT00997074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101293250|NCT01968005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101293251|NCT01968005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101293252|NCT01968005|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101293253|NCT01968005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101293254|NCT01968005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101293255|NCT01968018|Acetaminophen|acetaminophen|mesh-list
101293256|NCT01968018|Tramadol|tramadol|mesh-list
101293257|NCT01968018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101293258|NCT01968018|Analgesics|analgesics|mesh-ancestor
101293259|NCT01968018|Sensory System Agents|sensory system agents|mesh-ancestor
101293260|NCT01968018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101293261|NCT01968018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293262|NCT01968018|Antipyretics|antipyretics|mesh-ancestor
101293266|NCT01968044|Linagliptin|linagliptin|mesh-list
101293267|NCT01968044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101293268|NCT01968044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293269|NCT01968044|Incretins|incretins|mesh-ancestor
101293271|NCT01968044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101293272|NCT01968044|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101293273|NCT01968044|Protease Inhibitors|protease inhibitors|mesh-ancestor
101293274|NCT01968044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101293275|NCT01968044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293276|NCT01968083|Vaccines|vaccines|mesh-list
101293277|NCT01968083|Immunologic Factors|immunologic factors|mesh-ancestor
101293278|NCT01968083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293279|NCT01968161|Asenapine|asenapine|mesh-list
101293280|NCT01968161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101293281|NCT01968161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101293282|NCT01968161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101293283|NCT01968161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293284|NCT01968161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101293285|NCT01968239|Ranibizumab|ranibizumab|mesh-list
101293286|NCT01968239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101293287|NCT01968239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101293288|NCT01968239|Growth Substances|growth substances|mesh-ancestor
101293289|NCT01968239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293291|NCT01968239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101293293|NCT01968395|Antifungal Agents|antifungal agents|mesh-ancestor
101293294|NCT01968395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316983|NCT00700258|Sirolimus|sirolimus|mesh-list
101293295|NCT01968395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101293296|NCT01968395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293297|NCT01968486|Ranibizumab|ranibizumab|mesh-list
101293298|NCT01968486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101293299|NCT01968486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101293300|NCT01968486|Growth Substances|growth substances|mesh-ancestor
101293301|NCT01968486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821142|NCT00997074|Sensory System Agents|sensory system agents|mesh-ancestor
101821143|NCT00997074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101821144|NCT00997074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821145|NCT00997074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101821146|NCT00997074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101821147|NCT00997074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101293302|NCT01968486|Growth Inhibitors|growth inhibitors|mesh-ancestor
101293303|NCT01968486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101293304|NCT01968564|Curcumin|curcumin|mesh-list
101293305|NCT01968564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101293306|NCT01968564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101293307|NCT01968564|Analgesics|analgesics|mesh-ancestor
101293308|NCT01968564|Sensory System Agents|sensory system agents|mesh-ancestor
101293309|NCT01968564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101293310|NCT01968564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293311|NCT01968564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101293312|NCT01968564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101293313|NCT01968564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101293314|NCT01968564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101293315|NCT01968564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293316|NCT01968577|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101293317|NCT01968577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101293318|NCT01968577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101293319|NCT01968577|Antimetabolites|antimetabolites|mesh-ancestor
101293320|NCT01968577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293321|NCT01968577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101293322|NCT01968577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101293323|NCT01968577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101293324|NCT01968616|Ranibizumab|ranibizumab|mesh-list
101293325|NCT01968616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101293326|NCT01968616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101293327|NCT01968616|Growth Substances|growth substances|mesh-ancestor
101293328|NCT01968616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293329|NCT01968616|Growth Inhibitors|growth inhibitors|mesh-ancestor
101293330|NCT01968616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101293331|NCT01968655|Factor VIII|factor viii|mesh-list
101293332|NCT01968655|Coagulants|coagulants|mesh-ancestor
101293333|NCT01968759|Ramipril|ramipril|mesh-list
101293334|NCT01968759|Irbesartan|irbesartan|mesh-list
101293335|NCT01968759|Sevelamer|sevelamer|mesh-list
101293336|NCT01968759|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101293337|NCT01968759|Protease Inhibitors|protease inhibitors|mesh-ancestor
101293338|NCT01968759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101293339|NCT01968759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293340|NCT01968759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101293341|NCT01968759|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101293342|NCT01968759|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101293343|NCT01968759|Chelating Agents|chelating agents|mesh-ancestor
101293344|NCT01968759|Sequestering Agents|sequestering agents|mesh-ancestor
101293345|NCT01968798|Aspirin|aspirin|mesh-list
101293346|NCT01968798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101293347|NCT01968798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101293348|NCT01968798|Analgesics|analgesics|mesh-ancestor
101293349|NCT01968798|Sensory System Agents|sensory system agents|mesh-ancestor
101293350|NCT01968798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101293351|NCT01968798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293352|NCT01968798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101293353|NCT01968798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101293354|NCT01968798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101293355|NCT01968798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101293356|NCT01968798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293357|NCT01968798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101293358|NCT01968798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101293359|NCT01968798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101293360|NCT01968798|Antipyretics|antipyretics|mesh-ancestor
101293361|NCT01968850|Vitamin D|vitamin d|mesh-list
101293362|NCT01968850|Alendronate|alendronate|mesh-list
101821148|NCT00997074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821150|NCT05249712|Hormones|hormones|mesh-ancestor
101821151|NCT05249712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101821152|NCT05249712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821153|NCT01000896|Paclitaxel|paclitaxel|mesh-list
101821154|NCT01000896|Carboplatin|carboplatin|mesh-list
101821155|NCT01000896|Saracatinib|saracatinib|mesh-list
101821156|NCT01000896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101821157|NCT01000896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821158|NCT01000896|Tubulin Modulators|tubulin modulators|mesh-ancestor
101821159|NCT01000896|Antimitotic Agents|antimitotic agents|mesh-ancestor
101293363|NCT01968850|Vitamins|vitamins|mesh-ancestor
101293364|NCT01968850|Micronutrients|micronutrients|mesh-ancestor
101293365|NCT01968850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293366|NCT01968850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101293367|NCT01968915|Paclitaxel|paclitaxel|mesh-list
101293368|NCT01968915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101293369|NCT01968915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101293370|NCT01968915|Tubulin Modulators|tubulin modulators|mesh-ancestor
101293371|NCT01968915|Antimitotic Agents|antimitotic agents|mesh-ancestor
101293372|NCT01968915|Mitosis Modulators|mitosis modulators|mesh-ancestor
101293373|NCT01968915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293374|NCT01969006|Bupivacaine|bupivacaine|mesh-list
101293375|NCT01969006|Anesthetics, Local|anesthetics, local|mesh-ancestor
101293376|NCT01969006|Anesthetics|anesthetics|mesh-ancestor
101293377|NCT01969006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101293378|NCT01969006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293379|NCT01969006|Sensory System Agents|sensory system agents|mesh-ancestor
101293380|NCT01969006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101293381|NCT01969019|Prednisone|prednisone|mesh-list
101293382|NCT01969019|Methylprednisolone|methylprednisolone|mesh-list
101293383|NCT01969019|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101293384|NCT01969019|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101293385|NCT01969019|Prednisolone|prednisolone|mesh-list
101293386|NCT01969019|Prednisolone acetate|prednisolone acetate|mesh-list
101293387|NCT01969019|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101293388|NCT01969019|Prednisolone phosphate|prednisolone phosphate|mesh-list
101293389|NCT01969019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101293390|NCT01969019|Glucocorticoids|glucocorticoids|mesh-ancestor
101293391|NCT01969019|Hormones|hormones|mesh-ancestor
101293392|NCT01969019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101293393|NCT01969019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293394|NCT01969019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101293395|NCT01969019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101293396|NCT01969019|Antiemetics|antiemetics|mesh-ancestor
101293397|NCT01969019|Autonomic Agents|autonomic agents|mesh-ancestor
101293398|NCT01969019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101293399|NCT01969019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101293400|NCT01969019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101293401|NCT01969019|Protective Agents|protective agents|mesh-ancestor
101293402|NCT01969032|Paclitaxel|paclitaxel|mesh-list
101293403|NCT01969032|Doxorubicin|doxorubicin|mesh-list
101293404|NCT01969032|Capecitabine|capecitabine|mesh-list
101293405|NCT01969032|Cyclophosphamide|cyclophosphamide|mesh-list
101293406|NCT01969032|Carboplatin|carboplatin|mesh-list
101293407|NCT01969032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101293408|NCT01969032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101293409|NCT01969032|Tubulin Modulators|tubulin modulators|mesh-ancestor
101293410|NCT01969032|Antimitotic Agents|antimitotic agents|mesh-ancestor
101293411|NCT01969032|Mitosis Modulators|mitosis modulators|mesh-ancestor
101293412|NCT01969032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293413|NCT01969032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101293414|NCT01969032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101821160|NCT01000896|Mitosis Modulators|mitosis modulators|mesh-ancestor
101821161|NCT01000896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821162|NCT01000896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101821163|NCT00997542|Allopurinol|allopurinol|mesh-list
101821164|NCT00997542|Antimetabolites|antimetabolites|mesh-ancestor
101821165|NCT00997542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293415|NCT01969032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101293416|NCT01969032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101293417|NCT01969032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101293418|NCT01969032|Antimetabolites|antimetabolites|mesh-ancestor
101293419|NCT01969032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101293420|NCT01969032|Immunologic Factors|immunologic factors|mesh-ancestor
101293421|NCT01969032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293422|NCT01969032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101293423|NCT01969032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101293424|NCT01969032|Alkylating Agents|alkylating agents|mesh-ancestor
101293425|NCT01969032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101293426|NCT01969071|Simendan|simendan|mesh-list
101293427|NCT01969071|Dobutamine|dobutamine|mesh-list
101293428|NCT01969071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101293429|NCT01969071|Vasodilator Agents|vasodilator agents|mesh-ancestor
101293430|NCT01969071|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101293431|NCT01969071|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101293432|NCT01969071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101293433|NCT01969071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293434|NCT01969071|Protective Agents|protective agents|mesh-ancestor
101293435|NCT01969071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293436|NCT01969071|Sympathomimetics|sympathomimetics|mesh-ancestor
101293437|NCT01969071|Autonomic Agents|autonomic agents|mesh-ancestor
101317006|NCT00001113|Zidovudine|zidovudine|mesh-list
101293438|NCT01969071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101293439|NCT01969071|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101293440|NCT01969071|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101293441|NCT01969071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101293442|NCT01969071|Adrenergic Agents|adrenergic agents|mesh-ancestor
101293443|NCT01969071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101293444|NCT01969149|Insulin|insulin|mesh-list
101293445|NCT01969149|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101293446|NCT01969149|Exenatide|exenatide|mesh-list
101293447|NCT01969149|Insulin Lispro|insulin lispro|mesh-list
101293448|NCT01969149|Incretins|incretins|mesh-list
101293449|NCT01969149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101293450|NCT01969149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293451|NCT01969149|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101293452|NCT01969149|Hormones|hormones|mesh-ancestor
101293453|NCT01969149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101293454|NCT01969318|Metformin|metformin|mesh-list
101293455|NCT01969318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101293456|NCT01969318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293457|NCT01969357|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101293458|NCT01969357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101293459|NCT01969357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293460|NCT01969357|Incretins|incretins|mesh-ancestor
101293461|NCT01969357|Hormones|hormones|mesh-ancestor
101293462|NCT01969357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101293463|NCT01969357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101293464|NCT01969357|Protease Inhibitors|protease inhibitors|mesh-ancestor
101293465|NCT01969357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101293466|NCT01969357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293467|NCT01969617|Naltrexone|naltrexone|mesh-list
101293468|NCT01969617|Nalmefene|nalmefene|mesh-list
101293469|NCT01969617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101293470|NCT01969617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293471|NCT01969617|Sensory System Agents|sensory system agents|mesh-ancestor
101293472|NCT01969617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101293473|NCT01969617|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101293474|NCT01969656|Calcitriol|calcitriol|mesh-list
101293475|NCT01969656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101293476|NCT01969656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821166|NCT00997542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101821167|NCT00997542|Gout Suppressants|gout suppressants|mesh-ancestor
101821168|NCT00997542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101821169|NCT00997542|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101821171|NCT00997542|Protective Agents|protective agents|mesh-ancestor
101821172|NCT00997542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821173|NCT01001130|Fluticasone|fluticasone|mesh-list
101821174|NCT01001130|Xhance|xhance|mesh-list
101821175|NCT01001130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101821176|NCT01001130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101821177|NCT01001130|Autonomic Agents|autonomic agents|mesh-ancestor
101246516|NCT01666522|Cholecalciferol|cholecalciferol|mesh-list
101293477|NCT01969656|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101293478|NCT01969656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101293479|NCT01969656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293480|NCT01969656|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101293481|NCT01969656|Vitamins|vitamins|mesh-ancestor
101293482|NCT01969656|Micronutrients|micronutrients|mesh-ancestor
101293483|NCT01969656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101293484|NCT01969669|Ketoconazole|ketoconazole|mesh-list
101293485|NCT01969669|Venetoclax|venetoclax|mesh-list
101293486|NCT01969669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101293487|NCT01969669|Antifungal Agents|antifungal agents|mesh-ancestor
101293488|NCT01969669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101293489|NCT01969669|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101293490|NCT01969669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101293491|NCT01969669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101293492|NCT01969669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293493|NCT01969669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101293494|NCT01969669|Hormone Antagonists|hormone antagonists|mesh-ancestor
101293495|NCT01969669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101293496|NCT01969669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293497|NCT01969669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101293498|NCT01969682|Rifampin|rifampin|mesh-list
101293499|NCT01969682|Venetoclax|venetoclax|mesh-list
101293500|NCT01969682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101293501|NCT01969682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101293502|NCT01969682|Antitubercular Agents|antitubercular agents|mesh-ancestor
101293503|NCT01969682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101293504|NCT01969682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101293505|NCT01969682|Leprostatic Agents|leprostatic agents|mesh-ancestor
101293506|NCT01969682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101293507|NCT01969682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101293508|NCT01969682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293509|NCT01969682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101293510|NCT01969682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101293511|NCT01969682|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101293512|NCT01969682|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101293513|NCT01969682|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101293514|NCT01969682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101293516|NCT01969695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101293517|NCT01969773|Botulinum Toxins|botulinum toxins|mesh-list
101293518|NCT01969773|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101293519|NCT01969773|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101293520|NCT01969773|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101293521|NCT01969773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101293522|NCT01969773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293523|NCT01969773|Cholinergic Agents|cholinergic agents|mesh-ancestor
101293524|NCT01969773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101821178|NCT01001130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101821179|NCT01001130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821180|NCT01001130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101821181|NCT01001130|Respiratory System Agents|respiratory system agents|mesh-ancestor
101821182|NCT01001130|Dermatologic Agents|dermatologic agents|mesh-ancestor
101821183|NCT01001130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101821184|NCT00424827|Gemcitabine|gemcitabine|mesh-list
101821185|NCT00424827|Fluorouracil|fluorouracil|mesh-list
101821186|NCT00424827|Cetuximab|cetuximab|mesh-list
101821187|NCT00424827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101293525|NCT01969773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293526|NCT01969773|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101293527|NCT01969773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101293528|NCT01969877|Cetuximab|cetuximab|mesh-list
101293529|NCT01969877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101293530|NCT01969877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101293531|NCT01969903|Dexmedetomidine|dexmedetomidine|mesh-list
101293532|NCT01969903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101293533|NCT01969903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101293534|NCT01969903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293535|NCT01969903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101293536|NCT01969903|Analgesics|analgesics|mesh-ancestor
101293537|NCT01969903|Sensory System Agents|sensory system agents|mesh-ancestor
101293538|NCT01969903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101293539|NCT01969903|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101293540|NCT01969903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101293541|NCT01969903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101293542|NCT01969903|Adrenergic Agents|adrenergic agents|mesh-ancestor
101293543|NCT01969903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101293544|NCT01969903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293545|NCT01969942|Melphalan|melphalan|mesh-list
101293546|NCT01969942|Busulfan|busulfan|mesh-list
101293547|NCT01969942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101293548|NCT01969942|Alkylating Agents|alkylating agents|mesh-ancestor
101293549|NCT01969942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293550|NCT01969942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101293551|NCT01969942|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101293552|NCT01969942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101293553|NCT01969942|Immunologic Factors|immunologic factors|mesh-ancestor
101293554|NCT01969942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293555|NCT01969955|Paclitaxel|paclitaxel|mesh-list
101293556|NCT01969955|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101293557|NCT01969955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101293558|NCT01969955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101293559|NCT01969955|Tubulin Modulators|tubulin modulators|mesh-ancestor
101293560|NCT01969955|Antimitotic Agents|antimitotic agents|mesh-ancestor
101293561|NCT01969955|Mitosis Modulators|mitosis modulators|mesh-ancestor
101293562|NCT01969955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293563|NCT01970046|Metformin|metformin|mesh-list
101293564|NCT01970046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101293565|NCT01970046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293566|NCT01970059|Metoprolol|metoprolol|mesh-list
101293569|NCT01970059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101293570|NCT01970059|Sympatholytics|sympatholytics|mesh-ancestor
101293571|NCT01970059|Autonomic Agents|autonomic agents|mesh-ancestor
101293572|NCT01970059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101293573|NCT01970059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293574|NCT01970059|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101293575|NCT01970059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101293576|NCT01970059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101317012|NCT00001113|Antimetabolites|antimetabolites|mesh-ancestor
101293577|NCT01970059|Adrenergic Agents|adrenergic agents|mesh-ancestor
101293578|NCT01970059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101293579|NCT01970059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293581|NCT01970059|Protective Agents|protective agents|mesh-ancestor
101821188|NCT00424827|Antimetabolites|antimetabolites|mesh-ancestor
101821189|NCT00424827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821190|NCT00424827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821191|NCT00424827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101821192|NCT00424827|Immunologic Factors|immunologic factors|mesh-ancestor
101821193|NCT00424827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821194|NCT00424827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101821195|NCT01001364|Budesonide|budesonide|mesh-list
101293582|NCT01970059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101293583|NCT01970059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101293584|NCT01970059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101293585|NCT01970059|Vasodilator Agents|vasodilator agents|mesh-ancestor
101293586|NCT01970059|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101293587|NCT01970059|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101293589|NCT01970072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101293590|NCT01970072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101293591|NCT01970072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101293592|NCT01970072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293593|NCT01970072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101293594|NCT01970072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101293595|NCT01970072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101293596|NCT01970072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101293597|NCT01970072|Anesthetics, General|anesthetics, general|mesh-ancestor
101293598|NCT01970072|Anesthetics|anesthetics|mesh-ancestor
101293599|NCT01970072|GABA Modulators|gaba modulators|mesh-ancestor
101293600|NCT01970072|GABA Agents|gaba agents|mesh-ancestor
101293601|NCT01970072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101293602|NCT01970072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293604|NCT01970202|Enoxaparin sodium|enoxaparin sodium|mesh-list
101293605|NCT01970202|Anticoagulants|anticoagulants|mesh-ancestor
101293606|NCT01970202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101293607|NCT01970202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101293608|NCT01970202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293609|NCT01970215|Atorvastatin|atorvastatin|mesh-list
101293610|NCT01970215|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101293611|NCT01970215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101293612|NCT01970215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101293613|NCT01970215|Antimetabolites|antimetabolites|mesh-ancestor
101293614|NCT01970215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293615|NCT01970215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101293616|NCT01970215|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101293617|NCT01970215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101293618|NCT01970280|Enoxaparin|enoxaparin|mesh-list
101293619|NCT01970280|Anticoagulants|anticoagulants|mesh-ancestor
101293620|NCT01970280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101293621|NCT01970280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101293622|NCT01970280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293623|NCT01970358|Poly ICLC|poly iclc|mesh-list
101293624|NCT01970358|Interferon Inducers|interferon inducers|mesh-ancestor
101293625|NCT01970358|Immunologic Factors|immunologic factors|mesh-ancestor
101293626|NCT01970358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293627|NCT01970449|Vaccines|vaccines|mesh-list
101293628|NCT01970449|Immunologic Factors|immunologic factors|mesh-ancestor
101293629|NCT01970449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293630|NCT01970553|Gemcitabine|gemcitabine|mesh-list
101293631|NCT01970553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101293632|NCT01970553|Antimetabolites|antimetabolites|mesh-ancestor
101293633|NCT01970553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293634|NCT01970553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101293635|NCT01970579|Paclitaxel|paclitaxel|mesh-list
101293636|NCT01970579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101293637|NCT01970579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101293638|NCT01970579|Tubulin Modulators|tubulin modulators|mesh-ancestor
101293639|NCT01970579|Antimitotic Agents|antimitotic agents|mesh-ancestor
101821197|NCT01001364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101821198|NCT01001364|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101821199|NCT01001364|Autonomic Agents|autonomic agents|mesh-ancestor
101821200|NCT01001364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101821201|NCT01001364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821203|NCT01001364|Respiratory System Agents|respiratory system agents|mesh-ancestor
101821204|NCT01001364|Glucocorticoids|glucocorticoids|mesh-ancestor
101293640|NCT01970579|Mitosis Modulators|mitosis modulators|mesh-ancestor
101293641|NCT01970579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293642|NCT01970748|Propranolol|propranolol|mesh-list
101293643|NCT01970748|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101293644|NCT01970748|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101293645|NCT01970748|Adrenergic Agents|adrenergic agents|mesh-ancestor
101293646|NCT01970748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101293647|NCT01970748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293648|NCT01970748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293649|NCT01970748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101293650|NCT01970748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101293651|NCT01970748|Vasodilator Agents|vasodilator agents|mesh-ancestor
101293652|NCT01970800|Hormones|hormones|mesh-list
101293653|NCT01970800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101293654|NCT01970800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293655|NCT01970904|Ribavirin|ribavirin|mesh-list
101293656|NCT01970904|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101293657|NCT01970904|Antimetabolites|antimetabolites|mesh-ancestor
101293658|NCT01970904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293659|NCT01970904|Antiviral Agents|antiviral agents|mesh-ancestor
101293660|NCT01970904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101293661|NCT01970917|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101293662|NCT01970917|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101293663|NCT01971034|Metformin|metformin|mesh-list
101293664|NCT01971034|Paclitaxel|paclitaxel|mesh-list
101293665|NCT01971034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101293666|NCT01971034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101293667|NCT01971034|Tubulin Modulators|tubulin modulators|mesh-ancestor
101293668|NCT01971034|Antimitotic Agents|antimitotic agents|mesh-ancestor
101293669|NCT01971034|Mitosis Modulators|mitosis modulators|mesh-ancestor
101293670|NCT01971034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293671|NCT01971034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101293672|NCT01971034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293673|NCT01971047|Insulin|insulin|mesh-list
101293675|NCT01971047|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101293676|NCT01971047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101293677|NCT01971047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293678|NCT01971190|Aflibercept|aflibercept|mesh-list
101293679|NCT01971190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101293680|NCT01971190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101293681|NCT01971190|Growth Substances|growth substances|mesh-ancestor
101293682|NCT01971190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293683|NCT01971190|Growth Inhibitors|growth inhibitors|mesh-ancestor
101293684|NCT01971190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101293685|NCT01971242|Exenatide|exenatide|mesh-list
101293686|NCT01971242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101293687|NCT01971242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293688|NCT01971242|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101293689|NCT01971242|Incretins|incretins|mesh-ancestor
101293690|NCT01971242|Hormones|hormones|mesh-ancestor
101293691|NCT01971242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101293692|NCT01971268|Cimetidine|cimetidine|mesh-list
101293693|NCT01971268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101293694|NCT01971268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101293695|NCT01971268|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101293696|NCT01971268|Histamine Antagonists|histamine antagonists|mesh-ancestor
101293697|NCT01971268|Histamine Agents|histamine agents|mesh-ancestor
101293698|NCT01971268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101293699|NCT01971268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821205|NCT01001364|Hormones|hormones|mesh-ancestor
101821206|NCT01001364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101821207|NCT01001364|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101821208|NCT01001364|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101821209|NCT01001364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101293700|NCT01971268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293701|NCT01971268|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101293702|NCT01971268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101293703|NCT01971268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101293704|NCT01971281|Paclitaxel|paclitaxel|mesh-list
101293705|NCT01971281|Gemcitabine|gemcitabine|mesh-list
101293706|NCT01971281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101293707|NCT01971281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101293708|NCT01971281|Tubulin Modulators|tubulin modulators|mesh-ancestor
101293709|NCT01971281|Antimitotic Agents|antimitotic agents|mesh-ancestor
101293710|NCT01971281|Mitosis Modulators|mitosis modulators|mesh-ancestor
101293711|NCT01971281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293712|NCT01971281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101293713|NCT01971281|Antimetabolites|antimetabolites|mesh-ancestor
101293714|NCT01971411|Calcium, Dietary|calcium, dietary|mesh-list
101293715|NCT01971411|Vitamin D|vitamin d|mesh-list
101293716|NCT01971411|Ergocalciferols|ergocalciferols|mesh-list
101293717|NCT01971411|Cholecalciferol|cholecalciferol|mesh-list
101293718|NCT01971411|Vitamins|vitamins|mesh-list
101293719|NCT01971411|Calcium|calcium|mesh-list
101293720|NCT01971411|Micronutrients|micronutrients|mesh-ancestor
101293721|NCT01971411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293722|NCT01971411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101293723|NCT01971411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101293725|NCT01971424|Antacids|antacids|mesh-ancestor
101293726|NCT01971424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293727|NCT01971424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101293728|NCT01971450|Iloprost|iloprost|mesh-list
101293729|NCT01971450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101293730|NCT01971450|Vasodilator Agents|vasodilator agents|mesh-ancestor
101293731|NCT01971515|Tamoxifen|tamoxifen|mesh-list
101293732|NCT01971515|Trastuzumab|trastuzumab|mesh-list
101293733|NCT01971515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101293734|NCT01971515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101293735|NCT01971515|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101293736|NCT01971515|Hormone Antagonists|hormone antagonists|mesh-ancestor
101293737|NCT01971515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101293738|NCT01971515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293739|NCT01971515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101293740|NCT01971515|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101293742|NCT01971515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101293743|NCT01971606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101293744|NCT01971606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101293745|NCT01971606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101293746|NCT01971606|Antimetabolites|antimetabolites|mesh-ancestor
101293747|NCT01971606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293748|NCT01971606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101293749|NCT01971606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101293750|NCT01971606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101293751|NCT01971632|Oxycodone|oxycodone|mesh-list
101293752|NCT01971632|Naloxone|naloxone|mesh-list
101293753|NCT01971632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101293754|NCT01971632|Narcotics|narcotics|mesh-ancestor
101293755|NCT01971632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101293756|NCT01971632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293757|NCT01971632|Analgesics|analgesics|mesh-ancestor
101293758|NCT01971632|Sensory System Agents|sensory system agents|mesh-ancestor
101293759|NCT01971632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101293760|NCT01971632|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101293761|NCT01971658|Thalidomide|thalidomide|mesh-list
101293762|NCT01971658|Dexamethasone|dexamethasone|mesh-list
101293763|NCT01971658|Cyclophosphamide|cyclophosphamide|mesh-list
101293764|NCT01971658|Bortezomib|bortezomib|mesh-list
101821210|NCT01001364|Adrenergic Agents|adrenergic agents|mesh-ancestor
101821211|NCT01001364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101821212|NCT01001364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821214|NCT01031667|Probucol|probucol|mesh-list
101821215|NCT01031667|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101821216|NCT01031667|Autonomic Agents|autonomic agents|mesh-ancestor
101821217|NCT01031667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101821218|NCT01031667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821219|NCT01031667|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101293765|NCT01971658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101293766|NCT01971658|Immunologic Factors|immunologic factors|mesh-ancestor
101293767|NCT01971658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293768|NCT01971658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101293769|NCT01971658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101293770|NCT01971658|Alkylating Agents|alkylating agents|mesh-ancestor
101293771|NCT01971658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293772|NCT01971658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101293773|NCT01971658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101293774|NCT01971658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101293775|NCT01971658|Antiemetics|antiemetics|mesh-ancestor
101293776|NCT01971658|Autonomic Agents|autonomic agents|mesh-ancestor
101293777|NCT01971658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101293778|NCT01971658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101293779|NCT01971658|Glucocorticoids|glucocorticoids|mesh-ancestor
101293780|NCT01971658|Hormones|hormones|mesh-ancestor
101293781|NCT01971658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101293782|NCT01971658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101293783|NCT01971658|Leprostatic Agents|leprostatic agents|mesh-ancestor
101293784|NCT01971658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101293785|NCT01971658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101293786|NCT01971658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101293787|NCT01971658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101293790|NCT01971684|Mycophenolic Acid|mycophenolic acid|mesh-list
101293791|NCT01971684|Sirolimus|sirolimus|mesh-list
101293792|NCT01971684|Mercaptopurine|mercaptopurine|mesh-list
101293793|NCT01971684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101293794|NCT01971684|Immunologic Factors|immunologic factors|mesh-ancestor
101293795|NCT01971684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293796|NCT01971684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101293797|NCT01971684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101293798|NCT01971684|Antitubercular Agents|antitubercular agents|mesh-ancestor
101293799|NCT01971684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101293800|NCT01971684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101293801|NCT01971684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101293802|NCT01971684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293803|NCT01971684|Antifungal Agents|antifungal agents|mesh-ancestor
101293804|NCT01971684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101293805|NCT01971684|Antimetabolites|antimetabolites|mesh-ancestor
101293806|NCT01971684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101293807|NCT01971684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101293808|NCT01971801|Vitamin D|vitamin d|mesh-list
101293809|NCT01971801|Cholecalciferol|cholecalciferol|mesh-list
101293810|NCT01971801|Vitamins|vitamins|mesh-ancestor
101293811|NCT01971801|Micronutrients|micronutrients|mesh-ancestor
101293812|NCT01971801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293813|NCT01971801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101293814|NCT01971801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101293816|NCT01971814|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101293817|NCT01971814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101293818|NCT01971814|Dermatologic Agents|dermatologic agents|mesh-ancestor
101293819|NCT01971814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101821220|NCT01031667|Respiratory System Agents|respiratory system agents|mesh-ancestor
101821221|NCT01031667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101821222|NCT01031667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101821223|NCT01031667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821224|NCT01031667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101821225|NCT01031667|Vasodilator Agents|vasodilator agents|mesh-ancestor
101821226|NCT01031667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101821227|NCT01031667|Protective Agents|protective agents|mesh-ancestor
101293820|NCT01971814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101293822|NCT01971918|Immunologic Factors|immunologic factors|mesh-ancestor
101293823|NCT01971918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293824|NCT01972113|Vitamins|vitamins|mesh-list
101293825|NCT01972113|Vitamin K|vitamin k|mesh-list
101293826|NCT01972113|Vitamin K 2|vitamin k 2|mesh-list
101293827|NCT01972113|Menaquinone 7|menaquinone 7|mesh-list
101293828|NCT01972113|Micronutrients|micronutrients|mesh-ancestor
101293829|NCT01972113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293830|NCT01972113|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101293831|NCT01972113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101293832|NCT01972113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293833|NCT01972113|Hemostatics|hemostatics|mesh-ancestor
101293834|NCT01972113|Coagulants|coagulants|mesh-ancestor
101293835|NCT01972230|Remifentanil|remifentanil|mesh-list
101293836|NCT01972230|Sevoflurane|sevoflurane|mesh-list
101293837|NCT01972230|Propofol|propofol|mesh-list
101293838|NCT01972230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101293839|NCT01972230|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101293840|NCT01972230|Anesthetics, General|anesthetics, general|mesh-ancestor
101293841|NCT01972230|Anesthetics|anesthetics|mesh-ancestor
101293842|NCT01972230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101293843|NCT01972230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293844|NCT01972230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101293845|NCT01972230|Narcotics|narcotics|mesh-ancestor
101293846|NCT01972230|Analgesics|analgesics|mesh-ancestor
101293847|NCT01972230|Sensory System Agents|sensory system agents|mesh-ancestor
101293848|NCT01972230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101293849|NCT01972230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101293850|NCT01972230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101293851|NCT01972269|Lidocaine|lidocaine|mesh-list
101293852|NCT01972269|Fentanyl|fentanyl|mesh-list
101293853|NCT01972269|Bupivacaine|bupivacaine|mesh-list
101293855|NCT01972269|Anesthetics|anesthetics|mesh-ancestor
101293856|NCT01972269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101293857|NCT01972269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293858|NCT01972269|Sensory System Agents|sensory system agents|mesh-ancestor
101293859|NCT01972269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101293860|NCT01972269|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101293861|NCT01972269|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101293862|NCT01972269|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101293863|NCT01972269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101293864|NCT01972269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293865|NCT01972269|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101293866|NCT01972269|Narcotics|narcotics|mesh-ancestor
101293867|NCT01972269|Analgesics|analgesics|mesh-ancestor
101293868|NCT01972269|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101293869|NCT01972269|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101293870|NCT01972269|Anesthetics, General|anesthetics, general|mesh-ancestor
101293871|NCT01972373|Bevacizumab|bevacizumab|mesh-list
101293872|NCT01972373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101293873|NCT01972373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101293874|NCT01972373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101293875|NCT01972373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101293876|NCT01972373|Growth Substances|growth substances|mesh-ancestor
101293877|NCT01972373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293878|NCT01972373|Growth Inhibitors|growth inhibitors|mesh-ancestor
101821228|NCT01031667|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101821229|NCT01031667|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101821230|NCT01031667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101821231|NCT01031667|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101821232|NCT01031667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101821233|NCT01031667|Antimetabolites|antimetabolites|mesh-ancestor
101293879|NCT01972490|Bevacizumab|bevacizumab|mesh-list
101293880|NCT01972490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101293882|NCT01972490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101293883|NCT01972490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101293884|NCT01972490|Growth Substances|growth substances|mesh-ancestor
101293885|NCT01972490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293886|NCT01972490|Growth Inhibitors|growth inhibitors|mesh-ancestor
101293887|NCT01972503|Oxaliplatin|oxaliplatin|mesh-list
101293888|NCT01972503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101293889|NCT01972620|Bupivacaine|bupivacaine|mesh-list
101293890|NCT01972620|Anesthetics, Local|anesthetics, local|mesh-ancestor
101293891|NCT01972620|Anesthetics|anesthetics|mesh-ancestor
101293892|NCT01972620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101293893|NCT01972620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293894|NCT01972620|Sensory System Agents|sensory system agents|mesh-ancestor
101293895|NCT01972620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101293896|NCT01972711|Amisulpride|amisulpride|mesh-list
101293897|NCT01972711|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101293898|NCT01972711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101293899|NCT01972711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101293900|NCT01972711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293901|NCT01972711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101293902|NCT01972711|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101293903|NCT01972711|Dopamine Agents|dopamine agents|mesh-ancestor
101293904|NCT01972711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101293905|NCT01972711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293906|NCT01972711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101293907|NCT01972711|Antidepressive Agents|antidepressive agents|mesh-ancestor
101293908|NCT01972763|Ranibizumab|ranibizumab|mesh-list
101293909|NCT01972763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101293910|NCT01972763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101293911|NCT01972763|Growth Substances|growth substances|mesh-ancestor
101293912|NCT01972763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293913|NCT01972763|Growth Inhibitors|growth inhibitors|mesh-ancestor
101293914|NCT01972763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101293915|NCT01972828|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
101293916|NCT01972828|Plasma Substitutes|plasma substitutes|mesh-ancestor
101293917|NCT01972828|Blood Substitutes|blood substitutes|mesh-ancestor
101293918|NCT01972880|Ipragliflozin|ipragliflozin|mesh-list
101293919|NCT01972880|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101293920|NCT01972880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293921|NCT01972880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101293922|NCT01972880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293923|NCT01972906|Ibuprofen|ibuprofen|mesh-list
101293924|NCT01972906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101293925|NCT01972906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101293926|NCT01972906|Analgesics|analgesics|mesh-ancestor
101293927|NCT01972906|Sensory System Agents|sensory system agents|mesh-ancestor
101293928|NCT01972906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101293929|NCT01972906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293930|NCT01972906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101293931|NCT01972906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101293932|NCT01972906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101293933|NCT01972906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101293934|NCT01972906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293935|NCT01972984|Anastrozole|anastrozole|mesh-list
101293936|NCT01972984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101293937|NCT01972984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101293938|NCT01972984|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101293939|NCT01972984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101293940|NCT01972984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101821234|NCT01031667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101821236|NCT03995277|Biotin|biotin|mesh-list
101821237|NCT03995277|Vitamin B Complex|vitamin b complex|mesh-ancestor
101821238|NCT03995277|Vitamins|vitamins|mesh-ancestor
101821239|NCT03995277|Micronutrients|micronutrients|mesh-ancestor
101821240|NCT03995277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821241|NCT04000386|Zinc Oxide|zinc oxide|mesh-list
101821242|NCT04000386|Dermatologic Agents|dermatologic agents|mesh-ancestor
101821243|NCT04000386|Sunscreening Agents|sunscreening agents|mesh-ancestor
101821244|NCT04000386|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101821245|NCT04000386|Protective Agents|protective agents|mesh-ancestor
101821246|NCT04000386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293941|NCT01972984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293942|NCT01972984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101293943|NCT01972984|Hormone Antagonists|hormone antagonists|mesh-ancestor
101293944|NCT01972984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101293945|NCT01972984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293947|NCT01973010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101293948|NCT01973010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101293949|NCT01973010|Analgesics|analgesics|mesh-ancestor
101293950|NCT01973010|Sensory System Agents|sensory system agents|mesh-ancestor
101293951|NCT01973010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101293952|NCT01973010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293953|NCT01973010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101293954|NCT01973010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101293955|NCT01973010|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101293956|NCT01973010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101293957|NCT01973010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293958|NCT01973101|Cisplatin|cisplatin|mesh-list
101293959|NCT01973101|Gemcitabine|gemcitabine|mesh-list
101293960|NCT01973101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101293961|NCT01973101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101293962|NCT01973101|Antimetabolites|antimetabolites|mesh-ancestor
101293963|NCT01973101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293964|NCT01973114|Latanoprost|latanoprost|mesh-list
101293965|NCT01973114|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101293966|NCT01973114|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101293967|NCT01973140|Tolvaptan|tolvaptan|mesh-list
101293968|NCT01973140|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101293969|NCT01973140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293970|NCT01973140|Natriuretic Agents|natriuretic agents|mesh-ancestor
101293971|NCT01973140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293972|NCT01973309|Paclitaxel|paclitaxel|mesh-list
101293973|NCT01973309|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101293974|NCT01973309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101293975|NCT01973309|Tubulin Modulators|tubulin modulators|mesh-ancestor
101293976|NCT01973309|Antimitotic Agents|antimitotic agents|mesh-ancestor
101293977|NCT01973309|Mitosis Modulators|mitosis modulators|mesh-ancestor
101293978|NCT01973309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293979|NCT01973322|Vaccines|vaccines|mesh-list
101293980|NCT01973322|Complement Factor H|complement factor h|mesh-list
101293981|NCT01973322|Immunologic Factors|immunologic factors|mesh-ancestor
101293982|NCT01973322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293983|NCT01973322|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101293984|NCT01973322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101293985|NCT01973400|Tocotrienols|tocotrienols|mesh-list
101293986|NCT01973400|Vitamin E|vitamin e|mesh-list
101293987|NCT01973400|Tocopherols|tocopherols|mesh-list
101293988|NCT01973400|Antioxidants|antioxidants|mesh-ancestor
101293989|NCT01973400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101293990|NCT01973400|Protective Agents|protective agents|mesh-ancestor
101293991|NCT01973400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821248|NCT00998088|Hematinics|hematinics|mesh-ancestor
101821249|NCT00377962|Mycophenolic Acid|mycophenolic acid|mesh-list
101821250|NCT00377962|Everolimus|everolimus|mesh-list
101821251|NCT00377962|Azathioprine|azathioprine|mesh-list
101821252|NCT00377962|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
101821253|NCT00377962|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101821254|NCT00377962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101821255|NCT00377962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312747|NCT00006451|Antiemetics|antiemetics|mesh-ancestor
101821256|NCT00377962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821257|NCT00377962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101821258|NCT00377962|Immunologic Factors|immunologic factors|mesh-ancestor
101246517|NCT01666522|Vitamins|vitamins|mesh-ancestor
101293992|NCT01973400|Vitamins|vitamins|mesh-ancestor
101293993|NCT01973400|Micronutrients|micronutrients|mesh-ancestor
101293994|NCT01973504|Chrysarobin|chrysarobin|mesh-list
101293995|NCT01973504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101293996|NCT01973504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101293997|NCT01973504|Analgesics|analgesics|mesh-ancestor
101293998|NCT01973504|Sensory System Agents|sensory system agents|mesh-ancestor
101293999|NCT01973504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101294000|NCT01973504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294001|NCT01973504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101294002|NCT01973504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101294003|NCT01973517|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
101294004|NCT01973517|Hematinics|hematinics|mesh-ancestor
101294005|NCT01973517|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101294006|NCT01973517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101294007|NCT01973660|Tamoxifen|tamoxifen|mesh-list
101294008|NCT01973660|Paclitaxel|paclitaxel|mesh-list
101294009|NCT01973660|Trastuzumab|trastuzumab|mesh-list
101294010|NCT01973660|Letrozole|letrozole|mesh-list
101294011|NCT01973660|Lapatinib|lapatinib|mesh-list
101294012|NCT01973660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101294013|NCT01973660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101294014|NCT01973660|Tubulin Modulators|tubulin modulators|mesh-ancestor
101294015|NCT01973660|Antimitotic Agents|antimitotic agents|mesh-ancestor
101294016|NCT01973660|Mitosis Modulators|mitosis modulators|mesh-ancestor
101294017|NCT01973660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294018|NCT01973660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101294019|NCT01973660|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101294020|NCT01973660|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101294021|NCT01973660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101294022|NCT01973660|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101294023|NCT01973660|Hormone Antagonists|hormone antagonists|mesh-ancestor
101294024|NCT01973660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101294025|NCT01973660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294026|NCT01973660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101294027|NCT01973660|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101294028|NCT01973660|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101294029|NCT01973660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101294030|NCT01973660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101294031|NCT01973751|Budesonide|budesonide|mesh-list
101294032|NCT01973751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101294033|NCT01973751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101294034|NCT01973751|Autonomic Agents|autonomic agents|mesh-ancestor
101294035|NCT01973751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101294036|NCT01973751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294037|NCT01973751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101294038|NCT01973751|Respiratory System Agents|respiratory system agents|mesh-ancestor
101294039|NCT01973751|Glucocorticoids|glucocorticoids|mesh-ancestor
101294040|NCT01973751|Hormones|hormones|mesh-ancestor
101821259|NCT00377962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821260|NCT00377962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821261|NCT00377962|Antimetabolites|antimetabolites|mesh-ancestor
101821262|NCT00377962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101821263|NCT00377962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101821264|NCT00377962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101821265|NCT00377962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101821266|NCT00377962|Antitubercular Agents|antitubercular agents|mesh-ancestor
101821267|NCT00377962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101821268|NCT00377962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101294041|NCT01973751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101294042|NCT01973790|Z 338|z 338|mesh-list
101294043|NCT01973790|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101294044|NCT01973790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101294045|NCT01973790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294046|NCT01973790|Cholinergic Agents|cholinergic agents|mesh-ancestor
101294047|NCT01973790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101294048|NCT01973790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294049|NCT01973790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101294050|NCT01973816|Cyproterone Acetate|cyproterone acetate|mesh-list
101294051|NCT01973816|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101294052|NCT01973816|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101294053|NCT01973816|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101294054|NCT01973816|Estradiol|estradiol|mesh-list
101294055|NCT01973816|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101294056|NCT01973816|Cyproterone|cyproterone|mesh-list
101294057|NCT01973816|Estrogens|estrogens|mesh-ancestor
101294058|NCT01973816|Hormones|hormones|mesh-ancestor
101294059|NCT01973816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101317058|NCT00005870|Antimetabolites|antimetabolites|mesh-ancestor
101294060|NCT01973816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294061|NCT01973816|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101294062|NCT01973816|Contraceptive Agents|contraceptive agents|mesh-ancestor
101294063|NCT01973816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101294064|NCT01973816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101294065|NCT01973816|Androgen Antagonists|androgen antagonists|mesh-ancestor
101294066|NCT01973816|Hormone Antagonists|hormone antagonists|mesh-ancestor
101294067|NCT01973816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101294068|NCT01973816|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101294069|NCT01973816|Luteolytic Agents|luteolytic agents|mesh-ancestor
101294070|NCT01973816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101294071|NCT01973842|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101294072|NCT01973842|Luteolytic Agents|luteolytic agents|mesh-ancestor
101294073|NCT01973842|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101294074|NCT01973842|Contraceptive Agents|contraceptive agents|mesh-ancestor
101294075|NCT01973842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101294076|NCT01973842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294077|NCT01973842|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101294078|NCT01973842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101294079|NCT01973842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101294080|NCT01973855|Ribavirin|ribavirin|mesh-list
101294081|NCT01973855|Antimetabolites|antimetabolites|mesh-ancestor
101294082|NCT01973855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294083|NCT01973855|Antiviral Agents|antiviral agents|mesh-ancestor
101294084|NCT01973855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101294085|NCT01973868|Cetuximab|cetuximab|mesh-list
101294086|NCT01973868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101294087|NCT01973868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101294088|NCT01973920|Insulin|insulin|mesh-list
101294089|NCT01973920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101294090|NCT01973920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294091|NCT01973933|Metformin|metformin|mesh-list
101294092|NCT01973933|Pyrimethamine|pyrimethamine|mesh-list
101821270|NCT00424749|Rituximab|rituximab|mesh-list
101821271|NCT00424749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101821272|NCT00424749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821273|NCT00424749|Immunologic Factors|immunologic factors|mesh-ancestor
101821274|NCT00424749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821275|NCT00424749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101821276|NCT00424749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101821277|NCT00424749|Glucocorticoids|glucocorticoids|mesh-ancestor
101294093|NCT01973933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101294094|NCT01973933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294095|NCT01973933|Antimalarials|antimalarials|mesh-ancestor
101294096|NCT01973933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101294097|NCT01973933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101294098|NCT01973933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101294099|NCT01973933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101294100|NCT01973933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101294101|NCT01973933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294103|NCT01974024|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101294104|NCT01974024|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101294106|NCT01974024|Prednisolone acetate|prednisolone acetate|mesh-list
101294107|NCT01974024|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101294108|NCT01974024|Prednisolone phosphate|prednisolone phosphate|mesh-list
101294109|NCT01974024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101294110|NCT01974024|Antiemetics|antiemetics|mesh-ancestor
101294111|NCT01974024|Autonomic Agents|autonomic agents|mesh-ancestor
101294112|NCT01974024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101294113|NCT01974024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294114|NCT01974024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101294115|NCT01974024|Glucocorticoids|glucocorticoids|mesh-ancestor
101294116|NCT01974024|Hormones|hormones|mesh-ancestor
101294117|NCT01974024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101294118|NCT01974024|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101294119|NCT01974024|Protective Agents|protective agents|mesh-ancestor
101294120|NCT01974024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101294121|NCT01974024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101294122|NCT01974037|Capsaicin|capsaicin|mesh-list
101294123|NCT01974037|Antipruritics|antipruritics|mesh-ancestor
101294124|NCT01974037|Dermatologic Agents|dermatologic agents|mesh-ancestor
101294125|NCT01974037|Sensory System Agents|sensory system agents|mesh-ancestor
101294126|NCT01974037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101294127|NCT01974037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294129|NCT01974167|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
101294130|NCT01974167|Eldecalcitol|eldecalcitol|mesh-list
101294131|NCT01974167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101294132|NCT01974167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294133|NCT01974167|Vitamins|vitamins|mesh-ancestor
101294134|NCT01974167|Micronutrients|micronutrients|mesh-ancestor
101294135|NCT01974258|Vemurafenib|vemurafenib|mesh-list
101294136|NCT01974258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101294137|NCT01974258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101294138|NCT01974258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101294139|NCT01974258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294140|NCT01974297|Atorvastatin|atorvastatin|mesh-list
101294141|NCT01974297|Fenofibric acid|fenofibric acid|mesh-list
101294142|NCT01974297|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101294143|NCT01974297|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101294144|NCT01974297|Antimetabolites|antimetabolites|mesh-ancestor
101294145|NCT01974297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294146|NCT01974297|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101294147|NCT01974297|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101294148|NCT01974297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101294149|NCT01974336|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101294150|NCT01974336|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101294151|NCT01974336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101294152|NCT01974375|Fluconazole|fluconazole|mesh-list
101294154|NCT01974375|Antifungal Agents|antifungal agents|mesh-ancestor
101294155|NCT01974375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101821278|NCT00424749|Hormones|hormones|mesh-ancestor
101821279|NCT00424749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101821280|NCT00424749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101821281|NCT00424593|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101821282|NCT00424593|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101294156|NCT01974375|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101294157|NCT01974375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101294158|NCT01974375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101294159|NCT01974375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294160|NCT01974375|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101294161|NCT01974375|Hormone Antagonists|hormone antagonists|mesh-ancestor
101294162|NCT01974375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101294163|NCT01974375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294164|NCT01974375|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101294165|NCT01974375|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101294166|NCT01974401|Chlorhexidine|chlorhexidine|mesh-list
101294167|NCT01974401|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101294168|NCT01974401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101294169|NCT01974401|Disinfectants|disinfectants|mesh-ancestor
101294170|NCT01974518|Cyclophosphamide|cyclophosphamide|mesh-list
101294171|NCT01974518|Rituximab|rituximab|mesh-list
101294172|NCT01974518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101294173|NCT01974518|Immunologic Factors|immunologic factors|mesh-ancestor
101294174|NCT01974518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294176|NCT01974518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101294177|NCT01974518|Alkylating Agents|alkylating agents|mesh-ancestor
101294178|NCT01974518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294179|NCT01974518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101294180|NCT01974518|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101294181|NCT01974518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101294182|NCT01974622|Verteporfin|verteporfin|mesh-list
101294183|NCT01974622|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101294184|NCT01974622|Dermatologic Agents|dermatologic agents|mesh-ancestor
101294185|NCT01974648|Remifentanil|remifentanil|mesh-list
101294186|NCT01974648|Propofol|propofol|mesh-list
101294187|NCT01974648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101294188|NCT01974648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101294189|NCT01974648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294190|NCT01974648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101294191|NCT01974648|Anesthetics, General|anesthetics, general|mesh-ancestor
101294192|NCT01974648|Anesthetics|anesthetics|mesh-ancestor
101294193|NCT01974648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101294194|NCT01974648|Narcotics|narcotics|mesh-ancestor
101294195|NCT01974648|Analgesics|analgesics|mesh-ancestor
101294196|NCT01974648|Sensory System Agents|sensory system agents|mesh-ancestor
101294197|NCT01974648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101294198|NCT01974843|Bupivacaine|bupivacaine|mesh-list
101294199|NCT01974843|Levobupivacaine|levobupivacaine|mesh-list
101294200|NCT01974843|Anesthetics, Local|anesthetics, local|mesh-ancestor
101294201|NCT01974843|Anesthetics|anesthetics|mesh-ancestor
101294202|NCT01974843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101294203|NCT01974843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294204|NCT01974843|Sensory System Agents|sensory system agents|mesh-ancestor
101294205|NCT01974843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101294206|NCT01974934|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101294207|NCT01974934|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101294208|NCT01974934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101294209|NCT01974934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101294210|NCT01974934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294211|NCT01974934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101294212|NCT01974934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294213|NCT01974934|Antidepressive Agents|antidepressive agents|mesh-ancestor
101294214|NCT01974934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101294215|NCT01975012|Rilpivirine|rilpivirine|mesh-list
101294216|NCT01975012|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101294217|NCT01975012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101821283|NCT00424593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101821284|NCT00424593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101821285|NCT00424593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821286|NCT00424593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101821287|NCT00424593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821288|NCT00424593|Analgesics|analgesics|mesh-ancestor
101294218|NCT01975012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101294219|NCT01975012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294221|NCT01975012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101294222|NCT01975012|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101294223|NCT01975012|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101294224|NCT01975051|Miltefosine|miltefosine|mesh-list
101294225|NCT01975051|Antifungal Agents|antifungal agents|mesh-ancestor
101294226|NCT01975051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101294227|NCT01975051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101294228|NCT01975051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101294229|NCT01975051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101294231|NCT01975129|Oxytocics|oxytocics|mesh-ancestor
101294232|NCT01975129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101294233|NCT01975129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294234|NCT01975142|Trastuzumab|trastuzumab|mesh-list
101294235|NCT01975142|Maytansine|maytansine|mesh-list
101294236|NCT01975142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101294237|NCT01975142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101294238|NCT01975142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101294239|NCT01975142|Tubulin Modulators|tubulin modulators|mesh-ancestor
101294240|NCT01975142|Antimitotic Agents|antimitotic agents|mesh-ancestor
101294241|NCT01975142|Mitosis Modulators|mitosis modulators|mesh-ancestor
101294242|NCT01975142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294243|NCT01975194|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101294244|NCT01975194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101294245|NCT01975194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101294246|NCT01975194|Antimetabolites|antimetabolites|mesh-ancestor
101294247|NCT01975194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294248|NCT01975194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101294249|NCT01975194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101294250|NCT01975194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101294251|NCT01975259|Glucagon|glucagon|mesh-list
101294252|NCT01975259|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
101294253|NCT01975259|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101294254|NCT01975259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101294255|NCT01975259|Hormones|hormones|mesh-ancestor
101294256|NCT01975259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101294257|NCT01975259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294258|NCT01975259|Incretins|incretins|mesh-ancestor
101294259|NCT01975324|4-Aminopyridine|4-aminopyridine|mesh-list
101294260|NCT01975324|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101294261|NCT01975324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101294262|NCT01975324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294263|NCT01975363|Curcumin|curcumin|mesh-list
101294264|NCT01975363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101294265|NCT01975363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101294266|NCT01975363|Analgesics|analgesics|mesh-ancestor
101294267|NCT01975363|Sensory System Agents|sensory system agents|mesh-ancestor
101294268|NCT01975363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101294269|NCT01975363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294270|NCT01975363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101294271|NCT01975363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101294272|NCT01975363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101294273|NCT01975363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101294274|NCT01975363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294276|NCT01975441|Albendazole|albendazole|mesh-list
101294277|NCT01975441|Diethylcarbamazine|diethylcarbamazine|mesh-list
101294278|NCT01975441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101294279|NCT01975441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101294280|NCT01975441|Anthelmintics|anthelmintics|mesh-ancestor
101821289|NCT00424593|Sensory System Agents|sensory system agents|mesh-ancestor
101821290|NCT00424593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101821291|NCT00424593|Antidepressive Agents|antidepressive agents|mesh-ancestor
101821292|NCT00424593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101821293|NCT00424593|Dopamine Agents|dopamine agents|mesh-ancestor
101821294|NCT00369382|Cyclosporine|cyclosporine|mesh-list
101821295|NCT00369382|Sirolimus|sirolimus|mesh-list
101821296|NCT00369382|Tacrolimus|tacrolimus|mesh-list
101821297|NCT00369382|Cyclosporins|cyclosporins|mesh-list
101821298|NCT00369382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101294281|NCT01975441|Anticestodal Agents|anticestodal agents|mesh-ancestor
101294282|NCT01975441|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101294283|NCT01975441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101294284|NCT01975441|Tubulin Modulators|tubulin modulators|mesh-ancestor
101294285|NCT01975441|Antimitotic Agents|antimitotic agents|mesh-ancestor
101294286|NCT01975441|Mitosis Modulators|mitosis modulators|mesh-ancestor
101294287|NCT01975441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294288|NCT01975441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101294289|NCT01975441|Filaricides|filaricides|mesh-ancestor
101294290|NCT01975441|Antinematodal Agents|antinematodal agents|mesh-ancestor
101294291|NCT01975441|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101294292|NCT01975441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101294293|NCT01975454|Capecitabine|capecitabine|mesh-list
101294294|NCT01975454|Oxaliplatin|oxaliplatin|mesh-list
101294295|NCT01975454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101294296|NCT01975454|Antimetabolites|antimetabolites|mesh-ancestor
101294297|NCT01975454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294298|NCT01975454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101408787|NCT00110240|Vildagliptin|vildagliptin|mesh-list
101294299|NCT01975480|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101294300|NCT01975480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101294301|NCT01975480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101294302|NCT01975480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101294303|NCT01975480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294304|NCT01975480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101294305|NCT01975480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294306|NCT01975480|Antidepressive Agents|antidepressive agents|mesh-ancestor
101294307|NCT01975480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101294308|NCT01975662|Vancomycin|vancomycin|mesh-list
101294309|NCT01975662|Daptomycin|daptomycin|mesh-list
101294310|NCT01975662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101294311|NCT01975662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101294312|NCT01975688|Nabiximols|nabiximols|mesh-list
101294313|NCT01975688|Analgesics|analgesics|mesh-ancestor
101294314|NCT01975688|Sensory System Agents|sensory system agents|mesh-ancestor
101294315|NCT01975688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101294316|NCT01975688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294317|NCT01975714|Bimatoprost|bimatoprost|mesh-list
101294318|NCT01975714|Latanoprost|latanoprost|mesh-list
101294319|NCT01975714|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101294320|NCT01975714|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101294321|NCT01975714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101294322|NCT01975727|Dexamethasone|dexamethasone|mesh-list
101294323|NCT01975727|Dexamethasone acetate|dexamethasone acetate|mesh-list
101294324|NCT01975727|BB 1101|bb 1101|mesh-list
101294325|NCT01975727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101294326|NCT01975727|Antiemetics|antiemetics|mesh-ancestor
101294327|NCT01975727|Autonomic Agents|autonomic agents|mesh-ancestor
101294328|NCT01975727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101294329|NCT01975727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294330|NCT01975727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101294331|NCT01975727|Glucocorticoids|glucocorticoids|mesh-ancestor
101294332|NCT01975727|Hormones|hormones|mesh-ancestor
101294333|NCT01975727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101294334|NCT01975727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101821299|NCT00369382|Immunologic Factors|immunologic factors|mesh-ancestor
101821300|NCT00369382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821301|NCT00369382|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101821302|NCT00369382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101821303|NCT00369382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821304|NCT00369382|Antifungal Agents|antifungal agents|mesh-ancestor
101821305|NCT00369382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101821306|NCT00369382|Dermatologic Agents|dermatologic agents|mesh-ancestor
101821307|NCT00369382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101821308|NCT00369382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101294335|NCT01975727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101294336|NCT01975727|Protease Inhibitors|protease inhibitors|mesh-ancestor
101294337|NCT01975727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101294338|NCT01975727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294339|NCT01975753|Fentanyl|fentanyl|mesh-list
101294340|NCT01975753|Morphine|morphine|mesh-list
101294341|NCT01975753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101294342|NCT01975753|Narcotics|narcotics|mesh-ancestor
101294343|NCT01975753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101317073|NCT00017407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101294344|NCT01975753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294345|NCT01975753|Analgesics|analgesics|mesh-ancestor
101294346|NCT01975753|Sensory System Agents|sensory system agents|mesh-ancestor
101294347|NCT01975753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101294348|NCT01975753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101294349|NCT01975753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101294350|NCT01975753|Anesthetics, General|anesthetics, general|mesh-ancestor
101294351|NCT01975753|Anesthetics|anesthetics|mesh-ancestor
101294352|NCT01975779|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
101294353|NCT01975779|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101294354|NCT01975779|Serotonin Agents|serotonin agents|mesh-ancestor
101294355|NCT01975779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101294356|NCT01975779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294357|NCT01975779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294358|NCT01975805|Chlorhexidine|chlorhexidine|mesh-list
101294359|NCT01975805|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101294360|NCT01975805|Povidone-Iodine|povidone-iodine|mesh-list
101294361|NCT01975805|Povidone|povidone|mesh-list
101294362|NCT01975805|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101294363|NCT01975805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101294364|NCT01975805|Disinfectants|disinfectants|mesh-ancestor
101294365|NCT01975805|Dermatologic Agents|dermatologic agents|mesh-ancestor
101294366|NCT01975805|Plasma Substitutes|plasma substitutes|mesh-ancestor
101294367|NCT01975805|Blood Substitutes|blood substitutes|mesh-ancestor
101294368|NCT01975961|Telmisartan|telmisartan|mesh-list
101294369|NCT01975961|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101294370|NCT01975961|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101294371|NCT01975961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101294372|NCT01975961|Antimetabolites|antimetabolites|mesh-ancestor
101294373|NCT01975961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294374|NCT01975961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101294375|NCT01975961|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101294376|NCT01975961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101294377|NCT01975961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101294378|NCT01975961|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101294379|NCT01975961|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101294380|NCT01976078|Midazolam|midazolam|mesh-list
101294381|NCT01976078|Esomeprazole|esomeprazole|mesh-list
101294382|NCT01976078|Ranitidine|ranitidine|mesh-list
101294383|NCT01976078|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
101294384|NCT01976078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101294385|NCT01976078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101294386|NCT01976078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101294387|NCT01976078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294388|NCT01976078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101821310|NCT00369382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821311|NCT00424515|Imatinib Mesylate|imatinib mesylate|mesh-list
101821312|NCT00424515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821313|NCT00424515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101821314|NCT00424515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101821315|NCT00424515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821316|NCT00377260|Amoxicillin|amoxicillin|mesh-list
101821317|NCT00377260|Clavulanic Acid|clavulanic acid|mesh-list
101821318|NCT00377260|Clavulanic Acids|clavulanic acids|mesh-list
101821319|NCT00377260|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101294389|NCT01976078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101294390|NCT01976078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101294391|NCT01976078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101294392|NCT01976078|Anesthetics, General|anesthetics, general|mesh-ancestor
101294393|NCT01976078|Anesthetics|anesthetics|mesh-ancestor
101294394|NCT01976078|GABA Modulators|gaba modulators|mesh-ancestor
101294395|NCT01976078|GABA Agents|gaba agents|mesh-ancestor
101294396|NCT01976078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101294397|NCT01976078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294398|NCT01976078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101294399|NCT01976078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101294400|NCT01976078|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101294401|NCT01976078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101294402|NCT01976078|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101294403|NCT01976078|Histamine Antagonists|histamine antagonists|mesh-ancestor
101294404|NCT01976078|Histamine Agents|histamine agents|mesh-ancestor
101294405|NCT01976143|Etirinotecan pegol|etirinotecan pegol|mesh-list
101294406|NCT01976143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101294407|NCT01976143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101294408|NCT01976143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101294409|NCT01976143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101294410|NCT01976143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294411|NCT01976195|Thalidomide|thalidomide|mesh-list
101294413|NCT01976195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101294414|NCT01976195|Antiemetics|antiemetics|mesh-ancestor
101294415|NCT01976195|Autonomic Agents|autonomic agents|mesh-ancestor
101294416|NCT01976195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101294417|NCT01976195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294418|NCT01976195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101294419|NCT01976195|Glucocorticoids|glucocorticoids|mesh-ancestor
101294420|NCT01976195|Hormones|hormones|mesh-ancestor
101294421|NCT01976195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101294422|NCT01976195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101294423|NCT01976195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101294424|NCT01976195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101294425|NCT01976195|Immunologic Factors|immunologic factors|mesh-ancestor
101294426|NCT01976195|Leprostatic Agents|leprostatic agents|mesh-ancestor
101294427|NCT01976195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101294428|NCT01976195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101294429|NCT01976195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101294430|NCT01976195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101294431|NCT01976195|Growth Substances|growth substances|mesh-ancestor
101294432|NCT01976195|Growth Inhibitors|growth inhibitors|mesh-ancestor
101294433|NCT01976208|Omalizumab|omalizumab|mesh-list
101294434|NCT01976208|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101294435|NCT01976208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101294436|NCT01976208|Respiratory System Agents|respiratory system agents|mesh-ancestor
101294437|NCT01976520|Vaccines|vaccines|mesh-list
101294438|NCT01976520|Immunologic Factors|immunologic factors|mesh-ancestor
101294439|NCT01976520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294440|NCT01976611|Botulinum Toxins|botulinum toxins|mesh-list
101294441|NCT01976611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101821320|NCT00377260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101821321|NCT00377260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101821322|NCT00377260|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101821323|NCT00377260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101821324|NCT00377260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821325|NCT00441441|Fluticasone|fluticasone|mesh-list
101821326|NCT00441441|Xhance|xhance|mesh-list
101821327|NCT00441441|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101821328|NCT00441441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101821329|NCT00441441|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101821330|NCT00441441|Autonomic Agents|autonomic agents|mesh-ancestor
101294442|NCT01976611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101294443|NCT01976611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101294444|NCT01976611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101294445|NCT01976611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294446|NCT01976611|Cholinergic Agents|cholinergic agents|mesh-ancestor
101294447|NCT01976611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101294448|NCT01976611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294449|NCT01976611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101294450|NCT01976611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101294451|NCT01976676|Folic Acid|folic acid|mesh-list
101294452|NCT01976676|Hematinics|hematinics|mesh-ancestor
101294453|NCT01976676|Vitamin B Complex|vitamin b complex|mesh-ancestor
101294454|NCT01976676|Vitamins|vitamins|mesh-ancestor
101294455|NCT01976676|Micronutrients|micronutrients|mesh-ancestor
101294456|NCT01976676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294457|NCT01976780|Artesunate|artesunate|mesh-list
101294458|NCT01976780|Lumefantrine|lumefantrine|mesh-list
101294459|NCT01976780|Artemether|artemether|mesh-list
101294460|NCT01976780|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101294461|NCT01976780|Mefloquine|mefloquine|mesh-list
101294462|NCT01976780|Antimalarials|antimalarials|mesh-ancestor
101294463|NCT01976780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101294464|NCT01976780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101294465|NCT01976780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101294466|NCT01976780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101294467|NCT01976780|Antiviral Agents|antiviral agents|mesh-ancestor
101294468|NCT01976780|Schistosomicides|schistosomicides|mesh-ancestor
101294469|NCT01976780|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101294470|NCT01976780|Anthelmintics|anthelmintics|mesh-ancestor
101294471|NCT01976923|Bevacizumab|bevacizumab|mesh-list
101294472|NCT01976923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101294473|NCT01976923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101294474|NCT01976923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101294475|NCT01976923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101294476|NCT01976923|Growth Substances|growth substances|mesh-ancestor
101294477|NCT01976923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294478|NCT01976923|Growth Inhibitors|growth inhibitors|mesh-ancestor
101294479|NCT01976936|Lovastatin|lovastatin|mesh-list
101294480|NCT01976936|L 647318|l 647318|mesh-list
101294481|NCT01976936|Dihydromevinolin|dihydromevinolin|mesh-list
101294482|NCT01976936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101294483|NCT01976936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101294484|NCT01976936|Antimetabolites|antimetabolites|mesh-ancestor
101294485|NCT01976936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294486|NCT01976936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101294487|NCT01976936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101294488|NCT01976936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101294489|NCT01977118|Streptokinase|streptokinase|mesh-list
101294490|NCT01977118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101294491|NCT01977118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101294492|NCT01977118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294494|NCT01977209|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101294495|NCT01977209|Contraceptive Agents|contraceptive agents|mesh-ancestor
101294496|NCT01977209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101294497|NCT01977209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821331|NCT00441441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101821332|NCT00441441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821333|NCT00441441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101821334|NCT00441441|Respiratory System Agents|respiratory system agents|mesh-ancestor
101821335|NCT00441441|Dermatologic Agents|dermatologic agents|mesh-ancestor
101821336|NCT00441441|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101821337|NCT00441441|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101294498|NCT01977300|Valproic Acid|valproic acid|mesh-list
101294499|NCT01977300|Olanzapine|olanzapine|mesh-list
101294500|NCT01977300|Risperidone|risperidone|mesh-list
101294501|NCT01977300|Lithium Carbonate|lithium carbonate|mesh-list
101294502|NCT01977300|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101294503|NCT01977300|Serotonin Agents|serotonin agents|mesh-ancestor
101294504|NCT01977300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101294505|NCT01977300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294506|NCT01977300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294507|NCT01977300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101294508|NCT01977300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101294509|NCT01977300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101294510|NCT01977300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101294511|NCT01977300|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101294512|NCT01977300|Dopamine Agents|dopamine agents|mesh-ancestor
101294513|NCT01977300|Antiemetics|antiemetics|mesh-ancestor
101294514|NCT01977300|Autonomic Agents|autonomic agents|mesh-ancestor
101294515|NCT01977300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101294516|NCT01977300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101294517|NCT01977300|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101294518|NCT01977300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101294519|NCT01977300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101294520|NCT01977300|Antidepressive Agents|antidepressive agents|mesh-ancestor
101294521|NCT01977300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101294522|NCT01977300|Antimanic Agents|antimanic agents|mesh-ancestor
101294523|NCT01977300|Anticonvulsants|anticonvulsants|mesh-ancestor
101294524|NCT01977300|GABA Agents|gaba agents|mesh-ancestor
101294525|NCT01977339|Bupivacaine|bupivacaine|mesh-list
101294526|NCT01977339|Anesthetics, Local|anesthetics, local|mesh-ancestor
101294527|NCT01977339|Anesthetics|anesthetics|mesh-ancestor
101294528|NCT01977339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101294529|NCT01977339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294530|NCT01977339|Sensory System Agents|sensory system agents|mesh-ancestor
101294531|NCT01977339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101294532|NCT01977378|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101294533|NCT01977378|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101294534|NCT01977378|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101294535|NCT01977378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101294536|NCT01977378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101294537|NCT01977378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294538|NCT01977378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101294539|NCT01977378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294540|NCT01977378|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101294541|NCT01977378|Antidepressive Agents|antidepressive agents|mesh-ancestor
101294542|NCT01977378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101294543|NCT01977417|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
101294544|NCT01977417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101294546|NCT01977417|Analgesics|analgesics|mesh-ancestor
101294547|NCT01977417|Sensory System Agents|sensory system agents|mesh-ancestor
101294548|NCT01977417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101294549|NCT01977417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294550|NCT01977417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101294551|NCT01977417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101294552|NCT01977430|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101294553|NCT01977430|Furosemide|furosemide|mesh-list
101294554|NCT01977430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101294555|NCT01977430|Diuretics|diuretics|mesh-ancestor
101294556|NCT01977430|Natriuretic Agents|natriuretic agents|mesh-ancestor
101294557|NCT01977430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294558|NCT01977430|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101821338|NCT00441441|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101821339|NCT00441441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101821340|NCT00441441|Adrenergic Agents|adrenergic agents|mesh-ancestor
101821341|NCT00441441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101821342|NCT00441441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821343|NCT00436917|Zoledronic Acid|zoledronic acid|mesh-list
101821344|NCT00436917|Letrozole|letrozole|mesh-list
101821345|NCT00436917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821346|NCT00436917|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101246518|NCT01666522|Micronutrients|micronutrients|mesh-ancestor
101294559|NCT01977430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101294560|NCT01977430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294561|NCT01977430|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101294562|NCT01977235|Irinotecan|irinotecan|mesh-list
101294563|NCT01977235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101294564|NCT01977235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101294565|NCT01977235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101294566|NCT01977235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101294567|NCT01977235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294568|NCT01977443|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101294569|NCT01977443|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101294570|NCT01977859|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101294571|NCT01977859|Natriuretic Agents|natriuretic agents|mesh-ancestor
101294572|NCT01977859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294573|NCT01977989|Vancomycin|vancomycin|mesh-list
101294574|NCT01977989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101294575|NCT01977989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101294576|NCT01978015|Timolol|timolol|mesh-list
101294577|NCT01978015|Bimatoprost|bimatoprost|mesh-list
101294578|NCT01978015|Travoprost|travoprost|mesh-list
101294579|NCT01978015|Dextrans|dextrans|mesh-list
101294580|NCT01978015|Latanoprost|latanoprost|mesh-list
101294581|NCT01978015|Maleic acid|maleic acid|mesh-list
101294582|NCT01978015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101294583|NCT01978015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294584|NCT01978015|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101294585|NCT01978015|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101294586|NCT01978015|Adrenergic Agents|adrenergic agents|mesh-ancestor
101294587|NCT01978015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101294588|NCT01978015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294589|NCT01978015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101294590|NCT01978015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101294591|NCT01978015|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101294592|NCT01978015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101294593|NCT01978015|Anticoagulants|anticoagulants|mesh-ancestor
101294594|NCT01978015|Plasma Substitutes|plasma substitutes|mesh-ancestor
101294595|NCT01978015|Blood Substitutes|blood substitutes|mesh-ancestor
101294596|NCT01978041|Fluorides|fluorides|mesh-list
101294597|NCT01978041|Cariostatic Agents|cariostatic agents|mesh-ancestor
101294598|NCT01978041|Protective Agents|protective agents|mesh-ancestor
101294599|NCT01978041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294600|NCT01978301|Triamcinolone|triamcinolone|mesh-list
101294601|NCT01978301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101294602|NCT01978301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101294603|NCT01978301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101294604|NCT01978301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101294605|NCT01978301|Glucocorticoids|glucocorticoids|mesh-ancestor
101294606|NCT01978301|Hormones|hormones|mesh-ancestor
101294607|NCT01978301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101294609|NCT01978301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101294610|NCT01978301|Immunologic Factors|immunologic factors|mesh-ancestor
101294611|NCT01978301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101294612|NCT01978301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294613|NCT01978405|Thioctic Acid|thioctic acid|mesh-list
101294614|NCT01978405|Antioxidants|antioxidants|mesh-ancestor
101821347|NCT00436917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101821348|NCT00436917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101821349|NCT00436917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821350|NCT00436917|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101821351|NCT00436917|Hormone Antagonists|hormone antagonists|mesh-ancestor
101821352|NCT00436917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101821353|NCT00436917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821354|NCT00436917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101294615|NCT01978405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294616|NCT01978405|Protective Agents|protective agents|mesh-ancestor
101294617|NCT01978405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294619|NCT01978405|Vitamins|vitamins|mesh-ancestor
101294620|NCT01978405|Micronutrients|micronutrients|mesh-ancestor
101294621|NCT01978418|Albuterol|albuterol|mesh-list
101294622|NCT01978418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101294623|NCT01978418|Autonomic Agents|autonomic agents|mesh-ancestor
101294624|NCT01978418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101294625|NCT01978418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294626|NCT01978418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101294627|NCT01978418|Respiratory System Agents|respiratory system agents|mesh-ancestor
101294628|NCT01978418|Tocolytic Agents|tocolytic agents|mesh-ancestor
101294629|NCT01978418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101294630|NCT01978418|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101294631|NCT01978418|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101294632|NCT01978418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101294633|NCT01978418|Adrenergic Agents|adrenergic agents|mesh-ancestor
101294634|NCT01978418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101294635|NCT01978418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294636|NCT01978457|Propranolol|propranolol|mesh-list
101294637|NCT01978457|Cocaine|cocaine|mesh-list
101294638|NCT01978457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101294639|NCT01978457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101294641|NCT01978457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101294642|NCT01978457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294643|NCT01978457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294644|NCT01978457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101294645|NCT01978457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101294646|NCT01978457|Vasodilator Agents|vasodilator agents|mesh-ancestor
101294647|NCT01978457|Anesthetics, Local|anesthetics, local|mesh-ancestor
101294648|NCT01978457|Anesthetics|anesthetics|mesh-ancestor
101294649|NCT01978457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101294650|NCT01978457|Sensory System Agents|sensory system agents|mesh-ancestor
101294651|NCT01978457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101294652|NCT01978457|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101294653|NCT01978457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101294654|NCT01978457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101294655|NCT01978457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101294656|NCT01978457|Dopamine Agents|dopamine agents|mesh-ancestor
101294658|NCT01978483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101294659|NCT01978483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294660|NCT01978496|Eletriptan|eletriptan|mesh-list
101294661|NCT01978496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101294662|NCT01978496|Serotonin Agents|serotonin agents|mesh-ancestor
101294663|NCT01978496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101294664|NCT01978496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294665|NCT01978496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294666|NCT01978665|Prednisone|prednisone|mesh-list
101294667|NCT01978665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101294670|NCT01978665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101294671|NCT01978665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294672|NCT01978665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101294673|NCT01978665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101294674|NCT01978678|Budesonide|budesonide|mesh-list
101821356|NCT00436605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821357|NCT00436605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101821358|NCT00436605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101821359|NCT00436605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821360|NCT01034787|Tremelimumab|tremelimumab|mesh-list
101821361|NCT01034787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821362|NCT01028781|Thalidomide|thalidomide|mesh-list
101821363|NCT01028781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101821364|NCT01028781|Immunologic Factors|immunologic factors|mesh-ancestor
101821365|NCT01028781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821366|NCT01028781|Leprostatic Agents|leprostatic agents|mesh-ancestor
101294675|NCT01978678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101294676|NCT01978678|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101294677|NCT01978678|Autonomic Agents|autonomic agents|mesh-ancestor
101294678|NCT01978678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101294679|NCT01978678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294680|NCT01978678|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101294681|NCT01978678|Respiratory System Agents|respiratory system agents|mesh-ancestor
101294682|NCT01978678|Glucocorticoids|glucocorticoids|mesh-ancestor
101294683|NCT01978678|Hormones|hormones|mesh-ancestor
101294684|NCT01978678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101294685|NCT01978704|Insulin|insulin|mesh-list
101294686|NCT01978704|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101294687|NCT01978704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101294688|NCT01978704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294689|NCT01978717|Anesthetics|anesthetics|mesh-list
101294690|NCT01978717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101294691|NCT01978717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294692|NCT01978782|Raltegravir Potassium|raltegravir potassium|mesh-list
101294693|NCT01978782|Citalopram|citalopram|mesh-list
101294694|NCT01978782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101294695|NCT01978782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101294696|NCT01978782|Antiviral Agents|antiviral agents|mesh-ancestor
101294697|NCT01978782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101294698|NCT01978782|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101294699|NCT01978782|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101294700|NCT01978782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101294701|NCT01978782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294702|NCT01978782|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101294703|NCT01978782|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101294704|NCT01978782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101317091|NCT00001119|Ritonavir|ritonavir|mesh-list
101294705|NCT01978782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101294706|NCT01978782|Serotonin Agents|serotonin agents|mesh-ancestor
101294707|NCT01978782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294708|NCT01978782|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101294709|NCT01978782|Antidepressive Agents|antidepressive agents|mesh-ancestor
101294710|NCT01978782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101294711|NCT01978873|Ascorbic Acid|ascorbic acid|mesh-list
101294712|NCT01978873|Methyltestosterone|methyltestosterone|mesh-list
101294713|NCT01978873|Androgens|androgens|mesh-list
101294714|NCT01978873|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101294715|NCT01978873|Hormones|hormones|mesh-ancestor
101294716|NCT01978873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101294717|NCT01978873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294718|NCT01978873|Antioxidants|antioxidants|mesh-ancestor
101294719|NCT01978873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294720|NCT01978873|Protective Agents|protective agents|mesh-ancestor
101294721|NCT01978873|Vitamins|vitamins|mesh-ancestor
101294722|NCT01978873|Micronutrients|micronutrients|mesh-ancestor
101294723|NCT01978873|Estrogens|estrogens|mesh-ancestor
101821367|NCT01028781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101821368|NCT01028781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101821369|NCT01028781|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101821370|NCT01028781|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101821371|NCT01028781|Growth Substances|growth substances|mesh-ancestor
101821372|NCT01028781|Growth Inhibitors|growth inhibitors|mesh-ancestor
101294724|NCT01978873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101294725|NCT01978873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101294726|NCT01978873|Anabolic Agents|anabolic agents|mesh-ancestor
101294727|NCT01979341|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101294728|NCT01979341|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101294731|NCT01979341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101294732|NCT01979341|Contraceptive Agents|contraceptive agents|mesh-ancestor
101294733|NCT01979341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101294734|NCT01979341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101294735|NCT01979341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101294736|NCT01979341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101294738|NCT01979354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101294739|NCT01979354|Narcotics|narcotics|mesh-ancestor
101294740|NCT01979354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101294741|NCT01979354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294742|NCT01979354|Analgesics|analgesics|mesh-ancestor
101294743|NCT01979354|Sensory System Agents|sensory system agents|mesh-ancestor
101294744|NCT01979354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101294745|NCT01979406|Vaccines|vaccines|mesh-list
101294746|NCT01979406|Immunologic Factors|immunologic factors|mesh-ancestor
101294747|NCT01979406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294748|NCT01979510|Acetaminophen|acetaminophen|mesh-list
101294749|NCT01979510|Etoricoxib|etoricoxib|mesh-list
101294750|NCT01979510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101294751|NCT01979510|Analgesics|analgesics|mesh-ancestor
101294752|NCT01979510|Sensory System Agents|sensory system agents|mesh-ancestor
101294753|NCT01979510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101294754|NCT01979510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294755|NCT01979510|Antipyretics|antipyretics|mesh-ancestor
101294756|NCT01979510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101294757|NCT01979510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101294758|NCT01979510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101294759|NCT01979510|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101294760|NCT01979510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101294761|NCT01979510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101294762|NCT01979510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294763|NCT01979653|Midazolam|midazolam|mesh-list
101294764|NCT01979653|Dexmedetomidine|dexmedetomidine|mesh-list
101294765|NCT01979653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101294766|NCT01979653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101294767|NCT01979653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294768|NCT01979653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101294769|NCT01979653|Analgesics|analgesics|mesh-ancestor
101294770|NCT01979653|Sensory System Agents|sensory system agents|mesh-ancestor
101294771|NCT01979653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101294772|NCT01979653|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101294773|NCT01979653|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101294774|NCT01979653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101294775|NCT01979653|Adrenergic Agents|adrenergic agents|mesh-ancestor
101294776|NCT01979653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101294777|NCT01979653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294778|NCT01979653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101294779|NCT01979653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101294780|NCT01979653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101294781|NCT01979653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101294782|NCT01979653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101294783|NCT01979653|Anesthetics, General|anesthetics, general|mesh-ancestor
101294784|NCT01979653|Anesthetics|anesthetics|mesh-ancestor
101294785|NCT01979653|GABA Modulators|gaba modulators|mesh-ancestor
101294786|NCT01979653|GABA Agents|gaba agents|mesh-ancestor
101294787|NCT01979679|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
101294788|NCT01979679|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101312780|NCT00006457|Schistosomicides|schistosomicides|mesh-ancestor
101821373|NCT01028781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821375|NCT01031901|Temsirolimus|temsirolimus|mesh-list
101821376|NCT01031901|MTOR Inhibitors|mtor inhibitors|mesh-list
101821377|NCT01031901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101821378|NCT01031901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101821379|NCT01031901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101821380|NCT01031901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821381|NCT01031901|Antifungal Agents|antifungal agents|mesh-ancestor
101821382|NCT01031901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101294789|NCT01979679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101294790|NCT01979679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101294791|NCT01979679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294792|NCT01979679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101294793|NCT01979679|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101294794|NCT01979679|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101294795|NCT01979679|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101294796|NCT01979679|Adrenergic Agents|adrenergic agents|mesh-ancestor
101294797|NCT01979679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101294798|NCT01979679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294799|NCT01979679|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101294800|NCT01979679|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101294801|NCT01979679|Serotonin Agents|serotonin agents|mesh-ancestor
101294802|NCT01979679|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101294803|NCT01979679|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101294804|NCT01979679|Dopamine Agents|dopamine agents|mesh-ancestor
101294805|NCT01979965|Ranolazine|ranolazine|mesh-list
101294806|NCT01979965|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101294807|NCT01979965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101294808|NCT01979965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294809|NCT01980004|Potassium Citrate|potassium citrate|mesh-list
101294810|NCT01980004|Diuretics|diuretics|mesh-ancestor
101294811|NCT01980004|Natriuretic Agents|natriuretic agents|mesh-ancestor
101408797|NCT00455416|Quercetin|quercetin|mesh-list
101294812|NCT01980004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294813|NCT01980004|Expectorants|expectorants|mesh-ancestor
101294814|NCT01980004|Respiratory System Agents|respiratory system agents|mesh-ancestor
101294815|NCT01980069|Neostigmine|neostigmine|mesh-list
101294816|NCT01980069|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101294817|NCT01980069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101294818|NCT01980069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294819|NCT01980069|Cholinergic Agents|cholinergic agents|mesh-ancestor
101294820|NCT01980069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101294821|NCT01980069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294822|NCT01980069|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101294823|NCT01980069|Autonomic Agents|autonomic agents|mesh-ancestor
101294824|NCT01980069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101294825|NCT01980082|Cefazolin|cefazolin|mesh-list
101294826|NCT01980082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101294827|NCT01980082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101294828|NCT01980277|Paclitaxel|paclitaxel|mesh-list
101294829|NCT01980277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101294831|NCT01980277|Tubulin Modulators|tubulin modulators|mesh-ancestor
101294832|NCT01980277|Antimitotic Agents|antimitotic agents|mesh-ancestor
101294833|NCT01980277|Mitosis Modulators|mitosis modulators|mesh-ancestor
101294834|NCT01980277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294835|NCT01980303|Esketamine|esketamine|mesh-list
101294836|NCT01980303|Antidepressive Agents|antidepressive agents|mesh-ancestor
101294837|NCT01980303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101294838|NCT01980316|Heparin|heparin|mesh-list
101294839|NCT01980316|Calcium heparin|calcium heparin|mesh-list
101294840|NCT01980316|Argatroban|argatroban|mesh-list
101294841|NCT01980316|Anticoagulants|anticoagulants|mesh-ancestor
101294842|NCT01980316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101821383|NCT01031901|Immunologic Factors|immunologic factors|mesh-ancestor
101821384|NCT01031901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821385|NCT01031901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101821386|NCT01031901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101821387|NCT01031901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821388|NCT00368992|Paclitaxel|paclitaxel|mesh-list
101821389|NCT00368992|Bevacizumab|bevacizumab|mesh-list
101821390|NCT00368992|Cetuximab|cetuximab|mesh-list
101821391|NCT00368992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101821392|NCT00368992|Antibodies|antibodies|mesh-list
101294843|NCT01980316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101294844|NCT01980316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294845|NCT01980316|Antithrombins|antithrombins|mesh-ancestor
101294846|NCT01980316|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101294847|NCT01980316|Protease Inhibitors|protease inhibitors|mesh-ancestor
101294848|NCT01980316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317099|NCT00001119|Vaccines|vaccines|mesh-list
101294849|NCT01980316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101294850|NCT01980329|Maraviroc|maraviroc|mesh-list
101294851|NCT01980329|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101294852|NCT01980329|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101294853|NCT01980329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294854|NCT01980329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101294855|NCT01980329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101294856|NCT01980329|Antiviral Agents|antiviral agents|mesh-ancestor
101294857|NCT01980329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101294858|NCT01980329|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101294860|NCT01980407|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
101294861|NCT01980407|Oxaliplatin|oxaliplatin|mesh-list
101294862|NCT01980407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101294863|NCT01980407|Antidotes|antidotes|mesh-ancestor
101294864|NCT01980407|Protective Agents|protective agents|mesh-ancestor
101294865|NCT01980407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294866|NCT01980407|Vitamin B Complex|vitamin b complex|mesh-ancestor
101294868|NCT01980407|Micronutrients|micronutrients|mesh-ancestor
101294869|NCT01980472|Paclitaxel|paclitaxel|mesh-list
101294870|NCT01980472|Bevacizumab|bevacizumab|mesh-list
101294871|NCT01980472|Carboplatin|carboplatin|mesh-list
101294872|NCT01980472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101294873|NCT01980472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101294874|NCT01980472|Tubulin Modulators|tubulin modulators|mesh-ancestor
101294875|NCT01980472|Antimitotic Agents|antimitotic agents|mesh-ancestor
101294876|NCT01980472|Mitosis Modulators|mitosis modulators|mesh-ancestor
101294877|NCT01980472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294878|NCT01980472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101294879|NCT01980472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101294880|NCT01980472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101294881|NCT01980472|Growth Substances|growth substances|mesh-ancestor
101294882|NCT01980472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294883|NCT01980472|Growth Inhibitors|growth inhibitors|mesh-ancestor
101294884|NCT01980498|Fentanyl|fentanyl|mesh-list
101294885|NCT01980498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101294886|NCT01980498|Narcotics|narcotics|mesh-ancestor
101294887|NCT01980498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101294888|NCT01980498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294889|NCT01980498|Analgesics|analgesics|mesh-ancestor
101294890|NCT01980498|Sensory System Agents|sensory system agents|mesh-ancestor
101294891|NCT01980498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101294892|NCT01980498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101294893|NCT01980498|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101294894|NCT01980498|Anesthetics, General|anesthetics, general|mesh-ancestor
101294895|NCT01980498|Anesthetics|anesthetics|mesh-ancestor
101294896|NCT01980550|Nicotine|nicotine|mesh-list
101294897|NCT01980550|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101294898|NCT01980550|Autonomic Agents|autonomic agents|mesh-ancestor
101294899|NCT01980550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101294900|NCT01980550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821393|NCT00368992|Immunoglobulins|immunoglobulins|mesh-list
101821394|NCT00368992|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101821395|NCT00368992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101821396|NCT00368992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101294901|NCT01980550|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101294902|NCT01980550|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101294903|NCT01980550|Cholinergic Agents|cholinergic agents|mesh-ancestor
101294904|NCT01980550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101294905|NCT01980550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294906|NCT01980615|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101294907|NCT01980615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101294908|NCT01980615|Respiratory System Agents|respiratory system agents|mesh-ancestor
101294909|NCT01980667|Cisplatin|cisplatin|mesh-list
101294910|NCT01980667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101294911|NCT01980680|Estradiol|estradiol|mesh-list
101294912|NCT01980680|Progesterone|progesterone|mesh-list
101294913|NCT01980680|Estrogens|estrogens|mesh-ancestor
101294914|NCT01980680|Hormones|hormones|mesh-ancestor
101294915|NCT01980680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101294916|NCT01980680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294917|NCT01980680|Progestins|progestins|mesh-ancestor
101294918|NCT01980745|Chloroquine|chloroquine|mesh-list
101294919|NCT01980745|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
101294920|NCT01980745|Amebicides|amebicides|mesh-ancestor
101294921|NCT01980745|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101294923|NCT01980745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101294925|NCT01980745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101294926|NCT01980745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101294927|NCT01980745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101294928|NCT01980745|Analgesics|analgesics|mesh-ancestor
101294929|NCT01980745|Sensory System Agents|sensory system agents|mesh-ancestor
101294930|NCT01980745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101294931|NCT01980745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294932|NCT01980745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101294933|NCT01980745|Filaricides|filaricides|mesh-ancestor
101294934|NCT01980745|Antinematodal Agents|antinematodal agents|mesh-ancestor
101294935|NCT01980745|Anthelmintics|anthelmintics|mesh-ancestor
101294937|NCT01980810|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101294938|NCT01980810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101294939|NCT01980810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101294940|NCT01980810|Tubulin Modulators|tubulin modulators|mesh-ancestor
101294942|NCT01980810|Mitosis Modulators|mitosis modulators|mesh-ancestor
101294943|NCT01980810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294944|NCT01980849|Nadroparin|nadroparin|mesh-list
101294945|NCT01980849|Anticoagulants|anticoagulants|mesh-ancestor
101294946|NCT01980849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101294947|NCT01980849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101294948|NCT01980849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294949|NCT01980966|Oseltamivir|oseltamivir|mesh-list
101294950|NCT01980966|Antiviral Agents|antiviral agents|mesh-ancestor
101294951|NCT01980966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101294952|NCT01980966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101294953|NCT01980966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294954|NCT01980979|Treprostinil|treprostinil|mesh-list
101294955|NCT01980979|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101294956|NCT01981031|Insulin Lispro|insulin lispro|mesh-list
101294957|NCT01981031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101294958|NCT01981031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294959|NCT01981278|Tapentadol|tapentadol|mesh-list
101294960|NCT01981278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101294961|NCT01981278|Narcotics|narcotics|mesh-ancestor
101294962|NCT01981278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101294963|NCT01981278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294964|NCT01981278|Analgesics|analgesics|mesh-ancestor
101294965|NCT01981278|Sensory System Agents|sensory system agents|mesh-ancestor
101294966|NCT01981278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101294967|NCT01981278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101294968|NCT01981278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101294969|NCT01981278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101294970|NCT01981278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821398|NCT00368992|Antimitotic Agents|antimitotic agents|mesh-ancestor
101821399|NCT00368992|Mitosis Modulators|mitosis modulators|mesh-ancestor
101821400|NCT00368992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821401|NCT00368992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101821402|NCT00368992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101821403|NCT00368992|Growth Substances|growth substances|mesh-ancestor
101821404|NCT00368992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821405|NCT00368992|Growth Inhibitors|growth inhibitors|mesh-ancestor
101478701|NCT00318552|Meropenem|meropenem|mesh-list
101821406|NCT00368992|Immunologic Factors|immunologic factors|mesh-ancestor
101821408|NCT00376246|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101821409|NCT00376246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101294971|NCT01981278|Adrenergic Agents|adrenergic agents|mesh-ancestor
101294972|NCT01981278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101294973|NCT01981291|Anesthetics|anesthetics|mesh-list
101294974|NCT01981291|Mepivacaine|mepivacaine|mesh-list
101294975|NCT01981291|Anesthetics, Local|anesthetics, local|mesh-list
101294976|NCT01981291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101294977|NCT01981291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294978|NCT01981291|Sensory System Agents|sensory system agents|mesh-ancestor
101294979|NCT01981291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101294980|NCT01981330|Hyaluronic Acid|hyaluronic acid|mesh-list
101294981|NCT01981330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101294982|NCT01981330|Immunologic Factors|immunologic factors|mesh-ancestor
101294983|NCT01981330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294984|NCT01981330|Viscosupplements|viscosupplements|mesh-ancestor
101294985|NCT01981330|Protective Agents|protective agents|mesh-ancestor
101294986|NCT01981369|Dexmedetomidine|dexmedetomidine|mesh-list
101294987|NCT01981369|Propofol|propofol|mesh-list
101294988|NCT01981369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101294989|NCT01981369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101294990|NCT01981369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294991|NCT01981369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101294992|NCT01981369|Analgesics|analgesics|mesh-ancestor
101294993|NCT01981369|Sensory System Agents|sensory system agents|mesh-ancestor
101294994|NCT01981369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101317104|NCT00001119|Protease Inhibitors|protease inhibitors|mesh-ancestor
101294995|NCT01981369|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101294996|NCT01981369|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101294997|NCT01981369|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101294998|NCT01981369|Adrenergic Agents|adrenergic agents|mesh-ancestor
101294999|NCT01981369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101295000|NCT01981369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295001|NCT01981369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101295002|NCT01981369|Anesthetics, General|anesthetics, general|mesh-ancestor
101295003|NCT01981369|Anesthetics|anesthetics|mesh-ancestor
101295004|NCT01981447|Lacosamide|lacosamide|mesh-list
101295005|NCT01981447|Anticonvulsants|anticonvulsants|mesh-ancestor
101295006|NCT01981447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101295007|NCT01981447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101295008|NCT01981447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101295009|NCT01981447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295010|NCT01981460|Methylene Blue|methylene blue|mesh-list
101295011|NCT01981460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101295012|NCT01981460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295013|NCT01981499|Cetirizine|cetirizine|mesh-list
101295014|NCT01981499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101295015|NCT01981499|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101295016|NCT01981499|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101295017|NCT01981499|Histamine Antagonists|histamine antagonists|mesh-ancestor
101295019|NCT01981499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101821410|NCT00376246|Antimetabolites|antimetabolites|mesh-ancestor
101821411|NCT00376246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821412|NCT00376246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101821413|NCT01050088|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101295020|NCT01981499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295021|NCT01981499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295022|NCT01981525|Metformin|metformin|mesh-list
101295023|NCT01981525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101295024|NCT01981525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295025|NCT01981707|Choline|choline|mesh-list
101295026|NCT01981707|Lipotropic Agents|lipotropic agents|mesh-ancestor
101295027|NCT01981707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101295028|NCT01981707|Antimetabolites|antimetabolites|mesh-ancestor
101295029|NCT01981707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295030|NCT01981707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101295031|NCT01981707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101295032|NCT01981707|Nootropic Agents|nootropic agents|mesh-ancestor
101295033|NCT01981746|Ropivacaine|ropivacaine|mesh-list
101295034|NCT01981746|Anesthetics, Local|anesthetics, local|mesh-ancestor
101295035|NCT01981746|Anesthetics|anesthetics|mesh-ancestor
101295036|NCT01981746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101295037|NCT01981746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295038|NCT01981746|Sensory System Agents|sensory system agents|mesh-ancestor
101295039|NCT01981746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101295040|NCT01981811|Aripiprazole|aripiprazole|mesh-list
101295041|NCT01981811|Antidepressive Agents|antidepressive agents|mesh-ancestor
101295042|NCT01981811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101295043|NCT01981811|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101295044|NCT01981811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101295045|NCT01981811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101295046|NCT01981811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295047|NCT01981811|Dopamine Agonists|dopamine agonists|mesh-ancestor
101295048|NCT01981811|Dopamine Agents|dopamine agents|mesh-ancestor
101295049|NCT01981811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101295050|NCT01981811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295051|NCT01981811|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101295052|NCT01981811|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101295053|NCT01981811|Serotonin Agents|serotonin agents|mesh-ancestor
101295054|NCT01981811|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101295055|NCT01981811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101295056|NCT01981811|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101295057|NCT01981811|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101295058|NCT01981889|Prednisone|prednisone|mesh-list
101295059|NCT01981889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101295060|NCT01981889|Glucocorticoids|glucocorticoids|mesh-ancestor
101295061|NCT01981889|Hormones|hormones|mesh-ancestor
101295062|NCT01981889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101295063|NCT01981889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295064|NCT01981889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101295065|NCT01981889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101295066|NCT01981941|Gabapentin|gabapentin|mesh-list
101295067|NCT01981941|Analgesics|analgesics|mesh-ancestor
101295068|NCT01981941|Sensory System Agents|sensory system agents|mesh-ancestor
101295069|NCT01981941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101295070|NCT01981941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295071|NCT01981941|Anticonvulsants|anticonvulsants|mesh-ancestor
101295072|NCT01981941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101295073|NCT01981941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101295074|NCT01981941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101295075|NCT01981941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101295076|NCT01981941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101295077|NCT01981941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101295078|NCT01981941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101295079|NCT01981941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295080|NCT01981941|Antimanic Agents|antimanic agents|mesh-ancestor
101295081|NCT01982019|Hormones|hormones|mesh-list
101295082|NCT01982019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101295083|NCT01982019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295084|NCT01982071|Micafungin|micafungin|mesh-list
101821415|NCT00375934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101821416|NCT00375934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101821417|NCT00375934|Analgesics|analgesics|mesh-ancestor
101821418|NCT00375934|Sensory System Agents|sensory system agents|mesh-ancestor
101821419|NCT00375934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101821420|NCT00375934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295085|NCT01982071|Antifungal Agents|antifungal agents|mesh-ancestor
101295086|NCT01982071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101295087|NCT01982097|Sorafenib|sorafenib|mesh-list
101295088|NCT01982097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101295089|NCT01982097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101295090|NCT01982097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101295091|NCT01982097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295092|NCT01982201|Lesinurad|lesinurad|mesh-list
101295093|NCT01982201|Gout Suppressants|gout suppressants|mesh-ancestor
101295094|NCT01982201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101295095|NCT01982201|Uricosuric Agents|uricosuric agents|mesh-ancestor
101295096|NCT01982396|Lamivudine|lamivudine|mesh-list
101295097|NCT01982396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101295098|NCT01982396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101295099|NCT01982396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101295100|NCT01982396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295101|NCT01982396|Antiviral Agents|antiviral agents|mesh-ancestor
101295102|NCT01982396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101295103|NCT01982396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101295104|NCT01982396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101295105|NCT01982461|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101295106|NCT01982461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101295107|NCT01982461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101295108|NCT01982461|Antimetabolites|antimetabolites|mesh-ancestor
101295109|NCT01982461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295110|NCT01982461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101295111|NCT01982461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101295112|NCT01982461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101295113|NCT01982578|Genistein|genistein|mesh-list
101295114|NCT01982578|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101295115|NCT01982578|Protective Agents|protective agents|mesh-ancestor
101295116|NCT01982578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295117|NCT01982578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101295118|NCT01982578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101295119|NCT01982578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101295120|NCT01982578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295121|NCT01982578|Phytoestrogens|phytoestrogens|mesh-ancestor
101295122|NCT01982578|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101295123|NCT01982578|Estrogens|estrogens|mesh-ancestor
101295125|NCT01982578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101295126|NCT01982734|Curcumin|curcumin|mesh-list
101295127|NCT01982734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101295128|NCT01982734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101295129|NCT01982734|Analgesics|analgesics|mesh-ancestor
101295130|NCT01982734|Sensory System Agents|sensory system agents|mesh-ancestor
101295131|NCT01982734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101295132|NCT01982734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295133|NCT01982734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101295134|NCT01982734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101295135|NCT01982734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101295136|NCT01982734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101295137|NCT01982734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295138|NCT01982760|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101295139|NCT01982760|Hemostatics|hemostatics|mesh-ancestor
101295140|NCT01982760|Coagulants|coagulants|mesh-ancestor
101295141|NCT01982760|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101295142|NCT01982760|Natriuretic Agents|natriuretic agents|mesh-ancestor
101295143|NCT01982760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295144|NCT01982799|Acetaminophen|acetaminophen|mesh-list
101295146|NCT01982799|Naproxen|naproxen|mesh-list
101821421|NCT00375934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101821422|NCT00375934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101821423|NCT00375934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101821424|NCT00375934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101821425|NCT00375934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821426|NCT01052584|Chloroquine|chloroquine|mesh-list
101821427|NCT01052584|Lumefantrine|lumefantrine|mesh-list
101821428|NCT01052584|Artemether|artemether|mesh-list
101821429|NCT01052584|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101821430|NCT01052584|Amebicides|amebicides|mesh-ancestor
101821431|NCT01052584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101821432|NCT01052584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101312792|NCT00008268|Melphalan|melphalan|mesh-list
101821433|NCT01052584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101821434|NCT01052584|Antimalarials|antimalarials|mesh-ancestor
101821435|NCT01052584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101821436|NCT02534506|Nivolumab|nivolumab|mesh-list
101821437|NCT02534506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101821438|NCT02534506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821439|NCT02534506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101821440|NCT02534506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821441|NCT01050322|Gemcitabine|gemcitabine|mesh-list
101821442|NCT01050322|Capecitabine|capecitabine|mesh-list
101821443|NCT01050322|Vinorelbine|vinorelbine|mesh-list
101821444|NCT01050322|Lapatinib|lapatinib|mesh-list
101821445|NCT01050322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101821446|NCT01050322|Antimetabolites|antimetabolites|mesh-ancestor
101821447|NCT01050322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821448|NCT01050322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821449|NCT01050322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101821450|NCT01050322|Tubulin Modulators|tubulin modulators|mesh-ancestor
101295147|NCT01982799|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
101295148|NCT01982799|Hydrocodone|hydrocodone|mesh-list
101295149|NCT01982799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101295150|NCT01982799|Analgesics|analgesics|mesh-ancestor
101295151|NCT01982799|Sensory System Agents|sensory system agents|mesh-ancestor
101295152|NCT01982799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101295153|NCT01982799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295154|NCT01982799|Antipyretics|antipyretics|mesh-ancestor
101295155|NCT01982799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101295156|NCT01982799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101295157|NCT01982799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101295158|NCT01982799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101295159|NCT01982799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101295160|NCT01982799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821451|NCT01050322|Antimitotic Agents|antimitotic agents|mesh-ancestor
101821452|NCT01050322|Mitosis Modulators|mitosis modulators|mesh-ancestor
101821453|NCT01050322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101821454|NCT01050322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101821456|NCT00531960|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101821457|NCT00531960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101821458|NCT00531960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821459|NCT00531960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101295161|NCT01982799|Gout Suppressants|gout suppressants|mesh-ancestor
101295162|NCT01982799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101295163|NCT01982799|Narcotics|narcotics|mesh-ancestor
101295164|NCT01982799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101295165|NCT01982799|Antitussive Agents|antitussive agents|mesh-ancestor
101295166|NCT01982799|Respiratory System Agents|respiratory system agents|mesh-ancestor
101295167|NCT01982864|Gentamicins|gentamicins|mesh-list
101295168|NCT01982864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101295169|NCT01982864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101295170|NCT01982864|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101295171|NCT01982864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101295172|NCT01982864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295173|NCT01982929|Epinephrine|epinephrine|mesh-list
101295174|NCT01982929|Bupivacaine|bupivacaine|mesh-list
101295175|NCT01982929|Anesthetics, Local|anesthetics, local|mesh-ancestor
101295176|NCT01982929|Anesthetics|anesthetics|mesh-ancestor
101295177|NCT01982929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101295178|NCT01982929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295179|NCT01982929|Sensory System Agents|sensory system agents|mesh-ancestor
101295180|NCT01982929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101295181|NCT01982929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101295182|NCT01982929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101295183|NCT01982929|Adrenergic Agents|adrenergic agents|mesh-ancestor
101295184|NCT01982929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101295185|NCT01982929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295187|NCT01982929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101295188|NCT01982929|Autonomic Agents|autonomic agents|mesh-ancestor
101295189|NCT01982929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101295190|NCT01982929|Respiratory System Agents|respiratory system agents|mesh-ancestor
101295191|NCT01982929|Mydriatics|mydriatics|mesh-ancestor
101295192|NCT01982929|Sympathomimetics|sympathomimetics|mesh-ancestor
101295193|NCT01982929|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101295194|NCT01983124|Vemurafenib|vemurafenib|mesh-list
101295195|NCT01983124|Fotemustine|fotemustine|mesh-list
101295196|NCT01983124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101295197|NCT01983124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101295198|NCT01983124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101295199|NCT01983124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295200|NCT01983137|Oxycodone|oxycodone|mesh-list
101295201|NCT01983137|Naloxone|naloxone|mesh-list
101295202|NCT01983137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101295203|NCT01983137|Narcotics|narcotics|mesh-ancestor
101295204|NCT01983137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101295205|NCT01983137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295206|NCT01983137|Analgesics|analgesics|mesh-ancestor
101295207|NCT01983137|Sensory System Agents|sensory system agents|mesh-ancestor
101295208|NCT01983137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101295209|NCT01983137|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101295210|NCT01983371|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
101295211|NCT01983371|Hematinics|hematinics|mesh-ancestor
101295212|NCT01983371|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101295213|NCT01983371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101295214|NCT01983384|Anesthetics|anesthetics|mesh-list
101295215|NCT01983384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101295216|NCT01983384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295217|NCT01983449|Dexamethasone|dexamethasone|mesh-list
101295218|NCT01983449|Dexamethasone acetate|dexamethasone acetate|mesh-list
101295219|NCT01983449|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101821460|NCT00531960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101821461|NCT00531960|Growth Substances|growth substances|mesh-ancestor
101821462|NCT00531960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821463|NCT00531960|Growth Inhibitors|growth inhibitors|mesh-ancestor
101821464|NCT00531960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101821465|NCT00531960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101821466|NCT00531960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821467|NCT01001676|Paclitaxel|paclitaxel|mesh-list
101821468|NCT01001676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101821469|NCT01001676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821470|NCT01001676|Tubulin Modulators|tubulin modulators|mesh-ancestor
101295220|NCT01983449|BB 1101|bb 1101|mesh-list
101295221|NCT01983449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101295222|NCT01983449|Antiemetics|antiemetics|mesh-ancestor
101295223|NCT01983449|Autonomic Agents|autonomic agents|mesh-ancestor
101295224|NCT01983449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101295225|NCT01983449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295226|NCT01983449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101295227|NCT01983449|Glucocorticoids|glucocorticoids|mesh-ancestor
101295228|NCT01983449|Hormones|hormones|mesh-ancestor
101295229|NCT01983449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101295230|NCT01983449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101295231|NCT01983449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101295232|NCT01983449|Protease Inhibitors|protease inhibitors|mesh-ancestor
101295233|NCT01983449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101295234|NCT01983449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295235|NCT01983475|Denosumab|denosumab|mesh-list
101295236|NCT01983475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101295237|NCT01983475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295239|NCT01983501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101295240|NCT01983501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295241|NCT01983501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101295242|NCT01983501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101295243|NCT01983514|Oxytocin|oxytocin|mesh-list
101295244|NCT01983514|Oxytocics|oxytocics|mesh-ancestor
101295245|NCT01983514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101295246|NCT01983514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295247|NCT01983527|Methylprednisolone|methylprednisolone|mesh-list
101295248|NCT01983527|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101295249|NCT01983527|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101295250|NCT01983527|Prednisolone|prednisolone|mesh-list
101295251|NCT01983527|Prednisolone acetate|prednisolone acetate|mesh-list
101295252|NCT01983527|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101295253|NCT01983527|Prednisolone phosphate|prednisolone phosphate|mesh-list
101295254|NCT01983527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101295255|NCT01983527|Antiemetics|antiemetics|mesh-ancestor
101295256|NCT01983527|Autonomic Agents|autonomic agents|mesh-ancestor
101295257|NCT01983527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101295258|NCT01983527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295259|NCT01983527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101295260|NCT01983527|Glucocorticoids|glucocorticoids|mesh-ancestor
101295261|NCT01983527|Hormones|hormones|mesh-ancestor
101295262|NCT01983527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101295263|NCT01983527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101295264|NCT01983527|Protective Agents|protective agents|mesh-ancestor
101295265|NCT01983527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101295266|NCT01983527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101295267|NCT01983540|Vaccines|vaccines|mesh-list
101295268|NCT01983540|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101295269|NCT01983540|Immunologic Factors|immunologic factors|mesh-ancestor
101295270|NCT01983540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295271|NCT01983657|Molgramostim|molgramostim|mesh-list
101821471|NCT01001676|Antimitotic Agents|antimitotic agents|mesh-ancestor
101821472|NCT01001676|Mitosis Modulators|mitosis modulators|mesh-ancestor
101821473|NCT01001676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821474|NCT00816959|Bleomycin|bleomycin|mesh-list
101821475|NCT00816959|Dacarbazine|dacarbazine|mesh-list
101821476|NCT00816959|Vinblastine|vinblastine|mesh-list
101821477|NCT00816959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101295272|NCT01983657|Sargramostim|sargramostim|mesh-list
101295273|NCT01983657|Immunologic Factors|immunologic factors|mesh-ancestor
101295274|NCT01983657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295275|NCT01983657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101295276|NCT01983722|Stiripentol|stiripentol|mesh-list
101295277|NCT01983722|Anticonvulsants|anticonvulsants|mesh-ancestor
101295278|NCT01983735|Niacin|niacin|mesh-list
101295279|NCT01983735|Amlodipine|amlodipine|mesh-list
101295280|NCT01983735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101295281|NCT01983735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101295282|NCT01983735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101295283|NCT01983735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295284|NCT01983735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101295285|NCT01983735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295286|NCT01983735|Vasodilator Agents|vasodilator agents|mesh-ancestor
101295287|NCT01983735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101295288|NCT01983735|Antimetabolites|antimetabolites|mesh-ancestor
101295289|NCT01983735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101295290|NCT01983735|Vitamin B Complex|vitamin b complex|mesh-ancestor
101295292|NCT01983735|Micronutrients|micronutrients|mesh-ancestor
101295293|NCT01983761|Vidarabine|vidarabine|mesh-list
101295294|NCT01983761|Mycophenolic Acid|mycophenolic acid|mesh-list
101295295|NCT01983761|Fludarabine|fludarabine|mesh-list
101295296|NCT01983761|Fludarabine phosphate|fludarabine phosphate|mesh-list
101295297|NCT01983761|Melphalan|melphalan|mesh-list
101295298|NCT01983761|Busulfan|busulfan|mesh-list
101295299|NCT01983761|Clofarabine|clofarabine|mesh-list
101295300|NCT01983761|Tacrolimus|tacrolimus|mesh-list
101295301|NCT01983761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101295302|NCT01983761|Immunologic Factors|immunologic factors|mesh-ancestor
101295303|NCT01983761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295304|NCT01983761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101295305|NCT01983761|Antimetabolites|antimetabolites|mesh-ancestor
101295306|NCT01983761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295307|NCT01983761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101295308|NCT01983761|Antiviral Agents|antiviral agents|mesh-ancestor
101295309|NCT01983761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101295310|NCT01983761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101295311|NCT01983761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101295312|NCT01983761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101295313|NCT01983761|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101295315|NCT01983761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101295316|NCT01983761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101295317|NCT01983761|Alkylating Agents|alkylating agents|mesh-ancestor
101295318|NCT01983761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101295319|NCT01983800|Midazolam|midazolam|mesh-list
101295320|NCT01983800|Propofol|propofol|mesh-list
101295321|NCT01983800|Isoflurane|isoflurane|mesh-list
101295322|NCT01983800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101295323|NCT01983800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101295324|NCT01983800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295325|NCT01983800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101295326|NCT01983800|Anesthetics, General|anesthetics, general|mesh-ancestor
101295327|NCT01983800|Anesthetics|anesthetics|mesh-ancestor
101295328|NCT01983800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101295329|NCT01983800|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101295330|NCT01983800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101295331|NCT01983800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101295332|NCT01983800|GABA Modulators|gaba modulators|mesh-ancestor
101295333|NCT01983800|GABA Agents|gaba agents|mesh-ancestor
101295334|NCT01983800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101295335|NCT01983800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295336|NCT01983800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101821478|NCT00816959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821479|NCT00816959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821480|NCT00816959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101821481|NCT00816959|Alkylating Agents|alkylating agents|mesh-ancestor
101821482|NCT00816959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101821483|NCT00816959|Tubulin Modulators|tubulin modulators|mesh-ancestor
101821484|NCT00816959|Antimitotic Agents|antimitotic agents|mesh-ancestor
101821485|NCT00816959|Mitosis Modulators|mitosis modulators|mesh-ancestor
101295337|NCT01983943|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
101295338|NCT01983943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101295339|NCT01983943|Antioxidants|antioxidants|mesh-ancestor
101295340|NCT01983943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295341|NCT01983943|Protective Agents|protective agents|mesh-ancestor
101295342|NCT01983943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295343|NCT01983943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101295344|NCT01984008|Picosulfate sodium|picosulfate sodium|mesh-list
101295345|NCT01984008|Magnesium Oxide|magnesium oxide|mesh-list
101295346|NCT01984008|Citric Acid|citric acid|mesh-list
101295347|NCT01984008|Sodium Citrate|sodium citrate|mesh-list
101295348|NCT01984008|Cathartics|cathartics|mesh-ancestor
101295349|NCT01984008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101295350|NCT01984008|Anticoagulants|anticoagulants|mesh-ancestor
101295351|NCT01984008|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101295352|NCT01984008|Chelating Agents|chelating agents|mesh-ancestor
101295353|NCT01984008|Sequestering Agents|sequestering agents|mesh-ancestor
101295354|NCT01984008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295356|NCT01984073|Niacin|niacin|mesh-list
101295357|NCT01984073|Niacinamide|niacinamide|mesh-list
101295359|NCT01984073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101295360|NCT01984073|Antimetabolites|antimetabolites|mesh-ancestor
101295361|NCT01984073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295362|NCT01984073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101295363|NCT01984073|Vasodilator Agents|vasodilator agents|mesh-ancestor
101295364|NCT01984073|Vitamin B Complex|vitamin b complex|mesh-ancestor
101295365|NCT01984073|Vitamins|vitamins|mesh-ancestor
101295366|NCT01984073|Micronutrients|micronutrients|mesh-ancestor
101295367|NCT01984073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295368|NCT01984086|Albuterol|albuterol|mesh-list
101295369|NCT01984086|Charcoal|charcoal|mesh-list
101295370|NCT01984086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101295371|NCT01984086|Autonomic Agents|autonomic agents|mesh-ancestor
101295372|NCT01984086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101295373|NCT01984086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295374|NCT01984086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101295375|NCT01984086|Respiratory System Agents|respiratory system agents|mesh-ancestor
101295376|NCT01984086|Tocolytic Agents|tocolytic agents|mesh-ancestor
101295377|NCT01984086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101295378|NCT01984086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101295379|NCT01984086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101295381|NCT01984086|Adrenergic Agents|adrenergic agents|mesh-ancestor
101295382|NCT01984086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101295383|NCT01984086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295384|NCT01984086|Antidotes|antidotes|mesh-ancestor
101295385|NCT01984086|Protective Agents|protective agents|mesh-ancestor
101295386|NCT01984099|Folic Acid|folic acid|mesh-list
101295387|NCT01984099|Vitamin B Complex|vitamin b complex|mesh-list
101295388|NCT01984099|Methotrexate|methotrexate|mesh-list
101295389|NCT01984099|Vitamins|vitamins|mesh-ancestor
101295390|NCT01984099|Micronutrients|micronutrients|mesh-ancestor
101295391|NCT01984099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295392|NCT01984099|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101295393|NCT01984099|Abortifacient Agents|abortifacient agents|mesh-ancestor
101295394|NCT01984099|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101295395|NCT01984099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101295396|NCT01984099|Antimetabolites|antimetabolites|mesh-ancestor
101295397|NCT01984099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821487|NCT01001754|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101821488|NCT01001754|Antimetabolites|antimetabolites|mesh-ancestor
101821489|NCT01001754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821490|NCT01001754|Antiviral Agents|antiviral agents|mesh-ancestor
101821491|NCT01001754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101821492|NCT00825851|Nicotine|nicotine|mesh-list
101821493|NCT00825851|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101821494|NCT00825851|Autonomic Agents|autonomic agents|mesh-ancestor
101821495|NCT00825851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101821496|NCT00825851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821498|NCT00825851|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101821499|NCT00825851|Cholinergic Agents|cholinergic agents|mesh-ancestor
101821500|NCT00825851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101821501|NCT00825851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295398|NCT01984099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101295399|NCT01984099|Dermatologic Agents|dermatologic agents|mesh-ancestor
101295400|NCT01984099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101295401|NCT01984099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101295402|NCT01984099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101295403|NCT01984099|Immunologic Factors|immunologic factors|mesh-ancestor
101295404|NCT01984099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101295405|NCT01984099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101295406|NCT01984099|Hematinics|hematinics|mesh-ancestor
101295407|NCT01984177|Hormones|hormones|mesh-list
101295408|NCT01984177|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101295409|NCT01984177|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
101295410|NCT01984177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101295411|NCT01984177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295412|NCT01984255|Ipilimumab|ipilimumab|mesh-list
101295413|NCT01984255|Bavituximab|bavituximab|mesh-list
101295414|NCT01984255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101295415|NCT01984255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101295416|NCT01984255|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101295417|NCT01984255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295418|NCT01984372|Insulin|insulin|mesh-list
101295419|NCT01984372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101295420|NCT01984372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295421|NCT01984463|Fentanyl|fentanyl|mesh-list
101295422|NCT01984463|Morphine|morphine|mesh-list
101295423|NCT01984463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101295424|NCT01984463|Narcotics|narcotics|mesh-ancestor
101295425|NCT01984463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101295426|NCT01984463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295427|NCT01984463|Analgesics|analgesics|mesh-ancestor
101295428|NCT01984463|Sensory System Agents|sensory system agents|mesh-ancestor
101295429|NCT01984463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101295430|NCT01984463|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101295431|NCT01984463|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101295432|NCT01984463|Anesthetics, General|anesthetics, general|mesh-ancestor
101295433|NCT01984463|Anesthetics|anesthetics|mesh-ancestor
101295434|NCT01984567|Vitamin E|vitamin e|mesh-list
101295435|NCT01984567|Thioctic Acid|thioctic acid|mesh-list
101295436|NCT01984567|Vitamins|vitamins|mesh-ancestor
101295437|NCT01984567|Micronutrients|micronutrients|mesh-ancestor
101295439|NCT01984567|Antioxidants|antioxidants|mesh-ancestor
101295440|NCT01984567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295441|NCT01984567|Protective Agents|protective agents|mesh-ancestor
101295442|NCT01984567|Vitamin B Complex|vitamin b complex|mesh-ancestor
101295443|NCT01984606|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101295444|NCT01984606|Empagliflozin|empagliflozin|mesh-list
101295445|NCT01984606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101821502|NCT00361504|Oxycodone|oxycodone|mesh-list
101821503|NCT00361504|Tapentadol|tapentadol|mesh-list
101821504|NCT00361504|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101821505|NCT00361504|Narcotics|narcotics|mesh-ancestor
101821506|NCT00361504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101821507|NCT00361504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821508|NCT00361504|Analgesics|analgesics|mesh-ancestor
101821509|NCT00361504|Sensory System Agents|sensory system agents|mesh-ancestor
101821510|NCT00361504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101821511|NCT00361504|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101295446|NCT01984606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295447|NCT01984606|Incretins|incretins|mesh-ancestor
101295448|NCT01984606|Hormones|hormones|mesh-ancestor
101295449|NCT01984606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101295450|NCT01984606|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101295451|NCT01984606|Protease Inhibitors|protease inhibitors|mesh-ancestor
101295452|NCT01984606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101295453|NCT01984606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295454|NCT01984606|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101295455|NCT01984749|Febuxostat|febuxostat|mesh-list
101295456|NCT01984749|Gout Suppressants|gout suppressants|mesh-ancestor
101295457|NCT01984749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101295458|NCT01984827|Moxifloxacin|moxifloxacin|mesh-list
101295459|NCT01984827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101295460|NCT01984827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101295461|NCT01984827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101295462|NCT01984827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101295463|NCT01984827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101295464|NCT01984827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295465|NCT01984827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101295466|NCT01984931|Medazepam|medazepam|mesh-list
101295467|NCT01984931|Metoclopramide|metoclopramide|mesh-list
101295468|NCT01984931|Bromazepam|bromazepam|mesh-list
101295469|NCT01984931|Simethicone|simethicone|mesh-list
101295470|NCT01984931|Trimebutine|trimebutine|mesh-list
101295471|NCT01984931|Mosapride|mosapride|mesh-list
101295472|NCT01984931|Maleic acid|maleic acid|mesh-list
101295473|NCT01984931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101295474|NCT01984931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295475|NCT01984931|Antiemetics|antiemetics|mesh-ancestor
101295476|NCT01984931|Autonomic Agents|autonomic agents|mesh-ancestor
101295477|NCT01984931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101295478|NCT01984931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295479|NCT01984931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101295480|NCT01984931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101295481|NCT01984931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101295482|NCT01984931|Dopamine Agents|dopamine agents|mesh-ancestor
101295483|NCT01984931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101295484|NCT01984931|Parasympatholytics|parasympatholytics|mesh-ancestor
101295485|NCT01984931|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101295486|NCT01984931|Serotonin Agents|serotonin agents|mesh-ancestor
101295487|NCT01984931|Antifoaming Agents|antifoaming agents|mesh-ancestor
101295488|NCT01984931|Emollients|emollients|mesh-ancestor
101295489|NCT01984931|Dermatologic Agents|dermatologic agents|mesh-ancestor
101295490|NCT01984931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101295491|NCT01984931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101295492|NCT01984931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101295493|NCT01984931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101295494|NCT01984931|GABA Modulators|gaba modulators|mesh-ancestor
101295495|NCT01984931|GABA Agents|gaba agents|mesh-ancestor
101295496|NCT01984931|Anticonvulsants|anticonvulsants|mesh-ancestor
101295497|NCT01984931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101295498|NCT01984931|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101295499|NCT01984931|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101295500|NCT01985061|Busulfan|busulfan|mesh-list
101295502|NCT01985061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821512|NCT00361504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101821513|NCT00361504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101821514|NCT00361504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821515|NCT00361504|Adrenergic Agents|adrenergic agents|mesh-ancestor
101821516|NCT00361504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101821517|NCT00361270|Complement Factor H|complement factor h|mesh-list
101821518|NCT00361270|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101295503|NCT01985061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101295504|NCT01985061|Immunologic Factors|immunologic factors|mesh-ancestor
101295505|NCT01985061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295506|NCT01985061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101295507|NCT01985061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101295508|NCT01985061|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101295509|NCT01985087|Temozolomide|temozolomide|mesh-list
101295510|NCT01985087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101295511|NCT01985087|Alkylating Agents|alkylating agents|mesh-ancestor
101295512|NCT01985087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295513|NCT01985087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101295515|NCT01985152|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
101295516|NCT01985152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101295517|NCT01985152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101295518|NCT01985152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295519|NCT01985152|Lipotropic Agents|lipotropic agents|mesh-ancestor
101295520|NCT01985152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101295521|NCT01985152|Antimetabolites|antimetabolites|mesh-ancestor
101295522|NCT01985152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101295523|NCT01985152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101295524|NCT01985152|Nootropic Agents|nootropic agents|mesh-ancestor
101295525|NCT01985256|Flucytosine|flucytosine|mesh-list
101295526|NCT01985256|Antifungal Agents|antifungal agents|mesh-ancestor
101295527|NCT01985256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101295528|NCT01985256|Antimetabolites|antimetabolites|mesh-ancestor
101295529|NCT01985256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295530|NCT01985373|Immunoglobulins|immunoglobulins|mesh-list
101295531|NCT01985373|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101295533|NCT01985373|gamma-Globulins|gamma-globulins|mesh-list
101295534|NCT01985373|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101295535|NCT01985373|Immunologic Factors|immunologic factors|mesh-ancestor
101295536|NCT01985373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295537|NCT01985451|Temozolomide|temozolomide|mesh-list
101295538|NCT01985451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101295539|NCT01985451|Alkylating Agents|alkylating agents|mesh-ancestor
101295540|NCT01985451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295541|NCT01985451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101295542|NCT01985477|Dexamethasone|dexamethasone|mesh-list
101295543|NCT01985477|Lenalidomide|lenalidomide|mesh-list
101295544|NCT01985477|Tretinoin|tretinoin|mesh-list
101295545|NCT01985477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101295546|NCT01985477|Antiemetics|antiemetics|mesh-ancestor
101295547|NCT01985477|Autonomic Agents|autonomic agents|mesh-ancestor
101295548|NCT01985477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101295549|NCT01985477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295550|NCT01985477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101295551|NCT01985477|Glucocorticoids|glucocorticoids|mesh-ancestor
101295552|NCT01985477|Hormones|hormones|mesh-ancestor
101295553|NCT01985477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101295554|NCT01985477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101295555|NCT01985477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101295556|NCT01985477|Immunologic Factors|immunologic factors|mesh-ancestor
101295557|NCT01985477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101295558|NCT01985477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101295559|NCT01985477|Growth Substances|growth substances|mesh-ancestor
101295560|NCT01985477|Growth Inhibitors|growth inhibitors|mesh-ancestor
101295561|NCT01985477|Keratolytic Agents|keratolytic agents|mesh-ancestor
101821519|NCT00361270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101821520|NCT00361270|Immunologic Factors|immunologic factors|mesh-ancestor
101821521|NCT00361270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821522|NCT00826163|Budesonide|budesonide|mesh-list
101821523|NCT00826163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101821524|NCT00826163|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101821525|NCT00826163|Autonomic Agents|autonomic agents|mesh-ancestor
101295562|NCT01985477|Dermatologic Agents|dermatologic agents|mesh-ancestor
101295563|NCT01985594|Nifedipine|nifedipine|mesh-list
101295564|NCT01985594|Progesterone|progesterone|mesh-list
101295565|NCT01985594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101295566|NCT01985594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101295567|NCT01985594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295568|NCT01985594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101295570|NCT01985594|Vasodilator Agents|vasodilator agents|mesh-ancestor
101295571|NCT01985594|Tocolytic Agents|tocolytic agents|mesh-ancestor
101295572|NCT01985594|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101295573|NCT01985594|Progestins|progestins|mesh-ancestor
101295574|NCT01985594|Hormones|hormones|mesh-ancestor
101295575|NCT01985594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101295576|NCT01985724|Cyclophosphamide|cyclophosphamide|mesh-list
101295577|NCT01985724|Docetaxel|docetaxel|mesh-list
101295578|NCT01985724|Epirubicin|epirubicin|mesh-list
101295579|NCT01985724|Fluorouracil|fluorouracil|mesh-list
101295580|NCT01985724|Lenograstim|lenograstim|mesh-list
101295581|NCT01985724|Mitogens|mitogens|mesh-list
101295582|NCT01985724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101295583|NCT01985724|Immunologic Factors|immunologic factors|mesh-ancestor
101295584|NCT01985724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295585|NCT01985724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101295586|NCT01985724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101295587|NCT01985724|Alkylating Agents|alkylating agents|mesh-ancestor
101295588|NCT01985724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295589|NCT01985724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101295590|NCT01985724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101295591|NCT01985724|Tubulin Modulators|tubulin modulators|mesh-ancestor
101295592|NCT01985724|Antimitotic Agents|antimitotic agents|mesh-ancestor
101295593|NCT01985724|Mitosis Modulators|mitosis modulators|mesh-ancestor
101295594|NCT01985724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101295595|NCT01985724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101295596|NCT01985724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101295597|NCT01985724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101295599|NCT01985724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101295600|NCT01985724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101295601|NCT01985750|Cycloserine|cycloserine|mesh-list
101295602|NCT01985750|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101295603|NCT01985750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101295604|NCT01985750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101295605|NCT01985750|Antitubercular Agents|antitubercular agents|mesh-ancestor
101295606|NCT01985750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101295607|NCT01985750|Antimetabolites|antimetabolites|mesh-ancestor
101295608|NCT01985750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295609|NCT01985789|Diphenhydramine|diphenhydramine|mesh-list
101295610|NCT01985789|Promethazine|promethazine|mesh-list
101295611|NCT01985789|Cetirizine|cetirizine|mesh-list
101295612|NCT01985789|Desloratadine|desloratadine|mesh-list
101295613|NCT01985789|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101295614|NCT01985789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101295615|NCT01985789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101295616|NCT01985789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295617|NCT01985789|Anesthetics, Local|anesthetics, local|mesh-ancestor
101295618|NCT01985789|Anesthetics|anesthetics|mesh-ancestor
101295619|NCT01985789|Sensory System Agents|sensory system agents|mesh-ancestor
101295620|NCT01985789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101295621|NCT01985789|Antiemetics|antiemetics|mesh-ancestor
101295622|NCT01985789|Autonomic Agents|autonomic agents|mesh-ancestor
101295623|NCT01985789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101295624|NCT01985789|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101535167|NCT01139008|Metronidazole|metronidazole|mesh-list
101295625|NCT01985789|Histamine Antagonists|histamine antagonists|mesh-ancestor
101821526|NCT00826163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101821527|NCT00826163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821528|NCT00826163|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101821529|NCT00826163|Respiratory System Agents|respiratory system agents|mesh-ancestor
101821530|NCT00826163|Glucocorticoids|glucocorticoids|mesh-ancestor
101821531|NCT00826163|Hormones|hormones|mesh-ancestor
101821532|NCT00826163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101821533|NCT00998166|Bevacizumab|bevacizumab|mesh-list
101821534|NCT00998166|Pemetrexed|pemetrexed|mesh-list
101295627|NCT01985789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101295628|NCT01985789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295629|NCT01985789|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101295630|NCT01985789|Antipruritics|antipruritics|mesh-ancestor
101295631|NCT01985789|Dermatologic Agents|dermatologic agents|mesh-ancestor
101295632|NCT01985789|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101295633|NCT01985789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101295634|NCT01985789|Cholinergic Agents|cholinergic agents|mesh-ancestor
101295635|NCT01985828|Androgens|androgens|mesh-list
101295636|NCT01985828|Hormones|hormones|mesh-ancestor
101295637|NCT01985828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101295638|NCT01985828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295639|NCT01985841|Cyclophosphamide|cyclophosphamide|mesh-list
101295640|NCT01985841|Docetaxel|docetaxel|mesh-list
101295641|NCT01985841|Fluorouracil|fluorouracil|mesh-list
101295642|NCT01985841|Epirubicin|epirubicin|mesh-list
101295643|NCT01985841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101295644|NCT01985841|Immunologic Factors|immunologic factors|mesh-ancestor
101295645|NCT01985841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295646|NCT01985841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101295647|NCT01985841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101295648|NCT01985841|Alkylating Agents|alkylating agents|mesh-ancestor
101295649|NCT01985841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295650|NCT01985841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101295651|NCT01985841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101295652|NCT01985841|Tubulin Modulators|tubulin modulators|mesh-ancestor
101295653|NCT01985841|Antimitotic Agents|antimitotic agents|mesh-ancestor
101295654|NCT01985841|Mitosis Modulators|mitosis modulators|mesh-ancestor
101295655|NCT01985841|Antimetabolites|antimetabolites|mesh-ancestor
101295656|NCT01985841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101295657|NCT01985841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101295658|NCT01985841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101295659|NCT01985841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101295660|NCT01985841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101295663|NCT01985854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101295664|NCT01985854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101295665|NCT01985854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295666|NCT01985854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101295667|NCT01985854|Anesthetics, General|anesthetics, general|mesh-ancestor
101295668|NCT01985854|Anesthetics|anesthetics|mesh-ancestor
101295669|NCT01985854|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101295670|NCT01985893|Trastuzumab|trastuzumab|mesh-list
101295671|NCT01985893|Lapatinib|lapatinib|mesh-list
101295672|NCT01985893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101295673|NCT01985893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101295674|NCT01985893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101295675|NCT01985893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101295676|NCT01985893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295677|NCT01986036|Calcium|calcium|mesh-list
101295678|NCT01986036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101295679|NCT01986036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295680|NCT01986049|Bupivacaine|bupivacaine|mesh-list
101295681|NCT01986049|Anesthetics, Local|anesthetics, local|mesh-ancestor
101295682|NCT01986049|Anesthetics|anesthetics|mesh-ancestor
101295683|NCT01986049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101295684|NCT01986049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295685|NCT01986049|Sensory System Agents|sensory system agents|mesh-ancestor
101821535|NCT00998166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101821536|NCT00998166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821537|NCT00998166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101821538|NCT00998166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101821539|NCT00998166|Growth Substances|growth substances|mesh-ancestor
101821540|NCT00998166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295686|NCT01986049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101295687|NCT01986088|Sumatriptan|sumatriptan|mesh-list
101295688|NCT01986088|Eletriptan|eletriptan|mesh-list
101295689|NCT01986088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101295690|NCT01986088|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101295691|NCT01986088|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101295692|NCT01986088|Serotonin Agents|serotonin agents|mesh-ancestor
101295693|NCT01986088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101295694|NCT01986088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295695|NCT01986088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295696|NCT01986127|Adalimumab|adalimumab|mesh-list
101295697|NCT01986127|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101295698|NCT01986127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101295699|NCT01986127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101295702|NCT01986192|Anticoagulants|anticoagulants|mesh-ancestor
101295703|NCT01986192|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101295704|NCT01986192|Antithrombins|antithrombins|mesh-ancestor
101295705|NCT01986192|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101295706|NCT01986192|Protease Inhibitors|protease inhibitors|mesh-ancestor
101295707|NCT01986192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101295708|NCT01986192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295710|NCT01986218|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101295711|NCT01986218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101295712|NCT01986218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295713|NCT01986270|Sumatriptan|sumatriptan|mesh-list
101295714|NCT01986270|Eletriptan|eletriptan|mesh-list
101295715|NCT01986270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101295716|NCT01986270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101295717|NCT01986270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101295718|NCT01986270|Serotonin Agents|serotonin agents|mesh-ancestor
101295719|NCT01986270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101295720|NCT01986270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295721|NCT01986270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295722|NCT01986283|Oxycodone|oxycodone|mesh-list
101295723|NCT01986283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101295724|NCT01986283|Narcotics|narcotics|mesh-ancestor
101295725|NCT01986283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101295726|NCT01986283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295727|NCT01986283|Analgesics|analgesics|mesh-ancestor
101295728|NCT01986283|Sensory System Agents|sensory system agents|mesh-ancestor
101295729|NCT01986283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101295730|NCT01986309|Lidocaine|lidocaine|mesh-list
101295731|NCT01986309|Anesthetics, Local|anesthetics, local|mesh-ancestor
101295732|NCT01986309|Anesthetics|anesthetics|mesh-ancestor
101295733|NCT01986309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101295734|NCT01986309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295735|NCT01986309|Sensory System Agents|sensory system agents|mesh-ancestor
101295736|NCT01986309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101295737|NCT01986309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101295738|NCT01986309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101295739|NCT01986309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101295740|NCT01986309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101295741|NCT01986309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295743|NCT01986322|Immunologic Factors|immunologic factors|mesh-ancestor
101295744|NCT01986322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295745|NCT01986426|Pembrolizumab|pembrolizumab|mesh-list
101295746|NCT01986426|Ipilimumab|ipilimumab|mesh-list
101295747|NCT01986426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101295748|NCT01986426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821541|NCT00998166|Growth Inhibitors|growth inhibitors|mesh-ancestor
101821542|NCT00998166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101821543|NCT00998166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821544|NCT00998166|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101821545|NCT00998166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101821546|NCT03990922|Morphine|morphine|mesh-list
101821547|NCT03990922|Ropivacaine|ropivacaine|mesh-list
101821548|NCT03990922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101821549|NCT03990922|Narcotics|narcotics|mesh-ancestor
101312832|NCT00008307|Antiemetics|antiemetics|mesh-ancestor
101295749|NCT01986426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101295750|NCT01986426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295751|NCT01986465|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101295752|NCT01986465|Methylprednisolone|methylprednisolone|mesh-list
101295753|NCT01986465|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101295754|NCT01986465|Prednisolone|prednisolone|mesh-list
101295755|NCT01986465|Prednisolone acetate|prednisolone acetate|mesh-list
101295756|NCT01986465|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101295757|NCT01986465|Prednisolone phosphate|prednisolone phosphate|mesh-list
101295758|NCT01986465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101295759|NCT01986465|Antiemetics|antiemetics|mesh-ancestor
101295761|NCT01986465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101295762|NCT01986465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295763|NCT01986465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101295764|NCT01986465|Glucocorticoids|glucocorticoids|mesh-ancestor
101295765|NCT01986465|Hormones|hormones|mesh-ancestor
101295766|NCT01986465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101295767|NCT01986465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101295768|NCT01986465|Protective Agents|protective agents|mesh-ancestor
101295769|NCT01986465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101295770|NCT01986465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101295771|NCT01986556|Lesinurad|lesinurad|mesh-list
101295772|NCT01986556|Gout Suppressants|gout suppressants|mesh-ancestor
101295773|NCT01986556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101295774|NCT01986556|Uricosuric Agents|uricosuric agents|mesh-ancestor
101295775|NCT01986582|Phenylephrine|phenylephrine|mesh-list
101295776|NCT01986582|Oxymetazoline|oxymetazoline|mesh-list
101295777|NCT01986582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101295778|NCT01986582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101295779|NCT01986582|Adrenergic Agents|adrenergic agents|mesh-ancestor
101295780|NCT01986582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101295781|NCT01986582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295782|NCT01986582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295783|NCT01986582|Sympathomimetics|sympathomimetics|mesh-ancestor
101295784|NCT01986582|Autonomic Agents|autonomic agents|mesh-ancestor
101295785|NCT01986582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101295786|NCT01986582|Nasal Decongestants|nasal decongestants|mesh-ancestor
101295787|NCT01986582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101295788|NCT01986582|Respiratory System Agents|respiratory system agents|mesh-ancestor
101295789|NCT01986582|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101295790|NCT01986582|Mydriatics|mydriatics|mesh-ancestor
101295791|NCT01986582|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101295792|NCT01986582|Protective Agents|protective agents|mesh-ancestor
101295793|NCT01986608|Lacosamide|lacosamide|mesh-list
101295794|NCT01986608|Anticonvulsants|anticonvulsants|mesh-ancestor
101295795|NCT01986608|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101295796|NCT01986608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101295797|NCT01986608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101295798|NCT01986608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295799|NCT01986660|Ibuprofen|ibuprofen|mesh-list
101295800|NCT01986660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101295801|NCT01986660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101295802|NCT01986660|Analgesics|analgesics|mesh-ancestor
101295803|NCT01986660|Sensory System Agents|sensory system agents|mesh-ancestor
101295804|NCT01986660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101295805|NCT01986660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821550|NCT03990922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101821551|NCT03990922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821552|NCT03990922|Analgesics|analgesics|mesh-ancestor
101821553|NCT03990922|Sensory System Agents|sensory system agents|mesh-ancestor
101821554|NCT03990922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101821555|NCT03990922|Anesthetics, Local|anesthetics, local|mesh-ancestor
101821556|NCT03990922|Anesthetics|anesthetics|mesh-ancestor
101821557|NCT00822263|Acetylcysteine|acetylcysteine|mesh-list
101821558|NCT00822263|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101295806|NCT01986660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101295807|NCT01986660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101295808|NCT01986660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101295809|NCT01986660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101295810|NCT01986660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295812|NCT01986673|Vasodilator Agents|vasodilator agents|mesh-ancestor
101295813|NCT01986673|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101295814|NCT01986673|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101295815|NCT01986673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101295816|NCT01986673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295817|NCT01986673|Urological Agents|urological agents|mesh-ancestor
101408826|NCT00401492|Vinorelbine|vinorelbine|mesh-list
101295818|NCT01986764|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101295820|NCT01986764|Estrogens|estrogens|mesh-list
101295821|NCT01986764|Hormones|hormones|mesh-ancestor
101295822|NCT01986764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101295823|NCT01986764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295824|NCT01986764|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101295825|NCT01986764|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101295826|NCT01986764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101295827|NCT01986764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101295828|NCT01986764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295829|NCT01986764|Dopamine Agents|dopamine agents|mesh-ancestor
101295830|NCT01986764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101295831|NCT01986777|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101295832|NCT01986777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101295833|NCT01986777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295834|NCT01986777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101295835|NCT01986777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101295836|NCT01986777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101295837|NCT01986777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295838|NCT01986777|Dopamine Agents|dopamine agents|mesh-ancestor
101295839|NCT01986777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101295840|NCT01986894|Moxifloxacin|moxifloxacin|mesh-list
101295841|NCT01986894|Thalidomide|thalidomide|mesh-list
101295842|NCT01986894|Pomalidomide|pomalidomide|mesh-list
101295843|NCT01986894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101295844|NCT01986894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101295845|NCT01986894|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101295846|NCT01986894|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101295847|NCT01986894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101295848|NCT01986894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295849|NCT01986894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101295850|NCT01986894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295851|NCT01986894|Immunologic Factors|immunologic factors|mesh-ancestor
101295852|NCT01986894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101295853|NCT01986894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101295854|NCT01986894|Growth Substances|growth substances|mesh-ancestor
101295855|NCT01986894|Growth Inhibitors|growth inhibitors|mesh-ancestor
101295856|NCT01986894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101295857|NCT01986894|Leprostatic Agents|leprostatic agents|mesh-ancestor
101295858|NCT01986998|Methylprednisolone|methylprednisolone|mesh-list
101295859|NCT01986998|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101821559|NCT00822263|Antiviral Agents|antiviral agents|mesh-ancestor
101821560|NCT00822263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101821561|NCT00822263|Expectorants|expectorants|mesh-ancestor
101821562|NCT00822263|Respiratory System Agents|respiratory system agents|mesh-ancestor
101821563|NCT00822263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101821564|NCT00822263|Antioxidants|antioxidants|mesh-ancestor
101821565|NCT00822263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821566|NCT00822263|Protective Agents|protective agents|mesh-ancestor
101821567|NCT00822263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295860|NCT01986998|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101295861|NCT01986998|Prednisolone|prednisolone|mesh-list
101295862|NCT01986998|Prednisolone acetate|prednisolone acetate|mesh-list
101295863|NCT01986998|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101295864|NCT01986998|Prednisolone phosphate|prednisolone phosphate|mesh-list
101295866|NCT01986998|Antiemetics|antiemetics|mesh-ancestor
101295867|NCT01986998|Autonomic Agents|autonomic agents|mesh-ancestor
101295868|NCT01986998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101295869|NCT01986998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295870|NCT01986998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101295871|NCT01986998|Glucocorticoids|glucocorticoids|mesh-ancestor
101295872|NCT01986998|Hormones|hormones|mesh-ancestor
101295873|NCT01986998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101295874|NCT01986998|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101295875|NCT01986998|Protective Agents|protective agents|mesh-ancestor
101295876|NCT01986998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101295877|NCT01986998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101295878|NCT01987076|Prednisone|prednisone|mesh-list
101295879|NCT01987076|Clobetasol|clobetasol|mesh-list
101295881|NCT01987076|Glucocorticoids|glucocorticoids|mesh-ancestor
101295882|NCT01987076|Hormones|hormones|mesh-ancestor
101295883|NCT01987076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101295884|NCT01987076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295885|NCT01987076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101295886|NCT01987076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101295887|NCT01987128|Ropivacaine|ropivacaine|mesh-list
101295888|NCT01987128|Anesthetics, Local|anesthetics, local|mesh-ancestor
101295889|NCT01987128|Anesthetics|anesthetics|mesh-ancestor
101295890|NCT01987128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101295891|NCT01987128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295892|NCT01987128|Sensory System Agents|sensory system agents|mesh-ancestor
101295893|NCT01987128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101295894|NCT01987154|Caseins|caseins|mesh-list
101295895|NCT01987154|Chelating Agents|chelating agents|mesh-ancestor
101295896|NCT01987154|Sequestering Agents|sequestering agents|mesh-ancestor
101295897|NCT01987154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295898|NCT01987167|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101295899|NCT01987167|Hormones|hormones|mesh-ancestor
101295900|NCT01987167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101295901|NCT01987167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295902|NCT01987297|Cytarabine|cytarabine|mesh-list
101295903|NCT01987297|Daunorubicin|daunorubicin|mesh-list
101295904|NCT01987297|Idarubicin|idarubicin|mesh-list
101295905|NCT01987297|Tretinoin|tretinoin|mesh-list
101295906|NCT01987297|Arsenic Trioxide|arsenic trioxide|mesh-list
101295907|NCT01987297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101295908|NCT01987297|Antimetabolites|antimetabolites|mesh-ancestor
101295909|NCT01987297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295910|NCT01987297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101295911|NCT01987297|Antiviral Agents|antiviral agents|mesh-ancestor
101295912|NCT01987297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101295913|NCT01987297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101295914|NCT01987297|Immunologic Factors|immunologic factors|mesh-ancestor
101295915|NCT01987297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295916|NCT01987297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101295917|NCT01987297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101295918|NCT01987297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101821568|NCT00822263|Antidotes|antidotes|mesh-ancestor
101821569|NCT03992170|Daratumumab|daratumumab|mesh-list
101821570|NCT03992170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821571|NCT00817037|Nifedipine|nifedipine|mesh-list
101821572|NCT00817037|Sitaxsentan|sitaxsentan|mesh-list
101821573|NCT00817037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101821574|NCT00817037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101821575|NCT00817037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821576|NCT00817037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101821577|NCT00817037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821578|NCT00817037|Vasodilator Agents|vasodilator agents|mesh-ancestor
101821579|NCT00817037|Tocolytic Agents|tocolytic agents|mesh-ancestor
101295919|NCT01987297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101295920|NCT01987297|Keratolytic Agents|keratolytic agents|mesh-ancestor
101295921|NCT01987297|Dermatologic Agents|dermatologic agents|mesh-ancestor
101295923|NCT01987310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101295924|NCT01987310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101295925|NCT01987310|Antimetabolites|antimetabolites|mesh-ancestor
101295926|NCT01987310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295927|NCT01987310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101295928|NCT01987310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101295929|NCT01987310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101295930|NCT01987323|Latanoprost|latanoprost|mesh-list
101295931|NCT01987323|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101295932|NCT01987323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101295934|NCT01987375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101295935|NCT01987375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101295936|NCT01987570|Allopurinol|allopurinol|mesh-list
101295937|NCT01987570|Antimetabolites|antimetabolites|mesh-ancestor
101295938|NCT01987570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295939|NCT01987570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101295940|NCT01987570|Gout Suppressants|gout suppressants|mesh-ancestor
101295941|NCT01987570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101295942|NCT01987570|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101295943|NCT01987570|Antioxidants|antioxidants|mesh-ancestor
101295944|NCT01987570|Protective Agents|protective agents|mesh-ancestor
101295945|NCT01987570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295946|NCT01987739|Zolpidem|zolpidem|mesh-list
101295947|NCT01987739|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101295948|NCT01987739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101295949|NCT01987739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101295950|NCT01987739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295951|NCT01987739|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101295952|NCT01987739|GABA Agonists|gaba agonists|mesh-ancestor
101295953|NCT01987739|GABA Agents|gaba agents|mesh-ancestor
101295954|NCT01987739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101295955|NCT01987739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295956|NCT01987804|Oxytocin|oxytocin|mesh-list
101295957|NCT01987804|Oxytocics|oxytocics|mesh-ancestor
101295958|NCT01987804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101295959|NCT01987804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295960|NCT01988077|Ipilimumab|ipilimumab|mesh-list
101295961|NCT01988077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101295962|NCT01988077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101295963|NCT01988077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101295964|NCT01988077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295965|NCT01988116|Calcitriol|calcitriol|mesh-list
101295966|NCT01988116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101295967|NCT01988116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295968|NCT01988116|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101295969|NCT01988116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101821580|NCT00817037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101821581|NCT00817037|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101821582|NCT00998322|Gemcitabine|gemcitabine|mesh-list
101821583|NCT00998322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101821584|NCT00998322|Antimetabolites|antimetabolites|mesh-ancestor
101821585|NCT00998322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821586|NCT00998322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821587|NCT00367744|Rosiglitazone|rosiglitazone|mesh-list
101821588|NCT00367744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101821589|NCT00367744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821590|NCT01002300|Oxytocin|oxytocin|mesh-list
101821591|NCT01002300|Oxytocics|oxytocics|mesh-ancestor
101295970|NCT01988116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295971|NCT01988116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101295972|NCT01988116|Vitamins|vitamins|mesh-ancestor
101295973|NCT01988116|Micronutrients|micronutrients|mesh-ancestor
101295974|NCT01988116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101295975|NCT01988298|Acetaminophen|acetaminophen|mesh-list
101295976|NCT01988298|Ibuprofen|ibuprofen|mesh-list
101295977|NCT01988298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101295978|NCT01988298|Analgesics|analgesics|mesh-ancestor
101295979|NCT01988298|Sensory System Agents|sensory system agents|mesh-ancestor
101295980|NCT01988298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101295981|NCT01988298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295982|NCT01988298|Antipyretics|antipyretics|mesh-ancestor
101295983|NCT01988298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101295984|NCT01988298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101295985|NCT01988298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101295986|NCT01988298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101295987|NCT01988298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101295988|NCT01988298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101295989|NCT01988311|Psilocybin|psilocybin|mesh-list
101295990|NCT01988311|Hallucinogens|hallucinogens|mesh-ancestor
101295991|NCT01988311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101295992|NCT01988311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101295993|NCT01988428|Ceftriaxone|ceftriaxone|mesh-list
101295994|NCT01988428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101295995|NCT01988428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101295996|NCT01988506|Interleukin-2|interleukin-2|mesh-list
101295997|NCT01988506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101295998|NCT01988506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101296000|NCT01988506|Sensory System Agents|sensory system agents|mesh-ancestor
101296001|NCT01988506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101296002|NCT01988506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296004|NCT01988545|Glucagon|glucagon|mesh-list
101296005|NCT01988545|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101296006|NCT01988545|Incretins|incretins|mesh-ancestor
101296007|NCT01988545|Hormones|hormones|mesh-ancestor
101296008|NCT01988545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101296009|NCT01988545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296010|NCT01988545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101296011|NCT01988545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101296012|NCT01988545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101296013|NCT01988610|Mifepristone|mifepristone|mesh-list
101296014|NCT01988610|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101296015|NCT01988610|Abortifacient Agents|abortifacient agents|mesh-ancestor
101296016|NCT01988610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101296017|NCT01988610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296018|NCT01988610|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101296019|NCT01988610|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101296020|NCT01988610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101296021|NCT01988610|Contraceptive Agents|contraceptive agents|mesh-ancestor
101296022|NCT01988610|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101296023|NCT01988610|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101821592|NCT01002300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101821593|NCT01002300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821594|NCT00822419|Lidocaine|lidocaine|mesh-list
101821595|NCT00822419|Ketamine|ketamine|mesh-list
101821596|NCT00822419|Anesthetics, Local|anesthetics, local|mesh-ancestor
101821597|NCT00822419|Anesthetics|anesthetics|mesh-ancestor
101821598|NCT00822419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101821599|NCT00822419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821600|NCT00822419|Sensory System Agents|sensory system agents|mesh-ancestor
101296024|NCT01988610|Hormone Antagonists|hormone antagonists|mesh-ancestor
101296025|NCT01988610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101296026|NCT01988610|Luteolytic Agents|luteolytic agents|mesh-ancestor
101296027|NCT01988610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101296028|NCT01988610|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101296029|NCT01988649|Oxytocin|oxytocin|mesh-list
101296030|NCT01988649|Oxytocics|oxytocics|mesh-ancestor
101296031|NCT01988649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101296032|NCT01988649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296033|NCT01988831|Propranolol|propranolol|mesh-list
101296034|NCT01988831|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101296035|NCT01988831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101296036|NCT01988831|Adrenergic Agents|adrenergic agents|mesh-ancestor
101296037|NCT01988831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101296038|NCT01988831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296039|NCT01988831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296040|NCT01988831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101296041|NCT01988831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101296042|NCT01988831|Vasodilator Agents|vasodilator agents|mesh-ancestor
101296043|NCT01988896|Atezolizumab|atezolizumab|mesh-list
101296044|NCT01988896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101296045|NCT01988896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296046|NCT01988896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101296047|NCT01988896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101296048|NCT01988961|Golimumab|golimumab|mesh-list
101296049|NCT01988961|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101296050|NCT01988961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101296051|NCT01988961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101296052|NCT01988961|Immunologic Factors|immunologic factors|mesh-ancestor
101296053|NCT01988961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296054|NCT01989000|Gemcitabine|gemcitabine|mesh-list
101296055|NCT01989000|Imidazole|imidazole|mesh-list
101296056|NCT01989000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101296057|NCT01989000|Antimetabolites|antimetabolites|mesh-ancestor
101296058|NCT01989000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296059|NCT01989000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101296060|NCT01989000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101296062|NCT01989052|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
101296063|NCT01989052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101296064|NCT01989052|Alkylating Agents|alkylating agents|mesh-ancestor
101296065|NCT01989052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296066|NCT01989052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101296067|NCT01989052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101296068|NCT01989052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101296069|NCT01989052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101296070|NCT01989052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296072|NCT01989078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101296073|NCT01989078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101317158|NCT00009178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101296074|NCT01989078|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101296075|NCT01989078|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101296076|NCT01989078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296077|NCT01989091|Heparin|heparin|mesh-list
101821601|NCT00822419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101821602|NCT00822419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101821603|NCT00822419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101821604|NCT00822419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101821605|NCT00822419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101821606|NCT00822419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821607|NCT00822419|Analgesics|analgesics|mesh-ancestor
101821608|NCT00822419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101821609|NCT00822419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101821610|NCT00822419|Anesthetics, General|anesthetics, general|mesh-ancestor
101821611|NCT00822419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101821612|NCT00822419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101821613|NCT00822419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101821614|NCT01002534|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101296078|NCT01989091|Anticoagulants|anticoagulants|mesh-ancestor
101296079|NCT01989091|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101296080|NCT01989091|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101296081|NCT01989091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296082|NCT01989312|Lidocaine|lidocaine|mesh-list
101296083|NCT01989312|Epinephrine|epinephrine|mesh-list
101296084|NCT01989312|Midazolam|midazolam|mesh-list
101296085|NCT01989312|Levobupivacaine|levobupivacaine|mesh-list
101296086|NCT01989312|Anesthetics, Local|anesthetics, local|mesh-ancestor
101296087|NCT01989312|Anesthetics|anesthetics|mesh-ancestor
101296088|NCT01989312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101296089|NCT01989312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296090|NCT01989312|Sensory System Agents|sensory system agents|mesh-ancestor
101296091|NCT01989312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101296092|NCT01989312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101296093|NCT01989312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101296094|NCT01989312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101296095|NCT01989312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101296096|NCT01989312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296097|NCT01989312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101296098|NCT01989312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101296099|NCT01989312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101296100|NCT01989312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101296101|NCT01989312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101296102|NCT01989312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101296103|NCT01989312|Anesthetics, General|anesthetics, general|mesh-ancestor
101296104|NCT01989312|GABA Modulators|gaba modulators|mesh-ancestor
101296105|NCT01989312|GABA Agents|gaba agents|mesh-ancestor
101296106|NCT01989312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101296107|NCT01989312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101296108|NCT01989312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101296109|NCT01989312|Adrenergic Agents|adrenergic agents|mesh-ancestor
101296110|NCT01989312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101296111|NCT01989312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101296112|NCT01989312|Autonomic Agents|autonomic agents|mesh-ancestor
101296113|NCT01989312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101296114|NCT01989312|Respiratory System Agents|respiratory system agents|mesh-ancestor
101296115|NCT01989312|Mydriatics|mydriatics|mesh-ancestor
101296116|NCT01989312|Sympathomimetics|sympathomimetics|mesh-ancestor
101296117|NCT01989312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101296118|NCT01989416|Chlorhexidine|chlorhexidine|mesh-list
101296119|NCT01989416|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101296120|NCT01989416|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101821615|NCT01002534|Vasodilator Agents|vasodilator agents|mesh-ancestor
101821616|NCT01002534|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101821617|NCT01002534|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101821618|NCT01002534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101821619|NCT01002534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296121|NCT01989416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101296122|NCT01989416|Disinfectants|disinfectants|mesh-ancestor
101296123|NCT01989416|Dermatologic Agents|dermatologic agents|mesh-ancestor
101296125|NCT01989507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101296126|NCT01989507|Autonomic Agents|autonomic agents|mesh-ancestor
101296127|NCT01989507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101296128|NCT01989507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296129|NCT01989507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101296130|NCT01989507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101296131|NCT01989507|Cholinergic Agents|cholinergic agents|mesh-ancestor
101296132|NCT01989507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101296133|NCT01989507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296134|NCT01989559|Vaccines|vaccines|mesh-list
101296135|NCT01989559|Immunologic Factors|immunologic factors|mesh-ancestor
101296136|NCT01989559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296137|NCT01989611|Tenofovir|tenofovir|mesh-list
101296138|NCT01989611|Emtricitabine|emtricitabine|mesh-list
101296139|NCT01989611|Antiviral Agents|antiviral agents|mesh-ancestor
101296140|NCT01989611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101296141|NCT01989611|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101296142|NCT01989611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101296143|NCT01989611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101296144|NCT01989611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317161|NCT00009178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101296146|NCT01989611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101296147|NCT01989663|Tenofovir|tenofovir|mesh-list
101296148|NCT01989663|Antiviral Agents|antiviral agents|mesh-ancestor
101296149|NCT01989663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101296150|NCT01989663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101296151|NCT01989663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101296152|NCT01989663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101296153|NCT01989663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296154|NCT01989663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101296155|NCT01989663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101296156|NCT01989676|Paclitaxel|paclitaxel|mesh-list
101296157|NCT01989676|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101296158|NCT01989676|Trastuzumab|trastuzumab|mesh-list
101296159|NCT01989676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101296160|NCT01989676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101296161|NCT01989676|Tubulin Modulators|tubulin modulators|mesh-ancestor
101296162|NCT01989676|Antimitotic Agents|antimitotic agents|mesh-ancestor
101296163|NCT01989676|Mitosis Modulators|mitosis modulators|mesh-ancestor
101296164|NCT01989676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296165|NCT01989676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101296166|NCT01989845|Rivaroxaban|rivaroxaban|mesh-list
101296167|NCT01989845|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101296168|NCT01989845|Antithrombins|antithrombins|mesh-ancestor
101296169|NCT01989845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101296170|NCT01989845|Protease Inhibitors|protease inhibitors|mesh-ancestor
101296171|NCT01989845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101296172|NCT01989845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296173|NCT01989845|Anticoagulants|anticoagulants|mesh-ancestor
101296174|NCT01989884|IDN 5109|idn 5109|mesh-list
101296175|NCT01989884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101296176|NCT01989897|Phenol|phenol|mesh-list
101296177|NCT01989897|Histamine|histamine|mesh-list
101296178|NCT01989897|Histamine Agonists|histamine agonists|mesh-ancestor
101296179|NCT01989897|Histamine Agents|histamine agents|mesh-ancestor
101296180|NCT01989897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101296181|NCT01989897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296182|NCT01989897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296183|NCT01989897|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101296184|NCT01989897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101821620|NCT01002534|Urological Agents|urological agents|mesh-ancestor
101821622|NCT00817271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101821623|NCT00817271|Hormones|hormones|mesh-ancestor
101821624|NCT00817271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101821625|NCT00817271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821626|NCT01052896|Gabapentin|gabapentin|mesh-list
101821627|NCT01052896|Analgesics|analgesics|mesh-ancestor
101821628|NCT01052896|Sensory System Agents|sensory system agents|mesh-ancestor
101296185|NCT01989897|Disinfectants|disinfectants|mesh-ancestor
101296186|NCT01989897|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
101296187|NCT01989897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101296188|NCT01989923|Nicotine|nicotine|mesh-list
101296189|NCT01989923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101296190|NCT01989923|Autonomic Agents|autonomic agents|mesh-ancestor
101296191|NCT01989923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101296192|NCT01989923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296193|NCT01989923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101296194|NCT01989923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101296195|NCT01989923|Cholinergic Agents|cholinergic agents|mesh-ancestor
101296196|NCT01989923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101296197|NCT01989923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296198|NCT01989936|Eletriptan|eletriptan|mesh-list
101296199|NCT01989936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101296200|NCT01989936|Serotonin Agents|serotonin agents|mesh-ancestor
101296201|NCT01989936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101296202|NCT01989936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296203|NCT01989936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296204|NCT01990079|Bupropion|bupropion|mesh-list
101296205|NCT01990079|Nicotine|nicotine|mesh-list
101296206|NCT01990079|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101296207|NCT01990079|Autonomic Agents|autonomic agents|mesh-ancestor
101296208|NCT01990079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101296209|NCT01990079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296210|NCT01990079|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101296211|NCT01990079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101296212|NCT01990079|Cholinergic Agents|cholinergic agents|mesh-ancestor
101296213|NCT01990079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101296214|NCT01990079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296215|NCT01990079|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101296216|NCT01990079|Antidepressive Agents|antidepressive agents|mesh-ancestor
101296217|NCT01990079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101296218|NCT01990079|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101296219|NCT01990079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101296220|NCT01990079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101296221|NCT01990079|Dopamine Agents|dopamine agents|mesh-ancestor
101296222|NCT01990079|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101296223|NCT01990079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101296224|NCT01990079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101296225|NCT01990118|Cyclosporine|cyclosporine|mesh-list
101296226|NCT01990118|Cyclosporins|cyclosporins|mesh-list
101296227|NCT01990118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101296228|NCT01990118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296229|NCT01990118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101296230|NCT01990118|Immunologic Factors|immunologic factors|mesh-ancestor
101296231|NCT01990118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296232|NCT01990118|Antifungal Agents|antifungal agents|mesh-ancestor
101296233|NCT01990118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101296234|NCT01990118|Dermatologic Agents|dermatologic agents|mesh-ancestor
101296235|NCT01990118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101296236|NCT01990118|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101296237|NCT01990144|Rituximab|rituximab|mesh-list
101296238|NCT01990144|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101296239|NCT01990144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101296240|NCT01990144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821629|NCT01052896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101821630|NCT01052896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821631|NCT01052896|Anticonvulsants|anticonvulsants|mesh-ancestor
101821632|NCT01052896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101821633|NCT01052896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101821634|NCT01052896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101821635|NCT01052896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101821636|NCT01052896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101821637|NCT01052896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101296241|NCT01990144|Immunologic Factors|immunologic factors|mesh-ancestor
101296242|NCT01990144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296243|NCT01990144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101296244|NCT01990144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101296245|NCT01990144|Alkylating Agents|alkylating agents|mesh-ancestor
101296246|NCT01990144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296247|NCT01990378|Rabeprazole|rabeprazole|mesh-list
101296248|NCT01990378|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101296249|NCT01990378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101296250|NCT01990378|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101296251|NCT01990378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101296252|NCT01990378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296253|NCT01990404|Nitrous Oxide|nitrous oxide|mesh-list
101296254|NCT01990404|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101296255|NCT01990404|Anesthetics, General|anesthetics, general|mesh-ancestor
101296256|NCT01990404|Anesthetics|anesthetics|mesh-ancestor
101296257|NCT01990404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101296258|NCT01990404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296259|NCT01990404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101296260|NCT01990404|Analgesics|analgesics|mesh-ancestor
101296261|NCT01990404|Sensory System Agents|sensory system agents|mesh-ancestor
101296262|NCT01990404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101296263|NCT01990443|Reslizumab|reslizumab|mesh-list
101296264|NCT01990443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101296265|NCT01990443|Respiratory System Agents|respiratory system agents|mesh-ancestor
101296266|NCT01990586|Rabeprazole|rabeprazole|mesh-list
101296267|NCT01990586|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101296268|NCT01990586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101296269|NCT01990586|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101296270|NCT01990586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101296271|NCT01990586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296272|NCT01990690|Antioxidants|antioxidants|mesh-list
101296273|NCT01990690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296274|NCT01990690|Protective Agents|protective agents|mesh-ancestor
101296275|NCT01990690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296276|NCT01990755|Chlordesmethyldiazepam|chlordesmethyldiazepam|mesh-list
101296277|NCT01990755|Olanzapine|olanzapine|mesh-list
101296278|NCT01990755|Antiemetics|antiemetics|mesh-ancestor
101296279|NCT01990755|Autonomic Agents|autonomic agents|mesh-ancestor
101296280|NCT01990755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101296281|NCT01990755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296282|NCT01990755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101296283|NCT01990755|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101296285|NCT01990755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101296286|NCT01990755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101296287|NCT01990755|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101296288|NCT01990755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101296289|NCT01990755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101296290|NCT01990755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296291|NCT01990755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101296292|NCT01990755|Serotonin Agents|serotonin agents|mesh-ancestor
101296293|NCT01990755|Anticonvulsants|anticonvulsants|mesh-ancestor
101296294|NCT01990781|Dexamethasone|dexamethasone|mesh-list
101296295|NCT01990781|Dexamethasone acetate|dexamethasone acetate|mesh-list
101296296|NCT01990781|Lidocaine|lidocaine|mesh-list
101821639|NCT01052896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821640|NCT01052896|Antimanic Agents|antimanic agents|mesh-ancestor
101821641|NCT01002690|Etoricoxib|etoricoxib|mesh-list
101821642|NCT01002690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101821643|NCT01002690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101821644|NCT01002690|Analgesics|analgesics|mesh-ancestor
101821645|NCT01002690|Sensory System Agents|sensory system agents|mesh-ancestor
101821646|NCT01002690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101821647|NCT01002690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821648|NCT01002690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101296297|NCT01990781|BB 1101|bb 1101|mesh-list
101296298|NCT01990781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101296299|NCT01990781|Antiemetics|antiemetics|mesh-ancestor
101296300|NCT01990781|Autonomic Agents|autonomic agents|mesh-ancestor
101296301|NCT01990781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101296302|NCT01990781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296303|NCT01990781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101296304|NCT01990781|Glucocorticoids|glucocorticoids|mesh-ancestor
101296305|NCT01990781|Hormones|hormones|mesh-ancestor
101296306|NCT01990781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101296307|NCT01990781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101296308|NCT01990781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101296309|NCT01990781|Protease Inhibitors|protease inhibitors|mesh-ancestor
101296310|NCT01990781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101296311|NCT01990781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296312|NCT01990781|Anesthetics, Local|anesthetics, local|mesh-ancestor
101296313|NCT01990781|Anesthetics|anesthetics|mesh-ancestor
101296314|NCT01990781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101296315|NCT01990781|Sensory System Agents|sensory system agents|mesh-ancestor
101296316|NCT01990781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101296317|NCT01990781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101296318|NCT01990781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101296319|NCT01990781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101296320|NCT01990807|Idarubicin|idarubicin|mesh-list
101296321|NCT01990807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101296322|NCT01990807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101296323|NCT01990807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101296324|NCT01990807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101296325|NCT01990807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101296327|NCT01990872|Vitamin D|vitamin d|mesh-list
101296328|NCT01990872|Cholecalciferol|cholecalciferol|mesh-list
101296329|NCT01990872|Vitamins|vitamins|mesh-ancestor
101296330|NCT01990872|Micronutrients|micronutrients|mesh-ancestor
101296331|NCT01990872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296332|NCT01990872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101296333|NCT01990872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101296334|NCT01990937|Midazolam|midazolam|mesh-list
101296335|NCT01990937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101296336|NCT01990937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101296337|NCT01990937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101296338|NCT01990937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296339|NCT01990937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101296340|NCT01990937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101296341|NCT01990937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101296342|NCT01990937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101296343|NCT01990937|Anesthetics, General|anesthetics, general|mesh-ancestor
101296344|NCT01990937|Anesthetics|anesthetics|mesh-ancestor
101296345|NCT01990937|GABA Modulators|gaba modulators|mesh-ancestor
101296346|NCT01990937|GABA Agents|gaba agents|mesh-ancestor
101296347|NCT01990937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101296348|NCT01990937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821649|NCT01002690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101821650|NCT01002690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101821651|NCT01002690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101821652|NCT01002690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101296349|NCT01991028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101296350|NCT01991054|Vitamin D|vitamin d|mesh-list
101296351|NCT01991054|Cholecalciferol|cholecalciferol|mesh-list
101296352|NCT01991054|Vitamins|vitamins|mesh-ancestor
101296353|NCT01991054|Micronutrients|micronutrients|mesh-ancestor
101296354|NCT01991054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317178|NCT00005876|Rubitecan|rubitecan|mesh-list
101296355|NCT01991054|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101296356|NCT01991054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101528335|NCT04628676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528336|NCT04628676|Hemostatics|hemostatics|mesh-ancestor
101528337|NCT04628676|Coagulants|coagulants|mesh-ancestor
101528338|NCT04628676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101528339|NCT04628676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101528340|NCT04628676|Adrenergic Agents|adrenergic agents|mesh-ancestor
101528341|NCT04628676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101528342|NCT04628676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528343|NCT04628676|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101528344|NCT04628676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101528345|NCT04628676|Autonomic Agents|autonomic agents|mesh-ancestor
101528346|NCT04628676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101528347|NCT04628676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101296357|NCT01991119|Dronedarone|dronedarone|mesh-list
101296358|NCT01991119|Propafenone|propafenone|mesh-list
101296359|NCT01991119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101296360|NCT01991119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101296361|NCT01991119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101296362|NCT01991119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101296363|NCT01991119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296364|NCT01991145|Epoetin Alfa|epoetin alfa|mesh-list
101296365|NCT01991145|Hematinics|hematinics|mesh-ancestor
101296366|NCT01991158|Dexamethasone|dexamethasone|mesh-list
101296367|NCT01991158|Gemcitabine|gemcitabine|mesh-list
101296368|NCT01991158|Methotrexate|methotrexate|mesh-list
101296369|NCT01991158|Pegaspargase|pegaspargase|mesh-list
101296370|NCT01991158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101296371|NCT01991158|Antiemetics|antiemetics|mesh-ancestor
101296372|NCT01991158|Autonomic Agents|autonomic agents|mesh-ancestor
101296373|NCT01991158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101296374|NCT01991158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296375|NCT01991158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101296376|NCT01991158|Glucocorticoids|glucocorticoids|mesh-ancestor
101296377|NCT01991158|Hormones|hormones|mesh-ancestor
101296378|NCT01991158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101296379|NCT01991158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101296381|NCT01991158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101296382|NCT01991158|Antimetabolites|antimetabolites|mesh-ancestor
101296383|NCT01991158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296384|NCT01991158|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101296385|NCT01991158|Abortifacient Agents|abortifacient agents|mesh-ancestor
101296386|NCT01991158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101296387|NCT01991158|Dermatologic Agents|dermatologic agents|mesh-ancestor
101296388|NCT01991158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101296389|NCT01991158|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101296390|NCT01991158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101296391|NCT01991158|Immunologic Factors|immunologic factors|mesh-ancestor
101296392|NCT01991158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101296393|NCT01991158|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101296395|NCT01991275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101296396|NCT01991275|Narcotics|narcotics|mesh-ancestor
101296397|NCT01991275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101296398|NCT01991275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296399|NCT01991275|Analgesics|analgesics|mesh-ancestor
101296400|NCT01991275|Sensory System Agents|sensory system agents|mesh-ancestor
101296401|NCT01991275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101296402|NCT01991288|Epinephrine|epinephrine|mesh-list
101296403|NCT01991288|Racepinephrine|racepinephrine|mesh-list
101821653|NCT01002690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821654|NCT01048684|Mannitol|mannitol|mesh-list
101821655|NCT01048684|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101821656|NCT01048684|Diuretics|diuretics|mesh-ancestor
101821657|NCT01048684|Natriuretic Agents|natriuretic agents|mesh-ancestor
101821658|NCT01048684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296404|NCT01991288|Bupivacaine|bupivacaine|mesh-list
101296405|NCT01991288|Levobupivacaine|levobupivacaine|mesh-list
101296406|NCT01991288|Epinephryl borate|epinephryl borate|mesh-list
101296407|NCT01991288|Anesthetics, Local|anesthetics, local|mesh-ancestor
101296408|NCT01991288|Anesthetics|anesthetics|mesh-ancestor
101296409|NCT01991288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101296410|NCT01991288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296411|NCT01991288|Sensory System Agents|sensory system agents|mesh-ancestor
101296412|NCT01991288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101296413|NCT01991288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101296414|NCT01991288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101296415|NCT01991288|Adrenergic Agents|adrenergic agents|mesh-ancestor
101296416|NCT01991288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101296417|NCT01991288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296418|NCT01991288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101296419|NCT01991288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101296420|NCT01991288|Autonomic Agents|autonomic agents|mesh-ancestor
101296421|NCT01991288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101296422|NCT01991288|Respiratory System Agents|respiratory system agents|mesh-ancestor
101296423|NCT01991288|Mydriatics|mydriatics|mesh-ancestor
101296424|NCT01991288|Sympathomimetics|sympathomimetics|mesh-ancestor
101296425|NCT01991288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101296426|NCT01991327|Enclomiphene|enclomiphene|mesh-list
101296427|NCT01991327|Clomiphene|clomiphene|mesh-list
101296428|NCT01991327|Zuclomiphene|zuclomiphene|mesh-list
101296429|NCT01991327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101296430|NCT01991327|Hormone Antagonists|hormone antagonists|mesh-ancestor
101296431|NCT01991327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101296432|NCT01991327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296433|NCT01991327|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101296434|NCT01991327|Fertility Agents|fertility agents|mesh-ancestor
101296435|NCT01991327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101296436|NCT01991327|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101296437|NCT01991327|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101296438|NCT01991561|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101296439|NCT01991561|Vaccines|vaccines|mesh-list
101296440|NCT01991561|Immunologic Factors|immunologic factors|mesh-ancestor
101296441|NCT01991561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296442|NCT01991561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101296443|NCT01991561|Antacids|antacids|mesh-ancestor
101296444|NCT01991561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296445|NCT01991561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101296446|NCT01991574|Calcium|calcium|mesh-list
101296447|NCT01991574|Calcium acetate|calcium acetate|mesh-list
101296448|NCT01991574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101296449|NCT01991574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296450|NCT01991574|Chelating Agents|chelating agents|mesh-ancestor
101296451|NCT01991574|Sequestering Agents|sequestering agents|mesh-ancestor
101296452|NCT01991574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296453|NCT01991587|Vaccines|vaccines|mesh-list
101296454|NCT01991587|Immunologic Factors|immunologic factors|mesh-ancestor
101296455|NCT01991587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296456|NCT01991626|Iron|iron|mesh-list
101296457|NCT01991626|Trace Elements|trace elements|mesh-list
101296458|NCT01991626|Micronutrients|micronutrients|mesh-list
101296459|NCT01991626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296460|NCT01991678|Etirinotecan pegol|etirinotecan pegol|mesh-list
101296461|NCT01991678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101296462|NCT01991678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101296463|NCT01991678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101296464|NCT01991678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101296465|NCT01991678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296466|NCT01991834|Cefazolin|cefazolin|mesh-list
101296467|NCT01991834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101821659|NCT01002768|Insulin|insulin|mesh-list
101821660|NCT01002768|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101821661|NCT01002768|Insulin Glargine|insulin glargine|mesh-list
101821662|NCT01002768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101821663|NCT01002768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296468|NCT01991834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101296469|NCT01991951|Warfarin|warfarin|mesh-list
101296470|NCT01991951|Anticoagulants|anticoagulants|mesh-ancestor
101296471|NCT01992133|Vitamin D|vitamin d|mesh-list
101296472|NCT01992133|Cholecalciferol|cholecalciferol|mesh-list
101296473|NCT01992133|Vitamins|vitamins|mesh-ancestor
101296474|NCT01992133|Micronutrients|micronutrients|mesh-ancestor
101296475|NCT01992133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296476|NCT01992133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101296477|NCT01992133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101296478|NCT01992146|Naloxone|naloxone|mesh-list
101296479|NCT01992146|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101296480|NCT01992146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296481|NCT01992146|Sensory System Agents|sensory system agents|mesh-ancestor
101296482|NCT01992146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101296483|NCT01992198|Chlorhexidine|chlorhexidine|mesh-list
101296484|NCT01992198|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101296486|NCT01992198|Meropenem|meropenem|mesh-list
101296487|NCT01992198|Cefoperazone|cefoperazone|mesh-list
101296488|NCT01992198|Sulperazone|sulperazone|mesh-list
101296489|NCT01992198|Somatostatin|somatostatin|mesh-list
101296490|NCT01992198|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101296491|NCT01992198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101296492|NCT01992198|Disinfectants|disinfectants|mesh-ancestor
101296493|NCT01992198|Dermatologic Agents|dermatologic agents|mesh-ancestor
101296494|NCT01992198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101296495|NCT01992198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101296496|NCT01992198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101296497|NCT01992198|Hormones|hormones|mesh-ancestor
101296498|NCT01992198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101296499|NCT01992198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296500|NCT01992198|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101296501|NCT01992211|Metformin|metformin|mesh-list
101296502|NCT01992211|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101296503|NCT01992211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101296504|NCT01992211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296505|NCT01992211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101296506|NCT01992211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101296507|NCT01992211|Antimetabolites|antimetabolites|mesh-ancestor
101296508|NCT01992211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296509|NCT01992211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101528348|NCT04628676|Respiratory System Agents|respiratory system agents|mesh-ancestor
101296510|NCT01992211|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101296511|NCT01992211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101296512|NCT01992263|Vitamin D|vitamin d|mesh-list
101296513|NCT01992263|Ergocalciferols|ergocalciferols|mesh-list
101296514|NCT01992263|Cholecalciferol|cholecalciferol|mesh-list
101296515|NCT01992263|Vitamins|vitamins|mesh-list
101296516|NCT01992263|Micronutrients|micronutrients|mesh-ancestor
101296517|NCT01992263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296518|NCT01992263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101296519|NCT01992263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101296520|NCT01992328|Immunoglobulins|immunoglobulins|mesh-list
101296521|NCT01992328|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101296522|NCT01992328|Antibodies|antibodies|mesh-list
101296523|NCT01992328|Immunoglobulin G|immunoglobulin g|mesh-list
101296524|NCT01992328|gamma-Globulins|gamma-globulins|mesh-list
101296525|NCT01992328|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101296526|NCT01992328|Immunologic Factors|immunologic factors|mesh-ancestor
101296527|NCT01992328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296528|NCT01992341|Paclitaxel|paclitaxel|mesh-list
101296529|NCT01992341|Trebananib|trebananib|mesh-list
101296530|NCT01992341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101296531|NCT01992341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101296532|NCT01992341|Tubulin Modulators|tubulin modulators|mesh-ancestor
101296533|NCT01992341|Antimitotic Agents|antimitotic agents|mesh-ancestor
101296534|NCT01992341|Mitosis Modulators|mitosis modulators|mesh-ancestor
101296535|NCT01992341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296536|NCT01992341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101821664|NCT01050478|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101821665|NCT01050478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101821666|NCT01050478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101821667|NCT01050478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101821668|NCT01050478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821669|NCT01050478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101821670|NCT01050478|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101821671|NCT01050478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101296537|NCT01992341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101296538|NCT01992341|Growth Substances|growth substances|mesh-ancestor
101296539|NCT01992341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296540|NCT01992341|Growth Inhibitors|growth inhibitors|mesh-ancestor
101296541|NCT01992562|Ziconotide|ziconotide|mesh-list
101296542|NCT01992562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101296543|NCT01992562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101296544|NCT01992562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296545|NCT01992562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101296546|NCT01992562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296547|NCT01992562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101296548|NCT01992562|Protective Agents|protective agents|mesh-ancestor
101296549|NCT01992562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101296550|NCT01992562|Analgesics|analgesics|mesh-ancestor
101296551|NCT01992562|Sensory System Agents|sensory system agents|mesh-ancestor
101296552|NCT01992562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101296553|NCT01992588|Insulin|insulin|mesh-list
101296554|NCT01992588|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101296555|NCT01992588|Insulin Aspart|insulin aspart|mesh-list
101296556|NCT01992588|Insulin, Long-Acting|insulin, long-acting|mesh-list
101296557|NCT01992588|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101296558|NCT01992588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101296559|NCT01992588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296560|NCT01992601|Telmisartan|telmisartan|mesh-list
101296561|NCT01992601|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101296562|NCT01992601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101296563|NCT01992601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101296564|NCT01992601|Antimetabolites|antimetabolites|mesh-ancestor
101296565|NCT01992601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296566|NCT01992601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101296567|NCT01992601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101296568|NCT01992601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101296569|NCT01992601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101296570|NCT01992601|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101296571|NCT01992601|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101296572|NCT01992705|Fluorouracil|fluorouracil|mesh-list
101296573|NCT01992705|Oxaliplatin|oxaliplatin|mesh-list
101296574|NCT01992705|Irinotecan|irinotecan|mesh-list
101296575|NCT01992705|Folfirinox|folfirinox|mesh-list
101296576|NCT01992705|Antimetabolites|antimetabolites|mesh-ancestor
101296577|NCT01992705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296578|NCT01992705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101296579|NCT01992705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101296580|NCT01992705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101296581|NCT01992705|Immunologic Factors|immunologic factors|mesh-ancestor
101296582|NCT01992705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296583|NCT01992705|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101296584|NCT01992705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101296585|NCT01992705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101296586|NCT01992796|Telmisartan|telmisartan|mesh-list
101296587|NCT01992796|Candesartan|candesartan|mesh-list
101296589|NCT01992796|Irbesartan|irbesartan|mesh-list
101296590|NCT01992796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101296591|NCT01992796|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101296592|NCT01992796|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101296593|NCT01992796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296594|NCT01992900|Piperaquine|piperaquine|mesh-list
101296595|NCT01992900|Artenimol|artenimol|mesh-list
101821672|NCT01050478|Serotonin Agents|serotonin agents|mesh-ancestor
101821673|NCT01050478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101821674|NCT01050478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821675|NCT01050478|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101821676|NCT01050478|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101821677|NCT01050478|Dopamine Agents|dopamine agents|mesh-ancestor
101821678|NCT00998556|Bromocriptine|bromocriptine|mesh-list
101296596|NCT01992900|Artemisinins|artemisinins|mesh-list
101296597|NCT01992900|Antimalarials|antimalarials|mesh-ancestor
101296598|NCT01992900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101296599|NCT01992900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101296600|NCT01992900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101296601|NCT01993134|Cefazolin|cefazolin|mesh-list
101296602|NCT01993134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101296603|NCT01993134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101296604|NCT01993173|Vaccines|vaccines|mesh-list
101296605|NCT01993173|Immunologic Factors|immunologic factors|mesh-ancestor
101296606|NCT01993173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296607|NCT01993212|Enclomiphene|enclomiphene|mesh-list
101296608|NCT01993212|Testosterone|testosterone|mesh-list
101296609|NCT01993212|Androgens|androgens|mesh-ancestor
101296610|NCT01993212|Hormones|hormones|mesh-ancestor
101296611|NCT01993212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101296612|NCT01993212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296613|NCT01993212|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101296614|NCT01993212|Hormone Antagonists|hormone antagonists|mesh-ancestor
101296615|NCT01993212|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101296616|NCT01993212|Fertility Agents|fertility agents|mesh-ancestor
101296617|NCT01993212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101296618|NCT01993212|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101296619|NCT01993212|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101296620|NCT01993225|Enclomiphene|enclomiphene|mesh-list
101296621|NCT01993225|Testosterone|testosterone|mesh-list
101296622|NCT01993225|Androgens|androgens|mesh-ancestor
101296623|NCT01993225|Hormones|hormones|mesh-ancestor
101296624|NCT01993225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101296625|NCT01993225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296626|NCT01993225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101296627|NCT01993225|Hormone Antagonists|hormone antagonists|mesh-ancestor
101296628|NCT01993225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101296629|NCT01993225|Fertility Agents|fertility agents|mesh-ancestor
101296630|NCT01993225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101296631|NCT01993225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101296632|NCT01993225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101296634|NCT01993251|Antioxidants|antioxidants|mesh-ancestor
101296635|NCT01993251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296636|NCT01993251|Protective Agents|protective agents|mesh-ancestor
101296637|NCT01993251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296638|NCT01993251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101296639|NCT01993290|Ropivacaine|ropivacaine|mesh-list
101296640|NCT01993290|Anesthetics, Local|anesthetics, local|mesh-ancestor
101296641|NCT01993290|Anesthetics|anesthetics|mesh-ancestor
101296642|NCT01993290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101296643|NCT01993290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296644|NCT01993290|Sensory System Agents|sensory system agents|mesh-ancestor
101296645|NCT01993290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101296646|NCT01993459|Midazolam|midazolam|mesh-list
101296647|NCT01993459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101296648|NCT01993459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101296649|NCT01993459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101296650|NCT01993459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101296651|NCT01993459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296652|NCT01993459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101296653|NCT01993459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101296654|NCT01993459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101296655|NCT01993459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101296656|NCT01993459|Anesthetics, General|anesthetics, general|mesh-ancestor
101296657|NCT01993459|Anesthetics|anesthetics|mesh-ancestor
101296658|NCT01993459|GABA Modulators|gaba modulators|mesh-ancestor
101296659|NCT01993459|GABA Agents|gaba agents|mesh-ancestor
101821679|NCT00998556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101821680|NCT00998556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101821681|NCT00998556|Hormone Antagonists|hormone antagonists|mesh-ancestor
101821682|NCT00998556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101821683|NCT00998556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821684|NCT00998556|Dopamine Agonists|dopamine agonists|mesh-ancestor
101821685|NCT00998556|Dopamine Agents|dopamine agents|mesh-ancestor
101821686|NCT00998556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101821687|NCT00998556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821688|NCT01052974|Ropivacaine|ropivacaine|mesh-list
101821689|NCT01052974|Anesthetics, Local|anesthetics, local|mesh-ancestor
101821690|NCT01052974|Anesthetics|anesthetics|mesh-ancestor
101821691|NCT01052974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101821692|NCT01052974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296660|NCT01993459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101296661|NCT01993459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296662|NCT01993472|Andrographolide|andrographolide|mesh-list
101296663|NCT01993472|Capecitabine|capecitabine|mesh-list
101296664|NCT01993472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101296666|NCT01993472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296667|NCT01993472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101296668|NCT01993472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101296669|NCT01993472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101296670|NCT01993472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101296672|NCT01993472|Sensory System Agents|sensory system agents|mesh-ancestor
101296673|NCT01993472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101296674|NCT01993472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296675|NCT01993472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101296676|NCT01993472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101296677|NCT01993472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101296678|NCT01993472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101296679|NCT01993472|Antiviral Agents|antiviral agents|mesh-ancestor
101296680|NCT01993472|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101296681|NCT01993537|Vitamin D|vitamin d|mesh-list
101296682|NCT01993537|Vitamins|vitamins|mesh-ancestor
101296683|NCT01993537|Micronutrients|micronutrients|mesh-ancestor
101296684|NCT01993537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296685|NCT01993537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101296686|NCT01993589|Acetaminophen|acetaminophen|mesh-list
101296687|NCT01993589|Analgesics|analgesics|mesh-list
101296688|NCT01993589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101296689|NCT01993589|Sensory System Agents|sensory system agents|mesh-ancestor
101296690|NCT01993589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101296691|NCT01993589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296693|NCT01993680|Fludrocortisone|fludrocortisone|mesh-list
101296694|NCT01993680|Bromides|bromides|mesh-list
101296695|NCT01993680|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
101296696|NCT01993680|Anticonvulsants|anticonvulsants|mesh-ancestor
101296697|NCT01993680|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101296698|NCT01993680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101296699|NCT01993680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296700|NCT01993680|Cholinergic Agents|cholinergic agents|mesh-ancestor
101296701|NCT01993680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101296702|NCT01993680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296703|NCT01993680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101296704|NCT01993771|Anesthetics|anesthetics|mesh-list
101296705|NCT01993771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101296706|NCT01993771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821693|NCT01052974|Sensory System Agents|sensory system agents|mesh-ancestor
101821694|NCT01052974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101821695|NCT00998634|Lithium Carbonate|lithium carbonate|mesh-list
101821696|NCT00998634|Antidepressive Agents|antidepressive agents|mesh-ancestor
101821697|NCT00998634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101821698|NCT00998634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101821699|NCT00998634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821700|NCT00998634|Antimanic Agents|antimanic agents|mesh-ancestor
101821701|NCT00998634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101296707|NCT01993784|Nimotuzumab|nimotuzumab|mesh-list
101296708|NCT01993784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101296709|NCT01993784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101296710|NCT01993979|Cisplatin|cisplatin|mesh-list
101296711|NCT01993979|Carboplatin|carboplatin|mesh-list
101296712|NCT01993979|Gemcitabine|gemcitabine|mesh-list
101296713|NCT01993979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101296714|NCT01993979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101296715|NCT01993979|Antimetabolites|antimetabolites|mesh-ancestor
101296716|NCT01993979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296717|NCT01994031|Paclitaxel|paclitaxel|mesh-list
101296718|NCT01994031|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101296719|NCT01994031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101296720|NCT01994031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101296721|NCT01994031|Tubulin Modulators|tubulin modulators|mesh-ancestor
101296722|NCT01994031|Antimitotic Agents|antimitotic agents|mesh-ancestor
101296723|NCT01994031|Mitosis Modulators|mitosis modulators|mesh-ancestor
101296724|NCT01994031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296725|NCT01994070|Procainamide|procainamide|mesh-list
101296726|NCT01994070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101296727|NCT01994070|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101296728|NCT01994070|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101296729|NCT01994070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101296730|NCT01994070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296731|NCT01994096|Caspofungin|caspofungin|mesh-list
101296732|NCT01994096|Antifungal Agents|antifungal agents|mesh-ancestor
101296733|NCT01994096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101296734|NCT01994096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101296735|NCT01994096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296736|NCT01994265|Warfarin|warfarin|mesh-list
101296738|NCT01994265|Anticoagulants|anticoagulants|mesh-ancestor
101296739|NCT01994265|Antithrombins|antithrombins|mesh-ancestor
101296740|NCT01994265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101296741|NCT01994265|Protease Inhibitors|protease inhibitors|mesh-ancestor
101296742|NCT01994265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101296743|NCT01994265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296744|NCT01994330|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101296745|NCT01994330|Hemostatics|hemostatics|mesh-ancestor
101296746|NCT01994330|Coagulants|coagulants|mesh-ancestor
101296747|NCT01994330|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101296748|NCT01994330|Natriuretic Agents|natriuretic agents|mesh-ancestor
101296749|NCT01994330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296750|NCT01994356|Contraceptive Agents|contraceptive agents|mesh-list
101296751|NCT01994356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101296752|NCT01994356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296753|NCT01994460|Linezolid|linezolid|mesh-list
101296754|NCT01994460|Ethambutol|ethambutol|mesh-list
101296755|NCT01994460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101296756|NCT01994460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101296757|NCT01994460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101296758|NCT01994460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101296759|NCT01994460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296760|NCT01994460|Antitubercular Agents|antitubercular agents|mesh-ancestor
101296761|NCT01994642|Ciprofloxacin|ciprofloxacin|mesh-list
101296762|NCT01994642|Dexamethasone|dexamethasone|mesh-list
101296763|NCT01994642|Dexamethasone acetate|dexamethasone acetate|mesh-list
101296764|NCT01994642|BB 1101|bb 1101|mesh-list
101821702|NCT00998634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101821703|NCT00998634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479002|NCT00285389|Melphalan|melphalan|mesh-list
101821704|NCT01003002|Levodopa|levodopa|mesh-list
101821705|NCT01003002|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101821706|NCT01003002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101821707|NCT01003002|Dopamine Agents|dopamine agents|mesh-ancestor
101821708|NCT01003002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101821709|NCT01003002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821710|NCT01003002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821711|NCT01003158|Paclitaxel|paclitaxel|mesh-list
101821712|NCT01003158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101296765|NCT01994642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101296766|NCT01994642|Antiemetics|antiemetics|mesh-ancestor
101296767|NCT01994642|Autonomic Agents|autonomic agents|mesh-ancestor
101296768|NCT01994642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101296769|NCT01994642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296770|NCT01994642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101296771|NCT01994642|Glucocorticoids|glucocorticoids|mesh-ancestor
101296772|NCT01994642|Hormones|hormones|mesh-ancestor
101296773|NCT01994642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101296774|NCT01994642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101296776|NCT01994642|Protease Inhibitors|protease inhibitors|mesh-ancestor
101296777|NCT01994642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101296778|NCT01994642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296779|NCT01994642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101296780|NCT01994642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101296781|NCT01994642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101296782|NCT01994642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101296783|NCT01994642|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101296784|NCT01994642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101296785|NCT01994668|Lorazepam|lorazepam|mesh-list
101296786|NCT01994668|Anticonvulsants|anticonvulsants|mesh-ancestor
101296787|NCT01994668|Antiemetics|antiemetics|mesh-ancestor
101296788|NCT01994668|Autonomic Agents|autonomic agents|mesh-ancestor
101296789|NCT01994668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101296790|NCT01994668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296791|NCT01994668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101296792|NCT01994668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101296793|NCT01994668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101296794|NCT01994668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101296795|NCT01994668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101296796|NCT01994668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101296797|NCT01994668|GABA Modulators|gaba modulators|mesh-ancestor
101296798|NCT01994668|GABA Agents|gaba agents|mesh-ancestor
101296799|NCT01994668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101296800|NCT01994668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296801|NCT01994733|Calcium, Dietary|calcium, dietary|mesh-list
101296802|NCT01994733|Calcium Carbonate|calcium carbonate|mesh-list
101296803|NCT01994733|Calcium|calcium|mesh-list
101296804|NCT01994733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101296805|NCT01994733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296806|NCT01994733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101296807|NCT01994733|Antacids|antacids|mesh-ancestor
101296808|NCT01994733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296809|NCT01994733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101296810|NCT01994759|Methylprednisolone|methylprednisolone|mesh-list
101296811|NCT01994759|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101296812|NCT01994759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101296813|NCT01994759|Antiemetics|antiemetics|mesh-ancestor
101296814|NCT01994759|Autonomic Agents|autonomic agents|mesh-ancestor
101296815|NCT01994759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101821713|NCT01003158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821714|NCT01003158|Tubulin Modulators|tubulin modulators|mesh-ancestor
101821715|NCT01003158|Antimitotic Agents|antimitotic agents|mesh-ancestor
101821716|NCT01003158|Mitosis Modulators|mitosis modulators|mesh-ancestor
101821717|NCT01003158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821718|NCT03883386|Loratadine|loratadine|mesh-list
101821719|NCT03883386|Antipruritics|antipruritics|mesh-ancestor
101821720|NCT03883386|Dermatologic Agents|dermatologic agents|mesh-ancestor
101821721|NCT03883386|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101821722|NCT03883386|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101296816|NCT01994759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296817|NCT01994759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101296818|NCT01994759|Glucocorticoids|glucocorticoids|mesh-ancestor
101296820|NCT01994759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101296821|NCT01994759|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101296822|NCT01994759|Protective Agents|protective agents|mesh-ancestor
101296823|NCT01994824|Thymoglobulin|thymoglobulin|mesh-list
101296824|NCT01994824|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101296825|NCT01994824|Immunologic Factors|immunologic factors|mesh-ancestor
101296826|NCT01994824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296827|NCT01994824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101296828|NCT01994941|Clopidogrel|clopidogrel|mesh-list
101296829|NCT01994941|Ticagrelor|ticagrelor|mesh-list
101296830|NCT01994941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101296831|NCT01994941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101296832|NCT01994941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101296833|NCT01994941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101296834|NCT01994941|Purinergic Agents|purinergic agents|mesh-ancestor
101296835|NCT01994941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101296836|NCT01994941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296837|NCT01994941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296839|NCT01994967|Levobupivacaine|levobupivacaine|mesh-list
101296840|NCT01994967|Anesthetics, Local|anesthetics, local|mesh-ancestor
101296841|NCT01994967|Anesthetics|anesthetics|mesh-ancestor
101296842|NCT01994967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101296843|NCT01994967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296844|NCT01994967|Sensory System Agents|sensory system agents|mesh-ancestor
101296845|NCT01994967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101296846|NCT01995006|Dipyrone|dipyrone|mesh-list
101296847|NCT01995006|Naproxen|naproxen|mesh-list
101296848|NCT01995006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101296849|NCT01995006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101296850|NCT01995006|Analgesics|analgesics|mesh-ancestor
101296851|NCT01995006|Sensory System Agents|sensory system agents|mesh-ancestor
101296852|NCT01995006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101296853|NCT01995006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296854|NCT01995006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101296855|NCT01995006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101296856|NCT01995006|Gout Suppressants|gout suppressants|mesh-ancestor
101296857|NCT01995006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101296858|NCT01995006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101296859|NCT01995006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296860|NCT01995006|Antipyretics|antipyretics|mesh-ancestor
101296861|NCT01995019|Methylprednisolone|methylprednisolone|mesh-list
101296862|NCT01995019|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101296863|NCT01995019|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101296864|NCT01995019|Prednisolone|prednisolone|mesh-list
101296865|NCT01995019|Prednisolone acetate|prednisolone acetate|mesh-list
101296866|NCT01995019|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101296867|NCT01995019|Prednisolone phosphate|prednisolone phosphate|mesh-list
101296868|NCT01995019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101296869|NCT01995019|Antiemetics|antiemetics|mesh-ancestor
101296870|NCT01995019|Autonomic Agents|autonomic agents|mesh-ancestor
101296871|NCT01995019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101821723|NCT03883386|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101821724|NCT03883386|Histamine Antagonists|histamine antagonists|mesh-ancestor
101821725|NCT03883386|Histamine Agents|histamine agents|mesh-ancestor
101821726|NCT03883386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101821727|NCT03883386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821728|NCT03883386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821729|NCT00530946|Amlodipine|amlodipine|mesh-list
101821730|NCT00530946|Atorvastatin|atorvastatin|mesh-list
101821731|NCT00530946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101296872|NCT01995019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296873|NCT01995019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101296874|NCT01995019|Glucocorticoids|glucocorticoids|mesh-ancestor
101296876|NCT01995019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101296877|NCT01995019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101296878|NCT01995019|Protective Agents|protective agents|mesh-ancestor
101296879|NCT01995019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101296880|NCT01995019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101296881|NCT01995032|Metformin|metformin|mesh-list
101296882|NCT01995032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101296883|NCT01995032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296884|NCT01995058|Prednisone|prednisone|mesh-list
101296885|NCT01995058|Abiraterone Acetate|abiraterone acetate|mesh-list
101296886|NCT01995058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101296887|NCT01995058|Glucocorticoids|glucocorticoids|mesh-ancestor
101296889|NCT01995058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101296890|NCT01995058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296891|NCT01995058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101296892|NCT01995058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101296893|NCT01995058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101296894|NCT01995058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101296895|NCT01995058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296896|NCT01995058|Hormone Antagonists|hormone antagonists|mesh-ancestor
101296897|NCT01995058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101296898|NCT01995084|Imidazole|imidazole|mesh-list
101296899|NCT01995084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101296900|NCT01995084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296901|NCT01995188|Bevacizumab|bevacizumab|mesh-list
101296902|NCT01995188|Carboplatin|carboplatin|mesh-list
101296903|NCT01995188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101296904|NCT01995188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101296905|NCT01995188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101296906|NCT01995188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101296907|NCT01995188|Growth Substances|growth substances|mesh-ancestor
101296908|NCT01995188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296909|NCT01995188|Growth Inhibitors|growth inhibitors|mesh-ancestor
101296910|NCT01995214|Propofol|propofol|mesh-list
101296911|NCT01995214|Sevoflurane|sevoflurane|mesh-list
101296912|NCT01995214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101296913|NCT01995214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101296914|NCT01995214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296915|NCT01995214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101296916|NCT01995214|Anesthetics, General|anesthetics, general|mesh-ancestor
101296917|NCT01995214|Anesthetics|anesthetics|mesh-ancestor
101296918|NCT01995214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101296919|NCT01995214|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101296920|NCT01995292|Anesthetics|anesthetics|mesh-list
101296921|NCT01995292|Anesthetics, Local|anesthetics, local|mesh-list
101296922|NCT01995292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101296923|NCT01995292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296924|NCT01995292|Sensory System Agents|sensory system agents|mesh-ancestor
101296925|NCT01995292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101296927|NCT01995331|Cyclophosphamide|cyclophosphamide|mesh-list
101296928|NCT01995331|Cyclosporins|cyclosporins|mesh-list
101821732|NCT00530946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101821733|NCT00530946|Antimetabolites|antimetabolites|mesh-ancestor
101821734|NCT00530946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821735|NCT00530946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101821736|NCT00530946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101821737|NCT00530946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101296929|NCT01995331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101296930|NCT01995331|Immunologic Factors|immunologic factors|mesh-ancestor
101296931|NCT01995331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296932|NCT01995331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101296933|NCT01995331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101296934|NCT01995331|Alkylating Agents|alkylating agents|mesh-ancestor
101296935|NCT01995331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296936|NCT01995331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101296937|NCT01995331|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101296938|NCT01995331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101296939|NCT01995331|Antifungal Agents|antifungal agents|mesh-ancestor
101296940|NCT01995331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101296941|NCT01995331|Dermatologic Agents|dermatologic agents|mesh-ancestor
101296942|NCT01995331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101296943|NCT01995370|Aspirin|aspirin|mesh-list
101296944|NCT01995370|Cilostazol|cilostazol|mesh-list
101296945|NCT01995370|Clopidogrel|clopidogrel|mesh-list
101296946|NCT01995370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101296947|NCT01995370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101296948|NCT01995370|Analgesics|analgesics|mesh-ancestor
101296949|NCT01995370|Sensory System Agents|sensory system agents|mesh-ancestor
101296950|NCT01995370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101296951|NCT01995370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296952|NCT01995370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101296953|NCT01995370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101296954|NCT01995370|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101296955|NCT01995370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101296956|NCT01995370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296957|NCT01995370|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101296958|NCT01995370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101296959|NCT01995370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101296960|NCT01995370|Antipyretics|antipyretics|mesh-ancestor
101296961|NCT01995370|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101296962|NCT01995370|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101296963|NCT01995370|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101296964|NCT01995370|Purinergic Agents|purinergic agents|mesh-ancestor
101296965|NCT01995370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101296966|NCT01995370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101296967|NCT01995370|Autonomic Agents|autonomic agents|mesh-ancestor
101296968|NCT01995370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101296969|NCT01995370|Respiratory System Agents|respiratory system agents|mesh-ancestor
101296970|NCT01995370|Vasodilator Agents|vasodilator agents|mesh-ancestor
101296971|NCT01995370|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101296972|NCT01995370|Protective Agents|protective agents|mesh-ancestor
101296973|NCT01995370|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101296974|NCT01995370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101296975|NCT01995656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101296976|NCT01995695|Vaccines|vaccines|mesh-list
101296977|NCT01995695|Immunologic Factors|immunologic factors|mesh-ancestor
101296978|NCT01995695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296979|NCT01995734|Pasireotide|pasireotide|mesh-list
101296980|NCT01995734|Hormones|hormones|mesh-ancestor
101296981|NCT01995734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101296982|NCT01995734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296983|NCT01995799|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
101296984|NCT01995799|Hematinics|hematinics|mesh-ancestor
101296985|NCT01995799|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101296986|NCT01995799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101296987|NCT01995890|Nepafenac|nepafenac|mesh-list
101296988|NCT01995890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101821738|NCT00530946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101821739|NCT00530946|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101821740|NCT00530946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101821741|NCT00530946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101821742|NCT00530946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821743|NCT00530946|Vasodilator Agents|vasodilator agents|mesh-ancestor
101821744|NCT00424047|Dexamethasone|dexamethasone|mesh-list
101821745|NCT00424047|Dexamethasone acetate|dexamethasone acetate|mesh-list
101821746|NCT00424047|Lenalidomide|lenalidomide|mesh-list
101821747|NCT00424047|BB 1101|bb 1101|mesh-list
101296989|NCT01995890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101296990|NCT01995890|Analgesics|analgesics|mesh-ancestor
101296991|NCT01995890|Sensory System Agents|sensory system agents|mesh-ancestor
101296992|NCT01995890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101296993|NCT01995890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296994|NCT01995890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101296995|NCT01995890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101296997|NCT01996085|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101296998|NCT01996085|Telmisartan|telmisartan|mesh-list
101297000|NCT01996085|Nebivolol|nebivolol|mesh-list
101297001|NCT01996085|Indapamide|indapamide|mesh-list
101297002|NCT01996085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101297003|NCT01996085|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101297004|NCT01996085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101297005|NCT01996085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297006|NCT01996085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101297007|NCT01996085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297008|NCT01996085|Vasodilator Agents|vasodilator agents|mesh-ancestor
101297009|NCT01996085|Diuretics|diuretics|mesh-ancestor
101297010|NCT01996085|Natriuretic Agents|natriuretic agents|mesh-ancestor
101297011|NCT01996085|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101297012|NCT01996085|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101297013|NCT01996085|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101297014|NCT01996085|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101297015|NCT01996085|Protease Inhibitors|protease inhibitors|mesh-ancestor
101297016|NCT01996085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101297017|NCT01996085|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101297018|NCT01996085|Protective Agents|protective agents|mesh-ancestor
101297019|NCT01996085|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101297020|NCT01996085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101297021|NCT01996085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101297022|NCT01996085|Adrenergic Agents|adrenergic agents|mesh-ancestor
101297023|NCT01996085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101297024|NCT01996150|Sodium Hypochlorite|sodium hypochlorite|mesh-list
101297025|NCT01996150|Eusol|eusol|mesh-list
101297026|NCT01996150|Disinfectants|disinfectants|mesh-ancestor
101297027|NCT01996150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101297028|NCT01996189|Insulin|insulin|mesh-list
101297029|NCT01996189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101297030|NCT01996189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297031|NCT01996306|Leucovorin|leucovorin|mesh-list
101297032|NCT01996306|Bevacizumab|bevacizumab|mesh-list
101297033|NCT01996306|Fluorouracil|fluorouracil|mesh-list
101297034|NCT01996306|Capecitabine|capecitabine|mesh-list
101297035|NCT01996306|Irinotecan|irinotecan|mesh-list
101297036|NCT01996306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101297037|NCT01996306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101297038|NCT01996306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101297039|NCT01996306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101297040|NCT01996306|Growth Substances|growth substances|mesh-ancestor
101297041|NCT01996306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297042|NCT01996306|Growth Inhibitors|growth inhibitors|mesh-ancestor
101297043|NCT01996306|Antimetabolites|antimetabolites|mesh-ancestor
101297044|NCT01996306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297045|NCT01996306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101821748|NCT00424047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101821749|NCT00424047|Antiemetics|antiemetics|mesh-ancestor
101821750|NCT00424047|Autonomic Agents|autonomic agents|mesh-ancestor
101297046|NCT01996306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101297047|NCT01996306|Immunologic Factors|immunologic factors|mesh-ancestor
101297048|NCT01996306|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101297049|NCT01996306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101297050|NCT01996306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101297051|NCT01996306|Antidotes|antidotes|mesh-ancestor
101297052|NCT01996306|Protective Agents|protective agents|mesh-ancestor
101297053|NCT01996306|Vitamin B Complex|vitamin b complex|mesh-ancestor
101297054|NCT01996306|Vitamins|vitamins|mesh-ancestor
101297055|NCT01996306|Micronutrients|micronutrients|mesh-ancestor
101297056|NCT01996358|Rocuronium|rocuronium|mesh-list
101297057|NCT01996358|Succinylcholine|succinylcholine|mesh-list
101297058|NCT01996358|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101297059|NCT01996358|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101297060|NCT01996358|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101297061|NCT01996358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101297062|NCT01996358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297063|NCT01996358|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
101297065|NCT01996384|Anesthetics, Local|anesthetics, local|mesh-ancestor
101297067|NCT01996384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101297068|NCT01996384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297069|NCT01996384|Sensory System Agents|sensory system agents|mesh-ancestor
101297070|NCT01996384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101297071|NCT01996384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101297072|NCT01996384|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101297073|NCT01996384|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101297074|NCT01996384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101297075|NCT01996384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297076|NCT01996423|Vitamin D|vitamin d|mesh-list
101297077|NCT01996423|Cholecalciferol|cholecalciferol|mesh-list
101297078|NCT01996423|Vitamins|vitamins|mesh-ancestor
101297079|NCT01996423|Micronutrients|micronutrients|mesh-ancestor
101297080|NCT01996423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297081|NCT01996423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101297082|NCT01996423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101297083|NCT01996462|Dexetimide|dexetimide|mesh-list
101297084|NCT01996462|Citalopram|citalopram|mesh-list
101297085|NCT01996462|Escitalopram|escitalopram|mesh-list
101297086|NCT01996462|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101297087|NCT01996462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101297088|NCT01996462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101297089|NCT01996462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297090|NCT01996462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101297091|NCT01996462|Serotonin Agents|serotonin agents|mesh-ancestor
101297092|NCT01996462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297093|NCT01996462|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101297094|NCT01996462|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101297095|NCT01996462|Parasympatholytics|parasympatholytics|mesh-ancestor
101297096|NCT01996462|Autonomic Agents|autonomic agents|mesh-ancestor
101297097|NCT01996462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101297098|NCT01996462|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101297099|NCT01996462|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101297100|NCT01996462|Cholinergic Agents|cholinergic agents|mesh-ancestor
101297101|NCT01996462|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101297102|NCT01996462|Antidepressive Agents|antidepressive agents|mesh-ancestor
101297103|NCT01996462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101297104|NCT01996475|Dexetimide|dexetimide|mesh-list
101297105|NCT01996475|Citalopram|citalopram|mesh-list
101297106|NCT01996475|Escitalopram|escitalopram|mesh-list
101297107|NCT01996475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101297108|NCT01996475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101297109|NCT01996475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101297110|NCT01996475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297111|NCT01996475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101297112|NCT01996475|Serotonin Agents|serotonin agents|mesh-ancestor
101297113|NCT01996475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297114|NCT01996475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101297115|NCT01996475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101297116|NCT01996475|Parasympatholytics|parasympatholytics|mesh-ancestor
101821751|NCT00424047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101821752|NCT00424047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821753|NCT00424047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101821754|NCT00424047|Glucocorticoids|glucocorticoids|mesh-ancestor
101821755|NCT00424047|Hormones|hormones|mesh-ancestor
101821756|NCT00424047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101821757|NCT00424047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101821758|NCT00424047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821759|NCT00424047|Protease Inhibitors|protease inhibitors|mesh-ancestor
101821760|NCT00424047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101297117|NCT01996475|Autonomic Agents|autonomic agents|mesh-ancestor
101297120|NCT01996475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101297121|NCT01996475|Cholinergic Agents|cholinergic agents|mesh-ancestor
101297122|NCT01996475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101297123|NCT01996475|Antidepressive Agents|antidepressive agents|mesh-ancestor
101297124|NCT01996475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101297125|NCT01996488|Olanzapine|olanzapine|mesh-list
101297126|NCT01996488|Antiemetics|antiemetics|mesh-ancestor
101297127|NCT01996488|Autonomic Agents|autonomic agents|mesh-ancestor
101297128|NCT01996488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101297129|NCT01996488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297130|NCT01996488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101297131|NCT01996488|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101297132|NCT01996488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101297133|NCT01996488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101297134|NCT01996488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101297135|NCT01996488|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101297136|NCT01996488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101297137|NCT01996488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101297138|NCT01996488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297139|NCT01996488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101297140|NCT01996488|Serotonin Agents|serotonin agents|mesh-ancestor
101297142|NCT01996501|Antiemetics|antiemetics|mesh-ancestor
101297143|NCT01996501|Autonomic Agents|autonomic agents|mesh-ancestor
101297144|NCT01996501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101297145|NCT01996501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297146|NCT01996501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101297147|NCT01996501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101297148|NCT01996501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101297149|NCT01996501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101297150|NCT01996501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101297151|NCT01996501|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101297152|NCT01996501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101297153|NCT01996501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101297154|NCT01996501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297155|NCT01996501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101297156|NCT01996501|Serotonin Agents|serotonin agents|mesh-ancestor
101297157|NCT01996579|Lactoferrin|lactoferrin|mesh-list
101297158|NCT01996579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101297159|NCT01996618|Ranolazine|ranolazine|mesh-list
101297160|NCT01996618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101297161|NCT01996618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101297162|NCT01996618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297163|NCT01996683|Deferiprone|deferiprone|mesh-list
101297164|NCT01996683|Deferoxamine|deferoxamine|mesh-list
101297165|NCT01996683|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101297166|NCT01996683|Chelating Agents|chelating agents|mesh-ancestor
101297167|NCT01996683|Sequestering Agents|sequestering agents|mesh-ancestor
101297168|NCT01996683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297169|NCT01996683|Siderophores|siderophores|mesh-ancestor
101297170|NCT01996696|Metformin|metformin|mesh-list
101821761|NCT00424047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821762|NCT00424047|Immunologic Factors|immunologic factors|mesh-ancestor
101821763|NCT00424047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101821764|NCT00424047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101821765|NCT00424047|Growth Substances|growth substances|mesh-ancestor
101821766|NCT00424047|Growth Inhibitors|growth inhibitors|mesh-ancestor
101821767|NCT00530790|Ropinirole|ropinirole|mesh-list
101821768|NCT00530790|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101297171|NCT01996696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101297172|NCT01996696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297173|NCT01996735|Ticagrelor|ticagrelor|mesh-list
101297174|NCT01996735|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101297175|NCT01996735|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101297176|NCT01996735|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101297177|NCT01996735|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101297178|NCT01996735|Purinergic Agents|purinergic agents|mesh-ancestor
101297179|NCT01996735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101297180|NCT01996735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297181|NCT01996735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297182|NCT01996761|Cerebrolysin|cerebrolysin|mesh-list
101297183|NCT01996761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101297184|NCT01996761|Protective Agents|protective agents|mesh-ancestor
101297185|NCT01996761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297186|NCT01996761|Nootropic Agents|nootropic agents|mesh-ancestor
101297187|NCT01996891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101297189|NCT01996930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101297190|NCT01996930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101297191|NCT01997099|Diazepam|diazepam|mesh-list
101297192|NCT01997099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101297193|NCT01997099|Anticonvulsants|anticonvulsants|mesh-ancestor
101297194|NCT01997099|Antiemetics|antiemetics|mesh-ancestor
101297195|NCT01997099|Autonomic Agents|autonomic agents|mesh-ancestor
101297196|NCT01997099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101297197|NCT01997099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297198|NCT01997099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101297199|NCT01997099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101317224|NCT00009802|Calcitriol|calcitriol|mesh-list
101297200|NCT01997099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101297201|NCT01997099|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101297202|NCT01997099|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101297203|NCT01997099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101408863|NCT00113100|Ethanol|ethanol|mesh-list
101297204|NCT01997099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101297205|NCT01997099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101297206|NCT01997099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101297207|NCT01997099|Anesthetics, General|anesthetics, general|mesh-ancestor
101297209|NCT01997099|GABA Modulators|gaba modulators|mesh-ancestor
101297210|NCT01997099|GABA Agents|gaba agents|mesh-ancestor
101297211|NCT01997099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101297212|NCT01997099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297213|NCT01997112|Acetaminophen|acetaminophen|mesh-list
101297214|NCT01997112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101297215|NCT01997112|Analgesics|analgesics|mesh-ancestor
101297216|NCT01997112|Sensory System Agents|sensory system agents|mesh-ancestor
101297217|NCT01997112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101297218|NCT01997112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297219|NCT01997112|Antipyretics|antipyretics|mesh-ancestor
101297220|NCT01997138|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101297221|NCT01997138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101297222|NCT01997164|Aflibercept|aflibercept|mesh-list
101297223|NCT01997164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101297224|NCT01997164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101297225|NCT01997164|Growth Substances|growth substances|mesh-ancestor
101297226|NCT01997164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297227|NCT01997164|Growth Inhibitors|growth inhibitors|mesh-ancestor
101297228|NCT01997164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821769|NCT00530790|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101821770|NCT00530790|Dopamine Agonists|dopamine agonists|mesh-ancestor
101821771|NCT00530790|Dopamine Agents|dopamine agents|mesh-ancestor
101821772|NCT00530790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101821773|NCT00530790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821774|NCT00530790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821775|NCT01032057|Gemcitabine|gemcitabine|mesh-list
101821776|NCT01032057|Capecitabine|capecitabine|mesh-list
101821777|NCT01032057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101297229|NCT01997203|Vitamin D|vitamin d|mesh-list
101297230|NCT01997203|Interferons|interferons|mesh-list
101297231|NCT01997203|Ribavirin|ribavirin|mesh-list
101297232|NCT01997203|Vitamins|vitamins|mesh-ancestor
101297233|NCT01997203|Micronutrients|micronutrients|mesh-ancestor
101297234|NCT01997203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297235|NCT01997203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101297236|NCT01997203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101297237|NCT01997203|Antiviral Agents|antiviral agents|mesh-ancestor
101297238|NCT01997203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101297239|NCT01997203|Antimetabolites|antimetabolites|mesh-ancestor
101297240|NCT01997203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297241|NCT01997255|Everolimus|everolimus|mesh-list
101297242|NCT01997255|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101297243|NCT01997255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101297244|NCT01997255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101297245|NCT01997255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297246|NCT01997255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101297247|NCT01997255|Immunologic Factors|immunologic factors|mesh-ancestor
101297248|NCT01997255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297249|NCT01997255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101297250|NCT01997294|Atorvastatin|atorvastatin|mesh-list
101297251|NCT01997294|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101297252|NCT01997294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101297253|NCT01997294|Antimetabolites|antimetabolites|mesh-ancestor
101297254|NCT01997294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297255|NCT01997294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101297256|NCT01997294|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101297257|NCT01997294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101297258|NCT01997580|Escitalopram|escitalopram|mesh-list
101297259|NCT01997580|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101297260|NCT01997580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101297261|NCT01997580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101297262|NCT01997580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297263|NCT01997580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101297264|NCT01997580|Serotonin Agents|serotonin agents|mesh-ancestor
101297265|NCT01997580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297266|NCT01997593|Ropivacaine|ropivacaine|mesh-list
101297267|NCT01997593|Anesthetics, Local|anesthetics, local|mesh-ancestor
101297268|NCT01997593|Anesthetics|anesthetics|mesh-ancestor
101297269|NCT01997593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101297270|NCT01997593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297271|NCT01997593|Sensory System Agents|sensory system agents|mesh-ancestor
101297272|NCT01997593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101297273|NCT01997632|Vaccines|vaccines|mesh-list
101297274|NCT01997632|Immunologic Factors|immunologic factors|mesh-ancestor
101297275|NCT01997632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297276|NCT01997658|Methylprednisolone|methylprednisolone|mesh-list
101297277|NCT01997658|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101297278|NCT01997658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101297279|NCT01997658|Prednisolone|prednisolone|mesh-list
101297280|NCT01997658|Prednisolone acetate|prednisolone acetate|mesh-list
101297281|NCT01997658|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101297282|NCT01997658|Prednisolone phosphate|prednisolone phosphate|mesh-list
101297283|NCT01997658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101297284|NCT01997658|Antiemetics|antiemetics|mesh-ancestor
101297285|NCT01997658|Autonomic Agents|autonomic agents|mesh-ancestor
101821779|NCT01032057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821780|NCT01032057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821781|NCT01003314|Vaccines|vaccines|mesh-list
101821782|NCT01003314|Immunologic Factors|immunologic factors|mesh-ancestor
101821783|NCT01003314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821784|NCT00530088|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
101297286|NCT01997658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101297287|NCT01997658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297288|NCT01997658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101297289|NCT01997658|Glucocorticoids|glucocorticoids|mesh-ancestor
101297290|NCT01997658|Hormones|hormones|mesh-ancestor
101297291|NCT01997658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101297292|NCT01997658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101297293|NCT01997658|Protective Agents|protective agents|mesh-ancestor
101297294|NCT01997658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101297296|NCT01997762|Resveratrol|resveratrol|mesh-list
101297297|NCT01997762|Antioxidants|antioxidants|mesh-ancestor
101297298|NCT01997762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297299|NCT01997762|Protective Agents|protective agents|mesh-ancestor
101297300|NCT01997762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297301|NCT01997762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101297302|NCT01997762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101297303|NCT01997775|Metformin|metformin|mesh-list
101297304|NCT01997775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101297305|NCT01997775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297306|NCT01997788|Morphine|morphine|mesh-list
101297307|NCT01997788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101297308|NCT01997788|Narcotics|narcotics|mesh-ancestor
101297309|NCT01997788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101297310|NCT01997788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297311|NCT01997788|Analgesics|analgesics|mesh-ancestor
101297312|NCT01997788|Sensory System Agents|sensory system agents|mesh-ancestor
101297313|NCT01997788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101297314|NCT01997801|Ketamine|ketamine|mesh-list
101297315|NCT01997801|Analgesics|analgesics|mesh-ancestor
101297316|NCT01997801|Sensory System Agents|sensory system agents|mesh-ancestor
101297317|NCT01997801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101297318|NCT01997801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297319|NCT01997801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101297320|NCT01997801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101297321|NCT01997801|Anesthetics, General|anesthetics, general|mesh-ancestor
101297322|NCT01997801|Anesthetics|anesthetics|mesh-ancestor
101297323|NCT01997801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101297324|NCT01997801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101297325|NCT01997801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101297326|NCT01997801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101297327|NCT01997801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297328|NCT01997814|Immunologic Factors|immunologic factors|mesh-list
101297329|NCT01997814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
101297330|NCT01997814|Immunomodulating Agents|immunomodulating agents|mesh-list
101297331|NCT01997814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297332|NCT01997944|Interferons|interferons|mesh-list
101297333|NCT01997944|Interferon-alpha|interferon-alpha|mesh-list
101297334|NCT01997944|Interferon alpha-2|interferon alpha-2|mesh-list
101297335|NCT01997944|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101297336|NCT01997944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101297337|NCT01997944|Antiviral Agents|antiviral agents|mesh-ancestor
101297338|NCT01997944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101297339|NCT01997944|Immunologic Factors|immunologic factors|mesh-ancestor
101297340|NCT01997944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297341|NCT01997983|Botulinum Toxins|botulinum toxins|mesh-list
101297342|NCT01997983|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101297343|NCT01997983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101297344|NCT01997983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297346|NCT01997983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101297347|NCT01997983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821785|NCT00530088|Trioxsalen|trioxsalen|mesh-list
101821786|NCT00530088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821787|NCT00530088|Dermatologic Agents|dermatologic agents|mesh-ancestor
101821788|NCT00530088|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101821789|NCT01006668|Propofol|propofol|mesh-list
101821790|NCT01006668|Sevoflurane|sevoflurane|mesh-list
101821791|NCT01006668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101821792|NCT01006668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101821793|NCT01006668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297348|NCT01998061|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101297349|NCT01998061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101297350|NCT01998061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101297351|NCT01998061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297352|NCT01998113|Insulin|insulin|mesh-list
101297353|NCT01998113|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101297355|NCT01998113|Glyburide|glyburide|mesh-list
101297356|NCT01998113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101297357|NCT01998113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297358|NCT01998126|Nivolumab|nivolumab|mesh-list
101297359|NCT01998126|Ipilimumab|ipilimumab|mesh-list
101297360|NCT01998126|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101297361|NCT01998126|Crizotinib|crizotinib|mesh-list
101297362|NCT01998126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101297363|NCT01998126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101297364|NCT01998126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101297365|NCT01998126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297366|NCT01998126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101297367|NCT01998126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101297368|NCT01998165|Remifentanil|remifentanil|mesh-list
101297369|NCT01998165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101297370|NCT01998165|Narcotics|narcotics|mesh-ancestor
101297371|NCT01998165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101297372|NCT01998165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297373|NCT01998165|Analgesics|analgesics|mesh-ancestor
101297374|NCT01998165|Sensory System Agents|sensory system agents|mesh-ancestor
101297375|NCT01998165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101297376|NCT01998217|Flurbiprofen|flurbiprofen|mesh-list
101297377|NCT01998217|Remifentanil|remifentanil|mesh-list
101297378|NCT01998217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101297379|NCT01998217|Narcotics|narcotics|mesh-ancestor
101297380|NCT01998217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101297381|NCT01998217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297382|NCT01998217|Analgesics|analgesics|mesh-ancestor
101297383|NCT01998217|Sensory System Agents|sensory system agents|mesh-ancestor
101297384|NCT01998217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101297385|NCT01998217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101297386|NCT01998217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101297387|NCT01998217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101297388|NCT01998217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101297389|NCT01998217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101297390|NCT01998217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101297391|NCT01998217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297392|NCT01998295|Lumefantrine|lumefantrine|mesh-list
101297394|NCT01998295|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101297395|NCT01998295|Antimalarials|antimalarials|mesh-ancestor
101297396|NCT01998295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101297397|NCT01998295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101297398|NCT01998295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101297399|NCT01998308|Hyaluronic Acid|hyaluronic acid|mesh-list
101297400|NCT01998308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101297401|NCT01998308|Immunologic Factors|immunologic factors|mesh-ancestor
101297402|NCT01998308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297403|NCT01998308|Viscosupplements|viscosupplements|mesh-ancestor
101297404|NCT01998308|Protective Agents|protective agents|mesh-ancestor
101297405|NCT01998347|Paclitaxel|paclitaxel|mesh-list
101297406|NCT01998347|Fluorouracil|fluorouracil|mesh-list
101297407|NCT01998347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101297408|NCT01998347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821794|NCT01006668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101821795|NCT01006668|Anesthetics, General|anesthetics, general|mesh-ancestor
101821797|NCT01006668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101821798|NCT01006668|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101821799|NCT00360568|Levodopa|levodopa|mesh-list
101297409|NCT01998347|Tubulin Modulators|tubulin modulators|mesh-ancestor
101297410|NCT01998347|Antimitotic Agents|antimitotic agents|mesh-ancestor
101297411|NCT01998347|Mitosis Modulators|mitosis modulators|mesh-ancestor
101297412|NCT01998347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297413|NCT01998347|Antimetabolites|antimetabolites|mesh-ancestor
101297414|NCT01998347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101297415|NCT01998347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101297416|NCT01998347|Immunologic Factors|immunologic factors|mesh-ancestor
101317238|NCT00009802|Micronutrients|micronutrients|mesh-ancestor
101297417|NCT01998347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297418|NCT01998386|Hydrogen Peroxide|hydrogen peroxide|mesh-list
101297419|NCT01998386|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101297420|NCT01998386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101297421|NCT01998451|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
101297422|NCT01998451|Antiviral Agents|antiviral agents|mesh-ancestor
101297423|NCT01998451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101297424|NCT01998451|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101297425|NCT01998451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101297426|NCT01998503|Dexamethasone|dexamethasone|mesh-list
101297427|NCT01998503|Bortezomib|bortezomib|mesh-list
101297428|NCT01998503|Melphalan|melphalan|mesh-list
101297429|NCT01998503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101297430|NCT01998503|Antiemetics|antiemetics|mesh-ancestor
101297431|NCT01998503|Autonomic Agents|autonomic agents|mesh-ancestor
101297432|NCT01998503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101297433|NCT01998503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297434|NCT01998503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101297435|NCT01998503|Glucocorticoids|glucocorticoids|mesh-ancestor
101297437|NCT01998503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101297438|NCT01998503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101297439|NCT01998503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101297440|NCT01998503|Immunologic Factors|immunologic factors|mesh-ancestor
101297441|NCT01998503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101297442|NCT01998503|Alkylating Agents|alkylating agents|mesh-ancestor
101297443|NCT01998503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297444|NCT01998503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101297445|NCT01998503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101297446|NCT01998685|Fentanyl|fentanyl|mesh-list
101297447|NCT01998685|Midazolam|midazolam|mesh-list
101297448|NCT01998685|Remifentanil|remifentanil|mesh-list
101297449|NCT01998685|Propofol|propofol|mesh-list
101297450|NCT01998685|Sevoflurane|sevoflurane|mesh-list
101297451|NCT01998685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101297452|NCT01998685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101297453|NCT01998685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297454|NCT01998685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101297455|NCT01998685|Anesthetics, General|anesthetics, general|mesh-ancestor
101297456|NCT01998685|Anesthetics|anesthetics|mesh-ancestor
101297457|NCT01998685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101297458|NCT01998685|Narcotics|narcotics|mesh-ancestor
101297459|NCT01998685|Analgesics|analgesics|mesh-ancestor
101297460|NCT01998685|Sensory System Agents|sensory system agents|mesh-ancestor
101297461|NCT01998685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101297462|NCT01998685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101297463|NCT01998685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101297464|NCT01998685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101297465|NCT01998685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101297466|NCT01998685|GABA Modulators|gaba modulators|mesh-ancestor
101297467|NCT01998685|GABA Agents|gaba agents|mesh-ancestor
101297468|NCT01998685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101297469|NCT01998685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297470|NCT01998685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101297471|NCT01998685|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101297472|NCT01998698|Lidocaine|lidocaine|mesh-list
101297473|NCT01998698|Dipivefrin|dipivefrin|mesh-list
101297474|NCT01998698|Hyaluronic Acid|hyaluronic acid|mesh-list
101821801|NCT00360568|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101821802|NCT00360568|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101821803|NCT00360568|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101821804|NCT00360568|Dopamine Agents|dopamine agents|mesh-ancestor
101821805|NCT00360568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101821806|NCT00360568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821807|NCT00360568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312871|NCT00008424|Irinotecan|irinotecan|mesh-list
101821808|NCT00360568|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101821809|NCT00360568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101821810|NCT00360568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101821811|NCT00360568|Immunologic Factors|immunologic factors|mesh-ancestor
101297475|NCT01998698|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101297476|NCT01998698|Adrenergic Agents|adrenergic agents|mesh-ancestor
101297477|NCT01998698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101297478|NCT01998698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297479|NCT01998698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297480|NCT01998698|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101297481|NCT01998698|Immunologic Factors|immunologic factors|mesh-ancestor
101297482|NCT01998698|Viscosupplements|viscosupplements|mesh-ancestor
101297483|NCT01998698|Protective Agents|protective agents|mesh-ancestor
101297484|NCT01998698|Anesthetics, Local|anesthetics, local|mesh-ancestor
101297485|NCT01998698|Anesthetics|anesthetics|mesh-ancestor
101297486|NCT01998698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101297487|NCT01998698|Sensory System Agents|sensory system agents|mesh-ancestor
101317240|NCT00009841|Mitogens|mitogens|mesh-list
101297488|NCT01998698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101297489|NCT01998698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101297490|NCT01998698|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101297491|NCT01998698|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101297494|NCT01998763|Cholecalciferol|cholecalciferol|mesh-list
101297495|NCT01998763|Vitamins|vitamins|mesh-ancestor
101297496|NCT01998763|Micronutrients|micronutrients|mesh-ancestor
101297497|NCT01998763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297498|NCT01998763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101297499|NCT01998763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101297500|NCT01998776|Misoprostol|misoprostol|mesh-list
101297501|NCT01998776|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101297502|NCT01998776|Abortifacient Agents|abortifacient agents|mesh-ancestor
101297503|NCT01998776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101297504|NCT01998776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297505|NCT01998776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101297507|NCT01998776|Oxytocics|oxytocics|mesh-ancestor
101297508|NCT01998789|Everolimus|everolimus|mesh-list
101297509|NCT01998789|Tacrolimus|tacrolimus|mesh-list
101297510|NCT01998789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101297511|NCT01998789|Immunologic Factors|immunologic factors|mesh-ancestor
101297512|NCT01998789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297513|NCT01998789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101297514|NCT01998789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101297515|NCT01998789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297516|NCT01998789|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101297517|NCT01998789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101297518|NCT01998789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101297519|NCT01999153|Ropivacaine|ropivacaine|mesh-list
101297520|NCT01999153|Anesthetics, Local|anesthetics, local|mesh-ancestor
101297521|NCT01999153|Anesthetics|anesthetics|mesh-ancestor
101297522|NCT01999153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101297523|NCT01999153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821812|NCT00360568|Dopamine Agonists|dopamine agonists|mesh-ancestor
101821813|NCT00436215|Bevacizumab|bevacizumab|mesh-list
101821814|NCT00436215|Sorafenib|sorafenib|mesh-list
101821815|NCT00436215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101821816|NCT00436215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821817|NCT00436215|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101821818|NCT00436215|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101297524|NCT01999153|Sensory System Agents|sensory system agents|mesh-ancestor
101297525|NCT01999153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101297526|NCT01999270|Bevacizumab|bevacizumab|mesh-list
101297527|NCT01999270|Irinotecan|irinotecan|mesh-list
101297528|NCT01999270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101297529|NCT01999270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101297530|NCT01999270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101297531|NCT01999270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101297532|NCT01999270|Growth Substances|growth substances|mesh-ancestor
101297533|NCT01999270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297534|NCT01999270|Growth Inhibitors|growth inhibitors|mesh-ancestor
101297535|NCT01999270|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101297536|NCT01999270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101297537|NCT01999270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101297538|NCT01999270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297539|NCT01999309|Simvastatin|simvastatin|mesh-list
101297540|NCT01999309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101297541|NCT01999309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101297542|NCT01999309|Antimetabolites|antimetabolites|mesh-ancestor
101297543|NCT01999309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297544|NCT01999309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101297545|NCT01999309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101297546|NCT01999309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101297547|NCT01999413|Cytarabine|cytarabine|mesh-list
101297548|NCT01999413|Daunorubicin|daunorubicin|mesh-list
101297549|NCT01999413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101297550|NCT01999413|Antimetabolites|antimetabolites|mesh-ancestor
101297551|NCT01999413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297552|NCT01999413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101297553|NCT01999413|Antiviral Agents|antiviral agents|mesh-ancestor
101297554|NCT01999413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101297555|NCT01999413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101297556|NCT01999413|Immunologic Factors|immunologic factors|mesh-ancestor
101297557|NCT01999413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297558|NCT01999413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101297559|NCT01999413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101297560|NCT01999413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101297561|NCT01999413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101297562|NCT01999647|Ropivacaine|ropivacaine|mesh-list
101297563|NCT01999647|Anesthetics, Local|anesthetics, local|mesh-list
101297564|NCT01999647|Anesthetics|anesthetics|mesh-list
101297565|NCT01999647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101528349|NCT04628676|Mydriatics|mydriatics|mesh-ancestor
101297566|NCT01999647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297567|NCT01999647|Sensory System Agents|sensory system agents|mesh-ancestor
101297568|NCT01999647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101297569|NCT01999673|Docetaxel|docetaxel|mesh-list
101297570|NCT01999673|Bavituximab|bavituximab|mesh-list
101297571|NCT01999673|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101297572|NCT01999673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101297573|NCT01999673|Tubulin Modulators|tubulin modulators|mesh-ancestor
101297574|NCT01999673|Antimitotic Agents|antimitotic agents|mesh-ancestor
101297575|NCT01999673|Mitosis Modulators|mitosis modulators|mesh-ancestor
101297576|NCT01999673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297577|NCT01999673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101297578|NCT01999673|Immunologic Factors|immunologic factors|mesh-ancestor
101297579|NCT01999673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297581|NCT01999686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101297582|NCT01999686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297583|NCT01999738|Folic Acid|folic acid|mesh-list
101297584|NCT01999738|Hematinics|hematinics|mesh-ancestor
101297585|NCT01999738|Vitamin B Complex|vitamin b complex|mesh-ancestor
101821819|NCT00436215|Growth Substances|growth substances|mesh-ancestor
101821820|NCT00436215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821821|NCT00436215|Growth Inhibitors|growth inhibitors|mesh-ancestor
101821822|NCT00436215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101821823|NCT00436215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101821824|NCT00436215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821825|NCT05734248|Hyaluronic Acid|hyaluronic acid|mesh-list
101821826|NCT05734248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101297586|NCT01999738|Vitamins|vitamins|mesh-ancestor
101297587|NCT01999738|Micronutrients|micronutrients|mesh-ancestor
101297588|NCT01999738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297589|NCT01999829|Caffeine|caffeine|mesh-list
101297590|NCT01999829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297591|NCT01999829|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101297592|NCT01999829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297593|NCT01999829|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101297594|NCT01999829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101297595|NCT01999829|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101297596|NCT01999829|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101297597|NCT01999829|Purinergic Agents|purinergic agents|mesh-ancestor
101297598|NCT01999829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101297599|NCT01999842|Vaccines|vaccines|mesh-list
101297600|NCT01999842|Immunologic Factors|immunologic factors|mesh-ancestor
101297601|NCT01999842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297602|NCT01999907|Vitamin D|vitamin d|mesh-list
101297603|NCT01999907|Ergocalciferols|ergocalciferols|mesh-list
101297604|NCT01999907|Cholecalciferol|cholecalciferol|mesh-list
101297605|NCT01999907|Vitamins|vitamins|mesh-list
101297606|NCT01999907|Micronutrients|micronutrients|mesh-ancestor
101297607|NCT01999907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297608|NCT01999907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101297609|NCT01999907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101297610|NCT01999933|Cisplatin|cisplatin|mesh-list
101297611|NCT01999933|Docetaxel|docetaxel|mesh-list
101297612|NCT01999933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101297613|NCT01999933|Tubulin Modulators|tubulin modulators|mesh-ancestor
101297614|NCT01999933|Antimitotic Agents|antimitotic agents|mesh-ancestor
101297615|NCT01999933|Mitosis Modulators|mitosis modulators|mesh-ancestor
101297616|NCT01999933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297617|NCT02000102|Aflibercept|aflibercept|mesh-list
101297618|NCT02000102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101297619|NCT02000102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101297620|NCT02000102|Growth Substances|growth substances|mesh-ancestor
101297621|NCT02000102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297622|NCT02000102|Growth Inhibitors|growth inhibitors|mesh-ancestor
101297623|NCT02000102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101297624|NCT02000193|Fulvestrant|fulvestrant|mesh-list
101297625|NCT02000193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101297626|NCT02000193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101297627|NCT02000193|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101297629|NCT02000193|Hormone Antagonists|hormone antagonists|mesh-ancestor
101297630|NCT02000193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101297631|NCT02000193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297632|NCT02000206|Ketamine|ketamine|mesh-list
101297633|NCT02000206|Alfentanil|alfentanil|mesh-list
101297634|NCT02000206|Propofol|propofol|mesh-list
101297635|NCT02000206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101297636|NCT02000206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101297637|NCT02000206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297638|NCT02000206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101297639|NCT02000206|Anesthetics, General|anesthetics, general|mesh-ancestor
101297640|NCT02000206|Anesthetics|anesthetics|mesh-ancestor
101297641|NCT02000206|Analgesics|analgesics|mesh-ancestor
101821827|NCT05734248|Immunologic Factors|immunologic factors|mesh-ancestor
101821828|NCT05734248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821829|NCT05734248|Viscosupplements|viscosupplements|mesh-ancestor
101821830|NCT05734248|Protective Agents|protective agents|mesh-ancestor
101821831|NCT00441363|Bromocriptine|bromocriptine|mesh-list
101821832|NCT00441363|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101297642|NCT02000206|Sensory System Agents|sensory system agents|mesh-ancestor
101297643|NCT02000206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101297644|NCT02000206|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101297645|NCT02000206|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101297646|NCT02000206|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101297647|NCT02000206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101297648|NCT02000206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297649|NCT02000206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101297651|NCT02000336|Prednisolone|prednisolone|mesh-list
101297652|NCT02000336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101297654|NCT02000336|Hormones|hormones|mesh-ancestor
101297655|NCT02000336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101297656|NCT02000336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297657|NCT02000336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101297658|NCT02000336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101297659|NCT02000375|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101297660|NCT02000375|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101297661|NCT02000375|Immunologic Factors|immunologic factors|mesh-ancestor
101297662|NCT02000375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297663|NCT02000388|Ketorolac|ketorolac|mesh-list
101297664|NCT02000388|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101297665|NCT02000388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101297666|NCT02000388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101297667|NCT02000388|Analgesics|analgesics|mesh-ancestor
101297668|NCT02000388|Sensory System Agents|sensory system agents|mesh-ancestor
101297669|NCT02000388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101297670|NCT02000388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297671|NCT02000388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101297672|NCT02000388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101297673|NCT02000388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101297674|NCT02000388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101297675|NCT02000388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297676|NCT02000401|Ketorolac|ketorolac|mesh-list
101297677|NCT02000401|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101297678|NCT02000401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101297679|NCT02000401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101297680|NCT02000401|Analgesics|analgesics|mesh-ancestor
101297681|NCT02000401|Sensory System Agents|sensory system agents|mesh-ancestor
101297683|NCT02000401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297684|NCT02000401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101297685|NCT02000401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101297686|NCT02000401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101297687|NCT02000401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101297688|NCT02000401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297690|NCT02000414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101297691|NCT02000414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101297692|NCT02000674|Rocuronium|rocuronium|mesh-list
101297693|NCT02000674|Succinylcholine|succinylcholine|mesh-list
101297694|NCT02000674|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101297695|NCT02000674|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101297696|NCT02000674|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101297697|NCT02000674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101297698|NCT02000674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297699|NCT02000674|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
101297700|NCT02000700|Canagliflozin|canagliflozin|mesh-list
101297701|NCT02000700|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101297702|NCT02000700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297703|NCT02000700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101297704|NCT02000700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297705|NCT02000726|Antidepressive Agents|antidepressive agents|mesh-list
101821833|NCT00441363|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101821834|NCT00441363|Hormone Antagonists|hormone antagonists|mesh-ancestor
101821835|NCT00441363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101821836|NCT00441363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821837|NCT00441363|Dopamine Agonists|dopamine agonists|mesh-ancestor
101821838|NCT00441363|Dopamine Agents|dopamine agents|mesh-ancestor
101821839|NCT00441363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101821840|NCT00441363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297706|NCT02000726|Citalopram|citalopram|mesh-list
101297707|NCT02000726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101297708|NCT02000726|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101297709|NCT02000726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101297710|NCT02000726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101297711|NCT02000726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297712|NCT02000726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101297713|NCT02000726|Serotonin Agents|serotonin agents|mesh-ancestor
101297714|NCT02000726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297715|NCT02000726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101297717|NCT02000765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101297718|NCT02000765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101297719|NCT02000765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297720|NCT02000765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101297722|NCT02000804|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
101297723|NCT02000804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101297724|NCT02000804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297725|NCT02000830|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
101297726|NCT02000830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101297727|NCT02000830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297729|NCT02000947|Tremelimumab|tremelimumab|mesh-list
101297730|NCT02000947|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101297731|NCT02000947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101297732|NCT02000947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101297733|NCT02000947|Immunologic Factors|immunologic factors|mesh-ancestor
101297734|NCT02000947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297735|NCT02001012|Chloroquine|chloroquine|mesh-list
101297736|NCT02001012|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
101297737|NCT02001012|Lumefantrine|lumefantrine|mesh-list
101297738|NCT02001012|Artemether|artemether|mesh-list
101297739|NCT02001012|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101297740|NCT02001012|Amebicides|amebicides|mesh-ancestor
101297741|NCT02001012|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101297742|NCT02001012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101297743|NCT02001012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101297744|NCT02001012|Antimalarials|antimalarials|mesh-ancestor
101297745|NCT02001012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101297746|NCT02001012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101297747|NCT02001012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101297748|NCT02001012|Analgesics|analgesics|mesh-ancestor
101297749|NCT02001012|Sensory System Agents|sensory system agents|mesh-ancestor
101297750|NCT02001012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101297751|NCT02001012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297752|NCT02001012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101297753|NCT02001012|Filaricides|filaricides|mesh-ancestor
101297754|NCT02001012|Antinematodal Agents|antinematodal agents|mesh-ancestor
101297755|NCT02001012|Anthelmintics|anthelmintics|mesh-ancestor
101297756|NCT02001103|Memantine|memantine|mesh-list
101297757|NCT02001103|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101297758|NCT02001103|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101297759|NCT02001103|Dopamine Agents|dopamine agents|mesh-ancestor
101297760|NCT02001103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101297761|NCT02001103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297762|NCT02001103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297763|NCT02001103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101297764|NCT02001103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101821841|NCT00626795|Mupirocin|mupirocin|mesh-list
101821842|NCT00626795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101821843|NCT00626795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101821844|NCT00626795|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101821845|NCT00626795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101821846|NCT00626795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821847|NCT00826553|Midazolam|midazolam|mesh-list
101821848|NCT00826553|Dexmedetomidine|dexmedetomidine|mesh-list
101821849|NCT00826553|Lorazepam|lorazepam|mesh-list
101821850|NCT00826553|Propofol|propofol|mesh-list
101821851|NCT00826553|GABA Agonists|gaba agonists|mesh-list
101821852|NCT00826553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101821853|NCT00826553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101821854|NCT00826553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821855|NCT00826553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101821857|NCT00826553|Sensory System Agents|sensory system agents|mesh-ancestor
101821858|NCT00826553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101821859|NCT00826553|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101821860|NCT00826553|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101297765|NCT02001168|Docetaxel|docetaxel|mesh-list
101297766|NCT02001168|Pemetrexed|pemetrexed|mesh-list
101297767|NCT02001168|Cisplatin|cisplatin|mesh-list
101297768|NCT02001168|Endostatins|endostatins|mesh-list
101297769|NCT02001168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101297770|NCT02001168|Tubulin Modulators|tubulin modulators|mesh-ancestor
101297771|NCT02001168|Antimitotic Agents|antimitotic agents|mesh-ancestor
101297772|NCT02001168|Mitosis Modulators|mitosis modulators|mesh-ancestor
101297773|NCT02001168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297774|NCT02001168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101297775|NCT02001168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101297776|NCT02001168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101297777|NCT02001168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101317253|NCT00009880|Paclitaxel|paclitaxel|mesh-list
101297778|NCT02001168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101297779|NCT02001168|Growth Substances|growth substances|mesh-ancestor
101297780|NCT02001168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297781|NCT02001168|Growth Inhibitors|growth inhibitors|mesh-ancestor
101297782|NCT02001207|Hydrocortisone|hydrocortisone|mesh-list
101297783|NCT02001207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101297784|NCT02001259|Lidocaine|lidocaine|mesh-list
101297785|NCT02001259|Anesthetics, Local|anesthetics, local|mesh-ancestor
101297786|NCT02001259|Anesthetics|anesthetics|mesh-ancestor
101297787|NCT02001259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101297788|NCT02001259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297789|NCT02001259|Sensory System Agents|sensory system agents|mesh-ancestor
101297790|NCT02001259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101297791|NCT02001259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101297792|NCT02001259|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101297793|NCT02001259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101297794|NCT02001259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101297795|NCT02001259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297796|NCT02001272|Paclitaxel|paclitaxel|mesh-list
101297797|NCT02001272|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101297798|NCT02001272|Carboplatin|carboplatin|mesh-list
101297799|NCT02001272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101297800|NCT02001272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821861|NCT00826553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101821862|NCT00826553|Adrenergic Agents|adrenergic agents|mesh-ancestor
101821863|NCT00826553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101821864|NCT00826553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821865|NCT00826553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101821866|NCT00826553|Anesthetics, General|anesthetics, general|mesh-ancestor
101821867|NCT00826553|Anesthetics|anesthetics|mesh-ancestor
101297802|NCT02001272|Antimitotic Agents|antimitotic agents|mesh-ancestor
101297803|NCT02001272|Mitosis Modulators|mitosis modulators|mesh-ancestor
101297804|NCT02001272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297805|NCT02001285|Remifentanil|remifentanil|mesh-list
101297806|NCT02001285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101297807|NCT02001285|Narcotics|narcotics|mesh-ancestor
101297808|NCT02001285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101297809|NCT02001285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297810|NCT02001285|Analgesics|analgesics|mesh-ancestor
101297811|NCT02001285|Sensory System Agents|sensory system agents|mesh-ancestor
101297812|NCT02001285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101297813|NCT02001298|Nitroprusside|nitroprusside|mesh-list
101297814|NCT02001298|Remifentanil|remifentanil|mesh-list
101297815|NCT02001298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101297816|NCT02001298|Narcotics|narcotics|mesh-ancestor
101297817|NCT02001298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101297818|NCT02001298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297819|NCT02001298|Analgesics|analgesics|mesh-ancestor
101297820|NCT02001298|Sensory System Agents|sensory system agents|mesh-ancestor
101297821|NCT02001298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101297822|NCT02001298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101297823|NCT02001298|Vasodilator Agents|vasodilator agents|mesh-ancestor
101297824|NCT02001298|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101297825|NCT02001298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297826|NCT02001311|Chlorhexidine|chlorhexidine|mesh-list
101297827|NCT02001311|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101297828|NCT02001311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101297829|NCT02001311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101297830|NCT02001311|Disinfectants|disinfectants|mesh-ancestor
101297831|NCT02001311|Dermatologic Agents|dermatologic agents|mesh-ancestor
101297832|NCT02001363|Liraglutide|liraglutide|mesh-list
101297833|NCT02001363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101297834|NCT02001363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297835|NCT02001363|Incretins|incretins|mesh-ancestor
101297836|NCT02001363|Hormones|hormones|mesh-ancestor
101297837|NCT02001363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101297838|NCT02001428|Piperaquine|piperaquine|mesh-list
101297839|NCT02001428|Artenimol|artenimol|mesh-list
101297840|NCT02001428|Antimalarials|antimalarials|mesh-ancestor
101297841|NCT02001428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101297842|NCT02001428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101297843|NCT02001428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101297844|NCT02001506|Docetaxel|docetaxel|mesh-list
101297845|NCT02001506|Epirubicin|epirubicin|mesh-list
101297846|NCT02001506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101297847|NCT02001506|Tubulin Modulators|tubulin modulators|mesh-ancestor
101297848|NCT02001506|Antimitotic Agents|antimitotic agents|mesh-ancestor
101297849|NCT02001506|Mitosis Modulators|mitosis modulators|mesh-ancestor
101297850|NCT02001506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297851|NCT02001506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101297852|NCT02001506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101297853|NCT02001506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101297854|NCT02001506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101297855|NCT02001571|Abiraterone Acetate|abiraterone acetate|mesh-list
101297856|NCT02001571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101297857|NCT02001571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101297858|NCT02001571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101297859|NCT02001571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297860|NCT02001571|Hormone Antagonists|hormone antagonists|mesh-ancestor
101297861|NCT02001571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101821868|NCT00826553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101821869|NCT00826553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101821870|NCT00826553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101821871|NCT00826553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101821872|NCT00826553|GABA Modulators|gaba modulators|mesh-ancestor
101821873|NCT00826553|GABA Agents|gaba agents|mesh-ancestor
101821874|NCT00826553|Anticonvulsants|anticonvulsants|mesh-ancestor
101821875|NCT00826553|Antiemetics|antiemetics|mesh-ancestor
101297862|NCT02001571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297863|NCT02001571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101297865|NCT02001584|Baclofen|baclofen|mesh-list
101297866|NCT02001584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101297867|NCT02001584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101297868|NCT02001584|Dopamine Agents|dopamine agents|mesh-ancestor
101297869|NCT02001584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101297870|NCT02001584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297871|NCT02001584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297872|NCT02001584|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101297873|NCT02001584|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101297874|NCT02001584|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101297875|NCT02001584|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101297876|NCT02001584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101297877|NCT02001584|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101297879|NCT02001584|GABA Agents|gaba agents|mesh-ancestor
101297880|NCT02001740|Lidocaine|lidocaine|mesh-list
101297881|NCT02001740|Anesthetics, Local|anesthetics, local|mesh-ancestor
101297882|NCT02001740|Anesthetics|anesthetics|mesh-ancestor
101297883|NCT02001740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101297884|NCT02001740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297885|NCT02001740|Sensory System Agents|sensory system agents|mesh-ancestor
101297886|NCT02001740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101297887|NCT02001740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101297888|NCT02001740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101297889|NCT02001740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101297890|NCT02001740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101297894|NCT02001883|Policosanol|policosanol|mesh-list
101297895|NCT02001883|Atorvastatin|atorvastatin|mesh-list
101297896|NCT02001883|Simvastatin|simvastatin|mesh-list
101297897|NCT02001883|Red yeast rice|red yeast rice|mesh-list
101297898|NCT02001883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101297899|NCT02001883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101297900|NCT02001883|Antimetabolites|antimetabolites|mesh-ancestor
101297901|NCT02001883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297902|NCT02001883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101297903|NCT02001883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101297904|NCT02001883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101297905|NCT02001883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101297906|NCT02001896|Carboplatin|carboplatin|mesh-list
101297907|NCT02001896|Gemcitabine|gemcitabine|mesh-list
101297908|NCT02001896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101297909|NCT02001896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101297910|NCT02001896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101297911|NCT02001896|Antimetabolites|antimetabolites|mesh-ancestor
101297912|NCT02001896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297913|NCT02001896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101297914|NCT02001896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101297915|NCT02001909|Neomycin|neomycin|mesh-list
101297916|NCT02001909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101297917|NCT02001909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101297918|NCT02001909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101297919|NCT02001909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101297920|NCT02001909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297921|NCT02001935|Theophylline|theophylline|mesh-list
101297922|NCT02001935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101297923|NCT02001935|Autonomic Agents|autonomic agents|mesh-ancestor
101297924|NCT02001935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101297925|NCT02001935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821876|NCT00826553|Autonomic Agents|autonomic agents|mesh-ancestor
101821877|NCT00826553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101821878|NCT00626639|Cisplatin|cisplatin|mesh-list
101821879|NCT00626639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821880|NCT00626561|Paclitaxel|paclitaxel|mesh-list
101821881|NCT00626561|Bevacizumab|bevacizumab|mesh-list
101297926|NCT02001935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101297927|NCT02001935|Respiratory System Agents|respiratory system agents|mesh-ancestor
101297928|NCT02001935|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101297930|NCT02001935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297931|NCT02001935|Vasodilator Agents|vasodilator agents|mesh-ancestor
101297932|NCT02001935|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101297933|NCT02001935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101297934|NCT02001935|Purinergic Agents|purinergic agents|mesh-ancestor
101297935|NCT02001935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101297937|NCT02001948|Bupivacaine|bupivacaine|mesh-list
101297938|NCT02001948|Anesthetics, Local|anesthetics, local|mesh-ancestor
101297939|NCT02001948|Anesthetics|anesthetics|mesh-ancestor
101297940|NCT02001948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101297941|NCT02001948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297942|NCT02001948|Sensory System Agents|sensory system agents|mesh-ancestor
101297943|NCT02001948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101297944|NCT02001948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101297945|NCT02001948|Narcotics|narcotics|mesh-ancestor
101297946|NCT02001948|Analgesics|analgesics|mesh-ancestor
101297947|NCT02001974|Paclitaxel|paclitaxel|mesh-list
101297948|NCT02001974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101297949|NCT02001974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101297951|NCT02001974|Antimitotic Agents|antimitotic agents|mesh-ancestor
101297952|NCT02001974|Mitosis Modulators|mitosis modulators|mesh-ancestor
101297953|NCT02001974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297954|NCT02002000|Vitamin D|vitamin d|mesh-list
101297955|NCT02002000|Cholecalciferol|cholecalciferol|mesh-list
101297956|NCT02002000|Vitamins|vitamins|mesh-ancestor
101297957|NCT02002000|Micronutrients|micronutrients|mesh-ancestor
101297958|NCT02002000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297959|NCT02002000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101297960|NCT02002000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101297961|NCT02002039|Epoetin Alfa|epoetin alfa|mesh-list
101297962|NCT02002039|Hematinics|hematinics|mesh-ancestor
101297963|NCT02002065|Vaccines|vaccines|mesh-list
101297964|NCT02002065|Immunologic Factors|immunologic factors|mesh-ancestor
101297965|NCT02002065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297966|NCT02002078|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101297967|NCT02002078|Methylprednisolone|methylprednisolone|mesh-list
101297968|NCT02002078|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101297969|NCT02002078|Prednisolone|prednisolone|mesh-list
101297970|NCT02002078|Prednisolone acetate|prednisolone acetate|mesh-list
101297971|NCT02002078|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101297972|NCT02002078|Prednisolone phosphate|prednisolone phosphate|mesh-list
101297973|NCT02002078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101297974|NCT02002078|Antiemetics|antiemetics|mesh-ancestor
101297975|NCT02002078|Autonomic Agents|autonomic agents|mesh-ancestor
101297976|NCT02002078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101297977|NCT02002078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297978|NCT02002078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101297979|NCT02002078|Glucocorticoids|glucocorticoids|mesh-ancestor
101297980|NCT02002078|Hormones|hormones|mesh-ancestor
101297981|NCT02002078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101297983|NCT02002078|Protective Agents|protective agents|mesh-ancestor
101297984|NCT02002078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101297985|NCT02002078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101297986|NCT02002156|Vaccines|vaccines|mesh-list
101297987|NCT02002156|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101297988|NCT02002156|BCG Vaccine|bcg vaccine|mesh-list
101297989|NCT02002156|Immunologic Factors|immunologic factors|mesh-ancestor
101408879|NCT00143949|Losartan|losartan|mesh-list
101297990|NCT02002156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101297991|NCT02002156|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101297992|NCT02002195|Leucovorin|leucovorin|mesh-list
101297993|NCT02002195|Fluorouracil|fluorouracil|mesh-list
101297994|NCT02002195|Capecitabine|capecitabine|mesh-list
101821882|NCT00626561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101821883|NCT00626561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821884|NCT00626561|Tubulin Modulators|tubulin modulators|mesh-ancestor
101821885|NCT00626561|Antimitotic Agents|antimitotic agents|mesh-ancestor
101821886|NCT00626561|Mitosis Modulators|mitosis modulators|mesh-ancestor
101821887|NCT00626561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821888|NCT00626561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101297995|NCT02002195|Oxaliplatin|oxaliplatin|mesh-list
101297996|NCT02002195|Antimetabolites|antimetabolites|mesh-ancestor
101297997|NCT02002195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297998|NCT02002195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101297999|NCT02002195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101298000|NCT02002195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101298001|NCT02002195|Immunologic Factors|immunologic factors|mesh-ancestor
101298002|NCT02002195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298004|NCT02002195|Protective Agents|protective agents|mesh-ancestor
101298005|NCT02002195|Vitamin B Complex|vitamin b complex|mesh-ancestor
101298006|NCT02002195|Vitamins|vitamins|mesh-ancestor
101298007|NCT02002195|Micronutrients|micronutrients|mesh-ancestor
101298008|NCT02002247|Selenium|selenium|mesh-list
101298009|NCT02002247|Selenious Acid|selenious acid|mesh-list
101298010|NCT02002247|Sodium Selenite|sodium selenite|mesh-list
101298011|NCT02002247|Antioxidants|antioxidants|mesh-ancestor
101298012|NCT02002247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298013|NCT02002247|Protective Agents|protective agents|mesh-ancestor
101298014|NCT02002247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298015|NCT02002247|Trace Elements|trace elements|mesh-ancestor
101298016|NCT02002247|Micronutrients|micronutrients|mesh-ancestor
101298017|NCT02002260|Levonorgestrel|levonorgestrel|mesh-list
101298018|NCT02002260|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101298019|NCT02002260|Contraceptive Agents|contraceptive agents|mesh-list
101298020|NCT02002260|Contraceptives, Oral|contraceptives, oral|mesh-list
101298021|NCT02002260|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
101298023|NCT02002260|Estrogens|estrogens|mesh-ancestor
101298024|NCT02002260|Hormones|hormones|mesh-ancestor
101298025|NCT02002260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101298026|NCT02002260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298027|NCT02002260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101298029|NCT02002260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101298030|NCT02002260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101298031|NCT02002260|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101298032|NCT02002286|Triptolide|triptolide|mesh-list
101298033|NCT02002286|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
101298034|NCT02002286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298035|NCT02002286|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101298036|NCT02002286|Contraceptive Agents|contraceptive agents|mesh-ancestor
101298037|NCT02002286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101298038|NCT02002286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101298039|NCT02002286|Immunologic Factors|immunologic factors|mesh-ancestor
101298040|NCT02002286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101298041|NCT02002286|Alkylating Agents|alkylating agents|mesh-ancestor
101298042|NCT02002286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298043|NCT02002286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101298044|NCT02002312|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
101298045|NCT02002312|Chelating Agents|chelating agents|mesh-ancestor
101298046|NCT02002312|Sequestering Agents|sequestering agents|mesh-ancestor
101298047|NCT02002312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298048|NCT02002325|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101298049|NCT02002325|Plasminogen|plasminogen|mesh-list
101298050|NCT02002325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101298051|NCT02002325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101298052|NCT02002325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298053|NCT02002377|Aflibercept|aflibercept|mesh-list
101298054|NCT02002377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101298055|NCT02002377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101821889|NCT00626561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101821890|NCT00626561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101821892|NCT00626561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821893|NCT00626561|Growth Inhibitors|growth inhibitors|mesh-ancestor
101821894|NCT03880266|Glycopyrrolate|glycopyrrolate|mesh-list
101821895|NCT03880266|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101821896|NCT03880266|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101298056|NCT02002377|Growth Substances|growth substances|mesh-ancestor
101298057|NCT02002377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298058|NCT02002377|Growth Inhibitors|growth inhibitors|mesh-ancestor
101298059|NCT02002377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101298060|NCT02002390|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101298061|NCT02002390|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101298062|NCT02002390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298063|NCT02002390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101298064|NCT02002390|Immunologic Factors|immunologic factors|mesh-ancestor
101298065|NCT02002390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298066|NCT02002403|Danazol|danazol|mesh-list
101298067|NCT02002403|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101298068|NCT02002403|Hormone Antagonists|hormone antagonists|mesh-ancestor
101298069|NCT02002403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101298070|NCT02002403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298071|NCT02002442|Chlorhexidine|chlorhexidine|mesh-list
101298072|NCT02002442|Cetylpyridinium|cetylpyridinium|mesh-list
101298073|NCT02002442|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101298074|NCT02002442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101298075|NCT02002442|Disinfectants|disinfectants|mesh-ancestor
101298076|NCT02002598|Dexamethasone|dexamethasone|mesh-list
101298077|NCT02002598|Dexamethasone acetate|dexamethasone acetate|mesh-list
101298078|NCT02002598|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101298079|NCT02002598|BB 1101|bb 1101|mesh-list
101298080|NCT02002598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101298081|NCT02002598|Antiemetics|antiemetics|mesh-ancestor
101298082|NCT02002598|Autonomic Agents|autonomic agents|mesh-ancestor
101298083|NCT02002598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101298084|NCT02002598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298085|NCT02002598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101298086|NCT02002598|Glucocorticoids|glucocorticoids|mesh-ancestor
101298087|NCT02002598|Hormones|hormones|mesh-ancestor
101298088|NCT02002598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101298089|NCT02002598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101298090|NCT02002598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101298091|NCT02002598|Protease Inhibitors|protease inhibitors|mesh-ancestor
101298092|NCT02002598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101298093|NCT02002598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298094|NCT02002598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101298095|NCT02002598|Alkylating Agents|alkylating agents|mesh-ancestor
101298097|NCT02002611|Anticoagulants|anticoagulants|mesh-ancestor
101298098|NCT02002663|Methylprednisolone|methylprednisolone|mesh-list
101298099|NCT02002663|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101298100|NCT02002663|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101298101|NCT02002663|Prednisolone|prednisolone|mesh-list
101298102|NCT02002663|Prednisolone acetate|prednisolone acetate|mesh-list
101298103|NCT02002663|Morphine|morphine|mesh-list
101298104|NCT02002663|Ropivacaine|ropivacaine|mesh-list
101298105|NCT02002663|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101298106|NCT02002663|Prednisolone phosphate|prednisolone phosphate|mesh-list
101298107|NCT02002663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101298109|NCT02002663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101298110|NCT02002663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298112|NCT02002663|Sensory System Agents|sensory system agents|mesh-ancestor
101298113|NCT02002663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101298114|NCT02002663|Anesthetics, Local|anesthetics, local|mesh-ancestor
101298115|NCT02002663|Anesthetics|anesthetics|mesh-ancestor
101298116|NCT02002663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101821897|NCT03880266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101821898|NCT03880266|Cholinergic Agents|cholinergic agents|mesh-ancestor
101821899|NCT03880266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101821900|NCT03880266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821901|NCT03880266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821903|NCT00423891|Antiviral Agents|antiviral agents|mesh-ancestor
101821904|NCT00423891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101821905|NCT00830609|Ribavirin|ribavirin|mesh-list
101821906|NCT00830609|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101821907|NCT00830609|Interferon-alpha|interferon-alpha|mesh-list
101821908|NCT00830609|Antimetabolites|antimetabolites|mesh-ancestor
101298117|NCT02002663|Antiemetics|antiemetics|mesh-ancestor
101298118|NCT02002663|Autonomic Agents|autonomic agents|mesh-ancestor
101298119|NCT02002663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101298120|NCT02002663|Glucocorticoids|glucocorticoids|mesh-ancestor
101298121|NCT02002663|Hormones|hormones|mesh-ancestor
101298122|NCT02002663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101298123|NCT02002663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101298124|NCT02002663|Protective Agents|protective agents|mesh-ancestor
101298125|NCT02002663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101298126|NCT02002663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101298127|NCT02002715|Budesonide|budesonide|mesh-list
101298128|NCT02002715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101298129|NCT02002715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101298130|NCT02002715|Autonomic Agents|autonomic agents|mesh-ancestor
101298131|NCT02002715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101298132|NCT02002715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298133|NCT02002715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101298134|NCT02002715|Respiratory System Agents|respiratory system agents|mesh-ancestor
101298135|NCT02002715|Glucocorticoids|glucocorticoids|mesh-ancestor
101298136|NCT02002715|Hormones|hormones|mesh-ancestor
101298137|NCT02002715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101298139|NCT02002741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101298140|NCT02002741|Analgesics|analgesics|mesh-ancestor
101298141|NCT02002741|Sensory System Agents|sensory system agents|mesh-ancestor
101298142|NCT02002741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101298143|NCT02002741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298144|NCT02002741|Antipyretics|antipyretics|mesh-ancestor
101298145|NCT02002754|Bambuterol|bambuterol|mesh-list
101298146|NCT02002754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101298147|NCT02002754|Autonomic Agents|autonomic agents|mesh-ancestor
101298148|NCT02002754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101298149|NCT02002754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298150|NCT02002754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101298151|NCT02002754|Respiratory System Agents|respiratory system agents|mesh-ancestor
101298152|NCT02002806|Ethanol|ethanol|mesh-list
101298153|NCT02002806|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101298154|NCT02002806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101298155|NCT02002806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101298156|NCT02002806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298157|NCT02002858|Nicotine|nicotine|mesh-list
101298158|NCT02002858|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101298159|NCT02002858|Autonomic Agents|autonomic agents|mesh-ancestor
101298160|NCT02002858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101298161|NCT02002858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298162|NCT02002858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101298163|NCT02002858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101298164|NCT02002858|Cholinergic Agents|cholinergic agents|mesh-ancestor
101298165|NCT02002858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101298166|NCT02002858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298167|NCT02002923|Botulinum Toxins|botulinum toxins|mesh-list
101298168|NCT02002923|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101298169|NCT02002923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101821909|NCT00830609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821910|NCT00830609|Antiviral Agents|antiviral agents|mesh-ancestor
101821911|NCT00830609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101821912|NCT00830609|Immunologic Factors|immunologic factors|mesh-ancestor
101821913|NCT00830609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821914|NCT00822809|Prednisolone|prednisolone|mesh-list
101535252|NCT01137955|Rifaximin|rifaximin|mesh-list
101821915|NCT00822809|Catumaxomab|catumaxomab|mesh-list
101821916|NCT00822809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101821917|NCT00822809|Glucocorticoids|glucocorticoids|mesh-ancestor
101821918|NCT00822809|Hormones|hormones|mesh-ancestor
101298170|NCT02002923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298171|NCT02002923|Cholinergic Agents|cholinergic agents|mesh-ancestor
101298172|NCT02002923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101298173|NCT02002923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298174|NCT02002962|Botulinum Toxins|botulinum toxins|mesh-list
101298175|NCT02002962|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101298176|NCT02002962|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101298177|NCT02002962|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101298178|NCT02002962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101298179|NCT02002962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298180|NCT02002962|Cholinergic Agents|cholinergic agents|mesh-ancestor
101298181|NCT02002962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101298182|NCT02002962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298183|NCT02002962|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101298184|NCT02002962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101298185|NCT02003001|Botulinum Toxins|botulinum toxins|mesh-list
101298186|NCT02003001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101298187|NCT02003001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101298188|NCT02003001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298189|NCT02003001|Cholinergic Agents|cholinergic agents|mesh-ancestor
101298190|NCT02003001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101298191|NCT02003001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298192|NCT02001818|Interferons|interferons|mesh-list
101298193|NCT02001818|Interferon-alpha|interferon-alpha|mesh-list
101298194|NCT02001818|Interferon alpha-2|interferon alpha-2|mesh-list
101298195|NCT02001818|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101298196|NCT02001818|Imatinib Mesylate|imatinib mesylate|mesh-list
101298197|NCT02001818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101298198|NCT02001818|Antiviral Agents|antiviral agents|mesh-ancestor
101298199|NCT02001818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101298200|NCT02001818|Immunologic Factors|immunologic factors|mesh-ancestor
101298201|NCT02001818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298202|NCT02001818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101298203|NCT02001818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317276|NCT00009958|Metronidazole|metronidazole|mesh-list
101298204|NCT02001818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298205|NCT02003313|Vaccines|vaccines|mesh-list
101298206|NCT02003313|Immunologic Factors|immunologic factors|mesh-ancestor
101298207|NCT02003313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298208|NCT02003456|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101298209|NCT02003456|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101298210|NCT02003456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298211|NCT02003495|Vaccines|vaccines|mesh-list
101298212|NCT02003495|Immunologic Factors|immunologic factors|mesh-ancestor
101298213|NCT02003495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298214|NCT02003664|Baclofen|baclofen|mesh-list
101298215|NCT02003664|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101298216|NCT02003664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298217|NCT02003664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101298218|NCT02003664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101298219|NCT02003664|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101298220|NCT02003664|GABA Agonists|gaba agonists|mesh-ancestor
101298221|NCT02003664|GABA Agents|gaba agents|mesh-ancestor
101821919|NCT00822809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101821920|NCT00822809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821921|NCT00822809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101821922|NCT00822809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821923|NCT00822809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101821924|NCT02549651|Durvalumab|durvalumab|mesh-list
101821925|NCT02549651|Tremelimumab|tremelimumab|mesh-list
101821926|NCT02549651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101298222|NCT02003664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101298223|NCT02003664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298226|NCT02003677|Insulin Aspart|insulin aspart|mesh-list
101298227|NCT02003677|Insulin, Long-Acting|insulin, long-acting|mesh-list
101298228|NCT02003677|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101298229|NCT02003677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101298230|NCT02003677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298231|NCT02003768|Propofol|propofol|mesh-list
101298232|NCT02003768|Desflurane|desflurane|mesh-list
101298233|NCT02003768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101298234|NCT02003768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101298235|NCT02003768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298236|NCT02003768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101298237|NCT02003768|Anesthetics, General|anesthetics, general|mesh-ancestor
101298238|NCT02003768|Anesthetics|anesthetics|mesh-ancestor
101298239|NCT02003768|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101298241|NCT02003885|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101298242|NCT02003885|Anesthetics, General|anesthetics, general|mesh-ancestor
101298243|NCT02003885|Anesthetics|anesthetics|mesh-ancestor
101298244|NCT02003885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101298245|NCT02003885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298246|NCT02004067|Cyclosporine|cyclosporine|mesh-list
101298247|NCT02004067|Castor Oil|castor oil|mesh-list
101298248|NCT02004067|Cyclosporins|cyclosporins|mesh-list
101298249|NCT02004067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101298250|NCT02004067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298251|NCT02004067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101298252|NCT02004067|Immunologic Factors|immunologic factors|mesh-ancestor
101298253|NCT02004067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298254|NCT02004067|Antifungal Agents|antifungal agents|mesh-ancestor
101298255|NCT02004067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101298256|NCT02004067|Dermatologic Agents|dermatologic agents|mesh-ancestor
101298257|NCT02004067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101298258|NCT02004067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101298259|NCT02004067|Cathartics|cathartics|mesh-ancestor
101298260|NCT02004067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101298261|NCT02004171|Nicotine|nicotine|mesh-list
101298262|NCT02004171|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101298263|NCT02004171|Autonomic Agents|autonomic agents|mesh-ancestor
101298264|NCT02004171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101298265|NCT02004171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298266|NCT02004171|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101298267|NCT02004171|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101298268|NCT02004171|Cholinergic Agents|cholinergic agents|mesh-ancestor
101298269|NCT02004171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101298270|NCT02004171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298271|NCT02004184|Pemetrexed|pemetrexed|mesh-list
101298272|NCT02004184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101298273|NCT02004184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101298274|NCT02004184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298275|NCT02004184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101298276|NCT02004184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101298277|NCT02004197|Amoxicillin|amoxicillin|mesh-list
101298278|NCT02004197|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
101298279|NCT02004197|Bismuth|bismuth|mesh-list
101298280|NCT02004197|Ranitidine|ranitidine|mesh-list
101298281|NCT02004197|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
101298282|NCT02004197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821927|NCT02549651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821928|NCT03999372|Hyaluronic Acid|hyaluronic acid|mesh-list
101479227|NCT00286364|Androgens|androgens|mesh-list
101821929|NCT03999372|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101821930|NCT03999372|Immunologic Factors|immunologic factors|mesh-ancestor
101298283|NCT02004197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101298284|NCT02004197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101298285|NCT02004197|Antacids|antacids|mesh-ancestor
101298286|NCT02004197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101298287|NCT02004197|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101298289|NCT02004197|Histamine Antagonists|histamine antagonists|mesh-ancestor
101298290|NCT02004197|Histamine Agents|histamine agents|mesh-ancestor
101298291|NCT02004197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101298292|NCT02004197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298293|NCT02004301|Diclofenac|diclofenac|mesh-list
101298294|NCT02004301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101298295|NCT02004301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101298296|NCT02004301|Analgesics|analgesics|mesh-ancestor
101298297|NCT02004301|Sensory System Agents|sensory system agents|mesh-ancestor
101298298|NCT02004301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101298299|NCT02004301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298300|NCT02004301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101298301|NCT02004301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101298302|NCT02004301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101298303|NCT02004301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101298304|NCT02004301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298305|NCT02004314|Chloroquine|chloroquine|mesh-list
101298306|NCT02004314|Amebicides|amebicides|mesh-ancestor
101298307|NCT02004314|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101298308|NCT02004314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101298309|NCT02004314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101298310|NCT02004314|Antimalarials|antimalarials|mesh-ancestor
101298311|NCT02004314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101298312|NCT02004418|Choline|choline|mesh-list
101298313|NCT02004418|Lipotropic Agents|lipotropic agents|mesh-ancestor
101298314|NCT02004418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101298315|NCT02004418|Antimetabolites|antimetabolites|mesh-ancestor
101298316|NCT02004418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298317|NCT02004418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101298318|NCT02004418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101298319|NCT02004418|Nootropic Agents|nootropic agents|mesh-ancestor
101298321|NCT02004574|Betamethasone|betamethasone|mesh-list
101298322|NCT02004574|Betamethasone Valerate|betamethasone valerate|mesh-list
101298323|NCT02004574|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101298324|NCT02004574|Betamethasone benzoate|betamethasone benzoate|mesh-list
101298325|NCT02004574|Calcipotriene|calcipotriene|mesh-list
101298326|NCT02004574|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101298328|NCT02004574|Glucocorticoids|glucocorticoids|mesh-ancestor
101298329|NCT02004574|Hormones|hormones|mesh-ancestor
101298330|NCT02004574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101298331|NCT02004574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298332|NCT02004574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101298333|NCT02004574|Respiratory System Agents|respiratory system agents|mesh-ancestor
101298334|NCT02004574|Dermatologic Agents|dermatologic agents|mesh-ancestor
101298335|NCT02004652|Prucalopride|prucalopride|mesh-list
101298336|NCT02004652|Laxatives|laxatives|mesh-ancestor
101298337|NCT02004652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101298338|NCT02004652|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101298339|NCT02004652|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101298340|NCT02004652|Serotonin Agents|serotonin agents|mesh-ancestor
101298341|NCT02004652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101298342|NCT02004652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298343|NCT02004652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298344|NCT02004769|Docetaxel|docetaxel|mesh-list
101298345|NCT02004769|Capecitabine|capecitabine|mesh-list
101298346|NCT02004769|Trastuzumab|trastuzumab|mesh-list
101298347|NCT02004769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101298348|NCT02004769|Tubulin Modulators|tubulin modulators|mesh-ancestor
101298349|NCT02004769|Antimitotic Agents|antimitotic agents|mesh-ancestor
101298350|NCT02004769|Mitosis Modulators|mitosis modulators|mesh-ancestor
101298351|NCT02004769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298352|NCT02004769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101298353|NCT02004769|Antimetabolites|antimetabolites|mesh-ancestor
101821931|NCT03999372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821932|NCT03999372|Viscosupplements|viscosupplements|mesh-ancestor
101821933|NCT03999372|Protective Agents|protective agents|mesh-ancestor
101821934|NCT05733468|Calcium, Dietary|calcium, dietary|mesh-list
101821936|NCT05733468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101821937|NCT05733468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821938|NCT05733468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101821939|NCT00830843|Propofol|propofol|mesh-list
101821940|NCT00830843|Isoflurane|isoflurane|mesh-list
101821941|NCT00830843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101821942|NCT00830843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101821943|NCT00830843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821944|NCT00830843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101821945|NCT00830843|Anesthetics, General|anesthetics, general|mesh-ancestor
101298354|NCT02004769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101298355|NCT02004860|Ciclopirox|ciclopirox|mesh-list
101298356|NCT02004860|Tacrolimus|tacrolimus|mesh-list
101298357|NCT02004860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101298358|NCT02004860|Immunologic Factors|immunologic factors|mesh-ancestor
101298359|NCT02004860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298360|NCT02004860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101298361|NCT02004860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101298362|NCT02004860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298363|NCT02004860|Antifungal Agents|antifungal agents|mesh-ancestor
101298364|NCT02004860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101298365|NCT02004899|Fentanyl|fentanyl|mesh-list
101298366|NCT02004899|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101298367|NCT02004899|Narcotics|narcotics|mesh-ancestor
101298368|NCT02004899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101298369|NCT02004899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298370|NCT02004899|Analgesics|analgesics|mesh-ancestor
101298371|NCT02004899|Sensory System Agents|sensory system agents|mesh-ancestor
101298372|NCT02004899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101298373|NCT02004899|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101298374|NCT02004899|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101298375|NCT02004899|Anesthetics, General|anesthetics, general|mesh-ancestor
101298376|NCT02004899|Anesthetics|anesthetics|mesh-ancestor
101298377|NCT02005068|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
101298378|NCT02005068|Cephalosporins|cephalosporins|mesh-list
101298379|NCT02005068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101298380|NCT02005068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101298381|NCT02005107|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101298382|NCT02005107|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101298383|NCT02005107|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101298384|NCT02005107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101298385|NCT02005107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298386|NCT02005107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101298387|NCT02005107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298388|NCT02005107|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101298389|NCT02005107|Antidepressive Agents|antidepressive agents|mesh-ancestor
101298390|NCT02005107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101298391|NCT02005120|Bevacizumab|bevacizumab|mesh-list
101298392|NCT02005120|Endostatins|endostatins|mesh-list
101298393|NCT02005120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101298394|NCT02005120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101298395|NCT02005120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101298396|NCT02005120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101298397|NCT02005120|Growth Substances|growth substances|mesh-ancestor
101298398|NCT02005120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298399|NCT02005120|Growth Inhibitors|growth inhibitors|mesh-ancestor
101298400|NCT02005302|Vitamin D|vitamin d|mesh-list
101821946|NCT00830843|Anesthetics|anesthetics|mesh-ancestor
101821947|NCT00830843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101821948|NCT00826787|Levetiracetam|levetiracetam|mesh-list
101821949|NCT00826787|Anticonvulsants|anticonvulsants|mesh-ancestor
101821950|NCT00826787|Nootropic Agents|nootropic agents|mesh-ancestor
101821951|NCT00823121|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101821952|NCT00823121|Buserelin|buserelin|mesh-list
101821953|NCT00823121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101821954|NCT00823121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821955|NCT00823121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101821956|NCT00823121|Fertility Agents|fertility agents|mesh-ancestor
101821957|NCT03687372|Hydrogen Peroxide|hydrogen peroxide|mesh-list
101821958|NCT03687372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101821959|NCT03687372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101821960|NCT00626405|Paclitaxel|paclitaxel|mesh-list
101821961|NCT00626405|Bevacizumab|bevacizumab|mesh-list
101821962|NCT00626405|Carboplatin|carboplatin|mesh-list
101821963|NCT00626405|Temozolomide|temozolomide|mesh-list
101821964|NCT00626405|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101821965|NCT00626405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101821966|NCT00626405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821967|NCT00626405|Tubulin Modulators|tubulin modulators|mesh-ancestor
101821968|NCT00626405|Antimitotic Agents|antimitotic agents|mesh-ancestor
101821969|NCT00626405|Mitosis Modulators|mitosis modulators|mesh-ancestor
101821970|NCT00626405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821971|NCT00626405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101821972|NCT00626405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101821973|NCT00626405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101821974|NCT00626405|Growth Substances|growth substances|mesh-ancestor
101821975|NCT00626405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821976|NCT00626405|Growth Inhibitors|growth inhibitors|mesh-ancestor
101298401|NCT02005302|Ergocalciferols|ergocalciferols|mesh-list
101298402|NCT02005302|Cholecalciferol|cholecalciferol|mesh-list
101298403|NCT02005302|Vitamins|vitamins|mesh-list
101298404|NCT02005302|Micronutrients|micronutrients|mesh-ancestor
101298405|NCT02005302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298406|NCT02005302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101298407|NCT02005302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101298408|NCT02005315|Paclitaxel|paclitaxel|mesh-list
101298409|NCT02005315|Gemcitabine|gemcitabine|mesh-list
101298410|NCT02005315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101298411|NCT02005315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101298412|NCT02005315|Tubulin Modulators|tubulin modulators|mesh-ancestor
101298413|NCT02005315|Antimitotic Agents|antimitotic agents|mesh-ancestor
101298414|NCT02005315|Mitosis Modulators|mitosis modulators|mesh-ancestor
101298415|NCT02005315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298416|NCT02005315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101821977|NCT00626405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101821978|NCT00626405|Alkylating Agents|alkylating agents|mesh-ancestor
101821979|NCT00826865|Levetiracetam|levetiracetam|mesh-list
101821980|NCT00826865|Anticonvulsants|anticonvulsants|mesh-ancestor
101821981|NCT00826865|Nootropic Agents|nootropic agents|mesh-ancestor
101821982|NCT00358150|Eliglustat|eliglustat|mesh-list
101821983|NCT00358150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101821984|NCT00358150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101821985|NCT05427630|Dronabinol|dronabinol|mesh-list
101821986|NCT05427630|Hallucinogens|hallucinogens|mesh-ancestor
101821987|NCT05427630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101821988|NCT05427630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101821989|NCT05427630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101821990|NCT05427630|Analgesics|analgesics|mesh-ancestor
101821991|NCT05427630|Sensory System Agents|sensory system agents|mesh-ancestor
101298417|NCT02005315|Antimetabolites|antimetabolites|mesh-ancestor
101298418|NCT02005419|Metformin|metformin|mesh-list
101298419|NCT02005419|Gemcitabine|gemcitabine|mesh-list
101298420|NCT02005419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101298421|NCT02005419|Antimetabolites|antimetabolites|mesh-ancestor
101298422|NCT02005419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298424|NCT02005419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101298425|NCT02005419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298427|NCT02005523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101298428|NCT02005523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101298429|NCT02005523|Analgesics|analgesics|mesh-ancestor
101298430|NCT02005523|Sensory System Agents|sensory system agents|mesh-ancestor
101298431|NCT02005523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101298432|NCT02005523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298433|NCT02005523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101298434|NCT02005523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101298435|NCT02005523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101298436|NCT02005575|Dexamethasone|dexamethasone|mesh-list
101298437|NCT02005575|Bupivacaine|bupivacaine|mesh-list
101298438|NCT02005575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101298439|NCT02005575|Antiemetics|antiemetics|mesh-ancestor
101298440|NCT02005575|Autonomic Agents|autonomic agents|mesh-ancestor
101298441|NCT02005575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101298442|NCT02005575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298443|NCT02005575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101298444|NCT02005575|Glucocorticoids|glucocorticoids|mesh-ancestor
101298445|NCT02005575|Hormones|hormones|mesh-ancestor
101298446|NCT02005575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101298447|NCT02005575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101298448|NCT02005575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101298449|NCT02005575|Anesthetics, Local|anesthetics, local|mesh-ancestor
101298450|NCT02005575|Anesthetics|anesthetics|mesh-ancestor
101298451|NCT02005575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101298452|NCT02005575|Sensory System Agents|sensory system agents|mesh-ancestor
101298453|NCT02005588|Iron|iron|mesh-list
101298454|NCT02005588|Ferrous fumarate|ferrous fumarate|mesh-list
101298455|NCT02005588|Iron Chelating Agents|iron chelating agents|mesh-list
101298456|NCT02005588|Trace Elements|trace elements|mesh-ancestor
101298457|NCT02005588|Micronutrients|micronutrients|mesh-ancestor
101298458|NCT02005588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298459|NCT02005588|Chelating Agents|chelating agents|mesh-ancestor
101298460|NCT02005588|Sequestering Agents|sequestering agents|mesh-ancestor
101298461|NCT02005588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298462|NCT02005653|Doxycycline|doxycycline|mesh-list
101298463|NCT02005653|Albendazole|albendazole|mesh-list
101298464|NCT02005653|Diethylcarbamazine|diethylcarbamazine|mesh-list
101821992|NCT05427630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101821993|NCT05427630|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101821994|NCT05427630|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101821995|NCT05427630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101821996|NCT05427630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298465|NCT02005653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101298466|NCT02005653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101298467|NCT02005653|Antimalarials|antimalarials|mesh-ancestor
101298468|NCT02005653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101298469|NCT02005653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101298470|NCT02005653|Anthelmintics|anthelmintics|mesh-ancestor
101298471|NCT02005653|Anticestodal Agents|anticestodal agents|mesh-ancestor
101298472|NCT02005653|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101298473|NCT02005653|Tubulin Modulators|tubulin modulators|mesh-ancestor
101298474|NCT02005653|Antimitotic Agents|antimitotic agents|mesh-ancestor
101298475|NCT02005653|Mitosis Modulators|mitosis modulators|mesh-ancestor
101298476|NCT02005653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298477|NCT02005653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101298478|NCT02005653|Filaricides|filaricides|mesh-ancestor
101298479|NCT02005653|Antinematodal Agents|antinematodal agents|mesh-ancestor
101298480|NCT02005653|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101298481|NCT02005653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101298482|NCT02005718|Cholecalciferol|cholecalciferol|mesh-list
101298483|NCT02005718|Vitamin D|vitamin d|mesh-list
101298484|NCT02005718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101298485|NCT02005718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298487|NCT02005718|Micronutrients|micronutrients|mesh-ancestor
101298488|NCT02005718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101298489|NCT02005757|Mizoribine|mizoribine|mesh-list
101298490|NCT02005757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101298491|NCT02005757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101298492|NCT02005757|Analgesics|analgesics|mesh-ancestor
101298493|NCT02005757|Sensory System Agents|sensory system agents|mesh-ancestor
101298494|NCT02005757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101298495|NCT02005757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298496|NCT02005757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101298497|NCT02005757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101298498|NCT02005757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101298499|NCT02005757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101298500|NCT02005757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101298501|NCT02005757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101298502|NCT02005757|Antimalarials|antimalarials|mesh-ancestor
101298503|NCT02005757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101298504|NCT02005757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101298505|NCT02005757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101298506|NCT02005757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298507|NCT02005757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101298508|NCT02005757|Immunologic Factors|immunologic factors|mesh-ancestor
101298509|NCT02005770|Propofol|propofol|mesh-list
101298510|NCT02005770|Sevoflurane|sevoflurane|mesh-list
101298511|NCT02005770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101298512|NCT02005770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101298513|NCT02005770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298514|NCT02005770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101298515|NCT02005770|Anesthetics, General|anesthetics, general|mesh-ancestor
101298516|NCT02005770|Anesthetics|anesthetics|mesh-ancestor
101298517|NCT02005770|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101298518|NCT02005770|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101298519|NCT02005783|Cyclophosphamide|cyclophosphamide|mesh-list
101298520|NCT02005783|Docetaxel|docetaxel|mesh-list
101298521|NCT02005783|Epirubicin|epirubicin|mesh-list
101298522|NCT02005783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101298523|NCT02005783|Immunologic Factors|immunologic factors|mesh-ancestor
101298524|NCT02005783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298525|NCT02005783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101298526|NCT02005783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101298527|NCT02005783|Alkylating Agents|alkylating agents|mesh-ancestor
101298528|NCT02005783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535280|NCT00586287|Phenprocoumon|phenprocoumon|mesh-list
101298529|NCT02005783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101821997|NCT05427630|Hormones|hormones|mesh-ancestor
101821998|NCT05427630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101821999|NCT01050556|Folic Acid|folic acid|mesh-list
101822000|NCT01050556|Vitamin B Complex|vitamin b complex|mesh-list
101822001|NCT01050556|Hematinics|hematinics|mesh-ancestor
101822002|NCT01050556|Vitamins|vitamins|mesh-ancestor
101822003|NCT01050556|Micronutrients|micronutrients|mesh-ancestor
101298530|NCT02005783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101298531|NCT02005783|Tubulin Modulators|tubulin modulators|mesh-ancestor
101298532|NCT02005783|Antimitotic Agents|antimitotic agents|mesh-ancestor
101298533|NCT02005783|Mitosis Modulators|mitosis modulators|mesh-ancestor
101298534|NCT02005783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101298535|NCT02005783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101298536|NCT02005783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101298537|NCT02005783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101298538|NCT02005822|Valganciclovir|valganciclovir|mesh-list
101298539|NCT02005822|Antiviral Agents|antiviral agents|mesh-ancestor
101298540|NCT02005822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101298541|NCT02005848|Protease Inhibitors|protease inhibitors|mesh-list
101298542|NCT02005848|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
101298543|NCT02005848|Protein C Inhibitor|protein c inhibitor|mesh-list
101298544|NCT02005848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101298545|NCT02005848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298546|NCT02005848|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101298547|NCT02005848|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101298548|NCT02006043|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101298549|NCT02006043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101298550|NCT02006043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101298552|NCT02006043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298553|NCT02006173|Lidocaine|lidocaine|mesh-list
101298554|NCT02006173|Anesthetics, Local|anesthetics, local|mesh-ancestor
101298555|NCT02006173|Anesthetics|anesthetics|mesh-ancestor
101298556|NCT02006173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101298557|NCT02006173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298558|NCT02006173|Sensory System Agents|sensory system agents|mesh-ancestor
101298559|NCT02006173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101298560|NCT02006173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101298561|NCT02006173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101298562|NCT02006173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101298563|NCT02006173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101298564|NCT02006173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298565|NCT02006225|Plerixafor|plerixafor|mesh-list
101298566|NCT02006225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101298567|NCT02006225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101298568|NCT02006225|Antiviral Agents|antiviral agents|mesh-ancestor
101298569|NCT02006225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101298570|NCT02006277|Crizotinib|crizotinib|mesh-list
101298571|NCT02006277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101298572|NCT02006277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101298573|NCT02006277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101298574|NCT02006277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101298575|NCT02006277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298576|NCT02006355|Ropivacaine|ropivacaine|mesh-list
101298577|NCT02006355|Anesthetics, Local|anesthetics, local|mesh-ancestor
101298578|NCT02006355|Anesthetics|anesthetics|mesh-ancestor
101298579|NCT02006355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101298580|NCT02006355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298581|NCT02006355|Sensory System Agents|sensory system agents|mesh-ancestor
101298582|NCT02006355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101298583|NCT02006485|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101298584|NCT02006485|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101298585|NCT02006485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101298586|NCT02006485|Alkylating Agents|alkylating agents|mesh-ancestor
101298587|NCT02006485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298588|NCT02006485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101298589|NCT02006485|Immunologic Factors|immunologic factors|mesh-ancestor
101298590|NCT02006485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822006|NCT05889871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101822007|NCT05889871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101822008|NCT05889871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101822009|NCT05889871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298591|NCT05970900|Imatinib Mesylate|imatinib mesylate|mesh-list
101298592|NCT05970900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101298593|NCT05970900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101298594|NCT05970900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101298595|NCT05970900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298596|NCT05970887|Vaccines|vaccines|mesh-list
101298597|NCT05970887|Immunologic Factors|immunologic factors|mesh-ancestor
101298600|NCT05970822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101298601|NCT05970822|Antimetabolites|antimetabolites|mesh-ancestor
101298602|NCT05970822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298603|NCT05970822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101298604|NCT05970822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101298605|NCT05970731|Beclomethasone|beclomethasone|mesh-list
101298606|NCT05970731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101298607|NCT05970731|Glucocorticoids|glucocorticoids|mesh-ancestor
101298608|NCT05970731|Hormones|hormones|mesh-ancestor
101298609|NCT05970731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101298610|NCT05970731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298611|NCT05970731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101298612|NCT05970731|Respiratory System Agents|respiratory system agents|mesh-ancestor
101298613|NCT05970705|Trifluridine|trifluridine|mesh-list
101298614|NCT05970705|Antimetabolites|antimetabolites|mesh-ancestor
101298615|NCT05970705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298616|NCT05970705|Antiviral Agents|antiviral agents|mesh-ancestor
101298617|NCT05970705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101298618|NCT05970679|Atorvastatin|atorvastatin|mesh-list
101298619|NCT05970679|Ezetimibe|ezetimibe|mesh-list
101298620|NCT05970679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101298621|NCT05970679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101298622|NCT05970679|Antimetabolites|antimetabolites|mesh-ancestor
101298623|NCT05970679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298624|NCT05970679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101298625|NCT05970679|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101298626|NCT05970679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101298628|NCT05970666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101298629|NCT05970666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101298630|NCT05970666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101298631|NCT05970666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101298632|NCT05970666|Growth Substances|growth substances|mesh-ancestor
101298633|NCT05970666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298634|NCT05970666|Growth Inhibitors|growth inhibitors|mesh-ancestor
101298635|NCT05970627|Oxaliplatin|oxaliplatin|mesh-list
101298636|NCT05970627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101298637|NCT05970536|Acetic Acid|acetic acid|mesh-list
101298638|NCT05970536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101298639|NCT05970536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101298640|NCT05970354|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
101298641|NCT05970354|Anesthetics, Local|anesthetics, local|mesh-ancestor
101298642|NCT05970354|Anesthetics|anesthetics|mesh-ancestor
101298643|NCT05970354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101298644|NCT05970354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298645|NCT05970354|Sensory System Agents|sensory system agents|mesh-ancestor
101298646|NCT05970354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101298647|NCT05970354|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
101298648|NCT05970302|Bevacizumab|bevacizumab|mesh-list
101298649|NCT05970302|Tislelizumab|tislelizumab|mesh-list
101298650|NCT05970302|Capecitabine|capecitabine|mesh-list
101298651|NCT05970302|Oxaliplatin|oxaliplatin|mesh-list
101298652|NCT05970302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101298653|NCT05970302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101298654|NCT05970302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101298655|NCT05970302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101298656|NCT05970302|Growth Substances|growth substances|mesh-ancestor
101298657|NCT05970302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298658|NCT05970302|Growth Inhibitors|growth inhibitors|mesh-ancestor
101298659|NCT05970302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101298660|NCT05970302|Antimetabolites|antimetabolites|mesh-ancestor
101298661|NCT05970302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298662|NCT05970289|Interferons|interferons|mesh-list
101298663|NCT05970289|Interferon-alpha|interferon-alpha|mesh-list
101298664|NCT05970289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101298665|NCT05970289|Antiviral Agents|antiviral agents|mesh-ancestor
101298666|NCT05970289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101298667|NCT05970289|Immunologic Factors|immunologic factors|mesh-ancestor
101298668|NCT05970289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298670|NCT05970263|Glycopyrrolate|glycopyrrolate|mesh-list
101298671|NCT05970263|Formoterol Fumarate|formoterol fumarate|mesh-list
101298672|NCT05970263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101298673|NCT05970263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101298674|NCT05970263|Autonomic Agents|autonomic agents|mesh-ancestor
101298675|NCT05970263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101298676|NCT05970263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298677|NCT05970263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101298678|NCT05970263|Respiratory System Agents|respiratory system agents|mesh-ancestor
101298679|NCT05970263|Glucocorticoids|glucocorticoids|mesh-ancestor
101298680|NCT05970263|Hormones|hormones|mesh-ancestor
101298681|NCT05970263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101298682|NCT05970263|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101298683|NCT05970263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101298684|NCT05970263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101298685|NCT05970263|Adrenergic Agents|adrenergic agents|mesh-ancestor
101298686|NCT05970263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101298687|NCT05970263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298688|NCT05970263|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101298689|NCT05970263|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101298690|NCT05970263|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101298691|NCT05970263|Cholinergic Agents|cholinergic agents|mesh-ancestor
101298692|NCT05970250|Vitamin D|vitamin d|mesh-list
101298694|NCT05970250|Vitamins|vitamins|mesh-ancestor
101298695|NCT05970250|Micronutrients|micronutrients|mesh-ancestor
101298696|NCT05970250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298697|NCT05970250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101298698|NCT05970250|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101298699|NCT05969990|Tryptophan|tryptophan|mesh-list
101298700|NCT05969990|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101298701|NCT05969990|Antidepressive Agents|antidepressive agents|mesh-ancestor
101298702|NCT05969990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101298703|NCT05969899|Bevacizumab|bevacizumab|mesh-list
101298704|NCT05969899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101298705|NCT05969899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101298706|NCT05969899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101298707|NCT05969899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101298708|NCT05969899|Growth Substances|growth substances|mesh-ancestor
101298709|NCT05969899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298710|NCT05969899|Growth Inhibitors|growth inhibitors|mesh-ancestor
101298711|NCT05969847|Capecitabine|capecitabine|mesh-list
101298712|NCT05969847|Oxaliplatin|oxaliplatin|mesh-list
101298713|NCT05969847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101298714|NCT05969847|Antimetabolites|antimetabolites|mesh-ancestor
101298721|NCT05969834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101298722|NCT05969834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298723|NCT05969834|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101298724|NCT05969834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101298725|NCT05969834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101298726|NCT05969795|Progesterone|progesterone|mesh-list
101298727|NCT05969795|Progestins|progestins|mesh-ancestor
101298728|NCT05969795|Hormones|hormones|mesh-ancestor
101298729|NCT05969795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101298730|NCT05969795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298731|NCT05969743|Letermovir|letermovir|mesh-list
101298732|NCT05969743|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101298733|NCT05969743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101298734|NCT05969743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298735|NCT05969743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101298736|NCT05969743|Antiviral Agents|antiviral agents|mesh-ancestor
101298737|NCT05969743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101298738|NCT05969561|Analgesics|analgesics|mesh-list
101298739|NCT05969561|Sensory System Agents|sensory system agents|mesh-ancestor
101298740|NCT05969561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101298741|NCT05969561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298742|NCT05969522|Cyclophosphamide|cyclophosphamide|mesh-list
101298743|NCT05969522|Glucocorticoids|glucocorticoids|mesh-list
101298744|NCT05969522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101298745|NCT05969522|Immunologic Factors|immunologic factors|mesh-ancestor
101298746|NCT05969522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298747|NCT05969522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101298748|NCT05969522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101298749|NCT05969522|Alkylating Agents|alkylating agents|mesh-ancestor
101298750|NCT05969522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298751|NCT05969522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101298752|NCT05969522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101298753|NCT05969522|Hormones|hormones|mesh-ancestor
101298754|NCT05969522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101298755|NCT05969496|Pembrolizumab|pembrolizumab|mesh-list
101298756|NCT05969496|Axitinib|axitinib|mesh-list
101298757|NCT05969496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101298758|NCT05969496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101298759|NCT05969496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101298760|NCT05969496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298761|NCT05969496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101298762|NCT05969496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101298763|NCT05969457|Ropivacaine|ropivacaine|mesh-list
101298764|NCT05969457|Anesthetics, Local|anesthetics, local|mesh-ancestor
101298765|NCT05969457|Anesthetics|anesthetics|mesh-ancestor
101822028|NCT05889455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101822029|NCT05889455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101822030|NCT05889455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822031|NCT05889455|Urological Agents|urological agents|mesh-ancestor
101822032|NCT05889442|Cromakalim|cromakalim|mesh-list
101822033|NCT05889442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101822034|NCT05889442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101298766|NCT05969457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101298767|NCT05969457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298768|NCT05969457|Sensory System Agents|sensory system agents|mesh-ancestor
101298769|NCT05969457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101298770|NCT05969392|Ethanol|ethanol|mesh-list
101298771|NCT05969392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101298772|NCT05969392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101298773|NCT05969392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101298774|NCT05969392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298775|NCT05969236|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101298776|NCT05969236|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101298777|NCT05969184|Trastuzumab|trastuzumab|mesh-list
101298778|NCT05969184|Pertuzumab|pertuzumab|mesh-list
101298779|NCT05969184|Letrozole|letrozole|mesh-list
101298780|NCT05969184|Exemestane|exemestane|mesh-list
101298781|NCT05969184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101298782|NCT05969184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101298783|NCT05969184|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101298784|NCT05969184|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101298785|NCT05969184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101298786|NCT05969184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298787|NCT05969184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101298788|NCT05969184|Hormone Antagonists|hormone antagonists|mesh-ancestor
101298789|NCT05969184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101298790|NCT05969184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298791|NCT05969171|Gemcitabine|gemcitabine|mesh-list
101298792|NCT05969171|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101298793|NCT05969171|Paclitaxel|paclitaxel|mesh-list
101298794|NCT05969171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101298795|NCT05969171|Antimetabolites|antimetabolites|mesh-ancestor
101298796|NCT05969171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535302|NCT00574730|Rituximab|rituximab|mesh-list
101298797|NCT05969171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101298798|NCT05969171|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101298799|NCT05969171|Tubulin Modulators|tubulin modulators|mesh-ancestor
101298800|NCT05969171|Antimitotic Agents|antimitotic agents|mesh-ancestor
101298801|NCT05969171|Mitosis Modulators|mitosis modulators|mesh-ancestor
101298802|NCT05969119|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
101298803|NCT05969119|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101298804|NCT05969119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101298805|NCT05969119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298806|NCT05969119|Cholinergic Agents|cholinergic agents|mesh-ancestor
101298807|NCT05969119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101298808|NCT05969119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298809|NCT05968937|Baclofen|baclofen|mesh-list
101298810|NCT05968937|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101298811|NCT05968937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298812|NCT05968937|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101298813|NCT05968937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101298814|NCT05968937|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101298815|NCT05968937|GABA Agonists|gaba agonists|mesh-ancestor
101298816|NCT05968937|GABA Agents|gaba agents|mesh-ancestor
101298817|NCT05968937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101298818|NCT05968937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298819|NCT05968885|Solifenacin Succinate|solifenacin succinate|mesh-list
101298821|NCT05968885|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101298822|NCT05968885|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101298823|NCT05968885|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101298824|NCT05968885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101298825|NCT05968885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298826|NCT05968885|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101822036|NCT05889442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101822037|NCT05889442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822038|NCT05889442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101822039|NCT05889442|Respiratory System Agents|respiratory system agents|mesh-ancestor
101822040|NCT05889442|Parasympatholytics|parasympatholytics|mesh-ancestor
101822041|NCT05889442|Vasodilator Agents|vasodilator agents|mesh-ancestor
101822042|NCT05889390|Paclitaxel|paclitaxel|mesh-list
101822043|NCT05889390|Cyclophosphamide|cyclophosphamide|mesh-list
101822044|NCT05889390|Carboplatin|carboplatin|mesh-list
101822045|NCT05889390|Doxorubicin|doxorubicin|mesh-list
101822046|NCT05889390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101822047|NCT05889390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101822048|NCT05889390|Tubulin Modulators|tubulin modulators|mesh-ancestor
101822049|NCT05889390|Antimitotic Agents|antimitotic agents|mesh-ancestor
101822050|NCT05889390|Mitosis Modulators|mitosis modulators|mesh-ancestor
101298827|NCT05968885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101298828|NCT05968885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298829|NCT05968885|Cholinergic Agents|cholinergic agents|mesh-ancestor
101298830|NCT05968885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101298831|NCT05968885|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101317324|NCT00010075|Fluorouracil|fluorouracil|mesh-list
101298832|NCT05968885|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101298833|NCT05968885|Urological Agents|urological agents|mesh-ancestor
101298834|NCT05968885|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101298835|NCT05968885|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101298836|NCT05968885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101298837|NCT05968885|Adrenergic Agents|adrenergic agents|mesh-ancestor
101298839|NCT05968846|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101298840|NCT05968846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101298841|NCT05968846|Trace Elements|trace elements|mesh-ancestor
101298842|NCT05968846|Micronutrients|micronutrients|mesh-ancestor
101298843|NCT05968846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298844|NCT05968651|Oxytocin|oxytocin|mesh-list
101298845|NCT05968651|Oxytocics|oxytocics|mesh-ancestor
101298846|NCT05968651|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101298847|NCT05968651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298848|NCT05968612|Ivacaftor|ivacaftor|mesh-list
101298849|NCT05968612|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101298850|NCT05968612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101298851|NCT05968612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298852|NCT05968599|Abiraterone Acetate|abiraterone acetate|mesh-list
101298853|NCT05968599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101298854|NCT05968599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101298855|NCT05968599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101298856|NCT05968599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298857|NCT05968599|Hormone Antagonists|hormone antagonists|mesh-ancestor
101298858|NCT05968599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101298859|NCT05968599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298860|NCT05968599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101298861|NCT05968482|Diclofenac|diclofenac|mesh-list
101298862|NCT05968482|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101298863|NCT05968482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101298864|NCT05968482|Analgesics|analgesics|mesh-ancestor
101298865|NCT05968482|Sensory System Agents|sensory system agents|mesh-ancestor
101298866|NCT05968482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101298867|NCT05968482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298868|NCT05968482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101298869|NCT05968482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101822051|NCT05889390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822052|NCT05889390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101822053|NCT05889390|Immunologic Factors|immunologic factors|mesh-ancestor
101822054|NCT05889390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822055|NCT05889390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101822056|NCT05889390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101822057|NCT05889390|Alkylating Agents|alkylating agents|mesh-ancestor
101822058|NCT05889390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101298870|NCT05968482|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101298871|NCT05968482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101298872|NCT05968482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298873|NCT05968326|Atezolizumab|atezolizumab|mesh-list
101298874|NCT05968326|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101298875|NCT05968326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298876|NCT05968326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101298877|NCT05968326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101298878|NCT05968001|Obinutuzumab|obinutuzumab|mesh-list
101298879|NCT05968001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101298880|NCT05968001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101298882|NCT05967936|Anesthetics, Local|anesthetics, local|mesh-ancestor
101298884|NCT05967936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101298885|NCT05967936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298886|NCT05967936|Sensory System Agents|sensory system agents|mesh-ancestor
101298887|NCT05967936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101298888|NCT05967884|Cemiplimab|cemiplimab|mesh-list
101298889|NCT05967884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101298890|NCT05967884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101298891|NCT05967741|Erythritol|erythritol|mesh-list
101298892|NCT05967741|Vasodilator Agents|vasodilator agents|mesh-ancestor
101298893|NCT05967650|Vaccines|vaccines|mesh-list
101298894|NCT05967650|Immunologic Factors|immunologic factors|mesh-ancestor
101298895|NCT05967650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298896|NCT05967442|Magnesium Sulfate|magnesium sulfate|mesh-list
101298897|NCT05967442|Metoclopramide|metoclopramide|mesh-list
101298898|NCT05967442|Prochlorperazine|prochlorperazine|mesh-list
101298899|NCT05967442|Analgesics|analgesics|mesh-ancestor
101317330|NCT00010075|Antimetabolites|antimetabolites|mesh-ancestor
101298900|NCT05967442|Sensory System Agents|sensory system agents|mesh-ancestor
101298901|NCT05967442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101298902|NCT05967442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298903|NCT05967442|Anesthetics|anesthetics|mesh-ancestor
101298904|NCT05967442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101298905|NCT05967442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101298906|NCT05967442|Anticonvulsants|anticonvulsants|mesh-ancestor
101298907|NCT05967442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101298908|NCT05967442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101298909|NCT05967442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298910|NCT05967442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101298911|NCT05967442|Tocolytic Agents|tocolytic agents|mesh-ancestor
101298912|NCT05967442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101298913|NCT05967442|Antiemetics|antiemetics|mesh-ancestor
101298914|NCT05967442|Autonomic Agents|autonomic agents|mesh-ancestor
101298915|NCT05967442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101298916|NCT05967442|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101298917|NCT05967442|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101298918|NCT05967442|Dopamine Agents|dopamine agents|mesh-ancestor
101298919|NCT05967442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101298920|NCT05967442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101298921|NCT05967442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101298922|NCT05967442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101298923|NCT05967403|Propofol|propofol|mesh-list
101298924|NCT05967403|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101298925|NCT05967403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101822059|NCT05889390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101822060|NCT05889390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101822061|NCT05889390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101822062|NCT05889390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101822064|NCT05889338|Methotrexate|methotrexate|mesh-list
101822065|NCT05889338|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101822066|NCT05889338|Abortifacient Agents|abortifacient agents|mesh-ancestor
101822067|NCT05889338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101822068|NCT05889338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822069|NCT05889338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101822070|NCT05889338|Antimetabolites|antimetabolites|mesh-ancestor
101246519|NCT01666522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298926|NCT05967403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298927|NCT05967403|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101298928|NCT05967403|Anesthetics, General|anesthetics, general|mesh-ancestor
101298929|NCT05967403|Anesthetics|anesthetics|mesh-ancestor
101298930|NCT05967377|Leucovorin|leucovorin|mesh-list
101298931|NCT05967377|Sorafenib|sorafenib|mesh-list
101298932|NCT05967377|Fluorouracil|fluorouracil|mesh-list
101298933|NCT05967377|Methotrexate|methotrexate|mesh-list
101298934|NCT05967377|Carboplatin|carboplatin|mesh-list
101298935|NCT05967377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101298936|NCT05967377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101298937|NCT05967377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101298938|NCT05967377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298939|NCT05967377|Antidotes|antidotes|mesh-ancestor
101298940|NCT05967377|Protective Agents|protective agents|mesh-ancestor
101298941|NCT05967377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298942|NCT05967377|Vitamin B Complex|vitamin b complex|mesh-ancestor
101298943|NCT05967377|Vitamins|vitamins|mesh-ancestor
101298944|NCT05967377|Micronutrients|micronutrients|mesh-ancestor
101298945|NCT05967377|Antimetabolites|antimetabolites|mesh-ancestor
101298946|NCT05967377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101298947|NCT05967377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101298948|NCT05967377|Immunologic Factors|immunologic factors|mesh-ancestor
101298949|NCT05967377|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101298950|NCT05967377|Abortifacient Agents|abortifacient agents|mesh-ancestor
101298951|NCT05967377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101298952|NCT05967377|Dermatologic Agents|dermatologic agents|mesh-ancestor
101298953|NCT05967377|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101298954|NCT05967377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101298955|NCT05967377|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101298956|NCT05967182|Gemcitabine|gemcitabine|mesh-list
101298957|NCT05967182|Pembrolizumab|pembrolizumab|mesh-list
101298958|NCT05967182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101298959|NCT05967182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101298960|NCT05967182|Antimetabolites|antimetabolites|mesh-ancestor
101298961|NCT05967182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298962|NCT05967182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101298963|NCT05967182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101298964|NCT05967156|Empagliflozin|empagliflozin|mesh-list
101298965|NCT05967156|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101298966|NCT05967156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298967|NCT05967156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101298968|NCT05967156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298969|NCT05966818|Dapagliflozin|dapagliflozin|mesh-list
101298970|NCT05966818|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101298971|NCT05966818|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101298972|NCT05966818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298973|NCT05966818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101298974|NCT05966818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822071|NCT05889338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822072|NCT05889338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101822073|NCT05889338|Dermatologic Agents|dermatologic agents|mesh-ancestor
101822074|NCT05889338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101822075|NCT05889338|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101822076|NCT05889338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101822077|NCT05889338|Immunologic Factors|immunologic factors|mesh-ancestor
101298975|NCT05966818|Protease Inhibitors|protease inhibitors|mesh-ancestor
101298976|NCT05966818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101298977|NCT05966792|Metformin|metformin|mesh-list
101298978|NCT05966792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
101298979|NCT05966792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101298980|NCT05966792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298981|NCT05966792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298982|NCT05966727|Cholestyramine Resin|cholestyramine resin|mesh-list
101298983|NCT05966727|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101298984|NCT05966727|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101298985|NCT05966727|Antimetabolites|antimetabolites|mesh-ancestor
101298986|NCT05966727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298987|NCT05966727|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101298989|NCT05965908|Liraglutide|liraglutide|mesh-list
101298990|NCT05965908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101298991|NCT05965908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298992|NCT05965908|Incretins|incretins|mesh-ancestor
101298993|NCT05965908|Hormones|hormones|mesh-ancestor
101298994|NCT05965908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101298995|NCT05965895|Dexmedetomidine|dexmedetomidine|mesh-list
101298996|NCT05965895|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101298997|NCT05965895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101298998|NCT05965895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298999|NCT05965895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101299000|NCT05965895|Analgesics|analgesics|mesh-ancestor
101299001|NCT05965895|Sensory System Agents|sensory system agents|mesh-ancestor
101299002|NCT05965895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101299003|NCT05965895|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101299004|NCT05965895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101299005|NCT05965895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101299006|NCT05965895|Adrenergic Agents|adrenergic agents|mesh-ancestor
101299007|NCT05965895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101299008|NCT05965895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299009|NCT05965440|Dapagliflozin|dapagliflozin|mesh-list
101299010|NCT05965440|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101299011|NCT05965440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299012|NCT05965440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101299013|NCT05965440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299014|NCT05959252|Heparin|heparin|mesh-list
101299015|NCT05959252|Calcium heparin|calcium heparin|mesh-list
101299016|NCT05959252|Bivalirudin|bivalirudin|mesh-list
101299017|NCT05959252|Anticoagulants|anticoagulants|mesh-ancestor
101299018|NCT05959252|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101299019|NCT05959252|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101299020|NCT05959252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299021|NCT05959252|Antithrombins|antithrombins|mesh-ancestor
101299022|NCT05959252|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101299023|NCT05959252|Protease Inhibitors|protease inhibitors|mesh-ancestor
101299024|NCT05959252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101299025|NCT05958875|Antipsychotic Agents|antipsychotic agents|mesh-list
101299027|NCT05958875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101299028|NCT05958875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101299029|NCT05958875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299030|NCT05958875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101299031|NCT05958875|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101299032|NCT05958875|Serotonin Agents|serotonin agents|mesh-ancestor
101299033|NCT05958875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101822078|NCT05889338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101822079|NCT05889338|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101822080|NCT05889338|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101479369|NCT02960906|Nivolumab|nivolumab|mesh-list
101822081|NCT05889338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101822082|NCT05889143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101822084|NCT05889143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101822085|NCT05889143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101822086|NCT05889143|Antimetabolites|antimetabolites|mesh-ancestor
101822087|NCT05889143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822088|NCT05889143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101822089|NCT05889143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101822090|NCT05889143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101822091|NCT05889052|Pyrimethamine|pyrimethamine|mesh-list
101299034|NCT05958875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299035|NCT05958875|GABA Antagonists|gaba antagonists|mesh-ancestor
101299036|NCT05958875|GABA Agents|gaba agents|mesh-ancestor
101299037|NCT05951387|Dexmedetomidine|dexmedetomidine|mesh-list
101299038|NCT05951387|Ketamine|ketamine|mesh-list
101299039|NCT05951387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101299040|NCT05951387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101299041|NCT05951387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299042|NCT05951387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101299043|NCT05951387|Analgesics|analgesics|mesh-ancestor
101299044|NCT05951387|Sensory System Agents|sensory system agents|mesh-ancestor
101299045|NCT05951387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101299046|NCT05951387|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101299047|NCT05951387|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101299048|NCT05951387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101299049|NCT05951387|Adrenergic Agents|adrenergic agents|mesh-ancestor
101299050|NCT05951387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101299051|NCT05951387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299052|NCT05951387|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101299053|NCT05951387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101299054|NCT05951387|Anesthetics, General|anesthetics, general|mesh-ancestor
101299055|NCT05951387|Anesthetics|anesthetics|mesh-ancestor
101299056|NCT05951387|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101299060|NCT05944926|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101299061|NCT05944926|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101299062|NCT05944926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101528350|NCT04628676|Sympathomimetics|sympathomimetics|mesh-ancestor
101299063|NCT05944926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299064|NCT05944926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101299065|NCT05944926|Serotonin Agents|serotonin agents|mesh-ancestor
101299066|NCT05944926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299067|NCT05944926|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101299068|NCT05944926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101299069|NCT05944926|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101299070|NCT05944926|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101299071|NCT05944926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101299073|NCT05940220|Anticonvulsants|anticonvulsants|mesh-ancestor
101299074|NCT05940220|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101299075|NCT05940220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101299076|NCT05940220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299077|NCT05940220|Diuretics|diuretics|mesh-ancestor
101299078|NCT05940220|Natriuretic Agents|natriuretic agents|mesh-ancestor
101299079|NCT05940220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822092|NCT05889052|Sulfadoxine|sulfadoxine|mesh-list
101822093|NCT05889052|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101822094|NCT05889052|Antimalarials|antimalarials|mesh-ancestor
101822095|NCT05889052|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101299090|NCT05935631|Folic Acid|folic acid|mesh-list
101299091|NCT05935631|Hematinics|hematinics|mesh-ancestor
101299092|NCT05935631|Vitamin B Complex|vitamin b complex|mesh-ancestor
101299093|NCT05935631|Vitamins|vitamins|mesh-ancestor
101299094|NCT05935631|Micronutrients|micronutrients|mesh-ancestor
101299095|NCT05935631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299096|NCT05934214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101299097|NCT05934214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299098|NCT05934214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101299099|NCT05934214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101299100|NCT05928858|Calcium|calcium|mesh-list
101299101|NCT05928858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101299102|NCT05928858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299109|NCT05926427|Rituximab|rituximab|mesh-list
101299110|NCT05926427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101299111|NCT05926427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101299112|NCT05926427|Immunologic Factors|immunologic factors|mesh-ancestor
101299113|NCT05926427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299114|NCT05926427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101299115|NCT05923476|Lithium Carbonate|lithium carbonate|mesh-list
101299116|NCT05923476|Antidepressive Agents|antidepressive agents|mesh-ancestor
101299117|NCT05923476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101299118|NCT05923476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101299119|NCT05923476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299120|NCT05923476|Antimanic Agents|antimanic agents|mesh-ancestor
101299121|NCT05923476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101299122|NCT05923476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101299123|NCT05923476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299141|NCT05917340|Moxifloxacin|moxifloxacin|mesh-list
101299143|NCT05917340|Isoniazid|isoniazid|mesh-list
101299144|NCT05917340|Pyrazinamide|pyrazinamide|mesh-list
101299145|NCT05917340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101299146|NCT05917340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101299147|NCT05917340|Analgesics|analgesics|mesh-ancestor
101299148|NCT05917340|Sensory System Agents|sensory system agents|mesh-ancestor
101299149|NCT05917340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101299150|NCT05917340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299151|NCT05917340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101299152|NCT05917340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101299153|NCT05917340|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101299154|NCT05917340|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101299155|NCT05917340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299156|NCT05917340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101299157|NCT05917340|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101299158|NCT05917340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101299159|NCT05917340|Antipyretics|antipyretics|mesh-ancestor
101299160|NCT05917340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101299161|NCT05917340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101299162|NCT05917340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101299167|NCT05917340|Leprostatic Agents|leprostatic agents|mesh-ancestor
101299168|NCT05917340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101299169|NCT05917340|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101299170|NCT05917340|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101299171|NCT05917340|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101822100|NCT05889052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822101|NCT05889052|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101822102|NCT05889026|Botulinum Toxins|botulinum toxins|mesh-list
101822103|NCT05889026|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101299172|NCT05917340|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101299173|NCT05917340|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101299174|NCT05917340|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101299175|NCT05917340|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101299176|NCT05917340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101299177|NCT05917340|Antimetabolites|antimetabolites|mesh-ancestor
101299178|NCT05917340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101299179|NCT05911061|Vaccines|vaccines|mesh-list
101299180|NCT05911061|Immunologic Factors|immunologic factors|mesh-ancestor
101299181|NCT05911061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299182|NCT05911048|Vaccines|vaccines|mesh-list
101299183|NCT05911048|Immunologic Factors|immunologic factors|mesh-ancestor
101299184|NCT05911048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299185|NCT05907122|Nivolumab|nivolumab|mesh-list
101299186|NCT05907122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101299187|NCT05907122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101299188|NCT05907122|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101299189|NCT05907122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299193|NCT05896007|Rituximab|rituximab|mesh-list
101299194|NCT05896007|Methotrexate|methotrexate|mesh-list
101299195|NCT05896007|Temozolomide|temozolomide|mesh-list
101299196|NCT05896007|Zanubrutinib|zanubrutinib|mesh-list
101299197|NCT05896007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101299198|NCT05896007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101299199|NCT05896007|Immunologic Factors|immunologic factors|mesh-ancestor
101299200|NCT05896007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299201|NCT05896007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101299202|NCT05896007|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101299203|NCT05896007|Abortifacient Agents|abortifacient agents|mesh-ancestor
101299204|NCT05896007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101299205|NCT05896007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101299206|NCT05896007|Antimetabolites|antimetabolites|mesh-ancestor
101299207|NCT05896007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299208|NCT05896007|Dermatologic Agents|dermatologic agents|mesh-ancestor
101299209|NCT05896007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101299210|NCT05896007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101299211|NCT05896007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101299212|NCT05896007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101299213|NCT05896007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101299214|NCT05896007|Alkylating Agents|alkylating agents|mesh-ancestor
101299215|NCT05896007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101299222|NCT05882214|Nicotinic Acids|nicotinic acids|mesh-list
101299223|NCT05882214|Vitamin B Complex|vitamin b complex|mesh-ancestor
101299224|NCT05882214|Vitamins|vitamins|mesh-ancestor
101299225|NCT05882214|Micronutrients|micronutrients|mesh-ancestor
101299226|NCT05882214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299239|NCT05871684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101299241|NCT05862545|Budesonide|budesonide|mesh-list
101299242|NCT05862545|Glycopyrrolate|glycopyrrolate|mesh-list
101299243|NCT05862545|Formoterol Fumarate|formoterol fumarate|mesh-list
101299244|NCT05862545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101299245|NCT05862545|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101299246|NCT05862545|Autonomic Agents|autonomic agents|mesh-ancestor
101299247|NCT05862545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101822104|NCT05889026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101822105|NCT05889026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822106|NCT05889026|Cholinergic Agents|cholinergic agents|mesh-ancestor
101822107|NCT05889026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101822108|NCT05889026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822124|NCT05888922|Minoxidil|minoxidil|mesh-list
101822125|NCT05888922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101822126|NCT05888922|Vasodilator Agents|vasodilator agents|mesh-ancestor
101822127|NCT05888597|Menthol|menthol|mesh-list
101822128|NCT05888597|Antipruritics|antipruritics|mesh-ancestor
101822129|NCT05888597|Dermatologic Agents|dermatologic agents|mesh-ancestor
101822130|NCT05887947|Nicotine|nicotine|mesh-list
101822131|NCT05887947|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101822132|NCT05887947|Autonomic Agents|autonomic agents|mesh-ancestor
101822133|NCT05887947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101822134|NCT05887947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299248|NCT05862545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299249|NCT05862545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101299250|NCT05862545|Respiratory System Agents|respiratory system agents|mesh-ancestor
101299251|NCT05862545|Glucocorticoids|glucocorticoids|mesh-ancestor
101299252|NCT05862545|Hormones|hormones|mesh-ancestor
101299253|NCT05862545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101299254|NCT05862545|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101299255|NCT05862545|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101299256|NCT05862545|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101299257|NCT05862545|Adrenergic Agents|adrenergic agents|mesh-ancestor
101299258|NCT05862545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101299259|NCT05862545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299260|NCT05862545|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101299261|NCT05862545|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101299262|NCT05862545|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101299263|NCT05862545|Cholinergic Agents|cholinergic agents|mesh-ancestor
101299295|NCT05845645|Esomeprazole|esomeprazole|mesh-list
101299296|NCT05845645|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101299297|NCT05845645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101299298|NCT05845645|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101299299|NCT05845645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101299300|NCT05845645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299301|NCT05845359|Methadone|methadone|mesh-list
101299302|NCT05845359|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101299303|NCT05845359|Narcotics|narcotics|mesh-ancestor
101299304|NCT05845359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101299305|NCT05845359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299306|NCT05845359|Analgesics|analgesics|mesh-ancestor
101299311|NCT05845138|Capecitabine|capecitabine|mesh-list
101299312|NCT05845138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101299313|NCT05845138|Antimetabolites|antimetabolites|mesh-ancestor
101299314|NCT05845138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299315|NCT05845138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101299316|NCT05844501|Ondansetron|ondansetron|mesh-list
101299317|NCT05844501|Antiemetics|antiemetics|mesh-ancestor
101299318|NCT05844501|Autonomic Agents|autonomic agents|mesh-ancestor
101299319|NCT05844501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101299320|NCT05844501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299321|NCT05844501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101299322|NCT05844501|Antipruritics|antipruritics|mesh-ancestor
101299323|NCT05844501|Dermatologic Agents|dermatologic agents|mesh-ancestor
101299324|NCT05844501|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101299325|NCT05844501|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101299326|NCT05844501|Serotonin Agents|serotonin agents|mesh-ancestor
101299327|NCT05844501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101299328|NCT05844501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299342|NCT05835258|Melatonin|melatonin|mesh-list
101299343|NCT05835258|Capsaicin|capsaicin|mesh-list
101299344|NCT05835258|Antioxidants|antioxidants|mesh-ancestor
101299345|NCT05835258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299346|NCT05835258|Protective Agents|protective agents|mesh-ancestor
101299347|NCT05835258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299348|NCT05835258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101299349|NCT05835258|Antipruritics|antipruritics|mesh-ancestor
101299350|NCT05835258|Dermatologic Agents|dermatologic agents|mesh-ancestor
101299351|NCT05835258|Sensory System Agents|sensory system agents|mesh-ancestor
101299352|NCT05835258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101299354|NCT05834777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101299355|NCT05834777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101299356|NCT05834777|Analgesics|analgesics|mesh-ancestor
101299357|NCT05834777|Sensory System Agents|sensory system agents|mesh-ancestor
101299358|NCT05834777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101299359|NCT05834777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299360|NCT05834777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101299361|NCT05834777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101299362|NCT05834777|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
101299363|NCT05834777|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
101822145|NCT05887908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101822146|NCT05887908|Protease Inhibitors|protease inhibitors|mesh-ancestor
101822147|NCT05887908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101822148|NCT05887908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822149|NCT05887778|Dexamethasone|dexamethasone|mesh-list
101822150|NCT05887778|Dexamethasone acetate|dexamethasone acetate|mesh-list
101822151|NCT05887778|BB 1101|bb 1101|mesh-list
101822152|NCT05887778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101822153|NCT05887778|Antiemetics|antiemetics|mesh-ancestor
101299364|NCT05834777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299365|NCT05834777|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101299366|NCT05834777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101299367|NCT05834777|Immunologic Factors|immunologic factors|mesh-ancestor
101299368|NCT05809700|Hyaluronic Acid|hyaluronic acid|mesh-list
101299369|NCT05809700|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101299370|NCT05809700|Immunologic Factors|immunologic factors|mesh-ancestor
101299371|NCT05809700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299372|NCT05809700|Viscosupplements|viscosupplements|mesh-ancestor
101299373|NCT05809700|Protective Agents|protective agents|mesh-ancestor
101299374|NCT05803421|Insulin Glargine|insulin glargine|mesh-list
101299375|NCT05803421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101299376|NCT05803421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299377|NCT05798793|Cisplatin|cisplatin|mesh-list
101299378|NCT05798793|Docetaxel|docetaxel|mesh-list
101299379|NCT05798793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101299380|NCT05798793|Tubulin Modulators|tubulin modulators|mesh-ancestor
101299381|NCT05798793|Antimitotic Agents|antimitotic agents|mesh-ancestor
101299382|NCT05798793|Mitosis Modulators|mitosis modulators|mesh-ancestor
101299383|NCT05798793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299384|NCT05783544|Interferons|interferons|mesh-list
101299385|NCT05783544|Interferon-gamma|interferon-gamma|mesh-list
101299386|NCT05783544|Interleukin-4|interleukin-4|mesh-list
101299387|NCT05783544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101299388|NCT05783544|Antiviral Agents|antiviral agents|mesh-ancestor
101299389|NCT05783544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101299390|NCT05783544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101299391|NCT05783544|Immunologic Factors|immunologic factors|mesh-ancestor
101299392|NCT05783544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299393|NCT05783544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101299394|NCT05769881|Anesthetics|anesthetics|mesh-list
101299395|NCT05769881|Anesthetics, Local|anesthetics, local|mesh-list
101299396|NCT05769881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101299397|NCT05769881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299398|NCT05769881|Sensory System Agents|sensory system agents|mesh-ancestor
101299399|NCT05769881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101299400|NCT05760677|Metformin|metformin|mesh-list
101299401|NCT05760677|Pioglitazone|pioglitazone|mesh-list
101299402|NCT05760677|Orlistat|orlistat|mesh-list
101299403|NCT05760677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101299404|NCT05760677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299405|NCT05760677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101299406|NCT05760677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299407|NCT05760677|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101299408|NCT05760677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101299409|NCT05757843|Durvalumab|durvalumab|mesh-list
101299410|NCT05757843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101299411|NCT05757843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101299412|NCT05743036|Cetuximab|cetuximab|mesh-list
101299413|NCT05743036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101299414|NCT05743036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101299421|NCT05741502|Risperidone|risperidone|mesh-list
101299422|NCT05741502|Aripiprazole|aripiprazole|mesh-list
101299423|NCT05741502|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101299424|NCT05741502|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101299427|NCT05741502|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
101299428|NCT05741502|Clozapine|clozapine|mesh-list
101299429|NCT05741502|Cariprazine|cariprazine|mesh-list
101299430|NCT05741502|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101299431|NCT05741502|Serotonin Agents|serotonin agents|mesh-ancestor
101299432|NCT05741502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101822155|NCT05887778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101822156|NCT05887778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822158|NCT05887778|Glucocorticoids|glucocorticoids|mesh-ancestor
101822159|NCT05887778|Hormones|hormones|mesh-ancestor
101822160|NCT05887778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101822161|NCT05887778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101822162|NCT05887778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101822163|NCT05887778|Protease Inhibitors|protease inhibitors|mesh-ancestor
101822164|NCT05887778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101299433|NCT05741502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299434|NCT05741502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299435|NCT05741502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101299436|NCT05741502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101299437|NCT05741502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101299438|NCT05741502|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101299439|NCT05741502|Dopamine Agents|dopamine agents|mesh-ancestor
101299440|NCT05741502|Antiemetics|antiemetics|mesh-ancestor
101299441|NCT05741502|Autonomic Agents|autonomic agents|mesh-ancestor
101299442|NCT05741502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101299443|NCT05741502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101299444|NCT05741502|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101299445|NCT05741502|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101299446|NCT05741502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101299447|NCT05741502|Antidepressive Agents|antidepressive agents|mesh-ancestor
101299448|NCT05741502|Dopamine Agonists|dopamine agonists|mesh-ancestor
101299449|NCT05741502|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101299450|NCT05741502|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101299451|NCT05741502|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101299452|NCT05741502|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101299453|NCT05741502|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101299454|NCT05741502|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101299455|NCT05741502|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101299456|NCT05741502|Adrenergic Agents|adrenergic agents|mesh-ancestor
101299457|NCT05741502|GABA Antagonists|gaba antagonists|mesh-ancestor
101299458|NCT05741502|GABA Agents|gaba agents|mesh-ancestor
101299459|NCT05725031|Ephedrine|ephedrine|mesh-list
101299460|NCT05725031|Rocuronium|rocuronium|mesh-list
101299461|NCT05725031|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101299462|NCT05725031|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101299463|NCT05725031|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101408916|NCT00456313|Glucocorticoids|glucocorticoids|mesh-ancestor
101299464|NCT05725031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101299465|NCT05725031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299466|NCT05725031|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101299467|NCT05725031|Sympathomimetics|sympathomimetics|mesh-ancestor
101299468|NCT05725031|Autonomic Agents|autonomic agents|mesh-ancestor
101317386|NCT00010231|Antiemetics|antiemetics|mesh-ancestor
101299469|NCT05725031|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101299470|NCT05725031|Adrenergic Agents|adrenergic agents|mesh-ancestor
101299471|NCT05725031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101299472|NCT05725031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299473|NCT05724108|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
101299474|NCT05724108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299475|NCT05724108|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101299476|NCT05723588|Nicotine|nicotine|mesh-list
101299477|NCT05723588|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101299478|NCT05723588|Autonomic Agents|autonomic agents|mesh-ancestor
101299479|NCT05723588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101299480|NCT05723588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299481|NCT05723588|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101299482|NCT05723588|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101299483|NCT05723588|Cholinergic Agents|cholinergic agents|mesh-ancestor
101822165|NCT05887778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822167|NCT05887765|Dexamethasone acetate|dexamethasone acetate|mesh-list
101822168|NCT05887765|BB 1101|bb 1101|mesh-list
101822169|NCT05887765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101822170|NCT05887765|Antiemetics|antiemetics|mesh-ancestor
101299484|NCT05723588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101299485|NCT05723588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299486|NCT05707754|Bupivacaine|bupivacaine|mesh-list
101299487|NCT05707754|Anesthetics, Local|anesthetics, local|mesh-ancestor
101299488|NCT05707754|Anesthetics|anesthetics|mesh-ancestor
101299489|NCT05707754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101299490|NCT05707754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299491|NCT05707754|Sensory System Agents|sensory system agents|mesh-ancestor
101299492|NCT05707754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101299493|NCT05706506|Tirzepatide|tirzepatide|mesh-list
101299494|NCT05706506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101299495|NCT05706506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299496|NCT05706506|Incretins|incretins|mesh-ancestor
101299497|NCT05706506|Hormones|hormones|mesh-ancestor
101299498|NCT05706506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101299499|NCT05699824|Carvedilol|carvedilol|mesh-list
101299500|NCT05699824|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101299501|NCT05699824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101299502|NCT05699824|Adrenergic Agents|adrenergic agents|mesh-ancestor
101299503|NCT05699824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101299504|NCT05699824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299505|NCT05699824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299506|NCT05699824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101299507|NCT05699824|Antioxidants|antioxidants|mesh-ancestor
101299508|NCT05699824|Protective Agents|protective agents|mesh-ancestor
101299509|NCT05699824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101299510|NCT05699824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101299511|NCT05699824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101299512|NCT05699824|Vasodilator Agents|vasodilator agents|mesh-ancestor
101299513|NCT05699824|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101299514|NCT05699824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101299515|NCT05698095|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
101299516|NCT05698095|Hallucinogens|hallucinogens|mesh-ancestor
101299517|NCT05698095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299518|NCT05698095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101299519|NCT05698095|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101299520|NCT05698095|Serotonin Agents|serotonin agents|mesh-ancestor
101299521|NCT05698095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101299522|NCT05698095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299523|NCT05698095|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101299524|NCT05696626|Fulvestrant|fulvestrant|mesh-list
101299525|NCT05696626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101299526|NCT05696626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101299527|NCT05696626|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101299528|NCT05696626|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101299529|NCT05696626|Hormone Antagonists|hormone antagonists|mesh-ancestor
101299530|NCT05696626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101299531|NCT05696626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299532|NCT05694637|Varenicline|varenicline|mesh-list
101299533|NCT05694637|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101299534|NCT05694637|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101299535|NCT05694637|Cholinergic Agents|cholinergic agents|mesh-ancestor
101299536|NCT05694637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101299537|NCT05694637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317392|NCT00010231|Hormones|hormones|mesh-ancestor
101299538|NCT05694637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299539|NCT05687253|Bromides|bromides|mesh-list
101299540|NCT05687253|Rocuronium|rocuronium|mesh-list
101299541|NCT05687253|Anticonvulsants|anticonvulsants|mesh-ancestor
101299542|NCT05687253|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101299543|NCT05687253|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101299544|NCT05687253|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101822172|NCT05887765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101822173|NCT05887765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822174|NCT05887765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101822176|NCT05887765|Hormones|hormones|mesh-ancestor
101822177|NCT05887765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101822178|NCT05887765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101822179|NCT05887765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101299545|NCT05687253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101299546|NCT05687253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299547|NCT05686408|Tianeptine|tianeptine|mesh-list
101299548|NCT05686408|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101299549|NCT05686408|Antidepressive Agents|antidepressive agents|mesh-ancestor
101299550|NCT05686408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101299551|NCT05683977|Durvalumab|durvalumab|mesh-list
101299552|NCT05683977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101299553|NCT05683977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101299554|NCT05683821|Nicotine|nicotine|mesh-list
101299555|NCT05683821|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101299556|NCT05683821|Autonomic Agents|autonomic agents|mesh-ancestor
101299557|NCT05683821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101299558|NCT05683821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299559|NCT05683821|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101299560|NCT05683821|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101299561|NCT05683821|Cholinergic Agents|cholinergic agents|mesh-ancestor
101299562|NCT05683821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101299563|NCT05683821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299564|NCT05680805|Metformin|metformin|mesh-list
101299565|NCT05680805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101299566|NCT05680805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299568|NCT05651594|Pembrolizumab|pembrolizumab|mesh-list
101299569|NCT05651594|Fluorouracil|fluorouracil|mesh-list
101299570|NCT05651594|Oxaliplatin|oxaliplatin|mesh-list
101299571|NCT05651594|Propranolol|propranolol|mesh-list
101299572|NCT05651594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101299573|NCT05651594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101299574|NCT05651594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101299575|NCT05651594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299576|NCT05651594|Antimetabolites|antimetabolites|mesh-ancestor
101299577|NCT05651594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101299578|NCT05651594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101299579|NCT05651594|Immunologic Factors|immunologic factors|mesh-ancestor
101299580|NCT05651594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299581|NCT05651594|Antidotes|antidotes|mesh-ancestor
101299582|NCT05651594|Protective Agents|protective agents|mesh-ancestor
101299583|NCT05651594|Vitamin B Complex|vitamin b complex|mesh-ancestor
101299585|NCT05651594|Micronutrients|micronutrients|mesh-ancestor
101299586|NCT05651594|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101299587|NCT05651594|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101299588|NCT05651594|Adrenergic Agents|adrenergic agents|mesh-ancestor
101299589|NCT05651594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101299590|NCT05651594|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101299591|NCT05651594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101299592|NCT05651594|Vasodilator Agents|vasodilator agents|mesh-ancestor
101299593|NCT05643573|Apixaban|apixaban|mesh-list
101299594|NCT05643573|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101299595|NCT05643573|Antithrombins|antithrombins|mesh-ancestor
101299596|NCT05643573|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101299597|NCT05643573|Protease Inhibitors|protease inhibitors|mesh-ancestor
101299598|NCT05643573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101299599|NCT05643573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299600|NCT05643573|Anticoagulants|anticoagulants|mesh-ancestor
101299601|NCT05637970|Hemostatics|hemostatics|mesh-list
101299602|NCT05637970|Coagulants|coagulants|mesh-ancestor
101822180|NCT05887765|Protease Inhibitors|protease inhibitors|mesh-ancestor
101822181|NCT05887765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101822182|NCT05887765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822184|NCT05886712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101822185|NCT05886712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822186|NCT05886712|Sensory System Agents|sensory system agents|mesh-ancestor
101822187|NCT05886712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101822188|NCT05881382|Lenograstim|lenograstim|mesh-list
101822189|NCT05881382|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101822190|NCT05881382|Immunologic Factors|immunologic factors|mesh-ancestor
101822191|NCT05881382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822192|NCT05874414|Trametinib|trametinib|mesh-list
101822193|NCT05874414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101822194|NCT05874414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101822195|NCT05874414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101822196|NCT05874414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822197|NCT05851677|Disitamab vedotin|disitamab vedotin|mesh-list
101822198|NCT05851677|Immunoconjugates|immunoconjugates|mesh-ancestor
101822199|NCT05851677|Immunologic Factors|immunologic factors|mesh-ancestor
101822200|NCT05851677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822201|NCT05843708|Ciprofloxacin|ciprofloxacin|mesh-list
101822202|NCT05843708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101822203|NCT05843708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101822204|NCT05843708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101822205|NCT05843708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101822206|NCT05843708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101822207|NCT05843708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822208|NCT05843708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101822211|NCT05805826|Vaccines|vaccines|mesh-list
101822231|NCT05742789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101822232|NCT05742789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101299612|NCT05626803|Vaccines|vaccines|mesh-list
101299613|NCT05626803|Immunologic Factors|immunologic factors|mesh-ancestor
101299614|NCT05626803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299620|NCT05596747|Insulin Glargine|insulin glargine|mesh-list
101299621|NCT05596747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101299622|NCT05596747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299623|NCT05587894|Ritonavir|ritonavir|mesh-list
101299624|NCT05587894|Remdesivir|remdesivir|mesh-list
101299625|NCT05587894|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
101299626|NCT05587894|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101299627|NCT05587894|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101299628|NCT05587894|Protease Inhibitors|protease inhibitors|mesh-ancestor
101299629|NCT05587894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101299630|NCT05587894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299631|NCT05587894|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101299632|NCT05587894|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101299633|NCT05587894|Antiviral Agents|antiviral agents|mesh-ancestor
101299634|NCT05587894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101299635|NCT05587894|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101299636|NCT05587894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101299637|NCT05587894|Antimetabolites|antimetabolites|mesh-ancestor
101299638|NCT05584657|Amoxicillin|amoxicillin|mesh-list
101299639|NCT05584657|Clavulanic Acid|clavulanic acid|mesh-list
101299640|NCT05584657|Clavulanic Acids|clavulanic acids|mesh-list
101299641|NCT05584657|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101299642|NCT05584657|Lactams|lactams|mesh-list
101299643|NCT05584657|Probenecid|probenecid|mesh-list
101299645|NCT05584657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101299646|NCT05584657|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101299647|NCT05584657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101299648|NCT05584657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299649|NCT05584657|Uricosuric Agents|uricosuric agents|mesh-ancestor
101299650|NCT05584657|Gout Suppressants|gout suppressants|mesh-ancestor
101299651|NCT05584657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101299652|NCT05582694|UB-421|ub-421|mesh-list
101299653|NCT05582694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101299654|NCT05582694|Antiviral Agents|antiviral agents|mesh-ancestor
101299655|NCT05582694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101299656|NCT05564052|Rituximab|rituximab|mesh-list
101299657|NCT05564052|Lenalidomide|lenalidomide|mesh-list
101299658|NCT05564052|Bortezomib|bortezomib|mesh-list
101299659|NCT05564052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101299660|NCT05564052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101299661|NCT05564052|Immunologic Factors|immunologic factors|mesh-ancestor
101299662|NCT05564052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299663|NCT05564052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101299664|NCT05564052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101299665|NCT05564052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101299666|NCT05564052|Growth Substances|growth substances|mesh-ancestor
101299667|NCT05564052|Growth Inhibitors|growth inhibitors|mesh-ancestor
101299669|NCT05561543|Antiemetics|antiemetics|mesh-ancestor
101299670|NCT05561543|Autonomic Agents|autonomic agents|mesh-ancestor
101822233|NCT05742789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822234|NCT05742789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101822235|NCT05742789|Anesthetics, General|anesthetics, general|mesh-ancestor
101822236|NCT05742789|Anesthetics|anesthetics|mesh-ancestor
101822237|NCT05742789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101822238|NCT05742789|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101822239|NCT05741385|Metoprolol|metoprolol|mesh-list
101822240|NCT05741385|Midazolam|midazolam|mesh-list
101822241|NCT05741385|Caffeine|caffeine|mesh-list
101822242|NCT05741385|Omeprazole|omeprazole|mesh-list
101299671|NCT05561543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101299672|NCT05561543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299673|NCT05561543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101299674|NCT05561543|Parasympatholytics|parasympatholytics|mesh-ancestor
101299675|NCT05558124|Cytarabine|cytarabine|mesh-list
101299676|NCT05558124|Daunorubicin|daunorubicin|mesh-list
101299677|NCT05558124|Gemtuzumab|gemtuzumab|mesh-list
101299679|NCT05558124|Antimetabolites|antimetabolites|mesh-ancestor
101299680|NCT05558124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299681|NCT05558124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101299682|NCT05558124|Antiviral Agents|antiviral agents|mesh-ancestor
101299683|NCT05558124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101299684|NCT05558124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101299685|NCT05558124|Immunologic Factors|immunologic factors|mesh-ancestor
101299686|NCT05558124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299687|NCT05558124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101299688|NCT05558124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101299689|NCT05558124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101299690|NCT05558124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101299691|NCT05558124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101299692|NCT05558124|Immunotoxins|immunotoxins|mesh-ancestor
101299693|NCT05558124|Immunoconjugates|immunoconjugates|mesh-ancestor
101299694|NCT05555823|Repaglinide|repaglinide|mesh-list
101299695|NCT05555823|Celecoxib|celecoxib|mesh-list
101299696|NCT05555823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101299697|NCT05555823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101299698|NCT05555823|Analgesics|analgesics|mesh-ancestor
101299699|NCT05555823|Sensory System Agents|sensory system agents|mesh-ancestor
101299700|NCT05555823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101299701|NCT05555823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299702|NCT05555823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101299703|NCT05555823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101299704|NCT05555823|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101299705|NCT05555823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101299706|NCT05555823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101299707|NCT05555823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299708|NCT05555823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101299709|NCT05539729|Vancomycin|vancomycin|mesh-list
101299710|NCT05539729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101299711|NCT05539729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101299712|NCT05539365|Pembrolizumab|pembrolizumab|mesh-list
101299713|NCT05539365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101299714|NCT05539365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101299715|NCT05539365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101299716|NCT05539365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299717|NCT05536804|Tirzepatide|tirzepatide|mesh-list
101299718|NCT05536804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101299719|NCT05536804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299720|NCT05536804|Incretins|incretins|mesh-ancestor
101299721|NCT05536804|Hormones|hormones|mesh-ancestor
101299722|NCT05536804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101299723|NCT05518032|Pembrolizumab|pembrolizumab|mesh-list
101299724|NCT05518032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101299725|NCT05518032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101299726|NCT05518032|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101299727|NCT05518032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299728|NCT05515796|Trastuzumab|trastuzumab|mesh-list
101822243|NCT05741385|Warfarin|warfarin|mesh-list
101822244|NCT05741385|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101822245|NCT05741385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101822246|NCT05741385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101822247|NCT05741385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299729|NCT05515796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101299730|NCT05515796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101299731|NCT05509777|Mirikizumab|mirikizumab|mesh-list
101299732|NCT05509777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101299733|NCT05509777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101299734|NCT05509777|Analgesics|analgesics|mesh-ancestor
101299735|NCT05509777|Sensory System Agents|sensory system agents|mesh-ancestor
101299736|NCT05509777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101299737|NCT05509777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299738|NCT05509777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101299739|NCT05509777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101299740|NCT05509777|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101299741|NCT05509777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101299742|NCT05501886|Fulvestrant|fulvestrant|mesh-list
101299743|NCT05501886|Palbociclib|palbociclib|mesh-list
101299744|NCT05501886|Gedatolisib|gedatolisib|mesh-list
101299745|NCT05501886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101299746|NCT05501886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101299747|NCT05501886|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101299748|NCT05501886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101299749|NCT05501886|Hormone Antagonists|hormone antagonists|mesh-ancestor
101299750|NCT05501886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101299751|NCT05501886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299752|NCT05501886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101299753|NCT05501886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101299754|NCT05501886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299755|NCT05493371|Empagliflozin|empagliflozin|mesh-list
101299756|NCT05493371|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101299757|NCT05493371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299758|NCT05493371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101299759|NCT05493371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299760|NCT05490680|Sildenafil Citrate|sildenafil citrate|mesh-list
101299761|NCT05490680|Vasodilator Agents|vasodilator agents|mesh-ancestor
101299762|NCT05490680|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101299763|NCT05490680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101299764|NCT05490680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101299765|NCT05490680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299766|NCT05490680|Urological Agents|urological agents|mesh-ancestor
101299767|NCT05488366|Pembrolizumab|pembrolizumab|mesh-list
101299768|NCT05488366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101299769|NCT05488366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101299770|NCT05488366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101299771|NCT05488366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299782|NCT05474560|Allopurinol|allopurinol|mesh-list
101299783|NCT05474560|Febuxostat|febuxostat|mesh-list
101299784|NCT05474560|Antimetabolites|antimetabolites|mesh-ancestor
101299785|NCT05474560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299786|NCT05474560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101299787|NCT05474560|Gout Suppressants|gout suppressants|mesh-ancestor
101299788|NCT05474560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101299789|NCT05474560|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101299790|NCT05474560|Antioxidants|antioxidants|mesh-ancestor
101299791|NCT05474560|Protective Agents|protective agents|mesh-ancestor
101299792|NCT05474560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299794|NCT05469893|Lenalidomide|lenalidomide|mesh-list
101299795|NCT05469893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101299796|NCT05469893|Antiemetics|antiemetics|mesh-ancestor
101299797|NCT05469893|Autonomic Agents|autonomic agents|mesh-ancestor
101299798|NCT05469893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101299799|NCT05469893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299800|NCT05469893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101299801|NCT05469893|Glucocorticoids|glucocorticoids|mesh-ancestor
101299802|NCT05469893|Hormones|hormones|mesh-ancestor
101822248|NCT05741385|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101822249|NCT05741385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101822250|NCT05741385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101822251|NCT05741385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101299803|NCT05469893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101299807|NCT05469893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101299808|NCT05469893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101299809|NCT05469893|Growth Substances|growth substances|mesh-ancestor
101299810|NCT05469893|Growth Inhibitors|growth inhibitors|mesh-ancestor
101299812|NCT05468957|Coagulants|coagulants|mesh-ancestor
101299813|NCT05462756|Insulin|insulin|mesh-list
101299814|NCT05462756|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101299815|NCT05462756|Insulin Glargine|insulin glargine|mesh-list
101299816|NCT05462756|Insulin Lispro|insulin lispro|mesh-list
101299817|NCT05462756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101299818|NCT05462756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299819|NCT05444751|Anesthetics|anesthetics|mesh-list
101299820|NCT05444751|Anesthetics, General|anesthetics, general|mesh-list
101299821|NCT05444751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101299822|NCT05444751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299823|NCT05422534|Ubiquinone|ubiquinone|mesh-list
101299824|NCT05422534|Micronutrients|micronutrients|mesh-ancestor
101299825|NCT05422534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299826|NCT05422066|Prednisone|prednisone|mesh-list
101299827|NCT05422066|Cyclophosphamide|cyclophosphamide|mesh-list
101299828|NCT05422066|Rituximab|rituximab|mesh-list
101299829|NCT05422066|Doxorubicin|doxorubicin|mesh-list
101299830|NCT05422066|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101299831|NCT05422066|Vincristine|vincristine|mesh-list
101299832|NCT05422066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101299833|NCT05422066|Immunologic Factors|immunologic factors|mesh-ancestor
101299834|NCT05422066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299835|NCT05422066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101299836|NCT05422066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101299837|NCT05422066|Alkylating Agents|alkylating agents|mesh-ancestor
101299838|NCT05422066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299839|NCT05422066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101299840|NCT05422066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101299841|NCT05422066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101299842|NCT05422066|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101299843|NCT05422066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101299844|NCT05422066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101299845|NCT05422066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101299846|NCT05422066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101299847|NCT05422066|Glucocorticoids|glucocorticoids|mesh-ancestor
101299848|NCT05422066|Hormones|hormones|mesh-ancestor
101299849|NCT05422066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101299850|NCT05422066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101299851|NCT05422066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101299852|NCT05422066|Tubulin Modulators|tubulin modulators|mesh-ancestor
101299853|NCT05422066|Antimitotic Agents|antimitotic agents|mesh-ancestor
101299854|NCT05422066|Mitosis Modulators|mitosis modulators|mesh-ancestor
101299855|NCT05419505|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
101299856|NCT05419505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101299857|NCT05419505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299858|NCT05419505|Hemostatics|hemostatics|mesh-ancestor
101299859|NCT05419505|Coagulants|coagulants|mesh-ancestor
101299865|NCT05413343|Ceftazidime|ceftazidime|mesh-list
101299866|NCT05413343|Avibactam|avibactam|mesh-list
101299867|NCT05413343|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
101299868|NCT05413343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101299870|NCT05413343|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101299871|NCT05413343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101299872|NCT05413343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299873|NCT05375929|Abrocitinib|abrocitinib|mesh-list
101299874|NCT05375929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101299875|NCT05375929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101299876|NCT05375929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822252|NCT05741385|Anesthetics, General|anesthetics, general|mesh-ancestor
101822253|NCT05741385|Anesthetics|anesthetics|mesh-ancestor
101822254|NCT05741385|GABA Modulators|gaba modulators|mesh-ancestor
101822255|NCT05741385|GABA Agents|gaba agents|mesh-ancestor
101822256|NCT05741385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101822257|NCT05741385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822258|NCT05741385|Anticoagulants|anticoagulants|mesh-ancestor
101299877|NCT05367440|Abiraterone Acetate|abiraterone acetate|mesh-list
101299878|NCT05367440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101299879|NCT05367440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101299880|NCT05367440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101299881|NCT05367440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299882|NCT05367440|Hormone Antagonists|hormone antagonists|mesh-ancestor
101299883|NCT05367440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101299884|NCT05367440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299885|NCT05367440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101299893|NCT05334004|Ritonavir|ritonavir|mesh-list
101299894|NCT05334004|Lopinavir|lopinavir|mesh-list
101299895|NCT05334004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101299896|NCT05334004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101299897|NCT05334004|Protease Inhibitors|protease inhibitors|mesh-ancestor
101299898|NCT05334004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101299899|NCT05334004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299900|NCT05334004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101299901|NCT05334004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101299902|NCT05334004|Antiviral Agents|antiviral agents|mesh-ancestor
101299903|NCT05334004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101299904|NCT05334004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101299905|NCT05334004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101299906|NCT05319899|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
101299907|NCT05319899|Choline|choline|mesh-list
101299908|NCT05319899|Omeprazole|omeprazole|mesh-list
101299909|NCT05319899|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101299910|NCT05319899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101299911|NCT05319899|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101299912|NCT05319899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101299913|NCT05319899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299914|NCT05319899|Lipotropic Agents|lipotropic agents|mesh-ancestor
101299915|NCT05319899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101299916|NCT05319899|Antimetabolites|antimetabolites|mesh-ancestor
101299917|NCT05319899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101299918|NCT05319899|Nootropic Agents|nootropic agents|mesh-ancestor
101299919|NCT05319899|Chelating Agents|chelating agents|mesh-ancestor
101299920|NCT05319899|Sequestering Agents|sequestering agents|mesh-ancestor
101299921|NCT05319899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101299922|NCT05319899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101299923|NCT05319899|Growth Substances|growth substances|mesh-ancestor
101299924|NCT05319899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299925|NCT05319899|Growth Inhibitors|growth inhibitors|mesh-ancestor
101299926|NCT05319899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101299927|NCT05304767|Xanomeline|xanomeline|mesh-list
101299928|NCT05304767|Trospium chloride|trospium chloride|mesh-list
101299929|NCT05304767|Parasympatholytics|parasympatholytics|mesh-ancestor
101299930|NCT05304767|Autonomic Agents|autonomic agents|mesh-ancestor
101299931|NCT05304767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101299932|NCT05304767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299933|NCT05304767|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101299934|NCT05304767|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101299935|NCT05304767|Cholinergic Agents|cholinergic agents|mesh-ancestor
101299936|NCT05304767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101299937|NCT05304767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299938|NCT05304767|Urological Agents|urological agents|mesh-ancestor
101299939|NCT05304767|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101299940|NCT05304767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101299941|NCT05304767|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101299942|NCT05304767|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101299943|NCT05302271|Prednisone|prednisone|mesh-list
101299944|NCT05302271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101299945|NCT05302271|Glucocorticoids|glucocorticoids|mesh-ancestor
101299946|NCT05302271|Hormones|hormones|mesh-ancestor
101822259|NCT05741385|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101822260|NCT05741385|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101822261|NCT05741385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101822262|NCT05741385|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101822263|NCT05741385|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101822264|NCT05741385|Purinergic Agents|purinergic agents|mesh-ancestor
101822265|NCT05741385|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101822266|NCT05741385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101299947|NCT05302271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101299948|NCT05302271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299949|NCT05302271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101299950|NCT05302271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101299951|NCT05291364|Ethanol|ethanol|mesh-list
101299952|NCT05291364|Dexmedetomidine|dexmedetomidine|mesh-list
101299953|NCT05291364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101299954|NCT05291364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101299955|NCT05291364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299956|NCT05291364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101299957|NCT05291364|Analgesics|analgesics|mesh-ancestor
101299958|NCT05291364|Sensory System Agents|sensory system agents|mesh-ancestor
101299959|NCT05291364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101299960|NCT05291364|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101299961|NCT05291364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101299962|NCT05291364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101299963|NCT05291364|Adrenergic Agents|adrenergic agents|mesh-ancestor
101299964|NCT05291364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101299965|NCT05291364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299966|NCT05291364|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101299967|NCT05291364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101299968|NCT05291221|Lidocaine|lidocaine|mesh-list
101299969|NCT05291221|Dexmedetomidine|dexmedetomidine|mesh-list
101299970|NCT05291221|Anesthetics, Local|anesthetics, local|mesh-ancestor
101299971|NCT05291221|Anesthetics|anesthetics|mesh-ancestor
101299972|NCT05291221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101299973|NCT05291221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299974|NCT05291221|Sensory System Agents|sensory system agents|mesh-ancestor
101299975|NCT05291221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101299976|NCT05291221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101299977|NCT05291221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101299978|NCT05291221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101299979|NCT05291221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101299980|NCT05291221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299981|NCT05291221|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101299982|NCT05291221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101299984|NCT05291221|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101299985|NCT05291221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101299986|NCT05291221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101299987|NCT05291221|Adrenergic Agents|adrenergic agents|mesh-ancestor
101299988|NCT05291221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101299989|NCT05286762|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
101299990|NCT05286762|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101299991|NCT05286762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299992|NCT05286762|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101299993|NCT05286762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101299994|NCT05286762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101299995|NCT05286762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299996|NCT05286762|Dopamine Agents|dopamine agents|mesh-ancestor
101299997|NCT05286762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101299998|NCT05280132|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101299999|NCT05280132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101822267|NCT05741385|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101822268|NCT05741385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101822269|NCT05741385|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101822270|NCT05741385|Sympatholytics|sympatholytics|mesh-ancestor
101300000|NCT05280132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101300001|NCT05280132|Antitubercular Agents|antitubercular agents|mesh-ancestor
101300003|NCT05274269|Elexacaftor|elexacaftor|mesh-list
101300004|NCT05274269|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101300005|NCT05274269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101300006|NCT05274269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300007|NCT05268614|Cisplatin|cisplatin|mesh-list
101300008|NCT05268614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300009|NCT05266924|Hormones|hormones|mesh-list
101300010|NCT05266924|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101300011|NCT05266924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101300012|NCT05266924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300013|NCT05266196|Cyclophosphamide|cyclophosphamide|mesh-list
101300014|NCT05266196|Topotecan|topotecan|mesh-list
101300015|NCT05266196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101300016|NCT05266196|Immunologic Factors|immunologic factors|mesh-ancestor
101300017|NCT05266196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300018|NCT05266196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101300019|NCT05266196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101300020|NCT05266196|Alkylating Agents|alkylating agents|mesh-ancestor
101300021|NCT05266196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300022|NCT05266196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300023|NCT05266196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101300024|NCT05266196|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101300025|NCT05266196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101300026|NCT05266196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101300028|NCT05260021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101300029|NCT05260021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300030|NCT05260021|Incretins|incretins|mesh-ancestor
101300031|NCT05260021|Hormones|hormones|mesh-ancestor
101300032|NCT05260021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101300033|NCT05222555|Lenalidomide|lenalidomide|mesh-list
101300034|NCT05222555|Immunologic Factors|immunologic factors|mesh-ancestor
101300035|NCT05222555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300036|NCT05222555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101300037|NCT05222555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101300038|NCT05222555|Growth Substances|growth substances|mesh-ancestor
101300039|NCT05222555|Growth Inhibitors|growth inhibitors|mesh-ancestor
101300040|NCT05222555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300041|NCT05194592|Dapagliflozin|dapagliflozin|mesh-list
101300042|NCT05194592|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101300043|NCT05194592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300044|NCT05194592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101300045|NCT05194592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300046|NCT05190562|Zinc Sulfate|zinc sulfate|mesh-list
101300047|NCT05190562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300048|NCT05190562|Astringents|astringents|mesh-ancestor
101300049|NCT05190562|Dermatologic Agents|dermatologic agents|mesh-ancestor
101300050|NCT05184101|Heparin|heparin|mesh-list
101300051|NCT05184101|Calcium heparin|calcium heparin|mesh-list
101300052|NCT05184101|Anticoagulants|anticoagulants|mesh-ancestor
101300053|NCT05184101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101300054|NCT05184101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101300055|NCT05184101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300056|NCT05152472|Atezolizumab|atezolizumab|mesh-list
101300057|NCT05152472|Imatinib Mesylate|imatinib mesylate|mesh-list
101300058|NCT05152472|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101300059|NCT05152472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300060|NCT05152472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101300061|NCT05152472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300062|NCT05152472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101300063|NCT05152472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101300064|NCT05147272|Gemcitabine|gemcitabine|mesh-list
101300065|NCT05147272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101300066|NCT05147272|Antimetabolites|antimetabolites|mesh-ancestor
101300067|NCT05147272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822272|NCT05741385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101822273|NCT05741385|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101822274|NCT05741385|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101822275|NCT05741385|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101822276|NCT05741385|Adrenergic Agents|adrenergic agents|mesh-ancestor
101822277|NCT05721846|Nivolumab|nivolumab|mesh-list
101822278|NCT05721846|Ipilimumab|ipilimumab|mesh-list
101822279|NCT05721846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101822280|NCT05721846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101822281|NCT05721846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101300068|NCT05147272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300069|NCT05145413|Xanomeline|xanomeline|mesh-list
101300070|NCT05145413|Trospium chloride|trospium chloride|mesh-list
101300071|NCT05145413|Parasympatholytics|parasympatholytics|mesh-ancestor
101300072|NCT05145413|Autonomic Agents|autonomic agents|mesh-ancestor
101300073|NCT05145413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101300074|NCT05145413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300075|NCT05145413|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101300076|NCT05145413|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101300077|NCT05145413|Cholinergic Agents|cholinergic agents|mesh-ancestor
101300078|NCT05145413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101300079|NCT05145413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300080|NCT05145413|Urological Agents|urological agents|mesh-ancestor
101300081|NCT05145413|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101300082|NCT05145413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101300083|NCT05145413|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101300084|NCT05145413|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101300085|NCT05139017|Rituximab|rituximab|mesh-list
101300086|NCT05139017|Gemcitabine|gemcitabine|mesh-list
101300087|NCT05139017|Oxaliplatin|oxaliplatin|mesh-list
101300088|NCT05139017|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101300089|NCT05139017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101300091|NCT05139017|Immunologic Factors|immunologic factors|mesh-ancestor
101300092|NCT05139017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300093|NCT05139017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101300094|NCT05139017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101300095|NCT05139017|Antimetabolites|antimetabolites|mesh-ancestor
101300096|NCT05139017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300097|NCT05139017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101300098|NCT05139017|Alkylating Agents|alkylating agents|mesh-ancestor
101300099|NCT05136196|Nivolumab|nivolumab|mesh-list
101300100|NCT05136196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101300101|NCT05136196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300102|NCT05136196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101300103|NCT05136196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300114|NCT05113251|Paclitaxel|paclitaxel|mesh-list
101300115|NCT05113251|Cyclophosphamide|cyclophosphamide|mesh-list
101300116|NCT05113251|Doxorubicin|doxorubicin|mesh-list
101300117|NCT05113251|Trastuzumab|trastuzumab|mesh-list
101300118|NCT05113251|Pertuzumab|pertuzumab|mesh-list
101300119|NCT05113251|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
101300120|NCT05113251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101317418|NCT00010426|Cysteamine|cysteamine|mesh-list
101300121|NCT05113251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300122|NCT05113251|Tubulin Modulators|tubulin modulators|mesh-ancestor
101300123|NCT05113251|Antimitotic Agents|antimitotic agents|mesh-ancestor
101300124|NCT05113251|Mitosis Modulators|mitosis modulators|mesh-ancestor
101300125|NCT05113251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300126|NCT05113251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101300127|NCT05113251|Immunologic Factors|immunologic factors|mesh-ancestor
101300128|NCT05113251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300129|NCT05113251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101822282|NCT05721846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822283|NCT05696613|Rituximab|rituximab|mesh-list
101822284|NCT05696613|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101822285|NCT05696613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101822286|NCT05696613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101822287|NCT05696613|Immunologic Factors|immunologic factors|mesh-ancestor
101822288|NCT05696613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300130|NCT05113251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101300131|NCT05113251|Alkylating Agents|alkylating agents|mesh-ancestor
101300132|NCT05113251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101300133|NCT05113251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101300134|NCT05113251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101300135|NCT05113251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101300136|NCT05113251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101300148|NCT05077683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101300150|NCT05077683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101300151|NCT05077683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300152|NCT05077683|Anticoagulants|anticoagulants|mesh-ancestor
101300153|NCT05076942|Cisplatin|cisplatin|mesh-list
101300154|NCT05076942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300155|NCT05061368|Sildenafil Citrate|sildenafil citrate|mesh-list
101300156|NCT05061368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300157|NCT05061368|Vasodilator Agents|vasodilator agents|mesh-ancestor
101300158|NCT05061368|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101300159|NCT05061368|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101300160|NCT05061368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101300161|NCT05061368|Urological Agents|urological agents|mesh-ancestor
101300162|NCT05038735|Fulvestrant|fulvestrant|mesh-list
101300163|NCT05038735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101300164|NCT05038735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300165|NCT05038735|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101300167|NCT05038735|Hormone Antagonists|hormone antagonists|mesh-ancestor
101300168|NCT05038735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101300169|NCT05038735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300170|NCT05022147|Dopamine|dopamine|mesh-list
101300171|NCT05022147|Dopamine Agonists|dopamine agonists|mesh-list
101300172|NCT05022147|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101300173|NCT05022147|Sympathomimetics|sympathomimetics|mesh-ancestor
101300174|NCT05022147|Autonomic Agents|autonomic agents|mesh-ancestor
101300175|NCT05022147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101300176|NCT05022147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300177|NCT05022147|Dopamine Agents|dopamine agents|mesh-ancestor
101300178|NCT05022147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101300179|NCT05022147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300180|NCT05022147|Protective Agents|protective agents|mesh-ancestor
101300191|NCT05020860|Paclitaxel|paclitaxel|mesh-list
101300192|NCT05020860|Cyclophosphamide|cyclophosphamide|mesh-list
101300193|NCT05020860|Carboplatin|carboplatin|mesh-list
101300195|NCT05020860|Pembrolizumab|pembrolizumab|mesh-list
101300196|NCT05020860|Trastuzumab|trastuzumab|mesh-list
101300197|NCT05020860|Pertuzumab|pertuzumab|mesh-list
101300198|NCT05020860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101300199|NCT05020860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300200|NCT05020860|Tubulin Modulators|tubulin modulators|mesh-ancestor
101300201|NCT05020860|Antimitotic Agents|antimitotic agents|mesh-ancestor
101300202|NCT05020860|Mitosis Modulators|mitosis modulators|mesh-ancestor
101300203|NCT05020860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300204|NCT05020860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101300205|NCT05020860|Immunologic Factors|immunologic factors|mesh-ancestor
101300206|NCT05020860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300207|NCT05020860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101300208|NCT05020860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101300209|NCT05020860|Alkylating Agents|alkylating agents|mesh-ancestor
101300210|NCT05020860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101300211|NCT05020860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101300212|NCT05020860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101822290|NCT05696613|Hormones|hormones|mesh-ancestor
101822291|NCT05696613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101822292|NCT05669833|Golimumab|golimumab|mesh-list
101822293|NCT05669833|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101822294|NCT05669833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101300213|NCT05020860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101300214|NCT05020860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101300215|NCT05020860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101300216|NCT05020860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101300218|NCT05010538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101300219|NCT05010538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101300220|NCT05010538|Dermatologic Agents|dermatologic agents|mesh-ancestor
101300221|NCT05005299|Cyclophosphamide|cyclophosphamide|mesh-list
101300222|NCT05005299|Fludarabine|fludarabine|mesh-list
101300223|NCT05005299|Venetoclax|venetoclax|mesh-list
101300224|NCT05005299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101300225|NCT05005299|Immunologic Factors|immunologic factors|mesh-ancestor
101300226|NCT05005299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300227|NCT05005299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101300228|NCT05005299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101300229|NCT05005299|Alkylating Agents|alkylating agents|mesh-ancestor
101300230|NCT05005299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300231|NCT05005299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300232|NCT05005299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101300233|NCT04999449|Scopolamine|scopolamine|mesh-list
101300234|NCT04999449|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101300235|NCT04999449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101300236|NCT04999449|Antiemetics|antiemetics|mesh-ancestor
101300237|NCT04999449|Autonomic Agents|autonomic agents|mesh-ancestor
101300238|NCT04999449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101300239|NCT04999449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300241|NCT04999449|Mydriatics|mydriatics|mesh-ancestor
101300242|NCT04999449|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101300243|NCT04999449|Cholinergic Agents|cholinergic agents|mesh-ancestor
101300244|NCT04999449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101300245|NCT04999449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300246|NCT04999449|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101300247|NCT04999449|Parasympatholytics|parasympatholytics|mesh-ancestor
101300248|NCT04989283|Paclitaxel|paclitaxel|mesh-list
101300249|NCT04989283|Etoposide|etoposide|mesh-list
101408933|NCT00456430|Escitalopram|escitalopram|mesh-list
101300250|NCT04989283|Podophyllotoxin|podophyllotoxin|mesh-list
101300251|NCT04989283|Cisplatin|cisplatin|mesh-list
101300252|NCT04989283|Carboplatin|carboplatin|mesh-list
101300253|NCT04989283|Pemetrexed|pemetrexed|mesh-list
101300254|NCT04989283|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101300255|NCT04989283|Etoposide phosphate|etoposide phosphate|mesh-list
101300256|NCT04989283|Atezolizumab|atezolizumab|mesh-list
101300257|NCT04989283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101300258|NCT04989283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101300259|NCT04989283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300260|NCT04989283|Tubulin Modulators|tubulin modulators|mesh-ancestor
101300261|NCT04989283|Antimitotic Agents|antimitotic agents|mesh-ancestor
101300263|NCT04989283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300264|NCT04989283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101300265|NCT04989283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101300266|NCT04989283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317421|NCT00386516|Fluorouracil|fluorouracil|mesh-list
101300267|NCT04989283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101300268|NCT04989283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101300269|NCT04989283|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101300270|NCT04989283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101300271|NCT04989283|Immunologic Factors|immunologic factors|mesh-ancestor
101300272|NCT04989283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300273|NCT04989283|Keratolytic Agents|keratolytic agents|mesh-ancestor
101300274|NCT04989283|Dermatologic Agents|dermatologic agents|mesh-ancestor
101300275|NCT04985929|Sildenafil Citrate|sildenafil citrate|mesh-list
101300276|NCT04985929|Vasodilator Agents|vasodilator agents|mesh-ancestor
101822295|NCT05669833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101822296|NCT05669833|Immunologic Factors|immunologic factors|mesh-ancestor
101822297|NCT05669833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300277|NCT04985929|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101300278|NCT04985929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101300279|NCT04985929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101300280|NCT04985929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300281|NCT04985929|Urological Agents|urological agents|mesh-ancestor
101300282|NCT04971187|Cisplatin|cisplatin|mesh-list
101300283|NCT04971187|Carboplatin|carboplatin|mesh-list
101300284|NCT04971187|Pemetrexed|pemetrexed|mesh-list
101300285|NCT04971187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300286|NCT04971187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101300287|NCT04971187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300288|NCT04971187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101300289|NCT04971187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101300290|NCT04929379|Fenofibrate|fenofibrate|mesh-list
101300291|NCT04929379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101300292|NCT04929379|Antimetabolites|antimetabolites|mesh-ancestor
101300293|NCT04929379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300294|NCT04929379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101300295|NCT04929080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101300296|NCT04929080|Antibodies|antibodies|mesh-list
101300297|NCT04929080|Immunoglobulins|immunoglobulins|mesh-list
101300298|NCT04929080|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101300299|NCT04929080|Immunoglobulin G|immunoglobulin g|mesh-list
101300300|NCT04929080|Immunologic Factors|immunologic factors|mesh-ancestor
101300301|NCT04929080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300302|NCT04929080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300303|NCT04914676|Cytarabine|cytarabine|mesh-list
101300304|NCT04914676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101300305|NCT04914676|Antimetabolites|antimetabolites|mesh-ancestor
101300306|NCT04914676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300307|NCT04914676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300308|NCT04914676|Antiviral Agents|antiviral agents|mesh-ancestor
101300309|NCT04914676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101300310|NCT04914676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101300311|NCT04914676|Immunologic Factors|immunologic factors|mesh-ancestor
101300312|NCT04914676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300313|NCT04914195|Leuprolide|leuprolide|mesh-list
101300314|NCT04914195|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101300315|NCT04914195|Fertility Agents|fertility agents|mesh-ancestor
101300316|NCT04914195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101300317|NCT04914195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300318|NCT04914195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101300319|NCT04914195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300320|NCT04904588|Mycophenolic Acid|mycophenolic acid|mesh-list
101300321|NCT04904588|Cyclophosphamide|cyclophosphamide|mesh-list
101300322|NCT04904588|Melphalan|melphalan|mesh-list
101300323|NCT04904588|Busulfan|busulfan|mesh-list
101300324|NCT04904588|Fludarabine|fludarabine|mesh-list
101300325|NCT04904588|Tacrolimus|tacrolimus|mesh-list
101300326|NCT04904588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101300327|NCT04904588|Immunologic Factors|immunologic factors|mesh-ancestor
101300328|NCT04904588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300329|NCT04904588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101300330|NCT04904588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101300331|NCT04904588|Alkylating Agents|alkylating agents|mesh-ancestor
101300332|NCT04904588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300333|NCT04904588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300334|NCT04904588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101300335|NCT04904588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101300336|NCT04904588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101300337|NCT04904588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101300338|NCT04904588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101300339|NCT04904588|Antitubercular Agents|antitubercular agents|mesh-ancestor
101300340|NCT04904588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101300341|NCT04904588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101300343|NCT04901299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101300344|NCT04901299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101822299|NCT05645146|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101822300|NCT05645146|Autonomic Agents|autonomic agents|mesh-ancestor
101822301|NCT05645146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101822302|NCT05645146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822303|NCT05645146|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101822304|NCT05645146|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101822305|NCT05645146|Cholinergic Agents|cholinergic agents|mesh-ancestor
101822306|NCT05645146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101822307|NCT05645146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822308|NCT05636111|Paclitaxel|paclitaxel|mesh-list
101822309|NCT05636111|Bevacizumab|bevacizumab|mesh-list
101300345|NCT04901299|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101300346|NCT04901299|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101300347|NCT04901299|Hormone Antagonists|hormone antagonists|mesh-ancestor
101300348|NCT04901299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101300349|NCT04901299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300350|NCT04898075|Nicotine|nicotine|mesh-list
101300351|NCT04898075|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101300352|NCT04898075|Autonomic Agents|autonomic agents|mesh-ancestor
101300353|NCT04898075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101300354|NCT04898075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300355|NCT04898075|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101300356|NCT04898075|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101300357|NCT04898075|Cholinergic Agents|cholinergic agents|mesh-ancestor
101300358|NCT04898075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101300359|NCT04898075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300360|NCT04893655|Dobutamine|dobutamine|mesh-list
101300361|NCT04893655|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101300362|NCT04893655|Sympathomimetics|sympathomimetics|mesh-ancestor
101300363|NCT04893655|Autonomic Agents|autonomic agents|mesh-ancestor
101300364|NCT04893655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101300365|NCT04893655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300366|NCT04893655|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101300367|NCT04893655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101300368|NCT04893655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101300369|NCT04893655|Adrenergic Agents|adrenergic agents|mesh-ancestor
101300370|NCT04893655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101300371|NCT04893655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300372|NCT04893655|Protective Agents|protective agents|mesh-ancestor
101300373|NCT04886986|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101300374|NCT04886986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101300375|NCT04886986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300376|NCT04882072|Ustekinumab|ustekinumab|mesh-list
101300377|NCT04882072|Dermatologic Agents|dermatologic agents|mesh-ancestor
101300378|NCT04870034|Palbociclib|palbociclib|mesh-list
101300379|NCT04870034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300380|NCT04870034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101300381|NCT04870034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101300382|NCT04870034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300383|NCT04841343|Triamcinolone|triamcinolone|mesh-list
101300384|NCT04841343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101300385|NCT04841343|Glucocorticoids|glucocorticoids|mesh-ancestor
101300386|NCT04841343|Hormones|hormones|mesh-ancestor
101300387|NCT04841343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101300388|NCT04841343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300389|NCT04840602|Rituximab|rituximab|mesh-list
101300390|NCT04840602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101300392|NCT04840602|Antibodies|antibodies|mesh-list
101300393|NCT04840602|Immunoglobulins|immunoglobulins|mesh-list
101300394|NCT04840602|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101300395|NCT04840602|Immunologic Factors|immunologic factors|mesh-ancestor
101300396|NCT04840602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822310|NCT05636111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101822311|NCT05636111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300397|NCT04840602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300398|NCT04840602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101300399|NCT04840342|Amlodipine|amlodipine|mesh-list
101300400|NCT04840342|Eplerenone|eplerenone|mesh-list
101300401|NCT04840342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101300402|NCT04840342|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101300403|NCT04840342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101300404|NCT04840342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300405|NCT04840342|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101300406|NCT04840342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300407|NCT04840342|Vasodilator Agents|vasodilator agents|mesh-ancestor
101317429|NCT00010699|Vitamin E|vitamin e|mesh-list
101300408|NCT04840342|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101300409|NCT04840342|Hormone Antagonists|hormone antagonists|mesh-ancestor
101300410|NCT04840342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101300411|NCT04840342|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101300412|NCT04840342|Diuretics|diuretics|mesh-ancestor
101300413|NCT04840342|Natriuretic Agents|natriuretic agents|mesh-ancestor
101300414|NCT04839627|Progesterone|progesterone|mesh-list
101300415|NCT04839627|Progestins|progestins|mesh-ancestor
101300417|NCT04839627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101300418|NCT04839627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300422|NCT04818866|Fibrin fragment D|fibrin fragment d|mesh-list
101300423|NCT04818866|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101300424|NCT04818866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101300425|NCT04818866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300426|NCT04818866|Hemostatics|hemostatics|mesh-ancestor
101300427|NCT04818866|Coagulants|coagulants|mesh-ancestor
101300428|NCT04816162|Dexmedetomidine|dexmedetomidine|mesh-list
101300429|NCT04816162|Ketamine|ketamine|mesh-list
101300430|NCT04816162|Propofol|propofol|mesh-list
101300431|NCT04816162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101300432|NCT04816162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101300433|NCT04816162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300434|NCT04816162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101300435|NCT04816162|Analgesics|analgesics|mesh-ancestor
101300436|NCT04816162|Sensory System Agents|sensory system agents|mesh-ancestor
101300437|NCT04816162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101300438|NCT04816162|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101300439|NCT04816162|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101300440|NCT04816162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101300441|NCT04816162|Adrenergic Agents|adrenergic agents|mesh-ancestor
101300442|NCT04816162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101300443|NCT04816162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300444|NCT04816162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101300445|NCT04816162|Anesthetics, General|anesthetics, general|mesh-ancestor
101300446|NCT04816162|Anesthetics|anesthetics|mesh-ancestor
101300447|NCT04816162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101300448|NCT04816162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101300449|NCT04816162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101300450|NCT04814368|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101300451|NCT04814368|Immunologic Factors|immunologic factors|mesh-ancestor
101300452|NCT04814368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300453|NCT04811027|Pembrolizumab|pembrolizumab|mesh-list
101300454|NCT04811027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101300455|NCT04811027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300456|NCT04811027|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101300457|NCT04811027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300458|NCT04808778|Hydroxyurea|hydroxyurea|mesh-list
101300459|NCT04808778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300460|NCT04808778|Antisickling Agents|antisickling agents|mesh-ancestor
101300461|NCT04808778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101300462|NCT04808778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300463|NCT04808778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101300464|NCT04792580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101300465|NCT04792580|Lifitegrast|lifitegrast|mesh-list
101300466|NCT04792580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101300467|NCT04743804|Ravulizumab|ravulizumab|mesh-list
101300468|NCT04743804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101822312|NCT05636111|Tubulin Modulators|tubulin modulators|mesh-ancestor
101822313|NCT05636111|Antimitotic Agents|antimitotic agents|mesh-ancestor
101822314|NCT05636111|Mitosis Modulators|mitosis modulators|mesh-ancestor
101822315|NCT05636111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822316|NCT05636111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101822317|NCT05636111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101822318|NCT05636111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101822319|NCT05636111|Growth Substances|growth substances|mesh-ancestor
101822320|NCT05636111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822321|NCT05636111|Growth Inhibitors|growth inhibitors|mesh-ancestor
101822322|NCT05610072|Acetylcysteine|acetylcysteine|mesh-list
101822323|NCT05610072|Hydromorphone|hydromorphone|mesh-list
101822324|NCT05610072|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101822325|NCT05610072|Antiviral Agents|antiviral agents|mesh-ancestor
101300469|NCT04743804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101300471|NCT04743804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300472|NCT04742491|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101300473|NCT04742491|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
101300474|NCT04742491|Emtricitabine|emtricitabine|mesh-list
101300475|NCT04742491|Tenofovir|tenofovir|mesh-list
101300476|NCT04742491|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101300477|NCT04742491|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101300478|NCT04742491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101300479|NCT04742491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300480|NCT04742491|Antiviral Agents|antiviral agents|mesh-ancestor
101300481|NCT04742491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101300482|NCT04742491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101300483|NCT04742491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101300484|NCT04741945|Metformin|metformin|mesh-list
101300485|NCT04741945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101300486|NCT04741945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300515|NCT04736433|Valsartan|valsartan|mesh-list
101300516|NCT04736433|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101300517|NCT04736433|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101300518|NCT04736433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101300519|NCT04736433|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101300520|NCT04736433|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101300521|NCT04736433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300522|NCT04736433|Protease Inhibitors|protease inhibitors|mesh-ancestor
101300523|NCT04736433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101300524|NCT04735523|Warfarin|warfarin|mesh-list
101300525|NCT04735523|Dabigatran|dabigatran|mesh-list
101300526|NCT04735523|Anticoagulants|anticoagulants|mesh-ancestor
101300527|NCT04735523|Antithrombins|antithrombins|mesh-ancestor
101300528|NCT04735523|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101300529|NCT04735523|Protease Inhibitors|protease inhibitors|mesh-ancestor
101300530|NCT04735523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101300531|NCT04735523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300532|NCT04734730|Prednisone|prednisone|mesh-list
101300533|NCT04734730|Cortisone|cortisone|mesh-list
101300534|NCT04734730|Leuprolide|leuprolide|mesh-list
101300535|NCT04734730|Goserelin|goserelin|mesh-list
101300536|NCT04734730|Abiraterone Acetate|abiraterone acetate|mesh-list
101300537|NCT04734730|Bicalutamide|bicalutamide|mesh-list
101300538|NCT04734730|Talazoparib|talazoparib|mesh-list
101300539|NCT04734730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101300540|NCT04734730|Glucocorticoids|glucocorticoids|mesh-ancestor
101300541|NCT04734730|Hormones|hormones|mesh-ancestor
101326203|NCT00115726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101300542|NCT04734730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101300543|NCT04734730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822326|NCT05610072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101822327|NCT05610072|Expectorants|expectorants|mesh-ancestor
101822328|NCT05610072|Respiratory System Agents|respiratory system agents|mesh-ancestor
101822329|NCT05610072|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101300544|NCT04734730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101300545|NCT04734730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300546|NCT04734730|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101300547|NCT04734730|Fertility Agents|fertility agents|mesh-ancestor
101300548|NCT04734730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101300549|NCT04734730|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101300550|NCT04734730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101300551|NCT04734730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300552|NCT04734730|Hormone Antagonists|hormone antagonists|mesh-ancestor
101300553|NCT04734730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101300554|NCT04734730|Androgen Antagonists|androgen antagonists|mesh-ancestor
101300555|NCT04734730|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101300556|NCT04734080|Dronabinol|dronabinol|mesh-list
101300557|NCT04734080|Hallucinogens|hallucinogens|mesh-ancestor
101300559|NCT04734080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101300560|NCT04734080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101300562|NCT04734080|Sensory System Agents|sensory system agents|mesh-ancestor
101300563|NCT04734080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101300564|NCT04734080|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101300565|NCT04734080|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101300566|NCT04734080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101300567|NCT04734080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300568|NCT04734080|Hormones|hormones|mesh-ancestor
101300569|NCT04734080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101300570|NCT04702893|Nintedanib|nintedanib|mesh-list
101300571|NCT04702893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300572|NCT04702893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101300573|NCT04702893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101300574|NCT04702893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300575|NCT04681820|Flumatinib|flumatinib|mesh-list
101300576|NCT04681820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101300577|NCT04681820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101300578|NCT04681820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300579|NCT04677504|Bevacizumab|bevacizumab|mesh-list
101300580|NCT04677504|Atezolizumab|atezolizumab|mesh-list
101300581|NCT04677504|Gemcitabine|gemcitabine|mesh-list
101300582|NCT04677504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101300583|NCT04677504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300584|NCT04677504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101300585|NCT04677504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101300586|NCT04677504|Growth Substances|growth substances|mesh-ancestor
101300587|NCT04677504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300588|NCT04677504|Growth Inhibitors|growth inhibitors|mesh-ancestor
101300589|NCT04677504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101300590|NCT04677504|Antimetabolites|antimetabolites|mesh-ancestor
101300591|NCT04677504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300592|NCT04677504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101300593|NCT04675788|Ibutilide|ibutilide|mesh-list
101300594|NCT04675788|Testosterone|testosterone|mesh-list
101300595|NCT04675788|Progesterone|progesterone|mesh-list
101300596|NCT04675788|Androgens|androgens|mesh-ancestor
101300597|NCT04675788|Hormones|hormones|mesh-ancestor
101300598|NCT04675788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101300599|NCT04675788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300600|NCT04675788|Progestins|progestins|mesh-ancestor
101300601|NCT04675788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101300602|NCT04667572|Riboflavin|riboflavin|mesh-list
101300603|NCT04667572|Vitamin B Complex|vitamin b complex|mesh-ancestor
101300604|NCT04667572|Vitamins|vitamins|mesh-ancestor
101300605|NCT04667572|Micronutrients|micronutrients|mesh-ancestor
101300606|NCT04667572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300607|NCT04667572|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101300608|NCT04667572|Dermatologic Agents|dermatologic agents|mesh-ancestor
101300609|NCT04651166|Tranexamic Acid|tranexamic acid|mesh-list
101300610|NCT04651166|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101300611|NCT04651166|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101822331|NCT05610072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822332|NCT05610072|Protective Agents|protective agents|mesh-ancestor
101822333|NCT05610072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822334|NCT05610072|Antidotes|antidotes|mesh-ancestor
101300631|NCT04622007|Pemetrexed|pemetrexed|mesh-list
101300632|NCT04622007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101300633|NCT04622007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300634|NCT04622007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101300635|NCT04622007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300636|NCT04622007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101300637|NCT04622007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101300638|NCT04622007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101300639|NCT04574960|Carboplatin|carboplatin|mesh-list
101300640|NCT04574960|Gemcitabine|gemcitabine|mesh-list
101300641|NCT04574960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300642|NCT04574960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101300643|NCT04574960|Antimetabolites|antimetabolites|mesh-ancestor
101300644|NCT04574960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300645|NCT04541589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101300646|NCT04541589|Immunologic Factors|immunologic factors|mesh-ancestor
101300647|NCT04541589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300648|NCT04539964|Antirheumatic Agents|antirheumatic agents|mesh-list
101300649|NCT04539314|Dexmedetomidine|dexmedetomidine|mesh-list
101300650|NCT04539314|Bupivacaine|bupivacaine|mesh-list
101300651|NCT04539314|Anesthetics, Local|anesthetics, local|mesh-ancestor
101300652|NCT04539314|Anesthetics|anesthetics|mesh-ancestor
101300653|NCT04539314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101300654|NCT04539314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300655|NCT04539314|Sensory System Agents|sensory system agents|mesh-ancestor
101300656|NCT04539314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101300657|NCT04539314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101300658|NCT04539314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101300659|NCT04539314|Analgesics|analgesics|mesh-ancestor
101300660|NCT04539314|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101300661|NCT04539314|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101300662|NCT04539314|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101300663|NCT04539314|Adrenergic Agents|adrenergic agents|mesh-ancestor
101300664|NCT04539314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101300665|NCT04539314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300666|NCT04533750|Peposertib|peposertib|mesh-list
101317440|NCT00386555|Tubulin Modulators|tubulin modulators|mesh-ancestor
101300667|NCT04533750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101300668|NCT04533750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101300669|NCT04533750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300670|NCT04520711|Pembrolizumab|pembrolizumab|mesh-list
101300671|NCT04520711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101300672|NCT04520711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300673|NCT04520711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101300674|NCT04520711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300675|NCT04508894|Dexmedetomidine|dexmedetomidine|mesh-list
101300676|NCT04508894|Ketamine|ketamine|mesh-list
101300677|NCT04508894|Bupivacaine|bupivacaine|mesh-list
101300678|NCT04508894|Anesthetics, Local|anesthetics, local|mesh-ancestor
101300679|NCT04508894|Anesthetics|anesthetics|mesh-ancestor
101300680|NCT04508894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101300681|NCT04508894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300682|NCT04508894|Sensory System Agents|sensory system agents|mesh-ancestor
101300683|NCT04508894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101300684|NCT04508894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101300685|NCT04508894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101300686|NCT04508894|Analgesics|analgesics|mesh-ancestor
101300687|NCT04508894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101300688|NCT04508894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101300689|NCT04508894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101300690|NCT04508894|Adrenergic Agents|adrenergic agents|mesh-ancestor
101300691|NCT04508894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101300692|NCT04508894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300693|NCT04508894|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101822335|NCT05610072|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101822336|NCT05610072|Narcotics|narcotics|mesh-ancestor
101822337|NCT05610072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101822338|NCT05610072|Analgesics|analgesics|mesh-ancestor
101822339|NCT05610072|Sensory System Agents|sensory system agents|mesh-ancestor
101822340|NCT05610072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101822341|NCT05597085|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
101822342|NCT05597085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101300694|NCT04508894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101300695|NCT04508894|Anesthetics, General|anesthetics, general|mesh-ancestor
101300696|NCT04508894|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101300697|NCT04508894|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101300698|NCT04506125|Chrysarobin|chrysarobin|mesh-list
101300699|NCT04506125|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101300700|NCT04506125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101300701|NCT04506125|Analgesics|analgesics|mesh-ancestor
101300702|NCT04506125|Sensory System Agents|sensory system agents|mesh-ancestor
101300703|NCT04506125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101300704|NCT04506125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300705|NCT04506125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101300706|NCT04506125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101300707|NCT04487236|Capecitabine|capecitabine|mesh-list
101300708|NCT04487236|Trastuzumab|trastuzumab|mesh-list
101300709|NCT04487236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101300710|NCT04487236|Antimetabolites|antimetabolites|mesh-ancestor
101300711|NCT04487236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300712|NCT04487236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300713|NCT04487236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101300715|NCT04477772|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101300716|NCT04477772|Immunologic Factors|immunologic factors|mesh-ancestor
101300717|NCT04477772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300718|NCT04429022|Acetaminophen|acetaminophen|mesh-list
101300719|NCT04429022|Celecoxib|celecoxib|mesh-list
101300720|NCT04429022|Ketorolac|ketorolac|mesh-list
101300721|NCT04429022|Oxycodone|oxycodone|mesh-list
101300722|NCT04429022|Gabapentin|gabapentin|mesh-list
101300723|NCT04429022|Hydromorphone|hydromorphone|mesh-list
101300724|NCT04429022|Ropivacaine|ropivacaine|mesh-list
101300725|NCT04429022|Anesthetics, Local|anesthetics, local|mesh-list
101300726|NCT04429022|Anesthetics|anesthetics|mesh-list
101300727|NCT04429022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101300728|NCT04429022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300729|NCT04429022|Sensory System Agents|sensory system agents|mesh-ancestor
101300730|NCT04429022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101300731|NCT04429022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101300732|NCT04429022|Analgesics|analgesics|mesh-ancestor
101300733|NCT04429022|Antipyretics|antipyretics|mesh-ancestor
101300734|NCT04429022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101300735|NCT04429022|Narcotics|narcotics|mesh-ancestor
101300736|NCT04429022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101300738|NCT04429022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101300739|NCT04429022|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101300740|NCT04429022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101300741|NCT04429022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101300742|NCT04429022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300743|NCT04429022|Anticonvulsants|anticonvulsants|mesh-ancestor
101300744|NCT04429022|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101300745|NCT04429022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101300746|NCT04429022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101300747|NCT04429022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101300748|NCT04429022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101300749|NCT04429022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101300750|NCT04429022|Antimanic Agents|antimanic agents|mesh-ancestor
101300751|NCT04400838|Vaccines|vaccines|mesh-list
101300752|NCT04400838|Immunologic Factors|immunologic factors|mesh-ancestor
101300753|NCT04400838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300754|NCT04396990|Prednisolone|prednisolone|mesh-list
101822343|NCT05597085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101822344|NCT05597085|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101822345|NCT05597085|Immunotoxins|immunotoxins|mesh-ancestor
101822346|NCT05597085|Immunoconjugates|immunoconjugates|mesh-ancestor
101822347|NCT05597085|Immunologic Factors|immunologic factors|mesh-ancestor
101822348|NCT05597085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822349|NCT05577481|Antidepressive Agents|antidepressive agents|mesh-list
101822350|NCT05577481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101300755|NCT04396990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101300756|NCT04396990|Glucocorticoids|glucocorticoids|mesh-ancestor
101300757|NCT04396990|Hormones|hormones|mesh-ancestor
101300758|NCT04396990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101300759|NCT04396990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300760|NCT04396990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101300761|NCT04396990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300762|NCT04394624|Pembrolizumab|pembrolizumab|mesh-list
101300763|NCT04394624|Ramucirumab|ramucirumab|mesh-list
101300764|NCT04394624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101300765|NCT04394624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300766|NCT04394624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101300768|NCT04364555|Clobetasol|clobetasol|mesh-list
101300769|NCT04364555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101300770|NCT04364555|Glucocorticoids|glucocorticoids|mesh-ancestor
101300771|NCT04364555|Hormones|hormones|mesh-ancestor
101300772|NCT04364555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101300773|NCT04364555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300774|NCT04341350|Analgesics|analgesics|mesh-list
101300775|NCT04341350|Propofol|propofol|mesh-list
101300776|NCT04341350|Isoflurane|isoflurane|mesh-list
101300777|NCT04341350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101300778|NCT04341350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101300779|NCT04341350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300780|NCT04341350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101300781|NCT04341350|Anesthetics, General|anesthetics, general|mesh-ancestor
101300782|NCT04341350|Anesthetics|anesthetics|mesh-ancestor
101300783|NCT04341350|Sensory System Agents|sensory system agents|mesh-ancestor
101300784|NCT04341350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101300785|NCT04341350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101300786|NCT04339738|Paclitaxel|paclitaxel|mesh-list
101300787|NCT04339738|Nivolumab|nivolumab|mesh-list
101300788|NCT04339738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101300789|NCT04339738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101300790|NCT04339738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300791|NCT04339738|Tubulin Modulators|tubulin modulators|mesh-ancestor
101300792|NCT04339738|Antimitotic Agents|antimitotic agents|mesh-ancestor
101300793|NCT04339738|Mitosis Modulators|mitosis modulators|mesh-ancestor
101300794|NCT04339738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300795|NCT04339738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101300796|NCT04339738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101300797|NCT04334941|Atezolizumab|atezolizumab|mesh-list
101300798|NCT04334941|Talazoparib|talazoparib|mesh-list
101300799|NCT04334941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101300800|NCT04334941|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101300801|NCT04334941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300802|NCT04334941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101300803|NCT04334941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300804|NCT04334941|Immunologic Factors|immunologic factors|mesh-ancestor
101300805|NCT04334941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300806|NCT04334941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101300807|NCT04334941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101300808|NCT04324606|Acetaminophen|acetaminophen|mesh-list
101300809|NCT04324606|Vaccines|vaccines|mesh-list
101822360|NCT05484622|Pembrolizumab|pembrolizumab|mesh-list
101822361|NCT05484622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101822362|NCT05484622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312967|NCT00007033|Anesthetics|anesthetics|mesh-ancestor
101822363|NCT05484622|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101300810|NCT04324606|Immunologic Factors|immunologic factors|mesh-ancestor
101300811|NCT04324606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300812|NCT04324606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101300813|NCT04324606|Analgesics|analgesics|mesh-ancestor
101300814|NCT04324606|Sensory System Agents|sensory system agents|mesh-ancestor
101300815|NCT04324606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101300816|NCT04324606|Antipyretics|antipyretics|mesh-ancestor
101300818|NCT04321408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101300819|NCT04321408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101300820|NCT04321408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300821|NCT04321408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101300822|NCT04321408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300823|NCT04321408|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101300824|NCT04321408|Protective Agents|protective agents|mesh-ancestor
101300825|NCT04321408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101300827|NCT04321408|Sensory System Agents|sensory system agents|mesh-ancestor
101300828|NCT04321408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101300837|NCT04305054|Pembrolizumab|pembrolizumab|mesh-list
101300838|NCT04305054|Lenvatinib|lenvatinib|mesh-list
101300839|NCT04305054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101300840|NCT04305054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300841|NCT04305054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101300842|NCT04305054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300843|NCT04305054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101300844|NCT04305054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101300845|NCT04300309|Lumefantrine|lumefantrine|mesh-list
101300846|NCT04300309|Artemether|artemether|mesh-list
101300847|NCT04300309|Antimalarials|antimalarials|mesh-ancestor
101300848|NCT04300309|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101300849|NCT04300309|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101300850|NCT04300309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101300851|NCT04298606|Vaccines|vaccines|mesh-list
101300852|NCT04298606|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101300853|NCT04298606|Mitogens|mitogens|mesh-list
101300854|NCT04298606|Immunologic Factors|immunologic factors|mesh-ancestor
101300855|NCT04298606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300856|NCT04298606|Mitosis Modulators|mitosis modulators|mesh-ancestor
101300857|NCT04298606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300858|NCT04298606|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101300859|NCT04288089|Palbociclib|palbociclib|mesh-list
101300860|NCT04288089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300861|NCT04288089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101300862|NCT04288089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101300863|NCT04288089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300864|NCT04266938|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101300865|NCT04266938|Antiviral Agents|antiviral agents|mesh-ancestor
101300866|NCT04266938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101300867|NCT04254081|Lidocaine|lidocaine|mesh-list
101300868|NCT04254081|Buprenorphine|buprenorphine|mesh-list
101300869|NCT04254081|Anesthetics, Local|anesthetics, local|mesh-ancestor
101300870|NCT04254081|Anesthetics|anesthetics|mesh-ancestor
101300871|NCT04254081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101300872|NCT04254081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300873|NCT04254081|Sensory System Agents|sensory system agents|mesh-ancestor
101300874|NCT04254081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101300875|NCT04254081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101822364|NCT05484622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822365|NCT05465135|Artenimol|artenimol|mesh-list
101822366|NCT05465135|Antimalarials|antimalarials|mesh-ancestor
101822367|NCT05465135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101822368|NCT05465135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101822369|NCT05465135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101822370|NCT05425732|Vaccines|vaccines|mesh-list
101822371|NCT05425732|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101822372|NCT05425732|Immunologic Factors|immunologic factors|mesh-ancestor
101822373|NCT05425732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300876|NCT04254081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101300877|NCT04254081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101300878|NCT04254081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101300879|NCT04254081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317456|NCT00011089|Tenofovir|tenofovir|mesh-list
101300881|NCT04254081|Narcotics|narcotics|mesh-ancestor
101300882|NCT04254081|Analgesics|analgesics|mesh-ancestor
101300883|NCT04254081|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101300884|NCT04250948|Capecitabine|capecitabine|mesh-list
101300885|NCT04250948|Oxaliplatin|oxaliplatin|mesh-list
101300886|NCT04250948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101300887|NCT04250948|Antimetabolites|antimetabolites|mesh-ancestor
101300888|NCT04250948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300889|NCT04250948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300890|NCT04243122|Aspirin|aspirin|mesh-list
101300891|NCT04243122|Apixaban|apixaban|mesh-list
101300892|NCT04243122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101300893|NCT04243122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101300894|NCT04243122|Analgesics|analgesics|mesh-ancestor
101300895|NCT04243122|Sensory System Agents|sensory system agents|mesh-ancestor
101300896|NCT04243122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101300897|NCT04243122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300898|NCT04243122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101300899|NCT04243122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101300900|NCT04243122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101300901|NCT04243122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101300902|NCT04243122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300903|NCT04243122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101300904|NCT04243122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101300905|NCT04243122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101300906|NCT04243122|Antipyretics|antipyretics|mesh-ancestor
101300907|NCT04243122|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101300908|NCT04243122|Antithrombins|antithrombins|mesh-ancestor
101300909|NCT04243122|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101300910|NCT04243122|Protease Inhibitors|protease inhibitors|mesh-ancestor
101300911|NCT04243122|Anticoagulants|anticoagulants|mesh-ancestor
101300912|NCT04231760|Nitric Oxide|nitric oxide|mesh-list
101300913|NCT04231760|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101300914|NCT04231760|Autonomic Agents|autonomic agents|mesh-ancestor
101300915|NCT04231760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101300916|NCT04231760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300917|NCT04231760|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101300918|NCT04231760|Respiratory System Agents|respiratory system agents|mesh-ancestor
101300919|NCT04231760|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101300920|NCT04231760|Antioxidants|antioxidants|mesh-ancestor
101300921|NCT04231760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300922|NCT04231760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101300923|NCT04231760|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101300924|NCT04231760|Vasodilator Agents|vasodilator agents|mesh-ancestor
101300925|NCT04231760|Gasotransmitters|gasotransmitters|mesh-ancestor
101300926|NCT04231760|Protective Agents|protective agents|mesh-ancestor
101300927|NCT04230109|Pembrolizumab|pembrolizumab|mesh-list
101300928|NCT04230109|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
101300929|NCT04230109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101822375|NCT05389514|Gemcitabine|gemcitabine|mesh-list
101822376|NCT05389514|Pembrolizumab|pembrolizumab|mesh-list
101822377|NCT05389514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101822378|NCT05389514|Immunologic Factors|immunologic factors|mesh-ancestor
101822379|NCT05389514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822380|NCT05389514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101822381|NCT05389514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101300930|NCT04230109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300931|NCT04230109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101300932|NCT04230109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300933|NCT04230109|Immunoconjugates|immunoconjugates|mesh-ancestor
101300934|NCT04230109|Immunologic Factors|immunologic factors|mesh-ancestor
101300935|NCT04230109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300936|NCT04221191|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101300937|NCT04221191|Dermatologic Agents|dermatologic agents|mesh-ancestor
101300938|NCT04221191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101300939|NCT04221191|Immunologic Factors|immunologic factors|mesh-ancestor
101300940|NCT04221191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300941|NCT04209296|Ketamine|ketamine|mesh-list
101300942|NCT04209296|Analgesics|analgesics|mesh-ancestor
101300943|NCT04209296|Sensory System Agents|sensory system agents|mesh-ancestor
101300944|NCT04209296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101300945|NCT04209296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300946|NCT04209296|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101300947|NCT04209296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101300948|NCT04209296|Anesthetics, General|anesthetics, general|mesh-ancestor
101300950|NCT04209296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101300951|NCT04209296|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101300952|NCT04209296|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101300953|NCT04209296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101300954|NCT04209296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300955|NCT04181359|Nitric Oxide|nitric oxide|mesh-list
101300956|NCT04181359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101300957|NCT04181359|Autonomic Agents|autonomic agents|mesh-ancestor
101300958|NCT04181359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101300959|NCT04181359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300960|NCT04181359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101300961|NCT04181359|Respiratory System Agents|respiratory system agents|mesh-ancestor
101300962|NCT04181359|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101300963|NCT04181359|Antioxidants|antioxidants|mesh-ancestor
101300964|NCT04181359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300965|NCT04181359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101300966|NCT04181359|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101300967|NCT04181359|Vasodilator Agents|vasodilator agents|mesh-ancestor
101300968|NCT04181359|Gasotransmitters|gasotransmitters|mesh-ancestor
101300969|NCT04181359|Protective Agents|protective agents|mesh-ancestor
101300970|NCT04176705|Triamcinolone|triamcinolone|mesh-list
101300971|NCT04176705|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101300972|NCT04176705|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101300973|NCT04176705|Lidocaine|lidocaine|mesh-list
101300974|NCT04176705|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101300975|NCT04176705|Anesthetics, Local|anesthetics, local|mesh-ancestor
101300976|NCT04176705|Anesthetics|anesthetics|mesh-ancestor
101300977|NCT04176705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101300978|NCT04176705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300979|NCT04176705|Sensory System Agents|sensory system agents|mesh-ancestor
101300980|NCT04176705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101300981|NCT04176705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101300982|NCT04176705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101300983|NCT04176705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101300984|NCT04176705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101300985|NCT04176705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300986|NCT04176705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101822382|NCT05389514|Alkylating Agents|alkylating agents|mesh-ancestor
101822383|NCT05389514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822384|NCT05389514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101822385|NCT05389514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101822386|NCT05389514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101822387|NCT05389514|Antimetabolites|antimetabolites|mesh-ancestor
101300987|NCT04176705|Glucocorticoids|glucocorticoids|mesh-ancestor
101300988|NCT04176705|Hormones|hormones|mesh-ancestor
101300989|NCT04176705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101300990|NCT04176705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101300991|NCT04176705|Immunologic Factors|immunologic factors|mesh-ancestor
101300992|NCT04176705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101300993|NCT04175912|Paclitaxel|paclitaxel|mesh-list
101300994|NCT04175912|Carboplatin|carboplatin|mesh-list
101300995|NCT04175912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101300996|NCT04175912|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101300997|NCT04175912|Pevonedistat|pevonedistat|mesh-list
101300998|NCT04175912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101300999|NCT04175912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301000|NCT04175912|Tubulin Modulators|tubulin modulators|mesh-ancestor
101301001|NCT04175912|Antimitotic Agents|antimitotic agents|mesh-ancestor
101301002|NCT04175912|Mitosis Modulators|mitosis modulators|mesh-ancestor
101301003|NCT04175912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301004|NCT04166773|Tirzepatide|tirzepatide|mesh-list
101301005|NCT04166773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101301006|NCT04166773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301007|NCT04166773|Incretins|incretins|mesh-ancestor
101301008|NCT04166773|Hormones|hormones|mesh-ancestor
101301009|NCT04166773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101301010|NCT04122196|Pregabalin|pregabalin|mesh-list
101301011|NCT04122196|Analgesics|analgesics|mesh-ancestor
101301012|NCT04122196|Sensory System Agents|sensory system agents|mesh-ancestor
101301013|NCT04122196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101301014|NCT04122196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301015|NCT04122196|Anticonvulsants|anticonvulsants|mesh-ancestor
101301016|NCT04122196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101301017|NCT04122196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101301018|NCT04122196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301019|NCT04122196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101301020|NCT04122196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101301021|NCT04122196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101301022|NCT04122196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101301023|NCT04122196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101301025|NCT04106115|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101301026|NCT04106115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101301027|NCT04106115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301028|NCT04106115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101301029|NCT04106115|Immunologic Factors|immunologic factors|mesh-ancestor
101301030|NCT04106115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301031|NCT04105231|Cannabidiol|cannabidiol|mesh-list
101301032|NCT04105231|Risperidone|risperidone|mesh-list
101301033|NCT04105231|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101301034|NCT04105231|Serotonin Agents|serotonin agents|mesh-ancestor
101301035|NCT04105231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101301036|NCT04105231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301037|NCT04105231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301038|NCT04105231|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101301039|NCT04105231|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101301040|NCT04105231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101301041|NCT04105231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101301042|NCT04105231|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101301043|NCT04105231|Dopamine Agents|dopamine agents|mesh-ancestor
101301044|NCT04105231|Anticonvulsants|anticonvulsants|mesh-ancestor
101301045|NCT04073615|Trifluridine|trifluridine|mesh-list
101301046|NCT04073615|Apatinib|apatinib|mesh-list
101301047|NCT04073615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301048|NCT04073615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101301049|NCT04073615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101822388|NCT05389514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101822389|NCT05389514|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101822391|NCT05327777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101822392|NCT05327777|Narcotics|narcotics|mesh-ancestor
101822393|NCT05327777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101822394|NCT05327777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822395|NCT05327777|Analgesics|analgesics|mesh-ancestor
101822396|NCT05327777|Sensory System Agents|sensory system agents|mesh-ancestor
101822397|NCT05327777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101822398|NCT05309187|Pembrolizumab|pembrolizumab|mesh-list
101822399|NCT05309187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101822400|NCT05309187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301051|NCT04073615|Antimetabolites|antimetabolites|mesh-ancestor
101301052|NCT04073615|Antiviral Agents|antiviral agents|mesh-ancestor
101301053|NCT04073615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101301054|NCT04065399|Cobicistat|cobicistat|mesh-list
101301055|NCT04065399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101301056|NCT04065399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101301057|NCT04065399|Antiviral Agents|antiviral agents|mesh-ancestor
101301058|NCT04065399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101301059|NCT04065399|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101301060|NCT04065399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101301061|NCT04065399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101301062|NCT04065399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301063|NCT04058717|Nicotine|nicotine|mesh-list
101301064|NCT04058717|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101301065|NCT04058717|Autonomic Agents|autonomic agents|mesh-ancestor
101301066|NCT04058717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101301067|NCT04058717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301068|NCT04058717|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101301069|NCT04058717|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101301070|NCT04058717|Cholinergic Agents|cholinergic agents|mesh-ancestor
101301071|NCT04058717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101301072|NCT04058717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301073|NCT04050085|Nivolumab|nivolumab|mesh-list
101301074|NCT04050085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101301075|NCT04050085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301076|NCT04050085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101301077|NCT04050085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301078|NCT04042558|Bevacizumab|bevacizumab|mesh-list
101301079|NCT04042558|Atezolizumab|atezolizumab|mesh-list
101301080|NCT04042558|Carboplatin|carboplatin|mesh-list
101301082|NCT04042558|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101301083|NCT04042558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101301084|NCT04042558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301085|NCT04042558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101301086|NCT04042558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101301088|NCT04042558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301089|NCT04042558|Growth Inhibitors|growth inhibitors|mesh-ancestor
101301090|NCT04042558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101408954|NCT00110669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301091|NCT04042558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301092|NCT04042558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101301093|NCT04042558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101301094|NCT04042558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101301095|NCT04042558|Immunologic Factors|immunologic factors|mesh-ancestor
101301096|NCT04040946|Choline|choline|mesh-list
101301097|NCT04040946|Lipotropic Agents|lipotropic agents|mesh-ancestor
101301098|NCT04040946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101822401|NCT05309187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101822402|NCT05309187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822404|NCT05304546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101822405|NCT05304546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101822406|NCT05304546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101822407|NCT05304546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822408|NCT05261490|Doxorubicin|doxorubicin|mesh-list
101822409|NCT05261490|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101301099|NCT04040946|Antimetabolites|antimetabolites|mesh-ancestor
101301100|NCT04040946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301101|NCT04040946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101301102|NCT04040946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101301103|NCT04040946|Nootropic Agents|nootropic agents|mesh-ancestor
101301104|NCT04038099|Lidocaine|lidocaine|mesh-list
101301105|NCT04038099|Anesthetics, Local|anesthetics, local|mesh-ancestor
101301106|NCT04038099|Anesthetics|anesthetics|mesh-ancestor
101301107|NCT04038099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101301108|NCT04038099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301109|NCT04038099|Sensory System Agents|sensory system agents|mesh-ancestor
101301110|NCT04038099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101301111|NCT04038099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101301112|NCT04038099|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101301113|NCT04038099|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101301114|NCT04038099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101301115|NCT04038099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301116|NCT04034238|Tofacitinib|tofacitinib|mesh-list
101301117|NCT04034238|LMB-100|lmb-100|mesh-list
101301118|NCT04034238|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101301119|NCT04034238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101301120|NCT04034238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101301121|NCT04034238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301122|NCT04034238|Immunoconjugates|immunoconjugates|mesh-ancestor
101301123|NCT04034238|Immunologic Factors|immunologic factors|mesh-ancestor
101301124|NCT04034238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301125|NCT03994172|Calcium, Dietary|calcium, dietary|mesh-list
101301126|NCT03994172|Vitamin D|vitamin d|mesh-list
101301127|NCT03994172|Cholecalciferol|cholecalciferol|mesh-list
101301128|NCT03994172|Teriparatide|teriparatide|mesh-list
101301129|NCT03994172|Citric Acid|citric acid|mesh-list
101301130|NCT03994172|Sodium Citrate|sodium citrate|mesh-list
101301131|NCT03994172|Calcium|calcium|mesh-list
101301132|NCT03994172|Parathyroid Hormone|parathyroid hormone|mesh-list
101301133|NCT03994172|Cinacalcet|cinacalcet|mesh-list
101301134|NCT03994172|Hormones|hormones|mesh-list
101301135|NCT03994172|Vitamins|vitamins|mesh-ancestor
101301136|NCT03994172|Micronutrients|micronutrients|mesh-ancestor
101301137|NCT03994172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301138|NCT03994172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101301139|NCT03994172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101301140|NCT03994172|Anticoagulants|anticoagulants|mesh-ancestor
101301141|NCT03994172|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101301142|NCT03994172|Chelating Agents|chelating agents|mesh-ancestor
101301143|NCT03994172|Sequestering Agents|sequestering agents|mesh-ancestor
101301144|NCT03994172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301145|NCT03994172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101301146|NCT03994172|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101301147|NCT03994172|Hormone Antagonists|hormone antagonists|mesh-ancestor
101301150|NCT03978442|Bupropion|bupropion|mesh-list
101301151|NCT03978442|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101301152|NCT03978442|Antidepressive Agents|antidepressive agents|mesh-ancestor
101301153|NCT03978442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101301154|NCT03978442|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101301155|NCT03978442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101408960|NCT00113256|Rubitecan|rubitecan|mesh-list
101301156|NCT03978442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101822410|NCT05261490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101822411|NCT05261490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101822412|NCT05261490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101822413|NCT05261490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101822414|NCT05261490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101822415|NCT05261490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301157|NCT03978442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301158|NCT03978442|Dopamine Agents|dopamine agents|mesh-ancestor
101301159|NCT03978442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101301160|NCT03978442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301161|NCT03978442|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101301162|NCT03978442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101301163|NCT03978442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101301164|NCT03975829|Trametinib|trametinib|mesh-list
101301165|NCT03975829|Dabrafenib|dabrafenib|mesh-list
101301166|NCT03975829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301167|NCT03975829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101301168|NCT03975829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101301169|NCT03975829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301170|NCT03956966|Dexamethasone|dexamethasone|mesh-list
101301171|NCT03956966|Bupivacaine|bupivacaine|mesh-list
101301172|NCT03956966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101301173|NCT03956966|Antiemetics|antiemetics|mesh-ancestor
101301174|NCT03956966|Autonomic Agents|autonomic agents|mesh-ancestor
101301175|NCT03956966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101301176|NCT03956966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301177|NCT03956966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101301178|NCT03956966|Glucocorticoids|glucocorticoids|mesh-ancestor
101301179|NCT03956966|Hormones|hormones|mesh-ancestor
101301180|NCT03956966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101301181|NCT03956966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101301182|NCT03956966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301183|NCT03956966|Anesthetics, Local|anesthetics, local|mesh-ancestor
101301184|NCT03956966|Anesthetics|anesthetics|mesh-ancestor
101301185|NCT03956966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101301186|NCT03956966|Sensory System Agents|sensory system agents|mesh-ancestor
101301187|NCT03956056|Poly I-C|poly i-c|mesh-list
101301188|NCT03956056|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101301189|NCT03956056|Poly ICLC|poly iclc|mesh-list
101301190|NCT03956056|Interferon Inducers|interferon inducers|mesh-ancestor
101301191|NCT03956056|Immunologic Factors|immunologic factors|mesh-ancestor
101301192|NCT03956056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301193|NCT03956056|Laxatives|laxatives|mesh-ancestor
101301194|NCT03956056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101301195|NCT03956056|Antiviral Agents|antiviral agents|mesh-ancestor
101301196|NCT03956056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101301197|NCT03954041|Glyburide|glyburide|mesh-list
101301198|NCT03954041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101301199|NCT03954041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301202|NCT03950154|Bevacizumab|bevacizumab|mesh-list
101301203|NCT03950154|Capecitabine|capecitabine|mesh-list
101301204|NCT03950154|Oxaliplatin|oxaliplatin|mesh-list
101301205|NCT03950154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101301206|NCT03950154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301207|NCT03950154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101301208|NCT03950154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101301209|NCT03950154|Growth Substances|growth substances|mesh-ancestor
101301210|NCT03950154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301211|NCT03950154|Growth Inhibitors|growth inhibitors|mesh-ancestor
101301212|NCT03950154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101301213|NCT03950154|Antimetabolites|antimetabolites|mesh-ancestor
101301214|NCT03950154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301215|NCT03948867|Hydroxyurea|hydroxyurea|mesh-list
101301216|NCT03948867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301217|NCT03948867|Antisickling Agents|antisickling agents|mesh-ancestor
101301218|NCT03948867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101822416|NCT05234099|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101822417|NCT05234099|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101822418|NCT05234099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822420|NCT05180773|Rivaroxaban|rivaroxaban|mesh-list
101822421|NCT05180773|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101822422|NCT05180773|Antithrombins|antithrombins|mesh-ancestor
101822423|NCT05180773|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101822424|NCT05180773|Protease Inhibitors|protease inhibitors|mesh-ancestor
101822425|NCT05180773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101822426|NCT05180773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822427|NCT05180773|Anticoagulants|anticoagulants|mesh-ancestor
101822428|NCT05180773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101822429|NCT05180773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101822430|NCT05180773|Hormone Antagonists|hormone antagonists|mesh-ancestor
101822431|NCT05180773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101822432|NCT05180773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822433|NCT05180773|Dopamine Agonists|dopamine agonists|mesh-ancestor
101822434|NCT05180773|Dopamine Agents|dopamine agents|mesh-ancestor
101301219|NCT03948867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301220|NCT03948867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101301221|NCT03941860|Lenalidomide|lenalidomide|mesh-list
101301223|NCT03941860|Glycine|glycine|mesh-list
101301224|NCT03941860|Immunologic Factors|immunologic factors|mesh-ancestor
101301225|NCT03941860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301226|NCT03941860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101301227|NCT03941860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101301228|NCT03941860|Growth Substances|growth substances|mesh-ancestor
101301229|NCT03941860|Growth Inhibitors|growth inhibitors|mesh-ancestor
101301230|NCT03941860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301231|NCT03941860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301232|NCT03941860|Protease Inhibitors|protease inhibitors|mesh-ancestor
101301233|NCT03941860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101301234|NCT03941860|Glycine Agents|glycine agents|mesh-ancestor
101301235|NCT03941860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101301236|NCT03936829|Cyclophosphamide|cyclophosphamide|mesh-list
101301237|NCT03936829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101301238|NCT03936829|Immunologic Factors|immunologic factors|mesh-ancestor
101301239|NCT03936829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301240|NCT03936829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101301241|NCT03936829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101301242|NCT03936829|Alkylating Agents|alkylating agents|mesh-ancestor
101301243|NCT03936829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301244|NCT03936829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301245|NCT03936829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101301246|NCT03936023|Saxagliptin|saxagliptin|mesh-list
101301247|NCT03936023|Incretins|incretins|mesh-ancestor
101301248|NCT03936023|Hormones|hormones|mesh-ancestor
101301249|NCT03936023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101301250|NCT03936023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301251|NCT03936023|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101301252|NCT03936023|Protease Inhibitors|protease inhibitors|mesh-ancestor
101301253|NCT03936023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101822435|NCT05180773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101822436|NCT05092360|Paclitaxel|paclitaxel|mesh-list
101822437|NCT05092360|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101822438|NCT05092360|Gemcitabine|gemcitabine|mesh-list
101822439|NCT05092360|Doxorubicin|doxorubicin|mesh-list
101822440|NCT05092360|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101822441|NCT05092360|Pembrolizumab|pembrolizumab|mesh-list
101822442|NCT05092360|Topotecan|topotecan|mesh-list
101822443|NCT05092360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101822444|NCT05092360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101822445|NCT05092360|Tubulin Modulators|tubulin modulators|mesh-ancestor
101822446|NCT05092360|Antimitotic Agents|antimitotic agents|mesh-ancestor
101822447|NCT05092360|Mitosis Modulators|mitosis modulators|mesh-ancestor
101822448|NCT05092360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822449|NCT05092360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101822450|NCT05092360|Antimetabolites|antimetabolites|mesh-ancestor
101822451|NCT05092360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101822452|NCT05092360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101822453|NCT05092360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101822454|NCT05092360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101822455|NCT05092360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101822456|NCT05092360|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101822457|NCT05092360|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101822458|NCT05019430|Cocaine|cocaine|mesh-list
101301254|NCT03936023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301255|NCT03936023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101301256|NCT03896659|Hydrocortisone|hydrocortisone|mesh-list
101301257|NCT03896659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101301258|NCT03878199|Cytarabine|cytarabine|mesh-list
101301259|NCT03878199|Daunorubicin|daunorubicin|mesh-list
101301260|NCT03878199|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
101301261|NCT03878199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101301262|NCT03878199|Antimetabolites|antimetabolites|mesh-ancestor
101301263|NCT03878199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301264|NCT03878199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301265|NCT03878199|Antiviral Agents|antiviral agents|mesh-ancestor
101301266|NCT03878199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101301267|NCT03878199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101301268|NCT03878199|Immunologic Factors|immunologic factors|mesh-ancestor
101301269|NCT03878199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301270|NCT03878199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101301271|NCT03878199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101301272|NCT03878199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101301273|NCT03878199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101301274|NCT03878199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101301275|NCT03859024|Acetaminophen|acetaminophen|mesh-list
101301276|NCT03859024|Dexamethasone|dexamethasone|mesh-list
101301278|NCT03859024|Celecoxib|celecoxib|mesh-list
101301279|NCT03859024|Oxycodone|oxycodone|mesh-list
101301280|NCT03859024|Gabapentin|gabapentin|mesh-list
101301281|NCT03859024|Bupivacaine|bupivacaine|mesh-list
101301282|NCT03859024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101301283|NCT03859024|Antiemetics|antiemetics|mesh-ancestor
101301284|NCT03859024|Autonomic Agents|autonomic agents|mesh-ancestor
101822459|NCT05019430|Zolmitriptan|zolmitriptan|mesh-list
101822460|NCT05019430|Anesthetics, Local|anesthetics, local|mesh-ancestor
101822461|NCT05019430|Anesthetics|anesthetics|mesh-ancestor
101822462|NCT05019430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101822463|NCT05019430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822464|NCT05019430|Sensory System Agents|sensory system agents|mesh-ancestor
101822465|NCT05019430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101822466|NCT05019430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101822467|NCT05019430|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101822468|NCT05019430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101822469|NCT05019430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101822470|NCT05019430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822471|NCT05019430|Dopamine Agents|dopamine agents|mesh-ancestor
101822472|NCT05019430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101822473|NCT05019430|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101822474|NCT05019430|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101822475|NCT05019430|Serotonin Agents|serotonin agents|mesh-ancestor
101822476|NCT04957758|Varenicline|varenicline|mesh-list
101822477|NCT04957758|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101822478|NCT04957758|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101822479|NCT04957758|Cholinergic Agents|cholinergic agents|mesh-ancestor
101822480|NCT04957758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101301285|NCT03859024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101301286|NCT03859024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301287|NCT03859024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101301288|NCT03859024|Glucocorticoids|glucocorticoids|mesh-ancestor
101301289|NCT03859024|Hormones|hormones|mesh-ancestor
101301290|NCT03859024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101301291|NCT03859024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101301292|NCT03859024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301293|NCT03859024|Anesthetics, Local|anesthetics, local|mesh-ancestor
101301294|NCT03859024|Anesthetics|anesthetics|mesh-ancestor
101301295|NCT03859024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101301296|NCT03859024|Sensory System Agents|sensory system agents|mesh-ancestor
101301297|NCT03859024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101301298|NCT03859024|Analgesics|analgesics|mesh-ancestor
101301299|NCT03859024|Antipyretics|antipyretics|mesh-ancestor
101301300|NCT03859024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101301301|NCT03859024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101301302|NCT03859024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101301303|NCT03859024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101301304|NCT03859024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301305|NCT03859024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101301306|NCT03859024|Narcotics|narcotics|mesh-ancestor
101301307|NCT03859024|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101301308|NCT03859024|Anticonvulsants|anticonvulsants|mesh-ancestor
101301309|NCT03859024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101301310|NCT03859024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101301311|NCT03859024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101301312|NCT03859024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101301313|NCT03859024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101301314|NCT03859024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101822482|NCT04957758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822483|NCT04934722|Pembrolizumab|pembrolizumab|mesh-list
101822484|NCT04934722|Androgens|androgens|mesh-list
101822485|NCT04934722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101822486|NCT04934722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101822487|NCT04934722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101822488|NCT04934722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822489|NCT04934722|Hormones|hormones|mesh-ancestor
101822490|NCT04934722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101301315|NCT03859024|Antimanic Agents|antimanic agents|mesh-ancestor
101301316|NCT03830866|Carboplatin|carboplatin|mesh-list
101301318|NCT03830866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301319|NCT03830866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101301320|NCT03794388|Pregabalin|pregabalin|mesh-list
101301321|NCT03794388|Capsaicin|capsaicin|mesh-list
101301322|NCT03794388|Analgesics|analgesics|mesh-ancestor
101301323|NCT03794388|Sensory System Agents|sensory system agents|mesh-ancestor
101301324|NCT03794388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101301325|NCT03794388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301326|NCT03794388|Anticonvulsants|anticonvulsants|mesh-ancestor
101301327|NCT03794388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101301328|NCT03794388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101301329|NCT03794388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301330|NCT03794388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101301331|NCT03794388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101301332|NCT03794388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101301333|NCT03794388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101301334|NCT03794388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101301335|NCT03794388|Antipruritics|antipruritics|mesh-ancestor
101301336|NCT03794388|Dermatologic Agents|dermatologic agents|mesh-ancestor
101301337|NCT03783403|Rituximab|rituximab|mesh-list
101301338|NCT03783403|Cetuximab|cetuximab|mesh-list
101301339|NCT03783403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101301340|NCT03783403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301341|NCT03783403|Immunologic Factors|immunologic factors|mesh-ancestor
101301342|NCT03783403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301343|NCT03783403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101301371|NCT03707951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301372|NCT03707951|Antidotes|antidotes|mesh-ancestor
101301388|NCT03701282|Venetoclax|venetoclax|mesh-list
101301389|NCT03701282|Obinutuzumab|obinutuzumab|mesh-list
101301390|NCT03701282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301391|NCT03701282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101301393|NCT03679949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101301394|NCT03679949|Narcotics|narcotics|mesh-ancestor
101301395|NCT03679949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101301396|NCT03679949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301397|NCT03679949|Analgesics|analgesics|mesh-ancestor
101301398|NCT03679949|Sensory System Agents|sensory system agents|mesh-ancestor
101317483|NCT00011362|Hormones|hormones|mesh-ancestor
101301399|NCT03679949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101301400|NCT03679312|Nitric Oxide|nitric oxide|mesh-list
101301401|NCT03679312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101301402|NCT03679312|Autonomic Agents|autonomic agents|mesh-ancestor
101301403|NCT03679312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101301404|NCT03679312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301405|NCT03679312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101301406|NCT03679312|Respiratory System Agents|respiratory system agents|mesh-ancestor
101301407|NCT03679312|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101822491|NCT04934722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822492|NCT04920383|Pembrolizumab|pembrolizumab|mesh-list
101822493|NCT04920383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101822494|NCT04920383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101822495|NCT04920383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101301408|NCT03679312|Antioxidants|antioxidants|mesh-ancestor
101301409|NCT03679312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301410|NCT03679312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101301411|NCT03679312|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101301412|NCT03679312|Vasodilator Agents|vasodilator agents|mesh-ancestor
101301413|NCT03679312|Gasotransmitters|gasotransmitters|mesh-ancestor
101301414|NCT03679312|Protective Agents|protective agents|mesh-ancestor
101301415|NCT03637400|Doxycycline|doxycycline|mesh-list
101301416|NCT03637400|Trimethoprim|trimethoprim|mesh-list
101301417|NCT03637400|Sulfamethoxazole|sulfamethoxazole|mesh-list
101301418|NCT03637400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101301420|NCT03637400|Antimalarials|antimalarials|mesh-ancestor
101301421|NCT03637400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101301422|NCT03637400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101301423|NCT03637400|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101301424|NCT03637400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101301425|NCT03637400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101301426|NCT03637400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301427|NCT03637400|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101301428|NCT03637400|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101301429|NCT03637400|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101301431|NCT03631199|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101301432|NCT03631199|Carboplatin|carboplatin|mesh-list
101301433|NCT03631199|Pembrolizumab|pembrolizumab|mesh-list
101301435|NCT03631199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101301436|NCT03631199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101301437|NCT03631199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301438|NCT03631199|Tubulin Modulators|tubulin modulators|mesh-ancestor
101301439|NCT03631199|Antimitotic Agents|antimitotic agents|mesh-ancestor
101301440|NCT03631199|Mitosis Modulators|mitosis modulators|mesh-ancestor
101301441|NCT03631199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301442|NCT03631199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101301443|NCT03631199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101301444|NCT03631199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101301445|NCT03631199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101301446|NCT03631199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101301447|NCT03631199|Immunologic Factors|immunologic factors|mesh-ancestor
101301448|NCT03631199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301449|NCT03630666|Hormones|hormones|mesh-list
101301450|NCT03630666|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101301451|NCT03630666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101301452|NCT03630666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301453|NCT03607175|Triamcinolone|triamcinolone|mesh-list
101301454|NCT03607175|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101301455|NCT03607175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101301456|NCT03607175|Glucocorticoids|glucocorticoids|mesh-ancestor
101301457|NCT03607175|Hormones|hormones|mesh-ancestor
101301458|NCT03607175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101301459|NCT03607175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301460|NCT03607175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101301461|NCT03607175|Immunologic Factors|immunologic factors|mesh-ancestor
101301462|NCT03573024|Azacitidine|azacitidine|mesh-list
101301463|NCT03573024|Venetoclax|venetoclax|mesh-list
101301464|NCT03573024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101301465|NCT03573024|Antimetabolites|antimetabolites|mesh-ancestor
101301466|NCT03573024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301467|NCT03573024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301468|NCT03573024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101301469|NCT03560960|Pramlintide|pramlintide|mesh-list
101301470|NCT03560960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101301471|NCT03560960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301472|NCT03534323|Venetoclax|venetoclax|mesh-list
101301473|NCT03534323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101822496|NCT04920383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822497|NCT04899349|Metformin|metformin|mesh-list
101822498|NCT04899349|Dapagliflozin|dapagliflozin|mesh-list
101822499|NCT04899349|Fulvestrant|fulvestrant|mesh-list
101822500|NCT04899349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101822501|NCT04899349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822502|NCT04899349|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101822503|NCT04899349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822504|NCT04899349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101822505|NCT04899349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301474|NCT03520842|Methotrexate|methotrexate|mesh-list
101301475|NCT03520842|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101301476|NCT03520842|Abortifacient Agents|abortifacient agents|mesh-ancestor
101301477|NCT03520842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101301478|NCT03520842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301479|NCT03520842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101301480|NCT03520842|Antimetabolites|antimetabolites|mesh-ancestor
101301481|NCT03520842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301483|NCT03520842|Dermatologic Agents|dermatologic agents|mesh-ancestor
101301484|NCT03520842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101301485|NCT03520842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101301486|NCT03520842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101301487|NCT03520842|Immunologic Factors|immunologic factors|mesh-ancestor
101301488|NCT03520842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101301489|NCT03520842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101301490|NCT03479554|Antihypertensive Agents|antihypertensive agents|mesh-list
101301491|NCT03454529|Simvastatin|simvastatin|mesh-list
101301492|NCT03454529|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101301493|NCT03454529|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101301494|NCT03454529|Antimetabolites|antimetabolites|mesh-ancestor
101301495|NCT03454529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301496|NCT03454529|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101301497|NCT03454529|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101301498|NCT03454529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101301499|NCT03414658|Trastuzumab|trastuzumab|mesh-list
101301500|NCT03414658|Avelumab|avelumab|mesh-list
101301501|NCT03414658|Vinorelbine|vinorelbine|mesh-list
101301502|NCT03414658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101301503|NCT03414658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301504|NCT03414658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101301505|NCT03414658|Tubulin Modulators|tubulin modulators|mesh-ancestor
101301506|NCT03414658|Antimitotic Agents|antimitotic agents|mesh-ancestor
101301507|NCT03414658|Mitosis Modulators|mitosis modulators|mesh-ancestor
101301508|NCT03414658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301509|NCT03398148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101301510|NCT03398148|Immunologic Factors|immunologic factors|mesh-ancestor
101301511|NCT03398148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301512|NCT03377023|Nivolumab|nivolumab|mesh-list
101301513|NCT03377023|Ipilimumab|ipilimumab|mesh-list
101301514|NCT03377023|Nintedanib|nintedanib|mesh-list
101301515|NCT03377023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101301516|NCT03377023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301517|NCT03377023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101301518|NCT03377023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301519|NCT03377023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101301520|NCT03377023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101301521|NCT03358875|Docetaxel|docetaxel|mesh-list
101301522|NCT03358875|Tislelizumab|tislelizumab|mesh-list
101301523|NCT03358875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301524|NCT03358875|Tubulin Modulators|tubulin modulators|mesh-ancestor
101301525|NCT03358875|Antimitotic Agents|antimitotic agents|mesh-ancestor
101301526|NCT03358875|Mitosis Modulators|mitosis modulators|mesh-ancestor
101301527|NCT03358875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822506|NCT04899349|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101822507|NCT04899349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101822508|NCT04899349|Hormone Antagonists|hormone antagonists|mesh-ancestor
101822509|NCT04899349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101822510|NCT04897841|Bupivacaine|bupivacaine|mesh-list
101822511|NCT04897841|Anesthetics, Local|anesthetics, local|mesh-ancestor
101822512|NCT04897841|Anesthetics|anesthetics|mesh-ancestor
101822513|NCT04897841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101822514|NCT04897841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822515|NCT04897841|Sensory System Agents|sensory system agents|mesh-ancestor
101301528|NCT03358875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101301529|NCT03328884|Irinotecan|irinotecan|mesh-list
101301530|NCT03328884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101301531|NCT03328884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101301532|NCT03328884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101301533|NCT03328884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301534|NCT03328884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301535|NCT03301857|Denosumab|denosumab|mesh-list
101301536|NCT03301857|Immunoglobulins|immunoglobulins|mesh-list
101301537|NCT03301857|Immunoglobulin G|immunoglobulin g|mesh-list
101301538|NCT03301857|Immunologic Factors|immunologic factors|mesh-ancestor
101301540|NCT03301857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101301542|NCT03284502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101301543|NCT03284502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301545|NCT03277482|Tremelimumab|tremelimumab|mesh-list
101301546|NCT03277482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101301547|NCT03277482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301548|NCT03249142|Durvalumab|durvalumab|mesh-list
101301549|NCT03249142|Tremelimumab|tremelimumab|mesh-list
101301550|NCT03249142|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101301551|NCT03249142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101301552|NCT03249142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301553|NCT03249142|Immunologic Factors|immunologic factors|mesh-ancestor
101301554|NCT03249142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301555|NCT03236428|Daratumumab|daratumumab|mesh-list
101301556|NCT03236428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301557|NCT03201458|Atezolizumab|atezolizumab|mesh-list
101301558|NCT03201458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101301559|NCT03201458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101301560|NCT03201458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301561|NCT03201458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101301562|NCT03201458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301563|NCT03201458|Immunologic Factors|immunologic factors|mesh-ancestor
101301564|NCT03201458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301565|NCT03180502|Temozolomide|temozolomide|mesh-list
101301566|NCT03180502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101301567|NCT03180502|Alkylating Agents|alkylating agents|mesh-ancestor
101301568|NCT03180502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301569|NCT03180502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301575|NCT03149770|Naloxone|naloxone|mesh-list
101301576|NCT03149770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101301577|NCT03149770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301578|NCT03149770|Sensory System Agents|sensory system agents|mesh-ancestor
101301579|NCT03149770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101301580|NCT03095235|Riboflavin|riboflavin|mesh-list
101301581|NCT03095235|Vitamins|vitamins|mesh-ancestor
101301582|NCT03095235|Micronutrients|micronutrients|mesh-ancestor
101301583|NCT03095235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301584|NCT03095235|Vitamin B Complex|vitamin b complex|mesh-ancestor
101301585|NCT03095235|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101301586|NCT03095235|Dermatologic Agents|dermatologic agents|mesh-ancestor
101301587|NCT03092674|Cytarabine|cytarabine|mesh-list
101822516|NCT04897841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101822517|NCT04850599|Pomalidomide|pomalidomide|mesh-list
101822518|NCT04850599|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101822519|NCT04850599|Immunologic Factors|immunologic factors|mesh-ancestor
101822520|NCT04850599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822521|NCT04850599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101822522|NCT04850599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101822523|NCT04850599|Growth Substances|growth substances|mesh-ancestor
101301588|NCT03092674|Nivolumab|nivolumab|mesh-list
101301589|NCT03092674|Azacitidine|azacitidine|mesh-list
101301590|NCT03092674|Decitabine|decitabine|mesh-list
101301591|NCT03092674|Midostaurin|midostaurin|mesh-list
101301592|NCT03092674|Staurosporine|staurosporine|mesh-list
101301593|NCT03092674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101301594|NCT03092674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301595|NCT03092674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101301596|NCT03092674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301597|NCT03092674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101301598|NCT03092674|Antimetabolites|antimetabolites|mesh-ancestor
101301599|NCT03092674|Antiviral Agents|antiviral agents|mesh-ancestor
101301600|NCT03092674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101301601|NCT03092674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101301602|NCT03092674|Immunologic Factors|immunologic factors|mesh-ancestor
101301603|NCT03092674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301604|NCT03092674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101301605|NCT03092674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101301608|NCT03077542|Alemtuzumab|alemtuzumab|mesh-list
101301609|NCT03077542|Hydroxyurea|hydroxyurea|mesh-list
101301610|NCT03077542|Pentostatin|pentostatin|mesh-list
101301611|NCT03077542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101301612|NCT03077542|Immunologic Factors|immunologic factors|mesh-ancestor
101301613|NCT03077542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301614|NCT03077542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101301615|NCT03077542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101301616|NCT03077542|Alkylating Agents|alkylating agents|mesh-ancestor
101301617|NCT03077542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301618|NCT03077542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301619|NCT03077542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101301620|NCT03077542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101301621|NCT03077542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101301622|NCT03077542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101301623|NCT03077542|Antifungal Agents|antifungal agents|mesh-ancestor
101301624|NCT03077542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101301625|NCT03077542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101301626|NCT03077542|Antisickling Agents|antisickling agents|mesh-ancestor
101301627|NCT03077542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101301628|NCT03077542|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
101301629|NCT03055377|Acetylcysteine|acetylcysteine|mesh-list
101301630|NCT03055377|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101301631|NCT03055377|Antiviral Agents|antiviral agents|mesh-ancestor
101301632|NCT03055377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101301633|NCT03055377|Expectorants|expectorants|mesh-ancestor
101301634|NCT03055377|Respiratory System Agents|respiratory system agents|mesh-ancestor
101301635|NCT03055377|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101301636|NCT03055377|Antioxidants|antioxidants|mesh-ancestor
101301637|NCT03055377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301638|NCT03055377|Protective Agents|protective agents|mesh-ancestor
101301639|NCT03055377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301640|NCT03055377|Antidotes|antidotes|mesh-ancestor
101301641|NCT03016819|Dacarbazine|dacarbazine|mesh-list
101301642|NCT03016819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101301643|NCT03016819|Alkylating Agents|alkylating agents|mesh-ancestor
101301644|NCT03016819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301645|NCT03016819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301647|NCT03012971|Morphine|morphine|mesh-list
101301648|NCT03012971|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101301649|NCT03012971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101822525|NCT04850599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101822526|NCT04827134|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
101822527|NCT04827134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101822528|NCT04827134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101822529|NCT04827134|Antiviral Agents|antiviral agents|mesh-ancestor
101479826|NCT00321477|Casopitant|casopitant|mesh-list
101822530|NCT04827134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101301650|NCT03012971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301651|NCT03012971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101301652|NCT03012971|Analgesics|analgesics|mesh-ancestor
101301653|NCT03012971|Sensory System Agents|sensory system agents|mesh-ancestor
101301654|NCT03012971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101301655|NCT03012971|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101301656|NCT03012971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101301657|NCT03012971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101301658|NCT03012971|Adrenergic Agents|adrenergic agents|mesh-ancestor
101301659|NCT03012971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101301660|NCT03012971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301661|NCT03012971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101301662|NCT03012971|Narcotics|narcotics|mesh-ancestor
101301663|NCT02965963|Dopamine|dopamine|mesh-list
101301664|NCT02965963|Metoclopramide|metoclopramide|mesh-list
101301665|NCT02965963|Antiemetics|antiemetics|mesh-ancestor
101301666|NCT02965963|Autonomic Agents|autonomic agents|mesh-ancestor
101301668|NCT02965963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301670|NCT02965963|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101301671|NCT02965963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101301672|NCT02965963|Dopamine Agents|dopamine agents|mesh-ancestor
101301673|NCT02965963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101301674|NCT02965963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301675|NCT02965963|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101301676|NCT02965963|Sympathomimetics|sympathomimetics|mesh-ancestor
101301677|NCT02965963|Protective Agents|protective agents|mesh-ancestor
101301678|NCT02960659|Metformin|metformin|mesh-list
101301679|NCT02960659|Liraglutide|liraglutide|mesh-list
101301680|NCT02960659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101301681|NCT02960659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301682|NCT02960659|Incretins|incretins|mesh-ancestor
101301683|NCT02960659|Hormones|hormones|mesh-ancestor
101301684|NCT02960659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101301685|NCT02953509|Rituximab|rituximab|mesh-list
101301686|NCT02953509|Magrolimab|magrolimab|mesh-list
101301687|NCT02953509|Gemcitabine|gemcitabine|mesh-list
101301688|NCT02953509|Oxaliplatin|oxaliplatin|mesh-list
101301689|NCT02953509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101301690|NCT02953509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301691|NCT02953509|Immunologic Factors|immunologic factors|mesh-ancestor
101301692|NCT02953509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317490|NCT00001212|Cyclosporine|cyclosporine|mesh-list
101301693|NCT02953509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101301694|NCT02953509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101301696|NCT02953509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301698|NCT02936622|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101301699|NCT02936622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101301700|NCT02936622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301701|NCT02936622|Tubulin Modulators|tubulin modulators|mesh-ancestor
101301702|NCT02936622|Antimitotic Agents|antimitotic agents|mesh-ancestor
101301703|NCT02936622|Mitosis Modulators|mitosis modulators|mesh-ancestor
101301704|NCT02936622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301727|NCT02916771|Dexamethasone|dexamethasone|mesh-list
101301728|NCT02916771|Lenalidomide|lenalidomide|mesh-list
101301729|NCT02916771|Ixazomib|ixazomib|mesh-list
101301730|NCT02916771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101301731|NCT02916771|Antiemetics|antiemetics|mesh-ancestor
101301732|NCT02916771|Autonomic Agents|autonomic agents|mesh-ancestor
101301733|NCT02916771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101301734|NCT02916771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822531|NCT04792073|Avelumab|avelumab|mesh-list
101822532|NCT04792073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101822533|NCT04792073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101822544|NCT04736953|Sirolimus|sirolimus|mesh-list
101822545|NCT04736953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101822546|NCT04736953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101822547|NCT04736953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101822548|NCT04736953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101822549|NCT04736953|Antifungal Agents|antifungal agents|mesh-ancestor
101822550|NCT04736953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101301735|NCT02916771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101301736|NCT02916771|Glucocorticoids|glucocorticoids|mesh-ancestor
101301737|NCT02916771|Hormones|hormones|mesh-ancestor
101301738|NCT02916771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101301739|NCT02916771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101301740|NCT02916771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301741|NCT02916771|Immunologic Factors|immunologic factors|mesh-ancestor
101301742|NCT02916771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101301743|NCT02916771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101301744|NCT02916771|Growth Substances|growth substances|mesh-ancestor
101301745|NCT02916771|Growth Inhibitors|growth inhibitors|mesh-ancestor
101301746|NCT02916771|Protease Inhibitors|protease inhibitors|mesh-ancestor
101301747|NCT02916771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101301748|NCT02916771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301749|NCT02913196|Prednisone|prednisone|mesh-list
101301750|NCT02913196|Docetaxel|docetaxel|mesh-list
101301752|NCT02913196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301753|NCT02913196|Tubulin Modulators|tubulin modulators|mesh-ancestor
101301754|NCT02913196|Antimitotic Agents|antimitotic agents|mesh-ancestor
101301755|NCT02913196|Mitosis Modulators|mitosis modulators|mesh-ancestor
101301756|NCT02913196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301757|NCT02913196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101301758|NCT02913196|Glucocorticoids|glucocorticoids|mesh-ancestor
101301759|NCT02913196|Hormones|hormones|mesh-ancestor
101301760|NCT02913196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101301761|NCT02913196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301762|NCT02913196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101301763|NCT02913196|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101301765|NCT02913196|Hormone Antagonists|hormone antagonists|mesh-ancestor
101301766|NCT02913196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101301767|NCT02912559|Calcium, Dietary|calcium, dietary|mesh-list
101301768|NCT02912559|Leucovorin|leucovorin|mesh-list
101301769|NCT02912559|Folic Acid|folic acid|mesh-list
101301770|NCT02912559|Fluorouracil|fluorouracil|mesh-list
101301771|NCT02912559|Oxaliplatin|oxaliplatin|mesh-list
101301772|NCT02912559|Atezolizumab|atezolizumab|mesh-list
101301773|NCT02912559|Calcium|calcium|mesh-list
101301774|NCT02912559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101301775|NCT02912559|Levoleucovorin|levoleucovorin|mesh-list
101301776|NCT02912559|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101301777|NCT02912559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301778|NCT02912559|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101301779|NCT02912559|Antimetabolites|antimetabolites|mesh-ancestor
101301780|NCT02912559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301781|NCT02912559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101301782|NCT02912559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301783|NCT02912559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101301784|NCT02912559|Immunologic Factors|immunologic factors|mesh-ancestor
101301785|NCT02912559|Antidotes|antidotes|mesh-ancestor
101301786|NCT02912559|Protective Agents|protective agents|mesh-ancestor
101301787|NCT02912559|Vitamin B Complex|vitamin b complex|mesh-ancestor
101301788|NCT02912559|Vitamins|vitamins|mesh-ancestor
101301789|NCT02912559|Micronutrients|micronutrients|mesh-ancestor
101301790|NCT02912559|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101301791|NCT02912559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101301792|NCT02912559|Hematinics|hematinics|mesh-ancestor
101822551|NCT04736953|Immunologic Factors|immunologic factors|mesh-ancestor
101822552|NCT04736953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822553|NCT04725617|Varenicline|varenicline|mesh-list
101822554|NCT04725617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101822555|NCT04725617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101822556|NCT04725617|Cholinergic Agents|cholinergic agents|mesh-ancestor
101301793|NCT02890355|Calcium, Dietary|calcium, dietary|mesh-list
101301794|NCT02890355|Leucovorin|leucovorin|mesh-list
101301795|NCT02890355|Folic Acid|folic acid|mesh-list
101301796|NCT02890355|Fluorouracil|fluorouracil|mesh-list
101301797|NCT02890355|Irinotecan|irinotecan|mesh-list
101301798|NCT02890355|Veliparib|veliparib|mesh-list
101301799|NCT02890355|Camptothecin|camptothecin|mesh-list
101301800|NCT02890355|Calcium|calcium|mesh-list
101301801|NCT02890355|Levoleucovorin|levoleucovorin|mesh-list
101301802|NCT02890355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101301803|NCT02890355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301804|NCT02890355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101301805|NCT02890355|Antimetabolites|antimetabolites|mesh-ancestor
101301806|NCT02890355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301807|NCT02890355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101301808|NCT02890355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301809|NCT02890355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101301810|NCT02890355|Immunologic Factors|immunologic factors|mesh-ancestor
101301811|NCT02890355|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101301812|NCT02890355|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101301813|NCT02890355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101301814|NCT02890355|Antidotes|antidotes|mesh-ancestor
101301815|NCT02890355|Protective Agents|protective agents|mesh-ancestor
101301816|NCT02890355|Vitamin B Complex|vitamin b complex|mesh-ancestor
101301817|NCT02890355|Vitamins|vitamins|mesh-ancestor
101301818|NCT02890355|Micronutrients|micronutrients|mesh-ancestor
101301819|NCT02890355|Hematinics|hematinics|mesh-ancestor
101301820|NCT02890355|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101301821|NCT02890355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101301822|NCT02890082|Tamoxifen|tamoxifen|mesh-list
101301823|NCT02890082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101301824|NCT02890082|Hormone Antagonists|hormone antagonists|mesh-ancestor
101301825|NCT02890082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101301826|NCT02890082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301827|NCT02890082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101301828|NCT02890082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317499|NCT00001212|Alkylating Agents|alkylating agents|mesh-ancestor
101301829|NCT02890082|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101301830|NCT02890082|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101301831|NCT02890082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101301832|NCT02844933|Cannabidiol|cannabidiol|mesh-list
101301833|NCT02844933|Anticonvulsants|anticonvulsants|mesh-ancestor
101301834|NCT02844816|Atezolizumab|atezolizumab|mesh-list
101301835|NCT02844816|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101301836|NCT02844816|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101301837|NCT02844816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301838|NCT02844816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101301839|NCT02844816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301840|NCT02844816|Immunologic Factors|immunologic factors|mesh-ancestor
101301841|NCT02844816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301842|NCT02842749|Everolimus|everolimus|mesh-list
101301843|NCT02842749|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101301844|NCT02842749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101301845|NCT02842749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101301846|NCT02842749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301847|NCT02842749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101301848|NCT02842749|Immunologic Factors|immunologic factors|mesh-ancestor
101301849|NCT02842749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301850|NCT02842749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301851|NCT02834013|Nivolumab|nivolumab|mesh-list
101301852|NCT02834013|Ipilimumab|ipilimumab|mesh-list
101301853|NCT02834013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101301854|NCT02834013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301855|NCT02834013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101822557|NCT04725617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101822558|NCT04725617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822559|NCT04725617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822560|NCT04707391|Vaccines|vaccines|mesh-list
101822561|NCT04707391|Immunologic Factors|immunologic factors|mesh-ancestor
101822562|NCT04707391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822563|NCT04703075|Rifapentine|rifapentine|mesh-list
101822564|NCT04703075|Rifampin|rifampin|mesh-list
101822565|NCT04703075|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101822566|NCT04703075|Antitubercular Agents|antitubercular agents|mesh-ancestor
101822567|NCT04703075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101822568|NCT04703075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101822569|NCT04703075|Leprostatic Agents|leprostatic agents|mesh-ancestor
101822570|NCT04703075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101822571|NCT04703075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101822572|NCT04703075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822573|NCT04703075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101822574|NCT04703075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101822575|NCT04703075|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101822576|NCT04703075|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101822577|NCT04703075|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101822578|NCT04703075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101822579|NCT04702737|AMG 757|amg 757|mesh-list
101822580|NCT04702737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101822581|NCT04685421|Bupivacaine|bupivacaine|mesh-list
101822582|NCT04685421|Anesthetics, Local|anesthetics, local|mesh-ancestor
101822583|NCT04685421|Anesthetics|anesthetics|mesh-ancestor
101822584|NCT04685421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101822585|NCT04685421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822586|NCT04685421|Sensory System Agents|sensory system agents|mesh-ancestor
101822587|NCT04685421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101822588|NCT04682158|Paclitaxel|paclitaxel|mesh-list
101822589|NCT04682158|Carboplatin|carboplatin|mesh-list
101822590|NCT04682158|Propranolol|propranolol|mesh-list
101822592|NCT04682158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101822596|NCT04682158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822597|NCT04682158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101822598|NCT04682158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101822599|NCT04682158|Adrenergic Agents|adrenergic agents|mesh-ancestor
101822600|NCT04682158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101822601|NCT04682158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822602|NCT04682158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101822603|NCT04682158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101822604|NCT04682158|Vasodilator Agents|vasodilator agents|mesh-ancestor
101822606|NCT04680975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101822607|NCT04680975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101301856|NCT02834013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301857|NCT02831764|Tenofovir|tenofovir|mesh-list
101301858|NCT02831764|Lamivudine|lamivudine|mesh-list
101301859|NCT02831764|Emtricitabine|emtricitabine|mesh-list
101301860|NCT02831764|Dolutegravir|dolutegravir|mesh-list
101301861|NCT02831764|Antiviral Agents|antiviral agents|mesh-ancestor
101301862|NCT02831764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101301863|NCT02831764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101301864|NCT02831764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101301865|NCT02831764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101301866|NCT02831764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301867|NCT02831764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101301868|NCT02831764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101301869|NCT02831764|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101301870|NCT02831764|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101301871|NCT02797470|Cytarabine|cytarabine|mesh-list
101301872|NCT02797470|Etoposide|etoposide|mesh-list
101301873|NCT02797470|Podophyllotoxin|podophyllotoxin|mesh-list
101301874|NCT02797470|Etoposide phosphate|etoposide phosphate|mesh-list
101301875|NCT02797470|Melphalan|melphalan|mesh-list
101301876|NCT02797470|Mechlorethamine|mechlorethamine|mesh-list
101301877|NCT02797470|Carmustine|carmustine|mesh-list
101301878|NCT02797470|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
101301879|NCT02797470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101301880|NCT02797470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301881|NCT02797470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101301882|NCT02797470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101301883|NCT02797470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101301884|NCT02797470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301885|NCT02797470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101301886|NCT02797470|Antimetabolites|antimetabolites|mesh-ancestor
101301887|NCT02797470|Antiviral Agents|antiviral agents|mesh-ancestor
101301888|NCT02797470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101301889|NCT02797470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101301890|NCT02797470|Immunologic Factors|immunologic factors|mesh-ancestor
101301891|NCT02797470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301892|NCT02797470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101301893|NCT02797470|Alkylating Agents|alkylating agents|mesh-ancestor
101301894|NCT02797470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101301895|NCT02797470|Keratolytic Agents|keratolytic agents|mesh-ancestor
101301896|NCT02797470|Dermatologic Agents|dermatologic agents|mesh-ancestor
101301897|NCT02797470|Tubulin Modulators|tubulin modulators|mesh-ancestor
101301898|NCT02797470|Antimitotic Agents|antimitotic agents|mesh-ancestor
101301899|NCT02797470|Mitosis Modulators|mitosis modulators|mesh-ancestor
101301902|NCT02744690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101301903|NCT02744690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301904|NCT02744690|Alkylating Agents|alkylating agents|mesh-ancestor
101301905|NCT02744690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301906|NCT02744690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101301907|NCT02744690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101301908|NCT02721459|Vemurafenib|vemurafenib|mesh-list
101822608|NCT04680975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822610|NCT04673786|Dermatologic Agents|dermatologic agents|mesh-ancestor
101822611|NCT04605978|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101822612|NCT04602533|Durvalumab|durvalumab|mesh-list
101822613|NCT04602533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101822614|NCT04602533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301909|NCT02721459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301910|NCT02721459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101301911|NCT02721459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101301912|NCT02721459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301913|NCT02705820|Pembrolizumab|pembrolizumab|mesh-list
101301914|NCT02705820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101301915|NCT02705820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301916|NCT02705820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101301917|NCT02705820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301918|NCT02642042|Docetaxel|docetaxel|mesh-list
101301919|NCT02642042|Trametinib|trametinib|mesh-list
101301920|NCT02642042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301921|NCT02642042|Tubulin Modulators|tubulin modulators|mesh-ancestor
101301922|NCT02642042|Antimitotic Agents|antimitotic agents|mesh-ancestor
101301923|NCT02642042|Mitosis Modulators|mitosis modulators|mesh-ancestor
101301924|NCT02642042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301925|NCT02642042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101301926|NCT02642042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101301927|NCT02595905|Cisplatin|cisplatin|mesh-list
101301928|NCT02595905|Veliparib|veliparib|mesh-list
101301929|NCT02595905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301930|NCT02595905|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101301931|NCT02595905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101301932|NCT02595905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301933|NCT02582775|Mycophenolic Acid|mycophenolic acid|mesh-list
101301934|NCT02582775|Cyclophosphamide|cyclophosphamide|mesh-list
101301935|NCT02582775|Busulfan|busulfan|mesh-list
101301936|NCT02582775|Fludarabine|fludarabine|mesh-list
101301937|NCT02582775|Fludarabine phosphate|fludarabine phosphate|mesh-list
101301938|NCT02582775|Tacrolimus|tacrolimus|mesh-list
101301939|NCT02582775|Thymoglobulin|thymoglobulin|mesh-list
101301940|NCT02582775|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101301941|NCT02582775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101301942|NCT02582775|Immunologic Factors|immunologic factors|mesh-ancestor
101301943|NCT02582775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301944|NCT02582775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101301945|NCT02582775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101301946|NCT02582775|Alkylating Agents|alkylating agents|mesh-ancestor
101301947|NCT02582775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301948|NCT02582775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301949|NCT02582775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101301950|NCT02582775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101301951|NCT02582775|Antimetabolites|antimetabolites|mesh-ancestor
101301952|NCT02582775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101301954|NCT02582775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101301955|NCT02582775|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101301956|NCT02582775|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101301957|NCT02582775|Antitubercular Agents|antitubercular agents|mesh-ancestor
101301958|NCT02582775|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101301960|NCT02506517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301961|NCT02506517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101301962|NCT02506517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101301963|NCT02506517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301964|NCT02499835|Pembrolizumab|pembrolizumab|mesh-list
101301965|NCT02499835|Immunoglobulins|immunoglobulins|mesh-list
101301966|NCT02499835|Immunoglobulin G|immunoglobulin g|mesh-list
101301967|NCT02499835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101301968|NCT02499835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301969|NCT02499835|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101301970|NCT02499835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301971|NCT02499835|Immunologic Factors|immunologic factors|mesh-ancestor
101822615|NCT04597671|Durvalumab|durvalumab|mesh-list
101822616|NCT04597671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101822617|NCT04597671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101822618|NCT04583969|Remdesivir|remdesivir|mesh-list
101822619|NCT04583969|Lenzilumab|lenzilumab|mesh-list
101822620|NCT04583969|Antimetabolites|antimetabolites|mesh-ancestor
101822621|NCT04583969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301972|NCT02499835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301973|NCT02496663|Osimertinib|osimertinib|mesh-list
101301974|NCT02496663|Necitumumab|necitumumab|mesh-list
101301975|NCT02496663|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101301976|NCT02496663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301977|NCT02496663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301978|NCT02496663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101301979|NCT02496663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101301980|NCT02496663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101301981|NCT02496663|Immunologic Factors|immunologic factors|mesh-ancestor
101301982|NCT02496663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301983|NCT02460497|Minoxidil|minoxidil|mesh-list
101301984|NCT02460497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101301985|NCT02460497|Vasodilator Agents|vasodilator agents|mesh-ancestor
101301986|NCT02460289|Minoxidil|minoxidil|mesh-list
101301987|NCT02460289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101301988|NCT02460289|Vasodilator Agents|vasodilator agents|mesh-ancestor
101301989|NCT02311933|Tamoxifen|tamoxifen|mesh-list
101301990|NCT02311933|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101301991|NCT02311933|Hormone Antagonists|hormone antagonists|mesh-ancestor
101301992|NCT02311933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101301993|NCT02311933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301994|NCT02311933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101301995|NCT02311933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301996|NCT02311933|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101301997|NCT02311933|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101301998|NCT02311933|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101301999|NCT02286154|Hydroxyurea|hydroxyurea|mesh-list
101302000|NCT02286154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302001|NCT02286154|Antisickling Agents|antisickling agents|mesh-ancestor
101302002|NCT02286154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101302003|NCT02286154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302004|NCT02286154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101302005|NCT02274779|Leuprolide|leuprolide|mesh-list
101302006|NCT02274779|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101302007|NCT02274779|Fertility Agents|fertility agents|mesh-ancestor
101302008|NCT02274779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101408979|NCT00456820|Dopamine Agents|dopamine agents|mesh-ancestor
101302009|NCT02274779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302010|NCT02274779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101302011|NCT02274779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302012|NCT02261883|Treprostinil|treprostinil|mesh-list
101302013|NCT02261883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101302014|NCT02253316|Dexamethasone|dexamethasone|mesh-list
101302015|NCT02253316|Dexamethasone acetate|dexamethasone acetate|mesh-list
101302016|NCT02253316|Lenalidomide|lenalidomide|mesh-list
101302017|NCT02253316|Ixazomib|ixazomib|mesh-list
101302018|NCT02253316|BB 1101|bb 1101|mesh-list
101302019|NCT02253316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101302020|NCT02253316|Antiemetics|antiemetics|mesh-ancestor
101302021|NCT02253316|Autonomic Agents|autonomic agents|mesh-ancestor
101302022|NCT02253316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101302023|NCT02253316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302024|NCT02253316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101302025|NCT02253316|Glucocorticoids|glucocorticoids|mesh-ancestor
101302026|NCT02253316|Hormones|hormones|mesh-ancestor
101302027|NCT02253316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101302028|NCT02253316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101302029|NCT02253316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302030|NCT02253316|Protease Inhibitors|protease inhibitors|mesh-ancestor
101302031|NCT02253316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101302032|NCT02253316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302033|NCT02253316|Immunologic Factors|immunologic factors|mesh-ancestor
101822622|NCT04583969|Antiviral Agents|antiviral agents|mesh-ancestor
101822623|NCT04583969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101822624|NCT04583969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101822625|NCT04575857|Atorvastatin|atorvastatin|mesh-list
101822626|NCT04575857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101822627|NCT04575857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101822628|NCT04575857|Antimetabolites|antimetabolites|mesh-ancestor
101822629|NCT04575857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822630|NCT04575857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101302034|NCT02253316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101302035|NCT02253316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101302036|NCT02253316|Growth Substances|growth substances|mesh-ancestor
101302037|NCT02253316|Growth Inhibitors|growth inhibitors|mesh-ancestor
101302038|NCT02231749|Nivolumab|nivolumab|mesh-list
101302039|NCT02231749|Ipilimumab|ipilimumab|mesh-list
101302040|NCT02231749|Sunitinib|sunitinib|mesh-list
101302041|NCT02231749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101302042|NCT02231749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302043|NCT02231749|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101302044|NCT02231749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302045|NCT02231749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101302046|NCT02231749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101302047|NCT02231749|Growth Substances|growth substances|mesh-ancestor
101302048|NCT02231749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302049|NCT02231749|Growth Inhibitors|growth inhibitors|mesh-ancestor
101302050|NCT02231749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101302051|NCT02231749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101302052|NCT02224781|Nivolumab|nivolumab|mesh-list
101302053|NCT02224781|Ipilimumab|ipilimumab|mesh-list
101302054|NCT02224781|Trametinib|trametinib|mesh-list
101302055|NCT02224781|Dabrafenib|dabrafenib|mesh-list
101302056|NCT02224781|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
101302057|NCT02224781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101302058|NCT02224781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302059|NCT02224781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101302060|NCT02224781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302061|NCT02224781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101302062|NCT02224781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101302063|NCT02224781|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101302064|NCT02224781|Protective Agents|protective agents|mesh-ancestor
101302065|NCT02224781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302066|NCT02224781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101302067|NCT02224781|Antioxidants|antioxidants|mesh-ancestor
101302068|NCT02196181|Trametinib|trametinib|mesh-list
101302069|NCT02196181|Dabrafenib|dabrafenib|mesh-list
101302070|NCT02196181|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
101302071|NCT02196181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302072|NCT02196181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101302073|NCT02196181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101302074|NCT02196181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302075|NCT02196181|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101302076|NCT02196181|Protective Agents|protective agents|mesh-ancestor
101302077|NCT02196181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302078|NCT02196181|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101302079|NCT02196181|Antioxidants|antioxidants|mesh-ancestor
101302080|NCT02193282|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101302081|NCT02193282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302082|NCT02193282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101302083|NCT02193282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101302084|NCT02193282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302086|NCT02169089|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101302087|NCT02169089|Hormone Antagonists|hormone antagonists|mesh-ancestor
101302088|NCT02169089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101302089|NCT02169089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302090|NCT02169089|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101302091|NCT02169089|Diuretics|diuretics|mesh-ancestor
101822631|NCT04575857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101822632|NCT04575857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101822633|NCT04561115|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101822634|NCT04561115|Immunologic Factors|immunologic factors|mesh-ancestor
101822635|NCT04561115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822636|NCT04546425|Vaccines|vaccines|mesh-list
101822637|NCT04546425|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101822638|NCT04546425|Immunologic Factors|immunologic factors|mesh-ancestor
101822639|NCT04546425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822640|NCT04502706|Rituximab|rituximab|mesh-list
101302092|NCT02169089|Natriuretic Agents|natriuretic agents|mesh-ancestor
101302093|NCT02130453|Regadenoson|regadenoson|mesh-list
101302094|NCT02130453|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
101302095|NCT02130453|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101302096|NCT02130453|Purinergic Agonists|purinergic agonists|mesh-ancestor
101302097|NCT02130453|Purinergic Agents|purinergic agents|mesh-ancestor
101302098|NCT02130453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101302099|NCT02130453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302100|NCT02130453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302101|NCT02074839|Ivosidenib|ivosidenib|mesh-list
101302102|NCT02074839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302103|NCT02074839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101302104|NCT02074839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302105|NCT02059265|Dasatinib|dasatinib|mesh-list
101302106|NCT02059265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302107|NCT02059265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101302108|NCT02059265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101302109|NCT02059265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302110|NCT02003222|Cytarabine|cytarabine|mesh-list
101302111|NCT02003222|Dexamethasone|dexamethasone|mesh-list
101302112|NCT02003222|Dexamethasone acetate|dexamethasone acetate|mesh-list
101302113|NCT02003222|Prednisone|prednisone|mesh-list
101302114|NCT02003222|Cortisone|cortisone|mesh-list
101302115|NCT02003222|Cyclophosphamide|cyclophosphamide|mesh-list
101302116|NCT02003222|Rituximab|rituximab|mesh-list
101302117|NCT02003222|Methotrexate|methotrexate|mesh-list
101302119|NCT02003222|Vincristine|vincristine|mesh-list
101302120|NCT02003222|Etoposide phosphate|etoposide phosphate|mesh-list
101302121|NCT02003222|Daunorubicin|daunorubicin|mesh-list
101302122|NCT02003222|Asparaginase|asparaginase|mesh-list
101302123|NCT02003222|Mercaptopurine|mercaptopurine|mesh-list
101302124|NCT02003222|Podophyllotoxin|podophyllotoxin|mesh-list
101302125|NCT02003222|Pegaspargase|pegaspargase|mesh-list
101302126|NCT02003222|Blinatumomab|blinatumomab|mesh-list
101302127|NCT02003222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101302128|NCT02003222|Muromonab-CD3|muromonab-cd3|mesh-list
101302129|NCT02003222|Antibodies|antibodies|mesh-list
101302130|NCT02003222|Immunoglobulins|immunoglobulins|mesh-list
101302131|NCT02003222|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101302132|NCT02003222|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101302133|NCT02003222|BB 1101|bb 1101|mesh-list
101302134|NCT02003222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101302135|NCT02003222|Immunologic Factors|immunologic factors|mesh-ancestor
101302136|NCT02003222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302137|NCT02003222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101302138|NCT02003222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101302139|NCT02003222|Alkylating Agents|alkylating agents|mesh-ancestor
101302140|NCT02003222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302141|NCT02003222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302142|NCT02003222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101302143|NCT02003222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101302144|NCT02003222|Antiemetics|antiemetics|mesh-ancestor
101302145|NCT02003222|Autonomic Agents|autonomic agents|mesh-ancestor
101302146|NCT02003222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101302147|NCT02003222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101302148|NCT02003222|Glucocorticoids|glucocorticoids|mesh-ancestor
101302149|NCT02003222|Hormones|hormones|mesh-ancestor
101302150|NCT02003222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101822641|NCT04502706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101822642|NCT04502706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101822643|NCT04502706|Immunologic Factors|immunologic factors|mesh-ancestor
101822644|NCT04502706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822645|NCT04502706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101822646|NCT04486833|Cisplatin|cisplatin|mesh-list
101822647|NCT04486833|Carboplatin|carboplatin|mesh-list
101302151|NCT02003222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101302152|NCT02003222|Protease Inhibitors|protease inhibitors|mesh-ancestor
101302153|NCT02003222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101302154|NCT02003222|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101302155|NCT02003222|Abortifacient Agents|abortifacient agents|mesh-ancestor
101302156|NCT02003222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101302157|NCT02003222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101302158|NCT02003222|Antimetabolites|antimetabolites|mesh-ancestor
101302159|NCT02003222|Dermatologic Agents|dermatologic agents|mesh-ancestor
101302160|NCT02003222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101302161|NCT02003222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101302162|NCT02003222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101302163|NCT02003222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101302164|NCT02003222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101302165|NCT02003222|Antiviral Agents|antiviral agents|mesh-ancestor
101302166|NCT02003222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101302167|NCT02003222|Tubulin Modulators|tubulin modulators|mesh-ancestor
101302168|NCT02003222|Antimitotic Agents|antimitotic agents|mesh-ancestor
101302169|NCT02003222|Mitosis Modulators|mitosis modulators|mesh-ancestor
101302170|NCT02003222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101302171|NCT02003222|Keratolytic Agents|keratolytic agents|mesh-ancestor
101302172|NCT01990352|Doxorubicin|doxorubicin|mesh-list
101302173|NCT01990352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101302174|NCT01990352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101302175|NCT01990352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302176|NCT01990352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101302177|NCT01990352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101302178|NCT01990352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101302179|NCT01990352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302180|NCT01886872|Rituximab|rituximab|mesh-list
101302181|NCT01886872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101302182|NCT01886872|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101302183|NCT01886872|Antibodies|antibodies|mesh-list
101302184|NCT01886872|Immunoglobulins|immunoglobulins|mesh-list
101302185|NCT01886872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101302186|NCT01886872|Immunologic Factors|immunologic factors|mesh-ancestor
101302187|NCT01886872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302188|NCT01886872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302189|NCT01886872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101302190|NCT01886872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101302191|NCT01886872|Alkylating Agents|alkylating agents|mesh-ancestor
101302192|NCT01886872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302193|NCT01856192|Prednisone|prednisone|mesh-list
101302194|NCT01856192|Cortisone|cortisone|mesh-list
101302195|NCT01856192|Cyclophosphamide|cyclophosphamide|mesh-list
101302196|NCT01856192|Rituximab|rituximab|mesh-list
101302197|NCT01856192|Doxorubicin|doxorubicin|mesh-list
101302198|NCT01856192|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101302199|NCT01856192|Vincristine|vincristine|mesh-list
101302200|NCT01856192|Lenalidomide|lenalidomide|mesh-list
101302201|NCT01856192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101302202|NCT01856192|Antibodies|antibodies|mesh-list
101302203|NCT01856192|Immunoglobulins|immunoglobulins|mesh-list
101302204|NCT01856192|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101302205|NCT01856192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101302206|NCT01856192|Immunologic Factors|immunologic factors|mesh-ancestor
101302207|NCT01856192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302208|NCT01856192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101302209|NCT01856192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101302210|NCT01856192|Alkylating Agents|alkylating agents|mesh-ancestor
101302211|NCT01856192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302212|NCT01856192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302213|NCT01856192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101822649|NCT04486833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101822650|NCT04486833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101822651|NCT04486833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101822652|NCT04486833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822653|NCT04468776|Zolpidem|zolpidem|mesh-list
101822654|NCT04468776|Trazodone|trazodone|mesh-list
101822655|NCT04468776|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101822656|NCT04468776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101302214|NCT01856192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101302215|NCT01856192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101302216|NCT01856192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101302217|NCT01856192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101302218|NCT01856192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101302219|NCT01856192|Glucocorticoids|glucocorticoids|mesh-ancestor
101302220|NCT01856192|Hormones|hormones|mesh-ancestor
101302221|NCT01856192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101302222|NCT01856192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101302223|NCT01856192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101302224|NCT01856192|Tubulin Modulators|tubulin modulators|mesh-ancestor
101302226|NCT01856192|Mitosis Modulators|mitosis modulators|mesh-ancestor
101302227|NCT01856192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101302228|NCT01856192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101302229|NCT01856192|Growth Substances|growth substances|mesh-ancestor
101302230|NCT01856192|Growth Inhibitors|growth inhibitors|mesh-ancestor
101302231|NCT01757418|Immunoglobulins|immunoglobulins|mesh-list
101302232|NCT01757418|Antibodies|antibodies|mesh-list
101302233|NCT01757418|gamma-Globulins|gamma-globulins|mesh-list
101302234|NCT01757418|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101302235|NCT01757418|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101302236|NCT01757418|Immunologic Factors|immunologic factors|mesh-ancestor
101302237|NCT01757418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302238|NCT01708954|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101302239|NCT01708954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302240|NCT01708954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101302241|NCT01708954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101302242|NCT01708954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302243|NCT01708941|Interferons|interferons|mesh-list
101302244|NCT01708941|Interferon-alpha|interferon-alpha|mesh-list
101302245|NCT01708941|Interferon alpha-2|interferon alpha-2|mesh-list
101302246|NCT01708941|Ipilimumab|ipilimumab|mesh-list
101302247|NCT01708941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302248|NCT01708941|Antiviral Agents|antiviral agents|mesh-ancestor
101302249|NCT01708941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101302250|NCT01708941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101302251|NCT01708941|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101302252|NCT01708941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302253|NCT01708941|Immunologic Factors|immunologic factors|mesh-ancestor
101302254|NCT01708941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302255|NCT01661647|Anesthetics|anesthetics|mesh-list
101302256|NCT01661647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101302257|NCT01661647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302258|NCT01592370|Dexamethasone|dexamethasone|mesh-list
101302259|NCT01592370|Nivolumab|nivolumab|mesh-list
101302260|NCT01592370|Ipilimumab|ipilimumab|mesh-list
101302261|NCT01592370|Daratumumab|daratumumab|mesh-list
101302262|NCT01592370|Pomalidomide|pomalidomide|mesh-list
101302263|NCT01592370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101302264|NCT01592370|Antiemetics|antiemetics|mesh-ancestor
101302265|NCT01592370|Autonomic Agents|autonomic agents|mesh-ancestor
101302266|NCT01592370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101302267|NCT01592370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302268|NCT01592370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101302269|NCT01592370|Glucocorticoids|glucocorticoids|mesh-ancestor
101302270|NCT01592370|Hormones|hormones|mesh-ancestor
101302271|NCT01592370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101822657|NCT04468776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101822658|NCT04468776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822659|NCT04468776|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101822660|NCT04468776|GABA Agonists|gaba agonists|mesh-ancestor
101822661|NCT04468776|GABA Agents|gaba agents|mesh-ancestor
101822662|NCT04468776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101822663|NCT04468776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822664|NCT04468776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101822665|NCT04468776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101822666|NCT04468776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101302272|NCT01592370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101302273|NCT01592370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302274|NCT01592370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101302275|NCT01592370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101302276|NCT01592370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302277|NCT01592370|Immunologic Factors|immunologic factors|mesh-ancestor
101302278|NCT01592370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101302279|NCT01592370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101302280|NCT01592370|Growth Substances|growth substances|mesh-ancestor
101302281|NCT01592370|Growth Inhibitors|growth inhibitors|mesh-ancestor
101302282|NCT01522976|Lenalidomide|lenalidomide|mesh-list
101302283|NCT01522976|Azacitidine|azacitidine|mesh-list
101302284|NCT01522976|Vorinostat|vorinostat|mesh-list
101302285|NCT01522976|Immunologic Factors|immunologic factors|mesh-ancestor
101302286|NCT01522976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302287|NCT01522976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101302288|NCT01522976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101302289|NCT01522976|Growth Substances|growth substances|mesh-ancestor
101302290|NCT01522976|Growth Inhibitors|growth inhibitors|mesh-ancestor
101302291|NCT01522976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302292|NCT01522976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101302293|NCT01522976|Antimetabolites|antimetabolites|mesh-ancestor
101302294|NCT01522976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302295|NCT01522976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101302296|NCT01522976|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101302297|NCT01386385|Paclitaxel|paclitaxel|mesh-list
101302298|NCT01386385|Carboplatin|carboplatin|mesh-list
101302299|NCT01386385|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101302300|NCT01386385|Veliparib|veliparib|mesh-list
101302301|NCT01386385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101302302|NCT01386385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302303|NCT01386385|Tubulin Modulators|tubulin modulators|mesh-ancestor
101302304|NCT01386385|Antimitotic Agents|antimitotic agents|mesh-ancestor
101302305|NCT01386385|Mitosis Modulators|mitosis modulators|mesh-ancestor
101302306|NCT01386385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302307|NCT01386385|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101302308|NCT01386385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101302309|NCT01274338|Interferons|interferons|mesh-list
101302310|NCT01274338|Interferon-alpha|interferon-alpha|mesh-list
101302311|NCT01274338|Interferon alpha-2|interferon alpha-2|mesh-list
101302312|NCT01274338|Ipilimumab|ipilimumab|mesh-list
101302313|NCT01274338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302314|NCT01274338|Antiviral Agents|antiviral agents|mesh-ancestor
101302315|NCT01274338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101302316|NCT01274338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101302317|NCT01274338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101302318|NCT01274338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302320|NCT01274338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302321|NCT01196390|Paclitaxel|paclitaxel|mesh-list
101302322|NCT01196390|Carboplatin|carboplatin|mesh-list
101302323|NCT01196390|Trastuzumab|trastuzumab|mesh-list
101302324|NCT01196390|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101302325|NCT01196390|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
101302326|NCT01196390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101822667|NCT04468776|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101822668|NCT04468776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101822669|NCT04468776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101822670|NCT04468776|Serotonin Agents|serotonin agents|mesh-ancestor
101822671|NCT04468776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101822672|NCT04468776|Antidepressive Agents|antidepressive agents|mesh-ancestor
101822673|NCT04461639|Factor VIII|factor viii|mesh-list
101822674|NCT04461639|Coagulants|coagulants|mesh-ancestor
101822675|NCT04456673|Cholinergic Agents|cholinergic agents|mesh-list
101302327|NCT01196390|Antibodies|antibodies|mesh-list
101302328|NCT01196390|Immunoglobulins|immunoglobulins|mesh-list
101302329|NCT01196390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101302330|NCT01196390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101302331|NCT01196390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302332|NCT01196390|Tubulin Modulators|tubulin modulators|mesh-ancestor
101302333|NCT01196390|Antimitotic Agents|antimitotic agents|mesh-ancestor
101302334|NCT01196390|Mitosis Modulators|mitosis modulators|mesh-ancestor
101302335|NCT01196390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302336|NCT01196390|Immunologic Factors|immunologic factors|mesh-ancestor
101302337|NCT01196390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302338|NCT01169337|Lenalidomide|lenalidomide|mesh-list
101302339|NCT01169337|Immunologic Factors|immunologic factors|mesh-ancestor
101302340|NCT01169337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302341|NCT01169337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101302342|NCT01169337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101302343|NCT01169337|Growth Substances|growth substances|mesh-ancestor
101302344|NCT01169337|Growth Inhibitors|growth inhibitors|mesh-ancestor
101302345|NCT01169337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302346|NCT01167712|Paclitaxel|paclitaxel|mesh-list
101302347|NCT01167712|Bevacizumab|bevacizumab|mesh-list
101302348|NCT01167712|Carboplatin|carboplatin|mesh-list
101302349|NCT01167712|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101302350|NCT01167712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101302351|NCT01167712|Endothelial Growth Factors|endothelial growth factors|mesh-list
101302352|NCT01167712|Antibodies|antibodies|mesh-list
101302353|NCT01167712|Immunoglobulins|immunoglobulins|mesh-list
101302354|NCT01167712|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101302355|NCT01167712|Immunoglobulin G|immunoglobulin g|mesh-list
101302356|NCT01167712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101302357|NCT01167712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302358|NCT01167712|Tubulin Modulators|tubulin modulators|mesh-ancestor
101302359|NCT01167712|Antimitotic Agents|antimitotic agents|mesh-ancestor
101302360|NCT01167712|Mitosis Modulators|mitosis modulators|mesh-ancestor
101302361|NCT01167712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302362|NCT01167712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101302363|NCT01167712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101302364|NCT01167712|Growth Substances|growth substances|mesh-ancestor
101302365|NCT01167712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302366|NCT01167712|Growth Inhibitors|growth inhibitors|mesh-ancestor
101302367|NCT01167712|Immunologic Factors|immunologic factors|mesh-ancestor
101302368|NCT01149083|Carboplatin|carboplatin|mesh-list
101302369|NCT01149083|Veliparib|veliparib|mesh-list
101302370|NCT01149083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302371|NCT01149083|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101302372|NCT01149083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101302373|NCT01149083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302374|NCT01142388|Paclitaxel|paclitaxel|mesh-list
101302375|NCT01142388|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101302376|NCT01142388|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101302377|NCT01142388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101302378|NCT01142388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302379|NCT01142388|Tubulin Modulators|tubulin modulators|mesh-ancestor
101302380|NCT01142388|Antimitotic Agents|antimitotic agents|mesh-ancestor
101302381|NCT01142388|Mitosis Modulators|mitosis modulators|mesh-ancestor
101302382|NCT01142388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822676|NCT04456673|Muscarinic Antagonists|muscarinic antagonists|mesh-list
101822677|NCT04456673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101822678|NCT04456673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822679|NCT04456673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479969|NCT00323544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101822680|NCT04456673|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101822682|NCT04416269|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101302383|NCT01142388|Immunologic Factors|immunologic factors|mesh-ancestor
101302384|NCT01142388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302385|NCT01134614|Ipilimumab|ipilimumab|mesh-list
101302386|NCT01134614|Sargramostim|sargramostim|mesh-list
101302387|NCT01134614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101302388|NCT01134614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302389|NCT01134614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101302390|NCT01134614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302391|NCT01134614|Immunologic Factors|immunologic factors|mesh-ancestor
101302392|NCT01134614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302393|NCT01130519|Bevacizumab|bevacizumab|mesh-list
101302394|NCT01130519|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101302395|NCT01130519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101302396|NCT01130519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302397|NCT01130519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101302398|NCT01130519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101302399|NCT01130519|Growth Substances|growth substances|mesh-ancestor
101302400|NCT01130519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302401|NCT01130519|Growth Inhibitors|growth inhibitors|mesh-ancestor
101302402|NCT01130519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101302403|NCT01130519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101302404|NCT01130519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302406|NCT00977574|Paclitaxel|paclitaxel|mesh-list
101302407|NCT00977574|Epothilones|epothilones|mesh-list
101302408|NCT00977574|Epothilone B|epothilone b|mesh-list
101302409|NCT00977574|Bevacizumab|bevacizumab|mesh-list
101302410|NCT00977574|Carboplatin|carboplatin|mesh-list
101302411|NCT00977574|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101302412|NCT00977574|Temsirolimus|temsirolimus|mesh-list
101302413|NCT00977574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101302414|NCT00977574|MTOR Inhibitors|mtor inhibitors|mesh-list
101302415|NCT00977574|Endothelial Growth Factors|endothelial growth factors|mesh-list
101302416|NCT00977574|Antibodies|antibodies|mesh-list
101302417|NCT00977574|Immunoglobulins|immunoglobulins|mesh-list
101302418|NCT00977574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101302419|NCT00977574|Immunoglobulin G|immunoglobulin g|mesh-list
101302420|NCT00977574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101302421|NCT00977574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302422|NCT00977574|Tubulin Modulators|tubulin modulators|mesh-ancestor
101302423|NCT00977574|Antimitotic Agents|antimitotic agents|mesh-ancestor
101302424|NCT00977574|Mitosis Modulators|mitosis modulators|mesh-ancestor
101302425|NCT00977574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302426|NCT00977574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101302427|NCT00977574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101302428|NCT00977574|Growth Substances|growth substances|mesh-ancestor
101302429|NCT00977574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302430|NCT00977574|Growth Inhibitors|growth inhibitors|mesh-ancestor
101302431|NCT00977574|Immunologic Factors|immunologic factors|mesh-ancestor
101302432|NCT00977574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101302433|NCT00977574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101302434|NCT00977574|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101302435|NCT00977574|Antifungal Agents|antifungal agents|mesh-ancestor
101302436|NCT00977574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101302437|NCT00977574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101302438|NCT00977574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101302439|NCT00769379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101302440|NCT00769379|Trastuzumab|trastuzumab|mesh-list
101302447|NCT00769379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302448|NCT00655967|Acamprosate|acamprosate|mesh-list
101302449|NCT00655967|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101822683|NCT04416269|Metformin|metformin|mesh-list
101822684|NCT04416269|Pioglitazone|pioglitazone|mesh-list
101822685|NCT04416269|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
101822686|NCT04416269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101822687|NCT04416269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822688|NCT04416269|Protease Inhibitors|protease inhibitors|mesh-ancestor
101822689|NCT04416269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101246520|NCT01666522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101302450|NCT00601198|Leucovorin|leucovorin|mesh-list
101302451|NCT00601198|Oxaliplatin|oxaliplatin|mesh-list
101302452|NCT00601198|Levoleucovorin|levoleucovorin|mesh-list
101302453|NCT00601198|Amifostine|amifostine|mesh-list
101302454|NCT00601198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302455|NCT00601198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302456|NCT00601198|Antidotes|antidotes|mesh-ancestor
101302457|NCT00601198|Protective Agents|protective agents|mesh-ancestor
101302458|NCT00601198|Vitamin B Complex|vitamin b complex|mesh-ancestor
101302459|NCT00601198|Vitamins|vitamins|mesh-ancestor
101302460|NCT00601198|Micronutrients|micronutrients|mesh-ancestor
101302461|NCT00601198|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101302462|NCT00588770|Bevacizumab|bevacizumab|mesh-list
101302463|NCT00588770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101302464|NCT00588770|Cisplatin|cisplatin|mesh-list
101302465|NCT00588770|Carboplatin|carboplatin|mesh-list
101302466|NCT00588770|Docetaxel|docetaxel|mesh-list
101302467|NCT00588770|Fluorouracil|fluorouracil|mesh-list
101302468|NCT00588770|Endothelial Growth Factors|endothelial growth factors|mesh-list
101302469|NCT00588770|Antibodies|antibodies|mesh-list
101302470|NCT00588770|Immunoglobulins|immunoglobulins|mesh-list
101302471|NCT00588770|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101302472|NCT00588770|Immunoglobulin G|immunoglobulin g|mesh-list
101302473|NCT00588770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302474|NCT00588770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101302475|NCT00588770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101302476|NCT00588770|Growth Substances|growth substances|mesh-ancestor
101302477|NCT00588770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302478|NCT00588770|Growth Inhibitors|growth inhibitors|mesh-ancestor
101302479|NCT00588770|Immunologic Factors|immunologic factors|mesh-ancestor
101302480|NCT00588770|Tubulin Modulators|tubulin modulators|mesh-ancestor
101302481|NCT00588770|Antimitotic Agents|antimitotic agents|mesh-ancestor
101302482|NCT00588770|Mitosis Modulators|mitosis modulators|mesh-ancestor
101302483|NCT00588770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302484|NCT00588770|Antimetabolites|antimetabolites|mesh-ancestor
101302485|NCT00588770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101302486|NCT00588770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101302526|NCT00433511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302527|NCT00433511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101302528|NCT00433511|Immunologic Factors|immunologic factors|mesh-ancestor
101302529|NCT00433511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302532|NCT00433511|Alkylating Agents|alkylating agents|mesh-ancestor
101302533|NCT00433511|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101302534|NCT00433511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101302535|NCT00433511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101302536|NCT00433511|Growth Substances|growth substances|mesh-ancestor
101302537|NCT00433511|Growth Inhibitors|growth inhibitors|mesh-ancestor
101302538|NCT00433511|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101302539|NCT00433511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101302540|NCT00433511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101302541|NCT00433511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101302542|NCT00324805|Bevacizumab|bevacizumab|mesh-list
101302543|NCT00324805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101302544|NCT00324805|Cisplatin|cisplatin|mesh-list
101302545|NCT00324805|Gemcitabine|gemcitabine|mesh-list
101302546|NCT00324805|Docetaxel|docetaxel|mesh-list
101302547|NCT00324805|Pemetrexed|pemetrexed|mesh-list
101302548|NCT00324805|Vinorelbine|vinorelbine|mesh-list
101302549|NCT00324805|Endothelial Growth Factors|endothelial growth factors|mesh-list
101302550|NCT00324805|Antibodies|antibodies|mesh-list
101302551|NCT00324805|Immunoglobulins|immunoglobulins|mesh-list
101302552|NCT00324805|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101302553|NCT00324805|Immunoglobulin G|immunoglobulin g|mesh-list
101302554|NCT00324805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101646176|NCT02582476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646177|NCT04078204|3-n-butylphthalide|3-n-butylphthalide|mesh-list
101646178|NCT04078204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101646179|NCT04078204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101646180|NCT04078204|Protective Agents|protective agents|mesh-ancestor
101646181|NCT04078204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646182|NCT00668707|Melatonin|melatonin|mesh-list
101646183|NCT00668707|Antioxidants|antioxidants|mesh-ancestor
101646184|NCT00668707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646185|NCT00668707|Protective Agents|protective agents|mesh-ancestor
101646186|NCT00668707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646187|NCT00668707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101646188|NCT00766909|Cyclosporine|cyclosporine|mesh-list
101646189|NCT00766909|Tacrolimus|tacrolimus|mesh-list
101646191|NCT00766909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101646192|NCT00766909|Immunologic Factors|immunologic factors|mesh-ancestor
101646193|NCT00766909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646194|NCT00766909|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101646195|NCT00766909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101646196|NCT00766909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646197|NCT00766909|Antifungal Agents|antifungal agents|mesh-ancestor
101646198|NCT00766909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101646199|NCT00766909|Dermatologic Agents|dermatologic agents|mesh-ancestor
101646200|NCT00766909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101646201|NCT00771433|Lenograstim|lenograstim|mesh-list
101646202|NCT00771433|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101535339|NCT00586443|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101646203|NCT00771433|Immunologic Factors|immunologic factors|mesh-ancestor
101646204|NCT00771433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646205|NCT00668395|Efavirenz|efavirenz|mesh-list
101646206|NCT00668395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101646207|NCT00668395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101646208|NCT00668395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101646209|NCT00668395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646210|NCT00668395|Antiviral Agents|antiviral agents|mesh-ancestor
101646211|NCT00668395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101646212|NCT00668395|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101646213|NCT00668395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101646214|NCT00668395|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101646215|NCT00668395|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101646216|NCT00668395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101646217|NCT00668395|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101646218|NCT00668317|Omeprazole|omeprazole|mesh-list
101646219|NCT00668317|Ranitidine|ranitidine|mesh-list
101646220|NCT00668317|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
101646221|NCT00668317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101646222|NCT00668317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101646223|NCT00668317|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101646224|NCT00668317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101646225|NCT00668317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646226|NCT00668317|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101646227|NCT00668317|Histamine Antagonists|histamine antagonists|mesh-ancestor
101646228|NCT00668317|Histamine Agents|histamine agents|mesh-ancestor
101646229|NCT00668317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101646230|NCT00668317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646232|NCT00775879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101646233|NCT00775879|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101646234|NCT00775879|Anesthetics, General|anesthetics, general|mesh-ancestor
101646235|NCT00775879|Anesthetics|anesthetics|mesh-ancestor
101646236|NCT00775879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101646237|NCT00775879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646238|NCT00767221|Budesonide|budesonide|mesh-list
101646239|NCT00767221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101646240|NCT00767221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101646241|NCT00767221|Autonomic Agents|autonomic agents|mesh-ancestor
101646242|NCT00767221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101646243|NCT00767221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646244|NCT00767221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101646245|NCT00767221|Respiratory System Agents|respiratory system agents|mesh-ancestor
101646246|NCT00767221|Glucocorticoids|glucocorticoids|mesh-ancestor
101646247|NCT00767221|Hormones|hormones|mesh-ancestor
101646248|NCT00767221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101646249|NCT04024072|Brinzolamide|brinzolamide|mesh-list
101646250|NCT04024072|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101646251|NCT04024072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101646252|NCT04024072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646253|NCT00771511|Capsaicin|capsaicin|mesh-list
101646254|NCT00771511|Antipruritics|antipruritics|mesh-ancestor
101646255|NCT00771511|Dermatologic Agents|dermatologic agents|mesh-ancestor
101646256|NCT00771511|Sensory System Agents|sensory system agents|mesh-ancestor
101646257|NCT00771511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101646258|NCT00771511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646259|NCT00776113|Carvedilol|carvedilol|mesh-list
101646260|NCT00776113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101646261|NCT00776113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101646262|NCT00776113|Adrenergic Agents|adrenergic agents|mesh-ancestor
101303354|NCT04567420|Palbociclib|palbociclib|mesh-list
101646263|NCT00776113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101646264|NCT00776113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646265|NCT00776113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646266|NCT00776113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101646267|NCT00776113|Antioxidants|antioxidants|mesh-ancestor
101646268|NCT00776113|Protective Agents|protective agents|mesh-ancestor
101646269|NCT00776113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101646270|NCT00776113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101646271|NCT00776113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101646272|NCT00776113|Vasodilator Agents|vasodilator agents|mesh-ancestor
101646273|NCT00776113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101646274|NCT00776113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101646275|NCT02580448|Seviteronel|seviteronel|mesh-list
101646276|NCT02580448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101646277|NCT02580448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101646278|NCT02580448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101646279|NCT02580448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646280|NCT04008238|Trabectedin|trabectedin|mesh-list
101646281|NCT04008238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101646282|NCT04008238|Alkylating Agents|alkylating agents|mesh-ancestor
101646283|NCT04008238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646284|NCT04008238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101646285|NCT00672139|Bromides|bromides|mesh-list
101646286|NCT00672139|Methylnaltrexone|methylnaltrexone|mesh-list
101646287|NCT00672139|Anticonvulsants|anticonvulsants|mesh-ancestor
101646288|NCT00672139|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101646289|NCT00672139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646290|NCT00672139|Sensory System Agents|sensory system agents|mesh-ancestor
101646291|NCT00672139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101646292|NCT02557789|Lefamulin|lefamulin|mesh-list
101646293|NCT02557789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101646294|NCT02557789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101646295|NCT00771823|Maraviroc|maraviroc|mesh-list
101646296|NCT00771823|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101646297|NCT00771823|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101646298|NCT00771823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646299|NCT00771823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101646300|NCT00771823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101646301|NCT00771823|Antiviral Agents|antiviral agents|mesh-ancestor
101646302|NCT00771823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101646303|NCT00771823|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101646304|NCT04219540|Buprenorphine|buprenorphine|mesh-list
101646305|NCT04219540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101646306|NCT04219540|Narcotics|narcotics|mesh-ancestor
101646307|NCT04219540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101646308|NCT04219540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646309|NCT04219540|Analgesics|analgesics|mesh-ancestor
101646310|NCT04219540|Sensory System Agents|sensory system agents|mesh-ancestor
101646311|NCT04219540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101646312|NCT04219540|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101646314|NCT03955042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101646315|NCT03955042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101646316|NCT03955042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646317|NCT03955042|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101646318|NCT03955042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101646319|NCT00570739|Metformin|metformin|mesh-list
101646320|NCT00570739|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
101646321|NCT00570739|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101646322|NCT00570739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646323|NCT00570739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101646324|NCT00570739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101646325|NCT00570739|Antimetabolites|antimetabolites|mesh-ancestor
101646326|NCT00570739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646327|NCT00570739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101646328|NCT04076098|Minocycline|minocycline|mesh-list
101646329|NCT04076098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101646330|NCT04076098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101646331|NCT00771979|Saracatinib|saracatinib|mesh-list
101646332|NCT00771979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101646333|NCT00771979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101646334|NCT00771979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646335|NCT00767689|Pyridoxine|pyridoxine|mesh-list
101646336|NCT00767689|Pyridoxal|pyridoxal|mesh-list
101303429|NCT04221087|Hormones|hormones|mesh-ancestor
101646337|NCT00767689|Vitamin B 6|vitamin b 6|mesh-list
101646338|NCT00767689|Vitamins|vitamins|mesh-ancestor
101646339|NCT00767689|Micronutrients|micronutrients|mesh-ancestor
101646340|NCT00767689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646341|NCT00767689|Vitamin B Complex|vitamin b complex|mesh-ancestor
101646342|NCT00772057|Propranolol|propranolol|mesh-list
101646343|NCT00772057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101646344|NCT00772057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101646345|NCT00772057|Adrenergic Agents|adrenergic agents|mesh-ancestor
101646346|NCT00772057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101646347|NCT00772057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646348|NCT00772057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646349|NCT00772057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101646350|NCT00772057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101646351|NCT00772057|Vasodilator Agents|vasodilator agents|mesh-ancestor
101646352|NCT00776347|Donepezil|donepezil|mesh-list
101646353|NCT00776347|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101646354|NCT00776347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101646355|NCT00776347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646356|NCT00776347|Cholinergic Agents|cholinergic agents|mesh-ancestor
101646357|NCT00776347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101646358|NCT00776347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646359|NCT00776347|Nootropic Agents|nootropic agents|mesh-ancestor
101646360|NCT00776425|Epoetin Alfa|epoetin alfa|mesh-list
101646361|NCT00776425|Hematinics|hematinics|mesh-ancestor
101822717|NCT04317534|Pembrolizumab|pembrolizumab|mesh-list
101646362|NCT03913702|Methylprednisolone|methylprednisolone|mesh-list
101646363|NCT03913702|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101646364|NCT03913702|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101646365|NCT03913702|Prednisolone|prednisolone|mesh-list
101646366|NCT03913702|Prednisolone acetate|prednisolone acetate|mesh-list
101646367|NCT03913702|Ketorolac|ketorolac|mesh-list
101646368|NCT03913702|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101646369|NCT03913702|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101646370|NCT03913702|Prednisolone phosphate|prednisolone phosphate|mesh-list
101646371|NCT03913702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101646372|NCT03913702|Antiemetics|antiemetics|mesh-ancestor
101646373|NCT03913702|Autonomic Agents|autonomic agents|mesh-ancestor
101646374|NCT03913702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101646375|NCT03913702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646376|NCT03913702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101646377|NCT03913702|Glucocorticoids|glucocorticoids|mesh-ancestor
101646378|NCT03913702|Hormones|hormones|mesh-ancestor
101646379|NCT03913702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101646380|NCT03913702|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101646381|NCT03913702|Protective Agents|protective agents|mesh-ancestor
101646382|NCT03913702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101646384|NCT03913702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101646385|NCT03913702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101646386|NCT03913702|Analgesics|analgesics|mesh-ancestor
101646387|NCT03913702|Sensory System Agents|sensory system agents|mesh-ancestor
101646388|NCT03913702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101646389|NCT03913702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101646390|NCT03913702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101646391|NCT03913702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646392|NCT03909412|Dexamethasone|dexamethasone|mesh-list
101646393|NCT03909412|Cyclophosphamide|cyclophosphamide|mesh-list
101646394|NCT03909412|Lenograstim|lenograstim|mesh-list
101646395|NCT03909412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101646396|NCT03909412|Immunologic Factors|immunologic factors|mesh-ancestor
101646397|NCT03909412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646398|NCT03909412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101646399|NCT03909412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101646400|NCT03909412|Alkylating Agents|alkylating agents|mesh-ancestor
101646401|NCT03909412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646402|NCT03909412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101646403|NCT03909412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101646404|NCT03909412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101646405|NCT03909412|Antiemetics|antiemetics|mesh-ancestor
101646406|NCT03909412|Autonomic Agents|autonomic agents|mesh-ancestor
101646407|NCT03909412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101646408|NCT03909412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101646409|NCT03909412|Glucocorticoids|glucocorticoids|mesh-ancestor
101646410|NCT03909412|Hormones|hormones|mesh-ancestor
101646411|NCT03909412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101646412|NCT03909412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101646413|NCT03909412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101646415|NCT00772135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646416|NCT00772135|Vasodilator Agents|vasodilator agents|mesh-ancestor
101646417|NCT00772135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101646418|NCT00772135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101646419|NCT00772135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101646420|NCT00772135|Urological Agents|urological agents|mesh-ancestor
101646421|NCT00776503|Vorinostat|vorinostat|mesh-list
101646422|NCT00776503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101646423|NCT00776503|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101646424|NCT00776503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101646425|NCT00776503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646426|NCT04075006|Ketamine|ketamine|mesh-list
101646427|NCT04075006|Analgesics|analgesics|mesh-ancestor
101646428|NCT04075006|Sensory System Agents|sensory system agents|mesh-ancestor
101646429|NCT04075006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101646430|NCT04075006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646431|NCT04075006|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101646432|NCT04075006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101646433|NCT04075006|Anesthetics, General|anesthetics, general|mesh-ancestor
101646434|NCT04075006|Anesthetics|anesthetics|mesh-ancestor
101646435|NCT04075006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101646436|NCT04075006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101646437|NCT04075006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101646438|NCT04075006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101646439|NCT04075006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646440|NCT04188106|Hydroxyzine|hydroxyzine|mesh-list
101646441|NCT04188106|Varenicline|varenicline|mesh-list
101646442|NCT04188106|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101646443|NCT04188106|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101646444|NCT04188106|Cholinergic Agents|cholinergic agents|mesh-ancestor
101646445|NCT04188106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101646446|NCT04188106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646447|NCT04188106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646448|NCT04188106|Antipruritics|antipruritics|mesh-ancestor
101646449|NCT04188106|Dermatologic Agents|dermatologic agents|mesh-ancestor
101646450|NCT04188106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101646451|NCT04188106|Histamine Antagonists|histamine antagonists|mesh-ancestor
101646452|NCT04188106|Histamine Agents|histamine agents|mesh-ancestor
101646453|NCT00669955|Amoxicillin|amoxicillin|mesh-list
101646454|NCT00669955|Metronidazole|metronidazole|mesh-list
101646455|NCT00669955|Clarithromycin|clarithromycin|mesh-list
101646456|NCT00669955|Tetracycline|tetracycline|mesh-list
101646457|NCT00669955|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
101646458|NCT00669955|Omeprazole|omeprazole|mesh-list
101646459|NCT00669955|Bismuth|bismuth|mesh-list
101646460|NCT00669955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101646461|NCT00669955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101646462|NCT00669955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101646463|NCT00669955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101646464|NCT00669955|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101646465|NCT00669955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101646466|NCT00669955|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101646467|NCT00669955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101646468|NCT00669955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646469|NCT00669955|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101646470|NCT00669955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101646471|NCT00669955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101646472|NCT00669955|Antacids|antacids|mesh-ancestor
101646473|NCT00772291|Pregabalin|pregabalin|mesh-list
101646474|NCT00772291|Analgesics|analgesics|mesh-ancestor
101646475|NCT00772291|Sensory System Agents|sensory system agents|mesh-ancestor
101646476|NCT00772291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101646477|NCT00772291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646478|NCT00772291|Anticonvulsants|anticonvulsants|mesh-ancestor
101646479|NCT00772291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101646480|NCT00772291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101646481|NCT00772291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646482|NCT00772291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101646483|NCT00772291|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101646484|NCT00772291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101646485|NCT00772291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101646486|NCT00772291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101646487|NCT03595150|Diclofenac|diclofenac|mesh-list
101646488|NCT03595150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101646489|NCT03595150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101646490|NCT03595150|Analgesics|analgesics|mesh-ancestor
101646491|NCT03595150|Sensory System Agents|sensory system agents|mesh-ancestor
101646492|NCT03595150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101646493|NCT03595150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646494|NCT03595150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101646495|NCT03595150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101646496|NCT03595150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101646497|NCT03595150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101646498|NCT03595150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646499|NCT00768157|Lamivudine|lamivudine|mesh-list
101646500|NCT00768157|Entecavir|entecavir|mesh-list
101646501|NCT00768157|Antiviral Agents|antiviral agents|mesh-list
101646502|NCT00768157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101646503|NCT00768157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101646504|NCT00768157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101646505|NCT00768157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646506|NCT00768157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101646507|NCT00768157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101646508|NCT00768157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101646509|NCT00671749|Clindamycin|clindamycin|mesh-list
101646510|NCT00671749|Clindamycin palmitate|clindamycin palmitate|mesh-list
101646511|NCT00671749|Clindamycin phosphate|clindamycin phosphate|mesh-list
101646512|NCT00671749|Adapalene|adapalene|mesh-list
101646513|NCT00671749|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101646514|NCT00671749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101646515|NCT00671749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101646516|NCT00671749|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101646517|NCT00671749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101646518|NCT00671749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646519|NCT00671749|Dermatologic Agents|dermatologic agents|mesh-ancestor
101646520|NCT00671749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101646521|NCT00671749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101646522|NCT00671749|Analgesics|analgesics|mesh-ancestor
101646523|NCT00671749|Sensory System Agents|sensory system agents|mesh-ancestor
101646524|NCT00671749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101646525|NCT00671749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646526|NCT00671749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101646527|NCT00671749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101646528|NCT04149106|Pyrimethamine|pyrimethamine|mesh-list
101646529|NCT04149106|Sulfadoxine|sulfadoxine|mesh-list
101646530|NCT04149106|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101646531|NCT04149106|Amodiaquine|amodiaquine|mesh-list
101646532|NCT04149106|Artenimol|artenimol|mesh-list
101646533|NCT04149106|Antimalarials|antimalarials|mesh-ancestor
101646534|NCT04149106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101646535|NCT04149106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101646536|NCT04149106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101646537|NCT04149106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101646538|NCT04149106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101646539|NCT04149106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646540|NCT04149106|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101646541|NCT02580604|Calcium|calcium|mesh-list
101646542|NCT02580604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101646543|NCT02580604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646544|NCT00768391|Olaratumab|olaratumab|mesh-list
101646545|NCT00768391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101646546|NCT00669877|Cytarabine|cytarabine|mesh-list
101646547|NCT00669877|Dexamethasone|dexamethasone|mesh-list
101646548|NCT00669877|Cyclophosphamide|cyclophosphamide|mesh-list
101646549|NCT00669877|Rituximab|rituximab|mesh-list
101646550|NCT00669877|Doxorubicin|doxorubicin|mesh-list
101646551|NCT00669877|Methotrexate|methotrexate|mesh-list
101646552|NCT00669877|Vincristine|vincristine|mesh-list
101646553|NCT00669877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101646554|NCT00669877|Immunologic Factors|immunologic factors|mesh-ancestor
101646555|NCT00669877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646556|NCT00669877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101646557|NCT00669877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101646558|NCT00669877|Alkylating Agents|alkylating agents|mesh-ancestor
101646559|NCT00669877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646560|NCT00669877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101646561|NCT00669877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101646562|NCT00669877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101646563|NCT00669877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101646564|NCT00669877|Antiemetics|antiemetics|mesh-ancestor
101646565|NCT00669877|Autonomic Agents|autonomic agents|mesh-ancestor
101646566|NCT00669877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101646567|NCT00669877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101646568|NCT00669877|Glucocorticoids|glucocorticoids|mesh-ancestor
101646569|NCT00669877|Hormones|hormones|mesh-ancestor
101646570|NCT00669877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101646571|NCT00669877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101646572|NCT00669877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101646573|NCT00669877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101646574|NCT00669877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101646575|NCT00669877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101646576|NCT00669877|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101646577|NCT00669877|Abortifacient Agents|abortifacient agents|mesh-ancestor
101646578|NCT00669877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101646579|NCT00669877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101646580|NCT00669877|Antimetabolites|antimetabolites|mesh-ancestor
101646581|NCT00669877|Dermatologic Agents|dermatologic agents|mesh-ancestor
101646582|NCT00669877|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101646583|NCT00669877|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101646584|NCT00669877|Antiviral Agents|antiviral agents|mesh-ancestor
101646585|NCT00669877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101646586|NCT00669877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101646587|NCT00669877|Tubulin Modulators|tubulin modulators|mesh-ancestor
101646588|NCT00669877|Antimitotic Agents|antimitotic agents|mesh-ancestor
101646589|NCT00669877|Mitosis Modulators|mitosis modulators|mesh-ancestor
101646590|NCT00772681|Docetaxel|docetaxel|mesh-list
101646591|NCT00772681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101646592|NCT00772681|Tubulin Modulators|tubulin modulators|mesh-ancestor
101646593|NCT00772681|Antimitotic Agents|antimitotic agents|mesh-ancestor
101646594|NCT00772681|Mitosis Modulators|mitosis modulators|mesh-ancestor
101646595|NCT00772681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646596|NCT00772759|AZD-3199|azd-3199|mesh-list
101646597|NCT00772759|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101646598|NCT00772759|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101646599|NCT00772759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101646600|NCT00772759|Adrenergic Agents|adrenergic agents|mesh-ancestor
101646601|NCT00772759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101646602|NCT00772759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646603|NCT00772759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646604|NCT03866668|Esomeprazole|esomeprazole|mesh-list
101646605|NCT03866668|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101646606|NCT03866668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101646607|NCT03866668|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101646608|NCT03866668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101646609|NCT03866668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646610|NCT00772837|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101646611|NCT00772837|Amoxicillin|amoxicillin|mesh-list
101646612|NCT00772837|Clarithromycin|clarithromycin|mesh-list
101646613|NCT00772837|Omeprazole|omeprazole|mesh-list
101646614|NCT00772837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101646615|NCT00772837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101646616|NCT00772837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101646617|NCT00772837|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101646618|NCT00772837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101646619|NCT00772837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646620|NCT00772837|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101646621|NCT00772837|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101646622|NCT00772837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101646623|NCT00773149|Alemtuzumab|alemtuzumab|mesh-list
101646624|NCT00773149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101646625|NCT00773149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101646626|NCT00768859|Paclitaxel|paclitaxel|mesh-list
101646627|NCT00768859|Carboplatin|carboplatin|mesh-list
101646629|NCT00768859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101646630|NCT00768859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101646631|NCT00768859|Tubulin Modulators|tubulin modulators|mesh-ancestor
101646632|NCT00768859|Antimitotic Agents|antimitotic agents|mesh-ancestor
101646633|NCT00768859|Mitosis Modulators|mitosis modulators|mesh-ancestor
101646634|NCT00768859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646635|NCT00768859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101646636|NCT00768937|Sorafenib|sorafenib|mesh-list
101646637|NCT00768937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101646638|NCT00768937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101646639|NCT00768937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101646640|NCT00768937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646641|NCT04047745|Bupivacaine|bupivacaine|mesh-list
101646642|NCT04047745|Ropivacaine|ropivacaine|mesh-list
101646643|NCT04047745|Anesthetics, Local|anesthetics, local|mesh-ancestor
101646644|NCT04047745|Anesthetics|anesthetics|mesh-ancestor
101646645|NCT04047745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101646646|NCT04047745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646647|NCT04047745|Sensory System Agents|sensory system agents|mesh-ancestor
101646648|NCT04047745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101646649|NCT00777439|Domperidone|domperidone|mesh-list
101646650|NCT00777439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646651|NCT00777439|Antiemetics|antiemetics|mesh-ancestor
101646652|NCT00777439|Autonomic Agents|autonomic agents|mesh-ancestor
101646653|NCT00777439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101646654|NCT00777439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646655|NCT00777439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101646656|NCT00777439|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101646657|NCT00777439|Dopamine Agents|dopamine agents|mesh-ancestor
101646658|NCT00777439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101646659|NCT00769093|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
101646660|NCT00769093|Hematinics|hematinics|mesh-ancestor
101646661|NCT00769093|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101646662|NCT00769093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101646663|NCT00671437|Cetuximab|cetuximab|mesh-list
101646664|NCT00671437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101646665|NCT00671437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101646666|NCT00777517|Atorvastatin|atorvastatin|mesh-list
101646667|NCT00777517|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101646668|NCT00777517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101646669|NCT00777517|Antimetabolites|antimetabolites|mesh-ancestor
101646670|NCT00777517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646671|NCT00777517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101646672|NCT00777517|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101646673|NCT00777517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101646674|NCT00769171|Moxifloxacin|moxifloxacin|mesh-list
101646675|NCT00769171|Metronidazole|metronidazole|mesh-list
101646676|NCT00769171|Ceftriaxone|ceftriaxone|mesh-list
101646677|NCT00769171|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101646678|NCT00769171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101646679|NCT00769171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101646680|NCT00769171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101646681|NCT00769171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101646682|NCT00769171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101646683|NCT00769171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646684|NCT00769171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101646685|NCT00769171|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101646686|NCT00769171|Contraceptive Agents|contraceptive agents|mesh-ancestor
101646687|NCT00769171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101646688|NCT00769171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646689|NCT00769171|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101646690|NCT00769171|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101646691|NCT00769171|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101646692|NCT00769171|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101646693|NCT00769171|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101646695|NCT00777595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101646696|NCT00777595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101646697|NCT00777595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101646698|NCT00777595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101646699|NCT00777595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101646700|NCT00777595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646701|NCT00777595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101646702|NCT00769405|Leucovorin|leucovorin|mesh-list
101646703|NCT00769405|Fluorouracil|fluorouracil|mesh-list
101646704|NCT00769405|Oxaliplatin|oxaliplatin|mesh-list
101646705|NCT00769405|Calcium|calcium|mesh-list
101646706|NCT00769405|Levoleucovorin|levoleucovorin|mesh-list
101646707|NCT00769405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101646708|NCT00769405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646709|NCT00769405|Antimetabolites|antimetabolites|mesh-ancestor
101646710|NCT00769405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646711|NCT00769405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101646712|NCT00769405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101646713|NCT00769405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101646714|NCT00769405|Immunologic Factors|immunologic factors|mesh-ancestor
101646716|NCT00769405|Protective Agents|protective agents|mesh-ancestor
101646717|NCT00769405|Vitamin B Complex|vitamin b complex|mesh-ancestor
101646718|NCT00769405|Vitamins|vitamins|mesh-ancestor
101646719|NCT00769405|Micronutrients|micronutrients|mesh-ancestor
101646720|NCT02829502|Exenatide|exenatide|mesh-list
101646721|NCT02829502|Glucagon|glucagon|mesh-list
101646722|NCT02829502|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101646723|NCT02829502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101646724|NCT02829502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646725|NCT02829502|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101646726|NCT02829502|Incretins|incretins|mesh-ancestor
101646727|NCT02829502|Hormones|hormones|mesh-ancestor
101646728|NCT02829502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101646729|NCT02829502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101646730|NCT02635191|Amoxicillin|amoxicillin|mesh-list
101646731|NCT02635191|Metronidazole|metronidazole|mesh-list
101646732|NCT02635191|Clarithromycin|clarithromycin|mesh-list
101646733|NCT02635191|Esomeprazole|esomeprazole|mesh-list
101646734|NCT02635191|Omeprazole|omeprazole|mesh-list
101646735|NCT02635191|Rabeprazole|rabeprazole|mesh-list
101646736|NCT02635191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101646737|NCT02635191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101646738|NCT02635191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101646739|NCT02635191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101646740|NCT02635191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101646741|NCT02635191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101646742|NCT02635191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101646743|NCT02635191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101646744|NCT02635191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646745|NCT02635191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101646746|NCT02635191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101646747|NCT02635191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101646748|NCT00777673|Paclitaxel|paclitaxel|mesh-list
101646749|NCT00777673|Cyclophosphamide|cyclophosphamide|mesh-list
101646750|NCT00777673|Bevacizumab|bevacizumab|mesh-list
101646751|NCT00777673|Carboplatin|carboplatin|mesh-list
101646752|NCT00777673|Doxorubicin|doxorubicin|mesh-list
101646753|NCT00777673|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101822782|NCT04219280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101646754|NCT00777673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101646755|NCT00777673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101646756|NCT00777673|Tubulin Modulators|tubulin modulators|mesh-ancestor
101646757|NCT00777673|Antimitotic Agents|antimitotic agents|mesh-ancestor
101646758|NCT00777673|Mitosis Modulators|mitosis modulators|mesh-ancestor
101646759|NCT00777673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646760|NCT00777673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101646761|NCT00777673|Immunologic Factors|immunologic factors|mesh-ancestor
101646762|NCT00777673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646763|NCT00777673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101646764|NCT00777673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101646765|NCT00777673|Alkylating Agents|alkylating agents|mesh-ancestor
101646766|NCT00777673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101646767|NCT00777673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101646768|NCT00777673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101646769|NCT00777673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101646770|NCT00777673|Growth Substances|growth substances|mesh-ancestor
101646771|NCT00777673|Growth Inhibitors|growth inhibitors|mesh-ancestor
101646772|NCT00777673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101646773|NCT00777673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101646774|NCT00777673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101646775|NCT00777673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101646776|NCT02579902|Vitamin D|vitamin d|mesh-list
101646777|NCT02579902|Cholecalciferol|cholecalciferol|mesh-list
101646778|NCT02579902|Vitamins|vitamins|mesh-ancestor
101646779|NCT02579902|Micronutrients|micronutrients|mesh-ancestor
101646780|NCT02579902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646781|NCT02579902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101646782|NCT02579902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101646783|NCT02557087|Meperidine|meperidine|mesh-list
101646784|NCT02557087|Scopolamine|scopolamine|mesh-list
101646785|NCT02557087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101646786|NCT02557087|Narcotics|narcotics|mesh-ancestor
101646787|NCT02557087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101646788|NCT02557087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646789|NCT02557087|Analgesics|analgesics|mesh-ancestor
101646790|NCT02557087|Sensory System Agents|sensory system agents|mesh-ancestor
101646791|NCT02557087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101646792|NCT02557087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101646793|NCT02557087|Antiemetics|antiemetics|mesh-ancestor
101646794|NCT02557087|Autonomic Agents|autonomic agents|mesh-ancestor
101646795|NCT02557087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101646796|NCT02557087|Mydriatics|mydriatics|mesh-ancestor
101646797|NCT02557087|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101646798|NCT02557087|Cholinergic Agents|cholinergic agents|mesh-ancestor
101646799|NCT02557087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101646800|NCT02557087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646801|NCT02557087|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101646802|NCT02579590|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101646803|NCT02579590|Medroxyprogesterone|medroxyprogesterone|mesh-list
101646804|NCT02579590|Desogestrel|desogestrel|mesh-list
101646805|NCT02579590|Etonogestrel|etonogestrel|mesh-list
101646806|NCT02579590|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101646807|NCT02579590|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101646808|NCT02579590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101646809|NCT02579590|Contraceptive Agents|contraceptive agents|mesh-ancestor
101646810|NCT02579590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101646811|NCT02579590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822792|NCT04191096|Hormones|hormones|mesh-ancestor
101646812|NCT02579590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101646813|NCT02579590|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101646814|NCT02579590|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101646815|NCT02579590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101646816|NCT02579590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101646817|NCT02579590|Progestins|progestins|mesh-ancestor
101646818|NCT02579590|Hormones|hormones|mesh-ancestor
101646819|NCT02579590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101646820|NCT02634723|Factor VIII|factor viii|mesh-list
101646821|NCT02634723|Coagulants|coagulants|mesh-ancestor
101646822|NCT02634489|Tamsulosin|tamsulosin|mesh-list
101646823|NCT02634489|Solifenacin Succinate|solifenacin succinate|mesh-list
101646824|NCT02634489|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101646825|NCT02634489|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101646826|NCT02634489|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101646827|NCT02634489|Adrenergic Agents|adrenergic agents|mesh-ancestor
101646828|NCT02634489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101646829|NCT02634489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646830|NCT02634489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646831|NCT02634489|Urological Agents|urological agents|mesh-ancestor
101646832|NCT02634489|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101646833|NCT02634489|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101646834|NCT02634489|Cholinergic Agents|cholinergic agents|mesh-ancestor
101646835|NCT00582712|Lithium Carbonate|lithium carbonate|mesh-list
101646836|NCT00582712|Antidepressive Agents|antidepressive agents|mesh-ancestor
101646837|NCT00582712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101646838|NCT00582712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101646839|NCT00582712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646840|NCT00582712|Antimanic Agents|antimanic agents|mesh-ancestor
101646841|NCT00582712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101646842|NCT00582712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101646843|NCT00582712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646844|NCT03920566|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101646845|NCT03920566|Dalteparin|dalteparin|mesh-list
101646846|NCT03920566|Anticoagulants|anticoagulants|mesh-ancestor
101646847|NCT03920566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101646848|NCT03920566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101646849|NCT03920566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646850|NCT00582790|Zoledronic Acid|zoledronic acid|mesh-list
101646851|NCT00582790|Interleukin-2|interleukin-2|mesh-list
101646852|NCT00582790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101646853|NCT00582790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101646854|NCT00582790|Analgesics|analgesics|mesh-ancestor
101646855|NCT00582790|Sensory System Agents|sensory system agents|mesh-ancestor
101646856|NCT00582790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101646857|NCT00582790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646858|NCT00582790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101646859|NCT00774007|Mesalamine|mesalamine|mesh-list
101646860|NCT00774007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101646861|NCT00774007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101646862|NCT00774007|Analgesics|analgesics|mesh-ancestor
101646863|NCT00774007|Sensory System Agents|sensory system agents|mesh-ancestor
101646864|NCT00774007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101646865|NCT00774007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646866|NCT00774007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101646867|NCT00774007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101646869|NCT00769873|Enoxaparin|enoxaparin|mesh-list
101646870|NCT00769873|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101646871|NCT00769873|Tinzaparin|tinzaparin|mesh-list
101646872|NCT00769873|Dalteparin|dalteparin|mesh-list
101646873|NCT00769873|Anticoagulants|anticoagulants|mesh-ancestor
101646874|NCT00769873|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101646875|NCT00769873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101646876|NCT00769873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646877|NCT00777985|Bosentan|bosentan|mesh-list
101646878|NCT00777985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101646879|NCT00777985|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101646880|NCT00777985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646881|NCT00770107|Thiamine|thiamine|mesh-list
101646882|NCT00770107|Vitamin B Complex|vitamin b complex|mesh-ancestor
101646883|NCT00770107|Vitamins|vitamins|mesh-ancestor
101646884|NCT00770107|Micronutrients|micronutrients|mesh-ancestor
101646885|NCT00770107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646886|NCT00774241|Bevacizumab|bevacizumab|mesh-list
101646887|NCT00774241|Docetaxel|docetaxel|mesh-list
101646888|NCT00774241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101646889|NCT00774241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101646890|NCT00774241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101646891|NCT00774241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101646892|NCT00774241|Growth Substances|growth substances|mesh-ancestor
101646893|NCT00774241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646894|NCT00774241|Growth Inhibitors|growth inhibitors|mesh-ancestor
101646895|NCT00774241|Tubulin Modulators|tubulin modulators|mesh-ancestor
101646896|NCT00774241|Antimitotic Agents|antimitotic agents|mesh-ancestor
101646897|NCT00774241|Mitosis Modulators|mitosis modulators|mesh-ancestor
101646898|NCT00774241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646899|NCT00774319|Cisplatin|cisplatin|mesh-list
101646900|NCT00774319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101646901|NCT00881751|Bevacizumab|bevacizumab|mesh-list
101646902|NCT00881751|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101646903|NCT00881751|Sorafenib|sorafenib|mesh-list
101646904|NCT00881751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101646905|NCT00881751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101646906|NCT00881751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101646907|NCT00881751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101646908|NCT00881751|Growth Substances|growth substances|mesh-ancestor
101646909|NCT00881751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646910|NCT00881751|Growth Inhibitors|growth inhibitors|mesh-ancestor
101646911|NCT00881751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101646912|NCT00881751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101646913|NCT00881751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646914|NCT02634255|Fentanyl|fentanyl|mesh-list
101646915|NCT02634255|Propofol|propofol|mesh-list
101646916|NCT02634255|Rocuronium|rocuronium|mesh-list
101646917|NCT02634255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101646918|NCT02634255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101646919|NCT02634255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646920|NCT02634255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101646921|NCT02634255|Anesthetics, General|anesthetics, general|mesh-ancestor
101646922|NCT02634255|Anesthetics|anesthetics|mesh-ancestor
101646923|NCT02634255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101646924|NCT02634255|Narcotics|narcotics|mesh-ancestor
101646925|NCT02634255|Analgesics|analgesics|mesh-ancestor
101646926|NCT02634255|Sensory System Agents|sensory system agents|mesh-ancestor
101646927|NCT02634255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101646928|NCT02634255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101646929|NCT02634255|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101646930|NCT02634255|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101646931|NCT02634255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101646932|NCT02634021|Midazolam|midazolam|mesh-list
101646933|NCT02634021|Dexmedetomidine|dexmedetomidine|mesh-list
101646934|NCT02634021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101646935|NCT02634021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101646936|NCT02634021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646937|NCT02634021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101304039|NCT02010762|Micronutrients|micronutrients|mesh-ancestor
101646938|NCT02634021|Analgesics|analgesics|mesh-ancestor
101646939|NCT02634021|Sensory System Agents|sensory system agents|mesh-ancestor
101646940|NCT02634021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101646941|NCT02634021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101646942|NCT02634021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101646943|NCT02634021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101646944|NCT02634021|Adrenergic Agents|adrenergic agents|mesh-ancestor
101646945|NCT02634021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101646946|NCT02634021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646947|NCT02634021|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101646948|NCT02634021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101646949|NCT02634021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101646950|NCT02634021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101646951|NCT02634021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101646952|NCT02634021|Anesthetics, General|anesthetics, general|mesh-ancestor
101646953|NCT02634021|Anesthetics|anesthetics|mesh-ancestor
101646954|NCT02634021|GABA Modulators|gaba modulators|mesh-ancestor
101646955|NCT02634021|GABA Agents|gaba agents|mesh-ancestor
101646956|NCT04161729|Magnesium Sulfate|magnesium sulfate|mesh-list
101646957|NCT04161729|Analgesics|analgesics|mesh-ancestor
101646958|NCT04161729|Sensory System Agents|sensory system agents|mesh-ancestor
101646959|NCT04161729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101646960|NCT04161729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646961|NCT04161729|Anesthetics|anesthetics|mesh-ancestor
101646962|NCT04161729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101646963|NCT04161729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101646964|NCT04161729|Anticonvulsants|anticonvulsants|mesh-ancestor
101646965|NCT04161729|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101646966|NCT04161729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101646967|NCT04161729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646968|NCT04161729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101646969|NCT04161729|Tocolytic Agents|tocolytic agents|mesh-ancestor
101646970|NCT04161729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101646971|NCT04161339|Hydroxychloroquine|hydroxychloroquine|mesh-list
101646972|NCT04161339|Antimalarials|antimalarials|mesh-ancestor
101646973|NCT04161339|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101646974|NCT04161339|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101646975|NCT04161339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101646976|NCT04161339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101646977|NCT04161339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646978|NCT04161339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101646979|NCT00934856|Docetaxel|docetaxel|mesh-list
101646980|NCT00934856|Trastuzumab|trastuzumab|mesh-list
101646981|NCT00934856|Pertuzumab|pertuzumab|mesh-list
101646982|NCT00934856|Maytansine|maytansine|mesh-list
101646983|NCT00934856|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101646984|NCT00934856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101646985|NCT00934856|Tubulin Modulators|tubulin modulators|mesh-ancestor
101646986|NCT00934856|Antimitotic Agents|antimitotic agents|mesh-ancestor
101646987|NCT00934856|Mitosis Modulators|mitosis modulators|mesh-ancestor
101646988|NCT00934856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101646989|NCT00934856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101646990|NCT00934856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101646991|NCT00934856|Immunotoxins|immunotoxins|mesh-ancestor
101646992|NCT00934856|Immunoconjugates|immunoconjugates|mesh-ancestor
101646993|NCT00934856|Immunologic Factors|immunologic factors|mesh-ancestor
101646994|NCT00934856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101646995|NCT00934700|Xenon|xenon|mesh-list
101646996|NCT00934700|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101646997|NCT00934700|Anesthetics, General|anesthetics, general|mesh-ancestor
101646998|NCT00934700|Anesthetics|anesthetics|mesh-ancestor
101646999|NCT00934700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101647000|NCT00934700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647001|NCT00669409|Tanezumab|tanezumab|mesh-list
101647002|NCT00669409|Analgesics|analgesics|mesh-ancestor
101647003|NCT00669409|Sensory System Agents|sensory system agents|mesh-ancestor
101647004|NCT00669409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101647005|NCT00669409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647006|NCT00778141|Metformin|metformin|mesh-list
101647007|NCT00778141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101647008|NCT00778141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647009|NCT00774475|Clopidogrel|clopidogrel|mesh-list
101647010|NCT00774475|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101647011|NCT00774475|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101647012|NCT00774475|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101647013|NCT00774475|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101647014|NCT00774475|Purinergic Agents|purinergic agents|mesh-ancestor
101647015|NCT00774475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101647016|NCT00774475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304120|NCT02011191|Biotin|biotin|mesh-list
101647017|NCT00774475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647018|NCT00669331|Mannitol|mannitol|mesh-list
101647019|NCT00669331|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101647020|NCT00669331|Diuretics|diuretics|mesh-ancestor
101647021|NCT00669331|Natriuretic Agents|natriuretic agents|mesh-ancestor
101647022|NCT00669331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647023|NCT00778297|Vaccines|vaccines|mesh-list
101647024|NCT00778297|Immunologic Factors|immunologic factors|mesh-ancestor
101647025|NCT00778297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647026|NCT00779233|Zidovudine|zidovudine|mesh-list
101647027|NCT00779233|Antimetabolites|antimetabolites|mesh-ancestor
101647028|NCT00779233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647029|NCT00779233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101647030|NCT00779233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101647031|NCT00779233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101647032|NCT00779233|Antiviral Agents|antiviral agents|mesh-ancestor
101647033|NCT00779233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101647034|NCT00779233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101647035|NCT00779233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101647036|NCT00607178|Vaccines|vaccines|mesh-list
101647037|NCT00607178|Immunologic Factors|immunologic factors|mesh-ancestor
101647038|NCT00607178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647039|NCT02556463|Durvalumab|durvalumab|mesh-list
101647040|NCT02556463|MEDI9197|medi9197|mesh-list
101647041|NCT02556463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101647042|NCT02556463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101647043|NCT02556463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101647044|NCT02556463|Immunologic Factors|immunologic factors|mesh-ancestor
101647045|NCT02556463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647046|NCT00779389|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101647047|NCT00779389|Dasatinib|dasatinib|mesh-list
101647048|NCT00779389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101647049|NCT00779389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101647050|NCT00779389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101647051|NCT00779389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647052|NCT00778609|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
101647053|NCT00778609|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
101647054|NCT00778609|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101647055|NCT00778609|Contraceptive Agents|contraceptive agents|mesh-ancestor
101647056|NCT00778609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101647057|NCT00778609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647058|NCT00778609|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101647059|NCT00778609|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101647060|NCT00778609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101647061|NCT00778609|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101647062|NCT00778609|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101647063|NCT00778609|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
101647064|NCT00778609|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101647065|NCT00778609|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101647067|NCT00778765|Analgesics|analgesics|mesh-ancestor
101647068|NCT00778765|Sensory System Agents|sensory system agents|mesh-ancestor
101647069|NCT00778765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101647070|NCT00778765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647071|NCT00778765|Anticonvulsants|anticonvulsants|mesh-ancestor
101647072|NCT00778765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101647073|NCT00778765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101647074|NCT00778765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101647075|NCT00778765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101647076|NCT00778765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101647077|NCT00778765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101647078|NCT00778765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101647079|NCT00778765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647080|NCT00778765|Antimanic Agents|antimanic agents|mesh-ancestor
101647081|NCT00779935|Infliximab|infliximab|mesh-list
101647082|NCT00779935|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101647083|NCT00779935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101647084|NCT00779935|Dermatologic Agents|dermatologic agents|mesh-ancestor
101647085|NCT00779935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101647086|NCT00779935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101647087|NCT00780013|Metformin|metformin|mesh-list
101647088|NCT00780013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101647089|NCT00780013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647090|NCT00667225|Cantharidin|cantharidin|mesh-list
101647091|NCT00667225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101647092|NCT00667225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647094|NCT00780169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101647095|NCT00780169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101647096|NCT00780169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101647097|NCT00780169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647098|NCT00780325|Celecoxib|celecoxib|mesh-list
101647099|NCT00780325|Naproxen|naproxen|mesh-list
101647100|NCT00780325|Acetazolamide|acetazolamide|mesh-list
101647101|NCT00780325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101647102|NCT00780325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101647103|NCT00780325|Analgesics|analgesics|mesh-ancestor
101647104|NCT00780325|Sensory System Agents|sensory system agents|mesh-ancestor
101647105|NCT00780325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101647106|NCT00780325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647107|NCT00780325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101647108|NCT00780325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101647109|NCT00780325|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101647110|NCT00780325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101647111|NCT00780325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101647112|NCT00780325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647113|NCT00780325|Gout Suppressants|gout suppressants|mesh-ancestor
101647114|NCT00780325|Anticonvulsants|anticonvulsants|mesh-ancestor
101647115|NCT00780325|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101647116|NCT00780325|Diuretics|diuretics|mesh-ancestor
101647117|NCT00780325|Natriuretic Agents|natriuretic agents|mesh-ancestor
101647118|NCT02556229|Aflibercept|aflibercept|mesh-list
101647119|NCT02556229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101647120|NCT02556229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101647121|NCT02556229|Growth Substances|growth substances|mesh-ancestor
101647122|NCT02556229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647123|NCT02556229|Growth Inhibitors|growth inhibitors|mesh-ancestor
101647124|NCT02556229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101647125|NCT00929864|Adalimumab|adalimumab|mesh-list
101647126|NCT00929864|Abatacept|abatacept|mesh-list
101647127|NCT00929864|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101647128|NCT00929864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101647129|NCT00929864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101647130|NCT00929864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101647131|NCT00929864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101822855|NCT04068194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101647132|NCT00929864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101647134|NCT00929864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101647135|NCT00929864|Immunologic Factors|immunologic factors|mesh-ancestor
101647136|NCT00929864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647138|NCT00597753|Hematinics|hematinics|mesh-ancestor
101647139|NCT04262804|Gemcitabine|gemcitabine|mesh-list
101647140|NCT04262804|Capecitabine|capecitabine|mesh-list
101647141|NCT04262804|Trastuzumab|trastuzumab|mesh-list
101647142|NCT04262804|Vinorelbine|vinorelbine|mesh-list
101647143|NCT04262804|Margetuximab|margetuximab|mesh-list
101647144|NCT04262804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101647145|NCT04262804|Antimetabolites|antimetabolites|mesh-ancestor
101647146|NCT04262804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647147|NCT04262804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101647148|NCT04262804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101647149|NCT04262804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101647150|NCT04262804|Tubulin Modulators|tubulin modulators|mesh-ancestor
101647151|NCT04262804|Antimitotic Agents|antimitotic agents|mesh-ancestor
101647152|NCT04262804|Mitosis Modulators|mitosis modulators|mesh-ancestor
101647153|NCT00665431|Celecoxib|celecoxib|mesh-list
101647154|NCT00665431|Antacids|antacids|mesh-list
101647155|NCT00665431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101647156|NCT00665431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101647157|NCT00665431|Analgesics|analgesics|mesh-ancestor
101647158|NCT00665431|Sensory System Agents|sensory system agents|mesh-ancestor
101647159|NCT00665431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101647160|NCT00665431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647161|NCT00665431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101647162|NCT00665431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101647163|NCT00665431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101647164|NCT00665431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101647165|NCT00665431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101647166|NCT00665431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647167|NCT00665431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101647168|NCT02633709|Itraconazole|itraconazole|mesh-list
101647169|NCT02633709|Risdiplam|risdiplam|mesh-list
101647170|NCT02633709|Antifungal Agents|antifungal agents|mesh-ancestor
101647171|NCT02633709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101647172|NCT02633709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101647173|NCT02633709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101647174|NCT02633709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101647175|NCT02633709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647176|NCT02633709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101647177|NCT02633709|Hormone Antagonists|hormone antagonists|mesh-ancestor
101647178|NCT02633709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101647179|NCT02633709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647180|NCT02633709|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101647181|NCT02633709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101647182|NCT02633709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101647183|NCT04264988|Tin Fluorides|tin fluorides|mesh-list
101647184|NCT04264988|Cariostatic Agents|cariostatic agents|mesh-ancestor
101647185|NCT04264988|Protective Agents|protective agents|mesh-ancestor
101647186|NCT04264988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647187|NCT00657033|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101647188|NCT00657033|Vasodilator Agents|vasodilator agents|mesh-ancestor
101647189|NCT00657033|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101647190|NCT00657033|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101647191|NCT00657033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101647192|NCT00657033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647193|NCT00657033|Urological Agents|urological agents|mesh-ancestor
101647194|NCT02633007|Levodopa|levodopa|mesh-list
101647195|NCT02633007|Carbidopa|carbidopa|mesh-list
101647196|NCT02633007|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101647197|NCT02633007|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101647198|NCT02633007|Dopamine Agents|dopamine agents|mesh-ancestor
101647199|NCT02633007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101647200|NCT02633007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647201|NCT02633007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647203|NCT02633007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101647204|NCT01000727|Darapladib|darapladib|mesh-list
101647205|NCT01000727|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
101647206|NCT01000727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101647207|NCT01000727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647208|NCT00881205|Rivastigmine|rivastigmine|mesh-list
101647209|NCT00881205|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101647210|NCT00881205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101647211|NCT00881205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647212|NCT00881205|Cholinergic Agents|cholinergic agents|mesh-ancestor
101647213|NCT00881205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101647214|NCT00881205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647215|NCT00881205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101647216|NCT00881205|Protective Agents|protective agents|mesh-ancestor
101647218|NCT00879879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101647219|NCT00879879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101647220|NCT00879879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101647221|NCT00879879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101647222|NCT00879879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647223|NCT00661999|Darbepoetin alfa|darbepoetin alfa|mesh-list
101647224|NCT00661999|Ferric gluconate|ferric gluconate|mesh-list
101647225|NCT00661999|Hematinics|hematinics|mesh-ancestor
101647226|NCT00661167|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101647227|NCT00661167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101647228|NCT04156815|Isotretinoin|isotretinoin|mesh-list
101647229|NCT04156815|Dermatologic Agents|dermatologic agents|mesh-ancestor
101647230|NCT04156425|Golimumab|golimumab|mesh-list
101647231|NCT04156425|Dexetimide|dexetimide|mesh-list
101647232|NCT04156425|Citalopram|citalopram|mesh-list
101647233|NCT04156425|Calcium|calcium|mesh-list
101647234|NCT04156425|Escitalopram|escitalopram|mesh-list
101647235|NCT04156425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101647236|NCT04156425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647237|NCT04156425|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101647238|NCT04156425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101647239|NCT04156425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101647240|NCT04156425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647241|NCT04156425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101647243|NCT04156425|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101647244|NCT04156425|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101647245|NCT04156425|Parasympatholytics|parasympatholytics|mesh-ancestor
101647246|NCT04156425|Autonomic Agents|autonomic agents|mesh-ancestor
101647247|NCT04156425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101647248|NCT04156425|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101647249|NCT04156425|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101647250|NCT04156425|Cholinergic Agents|cholinergic agents|mesh-ancestor
101647251|NCT04156425|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101647252|NCT04156425|Antidepressive Agents|antidepressive agents|mesh-ancestor
101647253|NCT04156425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101647254|NCT04156425|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101647255|NCT04156425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101647256|NCT04156425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101647257|NCT04156425|Immunologic Factors|immunologic factors|mesh-ancestor
101647258|NCT02555059|Ciprofloxacin|ciprofloxacin|mesh-list
101647259|NCT02555059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101647260|NCT02555059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101647261|NCT02555059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101647262|NCT02555059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101647263|NCT02555059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101647264|NCT02555059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647265|NCT02555059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101647266|NCT02555059|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101647267|NCT02555059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101822866|NCT04026412|Nivolumab|nivolumab|mesh-list
101647268|NCT00790075|Risperidone|risperidone|mesh-list
101647269|NCT00790075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101647270|NCT00790075|Serotonin Agents|serotonin agents|mesh-ancestor
101647271|NCT00790075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101647272|NCT00790075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647273|NCT00790075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647274|NCT00790075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101647275|NCT00790075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101647276|NCT00790075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101647277|NCT00790075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101647278|NCT00790075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101647279|NCT00790075|Dopamine Agents|dopamine agents|mesh-ancestor
101647280|NCT00785083|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101647281|NCT00785083|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101647282|NCT00785083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647283|NCT00785083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101647284|NCT00785083|Immunologic Factors|immunologic factors|mesh-ancestor
101647285|NCT00785083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647287|NCT00780637|Kininogens|kininogens|mesh-list
101647288|NCT00780637|Vasodilator Agents|vasodilator agents|mesh-ancestor
101647289|NCT00780637|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
101647290|NCT00780637|Protease Inhibitors|protease inhibitors|mesh-ancestor
101647291|NCT00780637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101647292|NCT00780637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647293|NCT00661401|gamma-Globulins|gamma-globulins|mesh-list
101647294|NCT00661401|Immunologic Factors|immunologic factors|mesh-ancestor
101647295|NCT00661401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647296|NCT00790153|Insulin|insulin|mesh-list
101647297|NCT00790153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101647298|NCT00790153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647299|NCT02631603|Prednisolone|prednisolone|mesh-list
101647300|NCT02631603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101647301|NCT02631603|Glucocorticoids|glucocorticoids|mesh-ancestor
101647302|NCT02631603|Hormones|hormones|mesh-ancestor
101647303|NCT02631603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101647304|NCT02631603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647305|NCT02631603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101647306|NCT02631603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101647307|NCT00790387|Heparin|heparin|mesh-list
101647308|NCT00790387|Enoxaparin|enoxaparin|mesh-list
101647309|NCT00790387|Calcium heparin|calcium heparin|mesh-list
101647310|NCT00790387|Tirofiban|tirofiban|mesh-list
101647311|NCT00790387|Anticoagulants|anticoagulants|mesh-ancestor
101647312|NCT00790387|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101304413|NCT02012933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101647313|NCT00790387|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101647314|NCT00790387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647315|NCT00790387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101647316|NCT04156035|Lamotrigine|lamotrigine|mesh-list
101647318|NCT04156035|Analgesics|analgesics|mesh-ancestor
101647319|NCT04156035|Sensory System Agents|sensory system agents|mesh-ancestor
101647320|NCT04156035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101647321|NCT04156035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647322|NCT04156035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101647323|NCT04156035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101647324|NCT04156035|Anesthetics, General|anesthetics, general|mesh-ancestor
101647325|NCT04156035|Anesthetics|anesthetics|mesh-ancestor
101647326|NCT04156035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101647327|NCT04156035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101647328|NCT04156035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101647329|NCT04156035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101647330|NCT04156035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647331|NCT04156035|Anticonvulsants|anticonvulsants|mesh-ancestor
101647332|NCT04156035|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101647333|NCT04156035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101647334|NCT04156035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101647335|NCT04156035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101647336|NCT04156035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101647337|NCT04156035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101647338|NCT04156035|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101647339|NCT00662337|Diphenhydramine|diphenhydramine|mesh-list
101647340|NCT00662337|Promethazine|promethazine|mesh-list
101647341|NCT00662337|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101647342|NCT00662337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101647343|NCT00662337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101647344|NCT00662337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647345|NCT00662337|Anesthetics, Local|anesthetics, local|mesh-ancestor
101647346|NCT00662337|Anesthetics|anesthetics|mesh-ancestor
101647347|NCT00662337|Sensory System Agents|sensory system agents|mesh-ancestor
101647348|NCT00662337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101647349|NCT00662337|Antiemetics|antiemetics|mesh-ancestor
101647350|NCT00662337|Autonomic Agents|autonomic agents|mesh-ancestor
101647351|NCT00662337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101647352|NCT00662337|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101647353|NCT00662337|Histamine Antagonists|histamine antagonists|mesh-ancestor
101647354|NCT00662337|Histamine Agents|histamine agents|mesh-ancestor
101647355|NCT00662337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101647356|NCT00662337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647357|NCT00662337|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101647358|NCT00662337|Antipruritics|antipruritics|mesh-ancestor
101647359|NCT00662337|Dermatologic Agents|dermatologic agents|mesh-ancestor
101647361|NCT00665353|Ribavirin|ribavirin|mesh-list
101647362|NCT00665353|Antimetabolites|antimetabolites|mesh-ancestor
101647363|NCT00665353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647364|NCT00665353|Antiviral Agents|antiviral agents|mesh-ancestor
101647365|NCT00665353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101647366|NCT00665353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101647367|NCT00665353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647368|NCT00785395|Oxytocin|oxytocin|mesh-list
101647369|NCT00785395|Oxytocics|oxytocics|mesh-ancestor
101647370|NCT00785395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101647371|NCT00785395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647372|NCT00662571|Acamprosate|acamprosate|mesh-list
101647373|NCT00662571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101647374|NCT00780793|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
101647375|NCT00780793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101647376|NCT00661635|Valdecoxib|valdecoxib|mesh-list
101647377|NCT00661635|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101647378|NCT00661635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101647379|NCT00661635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101647380|NCT00661635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647381|NCT00661635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101647382|NCT00661635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101647383|NCT00661635|Analgesics|analgesics|mesh-ancestor
101647384|NCT00661635|Sensory System Agents|sensory system agents|mesh-ancestor
101647385|NCT00661635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101647386|NCT00661635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647387|NCT00661635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101647388|NCT00661635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101304486|NCT02013232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101647389|NCT02555761|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101647390|NCT02555761|Alcaftadine|alcaftadine|mesh-list
101647391|NCT02555761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101647392|NCT02555761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101647393|NCT02555761|Histamine Antagonists|histamine antagonists|mesh-ancestor
101822888|NCT03922048|Anesthetics|anesthetics|mesh-ancestor
101647394|NCT02555761|Histamine Agents|histamine agents|mesh-ancestor
101647395|NCT02555761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101647396|NCT02555761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647397|NCT02555761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647399|NCT04155879|Gout Suppressants|gout suppressants|mesh-ancestor
101647400|NCT04155879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101647401|NCT04155879|Tubulin Modulators|tubulin modulators|mesh-ancestor
101647402|NCT04155879|Antimitotic Agents|antimitotic agents|mesh-ancestor
101647403|NCT04155879|Mitosis Modulators|mitosis modulators|mesh-ancestor
101647404|NCT04155879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647405|NCT04155879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101647406|NCT00662805|Fluticasone|fluticasone|mesh-list
101647408|NCT00662805|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101647409|NCT00662805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101647410|NCT00662805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101647411|NCT00662805|Autonomic Agents|autonomic agents|mesh-ancestor
101647412|NCT00662805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101647413|NCT00662805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647414|NCT00662805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101647415|NCT00662805|Respiratory System Agents|respiratory system agents|mesh-ancestor
101647416|NCT00662805|Dermatologic Agents|dermatologic agents|mesh-ancestor
101647417|NCT00662805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101647418|NCT00662805|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101647419|NCT00662805|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101647420|NCT00662805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101647421|NCT00662805|Adrenergic Agents|adrenergic agents|mesh-ancestor
101647422|NCT00662805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101647423|NCT00662805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647424|NCT00662883|Mometasone Furoate|mometasone furoate|mesh-list
101647425|NCT00662883|Ketamine|ketamine|mesh-list
101647426|NCT00662883|Analgesics|analgesics|mesh-ancestor
101647427|NCT00662883|Sensory System Agents|sensory system agents|mesh-ancestor
101647428|NCT00662883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101647429|NCT00662883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647430|NCT00662883|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101647431|NCT00662883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101647432|NCT00662883|Anesthetics, General|anesthetics, general|mesh-ancestor
101647433|NCT00662883|Anesthetics|anesthetics|mesh-ancestor
101647434|NCT00662883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101647435|NCT00662883|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101647436|NCT00662883|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101647437|NCT00662883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101647438|NCT00662883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647439|NCT00662883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101647441|NCT00662883|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101647442|NCT00785473|Cholecalciferol|cholecalciferol|mesh-list
101647443|NCT00785473|Vitamin D|vitamin d|mesh-list
101647444|NCT00785473|Calcium Carbonate|calcium carbonate|mesh-list
101647445|NCT00785473|Calcium|calcium|mesh-list
101647446|NCT00785473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101647447|NCT00785473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647448|NCT00785473|Vitamins|vitamins|mesh-ancestor
101647449|NCT00785473|Micronutrients|micronutrients|mesh-ancestor
101647450|NCT00785473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101647451|NCT00785473|Antacids|antacids|mesh-ancestor
101647452|NCT00785473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647453|NCT00785473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101647454|NCT00785551|Quinine|quinine|mesh-list
101647455|NCT00785551|Antimalarials|antimalarials|mesh-ancestor
101647456|NCT00785551|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101647457|NCT00785551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101647458|NCT00785551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101647459|NCT00785551|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101647460|NCT00785551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647461|NCT00785551|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101647462|NCT00785551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101647463|NCT00785551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101647464|NCT00785551|Analgesics|analgesics|mesh-ancestor
101647465|NCT00785551|Sensory System Agents|sensory system agents|mesh-ancestor
101647466|NCT00790777|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101647467|NCT00790777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101647468|NCT00790777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101647469|NCT00790777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101647470|NCT00790777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647471|NCT00790777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101647472|NCT00790777|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101647473|NCT00790777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101647475|NCT00790777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101647476|NCT00790777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647477|NCT00790777|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101647478|NCT00790777|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101647479|NCT00790777|Dopamine Agents|dopamine agents|mesh-ancestor
101647480|NCT00663195|Furosemide|furosemide|mesh-list
101647481|NCT00663195|Spironolactone|spironolactone|mesh-list
101647482|NCT00663195|Diuretics|diuretics|mesh-ancestor
101647483|NCT00663195|Natriuretic Agents|natriuretic agents|mesh-ancestor
101647484|NCT00663195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647485|NCT00663195|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101647486|NCT00663195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101647487|NCT00663195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647488|NCT00663195|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101647489|NCT00663195|Hormone Antagonists|hormone antagonists|mesh-ancestor
101647490|NCT00663195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101647491|NCT00663195|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101647493|NCT00791011|Vorinostat|vorinostat|mesh-list
101647494|NCT00791011|Conatumumab|conatumumab|mesh-list
101647495|NCT00791011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101647496|NCT00791011|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101647497|NCT00791011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101647498|NCT00791011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647499|NCT00791011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101647500|NCT00781105|Telbivudine|telbivudine|mesh-list
101647501|NCT00781105|Antiviral Agents|antiviral agents|mesh-ancestor
101647502|NCT00781105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101647503|NCT00781105|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101647504|NCT00781105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101647505|NCT00781105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647506|NCT00785863|Ketorolac|ketorolac|mesh-list
101647507|NCT00785863|Parecoxib|parecoxib|mesh-list
101647508|NCT00785863|Remifentanil|remifentanil|mesh-list
101647509|NCT00785863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101647510|NCT00785863|Narcotics|narcotics|mesh-ancestor
101647511|NCT00785863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101647512|NCT00785863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647513|NCT00785863|Analgesics|analgesics|mesh-ancestor
101647514|NCT00785863|Sensory System Agents|sensory system agents|mesh-ancestor
101647515|NCT00785863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101647516|NCT00785863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101647517|NCT00785863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101647518|NCT00785863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101647519|NCT00785863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101647520|NCT00785863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101647521|NCT00785863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101647522|NCT00785863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647523|NCT00785863|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101647524|NCT00664105|Carboplatin|carboplatin|mesh-list
101647525|NCT00664105|Docetaxel|docetaxel|mesh-list
101647526|NCT00664105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101647527|NCT00664105|Tubulin Modulators|tubulin modulators|mesh-ancestor
101647528|NCT00664105|Antimitotic Agents|antimitotic agents|mesh-ancestor
101647529|NCT00664105|Mitosis Modulators|mitosis modulators|mesh-ancestor
101647530|NCT00664105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647531|NCT00785941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101647532|NCT00785941|Immunologic Factors|immunologic factors|mesh-ancestor
101647533|NCT00785941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647534|NCT02555605|Dexmedetomidine|dexmedetomidine|mesh-list
101647535|NCT02555605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101647536|NCT02555605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101647537|NCT02555605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647538|NCT02555605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101647539|NCT02555605|Analgesics|analgesics|mesh-ancestor
101647540|NCT02555605|Sensory System Agents|sensory system agents|mesh-ancestor
101647541|NCT02555605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101647542|NCT02555605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101647543|NCT02555605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101647544|NCT02555605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101647545|NCT02555605|Adrenergic Agents|adrenergic agents|mesh-ancestor
101647546|NCT02555605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101647547|NCT02555605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647548|NCT00791167|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101647549|NCT00791167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101647550|NCT00791167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101647551|NCT00791167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101647552|NCT00791167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647553|NCT00791167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101647554|NCT00791167|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101647555|NCT00791167|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101647556|NCT00791167|Serotonin Agents|serotonin agents|mesh-ancestor
101647557|NCT00791167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101647558|NCT00791167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647559|NCT00791167|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101647560|NCT00791167|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101647561|NCT00791167|Dopamine Agents|dopamine agents|mesh-ancestor
101647563|NCT00663741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101647564|NCT00663741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101647565|NCT00663741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101647566|NCT00663741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647567|NCT00663897|Lansoprazole|lansoprazole|mesh-list
101647568|NCT00663897|Dexlansoprazole|dexlansoprazole|mesh-list
101647569|NCT00663897|Mosapride|mosapride|mesh-list
101647570|NCT00663897|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101647571|NCT00663897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101647572|NCT00663897|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101647573|NCT00663897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101647574|NCT00663897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647575|NCT00663897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101647576|NCT00663897|Serotonin Agents|serotonin agents|mesh-ancestor
101647577|NCT00663897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101647578|NCT00663897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647579|NCT00664053|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101647580|NCT00664053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101647581|NCT00664053|Immunologic Factors|immunologic factors|mesh-ancestor
101647582|NCT00664053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647583|NCT04031859|Aspirin|aspirin|mesh-list
101647584|NCT04031859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101647585|NCT04031859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101647586|NCT04031859|Analgesics|analgesics|mesh-ancestor
101647587|NCT04031859|Sensory System Agents|sensory system agents|mesh-ancestor
101647588|NCT04031859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101647589|NCT04031859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647590|NCT04031859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101647591|NCT04031859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101822919|NCT03859869|Pancrelipase|pancrelipase|mesh-list
101647592|NCT04031859|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101647593|NCT04031859|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101647594|NCT04031859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647595|NCT04031859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101647596|NCT04031859|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101647597|NCT04031859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101647598|NCT04031859|Antipyretics|antipyretics|mesh-ancestor
101647599|NCT00664287|Niacin|niacin|mesh-list
101647600|NCT00664287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101647601|NCT00664287|Antimetabolites|antimetabolites|mesh-ancestor
101647602|NCT00664287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647603|NCT00664287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101647604|NCT00664287|Vasodilator Agents|vasodilator agents|mesh-ancestor
101647605|NCT00664287|Vitamin B Complex|vitamin b complex|mesh-ancestor
101647606|NCT00664287|Vitamins|vitamins|mesh-ancestor
101647607|NCT00664287|Micronutrients|micronutrients|mesh-ancestor
101647608|NCT00664287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647609|NCT00664599|Rituximab|rituximab|mesh-list
101647610|NCT00664599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101647611|NCT00664599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101304710|NCT02014636|Pembrolizumab|pembrolizumab|mesh-list
101647612|NCT00664599|Immunologic Factors|immunologic factors|mesh-ancestor
101647613|NCT00664599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647614|NCT00664599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101647615|NCT02631135|Dexmedetomidine|dexmedetomidine|mesh-list
101647616|NCT02631135|Remifentanil|remifentanil|mesh-list
101647618|NCT02631135|Rocuronium|rocuronium|mesh-list
101647619|NCT02631135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101647620|NCT02631135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101647621|NCT02631135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647622|NCT02631135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101647623|NCT02631135|Analgesics|analgesics|mesh-ancestor
101647624|NCT02631135|Sensory System Agents|sensory system agents|mesh-ancestor
101647625|NCT02631135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101647626|NCT02631135|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101647627|NCT02631135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101647629|NCT02631135|Adrenergic Agents|adrenergic agents|mesh-ancestor
101647630|NCT02631135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101647631|NCT02631135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647632|NCT02631135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101647633|NCT02631135|Anesthetics, General|anesthetics, general|mesh-ancestor
101647634|NCT02631135|Anesthetics|anesthetics|mesh-ancestor
101647635|NCT02631135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101647636|NCT02631135|Narcotics|narcotics|mesh-ancestor
101647637|NCT02631135|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101647638|NCT02631135|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101647639|NCT02631135|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101647640|NCT00664677|Masoprocol|masoprocol|mesh-list
101647641|NCT00664677|Antioxidants|antioxidants|mesh-ancestor
101647642|NCT00664677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647643|NCT00664677|Protective Agents|protective agents|mesh-ancestor
101647644|NCT00664677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647645|NCT00664677|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101647646|NCT00664677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101647647|NCT00664677|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101647648|NCT00664677|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101647649|NCT00664677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101647650|NCT00664677|Analgesics|analgesics|mesh-ancestor
101647651|NCT00664677|Sensory System Agents|sensory system agents|mesh-ancestor
101647652|NCT00664677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101647653|NCT00664677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101647654|NCT00664677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101647655|NCT00596817|Vortioxetine|vortioxetine|mesh-list
101822933|NCT03740204|Estradiol|estradiol|mesh-list
101647656|NCT00596817|Antidepressive Agents|antidepressive agents|mesh-ancestor
101647657|NCT00596817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101647658|NCT00596817|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101647659|NCT00596817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101647660|NCT00596817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101647661|NCT00596817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647662|NCT00596817|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101647663|NCT00596817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101647664|NCT00596817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101647665|NCT00596817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647666|NCT00596817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101647667|NCT00596817|Serotonin Agents|serotonin agents|mesh-ancestor
101647668|NCT00596817|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101647669|NCT00596817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101647670|NCT00596817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101647671|NCT00596817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101647672|NCT01000649|Vasopressins|vasopressins|mesh-list
101647673|NCT01000649|Hemostatics|hemostatics|mesh-ancestor
101647674|NCT01000649|Coagulants|coagulants|mesh-ancestor
101647675|NCT01000649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101647676|NCT01000649|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101647677|NCT01000649|Natriuretic Agents|natriuretic agents|mesh-ancestor
101647678|NCT01000649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647679|NCT00664833|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101647680|NCT00664833|Vasodilator Agents|vasodilator agents|mesh-ancestor
101647681|NCT00664833|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101647682|NCT00664833|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101647683|NCT00664833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101647684|NCT00664833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304787|NCT02015299|Linagliptin|linagliptin|mesh-list
101647686|NCT00879411|Telmisartan|telmisartan|mesh-list
101647687|NCT00879411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101647688|NCT00879411|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101647689|NCT00879411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101647690|NCT00879411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647691|NCT00671151|Theophylline|theophylline|mesh-list
101647692|NCT00671151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101647693|NCT00671151|Autonomic Agents|autonomic agents|mesh-ancestor
101647694|NCT00671151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101647695|NCT00671151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647696|NCT00671151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101647697|NCT00671151|Respiratory System Agents|respiratory system agents|mesh-ancestor
101647698|NCT00671151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101647699|NCT00671151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101647700|NCT00671151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647701|NCT00671151|Vasodilator Agents|vasodilator agents|mesh-ancestor
101647702|NCT00671151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101647703|NCT00671151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101647704|NCT00671151|Purinergic Agents|purinergic agents|mesh-ancestor
101647705|NCT00671151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101647706|NCT00666757|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101647708|NCT00666757|Fluoxetine|fluoxetine|mesh-list
101647709|NCT00666757|Paroxetine|paroxetine|mesh-list
101647710|NCT00666757|Citalopram|citalopram|mesh-list
101647711|NCT00666757|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101647712|NCT00666757|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101647713|NCT00666757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101647714|NCT00666757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647715|NCT00666757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101647716|NCT00666757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647717|NCT00666757|Analgesics|analgesics|mesh-ancestor
101647718|NCT00666757|Sensory System Agents|sensory system agents|mesh-ancestor
101647719|NCT00666757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101647720|NCT00666757|Antidepressive Agents|antidepressive agents|mesh-ancestor
101647721|NCT00666757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101647722|NCT00666757|Dopamine Agents|dopamine agents|mesh-ancestor
101647723|NCT00666757|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101647724|NCT00666757|Serotonin Agents|serotonin agents|mesh-ancestor
101647725|NCT00666757|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101647726|NCT00666757|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101647727|NCT00666757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101647728|NCT00666757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101647729|NCT01000337|Propofol|propofol|mesh-list
101647730|NCT01000337|Sevoflurane|sevoflurane|mesh-list
101647731|NCT01000337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101647732|NCT01000337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101647733|NCT01000337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647734|NCT01000337|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101647735|NCT01000337|Anesthetics, General|anesthetics, general|mesh-ancestor
101647736|NCT01000337|Anesthetics|anesthetics|mesh-ancestor
101647737|NCT01000337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101647738|NCT01000337|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101647739|NCT02869763|Ethanol|ethanol|mesh-list
101647740|NCT02869763|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101647741|NCT02869763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101647742|NCT02869763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101647743|NCT02869763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647744|NCT04153383|Milrinone|milrinone|mesh-list
101647745|NCT04153383|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101647746|NCT04153383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101647747|NCT04153383|Vasodilator Agents|vasodilator agents|mesh-ancestor
101647748|NCT04153383|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101647749|NCT04153383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101647750|NCT04153383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101647751|NCT04153383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647752|NCT04153383|Protective Agents|protective agents|mesh-ancestor
101647753|NCT04153383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647754|NCT00671697|Decitabine|decitabine|mesh-list
101647755|NCT00671697|Arsenic Trioxide|arsenic trioxide|mesh-list
101647756|NCT00671697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101647757|NCT00671697|Antimetabolites|antimetabolites|mesh-ancestor
101647758|NCT00671697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647759|NCT00671697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101647760|NCT00671697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101647761|NCT00666679|Mometasone Furoate|mometasone furoate|mesh-list
101647762|NCT00666679|Montelukast|montelukast|mesh-list
101647763|NCT00666679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101647764|NCT00666679|Respiratory System Agents|respiratory system agents|mesh-ancestor
101647765|NCT00666679|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101647766|NCT00666679|Hormone Antagonists|hormone antagonists|mesh-ancestor
101647767|NCT00666679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101647768|NCT00666679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647769|NCT00666679|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101647770|NCT00666679|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101647771|NCT00666679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647772|NCT00666679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101647773|NCT00666679|Dermatologic Agents|dermatologic agents|mesh-ancestor
101647774|NCT00666679|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101647775|NCT00791401|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101647776|NCT00791401|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101647777|NCT00791401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101647778|NCT00791401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101647779|NCT00791401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647780|NCT00791401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101647781|NCT00791401|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101647782|NCT00791401|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101647783|NCT00791401|Serotonin Agents|serotonin agents|mesh-ancestor
101647784|NCT00791401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101647785|NCT00791401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647786|NCT00791401|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101647787|NCT00791401|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101647788|NCT00791401|Dopamine Agents|dopamine agents|mesh-ancestor
101647789|NCT00786253|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101647790|NCT00786253|Vasodilator Agents|vasodilator agents|mesh-ancestor
101647791|NCT00786253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101535364|NCT00574964|Alkylating Agents|alkylating agents|mesh-ancestor
101647792|NCT00786253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101647793|NCT00786253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101647794|NCT00786253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647795|NCT00786253|Urological Agents|urological agents|mesh-ancestor
101647796|NCT00595413|Adalimumab|adalimumab|mesh-list
101647797|NCT00595413|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101647798|NCT00595413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101647799|NCT00595413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101647800|NCT00781261|Zoledronic Acid|zoledronic acid|mesh-list
101647801|NCT00781261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101647802|NCT00781261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647803|NCT00786331|Carboplatin|carboplatin|mesh-list
101647804|NCT00786331|Pemetrexed|pemetrexed|mesh-list
101647805|NCT00786331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101647807|NCT00786331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647808|NCT00786331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101647809|NCT00786331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101647810|NCT00791713|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101647811|NCT00791713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101647812|NCT00791713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101647813|NCT00791713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101647814|NCT00791713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647815|NCT00791713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101647816|NCT00791713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101647817|NCT00791713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101647818|NCT00791713|Serotonin Agents|serotonin agents|mesh-ancestor
101647819|NCT00791713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101647820|NCT00791713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647821|NCT00791713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101647822|NCT00791713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101647823|NCT00791713|Dopamine Agents|dopamine agents|mesh-ancestor
101647824|NCT00595335|Methylprednisolone|methylprednisolone|mesh-list
101647825|NCT00595335|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101647826|NCT00595335|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101647827|NCT00595335|Prednisolone|prednisolone|mesh-list
101647828|NCT00595335|Prednisolone acetate|prednisolone acetate|mesh-list
101647829|NCT00595335|Rituximab|rituximab|mesh-list
101304943|NCT02016261|Serotonin Agents|serotonin agents|mesh-ancestor
101647830|NCT00595335|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101647831|NCT00595335|Prednisolone phosphate|prednisolone phosphate|mesh-list
101647832|NCT00595335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101647833|NCT00595335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101647834|NCT00595335|Immunologic Factors|immunologic factors|mesh-ancestor
101647835|NCT00595335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647836|NCT00595335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101647837|NCT00595335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101647838|NCT00595335|Antiemetics|antiemetics|mesh-ancestor
101647839|NCT00595335|Autonomic Agents|autonomic agents|mesh-ancestor
101647840|NCT00595335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101647841|NCT00595335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101647842|NCT00595335|Glucocorticoids|glucocorticoids|mesh-ancestor
101647843|NCT00595335|Hormones|hormones|mesh-ancestor
101647844|NCT00595335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101647845|NCT00595335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101647846|NCT00595335|Protective Agents|protective agents|mesh-ancestor
101647847|NCT00595335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101647848|NCT00781417|Vitamin D|vitamin d|mesh-list
101647849|NCT00781417|Ergocalciferols|ergocalciferols|mesh-list
101647850|NCT00781417|Cholecalciferol|cholecalciferol|mesh-list
101647851|NCT00781417|Vitamins|vitamins|mesh-list
101647852|NCT00781417|Micronutrients|micronutrients|mesh-ancestor
101647853|NCT00781417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101822954|NCT03735563|Anesthetics|anesthetics|mesh-ancestor
101647854|NCT00781417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101647855|NCT00781417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101647857|NCT00672165|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101647858|NCT00672165|Immunologic Factors|immunologic factors|mesh-ancestor
101647859|NCT00672165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647860|NCT04293809|Bupivacaine|bupivacaine|mesh-list
101647861|NCT04293809|Anesthetics, Local|anesthetics, local|mesh-ancestor
101647862|NCT04293809|Anesthetics|anesthetics|mesh-ancestor
101647863|NCT04293809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101647864|NCT04293809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647865|NCT04293809|Sensory System Agents|sensory system agents|mesh-ancestor
101647866|NCT04293809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101647867|NCT00672399|Exenatide|exenatide|mesh-list
101647868|NCT00672399|Moxifloxacin|moxifloxacin|mesh-list
101647869|NCT00672399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101647870|NCT00672399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101647871|NCT00672399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101647872|NCT00672399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101647873|NCT00672399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101647874|NCT00672399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647875|NCT00672399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101647876|NCT00672399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647877|NCT00672399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101647878|NCT00672399|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101647880|NCT00672399|Hormones|hormones|mesh-ancestor
101647881|NCT00672399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101647882|NCT00661531|Anastrozole|anastrozole|mesh-list
101647883|NCT00661531|Estradiol|estradiol|mesh-list
101647884|NCT00661531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101647885|NCT00661531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101647886|NCT00661531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101647887|NCT00661531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101647888|NCT00661531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101647889|NCT00661531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647890|NCT00661531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101647891|NCT00661531|Hormone Antagonists|hormone antagonists|mesh-ancestor
101647892|NCT00661531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101647893|NCT00661531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647894|NCT00661531|Estrogens|estrogens|mesh-ancestor
101647895|NCT00661531|Hormones|hormones|mesh-ancestor
101647896|NCT00998309|Azithromycin|azithromycin|mesh-list
101647897|NCT00998309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101647898|NCT00998309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101647899|NCT02629575|Sirolimus|sirolimus|mesh-list
101647900|NCT02629575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101647901|NCT02629575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101647902|NCT02629575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101647903|NCT02629575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101647904|NCT02629575|Antifungal Agents|antifungal agents|mesh-ancestor
101647905|NCT02629575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101647906|NCT02629575|Immunologic Factors|immunologic factors|mesh-ancestor
101647907|NCT02629575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647908|NCT00781573|Clopidogrel|clopidogrel|mesh-list
101647909|NCT00781573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101647910|NCT00781573|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101647911|NCT00781573|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101647912|NCT00781573|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101647913|NCT00781573|Purinergic Agents|purinergic agents|mesh-ancestor
101647914|NCT00781573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101647915|NCT00781573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647916|NCT00781573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647917|NCT00671541|Gentamicins|gentamicins|mesh-list
101647918|NCT00671541|Bacitracin|bacitracin|mesh-list
101822961|NCT03735563|Narcotics|narcotics|mesh-ancestor
101647919|NCT00671541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101647920|NCT00671541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101647921|NCT00671541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101647922|NCT00671541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101647923|NCT00671541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647924|NCT00671541|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101647926|NCT04152681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101647927|NCT04152681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101647928|NCT04152681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101647929|NCT04152681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647930|NCT00999713|Calfactant|calfactant|mesh-list
101647931|NCT00999713|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
101647932|NCT00999713|Respiratory System Agents|respiratory system agents|mesh-ancestor
101647933|NCT00672867|Adefovir|adefovir|mesh-list
101647934|NCT00672867|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101647935|NCT00672867|Clevudine|clevudine|mesh-list
101647936|NCT00672867|Antiviral Agents|antiviral agents|mesh-ancestor
101647937|NCT00672867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101647938|NCT00672867|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101647939|NCT00672867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101647940|NCT00672867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101647941|NCT00672867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647942|NCT00997373|Letrozole|letrozole|mesh-list
101647943|NCT00997373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101647944|NCT00997373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101647945|NCT00997373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101647946|NCT00997373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101647947|NCT00997373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647948|NCT00997373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101647949|NCT00997373|Hormone Antagonists|hormone antagonists|mesh-ancestor
101647950|NCT00997373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101647951|NCT00997373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647952|NCT04152759|Golimumab|golimumab|mesh-list
101647954|NCT04152759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101647955|NCT04152759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101647956|NCT04152759|Immunologic Factors|immunologic factors|mesh-ancestor
101647957|NCT04152759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647959|NCT00792025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101647960|NCT00792025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101647961|NCT00792025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101647962|NCT00792025|Growth Substances|growth substances|mesh-ancestor
101647963|NCT00792025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647964|NCT00792025|Growth Inhibitors|growth inhibitors|mesh-ancestor
101647965|NCT00792025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101647966|NCT00792025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101647967|NCT00792025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647968|NCT02870231|Liraglutide|liraglutide|mesh-list
101647969|NCT02870231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101647970|NCT02870231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647971|NCT02870231|Incretins|incretins|mesh-ancestor
101647972|NCT02870231|Hormones|hormones|mesh-ancestor
101647973|NCT02870231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101647974|NCT00782041|Leucovorin|leucovorin|mesh-list
101647975|NCT00782041|Folic Acid|folic acid|mesh-list
101647976|NCT00782041|Fluorouracil|fluorouracil|mesh-list
101647977|NCT00782041|Oxaliplatin|oxaliplatin|mesh-list
101647978|NCT00782041|Levoleucovorin|levoleucovorin|mesh-list
101647979|NCT00782041|Antimetabolites|antimetabolites|mesh-ancestor
101647980|NCT00782041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647981|NCT00782041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101647982|NCT00782041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101647983|NCT00782041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101647984|NCT00782041|Immunologic Factors|immunologic factors|mesh-ancestor
101647985|NCT00782041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101647986|NCT00782041|Antidotes|antidotes|mesh-ancestor
101647987|NCT00782041|Protective Agents|protective agents|mesh-ancestor
101647988|NCT00782041|Vitamin B Complex|vitamin b complex|mesh-ancestor
101647989|NCT00782041|Vitamins|vitamins|mesh-ancestor
101647990|NCT00782041|Micronutrients|micronutrients|mesh-ancestor
101647991|NCT00782041|Hematinics|hematinics|mesh-ancestor
101647992|NCT00673569|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101647993|NCT00673569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101647994|NCT00673569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101647995|NCT00673569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101647996|NCT00673569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101647997|NCT00792181|Midazolam|midazolam|mesh-list
101647998|NCT00792181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101647999|NCT00792181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101648000|NCT00792181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101648001|NCT00792181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648002|NCT00792181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101648003|NCT00792181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101648004|NCT00792181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101648005|NCT00792181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101648006|NCT00792181|Anesthetics, General|anesthetics, general|mesh-ancestor
101648007|NCT00792181|Anesthetics|anesthetics|mesh-ancestor
101648008|NCT00792181|GABA Modulators|gaba modulators|mesh-ancestor
101648009|NCT00792181|GABA Agents|gaba agents|mesh-ancestor
101648010|NCT00792181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101648011|NCT00792181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648012|NCT00792337|Simvastatin|simvastatin|mesh-list
101648013|NCT00792337|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101648014|NCT00792337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101648015|NCT00792337|Antimetabolites|antimetabolites|mesh-ancestor
101648016|NCT00792337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648017|NCT00792337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101648018|NCT00792337|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101648019|NCT00792337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101648020|NCT00787111|Fluoxetine|fluoxetine|mesh-list
101648021|NCT00787111|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101648022|NCT00787111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101648023|NCT00787111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101648024|NCT00787111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648025|NCT00787111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101648026|NCT00787111|Serotonin Agents|serotonin agents|mesh-ancestor
101648027|NCT00787111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648028|NCT00787111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101648030|NCT00787111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101648031|NCT00787111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101648032|NCT00787111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101648033|NCT00787111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101648034|NCT00782197|Hyaluronic Acid|hyaluronic acid|mesh-list
101648035|NCT00782197|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101648036|NCT00782197|Immunologic Factors|immunologic factors|mesh-ancestor
101648037|NCT00782197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648038|NCT00782197|Viscosupplements|viscosupplements|mesh-ancestor
101648039|NCT00782197|Protective Agents|protective agents|mesh-ancestor
101648040|NCT04152291|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
101648041|NCT04152291|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101648042|NCT04152291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101648044|NCT00996593|Tositumomab I-131|tositumomab i-131|mesh-list
101648045|NCT00996593|Antibodies|antibodies|mesh-list
101648046|NCT00996593|Immunoglobulins|immunoglobulins|mesh-list
101648047|NCT00996593|Immunologic Factors|immunologic factors|mesh-ancestor
101648048|NCT00996593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648049|NCT00996593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101648050|NCT00996593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101648051|NCT00996593|Trace Elements|trace elements|mesh-ancestor
101648052|NCT00996593|Micronutrients|micronutrients|mesh-ancestor
101648053|NCT00996593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101648054|NCT00570661|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
101648055|NCT00570661|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
101648056|NCT00570661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101648057|NCT00570661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648058|NCT02870153|Oxaliplatin|oxaliplatin|mesh-list
101648059|NCT02870153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101648060|NCT00787501|Fluoxetine|fluoxetine|mesh-list
101648061|NCT00787501|Sertraline|sertraline|mesh-list
101648062|NCT00787501|Escitalopram|escitalopram|mesh-list
101648063|NCT00787501|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101648064|NCT00787501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101648065|NCT00787501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101648066|NCT00787501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648067|NCT00787501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101648068|NCT00787501|Serotonin Agents|serotonin agents|mesh-ancestor
101648069|NCT00787501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648070|NCT00787501|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101648071|NCT00787501|Antidepressive Agents|antidepressive agents|mesh-ancestor
101648072|NCT00787501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101648073|NCT00787501|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101648074|NCT00787501|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101648075|NCT00787501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101648077|NCT00787657|Interferon-beta|interferon-beta|mesh-list
101648078|NCT00787657|Interferon beta-1b|interferon beta-1b|mesh-list
101648079|NCT00787657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101648080|NCT00787657|Antiviral Agents|antiviral agents|mesh-ancestor
101648081|NCT00787657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101648083|NCT00787657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409062|NCT00457405|Dipyridamole|dipyridamole|mesh-list
101648084|NCT00787657|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101648085|NCT04264676|Metronidazole|metronidazole|mesh-list
101648086|NCT04264676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101648087|NCT04264676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101648088|NCT04264676|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101648089|NCT04264676|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101648090|NCT02869841|Levobupivacaine|levobupivacaine|mesh-list
101648091|NCT02869841|Anesthetics, Local|anesthetics, local|mesh-ancestor
101648092|NCT02869841|Anesthetics|anesthetics|mesh-ancestor
101648093|NCT02869841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101648094|NCT02869841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648095|NCT02869841|Sensory System Agents|sensory system agents|mesh-ancestor
101648096|NCT02869841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101648097|NCT00637637|Ritonavir|ritonavir|mesh-list
101648098|NCT00637637|Indinavir|indinavir|mesh-list
101648099|NCT00637637|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101648100|NCT00637637|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101648101|NCT00637637|Protease Inhibitors|protease inhibitors|mesh-ancestor
101648102|NCT00637637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101648103|NCT00637637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648104|NCT00637637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101648105|NCT00637637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101648106|NCT00637637|Antiviral Agents|antiviral agents|mesh-ancestor
101648107|NCT00637637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101648108|NCT00637637|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101648109|NCT00637637|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101648110|NCT00927758|Fluticasone|fluticasone|mesh-list
101648111|NCT00927758|Xhance|xhance|mesh-list
101648112|NCT00927758|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101648113|NCT00927758|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101648114|NCT00927758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101648115|NCT00927758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101648116|NCT00927758|Autonomic Agents|autonomic agents|mesh-ancestor
101648117|NCT00927758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101648118|NCT00927758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648119|NCT00927758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101648120|NCT00927758|Respiratory System Agents|respiratory system agents|mesh-ancestor
101648121|NCT00927758|Dermatologic Agents|dermatologic agents|mesh-ancestor
101648122|NCT00927758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101648123|NCT00927758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101648124|NCT00927758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101648125|NCT00927758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101648126|NCT00927758|Adrenergic Agents|adrenergic agents|mesh-ancestor
101648127|NCT00927758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101648128|NCT00927758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823041|NCT03397706|Valganciclovir|valganciclovir|mesh-list
101648129|NCT00927758|Glucocorticoids|glucocorticoids|mesh-ancestor
101305246|NCT02018289|Triclosan|triclosan|mesh-list
101648130|NCT00927758|Hormones|hormones|mesh-ancestor
101648131|NCT00927758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101648132|NCT00927758|Sympathomimetics|sympathomimetics|mesh-ancestor
101648133|NCT00783523|Doxycycline|doxycycline|mesh-list
101648134|NCT00783523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101648135|NCT00783523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101648136|NCT00783523|Antimalarials|antimalarials|mesh-ancestor
101648137|NCT00783523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101648138|NCT00783523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101648139|NCT00783601|Montelukast|montelukast|mesh-list
101648140|NCT00783601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101648141|NCT00783601|Respiratory System Agents|respiratory system agents|mesh-ancestor
101648142|NCT00783601|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101648143|NCT00783601|Hormone Antagonists|hormone antagonists|mesh-ancestor
101648144|NCT00783601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101648145|NCT00783601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648146|NCT00783601|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101648147|NCT00783601|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101648148|NCT00783601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648149|NCT00787813|Acetylcysteine|acetylcysteine|mesh-list
101648150|NCT00787813|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101648151|NCT00787813|Antiviral Agents|antiviral agents|mesh-ancestor
101648152|NCT00787813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101648153|NCT00787813|Expectorants|expectorants|mesh-ancestor
101648154|NCT00787813|Respiratory System Agents|respiratory system agents|mesh-ancestor
101823157|NCT02974725|Trametinib|trametinib|mesh-list
101648155|NCT00787813|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101648156|NCT00787813|Antioxidants|antioxidants|mesh-ancestor
101648157|NCT00787813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648158|NCT00787813|Protective Agents|protective agents|mesh-ancestor
101648159|NCT00787813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648160|NCT00787813|Antidotes|antidotes|mesh-ancestor
101648161|NCT04261634|Mitogens|mitogens|mesh-list
101648162|NCT04261634|Mitosis Modulators|mitosis modulators|mesh-ancestor
101648163|NCT04261634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648164|NCT00787969|Sirolimus|sirolimus|mesh-list
101648165|NCT00787969|Rituximab|rituximab|mesh-list
101648166|NCT00787969|Temsirolimus|temsirolimus|mesh-list
101648167|NCT00787969|Cladribine|cladribine|mesh-list
101648168|NCT00787969|MTOR Inhibitors|mtor inhibitors|mesh-list
101648169|NCT00787969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101648170|NCT00787969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101648171|NCT00787969|Immunologic Factors|immunologic factors|mesh-ancestor
101648172|NCT00787969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648173|NCT00787969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101648174|NCT00787969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101648175|NCT00787969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101648176|NCT00787969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648177|NCT00787969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101648178|NCT00787969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101648179|NCT00787969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101648180|NCT00787969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101648181|NCT00787969|Antifungal Agents|antifungal agents|mesh-ancestor
101648183|NCT00609596|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101648184|NCT00609596|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101648185|NCT00609596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101648186|NCT00609596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648187|NCT00609596|Hormone Antagonists|hormone antagonists|mesh-ancestor
101648188|NCT00609596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101648189|NCT00609596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648190|NCT00608816|Epinephrine|epinephrine|mesh-list
101648191|NCT00608816|Racepinephrine|racepinephrine|mesh-list
101648192|NCT00608816|Epinephryl borate|epinephryl borate|mesh-list
101648193|NCT00608816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101648194|NCT00608816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101648195|NCT00608816|Adrenergic Agents|adrenergic agents|mesh-ancestor
101648196|NCT00608816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101648197|NCT00608816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648198|NCT00608816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648199|NCT00608816|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101648200|NCT00608816|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101648201|NCT00608816|Autonomic Agents|autonomic agents|mesh-ancestor
101648202|NCT00608816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101648203|NCT00608816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101648204|NCT00608816|Respiratory System Agents|respiratory system agents|mesh-ancestor
101648205|NCT00608816|Mydriatics|mydriatics|mesh-ancestor
101648206|NCT00608816|Sympathomimetics|sympathomimetics|mesh-ancestor
101648207|NCT00608816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101648208|NCT02535273|Lidocaine|lidocaine|mesh-list
101648209|NCT02535273|Dexmedetomidine|dexmedetomidine|mesh-list
101648210|NCT02535273|Anesthetics, Local|anesthetics, local|mesh-ancestor
101648211|NCT02535273|Anesthetics|anesthetics|mesh-ancestor
101648212|NCT02535273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101648213|NCT02535273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648214|NCT02535273|Sensory System Agents|sensory system agents|mesh-ancestor
101648215|NCT02535273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101648216|NCT02535273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101648217|NCT02535273|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101648218|NCT02535273|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101648219|NCT02535273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101648220|NCT02535273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648221|NCT02535273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101648222|NCT02535273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101648223|NCT02535273|Analgesics|analgesics|mesh-ancestor
101648224|NCT02535273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101648225|NCT02535273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101648226|NCT02535273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101648227|NCT02535273|Adrenergic Agents|adrenergic agents|mesh-ancestor
101648228|NCT02535273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101648229|NCT00788047|Dextromethorphan|dextromethorphan|mesh-list
101648230|NCT00788047|Antitussive Agents|antitussive agents|mesh-ancestor
101648231|NCT00788047|Respiratory System Agents|respiratory system agents|mesh-ancestor
101648232|NCT00788047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101648233|NCT00788047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101648234|NCT00788047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101648235|NCT00788047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648236|NCT00788047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648237|NCT04152369|Anti-Infective Agents|anti-infective agents|mesh-list
101648238|NCT04152369|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101648239|NCT04259684|Nitric Oxide|nitric oxide|mesh-list
101648240|NCT04259684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101648241|NCT04259684|Autonomic Agents|autonomic agents|mesh-ancestor
101648242|NCT04259684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101648243|NCT04259684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648244|NCT04259684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101648245|NCT04259684|Respiratory System Agents|respiratory system agents|mesh-ancestor
101648246|NCT04259684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101648247|NCT04259684|Antioxidants|antioxidants|mesh-ancestor
101648248|NCT04259684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648250|NCT04259684|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101648251|NCT04259684|Vasodilator Agents|vasodilator agents|mesh-ancestor
101648252|NCT04259684|Gasotransmitters|gasotransmitters|mesh-ancestor
101648253|NCT04259684|Protective Agents|protective agents|mesh-ancestor
101648254|NCT00788515|Lormetazepam|lormetazepam|mesh-list
101648255|NCT00788515|Volinanserin|volinanserin|mesh-list
101648256|NCT00788515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101648257|NCT00788515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101648258|NCT00788515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648259|NCT00788515|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101648260|NCT00788515|Serotonin Agents|serotonin agents|mesh-ancestor
101648261|NCT00788515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101648262|NCT00788515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648263|NCT04259606|Magnesium Oxide|magnesium oxide|mesh-list
101648264|NCT04259606|Antacids|antacids|mesh-ancestor
101648265|NCT04259606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648266|NCT04259606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101648267|NCT00788749|Fluticasone|fluticasone|mesh-list
101648268|NCT00788749|Xhance|xhance|mesh-list
101648269|NCT00788749|Prednisolone|prednisolone|mesh-list
101648270|NCT00788749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101648271|NCT00788749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101648272|NCT00788749|Autonomic Agents|autonomic agents|mesh-ancestor
101648273|NCT00788749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101648274|NCT00788749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648275|NCT00788749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101648276|NCT00788749|Respiratory System Agents|respiratory system agents|mesh-ancestor
101648277|NCT00788749|Dermatologic Agents|dermatologic agents|mesh-ancestor
101648278|NCT00788749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101648279|NCT00788749|Glucocorticoids|glucocorticoids|mesh-ancestor
101648281|NCT00788749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101648282|NCT00788749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101648283|NCT00788749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101648284|NCT00609752|Prednisolone|prednisolone|mesh-list
101648285|NCT00609752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101648286|NCT00609752|Glucocorticoids|glucocorticoids|mesh-ancestor
101648288|NCT00609752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101648289|NCT00609752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648290|NCT00609752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101648291|NCT00609752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101648292|NCT00662857|Insulin|insulin|mesh-list
101648293|NCT00662857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101648294|NCT00662857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101648295|NCT00662857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648296|NCT00878553|Zaleplon|zaleplon|mesh-list
101648297|NCT00878553|Anticonvulsants|anticonvulsants|mesh-ancestor
101648298|NCT00878553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101648299|NCT00878553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101648300|NCT00878553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648301|NCT00878553|GABA Modulators|gaba modulators|mesh-ancestor
101648302|NCT00878553|GABA Agents|gaba agents|mesh-ancestor
101648303|NCT00878553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101648304|NCT00878553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648305|NCT05220020|Lenvatinib|lenvatinib|mesh-list
101648306|NCT05220020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101648307|NCT05220020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101648308|NCT05220020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101648309|NCT05220020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648310|NCT00789061|Lansoprazole|lansoprazole|mesh-list
101648311|NCT00789061|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101648312|NCT00789061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101648313|NCT00789061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101648314|NCT00789061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101648315|NCT00789061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648316|NCT00996437|Ranibizumab|ranibizumab|mesh-list
101648317|NCT00996437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101648318|NCT00996437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101648319|NCT00996437|Growth Substances|growth substances|mesh-ancestor
101648320|NCT00996437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648321|NCT00996437|Growth Inhibitors|growth inhibitors|mesh-ancestor
101648322|NCT00996437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101648323|NCT02628951|Paclitaxel|paclitaxel|mesh-list
101648324|NCT02628951|Ramucirumab|ramucirumab|mesh-list
101648325|NCT02628951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101648326|NCT02628951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101648327|NCT02628951|Tubulin Modulators|tubulin modulators|mesh-ancestor
101648328|NCT02628951|Antimitotic Agents|antimitotic agents|mesh-ancestor
101648329|NCT02628951|Mitosis Modulators|mitosis modulators|mesh-ancestor
101648330|NCT02628951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648331|NCT00662311|Paclitaxel|paclitaxel|mesh-list
101648332|NCT00662311|Vorinostat|vorinostat|mesh-list
101648333|NCT00662311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101648334|NCT00662311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101648335|NCT00662311|Tubulin Modulators|tubulin modulators|mesh-ancestor
101648336|NCT00662311|Antimitotic Agents|antimitotic agents|mesh-ancestor
101648337|NCT00662311|Mitosis Modulators|mitosis modulators|mesh-ancestor
101648338|NCT00662311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648339|NCT00662311|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101648340|NCT00662311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101648341|NCT00929708|Formoterol Fumarate|formoterol fumarate|mesh-list
101648342|NCT00929708|AZD-3199|azd-3199|mesh-list
101648343|NCT00929708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101648344|NCT00929708|Autonomic Agents|autonomic agents|mesh-ancestor
101648345|NCT00929708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101648346|NCT00929708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648347|NCT00929708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101648348|NCT00929708|Respiratory System Agents|respiratory system agents|mesh-ancestor
101648349|NCT00929708|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101648350|NCT00929708|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101648351|NCT00929708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101648352|NCT00929708|Adrenergic Agents|adrenergic agents|mesh-ancestor
101648353|NCT00929708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101648354|NCT00929708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648355|NCT00996281|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101648357|NCT00996281|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101648358|NCT00996281|Chlorthalidone|chlorthalidone|mesh-list
101648359|NCT00996281|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
101648360|NCT00996281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101648361|NCT00996281|Diuretics|diuretics|mesh-ancestor
101648362|NCT00996281|Natriuretic Agents|natriuretic agents|mesh-ancestor
101648363|NCT00996281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648364|NCT00996281|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101648365|NCT00996281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101648366|NCT00996281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648367|NCT00996281|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101648368|NCT00996281|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101648369|NCT04046653|Sulforaphane|sulforaphane|mesh-list
101648370|NCT04046653|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101648371|NCT04046653|Protective Agents|protective agents|mesh-ancestor
101648372|NCT04046653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648373|NCT04046653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101648374|NCT04293887|Interferons|interferons|mesh-list
101648375|NCT04293887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101648376|NCT04293887|Antiviral Agents|antiviral agents|mesh-ancestor
101648377|NCT04293887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101648378|NCT00675207|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101648379|NCT00675207|Dorzolamide|dorzolamide|mesh-list
101648380|NCT00675207|Brinzolamide|brinzolamide|mesh-list
101648381|NCT00675207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101648382|NCT00675207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101648383|NCT00675207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101648384|NCT00675207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101648385|NCT00675207|Adrenergic Agents|adrenergic agents|mesh-ancestor
101648386|NCT00675207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101648387|NCT00675207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648388|NCT00675207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648389|NCT00675207|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101648390|NCT00675207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101648391|NCT00795223|Morphine|morphine|mesh-list
101648392|NCT00795223|Bupivacaine|bupivacaine|mesh-list
101648393|NCT00795223|Anesthetics, Local|anesthetics, local|mesh-ancestor
101648394|NCT00795223|Anesthetics|anesthetics|mesh-ancestor
101648395|NCT00795223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101648396|NCT00795223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648397|NCT00795223|Sensory System Agents|sensory system agents|mesh-ancestor
101648398|NCT00795223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101648399|NCT00795223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101648400|NCT00795223|Narcotics|narcotics|mesh-ancestor
101648402|NCT00795301|Capecitabine|capecitabine|mesh-list
101648403|NCT00795301|Oxaliplatin|oxaliplatin|mesh-list
101648404|NCT00795301|Cetuximab|cetuximab|mesh-list
101648405|NCT00795301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101648406|NCT00795301|Antimetabolites|antimetabolites|mesh-ancestor
101648407|NCT00795301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648408|NCT00795301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101648409|NCT00795301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101648410|NCT00675285|Montelukast|montelukast|mesh-list
101648411|NCT00675285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101648412|NCT00675285|Respiratory System Agents|respiratory system agents|mesh-ancestor
101648413|NCT00675285|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101648414|NCT00675285|Hormone Antagonists|hormone antagonists|mesh-ancestor
101648415|NCT00675285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101648416|NCT00675285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648417|NCT00675285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101648418|NCT00675285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101648419|NCT00675285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648420|NCT00996203|Antirheumatic Agents|antirheumatic agents|mesh-list
101648421|NCT00789763|Gemcitabine|gemcitabine|mesh-list
101648422|NCT00789763|Sorafenib|sorafenib|mesh-list
101648423|NCT00789763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101648424|NCT00789763|Antimetabolites|antimetabolites|mesh-ancestor
101648425|NCT00789763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648426|NCT00789763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101648427|NCT00789763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101648428|NCT00789763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101648429|NCT02554357|Bupivacaine|bupivacaine|mesh-list
101648430|NCT02554357|Anesthetics, Local|anesthetics, local|mesh-ancestor
101648431|NCT02554357|Anesthetics|anesthetics|mesh-ancestor
101648432|NCT02554357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101648433|NCT02554357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648434|NCT02554357|Sensory System Agents|sensory system agents|mesh-ancestor
101648435|NCT02554357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101648436|NCT00877929|Amlodipine|amlodipine|mesh-list
101648437|NCT00877929|Telmisartan|telmisartan|mesh-list
101648438|NCT00877929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101648439|NCT00877929|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101648440|NCT00877929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101648441|NCT00877929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648442|NCT00877929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101648443|NCT00877929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648444|NCT00877929|Vasodilator Agents|vasodilator agents|mesh-ancestor
101648445|NCT00877929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101648446|NCT00877929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101648447|NCT00795457|Poly I-C|poly i-c|mesh-list
101648448|NCT00795457|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101648449|NCT00795457|Vaccines|vaccines|mesh-list
101648450|NCT00795457|Poly ICLC|poly iclc|mesh-list
101648451|NCT00795457|Immunologic Factors|immunologic factors|mesh-ancestor
101648452|NCT00795457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648453|NCT00795457|Interferon Inducers|interferon inducers|mesh-ancestor
101648454|NCT00795457|Laxatives|laxatives|mesh-ancestor
101648455|NCT00795457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101648456|NCT00795457|Antiviral Agents|antiviral agents|mesh-ancestor
101648457|NCT00795457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101648458|NCT00793195|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101648459|NCT00793195|SMOFlipid|smoflipid|mesh-list
101648460|NCT00793195|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101823349|NCT02516696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101648461|NCT00793195|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101648462|NCT00793195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101648463|NCT00793273|Insulin Detemir|insulin detemir|mesh-list
101648464|NCT00793273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101648465|NCT00793273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648466|NCT04979780|Heparin|heparin|mesh-list
101648467|NCT04979780|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101648468|NCT04979780|Tinzaparin|tinzaparin|mesh-list
101648469|NCT04979780|Dalteparin|dalteparin|mesh-list
101648470|NCT04979780|Rivaroxaban|rivaroxaban|mesh-list
101648471|NCT04979780|Anticoagulants|anticoagulants|mesh-list
101648472|NCT04979780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101648473|NCT04979780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101648474|NCT04979780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648475|NCT04979780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101648476|NCT04979780|Antithrombins|antithrombins|mesh-ancestor
101648477|NCT04979780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101648478|NCT04979780|Protease Inhibitors|protease inhibitors|mesh-ancestor
101648479|NCT04979780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101648480|NCT04598009|Imatinib Mesylate|imatinib mesylate|mesh-list
101648481|NCT04598009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101648482|NCT04598009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101648483|NCT04598009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101648484|NCT04598009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648485|NCT00795613|Doxorubicin|doxorubicin|mesh-list
101648486|NCT00795613|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101648487|NCT00795613|Vincristine|vincristine|mesh-list
101648488|NCT00795613|Procarbazine|procarbazine|mesh-list
101648489|NCT00795613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101648490|NCT00795613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101648491|NCT00795613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101648492|NCT00795613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101648493|NCT00795613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101648494|NCT00795613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648495|NCT00795613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101648496|NCT00795613|Tubulin Modulators|tubulin modulators|mesh-ancestor
101648497|NCT00795613|Antimitotic Agents|antimitotic agents|mesh-ancestor
101648498|NCT00795613|Mitosis Modulators|mitosis modulators|mesh-ancestor
101648499|NCT00800761|Deferiprone|deferiprone|mesh-list
101648500|NCT00800761|Deferoxamine|deferoxamine|mesh-list
101648501|NCT00800761|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101648502|NCT00800761|Chelating Agents|chelating agents|mesh-ancestor
101648503|NCT00800761|Sequestering Agents|sequestering agents|mesh-ancestor
101648504|NCT00800761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648506|NCT00676221|Mycophenolic Acid|mycophenolic acid|mesh-list
101648507|NCT00676221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101648508|NCT00676221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101648509|NCT00676221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101648510|NCT00676221|Antitubercular Agents|antitubercular agents|mesh-ancestor
101648511|NCT00676221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101648512|NCT00676221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101648513|NCT00676221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101648514|NCT00676221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648515|NCT00800917|Sirolimus|sirolimus|mesh-list
101648516|NCT00800917|Bevacizumab|bevacizumab|mesh-list
101648517|NCT00800917|Temsirolimus|temsirolimus|mesh-list
101648518|NCT00800917|MTOR Inhibitors|mtor inhibitors|mesh-list
101648519|NCT00800917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101648520|NCT00800917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101648521|NCT00800917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101648522|NCT00800917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101648523|NCT00800917|Growth Substances|growth substances|mesh-ancestor
101648524|NCT00800917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648525|NCT00800917|Growth Inhibitors|growth inhibitors|mesh-ancestor
101648526|NCT00800917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101648527|NCT00800917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101648528|NCT00800917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648529|NCT00800917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101648530|NCT00800917|Immunologic Factors|immunologic factors|mesh-ancestor
101648531|NCT00800917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101648532|NCT00800917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101648533|NCT00800917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101648534|NCT00800917|Antifungal Agents|antifungal agents|mesh-ancestor
101648536|NCT05003102|Dexmedetomidine|dexmedetomidine|mesh-list
101648537|NCT05003102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101648538|NCT05003102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101648539|NCT05003102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648540|NCT05003102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101648541|NCT05003102|Analgesics|analgesics|mesh-ancestor
101648542|NCT05003102|Sensory System Agents|sensory system agents|mesh-ancestor
101648543|NCT05003102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101648544|NCT05003102|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101648545|NCT05003102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101648546|NCT05003102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101648547|NCT05003102|Adrenergic Agents|adrenergic agents|mesh-ancestor
101648548|NCT05003102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101648549|NCT05003102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648550|NCT05003102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101648552|NCT05003102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101648553|NCT05003102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101648554|NCT05003102|Anesthetics, General|anesthetics, general|mesh-ancestor
101648555|NCT05003102|Anesthetics|anesthetics|mesh-ancestor
101648556|NCT00676377|Neostigmine|neostigmine|mesh-list
101648557|NCT00676377|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101648558|NCT00676377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101648559|NCT00676377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648560|NCT00676377|Cholinergic Agents|cholinergic agents|mesh-ancestor
101648561|NCT00676377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101648562|NCT00676377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648563|NCT00676377|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101648564|NCT00676377|Autonomic Agents|autonomic agents|mesh-ancestor
101648565|NCT00676377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101648566|NCT00676533|Ciprofloxacin|ciprofloxacin|mesh-list
101648567|NCT00676533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101648568|NCT00676533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101648569|NCT00676533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101648570|NCT00676533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101648571|NCT00676533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101648572|NCT00676533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648573|NCT00676533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101648574|NCT00676533|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101648575|NCT00676533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101648576|NCT00676845|Olmesartan|olmesartan|mesh-list
101648577|NCT00676845|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101648578|NCT00676845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101648580|NCT00676845|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101648581|NCT00676845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648582|NCT04152057|Paclitaxel|paclitaxel|mesh-list
101823395|NCT02278120|Tamoxifen|tamoxifen|mesh-list
101648584|NCT04152057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101648585|NCT04152057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101648586|NCT04152057|Tubulin Modulators|tubulin modulators|mesh-ancestor
101648587|NCT04152057|Antimitotic Agents|antimitotic agents|mesh-ancestor
101648588|NCT04152057|Mitosis Modulators|mitosis modulators|mesh-ancestor
101648589|NCT04152057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648590|NCT04152057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101648591|NCT00610142|Hydrocortisone|hydrocortisone|mesh-list
101648592|NCT00610142|Pimecrolimus|pimecrolimus|mesh-list
101648593|NCT00610142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101648594|NCT00610142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101648595|NCT00610142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101648596|NCT00610142|Analgesics|analgesics|mesh-ancestor
101648597|NCT00610142|Sensory System Agents|sensory system agents|mesh-ancestor
101648598|NCT00610142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101648599|NCT00610142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648600|NCT00610142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101648601|NCT00610142|Dermatologic Agents|dermatologic agents|mesh-ancestor
101648602|NCT00610142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101648603|NCT00610142|Immunologic Factors|immunologic factors|mesh-ancestor
101648604|NCT00610142|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101648605|NCT00610142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101648606|NCT00610142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648607|NCT04151823|Vitamin D|vitamin d|mesh-list
101648608|NCT04151823|Cholecalciferol|cholecalciferol|mesh-list
101648609|NCT04151823|Vitamins|vitamins|mesh-ancestor
101648610|NCT04151823|Micronutrients|micronutrients|mesh-ancestor
101648611|NCT04151823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648612|NCT04151823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101648613|NCT04151823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101648614|NCT05199038|Octreotide|octreotide|mesh-list
101648615|NCT05199038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101648616|NCT05199038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101648617|NCT05199038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101648618|NCT00660907|Metformin|metformin|mesh-list
101648619|NCT00660907|Dapagliflozin|dapagliflozin|mesh-list
101648620|NCT00660907|Glipizide|glipizide|mesh-list
101648621|NCT00660907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101648622|NCT00660907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648623|NCT00660907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101648624|NCT00660907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648625|NCT04992572|Lidocaine|lidocaine|mesh-list
101648626|NCT04992572|Propofol|propofol|mesh-list
101648628|NCT04992572|Anesthetics|anesthetics|mesh-ancestor
101648629|NCT04992572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101648630|NCT04992572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648631|NCT04992572|Sensory System Agents|sensory system agents|mesh-ancestor
101648632|NCT04992572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101648633|NCT04992572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101648634|NCT04992572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101648635|NCT04992572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101648636|NCT04992572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101648637|NCT04992572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648638|NCT04992572|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101648639|NCT04992572|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101648641|NCT05083052|Propolis|propolis|mesh-list
101648642|NCT05083052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101648643|NCT04031703|Paclitaxel|paclitaxel|mesh-list
101648644|NCT04031703|Docetaxel|docetaxel|mesh-list
101648645|NCT04031703|Cyclophosphamide|cyclophosphamide|mesh-list
101648646|NCT04031703|Carboplatin|carboplatin|mesh-list
101648647|NCT04031703|Fluorouracil|fluorouracil|mesh-list
101648648|NCT04031703|Epirubicin|epirubicin|mesh-list
101648649|NCT04031703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101648650|NCT04031703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101648651|NCT04031703|Tubulin Modulators|tubulin modulators|mesh-ancestor
101648652|NCT04031703|Antimitotic Agents|antimitotic agents|mesh-ancestor
101648653|NCT04031703|Mitosis Modulators|mitosis modulators|mesh-ancestor
101648654|NCT04031703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648655|NCT04031703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101648656|NCT04031703|Immunologic Factors|immunologic factors|mesh-ancestor
101648657|NCT04031703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648658|NCT04031703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101648659|NCT04031703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101648660|NCT04031703|Alkylating Agents|alkylating agents|mesh-ancestor
101648661|NCT04031703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101648663|NCT04031703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101648664|NCT04031703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101648665|NCT04031703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101648666|NCT04031703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101648667|NCT04031703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101648668|NCT00795847|Losartan|losartan|mesh-list
101648669|NCT00795847|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101648670|NCT00795847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101648671|NCT00795847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101648672|NCT00795847|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101648673|NCT00795847|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101648674|NCT00795847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648675|NCT00795847|Diuretics|diuretics|mesh-ancestor
101648676|NCT00795847|Natriuretic Agents|natriuretic agents|mesh-ancestor
101648677|NCT00795847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648678|NCT00795847|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101648679|NCT00795847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101648680|NCT00877773|Sirolimus|sirolimus|mesh-list
101648681|NCT00877773|Temsirolimus|temsirolimus|mesh-list
101648682|NCT00877773|MTOR Inhibitors|mtor inhibitors|mesh-list
101648683|NCT00877773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101648684|NCT00877773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101648685|NCT00877773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648686|NCT00877773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101648687|NCT00877773|Immunologic Factors|immunologic factors|mesh-ancestor
101648688|NCT00877773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648689|NCT00877773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101648690|NCT00877773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101648691|NCT00877773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101648692|NCT00877773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101648693|NCT00877773|Antifungal Agents|antifungal agents|mesh-ancestor
101648694|NCT00659815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101648695|NCT00994643|Aldesleukin|aldesleukin|mesh-list
101648696|NCT00994643|Rituximab|rituximab|mesh-list
101648697|NCT00994643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101648698|NCT00994643|Interleukin-2|interleukin-2|mesh-list
101648699|NCT00994643|Antibodies|antibodies|mesh-list
101648700|NCT00994643|Immunoglobulins|immunoglobulins|mesh-list
101648701|NCT00994643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101648702|NCT00994643|Immunologic Factors|immunologic factors|mesh-ancestor
101648703|NCT00994643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648705|NCT00994643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101648706|NCT00994643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101648707|NCT00994643|Analgesics|analgesics|mesh-ancestor
101648708|NCT00994643|Sensory System Agents|sensory system agents|mesh-ancestor
101648709|NCT00994643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101648711|NCT00994643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101648712|NCT00994643|Antiviral Agents|antiviral agents|mesh-ancestor
101648713|NCT00994643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101648714|NCT00912171|Budesonide|budesonide|mesh-list
101648715|NCT00912171|Montelukast|montelukast|mesh-list
101648716|NCT00912171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101648717|NCT00912171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101648718|NCT00912171|Autonomic Agents|autonomic agents|mesh-ancestor
101648719|NCT00912171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101648720|NCT00912171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648721|NCT00912171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101648722|NCT00912171|Respiratory System Agents|respiratory system agents|mesh-ancestor
101648723|NCT00912171|Glucocorticoids|glucocorticoids|mesh-ancestor
101648724|NCT00912171|Hormones|hormones|mesh-ancestor
101648725|NCT00912171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101648726|NCT00912171|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101648727|NCT00912171|Hormone Antagonists|hormone antagonists|mesh-ancestor
101648728|NCT00912171|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101648729|NCT00912171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101648730|NCT00912171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648731|NCT00677391|Sibutramine|sibutramine|mesh-list
101648732|NCT00677391|Antidepressive Agents|antidepressive agents|mesh-ancestor
101648733|NCT00677391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101648734|NCT00677391|Appetite Depressants|appetite depressants|mesh-ancestor
101648735|NCT00677391|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101648736|NCT00629057|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
101648737|NCT00629057|Antiviral Agents|antiviral agents|mesh-ancestor
101648738|NCT00629057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101648739|NCT00660829|Azelastine|azelastine|mesh-list
101648740|NCT00660829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101648741|NCT00660829|Autonomic Agents|autonomic agents|mesh-ancestor
101648742|NCT00660829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101648743|NCT00660829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648744|NCT00660829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101648745|NCT00660829|Respiratory System Agents|respiratory system agents|mesh-ancestor
101648746|NCT00660829|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101648747|NCT00660829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101648748|NCT00660829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648749|NCT00660829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101648750|NCT00660829|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101648751|NCT00660829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101648752|NCT00660829|Histamine Antagonists|histamine antagonists|mesh-ancestor
101648753|NCT00660829|Histamine Agents|histamine agents|mesh-ancestor
101648754|NCT00660829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101648755|NCT00677469|Cholestyramine Resin|cholestyramine resin|mesh-list
101648756|NCT00677469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101648757|NCT00677469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101648758|NCT00677469|Antimetabolites|antimetabolites|mesh-ancestor
101648759|NCT00677469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648760|NCT00677469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101648761|NCT00629135|Moxifloxacin|moxifloxacin|mesh-list
101648762|NCT00629135|Metronidazole|metronidazole|mesh-list
101648763|NCT00629135|Tazobactam|tazobactam|mesh-list
101648764|NCT00629135|Piperacillin|piperacillin|mesh-list
101648765|NCT00629135|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101648766|NCT00629135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101648767|NCT00629135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101648768|NCT00629135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101648769|NCT00629135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101648770|NCT00629135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101648771|NCT00629135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648772|NCT00629135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101648773|NCT00629135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101648774|NCT00629135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101648775|NCT00629135|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101648776|NCT00795925|Propiverine|propiverine|mesh-list
101648777|NCT00795925|Parasympatholytics|parasympatholytics|mesh-ancestor
101648778|NCT00795925|Autonomic Agents|autonomic agents|mesh-ancestor
101648779|NCT00795925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101648780|NCT00795925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648781|NCT00795925|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101648782|NCT00795925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101648783|NCT00795925|Cholinergic Agents|cholinergic agents|mesh-ancestor
101648784|NCT00795925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101648785|NCT00795925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648786|NCT00795925|Urological Agents|urological agents|mesh-ancestor
101648787|NCT04293419|Durvalumab|durvalumab|mesh-list
101648788|NCT04293419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101648789|NCT04293419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101648790|NCT00793429|Prucalopride|prucalopride|mesh-list
101648791|NCT00793429|Laxatives|laxatives|mesh-ancestor
101648792|NCT00793429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101648793|NCT00793429|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101648794|NCT00793429|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101648795|NCT00793429|Serotonin Agents|serotonin agents|mesh-ancestor
101648796|NCT00793429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101648797|NCT00793429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648798|NCT00793429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648800|NCT00801151|Vorinostat|vorinostat|mesh-list
101648801|NCT00801151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101648802|NCT00801151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101648803|NCT00801151|Tubulin Modulators|tubulin modulators|mesh-ancestor
101648804|NCT00801151|Antimitotic Agents|antimitotic agents|mesh-ancestor
101648805|NCT00801151|Mitosis Modulators|mitosis modulators|mesh-ancestor
101648806|NCT00801151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648807|NCT00801151|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101648808|NCT00801151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101648809|NCT00796081|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101648810|NCT00796081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101648811|NCT00796081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101648812|NCT00796081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101648813|NCT00796081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648814|NCT00796081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101648815|NCT00796081|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101535389|NCT00575354|Isoflurane|isoflurane|mesh-list
101648816|NCT00796081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101648818|NCT00796081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101648819|NCT00796081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648820|NCT00796081|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101648821|NCT00796081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101648822|NCT00796081|Dopamine Agents|dopamine agents|mesh-ancestor
101648823|NCT00877383|Tiotropium Bromide|tiotropium bromide|mesh-list
101648824|NCT00877383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101648825|NCT00877383|Autonomic Agents|autonomic agents|mesh-ancestor
101648826|NCT00877383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101648827|NCT00877383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648828|NCT00877383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101648829|NCT00877383|Respiratory System Agents|respiratory system agents|mesh-ancestor
101648830|NCT00877383|Parasympatholytics|parasympatholytics|mesh-ancestor
101648831|NCT00877383|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101648832|NCT00877383|Cholinergic Agents|cholinergic agents|mesh-ancestor
101648833|NCT00877383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101648834|NCT00877383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648835|NCT00796159|Olmesartan|olmesartan|mesh-list
101648836|NCT00796159|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101648837|NCT00796159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101648838|NCT00796159|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101648839|NCT00796159|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101648840|NCT00796159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648842|NCT00993473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101648843|NCT00993473|Insulin Glargine|insulin glargine|mesh-list
101648844|NCT00993473|Insulin Lispro|insulin lispro|mesh-list
101648845|NCT00993473|Protamines|protamines|mesh-list
101648846|NCT00993473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101648847|NCT00993473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648848|NCT00993473|Heparin Antagonists|heparin antagonists|mesh-ancestor
101648849|NCT00993473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648850|NCT00993473|Coagulants|coagulants|mesh-ancestor
101648851|NCT00660595|Risperidone|risperidone|mesh-list
101648852|NCT00660595|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101648853|NCT00660595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101648854|NCT00660595|Serotonin Agents|serotonin agents|mesh-ancestor
101648855|NCT00660595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101648856|NCT00660595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648857|NCT00660595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648858|NCT00660595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101648859|NCT00660595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101648860|NCT00660595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101648861|NCT00660595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101648862|NCT00660595|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101648863|NCT00660595|Dopamine Agents|dopamine agents|mesh-ancestor
101648864|NCT00660595|Antidepressive Agents|antidepressive agents|mesh-ancestor
101648866|NCT00929240|Capecitabine|capecitabine|mesh-list
101648867|NCT00929240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101648868|NCT00929240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101648869|NCT00929240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101648870|NCT00929240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101648871|NCT00929240|Growth Substances|growth substances|mesh-ancestor
101648872|NCT00929240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648873|NCT00929240|Growth Inhibitors|growth inhibitors|mesh-ancestor
101648874|NCT00929240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101648875|NCT00929240|Antimetabolites|antimetabolites|mesh-ancestor
101305989|NCT02023047|Vasodilator Agents|vasodilator agents|mesh-ancestor
101648876|NCT00929240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648877|NCT00793663|Dexamethasone|dexamethasone|mesh-list
101648878|NCT00793663|Dexamethasone acetate|dexamethasone acetate|mesh-list
101648879|NCT00793663|Ondansetron|ondansetron|mesh-list
101648880|NCT00793663|Sevoflurane|sevoflurane|mesh-list
101648881|NCT00793663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101648882|NCT00793663|Antiemetics|antiemetics|mesh-ancestor
101648883|NCT00793663|Autonomic Agents|autonomic agents|mesh-ancestor
101648884|NCT00793663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101648885|NCT00793663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648886|NCT00793663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101648887|NCT00793663|Glucocorticoids|glucocorticoids|mesh-ancestor
101648888|NCT00793663|Hormones|hormones|mesh-ancestor
101648889|NCT00793663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101648890|NCT00793663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101648891|NCT00793663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101648892|NCT00793663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101648893|NCT00793663|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101648894|NCT00793663|Anesthetics, General|anesthetics, general|mesh-ancestor
101648895|NCT00793663|Anesthetics|anesthetics|mesh-ancestor
101648896|NCT00793663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101648897|NCT00793663|Antipruritics|antipruritics|mesh-ancestor
101648898|NCT00793663|Dermatologic Agents|dermatologic agents|mesh-ancestor
101648899|NCT00793663|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101648900|NCT00793663|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101648901|NCT00793663|Serotonin Agents|serotonin agents|mesh-ancestor
101648902|NCT00793663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101648903|NCT00793663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648904|NCT02554045|Tadalafil|tadalafil|mesh-list
101648905|NCT02554045|Vasodilator Agents|vasodilator agents|mesh-ancestor
101648906|NCT02554045|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101648907|NCT02554045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101648908|NCT02554045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101648909|NCT02554045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648910|NCT02554045|Urological Agents|urological agents|mesh-ancestor
101648911|NCT05330390|Levetiracetam|levetiracetam|mesh-list
101648912|NCT05330390|Anticonvulsants|anticonvulsants|mesh-ancestor
101648913|NCT05330390|Nootropic Agents|nootropic agents|mesh-ancestor
101648914|NCT00993317|Certolizumab Pegol|certolizumab pegol|mesh-list
101648915|NCT00993317|Methotrexate|methotrexate|mesh-list
101648916|NCT00993317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101648917|NCT00993317|Abortifacient Agents|abortifacient agents|mesh-ancestor
101648918|NCT00993317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101648919|NCT00993317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648920|NCT00993317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101648921|NCT00993317|Antimetabolites|antimetabolites|mesh-ancestor
101648922|NCT00993317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648923|NCT00993317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101648924|NCT00993317|Dermatologic Agents|dermatologic agents|mesh-ancestor
101648925|NCT00993317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101648926|NCT00993317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101648927|NCT00993317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101648928|NCT00993317|Immunologic Factors|immunologic factors|mesh-ancestor
101648929|NCT00993317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101648930|NCT00993317|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101648931|NCT00993317|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101648932|NCT00993317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101648933|NCT00801385|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101648934|NCT00801385|Sorafenib|sorafenib|mesh-list
101648935|NCT00801385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101648936|NCT00801385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101648937|NCT00801385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101648938|NCT00801385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648940|NCT00677001|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101648941|NCT00677001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101648942|NCT00677001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648943|NCT00877071|Doxorubicin|doxorubicin|mesh-list
101648944|NCT00877071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101648945|NCT00877071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101648946|NCT00877071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101648947|NCT00877071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101648948|NCT00877071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101648949|NCT00877071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648951|NCT02868827|Cholecalciferol|cholecalciferol|mesh-list
101648952|NCT02868827|Vitamins|vitamins|mesh-ancestor
101648953|NCT02868827|Micronutrients|micronutrients|mesh-ancestor
101648954|NCT02868827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648955|NCT02868827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101648956|NCT02868827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101648957|NCT00987389|Glucocorticoids|glucocorticoids|mesh-list
101648958|NCT00987389|Hormones|hormones|mesh-ancestor
101409080|NCT00110864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101648959|NCT00987389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101648960|NCT00987389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648961|NCT00929162|Paclitaxel|paclitaxel|mesh-list
101648962|NCT00929162|Carboplatin|carboplatin|mesh-list
101648963|NCT00929162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101648964|NCT00929162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101648965|NCT00929162|Tubulin Modulators|tubulin modulators|mesh-ancestor
101648966|NCT00929162|Antimitotic Agents|antimitotic agents|mesh-ancestor
101648967|NCT00929162|Mitosis Modulators|mitosis modulators|mesh-ancestor
101648968|NCT00929162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648969|NCT02627625|Tiotropium Bromide|tiotropium bromide|mesh-list
101648970|NCT02627625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101648971|NCT02627625|Autonomic Agents|autonomic agents|mesh-ancestor
101648972|NCT02627625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101648973|NCT02627625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648974|NCT02627625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101648975|NCT02627625|Respiratory System Agents|respiratory system agents|mesh-ancestor
101648976|NCT02627625|Parasympatholytics|parasympatholytics|mesh-ancestor
101648977|NCT02627625|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101648978|NCT02627625|Cholinergic Agents|cholinergic agents|mesh-ancestor
101823453|NCT00958633|Bupropion|bupropion|mesh-list
101648979|NCT02627625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101648980|NCT02627625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648981|NCT00678483|Rimonabant|rimonabant|mesh-list
101648982|NCT00678483|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101648983|NCT00678483|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
101648984|NCT00678483|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101648985|NCT00678483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101648986|NCT00678483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648987|NCT00678483|Hormones|hormones|mesh-ancestor
101648988|NCT00678483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101648989|NCT00678483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101648990|NCT00610454|Levetiracetam|levetiracetam|mesh-list
101648991|NCT00610454|Anticonvulsants|anticonvulsants|mesh-ancestor
101648992|NCT00610454|Nootropic Agents|nootropic agents|mesh-ancestor
101648993|NCT04151355|Atorvastatin|atorvastatin|mesh-list
101648994|NCT04151355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101648995|NCT04151355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101648996|NCT04151355|Antimetabolites|antimetabolites|mesh-ancestor
101648997|NCT04151355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101648998|NCT04151355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101648999|NCT04151355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101649000|NCT04151355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101649001|NCT00609284|Carboplatin|carboplatin|mesh-list
101649002|NCT00609284|Cetuximab|cetuximab|mesh-list
101649003|NCT00609284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101649004|NCT00609284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101649005|NCT00992459|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
101649006|NCT00992459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101649007|NCT00930722|Quinapril|quinapril|mesh-list
101649008|NCT00930722|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101649009|NCT00930722|Protease Inhibitors|protease inhibitors|mesh-ancestor
101649010|NCT00930722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101649011|NCT00930722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649012|NCT00930722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101649013|NCT00610610|Paroxetine|paroxetine|mesh-list
101649014|NCT00610610|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101649015|NCT00610610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101649016|NCT00610610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101649017|NCT00610610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649018|NCT00610610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101649019|NCT00610610|Serotonin Agents|serotonin agents|mesh-ancestor
101649020|NCT00610610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649021|NCT00610610|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101306140|NCT02024009|Nelfinavir|nelfinavir|mesh-list
101649022|NCT00610610|Antidepressive Agents|antidepressive agents|mesh-ancestor
101649023|NCT00610610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101649024|NCT00610610|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101649025|NCT00610610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101649026|NCT00610610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101649027|NCT00912327|Cetuximab|cetuximab|mesh-list
101649028|NCT00912327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101649029|NCT00912327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101649030|NCT04257812|Tazobactam|tazobactam|mesh-list
101649031|NCT04257812|Ceftolozane|ceftolozane|mesh-list
101649032|NCT04257812|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
101649033|NCT04257812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101649034|NCT04257812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101649035|NCT04257812|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101649036|NCT04257812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101649037|NCT04257812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649038|NCT04257812|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101649039|NCT02868749|Hyaluronic Acid|hyaluronic acid|mesh-list
101649040|NCT02868749|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101649041|NCT02868749|Immunologic Factors|immunologic factors|mesh-ancestor
101649042|NCT02868749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649043|NCT02868749|Viscosupplements|viscosupplements|mesh-ancestor
101649044|NCT02868749|Protective Agents|protective agents|mesh-ancestor
101649045|NCT00659581|Telmisartan|telmisartan|mesh-list
101649046|NCT00659581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101649047|NCT00659581|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101649048|NCT00659581|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101649049|NCT00659581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649050|NCT00793741|Somatostatin|somatostatin|mesh-list
101649051|NCT00793741|Hormones|hormones|mesh-ancestor
101649052|NCT00793741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101649053|NCT00793741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649054|NCT00796471|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101649055|NCT00796471|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101649056|NCT00796471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101649057|NCT00796471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101649058|NCT00796471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649059|NCT00796471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101649060|NCT00796471|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101649061|NCT00796471|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101649062|NCT00796471|Serotonin Agents|serotonin agents|mesh-ancestor
101649063|NCT00796471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101649064|NCT00796471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649065|NCT00796471|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101649066|NCT00796471|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101649067|NCT00796471|Dopamine Agents|dopamine agents|mesh-ancestor
101649068|NCT00991289|Interferons|interferons|mesh-list
101649069|NCT00991289|Ribavirin|ribavirin|mesh-list
101649070|NCT00991289|Interferon-alpha|interferon-alpha|mesh-list
101649071|NCT00991289|Interferon alpha-2|interferon alpha-2|mesh-list
101649072|NCT00991289|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101649074|NCT00991289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101649075|NCT00991289|Antiviral Agents|antiviral agents|mesh-ancestor
101649076|NCT00991289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101649077|NCT00991289|Antimetabolites|antimetabolites|mesh-ancestor
101649078|NCT00991289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649079|NCT00991289|Immunologic Factors|immunologic factors|mesh-ancestor
101649080|NCT00991289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649081|NCT00991289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101649082|NCT04046029|Heparin|heparin|mesh-list
101649083|NCT04046029|Bivalirudin|bivalirudin|mesh-list
101649084|NCT04046029|Anticoagulants|anticoagulants|mesh-ancestor
101649085|NCT04046029|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101649086|NCT04046029|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101649087|NCT04046029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649088|NCT04046029|Antithrombins|antithrombins|mesh-ancestor
101649089|NCT04046029|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101649090|NCT04046029|Protease Inhibitors|protease inhibitors|mesh-ancestor
101649091|NCT04046029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101649092|NCT00679653|Sibutramine|sibutramine|mesh-list
101649093|NCT00679653|Metoprolol|metoprolol|mesh-list
101649094|NCT00679653|Verapamil|verapamil|mesh-list
101649095|NCT00679653|Felodipine|felodipine|mesh-list
101649096|NCT00679653|Ramipril|ramipril|mesh-list
101649097|NCT00679653|Trandolapril|trandolapril|mesh-list
101649098|NCT00679653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101649099|NCT00679653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101649100|NCT00679653|Sympatholytics|sympatholytics|mesh-ancestor
101649101|NCT00679653|Autonomic Agents|autonomic agents|mesh-ancestor
101823470|NCT00393783|Trastuzumab|trastuzumab|mesh-list
101649102|NCT00679653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101649103|NCT00679653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535393|NCT00575354|Anesthetics|anesthetics|mesh-ancestor
101649104|NCT00679653|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101649105|NCT00679653|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101649106|NCT00679653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101649107|NCT00679653|Adrenergic Agents|adrenergic agents|mesh-ancestor
101649108|NCT00679653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101649109|NCT00679653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649110|NCT00679653|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101649111|NCT00679653|Protease Inhibitors|protease inhibitors|mesh-ancestor
101649112|NCT00679653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101649113|NCT00679653|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101649114|NCT00679653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101649115|NCT00679653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101649116|NCT00679653|Vasodilator Agents|vasodilator agents|mesh-ancestor
101649117|NCT00679653|Antidepressive Agents|antidepressive agents|mesh-ancestor
101649118|NCT00679653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101649119|NCT00679653|Appetite Depressants|appetite depressants|mesh-ancestor
101649120|NCT00679653|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101649121|NCT00793897|Paclitaxel|paclitaxel|mesh-list
101649122|NCT00793897|Carboplatin|carboplatin|mesh-list
101649123|NCT00793897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101649124|NCT00793897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101649125|NCT00793897|Tubulin Modulators|tubulin modulators|mesh-ancestor
101649126|NCT00793897|Antimitotic Agents|antimitotic agents|mesh-ancestor
101649127|NCT00793897|Mitosis Modulators|mitosis modulators|mesh-ancestor
101649128|NCT00793897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649129|NCT00793975|Ramucirumab|ramucirumab|mesh-list
101649130|NCT00793975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101649131|NCT00679965|Tavaborole|tavaborole|mesh-list
101649132|NCT00679965|Antifungal Agents|antifungal agents|mesh-ancestor
101649133|NCT00679965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101649134|NCT00930644|Teduglutide|teduglutide|mesh-list
101649135|NCT00930644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101649136|NCT00930644|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101649137|NCT00930644|Protective Agents|protective agents|mesh-ancestor
101649138|NCT00930644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649139|NCT02627469|Listerine|listerine|mesh-list
101649140|NCT02627469|Fluorides|fluorides|mesh-list
101649141|NCT02627469|Sodium Fluoride|sodium fluoride|mesh-list
101649142|NCT02627469|Cariostatic Agents|cariostatic agents|mesh-ancestor
101649143|NCT02627469|Protective Agents|protective agents|mesh-ancestor
101649144|NCT02627469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649145|NCT02627469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101649146|NCT02627469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101649147|NCT00680277|Carotenoids|carotenoids|mesh-list
101649148|NCT00680277|Antioxidants|antioxidants|mesh-ancestor
101649149|NCT00680277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649150|NCT00680277|Protective Agents|protective agents|mesh-ancestor
101649151|NCT00680277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649152|NCT00680355|Carotenoids|carotenoids|mesh-list
101649153|NCT00680355|Antioxidants|antioxidants|mesh-ancestor
101649154|NCT00680355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649155|NCT00680355|Protective Agents|protective agents|mesh-ancestor
101649156|NCT00680355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649157|NCT00801697|Vaccines|vaccines|mesh-list
101649158|NCT00801697|Immunologic Factors|immunologic factors|mesh-ancestor
101649159|NCT00801697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649160|NCT00684489|Antihypertensive Agents|antihypertensive agents|mesh-list
101649161|NCT00684489|Coal Tar|coal tar|mesh-list
101649162|NCT00684489|Keratolytic Agents|keratolytic agents|mesh-ancestor
101649163|NCT00684489|Dermatologic Agents|dermatologic agents|mesh-ancestor
101649164|NCT00990821|Midazolam|midazolam|mesh-list
101649165|NCT00990821|Aprepitant|aprepitant|mesh-list
101649166|NCT00990821|Fosaprepitant|fosaprepitant|mesh-list
101649167|NCT00990821|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101649168|NCT00990821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101649169|NCT00990821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101649170|NCT00990821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649171|NCT00990821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101306288|NCT02024659|Autonomic Agents|autonomic agents|mesh-ancestor
101649172|NCT00990821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101649173|NCT00990821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101649174|NCT00990821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101649175|NCT00990821|Anesthetics, General|anesthetics, general|mesh-ancestor
101649176|NCT00990821|Anesthetics|anesthetics|mesh-ancestor
101649177|NCT00990821|GABA Modulators|gaba modulators|mesh-ancestor
101649178|NCT00990821|GABA Agents|gaba agents|mesh-ancestor
101649179|NCT00990821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101649180|NCT00990821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649181|NCT00990821|Antiemetics|antiemetics|mesh-ancestor
101649182|NCT00990821|Autonomic Agents|autonomic agents|mesh-ancestor
101649183|NCT00990821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101649184|NCT00990821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101649185|NCT00990821|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101649186|NCT00801853|Interleukin-4|interleukin-4|mesh-list
101649187|NCT00801853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101649188|NCT00801853|Immunologic Factors|immunologic factors|mesh-ancestor
101649189|NCT00801853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649190|NCT00801853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101649191|NCT00801853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101649192|NCT00990665|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
101649193|NCT00990665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101649194|NCT00990665|Contraceptive Agents|contraceptive agents|mesh-ancestor
101649195|NCT00990665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101649196|NCT00990665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649197|NCT00990665|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101649198|NCT00990665|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101649199|NCT00990665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101649200|NCT00658567|Pimavanserin|pimavanserin|mesh-list
101649201|NCT00658567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101649202|NCT00658567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101649203|NCT00658567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101649204|NCT00658567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101649205|NCT00658567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101649206|NCT00658567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649207|NCT00658567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101649208|NCT00658567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101649209|NCT00658567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101649210|NCT00658567|Serotonin Agents|serotonin agents|mesh-ancestor
101649211|NCT00658567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101649212|NCT00658567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649213|NCT00875433|Afatinib|afatinib|mesh-list
101649214|NCT00875433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101649215|NCT00875433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101649216|NCT00875433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101649217|NCT00875433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649218|NCT00684957|Hormones|hormones|mesh-list
101649219|NCT00684957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101649220|NCT00684957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649221|NCT00685191|Raltegravir Potassium|raltegravir potassium|mesh-list
101649222|NCT00685191|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101649223|NCT00685191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101649224|NCT00685191|Antiviral Agents|antiviral agents|mesh-ancestor
101649225|NCT00685191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101649226|NCT00685191|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101649227|NCT00685191|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101649228|NCT00685191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101649229|NCT00685191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649230|NCT00685269|Eszopiclone|eszopiclone|mesh-list
101649231|NCT00685269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101649232|NCT00685269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101649233|NCT00685269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649234|NCT00794209|Fentanyl|fentanyl|mesh-list
101649235|NCT00794209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101649236|NCT00794209|Narcotics|narcotics|mesh-ancestor
101649237|NCT00794209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101649238|NCT00794209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649239|NCT00794209|Analgesics|analgesics|mesh-ancestor
101649240|NCT00794209|Sensory System Agents|sensory system agents|mesh-ancestor
101649241|NCT00794209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101649242|NCT00794209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101649243|NCT00794209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101649244|NCT00794209|Anesthetics, General|anesthetics, general|mesh-ancestor
101649245|NCT00794209|Anesthetics|anesthetics|mesh-ancestor
101649246|NCT00985985|Nicotine|nicotine|mesh-list
101649247|NCT00985985|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101306364|NCT02025166|Antipyretics|antipyretics|mesh-ancestor
101649248|NCT00985985|Autonomic Agents|autonomic agents|mesh-ancestor
101649249|NCT00985985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101649250|NCT00985985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649251|NCT00985985|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101649252|NCT00985985|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101649253|NCT00985985|Cholinergic Agents|cholinergic agents|mesh-ancestor
101649254|NCT00985985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101649255|NCT00985985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649256|NCT00685347|Albuterol|albuterol|mesh-list
101649257|NCT00685347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101649258|NCT00685347|Autonomic Agents|autonomic agents|mesh-ancestor
101649259|NCT00685347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101649260|NCT00685347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649261|NCT00685347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101649262|NCT00685347|Respiratory System Agents|respiratory system agents|mesh-ancestor
101649263|NCT00685347|Tocolytic Agents|tocolytic agents|mesh-ancestor
101649264|NCT00685347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101649265|NCT00685347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101649266|NCT00685347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101649267|NCT00685347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101649268|NCT00685347|Adrenergic Agents|adrenergic agents|mesh-ancestor
101649269|NCT00685347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101649270|NCT00685347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649271|NCT00685425|Albuterol|albuterol|mesh-list
101649272|NCT00685425|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101649273|NCT00685425|Autonomic Agents|autonomic agents|mesh-ancestor
101649274|NCT00685425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101649275|NCT00685425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649276|NCT00685425|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101649277|NCT00685425|Respiratory System Agents|respiratory system agents|mesh-ancestor
101649278|NCT00685425|Tocolytic Agents|tocolytic agents|mesh-ancestor
101649279|NCT00685425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101649280|NCT00685425|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101649281|NCT00685425|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101649282|NCT00685425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101649283|NCT00685425|Adrenergic Agents|adrenergic agents|mesh-ancestor
101649284|NCT00685425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101649285|NCT00685425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649286|NCT04290455|Castor Oil|castor oil|mesh-list
101649287|NCT04290455|Cathartics|cathartics|mesh-ancestor
101649288|NCT04290455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101649289|NCT00685503|Ranibizumab|ranibizumab|mesh-list
101649290|NCT00685503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101649291|NCT00685503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101649292|NCT00685503|Growth Substances|growth substances|mesh-ancestor
101649293|NCT00685503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649294|NCT00685503|Growth Inhibitors|growth inhibitors|mesh-ancestor
101649295|NCT00685503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101649296|NCT00802009|Dexamethasone|dexamethasone|mesh-list
101649297|NCT00802009|Mepivacaine|mepivacaine|mesh-list
101649298|NCT00802009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101649299|NCT00802009|Antiemetics|antiemetics|mesh-ancestor
101649300|NCT00802009|Autonomic Agents|autonomic agents|mesh-ancestor
101823501|NCT00423735|Dasatinib|dasatinib|mesh-list
101649301|NCT00802009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101649302|NCT00802009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649303|NCT00802009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101649304|NCT00802009|Glucocorticoids|glucocorticoids|mesh-ancestor
101649306|NCT00802009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101649307|NCT00802009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101649308|NCT00802009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101649309|NCT00802009|Anesthetics, Local|anesthetics, local|mesh-ancestor
101649310|NCT00802009|Anesthetics|anesthetics|mesh-ancestor
101649311|NCT00802009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101649312|NCT00802009|Sensory System Agents|sensory system agents|mesh-ancestor
101649313|NCT02868437|Hyaluronic Acid|hyaluronic acid|mesh-list
101649314|NCT02868437|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101649315|NCT02868437|Immunologic Factors|immunologic factors|mesh-ancestor
101649316|NCT02868437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649317|NCT02868437|Viscosupplements|viscosupplements|mesh-ancestor
101649318|NCT02868437|Protective Agents|protective agents|mesh-ancestor
101649319|NCT00802087|Acetaminophen|acetaminophen|mesh-list
101649320|NCT00802087|Hydrocodone|hydrocodone|mesh-list
101649321|NCT00802087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101649322|NCT00802087|Analgesics|analgesics|mesh-ancestor
101649323|NCT00802087|Sensory System Agents|sensory system agents|mesh-ancestor
101649324|NCT00802087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101649325|NCT00802087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649326|NCT00802087|Antipyretics|antipyretics|mesh-ancestor
101649327|NCT00802087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101649328|NCT00802087|Narcotics|narcotics|mesh-ancestor
101649329|NCT00802087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101649330|NCT00802087|Antitussive Agents|antitussive agents|mesh-ancestor
101649331|NCT00802087|Respiratory System Agents|respiratory system agents|mesh-ancestor
101649332|NCT00923936|Bevacizumab|bevacizumab|mesh-list
101649333|NCT00923936|Doxorubicin|doxorubicin|mesh-list
101649334|NCT00923936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101649335|NCT00923936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101649336|NCT00923936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101649337|NCT00923936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101649338|NCT00923936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101649339|NCT00923936|Growth Substances|growth substances|mesh-ancestor
101649340|NCT00923936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649341|NCT00923936|Growth Inhibitors|growth inhibitors|mesh-ancestor
101649342|NCT00923936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101649343|NCT00923936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101649344|NCT00923936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101649345|NCT00923936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101649346|NCT00923936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649347|NCT00797017|Fentanyl|fentanyl|mesh-list
101649348|NCT00797017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101649349|NCT00797017|Narcotics|narcotics|mesh-ancestor
101649350|NCT00797017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101649351|NCT00797017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649352|NCT00797017|Analgesics|analgesics|mesh-ancestor
101649353|NCT00797017|Sensory System Agents|sensory system agents|mesh-ancestor
101649354|NCT00797017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101649355|NCT00797017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101649356|NCT00797017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101649357|NCT00797017|Anesthetics, General|anesthetics, general|mesh-ancestor
101649359|NCT05330000|Voriconazole|voriconazole|mesh-list
101649360|NCT05330000|Antifungal Agents|antifungal agents|mesh-ancestor
101649361|NCT05330000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101649362|NCT05330000|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101649363|NCT05330000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101649364|NCT05330000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101649365|NCT05330000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649366|NCT05330000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101649367|NCT05330000|Hormone Antagonists|hormone antagonists|mesh-ancestor
101649368|NCT05330000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101823506|NCT01032213|Magnesium Sulfate|magnesium sulfate|mesh-list
101649369|NCT05330000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649370|NCT05330000|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101649372|NCT00794443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101649373|NCT00794443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649374|NCT00924950|Calcitriol|calcitriol|mesh-list
101649375|NCT00924950|Betamethasone|betamethasone|mesh-list
101649376|NCT00924950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101649377|NCT00924950|Glucocorticoids|glucocorticoids|mesh-ancestor
101649378|NCT00924950|Hormones|hormones|mesh-ancestor
101649379|NCT00924950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101649380|NCT00924950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649381|NCT00924950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101649382|NCT00924950|Respiratory System Agents|respiratory system agents|mesh-ancestor
101649383|NCT00924950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101649384|NCT00924950|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101649385|NCT00924950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101649386|NCT00924950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649387|NCT00924950|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101649388|NCT00924950|Vitamins|vitamins|mesh-ancestor
101649389|NCT00924950|Micronutrients|micronutrients|mesh-ancestor
101649390|NCT00924950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101649391|NCT02626065|Nivolumab|nivolumab|mesh-list
101649392|NCT02626065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101649393|NCT02626065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101649394|NCT02626065|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101649395|NCT02626065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649396|NCT00794755|Vitamin K|vitamin k|mesh-list
101649397|NCT00794755|Vitamin K 1|vitamin k 1|mesh-list
101649398|NCT00794755|Vitamins|vitamins|mesh-ancestor
101649399|NCT00794755|Micronutrients|micronutrients|mesh-ancestor
101649400|NCT00794755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649401|NCT00794755|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101649402|NCT00794755|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101649403|NCT00794755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649404|NCT00794755|Hemostatics|hemostatics|mesh-ancestor
101649405|NCT00794755|Coagulants|coagulants|mesh-ancestor
101649406|NCT00685971|Cholecalciferol|cholecalciferol|mesh-list
101649408|NCT00685971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101649409|NCT00685971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649410|NCT00685971|Vitamins|vitamins|mesh-ancestor
101649411|NCT00685971|Micronutrients|micronutrients|mesh-ancestor
101649412|NCT00685971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101649413|NCT00802243|Leflunomide|leflunomide|mesh-list
101649414|NCT00802243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101649415|NCT00802243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649416|NCT00802243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101649417|NCT00802243|Immunologic Factors|immunologic factors|mesh-ancestor
101649418|NCT00802243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649419|NCT00988637|Calcitriol|calcitriol|mesh-list
101649420|NCT00988637|Clobetasol|clobetasol|mesh-list
101649421|NCT00988637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101649422|NCT00988637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649423|NCT00988637|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101649424|NCT00988637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101649425|NCT00988637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649426|NCT00988637|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101649427|NCT00988637|Vitamins|vitamins|mesh-ancestor
101649428|NCT00988637|Micronutrients|micronutrients|mesh-ancestor
101649429|NCT00988637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101649430|NCT00988637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101649431|NCT00988637|Glucocorticoids|glucocorticoids|mesh-ancestor
101649432|NCT00988637|Hormones|hormones|mesh-ancestor
101649433|NCT00988637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101649434|NCT00802321|Dutasteride|dutasteride|mesh-list
101649435|NCT00802321|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101649436|NCT00802321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101649437|NCT00802321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101649438|NCT00802321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649439|NCT00802321|Hormone Antagonists|hormone antagonists|mesh-ancestor
101649440|NCT00802321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101649441|NCT00802321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649442|NCT00686361|Choline|choline|mesh-list
101649443|NCT00686361|Lipotropic Agents|lipotropic agents|mesh-ancestor
101649444|NCT00686361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101649445|NCT00686361|Antimetabolites|antimetabolites|mesh-ancestor
101649446|NCT00686361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649447|NCT00686361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101649448|NCT00686361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101649449|NCT00686361|Nootropic Agents|nootropic agents|mesh-ancestor
101649451|NCT00686439|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101649452|NCT00686439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101649453|NCT00686439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101649454|NCT00797485|Leucovorin|leucovorin|mesh-list
101649455|NCT00797485|Bevacizumab|bevacizumab|mesh-list
101649456|NCT00797485|Fluorouracil|fluorouracil|mesh-list
101649457|NCT00797485|Capecitabine|capecitabine|mesh-list
101649458|NCT00797485|Irinotecan|irinotecan|mesh-list
101649459|NCT00797485|Calcium|calcium|mesh-list
101649460|NCT00797485|Levoleucovorin|levoleucovorin|mesh-list
101649461|NCT00797485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101649462|NCT00797485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101649463|NCT00797485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101649464|NCT00797485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101649465|NCT00797485|Growth Substances|growth substances|mesh-ancestor
101409100|NCT00457678|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101649466|NCT00797485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649467|NCT00797485|Growth Inhibitors|growth inhibitors|mesh-ancestor
101649468|NCT00797485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101649469|NCT00797485|Antimetabolites|antimetabolites|mesh-ancestor
101649470|NCT00797485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649471|NCT00797485|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101649472|NCT00797485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101649473|NCT00797485|Immunologic Factors|immunologic factors|mesh-ancestor
101649474|NCT00797485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101649475|NCT00797485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101649476|NCT00797485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101649477|NCT00797485|Antidotes|antidotes|mesh-ancestor
101649478|NCT00797485|Protective Agents|protective agents|mesh-ancestor
101649479|NCT00797485|Vitamin B Complex|vitamin b complex|mesh-ancestor
101649480|NCT00797485|Vitamins|vitamins|mesh-ancestor
101649481|NCT00797485|Micronutrients|micronutrients|mesh-ancestor
101649482|NCT00686985|Carboplatin|carboplatin|mesh-list
101649483|NCT00686985|Docetaxel|docetaxel|mesh-list
101649484|NCT00686985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101649485|NCT00686985|Tubulin Modulators|tubulin modulators|mesh-ancestor
101649486|NCT00686985|Antimitotic Agents|antimitotic agents|mesh-ancestor
101649487|NCT00686985|Mitosis Modulators|mitosis modulators|mesh-ancestor
101649488|NCT00686985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649489|NCT00687063|Insulin Detemir|insulin detemir|mesh-list
101649490|NCT00687063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101649491|NCT00687063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649493|NCT02866955|Estramustine|estramustine|mesh-list
101649494|NCT02866955|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101649495|NCT02866955|Hormone Antagonists|hormone antagonists|mesh-ancestor
101649496|NCT02866955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101649497|NCT02866955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649498|NCT02866955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101649499|NCT02866955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101649500|NCT02866955|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101649501|NCT02866955|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101649502|NCT02866955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101649503|NCT02866955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101649504|NCT02866955|Alkylating Agents|alkylating agents|mesh-ancestor
101649505|NCT02866955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649506|NCT02625753|Acetaminophen|acetaminophen|mesh-list
101649507|NCT02625753|Codeine|codeine|mesh-list
101649508|NCT02625753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101649509|NCT02625753|Analgesics|analgesics|mesh-ancestor
101649510|NCT02625753|Sensory System Agents|sensory system agents|mesh-ancestor
101649511|NCT02625753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101649512|NCT02625753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649513|NCT02625753|Antipyretics|antipyretics|mesh-ancestor
101649514|NCT02625753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101649515|NCT02625753|Narcotics|narcotics|mesh-ancestor
101649516|NCT02625753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101649517|NCT02625753|Antitussive Agents|antitussive agents|mesh-ancestor
101649518|NCT02625753|Respiratory System Agents|respiratory system agents|mesh-ancestor
101649519|NCT04257656|Remdesivir|remdesivir|mesh-list
101649520|NCT04257656|Antimetabolites|antimetabolites|mesh-ancestor
101649521|NCT04257656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649523|NCT04257656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101649524|NCT05329844|Vildagliptin|vildagliptin|mesh-list
101649525|NCT05329844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101649526|NCT05329844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649527|NCT05329844|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101649528|NCT05329844|Protease Inhibitors|protease inhibitors|mesh-ancestor
101649529|NCT05329844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101649530|NCT05329844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649531|NCT00687999|Interferons|interferons|mesh-list
101649532|NCT00687999|Ribavirin|ribavirin|mesh-list
101649533|NCT00687999|Interferon-alpha|interferon-alpha|mesh-list
101649534|NCT00687999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101649535|NCT00687999|Antiviral Agents|antiviral agents|mesh-ancestor
101649536|NCT00687999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101649537|NCT00687999|Antimetabolites|antimetabolites|mesh-ancestor
101649538|NCT00687999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649539|NCT00687999|Immunologic Factors|immunologic factors|mesh-ancestor
101649540|NCT00687999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649541|NCT00688077|Calcitonin|calcitonin|mesh-list
101649542|NCT00688077|Salmon calcitonin|salmon calcitonin|mesh-list
101649543|NCT00688077|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
101649544|NCT00688077|Katacalcin|katacalcin|mesh-list
101649545|NCT00688077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101649546|NCT00688077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649547|NCT00688077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101306671|NCT02026973|Hormones|hormones|mesh-ancestor
101649548|NCT00688077|Vasodilator Agents|vasodilator agents|mesh-ancestor
101649549|NCT00923156|Ramipril|ramipril|mesh-list
101649550|NCT00923156|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101649551|NCT00923156|Protease Inhibitors|protease inhibitors|mesh-ancestor
101649552|NCT00923156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101649553|NCT00923156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649554|NCT00923156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101649556|NCT00688857|Choline|choline|mesh-list
101649557|NCT00688857|Lipotropic Agents|lipotropic agents|mesh-ancestor
101649558|NCT00688857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101649559|NCT00688857|Antimetabolites|antimetabolites|mesh-ancestor
101649560|NCT00688857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649561|NCT00688857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101649562|NCT00688857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101649563|NCT00688857|Nootropic Agents|nootropic agents|mesh-ancestor
101649565|NCT00688857|Vasodilator Agents|vasodilator agents|mesh-ancestor
101649566|NCT04256798|Chlorhexidine|chlorhexidine|mesh-list
101649567|NCT04256798|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101649568|NCT04256798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101649569|NCT04256798|Disinfectants|disinfectants|mesh-ancestor
101649570|NCT00687843|polysaccharide-K|polysaccharide-k|mesh-list
101649571|NCT00687843|Tegafur|tegafur|mesh-list
101649572|NCT00687843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101649573|NCT00687843|Antimetabolites|antimetabolites|mesh-ancestor
101649574|NCT00687843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649575|NCT00687843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101649576|NCT00687843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101649577|NCT00687843|Immunologic Factors|immunologic factors|mesh-ancestor
101649578|NCT00687843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649579|NCT00687843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101649580|NCT00687843|Antiviral Agents|antiviral agents|mesh-ancestor
101649581|NCT00687843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101649582|NCT00687843|Interferon Inducers|interferon inducers|mesh-ancestor
101649583|NCT00687843|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101649584|NCT00687843|Protective Agents|protective agents|mesh-ancestor
101649585|NCT00689169|Cytarabine|cytarabine|mesh-list
101649586|NCT00689169|Rituximab|rituximab|mesh-list
101649587|NCT00689169|Etoposide|etoposide|mesh-list
101649588|NCT00689169|Melphalan|melphalan|mesh-list
101649589|NCT00689169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101649590|NCT00689169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101649591|NCT00689169|Immunologic Factors|immunologic factors|mesh-ancestor
101649592|NCT00689169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649593|NCT00689169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101649594|NCT00689169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101649595|NCT00689169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101649596|NCT00689169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101649597|NCT00689169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101649598|NCT00689169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649599|NCT00689169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101649600|NCT00689169|Alkylating Agents|alkylating agents|mesh-ancestor
101649601|NCT00689169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101649602|NCT00689169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101649603|NCT00689169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101649604|NCT00689169|Antimetabolites|antimetabolites|mesh-ancestor
101649605|NCT00689169|Antiviral Agents|antiviral agents|mesh-ancestor
101649606|NCT00689169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101649607|NCT04203914|Empagliflozin|empagliflozin|mesh-list
101649608|NCT04203914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101649609|NCT04203914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649610|NCT04203914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101649611|NCT04203914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649612|NCT00874731|Sirolimus|sirolimus|mesh-list
101649613|NCT00874731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101649614|NCT00874731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101649615|NCT00874731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101649616|NCT00874731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101649617|NCT00874731|Antifungal Agents|antifungal agents|mesh-ancestor
101649618|NCT00874731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101649619|NCT00874731|Immunologic Factors|immunologic factors|mesh-ancestor
101649620|NCT00874731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649621|NCT02625519|Hormones|hormones|mesh-list
101649622|NCT02625519|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101649623|NCT02625519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101306740|NCT02027337|Diuretics|diuretics|mesh-ancestor
101649624|NCT02625519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649625|NCT00912483|Heparin|heparin|mesh-list
101649626|NCT00912483|Calcium heparin|calcium heparin|mesh-list
101649627|NCT00912483|Anticoagulants|anticoagulants|mesh-ancestor
101649628|NCT00912483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101649629|NCT00912483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101649630|NCT00912483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649631|NCT04257032|Dabigatran|dabigatran|mesh-list
101649632|NCT04257032|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101649633|NCT04257032|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101649634|NCT04257032|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101649635|NCT04257032|Antimetabolites|antimetabolites|mesh-ancestor
101649636|NCT04257032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649637|NCT04257032|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101649638|NCT04257032|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101649639|NCT04257032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101649640|NCT04257032|Antithrombins|antithrombins|mesh-ancestor
101649641|NCT04257032|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101649642|NCT04257032|Protease Inhibitors|protease inhibitors|mesh-ancestor
101649643|NCT04257032|Anticoagulants|anticoagulants|mesh-ancestor
101649644|NCT00924560|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101649645|NCT00924560|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101649646|NCT00924560|Levonorgestrel|levonorgestrel|mesh-list
101649647|NCT00924560|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101649648|NCT00924560|Contraceptive Agents|contraceptive agents|mesh-list
101649649|NCT00924560|Contraceptives, Oral|contraceptives, oral|mesh-list
101649650|NCT00924560|Estradiol|estradiol|mesh-list
101649651|NCT00924560|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101649652|NCT00924560|Estrogens|estrogens|mesh-ancestor
101649653|NCT00924560|Hormones|hormones|mesh-ancestor
101649654|NCT00924560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101649655|NCT00924560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649656|NCT00924560|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101649657|NCT00924560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101649658|NCT00924560|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101649659|NCT00924560|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101649660|NCT00924560|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101649661|NCT00689559|Aripiprazole|aripiprazole|mesh-list
101649662|NCT00689559|Antidepressive Agents|antidepressive agents|mesh-ancestor
101649663|NCT00689559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101649664|NCT00689559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101649665|NCT00689559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101649666|NCT00689559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101649667|NCT00689559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649668|NCT00689559|Dopamine Agonists|dopamine agonists|mesh-ancestor
101649669|NCT00689559|Dopamine Agents|dopamine agents|mesh-ancestor
101649670|NCT00689559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101649671|NCT00689559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649672|NCT00689559|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101649673|NCT00689559|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101649674|NCT00689559|Serotonin Agents|serotonin agents|mesh-ancestor
101649675|NCT00689559|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101649676|NCT00689559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101649677|NCT00689559|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101649678|NCT00689559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101649679|NCT00689637|Warfarin|warfarin|mesh-list
101649680|NCT00689637|Anticoagulants|anticoagulants|mesh-ancestor
101649681|NCT00689715|Ethanol|ethanol|mesh-list
101649682|NCT00689715|Paclitaxel|paclitaxel|mesh-list
101649683|NCT00689715|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101649684|NCT00689715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101649685|NCT00689715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101649686|NCT00689715|Tubulin Modulators|tubulin modulators|mesh-ancestor
101649687|NCT00689715|Antimitotic Agents|antimitotic agents|mesh-ancestor
101649688|NCT00689715|Mitosis Modulators|mitosis modulators|mesh-ancestor
101649689|NCT00689715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649690|NCT00689715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101649691|NCT00689715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101649692|NCT00689715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101649693|NCT00689715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649694|NCT00689949|Folic Acid|folic acid|mesh-list
101649695|NCT00689949|Hematinics|hematinics|mesh-ancestor
101649696|NCT00689949|Vitamin B Complex|vitamin b complex|mesh-ancestor
101649697|NCT00689949|Vitamins|vitamins|mesh-ancestor
101306816|NCT02027961|Durvalumab|durvalumab|mesh-list
101649698|NCT00689949|Micronutrients|micronutrients|mesh-ancestor
101649699|NCT00689949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649700|NCT04256642|Morphine|morphine|mesh-list
101649701|NCT04256642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101649702|NCT04256642|Narcotics|narcotics|mesh-ancestor
101649703|NCT04256642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101649704|NCT04256642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649705|NCT04256642|Analgesics|analgesics|mesh-ancestor
101649706|NCT04256642|Sensory System Agents|sensory system agents|mesh-ancestor
101649707|NCT04256642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101649708|NCT00611000|Folic Acid|folic acid|mesh-list
101649709|NCT00611000|Hematinics|hematinics|mesh-ancestor
101649710|NCT00611000|Vitamin B Complex|vitamin b complex|mesh-ancestor
101649711|NCT00611000|Vitamins|vitamins|mesh-ancestor
101649712|NCT00611000|Micronutrients|micronutrients|mesh-ancestor
101649713|NCT00611000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649715|NCT04031157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101649716|NCT00690105|Fluticasone|fluticasone|mesh-list
101649717|NCT00690105|Tacrolimus|tacrolimus|mesh-list
101649718|NCT00690105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101649719|NCT00690105|Immunologic Factors|immunologic factors|mesh-ancestor
101649720|NCT00690105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649721|NCT00690105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101649722|NCT00690105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101649723|NCT00690105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649724|NCT00690105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101649725|NCT00690105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101649726|NCT00690105|Autonomic Agents|autonomic agents|mesh-ancestor
101649727|NCT00690105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101649728|NCT00690105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101649729|NCT00690105|Respiratory System Agents|respiratory system agents|mesh-ancestor
101649730|NCT00690105|Dermatologic Agents|dermatologic agents|mesh-ancestor
101649731|NCT00690105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101649732|NCT00694317|Zaleplon|zaleplon|mesh-list
101649733|NCT00694317|Anticonvulsants|anticonvulsants|mesh-ancestor
101649734|NCT00694317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101649735|NCT00694317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101649736|NCT00694317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649737|NCT00694317|GABA Modulators|gaba modulators|mesh-ancestor
101649738|NCT00694317|GABA Agents|gaba agents|mesh-ancestor
101649739|NCT00694317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101649740|NCT00694317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649741|NCT04136613|Copper|copper|mesh-list
101649742|NCT04136613|Trace Elements|trace elements|mesh-ancestor
101649743|NCT04136613|Micronutrients|micronutrients|mesh-ancestor
101649744|NCT04136613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649745|NCT00978731|Dasatinib|dasatinib|mesh-list
101649746|NCT00978731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101649747|NCT00978731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101649748|NCT00978731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101649749|NCT00978731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649750|NCT04136535|Carboplatin|carboplatin|mesh-list
101649751|NCT04136535|Pemetrexed|pemetrexed|mesh-list
101649752|NCT04136535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101649753|NCT04136535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101649754|NCT04136535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649755|NCT04136535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101649756|NCT04136535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101649757|NCT00694629|Rifampin|rifampin|mesh-list
101649758|NCT00694629|Rifapentine|rifapentine|mesh-list
101649759|NCT00694629|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101649760|NCT00694629|Antitubercular Agents|antitubercular agents|mesh-ancestor
101649761|NCT00694629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101649762|NCT00694629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101649763|NCT00694629|Leprostatic Agents|leprostatic agents|mesh-ancestor
101649764|NCT00694629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101649765|NCT00694629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101649766|NCT00694629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649767|NCT00694629|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101649768|NCT00694629|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101649769|NCT00694629|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101649770|NCT00694629|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101649771|NCT00694629|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101649772|NCT00694629|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101649773|NCT00912639|Paclitaxel|paclitaxel|mesh-list
101306890|NCT02028494|Capecitabine|capecitabine|mesh-list
101649774|NCT00912639|genexol-PM|genexol-pm|mesh-list
101649775|NCT00912639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101649776|NCT00912639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101649777|NCT00912639|Tubulin Modulators|tubulin modulators|mesh-ancestor
101649778|NCT00912639|Antimitotic Agents|antimitotic agents|mesh-ancestor
101649779|NCT00912639|Mitosis Modulators|mitosis modulators|mesh-ancestor
101649780|NCT00912639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649781|NCT02866409|Dexmedetomidine|dexmedetomidine|mesh-list
101649782|NCT02866409|Bupivacaine|bupivacaine|mesh-list
101649783|NCT02866409|Anesthetics, Local|anesthetics, local|mesh-ancestor
101649784|NCT02866409|Anesthetics|anesthetics|mesh-ancestor
101649785|NCT02866409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101649786|NCT02866409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649787|NCT02866409|Sensory System Agents|sensory system agents|mesh-ancestor
101649788|NCT02866409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101649789|NCT02866409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101649790|NCT02866409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101649791|NCT02866409|Analgesics|analgesics|mesh-ancestor
101649792|NCT02866409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101649793|NCT02866409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101649794|NCT02866409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101649795|NCT02866409|Adrenergic Agents|adrenergic agents|mesh-ancestor
101649796|NCT02866409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101649797|NCT02866409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649798|NCT05833984|Tislelizumab|tislelizumab|mesh-list
101649799|NCT05833984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101649800|NCT05833984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101649801|NCT05833919|Capecitabine|capecitabine|mesh-list
101649802|NCT05833919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101649803|NCT05833919|Antimetabolites|antimetabolites|mesh-ancestor
101649804|NCT05833919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649805|NCT05833919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101649806|NCT05833815|Everolimus|everolimus|mesh-list
101649807|NCT05833815|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101649808|NCT05833815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101649809|NCT05833815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101649810|NCT05833815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649811|NCT05833815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101649812|NCT05833815|Immunologic Factors|immunologic factors|mesh-ancestor
101649813|NCT05833815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649814|NCT05833815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101649815|NCT05833802|Antineoplastic Agents|antineoplastic agents|mesh-list
101649816|NCT05833763|Obinutuzumab|obinutuzumab|mesh-list
101649817|NCT05833763|Pirtobrutinib|pirtobrutinib|mesh-list
101649818|NCT05833763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101649819|NCT05833763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101649820|NCT05833763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101649821|NCT05833763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101649822|NCT05833763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649823|NCT05833477|Epoetin Alfa|epoetin alfa|mesh-list
101649824|NCT05833477|Hematinics|hematinics|mesh-ancestor
101649825|NCT05833399|Carbamazepine|carbamazepine|mesh-list
101649826|NCT05833399|Amitriptyline|amitriptyline|mesh-list
101649827|NCT05833399|Olanzapine|olanzapine|mesh-list
101649828|NCT05833399|Chlorpromazine|chlorpromazine|mesh-list
101649829|NCT05833399|Risperidone|risperidone|mesh-list
101649830|NCT05833399|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101649831|NCT05833399|Mirtazapine|mirtazapine|mesh-list
101649832|NCT05833399|Sertraline|sertraline|mesh-list
101823575|NCT02550119|Hormones|hormones|mesh-ancestor
101649833|NCT05833399|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101649834|NCT05833399|Serotonin Agents|serotonin agents|mesh-ancestor
101649835|NCT05833399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101649836|NCT05833399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649837|NCT05833399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649838|NCT05833399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101649839|NCT05833399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101649840|NCT05833399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101649841|NCT05833399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101649842|NCT05833399|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101649843|NCT05833399|Dopamine Agents|dopamine agents|mesh-ancestor
101649844|NCT05833399|Antiemetics|antiemetics|mesh-ancestor
101649845|NCT05833399|Autonomic Agents|autonomic agents|mesh-ancestor
101649846|NCT05833399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101649847|NCT05833399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101649848|NCT05833399|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101649849|NCT05833399|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101649850|NCT05833399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101649851|NCT05833399|Antidepressive Agents|antidepressive agents|mesh-ancestor
101649852|NCT05833399|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101649853|NCT05833399|Histamine Antagonists|histamine antagonists|mesh-ancestor
101649854|NCT05833399|Histamine Agents|histamine agents|mesh-ancestor
101649855|NCT05833399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101649856|NCT05833399|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101649857|NCT05833399|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101649858|NCT05833399|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101649859|NCT05833399|Adrenergic Agents|adrenergic agents|mesh-ancestor
101649860|NCT05833399|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101649861|NCT05833399|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101649862|NCT05833399|Anticonvulsants|anticonvulsants|mesh-ancestor
101649863|NCT05833399|Antimanic Agents|antimanic agents|mesh-ancestor
101649864|NCT05833399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101649865|NCT05833399|Analgesics|analgesics|mesh-ancestor
101649866|NCT05833399|Sensory System Agents|sensory system agents|mesh-ancestor
101649867|NCT05833399|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101649868|NCT05833399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101649869|NCT05833399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101649870|NCT05833399|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101649871|NCT05833399|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101649872|NCT05832996|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101649873|NCT05832996|Lubricant Eye Drops|lubricant eye drops|mesh-list
101649874|NCT05832996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101649875|NCT05832827|Paclitaxel|paclitaxel|mesh-list
101649876|NCT05832827|Carboplatin|carboplatin|mesh-list
101649877|NCT05832827|Pembrolizumab|pembrolizumab|mesh-list
101649878|NCT05832827|Lenvatinib|lenvatinib|mesh-list
101649879|NCT05832827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101649880|NCT05832827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101649881|NCT05832827|Tubulin Modulators|tubulin modulators|mesh-ancestor
101649882|NCT05832827|Antimitotic Agents|antimitotic agents|mesh-ancestor
101649883|NCT05832827|Mitosis Modulators|mitosis modulators|mesh-ancestor
101649884|NCT05832827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649885|NCT05832827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101649886|NCT05832827|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101649887|NCT05832827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101649888|NCT05832827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101649889|NCT05832749|Hyaluronic Acid|hyaluronic acid|mesh-list
101649890|NCT05832749|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101649891|NCT05832749|Immunologic Factors|immunologic factors|mesh-ancestor
101649892|NCT05832749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649893|NCT05832749|Viscosupplements|viscosupplements|mesh-ancestor
101649894|NCT05832749|Protective Agents|protective agents|mesh-ancestor
101649895|NCT05832697|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101649896|NCT05832697|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101649897|NCT05832697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101649899|NCT05832619|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101649900|NCT05832619|Serotonin Agents|serotonin agents|mesh-ancestor
101649901|NCT05832619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101649902|NCT05832619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649903|NCT05832619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649904|NCT05832580|Etidronic Acid|etidronic acid|mesh-list
101649905|NCT05832580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101649906|NCT05832580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649907|NCT05832515|Fludarabine|fludarabine|mesh-list
101649908|NCT05832515|Fludarabine phosphate|fludarabine phosphate|mesh-list
101649909|NCT05832515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101649910|NCT05832515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101649911|NCT05832515|Antimetabolites|antimetabolites|mesh-ancestor
101649912|NCT05832515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649913|NCT05832515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101649914|NCT05832515|Immunologic Factors|immunologic factors|mesh-ancestor
101649915|NCT05832515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649916|NCT05832489|Methylphenidate|methylphenidate|mesh-list
101649917|NCT05832489|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101649918|NCT05832489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649919|NCT05832489|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101649920|NCT05832489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101649921|NCT05832489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101649922|NCT05832489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649923|NCT05832489|Dopamine Agents|dopamine agents|mesh-ancestor
101649924|NCT05832489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101649926|NCT05832333|Immunologic Factors|immunologic factors|mesh-ancestor
101649927|NCT05832333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649928|NCT05832320|Etoposide|etoposide|mesh-list
101649929|NCT05832320|Daunorubicin|daunorubicin|mesh-list
101649930|NCT05832320|Tretinoin|tretinoin|mesh-list
101649931|NCT05832320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101649932|NCT05832320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101649933|NCT05832320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101649934|NCT05832320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101649935|NCT05832320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101649936|NCT05832320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649937|NCT05832320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101649938|NCT05832320|Keratolytic Agents|keratolytic agents|mesh-ancestor
101649939|NCT05832320|Dermatologic Agents|dermatologic agents|mesh-ancestor
101649940|NCT05832216|Daratumumab|daratumumab|mesh-list
101649941|NCT05832216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101649942|NCT05832190|Biotin|biotin|mesh-list
101649943|NCT05832190|Vitamin B Complex|vitamin b complex|mesh-ancestor
101649944|NCT05832190|Vitamins|vitamins|mesh-ancestor
101649945|NCT05832190|Micronutrients|micronutrients|mesh-ancestor
101649946|NCT05832190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649947|NCT05832073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101649948|NCT05832073|Antibodies|antibodies|mesh-list
101649949|NCT05832073|Immunoglobulins|immunoglobulins|mesh-list
101649950|NCT05832073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101649951|NCT05832073|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101649952|NCT05832073|Immunologic Factors|immunologic factors|mesh-ancestor
101649953|NCT05832073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649954|NCT05832073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101649955|NCT05832034|Immunoglobulins|immunoglobulins|mesh-list
101649957|NCT05832034|gamma-Globulins|gamma-globulins|mesh-list
101649958|NCT05832034|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101649959|NCT05832034|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101649960|NCT05832034|Immunologic Factors|immunologic factors|mesh-ancestor
101649961|NCT05832034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649962|NCT05830539|Doxorubicin|doxorubicin|mesh-list
101649963|NCT05830539|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101649964|NCT05830539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101649965|NCT05830539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101649966|NCT05830539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101649967|NCT05830539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101649968|NCT05830539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101649969|NCT05830539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649970|NCT05828940|Losartan|losartan|mesh-list
101649971|NCT05828940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101649972|NCT05828940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101823587|NCT02550119|Serotonin Agents|serotonin agents|mesh-ancestor
101649973|NCT05828940|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101649974|NCT05828940|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101649975|NCT05828940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649976|NCT05827055|Paclitaxel|paclitaxel|mesh-list
101649977|NCT05827055|Gemcitabine|gemcitabine|mesh-list
101649978|NCT05827055|Proglumide|proglumide|mesh-list
101649979|NCT05827055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101649980|NCT05827055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101649981|NCT05827055|Tubulin Modulators|tubulin modulators|mesh-ancestor
101649982|NCT05827055|Antimitotic Agents|antimitotic agents|mesh-ancestor
101649983|NCT05827055|Mitosis Modulators|mitosis modulators|mesh-ancestor
101649984|NCT05827055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101649985|NCT05827055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101649986|NCT05827055|Antimetabolites|antimetabolites|mesh-ancestor
101649987|NCT05827055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101649988|NCT05827055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101649989|NCT05818423|Benzocaine|benzocaine|mesh-list
101649990|NCT05818423|Anesthetics, Local|anesthetics, local|mesh-ancestor
101649991|NCT05818423|Anesthetics|anesthetics|mesh-ancestor
101649992|NCT05818423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101649993|NCT05818423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101649994|NCT05818423|Sensory System Agents|sensory system agents|mesh-ancestor
101649995|NCT05818423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101649996|NCT05816785|Cetuximab|cetuximab|mesh-list
101649997|NCT05816785|Imatinib Mesylate|imatinib mesylate|mesh-list
101649998|NCT05816785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101649999|NCT05816785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101650000|NCT05816785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101307111|NCT02029599|Antipyretics|antipyretics|mesh-ancestor
101650001|NCT05816785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101650002|NCT05816785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650003|NCT05813912|Insulin|insulin|mesh-list
101650004|NCT05813912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101650005|NCT05813912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650006|NCT05807399|Moxifloxacin|moxifloxacin|mesh-list
101650007|NCT05807399|Rifampin|rifampin|mesh-list
101650008|NCT05807399|Isoniazid|isoniazid|mesh-list
101650009|NCT05807399|Pyrazinamide|pyrazinamide|mesh-list
101650010|NCT05807399|Bedaquiline|bedaquiline|mesh-list
101650011|NCT05807399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101650012|NCT05807399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101650013|NCT05807399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101650014|NCT05807399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101650015|NCT05807399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101650016|NCT05807399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650017|NCT05807399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101650018|NCT05807399|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101650019|NCT05807399|Antitubercular Agents|antitubercular agents|mesh-ancestor
101650020|NCT05807399|Leprostatic Agents|leprostatic agents|mesh-ancestor
101650021|NCT05807399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101650023|NCT05807399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101650024|NCT05807399|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101650025|NCT05807399|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101650026|NCT05807399|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101650027|NCT05807399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101650028|NCT05807399|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101650029|NCT05807399|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101650030|NCT05807399|Antimetabolites|antimetabolites|mesh-ancestor
101650031|NCT05807399|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101650032|NCT05798390|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
101650033|NCT05798390|Ezetimibe|ezetimibe|mesh-list
101650034|NCT05798390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101650035|NCT05798390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101650036|NCT05798390|Antimetabolites|antimetabolites|mesh-ancestor
101823588|NCT02548403|Simethicone|simethicone|mesh-list
101650037|NCT05798390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650038|NCT05798390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101650039|NCT05798390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101650040|NCT05798390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101650041|NCT05798390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650042|NCT05796401|Leucovorin|leucovorin|mesh-list
101650043|NCT05796401|Folic Acid|folic acid|mesh-list
101650044|NCT05796401|Vitamin B 12|vitamin b 12|mesh-list
101650045|NCT05796401|Levoleucovorin|levoleucovorin|mesh-list
101650046|NCT05796401|Vitamins|vitamins|mesh-ancestor
101650047|NCT05796401|Micronutrients|micronutrients|mesh-ancestor
101650048|NCT05796401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650049|NCT05796401|Antidotes|antidotes|mesh-ancestor
101650050|NCT05796401|Protective Agents|protective agents|mesh-ancestor
101650051|NCT05796401|Vitamin B Complex|vitamin b complex|mesh-ancestor
101650052|NCT05796401|Hematinics|hematinics|mesh-ancestor
101650053|NCT05771402|Antibodies|antibodies|mesh-list
101650054|NCT05771402|Immunologic Factors|immunologic factors|mesh-ancestor
101650055|NCT05771402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650056|NCT05769816|Antibodies|antibodies|mesh-list
101650057|NCT05769816|Immunologic Factors|immunologic factors|mesh-ancestor
101650058|NCT05769816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650059|NCT05745142|Sunitinib|sunitinib|mesh-list
101650060|NCT05745142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101650061|NCT05745142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101409111|NCT00457717|Mydriatics|mydriatics|mesh-ancestor
101650062|NCT05745142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101650063|NCT05745142|Growth Substances|growth substances|mesh-ancestor
101650064|NCT05745142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650065|NCT05745142|Growth Inhibitors|growth inhibitors|mesh-ancestor
101650066|NCT05745142|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101650067|NCT05745142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101650068|NCT05745142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650069|NCT05737069|Ibuprofen|ibuprofen|mesh-list
101650070|NCT05737069|Ibuprofen arginine|ibuprofen arginine|mesh-list
101650071|NCT05737069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101650072|NCT05737069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101650073|NCT05737069|Analgesics|analgesics|mesh-ancestor
101650074|NCT05737069|Sensory System Agents|sensory system agents|mesh-ancestor
101650075|NCT05737069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101307188|NCT02031367|Triamcinolone|triamcinolone|mesh-list
101650076|NCT05737069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650077|NCT05737069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101650078|NCT05737069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101650079|NCT05737069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101650080|NCT05737069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101650081|NCT05737069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650082|NCT05709483|Aspirin|aspirin|mesh-list
101650083|NCT05709483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101650084|NCT05709483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101650085|NCT05709483|Analgesics|analgesics|mesh-ancestor
101650086|NCT05709483|Sensory System Agents|sensory system agents|mesh-ancestor
101650087|NCT05709483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101650088|NCT05709483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650089|NCT05709483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101650090|NCT05709483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101650091|NCT05709483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101650092|NCT05709483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101650093|NCT05709483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650094|NCT05709483|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101650095|NCT05709483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101650096|NCT05709483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101650097|NCT05709483|Antipyretics|antipyretics|mesh-ancestor
101650098|NCT05672134|Geranylgeranylacetone|geranylgeranylacetone|mesh-list
101650099|NCT05672134|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101650100|NCT05672134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101650101|NCT05672134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101650102|NCT05647057|Polygeline|polygeline|mesh-list
101650103|NCT05647057|Plasma Substitutes|plasma substitutes|mesh-ancestor
101650104|NCT05647057|Blood Substitutes|blood substitutes|mesh-ancestor
101650105|NCT05643794|Rozanolixizumab|rozanolixizumab|mesh-list
101650106|NCT05643794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101650107|NCT05643794|Immunologic Factors|immunologic factors|mesh-ancestor
101650108|NCT05643794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650109|NCT05641363|Ketorolac|ketorolac|mesh-list
101650110|NCT05641363|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101650111|NCT05641363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101650112|NCT05641363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101650113|NCT05641363|Analgesics|analgesics|mesh-ancestor
101650114|NCT05641363|Sensory System Agents|sensory system agents|mesh-ancestor
101650115|NCT05641363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101650116|NCT05641363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650117|NCT05641363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101650118|NCT05641363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101650119|NCT05641363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101650120|NCT05641363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101650121|NCT05641363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650122|NCT05639322|Ketamine|ketamine|mesh-list
101650123|NCT05639322|Analgesics|analgesics|mesh-ancestor
101650124|NCT05639322|Sensory System Agents|sensory system agents|mesh-ancestor
101650125|NCT05639322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101650126|NCT05639322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650127|NCT05639322|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101650128|NCT05639322|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101650129|NCT05639322|Anesthetics, General|anesthetics, general|mesh-ancestor
101650130|NCT05639322|Anesthetics|anesthetics|mesh-ancestor
101650131|NCT05639322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101650132|NCT05639322|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101650133|NCT05639322|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101409115|NCT00457717|Cholinergic Agents|cholinergic agents|mesh-ancestor
101650134|NCT05639322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101650135|NCT05639322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650147|NCT05594615|Caffeine|caffeine|mesh-list
101650148|NCT05594615|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101650149|NCT05594615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101650150|NCT05594615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101650151|NCT05594615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101650152|NCT05594615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650153|NCT05594615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101650154|NCT05594615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101650155|NCT05594615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101650156|NCT05594615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101650157|NCT05594615|Anesthetics, General|anesthetics, general|mesh-ancestor
101650158|NCT05594615|Anesthetics|anesthetics|mesh-ancestor
101650159|NCT05594615|GABA Modulators|gaba modulators|mesh-ancestor
101650160|NCT05594615|GABA Agents|gaba agents|mesh-ancestor
101650161|NCT05594615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101650162|NCT05594615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650163|NCT05594615|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101650164|NCT05594615|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101650165|NCT05594615|Antimetabolites|antimetabolites|mesh-ancestor
101650166|NCT05594615|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101650167|NCT05594615|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101650168|NCT05594615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101650169|NCT05594615|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101650170|NCT05594615|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101650171|NCT05594615|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101650172|NCT05594615|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101650173|NCT05594615|Purinergic Agents|purinergic agents|mesh-ancestor
101650174|NCT05594602|Itraconazole|itraconazole|mesh-list
101650175|NCT05594602|Quinidine|quinidine|mesh-list
101650176|NCT05594602|Carbamazepine|carbamazepine|mesh-list
101650177|NCT05594602|Antifungal Agents|antifungal agents|mesh-ancestor
101650178|NCT05594602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101650179|NCT05594602|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101650180|NCT05594602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101650181|NCT05594602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101650182|NCT05594602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650183|NCT05594602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101650184|NCT05594602|Hormone Antagonists|hormone antagonists|mesh-ancestor
101650185|NCT05594602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101650186|NCT05594602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650187|NCT05594602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101650188|NCT05594602|Anticonvulsants|anticonvulsants|mesh-ancestor
101650189|NCT05594602|Antimanic Agents|antimanic agents|mesh-ancestor
101650190|NCT05594602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101650191|NCT05594602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101650192|NCT05594602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101650193|NCT05594602|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101650194|NCT05594602|Analgesics|analgesics|mesh-ancestor
101650195|NCT05594602|Sensory System Agents|sensory system agents|mesh-ancestor
101650196|NCT05594602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101650197|NCT05594602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101650198|NCT05594602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101650199|NCT05594602|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101650200|NCT05594602|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101650201|NCT05594602|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101650202|NCT05594602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101650203|NCT05594602|Adrenergic Agents|adrenergic agents|mesh-ancestor
101650204|NCT05594602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101650205|NCT05594602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101650206|NCT05594602|Antimalarials|antimalarials|mesh-ancestor
101650207|NCT05594602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101650208|NCT05594602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101650209|NCT05594602|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101650210|NCT05594602|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101650211|NCT05594602|Cholinergic Agents|cholinergic agents|mesh-ancestor
101650212|NCT05594602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101650213|NCT05594602|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101650215|NCT05590260|Trace Elements|trace elements|mesh-ancestor
101650216|NCT05590260|Micronutrients|micronutrients|mesh-ancestor
101650217|NCT05590260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650219|NCT05589844|Immunologic Factors|immunologic factors|mesh-ancestor
101650220|NCT05589844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650221|NCT05485519|Midazolam|midazolam|mesh-list
101650222|NCT05485519|Dexmedetomidine|dexmedetomidine|mesh-list
101650223|NCT05485519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101650224|NCT05485519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101650225|NCT05485519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101307338|NCT02039492|Spironolactone|spironolactone|mesh-list
101650226|NCT05485519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101650228|NCT05485519|Sensory System Agents|sensory system agents|mesh-ancestor
101650229|NCT05485519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101650230|NCT05485519|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101650231|NCT05485519|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101650232|NCT05485519|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101650233|NCT05485519|Adrenergic Agents|adrenergic agents|mesh-ancestor
101650234|NCT05485519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101650235|NCT05485519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650236|NCT05485519|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101650237|NCT05485519|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101650238|NCT05485519|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101650239|NCT05485519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101650240|NCT05485519|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101650241|NCT05485519|Anesthetics, General|anesthetics, general|mesh-ancestor
101650242|NCT05485519|Anesthetics|anesthetics|mesh-ancestor
101650243|NCT05485519|GABA Modulators|gaba modulators|mesh-ancestor
101650244|NCT05485519|GABA Agents|gaba agents|mesh-ancestor
101650245|NCT05411744|Vitamin B 6|vitamin b 6|mesh-list
101650246|NCT05411744|Pyridoxal|pyridoxal|mesh-list
101650247|NCT05411744|Pyridoxine|pyridoxine|mesh-list
101650248|NCT05411744|Isoniazid|isoniazid|mesh-list
101650249|NCT05411744|Rifapentine|rifapentine|mesh-list
101650250|NCT05411744|Vitamins|vitamins|mesh-ancestor
101650251|NCT05411744|Micronutrients|micronutrients|mesh-ancestor
101650252|NCT05411744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650253|NCT05411744|Vitamin B Complex|vitamin b complex|mesh-ancestor
101650254|NCT05411744|Antitubercular Agents|antitubercular agents|mesh-ancestor
101650255|NCT05411744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101650256|NCT05411744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101650257|NCT05411744|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101650258|NCT05411744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101650259|NCT05411744|Antimetabolites|antimetabolites|mesh-ancestor
101650260|NCT05411744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650261|NCT05411744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101650262|NCT05411744|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101650263|NCT05411744|Leprostatic Agents|leprostatic agents|mesh-ancestor
101650264|NCT05400603|Zoledronic Acid|zoledronic acid|mesh-list
101650265|NCT05400603|Irinotecan|irinotecan|mesh-list
101650266|NCT05400603|Temozolomide|temozolomide|mesh-list
101650267|NCT05400603|Dinutuximab|dinutuximab|mesh-list
101650268|NCT05400603|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101650269|NCT05400603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101650270|NCT05400603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101650271|NCT05400603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650272|NCT05400603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101650273|NCT05400603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101650275|NCT05400603|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101650276|NCT05400603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650277|NCT05359627|Polymyxins|polymyxins|mesh-list
101650278|NCT05359627|Polymyxin B|polymyxin b|mesh-list
101650279|NCT05359627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101650280|NCT05359627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101650281|NCT05612490|Furosemide|furosemide|mesh-list
101650282|NCT05612490|Diuretics|diuretics|mesh-ancestor
101650283|NCT05612490|Natriuretic Agents|natriuretic agents|mesh-ancestor
101650284|NCT05612490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650285|NCT05612490|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101650286|NCT05612490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101650287|NCT05612490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650288|NCT05295784|Caffeine|caffeine|mesh-list
101650289|NCT05295784|Caffeine citrate|caffeine citrate|mesh-list
101650290|NCT05295784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650291|NCT05295784|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101650292|NCT05295784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650293|NCT05295784|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101650294|NCT05295784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101650295|NCT05295784|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101650296|NCT05295784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101650297|NCT05295784|Purinergic Agents|purinergic agents|mesh-ancestor
101650298|NCT05295784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101650299|NCT05246293|Tofacitinib|tofacitinib|mesh-list
101650300|NCT05246293|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101307415|NCT02040415|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101650301|NCT05246293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101650302|NCT05246293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101650303|NCT05246293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650304|NCT05243147|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
101650305|NCT05243147|Hemostatics|hemostatics|mesh-ancestor
101650306|NCT05243147|Coagulants|coagulants|mesh-ancestor
101650307|NCT05212610|Vaccines|vaccines|mesh-list
101650308|NCT05212610|Immunologic Factors|immunologic factors|mesh-ancestor
101650309|NCT05212610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650310|NCT05207280|Terlipressin|terlipressin|mesh-list
101650311|NCT05207280|Norepinephrine|norepinephrine|mesh-list
101650312|NCT05207280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101650313|NCT05207280|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101650314|NCT05207280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101650315|NCT05207280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101650316|NCT05207280|Adrenergic Agents|adrenergic agents|mesh-ancestor
101650317|NCT05207280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101650318|NCT05207280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650319|NCT05207280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650320|NCT05207280|Sympathomimetics|sympathomimetics|mesh-ancestor
101650321|NCT05207280|Autonomic Agents|autonomic agents|mesh-ancestor
101650322|NCT05207280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101650323|NCT05174832|Paclitaxel|paclitaxel|mesh-list
101650324|NCT05174832|Pembrolizumab|pembrolizumab|mesh-list
101650325|NCT05174832|Olaparib|olaparib|mesh-list
101650326|NCT05174832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101650327|NCT05174832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101650329|NCT05174832|Antimitotic Agents|antimitotic agents|mesh-ancestor
101650330|NCT05174832|Mitosis Modulators|mitosis modulators|mesh-ancestor
101650331|NCT05174832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650332|NCT05174832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101650333|NCT05174832|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101650334|NCT05174832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101650335|NCT05174832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101650336|NCT05149378|Azacitidine|azacitidine|mesh-list
101650337|NCT05149378|Venetoclax|venetoclax|mesh-list
101650338|NCT05149378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101650339|NCT05149378|Antimetabolites|antimetabolites|mesh-ancestor
101650340|NCT05149378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650341|NCT05149378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101650342|NCT05149378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101650343|NCT05134857|Zonisamide|zonisamide|mesh-list
101650344|NCT05134857|Anticonvulsants|anticonvulsants|mesh-ancestor
101650345|NCT05134857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101650346|NCT05134857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101650347|NCT05134857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650348|NCT05134857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101650349|NCT05134857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650350|NCT05114590|Insulin Glargine|insulin glargine|mesh-list
101650351|NCT05114590|Lixisenatide|lixisenatide|mesh-list
101650352|NCT05114590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101650353|NCT05114590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650354|NCT05108935|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101650355|NCT05108935|Buprenorphine|buprenorphine|mesh-list
101650356|NCT05108935|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101650357|NCT05108935|Naloxone|naloxone|mesh-list
101650358|NCT05108935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101650359|NCT05108935|Narcotics|narcotics|mesh-ancestor
101650360|NCT05108935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101650361|NCT05108935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650362|NCT05108935|Analgesics|analgesics|mesh-ancestor
101650363|NCT05108935|Sensory System Agents|sensory system agents|mesh-ancestor
101650364|NCT05108935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101650365|NCT05108935|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101650366|NCT05108935|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101650367|NCT05108935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101650368|NCT05108935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101650369|NCT05108935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650370|NCT05108935|Antiviral Agents|antiviral agents|mesh-ancestor
101650371|NCT05108935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101650372|NCT05108935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101650373|NCT05108935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101650374|NCT05051527|Silymarin|silymarin|mesh-list
101650375|NCT05051527|Antioxidants|antioxidants|mesh-ancestor
101650376|NCT05051527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650377|NCT05051527|Protective Agents|protective agents|mesh-ancestor
101650378|NCT05051527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650379|NCT04939753|Sevoflurane|sevoflurane|mesh-list
101650380|NCT04939753|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101650381|NCT04939753|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101650382|NCT04939753|Anesthetics, General|anesthetics, general|mesh-ancestor
101650383|NCT04939753|Anesthetics|anesthetics|mesh-ancestor
101650384|NCT04939753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101650385|NCT04939753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650386|NCT04924036|Glycopyrrolate|glycopyrrolate|mesh-list
101650387|NCT04924036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101650388|NCT04924036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101650389|NCT04924036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101650390|NCT04924036|Cholinergic Agents|cholinergic agents|mesh-ancestor
101650391|NCT04924036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101650392|NCT04924036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650393|NCT04924036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650394|NCT04902885|Carboplatin|carboplatin|mesh-list
101650395|NCT04902885|Etoposide|etoposide|mesh-list
101650396|NCT04902885|Topotecan|topotecan|mesh-list
101650397|NCT04902885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101650398|NCT04902885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101650399|NCT04902885|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101650400|NCT04902885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101650401|NCT04902885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101650402|NCT04902885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650403|NCT04902885|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101650404|NCT04868058|Ropivacaine|ropivacaine|mesh-list
101650405|NCT04868058|Anesthetics, Local|anesthetics, local|mesh-ancestor
101650406|NCT04868058|Anesthetics|anesthetics|mesh-ancestor
101650407|NCT04868058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101650408|NCT04868058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650409|NCT04868058|Sensory System Agents|sensory system agents|mesh-ancestor
101650410|NCT04868058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101650411|NCT04763759|Antibodies|antibodies|mesh-list
101650412|NCT04763759|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101650413|NCT04763759|Immunologic Factors|immunologic factors|mesh-ancestor
101650414|NCT04763759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650415|NCT04628988|Prednisone|prednisone|mesh-list
101650416|NCT04628988|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
101650417|NCT04628988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101650418|NCT04628988|Glucocorticoids|glucocorticoids|mesh-ancestor
101650419|NCT04628988|Hormones|hormones|mesh-ancestor
101650420|NCT04628988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101650421|NCT04628988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650422|NCT04628988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101650424|NCT04628988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101650425|NCT04628988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650426|NCT04614363|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101650427|NCT04614363|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101650428|NCT04614363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650429|NCT04525274|Dexmedetomidine|dexmedetomidine|mesh-list
101650430|NCT04525274|Ketamine|ketamine|mesh-list
101650431|NCT04525274|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101650432|NCT04525274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101650433|NCT04525274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650434|NCT04525274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101650435|NCT04525274|Analgesics|analgesics|mesh-ancestor
101650436|NCT04525274|Sensory System Agents|sensory system agents|mesh-ancestor
101650437|NCT04525274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101650438|NCT04525274|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101650439|NCT04525274|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101650440|NCT04525274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101650441|NCT04525274|Adrenergic Agents|adrenergic agents|mesh-ancestor
101650442|NCT04525274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101650443|NCT04525274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650444|NCT04525274|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101823642|NCT00622739|Ziprasidone|ziprasidone|mesh-list
101650445|NCT04525274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101650446|NCT04525274|Anesthetics, General|anesthetics, general|mesh-ancestor
101650447|NCT04525274|Anesthetics|anesthetics|mesh-ancestor
101650448|NCT04525274|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101650449|NCT04525274|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101650450|NCT04503668|Dexamethasone|dexamethasone|mesh-list
101650451|NCT04503668|Ondansetron|ondansetron|mesh-list
101650452|NCT04503668|Olanzapine|olanzapine|mesh-list
101650453|NCT04503668|Fosaprepitant|fosaprepitant|mesh-list
101650454|NCT04503668|Prochlorperazine|prochlorperazine|mesh-list
101650455|NCT04503668|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-list
101650456|NCT04503668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101650457|NCT04503668|Antiemetics|antiemetics|mesh-ancestor
101650458|NCT04503668|Autonomic Agents|autonomic agents|mesh-ancestor
101650459|NCT04503668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101650460|NCT04503668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650461|NCT04503668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101650462|NCT04503668|Glucocorticoids|glucocorticoids|mesh-ancestor
101650463|NCT04503668|Hormones|hormones|mesh-ancestor
101650464|NCT04503668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101650465|NCT04503668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101650466|NCT04503668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101650467|NCT04503668|Antipruritics|antipruritics|mesh-ancestor
101650468|NCT04503668|Dermatologic Agents|dermatologic agents|mesh-ancestor
101650469|NCT04503668|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101650470|NCT04503668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101650471|NCT04503668|Serotonin Agents|serotonin agents|mesh-ancestor
101650472|NCT04503668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101650473|NCT04503668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650474|NCT04503668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101650475|NCT04503668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101650476|NCT04503668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101650477|NCT04503668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101650478|NCT04503668|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101650479|NCT04503668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101650480|NCT04503668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101650481|NCT04503668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101650482|NCT04503668|Dopamine Agents|dopamine agents|mesh-ancestor
101650483|NCT04481113|Niraparib|niraparib|mesh-list
101650484|NCT04481113|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101650485|NCT04481113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101650486|NCT04481113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650487|NCT04481113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101650488|NCT04472611|Colchicine|colchicine|mesh-list
101650489|NCT04472611|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101650490|NCT04472611|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101650491|NCT04472611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101650492|NCT04472611|Antimetabolites|antimetabolites|mesh-ancestor
101650493|NCT04472611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650495|NCT04472611|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101650496|NCT04472611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101650497|NCT04472611|Gout Suppressants|gout suppressants|mesh-ancestor
101650498|NCT04472611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101650499|NCT04472611|Tubulin Modulators|tubulin modulators|mesh-ancestor
101650500|NCT04472611|Antimitotic Agents|antimitotic agents|mesh-ancestor
101650501|NCT04472611|Mitosis Modulators|mitosis modulators|mesh-ancestor
101650502|NCT04472611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101650503|NCT04472598|Navitoclax|navitoclax|mesh-list
101650504|NCT04472598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101650505|NCT04423718|Aflibercept|aflibercept|mesh-list
101650506|NCT04423718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101650507|NCT04423718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101650508|NCT04423718|Growth Substances|growth substances|mesh-ancestor
101650509|NCT04423718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650510|NCT04423718|Growth Inhibitors|growth inhibitors|mesh-ancestor
101650511|NCT04423718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101650512|NCT04367233|Anesthetics|anesthetics|mesh-list
101650513|NCT04367233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101650514|NCT04367233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650515|NCT04193215|Vaccines|vaccines|mesh-list
101650516|NCT04193215|Immunologic Factors|immunologic factors|mesh-ancestor
101650517|NCT04193215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650518|NCT04125563|Capsaicin|capsaicin|mesh-list
101650519|NCT04125563|Antipruritics|antipruritics|mesh-ancestor
101650520|NCT04125563|Dermatologic Agents|dermatologic agents|mesh-ancestor
101650521|NCT04125563|Sensory System Agents|sensory system agents|mesh-ancestor
101650522|NCT04125563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101650523|NCT04125563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650524|NCT04101357|Carboplatin|carboplatin|mesh-list
101650525|NCT04101357|Etoposide|etoposide|mesh-list
101650526|NCT04101357|Atezolizumab|atezolizumab|mesh-list
101650527|NCT04101357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101650528|NCT04101357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101650529|NCT04101357|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101650530|NCT04101357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101650531|NCT04101357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101650532|NCT04101357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650533|NCT04101357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101650534|NCT04101357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101650535|NCT04078295|Nivolumab|nivolumab|mesh-list
101650536|NCT04078295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101650537|NCT04078295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101650538|NCT04078295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101650539|NCT04078295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650540|NCT04004611|Mirikizumab|mirikizumab|mesh-list
101650541|NCT04004611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101650542|NCT04004611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101650543|NCT04004611|Analgesics|analgesics|mesh-ancestor
101650544|NCT04004611|Sensory System Agents|sensory system agents|mesh-ancestor
101650545|NCT04004611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101650546|NCT04004611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650547|NCT04004611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101650548|NCT04004611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101650549|NCT04004611|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101650550|NCT04004611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101650551|NCT03974828|Anesthetics|anesthetics|mesh-list
101650552|NCT03974828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101650553|NCT03974828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650554|NCT03953677|Dexmedetomidine|dexmedetomidine|mesh-list
101650555|NCT03953677|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101650556|NCT03953677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101650557|NCT03953677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101650558|NCT03953677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650559|NCT03953677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101650560|NCT03953677|Analgesics|analgesics|mesh-ancestor
101650561|NCT03953677|Sensory System Agents|sensory system agents|mesh-ancestor
101650562|NCT03953677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101650563|NCT03953677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101650564|NCT03953677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101650565|NCT03953677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101650566|NCT03953677|Adrenergic Agents|adrenergic agents|mesh-ancestor
101650567|NCT03953677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101650568|NCT03953677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650569|NCT03937713|Eszopiclone|eszopiclone|mesh-list
101650570|NCT03937713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101650571|NCT03937713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101650572|NCT03937713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650573|NCT03934216|Deucravacitinib|deucravacitinib|mesh-list
101650574|NCT03934216|Dermatologic Agents|dermatologic agents|mesh-ancestor
101650575|NCT03934216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101650576|NCT03934216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101650577|NCT03934216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650578|NCT03925480|Azithromycin|azithromycin|mesh-list
101650579|NCT03925480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101650580|NCT03925480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101650581|NCT03878069|Elapegademase|elapegademase|mesh-list
101650582|NCT03878069|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
101650583|NCT03878069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101650584|NCT03878069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650585|NCT03876873|Anesthetics|anesthetics|mesh-list
101650586|NCT03876873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101650587|NCT03876873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650588|NCT03842696|Cyclosporine|cyclosporine|mesh-list
101650589|NCT03842696|Mycophenolic Acid|mycophenolic acid|mesh-list
101650590|NCT03842696|Cyclophosphamide|cyclophosphamide|mesh-list
101650591|NCT03842696|Methotrexate|methotrexate|mesh-list
101650594|NCT03842696|Cyclosporins|cyclosporins|mesh-list
101650595|NCT03842696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101650596|NCT03842696|Immunologic Factors|immunologic factors|mesh-ancestor
101650597|NCT03842696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650598|NCT03842696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101650599|NCT03842696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101650600|NCT03842696|Alkylating Agents|alkylating agents|mesh-ancestor
101650601|NCT03842696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650602|NCT03842696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101650603|NCT03842696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101650604|NCT03842696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101650605|NCT03842696|Abortifacient Agents|abortifacient agents|mesh-ancestor
101650606|NCT03842696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101650607|NCT03842696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101650608|NCT03842696|Antimetabolites|antimetabolites|mesh-ancestor
101650609|NCT03842696|Dermatologic Agents|dermatologic agents|mesh-ancestor
101650610|NCT03842696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101650611|NCT03842696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101650612|NCT03842696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101650613|NCT03842696|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101650614|NCT03842696|Antifungal Agents|antifungal agents|mesh-ancestor
101650615|NCT03842696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101650616|NCT03842696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101650617|NCT03842696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101650618|NCT03842696|Antitubercular Agents|antitubercular agents|mesh-ancestor
101650619|NCT03842696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101650620|NCT03842696|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101650621|NCT03832361|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
101650622|NCT03832361|Immunoconjugates|immunoconjugates|mesh-ancestor
101650623|NCT03832361|Immunologic Factors|immunologic factors|mesh-ancestor
101650624|NCT03832361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650625|NCT03762850|Dapagliflozin|dapagliflozin|mesh-list
101650626|NCT03762850|Irbesartan|irbesartan|mesh-list
101650627|NCT03762850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101650628|NCT03762850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650629|NCT03762850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101650630|NCT03762850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650631|NCT03762850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101650632|NCT03762850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101650633|NCT03762850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101650634|NCT03601078|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
101650635|NCT03601078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101650636|NCT03601078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101650637|NCT03479502|Doxycycline|doxycycline|mesh-list
101650638|NCT03479502|Prednisone|prednisone|mesh-list
101650639|NCT03479502|Methylprednisolone|methylprednisolone|mesh-list
101650640|NCT03479502|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101650641|NCT03479502|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101650643|NCT03479502|Prednisolone acetate|prednisolone acetate|mesh-list
101650644|NCT03479502|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101650645|NCT03479502|Prednisolone phosphate|prednisolone phosphate|mesh-list
101650646|NCT03479502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101650648|NCT03479502|Hormones|hormones|mesh-ancestor
101650649|NCT03479502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101650650|NCT03479502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650651|NCT03479502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101650652|NCT03479502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101650653|NCT03479502|Antiemetics|antiemetics|mesh-ancestor
101650654|NCT03479502|Autonomic Agents|autonomic agents|mesh-ancestor
101650655|NCT03479502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101650656|NCT03479502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101650657|NCT03479502|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101650658|NCT03479502|Protective Agents|protective agents|mesh-ancestor
101650659|NCT03479502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101650660|NCT03479502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101650661|NCT03479502|Antimalarials|antimalarials|mesh-ancestor
101650662|NCT03479502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101650663|NCT03479502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101650670|NCT03097796|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
101650671|NCT03097796|Respiratory System Agents|respiratory system agents|mesh-ancestor
101650672|NCT03067051|Verteporfin|verteporfin|mesh-list
101650673|NCT03067051|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101650674|NCT03067051|Dermatologic Agents|dermatologic agents|mesh-ancestor
101650675|NCT03013998|Cytarabine|cytarabine|mesh-list
101650676|NCT03013998|Azacitidine|azacitidine|mesh-list
101650677|NCT03013998|Decitabine|decitabine|mesh-list
101650678|NCT03013998|Daunorubicin|daunorubicin|mesh-list
101650679|NCT03013998|Venetoclax|venetoclax|mesh-list
101650680|NCT03013998|AZD5991|azd5991|mesh-list
101650681|NCT03013998|Pevonedistat|pevonedistat|mesh-list
101650682|NCT03013998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101650683|NCT03013998|Antimetabolites|antimetabolites|mesh-ancestor
101650684|NCT03013998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650685|NCT03013998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101650686|NCT03013998|Antiviral Agents|antiviral agents|mesh-ancestor
101650687|NCT03013998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101650688|NCT03013998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101650689|NCT03013998|Immunologic Factors|immunologic factors|mesh-ancestor
101650690|NCT03013998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650691|NCT03013998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101650692|NCT03013998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101650693|NCT03013998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101650694|NCT03013998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101650695|NCT02901067|Aspirin|aspirin|mesh-list
101650696|NCT02901067|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101650697|NCT02901067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101650698|NCT02901067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101650699|NCT02901067|Analgesics|analgesics|mesh-ancestor
101650700|NCT02901067|Sensory System Agents|sensory system agents|mesh-ancestor
101650701|NCT02901067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101650702|NCT02901067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650703|NCT02901067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101650704|NCT02901067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101650705|NCT02901067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101650706|NCT02901067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101650707|NCT02901067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650708|NCT02901067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101650709|NCT02901067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101650710|NCT02901067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101650711|NCT02901067|Antipyretics|antipyretics|mesh-ancestor
101650712|NCT02901067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101650713|NCT02901067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101650714|NCT02901067|Antimetabolites|antimetabolites|mesh-ancestor
101650715|NCT02901067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101650716|NCT02901067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101650717|NCT02859896|Calcitriol|calcitriol|mesh-list
101823666|NCT00824057|Midazolam|midazolam|mesh-list
101650719|NCT02859896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101650720|NCT02859896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650721|NCT02859896|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101650722|NCT02859896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101650723|NCT02859896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650724|NCT02859896|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101650725|NCT02859896|Vitamins|vitamins|mesh-ancestor
101650726|NCT02859896|Micronutrients|micronutrients|mesh-ancestor
101650727|NCT02859896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101650728|NCT02711670|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101650729|NCT02711670|Chlorthalidone|chlorthalidone|mesh-list
101650730|NCT02711670|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101650731|NCT02711670|Diuretics|diuretics|mesh-ancestor
101650732|NCT02711670|Natriuretic Agents|natriuretic agents|mesh-ancestor
101650733|NCT02711670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650734|NCT02711670|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101650735|NCT02711670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101650736|NCT02711670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650737|NCT02658097|Pembrolizumab|pembrolizumab|mesh-list
101650738|NCT02658097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101650739|NCT02658097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101650740|NCT02658097|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101650741|NCT02658097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650742|NCT02581527|Rifampin|rifampin|mesh-list
101650743|NCT02581527|Isoniazid|isoniazid|mesh-list
101650744|NCT02581527|Pyrazinamide|pyrazinamide|mesh-list
101650745|NCT02581527|Ethambutol|ethambutol|mesh-list
101650746|NCT02581527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101650747|NCT02581527|Antitubercular Agents|antitubercular agents|mesh-ancestor
101650748|NCT02581527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101650749|NCT02581527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101650750|NCT02581527|Leprostatic Agents|leprostatic agents|mesh-ancestor
101650751|NCT02581527|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101650752|NCT02581527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101650753|NCT02581527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650754|NCT02581527|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101650755|NCT02581527|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101650756|NCT02581527|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101650757|NCT02581527|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101650758|NCT02581527|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101650759|NCT02581527|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101650760|NCT02581527|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101650761|NCT02581527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101650762|NCT02581527|Antimetabolites|antimetabolites|mesh-ancestor
101650763|NCT02581527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101650764|NCT02558010|Morphine|morphine|mesh-list
101650765|NCT02558010|Methadone|methadone|mesh-list
101650766|NCT02558010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101650767|NCT02558010|Narcotics|narcotics|mesh-ancestor
101650768|NCT02558010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101650769|NCT02558010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650770|NCT02558010|Analgesics|analgesics|mesh-ancestor
101650771|NCT02558010|Sensory System Agents|sensory system agents|mesh-ancestor
101650772|NCT02558010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101650773|NCT02558010|Antitussive Agents|antitussive agents|mesh-ancestor
101650774|NCT02558010|Respiratory System Agents|respiratory system agents|mesh-ancestor
101650775|NCT02473497|Crizotinib|crizotinib|mesh-list
101650776|NCT02473497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101650777|NCT02473497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101650779|NCT02473497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650780|NCT02466074|Acetazolamide|acetazolamide|mesh-list
101650781|NCT02466074|Anticonvulsants|anticonvulsants|mesh-ancestor
101650782|NCT02466074|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101650783|NCT02466074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101650784|NCT02466074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650785|NCT02466074|Diuretics|diuretics|mesh-ancestor
101650786|NCT02466074|Natriuretic Agents|natriuretic agents|mesh-ancestor
101650787|NCT02466074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650788|NCT02393794|Nivolumab|nivolumab|mesh-list
101650789|NCT02393794|Romidepsin|romidepsin|mesh-list
101650790|NCT02393794|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
101650791|NCT02393794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101650792|NCT02393794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101650793|NCT02393794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101650794|NCT02393794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650795|NCT02393794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101650796|NCT02393794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101650797|NCT02159950|Vaccines|vaccines|mesh-list
101650798|NCT02159950|Immunologic Factors|immunologic factors|mesh-ancestor
101650799|NCT02159950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650800|NCT02152137|Paclitaxel|paclitaxel|mesh-list
101650801|NCT02152137|Efatutazone|efatutazone|mesh-list
101650802|NCT02152137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101650803|NCT02152137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101650804|NCT02152137|Tubulin Modulators|tubulin modulators|mesh-ancestor
101650805|NCT02152137|Antimitotic Agents|antimitotic agents|mesh-ancestor
101650806|NCT02152137|Mitosis Modulators|mitosis modulators|mesh-ancestor
101650807|NCT02152137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650808|NCT02007512|Exemestane|exemestane|mesh-list
101650809|NCT02007512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101650810|NCT02007512|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101650811|NCT02007512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101650812|NCT02007512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101650813|NCT02007512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650814|NCT02007512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101650815|NCT02007512|Hormone Antagonists|hormone antagonists|mesh-ancestor
101650816|NCT02007512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101650817|NCT02007512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650818|NCT01971489|Cisplatin|cisplatin|mesh-list
101650819|NCT01971489|Gemcitabine|gemcitabine|mesh-list
101650820|NCT01971489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101650821|NCT01971489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101650822|NCT01971489|Antimetabolites|antimetabolites|mesh-ancestor
101650823|NCT01971489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650824|NCT01942135|Fulvestrant|fulvestrant|mesh-list
101650825|NCT01942135|Palbociclib|palbociclib|mesh-list
101650826|NCT01942135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101650827|NCT01942135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101650828|NCT01942135|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101650829|NCT01942135|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101650830|NCT01942135|Hormone Antagonists|hormone antagonists|mesh-ancestor
101650831|NCT01942135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101650832|NCT01942135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650833|NCT01942135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101650834|NCT01942135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101650835|NCT01942135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650836|NCT01838174|Methylprednisolone|methylprednisolone|mesh-list
101650837|NCT01838174|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101650838|NCT01838174|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101650839|NCT01838174|Prednisolone|prednisolone|mesh-list
101650840|NCT01838174|Prednisolone acetate|prednisolone acetate|mesh-list
101650841|NCT01838174|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101650842|NCT01838174|Prednisolone phosphate|prednisolone phosphate|mesh-list
101650843|NCT01838174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101650844|NCT01838174|Antiemetics|antiemetics|mesh-ancestor
101650845|NCT01838174|Autonomic Agents|autonomic agents|mesh-ancestor
101650846|NCT01838174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101650847|NCT01838174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650848|NCT01838174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101650849|NCT01838174|Glucocorticoids|glucocorticoids|mesh-ancestor
101650850|NCT01838174|Hormones|hormones|mesh-ancestor
101650851|NCT01838174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101650852|NCT01838174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101650853|NCT01838174|Protective Agents|protective agents|mesh-ancestor
101650854|NCT01838174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101650855|NCT01838174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101650856|NCT01743131|Abatacept|abatacept|mesh-list
101650857|NCT01743131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101650858|NCT01743131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650859|NCT01743131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101650860|NCT01743131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101650861|NCT01743131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101650862|NCT01743131|Immunologic Factors|immunologic factors|mesh-ancestor
101650863|NCT01743131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650864|NCT01743131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101650865|NCT01685814|Lenalidomide|lenalidomide|mesh-list
101650866|NCT01685814|Bortezomib|bortezomib|mesh-list
101650867|NCT01685814|Immunologic Factors|immunologic factors|mesh-ancestor
101650868|NCT01685814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650869|NCT01685814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101650870|NCT01685814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101650871|NCT01685814|Growth Substances|growth substances|mesh-ancestor
101650872|NCT01685814|Growth Inhibitors|growth inhibitors|mesh-ancestor
101650873|NCT01685814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101650874|NCT01147016|Paclitaxel|paclitaxel|mesh-list
101650875|NCT01147016|Cyclophosphamide|cyclophosphamide|mesh-list
101650876|NCT01147016|Doxorubicin|doxorubicin|mesh-list
101650877|NCT01147016|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101650878|NCT01147016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101650879|NCT01147016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101650880|NCT01147016|Tubulin Modulators|tubulin modulators|mesh-ancestor
101650881|NCT01147016|Antimitotic Agents|antimitotic agents|mesh-ancestor
101650882|NCT01147016|Mitosis Modulators|mitosis modulators|mesh-ancestor
101650883|NCT01147016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650884|NCT01147016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101650885|NCT01147016|Immunologic Factors|immunologic factors|mesh-ancestor
101650886|NCT01147016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650887|NCT01147016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101650888|NCT01147016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101650889|NCT01147016|Alkylating Agents|alkylating agents|mesh-ancestor
101650890|NCT01147016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101650891|NCT01147016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101650892|NCT01147016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101650893|NCT01147016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101650894|NCT01147016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101650895|NCT00200200|Bevacizumab|bevacizumab|mesh-list
101650896|NCT00200200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101650897|NCT00200200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101650898|NCT00200200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101650899|NCT00200200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101650900|NCT00200200|Growth Substances|growth substances|mesh-ancestor
101650901|NCT00200200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650902|NCT00200200|Growth Inhibitors|growth inhibitors|mesh-ancestor
101650904|NCT00106587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101650905|NCT00106587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101650906|NCT00106587|Tubulin Modulators|tubulin modulators|mesh-ancestor
101650907|NCT00106587|Antimitotic Agents|antimitotic agents|mesh-ancestor
101650908|NCT00106587|Mitosis Modulators|mitosis modulators|mesh-ancestor
101650909|NCT00106587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650910|NCT00694863|Cosyntropin|cosyntropin|mesh-list
101650911|NCT00694863|Adrenocorticotropin zinc|adrenocorticotropin zinc|mesh-list
101650912|NCT00694863|Hormones|hormones|mesh-ancestor
101451712|NCT00196469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650913|NCT00694863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101650914|NCT00694863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650915|NCT00629213|Acarbose|acarbose|mesh-list
101650916|NCT00629213|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101650917|NCT00629213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101650918|NCT00629213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650920|NCT00629213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650921|NCT00978341|Pregabalin|pregabalin|mesh-list
101650922|NCT00978341|Analgesics|analgesics|mesh-ancestor
101650923|NCT00978341|Sensory System Agents|sensory system agents|mesh-ancestor
101650924|NCT00978341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101650925|NCT00978341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650926|NCT00978341|Anticonvulsants|anticonvulsants|mesh-ancestor
101650927|NCT00978341|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101650928|NCT00978341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101650929|NCT00978341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650930|NCT00978341|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101650931|NCT00978341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101650932|NCT00978341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101650933|NCT00978341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101650934|NCT00978341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101650935|NCT00695331|Misoprostol|misoprostol|mesh-list
101650936|NCT00695331|Oxytocin|oxytocin|mesh-list
101650937|NCT00695331|Oxytocics|oxytocics|mesh-ancestor
101650938|NCT00695331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101650940|NCT00695331|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101650941|NCT00695331|Abortifacient Agents|abortifacient agents|mesh-ancestor
101650942|NCT00695331|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101650943|NCT00695331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101650944|NCT00695643|Mesalamine|mesalamine|mesh-list
101650945|NCT00695643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101650946|NCT00695643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101650947|NCT00695643|Analgesics|analgesics|mesh-ancestor
101650948|NCT00695643|Sensory System Agents|sensory system agents|mesh-ancestor
101650949|NCT00695643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101650950|NCT00695643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650951|NCT00695643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101650952|NCT00695643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101650953|NCT02623881|Progesterone|progesterone|mesh-list
101650954|NCT02623881|Progestins|progestins|mesh-ancestor
101650955|NCT02623881|Hormones|hormones|mesh-ancestor
101650956|NCT02623881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101650957|NCT02623881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650958|NCT04135833|Itraconazole|itraconazole|mesh-list
101650959|NCT04135833|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
101650960|NCT04135833|Rifampin|rifampin|mesh-list
101650961|NCT04135833|Antifungal Agents|antifungal agents|mesh-ancestor
101650962|NCT04135833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101650963|NCT04135833|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101650964|NCT04135833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101650965|NCT04135833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101650966|NCT04135833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101650967|NCT04135833|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101650968|NCT04135833|Hormone Antagonists|hormone antagonists|mesh-ancestor
101650969|NCT04135833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101650970|NCT04135833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650971|NCT04135833|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101650972|NCT04135833|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101650973|NCT04135833|Antitubercular Agents|antitubercular agents|mesh-ancestor
101650974|NCT04135833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101650975|NCT04135833|Leprostatic Agents|leprostatic agents|mesh-ancestor
101650976|NCT04135833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101650977|NCT04135833|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101650978|NCT04135833|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101650979|NCT04135833|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101650980|NCT04135833|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101650981|NCT04135833|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101650982|NCT04135833|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101650985|NCT00696033|Anticonvulsants|anticonvulsants|mesh-ancestor
101650986|NCT00696033|Antiemetics|antiemetics|mesh-ancestor
101650987|NCT00696033|Autonomic Agents|autonomic agents|mesh-ancestor
101650988|NCT00696033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101650989|NCT00696033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101650990|NCT00696033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101650991|NCT00696033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101650992|NCT00696033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101650993|NCT00696033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101650994|NCT00696033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101650995|NCT00696033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101650996|NCT00696033|GABA Modulators|gaba modulators|mesh-ancestor
101650997|NCT00696033|GABA Agents|gaba agents|mesh-ancestor
101650998|NCT00696033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101650999|NCT00696033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651000|NCT00696033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101651001|NCT00696033|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101651002|NCT00696033|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101651003|NCT00696033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101651004|NCT00696033|Anesthetics, General|anesthetics, general|mesh-ancestor
101651005|NCT00696033|Anesthetics|anesthetics|mesh-ancestor
101651006|NCT02623569|Atenolol|atenolol|mesh-list
101651007|NCT02623569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101651008|NCT02623569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101651009|NCT02623569|Sympatholytics|sympatholytics|mesh-ancestor
101651010|NCT02623569|Autonomic Agents|autonomic agents|mesh-ancestor
101651011|NCT02623569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101651012|NCT02623569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651013|NCT02623569|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101651015|NCT02623569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101651016|NCT02623569|Adrenergic Agents|adrenergic agents|mesh-ancestor
101651017|NCT02623569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101651018|NCT02623569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651019|NCT00977561|Cisplatin|cisplatin|mesh-list
101651020|NCT00977561|Carboplatin|carboplatin|mesh-list
101651021|NCT00977561|Etoposide|etoposide|mesh-list
101651022|NCT00977561|Etoposide phosphate|etoposide phosphate|mesh-list
101651023|NCT00977561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101651024|NCT00977561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101651025|NCT00977561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101651026|NCT00977561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101651027|NCT00977561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101651028|NCT00977561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651029|NCT04291313|Vitamin D|vitamin d|mesh-list
101651030|NCT04291313|Ergocalciferols|ergocalciferols|mesh-list
101651031|NCT04291313|Cholecalciferol|cholecalciferol|mesh-list
101651032|NCT04291313|Vitamins|vitamins|mesh-list
101651033|NCT04291313|Micronutrients|micronutrients|mesh-ancestor
101651034|NCT04291313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651035|NCT04291313|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101651036|NCT04291313|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101651038|NCT02866253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101651039|NCT02866253|Immunologic Factors|immunologic factors|mesh-ancestor
101651040|NCT02866253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651041|NCT02865785|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101651042|NCT02865785|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101651043|NCT02865785|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101651044|NCT02865785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101651045|NCT00594165|Rotigotine|rotigotine|mesh-list
101651046|NCT00594165|Dopamine Agonists|dopamine agonists|mesh-ancestor
101651047|NCT00594165|Dopamine Agents|dopamine agents|mesh-ancestor
101651048|NCT00594165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101651049|NCT00594165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651050|NCT00594165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651052|NCT00928070|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101651053|NCT00928070|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101651054|NCT00928070|Cholinergic Agents|cholinergic agents|mesh-ancestor
101651055|NCT00928070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101651056|NCT00928070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651057|NCT00928070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651058|NCT00928070|Urological Agents|urological agents|mesh-ancestor
101651059|NCT04012073|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
101651060|NCT04012073|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101651061|NCT04012073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101651062|NCT04012073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651064|NCT04001621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101651065|NCT04001621|Antimetabolites|antimetabolites|mesh-ancestor
101651066|NCT04001621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651067|NCT04001621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101651068|NCT00976937|Metformin|metformin|mesh-list
101651069|NCT00976937|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101651070|NCT00976937|Lixisenatide|lixisenatide|mesh-list
101651071|NCT00976937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101651072|NCT00976937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651073|NCT00976937|Incretins|incretins|mesh-ancestor
101651074|NCT00976937|Hormones|hormones|mesh-ancestor
101651075|NCT00976937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101823731|NCT00824135|Melphalan|melphalan|mesh-list
101651076|NCT00976937|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101651077|NCT00976937|Protease Inhibitors|protease inhibitors|mesh-ancestor
101651078|NCT00976937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101651079|NCT00976937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651080|NCT02623023|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
101651081|NCT02623023|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101651082|NCT02623023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101651083|NCT02623023|Adrenergic Agents|adrenergic agents|mesh-ancestor
101651084|NCT02623023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101651085|NCT02623023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651086|NCT02623023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651087|NCT02623023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101651088|NCT02623023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101651089|NCT02623023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101651090|NCT04256252|Rituximab|rituximab|mesh-list
101651091|NCT04256252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101651092|NCT04256252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101651093|NCT04256252|Immunologic Factors|immunologic factors|mesh-ancestor
101651094|NCT04256252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651095|NCT04256252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101651096|NCT02622555|Mirabegron|mirabegron|mesh-list
101651097|NCT02622555|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101651098|NCT02622555|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101651099|NCT02622555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101651100|NCT02622555|Adrenergic Agents|adrenergic agents|mesh-ancestor
101651101|NCT02622555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101651102|NCT02622555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651103|NCT02622555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651104|NCT02622555|Urological Agents|urological agents|mesh-ancestor
101651105|NCT05329454|Ibuprofen|ibuprofen|mesh-list
101651106|NCT05329454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101651107|NCT05329454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101651108|NCT05329454|Analgesics|analgesics|mesh-ancestor
101651109|NCT05329454|Sensory System Agents|sensory system agents|mesh-ancestor
101651110|NCT05329454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101651111|NCT05329454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651112|NCT05329454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101651113|NCT05329454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101651114|NCT05329454|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101651115|NCT05329454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101651116|NCT05329454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308240|NCT02046499|Oxytocin|oxytocin|mesh-list
101651118|NCT00629447|Anticoagulants|anticoagulants|mesh-ancestor
101651119|NCT00629447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101651120|NCT00629447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101651121|NCT00629447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651122|NCT02622477|Pirfenidone|pirfenidone|mesh-list
101651123|NCT02622477|Analgesics|analgesics|mesh-ancestor
101651124|NCT02622477|Sensory System Agents|sensory system agents|mesh-ancestor
101651125|NCT02622477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101651126|NCT02622477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651127|NCT02622477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101651128|NCT02622477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101651129|NCT02622477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101651130|NCT02622477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101651131|NCT02622477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101651132|NCT02622243|Glycopyrrolate|glycopyrrolate|mesh-list
101651133|NCT02622243|Tiotropium Bromide|tiotropium bromide|mesh-list
101651134|NCT02622243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101651135|NCT02622243|Autonomic Agents|autonomic agents|mesh-ancestor
101651136|NCT02622243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101651137|NCT02622243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651138|NCT02622243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101651139|NCT02622243|Respiratory System Agents|respiratory system agents|mesh-ancestor
101651140|NCT02622243|Parasympatholytics|parasympatholytics|mesh-ancestor
101651141|NCT02622243|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101651142|NCT02622243|Cholinergic Agents|cholinergic agents|mesh-ancestor
101651143|NCT02622243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101651144|NCT02622243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651145|NCT02622243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101651146|NCT02622243|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101651147|NCT04289675|Interferons|interferons|mesh-list
101651148|NCT04289675|Interferon-beta|interferon-beta|mesh-list
101651149|NCT04289675|Teriflunomide|teriflunomide|mesh-list
101651150|NCT04289675|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101823796|NCT00622505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823797|NCT00831857|Bevacizumab|bevacizumab|mesh-list
101823798|NCT00831857|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
101823799|NCT00831857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101823800|NCT00831857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101823801|NCT00831857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101823802|NCT00831857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101823803|NCT00831857|Growth Substances|growth substances|mesh-ancestor
101823804|NCT00831857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823805|NCT00831857|Growth Inhibitors|growth inhibitors|mesh-ancestor
101823806|NCT00831857|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101823807|NCT00831857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101823808|NCT00832013|Propofol|propofol|mesh-list
101823809|NCT00832013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101823810|NCT00832013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101823811|NCT00832013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651151|NCT04289675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101651152|NCT04289675|Antiviral Agents|antiviral agents|mesh-ancestor
101651153|NCT04289675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101651154|NCT04289675|Immunologic Factors|immunologic factors|mesh-ancestor
101651155|NCT04289675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651156|NCT04289675|Dermatologic Agents|dermatologic agents|mesh-ancestor
101651157|NCT04289675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101651158|NCT04289675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101651159|NCT04289675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101651160|NCT04289675|Analgesics|analgesics|mesh-ancestor
101651161|NCT04289675|Sensory System Agents|sensory system agents|mesh-ancestor
101651162|NCT04289675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101651163|NCT04289675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101651164|NCT04289675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101651165|NCT00696579|Gemcitabine|gemcitabine|mesh-list
101651166|NCT00696579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101651167|NCT00696579|Antimetabolites|antimetabolites|mesh-ancestor
101651168|NCT00696579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651169|NCT00696579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101651170|NCT02865629|Acetylcysteine|acetylcysteine|mesh-list
101651171|NCT02865629|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101651172|NCT02865629|Antiviral Agents|antiviral agents|mesh-ancestor
101651173|NCT02865629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101651174|NCT02865629|Expectorants|expectorants|mesh-ancestor
101651175|NCT02865629|Respiratory System Agents|respiratory system agents|mesh-ancestor
101651176|NCT02865629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101651177|NCT02865629|Antioxidants|antioxidants|mesh-ancestor
101651178|NCT02865629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651179|NCT02865629|Protective Agents|protective agents|mesh-ancestor
101651180|NCT02865629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651181|NCT02865629|Antidotes|antidotes|mesh-ancestor
101651182|NCT02867345|Cyclophosphamide|cyclophosphamide|mesh-list
101651183|NCT02867345|Interleukin-2|interleukin-2|mesh-list
101651184|NCT02867345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101651185|NCT02867345|Immunologic Factors|immunologic factors|mesh-ancestor
101651186|NCT02867345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651187|NCT02867345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101651188|NCT02867345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101651189|NCT02867345|Alkylating Agents|alkylating agents|mesh-ancestor
101651190|NCT02867345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651191|NCT02867345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101651192|NCT02867345|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101651193|NCT02867345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101651194|NCT02867345|Analgesics|analgesics|mesh-ancestor
101651195|NCT02867345|Sensory System Agents|sensory system agents|mesh-ancestor
101651196|NCT02867345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101651197|NCT00975689|Acetylcysteine|acetylcysteine|mesh-list
101651198|NCT00975689|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101651199|NCT00975689|Antiviral Agents|antiviral agents|mesh-ancestor
101651200|NCT00975689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101651201|NCT00975689|Expectorants|expectorants|mesh-ancestor
101651202|NCT00975689|Respiratory System Agents|respiratory system agents|mesh-ancestor
101651203|NCT00975689|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101651204|NCT00975689|Antioxidants|antioxidants|mesh-ancestor
101651205|NCT00975689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651206|NCT00975689|Protective Agents|protective agents|mesh-ancestor
101651207|NCT00975689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651208|NCT00975689|Antidotes|antidotes|mesh-ancestor
101651209|NCT02621385|Midazolam|midazolam|mesh-list
101823838|NCT04044287|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101823839|NCT04044287|Abortifacient Agents|abortifacient agents|mesh-ancestor
101651210|NCT02621385|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101651211|NCT02621385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101651212|NCT02621385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101651213|NCT02621385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651214|NCT02621385|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101651215|NCT02621385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101651216|NCT02621385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101651217|NCT02621385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101651218|NCT02621385|Anesthetics, General|anesthetics, general|mesh-ancestor
101651219|NCT02621385|Anesthetics|anesthetics|mesh-ancestor
101651220|NCT02621385|GABA Modulators|gaba modulators|mesh-ancestor
101651221|NCT02621385|GABA Agents|gaba agents|mesh-ancestor
101651222|NCT02621385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101651223|NCT02621385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651224|NCT00922766|Dalteparin|dalteparin|mesh-list
101651225|NCT00922766|Tinzaparin|tinzaparin|mesh-list
101651226|NCT00922766|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101651227|NCT00922766|Anticoagulants|anticoagulants|mesh-ancestor
101651228|NCT00922766|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101651229|NCT00922766|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101651230|NCT00922766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651231|NCT04134897|Capecitabine|capecitabine|mesh-list
101651232|NCT04134897|Oxaliplatin|oxaliplatin|mesh-list
101651233|NCT04134897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101651234|NCT04134897|Antimetabolites|antimetabolites|mesh-ancestor
101451713|NCT00208065|Pseudoephedrine|pseudoephedrine|mesh-list
101651235|NCT04134897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651236|NCT04134897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101651238|NCT02620995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651239|NCT02620995|Vasodilator Agents|vasodilator agents|mesh-ancestor
101651240|NCT02620995|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101651241|NCT02620995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101651242|NCT02620995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101651243|NCT02620995|Urological Agents|urological agents|mesh-ancestor
101651245|NCT02620839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101651246|NCT02620605|Cabergoline|cabergoline|mesh-list
101651247|NCT02620605|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101651248|NCT02620605|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101651249|NCT02620605|Dopamine Agonists|dopamine agonists|mesh-ancestor
101651250|NCT02620605|Dopamine Agents|dopamine agents|mesh-ancestor
101651251|NCT02620605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101651252|NCT02620605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651253|NCT02620605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651255|NCT00976391|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101651256|NCT00976391|Insulin Glargine|insulin glargine|mesh-list
101651257|NCT00976391|Insulin Lispro|insulin lispro|mesh-list
101651258|NCT00976391|rGLP-1 protein|rglp-1 protein|mesh-list
101651259|NCT00976391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101651260|NCT00976391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651261|NCT00976391|Incretins|incretins|mesh-ancestor
101651262|NCT00976391|Hormones|hormones|mesh-ancestor
101651263|NCT00976391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101651264|NCT04252664|Remdesivir|remdesivir|mesh-list
101651265|NCT04252664|Antimetabolites|antimetabolites|mesh-ancestor
101651266|NCT04252664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651267|NCT04252664|Antiviral Agents|antiviral agents|mesh-ancestor
101651268|NCT04252664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101651269|NCT00696969|Amphotericin B|amphotericin b|mesh-list
101651270|NCT00696969|Paromomycin|paromomycin|mesh-list
101651271|NCT00696969|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101651273|NCT00696969|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
101651274|NCT00696969|Deoxycholic Acid|deoxycholic acid|mesh-list
101823894|NCT00825149|Alkylating Agents|alkylating agents|mesh-ancestor
101651275|NCT00696969|Amebicides|amebicides|mesh-ancestor
101651276|NCT00696969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101651277|NCT00696969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101651278|NCT00696969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101651279|NCT00696969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101651280|NCT00696969|Antifungal Agents|antifungal agents|mesh-ancestor
101651281|NCT00696969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101651282|NCT00696969|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101651283|NCT00696969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101651284|NCT04203680|Cardioplegic Solutions|cardioplegic solutions|mesh-list
101651285|NCT04203680|Tryptophan|tryptophan|mesh-list
101651286|NCT04203680|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101651287|NCT04203680|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101651288|NCT04203680|Antidepressive Agents|antidepressive agents|mesh-ancestor
101651289|NCT04203680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101651290|NCT02620215|Dinoprostone|dinoprostone|mesh-list
101651291|NCT02620215|Oxytocics|oxytocics|mesh-ancestor
101651292|NCT02620215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101651293|NCT02620215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651294|NCT02620293|Emollients|emollients|mesh-list
101651295|NCT02620293|Dermatologic Agents|dermatologic agents|mesh-ancestor
101651296|NCT02619981|Lidocaine|lidocaine|mesh-list
101651297|NCT02619981|Anesthetics, Local|anesthetics, local|mesh-ancestor
101651298|NCT02619981|Anesthetics|anesthetics|mesh-ancestor
101651299|NCT02619981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101651300|NCT02619981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651301|NCT02619981|Sensory System Agents|sensory system agents|mesh-ancestor
101651302|NCT02619981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101651303|NCT02619981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101651304|NCT02619981|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101651305|NCT02619981|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101651306|NCT02619981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101651307|NCT02619981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651308|NCT02619669|Letrozole|letrozole|mesh-list
101651309|NCT02619669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101651310|NCT02619669|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101651311|NCT02619669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101651312|NCT02619669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101651313|NCT02619669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651314|NCT02619669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101651315|NCT02619669|Hormone Antagonists|hormone antagonists|mesh-ancestor
101651316|NCT02619669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101651317|NCT02619669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651319|NCT03965117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101651320|NCT03965117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101651321|NCT03965117|Adrenergic Agents|adrenergic agents|mesh-ancestor
101651322|NCT03965117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101651323|NCT03965117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651324|NCT03965117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651325|NCT03965117|Sympathomimetics|sympathomimetics|mesh-ancestor
101651326|NCT03965117|Autonomic Agents|autonomic agents|mesh-ancestor
101651327|NCT03965117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101651328|NCT03965117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101651329|NCT00917462|Sorafenib|sorafenib|mesh-list
101651330|NCT00917462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101651331|NCT00917462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101651332|NCT00917462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101651333|NCT00917462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651334|NCT02619513|Dexmedetomidine|dexmedetomidine|mesh-list
101651336|NCT02619513|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101651337|NCT02619513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101651338|NCT02619513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651339|NCT02619513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101651340|NCT02619513|Analgesics|analgesics|mesh-ancestor
101651341|NCT02619513|Sensory System Agents|sensory system agents|mesh-ancestor
101651342|NCT02619513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101651343|NCT02619513|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101651344|NCT02619513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101651345|NCT02619513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101651346|NCT02619513|Adrenergic Agents|adrenergic agents|mesh-ancestor
101651347|NCT02619513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101651348|NCT02619513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651349|NCT02619513|Anesthetics, Local|anesthetics, local|mesh-ancestor
101651350|NCT02619513|Anesthetics|anesthetics|mesh-ancestor
101651351|NCT03947255|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101651352|NCT03947255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101651353|NCT03947255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101651354|NCT03947255|Immunotoxins|immunotoxins|mesh-ancestor
101651355|NCT03947255|Immunoconjugates|immunoconjugates|mesh-ancestor
101651356|NCT03947255|Immunologic Factors|immunologic factors|mesh-ancestor
101651357|NCT03947255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101823949|NCT00624377|Cholinergic Agents|cholinergic agents|mesh-ancestor
101651358|NCT02619747|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
101651359|NCT02619747|Antacids|antacids|mesh-ancestor
101651360|NCT02619747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651361|NCT02619747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101651362|NCT00697125|Vaccines|vaccines|mesh-list
101651363|NCT00697125|Immunologic Factors|immunologic factors|mesh-ancestor
101651364|NCT00697125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651365|NCT04134273|Clindamycin|clindamycin|mesh-list
101651366|NCT04134273|Clindamycin palmitate|clindamycin palmitate|mesh-list
101651367|NCT04134273|Clindamycin phosphate|clindamycin phosphate|mesh-list
101651368|NCT04134273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101651369|NCT04134273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101651370|NCT04134273|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101651371|NCT04134273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101651372|NCT04134273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651373|NCT04134117|Tisagenlecleucel|tisagenlecleucel|mesh-list
101651374|NCT04134117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101651375|NCT04134117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101651376|NCT03853187|Durvalumab|durvalumab|mesh-list
101651377|NCT03853187|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101651378|NCT03853187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101651379|NCT03853187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101651380|NCT03853187|Immunologic Factors|immunologic factors|mesh-ancestor
101651381|NCT03853187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651382|NCT03849443|Tranexamic Acid|tranexamic acid|mesh-list
101651383|NCT03849443|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101651384|NCT03849443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101651385|NCT03849443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651386|NCT03849443|Hemostatics|hemostatics|mesh-ancestor
101651387|NCT03849443|Coagulants|coagulants|mesh-ancestor
101651388|NCT00697281|Indoleacetic Acids|indoleacetic acids|mesh-list
101651389|NCT00697281|Plant Growth Regulators|plant growth regulators|mesh-ancestor
101651390|NCT00697281|Growth Substances|growth substances|mesh-ancestor
101651391|NCT00697281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651392|NCT00979901|Loratadine|loratadine|mesh-list
101651393|NCT00979901|Montelukast|montelukast|mesh-list
101651394|NCT00979901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101651395|NCT00979901|Respiratory System Agents|respiratory system agents|mesh-ancestor
101651396|NCT00979901|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101651397|NCT00979901|Hormone Antagonists|hormone antagonists|mesh-ancestor
101651398|NCT00979901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101651399|NCT00979901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651400|NCT00979901|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101651401|NCT00979901|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101651402|NCT00979901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651403|NCT00979901|Antipruritics|antipruritics|mesh-ancestor
101651404|NCT00979901|Dermatologic Agents|dermatologic agents|mesh-ancestor
101651405|NCT00979901|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101651406|NCT00979901|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101651407|NCT00979901|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101651408|NCT00979901|Histamine Antagonists|histamine antagonists|mesh-ancestor
101651409|NCT00979901|Histamine Agents|histamine agents|mesh-ancestor
101651410|NCT00979901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101651411|NCT02619201|Ondansetron|ondansetron|mesh-list
101651412|NCT02619201|Metoclopramide|metoclopramide|mesh-list
101651413|NCT02619201|Antiemetics|antiemetics|mesh-ancestor
101651414|NCT02619201|Autonomic Agents|autonomic agents|mesh-ancestor
101651415|NCT02619201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101651416|NCT02619201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824001|NCT00360334|Exenatide|exenatide|mesh-list
101651417|NCT02619201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101651418|NCT02619201|Antipruritics|antipruritics|mesh-ancestor
101651419|NCT02619201|Dermatologic Agents|dermatologic agents|mesh-ancestor
101651420|NCT02619201|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101651421|NCT02619201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101651422|NCT02619201|Serotonin Agents|serotonin agents|mesh-ancestor
101651423|NCT02619201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101651424|NCT02619201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651425|NCT02619201|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101651426|NCT02619201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101651427|NCT02619201|Dopamine Agents|dopamine agents|mesh-ancestor
101651428|NCT00975611|Amantadine|amantadine|mesh-list
101651429|NCT00975611|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101651430|NCT00975611|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101651431|NCT00975611|Antiviral Agents|antiviral agents|mesh-ancestor
101651432|NCT00975611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101651433|NCT00975611|Dopamine Agents|dopamine agents|mesh-ancestor
101651434|NCT00975611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101651435|NCT00975611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651436|NCT00975611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651437|NCT00975611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101651438|NCT00975611|Analgesics|analgesics|mesh-ancestor
101651439|NCT00975611|Sensory System Agents|sensory system agents|mesh-ancestor
101651440|NCT00975611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101651441|NCT02865005|Dapsone|dapsone|mesh-list
101651442|NCT02865005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101651443|NCT02865005|Antimalarials|antimalarials|mesh-ancestor
101651444|NCT02865005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101651445|NCT02865005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101651446|NCT02865005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101651447|NCT02865005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101651448|NCT02865005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651449|NCT02865005|Leprostatic Agents|leprostatic agents|mesh-ancestor
101651450|NCT02865005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101651451|NCT02862977|Ketoprofen|ketoprofen|mesh-list
101651452|NCT02862977|Amitriptyline|amitriptyline|mesh-list
101651453|NCT02862977|Cyclobenzaprine|cyclobenzaprine|mesh-list
101651454|NCT02862977|Caffeine|caffeine|mesh-list
101651455|NCT02862977|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101651456|NCT02862977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651457|NCT02862977|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101651458|NCT02862977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101651459|NCT02862977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651460|NCT02862977|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101651461|NCT02862977|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101651462|NCT02862977|Purinergic Agents|purinergic agents|mesh-ancestor
101651463|NCT02862977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101651464|NCT02862977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101651465|NCT02862977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101651466|NCT02862977|Analgesics|analgesics|mesh-ancestor
101651467|NCT02862977|Sensory System Agents|sensory system agents|mesh-ancestor
101651468|NCT02862977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101651469|NCT02862977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101651470|NCT02862977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101651471|NCT02862977|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101651472|NCT02862977|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101651473|NCT02862977|Antidepressive Agents|antidepressive agents|mesh-ancestor
101651474|NCT02862977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101651475|NCT02862977|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101651476|NCT02862977|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101651477|NCT02862977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101651478|NCT02862977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101651479|NCT02862977|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101651480|NCT02862977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101651481|NCT02862977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101651482|NCT02862977|Adrenergic Agents|adrenergic agents|mesh-ancestor
101651483|NCT02864927|Vaccines|vaccines|mesh-list
101651484|NCT02864927|Immunologic Factors|immunologic factors|mesh-ancestor
101651485|NCT02864927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651486|NCT02618499|Oxytocin|oxytocin|mesh-list
101651487|NCT02618499|Oxytocics|oxytocics|mesh-ancestor
101651488|NCT02618499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101651489|NCT02618499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651490|NCT04133961|Phenylephrine|phenylephrine|mesh-list
101651491|NCT04133961|Oxymetazoline|oxymetazoline|mesh-list
101651492|NCT04133961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101651493|NCT04133961|Mydriatics|mydriatics|mesh-ancestor
101308616|NCT00005886|Tamoxifen|tamoxifen|mesh-list
101651494|NCT04133961|Autonomic Agents|autonomic agents|mesh-ancestor
101651495|NCT04133961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101651496|NCT04133961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651497|NCT04133961|Sympathomimetics|sympathomimetics|mesh-ancestor
101651498|NCT04133961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101651499|NCT04133961|Nasal Decongestants|nasal decongestants|mesh-ancestor
101651500|NCT04133961|Respiratory System Agents|respiratory system agents|mesh-ancestor
101651501|NCT04133961|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101651502|NCT04133961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101651503|NCT04133961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101651504|NCT04133961|Adrenergic Agents|adrenergic agents|mesh-ancestor
101651505|NCT04133961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101651506|NCT04133961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651507|NCT04133961|Protective Agents|protective agents|mesh-ancestor
101651508|NCT02618733|Clopidogrel|clopidogrel|mesh-list
101651509|NCT02618733|Ticagrelor|ticagrelor|mesh-list
101651510|NCT02618733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101651511|NCT02618733|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101451714|NCT00208065|Ephedrine|ephedrine|mesh-list
101651512|NCT02618733|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101651513|NCT02618733|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101651514|NCT02618733|Purinergic Agents|purinergic agents|mesh-ancestor
101651515|NCT02618733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101651516|NCT02618733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651517|NCT02618733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651518|NCT00970307|Vaccines|vaccines|mesh-list
101651519|NCT00970307|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101651520|NCT00970307|Immunologic Factors|immunologic factors|mesh-ancestor
101651521|NCT00970307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651522|NCT00917384|Ramucirumab|ramucirumab|mesh-list
101651523|NCT00917384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101651524|NCT04133571|Lidocaine|lidocaine|mesh-list
101651525|NCT04133571|Anesthetics, Local|anesthetics, local|mesh-ancestor
101651526|NCT04133571|Anesthetics|anesthetics|mesh-ancestor
101651527|NCT04133571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101651528|NCT04133571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651529|NCT04133571|Sensory System Agents|sensory system agents|mesh-ancestor
101651530|NCT04133571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101651531|NCT04133571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101651532|NCT04133571|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101651533|NCT04133571|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101651534|NCT04133571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101651535|NCT04133571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651537|NCT00629681|Analgesics|analgesics|mesh-ancestor
101651538|NCT00629681|Sensory System Agents|sensory system agents|mesh-ancestor
101651539|NCT00629681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101651540|NCT00629681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651541|NCT00629681|Anticonvulsants|anticonvulsants|mesh-ancestor
101651542|NCT00629681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101651543|NCT00629681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101651544|NCT00629681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651545|NCT00629681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101651546|NCT00629681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101651547|NCT00629681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101651548|NCT00629681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101651549|NCT00629681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101651550|NCT02617485|Prednisone|prednisone|mesh-list
101651551|NCT02617485|Cyclophosphamide|cyclophosphamide|mesh-list
101651552|NCT02617485|Rituximab|rituximab|mesh-list
101651553|NCT02617485|Doxorubicin|doxorubicin|mesh-list
101651554|NCT02617485|Vincristine|vincristine|mesh-list
101651555|NCT02617485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101651556|NCT02617485|Immunologic Factors|immunologic factors|mesh-ancestor
101651557|NCT02617485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651558|NCT02617485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101651559|NCT02617485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101651560|NCT02617485|Alkylating Agents|alkylating agents|mesh-ancestor
101651561|NCT02617485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651562|NCT02617485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101651563|NCT02617485|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101651564|NCT02617485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101651565|NCT02617485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101651566|NCT02617485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101651567|NCT02617485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101651568|NCT02617485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101651569|NCT02617485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101651570|NCT02617485|Glucocorticoids|glucocorticoids|mesh-ancestor
101651572|NCT02617485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101651573|NCT02617485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101651574|NCT02617485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101651575|NCT02617485|Tubulin Modulators|tubulin modulators|mesh-ancestor
101651576|NCT02617485|Antimitotic Agents|antimitotic agents|mesh-ancestor
101651577|NCT02617485|Mitosis Modulators|mitosis modulators|mesh-ancestor
101651578|NCT04289207|Danazol|danazol|mesh-list
101651579|NCT04289207|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101651580|NCT04289207|Hormone Antagonists|hormone antagonists|mesh-ancestor
101651581|NCT04289207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101651582|NCT04289207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651584|NCT02863835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101651585|NCT02863835|Autonomic Agents|autonomic agents|mesh-ancestor
101651586|NCT02863835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101651587|NCT02863835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651588|NCT02863835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101651589|NCT02863835|Respiratory System Agents|respiratory system agents|mesh-ancestor
101651590|NCT02863835|Tocolytic Agents|tocolytic agents|mesh-ancestor
101651591|NCT02863835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101651592|NCT02863835|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101651593|NCT02863835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101651594|NCT02863835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101651595|NCT02863835|Adrenergic Agents|adrenergic agents|mesh-ancestor
101651596|NCT02863835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101651597|NCT02863835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651598|NCT00697437|Ketoconazole|ketoconazole|mesh-list
101651599|NCT00697437|Docetaxel|docetaxel|mesh-list
101651600|NCT00697437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101651601|NCT00697437|Tubulin Modulators|tubulin modulators|mesh-ancestor
101651602|NCT00697437|Antimitotic Agents|antimitotic agents|mesh-ancestor
101651603|NCT00697437|Mitosis Modulators|mitosis modulators|mesh-ancestor
101651604|NCT00697437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651605|NCT00697437|Antifungal Agents|antifungal agents|mesh-ancestor
101651606|NCT00697437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101651607|NCT00697437|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101651608|NCT00697437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101651609|NCT00697437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101651610|NCT00697437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101651611|NCT00697437|Hormone Antagonists|hormone antagonists|mesh-ancestor
101651612|NCT00697437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101651613|NCT00697437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651614|NCT00697437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101651615|NCT04252274|Darunavir|darunavir|mesh-list
101651617|NCT04252274|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
101535399|NCT00586911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101651618|NCT04252274|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101651619|NCT04252274|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101651620|NCT04252274|Protease Inhibitors|protease inhibitors|mesh-ancestor
101651621|NCT04252274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101651622|NCT04252274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651623|NCT04252274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101651624|NCT04252274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101651625|NCT04252274|Antiviral Agents|antiviral agents|mesh-ancestor
101651626|NCT04252274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101651627|NCT04252274|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101651628|NCT04252274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101651629|NCT00864513|Pemetrexed|pemetrexed|mesh-list
101651630|NCT00864513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101651631|NCT00864513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101651632|NCT00864513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651633|NCT00864513|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101651634|NCT00864513|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101651635|NCT04128891|Valsartan|valsartan|mesh-list
101651636|NCT04128891|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101651637|NCT04128891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101651638|NCT04128891|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101651639|NCT04128891|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101651640|NCT04128891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651641|NCT04251962|Fentanyl|fentanyl|mesh-list
101651642|NCT04251962|Bupivacaine|bupivacaine|mesh-list
101651643|NCT04251962|Anesthetics, Local|anesthetics, local|mesh-ancestor
101651644|NCT04251962|Anesthetics|anesthetics|mesh-ancestor
101651645|NCT04251962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101651646|NCT04251962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651647|NCT04251962|Sensory System Agents|sensory system agents|mesh-ancestor
101651648|NCT04251962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101651649|NCT04251962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101651650|NCT04251962|Narcotics|narcotics|mesh-ancestor
101651651|NCT04251962|Analgesics|analgesics|mesh-ancestor
101651652|NCT04251962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101651653|NCT04251962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101651654|NCT04251962|Anesthetics, General|anesthetics, general|mesh-ancestor
101651655|NCT04255238|Dapagliflozin|dapagliflozin|mesh-list
101651656|NCT04255238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101651657|NCT04255238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651658|NCT04255238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101651659|NCT04255238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651660|NCT05251766|Paclitaxel|paclitaxel|mesh-list
101651661|NCT05251766|Docetaxel|docetaxel|mesh-list
101651662|NCT05251766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101651663|NCT05251766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101651664|NCT05251766|Tubulin Modulators|tubulin modulators|mesh-ancestor
101651665|NCT05251766|Antimitotic Agents|antimitotic agents|mesh-ancestor
101651666|NCT05251766|Mitosis Modulators|mitosis modulators|mesh-ancestor
101651667|NCT05251766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651668|NCT04254380|Insulin Lispro|insulin lispro|mesh-list
101651669|NCT04254380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101651670|NCT04254380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651671|NCT00631514|Acetaminophen|acetaminophen|mesh-list
101651672|NCT00631514|Ibuprofen|ibuprofen|mesh-list
101651673|NCT00631514|Piroxicam|piroxicam|mesh-list
101651674|NCT00631514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101651675|NCT00631514|Analgesics|analgesics|mesh-ancestor
101651676|NCT00631514|Sensory System Agents|sensory system agents|mesh-ancestor
101651677|NCT00631514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101651678|NCT00631514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651679|NCT00631514|Antipyretics|antipyretics|mesh-ancestor
101651680|NCT00631514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101651681|NCT00631514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101651682|NCT00631514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101651683|NCT00631514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101651685|NCT00631514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651686|NCT04623944|Cytarabine|cytarabine|mesh-list
101651688|NCT04623944|Fludarabine|fludarabine|mesh-list
101651689|NCT04623944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101651690|NCT04623944|Immunologic Factors|immunologic factors|mesh-ancestor
101651691|NCT04623944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651692|NCT04623944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101651693|NCT04623944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101651694|NCT04623944|Alkylating Agents|alkylating agents|mesh-ancestor
101651695|NCT04623944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651696|NCT04623944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101651697|NCT04623944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101651698|NCT04623944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101651699|NCT04623944|Antimetabolites|antimetabolites|mesh-ancestor
101651700|NCT04623944|Antiviral Agents|antiviral agents|mesh-ancestor
101651701|NCT04623944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101651702|NCT05253014|Acetaminophen|acetaminophen|mesh-list
101651703|NCT05253014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101651704|NCT05253014|Analgesics|analgesics|mesh-ancestor
101651705|NCT05253014|Sensory System Agents|sensory system agents|mesh-ancestor
101651706|NCT05253014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101651707|NCT05253014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651708|NCT05253014|Antipyretics|antipyretics|mesh-ancestor
101651709|NCT00659425|Immunotoxin HA22|immunotoxin ha22|mesh-list
101651710|NCT00659425|Immunotoxins|immunotoxins|mesh-ancestor
101651711|NCT00659425|Immunoconjugates|immunoconjugates|mesh-ancestor
101651712|NCT00659425|Immunologic Factors|immunologic factors|mesh-ancestor
101651713|NCT00659425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651714|NCT00659425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101651715|NCT00656851|Pioglitazone|pioglitazone|mesh-list
101651716|NCT00656851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101651717|NCT00656851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651719|NCT00803335|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101651720|NCT00803335|Hormones|hormones|mesh-ancestor
101651721|NCT00803335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101651722|NCT00803335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651723|NCT00797953|Cardiotonic Agents|cardiotonic agents|mesh-list
101651724|NCT00656617|Cytarabine|cytarabine|mesh-list
101651725|NCT00656617|Vorinostat|vorinostat|mesh-list
101651726|NCT00656617|Idarubicin|idarubicin|mesh-list
101651727|NCT00656617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101651728|NCT00656617|Antimetabolites|antimetabolites|mesh-ancestor
101651729|NCT00656617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651730|NCT00656617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101651731|NCT00656617|Antiviral Agents|antiviral agents|mesh-ancestor
101651732|NCT00656617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101651733|NCT00656617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101651734|NCT00656617|Immunologic Factors|immunologic factors|mesh-ancestor
101651735|NCT00656617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651736|NCT00656617|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101651737|NCT00656617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101651738|NCT00656617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101651739|NCT00656617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101651740|NCT00656617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101651741|NCT00798343|Vaccines|vaccines|mesh-list
101651742|NCT00798343|Immunologic Factors|immunologic factors|mesh-ancestor
101651743|NCT00798343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651744|NCT00803725|Fentanyl|fentanyl|mesh-list
101651745|NCT00803725|Mepivacaine|mepivacaine|mesh-list
101651746|NCT00803725|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101651747|NCT00803725|Narcotics|narcotics|mesh-ancestor
101651748|NCT00803725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101651749|NCT00803725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651750|NCT00803725|Analgesics|analgesics|mesh-ancestor
101651751|NCT00803725|Sensory System Agents|sensory system agents|mesh-ancestor
101651752|NCT00803725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101651753|NCT00803725|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101651754|NCT00803725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101651755|NCT00803725|Anesthetics, General|anesthetics, general|mesh-ancestor
101651756|NCT00803725|Anesthetics|anesthetics|mesh-ancestor
101651757|NCT00803725|Anesthetics, Local|anesthetics, local|mesh-ancestor
101651758|NCT00803803|Pilocarpine|pilocarpine|mesh-list
101651759|NCT00803803|Miotics|miotics|mesh-ancestor
101651760|NCT00803803|Autonomic Agents|autonomic agents|mesh-ancestor
101651761|NCT00803803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101651762|NCT00803803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651763|NCT00803803|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101651764|NCT00803803|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101651765|NCT00803803|Cholinergic Agents|cholinergic agents|mesh-ancestor
101651766|NCT00803803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101651767|NCT00803803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651769|NCT04775329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101651770|NCT04775329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101651771|NCT04775329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101651772|NCT00659269|Vitamins|vitamins|mesh-list
101651773|NCT00659269|Vitamin B 12|vitamin b 12|mesh-list
101651774|NCT00659269|Vitamin B 6|vitamin b 6|mesh-list
101651775|NCT00659269|Pyridoxal|pyridoxal|mesh-list
101651776|NCT00659269|Pyridoxine|pyridoxine|mesh-list
101651777|NCT00659269|Vitamin B Complex|vitamin b complex|mesh-list
101651778|NCT00659269|Vincristine|vincristine|mesh-list
101651779|NCT00659269|Vinorelbine|vinorelbine|mesh-list
101651780|NCT00659269|Docetaxel|docetaxel|mesh-list
101651781|NCT00659269|Cisplatin|cisplatin|mesh-list
101651782|NCT00659269|Oxaliplatin|oxaliplatin|mesh-list
101651783|NCT00659269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101651784|NCT00659269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101651785|NCT00659269|Tubulin Modulators|tubulin modulators|mesh-ancestor
101651786|NCT00659269|Antimitotic Agents|antimitotic agents|mesh-ancestor
101651787|NCT00659269|Mitosis Modulators|mitosis modulators|mesh-ancestor
101651788|NCT00659269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651789|NCT00659269|Micronutrients|micronutrients|mesh-ancestor
101651790|NCT00659269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651791|NCT00922129|Cyclosporine|cyclosporine|mesh-list
101651792|NCT00922129|Sirolimus|sirolimus|mesh-list
101651793|NCT00922129|Temsirolimus|temsirolimus|mesh-list
101651794|NCT00922129|MTOR Inhibitors|mtor inhibitors|mesh-list
101651795|NCT00922129|Tacrolimus|tacrolimus|mesh-list
101651796|NCT00922129|Cyclosporins|cyclosporins|mesh-list
101651797|NCT00922129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101651798|NCT00922129|Immunologic Factors|immunologic factors|mesh-ancestor
101651799|NCT00922129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651800|NCT00922129|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101651801|NCT00922129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101651802|NCT00922129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651803|NCT00922129|Antifungal Agents|antifungal agents|mesh-ancestor
101651804|NCT00922129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101651805|NCT00922129|Dermatologic Agents|dermatologic agents|mesh-ancestor
101651806|NCT00922129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101651807|NCT00922129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101651808|NCT00922129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101651809|NCT00922129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101651810|NCT00922129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101651811|NCT00806299|Loperamide|loperamide|mesh-list
101651812|NCT00806299|Antidiarrheals|antidiarrheals|mesh-list
101651813|NCT00806299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101651814|NCT00804115|Timolol|timolol|mesh-list
101651815|NCT00804115|Latanoprost|latanoprost|mesh-list
101651816|NCT00804115|Pilocarpine|pilocarpine|mesh-list
101651817|NCT00804115|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101651818|NCT00804115|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101651819|NCT00804115|Adrenergic Agents|adrenergic agents|mesh-ancestor
101651820|NCT00804115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101651821|NCT00804115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651822|NCT00804115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651823|NCT00804115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101651824|NCT00804115|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101651825|NCT00804115|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101651826|NCT00804115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101651827|NCT00804115|Miotics|miotics|mesh-ancestor
101651828|NCT00804115|Autonomic Agents|autonomic agents|mesh-ancestor
101651829|NCT00804115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101651830|NCT00804115|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101651831|NCT00804115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101651832|NCT00804115|Cholinergic Agents|cholinergic agents|mesh-ancestor
101651833|NCT02554123|Vitamin E|vitamin e|mesh-list
101651834|NCT02554123|Petrolatum|petrolatum|mesh-list
101651835|NCT02554123|Vitamins|vitamins|mesh-ancestor
101651836|NCT02554123|Micronutrients|micronutrients|mesh-ancestor
101651837|NCT02554123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651838|NCT02554123|Antioxidants|antioxidants|mesh-ancestor
101651839|NCT02554123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651840|NCT02554123|Protective Agents|protective agents|mesh-ancestor
101651841|NCT02554123|Emollients|emollients|mesh-ancestor
101651842|NCT02554123|Dermatologic Agents|dermatologic agents|mesh-ancestor
101651843|NCT00799045|Clopidogrel|clopidogrel|mesh-list
101651844|NCT00799045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101651845|NCT00799045|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101651846|NCT00799045|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101651847|NCT00799045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101651848|NCT00799045|Purinergic Agents|purinergic agents|mesh-ancestor
101651849|NCT00799045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101651850|NCT00799045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651851|NCT00799045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651852|NCT00658333|Mycophenolic Acid|mycophenolic acid|mesh-list
101651853|NCT00658333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101651854|NCT00658333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101651855|NCT00658333|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101651856|NCT00658333|Antitubercular Agents|antitubercular agents|mesh-ancestor
101651857|NCT00658333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101651858|NCT00658333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101651859|NCT00658333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101651860|NCT00658333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651861|NCT00804271|Memantine|memantine|mesh-list
101651862|NCT00804271|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101651863|NCT00804271|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101651864|NCT00804271|Dopamine Agents|dopamine agents|mesh-ancestor
101651865|NCT00804271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101651866|NCT00804271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651867|NCT00804271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651868|NCT00804271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101651869|NCT00804271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101651870|NCT00799201|Naloxone|naloxone|mesh-list
101651871|NCT00799201|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101651872|NCT00799201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651873|NCT00799201|Sensory System Agents|sensory system agents|mesh-ancestor
101651874|NCT00799201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101651875|NCT00806611|Ethanol|ethanol|mesh-list
101651876|NCT00806611|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101651877|NCT00806611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101651878|NCT00806611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101651879|NCT00806611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651880|NCT00799513|Lenalidomide|lenalidomide|mesh-list
101651881|NCT00799513|Immunologic Factors|immunologic factors|mesh-ancestor
101651882|NCT00799513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651883|NCT00799513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101651884|NCT00799513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101651885|NCT00799513|Growth Substances|growth substances|mesh-ancestor
101651886|NCT00799513|Growth Inhibitors|growth inhibitors|mesh-ancestor
101651887|NCT00799513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101651888|NCT00806767|Fludarabine|fludarabine|mesh-list
101651889|NCT00806767|Fludarabine phosphate|fludarabine phosphate|mesh-list
101651890|NCT00806767|Busulfan|busulfan|mesh-list
101651891|NCT00806767|Immunoglobulins|immunoglobulins|mesh-list
101651892|NCT00806767|Antibodies|antibodies|mesh-list
101651893|NCT00806767|gamma-Globulins|gamma-globulins|mesh-list
101651894|NCT00806767|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101651895|NCT00806767|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101651896|NCT00806767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101651897|NCT00806767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101651898|NCT00806767|Antimetabolites|antimetabolites|mesh-ancestor
101651899|NCT00806767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651900|NCT00806767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101651901|NCT00806767|Immunologic Factors|immunologic factors|mesh-ancestor
101651902|NCT00806767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651903|NCT00806767|Alkylating Agents|alkylating agents|mesh-ancestor
101651904|NCT00806767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101651905|NCT00806767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101651906|NCT00863655|Everolimus|everolimus|mesh-list
101651907|NCT00863655|Exemestane|exemestane|mesh-list
101651908|NCT00863655|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101651909|NCT00863655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101651910|NCT00863655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101651911|NCT00863655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651912|NCT00863655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101651913|NCT00863655|Immunologic Factors|immunologic factors|mesh-ancestor
101651914|NCT00863655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651915|NCT00863655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101651916|NCT00863655|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101651917|NCT00863655|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101651918|NCT00863655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101651919|NCT00863655|Hormone Antagonists|hormone antagonists|mesh-ancestor
101651920|NCT00863655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101651922|NCT00806923|Gemcitabine|gemcitabine|mesh-list
101651923|NCT00806923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101651924|NCT00806923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101651925|NCT00806923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101651926|NCT00806923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101651927|NCT00806923|Growth Substances|growth substances|mesh-ancestor
101651928|NCT00806923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651929|NCT00806923|Growth Inhibitors|growth inhibitors|mesh-ancestor
101651930|NCT00806923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101651931|NCT00806923|Antimetabolites|antimetabolites|mesh-ancestor
101651932|NCT00806923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651933|NCT00698607|Sirolimus|sirolimus|mesh-list
101651934|NCT00698607|Everolimus|everolimus|mesh-list
101651935|NCT00698607|Clopidogrel|clopidogrel|mesh-list
101651936|NCT00698607|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101651937|NCT00698607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101651938|NCT00698607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101651939|NCT00698607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651940|NCT00698607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101651941|NCT00698607|Immunologic Factors|immunologic factors|mesh-ancestor
101651942|NCT00698607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651943|NCT00698607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101651944|NCT00698607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101651945|NCT00698607|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101651946|NCT00698607|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101651947|NCT00698607|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101651948|NCT00698607|Purinergic Agents|purinergic agents|mesh-ancestor
101651949|NCT00698607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101651950|NCT00698607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101651951|NCT00698607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101824072|NCT00833963|Pertuzumab|pertuzumab|mesh-list
101651952|NCT00698607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101651953|NCT00698607|Antifungal Agents|antifungal agents|mesh-ancestor
101651954|NCT04124757|Rocuronium|rocuronium|mesh-list
101651955|NCT04124757|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101651956|NCT04124757|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101651957|NCT04124757|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101651958|NCT04124757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101651959|NCT04124757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651960|NCT04123041|Nicotine|nicotine|mesh-list
101651961|NCT04123041|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101651962|NCT04123041|Autonomic Agents|autonomic agents|mesh-ancestor
101651963|NCT04123041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101651964|NCT04123041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651965|NCT04123041|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101651966|NCT04123041|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101651967|NCT04123041|Cholinergic Agents|cholinergic agents|mesh-ancestor
101651968|NCT04123041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101651969|NCT04123041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651970|NCT00698763|Simendan|simendan|mesh-list
101651971|NCT00698763|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101651972|NCT00698763|Vasodilator Agents|vasodilator agents|mesh-ancestor
101651973|NCT00698763|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101651974|NCT00698763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101651975|NCT00698763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101651976|NCT00698763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651977|NCT00698763|Protective Agents|protective agents|mesh-ancestor
101651978|NCT00698763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651979|NCT00804895|Cortivazol|cortivazol|mesh-list
101651980|NCT00804895|Verapamil|verapamil|mesh-list
101651981|NCT00804895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101651982|NCT00804895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101651983|NCT00804895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101651984|NCT00804895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651985|NCT00804895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101651986|NCT00804895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101651987|NCT00804895|Vasodilator Agents|vasodilator agents|mesh-ancestor
101651988|NCT00804895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101651989|NCT00800137|Heparin|heparin|mesh-list
101651990|NCT00800137|Calcium heparin|calcium heparin|mesh-list
101651991|NCT00800137|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101651992|NCT00800137|Tinzaparin|tinzaparin|mesh-list
101651993|NCT00800137|Dalteparin|dalteparin|mesh-list
101651994|NCT00800137|Warfarin|warfarin|mesh-list
101651995|NCT00800137|Anticoagulants|anticoagulants|mesh-ancestor
101651996|NCT00800137|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101651997|NCT00800137|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101651998|NCT00800137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101651999|NCT00807079|Carboplatin|carboplatin|mesh-list
101652000|NCT00807079|Topotecan|topotecan|mesh-list
101652001|NCT00807079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101652002|NCT00807079|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101652003|NCT00807079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101652004|NCT00807079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101652005|NCT00807079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652006|NCT00800293|Betamethasone|betamethasone|mesh-list
101652007|NCT00800293|Betamethasone Valerate|betamethasone valerate|mesh-list
101652008|NCT00800293|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101652009|NCT00800293|Betamethasone benzoate|betamethasone benzoate|mesh-list
101652010|NCT00800293|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101652011|NCT00800293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101652012|NCT00800293|Glucocorticoids|glucocorticoids|mesh-ancestor
101652013|NCT00800293|Hormones|hormones|mesh-ancestor
101652014|NCT00800293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101652015|NCT00800293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652016|NCT00800293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101652017|NCT00800293|Respiratory System Agents|respiratory system agents|mesh-ancestor
101652018|NCT00658021|Exenatide|exenatide|mesh-list
101652019|NCT00658021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101652021|NCT00658021|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101652022|NCT00658021|Incretins|incretins|mesh-ancestor
101652023|NCT00658021|Hormones|hormones|mesh-ancestor
101652024|NCT00658021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101652025|NCT00920816|Sorafenib|sorafenib|mesh-list
101652026|NCT00920816|Axitinib|axitinib|mesh-list
101652027|NCT00920816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101652028|NCT00920816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101652029|NCT00920816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101652030|NCT00920816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652031|NCT00631592|Dolutegravir|dolutegravir|mesh-list
101652032|NCT00631592|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101652033|NCT00631592|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101652034|NCT00631592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101652035|NCT00631592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652036|NCT00631592|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101652037|NCT00631592|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101652038|NCT00631592|Antiviral Agents|antiviral agents|mesh-ancestor
101652039|NCT00631592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101652040|NCT05251610|Propranolol|propranolol|mesh-list
101652041|NCT05251610|Oxytocin|oxytocin|mesh-list
101652042|NCT05251610|Oxytocics|oxytocics|mesh-ancestor
101652043|NCT05251610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101652044|NCT05251610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652045|NCT05251610|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101652046|NCT05251610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101652047|NCT05251610|Adrenergic Agents|adrenergic agents|mesh-ancestor
101652048|NCT05251610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101652049|NCT05251610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652050|NCT05251610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101652051|NCT05251610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101652052|NCT05251610|Vasodilator Agents|vasodilator agents|mesh-ancestor
101652053|NCT00657709|Vaccines|vaccines|mesh-list
101652054|NCT00657709|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101652055|NCT00657709|Immunologic Factors|immunologic factors|mesh-ancestor
101652056|NCT00657709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652057|NCT00657553|Bortezomib|bortezomib|mesh-list
101652058|NCT00657553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101652059|NCT04253912|Povidone-Iodine|povidone-iodine|mesh-list
101652060|NCT04253912|Povidone|povidone|mesh-list
101652061|NCT04253912|Plasma Substitutes|plasma substitutes|mesh-ancestor
101652062|NCT04253912|Blood Substitutes|blood substitutes|mesh-ancestor
101652063|NCT04253912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101652064|NCT04253912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101652065|NCT00800527|Diclofenac|diclofenac|mesh-list
101652066|NCT00800527|Gabapentin|gabapentin|mesh-list
101652067|NCT00800527|Analgesics|analgesics|mesh-ancestor
101652068|NCT00800527|Sensory System Agents|sensory system agents|mesh-ancestor
101652069|NCT00800527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101652070|NCT00800527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652071|NCT00800527|Anticonvulsants|anticonvulsants|mesh-ancestor
101652072|NCT00800527|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101652073|NCT00800527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101652074|NCT00800527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101652075|NCT00800527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101652076|NCT00800527|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101652077|NCT00800527|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101652078|NCT00800527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101652079|NCT00800527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652080|NCT00800527|Antimanic Agents|antimanic agents|mesh-ancestor
101652081|NCT00800527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101652082|NCT00800527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101652083|NCT00800527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101652084|NCT00800527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101652085|NCT00800527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101652086|NCT00800527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101652087|NCT00862719|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101652088|NCT00862719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101652089|NCT00862719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652090|NCT00862719|Incretins|incretins|mesh-ancestor
101652091|NCT00862719|Hormones|hormones|mesh-ancestor
101652092|NCT00862719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101652093|NCT00862719|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101652094|NCT00862719|Protease Inhibitors|protease inhibitors|mesh-ancestor
101652095|NCT00862719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101652096|NCT00862719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652097|NCT04120779|Sulfamethazine|sulfamethazine|mesh-list
101652098|NCT04120779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101652099|NCT00862641|Regadenoson|regadenoson|mesh-list
101652100|NCT00862641|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
101652101|NCT00862641|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101652102|NCT00862641|Purinergic Agonists|purinergic agonists|mesh-ancestor
101652103|NCT00862641|Purinergic Agents|purinergic agents|mesh-ancestor
101652104|NCT00862641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101652105|NCT00862641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652106|NCT00862641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652107|NCT04119921|Ketorolac|ketorolac|mesh-list
101652108|NCT04119921|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101652109|NCT04119921|Lubricant Eye Drops|lubricant eye drops|mesh-list
101652110|NCT04119921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101652111|NCT04119921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101652112|NCT04119921|Analgesics|analgesics|mesh-ancestor
101652113|NCT04119921|Sensory System Agents|sensory system agents|mesh-ancestor
101652114|NCT04119921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101652115|NCT04119921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652116|NCT04119921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101652117|NCT04119921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101652118|NCT04119921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101652119|NCT04119921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101652120|NCT04119921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652121|NCT04119921|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101652122|NCT04119921|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101652123|NCT00861471|Docetaxel|docetaxel|mesh-list
101652124|NCT00861471|Imatinib Mesylate|imatinib mesylate|mesh-list
101652125|NCT00861471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101652126|NCT00861471|Tubulin Modulators|tubulin modulators|mesh-ancestor
101652127|NCT00861471|Antimitotic Agents|antimitotic agents|mesh-ancestor
101652128|NCT00861471|Mitosis Modulators|mitosis modulators|mesh-ancestor
101652129|NCT00861471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652130|NCT00861471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101652131|NCT00861471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101652133|NCT02613585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101652134|NCT02613585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652135|NCT04119297|Heparinoids|heparinoids|mesh-list
101652136|NCT04119297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101652137|NCT04119297|Anticoagulants|anticoagulants|mesh-ancestor
101652138|NCT00699387|Benzonidazole|benzonidazole|mesh-list
101652139|NCT00699387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101652140|NCT00699387|Immunologic Factors|immunologic factors|mesh-ancestor
101652141|NCT00699387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652142|NCT00699387|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101652143|NCT00699387|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101652144|NCT00699387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101652145|NCT00699387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101652146|NCT00699465|Enoxaparin|enoxaparin|mesh-list
101652147|NCT00699465|Enoxaparin sodium|enoxaparin sodium|mesh-list
101652148|NCT00699465|Anticoagulants|anticoagulants|mesh-ancestor
101652149|NCT00699465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101652150|NCT00699465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101652151|NCT00699465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652153|NCT00858117|Alemtuzumab|alemtuzumab|mesh-list
101652154|NCT00858117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101652155|NCT00858117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101652156|NCT00858117|Immunologic Factors|immunologic factors|mesh-ancestor
101652157|NCT00858117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652158|NCT00858117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101652159|NCT00700947|Metoprolol|metoprolol|mesh-list
101652160|NCT00700947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101652161|NCT00700947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101652162|NCT00700947|Adrenergic Agents|adrenergic agents|mesh-ancestor
101652163|NCT00700947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101652164|NCT00700947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652165|NCT00700947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652166|NCT00700947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101652167|NCT00700947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101652168|NCT00700947|Sympatholytics|sympatholytics|mesh-ancestor
101652169|NCT00700947|Autonomic Agents|autonomic agents|mesh-ancestor
101652170|NCT00700947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101652171|NCT00700947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101652172|NCT00652951|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101652173|NCT00652951|Immunologic Factors|immunologic factors|mesh-ancestor
101652174|NCT00652951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652176|NCT04116255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101652177|NCT04116255|Antifungal Agents|antifungal agents|mesh-ancestor
101652178|NCT04116255|Keratolytic Agents|keratolytic agents|mesh-ancestor
101652179|NCT04116255|Dermatologic Agents|dermatologic agents|mesh-ancestor
101652180|NCT00805519|Chloroquine|chloroquine|mesh-list
101652181|NCT00805519|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
101652182|NCT00805519|Prednisolone|prednisolone|mesh-list
101652183|NCT00805519|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101652184|NCT00805519|Methylprednisolone|methylprednisolone|mesh-list
101652185|NCT00805519|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101652186|NCT00805519|Prednisolone acetate|prednisolone acetate|mesh-list
101652187|NCT00805519|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101652188|NCT00805519|Prednisolone phosphate|prednisolone phosphate|mesh-list
101652189|NCT00805519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101652190|NCT00805519|Glucocorticoids|glucocorticoids|mesh-ancestor
101652191|NCT00805519|Hormones|hormones|mesh-ancestor
101652192|NCT00805519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101652193|NCT00805519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652194|NCT00805519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101652195|NCT00805519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101652196|NCT00805519|Antiemetics|antiemetics|mesh-ancestor
101652197|NCT00805519|Autonomic Agents|autonomic agents|mesh-ancestor
101652198|NCT00805519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101652199|NCT00805519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101652200|NCT00805519|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101652201|NCT00805519|Protective Agents|protective agents|mesh-ancestor
101652202|NCT00805519|Amebicides|amebicides|mesh-ancestor
101652203|NCT00805519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101652204|NCT00805519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101652205|NCT00805519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101652206|NCT00805519|Antimalarials|antimalarials|mesh-ancestor
101652207|NCT00805519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101652208|NCT00805519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101652209|NCT00805519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101652210|NCT00805519|Analgesics|analgesics|mesh-ancestor
101652211|NCT00805519|Sensory System Agents|sensory system agents|mesh-ancestor
101652212|NCT00805519|Filaricides|filaricides|mesh-ancestor
101652213|NCT00805519|Antinematodal Agents|antinematodal agents|mesh-ancestor
101652214|NCT00805519|Anthelmintics|anthelmintics|mesh-ancestor
101652215|NCT00592683|Aripiprazole|aripiprazole|mesh-list
101652216|NCT00592683|Antidepressive Agents|antidepressive agents|mesh-ancestor
101652217|NCT00592683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101652218|NCT00592683|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101652219|NCT00592683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101652220|NCT00592683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101824110|NCT00828503|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101652221|NCT00592683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652222|NCT00592683|Dopamine Agonists|dopamine agonists|mesh-ancestor
101652223|NCT00592683|Dopamine Agents|dopamine agents|mesh-ancestor
101652224|NCT00592683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101652225|NCT00592683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652226|NCT00592683|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101652227|NCT00592683|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101652228|NCT00592683|Serotonin Agents|serotonin agents|mesh-ancestor
101652229|NCT00592683|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101652230|NCT00592683|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101652231|NCT00592683|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101652232|NCT00592683|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101652233|NCT02613039|Contraceptive Agents|contraceptive agents|mesh-list
101652234|NCT02613039|Contraceptives, Oral|contraceptives, oral|mesh-list
101652235|NCT02613039|Estrogens|estrogens|mesh-list
101652236|NCT02613039|Progestins|progestins|mesh-list
101652237|NCT02613039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101652238|NCT02613039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652239|NCT02613039|Hormones|hormones|mesh-ancestor
101652240|NCT02613039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101652241|NCT02613039|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101652242|NCT00813475|Insulin|insulin|mesh-list
101652243|NCT00813475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101652244|NCT00813475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101652245|NCT00813475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652246|NCT00701259|Lansoprazole|lansoprazole|mesh-list
101652247|NCT00701259|Dexlansoprazole|dexlansoprazole|mesh-list
101652248|NCT00701259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101652249|NCT00701259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101652250|NCT00701259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101652251|NCT00701259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101652252|NCT00701259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652253|NCT00701337|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101652254|NCT00701337|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101652255|NCT00701337|Estradiol|estradiol|mesh-list
101652256|NCT00701337|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101652257|NCT00701337|Estrogens|estrogens|mesh-ancestor
101652258|NCT00701337|Hormones|hormones|mesh-ancestor
101652259|NCT00701337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101652260|NCT00701337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652261|NCT00701337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101652262|NCT00701337|Contraceptive Agents|contraceptive agents|mesh-ancestor
101652263|NCT00701337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101652264|NCT00701337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101652265|NCT00654901|Vaccines|vaccines|mesh-list
101652266|NCT00654901|Immunologic Factors|immunologic factors|mesh-ancestor
101652267|NCT00654901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652268|NCT00701493|Topiramate|topiramate|mesh-list
101652269|NCT00701493|Anticonvulsants|anticonvulsants|mesh-ancestor
101652270|NCT00701493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101652271|NCT00701493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652272|NCT04253678|Vortioxetine|vortioxetine|mesh-list
101652273|NCT04253678|Antidepressive Agents|antidepressive agents|mesh-ancestor
101652274|NCT04253678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101652275|NCT04253678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101652276|NCT04253678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101652277|NCT04253678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101652278|NCT04253678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652279|NCT04253678|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101652280|NCT04253678|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101652281|NCT04253678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101652282|NCT04253678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652283|NCT04253678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101652284|NCT04253678|Serotonin Agents|serotonin agents|mesh-ancestor
101652285|NCT04253678|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101824115|NCT00828503|Immunologic Factors|immunologic factors|mesh-ancestor
101652286|NCT04253678|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101652287|NCT04253678|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101652288|NCT04253678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101652289|NCT00813631|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101652290|NCT00813631|Laxatives|laxatives|mesh-ancestor
101652291|NCT00813631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101652292|NCT02551861|Ribavirin|ribavirin|mesh-list
101652294|NCT02551861|Antimetabolites|antimetabolites|mesh-ancestor
101652295|NCT02551861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652296|NCT02551861|Antiviral Agents|antiviral agents|mesh-ancestor
101652297|NCT02551861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101652298|NCT00846495|Topiramate|topiramate|mesh-list
101652299|NCT00846495|Frovatriptan|frovatriptan|mesh-list
101652300|NCT00846495|Anticonvulsants|anticonvulsants|mesh-ancestor
101652301|NCT00846495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101652302|NCT00846495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652303|NCT00846495|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101652304|NCT00846495|Serotonin Agents|serotonin agents|mesh-ancestor
101652305|NCT00846495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101652306|NCT00846495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652307|NCT00654745|Amlodipine|amlodipine|mesh-list
101652308|NCT00654745|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101652309|NCT00654745|Olmesartan|olmesartan|mesh-list
101652310|NCT00654745|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101652311|NCT00654745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101652312|NCT00654745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101652313|NCT00654745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101652314|NCT00654745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652315|NCT00654745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101652316|NCT00654745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652317|NCT00654745|Vasodilator Agents|vasodilator agents|mesh-ancestor
101652318|NCT00654745|Diuretics|diuretics|mesh-ancestor
101652319|NCT00654745|Natriuretic Agents|natriuretic agents|mesh-ancestor
101652320|NCT00654745|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101652321|NCT00654745|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101652322|NCT00654745|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101652323|NCT00809887|Micafungin|micafungin|mesh-list
101652324|NCT00809887|Antifungal Agents|antifungal agents|mesh-ancestor
101652325|NCT00809887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101652326|NCT00846027|Paclitaxel|paclitaxel|mesh-list
101652327|NCT00846027|Bevacizumab|bevacizumab|mesh-list
101652328|NCT00846027|Gemcitabine|gemcitabine|mesh-list
101652329|NCT00846027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101652330|NCT00846027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101652331|NCT00846027|Tubulin Modulators|tubulin modulators|mesh-ancestor
101652332|NCT00846027|Antimitotic Agents|antimitotic agents|mesh-ancestor
101652333|NCT00846027|Mitosis Modulators|mitosis modulators|mesh-ancestor
101652334|NCT00846027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652335|NCT00846027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101652336|NCT00846027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101652337|NCT00846027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101652338|NCT00846027|Growth Substances|growth substances|mesh-ancestor
101652339|NCT00846027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652340|NCT00846027|Growth Inhibitors|growth inhibitors|mesh-ancestor
101652341|NCT00846027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101652342|NCT00846027|Antimetabolites|antimetabolites|mesh-ancestor
101652343|NCT00807625|Copper|copper|mesh-list
101652344|NCT00807625|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101652345|NCT00807625|Medroxyprogesterone|medroxyprogesterone|mesh-list
101652346|NCT00807625|Trace Elements|trace elements|mesh-ancestor
101652347|NCT00807625|Micronutrients|micronutrients|mesh-ancestor
101652348|NCT00807625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652349|NCT00807625|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101652350|NCT00807625|Contraceptive Agents|contraceptive agents|mesh-ancestor
101652351|NCT00807625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101652352|NCT00807625|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101652353|NCT00807625|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101652354|NCT00807625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101652355|NCT00807625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101652356|NCT00807625|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101652357|NCT00807625|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101652358|NCT00807625|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101652359|NCT02551549|Rezafungin|rezafungin|mesh-list
101652360|NCT02551549|Antifungal Agents|antifungal agents|mesh-ancestor
101652361|NCT02551549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101652362|NCT00810121|Ketoprofen|ketoprofen|mesh-list
101652363|NCT00810121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101652364|NCT00810121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101652365|NCT00810121|Analgesics|analgesics|mesh-ancestor
101652366|NCT00810121|Sensory System Agents|sensory system agents|mesh-ancestor
101652367|NCT00810121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101652368|NCT00810121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652369|NCT00810121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101652370|NCT00810121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101652371|NCT00810121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101652372|NCT00810121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101652373|NCT00810121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652375|NCT00652327|Simvastatin|simvastatin|mesh-list
101652376|NCT00652327|Ezetimibe|ezetimibe|mesh-list
101652377|NCT00652327|Pravastatin|pravastatin|mesh-list
101652378|NCT00652327|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
101652379|NCT00652327|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101652380|NCT00652327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101652381|NCT00652327|Antimetabolites|antimetabolites|mesh-ancestor
101652382|NCT00652327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652383|NCT00652327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101652384|NCT00652327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101652385|NCT00814021|Sunitinib|sunitinib|mesh-list
101652386|NCT00814021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101652387|NCT00814021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101652388|NCT00814021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101652389|NCT00814021|Growth Substances|growth substances|mesh-ancestor
101652390|NCT00814021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652391|NCT00814021|Growth Inhibitors|growth inhibitors|mesh-ancestor
101652392|NCT00814021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101652393|NCT00814021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101652394|NCT00814021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652395|NCT00645853|Warfarin|warfarin|mesh-list
101652396|NCT00645853|Anticoagulants|anticoagulants|mesh-ancestor
101652397|NCT00652093|Acetaminophen|acetaminophen|mesh-list
101652398|NCT00652093|Oxymorphone|oxymorphone|mesh-list
101652399|NCT00652093|Acetaminophen, dextropropoxyphene, drug combination|acetaminophen, dextropropoxyphene, drug combination|mesh-list
101652400|NCT00652093|Dextropropoxyphene|dextropropoxyphene|mesh-list
101652401|NCT00652093|Levopropoxyphene|levopropoxyphene|mesh-list
101309534|NCT02648997|Nivolumab|nivolumab|mesh-list
101652402|NCT00652093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101652403|NCT00652093|Analgesics|analgesics|mesh-ancestor
101652404|NCT00652093|Sensory System Agents|sensory system agents|mesh-ancestor
101652405|NCT00652093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101652406|NCT00652093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652407|NCT00652093|Antipyretics|antipyretics|mesh-ancestor
101652408|NCT00652093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101652409|NCT00652093|Narcotics|narcotics|mesh-ancestor
101652410|NCT00652093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101652411|NCT00652093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101652412|NCT00652093|Antitussive Agents|antitussive agents|mesh-ancestor
101652413|NCT00652093|Respiratory System Agents|respiratory system agents|mesh-ancestor
101652414|NCT00651937|Melphalan|melphalan|mesh-list
101652415|NCT00651937|Lenograstim|lenograstim|mesh-list
101652416|NCT00651937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101652417|NCT00651937|Alkylating Agents|alkylating agents|mesh-ancestor
101652418|NCT00651937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652419|NCT00651937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101652420|NCT00651937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101652421|NCT00651937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101652422|NCT00651937|Immunologic Factors|immunologic factors|mesh-ancestor
101652423|NCT00651937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652424|NCT00651937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101652426|NCT00654355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101652427|NCT00654355|Immunologic Factors|immunologic factors|mesh-ancestor
101652428|NCT00654355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652429|NCT00654355|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101652430|NCT00654355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101652431|NCT00654355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652432|NCT00651313|Lidocaine|lidocaine|mesh-list
101652433|NCT00651313|Anesthetics, Local|anesthetics, local|mesh-ancestor
101652434|NCT00651313|Anesthetics|anesthetics|mesh-ancestor
101652435|NCT00651313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101652436|NCT00651313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652437|NCT00651313|Sensory System Agents|sensory system agents|mesh-ancestor
101652438|NCT00651313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101652439|NCT00651313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101652440|NCT00651313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101652441|NCT00651313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101652442|NCT00651313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101652443|NCT00651313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652445|NCT00808171|Nitrous Oxide|nitrous oxide|mesh-list
101652446|NCT00808171|Anesthetics, Local|anesthetics, local|mesh-list
101652447|NCT00808171|Prilocaine|prilocaine|mesh-list
101652448|NCT00808171|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
101652449|NCT00808171|Anesthetics|anesthetics|mesh-list
101652450|NCT00808171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101652451|NCT00808171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652452|NCT00808171|Sensory System Agents|sensory system agents|mesh-ancestor
101652453|NCT00808171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101451715|NCT00208065|Almotriptan|almotriptan|mesh-list
101652454|NCT00808171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101652455|NCT00808171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101652456|NCT00808171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101652457|NCT00808171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101652458|NCT00808171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652459|NCT00808171|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101652460|NCT00808171|Anesthetics, General|anesthetics, general|mesh-ancestor
101652461|NCT00808171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101652462|NCT00808171|Analgesics|analgesics|mesh-ancestor
101652463|NCT00808171|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
101652464|NCT04703257|Dipyrone|dipyrone|mesh-list
101652465|NCT04703257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101652466|NCT04703257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101652467|NCT04703257|Analgesics|analgesics|mesh-ancestor
101652468|NCT04703257|Sensory System Agents|sensory system agents|mesh-ancestor
101652469|NCT04703257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101652470|NCT04703257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652471|NCT04703257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101652472|NCT04703257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101652473|NCT04703257|Antipyretics|antipyretics|mesh-ancestor
101652474|NCT00808327|Fentanyl|fentanyl|mesh-list
101652475|NCT00808327|Bupivacaine|bupivacaine|mesh-list
101309597|NCT00006045|Cytarabine|cytarabine|mesh-list
101652476|NCT00808327|Anesthetics, Local|anesthetics, local|mesh-ancestor
101652477|NCT00808327|Anesthetics|anesthetics|mesh-ancestor
101652478|NCT00808327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101652479|NCT00808327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652480|NCT00808327|Sensory System Agents|sensory system agents|mesh-ancestor
101652481|NCT00808327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101652482|NCT00808327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101652483|NCT00808327|Narcotics|narcotics|mesh-ancestor
101652484|NCT00808327|Analgesics|analgesics|mesh-ancestor
101652485|NCT00808327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101652486|NCT00808327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101652487|NCT00808327|Anesthetics, General|anesthetics, general|mesh-ancestor
101652488|NCT00814645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101652489|NCT00814723|Ezetimibe|ezetimibe|mesh-list
101652490|NCT00814723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101652491|NCT00814723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101652492|NCT00814723|Antimetabolites|antimetabolites|mesh-ancestor
101652493|NCT00814723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652494|NCT00814723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101652495|NCT00845871|Deferasirox|deferasirox|mesh-list
101652496|NCT00845871|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101652497|NCT00845871|Chelating Agents|chelating agents|mesh-ancestor
101652498|NCT00845871|Sequestering Agents|sequestering agents|mesh-ancestor
101652499|NCT00845871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652500|NCT02864849|Capecitabine|capecitabine|mesh-list
101652501|NCT02864849|Oxaliplatin|oxaliplatin|mesh-list
101652502|NCT02864849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101652503|NCT02864849|Antimetabolites|antimetabolites|mesh-ancestor
101652504|NCT02864849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652505|NCT02864849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101652506|NCT00701961|Artesunate|artesunate|mesh-list
101652507|NCT00701961|Mefloquine|mefloquine|mesh-list
101652508|NCT00701961|Antimalarials|antimalarials|mesh-ancestor
101652509|NCT00701961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101652510|NCT00701961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101652511|NCT00701961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101652512|NCT00701961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101652513|NCT00701961|Antiviral Agents|antiviral agents|mesh-ancestor
101652514|NCT00701961|Schistosomicides|schistosomicides|mesh-ancestor
101652515|NCT00701961|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101652516|NCT00701961|Anthelmintics|anthelmintics|mesh-ancestor
101652517|NCT04286711|Paclitaxel|paclitaxel|mesh-list
101652518|NCT04286711|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101652520|NCT04286711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101652521|NCT04286711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101652522|NCT04286711|Tubulin Modulators|tubulin modulators|mesh-ancestor
101652523|NCT04286711|Antimitotic Agents|antimitotic agents|mesh-ancestor
101652524|NCT04286711|Mitosis Modulators|mitosis modulators|mesh-ancestor
101652525|NCT04286711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652526|NCT04286711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101652527|NCT04286711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101652528|NCT02863913|Cyclophosphamide|cyclophosphamide|mesh-list
101652529|NCT02863913|Interleukin-2|interleukin-2|mesh-list
101652530|NCT02863913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101652531|NCT02863913|Immunologic Factors|immunologic factors|mesh-ancestor
101652532|NCT02863913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652533|NCT02863913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101652534|NCT02863913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101652535|NCT02863913|Alkylating Agents|alkylating agents|mesh-ancestor
101652536|NCT02863913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652537|NCT02863913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101652538|NCT02863913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101652539|NCT02863913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101652540|NCT02863913|Analgesics|analgesics|mesh-ancestor
101652541|NCT02863913|Sensory System Agents|sensory system agents|mesh-ancestor
101652542|NCT02863913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101652543|NCT02612649|Ramosetron|ramosetron|mesh-list
101652544|NCT02612649|Antiemetics|antiemetics|mesh-ancestor
101652545|NCT02612649|Autonomic Agents|autonomic agents|mesh-ancestor
101652546|NCT02612649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101652547|NCT02612649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652548|NCT02612649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101652549|NCT02612649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101652550|NCT02612649|Serotonin Agents|serotonin agents|mesh-ancestor
101652551|NCT02612649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101652552|NCT02612649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652553|NCT04908800|Itraconazole|itraconazole|mesh-list
101652554|NCT04908800|Antifungal Agents|antifungal agents|mesh-ancestor
101652555|NCT04908800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101652556|NCT04908800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101652557|NCT04908800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101652558|NCT04908800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101652559|NCT04908800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652560|NCT04908800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101652561|NCT04908800|Hormone Antagonists|hormone antagonists|mesh-ancestor
101652562|NCT04908800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101652563|NCT04908800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652564|NCT04908800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101652566|NCT00844857|Fluoxetine|fluoxetine|mesh-list
101652567|NCT00844857|Antiemetics|antiemetics|mesh-ancestor
101652568|NCT00844857|Autonomic Agents|autonomic agents|mesh-ancestor
101652569|NCT00844857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101652570|NCT00844857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652571|NCT00844857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101652572|NCT00844857|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101652573|NCT00844857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101652574|NCT00844857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101652575|NCT00844857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101652576|NCT00844857|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101652577|NCT00844857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101652578|NCT00844857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101652579|NCT00844857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652580|NCT00844857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101652581|NCT00844857|Serotonin Agents|serotonin agents|mesh-ancestor
101652582|NCT00844857|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101652583|NCT00844857|Antidepressive Agents|antidepressive agents|mesh-ancestor
101652584|NCT00844857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101652585|NCT00844857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101652586|NCT00844857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101652587|NCT00702117|Flecainide|flecainide|mesh-list
101652588|NCT00702117|Procainamide|procainamide|mesh-list
101652589|NCT00702117|Ajmaline|ajmaline|mesh-list
101652590|NCT00702117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101652591|NCT00702117|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101652592|NCT00702117|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101652593|NCT00702117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101652594|NCT00702117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652595|NCT00913107|Lamotrigine|lamotrigine|mesh-list
101652596|NCT00913107|Carbamazepine|carbamazepine|mesh-list
101652597|NCT00913107|Anticonvulsants|anticonvulsants|mesh-list
101652598|NCT00913107|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101652599|NCT00913107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101652600|NCT00913107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652601|NCT00913107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101652602|NCT00913107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652603|NCT00913107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101652604|NCT00913107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101652605|NCT00913107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101652606|NCT00913107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101652607|NCT00913107|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101652608|NCT00913107|Antimanic Agents|antimanic agents|mesh-ancestor
101652609|NCT00913107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101652610|NCT00913107|Analgesics|analgesics|mesh-ancestor
101652611|NCT00913107|Sensory System Agents|sensory system agents|mesh-ancestor
101652612|NCT00913107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101652613|NCT00913107|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101652614|NCT00913107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101652615|NCT00569803|Abatacept|abatacept|mesh-list
101652616|NCT00569803|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101652617|NCT00569803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652618|NCT00569803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101652619|NCT00569803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101652620|NCT00569803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101652621|NCT00569803|Immunologic Factors|immunologic factors|mesh-ancestor
101652622|NCT00569803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652623|NCT00569803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101309747|NCT00006111|Fluorouracil|fluorouracil|mesh-list
101652624|NCT00920426|Cabotegravir|cabotegravir|mesh-list
101652625|NCT00920426|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101652626|NCT00920426|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101652627|NCT00920426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101652628|NCT00920426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652629|NCT00920426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101652630|NCT00920426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101652631|NCT00920426|Antiviral Agents|antiviral agents|mesh-ancestor
101652632|NCT00920426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101652633|NCT04046185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101652634|NCT04046185|Progesterone|progesterone|mesh-list
101652635|NCT04046185|Progestins|progestins|mesh-ancestor
101652636|NCT04046185|Hormones|hormones|mesh-ancestor
101652637|NCT04046185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101652638|NCT04046185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652639|NCT04046185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652640|NCT04046185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101652641|NCT04046185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101652642|NCT00810589|Insulin|insulin|mesh-list
101652643|NCT00810589|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101652644|NCT00810589|Insulin Lispro|insulin lispro|mesh-list
101652645|NCT00810589|Insulin Detemir|insulin detemir|mesh-list
101652646|NCT00810589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101652647|NCT00810589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652648|NCT00810667|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
101652649|NCT00810667|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101652650|NCT00810667|Serotonin Agents|serotonin agents|mesh-ancestor
101652651|NCT00810667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101652652|NCT00810667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652653|NCT00810667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652654|NCT04253132|Tolfenamic acid|tolfenamic acid|mesh-list
101652655|NCT04253132|Analgesics|analgesics|mesh-ancestor
101652656|NCT04253132|Sensory System Agents|sensory system agents|mesh-ancestor
101409150|NCT00465673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101652657|NCT04253132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101652658|NCT04253132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652659|NCT04253132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101652660|NCT04253132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101652661|NCT04253132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101652663|NCT04253132|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101652664|NCT04253132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101652665|NCT04253132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652666|NCT04253132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101652667|NCT04253132|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
101652668|NCT04253132|Hormone Antagonists|hormone antagonists|mesh-ancestor
101652669|NCT04253132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101652670|NCT04253132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101652671|NCT04253132|Serotonin Agents|serotonin agents|mesh-ancestor
101652672|NCT04253132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101652673|NCT00914966|Complement C1s|complement c1s|mesh-list
101652674|NCT00914966|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
101652675|NCT00914966|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
101652676|NCT00914966|Immunologic Factors|immunologic factors|mesh-ancestor
101652677|NCT00914966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652678|NCT00914966|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101652679|NCT00914966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101652680|NCT00815269|Sevoflurane|sevoflurane|mesh-list
101652681|NCT00815269|Desflurane|desflurane|mesh-list
101652682|NCT00815269|Isoflurane|isoflurane|mesh-list
101652683|NCT00815269|Halothane|halothane|mesh-list
101652684|NCT00815269|Enflurane|enflurane|mesh-list
101652685|NCT00815269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101652686|NCT00815269|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101652687|NCT00815269|Anesthetics, General|anesthetics, general|mesh-ancestor
101652688|NCT00815269|Anesthetics|anesthetics|mesh-ancestor
101652689|NCT00815269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101824162|NCT00356278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101652690|NCT00815269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652691|NCT00914810|Vitamin D|vitamin d|mesh-list
101652692|NCT00914810|Cholecalciferol|cholecalciferol|mesh-list
101652693|NCT00914810|Vitamins|vitamins|mesh-ancestor
101652694|NCT00914810|Micronutrients|micronutrients|mesh-ancestor
101652695|NCT00914810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652696|NCT00914810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101309814|NCT00006126|Antimetabolites|antimetabolites|mesh-ancestor
101652697|NCT00914810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101652698|NCT00808717|Atorvastatin|atorvastatin|mesh-list
101652699|NCT00808717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101652700|NCT00808717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101652701|NCT00808717|Antimetabolites|antimetabolites|mesh-ancestor
101652702|NCT00808717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652703|NCT00808717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101652704|NCT00808717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101652705|NCT00808717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101652706|NCT00914732|Vaccines|vaccines|mesh-list
101652707|NCT00914732|Immunologic Factors|immunologic factors|mesh-ancestor
101652708|NCT00914732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652709|NCT00844545|Eculizumab|eculizumab|mesh-list
101652710|NCT00844545|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101652711|NCT00844545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101652712|NCT00844545|Immunologic Factors|immunologic factors|mesh-ancestor
101652713|NCT00844545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652714|NCT00815503|Ropivacaine|ropivacaine|mesh-list
101652715|NCT00815503|Anesthetics, Local|anesthetics, local|mesh-ancestor
101652716|NCT00815503|Anesthetics|anesthetics|mesh-ancestor
101652717|NCT00815503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101652718|NCT00815503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652719|NCT00815503|Sensory System Agents|sensory system agents|mesh-ancestor
101652720|NCT00815503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101652721|NCT00702819|Bevacizumab|bevacizumab|mesh-list
101652722|NCT00702819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101652723|NCT00702819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101652724|NCT00702819|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101652725|NCT00702819|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101652726|NCT00702819|Growth Substances|growth substances|mesh-ancestor
101652727|NCT00702819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652728|NCT00702819|Growth Inhibitors|growth inhibitors|mesh-ancestor
101652729|NCT00650845|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
101652730|NCT00650845|Chelating Agents|chelating agents|mesh-ancestor
101652731|NCT00650845|Sequestering Agents|sequestering agents|mesh-ancestor
101652732|NCT00650845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652733|NCT00842985|Dronabinol|dronabinol|mesh-list
101652734|NCT00842985|Modafinil|modafinil|mesh-list
101652735|NCT00842985|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101652736|NCT00842985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652737|NCT00842985|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101652738|NCT00842985|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101652739|NCT00842985|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101652740|NCT00842985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652741|NCT00842985|Hallucinogens|hallucinogens|mesh-ancestor
101652742|NCT00842985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101652743|NCT00842985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101652744|NCT00842985|Analgesics|analgesics|mesh-ancestor
101652745|NCT00842985|Sensory System Agents|sensory system agents|mesh-ancestor
101652746|NCT00842985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101652747|NCT00842985|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101652748|NCT00842985|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101652749|NCT00842985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101652750|NCT00842985|Hormones|hormones|mesh-ancestor
101652751|NCT00842985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101652752|NCT00808795|Acetylcysteine|acetylcysteine|mesh-list
101652753|NCT00808795|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101652754|NCT00808795|Antiviral Agents|antiviral agents|mesh-ancestor
101652755|NCT00808795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101652756|NCT00808795|Expectorants|expectorants|mesh-ancestor
101652757|NCT00808795|Respiratory System Agents|respiratory system agents|mesh-ancestor
101652758|NCT00808795|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101652760|NCT00808795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652761|NCT00808795|Protective Agents|protective agents|mesh-ancestor
101652762|NCT00808795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652763|NCT00808795|Antidotes|antidotes|mesh-ancestor
101652764|NCT00808951|Artesunate|artesunate|mesh-list
101652765|NCT00808951|Lumefantrine|lumefantrine|mesh-list
101652766|NCT00808951|Artemether|artemether|mesh-list
101652767|NCT00808951|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101652768|NCT00808951|Amodiaquine|amodiaquine|mesh-list
101652769|NCT00808951|Antimalarials|antimalarials|mesh-ancestor
101652770|NCT00808951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101652771|NCT00808951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101652772|NCT00808951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101652773|NCT00808951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101652774|NCT00808951|Antiviral Agents|antiviral agents|mesh-ancestor
101652775|NCT00808951|Schistosomicides|schistosomicides|mesh-ancestor
101652776|NCT00808951|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101652777|NCT00808951|Anthelmintics|anthelmintics|mesh-ancestor
101652778|NCT00809029|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
101652779|NCT00809029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101652780|NCT00809029|Incretins|incretins|mesh-ancestor
101652781|NCT00809029|Hormones|hormones|mesh-ancestor
101652782|NCT00809029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101652783|NCT00809029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652784|NCT00842829|Fentanyl|fentanyl|mesh-list
101652785|NCT00842829|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101652786|NCT00842829|Narcotics|narcotics|mesh-ancestor
101652787|NCT00842829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101652788|NCT00842829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652789|NCT00842829|Analgesics|analgesics|mesh-ancestor
101652790|NCT00842829|Sensory System Agents|sensory system agents|mesh-ancestor
101652791|NCT00842829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101652792|NCT00842829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101652793|NCT00842829|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101652794|NCT00842829|Anesthetics, General|anesthetics, general|mesh-ancestor
101652795|NCT00842829|Anesthetics|anesthetics|mesh-ancestor
101652796|NCT04045093|Warfarin|warfarin|mesh-list
101652797|NCT04045093|Dabigatran|dabigatran|mesh-list
101652798|NCT04045093|Anticoagulants|anticoagulants|mesh-ancestor
101652799|NCT04045093|Antithrombins|antithrombins|mesh-ancestor
101652800|NCT04045093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101652801|NCT04045093|Protease Inhibitors|protease inhibitors|mesh-ancestor
101652802|NCT04045093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101652803|NCT04045093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652805|NCT00811291|Folic Acid|folic acid|mesh-list
101652806|NCT00811291|Calcium|calcium|mesh-list
101652807|NCT00811291|Vitamins|vitamins|mesh-ancestor
101652808|NCT00811291|Micronutrients|micronutrients|mesh-ancestor
101652809|NCT00811291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652810|NCT00811291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101652811|NCT00811291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101652812|NCT00811291|Hematinics|hematinics|mesh-ancestor
101652813|NCT00811291|Vitamin B Complex|vitamin b complex|mesh-ancestor
101652814|NCT00811369|Fulvestrant|fulvestrant|mesh-list
101652815|NCT00811369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101652816|NCT00811369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101652817|NCT00811369|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101652818|NCT00811369|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101652819|NCT00811369|Hormone Antagonists|hormone antagonists|mesh-ancestor
101652820|NCT00811369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101652821|NCT00811369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652822|NCT00842361|Insulin|insulin|mesh-list
101652823|NCT00842361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101652824|NCT00842361|Insulin Aspart|insulin aspart|mesh-list
101652825|NCT00842361|Insulin, Long-Acting|insulin, long-acting|mesh-list
101652826|NCT00842361|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101652827|NCT00842361|Biphasic Insulins|biphasic insulins|mesh-list
101652828|NCT00842361|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101652829|NCT00842361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101652830|NCT00842361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652831|NCT00811447|Docetaxel|docetaxel|mesh-list
101652832|NCT00811447|Fluorouracil|fluorouracil|mesh-list
101652833|NCT00811447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101652834|NCT00811447|Tubulin Modulators|tubulin modulators|mesh-ancestor
101652835|NCT00811447|Antimitotic Agents|antimitotic agents|mesh-ancestor
101652836|NCT00811447|Mitosis Modulators|mitosis modulators|mesh-ancestor
101652837|NCT00811447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652838|NCT00811447|Antimetabolites|antimetabolites|mesh-ancestor
101652839|NCT00811447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101652840|NCT00811447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101652841|NCT00811447|Immunologic Factors|immunologic factors|mesh-ancestor
101652842|NCT00811447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652843|NCT00702975|Paclitaxel|paclitaxel|mesh-list
101652844|NCT00702975|Bevacizumab|bevacizumab|mesh-list
101652845|NCT00702975|Carboplatin|carboplatin|mesh-list
101652846|NCT00702975|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101652847|NCT00702975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101652848|NCT00702975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101652849|NCT00702975|Tubulin Modulators|tubulin modulators|mesh-ancestor
101652850|NCT00702975|Antimitotic Agents|antimitotic agents|mesh-ancestor
101652851|NCT00702975|Mitosis Modulators|mitosis modulators|mesh-ancestor
101652852|NCT00702975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652853|NCT00702975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101652854|NCT00702975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101652855|NCT00702975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101652856|NCT00702975|Growth Substances|growth substances|mesh-ancestor
101652857|NCT00702975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652858|NCT00702975|Growth Inhibitors|growth inhibitors|mesh-ancestor
101652859|NCT00702975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101652860|NCT00702975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101652861|NCT00809107|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101652862|NCT00809107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101652863|NCT00809107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652864|NCT02612181|Dexmedetomidine|dexmedetomidine|mesh-list
101652865|NCT02612181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101652866|NCT02612181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101652867|NCT02612181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652868|NCT02612181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101652869|NCT02612181|Analgesics|analgesics|mesh-ancestor
101652870|NCT02612181|Sensory System Agents|sensory system agents|mesh-ancestor
101652871|NCT02612181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101652872|NCT02612181|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101652873|NCT02612181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101652874|NCT02612181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101652875|NCT02612181|Adrenergic Agents|adrenergic agents|mesh-ancestor
101652876|NCT02612181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101652877|NCT02612181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652879|NCT02612259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101652880|NCT02612259|Antidepressive Agents|antidepressive agents|mesh-ancestor
101652881|NCT02612259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101652882|NCT00841035|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101652883|NCT00841035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101652884|NCT00841035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101652885|NCT00841035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101652886|NCT00841035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652888|NCT00642811|Clopidogrel|clopidogrel|mesh-list
101652889|NCT00642811|Ticagrelor|ticagrelor|mesh-list
101652890|NCT00642811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101652891|NCT00642811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101652892|NCT00642811|Analgesics|analgesics|mesh-ancestor
101652893|NCT00642811|Sensory System Agents|sensory system agents|mesh-ancestor
101652894|NCT00642811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101824175|NCT00356278|GABA Agents|gaba agents|mesh-ancestor
101652895|NCT00642811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652896|NCT00642811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101652897|NCT00642811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101652898|NCT00642811|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101652899|NCT00642811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101652900|NCT00642811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652901|NCT00642811|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101652902|NCT00642811|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101652903|NCT00642811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101652904|NCT00642811|Antipyretics|antipyretics|mesh-ancestor
101652905|NCT00642811|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101652906|NCT00642811|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101652907|NCT00642811|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101652908|NCT00642811|Purinergic Agents|purinergic agents|mesh-ancestor
101652909|NCT00642811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101652910|NCT00838929|Vorinostat|vorinostat|mesh-list
101652911|NCT00838929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101652912|NCT00838929|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101652913|NCT00838929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101652914|NCT00838929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652915|NCT00811603|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101652916|NCT00811603|Cefazolin|cefazolin|mesh-list
101652917|NCT00811603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101652918|NCT00811681|Pioglitazone|pioglitazone|mesh-list
101652919|NCT00811681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101652920|NCT00811681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652921|NCT00811759|Temozolomide|temozolomide|mesh-list
101652922|NCT00811759|Sorafenib|sorafenib|mesh-list
101652923|NCT00811759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101652924|NCT00811759|Alkylating Agents|alkylating agents|mesh-ancestor
101652925|NCT00811759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652926|NCT00811759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101652927|NCT00811759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101652928|NCT00811759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101652929|NCT00815893|Dexmedetomidine|dexmedetomidine|mesh-list
101652930|NCT00815893|Propofol|propofol|mesh-list
101652931|NCT00815893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101652932|NCT00815893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101652933|NCT00815893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652934|NCT00815893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101652935|NCT00815893|Analgesics|analgesics|mesh-ancestor
101652936|NCT00815893|Sensory System Agents|sensory system agents|mesh-ancestor
101652937|NCT00815893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101652938|NCT00815893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101652939|NCT00815893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101652940|NCT00815893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101652941|NCT00815893|Adrenergic Agents|adrenergic agents|mesh-ancestor
101652942|NCT00815893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101652943|NCT00815893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652944|NCT00815893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101652945|NCT00815893|Anesthetics, General|anesthetics, general|mesh-ancestor
101652947|NCT00816049|Mercaptopurine|mercaptopurine|mesh-list
101652948|NCT00816049|Antimetabolites|antimetabolites|mesh-ancestor
101652949|NCT00816049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652950|NCT00816049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101652951|NCT00816049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101652952|NCT00816049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101652953|NCT00816049|Immunologic Factors|immunologic factors|mesh-ancestor
101652954|NCT00816049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652955|NCT00816049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101652956|NCT00816049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101652957|NCT04648891|Lidocaine|lidocaine|mesh-list
101652958|NCT04648891|Anesthetics, Local|anesthetics, local|mesh-ancestor
101652959|NCT04648891|Anesthetics|anesthetics|mesh-ancestor
101824183|NCT00837941|Pregabalin|pregabalin|mesh-list
101652960|NCT04648891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101652961|NCT04648891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652962|NCT04648891|Sensory System Agents|sensory system agents|mesh-ancestor
101652963|NCT04648891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101652964|NCT04648891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101652965|NCT04648891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101652966|NCT04648891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101652967|NCT04648891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101652968|NCT04648891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652970|NCT04045015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101652971|NCT00811837|Midazolam|midazolam|mesh-list
101652972|NCT00811837|Remifentanil|remifentanil|mesh-list
101652973|NCT00811837|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101652974|NCT00811837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101652975|NCT00811837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101652976|NCT00811837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101652977|NCT00811837|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101652978|NCT00811837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101652979|NCT00811837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101652980|NCT00811837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101652981|NCT00811837|Anesthetics, General|anesthetics, general|mesh-ancestor
101652982|NCT00811837|Anesthetics|anesthetics|mesh-ancestor
101652983|NCT00811837|GABA Modulators|gaba modulators|mesh-ancestor
101652984|NCT00811837|GABA Agents|gaba agents|mesh-ancestor
101652985|NCT00811837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101652986|NCT00811837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101652987|NCT00811837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101652988|NCT00811837|Narcotics|narcotics|mesh-ancestor
101652989|NCT00811837|Analgesics|analgesics|mesh-ancestor
101652990|NCT00811837|Sensory System Agents|sensory system agents|mesh-ancestor
101652991|NCT00811837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101652992|NCT00811915|Sirolimus|sirolimus|mesh-list
101652993|NCT00811915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101652994|NCT00811915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101652995|NCT00811915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101652996|NCT00811915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101652997|NCT00811915|Antifungal Agents|antifungal agents|mesh-ancestor
101652998|NCT00811915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101652999|NCT00811915|Immunologic Factors|immunologic factors|mesh-ancestor
101653000|NCT00811915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653001|NCT00816127|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101653002|NCT00816127|Hemostatics|hemostatics|mesh-ancestor
101653003|NCT00816127|Coagulants|coagulants|mesh-ancestor
101653004|NCT00816127|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101653005|NCT00816127|Natriuretic Agents|natriuretic agents|mesh-ancestor
101653006|NCT00816127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653007|NCT00916058|Melphalan|melphalan|mesh-list
101653008|NCT00916058|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101653009|NCT00916058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101653010|NCT00916058|Alkylating Agents|alkylating agents|mesh-ancestor
101653011|NCT00916058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653012|NCT00916058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101653013|NCT00916058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101653014|NCT00916058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101653015|NCT00916058|Immunologic Factors|immunologic factors|mesh-ancestor
101653016|NCT00916058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653017|NCT04559906|Ethyl Chloride|ethyl chloride|mesh-list
101653018|NCT04559906|Anesthetics, Local|anesthetics, local|mesh-ancestor
101653019|NCT04559906|Anesthetics|anesthetics|mesh-ancestor
101653020|NCT04559906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101653021|NCT04559906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653022|NCT04559906|Sensory System Agents|sensory system agents|mesh-ancestor
101653023|NCT04559906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101653024|NCT00912782|Vitamin D|vitamin d|mesh-list
101653025|NCT00912782|Cholecalciferol|cholecalciferol|mesh-list
101653026|NCT00912782|Vitamins|vitamins|mesh-ancestor
101653028|NCT00912782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653029|NCT00912782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101653030|NCT00912782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101653031|NCT04202978|Capecitabine|capecitabine|mesh-list
101653032|NCT04202978|Oxaliplatin|oxaliplatin|mesh-list
101653033|NCT04202978|Apatinib|apatinib|mesh-list
101653034|NCT04202978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101653035|NCT04202978|Antimetabolites|antimetabolites|mesh-ancestor
101653036|NCT04202978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653037|NCT04202978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101653038|NCT04202978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101653039|NCT04202978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101653040|NCT04186442|Botulinum Toxins|botulinum toxins|mesh-list
101653041|NCT04186442|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101653042|NCT04186442|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101653043|NCT04186442|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101653044|NCT04186442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101653045|NCT04186442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653046|NCT04186442|Cholinergic Agents|cholinergic agents|mesh-ancestor
101653047|NCT04186442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101653048|NCT04186442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653049|NCT04186442|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101653050|NCT04186442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101653052|NCT04203368|Verapamil|verapamil|mesh-list
101653053|NCT04203368|Analgesics|analgesics|mesh-ancestor
101653054|NCT04203368|Sensory System Agents|sensory system agents|mesh-ancestor
101653055|NCT04203368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101653056|NCT04203368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653057|NCT04203368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101653058|NCT04203368|Vasodilator Agents|vasodilator agents|mesh-ancestor
101653059|NCT04203368|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101653060|NCT04203368|Purinergic Agonists|purinergic agonists|mesh-ancestor
101653061|NCT04203368|Purinergic Agents|purinergic agents|mesh-ancestor
101653062|NCT04203368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101653063|NCT04203368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653064|NCT04203368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101653065|NCT04203368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101653066|NCT04203368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101653067|NCT04133948|Nivolumab|nivolumab|mesh-list
101653068|NCT04133948|Ipilimumab|ipilimumab|mesh-list
101653069|NCT04133948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101653070|NCT04133948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101653071|NCT04133948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101653072|NCT04133948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653073|NCT00911534|Rabeprazole|rabeprazole|mesh-list
101653074|NCT00911534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101653075|NCT00911534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101653076|NCT00911534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101653077|NCT00911534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101653078|NCT00911534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653079|NCT00911300|Vitamin K|vitamin k|mesh-list
101653080|NCT00911300|Heparin|heparin|mesh-list
101653081|NCT00911300|Calcium heparin|calcium heparin|mesh-list
101653082|NCT00911300|PENTA|penta|mesh-list
101653083|NCT00911300|Fondaparinux|fondaparinux|mesh-list
101653084|NCT00911300|Vitamins|vitamins|mesh-ancestor
101653085|NCT00911300|Micronutrients|micronutrients|mesh-ancestor
101653086|NCT00911300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653087|NCT00911300|Anticoagulants|anticoagulants|mesh-ancestor
101653088|NCT00911300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101653089|NCT00911300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101653090|NCT00911300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653091|NCT00911300|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101653092|NCT00911300|Hemostatics|hemostatics|mesh-ancestor
101653093|NCT00911300|Coagulants|coagulants|mesh-ancestor
101653094|NCT00911300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101653095|NCT00911300|Antithrombins|antithrombins|mesh-ancestor
101653096|NCT00911300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101653097|NCT00911300|Protease Inhibitors|protease inhibitors|mesh-ancestor
101653099|NCT00911144|Vaccines|vaccines|mesh-list
101653100|NCT00911144|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101653101|NCT00911144|Immunologic Factors|immunologic factors|mesh-ancestor
101653102|NCT00911144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653103|NCT04395248|Anesthetics|anesthetics|mesh-list
101653104|NCT04395248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101653105|NCT04395248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653106|NCT00632216|Risedronic Acid|risedronic acid|mesh-list
101653107|NCT00632216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101653108|NCT00632216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101653109|NCT00632216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653110|NCT00632216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101653111|NCT00632216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653112|NCT00632216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101653113|NCT04276298|Metronidazole|metronidazole|mesh-list
101653114|NCT04276298|Lidocaine|lidocaine|mesh-list
101653115|NCT04276298|Diltiazem|diltiazem|mesh-list
101653116|NCT04276298|Anesthetics, Local|anesthetics, local|mesh-ancestor
101653117|NCT04276298|Anesthetics|anesthetics|mesh-ancestor
101653118|NCT04276298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101653119|NCT04276298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653120|NCT04276298|Sensory System Agents|sensory system agents|mesh-ancestor
101653121|NCT04276298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101653122|NCT04276298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101653123|NCT04276298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101653124|NCT04276298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101653125|NCT04276298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101653126|NCT04276298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653127|NCT04276298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101653128|NCT04276298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101653129|NCT04276298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101653130|NCT04276298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101653131|NCT04276298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101653132|NCT04276298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101653133|NCT04276298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101653134|NCT04276298|Vasodilator Agents|vasodilator agents|mesh-ancestor
101653135|NCT04273880|Ascorbic Acid|ascorbic acid|mesh-list
101653136|NCT04273880|Methylphenidate|methylphenidate|mesh-list
101653137|NCT04273880|Vitamins|vitamins|mesh-ancestor
101653138|NCT04273880|Micronutrients|micronutrients|mesh-ancestor
101653139|NCT04273880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653140|NCT04273880|Antioxidants|antioxidants|mesh-ancestor
101653141|NCT04273880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653142|NCT04273880|Protective Agents|protective agents|mesh-ancestor
101653143|NCT04273880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101653144|NCT04273880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101653145|NCT04273880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101653146|NCT04273880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101653147|NCT04273880|Dopamine Agents|dopamine agents|mesh-ancestor
101653148|NCT04273880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101653150|NCT00910988|Ziprasidone|ziprasidone|mesh-list
101653151|NCT00910988|Antiemetics|antiemetics|mesh-ancestor
101653152|NCT00910988|Autonomic Agents|autonomic agents|mesh-ancestor
101653153|NCT00910988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101653154|NCT00910988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653155|NCT00910988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101653156|NCT00910988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101653157|NCT00910988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101653158|NCT00910988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101653159|NCT00910988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101653160|NCT00910988|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101653161|NCT00910988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101653162|NCT00910988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101824206|NCT00837941|Anesthetics|anesthetics|mesh-ancestor
101653163|NCT00910988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653164|NCT00910988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101653165|NCT00910988|Serotonin Agents|serotonin agents|mesh-ancestor
101653166|NCT00910988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101653167|NCT00910988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101653168|NCT00910988|Dopamine Agents|dopamine agents|mesh-ancestor
101653169|NCT00644059|Vaccines|vaccines|mesh-list
101653170|NCT00644059|Immunologic Factors|immunologic factors|mesh-ancestor
101653171|NCT00644059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653172|NCT00817687|Mycophenolic Acid|mycophenolic acid|mesh-list
101653173|NCT00817687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101653174|NCT00817687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101653175|NCT00817687|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101653176|NCT00817687|Antitubercular Agents|antitubercular agents|mesh-ancestor
101653177|NCT00817687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101653178|NCT00817687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101653179|NCT00817687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101653180|NCT00817687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653181|NCT00811993|Etoposide|etoposide|mesh-list
101653182|NCT00811993|Docetaxel|docetaxel|mesh-list
101653183|NCT00811993|Bevacizumab|bevacizumab|mesh-list
101653184|NCT00811993|Carboplatin|carboplatin|mesh-list
101653185|NCT00811993|Gemcitabine|gemcitabine|mesh-list
101653186|NCT00811993|Capecitabine|capecitabine|mesh-list
101653187|NCT00811993|Trastuzumab|trastuzumab|mesh-list
101653188|NCT00811993|Irinotecan|irinotecan|mesh-list
101653189|NCT00811993|Cetuximab|cetuximab|mesh-list
101653190|NCT00811993|Temozolomide|temozolomide|mesh-list
101653191|NCT00811993|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101653192|NCT00811993|Sorafenib|sorafenib|mesh-list
101653193|NCT00811993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101653194|NCT00811993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101653195|NCT00811993|Tubulin Modulators|tubulin modulators|mesh-ancestor
101653196|NCT00811993|Antimitotic Agents|antimitotic agents|mesh-ancestor
101653197|NCT00811993|Mitosis Modulators|mitosis modulators|mesh-ancestor
101653198|NCT00811993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653199|NCT00811993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101653200|NCT00811993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101653201|NCT00811993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101653202|NCT00811993|Growth Substances|growth substances|mesh-ancestor
101653203|NCT00811993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653204|NCT00811993|Growth Inhibitors|growth inhibitors|mesh-ancestor
101653205|NCT00811993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101653206|NCT00811993|Antimetabolites|antimetabolites|mesh-ancestor
101653207|NCT00811993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101653208|NCT00811993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101653209|NCT00811993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101653210|NCT00811993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101653211|NCT00811993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101653212|NCT00811993|Alkylating Agents|alkylating agents|mesh-ancestor
101653213|NCT00811993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101653214|NCT00817765|Ritonavir|ritonavir|mesh-list
101653215|NCT00817765|Fosamprenavir|fosamprenavir|mesh-list
101653216|NCT00817765|Posaconazole|posaconazole|mesh-list
101653217|NCT00817765|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101653218|NCT00817765|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101653219|NCT00817765|Protease Inhibitors|protease inhibitors|mesh-ancestor
101653220|NCT00817765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101653221|NCT00817765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653222|NCT00817765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101653223|NCT00817765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101653224|NCT00817765|Antiviral Agents|antiviral agents|mesh-ancestor
101653225|NCT00817765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101653226|NCT00817765|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101653227|NCT00817765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101653228|NCT00817765|Antifungal Agents|antifungal agents|mesh-ancestor
101653229|NCT00817765|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101653230|NCT00817765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101653231|NCT00817765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101653232|NCT00817765|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101653233|NCT00817765|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101653234|NCT00817765|Hormone Antagonists|hormone antagonists|mesh-ancestor
101653235|NCT00817765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101653236|NCT00817765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653238|NCT00816205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101653239|NCT00816205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101653240|NCT00816205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653241|NCT00816205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101653242|NCT00816205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653243|NCT00816205|Vasodilator Agents|vasodilator agents|mesh-ancestor
101653244|NCT00816205|Tocolytic Agents|tocolytic agents|mesh-ancestor
101653245|NCT00816205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101653246|NCT00816283|Dasatinib|dasatinib|mesh-list
101653247|NCT00816283|Vorinostat|vorinostat|mesh-list
101653248|NCT00816283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101653249|NCT00816283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101653250|NCT00816283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101653251|NCT00816283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653252|NCT00816283|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101653253|NCT00910910|Lenalidomide|lenalidomide|mesh-list
101653254|NCT00910910|Chlorambucil|chlorambucil|mesh-list
101653255|NCT00910910|Immunologic Factors|immunologic factors|mesh-ancestor
101653256|NCT00910910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653257|NCT00910910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101653258|NCT00910910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101653259|NCT00910910|Growth Substances|growth substances|mesh-ancestor
101653261|NCT00910910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101653262|NCT00910910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101653263|NCT00910910|Alkylating Agents|alkylating agents|mesh-ancestor
101653264|NCT00910910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653265|NCT04522544|Durvalumab|durvalumab|mesh-list
101653266|NCT04522544|Tremelimumab|tremelimumab|mesh-list
101653267|NCT04522544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101653268|NCT04522544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101653269|NCT04384562|Methylphenidate|methylphenidate|mesh-list
101653270|NCT04384562|Reboxetine|reboxetine|mesh-list
101653271|NCT04384562|Nicotine|nicotine|mesh-list
101653272|NCT04384562|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101653273|NCT04384562|Autonomic Agents|autonomic agents|mesh-ancestor
101653274|NCT04384562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101653275|NCT04384562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653276|NCT04384562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101653277|NCT04384562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101653278|NCT04384562|Cholinergic Agents|cholinergic agents|mesh-ancestor
101653279|NCT04384562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101653280|NCT04384562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653281|NCT04384562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101653282|NCT04384562|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101653283|NCT04384562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101653284|NCT04384562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101653285|NCT04384562|Dopamine Agents|dopamine agents|mesh-ancestor
101653286|NCT04384562|Antidepressive Agents|antidepressive agents|mesh-ancestor
101653287|NCT04384562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101653288|NCT04384562|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101653289|NCT04384562|Adrenergic Agents|adrenergic agents|mesh-ancestor
101653290|NCT04515134|Ubiquinone|ubiquinone|mesh-list
101653291|NCT04515134|Coenzyme Q10|coenzyme q10|mesh-list
101653292|NCT04515134|Micronutrients|micronutrients|mesh-ancestor
101653293|NCT04515134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653294|NCT04515134|Vitamins|vitamins|mesh-ancestor
101653295|NCT04238390|Meropenem|meropenem|mesh-list
101653296|NCT04238390|Tazobactam|tazobactam|mesh-list
101653297|NCT04238390|Ceftolozane|ceftolozane|mesh-list
101653298|NCT04238390|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
101653299|NCT04238390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101653300|NCT04238390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101653301|NCT04238390|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101653302|NCT04238390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101653303|NCT04238390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653304|NCT04238390|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101653305|NCT04236830|Fluorides|fluorides|mesh-list
101653306|NCT04236830|Cariostatic Agents|cariostatic agents|mesh-ancestor
101653307|NCT04236830|Protective Agents|protective agents|mesh-ancestor
101653308|NCT04236830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653309|NCT04203212|Goserelin|goserelin|mesh-list
101653310|NCT04203212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101653311|NCT04203212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101653312|NCT00637910|Docetaxel|docetaxel|mesh-list
101653313|NCT00637910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101653314|NCT00637910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101653315|NCT00637910|Tubulin Modulators|tubulin modulators|mesh-ancestor
101653316|NCT00637910|Antimitotic Agents|antimitotic agents|mesh-ancestor
101653317|NCT00637910|Mitosis Modulators|mitosis modulators|mesh-ancestor
101653318|NCT00637910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653319|NCT00637910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101653320|NCT00637910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101653321|NCT03408236|Botulinum Toxins|botulinum toxins|mesh-list
101653322|NCT03408236|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101653323|NCT03408236|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101653324|NCT03408236|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101653325|NCT03408236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101653326|NCT03408236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653327|NCT03408236|Cholinergic Agents|cholinergic agents|mesh-ancestor
101653328|NCT03408236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101653329|NCT03408236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653330|NCT03408236|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101653331|NCT03408236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101653333|NCT04449536|Protective Agents|protective agents|mesh-ancestor
101653334|NCT04449536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653335|NCT03960554|Denosumab|denosumab|mesh-list
101653336|NCT03960554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101653337|NCT03960554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653338|NCT04084106|Amoxicillin|amoxicillin|mesh-list
101653339|NCT04084106|Clavulanic Acids|clavulanic acids|mesh-list
101653340|NCT04084106|Clavulanic Acid|clavulanic acid|mesh-list
101653341|NCT04084106|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101653342|NCT04084106|Penicillin V|penicillin v|mesh-list
101653343|NCT04084106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101653344|NCT04084106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101653345|NCT04084106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101653346|NCT04084106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653347|NCT04084106|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101653349|NCT02977052|Ipilimumab|ipilimumab|mesh-list
101653350|NCT02977052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101653351|NCT02977052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101653352|NCT02977052|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101653353|NCT02977052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653354|NCT02973542|Ethosuximide|ethosuximide|mesh-list
101653355|NCT02973542|Anticonvulsants|anticonvulsants|mesh-ancestor
101653356|NCT02973386|Cisplatin|cisplatin|mesh-list
101653357|NCT02973386|Capecitabine|capecitabine|mesh-list
101653358|NCT02973386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101653359|NCT02973386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101653360|NCT02973386|Antimetabolites|antimetabolites|mesh-ancestor
101653361|NCT02973386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653362|NCT00909428|Solifenacin Succinate|solifenacin succinate|mesh-list
101653363|NCT00909428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101653364|NCT00909428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101653365|NCT00909428|Cholinergic Agents|cholinergic agents|mesh-ancestor
101653366|NCT00909428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101653367|NCT00909428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653368|NCT00909428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653369|NCT00909428|Urological Agents|urological agents|mesh-ancestor
101653370|NCT03718130|Vaccines|vaccines|mesh-list
101653371|NCT03718130|Immunologic Factors|immunologic factors|mesh-ancestor
101653372|NCT03718130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653373|NCT00908960|Enoxaparin|enoxaparin|mesh-list
101653374|NCT00908960|Anticoagulants|anticoagulants|mesh-ancestor
101653375|NCT00908960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101653376|NCT00908960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101653377|NCT00908960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653378|NCT05332106|Dienogest|dienogest|mesh-list
101653379|NCT05332106|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101653380|NCT05332106|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101653381|NCT05332106|Estradiol|estradiol|mesh-list
101653382|NCT05332106|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101653383|NCT05332106|Nandrolone|nandrolone|mesh-list
101653384|NCT05332106|Estrogens|estrogens|mesh-ancestor
101653385|NCT05332106|Hormones|hormones|mesh-ancestor
101653386|NCT05332106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101653387|NCT05332106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653388|NCT05332106|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101653389|NCT05332106|Contraceptive Agents|contraceptive agents|mesh-ancestor
101653390|NCT05332106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101653391|NCT05332106|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101653392|NCT05332106|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101653393|NCT05332106|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101653394|NCT05332106|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101653395|NCT05332106|Hormone Antagonists|hormone antagonists|mesh-ancestor
101653396|NCT05332106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101653397|NCT05332106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101653398|NCT05332106|Androgens|androgens|mesh-ancestor
101653399|NCT05332106|Anabolic Agents|anabolic agents|mesh-ancestor
101653400|NCT05332028|Fentanyl|fentanyl|mesh-list
101653401|NCT05332028|Bupivacaine|bupivacaine|mesh-list
101653402|NCT05332028|Propofol|propofol|mesh-list
101653403|NCT05332028|Anesthetics, Local|anesthetics, local|mesh-ancestor
101653404|NCT05332028|Anesthetics|anesthetics|mesh-ancestor
101653405|NCT05332028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101653406|NCT05332028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653407|NCT05332028|Sensory System Agents|sensory system agents|mesh-ancestor
101653408|NCT05332028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101653409|NCT05332028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101653410|NCT05332028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101653411|NCT05332028|Anesthetics, General|anesthetics, general|mesh-ancestor
101653412|NCT05332028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101653413|NCT05332028|Narcotics|narcotics|mesh-ancestor
101653414|NCT05332028|Analgesics|analgesics|mesh-ancestor
101653415|NCT05332028|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101653416|NCT00816517|Botulinum Toxins|botulinum toxins|mesh-list
101653417|NCT00816517|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101653418|NCT00816517|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101653419|NCT00816517|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101653420|NCT00816517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101653421|NCT00816517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653422|NCT00816517|Cholinergic Agents|cholinergic agents|mesh-ancestor
101653423|NCT00816517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101653424|NCT00816517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653425|NCT00816517|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101653426|NCT00816517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101653427|NCT00643201|Enoxaparin|enoxaparin|mesh-list
101653428|NCT00643201|Warfarin|warfarin|mesh-list
101653429|NCT00643201|Enoxaparin sodium|enoxaparin sodium|mesh-list
101653430|NCT00643201|Apixaban|apixaban|mesh-list
101653431|NCT00643201|Anticoagulants|anticoagulants|mesh-ancestor
101653432|NCT00643201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101653433|NCT00643201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101653434|NCT00643201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653435|NCT00643201|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101653436|NCT00643201|Antithrombins|antithrombins|mesh-ancestor
101653437|NCT00643201|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101653438|NCT00643201|Protease Inhibitors|protease inhibitors|mesh-ancestor
101653439|NCT00643201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101653440|NCT00643123|Allopurinol|allopurinol|mesh-list
101653441|NCT00643123|Antimetabolites|antimetabolites|mesh-ancestor
101653442|NCT00643123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653443|NCT00643123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101653444|NCT00643123|Gout Suppressants|gout suppressants|mesh-ancestor
101653445|NCT00643123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101653446|NCT00643123|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101653447|NCT00643123|Antioxidants|antioxidants|mesh-ancestor
101653448|NCT00643123|Protective Agents|protective agents|mesh-ancestor
101653449|NCT00643123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653450|NCT00816673|Melatonin|melatonin|mesh-list
101653451|NCT00816673|Antioxidants|antioxidants|mesh-ancestor
101653452|NCT00816673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653453|NCT00816673|Protective Agents|protective agents|mesh-ancestor
101653454|NCT00816673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653455|NCT00816673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101653456|NCT00818155|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101653457|NCT00818155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101653458|NCT00818155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101653459|NCT00818155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101653460|NCT00818155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653461|NCT00818155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101653462|NCT00818155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653463|NCT00818155|Antidepressive Agents|antidepressive agents|mesh-ancestor
101653464|NCT00818155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101653465|NCT00641719|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101653466|NCT00641719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101653467|NCT00641719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101653468|NCT00641719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101653469|NCT00641719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653470|NCT00641719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101653471|NCT00641719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653472|NCT00641719|Analgesics|analgesics|mesh-ancestor
101653473|NCT00641719|Sensory System Agents|sensory system agents|mesh-ancestor
101653474|NCT00641719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101653475|NCT00641719|Antidepressive Agents|antidepressive agents|mesh-ancestor
101653476|NCT00641719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101653477|NCT00641719|Dopamine Agents|dopamine agents|mesh-ancestor
101653478|NCT02863367|Gemcitabine|gemcitabine|mesh-list
101653479|NCT02863367|Apatinib|apatinib|mesh-list
101653480|NCT02863367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101653481|NCT02863367|Antimetabolites|antimetabolites|mesh-ancestor
101653482|NCT02863367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653483|NCT02863367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101653484|NCT02863367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101653485|NCT02863367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101653487|NCT00648895|Nebivolol|nebivolol|mesh-list
101653488|NCT00648895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101653489|NCT00648895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101653490|NCT00648895|Sympatholytics|sympatholytics|mesh-ancestor
101653491|NCT00648895|Autonomic Agents|autonomic agents|mesh-ancestor
101653492|NCT00648895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101653493|NCT00648895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653494|NCT00648895|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101653495|NCT00648895|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101653496|NCT00648895|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101653497|NCT00648895|Adrenergic Agents|adrenergic agents|mesh-ancestor
101653498|NCT00648895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101653499|NCT00648895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653500|NCT00648895|Vasodilator Agents|vasodilator agents|mesh-ancestor
101653501|NCT00648895|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101653502|NCT00648895|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101653503|NCT00648895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101653505|NCT00975221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101653506|NCT00975221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653507|NCT00975221|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101653508|NCT00975221|Hormone Antagonists|hormone antagonists|mesh-ancestor
101653509|NCT00975221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101653510|NCT02863679|Tetracaine|tetracaine|mesh-list
101653511|NCT02863679|Anesthetics, Local|anesthetics, local|mesh-ancestor
101653512|NCT02863679|Anesthetics|anesthetics|mesh-ancestor
101653513|NCT02863679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101653514|NCT02863679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653515|NCT02863679|Sensory System Agents|sensory system agents|mesh-ancestor
101653516|NCT02863679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101653517|NCT00906698|Vinorelbine|vinorelbine|mesh-list
101653518|NCT00906698|Afatinib|afatinib|mesh-list
101653519|NCT00906698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101653520|NCT00906698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101653521|NCT00906698|Tubulin Modulators|tubulin modulators|mesh-ancestor
101653522|NCT00906698|Antimitotic Agents|antimitotic agents|mesh-ancestor
101653523|NCT00906698|Mitosis Modulators|mitosis modulators|mesh-ancestor
101653524|NCT00906698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653525|NCT00906698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101653526|NCT00906698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101653527|NCT00972023|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101653528|NCT00972023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101653529|NCT00972023|Immunologic Factors|immunologic factors|mesh-ancestor
101653530|NCT00972023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653531|NCT03396926|Bevacizumab|bevacizumab|mesh-list
101653532|NCT03396926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101653533|NCT03396926|Pembrolizumab|pembrolizumab|mesh-list
101653534|NCT03396926|Capecitabine|capecitabine|mesh-list
101653535|NCT03396926|Endothelial Growth Factors|endothelial growth factors|mesh-list
101653537|NCT03396926|Immunoglobulins|immunoglobulins|mesh-list
101653538|NCT03396926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101653539|NCT03396926|Immunoglobulin G|immunoglobulin g|mesh-list
101653540|NCT03396926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101653541|NCT03396926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101653542|NCT03396926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101653543|NCT03396926|Growth Substances|growth substances|mesh-ancestor
101653544|NCT03396926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653545|NCT03396926|Growth Inhibitors|growth inhibitors|mesh-ancestor
101653546|NCT03396926|Immunologic Factors|immunologic factors|mesh-ancestor
101653547|NCT03396926|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101653548|NCT03396926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653549|NCT03396926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101653550|NCT03396926|Antimetabolites|antimetabolites|mesh-ancestor
101653551|NCT00971945|Paclitaxel|paclitaxel|mesh-list
101653552|NCT00971945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101653553|NCT00971945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101653554|NCT00971945|Tubulin Modulators|tubulin modulators|mesh-ancestor
101653555|NCT00971945|Antimitotic Agents|antimitotic agents|mesh-ancestor
101653556|NCT00971945|Mitosis Modulators|mitosis modulators|mesh-ancestor
101653557|NCT00971945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653558|NCT03672500|Epinephrine|epinephrine|mesh-list
101653559|NCT03672500|Bupivacaine|bupivacaine|mesh-list
101653560|NCT03672500|Anesthetics, Local|anesthetics, local|mesh-ancestor
101653561|NCT03672500|Anesthetics|anesthetics|mesh-ancestor
101653562|NCT03672500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101653563|NCT03672500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653564|NCT03672500|Sensory System Agents|sensory system agents|mesh-ancestor
101653565|NCT03672500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101653566|NCT03672500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101653567|NCT03672500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101653568|NCT03672500|Adrenergic Agents|adrenergic agents|mesh-ancestor
101653569|NCT03672500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101653570|NCT03672500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653571|NCT03672500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101653572|NCT03672500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101653573|NCT03672500|Autonomic Agents|autonomic agents|mesh-ancestor
101653574|NCT03672500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101653575|NCT03672500|Respiratory System Agents|respiratory system agents|mesh-ancestor
101653576|NCT03672500|Mydriatics|mydriatics|mesh-ancestor
101653577|NCT03672500|Sympathomimetics|sympathomimetics|mesh-ancestor
101653578|NCT03672500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101653579|NCT00971867|Paclitaxel|paclitaxel|mesh-list
101653580|NCT00971867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101653581|NCT00971867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101653582|NCT00971867|Tubulin Modulators|tubulin modulators|mesh-ancestor
101653583|NCT00971867|Antimitotic Agents|antimitotic agents|mesh-ancestor
101653584|NCT00971867|Mitosis Modulators|mitosis modulators|mesh-ancestor
101653585|NCT00971867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653586|NCT00812851|Dronabinol|dronabinol|mesh-list
101653587|NCT00812851|Hallucinogens|hallucinogens|mesh-ancestor
101653588|NCT00812851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653589|NCT00812851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101653590|NCT00812851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101653591|NCT00812851|Analgesics|analgesics|mesh-ancestor
101653592|NCT00812851|Sensory System Agents|sensory system agents|mesh-ancestor
101653593|NCT00812851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101653594|NCT00812851|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101653595|NCT00812851|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101653596|NCT00812851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101653597|NCT00812851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653598|NCT00812851|Hormones|hormones|mesh-ancestor
101653599|NCT00812851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101653601|NCT00648037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101653602|NCT00648037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101653603|NCT00648037|Immunologic Factors|immunologic factors|mesh-ancestor
101653604|NCT00648037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653605|NCT00648037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101653606|NCT00817375|Milnacipran|milnacipran|mesh-list
101653607|NCT00817375|Mirtazapine|mirtazapine|mesh-list
101653608|NCT00817375|Sertraline|sertraline|mesh-list
101653609|NCT00817375|Fluoxetine|fluoxetine|mesh-list
101653610|NCT00817375|Paroxetine|paroxetine|mesh-list
101653611|NCT00817375|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101653612|NCT00817375|Nortriptyline|nortriptyline|mesh-list
101653613|NCT00817375|Antidepressive Agents|antidepressive agents|mesh-ancestor
101653614|NCT00817375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101653615|NCT00817375|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101653616|NCT00817375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101653617|NCT00817375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101653618|NCT00817375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653619|NCT00817375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101653620|NCT00817375|Serotonin Agents|serotonin agents|mesh-ancestor
101653621|NCT00817375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653622|NCT00817375|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101653623|NCT00817375|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101653624|NCT00817375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101653625|NCT00817375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101653626|NCT00817375|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101653627|NCT00817375|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101653628|NCT00817375|Histamine Antagonists|histamine antagonists|mesh-ancestor
101653629|NCT00817375|Histamine Agents|histamine agents|mesh-ancestor
101653630|NCT00817375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101653631|NCT00817375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101653632|NCT00817375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101653633|NCT00817375|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101653634|NCT00817375|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101653635|NCT00817375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101653636|NCT00817375|Adrenergic Agents|adrenergic agents|mesh-ancestor
101653637|NCT00817375|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101653638|NCT00817375|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101653639|NCT00817375|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101653640|NCT00817375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101653642|NCT00817375|Sensory System Agents|sensory system agents|mesh-ancestor
101653643|NCT00817375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101653644|NCT00817375|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101653645|NCT00817375|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101653646|NCT00818701|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101653647|NCT00818701|Sildenafil Citrate|sildenafil citrate|mesh-list
101653648|NCT00818701|Vasodilator Agents|vasodilator agents|mesh-ancestor
101653649|NCT00818701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101653650|NCT00818701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101653651|NCT00818701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101653652|NCT00818701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653653|NCT00818701|Urological Agents|urological agents|mesh-ancestor
101653654|NCT00818701|Natriuretic Agents|natriuretic agents|mesh-ancestor
101653655|NCT00818701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653657|NCT00813241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101653658|NCT00813241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101653659|NCT00813241|Analgesics|analgesics|mesh-ancestor
101653660|NCT00813241|Sensory System Agents|sensory system agents|mesh-ancestor
101653661|NCT00813241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101653662|NCT00813241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653663|NCT00813241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101653664|NCT00813241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101653665|NCT00813241|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101653666|NCT00813241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101653667|NCT00813241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101653668|NCT00813241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653669|NCT00640393|Etanercept|etanercept|mesh-list
101653670|NCT00640393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101653671|NCT00640393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101653673|NCT00640393|Sensory System Agents|sensory system agents|mesh-ancestor
101653674|NCT00640393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101653675|NCT00640393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653676|NCT00640393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101653677|NCT00640393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101653678|NCT00640393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101653679|NCT00640393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101653680|NCT00640393|Immunologic Factors|immunologic factors|mesh-ancestor
101653681|NCT00821353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
101653682|NCT05315024|Imiquimod|imiquimod|mesh-list
101653683|NCT05315024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101653684|NCT05315024|Immunologic Factors|immunologic factors|mesh-ancestor
101653685|NCT05315024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653686|NCT05315024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101653687|NCT05315024|Interferon Inducers|interferon inducers|mesh-ancestor
101653688|NCT00627445|Insulin|insulin|mesh-list
101653689|NCT00627445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101653690|NCT00627445|Metformin|metformin|mesh-list
101653691|NCT00627445|Insulin Aspart|insulin aspart|mesh-list
101653692|NCT00627445|Insulin, Long-Acting|insulin, long-acting|mesh-list
101653693|NCT00627445|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101653694|NCT00627445|Biphasic Insulins|biphasic insulins|mesh-list
101653695|NCT00627445|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101653696|NCT00627445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101653697|NCT00627445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653698|NCT02030990|Fluorometholone|fluorometholone|mesh-list
101653699|NCT02030990|Mitomycins|mitomycins|mesh-list
101653700|NCT02030990|Mitomycin|mitomycin|mesh-list
101653701|NCT02030990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101653702|NCT02030990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101653703|NCT02030990|Alkylating Agents|alkylating agents|mesh-ancestor
101653704|NCT02030990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653705|NCT02030990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101653706|NCT02030990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101653707|NCT02030990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101653708|NCT02030990|Glucocorticoids|glucocorticoids|mesh-ancestor
101653709|NCT02030990|Hormones|hormones|mesh-ancestor
101653710|NCT02030990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101653711|NCT02030990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653712|NCT02030990|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101653713|NCT00822055|Timolol|timolol|mesh-list
101653714|NCT00822055|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101653715|NCT00822055|Dorzolamide|dorzolamide|mesh-list
101653716|NCT00822055|Maleic acid|maleic acid|mesh-list
101653717|NCT00822055|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
101653718|NCT00822055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101653719|NCT00822055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653720|NCT00822055|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101653721|NCT00822055|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101653722|NCT00822055|Adrenergic Agents|adrenergic agents|mesh-ancestor
101653723|NCT00822055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101653724|NCT00822055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653725|NCT00822055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101653726|NCT00822055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101653727|NCT00822055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101653728|NCT00822055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101653729|NCT00822055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101653730|NCT00822055|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101653731|NCT00822133|Lidocaine|lidocaine|mesh-list
101653732|NCT00822133|Ketamine|ketamine|mesh-list
101653733|NCT00822133|Anesthetics, Local|anesthetics, local|mesh-ancestor
101653734|NCT00822133|Anesthetics|anesthetics|mesh-ancestor
101653735|NCT00822133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101653736|NCT00822133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653737|NCT00822133|Sensory System Agents|sensory system agents|mesh-ancestor
101653738|NCT00822133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101653739|NCT00822133|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101653740|NCT00822133|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101653741|NCT00822133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101653742|NCT00822133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101653743|NCT00822133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653744|NCT00822133|Analgesics|analgesics|mesh-ancestor
101653745|NCT00822133|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101653746|NCT00822133|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101653747|NCT00822133|Anesthetics, General|anesthetics, general|mesh-ancestor
101653748|NCT00822133|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101653749|NCT00822133|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101653750|NCT00822133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101653751|NCT00822211|Vildagliptin|vildagliptin|mesh-list
101653752|NCT00822211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101653753|NCT00822211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653754|NCT00822211|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101653755|NCT00822211|Protease Inhibitors|protease inhibitors|mesh-ancestor
101653756|NCT00822211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101653757|NCT00822211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653758|NCT04018417|Amphotericin B|amphotericin b|mesh-list
101653759|NCT04018417|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101653760|NCT04018417|Amebicides|amebicides|mesh-ancestor
101653761|NCT04018417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101653762|NCT04018417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101653763|NCT04018417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101653764|NCT04018417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101653765|NCT04018417|Antifungal Agents|antifungal agents|mesh-ancestor
101653766|NCT01791920|Botulinum Toxins|botulinum toxins|mesh-list
101653767|NCT01791920|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101653768|NCT01791920|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101653769|NCT01791920|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101653770|NCT01791920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101653771|NCT01791920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653772|NCT01791920|Cholinergic Agents|cholinergic agents|mesh-ancestor
101409166|NCT00465751|Cathartics|cathartics|mesh-ancestor
101653773|NCT01791920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101653774|NCT01791920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653775|NCT01791920|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101653776|NCT01791920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101653777|NCT00826657|Vitamin B 12|vitamin b 12|mesh-list
101653778|NCT00826657|Hydroxocobalamin|hydroxocobalamin|mesh-list
101653779|NCT00826657|Vitamins|vitamins|mesh-ancestor
101653780|NCT00826657|Micronutrients|micronutrients|mesh-ancestor
101653781|NCT00826657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653782|NCT00826657|Vitamin B Complex|vitamin b complex|mesh-ancestor
101653783|NCT00826657|Hematinics|hematinics|mesh-ancestor
101653785|NCT02992964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101653786|NCT02992964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101653787|NCT02992964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101653788|NCT02992964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653789|NCT03597776|Lidocaine|lidocaine|mesh-list
101653790|NCT03597776|Anesthetics, Local|anesthetics, local|mesh-ancestor
101653791|NCT03597776|Anesthetics|anesthetics|mesh-ancestor
101653792|NCT03597776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101653793|NCT03597776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653794|NCT03597776|Sensory System Agents|sensory system agents|mesh-ancestor
101653795|NCT03597776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101653796|NCT03597776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101653797|NCT03597776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101653798|NCT03597776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101653799|NCT03597776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101653800|NCT03597776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653801|NCT00625183|Selenium|selenium|mesh-list
101653802|NCT00625183|Capecitabine|capecitabine|mesh-list
101653803|NCT00625183|Oxaliplatin|oxaliplatin|mesh-list
101653804|NCT00625183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101653805|NCT00625183|Antimetabolites|antimetabolites|mesh-ancestor
101653806|NCT00625183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653807|NCT00625183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101653808|NCT00625183|Antioxidants|antioxidants|mesh-ancestor
101653809|NCT00625183|Protective Agents|protective agents|mesh-ancestor
101653810|NCT00625183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653811|NCT00625183|Trace Elements|trace elements|mesh-ancestor
101653812|NCT00625183|Micronutrients|micronutrients|mesh-ancestor
101653813|NCT00826891|Topotecan|topotecan|mesh-list
101653814|NCT00826891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101653815|NCT00826891|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101653816|NCT00826891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101653817|NCT00826891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101653818|NCT00826891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310952|NCT00006363|Cytarabine|cytarabine|mesh-list
101653820|NCT00826969|Glucocorticoids|glucocorticoids|mesh-ancestor
101653821|NCT00826969|Hormones|hormones|mesh-ancestor
101653822|NCT00826969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101653823|NCT00826969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653824|NCT00826969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101653825|NCT03560882|Atorvastatin|atorvastatin|mesh-list
101653826|NCT03560882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101653827|NCT03560882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101653828|NCT03560882|Antimetabolites|antimetabolites|mesh-ancestor
101653829|NCT03560882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653830|NCT03560882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101653831|NCT03560882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101653832|NCT03560882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101653833|NCT04044547|Rotigotine|rotigotine|mesh-list
101653834|NCT04044547|Dopamine Agonists|dopamine agonists|mesh-ancestor
101653835|NCT04044547|Dopamine Agents|dopamine agents|mesh-ancestor
101653836|NCT04044547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101653837|NCT04044547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653838|NCT04044547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653839|NCT02768948|Losartan|losartan|mesh-list
101653840|NCT02768948|Telmisartan|telmisartan|mesh-list
101653841|NCT02768948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101653842|NCT02768948|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101653843|NCT02768948|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101653844|NCT02768948|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101653845|NCT02768948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653846|NCT00640315|Riociguat|riociguat|mesh-list
101653847|NCT00640315|Enzyme Activators|enzyme activators|mesh-ancestor
101653848|NCT00640315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653849|NCT00904748|Sildenafil Citrate|sildenafil citrate|mesh-list
101653850|NCT00904748|Citric Acid|citric acid|mesh-list
101653851|NCT00904748|Sodium Citrate|sodium citrate|mesh-list
101653852|NCT00904748|Anticoagulants|anticoagulants|mesh-ancestor
101653853|NCT00904748|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101653854|NCT00904748|Chelating Agents|chelating agents|mesh-ancestor
101653855|NCT00904748|Sequestering Agents|sequestering agents|mesh-ancestor
101653856|NCT00904748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653857|NCT00904748|Vasodilator Agents|vasodilator agents|mesh-ancestor
101653858|NCT00904748|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101653859|NCT00904748|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101653860|NCT00904748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101653861|NCT00904748|Urological Agents|urological agents|mesh-ancestor
101653863|NCT00574405|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101653864|NCT00574405|Insulin Lispro|insulin lispro|mesh-list
101653865|NCT00574405|Insulin Aspart|insulin aspart|mesh-list
101653866|NCT00574405|Insulin, Isophane|insulin, isophane|mesh-list
101653867|NCT00574405|Isophane Insulin, Human|isophane insulin, human|mesh-list
101653868|NCT00574405|Isophane insulin, beef|isophane insulin, beef|mesh-list
101653869|NCT00574405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101653870|NCT00574405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653871|NCT00971243|Metformin|metformin|mesh-list
101653872|NCT00971243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101653873|NCT00971243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653874|NCT00822913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101653875|NCT00822913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101653876|NCT00822913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101653877|NCT00822913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101653878|NCT00822913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653879|NCT00822913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101653880|NCT00822913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101653881|NCT00822913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653882|NCT00822913|Cholinergic Agents|cholinergic agents|mesh-ancestor
101653883|NCT00822913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101653884|NCT04400383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101653885|NCT04400383|Antibodies|antibodies|mesh-list
101653886|NCT04400383|Immunoglobulins|immunoglobulins|mesh-list
101653887|NCT04400383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101653888|NCT04400383|Immunologic Factors|immunologic factors|mesh-ancestor
101653889|NCT04400383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653890|NCT04400383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101653891|NCT04381429|Insulin Aspart|insulin aspart|mesh-list
101653892|NCT04381429|Insulin, Long-Acting|insulin, long-acting|mesh-list
101653893|NCT04381429|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101653894|NCT04381429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101653895|NCT04381429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653896|NCT00568555|Naltrexone|naltrexone|mesh-list
101653897|NCT00568555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101653898|NCT00568555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101653899|NCT00568555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653900|NCT00568555|Sensory System Agents|sensory system agents|mesh-ancestor
101653901|NCT00568555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101653902|NCT00819325|Pioglitazone|pioglitazone|mesh-list
101653903|NCT00819325|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101653904|NCT00819325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653905|NCT00904670|Methylphenidate|methylphenidate|mesh-list
101653906|NCT00904670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101653907|NCT00904670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653908|NCT00904670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101653909|NCT00904670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101653910|NCT00904670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101653911|NCT00904670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653912|NCT00904670|Dopamine Agents|dopamine agents|mesh-ancestor
101653913|NCT00904670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101653914|NCT00827281|Cycloserine|cycloserine|mesh-list
101653915|NCT00827281|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101653916|NCT00827281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101653917|NCT00827281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101653918|NCT00827281|Antitubercular Agents|antitubercular agents|mesh-ancestor
101653919|NCT00827281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101653920|NCT00827281|Antimetabolites|antimetabolites|mesh-ancestor
101653921|NCT00827281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653922|NCT00823381|Resveratrol|resveratrol|mesh-list
101653923|NCT00823381|Antioxidants|antioxidants|mesh-ancestor
101653924|NCT00823381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653925|NCT00823381|Protective Agents|protective agents|mesh-ancestor
101653926|NCT00823381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653927|NCT00823381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101653928|NCT00823381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101653929|NCT00638443|Diphenhydramine|diphenhydramine|mesh-list
101653930|NCT00638443|Promethazine|promethazine|mesh-list
101653931|NCT00638443|Pregabalin|pregabalin|mesh-list
101653932|NCT00638443|Analgesics|analgesics|mesh-ancestor
101653933|NCT00638443|Sensory System Agents|sensory system agents|mesh-ancestor
101653934|NCT00638443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101653935|NCT00638443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653936|NCT00638443|Anticonvulsants|anticonvulsants|mesh-ancestor
101653937|NCT00638443|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101653938|NCT00638443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101653939|NCT00638443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653940|NCT00638443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101653941|NCT00638443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101653942|NCT00638443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101653943|NCT00638443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101653944|NCT00638443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101653945|NCT00638443|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101653946|NCT00638443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101653947|NCT00638443|Anesthetics, Local|anesthetics, local|mesh-ancestor
101653949|NCT00638443|Antiemetics|antiemetics|mesh-ancestor
101653950|NCT00638443|Autonomic Agents|autonomic agents|mesh-ancestor
101653951|NCT00638443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101653952|NCT00638443|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101653953|NCT00638443|Histamine Antagonists|histamine antagonists|mesh-ancestor
101653954|NCT00638443|Histamine Agents|histamine agents|mesh-ancestor
101653955|NCT00638443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101653956|NCT00638443|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101653957|NCT00638443|Antipruritics|antipruritics|mesh-ancestor
101653958|NCT00638443|Dermatologic Agents|dermatologic agents|mesh-ancestor
101653959|NCT00568399|Sodium thiosulfate|sodium thiosulfate|mesh-list
101653960|NCT00568399|Antidotes|antidotes|mesh-ancestor
101653961|NCT00568399|Protective Agents|protective agents|mesh-ancestor
101653962|NCT00568399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653963|NCT00568399|Antioxidants|antioxidants|mesh-ancestor
101653964|NCT00568399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653965|NCT00568399|Antitubercular Agents|antitubercular agents|mesh-ancestor
101653966|NCT00568399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101653967|NCT00568399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101653968|NCT00568399|Chelating Agents|chelating agents|mesh-ancestor
101653969|NCT00568399|Sequestering Agents|sequestering agents|mesh-ancestor
101653970|NCT00975143|Isotretinoin|isotretinoin|mesh-list
101653971|NCT00975143|Dermatologic Agents|dermatologic agents|mesh-ancestor
101653972|NCT04286087|Anesthetics|anesthetics|mesh-list
101653973|NCT04286087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101653974|NCT04286087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653975|NCT04288349|Epinephrine|epinephrine|mesh-list
101653976|NCT04288349|Racepinephrine|racepinephrine|mesh-list
101653977|NCT04288349|Ropivacaine|ropivacaine|mesh-list
101653978|NCT04288349|Epinephryl borate|epinephryl borate|mesh-list
101653979|NCT04288349|Anesthetics, Local|anesthetics, local|mesh-ancestor
101653980|NCT04288349|Anesthetics|anesthetics|mesh-ancestor
101653981|NCT04288349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101653982|NCT04288349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101653983|NCT04288349|Sensory System Agents|sensory system agents|mesh-ancestor
101653984|NCT04288349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101653985|NCT04288349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101653986|NCT04288349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101653987|NCT04288349|Adrenergic Agents|adrenergic agents|mesh-ancestor
101653988|NCT04288349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101653989|NCT04288349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101653990|NCT04288349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101653991|NCT04288349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101653992|NCT04288349|Autonomic Agents|autonomic agents|mesh-ancestor
101653993|NCT04288349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101653994|NCT04288349|Respiratory System Agents|respiratory system agents|mesh-ancestor
101653995|NCT04288349|Mydriatics|mydriatics|mesh-ancestor
101653996|NCT04288349|Sympathomimetics|sympathomimetics|mesh-ancestor
101653997|NCT04288349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101653998|NCT03667313|Sirolimus|sirolimus|mesh-list
101653999|NCT03667313|Paclitaxel|paclitaxel|mesh-list
101654000|NCT03667313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101654001|NCT03667313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101654002|NCT03667313|Tubulin Modulators|tubulin modulators|mesh-ancestor
101654003|NCT03667313|Antimitotic Agents|antimitotic agents|mesh-ancestor
101654004|NCT03667313|Mitosis Modulators|mitosis modulators|mesh-ancestor
101654005|NCT03667313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654006|NCT03667313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101654007|NCT03667313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101654008|NCT03667313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101654010|NCT03667313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101654011|NCT03667313|Immunologic Factors|immunologic factors|mesh-ancestor
101654012|NCT03667313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654013|NCT00974675|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101654014|NCT00974675|Immunologic Factors|immunologic factors|mesh-ancestor
101654015|NCT00974675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654016|NCT04925531|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101654017|NCT04925531|Ampicillin|ampicillin|mesh-list
101654018|NCT04925531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101654020|NCT00634933|Methylprednisolone|methylprednisolone|mesh-list
101654021|NCT00634933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101654022|NCT00634933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101654023|NCT00634933|Prednisolone|prednisolone|mesh-list
101654024|NCT00634933|Prednisolone acetate|prednisolone acetate|mesh-list
101654025|NCT00634933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101654026|NCT00634933|Prednisolone phosphate|prednisolone phosphate|mesh-list
101654027|NCT00634933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101654028|NCT00634933|Glucocorticoids|glucocorticoids|mesh-ancestor
101654030|NCT00634933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101654031|NCT00634933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654032|NCT00634933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101654033|NCT00634933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101654034|NCT00634933|Antiemetics|antiemetics|mesh-ancestor
101654035|NCT00634933|Autonomic Agents|autonomic agents|mesh-ancestor
101654036|NCT00634933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101654037|NCT00634933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101654038|NCT00634933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101654039|NCT00634933|Protective Agents|protective agents|mesh-ancestor
101654040|NCT00967499|Ondansetron|ondansetron|mesh-list
101311172|NCT05546320|Analgesics|analgesics|mesh-ancestor
101654041|NCT00967499|Palonosetron|palonosetron|mesh-list
101654042|NCT00967499|Antiemetics|antiemetics|mesh-ancestor
101654043|NCT00967499|Autonomic Agents|autonomic agents|mesh-ancestor
101654044|NCT00967499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101654045|NCT00967499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654046|NCT00967499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101654048|NCT00967499|Dermatologic Agents|dermatologic agents|mesh-ancestor
101654049|NCT00967499|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101654050|NCT00967499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101654051|NCT00967499|Serotonin Agents|serotonin agents|mesh-ancestor
101654052|NCT00967499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101654053|NCT00967499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654054|NCT04286399|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
101654055|NCT04286399|Angiotensin II|angiotensin ii|mesh-list
101654056|NCT04286399|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101654057|NCT04286399|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
101654058|NCT04286399|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101654059|NCT04286399|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101654060|NCT04286399|Adrenergic Agents|adrenergic agents|mesh-ancestor
101654061|NCT04286399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101654062|NCT04286399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654063|NCT04286399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654064|NCT04286399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101654065|NCT04286399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101654066|NCT04286399|Protease Inhibitors|protease inhibitors|mesh-ancestor
101654067|NCT04286399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101654068|NCT00629837|Factor VIII|factor viii|mesh-list
101654069|NCT00629837|Coagulants|coagulants|mesh-ancestor
101654070|NCT00827671|Cetuximab|cetuximab|mesh-list
101654071|NCT00827671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101654072|NCT00827671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101654073|NCT03643133|Mifamurtide|mifamurtide|mesh-list
101654074|NCT03643133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101654075|NCT03643133|Immunologic Factors|immunologic factors|mesh-ancestor
101654076|NCT03643133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654077|NCT00823849|Cilostazol|cilostazol|mesh-list
101654078|NCT00823849|Probucol|probucol|mesh-list
101654079|NCT00823849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101654080|NCT00823849|Autonomic Agents|autonomic agents|mesh-ancestor
101654081|NCT00823849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101654082|NCT00823849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654083|NCT00823849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101654084|NCT00823849|Respiratory System Agents|respiratory system agents|mesh-ancestor
101654085|NCT00823849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101654086|NCT00823849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101451716|NCT00208065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101654087|NCT00823849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654088|NCT00823849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101654089|NCT00823849|Vasodilator Agents|vasodilator agents|mesh-ancestor
101654090|NCT00823849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101654091|NCT00823849|Protective Agents|protective agents|mesh-ancestor
101654092|NCT00823849|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101654093|NCT00823849|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101654094|NCT00823849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101654095|NCT00823849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101654096|NCT00823849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101654097|NCT00823849|Antimetabolites|antimetabolites|mesh-ancestor
101654098|NCT00823849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101654099|NCT00823849|Antioxidants|antioxidants|mesh-ancestor
101654100|NCT02550067|Copper|copper|mesh-list
101654101|NCT02550067|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101654102|NCT02550067|Levonorgestrel|levonorgestrel|mesh-list
101654103|NCT02550067|Medroxyprogesterone|medroxyprogesterone|mesh-list
101654104|NCT02550067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101654105|NCT02550067|Contraceptive Agents|contraceptive agents|mesh-ancestor
101654106|NCT02550067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101654107|NCT02550067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654108|NCT02550067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101654109|NCT02550067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101654110|NCT02550067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101654111|NCT02550067|Trace Elements|trace elements|mesh-ancestor
101654112|NCT02550067|Micronutrients|micronutrients|mesh-ancestor
101824315|NCT05416476|Anisodine|anisodine|mesh-list
101654113|NCT02550067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101654114|NCT02550067|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101654115|NCT02550067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101654116|NCT02550067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101654117|NCT02862509|Budesonide|budesonide|mesh-list
101654118|NCT02862509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101654119|NCT02862509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101654120|NCT02862509|Autonomic Agents|autonomic agents|mesh-ancestor
101654121|NCT02862509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101654122|NCT02862509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654123|NCT02862509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101654124|NCT02862509|Respiratory System Agents|respiratory system agents|mesh-ancestor
101654125|NCT02862509|Glucocorticoids|glucocorticoids|mesh-ancestor
101654127|NCT02862509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101654128|NCT04285775|Chrysarobin|chrysarobin|mesh-list
101654129|NCT04285775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101654130|NCT04285775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101654131|NCT04285775|Analgesics|analgesics|mesh-ancestor
101654132|NCT04285775|Sensory System Agents|sensory system agents|mesh-ancestor
101654133|NCT04285775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101654134|NCT04285775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654135|NCT04285775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101654136|NCT04285775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101654137|NCT00965081|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101654138|NCT00965081|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101654139|NCT00965081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101654140|NCT00965081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101654141|NCT00965081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654142|NCT00965081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101654143|NCT00965081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654144|NCT00965081|Analgesics|analgesics|mesh-ancestor
101654145|NCT00965081|Sensory System Agents|sensory system agents|mesh-ancestor
101654146|NCT00965081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101654147|NCT00965081|Antidepressive Agents|antidepressive agents|mesh-ancestor
101654148|NCT00965081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101654149|NCT00965081|Dopamine Agents|dopamine agents|mesh-ancestor
101654150|NCT00961649|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101654151|NCT00961649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101654152|NCT00961649|Brinzolamide|brinzolamide|mesh-list
101654153|NCT00961649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101654154|NCT00961649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101654155|NCT00961649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101654156|NCT00961649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101654157|NCT00961649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101654158|NCT00961649|Adrenergic Agents|adrenergic agents|mesh-ancestor
101654159|NCT00961649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101654160|NCT00961649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654161|NCT00961649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654162|NCT00961649|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101654163|NCT00961649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101654164|NCT04267601|Anagliptin|anagliptin|mesh-list
101654165|NCT04267601|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101654166|NCT04267601|Protease Inhibitors|protease inhibitors|mesh-ancestor
101654167|NCT04267601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101654168|NCT04267601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654169|NCT04267601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101654170|NCT04267601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654171|NCT02861261|Promethazine|promethazine|mesh-list
101654172|NCT02861261|Diphenhydramine|diphenhydramine|mesh-list
101654173|NCT02861261|Antipruritics|antipruritics|mesh-ancestor
101654174|NCT02861261|Dermatologic Agents|dermatologic agents|mesh-ancestor
101654175|NCT02861261|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101654176|NCT02861261|Histamine Antagonists|histamine antagonists|mesh-ancestor
101654177|NCT02861261|Histamine Agents|histamine agents|mesh-ancestor
101654178|NCT02861261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101824318|NCT05416476|Analgesics|analgesics|mesh-ancestor
101654179|NCT02861261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654180|NCT02861261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654181|NCT02861261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101654182|NCT02861261|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101654183|NCT02861261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101654184|NCT02861261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101654185|NCT02861261|Anesthetics, Local|anesthetics, local|mesh-ancestor
101654186|NCT02861261|Anesthetics|anesthetics|mesh-ancestor
101654187|NCT02861261|Sensory System Agents|sensory system agents|mesh-ancestor
101654188|NCT02861261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101654189|NCT02861261|Antiemetics|antiemetics|mesh-ancestor
101654190|NCT02861261|Autonomic Agents|autonomic agents|mesh-ancestor
101654191|NCT02861261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101654192|NCT04283435|Sildenafil Citrate|sildenafil citrate|mesh-list
101654193|NCT04283435|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101654195|NCT04283435|Estradiol|estradiol|mesh-list
101654196|NCT04283435|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101654197|NCT04283435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654198|NCT04283435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654199|NCT04283435|Estrogens|estrogens|mesh-ancestor
101654200|NCT04283435|Hormones|hormones|mesh-ancestor
101654201|NCT04283435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101654202|NCT04283435|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101654203|NCT04283435|Contraceptive Agents|contraceptive agents|mesh-ancestor
101654204|NCT04283435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101654205|NCT04283435|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101654206|NCT04283435|Vasodilator Agents|vasodilator agents|mesh-ancestor
101654207|NCT04283435|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101654208|NCT04283435|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101654209|NCT04283435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101654210|NCT04283435|Urological Agents|urological agents|mesh-ancestor
101654211|NCT00632125|Epoetin Alfa|epoetin alfa|mesh-list
101654212|NCT00632125|Hematinics|hematinics|mesh-ancestor
101654213|NCT00903968|Plerixafor|plerixafor|mesh-list
101654214|NCT00903968|Dexamethasone|dexamethasone|mesh-list
101654215|NCT00903968|Bortezomib|bortezomib|mesh-list
101654216|NCT00903968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101654217|NCT00903968|Antiemetics|antiemetics|mesh-ancestor
101654218|NCT00903968|Autonomic Agents|autonomic agents|mesh-ancestor
101654219|NCT00903968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101654220|NCT00903968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654221|NCT00903968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101654222|NCT00903968|Glucocorticoids|glucocorticoids|mesh-ancestor
101654223|NCT00903968|Hormones|hormones|mesh-ancestor
101654224|NCT00903968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101654225|NCT00903968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101654226|NCT00903968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101654227|NCT00903968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101654228|NCT00903968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101654229|NCT00903968|Antiviral Agents|antiviral agents|mesh-ancestor
101654230|NCT00903968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101654231|NCT00632606|Magnesium Sulfate|magnesium sulfate|mesh-list
101654232|NCT00632606|Metoclopramide|metoclopramide|mesh-list
101654233|NCT00632606|Analgesics|analgesics|mesh-ancestor
101654234|NCT00632606|Sensory System Agents|sensory system agents|mesh-ancestor
101654235|NCT00632606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101654236|NCT00632606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654237|NCT00632606|Anesthetics|anesthetics|mesh-ancestor
101654238|NCT00632606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101654239|NCT00632606|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101654240|NCT00632606|Anticonvulsants|anticonvulsants|mesh-ancestor
101654241|NCT00632606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101654242|NCT00632606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101654243|NCT00632606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654244|NCT00632606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101654245|NCT00632606|Tocolytic Agents|tocolytic agents|mesh-ancestor
101654246|NCT00632606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101654247|NCT00632606|Antiemetics|antiemetics|mesh-ancestor
101654248|NCT00632606|Autonomic Agents|autonomic agents|mesh-ancestor
101654249|NCT00632606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101654250|NCT00632606|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101654251|NCT00632606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101654252|NCT00632606|Dopamine Agents|dopamine agents|mesh-ancestor
101654253|NCT00632606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101654255|NCT00903344|Cholecalciferol|cholecalciferol|mesh-list
101654256|NCT00903344|Vitamins|vitamins|mesh-ancestor
101654257|NCT00903344|Micronutrients|micronutrients|mesh-ancestor
101654258|NCT00903344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654259|NCT00903344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101654260|NCT00903344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101654261|NCT02847338|Amlodipine|amlodipine|mesh-list
101654262|NCT02847338|Lisinopril|lisinopril|mesh-list
101654263|NCT02847338|Chlorthalidone|chlorthalidone|mesh-list
101654264|NCT02847338|Amiloride|amiloride|mesh-list
101654265|NCT02847338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101654266|NCT02847338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101654267|NCT02847338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101654268|NCT02847338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654269|NCT02847338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101654270|NCT02847338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654271|NCT02847338|Vasodilator Agents|vasodilator agents|mesh-ancestor
101654272|NCT02847338|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101654273|NCT02847338|Protease Inhibitors|protease inhibitors|mesh-ancestor
101654274|NCT02847338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101654275|NCT02847338|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101654276|NCT02847338|Protective Agents|protective agents|mesh-ancestor
101654277|NCT02847338|Diuretics|diuretics|mesh-ancestor
101654278|NCT02847338|Natriuretic Agents|natriuretic agents|mesh-ancestor
101654279|NCT02847338|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101654280|NCT02847338|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
101654281|NCT02847338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101654282|NCT02847338|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101654283|NCT02847338|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101654284|NCT02847104|Insulin|insulin|mesh-list
101654285|NCT02847104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101654286|NCT02847104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101654287|NCT02847104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654288|NCT02849366|Immunomodulating Agents|immunomodulating agents|mesh-list
101654289|NCT02849366|Immunologic Factors|immunologic factors|mesh-ancestor
101654290|NCT02849366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654291|NCT02849132|Entecavir|entecavir|mesh-list
101654292|NCT02849132|Antiviral Agents|antiviral agents|mesh-ancestor
101654293|NCT02849132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101654294|NCT05116826|Nitazoxanide|nitazoxanide|mesh-list
101654295|NCT05116826|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101654296|NCT05116826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101654297|NCT02848508|Metformin|metformin|mesh-list
101654298|NCT02848508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101654299|NCT02848508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654300|NCT00902564|Escitalopram|escitalopram|mesh-list
101654301|NCT00902564|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101654302|NCT00902564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101654303|NCT00902564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101654304|NCT00902564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654306|NCT00902564|Serotonin Agents|serotonin agents|mesh-ancestor
101654307|NCT00902564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654308|NCT00626197|Mycophenolic Acid|mycophenolic acid|mesh-list
101654309|NCT00626197|Cyclophosphamide|cyclophosphamide|mesh-list
101654310|NCT00626197|Azathioprine|azathioprine|mesh-list
101654311|NCT00626197|Ocrelizumab|ocrelizumab|mesh-list
101654312|NCT00626197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101654313|NCT00626197|Immunologic Factors|immunologic factors|mesh-ancestor
101654314|NCT00626197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654315|NCT00626197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101654316|NCT00626197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101654317|NCT00626197|Alkylating Agents|alkylating agents|mesh-ancestor
101654318|NCT00626197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654319|NCT00626197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101654320|NCT00626197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101654321|NCT00626197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101654322|NCT00626197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101654323|NCT00626197|Antitubercular Agents|antitubercular agents|mesh-ancestor
101654324|NCT00626197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101654325|NCT00626197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101654326|NCT00626197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101654327|NCT00626197|Antimetabolites|antimetabolites|mesh-ancestor
101654328|NCT00626197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101654329|NCT00626275|Naproxen|naproxen|mesh-list
101654330|NCT00626275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101654331|NCT00626275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101654332|NCT00626275|Analgesics|analgesics|mesh-ancestor
101654333|NCT00626275|Sensory System Agents|sensory system agents|mesh-ancestor
101654334|NCT00626275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101654335|NCT00626275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654336|NCT00626275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101654337|NCT00626275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101654338|NCT00626275|Gout Suppressants|gout suppressants|mesh-ancestor
101654339|NCT00626275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101654340|NCT00626275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101654341|NCT00626275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654342|NCT02847884|Infliximab|infliximab|mesh-list
101654343|NCT02847884|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101311476|NCT03265405|Prednisolone|prednisolone|mesh-list
101654344|NCT02847884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101654345|NCT02847884|Dermatologic Agents|dermatologic agents|mesh-ancestor
101654346|NCT02847884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101654347|NCT02847884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101654348|NCT00623935|Fludarabine|fludarabine|mesh-list
101654349|NCT00623935|Busulfan|busulfan|mesh-list
101654350|NCT00623935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101654351|NCT00623935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654352|NCT00623935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101654353|NCT00623935|Immunologic Factors|immunologic factors|mesh-ancestor
101654354|NCT00623935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654355|NCT00623935|Alkylating Agents|alkylating agents|mesh-ancestor
101654356|NCT00623935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101654357|NCT00623935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101654358|NCT00623779|Aspirin|aspirin|mesh-list
101654359|NCT00623779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101654360|NCT00623779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101654361|NCT00623779|Analgesics|analgesics|mesh-ancestor
101654362|NCT00623779|Sensory System Agents|sensory system agents|mesh-ancestor
101654363|NCT00623779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101654364|NCT00623779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654365|NCT00623779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101654366|NCT00623779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101654367|NCT00623779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101654368|NCT00623779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101654369|NCT00623779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654370|NCT00623779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101654371|NCT00623779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101654372|NCT00623779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101654373|NCT00623779|Antipyretics|antipyretics|mesh-ancestor
101654374|NCT00828373|Lidocaine|lidocaine|mesh-list
101654375|NCT00828373|Anesthetics, Local|anesthetics, local|mesh-ancestor
101654376|NCT00828373|Anesthetics|anesthetics|mesh-ancestor
101654377|NCT00828373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101654378|NCT00828373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654379|NCT00828373|Sensory System Agents|sensory system agents|mesh-ancestor
101654380|NCT00828373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101654381|NCT00828373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101654382|NCT00828373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101654383|NCT00828373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101654384|NCT00828373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101654385|NCT00828373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654388|NCT00824239|Propofol|propofol|mesh-list
101654389|NCT00824239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101654390|NCT00824239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101654391|NCT00824239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654392|NCT00824239|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101654393|NCT00824239|Anesthetics, General|anesthetics, general|mesh-ancestor
101654394|NCT00824239|Anesthetics|anesthetics|mesh-ancestor
101654395|NCT00824239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101654396|NCT00824239|Narcotics|narcotics|mesh-ancestor
101654397|NCT00824239|Analgesics|analgesics|mesh-ancestor
101654398|NCT00824239|Sensory System Agents|sensory system agents|mesh-ancestor
101654399|NCT00824239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101654400|NCT00824239|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101654401|NCT00824239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101654402|NCT00824239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101654403|NCT00824239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101654404|NCT00824239|GABA Modulators|gaba modulators|mesh-ancestor
101654405|NCT00824239|GABA Agents|gaba agents|mesh-ancestor
101654406|NCT00824239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101654407|NCT00824239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654408|NCT04777760|Pulmonary Surfactants|pulmonary surfactants|mesh-list
101654409|NCT04777760|Respiratory System Agents|respiratory system agents|mesh-ancestor
101654410|NCT02548975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
101654411|NCT02548975|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101654412|NCT02548975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101654413|NCT02548975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101654414|NCT02548975|Antimetabolites|antimetabolites|mesh-ancestor
101654415|NCT02548975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654416|NCT02548975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101654417|NCT02548975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101654418|NCT02548975|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101654419|NCT02548975|Adrenergic Agents|adrenergic agents|mesh-ancestor
101654420|NCT02548975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101654421|NCT02548975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654422|NCT04044703|Vancomycin|vancomycin|mesh-list
101654423|NCT04044703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101654424|NCT04044703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101654425|NCT02848040|Bile Acids and Salts|bile acids and salts|mesh-list
101654426|NCT02848040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101654427|NCT00824317|Methylphenidate|methylphenidate|mesh-list
101654428|NCT00824317|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101654429|NCT00824317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654430|NCT00824317|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101654431|NCT00824317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101654432|NCT00824317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101654433|NCT00824317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654434|NCT00824317|Dopamine Agents|dopamine agents|mesh-ancestor
101654435|NCT00824317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101654436|NCT02847806|Insulin|insulin|mesh-list
101654437|NCT02847806|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101654438|NCT02847806|Estradiol|estradiol|mesh-list
101654439|NCT02847806|Testosterone|testosterone|mesh-list
101654440|NCT02847806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101654441|NCT02847806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654442|NCT02847806|Estrogens|estrogens|mesh-ancestor
101654443|NCT02847806|Hormones|hormones|mesh-ancestor
101654444|NCT02847806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101654446|NCT00828529|Bedaquiline|bedaquiline|mesh-list
101654447|NCT00828529|Antitubercular Agents|antitubercular agents|mesh-ancestor
101654448|NCT00828529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101654449|NCT00828529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101654450|NCT00632762|Amantadine|amantadine|mesh-list
101654451|NCT00632762|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101654452|NCT00632762|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101654453|NCT00632762|Antiviral Agents|antiviral agents|mesh-ancestor
101654454|NCT00632762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101654455|NCT00632762|Dopamine Agents|dopamine agents|mesh-ancestor
101654456|NCT00632762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101654457|NCT00632762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654458|NCT00632762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654459|NCT00632762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101654460|NCT00632762|Analgesics|analgesics|mesh-ancestor
101654461|NCT00632762|Sensory System Agents|sensory system agents|mesh-ancestor
101654462|NCT00632762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101654463|NCT01351766|Nicotine|nicotine|mesh-list
101654464|NCT01351766|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101654465|NCT01351766|Autonomic Agents|autonomic agents|mesh-ancestor
101654466|NCT01351766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101654467|NCT01351766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654468|NCT01351766|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101654469|NCT01351766|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101654470|NCT01351766|Cholinergic Agents|cholinergic agents|mesh-ancestor
101654471|NCT01351766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101654472|NCT01351766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654473|NCT02846090|Dexmedetomidine|dexmedetomidine|mesh-list
101654474|NCT02846090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101654475|NCT02846090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101654476|NCT02846090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654477|NCT02846090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101654478|NCT02846090|Analgesics|analgesics|mesh-ancestor
101654479|NCT02846090|Sensory System Agents|sensory system agents|mesh-ancestor
101654480|NCT02846090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101654481|NCT02846090|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101654482|NCT02846090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101654483|NCT02846090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101654484|NCT02846090|Adrenergic Agents|adrenergic agents|mesh-ancestor
101654485|NCT02846090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101654486|NCT02846090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654487|NCT00828763|Dolutegravir|dolutegravir|mesh-list
101654488|NCT00828763|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101654489|NCT00828763|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101654490|NCT00828763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101654491|NCT00828763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654492|NCT00828763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101311623|NCT00006708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101654493|NCT00828763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101654494|NCT00828763|Antiviral Agents|antiviral agents|mesh-ancestor
101654495|NCT00828763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101654497|NCT00824707|Antiviral Agents|antiviral agents|mesh-ancestor
101654498|NCT00824707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101654499|NCT00824785|Capecitabine|capecitabine|mesh-list
101654500|NCT00824785|Oxaliplatin|oxaliplatin|mesh-list
101654501|NCT00824785|Epirubicin|epirubicin|mesh-list
101654502|NCT00824785|Panitumumab|panitumumab|mesh-list
101654503|NCT00824785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101654504|NCT00824785|Antimetabolites|antimetabolites|mesh-ancestor
101654505|NCT00824785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654506|NCT00824785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101654507|NCT00824785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101654508|NCT00824785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101654509|NCT00824785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101654510|NCT00824785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101654511|NCT00824785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101654512|NCT00824863|Ketoconazole|ketoconazole|mesh-list
101654513|NCT00824863|Antifungal Agents|antifungal agents|mesh-ancestor
101654514|NCT00824863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101654515|NCT00824863|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101654516|NCT00824863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101654517|NCT00824863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101654518|NCT00824863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654519|NCT00824863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101654520|NCT00824863|Hormone Antagonists|hormone antagonists|mesh-ancestor
101654521|NCT00824863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101654522|NCT00824863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654523|NCT00824863|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101654524|NCT02844530|Epratuzumab|epratuzumab|mesh-list
101654525|NCT02844530|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
101654526|NCT02844530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101654527|NCT02844530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101654528|NCT02844530|Chelating Agents|chelating agents|mesh-ancestor
101654529|NCT02844530|Sequestering Agents|sequestering agents|mesh-ancestor
101654530|NCT02844530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654531|NCT00820417|Cetuximab|cetuximab|mesh-list
101654532|NCT00820417|Gefitinib|gefitinib|mesh-list
101654533|NCT00820417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101654534|NCT00820417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101654535|NCT00820417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101654536|NCT00820417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101654537|NCT00820417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654538|NCT04923620|Cetuximab|cetuximab|mesh-list
101654539|NCT04923620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101654540|NCT04923620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101654541|NCT00828919|Axitinib|axitinib|mesh-list
101654542|NCT00828919|Crizotinib|crizotinib|mesh-list
101654543|NCT00828919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101654544|NCT00828919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101654545|NCT00828919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101654546|NCT00828919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654547|NCT00828997|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101654548|NCT00828997|Immunologic Factors|immunologic factors|mesh-ancestor
101654549|NCT00828997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654550|NCT02548741|Metformin|metformin|mesh-list
101654551|NCT02548741|Calcium Carbonate|calcium carbonate|mesh-list
101654552|NCT02548741|Calcium|calcium|mesh-list
101654553|NCT02548741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101654554|NCT02548741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654555|NCT02548741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101654556|NCT02548741|Antacids|antacids|mesh-ancestor
101654557|NCT02548741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654558|NCT02548741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101654559|NCT02845856|Cetuximab|cetuximab|mesh-list
101654560|NCT02845856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101654561|NCT02845856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101654562|NCT00825019|Paroxetine|paroxetine|mesh-list
101654563|NCT00825019|Amibegron|amibegron|mesh-list
101654564|NCT00825019|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
101654565|NCT00825019|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101311753|NCT00006049|Paclitaxel|paclitaxel|mesh-list
101654566|NCT00825019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101654567|NCT00825019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101451717|NCT00208065|Autonomic Agents|autonomic agents|mesh-ancestor
101654568|NCT00825019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654569|NCT00825019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101654572|NCT00825019|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101654573|NCT00825019|Antidepressive Agents|antidepressive agents|mesh-ancestor
101654574|NCT00825019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101654575|NCT00825019|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101654576|NCT00825019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101654577|NCT00825019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101654578|NCT00825019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101654579|NCT00825019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101654580|NCT00825019|Adrenergic Agents|adrenergic agents|mesh-ancestor
101654581|NCT00825019|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101654582|NCT00929006|Progesterone|progesterone|mesh-list
101654583|NCT00929006|Progestins|progestins|mesh-ancestor
101654584|NCT00929006|Hormones|hormones|mesh-ancestor
101654585|NCT00929006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101654586|NCT00929006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654587|NCT00877214|Rituximab|rituximab|mesh-list
101654588|NCT00877214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101654589|NCT00877214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101654590|NCT00877214|Immunologic Factors|immunologic factors|mesh-ancestor
101654591|NCT00877214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654592|NCT00877214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101654593|NCT00474032|Botulinum Toxins|botulinum toxins|mesh-list
101654594|NCT00474032|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101654595|NCT00474032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101654596|NCT00474032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654597|NCT00474032|Cholinergic Agents|cholinergic agents|mesh-ancestor
101654598|NCT00474032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101654599|NCT00474032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654600|NCT05242718|Palmidrol|palmidrol|mesh-list
101654601|NCT05242718|Acetylcysteine|acetylcysteine|mesh-list
101654602|NCT05242718|Curcumin|curcumin|mesh-list
101654603|NCT05242718|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101654604|NCT05242718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101654605|NCT05242718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101654606|NCT05242718|Analgesics|analgesics|mesh-ancestor
101654607|NCT05242718|Sensory System Agents|sensory system agents|mesh-ancestor
101654608|NCT05242718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101654609|NCT05242718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654611|NCT05242718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101654612|NCT05242718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101654613|NCT05242718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101654614|NCT05242718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654615|NCT05242718|Antiviral Agents|antiviral agents|mesh-ancestor
101654616|NCT05242718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101654617|NCT05242718|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101654618|NCT05242718|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101654619|NCT05242718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101654620|NCT05242718|Hormones|hormones|mesh-ancestor
101654621|NCT05242718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101654622|NCT05242718|Expectorants|expectorants|mesh-ancestor
101654623|NCT05242718|Respiratory System Agents|respiratory system agents|mesh-ancestor
101654624|NCT05242718|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101654625|NCT05242718|Antioxidants|antioxidants|mesh-ancestor
101654626|NCT05242718|Protective Agents|protective agents|mesh-ancestor
101654627|NCT05242718|Antidotes|antidotes|mesh-ancestor
101654628|NCT00045968|Immunomodulating Agents|immunomodulating agents|mesh-list
101654629|NCT00045968|Immunologic Factors|immunologic factors|mesh-ancestor
101654630|NCT00045968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654631|NCT02845778|Melatonin|melatonin|mesh-list
101654632|NCT02845778|Antioxidants|antioxidants|mesh-ancestor
101654633|NCT02845778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654634|NCT02845778|Protective Agents|protective agents|mesh-ancestor
101654635|NCT02845778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654636|NCT02845778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101654637|NCT05241938|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101311786|NCT00006055|Hormones|hormones|mesh-ancestor
101654638|NCT05241938|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101654639|NCT05337332|Triamcinolone|triamcinolone|mesh-list
101654640|NCT05337332|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101654641|NCT05337332|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101654642|NCT05337332|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101654643|NCT05337332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101654645|NCT05337332|Hormones|hormones|mesh-ancestor
101654646|NCT05337332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101654647|NCT05337332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654648|NCT05337332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101654649|NCT05337332|Immunologic Factors|immunologic factors|mesh-ancestor
101654650|NCT05337332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101654651|NCT05337332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654652|NCT00901394|Folic Acid|folic acid|mesh-list
101654653|NCT00901394|Nitrous Oxide|nitrous oxide|mesh-list
101654654|NCT00901394|Hematinics|hematinics|mesh-ancestor
101654655|NCT00901394|Vitamin B Complex|vitamin b complex|mesh-ancestor
101654656|NCT00901394|Vitamins|vitamins|mesh-ancestor
101654657|NCT00901394|Micronutrients|micronutrients|mesh-ancestor
101654658|NCT00901394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654659|NCT00901394|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101654660|NCT00901394|Anesthetics, General|anesthetics, general|mesh-ancestor
101654661|NCT00901394|Anesthetics|anesthetics|mesh-ancestor
101654662|NCT00901394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101654663|NCT00901394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101654664|NCT00901394|Analgesics|analgesics|mesh-ancestor
101654665|NCT00901394|Sensory System Agents|sensory system agents|mesh-ancestor
101654666|NCT00901394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101654667|NCT05337254|Dihydroergotamine|dihydroergotamine|mesh-list
101654668|NCT05337254|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101654669|NCT05337254|Dopamine Agonists|dopamine agonists|mesh-ancestor
101654670|NCT05337254|Dopamine Agents|dopamine agents|mesh-ancestor
101654671|NCT05337254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101654672|NCT05337254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654673|NCT05337254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654674|NCT05337254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101654675|NCT05337254|Analgesics|analgesics|mesh-ancestor
101654676|NCT05337254|Sensory System Agents|sensory system agents|mesh-ancestor
101654677|NCT05337254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101654678|NCT00896532|Zoledronic Acid|zoledronic acid|mesh-list
101654679|NCT00896532|Denosumab|denosumab|mesh-list
101654680|NCT00896532|Alendronate|alendronate|mesh-list
101654681|NCT00896532|Teriparatide|teriparatide|mesh-list
101654682|NCT00896532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101654683|NCT00896532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101654684|NCT00896532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654685|NCT00896532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101654686|NCT00896532|Immunologic Factors|immunologic factors|mesh-ancestor
101654687|NCT00574873|Imatinib Mesylate|imatinib mesylate|mesh-list
101654688|NCT00574873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101654689|NCT00574873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101654690|NCT00574873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101654691|NCT00574873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654692|NCT02843490|Ranibizumab|ranibizumab|mesh-list
101654693|NCT02843490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101654694|NCT02843490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101654695|NCT02843490|Growth Substances|growth substances|mesh-ancestor
101654696|NCT02843490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654697|NCT02843490|Growth Inhibitors|growth inhibitors|mesh-ancestor
101654698|NCT02843490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101654699|NCT00902174|Imatinib Mesylate|imatinib mesylate|mesh-list
101654700|NCT00902174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101654701|NCT00902174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101654702|NCT00902174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101654703|NCT00902174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654704|NCT04201808|Tenofovir|tenofovir|mesh-list
101654705|NCT04201808|Antiviral Agents|antiviral agents|mesh-ancestor
101654706|NCT04201808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101654707|NCT04201808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101654708|NCT04201808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101654710|NCT04201808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654711|NCT04201808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101654712|NCT04201808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101654713|NCT01341600|Omeprazole|omeprazole|mesh-list
101654714|NCT01341600|Clopidogrel|clopidogrel|mesh-list
101654715|NCT01341600|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101654716|NCT01341600|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101654717|NCT01341600|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101654718|NCT01341600|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101654719|NCT01341600|Purinergic Agents|purinergic agents|mesh-ancestor
101654720|NCT01341600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101654721|NCT01341600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654722|NCT01341600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654723|NCT01341600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101654724|NCT01341600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101654725|NCT01341600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101654726|NCT01341600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101654727|NCT02845388|Sildenafil Citrate|sildenafil citrate|mesh-list
101654728|NCT02845388|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101654729|NCT02845388|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101654730|NCT02845388|Estradiol|estradiol|mesh-list
101654731|NCT02845388|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101654732|NCT02845388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654733|NCT02845388|Estrogens|estrogens|mesh-ancestor
101654734|NCT02845388|Hormones|hormones|mesh-ancestor
101654735|NCT02845388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101654736|NCT02845388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654737|NCT02845388|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101654738|NCT02845388|Contraceptive Agents|contraceptive agents|mesh-ancestor
101654739|NCT02845388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101654740|NCT02845388|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101654741|NCT02845388|Vasodilator Agents|vasodilator agents|mesh-ancestor
101654742|NCT02845388|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101654743|NCT02845388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101654744|NCT02845388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101654745|NCT02845388|Urological Agents|urological agents|mesh-ancestor
101654746|NCT02845466|Becaplermin|becaplermin|mesh-list
101654747|NCT02845466|Anticoagulants|anticoagulants|mesh-ancestor
101654748|NCT02845466|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
101654749|NCT02845466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101654750|NCT02845466|Growth Substances|growth substances|mesh-ancestor
101654751|NCT02845466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654752|NCT00623623|Enoxaparin|enoxaparin|mesh-list
101654753|NCT00623623|Tenecteplase|tenecteplase|mesh-list
101654754|NCT00623623|Clopidogrel|clopidogrel|mesh-list
101654755|NCT00623623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101654756|NCT00623623|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101654757|NCT00623623|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101654758|NCT00623623|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101654759|NCT00623623|Purinergic Agents|purinergic agents|mesh-ancestor
101654760|NCT00623623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101654761|NCT00623623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654762|NCT00623623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654764|NCT00623623|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101654765|NCT00623623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101654766|NCT00896454|Denosumab|denosumab|mesh-list
101654767|NCT00896454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101654768|NCT00896454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824392|NCT04944888|Eliglustat|eliglustat|mesh-list
101654770|NCT04224584|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101654771|NCT04224584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101654772|NCT04224584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101654773|NCT04224584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654774|NCT04224584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101654775|NCT04224584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654776|NCT04224584|Analgesics|analgesics|mesh-ancestor
101654778|NCT04224584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101654779|NCT04224584|Antidepressive Agents|antidepressive agents|mesh-ancestor
101654780|NCT04224584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101654781|NCT04224584|Dopamine Agents|dopamine agents|mesh-ancestor
101654782|NCT02993198|Carvedilol|carvedilol|mesh-list
101654783|NCT02993198|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101654784|NCT02993198|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101654785|NCT02993198|Adrenergic Agents|adrenergic agents|mesh-ancestor
101654786|NCT02993198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101654787|NCT02993198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654788|NCT02993198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654789|NCT02993198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101654790|NCT02993198|Antioxidants|antioxidants|mesh-ancestor
101654791|NCT02993198|Protective Agents|protective agents|mesh-ancestor
101654792|NCT02993198|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101654793|NCT02993198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101654794|NCT02993198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101654795|NCT02993198|Vasodilator Agents|vasodilator agents|mesh-ancestor
101654796|NCT02993198|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101654797|NCT02993198|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101654798|NCT00829231|Sorafenib|sorafenib|mesh-list
101654799|NCT00829231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101654800|NCT00829231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101654801|NCT00829231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101654802|NCT00829231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654803|NCT00901628|Cefuroxime|cefuroxime|mesh-list
101654804|NCT00901628|Cefuroxime axetil|cefuroxime axetil|mesh-list
101654805|NCT00901628|Ketorolac|ketorolac|mesh-list
101654806|NCT00901628|Epinephrine|epinephrine|mesh-list
101654807|NCT00901628|Morphine|morphine|mesh-list
101654808|NCT00901628|Ropivacaine|ropivacaine|mesh-list
101654809|NCT00901628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101654810|NCT00901628|Narcotics|narcotics|mesh-ancestor
101654811|NCT00901628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101654812|NCT00901628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654813|NCT00901628|Analgesics|analgesics|mesh-ancestor
101654814|NCT00901628|Sensory System Agents|sensory system agents|mesh-ancestor
101654815|NCT00901628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101654816|NCT00901628|Anesthetics, Local|anesthetics, local|mesh-ancestor
101654817|NCT00901628|Anesthetics|anesthetics|mesh-ancestor
101654818|NCT00901628|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101654819|NCT00901628|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101654820|NCT00901628|Adrenergic Agents|adrenergic agents|mesh-ancestor
101654821|NCT00901628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101654822|NCT00901628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654823|NCT00901628|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101654824|NCT00901628|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101654825|NCT00901628|Autonomic Agents|autonomic agents|mesh-ancestor
101654826|NCT00901628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101654827|NCT00901628|Respiratory System Agents|respiratory system agents|mesh-ancestor
101654828|NCT00901628|Mydriatics|mydriatics|mesh-ancestor
101654830|NCT00901628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101654831|NCT00901628|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101654832|NCT00901628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101654833|NCT00901628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101654834|NCT00901628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101654835|NCT00901628|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101654836|NCT00901628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101654837|NCT00901628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101654838|NCT00901628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101654839|NCT00623545|Exenatide|exenatide|mesh-list
101654840|NCT00623545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101654841|NCT00623545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654842|NCT00623545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101654843|NCT00623545|Incretins|incretins|mesh-ancestor
101654844|NCT00623545|Hormones|hormones|mesh-ancestor
101654845|NCT00623545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101654846|NCT00825097|Botulinum Toxins|botulinum toxins|mesh-list
101654847|NCT00825097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101654848|NCT00825097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101654849|NCT00825097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654850|NCT00825097|Cholinergic Agents|cholinergic agents|mesh-ancestor
101654851|NCT00825097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101654852|NCT00825097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654853|NCT02839668|Acetaminophen|acetaminophen|mesh-list
101654854|NCT02839668|Lidocaine|lidocaine|mesh-list
101654855|NCT02839668|Atropine|atropine|mesh-list
101654856|NCT02839668|Tramadol|tramadol|mesh-list
101654857|NCT02839668|Sevoflurane|sevoflurane|mesh-list
101654858|NCT02839668|Neostigmine|neostigmine|mesh-list
101654859|NCT02839668|Anesthetics, Local|anesthetics, local|mesh-ancestor
101654860|NCT02839668|Anesthetics|anesthetics|mesh-ancestor
101654861|NCT02839668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101654862|NCT02839668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654863|NCT02839668|Sensory System Agents|sensory system agents|mesh-ancestor
101654864|NCT02839668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101654865|NCT02839668|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101654866|NCT02839668|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101654867|NCT02839668|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101654868|NCT02839668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101654869|NCT02839668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654870|NCT02839668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101654872|NCT02839668|Antipyretics|antipyretics|mesh-ancestor
101654873|NCT02839668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101654874|NCT02839668|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101654875|NCT02839668|Anesthetics, General|anesthetics, general|mesh-ancestor
101654876|NCT02839668|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101654877|NCT02839668|Narcotics|narcotics|mesh-ancestor
101654878|NCT02839668|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101654879|NCT02839668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101654880|NCT02839668|Autonomic Agents|autonomic agents|mesh-ancestor
101654881|NCT02839668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101654882|NCT02839668|Respiratory System Agents|respiratory system agents|mesh-ancestor
101654883|NCT02839668|Mydriatics|mydriatics|mesh-ancestor
101654884|NCT02839668|Parasympatholytics|parasympatholytics|mesh-ancestor
101654885|NCT02839668|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101654886|NCT02839668|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101654887|NCT02839668|Cholinergic Agents|cholinergic agents|mesh-ancestor
101654888|NCT02839668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101654889|NCT02839668|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101654890|NCT02839668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101654891|NCT02839668|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101654892|NCT04701788|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101654893|NCT04701788|Immunologic Factors|immunologic factors|mesh-ancestor
101654894|NCT04701788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654895|NCT04700618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101654896|NCT04700618|Immunologic Factors|immunologic factors|mesh-ancestor
101654897|NCT04700618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654898|NCT00829465|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101654899|NCT00829465|Immunologic Factors|immunologic factors|mesh-ancestor
101824417|NCT05367960|BPN14770|bpn14770|mesh-list
101654900|NCT00829465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654901|NCT02839356|Epinephrine|epinephrine|mesh-list
101654902|NCT02839356|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101654903|NCT02839356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101654904|NCT02839356|Adrenergic Agents|adrenergic agents|mesh-ancestor
101654905|NCT02839356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101654906|NCT02839356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654907|NCT02839356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654908|NCT02839356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101654909|NCT02839356|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101654910|NCT02839356|Autonomic Agents|autonomic agents|mesh-ancestor
101654911|NCT02839356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101654912|NCT02839356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101654913|NCT02839356|Respiratory System Agents|respiratory system agents|mesh-ancestor
101654914|NCT02839356|Mydriatics|mydriatics|mesh-ancestor
101654915|NCT02839356|Sympathomimetics|sympathomimetics|mesh-ancestor
101654916|NCT02839356|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101654917|NCT04674410|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101654918|NCT04674410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101654919|NCT02840526|Acetaminophen|acetaminophen|mesh-list
101654921|NCT02840526|Bupivacaine|bupivacaine|mesh-list
101654922|NCT02840526|Propofol|propofol|mesh-list
101654923|NCT02840526|Sevoflurane|sevoflurane|mesh-list
101654924|NCT02840526|Anesthetics, Local|anesthetics, local|mesh-ancestor
101654925|NCT02840526|Anesthetics|anesthetics|mesh-ancestor
101654926|NCT02840526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101654927|NCT02840526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654928|NCT02840526|Sensory System Agents|sensory system agents|mesh-ancestor
101654929|NCT02840526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101654930|NCT02840526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101654931|NCT02840526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101654932|NCT02840526|Anesthetics, General|anesthetics, general|mesh-ancestor
101654933|NCT02840526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101654934|NCT02840526|Narcotics|narcotics|mesh-ancestor
101654935|NCT02840526|Analgesics|analgesics|mesh-ancestor
101654936|NCT02840526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101654937|NCT02840526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101654938|NCT02840526|Antipyretics|antipyretics|mesh-ancestor
101654939|NCT02840526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101654940|NCT02840526|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101654942|NCT02342444|Enoxaparin sodium|enoxaparin sodium|mesh-list
101654943|NCT02342444|Anticoagulants|anticoagulants|mesh-ancestor
101654944|NCT02342444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101654945|NCT02342444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101654946|NCT02342444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654947|NCT00825253|Insulin|insulin|mesh-list
101654948|NCT00825253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101654949|NCT00825253|Insulin Aspart|insulin aspart|mesh-list
101654950|NCT00825253|Biphasic Insulins|biphasic insulins|mesh-list
101654951|NCT00825253|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101654952|NCT00825253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101654953|NCT00825253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654954|NCT00820885|Teduglutide|teduglutide|mesh-list
101654955|NCT00820885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101654956|NCT00820885|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101654957|NCT00820885|Protective Agents|protective agents|mesh-ancestor
101654958|NCT00820885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654959|NCT03845582|Vitamin A|vitamin a|mesh-list
101654960|NCT03845582|Retinol acetate|retinol acetate|mesh-list
101654961|NCT03845582|Vitamins|vitamins|mesh-ancestor
101654962|NCT03845582|Micronutrients|micronutrients|mesh-ancestor
101654963|NCT03845582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654964|NCT03845582|Protective Agents|protective agents|mesh-ancestor
101654965|NCT03845582|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101654966|NCT03845582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101654967|NCT03845582|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101654968|NCT03845582|Immunologic Factors|immunologic factors|mesh-ancestor
101654969|NCT00820963|Temozolomide|temozolomide|mesh-list
101824427|NCT01053910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101654970|NCT00820963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101654971|NCT00820963|Alkylating Agents|alkylating agents|mesh-ancestor
101654972|NCT00820963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654973|NCT00820963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101654975|NCT02834676|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101654976|NCT02834676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101654977|NCT02834676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101654978|NCT02834676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654979|NCT00632840|Atorvastatin|atorvastatin|mesh-list
101654980|NCT00632840|Fenofibrate|fenofibrate|mesh-list
101654981|NCT00632840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101654982|NCT00632840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101654983|NCT00632840|Antimetabolites|antimetabolites|mesh-ancestor
101654984|NCT00632840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101654985|NCT00632840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101654986|NCT00632840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101654987|NCT00632840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101654988|NCT00829699|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101654989|NCT00829699|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101654990|NCT00829699|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101654991|NCT00829699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101654992|NCT00829777|Naloxone|naloxone|mesh-list
101654993|NCT00829777|Lactulose|lactulose|mesh-list
101654994|NCT00829777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101654995|NCT00829777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101654996|NCT00829777|Sensory System Agents|sensory system agents|mesh-ancestor
101654997|NCT00829777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101654998|NCT00829777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101654999|NCT02834754|Vedolizumab|vedolizumab|mesh-list
101655000|NCT02834754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101655002|NCT02839122|Dutasteride|dutasteride|mesh-list
101655003|NCT02839122|Vasodilator Agents|vasodilator agents|mesh-ancestor
101655004|NCT02839122|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101655005|NCT02839122|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101655006|NCT02839122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101655007|NCT02839122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655008|NCT02839122|Urological Agents|urological agents|mesh-ancestor
101655009|NCT02839122|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101655010|NCT02839122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101655011|NCT02839122|Hormone Antagonists|hormone antagonists|mesh-ancestor
101655012|NCT02839122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101655013|NCT02839122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655014|NCT00633282|Pioglitazone|pioglitazone|mesh-list
101655015|NCT00633282|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
101655016|NCT00633282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101655017|NCT00633282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655018|NCT00830089|Levobupivacaine|levobupivacaine|mesh-list
101655019|NCT00830089|Anesthetics, Local|anesthetics, local|mesh-ancestor
101655020|NCT00830089|Anesthetics|anesthetics|mesh-ancestor
101655021|NCT00830089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101655022|NCT00830089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655023|NCT00830089|Sensory System Agents|sensory system agents|mesh-ancestor
101655024|NCT00830089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101655025|NCT00830245|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101655026|NCT00830245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101655027|NCT00830245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101655028|NCT00830245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101655029|NCT00830245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655030|NCT02837874|Antidiarrheals|antidiarrheals|mesh-list
101655031|NCT02837874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101655032|NCT02838030|Aspirin|aspirin|mesh-list
101655033|NCT02838030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101655034|NCT02838030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101655035|NCT02838030|Analgesics|analgesics|mesh-ancestor
101655036|NCT02838030|Sensory System Agents|sensory system agents|mesh-ancestor
101655037|NCT02838030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101655038|NCT02838030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655039|NCT02838030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101655040|NCT02838030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101655041|NCT02838030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101655042|NCT02838030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101655043|NCT02838030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655044|NCT02838030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101655045|NCT02838030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101655046|NCT02838030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101655047|NCT02838030|Antipyretics|antipyretics|mesh-ancestor
101655048|NCT00825643|Insulin Detemir|insulin detemir|mesh-list
101655049|NCT00825643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101655050|NCT00825643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655051|NCT04044079|Misoprostol|misoprostol|mesh-list
101655052|NCT04044079|Dinoprostone|dinoprostone|mesh-list
101655053|NCT04044079|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101655054|NCT04044079|Abortifacient Agents|abortifacient agents|mesh-ancestor
101655055|NCT04044079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101655056|NCT04044079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655057|NCT04044079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101655058|NCT04044079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101655059|NCT04044079|Oxytocics|oxytocics|mesh-ancestor
101655060|NCT00830323|Oseltamivir|oseltamivir|mesh-list
101655062|NCT00830323|Zanamivir|zanamivir|mesh-list
101655063|NCT00830323|Antiviral Agents|antiviral agents|mesh-ancestor
101655064|NCT00830323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101655065|NCT00830323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101655066|NCT00830323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655067|NCT00830323|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101655068|NCT00830323|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101655069|NCT00830323|Dopamine Agents|dopamine agents|mesh-ancestor
101655070|NCT00830323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101655071|NCT00830323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655072|NCT00830323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101655073|NCT00830323|Analgesics|analgesics|mesh-ancestor
101655074|NCT00830323|Sensory System Agents|sensory system agents|mesh-ancestor
101655075|NCT00830323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101655076|NCT00830401|Doxycycline|doxycycline|mesh-list
101655077|NCT00830401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101655078|NCT00830401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101655079|NCT00830401|Antimalarials|antimalarials|mesh-ancestor
101655080|NCT00830401|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101655081|NCT00830401|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101655082|NCT04249908|Maleic acid|maleic acid|mesh-list
101655083|NCT04249908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101655084|NCT04249908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655085|NCT00825721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101655086|NCT00825721|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101655088|NCT02837640|Carbidopa|carbidopa|mesh-list
101655089|NCT02837640|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101655090|NCT02837640|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101655091|NCT02837640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101655093|NCT02837640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101655094|NCT02837640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655095|NCT02837640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655096|NCT02837640|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101655097|NCT02837640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101655098|NCT02837640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101655099|NCT02837640|Immunologic Factors|immunologic factors|mesh-ancestor
101655100|NCT02837640|Dopamine Agonists|dopamine agonists|mesh-ancestor
101655101|NCT02834286|Dexamethasone|dexamethasone|mesh-list
101655102|NCT02834286|Rituximab|rituximab|mesh-list
101655103|NCT02834286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101655104|NCT02834286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101655105|NCT02834286|Immunologic Factors|immunologic factors|mesh-ancestor
101655106|NCT02834286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655107|NCT02834286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101655108|NCT02834286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101655109|NCT02834286|Antiemetics|antiemetics|mesh-ancestor
101655110|NCT02834286|Autonomic Agents|autonomic agents|mesh-ancestor
101655111|NCT02834286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101655112|NCT02834286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101655113|NCT02834286|Glucocorticoids|glucocorticoids|mesh-ancestor
101655114|NCT02834286|Hormones|hormones|mesh-ancestor
101655115|NCT02834286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101655116|NCT02834286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101655117|NCT02839044|Vitamin K 2|vitamin k 2|mesh-list
101655118|NCT02839044|Vitamin K|vitamin k|mesh-list
101655119|NCT02839044|Menaquinone 7|menaquinone 7|mesh-list
101655120|NCT02839044|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101655121|NCT02839044|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101655122|NCT02839044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655123|NCT02839044|Hemostatics|hemostatics|mesh-ancestor
101655124|NCT02839044|Coagulants|coagulants|mesh-ancestor
101655125|NCT02839044|Vitamins|vitamins|mesh-ancestor
101655126|NCT02839044|Micronutrients|micronutrients|mesh-ancestor
101655127|NCT02839044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655128|NCT02833506|Sirolimus|sirolimus|mesh-list
101655129|NCT02833506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101655130|NCT02833506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101655131|NCT02833506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101655132|NCT02833506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101655133|NCT02833506|Antifungal Agents|antifungal agents|mesh-ancestor
101655134|NCT02833506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101655135|NCT02833506|Immunologic Factors|immunologic factors|mesh-ancestor
101655136|NCT02833506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655138|NCT02838576|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101655139|NCT02838576|Hormones|hormones|mesh-ancestor
101655140|NCT02838576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101655141|NCT02838576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655142|NCT00838539|Sirolimus|sirolimus|mesh-list
101655143|NCT00838539|Temsirolimus|temsirolimus|mesh-list
101655144|NCT00838539|MTOR Inhibitors|mtor inhibitors|mesh-list
101655145|NCT00838539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101655146|NCT00838539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101655147|NCT00838539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655148|NCT00838539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101655149|NCT00838539|Immunologic Factors|immunologic factors|mesh-ancestor
101655150|NCT00838539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655151|NCT00838539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101655152|NCT00838539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101655153|NCT00838539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101655154|NCT00838539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101655155|NCT00838539|Antifungal Agents|antifungal agents|mesh-ancestor
101655156|NCT02836548|Vorinostat|vorinostat|mesh-list
101655157|NCT02836548|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
101655158|NCT02836548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101655159|NCT02836548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101655160|NCT02836548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655161|NCT02836704|Metformin|metformin|mesh-list
101655162|NCT02836704|Insulin Glargine|insulin glargine|mesh-list
101655163|NCT02836704|Acarbose|acarbose|mesh-list
101655164|NCT02836704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101655165|NCT02836704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655166|NCT02836704|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101655167|NCT02836704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101655168|NCT02836704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655170|NCT02833584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101655171|NCT02833584|Analgesics|analgesics|mesh-ancestor
101655172|NCT02833584|Sensory System Agents|sensory system agents|mesh-ancestor
101824451|NCT00839345|Clopidogrel|clopidogrel|mesh-list
101655173|NCT02833584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101655174|NCT02833584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655176|NCT00837759|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101655177|NCT00837759|Lansoprazole|lansoprazole|mesh-list
101655178|NCT00837759|Dexlansoprazole|dexlansoprazole|mesh-list
101655179|NCT00837759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101655180|NCT00837759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655181|NCT00837759|Incretins|incretins|mesh-ancestor
101655182|NCT00837759|Hormones|hormones|mesh-ancestor
101655183|NCT00837759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101655184|NCT00837759|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101655185|NCT00837759|Protease Inhibitors|protease inhibitors|mesh-ancestor
101655186|NCT00837759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101655187|NCT00837759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655188|NCT00837759|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101655189|NCT00837759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101655190|NCT00837759|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101655191|NCT00703365|Gemcitabine|gemcitabine|mesh-list
101655192|NCT00703365|Sorafenib|sorafenib|mesh-list
101655193|NCT00703365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101655194|NCT00703365|Antimetabolites|antimetabolites|mesh-ancestor
101655195|NCT00703365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655196|NCT00703365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101655197|NCT00703365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101655198|NCT00703365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101655199|NCT05878899|Enoxaparin|enoxaparin|mesh-list
101655200|NCT05878899|Anticoagulants|anticoagulants|mesh-ancestor
101655201|NCT05878899|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101655202|NCT05878899|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101655203|NCT05878899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655204|NCT05878574|Heparin|heparin|mesh-list
101655205|NCT05878574|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101655206|NCT05878574|Tinzaparin|tinzaparin|mesh-list
101655207|NCT05878574|Dalteparin|dalteparin|mesh-list
101655208|NCT05878574|Anticoagulants|anticoagulants|mesh-ancestor
101655209|NCT05878574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101655210|NCT05878574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101655211|NCT05878574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655212|NCT05878561|Indapamide|indapamide|mesh-list
101655214|NCT05878561|Diuretics|diuretics|mesh-ancestor
101655215|NCT05878561|Natriuretic Agents|natriuretic agents|mesh-ancestor
101655216|NCT05878561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655217|NCT05878561|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101655218|NCT05878561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101655219|NCT05878561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655220|NCT05878379|Iron|iron|mesh-list
101655221|NCT05878379|Trace Elements|trace elements|mesh-ancestor
101655222|NCT05878379|Micronutrients|micronutrients|mesh-ancestor
101655223|NCT05878379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655224|NCT05878353|Doxycycline|doxycycline|mesh-list
101655225|NCT05878353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101655226|NCT05878353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101655227|NCT05878353|Antimalarials|antimalarials|mesh-ancestor
101655228|NCT05878353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101655229|NCT05878353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101655230|NCT05878288|Cemiplimab|cemiplimab|mesh-list
101655231|NCT05878288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101655232|NCT05878288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101655233|NCT05878262|Ibuprofen|ibuprofen|mesh-list
101655234|NCT05878262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101655235|NCT05878262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101655236|NCT05878262|Analgesics|analgesics|mesh-ancestor
101655237|NCT05878262|Sensory System Agents|sensory system agents|mesh-ancestor
101655238|NCT05878262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101655239|NCT05878262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655247|NCT05878249|Edetic Acid|edetic acid|mesh-list
101655248|NCT05878249|Pentetic Acid|pentetic acid|mesh-list
101655249|NCT05878249|Disinfectants|disinfectants|mesh-ancestor
101655250|NCT05878249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101655251|NCT05878249|Anticoagulants|anticoagulants|mesh-ancestor
101655252|NCT05878249|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101655253|NCT05878249|Chelating Agents|chelating agents|mesh-ancestor
101655254|NCT05878249|Sequestering Agents|sequestering agents|mesh-ancestor
101655255|NCT05878249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655256|NCT05878249|Antidotes|antidotes|mesh-ancestor
101655257|NCT05878249|Protective Agents|protective agents|mesh-ancestor
101655258|NCT05878249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655259|NCT05878249|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101655260|NCT05878158|Simvastatin|simvastatin|mesh-list
101655261|NCT05878158|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101655262|NCT05878158|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101655263|NCT05878158|Antimetabolites|antimetabolites|mesh-ancestor
101655264|NCT05878158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655265|NCT05878158|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101655266|NCT05878158|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101655268|NCT05878028|Docetaxel|docetaxel|mesh-list
101655269|NCT05878028|Tislelizumab|tislelizumab|mesh-list
101655270|NCT05878028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101655271|NCT05878028|Tubulin Modulators|tubulin modulators|mesh-ancestor
101655272|NCT05878028|Antimitotic Agents|antimitotic agents|mesh-ancestor
101655273|NCT05878028|Mitosis Modulators|mitosis modulators|mesh-ancestor
101655274|NCT05878028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655275|NCT05878028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101655276|NCT05878015|Acetaminophen|acetaminophen|mesh-list
101655277|NCT05878015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101655278|NCT05878015|Analgesics|analgesics|mesh-ancestor
101655279|NCT05878015|Sensory System Agents|sensory system agents|mesh-ancestor
101655280|NCT05878015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101655281|NCT05878015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655282|NCT05878015|Antipyretics|antipyretics|mesh-ancestor
101655283|NCT05877911|Sodium sulfate|sodium sulfate|mesh-list
101655284|NCT05877911|Cathartics|cathartics|mesh-ancestor
101655285|NCT05877911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101655286|NCT05877872|Immunomodulating Agents|immunomodulating agents|mesh-list
101655287|NCT05877872|Immunologic Factors|immunologic factors|mesh-ancestor
101655288|NCT05877872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655289|NCT05877846|Vitamin D|vitamin d|mesh-list
101655291|NCT05877846|Cholecalciferol|cholecalciferol|mesh-list
101655292|NCT05877846|Vitamins|vitamins|mesh-list
101655293|NCT05877846|Micronutrients|micronutrients|mesh-ancestor
101655294|NCT05877846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655295|NCT05877846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101655296|NCT05877846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101655305|NCT05877807|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101655306|NCT05877807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655307|NCT05877807|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101655308|NCT05877807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101655309|NCT05877807|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101655310|NCT05877807|GABA Agonists|gaba agonists|mesh-ancestor
101655311|NCT05877807|GABA Agents|gaba agents|mesh-ancestor
101655312|NCT05877807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101655313|NCT05877807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655315|NCT05877781|Analgesics|analgesics|mesh-ancestor
101655316|NCT05877781|Sensory System Agents|sensory system agents|mesh-ancestor
101655317|NCT05877781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101655318|NCT05877781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655319|NCT05877781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101655320|NCT05877781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101655321|NCT05877781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101655322|NCT05877781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101655323|NCT05877781|Antiviral Agents|antiviral agents|mesh-ancestor
101655324|NCT05877781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101409266|NCT00347698|Bevacizumab|bevacizumab|mesh-list
101655325|NCT05877781|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101655326|NCT05877781|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101655327|NCT05877781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101655328|NCT05877781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655329|NCT05877781|Hormones|hormones|mesh-ancestor
101655330|NCT05877781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101655331|NCT05877690|Bupivacaine|bupivacaine|mesh-list
101655332|NCT05877690|Prilocaine|prilocaine|mesh-list
101655333|NCT05877690|Anesthetics, Local|anesthetics, local|mesh-ancestor
101655334|NCT05877690|Anesthetics|anesthetics|mesh-ancestor
101655335|NCT05877690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101655336|NCT05877690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655337|NCT05877690|Sensory System Agents|sensory system agents|mesh-ancestor
101655338|NCT05877690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101655339|NCT05877638|Sulfadiazine|sulfadiazine|mesh-list
101655340|NCT05877638|Silver Sulfadiazine|silver sulfadiazine|mesh-list
101655341|NCT05877638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101655342|NCT05877638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101655343|NCT05877638|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101655344|NCT05877638|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101655345|NCT05877638|Coccidiostats|coccidiostats|mesh-ancestor
101655346|NCT05877638|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101655347|NCT05877235|Quercetin|quercetin|mesh-list
101655348|NCT05877235|Antioxidants|antioxidants|mesh-ancestor
101655349|NCT05877235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655350|NCT05877235|Protective Agents|protective agents|mesh-ancestor
101655351|NCT05877235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655352|NCT05877131|Ropivacaine|ropivacaine|mesh-list
101655353|NCT05877131|Levobupivacaine|levobupivacaine|mesh-list
101655354|NCT05877131|Anesthetics, Local|anesthetics, local|mesh-ancestor
101655355|NCT05877131|Anesthetics|anesthetics|mesh-ancestor
101655356|NCT05877131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101655357|NCT05877131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655358|NCT05877131|Sensory System Agents|sensory system agents|mesh-ancestor
101655359|NCT05877131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101655360|NCT05877079|Menthol|menthol|mesh-list
101655361|NCT05877079|Antipruritics|antipruritics|mesh-ancestor
101655362|NCT05877079|Dermatologic Agents|dermatologic agents|mesh-ancestor
101655363|NCT05877040|Rituximab|rituximab|mesh-list
101655364|NCT05877040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101655365|NCT05877040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101655366|NCT05877040|Immunologic Factors|immunologic factors|mesh-ancestor
101655367|NCT05877040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655368|NCT05877040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101655369|NCT05877001|Tislelizumab|tislelizumab|mesh-list
101655370|NCT05877001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101655371|NCT05877001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101655372|NCT05876949|Denosumab|denosumab|mesh-list
101655373|NCT05876949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101655374|NCT05876949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655375|NCT05873777|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101655376|NCT05873777|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101655377|NCT05873777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655378|NCT05859009|Propranolol|propranolol|mesh-list
101655379|NCT05859009|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101655380|NCT05859009|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101655381|NCT05859009|Adrenergic Agents|adrenergic agents|mesh-ancestor
101655382|NCT05859009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101655383|NCT05859009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655384|NCT05859009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655385|NCT05859009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101655386|NCT05859009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101655387|NCT05859009|Vasodilator Agents|vasodilator agents|mesh-ancestor
101655388|NCT05838560|Dasatinib|dasatinib|mesh-list
101655389|NCT05838560|Quercetin|quercetin|mesh-list
101655390|NCT05838560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101655391|NCT05838560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101655392|NCT05838560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101655393|NCT05838560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655394|NCT05838560|Antioxidants|antioxidants|mesh-ancestor
101655395|NCT05838560|Protective Agents|protective agents|mesh-ancestor
101655396|NCT05838560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655397|NCT05795309|Insulin|insulin|mesh-list
101655398|NCT05795309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101655399|NCT05795309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655400|NCT05790707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
101655401|NCT05737121|Lidocaine|lidocaine|mesh-list
101655402|NCT05737121|Heparin|heparin|mesh-list
101655403|NCT05737121|Calcium heparin|calcium heparin|mesh-list
101655404|NCT05737121|Anesthetics, Local|anesthetics, local|mesh-ancestor
101655405|NCT05737121|Anesthetics|anesthetics|mesh-ancestor
101655406|NCT05737121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101655407|NCT05737121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655408|NCT05737121|Sensory System Agents|sensory system agents|mesh-ancestor
101655409|NCT05737121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101655410|NCT05737121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101655411|NCT05737121|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101655412|NCT05737121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101655413|NCT05737121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101655414|NCT05737121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655415|NCT05737121|Anticoagulants|anticoagulants|mesh-ancestor
101655416|NCT05737121|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101655417|NCT05737121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101655418|NCT05721235|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
101655419|NCT05721235|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101655420|NCT05721235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655421|NCT05721235|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101655422|NCT05721235|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101655423|NCT05721235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101655424|NCT05721235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655425|NCT05721235|Dopamine Agents|dopamine agents|mesh-ancestor
101655426|NCT05721235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101655427|NCT05675579|Pembrolizumab|pembrolizumab|mesh-list
101655428|NCT05675579|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
101655429|NCT05675579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101655430|NCT05675579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101655431|NCT05675579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101655432|NCT05675579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655433|NCT05675579|Immunoconjugates|immunoconjugates|mesh-ancestor
101655434|NCT05675579|Immunologic Factors|immunologic factors|mesh-ancestor
101655435|NCT05675579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655437|NCT05663658|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101655438|NCT05663658|Narcotics|narcotics|mesh-ancestor
101655439|NCT05663658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101655440|NCT05663658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655441|NCT05663658|Analgesics|analgesics|mesh-ancestor
101655442|NCT05663658|Sensory System Agents|sensory system agents|mesh-ancestor
101655443|NCT05663658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101655444|NCT05660135|Amlodipine|amlodipine|mesh-list
101655445|NCT05660135|Olmesartan|olmesartan|mesh-list
101655446|NCT05660135|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101655447|NCT05660135|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101655448|NCT05660135|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101655449|NCT05660135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101655450|NCT05660135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101655451|NCT05660135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655452|NCT05660135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101655453|NCT05660135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655454|NCT05660135|Vasodilator Agents|vasodilator agents|mesh-ancestor
101655455|NCT05660135|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101655456|NCT05660135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101655457|NCT05660135|Antimetabolites|antimetabolites|mesh-ancestor
101655458|NCT05660135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101655459|NCT05660135|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101655460|NCT05660135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101655461|NCT05660135|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101655462|NCT05660135|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101655463|NCT05635929|Betaine|betaine|mesh-list
101655464|NCT05635929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101655465|NCT05635929|Lipotropic Agents|lipotropic agents|mesh-ancestor
101655466|NCT05635929|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101655467|NCT05635929|Antimetabolites|antimetabolites|mesh-ancestor
101655468|NCT05635929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655469|NCT05635929|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101655470|NCT05621668|Cyclophosphamide|cyclophosphamide|mesh-list
101655471|NCT05621668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101655472|NCT05621668|Immunologic Factors|immunologic factors|mesh-ancestor
101655473|NCT05621668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655474|NCT05621668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101655475|NCT05621668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101655476|NCT05621668|Alkylating Agents|alkylating agents|mesh-ancestor
101824522|NCT04926324|Niraparib|niraparib|mesh-list
101655477|NCT05621668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655478|NCT05621668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101655479|NCT05621668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101655480|NCT05606263|Nimotuzumab|nimotuzumab|mesh-list
101655481|NCT05606263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101655482|NCT05606263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101655483|NCT05599451|Pyrithione zinc|pyrithione zinc|mesh-list
101655484|NCT05599451|Keratolytic Agents|keratolytic agents|mesh-ancestor
101655485|NCT05599451|Dermatologic Agents|dermatologic agents|mesh-ancestor
101655486|NCT05597722|Amphetamine|amphetamine|mesh-list
101655487|NCT05597722|Adderall|adderall|mesh-list
101655488|NCT05597722|Dextroamphetamine|dextroamphetamine|mesh-list
101655489|NCT05597722|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101655490|NCT05597722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655491|NCT05597722|Sympathomimetics|sympathomimetics|mesh-ancestor
101655492|NCT05597722|Autonomic Agents|autonomic agents|mesh-ancestor
101655493|NCT05597722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101655494|NCT05597722|Dopamine Agents|dopamine agents|mesh-ancestor
101655495|NCT05597722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101655496|NCT05597722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655497|NCT05597722|Adrenergic Agents|adrenergic agents|mesh-ancestor
101655498|NCT05597722|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101655499|NCT05597722|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101655500|NCT05597722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101655501|NCT05597722|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101655502|NCT05555667|Propofol|propofol|mesh-list
101655503|NCT05555667|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101655504|NCT05555667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101655505|NCT05555667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655506|NCT05555667|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101655507|NCT05555667|Anesthetics, General|anesthetics, general|mesh-ancestor
101655508|NCT05555667|Anesthetics|anesthetics|mesh-ancestor
101655509|NCT05474846|Melatonin|melatonin|mesh-list
101655510|NCT05474846|Methylphenidate|methylphenidate|mesh-list
101655511|NCT05474846|Antioxidants|antioxidants|mesh-ancestor
101655512|NCT05474846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655514|NCT05474846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655515|NCT05474846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101655516|NCT05474846|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101655517|NCT05474846|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101655518|NCT05474846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101655519|NCT05474846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101655520|NCT05474846|Dopamine Agents|dopamine agents|mesh-ancestor
101655521|NCT05474846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101655522|NCT05462613|Aspirin|aspirin|mesh-list
101655523|NCT05462613|Bevacizumab|bevacizumab|mesh-list
101655524|NCT05462613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101655525|NCT05462613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101655526|NCT05462613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101655527|NCT05462613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101655528|NCT05462613|Growth Substances|growth substances|mesh-ancestor
101655529|NCT05462613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655530|NCT05462613|Growth Inhibitors|growth inhibitors|mesh-ancestor
101655531|NCT05462613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101655532|NCT05462613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101655533|NCT05462613|Analgesics|analgesics|mesh-ancestor
101655534|NCT05462613|Sensory System Agents|sensory system agents|mesh-ancestor
101655535|NCT05462613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101655536|NCT05462613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101655537|NCT05462613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101655538|NCT05462613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101655539|NCT05462613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101655540|NCT05462613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655541|NCT05462613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101655542|NCT05462613|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101655544|NCT05462613|Antipyretics|antipyretics|mesh-ancestor
101655545|NCT05411887|Olmesartan|olmesartan|mesh-list
101655546|NCT05411887|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101655547|NCT05411887|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101655548|NCT05411887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101655549|NCT05411887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101655550|NCT05411887|Antimetabolites|antimetabolites|mesh-ancestor
101451718|NCT00208065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101655551|NCT05411887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655552|NCT05411887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101655553|NCT05411887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101655554|NCT05411887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101655555|NCT05411887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101655556|NCT05411887|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101655557|NCT05411887|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101655558|NCT05398081|Ceftriaxone|ceftriaxone|mesh-list
101655559|NCT05398081|Cefuroxime|cefuroxime|mesh-list
101655560|NCT05398081|Cefuroxime axetil|cefuroxime axetil|mesh-list
101655561|NCT05398081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101655562|NCT05398081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101655563|NCT05364008|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
101655564|NCT05364008|Antioxidants|antioxidants|mesh-ancestor
101655565|NCT05364008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655566|NCT05364008|Protective Agents|protective agents|mesh-ancestor
101655567|NCT05364008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655568|NCT05364008|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101655569|NCT05364008|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101655570|NCT05364008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101655571|NCT05364008|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101655572|NCT05357898|Pembrolizumab|pembrolizumab|mesh-list
101655573|NCT05357898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101655574|NCT05357898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101655575|NCT05357898|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101655576|NCT05357898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655577|NCT05318573|Gemcitabine|gemcitabine|mesh-list
101655578|NCT05318573|Pembrolizumab|pembrolizumab|mesh-list
101655579|NCT05318573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101655580|NCT05318573|Antimetabolites|antimetabolites|mesh-ancestor
101655581|NCT05318573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655582|NCT05318573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101655583|NCT05318573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101655584|NCT05318573|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101655585|NCT05307770|Melatonin|melatonin|mesh-list
101655586|NCT05307770|Antioxidants|antioxidants|mesh-ancestor
101655592|NCT05307458|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101655593|NCT05307458|Naloxone|naloxone|mesh-list
101655594|NCT05307458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101655595|NCT05307458|Narcotics|narcotics|mesh-ancestor
101655596|NCT05307458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101655597|NCT05307458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655598|NCT05307458|Analgesics|analgesics|mesh-ancestor
101655599|NCT05307458|Sensory System Agents|sensory system agents|mesh-ancestor
101655600|NCT05307458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101655601|NCT05307458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101655608|NCT05199662|Tenecteplase|tenecteplase|mesh-list
101655609|NCT05199662|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101655610|NCT05199662|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101655611|NCT05199662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655612|NCT05198934|Trifluridine|trifluridine|mesh-list
101655613|NCT05198934|Panitumumab|panitumumab|mesh-list
101655614|NCT05198934|Sotorasib|sotorasib|mesh-list
101655615|NCT05198934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101655616|NCT05198934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101655617|NCT05198934|Antimetabolites|antimetabolites|mesh-ancestor
101824538|NCT00840671|Protective Agents|protective agents|mesh-ancestor
101655618|NCT05198934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655620|NCT05198934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101655621|NCT05198934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101655623|NCT05123053|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101655624|NCT05123053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101655625|NCT05123053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655626|NCT05123053|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101655627|NCT05123053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101655628|NCT05123053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655629|NCT05109702|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101655630|NCT05109702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101655631|NCT05060744|Antacids|antacids|mesh-list
101655632|NCT05060744|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
101655633|NCT05060744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655634|NCT05060744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101655635|NCT05057117|Botulinum Toxins|botulinum toxins|mesh-list
101655636|NCT05057117|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101655637|NCT05057117|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101655638|NCT05057117|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101655639|NCT05057117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101655640|NCT05057117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655641|NCT05057117|Cholinergic Agents|cholinergic agents|mesh-ancestor
101655642|NCT05057117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101655643|NCT05057117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655644|NCT05057117|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101655645|NCT05057117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101655646|NCT05047939|Propofol|propofol|mesh-list
101655647|NCT05047939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101655648|NCT05047939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101655649|NCT05047939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655650|NCT05047939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101655651|NCT05047939|Anesthetics, General|anesthetics, general|mesh-ancestor
101655652|NCT05047939|Anesthetics|anesthetics|mesh-ancestor
101655653|NCT05041127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101655654|NCT05041127|Cetuximab|cetuximab|mesh-list
101655655|NCT05041127|Antibodies|antibodies|mesh-list
101655656|NCT05041127|Immunoglobulins|immunoglobulins|mesh-list
101655657|NCT05041127|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101655658|NCT05041127|Immunologic Factors|immunologic factors|mesh-ancestor
101655659|NCT05041127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655660|NCT05041127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101655661|NCT04926285|Venetoclax|venetoclax|mesh-list
101655662|NCT04926285|Homoharringtonine|homoharringtonine|mesh-list
101655663|NCT04926285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101655664|NCT04926285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101655665|NCT04926285|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101655666|NCT04926285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101655667|NCT04926285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655668|NCT04858854|Sulforaphane|sulforaphane|mesh-list
101655669|NCT04858854|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101655670|NCT04858854|Protective Agents|protective agents|mesh-ancestor
101655671|NCT04858854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655672|NCT04858854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101655673|NCT04856566|Ethanol|ethanol|mesh-list
101655674|NCT04856566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101655675|NCT04856566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101655676|NCT04856566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101655677|NCT04856566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655678|NCT04798482|Dexmedetomidine|dexmedetomidine|mesh-list
101655679|NCT04798482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101655680|NCT04798482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101655681|NCT04798482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655682|NCT04798482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101655683|NCT04798482|Analgesics|analgesics|mesh-ancestor
101655684|NCT04798482|Sensory System Agents|sensory system agents|mesh-ancestor
101655685|NCT04798482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101655686|NCT04798482|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101655687|NCT04798482|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101655688|NCT04798482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101655689|NCT04798482|Adrenergic Agents|adrenergic agents|mesh-ancestor
101655690|NCT04798482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101655691|NCT04798482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655692|NCT04774250|Zonisamide|zonisamide|mesh-list
101655693|NCT04774250|Anticonvulsants|anticonvulsants|mesh-ancestor
101655694|NCT04774250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101655695|NCT04774250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101655696|NCT04774250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655697|NCT04774250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101655698|NCT04774250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655699|NCT04768569|Zonisamide|zonisamide|mesh-list
101655700|NCT04768569|Anticonvulsants|anticonvulsants|mesh-ancestor
101655701|NCT04768569|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101655702|NCT04768569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101655703|NCT04768569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655704|NCT04768569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101655705|NCT04768569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655706|NCT04721132|Bevacizumab|bevacizumab|mesh-list
101655707|NCT04721132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101655708|NCT04721132|Atezolizumab|atezolizumab|mesh-list
101655709|NCT04721132|Endothelial Growth Factors|endothelial growth factors|mesh-list
101655710|NCT04721132|Antibodies|antibodies|mesh-list
101655711|NCT04721132|Immunoglobulins|immunoglobulins|mesh-list
101655712|NCT04721132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101655713|NCT04721132|Immunoglobulin G|immunoglobulin g|mesh-list
101655714|NCT04721132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101655715|NCT04721132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101655716|NCT04721132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101655717|NCT04721132|Growth Substances|growth substances|mesh-ancestor
101655718|NCT04721132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655719|NCT04721132|Growth Inhibitors|growth inhibitors|mesh-ancestor
101655720|NCT04721132|Immunologic Factors|immunologic factors|mesh-ancestor
101655721|NCT04721132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101655722|NCT04721132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655723|NCT04711837|Propofol|propofol|mesh-list
101655724|NCT04711837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101655725|NCT04711837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101655726|NCT04711837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655727|NCT04711837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101655728|NCT04711837|Anesthetics, General|anesthetics, general|mesh-ancestor
101655729|NCT04711837|Anesthetics|anesthetics|mesh-ancestor
101655730|NCT04669457|Midazolam|midazolam|mesh-list
101655731|NCT04669457|Dexmedetomidine|dexmedetomidine|mesh-list
101655732|NCT04669457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101655733|NCT04669457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101655734|NCT04669457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655735|NCT04669457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101655736|NCT04669457|Analgesics|analgesics|mesh-ancestor
101655737|NCT04669457|Sensory System Agents|sensory system agents|mesh-ancestor
101655738|NCT04669457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101655739|NCT04669457|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101655740|NCT04669457|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101655741|NCT04669457|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101655742|NCT04669457|Adrenergic Agents|adrenergic agents|mesh-ancestor
101655743|NCT04669457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101655744|NCT04669457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655745|NCT04669457|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101655746|NCT04669457|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101655747|NCT04669457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101655748|NCT04669457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101655749|NCT04669457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101655750|NCT04669457|Anesthetics, General|anesthetics, general|mesh-ancestor
101655751|NCT04669457|Anesthetics|anesthetics|mesh-ancestor
101824560|NCT04042805|Lenvatinib|lenvatinib|mesh-list
101655752|NCT04669457|GABA Modulators|gaba modulators|mesh-ancestor
101655753|NCT04669457|GABA Agents|gaba agents|mesh-ancestor
101655754|NCT04642365|Atezolizumab|atezolizumab|mesh-list
101655755|NCT04642365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101655756|NCT04642365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655757|NCT04642365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101655758|NCT04642365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101655759|NCT04626635|Cemiplimab|cemiplimab|mesh-list
101655760|NCT04626635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101655761|NCT04626635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101655762|NCT04537715|Itraconazole|itraconazole|mesh-list
101655763|NCT04537715|Rifampin|rifampin|mesh-list
101655764|NCT04537715|Antifungal Agents|antifungal agents|mesh-ancestor
101655765|NCT04537715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101655766|NCT04537715|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101655767|NCT04537715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101655768|NCT04537715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101655769|NCT04537715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655770|NCT04537715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101655771|NCT04537715|Hormone Antagonists|hormone antagonists|mesh-ancestor
101451719|NCT00208065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655772|NCT04537715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101655773|NCT04537715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655774|NCT04537715|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101655775|NCT04537715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101655776|NCT04537715|Antitubercular Agents|antitubercular agents|mesh-ancestor
101655777|NCT04537715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101655778|NCT04537715|Leprostatic Agents|leprostatic agents|mesh-ancestor
101655779|NCT04537715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101655780|NCT04537715|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101655781|NCT04537715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101655782|NCT04537715|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101655783|NCT04537715|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101655784|NCT04537715|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101655785|NCT04537715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101655788|NCT04532528|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101655789|NCT04532528|Protease Inhibitors|protease inhibitors|mesh-ancestor
101655790|NCT04532528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101655791|NCT04532528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655792|NCT04532528|Anticoagulants|anticoagulants|mesh-ancestor
101655793|NCT04427956|Riboflavin|riboflavin|mesh-list
101655794|NCT04427956|Vitamin B Complex|vitamin b complex|mesh-ancestor
101655795|NCT04427956|Vitamins|vitamins|mesh-ancestor
101655796|NCT04427956|Micronutrients|micronutrients|mesh-ancestor
101655797|NCT04427956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655798|NCT04427956|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101655799|NCT04427956|Dermatologic Agents|dermatologic agents|mesh-ancestor
101655800|NCT04427241|Cerebrolysin|cerebrolysin|mesh-list
101655801|NCT04427241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101655802|NCT04427241|Protective Agents|protective agents|mesh-ancestor
101655803|NCT04427241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655804|NCT04427241|Nootropic Agents|nootropic agents|mesh-ancestor
101655805|NCT04324463|Aspirin|aspirin|mesh-list
101655806|NCT04324463|Interferons|interferons|mesh-list
101655807|NCT04324463|Interferon-beta|interferon-beta|mesh-list
101655808|NCT04324463|Colchicine|colchicine|mesh-list
101655809|NCT04324463|Rivaroxaban|rivaroxaban|mesh-list
101655810|NCT04324463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101655811|NCT04324463|Antiviral Agents|antiviral agents|mesh-ancestor
101655812|NCT04324463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101655813|NCT04324463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101655814|NCT04324463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101655815|NCT04324463|Analgesics|analgesics|mesh-ancestor
101655816|NCT04324463|Sensory System Agents|sensory system agents|mesh-ancestor
101655817|NCT04324463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101655818|NCT04324463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655819|NCT04324463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101655820|NCT04324463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101655821|NCT04324463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101655822|NCT04324463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101655823|NCT04324463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655824|NCT04324463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101655825|NCT04324463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101655826|NCT04324463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101655827|NCT04324463|Antipyretics|antipyretics|mesh-ancestor
101655828|NCT04324463|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101655829|NCT04324463|Antithrombins|antithrombins|mesh-ancestor
101655830|NCT04324463|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101655831|NCT04324463|Protease Inhibitors|protease inhibitors|mesh-ancestor
101655832|NCT04324463|Anticoagulants|anticoagulants|mesh-ancestor
101655833|NCT04324463|Gout Suppressants|gout suppressants|mesh-ancestor
101655834|NCT04324463|Tubulin Modulators|tubulin modulators|mesh-ancestor
101655835|NCT04324463|Antimitotic Agents|antimitotic agents|mesh-ancestor
101655836|NCT04324463|Mitosis Modulators|mitosis modulators|mesh-ancestor
101655837|NCT04324463|Immunologic Factors|immunologic factors|mesh-ancestor
101655839|NCT04315701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101313003|NCT00388258|Alvimopan|alvimopan|mesh-list
101655840|NCT04315701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101655841|NCT04240093|Analgesics, Opioid|analgesics, opioid|mesh-list
101655842|NCT04240093|Narcotics|narcotics|mesh-ancestor
101655843|NCT04240093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101655844|NCT04240093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655845|NCT04240093|Analgesics|analgesics|mesh-ancestor
101655846|NCT04240093|Sensory System Agents|sensory system agents|mesh-ancestor
101655847|NCT04240093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101655848|NCT04213794|Sodium thiosulfate|sodium thiosulfate|mesh-list
101655849|NCT04213794|Cisplatin|cisplatin|mesh-list
101655850|NCT04213794|Doxorubicin|doxorubicin|mesh-list
101655851|NCT04213794|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101655852|NCT04213794|Daunorubicin|daunorubicin|mesh-list
101655853|NCT04213794|Antidotes|antidotes|mesh-list
101655854|NCT04213794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101655855|NCT04213794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101655856|NCT04213794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101655857|NCT04213794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101655858|NCT04213794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101655859|NCT04213794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655860|NCT04213794|Protective Agents|protective agents|mesh-ancestor
101655861|NCT04213794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655862|NCT04213794|Antioxidants|antioxidants|mesh-ancestor
101655863|NCT04213794|Antitubercular Agents|antitubercular agents|mesh-ancestor
101655864|NCT04213794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101655865|NCT04213794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101655866|NCT04213794|Chelating Agents|chelating agents|mesh-ancestor
101655867|NCT04213794|Sequestering Agents|sequestering agents|mesh-ancestor
101655868|NCT04157335|Benralizumab|benralizumab|mesh-list
101655869|NCT04157335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101655870|NCT04157335|Respiratory System Agents|respiratory system agents|mesh-ancestor
101655871|NCT04115774|Diphosphonates|diphosphonates|mesh-list
101655872|NCT04115774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101655873|NCT04115774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655874|NCT04083170|Vidarabine|vidarabine|mesh-list
101655875|NCT04083170|Cyclophosphamide|cyclophosphamide|mesh-list
101655876|NCT04083170|Thiotepa|thiotepa|mesh-list
101655877|NCT04083170|Fludarabine|fludarabine|mesh-list
101655878|NCT04083170|Fludarabine phosphate|fludarabine phosphate|mesh-list
101655879|NCT04083170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101655880|NCT04083170|Immunologic Factors|immunologic factors|mesh-ancestor
101655881|NCT04083170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655882|NCT04083170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101655883|NCT04083170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101655884|NCT04083170|Alkylating Agents|alkylating agents|mesh-ancestor
101655885|NCT04083170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824572|NCT00841139|Perhexiline|perhexiline|mesh-list
101655886|NCT04083170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101655887|NCT04083170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101655888|NCT04083170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101655889|NCT04083170|Antimetabolites|antimetabolites|mesh-ancestor
101655890|NCT04083170|Antiviral Agents|antiviral agents|mesh-ancestor
101655891|NCT04083170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101655892|NCT04025359|Dronabinol|dronabinol|mesh-list
101655893|NCT04025359|Hallucinogens|hallucinogens|mesh-ancestor
101655894|NCT04025359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655895|NCT04025359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101655896|NCT04025359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101655897|NCT04025359|Analgesics|analgesics|mesh-ancestor
101655898|NCT04025359|Sensory System Agents|sensory system agents|mesh-ancestor
101655899|NCT04025359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101655900|NCT04025359|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101655901|NCT04025359|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101655902|NCT04025359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101655903|NCT04025359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655904|NCT04025359|Hormones|hormones|mesh-ancestor
101655905|NCT04025359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101655906|NCT04005716|Cisplatin|cisplatin|mesh-list
101655907|NCT04005716|Carboplatin|carboplatin|mesh-list
101655908|NCT04005716|Etoposide|etoposide|mesh-list
101655909|NCT04005716|Etoposide phosphate|etoposide phosphate|mesh-list
101655910|NCT04005716|Tislelizumab|tislelizumab|mesh-list
101655911|NCT04005716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101655912|NCT04005716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101655913|NCT04005716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101655914|NCT04005716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101655915|NCT04005716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101655916|NCT04005716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655917|NCT04005716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101655918|NCT03972280|Antibodies|antibodies|mesh-list
101655919|NCT03972280|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101655920|NCT03972280|Lenograstim|lenograstim|mesh-list
101655921|NCT03972280|Immunologic Factors|immunologic factors|mesh-ancestor
101655922|NCT03972280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655923|NCT03972280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101655924|NCT03961568|Cenobamate|cenobamate|mesh-list
101655925|NCT03961568|Anticonvulsants|anticonvulsants|mesh-ancestor
101655926|NCT03941886|Aspirin|aspirin|mesh-list
101655927|NCT03941886|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101655928|NCT03941886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101655929|NCT03941886|Analgesics|analgesics|mesh-ancestor
101655930|NCT03941886|Sensory System Agents|sensory system agents|mesh-ancestor
101655931|NCT03941886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101655932|NCT03941886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655933|NCT03941886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101655934|NCT03941886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101655935|NCT03941886|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101655936|NCT03941886|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101655937|NCT03941886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655938|NCT03941886|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101655939|NCT03941886|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101655940|NCT03941886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101655941|NCT03941886|Antipyretics|antipyretics|mesh-ancestor
101655942|NCT03921008|Paclitaxel|paclitaxel|mesh-list
101655943|NCT03921008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101655944|NCT03921008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101655945|NCT03921008|Tubulin Modulators|tubulin modulators|mesh-ancestor
101655946|NCT03921008|Antimitotic Agents|antimitotic agents|mesh-ancestor
101655947|NCT03921008|Mitosis Modulators|mitosis modulators|mesh-ancestor
101655948|NCT03921008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655949|NCT03845296|Rucaparib|rucaparib|mesh-list
101655950|NCT03845296|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101655951|NCT03845296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101655952|NCT03845296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101824579|NCT00844337|Amoxicillin|amoxicillin|mesh-list
101655953|NCT03845296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101655954|NCT03813108|Lumefantrine|lumefantrine|mesh-list
101655955|NCT03813108|Artemether|artemether|mesh-list
101655956|NCT03813108|Mefloquine|mefloquine|mesh-list
101655957|NCT03813108|Atovaquone|atovaquone|mesh-list
101655958|NCT03813108|Proguanil|proguanil|mesh-list
101655959|NCT03813108|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
101655960|NCT03813108|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101655961|NCT03813108|Antimalarials|antimalarials|mesh-ancestor
101655962|NCT03813108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101655963|NCT03813108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101655964|NCT03813108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101655965|NCT03813108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101655966|NCT03813108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655967|NCT03813108|Antimetabolites|antimetabolites|mesh-ancestor
101655968|NCT03675737|Pembrolizumab|pembrolizumab|mesh-list
101655969|NCT03675737|Fluorouracil|fluorouracil|mesh-list
101655970|NCT03675737|Capecitabine|capecitabine|mesh-list
101655971|NCT03675737|Oxaliplatin|oxaliplatin|mesh-list
101655972|NCT03675737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101655973|NCT03675737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101655974|NCT03675737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101655975|NCT03675737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655977|NCT03675737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101655978|NCT03675737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101655979|NCT03675737|Immunologic Factors|immunologic factors|mesh-ancestor
101655980|NCT03675737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655981|NCT03621748|Anesthetics|anesthetics|mesh-list
101655982|NCT03621748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101655983|NCT03621748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655984|NCT03586453|Osimertinib|osimertinib|mesh-list
101655985|NCT03586453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101655986|NCT03586453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101655987|NCT03586453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101655988|NCT03586453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655989|NCT03440450|Gemcitabine|gemcitabine|mesh-list
101655990|NCT03440450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101655991|NCT03440450|Antimetabolites|antimetabolites|mesh-ancestor
101655992|NCT03440450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101655993|NCT03440450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101655994|NCT03417154|Cyclophosphamide|cyclophosphamide|mesh-list
101655995|NCT03417154|Nivolumab|nivolumab|mesh-list
101655996|NCT03417154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101655997|NCT03417154|Immunologic Factors|immunologic factors|mesh-ancestor
101655998|NCT03417154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101655999|NCT03417154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101656000|NCT03417154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101656001|NCT03417154|Alkylating Agents|alkylating agents|mesh-ancestor
101656002|NCT03417154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409273|NCT00347698|Growth Inhibitors|growth inhibitors|mesh-ancestor
101656003|NCT03417154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101656004|NCT03417154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101656005|NCT03417154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101656006|NCT03417154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101656007|NCT03396315|Zoledronic Acid|zoledronic acid|mesh-list
101656008|NCT03396315|Alendronate|alendronate|mesh-list
101656009|NCT03396315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101656010|NCT03396315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656011|NCT03332017|Obinutuzumab|obinutuzumab|mesh-list
101656012|NCT03332017|Zanubrutinib|zanubrutinib|mesh-list
101656013|NCT03332017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101656014|NCT03332017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101656015|NCT03332017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101656016|NCT03332017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101656017|NCT03332017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656018|NCT03221036|Vedolizumab|vedolizumab|mesh-list
101656019|NCT03221036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101656053|NCT03032783|Antitubercular Agents|antitubercular agents|mesh-ancestor
101656054|NCT03032783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101656055|NCT03032783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101656056|NCT02778685|Pembrolizumab|pembrolizumab|mesh-list
101656057|NCT02778685|Letrozole|letrozole|mesh-list
101656058|NCT02778685|Fulvestrant|fulvestrant|mesh-list
101656059|NCT02778685|Palbociclib|palbociclib|mesh-list
101656060|NCT02778685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101656061|NCT02778685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101656062|NCT02778685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101656063|NCT02778685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656064|NCT02778685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101656065|NCT02778685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101656066|NCT02778685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101656067|NCT02778685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101656068|NCT02778685|Hormone Antagonists|hormone antagonists|mesh-ancestor
101656069|NCT02778685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101656070|NCT02778685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656071|NCT02778685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101656072|NCT02778685|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101656073|NCT02778685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101656074|NCT02740985|Docetaxel|docetaxel|mesh-list
101656075|NCT02740985|Durvalumab|durvalumab|mesh-list
101656076|NCT02740985|Abiraterone Acetate|abiraterone acetate|mesh-list
101656077|NCT02740985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101656078|NCT02740985|Tubulin Modulators|tubulin modulators|mesh-ancestor
101656079|NCT02740985|Antimitotic Agents|antimitotic agents|mesh-ancestor
101656080|NCT02740985|Mitosis Modulators|mitosis modulators|mesh-ancestor
101656081|NCT02740985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656082|NCT02740985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101656083|NCT02740985|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101656084|NCT02740985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101656085|NCT02740985|Hormone Antagonists|hormone antagonists|mesh-ancestor
101824594|NCT00851513|Lidocaine|lidocaine|mesh-list
101656086|NCT02740985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101656087|NCT02740985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656088|NCT02740985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101656090|NCT02728531|Rituximab|rituximab|mesh-list
101656091|NCT02728531|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101656092|NCT02728531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101656093|NCT02728531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101656094|NCT02728531|Immunologic Factors|immunologic factors|mesh-ancestor
101656095|NCT02728531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656096|NCT02728531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101656097|NCT02728531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101656098|NCT02728531|Antimetabolites|antimetabolites|mesh-ancestor
101656099|NCT02728531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656100|NCT02728531|Antiviral Agents|antiviral agents|mesh-ancestor
101656101|NCT02728531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101656102|NCT02728531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101656103|NCT02728531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101656104|NCT02728531|Alkylating Agents|alkylating agents|mesh-ancestor
101656105|NCT02723331|Paclitaxel|paclitaxel|mesh-list
101656106|NCT02723331|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101656107|NCT02723331|Gemcitabine|gemcitabine|mesh-list
101656108|NCT02723331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101656109|NCT02723331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101656110|NCT02723331|Tubulin Modulators|tubulin modulators|mesh-ancestor
101656111|NCT02723331|Antimitotic Agents|antimitotic agents|mesh-ancestor
101656112|NCT02723331|Mitosis Modulators|mitosis modulators|mesh-ancestor
101656113|NCT02723331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656114|NCT02723331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101656117|NCT02593526|Dialysis Solutions|dialysis solutions|mesh-list
101656118|NCT02593526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101656119|NCT02593526|Diuretics|diuretics|mesh-ancestor
101656120|NCT02593526|Natriuretic Agents|natriuretic agents|mesh-ancestor
101656121|NCT02593526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656122|NCT02593526|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101656123|NCT02593526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101656124|NCT02593526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656125|NCT02484677|Docetaxel|docetaxel|mesh-list
101656126|NCT02484677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101656127|NCT02484677|Tubulin Modulators|tubulin modulators|mesh-ancestor
101656128|NCT02484677|Antimitotic Agents|antimitotic agents|mesh-ancestor
101656129|NCT02484677|Mitosis Modulators|mitosis modulators|mesh-ancestor
101656130|NCT02484677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656131|NCT02476097|Esomeprazole|esomeprazole|mesh-list
101656132|NCT02476097|Omeprazole|omeprazole|mesh-list
101656133|NCT02476097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101656134|NCT02476097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101656135|NCT02476097|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101656136|NCT02476097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101656137|NCT02476097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656138|NCT02456857|Bevacizumab|bevacizumab|mesh-list
101656139|NCT02456857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101656140|NCT02456857|Doxorubicin|doxorubicin|mesh-list
101656141|NCT02456857|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101313291|NCT05637073|Dienogest|dienogest|mesh-list
101656142|NCT02456857|Everolimus|everolimus|mesh-list
101656143|NCT02456857|Endothelial Growth Factors|endothelial growth factors|mesh-list
101656144|NCT02456857|Antibodies|antibodies|mesh-list
101656145|NCT02456857|Immunoglobulins|immunoglobulins|mesh-list
101656146|NCT02456857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101656147|NCT02456857|Immunoglobulin G|immunoglobulin g|mesh-list
101656148|NCT02456857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101656149|NCT02456857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101656150|NCT02456857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101656152|NCT02456857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656153|NCT02456857|Growth Inhibitors|growth inhibitors|mesh-ancestor
101656154|NCT02456857|Immunologic Factors|immunologic factors|mesh-ancestor
101656155|NCT02456857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101656156|NCT02456857|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101656157|NCT02456857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101656158|NCT02456857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101656159|NCT02456857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656160|NCT02456857|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101656161|NCT02456857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101656162|NCT02456857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101656163|NCT03946358|Atezolizumab|atezolizumab|mesh-list
101656164|NCT03946358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101656165|NCT03946358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656166|NCT03946358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101656167|NCT03946358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101656168|NCT02115282|Exemestane|exemestane|mesh-list
101656169|NCT02115282|Goserelin|goserelin|mesh-list
101656170|NCT02115282|Entinostat|entinostat|mesh-list
101656171|NCT02115282|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
101656172|NCT02115282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101656173|NCT02115282|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101656174|NCT02115282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101656175|NCT02115282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101656176|NCT02115282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656177|NCT02115282|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101656178|NCT02115282|Hormone Antagonists|hormone antagonists|mesh-ancestor
101656179|NCT02115282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101656180|NCT02115282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656181|NCT02115282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101656182|NCT02106507|Everolimus|everolimus|mesh-list
101656183|NCT02106507|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101656184|NCT02106507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101656186|NCT02106507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656187|NCT02106507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101656188|NCT02106507|Immunologic Factors|immunologic factors|mesh-ancestor
101656189|NCT02106507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656190|NCT02106507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101656192|NCT02051218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101656193|NCT02051218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656194|NCT01940094|Prednisone|prednisone|mesh-list
101656195|NCT01940094|Glucocorticoids|glucocorticoids|mesh-list
101656196|NCT01940094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101656197|NCT01940094|Hormones|hormones|mesh-ancestor
101656198|NCT01940094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101656199|NCT01940094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656200|NCT01940094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101656201|NCT01940094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101656202|NCT01905046|Metformin|metformin|mesh-list
101656203|NCT01905046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101656204|NCT01905046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656205|NCT01786265|Prednisone|prednisone|mesh-list
101656206|NCT01786265|Cortisone|cortisone|mesh-list
101656207|NCT01786265|Leuprolide|leuprolide|mesh-list
101656208|NCT01786265|Goserelin|goserelin|mesh-list
101656209|NCT01786265|Flutamide|flutamide|mesh-list
101656210|NCT01786265|Abiraterone Acetate|abiraterone acetate|mesh-list
101656211|NCT01786265|Bicalutamide|bicalutamide|mesh-list
101656212|NCT01786265|Nilutamide|nilutamide|mesh-list
101656213|NCT01786265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101656214|NCT01786265|Glucocorticoids|glucocorticoids|mesh-ancestor
101656215|NCT01786265|Hormones|hormones|mesh-ancestor
101313369|NCT05639257|Mexiletine|mexiletine|mesh-list
101656216|NCT01786265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101656217|NCT01786265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656218|NCT01786265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101656219|NCT01786265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101824613|NCT00841841|Antipyretics|antipyretics|mesh-ancestor
101656220|NCT01786265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101656221|NCT01786265|Fertility Agents|fertility agents|mesh-ancestor
101656222|NCT01786265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101656223|NCT01786265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101656224|NCT01786265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101656225|NCT01786265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656226|NCT01786265|Hormone Antagonists|hormone antagonists|mesh-ancestor
101656227|NCT01786265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101656228|NCT01786265|Androgen Antagonists|androgen antagonists|mesh-ancestor
101656229|NCT01596621|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101656230|NCT01596621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101656231|NCT01596621|Alkylating Agents|alkylating agents|mesh-ancestor
101656232|NCT01596621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656233|NCT01596621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101656234|NCT01264315|Lenalidomide|lenalidomide|mesh-list
101656235|NCT01264315|Immunologic Factors|immunologic factors|mesh-ancestor
101656236|NCT01264315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656237|NCT01264315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101656238|NCT01264315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101656239|NCT01264315|Growth Substances|growth substances|mesh-ancestor
101656240|NCT01264315|Growth Inhibitors|growth inhibitors|mesh-ancestor
101656241|NCT01264315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101656242|NCT01108627|Formoterol Fumarate|formoterol fumarate|mesh-list
101656243|NCT01108627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101656244|NCT01108627|Autonomic Agents|autonomic agents|mesh-ancestor
101656245|NCT01108627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101656246|NCT01108627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656247|NCT01108627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101656248|NCT01108627|Respiratory System Agents|respiratory system agents|mesh-ancestor
101656249|NCT01108627|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101656250|NCT01108627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101656251|NCT01108627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101656252|NCT01108627|Adrenergic Agents|adrenergic agents|mesh-ancestor
101656253|NCT01108627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101656254|NCT01108627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656255|NCT00890149|Ondansetron|ondansetron|mesh-list
101656257|NCT00890149|Autonomic Agents|autonomic agents|mesh-ancestor
101656258|NCT00890149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101656259|NCT00890149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656260|NCT00890149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101656261|NCT00890149|Antipruritics|antipruritics|mesh-ancestor
101656262|NCT00890149|Dermatologic Agents|dermatologic agents|mesh-ancestor
101656263|NCT00890149|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101656264|NCT00890149|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101656265|NCT00890149|Serotonin Agents|serotonin agents|mesh-ancestor
101656266|NCT00890149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101656267|NCT00890149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656268|NCT00566098|Melphalan|melphalan|mesh-list
101656269|NCT00566098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101656270|NCT00566098|Alkylating Agents|alkylating agents|mesh-ancestor
101656271|NCT00566098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656272|NCT00566098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101656273|NCT00566098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101656274|NCT00566098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101656275|NCT00566098|Immunologic Factors|immunologic factors|mesh-ancestor
101656276|NCT00566098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656277|NCT00248287|Carboplatin|carboplatin|mesh-list
101656278|NCT00248287|Irinotecan|irinotecan|mesh-list
101656279|NCT00248287|Cetuximab|cetuximab|mesh-list
101656280|NCT00248287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101656281|NCT00248287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101656282|NCT00248287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101656283|NCT00248287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101656284|NCT00248287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656285|NCT00248287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101656286|NCT04249284|Deucravacitinib|deucravacitinib|mesh-list
101656287|NCT04249284|Dermatologic Agents|dermatologic agents|mesh-ancestor
101656288|NCT04249284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101656289|NCT04249284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101656290|NCT04249284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656292|NCT04474938|Bortezomib|bortezomib|mesh-list
101656293|NCT04474938|Daratumumab|daratumumab|mesh-list
101656294|NCT04474938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101656295|NCT04474938|Antiemetics|antiemetics|mesh-ancestor
101656296|NCT04474938|Autonomic Agents|autonomic agents|mesh-ancestor
101656297|NCT04474938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101656298|NCT04474938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656299|NCT04474938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101656300|NCT04474938|Glucocorticoids|glucocorticoids|mesh-ancestor
101656301|NCT04474938|Hormones|hormones|mesh-ancestor
101656302|NCT04474938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101656303|NCT04474938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101656304|NCT04474938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101656305|NCT00837213|Doxycycline|doxycycline|mesh-list
101656306|NCT00837213|Clindamycin|clindamycin|mesh-list
101656307|NCT00837213|Clindamycin palmitate|clindamycin palmitate|mesh-list
101656308|NCT00837213|Clindamycin phosphate|clindamycin phosphate|mesh-list
101656309|NCT00837213|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101656310|NCT00837213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101656311|NCT00837213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101656312|NCT00837213|Antimalarials|antimalarials|mesh-ancestor
101656313|NCT00837213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101656314|NCT00837213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101656315|NCT00837213|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101656316|NCT00837213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101656317|NCT00837213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656318|NCT00837213|Dermatologic Agents|dermatologic agents|mesh-ancestor
101656319|NCT02833038|Magnesium Sulfate|magnesium sulfate|mesh-list
101656320|NCT02833038|Analgesics|analgesics|mesh-ancestor
101656321|NCT02833038|Sensory System Agents|sensory system agents|mesh-ancestor
101656322|NCT02833038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101656323|NCT02833038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656324|NCT02833038|Anesthetics|anesthetics|mesh-ancestor
101656325|NCT02833038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101656326|NCT02833038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101656327|NCT02833038|Anticonvulsants|anticonvulsants|mesh-ancestor
101656328|NCT02833038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101656329|NCT02833038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101656330|NCT02833038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656331|NCT02833038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101656332|NCT02833038|Tocolytic Agents|tocolytic agents|mesh-ancestor
101656333|NCT02833038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101656334|NCT00703755|Metformin|metformin|mesh-list
101656335|NCT00703755|Fenofibrate|fenofibrate|mesh-list
101656336|NCT00703755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101656337|NCT00703755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656338|NCT00703755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101656339|NCT00703755|Antimetabolites|antimetabolites|mesh-ancestor
101656340|NCT00703755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656341|NCT00703755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101656342|NCT02838342|Interferons|interferons|mesh-list
101656343|NCT02838342|Interferon-alpha|interferon-alpha|mesh-list
101656344|NCT02838342|Cyclophosphamide|cyclophosphamide|mesh-list
101656345|NCT02838342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101656346|NCT02838342|Immunologic Factors|immunologic factors|mesh-ancestor
101656347|NCT02838342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656348|NCT02838342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101656349|NCT02838342|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101656350|NCT02838342|Alkylating Agents|alkylating agents|mesh-ancestor
101656351|NCT02838342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656352|NCT02838342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101656353|NCT02838342|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101656354|NCT02838342|Antiviral Agents|antiviral agents|mesh-ancestor
101824621|NCT00841919|Insulin|insulin|mesh-list
101656355|NCT02838342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101656357|NCT05333640|Paclitaxel|paclitaxel|mesh-list
101656358|NCT05333640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101656359|NCT05333640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101656360|NCT05333640|Tubulin Modulators|tubulin modulators|mesh-ancestor
101656361|NCT05333640|Antimitotic Agents|antimitotic agents|mesh-ancestor
101656362|NCT05333640|Mitosis Modulators|mitosis modulators|mesh-ancestor
101656363|NCT05333640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656364|NCT05333640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101656365|NCT05333640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101656366|NCT05333640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101656367|NCT05333640|Antifungal Agents|antifungal agents|mesh-ancestor
101656368|NCT05333640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101656369|NCT05333640|Immunologic Factors|immunologic factors|mesh-ancestor
101656370|NCT05333640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656372|NCT02838264|Antifungal Agents|antifungal agents|mesh-ancestor
101656373|NCT02838264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101656374|NCT02838264|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101656375|NCT02838264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101656376|NCT02838264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101656377|NCT02838264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656378|NCT02838264|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101656379|NCT02838264|Hormone Antagonists|hormone antagonists|mesh-ancestor
101656380|NCT02838264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101656381|NCT02838264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656382|NCT02838264|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101656383|NCT00633438|Celecoxib|celecoxib|mesh-list
101656384|NCT00633438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101656385|NCT00633438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101656386|NCT00633438|Analgesics|analgesics|mesh-ancestor
101656387|NCT00633438|Sensory System Agents|sensory system agents|mesh-ancestor
101656388|NCT00633438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101656389|NCT00633438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656390|NCT00633438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101656391|NCT00633438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101656392|NCT00633438|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101656393|NCT00633438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101656395|NCT00633438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656396|NCT02833116|Dexamethasone|dexamethasone|mesh-list
101656397|NCT02833116|Betamethasone|betamethasone|mesh-list
101656398|NCT02833116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101656399|NCT02833116|Antiemetics|antiemetics|mesh-ancestor
101656400|NCT02833116|Autonomic Agents|autonomic agents|mesh-ancestor
101656401|NCT02833116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101656402|NCT02833116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656403|NCT02833116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101656404|NCT02833116|Glucocorticoids|glucocorticoids|mesh-ancestor
101656405|NCT02833116|Hormones|hormones|mesh-ancestor
101656406|NCT02833116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101656407|NCT02833116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101656408|NCT02833116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101656409|NCT02833116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101656410|NCT02833116|Respiratory System Agents|respiratory system agents|mesh-ancestor
101656411|NCT00703989|Thioctic Acid|thioctic acid|mesh-list
101656412|NCT00703989|Benphothiamine|benphothiamine|mesh-list
101656413|NCT00703989|Antioxidants|antioxidants|mesh-ancestor
101656414|NCT00703989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656415|NCT00703989|Protective Agents|protective agents|mesh-ancestor
101656416|NCT00703989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656417|NCT00703989|Vitamin B Complex|vitamin b complex|mesh-ancestor
101656418|NCT00703989|Vitamins|vitamins|mesh-ancestor
101656419|NCT00703989|Micronutrients|micronutrients|mesh-ancestor
101656420|NCT00703989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101656421|NCT00703989|Immunologic Factors|immunologic factors|mesh-ancestor
101656422|NCT00703989|Chelating Agents|chelating agents|mesh-ancestor
101656423|NCT00703989|Sequestering Agents|sequestering agents|mesh-ancestor
101656424|NCT05335460|Capecitabine|capecitabine|mesh-list
101656425|NCT05335460|Oxaliplatin|oxaliplatin|mesh-list
101656426|NCT05335460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101656427|NCT05335460|Antimetabolites|antimetabolites|mesh-ancestor
101656428|NCT05335460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656429|NCT05335460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101656430|NCT02836002|Pyrimethamine|pyrimethamine|mesh-list
101656431|NCT02836002|Piperaquine|piperaquine|mesh-list
101656432|NCT02836002|Sulfadoxine|sulfadoxine|mesh-list
101656433|NCT02836002|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101656434|NCT02836002|Atovaquone|atovaquone|mesh-list
101656435|NCT02836002|Proguanil|proguanil|mesh-list
101656436|NCT02836002|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
101656437|NCT02836002|Antimalarials|antimalarials|mesh-ancestor
101656438|NCT02836002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101656439|NCT02836002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101656440|NCT02836002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101656441|NCT02836002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101656442|NCT02836002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101656443|NCT02836002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656444|NCT02836002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101656445|NCT02836002|Antimetabolites|antimetabolites|mesh-ancestor
101656446|NCT02297516|Botulinum Toxins|botulinum toxins|mesh-list
101656447|NCT02297516|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101656448|NCT02297516|Hyaluronic Acid|hyaluronic acid|mesh-list
101656449|NCT02297516|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101656450|NCT02297516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101656451|NCT02297516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656452|NCT02297516|Cholinergic Agents|cholinergic agents|mesh-ancestor
101656453|NCT02297516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101656454|NCT02297516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656455|NCT02297516|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101656456|NCT02297516|Immunologic Factors|immunologic factors|mesh-ancestor
101656457|NCT02297516|Viscosupplements|viscosupplements|mesh-ancestor
101656458|NCT02297516|Protective Agents|protective agents|mesh-ancestor
101656459|NCT02842580|Leucovorin|leucovorin|mesh-list
101656460|NCT02842580|Bevacizumab|bevacizumab|mesh-list
101656461|NCT02842580|Capecitabine|capecitabine|mesh-list
101656462|NCT02842580|Oxaliplatin|oxaliplatin|mesh-list
101656463|NCT02842580|Irinotecan|irinotecan|mesh-list
101656464|NCT02842580|Levoleucovorin|levoleucovorin|mesh-list
101656465|NCT02842580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101656466|NCT02842580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101656467|NCT02842580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101656468|NCT02842580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101656469|NCT02842580|Growth Substances|growth substances|mesh-ancestor
101656470|NCT02842580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656471|NCT02842580|Growth Inhibitors|growth inhibitors|mesh-ancestor
101656472|NCT02842580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101656473|NCT02842580|Antimetabolites|antimetabolites|mesh-ancestor
101656474|NCT02842580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656475|NCT02842580|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101656476|NCT02842580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101656477|NCT02842580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101656478|NCT02842580|Antidotes|antidotes|mesh-ancestor
101656479|NCT02842580|Protective Agents|protective agents|mesh-ancestor
101656480|NCT02842580|Vitamin B Complex|vitamin b complex|mesh-ancestor
101656481|NCT02842580|Vitamins|vitamins|mesh-ancestor
101656482|NCT02842580|Micronutrients|micronutrients|mesh-ancestor
101656483|NCT00836277|Irinotecan|irinotecan|mesh-list
101656484|NCT00836277|Panitumumab|panitumumab|mesh-list
101656485|NCT00836277|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101656486|NCT00836277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101656487|NCT00836277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101656488|NCT00836277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656489|NCT00836277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101656490|NCT00836277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101656491|NCT00831025|Immunomodulating Agents|immunomodulating agents|mesh-list
101656492|NCT00831025|Immunologic Factors|immunologic factors|mesh-ancestor
101656493|NCT00831025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656494|NCT00835731|Vitamin B 12|vitamin b 12|mesh-list
101656495|NCT00835731|Hydroxocobalamin|hydroxocobalamin|mesh-list
101656496|NCT00835731|Misoprostol|misoprostol|mesh-list
101656498|NCT00835731|Micronutrients|micronutrients|mesh-ancestor
101656499|NCT00835731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656500|NCT00835731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101656501|NCT00835731|Abortifacient Agents|abortifacient agents|mesh-ancestor
101656502|NCT00835731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101656503|NCT00835731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101656504|NCT00835731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101656505|NCT00835731|Oxytocics|oxytocics|mesh-ancestor
101656506|NCT00835731|Vitamin B Complex|vitamin b complex|mesh-ancestor
101656507|NCT00835731|Hematinics|hematinics|mesh-ancestor
101656508|NCT03721406|Ropivacaine|ropivacaine|mesh-list
101656509|NCT03721406|Anesthetics, Local|anesthetics, local|mesh-ancestor
101656510|NCT03721406|Anesthetics|anesthetics|mesh-ancestor
101656511|NCT03721406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101656512|NCT03721406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656513|NCT03721406|Sensory System Agents|sensory system agents|mesh-ancestor
101656514|NCT03721406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101656515|NCT00751166|Cetirizine|cetirizine|mesh-list
101656516|NCT00751166|Desloratadine|desloratadine|mesh-list
101656517|NCT00751166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101656518|NCT00751166|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101656519|NCT00751166|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101656520|NCT00751166|Histamine Antagonists|histamine antagonists|mesh-ancestor
101656521|NCT00751166|Histamine Agents|histamine agents|mesh-ancestor
101656522|NCT00751166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101656523|NCT00751166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656524|NCT00751166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656525|NCT00751166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101656526|NCT00751166|Cholinergic Agents|cholinergic agents|mesh-ancestor
101656527|NCT00837343|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101656528|NCT00837343|Antidepressive Agents|antidepressive agents|mesh-ancestor
101656529|NCT00837343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101656530|NCT00837343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101656531|NCT00837343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101656532|NCT00837343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101656533|NCT00837343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656534|NCT00732368|Mometasone Furoate|mometasone furoate|mesh-list
101656535|NCT00732368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101656536|NCT00732368|Dermatologic Agents|dermatologic agents|mesh-ancestor
101656537|NCT00732368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101656538|NCT00704145|Paclitaxel|paclitaxel|mesh-list
101656539|NCT00704145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101656540|NCT00704145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101656541|NCT00704145|Tubulin Modulators|tubulin modulators|mesh-ancestor
101656542|NCT00704145|Antimitotic Agents|antimitotic agents|mesh-ancestor
101656543|NCT00704145|Mitosis Modulators|mitosis modulators|mesh-ancestor
101656544|NCT00704145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656545|NCT03508232|Doxycycline|doxycycline|mesh-list
101656546|NCT03508232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101656547|NCT03508232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101656548|NCT03508232|Antimalarials|antimalarials|mesh-ancestor
101656549|NCT03508232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101656550|NCT03508232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101656551|NCT00704223|Insulin Aspart|insulin aspart|mesh-list
101656552|NCT00704223|Biphasic Insulins|biphasic insulins|mesh-list
101656553|NCT00704223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101656554|NCT00704223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656555|NCT00704301|Rivastigmine|rivastigmine|mesh-list
101656556|NCT00704301|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101656557|NCT00704301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101656558|NCT00704301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656559|NCT00704301|Cholinergic Agents|cholinergic agents|mesh-ancestor
101656560|NCT00704301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101656561|NCT00704301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656562|NCT00704301|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101656563|NCT00704301|Protective Agents|protective agents|mesh-ancestor
101656565|NCT00831103|Antiviral Agents|antiviral agents|mesh-ancestor
101656566|NCT00831103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101656568|NCT00704444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101656569|NCT00704444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101656570|NCT00704444|Antimetabolites|antimetabolites|mesh-ancestor
101656571|NCT00704444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656572|NCT00704444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101656573|NCT00704691|Lenalidomide|lenalidomide|mesh-list
101656574|NCT00704691|Immunologic Factors|immunologic factors|mesh-ancestor
101656575|NCT00704691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656576|NCT00704691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101656577|NCT00704691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101656578|NCT00704691|Growth Substances|growth substances|mesh-ancestor
101656579|NCT00704691|Growth Inhibitors|growth inhibitors|mesh-ancestor
101656580|NCT00704691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101656581|NCT00704925|Amifampridine|amifampridine|mesh-list
101656582|NCT00704925|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101656583|NCT00704925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101656584|NCT00704925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656585|NCT00704925|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101656586|NCT00704925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101656587|NCT00704925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656588|NCT00574249|Adalimumab|adalimumab|mesh-list
101656589|NCT00574249|Betamethasone|betamethasone|mesh-list
101656590|NCT00574249|Calcipotriene|calcipotriene|mesh-list
101656591|NCT00574249|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101656592|NCT00574249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101656593|NCT00574249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101656594|NCT00574249|Glucocorticoids|glucocorticoids|mesh-ancestor
101656595|NCT00574249|Hormones|hormones|mesh-ancestor
101313759|NCT00000553|Niacin|niacin|mesh-list
101656596|NCT00574249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101656597|NCT00574249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656598|NCT00574249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101656599|NCT00574249|Respiratory System Agents|respiratory system agents|mesh-ancestor
101656600|NCT00574249|Dermatologic Agents|dermatologic agents|mesh-ancestor
101656601|NCT00891228|ST 1435|st 1435|mesh-list
101656602|NCT00891228|Testosterone|testosterone|mesh-list
101656603|NCT00891228|Androgens|androgens|mesh-ancestor
101656604|NCT00891228|Hormones|hormones|mesh-ancestor
101656605|NCT00891228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101656606|NCT00891228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656607|NCT00891228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101656608|NCT00891228|Contraceptive Agents|contraceptive agents|mesh-ancestor
101656609|NCT00891228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101656610|NCT00891228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101656611|NCT00896168|Infliximab|infliximab|mesh-list
101656612|NCT00896168|Methotrexate|methotrexate|mesh-list
101656613|NCT00896168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101656614|NCT00896168|Abortifacient Agents|abortifacient agents|mesh-ancestor
101656615|NCT00896168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101656616|NCT00896168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656617|NCT00896168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101656618|NCT00896168|Antimetabolites|antimetabolites|mesh-ancestor
101656619|NCT00896168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656620|NCT00896168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101656621|NCT00896168|Dermatologic Agents|dermatologic agents|mesh-ancestor
101656622|NCT00896168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101656623|NCT00896168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101656624|NCT00896168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101656625|NCT00896168|Immunologic Factors|immunologic factors|mesh-ancestor
101656626|NCT00896168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101656627|NCT00896168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101824654|NCT00528528|Interferon alpha-2|interferon alpha-2|mesh-list
101656628|NCT00896168|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101656629|NCT00896168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101656630|NCT00896168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101656631|NCT00833703|Clopidogrel|clopidogrel|mesh-list
101656632|NCT00833703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101656633|NCT00833703|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101656634|NCT00833703|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101656635|NCT00833703|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101656636|NCT00833703|Purinergic Agents|purinergic agents|mesh-ancestor
101656637|NCT00833703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101656638|NCT00833703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656639|NCT00833703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656640|NCT00833547|Eszopiclone|eszopiclone|mesh-list
101656641|NCT00833547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101656642|NCT00833547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101656643|NCT00833547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656644|NCT00833469|Escitalopram|escitalopram|mesh-list
101656645|NCT00833469|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101656646|NCT00833469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101656647|NCT00833469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101656648|NCT00833469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656649|NCT00833469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101656650|NCT00833469|Serotonin Agents|serotonin agents|mesh-ancestor
101656651|NCT00833469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656652|NCT02831478|Sunscreening Agents|sunscreening agents|mesh-list
101656653|NCT02831478|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101656654|NCT02831478|Protective Agents|protective agents|mesh-ancestor
101656655|NCT02831478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656656|NCT02831478|Dermatologic Agents|dermatologic agents|mesh-ancestor
101656657|NCT00837655|Calcium Carbonate|calcium carbonate|mesh-list
101656658|NCT00837655|Calcium|calcium|mesh-list
101656659|NCT00837655|Sevelamer|sevelamer|mesh-list
101656660|NCT00837655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101656661|NCT00837655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656662|NCT00837655|Antacids|antacids|mesh-ancestor
101656663|NCT00837655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656664|NCT00837655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101656665|NCT00837655|Chelating Agents|chelating agents|mesh-ancestor
101656666|NCT00837655|Sequestering Agents|sequestering agents|mesh-ancestor
101656667|NCT00843661|Ezetimibe|ezetimibe|mesh-list
101656668|NCT00843661|Pravastatin|pravastatin|mesh-list
101656670|NCT00843661|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101656671|NCT00843661|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101656672|NCT00843661|Antimetabolites|antimetabolites|mesh-ancestor
101656673|NCT00843661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656674|NCT00843661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101656675|NCT00843661|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101656676|NCT00843661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101656677|NCT00832377|Timolol|timolol|mesh-list
101656678|NCT00832377|Dorzolamide|dorzolamide|mesh-list
101656679|NCT00832377|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101656680|NCT00832377|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101656681|NCT00832377|Adrenergic Agents|adrenergic agents|mesh-ancestor
101656683|NCT00832377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656684|NCT00832377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656685|NCT00832377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101656686|NCT00832377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101656687|NCT00832377|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101656688|NCT00832377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101656689|NCT00843895|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101656690|NCT00843895|Immunologic Factors|immunologic factors|mesh-ancestor
101656691|NCT00843895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656692|NCT00705315|Bevacizumab|bevacizumab|mesh-list
101656693|NCT00705315|Docetaxel|docetaxel|mesh-list
101656694|NCT00705315|Epirubicin|epirubicin|mesh-list
101656695|NCT00705315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101656696|NCT00705315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101656697|NCT00705315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101656698|NCT00705315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101656699|NCT00705315|Growth Substances|growth substances|mesh-ancestor
101656700|NCT00705315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656701|NCT00705315|Growth Inhibitors|growth inhibitors|mesh-ancestor
101656702|NCT00705315|Tubulin Modulators|tubulin modulators|mesh-ancestor
101656703|NCT00705315|Antimitotic Agents|antimitotic agents|mesh-ancestor
101656704|NCT00705315|Mitosis Modulators|mitosis modulators|mesh-ancestor
101656705|NCT00705315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656706|NCT00705315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101656707|NCT00705315|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101656708|NCT00705315|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101656709|NCT00705315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101656710|NCT00892008|Pregabalin|pregabalin|mesh-list
101656711|NCT00892008|Analgesics|analgesics|mesh-ancestor
101656712|NCT00892008|Sensory System Agents|sensory system agents|mesh-ancestor
101656713|NCT00892008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101656714|NCT00892008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656716|NCT00892008|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101656717|NCT00892008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101656718|NCT00892008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656719|NCT00892008|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101656720|NCT00892008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101656721|NCT00892008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101656722|NCT00892008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101656723|NCT00892008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101656724|NCT00623233|Bevacizumab|bevacizumab|mesh-list
101656725|NCT00623233|Gemcitabine|gemcitabine|mesh-list
101656726|NCT00623233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101656727|NCT00623233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101656728|NCT00623233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101656729|NCT00623233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101656730|NCT00623233|Growth Substances|growth substances|mesh-ancestor
101656731|NCT00623233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656732|NCT00623233|Growth Inhibitors|growth inhibitors|mesh-ancestor
101656733|NCT00623233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101656734|NCT00623233|Antimetabolites|antimetabolites|mesh-ancestor
101656735|NCT00623233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656736|NCT00837889|Diuretics|diuretics|mesh-list
101656737|NCT00837889|Natriuretic Agents|natriuretic agents|mesh-ancestor
101656738|NCT00837889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656739|NCT02841488|Fentanyl|fentanyl|mesh-list
101656740|NCT02841488|Ropivacaine|ropivacaine|mesh-list
101656741|NCT02841488|Anesthetics, Local|anesthetics, local|mesh-ancestor
101656742|NCT02841488|Anesthetics|anesthetics|mesh-ancestor
101656743|NCT02841488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101656744|NCT02841488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656746|NCT02841488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101656747|NCT02841488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101656748|NCT02841488|Narcotics|narcotics|mesh-ancestor
101656749|NCT02841488|Analgesics|analgesics|mesh-ancestor
101656750|NCT02841488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101656751|NCT02841488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101656752|NCT02841488|Anesthetics, General|anesthetics, general|mesh-ancestor
101656753|NCT02832726|Vitamin B 12|vitamin b 12|mesh-list
101656754|NCT02832726|Hydroxocobalamin|hydroxocobalamin|mesh-list
101656755|NCT02832726|Vitamins|vitamins|mesh-ancestor
101656756|NCT02832726|Micronutrients|micronutrients|mesh-ancestor
101656757|NCT02832726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656758|NCT02832726|Vitamin B Complex|vitamin b complex|mesh-ancestor
101656759|NCT02832726|Hematinics|hematinics|mesh-ancestor
101656760|NCT00202904|Ezetimibe|ezetimibe|mesh-list
101656761|NCT00202904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101656762|NCT00202904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101656763|NCT00202904|Antimetabolites|antimetabolites|mesh-ancestor
101656764|NCT00202904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656765|NCT00202904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101656766|NCT02690870|Tamoxifen|tamoxifen|mesh-list
101656767|NCT02690870|Clomiphene|clomiphene|mesh-list
101656768|NCT02690870|Enclomiphene|enclomiphene|mesh-list
101656769|NCT02690870|Zuclomiphene|zuclomiphene|mesh-list
101656770|NCT02690870|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101656771|NCT02690870|Hormone Antagonists|hormone antagonists|mesh-ancestor
101656772|NCT02690870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101656773|NCT02690870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656774|NCT02690870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101656775|NCT02690870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101656776|NCT02690870|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101656777|NCT02690870|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101656778|NCT02690870|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101656779|NCT02690870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101656780|NCT02690870|Fertility Agents|fertility agents|mesh-ancestor
101656781|NCT02690870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101656782|NCT00844207|Azithromycin|azithromycin|mesh-list
101656783|NCT00844207|Chloroquine|chloroquine|mesh-list
101656784|NCT00844207|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
101656785|NCT00844207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101656786|NCT00844207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101656787|NCT00844207|Amebicides|amebicides|mesh-ancestor
101656788|NCT00844207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101656789|NCT00844207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101656790|NCT00844207|Antimalarials|antimalarials|mesh-ancestor
101656791|NCT00844207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101656792|NCT00844207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101656793|NCT00844207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101656794|NCT00844207|Analgesics|analgesics|mesh-ancestor
101656795|NCT00844207|Sensory System Agents|sensory system agents|mesh-ancestor
101656796|NCT00844207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101656797|NCT00844207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656798|NCT00844207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101656799|NCT00844207|Filaricides|filaricides|mesh-ancestor
101656800|NCT00844207|Antinematodal Agents|antinematodal agents|mesh-ancestor
101656801|NCT00844207|Anthelmintics|anthelmintics|mesh-ancestor
101656802|NCT02841722|Lenograstim|lenograstim|mesh-list
101656803|NCT02841722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101656804|NCT02841722|Immunologic Factors|immunologic factors|mesh-ancestor
101656805|NCT02841722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656806|NCT02548117|Finasteride|finasteride|mesh-list
101656807|NCT02548117|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101656808|NCT02548117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101656809|NCT02548117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101656810|NCT02548117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656811|NCT02548117|Hormone Antagonists|hormone antagonists|mesh-ancestor
101656812|NCT02548117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101656813|NCT02548117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656814|NCT02548117|Urological Agents|urological agents|mesh-ancestor
101656815|NCT02841800|Phenobarbital|phenobarbital|mesh-list
101656816|NCT02841800|Anticonvulsants|anticonvulsants|mesh-ancestor
101656817|NCT02841800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101656818|NCT02841800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101656819|NCT02841800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656820|NCT02841800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101656822|NCT02841800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101656823|NCT02841800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656824|NCT02841800|GABA Modulators|gaba modulators|mesh-ancestor
101656825|NCT02841800|GABA Agents|gaba agents|mesh-ancestor
101656826|NCT02841800|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101656827|NCT02841800|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101656828|NCT02841800|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101656829|NCT02832336|Caffeine|caffeine|mesh-list
101656830|NCT02832336|Caffeine citrate|caffeine citrate|mesh-list
101656831|NCT02832336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656832|NCT02832336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101656833|NCT02832336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656834|NCT02832336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101656835|NCT02832336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101656836|NCT02832336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101656837|NCT02832336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101656838|NCT02832336|Purinergic Agents|purinergic agents|mesh-ancestor
101656839|NCT02832336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101656840|NCT00621751|Carbamazepine|carbamazepine|mesh-list
101656841|NCT00621751|Anticonvulsants|anticonvulsants|mesh-ancestor
101656842|NCT00621751|Antimanic Agents|antimanic agents|mesh-ancestor
101656843|NCT00621751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101656844|NCT00621751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101656845|NCT00621751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656846|NCT00621751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101656847|NCT00621751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101656848|NCT00621751|Analgesics|analgesics|mesh-ancestor
101656849|NCT00621751|Sensory System Agents|sensory system agents|mesh-ancestor
101656850|NCT00621751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101656851|NCT00621751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101656852|NCT00621751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101656853|NCT00621751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656854|NCT00621751|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101656855|NCT00621751|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101656856|NCT02690792|Vitamin E|vitamin e|mesh-list
101656857|NCT02690792|Vitamins|vitamins|mesh-ancestor
101656858|NCT02690792|Micronutrients|micronutrients|mesh-ancestor
101656859|NCT02690792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656860|NCT02690792|Antioxidants|antioxidants|mesh-ancestor
101656861|NCT02690792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656862|NCT02690792|Protective Agents|protective agents|mesh-ancestor
101656863|NCT00831649|Natalizumab|natalizumab|mesh-list
101656864|NCT00831649|Immunologic Factors|immunologic factors|mesh-ancestor
101656865|NCT00831649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656866|NCT02841332|Misonidazole|misonidazole|mesh-list
101656867|NCT02841332|Bevacizumab|bevacizumab|mesh-list
101656868|NCT02841332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101656869|NCT02841332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101656870|NCT02841332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101656871|NCT02841332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101656872|NCT02841332|Growth Substances|growth substances|mesh-ancestor
101656873|NCT02841332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656874|NCT02841332|Growth Inhibitors|growth inhibitors|mesh-ancestor
101656875|NCT02841332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101656876|NCT02841332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101656877|NCT02841332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101656878|NCT00838357|Plerixafor|plerixafor|mesh-list
101656879|NCT00838357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101656880|NCT00838357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101656881|NCT00838357|Antiviral Agents|antiviral agents|mesh-ancestor
101656882|NCT00838357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101656883|NCT00156104|Haloperidol|haloperidol|mesh-list
101656884|NCT00156104|Haloperidol decanoate|haloperidol decanoate|mesh-list
101656885|NCT00156104|Asenapine|asenapine|mesh-list
101656886|NCT00156104|Antiemetics|antiemetics|mesh-ancestor
101656887|NCT00156104|Autonomic Agents|autonomic agents|mesh-ancestor
101656888|NCT00156104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101656889|NCT00156104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656890|NCT00156104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101656891|NCT00156104|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101656892|NCT00156104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101314044|NCT00000742|Zidovudine|zidovudine|mesh-list
101656893|NCT00156104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101656894|NCT00156104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101656895|NCT00156104|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101656896|NCT00156104|Dopamine Agents|dopamine agents|mesh-ancestor
101656897|NCT00156104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101656898|NCT00156104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656899|NCT00156104|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101656900|NCT00254462|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101656901|NCT00254462|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101656902|NCT00254462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101656903|NCT00254462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101656904|NCT00254462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656905|NCT00254462|Adrenergic Agents|adrenergic agents|mesh-ancestor
101656906|NCT00254462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101656907|NCT00254462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656909|NCT00891930|Panitumumab|panitumumab|mesh-list
101656910|NCT00891930|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101656911|NCT00891930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101656912|NCT00891930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101656913|NCT00891930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656914|NCT00891930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101656915|NCT00891930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101656916|NCT02831088|Salicylates|salicylates|mesh-list
101656917|NCT02831088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101656918|NCT02831088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101656919|NCT02831088|Analgesics|analgesics|mesh-ancestor
101656920|NCT02831088|Sensory System Agents|sensory system agents|mesh-ancestor
101656921|NCT02831088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101656922|NCT02831088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656923|NCT02831088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101656924|NCT02831088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101656925|NCT02831088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101656926|NCT02831088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101656927|NCT02831088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656928|NCT02841176|Golimumab|golimumab|mesh-list
101656929|NCT02841176|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101656930|NCT02841176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101656931|NCT02841176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101656932|NCT02841176|Immunologic Factors|immunologic factors|mesh-ancestor
101656933|NCT02841176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656934|NCT01615874|Prednisone|prednisone|mesh-list
101656935|NCT01615874|Prednisolone|prednisolone|mesh-list
101656936|NCT01615874|Montelukast|montelukast|mesh-list
101656937|NCT01615874|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
101656938|NCT01615874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101656939|NCT01615874|Glucocorticoids|glucocorticoids|mesh-ancestor
101656940|NCT01615874|Hormones|hormones|mesh-ancestor
101656941|NCT01615874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101656942|NCT01615874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656943|NCT01615874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101656944|NCT01615874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101656945|NCT01615874|Autonomic Agents|autonomic agents|mesh-ancestor
101656946|NCT01615874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101656947|NCT01615874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101656948|NCT01615874|Respiratory System Agents|respiratory system agents|mesh-ancestor
101656949|NCT01615874|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101656950|NCT01615874|Hormone Antagonists|hormone antagonists|mesh-ancestor
101656951|NCT01615874|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101656952|NCT01615874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101656953|NCT01615874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656954|NCT01615874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101656955|NCT00891462|Bromides|bromides|mesh-list
101656956|NCT00891462|Anticonvulsants|anticonvulsants|mesh-ancestor
101656957|NCT04248348|Heparin|heparin|mesh-list
101656958|NCT04248348|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101656959|NCT04248348|Tinzaparin|tinzaparin|mesh-list
101656960|NCT04248348|Dalteparin|dalteparin|mesh-list
101656961|NCT04248348|Anticoagulants|anticoagulants|mesh-ancestor
101656962|NCT04248348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101656963|NCT04248348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101656964|NCT04248348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656965|NCT04245774|Bupivacaine|bupivacaine|mesh-list
101656966|NCT04245774|Levobupivacaine|levobupivacaine|mesh-list
101656967|NCT04245774|Anesthetics, Local|anesthetics, local|mesh-ancestor
101656969|NCT04245774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101656970|NCT04245774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656971|NCT04245774|Sensory System Agents|sensory system agents|mesh-ancestor
101656972|NCT04245774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101656974|NCT04247646|Antioxidants|antioxidants|mesh-ancestor
101656975|NCT04247646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656976|NCT04247646|Protective Agents|protective agents|mesh-ancestor
101656977|NCT04247646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656978|NCT04247646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101656979|NCT00900146|Metformin|metformin|mesh-list
101656980|NCT00900146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101656981|NCT00900146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656982|NCT00140972|Diclofenac|diclofenac|mesh-list
101656983|NCT00140972|Etoricoxib|etoricoxib|mesh-list
101656984|NCT00140972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101656985|NCT00140972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101656986|NCT00140972|Analgesics|analgesics|mesh-ancestor
101656987|NCT00140972|Sensory System Agents|sensory system agents|mesh-ancestor
101656988|NCT00140972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101656989|NCT00140972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656990|NCT00140972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101656991|NCT00140972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101656992|NCT00140972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101656993|NCT00140972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101656994|NCT00140972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101656995|NCT00140972|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101656996|NCT02830932|Vaccines|vaccines|mesh-list
101656997|NCT02830932|Immunologic Factors|immunologic factors|mesh-ancestor
101656998|NCT02830932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101656999|NCT00895310|Ketoconazole|ketoconazole|mesh-list
101657000|NCT00895310|Hydrocortisone|hydrocortisone|mesh-list
101657001|NCT00895310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101657002|NCT00895310|Antifungal Agents|antifungal agents|mesh-ancestor
101657003|NCT00895310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101657004|NCT00895310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101657005|NCT00895310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101657006|NCT00895310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101657007|NCT00895310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657008|NCT00895310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101657009|NCT00895310|Hormone Antagonists|hormone antagonists|mesh-ancestor
101657010|NCT00895310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101657011|NCT00895310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657012|NCT00895310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101657013|NCT04245618|Cisplatin|cisplatin|mesh-list
101657014|NCT04245618|Gemcitabine|gemcitabine|mesh-list
101657015|NCT04245618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101657016|NCT04245618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101657017|NCT04245618|Antimetabolites|antimetabolites|mesh-ancestor
101657018|NCT04245618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657019|NCT00092768|Celecoxib|celecoxib|mesh-list
101657020|NCT00092768|Etoricoxib|etoricoxib|mesh-list
101657021|NCT00092768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101657022|NCT00092768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101657023|NCT00092768|Analgesics|analgesics|mesh-ancestor
101657024|NCT00092768|Sensory System Agents|sensory system agents|mesh-ancestor
101657025|NCT00092768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101657026|NCT00092768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657027|NCT00092768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101657028|NCT00092768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101657029|NCT00092768|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101657030|NCT00092768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101657031|NCT00092768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101657032|NCT00092768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657033|NCT02831712|Ferrous fumarate|ferrous fumarate|mesh-list
101657034|NCT02831712|Trace Elements|trace elements|mesh-ancestor
101657035|NCT02831712|Micronutrients|micronutrients|mesh-ancestor
101657036|NCT02831712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657037|NCT02843984|Lactoferrin|lactoferrin|mesh-list
101657038|NCT02843984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101657039|NCT02840708|Sargramostim|sargramostim|mesh-list
101657040|NCT02840708|Immunologic Factors|immunologic factors|mesh-ancestor
101657041|NCT02840708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657042|NCT00817076|Desloratadine|desloratadine|mesh-list
101657043|NCT00817076|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101657044|NCT00817076|Cholinergic Agents|cholinergic agents|mesh-ancestor
101657045|NCT00817076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101657046|NCT00817076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657047|NCT00817076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657048|NCT00817076|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101657049|NCT00817076|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101657050|NCT00817076|Histamine Antagonists|histamine antagonists|mesh-ancestor
101657051|NCT00817076|Histamine Agents|histamine agents|mesh-ancestor
101657052|NCT02844062|Cyclophosphamide|cyclophosphamide|mesh-list
101657053|NCT02844062|Fludarabine|fludarabine|mesh-list
101657054|NCT02844062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101657055|NCT02844062|Immunologic Factors|immunologic factors|mesh-ancestor
101657056|NCT02844062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657057|NCT02844062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101657058|NCT02844062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101657059|NCT02844062|Alkylating Agents|alkylating agents|mesh-ancestor
101657060|NCT02844062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657061|NCT02844062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101657062|NCT02844062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101657063|NCT02830230|Azithromycin|azithromycin|mesh-list
101657065|NCT02830230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101657066|NCT02830230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101657067|NCT02840240|Gabapentin|gabapentin|mesh-list
101657068|NCT02840240|Analgesics|analgesics|mesh-ancestor
101657069|NCT02840240|Sensory System Agents|sensory system agents|mesh-ancestor
101657070|NCT02840240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101657071|NCT02840240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657072|NCT02840240|Anticonvulsants|anticonvulsants|mesh-ancestor
101657073|NCT02840240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101657074|NCT02840240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101657075|NCT02840240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101657076|NCT02840240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101657077|NCT02840240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101657078|NCT02840240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101657079|NCT02840240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101657080|NCT02840240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657081|NCT02840240|Antimanic Agents|antimanic agents|mesh-ancestor
101657082|NCT00888654|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
101657083|NCT00888654|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101657084|NCT00888654|Protective Agents|protective agents|mesh-ancestor
101657085|NCT00888654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657087|NCT03238430|Morphine|morphine|mesh-list
101657088|NCT03238430|Ropivacaine|ropivacaine|mesh-list
101657089|NCT03238430|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101657090|NCT03238430|Narcotics|narcotics|mesh-ancestor
101657091|NCT03238430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101657092|NCT03238430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657093|NCT03238430|Analgesics|analgesics|mesh-ancestor
101657094|NCT03238430|Sensory System Agents|sensory system agents|mesh-ancestor
101657095|NCT03238430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101657096|NCT03238430|Anesthetics, Local|anesthetics, local|mesh-ancestor
101657097|NCT03238430|Anesthetics|anesthetics|mesh-ancestor
101657098|NCT02829840|Azacitidine|azacitidine|mesh-list
101657099|NCT02829840|Ponatinib|ponatinib|mesh-list
101657100|NCT02829840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101657101|NCT02829840|Antimetabolites|antimetabolites|mesh-ancestor
101657102|NCT02829840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657103|NCT02829840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101657104|NCT02829840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101657105|NCT02829840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101657106|NCT03223220|Midazolam|midazolam|mesh-list
101657107|NCT03223220|Ketamine|ketamine|mesh-list
101657108|NCT03223220|Analgesics|analgesics|mesh-ancestor
101657109|NCT03223220|Sensory System Agents|sensory system agents|mesh-ancestor
101657110|NCT03223220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101657111|NCT03223220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657112|NCT03223220|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101657113|NCT03223220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101657114|NCT03223220|Anesthetics, General|anesthetics, general|mesh-ancestor
101657115|NCT03223220|Anesthetics|anesthetics|mesh-ancestor
101657116|NCT03223220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101657117|NCT03223220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101657118|NCT03223220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101657119|NCT03223220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101657120|NCT03223220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657121|NCT03223220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101657122|NCT03223220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101657123|NCT03223220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101657124|NCT03223220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101657125|NCT03223220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101657126|NCT03223220|GABA Modulators|gaba modulators|mesh-ancestor
101657127|NCT03223220|GABA Agents|gaba agents|mesh-ancestor
101657128|NCT02827890|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101657129|NCT02827890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101657130|NCT02827890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657131|NCT02827890|Incretins|incretins|mesh-ancestor
101657132|NCT02827890|Hormones|hormones|mesh-ancestor
101657133|NCT02827890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101657134|NCT02827890|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101657135|NCT02827890|Protease Inhibitors|protease inhibitors|mesh-ancestor
101657136|NCT02827890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101657137|NCT02827890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657138|NCT04250792|Naltrexone|naltrexone|mesh-list
101657139|NCT04250792|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101657140|NCT04250792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101657141|NCT04250792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657142|NCT04250792|Sensory System Agents|sensory system agents|mesh-ancestor
101657143|NCT04250792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101657144|NCT02840162|Celecoxib|celecoxib|mesh-list
101657145|NCT02840162|Benzenesulfonamide|benzenesulfonamide|mesh-list
101657146|NCT02840162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101657147|NCT02840162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101657148|NCT02840162|Analgesics|analgesics|mesh-ancestor
101657149|NCT02840162|Sensory System Agents|sensory system agents|mesh-ancestor
101657150|NCT02840162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101657151|NCT02840162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657152|NCT02840162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101657153|NCT02840162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101657154|NCT02840162|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101657155|NCT02840162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101657156|NCT02840162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101657157|NCT02840162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657158|NCT02840162|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101657159|NCT02827656|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101657160|NCT02827656|Luteolytic Agents|luteolytic agents|mesh-ancestor
101657161|NCT02827656|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101657163|NCT02827656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101657164|NCT02827656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657165|NCT02827656|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101657166|NCT02827656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101657167|NCT02827656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101657168|NCT02827578|Tamsulosin|tamsulosin|mesh-list
101657169|NCT02827578|Solifenacin Succinate|solifenacin succinate|mesh-list
101657170|NCT02827578|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101657171|NCT02827578|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101657172|NCT02827578|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101657173|NCT02827578|Adrenergic Agents|adrenergic agents|mesh-ancestor
101657174|NCT02827578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101657175|NCT02827578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657176|NCT02827578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657177|NCT02827578|Urological Agents|urological agents|mesh-ancestor
101657178|NCT02827578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101657179|NCT02827578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101657180|NCT02827578|Cholinergic Agents|cholinergic agents|mesh-ancestor
101657181|NCT02829372|Antibodies|antibodies|mesh-list
101657182|NCT02829372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101657183|NCT02829372|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101657184|NCT02829372|Immunologic Factors|immunologic factors|mesh-ancestor
101657185|NCT02829372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657186|NCT00899678|Certolizumab Pegol|certolizumab pegol|mesh-list
101657187|NCT00899678|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101657188|NCT00899678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101657189|NCT00899678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101657190|NCT00899678|Immunologic Factors|immunologic factors|mesh-ancestor
101657191|NCT00899678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657192|NCT00899678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101657193|NCT00887484|Clindamycin|clindamycin|mesh-list
101657194|NCT00887484|Clindamycin palmitate|clindamycin palmitate|mesh-list
101657195|NCT00887484|Clindamycin phosphate|clindamycin phosphate|mesh-list
101657196|NCT00887484|Adapalene|adapalene|mesh-list
101657197|NCT00887484|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101657198|NCT00887484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101657199|NCT00887484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101657200|NCT00887484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101657201|NCT00887484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101657202|NCT00887484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657203|NCT00887484|Dermatologic Agents|dermatologic agents|mesh-ancestor
101657204|NCT00887484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101657205|NCT00887484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101657206|NCT00887484|Analgesics|analgesics|mesh-ancestor
101657207|NCT00887484|Sensory System Agents|sensory system agents|mesh-ancestor
101657208|NCT00887484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101657209|NCT00887484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657210|NCT00887484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101657211|NCT00887484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101657212|NCT00794378|Cetirizine|cetirizine|mesh-list
101657213|NCT00794378|Desloratadine|desloratadine|mesh-list
101657214|NCT00794378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101657215|NCT00794378|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101657216|NCT00794378|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101657217|NCT00794378|Histamine Antagonists|histamine antagonists|mesh-ancestor
101657218|NCT00794378|Histamine Agents|histamine agents|mesh-ancestor
101657219|NCT00794378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101657220|NCT00794378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657221|NCT00794378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657222|NCT00794378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101657223|NCT00794378|Cholinergic Agents|cholinergic agents|mesh-ancestor
101657224|NCT00789152|Levocetirizine|levocetirizine|mesh-list
101657225|NCT00789152|Desloratadine|desloratadine|mesh-list
101657226|NCT00789152|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101657227|NCT00789152|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101657228|NCT00789152|Histamine Antagonists|histamine antagonists|mesh-ancestor
101657229|NCT00789152|Histamine Agents|histamine agents|mesh-ancestor
101657230|NCT00789152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101824729|NCT03998982|Hormones|hormones|mesh-ancestor
101657231|NCT00789152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657232|NCT00789152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657233|NCT00789152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101657234|NCT00789152|Cholinergic Agents|cholinergic agents|mesh-ancestor
101657235|NCT00783458|Fluticasone|fluticasone|mesh-list
101657236|NCT00783458|Mometasone Furoate|mometasone furoate|mesh-list
101657237|NCT00783458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101657238|NCT00783458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101657239|NCT00783458|Autonomic Agents|autonomic agents|mesh-ancestor
101657240|NCT00783458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101657241|NCT00783458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657242|NCT00783458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101657243|NCT00783458|Respiratory System Agents|respiratory system agents|mesh-ancestor
101657244|NCT00783458|Dermatologic Agents|dermatologic agents|mesh-ancestor
101657245|NCT00783458|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101657246|NCT00620659|Modafinil|modafinil|mesh-list
101657247|NCT00620659|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101657248|NCT00620659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657249|NCT00620659|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101657250|NCT00620659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101657251|NCT00620659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101657252|NCT00620659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657254|NCT02829060|Ampicillin|ampicillin|mesh-list
101657255|NCT02829060|Nitrofurantoin|nitrofurantoin|mesh-list
101657256|NCT02829060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101657257|NCT02829060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101657258|NCT02829060|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101657259|NCT02829060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101657260|NCT02829060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657261|NCT02829060|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101657262|NCT00838669|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101657263|NCT00838669|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101657264|NCT00838669|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101314419|NCT00000952|Antiviral Agents|antiviral agents|mesh-ancestor
101657265|NCT00838669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101657266|NCT00838669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657268|NCT00838669|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101657269|NCT00838669|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101657270|NCT00838669|Serotonin Agents|serotonin agents|mesh-ancestor
101657271|NCT00838669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101657272|NCT00838669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657273|NCT00838669|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101657274|NCT00838669|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101657275|NCT00838669|Dopamine Agents|dopamine agents|mesh-ancestor
101657276|NCT00783146|Fexofenadine|fexofenadine|mesh-list
101657277|NCT00783146|Desloratadine|desloratadine|mesh-list
101657278|NCT00783146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101657279|NCT00783146|Cholinergic Agents|cholinergic agents|mesh-ancestor
101657280|NCT00783146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101657281|NCT00783146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657282|NCT00783146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657283|NCT00783146|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101657284|NCT00783146|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101657285|NCT00783146|Histamine Antagonists|histamine antagonists|mesh-ancestor
101657286|NCT00783146|Histamine Agents|histamine agents|mesh-ancestor
101657287|NCT00783146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101657288|NCT00844675|Rabeprazole|rabeprazole|mesh-list
101657289|NCT00844675|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101657290|NCT00844675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101657291|NCT00844675|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101657292|NCT00844675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101657293|NCT00844675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657294|NCT02840006|Anesthetics|anesthetics|mesh-list
101657295|NCT02840006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101657296|NCT02840006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657297|NCT02826252|Iloprost|iloprost|mesh-list
101657298|NCT02826252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101657299|NCT02826252|Vasodilator Agents|vasodilator agents|mesh-ancestor
101657300|NCT02839928|Ketamine|ketamine|mesh-list
101657301|NCT02839928|Analgesics|analgesics|mesh-list
101657302|NCT02839928|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
101657303|NCT02839928|Sensory System Agents|sensory system agents|mesh-ancestor
101657304|NCT02839928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101657305|NCT02839928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657306|NCT02839928|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101657307|NCT02839928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101657308|NCT02839928|Anesthetics, General|anesthetics, general|mesh-ancestor
101657310|NCT02839928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101657311|NCT02839928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101657312|NCT02839928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101657313|NCT02839928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101657314|NCT02839928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657315|NCT02839928|Anesthetics, Local|anesthetics, local|mesh-ancestor
101657316|NCT02839928|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
101657317|NCT05018520|Prednisone|prednisone|mesh-list
101657318|NCT05018520|Rituximab|rituximab|mesh-list
101657319|NCT05018520|Cyclophosphamide|cyclophosphamide|mesh-list
101657320|NCT05018520|Vincristine|vincristine|mesh-list
101657321|NCT05018520|Doxorubicin|doxorubicin|mesh-list
101657322|NCT05018520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101657323|NCT05018520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101657324|NCT05018520|Immunologic Factors|immunologic factors|mesh-ancestor
101657325|NCT05018520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657326|NCT05018520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101657327|NCT05018520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101657328|NCT05018520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101657329|NCT05018520|Alkylating Agents|alkylating agents|mesh-ancestor
101657330|NCT05018520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657331|NCT05018520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101657332|NCT05018520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101657333|NCT05018520|Glucocorticoids|glucocorticoids|mesh-ancestor
101657334|NCT05018520|Hormones|hormones|mesh-ancestor
101657335|NCT05018520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101657336|NCT05018520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101314497|NCT00001003|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101657337|NCT05018520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101657338|NCT05018520|Tubulin Modulators|tubulin modulators|mesh-ancestor
101657339|NCT05018520|Antimitotic Agents|antimitotic agents|mesh-ancestor
101657340|NCT05018520|Mitosis Modulators|mitosis modulators|mesh-ancestor
101657341|NCT05018520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101657342|NCT05018520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101657343|NCT05018520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101657344|NCT05018520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101657345|NCT04321746|Ketamine|ketamine|mesh-list
101657346|NCT04321746|Analgesics|analgesics|mesh-ancestor
101657347|NCT04321746|Sensory System Agents|sensory system agents|mesh-ancestor
101657348|NCT04321746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101657349|NCT04321746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657350|NCT04321746|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101657351|NCT04321746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101657352|NCT04321746|Anesthetics, General|anesthetics, general|mesh-ancestor
101657353|NCT04321746|Anesthetics|anesthetics|mesh-ancestor
101657354|NCT04321746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101657355|NCT04321746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101657356|NCT04321746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101824748|NCT00621023|Ascorbic Acid|ascorbic acid|mesh-list
101657357|NCT04321746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101657358|NCT04321746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657359|NCT02839694|Celecoxib|celecoxib|mesh-list
101657360|NCT02839694|Decitabine|decitabine|mesh-list
101657361|NCT02839694|Tetrahydrouridine|tetrahydrouridine|mesh-list
101657362|NCT02839694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101657363|NCT02839694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101657364|NCT02839694|Analgesics|analgesics|mesh-ancestor
101657365|NCT02839694|Sensory System Agents|sensory system agents|mesh-ancestor
101657366|NCT02839694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101657367|NCT02839694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657368|NCT02839694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101657369|NCT02839694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101657370|NCT02839694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101657371|NCT02839694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101657372|NCT02839694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101657373|NCT02839694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657374|NCT02839694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101657375|NCT02839694|Antimetabolites|antimetabolites|mesh-ancestor
101657376|NCT02839694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101657377|NCT04243434|Prednisone|prednisone|mesh-list
101657378|NCT04243434|Cyclophosphamide|cyclophosphamide|mesh-list
101657379|NCT04243434|Doxorubicin|doxorubicin|mesh-list
101657380|NCT04243434|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101657381|NCT04243434|Vincristine|vincristine|mesh-list
101657382|NCT04243434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101657383|NCT04243434|Immunologic Factors|immunologic factors|mesh-ancestor
101657384|NCT04243434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657385|NCT04243434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101657386|NCT04243434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101657387|NCT04243434|Alkylating Agents|alkylating agents|mesh-ancestor
101657388|NCT04243434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657389|NCT04243434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101657390|NCT04243434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101657391|NCT04243434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101657392|NCT04243434|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101657393|NCT04243434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101657394|NCT04243434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101657395|NCT04243434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101657396|NCT04243434|Glucocorticoids|glucocorticoids|mesh-ancestor
101657398|NCT04243434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101657399|NCT04243434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101657400|NCT04243434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101657401|NCT04243434|Tubulin Modulators|tubulin modulators|mesh-ancestor
101657402|NCT04243434|Antimitotic Agents|antimitotic agents|mesh-ancestor
101657403|NCT04243434|Mitosis Modulators|mitosis modulators|mesh-ancestor
101657404|NCT00832039|Selenious Acid|selenious acid|mesh-list
101657405|NCT00832039|Sodium Selenite|sodium selenite|mesh-list
101657406|NCT00832039|Trace Elements|trace elements|mesh-ancestor
101657407|NCT00832039|Micronutrients|micronutrients|mesh-ancestor
101657408|NCT00832039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657409|NCT02826564|Pembrolizumab|pembrolizumab|mesh-list
101657410|NCT02826564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101314582|NCT00001045|Zidovudine|zidovudine|mesh-list
101657411|NCT02826564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101657412|NCT02826564|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101657413|NCT02826564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657415|NCT02837978|Tacrolimus|tacrolimus|mesh-list
101657416|NCT02837978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101657417|NCT02837978|Abortifacient Agents|abortifacient agents|mesh-ancestor
101657418|NCT02837978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101657419|NCT02837978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657420|NCT02837978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101657421|NCT02837978|Antimetabolites|antimetabolites|mesh-ancestor
101657422|NCT02837978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657423|NCT02837978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101657424|NCT02837978|Dermatologic Agents|dermatologic agents|mesh-ancestor
101657425|NCT02837978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101657426|NCT02837978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101657427|NCT02837978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101657428|NCT02837978|Immunologic Factors|immunologic factors|mesh-ancestor
101657429|NCT02837978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101657430|NCT02837978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101657431|NCT02837978|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101657432|NCT00839059|Lenalidomide|lenalidomide|mesh-list
101657433|NCT00839059|Immunologic Factors|immunologic factors|mesh-ancestor
101657434|NCT00839059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657435|NCT00839059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101657436|NCT00839059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101657437|NCT00839059|Growth Substances|growth substances|mesh-ancestor
101657438|NCT00839059|Growth Inhibitors|growth inhibitors|mesh-ancestor
101657439|NCT00839059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101657440|NCT02839538|Anesthetics|anesthetics|mesh-list
101657441|NCT02839538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101657442|NCT02839538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657443|NCT02826174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101657444|NCT02826174|Anesthetics|anesthetics|mesh-list
101657445|NCT02826174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101657446|NCT02826174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657448|NCT00621517|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101657449|NCT00621517|Antidepressive Agents|antidepressive agents|mesh-ancestor
101657450|NCT00621517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101657451|NCT00621517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101657452|NCT00621517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101657453|NCT00621517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101657454|NCT00621517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657456|NCT00621517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101657457|NCT00621517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657458|NCT00621517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101657459|NCT00621517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101657460|NCT00621517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101657462|NCT02827266|Hematinics|hematinics|mesh-ancestor
101657463|NCT00845221|Imatinib Mesylate|imatinib mesylate|mesh-list
101657464|NCT00845221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101657465|NCT00845221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101657466|NCT00845221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101657467|NCT00845221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657468|NCT02546401|Insulin Aspart|insulin aspart|mesh-list
101657469|NCT02546401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101657470|NCT02546401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657471|NCT02826876|Ropivacaine|ropivacaine|mesh-list
101657472|NCT02826876|Anesthetics, Local|anesthetics, local|mesh-ancestor
101657473|NCT02826876|Anesthetics|anesthetics|mesh-ancestor
101657474|NCT02826876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101657475|NCT02826876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657476|NCT02826876|Sensory System Agents|sensory system agents|mesh-ancestor
101657477|NCT02826876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101657478|NCT04244448|Emtricitabine|emtricitabine|mesh-list
101657479|NCT04244448|Antiviral Agents|antiviral agents|mesh-ancestor
101657480|NCT04244448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101657481|NCT04244448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101657482|NCT04244448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101657483|NCT04244448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101657484|NCT04244448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657485|NCT04244448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101657486|NCT04244448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101657487|NCT02547025|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101657488|NCT02547025|Amoxicillin|amoxicillin|mesh-list
101657489|NCT02547025|Clarithromycin|clarithromycin|mesh-list
101657490|NCT02547025|Levofloxacin|levofloxacin|mesh-list
101657491|NCT02547025|Ofloxacin|ofloxacin|mesh-list
101657492|NCT02547025|Tetracycline|tetracycline|mesh-list
101657493|NCT02547025|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101657494|NCT02547025|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
101657495|NCT02547025|Rabeprazole|rabeprazole|mesh-list
101657496|NCT02547025|Bismuth|bismuth|mesh-list
101657497|NCT02547025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101657498|NCT02547025|Antitubercular Agents|antitubercular agents|mesh-ancestor
101657499|NCT02547025|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101657500|NCT02547025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101657501|NCT02547025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657502|NCT02547025|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101657503|NCT02547025|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101657504|NCT02547025|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101657505|NCT02547025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101657506|NCT02547025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101657507|NCT02547025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101657508|NCT02547025|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101657509|NCT02547025|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101657510|NCT02547025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101657511|NCT02547025|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101657512|NCT02547025|Antacids|antacids|mesh-ancestor
101657513|NCT00839293|Fenofibric acid|fenofibric acid|mesh-list
101657514|NCT00839293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101657515|NCT00839293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101657516|NCT00839293|Antimetabolites|antimetabolites|mesh-ancestor
101657517|NCT00839293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657518|NCT00839293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101657519|NCT05660382|Miconazole|miconazole|mesh-list
101657520|NCT05660382|Clotrimazole|clotrimazole|mesh-list
101657521|NCT05660382|Mineral Oil|mineral oil|mesh-list
101657522|NCT05660382|Antifungal Agents|antifungal agents|mesh-ancestor
101657523|NCT05660382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101657524|NCT05660382|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101657525|NCT05660382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101657526|NCT05660382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101657527|NCT05660382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657528|NCT05660382|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101657529|NCT05660382|Hormone Antagonists|hormone antagonists|mesh-ancestor
101657530|NCT05660382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101657531|NCT05660382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657532|NCT05660382|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101657533|NCT05660382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101657534|NCT05660382|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101657535|NCT05660382|Emollients|emollients|mesh-ancestor
101657536|NCT05660382|Dermatologic Agents|dermatologic agents|mesh-ancestor
101657537|NCT00839371|Midazolam|midazolam|mesh-list
101657538|NCT00839371|Propofol|propofol|mesh-list
101657539|NCT00839371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101657540|NCT00839371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101657541|NCT00839371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657542|NCT00839371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101657543|NCT00839371|Anesthetics, General|anesthetics, general|mesh-ancestor
101657544|NCT00839371|Anesthetics|anesthetics|mesh-ancestor
101657545|NCT00839371|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101657546|NCT00839371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101657547|NCT00839371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101657548|NCT00839371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101657549|NCT00839371|GABA Modulators|gaba modulators|mesh-ancestor
101657550|NCT00839371|GABA Agents|gaba agents|mesh-ancestor
101657551|NCT00839371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101657552|NCT00839371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657554|NCT02826408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101657555|NCT02826408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101657556|NCT02826408|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101657557|NCT02826408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101657558|NCT02826408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657560|NCT00573937|Methadone|methadone|mesh-list
101657561|NCT00573937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101657562|NCT00573937|Narcotics|narcotics|mesh-ancestor
101657563|NCT00573937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101657564|NCT00573937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657565|NCT00573937|Analgesics|analgesics|mesh-ancestor
101657566|NCT00573937|Sensory System Agents|sensory system agents|mesh-ancestor
101657567|NCT00573937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101657568|NCT00573937|Antitussive Agents|antitussive agents|mesh-ancestor
101657569|NCT00573937|Respiratory System Agents|respiratory system agents|mesh-ancestor
101657570|NCT00845533|Piperaquine|piperaquine|mesh-list
101657571|NCT00845533|Artenimol|artenimol|mesh-list
101657572|NCT00845533|Antimalarials|antimalarials|mesh-ancestor
101657573|NCT00845533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101657574|NCT00845533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101657575|NCT00845533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101657576|NCT00839449|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
101657577|NCT00839449|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101657578|NCT00839449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101657579|NCT04958538|Methotrexate|methotrexate|mesh-list
101657580|NCT04958538|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101657581|NCT04958538|Abortifacient Agents|abortifacient agents|mesh-ancestor
101657582|NCT04958538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101657583|NCT04958538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657584|NCT04958538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101657585|NCT04958538|Antimetabolites|antimetabolites|mesh-ancestor
101657586|NCT04958538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657587|NCT04958538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101657588|NCT04958538|Dermatologic Agents|dermatologic agents|mesh-ancestor
101657590|NCT04958538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101657591|NCT04958538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101657592|NCT04958538|Immunologic Factors|immunologic factors|mesh-ancestor
101657593|NCT04958538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101657594|NCT04958538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101657595|NCT02548195|Gemcitabine|gemcitabine|mesh-list
101657596|NCT02548195|Capecitabine|capecitabine|mesh-list
101657597|NCT02548195|Oxaliplatin|oxaliplatin|mesh-list
101657598|NCT02548195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101657599|NCT02548195|Antimetabolites|antimetabolites|mesh-ancestor
101657600|NCT02548195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657601|NCT02548195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101657602|NCT00573859|Methylphenidate|methylphenidate|mesh-list
101657603|NCT00573859|Amphetamine|amphetamine|mesh-list
101657604|NCT00573859|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101657605|NCT00573859|Dextroamphetamine|dextroamphetamine|mesh-list
101657606|NCT00573859|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101657607|NCT00573859|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101657608|NCT00573859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657609|NCT00573859|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101657610|NCT00573859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101657611|NCT00573859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101657612|NCT00573859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657613|NCT00573859|Dopamine Agents|dopamine agents|mesh-ancestor
101657614|NCT00573859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101657615|NCT00573859|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101657616|NCT00573859|Adrenergic Agents|adrenergic agents|mesh-ancestor
101657617|NCT00573859|Sympathomimetics|sympathomimetics|mesh-ancestor
101657618|NCT00573859|Autonomic Agents|autonomic agents|mesh-ancestor
101657619|NCT00573859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101657620|NCT04043065|Anti-Infective Agents|anti-infective agents|mesh-list
101657621|NCT04043065|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101657622|NCT00839605|Dexmedetomidine|dexmedetomidine|mesh-list
101657623|NCT00839605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101657624|NCT00839605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101657625|NCT00839605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657626|NCT00839605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101657627|NCT00839605|Analgesics|analgesics|mesh-ancestor
101657628|NCT00839605|Sensory System Agents|sensory system agents|mesh-ancestor
101657629|NCT00839605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101657630|NCT00839605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101657631|NCT00839605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101657632|NCT00839605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101657633|NCT00839605|Adrenergic Agents|adrenergic agents|mesh-ancestor
101657634|NCT00839605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101657635|NCT00839605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657636|NCT00839683|Dapagliflozin|dapagliflozin|mesh-list
101657637|NCT00839683|Valsartan|valsartan|mesh-list
101657638|NCT00839683|Simvastatin|simvastatin|mesh-list
101657639|NCT00839683|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101657640|NCT00839683|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101657641|NCT00839683|Antimetabolites|antimetabolites|mesh-ancestor
101657642|NCT00839683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657643|NCT00839683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101657644|NCT00839683|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101657645|NCT00839683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101657646|NCT00839683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101657647|NCT00839683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101657648|NCT00839683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657649|NCT00839683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101657650|NCT00839683|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101657651|NCT00839683|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101657652|NCT00839761|Iron|iron|mesh-list
101657653|NCT00839761|Trace Elements|trace elements|mesh-ancestor
101657654|NCT00839761|Micronutrients|micronutrients|mesh-ancestor
101657655|NCT00839761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657656|NCT02825394|Ecarin|ecarin|mesh-list
101657657|NCT02825394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101657658|NCT02825394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101657659|NCT02825394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657660|NCT00845611|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101657661|NCT00845611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101657662|NCT00845611|Immunologic Factors|immunologic factors|mesh-ancestor
101657663|NCT00845611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657664|NCT00845689|Adenosine|adenosine|mesh-list
101657665|NCT00845689|Analgesics|analgesics|mesh-ancestor
101657666|NCT00845689|Sensory System Agents|sensory system agents|mesh-ancestor
101657667|NCT00845689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101657668|NCT00845689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657669|NCT00845689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101657670|NCT00845689|Vasodilator Agents|vasodilator agents|mesh-ancestor
101657671|NCT00845689|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101657672|NCT00845689|Purinergic Agonists|purinergic agonists|mesh-ancestor
101657674|NCT00845689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101657675|NCT00845689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657676|NCT05660694|Vitamin E|vitamin e|mesh-list
101657677|NCT05660694|Triamcinolone|triamcinolone|mesh-list
101657678|NCT05660694|Pentoxifylline|pentoxifylline|mesh-list
101657679|NCT05660694|Vitamins|vitamins|mesh-ancestor
101657681|NCT05660694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657682|NCT05660694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101657683|NCT05660694|Glucocorticoids|glucocorticoids|mesh-ancestor
101657684|NCT05660694|Hormones|hormones|mesh-ancestor
101657685|NCT05660694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101657686|NCT05660694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101657687|NCT05660694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657688|NCT05660694|Antioxidants|antioxidants|mesh-ancestor
101657689|NCT05660694|Protective Agents|protective agents|mesh-ancestor
101657690|NCT05660694|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101657691|NCT05660694|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101657692|NCT05660694|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101657693|NCT05660694|Vasodilator Agents|vasodilator agents|mesh-ancestor
101657694|NCT05660694|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101657695|NCT05113368|Fulvestrant|fulvestrant|mesh-list
101657696|NCT05113368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101657697|NCT05113368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101657698|NCT05113368|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101657699|NCT05113368|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101657700|NCT05113368|Hormone Antagonists|hormone antagonists|mesh-ancestor
101657701|NCT05113368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101657702|NCT05113368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657703|NCT02824614|Erythritol|erythritol|mesh-list
101657704|NCT02824614|Vasodilator Agents|vasodilator agents|mesh-ancestor
101657705|NCT00840229|Triamcinolone|triamcinolone|mesh-list
101657706|NCT00840229|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101657707|NCT00840229|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101657708|NCT00840229|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101657709|NCT00840229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101657710|NCT00840229|Glucocorticoids|glucocorticoids|mesh-ancestor
101657711|NCT00840229|Hormones|hormones|mesh-ancestor
101657712|NCT00840229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101657713|NCT00840229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657714|NCT00840229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101657715|NCT00840229|Immunologic Factors|immunologic factors|mesh-ancestor
101657716|NCT00840229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101657717|NCT00840229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657718|NCT00831441|Apixaban|apixaban|mesh-list
101657719|NCT00831441|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101657720|NCT00831441|Antithrombins|antithrombins|mesh-ancestor
101657721|NCT00831441|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101657722|NCT00831441|Protease Inhibitors|protease inhibitors|mesh-ancestor
101657723|NCT00831441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101657724|NCT00831441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657725|NCT00831441|Anticoagulants|anticoagulants|mesh-ancestor
101657726|NCT00840385|Vidarabine|vidarabine|mesh-list
101657727|NCT00840385|Fludarabine|fludarabine|mesh-list
101657728|NCT00840385|Fludarabine phosphate|fludarabine phosphate|mesh-list
101657729|NCT00840385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101657730|NCT00840385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101657731|NCT00840385|Antimetabolites|antimetabolites|mesh-ancestor
101657732|NCT00840385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657733|NCT00840385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101657734|NCT00840385|Immunologic Factors|immunologic factors|mesh-ancestor
101657735|NCT00840385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657736|NCT00840385|Antiviral Agents|antiviral agents|mesh-ancestor
101657737|NCT00840385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101657738|NCT02824458|Apatinib|apatinib|mesh-list
101657739|NCT02824458|Gefitinib|gefitinib|mesh-list
101657740|NCT02824458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101657741|NCT02824458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101657742|NCT02824458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101657743|NCT02824458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657744|NCT00840931|Lenalidomide|lenalidomide|mesh-list
101657745|NCT00840931|Immunologic Factors|immunologic factors|mesh-ancestor
101657746|NCT00840931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657747|NCT00840931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101657748|NCT00840931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101657749|NCT00840931|Growth Substances|growth substances|mesh-ancestor
101657750|NCT00840931|Growth Inhibitors|growth inhibitors|mesh-ancestor
101657751|NCT00840931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101657752|NCT05659992|Cytarabine|cytarabine|mesh-list
101657753|NCT05659992|Azacitidine|azacitidine|mesh-list
101657754|NCT05659992|Venetoclax|venetoclax|mesh-list
101657755|NCT05659992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101657757|NCT05659992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657758|NCT05659992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101657759|NCT05659992|Antiviral Agents|antiviral agents|mesh-ancestor
101657760|NCT05659992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101657761|NCT05659992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101657762|NCT05659992|Immunologic Factors|immunologic factors|mesh-ancestor
101657763|NCT05659992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657764|NCT05659992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101657765|NCT00834379|Pravastatin|pravastatin|mesh-list
101657766|NCT00834379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101657767|NCT00834379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101657768|NCT00834379|Antimetabolites|antimetabolites|mesh-ancestor
101657769|NCT00834379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657770|NCT00834379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101657771|NCT00834379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101657772|NCT00834379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101657773|NCT00834457|Ritonavir|ritonavir|mesh-list
101657774|NCT00834457|Lopinavir|lopinavir|mesh-list
101657775|NCT00834457|Zidovudine|zidovudine|mesh-list
101657776|NCT00834457|Lamivudine|lamivudine|mesh-list
101657777|NCT00834457|Abacavir|abacavir|mesh-list
101657778|NCT00834457|Dideoxynucleosides|dideoxynucleosides|mesh-list
101657779|NCT00834457|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101657780|NCT00834457|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101657781|NCT00834457|Protease Inhibitors|protease inhibitors|mesh-ancestor
101657782|NCT00834457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101657783|NCT00834457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657784|NCT00834457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101657785|NCT00834457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101657786|NCT00834457|Antiviral Agents|antiviral agents|mesh-ancestor
101657787|NCT00834457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101657788|NCT00834457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101657789|NCT00834457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101657790|NCT00834457|Antimetabolites|antimetabolites|mesh-ancestor
101657791|NCT00834457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101657792|NCT00834457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101657793|NCT03851965|Plasminogen|plasminogen|mesh-list
101657794|NCT03851965|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101824810|NCT01564680|Antipyretics|antipyretics|mesh-ancestor
101657795|NCT03851965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101657796|NCT03851965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657797|NCT02611635|Warfarin|warfarin|mesh-list
101657798|NCT02611635|Rivaroxaban|rivaroxaban|mesh-list
101657799|NCT02611635|Dabigatran|dabigatran|mesh-list
101657800|NCT02611635|Apixaban|apixaban|mesh-list
101657801|NCT02611635|Edoxaban|edoxaban|mesh-list
101657802|NCT02611635|Anticoagulants|anticoagulants|mesh-ancestor
101657803|NCT02611635|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101657804|NCT02611635|Antithrombins|antithrombins|mesh-ancestor
101657805|NCT02611635|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101657806|NCT02611635|Protease Inhibitors|protease inhibitors|mesh-ancestor
101657807|NCT02611635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101657808|NCT02611635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657809|NCT02824926|Ketoconazole|ketoconazole|mesh-list
101657810|NCT02824926|Antifungal Agents|antifungal agents|mesh-ancestor
101657811|NCT02824926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101657812|NCT02824926|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101657813|NCT02824926|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101657814|NCT02824926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101657815|NCT02824926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657816|NCT02824926|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101657817|NCT02824926|Hormone Antagonists|hormone antagonists|mesh-ancestor
101657818|NCT02824926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101657819|NCT02824926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657820|NCT02824926|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101657821|NCT00705471|Infliximab|infliximab|mesh-list
101657822|NCT00705471|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101657823|NCT00705471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101657824|NCT00705471|Dermatologic Agents|dermatologic agents|mesh-ancestor
101657825|NCT00705471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101657826|NCT00705471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101657827|NCT00705549|Cisplatin|cisplatin|mesh-list
101657828|NCT00705549|Gemcitabine|gemcitabine|mesh-list
101657829|NCT00705549|Docetaxel|docetaxel|mesh-list
101657830|NCT00705549|Vinorelbine|vinorelbine|mesh-list
101657832|NCT00705549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101657833|NCT00705549|Antimetabolites|antimetabolites|mesh-ancestor
101657834|NCT00705549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657835|NCT00705549|Tubulin Modulators|tubulin modulators|mesh-ancestor
101657836|NCT00705549|Antimitotic Agents|antimitotic agents|mesh-ancestor
101657837|NCT00705549|Mitosis Modulators|mitosis modulators|mesh-ancestor
101657838|NCT00705549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101657839|NCT02824770|Tramadol|tramadol|mesh-list
101657840|NCT02824770|Bupivacaine|bupivacaine|mesh-list
101657841|NCT02824770|Anesthetics, Local|anesthetics, local|mesh-ancestor
101657842|NCT02824770|Anesthetics|anesthetics|mesh-ancestor
101657843|NCT02824770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101657844|NCT02824770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657845|NCT02824770|Sensory System Agents|sensory system agents|mesh-ancestor
101657846|NCT02824770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101657847|NCT02824770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101657848|NCT02824770|Narcotics|narcotics|mesh-ancestor
101657849|NCT02824770|Analgesics|analgesics|mesh-ancestor
101657850|NCT02824536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101657851|NCT02824536|Antibodies|antibodies|mesh-list
101657852|NCT02824536|Immunoglobulins|immunoglobulins|mesh-list
101657853|NCT02824536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101657854|NCT02824536|Immunologic Factors|immunologic factors|mesh-ancestor
101657855|NCT02824536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657856|NCT02824536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101657857|NCT00831129|Rosiglitazone|rosiglitazone|mesh-list
101657858|NCT00831129|Simvastatin|simvastatin|mesh-list
101657859|NCT00831129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101657860|NCT00831129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101657861|NCT00831129|Antimetabolites|antimetabolites|mesh-ancestor
101657862|NCT00831129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657863|NCT00831129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101657864|NCT00831129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101657865|NCT00831129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101657866|NCT00831129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101657867|NCT00831129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657868|NCT00637962|polysaccharide-K|polysaccharide-k|mesh-list
101657869|NCT00637962|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101657870|NCT00637962|Immunologic Factors|immunologic factors|mesh-ancestor
101657871|NCT00637962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657872|NCT00637962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101657873|NCT00637962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101657874|NCT00637962|Antiviral Agents|antiviral agents|mesh-ancestor
101657875|NCT00637962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101657876|NCT00637962|Interferon Inducers|interferon inducers|mesh-ancestor
101657877|NCT00637962|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101657878|NCT00637962|Protective Agents|protective agents|mesh-ancestor
101657879|NCT00913341|Alprazolam|alprazolam|mesh-list
101657880|NCT00913341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101657881|NCT00913341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101657882|NCT00913341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657883|NCT00913341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101657884|NCT00913341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101657885|NCT00913341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101657886|NCT00913341|GABA Modulators|gaba modulators|mesh-ancestor
101657887|NCT00913341|GABA Agents|gaba agents|mesh-ancestor
101657888|NCT00913341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101657889|NCT00913341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657890|NCT00620113|Vitamin D|vitamin d|mesh-list
101657891|NCT00620113|Cholecalciferol|cholecalciferol|mesh-list
101657892|NCT00620113|Calcium Carbonate|calcium carbonate|mesh-list
101657893|NCT00620113|Calcium|calcium|mesh-list
101657894|NCT00620113|Vitamins|vitamins|mesh-ancestor
101657895|NCT00620113|Micronutrients|micronutrients|mesh-ancestor
101657896|NCT00620113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657897|NCT00620113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101657898|NCT00620113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101657899|NCT00620113|Antacids|antacids|mesh-ancestor
101657900|NCT00620113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657901|NCT00620113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101657902|NCT00830115|Pantoprazole|pantoprazole|mesh-list
101657903|NCT00830115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101657904|NCT00830115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101657905|NCT00830115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101657906|NCT00830115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101657907|NCT00830115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657908|NCT00633672|Esomeprazole|esomeprazole|mesh-list
101657909|NCT00633672|Ranitidine|ranitidine|mesh-list
101657910|NCT00633672|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
101657911|NCT00633672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101657912|NCT00633672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101657913|NCT00633672|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101657914|NCT00633672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101657915|NCT00633672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657916|NCT00633672|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101657917|NCT00633672|Histamine Antagonists|histamine antagonists|mesh-ancestor
101657918|NCT00633672|Histamine Agents|histamine agents|mesh-ancestor
101657919|NCT00633672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101657920|NCT00633672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657921|NCT02547103|Chlorhexidine|chlorhexidine|mesh-list
101657922|NCT02547103|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101657923|NCT02547103|Mupirocin|mupirocin|mesh-list
101657924|NCT02547103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101657925|NCT02547103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101657926|NCT02547103|Disinfectants|disinfectants|mesh-ancestor
101657927|NCT02547103|Dermatologic Agents|dermatologic agents|mesh-ancestor
101657928|NCT02547103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101657929|NCT02547103|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101657930|NCT02547103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101657931|NCT02547103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657932|NCT02822586|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101657933|NCT02822586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101657934|NCT02822586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101657936|NCT02822586|Immunoconjugates|immunoconjugates|mesh-ancestor
101657937|NCT02822586|Immunologic Factors|immunologic factors|mesh-ancestor
101657938|NCT02822586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657939|NCT00848809|Vancomycin|vancomycin|mesh-list
101657940|NCT00848809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101657941|NCT00848809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101657942|NCT00834847|Pravastatin|pravastatin|mesh-list
101657943|NCT00834847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101657944|NCT00834847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101657945|NCT00834847|Antimetabolites|antimetabolites|mesh-ancestor
101657946|NCT00834847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657947|NCT00834847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101657948|NCT00834847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101657949|NCT00834847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101657950|NCT00841477|Vaccines|vaccines|mesh-list
101657951|NCT00841477|Immunologic Factors|immunologic factors|mesh-ancestor
101657952|NCT00841477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657953|NCT00834925|Diltiazem|diltiazem|mesh-list
101657954|NCT00834925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101657955|NCT00834925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101657956|NCT00834925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101657957|NCT00834925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657958|NCT00834925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101657959|NCT00834925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657960|NCT00834925|Vasodilator Agents|vasodilator agents|mesh-ancestor
101657961|NCT00841633|Norepinephrine|norepinephrine|mesh-list
101657962|NCT00841633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101657963|NCT00841633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101657964|NCT00841633|Adrenergic Agents|adrenergic agents|mesh-ancestor
101657965|NCT00841633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101657966|NCT00841633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657967|NCT00841633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657968|NCT00841633|Sympathomimetics|sympathomimetics|mesh-ancestor
101657969|NCT00841633|Autonomic Agents|autonomic agents|mesh-ancestor
101657970|NCT00841633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101657971|NCT00841633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101657972|NCT02823912|Capsaicin|capsaicin|mesh-list
101657973|NCT02823912|Magnesium Oxide|magnesium oxide|mesh-list
101657974|NCT02823912|Antipruritics|antipruritics|mesh-ancestor
101657975|NCT02823912|Dermatologic Agents|dermatologic agents|mesh-ancestor
101657976|NCT02823912|Sensory System Agents|sensory system agents|mesh-ancestor
101657977|NCT02823912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101657978|NCT02823912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657979|NCT02823912|Antacids|antacids|mesh-ancestor
101657980|NCT02823912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657981|NCT02823912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101657983|NCT00841945|Rituximab|rituximab|mesh-list
101657984|NCT00841945|Doxorubicin|doxorubicin|mesh-list
101657985|NCT00841945|Vincristine|vincristine|mesh-list
101657986|NCT00841945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101657987|NCT00841945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101657988|NCT00841945|Immunologic Factors|immunologic factors|mesh-ancestor
101657989|NCT00841945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101657990|NCT00841945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101657991|NCT00841945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101657992|NCT00841945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101657993|NCT00841945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101657994|NCT00841945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101657995|NCT00841945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101657996|NCT00841945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101657997|NCT00841945|Glucocorticoids|glucocorticoids|mesh-ancestor
101657998|NCT00841945|Hormones|hormones|mesh-ancestor
101657999|NCT00841945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101658000|NCT00841945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101658001|NCT00841945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101658002|NCT00841945|Tubulin Modulators|tubulin modulators|mesh-ancestor
101658003|NCT00841945|Antimitotic Agents|antimitotic agents|mesh-ancestor
101658004|NCT00841945|Mitosis Modulators|mitosis modulators|mesh-ancestor
101658005|NCT02822196|Lidocaine|lidocaine|mesh-list
101658006|NCT02822196|Bupivacaine|bupivacaine|mesh-list
101658007|NCT02822196|Anesthetics, Local|anesthetics, local|mesh-ancestor
101658008|NCT02822196|Anesthetics|anesthetics|mesh-ancestor
101658009|NCT02822196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101658010|NCT02822196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658011|NCT02822196|Sensory System Agents|sensory system agents|mesh-ancestor
101658012|NCT02822196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101658013|NCT02822196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101658014|NCT02822196|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101658015|NCT02822196|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101658016|NCT02822196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101451720|NCT00208065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101658017|NCT02822196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658018|NCT00706017|Insulin Detemir|insulin detemir|mesh-list
101658019|NCT00706017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101658020|NCT00706017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658021|NCT00829179|Omalizumab|omalizumab|mesh-list
101658022|NCT00829179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101658023|NCT00829179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101658024|NCT00829179|Respiratory System Agents|respiratory system agents|mesh-ancestor
101658025|NCT00849355|Rituximab|rituximab|mesh-list
101658026|NCT00849355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101658027|NCT00849355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101658028|NCT00849355|Immunologic Factors|immunologic factors|mesh-ancestor
101658029|NCT00849355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658030|NCT00849355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101658031|NCT00835393|Pantoprazole|pantoprazole|mesh-list
101658032|NCT00835393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101658033|NCT00835393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101658034|NCT00835393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101658035|NCT00835393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101658036|NCT00835393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658037|NCT00706173|Hydrocortisone|hydrocortisone|mesh-list
101658038|NCT00706173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101658039|NCT02822742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101658040|NCT02822742|Latanoprost|latanoprost|mesh-list
101658041|NCT02822742|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101658042|NCT00835471|Docetaxel|docetaxel|mesh-list
101658043|NCT00835471|Pemetrexed|pemetrexed|mesh-list
101658044|NCT00835471|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101658045|NCT00835471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101658046|NCT00835471|Tubulin Modulators|tubulin modulators|mesh-ancestor
101658047|NCT00835471|Antimitotic Agents|antimitotic agents|mesh-ancestor
101658048|NCT00835471|Mitosis Modulators|mitosis modulators|mesh-ancestor
101658049|NCT00835471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658050|NCT00835471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101658051|NCT00835471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101658052|NCT00835471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101658053|NCT00835471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101658054|NCT00849511|Melatonin|melatonin|mesh-list
101658055|NCT00849511|Antioxidants|antioxidants|mesh-ancestor
101658056|NCT00849511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658058|NCT00849511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658059|NCT00849511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101658060|NCT02546791|Dasatinib|dasatinib|mesh-list
101658061|NCT02546791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101658062|NCT02546791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101658063|NCT02546791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101658064|NCT02546791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658065|NCT00966875|Ixekizumab|ixekizumab|mesh-list
101658066|NCT00966875|Dermatologic Agents|dermatologic agents|mesh-ancestor
101658067|NCT00849745|Alemtuzumab|alemtuzumab|mesh-list
101658068|NCT00849745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101658070|NCT00835627|Sertraline|sertraline|mesh-list
101658071|NCT00835627|Antidepressive Agents|antidepressive agents|mesh-ancestor
101658072|NCT00835627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101658073|NCT00835627|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101658074|NCT00835627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101658075|NCT00835627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101658076|NCT00835627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658077|NCT00835627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101658078|NCT00835627|Serotonin Agents|serotonin agents|mesh-ancestor
101658079|NCT00835627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658080|NCT00842491|Cisplatin|cisplatin|mesh-list
101658081|NCT00842491|Capecitabine|capecitabine|mesh-list
101658082|NCT00842491|Endostar protein|endostar protein|mesh-list
101658083|NCT00842491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101658084|NCT00842491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101658085|NCT00842491|Antimetabolites|antimetabolites|mesh-ancestor
101658086|NCT00842491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658087|NCT00842491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101658088|NCT00842491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101658089|NCT00842491|Growth Substances|growth substances|mesh-ancestor
101658090|NCT00842491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658091|NCT00842491|Growth Inhibitors|growth inhibitors|mesh-ancestor
101658092|NCT05659212|Lidocaine|lidocaine|mesh-list
101658093|NCT05659212|Magnesium Sulfate|magnesium sulfate|mesh-list
101658094|NCT05659212|Dexmedetomidine|dexmedetomidine|mesh-list
101658095|NCT05659212|Anesthetics, Local|anesthetics, local|mesh-ancestor
101658096|NCT05659212|Anesthetics|anesthetics|mesh-ancestor
101658097|NCT05659212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101658098|NCT05659212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658099|NCT05659212|Sensory System Agents|sensory system agents|mesh-ancestor
101658100|NCT05659212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101658101|NCT05659212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101658102|NCT05659212|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101658103|NCT05659212|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101658104|NCT05659212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101658105|NCT05659212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658106|NCT05659212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101658107|NCT05659212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101658108|NCT05659212|Analgesics|analgesics|mesh-ancestor
101658109|NCT05659212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101658110|NCT05659212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101658111|NCT05659212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101658112|NCT05659212|Adrenergic Agents|adrenergic agents|mesh-ancestor
101658113|NCT05659212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101658114|NCT05659212|Anticonvulsants|anticonvulsants|mesh-ancestor
101658115|NCT05659212|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101658116|NCT05659212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101658117|NCT05659212|Tocolytic Agents|tocolytic agents|mesh-ancestor
101658118|NCT05659212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101658119|NCT00835939|Lidocaine|lidocaine|mesh-list
101658120|NCT00835939|Anesthetics, Local|anesthetics, local|mesh-ancestor
101658121|NCT00835939|Anesthetics|anesthetics|mesh-ancestor
101658122|NCT00835939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101658123|NCT00835939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658124|NCT00835939|Sensory System Agents|sensory system agents|mesh-ancestor
101658125|NCT00835939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101658126|NCT00835939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101658127|NCT00835939|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101658128|NCT00835939|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101658129|NCT00835939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101658130|NCT00835939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658131|NCT05659368|Tirzepatide|tirzepatide|mesh-list
101658132|NCT05659368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101658133|NCT05659368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658135|NCT05659368|Hormones|hormones|mesh-ancestor
101658136|NCT05659368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101658137|NCT00818649|Bortezomib|bortezomib|mesh-list
101658138|NCT00818649|Vorinostat|vorinostat|mesh-list
101658139|NCT00818649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101658140|NCT00818649|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101658141|NCT00818649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101658142|NCT00818649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658143|NCT02861105|Enoxaparin|enoxaparin|mesh-list
101658144|NCT02861105|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101658145|NCT02861105|Anticoagulants|anticoagulants|mesh-ancestor
101658146|NCT02861105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101658147|NCT02861105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101658148|NCT02861105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658149|NCT02820558|Substance P|substance p|mesh-list
101658150|NCT02820558|Neurokinin A|neurokinin a|mesh-list
101658151|NCT02820558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101658152|NCT02820558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658153|NCT02820558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658154|NCT00961571|Capecitabine|capecitabine|mesh-list
101658155|NCT00961571|Sunitinib|sunitinib|mesh-list
101658156|NCT00961571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101658157|NCT00961571|Antimetabolites|antimetabolites|mesh-ancestor
101658158|NCT00961571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658159|NCT00961571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101658160|NCT00961571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101658161|NCT00961571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101315328|NCT02972476|Hormones|hormones|mesh-ancestor
101658162|NCT00961571|Growth Substances|growth substances|mesh-ancestor
101658163|NCT00961571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658164|NCT00961571|Growth Inhibitors|growth inhibitors|mesh-ancestor
101658165|NCT00961571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101658166|NCT00961571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101658167|NCT02820948|Vitamins|vitamins|mesh-list
101658168|NCT02820948|Vitamin E|vitamin e|mesh-list
101658169|NCT02820948|Tocopherols|tocopherols|mesh-list
101658170|NCT02820948|Tocotrienols|tocotrienols|mesh-list
101658171|NCT02820948|alpha-Tocopherol|alpha-tocopherol|mesh-list
101658172|NCT02820948|Micronutrients|micronutrients|mesh-ancestor
101658173|NCT02820948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658174|NCT02820948|Antioxidants|antioxidants|mesh-ancestor
101658175|NCT02820948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658176|NCT02820948|Protective Agents|protective agents|mesh-ancestor
101658177|NCT02860949|Ketorolac|ketorolac|mesh-list
101658178|NCT02860949|Epinephrine|epinephrine|mesh-list
101658179|NCT02860949|Morphine|morphine|mesh-list
101658180|NCT02860949|Bupivacaine|bupivacaine|mesh-list
101658181|NCT02860949|Anesthetics, Local|anesthetics, local|mesh-ancestor
101658182|NCT02860949|Anesthetics|anesthetics|mesh-ancestor
101658183|NCT02860949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101658184|NCT02860949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658185|NCT02860949|Sensory System Agents|sensory system agents|mesh-ancestor
101658186|NCT02860949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101658187|NCT02860949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101658188|NCT02860949|Narcotics|narcotics|mesh-ancestor
101658189|NCT02860949|Analgesics|analgesics|mesh-ancestor
101658190|NCT02860949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101658191|NCT02860949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101658192|NCT02860949|Adrenergic Agents|adrenergic agents|mesh-ancestor
101658193|NCT02860949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101658194|NCT02860949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658195|NCT02860949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101658196|NCT02860949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101658197|NCT02860949|Autonomic Agents|autonomic agents|mesh-ancestor
101658198|NCT02860949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101658199|NCT02860949|Respiratory System Agents|respiratory system agents|mesh-ancestor
101658200|NCT02860949|Mydriatics|mydriatics|mesh-ancestor
101658201|NCT02860949|Sympathomimetics|sympathomimetics|mesh-ancestor
101658202|NCT02860949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101658203|NCT02860949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101658204|NCT02860949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101658205|NCT02860949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101658206|NCT02860949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101658207|NCT02860949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101658208|NCT02860949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101658209|NCT03248063|Cefazolin|cefazolin|mesh-list
101658210|NCT03248063|Cloxacillin|cloxacillin|mesh-list
101658211|NCT03248063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101658212|NCT03248063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101658213|NCT00964223|Clindamycin|clindamycin|mesh-list
101658214|NCT00964223|Clindamycin palmitate|clindamycin palmitate|mesh-list
101658215|NCT00964223|Clindamycin phosphate|clindamycin phosphate|mesh-list
101658216|NCT00964223|Adapalene|adapalene|mesh-list
101658217|NCT00964223|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
101658218|NCT00964223|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101658219|NCT00964223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101658220|NCT00964223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101658221|NCT00964223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101658222|NCT00964223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101658223|NCT00964223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658224|NCT00964223|Dermatologic Agents|dermatologic agents|mesh-ancestor
101658225|NCT00964223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101658226|NCT00964223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101658227|NCT00964223|Analgesics|analgesics|mesh-ancestor
101658228|NCT00964223|Sensory System Agents|sensory system agents|mesh-ancestor
101658229|NCT00964223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101658230|NCT00964223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658231|NCT00964223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101658232|NCT00964223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101658233|NCT00620815|Vaccines|vaccines|mesh-list
101658234|NCT00620815|MF59 oil emulsion|mf59 oil emulsion|mesh-list
101658235|NCT00620815|Immunologic Factors|immunologic factors|mesh-ancestor
101658236|NCT00620815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658237|NCT00620815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101658238|NCT04238988|Paclitaxel|paclitaxel|mesh-list
101658239|NCT04238988|Carboplatin|carboplatin|mesh-list
101658240|NCT04238988|Pembrolizumab|pembrolizumab|mesh-list
101658241|NCT04238988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101658242|NCT04238988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101658243|NCT04238988|Tubulin Modulators|tubulin modulators|mesh-ancestor
101658244|NCT04238988|Antimitotic Agents|antimitotic agents|mesh-ancestor
101658245|NCT04238988|Mitosis Modulators|mitosis modulators|mesh-ancestor
101658246|NCT04238988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658247|NCT04238988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101658248|NCT04238988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101658249|NCT04284215|Paclitaxel|paclitaxel|mesh-list
101658250|NCT04284215|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101658251|NCT04284215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101658252|NCT04284215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101658253|NCT04284215|Tubulin Modulators|tubulin modulators|mesh-ancestor
101658254|NCT04284215|Antimitotic Agents|antimitotic agents|mesh-ancestor
101658255|NCT04284215|Mitosis Modulators|mitosis modulators|mesh-ancestor
101658256|NCT04284215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658257|NCT02816970|Vildagliptin|vildagliptin|mesh-list
101658258|NCT02816970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101658259|NCT02816970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101824879|NCT00849095|Budesonide|budesonide|mesh-list
101658260|NCT02816970|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101658261|NCT02816970|Protease Inhibitors|protease inhibitors|mesh-ancestor
101658262|NCT02816970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101658263|NCT02816970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658265|NCT03372941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101658266|NCT03372941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101658267|NCT04238832|Nicotine|nicotine|mesh-list
101658268|NCT04238832|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101658269|NCT04238832|Autonomic Agents|autonomic agents|mesh-ancestor
101658270|NCT04238832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101658271|NCT04238832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658272|NCT04238832|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101658273|NCT04238832|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101658274|NCT04238832|Cholinergic Agents|cholinergic agents|mesh-ancestor
101658275|NCT04238832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101658276|NCT04238832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658277|NCT04622904|Lidocaine|lidocaine|mesh-list
101658278|NCT04622904|Ketamine|ketamine|mesh-list
101658279|NCT04622904|Anesthetics, Local|anesthetics, local|mesh-ancestor
101658280|NCT04622904|Anesthetics|anesthetics|mesh-ancestor
101658281|NCT04622904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101658282|NCT04622904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658283|NCT04622904|Sensory System Agents|sensory system agents|mesh-ancestor
101658284|NCT04622904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101658285|NCT04622904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101658286|NCT04622904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101658287|NCT04622904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101658288|NCT04622904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101658289|NCT04622904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658290|NCT04622904|Analgesics|analgesics|mesh-ancestor
101658291|NCT04622904|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101658292|NCT04622904|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101658293|NCT04622904|Anesthetics, General|anesthetics, general|mesh-ancestor
101658294|NCT04622904|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101658295|NCT04622904|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101658296|NCT04622904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101658297|NCT00634062|Lamotrigine|lamotrigine|mesh-list
101658298|NCT00634062|Anticonvulsants|anticonvulsants|mesh-ancestor
101658299|NCT00634062|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101658300|NCT00634062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101658301|NCT00634062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658302|NCT00634062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101658303|NCT00634062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658304|NCT00634062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101658305|NCT00634062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101658306|NCT00634062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101658307|NCT00634062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101658308|NCT00634062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101658309|NCT00634140|Ezetimibe|ezetimibe|mesh-list
101658310|NCT00634140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101658311|NCT00634140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101658312|NCT00634140|Antimetabolites|antimetabolites|mesh-ancestor
101658313|NCT00634140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658314|NCT00634140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101658315|NCT02819544|Ropivacaine|ropivacaine|mesh-list
101658316|NCT02819544|Anesthetics, Local|anesthetics, local|mesh-ancestor
101658318|NCT02819544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101658319|NCT02819544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658320|NCT02819544|Sensory System Agents|sensory system agents|mesh-ancestor
101658321|NCT02819544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101658322|NCT02819388|Contraceptive Agents|contraceptive agents|mesh-list
101658323|NCT02819388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101658324|NCT02819388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658325|NCT02818140|Ropivacaine|ropivacaine|mesh-list
101658326|NCT02818140|Anesthetics, Local|anesthetics, local|mesh-ancestor
101658327|NCT02818140|Anesthetics|anesthetics|mesh-ancestor
101658328|NCT02818140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101658329|NCT02818140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658330|NCT02818140|Sensory System Agents|sensory system agents|mesh-ancestor
101658331|NCT02818140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101658332|NCT04238208|Lidocaine|lidocaine|mesh-list
101658333|NCT04238208|Capsaicin|capsaicin|mesh-list
101658334|NCT04238208|Anesthetics, Local|anesthetics, local|mesh-ancestor
101658335|NCT04238208|Anesthetics|anesthetics|mesh-ancestor
101658336|NCT04238208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101658337|NCT04238208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658338|NCT04238208|Sensory System Agents|sensory system agents|mesh-ancestor
101658339|NCT04238208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101658340|NCT04238208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101658341|NCT04238208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101658342|NCT04238208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101658343|NCT04238208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101658344|NCT04238208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658345|NCT04238208|Antipruritics|antipruritics|mesh-ancestor
101658346|NCT04238208|Dermatologic Agents|dermatologic agents|mesh-ancestor
101658347|NCT02816112|Ciprofloxacin|ciprofloxacin|mesh-list
101658348|NCT02816112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101658349|NCT02816112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101658350|NCT02816112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101658351|NCT02816112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101658352|NCT02816112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101658353|NCT02816112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658354|NCT02816112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101658355|NCT02816112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101658356|NCT02816112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101658357|NCT02815722|Simvastatin|simvastatin|mesh-list
101658358|NCT02815722|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101658359|NCT02815722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101658360|NCT02815722|Antimetabolites|antimetabolites|mesh-ancestor
101658361|NCT02815722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658362|NCT02815722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101658363|NCT02815722|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101658364|NCT02815722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101658365|NCT02817750|Zolpidem|zolpidem|mesh-list
101658366|NCT02817750|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101658367|NCT02817750|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101658368|NCT02817750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101658369|NCT02817750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658370|NCT02817750|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101658371|NCT02817750|GABA Agonists|gaba agonists|mesh-ancestor
101658372|NCT02817750|GABA Agents|gaba agents|mesh-ancestor
101658373|NCT02817750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101658374|NCT02817750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658375|NCT02815410|Levetiracetam|levetiracetam|mesh-list
101658376|NCT02815410|Anticonvulsants|anticonvulsants|mesh-ancestor
101658377|NCT02815410|Nootropic Agents|nootropic agents|mesh-ancestor
101658378|NCT02814630|Omalizumab|omalizumab|mesh-list
101658379|NCT02814630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101658380|NCT02814630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101658381|NCT02814630|Respiratory System Agents|respiratory system agents|mesh-ancestor
101658383|NCT00619957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101658384|NCT00619957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101658385|NCT00619957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658386|NCT00619957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101315542|NCT00000531|Autonomic Agents|autonomic agents|mesh-ancestor
101658387|NCT00619957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658388|NCT00619957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101658389|NCT04519476|Methylprednisolone|methylprednisolone|mesh-list
101658390|NCT04519476|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101658391|NCT04519476|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101658393|NCT04519476|Prednisolone acetate|prednisolone acetate|mesh-list
101658394|NCT04519476|Lenalidomide|lenalidomide|mesh-list
101658395|NCT04519476|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101658396|NCT04519476|Prednisolone phosphate|prednisolone phosphate|mesh-list
101658397|NCT04519476|Immunologic Factors|immunologic factors|mesh-ancestor
101658398|NCT04519476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658399|NCT04519476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101658400|NCT04519476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101658401|NCT04519476|Growth Substances|growth substances|mesh-ancestor
101658402|NCT04519476|Growth Inhibitors|growth inhibitors|mesh-ancestor
101658403|NCT04519476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101658404|NCT04519476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101658405|NCT04519476|Antiemetics|antiemetics|mesh-ancestor
101658406|NCT04519476|Autonomic Agents|autonomic agents|mesh-ancestor
101658407|NCT04519476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101658408|NCT04519476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101658409|NCT04519476|Glucocorticoids|glucocorticoids|mesh-ancestor
101658410|NCT04519476|Hormones|hormones|mesh-ancestor
101658411|NCT04519476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101658412|NCT04519476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101658413|NCT04519476|Protective Agents|protective agents|mesh-ancestor
101658414|NCT04519476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101658415|NCT00961415|Bevacizumab|bevacizumab|mesh-list
101658416|NCT00961415|Pemetrexed|pemetrexed|mesh-list
101658417|NCT00961415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101658418|NCT00961415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101658419|NCT00961415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101658420|NCT00961415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101658421|NCT00961415|Growth Substances|growth substances|mesh-ancestor
101658422|NCT00961415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658423|NCT00961415|Growth Inhibitors|growth inhibitors|mesh-ancestor
101658424|NCT00961415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101658425|NCT00961415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658426|NCT00961415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101658427|NCT00961415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101658428|NCT00851227|Conivaptan|conivaptan|mesh-list
101658429|NCT00851227|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101658430|NCT00851227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658431|NCT00851227|Natriuretic Agents|natriuretic agents|mesh-ancestor
101658432|NCT00851227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658433|NCT03365609|Bismuth|bismuth|mesh-list
101658434|NCT03365609|Antacids|antacids|mesh-ancestor
101658435|NCT03365609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658436|NCT03365609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101658437|NCT05636904|Minoxidil|minoxidil|mesh-list
101658438|NCT05636904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101658439|NCT05636904|Dinoprost|dinoprost|mesh-list
101658440|NCT05636904|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
101658441|NCT05636904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101658442|NCT05636904|Vasodilator Agents|vasodilator agents|mesh-ancestor
101658443|NCT05636904|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101658444|NCT05636904|Abortifacient Agents|abortifacient agents|mesh-ancestor
101658445|NCT05636904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101658446|NCT05636904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658447|NCT05636904|Oxytocics|oxytocics|mesh-ancestor
101658448|NCT00963599|Loratadine|loratadine|mesh-list
101658449|NCT00963599|Montelukast|montelukast|mesh-list
101658450|NCT00963599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101658451|NCT00963599|Respiratory System Agents|respiratory system agents|mesh-ancestor
101658452|NCT00963599|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101658453|NCT00963599|Hormone Antagonists|hormone antagonists|mesh-ancestor
101658454|NCT00963599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101658455|NCT00963599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658456|NCT00963599|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101658457|NCT00963599|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101658458|NCT00963599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658459|NCT00963599|Antipruritics|antipruritics|mesh-ancestor
101658460|NCT00963599|Dermatologic Agents|dermatologic agents|mesh-ancestor
101658461|NCT00963599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101658462|NCT00963599|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101658463|NCT00963599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101658464|NCT00963599|Histamine Antagonists|histamine antagonists|mesh-ancestor
101658465|NCT00963599|Histamine Agents|histamine agents|mesh-ancestor
101658466|NCT00963599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101658467|NCT05636592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101658468|NCT05636592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658469|NCT05636592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101658470|NCT05636592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101658472|NCT00851461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101658473|NCT00851461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101658474|NCT04205136|Spironolactone|spironolactone|mesh-list
101658475|NCT04205136|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101658476|NCT04205136|Hormone Antagonists|hormone antagonists|mesh-ancestor
101658477|NCT04205136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101658478|NCT04205136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658479|NCT04205136|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101658480|NCT04205136|Diuretics|diuretics|mesh-ancestor
101658481|NCT04205136|Natriuretic Agents|natriuretic agents|mesh-ancestor
101658482|NCT02815332|Minocycline|minocycline|mesh-list
101658483|NCT02815332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101658484|NCT02815332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101658485|NCT02811354|Osimertinib|osimertinib|mesh-list
101658486|NCT02811354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101658487|NCT02811354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101658488|NCT02811354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101658489|NCT02811354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658490|NCT02810808|Ranibizumab|ranibizumab|mesh-list
101658491|NCT02810808|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101658492|NCT02810808|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101658493|NCT02810808|Growth Substances|growth substances|mesh-ancestor
101658494|NCT02810808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658495|NCT02810808|Growth Inhibitors|growth inhibitors|mesh-ancestor
101658496|NCT02810808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101658497|NCT00619801|Levocetirizine|levocetirizine|mesh-list
101658498|NCT00619801|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101658499|NCT00619801|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101658500|NCT00619801|Histamine Antagonists|histamine antagonists|mesh-ancestor
101658501|NCT00619801|Histamine Agents|histamine agents|mesh-ancestor
101658502|NCT00619801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101658503|NCT00619801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658506|NCT02545777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101658507|NCT02545777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101658508|NCT02545777|Analgesics|analgesics|mesh-ancestor
101658509|NCT02545777|Sensory System Agents|sensory system agents|mesh-ancestor
101658510|NCT02545777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101658511|NCT02545777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658512|NCT02545777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101658513|NCT02545777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101658514|NCT02545777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101658515|NCT02545777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101658516|NCT02545777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658518|NCT02810886|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101658519|NCT02810886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658520|NCT00962741|Etanercept|etanercept|mesh-list
101658521|NCT00962741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101658522|NCT00962741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101658523|NCT00962741|Analgesics|analgesics|mesh-ancestor
101658524|NCT00962741|Sensory System Agents|sensory system agents|mesh-ancestor
101658525|NCT00962741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101658526|NCT00962741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658527|NCT00962741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101658528|NCT00962741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101658529|NCT00962741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101658530|NCT00962741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101658531|NCT00962741|Immunologic Factors|immunologic factors|mesh-ancestor
101658532|NCT00851929|Ambrisentan|ambrisentan|mesh-list
101315693|NCT04601077|Antioxidants|antioxidants|mesh-ancestor
101658534|NCT02813382|Bupivacaine|bupivacaine|mesh-list
101658535|NCT02813382|Prilocaine|prilocaine|mesh-list
101658536|NCT02813382|Chloroprocaine|chloroprocaine|mesh-list
101658537|NCT02813382|Procaine|procaine|mesh-list
101658538|NCT02813382|Anesthetics, Local|anesthetics, local|mesh-ancestor
101658539|NCT02813382|Anesthetics|anesthetics|mesh-ancestor
101658540|NCT02813382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101658541|NCT02813382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658542|NCT02813382|Sensory System Agents|sensory system agents|mesh-ancestor
101658543|NCT02813382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101658544|NCT00619645|Cyclosporine|cyclosporine|mesh-list
101658545|NCT00619645|Mycophenolic Acid|mycophenolic acid|mesh-list
101658546|NCT00619645|Fludarabine|fludarabine|mesh-list
101658547|NCT00619645|Fludarabine phosphate|fludarabine phosphate|mesh-list
101658548|NCT00619645|Busulfan|busulfan|mesh-list
101658549|NCT00619645|Cyclosporins|cyclosporins|mesh-list
101658550|NCT00619645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101658551|NCT00619645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101658552|NCT00619645|Antimetabolites|antimetabolites|mesh-ancestor
101658553|NCT00619645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658554|NCT00619645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101658555|NCT00619645|Immunologic Factors|immunologic factors|mesh-ancestor
101658556|NCT00619645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658557|NCT00619645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101658558|NCT00619645|Antifungal Agents|antifungal agents|mesh-ancestor
101658559|NCT00619645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101658560|NCT00619645|Dermatologic Agents|dermatologic agents|mesh-ancestor
101658561|NCT00619645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101658562|NCT00619645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101658563|NCT00619645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101658564|NCT00619645|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101658565|NCT00619645|Antitubercular Agents|antitubercular agents|mesh-ancestor
101658566|NCT00619645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101658567|NCT00619645|Alkylating Agents|alkylating agents|mesh-ancestor
101658568|NCT00619645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101658569|NCT00619645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101658570|NCT00852163|Busulfan|busulfan|mesh-list
101658571|NCT00852163|Clofarabine|clofarabine|mesh-list
101658572|NCT00852163|Alkylating Agents|alkylating agents|mesh-ancestor
101658573|NCT00852163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658574|NCT00852163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101658575|NCT00852163|Immunologic Factors|immunologic factors|mesh-ancestor
101658576|NCT00852163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658577|NCT00852163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101658578|NCT00852163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101658579|NCT00852163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101658580|NCT00852163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101658582|NCT00855517|Latanoprost|latanoprost|mesh-list
101658583|NCT00855517|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101658584|NCT00855517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101658585|NCT02544919|SMOFlipid|smoflipid|mesh-list
101658586|NCT02544919|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101658587|NCT02544919|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101658588|NCT02544919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101658589|NCT00818259|Dexamethasone|dexamethasone|mesh-list
101658590|NCT00818259|Ondansetron|ondansetron|mesh-list
101658591|NCT00818259|Aprepitant|aprepitant|mesh-list
101658592|NCT00818259|Fosaprepitant|fosaprepitant|mesh-list
101658593|NCT00818259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101658594|NCT00818259|Antiemetics|antiemetics|mesh-ancestor
101658595|NCT00818259|Autonomic Agents|autonomic agents|mesh-ancestor
101658596|NCT00818259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101658597|NCT00818259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658598|NCT00818259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101658599|NCT00818259|Glucocorticoids|glucocorticoids|mesh-ancestor
101658600|NCT00818259|Hormones|hormones|mesh-ancestor
101658601|NCT00818259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101658602|NCT00818259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101658603|NCT00818259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101658604|NCT00818259|Antipruritics|antipruritics|mesh-ancestor
101658605|NCT00818259|Dermatologic Agents|dermatologic agents|mesh-ancestor
101658606|NCT00818259|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101658607|NCT00818259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101658608|NCT00818259|Serotonin Agents|serotonin agents|mesh-ancestor
101658609|NCT00818259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101658610|NCT00818259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658611|NCT00818259|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101658613|NCT05578482|Dicloxacillin|dicloxacillin|mesh-list
101658614|NCT05578482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101658615|NCT05578482|Dermatologic Agents|dermatologic agents|mesh-ancestor
101658616|NCT05578482|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101658617|NCT05578482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101658618|NCT05578482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101658619|NCT02809404|Everolimus|everolimus|mesh-list
101658620|NCT02809404|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101658621|NCT02809404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101658622|NCT02809404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101658623|NCT02809404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658624|NCT02809404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101658625|NCT02809404|Immunologic Factors|immunologic factors|mesh-ancestor
101658626|NCT02809404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658627|NCT02809404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101658628|NCT00619099|Decitabine|decitabine|mesh-list
101658629|NCT00619099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101658630|NCT00619099|Antimetabolites|antimetabolites|mesh-ancestor
101658631|NCT00619099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658632|NCT00619099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101658633|NCT00619099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101658634|NCT02812992|Paclitaxel|paclitaxel|mesh-list
101658635|NCT02812992|Gemcitabine|gemcitabine|mesh-list
101658636|NCT02812992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101658637|NCT02812992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101658638|NCT02812992|Tubulin Modulators|tubulin modulators|mesh-ancestor
101658639|NCT02812992|Antimitotic Agents|antimitotic agents|mesh-ancestor
101658640|NCT02812992|Mitosis Modulators|mitosis modulators|mesh-ancestor
101658641|NCT02812992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658642|NCT02812992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101658643|NCT02812992|Antimetabolites|antimetabolites|mesh-ancestor
101658644|NCT00856063|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101658645|NCT00856063|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101658646|NCT00856063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101658647|NCT00856063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101658648|NCT00856063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658649|NCT00856063|Adrenergic Agents|adrenergic agents|mesh-ancestor
101658650|NCT00856063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101658651|NCT00856063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658652|NCT02812602|Lidocaine|lidocaine|mesh-list
101658653|NCT02812602|Anesthetics, Local|anesthetics, local|mesh-ancestor
101658654|NCT02812602|Anesthetics|anesthetics|mesh-ancestor
101658655|NCT02812602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101658656|NCT02812602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658657|NCT02812602|Sensory System Agents|sensory system agents|mesh-ancestor
101658658|NCT02812602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101658659|NCT02812602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101658660|NCT02812602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101658661|NCT02812602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101658662|NCT02812602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101658663|NCT02812602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658664|NCT00837187|Dexmedetomidine|dexmedetomidine|mesh-list
101658665|NCT00837187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101658666|NCT00837187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101658667|NCT00837187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658668|NCT00837187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101658669|NCT00837187|Analgesics|analgesics|mesh-ancestor
101658670|NCT00837187|Sensory System Agents|sensory system agents|mesh-ancestor
101658671|NCT00837187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101658672|NCT00837187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101658673|NCT00837187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101658674|NCT00837187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101658675|NCT00837187|Adrenergic Agents|adrenergic agents|mesh-ancestor
101658676|NCT00837187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101658677|NCT00837187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658679|NCT00962585|Phytoestrogens|phytoestrogens|mesh-ancestor
101658680|NCT00962585|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101658681|NCT00962585|Estrogens|estrogens|mesh-ancestor
101658682|NCT00962585|Hormones|hormones|mesh-ancestor
101658683|NCT00962585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101658684|NCT00962585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658686|NCT00621985|Hydrocortisone|hydrocortisone|mesh-list
101658687|NCT00621985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101658688|NCT00621985|Antiemetics|antiemetics|mesh-ancestor
101658689|NCT00621985|Autonomic Agents|autonomic agents|mesh-ancestor
101658690|NCT00621985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101658691|NCT00621985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658692|NCT00621985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101658693|NCT00621985|Glucocorticoids|glucocorticoids|mesh-ancestor
101658694|NCT00621985|Hormones|hormones|mesh-ancestor
101658695|NCT00621985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101658696|NCT00621985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101658697|NCT00621985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101658698|NCT02812368|Clonidine|clonidine|mesh-list
101658699|NCT02812368|Analgesics|analgesics|mesh-ancestor
101658700|NCT02812368|Sensory System Agents|sensory system agents|mesh-ancestor
101658701|NCT02812368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101658702|NCT02812368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658703|NCT02812368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101658704|NCT02812368|Sympatholytics|sympatholytics|mesh-ancestor
101658705|NCT02812368|Autonomic Agents|autonomic agents|mesh-ancestor
101658706|NCT02812368|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101658707|NCT02812368|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101658708|NCT02812368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101658709|NCT02812368|Adrenergic Agents|adrenergic agents|mesh-ancestor
101658710|NCT02812368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101658711|NCT02812368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658712|NCT03312257|Atropine|atropine|mesh-list
101658713|NCT03312257|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101658714|NCT03312257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101658715|NCT03312257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101658716|NCT03312257|Autonomic Agents|autonomic agents|mesh-ancestor
101658717|NCT03312257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101658718|NCT03312257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658719|NCT03312257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101658720|NCT03312257|Respiratory System Agents|respiratory system agents|mesh-ancestor
101658721|NCT03312257|Mydriatics|mydriatics|mesh-ancestor
101658722|NCT03312257|Parasympatholytics|parasympatholytics|mesh-ancestor
101658723|NCT03312257|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101658724|NCT03312257|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101658725|NCT03312257|Cholinergic Agents|cholinergic agents|mesh-ancestor
101658726|NCT03312257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101658727|NCT03312257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658728|NCT00856687|Montelukast|montelukast|mesh-list
101658729|NCT00856687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101658730|NCT00856687|Respiratory System Agents|respiratory system agents|mesh-ancestor
101658731|NCT00856687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101658732|NCT00856687|Hormone Antagonists|hormone antagonists|mesh-ancestor
101658733|NCT00856687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101658734|NCT00856687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409307|NCT00113958|Cinacalcet|cinacalcet|mesh-list
101658735|NCT00856687|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101658736|NCT00856687|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101658737|NCT00856687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658738|NCT02862665|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
101658739|NCT02862665|Hematinics|hematinics|mesh-ancestor
101658740|NCT02807922|Zopiclone|zopiclone|mesh-list
101658741|NCT02807922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101658742|NCT02807922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101658743|NCT02807922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658744|NCT00861367|Aspirin|aspirin|mesh-list
101658745|NCT00861367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101658746|NCT00861367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101658747|NCT00861367|Analgesics|analgesics|mesh-ancestor
101658748|NCT00861367|Sensory System Agents|sensory system agents|mesh-ancestor
101658749|NCT00861367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101658750|NCT00861367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658751|NCT00861367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101658752|NCT00861367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101658753|NCT00861367|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101658754|NCT00861367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101315917|NCT00000681|Tubulin Modulators|tubulin modulators|mesh-ancestor
101658755|NCT00861367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658756|NCT00861367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101658757|NCT00861367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101658760|NCT04285073|Paclitaxel|paclitaxel|mesh-list
101658761|NCT04285073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101658762|NCT04285073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101658763|NCT04285073|Tubulin Modulators|tubulin modulators|mesh-ancestor
101658764|NCT04285073|Antimitotic Agents|antimitotic agents|mesh-ancestor
101658765|NCT04285073|Mitosis Modulators|mitosis modulators|mesh-ancestor
101658766|NCT04285073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658767|NCT00861445|Lacosamide|lacosamide|mesh-list
101658768|NCT00861445|Anticonvulsants|anticonvulsants|mesh-ancestor
101658769|NCT00861445|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101658770|NCT00861445|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101658771|NCT00861445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101658772|NCT00861445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658773|NCT04284059|Vitamin D|vitamin d|mesh-list
101658774|NCT04284059|Vitamins|vitamins|mesh-list
101658775|NCT04284059|Micronutrients|micronutrients|mesh-ancestor
101658776|NCT04284059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658777|NCT04284059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101658778|NCT00852709|Cyclophosphamide|cyclophosphamide|mesh-list
101658779|NCT00852709|Clofarabine|clofarabine|mesh-list
101658780|NCT00852709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101658781|NCT00852709|Immunologic Factors|immunologic factors|mesh-ancestor
101658782|NCT00852709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658783|NCT00852709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101658784|NCT00852709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101658785|NCT00852709|Alkylating Agents|alkylating agents|mesh-ancestor
101658786|NCT00852709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658787|NCT00852709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101658788|NCT00852709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101658789|NCT00852709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101658790|NCT00852709|Antimetabolites|antimetabolites|mesh-ancestor
101658791|NCT00861523|Thiamine|thiamine|mesh-list
101658792|NCT00861523|Promethazine|promethazine|mesh-list
101658793|NCT00861523|Diphenhydramine|diphenhydramine|mesh-list
101658794|NCT00861523|Vitamin B Complex|vitamin b complex|mesh-ancestor
101658795|NCT00861523|Vitamins|vitamins|mesh-ancestor
101658796|NCT00861523|Micronutrients|micronutrients|mesh-ancestor
101658797|NCT00861523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658798|NCT00861523|Antipruritics|antipruritics|mesh-ancestor
101658799|NCT00861523|Dermatologic Agents|dermatologic agents|mesh-ancestor
101658800|NCT00861523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101658801|NCT00861523|Histamine Antagonists|histamine antagonists|mesh-ancestor
101658802|NCT00861523|Histamine Agents|histamine agents|mesh-ancestor
101658803|NCT00861523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101658804|NCT00861523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658805|NCT00861523|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101658806|NCT00861523|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101658807|NCT00861523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101658808|NCT00861523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101658809|NCT00861523|Anesthetics, Local|anesthetics, local|mesh-ancestor
101658810|NCT00861523|Anesthetics|anesthetics|mesh-ancestor
101658811|NCT00861523|Sensory System Agents|sensory system agents|mesh-ancestor
101658812|NCT00861523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101658813|NCT00861523|Antiemetics|antiemetics|mesh-ancestor
101658814|NCT00861523|Autonomic Agents|autonomic agents|mesh-ancestor
101658815|NCT00861523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101658816|NCT02811978|Dexamethasone|dexamethasone|mesh-list
101658817|NCT02811978|Bortezomib|bortezomib|mesh-list
101658818|NCT02811978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101658819|NCT02811978|Antiemetics|antiemetics|mesh-ancestor
101658820|NCT02811978|Autonomic Agents|autonomic agents|mesh-ancestor
101658821|NCT02811978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101658822|NCT02811978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658823|NCT02811978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101658824|NCT02811978|Glucocorticoids|glucocorticoids|mesh-ancestor
101658825|NCT02811978|Hormones|hormones|mesh-ancestor
101658826|NCT02811978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101658827|NCT02811978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101658828|NCT02811978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101658829|NCT00630149|Pemetrexed|pemetrexed|mesh-list
101315995|NCT00000708|Amebicides|amebicides|mesh-ancestor
101658830|NCT00630149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101658831|NCT00630149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101658832|NCT00630149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658833|NCT00630149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101658834|NCT00630149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101658836|NCT04204577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101658837|NCT04204577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101658838|NCT04204577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101658839|NCT04204577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658840|NCT00852787|Digoxin|digoxin|mesh-list
101658841|NCT00852787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101658842|NCT00852787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101658843|NCT00852787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101658844|NCT00852787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658845|NCT00852787|Protective Agents|protective agents|mesh-ancestor
101658846|NCT00852787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658847|NCT02545465|Riociguat|riociguat|mesh-list
101658848|NCT02545465|Enzyme Activators|enzyme activators|mesh-ancestor
101658849|NCT02545465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658850|NCT00961259|Fenofibric acid|fenofibric acid|mesh-list
101658851|NCT00961259|Fenofibrate|fenofibrate|mesh-list
101658852|NCT00961259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101658853|NCT00961259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101658854|NCT00961259|Antimetabolites|antimetabolites|mesh-ancestor
101658855|NCT00961259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658856|NCT00961259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101658857|NCT04283747|Immunoglobulins|immunoglobulins|mesh-list
101658858|NCT04283747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101658859|NCT04283747|Antibodies|antibodies|mesh-list
101658860|NCT04283747|Immunologic Factors|immunologic factors|mesh-ancestor
101658861|NCT04283747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658862|NCT04111926|Dexmedetomidine|dexmedetomidine|mesh-list
101658863|NCT04111926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101658864|NCT04111926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101658865|NCT04111926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658866|NCT04111926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101658867|NCT04111926|Analgesics|analgesics|mesh-ancestor
101658868|NCT04111926|Sensory System Agents|sensory system agents|mesh-ancestor
101658869|NCT04111926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101658870|NCT04111926|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101658871|NCT04111926|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101658872|NCT04111926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101658873|NCT04111926|Adrenergic Agents|adrenergic agents|mesh-ancestor
101658874|NCT04111926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101658875|NCT04111926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658876|NCT04041349|Mitogens|mitogens|mesh-list
101658877|NCT04041349|Mitosis Modulators|mitosis modulators|mesh-ancestor
101658878|NCT04041349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658879|NCT00961181|Paclitaxel|paclitaxel|mesh-list
101658880|NCT00961181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101658881|NCT00961181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101658882|NCT00961181|Tubulin Modulators|tubulin modulators|mesh-ancestor
101658883|NCT00961181|Antimitotic Agents|antimitotic agents|mesh-ancestor
101658884|NCT00961181|Mitosis Modulators|mitosis modulators|mesh-ancestor
101658885|NCT00961181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658887|NCT02807610|Etomidate|etomidate|mesh-list
101658888|NCT02807610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101658889|NCT02807610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101658890|NCT02807610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658891|NCT02807610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101658892|NCT02807610|Anesthetics, General|anesthetics, general|mesh-ancestor
101658893|NCT02807610|Anesthetics|anesthetics|mesh-ancestor
101658894|NCT00857077|Pyrimethamine|pyrimethamine|mesh-list
101658895|NCT00857077|Sulfadoxine|sulfadoxine|mesh-list
101658896|NCT00857077|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101658897|NCT00857077|Antimalarials|antimalarials|mesh-ancestor
101658898|NCT00857077|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101658899|NCT00857077|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101658900|NCT00857077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101658901|NCT00857077|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101658903|NCT00857077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658904|NCT00857077|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101658905|NCT00857155|Clopidogrel|clopidogrel|mesh-list
101658906|NCT00857155|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101658907|NCT00857155|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101658908|NCT00857155|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101658909|NCT00857155|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101658910|NCT00857155|Purinergic Agents|purinergic agents|mesh-ancestor
101658911|NCT00857155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101658912|NCT00857155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658913|NCT00857155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658914|NCT00817635|Eplerenone|eplerenone|mesh-list
101658915|NCT00817635|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101658916|NCT00817635|Hormone Antagonists|hormone antagonists|mesh-ancestor
101658917|NCT00817635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101658918|NCT00817635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658919|NCT00817635|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101658920|NCT00817635|Diuretics|diuretics|mesh-ancestor
101658921|NCT00817635|Natriuretic Agents|natriuretic agents|mesh-ancestor
101658922|NCT00817635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101658923|NCT00853177|Lidocaine|lidocaine|mesh-list
101658924|NCT00853177|Anesthetics, Local|anesthetics, local|mesh-ancestor
101658925|NCT00853177|Anesthetics|anesthetics|mesh-ancestor
101658926|NCT00853177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101658927|NCT00853177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658928|NCT00853177|Sensory System Agents|sensory system agents|mesh-ancestor
101658929|NCT00853177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101658930|NCT00853177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101658931|NCT00853177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101658932|NCT00853177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101658933|NCT00853177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101658934|NCT00853177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658935|NCT00924079|Nalbuphine|nalbuphine|mesh-list
101658936|NCT00924079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101658937|NCT00924079|Narcotics|narcotics|mesh-ancestor
101658938|NCT00924079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101658939|NCT00924079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658940|NCT00924079|Analgesics|analgesics|mesh-ancestor
101658941|NCT00924079|Sensory System Agents|sensory system agents|mesh-ancestor
101658942|NCT00924079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101658943|NCT00817479|Dexamethasone|dexamethasone|mesh-list
101658944|NCT00817479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101658945|NCT00817479|Antiemetics|antiemetics|mesh-ancestor
101658946|NCT00817479|Autonomic Agents|autonomic agents|mesh-ancestor
101658947|NCT00817479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101658948|NCT00817479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658949|NCT00817479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101658950|NCT00817479|Glucocorticoids|glucocorticoids|mesh-ancestor
101658951|NCT00817479|Hormones|hormones|mesh-ancestor
101658952|NCT00817479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101658953|NCT00817479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101658954|NCT00817479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101658955|NCT00853411|Prednisone|prednisone|mesh-list
101658956|NCT00853411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101658957|NCT00853411|Glucocorticoids|glucocorticoids|mesh-ancestor
101658958|NCT00853411|Hormones|hormones|mesh-ancestor
101658959|NCT00853411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101658960|NCT00853411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658961|NCT00853411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101658962|NCT00853411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101658963|NCT04030533|Ustekinumab|ustekinumab|mesh-list
101658964|NCT04030533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101658965|NCT04030533|Dermatologic Agents|dermatologic agents|mesh-ancestor
101658966|NCT04030533|Immunologic Factors|immunologic factors|mesh-ancestor
101658967|NCT04030533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101658969|NCT02807298|Epinephrine|epinephrine|mesh-list
101658970|NCT02807298|Carticaine|carticaine|mesh-list
101658971|NCT02807298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101658972|NCT02807298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101658973|NCT02807298|Adrenergic Agents|adrenergic agents|mesh-ancestor
101658974|NCT02807298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101658975|NCT02807298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101658976|NCT02807298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316142|NCT00000753|Antiviral Agents|antiviral agents|mesh-ancestor
101658977|NCT02807298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101658978|NCT02807298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101658979|NCT02807298|Autonomic Agents|autonomic agents|mesh-ancestor
101658980|NCT02807298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101658981|NCT02807298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101658982|NCT02807298|Respiratory System Agents|respiratory system agents|mesh-ancestor
101658983|NCT02807298|Mydriatics|mydriatics|mesh-ancestor
101658984|NCT02807298|Sympathomimetics|sympathomimetics|mesh-ancestor
101658985|NCT02807298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101658986|NCT02807298|Anesthetics, Local|anesthetics, local|mesh-ancestor
101658987|NCT02807298|Anesthetics|anesthetics|mesh-ancestor
101658988|NCT02807298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101658989|NCT02807298|Sensory System Agents|sensory system agents|mesh-ancestor
101658990|NCT02807298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101658991|NCT02807298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101658992|NCT02807298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101658993|NCT02807298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101658994|NCT04041427|Albendazole|albendazole|mesh-list
101658995|NCT04041427|Anthelmintics|anthelmintics|mesh-ancestor
101658996|NCT04041427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101658997|NCT04041427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101658998|NCT04041427|Anticestodal Agents|anticestodal agents|mesh-ancestor
101658999|NCT04041427|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101659000|NCT04041427|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101659001|NCT04041427|Tubulin Modulators|tubulin modulators|mesh-ancestor
101659002|NCT04041427|Antimitotic Agents|antimitotic agents|mesh-ancestor
101659003|NCT04041427|Mitosis Modulators|mitosis modulators|mesh-ancestor
101659004|NCT04041427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659005|NCT04041427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101659006|NCT00961961|Lithium Carbonate|lithium carbonate|mesh-list
101659007|NCT00961961|Fluoxetine|fluoxetine|mesh-list
101659008|NCT00961961|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101659009|NCT00961961|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101659010|NCT00961961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101659011|NCT00961961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659012|NCT00961961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101659013|NCT00961961|Serotonin Agents|serotonin agents|mesh-ancestor
101659014|NCT00961961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659015|NCT00961961|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101659016|NCT00961961|Antidepressive Agents|antidepressive agents|mesh-ancestor
101659017|NCT00961961|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101659018|NCT00961961|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101659019|NCT00961961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101659020|NCT00961961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101659021|NCT00961961|Antimanic Agents|antimanic agents|mesh-ancestor
101659022|NCT00961961|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101659023|NCT00961961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101659025|NCT02610933|Vitamin K 2|vitamin k 2|mesh-list
101659026|NCT02610933|Rivaroxaban|rivaroxaban|mesh-list
101659027|NCT02610933|Vitamins|vitamins|mesh-ancestor
101659028|NCT02610933|Micronutrients|micronutrients|mesh-ancestor
101659029|NCT02610933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659030|NCT02610933|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101659031|NCT02610933|Antithrombins|antithrombins|mesh-ancestor
101659032|NCT02610933|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101659033|NCT02610933|Protease Inhibitors|protease inhibitors|mesh-ancestor
101659034|NCT02610933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101659035|NCT02610933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659036|NCT02610933|Anticoagulants|anticoagulants|mesh-ancestor
101659037|NCT02610933|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101659038|NCT02610933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101659039|NCT02610933|Hemostatics|hemostatics|mesh-ancestor
101659040|NCT02610933|Coagulants|coagulants|mesh-ancestor
101659041|NCT04042441|Insulin|insulin|mesh-list
101659042|NCT04042441|Insulin Aspart|insulin aspart|mesh-list
101659043|NCT04042441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101659044|NCT04042441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659045|NCT00817089|Naltrexone|naltrexone|mesh-list
101659046|NCT00817089|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101659047|NCT00817089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101659048|NCT00817089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659049|NCT00817089|Sensory System Agents|sensory system agents|mesh-ancestor
101659050|NCT00817089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101659051|NCT03296033|Enoxaparin|enoxaparin|mesh-list
101659052|NCT03296033|Enoxaparin sodium|enoxaparin sodium|mesh-list
101659053|NCT03296033|Anticoagulants|anticoagulants|mesh-ancestor
101659054|NCT03296033|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101659055|NCT03296033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101659056|NCT03296033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659057|NCT00857779|Immunomodulating Agents|immunomodulating agents|mesh-list
101659058|NCT00857779|Immunologic Factors|immunologic factors|mesh-ancestor
101659059|NCT00857779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659061|NCT05758389|Tislelizumab|tislelizumab|mesh-list
101659062|NCT05758389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101659063|NCT05758389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101659064|NCT05758389|Tubulin Modulators|tubulin modulators|mesh-ancestor
101659065|NCT05758389|Antimitotic Agents|antimitotic agents|mesh-ancestor
101659066|NCT05758389|Mitosis Modulators|mitosis modulators|mesh-ancestor
101659067|NCT05758389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659068|NCT05758389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101659069|NCT00857935|Permethrin|permethrin|mesh-list
101659070|NCT00857935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101659071|NCT00857935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659072|NCT00853879|Vitamins|vitamins|mesh-list
101659073|NCT00853879|Folic Acid|folic acid|mesh-list
101659074|NCT00853879|Hydroxocobalamin|hydroxocobalamin|mesh-list
101659075|NCT00853879|Vitamin B 12|vitamin b 12|mesh-list
101659076|NCT00853879|Vitamin B 6|vitamin b 6|mesh-list
101659077|NCT00853879|Pyridoxal|pyridoxal|mesh-list
101659078|NCT00853879|Pyridoxine|pyridoxine|mesh-list
101659079|NCT00853879|Vitamin B Complex|vitamin b complex|mesh-list
101659080|NCT00853879|Micronutrients|micronutrients|mesh-ancestor
101659081|NCT00853879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659082|NCT00853879|Hematinics|hematinics|mesh-ancestor
101659083|NCT04171843|Cyclophosphamide|cyclophosphamide|mesh-list
101659084|NCT04171843|Fludarabine|fludarabine|mesh-list
101659085|NCT04171843|Nirogacestat|nirogacestat|mesh-list
101825028|NCT00856037|Doxorubicin|doxorubicin|mesh-list
101659086|NCT04171843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101659087|NCT04171843|Immunologic Factors|immunologic factors|mesh-ancestor
101659088|NCT04171843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659089|NCT04171843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101659090|NCT04171843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101659091|NCT04171843|Alkylating Agents|alkylating agents|mesh-ancestor
101659092|NCT04171843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659093|NCT04171843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101659094|NCT04171843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101659095|NCT04171843|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101659096|NCT04171843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101659097|NCT00815919|Prednisone|prednisone|mesh-list
101659098|NCT00815919|Bortezomib|bortezomib|mesh-list
101659099|NCT00815919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101659100|NCT00815919|Glucocorticoids|glucocorticoids|mesh-ancestor
101659101|NCT00815919|Hormones|hormones|mesh-ancestor
101659102|NCT00815919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101659103|NCT00815919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659104|NCT00815919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101659105|NCT00815919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101659106|NCT02545153|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101659107|NCT02545153|Aprotinin|aprotinin|mesh-list
101659108|NCT02545153|Hemostatics|hemostatics|mesh-ancestor
101659109|NCT02545153|Coagulants|coagulants|mesh-ancestor
101659110|NCT02545153|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101659111|NCT02545153|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101659112|NCT02545153|Protease Inhibitors|protease inhibitors|mesh-ancestor
101659113|NCT02545153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101659114|NCT02545153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659115|NCT00913653|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101659116|NCT00913653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101659117|NCT00913653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659118|NCT00854035|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101659119|NCT00854035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101659120|NCT00854035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659121|NCT00854035|Incretins|incretins|mesh-ancestor
101659123|NCT00854035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101659124|NCT00854035|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101659125|NCT00854035|Protease Inhibitors|protease inhibitors|mesh-ancestor
101659126|NCT00854035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101659127|NCT00854035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316292|NCT03574402|Maleic acid|maleic acid|mesh-list
101659128|NCT00957905|Calcium, Dietary|calcium, dietary|mesh-list
101659129|NCT00957905|Leucovorin|leucovorin|mesh-list
101659130|NCT00957905|Folic Acid|folic acid|mesh-list
101659131|NCT00957905|Fluorouracil|fluorouracil|mesh-list
101659132|NCT00957905|Oxaliplatin|oxaliplatin|mesh-list
101659133|NCT00957905|Alvocidib|alvocidib|mesh-list
101659134|NCT00957905|Calcium|calcium|mesh-list
101659135|NCT00957905|Levoleucovorin|levoleucovorin|mesh-list
101659136|NCT00957905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101659137|NCT00957905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659138|NCT00957905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101659139|NCT00957905|Antimetabolites|antimetabolites|mesh-ancestor
101659140|NCT00957905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659141|NCT00957905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101659142|NCT00957905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101659143|NCT00957905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101659144|NCT00957905|Immunologic Factors|immunologic factors|mesh-ancestor
101659145|NCT00957905|Antidotes|antidotes|mesh-ancestor
101659146|NCT00957905|Protective Agents|protective agents|mesh-ancestor
101659147|NCT00957905|Vitamin B Complex|vitamin b complex|mesh-ancestor
101659148|NCT00957905|Vitamins|vitamins|mesh-ancestor
101659149|NCT00957905|Micronutrients|micronutrients|mesh-ancestor
101659150|NCT00957905|Hematinics|hematinics|mesh-ancestor
101659151|NCT00957905|Growth Inhibitors|growth inhibitors|mesh-ancestor
101659152|NCT00957905|Growth Substances|growth substances|mesh-ancestor
101659153|NCT00957905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101659154|NCT00957905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101659155|NCT02804646|Carboplatin|carboplatin|mesh-list
101659156|NCT02804646|Pemetrexed|pemetrexed|mesh-list
101659157|NCT02804646|Endostatins|endostatins|mesh-list
101659158|NCT02804646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101659159|NCT02804646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101659160|NCT02804646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659161|NCT02804646|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101659162|NCT02804646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101659163|NCT02804646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101659164|NCT02804646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101659165|NCT02804646|Growth Substances|growth substances|mesh-ancestor
101659166|NCT02804646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659167|NCT02804646|Growth Inhibitors|growth inhibitors|mesh-ancestor
101659168|NCT02858297|Triamcinolone|triamcinolone|mesh-list
101659169|NCT02858297|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101659170|NCT02858297|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101659171|NCT02858297|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101659172|NCT02858297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101659173|NCT02858297|Glucocorticoids|glucocorticoids|mesh-ancestor
101659174|NCT02858297|Hormones|hormones|mesh-ancestor
101659175|NCT02858297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101659176|NCT02858297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659177|NCT02858297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101659178|NCT02858297|Immunologic Factors|immunologic factors|mesh-ancestor
101659179|NCT02858297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101659180|NCT02858297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659182|NCT00858325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101659183|NCT00858325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101659184|NCT02804490|Vitamin A|vitamin a|mesh-list
101659185|NCT02804490|Beta Carotene|beta carotene|mesh-list
101659186|NCT02804490|Provitamins|provitamins|mesh-list
101659187|NCT02804490|Carotenoids|carotenoids|mesh-list
101659188|NCT02804490|Vitamins|vitamins|mesh-ancestor
101659189|NCT02804490|Micronutrients|micronutrients|mesh-ancestor
101659190|NCT02804490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659191|NCT02804490|Antioxidants|antioxidants|mesh-ancestor
101659192|NCT02804490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659193|NCT02804490|Protective Agents|protective agents|mesh-ancestor
101659194|NCT00960323|Colchicine|colchicine|mesh-list
101659195|NCT00960323|Atorvastatin|atorvastatin|mesh-list
101659196|NCT00960323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101659197|NCT00960323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101659198|NCT00960323|Antimetabolites|antimetabolites|mesh-ancestor
101659199|NCT00960323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659200|NCT00960323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101659201|NCT00960323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101659202|NCT00960323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101659203|NCT00960323|Gout Suppressants|gout suppressants|mesh-ancestor
101659204|NCT00960323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101316369|NCT00000870|Antiviral Agents|antiviral agents|mesh-ancestor
101659205|NCT00960323|Tubulin Modulators|tubulin modulators|mesh-ancestor
101659206|NCT00960323|Antimitotic Agents|antimitotic agents|mesh-ancestor
101659207|NCT00960323|Mitosis Modulators|mitosis modulators|mesh-ancestor
101659208|NCT00960323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101659209|NCT00617929|Rituximab|rituximab|mesh-list
101659210|NCT00617929|Clofarabine|clofarabine|mesh-list
101659211|NCT00617929|Thymoglobulin|thymoglobulin|mesh-list
101659212|NCT00617929|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101659213|NCT00617929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101659214|NCT00617929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101659215|NCT00617929|Immunologic Factors|immunologic factors|mesh-ancestor
101659216|NCT00617929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659217|NCT00617929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101659218|NCT00617929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101659219|NCT00617929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101659220|NCT00617929|Antimetabolites|antimetabolites|mesh-ancestor
101659221|NCT00617929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659222|NCT00862381|Hydrocortisone|hydrocortisone|mesh-list
101659223|NCT00862381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101659224|NCT02800590|Abp-700|abp-700|mesh-list
101659225|NCT02800590|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101659226|NCT02800590|GABA Agonists|gaba agonists|mesh-ancestor
101659227|NCT02800590|GABA Agents|gaba agents|mesh-ancestor
101659228|NCT02800590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101659229|NCT02800590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659230|NCT02800590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659231|NCT00815295|Cetuximab|cetuximab|mesh-list
101659232|NCT00815295|Sorafenib|sorafenib|mesh-list
101659233|NCT00815295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101659234|NCT00815295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101659235|NCT00815295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101659236|NCT00815295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101659237|NCT00815295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659238|NCT00630383|Histamine|histamine|mesh-list
101659239|NCT00630383|Histamine Agonists|histamine agonists|mesh-ancestor
101659240|NCT00630383|Histamine Agents|histamine agents|mesh-ancestor
101659241|NCT00630383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101659242|NCT00630383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659243|NCT00630383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659244|NCT02806752|Triamcinolone|triamcinolone|mesh-list
101659245|NCT02806752|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101659246|NCT02806752|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101659247|NCT02806752|Ranibizumab|ranibizumab|mesh-list
101659248|NCT02806752|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101659249|NCT02806752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101659250|NCT02806752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101659251|NCT02806752|Growth Substances|growth substances|mesh-ancestor
101659252|NCT02806752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659253|NCT02806752|Growth Inhibitors|growth inhibitors|mesh-ancestor
101659254|NCT02806752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101659255|NCT02806752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101659256|NCT02806752|Glucocorticoids|glucocorticoids|mesh-ancestor
101659257|NCT02806752|Hormones|hormones|mesh-ancestor
101659258|NCT02806752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101659259|NCT02806752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101659260|NCT02806752|Immunologic Factors|immunologic factors|mesh-ancestor
101659261|NCT02806752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101659262|NCT02806752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659263|NCT00854425|Asparaginase|asparaginase|mesh-list
101659264|NCT00854425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101659265|NCT02544529|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101659266|NCT02544529|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101659267|NCT02544529|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101659268|NCT02544529|Echothiophate Iodide|echothiophate iodide|mesh-list
101659269|NCT02544529|Laxatives|laxatives|mesh-ancestor
101659270|NCT02544529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101659271|NCT02544529|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101659272|NCT02544529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101659273|NCT02544529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659274|NCT02544529|Cholinergic Agents|cholinergic agents|mesh-ancestor
101659275|NCT02544529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101659276|NCT02544529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659277|NCT02544529|Miotics|miotics|mesh-ancestor
101659278|NCT02544529|Autonomic Agents|autonomic agents|mesh-ancestor
101659279|NCT02544529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101659280|NCT02544529|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101659281|NCT02806596|Sevoflurane|sevoflurane|mesh-list
101659282|NCT02806596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101659283|NCT02806596|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101659284|NCT02806596|Anesthetics, General|anesthetics, general|mesh-ancestor
101659285|NCT02806596|Anesthetics|anesthetics|mesh-ancestor
101659286|NCT02806596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101659287|NCT02806596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659288|NCT04282031|Letrozole|letrozole|mesh-list
101659289|NCT04282031|Fulvestrant|fulvestrant|mesh-list
101659290|NCT04282031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101659291|NCT04282031|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101659292|NCT04282031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101659293|NCT04282031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101659294|NCT04282031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659295|NCT04282031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101659296|NCT04282031|Hormone Antagonists|hormone antagonists|mesh-ancestor
101659297|NCT04282031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101659298|NCT04282031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659299|NCT04282031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101659300|NCT04282031|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101659301|NCT00854503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101659302|NCT00854503|Simvastatin|simvastatin|mesh-list
101659303|NCT00854503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101659304|NCT00854503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101659305|NCT00854503|Antimetabolites|antimetabolites|mesh-ancestor
101659306|NCT00854503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659307|NCT00854503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101659308|NCT00854503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101659309|NCT00854503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101659310|NCT00858715|Aspirin|aspirin|mesh-list
101659311|NCT00858715|Clopidogrel|clopidogrel|mesh-list
101659312|NCT00858715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101659313|NCT00858715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101659314|NCT00858715|Analgesics|analgesics|mesh-ancestor
101659315|NCT00858715|Sensory System Agents|sensory system agents|mesh-ancestor
101659316|NCT00858715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101659317|NCT00858715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659318|NCT00858715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101659320|NCT00858715|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101659321|NCT00858715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101659322|NCT00858715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659323|NCT00858715|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101659324|NCT00858715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101659325|NCT00858715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101659327|NCT00858715|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101659328|NCT00858715|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101659329|NCT00858715|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101659330|NCT00858715|Purinergic Agents|purinergic agents|mesh-ancestor
101659331|NCT00858715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101659332|NCT02806284|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101659333|NCT02806284|Immunologic Factors|immunologic factors|mesh-ancestor
101659334|NCT02806284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659335|NCT00960869|Aspirin|aspirin|mesh-list
101659336|NCT00960869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101659337|NCT00960869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101659338|NCT00960869|Analgesics|analgesics|mesh-ancestor
101659339|NCT00960869|Sensory System Agents|sensory system agents|mesh-ancestor
101659340|NCT00960869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101659341|NCT00960869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659342|NCT00960869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101659343|NCT00960869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101659344|NCT00960869|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101659345|NCT00960869|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101659346|NCT00960869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659347|NCT00960869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101659348|NCT00960869|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101659349|NCT00960869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101659350|NCT00960869|Antipyretics|antipyretics|mesh-ancestor
101659351|NCT02799888|Cyclosporine|cyclosporine|mesh-list
101659352|NCT02799888|Maraviroc|maraviroc|mesh-list
101659353|NCT02799888|Methotrexate|methotrexate|mesh-list
101659354|NCT02799888|Tacrolimus|tacrolimus|mesh-list
101659355|NCT02799888|Cyclosporins|cyclosporins|mesh-list
101659356|NCT02799888|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101659357|NCT02799888|Abortifacient Agents|abortifacient agents|mesh-ancestor
101659358|NCT02799888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101659359|NCT02799888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659360|NCT02799888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101659361|NCT02799888|Antimetabolites|antimetabolites|mesh-ancestor
101659362|NCT02799888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659363|NCT02799888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101659364|NCT02799888|Dermatologic Agents|dermatologic agents|mesh-ancestor
101659365|NCT02799888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101659366|NCT02799888|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101659367|NCT02799888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101659368|NCT02799888|Immunologic Factors|immunologic factors|mesh-ancestor
101659369|NCT02799888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101659370|NCT02799888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101659371|NCT02799888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101659372|NCT02799888|Antifungal Agents|antifungal agents|mesh-ancestor
101659373|NCT02799888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101659374|NCT02799888|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101659375|NCT02799888|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101659376|NCT02799888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101659377|NCT02799888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101659378|NCT02799888|Antiviral Agents|antiviral agents|mesh-ancestor
101659379|NCT02799888|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101659381|NCT00859105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101659382|NCT00859105|Immunologic Factors|immunologic factors|mesh-ancestor
101659383|NCT00859105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659384|NCT00859105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101659385|NCT00859105|Interferon Inducers|interferon inducers|mesh-ancestor
101659386|NCT00859183|Sirolimus|sirolimus|mesh-list
101659387|NCT00859183|Temsirolimus|temsirolimus|mesh-list
101659388|NCT00859183|MTOR Inhibitors|mtor inhibitors|mesh-list
101659389|NCT00859183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101659390|NCT00859183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101659391|NCT00859183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101659392|NCT00859183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101659393|NCT00859183|Antifungal Agents|antifungal agents|mesh-ancestor
101659394|NCT00859183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101659395|NCT00859183|Immunologic Factors|immunologic factors|mesh-ancestor
101659396|NCT00859183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659397|NCT00859183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101659398|NCT00859183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101825071|NCT02544893|Analgesics|analgesics|mesh-ancestor
101659399|NCT00859183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659400|NCT02803944|Azithromycin|azithromycin|mesh-list
101659401|NCT02803944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101659402|NCT02803944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101659403|NCT05980260|Analgesics, Opioid|analgesics, opioid|mesh-list
101659404|NCT05980260|Narcotics|narcotics|mesh-ancestor
101659405|NCT05980260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101659406|NCT05980260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659407|NCT05980260|Analgesics|analgesics|mesh-ancestor
101659408|NCT05980260|Sensory System Agents|sensory system agents|mesh-ancestor
101659409|NCT05980260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101659410|NCT05980156|Hydroxychloroquine|hydroxychloroquine|mesh-list
101659411|NCT05980156|Chloroquine|chloroquine|mesh-list
101659412|NCT05980156|Pyrimethamine|pyrimethamine|mesh-list
101659413|NCT05980156|Piperaquine|piperaquine|mesh-list
101659414|NCT05980156|Sulfadoxine|sulfadoxine|mesh-list
101659415|NCT05980156|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101659416|NCT05980156|Artenimol|artenimol|mesh-list
101659417|NCT05980156|Antimalarials|antimalarials|mesh-ancestor
101659418|NCT05980156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101659419|NCT05980156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101659420|NCT05980156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101659421|NCT05980156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101659422|NCT05980156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659423|NCT05980156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101659424|NCT05980156|Amebicides|amebicides|mesh-ancestor
101659425|NCT05980156|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101659426|NCT05980156|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101659427|NCT05980117|Midazolam|midazolam|mesh-list
101659428|NCT05980117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101659429|NCT05980117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101659430|NCT05980117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101659431|NCT05980117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659432|NCT05980117|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101659433|NCT05980117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101659434|NCT05980117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101659435|NCT05980117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101659436|NCT05980117|Anesthetics, General|anesthetics, general|mesh-ancestor
101659437|NCT05980117|Anesthetics|anesthetics|mesh-ancestor
101659438|NCT05980117|GABA Modulators|gaba modulators|mesh-ancestor
101659439|NCT05980117|GABA Agents|gaba agents|mesh-ancestor
101659440|NCT05980117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101659441|NCT05980117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659442|NCT05980000|Pembrolizumab|pembrolizumab|mesh-list
101659443|NCT05980000|Ramucirumab|ramucirumab|mesh-list
101659444|NCT05980000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101659445|NCT05980000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101659446|NCT05980000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101659447|NCT05980000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659449|NCT05979961|Gemcitabine|gemcitabine|mesh-list
101659450|NCT05979961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101659451|NCT05979961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101659452|NCT05979961|Antimetabolites|antimetabolites|mesh-ancestor
101659453|NCT05979961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659454|NCT05979948|Rituximab|rituximab|mesh-list
101659455|NCT05979948|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101659456|NCT05979948|Zanubrutinib|zanubrutinib|mesh-list
101659457|NCT05979948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101659458|NCT05979948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101659459|NCT05979948|Immunologic Factors|immunologic factors|mesh-ancestor
101659460|NCT05979948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659461|NCT05979948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101659462|NCT05979948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101659463|NCT05979948|Alkylating Agents|alkylating agents|mesh-ancestor
101659468|NCT05979909|Mitomycin|mitomycin|mesh-list
101659469|NCT05979909|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101659470|NCT05979909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101659471|NCT05979909|Alkylating Agents|alkylating agents|mesh-ancestor
101659472|NCT05979909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659473|NCT05979909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101659474|NCT05979909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101659475|NCT05979818|Propranolol|propranolol|mesh-list
101659476|NCT05979818|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101659477|NCT05979818|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101659478|NCT05979818|Adrenergic Agents|adrenergic agents|mesh-ancestor
101659479|NCT05979818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101659480|NCT05979818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659481|NCT05979818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659482|NCT05979818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101659483|NCT05979818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101659484|NCT05979818|Vasodilator Agents|vasodilator agents|mesh-ancestor
101659489|NCT05979636|Fluorides|fluorides|mesh-list
101659490|NCT05979636|Cariostatic Agents|cariostatic agents|mesh-ancestor
101659491|NCT05979636|Protective Agents|protective agents|mesh-ancestor
101659492|NCT05979636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659493|NCT05979558|Dexmedetomidine|dexmedetomidine|mesh-list
101659494|NCT05979558|Ropivacaine|ropivacaine|mesh-list
101659495|NCT05979558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101659496|NCT05979558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101659497|NCT05979558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659498|NCT05979558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101659499|NCT05979558|Analgesics|analgesics|mesh-ancestor
101659500|NCT05979558|Sensory System Agents|sensory system agents|mesh-ancestor
101659501|NCT05979558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101659502|NCT05979558|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101659503|NCT05979558|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101659504|NCT05979558|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101659505|NCT05979558|Adrenergic Agents|adrenergic agents|mesh-ancestor
101659506|NCT05979558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101659507|NCT05979558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659508|NCT05979558|Anesthetics, Local|anesthetics, local|mesh-ancestor
101659509|NCT05979558|Anesthetics|anesthetics|mesh-ancestor
101659510|NCT05979493|Bupivacaine|bupivacaine|mesh-list
101659511|NCT05979493|Anesthetics, Local|anesthetics, local|mesh-ancestor
101659512|NCT05979493|Anesthetics|anesthetics|mesh-ancestor
101659513|NCT05979493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101659514|NCT05979493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659515|NCT05979493|Sensory System Agents|sensory system agents|mesh-ancestor
101659516|NCT05979493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101659517|NCT05979415|Apomorphine|apomorphine|mesh-list
101659519|NCT05979415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659520|NCT05979415|Autonomic Agents|autonomic agents|mesh-ancestor
101659521|NCT05979415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101659522|NCT05979415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101659523|NCT05979415|Dopamine Agonists|dopamine agonists|mesh-ancestor
101659524|NCT05979415|Dopamine Agents|dopamine agents|mesh-ancestor
101659525|NCT05979415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101659526|NCT05979415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659527|NCT05979324|Coal Tar|coal tar|mesh-list
101659528|NCT05979324|Keratolytic Agents|keratolytic agents|mesh-ancestor
101659529|NCT05979324|Dermatologic Agents|dermatologic agents|mesh-ancestor
101659530|NCT05979311|Tenofovir|tenofovir|mesh-list
101659531|NCT05979311|Lamivudine|lamivudine|mesh-list
101659532|NCT05979311|Emtricitabine|emtricitabine|mesh-list
101659533|NCT05979311|Dolutegravir|dolutegravir|mesh-list
101659534|NCT05979311|Antiviral Agents|antiviral agents|mesh-ancestor
101659535|NCT05979311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101659536|NCT05979311|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101659537|NCT05979311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101659538|NCT05979311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101659539|NCT05979311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659541|NCT05979311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101659542|NCT05979311|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101659543|NCT05979311|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101659544|NCT05979298|Gemcitabine|gemcitabine|mesh-list
101659545|NCT05979298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101659546|NCT05979298|Antimetabolites|antimetabolites|mesh-ancestor
101659547|NCT05979298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659548|NCT05979298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101659549|NCT05979220|Letrozole|letrozole|mesh-list
101659550|NCT05979220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101659551|NCT05979220|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101659552|NCT05979220|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101659553|NCT05979220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101659554|NCT05979220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659555|NCT05979220|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101659556|NCT05979220|Hormone Antagonists|hormone antagonists|mesh-ancestor
101659557|NCT05979220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101659558|NCT05979220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659559|NCT05978726|Aspirin|aspirin|mesh-list
101659560|NCT05978726|Clopidogrel|clopidogrel|mesh-list
101659561|NCT05978726|Ticagrelor|ticagrelor|mesh-list
101659562|NCT05978726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101659563|NCT05978726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101659564|NCT05978726|Analgesics|analgesics|mesh-ancestor
101659565|NCT05978726|Sensory System Agents|sensory system agents|mesh-ancestor
101659566|NCT05978726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101659567|NCT05978726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659568|NCT05978726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101659569|NCT05978726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101659570|NCT05978726|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101659571|NCT05978726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101659572|NCT05978726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659573|NCT05978726|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101659574|NCT05978726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101659575|NCT05978726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101659576|NCT05978726|Antipyretics|antipyretics|mesh-ancestor
101659577|NCT05978726|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101659578|NCT05978726|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101659579|NCT05978726|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101659580|NCT05978726|Purinergic Agents|purinergic agents|mesh-ancestor
101659581|NCT05978726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101659582|NCT05978713|Tirzepatide|tirzepatide|mesh-list
101659583|NCT05978713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101659584|NCT05978713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659585|NCT05978713|Incretins|incretins|mesh-ancestor
101659586|NCT05978713|Hormones|hormones|mesh-ancestor
101659587|NCT05978713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101659588|NCT05978687|Lidocaine|lidocaine|mesh-list
101659589|NCT05978687|Epinephrine|epinephrine|mesh-list
101659591|NCT05978687|Anesthetics|anesthetics|mesh-ancestor
101659592|NCT05978687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101659593|NCT05978687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659594|NCT05978687|Sensory System Agents|sensory system agents|mesh-ancestor
101659595|NCT05978687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101659596|NCT05978687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101659597|NCT05978687|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101659598|NCT05978687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101659599|NCT05978687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101659600|NCT05978687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659601|NCT05978687|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101659602|NCT05978687|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101659603|NCT05978687|Adrenergic Agents|adrenergic agents|mesh-ancestor
101659604|NCT05978687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101659605|NCT05978687|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101659606|NCT05978687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101659607|NCT05978687|Autonomic Agents|autonomic agents|mesh-ancestor
101659608|NCT05978687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101659609|NCT05978687|Respiratory System Agents|respiratory system agents|mesh-ancestor
101659610|NCT05978687|Mydriatics|mydriatics|mesh-ancestor
101659611|NCT05978687|Sympathomimetics|sympathomimetics|mesh-ancestor
101659612|NCT05978687|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101659614|NCT05978648|Docetaxel|docetaxel|mesh-list
101659615|NCT05978648|Cyclophosphamide|cyclophosphamide|mesh-list
101659616|NCT05978648|Carboplatin|carboplatin|mesh-list
101659617|NCT05978648|Trastuzumab|trastuzumab|mesh-list
101659618|NCT05978648|Epirubicin|epirubicin|mesh-list
101659619|NCT05978648|Pertuzumab|pertuzumab|mesh-list
101659620|NCT05978648|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101659621|NCT05978648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101659622|NCT05978648|Tubulin Modulators|tubulin modulators|mesh-ancestor
101659623|NCT05978648|Antimitotic Agents|antimitotic agents|mesh-ancestor
101659624|NCT05978648|Mitosis Modulators|mitosis modulators|mesh-ancestor
101659625|NCT05978648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659626|NCT05978648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101659627|NCT05978648|Immunologic Factors|immunologic factors|mesh-ancestor
101659628|NCT05978648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659629|NCT05978648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101659630|NCT05978648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101659631|NCT05978648|Alkylating Agents|alkylating agents|mesh-ancestor
101659632|NCT05978648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101659633|NCT05978648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101659634|NCT05978648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101659635|NCT05978648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101659636|NCT05978648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101659637|NCT05978648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101659638|NCT05978609|Gemcitabine|gemcitabine|mesh-list
101659639|NCT05978609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101659640|NCT05978609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101659641|NCT05978609|Antimetabolites|antimetabolites|mesh-ancestor
101659642|NCT05978609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659643|NCT05978505|Reboxetine|reboxetine|mesh-list
101659644|NCT05978505|Antidepressive Agents|antidepressive agents|mesh-ancestor
101659645|NCT05978505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101659646|NCT05978505|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101659647|NCT05978505|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101659648|NCT05978505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101659649|NCT05978505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659650|NCT05978505|Adrenergic Agents|adrenergic agents|mesh-ancestor
101659651|NCT05978505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101659652|NCT05978505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659653|NCT05978401|Paclitaxel|paclitaxel|mesh-list
101659654|NCT05978401|Carboplatin|carboplatin|mesh-list
101659655|NCT05978401|Pemetrexed|pemetrexed|mesh-list
101659656|NCT05978401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101659657|NCT05978401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101659658|NCT05978401|Tubulin Modulators|tubulin modulators|mesh-ancestor
101659659|NCT05978401|Antimitotic Agents|antimitotic agents|mesh-ancestor
101659660|NCT05978401|Mitosis Modulators|mitosis modulators|mesh-ancestor
101659661|NCT05978401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659662|NCT05978401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101659663|NCT05978401|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101659664|NCT05978401|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101659665|NCT05978206|Nandrolone Decanoate|nandrolone decanoate|mesh-list
101659666|NCT05978206|Nandrolone|nandrolone|mesh-list
101659667|NCT05978206|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
101659668|NCT05978206|Androgens|androgens|mesh-ancestor
101659669|NCT05978206|Hormones|hormones|mesh-ancestor
101659670|NCT05978206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101659671|NCT05978206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659672|NCT05978206|Anabolic Agents|anabolic agents|mesh-ancestor
101659673|NCT05978206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101659674|NCT05978193|Immunomodulating Agents|immunomodulating agents|mesh-list
101659675|NCT05978193|Immunologic Factors|immunologic factors|mesh-ancestor
101659676|NCT05978193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659677|NCT05978167|Methylphenidate|methylphenidate|mesh-list
101659678|NCT05978167|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101659679|NCT05978167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659680|NCT05978167|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101659681|NCT05978167|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101659682|NCT05978167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101659683|NCT05978167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659684|NCT05978167|Dopamine Agents|dopamine agents|mesh-ancestor
101659685|NCT05978167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101659686|NCT05978102|Pembrolizumab|pembrolizumab|mesh-list
101659687|NCT05978102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101659688|NCT05978102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101659689|NCT05978102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101659690|NCT05978102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659691|NCT05978050|Paclitaxel|paclitaxel|mesh-list
101659692|NCT05978050|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101659693|NCT05978050|Nimotuzumab|nimotuzumab|mesh-list
101659694|NCT05978050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101659695|NCT05978050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101659696|NCT05978050|Tubulin Modulators|tubulin modulators|mesh-ancestor
101659697|NCT05978050|Antimitotic Agents|antimitotic agents|mesh-ancestor
101659698|NCT05978050|Mitosis Modulators|mitosis modulators|mesh-ancestor
101659699|NCT05978050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659700|NCT05978050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101659701|NCT05977920|Caffeine|caffeine|mesh-list
101659702|NCT05977920|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101659703|NCT05977920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659704|NCT05977920|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101659705|NCT05977920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101659706|NCT05977920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659707|NCT05977920|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101659708|NCT05977920|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101659709|NCT05977920|Purinergic Agents|purinergic agents|mesh-ancestor
101659710|NCT05977920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101659711|NCT05977907|Pembrolizumab|pembrolizumab|mesh-list
101659712|NCT05977907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101825155|NCT00854009|BLI-489|bli-489|mesh-list
101659713|NCT05977907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101659714|NCT05977907|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101659715|NCT05977907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659716|NCT05977868|Amoxicillin|amoxicillin|mesh-list
101659717|NCT05977868|Moxifloxacin|moxifloxacin|mesh-list
101659718|NCT05977868|Metronidazole|metronidazole|mesh-list
101659720|NCT05977868|Doxycycline|doxycycline|mesh-list
101659721|NCT05977868|Ciprofloxacin|ciprofloxacin|mesh-list
101659722|NCT05977868|Levofloxacin|levofloxacin|mesh-list
101659723|NCT05977868|Rifampin|rifampin|mesh-list
101659724|NCT05977868|Meropenem|meropenem|mesh-list
101659725|NCT05977868|Cefazolin|cefazolin|mesh-list
101659726|NCT05977868|Tazobactam|tazobactam|mesh-list
101659727|NCT05977868|Linezolid|linezolid|mesh-list
101659728|NCT05977868|Piperacillin|piperacillin|mesh-list
101659729|NCT05977868|Clavulanic Acid|clavulanic acid|mesh-list
101659730|NCT05977868|Daptomycin|daptomycin|mesh-list
101659731|NCT05977868|Penicillins|penicillins|mesh-list
101659732|NCT05977868|Ceftazidime|ceftazidime|mesh-list
101659733|NCT05977868|Cephalexin|cephalexin|mesh-list
101659734|NCT05977868|Ampicillin|ampicillin|mesh-list
101659735|NCT05977868|Ertapenem|ertapenem|mesh-list
101659736|NCT05977868|Cefepime|cefepime|mesh-list
101659737|NCT05977868|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
101659738|NCT05977868|Tigecycline|tigecycline|mesh-list
101659739|NCT05977868|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101659740|NCT05977868|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101659741|NCT05977868|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101659742|NCT05977868|Avibactam|avibactam|mesh-list
101659743|NCT05977868|Sulbactam|sulbactam|mesh-list
101659744|NCT05977868|Dalbavancin|dalbavancin|mesh-list
101659745|NCT05977868|Oritavancin|oritavancin|mesh-list
101659746|NCT05977868|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
101659747|NCT05977868|Oxacillin|oxacillin|mesh-list
101659748|NCT05977868|Cefadroxil|cefadroxil|mesh-list
101659749|NCT05977868|Cefpodoxime|cefpodoxime|mesh-list
101659750|NCT05977868|Sultamicillin|sultamicillin|mesh-list
101659751|NCT05977868|Trimethoprim|trimethoprim|mesh-list
101659752|NCT05977868|Sulfamethoxazole|sulfamethoxazole|mesh-list
101659753|NCT05977868|Delafloxacin|delafloxacin|mesh-list
101659754|NCT05977868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101659755|NCT05977868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101659756|NCT05977868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101659757|NCT05977868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101659758|NCT05977868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101659759|NCT05977868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659760|NCT05977868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101659761|NCT05977868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101659762|NCT05977868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101659763|NCT05977868|Antimalarials|antimalarials|mesh-ancestor
101659764|NCT05977868|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101659765|NCT05977868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101659766|NCT05977868|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101659767|NCT05977868|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101659768|NCT05977868|Antitubercular Agents|antitubercular agents|mesh-ancestor
101659769|NCT05977868|Leprostatic Agents|leprostatic agents|mesh-ancestor
101659770|NCT05977868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101659771|NCT05977868|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101659772|NCT05977868|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101659773|NCT05977868|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101659774|NCT05977868|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101659775|NCT05977868|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101659776|NCT05977868|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101659777|NCT05977868|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101659778|NCT05977868|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101659779|NCT05977868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101659780|NCT05977868|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101825157|NCT00854009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101659781|NCT05977868|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101659782|NCT05975307|Carboplatin|carboplatin|mesh-list
101659783|NCT05975307|Gemcitabine|gemcitabine|mesh-list
101659784|NCT05975307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101659785|NCT05975307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101659787|NCT05975307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659788|NCT05974241|Aripiprazole|aripiprazole|mesh-list
101659789|NCT05974241|Methylphenidate|methylphenidate|mesh-list
101659790|NCT05974241|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101659791|NCT05974241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659792|NCT05974241|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101659793|NCT05974241|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101659794|NCT05974241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101659795|NCT05974241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659796|NCT05974241|Dopamine Agents|dopamine agents|mesh-ancestor
101659797|NCT05974241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101659798|NCT05974241|Antidepressive Agents|antidepressive agents|mesh-ancestor
101659799|NCT05974241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101659800|NCT05974241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101659801|NCT05974241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101659802|NCT05974241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101659803|NCT05974241|Dopamine Agonists|dopamine agonists|mesh-ancestor
101659804|NCT05974241|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101659805|NCT05974241|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101659806|NCT05974241|Serotonin Agents|serotonin agents|mesh-ancestor
101659807|NCT05974241|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101659808|NCT05974241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101659809|NCT05974241|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101659810|NCT05974241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101659811|NCT05969587|Cysteamine|cysteamine|mesh-list
101659812|NCT05969587|Hydroquinone|hydroquinone|mesh-list
101659813|NCT05969587|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
101659814|NCT05969587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659815|NCT05969587|Antioxidants|antioxidants|mesh-ancestor
101659816|NCT05969587|Protective Agents|protective agents|mesh-ancestor
101659817|NCT05969587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659818|NCT05969587|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101659819|NCT05964868|Epinephrine|epinephrine|mesh-list
101659820|NCT05964868|Bupivacaine|bupivacaine|mesh-list
101659821|NCT05964868|Anesthetics, Local|anesthetics, local|mesh-ancestor
101659822|NCT05964868|Anesthetics|anesthetics|mesh-ancestor
101659823|NCT05964868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101659824|NCT05964868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659825|NCT05964868|Sensory System Agents|sensory system agents|mesh-ancestor
101659826|NCT05964868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101659827|NCT05964868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101659828|NCT05964868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101659829|NCT05964868|Adrenergic Agents|adrenergic agents|mesh-ancestor
101659830|NCT05964868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101659831|NCT05964868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659832|NCT05964868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101659833|NCT05964868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101659834|NCT05964868|Autonomic Agents|autonomic agents|mesh-ancestor
101659835|NCT05964868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101659836|NCT05964868|Respiratory System Agents|respiratory system agents|mesh-ancestor
101659837|NCT05964868|Mydriatics|mydriatics|mesh-ancestor
101659838|NCT05964868|Sympathomimetics|sympathomimetics|mesh-ancestor
101659839|NCT05964868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101659840|NCT05964335|Nalbuphine|nalbuphine|mesh-list
101659841|NCT05964335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101659842|NCT05964335|Narcotics|narcotics|mesh-ancestor
101659843|NCT05964335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101659844|NCT05964335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659845|NCT05964335|Analgesics|analgesics|mesh-ancestor
101659846|NCT05964335|Sensory System Agents|sensory system agents|mesh-ancestor
101659847|NCT05964335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101659848|NCT05948579|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
101659849|NCT05948579|Antidepressive Agents|antidepressive agents|mesh-ancestor
101659850|NCT05948579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101659851|NCT05948579|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101659852|NCT05948579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101659853|NCT05948579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101659854|NCT05948579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659855|NCT05948579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101659856|NCT05948579|Serotonin Agents|serotonin agents|mesh-ancestor
101659857|NCT05948579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659858|NCT05948579|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101659859|NCT05948579|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101659860|NCT05948553|Fluoxetine|fluoxetine|mesh-list
101659861|NCT05948553|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101659862|NCT05948553|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101659863|NCT05948553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101659864|NCT05948553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659865|NCT05948553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101659866|NCT05948553|Serotonin Agents|serotonin agents|mesh-ancestor
101659867|NCT05948553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659868|NCT05948553|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101659869|NCT05948553|Antidepressive Agents|antidepressive agents|mesh-ancestor
101659870|NCT05948553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101659871|NCT05948553|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101659872|NCT05948553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101659873|NCT05948553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101659874|NCT05939414|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
101659875|NCT05939414|Chelating Agents|chelating agents|mesh-ancestor
101659876|NCT05939414|Sequestering Agents|sequestering agents|mesh-ancestor
101659877|NCT05939414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659878|NCT05929898|Dopamine|dopamine|mesh-list
101659879|NCT05929898|Dopamine Agonists|dopamine agonists|mesh-list
101659880|NCT05929898|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101659881|NCT05929898|Sympathomimetics|sympathomimetics|mesh-ancestor
101659882|NCT05929898|Autonomic Agents|autonomic agents|mesh-ancestor
101659883|NCT05929898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101659884|NCT05929898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659885|NCT05929898|Dopamine Agents|dopamine agents|mesh-ancestor
101659886|NCT05929898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101659887|NCT05929898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659888|NCT05929898|Protective Agents|protective agents|mesh-ancestor
101659889|NCT05875441|Moxidectin|moxidectin|mesh-list
101659890|NCT05875441|Anthelmintics|anthelmintics|mesh-ancestor
101659891|NCT05875441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101659892|NCT05875441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101659893|NCT05875441|Antinematodal Agents|antinematodal agents|mesh-ancestor
101659894|NCT05867121|Paclitaxel|paclitaxel|mesh-list
101659895|NCT05867121|Gemcitabine|gemcitabine|mesh-list
101659896|NCT05867121|Capecitabine|capecitabine|mesh-list
101659897|NCT05867121|Oxaliplatin|oxaliplatin|mesh-list
101659898|NCT05867121|Nivolumab|nivolumab|mesh-list
101659899|NCT05867121|Atezolizumab|atezolizumab|mesh-list
101659900|NCT05867121|Tegafur|tegafur|mesh-list
101659901|NCT05867121|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101659902|NCT05867121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101659903|NCT05867121|Tubulin Modulators|tubulin modulators|mesh-ancestor
101659904|NCT05867121|Antimitotic Agents|antimitotic agents|mesh-ancestor
101659905|NCT05867121|Mitosis Modulators|mitosis modulators|mesh-ancestor
101659906|NCT05867121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659907|NCT05867121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101659908|NCT05867121|Antimetabolites|antimetabolites|mesh-ancestor
101659909|NCT05867121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101659910|NCT05867121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101659911|NCT05840718|Thiamine|thiamine|mesh-list
101659912|NCT05840718|Vitamin B Complex|vitamin b complex|mesh-ancestor
101659913|NCT05840718|Vitamins|vitamins|mesh-ancestor
101659914|NCT05840718|Micronutrients|micronutrients|mesh-ancestor
101659915|NCT05840718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659916|NCT05838521|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
101659917|NCT05838521|Immunoconjugates|immunoconjugates|mesh-ancestor
101659918|NCT05838521|Immunologic Factors|immunologic factors|mesh-ancestor
101659919|NCT05838521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659920|NCT05837091|Sodium Oxybate|sodium oxybate|mesh-list
101659921|NCT05837091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659922|NCT05837091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101659923|NCT05837091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101659924|NCT05837091|Anesthetics, General|anesthetics, general|mesh-ancestor
101659925|NCT05837091|Anesthetics|anesthetics|mesh-ancestor
101659926|NCT05837091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101659927|NCT05836740|Minocycline|minocycline|mesh-list
101659928|NCT05836740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101659929|NCT05836740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101659930|NCT05831176|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101659931|NCT05831176|Immunologic Factors|immunologic factors|mesh-ancestor
101659932|NCT05831176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659933|NCT05829603|Harmine|harmine|mesh-list
101659934|NCT05829603|Hallucinogens|hallucinogens|mesh-ancestor
101659935|NCT05829603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659936|NCT05829603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101659937|NCT05829603|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101659938|NCT05829603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101659939|NCT05829603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659940|NCT05825430|Bupivacaine|bupivacaine|mesh-list
101659941|NCT05825430|Anesthetics|anesthetics|mesh-list
101659942|NCT05825430|Anesthetics, General|anesthetics, general|mesh-list
101659943|NCT05825430|Anesthetics, Local|anesthetics, local|mesh-ancestor
101659944|NCT05825430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101659945|NCT05825430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659946|NCT05825430|Sensory System Agents|sensory system agents|mesh-ancestor
101659947|NCT05825430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101659948|NCT05789082|Pembrolizumab|pembrolizumab|mesh-list
101659949|NCT05789082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101659950|NCT05789082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101659951|NCT05789082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101659952|NCT05789082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659954|NCT05782270|Anticoagulants|anticoagulants|mesh-ancestor
101659955|NCT05780710|Antihypertensive Agents|antihypertensive agents|mesh-list
101659956|NCT05767346|Metoprolol|metoprolol|mesh-list
101659957|NCT05767346|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101659958|NCT05767346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101659959|NCT05767346|Sympatholytics|sympatholytics|mesh-ancestor
101659960|NCT05767346|Autonomic Agents|autonomic agents|mesh-ancestor
101659961|NCT05767346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101659962|NCT05767346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659963|NCT05767346|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101659964|NCT05767346|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101659965|NCT05767346|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101659966|NCT05767346|Adrenergic Agents|adrenergic agents|mesh-ancestor
101659967|NCT05767346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101659968|NCT05767346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659969|NCT05753189|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101659970|NCT05753189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101659971|NCT05753189|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101659972|NCT05753189|Aceclidine|aceclidine|mesh-list
101659973|NCT05753189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101659974|NCT05753189|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101659975|NCT05753189|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101659976|NCT05753189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101659977|NCT05753189|Adrenergic Agents|adrenergic agents|mesh-ancestor
101659978|NCT05753189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101659979|NCT05753189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101659980|NCT05753189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659981|NCT05753189|Miotics|miotics|mesh-ancestor
101659982|NCT05753189|Autonomic Agents|autonomic agents|mesh-ancestor
101659983|NCT05753189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101659984|NCT05753189|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101659985|NCT05750992|Fentanyl|fentanyl|mesh-list
101659986|NCT05750992|Meperidine|meperidine|mesh-list
101659987|NCT05750992|Bupivacaine|bupivacaine|mesh-list
101659988|NCT05750992|Anesthetics, Local|anesthetics, local|mesh-ancestor
101659989|NCT05750992|Anesthetics|anesthetics|mesh-ancestor
101659990|NCT05750992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101659991|NCT05750992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101659992|NCT05750992|Sensory System Agents|sensory system agents|mesh-ancestor
101659993|NCT05750992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101659994|NCT05750992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101659995|NCT05750992|Narcotics|narcotics|mesh-ancestor
101659996|NCT05750992|Analgesics|analgesics|mesh-ancestor
101659997|NCT05750992|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101659998|NCT05750992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101659999|NCT05750992|Anesthetics, General|anesthetics, general|mesh-ancestor
101660000|NCT05748483|Topiramate|topiramate|mesh-list
101660001|NCT05748483|Anticonvulsants|anticonvulsants|mesh-ancestor
101660002|NCT05748483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101660003|NCT05748483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660004|NCT05698524|Temozolomide|temozolomide|mesh-list
101660005|NCT05698524|Abexinostat|abexinostat|mesh-list
101660006|NCT05698524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101660007|NCT05698524|Alkylating Agents|alkylating agents|mesh-ancestor
101660008|NCT05698524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660009|NCT05698524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660010|NCT05698524|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101660012|NCT05660941|Insulin Lispro|insulin lispro|mesh-list
101660013|NCT05660941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101660014|NCT05660941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660015|NCT05631236|Methamphetamine|methamphetamine|mesh-list
101660016|NCT05631236|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101660017|NCT05631236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101825220|NCT03684642|Efpeglenatide|efpeglenatide|mesh-list
101660028|NCT05631236|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101660041|NCT05602636|Midazolam|midazolam|mesh-list
101660042|NCT05602636|Bupivacaine|bupivacaine|mesh-list
101660043|NCT05602636|Anesthetics, Local|anesthetics, local|mesh-ancestor
101660044|NCT05602636|Anesthetics|anesthetics|mesh-ancestor
101660045|NCT05602636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101660046|NCT05602636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660047|NCT05602636|Sensory System Agents|sensory system agents|mesh-ancestor
101660048|NCT05602636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101660049|NCT05602636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101660050|NCT05602636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101660051|NCT05602636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101660052|NCT05602636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101660053|NCT05602636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101660054|NCT05602636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101660055|NCT05602636|Anesthetics, General|anesthetics, general|mesh-ancestor
101660056|NCT05602636|GABA Modulators|gaba modulators|mesh-ancestor
101660057|NCT05602636|GABA Agents|gaba agents|mesh-ancestor
101660058|NCT05602636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101660059|NCT05602636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660060|NCT05602519|Fentanyl|fentanyl|mesh-list
101660061|NCT05602519|Propofol|propofol|mesh-list
101660062|NCT05602519|Rocuronium|rocuronium|mesh-list
101660063|NCT05602519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101660064|NCT05602519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101660065|NCT05602519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660066|NCT05602519|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101660067|NCT05602519|Anesthetics, General|anesthetics, general|mesh-ancestor
101660068|NCT05602519|Anesthetics|anesthetics|mesh-ancestor
101660069|NCT05602519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101660070|NCT05602519|Narcotics|narcotics|mesh-ancestor
101660071|NCT05602519|Analgesics|analgesics|mesh-ancestor
101660072|NCT05602519|Sensory System Agents|sensory system agents|mesh-ancestor
101660073|NCT05602519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101660074|NCT05602519|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101660075|NCT05602519|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101660076|NCT05602519|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101660077|NCT05602519|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101660078|NCT05583227|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101660079|NCT05583227|Immunologic Factors|immunologic factors|mesh-ancestor
101660080|NCT05583227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660081|NCT05557695|Acalabrutinib|acalabrutinib|mesh-list
101660082|NCT05557695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660083|NCT05555615|Pimavanserin|pimavanserin|mesh-list
101660084|NCT05555615|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101660085|NCT05555615|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101660086|NCT05555615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101660087|NCT05555615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101660088|NCT05555615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101660089|NCT05555615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660090|NCT05555615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101660091|NCT05555615|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101660092|NCT05555615|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101660093|NCT05555615|Serotonin Agents|serotonin agents|mesh-ancestor
101660094|NCT05555615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101660095|NCT05555615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660096|NCT05536856|Fluorouracil|fluorouracil|mesh-list
101660097|NCT05536856|Antimetabolites|antimetabolites|mesh-ancestor
101660098|NCT05536856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660099|NCT05536856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101660100|NCT05536856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660101|NCT05536856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101660102|NCT05536856|Immunologic Factors|immunologic factors|mesh-ancestor
101660103|NCT05536856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660121|NCT05523895|Pimavanserin|pimavanserin|mesh-list
101660122|NCT05523895|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101660123|NCT05523895|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101660124|NCT05523895|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101660125|NCT05523895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101660126|NCT05523895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101660127|NCT05523895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660128|NCT05523895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101660129|NCT05523895|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101660130|NCT05523895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101660131|NCT05523895|Serotonin Agents|serotonin agents|mesh-ancestor
101660132|NCT05523895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101660133|NCT05523895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660134|NCT05493709|Leuprolide|leuprolide|mesh-list
101660135|NCT05493709|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101660136|NCT05493709|Fertility Agents|fertility agents|mesh-ancestor
101660137|NCT05493709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101660138|NCT05493709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660139|NCT05493709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101660140|NCT05493709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660141|NCT05487885|Ketamine|ketamine|mesh-list
101660142|NCT05487885|Analgesics|analgesics|mesh-ancestor
101660143|NCT05487885|Sensory System Agents|sensory system agents|mesh-ancestor
101660144|NCT05487885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101660145|NCT05487885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660146|NCT05487885|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101660147|NCT05487885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101660148|NCT05487885|Anesthetics, General|anesthetics, general|mesh-ancestor
101660149|NCT05487885|Anesthetics|anesthetics|mesh-ancestor
101660150|NCT05487885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101660151|NCT05487885|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101660152|NCT05487885|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101660153|NCT05487885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101660154|NCT05487885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660156|NCT05485805|Caffeine|caffeine|mesh-list
101660157|NCT05485805|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101660158|NCT05485805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660159|NCT05485805|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101660160|NCT05485805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101660161|NCT05485805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660162|NCT05485805|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101660163|NCT05485805|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101660164|NCT05485805|Purinergic Agents|purinergic agents|mesh-ancestor
101660165|NCT05485805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101660166|NCT05485805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101660167|NCT05485805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101660168|NCT05485805|Analgesics|analgesics|mesh-ancestor
101660169|NCT05485805|Sensory System Agents|sensory system agents|mesh-ancestor
101660170|NCT05485805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101660171|NCT05485805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101660172|NCT05485805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101660173|NCT05485805|Gout Suppressants|gout suppressants|mesh-ancestor
101660174|NCT05485805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101660176|NCT05480800|Immunologic Factors|immunologic factors|mesh-ancestor
101660177|NCT05480800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660178|NCT05465330|Propofol|propofol|mesh-list
101660179|NCT05465330|Desflurane|desflurane|mesh-list
101660180|NCT05465330|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101660181|NCT05465330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101660182|NCT05465330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660183|NCT05465330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101660184|NCT05465330|Anesthetics, General|anesthetics, general|mesh-ancestor
101660185|NCT05465330|Anesthetics|anesthetics|mesh-ancestor
101660186|NCT05465330|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101660187|NCT05458856|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101660188|NCT05458856|Luteolytic Agents|luteolytic agents|mesh-ancestor
101660189|NCT05458856|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101660190|NCT05458856|Contraceptive Agents|contraceptive agents|mesh-ancestor
101660191|NCT05458856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101660192|NCT05458856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660193|NCT05458856|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101660194|NCT05458856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101660195|NCT05458856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660196|NCT05445609|Nivolumab|nivolumab|mesh-list
101660197|NCT05445609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101660198|NCT05445609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660199|NCT05445609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101660200|NCT05445609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660201|NCT05442060|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101660202|NCT05442060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660203|NCT05442060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101660204|NCT05442060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101660205|NCT05442060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660206|NCT05406388|Fentanyl|fentanyl|mesh-list
101660207|NCT05406388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101660208|NCT05406388|Narcotics|narcotics|mesh-ancestor
101660209|NCT05406388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101660210|NCT05406388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660211|NCT05406388|Analgesics|analgesics|mesh-ancestor
101660212|NCT05406388|Sensory System Agents|sensory system agents|mesh-ancestor
101660213|NCT05406388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101660214|NCT05406388|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101660215|NCT05406388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101660216|NCT05406388|Anesthetics, General|anesthetics, general|mesh-ancestor
101660217|NCT05406388|Anesthetics|anesthetics|mesh-ancestor
101660218|NCT05403502|Insulin|insulin|mesh-list
101660219|NCT05403502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101660220|NCT05403502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660221|NCT05399550|Balovaptan|balovaptan|mesh-list
101660222|NCT05399550|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101660223|NCT05399550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660224|NCT05399550|Natriuretic Agents|natriuretic agents|mesh-ancestor
101660225|NCT05399550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660226|NCT05368558|Cariprazine|cariprazine|mesh-list
101660227|NCT05368558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101660228|NCT05368558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101660229|NCT05368558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101660230|NCT05368558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660231|NCT05368558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101660232|NCT05345171|Prednisolone|prednisolone|mesh-list
101660233|NCT05345171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101660234|NCT05345171|Glucocorticoids|glucocorticoids|mesh-ancestor
101660236|NCT05345171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101660237|NCT05345171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660238|NCT05345171|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101660239|NCT05345171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660240|NCT05304351|Vaccines|vaccines|mesh-list
101660241|NCT05304351|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
101660242|NCT05304351|Immunologic Factors|immunologic factors|mesh-ancestor
101660243|NCT05304351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660244|NCT05304351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101660245|NCT05281510|Vesatolimod|vesatolimod|mesh-list
101660246|NCT05281510|Antiviral Agents|antiviral agents|mesh-ancestor
101660247|NCT05281510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101660248|NCT05253131|Durvalumab|durvalumab|mesh-list
101660249|NCT05253131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101660250|NCT05253131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660251|NCT05239624|Pembrolizumab|pembrolizumab|mesh-list
101660252|NCT05239624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101660253|NCT05239624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660254|NCT05239624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101660255|NCT05239624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660256|NCT05239468|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
101660257|NCT05239468|Bezafibrate|bezafibrate|mesh-list
101660258|NCT05239468|Cathartics|cathartics|mesh-ancestor
101660259|NCT05239468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101660260|NCT05239468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101660261|NCT05239468|Antimetabolites|antimetabolites|mesh-ancestor
101660262|NCT05239468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660263|NCT05239468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101660264|NCT05231629|Dexamethasone|dexamethasone|mesh-list
101660265|NCT05231629|Dexamethasone acetate|dexamethasone acetate|mesh-list
101660267|NCT05231629|Lenalidomide|lenalidomide|mesh-list
101660268|NCT05231629|Bortezomib|bortezomib|mesh-list
101660269|NCT05231629|Daratumumab|daratumumab|mesh-list
101660270|NCT05231629|BB 1101|bb 1101|mesh-list
101660271|NCT05231629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101660272|NCT05231629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101660273|NCT05231629|Antiemetics|antiemetics|mesh-ancestor
101660274|NCT05231629|Autonomic Agents|autonomic agents|mesh-ancestor
101660275|NCT05231629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101660276|NCT05231629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660277|NCT05231629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101660278|NCT05231629|Glucocorticoids|glucocorticoids|mesh-ancestor
101660279|NCT05231629|Hormones|hormones|mesh-ancestor
101660280|NCT05231629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101660281|NCT05231629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101660282|NCT05231629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660283|NCT05231629|Protease Inhibitors|protease inhibitors|mesh-ancestor
101660284|NCT05231629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101825272|NCT00854633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660285|NCT05231629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660286|NCT05231629|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101660287|NCT05231629|Alkylating Agents|alkylating agents|mesh-ancestor
101660288|NCT05231629|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101660289|NCT05231629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101660290|NCT05231629|Immunologic Factors|immunologic factors|mesh-ancestor
101660291|NCT05231629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101660292|NCT05231629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101660293|NCT05231629|Growth Substances|growth substances|mesh-ancestor
101660294|NCT05231629|Growth Inhibitors|growth inhibitors|mesh-ancestor
101660295|NCT05230810|Fulvestrant|fulvestrant|mesh-list
101660296|NCT05230810|Tucatinib|tucatinib|mesh-list
101660297|NCT05230810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101660298|NCT05230810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660299|NCT05230810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101660300|NCT05230810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101660301|NCT05230810|Hormone Antagonists|hormone antagonists|mesh-ancestor
101660302|NCT05230810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101660303|NCT05230810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660304|NCT05230810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101660305|NCT05230810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101660306|NCT05230810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660307|NCT05204927|Prednisone|prednisone|mesh-list
101660308|NCT05204927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101660309|NCT05204927|Glucocorticoids|glucocorticoids|mesh-ancestor
101660310|NCT05204927|Hormones|hormones|mesh-ancestor
101660311|NCT05204927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101660312|NCT05204927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660313|NCT05204927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101660314|NCT05204927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660315|NCT05193591|Autoantibodies|autoantibodies|mesh-list
101660316|NCT05193591|Immunologic Factors|immunologic factors|mesh-ancestor
101660317|NCT05193591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660318|NCT05183126|Paclitaxel|paclitaxel|mesh-list
101660319|NCT05183126|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101660320|NCT05183126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101660321|NCT05183126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660322|NCT05183126|Tubulin Modulators|tubulin modulators|mesh-ancestor
101660323|NCT05183126|Antimitotic Agents|antimitotic agents|mesh-ancestor
101660324|NCT05183126|Mitosis Modulators|mitosis modulators|mesh-ancestor
101660325|NCT05183126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660326|NCT05173831|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
101660327|NCT05173831|Hallucinogens|hallucinogens|mesh-ancestor
101660328|NCT05173831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660329|NCT05173831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101660330|NCT05173831|Serotonin Agents|serotonin agents|mesh-ancestor
101660331|NCT05173831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101660332|NCT05173831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660333|NCT05173831|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101660334|NCT05173831|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101660335|NCT05173831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101660336|NCT05173831|Adrenergic Agents|adrenergic agents|mesh-ancestor
101660337|NCT05171387|Androgens|androgens|mesh-list
101660338|NCT05171387|Hormones|hormones|mesh-ancestor
101660339|NCT05171387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101660340|NCT05171387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660341|NCT05168657|Pancrelipase|pancrelipase|mesh-list
101660342|NCT05168657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101660343|NCT05135910|Terbinafine|terbinafine|mesh-list
101660344|NCT05135910|Antifungal Agents|antifungal agents|mesh-ancestor
101660345|NCT05135910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101825282|NCT00858299|Valsartan|valsartan|mesh-list
101660364|NCT05074121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101660366|NCT05074121|Respiratory System Agents|respiratory system agents|mesh-ancestor
101660367|NCT05074121|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101660368|NCT05074121|Antioxidants|antioxidants|mesh-ancestor
101660369|NCT05074121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660370|NCT05074121|Protective Agents|protective agents|mesh-ancestor
101660371|NCT05074121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660372|NCT05074121|Antidotes|antidotes|mesh-ancestor
101660373|NCT05053503|Lofexidine|lofexidine|mesh-list
101660374|NCT05053503|Naltrexone|naltrexone|mesh-list
101660375|NCT05053503|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101660376|NCT05053503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101409318|NCT00348010|Analgesics|analgesics|mesh-ancestor
101660377|NCT05053503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660378|NCT05053503|Sensory System Agents|sensory system agents|mesh-ancestor
101660379|NCT05053503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101660380|NCT05053503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101660381|NCT05053503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101660382|NCT05053503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101660383|NCT05053503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101660384|NCT05053503|Adrenergic Agents|adrenergic agents|mesh-ancestor
101660385|NCT05053503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101660386|NCT05053503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660387|NCT04998851|Ocrelizumab|ocrelizumab|mesh-list
101660388|NCT04998851|Immunologic Factors|immunologic factors|mesh-ancestor
101660389|NCT04998851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660390|NCT04974528|Insulin|insulin|mesh-list
101660391|NCT04974528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101660392|NCT04974528|Insulin Glargine|insulin glargine|mesh-list
101660394|NCT04974528|Insulin Lispro|insulin lispro|mesh-list
101660395|NCT04974528|Insulin Detemir|insulin detemir|mesh-list
101660396|NCT04974528|Insulin glulisine|insulin glulisine|mesh-list
101660397|NCT04974528|Insulin, Short-Acting|insulin, short-acting|mesh-list
101660398|NCT04974528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101660399|NCT04974528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660400|NCT04969991|Varespladib methyl|varespladib methyl|mesh-list
101660401|NCT04969991|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
101660402|NCT04969991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101660403|NCT04969991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660404|NCT04960709|Durvalumab|durvalumab|mesh-list
101660405|NCT04960709|Tremelimumab|tremelimumab|mesh-list
101660406|NCT04960709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101660407|NCT04960709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660408|NCT04960618|Gemcitabine|gemcitabine|mesh-list
101660409|NCT04960618|Pembrolizumab|pembrolizumab|mesh-list
101660410|NCT04960618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101660411|NCT04960618|Antimetabolites|antimetabolites|mesh-ancestor
101660412|NCT04960618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660413|NCT04960618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660414|NCT04960618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101660415|NCT04960618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101660416|NCT04958785|Paclitaxel|paclitaxel|mesh-list
101660417|NCT04958785|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101660418|NCT04958785|Magrolimab|magrolimab|mesh-list
101660419|NCT04958785|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
101660420|NCT04958785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101660421|NCT04958785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660422|NCT04958785|Tubulin Modulators|tubulin modulators|mesh-ancestor
101660423|NCT04958785|Antimitotic Agents|antimitotic agents|mesh-ancestor
101660424|NCT04958785|Mitosis Modulators|mitosis modulators|mesh-ancestor
101660425|NCT04958785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660426|NCT04958785|Immunoconjugates|immunoconjugates|mesh-ancestor
101660427|NCT04958785|Immunologic Factors|immunologic factors|mesh-ancestor
101660428|NCT04958785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660429|NCT04958785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101660430|NCT04954664|Dimenhydrinate|dimenhydrinate|mesh-list
101660431|NCT04954664|Antiemetics|antiemetics|mesh-ancestor
101660432|NCT04954664|Autonomic Agents|autonomic agents|mesh-ancestor
101660433|NCT04954664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101660434|NCT04954664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660435|NCT04954664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101660436|NCT04954664|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101660437|NCT04954664|Histamine Antagonists|histamine antagonists|mesh-ancestor
101660438|NCT04954664|Histamine Agents|histamine agents|mesh-ancestor
101660439|NCT04954664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101660440|NCT04954664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660441|NCT04900792|Ascorbic Acid|ascorbic acid|mesh-list
101660442|NCT04900792|Temozolomide|temozolomide|mesh-list
101660443|NCT04900792|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
101660444|NCT04900792|Vitamins|vitamins|mesh-ancestor
101660445|NCT04900792|Micronutrients|micronutrients|mesh-ancestor
101660446|NCT04900792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660447|NCT04900792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101660448|NCT04900792|Alkylating Agents|alkylating agents|mesh-ancestor
101660449|NCT04900792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660450|NCT04900792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660451|NCT04900792|Antioxidants|antioxidants|mesh-ancestor
101660452|NCT04900792|Protective Agents|protective agents|mesh-ancestor
101660453|NCT04900792|Hematinics|hematinics|mesh-ancestor
101660454|NCT04900792|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101660455|NCT04900792|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101660456|NCT04882202|Acetaminophen|acetaminophen|mesh-list
101660457|NCT04882202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101660458|NCT04882202|Analgesics|analgesics|mesh-ancestor
101660459|NCT04882202|Sensory System Agents|sensory system agents|mesh-ancestor
101660460|NCT04882202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101660461|NCT04882202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660462|NCT04882202|Antipyretics|antipyretics|mesh-ancestor
101660463|NCT04878432|Azacitidine|azacitidine|mesh-list
101660464|NCT04878432|Decitabine|decitabine|mesh-list
101660465|NCT04878432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101660466|NCT04878432|Antimetabolites|antimetabolites|mesh-ancestor
101660467|NCT04878432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660468|NCT04878432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660469|NCT04878432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101660470|NCT04872543|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
101660471|NCT04872543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101660472|NCT04872543|Antimetabolites|antimetabolites|mesh-ancestor
101825311|NCT00858377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101660473|NCT04872543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660474|NCT04872543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660475|NCT04853251|Ranibizumab|ranibizumab|mesh-list
101660476|NCT04853251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101660477|NCT04853251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101660478|NCT04853251|Growth Substances|growth substances|mesh-ancestor
101660479|NCT04853251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660480|NCT04853251|Growth Inhibitors|growth inhibitors|mesh-ancestor
101660481|NCT04853251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660482|NCT04822350|Avelumab|avelumab|mesh-list
101660483|NCT04822350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101660484|NCT04822350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660485|NCT04813926|Riociguat|riociguat|mesh-list
101660486|NCT04813926|Enzyme Activators|enzyme activators|mesh-ancestor
101660487|NCT04813926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660488|NCT04782245|Dapagliflozin|dapagliflozin|mesh-list
101660489|NCT04782245|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101660490|NCT04782245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660491|NCT04782245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101660492|NCT04782245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660493|NCT04776148|Trifluridine|trifluridine|mesh-list
101660494|NCT04776148|Pembrolizumab|pembrolizumab|mesh-list
101660495|NCT04776148|Lenvatinib|lenvatinib|mesh-list
101660496|NCT04776148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101660497|NCT04776148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660498|NCT04776148|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101660499|NCT04776148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660500|NCT04776148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101660501|NCT04776148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101660502|NCT04776148|Antimetabolites|antimetabolites|mesh-ancestor
101660503|NCT04776148|Antiviral Agents|antiviral agents|mesh-ancestor
101660504|NCT04776148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101660505|NCT04762069|Lomustine|lomustine|mesh-list
101660506|NCT04762069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101660507|NCT04762069|Alkylating Agents|alkylating agents|mesh-ancestor
101660508|NCT04762069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660509|NCT04762069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660510|NCT04750707|Hydroxyurea|hydroxyurea|mesh-list
101660511|NCT04750707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660512|NCT04750707|Antisickling Agents|antisickling agents|mesh-ancestor
101660513|NCT04750707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101660514|NCT04750707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660515|NCT04750707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101660518|NCT04748809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101660519|NCT04692831|Pertuzumab|pertuzumab|mesh-list
101660520|NCT04692831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101660521|NCT04692831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660522|NCT04691986|Niacinamide|niacinamide|mesh-list
101660524|NCT04691986|Nicotinic Acids|nicotinic acids|mesh-list
101660525|NCT04691986|Vitamin B Complex|vitamin b complex|mesh-ancestor
101660526|NCT04691986|Vitamins|vitamins|mesh-ancestor
101660527|NCT04691986|Micronutrients|micronutrients|mesh-ancestor
101660528|NCT04691986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660529|NCT04691986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101660530|NCT04691986|Antimetabolites|antimetabolites|mesh-ancestor
101660531|NCT04691986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660532|NCT04691986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101660533|NCT04691986|Vasodilator Agents|vasodilator agents|mesh-ancestor
101660534|NCT04665037|Posaconazole|posaconazole|mesh-list
101660535|NCT04665037|Antifungal Agents|antifungal agents|mesh-ancestor
101660536|NCT04665037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101660548|NCT04644029|Tenofovir|tenofovir|mesh-list
101660549|NCT04644029|Emtricitabine|emtricitabine|mesh-list
101825318|NCT00854711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660553|NCT04644029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101660554|NCT04644029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101660555|NCT04644029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101660556|NCT04644029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101660557|NCT04644029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660558|NCT04644029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101660559|NCT04644029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101660573|NCT04609046|Rituximab|rituximab|mesh-list
101660574|NCT04609046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101660575|NCT04609046|Nivolumab|nivolumab|mesh-list
101660576|NCT04609046|Methotrexate|methotrexate|mesh-list
101660577|NCT04609046|Lenalidomide|lenalidomide|mesh-list
101660578|NCT04609046|Antibodies|antibodies|mesh-list
101660579|NCT04609046|Immunoglobulins|immunoglobulins|mesh-list
101660580|NCT04609046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101660581|NCT04609046|Immunologic Factors|immunologic factors|mesh-ancestor
101660582|NCT04609046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660583|NCT04609046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660584|NCT04609046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101660585|NCT04609046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101660586|NCT04609046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660587|NCT04609046|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101660588|NCT04609046|Abortifacient Agents|abortifacient agents|mesh-ancestor
101660589|NCT04609046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101660590|NCT04609046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101660591|NCT04609046|Antimetabolites|antimetabolites|mesh-ancestor
101660592|NCT04609046|Dermatologic Agents|dermatologic agents|mesh-ancestor
101660593|NCT04609046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101660594|NCT04609046|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101660595|NCT04609046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101660596|NCT04609046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101660597|NCT04609046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101660598|NCT04609046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101660599|NCT04609046|Growth Substances|growth substances|mesh-ancestor
101660600|NCT04609046|Growth Inhibitors|growth inhibitors|mesh-ancestor
101660601|NCT04594694|Bezafibrate|bezafibrate|mesh-list
101660602|NCT04594694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101660603|NCT04594694|Antimetabolites|antimetabolites|mesh-ancestor
101660604|NCT04594694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660605|NCT04594694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101660609|NCT04586504|Midazolam|midazolam|mesh-list
101660610|NCT04586504|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101660611|NCT04586504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101660612|NCT04586504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101660613|NCT04586504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660615|NCT04586504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101660616|NCT04586504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101660617|NCT04586504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101660618|NCT04586504|Anesthetics, General|anesthetics, general|mesh-ancestor
101660619|NCT04586504|Anesthetics|anesthetics|mesh-ancestor
101660620|NCT04586504|GABA Modulators|gaba modulators|mesh-ancestor
101660621|NCT04586504|GABA Agents|gaba agents|mesh-ancestor
101660622|NCT04586504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101660623|NCT04586504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660624|NCT04583501|Omalizumab|omalizumab|mesh-list
101660625|NCT04583501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101660626|NCT04583501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101660627|NCT04583501|Respiratory System Agents|respiratory system agents|mesh-ancestor
101660628|NCT04566692|Immunoglobulins|immunoglobulins|mesh-list
101660629|NCT04566692|gamma-Globulins|gamma-globulins|mesh-list
101660630|NCT04566692|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101660631|NCT04566692|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101660632|NCT04566692|Immunologic Factors|immunologic factors|mesh-ancestor
101660633|NCT04566692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660634|NCT04544995|Niraparib|niraparib|mesh-list
101660635|NCT04544995|Dostarlimab|dostarlimab|mesh-list
101409322|NCT00144417|Rifampin|rifampin|mesh-list
101660636|NCT04544995|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101660637|NCT04544995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101660638|NCT04544995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660639|NCT04544995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660640|NCT04512235|Dexamethasone|dexamethasone|mesh-list
101660641|NCT04512235|Cyclophosphamide|cyclophosphamide|mesh-list
101660642|NCT04512235|Bortezomib|bortezomib|mesh-list
101660643|NCT04512235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101660644|NCT04512235|Immunologic Factors|immunologic factors|mesh-ancestor
101660645|NCT04512235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660646|NCT04512235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101660647|NCT04512235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101660648|NCT04512235|Alkylating Agents|alkylating agents|mesh-ancestor
101660649|NCT04512235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660650|NCT04512235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660651|NCT04512235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101660652|NCT04512235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101660653|NCT04512235|Antiemetics|antiemetics|mesh-ancestor
101660654|NCT04512235|Autonomic Agents|autonomic agents|mesh-ancestor
101660655|NCT04512235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101660656|NCT04512235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101660657|NCT04512235|Glucocorticoids|glucocorticoids|mesh-ancestor
101660658|NCT04512235|Hormones|hormones|mesh-ancestor
101660659|NCT04512235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101660660|NCT04512235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101660661|NCT04479306|Osimertinib|osimertinib|mesh-list
101660662|NCT04479306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660663|NCT04479306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101660664|NCT04479306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101660665|NCT04479306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660666|NCT04474353|Temozolomide|temozolomide|mesh-list
101660667|NCT04474353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101660668|NCT04474353|Alkylating Agents|alkylating agents|mesh-ancestor
101660669|NCT04474353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660670|NCT04474353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660671|NCT04468984|Navitoclax|navitoclax|mesh-list
101660672|NCT04468984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660673|NCT04449952|Listerine|listerine|mesh-list
101660674|NCT04449952|Sodium Fluoride|sodium fluoride|mesh-list
101660675|NCT04449952|Cariostatic Agents|cariostatic agents|mesh-ancestor
101660676|NCT04449952|Protective Agents|protective agents|mesh-ancestor
101660677|NCT04449952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660678|NCT04449952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101660679|NCT04449952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101660685|NCT04419389|Rituximab|rituximab|mesh-list
101660686|NCT04419389|Venetoclax|venetoclax|mesh-list
101660687|NCT04419389|Acalabrutinib|acalabrutinib|mesh-list
101660688|NCT04419389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101660689|NCT04419389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660690|NCT04419389|Immunologic Factors|immunologic factors|mesh-ancestor
101660691|NCT04419389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660692|NCT04419389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101660693|NCT04410991|Teriflunomide|teriflunomide|mesh-list
101660694|NCT04410991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101660695|NCT04410991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101660696|NCT04410991|Analgesics|analgesics|mesh-ancestor
101660697|NCT04410991|Sensory System Agents|sensory system agents|mesh-ancestor
101660699|NCT04410991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660700|NCT04410991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101660701|NCT04410991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101660702|NCT04410991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101660703|NCT04410991|Immunologic Factors|immunologic factors|mesh-ancestor
101660704|NCT04410978|Teriflunomide|teriflunomide|mesh-list
101660705|NCT04410978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101660706|NCT04410978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101660707|NCT04410978|Analgesics|analgesics|mesh-ancestor
101660708|NCT04410978|Sensory System Agents|sensory system agents|mesh-ancestor
101660709|NCT04410978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101660710|NCT04410978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660711|NCT04410978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101660712|NCT04410978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101660713|NCT04410978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101660714|NCT04410978|Immunologic Factors|immunologic factors|mesh-ancestor
101660715|NCT04405349|Atezolizumab|atezolizumab|mesh-list
101660716|NCT04405349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101660717|NCT04405349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660718|NCT04405349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101660719|NCT04405349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660720|NCT04373707|Enoxaparin|enoxaparin|mesh-list
101660721|NCT04373707|Dalteparin|dalteparin|mesh-list
101660722|NCT04373707|Tinzaparin|tinzaparin|mesh-list
101660723|NCT04373707|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101660724|NCT04373707|Nadroparin|nadroparin|mesh-list
101660725|NCT04373707|Enoxaparin sodium|enoxaparin sodium|mesh-list
101660726|NCT04373707|Anticoagulants|anticoagulants|mesh-ancestor
101660727|NCT04373707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101660728|NCT04373707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101660729|NCT04373707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660730|NCT04335383|Antibodies|antibodies|mesh-list
101660731|NCT04335383|Immunologic Factors|immunologic factors|mesh-ancestor
101660732|NCT04335383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660733|NCT04334759|Cisplatin|cisplatin|mesh-list
101660734|NCT04334759|Carboplatin|carboplatin|mesh-list
101660735|NCT04334759|Nivolumab|nivolumab|mesh-list
101660736|NCT04334759|Pemetrexed|pemetrexed|mesh-list
101660737|NCT04334759|Ipilimumab|ipilimumab|mesh-list
101660738|NCT04334759|Durvalumab|durvalumab|mesh-list
101660739|NCT04334759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660740|NCT04334759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101660741|NCT04334759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101660742|NCT04334759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660743|NCT04334759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101660744|NCT04334759|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101660745|NCT04334759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101660750|NCT04267939|Niraparib|niraparib|mesh-list
101660751|NCT04267939|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101660752|NCT04267939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101660753|NCT04267939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660754|NCT04267939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660760|NCT04211259|Loratadine|loratadine|mesh-list
101660761|NCT04211259|Antipruritics|antipruritics|mesh-ancestor
101660762|NCT04211259|Dermatologic Agents|dermatologic agents|mesh-ancestor
101660763|NCT04211259|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101660764|NCT04211259|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101660765|NCT04211259|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101660766|NCT04211259|Histamine Antagonists|histamine antagonists|mesh-ancestor
101660767|NCT04211259|Histamine Agents|histamine agents|mesh-ancestor
101660768|NCT04211259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101660769|NCT04211259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660770|NCT04211259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660771|NCT04158258|Bevacizumab|bevacizumab|mesh-list
101660772|NCT04158258|Trastuzumab|trastuzumab|mesh-list
101660773|NCT04158258|Atezolizumab|atezolizumab|mesh-list
101660776|NCT04158258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101660777|NCT04158258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660778|NCT04158258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101660779|NCT04158258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101660780|NCT04158258|Growth Substances|growth substances|mesh-ancestor
101660781|NCT04158258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660782|NCT04158258|Growth Inhibitors|growth inhibitors|mesh-ancestor
101660783|NCT04158258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101660784|NCT04158258|Antimetabolites|antimetabolites|mesh-ancestor
101660785|NCT04158258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660786|NCT04158258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101660788|NCT04154189|Ifosfamide|ifosfamide|mesh-list
101660789|NCT04154189|Lenvatinib|lenvatinib|mesh-list
101660790|NCT04154189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101660791|NCT04154189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660792|NCT04154189|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101660793|NCT04154189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101660794|NCT04154189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101660795|NCT04154189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660796|NCT04154189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101660797|NCT04154189|Alkylating Agents|alkylating agents|mesh-ancestor
101660798|NCT04154189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101660799|NCT04152161|BCG Vaccine|bcg vaccine|mesh-list
101660800|NCT04152161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101660801|NCT04152161|Immunologic Factors|immunologic factors|mesh-ancestor
101660802|NCT04152161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660803|NCT04116320|Poly ICLC|poly iclc|mesh-list
101660804|NCT04116320|Interferon Inducers|interferon inducers|mesh-ancestor
101660805|NCT04116320|Immunologic Factors|immunologic factors|mesh-ancestor
101660806|NCT04116320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660807|NCT04094311|Tisagenlecleucel|tisagenlecleucel|mesh-list
101660808|NCT04094311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101660809|NCT04094311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660810|NCT04034056|Obinutuzumab|obinutuzumab|mesh-list
101660811|NCT04034056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101660812|NCT04034056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660813|NCT04008355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101660814|NCT03994601|Nivolumab|nivolumab|mesh-list
101660815|NCT03994601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101660816|NCT03994601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660817|NCT03994601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101660818|NCT03994601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660819|NCT03964727|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
101660820|NCT03964727|Immunoconjugates|immunoconjugates|mesh-ancestor
101660821|NCT03964727|Immunologic Factors|immunologic factors|mesh-ancestor
101660822|NCT03964727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660823|NCT03934905|Sulforaphane|sulforaphane|mesh-list
101660824|NCT03934905|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101660825|NCT03934905|Protective Agents|protective agents|mesh-ancestor
101660826|NCT03934905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660827|NCT03934905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660828|NCT03916263|Metformin|metformin|mesh-list
101660829|NCT03916263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101660830|NCT03916263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660831|NCT03889418|Analgesics, Opioid|analgesics, opioid|mesh-list
101660832|NCT03889418|Narcotics|narcotics|mesh-ancestor
101660833|NCT03889418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101660834|NCT03889418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660835|NCT03889418|Analgesics|analgesics|mesh-ancestor
101660836|NCT03889418|Sensory System Agents|sensory system agents|mesh-ancestor
101660837|NCT03889418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101660838|NCT03856658|Floxuridine|floxuridine|mesh-list
101660839|NCT03856658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101660840|NCT03856658|Antimetabolites|antimetabolites|mesh-ancestor
101660841|NCT03856658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660842|NCT03856658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660843|NCT03788694|Ketamine|ketamine|mesh-list
101660844|NCT03788694|Analgesics|analgesics|mesh-ancestor
101660845|NCT03788694|Sensory System Agents|sensory system agents|mesh-ancestor
101660846|NCT03788694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101660847|NCT03788694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660848|NCT03788694|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101660849|NCT03788694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101660850|NCT03788694|Anesthetics, General|anesthetics, general|mesh-ancestor
101660851|NCT03788694|Anesthetics|anesthetics|mesh-ancestor
101660852|NCT03788694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101660853|NCT03788694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101660854|NCT03788694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101660855|NCT03788694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101660856|NCT03788694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660857|NCT03749109|Quinagolide|quinagolide|mesh-list
101660858|NCT03749109|Dopamine Agonists|dopamine agonists|mesh-ancestor
101660859|NCT03749109|Dopamine Agents|dopamine agents|mesh-ancestor
101660860|NCT03749109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101660861|NCT03749109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660862|NCT03749109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660863|NCT03742102|Paclitaxel|paclitaxel|mesh-list
101660864|NCT03742102|Trastuzumab|trastuzumab|mesh-list
101660865|NCT03742102|Durvalumab|durvalumab|mesh-list
101660866|NCT03742102|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
101660867|NCT03742102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101660868|NCT03742102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660869|NCT03742102|Tubulin Modulators|tubulin modulators|mesh-ancestor
101660870|NCT03742102|Antimitotic Agents|antimitotic agents|mesh-ancestor
101660871|NCT03742102|Mitosis Modulators|mitosis modulators|mesh-ancestor
101660872|NCT03742102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660873|NCT03742102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101660874|NCT03742102|Immunoconjugates|immunoconjugates|mesh-ancestor
101660875|NCT03742102|Immunologic Factors|immunologic factors|mesh-ancestor
101660876|NCT03742102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660877|NCT03726879|Paclitaxel|paclitaxel|mesh-list
101660878|NCT03726879|Maytansine|maytansine|mesh-list
101660879|NCT03726879|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101660880|NCT03726879|Cyclophosphamide|cyclophosphamide|mesh-list
101660881|NCT03726879|Doxorubicin|doxorubicin|mesh-list
101660882|NCT03726879|Trastuzumab|trastuzumab|mesh-list
101660883|NCT03726879|Atezolizumab|atezolizumab|mesh-list
101660884|NCT03726879|Pertuzumab|pertuzumab|mesh-list
101660885|NCT03726879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101660886|NCT03726879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660887|NCT03726879|Tubulin Modulators|tubulin modulators|mesh-ancestor
101660888|NCT03726879|Antimitotic Agents|antimitotic agents|mesh-ancestor
101660889|NCT03726879|Mitosis Modulators|mitosis modulators|mesh-ancestor
101660890|NCT03726879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660891|NCT03726879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101660892|NCT03726879|Immunologic Factors|immunologic factors|mesh-ancestor
101660893|NCT03726879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660894|NCT03726879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101660895|NCT03726879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101660896|NCT03726879|Alkylating Agents|alkylating agents|mesh-ancestor
101660897|NCT03726879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101660898|NCT03726879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101660899|NCT03726879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101660900|NCT03726879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101660901|NCT03726879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101660902|NCT03726879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101660903|NCT03726879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101660904|NCT03726879|Immunotoxins|immunotoxins|mesh-ancestor
101660905|NCT03726879|Immunoconjugates|immunoconjugates|mesh-ancestor
101660906|NCT03709706|Pembrolizumab|pembrolizumab|mesh-list
101660907|NCT03709706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101660908|NCT03709706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660909|NCT03709706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101660910|NCT03709706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660911|NCT03682068|Carboplatin|carboplatin|mesh-list
101660912|NCT03682068|Gemcitabine|gemcitabine|mesh-list
101660913|NCT03682068|Durvalumab|durvalumab|mesh-list
101660914|NCT03682068|Tremelimumab|tremelimumab|mesh-list
101660915|NCT03682068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660916|NCT03682068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101660918|NCT03682068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660919|NCT03682068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101660920|NCT03653832|Clonidine|clonidine|mesh-list
101660921|NCT03653832|Dexmedetomidine|dexmedetomidine|mesh-list
101660922|NCT03653832|Propofol|propofol|mesh-list
101660923|NCT03653832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101660924|NCT03653832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101660925|NCT03653832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660926|NCT03653832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101660927|NCT03653832|Analgesics|analgesics|mesh-ancestor
101660928|NCT03653832|Sensory System Agents|sensory system agents|mesh-ancestor
101660929|NCT03653832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101660930|NCT03653832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101660931|NCT03653832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101660932|NCT03653832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101660933|NCT03653832|Adrenergic Agents|adrenergic agents|mesh-ancestor
101660934|NCT03653832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101660935|NCT03653832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660936|NCT03653832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101660937|NCT03653832|Anesthetics, General|anesthetics, general|mesh-ancestor
101660938|NCT03653832|Anesthetics|anesthetics|mesh-ancestor
101660939|NCT03653832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101660943|NCT03599245|Immunologic Factors|immunologic factors|mesh-ancestor
101660944|NCT03599245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660946|NCT03565991|Talazoparib|talazoparib|mesh-list
101660947|NCT03565991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101660948|NCT03565991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660949|NCT03565991|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101660950|NCT03565991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101660951|NCT03565991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660952|NCT03555188|Ondansetron|ondansetron|mesh-list
101660953|NCT03555188|Antiemetics|antiemetics|mesh-ancestor
101660954|NCT03555188|Autonomic Agents|autonomic agents|mesh-ancestor
101660955|NCT03555188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101660956|NCT03555188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660957|NCT03555188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101660958|NCT03555188|Antipruritics|antipruritics|mesh-ancestor
101660959|NCT03555188|Dermatologic Agents|dermatologic agents|mesh-ancestor
101660960|NCT03555188|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101660961|NCT03555188|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101660962|NCT03555188|Serotonin Agents|serotonin agents|mesh-ancestor
101660963|NCT03555188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101660964|NCT03555188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660965|NCT03547973|Carboplatin|carboplatin|mesh-list
101660966|NCT03547973|Gemcitabine|gemcitabine|mesh-list
101660967|NCT03547973|Pembrolizumab|pembrolizumab|mesh-list
101660968|NCT03547973|Avelumab|avelumab|mesh-list
101660969|NCT03547973|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
101660970|NCT03547973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660971|NCT03547973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101660972|NCT03547973|Antimetabolites|antimetabolites|mesh-ancestor
101660973|NCT03547973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660974|NCT03547973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101660975|NCT03547973|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101660976|NCT03547973|Immunoconjugates|immunoconjugates|mesh-ancestor
101660977|NCT03547973|Immunologic Factors|immunologic factors|mesh-ancestor
101660978|NCT03547973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101660979|NCT03547115|Venetoclax|venetoclax|mesh-list
101660980|NCT03547115|Voruciclib|voruciclib|mesh-list
101660981|NCT03547115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101660982|NCT03547115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101660983|NCT03547115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101660984|NCT03547115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101660988|NCT03497689|Treprostinil|treprostinil|mesh-list
101660989|NCT03497689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101660991|NCT03492437|Dabigatran|dabigatran|mesh-list
101660992|NCT03492437|Antithrombins|antithrombins|mesh-ancestor
101661000|NCT03473756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101661001|NCT03473756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661002|NCT03473756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101661003|NCT03473756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101661004|NCT03471182|Cocaine|cocaine|mesh-list
101661005|NCT03471182|Anesthetics, Local|anesthetics, local|mesh-ancestor
101661006|NCT03471182|Anesthetics|anesthetics|mesh-ancestor
101661007|NCT03471182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101661008|NCT03471182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661009|NCT03471182|Sensory System Agents|sensory system agents|mesh-ancestor
101661010|NCT03471182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101661011|NCT03471182|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101661012|NCT03471182|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101661013|NCT03471182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101661014|NCT03471182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101661015|NCT03471182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661016|NCT03471182|Dopamine Agents|dopamine agents|mesh-ancestor
101318198|NCT00006002|Hormones|hormones|mesh-ancestor
101661018|NCT03466294|Azacitidine|azacitidine|mesh-list
101661019|NCT03466294|Venetoclax|venetoclax|mesh-list
101661020|NCT03466294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101661021|NCT03466294|Antimetabolites|antimetabolites|mesh-ancestor
101661022|NCT03466294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661023|NCT03466294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101661024|NCT03466294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101661031|NCT03363867|Bevacizumab|bevacizumab|mesh-list
101661032|NCT03363867|Atezolizumab|atezolizumab|mesh-list
101661033|NCT03363867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101661034|NCT03363867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101661035|NCT03363867|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101661036|NCT03363867|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101661037|NCT03363867|Growth Substances|growth substances|mesh-ancestor
101661038|NCT03363867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661039|NCT03363867|Growth Inhibitors|growth inhibitors|mesh-ancestor
101661040|NCT03363867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101661041|NCT03363867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661042|NCT03310125|Colchicine|colchicine|mesh-list
101661043|NCT03310125|Gout Suppressants|gout suppressants|mesh-ancestor
101661044|NCT03310125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101661045|NCT03310125|Tubulin Modulators|tubulin modulators|mesh-ancestor
101661046|NCT03310125|Antimitotic Agents|antimitotic agents|mesh-ancestor
101661047|NCT03310125|Mitosis Modulators|mitosis modulators|mesh-ancestor
101661048|NCT03310125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661049|NCT03310125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101661050|NCT03252938|Avelumab|avelumab|mesh-list
101661051|NCT03252938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101661052|NCT03252938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101661053|NCT03206060|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101661054|NCT03206060|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101661055|NCT03206060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661057|NCT03193853|Serabelisib|serabelisib|mesh-list
101661058|NCT03193853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101661059|NCT03193853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101661060|NCT03193853|Tubulin Modulators|tubulin modulators|mesh-ancestor
101661061|NCT03193853|Antimitotic Agents|antimitotic agents|mesh-ancestor
101661062|NCT03193853|Mitosis Modulators|mitosis modulators|mesh-ancestor
101661063|NCT03193853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661064|NCT03193853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101661065|NCT03191084|Dronabinol|dronabinol|mesh-list
101661066|NCT03191084|Hallucinogens|hallucinogens|mesh-ancestor
101661067|NCT03191084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661068|NCT03191084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101661069|NCT03191084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101661070|NCT03191084|Analgesics|analgesics|mesh-ancestor
101661071|NCT03191084|Sensory System Agents|sensory system agents|mesh-ancestor
101661072|NCT03191084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101661073|NCT03191084|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101661074|NCT03191084|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101661075|NCT03191084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101661076|NCT03191084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661077|NCT03191084|Hormones|hormones|mesh-ancestor
101661078|NCT03191084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101661079|NCT03190915|Trametinib|trametinib|mesh-list
101661080|NCT03190915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101661081|NCT03190915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101661082|NCT03190915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101661083|NCT03190915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661084|NCT03006172|Metformin|metformin|mesh-list
101661085|NCT03006172|Trastuzumab|trastuzumab|mesh-list
101661086|NCT03006172|Pertuzumab|pertuzumab|mesh-list
101661087|NCT03006172|Letrozole|letrozole|mesh-list
101661088|NCT03006172|Fulvestrant|fulvestrant|mesh-list
101661089|NCT03006172|Palbociclib|palbociclib|mesh-list
101661090|NCT03006172|Inavolisib|inavolisib|mesh-list
101661091|NCT03006172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101661092|NCT03006172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661093|NCT03006172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101661094|NCT03006172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101661095|NCT03006172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101661096|NCT03006172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101661097|NCT03006172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101661098|NCT03006172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661099|NCT03006172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101661100|NCT03006172|Hormone Antagonists|hormone antagonists|mesh-ancestor
101661101|NCT03006172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101661102|NCT03006172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101661103|NCT03006172|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101661104|NCT03006172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101661105|NCT03006172|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
101661107|NCT03005366|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101661108|NCT03005366|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101661109|NCT03005366|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101661110|NCT03005366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101661111|NCT03005366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661112|NCT02922764|Carboplatin|carboplatin|mesh-list
101661113|NCT02922764|Docetaxel|docetaxel|mesh-list
101661114|NCT02922764|Pembrolizumab|pembrolizumab|mesh-list
101661115|NCT02922764|Pemetrexed|pemetrexed|mesh-list
101661116|NCT02922764|Ipilimumab|ipilimumab|mesh-list
101661117|NCT02922764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101661118|NCT02922764|Tubulin Modulators|tubulin modulators|mesh-ancestor
101661119|NCT02922764|Antimitotic Agents|antimitotic agents|mesh-ancestor
101661120|NCT02922764|Mitosis Modulators|mitosis modulators|mesh-ancestor
101661121|NCT02922764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661122|NCT02922764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101661123|NCT02922764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101661124|NCT02922764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101661125|NCT02922764|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101661126|NCT02922764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101661127|NCT02738866|Fulvestrant|fulvestrant|mesh-list
101661128|NCT02738866|Palbociclib|palbociclib|mesh-list
101661129|NCT02738866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101661130|NCT02738866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101661131|NCT02738866|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101661132|NCT02738866|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101661133|NCT02738866|Hormone Antagonists|hormone antagonists|mesh-ancestor
101661134|NCT02738866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101661135|NCT02738866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661136|NCT02738866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101661138|NCT02738866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661139|NCT02576912|Dronabinol|dronabinol|mesh-list
101661140|NCT02576912|Hallucinogens|hallucinogens|mesh-ancestor
101661141|NCT02576912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661142|NCT02576912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101661143|NCT02576912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101661144|NCT02576912|Analgesics|analgesics|mesh-ancestor
101661145|NCT02576912|Sensory System Agents|sensory system agents|mesh-ancestor
101661146|NCT02576912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101661147|NCT02576912|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101661148|NCT02576912|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101661149|NCT02576912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101661150|NCT02576912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661151|NCT02576912|Hormones|hormones|mesh-ancestor
101661152|NCT02576912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101661153|NCT02232152|Thioctic Acid|thioctic acid|mesh-list
101661154|NCT02232152|Fluorouracil|fluorouracil|mesh-list
101661155|NCT02232152|Antimetabolites|antimetabolites|mesh-ancestor
101661156|NCT02232152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661157|NCT02232152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101661158|NCT02232152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101661159|NCT02232152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101661160|NCT02232152|Immunologic Factors|immunologic factors|mesh-ancestor
101661161|NCT02232152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318336|NCT00016315|Antimetabolites|antimetabolites|mesh-ancestor
101661163|NCT02232152|Protective Agents|protective agents|mesh-ancestor
101661164|NCT02232152|Vitamin B Complex|vitamin b complex|mesh-ancestor
101661165|NCT02232152|Vitamins|vitamins|mesh-ancestor
101661166|NCT02232152|Micronutrients|micronutrients|mesh-ancestor
101661167|NCT02211755|Bortezomib|bortezomib|mesh-list
101661168|NCT02211755|Clofarabine|clofarabine|mesh-list
101661169|NCT02211755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101661170|NCT02211755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101661171|NCT02211755|Antimetabolites|antimetabolites|mesh-ancestor
101661172|NCT02211755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661173|NCT02203526|Cytarabine|cytarabine|mesh-list
101661174|NCT02203526|Isavuconazole|isavuconazole|mesh-list
101661175|NCT02203526|Rituximab|rituximab|mesh-list
101661176|NCT02203526|Methotrexate|methotrexate|mesh-list
101661177|NCT02203526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101661178|NCT02203526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101661179|NCT02203526|Immunologic Factors|immunologic factors|mesh-ancestor
101661180|NCT02203526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661181|NCT02203526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101661182|NCT02203526|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101661183|NCT02203526|Abortifacient Agents|abortifacient agents|mesh-ancestor
101661184|NCT02203526|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101661185|NCT02203526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101661186|NCT02203526|Antimetabolites|antimetabolites|mesh-ancestor
101661187|NCT02203526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661188|NCT02203526|Dermatologic Agents|dermatologic agents|mesh-ancestor
101661189|NCT02203526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101661190|NCT02203526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101661191|NCT02203526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101661192|NCT02203526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101661193|NCT02203526|Antiviral Agents|antiviral agents|mesh-ancestor
101661194|NCT02203526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101661195|NCT02203526|Antifungal Agents|antifungal agents|mesh-ancestor
101661196|NCT02127073|Oxytocin|oxytocin|mesh-list
101661197|NCT02127073|Oxytocics|oxytocics|mesh-ancestor
101661198|NCT02127073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101661199|NCT02127073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661200|NCT02102113|Dronabinol|dronabinol|mesh-list
101661201|NCT02102113|Hallucinogens|hallucinogens|mesh-ancestor
101661202|NCT02102113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661203|NCT02102113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101661204|NCT02102113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101661205|NCT02102113|Analgesics|analgesics|mesh-ancestor
101661206|NCT02102113|Sensory System Agents|sensory system agents|mesh-ancestor
101661207|NCT02102113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101661208|NCT02102113|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101661209|NCT02102113|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101661210|NCT02102113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101661211|NCT02102113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661212|NCT02102113|Hormones|hormones|mesh-ancestor
101661213|NCT02102113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101661214|NCT02070705|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
101661215|NCT02070705|Hematinics|hematinics|mesh-ancestor
101661216|NCT02070705|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101661217|NCT02070705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101661218|NCT01980355|Tranexamic Acid|tranexamic acid|mesh-list
101661219|NCT01980355|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101661220|NCT01980355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101661221|NCT01980355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661222|NCT01980355|Hemostatics|hemostatics|mesh-ancestor
101661223|NCT01980355|Coagulants|coagulants|mesh-ancestor
101661224|NCT01950520|Topiramate|topiramate|mesh-list
101661225|NCT01950520|Phentermine|phentermine|mesh-list
101661226|NCT01950520|Magnesium Sulfate|magnesium sulfate|mesh-list
101661227|NCT01950520|Propranolol|propranolol|mesh-list
101661229|NCT01950520|Naltrexone|naltrexone|mesh-list
101661230|NCT01950520|Caffeine|caffeine|mesh-list
101661231|NCT01950520|Dantrolene|dantrolene|mesh-list
101661232|NCT01950520|Mirabegron|mirabegron|mesh-list
101661233|NCT01950520|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101661234|NCT01950520|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101661236|NCT01950520|Sensory System Agents|sensory system agents|mesh-ancestor
101661237|NCT01950520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101661238|NCT01950520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101661239|NCT01950520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101661240|NCT01950520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101661241|NCT01950520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661242|NCT01950520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101661243|NCT01950520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101661244|NCT01950520|Purinergic Agents|purinergic agents|mesh-ancestor
101661245|NCT01950520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101661247|NCT01950520|Anesthetics|anesthetics|mesh-ancestor
101661248|NCT01950520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101661249|NCT01950520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101661250|NCT01950520|Anticonvulsants|anticonvulsants|mesh-ancestor
101661251|NCT01950520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101661252|NCT01950520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101661253|NCT01950520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101661254|NCT01950520|Tocolytic Agents|tocolytic agents|mesh-ancestor
101661255|NCT01950520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101661256|NCT01950520|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101661257|NCT01950520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101661258|NCT01950520|Adrenergic Agents|adrenergic agents|mesh-ancestor
101661259|NCT01950520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101661260|NCT01950520|Vasodilator Agents|vasodilator agents|mesh-ancestor
101661261|NCT01950520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101661262|NCT01950520|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101661263|NCT01950520|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101661264|NCT01950520|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101661265|NCT01950520|Urological Agents|urological agents|mesh-ancestor
101661266|NCT01950520|Appetite Depressants|appetite depressants|mesh-ancestor
101661267|NCT01950520|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101661268|NCT01950520|Sympathomimetics|sympathomimetics|mesh-ancestor
101661269|NCT01950520|Autonomic Agents|autonomic agents|mesh-ancestor
101661270|NCT01950520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101661271|NCT01950520|Serotonin Agents|serotonin agents|mesh-ancestor
101661272|NCT01950520|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101661273|NCT01950520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101661274|NCT01771107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101661275|NCT01771107|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101661276|NCT01771107|Doxorubicin|doxorubicin|mesh-list
101661277|NCT01771107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101661278|NCT01771107|Dacarbazine|dacarbazine|mesh-list
101661279|NCT01771107|Vinblastine|vinblastine|mesh-list
101661280|NCT01771107|Antibodies|antibodies|mesh-list
101661281|NCT01771107|Immunoglobulins|immunoglobulins|mesh-list
101661282|NCT01771107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101661283|NCT01771107|Imidazole|imidazole|mesh-list
101661284|NCT01771107|Immunoconjugates|immunoconjugates|mesh-list
101661285|NCT01771107|Immunologic Factors|immunologic factors|mesh-ancestor
101661286|NCT01771107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661287|NCT01771107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101661288|NCT01771107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101661289|NCT01771107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101661290|NCT01771107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101661291|NCT01771107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101661292|NCT01771107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661293|NCT01771107|Immunotoxins|immunotoxins|mesh-ancestor
101661294|NCT01771107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101661295|NCT01771107|Alkylating Agents|alkylating agents|mesh-ancestor
101661296|NCT01771107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101661297|NCT01771107|Tubulin Modulators|tubulin modulators|mesh-ancestor
101661298|NCT01771107|Antimitotic Agents|antimitotic agents|mesh-ancestor
101661299|NCT01771107|Mitosis Modulators|mitosis modulators|mesh-ancestor
101661301|NCT01758432|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101661302|NCT01758432|Antithrombins|antithrombins|mesh-ancestor
101661303|NCT01758432|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101661304|NCT01758432|Protease Inhibitors|protease inhibitors|mesh-ancestor
101661305|NCT01758432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101661306|NCT01758432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661307|NCT01758432|Anticoagulants|anticoagulants|mesh-ancestor
101661308|NCT01583218|Enoxaparin|enoxaparin|mesh-list
101661309|NCT01583218|Betrixaban|betrixaban|mesh-list
101661310|NCT01583218|Anticoagulants|anticoagulants|mesh-ancestor
101661311|NCT01583218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101661312|NCT01583218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101661313|NCT01583218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661314|NCT01583218|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101318509|NCT00371059|Memantine|memantine|mesh-list
101661315|NCT01583218|Antithrombins|antithrombins|mesh-ancestor
101661316|NCT01583218|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101661317|NCT01583218|Protease Inhibitors|protease inhibitors|mesh-ancestor
101661318|NCT01583218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101661319|NCT00742859|Warfarin|warfarin|mesh-list
101661320|NCT00742859|Acenocoumarol|acenocoumarol|mesh-list
101661321|NCT00742859|Betrixaban|betrixaban|mesh-list
101661322|NCT00742859|Anticoagulants|anticoagulants|mesh-ancestor
101661323|NCT00742859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101661324|NCT00742859|Antithrombins|antithrombins|mesh-ancestor
101661325|NCT00742859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101661326|NCT00742859|Protease Inhibitors|protease inhibitors|mesh-ancestor
101661327|NCT00742859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101661328|NCT00742859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661329|NCT00667342|Bevacizumab|bevacizumab|mesh-list
101661330|NCT00667342|Doxorubicin|doxorubicin|mesh-list
101661331|NCT00667342|Methotrexate|methotrexate|mesh-list
101661332|NCT00667342|Etoposide|etoposide|mesh-list
101661333|NCT00667342|Ifosfamide|ifosfamide|mesh-list
101661334|NCT00667342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101661335|NCT00667342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101661336|NCT00667342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101661337|NCT00667342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101661338|NCT00667342|Growth Substances|growth substances|mesh-ancestor
101661339|NCT00667342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661340|NCT00667342|Growth Inhibitors|growth inhibitors|mesh-ancestor
101661341|NCT00667342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101661342|NCT00667342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101661343|NCT00667342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101661344|NCT00667342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101661345|NCT00667342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661346|NCT00667342|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101661347|NCT00667342|Abortifacient Agents|abortifacient agents|mesh-ancestor
101661348|NCT00667342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101661349|NCT00667342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101661350|NCT00667342|Antimetabolites|antimetabolites|mesh-ancestor
101661351|NCT00667342|Dermatologic Agents|dermatologic agents|mesh-ancestor
101661352|NCT00667342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101661353|NCT00667342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101661354|NCT00667342|Immunologic Factors|immunologic factors|mesh-ancestor
101661355|NCT00667342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101661356|NCT00667342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101661357|NCT00667342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101661358|NCT00667342|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101661359|NCT00667342|Alkylating Agents|alkylating agents|mesh-ancestor
101661360|NCT00375609|Enoxaparin|enoxaparin|mesh-list
101661361|NCT00375609|Betrixaban|betrixaban|mesh-list
101661362|NCT00375609|Anticoagulants|anticoagulants|mesh-ancestor
101661363|NCT00375609|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101661364|NCT00375609|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101661365|NCT00375609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661366|NCT00375609|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101661367|NCT00375609|Antithrombins|antithrombins|mesh-ancestor
101661369|NCT00375609|Protease Inhibitors|protease inhibitors|mesh-ancestor
101661370|NCT00375609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101661371|NCT02545231|Pitavastatin|pitavastatin|mesh-list
101661372|NCT02545231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101661373|NCT02545231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101661374|NCT02545231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101661375|NCT02545231|Antimetabolites|antimetabolites|mesh-ancestor
101661376|NCT02545231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661377|NCT02545231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101661378|NCT02545231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101661379|NCT02803788|Dexamethasone|dexamethasone|mesh-list
101661380|NCT02803788|Ondansetron|ondansetron|mesh-list
101661381|NCT02803788|Ramosetron|ramosetron|mesh-list
101661382|NCT02803788|Antiemetics|antiemetics|mesh-list
101661383|NCT02803788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101661384|NCT02803788|Autonomic Agents|autonomic agents|mesh-ancestor
101661385|NCT02803788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101661386|NCT02803788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661387|NCT02803788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101661388|NCT02803788|Glucocorticoids|glucocorticoids|mesh-ancestor
101661389|NCT02803788|Hormones|hormones|mesh-ancestor
101661390|NCT02803788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101661391|NCT02803788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101661392|NCT02803788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101661393|NCT02803788|Antipruritics|antipruritics|mesh-ancestor
101661394|NCT02803788|Dermatologic Agents|dermatologic agents|mesh-ancestor
101661395|NCT02803788|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101661396|NCT02803788|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101661397|NCT02803788|Serotonin Agents|serotonin agents|mesh-ancestor
101661398|NCT02803788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101661399|NCT02803788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661400|NCT02610153|Vitamin K|vitamin k|mesh-list
101661401|NCT02610153|Vitamins|vitamins|mesh-ancestor
101661402|NCT02610153|Micronutrients|micronutrients|mesh-ancestor
101661403|NCT02610153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661404|NCT02610153|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101661405|NCT02610153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101661406|NCT02610153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661407|NCT02610153|Hemostatics|hemostatics|mesh-ancestor
101661408|NCT02610153|Coagulants|coagulants|mesh-ancestor
101661409|NCT00862693|Calcitriol|calcitriol|mesh-list
101661410|NCT00862693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101661411|NCT00862693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661412|NCT00862693|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101661413|NCT00862693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101661414|NCT00862693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661415|NCT00862693|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101661416|NCT00862693|Vitamins|vitamins|mesh-ancestor
101661417|NCT00862693|Micronutrients|micronutrients|mesh-ancestor
101661418|NCT00862693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101661419|NCT05757063|Dexmedetomidine|dexmedetomidine|mesh-list
101661420|NCT05757063|Propofol|propofol|mesh-list
101661421|NCT05757063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101661422|NCT05757063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101661423|NCT05757063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661424|NCT05757063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101661425|NCT05757063|Analgesics|analgesics|mesh-ancestor
101661426|NCT05757063|Sensory System Agents|sensory system agents|mesh-ancestor
101661427|NCT05757063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101825518|NCT00865085|Citalopram|citalopram|mesh-list
101661428|NCT05757063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101661429|NCT05757063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101661430|NCT05757063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101661431|NCT05757063|Adrenergic Agents|adrenergic agents|mesh-ancestor
101661432|NCT05757063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101661433|NCT05757063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661434|NCT05757063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101661435|NCT05757063|Anesthetics, General|anesthetics, general|mesh-ancestor
101661436|NCT05757063|Anesthetics|anesthetics|mesh-ancestor
101661437|NCT02799498|Etanercept|etanercept|mesh-list
101661438|NCT02799498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101661439|NCT02799498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101661440|NCT02799498|Analgesics|analgesics|mesh-ancestor
101661441|NCT02799498|Sensory System Agents|sensory system agents|mesh-ancestor
101661442|NCT02799498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101661443|NCT02799498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661444|NCT02799498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101661445|NCT02799498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101661446|NCT02799498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101661447|NCT02799498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101661448|NCT02799498|Immunologic Factors|immunologic factors|mesh-ancestor
101661449|NCT00617851|Vaccines|vaccines|mesh-list
101661450|NCT00617851|Immunologic Factors|immunologic factors|mesh-ancestor
101661451|NCT00617851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661452|NCT02806440|Naltrexone|naltrexone|mesh-list
101661453|NCT02806440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101661454|NCT02806440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101661455|NCT02806440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661456|NCT02806440|Sensory System Agents|sensory system agents|mesh-ancestor
101661457|NCT02806440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101661458|NCT00913809|Desipramine|desipramine|mesh-list
101661459|NCT00913809|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101661460|NCT00913809|Antidepressive Agents|antidepressive agents|mesh-ancestor
101661461|NCT00913809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101661462|NCT00913809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101661463|NCT00913809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661464|NCT00913809|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101661465|NCT00913809|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101661466|NCT00913809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101661467|NCT00913809|Adrenergic Agents|adrenergic agents|mesh-ancestor
101661468|NCT00913809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101661469|NCT00913809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661470|NCT02806362|Ritonavir|ritonavir|mesh-list
101661471|NCT02806362|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101661472|NCT02806362|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101661473|NCT02806362|Protease Inhibitors|protease inhibitors|mesh-ancestor
101661474|NCT02806362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101661475|NCT02806362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661476|NCT02806362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101661477|NCT02806362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101661478|NCT02806362|Antiviral Agents|antiviral agents|mesh-ancestor
101661479|NCT02806362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101661480|NCT02806362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101661481|NCT02806362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101661482|NCT00855049|Acetaminophen|acetaminophen|mesh-list
101661483|NCT00855049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101661484|NCT00855049|Analgesics|analgesics|mesh-ancestor
101661485|NCT00855049|Sensory System Agents|sensory system agents|mesh-ancestor
101661486|NCT00855049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101661487|NCT00855049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661489|NCT02799030|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101661490|NCT02799030|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101661491|NCT02799030|Dermatologic Agents|dermatologic agents|mesh-ancestor
101661492|NCT00812955|Simvastatin|simvastatin|mesh-list
101661493|NCT00812955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101661494|NCT00812955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101661495|NCT00812955|Antimetabolites|antimetabolites|mesh-ancestor
101661496|NCT00812955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661497|NCT00812955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101661498|NCT00812955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101661499|NCT00812955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101661500|NCT04235478|Triamcinolone|triamcinolone|mesh-list
101661501|NCT04235478|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101661502|NCT04235478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101661503|NCT04235478|Glucocorticoids|glucocorticoids|mesh-ancestor
101661504|NCT04235478|Hormones|hormones|mesh-ancestor
101661505|NCT04235478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101661506|NCT04235478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661507|NCT04235478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101661508|NCT04235478|Immunologic Factors|immunologic factors|mesh-ancestor
101661509|NCT00619489|Vedolizumab|vedolizumab|mesh-list
101661510|NCT00619489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101661511|NCT02806206|Prucalopride|prucalopride|mesh-list
101661512|NCT02806206|Laxatives|laxatives|mesh-ancestor
101661513|NCT02806206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101661514|NCT02806206|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101661515|NCT02806206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101661516|NCT02806206|Serotonin Agents|serotonin agents|mesh-ancestor
101661517|NCT02806206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101661518|NCT02806206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661519|NCT02806206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661521|NCT00855205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101661522|NCT00855205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101661523|NCT00855205|Immunologic Factors|immunologic factors|mesh-ancestor
101661524|NCT00855205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661525|NCT00855205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101661526|NCT00859807|Amodiaquine|amodiaquine|mesh-list
101661527|NCT00859807|Antimalarials|antimalarials|mesh-ancestor
101661528|NCT00859807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101661529|NCT00859807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101661530|NCT00859807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101661531|NCT00859885|Clopidogrel|clopidogrel|mesh-list
101661532|NCT00859885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661533|NCT00859885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661534|NCT00859885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101661535|NCT00859885|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101661536|NCT00859885|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101661537|NCT00859885|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101661538|NCT00859885|Purinergic Agents|purinergic agents|mesh-ancestor
101661539|NCT00859885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101661540|NCT02798874|Clopidogrel|clopidogrel|mesh-list
101661541|NCT02798874|Ticagrelor|ticagrelor|mesh-list
101318711|NCT00001533|Cyclosporins|cyclosporins|mesh-list
101661542|NCT02798874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101661543|NCT02798874|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101661544|NCT02798874|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101661545|NCT02798874|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101661546|NCT02798874|Purinergic Agents|purinergic agents|mesh-ancestor
101661547|NCT02798874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101661548|NCT02798874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661549|NCT02798874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661550|NCT02799264|Cabotegravir|cabotegravir|mesh-list
101661551|NCT02799264|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101661552|NCT02799264|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101661553|NCT02799264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101661554|NCT02799264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661555|NCT02799264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101661556|NCT02799264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101661557|NCT02799264|Antiviral Agents|antiviral agents|mesh-ancestor
101661558|NCT02799264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101661559|NCT00959699|Interferons|interferons|mesh-list
101661560|NCT00959699|Ribavirin|ribavirin|mesh-list
101661561|NCT00959699|Interferon-alpha|interferon-alpha|mesh-list
101661562|NCT00959699|Interferon alpha-2|interferon alpha-2|mesh-list
101661563|NCT00959699|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101661564|NCT00959699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101661565|NCT00959699|Antiviral Agents|antiviral agents|mesh-ancestor
101661566|NCT00959699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101661567|NCT00959699|Antimetabolites|antimetabolites|mesh-ancestor
101661568|NCT00959699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661569|NCT00959699|Immunologic Factors|immunologic factors|mesh-ancestor
101661570|NCT00959699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661571|NCT02806128|Kallikreins|kallikreins|mesh-list
101661572|NCT02806128|Coagulants|coagulants|mesh-ancestor
101661573|NCT02806128|Fertility Agents, Male|fertility agents, male|mesh-ancestor
101661574|NCT02806128|Fertility Agents|fertility agents|mesh-ancestor
101661575|NCT02806128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101661576|NCT02806128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661577|NCT00860119|Alprazolam|alprazolam|mesh-list
101661578|NCT00860119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101661579|NCT00860119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101661580|NCT00860119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661581|NCT00860119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101661582|NCT00860119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101661583|NCT00860119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101661585|NCT00860119|GABA Agents|gaba agents|mesh-ancestor
101661586|NCT00860119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101661587|NCT00860119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661588|NCT00855283|Glycopyrrolate|glycopyrrolate|mesh-list
101661589|NCT00855283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101661590|NCT00855283|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101661591|NCT00855283|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101661592|NCT00855283|Cholinergic Agents|cholinergic agents|mesh-ancestor
101661593|NCT00855283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101661594|NCT00855283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661595|NCT00855283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661597|NCT02805738|Antiviral Agents|antiviral agents|mesh-ancestor
101661598|NCT02805738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101661599|NCT02805738|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101661600|NCT02805738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101661601|NCT02805738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101661602|NCT02805738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661603|NCT02805738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101661604|NCT02805738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101661605|NCT00855361|Rabeprazole|rabeprazole|mesh-list
101661606|NCT00855361|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101661607|NCT00855361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101661608|NCT00855361|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101661609|NCT00855361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101661610|NCT00855361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661611|NCT02798406|Pembrolizumab|pembrolizumab|mesh-list
101661612|NCT02798406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101661613|NCT02798406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101661614|NCT02798406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101661615|NCT02798406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318804|NCT00017992|Ritonavir|ritonavir|mesh-list
101661616|NCT05550636|Midazolam|midazolam|mesh-list
101661618|NCT05550636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101661619|NCT05550636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101661620|NCT05550636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661621|NCT05550636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101661622|NCT05550636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101661623|NCT05550636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101661624|NCT05550636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101661625|NCT05550636|Anesthetics, General|anesthetics, general|mesh-ancestor
101661626|NCT05550636|Anesthetics|anesthetics|mesh-ancestor
101661627|NCT05550636|GABA Modulators|gaba modulators|mesh-ancestor
101661628|NCT05550636|GABA Agents|gaba agents|mesh-ancestor
101661629|NCT05550636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101661630|NCT05550636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661631|NCT02857829|Caffeine|caffeine|mesh-list
101661632|NCT02857829|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101661633|NCT02857829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661634|NCT02857829|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101661635|NCT02857829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101661636|NCT02857829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661637|NCT02857829|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101661638|NCT02857829|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101661639|NCT02857829|Purinergic Agents|purinergic agents|mesh-ancestor
101661640|NCT02857829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101661641|NCT00860275|Fluconazole|fluconazole|mesh-list
101661642|NCT00860275|Ketoconazole|ketoconazole|mesh-list
101661643|NCT00860275|BMS 708163|bms 708163|mesh-list
101661644|NCT00860275|Antifungal Agents|antifungal agents|mesh-ancestor
101661645|NCT00860275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101661646|NCT00860275|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101661647|NCT00860275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101661648|NCT00860275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101661649|NCT00860275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661650|NCT00860275|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101661651|NCT00860275|Hormone Antagonists|hormone antagonists|mesh-ancestor
101661652|NCT00860275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101661653|NCT00860275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661654|NCT00860275|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101661655|NCT00860275|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101661656|NCT00860275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101661657|NCT00860275|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101661659|NCT02798250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101661660|NCT02798250|Glucagon|glucagon|mesh-list
101661661|NCT02798250|Hormones|hormones|mesh-list
101661663|NCT02798250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661664|NCT02798250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101661665|NCT02798250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101661666|NCT00865111|Bupropion|bupropion|mesh-list
101661667|NCT00865111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101661668|NCT00865111|Antidepressive Agents|antidepressive agents|mesh-ancestor
101661669|NCT00865111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101661670|NCT00865111|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101661671|NCT00865111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101661672|NCT00865111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101661673|NCT00865111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661674|NCT00865111|Dopamine Agents|dopamine agents|mesh-ancestor
101661675|NCT00865111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101661676|NCT00865111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661677|NCT00865111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101825572|NCT04732182|Nootropic Agents|nootropic agents|mesh-ancestor
101661678|NCT00865111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101661679|NCT00865111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101661680|NCT02802696|Furosemide|furosemide|mesh-list
101661681|NCT02802696|Diuretics|diuretics|mesh-ancestor
101661682|NCT02802696|Natriuretic Agents|natriuretic agents|mesh-ancestor
101661683|NCT02802696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661684|NCT02802696|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101661685|NCT02802696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101661686|NCT02802696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661687|NCT00865267|Halobetasol|halobetasol|mesh-list
101661688|NCT00865267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101661689|NCT02798172|Metformin|metformin|mesh-list
101661690|NCT02798172|Alogliptin|alogliptin|mesh-list
101661691|NCT02798172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101661692|NCT02798172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661693|NCT02798172|Incretins|incretins|mesh-ancestor
101661694|NCT02798172|Hormones|hormones|mesh-ancestor
101661695|NCT02798172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101661696|NCT02798172|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101661697|NCT02798172|Protease Inhibitors|protease inhibitors|mesh-ancestor
101661698|NCT02798172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101661699|NCT02798172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661700|NCT00865423|Gabapentin|gabapentin|mesh-list
101661701|NCT00865423|Analgesics|analgesics|mesh-ancestor
101661702|NCT00865423|Sensory System Agents|sensory system agents|mesh-ancestor
101661703|NCT00865423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101661704|NCT00865423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661705|NCT00865423|Anticonvulsants|anticonvulsants|mesh-ancestor
101661706|NCT00865423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101661707|NCT00865423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101661708|NCT00865423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101661709|NCT00865423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101409332|NCT00144417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101661710|NCT00865423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101661711|NCT00865423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101661712|NCT00865423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101661713|NCT00865423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661714|NCT00865423|Antimanic Agents|antimanic agents|mesh-ancestor
101661715|NCT00955721|Gemcitabine|gemcitabine|mesh-list
101661716|NCT00955721|Oxaliplatin|oxaliplatin|mesh-list
101661717|NCT00955721|Sorafenib|sorafenib|mesh-list
101661718|NCT00955721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101661719|NCT00955721|Antimetabolites|antimetabolites|mesh-ancestor
101661720|NCT00955721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661721|NCT00955721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101661722|NCT00955721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101661723|NCT00955721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101661724|NCT02802540|Nabilone|nabilone|mesh-list
101661725|NCT02802540|Antiemetics|antiemetics|mesh-ancestor
101661726|NCT02802540|Autonomic Agents|autonomic agents|mesh-ancestor
101661727|NCT02802540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101661728|NCT02802540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661729|NCT02802540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101661730|NCT02802540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101661731|NCT02802540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101661732|NCT02802540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101661733|NCT02802540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101661734|NCT00865501|Spironolactone|spironolactone|mesh-list
101661735|NCT00865501|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101661736|NCT00865501|Hormone Antagonists|hormone antagonists|mesh-ancestor
101661737|NCT00865501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101661738|NCT00865501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661739|NCT00865501|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101661741|NCT00865501|Natriuretic Agents|natriuretic agents|mesh-ancestor
101661742|NCT02797704|Aflibercept|aflibercept|mesh-list
101661743|NCT02797704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101661744|NCT02797704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101661745|NCT02797704|Growth Substances|growth substances|mesh-ancestor
101661746|NCT02797704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661747|NCT02797704|Growth Inhibitors|growth inhibitors|mesh-ancestor
101661748|NCT02797704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101661749|NCT04281095|Botulinum Toxins|botulinum toxins|mesh-list
101661750|NCT04281095|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101661751|NCT04281095|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101661752|NCT04281095|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101661753|NCT04281095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101661754|NCT04281095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661755|NCT04281095|Cholinergic Agents|cholinergic agents|mesh-ancestor
101661756|NCT04281095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101661757|NCT04281095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661758|NCT04281095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101661759|NCT04281095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101661760|NCT00863161|Lesogaberan|lesogaberan|mesh-list
101661761|NCT00863161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101661762|NCT00863161|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101318939|NCT00392002|Esomeprazole|esomeprazole|mesh-list
101661763|NCT00863161|GABA Agonists|gaba agonists|mesh-ancestor
101661764|NCT00863161|GABA Agents|gaba agents|mesh-ancestor
101661765|NCT00863161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101661766|NCT00863161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661767|NCT00863161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661768|NCT00863239|Interferons|interferons|mesh-list
101661769|NCT00863239|Ribavirin|ribavirin|mesh-list
101661770|NCT00863239|Interferon-alpha|interferon-alpha|mesh-list
101661771|NCT00863239|Interferon alpha-2|interferon alpha-2|mesh-list
101661772|NCT00863239|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101661773|NCT00863239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101661774|NCT00863239|Antiviral Agents|antiviral agents|mesh-ancestor
101661775|NCT00863239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101661776|NCT00863239|Antimetabolites|antimetabolites|mesh-ancestor
101661777|NCT00863239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661778|NCT00863239|Immunologic Factors|immunologic factors|mesh-ancestor
101661779|NCT00863239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661780|NCT02802072|Aspirin|aspirin|mesh-list
101661781|NCT02802072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101661782|NCT02802072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101661783|NCT02802072|Analgesics|analgesics|mesh-ancestor
101661784|NCT02802072|Sensory System Agents|sensory system agents|mesh-ancestor
101661785|NCT02802072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101661786|NCT02802072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661787|NCT02802072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101661788|NCT02802072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101661789|NCT02802072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101661790|NCT02802072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101661791|NCT02802072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661792|NCT02802072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101661793|NCT02802072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101661794|NCT02802072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101661795|NCT02802072|Antipyretics|antipyretics|mesh-ancestor
101661796|NCT04276883|Dexmedetomidine|dexmedetomidine|mesh-list
101661797|NCT04276883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101661798|NCT04276883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101661799|NCT04276883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661800|NCT04276883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101661801|NCT04276883|Analgesics|analgesics|mesh-ancestor
101661802|NCT04276883|Sensory System Agents|sensory system agents|mesh-ancestor
101661803|NCT04276883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101661804|NCT04276883|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101661805|NCT04276883|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101661806|NCT04276883|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101661807|NCT04276883|Adrenergic Agents|adrenergic agents|mesh-ancestor
101661808|NCT04276883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101661809|NCT04276883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661810|NCT00865657|Alprazolam|alprazolam|mesh-list
101661811|NCT00865657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101661812|NCT00865657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101661813|NCT00865657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661814|NCT00865657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101661815|NCT00865657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101661816|NCT00865657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101661817|NCT00865657|GABA Modulators|gaba modulators|mesh-ancestor
101661818|NCT00865657|GABA Agents|gaba agents|mesh-ancestor
101661819|NCT00865657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101661820|NCT00865657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661821|NCT00863395|Lidocaine|lidocaine|mesh-list
101661822|NCT00863395|Anesthetics, Local|anesthetics, local|mesh-ancestor
101661823|NCT00863395|Anesthetics|anesthetics|mesh-ancestor
101661824|NCT00863395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101661825|NCT00863395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661826|NCT00863395|Sensory System Agents|sensory system agents|mesh-ancestor
101661827|NCT00863395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101661828|NCT00863395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101661829|NCT00863395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101661830|NCT00863395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101661831|NCT00863395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101661832|NCT00863395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661833|NCT02939183|Dexamethasone|dexamethasone|mesh-list
101661834|NCT02939183|Pomalidomide|pomalidomide|mesh-list
101661835|NCT02939183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101661836|NCT02939183|Antiemetics|antiemetics|mesh-ancestor
101661837|NCT02939183|Autonomic Agents|autonomic agents|mesh-ancestor
101661838|NCT02939183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101661839|NCT02939183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661840|NCT02939183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101661841|NCT02939183|Glucocorticoids|glucocorticoids|mesh-ancestor
101661842|NCT02939183|Hormones|hormones|mesh-ancestor
101661843|NCT02939183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101661844|NCT02939183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101661845|NCT02939183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101661847|NCT02939183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101661848|NCT02939183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101661849|NCT02939183|Growth Substances|growth substances|mesh-ancestor
101661850|NCT02939183|Growth Inhibitors|growth inhibitors|mesh-ancestor
101661851|NCT02801838|Morphine|morphine|mesh-list
101661852|NCT02801838|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101661853|NCT02801838|Narcotics|narcotics|mesh-ancestor
101661854|NCT02801838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101661855|NCT02801838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661856|NCT02801838|Analgesics|analgesics|mesh-ancestor
101661857|NCT02801838|Sensory System Agents|sensory system agents|mesh-ancestor
101661858|NCT02801838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101661859|NCT04276025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101661860|NCT04276025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101661861|NCT04276025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661862|NCT02797860|Rocuronium|rocuronium|mesh-list
101661863|NCT02797860|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101661864|NCT02797860|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101661865|NCT02797860|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101661866|NCT02797860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101661867|NCT02797860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661868|NCT00860899|Clonidine|clonidine|mesh-list
101661869|NCT00860899|Levobupivacaine|levobupivacaine|mesh-list
101661870|NCT00860899|Analgesics|analgesics|mesh-ancestor
101661871|NCT00860899|Sensory System Agents|sensory system agents|mesh-ancestor
101661872|NCT00860899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101661873|NCT00860899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661875|NCT00860899|Sympatholytics|sympatholytics|mesh-ancestor
101661876|NCT00860899|Autonomic Agents|autonomic agents|mesh-ancestor
101661877|NCT00860899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101661878|NCT00860899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101661879|NCT00860899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101661880|NCT00860899|Adrenergic Agents|adrenergic agents|mesh-ancestor
101661881|NCT00860899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101661882|NCT00860899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661883|NCT00860899|Anesthetics, Local|anesthetics, local|mesh-ancestor
101661884|NCT00860899|Anesthetics|anesthetics|mesh-ancestor
101661885|NCT00860899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101661886|NCT02797782|Antibodies|antibodies|mesh-list
101661887|NCT02797782|Immunologic Factors|immunologic factors|mesh-ancestor
101661888|NCT02797782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661889|NCT00863629|Insulin|insulin|mesh-list
101661890|NCT00863629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101661891|NCT00863629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661892|NCT00860977|Valacyclovir|valacyclovir|mesh-list
101661893|NCT00860977|Antiviral Agents|antiviral agents|mesh-ancestor
101661894|NCT00860977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101661895|NCT00865891|Nifedipine|nifedipine|mesh-list
101661896|NCT00865891|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101661897|NCT00865891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101661898|NCT00865891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661899|NCT00865891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101661900|NCT00865891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661901|NCT00865891|Vasodilator Agents|vasodilator agents|mesh-ancestor
101661902|NCT00865891|Tocolytic Agents|tocolytic agents|mesh-ancestor
101661903|NCT00865891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101661904|NCT02797236|Vaccines|vaccines|mesh-list
101661905|NCT02797236|Immunologic Factors|immunologic factors|mesh-ancestor
101661906|NCT02797236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661907|NCT00863785|Acetylcysteine|acetylcysteine|mesh-list
101661908|NCT00863785|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101661909|NCT00863785|Antiviral Agents|antiviral agents|mesh-ancestor
101661910|NCT00863785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101661911|NCT00863785|Expectorants|expectorants|mesh-ancestor
101661912|NCT00863785|Respiratory System Agents|respiratory system agents|mesh-ancestor
101661913|NCT00863785|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101661914|NCT00863785|Antioxidants|antioxidants|mesh-ancestor
101661915|NCT00863785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661916|NCT00863785|Protective Agents|protective agents|mesh-ancestor
101661917|NCT00863785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661918|NCT00863785|Antidotes|antidotes|mesh-ancestor
101661919|NCT02801526|Amlodipine|amlodipine|mesh-list
101661920|NCT02801526|Candesartan|candesartan|mesh-list
101661921|NCT02801526|Candesartan cilexetil|candesartan cilexetil|mesh-list
101661922|NCT02801526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101661923|NCT02801526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101661924|NCT02801526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101661925|NCT02801526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661926|NCT02801526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101661927|NCT02801526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661928|NCT02801526|Vasodilator Agents|vasodilator agents|mesh-ancestor
101661929|NCT02801526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101661930|NCT02801526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101661931|NCT02805426|Misoprostol|misoprostol|mesh-list
101661932|NCT02805426|Tranexamic Acid|tranexamic acid|mesh-list
101661933|NCT02805426|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101661934|NCT02805426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101661935|NCT02805426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661936|NCT02805426|Hemostatics|hemostatics|mesh-ancestor
101661937|NCT02805426|Coagulants|coagulants|mesh-ancestor
101661938|NCT02805426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101661940|NCT02805426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101661941|NCT02805426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661942|NCT02805426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101661943|NCT02805426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101661944|NCT02805426|Oxytocics|oxytocics|mesh-ancestor
101661945|NCT02801292|Ketamine|ketamine|mesh-list
101661946|NCT02801292|Analgesics|analgesics|mesh-ancestor
101661947|NCT02801292|Sensory System Agents|sensory system agents|mesh-ancestor
101661948|NCT02801292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101661949|NCT02801292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661950|NCT02801292|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101661951|NCT02801292|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101661952|NCT02801292|Anesthetics, General|anesthetics, general|mesh-ancestor
101661953|NCT02801292|Anesthetics|anesthetics|mesh-ancestor
101661954|NCT02801292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101661955|NCT02801292|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101661956|NCT02801292|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101661957|NCT02801292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101661958|NCT02801292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661959|NCT02544061|Interleukin-12|interleukin-12|mesh-list
101661960|NCT02544061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101661961|NCT02544061|Immunologic Factors|immunologic factors|mesh-ancestor
101661962|NCT02544061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661963|NCT02544061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101661964|NCT02544061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101661965|NCT02544061|Growth Substances|growth substances|mesh-ancestor
101661966|NCT02544061|Growth Inhibitors|growth inhibitors|mesh-ancestor
101661967|NCT02544061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101661968|NCT00863863|Griseofulvin|griseofulvin|mesh-list
101661969|NCT00863863|Antifungal Agents|antifungal agents|mesh-ancestor
101661970|NCT00863863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101661971|NCT03853044|Prednisone|prednisone|mesh-list
101661972|NCT03853044|Cyclophosphamide|cyclophosphamide|mesh-list
101661973|NCT03853044|Doxorubicin|doxorubicin|mesh-list
101661974|NCT03853044|Vincristine|vincristine|mesh-list
101661975|NCT03853044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101661976|NCT03853044|Immunologic Factors|immunologic factors|mesh-ancestor
101661977|NCT03853044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101661978|NCT03853044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101661979|NCT03853044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101661980|NCT03853044|Alkylating Agents|alkylating agents|mesh-ancestor
101661981|NCT03853044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101661982|NCT03853044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101661983|NCT03853044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101661984|NCT03853044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101661985|NCT03853044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101661986|NCT03853044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101661987|NCT03853044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101661988|NCT03853044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101661989|NCT03853044|Glucocorticoids|glucocorticoids|mesh-ancestor
101661990|NCT03853044|Hormones|hormones|mesh-ancestor
101451721|NCT00208065|Respiratory System Agents|respiratory system agents|mesh-ancestor
101661991|NCT03853044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101661992|NCT03853044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101661993|NCT03853044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101661994|NCT03853044|Tubulin Modulators|tubulin modulators|mesh-ancestor
101661995|NCT03853044|Antimitotic Agents|antimitotic agents|mesh-ancestor
101661996|NCT03853044|Mitosis Modulators|mitosis modulators|mesh-ancestor
101661997|NCT00870337|Everolimus|everolimus|mesh-list
101661998|NCT00870337|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101661999|NCT00870337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101662000|NCT00870337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101825618|NCT00523848|Immunologic Factors|immunologic factors|mesh-ancestor
101662001|NCT00870337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662002|NCT00870337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101662003|NCT00870337|Immunologic Factors|immunologic factors|mesh-ancestor
101662004|NCT00870337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662005|NCT00870337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101662006|NCT00866437|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101662007|NCT00866437|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101662009|NCT00866437|Estradiol|estradiol|mesh-list
101662010|NCT00866437|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101662011|NCT00866437|Estrone|estrone|mesh-list
101662012|NCT00866437|Progesterone|progesterone|mesh-list
101662013|NCT00866437|Estrogens|estrogens|mesh-ancestor
101662014|NCT00866437|Hormones|hormones|mesh-ancestor
101662015|NCT00866437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101662016|NCT00866437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662017|NCT00866437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101662018|NCT00866437|Contraceptive Agents|contraceptive agents|mesh-ancestor
101662019|NCT00866437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101662020|NCT00866437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101662021|NCT00866437|Progestins|progestins|mesh-ancestor
101662022|NCT00863941|Bupropion|bupropion|mesh-list
101662023|NCT00863941|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101662024|NCT00863941|Antidepressive Agents|antidepressive agents|mesh-ancestor
101662025|NCT00863941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101662026|NCT00863941|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101662027|NCT00863941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101662028|NCT00863941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101662029|NCT00863941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662030|NCT00863941|Dopamine Agents|dopamine agents|mesh-ancestor
101662031|NCT00863941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101662032|NCT00863941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662033|NCT00863941|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101662034|NCT00863941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101662035|NCT00863941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101662036|NCT00812565|gamma-Globulins|gamma-globulins|mesh-list
101662037|NCT00812565|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101662038|NCT00812565|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101662039|NCT00812565|Immunologic Factors|immunologic factors|mesh-ancestor
101662040|NCT00812565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662041|NCT00866515|Ketoconazole|ketoconazole|mesh-list
101662042|NCT00866515|Antifungal Agents|antifungal agents|mesh-ancestor
101662043|NCT00866515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101662044|NCT00866515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101662045|NCT00866515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101662046|NCT00866515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101662047|NCT00866515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662048|NCT00866515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101662049|NCT00866515|Hormone Antagonists|hormone antagonists|mesh-ancestor
101662050|NCT00866515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101662051|NCT00866515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662052|NCT00866515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101662053|NCT02795754|Ritonavir|ritonavir|mesh-list
101662054|NCT02795754|GSK-2838232|gsk-2838232|mesh-list
101662055|NCT02795754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101662056|NCT02795754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101662057|NCT02795754|Protease Inhibitors|protease inhibitors|mesh-ancestor
101662058|NCT02795754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101662059|NCT02795754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662060|NCT02795754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101319231|NCT05620628|Durvalumab|durvalumab|mesh-list
101662061|NCT02795754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101825634|NCT04018157|Ketamine|ketamine|mesh-list
101662062|NCT02795754|Antiviral Agents|antiviral agents|mesh-ancestor
101662063|NCT02795754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101662064|NCT02795754|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101662065|NCT02795754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101662066|NCT00864019|Sertraline|sertraline|mesh-list
101662067|NCT00864019|Antidepressive Agents|antidepressive agents|mesh-ancestor
101662068|NCT00864019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101662069|NCT00864019|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101662070|NCT00864019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101662071|NCT00864019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101662072|NCT00864019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662073|NCT00864019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101662074|NCT00864019|Serotonin Agents|serotonin agents|mesh-ancestor
101662075|NCT00864019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662076|NCT00812487|Insulin|insulin|mesh-list
101662077|NCT00812487|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101662078|NCT00812487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101662079|NCT00812487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662080|NCT04235868|Mitogens|mitogens|mesh-list
101662081|NCT04235868|Mitosis Modulators|mitosis modulators|mesh-ancestor
101662082|NCT04235868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662083|NCT02800902|Atorvastatin|atorvastatin|mesh-list
101662084|NCT02800902|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101662085|NCT02800902|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101662086|NCT02800902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101662087|NCT02800902|Antimetabolites|antimetabolites|mesh-ancestor
101662088|NCT02800902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662089|NCT02800902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101662090|NCT02800902|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101662091|NCT02800902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101662092|NCT05756595|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101662093|NCT00617461|Gabapentin|gabapentin|mesh-list
101662094|NCT00617461|Analgesics|analgesics|mesh-ancestor
101662095|NCT00617461|Sensory System Agents|sensory system agents|mesh-ancestor
101662096|NCT00617461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101662097|NCT00617461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662098|NCT00617461|Anticonvulsants|anticonvulsants|mesh-ancestor
101662099|NCT00617461|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101662100|NCT00617461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101662101|NCT00617461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101662102|NCT00617461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101662103|NCT00617461|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101662104|NCT00617461|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101662105|NCT00617461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101662106|NCT00617461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662107|NCT00617461|Antimanic Agents|antimanic agents|mesh-ancestor
101662109|NCT00812331|Antiviral Agents|antiviral agents|mesh-ancestor
101662110|NCT00812331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101662111|NCT00812331|Protease Inhibitors|protease inhibitors|mesh-ancestor
101662112|NCT00812331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101662113|NCT00812331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662114|NCT04233996|Meropenem|meropenem|mesh-list
101662115|NCT04233996|Tazobactam|tazobactam|mesh-list
101662116|NCT04233996|Piperacillin|piperacillin|mesh-list
101662117|NCT04233996|Cefepime|cefepime|mesh-list
101662118|NCT04233996|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101662119|NCT04233996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101662120|NCT04233996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101662121|NCT04233996|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101662122|NCT04233996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101662123|NCT04233996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662124|NCT00812253|Insulin|insulin|mesh-list
101662125|NCT00812253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101662126|NCT00812253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101662127|NCT00812253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662129|NCT00870571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101662130|NCT00870571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101662131|NCT00870571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101662132|NCT00870571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662133|NCT00870571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101662134|NCT00870571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662135|NCT00870571|Vasodilator Agents|vasodilator agents|mesh-ancestor
101662136|NCT05756439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
101662137|NCT05756439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101662138|NCT05756439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662140|NCT00616759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101662141|NCT00616759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101662142|NCT00616759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662143|NCT00616759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101662144|NCT00616759|Anesthetics, General|anesthetics, general|mesh-ancestor
101662145|NCT00616759|Anesthetics|anesthetics|mesh-ancestor
101662146|NCT00866593|Dexetimide|dexetimide|mesh-list
101662147|NCT00866593|Citalopram|citalopram|mesh-list
101662148|NCT00866593|Escitalopram|escitalopram|mesh-list
101662149|NCT00866593|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101662150|NCT00866593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101662151|NCT00866593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101662152|NCT00866593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662153|NCT00866593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101662154|NCT00866593|Serotonin Agents|serotonin agents|mesh-ancestor
101662155|NCT00866593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662156|NCT00866593|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101662157|NCT00866593|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101662158|NCT00866593|Parasympatholytics|parasympatholytics|mesh-ancestor
101662159|NCT00866593|Autonomic Agents|autonomic agents|mesh-ancestor
101662160|NCT00866593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101662161|NCT00866593|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101662162|NCT00866593|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101662163|NCT00866593|Cholinergic Agents|cholinergic agents|mesh-ancestor
101662164|NCT00866593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101662165|NCT00866593|Antidepressive Agents|antidepressive agents|mesh-ancestor
101662166|NCT00866593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101662167|NCT02796378|Ubiquinone|ubiquinone|mesh-list
101662168|NCT02796378|Coenzyme Q10|coenzyme q10|mesh-list
101662169|NCT02796378|Simvastatin|simvastatin|mesh-list
101662170|NCT02796378|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101662171|NCT02796378|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101662172|NCT02796378|Antimetabolites|antimetabolites|mesh-ancestor
101662173|NCT02796378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662174|NCT02796378|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101662175|NCT02796378|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101662176|NCT02796378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101662177|NCT02796378|Micronutrients|micronutrients|mesh-ancestor
101662178|NCT02796378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662179|NCT02796378|Vitamins|vitamins|mesh-ancestor
101662180|NCT00864409|Ropivacaine|ropivacaine|mesh-list
101662181|NCT00864409|Anesthetics, Local|anesthetics, local|mesh-ancestor
101662182|NCT00864409|Anesthetics|anesthetics|mesh-ancestor
101662183|NCT00864409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101662184|NCT00864409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662185|NCT00864409|Sensory System Agents|sensory system agents|mesh-ancestor
101662186|NCT00864409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101662187|NCT00866983|Sildenafil Citrate|sildenafil citrate|mesh-list
101662188|NCT00866983|Vasodilator Agents|vasodilator agents|mesh-ancestor
101662189|NCT00866983|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101662190|NCT00866983|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101662191|NCT00866983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101662192|NCT00866983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662193|NCT00866983|Urological Agents|urological agents|mesh-ancestor
101662194|NCT05226013|Rasburicase|rasburicase|mesh-list
101662195|NCT05226013|Gout Suppressants|gout suppressants|mesh-ancestor
101662196|NCT05226013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101662197|NCT00870883|Acetylcysteine|acetylcysteine|mesh-list
101662198|NCT00870883|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101662199|NCT00870883|Deferoxamine|deferoxamine|mesh-list
101662200|NCT00870883|Antiviral Agents|antiviral agents|mesh-ancestor
101662201|NCT00870883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101662202|NCT00870883|Expectorants|expectorants|mesh-ancestor
101662203|NCT00870883|Respiratory System Agents|respiratory system agents|mesh-ancestor
101662204|NCT00870883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101662205|NCT00870883|Antioxidants|antioxidants|mesh-ancestor
101662206|NCT00870883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662207|NCT00870883|Protective Agents|protective agents|mesh-ancestor
101662208|NCT00870883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662209|NCT00870883|Antidotes|antidotes|mesh-ancestor
101662210|NCT00870883|Siderophores|siderophores|mesh-ancestor
101319375|NCT03959761|Nivolumab|nivolumab|mesh-list
101662211|NCT00870883|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101662212|NCT00870883|Chelating Agents|chelating agents|mesh-ancestor
101662213|NCT00870883|Sequestering Agents|sequestering agents|mesh-ancestor
101662214|NCT00870961|Cholecalciferol|cholecalciferol|mesh-list
101662215|NCT00870961|Vitamin D|vitamin d|mesh-list
101662216|NCT00870961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101662217|NCT00870961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662218|NCT00870961|Vitamins|vitamins|mesh-ancestor
101662219|NCT00870961|Micronutrients|micronutrients|mesh-ancestor
101662220|NCT00870961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101662221|NCT00811941|Nalmefene|nalmefene|mesh-list
101662222|NCT00811941|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101662223|NCT00811941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662224|NCT00811941|Sensory System Agents|sensory system agents|mesh-ancestor
101662225|NCT00811941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101662226|NCT00864565|Fentanyl|fentanyl|mesh-list
101662227|NCT00864565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101662228|NCT00864565|Narcotics|narcotics|mesh-ancestor
101662229|NCT00864565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101662230|NCT00864565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662231|NCT00864565|Analgesics|analgesics|mesh-ancestor
101662232|NCT00864565|Sensory System Agents|sensory system agents|mesh-ancestor
101662233|NCT00864565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101662234|NCT00864565|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101662235|NCT00864565|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101662236|NCT00864565|Anesthetics, General|anesthetics, general|mesh-ancestor
101662237|NCT00864565|Anesthetics|anesthetics|mesh-ancestor
101662238|NCT00864643|Atorvastatin|atorvastatin|mesh-list
101662239|NCT00864643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101662240|NCT00864643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101662241|NCT00864643|Antimetabolites|antimetabolites|mesh-ancestor
101662242|NCT00864643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662243|NCT00864643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101662244|NCT00864643|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101662245|NCT00864643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101662246|NCT00871039|Midazolam|midazolam|mesh-list
101662247|NCT00871039|Propofol|propofol|mesh-list
101662248|NCT00871039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101662249|NCT00871039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101662250|NCT00871039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662251|NCT00871039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101662252|NCT00871039|Anesthetics, General|anesthetics, general|mesh-ancestor
101662253|NCT00871039|Anesthetics|anesthetics|mesh-ancestor
101662254|NCT00871039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101662255|NCT00871039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101662256|NCT00871039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101662257|NCT00871039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101662258|NCT00871039|GABA Modulators|gaba modulators|mesh-ancestor
101662260|NCT00871039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101662261|NCT00871039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662262|NCT00867061|ON 01910|on 01910|mesh-list
101662263|NCT00867061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101662264|NCT00867061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101662265|NCT00867061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101662266|NCT00867061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662267|NCT00864799|Misoprostol|misoprostol|mesh-list
101662268|NCT00864799|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101662269|NCT00864799|Abortifacient Agents|abortifacient agents|mesh-ancestor
101662270|NCT00864799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101662271|NCT00864799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662272|NCT00864799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101662273|NCT00864799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101662274|NCT00864799|Oxytocics|oxytocics|mesh-ancestor
101662275|NCT04234776|Ketamine|ketamine|mesh-list
101662276|NCT04234776|Aripiprazole|aripiprazole|mesh-list
101662277|NCT04234776|Escitalopram|escitalopram|mesh-list
101662278|NCT04234776|Analgesics|analgesics|mesh-ancestor
101662279|NCT04234776|Sensory System Agents|sensory system agents|mesh-ancestor
101662280|NCT04234776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101662281|NCT04234776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662282|NCT04234776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101662283|NCT04234776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101662284|NCT04234776|Anesthetics, General|anesthetics, general|mesh-ancestor
101662285|NCT04234776|Anesthetics|anesthetics|mesh-ancestor
101662286|NCT04234776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101662287|NCT04234776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101662288|NCT04234776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101662289|NCT04234776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101662290|NCT04234776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662291|NCT04234776|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101662292|NCT04234776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101662293|NCT04234776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101662294|NCT04234776|Serotonin Agents|serotonin agents|mesh-ancestor
101662295|NCT04234776|Antidepressive Agents|antidepressive agents|mesh-ancestor
101662296|NCT04234776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101662297|NCT04234776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101662298|NCT04234776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101662299|NCT04234776|Dopamine Agonists|dopamine agonists|mesh-ancestor
101662300|NCT04234776|Dopamine Agents|dopamine agents|mesh-ancestor
101662301|NCT04234776|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101662302|NCT04234776|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101662303|NCT04234776|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101662304|NCT04234776|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101662305|NCT04234776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101662306|NCT04234776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101662307|NCT05756049|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101662308|NCT05756049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101662309|NCT00871273|Capecitabine|capecitabine|mesh-list
101662310|NCT00871273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101662311|NCT00871273|Antimetabolites|antimetabolites|mesh-ancestor
101662312|NCT00871273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662313|NCT00871273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101662314|NCT00867295|Cefazolin|cefazolin|mesh-list
101662315|NCT00867295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101662316|NCT00867295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101662317|NCT02794506|Propolis|propolis|mesh-list
101662318|NCT02794506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101662319|NCT04040491|Gemcitabine|gemcitabine|mesh-list
101662320|NCT04040491|Lenalidomide|lenalidomide|mesh-list
101662321|NCT04040491|Antibodies|antibodies|mesh-list
101662322|NCT04040491|Antibodies, Blocking|antibodies, blocking|mesh-list
101662323|NCT04040491|Immunologic Factors|immunologic factors|mesh-ancestor
101662324|NCT04040491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662325|NCT04040491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101662326|NCT04040491|Antimetabolites|antimetabolites|mesh-ancestor
101662327|NCT04040491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662328|NCT04040491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101662329|NCT04040491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101662330|NCT04040491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101662331|NCT04040491|Growth Substances|growth substances|mesh-ancestor
101662332|NCT04040491|Growth Inhibitors|growth inhibitors|mesh-ancestor
101662333|NCT02794584|Sufentanil|sufentanil|mesh-list
101662335|NCT02794584|Anesthetics|anesthetics|mesh-ancestor
101662336|NCT02794584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101662337|NCT02794584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662338|NCT02794584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101662339|NCT02794584|Narcotics|narcotics|mesh-ancestor
101662340|NCT02794584|Analgesics|analgesics|mesh-ancestor
101662341|NCT02794584|Sensory System Agents|sensory system agents|mesh-ancestor
101662342|NCT02794584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101662343|NCT02794584|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101662344|NCT02794584|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101662345|NCT02794584|Anesthetics, General|anesthetics, general|mesh-ancestor
101662346|NCT00811473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101662347|NCT00811473|Antidepressive Agents|antidepressive agents|mesh-ancestor
101662348|NCT00811473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101662349|NCT00811473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101662350|NCT00811473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101662351|NCT00811473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101662352|NCT00811473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662353|NCT00871507|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101662354|NCT00871507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101662355|NCT00871507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662356|NCT00871507|Incretins|incretins|mesh-ancestor
101662357|NCT00871507|Hormones|hormones|mesh-ancestor
101662358|NCT00871507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101662359|NCT00871507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101662360|NCT00871507|Protease Inhibitors|protease inhibitors|mesh-ancestor
101662361|NCT00871507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101662362|NCT00871507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662363|NCT00865033|Metformin|metformin|mesh-list
101662364|NCT00865033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101662365|NCT00865033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662366|NCT04234932|Latanoprost|latanoprost|mesh-list
101662367|NCT04234932|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101662368|NCT04234932|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101662369|NCT02789592|Clonazepam|clonazepam|mesh-list
101662370|NCT02789592|Melatonin|melatonin|mesh-list
101662371|NCT02789592|Antioxidants|antioxidants|mesh-ancestor
101662372|NCT02789592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662373|NCT02789592|Protective Agents|protective agents|mesh-ancestor
101662374|NCT02789592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662375|NCT02789592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101662376|NCT02789592|Anticonvulsants|anticonvulsants|mesh-ancestor
101662377|NCT02789592|GABA Modulators|gaba modulators|mesh-ancestor
101662378|NCT02789592|GABA Agents|gaba agents|mesh-ancestor
101662379|NCT02789592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101662380|NCT00876421|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101662381|NCT00876421|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101825695|NCT00861029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101662382|NCT00876421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101662383|NCT00876421|Cholinergic Agents|cholinergic agents|mesh-ancestor
101662384|NCT00876421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101662385|NCT00876421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662386|NCT00876421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662387|NCT00876421|Urological Agents|urological agents|mesh-ancestor
101662388|NCT00872131|Sertraline|sertraline|mesh-list
101662389|NCT00872131|Antidepressive Agents|antidepressive agents|mesh-ancestor
101662390|NCT00872131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101662391|NCT00872131|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101662392|NCT00872131|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101662393|NCT00872131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101662394|NCT00872131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662395|NCT00872131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101662396|NCT00872131|Serotonin Agents|serotonin agents|mesh-ancestor
101662397|NCT00872131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662398|NCT04233294|Decitabine|decitabine|mesh-list
101662399|NCT04233294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101662400|NCT04233294|Antimetabolites|antimetabolites|mesh-ancestor
101451722|NCT00208065|Nasal Decongestants|nasal decongestants|mesh-ancestor
101662401|NCT04233294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662402|NCT04233294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101662403|NCT04233294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101662404|NCT00872209|Ciprofloxacin|ciprofloxacin|mesh-list
101662405|NCT00872209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101662406|NCT00872209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101662407|NCT00872209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101662408|NCT00872209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101662409|NCT00872209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101662410|NCT00872209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662411|NCT00872209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101662412|NCT00872209|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101662413|NCT00872209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101662414|NCT00872365|Micronutrients|micronutrients|mesh-list
101662415|NCT00872365|Trace Elements|trace elements|mesh-list
101662416|NCT00872365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662417|NCT03637062|Progesterone|progesterone|mesh-list
101662418|NCT03637062|Progestins|progestins|mesh-ancestor
101662420|NCT03637062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101662421|NCT03637062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662422|NCT02793648|Vitamins|vitamins|mesh-list
101662423|NCT02793648|Ascorbic Acid|ascorbic acid|mesh-list
101662424|NCT02793648|Vitamin E|vitamin e|mesh-list
101662425|NCT02793648|Tocopherols|tocopherols|mesh-list
101662426|NCT02793648|alpha-Tocopherol|alpha-tocopherol|mesh-list
101662427|NCT02793648|Micronutrients|micronutrients|mesh-ancestor
101662428|NCT02793648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662429|NCT02793648|Antioxidants|antioxidants|mesh-ancestor
101662430|NCT02793648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662431|NCT02793648|Protective Agents|protective agents|mesh-ancestor
101662432|NCT02789358|Adenosine|adenosine|mesh-list
101662433|NCT02789358|Analgesics|analgesics|mesh-ancestor
101662434|NCT02789358|Sensory System Agents|sensory system agents|mesh-ancestor
101662435|NCT02789358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101662436|NCT02789358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662437|NCT02789358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101662438|NCT02789358|Vasodilator Agents|vasodilator agents|mesh-ancestor
101662439|NCT02789358|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101662440|NCT02789358|Purinergic Agonists|purinergic agonists|mesh-ancestor
101662441|NCT02789358|Purinergic Agents|purinergic agents|mesh-ancestor
101662442|NCT02789358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101662443|NCT02789358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662445|NCT03847506|Candesartan|candesartan|mesh-list
101662446|NCT03847506|Candesartan cilexetil|candesartan cilexetil|mesh-list
101662447|NCT03847506|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101662448|NCT03847506|Ezetimibe|ezetimibe|mesh-list
101662449|NCT03847506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101662450|NCT03847506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101662451|NCT03847506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101662452|NCT03847506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662453|NCT03847506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101662454|NCT03847506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662455|NCT03847506|Vasodilator Agents|vasodilator agents|mesh-ancestor
101662456|NCT03847506|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101662457|NCT03847506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101662458|NCT03847506|Antimetabolites|antimetabolites|mesh-ancestor
101662459|NCT03847506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101662460|NCT03847506|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101662461|NCT03847506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101662462|NCT03847506|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101662463|NCT03847506|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101662464|NCT00617305|Ambrisentan|ambrisentan|mesh-list
101662465|NCT00617305|Sildenafil Citrate|sildenafil citrate|mesh-list
101662466|NCT00617305|Tadalafil|tadalafil|mesh-list
101662467|NCT00617305|Vasodilator Agents|vasodilator agents|mesh-ancestor
101662468|NCT00617305|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101662469|NCT00617305|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101662470|NCT00617305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101662471|NCT00617305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662473|NCT00617305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101662474|NCT02792712|Clopidogrel|clopidogrel|mesh-list
101662475|NCT02792712|Ticagrelor|ticagrelor|mesh-list
101662476|NCT02792712|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101662477|NCT02792712|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101662478|NCT02792712|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101662479|NCT02792712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101662480|NCT02792712|Purinergic Agents|purinergic agents|mesh-ancestor
101662481|NCT02792712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101662482|NCT02792712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662483|NCT02792712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662484|NCT02789202|Fluorides|fluorides|mesh-list
101662485|NCT02789202|Sodium Fluoride|sodium fluoride|mesh-list
101662486|NCT02789202|Fluorides, Topical|fluorides, topical|mesh-list
101662487|NCT02789202|Cariostatic Agents|cariostatic agents|mesh-ancestor
101662488|NCT02789202|Protective Agents|protective agents|mesh-ancestor
101662489|NCT02789202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662490|NCT00811395|Interferons|interferons|mesh-list
101662491|NCT00811395|Interferon-beta|interferon-beta|mesh-list
101662492|NCT00811395|Teriflunomide|teriflunomide|mesh-list
101662493|NCT00811395|Glatiramer Acetate|glatiramer acetate|mesh-list
101662494|NCT00811395|Interferon beta-1b|interferon beta-1b|mesh-list
101662495|NCT00811395|(T,G)-A-L|(t,g)-a-l|mesh-list
101662496|NCT00811395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101662497|NCT00811395|Antiviral Agents|antiviral agents|mesh-ancestor
101662498|NCT00811395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101662499|NCT00811395|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101662500|NCT00811395|Immunologic Factors|immunologic factors|mesh-ancestor
101662501|NCT00811395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662502|NCT00811395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101662503|NCT00811395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101662504|NCT00811395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101662505|NCT00811395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101662506|NCT00811395|Analgesics|analgesics|mesh-ancestor
101662507|NCT00811395|Sensory System Agents|sensory system agents|mesh-ancestor
101662508|NCT00811395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101662509|NCT00811395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101662511|NCT02792946|Expectorants|expectorants|mesh-ancestor
101662512|NCT02792946|Respiratory System Agents|respiratory system agents|mesh-ancestor
101662513|NCT00876577|Moxifloxacin|moxifloxacin|mesh-list
101662514|NCT00876577|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101662515|NCT00876577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101662516|NCT00876577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101662517|NCT00876577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101662518|NCT00876577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101662519|NCT00876577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101662520|NCT00876577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662521|NCT00876577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101662522|NCT00876577|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101662523|NCT00876577|Contraceptive Agents|contraceptive agents|mesh-ancestor
101662524|NCT00876577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101662525|NCT00876577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662526|NCT00876577|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101662527|NCT00876577|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101662528|NCT00876577|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101662529|NCT02787798|Valsartan|valsartan|mesh-list
101662530|NCT02787798|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101662531|NCT02787798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101662532|NCT02787798|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101662533|NCT02787798|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101662534|NCT02787798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662535|NCT02609997|Dexamethasone|dexamethasone|mesh-list
101662536|NCT02609997|Proxymetacaine|proxymetacaine|mesh-list
101662537|NCT02609997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101662538|NCT02609997|Antiemetics|antiemetics|mesh-ancestor
101662539|NCT02609997|Autonomic Agents|autonomic agents|mesh-ancestor
101662540|NCT02609997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101662541|NCT02609997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662542|NCT02609997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101662543|NCT02609997|Glucocorticoids|glucocorticoids|mesh-ancestor
101662544|NCT02609997|Hormones|hormones|mesh-ancestor
101662545|NCT02609997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101662546|NCT02609997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101662547|NCT02609997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101662548|NCT02609997|Anesthetics, Local|anesthetics, local|mesh-ancestor
101662549|NCT02609997|Anesthetics|anesthetics|mesh-ancestor
101662550|NCT02609997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101662551|NCT02609997|Sensory System Agents|sensory system agents|mesh-ancestor
101662552|NCT00876655|Tedizolid phosphate|tedizolid phosphate|mesh-list
101662553|NCT00876655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101662554|NCT00876655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101662555|NCT02609919|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
101662556|NCT02609919|Chelating Agents|chelating agents|mesh-ancestor
101662557|NCT02609919|Sequestering Agents|sequestering agents|mesh-ancestor
101662558|NCT02609919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662559|NCT04114500|Estradiol|estradiol|mesh-list
101662560|NCT04114500|Progesterone|progesterone|mesh-list
101662561|NCT04114500|Estrogens|estrogens|mesh-ancestor
101662562|NCT04114500|Hormones|hormones|mesh-ancestor
101662563|NCT04114500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101662564|NCT04114500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662565|NCT04114500|Progestins|progestins|mesh-ancestor
101662566|NCT05755659|Fosaprepitant|fosaprepitant|mesh-list
101662567|NCT05755659|Aprepitant|aprepitant|mesh-list
101662568|NCT05755659|Antiemetics|antiemetics|mesh-ancestor
101662569|NCT05755659|Autonomic Agents|autonomic agents|mesh-ancestor
101662570|NCT05755659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101662571|NCT05755659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662572|NCT05755659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101662573|NCT05755659|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101662574|NCT05755659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101662575|NCT05755659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662576|NCT00913887|Diclofenac|diclofenac|mesh-list
101662577|NCT00913887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101662578|NCT00913887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101662579|NCT00913887|Analgesics|analgesics|mesh-ancestor
101662580|NCT00913887|Sensory System Agents|sensory system agents|mesh-ancestor
101662581|NCT00913887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101662582|NCT00913887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662583|NCT00913887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101662584|NCT00913887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101662585|NCT00913887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101662586|NCT00913887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101319752|NCT03151096|Riboflavin|riboflavin|mesh-list
101662587|NCT00913887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662589|NCT02792400|Linagliptin|linagliptin|mesh-list
101662590|NCT02792400|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101662591|NCT02792400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662592|NCT02792400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101662593|NCT02792400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662594|NCT02792400|Incretins|incretins|mesh-ancestor
101662595|NCT02792400|Hormones|hormones|mesh-ancestor
101662596|NCT02792400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101662597|NCT02792400|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101662598|NCT02792400|Protease Inhibitors|protease inhibitors|mesh-ancestor
101662599|NCT02792400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101662600|NCT04040023|Vitamins|vitamins|mesh-list
101662601|NCT04040023|Micronutrients|micronutrients|mesh-ancestor
101662602|NCT04040023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662603|NCT05755581|Antineoplastic Agents|antineoplastic agents|mesh-list
101662604|NCT05755581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-list
101662605|NCT05017155|Mexiletine|mexiletine|mesh-list
101662606|NCT05017155|Lamotrigine|lamotrigine|mesh-list
101662607|NCT05017155|Anticonvulsants|anticonvulsants|mesh-ancestor
101662608|NCT05017155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101662609|NCT05017155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101662610|NCT05017155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662611|NCT05017155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101662612|NCT05017155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662613|NCT05017155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101662614|NCT05017155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101825729|NCT00870311|Lithium Carbonate|lithium carbonate|mesh-list
101662615|NCT05017155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101662616|NCT05017155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101662617|NCT05017155|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101662618|NCT05017155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101662619|NCT05017155|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101662620|NCT05162131|Ticagrelor|ticagrelor|mesh-list
101662621|NCT05162131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101662622|NCT05162131|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101662623|NCT05162131|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101662624|NCT05162131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101662625|NCT05162131|Purinergic Agents|purinergic agents|mesh-ancestor
101662626|NCT05162131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101662627|NCT05162131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662628|NCT05162131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662630|NCT00868153|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101662631|NCT00868153|Contraceptive Agents|contraceptive agents|mesh-ancestor
101662632|NCT00868153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101662633|NCT00868153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662634|NCT00868153|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101662635|NCT00868153|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101662636|NCT00868153|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101662637|NCT00876889|Riluzole|riluzole|mesh-list
101662638|NCT00876889|Anticonvulsants|anticonvulsants|mesh-ancestor
101662639|NCT00876889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101662640|NCT00876889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101662641|NCT00876889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101662642|NCT00876889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662643|NCT00876889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662644|NCT00876889|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101662645|NCT00876889|Protective Agents|protective agents|mesh-ancestor
101662646|NCT00868465|Lumefantrine|lumefantrine|mesh-list
101662647|NCT00868465|Artemether|artemether|mesh-list
101662648|NCT00868465|Piperaquine|piperaquine|mesh-list
101662649|NCT00868465|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101662650|NCT00868465|Artenimol|artenimol|mesh-list
101662651|NCT00868465|Antimalarials|antimalarials|mesh-ancestor
101662652|NCT00868465|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101662653|NCT00868465|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101662654|NCT00868465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101662655|NCT02689986|Rituximab|rituximab|mesh-list
101662656|NCT02689986|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101662657|NCT02689986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101662658|NCT02689986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101662659|NCT02689986|Immunologic Factors|immunologic factors|mesh-ancestor
101662660|NCT02689986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662661|NCT02689986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101662662|NCT02689986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101662663|NCT02689986|Alkylating Agents|alkylating agents|mesh-ancestor
101662664|NCT02689986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662665|NCT00876967|Pyrithione zinc|pyrithione zinc|mesh-list
101662666|NCT00876967|Keratolytic Agents|keratolytic agents|mesh-ancestor
101662667|NCT00876967|Dermatologic Agents|dermatologic agents|mesh-ancestor
101662668|NCT00955409|Saponin QA-21V1|saponin qa-21v1|mesh-list
101662669|NCT00955409|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101662670|NCT00955409|Immunologic Factors|immunologic factors|mesh-ancestor
101662671|NCT00955409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662672|NCT00877123|Vitamin D|vitamin d|mesh-list
101662673|NCT00877123|Vitamins|vitamins|mesh-ancestor
101662674|NCT00877123|Micronutrients|micronutrients|mesh-ancestor
101662675|NCT00877123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662676|NCT00877123|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101662677|NCT00873223|Liraglutide|liraglutide|mesh-list
101662678|NCT00873223|Insulin Detemir|insulin detemir|mesh-list
101662679|NCT00873223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101662680|NCT00873223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662681|NCT00873223|Incretins|incretins|mesh-ancestor
101662682|NCT00873223|Hormones|hormones|mesh-ancestor
101662683|NCT00873223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101662684|NCT00873379|Melatonin|melatonin|mesh-list
101662685|NCT00873379|Antioxidants|antioxidants|mesh-ancestor
101662686|NCT00873379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662687|NCT00873379|Protective Agents|protective agents|mesh-ancestor
101662688|NCT00873379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662689|NCT00873379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101662690|NCT00868855|Bradykinin|bradykinin|mesh-list
101662691|NCT00868855|Kininogens|kininogens|mesh-list
101662692|NCT00868855|Vasodilator Agents|vasodilator agents|mesh-ancestor
101662693|NCT00868855|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
101662694|NCT00868855|Protease Inhibitors|protease inhibitors|mesh-ancestor
101662695|NCT00868855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101662696|NCT00868855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662697|NCT00615901|Cyclophosphamide|cyclophosphamide|mesh-list
101662698|NCT00615901|Fluorouracil|fluorouracil|mesh-list
101662699|NCT00615901|Methotrexate|methotrexate|mesh-list
101662700|NCT00615901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101662701|NCT00615901|Immunologic Factors|immunologic factors|mesh-ancestor
101662702|NCT00615901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662703|NCT00615901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101662704|NCT00615901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101662705|NCT00615901|Alkylating Agents|alkylating agents|mesh-ancestor
101662706|NCT00615901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662707|NCT00615901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101662708|NCT00615901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101662709|NCT00615901|Antimetabolites|antimetabolites|mesh-ancestor
101662710|NCT00615901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101662711|NCT00615901|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101662712|NCT00615901|Abortifacient Agents|abortifacient agents|mesh-ancestor
101662713|NCT00615901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101662714|NCT00615901|Dermatologic Agents|dermatologic agents|mesh-ancestor
101662715|NCT00615901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101662716|NCT00615901|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101662717|NCT00615901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101662718|NCT00616603|Dexamethasone|dexamethasone|mesh-list
101662719|NCT00616603|Dexamethasone acetate|dexamethasone acetate|mesh-list
101662720|NCT00616603|Ropivacaine|ropivacaine|mesh-list
101662722|NCT00616603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101662723|NCT00616603|Antiemetics|antiemetics|mesh-ancestor
101662724|NCT00616603|Autonomic Agents|autonomic agents|mesh-ancestor
101662725|NCT00616603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101662726|NCT00616603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662727|NCT00616603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101662728|NCT00616603|Glucocorticoids|glucocorticoids|mesh-ancestor
101662729|NCT00616603|Hormones|hormones|mesh-ancestor
101662730|NCT00616603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101662731|NCT00616603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101662732|NCT00616603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101662733|NCT00616603|Protease Inhibitors|protease inhibitors|mesh-ancestor
101662734|NCT00616603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101662735|NCT00616603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662736|NCT00616603|Anesthetics, Local|anesthetics, local|mesh-ancestor
101662737|NCT00616603|Anesthetics|anesthetics|mesh-ancestor
101662738|NCT00616603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101662739|NCT00616603|Sensory System Agents|sensory system agents|mesh-ancestor
101662740|NCT00873535|Varenicline|varenicline|mesh-list
101662741|NCT00873535|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101662742|NCT00873535|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101662743|NCT00873535|Cholinergic Agents|cholinergic agents|mesh-ancestor
101662744|NCT00873535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101662745|NCT00873535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662746|NCT00873535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662747|NCT02790996|Vancomycin|vancomycin|mesh-list
101662748|NCT02790996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101662749|NCT02790996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101662750|NCT00810693|Riociguat|riociguat|mesh-list
101662751|NCT00810693|Enzyme Activators|enzyme activators|mesh-ancestor
101662752|NCT00810693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662753|NCT02790840|Omeprazole|omeprazole|mesh-list
101662754|NCT02790840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101662755|NCT02790840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101662756|NCT02790840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101662757|NCT02790840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101662758|NCT02790840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662759|NCT02790684|Firuglipel|firuglipel|mesh-list
101662760|NCT02790684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101662761|NCT02790684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662762|NCT02790450|Benzbromarone|benzbromarone|mesh-list
101662763|NCT02790450|Uricosuric Agents|uricosuric agents|mesh-ancestor
101662764|NCT02790450|Gout Suppressants|gout suppressants|mesh-ancestor
101662765|NCT02790450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101662766|NCT02790528|Atorvastatin|atorvastatin|mesh-list
101662767|NCT02790528|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101662768|NCT02790528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101662769|NCT02790528|Antimetabolites|antimetabolites|mesh-ancestor
101662770|NCT02790528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662771|NCT02790528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101662772|NCT02790528|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101662773|NCT02790528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101662774|NCT00953615|Thalidomide|thalidomide|mesh-list
101662775|NCT00953615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101662776|NCT00953615|Immunologic Factors|immunologic factors|mesh-ancestor
101662777|NCT00953615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662778|NCT00953615|Leprostatic Agents|leprostatic agents|mesh-ancestor
101662779|NCT00953615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101662780|NCT00953615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101662781|NCT00953615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101662782|NCT00953615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101662783|NCT00953615|Growth Substances|growth substances|mesh-ancestor
101825787|NCT00864071|Griseofulvin|griseofulvin|mesh-list
101662784|NCT00953615|Growth Inhibitors|growth inhibitors|mesh-ancestor
101662785|NCT00953615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101662786|NCT00873769|Loxapine|loxapine|mesh-list
101662787|NCT00873769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101662788|NCT00873769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101662789|NCT00873769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101662790|NCT00873769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662791|NCT00873769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101662792|NCT00873769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101662793|NCT00873769|Dopamine Agents|dopamine agents|mesh-ancestor
101662794|NCT00873769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101662795|NCT00873769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662796|NCT02785614|Trazodone|trazodone|mesh-list
101662797|NCT02785614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101662798|NCT02785614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101662799|NCT02785614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101662800|NCT02785614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662801|NCT02785614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101662802|NCT02785614|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101662803|NCT02785614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101662804|NCT02785614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101662805|NCT02785614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662806|NCT02785614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101662807|NCT02785614|Serotonin Agents|serotonin agents|mesh-ancestor
101662808|NCT02785614|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101662809|NCT02785614|Antidepressive Agents|antidepressive agents|mesh-ancestor
101662810|NCT02787018|Dexamethasone|dexamethasone|mesh-list
101662812|NCT02787018|Ropivacaine|ropivacaine|mesh-list
101662813|NCT02787018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101662814|NCT02787018|Antiemetics|antiemetics|mesh-ancestor
101662815|NCT02787018|Autonomic Agents|autonomic agents|mesh-ancestor
101662816|NCT02787018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101662817|NCT02787018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662818|NCT02787018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101662819|NCT02787018|Glucocorticoids|glucocorticoids|mesh-ancestor
101662820|NCT02787018|Hormones|hormones|mesh-ancestor
101662821|NCT02787018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101662822|NCT02787018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101662823|NCT02787018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101662824|NCT02787018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101662825|NCT02787018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101662826|NCT02787018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101662827|NCT02787018|Analgesics|analgesics|mesh-ancestor
101662828|NCT02787018|Sensory System Agents|sensory system agents|mesh-ancestor
101662829|NCT02787018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101662830|NCT02787018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101662831|NCT02787018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101662832|NCT02787018|Adrenergic Agents|adrenergic agents|mesh-ancestor
101662833|NCT02787018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101662834|NCT02787018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662835|NCT02787018|Anesthetics, Local|anesthetics, local|mesh-ancestor
101662836|NCT02787018|Anesthetics|anesthetics|mesh-ancestor
101662837|NCT00873925|Vitamin D|vitamin d|mesh-list
101662838|NCT00873925|Vitamins|vitamins|mesh-ancestor
101662839|NCT00873925|Micronutrients|micronutrients|mesh-ancestor
101662840|NCT00873925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662841|NCT00873925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101662842|NCT03412266|Cytarabine|cytarabine|mesh-list
101662843|NCT03412266|Cyclophosphamide|cyclophosphamide|mesh-list
101662844|NCT03412266|Busulfan|busulfan|mesh-list
101662845|NCT03412266|Semustine|semustine|mesh-list
101662846|NCT03412266|Fludarabine|fludarabine|mesh-list
101662847|NCT03412266|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101662848|NCT03412266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101662849|NCT03412266|Immunologic Factors|immunologic factors|mesh-ancestor
101825809|NCT00864149|Antioxidants|antioxidants|mesh-ancestor
101662850|NCT03412266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662851|NCT03412266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101662852|NCT03412266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101662853|NCT03412266|Alkylating Agents|alkylating agents|mesh-ancestor
101662854|NCT03412266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662855|NCT03412266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101662856|NCT03412266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101662857|NCT03412266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101662858|NCT03412266|Antimetabolites|antimetabolites|mesh-ancestor
101662859|NCT03412266|Antiviral Agents|antiviral agents|mesh-ancestor
101662860|NCT03412266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101662861|NCT00877591|Ritonavir|ritonavir|mesh-list
101662862|NCT00877591|Darunavir|darunavir|mesh-list
101662863|NCT00877591|Fosamprenavir|fosamprenavir|mesh-list
101662864|NCT00877591|Rifampin|rifampin|mesh-list
101662865|NCT00877591|Rifabutin|rifabutin|mesh-list
101662866|NCT00877591|Buprenorphine|buprenorphine|mesh-list
101662867|NCT00877591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101662868|NCT00877591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101662869|NCT00877591|Protease Inhibitors|protease inhibitors|mesh-ancestor
101662870|NCT00877591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101662871|NCT00877591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662872|NCT00877591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101662873|NCT00877591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101662874|NCT00877591|Antiviral Agents|antiviral agents|mesh-ancestor
101662875|NCT00877591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101662876|NCT00877591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101662877|NCT00877591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101662878|NCT00877591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101662879|NCT00877591|Narcotics|narcotics|mesh-ancestor
101662880|NCT00877591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101662881|NCT00877591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662882|NCT00877591|Analgesics|analgesics|mesh-ancestor
101662883|NCT00877591|Sensory System Agents|sensory system agents|mesh-ancestor
101662884|NCT00877591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101662885|NCT00877591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101662886|NCT00877591|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101662887|NCT00877591|Antitubercular Agents|antitubercular agents|mesh-ancestor
101662888|NCT00877591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101662889|NCT00877591|Leprostatic Agents|leprostatic agents|mesh-ancestor
101662890|NCT00877591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101662891|NCT00877591|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101662892|NCT00877591|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101662893|NCT00877591|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101662894|NCT00877591|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101662895|NCT00877591|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101662896|NCT00877591|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101662897|NCT04200222|Vanadium|vanadium|mesh-list
101662898|NCT04200222|Trace Elements|trace elements|mesh-ancestor
101662899|NCT04200222|Micronutrients|micronutrients|mesh-ancestor
101662900|NCT04200222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662901|NCT00874003|Mirtazapine|mirtazapine|mesh-list
101662902|NCT00874003|Antidepressive Agents|antidepressive agents|mesh-ancestor
101662903|NCT00874003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101662904|NCT00874003|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101662905|NCT00874003|Histamine Antagonists|histamine antagonists|mesh-ancestor
101662906|NCT00874003|Histamine Agents|histamine agents|mesh-ancestor
101662907|NCT00874003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101662908|NCT00874003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662909|NCT00874003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662910|NCT00874003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101662911|NCT00874003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101662912|NCT00874003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101662913|NCT00874003|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101662914|NCT00874003|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101662915|NCT00874003|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101662916|NCT00874003|Adrenergic Agents|adrenergic agents|mesh-ancestor
101662917|NCT00874003|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101662918|NCT00874003|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101662919|NCT00874003|Serotonin Agents|serotonin agents|mesh-ancestor
101662920|NCT00874003|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101662921|NCT04915365|Acetazolamide|acetazolamide|mesh-list
101662922|NCT04915365|Anticonvulsants|anticonvulsants|mesh-ancestor
101662923|NCT04915365|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101662924|NCT04915365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101662925|NCT04915365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662926|NCT04915365|Diuretics|diuretics|mesh-ancestor
101662927|NCT04915365|Natriuretic Agents|natriuretic agents|mesh-ancestor
101662928|NCT04915365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662930|NCT02785146|Leucovorin|leucovorin|mesh-list
101662931|NCT02785146|Fluorouracil|fluorouracil|mesh-list
101662932|NCT02785146|Oxaliplatin|oxaliplatin|mesh-list
101662933|NCT02785146|Calcium|calcium|mesh-list
101662934|NCT02785146|Levoleucovorin|levoleucovorin|mesh-list
101662935|NCT02785146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101662936|NCT02785146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662937|NCT02785146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101662938|NCT02785146|Antimetabolites|antimetabolites|mesh-ancestor
101662939|NCT02785146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662940|NCT02785146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101662941|NCT02785146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101662942|NCT02785146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101662943|NCT02785146|Immunologic Factors|immunologic factors|mesh-ancestor
101662944|NCT02785146|Antidotes|antidotes|mesh-ancestor
101662945|NCT02785146|Protective Agents|protective agents|mesh-ancestor
101662946|NCT02785146|Vitamin B Complex|vitamin b complex|mesh-ancestor
101662947|NCT02785146|Vitamins|vitamins|mesh-ancestor
101662948|NCT02785146|Micronutrients|micronutrients|mesh-ancestor
101662949|NCT00913965|Atenolol|atenolol|mesh-list
101662950|NCT00913965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101662951|NCT00913965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101662952|NCT00913965|Sympatholytics|sympatholytics|mesh-ancestor
101662953|NCT00913965|Autonomic Agents|autonomic agents|mesh-ancestor
101662954|NCT00913965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101662955|NCT00913965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662956|NCT00913965|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101662957|NCT00913965|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101662958|NCT00913965|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101662959|NCT00913965|Adrenergic Agents|adrenergic agents|mesh-ancestor
101662960|NCT00913965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101662961|NCT00913965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662962|NCT05753865|Paclitaxel|paclitaxel|mesh-list
101662963|NCT05753865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101662964|NCT05753865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101662965|NCT05753865|Tubulin Modulators|tubulin modulators|mesh-ancestor
101662966|NCT05753865|Antimitotic Agents|antimitotic agents|mesh-ancestor
101662967|NCT05753865|Mitosis Modulators|mitosis modulators|mesh-ancestor
101662968|NCT05753865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662970|NCT00869869|Antioxidants|antioxidants|mesh-ancestor
101662971|NCT00869869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662972|NCT00869869|Protective Agents|protective agents|mesh-ancestor
101662973|NCT00869869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662974|NCT00869869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101662975|NCT05753787|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101662976|NCT05753787|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101662977|NCT00874315|Cyclosporine|cyclosporine|mesh-list
101662978|NCT00874315|Mycophenolic Acid|mycophenolic acid|mesh-list
101662979|NCT00874315|Fludarabine|fludarabine|mesh-list
101662980|NCT00874315|Fludarabine phosphate|fludarabine phosphate|mesh-list
101662981|NCT00874315|Busulfan|busulfan|mesh-list
101662982|NCT00874315|Tacrolimus|tacrolimus|mesh-list
101662983|NCT00874315|Cyclosporins|cyclosporins|mesh-list
101662984|NCT00874315|Thymoglobulin|thymoglobulin|mesh-list
101662985|NCT00874315|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101662986|NCT00874315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101662987|NCT00874315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101662988|NCT00874315|Antimetabolites|antimetabolites|mesh-ancestor
101662989|NCT00874315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101662990|NCT00874315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101662991|NCT00874315|Immunologic Factors|immunologic factors|mesh-ancestor
101662992|NCT00874315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101662993|NCT00874315|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101662994|NCT00874315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101662995|NCT00874315|Antifungal Agents|antifungal agents|mesh-ancestor
101662996|NCT00874315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101662997|NCT00874315|Dermatologic Agents|dermatologic agents|mesh-ancestor
101662998|NCT00874315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101662999|NCT00874315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101663000|NCT00874315|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101663001|NCT00874315|Antitubercular Agents|antitubercular agents|mesh-ancestor
101663002|NCT00874315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101663003|NCT00874315|Alkylating Agents|alkylating agents|mesh-ancestor
101663004|NCT00874315|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101663005|NCT00874315|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101663007|NCT00874393|Dopamine|dopamine|mesh-list
101663008|NCT00874393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101663009|NCT00874393|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101663010|NCT00874393|Sympathomimetics|sympathomimetics|mesh-ancestor
101663011|NCT00874393|Autonomic Agents|autonomic agents|mesh-ancestor
101663012|NCT00874393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101663013|NCT00874393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663014|NCT00874393|Dopamine Agents|dopamine agents|mesh-ancestor
101663015|NCT00874393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101663016|NCT00874393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663017|NCT00874393|Protective Agents|protective agents|mesh-ancestor
101663018|NCT04199364|Poractant alfa|poractant alfa|mesh-list
101663019|NCT04199364|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
101663020|NCT04199364|Respiratory System Agents|respiratory system agents|mesh-ancestor
101663021|NCT00870025|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101663022|NCT00870025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101663023|NCT00870025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663024|NCT00877981|Parathyroid Hormone|parathyroid hormone|mesh-list
101663025|NCT00877981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101663026|NCT00877981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663028|NCT02786550|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101663029|NCT02786550|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101663030|NCT02786550|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101663031|NCT02786550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101663032|NCT02786550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663033|NCT02786550|Cholinergic Agents|cholinergic agents|mesh-ancestor
101663034|NCT02786550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101663035|NCT02786550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663036|NCT02786550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101320201|NCT01465906|Parasympatholytics|parasympatholytics|mesh-ancestor
101663037|NCT02786550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101663038|NCT02784054|Cyclophosphamide|cyclophosphamide|mesh-list
101663040|NCT02784054|Thiotepa|thiotepa|mesh-list
101663041|NCT02784054|Carboplatin|carboplatin|mesh-list
101663042|NCT02784054|Etoposide|etoposide|mesh-list
101663043|NCT02784054|Bleomycin|bleomycin|mesh-list
101663044|NCT02784054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101663045|NCT02784054|Immunologic Factors|immunologic factors|mesh-ancestor
101663046|NCT02784054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663047|NCT02784054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101663048|NCT02784054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101663049|NCT02784054|Alkylating Agents|alkylating agents|mesh-ancestor
101663050|NCT02784054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663051|NCT02784054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101663052|NCT02784054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101663053|NCT02784054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101663054|NCT02784054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101663055|NCT02784054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101663056|NCT02784054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101663057|NCT02784054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101663058|NCT00874861|Poly ICLC|poly iclc|mesh-list
101663059|NCT00874861|Interferon Inducers|interferon inducers|mesh-ancestor
101663060|NCT00874861|Immunologic Factors|immunologic factors|mesh-ancestor
101663061|NCT00874861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663062|NCT04038853|Vitamin D|vitamin d|mesh-list
101663063|NCT04038853|Cholecalciferol|cholecalciferol|mesh-list
101663064|NCT04038853|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
101663065|NCT04038853|Calcitriol|calcitriol|mesh-list
101663066|NCT04038853|Vitamins|vitamins|mesh-ancestor
101663067|NCT04038853|Micronutrients|micronutrients|mesh-ancestor
101663068|NCT04038853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663069|NCT04038853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101663070|NCT04038853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101663071|NCT04038853|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101663072|NCT04038853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101663073|NCT04038853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663074|NCT04038853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101663075|NCT02066220|Cyclophosphamide|cyclophosphamide|mesh-list
101663076|NCT02066220|Lomustine|lomustine|mesh-list
101663077|NCT02066220|Cisplatin|cisplatin|mesh-list
101663078|NCT02066220|Carboplatin|carboplatin|mesh-list
101663079|NCT02066220|Vincristine|vincristine|mesh-list
101663080|NCT02066220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101663081|NCT02066220|Immunologic Factors|immunologic factors|mesh-ancestor
101663082|NCT02066220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663083|NCT02066220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101663084|NCT02066220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101663085|NCT02066220|Alkylating Agents|alkylating agents|mesh-ancestor
101663086|NCT02066220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663087|NCT02066220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101663088|NCT02066220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101663089|NCT02066220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101663090|NCT02066220|Tubulin Modulators|tubulin modulators|mesh-ancestor
101663091|NCT02066220|Antimitotic Agents|antimitotic agents|mesh-ancestor
101663092|NCT02066220|Mitosis Modulators|mitosis modulators|mesh-ancestor
101663093|NCT00573391|Thalidomide|thalidomide|mesh-list
101663094|NCT00573391|Dexamethasone|dexamethasone|mesh-list
101663095|NCT00573391|Dexamethasone acetate|dexamethasone acetate|mesh-list
101663096|NCT00573391|Melphalan|melphalan|mesh-list
101663097|NCT00573391|Bortezomib|bortezomib|mesh-list
101663098|NCT00573391|BB 1101|bb 1101|mesh-list
101663099|NCT00573391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101663100|NCT00573391|Antiemetics|antiemetics|mesh-ancestor
101663101|NCT00573391|Autonomic Agents|autonomic agents|mesh-ancestor
101663102|NCT00573391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101663103|NCT00573391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663104|NCT00573391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101663105|NCT00573391|Glucocorticoids|glucocorticoids|mesh-ancestor
101663107|NCT00573391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101663108|NCT00573391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101663109|NCT00573391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101663110|NCT00573391|Protease Inhibitors|protease inhibitors|mesh-ancestor
101663111|NCT00573391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101663112|NCT00573391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663113|NCT00573391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101663114|NCT00573391|Alkylating Agents|alkylating agents|mesh-ancestor
101663115|NCT00573391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101663116|NCT00573391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101663117|NCT00573391|Immunologic Factors|immunologic factors|mesh-ancestor
101663118|NCT00573391|Leprostatic Agents|leprostatic agents|mesh-ancestor
101663119|NCT00573391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101663120|NCT00573391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101663121|NCT00573391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101663122|NCT00573391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101663123|NCT00573391|Growth Substances|growth substances|mesh-ancestor
101663124|NCT00573391|Growth Inhibitors|growth inhibitors|mesh-ancestor
101663125|NCT00590967|Cisplatin|cisplatin|mesh-list
101663126|NCT00590967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101663127|NCT02783976|Sofosbuvir|sofosbuvir|mesh-list
101663128|NCT02783976|Antiviral Agents|antiviral agents|mesh-ancestor
101663129|NCT02783976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101663130|NCT00878371|Morphine|morphine|mesh-list
101663131|NCT00878371|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101663132|NCT00878371|Narcotics|narcotics|mesh-ancestor
101663133|NCT00878371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101663134|NCT00878371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663135|NCT00878371|Analgesics|analgesics|mesh-ancestor
101663136|NCT00878371|Sensory System Agents|sensory system agents|mesh-ancestor
101663137|NCT00878371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101663138|NCT04054635|Fluorides|fluorides|mesh-list
101663139|NCT04054635|Cariostatic Agents|cariostatic agents|mesh-ancestor
101663140|NCT04054635|Protective Agents|protective agents|mesh-ancestor
101663141|NCT04054635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663142|NCT00923299|Trastuzumab|trastuzumab|mesh-list
101663143|NCT00923299|Cetuximab|cetuximab|mesh-list
101663144|NCT00923299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101663145|NCT00923299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101663146|NCT05753397|Ropivacaine|ropivacaine|mesh-list
101663147|NCT05753397|Anesthetics, Local|anesthetics, local|mesh-ancestor
101663148|NCT05753397|Anesthetics|anesthetics|mesh-ancestor
101663149|NCT05753397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101663150|NCT05753397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663151|NCT05753397|Sensory System Agents|sensory system agents|mesh-ancestor
101663152|NCT05753397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101663153|NCT00875173|Selenium|selenium|mesh-list
101663154|NCT00875173|Antioxidants|antioxidants|mesh-list
101663155|NCT00875173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663156|NCT00875173|Protective Agents|protective agents|mesh-ancestor
101663157|NCT00875173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663158|NCT00875173|Trace Elements|trace elements|mesh-ancestor
101663159|NCT00875173|Micronutrients|micronutrients|mesh-ancestor
101663161|NCT04029831|Propofol|propofol|mesh-list
101663162|NCT04029831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101663163|NCT04029831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101663164|NCT04029831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663165|NCT04029831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101663166|NCT04029831|Anesthetics, General|anesthetics, general|mesh-ancestor
101663167|NCT04029831|Anesthetics|anesthetics|mesh-ancestor
101663168|NCT04029831|Analgesics|analgesics|mesh-ancestor
101663169|NCT04029831|Sensory System Agents|sensory system agents|mesh-ancestor
101663170|NCT04029831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101663171|NCT04029831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101663172|NCT04029831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101663173|NCT04029831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101663174|NCT04029831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101663175|NCT04029831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663176|NCT00878449|Etoposide|etoposide|mesh-list
101663177|NCT00878449|Navitoclax|navitoclax|mesh-list
101663178|NCT00878449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101663179|NCT00878449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101663180|NCT00878449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101663181|NCT00878449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101663182|NCT00878449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101663183|NCT00878449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663184|NCT00875407|3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide|3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide|mesh-list
101663185|NCT00875407|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101663186|NCT00875407|Dopamine Agents|dopamine agents|mesh-ancestor
101663187|NCT00875407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101663188|NCT00875407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663189|NCT00875407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663190|NCT00875875|Rifaximin|rifaximin|mesh-list
101663191|NCT00875875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101663192|NCT00875875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101663193|NCT00875875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101663194|NCT01716312|Omalizumab|omalizumab|mesh-list
101663195|NCT01716312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101663196|NCT01716312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101663197|NCT01716312|Respiratory System Agents|respiratory system agents|mesh-ancestor
101663198|NCT00880243|Cytarabine|cytarabine|mesh-list
101663199|NCT00880243|Etoposide|etoposide|mesh-list
101663200|NCT00880243|Mitoxantrone|mitoxantrone|mesh-list
101663201|NCT00880243|Daunorubicin|daunorubicin|mesh-list
101663202|NCT00880243|Molgramostim|molgramostim|mesh-list
101663203|NCT00880243|Sargramostim|sargramostim|mesh-list
101663204|NCT00880243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101663205|NCT00880243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101663206|NCT00880243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101663207|NCT00880243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101663208|NCT00880243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101663209|NCT00880243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663210|NCT00880243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101663211|NCT00880243|Antimetabolites|antimetabolites|mesh-ancestor
101663212|NCT00880243|Antiviral Agents|antiviral agents|mesh-ancestor
101663213|NCT00880243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101663214|NCT00880243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101663215|NCT00880243|Immunologic Factors|immunologic factors|mesh-ancestor
101663216|NCT00880243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663217|NCT00880243|Analgesics|analgesics|mesh-ancestor
101663218|NCT00880243|Sensory System Agents|sensory system agents|mesh-ancestor
101663219|NCT00880243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101663220|NCT00880243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101663221|NCT02783586|Bupivacaine|bupivacaine|mesh-list
101663222|NCT02783586|Anesthetics, Local|anesthetics, local|mesh-ancestor
101663223|NCT02783586|Anesthetics|anesthetics|mesh-ancestor
101663224|NCT02783586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101663225|NCT02783586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663226|NCT02783586|Sensory System Agents|sensory system agents|mesh-ancestor
101663227|NCT02783586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101663228|NCT00590577|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101663229|NCT00590577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101663230|NCT00590577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101663231|NCT00590577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101663232|NCT00590577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663233|NCT00590577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101663234|NCT00590577|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101663236|NCT00590577|Serotonin Agents|serotonin agents|mesh-ancestor
101663237|NCT00590577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101663238|NCT00590577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101825877|NCT00864305|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101663239|NCT00590577|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101663240|NCT00590577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101663241|NCT00590577|Dopamine Agents|dopamine agents|mesh-ancestor
101663242|NCT00880321|Dabrafenib|dabrafenib|mesh-list
101663243|NCT00880321|Midazolam|midazolam|mesh-list
101663244|NCT00880321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101663245|NCT00880321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101663246|NCT00880321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101663247|NCT00880321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663248|NCT00880321|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101663249|NCT00880321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101663250|NCT00880321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101663251|NCT00880321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101663252|NCT00880321|Anesthetics, General|anesthetics, general|mesh-ancestor
101663254|NCT00880321|GABA Modulators|gaba modulators|mesh-ancestor
101663255|NCT00880321|GABA Agents|gaba agents|mesh-ancestor
101663256|NCT00880321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101663257|NCT00880321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663258|NCT00880321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101663259|NCT00880321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101663260|NCT00880321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101663261|NCT02608437|Ipilimumab|ipilimumab|mesh-list
101663262|NCT02608437|Guadecitabine|guadecitabine|mesh-list
101663263|NCT02608437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101663264|NCT02608437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320429|NCT05321160|Sevoflurane|sevoflurane|mesh-list
101663265|NCT02608437|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101663266|NCT02608437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663267|NCT05753007|Cannabidiol|cannabidiol|mesh-list
101663268|NCT05753007|Anticonvulsants|anticonvulsants|mesh-ancestor
101663269|NCT04230330|Dexamethasone|dexamethasone|mesh-list
101663270|NCT04230330|Gemcitabine|gemcitabine|mesh-list
101663271|NCT04230330|Nivolumab|nivolumab|mesh-list
101663272|NCT04230330|Asparaginase|asparaginase|mesh-list
101663273|NCT04230330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101663274|NCT04230330|Antiemetics|antiemetics|mesh-ancestor
101663275|NCT04230330|Autonomic Agents|autonomic agents|mesh-ancestor
101663276|NCT04230330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101663277|NCT04230330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663278|NCT04230330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101663279|NCT04230330|Glucocorticoids|glucocorticoids|mesh-ancestor
101663280|NCT04230330|Hormones|hormones|mesh-ancestor
101663281|NCT04230330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101663282|NCT04230330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101663283|NCT04230330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101663284|NCT04230330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101663285|NCT04230330|Antimetabolites|antimetabolites|mesh-ancestor
101663286|NCT04230330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663287|NCT04230330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101663288|NCT04230330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101663289|NCT02785068|Leucovorin|leucovorin|mesh-list
101663290|NCT02785068|Fluorouracil|fluorouracil|mesh-list
101663291|NCT02785068|Antimetabolites|antimetabolites|mesh-ancestor
101663292|NCT02785068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663293|NCT02785068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101663294|NCT02785068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101663295|NCT02785068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101663296|NCT02785068|Immunologic Factors|immunologic factors|mesh-ancestor
101663297|NCT02785068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663298|NCT02785068|Antidotes|antidotes|mesh-ancestor
101663299|NCT02785068|Protective Agents|protective agents|mesh-ancestor
101663300|NCT02785068|Vitamin B Complex|vitamin b complex|mesh-ancestor
101663301|NCT02785068|Vitamins|vitamins|mesh-ancestor
101663302|NCT02785068|Micronutrients|micronutrients|mesh-ancestor
101663303|NCT05752929|Insulin|insulin|mesh-list
101663304|NCT05752929|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101663306|NCT05752929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663307|NCT00880477|Edetic Acid|edetic acid|mesh-list
101663308|NCT00880477|Vaccines|vaccines|mesh-list
101663309|NCT00880477|Pentetic Acid|pentetic acid|mesh-list
101663310|NCT00880477|Immunologic Factors|immunologic factors|mesh-ancestor
101663311|NCT00880477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663312|NCT00880477|Antidotes|antidotes|mesh-ancestor
101663313|NCT00880477|Protective Agents|protective agents|mesh-ancestor
101663314|NCT00880477|Chelating Agents|chelating agents|mesh-ancestor
101663315|NCT00880477|Sequestering Agents|sequestering agents|mesh-ancestor
101663316|NCT00880477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663317|NCT00880477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101663318|NCT00880477|Anticoagulants|anticoagulants|mesh-ancestor
101663319|NCT00880477|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101663320|NCT05293938|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
101663321|NCT05293938|Cathartics|cathartics|mesh-ancestor
101663322|NCT05293938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101663323|NCT00882739|Clopidogrel|clopidogrel|mesh-list
101663324|NCT00882739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101663325|NCT00882739|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101663326|NCT00882739|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101663327|NCT00882739|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101663328|NCT00882739|Purinergic Agents|purinergic agents|mesh-ancestor
101663329|NCT00882739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101663330|NCT00882739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663331|NCT00882739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663332|NCT02783040|Digoxin|digoxin|mesh-list
101663333|NCT02783040|Midazolam|midazolam|mesh-list
101663334|NCT02783040|BI 425809|bi 425809|mesh-list
101663335|NCT02783040|Omeprazole|omeprazole|mesh-list
101663336|NCT02783040|Warfarin|warfarin|mesh-list
101663337|NCT02783040|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101663338|NCT02783040|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101663339|NCT02783040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101663340|NCT02783040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663341|NCT02783040|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101663342|NCT02783040|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101663343|NCT02783040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101663344|NCT02783040|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101663345|NCT02783040|Anesthetics, General|anesthetics, general|mesh-ancestor
101663346|NCT02783040|Anesthetics|anesthetics|mesh-ancestor
101663347|NCT02783040|GABA Modulators|gaba modulators|mesh-ancestor
101663348|NCT02783040|GABA Agents|gaba agents|mesh-ancestor
101663349|NCT02783040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101663350|NCT02783040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663351|NCT02783040|Anticoagulants|anticoagulants|mesh-ancestor
101663352|NCT02783040|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101663353|NCT02783040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101663354|NCT02783040|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101663355|NCT02783040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101663356|NCT02783040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101663357|NCT02783040|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101663358|NCT02783040|Protective Agents|protective agents|mesh-ancestor
101663359|NCT02783040|Nootropic Agents|nootropic agents|mesh-ancestor
101663360|NCT02512926|Cyclophosphamide|cyclophosphamide|mesh-list
101663361|NCT02512926|Etoposide|etoposide|mesh-list
101663362|NCT02512926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101663363|NCT02512926|Immunologic Factors|immunologic factors|mesh-ancestor
101663364|NCT02512926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663365|NCT02512926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101663366|NCT02512926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101663367|NCT02512926|Alkylating Agents|alkylating agents|mesh-ancestor
101663368|NCT02512926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663369|NCT02512926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101663370|NCT02512926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101663371|NCT02512926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101825889|NCT00864617|Nifedipine|nifedipine|mesh-list
101663372|NCT02512926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101663373|NCT02512926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101663374|NCT02512926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101663375|NCT02786082|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
101663376|NCT02786082|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101663377|NCT02786082|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101663378|NCT02786082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663379|NCT05275686|Fluticasone|fluticasone|mesh-list
101663381|NCT05275686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101663382|NCT05275686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101663383|NCT05275686|Autonomic Agents|autonomic agents|mesh-ancestor
101663384|NCT05275686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101663385|NCT05275686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663386|NCT05275686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101663387|NCT05275686|Respiratory System Agents|respiratory system agents|mesh-ancestor
101663388|NCT05275686|Dermatologic Agents|dermatologic agents|mesh-ancestor
101663389|NCT05275686|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101663390|NCT01503606|Clarithromycin|clarithromycin|mesh-list
101663391|NCT01503606|Cefazolin|cefazolin|mesh-list
101663392|NCT01503606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101663393|NCT01503606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101663394|NCT01503606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101663395|NCT01503606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101663396|NCT01503606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663397|NCT01503606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101663398|NCT01503606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101663399|NCT00882973|genexol-PM|genexol-pm|mesh-list
101663400|NCT00882973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101663401|NCT00882973|Tubulin Modulators|tubulin modulators|mesh-ancestor
101663402|NCT00882973|Antimitotic Agents|antimitotic agents|mesh-ancestor
101663403|NCT00882973|Mitosis Modulators|mitosis modulators|mesh-ancestor
101663404|NCT00882973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663405|NCT00805935|Leuprolide|leuprolide|mesh-list
101663406|NCT00805935|Menotropins|menotropins|mesh-list
101663407|NCT00805935|Progesterone|progesterone|mesh-list
101663408|NCT00805935|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101663409|NCT00805935|Progestins|progestins|mesh-ancestor
101663410|NCT00805935|Hormones|hormones|mesh-ancestor
101663411|NCT00805935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101663412|NCT00805935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663413|NCT00805935|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101663414|NCT00805935|Fertility Agents|fertility agents|mesh-ancestor
101663415|NCT00805935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101663416|NCT00805935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101663417|NCT00805935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101663418|NCT00878917|Dorzolamide|dorzolamide|mesh-list
101663419|NCT00878917|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101663420|NCT00878917|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101663421|NCT00878917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101663422|NCT00878917|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101663423|NCT00878917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101663424|NCT00878917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663426|NCT00638118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101663427|NCT00638118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101663428|NCT00638118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101663429|NCT00638118|Histamine Antagonists|histamine antagonists|mesh-ancestor
101663430|NCT00638118|Histamine Agents|histamine agents|mesh-ancestor
101663431|NCT00638118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101663432|NCT00638118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663433|NCT00638118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663434|NCT00805545|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101663435|NCT00805545|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101663436|NCT00805545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101663437|NCT00805545|Antitubercular Agents|antitubercular agents|mesh-ancestor
101663438|NCT00590031|Irinotecan|irinotecan|mesh-list
101663439|NCT00590031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101663440|NCT00590031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101663441|NCT00590031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101663442|NCT00590031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101663443|NCT00590031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663444|NCT02783196|Liraglutide|liraglutide|mesh-list
101663445|NCT02783196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101663446|NCT02783196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663447|NCT02783196|Incretins|incretins|mesh-ancestor
101663448|NCT02783196|Hormones|hormones|mesh-ancestor
101663449|NCT02783196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101663450|NCT05188170|Niclosamide|niclosamide|mesh-list
101663451|NCT05188170|Anticestodal Agents|anticestodal agents|mesh-ancestor
101663452|NCT05188170|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101663453|NCT05188170|Anthelmintics|anthelmintics|mesh-ancestor
101663454|NCT05188170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101663455|NCT05188170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101663456|NCT05188170|Antinematodal Agents|antinematodal agents|mesh-ancestor
101663457|NCT02782338|Diclofenac|diclofenac|mesh-list
101663458|NCT02782338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101663459|NCT02782338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101663460|NCT02782338|Analgesics|analgesics|mesh-ancestor
101663461|NCT02782338|Sensory System Agents|sensory system agents|mesh-ancestor
101663462|NCT02782338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101663463|NCT02782338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663464|NCT02782338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101663465|NCT02782338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101663466|NCT02782338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101663467|NCT02782338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101663468|NCT02782338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663469|NCT02782260|Dipyridamole|dipyridamole|mesh-list
101663470|NCT02782260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101663471|NCT02782260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101663472|NCT02782260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663473|NCT02782260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101663474|NCT02782260|Vasodilator Agents|vasodilator agents|mesh-ancestor
101663475|NCT05031936|Ropivacaine|ropivacaine|mesh-list
101663476|NCT05031936|Anesthetics, Local|anesthetics, local|mesh-ancestor
101663477|NCT05031936|Anesthetics|anesthetics|mesh-ancestor
101663478|NCT05031936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101663479|NCT05031936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663480|NCT05031936|Sensory System Agents|sensory system agents|mesh-ancestor
101663481|NCT05031936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101663482|NCT03577704|Paclitaxel|paclitaxel|mesh-list
101663483|NCT03577704|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101663484|NCT03577704|Cisplatin|cisplatin|mesh-list
101663485|NCT03577704|Carboplatin|carboplatin|mesh-list
101663486|NCT03577704|Gemcitabine|gemcitabine|mesh-list
101663487|NCT03577704|Oxaliplatin|oxaliplatin|mesh-list
101663488|NCT03577704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101663489|NCT03577704|Antibodies|antibodies|mesh-list
101663490|NCT03577704|Immunoglobulins|immunoglobulins|mesh-list
101663491|NCT03577704|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101663492|NCT03577704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101663493|NCT03577704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101663494|NCT03577704|Tubulin Modulators|tubulin modulators|mesh-ancestor
101663495|NCT03577704|Antimitotic Agents|antimitotic agents|mesh-ancestor
101663496|NCT03577704|Mitosis Modulators|mitosis modulators|mesh-ancestor
101663497|NCT03577704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663498|NCT03577704|Immunologic Factors|immunologic factors|mesh-ancestor
101663499|NCT03577704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663500|NCT03577704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101663501|NCT03577704|Antimetabolites|antimetabolites|mesh-ancestor
101663502|NCT05176626|Phentermine|phentermine|mesh-list
101663503|NCT05176626|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101663504|NCT05176626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663505|NCT05176626|Appetite Depressants|appetite depressants|mesh-ancestor
101663506|NCT05176626|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101663507|NCT05176626|Sympathomimetics|sympathomimetics|mesh-ancestor
101663508|NCT05176626|Autonomic Agents|autonomic agents|mesh-ancestor
101663509|NCT05176626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101663510|NCT05176626|Adrenergic Agents|adrenergic agents|mesh-ancestor
101663511|NCT05176626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101663512|NCT05176626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663513|NCT05030766|Nicotine|nicotine|mesh-list
101663514|NCT05030766|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101663515|NCT05030766|Autonomic Agents|autonomic agents|mesh-ancestor
101663516|NCT05030766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101663517|NCT05030766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663518|NCT05030766|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101663519|NCT05030766|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101663520|NCT05030766|Cholinergic Agents|cholinergic agents|mesh-ancestor
101663521|NCT05030766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101663522|NCT05030766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663523|NCT00615199|Tofacitinib|tofacitinib|mesh-list
101663524|NCT00615199|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101663525|NCT00615199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101663526|NCT00615199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101663527|NCT00615199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663528|NCT05328024|Immunomodulating Agents|immunomodulating agents|mesh-list
101663530|NCT05328024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663531|NCT00879073|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101663532|NCT00879073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101663533|NCT00879073|Alkylating Agents|alkylating agents|mesh-ancestor
101663534|NCT00879073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663535|NCT00879073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101663537|NCT00880867|Interferon Inducers|interferon inducers|mesh-ancestor
101663538|NCT00880867|Immunologic Factors|immunologic factors|mesh-ancestor
101663539|NCT00880867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663540|NCT04228926|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101663541|NCT04228926|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101663542|NCT02782182|Leucovorin|leucovorin|mesh-list
101663543|NCT02782182|Oxaliplatin|oxaliplatin|mesh-list
101663544|NCT02782182|Irinotecan|irinotecan|mesh-list
101663545|NCT02782182|Folfirinox|folfirinox|mesh-list
101663546|NCT02782182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101663547|NCT02782182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101663548|NCT02782182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101663549|NCT02782182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101663550|NCT02782182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663551|NCT02782182|Antidotes|antidotes|mesh-ancestor
101663552|NCT02782182|Protective Agents|protective agents|mesh-ancestor
101663553|NCT02782182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663554|NCT02782182|Vitamin B Complex|vitamin b complex|mesh-ancestor
101663555|NCT02782182|Vitamins|vitamins|mesh-ancestor
101663556|NCT02782182|Micronutrients|micronutrients|mesh-ancestor
101663557|NCT02780778|Docetaxel|docetaxel|mesh-list
101663558|NCT02780778|Apatinib|apatinib|mesh-list
101663559|NCT02780778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101663560|NCT02780778|Tubulin Modulators|tubulin modulators|mesh-ancestor
101663561|NCT02780778|Antimitotic Agents|antimitotic agents|mesh-ancestor
101663562|NCT02780778|Mitosis Modulators|mitosis modulators|mesh-ancestor
101663563|NCT02780778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663564|NCT02780778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101663565|NCT02780778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101663566|NCT00881101|Paclitaxel|paclitaxel|mesh-list
101663567|NCT00881101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101663568|NCT00881101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101663569|NCT00881101|Tubulin Modulators|tubulin modulators|mesh-ancestor
101663570|NCT00881101|Antimitotic Agents|antimitotic agents|mesh-ancestor
101663571|NCT00881101|Mitosis Modulators|mitosis modulators|mesh-ancestor
101663572|NCT00881101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663573|NCT00883909|Dutasteride|dutasteride|mesh-list
101663574|NCT00883909|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101663575|NCT00883909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101663576|NCT00883909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101663577|NCT00883909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663578|NCT00883909|Hormone Antagonists|hormone antagonists|mesh-ancestor
101663579|NCT00883909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101663580|NCT00883909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663581|NCT00634686|Vitamin D|vitamin d|mesh-list
101663582|NCT00634686|Calcium|calcium|mesh-list
101663583|NCT00634686|Vitamins|vitamins|mesh-ancestor
101663584|NCT00634686|Micronutrients|micronutrients|mesh-ancestor
101663585|NCT00634686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663586|NCT00634686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101663587|NCT00634686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101663588|NCT05340192|Octreotide|octreotide|mesh-list
101663589|NCT05340192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101663590|NCT05340192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101663591|NCT05340192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101663592|NCT03955861|Adalimumab|adalimumab|mesh-list
101663593|NCT03955861|Golimumab|golimumab|mesh-list
101663594|NCT03955861|Certolizumab Pegol|certolizumab pegol|mesh-list
101663595|NCT03955861|Etanercept|etanercept|mesh-list
101663596|NCT03955861|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101663597|NCT03955861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101663598|NCT03955861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101663599|NCT03955861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101663600|NCT03955861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101663601|NCT03955861|Analgesics|analgesics|mesh-ancestor
101663602|NCT03955861|Sensory System Agents|sensory system agents|mesh-ancestor
101663603|NCT03955861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101663604|NCT03955861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663605|NCT03955861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101663606|NCT03955861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101663607|NCT03955861|Immunologic Factors|immunologic factors|mesh-ancestor
101663608|NCT00881179|Clarithromycin|clarithromycin|mesh-list
101663609|NCT00881179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101663610|NCT00881179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101663611|NCT00881179|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101663612|NCT00881179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101663613|NCT00881179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663615|NCT00881179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101663616|NCT02781246|Dexmedetomidine|dexmedetomidine|mesh-list
101663617|NCT02781246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101663618|NCT02781246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101663619|NCT02781246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663620|NCT02781246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101663621|NCT02781246|Analgesics|analgesics|mesh-ancestor
101663622|NCT02781246|Sensory System Agents|sensory system agents|mesh-ancestor
101663623|NCT02781246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101663624|NCT02781246|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101663625|NCT02781246|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101663626|NCT02781246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101663627|NCT02781246|Adrenergic Agents|adrenergic agents|mesh-ancestor
101663628|NCT02781246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101663629|NCT02781246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663630|NCT00613951|Insulin|insulin|mesh-list
101663631|NCT00613951|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101663632|NCT00613951|Metformin|metformin|mesh-list
101663633|NCT00613951|Insulin Aspart|insulin aspart|mesh-list
101663634|NCT00613951|Insulin, Long-Acting|insulin, long-acting|mesh-list
101663635|NCT00613951|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101663636|NCT00613951|Biphasic Insulins|biphasic insulins|mesh-list
101663637|NCT00613951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101663638|NCT00613951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663639|NCT00881413|Esomeprazole|esomeprazole|mesh-list
101663640|NCT00881413|Pantoprazole|pantoprazole|mesh-list
101663641|NCT00881413|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101663642|NCT00881413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101320803|NCT00276523|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101663643|NCT00881413|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101663644|NCT00881413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101663645|NCT00881413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663646|NCT00881491|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101663647|NCT00881491|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101663648|NCT00881491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101663649|NCT00881491|Antitubercular Agents|antitubercular agents|mesh-ancestor
101663650|NCT00958841|Pasireotide|pasireotide|mesh-list
101663651|NCT00958841|Hormones|hormones|mesh-ancestor
101663652|NCT00958841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101663653|NCT00958841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663654|NCT02937116|Cisplatin|cisplatin|mesh-list
101663655|NCT02937116|Gemcitabine|gemcitabine|mesh-list
101663656|NCT02937116|Capecitabine|capecitabine|mesh-list
101663657|NCT02937116|Oxaliplatin|oxaliplatin|mesh-list
101663658|NCT02937116|Irinotecan|irinotecan|mesh-list
101663659|NCT02937116|Etoposide|etoposide|mesh-list
101663660|NCT02937116|Pemetrexed|pemetrexed|mesh-list
101663661|NCT02937116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101663662|NCT02937116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101663664|NCT02937116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663665|NCT02937116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101663666|NCT02937116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101663667|NCT02937116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101663668|NCT02937116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101663669|NCT02937116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101663670|NCT02937116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101663671|NCT02937116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101663672|NCT03927105|Nivolumab|nivolumab|mesh-list
101663673|NCT03927105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101663674|NCT03927105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101663675|NCT03927105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101663676|NCT03927105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663677|NCT00613327|Oxybutynin|oxybutynin|mesh-list
101663678|NCT00613327|Parasympatholytics|parasympatholytics|mesh-ancestor
101663679|NCT00613327|Autonomic Agents|autonomic agents|mesh-ancestor
101663680|NCT00613327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101663681|NCT00613327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663682|NCT00613327|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101663683|NCT00613327|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101663684|NCT00613327|Cholinergic Agents|cholinergic agents|mesh-ancestor
101663685|NCT00613327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101663686|NCT00613327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663687|NCT00613327|Urological Agents|urological agents|mesh-ancestor
101663688|NCT04273997|Metronidazole|metronidazole|mesh-list
101663689|NCT04273997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101663690|NCT04273997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101663691|NCT04273997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101663692|NCT04273997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101663693|NCT05339802|Linezolid|linezolid|mesh-list
101663694|NCT05339802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101663695|NCT05339802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101663696|NCT05339802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101663697|NCT05339802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101825941|NCT04137120|Aflibercept|aflibercept|mesh-list
101663698|NCT05339802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663700|NCT04649203|Niacinamide|niacinamide|mesh-list
101663701|NCT04649203|Niacin|niacin|mesh-list
101663702|NCT04649203|Nicotinic Acids|nicotinic acids|mesh-list
101663703|NCT04649203|Vitamin B Complex|vitamin b complex|mesh-ancestor
101663704|NCT04649203|Vitamins|vitamins|mesh-ancestor
101663705|NCT04649203|Micronutrients|micronutrients|mesh-ancestor
101663706|NCT04649203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663707|NCT04649203|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101663708|NCT04649203|Dermatologic Agents|dermatologic agents|mesh-ancestor
101663709|NCT04649203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101663710|NCT04649203|Antimetabolites|antimetabolites|mesh-ancestor
101663711|NCT04649203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663712|NCT04649203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101663713|NCT04649203|Vasodilator Agents|vasodilator agents|mesh-ancestor
101663714|NCT00881725|Metformin|metformin|mesh-list
101663715|NCT00881725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101663716|NCT00881725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663717|NCT00954941|Ondansetron|ondansetron|mesh-list
101663718|NCT00954941|Aprepitant|aprepitant|mesh-list
101663719|NCT00954941|Antiemetics|antiemetics|mesh-ancestor
101320889|NCT00275938|Interferons|interferons|mesh-list
101663720|NCT00954941|Autonomic Agents|autonomic agents|mesh-ancestor
101663721|NCT00954941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101663722|NCT00954941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663723|NCT00954941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101663724|NCT00954941|Antipruritics|antipruritics|mesh-ancestor
101663725|NCT00954941|Dermatologic Agents|dermatologic agents|mesh-ancestor
101663726|NCT00954941|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101663727|NCT00954941|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101663728|NCT00954941|Serotonin Agents|serotonin agents|mesh-ancestor
101663729|NCT00954941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101663730|NCT00954941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663731|NCT00954941|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101663733|NCT05339646|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101663734|NCT05339646|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101663735|NCT05339646|Protease Inhibitors|protease inhibitors|mesh-ancestor
101663736|NCT05339646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101663737|NCT05339646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663738|NCT05339646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101663739|NCT05339646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101663740|NCT05339646|Antiviral Agents|antiviral agents|mesh-ancestor
101663741|NCT05339646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101663742|NCT05339646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101663743|NCT05339646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101663744|NCT00630695|Lanreotide|lanreotide|mesh-list
101663745|NCT00630695|Somatostatin|somatostatin|mesh-list
101663746|NCT00630695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101663747|NCT00630695|Hormones|hormones|mesh-ancestor
101663748|NCT00630695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101663749|NCT00630695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663750|NCT02843438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101663751|NCT00954707|Aspirin|aspirin|mesh-list
101663752|NCT00954707|Clopidogrel|clopidogrel|mesh-list
101663753|NCT00954707|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101663754|NCT00954707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101663755|NCT00954707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101663756|NCT00954707|Analgesics|analgesics|mesh-ancestor
101663757|NCT00954707|Sensory System Agents|sensory system agents|mesh-ancestor
101663758|NCT00954707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101663759|NCT00954707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663760|NCT00954707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101663761|NCT00954707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101663762|NCT00954707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101663763|NCT00954707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101663764|NCT00954707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663765|NCT00954707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101663766|NCT00954707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101663767|NCT00954707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101663768|NCT00954707|Antipyretics|antipyretics|mesh-ancestor
101663769|NCT00954707|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101663770|NCT00954707|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101663771|NCT00954707|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101663772|NCT00954707|Purinergic Agents|purinergic agents|mesh-ancestor
101663773|NCT00954707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101663774|NCT00630851|Donepezil|donepezil|mesh-list
101663775|NCT00630851|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101663776|NCT00630851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101663777|NCT00630851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663778|NCT00630851|Cholinergic Agents|cholinergic agents|mesh-ancestor
101663779|NCT00630851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101663780|NCT00630851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663781|NCT00630851|Nootropic Agents|nootropic agents|mesh-ancestor
101663782|NCT00613171|Imatinib Mesylate|imatinib mesylate|mesh-list
101663783|NCT00613171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101663784|NCT00613171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101663785|NCT00613171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101663786|NCT00613171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663787|NCT05156892|Tamoxifen|tamoxifen|mesh-list
101663788|NCT05156892|Itraconazole|itraconazole|mesh-list
101663789|NCT05156892|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101663790|NCT05156892|Hormone Antagonists|hormone antagonists|mesh-ancestor
101663791|NCT05156892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101663792|NCT05156892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663793|NCT05156892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101825961|NCT00516048|Exenatide|exenatide|mesh-list
101663794|NCT05156892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101663795|NCT05156892|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101663796|NCT05156892|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101663797|NCT05156892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101663798|NCT05156892|Antifungal Agents|antifungal agents|mesh-ancestor
101663799|NCT05156892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101663800|NCT05156892|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101663801|NCT05156892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101663802|NCT05156892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101663803|NCT05156892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663804|NCT05156892|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101663805|NCT05156892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101663807|NCT03894345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101663808|NCT03894345|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101663809|NCT03894345|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101663810|NCT03894345|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101663811|NCT03894345|Adrenergic Agents|adrenergic agents|mesh-ancestor
101663812|NCT03894345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101663813|NCT03894345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663814|NCT03894345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663815|NCT02859077|Carboplatin|carboplatin|mesh-list
101663816|NCT02859077|Gemcitabine|gemcitabine|mesh-list
101663817|NCT02859077|Pemetrexed|pemetrexed|mesh-list
101663818|NCT02859077|Gefitinib|gefitinib|mesh-list
101663819|NCT02859077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101663820|NCT02859077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101663821|NCT02859077|Antimetabolites|antimetabolites|mesh-ancestor
101663822|NCT02859077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663823|NCT02859077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101663824|NCT02859077|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101663825|NCT02859077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101663826|NCT02859077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101663827|NCT00879307|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101663828|NCT00879307|Antidepressive Agents|antidepressive agents|mesh-ancestor
101663829|NCT00879307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101663830|NCT00879307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101663831|NCT00879307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101663832|NCT00879307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101663833|NCT00879307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663834|NCT03851835|Ondansetron|ondansetron|mesh-list
101663835|NCT03851835|Antiemetics|antiemetics|mesh-ancestor
101663836|NCT03851835|Autonomic Agents|autonomic agents|mesh-ancestor
101663837|NCT03851835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101663838|NCT03851835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663839|NCT03851835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101663840|NCT03851835|Antipruritics|antipruritics|mesh-ancestor
101663841|NCT03851835|Dermatologic Agents|dermatologic agents|mesh-ancestor
101663842|NCT03851835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101663843|NCT03851835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101663844|NCT03851835|Serotonin Agents|serotonin agents|mesh-ancestor
101663845|NCT03851835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101663846|NCT03851835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663847|NCT00879385|Decitabine|decitabine|mesh-list
101663848|NCT00879385|Panitumumab|panitumumab|mesh-list
101663849|NCT00879385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101663850|NCT00879385|Antimetabolites|antimetabolites|mesh-ancestor
101663851|NCT00879385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663852|NCT00879385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101663853|NCT00879385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101663854|NCT00879385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101663855|NCT00914121|Moxifloxacin|moxifloxacin|mesh-list
101663856|NCT00914121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101663857|NCT00914121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101663858|NCT00914121|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101663859|NCT00914121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101663860|NCT00914121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101663861|NCT00914121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663862|NCT00914121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101663863|NCT00953225|Vitamin D|vitamin d|mesh-list
101663864|NCT00953225|Cholecalciferol|cholecalciferol|mesh-list
101663865|NCT00953225|Vitamins|vitamins|mesh-ancestor
101663866|NCT00953225|Micronutrients|micronutrients|mesh-ancestor
101663867|NCT00953225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663868|NCT00953225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101663869|NCT00953225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101663870|NCT03819231|Oxytocin|oxytocin|mesh-list
101663871|NCT03819231|Oxytocics|oxytocics|mesh-ancestor
101663872|NCT03819231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101663873|NCT03819231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663874|NCT00613015|Guanfacine|guanfacine|mesh-list
101663875|NCT00613015|Modafinil|modafinil|mesh-list
101663876|NCT00613015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101663877|NCT00613015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663878|NCT00613015|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101663879|NCT00613015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101663880|NCT00613015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101663881|NCT00613015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663882|NCT00613015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101663883|NCT00613015|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101663884|NCT00613015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101663885|NCT00613015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101663886|NCT00613015|Adrenergic Agents|adrenergic agents|mesh-ancestor
101663887|NCT00613015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101663888|NCT02779608|Docetaxel|docetaxel|mesh-list
101663889|NCT02779608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101663890|NCT02779608|Tubulin Modulators|tubulin modulators|mesh-ancestor
101663891|NCT02779608|Antimitotic Agents|antimitotic agents|mesh-ancestor
101663892|NCT02779608|Mitosis Modulators|mitosis modulators|mesh-ancestor
101663893|NCT02779608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663894|NCT02543671|Vitamin D|vitamin d|mesh-list
101663895|NCT02543671|Cholecalciferol|cholecalciferol|mesh-list
101663896|NCT02543671|Vitamins|vitamins|mesh-ancestor
101663897|NCT02543671|Micronutrients|micronutrients|mesh-ancestor
101663898|NCT02543671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663899|NCT02543671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101663900|NCT02543671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101663901|NCT02838992|Cyclosporine|cyclosporine|mesh-list
101663902|NCT02838992|Cyclophosphamide|cyclophosphamide|mesh-list
101663903|NCT02838992|Cyclosporins|cyclosporins|mesh-list
101663904|NCT02838992|Thymoglobulin|thymoglobulin|mesh-list
101663905|NCT02838992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101663906|NCT02838992|Immunologic Factors|immunologic factors|mesh-ancestor
101663907|NCT02838992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663908|NCT02838992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101663909|NCT02838992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101663911|NCT02838992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663912|NCT02838992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101663913|NCT02838992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101663914|NCT02838992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101663915|NCT02838992|Antifungal Agents|antifungal agents|mesh-ancestor
101663916|NCT02838992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101663917|NCT02838992|Dermatologic Agents|dermatologic agents|mesh-ancestor
101663918|NCT02838992|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101663919|NCT00879541|Factor VIII|factor viii|mesh-list
101663920|NCT00879541|Coagulants|coagulants|mesh-ancestor
101663921|NCT00884299|Antioxidants|antioxidants|mesh-list
101663922|NCT00884299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663923|NCT00884299|Protective Agents|protective agents|mesh-ancestor
101663924|NCT00884299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663925|NCT02843126|Trastuzumab|trastuzumab|mesh-list
101663926|NCT02843126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101663927|NCT02843126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101663928|NCT04201652|Anesthetics|anesthetics|mesh-list
101663929|NCT04201652|Anesthetics, Local|anesthetics, local|mesh-list
101663930|NCT04201652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101663931|NCT04201652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663932|NCT04201652|Sensory System Agents|sensory system agents|mesh-ancestor
101663933|NCT04201652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101663934|NCT05338476|Midazolam|midazolam|mesh-list
101663935|NCT05338476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101663936|NCT05338476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101663937|NCT05338476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101663938|NCT05338476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663939|NCT05338476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101663940|NCT05338476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101663941|NCT05338476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101663942|NCT05338476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101663943|NCT05338476|Anesthetics, General|anesthetics, general|mesh-ancestor
101663944|NCT05338476|Anesthetics|anesthetics|mesh-ancestor
101663945|NCT05338476|GABA Modulators|gaba modulators|mesh-ancestor
101663946|NCT05338476|GABA Agents|gaba agents|mesh-ancestor
101663947|NCT05338476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101663948|NCT05338476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663949|NCT02838758|Lidocaine|lidocaine|mesh-list
101663950|NCT02838758|Anesthetics, Local|anesthetics, local|mesh-ancestor
101663951|NCT02838758|Anesthetics|anesthetics|mesh-ancestor
101663952|NCT02838758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101663953|NCT02838758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663954|NCT02838758|Sensory System Agents|sensory system agents|mesh-ancestor
101663955|NCT02838758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101663956|NCT02838758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101663957|NCT02838758|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101663958|NCT02838758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101663959|NCT02838758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101663960|NCT02838758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663961|NCT00803595|Oseltamivir|oseltamivir|mesh-list
101663962|NCT00803595|Antiviral Agents|antiviral agents|mesh-ancestor
101663963|NCT00803595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101663964|NCT00803595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101663965|NCT00803595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663966|NCT02843204|Pembrolizumab|pembrolizumab|mesh-list
101663967|NCT02843204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101663968|NCT02843204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101663969|NCT02843204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101663970|NCT02843204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663971|NCT02606565|Chlorhexidine|chlorhexidine|mesh-list
101663972|NCT02606565|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101663973|NCT02606565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101663974|NCT02606565|Disinfectants|disinfectants|mesh-ancestor
101663975|NCT04227990|Cyclophosphamide|cyclophosphamide|mesh-list
101663976|NCT04227990|Docetaxel|docetaxel|mesh-list
101663977|NCT04227990|Doxorubicin|doxorubicin|mesh-list
101663978|NCT04227990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101663979|NCT04227990|Immunologic Factors|immunologic factors|mesh-ancestor
101663980|NCT04227990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663981|NCT04227990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101663982|NCT04227990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101663983|NCT04227990|Alkylating Agents|alkylating agents|mesh-ancestor
101663984|NCT04227990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101663985|NCT04227990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101663986|NCT04227990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101663987|NCT04227990|Tubulin Modulators|tubulin modulators|mesh-ancestor
101663988|NCT04227990|Antimitotic Agents|antimitotic agents|mesh-ancestor
101663989|NCT04227990|Mitosis Modulators|mitosis modulators|mesh-ancestor
101663990|NCT04227990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101663992|NCT04227990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101663993|NCT04227990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101663994|NCT02606409|Dexmedetomidine|dexmedetomidine|mesh-list
101663995|NCT02606409|Propofol|propofol|mesh-list
101663996|NCT02606409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101663997|NCT02606409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101663998|NCT02606409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101663999|NCT02606409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101664000|NCT02606409|Analgesics|analgesics|mesh-ancestor
101664001|NCT02606409|Sensory System Agents|sensory system agents|mesh-ancestor
101664002|NCT02606409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101664003|NCT02606409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101664004|NCT02606409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101664005|NCT02606409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101664006|NCT02606409|Adrenergic Agents|adrenergic agents|mesh-ancestor
101664007|NCT02606409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101664008|NCT02606409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664009|NCT02606409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101664010|NCT02606409|Anesthetics, General|anesthetics, general|mesh-ancestor
101664011|NCT02606409|Anesthetics|anesthetics|mesh-ancestor
101664012|NCT00611767|Thiopental|thiopental|mesh-list
101664013|NCT00611767|Anticonvulsants|anticonvulsants|mesh-ancestor
101664014|NCT00611767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101664015|NCT00611767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101664016|NCT00611767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664017|NCT00611767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101321175|NCT00390039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101664018|NCT00611767|Anesthetics, General|anesthetics, general|mesh-ancestor
101664020|NCT00611767|GABA Modulators|gaba modulators|mesh-ancestor
101664021|NCT00611767|GABA Agents|gaba agents|mesh-ancestor
101664022|NCT00611767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101664023|NCT00611767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664024|NCT04967508|Ustekinumab|ustekinumab|mesh-list
101664025|NCT04967508|Dermatologic Agents|dermatologic agents|mesh-ancestor
101664026|NCT00803361|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101664027|NCT00803361|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101664028|NCT00803361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101664029|NCT00803361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101664030|NCT00803361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664031|NCT00803361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101664032|NCT00803361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664033|NCT00803361|Analgesics|analgesics|mesh-ancestor
101664034|NCT00803361|Sensory System Agents|sensory system agents|mesh-ancestor
101664035|NCT00803361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101664036|NCT00803361|Antidepressive Agents|antidepressive agents|mesh-ancestor
101664037|NCT00803361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101664038|NCT00803361|Dopamine Agents|dopamine agents|mesh-ancestor
101664039|NCT02837198|Dotinurad|dotinurad|mesh-list
101664040|NCT02837198|FYX-051|fyx-051|mesh-list
101664041|NCT02837198|Uricosuric Agents|uricosuric agents|mesh-ancestor
101664042|NCT02837198|Gout Suppressants|gout suppressants|mesh-ancestor
101664043|NCT02837198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101664044|NCT02837198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101664045|NCT02837198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664046|NCT00611533|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101664047|NCT00611533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101664048|NCT00611533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101664049|NCT00611533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101664050|NCT00611533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664051|NCT00611533|Adrenergic Agents|adrenergic agents|mesh-ancestor
101664052|NCT00611533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101664053|NCT00611533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664054|NCT04038307|Acetaminophen|acetaminophen|mesh-list
101826010|NCT00866645|Sulpiride|sulpiride|mesh-list
101664055|NCT04038307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101664056|NCT04038307|Analgesics|analgesics|mesh-ancestor
101664057|NCT04038307|Sensory System Agents|sensory system agents|mesh-ancestor
101664058|NCT04038307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101664059|NCT04038307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664060|NCT04038307|Antipyretics|antipyretics|mesh-ancestor
101664061|NCT00884533|Moxifloxacin|moxifloxacin|mesh-list
101664062|NCT00884533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101664063|NCT00884533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101664064|NCT00884533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101664065|NCT00884533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101664066|NCT00884533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101664067|NCT00884533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664068|NCT00884533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101664069|NCT02842814|Hydroxychloroquine|hydroxychloroquine|mesh-list
101664070|NCT02842814|Glucocorticoids|glucocorticoids|mesh-list
101664071|NCT02842814|Antimalarials|antimalarials|mesh-ancestor
101664072|NCT02842814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101664073|NCT02842814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101664074|NCT02842814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101664075|NCT02842814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101664076|NCT02842814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664077|NCT02842814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101664078|NCT02842814|Hormones|hormones|mesh-ancestor
101664079|NCT02842814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101664080|NCT02842814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664081|NCT02778360|Methylphenidate|methylphenidate|mesh-list
101664082|NCT02778360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101664083|NCT02778360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664084|NCT02778360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101409363|NCT00348166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101664085|NCT02778360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101664086|NCT02778360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101664087|NCT02778360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664088|NCT02778360|Dopamine Agents|dopamine agents|mesh-ancestor
101664089|NCT02778360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101664090|NCT00953147|Ciclesonide|ciclesonide|mesh-list
101664091|NCT00953147|Glucocorticoids|glucocorticoids|mesh-ancestor
101664092|NCT00953147|Hormones|hormones|mesh-ancestor
101664093|NCT00953147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101664094|NCT00953147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664095|NCT00953147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101664096|NCT05333744|Prednisone|prednisone|mesh-list
101664097|NCT05333744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101664098|NCT05333744|Glucocorticoids|glucocorticoids|mesh-ancestor
101664099|NCT05333744|Hormones|hormones|mesh-ancestor
101664100|NCT05333744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101664101|NCT05333744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664102|NCT05333744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101664103|NCT05333744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101664104|NCT04250246|Nivolumab|nivolumab|mesh-list
101664105|NCT04250246|Ipilimumab|ipilimumab|mesh-list
101664106|NCT04250246|Guadecitabine|guadecitabine|mesh-list
101664107|NCT04250246|Azacitidine|azacitidine|mesh-list
101664108|NCT04250246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101664109|NCT04250246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101664110|NCT04250246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101664111|NCT04250246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664112|NCT04250246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101664113|NCT04250246|Antimetabolites|antimetabolites|mesh-ancestor
101664114|NCT04250246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101664115|NCT04273529|Thalidomide|thalidomide|mesh-list
101664116|NCT04273529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101664117|NCT04273529|Immunologic Factors|immunologic factors|mesh-ancestor
101664118|NCT04273529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664119|NCT04273529|Leprostatic Agents|leprostatic agents|mesh-ancestor
101664120|NCT04273529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101664121|NCT04273529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101664122|NCT04273529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101664123|NCT04273529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101664124|NCT04273529|Growth Substances|growth substances|mesh-ancestor
101664125|NCT04273529|Growth Inhibitors|growth inhibitors|mesh-ancestor
101664126|NCT04273529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101664128|NCT02858843|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101664129|NCT02858843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101664130|NCT02858843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664131|NCT02779530|Diclofenac|diclofenac|mesh-list
101664133|NCT02779530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101664134|NCT02779530|Analgesics|analgesics|mesh-ancestor
101664135|NCT02779530|Sensory System Agents|sensory system agents|mesh-ancestor
101664136|NCT02779530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101664137|NCT02779530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664138|NCT02779530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101664139|NCT02779530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101664140|NCT02779530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101664141|NCT02779530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101664142|NCT02779530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664143|NCT00952523|Adapalene|adapalene|mesh-list
101664144|NCT00952523|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
101664145|NCT00952523|Tretinoin|tretinoin|mesh-list
101664146|NCT00952523|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101664147|NCT00952523|Dermatologic Agents|dermatologic agents|mesh-ancestor
101664148|NCT00952523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101664149|NCT00952523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101664150|NCT00952523|Analgesics|analgesics|mesh-ancestor
101664151|NCT00952523|Sensory System Agents|sensory system agents|mesh-ancestor
101664152|NCT00952523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101664153|NCT00952523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664154|NCT00952523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101664155|NCT00952523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101664156|NCT00952523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101664157|NCT00952523|Keratolytic Agents|keratolytic agents|mesh-ancestor
101664158|NCT04249154|Leuprolide|leuprolide|mesh-list
101664159|NCT04249154|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101664160|NCT04249154|Fertility Agents|fertility agents|mesh-ancestor
101664161|NCT04249154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101664162|NCT04249154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664163|NCT04249154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101664164|NCT04249154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101664165|NCT02857361|Ketamine|ketamine|mesh-list
101664166|NCT02857361|Analgesics|analgesics|mesh-ancestor
101664167|NCT02857361|Sensory System Agents|sensory system agents|mesh-ancestor
101664168|NCT02857361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101664169|NCT02857361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664170|NCT02857361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101664171|NCT02857361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101664172|NCT02857361|Anesthetics, General|anesthetics, general|mesh-ancestor
101664173|NCT02857361|Anesthetics|anesthetics|mesh-ancestor
101664174|NCT02857361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101664175|NCT02857361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101664176|NCT02857361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101664177|NCT02857361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101664178|NCT02857361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664179|NCT02778126|Prexasertib|prexasertib|mesh-list
101664180|NCT02778126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101664181|NCT02778126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101664182|NCT02778126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664183|NCT05050500|Dapagliflozin|dapagliflozin|mesh-list
101664184|NCT05050500|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101664185|NCT05050500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664186|NCT05050500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101664187|NCT05050500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664188|NCT02232737|Nicotine|nicotine|mesh-list
101664189|NCT02232737|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101664191|NCT02232737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101664192|NCT02232737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664193|NCT02232737|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101664194|NCT02232737|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101664195|NCT02232737|Cholinergic Agents|cholinergic agents|mesh-ancestor
101664196|NCT02232737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101664197|NCT02232737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664198|NCT04272359|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101664199|NCT04272359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664200|NCT02777814|Entecavir|entecavir|mesh-list
101664201|NCT02777814|Antiviral Agents|antiviral agents|mesh-ancestor
101664202|NCT02777814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101664203|NCT02778906|Abatacept|abatacept|mesh-list
101664204|NCT02778906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101664205|NCT02778906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664206|NCT02778906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101664208|NCT02778906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101664209|NCT02778906|Immunologic Factors|immunologic factors|mesh-ancestor
101664210|NCT02778906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664211|NCT02778906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101664212|NCT00630929|Ibuprofen|ibuprofen|mesh-list
101664213|NCT00630929|Celecoxib|celecoxib|mesh-list
101664214|NCT00630929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101664215|NCT00630929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101664216|NCT00630929|Analgesics|analgesics|mesh-ancestor
101664217|NCT00630929|Sensory System Agents|sensory system agents|mesh-ancestor
101664218|NCT00630929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101664219|NCT00630929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664220|NCT00630929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101664221|NCT00630929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101664222|NCT00630929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101664223|NCT00630929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101664224|NCT00630929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664225|NCT00630929|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101664226|NCT04204928|Pralsetinib|pralsetinib|mesh-list
101664227|NCT04204928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101664228|NCT02834546|Sorafenib|sorafenib|mesh-list
101664229|NCT02834546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101664230|NCT02834546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101664231|NCT02834546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101664232|NCT02834546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664233|NCT00948857|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101664234|NCT00948857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101664235|NCT00948857|Immunologic Factors|immunologic factors|mesh-ancestor
101664236|NCT00948857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664237|NCT04227912|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
101664238|NCT04227912|Anesthetics|anesthetics|mesh-list
101664239|NCT04227912|Anesthetics, Local|anesthetics, local|mesh-list
101664240|NCT04227912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101664241|NCT04227912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664242|NCT04227912|Sensory System Agents|sensory system agents|mesh-ancestor
101664243|NCT04227912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101664244|NCT04227912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101664245|NCT04227912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101664246|NCT04227912|Analgesics|analgesics|mesh-ancestor
101664247|NCT04227912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101664248|NCT04227912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101664249|NCT02854787|Phenylephrine|phenylephrine|mesh-list
101664250|NCT02854787|Oxymetazoline|oxymetazoline|mesh-list
101664251|NCT02854787|Norepinephrine|norepinephrine|mesh-list
101664252|NCT02854787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101664253|NCT02854787|Mydriatics|mydriatics|mesh-ancestor
101664254|NCT02854787|Autonomic Agents|autonomic agents|mesh-ancestor
101664255|NCT02854787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101664256|NCT02854787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664257|NCT02854787|Sympathomimetics|sympathomimetics|mesh-ancestor
101664258|NCT02854787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101664259|NCT02854787|Nasal Decongestants|nasal decongestants|mesh-ancestor
101181950|NCT02665728|Laxatives|laxatives|mesh-list
101664260|NCT02854787|Respiratory System Agents|respiratory system agents|mesh-ancestor
101664261|NCT02854787|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101664262|NCT02854787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101664263|NCT02854787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101664264|NCT02854787|Adrenergic Agents|adrenergic agents|mesh-ancestor
101664265|NCT02854787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101664266|NCT02854787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664267|NCT02854787|Protective Agents|protective agents|mesh-ancestor
101664268|NCT02778828|Linezolid|linezolid|mesh-list
101664269|NCT02778828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101664270|NCT02778828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101664271|NCT02778828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101664272|NCT02778828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101664273|NCT02778828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664274|NCT02777736|Methotrexate|methotrexate|mesh-list
101664275|NCT02777736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101664276|NCT02777736|Abortifacient Agents|abortifacient agents|mesh-ancestor
101664277|NCT02777736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101664278|NCT02777736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664279|NCT02777736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101664280|NCT02777736|Antimetabolites|antimetabolites|mesh-ancestor
101664281|NCT02777736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664282|NCT02777736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101664283|NCT02777736|Dermatologic Agents|dermatologic agents|mesh-ancestor
101664284|NCT02777736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101664285|NCT02777736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101664286|NCT02777736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101664287|NCT02777736|Immunologic Factors|immunologic factors|mesh-ancestor
101664288|NCT02777736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101664289|NCT02777736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101664291|NCT02836184|Nicotinic Acids|nicotinic acids|mesh-list
101664292|NCT02836184|Niacinamide|niacinamide|mesh-list
101664293|NCT02836184|Calcium Carbonate|calcium carbonate|mesh-list
101664294|NCT02836184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664295|NCT02836184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101664296|NCT02836184|Antimetabolites|antimetabolites|mesh-ancestor
101664297|NCT02836184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664298|NCT02836184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101664299|NCT02836184|Vasodilator Agents|vasodilator agents|mesh-ancestor
101664300|NCT02836184|Vitamin B Complex|vitamin b complex|mesh-ancestor
101664301|NCT02836184|Vitamins|vitamins|mesh-ancestor
101664302|NCT02836184|Micronutrients|micronutrients|mesh-ancestor
101664303|NCT02836184|Antacids|antacids|mesh-ancestor
101664304|NCT02836184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101664305|NCT04824144|Dexmedetomidine|dexmedetomidine|mesh-list
101664306|NCT04824144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101409372|NCT00348244|Prednisolone acetate|prednisolone acetate|mesh-list
101664307|NCT04824144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101664308|NCT04824144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664309|NCT04824144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101664310|NCT04824144|Analgesics|analgesics|mesh-ancestor
101664311|NCT04824144|Sensory System Agents|sensory system agents|mesh-ancestor
101664312|NCT04824144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101664313|NCT04824144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101664314|NCT04824144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101321484|NCT00084643|Capecitabine|capecitabine|mesh-list
101664315|NCT04824144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101664316|NCT04824144|Adrenergic Agents|adrenergic agents|mesh-ancestor
101664317|NCT04824144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101664318|NCT04824144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664319|NCT02775474|Fentanyl|fentanyl|mesh-list
101664320|NCT02775474|Methadone|methadone|mesh-list
101664321|NCT02775474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101664322|NCT02775474|Narcotics|narcotics|mesh-ancestor
101664323|NCT02775474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101664324|NCT02775474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664325|NCT02775474|Analgesics|analgesics|mesh-ancestor
101664326|NCT02775474|Sensory System Agents|sensory system agents|mesh-ancestor
101664327|NCT02775474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101826041|NCT00872963|Vaccines|vaccines|mesh-list
101664328|NCT02775474|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101664329|NCT02775474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101664330|NCT02775474|Anesthetics, General|anesthetics, general|mesh-ancestor
101664332|NCT02775474|Antitussive Agents|antitussive agents|mesh-ancestor
101664333|NCT02775474|Respiratory System Agents|respiratory system agents|mesh-ancestor
101664334|NCT05158686|Paclitaxel|paclitaxel|mesh-list
101664335|NCT05158686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101664336|NCT05158686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101664337|NCT05158686|Tubulin Modulators|tubulin modulators|mesh-ancestor
101664338|NCT05158686|Antimitotic Agents|antimitotic agents|mesh-ancestor
101664339|NCT05158686|Mitosis Modulators|mitosis modulators|mesh-ancestor
101664340|NCT05158686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664341|NCT02835794|Azacitidine|azacitidine|mesh-list
101664342|NCT02835794|Homoharringtonine|homoharringtonine|mesh-list
101664343|NCT02835794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101664344|NCT02835794|Antimetabolites|antimetabolites|mesh-ancestor
101664345|NCT02835794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664346|NCT02835794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101664347|NCT02835794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101664348|NCT02835794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101664349|NCT02835794|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101664350|NCT02836028|Temozolomide|temozolomide|mesh-list
101664351|NCT02836028|Talazoparib|talazoparib|mesh-list
101664352|NCT02836028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101664353|NCT02836028|Alkylating Agents|alkylating agents|mesh-ancestor
101664354|NCT02836028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664355|NCT02836028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101664356|NCT02836028|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101664357|NCT02836028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101664359|NCT01778946|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101664360|NCT01778946|Autonomic Agents|autonomic agents|mesh-ancestor
101664361|NCT01778946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101664362|NCT01778946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664363|NCT01778946|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101664364|NCT01778946|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101664365|NCT01778946|Cholinergic Agents|cholinergic agents|mesh-ancestor
101664366|NCT01778946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101664367|NCT01778946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664368|NCT04227210|Vaccines|vaccines|mesh-list
101664369|NCT04227210|Immunologic Factors|immunologic factors|mesh-ancestor
101664370|NCT04227210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664371|NCT02833766|Doxorubicin|doxorubicin|mesh-list
101664372|NCT02833766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101664373|NCT02833766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101664374|NCT02833766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101664375|NCT02833766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101664376|NCT02833766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101664377|NCT02833766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664378|NCT04813380|Immunomodulating Agents|immunomodulating agents|mesh-list
101664379|NCT04813380|Immunologic Factors|immunologic factors|mesh-ancestor
101664380|NCT04813380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664381|NCT04951362|Ivermectin|ivermectin|mesh-list
101664382|NCT04951362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101664383|NCT04951362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101664385|NCT02833610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101664386|NCT02833610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664387|NCT04225728|Iron|iron|mesh-list
101664388|NCT04225728|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101664389|NCT04225728|Teferrol|teferrol|mesh-list
101664390|NCT04225728|Trace Elements|trace elements|mesh-ancestor
101664391|NCT04225728|Micronutrients|micronutrients|mesh-ancestor
101664392|NCT04225728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664393|NCT04225728|Hematinics|hematinics|mesh-ancestor
101664394|NCT02835716|Ustekinumab|ustekinumab|mesh-list
101664395|NCT02835716|Dermatologic Agents|dermatologic agents|mesh-ancestor
101664396|NCT04247984|Bevacizumab|bevacizumab|mesh-list
101664397|NCT04247984|Fluorouracil|fluorouracil|mesh-list
101664398|NCT04247984|Capecitabine|capecitabine|mesh-list
101664399|NCT04247984|Irinotecan|irinotecan|mesh-list
101664400|NCT04247984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101664401|NCT04247984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101664402|NCT04247984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101664403|NCT04247984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101664404|NCT04247984|Growth Substances|growth substances|mesh-ancestor
101664405|NCT04247984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664406|NCT04247984|Growth Inhibitors|growth inhibitors|mesh-ancestor
101664407|NCT04247984|Antimetabolites|antimetabolites|mesh-ancestor
101664408|NCT04247984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664409|NCT04247984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101664410|NCT04247984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101664411|NCT04247984|Immunologic Factors|immunologic factors|mesh-ancestor
101664412|NCT04247984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101664413|NCT04247984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101664414|NCT04247984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101664415|NCT00948389|Dasatinib|dasatinib|mesh-list
101664416|NCT00948389|Lomustine|lomustine|mesh-list
101664417|NCT00948389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101664418|NCT00948389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101664419|NCT00948389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101664420|NCT00948389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664421|NCT00948389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101664422|NCT00948389|Alkylating Agents|alkylating agents|mesh-ancestor
101664423|NCT02775318|Bupivacaine|bupivacaine|mesh-list
101664424|NCT02775318|Anesthetics, Local|anesthetics, local|mesh-ancestor
101664425|NCT02775318|Anesthetics|anesthetics|mesh-ancestor
101664426|NCT02775318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101664427|NCT02775318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664428|NCT02775318|Sensory System Agents|sensory system agents|mesh-ancestor
101664429|NCT02775318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101664430|NCT00948155|Varenicline|varenicline|mesh-list
101664431|NCT00948155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101664432|NCT00948155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101664433|NCT00948155|Cholinergic Agents|cholinergic agents|mesh-ancestor
101664434|NCT00948155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101664435|NCT00948155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664436|NCT00948155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664437|NCT02776956|Atorvastatin|atorvastatin|mesh-list
101664438|NCT02776956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101664439|NCT02776956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101664440|NCT02776956|Antimetabolites|antimetabolites|mesh-ancestor
101664441|NCT02776956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664442|NCT02776956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101664443|NCT02776956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101664444|NCT02776956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101664445|NCT04910178|Empagliflozin|empagliflozin|mesh-list
101664446|NCT04910178|Pentoxifylline|pentoxifylline|mesh-list
101664447|NCT04910178|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101664448|NCT04910178|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101664449|NCT04910178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664450|NCT04910178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101664451|NCT04910178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664452|NCT04910178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101664453|NCT04910178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101664454|NCT04910178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101664455|NCT04910178|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101664456|NCT04910178|Protective Agents|protective agents|mesh-ancestor
101321635|NCT00006080|Fenretinide|fenretinide|mesh-list
101664466|NCT02778594|Dopamine Agents|dopamine agents|mesh-ancestor
101664467|NCT02778594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101664468|NCT02778594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664469|NCT02778594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664470|NCT02778594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101664472|NCT02775006|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101664473|NCT02775006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101664474|NCT02775006|Tubulin Modulators|tubulin modulators|mesh-ancestor
101664475|NCT02775006|Antimitotic Agents|antimitotic agents|mesh-ancestor
101664476|NCT02775006|Mitosis Modulators|mitosis modulators|mesh-ancestor
101664477|NCT02775006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664478|NCT02775006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101664479|NCT02775006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101664480|NCT04851834|Cisplatin|cisplatin|mesh-list
101664481|NCT04851834|Carboplatin|carboplatin|mesh-list
101664482|NCT04851834|Temozolomide|temozolomide|mesh-list
101664483|NCT04851834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101664484|NCT04851834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101664485|NCT04851834|Alkylating Agents|alkylating agents|mesh-ancestor
101664486|NCT04851834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664496|NCT02776722|Tagatose|tagatose|mesh-list
101664497|NCT02776722|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101664498|NCT02776722|Chelating Agents|chelating agents|mesh-ancestor
101664499|NCT02776722|Sequestering Agents|sequestering agents|mesh-ancestor
101664500|NCT02776722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664501|NCT02776878|Dasatinib|dasatinib|mesh-list
101664502|NCT02776878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101664503|NCT02776878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101664504|NCT02776878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101664505|NCT02776878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664507|NCT02772822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101664508|NCT02772822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101664509|NCT02772822|Immunologic Factors|immunologic factors|mesh-ancestor
101664510|NCT02772822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664511|NCT02772822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101664512|NCT00635076|Alprazolam|alprazolam|mesh-list
101664513|NCT00635076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101664514|NCT00635076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101664515|NCT00635076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664516|NCT00635076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101664517|NCT00635076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101664518|NCT00635076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101664519|NCT00635076|GABA Modulators|gaba modulators|mesh-ancestor
101664520|NCT00635076|GABA Agents|gaba agents|mesh-ancestor
101664521|NCT00635076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101664522|NCT00635076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664523|NCT02772744|Ribavirin|ribavirin|mesh-list
101664524|NCT02772744|Sofosbuvir|sofosbuvir|mesh-list
101664525|NCT02772744|Antimetabolites|antimetabolites|mesh-ancestor
101664526|NCT02772744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664527|NCT02772744|Antiviral Agents|antiviral agents|mesh-ancestor
101664528|NCT02772744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101664529|NCT02774382|Vancomycin|vancomycin|mesh-list
101664530|NCT02774382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101664531|NCT02774382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101664532|NCT02774460|Amlodipine|amlodipine|mesh-list
101664533|NCT02774460|Candesartan|candesartan|mesh-list
101664534|NCT02774460|Candesartan cilexetil|candesartan cilexetil|mesh-list
101664535|NCT02774460|Lisinopril|lisinopril|mesh-list
101664536|NCT02774460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101664537|NCT02774460|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101664538|NCT02774460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101664539|NCT02774460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664540|NCT02774460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101664541|NCT02774460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664542|NCT02774460|Vasodilator Agents|vasodilator agents|mesh-ancestor
101664543|NCT02774460|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101664544|NCT02774460|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101664545|NCT02774460|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101664546|NCT02774460|Protease Inhibitors|protease inhibitors|mesh-ancestor
101664547|NCT02774460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101664548|NCT02774460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101664549|NCT02774460|Protective Agents|protective agents|mesh-ancestor
101664550|NCT02772354|Metoprolol|metoprolol|mesh-list
101664551|NCT02772354|Verapamil|verapamil|mesh-list
101664552|NCT02772354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101664553|NCT02772354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101664554|NCT02772354|Sympatholytics|sympatholytics|mesh-ancestor
101664555|NCT02772354|Autonomic Agents|autonomic agents|mesh-ancestor
101664556|NCT02772354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101664557|NCT02772354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664558|NCT02772354|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101664559|NCT02772354|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101664560|NCT02772354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101664561|NCT02772354|Adrenergic Agents|adrenergic agents|mesh-ancestor
101664562|NCT02772354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101664563|NCT02772354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664564|NCT02772354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101664565|NCT02772354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101664566|NCT02772354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101664567|NCT02772354|Vasodilator Agents|vasodilator agents|mesh-ancestor
101664568|NCT00611455|Ofatumumab|ofatumumab|mesh-list
101664569|NCT00611455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101664570|NCT02767752|Gemcitabine|gemcitabine|mesh-list
101664571|NCT02767752|Capecitabine|capecitabine|mesh-list
101664572|NCT02767752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101664573|NCT02767752|Antimetabolites|antimetabolites|mesh-ancestor
101664574|NCT02767752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664575|NCT02767752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101664576|NCT00885625|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101664577|NCT00885625|Immunologic Factors|immunologic factors|mesh-ancestor
101664578|NCT00885625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664580|NCT02835404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101664581|NCT00885781|SMOFlipid|smoflipid|mesh-list
101664582|NCT00885781|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101664583|NCT00885781|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101664584|NCT00885781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101664585|NCT02767674|Prednisone|prednisone|mesh-list
101664586|NCT02767674|Cyclophosphamide|cyclophosphamide|mesh-list
101664587|NCT02767674|Rituximab|rituximab|mesh-list
101664588|NCT02767674|Gemcitabine|gemcitabine|mesh-list
101664589|NCT02767674|Oxaliplatin|oxaliplatin|mesh-list
101664590|NCT02767674|Epirubicin|epirubicin|mesh-list
101664591|NCT02767674|Vindesine|vindesine|mesh-list
101664592|NCT02767674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101664593|NCT02767674|Immunologic Factors|immunologic factors|mesh-ancestor
101664594|NCT02767674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664595|NCT02767674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101664596|NCT02767674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101664597|NCT02767674|Alkylating Agents|alkylating agents|mesh-ancestor
101664598|NCT02767674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664599|NCT02767674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101664600|NCT02767674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101664601|NCT02767674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101664602|NCT02767674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101664603|NCT02767674|Antimetabolites|antimetabolites|mesh-ancestor
101664604|NCT02767674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101664605|NCT02767674|Glucocorticoids|glucocorticoids|mesh-ancestor
101664606|NCT02767674|Hormones|hormones|mesh-ancestor
101664607|NCT02767674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101664608|NCT02767674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101664609|NCT02767674|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101664610|NCT02767674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101664611|NCT02767674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101664612|NCT02767674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101664613|NCT02767674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101664614|NCT02767674|Tubulin Modulators|tubulin modulators|mesh-ancestor
101664615|NCT02767674|Antimitotic Agents|antimitotic agents|mesh-ancestor
101321788|NCT00086359|Antimetabolites|antimetabolites|mesh-ancestor
101664616|NCT02767674|Mitosis Modulators|mitosis modulators|mesh-ancestor
101664617|NCT02833688|Dexmedetomidine|dexmedetomidine|mesh-list
101664618|NCT02833688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101664619|NCT02833688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101664620|NCT02833688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664621|NCT02833688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101664622|NCT02833688|Analgesics|analgesics|mesh-ancestor
101664623|NCT02833688|Sensory System Agents|sensory system agents|mesh-ancestor
101664624|NCT02833688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101664625|NCT02833688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101664626|NCT02833688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101664627|NCT02833688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101664628|NCT02833688|Adrenergic Agents|adrenergic agents|mesh-ancestor
101664629|NCT02833688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101664630|NCT02833688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664631|NCT00947531|Cerebrolysin|cerebrolysin|mesh-list
101664632|NCT00947531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101664633|NCT00947531|Protective Agents|protective agents|mesh-ancestor
101664634|NCT00947531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664635|NCT00947531|Nootropic Agents|nootropic agents|mesh-ancestor
101664636|NCT00612313|Fluoxetine|fluoxetine|mesh-list
101664637|NCT00612313|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101664638|NCT00612313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101664639|NCT00612313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101664640|NCT00612313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664641|NCT00612313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101664642|NCT00612313|Serotonin Agents|serotonin agents|mesh-ancestor
101664643|NCT00612313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664644|NCT00612313|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101664645|NCT00612313|Antidepressive Agents|antidepressive agents|mesh-ancestor
101664646|NCT00612313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101664647|NCT00612313|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101664648|NCT00612313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101664649|NCT00612313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101664650|NCT00890552|Dexamethasone|dexamethasone|mesh-list
101664651|NCT00890552|Dexamethasone acetate|dexamethasone acetate|mesh-list
101664652|NCT00890552|Lenalidomide|lenalidomide|mesh-list
101664654|NCT00890552|BB 1101|bb 1101|mesh-list
101664655|NCT00890552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101664656|NCT00890552|Antiemetics|antiemetics|mesh-ancestor
101664657|NCT00890552|Autonomic Agents|autonomic agents|mesh-ancestor
101664658|NCT00890552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101664659|NCT00890552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664660|NCT00890552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101664661|NCT00890552|Glucocorticoids|glucocorticoids|mesh-ancestor
101664662|NCT00890552|Hormones|hormones|mesh-ancestor
101664663|NCT00890552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101664664|NCT00890552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101664665|NCT00890552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101664666|NCT00890552|Protease Inhibitors|protease inhibitors|mesh-ancestor
101664667|NCT00890552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101664668|NCT00890552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664669|NCT00890552|Immunologic Factors|immunologic factors|mesh-ancestor
101664670|NCT00890552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101664671|NCT00890552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101664672|NCT00890552|Growth Substances|growth substances|mesh-ancestor
101664673|NCT00890552|Growth Inhibitors|growth inhibitors|mesh-ancestor
101664674|NCT00890552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101664675|NCT00890552|Alkylating Agents|alkylating agents|mesh-ancestor
101664676|NCT00890552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101664677|NCT00890552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101664679|NCT02856503|Cholecalciferol|cholecalciferol|mesh-list
101664680|NCT02856503|Vitamins|vitamins|mesh-ancestor
101664681|NCT02856503|Micronutrients|micronutrients|mesh-ancestor
101664682|NCT02856503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664683|NCT02856503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101664684|NCT02856503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101664685|NCT02833376|Chlorhexidine|chlorhexidine|mesh-list
101664686|NCT02833376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101664687|NCT02833376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101664688|NCT02833376|Disinfectants|disinfectants|mesh-ancestor
101664689|NCT02542813|Oxytocin|oxytocin|mesh-list
101664690|NCT02542813|Oxytocics|oxytocics|mesh-ancestor
101664691|NCT02542813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101664692|NCT02542813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664693|NCT02772120|Progesterone|progesterone|mesh-list
101664694|NCT02772120|Progestins|progestins|mesh-ancestor
101664695|NCT02772120|Hormones|hormones|mesh-ancestor
101664696|NCT02772120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101664697|NCT02772120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664698|NCT04248608|Morphine|morphine|mesh-list
101664699|NCT04248608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101664700|NCT04248608|Narcotics|narcotics|mesh-ancestor
101664701|NCT04248608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101664702|NCT04248608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664703|NCT04248608|Analgesics|analgesics|mesh-ancestor
101664704|NCT04248608|Sensory System Agents|sensory system agents|mesh-ancestor
101664705|NCT04248608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101664706|NCT04783194|Dexamethasone|dexamethasone|mesh-list
101664707|NCT04783194|Bupivacaine|bupivacaine|mesh-list
101664708|NCT04783194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101664709|NCT04783194|Antiemetics|antiemetics|mesh-ancestor
101664710|NCT04783194|Autonomic Agents|autonomic agents|mesh-ancestor
101664711|NCT04783194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101664712|NCT04783194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664713|NCT04783194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101664714|NCT04783194|Glucocorticoids|glucocorticoids|mesh-ancestor
101664715|NCT04783194|Hormones|hormones|mesh-ancestor
101664716|NCT04783194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101826101|NCT00420927|Adalimumab|adalimumab|mesh-list
101664717|NCT04783194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101664718|NCT04783194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101664720|NCT04783194|Anesthetics|anesthetics|mesh-ancestor
101664721|NCT04783194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101664722|NCT04783194|Sensory System Agents|sensory system agents|mesh-ancestor
101664723|NCT02854241|Liver Extracts|liver extracts|mesh-list
101664724|NCT02854241|Hematinics|hematinics|mesh-ancestor
101664725|NCT02835170|Immunoglobulins|immunoglobulins|mesh-list
101664726|NCT02835170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101664727|NCT02835170|Antibodies|antibodies|mesh-list
101664728|NCT02835170|Immunologic Factors|immunologic factors|mesh-ancestor
101664729|NCT02835170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664730|NCT00946985|Risperidone|risperidone|mesh-list
101664731|NCT00946985|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101664732|NCT00946985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101664733|NCT00946985|Serotonin Agents|serotonin agents|mesh-ancestor
101664734|NCT00946985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101664735|NCT00946985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664736|NCT00946985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664738|NCT00946985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101664739|NCT00946985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101664740|NCT00946985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101664741|NCT00946985|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101664742|NCT00946985|Dopamine Agents|dopamine agents|mesh-ancestor
101664743|NCT00946985|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101664744|NCT00946985|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101664745|NCT00611923|Flutamide|flutamide|mesh-list
101664746|NCT00611923|Androgen Antagonists|androgen antagonists|mesh-ancestor
101664747|NCT00611923|Hormone Antagonists|hormone antagonists|mesh-ancestor
101664748|NCT00611923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101664749|NCT00611923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664750|NCT00611923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101664751|NCT00611923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101664752|NCT04246502|Capecitabine|capecitabine|mesh-list
101664753|NCT04246502|Trastuzumab|trastuzumab|mesh-list
101664754|NCT04246502|Pertuzumab|pertuzumab|mesh-list
101664755|NCT04246502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101664756|NCT04246502|Antimetabolites|antimetabolites|mesh-ancestor
101664757|NCT04246502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664758|NCT04246502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101664759|NCT04246502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101664760|NCT02767362|Atorvastatin|atorvastatin|mesh-list
101664761|NCT02767362|Ezetimibe|ezetimibe|mesh-list
101664762|NCT02767362|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101664763|NCT02767362|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101664764|NCT02767362|Antimetabolites|antimetabolites|mesh-ancestor
101664765|NCT02767362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664766|NCT02767362|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101664767|NCT02767362|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101664769|NCT00609973|Ciprofloxacin|ciprofloxacin|mesh-list
101664770|NCT00609973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101664771|NCT00609973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101664772|NCT00609973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101664773|NCT00609973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101664774|NCT00609973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101664775|NCT00609973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664776|NCT00609973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101664777|NCT00609973|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101664778|NCT00609973|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101664779|NCT02541643|Elotuzumab|elotuzumab|mesh-list
101664780|NCT02541643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101664781|NCT02696694|Progesterone|progesterone|mesh-list
101664782|NCT02696694|Progestins|progestins|mesh-ancestor
101664783|NCT02696694|Hormones|hormones|mesh-ancestor
101664784|NCT02696694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101664785|NCT02696694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664786|NCT04038073|Antibodies|antibodies|mesh-list
101664787|NCT04038073|Antistreptolysin|antistreptolysin|mesh-list
101664788|NCT04038073|Immunologic Factors|immunologic factors|mesh-ancestor
101664789|NCT04038073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664790|NCT04739592|Vitamin D|vitamin d|mesh-list
101664791|NCT04739592|Cholecalciferol|cholecalciferol|mesh-list
101664792|NCT04739592|Alendronate|alendronate|mesh-list
101664793|NCT04739592|Vitamins|vitamins|mesh-ancestor
101664794|NCT04739592|Micronutrients|micronutrients|mesh-ancestor
101664795|NCT04739592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664796|NCT04739592|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101664797|NCT04739592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101664798|NCT00633386|Celecoxib|celecoxib|mesh-list
101664799|NCT00633386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101664800|NCT00633386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101664801|NCT00633386|Analgesics|analgesics|mesh-ancestor
101664802|NCT00633386|Sensory System Agents|sensory system agents|mesh-ancestor
101664803|NCT00633386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101664804|NCT00633386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664805|NCT00633386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101664806|NCT00633386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101664807|NCT00633386|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101664808|NCT00633386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101664809|NCT00633386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101664810|NCT00633386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664811|NCT02771418|Anesthetics|anesthetics|mesh-list
101664812|NCT02771418|Propofol|propofol|mesh-list
101664813|NCT02771418|Sevoflurane|sevoflurane|mesh-list
101664814|NCT02771418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101664815|NCT02771418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664816|NCT02771418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101664817|NCT02771418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101664818|NCT02771418|Anesthetics, General|anesthetics, general|mesh-ancestor
101664819|NCT02771418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101664820|NCT02771418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101664821|NCT00888901|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101664822|NCT00888901|Methylprednisolone|methylprednisolone|mesh-list
101664823|NCT00888901|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101664824|NCT00888901|Prednisolone|prednisolone|mesh-list
101664825|NCT00888901|Prednisolone acetate|prednisolone acetate|mesh-list
101664826|NCT00888901|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101664827|NCT00888901|Prednisolone phosphate|prednisolone phosphate|mesh-list
101664828|NCT00888901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101664829|NCT00888901|Antiemetics|antiemetics|mesh-ancestor
101664830|NCT00888901|Autonomic Agents|autonomic agents|mesh-ancestor
101664831|NCT00888901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101664832|NCT00888901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664833|NCT00888901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101664834|NCT00888901|Glucocorticoids|glucocorticoids|mesh-ancestor
101664835|NCT00888901|Hormones|hormones|mesh-ancestor
101664836|NCT00888901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101664837|NCT00888901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101664838|NCT00888901|Protective Agents|protective agents|mesh-ancestor
101664839|NCT00888901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101664840|NCT00888901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101664841|NCT00803049|Teriflunomide|teriflunomide|mesh-list
101664842|NCT00803049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101664844|NCT00803049|Analgesics|analgesics|mesh-ancestor
101664845|NCT00803049|Sensory System Agents|sensory system agents|mesh-ancestor
101664846|NCT00803049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101664847|NCT00803049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664848|NCT00803049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101664849|NCT00803049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101664850|NCT00803049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101664851|NCT00803049|Immunologic Factors|immunologic factors|mesh-ancestor
101664853|NCT00884767|Fluorouracil|fluorouracil|mesh-list
101664854|NCT00884767|Oxaliplatin|oxaliplatin|mesh-list
101664855|NCT00884767|Calcium|calcium|mesh-list
101664856|NCT00884767|Levoleucovorin|levoleucovorin|mesh-list
101664857|NCT00884767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101664858|NCT00884767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664859|NCT00884767|Antimetabolites|antimetabolites|mesh-ancestor
101664860|NCT00884767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664861|NCT00884767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101664862|NCT00884767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101664863|NCT00884767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101664864|NCT00884767|Immunologic Factors|immunologic factors|mesh-ancestor
101664865|NCT00884767|Antidotes|antidotes|mesh-ancestor
101664866|NCT00884767|Protective Agents|protective agents|mesh-ancestor
101664867|NCT00884767|Vitamin B Complex|vitamin b complex|mesh-ancestor
101664868|NCT00884767|Vitamins|vitamins|mesh-ancestor
101664869|NCT00884767|Micronutrients|micronutrients|mesh-ancestor
101664870|NCT00890084|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101664871|NCT00890084|Telmisartan|telmisartan|mesh-list
101664872|NCT00890084|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
101664873|NCT00890084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101664874|NCT00890084|Diuretics|diuretics|mesh-ancestor
101664875|NCT00890084|Natriuretic Agents|natriuretic agents|mesh-ancestor
101664876|NCT00890084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664877|NCT00890084|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101664878|NCT00890084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101664879|NCT00890084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664880|NCT00890084|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101664881|NCT00890084|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101664882|NCT00884845|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101664883|NCT00884845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101664884|NCT00884845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101664885|NCT00884845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101664886|NCT00884845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664887|NCT02773602|Dexamethasone|dexamethasone|mesh-list
101664888|NCT02773602|Clonidine|clonidine|mesh-list
101664889|NCT02773602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101664890|NCT02773602|Antiemetics|antiemetics|mesh-ancestor
101664891|NCT02773602|Autonomic Agents|autonomic agents|mesh-ancestor
101664892|NCT02773602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101664893|NCT02773602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664894|NCT02773602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101664895|NCT02773602|Glucocorticoids|glucocorticoids|mesh-ancestor
101664896|NCT02773602|Hormones|hormones|mesh-ancestor
101664897|NCT02773602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101664898|NCT02773602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101664899|NCT02773602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101664900|NCT02773602|Analgesics|analgesics|mesh-ancestor
101664901|NCT02773602|Sensory System Agents|sensory system agents|mesh-ancestor
101664902|NCT02773602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101664903|NCT02773602|Sympatholytics|sympatholytics|mesh-ancestor
101664904|NCT02773602|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101826122|NCT00573443|Dextromethorphan|dextromethorphan|mesh-list
101664905|NCT02773602|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101664907|NCT02773602|Adrenergic Agents|adrenergic agents|mesh-ancestor
101664908|NCT02773602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101664909|NCT02773602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664910|NCT02770950|Indomethacin|indomethacin|mesh-list
101664911|NCT02770950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101664912|NCT02770950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101664913|NCT02770950|Analgesics|analgesics|mesh-ancestor
101664914|NCT02770950|Sensory System Agents|sensory system agents|mesh-ancestor
101664915|NCT02770950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101664916|NCT02770950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664917|NCT02770950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101664918|NCT02770950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101664919|NCT02770950|Gout Suppressants|gout suppressants|mesh-ancestor
101664920|NCT02770950|Tocolytic Agents|tocolytic agents|mesh-ancestor
101664921|NCT02770950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101664922|NCT02770950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101664923|NCT02770950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101664924|NCT02770950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664925|NCT00889057|Sorafenib|sorafenib|mesh-list
101664926|NCT00889057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101664927|NCT00889057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101664928|NCT00889057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101664929|NCT00889057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664930|NCT02829008|Bevacizumab|bevacizumab|mesh-list
101664931|NCT02829008|Pemetrexed|pemetrexed|mesh-list
101664932|NCT02829008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101664933|NCT02829008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101664934|NCT02829008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101664935|NCT02829008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101664936|NCT02829008|Growth Substances|growth substances|mesh-ancestor
101664937|NCT02829008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664938|NCT02829008|Growth Inhibitors|growth inhibitors|mesh-ancestor
101664939|NCT02829008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101664940|NCT02829008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664941|NCT02829008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101664942|NCT02829008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101664943|NCT00889135|Droxidopa|droxidopa|mesh-list
101664944|NCT00889135|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101664945|NCT00889135|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101664946|NCT00889213|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101664947|NCT00889213|Hemostatics|hemostatics|mesh-ancestor
101664948|NCT00889213|Coagulants|coagulants|mesh-ancestor
101664949|NCT00382200|Decitabine|decitabine|mesh-list
101664950|NCT00382200|Tretinoin|tretinoin|mesh-list
101664951|NCT00382200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101664952|NCT00382200|Antimetabolites|antimetabolites|mesh-ancestor
101664953|NCT00382200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664954|NCT00382200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101664955|NCT00382200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101664956|NCT00382200|Keratolytic Agents|keratolytic agents|mesh-ancestor
101664957|NCT00382200|Dermatologic Agents|dermatologic agents|mesh-ancestor
101664958|NCT02696928|Lumefantrine|lumefantrine|mesh-list
101664959|NCT02696928|Primaquine|primaquine|mesh-list
101664960|NCT02696928|Antimalarials|antimalarials|mesh-ancestor
101664961|NCT02696928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101664962|NCT02696928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101664963|NCT02696928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101664964|NCT00886405|Nitroglycerin|nitroglycerin|mesh-list
101826148|NCT05225831|Fludarabine|fludarabine|mesh-list
101664965|NCT00886405|Vasodilator Agents|vasodilator agents|mesh-ancestor
101664966|NCT00889369|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101664967|NCT00889369|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101664968|NCT00889369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101664969|NCT00889369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101664970|NCT00889369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664971|NCT00889369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101664972|NCT00889369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664973|NCT00889369|Analgesics|analgesics|mesh-ancestor
101664974|NCT00889369|Sensory System Agents|sensory system agents|mesh-ancestor
101664975|NCT00889369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101664976|NCT00889369|Antidepressive Agents|antidepressive agents|mesh-ancestor
101664977|NCT00889369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101664978|NCT00889369|Dopamine Agents|dopamine agents|mesh-ancestor
101664979|NCT02766192|Ketamine|ketamine|mesh-list
101664980|NCT02766192|Analgesics|analgesics|mesh-ancestor
101664981|NCT02766192|Sensory System Agents|sensory system agents|mesh-ancestor
101664982|NCT02766192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101664983|NCT02766192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664984|NCT02766192|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101664985|NCT02766192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101664986|NCT02766192|Anesthetics, General|anesthetics, general|mesh-ancestor
101664987|NCT02766192|Anesthetics|anesthetics|mesh-ancestor
101664988|NCT02766192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101664989|NCT02766192|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101664990|NCT02766192|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101322165|NCT00006152|Ritonavir|ritonavir|mesh-list
101664991|NCT02766192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101664992|NCT02766192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101664993|NCT05278897|Hyaluronic Acid|hyaluronic acid|mesh-list
101664994|NCT05278897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101664995|NCT05278897|Immunologic Factors|immunologic factors|mesh-ancestor
101664996|NCT05278897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101664997|NCT05278897|Viscosupplements|viscosupplements|mesh-ancestor
101664998|NCT05278897|Protective Agents|protective agents|mesh-ancestor
101664999|NCT00889525|Cabergoline|cabergoline|mesh-list
101665000|NCT00889525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101665001|NCT00889525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101665002|NCT00889525|Dopamine Agonists|dopamine agonists|mesh-ancestor
101665003|NCT00889525|Dopamine Agents|dopamine agents|mesh-ancestor
101665004|NCT00889525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101535443|NCT00587145|Docetaxel|docetaxel|mesh-list
101665005|NCT00889525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665006|NCT00889525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665007|NCT02770794|Infliximab|infliximab|mesh-list
101665008|NCT02770794|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101665009|NCT02770794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101665010|NCT02770794|Dermatologic Agents|dermatologic agents|mesh-ancestor
101665011|NCT02770794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101665012|NCT02770794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101665013|NCT04224246|Sodium Oxybate|sodium oxybate|mesh-list
101665014|NCT04224246|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101665015|NCT04224246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101665016|NCT04224246|Anesthetics, General|anesthetics, general|mesh-ancestor
101665017|NCT04224246|Anesthetics|anesthetics|mesh-ancestor
101665018|NCT04224246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101665019|NCT04224246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665020|NCT02766270|Temozolomide|temozolomide|mesh-list
101665021|NCT02766270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101665022|NCT02766270|Alkylating Agents|alkylating agents|mesh-ancestor
101665023|NCT02766270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665024|NCT02766270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101665025|NCT04300010|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101665026|NCT04300010|Dermatologic Agents|dermatologic agents|mesh-ancestor
101665027|NCT02766348|Gemcitabine|gemcitabine|mesh-list
101665028|NCT02766348|Cisplatin|cisplatin|mesh-list
101665029|NCT02766348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101665030|NCT02766348|Antimetabolites|antimetabolites|mesh-ancestor
101665031|NCT02766348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665032|NCT02766348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101665033|NCT00608569|Ritonavir|ritonavir|mesh-list
101665034|NCT00608569|Lopinavir|lopinavir|mesh-list
101665035|NCT00608569|Tenofovir|tenofovir|mesh-list
101665036|NCT00608569|Emtricitabine|emtricitabine|mesh-list
101665037|NCT00608569|Zidovudine|zidovudine|mesh-list
101665038|NCT00608569|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101665039|NCT00608569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101665040|NCT00608569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101665041|NCT00608569|Protease Inhibitors|protease inhibitors|mesh-ancestor
101665042|NCT00608569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101665043|NCT00608569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665044|NCT00608569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101665045|NCT00608569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101665046|NCT00608569|Antiviral Agents|antiviral agents|mesh-ancestor
101665047|NCT00608569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101665048|NCT00608569|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101665049|NCT00608569|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101665050|NCT00608569|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101665051|NCT00608569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101665052|NCT00608569|Antimetabolites|antimetabolites|mesh-ancestor
101665053|NCT04699422|Pirinitramide|pirinitramide|mesh-list
101665054|NCT04699422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101665055|NCT04699422|Narcotics|narcotics|mesh-ancestor
101665056|NCT04699422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101665057|NCT04699422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665058|NCT04699422|Analgesics|analgesics|mesh-ancestor
101665059|NCT04699422|Sensory System Agents|sensory system agents|mesh-ancestor
101665060|NCT04699422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101665061|NCT02828384|Psyllium|psyllium|mesh-list
101665062|NCT02828384|Cathartics|cathartics|mesh-ancestor
101665063|NCT02828384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101665064|NCT00886717|Paclitaxel|paclitaxel|mesh-list
101665065|NCT00886717|genexol-PM|genexol-pm|mesh-list
101665066|NCT00886717|Carboplatin|carboplatin|mesh-list
101322244|NCT00089167|Hormones|hormones|mesh-ancestor
101665067|NCT00886717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101665068|NCT00886717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101665069|NCT00886717|Tubulin Modulators|tubulin modulators|mesh-ancestor
101665070|NCT00886717|Antimitotic Agents|antimitotic agents|mesh-ancestor
101665071|NCT00886717|Mitosis Modulators|mitosis modulators|mesh-ancestor
101665072|NCT00886717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665073|NCT00889837|Loxapine|loxapine|mesh-list
101665074|NCT00889837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101665075|NCT00889837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101409377|NCT00348244|Glucocorticoids|glucocorticoids|mesh-ancestor
101665076|NCT00889837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101665077|NCT00889837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665078|NCT00889837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101665079|NCT00889837|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101665080|NCT00889837|Dopamine Agents|dopamine agents|mesh-ancestor
101665081|NCT00889837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101665082|NCT00889837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665083|NCT02770404|Nafithromycin|nafithromycin|mesh-list
101665084|NCT02770404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101665085|NCT02770404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101665086|NCT02770404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101665087|NCT02770404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101665088|NCT02770404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665089|NCT00886873|Mifepristone|mifepristone|mesh-list
101665090|NCT00886873|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101665091|NCT00886873|Abortifacient Agents|abortifacient agents|mesh-ancestor
101665092|NCT00886873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101665093|NCT00886873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665094|NCT00886873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101665095|NCT00886873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101665096|NCT00886873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101665097|NCT00886873|Contraceptive Agents|contraceptive agents|mesh-ancestor
101665098|NCT00886873|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101665099|NCT00886873|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101665100|NCT00886873|Hormone Antagonists|hormone antagonists|mesh-ancestor
101665101|NCT00886873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101665102|NCT00886873|Luteolytic Agents|luteolytic agents|mesh-ancestor
101665103|NCT00886873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101665104|NCT00886873|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101665106|NCT04243850|Caffeine|caffeine|mesh-list
101665107|NCT04243850|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101665108|NCT04243850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665109|NCT04243850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101665110|NCT04243850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101665111|NCT04243850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665112|NCT04243850|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101665113|NCT04243850|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101665114|NCT04243850|Purinergic Agents|purinergic agents|mesh-ancestor
101665115|NCT04243850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101665116|NCT04243850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101665117|NCT04243850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101665118|NCT00892801|Everolimus|everolimus|mesh-list
101665119|NCT00892801|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101665120|NCT00892801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101665121|NCT00892801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101665122|NCT00892801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665123|NCT00892801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101665124|NCT00892801|Immunologic Factors|immunologic factors|mesh-ancestor
101665125|NCT00892801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665126|NCT00892801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101665127|NCT04222842|Vorolanib|vorolanib|mesh-list
101665128|NCT04222842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101665129|NCT04222842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101665130|NCT04222842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665131|NCT00633542|Interferons|interferons|mesh-list
101665132|NCT00633542|Interferon-alpha|interferon-alpha|mesh-list
101665133|NCT00633542|Thalidomide|thalidomide|mesh-list
101665134|NCT00633542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101665135|NCT00633542|Antiviral Agents|antiviral agents|mesh-ancestor
101665136|NCT00633542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101665137|NCT00633542|Immunologic Factors|immunologic factors|mesh-ancestor
101665138|NCT00633542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665139|NCT00633542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101665140|NCT00633542|Leprostatic Agents|leprostatic agents|mesh-ancestor
101665141|NCT00633542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101665142|NCT00633542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101665143|NCT00633542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101665144|NCT00633542|Growth Substances|growth substances|mesh-ancestor
101665145|NCT00633542|Growth Inhibitors|growth inhibitors|mesh-ancestor
101665148|NCT00610675|Mirtazapine|mirtazapine|mesh-list
101665149|NCT00610675|Antidepressive Agents|antidepressive agents|mesh-ancestor
101665150|NCT00610675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101665151|NCT00610675|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101665152|NCT00610675|Histamine Antagonists|histamine antagonists|mesh-ancestor
101665153|NCT00610675|Histamine Agents|histamine agents|mesh-ancestor
101665154|NCT00610675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101665155|NCT00610675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665156|NCT00610675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665157|NCT00610675|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101665158|NCT00610675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101665159|NCT00610675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101665160|NCT00610675|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101665161|NCT00610675|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101665162|NCT00610675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101665163|NCT00610675|Adrenergic Agents|adrenergic agents|mesh-ancestor
101826172|NCT00877253|Antimitotic Agents|antimitotic agents|mesh-ancestor
101665164|NCT00610675|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101665165|NCT00610675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101665166|NCT00610675|Serotonin Agents|serotonin agents|mesh-ancestor
101665167|NCT00610675|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101665168|NCT02828228|Vitamin D|vitamin d|mesh-list
101665169|NCT02828228|Cholecalciferol|cholecalciferol|mesh-list
101665170|NCT02828228|Vitamins|vitamins|mesh-ancestor
101665171|NCT02828228|Micronutrients|micronutrients|mesh-ancestor
101665172|NCT02828228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665173|NCT02828228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101665174|NCT02828228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101665175|NCT02769936|Cycloserine|cycloserine|mesh-list
101665176|NCT02769936|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101665177|NCT02769936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101665178|NCT02769936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101665179|NCT02769936|Antitubercular Agents|antitubercular agents|mesh-ancestor
101665180|NCT02769936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101665181|NCT02769936|Antimetabolites|antimetabolites|mesh-ancestor
101665182|NCT02769936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665183|NCT00887029|Timolol|timolol|mesh-list
101665184|NCT00887029|Travoprost|travoprost|mesh-list
101665185|NCT00887029|Latanoprost|latanoprost|mesh-list
101665186|NCT00887029|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101665187|NCT00887029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101665188|NCT00887029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101665189|NCT00887029|Adrenergic Agents|adrenergic agents|mesh-ancestor
101665190|NCT00887029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101665191|NCT00887029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665192|NCT00887029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665193|NCT00887029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101665194|NCT00887029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101665195|NCT00887029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101665196|NCT00635310|Liver Extracts|liver extracts|mesh-list
101665197|NCT00635310|Hematinics|hematinics|mesh-ancestor
101665198|NCT02762448|Asunaprevir|asunaprevir|mesh-list
101665199|NCT02762448|Protease Inhibitors|protease inhibitors|mesh-ancestor
101665200|NCT02762448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101665201|NCT02762448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665202|NCT00573157|Mycophenolic Acid|mycophenolic acid|mesh-list
101665203|NCT00573157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101665204|NCT00573157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101665205|NCT00573157|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101665206|NCT00573157|Antitubercular Agents|antitubercular agents|mesh-ancestor
101665207|NCT00573157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101665208|NCT00573157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101665209|NCT00573157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101665210|NCT00573157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665211|NCT00890383|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
101665212|NCT00890383|Plasma Substitutes|plasma substitutes|mesh-ancestor
101665213|NCT00890383|Blood Substitutes|blood substitutes|mesh-ancestor
101665214|NCT00887107|Sorafenib|sorafenib|mesh-list
101665215|NCT00887107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101665216|NCT00887107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101665217|NCT00887107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101665218|NCT00887107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665219|NCT00802737|Ofatumumab|ofatumumab|mesh-list
101665220|NCT00802737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101665221|NCT02769390|Clonidine|clonidine|mesh-list
101665222|NCT02769390|Diazepam|diazepam|mesh-list
101665223|NCT02769390|Analgesics|analgesics|mesh-ancestor
101665224|NCT02769390|Sensory System Agents|sensory system agents|mesh-ancestor
101665225|NCT02769390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101665226|NCT02769390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665227|NCT02769390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101665228|NCT02769390|Sympatholytics|sympatholytics|mesh-ancestor
101665229|NCT02769390|Autonomic Agents|autonomic agents|mesh-ancestor
101665230|NCT02769390|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101665231|NCT02769390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101665232|NCT02769390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101665233|NCT02769390|Adrenergic Agents|adrenergic agents|mesh-ancestor
101665234|NCT02769390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101665235|NCT02769390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665236|NCT02769390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101665237|NCT02769390|Anticonvulsants|anticonvulsants|mesh-ancestor
101665238|NCT02769390|Antiemetics|antiemetics|mesh-ancestor
101665239|NCT02769390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101665240|NCT02769390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101665241|NCT02769390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101665242|NCT02769390|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101665243|NCT02769390|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101665244|NCT02769390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101665245|NCT02769390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101665246|NCT02769390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101665247|NCT02769390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101665248|NCT02769390|Anesthetics, General|anesthetics, general|mesh-ancestor
101665249|NCT02769390|Anesthetics|anesthetics|mesh-ancestor
101665250|NCT02769390|GABA Modulators|gaba modulators|mesh-ancestor
101665251|NCT02769390|GABA Agents|gaba agents|mesh-ancestor
101665252|NCT00890539|Methacholine Chloride|methacholine chloride|mesh-list
101665253|NCT00890539|Miotics|miotics|mesh-ancestor
101665254|NCT00890539|Autonomic Agents|autonomic agents|mesh-ancestor
101665255|NCT00890539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101665257|NCT00890539|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101665258|NCT00890539|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
101665259|NCT00890539|Respiratory System Agents|respiratory system agents|mesh-ancestor
101665260|NCT00890539|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101665261|NCT00890539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101665262|NCT00890539|Cholinergic Agents|cholinergic agents|mesh-ancestor
101665263|NCT00890539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101665264|NCT00890539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665265|NCT00887263|Budesonide|budesonide|mesh-list
101665266|NCT00887263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101665267|NCT00887263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101665268|NCT00887263|Autonomic Agents|autonomic agents|mesh-ancestor
101665269|NCT00887263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101665270|NCT00887263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665271|NCT00887263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101665272|NCT00887263|Respiratory System Agents|respiratory system agents|mesh-ancestor
101665273|NCT00887263|Glucocorticoids|glucocorticoids|mesh-ancestor
101665274|NCT00887263|Hormones|hormones|mesh-ancestor
101665275|NCT00887263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101665276|NCT00415233|Hormones|hormones|mesh-list
101665277|NCT00415233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101665278|NCT00415233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665279|NCT00914667|Warfarin|warfarin|mesh-list
101665280|NCT00914667|Fesoterodine|fesoterodine|mesh-list
101665281|NCT00914667|Anticoagulants|anticoagulants|mesh-ancestor
101665282|NCT00914667|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101665283|NCT00914667|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101665284|NCT00914667|Cholinergic Agents|cholinergic agents|mesh-ancestor
101665285|NCT00914667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101665286|NCT00914667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665287|NCT00914667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665288|NCT00914667|Urological Agents|urological agents|mesh-ancestor
101665289|NCT00887978|Treprostinil|treprostinil|mesh-list
101665290|NCT00887978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101665291|NCT00608023|Tesamorelin|tesamorelin|mesh-list
101665292|NCT00608023|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
101665293|NCT00608023|Growth Substances|growth substances|mesh-ancestor
101665294|NCT00608023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665295|NCT00608023|Hormones|hormones|mesh-ancestor
101665296|NCT00608023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101665297|NCT02765022|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101665298|NCT02765022|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
101665299|NCT02765022|beta-Endorphin|beta-endorphin|mesh-list
101665300|NCT02765022|Hormones|hormones|mesh-ancestor
101665301|NCT02765022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101665302|NCT02765022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665303|NCT02765022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101665304|NCT02765022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665305|NCT04224636|Bevacizumab|bevacizumab|mesh-list
101665306|NCT04224636|Atezolizumab|atezolizumab|mesh-list
101665307|NCT04224636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101665308|NCT04224636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101665309|NCT04224636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101665310|NCT04224636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101665311|NCT04224636|Growth Substances|growth substances|mesh-ancestor
101665312|NCT04224636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665313|NCT04224636|Growth Inhibitors|growth inhibitors|mesh-ancestor
101665314|NCT04224636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101665315|NCT04224636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665316|NCT00607789|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101665317|NCT00607789|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101665318|NCT00607789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101665319|NCT00607789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101665320|NCT00607789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665321|NCT00607789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101665322|NCT00607789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665323|NCT00607789|Analgesics|analgesics|mesh-ancestor
101665324|NCT00607789|Sensory System Agents|sensory system agents|mesh-ancestor
101665325|NCT00607789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101665326|NCT00607789|Antidepressive Agents|antidepressive agents|mesh-ancestor
101665327|NCT00607789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101665328|NCT00607789|Dopamine Agents|dopamine agents|mesh-ancestor
101665329|NCT02761512|Lansoprazole|lansoprazole|mesh-list
101665330|NCT02761512|Dexlansoprazole|dexlansoprazole|mesh-list
101665331|NCT02761512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101665332|NCT02761512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101665333|NCT02761512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101665334|NCT02761512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101665335|NCT02761512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665336|NCT00893269|Zolpidem|zolpidem|mesh-list
101665337|NCT00893269|Eszopiclone|eszopiclone|mesh-list
101665338|NCT00893269|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101665339|NCT00893269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101665340|NCT00893269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101665341|NCT00893269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665342|NCT00893269|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101665343|NCT00893269|GABA Agonists|gaba agonists|mesh-ancestor
101665344|NCT00893269|GABA Agents|gaba agents|mesh-ancestor
101665345|NCT00893269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101665346|NCT00893269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665347|NCT05672667|Oxytocin|oxytocin|mesh-list
101665348|NCT05672667|Oxytocics|oxytocics|mesh-ancestor
101665349|NCT05672667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101665350|NCT05672667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665351|NCT04115397|Zoledronic Acid|zoledronic acid|mesh-list
101826212|NCT00867737|Hormones|hormones|mesh-ancestor
101665352|NCT04115397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101665353|NCT04115397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665354|NCT00887822|Bevacizumab|bevacizumab|mesh-list
101665355|NCT00887822|Capecitabine|capecitabine|mesh-list
101665356|NCT00887822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101665357|NCT00887822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101665358|NCT00887822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101665359|NCT00887822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101665360|NCT00887822|Growth Substances|growth substances|mesh-ancestor
101665361|NCT00887822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665362|NCT00887822|Growth Inhibitors|growth inhibitors|mesh-ancestor
101665363|NCT00887822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101665364|NCT00887822|Antimetabolites|antimetabolites|mesh-ancestor
101665365|NCT00887822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665366|NCT04222920|Adalimumab|adalimumab|mesh-list
101665367|NCT04222920|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101665368|NCT04222920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101665369|NCT04222920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101665370|NCT02542111|Dexamethasone|dexamethasone|mesh-list
101665371|NCT02542111|Gemcitabine|gemcitabine|mesh-list
101665372|NCT02542111|Bortezomib|bortezomib|mesh-list
101665373|NCT02542111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101665374|NCT02542111|Antiemetics|antiemetics|mesh-ancestor
101665375|NCT02542111|Autonomic Agents|autonomic agents|mesh-ancestor
101665376|NCT02542111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101665377|NCT02542111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665378|NCT02542111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101665379|NCT02542111|Glucocorticoids|glucocorticoids|mesh-ancestor
101665380|NCT02542111|Hormones|hormones|mesh-ancestor
101665381|NCT02542111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101665382|NCT02542111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101665383|NCT02542111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101665384|NCT02542111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101665385|NCT02542111|Antimetabolites|antimetabolites|mesh-ancestor
101665386|NCT02542111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665387|NCT02768688|Dexmedetomidine|dexmedetomidine|mesh-list
101665388|NCT02768688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101665389|NCT02768688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101665390|NCT02768688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665391|NCT02768688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101665392|NCT02768688|Analgesics|analgesics|mesh-ancestor
101665393|NCT02768688|Sensory System Agents|sensory system agents|mesh-ancestor
101665394|NCT02768688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101665395|NCT02768688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101665396|NCT02768688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101665397|NCT02768688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101665398|NCT02768688|Adrenergic Agents|adrenergic agents|mesh-ancestor
101665399|NCT02768688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101665400|NCT02768688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665401|NCT00891163|Lidocaine|lidocaine|mesh-list
101665402|NCT00891163|Tetracaine|tetracaine|mesh-list
101665403|NCT00891163|Anesthetics, Local|anesthetics, local|mesh-ancestor
101665404|NCT00891163|Anesthetics|anesthetics|mesh-ancestor
101665405|NCT00891163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101665406|NCT00891163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665407|NCT00891163|Sensory System Agents|sensory system agents|mesh-ancestor
101665408|NCT00891163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101665409|NCT00891163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101665410|NCT00891163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101665411|NCT00891163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101665412|NCT00891163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101665413|NCT00891163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665414|NCT02541331|Broncho-Vaxom|broncho-vaxom|mesh-list
101665415|NCT02541331|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101665416|NCT02541331|Immunologic Factors|immunologic factors|mesh-ancestor
101665417|NCT02541331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665418|NCT00893425|Ramipril|ramipril|mesh-list
101665419|NCT00893425|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101665420|NCT00893425|Protease Inhibitors|protease inhibitors|mesh-ancestor
101665421|NCT00893425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101665422|NCT00893425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665423|NCT00893425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101665424|NCT00951665|Paclitaxel|paclitaxel|mesh-list
101665425|NCT00951665|Maytansine|maytansine|mesh-list
101665426|NCT00951665|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101665427|NCT00951665|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101665428|NCT00951665|Trastuzumab|trastuzumab|mesh-list
101665429|NCT00951665|Pertuzumab|pertuzumab|mesh-list
101665430|NCT00951665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101665431|NCT00951665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101665432|NCT00951665|Tubulin Modulators|tubulin modulators|mesh-ancestor
101665433|NCT00951665|Antimitotic Agents|antimitotic agents|mesh-ancestor
101665434|NCT00951665|Mitosis Modulators|mitosis modulators|mesh-ancestor
101665435|NCT00951665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665436|NCT00951665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101665437|NCT00951665|Immunotoxins|immunotoxins|mesh-ancestor
101665438|NCT00951665|Immunoconjugates|immunoconjugates|mesh-ancestor
101665439|NCT00951665|Immunologic Factors|immunologic factors|mesh-ancestor
101665440|NCT00951665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665441|NCT02769078|Warfarin|warfarin|mesh-list
101665442|NCT02769078|Rivaroxaban|rivaroxaban|mesh-list
101665443|NCT02769078|Dabigatran|dabigatran|mesh-list
101665444|NCT02769078|Apixaban|apixaban|mesh-list
101665445|NCT02769078|Anticoagulants|anticoagulants|mesh-ancestor
101665446|NCT02769078|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101665447|NCT02769078|Antithrombins|antithrombins|mesh-ancestor
101665448|NCT02769078|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101665449|NCT02769078|Protease Inhibitors|protease inhibitors|mesh-ancestor
101665450|NCT02769078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101665451|NCT02769078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665452|NCT04036201|Bupivacaine|bupivacaine|mesh-list
101665453|NCT04036201|Hyaluronic Acid|hyaluronic acid|mesh-list
101665454|NCT04036201|Anesthetics, Local|anesthetics, local|mesh-ancestor
101665455|NCT04036201|Anesthetics|anesthetics|mesh-ancestor
101665456|NCT04036201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101665457|NCT04036201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665458|NCT04036201|Sensory System Agents|sensory system agents|mesh-ancestor
101665459|NCT04036201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101665460|NCT04036201|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101665461|NCT04036201|Immunologic Factors|immunologic factors|mesh-ancestor
101665462|NCT04036201|Viscosupplements|viscosupplements|mesh-ancestor
101665463|NCT04036201|Protective Agents|protective agents|mesh-ancestor
101665464|NCT00801099|Amoxicillin|amoxicillin|mesh-list
101665465|NCT00801099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101665466|NCT00801099|Clavulanic Acids|clavulanic acids|mesh-list
101665467|NCT00801099|Clavulanic Acid|clavulanic acid|mesh-list
101665468|NCT00801099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101665469|NCT00801099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101665470|NCT00801099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101665471|NCT00801099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101665472|NCT00801099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665474|NCT02768610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101665475|NCT02768610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101665476|NCT02768610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665477|NCT02768610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101665478|NCT02768610|Analgesics|analgesics|mesh-ancestor
101665479|NCT02768610|Sensory System Agents|sensory system agents|mesh-ancestor
101665480|NCT02768610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101665481|NCT02768610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101665482|NCT02768610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101665483|NCT02768610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101665484|NCT02768610|Adrenergic Agents|adrenergic agents|mesh-ancestor
101665485|NCT02768610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101665486|NCT02768610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665487|NCT02764710|Amoxicillin|amoxicillin|mesh-list
101665488|NCT02764710|Clavulanic Acid|clavulanic acid|mesh-list
101665489|NCT02764710|Clavulanic Acids|clavulanic acids|mesh-list
101665490|NCT02764710|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101665491|NCT02764710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101665492|NCT02764710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101665493|NCT02764710|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101665494|NCT02764710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101665495|NCT02764710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665496|NCT00923169|Mitogens|mitogens|mesh-list
101665497|NCT00923169|Mitosis Modulators|mitosis modulators|mesh-ancestor
101665498|NCT00923169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665499|NCT02541019|Ondansetron|ondansetron|mesh-list
101665500|NCT02541019|Palonosetron|palonosetron|mesh-list
101665501|NCT02541019|Antiemetics|antiemetics|mesh-ancestor
101665502|NCT02541019|Autonomic Agents|autonomic agents|mesh-ancestor
101665503|NCT02541019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101665504|NCT02541019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665505|NCT02541019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101665506|NCT02541019|Antipruritics|antipruritics|mesh-ancestor
101665507|NCT02541019|Dermatologic Agents|dermatologic agents|mesh-ancestor
101665508|NCT02541019|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101665509|NCT02541019|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101665510|NCT02541019|Serotonin Agents|serotonin agents|mesh-ancestor
101665511|NCT02541019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101665512|NCT02541019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665513|NCT00893581|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101322689|NCT00006215|Docetaxel|docetaxel|mesh-list
101665514|NCT00893581|Antidepressive Agents|antidepressive agents|mesh-ancestor
101665515|NCT00893581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101665516|NCT00893581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101665517|NCT00893581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101665518|NCT00893581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101665519|NCT00893581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665520|NCT04114383|Deuterium Oxide|deuterium oxide|mesh-list
101665521|NCT04114383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101665522|NCT04114383|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101665523|NCT04114383|Protective Agents|protective agents|mesh-ancestor
101665524|NCT04114383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665525|NCT04114461|Tofacitinib|tofacitinib|mesh-list
101665526|NCT04114461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665527|NCT04114461|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101665528|NCT04114461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101665529|NCT04114461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101665530|NCT02768454|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101665531|NCT02768454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101665532|NCT02768376|Fentanyl|fentanyl|mesh-list
101665533|NCT02768376|Bupivacaine|bupivacaine|mesh-list
101665534|NCT02768376|Anesthetics|anesthetics|mesh-list
101665535|NCT02768376|Anesthetics, Local|anesthetics, local|mesh-ancestor
101665536|NCT02768376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101665537|NCT02768376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665538|NCT02768376|Sensory System Agents|sensory system agents|mesh-ancestor
101665539|NCT02768376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101665540|NCT02768376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101665541|NCT02768376|Narcotics|narcotics|mesh-ancestor
101665542|NCT02768376|Analgesics|analgesics|mesh-ancestor
101665543|NCT02768376|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101665544|NCT02768376|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101665545|NCT02768376|Anesthetics, General|anesthetics, general|mesh-ancestor
101665546|NCT02696460|Lidocaine|lidocaine|mesh-list
101665547|NCT02696460|Prilocaine|prilocaine|mesh-list
101665548|NCT02696460|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
101665549|NCT02696460|Anesthetics, Local|anesthetics, local|mesh-ancestor
101665550|NCT02696460|Anesthetics|anesthetics|mesh-ancestor
101665551|NCT02696460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101665552|NCT02696460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665553|NCT02696460|Sensory System Agents|sensory system agents|mesh-ancestor
101665554|NCT02696460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101665555|NCT02696460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101665556|NCT02696460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101665557|NCT02696460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101665558|NCT02696460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101665559|NCT02696460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665560|NCT02696460|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
101665561|NCT00888043|Bevacizumab|bevacizumab|mesh-list
101665562|NCT00888043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101665563|NCT00888043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101665564|NCT00888043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101665565|NCT00888043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101665566|NCT00888043|Growth Substances|growth substances|mesh-ancestor
101665567|NCT00888043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665568|NCT00888043|Growth Inhibitors|growth inhibitors|mesh-ancestor
101665569|NCT02768220|Empagliflozin|empagliflozin|mesh-list
101665570|NCT02768220|Linagliptin|linagliptin|mesh-list
101665571|NCT02768220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101665572|NCT02768220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665573|NCT02768220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101665574|NCT02768220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665575|NCT02768220|Incretins|incretins|mesh-ancestor
101665576|NCT02768220|Hormones|hormones|mesh-ancestor
101826261|NCT00874523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101665577|NCT02768220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101665578|NCT02768220|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101665580|NCT02768220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101665581|NCT02760888|Diclofenac|diclofenac|mesh-list
101665582|NCT02760888|Tramadol|tramadol|mesh-list
101665583|NCT02760888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101665584|NCT02760888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101665585|NCT02760888|Analgesics|analgesics|mesh-ancestor
101665586|NCT02760888|Sensory System Agents|sensory system agents|mesh-ancestor
101665587|NCT02760888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101665588|NCT02760888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665589|NCT02760888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101665590|NCT02760888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101665591|NCT02760888|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101665592|NCT02760888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101665593|NCT02760888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665594|NCT02760888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101665596|NCT02760888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101665597|NCT00799617|Methyltestosterone|methyltestosterone|mesh-list
101665598|NCT00799617|Testosterone|testosterone|mesh-list
101665599|NCT00799617|Testosterone undecanoate|testosterone undecanoate|mesh-list
101665600|NCT00799617|Testosterone enanthate|testosterone enanthate|mesh-list
101665601|NCT00799617|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101665602|NCT00799617|Androgens|androgens|mesh-ancestor
101665603|NCT00799617|Hormones|hormones|mesh-ancestor
101665604|NCT00799617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101665605|NCT00799617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665606|NCT00799617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101665607|NCT00799617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101665608|NCT00799617|Anabolic Agents|anabolic agents|mesh-ancestor
101665609|NCT00607087|Insulin|insulin|mesh-list
101665610|NCT00607087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101665611|NCT00607087|Insulin Aspart|insulin aspart|mesh-list
101665612|NCT00607087|Insulin Lispro|insulin lispro|mesh-list
101665613|NCT00607087|Insulin glulisine|insulin glulisine|mesh-list
101665614|NCT00607087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101665615|NCT00607087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665616|NCT00610363|Rilonacept|rilonacept|mesh-list
101665617|NCT00610363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101665618|NCT00887588|Valsartan|valsartan|mesh-list
101665619|NCT00887588|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101665620|NCT00887588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101665621|NCT00887588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101665622|NCT00887588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101665623|NCT00887588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665624|NCT00799383|Vitamin D|vitamin d|mesh-list
101665625|NCT00799383|Calcium|calcium|mesh-list
101665626|NCT00799383|Vitamins|vitamins|mesh-ancestor
101665628|NCT00799383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665629|NCT00799383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101826294|NCT00420303|Analgesics|analgesics|mesh-ancestor
101665630|NCT00799383|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101665631|NCT02763852|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
101665632|NCT02763852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101665633|NCT02763852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665634|NCT02763852|Dopamine Agents|dopamine agents|mesh-ancestor
101665635|NCT02763852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101665636|NCT02763852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665637|NCT04114149|Analgesics, Opioid|analgesics, opioid|mesh-list
101665638|NCT04114149|Narcotics|narcotics|mesh-ancestor
101665639|NCT04114149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101665640|NCT04114149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665641|NCT04114149|Analgesics|analgesics|mesh-ancestor
101665642|NCT04114149|Sensory System Agents|sensory system agents|mesh-ancestor
101665643|NCT04114149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101665644|NCT00891397|Pregabalin|pregabalin|mesh-list
101665645|NCT00891397|Analgesics|analgesics|mesh-ancestor
101665646|NCT00891397|Sensory System Agents|sensory system agents|mesh-ancestor
101665647|NCT00891397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101665648|NCT00891397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665649|NCT00891397|Anticonvulsants|anticonvulsants|mesh-ancestor
101665650|NCT00891397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101665651|NCT00891397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101665652|NCT00891397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665653|NCT00891397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101665654|NCT00891397|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101665655|NCT00891397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101665656|NCT00891397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101665657|NCT00891397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101665658|NCT02767596|Lixisenatide|lixisenatide|mesh-list
101665659|NCT02767596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101665660|NCT02767596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665661|NCT02826902|Remifentanil|remifentanil|mesh-list
101665662|NCT02826902|Propofol|propofol|mesh-list
101665663|NCT02826902|Desflurane|desflurane|mesh-list
101665664|NCT02826902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101665665|NCT02826902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101665666|NCT02826902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665667|NCT02826902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101665668|NCT02826902|Anesthetics, General|anesthetics, general|mesh-ancestor
101665669|NCT02826902|Anesthetics|anesthetics|mesh-ancestor
101665670|NCT02826902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101665671|NCT02826902|Narcotics|narcotics|mesh-ancestor
101665672|NCT02826902|Analgesics|analgesics|mesh-ancestor
101665673|NCT02826902|Sensory System Agents|sensory system agents|mesh-ancestor
101665674|NCT02826902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101665675|NCT02826902|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101665676|NCT00798759|Travoprost|travoprost|mesh-list
101665677|NCT00798759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101665678|NCT00798759|Latanoprost|latanoprost|mesh-list
101665679|NCT00798759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101665680|NCT00798759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101665681|NCT00891475|Interferons|interferons|mesh-list
101665682|NCT00891475|Interferon-alpha|interferon-alpha|mesh-list
101665683|NCT00891475|Sunitinib|sunitinib|mesh-list
101665684|NCT00891475|Maleic acid|maleic acid|mesh-list
101665685|NCT00891475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101665686|NCT00891475|Antiviral Agents|antiviral agents|mesh-ancestor
101665687|NCT00891475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101665688|NCT00891475|Immunologic Factors|immunologic factors|mesh-ancestor
101665689|NCT00891475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665690|NCT00891475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101665691|NCT00891475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101665692|NCT00891475|Growth Substances|growth substances|mesh-ancestor
101665693|NCT00891475|Growth Inhibitors|growth inhibitors|mesh-ancestor
101665694|NCT00891475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101665695|NCT00891475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101665696|NCT00891475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665697|NCT00887432|Vitamin D|vitamin d|mesh-list
101665698|NCT00887432|Cholecalciferol|cholecalciferol|mesh-list
101665699|NCT00887432|Vitamins|vitamins|mesh-ancestor
101665700|NCT00887432|Micronutrients|micronutrients|mesh-ancestor
101665701|NCT00887432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665702|NCT00887432|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101665703|NCT00887432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101665705|NCT04222686|Perindopril|perindopril|mesh-list
101665706|NCT04222686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101665707|NCT04222686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101665708|NCT04222686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101665709|NCT04222686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101665710|NCT04222686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665711|NCT04222686|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101665712|NCT04222686|Protease Inhibitors|protease inhibitors|mesh-ancestor
101665713|NCT04222686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101665714|NCT04113915|Cyclosporine|cyclosporine|mesh-list
101665715|NCT04113915|Dexamethasone|dexamethasone|mesh-list
101665716|NCT04113915|Cyclosporins|cyclosporins|mesh-list
101665717|NCT04113915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101665718|NCT04113915|Immunologic Factors|immunologic factors|mesh-ancestor
101665719|NCT04113915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665720|NCT04113915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101665721|NCT04113915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101665722|NCT04113915|Antiemetics|antiemetics|mesh-ancestor
101665723|NCT04113915|Autonomic Agents|autonomic agents|mesh-ancestor
101665724|NCT04113915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101665725|NCT04113915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101665726|NCT04113915|Glucocorticoids|glucocorticoids|mesh-ancestor
101665727|NCT04113915|Hormones|hormones|mesh-ancestor
101665728|NCT04113915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101665729|NCT04113915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101665730|NCT04113915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101665731|NCT04113915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665732|NCT04113915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101665733|NCT04113915|Antifungal Agents|antifungal agents|mesh-ancestor
101665734|NCT04113915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101665735|NCT04113915|Dermatologic Agents|dermatologic agents|mesh-ancestor
101665736|NCT04113915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101665737|NCT03590821|Aspirin|aspirin|mesh-list
101665738|NCT03590821|Celecoxib|celecoxib|mesh-list
101665739|NCT03590821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101665740|NCT03590821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101665741|NCT03590821|Analgesics|analgesics|mesh-ancestor
101665742|NCT03590821|Sensory System Agents|sensory system agents|mesh-ancestor
101665743|NCT03590821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101665744|NCT03590821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665745|NCT03590821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101665746|NCT03590821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101665747|NCT03590821|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101665748|NCT03590821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101665749|NCT03590821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665750|NCT03590821|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101665751|NCT03590821|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101665752|NCT03590821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101665753|NCT03590821|Antipyretics|antipyretics|mesh-ancestor
101665754|NCT03590821|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101665755|NCT04113993|Bazedoxifene|bazedoxifene|mesh-list
101665756|NCT04113993|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101665757|NCT04113993|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101665758|NCT04113993|Hormone Antagonists|hormone antagonists|mesh-ancestor
101665759|NCT04113993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101665760|NCT04113993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665761|NCT04113993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101665762|NCT02758470|Acetazolamide|acetazolamide|mesh-list
101665763|NCT02758470|Methazolamide|methazolamide|mesh-list
101665764|NCT02758470|Anticonvulsants|anticonvulsants|mesh-ancestor
101665765|NCT02758470|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101665766|NCT02758470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101665767|NCT02758470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665768|NCT02758470|Diuretics|diuretics|mesh-ancestor
101665769|NCT02758470|Natriuretic Agents|natriuretic agents|mesh-ancestor
101665770|NCT02758470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665771|NCT04223076|Chlorhexidine|chlorhexidine|mesh-list
101665772|NCT04223076|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101665773|NCT04223076|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101665774|NCT04223076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101665775|NCT04223076|Disinfectants|disinfectants|mesh-ancestor
101665776|NCT04223076|Dermatologic Agents|dermatologic agents|mesh-ancestor
101665777|NCT00951275|Antirheumatic Agents|antirheumatic agents|mesh-list
101665778|NCT02764008|Bupivacaine|bupivacaine|mesh-list
101665779|NCT02764008|Anesthetics, Local|anesthetics, local|mesh-ancestor
101665780|NCT02764008|Anesthetics|anesthetics|mesh-ancestor
101665781|NCT02764008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101665782|NCT02764008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665783|NCT02764008|Sensory System Agents|sensory system agents|mesh-ancestor
101665784|NCT02764008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101665785|NCT00798603|Bevacizumab|bevacizumab|mesh-list
101665786|NCT00798603|Carboplatin|carboplatin|mesh-list
101665787|NCT00798603|Pemetrexed|pemetrexed|mesh-list
101665788|NCT00798603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101665789|NCT00798603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101665790|NCT00798603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101665791|NCT00798603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101665792|NCT00798603|Growth Substances|growth substances|mesh-ancestor
101665793|NCT00798603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665794|NCT00798603|Growth Inhibitors|growth inhibitors|mesh-ancestor
101665795|NCT00798603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101665796|NCT00798603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665797|NCT00798603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101665798|NCT00798603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101665799|NCT04036981|Botulinum Toxins|botulinum toxins|mesh-list
101665800|NCT04036981|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101665801|NCT04036981|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101665802|NCT04036981|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101665803|NCT04036981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101665804|NCT04036981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665805|NCT04036981|Cholinergic Agents|cholinergic agents|mesh-ancestor
101665806|NCT04036981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101665807|NCT04036981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665808|NCT04036981|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101665809|NCT04036981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101665810|NCT00887354|Vitamin D|vitamin d|mesh-list
101665811|NCT00887354|Teriparatide|teriparatide|mesh-list
101665812|NCT00887354|Risedronic Acid|risedronic acid|mesh-list
101665813|NCT00887354|Calcium|calcium|mesh-list
101665814|NCT00887354|Vitamins|vitamins|mesh-ancestor
101322988|NCT00094627|Analgesics|analgesics|mesh-ancestor
101665815|NCT00887354|Micronutrients|micronutrients|mesh-ancestor
101665816|NCT00887354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665817|NCT00887354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101665818|NCT00887354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101665819|NCT00887354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101665820|NCT00887354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101665821|NCT00887354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665822|NCT00951041|Vaccines|vaccines|mesh-list
101665823|NCT00951041|Immunologic Factors|immunologic factors|mesh-ancestor
101665824|NCT00951041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665825|NCT02832596|Norepinephrine|norepinephrine|mesh-list
101665826|NCT02832596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101665827|NCT02832596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101665828|NCT02832596|Adrenergic Agents|adrenergic agents|mesh-ancestor
101665829|NCT02832596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101665830|NCT02832596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665831|NCT02832596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665832|NCT02832596|Sympathomimetics|sympathomimetics|mesh-ancestor
101665833|NCT02832596|Autonomic Agents|autonomic agents|mesh-ancestor
101665834|NCT02832596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101665835|NCT02832596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101665836|NCT02760420|Amoxicillin|amoxicillin|mesh-list
101665837|NCT02760420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101665838|NCT02760420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101665839|NCT04612530|Nivolumab|nivolumab|mesh-list
101665840|NCT04612530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101665841|NCT04612530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101665842|NCT04612530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101665843|NCT04612530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665844|NCT00945815|Cytarabine|cytarabine|mesh-list
101665845|NCT00945815|Clofarabine|clofarabine|mesh-list
101665846|NCT00945815|Epratuzumab|epratuzumab|mesh-list
101665847|NCT00945815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101665848|NCT00945815|Antimetabolites|antimetabolites|mesh-ancestor
101665849|NCT00945815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665850|NCT00945815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101665852|NCT00945815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101665853|NCT00945815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101665854|NCT00945815|Immunologic Factors|immunologic factors|mesh-ancestor
101665855|NCT00945815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665856|NCT00945815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101665857|NCT00606307|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
101665858|NCT00606307|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101665859|NCT00606307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101665860|NCT00606307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665861|NCT00798369|Triamcinolone|triamcinolone|mesh-list
101665862|NCT00798369|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101665863|NCT00798369|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101665864|NCT00798369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101665865|NCT00798369|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101665866|NCT00798369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101665867|NCT00798369|Glucocorticoids|glucocorticoids|mesh-ancestor
101665868|NCT00798369|Hormones|hormones|mesh-ancestor
101665869|NCT00798369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101665870|NCT00798369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665871|NCT00798369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101665872|NCT00798369|Immunologic Factors|immunologic factors|mesh-ancestor
101665873|NCT00798369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101665874|NCT00798369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665875|NCT00608959|Chlorhexidine|chlorhexidine|mesh-list
101665876|NCT00608959|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101665877|NCT00608959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101665878|NCT00608959|Disinfectants|disinfectants|mesh-ancestor
101665879|NCT02760342|Metformin|metformin|mesh-list
101665880|NCT02760342|Peficitinib|peficitinib|mesh-list
101665881|NCT02760342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101665882|NCT02760342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665883|NCT02760342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101665884|NCT02760342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665885|NCT02760342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101665886|NCT02760342|Immunologic Factors|immunologic factors|mesh-ancestor
101665887|NCT04221282|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
101323064|NCT00006257|Growth Inhibitors|growth inhibitors|mesh-ancestor
101665888|NCT04221282|Anticonvulsants|anticonvulsants|mesh-ancestor
101665889|NCT04221282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101665890|NCT04221282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101665891|NCT04221282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101665892|NCT04221282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665893|NCT00894283|Enoxaparin|enoxaparin|mesh-list
101665895|NCT00894283|Fondaparinux|fondaparinux|mesh-list
101665896|NCT00894283|Anticoagulants|anticoagulants|mesh-ancestor
101665897|NCT00894283|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101665898|NCT00894283|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101665899|NCT00894283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665900|NCT00894283|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101665901|NCT00894283|Antithrombins|antithrombins|mesh-ancestor
101665902|NCT00894283|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101665903|NCT00894283|Protease Inhibitors|protease inhibitors|mesh-ancestor
101665904|NCT00894283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101665905|NCT00895609|Neostigmine|neostigmine|mesh-list
101665906|NCT00895609|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101665907|NCT00895609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101665908|NCT00895609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665909|NCT00895609|Cholinergic Agents|cholinergic agents|mesh-ancestor
101665910|NCT00895609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101665911|NCT00895609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665912|NCT00895609|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101665913|NCT00895609|Autonomic Agents|autonomic agents|mesh-ancestor
101665914|NCT00895609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101665915|NCT00894439|Piperacillin|piperacillin|mesh-list
101665916|NCT00894439|BLI-489|bli-489|mesh-list
101665917|NCT00894439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101665918|NCT00894439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101665919|NCT00894439|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101665920|NCT00894439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101665921|NCT00894439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665922|NCT04035889|Melatonin|melatonin|mesh-list
101665923|NCT04035889|Antioxidants|antioxidants|mesh-ancestor
101537506|NCT04998981|Antimetabolites|antimetabolites|mesh-ancestor
101665924|NCT04035889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665925|NCT04035889|Protective Agents|protective agents|mesh-ancestor
101665926|NCT04035889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665927|NCT04035889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101665928|NCT00895687|Bortezomib|bortezomib|mesh-list
101665929|NCT00895687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101665930|NCT00895687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101826363|NCT00433329|Bosentan|bosentan|mesh-list
101665931|NCT00895687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101665932|NCT00895687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101665933|NCT00895687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665934|NCT00798135|Itraconazole|itraconazole|mesh-list
101665935|NCT00798135|Antifungal Agents|antifungal agents|mesh-ancestor
101665936|NCT00798135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101665937|NCT00798135|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101665938|NCT00798135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101665939|NCT00798135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101665940|NCT00798135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665941|NCT00798135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101665942|NCT00798135|Hormone Antagonists|hormone antagonists|mesh-ancestor
101665943|NCT00798135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101665944|NCT00798135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665945|NCT00798135|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101665946|NCT02762838|Folic Acid|folic acid|mesh-list
101665947|NCT02762838|Infliximab|infliximab|mesh-list
101665948|NCT02762838|Methotrexate|methotrexate|mesh-list
101665949|NCT02762838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101665950|NCT02762838|Abortifacient Agents|abortifacient agents|mesh-ancestor
101665951|NCT02762838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101665952|NCT02762838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665953|NCT02762838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101665954|NCT02762838|Antimetabolites|antimetabolites|mesh-ancestor
101665955|NCT02762838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101665956|NCT02762838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101665957|NCT02762838|Dermatologic Agents|dermatologic agents|mesh-ancestor
101665958|NCT02762838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101665959|NCT02762838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101665960|NCT02762838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101323140|NCT00095641|Capecitabine|capecitabine|mesh-list
101665961|NCT02762838|Immunologic Factors|immunologic factors|mesh-ancestor
101665962|NCT02762838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101665963|NCT02762838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101665964|NCT02762838|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101665965|NCT02762838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101665966|NCT02762838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101665968|NCT02762838|Vitamin B Complex|vitamin b complex|mesh-ancestor
101665969|NCT02762838|Vitamins|vitamins|mesh-ancestor
101665970|NCT02762838|Micronutrients|micronutrients|mesh-ancestor
101665971|NCT02753166|Dexamethasone|dexamethasone|mesh-list
101665972|NCT02753166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101665973|NCT02753166|Antiemetics|antiemetics|mesh-ancestor
101665974|NCT02753166|Autonomic Agents|autonomic agents|mesh-ancestor
101665975|NCT02753166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101665976|NCT02753166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665977|NCT02753166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101665978|NCT02753166|Glucocorticoids|glucocorticoids|mesh-ancestor
101665979|NCT02753166|Hormones|hormones|mesh-ancestor
101665980|NCT02753166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101665981|NCT02753166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101665982|NCT02753166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101665983|NCT02753088|Glatiramer Acetate|glatiramer acetate|mesh-list
101665984|NCT02753088|Mannitol|mannitol|mesh-list
101665985|NCT02753088|(T,G)-A-L|(t,g)-a-l|mesh-list
101665986|NCT02753088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101665987|NCT02753088|Diuretics|diuretics|mesh-ancestor
101665988|NCT02753088|Natriuretic Agents|natriuretic agents|mesh-ancestor
101665989|NCT02753088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665990|NCT02753088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101665991|NCT02753088|Immunologic Factors|immunologic factors|mesh-ancestor
101665992|NCT02753088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101665993|NCT02753088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101665994|NCT02757534|Domperidone|domperidone|mesh-list
101665995|NCT02757534|Antiemetics|antiemetics|mesh-ancestor
101665996|NCT02757534|Autonomic Agents|autonomic agents|mesh-ancestor
101665997|NCT02757534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101665998|NCT02757534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101665999|NCT02757534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101666000|NCT02757534|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101666001|NCT02757534|Dopamine Agents|dopamine agents|mesh-ancestor
101666002|NCT02757534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101666003|NCT02757534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666004|NCT00914901|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101666005|NCT00914901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101666006|NCT00914901|Autonomic Agents|autonomic agents|mesh-ancestor
101666007|NCT00914901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101666008|NCT00914901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666009|NCT00914901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101666010|NCT00914901|Respiratory System Agents|respiratory system agents|mesh-ancestor
101666011|NCT00914901|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101666012|NCT00914901|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101666013|NCT00914901|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101666014|NCT00914901|Adrenergic Agents|adrenergic agents|mesh-ancestor
101666015|NCT00914901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101666016|NCT00914901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666017|NCT00797823|Insulin|insulin|mesh-list
101666018|NCT00797823|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101666019|NCT00797823|Glucagon|glucagon|mesh-list
101666020|NCT00797823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101666021|NCT00797823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666022|NCT00797823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101666023|NCT00797823|Hormones|hormones|mesh-ancestor
101666024|NCT00797823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101666025|NCT02757144|Esomeprazole|esomeprazole|mesh-list
101666026|NCT02757144|Fexuprazan|fexuprazan|mesh-list
101666027|NCT02757144|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101666028|NCT02757144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101666029|NCT02757144|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101666030|NCT02757144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101666031|NCT02757144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666032|NCT04568616|Letrozole|letrozole|mesh-list
101666033|NCT04568616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101666034|NCT04568616|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101666035|NCT04568616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101666036|NCT04568616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101323212|NCT00095914|Paclitaxel|paclitaxel|mesh-list
101666037|NCT04568616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666038|NCT04568616|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101666039|NCT04568616|Hormone Antagonists|hormone antagonists|mesh-ancestor
101826386|NCT00878345|Sensory System Agents|sensory system agents|mesh-ancestor
101666040|NCT04568616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101666041|NCT04568616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666042|NCT00950807|Tiotropium Bromide|tiotropium bromide|mesh-list
101666043|NCT00950807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101666044|NCT00950807|Autonomic Agents|autonomic agents|mesh-ancestor
101666045|NCT00950807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101666046|NCT00950807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666047|NCT00950807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101666048|NCT00950807|Respiratory System Agents|respiratory system agents|mesh-ancestor
101666049|NCT00950807|Parasympatholytics|parasympatholytics|mesh-ancestor
101666050|NCT00950807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101666051|NCT00950807|Cholinergic Agents|cholinergic agents|mesh-ancestor
101666052|NCT00950807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101666053|NCT00950807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666054|NCT00608881|Ubiquinone|ubiquinone|mesh-list
101666055|NCT00608881|Coenzyme Q10|coenzyme q10|mesh-list
101666056|NCT00608881|Micronutrients|micronutrients|mesh-ancestor
101666057|NCT00608881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666058|NCT00608881|Vitamins|vitamins|mesh-ancestor
101666059|NCT05608395|Carbon-11 methionine|carbon-11 methionine|mesh-list
101666060|NCT05608395|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101666061|NCT05608395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666062|NCT04221906|Betamethasone|betamethasone|mesh-list
101666063|NCT04221906|Calcipotriene|calcipotriene|mesh-list
101666064|NCT04221906|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101666065|NCT04221906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101666066|NCT04221906|Glucocorticoids|glucocorticoids|mesh-ancestor
101666067|NCT04221906|Hormones|hormones|mesh-ancestor
101666068|NCT04221906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101666069|NCT04221906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666070|NCT04221906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101666071|NCT04221906|Respiratory System Agents|respiratory system agents|mesh-ancestor
101666072|NCT04221906|Dermatologic Agents|dermatologic agents|mesh-ancestor
101666074|NCT00945191|Carboplatin|carboplatin|mesh-list
101666075|NCT00945191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101666076|NCT00945191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101666077|NCT00945191|Tubulin Modulators|tubulin modulators|mesh-ancestor
101666078|NCT00945191|Antimitotic Agents|antimitotic agents|mesh-ancestor
101666079|NCT00945191|Mitosis Modulators|mitosis modulators|mesh-ancestor
101666080|NCT00945191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666081|NCT01082393|Mometasone Furoate|mometasone furoate|mesh-list
101666082|NCT01082393|Pimecrolimus|pimecrolimus|mesh-list
101666083|NCT01082393|Tacrolimus|tacrolimus|mesh-list
101666084|NCT01082393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101666085|NCT01082393|Immunologic Factors|immunologic factors|mesh-ancestor
101666086|NCT01082393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666087|NCT01082393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101666088|NCT01082393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101666089|NCT01082393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666090|NCT01082393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101666091|NCT01082393|Dermatologic Agents|dermatologic agents|mesh-ancestor
101666092|NCT01082393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101666093|NCT01082393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101666094|NCT01082393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101666095|NCT01082393|Analgesics|analgesics|mesh-ancestor
101666096|NCT01082393|Sensory System Agents|sensory system agents|mesh-ancestor
101666097|NCT01082393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101666098|NCT01082393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101666099|NCT02757066|Melatonin|melatonin|mesh-list
101666100|NCT02757066|Antioxidants|antioxidants|mesh-ancestor
101666101|NCT02757066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666102|NCT02757066|Protective Agents|protective agents|mesh-ancestor
101666103|NCT02757066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666104|NCT02757066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101666105|NCT00894673|Heparin|heparin|mesh-list
101666106|NCT00894673|Calcium heparin|calcium heparin|mesh-list
101666107|NCT00894673|Anticoagulants|anticoagulants|mesh-ancestor
101666108|NCT00894673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101666109|NCT00894673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101666110|NCT00894673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666111|NCT00892489|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101666112|NCT00892489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101666113|NCT00892489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101666114|NCT00892489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101666115|NCT00892489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666116|NCT00892489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101666117|NCT00892489|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101666118|NCT00892489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101666119|NCT00892489|Serotonin Agents|serotonin agents|mesh-ancestor
101666120|NCT00892489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101666121|NCT00892489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666122|NCT00892489|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101666123|NCT00892489|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101666124|NCT00892489|Dopamine Agents|dopamine agents|mesh-ancestor
101666125|NCT02752308|Atropine|atropine|mesh-list
101666126|NCT02752308|Epinephrine|epinephrine|mesh-list
101666127|NCT02752308|Fentanyl|fentanyl|mesh-list
101666128|NCT02752308|Bupivacaine|bupivacaine|mesh-list
101666129|NCT02752308|Neostigmine|neostigmine|mesh-list
101666130|NCT02752308|Anesthetics, Local|anesthetics, local|mesh-ancestor
101666131|NCT02752308|Anesthetics|anesthetics|mesh-ancestor
101666132|NCT02752308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101666133|NCT02752308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666134|NCT02752308|Sensory System Agents|sensory system agents|mesh-ancestor
101666135|NCT02752308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101666136|NCT02752308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101666137|NCT02752308|Narcotics|narcotics|mesh-ancestor
101666138|NCT02752308|Analgesics|analgesics|mesh-ancestor
101666139|NCT02752308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101666140|NCT02752308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101666141|NCT02752308|Anesthetics, General|anesthetics, general|mesh-ancestor
101666142|NCT02752308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101666143|NCT02752308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101666144|NCT02752308|Adrenergic Agents|adrenergic agents|mesh-ancestor
101666145|NCT02752308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101666146|NCT02752308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666147|NCT02752308|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101666149|NCT02752308|Autonomic Agents|autonomic agents|mesh-ancestor
101666150|NCT02752308|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101666151|NCT02752308|Respiratory System Agents|respiratory system agents|mesh-ancestor
101666152|NCT02752308|Mydriatics|mydriatics|mesh-ancestor
101666153|NCT02752308|Sympathomimetics|sympathomimetics|mesh-ancestor
101666154|NCT02752308|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101666155|NCT02752308|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101666156|NCT02752308|Parasympatholytics|parasympatholytics|mesh-ancestor
101666157|NCT02752308|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101666158|NCT02752308|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101826429|NCT00875537|Capsaicin|capsaicin|mesh-list
101666159|NCT02752308|Cholinergic Agents|cholinergic agents|mesh-ancestor
101666160|NCT02752308|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101666161|NCT02752308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101666162|NCT02752308|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101666164|NCT00894751|Propofol|propofol|mesh-list
101666165|NCT00894751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101666166|NCT00894751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101666167|NCT00894751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666168|NCT00894751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101666169|NCT00894751|Analgesics|analgesics|mesh-ancestor
101666170|NCT00894751|Sensory System Agents|sensory system agents|mesh-ancestor
101666171|NCT00894751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101666172|NCT00894751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101666173|NCT00894751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101666174|NCT00894751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101666175|NCT00894751|Adrenergic Agents|adrenergic agents|mesh-ancestor
101666176|NCT00894751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101666177|NCT00894751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666178|NCT00894751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101666179|NCT00894751|Anesthetics, General|anesthetics, general|mesh-ancestor
101666181|NCT00896077|Lisofylline|lisofylline|mesh-list
101666182|NCT00896077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101666183|NCT00896077|Immunologic Factors|immunologic factors|mesh-ancestor
101666184|NCT00896077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666185|NCT00896077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101666186|NCT00896077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101666187|NCT00896077|Analgesics|analgesics|mesh-ancestor
101323379|NCT04340076|Ixekizumab|ixekizumab|mesh-list
101666188|NCT00896077|Sensory System Agents|sensory system agents|mesh-ancestor
101666189|NCT00896077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101666190|NCT00896077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101666191|NCT00896077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101666192|NCT00896077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101666194|NCT00792909|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101666195|NCT00792909|Immunologic Factors|immunologic factors|mesh-ancestor
101666196|NCT00792909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666197|NCT00896155|Tamoxifen|tamoxifen|mesh-list
101666198|NCT00896155|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101666199|NCT00896155|Hormone Antagonists|hormone antagonists|mesh-ancestor
101666200|NCT00896155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101666201|NCT00896155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666202|NCT00896155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101666203|NCT00896155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101666204|NCT00896155|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101666205|NCT00896155|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101666206|NCT00896155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101666207|NCT00896311|Nitroglycerin|nitroglycerin|mesh-list
101666208|NCT00896311|Vasodilator Agents|vasodilator agents|mesh-ancestor
101666209|NCT02751996|Tenofovir|tenofovir|mesh-list
101666210|NCT02751996|Antiviral Agents|antiviral agents|mesh-ancestor
101666211|NCT02751996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101666212|NCT02751996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101666213|NCT02751996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101666214|NCT02751996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101666215|NCT02751996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666216|NCT02751996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101666217|NCT02751996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101666218|NCT00944645|Niacin|niacin|mesh-list
101666219|NCT00944645|Niacinamide|niacinamide|mesh-list
101826451|NCT00875849|Cetuximab|cetuximab|mesh-list
101666220|NCT00944645|Nicotinic Acids|nicotinic acids|mesh-list
101666221|NCT00944645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101666222|NCT00944645|Antimetabolites|antimetabolites|mesh-ancestor
101666223|NCT00944645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666224|NCT00944645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101666225|NCT00944645|Vasodilator Agents|vasodilator agents|mesh-ancestor
101666226|NCT00944645|Vitamin B Complex|vitamin b complex|mesh-ancestor
101666227|NCT00944645|Vitamins|vitamins|mesh-ancestor
101666228|NCT00944645|Micronutrients|micronutrients|mesh-ancestor
101666229|NCT00944645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666230|NCT02751918|Doxorubicin|doxorubicin|mesh-list
101666231|NCT02751918|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101666232|NCT02751918|Maytansine|maytansine|mesh-list
101666233|NCT02751918|Anetumab ravtansine|anetumab ravtansine|mesh-list
101666234|NCT02751918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101666235|NCT02751918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101666236|NCT02751918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101666237|NCT02751918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101666238|NCT02751918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101666239|NCT02751918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666240|NCT02751918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101666241|NCT02751918|Tubulin Modulators|tubulin modulators|mesh-ancestor
101666242|NCT02751918|Antimitotic Agents|antimitotic agents|mesh-ancestor
101666243|NCT02751918|Mitosis Modulators|mitosis modulators|mesh-ancestor
101666244|NCT02751918|Immunoconjugates|immunoconjugates|mesh-ancestor
101666245|NCT02751918|Immunologic Factors|immunologic factors|mesh-ancestor
101666246|NCT02751918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666247|NCT00901069|Cyclophosphamide|cyclophosphamide|mesh-list
101666248|NCT00901069|Rituximab|rituximab|mesh-list
101666249|NCT00901069|Vincristine|vincristine|mesh-list
101666251|NCT00901069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101666252|NCT00901069|Immunologic Factors|immunologic factors|mesh-ancestor
101666253|NCT00901069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666254|NCT00901069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101666255|NCT00901069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101666256|NCT00901069|Alkylating Agents|alkylating agents|mesh-ancestor
101666257|NCT00901069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666258|NCT00901069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101666259|NCT00901069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101666260|NCT00901069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101666261|NCT00901069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101666262|NCT00901069|Tubulin Modulators|tubulin modulators|mesh-ancestor
101666263|NCT00901069|Antimitotic Agents|antimitotic agents|mesh-ancestor
101666264|NCT00901069|Mitosis Modulators|mitosis modulators|mesh-ancestor
101666265|NCT00901069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101666266|NCT00901069|Antimetabolites|antimetabolites|mesh-ancestor
101666267|NCT00901069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101666268|NCT02853539|Denosumab|denosumab|mesh-list
101666269|NCT02853539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101666270|NCT02853539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666271|NCT02751840|Caffeine|caffeine|mesh-list
101666272|NCT02751840|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101666273|NCT02751840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666274|NCT02751840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101666275|NCT02751840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101666276|NCT02751840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666277|NCT02751840|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101666278|NCT02751840|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101666279|NCT02751840|Purinergic Agents|purinergic agents|mesh-ancestor
101666280|NCT02751840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101666281|NCT00894829|Heparin|heparin|mesh-list
101666282|NCT00894829|Calcium heparin|calcium heparin|mesh-list
101666283|NCT00894829|Anticoagulants|anticoagulants|mesh-ancestor
101666284|NCT00894829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101666285|NCT00894829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101666286|NCT00894829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666287|NCT04108845|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101666288|NCT04108845|Immunologic Factors|immunologic factors|mesh-ancestor
101666289|NCT04108845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666290|NCT00606229|Aripiprazole|aripiprazole|mesh-list
101666291|NCT00606229|Antidepressive Agents|antidepressive agents|mesh-ancestor
101666292|NCT00606229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101666293|NCT00606229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101666294|NCT00606229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101666295|NCT00606229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101666296|NCT00606229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666297|NCT00606229|Dopamine Agonists|dopamine agonists|mesh-ancestor
101666298|NCT00606229|Dopamine Agents|dopamine agents|mesh-ancestor
101666299|NCT00606229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101666300|NCT00606229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666301|NCT00606229|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101666302|NCT00606229|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101666303|NCT00606229|Serotonin Agents|serotonin agents|mesh-ancestor
101666304|NCT00606229|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101666305|NCT00606229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101666306|NCT00606229|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101666307|NCT00606229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101666308|NCT02756598|Sufentanil|sufentanil|mesh-list
101666309|NCT02756598|Dsuvia|dsuvia|mesh-list
101666310|NCT02756598|Propofol|propofol|mesh-list
101666311|NCT02756598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101666312|NCT02756598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101666313|NCT02756598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666314|NCT02756598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101666315|NCT02756598|Anesthetics, General|anesthetics, general|mesh-ancestor
101666316|NCT02756598|Anesthetics|anesthetics|mesh-ancestor
101666317|NCT02756598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101666318|NCT02756598|Narcotics|narcotics|mesh-ancestor
101666319|NCT02756598|Analgesics|analgesics|mesh-ancestor
101666320|NCT02756598|Sensory System Agents|sensory system agents|mesh-ancestor
101666321|NCT02756598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101666322|NCT02756598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101666323|NCT00950651|Tramadol|tramadol|mesh-list
101666324|NCT00950651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101666325|NCT00950651|Narcotics|narcotics|mesh-ancestor
101666326|NCT00950651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101666327|NCT00950651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666328|NCT00950651|Analgesics|analgesics|mesh-ancestor
101666329|NCT00950651|Sensory System Agents|sensory system agents|mesh-ancestor
101666330|NCT00950651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101666331|NCT00901147|Bortezomib|bortezomib|mesh-list
101666332|NCT00901147|Panobinostat|panobinostat|mesh-list
101666333|NCT00901147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101666334|NCT00901147|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101666335|NCT00901147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101666336|NCT00901147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666337|NCT04268537|Antibodies|antibodies|mesh-list
101666338|NCT04268537|Antibodies, Blocking|antibodies, blocking|mesh-list
101666339|NCT04268537|Immunologic Factors|immunologic factors|mesh-ancestor
101666340|NCT04268537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666341|NCT02756130|Carboplatin|carboplatin|mesh-list
101666342|NCT02756130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101666343|NCT05598723|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101666344|NCT05598723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
101666345|NCT05598723|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101666346|NCT05598723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101666347|NCT05598723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101666348|NCT05598723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666349|NCT05598723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101666350|NCT05598723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101666351|NCT05598723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666352|NCT05598723|Cholinergic Agents|cholinergic agents|mesh-ancestor
101666353|NCT05598723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101666354|NCT00605293|Epoetin Alfa|epoetin alfa|mesh-list
101666355|NCT00605293|Hematinics|hematinics|mesh-ancestor
101666356|NCT04221126|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101666357|NCT04221126|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101666358|NCT04221126|Dermatologic Agents|dermatologic agents|mesh-ancestor
101666359|NCT05594589|Lemborexant|lemborexant|mesh-list
101666360|NCT05594589|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
101666361|NCT05594589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101666362|NCT05594589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666363|NCT05594589|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101666364|NCT05594589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101666365|NCT05594589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101666366|NCT05594589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666367|NCT00602303|Torsemide|torsemide|mesh-list
101666368|NCT00602303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101666369|NCT00602303|Diuretics|diuretics|mesh-ancestor
101666370|NCT00602303|Natriuretic Agents|natriuretic agents|mesh-ancestor
101666371|NCT00602303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666372|NCT00602303|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101666373|NCT00602303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101666374|NCT00602303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666375|NCT00631085|Tocopherols|tocopherols|mesh-list
101666376|NCT00631085|Vitamin E|vitamin e|mesh-list
101666377|NCT00631085|Tocotrienols|tocotrienols|mesh-list
101666378|NCT00631085|alpha-Tocopherol|alpha-tocopherol|mesh-list
101666379|NCT00631085|gamma-Tocopherol|gamma-tocopherol|mesh-list
101666380|NCT00631085|Antioxidants|antioxidants|mesh-ancestor
101666381|NCT00631085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666382|NCT00631085|Protective Agents|protective agents|mesh-ancestor
101666383|NCT00631085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666384|NCT00631085|Vitamins|vitamins|mesh-ancestor
101666385|NCT00631085|Micronutrients|micronutrients|mesh-ancestor
101666386|NCT04269863|Aspirin|aspirin|mesh-list
101666387|NCT04269863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101666388|NCT04269863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101666389|NCT04269863|Analgesics|analgesics|mesh-ancestor
101666390|NCT04269863|Sensory System Agents|sensory system agents|mesh-ancestor
101666391|NCT04269863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101666392|NCT04269863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666393|NCT04269863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101666394|NCT04269863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101666395|NCT04269863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101666396|NCT04269863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101666397|NCT04269863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666398|NCT04269863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101666399|NCT04269863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101666400|NCT04269863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101666401|NCT04269863|Antipyretics|antipyretics|mesh-ancestor
101666402|NCT00901381|Lenograstim|lenograstim|mesh-list
101666403|NCT00901381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101666404|NCT00901381|Immunologic Factors|immunologic factors|mesh-ancestor
101666405|NCT00901381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666406|NCT00602381|Lithium Carbonate|lithium carbonate|mesh-list
101666407|NCT00602381|Antidepressive Agents|antidepressive agents|mesh-ancestor
101666408|NCT00602381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101666409|NCT00602381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101666410|NCT00602381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666411|NCT00602381|Antimanic Agents|antimanic agents|mesh-ancestor
101666412|NCT00602381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101666413|NCT00602381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101666414|NCT00602381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666415|NCT02751528|Vaccines|vaccines|mesh-list
101666416|NCT02751528|Immunologic Factors|immunologic factors|mesh-ancestor
101666417|NCT02751528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666418|NCT00901537|Azacitidine|azacitidine|mesh-list
101666419|NCT00901537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101666420|NCT00901537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101666421|NCT00901537|Antimetabolites|antimetabolites|mesh-ancestor
101666422|NCT00901537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666423|NCT00901537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101666424|NCT00894985|Heparin|heparin|mesh-list
101666425|NCT00894985|Calcium heparin|calcium heparin|mesh-list
101666426|NCT00894985|Anticoagulants|anticoagulants|mesh-ancestor
101666427|NCT00894985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101666428|NCT00894985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101666429|NCT00894985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666430|NCT04585152|Rituximab|rituximab|mesh-list
101666431|NCT04585152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101666432|NCT04585152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101666433|NCT04585152|Immunologic Factors|immunologic factors|mesh-ancestor
101666434|NCT04585152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666435|NCT04585152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101666436|NCT00943787|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101666437|NCT00943787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666438|NCT00895063|Botulinum Toxins|botulinum toxins|mesh-list
101666439|NCT00895063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101666440|NCT00895063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101666441|NCT00895063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666442|NCT00895063|Cholinergic Agents|cholinergic agents|mesh-ancestor
101666443|NCT00895063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101666444|NCT00895063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666445|NCT02751294|Tafenoquine|tafenoquine|mesh-list
101666447|NCT02751294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101666448|NCT02751294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101666449|NCT02751294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101666450|NCT00901615|Lenalidomide|lenalidomide|mesh-list
101666451|NCT00901615|Immunologic Factors|immunologic factors|mesh-ancestor
101666452|NCT00901615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666453|NCT00901615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101666454|NCT00901615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101666455|NCT00901615|Growth Substances|growth substances|mesh-ancestor
101666456|NCT00901615|Growth Inhibitors|growth inhibitors|mesh-ancestor
101666457|NCT00901615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101666458|NCT00949325|Sirolimus|sirolimus|mesh-list
101666459|NCT00949325|Doxorubicin|doxorubicin|mesh-list
101666460|NCT00949325|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101666461|NCT00949325|Temsirolimus|temsirolimus|mesh-list
101666462|NCT00949325|MTOR Inhibitors|mtor inhibitors|mesh-list
101666463|NCT00949325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101666464|NCT00949325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101666465|NCT00949325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101666466|NCT00949325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101666467|NCT00949325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101666468|NCT00949325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666469|NCT00949325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101666470|NCT00949325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101666471|NCT00949325|Immunologic Factors|immunologic factors|mesh-ancestor
101666472|NCT00949325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666473|NCT00949325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101666474|NCT00949325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101666475|NCT00949325|Antifungal Agents|antifungal agents|mesh-ancestor
101666476|NCT02853071|Estramustine|estramustine|mesh-list
101666477|NCT02853071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101666479|NCT02853071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666480|NCT02853071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101666481|NCT02853071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101666482|NCT02603757|Vitamin D|vitamin d|mesh-list
101666483|NCT02603757|Cholecalciferol|cholecalciferol|mesh-list
101666484|NCT02603757|Vitamins|vitamins|mesh-ancestor
101666485|NCT02603757|Micronutrients|micronutrients|mesh-ancestor
101666486|NCT02603757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666487|NCT02603757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101666488|NCT02603757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101666489|NCT02758782|Celecoxib|celecoxib|mesh-list
101666490|NCT02758782|Golimumab|golimumab|mesh-list
101666491|NCT02758782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101666492|NCT02758782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101666493|NCT02758782|Analgesics|analgesics|mesh-ancestor
101666494|NCT02758782|Sensory System Agents|sensory system agents|mesh-ancestor
101666495|NCT02758782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101666496|NCT02758782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666497|NCT02758782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101666498|NCT02758782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101666499|NCT02758782|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101666500|NCT02758782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101666501|NCT02758782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101666502|NCT02758782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666503|NCT02758782|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101666504|NCT02758782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101666505|NCT02758782|Immunologic Factors|immunologic factors|mesh-ancestor
101666506|NCT04221672|Terlipressin|terlipressin|mesh-list
101666507|NCT04221672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101666508|NCT04221672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101666509|NCT00895297|Dasatinib|dasatinib|mesh-list
101666510|NCT00895297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101666511|NCT00895297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101666512|NCT00895297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101666513|NCT00895297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666514|NCT00943319|Fludarabine|fludarabine|mesh-list
101666515|NCT00943319|Busulfan|busulfan|mesh-list
101666516|NCT00943319|Alemtuzumab|alemtuzumab|mesh-list
101666517|NCT00943319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101666518|NCT00943319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666519|NCT00943319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101666520|NCT00943319|Immunologic Factors|immunologic factors|mesh-ancestor
101666521|NCT00943319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666522|NCT00943319|Alkylating Agents|alkylating agents|mesh-ancestor
101666523|NCT00943319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101666524|NCT00943319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101666525|NCT00943319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101666526|NCT02603991|Levetiracetam|levetiracetam|mesh-list
101666527|NCT02603991|Anticonvulsants|anticonvulsants|mesh-ancestor
101666528|NCT02603991|Nootropic Agents|nootropic agents|mesh-ancestor
101666529|NCT02540785|Levofloxacin|levofloxacin|mesh-list
101666530|NCT02540785|Ofloxacin|ofloxacin|mesh-list
101666531|NCT02540785|Tobramycin|tobramycin|mesh-list
101666532|NCT02540785|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
101666533|NCT02540785|Dexamethasone|dexamethasone|mesh-list
101666534|NCT02540785|Dexamethasone acetate|dexamethasone acetate|mesh-list
101666535|NCT02540785|BB 1101|bb 1101|mesh-list
101666536|NCT02540785|Hyaluronic Acid|hyaluronic acid|mesh-list
101666537|NCT02540785|Dipivefrin|dipivefrin|mesh-list
101666538|NCT02540785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101666539|NCT02540785|Antiemetics|antiemetics|mesh-ancestor
101666540|NCT02540785|Autonomic Agents|autonomic agents|mesh-ancestor
101666541|NCT02540785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101666542|NCT02540785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666543|NCT02540785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101666544|NCT02540785|Glucocorticoids|glucocorticoids|mesh-ancestor
101666545|NCT02540785|Hormones|hormones|mesh-ancestor
101666546|NCT02540785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101666547|NCT02540785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101666548|NCT02540785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101666549|NCT02540785|Protease Inhibitors|protease inhibitors|mesh-ancestor
101666550|NCT02540785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101666551|NCT02540785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666552|NCT02540785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101666553|NCT02540785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101666554|NCT02540785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101666555|NCT02540785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101666556|NCT02540785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101666557|NCT02540785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101666558|NCT02540785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101666559|NCT02540785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101666560|NCT02540785|Immunologic Factors|immunologic factors|mesh-ancestor
101666561|NCT02540785|Viscosupplements|viscosupplements|mesh-ancestor
101666562|NCT02540785|Protective Agents|protective agents|mesh-ancestor
101666563|NCT02540785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101666564|NCT02540785|Adrenergic Agents|adrenergic agents|mesh-ancestor
101666565|NCT02540785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101666566|NCT02540785|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101666567|NCT02540785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101666568|NCT04243278|Aspirin|aspirin|mesh-list
101666569|NCT04243278|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101666570|NCT04243278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101666571|NCT04243278|Analgesics|analgesics|mesh-ancestor
101666572|NCT04243278|Sensory System Agents|sensory system agents|mesh-ancestor
101666573|NCT04243278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101666574|NCT04243278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666575|NCT04243278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101666576|NCT04243278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101666577|NCT04243278|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101666578|NCT04243278|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101666579|NCT04243278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666580|NCT04243278|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101666581|NCT04243278|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101666582|NCT04243278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101666583|NCT04243278|Antipyretics|antipyretics|mesh-ancestor
101666584|NCT00915369|Paclitaxel|paclitaxel|mesh-list
101666585|NCT00915369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101666586|NCT00915369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101666587|NCT00915369|Tubulin Modulators|tubulin modulators|mesh-ancestor
101666588|NCT00915369|Antimitotic Agents|antimitotic agents|mesh-ancestor
101666589|NCT00915369|Mitosis Modulators|mitosis modulators|mesh-ancestor
101666590|NCT00915369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666591|NCT00901849|Sirolimus|sirolimus|mesh-list
101666592|NCT00901849|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101666593|NCT00901849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101666594|NCT00901849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101666595|NCT00901849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101826525|NCT00531284|Autonomic Agents|autonomic agents|mesh-ancestor
101666596|NCT00901849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101666597|NCT00901849|Antifungal Agents|antifungal agents|mesh-ancestor
101666598|NCT00901849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101666599|NCT00901849|Immunologic Factors|immunologic factors|mesh-ancestor
101666600|NCT00901849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666601|NCT00901849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101666602|NCT00901849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101666603|NCT00901849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666604|NCT04268927|Letrozole|letrozole|mesh-list
101666605|NCT04268927|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
101666606|NCT04268927|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101666607|NCT04268927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101666608|NCT04268927|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101666609|NCT04268927|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101666610|NCT04268927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101666611|NCT04268927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666612|NCT04268927|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101666613|NCT04268927|Hormone Antagonists|hormone antagonists|mesh-ancestor
101666614|NCT04268927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101666615|NCT04268927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666616|NCT04268927|Hormones|hormones|mesh-ancestor
101666617|NCT05429580|Tranexamic Acid|tranexamic acid|mesh-list
101666618|NCT05429580|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101666619|NCT05429580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101666620|NCT05429580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666621|NCT05429580|Hemostatics|hemostatics|mesh-ancestor
101666622|NCT05429580|Coagulants|coagulants|mesh-ancestor
101666623|NCT00790647|Bortezomib|bortezomib|mesh-list
101666624|NCT00790647|Melphalan|melphalan|mesh-list
101666625|NCT00790647|Immunologic Factors|immunologic factors|mesh-ancestor
101666626|NCT00790647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666627|NCT00790647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101666628|NCT00790647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101666629|NCT00790647|Alkylating Agents|alkylating agents|mesh-ancestor
101666630|NCT00790647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666631|NCT00790647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101666632|NCT00790647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101666633|NCT00286013|Gemcitabine|gemcitabine|mesh-list
101666634|NCT00286013|Oxaliplatin|oxaliplatin|mesh-list
101666635|NCT00286013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101666636|NCT00286013|Antimetabolites|antimetabolites|mesh-ancestor
101666637|NCT00286013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666638|NCT00286013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101666640|NCT02754882|Bevacizumab|bevacizumab|mesh-list
101666641|NCT02754882|Carboplatin|carboplatin|mesh-list
101666642|NCT02754882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101666643|NCT02754882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101666644|NCT02754882|Tubulin Modulators|tubulin modulators|mesh-ancestor
101666645|NCT02754882|Antimitotic Agents|antimitotic agents|mesh-ancestor
101666646|NCT02754882|Mitosis Modulators|mitosis modulators|mesh-ancestor
101666647|NCT02754882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666648|NCT02754882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101666649|NCT02754882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101666650|NCT02754882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101666651|NCT02754882|Growth Substances|growth substances|mesh-ancestor
101666652|NCT02754882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666653|NCT02754882|Growth Inhibitors|growth inhibitors|mesh-ancestor
101666654|NCT00790569|Nicotine|nicotine|mesh-list
101666655|NCT00790569|Varenicline|varenicline|mesh-list
101666656|NCT00790569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101666657|NCT00790569|Autonomic Agents|autonomic agents|mesh-ancestor
101666658|NCT00790569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101666659|NCT00790569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666660|NCT00790569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101666661|NCT00790569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101666662|NCT00790569|Cholinergic Agents|cholinergic agents|mesh-ancestor
101666663|NCT00790569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101666664|NCT00790569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666665|NCT00939029|Nicotine|nicotine|mesh-list
101666666|NCT00939029|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101666667|NCT00939029|Autonomic Agents|autonomic agents|mesh-ancestor
101666668|NCT00939029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101666669|NCT00939029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666670|NCT00939029|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101666671|NCT00939029|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101666672|NCT00939029|Cholinergic Agents|cholinergic agents|mesh-ancestor
101666673|NCT00939029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101666674|NCT00939029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666675|NCT00602615|Torsemide|torsemide|mesh-list
101666676|NCT00602615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101666677|NCT00602615|Diuretics|diuretics|mesh-ancestor
101666678|NCT00602615|Natriuretic Agents|natriuretic agents|mesh-ancestor
101666679|NCT00602615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666680|NCT00602615|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101666681|NCT00602615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101666682|NCT00602615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666683|NCT00604253|Insulin|insulin|mesh-list
101666684|NCT00604253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101666685|NCT00604253|Insulin Detemir|insulin detemir|mesh-list
101666686|NCT00604253|Isophane Insulin, Human|isophane insulin, human|mesh-list
101666687|NCT00604253|Insulin, Isophane|insulin, isophane|mesh-list
101666688|NCT00604253|Isophane insulin, beef|isophane insulin, beef|mesh-list
101666689|NCT00604253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101666690|NCT00604253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666691|NCT02754960|Thalidomide|thalidomide|mesh-list
101666692|NCT02754960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101666693|NCT02754960|Immunologic Factors|immunologic factors|mesh-ancestor
101666694|NCT02754960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666695|NCT02754960|Leprostatic Agents|leprostatic agents|mesh-ancestor
101666696|NCT02754960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101666697|NCT02754960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101666698|NCT02754960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101666699|NCT02754960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101666700|NCT02754960|Growth Substances|growth substances|mesh-ancestor
101666701|NCT02754960|Growth Inhibitors|growth inhibitors|mesh-ancestor
101666702|NCT02754960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101666703|NCT00587847|Alemtuzumab|alemtuzumab|mesh-list
101666704|NCT00587847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101666705|NCT00587847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101666706|NCT02540239|Simethicone|simethicone|mesh-list
101666707|NCT02540239|Antifoaming Agents|antifoaming agents|mesh-ancestor
101666708|NCT02540239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666709|NCT02540239|Emollients|emollients|mesh-ancestor
101666710|NCT02540239|Dermatologic Agents|dermatologic agents|mesh-ancestor
101666711|NCT02540395|Mycophenolic Acid|mycophenolic acid|mesh-list
101666712|NCT02540395|Prednisolone|prednisolone|mesh-list
101323898|NCT00100945|Gefitinib|gefitinib|mesh-list
101666713|NCT02540395|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101666714|NCT02540395|Methylprednisolone|methylprednisolone|mesh-list
101666715|NCT02540395|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101666717|NCT02540395|Tacrolimus|tacrolimus|mesh-list
101666718|NCT02540395|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101666719|NCT02540395|Prednisolone phosphate|prednisolone phosphate|mesh-list
101666720|NCT02540395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101666721|NCT02540395|Immunologic Factors|immunologic factors|mesh-ancestor
101666722|NCT02540395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666723|NCT02540395|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101666724|NCT02540395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101666725|NCT02540395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666726|NCT02540395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101666727|NCT02540395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101666728|NCT02540395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101666729|NCT02540395|Antitubercular Agents|antitubercular agents|mesh-ancestor
101666730|NCT02540395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101666731|NCT02540395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101666732|NCT02540395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101666733|NCT02540395|Glucocorticoids|glucocorticoids|mesh-ancestor
101666734|NCT02540395|Hormones|hormones|mesh-ancestor
101666735|NCT02540395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101666736|NCT02540395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101666737|NCT02540395|Antiemetics|antiemetics|mesh-ancestor
101666738|NCT02540395|Autonomic Agents|autonomic agents|mesh-ancestor
101666739|NCT02540395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101666740|NCT02540395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101666741|NCT02540395|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101666742|NCT02540395|Protective Agents|protective agents|mesh-ancestor
101666743|NCT05565729|Levocetirizine|levocetirizine|mesh-list
101666744|NCT05565729|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101666745|NCT05565729|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101666746|NCT05565729|Histamine Antagonists|histamine antagonists|mesh-ancestor
101666747|NCT05565729|Histamine Agents|histamine agents|mesh-ancestor
101666748|NCT05565729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101666749|NCT05565729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666750|NCT05565729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666752|NCT04547166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101666753|NCT04547166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101666754|NCT04547166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101666755|NCT04547166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101666756|NCT04547166|Growth Substances|growth substances|mesh-ancestor
101666757|NCT04547166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666758|NCT04547166|Growth Inhibitors|growth inhibitors|mesh-ancestor
101666759|NCT00602693|Sirolimus|sirolimus|mesh-list
101666760|NCT00602693|Cyclophosphamide|cyclophosphamide|mesh-list
101666761|NCT00602693|Fludarabine|fludarabine|mesh-list
101666762|NCT00602693|Fludarabine phosphate|fludarabine phosphate|mesh-list
101666763|NCT00602693|Allopurinol|allopurinol|mesh-list
101666764|NCT00602693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101666765|NCT00602693|Immunologic Factors|immunologic factors|mesh-ancestor
101666766|NCT00602693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666767|NCT00602693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101666768|NCT00602693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101666769|NCT00602693|Alkylating Agents|alkylating agents|mesh-ancestor
101666770|NCT00602693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666771|NCT00602693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101666772|NCT00602693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101666773|NCT00602693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101666774|NCT00602693|Antimetabolites|antimetabolites|mesh-ancestor
101666775|NCT00602693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101666776|NCT00602693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101666777|NCT00602693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101666778|NCT00602693|Antifungal Agents|antifungal agents|mesh-ancestor
101666779|NCT00602693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101666780|NCT00602693|Gout Suppressants|gout suppressants|mesh-ancestor
101666781|NCT00602693|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101666783|NCT00602693|Protective Agents|protective agents|mesh-ancestor
101666784|NCT00902395|Midazolam|midazolam|mesh-list
101666785|NCT00902395|Ketamine|ketamine|mesh-list
101666786|NCT00902395|Analgesics|analgesics|mesh-ancestor
101666787|NCT00902395|Sensory System Agents|sensory system agents|mesh-ancestor
101666788|NCT00902395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101666789|NCT00902395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666790|NCT00902395|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101666791|NCT00902395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101666792|NCT00902395|Anesthetics, General|anesthetics, general|mesh-ancestor
101666793|NCT00902395|Anesthetics|anesthetics|mesh-ancestor
101666794|NCT00902395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101666795|NCT00902395|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101666796|NCT00902395|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101666797|NCT00902395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101666798|NCT00902395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666799|NCT00902395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101666800|NCT00902395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101666801|NCT00902395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101666802|NCT00902395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101666803|NCT00902395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101666804|NCT00902395|GABA Modulators|gaba modulators|mesh-ancestor
101666805|NCT00902395|GABA Agents|gaba agents|mesh-ancestor
101666806|NCT04213404|Spartalizumab|spartalizumab|mesh-list
101666807|NCT04213404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101666808|NCT04213404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666809|NCT04213404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101666810|NCT04213404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101666811|NCT00604409|Capecitabine|capecitabine|mesh-list
101666812|NCT00604409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101666813|NCT00604409|Antimetabolites|antimetabolites|mesh-ancestor
101666814|NCT00604409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666815|NCT00604409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101666816|NCT00905905|Simvastatin|simvastatin|mesh-list
101666817|NCT00905905|Ezetimibe|ezetimibe|mesh-list
101666818|NCT00905905|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
101666819|NCT00905905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101666820|NCT00905905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101666822|NCT00905905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666823|NCT00905905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101666824|NCT00905905|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101666825|NCT00905905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101666826|NCT00902473|Topiramate|topiramate|mesh-list
101666827|NCT00902473|Anticonvulsants|anticonvulsants|mesh-ancestor
101666828|NCT00902473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101666829|NCT00902473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666830|NCT05177484|Ferric maltol|ferric maltol|mesh-list
101666831|NCT05177484|Hematinics|hematinics|mesh-ancestor
101666832|NCT04104789|Oxymetazoline|oxymetazoline|mesh-list
101666833|NCT04104789|Tetracaine|tetracaine|mesh-list
101666834|NCT04104789|Carticaine|carticaine|mesh-list
101666835|NCT04104789|Anesthetics, Local|anesthetics, local|mesh-ancestor
101666836|NCT04104789|Anesthetics|anesthetics|mesh-ancestor
101666837|NCT04104789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101666838|NCT04104789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666839|NCT04104789|Sensory System Agents|sensory system agents|mesh-ancestor
101666840|NCT04104789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101666841|NCT04104789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101666842|NCT04104789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101666843|NCT04104789|Adrenergic Agents|adrenergic agents|mesh-ancestor
101666844|NCT04104789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101666845|NCT04104789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666846|NCT04104789|Sympathomimetics|sympathomimetics|mesh-ancestor
101666847|NCT04104789|Autonomic Agents|autonomic agents|mesh-ancestor
101666848|NCT04104789|Nasal Decongestants|nasal decongestants|mesh-ancestor
101666849|NCT04104789|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101666850|NCT04104789|Respiratory System Agents|respiratory system agents|mesh-ancestor
101666851|NCT00938717|Linaclotide|linaclotide|mesh-list
101666852|NCT00938717|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
101666853|NCT00938717|Enzyme Activators|enzyme activators|mesh-ancestor
101666854|NCT00938717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666855|NCT00938717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101666856|NCT00905983|Gemcitabine|gemcitabine|mesh-list
101666857|NCT00905983|Docetaxel|docetaxel|mesh-list
101666858|NCT00905983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101666859|NCT00905983|Antimetabolites|antimetabolites|mesh-ancestor
101666860|NCT00905983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666861|NCT00905983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101666862|NCT00905983|Tubulin Modulators|tubulin modulators|mesh-ancestor
101666863|NCT00905983|Antimitotic Agents|antimitotic agents|mesh-ancestor
101666864|NCT00905983|Mitosis Modulators|mitosis modulators|mesh-ancestor
101666865|NCT00906061|Gemcitabine|gemcitabine|mesh-list
101666866|NCT00906061|Docetaxel|docetaxel|mesh-list
101666867|NCT00906061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101666868|NCT00906061|Antimetabolites|antimetabolites|mesh-ancestor
101666869|NCT00906061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666870|NCT00906061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101666871|NCT00906061|Tubulin Modulators|tubulin modulators|mesh-ancestor
101666872|NCT00906061|Antimitotic Agents|antimitotic agents|mesh-ancestor
101666873|NCT00906061|Mitosis Modulators|mitosis modulators|mesh-ancestor
101666874|NCT02602509|Rifampin|rifampin|mesh-list
101666875|NCT02602509|Pyrazinamide|pyrazinamide|mesh-list
101666876|NCT02602509|Celecoxib|celecoxib|mesh-list
101666877|NCT02602509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101666878|NCT02602509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101666879|NCT02602509|Analgesics|analgesics|mesh-ancestor
101666880|NCT02602509|Sensory System Agents|sensory system agents|mesh-ancestor
101666881|NCT02602509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101666882|NCT02602509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666883|NCT02602509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101666884|NCT02602509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101666885|NCT02602509|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101666886|NCT02602509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101666887|NCT02602509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101666888|NCT02602509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666889|NCT02602509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101666890|NCT02602509|Antitubercular Agents|antitubercular agents|mesh-ancestor
101666891|NCT02602509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101666892|NCT02602509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101666893|NCT02602509|Leprostatic Agents|leprostatic agents|mesh-ancestor
101666894|NCT02602509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101666895|NCT02602509|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101666896|NCT02602509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101666897|NCT02602509|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101666898|NCT02602509|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101666899|NCT02602509|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101666900|NCT02602509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101666901|NCT02852837|Daratumumab|daratumumab|mesh-list
101666902|NCT02852837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101666903|NCT00897871|Cyclophosphamide|cyclophosphamide|mesh-list
101666904|NCT00897871|Carboplatin|carboplatin|mesh-list
101666905|NCT00897871|Etoposide|etoposide|mesh-list
101666906|NCT00897871|Etoposide phosphate|etoposide phosphate|mesh-list
101666907|NCT00897871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101666908|NCT00897871|Immunologic Factors|immunologic factors|mesh-ancestor
101666909|NCT00897871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666910|NCT00897871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101666911|NCT00897871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101666912|NCT00897871|Alkylating Agents|alkylating agents|mesh-ancestor
101666913|NCT00897871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666914|NCT00897871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101666915|NCT00897871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101666916|NCT00897871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101666917|NCT00897871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101666918|NCT00897871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101666919|NCT00897871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101666920|NCT00902707|Phenylpropanolamine|phenylpropanolamine|mesh-list
101666921|NCT00902707|Guaifenesin|guaifenesin|mesh-list
101666922|NCT00902707|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
101666923|NCT00902707|Expectorants|expectorants|mesh-ancestor
101666924|NCT00902707|Respiratory System Agents|respiratory system agents|mesh-ancestor
101666925|NCT00902707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101666926|NCT00902707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101666927|NCT00902707|Adrenergic Agents|adrenergic agents|mesh-ancestor
101666928|NCT00902707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101666929|NCT00902707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666930|NCT00902707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666931|NCT00902707|Appetite Depressants|appetite depressants|mesh-ancestor
101666932|NCT00902707|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101666933|NCT00902707|Sympathomimetics|sympathomimetics|mesh-ancestor
101666934|NCT00902707|Autonomic Agents|autonomic agents|mesh-ancestor
101666935|NCT00902707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101666936|NCT00902707|Nasal Decongestants|nasal decongestants|mesh-ancestor
101666937|NCT00902707|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101666938|NCT00906139|Fentanyl|fentanyl|mesh-list
101666939|NCT00906139|Midazolam|midazolam|mesh-list
101666940|NCT00906139|Propofol|propofol|mesh-list
101666941|NCT00906139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101666942|NCT00906139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101666943|NCT00906139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666944|NCT00906139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101666945|NCT00906139|Anesthetics, General|anesthetics, general|mesh-ancestor
101666946|NCT00906139|Anesthetics|anesthetics|mesh-ancestor
101666947|NCT00906139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101666948|NCT00906139|Narcotics|narcotics|mesh-ancestor
101666949|NCT00906139|Analgesics|analgesics|mesh-ancestor
101666950|NCT00906139|Sensory System Agents|sensory system agents|mesh-ancestor
101666951|NCT00906139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101666952|NCT00906139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101666953|NCT00906139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101666954|NCT00906139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101666955|NCT00906139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101666956|NCT00906139|GABA Modulators|gaba modulators|mesh-ancestor
101666957|NCT00906139|GABA Agents|gaba agents|mesh-ancestor
101666958|NCT00906139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101666959|NCT00906139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666960|NCT00906295|Chrysarobin|chrysarobin|mesh-list
101666961|NCT00906295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101666962|NCT00906295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101666963|NCT00906295|Analgesics|analgesics|mesh-ancestor
101666964|NCT00906295|Sensory System Agents|sensory system agents|mesh-ancestor
101666965|NCT00906295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101666966|NCT00906295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666967|NCT00906295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101666968|NCT00906295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101666969|NCT02754102|Sunscreening Agents|sunscreening agents|mesh-list
101666970|NCT02754102|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101666971|NCT02754102|Protective Agents|protective agents|mesh-ancestor
101666972|NCT02754102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666973|NCT02754102|Dermatologic Agents|dermatologic agents|mesh-ancestor
101666974|NCT00134303|Metformin|metformin|mesh-list
101666975|NCT00134303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101666976|NCT00134303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666977|NCT00902941|Rasagiline|rasagiline|mesh-list
101666978|NCT00902941|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101826590|NCT01005758|Etoposide|etoposide|mesh-list
101666979|NCT00902941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101666980|NCT00902941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666981|NCT00902941|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101666982|NCT00902941|Protective Agents|protective agents|mesh-ancestor
101666983|NCT00902941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666984|NCT02754258|Methylphenidate|methylphenidate|mesh-list
101666985|NCT02754258|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101666986|NCT02754258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666987|NCT02754258|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101666988|NCT02754258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101666989|NCT02754258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101666990|NCT02754258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101666991|NCT02754258|Dopamine Agents|dopamine agents|mesh-ancestor
101666992|NCT02754258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101666993|NCT04267991|Tacrolimus|tacrolimus|mesh-list
101666994|NCT04267991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101666995|NCT04267991|Immunologic Factors|immunologic factors|mesh-ancestor
101666996|NCT04267991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101666997|NCT04267991|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101666998|NCT04267991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101666999|NCT04267991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667000|NCT02852681|Drospirenone|drospirenone|mesh-list
101667001|NCT02852681|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101667002|NCT02852681|Hormone Antagonists|hormone antagonists|mesh-ancestor
101667003|NCT02852681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101667004|NCT02852681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667005|NCT02852681|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101667006|NCT02852681|Diuretics|diuretics|mesh-ancestor
101667007|NCT02852681|Natriuretic Agents|natriuretic agents|mesh-ancestor
101667008|NCT02754180|Gemcitabine|gemcitabine|mesh-list
101667009|NCT02754180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101667010|NCT02754180|Antimetabolites|antimetabolites|mesh-ancestor
101667011|NCT02754180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667012|NCT02754180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101667013|NCT00602849|Sertraline|sertraline|mesh-list
101667014|NCT00602849|Antidepressive Agents|antidepressive agents|mesh-ancestor
101667015|NCT00602849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101667016|NCT00602849|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101667017|NCT00602849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101667018|NCT00602849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101667019|NCT00602849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667020|NCT00602849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101667021|NCT00602849|Serotonin Agents|serotonin agents|mesh-ancestor
101667022|NCT00602849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667023|NCT00906451|Simvastatin|simvastatin|mesh-list
101667024|NCT00906451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101667025|NCT00906451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101667026|NCT00906451|Antimetabolites|antimetabolites|mesh-ancestor
101667027|NCT00906451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667028|NCT00906451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101667029|NCT00906451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101667030|NCT00906451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101667032|NCT00898417|Bevacizumab|bevacizumab|mesh-list
101667033|NCT00898417|Carboplatin|carboplatin|mesh-list
101826606|NCT01005758|Antiemetics|antiemetics|mesh-ancestor
101667034|NCT00898417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101667035|NCT00898417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101667036|NCT00898417|Tubulin Modulators|tubulin modulators|mesh-ancestor
101667037|NCT00898417|Antimitotic Agents|antimitotic agents|mesh-ancestor
101667038|NCT00898417|Mitosis Modulators|mitosis modulators|mesh-ancestor
101667039|NCT00898417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667040|NCT00898417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101667041|NCT00898417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101667042|NCT00898417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101667043|NCT00898417|Growth Substances|growth substances|mesh-ancestor
101667044|NCT00898417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667045|NCT00898417|Growth Inhibitors|growth inhibitors|mesh-ancestor
101667046|NCT05381363|Interferons|interferons|mesh-list
101667047|NCT05381363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101667048|NCT05381363|Antiviral Agents|antiviral agents|mesh-ancestor
101667049|NCT05381363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101667050|NCT00906529|Insulin Aspart|insulin aspart|mesh-list
101667051|NCT00906529|Insulin Detemir|insulin detemir|mesh-list
101667052|NCT00906529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101667053|NCT00906529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667054|NCT00783705|Inositol|inositol|mesh-list
101667055|NCT00783705|Vitamin B Complex|vitamin b complex|mesh-ancestor
101667056|NCT00783705|Vitamins|vitamins|mesh-ancestor
101667057|NCT00783705|Micronutrients|micronutrients|mesh-ancestor
101667058|NCT00783705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667059|NCT02755350|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101667060|NCT02755350|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101667061|NCT02755350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101667062|NCT02755350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101667063|NCT02755350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667064|NCT02755350|Antiviral Agents|antiviral agents|mesh-ancestor
101667065|NCT02755350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101667066|NCT02755350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101667067|NCT02755350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101667068|NCT04103697|Capecitabine|capecitabine|mesh-list
101667069|NCT04103697|Oxaliplatin|oxaliplatin|mesh-list
101667070|NCT04103697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101667071|NCT04103697|Antimetabolites|antimetabolites|mesh-ancestor
101667072|NCT04103697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667073|NCT04103697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101667074|NCT00898573|Lapatinib|lapatinib|mesh-list
101667075|NCT00898573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101667076|NCT00898573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101667077|NCT00898573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101667078|NCT00898573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667079|NCT04321668|Hylan|hylan|mesh-list
101667080|NCT04321668|Viscosupplements|viscosupplements|mesh-ancestor
101667081|NCT04321668|Protective Agents|protective agents|mesh-ancestor
101667082|NCT04321668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667083|NCT02851745|Linagliptin|linagliptin|mesh-list
101667084|NCT02851745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101667085|NCT02851745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667086|NCT02851745|Incretins|incretins|mesh-ancestor
101667087|NCT02851745|Hormones|hormones|mesh-ancestor
101667088|NCT02851745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101667089|NCT02851745|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101667090|NCT02851745|Protease Inhibitors|protease inhibitors|mesh-ancestor
101667091|NCT02851745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101667092|NCT02851745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667093|NCT02602197|Acetaminophen|acetaminophen|mesh-list
101667094|NCT02602197|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
101667095|NCT02602197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101667096|NCT02602197|Analgesics|analgesics|mesh-ancestor
101667097|NCT02602197|Sensory System Agents|sensory system agents|mesh-ancestor
101667098|NCT02602197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101667099|NCT02602197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667101|NCT02602197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101667102|NCT02602197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101667103|NCT02602197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101667104|NCT02753712|Fluticasone|fluticasone|mesh-list
101667105|NCT02753712|Xhance|xhance|mesh-list
101667106|NCT02753712|Formoterol Fumarate|formoterol fumarate|mesh-list
101667107|NCT02753712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101667108|NCT02753712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101667109|NCT02753712|Autonomic Agents|autonomic agents|mesh-ancestor
101667110|NCT02753712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101667111|NCT02753712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667112|NCT02753712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101667113|NCT02753712|Respiratory System Agents|respiratory system agents|mesh-ancestor
101667114|NCT02753712|Dermatologic Agents|dermatologic agents|mesh-ancestor
101667115|NCT02753712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101667116|NCT02753712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101667117|NCT02753712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101667118|NCT02753712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101667119|NCT02753712|Adrenergic Agents|adrenergic agents|mesh-ancestor
101667120|NCT02753712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101667121|NCT02753712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667123|NCT04220892|Pemetrexed|pemetrexed|mesh-list
101667124|NCT04220892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101667125|NCT04220892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101667126|NCT04220892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101667127|NCT04220892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667128|NCT04220892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101667129|NCT04220892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101667130|NCT04220892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101667131|NCT02696148|Liraglutide|liraglutide|mesh-list
101667132|NCT02696148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101667133|NCT02696148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667134|NCT02696148|Incretins|incretins|mesh-ancestor
101667135|NCT02696148|Hormones|hormones|mesh-ancestor
101667136|NCT02696148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101667137|NCT00887198|Prednisone|prednisone|mesh-list
101667138|NCT00887198|Abiraterone Acetate|abiraterone acetate|mesh-list
101667139|NCT00887198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101667140|NCT00887198|Glucocorticoids|glucocorticoids|mesh-ancestor
101667141|NCT00887198|Hormones|hormones|mesh-ancestor
101667142|NCT00887198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101667143|NCT00887198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667144|NCT00887198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101667145|NCT00887198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101667146|NCT00887198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101667147|NCT00887198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101667148|NCT00887198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667149|NCT00887198|Hormone Antagonists|hormone antagonists|mesh-ancestor
101667150|NCT00887198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101667151|NCT04342585|Progesterone|progesterone|mesh-list
101667152|NCT04342585|Progestins|progestins|mesh-ancestor
101667153|NCT04342585|Hormones|hormones|mesh-ancestor
101667154|NCT04342585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101667155|NCT04342585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667156|NCT02831894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
101667157|NCT02831894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101667158|NCT02831894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667159|NCT00782067|Midostaurin|midostaurin|mesh-list
101667160|NCT00782067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101667161|NCT00782067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101324337|NCT03879408|Acetaminophen|acetaminophen|mesh-list
101667162|NCT00782067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101667163|NCT00782067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667164|NCT05520723|Loperamide|loperamide|mesh-list
101667165|NCT05520723|Antidiarrheals|antidiarrheals|mesh-list
101667166|NCT05520723|Lenograstim|lenograstim|mesh-list
101667167|NCT05520723|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
101667168|NCT05520723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101667169|NCT05520723|Immunologic Factors|immunologic factors|mesh-ancestor
101667170|NCT05520723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667171|NCT05520723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101667172|NCT05520723|Immunoconjugates|immunoconjugates|mesh-ancestor
101667173|NCT02826746|Magnesium Sulfate|magnesium sulfate|mesh-list
101667174|NCT02826746|Analgesics|analgesics|mesh-ancestor
101667175|NCT02826746|Sensory System Agents|sensory system agents|mesh-ancestor
101667176|NCT02826746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101667177|NCT02826746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667178|NCT02826746|Anesthetics|anesthetics|mesh-ancestor
101667179|NCT02826746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101667180|NCT02826746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101667181|NCT02826746|Anticonvulsants|anticonvulsants|mesh-ancestor
101667182|NCT02826746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101667183|NCT02826746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101667184|NCT02826746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667185|NCT02826746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101667186|NCT02826746|Tocolytic Agents|tocolytic agents|mesh-ancestor
101667187|NCT02826746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101667188|NCT02750904|Nicotine|nicotine|mesh-list
101667189|NCT02750904|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101667190|NCT02750904|Autonomic Agents|autonomic agents|mesh-ancestor
101667191|NCT02750904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101667192|NCT02750904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667193|NCT02750904|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101667194|NCT02750904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101667195|NCT02750904|Cholinergic Agents|cholinergic agents|mesh-ancestor
101667196|NCT02750904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101667197|NCT02750904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667198|NCT02831972|Itraconazole|itraconazole|mesh-list
101667199|NCT02831972|Antifungal Agents|antifungal agents|mesh-ancestor
101667200|NCT02831972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101667201|NCT02831972|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101667202|NCT02831972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101667203|NCT02831972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101667204|NCT02831972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667205|NCT02831972|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101667206|NCT02831972|Hormone Antagonists|hormone antagonists|mesh-ancestor
101667207|NCT02831972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101667208|NCT02831972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667209|NCT02831972|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101667210|NCT02695758|Bupivacaine|bupivacaine|mesh-list
101667211|NCT02695758|Anesthetics, Local|anesthetics, local|mesh-ancestor
101667212|NCT02695758|Anesthetics|anesthetics|mesh-ancestor
101667213|NCT02695758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101667214|NCT02695758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667215|NCT02695758|Sensory System Agents|sensory system agents|mesh-ancestor
101667216|NCT02695758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101667217|NCT00605215|Interferons|interferons|mesh-list
101667218|NCT00605215|Interferon beta-1a|interferon beta-1a|mesh-list
101667219|NCT00605215|Interferon-beta|interferon-beta|mesh-list
101667220|NCT00605215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101667221|NCT00605215|Antiviral Agents|antiviral agents|mesh-ancestor
101667222|NCT00605215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101667223|NCT00605215|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101667224|NCT00605215|Immunologic Factors|immunologic factors|mesh-ancestor
101667225|NCT00605215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667226|NCT02827682|Anesthetics|anesthetics|mesh-list
101667227|NCT02827682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101184912|NCT01151904|Timolol|timolol|mesh-list
101667228|NCT02827682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667229|NCT02826200|Acenocoumarol|acenocoumarol|mesh-list
101667230|NCT02826200|Anticoagulants|anticoagulants|mesh-ancestor
101667231|NCT04244708|Temozolomide|temozolomide|mesh-list
101667232|NCT04244708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101667233|NCT04244708|Alkylating Agents|alkylating agents|mesh-ancestor
101667234|NCT04244708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667235|NCT04244708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101667236|NCT02750748|Naltrexone|naltrexone|mesh-list
101667237|NCT02750748|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101667238|NCT02750748|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101667239|NCT02750748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667240|NCT02750748|Sensory System Agents|sensory system agents|mesh-ancestor
101667241|NCT02750748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101667242|NCT00604279|Risperidone|risperidone|mesh-list
101667243|NCT00604279|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101667244|NCT00604279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101667245|NCT00604279|Serotonin Agents|serotonin agents|mesh-ancestor
101667246|NCT00604279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101667247|NCT00604279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667248|NCT00604279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667249|NCT00604279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101667250|NCT00604279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101667251|NCT00604279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101667252|NCT00604279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101667253|NCT00604279|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101667254|NCT00604279|Dopamine Agents|dopamine agents|mesh-ancestor
101667255|NCT00604279|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101667256|NCT00604279|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101667257|NCT00635856|Gefitinib|gefitinib|mesh-list
101667258|NCT00635856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101667259|NCT00635856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101667260|NCT00635856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101667261|NCT00635856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667262|NCT00906685|Bevacizumab|bevacizumab|mesh-list
101667263|NCT00906685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101667264|NCT00906685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101667265|NCT00906685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101667266|NCT00906685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101667267|NCT00906685|Growth Substances|growth substances|mesh-ancestor
101667268|NCT00906685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667269|NCT00906685|Growth Inhibitors|growth inhibitors|mesh-ancestor
101667270|NCT05660720|Moxifloxacin|moxifloxacin|mesh-list
101667271|NCT05660720|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101667272|NCT05660720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101667273|NCT05660720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101667274|NCT05660720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101667275|NCT05660720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101667276|NCT05660720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101667277|NCT05660720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667278|NCT05660720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101667279|NCT05660720|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101667280|NCT05660720|Contraceptive Agents|contraceptive agents|mesh-ancestor
101667281|NCT05660720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101667282|NCT05660720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667283|NCT05660720|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101667284|NCT05660720|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101667285|NCT05660720|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101667286|NCT02695212|Apremilast|apremilast|mesh-list
101667287|NCT02695212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101667288|NCT02695212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101667289|NCT02695212|Analgesics|analgesics|mesh-ancestor
101826650|NCT01000220|Omeprazole|omeprazole|mesh-list
101667290|NCT02695212|Sensory System Agents|sensory system agents|mesh-ancestor
101667291|NCT02695212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101667292|NCT02695212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667293|NCT02695212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101667294|NCT02695212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101667295|NCT02695212|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101667296|NCT02695212|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101667297|NCT02695212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101667298|NCT02695212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667299|NCT05381207|Fluticasone|fluticasone|mesh-list
101667300|NCT05381207|Xhance|xhance|mesh-list
101667301|NCT05381207|Montelukast|montelukast|mesh-list
101667302|NCT05381207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101667303|NCT05381207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101667304|NCT05381207|Autonomic Agents|autonomic agents|mesh-ancestor
101667305|NCT05381207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101667306|NCT05381207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667307|NCT05381207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101667308|NCT05381207|Respiratory System Agents|respiratory system agents|mesh-ancestor
101667309|NCT05381207|Dermatologic Agents|dermatologic agents|mesh-ancestor
101667310|NCT05381207|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101667311|NCT05381207|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101667312|NCT05381207|Hormone Antagonists|hormone antagonists|mesh-ancestor
101667313|NCT05381207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101667314|NCT05381207|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101667315|NCT05381207|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101667316|NCT05381207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667317|NCT02750670|Dexamethasone|dexamethasone|mesh-list
101667318|NCT02750670|Gemcitabine|gemcitabine|mesh-list
101667319|NCT02750670|Obinutuzumab|obinutuzumab|mesh-list
101667320|NCT02750670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101667321|NCT02750670|Antiemetics|antiemetics|mesh-ancestor
101667322|NCT02750670|Autonomic Agents|autonomic agents|mesh-ancestor
101667323|NCT02750670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101667324|NCT02750670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667325|NCT02750670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101667326|NCT02750670|Glucocorticoids|glucocorticoids|mesh-ancestor
101667328|NCT02750670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101667329|NCT02750670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101667330|NCT02750670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101667331|NCT02750670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101667332|NCT02750670|Antimetabolites|antimetabolites|mesh-ancestor
101667333|NCT02750670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667334|NCT02750670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101667335|NCT00605891|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101667336|NCT00605891|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101667337|NCT00605891|Autonomic Agents|autonomic agents|mesh-ancestor
101667338|NCT00605891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101667339|NCT00605891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667341|NCT00605891|Respiratory System Agents|respiratory system agents|mesh-ancestor
101667342|NCT00605891|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101667343|NCT00605891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101667344|NCT00605891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101667345|NCT00605891|Adrenergic Agents|adrenergic agents|mesh-ancestor
101667346|NCT00605891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101667347|NCT00605891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667348|NCT05122208|Famotidine|famotidine|mesh-list
101667349|NCT05122208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101667350|NCT05122208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101667351|NCT05122208|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101667352|NCT05122208|Histamine Antagonists|histamine antagonists|mesh-ancestor
101667353|NCT05122208|Histamine Agents|histamine agents|mesh-ancestor
101667354|NCT05122208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101667355|NCT05122208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667356|NCT05122208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667357|NCT00781911|Octreotide|octreotide|mesh-list
101667358|NCT00781911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101667359|NCT00781911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101667360|NCT00781911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101667361|NCT00605917|Sertraline|sertraline|mesh-list
101667362|NCT00605917|Antidepressive Agents|antidepressive agents|mesh-ancestor
101667363|NCT00605917|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101667364|NCT00605917|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101667365|NCT00605917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101667366|NCT00605917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101667367|NCT00605917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667368|NCT00605917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101667369|NCT00605917|Serotonin Agents|serotonin agents|mesh-ancestor
101667370|NCT00605917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667371|NCT04919096|Aflibercept|aflibercept|mesh-list
101667372|NCT04919096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101667373|NCT04919096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101667374|NCT04919096|Growth Substances|growth substances|mesh-ancestor
101667375|NCT04919096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667376|NCT04919096|Growth Inhibitors|growth inhibitors|mesh-ancestor
101667377|NCT04919096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101667378|NCT02746848|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101667379|NCT02746848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101667380|NCT00781599|Varenicline|varenicline|mesh-list
101667381|NCT00781599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101667382|NCT00781599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101667383|NCT00781599|Cholinergic Agents|cholinergic agents|mesh-ancestor
101667384|NCT00781599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101667385|NCT00781599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667386|NCT00781599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667387|NCT00904111|Lidocaine|lidocaine|mesh-list
101667388|NCT00904111|Anesthetics, Local|anesthetics, local|mesh-ancestor
101667389|NCT00904111|Anesthetics|anesthetics|mesh-ancestor
101667390|NCT00904111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101667391|NCT00904111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667392|NCT00904111|Sensory System Agents|sensory system agents|mesh-ancestor
101667393|NCT00904111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101667394|NCT00904111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101667395|NCT00904111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101667396|NCT00904111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101667397|NCT00904111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101667398|NCT00904111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667399|NCT03240211|Pembrolizumab|pembrolizumab|mesh-list
101667400|NCT03240211|Decitabine|decitabine|mesh-list
101667401|NCT03240211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101667402|NCT03240211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101667403|NCT03240211|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101667404|NCT03240211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667405|NCT03240211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101667406|NCT03240211|Antimetabolites|antimetabolites|mesh-ancestor
101667407|NCT03240211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101667408|NCT04278144|Nivolumab|nivolumab|mesh-list
101667409|NCT04278144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101667410|NCT04278144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101667411|NCT04278144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101667412|NCT04278144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667414|NCT00899197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101667415|NCT00899197|Hormone Antagonists|hormone antagonists|mesh-ancestor
101667416|NCT00899197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101667417|NCT00899197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667418|NCT00899197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101667419|NCT00899197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101667420|NCT00899197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101667421|NCT00899197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101667422|NCT00899197|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101667423|NCT00603083|Ketorolac|ketorolac|mesh-list
101667424|NCT00603083|Ropivacaine|ropivacaine|mesh-list
101667425|NCT00603083|Anesthetics, Local|anesthetics, local|mesh-ancestor
101667426|NCT00603083|Anesthetics|anesthetics|mesh-ancestor
101667427|NCT00603083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101667428|NCT00603083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667429|NCT00603083|Sensory System Agents|sensory system agents|mesh-ancestor
101667430|NCT00603083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101667431|NCT00603083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101667432|NCT00603083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101667433|NCT00603083|Analgesics|analgesics|mesh-ancestor
101667434|NCT00603083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101667435|NCT00603083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101667436|NCT00603083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101667437|NCT00603083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101667438|NCT00603083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667439|NCT05379257|Furosemide|furosemide|mesh-list
101667440|NCT05379257|Diuretics|diuretics|mesh-ancestor
101667441|NCT05379257|Natriuretic Agents|natriuretic agents|mesh-ancestor
101667442|NCT05379257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667443|NCT05379257|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101667444|NCT05379257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101667445|NCT05379257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667446|NCT04241744|Vancomycin|vancomycin|mesh-list
101667447|NCT04241744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101667448|NCT04241744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101667449|NCT02824094|Crizotinib|crizotinib|mesh-list
101667450|NCT02824094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101667451|NCT02824094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101667452|NCT02824094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101667453|NCT02824094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667454|NCT00899587|Enalapril|enalapril|mesh-list
101667455|NCT00899587|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101667456|NCT00899587|Protease Inhibitors|protease inhibitors|mesh-ancestor
101667457|NCT00899587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101667458|NCT00899587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667459|NCT00899587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101667460|NCT04268069|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101667461|NCT04268069|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101667462|NCT02824406|Acetazolamide|acetazolamide|mesh-list
101667463|NCT02824406|Anticonvulsants|anticonvulsants|mesh-ancestor
101667464|NCT02824406|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101667465|NCT02824406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101667466|NCT02824406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667467|NCT02824406|Diuretics|diuretics|mesh-ancestor
101667468|NCT02824406|Natriuretic Agents|natriuretic agents|mesh-ancestor
101667469|NCT02824406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667470|NCT04267679|Cannabidiol|cannabidiol|mesh-list
101667471|NCT04267679|Anticonvulsants|anticonvulsants|mesh-ancestor
101667472|NCT04951388|Somatomedin B|somatomedin b|mesh-list
101667473|NCT04951388|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101667474|NCT04951388|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101667475|NCT04951388|Protease Inhibitors|protease inhibitors|mesh-ancestor
101667476|NCT04951388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101667477|NCT04951388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667478|NCT04242914|Midazolam|midazolam|mesh-list
101667479|NCT04242914|Ketamine|ketamine|mesh-list
101667480|NCT04242914|Analgesics|analgesics|mesh-ancestor
101667481|NCT04242914|Sensory System Agents|sensory system agents|mesh-ancestor
101667482|NCT04242914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101667483|NCT04242914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667484|NCT04242914|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101667485|NCT04242914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101667487|NCT04242914|Anesthetics|anesthetics|mesh-ancestor
101667488|NCT04242914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101667489|NCT04242914|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101667490|NCT04242914|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101667491|NCT04242914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101667492|NCT04242914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667493|NCT04242914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101667494|NCT04242914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101667495|NCT04242914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101667496|NCT04242914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101667497|NCT04242914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101667498|NCT04242914|GABA Modulators|gaba modulators|mesh-ancestor
101667499|NCT04242914|GABA Agents|gaba agents|mesh-ancestor
101667500|NCT00780273|Cimetidine|cimetidine|mesh-list
101667501|NCT00780273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101667502|NCT00780273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101667503|NCT00780273|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101667504|NCT00780273|Histamine Antagonists|histamine antagonists|mesh-ancestor
101667505|NCT00780273|Histamine Agents|histamine agents|mesh-ancestor
101667506|NCT00780273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101667507|NCT00780273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667508|NCT00780273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667509|NCT00780273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101667510|NCT00780273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101667511|NCT00780273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101667512|NCT02827136|Lidocaine|lidocaine|mesh-list
101667513|NCT02827136|Anesthetics, Local|anesthetics, local|mesh-ancestor
101667514|NCT02827136|Anesthetics|anesthetics|mesh-ancestor
101667515|NCT02827136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101667516|NCT02827136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667517|NCT02827136|Sensory System Agents|sensory system agents|mesh-ancestor
101667518|NCT02827136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101667519|NCT02827136|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101667520|NCT02827136|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101667521|NCT02827136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101667522|NCT02827136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101667523|NCT02827136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667524|NCT04102995|Pregnanolone|pregnanolone|mesh-list
101667525|NCT04102995|Anesthetics|anesthetics|mesh-ancestor
101667526|NCT04102995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101667527|NCT04102995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667528|NCT00899821|Aldesleukin|aldesleukin|mesh-list
101667529|NCT00899821|Interleukin-12|interleukin-12|mesh-list
101667531|NCT00899821|Immunologic Factors|immunologic factors|mesh-ancestor
101667532|NCT00899821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667533|NCT00899821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101667534|NCT00899821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101667535|NCT00899821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101667536|NCT00899821|Antiviral Agents|antiviral agents|mesh-ancestor
101667537|NCT00899821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101667538|NCT00899821|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101667539|NCT00899821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101667540|NCT00899821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101667541|NCT00899821|Growth Substances|growth substances|mesh-ancestor
101667542|NCT00899821|Growth Inhibitors|growth inhibitors|mesh-ancestor
101667544|NCT00005112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101667545|NCT00005112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667546|NCT04163406|Ferrous fumarate|ferrous fumarate|mesh-list
101667547|NCT04163406|Trace Elements|trace elements|mesh-ancestor
101667548|NCT04163406|Micronutrients|micronutrients|mesh-ancestor
101667549|NCT04163406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667550|NCT04218552|Amlodipine|amlodipine|mesh-list
101667551|NCT04218552|Telmisartan|telmisartan|mesh-list
101667552|NCT04218552|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101667553|NCT04218552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101667554|NCT04218552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101667555|NCT04218552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667556|NCT04218552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101667557|NCT04218552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667558|NCT04218552|Vasodilator Agents|vasodilator agents|mesh-ancestor
101667559|NCT04218552|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101667560|NCT04218552|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101667561|NCT00904657|Sunitinib|sunitinib|mesh-list
101667562|NCT00904657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101667563|NCT00904657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101667564|NCT00904657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101667565|NCT00904657|Growth Substances|growth substances|mesh-ancestor
101667566|NCT00904657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667567|NCT00904657|Growth Inhibitors|growth inhibitors|mesh-ancestor
101667568|NCT00904657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101667569|NCT00904657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101667570|NCT00904657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667571|NCT00904735|Imatinib Mesylate|imatinib mesylate|mesh-list
101667572|NCT00904735|Hydroxyurea|hydroxyurea|mesh-list
101667573|NCT00904735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101667574|NCT00904735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101667575|NCT00904735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101667576|NCT00904735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667577|NCT00904735|Antisickling Agents|antisickling agents|mesh-ancestor
101667578|NCT00904735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101667579|NCT02823626|Spironolactone|spironolactone|mesh-list
101667580|NCT02823626|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101667581|NCT02823626|Hormone Antagonists|hormone antagonists|mesh-ancestor
101667582|NCT02823626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101667583|NCT02823626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667584|NCT02823626|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101667585|NCT02823626|Diuretics|diuretics|mesh-ancestor
101667586|NCT02823626|Natriuretic Agents|natriuretic agents|mesh-ancestor
101667587|NCT00779259|Quinine|quinine|mesh-list
101667588|NCT00779259|Theophylline|theophylline|mesh-list
101667589|NCT00779259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101667590|NCT00779259|Autonomic Agents|autonomic agents|mesh-ancestor
101667591|NCT00779259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101667592|NCT00779259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667593|NCT00779259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101667594|NCT00779259|Respiratory System Agents|respiratory system agents|mesh-ancestor
101667595|NCT00779259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101667596|NCT00779259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101667597|NCT00779259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667599|NCT00779259|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101667600|NCT00779259|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101667601|NCT00779259|Purinergic Agents|purinergic agents|mesh-ancestor
101667602|NCT00779259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101667603|NCT00779259|Antimalarials|antimalarials|mesh-ancestor
101667604|NCT00779259|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101667605|NCT00779259|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101667606|NCT00779259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101667607|NCT00779259|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101667608|NCT00779259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101667609|NCT00779259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101667610|NCT00779259|Analgesics|analgesics|mesh-ancestor
101667611|NCT00779259|Sensory System Agents|sensory system agents|mesh-ancestor
101667612|NCT02746380|Adalimumab|adalimumab|mesh-list
101667613|NCT02746380|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101667614|NCT02746380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101667615|NCT02746380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101667616|NCT02745990|Epoetin Alfa|epoetin alfa|mesh-list
101667617|NCT02745990|Hematinics|hematinics|mesh-ancestor
101667618|NCT00915915|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101667619|NCT00915915|Gestodene|gestodene|mesh-list
101667620|NCT00915915|Femovan|femovan|mesh-list
101667621|NCT00915915|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101667622|NCT00915915|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101667623|NCT00915915|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101667624|NCT00915915|Contraceptive Agents|contraceptive agents|mesh-ancestor
101667625|NCT00915915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101667626|NCT00915915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667627|NCT00915915|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101667628|NCT00915915|Estrogens|estrogens|mesh-ancestor
101667629|NCT00915915|Hormones|hormones|mesh-ancestor
101667630|NCT00915915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101667631|NCT00915915|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101667632|NCT00915915|Progestins|progestins|mesh-ancestor
101667633|NCT00915915|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101667635|NCT02538367|YH12852|yh12852|mesh-list
101667637|NCT02538367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101667638|NCT02538367|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101667639|NCT02538367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101667640|NCT02538367|Serotonin Agents|serotonin agents|mesh-ancestor
101667641|NCT02538367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101667642|NCT02538367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667643|NCT02538367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667645|NCT00900445|Prednisolone|prednisolone|mesh-list
101667646|NCT00900445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101667647|NCT00900445|Methylprednisolone|methylprednisolone|mesh-list
101667648|NCT00900445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101667649|NCT00900445|Prednisolone acetate|prednisolone acetate|mesh-list
101667650|NCT00900445|Hydrocortisone|hydrocortisone|mesh-list
101667651|NCT00900445|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101667652|NCT00900445|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101667653|NCT00900445|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101667654|NCT00900445|Cortisone|cortisone|mesh-list
101667655|NCT00900445|Vincristine|vincristine|mesh-list
101667656|NCT00900445|Daunorubicin|daunorubicin|mesh-list
101667657|NCT00900445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101667658|NCT00900445|Prednisolone phosphate|prednisolone phosphate|mesh-list
101667659|NCT00900445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101667660|NCT00900445|Glucocorticoids|glucocorticoids|mesh-ancestor
101667661|NCT00900445|Hormones|hormones|mesh-ancestor
101826719|NCT00880061|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
101667662|NCT00900445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101667663|NCT00900445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667664|NCT00900445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101667665|NCT00900445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101667666|NCT00900445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101667667|NCT00900445|Tubulin Modulators|tubulin modulators|mesh-ancestor
101667668|NCT00900445|Antimitotic Agents|antimitotic agents|mesh-ancestor
101667669|NCT00900445|Mitosis Modulators|mitosis modulators|mesh-ancestor
101667670|NCT00900445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667671|NCT00900445|Antiemetics|antiemetics|mesh-ancestor
101667672|NCT00900445|Autonomic Agents|autonomic agents|mesh-ancestor
101667673|NCT00900445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101667674|NCT00900445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101667675|NCT00900445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101667676|NCT00900445|Protective Agents|protective agents|mesh-ancestor
101667677|NCT00900445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101667678|NCT00900445|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101667679|NCT00900445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101667680|NCT00900445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101667681|NCT03994419|Anesthetics|anesthetics|mesh-list
101667682|NCT03994419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101667683|NCT03994419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667684|NCT00936065|Etanercept|etanercept|mesh-list
101667685|NCT00936065|Acitretin|acitretin|mesh-list
101667686|NCT00936065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101667687|NCT00936065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101667688|NCT00936065|Analgesics|analgesics|mesh-ancestor
101667689|NCT00936065|Sensory System Agents|sensory system agents|mesh-ancestor
101667690|NCT00936065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101667691|NCT00936065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667692|NCT00936065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101667693|NCT00936065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101667694|NCT00936065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101667695|NCT00936065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101667696|NCT00936065|Immunologic Factors|immunologic factors|mesh-ancestor
101667697|NCT00936065|Keratolytic Agents|keratolytic agents|mesh-ancestor
101667698|NCT00936065|Dermatologic Agents|dermatologic agents|mesh-ancestor
101667699|NCT04241276|Paclitaxel|paclitaxel|mesh-list
101667700|NCT04241276|Gemcitabine|gemcitabine|mesh-list
101667701|NCT04241276|Tretinoin|tretinoin|mesh-list
101667702|NCT04241276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101667703|NCT04241276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101667704|NCT04241276|Tubulin Modulators|tubulin modulators|mesh-ancestor
101667705|NCT04241276|Antimitotic Agents|antimitotic agents|mesh-ancestor
101667706|NCT04241276|Mitosis Modulators|mitosis modulators|mesh-ancestor
101667707|NCT04241276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667708|NCT04241276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101667709|NCT04241276|Antimetabolites|antimetabolites|mesh-ancestor
101667710|NCT04241276|Keratolytic Agents|keratolytic agents|mesh-ancestor
101667711|NCT04241276|Dermatologic Agents|dermatologic agents|mesh-ancestor
101667712|NCT00905047|Leucovorin|leucovorin|mesh-list
101667713|NCT00905047|Folic Acid|folic acid|mesh-list
101667714|NCT00905047|Tegafur|tegafur|mesh-list
101667715|NCT00905047|Levoleucovorin|levoleucovorin|mesh-list
101667716|NCT00905047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101667717|NCT00905047|Antimetabolites|antimetabolites|mesh-ancestor
101667718|NCT00905047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667719|NCT00905047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101667720|NCT00905047|Antidotes|antidotes|mesh-ancestor
101667721|NCT00905047|Protective Agents|protective agents|mesh-ancestor
101667722|NCT00905047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667723|NCT00905047|Vitamin B Complex|vitamin b complex|mesh-ancestor
101667724|NCT00905047|Vitamins|vitamins|mesh-ancestor
101667725|NCT00905047|Micronutrients|micronutrients|mesh-ancestor
101667726|NCT00905047|Hematinics|hematinics|mesh-ancestor
101667727|NCT04102449|Apremilast|apremilast|mesh-list
101667728|NCT04102449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101667729|NCT04102449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101667730|NCT04102449|Analgesics|analgesics|mesh-ancestor
101667731|NCT04102449|Sensory System Agents|sensory system agents|mesh-ancestor
101667732|NCT04102449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101667733|NCT04102449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667734|NCT04102449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101667735|NCT04102449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101667736|NCT04102449|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101667737|NCT04102449|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101667738|NCT04102449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101667739|NCT04102449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667741|NCT02823236|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101667742|NCT02823236|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101667743|NCT02823236|Pirfenidone|pirfenidone|mesh-list
101667744|NCT02823236|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101667745|NCT02823236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101667746|NCT02823236|Glucocorticoids|glucocorticoids|mesh-ancestor
101667747|NCT02823236|Hormones|hormones|mesh-ancestor
101667748|NCT02823236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101667749|NCT02823236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667750|NCT02823236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101667751|NCT02823236|Immunologic Factors|immunologic factors|mesh-ancestor
101667752|NCT02823236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101667753|NCT02823236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667754|NCT02823236|Analgesics|analgesics|mesh-ancestor
101667755|NCT02823236|Sensory System Agents|sensory system agents|mesh-ancestor
101667756|NCT02823236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101667757|NCT02823236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101667758|NCT02823236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101667759|NCT02823236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101667760|NCT02823236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101667762|NCT00633698|Nicotinic Acids|nicotinic acids|mesh-list
101667763|NCT00633698|Niacinamide|niacinamide|mesh-list
101667764|NCT00633698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101667765|NCT00633698|Antimetabolites|antimetabolites|mesh-ancestor
101667766|NCT00633698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667767|NCT00633698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101667768|NCT00633698|Vasodilator Agents|vasodilator agents|mesh-ancestor
101667769|NCT00633698|Vitamin B Complex|vitamin b complex|mesh-ancestor
101667770|NCT00633698|Vitamins|vitamins|mesh-ancestor
101667771|NCT00633698|Micronutrients|micronutrients|mesh-ancestor
101667772|NCT00633698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667773|NCT02825342|Citalopram|citalopram|mesh-list
101667774|NCT02825342|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101667775|NCT02825342|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101667776|NCT02825342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101667777|NCT02825342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101667778|NCT02825342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667779|NCT02825342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101667780|NCT02825342|Serotonin Agents|serotonin agents|mesh-ancestor
101667781|NCT02825342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667782|NCT02825342|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101667783|NCT02825342|Antidepressive Agents|antidepressive agents|mesh-ancestor
101667784|NCT02825342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101667785|NCT02825342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101667786|NCT02749890|Insulin Glargine|insulin glargine|mesh-list
101667787|NCT02749890|Lixisenatide|lixisenatide|mesh-list
101667789|NCT02749890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667790|NCT04242758|Dapagliflozin|dapagliflozin|mesh-list
101667791|NCT04242758|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101667792|NCT04242758|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101667793|NCT04242758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667794|NCT04242758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101667795|NCT04242758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667796|NCT04242758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101667797|NCT04242758|Diuretics|diuretics|mesh-ancestor
101667798|NCT04242758|Natriuretic Agents|natriuretic agents|mesh-ancestor
101667799|NCT04242758|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101667800|NCT04242758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101667801|NCT02745912|Metformin|metformin|mesh-list
101667802|NCT02745912|Naltrexone|naltrexone|mesh-list
101667803|NCT02745912|Bupropion|bupropion|mesh-list
101667804|NCT02745912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101667805|NCT02745912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667806|NCT02745912|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101667807|NCT02745912|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101667808|NCT02745912|Sensory System Agents|sensory system agents|mesh-ancestor
101667809|NCT02745912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101667810|NCT02745912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101667811|NCT02745912|Antidepressive Agents|antidepressive agents|mesh-ancestor
101667812|NCT02745912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101667813|NCT02745912|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101667814|NCT02745912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101667815|NCT02745912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101667816|NCT02745912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667817|NCT02745912|Dopamine Agents|dopamine agents|mesh-ancestor
101667818|NCT02745912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101667819|NCT02745912|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101667820|NCT02745912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101667821|NCT02745912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101667822|NCT02825186|Dexamethasone|dexamethasone|mesh-list
101667823|NCT02825186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101667824|NCT02825186|Antiemetics|antiemetics|mesh-ancestor
101667825|NCT02825186|Autonomic Agents|autonomic agents|mesh-ancestor
101667826|NCT02825186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101667827|NCT02825186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325018|NCT00108979|Escitalopram|escitalopram|mesh-list
101667828|NCT02825186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101667829|NCT02825186|Glucocorticoids|glucocorticoids|mesh-ancestor
101667830|NCT02825186|Hormones|hormones|mesh-ancestor
101667831|NCT02825186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101667832|NCT02825186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101667833|NCT02825186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101667834|NCT00604825|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101667835|NCT00604825|Estrogens|estrogens|mesh-ancestor
101667836|NCT00604825|Hormones|hormones|mesh-ancestor
101667837|NCT00604825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101667838|NCT00604825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667839|NCT04239560|Boron|boron|mesh-list
101667840|NCT04239560|Trace Elements|trace elements|mesh-ancestor
101667841|NCT04239560|Micronutrients|micronutrients|mesh-ancestor
101667842|NCT04239560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667843|NCT04218162|Lasmiditan|lasmiditan|mesh-list
101667844|NCT04218162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101667845|NCT04218162|Serotonin Agents|serotonin agents|mesh-ancestor
101667846|NCT04218162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101667847|NCT04218162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667848|NCT04218162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667849|NCT00606125|Sorafenib|sorafenib|mesh-list
101667850|NCT00606125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101667851|NCT00606125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101667852|NCT00606125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101667853|NCT00606125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667854|NCT04242212|Misoprostol|misoprostol|mesh-list
101667855|NCT04242212|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101667856|NCT04242212|Abortifacient Agents|abortifacient agents|mesh-ancestor
101667857|NCT04242212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101667858|NCT04242212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667859|NCT04242212|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101667860|NCT04242212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101667861|NCT04242212|Oxytocics|oxytocics|mesh-ancestor
101667862|NCT02851433|Anesthetics|anesthetics|mesh-list
101667864|NCT02851433|Sevoflurane|sevoflurane|mesh-list
101667865|NCT02851433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101667866|NCT02851433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667867|NCT02851433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101667868|NCT02851433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101667869|NCT02851433|Anesthetics, General|anesthetics, general|mesh-ancestor
101667870|NCT02851433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101667871|NCT02851433|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101667872|NCT05629806|Metformin|metformin|mesh-list
101667873|NCT05629806|Pioglitazone|pioglitazone|mesh-list
101667874|NCT05629806|Acarbose|acarbose|mesh-list
101667875|NCT05629806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101667876|NCT05629806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667877|NCT05629806|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101667878|NCT05629806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101667879|NCT05629806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667880|NCT02745756|Vaccines|vaccines|mesh-list
101667881|NCT02745756|Immunologic Factors|immunologic factors|mesh-ancestor
101667882|NCT02745756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667883|NCT04242368|Fluticasone|fluticasone|mesh-list
101667884|NCT04242368|Xhance|xhance|mesh-list
101667885|NCT04242368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101667886|NCT04242368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101667887|NCT04242368|Autonomic Agents|autonomic agents|mesh-ancestor
101667888|NCT04242368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101667889|NCT04242368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667890|NCT04242368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101667891|NCT04242368|Respiratory System Agents|respiratory system agents|mesh-ancestor
101667892|NCT04242368|Dermatologic Agents|dermatologic agents|mesh-ancestor
101667893|NCT04242368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101667894|NCT04217148|Dexamethasone|dexamethasone|mesh-list
101667895|NCT04217148|Dexamethasone acetate|dexamethasone acetate|mesh-list
101667896|NCT04217148|Tretinoin|tretinoin|mesh-list
101667897|NCT04217148|BB 1101|bb 1101|mesh-list
101667898|NCT04217148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101667899|NCT04217148|Antiemetics|antiemetics|mesh-ancestor
101667900|NCT04217148|Autonomic Agents|autonomic agents|mesh-ancestor
101667901|NCT04217148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101667902|NCT04217148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667903|NCT04217148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101667904|NCT04217148|Glucocorticoids|glucocorticoids|mesh-ancestor
101667905|NCT04217148|Hormones|hormones|mesh-ancestor
101325088|NCT00109408|Methotrexate|methotrexate|mesh-list
101667906|NCT04217148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101667907|NCT04217148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101667908|NCT04217148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101667909|NCT04217148|Protease Inhibitors|protease inhibitors|mesh-ancestor
101667910|NCT04217148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101667911|NCT04217148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667912|NCT04217148|Keratolytic Agents|keratolytic agents|mesh-ancestor
101667913|NCT04217148|Dermatologic Agents|dermatologic agents|mesh-ancestor
101667914|NCT00900913|Ropivacaine|ropivacaine|mesh-list
101667915|NCT00900913|Anesthetics, Local|anesthetics, local|mesh-ancestor
101667916|NCT00900913|Anesthetics|anesthetics|mesh-ancestor
101667917|NCT00900913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101667918|NCT00900913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667919|NCT00900913|Sensory System Agents|sensory system agents|mesh-ancestor
101667920|NCT00900913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101667921|NCT04216836|Magnesium Oxide|magnesium oxide|mesh-list
101667922|NCT04216836|Antacids|antacids|mesh-ancestor
101667923|NCT04216836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667924|NCT04216836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101667925|NCT00937157|Glatiramer Acetate|glatiramer acetate|mesh-list
101667926|NCT00937157|(T,G)-A-L|(t,g)-a-l|mesh-list
101667927|NCT00937157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101667928|NCT00937157|Immunologic Factors|immunologic factors|mesh-ancestor
101667929|NCT00937157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667930|NCT00937157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101667931|NCT00937157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101667932|NCT04034173|Leucovorin|leucovorin|mesh-list
101667933|NCT04034173|Folic Acid|folic acid|mesh-list
101667934|NCT04034173|Irinotecan|irinotecan|mesh-list
101667935|NCT04034173|Panitumumab|panitumumab|mesh-list
101667936|NCT04034173|Levoleucovorin|levoleucovorin|mesh-list
101667937|NCT04034173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101667939|NCT04034173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101667940|NCT04034173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667941|NCT04034173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101667942|NCT04034173|Antidotes|antidotes|mesh-ancestor
101667943|NCT04034173|Protective Agents|protective agents|mesh-ancestor
101667944|NCT04034173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667945|NCT04034173|Vitamin B Complex|vitamin b complex|mesh-ancestor
101667946|NCT04034173|Vitamins|vitamins|mesh-ancestor
101667947|NCT04034173|Micronutrients|micronutrients|mesh-ancestor
101667948|NCT04034173|Hematinics|hematinics|mesh-ancestor
101667949|NCT04034173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101667950|NCT00606203|Milnacipran|milnacipran|mesh-list
101667951|NCT00606203|Levomilnacipran|levomilnacipran|mesh-list
101667952|NCT00606203|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101667953|NCT00606203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101667954|NCT00606203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101667955|NCT00606203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667956|NCT00606203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101667957|NCT00606203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667958|NCT00606203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101667959|NCT00606203|Analgesics|analgesics|mesh-ancestor
101667960|NCT00606203|Sensory System Agents|sensory system agents|mesh-ancestor
101667961|NCT00606203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101667962|NCT00606203|Antidepressive Agents|antidepressive agents|mesh-ancestor
101667963|NCT00606203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101667964|NCT02539849|Adalimumab|adalimumab|mesh-list
101667965|NCT02539849|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101667966|NCT02539849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101667967|NCT02539849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101667968|NCT02749578|Atorvastatin|atorvastatin|mesh-list
101667969|NCT02749578|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101667970|NCT02749578|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101667971|NCT02749578|Antimetabolites|antimetabolites|mesh-ancestor
101667972|NCT02749578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667973|NCT02749578|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101667974|NCT02749578|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101667975|NCT02749578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101667976|NCT05378867|Bevacizumab|bevacizumab|mesh-list
101667977|NCT05378867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101667978|NCT05378867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101667979|NCT05378867|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101667980|NCT05378867|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101667981|NCT05378867|Growth Substances|growth substances|mesh-ancestor
101325160|NCT00110032|Etanidazole|etanidazole|mesh-list
101667982|NCT05378867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667983|NCT05378867|Growth Inhibitors|growth inhibitors|mesh-ancestor
101667984|NCT02749656|Desoximetasone|desoximetasone|mesh-list
101667985|NCT02749656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101667986|NCT02749656|Glucocorticoids|glucocorticoids|mesh-ancestor
101667988|NCT02749656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101667989|NCT02749656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101667990|NCT00603317|Amoxicillin|amoxicillin|mesh-list
101667991|NCT00603317|Clavulanic Acids|clavulanic acids|mesh-list
101667992|NCT00603317|Clavulanic Acid|clavulanic acid|mesh-list
101667993|NCT00603317|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101667994|NCT00603317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101667995|NCT00603317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101667996|NCT00603317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101667997|NCT00603317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101667998|NCT00603317|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101667999|NCT02745522|Oxytocin|oxytocin|mesh-list
101668000|NCT02745522|Oxytocics|oxytocics|mesh-ancestor
101668001|NCT02745522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101668002|NCT02745522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668003|NCT02824718|Teriparatide|teriparatide|mesh-list
101668004|NCT02824718|Alfacalcidol|alfacalcidol|mesh-list
101668005|NCT02824718|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
101668006|NCT02824718|Sodium Channel Blockers|sodium channel blockers|mesh-list
101668007|NCT02824718|Diuretics|diuretics|mesh-list
101668008|NCT02824718|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-list
101668009|NCT02824718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101668010|NCT02824718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668011|NCT02824718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101668012|NCT02824718|Natriuretic Agents|natriuretic agents|mesh-ancestor
101668013|NCT02824718|Vitamins|vitamins|mesh-ancestor
101668014|NCT02824718|Micronutrients|micronutrients|mesh-ancestor
101668015|NCT02824718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101668016|NCT02824718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668017|NCT05378711|Fluoxetine|fluoxetine|mesh-list
101668018|NCT05378711|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101668019|NCT05378711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101668020|NCT05378711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101668021|NCT05378711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668022|NCT05378711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101668023|NCT05378711|Serotonin Agents|serotonin agents|mesh-ancestor
101668024|NCT05378711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668025|NCT05378711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101668026|NCT05378711|Antidepressive Agents|antidepressive agents|mesh-ancestor
101668027|NCT05378711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101668028|NCT05378711|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101668029|NCT05378711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101668030|NCT05378711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101668031|NCT00777153|Cediranib|cediranib|mesh-list
101668032|NCT00777153|Lomustine|lomustine|mesh-list
101668033|NCT00777153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101668034|NCT00777153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101668035|NCT00777153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101668036|NCT00777153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668037|NCT00777153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101668038|NCT00777153|Alkylating Agents|alkylating agents|mesh-ancestor
101668039|NCT02821520|Verteporfin|verteporfin|mesh-list
101668040|NCT02821520|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101668041|NCT02821520|Dermatologic Agents|dermatologic agents|mesh-ancestor
101668042|NCT00604955|Paromomycin|paromomycin|mesh-list
101668043|NCT00604955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101668044|NCT00604955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101668045|NCT00604955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101668046|NCT00604955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101668047|NCT04266509|Rifampin|rifampin|mesh-list
101668048|NCT04266509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101668049|NCT04266509|Antitubercular Agents|antitubercular agents|mesh-ancestor
101668050|NCT04266509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101668051|NCT04266509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101668052|NCT04266509|Leprostatic Agents|leprostatic agents|mesh-ancestor
101668053|NCT04266509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101668054|NCT04266509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101668055|NCT04266509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668056|NCT04266509|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101668057|NCT04266509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101668058|NCT04266509|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101668059|NCT04266509|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101668060|NCT04266509|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101668061|NCT04266509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101668063|NCT02824874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101668064|NCT02824874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668065|NCT02824874|Incretins|incretins|mesh-ancestor
101668066|NCT02824874|Hormones|hormones|mesh-ancestor
101668067|NCT02824874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101668068|NCT02824874|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101668069|NCT02824874|Protease Inhibitors|protease inhibitors|mesh-ancestor
101668070|NCT02824874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101668071|NCT02824874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668072|NCT04204265|Hyaluronic Acid|hyaluronic acid|mesh-list
101668073|NCT04204265|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101668074|NCT04204265|Immunologic Factors|immunologic factors|mesh-ancestor
101668075|NCT04204265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668076|NCT04204265|Viscosupplements|viscosupplements|mesh-ancestor
101668077|NCT04204265|Protective Agents|protective agents|mesh-ancestor
101668078|NCT04267913|Dexamethasone|dexamethasone|mesh-list
101668079|NCT04267913|Dexamethasone acetate|dexamethasone acetate|mesh-list
101668080|NCT04267913|Docetaxel|docetaxel|mesh-list
101668081|NCT04267913|Ramucirumab|ramucirumab|mesh-list
101668082|NCT04267913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101668083|NCT04267913|Antibodies|antibodies|mesh-list
101668084|NCT04267913|Immunoglobulins|immunoglobulins|mesh-list
101668085|NCT04267913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101668086|NCT04267913|Lexatumumab|lexatumumab|mesh-list
101668087|NCT04267913|BB 1101|bb 1101|mesh-list
101668088|NCT04267913|Immunologic Factors|immunologic factors|mesh-ancestor
101668089|NCT04267913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668090|NCT04267913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101668091|NCT04267913|Antiemetics|antiemetics|mesh-ancestor
101668092|NCT04267913|Autonomic Agents|autonomic agents|mesh-ancestor
101668093|NCT04267913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101668094|NCT04267913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101668095|NCT04267913|Glucocorticoids|glucocorticoids|mesh-ancestor
101668096|NCT04267913|Hormones|hormones|mesh-ancestor
101668097|NCT04267913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101668098|NCT04267913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101668099|NCT04267913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101668100|NCT04267913|Protease Inhibitors|protease inhibitors|mesh-ancestor
101668101|NCT04267913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101668102|NCT04267913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668103|NCT04267913|Tubulin Modulators|tubulin modulators|mesh-ancestor
101668104|NCT04267913|Antimitotic Agents|antimitotic agents|mesh-ancestor
101668105|NCT04267913|Mitosis Modulators|mitosis modulators|mesh-ancestor
101668107|NCT04216758|Gemcitabine|gemcitabine|mesh-list
101668108|NCT04216758|Tegafur|tegafur|mesh-list
101668109|NCT04216758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101668110|NCT04216758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101668111|NCT04216758|Tubulin Modulators|tubulin modulators|mesh-ancestor
101668112|NCT04216758|Antimitotic Agents|antimitotic agents|mesh-ancestor
101668113|NCT04216758|Mitosis Modulators|mitosis modulators|mesh-ancestor
101668114|NCT04216758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668115|NCT04216758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101668116|NCT04216758|Antimetabolites|antimetabolites|mesh-ancestor
101668117|NCT00606437|Fludarabine|fludarabine|mesh-list
101668118|NCT00606437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101668119|NCT02538211|Vaccines|vaccines|mesh-list
101668120|NCT02538211|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101668121|NCT02538211|Immunologic Factors|immunologic factors|mesh-ancestor
101668122|NCT02538211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668123|NCT02821676|Anesthetics|anesthetics|mesh-list
101668124|NCT02821676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101668125|NCT02821676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668126|NCT02745054|Anticoagulants|anticoagulants|mesh-list
101668127|NCT00908089|Sulfasalazine|sulfasalazine|mesh-list
101668128|NCT00908089|Hydroxychloroquine|hydroxychloroquine|mesh-list
101668129|NCT00908089|Prednisolone|prednisolone|mesh-list
101668130|NCT00908089|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101668131|NCT00908089|Methylprednisolone|methylprednisolone|mesh-list
101668132|NCT00908089|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101668133|NCT00908089|Prednisolone acetate|prednisolone acetate|mesh-list
101668134|NCT00908089|Infliximab|infliximab|mesh-list
101668135|NCT00908089|Naltrexone|naltrexone|mesh-list
101668136|NCT00908089|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101668137|NCT00908089|Prednisolone phosphate|prednisolone phosphate|mesh-list
101668138|NCT00908089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101668139|NCT00908089|Glucocorticoids|glucocorticoids|mesh-ancestor
101668140|NCT00908089|Hormones|hormones|mesh-ancestor
101668141|NCT00908089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101668142|NCT00908089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668143|NCT00908089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101668144|NCT00908089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101668145|NCT00908089|Antiemetics|antiemetics|mesh-ancestor
101668146|NCT00908089|Autonomic Agents|autonomic agents|mesh-ancestor
101668147|NCT00908089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101668148|NCT00908089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101668149|NCT00908089|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101668150|NCT00908089|Protective Agents|protective agents|mesh-ancestor
101668151|NCT00908089|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101668152|NCT00908089|Dermatologic Agents|dermatologic agents|mesh-ancestor
101668153|NCT00908089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101668154|NCT00908089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101668155|NCT00908089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101668156|NCT00908089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101668157|NCT00908089|Analgesics|analgesics|mesh-ancestor
101668158|NCT00908089|Sensory System Agents|sensory system agents|mesh-ancestor
101668159|NCT00908089|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101668160|NCT00908089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101668161|NCT00908089|Antimalarials|antimalarials|mesh-ancestor
101668162|NCT00908089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101668163|NCT00908089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101668165|NCT00908089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668166|NCT04758416|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101668167|NCT04758416|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101668168|NCT04758416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668169|NCT03553446|Sevoflurane|sevoflurane|mesh-list
101668170|NCT03553446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101668171|NCT03553446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101668172|NCT03553446|Anesthetics, General|anesthetics, general|mesh-ancestor
101668173|NCT03553446|Anesthetics|anesthetics|mesh-ancestor
101668174|NCT03553446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101668175|NCT03553446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668176|NCT00908167|Cytarabine|cytarabine|mesh-list
101668177|NCT00908167|Clofarabine|clofarabine|mesh-list
101668178|NCT00908167|Sorafenib|sorafenib|mesh-list
101668179|NCT00908167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101668180|NCT00908167|Antimetabolites|antimetabolites|mesh-ancestor
101668181|NCT00908167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668182|NCT00908167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101668183|NCT00908167|Antiviral Agents|antiviral agents|mesh-ancestor
101668184|NCT00908167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101668185|NCT00908167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101668186|NCT00908167|Immunologic Factors|immunologic factors|mesh-ancestor
101668187|NCT00908167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668188|NCT00908167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101668189|NCT00908167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101668190|NCT02821052|Insulin|insulin|mesh-list
101668191|NCT02821052|Insulin Aspart|insulin aspart|mesh-list
101668192|NCT02821052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101668193|NCT02821052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668194|NCT05659628|Tislelizumab|tislelizumab|mesh-list
101668195|NCT05659628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101668196|NCT05659628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101668197|NCT00606515|Paclitaxel|paclitaxel|mesh-list
101668198|NCT00606515|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101668199|NCT00606515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101668200|NCT00606515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101668201|NCT00606515|Tubulin Modulators|tubulin modulators|mesh-ancestor
101668202|NCT00606515|Antimitotic Agents|antimitotic agents|mesh-ancestor
101668203|NCT00606515|Mitosis Modulators|mitosis modulators|mesh-ancestor
101668204|NCT00606515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668206|NCT00908323|Immunologic Factors|immunologic factors|mesh-ancestor
101668207|NCT00908323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668208|NCT02749032|Metformin|metformin|mesh-list
101668209|NCT02749032|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101668210|NCT02749032|Vildagliptin|vildagliptin|mesh-list
101668211|NCT02749032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101668212|NCT02749032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826828|NCT05883046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313328|NCT05638087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101826841|NCT05882864|Triamcinolone|triamcinolone|mesh-list
101826842|NCT05882864|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101826843|NCT05882864|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101826844|NCT05882864|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101826845|NCT05882864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101826846|NCT05882864|Glucocorticoids|glucocorticoids|mesh-ancestor
101826847|NCT05882864|Hormones|hormones|mesh-ancestor
101826848|NCT05882864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101826849|NCT05882864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101826850|NCT05882864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101668213|NCT02749032|Incretins|incretins|mesh-ancestor
101668214|NCT02749032|Hormones|hormones|mesh-ancestor
101668215|NCT02749032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101668216|NCT02749032|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101668217|NCT02749032|Protease Inhibitors|protease inhibitors|mesh-ancestor
101668218|NCT02749032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101668219|NCT02749032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668220|NCT00908713|Methylprednisolone|methylprednisolone|mesh-list
101668221|NCT00908713|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101668222|NCT00908713|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101668223|NCT00908713|Prednisolone|prednisolone|mesh-list
101668224|NCT00908713|Prednisolone acetate|prednisolone acetate|mesh-list
101668225|NCT00908713|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101668226|NCT00908713|Prednisolone phosphate|prednisolone phosphate|mesh-list
101668227|NCT00908713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101668228|NCT00908713|Antiemetics|antiemetics|mesh-ancestor
101668229|NCT00908713|Autonomic Agents|autonomic agents|mesh-ancestor
101668230|NCT00908713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101668231|NCT00908713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668232|NCT00908713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101668233|NCT00908713|Glucocorticoids|glucocorticoids|mesh-ancestor
101668234|NCT00908713|Hormones|hormones|mesh-ancestor
101668235|NCT00908713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101668236|NCT00908713|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101668237|NCT00908713|Protective Agents|protective agents|mesh-ancestor
101668238|NCT00908713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101668239|NCT00908713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101668240|NCT00908869|Interferons|interferons|mesh-list
101668241|NCT00908869|Interferon-alpha|interferon-alpha|mesh-list
101668242|NCT00908869|Interferon alpha-2|interferon alpha-2|mesh-list
101668243|NCT00908869|Cyclophosphamide|cyclophosphamide|mesh-list
101668244|NCT00908869|Vinorelbine|vinorelbine|mesh-list
101668245|NCT00908869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101668246|NCT00908869|Immunologic Factors|immunologic factors|mesh-ancestor
101668247|NCT00908869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668248|NCT00908869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101668249|NCT00908869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101668250|NCT00908869|Alkylating Agents|alkylating agents|mesh-ancestor
101668251|NCT00908869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668252|NCT00908869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101668253|NCT00908869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101668254|NCT00908869|Antiviral Agents|antiviral agents|mesh-ancestor
101668255|NCT00908869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101668256|NCT00908869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101668257|NCT00908869|Tubulin Modulators|tubulin modulators|mesh-ancestor
101668258|NCT00908869|Antimitotic Agents|antimitotic agents|mesh-ancestor
101668259|NCT00908869|Mitosis Modulators|mitosis modulators|mesh-ancestor
101668260|NCT00605111|Insulin Aspart|insulin aspart|mesh-list
101668261|NCT00605111|Biphasic Insulins|biphasic insulins|mesh-list
101668262|NCT00605111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101668263|NCT00605111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668264|NCT03465774|Doxycycline|doxycycline|mesh-list
101668265|NCT03465774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101668266|NCT03465774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101668267|NCT03465774|Antimalarials|antimalarials|mesh-ancestor
101668268|NCT03465774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101668269|NCT03465774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101668270|NCT04240496|Clozapine|clozapine|mesh-list
101668271|NCT04240496|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101668272|NCT04240496|Serotonin Agents|serotonin agents|mesh-ancestor
101668274|NCT04240496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668275|NCT04240496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668276|NCT04240496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101668277|NCT04240496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101826865|NCT05882604|Mesna|mesna|mesh-list
101668278|NCT04240496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101668279|NCT04240496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101668280|NCT04240496|GABA Antagonists|gaba antagonists|mesh-ancestor
101668281|NCT04240496|GABA Agents|gaba agents|mesh-ancestor
101668282|NCT00909337|Bosentan|bosentan|mesh-list
101325460|NCT00007358|Hormones|hormones|mesh-ancestor
101668283|NCT00909337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101668284|NCT00909337|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101668285|NCT00909337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668286|NCT00909571|Tacrolimus|tacrolimus|mesh-list
101668287|NCT00909571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101668288|NCT00909571|Immunologic Factors|immunologic factors|mesh-ancestor
101668289|NCT00909571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668290|NCT00909571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101668291|NCT00909571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101668292|NCT00909571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668293|NCT04015375|Dapsone|dapsone|mesh-list
101668294|NCT04015375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101668295|NCT04015375|Antimalarials|antimalarials|mesh-ancestor
101668296|NCT04015375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101668297|NCT04015375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101668298|NCT04015375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101668299|NCT04015375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101668300|NCT04015375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668301|NCT04015375|Leprostatic Agents|leprostatic agents|mesh-ancestor
101668302|NCT04015375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101668303|NCT04239794|Propofol|propofol|mesh-list
101668304|NCT04239794|Sevoflurane|sevoflurane|mesh-list
101668305|NCT04239794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101668306|NCT04239794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101668307|NCT04239794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668308|NCT04239794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101668309|NCT04239794|Anesthetics, General|anesthetics, general|mesh-ancestor
101668310|NCT04239794|Anesthetics|anesthetics|mesh-ancestor
101668311|NCT04239794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101668312|NCT04239794|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101668313|NCT02850887|Anesthetics|anesthetics|mesh-list
101668314|NCT02850887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101668315|NCT02850887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668316|NCT00931645|Cytarabine|cytarabine|mesh-list
101668317|NCT00931645|Dexamethasone|dexamethasone|mesh-list
101668318|NCT00931645|Cyclophosphamide|cyclophosphamide|mesh-list
101668319|NCT00931645|Cisplatin|cisplatin|mesh-list
101668320|NCT00931645|Fludarabine|fludarabine|mesh-list
101668321|NCT00931645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101668322|NCT00931645|Immunologic Factors|immunologic factors|mesh-ancestor
101668323|NCT00931645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668324|NCT00931645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101668325|NCT00931645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101668326|NCT00931645|Alkylating Agents|alkylating agents|mesh-ancestor
101668327|NCT00931645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668328|NCT00931645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101668329|NCT00931645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101668330|NCT00931645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101668331|NCT00931645|Antiemetics|antiemetics|mesh-ancestor
101668332|NCT00931645|Autonomic Agents|autonomic agents|mesh-ancestor
101668333|NCT00931645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101668334|NCT00931645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101668335|NCT00931645|Glucocorticoids|glucocorticoids|mesh-ancestor
101668337|NCT00931645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101668338|NCT00931645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101668339|NCT00931645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101668340|NCT00931645|Antimetabolites|antimetabolites|mesh-ancestor
101668341|NCT00931645|Antiviral Agents|antiviral agents|mesh-ancestor
101668342|NCT00931645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101668343|NCT05658692|Anti-Infective Agents|anti-infective agents|mesh-list
101668344|NCT05658692|Dexamethasone|dexamethasone|mesh-list
101668345|NCT05658692|Hydrocortisone|hydrocortisone|mesh-list
101668347|NCT05658692|Dopamine|dopamine|mesh-list
101668348|NCT05658692|Isoproterenol|isoproterenol|mesh-list
101668349|NCT05658692|Olprinone|olprinone|mesh-list
101668350|NCT05658692|Epinephrine|epinephrine|mesh-list
101668351|NCT05658692|Norepinephrine|norepinephrine|mesh-list
101668352|NCT05658692|Metaraminol|metaraminol|mesh-list
101668353|NCT05658692|Midazolam|midazolam|mesh-list
101668354|NCT05658692|Dexmedetomidine|dexmedetomidine|mesh-list
101668355|NCT05658692|Bromides|bromides|mesh-list
101668356|NCT05658692|Propofol|propofol|mesh-list
101668357|NCT05658692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
101668358|NCT05658692|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101668359|NCT05658692|Simvastatin|simvastatin|mesh-list
101668360|NCT05658692|Glucocorticoids|glucocorticoids|mesh-list
101325534|NCT00112567|Fludarabine|fludarabine|mesh-list
101668361|NCT05658692|Succinylcholine|succinylcholine|mesh-list
101668362|NCT05658692|Vecuronium Bromide|vecuronium bromide|mesh-list
101668363|NCT05658692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101668364|NCT05658692|Antiemetics|antiemetics|mesh-ancestor
101668365|NCT05658692|Autonomic Agents|autonomic agents|mesh-ancestor
101668366|NCT05658692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101668367|NCT05658692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668368|NCT05658692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101668369|NCT05658692|Hormones|hormones|mesh-ancestor
101668370|NCT05658692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101668371|NCT05658692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101668372|NCT05658692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101668373|NCT05658692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101668374|NCT05658692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668375|NCT05658692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101668376|NCT05658692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101668377|NCT05658692|Analgesics|analgesics|mesh-ancestor
101668378|NCT05658692|Sensory System Agents|sensory system agents|mesh-ancestor
101668379|NCT05658692|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101668380|NCT05658692|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101668381|NCT05658692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101668382|NCT05658692|Adrenergic Agents|adrenergic agents|mesh-ancestor
101668383|NCT05658692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101668384|NCT05658692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101668386|NCT05658692|Anesthetics|anesthetics|mesh-ancestor
101668387|NCT05658692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101668388|NCT05658692|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101668389|NCT05658692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101668390|NCT05658692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101668391|NCT05658692|GABA Modulators|gaba modulators|mesh-ancestor
101668392|NCT05658692|GABA Agents|gaba agents|mesh-ancestor
101668393|NCT05658692|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101668394|NCT05658692|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101668395|NCT05658692|Antimetabolites|antimetabolites|mesh-ancestor
101668396|NCT05658692|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101668397|NCT05658692|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101668398|NCT05658692|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101668399|NCT05658692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101668408|NCT05658692|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101668409|NCT05658692|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101668411|NCT05658692|Dopamine Agents|dopamine agents|mesh-ancestor
101668412|NCT05658692|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
101668413|NCT05658692|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101668414|NCT05658692|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101668415|NCT05658692|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101668416|NCT05658692|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101668417|NCT05658692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101668418|NCT05658692|Cholinergic Agents|cholinergic agents|mesh-ancestor
101668419|NCT05658692|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101668420|NCT02744508|Dexamethasone|dexamethasone|mesh-list
101668421|NCT02744508|Palonosetron|palonosetron|mesh-list
101668422|NCT02744508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101668423|NCT02744508|Antiemetics|antiemetics|mesh-ancestor
101668424|NCT02744508|Autonomic Agents|autonomic agents|mesh-ancestor
101668425|NCT02744508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101668426|NCT02744508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668427|NCT02744508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101668428|NCT02744508|Glucocorticoids|glucocorticoids|mesh-ancestor
101668429|NCT02744508|Hormones|hormones|mesh-ancestor
101668430|NCT02744508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101668431|NCT02744508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101668432|NCT02744508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101668433|NCT02744508|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101668434|NCT02744508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101668435|NCT02744508|Serotonin Agents|serotonin agents|mesh-ancestor
101668436|NCT02744508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101668437|NCT02744508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668438|NCT00927511|Fulvestrant|fulvestrant|mesh-list
101668439|NCT00927511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101668440|NCT00927511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101668441|NCT00927511|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101668442|NCT00927511|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101668443|NCT00927511|Hormone Antagonists|hormone antagonists|mesh-ancestor
101668444|NCT00927511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101668445|NCT00927511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668455|NCT03211338|Progesterone|progesterone|mesh-list
101668456|NCT03211338|Mitogens|mitogens|mesh-list
101668457|NCT03211338|Progestins|progestins|mesh-ancestor
101668458|NCT03211338|Hormones|hormones|mesh-ancestor
101668459|NCT03211338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101668460|NCT03211338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668461|NCT03211338|Mitosis Modulators|mitosis modulators|mesh-ancestor
101668462|NCT03211338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668463|NCT00936611|Panobinostat|panobinostat|mesh-list
101826900|NCT05881915|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101668464|NCT00936611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101668465|NCT00936611|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101668466|NCT00936611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101668467|NCT00936611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668469|NCT02744196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101668470|NCT02744196|Immunologic Factors|immunologic factors|mesh-ancestor
101668471|NCT02744196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668472|NCT02744196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101668473|NCT02744196|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101668474|NCT02744196|Abortifacient Agents|abortifacient agents|mesh-ancestor
101668475|NCT02744196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101668476|NCT02744196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101668477|NCT02744196|Antimetabolites|antimetabolites|mesh-ancestor
101668478|NCT02744196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668479|NCT02744196|Dermatologic Agents|dermatologic agents|mesh-ancestor
101668480|NCT02744196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101668481|NCT02744196|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101668482|NCT02744196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101668483|NCT02744196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101668484|NCT02139852|Capsaicin|capsaicin|mesh-list
101668485|NCT02139852|Antipruritics|antipruritics|mesh-ancestor
101668486|NCT02139852|Dermatologic Agents|dermatologic agents|mesh-ancestor
101668487|NCT02139852|Sensory System Agents|sensory system agents|mesh-ancestor
101668488|NCT02139852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101668489|NCT02139852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668490|NCT05379647|Cyclophosphamide|cyclophosphamide|mesh-list
101668491|NCT05379647|Rituximab|rituximab|mesh-list
101668492|NCT05379647|Fludarabine|fludarabine|mesh-list
101668493|NCT05379647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101668494|NCT05379647|Immunologic Factors|immunologic factors|mesh-ancestor
101668495|NCT05379647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668496|NCT05379647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101668497|NCT05379647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101668498|NCT05379647|Alkylating Agents|alkylating agents|mesh-ancestor
101668499|NCT05379647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668500|NCT05379647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101668501|NCT05379647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101668502|NCT05379647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101668503|NCT02748330|Aspirin|aspirin|mesh-list
101668504|NCT02748330|Clopidogrel|clopidogrel|mesh-list
101668505|NCT02748330|Ticagrelor|ticagrelor|mesh-list
101668506|NCT02748330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101668507|NCT02748330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101668508|NCT02748330|Analgesics|analgesics|mesh-ancestor
101668509|NCT02748330|Sensory System Agents|sensory system agents|mesh-ancestor
101668510|NCT02748330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101668511|NCT02748330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668512|NCT02748330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101668513|NCT02748330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101668514|NCT02748330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101668515|NCT02748330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101668516|NCT02748330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668517|NCT02748330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101668518|NCT02748330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101668519|NCT02748330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101668521|NCT02748330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101668522|NCT02748330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101668523|NCT02748330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101668524|NCT02748330|Purinergic Agents|purinergic agents|mesh-ancestor
101668525|NCT02748330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101668526|NCT05379569|Cyclophosphamide|cyclophosphamide|mesh-list
101668527|NCT05379569|Fludarabine|fludarabine|mesh-list
101668528|NCT05379569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101668529|NCT05379569|Immunologic Factors|immunologic factors|mesh-ancestor
101668530|NCT05379569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668531|NCT05379569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101668532|NCT05379569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101668533|NCT05379569|Alkylating Agents|alkylating agents|mesh-ancestor
101668534|NCT05379569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668535|NCT05379569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101668536|NCT05379569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101668537|NCT02818556|Hyaluronic Acid|hyaluronic acid|mesh-list
101668538|NCT02818556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101668539|NCT02818556|Immunologic Factors|immunologic factors|mesh-ancestor
101668540|NCT02818556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668541|NCT02818556|Viscosupplements|viscosupplements|mesh-ancestor
101668542|NCT02818556|Protective Agents|protective agents|mesh-ancestor
101668543|NCT04171128|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101668544|NCT04171128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101668545|NCT04238936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101668546|NCT04238936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101668548|NCT04627142|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101668549|NCT04627142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101668550|NCT04627142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101668551|NCT04627142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668552|NCT04627142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101668553|NCT00936221|Dacarbazine|dacarbazine|mesh-list
101668554|NCT00936221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101668555|NCT00936221|Alkylating Agents|alkylating agents|mesh-ancestor
101668556|NCT00936221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668557|NCT00936221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101668558|NCT00776919|Clindamycin|clindamycin|mesh-list
101668559|NCT00776919|Clindamycin palmitate|clindamycin palmitate|mesh-list
101668560|NCT00776919|Clindamycin phosphate|clindamycin phosphate|mesh-list
101668561|NCT00776919|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101668562|NCT00776919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101668563|NCT00776919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101668564|NCT00776919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101668565|NCT00776919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101668566|NCT00776919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668567|NCT00776919|Dermatologic Agents|dermatologic agents|mesh-ancestor
101668568|NCT05657678|Vitamin D|vitamin d|mesh-list
101668569|NCT05657678|Ergocalciferols|ergocalciferols|mesh-list
101668570|NCT05657678|Cholecalciferol|cholecalciferol|mesh-list
101668571|NCT05657678|Vitamins|vitamins|mesh-list
101668572|NCT05657678|Micronutrients|micronutrients|mesh-ancestor
101668573|NCT05657678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668574|NCT05657678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101668575|NCT05657678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101668576|NCT02747940|Pregabalin|pregabalin|mesh-list
101668577|NCT02747940|Flunarizine|flunarizine|mesh-list
101668578|NCT02747940|Analgesics|analgesics|mesh-ancestor
101668579|NCT02747940|Sensory System Agents|sensory system agents|mesh-ancestor
101668580|NCT02747940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101668581|NCT02747940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668582|NCT02747940|Anticonvulsants|anticonvulsants|mesh-ancestor
101668583|NCT02747940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101668584|NCT02747940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101668585|NCT02747940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668586|NCT02747940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101668587|NCT02747940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101668588|NCT02747940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101668589|NCT02747940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101668590|NCT02747940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101668591|NCT02747940|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101668592|NCT02747940|Histamine Antagonists|histamine antagonists|mesh-ancestor
101668593|NCT02747940|Histamine Agents|histamine agents|mesh-ancestor
101668594|NCT02747940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101668595|NCT02747940|Vasodilator Agents|vasodilator agents|mesh-ancestor
101668596|NCT04238702|Empagliflozin|empagliflozin|mesh-list
101668597|NCT04238702|Losartan|losartan|mesh-list
101668598|NCT04238702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101668599|NCT04238702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101668600|NCT04238702|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101668601|NCT04238702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101668602|NCT04238702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668603|NCT04238702|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101668604|NCT04238702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101668605|NCT04238702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668606|NCT00603785|Omalizumab|omalizumab|mesh-list
101668607|NCT00603785|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101668608|NCT00603785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101668609|NCT00603785|Respiratory System Agents|respiratory system agents|mesh-ancestor
101668610|NCT00633776|Formoterol Fumarate|formoterol fumarate|mesh-list
101668611|NCT00633776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101668612|NCT00633776|Autonomic Agents|autonomic agents|mesh-ancestor
101668613|NCT00633776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101668614|NCT00633776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668615|NCT00633776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101668616|NCT00633776|Respiratory System Agents|respiratory system agents|mesh-ancestor
101668617|NCT00633776|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101668618|NCT00633776|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101668619|NCT00633776|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101668620|NCT00633776|Adrenergic Agents|adrenergic agents|mesh-ancestor
101668621|NCT00633776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101668622|NCT00633776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668623|NCT05382923|Melatonin|melatonin|mesh-list
101668624|NCT05382923|Antioxidants|antioxidants|mesh-ancestor
101668625|NCT05382923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668626|NCT05382923|Protective Agents|protective agents|mesh-ancestor
101668627|NCT05382923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668628|NCT05382923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101668629|NCT02743572|Iron|iron|mesh-list
101668630|NCT02743572|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101668631|NCT02743572|Trace Elements|trace elements|mesh-ancestor
101668632|NCT02743572|Micronutrients|micronutrients|mesh-ancestor
101668633|NCT02743572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668634|NCT02743572|Hematinics|hematinics|mesh-ancestor
101668635|NCT00775593|Sirolimus|sirolimus|mesh-list
101668636|NCT00775593|Temsirolimus|temsirolimus|mesh-list
101668637|NCT00775593|MTOR Inhibitors|mtor inhibitors|mesh-list
101668638|NCT00775593|Clofarabine|clofarabine|mesh-list
101668639|NCT00775593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101668640|NCT00775593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101668641|NCT00775593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668642|NCT00775593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101668643|NCT00775593|Immunologic Factors|immunologic factors|mesh-ancestor
101668644|NCT00775593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668645|NCT00775593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101668646|NCT00775593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101668647|NCT00775593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101668648|NCT00775593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101668649|NCT00775593|Antifungal Agents|antifungal agents|mesh-ancestor
101668650|NCT00775593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101826943|NCT05881135|Choline|choline|mesh-list
101668651|NCT00775593|Antimetabolites|antimetabolites|mesh-ancestor
101668653|NCT00606983|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101668654|NCT00606983|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101668655|NCT00606983|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101668656|NCT00606983|Adrenergic Agents|adrenergic agents|mesh-ancestor
101668657|NCT00606983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101668658|NCT00606983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668659|NCT00606983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668660|NCT00606983|Urological Agents|urological agents|mesh-ancestor
101668661|NCT02817932|Ranolazine|ranolazine|mesh-list
101668662|NCT02817932|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101668663|NCT02817932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101668664|NCT02817932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668665|NCT02743260|Metformin|metformin|mesh-list
101668666|NCT02743260|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101668667|NCT02743260|Adefovir|adefovir|mesh-list
101668668|NCT02743260|Digoxin|digoxin|mesh-list
101668669|NCT02743260|Pitavastatin|pitavastatin|mesh-list
101668670|NCT02743260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101668671|NCT02743260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668672|NCT02743260|Incretins|incretins|mesh-ancestor
101668673|NCT02743260|Hormones|hormones|mesh-ancestor
101668674|NCT02743260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101668675|NCT02743260|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101668676|NCT02743260|Protease Inhibitors|protease inhibitors|mesh-ancestor
101668677|NCT02743260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101668678|NCT02743260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668679|NCT02743260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101668680|NCT02743260|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101668681|NCT02743260|Protective Agents|protective agents|mesh-ancestor
101668682|NCT02743260|Antiviral Agents|antiviral agents|mesh-ancestor
101668683|NCT02743260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101668684|NCT02743260|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101668685|NCT02743260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101668686|NCT02743260|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101668687|NCT02743260|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101668688|NCT02743260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101668689|NCT02743260|Antimetabolites|antimetabolites|mesh-ancestor
101668690|NCT02743260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101668691|NCT05629260|Cyclophosphamide|cyclophosphamide|mesh-list
101668692|NCT05629260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101668694|NCT05629260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668695|NCT05629260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101668696|NCT05629260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101668697|NCT05629260|Alkylating Agents|alkylating agents|mesh-ancestor
101668698|NCT05629260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668699|NCT05629260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101668700|NCT05629260|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101668701|NCT02819648|Prednisolone|prednisolone|mesh-list
101668702|NCT02819648|Glucocorticoids|glucocorticoids|mesh-list
101668703|NCT02819648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101668704|NCT02819648|Hormones|hormones|mesh-ancestor
101668705|NCT02819648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101668706|NCT02819648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668707|NCT02819648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101668708|NCT02819648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101668709|NCT00934661|Morphine|morphine|mesh-list
101668710|NCT00934661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101668711|NCT00934661|Narcotics|narcotics|mesh-ancestor
101826947|NCT05881135|Antimetabolites|antimetabolites|mesh-ancestor
101668712|NCT00934661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101668713|NCT00934661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668714|NCT00934661|Analgesics|analgesics|mesh-ancestor
101668715|NCT00934661|Sensory System Agents|sensory system agents|mesh-ancestor
101668716|NCT00934661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101668717|NCT02743182|Interferons|interferons|mesh-list
101668718|NCT02743182|Interferon-alpha|interferon-alpha|mesh-list
101668719|NCT02743182|Interferon alpha-2|interferon alpha-2|mesh-list
101668720|NCT02743182|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101668721|NCT02743182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101668722|NCT02743182|Antiviral Agents|antiviral agents|mesh-ancestor
101668723|NCT02743182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101668724|NCT02743182|Immunologic Factors|immunologic factors|mesh-ancestor
101668725|NCT02743182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668726|NCT00775437|Adalimumab|adalimumab|mesh-list
101668727|NCT00775437|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101668728|NCT00775437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101668729|NCT00775437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101668730|NCT04238078|Contraceptive Agents|contraceptive agents|mesh-list
101668731|NCT04238078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101668732|NCT04238078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668733|NCT02742168|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
101668734|NCT02742168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101668735|NCT02742168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668736|NCT02819414|Acetaminophen|acetaminophen|mesh-list
101325911|NCT00114556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668737|NCT02819414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101668739|NCT02819414|Sensory System Agents|sensory system agents|mesh-ancestor
101668740|NCT02819414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101668741|NCT02819414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668742|NCT02819414|Antipyretics|antipyretics|mesh-ancestor
101668743|NCT02743104|Lidocaine|lidocaine|mesh-list
101668744|NCT02743104|Atropine|atropine|mesh-list
101668745|NCT02743104|Midazolam|midazolam|mesh-list
101668746|NCT02743104|Ketamine|ketamine|mesh-list
101668747|NCT02743104|Propofol|propofol|mesh-list
101668748|NCT02743104|Anesthetics, Local|anesthetics, local|mesh-ancestor
101668749|NCT02743104|Anesthetics|anesthetics|mesh-ancestor
101668750|NCT02743104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101668751|NCT02743104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668752|NCT02743104|Sensory System Agents|sensory system agents|mesh-ancestor
101668753|NCT02743104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101668754|NCT02743104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101668755|NCT02743104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101668756|NCT02743104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101668757|NCT02743104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101668758|NCT02743104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668759|NCT02743104|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101668760|NCT02743104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101668761|NCT02743104|Anesthetics, General|anesthetics, general|mesh-ancestor
101668762|NCT02743104|Analgesics|analgesics|mesh-ancestor
101668763|NCT02743104|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101668764|NCT02743104|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101668765|NCT02743104|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101668766|NCT02743104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101668767|NCT02743104|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101668768|NCT02743104|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101668769|NCT02743104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101668770|NCT02743104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101668771|NCT02743104|GABA Modulators|gaba modulators|mesh-ancestor
101668772|NCT02743104|GABA Agents|gaba agents|mesh-ancestor
101668773|NCT02743104|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101668774|NCT02743104|Autonomic Agents|autonomic agents|mesh-ancestor
101668775|NCT02743104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101668776|NCT02743104|Respiratory System Agents|respiratory system agents|mesh-ancestor
101668777|NCT02743104|Mydriatics|mydriatics|mesh-ancestor
101668778|NCT02743104|Parasympatholytics|parasympatholytics|mesh-ancestor
101668779|NCT02743104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101668780|NCT02743104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101668781|NCT02743104|Cholinergic Agents|cholinergic agents|mesh-ancestor
101668782|NCT00775203|Trazodone|trazodone|mesh-list
101668783|NCT00775203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101668784|NCT00775203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101668785|NCT00775203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101668786|NCT00775203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668787|NCT00775203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101668788|NCT00775203|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101668790|NCT00775203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101668791|NCT00775203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668792|NCT00775203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101668793|NCT00775203|Serotonin Agents|serotonin agents|mesh-ancestor
101668794|NCT00775203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101668795|NCT00775203|Antidepressive Agents|antidepressive agents|mesh-ancestor
101668796|NCT02816684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101668797|NCT02816684|Antiviral Agents|antiviral agents|mesh-ancestor
101668798|NCT02816684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101668799|NCT00607217|Vaccines|vaccines|mesh-list
101668800|NCT00607217|Immunologic Factors|immunologic factors|mesh-ancestor
101668801|NCT00607217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668802|NCT02747316|Iron|iron|mesh-list
101668803|NCT02747316|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101668804|NCT02747316|Trace Elements|trace elements|mesh-ancestor
101668805|NCT02747316|Micronutrients|micronutrients|mesh-ancestor
101668806|NCT02747316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668807|NCT05648708|Bupivacaine|bupivacaine|mesh-list
101668808|NCT05648708|Prilocaine|prilocaine|mesh-list
101668809|NCT05648708|Anesthetics, Local|anesthetics, local|mesh-ancestor
101668810|NCT05648708|Anesthetics|anesthetics|mesh-ancestor
101668811|NCT05648708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101668812|NCT05648708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325990|NCT00008177|Iodine|iodine|mesh-list
101668813|NCT05648708|Sensory System Agents|sensory system agents|mesh-ancestor
101668814|NCT05648708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101668815|NCT02742948|Ceftriaxone|ceftriaxone|mesh-list
101668816|NCT02742948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101668817|NCT02742948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101668819|NCT00636246|Reboxetine|reboxetine|mesh-list
101668820|NCT00636246|Antidepressive Agents|antidepressive agents|mesh-ancestor
101668821|NCT00636246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101668822|NCT00636246|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101668823|NCT00636246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101668824|NCT00636246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101668825|NCT00636246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668826|NCT00636246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101668827|NCT00636246|Serotonin Agents|serotonin agents|mesh-ancestor
101668828|NCT00636246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668829|NCT00636246|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101668830|NCT00636246|Adrenergic Agents|adrenergic agents|mesh-ancestor
101668831|NCT02819570|Ampicillin|ampicillin|mesh-list
101668832|NCT02819570|Cefuroxime|cefuroxime|mesh-list
101668833|NCT02819570|Cefuroxime axetil|cefuroxime axetil|mesh-list
101668834|NCT02819570|Roxithromycin|roxithromycin|mesh-list
101668835|NCT02819570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101668836|NCT02819570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101668837|NCT04239170|Gemcitabine|gemcitabine|mesh-list
101668838|NCT04239170|Oxaliplatin|oxaliplatin|mesh-list
101668839|NCT04239170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101668841|NCT04239170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668842|NCT04239170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101668843|NCT04480190|Gemcitabine|gemcitabine|mesh-list
101668844|NCT04480190|Fluorouracil|fluorouracil|mesh-list
101668845|NCT04480190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101668846|NCT04480190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101668847|NCT04480190|Antimetabolites|antimetabolites|mesh-ancestor
101668848|NCT04480190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668850|NCT04480190|Immunologic Factors|immunologic factors|mesh-ancestor
101668851|NCT04480190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668852|NCT02741856|Paclitaxel|paclitaxel|mesh-list
101668853|NCT02741856|Carboplatin|carboplatin|mesh-list
101668854|NCT02741856|Capecitabine|capecitabine|mesh-list
101668855|NCT02741856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101668856|NCT02741856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101668857|NCT02741856|Tubulin Modulators|tubulin modulators|mesh-ancestor
101668858|NCT02741856|Antimitotic Agents|antimitotic agents|mesh-ancestor
101668859|NCT02741856|Mitosis Modulators|mitosis modulators|mesh-ancestor
101668860|NCT02741856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668861|NCT02741856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101668862|NCT02741856|Antimetabolites|antimetabolites|mesh-ancestor
101668863|NCT02741232|Lidocaine|lidocaine|mesh-list
101668864|NCT02741232|Epinephrine|epinephrine|mesh-list
101668865|NCT02741232|Racepinephrine|racepinephrine|mesh-list
101668866|NCT02741232|Epinephryl borate|epinephryl borate|mesh-list
101668867|NCT02741232|Anesthetics, Local|anesthetics, local|mesh-ancestor
101668868|NCT02741232|Anesthetics|anesthetics|mesh-ancestor
101668869|NCT02741232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101668870|NCT02741232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668871|NCT02741232|Sensory System Agents|sensory system agents|mesh-ancestor
101668872|NCT02741232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101668873|NCT02741232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101668874|NCT02741232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101668875|NCT02741232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101668876|NCT02741232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101668877|NCT02741232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668878|NCT02741232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101668879|NCT02741232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101668880|NCT02741232|Adrenergic Agents|adrenergic agents|mesh-ancestor
101668881|NCT02741232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101668882|NCT02741232|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101668883|NCT02741232|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101668884|NCT02741232|Autonomic Agents|autonomic agents|mesh-ancestor
101668885|NCT02741232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101668886|NCT02741232|Respiratory System Agents|respiratory system agents|mesh-ancestor
101668887|NCT02741232|Mydriatics|mydriatics|mesh-ancestor
101326066|NCT00115414|Cyclophosphamide|cyclophosphamide|mesh-list
101668888|NCT02741232|Sympathomimetics|sympathomimetics|mesh-ancestor
101668889|NCT02741232|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101668890|NCT04239014|Olaparib|olaparib|mesh-list
101668891|NCT04239014|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101668892|NCT04239014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101668893|NCT04239014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668894|NCT04239014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101668895|NCT00568321|Tanezumab|tanezumab|mesh-list
101668896|NCT00568321|Analgesics|analgesics|mesh-ancestor
101668897|NCT00568321|Sensory System Agents|sensory system agents|mesh-ancestor
101668898|NCT00568321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101668899|NCT00568321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668900|NCT02742480|Dabigatran|dabigatran|mesh-list
101668901|NCT02742480|Acenocoumarol|acenocoumarol|mesh-list
101668902|NCT02742480|Antithrombins|antithrombins|mesh-ancestor
101668903|NCT02742480|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101668904|NCT02742480|Protease Inhibitors|protease inhibitors|mesh-ancestor
101668905|NCT02742480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101826985|NCT05880693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101668906|NCT02742480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668907|NCT02742480|Anticoagulants|anticoagulants|mesh-ancestor
101668908|NCT00774345|Lenalidomide|lenalidomide|mesh-list
101668909|NCT00774345|Immunologic Factors|immunologic factors|mesh-ancestor
101668910|NCT00774345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668911|NCT00774345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101668912|NCT00774345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101668913|NCT00774345|Growth Substances|growth substances|mesh-ancestor
101668914|NCT00774345|Growth Inhibitors|growth inhibitors|mesh-ancestor
101668915|NCT00774345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101668916|NCT02819102|Berotralstat|berotralstat|mesh-list
101668917|NCT02819102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101668919|NCT02819102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101668920|NCT02819102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668921|NCT04342026|Endocrine Disruptors|endocrine disruptors|mesh-list
101668922|NCT04342026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668923|NCT02819180|Vaccines|vaccines|mesh-list
101668924|NCT02819180|Immunologic Factors|immunologic factors|mesh-ancestor
101668925|NCT02819180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668926|NCT04661930|Fenofibrate|fenofibrate|mesh-list
101668927|NCT04661930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101668928|NCT04661930|Antimetabolites|antimetabolites|mesh-ancestor
101668929|NCT04661930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668930|NCT04661930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101668931|NCT02815046|Botulinum Toxins|botulinum toxins|mesh-list
101668932|NCT02815046|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101668933|NCT02815046|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101668934|NCT02815046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101668935|NCT02815046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101668936|NCT02815046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668937|NCT02815046|Cholinergic Agents|cholinergic agents|mesh-ancestor
101668938|NCT02815046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101668939|NCT02815046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668940|NCT02815046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101668941|NCT02815046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101668942|NCT02601963|Minocycline|minocycline|mesh-list
101668943|NCT02601963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101668944|NCT02601963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101668945|NCT00927979|Ropivacaine|ropivacaine|mesh-list
101668946|NCT00927979|Anesthetics, Local|anesthetics, local|mesh-ancestor
101668947|NCT00927979|Anesthetics|anesthetics|mesh-ancestor
101668948|NCT00927979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101668949|NCT00927979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668950|NCT00927979|Sensory System Agents|sensory system agents|mesh-ancestor
101668951|NCT00927979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101668952|NCT00931957|Prednisolone|prednisolone|mesh-list
101668953|NCT00931957|Etanercept|etanercept|mesh-list
101668954|NCT00931957|Methotrexate|methotrexate|mesh-list
101668955|NCT00931957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101668956|NCT00931957|Abortifacient Agents|abortifacient agents|mesh-ancestor
101668957|NCT00931957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101668958|NCT00931957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668959|NCT00931957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101668960|NCT00931957|Antimetabolites|antimetabolites|mesh-ancestor
101668961|NCT00931957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101668962|NCT00931957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101326146|NCT00115648|Zidovudine|zidovudine|mesh-list
101668963|NCT00931957|Dermatologic Agents|dermatologic agents|mesh-ancestor
101668964|NCT00931957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101668965|NCT00931957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101668966|NCT00931957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101668967|NCT00931957|Immunologic Factors|immunologic factors|mesh-ancestor
101668968|NCT00931957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101668969|NCT00931957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101668970|NCT00931957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101668971|NCT00931957|Glucocorticoids|glucocorticoids|mesh-ancestor
101668972|NCT00931957|Hormones|hormones|mesh-ancestor
101668973|NCT00931957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101668974|NCT00931957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101668975|NCT00931957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101668976|NCT00931957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101668977|NCT00931957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101668978|NCT00931957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101668979|NCT00931957|Analgesics|analgesics|mesh-ancestor
101668980|NCT00931957|Sensory System Agents|sensory system agents|mesh-ancestor
101668982|NCT02731950|Bupivacaine|bupivacaine|mesh-list
101668983|NCT02731950|Anesthetics, Local|anesthetics, local|mesh-ancestor
101668984|NCT02731950|Anesthetics|anesthetics|mesh-ancestor
101668985|NCT02731950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101668986|NCT02731950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101668987|NCT02731950|Sensory System Agents|sensory system agents|mesh-ancestor
101668988|NCT02731950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101668989|NCT02731950|Analgesics|analgesics|mesh-ancestor
101668990|NCT02731950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101668991|NCT02731950|Anticonvulsants|anticonvulsants|mesh-ancestor
101668992|NCT02731950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101668993|NCT02731950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101668995|NCT02731950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101668996|NCT02731950|Tocolytic Agents|tocolytic agents|mesh-ancestor
101668997|NCT02731950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101668998|NCT00773253|Botulinum Toxins|botulinum toxins|mesh-list
101668999|NCT00773253|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101669000|NCT00773253|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101669001|NCT00773253|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101669002|NCT00773253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101669003|NCT00773253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669004|NCT00773253|Cholinergic Agents|cholinergic agents|mesh-ancestor
101669005|NCT00773253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101669006|NCT00773253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669007|NCT00773253|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101669008|NCT00773253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101669009|NCT00928213|Heparin|heparin|mesh-list
101669010|NCT00928213|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101669011|NCT00928213|Tinzaparin|tinzaparin|mesh-list
101669012|NCT00928213|Dalteparin|dalteparin|mesh-list
101669013|NCT00928213|Progesterone|progesterone|mesh-list
101669014|NCT00928213|Hormones|hormones|mesh-ancestor
101669015|NCT00928213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101669016|NCT00928213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669017|NCT00928213|Anticoagulants|anticoagulants|mesh-ancestor
101669018|NCT00928213|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101669019|NCT00928213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101669020|NCT00928213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669021|NCT00928213|Progestins|progestins|mesh-ancestor
101669022|NCT00928291|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101669023|NCT00928291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101669024|NCT02736240|Vaccines|vaccines|mesh-list
101669025|NCT02736240|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101669026|NCT02736240|Immunologic Factors|immunologic factors|mesh-ancestor
101669027|NCT02736240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669028|NCT02741154|Letrozole|letrozole|mesh-list
101669029|NCT02741154|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101669030|NCT02741154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101669031|NCT02741154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101669032|NCT02741154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101669033|NCT02741154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101669034|NCT02741154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669035|NCT02741154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101669036|NCT02741154|Hormone Antagonists|hormone antagonists|mesh-ancestor
101326214|NCT00008372|Sulfanilamides|sulfanilamides|mesh-list
101669037|NCT02741154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101669038|NCT02741154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669040|NCT02741154|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101669041|NCT02741154|Contraceptive Agents|contraceptive agents|mesh-ancestor
101669042|NCT02741154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101669043|NCT02741154|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101669044|NCT02741154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101669045|NCT04287816|Antithrombin III|antithrombin iii|mesh-list
101669046|NCT04287816|Antithrombins|antithrombins|mesh-list
101669047|NCT04287816|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101669048|NCT04287816|Protease Inhibitors|protease inhibitors|mesh-ancestor
101669049|NCT04287816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101669050|NCT04287816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669051|NCT04287816|Anticoagulants|anticoagulants|mesh-ancestor
101669052|NCT02735928|Doxorubicin|doxorubicin|mesh-list
101669053|NCT02735928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101669054|NCT02735928|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101669055|NCT02735928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101669056|NCT02735928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101669057|NCT02735928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101669058|NCT02735928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669059|NCT02731560|Rituximab|rituximab|mesh-list
101669060|NCT02731560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101669061|NCT02731560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101669062|NCT02731560|Immunologic Factors|immunologic factors|mesh-ancestor
101669063|NCT02731560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669064|NCT02731560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101669065|NCT00773097|Poly ICLC|poly iclc|mesh-list
101669066|NCT00773097|Interferon Inducers|interferon inducers|mesh-ancestor
101669067|NCT00773097|Immunologic Factors|immunologic factors|mesh-ancestor
101669068|NCT00773097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669069|NCT00933335|Tositumomab I-131|tositumomab i-131|mesh-list
101669070|NCT00933335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101669071|NCT02814110|Lenograstim|lenograstim|mesh-list
101669072|NCT02814110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101669073|NCT02814110|Immunologic Factors|immunologic factors|mesh-ancestor
101669074|NCT02814110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669075|NCT00928525|Imatinib Mesylate|imatinib mesylate|mesh-list
101669076|NCT00928525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101669077|NCT00928525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101669078|NCT00928525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101669079|NCT00928525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669080|NCT04264481|Lidocaine|lidocaine|mesh-list
101669081|NCT04264481|Anesthetics, Local|anesthetics, local|mesh-ancestor
101669082|NCT04264481|Anesthetics|anesthetics|mesh-ancestor
101669083|NCT04264481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101669084|NCT04264481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669085|NCT04264481|Sensory System Agents|sensory system agents|mesh-ancestor
101669086|NCT04264481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101669087|NCT04264481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101669088|NCT04264481|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101669089|NCT04264481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101669090|NCT04264481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101669091|NCT04264481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669092|NCT05303909|Gentamicins|gentamicins|mesh-list
101669093|NCT05303909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101669094|NCT05303909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101669095|NCT05303909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101669096|NCT05303909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101669097|NCT05303909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669098|NCT04306692|Inositol|inositol|mesh-list
101669099|NCT04306692|Clomiphene|clomiphene|mesh-list
101669100|NCT04306692|Enclomiphene|enclomiphene|mesh-list
101669101|NCT04306692|Zuclomiphene|zuclomiphene|mesh-list
101669102|NCT04306692|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101669103|NCT04306692|Hormone Antagonists|hormone antagonists|mesh-ancestor
101827008|NCT05880342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101669104|NCT04306692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101669105|NCT04306692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669106|NCT04306692|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101669107|NCT04306692|Fertility Agents|fertility agents|mesh-ancestor
101669108|NCT04306692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101669109|NCT04306692|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101669110|NCT04306692|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101669111|NCT04306692|Vitamin B Complex|vitamin b complex|mesh-ancestor
101669112|NCT04306692|Vitamins|vitamins|mesh-ancestor
101669113|NCT04306692|Micronutrients|micronutrients|mesh-ancestor
101669114|NCT00772941|Varenicline|varenicline|mesh-list
101669115|NCT00772941|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101669116|NCT00772941|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101669117|NCT00772941|Cholinergic Agents|cholinergic agents|mesh-ancestor
101669118|NCT00772941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101669119|NCT00772941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669120|NCT00772941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669121|NCT02735694|Cycloserine|cycloserine|mesh-list
101669122|NCT02735694|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101669123|NCT02735694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101669124|NCT02735694|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101669125|NCT02735694|Antitubercular Agents|antitubercular agents|mesh-ancestor
101669126|NCT02735694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101669127|NCT02735694|Antimetabolites|antimetabolites|mesh-ancestor
101669128|NCT02735694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669129|NCT04237532|Dexmedetomidine|dexmedetomidine|mesh-list
101669130|NCT04237532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101669131|NCT04237532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101669132|NCT04237532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669133|NCT04237532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101669134|NCT04237532|Analgesics|analgesics|mesh-ancestor
101669135|NCT04237532|Sensory System Agents|sensory system agents|mesh-ancestor
101669136|NCT04237532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101669137|NCT04237532|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101669138|NCT04237532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101669139|NCT04237532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101669140|NCT04237532|Adrenergic Agents|adrenergic agents|mesh-ancestor
101669141|NCT04237532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101669142|NCT04237532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669143|NCT02731092|Lactoferrin|lactoferrin|mesh-list
101669144|NCT02731092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101669145|NCT00928837|Naproxen|naproxen|mesh-list
101669146|NCT00928837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101669147|NCT00928837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101669148|NCT00928837|Analgesics|analgesics|mesh-ancestor
101669149|NCT00928837|Sensory System Agents|sensory system agents|mesh-ancestor
101669150|NCT00928837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101669151|NCT00928837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669152|NCT00928837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101669153|NCT00928837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101669154|NCT00928837|Gout Suppressants|gout suppressants|mesh-ancestor
101669155|NCT00928837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101669156|NCT00928837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101669157|NCT00928837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669158|NCT02730936|Anti-Infective Agents|anti-infective agents|mesh-list
101669159|NCT02730936|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101669160|NCT00925093|Vancomycin|vancomycin|mesh-list
101669161|NCT00925093|Linezolid|linezolid|mesh-list
101669162|NCT00925093|Teicoplanin|teicoplanin|mesh-list
101669163|NCT00925093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101669164|NCT00925093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101669165|NCT00925093|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101669166|NCT00925093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101669167|NCT00925093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669168|NCT01562977|Rituximab|rituximab|mesh-list
101669169|NCT01562977|Gemcitabine|gemcitabine|mesh-list
101669170|NCT01562977|Oxaliplatin|oxaliplatin|mesh-list
101669171|NCT01562977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101669172|NCT01562977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101669173|NCT01562977|Immunologic Factors|immunologic factors|mesh-ancestor
101669174|NCT01562977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669175|NCT01562977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101669176|NCT01562977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101669177|NCT01562977|Antimetabolites|antimetabolites|mesh-ancestor
101669178|NCT01562977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669179|NCT00607685|Fluorouracil|fluorouracil|mesh-list
101669180|NCT00607685|Hyaluronic Acid|hyaluronic acid|mesh-list
101669181|NCT00607685|Antimetabolites|antimetabolites|mesh-ancestor
101669182|NCT00607685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669183|NCT00607685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101669184|NCT00607685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101669185|NCT00607685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101669186|NCT00607685|Immunologic Factors|immunologic factors|mesh-ancestor
101669187|NCT00607685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669188|NCT00607685|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101669189|NCT00607685|Viscosupplements|viscosupplements|mesh-ancestor
101669190|NCT00607685|Protective Agents|protective agents|mesh-ancestor
101669191|NCT05450718|Buprenorphine|buprenorphine|mesh-list
101669192|NCT05450718|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101669193|NCT05450718|Naloxone|naloxone|mesh-list
101669194|NCT05450718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101669195|NCT05450718|Narcotics|narcotics|mesh-ancestor
101669196|NCT05450718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101669197|NCT05450718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669198|NCT05450718|Analgesics|analgesics|mesh-ancestor
101669199|NCT05450718|Sensory System Agents|sensory system agents|mesh-ancestor
101669200|NCT05450718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101669201|NCT05450718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101669202|NCT04265027|Opicapone|opicapone|mesh-list
101669203|NCT04265027|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101669204|NCT04265027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101669205|NCT04265027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669206|NCT04265027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101669207|NCT04265027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101669208|NCT00607763|Micafungin|micafungin|mesh-list
101669209|NCT00607763|Antifungal Agents|antifungal agents|mesh-ancestor
101669210|NCT00607763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101669211|NCT00928915|Thrombin|thrombin|mesh-list
101669212|NCT00928915|Hemostatics|hemostatics|mesh-ancestor
101669213|NCT00928915|Coagulants|coagulants|mesh-ancestor
101669214|NCT02814500|Amlodipine|amlodipine|mesh-list
101669215|NCT02814500|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101669216|NCT02814500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101669217|NCT02814500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101669218|NCT02814500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101669219|NCT02814500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669220|NCT02814500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101669221|NCT02814500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669222|NCT02814500|Vasodilator Agents|vasodilator agents|mesh-ancestor
101669223|NCT02814500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101669224|NCT02814500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101669225|NCT02814500|Antimetabolites|antimetabolites|mesh-ancestor
101669226|NCT02814500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101669227|NCT02814500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101669230|NCT00939341|Formoterol Fumarate|formoterol fumarate|mesh-list
101669231|NCT00939341|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101669232|NCT00939341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101669233|NCT00939341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101669234|NCT00939341|Autonomic Agents|autonomic agents|mesh-ancestor
101669235|NCT00939341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101669236|NCT00939341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669237|NCT00939341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101669238|NCT00939341|Respiratory System Agents|respiratory system agents|mesh-ancestor
101669239|NCT00939341|Glucocorticoids|glucocorticoids|mesh-ancestor
101669241|NCT00939341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101669242|NCT00939341|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101669243|NCT00939341|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101669244|NCT00939341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101669245|NCT00939341|Adrenergic Agents|adrenergic agents|mesh-ancestor
101669246|NCT00939341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101669247|NCT00939341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669248|NCT00925327|Riboflavin|riboflavin|mesh-list
101669249|NCT00925327|Vitamin B Complex|vitamin b complex|mesh-ancestor
101669250|NCT00925327|Vitamins|vitamins|mesh-ancestor
101669251|NCT00925327|Micronutrients|micronutrients|mesh-ancestor
101669252|NCT00925327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669253|NCT00925327|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101669254|NCT00925327|Dermatologic Agents|dermatologic agents|mesh-ancestor
101669255|NCT04237376|Tenofovir|tenofovir|mesh-list
101669256|NCT04237376|Antiviral Agents|antiviral agents|mesh-ancestor
101669257|NCT04237376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101669258|NCT04237376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101669259|NCT04237376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101669260|NCT04237376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101669261|NCT04237376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669262|NCT04237376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101669263|NCT04237376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101669264|NCT04015687|Lamotrigine|lamotrigine|mesh-list
101669265|NCT04015687|Anticonvulsants|anticonvulsants|mesh-ancestor
101669266|NCT04015687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101669267|NCT04015687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101669268|NCT04015687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669269|NCT04015687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101669270|NCT04015687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669271|NCT04015687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101669272|NCT04015687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101669273|NCT04015687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101669274|NCT04015687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101669275|NCT04015687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101669276|NCT02739906|Insulin|insulin|mesh-list
101669277|NCT02739906|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101669278|NCT02739906|Insulin Lispro|insulin lispro|mesh-list
101669279|NCT02739906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101669280|NCT02739906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669281|NCT02739672|Amlodipine|amlodipine|mesh-list
101669282|NCT02739672|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101669283|NCT02739672|Telmisartan|telmisartan|mesh-list
101669284|NCT02739672|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
101669285|NCT02739672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101669286|NCT02739672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101669287|NCT02739672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101669288|NCT02739672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669289|NCT02739672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101827049|NCT05879926|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101669290|NCT02739672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669291|NCT02739672|Vasodilator Agents|vasodilator agents|mesh-ancestor
101669292|NCT02739672|Diuretics|diuretics|mesh-ancestor
101669293|NCT02739672|Natriuretic Agents|natriuretic agents|mesh-ancestor
101669294|NCT02739672|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101669295|NCT02739672|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101669296|NCT02739672|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101669297|NCT00932971|Tenofovir|tenofovir|mesh-list
101669298|NCT00932971|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101669299|NCT00932971|Interferon-alpha|interferon-alpha|mesh-list
101669300|NCT00932971|Interferon alpha-2|interferon alpha-2|mesh-list
101669301|NCT00932971|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
101669302|NCT00932971|Antiviral Agents|antiviral agents|mesh-ancestor
101669303|NCT00932971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101669304|NCT00932971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101669305|NCT00932971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101669306|NCT00932971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101669307|NCT00932971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669308|NCT00932971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101669309|NCT00932971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101669310|NCT00932971|Immunologic Factors|immunologic factors|mesh-ancestor
101669311|NCT00932971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669312|NCT00932971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101669313|NCT05382143|Atosiban|atosiban|mesh-list
101669314|NCT05382143|Hormone Antagonists|hormone antagonists|mesh-ancestor
101669315|NCT05382143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101669316|NCT05382143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669317|NCT05382143|Tocolytic Agents|tocolytic agents|mesh-ancestor
101669318|NCT05382143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101669319|NCT00933049|Amoxicillin|amoxicillin|mesh-list
101669320|NCT00933049|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101669321|NCT00933049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101669322|NCT00933049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101669323|NCT00933049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101669324|NCT00933049|Antimalarials|antimalarials|mesh-ancestor
101669325|NCT00933049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101669326|NCT00933049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101669327|NCT05788458|Bupivacaine|bupivacaine|mesh-list
101669328|NCT05788458|Anesthetics, Local|anesthetics, local|mesh-ancestor
101669329|NCT05788458|Anesthetics|anesthetics|mesh-ancestor
101669330|NCT05788458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101669331|NCT05788458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669332|NCT05788458|Sensory System Agents|sensory system agents|mesh-ancestor
101669333|NCT05788458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101326519|NCT00118066|Vitamins|vitamins|mesh-ancestor
101669334|NCT05788393|Lidocaine|lidocaine|mesh-list
101669335|NCT05788393|Dexmedetomidine|dexmedetomidine|mesh-list
101669336|NCT05788393|Anesthetics, Local|anesthetics, local|mesh-ancestor
101669337|NCT05788393|Anesthetics|anesthetics|mesh-ancestor
101669338|NCT05788393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101669339|NCT05788393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669340|NCT05788393|Sensory System Agents|sensory system agents|mesh-ancestor
101669341|NCT05788393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101669342|NCT05788393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101827061|NCT05879653|Pembrolizumab|pembrolizumab|mesh-list
101669343|NCT05788393|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101669344|NCT05788393|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101669345|NCT05788393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101669346|NCT05788393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669347|NCT05788393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101669348|NCT05788393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101669349|NCT05788393|Analgesics|analgesics|mesh-ancestor
101669350|NCT05788393|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101669351|NCT05788393|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101669352|NCT05788393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101669353|NCT05788393|Adrenergic Agents|adrenergic agents|mesh-ancestor
101669354|NCT05788393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101669355|NCT05788159|Lacosamide|lacosamide|mesh-list
101669356|NCT05788159|Anticonvulsants|anticonvulsants|mesh-ancestor
101669357|NCT05788159|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101669358|NCT05788159|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101669359|NCT05788159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101669360|NCT05788159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669361|NCT05788094|Chloroquine|chloroquine|mesh-list
101669362|NCT05788094|Piperaquine|piperaquine|mesh-list
101669363|NCT05788094|Artenimol|artenimol|mesh-list
101669365|NCT05788094|Amebicides|amebicides|mesh-ancestor
101669366|NCT05788094|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101669367|NCT05788094|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101669368|NCT05788094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101669369|NCT05788094|Antimalarials|antimalarials|mesh-ancestor
101669370|NCT05788094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101669371|NCT05787925|Vitamin E|vitamin e|mesh-list
101669372|NCT05787925|Vitamins|vitamins|mesh-ancestor
101669373|NCT05787925|Micronutrients|micronutrients|mesh-ancestor
101669374|NCT05787925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669375|NCT05787925|Antioxidants|antioxidants|mesh-ancestor
101669376|NCT05787925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669377|NCT05787925|Protective Agents|protective agents|mesh-ancestor
101669378|NCT05787912|Hyaluronic Acid|hyaluronic acid|mesh-list
101669379|NCT05787912|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101669380|NCT05787912|Immunologic Factors|immunologic factors|mesh-ancestor
101669381|NCT05787912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669382|NCT05787912|Viscosupplements|viscosupplements|mesh-ancestor
101669383|NCT05787912|Protective Agents|protective agents|mesh-ancestor
101669384|NCT05787808|Vitamin D|vitamin d|mesh-list
101669385|NCT05787808|Vitamins|vitamins|mesh-ancestor
101669386|NCT05787808|Micronutrients|micronutrients|mesh-ancestor
101669387|NCT05787808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669388|NCT05787808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101669389|NCT05787743|Tocotrienols|tocotrienols|mesh-list
101669390|NCT05787743|Vitamin E|vitamin e|mesh-list
101669391|NCT05787743|Tocopherols|tocopherols|mesh-list
101669392|NCT05787743|Antioxidants|antioxidants|mesh-ancestor
101669393|NCT05787743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669394|NCT05787743|Protective Agents|protective agents|mesh-ancestor
101669395|NCT05787743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669396|NCT05787743|Vitamins|vitamins|mesh-ancestor
101669397|NCT05787743|Micronutrients|micronutrients|mesh-ancestor
101669398|NCT05787574|Dexamethasone|dexamethasone|mesh-list
101669399|NCT05787574|Fludarabine|fludarabine|mesh-list
101669400|NCT05787574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101669401|NCT05787574|Antiemetics|antiemetics|mesh-ancestor
101669402|NCT05787574|Autonomic Agents|autonomic agents|mesh-ancestor
101669403|NCT05787574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101669404|NCT05787574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669405|NCT05787574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101669406|NCT05787574|Glucocorticoids|glucocorticoids|mesh-ancestor
101669407|NCT05787574|Hormones|hormones|mesh-ancestor
101827079|NCT05879536|Sensory System Agents|sensory system agents|mesh-ancestor
101669408|NCT05787574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101669409|NCT05787574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101669410|NCT05787574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101669411|NCT05787535|Cyclophosphamide|cyclophosphamide|mesh-list
101669412|NCT05787535|Fludarabine|fludarabine|mesh-list
101669413|NCT05787535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101669414|NCT05787535|Immunologic Factors|immunologic factors|mesh-ancestor
101669415|NCT05787535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669416|NCT05787535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101669417|NCT05787535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101669418|NCT05787535|Alkylating Agents|alkylating agents|mesh-ancestor
101669419|NCT05787535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669420|NCT05787535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101669421|NCT05787535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101669422|NCT05787509|Progesterone|progesterone|mesh-list
101669423|NCT05787509|Progestins|progestins|mesh-ancestor
101669424|NCT05787509|Hormones|hormones|mesh-ancestor
101669425|NCT05787509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101669426|NCT05787509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669427|NCT05787002|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101669428|NCT05787002|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101669429|NCT05787002|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101669430|NCT05787002|Antimetabolites|antimetabolites|mesh-ancestor
101669431|NCT05787002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669432|NCT05787002|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101669433|NCT05787002|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101669434|NCT05787002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101669435|NCT05786950|Bromides|bromides|mesh-list
101669436|NCT05786950|Albuterol|albuterol|mesh-list
101669437|NCT05786950|Ipratropium|ipratropium|mesh-list
101669438|NCT05786950|Anticonvulsants|anticonvulsants|mesh-ancestor
101669439|NCT05786950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101669440|NCT05786950|Autonomic Agents|autonomic agents|mesh-ancestor
101669441|NCT05786950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101669442|NCT05786950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669443|NCT05786950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101669444|NCT05786950|Respiratory System Agents|respiratory system agents|mesh-ancestor
101669445|NCT05786950|Tocolytic Agents|tocolytic agents|mesh-ancestor
101669446|NCT05786950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101669447|NCT05786950|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101669448|NCT05786950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101669449|NCT05786950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101669450|NCT05786950|Adrenergic Agents|adrenergic agents|mesh-ancestor
101669451|NCT05786950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101669452|NCT05786950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669453|NCT05786950|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101669454|NCT05786950|Cholinergic Agents|cholinergic agents|mesh-ancestor
101669455|NCT05786885|Vitamins|vitamins|mesh-list
101669456|NCT05786885|Ascorbic Acid|ascorbic acid|mesh-list
101669457|NCT05786885|Micronutrients|micronutrients|mesh-ancestor
101669458|NCT05786885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669459|NCT05786885|Antioxidants|antioxidants|mesh-ancestor
101669460|NCT05786885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669461|NCT05786885|Protective Agents|protective agents|mesh-ancestor
101669462|NCT05786859|Rifaximin|rifaximin|mesh-list
101669463|NCT05786859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101669464|NCT05786859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101669465|NCT05786859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101669466|NCT05786768|Rituximab|rituximab|mesh-list
101669467|NCT05786768|Obinutuzumab|obinutuzumab|mesh-list
101669468|NCT05786768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101669469|NCT05786768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187147|NCT00002490|Mitomycins|mitomycins|mesh-list
101669470|NCT05786768|Immunologic Factors|immunologic factors|mesh-ancestor
101669471|NCT05786768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669472|NCT05786768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101669473|NCT05786638|Immunomodulating Agents|immunomodulating agents|mesh-list
101669474|NCT05786638|Immunologic Factors|immunologic factors|mesh-ancestor
101669475|NCT05786638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669476|NCT05785897|Sirolimus|sirolimus|mesh-list
101669477|NCT05785897|Ticagrelor|ticagrelor|mesh-list
101669478|NCT05785897|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101669479|NCT05785897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669480|NCT05785897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669481|NCT05785897|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101669482|NCT05785897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101669483|NCT05785897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101669484|NCT05785897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101669485|NCT05785897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101669486|NCT05785897|Antifungal Agents|antifungal agents|mesh-ancestor
101326670|NCT00118807|Amebicides|amebicides|mesh-ancestor
101669487|NCT05785897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101669488|NCT05785897|Immunologic Factors|immunologic factors|mesh-ancestor
101669489|NCT05785897|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101669490|NCT05785897|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101669491|NCT05785897|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101669492|NCT05785897|Purinergic Agents|purinergic agents|mesh-ancestor
101669493|NCT05785897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101669494|NCT05785819|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101669495|NCT05785819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669496|NCT05784688|Pembrolizumab|pembrolizumab|mesh-list
101669497|NCT05784688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101669498|NCT05784688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101669499|NCT05784688|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101669500|NCT05784688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669501|NCT05776459|Prednisolone|prednisolone|mesh-list
101669502|NCT05776459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101669503|NCT05776459|Glucocorticoids|glucocorticoids|mesh-ancestor
101669504|NCT05776459|Hormones|hormones|mesh-ancestor
101669505|NCT05776459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101669506|NCT05776459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669507|NCT05776459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101669508|NCT05776459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101669509|NCT05764044|Gemcitabine|gemcitabine|mesh-list
101669510|NCT05764044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101669511|NCT05764044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101669512|NCT05764044|Antimetabolites|antimetabolites|mesh-ancestor
101669513|NCT05764044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669514|NCT05739136|Norethindrone|norethindrone|mesh-list
101669536|NCT05737030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669537|NCT05716295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101669538|NCT05716295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669539|NCT05716295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101669540|NCT05716295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101669562|NCT05706844|Anesthetics|anesthetics|mesh-list
101669563|NCT05706844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101669564|NCT05706844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669566|NCT05702827|Bupivacaine|bupivacaine|mesh-list
101669567|NCT05702827|Anesthetics, Local|anesthetics, local|mesh-ancestor
101669568|NCT05702827|Anesthetics|anesthetics|mesh-ancestor
101669569|NCT05702827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101827106|NCT05879276|Empagliflozin|empagliflozin|mesh-list
101669589|NCT05673889|Protease Inhibitors|protease inhibitors|mesh-ancestor
101669590|NCT05673889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101669591|NCT05673889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669592|NCT05673889|Anticoagulants|anticoagulants|mesh-ancestor
101669594|NCT05654298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101669595|NCT05654298|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101669596|NCT05654298|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101669597|NCT05654298|Serotonin Agents|serotonin agents|mesh-ancestor
101669598|NCT05654298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101669599|NCT05654298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669600|NCT05654298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669601|NCT05649293|Vitamin B 6|vitamin b 6|mesh-list
101669602|NCT05649293|Pyridoxal|pyridoxal|mesh-list
101669603|NCT05649293|Pyridoxine|pyridoxine|mesh-list
101669604|NCT05649293|Vitamins|vitamins|mesh-ancestor
101669605|NCT05649293|Micronutrients|micronutrients|mesh-ancestor
101669606|NCT05649293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669607|NCT05649293|Vitamin B Complex|vitamin b complex|mesh-ancestor
101669608|NCT05639972|Aldesleukin|aldesleukin|mesh-list
101669609|NCT05639972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101669610|NCT05639972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101669611|NCT05639972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101669612|NCT05639972|Antiviral Agents|antiviral agents|mesh-ancestor
101669613|NCT05639972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101827122|NCT05879068|Paclitaxel|paclitaxel|mesh-list
101669633|NCT05618613|Onapristone|onapristone|mesh-list
101669634|NCT05618613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101669635|NCT05618613|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101669636|NCT05618613|Fertility Agents|fertility agents|mesh-ancestor
101669637|NCT05618613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101669638|NCT05618613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669639|NCT05618613|Hormone Antagonists|hormone antagonists|mesh-ancestor
101669640|NCT05618613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101669642|NCT05617963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101669643|NCT05617963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101669644|NCT05587036|Rifaximin|rifaximin|mesh-list
101669645|NCT05587036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101669646|NCT05587036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101669647|NCT05587036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101669648|NCT05570305|Dapagliflozin|dapagliflozin|mesh-list
101669649|NCT05570305|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101669650|NCT05570305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669651|NCT05570305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101669652|NCT05570305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669653|NCT05567731|Hormones|hormones|mesh-list
101669654|NCT05567731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101669655|NCT05567731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669656|NCT05506046|Nicotine|nicotine|mesh-list
101669657|NCT05506046|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101669658|NCT05506046|Autonomic Agents|autonomic agents|mesh-ancestor
101669659|NCT05506046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101669660|NCT05506046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669661|NCT05506046|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101669662|NCT05506046|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101669664|NCT05506046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101669665|NCT05506046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669666|NCT05503875|Adalimumab|adalimumab|mesh-list
101669667|NCT05503875|Methotrexate|methotrexate|mesh-list
101669668|NCT05503875|Ixekizumab|ixekizumab|mesh-list
101669669|NCT05503875|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
101669670|NCT05503875|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101669671|NCT05503875|Abortifacient Agents|abortifacient agents|mesh-ancestor
101669672|NCT05503875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101669673|NCT05503875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669674|NCT05503875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101669675|NCT05503875|Antimetabolites|antimetabolites|mesh-ancestor
101669676|NCT05503875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669677|NCT05503875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101669678|NCT05503875|Dermatologic Agents|dermatologic agents|mesh-ancestor
101669679|NCT05503875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101669680|NCT05503875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101669681|NCT05503875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101669682|NCT05503875|Immunologic Factors|immunologic factors|mesh-ancestor
101669683|NCT05503875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101669684|NCT05503875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101669685|NCT05503875|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101669686|NCT05503875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101669687|NCT05503875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101669688|NCT05487950|Rivaroxaban|rivaroxaban|mesh-list
101669689|NCT05487950|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101669690|NCT05487950|Antithrombins|antithrombins|mesh-ancestor
101669691|NCT05487950|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101669693|NCT05487950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101669694|NCT05487950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669695|NCT05487950|Anticoagulants|anticoagulants|mesh-ancestor
101669696|NCT05477823|Androgens|androgens|mesh-list
101669697|NCT05477823|Hormones|hormones|mesh-ancestor
101827129|NCT05879029|Rabeprazole|rabeprazole|mesh-list
101669698|NCT05477823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101669699|NCT05477823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669700|NCT05452512|Vitamin D|vitamin d|mesh-list
101669701|NCT05452512|Vitamins|vitamins|mesh-list
101669702|NCT05452512|Micronutrients|micronutrients|mesh-ancestor
101669703|NCT05452512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669704|NCT05452512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101669705|NCT05432089|Oxytocin|oxytocin|mesh-list
101669706|NCT05432089|Oxytocics|oxytocics|mesh-ancestor
101669707|NCT05432089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101669708|NCT05432089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669709|NCT05428826|Prednisone|prednisone|mesh-list
101326904|NCT00121264|Sorafenib|sorafenib|mesh-list
101669710|NCT05428826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101669711|NCT05428826|Glucocorticoids|glucocorticoids|mesh-ancestor
101669712|NCT05428826|Hormones|hormones|mesh-ancestor
101669713|NCT05428826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101669714|NCT05428826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669715|NCT05428826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101669716|NCT05428826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101669717|NCT05427513|Tranexamic Acid|tranexamic acid|mesh-list
101669718|NCT05427513|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101669719|NCT05427513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101669720|NCT05427513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669721|NCT05427513|Hemostatics|hemostatics|mesh-ancestor
101669722|NCT05427513|Coagulants|coagulants|mesh-ancestor
101669723|NCT05411718|Aspirin|aspirin|mesh-list
101669724|NCT05411718|Naproxen|naproxen|mesh-list
101669725|NCT05411718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101669726|NCT05411718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101669727|NCT05411718|Analgesics|analgesics|mesh-ancestor
101669728|NCT05411718|Sensory System Agents|sensory system agents|mesh-ancestor
101669729|NCT05411718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101669730|NCT05411718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669731|NCT05411718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101669732|NCT05411718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101669733|NCT05411718|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101669734|NCT05411718|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101669735|NCT05411718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669736|NCT05411718|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101669737|NCT05411718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101669738|NCT05411718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101669740|NCT05411718|Gout Suppressants|gout suppressants|mesh-ancestor
101669741|NCT05403723|Carboplatin|carboplatin|mesh-list
101669742|NCT05403723|Etoposide|etoposide|mesh-list
101669743|NCT05403723|Durvalumab|durvalumab|mesh-list
101669744|NCT05403723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101669745|NCT05403723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101669746|NCT05403723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101669747|NCT05403723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101669748|NCT05403723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101669749|NCT05403723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669750|NCT05403723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101669751|NCT05386095|Bupivacaine|bupivacaine|mesh-list
101669752|NCT05386095|Anesthetics, Local|anesthetics, local|mesh-ancestor
101669753|NCT05386095|Anesthetics|anesthetics|mesh-ancestor
101669754|NCT05386095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101669755|NCT05386095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669756|NCT05386095|Sensory System Agents|sensory system agents|mesh-ancestor
101669757|NCT05386095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101669758|NCT05360264|Decitabine|decitabine|mesh-list
101669759|NCT05360264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101669760|NCT05360264|Antimetabolites|antimetabolites|mesh-ancestor
101669761|NCT05360264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669762|NCT05360264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101669763|NCT05360264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101669764|NCT05321524|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
101669765|NCT05321524|Cathartics|cathartics|mesh-ancestor
101669766|NCT05321524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101669767|NCT05280496|Metformin|metformin|mesh-list
101669768|NCT05280496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101669769|NCT05280496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669770|NCT05280457|Nivolumab|nivolumab|mesh-list
101669771|NCT05280457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101669772|NCT05280457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101669773|NCT05280457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101669774|NCT05280457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669775|NCT05247268|Letrozole|letrozole|mesh-list
101669776|NCT05247268|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101669777|NCT05247268|Megestrol|megestrol|mesh-list
101669778|NCT05247268|Megestrol Acetate|megestrol acetate|mesh-list
101669779|NCT05247268|Medroxyprogesterone|medroxyprogesterone|mesh-list
101669780|NCT05247268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101669781|NCT05247268|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101669782|NCT05247268|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101326990|NCT04705948|Ketamine|ketamine|mesh-list
101669783|NCT05247268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101669784|NCT05247268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669785|NCT05247268|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101669786|NCT05247268|Hormone Antagonists|hormone antagonists|mesh-ancestor
101669787|NCT05247268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101669788|NCT05247268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669789|NCT05247268|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101669790|NCT05247268|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101669791|NCT05247268|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101669792|NCT05247268|Contraceptive Agents|contraceptive agents|mesh-ancestor
101669793|NCT05247268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101669794|NCT05247268|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101669795|NCT05247268|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101669796|NCT05247268|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101669797|NCT05247268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101669798|NCT05247268|Appetite Stimulants|appetite stimulants|mesh-ancestor
101669799|NCT05247268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101669800|NCT05239546|Dostarlimab|dostarlimab|mesh-list
101669801|NCT05239546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101669802|NCT05211804|Ranibizumab|ranibizumab|mesh-list
101669803|NCT05211804|Aflibercept|aflibercept|mesh-list
101669804|NCT05211804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101669805|NCT05211804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101669806|NCT05211804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101669807|NCT05211804|Growth Substances|growth substances|mesh-ancestor
101669808|NCT05211804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669810|NCT05136560|Dexamethasone|dexamethasone|mesh-list
101669811|NCT05136560|Dexamethasone acetate|dexamethasone acetate|mesh-list
101669812|NCT05136560|BB 1101|bb 1101|mesh-list
101669813|NCT05136560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101669814|NCT05136560|Antiemetics|antiemetics|mesh-ancestor
101669815|NCT05136560|Autonomic Agents|autonomic agents|mesh-ancestor
101669816|NCT05136560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101669817|NCT05136560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669818|NCT05136560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101669819|NCT05136560|Glucocorticoids|glucocorticoids|mesh-ancestor
101669820|NCT05136560|Hormones|hormones|mesh-ancestor
101669821|NCT05136560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101669822|NCT05136560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101669823|NCT05136560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101669824|NCT05136560|Protease Inhibitors|protease inhibitors|mesh-ancestor
101669826|NCT05136560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669827|NCT05125016|Cemiplimab|cemiplimab|mesh-list
101669828|NCT05125016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101669829|NCT05125016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101669830|NCT05084586|Epirubicin|epirubicin|mesh-list
101669831|NCT05084586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101669832|NCT05084586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101669833|NCT05084586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101669834|NCT05084586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101669835|NCT05084586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101669836|NCT05084586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101669837|NCT05084586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669838|NCT05077085|Vancomycin|vancomycin|mesh-list
101669839|NCT05077085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101669840|NCT05077085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101669841|NCT04975958|Atezolizumab|atezolizumab|mesh-list
101669842|NCT04975958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101669843|NCT04975958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669844|NCT04975958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101669845|NCT04975958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101669846|NCT04930744|Metformin|metformin|mesh-list
101669847|NCT04930744|Rifampin|rifampin|mesh-list
101669848|NCT04930744|Isoniazid|isoniazid|mesh-list
101669849|NCT04930744|Pyrazinamide|pyrazinamide|mesh-list
101669850|NCT04930744|Ethambutol|ethambutol|mesh-list
101669851|NCT04930744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101669852|NCT04930744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669853|NCT04930744|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101669854|NCT04930744|Antitubercular Agents|antitubercular agents|mesh-ancestor
101669855|NCT04930744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101669856|NCT04930744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101669857|NCT04930744|Leprostatic Agents|leprostatic agents|mesh-ancestor
101669858|NCT04930744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101669859|NCT04930744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101669860|NCT04930744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669862|NCT04930744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101669863|NCT04930744|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101669864|NCT04930744|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101669865|NCT04930744|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101669866|NCT04930744|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101669867|NCT04930744|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101669868|NCT04930744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101669869|NCT04930744|Antimetabolites|antimetabolites|mesh-ancestor
101669870|NCT04930744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101669871|NCT04877093|Clonidine|clonidine|mesh-list
101669872|NCT04877093|Analgesics|analgesics|mesh-ancestor
101669873|NCT04877093|Sensory System Agents|sensory system agents|mesh-ancestor
101669874|NCT04877093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101669875|NCT04877093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669876|NCT04877093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101669877|NCT04877093|Sympatholytics|sympatholytics|mesh-ancestor
101669878|NCT04877093|Autonomic Agents|autonomic agents|mesh-ancestor
101669879|NCT04877093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101669880|NCT04877093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101669881|NCT04877093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101669882|NCT04877093|Adrenergic Agents|adrenergic agents|mesh-ancestor
101669883|NCT04877093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101669884|NCT04877093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669885|NCT04866017|Durvalumab|durvalumab|mesh-list
101669886|NCT04866017|Tislelizumab|tislelizumab|mesh-list
101669887|NCT04866017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101669888|NCT04866017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101669889|NCT04850911|Ketamine|ketamine|mesh-list
101669890|NCT04850911|Analgesics|analgesics|mesh-ancestor
101669891|NCT04850911|Sensory System Agents|sensory system agents|mesh-ancestor
101827161|NCT05876273|Pancrelipase|pancrelipase|mesh-list
101669892|NCT04850911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101669893|NCT04850911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669894|NCT04850911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101669895|NCT04850911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101669896|NCT04850911|Anesthetics, General|anesthetics, general|mesh-ancestor
101669897|NCT04850911|Anesthetics|anesthetics|mesh-ancestor
101669898|NCT04850911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101669899|NCT04850911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101669900|NCT04850911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101669901|NCT04850911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101669902|NCT04850911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669903|NCT04836533|Antidepressive Agents|antidepressive agents|mesh-list
101669904|NCT04836533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101669905|NCT04827056|Ethanol|ethanol|mesh-list
101669906|NCT04827056|Dexmedetomidine|dexmedetomidine|mesh-list
101669907|NCT04827056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101669908|NCT04827056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101669909|NCT04827056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669910|NCT04827056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101669911|NCT04827056|Analgesics|analgesics|mesh-ancestor
101669912|NCT04827056|Sensory System Agents|sensory system agents|mesh-ancestor
101669913|NCT04827056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101669914|NCT04827056|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101669915|NCT04827056|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101669916|NCT04827056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101669917|NCT04827056|Adrenergic Agents|adrenergic agents|mesh-ancestor
101669918|NCT04827056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101669919|NCT04827056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669920|NCT04827056|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101669921|NCT04827056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101669922|NCT04807127|Pembrolizumab|pembrolizumab|mesh-list
101669923|NCT04807127|Durvalumab|durvalumab|mesh-list
101669924|NCT04807127|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101669925|NCT04807127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101669926|NCT04807127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101669927|NCT04807127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669928|NCT04807114|Pembrolizumab|pembrolizumab|mesh-list
101669929|NCT04807114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101669930|NCT04807114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101669931|NCT04807114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101669932|NCT04807114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669933|NCT04759664|LUT014|lut014|mesh-list
101669934|NCT04759664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101669935|NCT04759664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101669936|NCT04759664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669937|NCT04642404|Cannabidiol|cannabidiol|mesh-list
101669938|NCT04642404|Anticonvulsants|anticonvulsants|mesh-ancestor
101669939|NCT04642352|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101669940|NCT04642352|Bupivacaine|bupivacaine|mesh-list
101669941|NCT04642352|Anesthetics, Local|anesthetics, local|mesh-ancestor
101669942|NCT04642352|Anesthetics|anesthetics|mesh-ancestor
101669943|NCT04642352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101669944|NCT04642352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669945|NCT04642352|Sensory System Agents|sensory system agents|mesh-ancestor
101669946|NCT04642352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101669947|NCT04642352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101669948|NCT04642352|Glucocorticoids|glucocorticoids|mesh-ancestor
101669949|NCT04642352|Hormones|hormones|mesh-ancestor
101669950|NCT04642352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101669951|NCT04642352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101669952|NCT04642352|Immunologic Factors|immunologic factors|mesh-ancestor
101669953|NCT04637282|Gemfibrozil|gemfibrozil|mesh-list
101669954|NCT04637282|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101669955|NCT04637282|Antimetabolites|antimetabolites|mesh-ancestor
101669956|NCT04637282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669957|NCT04637282|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101669958|NCT04637282|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101669959|NCT04637282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101669970|NCT04594408|Racepinephrine|racepinephrine|mesh-list
101669971|NCT04594408|Tranexamic Acid|tranexamic acid|mesh-list
101669972|NCT04594408|Epinephryl borate|epinephryl borate|mesh-list
101669973|NCT04594408|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101669974|NCT04594408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101669975|NCT04594408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101669976|NCT04594408|Hemostatics|hemostatics|mesh-ancestor
101669977|NCT04594408|Coagulants|coagulants|mesh-ancestor
101669978|NCT04594408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101669979|NCT04594408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101669980|NCT04594408|Adrenergic Agents|adrenergic agents|mesh-ancestor
101669981|NCT04594408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101669982|NCT04594408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101669983|NCT04594408|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101669984|NCT04594408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101669985|NCT04594408|Autonomic Agents|autonomic agents|mesh-ancestor
101669986|NCT04594408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101669987|NCT04594408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101669988|NCT04594408|Respiratory System Agents|respiratory system agents|mesh-ancestor
101669989|NCT04594408|Mydriatics|mydriatics|mesh-ancestor
101669990|NCT04594408|Sympathomimetics|sympathomimetics|mesh-ancestor
101669991|NCT04594408|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101669992|NCT04557215|Acetylcysteine|acetylcysteine|mesh-list
101669993|NCT04557215|Rifaximin|rifaximin|mesh-list
101669994|NCT04557215|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101669995|NCT04557215|Antiviral Agents|antiviral agents|mesh-ancestor
101669996|NCT04557215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101669997|NCT04557215|Expectorants|expectorants|mesh-ancestor
101669998|NCT04557215|Respiratory System Agents|respiratory system agents|mesh-ancestor
101669999|NCT04557215|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101670000|NCT04557215|Antioxidants|antioxidants|mesh-ancestor
101670001|NCT04557215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670002|NCT04557215|Protective Agents|protective agents|mesh-ancestor
101670003|NCT04557215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670004|NCT04557215|Antidotes|antidotes|mesh-ancestor
101670005|NCT04557215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101670006|NCT04557215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101670007|NCT04498117|Paclitaxel|paclitaxel|mesh-list
101670008|NCT04498117|Carboplatin|carboplatin|mesh-list
101670009|NCT04498117|Oregovomab|oregovomab|mesh-list
101670010|NCT04498117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101670011|NCT04498117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670012|NCT04498117|Tubulin Modulators|tubulin modulators|mesh-ancestor
101670013|NCT04498117|Antimitotic Agents|antimitotic agents|mesh-ancestor
101670014|NCT04498117|Mitosis Modulators|mitosis modulators|mesh-ancestor
101670015|NCT04498117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670016|NCT04498117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101670027|NCT04432857|Pembrolizumab|pembrolizumab|mesh-list
101670028|NCT04432857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101670029|NCT04432857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670030|NCT04432857|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101670031|NCT04432857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670032|NCT04423627|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101670033|NCT04423627|Clonidine|clonidine|mesh-list
101670034|NCT04423627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101670035|NCT04423627|Diuretics|diuretics|mesh-ancestor
101670036|NCT04423627|Natriuretic Agents|natriuretic agents|mesh-ancestor
101670037|NCT04423627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827178|NCT05875506|Coagulants|coagulants|mesh-ancestor
101670038|NCT04423627|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101670039|NCT04423627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101670040|NCT04423627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670042|NCT04423627|Sensory System Agents|sensory system agents|mesh-ancestor
101670043|NCT04423627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101670044|NCT04423627|Sympatholytics|sympatholytics|mesh-ancestor
101670045|NCT04423627|Autonomic Agents|autonomic agents|mesh-ancestor
101670046|NCT04423627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101670047|NCT04423627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101670048|NCT04423627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101670049|NCT04423627|Adrenergic Agents|adrenergic agents|mesh-ancestor
101670050|NCT04423627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101670051|NCT04395001|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101670052|NCT04395001|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101670053|NCT04395001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101670054|NCT04395001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101670055|NCT04395001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670056|NCT04395001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101670057|NCT04395001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670058|NCT04395001|Analgesics|analgesics|mesh-ancestor
101670059|NCT04395001|Sensory System Agents|sensory system agents|mesh-ancestor
101670060|NCT04395001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101670061|NCT04395001|Antidepressive Agents|antidepressive agents|mesh-ancestor
101670062|NCT04395001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101670063|NCT04395001|Dopamine Agents|dopamine agents|mesh-ancestor
101670064|NCT04391764|Naltrexone|naltrexone|mesh-list
101670065|NCT04391764|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101670066|NCT04391764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101670067|NCT04391764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670068|NCT04391764|Sensory System Agents|sensory system agents|mesh-ancestor
101670069|NCT04391764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101670070|NCT04339062|Sirolimus|sirolimus|mesh-list
101670071|NCT04339062|Prednisone|prednisone|mesh-list
101670072|NCT04339062|Everolimus|everolimus|mesh-list
101670073|NCT04339062|Cemiplimab|cemiplimab|mesh-list
101670074|NCT04339062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101670075|NCT04339062|Glucocorticoids|glucocorticoids|mesh-ancestor
101670076|NCT04339062|Hormones|hormones|mesh-ancestor
101670077|NCT04339062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101670078|NCT04339062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670079|NCT04339062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101670080|NCT04339062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670081|NCT04339062|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101670082|NCT04339062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101670083|NCT04339062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101670084|NCT04339062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670085|NCT04339062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101670086|NCT04339062|Immunologic Factors|immunologic factors|mesh-ancestor
101670087|NCT04339062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101670088|NCT04339062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101670089|NCT04339062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101670090|NCT04339062|Antifungal Agents|antifungal agents|mesh-ancestor
101670091|NCT04339062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101670092|NCT04305158|Nitrous Oxide|nitrous oxide|mesh-list
101670093|NCT04305158|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101670094|NCT04305158|Anesthetics, General|anesthetics, general|mesh-ancestor
101670095|NCT04305158|Anesthetics|anesthetics|mesh-ancestor
101670096|NCT04305158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101670097|NCT04305158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670098|NCT04305158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101670100|NCT04305158|Sensory System Agents|sensory system agents|mesh-ancestor
101670101|NCT04305158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101670103|NCT04303195|Antiemetics|antiemetics|mesh-ancestor
101670104|NCT04303195|Autonomic Agents|autonomic agents|mesh-ancestor
101670105|NCT04303195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101670106|NCT04303195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670107|NCT04303195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101670108|NCT04292470|Amitriptyline|amitriptyline|mesh-list
101670109|NCT04292470|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101670110|NCT04292470|Antidepressive Agents|antidepressive agents|mesh-ancestor
101670112|NCT04292470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101670113|NCT04292470|Analgesics|analgesics|mesh-ancestor
101670114|NCT04292470|Sensory System Agents|sensory system agents|mesh-ancestor
101670115|NCT04292470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101670116|NCT04292470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670117|NCT04292470|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101670118|NCT04292470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101670119|NCT04292470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101670120|NCT04292470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409483|NCT00349180|Enoxaparin|enoxaparin|mesh-list
101670121|NCT04292470|Adrenergic Agents|adrenergic agents|mesh-ancestor
101670122|NCT04292470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101670123|NCT04208334|Curcumin|curcumin|mesh-list
101670124|NCT04208334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101670125|NCT04208334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101670126|NCT04208334|Analgesics|analgesics|mesh-ancestor
101670127|NCT04208334|Sensory System Agents|sensory system agents|mesh-ancestor
101670128|NCT04208334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101670129|NCT04208334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670130|NCT04208334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101670131|NCT04208334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101670132|NCT04208334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670133|NCT04208334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101670134|NCT04208334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670135|NCT04080284|Niraparib|niraparib|mesh-list
101670136|NCT04080284|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101670137|NCT04080284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101670138|NCT04080284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670139|NCT04080284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670140|NCT04074967|Nivolumab|nivolumab|mesh-list
101670141|NCT04074967|Ipilimumab|ipilimumab|mesh-list
101670142|NCT04074967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101670143|NCT04074967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670144|NCT04074967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101670145|NCT04074967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670146|NCT04073797|Colchicine|colchicine|mesh-list
101670147|NCT04073797|Gout Suppressants|gout suppressants|mesh-ancestor
101670148|NCT04073797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101670149|NCT04073797|Tubulin Modulators|tubulin modulators|mesh-ancestor
101670150|NCT04073797|Antimitotic Agents|antimitotic agents|mesh-ancestor
101670151|NCT04073797|Mitosis Modulators|mitosis modulators|mesh-ancestor
101670152|NCT04073797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670153|NCT04073797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670154|NCT04060017|Calcium, Dietary|calcium, dietary|mesh-list
101670155|NCT04060017|Leucovorin|leucovorin|mesh-list
101670156|NCT04060017|Calcium|calcium|mesh-list
101670157|NCT04060017|Levoleucovorin|levoleucovorin|mesh-list
101670158|NCT04060017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101827206|NCT05864404|Dexmedetomidine|dexmedetomidine|mesh-list
101670159|NCT04060017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670160|NCT04060017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101670161|NCT04060017|Antidotes|antidotes|mesh-ancestor
101670162|NCT04060017|Protective Agents|protective agents|mesh-ancestor
101670163|NCT04060017|Vitamin B Complex|vitamin b complex|mesh-ancestor
101670164|NCT04060017|Vitamins|vitamins|mesh-ancestor
101670165|NCT04060017|Micronutrients|micronutrients|mesh-ancestor
101670166|NCT04052334|Cyclophosphamide|cyclophosphamide|mesh-list
101670167|NCT04052334|Fludarabine|fludarabine|mesh-list
101670168|NCT04052334|Interleukin-2|interleukin-2|mesh-list
101670169|NCT04052334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101670170|NCT04052334|Immunologic Factors|immunologic factors|mesh-ancestor
101670171|NCT04052334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670172|NCT04052334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101670174|NCT04052334|Alkylating Agents|alkylating agents|mesh-ancestor
101670175|NCT04052334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670176|NCT04052334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670177|NCT04052334|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101670178|NCT04052334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101670179|NCT04052334|Analgesics|analgesics|mesh-ancestor
101670180|NCT04052334|Sensory System Agents|sensory system agents|mesh-ancestor
101670181|NCT04052334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101670182|NCT04046549|Abatacept|abatacept|mesh-list
101670183|NCT04046549|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101670184|NCT04046549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670186|NCT04046549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670187|NCT04046549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101670188|NCT04046549|Immunologic Factors|immunologic factors|mesh-ancestor
101670189|NCT04046549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670190|NCT04046549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101670191|NCT04042935|Thioctic Acid|thioctic acid|mesh-list
101670192|NCT04042935|Antioxidants|antioxidants|mesh-ancestor
101670193|NCT04042935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670194|NCT04042935|Protective Agents|protective agents|mesh-ancestor
101670195|NCT04042935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670196|NCT04042935|Vitamin B Complex|vitamin b complex|mesh-ancestor
101670197|NCT04042935|Vitamins|vitamins|mesh-ancestor
101670198|NCT04042935|Micronutrients|micronutrients|mesh-ancestor
101670199|NCT04027309|Midostaurin|midostaurin|mesh-list
101670200|NCT04027309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670201|NCT04027309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101670202|NCT04027309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101670203|NCT04027309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670204|NCT03988933|Rifampin|rifampin|mesh-list
101670205|NCT03988933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101670206|NCT03988933|Antitubercular Agents|antitubercular agents|mesh-ancestor
101670207|NCT03988933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101670208|NCT03988933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101670209|NCT03988933|Leprostatic Agents|leprostatic agents|mesh-ancestor
101670210|NCT03988933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101670211|NCT03988933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101670212|NCT03988933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670213|NCT03988933|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101670214|NCT03988933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101670215|NCT03988933|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101670216|NCT03988933|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101670217|NCT03988933|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101670218|NCT03988933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101670219|NCT03958565|Zoledronic Acid|zoledronic acid|mesh-list
101670220|NCT03958565|Denosumab|denosumab|mesh-list
101670221|NCT03958565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101670222|NCT03958565|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101670223|NCT03958565|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101670225|NCT03958565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101670226|NCT03958565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101670227|NCT03958565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670228|NCT03785925|Nivolumab|nivolumab|mesh-list
101670229|NCT03785925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101670230|NCT03785925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670231|NCT03785925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101670232|NCT03785925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670234|NCT03752398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101670235|NCT03752398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670236|NCT03752398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101670237|NCT03752398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670238|NCT03734692|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
101670239|NCT03734692|Pembrolizumab|pembrolizumab|mesh-list
101670240|NCT03734692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670241|NCT03734692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101670242|NCT03734692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101670243|NCT03734692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670244|NCT03734692|Antiviral Agents|antiviral agents|mesh-ancestor
101670245|NCT03734692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101670246|NCT03700476|Gemcitabine|gemcitabine|mesh-list
101670247|NCT03700476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670248|NCT03700476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101670249|NCT03700476|Antimetabolites|antimetabolites|mesh-ancestor
101670250|NCT03700476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670251|NCT03644667|Mycophenolic Acid|mycophenolic acid|mesh-list
101670252|NCT03644667|Prednisone|prednisone|mesh-list
101670253|NCT03644667|Methylprednisolone|methylprednisolone|mesh-list
101670254|NCT03644667|Tacrolimus|tacrolimus|mesh-list
101670255|NCT03644667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
101670256|NCT03644667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101670257|NCT03644667|Glucocorticoids|glucocorticoids|mesh-ancestor
101670268|NCT03644667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101670269|NCT03644667|Antitubercular Agents|antitubercular agents|mesh-ancestor
101670270|NCT03644667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101670271|NCT03644667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101670272|NCT03644667|Antiemetics|antiemetics|mesh-ancestor
101670273|NCT03644667|Autonomic Agents|autonomic agents|mesh-ancestor
101670274|NCT03644667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101670275|NCT03644667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101670276|NCT03644667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101670277|NCT03644667|Protective Agents|protective agents|mesh-ancestor
101670288|NCT03330106|Paclitaxel|paclitaxel|mesh-list
101670289|NCT03330106|Docetaxel|docetaxel|mesh-list
101670290|NCT03330106|Carboplatin|carboplatin|mesh-list
101670291|NCT03330106|Pevonedistat|pevonedistat|mesh-list
101670292|NCT03330106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101670293|NCT03330106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670294|NCT03330106|Tubulin Modulators|tubulin modulators|mesh-ancestor
101670295|NCT03330106|Antimitotic Agents|antimitotic agents|mesh-ancestor
101670296|NCT03330106|Mitosis Modulators|mitosis modulators|mesh-ancestor
101670297|NCT03330106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670298|NCT03330106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101670299|NCT03239145|Pembrolizumab|pembrolizumab|mesh-list
101670300|NCT03239145|Trebananib|trebananib|mesh-list
101670301|NCT03239145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101670302|NCT03239145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670303|NCT03239145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101670304|NCT03239145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670305|NCT03239145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101670306|NCT03239145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101670307|NCT03239145|Growth Substances|growth substances|mesh-ancestor
101670308|NCT03239145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670309|NCT03239145|Growth Inhibitors|growth inhibitors|mesh-ancestor
101670311|NCT03164564|Emtricitabine|emtricitabine|mesh-list
101670312|NCT03164564|Cabotegravir|cabotegravir|mesh-list
101670313|NCT03164564|Antiviral Agents|antiviral agents|mesh-ancestor
101670314|NCT03164564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101670315|NCT03164564|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101670316|NCT03164564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101670317|NCT03164564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101670318|NCT03164564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670319|NCT03164564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101670320|NCT03164564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101670321|NCT03164564|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101670322|NCT03164564|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101670323|NCT03153410|Cyclophosphamide|cyclophosphamide|mesh-list
101670324|NCT03153410|Pembrolizumab|pembrolizumab|mesh-list
101670325|NCT03153410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101670326|NCT03153410|Immunologic Factors|immunologic factors|mesh-ancestor
101670327|NCT03153410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670328|NCT03153410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101670329|NCT03153410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101670330|NCT03153410|Alkylating Agents|alkylating agents|mesh-ancestor
101670331|NCT03153410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670332|NCT03153410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670333|NCT03153410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101670334|NCT03153410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101670336|NCT03113422|Venetoclax|venetoclax|mesh-list
101670337|NCT03113422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670338|NCT03070886|Docetaxel|docetaxel|mesh-list
101670339|NCT03070886|Leuprolide|leuprolide|mesh-list
101670340|NCT03070886|Goserelin|goserelin|mesh-list
101670341|NCT03070886|Bicalutamide|bicalutamide|mesh-list
101670342|NCT03070886|Flutamide|flutamide|mesh-list
101670343|NCT03070886|Nilutamide|nilutamide|mesh-list
101670344|NCT03070886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670345|NCT03070886|Tubulin Modulators|tubulin modulators|mesh-ancestor
101670346|NCT03070886|Antimitotic Agents|antimitotic agents|mesh-ancestor
101670347|NCT03070886|Mitosis Modulators|mitosis modulators|mesh-ancestor
101670348|NCT03070886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670349|NCT03070886|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101670350|NCT03070886|Fertility Agents|fertility agents|mesh-ancestor
101670351|NCT03070886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101670352|NCT03070886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670353|NCT03070886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101670354|NCT03070886|Androgen Antagonists|androgen antagonists|mesh-ancestor
101670355|NCT03070886|Hormone Antagonists|hormone antagonists|mesh-ancestor
101670356|NCT03070886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101670357|NCT02987257|Cyclosporine|cyclosporine|mesh-list
101670358|NCT02987257|Etanercept|etanercept|mesh-list
101670359|NCT02987257|Cyclosporins|cyclosporins|mesh-list
101670360|NCT02987257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101670361|NCT02987257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670362|NCT02987257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101670363|NCT02987257|Immunologic Factors|immunologic factors|mesh-ancestor
101670364|NCT02987257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670365|NCT02987257|Antifungal Agents|antifungal agents|mesh-ancestor
101670366|NCT02987257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101670367|NCT02987257|Dermatologic Agents|dermatologic agents|mesh-ancestor
101670368|NCT02987257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101670369|NCT02987257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101670370|NCT02987257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101670371|NCT02987257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101670373|NCT02987257|Sensory System Agents|sensory system agents|mesh-ancestor
101670374|NCT02987257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101670375|NCT02987257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101670376|NCT02987257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101670377|NCT02913274|Paclitaxel|paclitaxel|mesh-list
101670378|NCT02913274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101670379|NCT02913274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670380|NCT02913274|Tubulin Modulators|tubulin modulators|mesh-ancestor
101327575|NCT00019513|Vitamin B Complex|vitamin b complex|mesh-ancestor
101670381|NCT02913274|Antimitotic Agents|antimitotic agents|mesh-ancestor
101670382|NCT02913274|Mitosis Modulators|mitosis modulators|mesh-ancestor
101670383|NCT02913274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670384|NCT02896335|Palbociclib|palbociclib|mesh-list
101670385|NCT02896335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670386|NCT02896335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101670387|NCT02896335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101670388|NCT02896335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670389|NCT02821754|Durvalumab|durvalumab|mesh-list
101670390|NCT02821754|Tremelimumab|tremelimumab|mesh-list
101670391|NCT02821754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101670392|NCT02821754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670393|NCT02781883|Decitabine|decitabine|mesh-list
101670394|NCT02781883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101670395|NCT02781883|Antimetabolites|antimetabolites|mesh-ancestor
101670396|NCT02781883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670397|NCT02781883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670398|NCT02781883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101670399|NCT02772003|Interleukin-12|interleukin-12|mesh-list
101670400|NCT02772003|Vaccines|vaccines|mesh-list
101670401|NCT02772003|Immunologic Factors|immunologic factors|mesh-ancestor
101670402|NCT02772003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670403|NCT02772003|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101670404|NCT02772003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101670405|NCT02772003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101670407|NCT02772003|Growth Inhibitors|growth inhibitors|mesh-ancestor
101670410|NCT02684162|Azacitidine|azacitidine|mesh-list
101670411|NCT02684162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670412|NCT02684162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101670413|NCT02684162|Antimetabolites|antimetabolites|mesh-ancestor
101670414|NCT02684162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670415|NCT02684162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101670416|NCT02619682|Lenalidomide|lenalidomide|mesh-list
101670417|NCT02619682|Ixazomib|ixazomib|mesh-list
101670418|NCT02619682|Glycine|glycine|mesh-list
101670419|NCT02619682|Immunologic Factors|immunologic factors|mesh-ancestor
101670420|NCT02619682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670421|NCT02619682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101670422|NCT02619682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101670423|NCT02619682|Growth Substances|growth substances|mesh-ancestor
101670424|NCT02619682|Growth Inhibitors|growth inhibitors|mesh-ancestor
101670425|NCT02619682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670426|NCT02619682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670427|NCT02619682|Protease Inhibitors|protease inhibitors|mesh-ancestor
101670428|NCT02619682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101670429|NCT02619682|Glycine Agents|glycine agents|mesh-ancestor
101827260|NCT05846906|Fertility Agents|fertility agents|mesh-ancestor
101670430|NCT02619682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101670431|NCT02617589|Nivolumab|nivolumab|mesh-list
101670432|NCT02617589|Temozolomide|temozolomide|mesh-list
101670433|NCT02617589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101670434|NCT02617589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670435|NCT02617589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101670436|NCT02617589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670437|NCT02617589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101670438|NCT02617589|Alkylating Agents|alkylating agents|mesh-ancestor
101670439|NCT02540707|Solifenacin Succinate|solifenacin succinate|mesh-list
101670440|NCT02540707|Mirabegron|mirabegron|mesh-list
101670441|NCT02540707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101670442|NCT02540707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101670443|NCT02540707|Cholinergic Agents|cholinergic agents|mesh-ancestor
101670444|NCT02540707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101670445|NCT02540707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670446|NCT02540707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670447|NCT02540707|Urological Agents|urological agents|mesh-ancestor
101670448|NCT02540707|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101670449|NCT02540707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101670450|NCT02540707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101670451|NCT02540707|Adrenergic Agents|adrenergic agents|mesh-ancestor
101670452|NCT02531932|Carboplatin|carboplatin|mesh-list
101670453|NCT02531932|Everolimus|everolimus|mesh-list
101670454|NCT02531932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670455|NCT02531932|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101670456|NCT02531932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101670457|NCT02531932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101670458|NCT02531932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670459|NCT02531932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101670460|NCT02531932|Immunologic Factors|immunologic factors|mesh-ancestor
101670461|NCT02531932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670462|NCT02504346|Osimertinib|osimertinib|mesh-list
101670463|NCT02504346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670464|NCT02504346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101670465|NCT02504346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101670466|NCT02504346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670467|NCT02345265|Olaparib|olaparib|mesh-list
101670468|NCT02345265|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
101670469|NCT02345265|Cediranib|cediranib|mesh-list
101670470|NCT02345265|Maleic acid|maleic acid|mesh-list
101670471|NCT02345265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101670472|NCT02345265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670473|NCT02345265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670474|NCT02345265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101670475|NCT02340169|Desoximetasone|desoximetasone|mesh-list
101670476|NCT02340169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101670477|NCT02340169|Glucocorticoids|glucocorticoids|mesh-ancestor
101670478|NCT02340169|Hormones|hormones|mesh-ancestor
101670479|NCT02340169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101670481|NCT02337829|Acalabrutinib|acalabrutinib|mesh-list
101670505|NCT01899326|Desipramine|desipramine|mesh-list
101670506|NCT01899326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670507|NCT01899326|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101670508|NCT01899326|Antidepressive Agents|antidepressive agents|mesh-ancestor
101670509|NCT01899326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101670510|NCT01899326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101670511|NCT01899326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670512|NCT01899326|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101670513|NCT01899326|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101670514|NCT01899326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101670515|NCT01899326|Adrenergic Agents|adrenergic agents|mesh-ancestor
101670516|NCT01899326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101670517|NCT01572480|Dexamethasone|dexamethasone|mesh-list
101670518|NCT01572480|Lenalidomide|lenalidomide|mesh-list
101670519|NCT01572480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101670520|NCT01572480|Antiemetics|antiemetics|mesh-ancestor
101670521|NCT01572480|Autonomic Agents|autonomic agents|mesh-ancestor
101670522|NCT01572480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101670523|NCT01572480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670524|NCT01572480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101670525|NCT01572480|Glucocorticoids|glucocorticoids|mesh-ancestor
101670526|NCT01572480|Hormones|hormones|mesh-ancestor
101670527|NCT01572480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101670528|NCT01572480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101670529|NCT01572480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670530|NCT01572480|Immunologic Factors|immunologic factors|mesh-ancestor
101670531|NCT01572480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101670532|NCT01572480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101670533|NCT01572480|Growth Substances|growth substances|mesh-ancestor
101670534|NCT01572480|Growth Inhibitors|growth inhibitors|mesh-ancestor
101670535|NCT01515137|Sulindac|sulindac|mesh-list
101670536|NCT01515137|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101670537|NCT01515137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670538|NCT01515137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101670539|NCT01515137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101670540|NCT01515137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670541|NCT01515137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101670542|NCT01515137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101670543|NCT01515137|Analgesics|analgesics|mesh-ancestor
101670544|NCT01515137|Sensory System Agents|sensory system agents|mesh-ancestor
101670545|NCT01515137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101670546|NCT01515137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670547|NCT01515137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101670548|NCT01515137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101670549|NCT01515137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101670550|NCT01393509|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
101670551|NCT01393509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670552|NCT01375829|Sirolimus|sirolimus|mesh-list
101670553|NCT01375829|Temsirolimus|temsirolimus|mesh-list
101670554|NCT01375829|Epothilone B|epothilone b|mesh-list
101670556|NCT01375829|Epothilones|epothilones|mesh-list
101670557|NCT01375829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101670558|NCT01375829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101670559|NCT01375829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101670560|NCT01375829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670561|NCT01375829|Antifungal Agents|antifungal agents|mesh-ancestor
101670562|NCT01375829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101670563|NCT01375829|Immunologic Factors|immunologic factors|mesh-ancestor
101670564|NCT01375829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670565|NCT01375829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101670566|NCT01375829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101670567|NCT01375829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670568|NCT01375829|Tubulin Modulators|tubulin modulators|mesh-ancestor
101670569|NCT01375829|Antimitotic Agents|antimitotic agents|mesh-ancestor
101670570|NCT01375829|Mitosis Modulators|mitosis modulators|mesh-ancestor
101670571|NCT01126190|Docetaxel|docetaxel|mesh-list
101670572|NCT01126190|Doxorubicin|doxorubicin|mesh-list
101670573|NCT01126190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670574|NCT01126190|Tubulin Modulators|tubulin modulators|mesh-ancestor
101670575|NCT01126190|Antimitotic Agents|antimitotic agents|mesh-ancestor
101670576|NCT01126190|Mitosis Modulators|mitosis modulators|mesh-ancestor
101670577|NCT01126190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670578|NCT01126190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101670579|NCT01126190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101670580|NCT01126190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101670581|NCT01126190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101670583|NCT00472654|Vitamins|vitamins|mesh-ancestor
101670584|NCT00472654|Micronutrients|micronutrients|mesh-ancestor
101670585|NCT00472654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670586|NCT00472654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101670587|NCT00323037|Carvedilol|carvedilol|mesh-list
101670588|NCT00323037|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101670589|NCT00323037|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101670590|NCT00323037|Adrenergic Agents|adrenergic agents|mesh-ancestor
101670591|NCT00323037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101670592|NCT00323037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670593|NCT00323037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670594|NCT00323037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101670595|NCT00323037|Antioxidants|antioxidants|mesh-ancestor
101670596|NCT00323037|Protective Agents|protective agents|mesh-ancestor
101670597|NCT00323037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101670598|NCT00323037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101670599|NCT00323037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101670600|NCT00323037|Vasodilator Agents|vasodilator agents|mesh-ancestor
101670601|NCT00323037|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101670602|NCT00323037|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101670603|NCT00128297|Pamidronate|pamidronate|mesh-list
101670604|NCT00128297|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101670605|NCT00128297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670606|NCT00939185|Azithromycin|azithromycin|mesh-list
101670607|NCT00939185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101670608|NCT00939185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101670609|NCT02808104|Mazindol|mazindol|mesh-list
101827337|NCT05795647|Tocopherols|tocopherols|mesh-list
101670610|NCT02808104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101670611|NCT02808104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670612|NCT02808104|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101670613|NCT02808104|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101670614|NCT02808104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101670615|NCT02808104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670616|NCT02808104|Adrenergic Agents|adrenergic agents|mesh-ancestor
101670617|NCT02808104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101670618|NCT02808104|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101670620|NCT05165771|Tofacitinib|tofacitinib|mesh-list
101670621|NCT05165771|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101670622|NCT05165771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101670623|NCT05165771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101670624|NCT05165771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670625|NCT02730624|Tazobactam|tazobactam|mesh-list
101670626|NCT02730624|Piperacillin|piperacillin|mesh-list
101670627|NCT02730624|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101670628|NCT02730624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101670630|NCT02730624|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101670631|NCT02730624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101670632|NCT02730624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670633|NCT02807870|Methylphenidate|methylphenidate|mesh-list
101670634|NCT02807870|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101670635|NCT02807870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670636|NCT02807870|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101670637|NCT02807870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101670638|NCT02807870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101670639|NCT02807870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670640|NCT02807870|Dopamine Agents|dopamine agents|mesh-ancestor
101670641|NCT02807870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101670642|NCT00925873|Vidarabine|vidarabine|mesh-list
101670643|NCT00925873|Fludarabine|fludarabine|mesh-list
101670644|NCT00925873|Fludarabine phosphate|fludarabine phosphate|mesh-list
101670645|NCT00925873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670646|NCT00925873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101670647|NCT00925873|Antimetabolites|antimetabolites|mesh-ancestor
101670648|NCT00925873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670649|NCT00925873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101670650|NCT00925873|Immunologic Factors|immunologic factors|mesh-ancestor
101670651|NCT00925873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670652|NCT00925873|Antiviral Agents|antiviral agents|mesh-ancestor
101670653|NCT00925873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101670654|NCT00925951|Acetaminophen|acetaminophen|mesh-list
101670655|NCT00925951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101670656|NCT00925951|Analgesics|analgesics|mesh-ancestor
101670657|NCT00925951|Sensory System Agents|sensory system agents|mesh-ancestor
101670658|NCT00925951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101670659|NCT00925951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670660|NCT00925951|Antipyretics|antipyretics|mesh-ancestor
101670661|NCT00933205|Tipranavir|tipranavir|mesh-list
101670662|NCT00933205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101670663|NCT00933205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101670664|NCT00933205|Antiviral Agents|antiviral agents|mesh-ancestor
101670665|NCT00933205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101670666|NCT02813486|Vaccines|vaccines|mesh-list
101670667|NCT02813486|Immunologic Factors|immunologic factors|mesh-ancestor
101670668|NCT02813486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670669|NCT02739516|Letrozole|letrozole|mesh-list
101670670|NCT02739516|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101670671|NCT02739516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670672|NCT02739516|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101670673|NCT02739516|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101670674|NCT02739516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101670675|NCT02739516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670676|NCT02739516|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101670677|NCT02739516|Hormone Antagonists|hormone antagonists|mesh-ancestor
101670678|NCT02739516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101327881|NCT00020878|Analgesics|analgesics|mesh-ancestor
101670679|NCT02739516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670680|NCT02739516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101670681|NCT00933283|Methadone|methadone|mesh-list
101670682|NCT00933283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101670683|NCT00933283|Narcotics|narcotics|mesh-ancestor
101670684|NCT00933283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101670685|NCT00933283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670686|NCT00933283|Analgesics|analgesics|mesh-ancestor
101670687|NCT00933283|Sensory System Agents|sensory system agents|mesh-ancestor
101670688|NCT00933283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101670689|NCT00933283|Antitussive Agents|antitussive agents|mesh-ancestor
101670690|NCT00933283|Respiratory System Agents|respiratory system agents|mesh-ancestor
101670691|NCT02813018|Ropivacaine|ropivacaine|mesh-list
101670692|NCT02813018|Anesthetics, Local|anesthetics, local|mesh-ancestor
101670693|NCT02813018|Anesthetics|anesthetics|mesh-ancestor
101670694|NCT02813018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101670695|NCT02813018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670696|NCT02813018|Sensory System Agents|sensory system agents|mesh-ancestor
101670697|NCT02813018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101670698|NCT04253964|Paclitaxel|paclitaxel|mesh-list
101670699|NCT04253964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101670700|NCT04253964|Carboplatin|carboplatin|mesh-list
101670701|NCT04253964|Pembrolizumab|pembrolizumab|mesh-list
101670702|NCT04253964|Pemetrexed|pemetrexed|mesh-list
101670703|NCT04253964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101670704|NCT04253964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670706|NCT04253964|Antimitotic Agents|antimitotic agents|mesh-ancestor
101670707|NCT04253964|Mitosis Modulators|mitosis modulators|mesh-ancestor
101670708|NCT04253964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670709|NCT04253964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101670710|NCT04253964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101670711|NCT04253964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101670712|NCT04253964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101670713|NCT04253964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101670715|NCT02810132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101670716|NCT02810132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670717|NCT02734524|Carboplatin|carboplatin|mesh-list
101670718|NCT02734524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670719|NCT04173962|Midazolam|midazolam|mesh-list
101670720|NCT04173962|Ketamine|ketamine|mesh-list
101670721|NCT04173962|Analgesics|analgesics|mesh-ancestor
101670722|NCT04173962|Sensory System Agents|sensory system agents|mesh-ancestor
101670723|NCT04173962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101670724|NCT04173962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670725|NCT04173962|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101670726|NCT04173962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101670727|NCT04173962|Anesthetics, General|anesthetics, general|mesh-ancestor
101670728|NCT04173962|Anesthetics|anesthetics|mesh-ancestor
101670729|NCT04173962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101670730|NCT04173962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101670731|NCT04173962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101670732|NCT04173962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101670733|NCT04173962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670734|NCT04173962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101670735|NCT04173962|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101670736|NCT04173962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101670737|NCT04173962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101670738|NCT04173962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101670739|NCT04173962|GABA Modulators|gaba modulators|mesh-ancestor
101670740|NCT04173962|GABA Agents|gaba agents|mesh-ancestor
101670741|NCT00772005|Modafinil|modafinil|mesh-list
101670742|NCT00772005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101670743|NCT00772005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670744|NCT00772005|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101670745|NCT00772005|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101670746|NCT00772005|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101670747|NCT00772005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670748|NCT03333408|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101670749|NCT03333408|Clindamycin|clindamycin|mesh-list
101670750|NCT03333408|Clindamycin palmitate|clindamycin palmitate|mesh-list
101670751|NCT03333408|Clindamycin phosphate|clindamycin phosphate|mesh-list
101670752|NCT03333408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101670753|NCT03333408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101327979|NCT00021385|Squalamine|squalamine|mesh-list
101670754|NCT03333408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101670755|NCT03333408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101670756|NCT03333408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670757|NCT03333408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101670759|NCT04262999|Valproic Acid|valproic acid|mesh-list
101670760|NCT04262999|Anticonvulsants|anticonvulsants|mesh-ancestor
101670761|NCT04262999|Nootropic Agents|nootropic agents|mesh-ancestor
101670762|NCT04262999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101670763|NCT04262999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670764|NCT04262999|GABA Agents|gaba agents|mesh-ancestor
101670765|NCT04262999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101670766|NCT04262999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670767|NCT04262999|Antimanic Agents|antimanic agents|mesh-ancestor
101670768|NCT04262999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101670769|NCT04262999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101670770|NCT04262999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101670771|NCT00926107|Sirolimus|sirolimus|mesh-list
101827387|NCT05771480|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101670772|NCT00926107|Temsirolimus|temsirolimus|mesh-list
101670773|NCT00926107|MTOR Inhibitors|mtor inhibitors|mesh-list
101670774|NCT00926107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101670775|NCT00926107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101670776|NCT00926107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670777|NCT00926107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101670778|NCT00926107|Immunologic Factors|immunologic factors|mesh-ancestor
101670779|NCT00926107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670780|NCT00926107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670781|NCT00926107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101670782|NCT00926107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101670783|NCT00926107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101670784|NCT00926107|Antifungal Agents|antifungal agents|mesh-ancestor
101670786|NCT02729766|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101670787|NCT02729766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670788|NCT02729766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101670789|NCT02729766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670791|NCT02812940|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101670792|NCT02812940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101670793|NCT02812940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101670794|NCT02812940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670795|NCT02812940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101670796|NCT02812940|Immunologic Factors|immunologic factors|mesh-ancestor
101670797|NCT02812940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670798|NCT02812940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670799|NCT00933439|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101670800|NCT00933439|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101670801|NCT00933439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101670802|NCT00933439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101670803|NCT00933439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670804|NCT00933439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101670805|NCT00933439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670806|NCT00933439|Analgesics|analgesics|mesh-ancestor
101670807|NCT00933439|Sensory System Agents|sensory system agents|mesh-ancestor
101670808|NCT00933439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101670809|NCT00933439|Antidepressive Agents|antidepressive agents|mesh-ancestor
101670810|NCT00933439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101670811|NCT00933439|Dopamine Agents|dopamine agents|mesh-ancestor
101670812|NCT00608075|Lithium Carbonate|lithium carbonate|mesh-list
101670813|NCT00608075|Antidepressive Agents|antidepressive agents|mesh-ancestor
101670814|NCT00608075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101670815|NCT00608075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101670816|NCT00608075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670817|NCT00608075|Antimanic Agents|antimanic agents|mesh-ancestor
101670818|NCT00608075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101670819|NCT00608075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101670820|NCT00608075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670821|NCT02809742|Ropivacaine|ropivacaine|mesh-list
101670822|NCT02809742|Anesthetics, Local|anesthetics, local|mesh-ancestor
101670823|NCT02809742|Anesthetics|anesthetics|mesh-ancestor
101670824|NCT02809742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101670825|NCT02809742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670826|NCT02809742|Sensory System Agents|sensory system agents|mesh-ancestor
101670827|NCT02809742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101670828|NCT00929851|Formoterol Fumarate|formoterol fumarate|mesh-list
101670829|NCT00929851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101670830|NCT00929851|Autonomic Agents|autonomic agents|mesh-ancestor
101670831|NCT00929851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101670832|NCT00929851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670833|NCT00929851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101670834|NCT00929851|Respiratory System Agents|respiratory system agents|mesh-ancestor
101827406|NCT05746546|Autonomic Agents|autonomic agents|mesh-ancestor
101827414|NCT05727371|Hylan|hylan|mesh-list
101670835|NCT00929851|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101670836|NCT00929851|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101670837|NCT00929851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101670838|NCT00929851|Adrenergic Agents|adrenergic agents|mesh-ancestor
101670839|NCT00929851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101670840|NCT00929851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670841|NCT02729376|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
101670842|NCT02729376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101670843|NCT02729376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670844|NCT00933517|Cyclophosphamide|cyclophosphamide|mesh-list
101670845|NCT00933517|Docetaxel|docetaxel|mesh-list
101670846|NCT00933517|Panitumumab|panitumumab|mesh-list
101670847|NCT00933517|Epirubicin|epirubicin|mesh-list
101670848|NCT00933517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101670849|NCT00933517|Immunologic Factors|immunologic factors|mesh-ancestor
101670850|NCT00933517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670851|NCT00933517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101670852|NCT00933517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101670853|NCT00933517|Alkylating Agents|alkylating agents|mesh-ancestor
101670854|NCT00933517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670855|NCT00933517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670856|NCT00933517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101670857|NCT00933517|Tubulin Modulators|tubulin modulators|mesh-ancestor
101670858|NCT00933517|Antimitotic Agents|antimitotic agents|mesh-ancestor
101670859|NCT00933517|Mitosis Modulators|mitosis modulators|mesh-ancestor
101670860|NCT00933517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101670861|NCT00933517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101670862|NCT00933517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101670863|NCT00933517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101670864|NCT00933517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101670865|NCT00926341|Pioglitazone|pioglitazone|mesh-list
101670866|NCT00926341|Telmisartan|telmisartan|mesh-list
101670867|NCT00926341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101670868|NCT00926341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670869|NCT00926341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101670870|NCT00926341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101670871|NCT00926341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101670872|NCT00926341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670873|NCT00926419|Vaccines|vaccines|mesh-list
101670874|NCT00926419|Immunologic Factors|immunologic factors|mesh-ancestor
101670875|NCT00926419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670876|NCT00608231|Dexmedetomidine|dexmedetomidine|mesh-list
101670877|NCT00608231|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101670878|NCT00608231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101670879|NCT00608231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670880|NCT00608231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101670881|NCT00608231|Analgesics|analgesics|mesh-ancestor
101670882|NCT00608231|Sensory System Agents|sensory system agents|mesh-ancestor
101670883|NCT00608231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101670884|NCT00608231|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101670885|NCT00608231|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101670886|NCT00608231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101670887|NCT00608231|Adrenergic Agents|adrenergic agents|mesh-ancestor
101670888|NCT00608231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101670889|NCT00608231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670890|NCT02739204|Celecoxib|celecoxib|mesh-list
101670891|NCT02739204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101670892|NCT02739204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101670893|NCT02739204|Analgesics|analgesics|mesh-ancestor
101670894|NCT02739204|Sensory System Agents|sensory system agents|mesh-ancestor
101670895|NCT02739204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101670896|NCT02739204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670897|NCT02739204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101670898|NCT02739204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101670899|NCT02739204|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101827416|NCT05727371|Protective Agents|protective agents|mesh-ancestor
101670900|NCT02739204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101670902|NCT02739204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670903|NCT00927485|Curcumin|curcumin|mesh-list
101670904|NCT00927485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101670905|NCT00927485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101670906|NCT00927485|Analgesics|analgesics|mesh-ancestor
101670907|NCT00927485|Sensory System Agents|sensory system agents|mesh-ancestor
101670908|NCT00927485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101670909|NCT00927485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670910|NCT00927485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101670911|NCT00927485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101670912|NCT00927485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670913|NCT00927485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101670914|NCT00927485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670915|NCT00926653|Escitalopram|escitalopram|mesh-list
101670916|NCT00926653|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101670917|NCT00926653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101670918|NCT00926653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101670919|NCT00926653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670920|NCT00926653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101670922|NCT00926653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670923|NCT02733822|Naloxone|naloxone|mesh-list
101670924|NCT02733822|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101670925|NCT02733822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670926|NCT02733822|Sensory System Agents|sensory system agents|mesh-ancestor
101670927|NCT02733822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101670928|NCT00930241|Tacrolimus|tacrolimus|mesh-list
101670929|NCT00930241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101670930|NCT00930241|Immunologic Factors|immunologic factors|mesh-ancestor
101670931|NCT00930241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670932|NCT00930241|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101670933|NCT00930241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101670934|NCT00930241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670935|NCT04260269|Trifluridine|trifluridine|mesh-list
101670936|NCT04260269|Fluorouracil|fluorouracil|mesh-list
101670937|NCT04260269|Capecitabine|capecitabine|mesh-list
101670938|NCT04260269|Tegafur|tegafur|mesh-list
101670939|NCT04260269|Antimetabolites|antimetabolites|mesh-ancestor
101670940|NCT04260269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670941|NCT04260269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101670942|NCT04260269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670943|NCT04260269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101670944|NCT04260269|Immunologic Factors|immunologic factors|mesh-ancestor
101670945|NCT04260269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670946|NCT04260269|Antiviral Agents|antiviral agents|mesh-ancestor
101670947|NCT04260269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101670948|NCT02738970|Trastuzumab|trastuzumab|mesh-list
101670949|NCT02738970|Pertuzumab|pertuzumab|mesh-list
101670950|NCT02738970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101670951|NCT02738970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670952|NCT00926731|Cytarabine|cytarabine|mesh-list
101670953|NCT00926731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101670954|NCT00926731|Antimetabolites|antimetabolites|mesh-ancestor
101670955|NCT00926731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670956|NCT00926731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101670957|NCT00926731|Antiviral Agents|antiviral agents|mesh-ancestor
101670958|NCT00926731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101670959|NCT00926731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101670960|NCT00926731|Immunologic Factors|immunologic factors|mesh-ancestor
101670961|NCT00926731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670962|NCT00926809|Amoxicillin|amoxicillin|mesh-list
101670963|NCT00926809|Clarithromycin|clarithromycin|mesh-list
101670964|NCT00926809|Lansoprazole|lansoprazole|mesh-list
101670965|NCT00926809|Dexlansoprazole|dexlansoprazole|mesh-list
101827428|NCT05706259|Vitamin D|vitamin d|mesh-list
101670966|NCT00926809|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101670967|NCT00926809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101670968|NCT00926809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101670969|NCT00926809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101670970|NCT00926809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101670971|NCT00926809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670972|NCT00926809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101670973|NCT00926809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101670975|NCT00926809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101670977|NCT02805920|Anesthetics, Local|anesthetics, local|mesh-ancestor
101670978|NCT02805920|Anesthetics|anesthetics|mesh-ancestor
101670979|NCT02805920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101670980|NCT02805920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670981|NCT02805920|Sensory System Agents|sensory system agents|mesh-ancestor
101670982|NCT02805920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101670984|NCT04262765|Ramipril|ramipril|mesh-list
101670985|NCT04262765|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
101670986|NCT04262765|Atorvastatin|atorvastatin|mesh-list
101670987|NCT04262765|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101670988|NCT04262765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101670989|NCT04262765|Antimetabolites|antimetabolites|mesh-ancestor
101670990|NCT04262765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101670991|NCT04262765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101670992|NCT04262765|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101670993|NCT04262765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101670994|NCT04262765|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101670995|NCT04262765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101670996|NCT04262765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101670997|NCT04262765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101670998|NCT04262765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101670999|NCT04262765|Vasodilator Agents|vasodilator agents|mesh-ancestor
101671000|NCT04262765|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101671001|NCT04262765|Protease Inhibitors|protease inhibitors|mesh-ancestor
101671002|NCT03112434|Botulinum Toxins|botulinum toxins|mesh-list
101671003|NCT03112434|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101671004|NCT03112434|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101671005|NCT03112434|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101671006|NCT03112434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101671007|NCT03112434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671008|NCT03112434|Cholinergic Agents|cholinergic agents|mesh-ancestor
101671009|NCT03112434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101671010|NCT03112434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671011|NCT03112434|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101671012|NCT03112434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101671014|NCT02738814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101671015|NCT02738814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101671016|NCT02738814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671017|NCT02738814|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101671018|NCT02738814|Anesthetics, General|anesthetics, general|mesh-ancestor
101671019|NCT02738814|Anesthetics|anesthetics|mesh-ancestor
101671020|NCT02805608|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101671021|NCT02805608|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101671022|NCT02805608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671023|NCT02729064|Insulin|insulin|mesh-list
101671024|NCT02729064|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101671025|NCT02729064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101671026|NCT02729064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671027|NCT00609401|Sorafenib|sorafenib|mesh-list
101671028|NCT00609401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101671029|NCT00609401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101671030|NCT00609401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101671031|NCT00609401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671032|NCT02805842|Tacrolimus|tacrolimus|mesh-list
101671033|NCT02805842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101671034|NCT02805842|Immunologic Factors|immunologic factors|mesh-ancestor
101671035|NCT02805842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671036|NCT02805842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101671037|NCT02805842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101671038|NCT02805842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671039|NCT00926965|Olanzapine|olanzapine|mesh-list
101671040|NCT00926965|Antipsychotic Agents|antipsychotic agents|mesh-list
101671041|NCT00926965|Amisulpride|amisulpride|mesh-list
101671042|NCT00926965|Antiemetics|antiemetics|mesh-ancestor
101671043|NCT00926965|Autonomic Agents|autonomic agents|mesh-ancestor
101671044|NCT00926965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101671045|NCT00926965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671047|NCT00926965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101671048|NCT00926965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101671049|NCT00926965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101671050|NCT00926965|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101671051|NCT00926965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101671052|NCT00926965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101671053|NCT00926965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671054|NCT00926965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101671055|NCT00926965|Serotonin Agents|serotonin agents|mesh-ancestor
101671056|NCT00926965|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101671057|NCT00926965|Dopamine Agents|dopamine agents|mesh-ancestor
101671058|NCT00926965|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101671059|NCT00926965|Antidepressive Agents|antidepressive agents|mesh-ancestor
101671060|NCT04260113|Apatinib|apatinib|mesh-list
101671061|NCT04260113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101671062|NCT04260113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101671063|NCT04260113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101671064|NCT04260113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671065|NCT02738658|Everolimus|everolimus|mesh-list
101671066|NCT02738658|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101671067|NCT02738658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101671068|NCT02738658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101671069|NCT02738658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671070|NCT02738658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101671071|NCT02738658|Immunologic Factors|immunologic factors|mesh-ancestor
101671072|NCT02738658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671073|NCT02738658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101671074|NCT02733510|Methylprednisolone|methylprednisolone|mesh-list
101671075|NCT02733510|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101671076|NCT02733510|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101671077|NCT02733510|Prednisolone|prednisolone|mesh-list
101671078|NCT02733510|Prednisolone acetate|prednisolone acetate|mesh-list
101671079|NCT02733510|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101671080|NCT02733510|Prednisolone phosphate|prednisolone phosphate|mesh-list
101671081|NCT02733510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101671082|NCT02733510|Antiemetics|antiemetics|mesh-ancestor
101671083|NCT02733510|Autonomic Agents|autonomic agents|mesh-ancestor
101671084|NCT02733510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101671085|NCT02733510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671086|NCT02733510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101671087|NCT02733510|Glucocorticoids|glucocorticoids|mesh-ancestor
101671088|NCT02733510|Hormones|hormones|mesh-ancestor
101671089|NCT02733510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101671090|NCT02733510|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101671091|NCT02733510|Protective Agents|protective agents|mesh-ancestor
101671092|NCT02733510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101671093|NCT02733510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101671094|NCT00927095|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
101671095|NCT00927095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101671096|NCT00927095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671097|NCT00933985|Doxorubicin|doxorubicin|mesh-list
101671098|NCT00933985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101671099|NCT00933985|Dexrazoxane|dexrazoxane|mesh-list
101671100|NCT00933985|Vincristine|vincristine|mesh-list
101671101|NCT00933985|Razoxane|razoxane|mesh-list
101671102|NCT00933985|Obatoclax|obatoclax|mesh-list
101671103|NCT00933985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101671104|NCT00933985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101671105|NCT00933985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101671106|NCT00933985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101671107|NCT00933985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101671108|NCT00933985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671109|NCT00933985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101671110|NCT00933985|Tubulin Modulators|tubulin modulators|mesh-ancestor
101671111|NCT00933985|Antimitotic Agents|antimitotic agents|mesh-ancestor
101671112|NCT00933985|Mitosis Modulators|mitosis modulators|mesh-ancestor
101671113|NCT00933985|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101671114|NCT00933985|Protective Agents|protective agents|mesh-ancestor
101671115|NCT00933985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671116|NCT02812394|Levodopa|levodopa|mesh-list
101671117|NCT02812394|Carbidopa|carbidopa|mesh-list
101671118|NCT02812394|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101671119|NCT02812394|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101671120|NCT02812394|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101671121|NCT02812394|Dopamine Agents|dopamine agents|mesh-ancestor
101671122|NCT02812394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101671123|NCT02812394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671124|NCT02812394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671125|NCT02812394|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101671127|NCT02812394|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101671128|NCT02812394|Immunologic Factors|immunologic factors|mesh-ancestor
101671129|NCT02812394|Dopamine Agonists|dopamine agonists|mesh-ancestor
101671130|NCT00930475|Carboplatin|carboplatin|mesh-list
101671131|NCT00930475|Everolimus|everolimus|mesh-list
101671132|NCT00930475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101671133|NCT00930475|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101671134|NCT00930475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101671135|NCT00930475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101671136|NCT00930475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671137|NCT00930475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101671138|NCT00930475|Immunologic Factors|immunologic factors|mesh-ancestor
101671139|NCT00930475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671140|NCT05623592|Methotrexate|methotrexate|mesh-list
101671141|NCT05623592|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101671142|NCT05623592|Abortifacient Agents|abortifacient agents|mesh-ancestor
101671143|NCT05623592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101671144|NCT05623592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671145|NCT05623592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101671146|NCT05623592|Antimetabolites|antimetabolites|mesh-ancestor
101671147|NCT05623592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671148|NCT05623592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101671149|NCT05623592|Dermatologic Agents|dermatologic agents|mesh-ancestor
101671150|NCT05623592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101827460|NCT05680558|Methoxsalen|methoxsalen|mesh-list
101671151|NCT05623592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101671152|NCT05623592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101671153|NCT05623592|Immunologic Factors|immunologic factors|mesh-ancestor
101671154|NCT05623592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101671155|NCT05623592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101671156|NCT02728518|Amikacin|amikacin|mesh-list
101671157|NCT02728518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101671158|NCT02728518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101671159|NCT00634400|Candesartan|candesartan|mesh-list
101671160|NCT00634400|Candesartan cilexetil|candesartan cilexetil|mesh-list
101671161|NCT00634400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101671162|NCT00634400|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101671163|NCT00634400|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101671164|NCT00634400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671165|NCT04262375|Durvalumab|durvalumab|mesh-list
101671166|NCT04262375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101671167|NCT04262375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101671168|NCT00936793|Ritonavir|ritonavir|mesh-list
101671169|NCT00936793|Darunavir|darunavir|mesh-list
101671170|NCT00936793|Beclomethasone|beclomethasone|mesh-list
101671171|NCT00936793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101671172|NCT00936793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101671173|NCT00936793|Protease Inhibitors|protease inhibitors|mesh-ancestor
101671174|NCT00936793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101671175|NCT00936793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671176|NCT00936793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101671177|NCT00936793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101671178|NCT00936793|Antiviral Agents|antiviral agents|mesh-ancestor
101671179|NCT00936793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101671180|NCT00936793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101671181|NCT00936793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101671182|NCT00936793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101671183|NCT00936793|Glucocorticoids|glucocorticoids|mesh-ancestor
101671184|NCT00936793|Hormones|hormones|mesh-ancestor
101671185|NCT00936793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101671186|NCT00936793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671187|NCT00936793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101671188|NCT00936793|Respiratory System Agents|respiratory system agents|mesh-ancestor
101671190|NCT02805452|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101671191|NCT02805452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101671192|NCT02805452|Cholinergic Agents|cholinergic agents|mesh-ancestor
101671193|NCT02805452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101671194|NCT02805452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328415|NCT00000170|Atropine|atropine|mesh-list
101671195|NCT02805452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671196|NCT02805452|Urological Agents|urological agents|mesh-ancestor
101671197|NCT00937027|Aminopterin|aminopterin|mesh-list
101671198|NCT00937027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101671199|NCT00937027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101671200|NCT00937027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671201|NCT02738502|Ritonavir|ritonavir|mesh-list
101671202|NCT02738502|Darunavir|darunavir|mesh-list
101671203|NCT02738502|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101671204|NCT02738502|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101671205|NCT02738502|Protease Inhibitors|protease inhibitors|mesh-ancestor
101671206|NCT02738502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101671207|NCT02738502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671208|NCT02738502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101671209|NCT02738502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101671210|NCT02738502|Antiviral Agents|antiviral agents|mesh-ancestor
101671211|NCT02738502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101671212|NCT02738502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101671213|NCT02738502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101671214|NCT04261907|Ritonavir|ritonavir|mesh-list
101671215|NCT04261907|Lopinavir|lopinavir|mesh-list
101827481|NCT05663242|Propofol|propofol|mesh-list
101671216|NCT04261907|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101671217|NCT04261907|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101671218|NCT04261907|Protease Inhibitors|protease inhibitors|mesh-ancestor
101671219|NCT04261907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101671220|NCT04261907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671221|NCT04261907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101671222|NCT04261907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101671223|NCT04261907|Antiviral Agents|antiviral agents|mesh-ancestor
101671224|NCT04261907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101671225|NCT04261907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101671226|NCT04261907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101671227|NCT00930709|Botulinum Toxins|botulinum toxins|mesh-list
101671228|NCT00930709|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101671229|NCT00930709|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101671230|NCT00930709|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101671231|NCT00930709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101671232|NCT00930709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671233|NCT00930709|Cholinergic Agents|cholinergic agents|mesh-ancestor
101671234|NCT00930709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101671235|NCT00930709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671236|NCT00930709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101671237|NCT00930709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101671238|NCT02738346|Carboplatin|carboplatin|mesh-list
101671239|NCT02738346|Etoposide|etoposide|mesh-list
101671240|NCT02738346|Topotecan|topotecan|mesh-list
101671241|NCT02738346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101671242|NCT02738346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101671243|NCT02738346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101671244|NCT02738346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101671245|NCT02738346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101671246|NCT02738346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671247|NCT02738346|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101671248|NCT00932165|Exemestane|exemestane|mesh-list
101671249|NCT00932165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101671250|NCT00932165|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101671251|NCT00932165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101671252|NCT00932165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101671253|NCT00932165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671254|NCT00932165|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101671255|NCT00932165|Hormone Antagonists|hormone antagonists|mesh-ancestor
101451723|NCT00208065|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101671256|NCT00932165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101671257|NCT00932165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671258|NCT00937183|Vaccines|vaccines|mesh-list
101671259|NCT00937183|Immunologic Factors|immunologic factors|mesh-ancestor
101671260|NCT00937183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671261|NCT00937261|Risperidone|risperidone|mesh-list
101671262|NCT00937261|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101671263|NCT00937261|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101671264|NCT00937261|Serotonin Agents|serotonin agents|mesh-ancestor
101671265|NCT00937261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101671266|NCT00937261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671267|NCT00937261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328494|NCT00000173|Nootropic Agents|nootropic agents|mesh-ancestor
101671268|NCT00937261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101671269|NCT00937261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101671270|NCT00937261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101671271|NCT00937261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101671272|NCT00937261|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101671273|NCT00937261|Dopamine Agents|dopamine agents|mesh-ancestor
101671274|NCT00937261|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101671275|NCT00937261|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101671276|NCT05906433|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101671277|NCT05906433|Triamcinolone|triamcinolone|mesh-list
101827483|NCT05663242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101827484|NCT05663242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671278|NCT05906433|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101671279|NCT05906433|Bupivacaine|bupivacaine|mesh-list
101671280|NCT05906433|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101671281|NCT05906433|Anesthetics, Local|anesthetics, local|mesh-ancestor
101671282|NCT05906433|Anesthetics|anesthetics|mesh-ancestor
101671283|NCT05906433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101671284|NCT05906433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671285|NCT05906433|Sensory System Agents|sensory system agents|mesh-ancestor
101671286|NCT05906433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101671287|NCT05906433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101671288|NCT05906433|Glucocorticoids|glucocorticoids|mesh-ancestor
101671290|NCT05906433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101671291|NCT05906433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101671292|NCT05906433|Immunologic Factors|immunologic factors|mesh-ancestor
101671293|NCT05906433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101671294|NCT05906433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671296|NCT05906225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101671297|NCT05906225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671298|NCT05906199|Aspirin|aspirin|mesh-list
101671299|NCT05906199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101671300|NCT05906199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101671301|NCT05906199|Analgesics|analgesics|mesh-ancestor
101671302|NCT05906199|Sensory System Agents|sensory system agents|mesh-ancestor
101671303|NCT05906199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101671304|NCT05906199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671305|NCT05906199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101671306|NCT05906199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101671307|NCT05906199|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101671308|NCT05906199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101671309|NCT05906199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671310|NCT05906199|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101671311|NCT05906199|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101671312|NCT05906199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101671313|NCT05906199|Antipyretics|antipyretics|mesh-ancestor
101671314|NCT05905965|Empagliflozin|empagliflozin|mesh-list
101671315|NCT05905965|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101671316|NCT05905965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671317|NCT05905965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101671318|NCT05905965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671319|NCT05905913|Meropenem|meropenem|mesh-list
101671320|NCT05905913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101671321|NCT05905913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101671322|NCT05905887|Paclitaxel|paclitaxel|mesh-list
101671323|NCT05905887|Apatinib|apatinib|mesh-list
101671324|NCT05905887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101671325|NCT05905887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101671326|NCT05905887|Tubulin Modulators|tubulin modulators|mesh-ancestor
101671327|NCT05905887|Antimitotic Agents|antimitotic agents|mesh-ancestor
101827491|NCT05661851|Lubricant Eye Drops|lubricant eye drops|mesh-list
101827493|NCT05656521|Dexamethasone|dexamethasone|mesh-list
101671328|NCT05905887|Mitosis Modulators|mitosis modulators|mesh-ancestor
101671329|NCT05905887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671330|NCT05905887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101671331|NCT05905887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101671333|NCT05905757|Dexmedetomidine|dexmedetomidine|mesh-list
101671334|NCT05905757|Bupivacaine|bupivacaine|mesh-list
101671335|NCT05905757|Anesthetics, Local|anesthetics, local|mesh-ancestor
101671336|NCT05905757|Anesthetics|anesthetics|mesh-ancestor
101671337|NCT05905757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101671338|NCT05905757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671339|NCT05905757|Sensory System Agents|sensory system agents|mesh-ancestor
101671340|NCT05905757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101671341|NCT05905757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101671342|NCT05905757|Narcotics|narcotics|mesh-ancestor
101671343|NCT05905757|Analgesics|analgesics|mesh-ancestor
101671344|NCT05905757|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101671345|NCT05905757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101671346|NCT05905757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101671347|NCT05905757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101671348|NCT05905757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101671349|NCT05905757|Adrenergic Agents|adrenergic agents|mesh-ancestor
101671350|NCT05905757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101671351|NCT05905757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671352|NCT05905653|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101671353|NCT05905653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101671354|NCT05905484|Moxifloxacin|moxifloxacin|mesh-list
101671355|NCT05905484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101671356|NCT05905484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101671357|NCT05905484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101671358|NCT05905484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101671359|NCT05905484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101671360|NCT05905484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671361|NCT05905484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101671362|NCT05905367|Fentanyl|fentanyl|mesh-list
101671363|NCT05905367|Morphine|morphine|mesh-list
101671364|NCT05905367|Methadone|methadone|mesh-list
101671365|NCT05905367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101671366|NCT05905367|Narcotics|narcotics|mesh-ancestor
101671367|NCT05905367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101671368|NCT05905367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671369|NCT05905367|Analgesics|analgesics|mesh-ancestor
101671370|NCT05905367|Sensory System Agents|sensory system agents|mesh-ancestor
101671371|NCT05905367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101671372|NCT05905367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101671373|NCT05905367|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101671374|NCT05905367|Anesthetics, General|anesthetics, general|mesh-ancestor
101671375|NCT05905367|Anesthetics|anesthetics|mesh-ancestor
101671376|NCT05905367|Antitussive Agents|antitussive agents|mesh-ancestor
101671377|NCT05905367|Respiratory System Agents|respiratory system agents|mesh-ancestor
101671378|NCT05905315|Paclitaxel|paclitaxel|mesh-list
101671379|NCT05905315|Carboplatin|carboplatin|mesh-list
101671380|NCT05905315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101671381|NCT05905315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101671382|NCT05905315|Tubulin Modulators|tubulin modulators|mesh-ancestor
101671383|NCT05905315|Antimitotic Agents|antimitotic agents|mesh-ancestor
101671384|NCT05905315|Mitosis Modulators|mitosis modulators|mesh-ancestor
101671385|NCT05905315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671386|NCT05905185|Vitamin E|vitamin e|mesh-list
101671387|NCT05905185|Tocopherols|tocopherols|mesh-list
101671388|NCT05905185|Tocotrienols|tocotrienols|mesh-list
101671389|NCT05905185|Vitamins|vitamins|mesh-ancestor
101671390|NCT05905185|Micronutrients|micronutrients|mesh-ancestor
101671391|NCT05905185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671392|NCT05905185|Antioxidants|antioxidants|mesh-ancestor
101671393|NCT05905185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671394|NCT05905185|Protective Agents|protective agents|mesh-ancestor
101671395|NCT05905055|Cefepime|cefepime|mesh-list
101671396|NCT05905055|Aztreonam|aztreonam|mesh-list
101671397|NCT05905055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101671398|NCT05905055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101671399|NCT05904912|Bupivacaine|bupivacaine|mesh-list
101671400|NCT05904912|Anesthetics, Local|anesthetics, local|mesh-ancestor
101671401|NCT05904912|Anesthetics|anesthetics|mesh-ancestor
101671402|NCT05904912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101671403|NCT05904912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671404|NCT05904912|Sensory System Agents|sensory system agents|mesh-ancestor
101671405|NCT05904912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101671406|NCT05898841|Tenofovir|tenofovir|mesh-list
101671407|NCT05898841|Emtricitabine|emtricitabine|mesh-list
101671408|NCT05898841|Dolutegravir|dolutegravir|mesh-list
101671409|NCT05898841|Rilpivirine|rilpivirine|mesh-list
101671410|NCT05898841|Antiviral Agents|antiviral agents|mesh-ancestor
101671411|NCT05898841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101671412|NCT05898841|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101671413|NCT05898841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101671414|NCT05898841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101671415|NCT05898841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671416|NCT05898841|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101671417|NCT05898841|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101671418|NCT05898841|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101671419|NCT05898841|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101671420|NCT05893069|Oxandrolone|oxandrolone|mesh-list
101671421|NCT05893069|Androgens|androgens|mesh-ancestor
101671422|NCT05893069|Hormones|hormones|mesh-ancestor
101671423|NCT05893069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101671424|NCT05893069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671425|NCT05893069|Anabolic Agents|anabolic agents|mesh-ancestor
101671426|NCT05881811|Probenecid|probenecid|mesh-list
101671427|NCT05881811|Cimetidine|cimetidine|mesh-list
101671428|NCT05881811|Uricosuric Agents|uricosuric agents|mesh-ancestor
101671429|NCT05881811|Gout Suppressants|gout suppressants|mesh-ancestor
101671430|NCT05881811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101671431|NCT05881811|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101671432|NCT05881811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101671433|NCT05881811|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101671434|NCT05881811|Histamine Antagonists|histamine antagonists|mesh-ancestor
101671435|NCT05881811|Histamine Agents|histamine agents|mesh-ancestor
101671436|NCT05881811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101671437|NCT05881811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671438|NCT05881811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671439|NCT05881811|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101671440|NCT05881811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101671441|NCT05881811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101671442|NCT05867654|Amoxicillin|amoxicillin|mesh-list
101671443|NCT05867654|Levofloxacin|levofloxacin|mesh-list
101671444|NCT05867654|Clindamycin|clindamycin|mesh-list
101671445|NCT05867654|Clindamycin palmitate|clindamycin palmitate|mesh-list
101671446|NCT05867654|Clindamycin phosphate|clindamycin phosphate|mesh-list
101671447|NCT05867654|Clavulanic Acid|clavulanic acid|mesh-list
101671448|NCT05867654|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101671449|NCT05867654|Ampicillin|ampicillin|mesh-list
101671450|NCT05867654|Sulbactam|sulbactam|mesh-list
101671451|NCT05867654|Sultamicillin|sultamicillin|mesh-list
101671452|NCT05867654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101671453|NCT05867654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101671454|NCT05867654|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101671455|NCT05867654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101671456|NCT05867654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101671457|NCT05867654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101827524|NCT05644041|Gemcitabine|gemcitabine|mesh-list
101671458|NCT05867654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671459|NCT05867654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101313392|NCT00000136|Ganciclovir|ganciclovir|mesh-list
101827532|NCT05628623|Cytarabine|cytarabine|mesh-list
101671460|NCT05867654|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101671461|NCT05867654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101671462|NCT05867654|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101671463|NCT05867654|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101671465|NCT05843565|Trace Elements|trace elements|mesh-ancestor
101671466|NCT05843565|Micronutrients|micronutrients|mesh-ancestor
101671467|NCT05843565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671468|NCT05838703|Bromides|bromides|mesh-list
101671469|NCT05838703|Tiotropium Bromide|tiotropium bromide|mesh-list
101671470|NCT05838703|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101671471|NCT05838703|Autonomic Agents|autonomic agents|mesh-ancestor
101671472|NCT05838703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101671473|NCT05838703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671474|NCT05838703|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101671475|NCT05838703|Respiratory System Agents|respiratory system agents|mesh-ancestor
101671476|NCT05838703|Parasympatholytics|parasympatholytics|mesh-ancestor
101671477|NCT05838703|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101671478|NCT05838703|Cholinergic Agents|cholinergic agents|mesh-ancestor
101671479|NCT05838703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101671480|NCT05838703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671481|NCT05838703|Anticonvulsants|anticonvulsants|mesh-ancestor
101671482|NCT05831683|Anesthetics|anesthetics|mesh-list
101671483|NCT05831683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101671484|NCT05831683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671486|NCT05825924|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101671487|NCT05825924|Autonomic Agents|autonomic agents|mesh-ancestor
101671488|NCT05825924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101671489|NCT05825924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671490|NCT05825924|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101671491|NCT05825924|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101671492|NCT05825924|Cholinergic Agents|cholinergic agents|mesh-ancestor
101671493|NCT05825924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101671494|NCT05825924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671495|NCT05807048|Daratumumab|daratumumab|mesh-list
101671496|NCT05807048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101671497|NCT05789992|Remifentanil|remifentanil|mesh-list
101671498|NCT05789992|Propofol|propofol|mesh-list
101671499|NCT05789992|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101671500|NCT05789992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101671501|NCT05789992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671502|NCT05789992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101671503|NCT05789992|Anesthetics, General|anesthetics, general|mesh-ancestor
101671504|NCT05789992|Anesthetics|anesthetics|mesh-ancestor
101671505|NCT05789992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101671506|NCT05789992|Narcotics|narcotics|mesh-ancestor
101671507|NCT05789992|Analgesics|analgesics|mesh-ancestor
101671508|NCT05789992|Sensory System Agents|sensory system agents|mesh-ancestor
101671509|NCT05789992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101671510|NCT05765266|Methylprednisolone|methylprednisolone|mesh-list
101671511|NCT05765266|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101671512|NCT05765266|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101671513|NCT05765266|Prednisolone|prednisolone|mesh-list
101671514|NCT05765266|Prednisolone acetate|prednisolone acetate|mesh-list
101671515|NCT05765266|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101671516|NCT05765266|Prednisolone phosphate|prednisolone phosphate|mesh-list
101671517|NCT05765266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101671518|NCT05765266|Antiemetics|antiemetics|mesh-ancestor
101671519|NCT05765266|Autonomic Agents|autonomic agents|mesh-ancestor
101671520|NCT05765266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101671521|NCT05765266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671522|NCT05765266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101671523|NCT05765266|Glucocorticoids|glucocorticoids|mesh-ancestor
101671524|NCT05765266|Hormones|hormones|mesh-ancestor
101671525|NCT05765266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101671526|NCT05765266|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101671527|NCT05765266|Protective Agents|protective agents|mesh-ancestor
101671528|NCT05765266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101671529|NCT05765266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101671530|NCT05764993|Immunoglobulins|immunoglobulins|mesh-list
101671531|NCT05764993|gamma-Globulins|gamma-globulins|mesh-list
101671532|NCT05764993|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101671533|NCT05764993|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101671534|NCT05764993|Immunologic Factors|immunologic factors|mesh-ancestor
101671535|NCT05764993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671536|NCT05743192|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101671537|NCT05743192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101671538|NCT05727176|Futibatinib|futibatinib|mesh-list
101671539|NCT05727176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101671540|NCT05720325|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101671541|NCT05720325|Immunologic Factors|immunologic factors|mesh-ancestor
101671542|NCT05720325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671543|NCT05701501|Pantothenic Acid|pantothenic acid|mesh-list
101671544|NCT05701501|Vitamins|vitamins|mesh-ancestor
101671545|NCT05701501|Micronutrients|micronutrients|mesh-ancestor
101671546|NCT05701501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671547|NCT05701501|Vitamin B Complex|vitamin b complex|mesh-ancestor
101671548|NCT05700812|Levonorgestrel|levonorgestrel|mesh-list
101671549|NCT05700812|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101671550|NCT05700812|Contraceptive Agents|contraceptive agents|mesh-ancestor
101671551|NCT05700812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101671552|NCT05700812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671553|NCT05700812|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101671554|NCT05700812|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101671555|NCT05700812|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101671556|NCT05681273|Empagliflozin|empagliflozin|mesh-list
101671557|NCT05681273|Valsartan|valsartan|mesh-list
101671558|NCT05681273|Atorvastatin|atorvastatin|mesh-list
101671559|NCT05681273|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101671560|NCT05681273|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101671561|NCT05681273|Antimetabolites|antimetabolites|mesh-ancestor
101671562|NCT05681273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671563|NCT05681273|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101671564|NCT05681273|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101671565|NCT05681273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101671566|NCT05681273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101671567|NCT05681273|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101671568|NCT05681273|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101671569|NCT05681273|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101671570|NCT05681273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101671571|NCT05681273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671572|NCT05656742|Vitamin D|vitamin d|mesh-list
101671573|NCT05656742|Vitamins|vitamins|mesh-ancestor
101671575|NCT05656742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671576|NCT05656742|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101671601|NCT05549505|Anastrozole|anastrozole|mesh-list
101671602|NCT05549505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101671603|NCT05549505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101671604|NCT05549505|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101827549|NCT05616923|Trametinib|trametinib|mesh-list
101671605|NCT05549505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101671606|NCT05549505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101671607|NCT05549505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671608|NCT05549505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101671609|NCT05549505|Hormone Antagonists|hormone antagonists|mesh-ancestor
101671610|NCT05549505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101671611|NCT05549505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671613|NCT05538767|Emodepside|emodepside|mesh-list
101671614|NCT05538767|Anthelmintics|anthelmintics|mesh-ancestor
101671615|NCT05538767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101671616|NCT05538767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101671617|NCT05538767|Anticestodal Agents|anticestodal agents|mesh-ancestor
101671618|NCT05538767|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101671619|NCT05538767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101671620|NCT05538767|Tubulin Modulators|tubulin modulators|mesh-ancestor
101671621|NCT05538767|Antimitotic Agents|antimitotic agents|mesh-ancestor
101671622|NCT05538767|Mitosis Modulators|mitosis modulators|mesh-ancestor
101671623|NCT05538767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671624|NCT05538767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101671625|NCT05524168|Gemcitabine|gemcitabine|mesh-list
101671626|NCT05524168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101671627|NCT05524168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101671628|NCT05524168|Antimetabolites|antimetabolites|mesh-ancestor
101671629|NCT05524168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671630|NCT05488847|Acetaminophen|acetaminophen|mesh-list
101671631|NCT05488847|Dexamethasone|dexamethasone|mesh-list
101671632|NCT05488847|Ibuprofen|ibuprofen|mesh-list
101671633|NCT05488847|Celecoxib|celecoxib|mesh-list
101671634|NCT05488847|Ketorolac|ketorolac|mesh-list
101671635|NCT05488847|Pregabalin|pregabalin|mesh-list
101671636|NCT05488847|Epinephrine|epinephrine|mesh-list
101671637|NCT05488847|Oxycodone|oxycodone|mesh-list
101671638|NCT05488847|Tramadol|tramadol|mesh-list
101671639|NCT05488847|Tizanidine|tizanidine|mesh-list
101671640|NCT05488847|Magnesium Oxide|magnesium oxide|mesh-list
101671641|NCT05488847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101671642|NCT05488847|Antiemetics|antiemetics|mesh-ancestor
101671643|NCT05488847|Autonomic Agents|autonomic agents|mesh-ancestor
101671644|NCT05488847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101671645|NCT05488847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671646|NCT05488847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101671647|NCT05488847|Glucocorticoids|glucocorticoids|mesh-ancestor
101671648|NCT05488847|Hormones|hormones|mesh-ancestor
101671649|NCT05488847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101671650|NCT05488847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101671651|NCT05488847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101671652|NCT05488847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101671653|NCT05488847|Analgesics|analgesics|mesh-ancestor
101671654|NCT05488847|Sensory System Agents|sensory system agents|mesh-ancestor
101671655|NCT05488847|Antipyretics|antipyretics|mesh-ancestor
101671656|NCT05488847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101671657|NCT05488847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101671658|NCT05488847|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101671659|NCT05488847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101671660|NCT05488847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671661|NCT05488847|Anticonvulsants|anticonvulsants|mesh-ancestor
101671662|NCT05488847|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101671663|NCT05488847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101671664|NCT05488847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101671665|NCT05488847|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101671666|NCT05488847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101671667|NCT05488847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101671668|NCT05488847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101671669|NCT05488847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101671670|NCT05488847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101671671|NCT05488847|Adrenergic Agents|adrenergic agents|mesh-ancestor
101671672|NCT05488847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101671673|NCT05488847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101671674|NCT05488847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101671675|NCT05488847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101671676|NCT05488847|Respiratory System Agents|respiratory system agents|mesh-ancestor
101671678|NCT05488847|Sympathomimetics|sympathomimetics|mesh-ancestor
101671679|NCT05488847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101671680|NCT05488847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101671681|NCT05488847|Narcotics|narcotics|mesh-ancestor
101671682|NCT05488847|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101671683|NCT05488847|Antacids|antacids|mesh-ancestor
101671684|NCT05488847|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101671685|NCT05488847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101671686|NCT05488847|Parasympatholytics|parasympatholytics|mesh-ancestor
101671687|NCT05488847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101671688|NCT05487599|Sirolimus|sirolimus|mesh-list
101671689|NCT05487599|Prednisone|prednisone|mesh-list
101671690|NCT05487599|Methylprednisolone|methylprednisolone|mesh-list
101671691|NCT05487599|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101671692|NCT05487599|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101671693|NCT05487599|Prednisolone|prednisolone|mesh-list
101671694|NCT05487599|Prednisolone acetate|prednisolone acetate|mesh-list
101671695|NCT05487599|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101671696|NCT05487599|Prednisolone phosphate|prednisolone phosphate|mesh-list
101671697|NCT05487599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101671698|NCT05487599|Glucocorticoids|glucocorticoids|mesh-ancestor
101671699|NCT05487599|Hormones|hormones|mesh-ancestor
101671700|NCT05487599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101671701|NCT05487599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671702|NCT05487599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101671703|NCT05487599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101671704|NCT05487599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101671705|NCT05487599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101671706|NCT05487599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101671707|NCT05487599|Antifungal Agents|antifungal agents|mesh-ancestor
101671708|NCT05487599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101671709|NCT05487599|Immunologic Factors|immunologic factors|mesh-ancestor
101671710|NCT05487599|Antiemetics|antiemetics|mesh-ancestor
101671711|NCT05487599|Autonomic Agents|autonomic agents|mesh-ancestor
101671712|NCT05487599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101671713|NCT05487599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101671714|NCT05487599|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101671715|NCT05487599|Protective Agents|protective agents|mesh-ancestor
101671716|NCT05464420|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101671717|NCT05464420|Immunologic Factors|immunologic factors|mesh-ancestor
101671718|NCT05464420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671719|NCT05431582|Bevacizumab|bevacizumab|mesh-list
101671720|NCT05431582|Pembrolizumab|pembrolizumab|mesh-list
101671721|NCT05431582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101671722|NCT05431582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101671723|NCT05431582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101671724|NCT05431582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101671725|NCT05431582|Growth Substances|growth substances|mesh-ancestor
101671726|NCT05431582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671727|NCT05431582|Growth Inhibitors|growth inhibitors|mesh-ancestor
101671728|NCT05431582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101671729|NCT05431582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671730|NCT05418556|Aspirin|aspirin|mesh-list
101671731|NCT05418556|Clopidogrel|clopidogrel|mesh-list
101827582|NCT05601336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101827583|NCT05601336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671732|NCT05418556|Ticagrelor|ticagrelor|mesh-list
101671733|NCT05418556|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101671734|NCT05418556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101671735|NCT05418556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101671736|NCT05418556|Analgesics|analgesics|mesh-ancestor
101671737|NCT05418556|Sensory System Agents|sensory system agents|mesh-ancestor
101671738|NCT05418556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101671739|NCT05418556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671740|NCT05418556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101671741|NCT05418556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101671742|NCT05418556|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101671743|NCT05418556|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101671744|NCT05418556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671745|NCT05418556|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101671746|NCT05418556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101671747|NCT05418556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101671748|NCT05418556|Antipyretics|antipyretics|mesh-ancestor
101671749|NCT05418556|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101671750|NCT05418556|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101671751|NCT05418556|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101671752|NCT05418556|Purinergic Agents|purinergic agents|mesh-ancestor
101671753|NCT05418556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101671754|NCT05412030|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101671755|NCT05412030|Immunologic Factors|immunologic factors|mesh-ancestor
101671756|NCT05412030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671757|NCT05384756|Sirolimus|sirolimus|mesh-list
101671758|NCT05384756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101671759|NCT05384756|Alemtuzumab|alemtuzumab|mesh-list
101671760|NCT05384756|Antibodies|antibodies|mesh-list
101671761|NCT05384756|Immunoglobulins|immunoglobulins|mesh-list
101671762|NCT05384756|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101671763|NCT05384756|Immunologic Factors|immunologic factors|mesh-ancestor
101671764|NCT05384756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671765|NCT05384756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101671766|NCT05384756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101671767|NCT05384756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101671768|NCT05384756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101671769|NCT05384756|Antifungal Agents|antifungal agents|mesh-ancestor
101671770|NCT05384756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101671771|NCT05364866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
101671772|NCT05331027|Sevoflurane|sevoflurane|mesh-list
101671773|NCT05331027|Desflurane|desflurane|mesh-list
101671774|NCT05331027|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101671775|NCT05331027|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101671776|NCT05331027|Anesthetics, General|anesthetics, general|mesh-ancestor
101671777|NCT05331027|Anesthetics|anesthetics|mesh-ancestor
101671778|NCT05331027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101671779|NCT05331027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671780|NCT05299242|Adalimumab|adalimumab|mesh-list
101671781|NCT05299242|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101671782|NCT05299242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101671783|NCT05299242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101671784|NCT05299125|Pemetrexed|pemetrexed|mesh-list
101671785|NCT05299125|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
101671786|NCT05299125|Lazertinib|lazertinib|mesh-list
101671787|NCT05299125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101671788|NCT05299125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101671789|NCT05299125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671790|NCT05299125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101671791|NCT05299125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101671792|NCT05299125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101671793|NCT05299125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101671794|NCT05290727|Hyaluronic Acid|hyaluronic acid|mesh-list
101671795|NCT05290727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101671796|NCT05290727|Immunologic Factors|immunologic factors|mesh-ancestor
101671797|NCT05290727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671798|NCT05290727|Viscosupplements|viscosupplements|mesh-ancestor
101671808|NCT05222984|Venetoclax|venetoclax|mesh-list
101671809|NCT05222984|Navitoclax|navitoclax|mesh-list
101671810|NCT05222984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101671811|NCT05222984|Antimetabolites|antimetabolites|mesh-ancestor
101671812|NCT05222984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671813|NCT05222984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101671814|NCT05222984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101671815|NCT05177848|Nicotine|nicotine|mesh-list
101671816|NCT05177848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101671817|NCT05177848|Autonomic Agents|autonomic agents|mesh-ancestor
101671819|NCT05177848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671820|NCT05177848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101671821|NCT05177848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101671822|NCT05177848|Cholinergic Agents|cholinergic agents|mesh-ancestor
101671823|NCT05177848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101671824|NCT05177848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671825|NCT05169008|Vaccines|vaccines|mesh-list
101671826|NCT05169008|Immunologic Factors|immunologic factors|mesh-ancestor
101671827|NCT05169008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671828|NCT05159453|Insulin|insulin|mesh-list
101671829|NCT05159453|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101671831|NCT05159453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671832|NCT05096195|Calcium, Dietary|calcium, dietary|mesh-list
101671833|NCT05096195|Vitamin D|vitamin d|mesh-list
101671834|NCT05096195|Denosumab|denosumab|mesh-list
101671835|NCT05096195|Calcium|calcium|mesh-list
101671836|NCT05096195|Vitamins|vitamins|mesh-ancestor
101671837|NCT05096195|Micronutrients|micronutrients|mesh-ancestor
101671838|NCT05096195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671839|NCT05096195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101671840|NCT05096195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101671841|NCT05067933|Vaccines|vaccines|mesh-list
101671842|NCT05067933|Immunologic Factors|immunologic factors|mesh-ancestor
101671843|NCT05067933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671844|NCT05059860|Insulin|insulin|mesh-list
101671845|NCT05059860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101671846|NCT05059860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671847|NCT05022524|Acetic Acid|acetic acid|mesh-list
101671848|NCT05022524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101671849|NCT05022524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101671850|NCT04852068|Vaccines|vaccines|mesh-list
101671851|NCT04852068|Immunologic Factors|immunologic factors|mesh-ancestor
101671852|NCT04852068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671853|NCT04806100|Carbon Fiber|carbon fiber|mesh-list
101671854|NCT04806100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101671855|NCT04806100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101671864|NCT04761822|Vaccines|vaccines|mesh-list
101671865|NCT04761822|Immunologic Factors|immunologic factors|mesh-ancestor
101671866|NCT04761822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671868|NCT04716725|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101671869|NCT04716725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671870|NCT04707235|Hydroxyurea|hydroxyurea|mesh-list
101409566|NCT00349492|Cisplatin|cisplatin|mesh-list
101671871|NCT04707235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101671872|NCT04707235|Antisickling Agents|antisickling agents|mesh-ancestor
101671873|NCT04707235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101671874|NCT04707235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671875|NCT04707235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101671876|NCT04668157|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
101671877|NCT04668157|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101671878|NCT04668157|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101671879|NCT04668157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671880|NCT04639466|Vaccines|vaccines|mesh-list
101671881|NCT04639466|Immunologic Factors|immunologic factors|mesh-ancestor
101671882|NCT04639466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671883|NCT04548999|Methylprednisolone|methylprednisolone|mesh-list
101671884|NCT04548999|Ocrelizumab|ocrelizumab|mesh-list
101671885|NCT04548999|Histamine Antagonists|histamine antagonists|mesh-list
101671886|NCT04548999|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
101671887|NCT04548999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101671888|NCT04548999|Antiemetics|antiemetics|mesh-ancestor
101671889|NCT04548999|Autonomic Agents|autonomic agents|mesh-ancestor
101671890|NCT04548999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101671891|NCT04548999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671892|NCT04548999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101671893|NCT04548999|Glucocorticoids|glucocorticoids|mesh-ancestor
101671894|NCT04548999|Hormones|hormones|mesh-ancestor
101671895|NCT04548999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101671896|NCT04548999|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101671897|NCT04548999|Protective Agents|protective agents|mesh-ancestor
101671898|NCT04548999|Immunologic Factors|immunologic factors|mesh-ancestor
101671899|NCT04548999|Histamine Agents|histamine agents|mesh-ancestor
101671900|NCT04548999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101671901|NCT04548999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671902|NCT04544436|Methylprednisolone|methylprednisolone|mesh-list
101671903|NCT04544436|Ocrelizumab|ocrelizumab|mesh-list
101671904|NCT04544436|Histamine Antagonists|histamine antagonists|mesh-list
101671905|NCT04544436|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
101671907|NCT04544436|Antiemetics|antiemetics|mesh-ancestor
101671908|NCT04544436|Autonomic Agents|autonomic agents|mesh-ancestor
101671909|NCT04544436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101671910|NCT04544436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671911|NCT04544436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101671912|NCT04544436|Glucocorticoids|glucocorticoids|mesh-ancestor
101671913|NCT04544436|Hormones|hormones|mesh-ancestor
101671914|NCT04544436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101671915|NCT04544436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101671916|NCT04544436|Protective Agents|protective agents|mesh-ancestor
101671917|NCT04544436|Immunologic Factors|immunologic factors|mesh-ancestor
101671918|NCT04544436|Histamine Agents|histamine agents|mesh-ancestor
101671919|NCT04544436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101671920|NCT04544436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671921|NCT04537156|Vaccines|vaccines|mesh-list
101671922|NCT04537156|Immunologic Factors|immunologic factors|mesh-ancestor
101671923|NCT04537156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671924|NCT04536298|Vitamin D|vitamin d|mesh-list
101671925|NCT04536298|Ergocalciferols|ergocalciferols|mesh-list
101671926|NCT04536298|Cholecalciferol|cholecalciferol|mesh-list
101671927|NCT04536298|Vitamins|vitamins|mesh-list
101671928|NCT04536298|Micronutrients|micronutrients|mesh-ancestor
101671929|NCT04536298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671930|NCT04536298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101671931|NCT04536298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101671932|NCT04465318|Nicotine|nicotine|mesh-list
101827611|NCT05557110|Blinatumomab|blinatumomab|mesh-list
101671933|NCT04465318|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101671934|NCT04465318|Autonomic Agents|autonomic agents|mesh-ancestor
101671935|NCT04465318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101671936|NCT04465318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671937|NCT04465318|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101671938|NCT04465318|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101409573|NCT00349531|Pramipexole|pramipexole|mesh-list
101671939|NCT04465318|Cholinergic Agents|cholinergic agents|mesh-ancestor
101671940|NCT04465318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101671941|NCT04465318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671942|NCT04462523|Prednisolone|prednisolone|mesh-list
101671943|NCT04462523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101671944|NCT04462523|Glucocorticoids|glucocorticoids|mesh-ancestor
101671946|NCT04462523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101671947|NCT04462523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671948|NCT04462523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101671949|NCT04462523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101671950|NCT04437108|Solifenacin Succinate|solifenacin succinate|mesh-list
101671951|NCT04437108|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101671952|NCT04437108|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101671953|NCT04437108|Cholinergic Agents|cholinergic agents|mesh-ancestor
101671954|NCT04437108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101671955|NCT04437108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671956|NCT04437108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671957|NCT04437108|Urological Agents|urological agents|mesh-ancestor
101671959|NCT04395079|Ipilimumab|ipilimumab|mesh-list
101671960|NCT04395079|Tremelimumab|tremelimumab|mesh-list
101671961|NCT04395079|Immunoglobulins|immunoglobulins|mesh-list
101671962|NCT04395079|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101671963|NCT04395079|Immunoglobulin G|immunoglobulin g|mesh-list
101671964|NCT04395079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101671965|NCT04395079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101671966|NCT04395079|Immunologic Factors|immunologic factors|mesh-ancestor
101671967|NCT04395079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671968|NCT04395079|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101671969|NCT04395079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671970|NCT04391309|Remdesivir|remdesivir|mesh-list
101671971|NCT04391309|Antimetabolites|antimetabolites|mesh-ancestor
101671972|NCT04391309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671973|NCT04391309|Antiviral Agents|antiviral agents|mesh-ancestor
101671974|NCT04391309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101671975|NCT04381897|Acetylcysteine|acetylcysteine|mesh-list
101671976|NCT04381897|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101671977|NCT04381897|Antiviral Agents|antiviral agents|mesh-ancestor
101671978|NCT04381897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101671979|NCT04381897|Expectorants|expectorants|mesh-ancestor
101671980|NCT04381897|Respiratory System Agents|respiratory system agents|mesh-ancestor
101671981|NCT04381897|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101671982|NCT04381897|Antioxidants|antioxidants|mesh-ancestor
101671983|NCT04381897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671984|NCT04381897|Protective Agents|protective agents|mesh-ancestor
101671985|NCT04381897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101671986|NCT04381897|Antidotes|antidotes|mesh-ancestor
101671987|NCT04356690|Etoposide|etoposide|mesh-list
101671988|NCT04356690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101671989|NCT04356690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101671990|NCT04356690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101671991|NCT04356690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101671992|NCT04356690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101671993|NCT04356690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101671994|NCT04352205|Thalidomide|thalidomide|mesh-list
101671995|NCT04352205|Dexamethasone|dexamethasone|mesh-list
101671996|NCT04352205|Dexamethasone acetate|dexamethasone acetate|mesh-list
101671997|NCT04352205|Lenalidomide|lenalidomide|mesh-list
101671999|NCT04352205|Daratumumab|daratumumab|mesh-list
101672000|NCT04352205|Ichthammol|ichthammol|mesh-list
101672001|NCT04352205|BB 1101|bb 1101|mesh-list
101672002|NCT04352205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101672003|NCT04352205|Antiemetics|antiemetics|mesh-ancestor
101672004|NCT04352205|Autonomic Agents|autonomic agents|mesh-ancestor
101672005|NCT04352205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101672006|NCT04352205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672007|NCT04352205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101672008|NCT04352205|Glucocorticoids|glucocorticoids|mesh-ancestor
101672009|NCT04352205|Hormones|hormones|mesh-ancestor
101672010|NCT04352205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101672011|NCT04352205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101672012|NCT04352205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672013|NCT04352205|Protease Inhibitors|protease inhibitors|mesh-ancestor
101672014|NCT04352205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101672015|NCT04352205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672016|NCT04352205|Immunologic Factors|immunologic factors|mesh-ancestor
101672017|NCT04352205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101672018|NCT04352205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101672019|NCT04352205|Growth Substances|growth substances|mesh-ancestor
101672020|NCT04352205|Growth Inhibitors|growth inhibitors|mesh-ancestor
101672021|NCT04352205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101672022|NCT04352205|Leprostatic Agents|leprostatic agents|mesh-ancestor
101672023|NCT04352205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101672024|NCT04352205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101672025|NCT04352205|Dermatologic Agents|dermatologic agents|mesh-ancestor
101672026|NCT04339140|Zafirlukast|zafirlukast|mesh-list
101672027|NCT04339140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101672028|NCT04339140|Respiratory System Agents|respiratory system agents|mesh-ancestor
101672029|NCT04339140|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101329248|NCT00026104|Tipifarnib|tipifarnib|mesh-list
101672030|NCT04339140|Hormone Antagonists|hormone antagonists|mesh-ancestor
101672031|NCT04339140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101672032|NCT04339140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672033|NCT04337827|Rituximab|rituximab|mesh-list
101672034|NCT04337827|Acalabrutinib|acalabrutinib|mesh-list
101672035|NCT04337827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101672036|NCT04337827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672037|NCT04337827|Immunologic Factors|immunologic factors|mesh-ancestor
101672038|NCT04337827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672039|NCT04337827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101672040|NCT04308785|Atezolizumab|atezolizumab|mesh-list
101672041|NCT04308785|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101672042|NCT04308785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672043|NCT04308785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101672044|NCT04308785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672045|NCT04266301|Azacitidine|azacitidine|mesh-list
101672046|NCT04266301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101672047|NCT04266301|Antimetabolites|antimetabolites|mesh-ancestor
101672048|NCT04266301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672049|NCT04266301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672050|NCT04266301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101672051|NCT04263922|Valsartan|valsartan|mesh-list
101672052|NCT04263922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101672053|NCT04263922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101672054|NCT04263922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101672055|NCT04263922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672056|NCT04251117|Pembrolizumab|pembrolizumab|mesh-list
101672057|NCT04251117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101672058|NCT04251117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672059|NCT04251117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101672060|NCT04251117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672061|NCT04249622|Rifaximin|rifaximin|mesh-list
101672062|NCT04249622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101672063|NCT04249622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101672064|NCT04249622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101672065|NCT04246047|Dexamethasone|dexamethasone|mesh-list
101672066|NCT04246047|Bortezomib|bortezomib|mesh-list
101672067|NCT04246047|Daratumumab|daratumumab|mesh-list
101672068|NCT04246047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101672069|NCT04246047|Antiemetics|antiemetics|mesh-ancestor
101672070|NCT04246047|Autonomic Agents|autonomic agents|mesh-ancestor
101672071|NCT04246047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101672072|NCT04246047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672073|NCT04246047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101672074|NCT04246047|Glucocorticoids|glucocorticoids|mesh-ancestor
101672075|NCT04246047|Hormones|hormones|mesh-ancestor
101672076|NCT04246047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101672077|NCT04246047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101672078|NCT04246047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672079|NCT04221529|Atezolizumab|atezolizumab|mesh-list
101672080|NCT04221529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101672081|NCT04221529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672082|NCT04221529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101672083|NCT04221529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672084|NCT04219774|Aspirin|aspirin|mesh-list
101672085|NCT04219774|Clopidogrel|clopidogrel|mesh-list
101672086|NCT04219774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101672087|NCT04219774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101672088|NCT04219774|Analgesics|analgesics|mesh-ancestor
101672089|NCT04219774|Sensory System Agents|sensory system agents|mesh-ancestor
101672090|NCT04219774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101672091|NCT04219774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672092|NCT04219774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101672093|NCT04219774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101672094|NCT04219774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101672095|NCT04219774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101672096|NCT04219774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672097|NCT04219774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101672098|NCT04219774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101672099|NCT04219774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101672100|NCT04219774|Antipyretics|antipyretics|mesh-ancestor
101672101|NCT04219774|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101672102|NCT04219774|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101672103|NCT04219774|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101672104|NCT04219774|Purinergic Agents|purinergic agents|mesh-ancestor
101672105|NCT04219774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101672106|NCT04195139|Nivolumab|nivolumab|mesh-list
101672107|NCT04195139|Temozolomide|temozolomide|mesh-list
101672108|NCT04195139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101672109|NCT04195139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672110|NCT04195139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101672111|NCT04195139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672112|NCT04195139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101672113|NCT04195139|Alkylating Agents|alkylating agents|mesh-ancestor
101672114|NCT04174352|Tamoxifen|tamoxifen|mesh-list
101672115|NCT04174352|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101672116|NCT04174352|Hormone Antagonists|hormone antagonists|mesh-ancestor
101672117|NCT04174352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101672118|NCT04174352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672119|NCT04174352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101672120|NCT04174352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672121|NCT04174352|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101672122|NCT04174352|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101672123|NCT04174352|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101672124|NCT04150289|Panobinostat|panobinostat|mesh-list
101672125|NCT04150289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672126|NCT04150289|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101672127|NCT04150289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101672128|NCT04150289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672130|NCT04136756|Daratumumab|daratumumab|mesh-list
101672131|NCT04136756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101672132|NCT04136756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672133|NCT04136756|Immunologic Factors|immunologic factors|mesh-ancestor
101672134|NCT04136756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672135|NCT04136756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101672136|NCT04123366|Pembrolizumab|pembrolizumab|mesh-list
101672137|NCT04123366|Olaparib|olaparib|mesh-list
101672138|NCT04123366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101672139|NCT04123366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672140|NCT04123366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101672141|NCT04123366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672142|NCT04123366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101672143|NCT04123366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101672144|NCT04056624|Carotenoids|carotenoids|mesh-list
101672145|NCT04056624|Antioxidants|antioxidants|mesh-ancestor
101672146|NCT04056624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672147|NCT04056624|Protective Agents|protective agents|mesh-ancestor
101672148|NCT04056624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672149|NCT04052880|Dexamethasone|dexamethasone|mesh-list
101672150|NCT04052880|Lenalidomide|lenalidomide|mesh-list
101672151|NCT04052880|Bortezomib|bortezomib|mesh-list
101672152|NCT04052880|Daratumumab|daratumumab|mesh-list
101672153|NCT04052880|Ixazomib|ixazomib|mesh-list
101672154|NCT04052880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101672155|NCT04052880|Antiemetics|antiemetics|mesh-ancestor
101672156|NCT04052880|Autonomic Agents|autonomic agents|mesh-ancestor
101672157|NCT04052880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101672158|NCT04052880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672159|NCT04052880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101672161|NCT04052880|Hormones|hormones|mesh-ancestor
101672162|NCT04052880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101672163|NCT04052880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101672164|NCT04052880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672165|NCT04052880|Immunologic Factors|immunologic factors|mesh-ancestor
101672166|NCT04052880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101672167|NCT04052880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101672168|NCT04052880|Growth Substances|growth substances|mesh-ancestor
101672169|NCT04052880|Growth Inhibitors|growth inhibitors|mesh-ancestor
101672170|NCT04052880|Protease Inhibitors|protease inhibitors|mesh-ancestor
101672171|NCT04052880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101672172|NCT04052880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672173|NCT04007276|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101672174|NCT04007276|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101672175|NCT04007276|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101672176|NCT04007276|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101672177|NCT04007276|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101672178|NCT04007276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101672179|NCT04007276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101672180|NCT04007276|Adrenergic Agents|adrenergic agents|mesh-ancestor
101672181|NCT04007276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101672182|NCT04007276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672193|NCT03969446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101672194|NCT03927690|Ranibizumab|ranibizumab|mesh-list
101672195|NCT03927690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101672196|NCT03927690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101672197|NCT03927690|Growth Substances|growth substances|mesh-ancestor
101672198|NCT03927690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672199|NCT03927690|Growth Inhibitors|growth inhibitors|mesh-ancestor
101672200|NCT03927690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672201|NCT03900715|Luspatercept|luspatercept|mesh-list
101672202|NCT03900715|Hematinics|hematinics|mesh-ancestor
101672203|NCT03870763|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101672204|NCT03870763|Dermatologic Agents|dermatologic agents|mesh-ancestor
101672205|NCT03870763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101672206|NCT03870763|Immunologic Factors|immunologic factors|mesh-ancestor
101672207|NCT03870763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672208|NCT03858231|Acetaminophen|acetaminophen|mesh-list
101672209|NCT03858231|Ibuprofen|ibuprofen|mesh-list
101672210|NCT03858231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101672211|NCT03858231|Analgesics|analgesics|mesh-ancestor
101672212|NCT03858231|Sensory System Agents|sensory system agents|mesh-ancestor
101672213|NCT03858231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101672214|NCT03858231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672215|NCT03858231|Antipyretics|antipyretics|mesh-ancestor
101672216|NCT03858231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101672217|NCT03858231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101672218|NCT03858231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101672219|NCT03858231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101672220|NCT03858231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101672221|NCT03858231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672232|NCT03853954|Methoxyflurane|methoxyflurane|mesh-list
101672233|NCT03853954|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101672234|NCT03853954|Anesthetics, General|anesthetics, general|mesh-ancestor
101672235|NCT03853954|Anesthetics|anesthetics|mesh-ancestor
101672236|NCT03853954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101672237|NCT03853954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672238|NCT03806985|Psilocybin|psilocybin|mesh-list
101672239|NCT03806985|Hallucinogens|hallucinogens|mesh-ancestor
101672240|NCT03806985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672241|NCT03806985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101672242|NCT03806452|Hydroxyurea|hydroxyurea|mesh-list
101672243|NCT03806452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672244|NCT03806452|Antisickling Agents|antisickling agents|mesh-ancestor
101827674|NCT05479812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672245|NCT03806452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101672246|NCT03806452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672247|NCT03806452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101672248|NCT03742414|Fluticasone|fluticasone|mesh-list
101672250|NCT03742414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101672251|NCT03742414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101672252|NCT03742414|Autonomic Agents|autonomic agents|mesh-ancestor
101672253|NCT03742414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101672254|NCT03742414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672255|NCT03742414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101672256|NCT03742414|Respiratory System Agents|respiratory system agents|mesh-ancestor
101672257|NCT03742414|Dermatologic Agents|dermatologic agents|mesh-ancestor
101672258|NCT03742414|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101672259|NCT03728556|Antibodies|antibodies|mesh-list
101672260|NCT03728556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101672261|NCT03728556|Immunologic Factors|immunologic factors|mesh-ancestor
101672262|NCT03728556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672263|NCT03634228|Cytarabine|cytarabine|mesh-list
101672264|NCT03634228|Venetoclax|venetoclax|mesh-list
101672265|NCT03634228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101672266|NCT03634228|Antimetabolites|antimetabolites|mesh-ancestor
101672267|NCT03634228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672268|NCT03634228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672269|NCT03634228|Antiviral Agents|antiviral agents|mesh-ancestor
101672270|NCT03634228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101672271|NCT03634228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101672272|NCT03634228|Immunologic Factors|immunologic factors|mesh-ancestor
101672273|NCT03634228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672274|NCT03612973|Insulin|insulin|mesh-list
101672275|NCT03612973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101672276|NCT03612973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672277|NCT03603223|Pembrolizumab|pembrolizumab|mesh-list
101672278|NCT03603223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101672279|NCT03603223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672280|NCT03603223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101672281|NCT03603223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672283|NCT03593590|Immunologic Factors|immunologic factors|mesh-ancestor
101672284|NCT03593590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672285|NCT03587142|Buspirone|buspirone|mesh-list
101672286|NCT03587142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101672287|NCT03587142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101672288|NCT03587142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101672289|NCT03587142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672290|NCT03587142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101672291|NCT03587142|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101672292|NCT03587142|Serotonin Agents|serotonin agents|mesh-ancestor
101672293|NCT03587142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101672294|NCT03587142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672295|NCT03535688|Cycloserine|cycloserine|mesh-list
101672296|NCT03535688|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101672297|NCT03535688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101672298|NCT03535688|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101672299|NCT03535688|Antitubercular Agents|antitubercular agents|mesh-ancestor
101672300|NCT03535688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101672301|NCT03535688|Antimetabolites|antimetabolites|mesh-ancestor
101672302|NCT03535688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672303|NCT03532139|Enoxaparin|enoxaparin|mesh-list
101672304|NCT03532139|Enoxaparin sodium|enoxaparin sodium|mesh-list
101672305|NCT03532139|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101672306|NCT03532139|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101672307|NCT03532139|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101672308|NCT03532139|Antimetabolites|antimetabolites|mesh-ancestor
101672309|NCT03532139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101827686|NCT05443035|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101827687|NCT05440201|Enoxaparin|enoxaparin|mesh-list
101672310|NCT03532139|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101672311|NCT03532139|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101672312|NCT03532139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101672313|NCT03532139|Anticoagulants|anticoagulants|mesh-ancestor
101672314|NCT03532139|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101672315|NCT03532139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101672316|NCT03509584|Nivolumab|nivolumab|mesh-list
101672317|NCT03509584|Ipilimumab|ipilimumab|mesh-list
101672318|NCT03509584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101672319|NCT03509584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672320|NCT03509584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101672321|NCT03509584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672322|NCT03493854|Paclitaxel|paclitaxel|mesh-list
101672323|NCT03493854|Docetaxel|docetaxel|mesh-list
101672324|NCT03493854|Cyclophosphamide|cyclophosphamide|mesh-list
101672325|NCT03493854|Doxorubicin|doxorubicin|mesh-list
101672326|NCT03493854|Trastuzumab|trastuzumab|mesh-list
101672327|NCT03493854|Pertuzumab|pertuzumab|mesh-list
101672328|NCT03493854|Hormones|hormones|mesh-list
101672329|NCT03493854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101329555|NCT00027625|Temozolomide|temozolomide|mesh-list
101672330|NCT03493854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672332|NCT03493854|Antimitotic Agents|antimitotic agents|mesh-ancestor
101672333|NCT03493854|Mitosis Modulators|mitosis modulators|mesh-ancestor
101672334|NCT03493854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672335|NCT03493854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101672336|NCT03493854|Immunologic Factors|immunologic factors|mesh-ancestor
101672337|NCT03493854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672338|NCT03493854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101672339|NCT03493854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101672340|NCT03493854|Alkylating Agents|alkylating agents|mesh-ancestor
101672341|NCT03493854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101672342|NCT03493854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101672343|NCT03493854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101672344|NCT03493854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101672345|NCT03493854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101672346|NCT03493854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101672347|NCT03493854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101672348|NCT03390686|Paclitaxel|paclitaxel|mesh-list
101672349|NCT03390686|Bevacizumab|bevacizumab|mesh-list
101672350|NCT03390686|Carboplatin|carboplatin|mesh-list
101672351|NCT03390686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101672352|NCT03390686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672353|NCT03390686|Tubulin Modulators|tubulin modulators|mesh-ancestor
101672354|NCT03390686|Antimitotic Agents|antimitotic agents|mesh-ancestor
101672355|NCT03390686|Mitosis Modulators|mitosis modulators|mesh-ancestor
101672356|NCT03390686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672357|NCT03390686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101672359|NCT03390686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101672360|NCT03390686|Growth Substances|growth substances|mesh-ancestor
101672361|NCT03390686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672362|NCT03390686|Growth Inhibitors|growth inhibitors|mesh-ancestor
101672363|NCT03384277|Cyclophosphamide|cyclophosphamide|mesh-list
101672365|NCT03384277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101672366|NCT03384277|Immunologic Factors|immunologic factors|mesh-ancestor
101672367|NCT03384277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672368|NCT03384277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101672369|NCT03384277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101672370|NCT03384277|Alkylating Agents|alkylating agents|mesh-ancestor
101672371|NCT03384277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672372|NCT03384277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672373|NCT03384277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101672374|NCT03384277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101672376|NCT03370367|Isotretinoin|isotretinoin|mesh-list
101672377|NCT03370367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672378|NCT03370367|Keratolytic Agents|keratolytic agents|mesh-ancestor
101672379|NCT03370367|Dermatologic Agents|dermatologic agents|mesh-ancestor
101672380|NCT03341689|Psilocybin|psilocybin|mesh-list
101672381|NCT03341689|Hallucinogens|hallucinogens|mesh-ancestor
101672382|NCT03341689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672383|NCT03341689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101672384|NCT03324425|Simvastatin|simvastatin|mesh-list
101672385|NCT03324425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101672386|NCT03324425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101672387|NCT03324425|Antimetabolites|antimetabolites|mesh-ancestor
101672388|NCT03324425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672389|NCT03324425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101672390|NCT03324425|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101672391|NCT03324425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101672392|NCT03317457|Doxorubicin|doxorubicin|mesh-list
101672393|NCT03317457|Durvalumab|durvalumab|mesh-list
101672394|NCT03317457|Tremelimumab|tremelimumab|mesh-list
101672395|NCT03317457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101672396|NCT03317457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672397|NCT03317457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101672398|NCT03317457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101672399|NCT03317457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101672400|NCT03317457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672401|NCT03317457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101672402|NCT03267836|Avelumab|avelumab|mesh-list
101329635|NCT00011973|Fenretinide|fenretinide|mesh-list
101672403|NCT03267836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101672405|NCT03197506|Pembrolizumab|pembrolizumab|mesh-list
101672406|NCT03197506|Temozolomide|temozolomide|mesh-list
101672407|NCT03197506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101672408|NCT03197506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672409|NCT03197506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101672410|NCT03197506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672411|NCT03197506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101672412|NCT03197506|Alkylating Agents|alkylating agents|mesh-ancestor
101672413|NCT03188705|Aspirin|aspirin|mesh-list
101672414|NCT03188705|Clopidogrel|clopidogrel|mesh-list
101672415|NCT03188705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101672416|NCT03188705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101672417|NCT03188705|Analgesics|analgesics|mesh-ancestor
101672418|NCT03188705|Sensory System Agents|sensory system agents|mesh-ancestor
101672419|NCT03188705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101672420|NCT03188705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672421|NCT03188705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101672422|NCT03188705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101672423|NCT03188705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101672424|NCT03188705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101451724|NCT00208065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101672425|NCT03188705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672426|NCT03188705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101672427|NCT03188705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101672428|NCT03188705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101672430|NCT03188705|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101672431|NCT03188705|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101672432|NCT03188705|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101672433|NCT03188705|Purinergic Agents|purinergic agents|mesh-ancestor
101672434|NCT03188705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101672435|NCT03113487|Pembrolizumab|pembrolizumab|mesh-list
101672436|NCT03113487|Vaccines|vaccines|mesh-list
101672437|NCT03113487|Immunologic Factors|immunologic factors|mesh-ancestor
101672438|NCT03113487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672439|NCT03113487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101672440|NCT03113487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672441|NCT03113487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101672442|NCT03113487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672443|NCT03072238|Prednisone|prednisone|mesh-list
101672444|NCT03072238|Prednisolone|prednisolone|mesh-list
101672445|NCT03072238|Ipatasertib|ipatasertib|mesh-list
101672446|NCT03072238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101672447|NCT03072238|Glucocorticoids|glucocorticoids|mesh-ancestor
101672448|NCT03072238|Hormones|hormones|mesh-ancestor
101672449|NCT03072238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101672450|NCT03072238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672451|NCT03072238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101672452|NCT03072238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672453|NCT03072238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101672454|NCT03072238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101672455|NCT03072238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672456|NCT03032484|Bevacizumab|bevacizumab|mesh-list
101672457|NCT03032484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101672458|NCT03032484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672459|NCT03032484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101672460|NCT03032484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101672461|NCT03032484|Growth Substances|growth substances|mesh-ancestor
101672462|NCT03032484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672463|NCT03032484|Growth Inhibitors|growth inhibitors|mesh-ancestor
101672464|NCT03003546|Paclitaxel|paclitaxel|mesh-list
101672465|NCT03003546|Rituximab|rituximab|mesh-list
101672466|NCT03003546|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101672467|NCT03003546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101672468|NCT03003546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672469|NCT03003546|Tubulin Modulators|tubulin modulators|mesh-ancestor
101672470|NCT03003546|Antimitotic Agents|antimitotic agents|mesh-ancestor
101672471|NCT03003546|Mitosis Modulators|mitosis modulators|mesh-ancestor
101672472|NCT03003546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672473|NCT03003546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101672474|NCT03003546|Immunologic Factors|immunologic factors|mesh-ancestor
101329710|NCT00012051|Antiviral Agents|antiviral agents|mesh-ancestor
101672475|NCT03003546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672476|NCT03003546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101672477|NCT02996825|Gemcitabine|gemcitabine|mesh-list
101672478|NCT02996825|Maytansine|maytansine|mesh-list
101672479|NCT02996825|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
101672480|NCT02996825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101672482|NCT02996825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672483|NCT02996825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672484|NCT02996825|Immunoconjugates|immunoconjugates|mesh-ancestor
101672485|NCT02996825|Immunologic Factors|immunologic factors|mesh-ancestor
101672486|NCT02996825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672487|NCT02996825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101672488|NCT02996825|Tubulin Modulators|tubulin modulators|mesh-ancestor
101672489|NCT02996825|Antimitotic Agents|antimitotic agents|mesh-ancestor
101672490|NCT02996825|Mitosis Modulators|mitosis modulators|mesh-ancestor
101672491|NCT02981173|Psilocybin|psilocybin|mesh-list
101672492|NCT02981173|Hallucinogens|hallucinogens|mesh-ancestor
101672493|NCT02981173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672494|NCT02981173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101672495|NCT02975349|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101672496|NCT02975349|Dermatologic Agents|dermatologic agents|mesh-ancestor
101672497|NCT02975349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101672498|NCT02975349|Immunologic Factors|immunologic factors|mesh-ancestor
101672499|NCT02975349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672500|NCT02955394|Fulvestrant|fulvestrant|mesh-list
101672501|NCT02955394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101672502|NCT02955394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672503|NCT02955394|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101672504|NCT02955394|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101672505|NCT02955394|Hormone Antagonists|hormone antagonists|mesh-ancestor
101672506|NCT02955394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101672507|NCT02955394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672508|NCT02768532|Vedolizumab|vedolizumab|mesh-list
101672509|NCT02768532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101672510|NCT02710851|Vaccines|vaccines|mesh-list
101672511|NCT02710851|Immunologic Factors|immunologic factors|mesh-ancestor
101672512|NCT02710851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672513|NCT02675829|Trastuzumab|trastuzumab|mesh-list
101672514|NCT02675829|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101672515|NCT02675829|Maytansine|maytansine|mesh-list
101672516|NCT02675829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101672517|NCT02675829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672518|NCT02675829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101672519|NCT02675829|Tubulin Modulators|tubulin modulators|mesh-ancestor
101672520|NCT02675829|Antimitotic Agents|antimitotic agents|mesh-ancestor
101672521|NCT02675829|Mitosis Modulators|mitosis modulators|mesh-ancestor
101672522|NCT02675829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672523|NCT02675829|Immunotoxins|immunotoxins|mesh-ancestor
101672524|NCT02675829|Immunoconjugates|immunoconjugates|mesh-ancestor
101672525|NCT02675829|Immunologic Factors|immunologic factors|mesh-ancestor
101672526|NCT02675829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672527|NCT02554851|Mitogens|mitogens|mesh-list
101672528|NCT02554851|Mitosis Modulators|mitosis modulators|mesh-ancestor
101672529|NCT02554851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672530|NCT02520141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101672531|NCT02520141|Ramucirumab|ramucirumab|mesh-list
101672532|NCT02520141|Antibodies|antibodies|mesh-list
101672533|NCT02520141|Immunoglobulins|immunoglobulins|mesh-list
101672534|NCT02520141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101672535|NCT02520141|Lexatumumab|lexatumumab|mesh-list
101672536|NCT02520141|Immunologic Factors|immunologic factors|mesh-ancestor
101672537|NCT02520141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672538|NCT02520141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672539|NCT02513875|Vitamin D|vitamin d|mesh-list
101672540|NCT02513875|Vitamins|vitamins|mesh-ancestor
101672541|NCT02513875|Micronutrients|micronutrients|mesh-ancestor
101672542|NCT02513875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672543|NCT02513875|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101672544|NCT02513394|Palbociclib|palbociclib|mesh-list
101672545|NCT02513394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672546|NCT02513394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101672547|NCT02513394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101672548|NCT02513394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672549|NCT02329847|Nivolumab|nivolumab|mesh-list
101672550|NCT02329847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101329781|NCT00395434|Bevacizumab|bevacizumab|mesh-list
101672551|NCT02329847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672552|NCT02329847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101672553|NCT02329847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672554|NCT02287428|Pembrolizumab|pembrolizumab|mesh-list
101672555|NCT02287428|Temozolomide|temozolomide|mesh-list
101672556|NCT02287428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101672557|NCT02287428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672558|NCT02287428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101672559|NCT02287428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672560|NCT02287428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101672561|NCT02287428|Alkylating Agents|alkylating agents|mesh-ancestor
101672562|NCT02286687|Talazoparib|talazoparib|mesh-list
101672563|NCT02286687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101827730|NCT05411484|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101672564|NCT02286687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101672565|NCT02286687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672566|NCT02286687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672567|NCT02255227|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101672568|NCT02255227|Immunologic Factors|immunologic factors|mesh-ancestor
101672569|NCT02255227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672570|NCT02192359|Irinotecan|irinotecan|mesh-list
101672571|NCT02192359|Camptothecin|camptothecin|mesh-list
101672572|NCT02192359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101672573|NCT02192359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101672574|NCT02192359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101672575|NCT02192359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672576|NCT02192359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672577|NCT02192359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101672578|NCT02145143|Vemurafenib|vemurafenib|mesh-list
101672579|NCT02145143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672580|NCT02145143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101672581|NCT02145143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101672582|NCT02145143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672583|NCT02119468|Dexamethasone|dexamethasone|mesh-list
101672584|NCT02119468|Pomalidomide|pomalidomide|mesh-list
101672585|NCT02119468|Ixazomib|ixazomib|mesh-list
101672586|NCT02119468|Glycine|glycine|mesh-list
101672587|NCT02119468|Proteasome Inhibitors|proteasome inhibitors|mesh-list
101672588|NCT02119468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101672589|NCT02119468|Antiemetics|antiemetics|mesh-ancestor
101672590|NCT02119468|Autonomic Agents|autonomic agents|mesh-ancestor
101672591|NCT02119468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101672592|NCT02119468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672593|NCT02119468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101672594|NCT02119468|Glucocorticoids|glucocorticoids|mesh-ancestor
101672595|NCT02119468|Hormones|hormones|mesh-ancestor
101672596|NCT02119468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101672597|NCT02119468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101672598|NCT02119468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672599|NCT02119468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672600|NCT02119468|Immunologic Factors|immunologic factors|mesh-ancestor
101672601|NCT02119468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101672602|NCT02119468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101672603|NCT02119468|Growth Substances|growth substances|mesh-ancestor
101672604|NCT02119468|Growth Inhibitors|growth inhibitors|mesh-ancestor
101672605|NCT02119468|Protease Inhibitors|protease inhibitors|mesh-ancestor
101672606|NCT02119468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101672607|NCT02119468|Glycine Agents|glycine agents|mesh-ancestor
101672608|NCT02119468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101672609|NCT02017717|Bevacizumab|bevacizumab|mesh-list
101672610|NCT02017717|Nivolumab|nivolumab|mesh-list
101672611|NCT02017717|Ipilimumab|ipilimumab|mesh-list
101672612|NCT02017717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101672613|NCT02017717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672614|NCT02017717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101672615|NCT02017717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101672616|NCT02017717|Growth Substances|growth substances|mesh-ancestor
101672617|NCT02017717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672619|NCT02017717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101672620|NCT02017717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672621|NCT01935921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101672622|NCT01935921|Cetuximab|cetuximab|mesh-list
101672623|NCT01935921|Ipilimumab|ipilimumab|mesh-list
101827741|NCT05369676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101827743|NCT05369676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101672624|NCT01935921|Antibodies|antibodies|mesh-list
101329868|NCT00028405|Talaporfin|talaporfin|mesh-list
101672625|NCT01935921|Immunoglobulins|immunoglobulins|mesh-list
101672626|NCT01935921|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101672627|NCT01935921|Immunologic Factors|immunologic factors|mesh-ancestor
101672628|NCT01935921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672629|NCT01935921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672630|NCT01935921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101672631|NCT01935921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672632|NCT01863550|Dexamethasone|dexamethasone|mesh-list
101672633|NCT01863550|Dexamethasone acetate|dexamethasone acetate|mesh-list
101672634|NCT01863550|Lenalidomide|lenalidomide|mesh-list
101672635|NCT01863550|Bortezomib|bortezomib|mesh-list
101672636|NCT01863550|Ichthammol|ichthammol|mesh-list
101672637|NCT01863550|BB 1101|bb 1101|mesh-list
101672638|NCT01863550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101672639|NCT01863550|Antiemetics|antiemetics|mesh-ancestor
101672640|NCT01863550|Autonomic Agents|autonomic agents|mesh-ancestor
101672641|NCT01863550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101672642|NCT01863550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672643|NCT01863550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101672644|NCT01863550|Glucocorticoids|glucocorticoids|mesh-ancestor
101672645|NCT01863550|Hormones|hormones|mesh-ancestor
101672646|NCT01863550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101672647|NCT01863550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101672648|NCT01863550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672649|NCT01863550|Immunologic Factors|immunologic factors|mesh-ancestor
101672650|NCT01863550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101672651|NCT01863550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101672652|NCT01863550|Growth Substances|growth substances|mesh-ancestor
101672653|NCT01863550|Growth Inhibitors|growth inhibitors|mesh-ancestor
101672654|NCT01863550|Protease Inhibitors|protease inhibitors|mesh-ancestor
101672655|NCT01863550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101672656|NCT01863550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672657|NCT01863550|Dermatologic Agents|dermatologic agents|mesh-ancestor
101672658|NCT01824836|Anastrozole|anastrozole|mesh-list
101672659|NCT01824836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101672660|NCT01824836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672661|NCT01824836|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101672662|NCT01824836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101672663|NCT01824836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101672664|NCT01824836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672665|NCT01824836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101672666|NCT01824836|Hormone Antagonists|hormone antagonists|mesh-ancestor
101672667|NCT01824836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101672668|NCT01824836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672669|NCT01552434|Sirolimus|sirolimus|mesh-list
101672670|NCT01552434|Bevacizumab|bevacizumab|mesh-list
101672671|NCT01552434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101672672|NCT01552434|Cetuximab|cetuximab|mesh-list
101672673|NCT01552434|Temsirolimus|temsirolimus|mesh-list
101672674|NCT01552434|MTOR Inhibitors|mtor inhibitors|mesh-list
101672675|NCT01552434|Valproic Acid|valproic acid|mesh-list
101672676|NCT01552434|Endothelial Growth Factors|endothelial growth factors|mesh-list
101672677|NCT01552434|Antibodies|antibodies|mesh-list
101672678|NCT01552434|Immunoglobulins|immunoglobulins|mesh-list
101672679|NCT01552434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101672680|NCT01552434|Immunoglobulin G|immunoglobulin g|mesh-list
101672681|NCT01552434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672682|NCT01552434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101672683|NCT01552434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101672684|NCT01552434|Growth Substances|growth substances|mesh-ancestor
101672685|NCT01552434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672686|NCT01552434|Growth Inhibitors|growth inhibitors|mesh-ancestor
101672687|NCT01552434|Immunologic Factors|immunologic factors|mesh-ancestor
101827755|NCT06014957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672688|NCT01552434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101672689|NCT01552434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101672690|NCT01552434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101672691|NCT01552434|Antifungal Agents|antifungal agents|mesh-ancestor
101672692|NCT01552434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101672693|NCT01552434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101672694|NCT01552434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101672695|NCT01552434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672696|NCT01552434|Anticonvulsants|anticonvulsants|mesh-ancestor
101672697|NCT01552434|GABA Agents|gaba agents|mesh-ancestor
101672698|NCT01552434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101672699|NCT01552434|Antimanic Agents|antimanic agents|mesh-ancestor
101329960|NCT00028717|Prednisone|prednisone|mesh-list
101672700|NCT01552434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101672701|NCT01552434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101672703|NCT01415752|Rituximab|rituximab|mesh-list
101672704|NCT01415752|Lenalidomide|lenalidomide|mesh-list
101672705|NCT01415752|Bortezomib|bortezomib|mesh-list
101672706|NCT01415752|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101672707|NCT01415752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101672708|NCT01415752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672709|NCT01415752|Immunologic Factors|immunologic factors|mesh-ancestor
101672710|NCT01415752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672711|NCT01415752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101672712|NCT01415752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101672713|NCT01415752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101672714|NCT01415752|Growth Substances|growth substances|mesh-ancestor
101672715|NCT01415752|Growth Inhibitors|growth inhibitors|mesh-ancestor
101672716|NCT01415752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101672717|NCT01415752|Alkylating Agents|alkylating agents|mesh-ancestor
101672718|NCT01415752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672719|NCT01164228|Gemcitabine|gemcitabine|mesh-list
101672720|NCT01164228|Sunitinib|sunitinib|mesh-list
101672721|NCT01164228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101672722|NCT01164228|Antimetabolites|antimetabolites|mesh-ancestor
101672723|NCT01164228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672724|NCT01164228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672725|NCT01164228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101672726|NCT01164228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101672727|NCT01164228|Growth Substances|growth substances|mesh-ancestor
101672728|NCT01164228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672729|NCT01164228|Growth Inhibitors|growth inhibitors|mesh-ancestor
101672730|NCT01164228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101672731|NCT01164228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101672732|NCT00950846|Cyclophosphamide|cyclophosphamide|mesh-list
101672733|NCT00950846|Busulfan|busulfan|mesh-list
101672734|NCT00950846|Fludarabine|fludarabine|mesh-list
101672735|NCT00950846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101672736|NCT00950846|Immunologic Factors|immunologic factors|mesh-ancestor
101672737|NCT00950846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672738|NCT00950846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101672739|NCT00950846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101672740|NCT00950846|Alkylating Agents|alkylating agents|mesh-ancestor
101672741|NCT00950846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672742|NCT00950846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672743|NCT00950846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101672744|NCT00641030|Melphalan|melphalan|mesh-list
101672745|NCT00641030|Clofarabine|clofarabine|mesh-list
101672746|NCT00641030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101672747|NCT00641030|Alkylating Agents|alkylating agents|mesh-ancestor
101672748|NCT00641030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672749|NCT00641030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672750|NCT00641030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101827763|NCT06014853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101672752|NCT00641030|Immunologic Factors|immunologic factors|mesh-ancestor
101672753|NCT00641030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672754|NCT00641030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101672755|NCT00641030|Antimetabolites|antimetabolites|mesh-ancestor
101672756|NCT00554515|Aldesleukin|aldesleukin|mesh-list
101672757|NCT00554515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672758|NCT00554515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101672759|NCT00554515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101672760|NCT00554515|Antiviral Agents|antiviral agents|mesh-ancestor
101672761|NCT00554515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101672762|NCT00329043|Sunitinib|sunitinib|mesh-list
101672763|NCT00329043|Leuprolide|leuprolide|mesh-list
101672764|NCT00329043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672765|NCT00329043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101672766|NCT00329043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101672767|NCT00329043|Growth Substances|growth substances|mesh-ancestor
101672768|NCT00329043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672769|NCT00329043|Growth Inhibitors|growth inhibitors|mesh-ancestor
101672770|NCT00329043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101672771|NCT00329043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101672772|NCT00329043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672773|NCT00329043|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101672774|NCT00329043|Fertility Agents|fertility agents|mesh-ancestor
101672775|NCT00329043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101672776|NCT00329043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101672777|NCT00209586|Fospropofol|fospropofol|mesh-list
101672778|NCT00209586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101672779|NCT00209586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101672780|NCT00209586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672781|NCT00107289|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
101672782|NCT00107289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672783|NCT00107289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101672784|NCT00107289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672785|NCT00107289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101672787|NCT00082797|Methotrexate|methotrexate|mesh-list
101672788|NCT00082797|Calcium|calcium|mesh-list
101672789|NCT00082797|Levoleucovorin|levoleucovorin|mesh-list
101672790|NCT00082797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101672791|NCT00082797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672792|NCT00082797|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101672793|NCT00082797|Abortifacient Agents|abortifacient agents|mesh-ancestor
101672794|NCT00082797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101672795|NCT00082797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101672796|NCT00082797|Antimetabolites|antimetabolites|mesh-ancestor
101672797|NCT00082797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672798|NCT00082797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672799|NCT00082797|Dermatologic Agents|dermatologic agents|mesh-ancestor
101672800|NCT00082797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101672801|NCT00082797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101672802|NCT00082797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101672803|NCT00082797|Immunologic Factors|immunologic factors|mesh-ancestor
101672804|NCT00082797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101672805|NCT00082797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101672806|NCT00082797|Antidotes|antidotes|mesh-ancestor
101672807|NCT00082797|Protective Agents|protective agents|mesh-ancestor
101672808|NCT00082797|Vitamin B Complex|vitamin b complex|mesh-ancestor
101672809|NCT00082797|Vitamins|vitamins|mesh-ancestor
101672810|NCT00082797|Micronutrients|micronutrients|mesh-ancestor
101672811|NCT00060398|Dexamethasone|dexamethasone|mesh-list
101672812|NCT00060398|Epoetin Alfa|epoetin alfa|mesh-list
101672813|NCT00060398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101672814|NCT00060398|Antiemetics|antiemetics|mesh-ancestor
101672815|NCT00060398|Autonomic Agents|autonomic agents|mesh-ancestor
101672816|NCT00060398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101672817|NCT00060398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672818|NCT00060398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101672819|NCT00060398|Glucocorticoids|glucocorticoids|mesh-ancestor
101672820|NCT00060398|Hormones|hormones|mesh-ancestor
101672821|NCT00060398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101672822|NCT00060398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101672823|NCT00060398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672824|NCT00060398|Hematinics|hematinics|mesh-ancestor
101672825|NCT00054561|Vitamin E|vitamin e|mesh-list
101672826|NCT00054561|Interferons|interferons|mesh-list
101672827|NCT00054561|Interferon-alpha|interferon-alpha|mesh-list
101672828|NCT00054561|Isotretinoin|isotretinoin|mesh-list
101672829|NCT00054561|Vitamins|vitamins|mesh-ancestor
101672830|NCT00054561|Micronutrients|micronutrients|mesh-ancestor
101672831|NCT00054561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672832|NCT00054561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672833|NCT00054561|Antiviral Agents|antiviral agents|mesh-ancestor
101672834|NCT00054561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101672835|NCT00054561|Immunologic Factors|immunologic factors|mesh-ancestor
101672836|NCT00054561|Antioxidants|antioxidants|mesh-ancestor
101672837|NCT00054561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672838|NCT00054561|Protective Agents|protective agents|mesh-ancestor
101672839|NCT00054561|Dermatologic Agents|dermatologic agents|mesh-ancestor
101672840|NCT00049517|Cytarabine|cytarabine|mesh-list
101672841|NCT00049517|Cyclophosphamide|cyclophosphamide|mesh-list
101672842|NCT00049517|Busulfan|busulfan|mesh-list
101672843|NCT00049517|Daunorubicin|daunorubicin|mesh-list
101672844|NCT00049517|Gemtuzumab|gemtuzumab|mesh-list
101672845|NCT00049517|Sargramostim|sargramostim|mesh-list
101672846|NCT00049517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101672847|NCT00049517|Immunologic Factors|immunologic factors|mesh-ancestor
101672848|NCT00049517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672849|NCT00049517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101330087|NCT01803555|Glucocorticoids|glucocorticoids|mesh-ancestor
101672850|NCT00049517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101672851|NCT00049517|Alkylating Agents|alkylating agents|mesh-ancestor
101672852|NCT00049517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672853|NCT00049517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672854|NCT00049517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101672855|NCT00049517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101672856|NCT00049517|Antimetabolites|antimetabolites|mesh-ancestor
101672857|NCT00049517|Antiviral Agents|antiviral agents|mesh-ancestor
101672858|NCT00049517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101672859|NCT00049517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101672860|NCT00049517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101672861|NCT00049517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101672862|NCT00049517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101672863|NCT00049517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101672864|NCT00049517|Immunotoxins|immunotoxins|mesh-ancestor
101672865|NCT00049517|Immunoconjugates|immunoconjugates|mesh-ancestor
101672866|NCT00041314|Sulindac sulfone|sulindac sulfone|mesh-list
101672867|NCT00041314|Carboplatin|carboplatin|mesh-list
101672868|NCT00041314|Gemcitabine|gemcitabine|mesh-list
101672869|NCT00041314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672870|NCT00041314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101672871|NCT00041314|Antimetabolites|antimetabolites|mesh-ancestor
101672872|NCT00041314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672873|NCT00041314|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101672874|NCT00041314|Protective Agents|protective agents|mesh-ancestor
101672875|NCT00041314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827788|NCT06014658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827789|NCT06014606|Propranolol|propranolol|mesh-list
101827790|NCT06014606|Haloperidol|haloperidol|mesh-list
101672876|NCT00041314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101672877|NCT00041314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101827791|NCT06014606|Haloperidol decanoate|haloperidol decanoate|mesh-list
101672878|NCT00041314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101672879|NCT00041314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101672880|NCT00041314|Analgesics|analgesics|mesh-ancestor
101672881|NCT00041314|Sensory System Agents|sensory system agents|mesh-ancestor
101672882|NCT00041314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101672883|NCT00041314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101672884|NCT00041314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101672885|NCT00028990|Paclitaxel|paclitaxel|mesh-list
101672886|NCT00028990|Bevacizumab|bevacizumab|mesh-list
101672887|NCT00028990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101672888|NCT00028990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672889|NCT00028990|Tubulin Modulators|tubulin modulators|mesh-ancestor
101672890|NCT00028990|Antimitotic Agents|antimitotic agents|mesh-ancestor
101672891|NCT00028990|Mitosis Modulators|mitosis modulators|mesh-ancestor
101672892|NCT00028990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672893|NCT00028990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101672894|NCT00028990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101672895|NCT00028990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101672896|NCT00028990|Growth Substances|growth substances|mesh-ancestor
101672897|NCT00028990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672898|NCT00028990|Growth Inhibitors|growth inhibitors|mesh-ancestor
101672899|NCT00027859|Ketoconazole|ketoconazole|mesh-list
101672900|NCT00027859|Hydrocortisone|hydrocortisone|mesh-list
101672901|NCT00027859|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101672902|NCT00027859|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101672903|NCT00027859|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101672904|NCT00027859|Docetaxel|docetaxel|mesh-list
101672905|NCT00027859|Estramustine|estramustine|mesh-list
101672906|NCT00027859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672907|NCT00027859|Tubulin Modulators|tubulin modulators|mesh-ancestor
101672908|NCT00027859|Antimitotic Agents|antimitotic agents|mesh-ancestor
101672909|NCT00027859|Mitosis Modulators|mitosis modulators|mesh-ancestor
101672910|NCT00027859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672911|NCT00027859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101672912|NCT00027859|Antifungal Agents|antifungal agents|mesh-ancestor
101672913|NCT00027859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101672914|NCT00027859|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101672915|NCT00027859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101672916|NCT00027859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101672917|NCT00027859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101672918|NCT00027859|Hormone Antagonists|hormone antagonists|mesh-ancestor
101672919|NCT00027859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101672920|NCT00027859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672921|NCT00027859|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101672922|NCT00027859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101672923|NCT00027859|Alkylating Agents|alkylating agents|mesh-ancestor
101672924|NCT00027859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101672925|NCT00026286|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101672926|NCT00026286|Medroxyprogesterone|medroxyprogesterone|mesh-list
101672927|NCT00026286|Estrogens|estrogens|mesh-list
101672928|NCT00026286|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101672929|NCT00026286|Hormones|hormones|mesh-ancestor
101672930|NCT00026286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101672931|NCT00026286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672932|NCT00026286|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101672933|NCT00026286|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101672934|NCT00026286|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101672935|NCT00026286|Contraceptive Agents|contraceptive agents|mesh-ancestor
101672936|NCT00026286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101672937|NCT00026286|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101672938|NCT00026286|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101672939|NCT00026286|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101672940|NCT00026286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101672941|NCT00026286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101827800|NCT06014606|Vasodilator Agents|vasodilator agents|mesh-ancestor
101827801|NCT06014606|Antiemetics|antiemetics|mesh-ancestor
101672942|NCT00014118|Paclitaxel|paclitaxel|mesh-list
101672943|NCT00014118|Carboplatin|carboplatin|mesh-list
101672944|NCT00014118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101672945|NCT00014118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672946|NCT00014118|Tubulin Modulators|tubulin modulators|mesh-ancestor
101672947|NCT00014118|Antimitotic Agents|antimitotic agents|mesh-ancestor
101672948|NCT00014118|Mitosis Modulators|mitosis modulators|mesh-ancestor
101672949|NCT00014118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672950|NCT00006004|Paclitaxel|paclitaxel|mesh-list
101672951|NCT00006004|Carboplatin|carboplatin|mesh-list
101672952|NCT00006004|Gemcitabine|gemcitabine|mesh-list
101672953|NCT00006004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101672954|NCT00006004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672955|NCT00006004|Tubulin Modulators|tubulin modulators|mesh-ancestor
101672956|NCT00006004|Antimitotic Agents|antimitotic agents|mesh-ancestor
101672957|NCT00006004|Mitosis Modulators|mitosis modulators|mesh-ancestor
101672958|NCT00006004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672959|NCT00006004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101672960|NCT00006004|Antimetabolites|antimetabolites|mesh-ancestor
101672961|NCT00004860|Leucovorin|leucovorin|mesh-list
101672962|NCT00004860|Tegafur|tegafur|mesh-list
101672963|NCT00004860|Calcium|calcium|mesh-list
101672964|NCT00004860|Levoleucovorin|levoleucovorin|mesh-list
101672965|NCT00004860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101672966|NCT00004860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101672967|NCT00004860|Antidotes|antidotes|mesh-ancestor
101672968|NCT00004860|Protective Agents|protective agents|mesh-ancestor
101672969|NCT00004860|Vitamin B Complex|vitamin b complex|mesh-ancestor
101672970|NCT00004860|Vitamins|vitamins|mesh-ancestor
101672971|NCT00004860|Micronutrients|micronutrients|mesh-ancestor
101672972|NCT00004860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101672973|NCT00004860|Antimetabolites|antimetabolites|mesh-ancestor
101672974|NCT00004860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672975|NCT00004860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672976|NCT00003864|Carboplatin|carboplatin|mesh-list
101672977|NCT00003864|Docetaxel|docetaxel|mesh-list
101672978|NCT00003864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672979|NCT00003864|Tubulin Modulators|tubulin modulators|mesh-ancestor
101672980|NCT00003864|Antimitotic Agents|antimitotic agents|mesh-ancestor
101672981|NCT00003864|Mitosis Modulators|mitosis modulators|mesh-ancestor
101672982|NCT00003864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672983|NCT00003810|Gemcitabine|gemcitabine|mesh-list
101672984|NCT00003810|Docetaxel|docetaxel|mesh-list
101672985|NCT00003810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101672986|NCT00003810|Antimetabolites|antimetabolites|mesh-ancestor
101672987|NCT00003810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101672988|NCT00003810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101672989|NCT00003810|Tubulin Modulators|tubulin modulators|mesh-ancestor
101672990|NCT00003810|Antimitotic Agents|antimitotic agents|mesh-ancestor
101672991|NCT00003810|Mitosis Modulators|mitosis modulators|mesh-ancestor
101672992|NCT00003701|Paclitaxel|paclitaxel|mesh-list
101672993|NCT00003701|Vinblastine|vinblastine|mesh-list
101672994|NCT00003701|Carboplatin|carboplatin|mesh-list
101672995|NCT00003701|Doxorubicin|doxorubicin|mesh-list
101672996|NCT00003701|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101672998|NCT00003701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101672999|NCT00003701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101673000|NCT00003701|Tubulin Modulators|tubulin modulators|mesh-ancestor
101673001|NCT00003701|Antimitotic Agents|antimitotic agents|mesh-ancestor
101673002|NCT00003701|Mitosis Modulators|mitosis modulators|mesh-ancestor
101673003|NCT00003701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673004|NCT00003701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101673005|NCT00003701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101673006|NCT00003701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101673007|NCT00003701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101673008|NCT00003701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101673009|NCT00003701|Abortifacient Agents|abortifacient agents|mesh-ancestor
101673010|NCT00003701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101673011|NCT00003701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673012|NCT00003701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101673013|NCT00003701|Antimetabolites|antimetabolites|mesh-ancestor
101673014|NCT00003701|Dermatologic Agents|dermatologic agents|mesh-ancestor
101673015|NCT00003701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101673016|NCT00003701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101673017|NCT00003701|Immunologic Factors|immunologic factors|mesh-ancestor
101673018|NCT00003701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101673019|NCT00003701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101673020|NCT00003615|Denileukin diftitox|denileukin diftitox|mesh-list
101673021|NCT00003615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101673022|NCT00003614|Paclitaxel|paclitaxel|mesh-list
101673023|NCT00003614|Estramustine|estramustine|mesh-list
101673024|NCT00003614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101673025|NCT00003614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101673026|NCT00003614|Tubulin Modulators|tubulin modulators|mesh-ancestor
101673027|NCT00003614|Antimitotic Agents|antimitotic agents|mesh-ancestor
101673028|NCT00003614|Mitosis Modulators|mitosis modulators|mesh-ancestor
101673029|NCT00003614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673030|NCT00003614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101673031|NCT00003614|Alkylating Agents|alkylating agents|mesh-ancestor
101673032|NCT00003614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101673033|NCT00003519|Cyclophosphamide|cyclophosphamide|mesh-list
101673035|NCT00003519|Doxorubicin|doxorubicin|mesh-list
101673036|NCT00003519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101673037|NCT00003519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101673038|NCT00003519|Immunologic Factors|immunologic factors|mesh-ancestor
101673039|NCT00003519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673040|NCT00003519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101673041|NCT00003519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101673042|NCT00003519|Alkylating Agents|alkylating agents|mesh-ancestor
101673043|NCT00003519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673044|NCT00003519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101673045|NCT00003519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101673046|NCT00003519|Tubulin Modulators|tubulin modulators|mesh-ancestor
101673047|NCT00003519|Antimitotic Agents|antimitotic agents|mesh-ancestor
101673048|NCT00003519|Mitosis Modulators|mitosis modulators|mesh-ancestor
101673049|NCT00003519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101673050|NCT00003519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101673051|NCT00003519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101673052|NCT00003519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101673054|NCT00003283|Octreotide|octreotide|mesh-list
101673055|NCT00003283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101673056|NCT00003283|Glucocorticoids|glucocorticoids|mesh-ancestor
101673057|NCT00003283|Hormones|hormones|mesh-ancestor
101673058|NCT00003283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101673059|NCT00003283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673060|NCT00003283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101673062|NCT00003283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101673063|NCT00003235|Paclitaxel|paclitaxel|mesh-list
101673064|NCT00003235|Carboplatin|carboplatin|mesh-list
101673065|NCT00003235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101673066|NCT00003235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101673067|NCT00003235|Tubulin Modulators|tubulin modulators|mesh-ancestor
101673068|NCT00003235|Antimitotic Agents|antimitotic agents|mesh-ancestor
101673069|NCT00003235|Mitosis Modulators|mitosis modulators|mesh-ancestor
101673070|NCT00003235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673071|NCT00003206|Paclitaxel|paclitaxel|mesh-list
101673072|NCT00003206|Carboplatin|carboplatin|mesh-list
101673073|NCT00003206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101673074|NCT00003206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101673075|NCT00003206|Tubulin Modulators|tubulin modulators|mesh-ancestor
101673076|NCT00003206|Antimitotic Agents|antimitotic agents|mesh-ancestor
101673077|NCT00003206|Mitosis Modulators|mitosis modulators|mesh-ancestor
101673078|NCT00003206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673080|NCT00003010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101673081|NCT00003010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673082|NCT00003008|Ritonavir|ritonavir|mesh-list
101673083|NCT00003008|Nelfinavir|nelfinavir|mesh-list
101673084|NCT00003008|Indinavir|indinavir|mesh-list
101673085|NCT00003008|Saquinavir|saquinavir|mesh-list
101673086|NCT00003008|Paclitaxel|paclitaxel|mesh-list
101673087|NCT00003008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101673088|NCT00003008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101673089|NCT00003008|Tubulin Modulators|tubulin modulators|mesh-ancestor
101673090|NCT00003008|Antimitotic Agents|antimitotic agents|mesh-ancestor
101673091|NCT00003008|Mitosis Modulators|mitosis modulators|mesh-ancestor
101673092|NCT00003008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673093|NCT00003008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101673094|NCT00003008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101673095|NCT00003008|Protease Inhibitors|protease inhibitors|mesh-ancestor
101673096|NCT00003008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101673097|NCT00003008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101673098|NCT00003008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101673099|NCT00003008|Antiviral Agents|antiviral agents|mesh-ancestor
101673100|NCT00003008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101673101|NCT00003008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101673102|NCT00003008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101673103|NCT00002996|Flecainide|flecainide|mesh-list
101673104|NCT00002996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101673105|NCT00002996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101538459|NCT00470054|Dasatinib|dasatinib|mesh-list
101673106|NCT00002996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101673107|NCT00002996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101673108|NCT00002996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673109|NCT00002878|Dexamethasone|dexamethasone|mesh-list
101673110|NCT00002878|Doxorubicin|doxorubicin|mesh-list
101673111|NCT00002878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101673112|NCT00002878|Vincristine|vincristine|mesh-list
101673113|NCT00002878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101673114|NCT00002878|Antiemetics|antiemetics|mesh-ancestor
101673115|NCT00002878|Autonomic Agents|autonomic agents|mesh-ancestor
101673116|NCT00002878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101673117|NCT00002878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673118|NCT00002878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101673119|NCT00002878|Glucocorticoids|glucocorticoids|mesh-ancestor
101673120|NCT00002878|Hormones|hormones|mesh-ancestor
101673121|NCT00002878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101673122|NCT00002878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101673123|NCT00002878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101673124|NCT00002878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101827845|NCT06014385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101673125|NCT00002878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101673126|NCT00002878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101673127|NCT00002878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101673128|NCT00002878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673129|NCT00002878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101673130|NCT00002878|Tubulin Modulators|tubulin modulators|mesh-ancestor
101673131|NCT00002878|Antimitotic Agents|antimitotic agents|mesh-ancestor
101673132|NCT00002878|Mitosis Modulators|mitosis modulators|mesh-ancestor
101673133|NCT00002632|Paclitaxel|paclitaxel|mesh-list
101673134|NCT00002632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101673135|NCT00002632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101673136|NCT00002632|Tubulin Modulators|tubulin modulators|mesh-ancestor
101673137|NCT00002632|Antimitotic Agents|antimitotic agents|mesh-ancestor
101673138|NCT00002632|Mitosis Modulators|mitosis modulators|mesh-ancestor
101673139|NCT00002632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673140|NCT00002520|Nicotine|nicotine|mesh-list
101673141|NCT00002520|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101673142|NCT00002520|Autonomic Agents|autonomic agents|mesh-ancestor
101673143|NCT00002520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101673144|NCT00002520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673145|NCT00002520|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101673146|NCT00002520|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101673147|NCT00002520|Cholinergic Agents|cholinergic agents|mesh-ancestor
101673148|NCT00002520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101673149|NCT00002520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673150|NCT00609557|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101673151|NCT00609557|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101673152|NCT00609557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101673153|NCT00609557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101673154|NCT00609557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673155|NCT00609557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101673156|NCT00609557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673157|NCT00609557|Analgesics|analgesics|mesh-ancestor
101673158|NCT00609557|Sensory System Agents|sensory system agents|mesh-ancestor
101673159|NCT00609557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101673160|NCT00609557|Antidepressive Agents|antidepressive agents|mesh-ancestor
101673161|NCT00609557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101673162|NCT00609557|Dopamine Agents|dopamine agents|mesh-ancestor
101673163|NCT05122481|Ascorbic Acid|ascorbic acid|mesh-list
101673164|NCT05122481|Vitamins|vitamins|mesh-ancestor
101673165|NCT05122481|Micronutrients|micronutrients|mesh-ancestor
101673166|NCT05122481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673167|NCT05122481|Antioxidants|antioxidants|mesh-ancestor
101673168|NCT05122481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673169|NCT05122481|Protective Agents|protective agents|mesh-ancestor
101673170|NCT00937417|Docetaxel|docetaxel|mesh-list
101673171|NCT00937417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101673172|NCT00937417|Tubulin Modulators|tubulin modulators|mesh-ancestor
101673173|NCT00937417|Antimitotic Agents|antimitotic agents|mesh-ancestor
101673174|NCT00937417|Mitosis Modulators|mitosis modulators|mesh-ancestor
101673175|NCT00937417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673176|NCT02728440|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101673177|NCT02728440|Menotropins|menotropins|mesh-list
101673178|NCT02728440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101673179|NCT02728440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673180|NCT02728440|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101673181|NCT02728440|Fertility Agents|fertility agents|mesh-ancestor
101673182|NCT05358912|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
101673183|NCT04261517|Hydroxychloroquine|hydroxychloroquine|mesh-list
101673184|NCT04261517|Antimalarials|antimalarials|mesh-ancestor
101673185|NCT04261517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101673186|NCT04261517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101673187|NCT04261517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101673188|NCT04261517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101673189|NCT04261517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673190|NCT04261517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101673192|NCT00930865|Bumetanide|bumetanide|mesh-list
101673193|NCT00930865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101673194|NCT00930865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673195|NCT00930865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101673196|NCT00930865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673197|NCT00930865|Diuretics|diuretics|mesh-ancestor
101673198|NCT00930865|Natriuretic Agents|natriuretic agents|mesh-ancestor
101673199|NCT00930865|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101673200|NCT00930865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101673201|NCT02737800|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101673202|NCT02737800|Luteolytic Agents|luteolytic agents|mesh-ancestor
101673203|NCT02737800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101673204|NCT02737800|Contraceptive Agents|contraceptive agents|mesh-ancestor
101673205|NCT02737800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101673206|NCT02737800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673207|NCT02737800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101673208|NCT02737800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101673209|NCT02737800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101673210|NCT00934531|Donepezil|donepezil|mesh-list
101673211|NCT00934531|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101673212|NCT00934531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101673213|NCT00934531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673214|NCT00934531|Cholinergic Agents|cholinergic agents|mesh-ancestor
101673215|NCT00934531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101673216|NCT00934531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673217|NCT00934531|Nootropic Agents|nootropic agents|mesh-ancestor
101673218|NCT00931021|Nicotine|nicotine|mesh-list
101673219|NCT00931021|Varenicline|varenicline|mesh-list
101673220|NCT00931021|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101673221|NCT00931021|Autonomic Agents|autonomic agents|mesh-ancestor
101673222|NCT00931021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101673223|NCT00931021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673224|NCT00931021|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101673225|NCT00931021|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101673226|NCT00931021|Cholinergic Agents|cholinergic agents|mesh-ancestor
101330456|NCT00000530|Tocolytic Agents|tocolytic agents|mesh-ancestor
101673227|NCT00931021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101673228|NCT00931021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673229|NCT00937807|Sevoflurane|sevoflurane|mesh-list
101673230|NCT00937807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101673231|NCT00937807|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101673232|NCT00937807|Anesthetics, General|anesthetics, general|mesh-ancestor
101673233|NCT00937807|Anesthetics|anesthetics|mesh-ancestor
101451725|NCT00208065|Sympathomimetics|sympathomimetics|mesh-ancestor
101673234|NCT00937807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101673235|NCT00937807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673236|NCT00934687|Botulinum Toxins|botulinum toxins|mesh-list
101673237|NCT00934687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101673238|NCT00934687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101673239|NCT00934687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101673240|NCT00934687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101673241|NCT00934687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673242|NCT00934687|Cholinergic Agents|cholinergic agents|mesh-ancestor
101673243|NCT00934687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101673244|NCT00934687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673245|NCT00934687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101673246|NCT00934687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101673247|NCT02808728|Bupivacaine|bupivacaine|mesh-list
101673248|NCT02808728|Ropivacaine|ropivacaine|mesh-list
101673249|NCT02808728|Anesthetics, Local|anesthetics, local|mesh-ancestor
101673250|NCT02808728|Anesthetics|anesthetics|mesh-ancestor
101673251|NCT02808728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101673252|NCT02808728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673253|NCT02808728|Sensory System Agents|sensory system agents|mesh-ancestor
101673254|NCT02808728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101673255|NCT05331053|Atorvastatin|atorvastatin|mesh-list
101673256|NCT05331053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101673257|NCT05331053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101673258|NCT05331053|Antimetabolites|antimetabolites|mesh-ancestor
101673259|NCT05331053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673260|NCT05331053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101673261|NCT05331053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101673262|NCT05331053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101673263|NCT02732730|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101673264|NCT02732730|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101673265|NCT02732730|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101673266|NCT02732730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101673267|NCT02732730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673268|NCT02732730|Antiviral Agents|antiviral agents|mesh-ancestor
101673269|NCT02732730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101673270|NCT02732730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101673271|NCT02732730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101673272|NCT02808650|Prexasertib|prexasertib|mesh-list
101673273|NCT02808650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101673274|NCT02808650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101673275|NCT02808650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673276|NCT04996667|Nitric Oxide|nitric oxide|mesh-list
101673277|NCT04996667|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101673278|NCT04996667|Autonomic Agents|autonomic agents|mesh-ancestor
101673279|NCT04996667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101673280|NCT04996667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673281|NCT04996667|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101673282|NCT04996667|Respiratory System Agents|respiratory system agents|mesh-ancestor
101673283|NCT04996667|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101673284|NCT04996667|Antioxidants|antioxidants|mesh-ancestor
101673285|NCT04996667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673286|NCT04996667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101673287|NCT04996667|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101673288|NCT04996667|Vasodilator Agents|vasodilator agents|mesh-ancestor
101673289|NCT04996667|Gasotransmitters|gasotransmitters|mesh-ancestor
101673290|NCT04996667|Protective Agents|protective agents|mesh-ancestor
101673291|NCT00929669|Pasireotide|pasireotide|mesh-list
101673292|NCT00929669|Hormones|hormones|mesh-ancestor
101673293|NCT00929669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101673294|NCT00929669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673295|NCT02804360|Dexamethasone|dexamethasone|mesh-list
101673296|NCT02804360|Dexamethasone acetate|dexamethasone acetate|mesh-list
101673297|NCT02804360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101673298|NCT02804360|Antiemetics|antiemetics|mesh-ancestor
101673299|NCT02804360|Autonomic Agents|autonomic agents|mesh-ancestor
101673300|NCT02804360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101673301|NCT02804360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673302|NCT02804360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101673303|NCT02804360|Glucocorticoids|glucocorticoids|mesh-ancestor
101673304|NCT02804360|Hormones|hormones|mesh-ancestor
101673305|NCT02804360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101673306|NCT02804360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101673307|NCT02804360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101673308|NCT02727738|Selenium|selenium|mesh-list
101673309|NCT02727738|Methimazole|methimazole|mesh-list
101673310|NCT02727738|Antioxidants|antioxidants|mesh-ancestor
101673311|NCT02727738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673312|NCT02727738|Protective Agents|protective agents|mesh-ancestor
101673313|NCT02727738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673314|NCT02727738|Trace Elements|trace elements|mesh-ancestor
101673315|NCT02727738|Micronutrients|micronutrients|mesh-ancestor
101827873|NCT06014138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101673316|NCT02727738|Antithyroid Agents|antithyroid agents|mesh-ancestor
101673317|NCT02727738|Hormone Antagonists|hormone antagonists|mesh-ancestor
101673318|NCT02727738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101673319|NCT02732418|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101673320|NCT02732418|Contraceptive Agents|contraceptive agents|mesh-list
101673321|NCT02732418|Medroxyprogesterone|medroxyprogesterone|mesh-list
101673322|NCT02732418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101673323|NCT02732418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673324|NCT02732418|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101673325|NCT02732418|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101673326|NCT02732418|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101673327|NCT02732418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101673328|NCT02732418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101673329|NCT02732418|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101673330|NCT02732418|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101673331|NCT02732418|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101673333|NCT02811692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101673334|NCT02811692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101673335|NCT02811692|Growth Substances|growth substances|mesh-ancestor
101673336|NCT02811692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673337|NCT02811692|Growth Inhibitors|growth inhibitors|mesh-ancestor
101673338|NCT02811692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101673339|NCT04004078|Antifungal Agents|antifungal agents|mesh-list
101673340|NCT04004078|Clotrimazole|clotrimazole|mesh-list
101673342|NCT04004078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101673343|NCT04004078|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101673344|NCT04004078|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101673345|NCT04004078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101673346|NCT04004078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101673347|NCT04004078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673348|NCT04004078|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101673349|NCT04004078|Hormone Antagonists|hormone antagonists|mesh-ancestor
101673350|NCT04004078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101673351|NCT04004078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673352|NCT04004078|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101673353|NCT04004078|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101673354|NCT02732262|Oxycodone|oxycodone|mesh-list
101673355|NCT02732262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101673356|NCT02732262|Narcotics|narcotics|mesh-ancestor
101673357|NCT02732262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101673358|NCT02732262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673359|NCT02732262|Analgesics|analgesics|mesh-ancestor
101673360|NCT02732262|Sensory System Agents|sensory system agents|mesh-ancestor
101673361|NCT02732262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101673362|NCT00926393|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101673363|NCT00926393|Antidepressive Agents|antidepressive agents|mesh-ancestor
101673364|NCT00926393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101673365|NCT00926393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101673366|NCT00926393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101673367|NCT00926393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101673368|NCT00926393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673369|NCT02737254|Oxytocin|oxytocin|mesh-list
101673370|NCT02737254|Oxytocics|oxytocics|mesh-ancestor
101673371|NCT02737254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101673372|NCT02737254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673373|NCT00938197|Amlodipine|amlodipine|mesh-list
101673374|NCT00938197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101673375|NCT00938197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101673376|NCT00938197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101827882|NCT06014073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101827883|NCT06014073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101673377|NCT00938197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673378|NCT00938197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101673379|NCT00938197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673380|NCT00938197|Vasodilator Agents|vasodilator agents|mesh-ancestor
101673382|NCT02727504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101673383|NCT02727504|Sympathomimetics|sympathomimetics|mesh-ancestor
101673384|NCT02727504|Autonomic Agents|autonomic agents|mesh-ancestor
101673385|NCT02727504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101673386|NCT02727504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673387|NCT02727504|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101673388|NCT02727504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101673389|NCT02727504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101673390|NCT02727504|Adrenergic Agents|adrenergic agents|mesh-ancestor
101673391|NCT02727504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101673392|NCT02727504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673393|NCT02727504|Protective Agents|protective agents|mesh-ancestor
101673394|NCT02727348|Anesthetics|anesthetics|mesh-list
101673395|NCT02727348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101673396|NCT02727348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673397|NCT02804126|Acetaminophen|acetaminophen|mesh-list
101673398|NCT02804126|Dipyrone|dipyrone|mesh-list
101673399|NCT02804126|Ketoprofen|ketoprofen|mesh-list
101673400|NCT02804126|Morphine|morphine|mesh-list
101673401|NCT02804126|Bupivacaine|bupivacaine|mesh-list
101673402|NCT02804126|Anesthetics, Local|anesthetics, local|mesh-ancestor
101673403|NCT02804126|Anesthetics|anesthetics|mesh-ancestor
101673404|NCT02804126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101673405|NCT02804126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673406|NCT02804126|Sensory System Agents|sensory system agents|mesh-ancestor
101673407|NCT02804126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101673408|NCT02804126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101673409|NCT02804126|Narcotics|narcotics|mesh-ancestor
101673410|NCT02804126|Analgesics|analgesics|mesh-ancestor
101673411|NCT02804126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101673412|NCT02804126|Antipyretics|antipyretics|mesh-ancestor
101673413|NCT02804126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101673414|NCT02804126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101673415|NCT02804126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101673416|NCT02804126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101673417|NCT02804126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101673418|NCT02804126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673419|NCT04013815|Ropivacaine|ropivacaine|mesh-list
101673420|NCT04013815|Anesthetics, Local|anesthetics, local|mesh-ancestor
101673421|NCT04013815|Anesthetics|anesthetics|mesh-ancestor
101827895|NCT06013956|Dopamine Agents|dopamine agents|mesh-ancestor
101673422|NCT04013815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101673423|NCT04013815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673424|NCT04013815|Sensory System Agents|sensory system agents|mesh-ancestor
101673425|NCT04013815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101673426|NCT00610103|Apomorphine|apomorphine|mesh-list
101673427|NCT00610103|Emetics|emetics|mesh-ancestor
101673428|NCT00610103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673429|NCT00610103|Autonomic Agents|autonomic agents|mesh-ancestor
101673430|NCT00610103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101673431|NCT00610103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101673432|NCT00610103|Dopamine Agonists|dopamine agonists|mesh-ancestor
101673433|NCT00610103|Dopamine Agents|dopamine agents|mesh-ancestor
101673434|NCT00610103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101673435|NCT00610103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673436|NCT05624190|Plasminogen|plasminogen|mesh-list
101673437|NCT05624190|Tenecteplase|tenecteplase|mesh-list
101673438|NCT05624190|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101673439|NCT05624190|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101673440|NCT05624190|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101673441|NCT05624190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673442|NCT00938353|Beclomethasone|beclomethasone|mesh-list
101673443|NCT00938353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101673444|NCT00938353|Glucocorticoids|glucocorticoids|mesh-ancestor
101673445|NCT00938353|Hormones|hormones|mesh-ancestor
101673446|NCT00938353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101673447|NCT00938353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673448|NCT00938353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101673449|NCT00938353|Respiratory System Agents|respiratory system agents|mesh-ancestor
101673450|NCT04259333|Acetaminophen|acetaminophen|mesh-list
101673451|NCT04259333|Celecoxib|celecoxib|mesh-list
101673452|NCT04259333|Codeine|codeine|mesh-list
101673453|NCT04259333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101673454|NCT04259333|Analgesics|analgesics|mesh-ancestor
101673455|NCT04259333|Sensory System Agents|sensory system agents|mesh-ancestor
101673456|NCT04259333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101673457|NCT04259333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673458|NCT04259333|Antipyretics|antipyretics|mesh-ancestor
101673459|NCT04259333|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101673460|NCT04259333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101673461|NCT04259333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101673462|NCT04259333|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101673463|NCT04259333|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101673464|NCT04259333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101673465|NCT04259333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673466|NCT04259333|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101673467|NCT04259333|Narcotics|narcotics|mesh-ancestor
101673468|NCT04259333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101673469|NCT04259333|Antitussive Agents|antitussive agents|mesh-ancestor
101673470|NCT04259333|Respiratory System Agents|respiratory system agents|mesh-ancestor
101673471|NCT02721420|Piperaquine|piperaquine|mesh-list
101673472|NCT02721420|Artenimol|artenimol|mesh-list
101673473|NCT02721420|Antimalarials|antimalarials|mesh-ancestor
101673474|NCT02721420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101673475|NCT02721420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101673476|NCT02721420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101673477|NCT00608699|Niacin|niacin|mesh-list
101673478|NCT00608699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101673480|NCT00608699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673481|NCT00608699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101673482|NCT00608699|Vasodilator Agents|vasodilator agents|mesh-ancestor
101673483|NCT00608699|Vitamin B Complex|vitamin b complex|mesh-ancestor
101673484|NCT00608699|Vitamins|vitamins|mesh-ancestor
101673485|NCT00608699|Micronutrients|micronutrients|mesh-ancestor
101673486|NCT00608699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673487|NCT05193396|Hydrocortisone|hydrocortisone|mesh-list
101673488|NCT05193396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101673489|NCT02726490|Metformin|metformin|mesh-list
101673490|NCT02726490|Glyburide|glyburide|mesh-list
101673491|NCT02726490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101673492|NCT02726490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673493|NCT02726646|Doxycycline|doxycycline|mesh-list
101673494|NCT02726646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101673495|NCT02726646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101673496|NCT02726646|Antimalarials|antimalarials|mesh-ancestor
101673497|NCT02726646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101673498|NCT02726646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101673499|NCT02803892|Vildagliptin|vildagliptin|mesh-list
101673500|NCT02803892|Sirolimus|sirolimus|mesh-list
101673501|NCT02803892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101673502|NCT02803892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101673503|NCT02803892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101673504|NCT02803892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101673505|NCT02803892|Antifungal Agents|antifungal agents|mesh-ancestor
101673506|NCT02803892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101673507|NCT02803892|Immunologic Factors|immunologic factors|mesh-ancestor
101673508|NCT02803892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673509|NCT02803892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101673510|NCT02803892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673511|NCT02803892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101673512|NCT02803892|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101673513|NCT02803892|Protease Inhibitors|protease inhibitors|mesh-ancestor
101673514|NCT02721186|Primaquine|primaquine|mesh-list
101673515|NCT02721186|Piperaquine|piperaquine|mesh-list
101673516|NCT02721186|Artenimol|artenimol|mesh-list
101673517|NCT02721186|Antimalarials|antimalarials|mesh-ancestor
101673518|NCT02721186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101673519|NCT02721186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101673520|NCT02721186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101673521|NCT02716428|Ribavirin|ribavirin|mesh-list
101673522|NCT02716428|Antimetabolites|antimetabolites|mesh-ancestor
101673523|NCT02716428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673524|NCT02716428|Antiviral Agents|antiviral agents|mesh-ancestor
101330756|NCT00032149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101673525|NCT02716428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101673526|NCT05511428|Daratumumab|daratumumab|mesh-list
101673527|NCT05511428|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101673528|NCT05511428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101673529|NCT05511428|Immunologic Factors|immunologic factors|mesh-ancestor
101673530|NCT05511428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673531|NCT00931463|Ritonavir|ritonavir|mesh-list
101673532|NCT00931463|Lopinavir|lopinavir|mesh-list
101673533|NCT00931463|Raltegravir Potassium|raltegravir potassium|mesh-list
101673534|NCT00931463|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101673535|NCT00931463|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101673536|NCT00931463|Protease Inhibitors|protease inhibitors|mesh-ancestor
101673537|NCT00931463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101673538|NCT00931463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673539|NCT00931463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101673540|NCT00931463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101673541|NCT00931463|Antiviral Agents|antiviral agents|mesh-ancestor
101673542|NCT00931463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101673543|NCT00931463|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101673544|NCT00931463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101673545|NCT00931463|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101673546|NCT00931463|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101673547|NCT03974594|Trifluridine|trifluridine|mesh-list
101673548|NCT03974594|Antimetabolites|antimetabolites|mesh-ancestor
101673549|NCT03974594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673550|NCT03974594|Antiviral Agents|antiviral agents|mesh-ancestor
101673551|NCT03974594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101673552|NCT03964688|Ascorbic Acid|ascorbic acid|mesh-list
101673553|NCT03964688|Vitamins|vitamins|mesh-ancestor
101673554|NCT03964688|Micronutrients|micronutrients|mesh-ancestor
101538894|NCT04671836|Lorazepam|lorazepam|mesh-list
101673555|NCT03964688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673556|NCT03964688|Antioxidants|antioxidants|mesh-ancestor
101673557|NCT03964688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673558|NCT03964688|Protective Agents|protective agents|mesh-ancestor
101673559|NCT00929201|Metformin|metformin|mesh-list
101673560|NCT00929201|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101673561|NCT00929201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101673562|NCT00929201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673563|NCT00929201|Incretins|incretins|mesh-ancestor
101673564|NCT00929201|Hormones|hormones|mesh-ancestor
101673565|NCT00929201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101673566|NCT00929201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101673567|NCT00929201|Protease Inhibitors|protease inhibitors|mesh-ancestor
101673568|NCT00929201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101673569|NCT00929201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673570|NCT02800772|Acetic Acid|acetic acid|mesh-list
101673571|NCT02800772|Retinol acetate|retinol acetate|mesh-list
101673572|NCT02800772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101673573|NCT02800772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101673574|NCT02800772|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101673575|NCT02800772|Immunologic Factors|immunologic factors|mesh-ancestor
101673576|NCT02800772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673577|NCT02800772|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101673578|NCT02800772|Protective Agents|protective agents|mesh-ancestor
101673579|NCT02800772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101673580|NCT02773212|Amphetamine|amphetamine|mesh-list
101673581|NCT02773212|Dextroamphetamine|dextroamphetamine|mesh-list
101673582|NCT02773212|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101673583|NCT02773212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673584|NCT02773212|Sympathomimetics|sympathomimetics|mesh-ancestor
101673585|NCT02773212|Autonomic Agents|autonomic agents|mesh-ancestor
101673586|NCT02773212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101673588|NCT02773212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101673589|NCT02773212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673590|NCT02773212|Adrenergic Agents|adrenergic agents|mesh-ancestor
101673591|NCT02773212|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101673592|NCT02773212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101673593|NCT02773212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101673594|NCT02773212|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101673595|NCT00610493|Sirolimus|sirolimus|mesh-list
101673596|NCT00610493|Bevacizumab|bevacizumab|mesh-list
101673597|NCT00610493|Temsirolimus|temsirolimus|mesh-list
101673598|NCT00610493|MTOR Inhibitors|mtor inhibitors|mesh-list
101673599|NCT00610493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101673600|NCT00610493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101673601|NCT00610493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101673602|NCT00610493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101673603|NCT00610493|Growth Substances|growth substances|mesh-ancestor
101673604|NCT00610493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673605|NCT00610493|Growth Inhibitors|growth inhibitors|mesh-ancestor
101673606|NCT00610493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101673607|NCT00610493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101673608|NCT00610493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673609|NCT00610493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101673610|NCT00610493|Immunologic Factors|immunologic factors|mesh-ancestor
101673611|NCT00610493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101673612|NCT00610493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101673613|NCT00610493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101673614|NCT00610493|Antifungal Agents|antifungal agents|mesh-ancestor
101673615|NCT02716272|Nivolumab|nivolumab|mesh-list
101673616|NCT02716272|Ipilimumab|ipilimumab|mesh-list
101673617|NCT02716272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101673618|NCT02716272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101673619|NCT02716272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101673620|NCT02716272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673621|NCT02720406|Ketamine|ketamine|mesh-list
101673622|NCT02720406|Analgesics|analgesics|mesh-ancestor
101673623|NCT02720406|Sensory System Agents|sensory system agents|mesh-ancestor
101673624|NCT02720406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101673625|NCT02720406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673626|NCT02720406|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101673627|NCT02720406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101673628|NCT02720406|Anesthetics, General|anesthetics, general|mesh-ancestor
101673629|NCT02720406|Anesthetics|anesthetics|mesh-ancestor
101673630|NCT02720406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101673631|NCT02720406|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101673632|NCT02720406|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101673633|NCT02720406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101673634|NCT02720406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673635|NCT05504876|Midazolam|midazolam|mesh-list
101673636|NCT05504876|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101673637|NCT05504876|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101673638|NCT05504876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101673639|NCT05504876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673640|NCT05504876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101673641|NCT05504876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101673642|NCT05504876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101673643|NCT05504876|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101673644|NCT05504876|Anesthetics, General|anesthetics, general|mesh-ancestor
101673645|NCT05504876|Anesthetics|anesthetics|mesh-ancestor
101673646|NCT05504876|GABA Modulators|gaba modulators|mesh-ancestor
101673647|NCT05504876|GABA Agents|gaba agents|mesh-ancestor
101673648|NCT05504876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101673649|NCT05504876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673650|NCT02802722|Vitamin D|vitamin d|mesh-list
101673651|NCT02802722|Cholecalciferol|cholecalciferol|mesh-list
101673652|NCT02802722|Vitamins|vitamins|mesh-ancestor
101673653|NCT02802722|Micronutrients|micronutrients|mesh-ancestor
101673654|NCT02802722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451726|NCT00208065|Adrenergic Agents|adrenergic agents|mesh-ancestor
101673655|NCT02802722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101673656|NCT02802722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101673657|NCT02802644|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101673658|NCT02802644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101673659|NCT02802644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673660|NCT02802644|Incretins|incretins|mesh-ancestor
101673661|NCT02802644|Hormones|hormones|mesh-ancestor
101673662|NCT02802644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101673663|NCT02802644|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101673664|NCT02802644|Protease Inhibitors|protease inhibitors|mesh-ancestor
101673665|NCT02802644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101673666|NCT02802644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673667|NCT02744976|Metformin|metformin|mesh-list
101673668|NCT02744976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101673669|NCT02744976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673670|NCT00928889|Acarbose|acarbose|mesh-list
101673671|NCT00928889|Nateglinide|nateglinide|mesh-list
101673672|NCT00928889|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101673673|NCT00928889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101673674|NCT00928889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673675|NCT00928889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101673676|NCT00928889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673677|NCT02725398|Scopolamine|scopolamine|mesh-list
101673678|NCT02725398|Bromides|bromides|mesh-list
101673679|NCT02725398|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101673680|NCT02725398|Anticonvulsants|anticonvulsants|mesh-ancestor
101673681|NCT02725398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101673682|NCT02725398|Antiemetics|antiemetics|mesh-ancestor
101673683|NCT02725398|Autonomic Agents|autonomic agents|mesh-ancestor
101673684|NCT02725398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101673685|NCT02725398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673686|NCT02725398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101673687|NCT02725398|Mydriatics|mydriatics|mesh-ancestor
101673688|NCT02725398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101673689|NCT02725398|Cholinergic Agents|cholinergic agents|mesh-ancestor
101673690|NCT02725398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101673691|NCT02725398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673692|NCT02725398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101673693|NCT02725398|Parasympatholytics|parasympatholytics|mesh-ancestor
101673694|NCT02795546|Alendronate|alendronate|mesh-list
101673695|NCT02795546|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101673696|NCT02795546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673697|NCT03978091|Ceftazidime|ceftazidime|mesh-list
101673698|NCT03978091|Avibactam|avibactam|mesh-list
101673699|NCT03978091|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
101673700|NCT03978091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101673701|NCT03978091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101673702|NCT03978091|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101673703|NCT03978091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101673704|NCT03978091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673705|NCT00610571|Temozolomide|temozolomide|mesh-list
101673706|NCT00610571|Topotecan|topotecan|mesh-list
101673707|NCT00610571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101673708|NCT00610571|Alkylating Agents|alkylating agents|mesh-ancestor
101673709|NCT00610571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673710|NCT00610571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101673711|NCT00610571|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101673712|NCT00610571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101673713|NCT00610571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101673714|NCT02725242|Budesonide|budesonide|mesh-list
101673715|NCT02725242|Formoterol Fumarate|formoterol fumarate|mesh-list
101673716|NCT02725242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101673717|NCT02725242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101673718|NCT02725242|Autonomic Agents|autonomic agents|mesh-ancestor
101673719|NCT02725242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101673720|NCT02725242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673721|NCT02725242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101673722|NCT02725242|Respiratory System Agents|respiratory system agents|mesh-ancestor
101673723|NCT02725242|Glucocorticoids|glucocorticoids|mesh-ancestor
101673724|NCT02725242|Hormones|hormones|mesh-ancestor
101673725|NCT02725242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101673726|NCT02725242|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101673727|NCT02725242|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101673728|NCT02725242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101673729|NCT02725242|Adrenergic Agents|adrenergic agents|mesh-ancestor
101673730|NCT02725242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101673731|NCT02725242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673732|NCT00564733|Paclitaxel|paclitaxel|mesh-list
101673733|NCT00564733|Docetaxel|docetaxel|mesh-list
101673734|NCT00564733|Carboplatin|carboplatin|mesh-list
101673735|NCT00564733|Gemcitabine|gemcitabine|mesh-list
101673736|NCT00564733|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101673737|NCT00564733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101673738|NCT00564733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101673739|NCT00564733|Tubulin Modulators|tubulin modulators|mesh-ancestor
101673740|NCT00564733|Antimitotic Agents|antimitotic agents|mesh-ancestor
101673741|NCT00564733|Mitosis Modulators|mitosis modulators|mesh-ancestor
101673742|NCT00564733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673743|NCT00564733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101673744|NCT00564733|Antimetabolites|antimetabolites|mesh-ancestor
101673745|NCT00564733|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101673746|NCT02725164|Nitrous Oxide|nitrous oxide|mesh-list
101673747|NCT02725164|Sevoflurane|sevoflurane|mesh-list
101673748|NCT02725164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101673749|NCT02725164|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101827963|NCT06013423|Fludarabine|fludarabine|mesh-list
101673750|NCT02725164|Anesthetics, General|anesthetics, general|mesh-ancestor
101673751|NCT02725164|Anesthetics|anesthetics|mesh-ancestor
101673752|NCT02725164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101331030|NCT00033319|Aspirin|aspirin|mesh-list
101673753|NCT02725164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673754|NCT02725164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101673755|NCT02725164|Analgesics|analgesics|mesh-ancestor
101673756|NCT02725164|Sensory System Agents|sensory system agents|mesh-ancestor
101673757|NCT02725164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101673758|NCT02800694|Fentanyl|fentanyl|mesh-list
101673759|NCT02800694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101673760|NCT02800694|Narcotics|narcotics|mesh-ancestor
101673761|NCT02800694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101673762|NCT02800694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673763|NCT02800694|Analgesics|analgesics|mesh-ancestor
101673764|NCT02800694|Sensory System Agents|sensory system agents|mesh-ancestor
101673765|NCT02800694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101673766|NCT02800694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101673767|NCT02800694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101673768|NCT02800694|Anesthetics, General|anesthetics, general|mesh-ancestor
101673769|NCT02800694|Anesthetics|anesthetics|mesh-ancestor
101673770|NCT00931385|Formoterol Fumarate|formoterol fumarate|mesh-list
101673771|NCT00931385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101673772|NCT00931385|Autonomic Agents|autonomic agents|mesh-ancestor
101673773|NCT00931385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101673774|NCT00931385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673775|NCT00931385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101673776|NCT00931385|Respiratory System Agents|respiratory system agents|mesh-ancestor
101673777|NCT00931385|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101673778|NCT00931385|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101673779|NCT00931385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101673780|NCT00931385|Adrenergic Agents|adrenergic agents|mesh-ancestor
101673781|NCT00931385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101673782|NCT00931385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673783|NCT00938509|Ibuprofen|ibuprofen|mesh-list
101673784|NCT00938509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101673785|NCT00938509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101673786|NCT00938509|Analgesics|analgesics|mesh-ancestor
101673787|NCT00938509|Sensory System Agents|sensory system agents|mesh-ancestor
101673788|NCT00938509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101673789|NCT00938509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673790|NCT00938509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101673791|NCT00938509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101673792|NCT00938509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101673793|NCT00938509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101673794|NCT00938509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673795|NCT02724618|Curcumin|curcumin|mesh-list
101673796|NCT02724618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101673797|NCT02724618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101673798|NCT02724618|Analgesics|analgesics|mesh-ancestor
101673799|NCT02724618|Sensory System Agents|sensory system agents|mesh-ancestor
101673800|NCT02724618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101673801|NCT02724618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673802|NCT02724618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101673803|NCT02724618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101673804|NCT02724618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101673805|NCT02724618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101673806|NCT02724618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673807|NCT02801786|Tamoxifen|tamoxifen|mesh-list
101673808|NCT02801786|Lidocaine|lidocaine|mesh-list
101673809|NCT02801786|Anesthetics, Local|anesthetics, local|mesh-ancestor
101673810|NCT02801786|Anesthetics|anesthetics|mesh-ancestor
101673811|NCT02801786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101673812|NCT02801786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673813|NCT02801786|Sensory System Agents|sensory system agents|mesh-ancestor
101673814|NCT02801786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101673815|NCT02801786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101673816|NCT02801786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101673817|NCT02801786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101673818|NCT02801786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101673819|NCT02801786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673820|NCT02801786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101673821|NCT02801786|Hormone Antagonists|hormone antagonists|mesh-ancestor
101673822|NCT02801786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101673823|NCT02801786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101673824|NCT02801786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101673825|NCT02801786|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101673826|NCT02801786|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101673828|NCT04258553|Antioxidants|antioxidants|mesh-list
101673829|NCT04258553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673830|NCT04258553|Protective Agents|protective agents|mesh-ancestor
101673831|NCT04258553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673832|NCT00938743|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101673833|NCT00938743|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101673834|NCT00938743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101673835|NCT00938743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101673836|NCT00938743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673837|NCT00938743|Adrenergic Agents|adrenergic agents|mesh-ancestor
101673838|NCT00938743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101673839|NCT00938743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673840|NCT02719392|Acetylcysteine|acetylcysteine|mesh-list
101673841|NCT02719392|Minocycline|minocycline|mesh-list
101673842|NCT02719392|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101673843|NCT02719392|Antiviral Agents|antiviral agents|mesh-ancestor
101673844|NCT02719392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101673845|NCT02719392|Expectorants|expectorants|mesh-ancestor
101673846|NCT02719392|Respiratory System Agents|respiratory system agents|mesh-ancestor
101673847|NCT02719392|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101673848|NCT02719392|Antioxidants|antioxidants|mesh-ancestor
101673849|NCT02719392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673850|NCT02719392|Protective Agents|protective agents|mesh-ancestor
101673851|NCT02719392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673852|NCT02719392|Antidotes|antidotes|mesh-ancestor
101673853|NCT02719392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101673854|NCT02802098|Bevacizumab|bevacizumab|mesh-list
101673855|NCT02802098|Durvalumab|durvalumab|mesh-list
101673856|NCT02802098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101673857|NCT02802098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101673858|NCT02802098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101673859|NCT02802098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101673860|NCT02802098|Growth Substances|growth substances|mesh-ancestor
101673861|NCT02802098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673862|NCT02802098|Growth Inhibitors|growth inhibitors|mesh-ancestor
101673863|NCT00938821|Morphine|morphine|mesh-list
101673864|NCT00938821|Bupivacaine|bupivacaine|mesh-list
101673865|NCT00938821|Anesthetics, Local|anesthetics, local|mesh-ancestor
101673866|NCT00938821|Anesthetics|anesthetics|mesh-ancestor
101673867|NCT00938821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101673868|NCT00938821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673869|NCT00938821|Sensory System Agents|sensory system agents|mesh-ancestor
101673870|NCT00938821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101673871|NCT00938821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101673872|NCT00938821|Narcotics|narcotics|mesh-ancestor
101673873|NCT00938821|Analgesics|analgesics|mesh-ancestor
101673874|NCT04013581|Empagliflozin|empagliflozin|mesh-list
101673875|NCT04013581|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101673876|NCT04013581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673877|NCT04013581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101673878|NCT04013581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673879|NCT02715960|Vitamin A|vitamin a|mesh-list
101673880|NCT02715960|Tretinoin|tretinoin|mesh-list
101673881|NCT02715960|Acitretin|acitretin|mesh-list
101673882|NCT02715960|Vitamins|vitamins|mesh-ancestor
101673883|NCT02715960|Micronutrients|micronutrients|mesh-ancestor
101673884|NCT02715960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673885|NCT02715960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101673886|NCT02715960|Keratolytic Agents|keratolytic agents|mesh-ancestor
101673887|NCT02715960|Dermatologic Agents|dermatologic agents|mesh-ancestor
101673888|NCT03983018|Rituximab|rituximab|mesh-list
101673889|NCT03983018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101673890|NCT03983018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101673891|NCT03983018|Immunologic Factors|immunologic factors|mesh-ancestor
101673892|NCT03983018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673893|NCT03983018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101673894|NCT02794922|Vitamin B Complex|vitamin b complex|mesh-list
101673895|NCT02794922|Vitamins|vitamins|mesh-ancestor
101673896|NCT02794922|Micronutrients|micronutrients|mesh-ancestor
101673897|NCT02794922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673898|NCT00935467|Saxagliptin|saxagliptin|mesh-list
101673899|NCT00935467|Incretins|incretins|mesh-ancestor
101673900|NCT00935467|Hormones|hormones|mesh-ancestor
101673901|NCT00935467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101673902|NCT00935467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673903|NCT00935467|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101673904|NCT00935467|Protease Inhibitors|protease inhibitors|mesh-ancestor
101673905|NCT00935467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101673906|NCT00935467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673907|NCT00935467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101673908|NCT00935545|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101673909|NCT00935545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101673910|NCT00935545|Immunologic Factors|immunologic factors|mesh-ancestor
101673911|NCT00935545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673912|NCT04235816|Azithromycin|azithromycin|mesh-list
101673913|NCT04235816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101673914|NCT04235816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101673915|NCT00936013|Oseltamivir|oseltamivir|mesh-list
101673916|NCT00936013|Antiviral Agents|antiviral agents|mesh-ancestor
101673917|NCT00936013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101673918|NCT00936013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101673919|NCT00936013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673920|NCT00936091|Vitamin A|vitamin a|mesh-list
101673921|NCT00936091|Vitamins|vitamins|mesh-ancestor
101673922|NCT00936091|Micronutrients|micronutrients|mesh-ancestor
101673923|NCT00936091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673924|NCT00563797|Mecamylamine|mecamylamine|mesh-list
101673925|NCT00563797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101673926|NCT00563797|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
101673927|NCT00563797|Autonomic Agents|autonomic agents|mesh-ancestor
101673928|NCT00563797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101673929|NCT00563797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673930|NCT00563797|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101673931|NCT00563797|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101673932|NCT00563797|Cholinergic Agents|cholinergic agents|mesh-ancestor
101673933|NCT00563797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101673934|NCT00563797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673935|NCT01192698|Interferons|interferons|mesh-list
101673936|NCT01192698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101673937|NCT01192698|Antiviral Agents|antiviral agents|mesh-ancestor
101673938|NCT01192698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101673939|NCT04014361|Itraconazole|itraconazole|mesh-list
101673940|NCT04014361|Antifungal Agents|antifungal agents|mesh-ancestor
101673941|NCT04014361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101673942|NCT04014361|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101673943|NCT04014361|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101673944|NCT04014361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101673945|NCT04014361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673946|NCT04014361|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101673947|NCT04014361|Hormone Antagonists|hormone antagonists|mesh-ancestor
101673948|NCT04014361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101673949|NCT04014361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673950|NCT04014361|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101673951|NCT00771927|Lacosamide|lacosamide|mesh-list
101673952|NCT00771927|Anticonvulsants|anticonvulsants|mesh-ancestor
101673953|NCT00771927|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101673954|NCT00771927|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101673955|NCT00771927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101673956|NCT00771927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673957|NCT02715492|Enoxaparin|enoxaparin|mesh-list
101673958|NCT02715492|Anticoagulants|anticoagulants|mesh-ancestor
101673959|NCT02715492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101673960|NCT02715492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101673961|NCT02715492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673962|NCT03940196|Paclitaxel|paclitaxel|mesh-list
101673963|NCT03940196|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101673964|NCT03940196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101673965|NCT03940196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101673966|NCT03940196|Tubulin Modulators|tubulin modulators|mesh-ancestor
101673967|NCT03940196|Antimitotic Agents|antimitotic agents|mesh-ancestor
101673968|NCT03940196|Mitosis Modulators|mitosis modulators|mesh-ancestor
101673969|NCT03940196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673970|NCT03988179|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
101673971|NCT03988179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101673972|NCT03988179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673973|NCT03988179|Cholinergic Agents|cholinergic agents|mesh-ancestor
101673974|NCT03988179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101673975|NCT03988179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673976|NCT02724150|Omeprazole|omeprazole|mesh-list
101673977|NCT02724150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101673978|NCT02724150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101673979|NCT02724150|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101673980|NCT02724150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101673981|NCT02724150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673982|NCT00936247|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101673984|NCT02715336|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101673985|NCT02715336|Fertility Agents|fertility agents|mesh-ancestor
101673986|NCT02715336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101673987|NCT02715336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673988|NCT02715336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101673989|NCT02715336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101673990|NCT02794610|Tacrolimus|tacrolimus|mesh-list
101828022|NCT06013150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101828025|NCT06013150|Autonomic Agents|autonomic agents|mesh-ancestor
101673991|NCT02794610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101673992|NCT02794610|Immunologic Factors|immunologic factors|mesh-ancestor
101673993|NCT02794610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101673994|NCT02794610|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101673995|NCT02794610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101673996|NCT02794610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101673997|NCT02799758|Pitavastatin|pitavastatin|mesh-list
101673998|NCT02799758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101673999|NCT02799758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101674000|NCT02799758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101674002|NCT02799758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674003|NCT02799758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101674004|NCT02799758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101674005|NCT00938899|Simeprevir|simeprevir|mesh-list
101674006|NCT00938899|Antiviral Agents|antiviral agents|mesh-ancestor
101674007|NCT00938899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101674008|NCT00938899|Protease Inhibitors|protease inhibitors|mesh-ancestor
101674009|NCT00938899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101409607|NCT00350038|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101674010|NCT00938899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674011|NCT03259165|Diuretics|diuretics|mesh-list
101674012|NCT03259165|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
101674013|NCT03259165|Natriuretic Agents|natriuretic agents|mesh-ancestor
101674014|NCT03259165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674015|NCT03259165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101674016|NCT03259165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674017|NCT04013659|Hydrogen Peroxide|hydrogen peroxide|mesh-list
101674018|NCT04013659|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101674019|NCT04013659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101674020|NCT00939133|Tretinoin|tretinoin|mesh-list
101674021|NCT00939133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101674022|NCT00939133|Keratolytic Agents|keratolytic agents|mesh-ancestor
101674023|NCT00939133|Dermatologic Agents|dermatologic agents|mesh-ancestor
101674024|NCT02799446|Reslizumab|reslizumab|mesh-list
101674025|NCT02799446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101674026|NCT02799446|Respiratory System Agents|respiratory system agents|mesh-ancestor
101674027|NCT00564889|Dexamethasone|dexamethasone|mesh-list
101674028|NCT00564889|Cyclophosphamide|cyclophosphamide|mesh-list
101674029|NCT00564889|Lenalidomide|lenalidomide|mesh-list
101674030|NCT00564889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101674031|NCT00564889|Immunologic Factors|immunologic factors|mesh-ancestor
101674032|NCT00564889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674033|NCT00564889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101674034|NCT00564889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101674035|NCT00564889|Alkylating Agents|alkylating agents|mesh-ancestor
101674036|NCT00564889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674037|NCT00564889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101674038|NCT00564889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101674039|NCT00564889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101674040|NCT00564889|Antiemetics|antiemetics|mesh-ancestor
101674041|NCT00564889|Autonomic Agents|autonomic agents|mesh-ancestor
101674042|NCT00564889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101674043|NCT00564889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101674044|NCT00564889|Glucocorticoids|glucocorticoids|mesh-ancestor
101674045|NCT00564889|Hormones|hormones|mesh-ancestor
101674046|NCT00564889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101674047|NCT00564889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101828030|NCT06013150|Sympathomimetics|sympathomimetics|mesh-ancestor
101674048|NCT00564889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101674049|NCT00564889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101674050|NCT00564889|Growth Substances|growth substances|mesh-ancestor
101674051|NCT00564889|Growth Inhibitors|growth inhibitors|mesh-ancestor
101674053|NCT02790164|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101674054|NCT02790164|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101674055|NCT02790164|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101674056|NCT02790164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101674057|NCT02790164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674058|NCT00939757|Mirabegron|mirabegron|mesh-list
101674059|NCT00939757|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101674060|NCT00939757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101674061|NCT00939757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101674062|NCT00939757|Adrenergic Agents|adrenergic agents|mesh-ancestor
101674063|NCT00939757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101674064|NCT00939757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674065|NCT00939757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674066|NCT00939757|Urological Agents|urological agents|mesh-ancestor
101674067|NCT05415644|Metformin|metformin|mesh-list
101674068|NCT05415644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101674069|NCT05415644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674070|NCT00939835|Dexetimide|dexetimide|mesh-list
101674071|NCT00939835|Citalopram|citalopram|mesh-list
101674072|NCT00939835|Escitalopram|escitalopram|mesh-list
101674073|NCT00939835|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101674074|NCT00939835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101674075|NCT00939835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101674076|NCT00939835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674077|NCT00939835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101674079|NCT00939835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674080|NCT00939835|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101674081|NCT00939835|Antidepressive Agents|antidepressive agents|mesh-ancestor
101674082|NCT00939835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101674083|NCT00939835|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101674084|NCT00939835|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101674085|NCT00939835|Parasympatholytics|parasympatholytics|mesh-ancestor
101674086|NCT00939835|Autonomic Agents|autonomic agents|mesh-ancestor
101674087|NCT00939835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101674088|NCT00939835|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101674089|NCT00939835|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101674090|NCT00939835|Cholinergic Agents|cholinergic agents|mesh-ancestor
101674091|NCT02690012|Magnesium citrate|magnesium citrate|mesh-list
101674092|NCT02690012|Magnesium Oxide|magnesium oxide|mesh-list
101674093|NCT02690012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674094|NCT02690012|Cathartics|cathartics|mesh-ancestor
101674095|NCT02690012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101674096|NCT02690012|Antacids|antacids|mesh-ancestor
101674097|NCT02793986|Dexmedetomidine|dexmedetomidine|mesh-list
101674098|NCT02793986|Propofol|propofol|mesh-list
101674099|NCT02793986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101674100|NCT02793986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101674101|NCT02793986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674102|NCT02793986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101674103|NCT02793986|Analgesics|analgesics|mesh-ancestor
101674104|NCT02793986|Sensory System Agents|sensory system agents|mesh-ancestor
101674105|NCT02793986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101674106|NCT02793986|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101674107|NCT02793986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101828048|NCT06013020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101674108|NCT02793986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101674109|NCT02793986|Adrenergic Agents|adrenergic agents|mesh-ancestor
101674110|NCT02793986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101674111|NCT02793986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674112|NCT02793986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101674113|NCT02793986|Anesthetics, General|anesthetics, general|mesh-ancestor
101674114|NCT02793986|Anesthetics|anesthetics|mesh-ancestor
101674116|NCT00940069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101674117|NCT00940069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101674118|NCT00940069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674119|NCT00940069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101674120|NCT00940069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101674121|NCT00940303|Leucovorin|leucovorin|mesh-list
101674122|NCT00940303|Bevacizumab|bevacizumab|mesh-list
101674123|NCT00940303|Oxaliplatin|oxaliplatin|mesh-list
101674124|NCT00940303|Irinotecan|irinotecan|mesh-list
101674125|NCT00940303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101674126|NCT00940303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101674127|NCT00940303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101674128|NCT00940303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101674129|NCT00940303|Growth Substances|growth substances|mesh-ancestor
101674130|NCT00940303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674131|NCT00940303|Growth Inhibitors|growth inhibitors|mesh-ancestor
101674132|NCT00940303|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101674133|NCT00940303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101674134|NCT00940303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101674135|NCT00940303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674136|NCT00940303|Antidotes|antidotes|mesh-ancestor
101674137|NCT00940303|Protective Agents|protective agents|mesh-ancestor
101674138|NCT00940303|Vitamin B Complex|vitamin b complex|mesh-ancestor
101674139|NCT00940303|Vitamins|vitamins|mesh-ancestor
101674140|NCT00940303|Micronutrients|micronutrients|mesh-ancestor
101674141|NCT02794220|Nicotine|nicotine|mesh-list
101674142|NCT02794220|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101674143|NCT02794220|Autonomic Agents|autonomic agents|mesh-ancestor
101674144|NCT02794220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101674145|NCT02794220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674146|NCT02794220|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101674147|NCT02794220|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101674148|NCT02794220|Cholinergic Agents|cholinergic agents|mesh-ancestor
101674149|NCT02794220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101674150|NCT02794220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674151|NCT00941083|Raltegravir Potassium|raltegravir potassium|mesh-list
101674152|NCT00941083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101674153|NCT00941083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101674154|NCT00941083|Antiviral Agents|antiviral agents|mesh-ancestor
101674155|NCT00941083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101674156|NCT00941083|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101674157|NCT00941083|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101674158|NCT00941083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101674159|NCT00941083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674161|NCT04405999|Expectorants|expectorants|mesh-ancestor
101674162|NCT04405999|Respiratory System Agents|respiratory system agents|mesh-ancestor
101674163|NCT02793908|Progesterone|progesterone|mesh-list
101674164|NCT02793908|Progestins|progestins|mesh-ancestor
101674165|NCT02793908|Hormones|hormones|mesh-ancestor
101674166|NCT02793908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101674167|NCT02793908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674168|NCT02789930|Anesthetics|anesthetics|mesh-list
101674169|NCT02789930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101674170|NCT02789930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674171|NCT00560833|Mirtazapine|mirtazapine|mesh-list
101674172|NCT00560833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674173|NCT00560833|Antidepressive Agents|antidepressive agents|mesh-ancestor
101674174|NCT00560833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101828064|NCT06013020|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101674175|NCT00560833|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101674176|NCT00560833|Histamine Antagonists|histamine antagonists|mesh-ancestor
101674177|NCT00560833|Histamine Agents|histamine agents|mesh-ancestor
101674178|NCT00560833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101674179|NCT00560833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674180|NCT00560833|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101674181|NCT00560833|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101674182|NCT00560833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101674183|NCT00560833|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101674184|NCT00560833|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101674185|NCT00560833|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101674186|NCT00560833|Adrenergic Agents|adrenergic agents|mesh-ancestor
101674187|NCT00560833|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101674188|NCT00560833|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101674189|NCT00560833|Serotonin Agents|serotonin agents|mesh-ancestor
101674190|NCT00560833|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101674191|NCT02723760|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
101674192|NCT02723760|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101674193|NCT02723760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674194|NCT00941161|Metformin|metformin|mesh-list
101674195|NCT00941161|Glimepiride|glimepiride|mesh-list
101674196|NCT00941161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101674197|NCT00941161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674198|NCT00941161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101331439|NCT00034606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101674199|NCT00941161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101674201|NCT00944515|Azithromycin|azithromycin|mesh-list
101674202|NCT00944515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101674203|NCT00944515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101674204|NCT00771654|Phentermine|phentermine|mesh-list
101674205|NCT00771654|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101674206|NCT00771654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674207|NCT00771654|Appetite Depressants|appetite depressants|mesh-ancestor
101674208|NCT00771654|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101674209|NCT00771654|Sympathomimetics|sympathomimetics|mesh-ancestor
101674210|NCT00771654|Autonomic Agents|autonomic agents|mesh-ancestor
101674211|NCT00771654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101674212|NCT00771654|Adrenergic Agents|adrenergic agents|mesh-ancestor
101674213|NCT00771654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101674214|NCT00771654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674215|NCT00941239|Metformin|metformin|mesh-list
101674216|NCT00941239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101674217|NCT00941239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674218|NCT04235426|Vitamin B 12|vitamin b 12|mesh-list
101674219|NCT04235426|Hydroxocobalamin|hydroxocobalamin|mesh-list
101674220|NCT04235426|Diclofenac|diclofenac|mesh-list
101674221|NCT04235426|Vitamins|vitamins|mesh-ancestor
101674222|NCT04235426|Micronutrients|micronutrients|mesh-ancestor
101674223|NCT04235426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674224|NCT04235426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101674225|NCT04235426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101674226|NCT04235426|Analgesics|analgesics|mesh-ancestor
101539538|NCT02214498|Enalapril|enalapril|mesh-list
101674227|NCT04235426|Sensory System Agents|sensory system agents|mesh-ancestor
101674228|NCT04235426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101674229|NCT04235426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101674230|NCT04235426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101674231|NCT04235426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101674232|NCT04235426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101674233|NCT04235426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674234|NCT04235426|Vitamin B Complex|vitamin b complex|mesh-ancestor
101674235|NCT04235426|Hematinics|hematinics|mesh-ancestor
101674236|NCT02793440|Cortivazol|cortivazol|mesh-list
101674237|NCT02793440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101674238|NCT02723838|Gemcitabine|gemcitabine|mesh-list
101674239|NCT02723838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101674240|NCT02723838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101674241|NCT02723838|Antimetabolites|antimetabolites|mesh-ancestor
101674242|NCT02723838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674243|NCT02789150|Norepinephrine|norepinephrine|mesh-list
101674244|NCT02789150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101674245|NCT02789150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101674246|NCT02789150|Adrenergic Agents|adrenergic agents|mesh-ancestor
101674247|NCT02789150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101674248|NCT02789150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674249|NCT02789150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674250|NCT02789150|Sympathomimetics|sympathomimetics|mesh-ancestor
101674251|NCT02789150|Autonomic Agents|autonomic agents|mesh-ancestor
101674252|NCT02789150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101674253|NCT02789150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101674255|NCT02715024|Solifenacin Succinate|solifenacin succinate|mesh-list
101674256|NCT02715024|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101674257|NCT02715024|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101674258|NCT02715024|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101674259|NCT02715024|Adrenergic Agents|adrenergic agents|mesh-ancestor
101674260|NCT02715024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101674261|NCT02715024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674262|NCT02715024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674263|NCT02715024|Urological Agents|urological agents|mesh-ancestor
101674264|NCT02715024|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101674265|NCT02715024|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101674266|NCT02715024|Cholinergic Agents|cholinergic agents|mesh-ancestor
101674267|NCT02798744|Empagliflozin|empagliflozin|mesh-list
101674268|NCT02798744|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101674269|NCT02798744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674270|NCT02798744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101674271|NCT02798744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674272|NCT00925769|Bevacizumab|bevacizumab|mesh-list
101674273|NCT00925769|Capecitabine|capecitabine|mesh-list
101674274|NCT00925769|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101674275|NCT00925769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101674276|NCT00925769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101674277|NCT00925769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101674278|NCT00925769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101674279|NCT00925769|Growth Substances|growth substances|mesh-ancestor
101674280|NCT00925769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674281|NCT00925769|Growth Inhibitors|growth inhibitors|mesh-ancestor
101674282|NCT00925769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101674284|NCT00925769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674285|NCT00925769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101674287|NCT00770913|Rabeprazole|rabeprazole|mesh-list
101674288|NCT00770913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101674289|NCT00770913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101674290|NCT00770913|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101674291|NCT00770913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101674292|NCT00770913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674293|NCT00562861|Lamotrigine|lamotrigine|mesh-list
101674294|NCT00562861|Carbamazepine|carbamazepine|mesh-list
101674295|NCT00562861|Valproic Acid|valproic acid|mesh-list
101674296|NCT00562861|Citalopram|citalopram|mesh-list
101674297|NCT00562861|Anticonvulsants|anticonvulsants|mesh-ancestor
101674298|NCT00562861|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101674299|NCT00562861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101674300|NCT00562861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674301|NCT00562861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101674302|NCT00562861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674303|NCT00562861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101674304|NCT00562861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101674305|NCT00562861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101674306|NCT00562861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101674307|NCT00562861|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101674308|NCT00562861|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101674309|NCT00562861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101674310|NCT00562861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101674311|NCT00562861|Serotonin Agents|serotonin agents|mesh-ancestor
101674312|NCT00562861|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101674313|NCT00562861|Antidepressive Agents|antidepressive agents|mesh-ancestor
101674314|NCT00562861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101674315|NCT00562861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101674316|NCT00562861|GABA Agents|gaba agents|mesh-ancestor
101674317|NCT00562861|Antimanic Agents|antimanic agents|mesh-ancestor
101674318|NCT00562861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101674319|NCT00562861|Analgesics|analgesics|mesh-ancestor
101674320|NCT00562861|Sensory System Agents|sensory system agents|mesh-ancestor
101674321|NCT00562861|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101674322|NCT00562861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101674323|NCT02723448|Aclarubicin|aclarubicin|mesh-list
101674324|NCT02723448|Aclacinomycins|aclacinomycins|mesh-list
101674325|NCT02723448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101674326|NCT02723448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101674327|NCT02723448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101674328|NCT02723448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101674329|NCT02723448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101674330|NCT02723448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674331|NCT02723448|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101674332|NCT02723448|Immunologic Factors|immunologic factors|mesh-ancestor
101674333|NCT02723448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674334|NCT02798510|Gemcitabine|gemcitabine|mesh-list
101674335|NCT02798510|Capecitabine|capecitabine|mesh-list
101674336|NCT02798510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101674337|NCT02798510|Antimetabolites|antimetabolites|mesh-ancestor
101674338|NCT02798510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674339|NCT02798510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101674340|NCT00941473|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101674341|NCT00941473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101674342|NCT00941473|Glucocorticoids|glucocorticoids|mesh-ancestor
101674343|NCT00941473|Hormones|hormones|mesh-ancestor
101674344|NCT00941473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101674345|NCT00941473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674346|NCT00941473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101331589|NCT00014235|Dermatologic Agents|dermatologic agents|mesh-ancestor
101674347|NCT00941473|Immunologic Factors|immunologic factors|mesh-ancestor
101674348|NCT04258475|Raltegravir Potassium|raltegravir potassium|mesh-list
101674349|NCT04258475|Calcium|calcium|mesh-list
101674350|NCT04258475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101674351|NCT04258475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674352|NCT04258475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101674353|NCT04258475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101674354|NCT04258475|Antiviral Agents|antiviral agents|mesh-ancestor
101674355|NCT04258475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101674356|NCT04258475|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101674357|NCT04258475|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101674358|NCT04258475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101674359|NCT04258475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828113|NCT05985954|Cetuximab|cetuximab|mesh-list
101674361|NCT00609011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101674362|NCT00609011|Alkylating Agents|alkylating agents|mesh-ancestor
101674363|NCT00609011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674364|NCT00609011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101674365|NCT00770679|Atorvastatin|atorvastatin|mesh-list
101674366|NCT00770679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101674367|NCT00770679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101674368|NCT00770679|Antimetabolites|antimetabolites|mesh-ancestor
101674369|NCT00770679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674370|NCT00770679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101674371|NCT00770679|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101674372|NCT00770679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101674373|NCT04042116|Nivolumab|nivolumab|mesh-list
101674374|NCT04042116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101674375|NCT04042116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101674376|NCT04042116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101674377|NCT04042116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674378|NCT04260581|Amantadine|amantadine|mesh-list
101674379|NCT04260581|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101674380|NCT04260581|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101674381|NCT04260581|Antiviral Agents|antiviral agents|mesh-ancestor
101674382|NCT04260581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101674383|NCT04260581|Dopamine Agents|dopamine agents|mesh-ancestor
101674384|NCT04260581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101674385|NCT04260581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674386|NCT04260581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674387|NCT04260581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101674388|NCT04260581|Analgesics|analgesics|mesh-ancestor
101674389|NCT04260581|Sensory System Agents|sensory system agents|mesh-ancestor
101674390|NCT04260581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101674391|NCT00770367|Pioglitazone|pioglitazone|mesh-list
101674392|NCT00770367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101674393|NCT00770367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674394|NCT00941785|Amodiaquine|amodiaquine|mesh-list
101674395|NCT00941785|Antimalarials|antimalarials|mesh-ancestor
101674396|NCT00941785|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101674397|NCT00941785|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101674398|NCT00941785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101674399|NCT02793050|Trabectedin|trabectedin|mesh-list
101674400|NCT02793050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101674401|NCT02793050|Alkylating Agents|alkylating agents|mesh-ancestor
101674402|NCT02793050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674403|NCT02793050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101674404|NCT00944905|MDX-1203|mdx-1203|mesh-list
101674405|NCT00944905|Immunoconjugates|immunoconjugates|mesh-ancestor
101674406|NCT00944905|Immunologic Factors|immunologic factors|mesh-ancestor
101674407|NCT00944905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674408|NCT00942253|Dopamine|dopamine|mesh-list
101674409|NCT00942253|Dopamine Agonists|dopamine agonists|mesh-list
101674410|NCT00942253|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101674411|NCT00942253|Sympathomimetics|sympathomimetics|mesh-ancestor
101674412|NCT00942253|Autonomic Agents|autonomic agents|mesh-ancestor
101674413|NCT00942253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101674414|NCT00942253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674415|NCT00942253|Dopamine Agents|dopamine agents|mesh-ancestor
101674416|NCT00942253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101674417|NCT00942253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674418|NCT00942253|Protective Agents|protective agents|mesh-ancestor
101674419|NCT02792816|Artesunate|artesunate|mesh-list
101674420|NCT02792816|Artemether|artemether|mesh-list
101331664|NCT00014313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101674421|NCT02792816|Piperaquine|piperaquine|mesh-list
101674423|NCT02792816|Mefloquine|mefloquine|mesh-list
101674424|NCT02792816|Antimalarials|antimalarials|mesh-list
101674425|NCT02792816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101674426|NCT02792816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101674427|NCT02792816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101674428|NCT02792816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101674429|NCT02792816|Antiviral Agents|antiviral agents|mesh-ancestor
101674430|NCT02792816|Schistosomicides|schistosomicides|mesh-ancestor
101674431|NCT02792816|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101674432|NCT02792816|Anthelmintics|anthelmintics|mesh-ancestor
101674433|NCT00940381|Sirolimus|sirolimus|mesh-list
101674434|NCT00940381|Cetuximab|cetuximab|mesh-list
101674435|NCT00940381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101674436|NCT00940381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101674437|NCT00940381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101674438|NCT00940381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101674439|NCT00940381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101674440|NCT00940381|Antifungal Agents|antifungal agents|mesh-ancestor
101674441|NCT00940381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101674442|NCT00940381|Immunologic Factors|immunologic factors|mesh-ancestor
101674443|NCT00940381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674444|NCT00637988|Aspirin|aspirin|mesh-list
101674445|NCT00637988|Rofecoxib|rofecoxib|mesh-list
101674446|NCT00637988|Esomeprazole|esomeprazole|mesh-list
101674447|NCT00637988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101674448|NCT00637988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101674449|NCT00637988|Analgesics|analgesics|mesh-ancestor
101674450|NCT00637988|Sensory System Agents|sensory system agents|mesh-ancestor
101674451|NCT00637988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101674452|NCT00637988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674453|NCT00637988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101674455|NCT00637988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101674456|NCT00637988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101674457|NCT00637988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674458|NCT00637988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101674459|NCT00637988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101674460|NCT00637988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101674461|NCT00637988|Antipyretics|antipyretics|mesh-ancestor
101674462|NCT00637988|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101674463|NCT00637988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101674464|NCT00637988|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101674465|NCT00637988|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101674466|NCT04258163|Gemcitabine|gemcitabine|mesh-list
101674467|NCT04258163|Capecitabine|capecitabine|mesh-list
101674468|NCT04258163|Doxorubicin|doxorubicin|mesh-list
101674469|NCT04258163|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101674470|NCT04258163|Letrozole|letrozole|mesh-list
101674471|NCT04258163|Fulvestrant|fulvestrant|mesh-list
101674472|NCT04258163|Anastrozole|anastrozole|mesh-list
101674473|NCT04258163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101674474|NCT04258163|Antimetabolites|antimetabolites|mesh-ancestor
101674475|NCT04258163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674476|NCT04258163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101674477|NCT04258163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101674478|NCT04258163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101674479|NCT04258163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101674480|NCT04258163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101674481|NCT04258163|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101674482|NCT04258163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101674483|NCT04258163|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101674484|NCT04258163|Hormone Antagonists|hormone antagonists|mesh-ancestor
101674485|NCT04258163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101674486|NCT04258163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674487|NCT04258163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101674488|NCT04258163|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101674489|NCT00942487|Nebivolol|nebivolol|mesh-list
101674490|NCT00942487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101674491|NCT00942487|Vasodilator Agents|vasodilator agents|mesh-ancestor
101828158|NCT05919823|Xanomeline|xanomeline|mesh-list
101674492|NCT00942487|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101674493|NCT00942487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101674494|NCT00942487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101674495|NCT00942487|Adrenergic Agents|adrenergic agents|mesh-ancestor
101674496|NCT00942487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101331736|NCT00035191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101674497|NCT00942487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674498|NCT00942487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674500|NCT00611039|Darunavir|darunavir|mesh-list
101674501|NCT00611039|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101674502|NCT00611039|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101674503|NCT00611039|Protease Inhibitors|protease inhibitors|mesh-ancestor
101674504|NCT00611039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101674505|NCT00611039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674506|NCT00611039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101674507|NCT00611039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101674508|NCT00611039|Antiviral Agents|antiviral agents|mesh-ancestor
101674509|NCT00611039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101674510|NCT00611039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101674511|NCT00611039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101674512|NCT00942565|Acetaminophen|acetaminophen|mesh-list
101674513|NCT00942565|Tramadol|tramadol|mesh-list
101674514|NCT00942565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101674515|NCT00942565|Analgesics|analgesics|mesh-ancestor
101674516|NCT00942565|Sensory System Agents|sensory system agents|mesh-ancestor
101674517|NCT00942565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101674518|NCT00942565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674519|NCT00942565|Antipyretics|antipyretics|mesh-ancestor
101674520|NCT00942565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101674521|NCT00942565|Narcotics|narcotics|mesh-ancestor
101674522|NCT00942565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101674523|NCT00945373|Calcium Dobesilate|calcium dobesilate|mesh-list
101674524|NCT00945373|Calcium|calcium|mesh-list
101674525|NCT00945373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101674526|NCT00945373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674527|NCT00945373|Hemostatics|hemostatics|mesh-ancestor
101674528|NCT00945373|Coagulants|coagulants|mesh-ancestor
101674529|NCT04100655|Molgramostim|molgramostim|mesh-list
101674530|NCT04100655|Estradiol|estradiol|mesh-list
101674531|NCT04100655|Sargramostim|sargramostim|mesh-list
101674532|NCT04100655|Estrogens|estrogens|mesh-ancestor
101674533|NCT04100655|Hormones|hormones|mesh-ancestor
101674534|NCT04100655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101674535|NCT04100655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674536|NCT04100655|Immunologic Factors|immunologic factors|mesh-ancestor
101674537|NCT04100655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101674538|NCT00556933|Mycophenolic Acid|mycophenolic acid|mesh-list
101674539|NCT00556933|Sirolimus|sirolimus|mesh-list
101674540|NCT00556933|Tacrolimus|tacrolimus|mesh-list
101674541|NCT00556933|Thymoglobulin|thymoglobulin|mesh-list
101674542|NCT00556933|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101674543|NCT00556933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101674544|NCT00556933|Immunologic Factors|immunologic factors|mesh-ancestor
101674545|NCT00556933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674546|NCT00556933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101674547|NCT00556933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101674548|NCT00556933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674549|NCT00556933|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101674550|NCT00556933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101674551|NCT00556933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101674552|NCT00556933|Antitubercular Agents|antitubercular agents|mesh-ancestor
101674553|NCT00556933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101674554|NCT00556933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101674555|NCT00556933|Antifungal Agents|antifungal agents|mesh-ancestor
101674556|NCT02792426|Nicotine|nicotine|mesh-list
101674557|NCT02792426|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101674558|NCT02792426|Autonomic Agents|autonomic agents|mesh-ancestor
101674559|NCT02792426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101674560|NCT02792426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674561|NCT02792426|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101674562|NCT02792426|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101674563|NCT02792426|Cholinergic Agents|cholinergic agents|mesh-ancestor
101674564|NCT02792426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101674565|NCT02792426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674567|NCT00770211|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101674568|NCT00770211|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101674569|NCT00770211|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
101674570|NCT00770211|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101674571|NCT00770211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101674572|NCT00770211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674573|NCT00770211|Cholinergic Agents|cholinergic agents|mesh-ancestor
101674574|NCT00770211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101674575|NCT00770211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674576|NCT00770211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101674577|NCT00770211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101674578|NCT02792036|Carboplatin|carboplatin|mesh-list
101674579|NCT02792036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101674580|NCT02797340|Metformin|metformin|mesh-list
101674581|NCT02797340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101674582|NCT02797340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674583|NCT00928187|Ritonavir|ritonavir|mesh-list
101674584|NCT00928187|Lopinavir|lopinavir|mesh-list
101674585|NCT00928187|Darunavir|darunavir|mesh-list
101674586|NCT00928187|Tenofovir|tenofovir|mesh-list
101674587|NCT00928187|Emtricitabine|emtricitabine|mesh-list
101674588|NCT00928187|Abacavir|abacavir|mesh-list
101674589|NCT00928187|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101674590|NCT00928187|Didanosine|didanosine|mesh-list
101674591|NCT00928187|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101674592|NCT00928187|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101674593|NCT00928187|Protease Inhibitors|protease inhibitors|mesh-ancestor
101674594|NCT00928187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101674595|NCT00928187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674596|NCT00928187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101674597|NCT00928187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101674598|NCT00928187|Antiviral Agents|antiviral agents|mesh-ancestor
101674599|NCT00928187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101674600|NCT00928187|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101674601|NCT00928187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101674602|NCT00928187|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101674603|NCT00928187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101674604|NCT00928187|Antimetabolites|antimetabolites|mesh-ancestor
101674605|NCT04235270|Tadalafil|tadalafil|mesh-list
101674606|NCT04235270|Macitentan|macitentan|mesh-list
101674607|NCT04235270|Vasodilator Agents|vasodilator agents|mesh-ancestor
101674608|NCT04235270|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101674609|NCT04235270|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101674610|NCT04235270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101674611|NCT04235270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674612|NCT04235270|Urological Agents|urological agents|mesh-ancestor
101674613|NCT04235270|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101674614|NCT04235270|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101674615|NCT04235270|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
101674616|NCT04256525|Aspirin|aspirin|mesh-list
101674617|NCT04256525|Heparin|heparin|mesh-list
101674618|NCT04256525|Rivaroxaban|rivaroxaban|mesh-list
101674619|NCT04256525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101674620|NCT04256525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101674621|NCT04256525|Analgesics|analgesics|mesh-ancestor
101674622|NCT04256525|Sensory System Agents|sensory system agents|mesh-ancestor
101828269|NCT05839119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101674623|NCT04256525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101674624|NCT04256525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674625|NCT04256525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101674626|NCT04256525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101674627|NCT04256525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101674628|NCT04256525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101674629|NCT04256525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674630|NCT04256525|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101674631|NCT04256525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101674632|NCT04256525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101674634|NCT04256525|Anticoagulants|anticoagulants|mesh-ancestor
101674635|NCT04256525|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101674636|NCT04256525|Antithrombins|antithrombins|mesh-ancestor
101674637|NCT04256525|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101674638|NCT04256525|Protease Inhibitors|protease inhibitors|mesh-ancestor
101674639|NCT02791958|Ramipril|ramipril|mesh-list
101674640|NCT02791958|Atorvastatin|atorvastatin|mesh-list
101674641|NCT02791958|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101674642|NCT02791958|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101674643|NCT02791958|Antimetabolites|antimetabolites|mesh-ancestor
101674644|NCT02791958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674645|NCT02791958|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101674646|NCT02791958|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101674647|NCT02791958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331888|NCT02971306|Antioxidants|antioxidants|mesh-ancestor
101674648|NCT02791958|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101674649|NCT02791958|Protease Inhibitors|protease inhibitors|mesh-ancestor
101674650|NCT02791958|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101674651|NCT02601651|Lidocaine|lidocaine|mesh-list
101674652|NCT02601651|Anesthetics, Local|anesthetics, local|mesh-ancestor
101674653|NCT02601651|Anesthetics|anesthetics|mesh-ancestor
101674654|NCT02601651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101674655|NCT02601651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674656|NCT02601651|Sensory System Agents|sensory system agents|mesh-ancestor
101674657|NCT02601651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101674658|NCT02601651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101674659|NCT02601651|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101674660|NCT02601651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101674661|NCT02601651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101674662|NCT02601651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674663|NCT00943267|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
101674664|NCT00943267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101674665|NCT00945919|Oxymorphone|oxymorphone|mesh-list
101674666|NCT00945919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101674667|NCT00945919|Narcotics|narcotics|mesh-ancestor
101674668|NCT00945919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101674669|NCT00945919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674670|NCT00945919|Analgesics|analgesics|mesh-ancestor
101674671|NCT00945919|Sensory System Agents|sensory system agents|mesh-ancestor
101674672|NCT00945919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101674673|NCT00945919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101674674|NCT00945997|Misoprostol|misoprostol|mesh-list
101674675|NCT00945997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101674676|NCT00945997|Abortifacient Agents|abortifacient agents|mesh-ancestor
101674677|NCT00945997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101674678|NCT00945997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674679|NCT00945997|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101674680|NCT00945997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101674681|NCT00945997|Oxytocics|oxytocics|mesh-ancestor
101674682|NCT00943345|Indomethacin|indomethacin|mesh-list
101674683|NCT00943345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101674684|NCT00943345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101674685|NCT00943345|Analgesics|analgesics|mesh-ancestor
101674686|NCT00943345|Sensory System Agents|sensory system agents|mesh-ancestor
101828301|NCT05789069|Tislelizumab|tislelizumab|mesh-list
101674687|NCT00943345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101674688|NCT00943345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674689|NCT00943345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101674690|NCT00943345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101674691|NCT00943345|Gout Suppressants|gout suppressants|mesh-ancestor
101674692|NCT00943345|Tocolytic Agents|tocolytic agents|mesh-ancestor
101674693|NCT00943345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101674694|NCT00943345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101674695|NCT00943345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101674696|NCT00943345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674697|NCT02797028|Allopurinol|allopurinol|mesh-list
101674698|NCT02797028|Antimetabolites|antimetabolites|mesh-ancestor
101674699|NCT02797028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674700|NCT02797028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101674701|NCT02797028|Gout Suppressants|gout suppressants|mesh-ancestor
101674702|NCT02797028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101674703|NCT02797028|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101674704|NCT02797028|Antioxidants|antioxidants|mesh-ancestor
101674705|NCT02797028|Protective Agents|protective agents|mesh-ancestor
101674706|NCT02797028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674707|NCT00916461|Minocycline|minocycline|mesh-list
101674708|NCT00916461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101674709|NCT00916461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101674710|NCT04260035|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
101674711|NCT04260035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101674712|NCT04260035|Vasodilator Agents|vasodilator agents|mesh-ancestor
101674713|NCT04260035|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101674714|NCT04260035|Protective Agents|protective agents|mesh-ancestor
101674715|NCT04260035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674716|NCT00768651|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101674717|NCT00768651|Pantoprazole|pantoprazole|mesh-list
101674718|NCT00768651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101674719|NCT00768651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674720|NCT00768651|Incretins|incretins|mesh-ancestor
101674721|NCT00768651|Hormones|hormones|mesh-ancestor
101674722|NCT00768651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101674723|NCT00768651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101674724|NCT00768651|Protease Inhibitors|protease inhibitors|mesh-ancestor
101674725|NCT00768651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101674726|NCT00768651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674727|NCT00768651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101674728|NCT00768651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101674729|NCT00768651|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101674731|NCT00943501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101674732|NCT00943501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674733|NCT00943501|Incretins|incretins|mesh-ancestor
101674734|NCT00943501|Hormones|hormones|mesh-ancestor
101674735|NCT00943501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101674736|NCT04258241|Bupivacaine|bupivacaine|mesh-list
101674737|NCT04258241|Anesthetics, Local|anesthetics, local|mesh-list
101674738|NCT04258241|Anesthetics|anesthetics|mesh-list
101674739|NCT04258241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101674740|NCT04258241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101674741|NCT04258241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674742|NCT04258241|Sensory System Agents|sensory system agents|mesh-ancestor
101674743|NCT04258241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101674744|NCT02796794|Genistein|genistein|mesh-list
101674745|NCT02796794|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101674746|NCT02796794|Protective Agents|protective agents|mesh-ancestor
101674747|NCT02796794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674748|NCT02796794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101674749|NCT02796794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101674750|NCT02796794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101828305|NCT05784246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101674751|NCT02796794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674752|NCT02796794|Phytoestrogens|phytoestrogens|mesh-ancestor
101674753|NCT02796794|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101674754|NCT02796794|Estrogens|estrogens|mesh-ancestor
101674755|NCT02796794|Hormones|hormones|mesh-ancestor
101674756|NCT02796794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101674757|NCT04097613|Povidone-Iodine|povidone-iodine|mesh-list
101674758|NCT04097613|Budesonide|budesonide|mesh-list
101674759|NCT04097613|Povidone|povidone|mesh-list
101674760|NCT04097613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101674761|NCT04097613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101674762|NCT04097613|Autonomic Agents|autonomic agents|mesh-ancestor
101674763|NCT04097613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101674764|NCT04097613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674765|NCT04097613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101674766|NCT04097613|Respiratory System Agents|respiratory system agents|mesh-ancestor
101674767|NCT04097613|Glucocorticoids|glucocorticoids|mesh-ancestor
101674768|NCT04097613|Hormones|hormones|mesh-ancestor
101674769|NCT04097613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101674770|NCT04097613|Plasma Substitutes|plasma substitutes|mesh-ancestor
101674771|NCT04097613|Blood Substitutes|blood substitutes|mesh-ancestor
101674772|NCT04097613|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101674773|NCT04097613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101674774|NCT00946387|Ondansetron|ondansetron|mesh-list
101674775|NCT00946387|Antiemetics|antiemetics|mesh-ancestor
101674776|NCT00946387|Autonomic Agents|autonomic agents|mesh-ancestor
101674777|NCT00946387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101674778|NCT00946387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674779|NCT00946387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101674780|NCT00946387|Antipruritics|antipruritics|mesh-ancestor
101674781|NCT00946387|Dermatologic Agents|dermatologic agents|mesh-ancestor
101674782|NCT00946387|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101674783|NCT00946387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101674784|NCT00946387|Serotonin Agents|serotonin agents|mesh-ancestor
101674785|NCT00946387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101674786|NCT00946387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674787|NCT00916695|Everolimus|everolimus|mesh-list
101674788|NCT00916695|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101674789|NCT00916695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101674790|NCT00916695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101674791|NCT00916695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674792|NCT00916695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101674793|NCT00916695|Immunologic Factors|immunologic factors|mesh-ancestor
101674794|NCT00916695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674795|NCT00916695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101674796|NCT00946465|Ramipril|ramipril|mesh-list
101674797|NCT00946465|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101674798|NCT00946465|Protease Inhibitors|protease inhibitors|mesh-ancestor
101674799|NCT00946465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101674800|NCT00946465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674801|NCT00946465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101674802|NCT00756717|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
101674803|NCT00756717|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101674804|NCT00756717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101674805|NCT00756717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674806|NCT06005714|Cyclosporine|cyclosporine|mesh-list
101674807|NCT06005714|Clarithromycin|clarithromycin|mesh-list
101674808|NCT06005714|Cyclosporins|cyclosporins|mesh-list
101674809|NCT06005714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101674810|NCT06005714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674811|NCT06005714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101674812|NCT06005714|Immunologic Factors|immunologic factors|mesh-ancestor
101674813|NCT06005714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674814|NCT06005714|Antifungal Agents|antifungal agents|mesh-ancestor
101674815|NCT06005714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101674816|NCT06005714|Dermatologic Agents|dermatologic agents|mesh-ancestor
101674817|NCT06005714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101674818|NCT06005714|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101674819|NCT06005714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101674820|NCT06005714|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101674821|NCT06005714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101674822|NCT06005714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101674823|NCT06005688|Carbamazepine|carbamazepine|mesh-list
101674824|NCT06005688|Anticonvulsants|anticonvulsants|mesh-ancestor
101674825|NCT06005688|Antimanic Agents|antimanic agents|mesh-ancestor
101674826|NCT06005688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101674827|NCT06005688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101674828|NCT06005688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674829|NCT06005688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101674830|NCT06005688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101674832|NCT06005688|Sensory System Agents|sensory system agents|mesh-ancestor
101674833|NCT06005688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101674834|NCT06005688|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101674835|NCT06005688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101674836|NCT06005688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674837|NCT06005688|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101674838|NCT06005688|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101674839|NCT06005662|Buprenorphine|buprenorphine|mesh-list
101674840|NCT06005662|Psilocybin|psilocybin|mesh-list
101674841|NCT06005662|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101674842|NCT06005662|Narcotics|narcotics|mesh-ancestor
101674843|NCT06005662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101674844|NCT06005662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674845|NCT06005662|Analgesics|analgesics|mesh-ancestor
101674846|NCT06005662|Sensory System Agents|sensory system agents|mesh-ancestor
101674847|NCT06005662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101674848|NCT06005662|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101674849|NCT06005662|Hallucinogens|hallucinogens|mesh-ancestor
101674850|NCT06005662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101674851|NCT06005610|Estradiol|estradiol|mesh-list
101674852|NCT06005610|Estrogens|estrogens|mesh-ancestor
101674853|NCT06005610|Hormones|hormones|mesh-ancestor
101674854|NCT06005610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101674855|NCT06005610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674856|NCT06005571|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101674857|NCT06005558|Methylene Blue|methylene blue|mesh-list
101674858|NCT06005558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101674859|NCT06005558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674860|NCT06005532|Adalimumab|adalimumab|mesh-list
101674861|NCT06005532|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101674862|NCT06005532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101674863|NCT06005532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101674872|NCT06005363|Dexmedetomidine|dexmedetomidine|mesh-list
101674873|NCT06005363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101674874|NCT06005363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674875|NCT06005363|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101674876|NCT06005363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101674877|NCT06005363|Analgesics|analgesics|mesh-ancestor
101674878|NCT06005363|Sensory System Agents|sensory system agents|mesh-ancestor
101674879|NCT06005363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101828336|NCT05765812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101674880|NCT06005363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101674881|NCT06005363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101674882|NCT06005363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101674883|NCT06005363|Adrenergic Agents|adrenergic agents|mesh-ancestor
101828337|NCT05765812|Alkylating Agents|alkylating agents|mesh-ancestor
101674884|NCT06005363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101674885|NCT06005363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674886|NCT06005324|Paclitaxel|paclitaxel|mesh-list
101674887|NCT06005324|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101674888|NCT06005324|Carboplatin|carboplatin|mesh-list
101674889|NCT06005324|Fluorouracil|fluorouracil|mesh-list
101674890|NCT06005324|Cetuximab|cetuximab|mesh-list
101674891|NCT06005324|Hydroxyurea|hydroxyurea|mesh-list
101674892|NCT06005324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101674893|NCT06005324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101674894|NCT06005324|Tubulin Modulators|tubulin modulators|mesh-ancestor
101674895|NCT06005324|Antimitotic Agents|antimitotic agents|mesh-ancestor
101674896|NCT06005324|Mitosis Modulators|mitosis modulators|mesh-ancestor
101674897|NCT06005324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674898|NCT06005324|Antimetabolites|antimetabolites|mesh-ancestor
101674899|NCT06005324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101674900|NCT06005324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101674901|NCT06005324|Immunologic Factors|immunologic factors|mesh-ancestor
101674902|NCT06005324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674903|NCT06005324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101674904|NCT06005324|Antisickling Agents|antisickling agents|mesh-ancestor
101674905|NCT06005324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101674906|NCT06005324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101674908|NCT06005259|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101674909|NCT06005259|Hormone Antagonists|hormone antagonists|mesh-ancestor
101674910|NCT06005259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101674911|NCT06005259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674912|NCT06005259|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101674913|NCT06005259|Diuretics|diuretics|mesh-ancestor
101674914|NCT06005259|Natriuretic Agents|natriuretic agents|mesh-ancestor
101674915|NCT06005207|Progesterone|progesterone|mesh-list
101674916|NCT06005207|Progestins|progestins|mesh-ancestor
101674917|NCT06005207|Hormones|hormones|mesh-ancestor
101674918|NCT06005207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101674919|NCT06005207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674920|NCT06005168|Cefazolin|cefazolin|mesh-list
101674921|NCT06005168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101674922|NCT06005168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101674923|NCT06005155|Valproic Acid|valproic acid|mesh-list
101674924|NCT06005155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101674925|NCT06005155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101674926|NCT06005155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674927|NCT06005155|Antimanic Agents|antimanic agents|mesh-ancestor
101674928|NCT06005155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101674929|NCT06005155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101674930|NCT06005155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674931|NCT06005155|Anticonvulsants|anticonvulsants|mesh-ancestor
101674932|NCT06005155|GABA Agents|gaba agents|mesh-ancestor
101674933|NCT06005155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101674934|NCT06004947|Itraconazole|itraconazole|mesh-list
101674935|NCT06004947|Rifampin|rifampin|mesh-list
101674936|NCT06004947|Celecoxib|celecoxib|mesh-list
101674937|NCT06004947|Midazolam|midazolam|mesh-list
101674938|NCT06004947|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101674939|NCT06004947|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101674940|NCT06004947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101674941|NCT06004947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674942|NCT06004947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101674943|NCT06004947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101674944|NCT06004947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101674945|NCT06004947|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101674946|NCT06004947|Anesthetics, General|anesthetics, general|mesh-ancestor
101674947|NCT06004947|Anesthetics|anesthetics|mesh-ancestor
101332187|NCT00036868|Antimetabolites|antimetabolites|mesh-ancestor
101674948|NCT06004947|GABA Modulators|gaba modulators|mesh-ancestor
101674949|NCT06004947|GABA Agents|gaba agents|mesh-ancestor
101674950|NCT06004947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101828348|NCT05728346|Hyaluronic Acid|hyaluronic acid|mesh-list
101674951|NCT06004947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101674952|NCT06004947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101674953|NCT06004947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101674954|NCT06004947|Analgesics|analgesics|mesh-ancestor
101674955|NCT06004947|Sensory System Agents|sensory system agents|mesh-ancestor
101674956|NCT06004947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101674957|NCT06004947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101674958|NCT06004947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101674959|NCT06004947|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101674960|NCT06004947|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101674961|NCT06004947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101674962|NCT06004947|Antifungal Agents|antifungal agents|mesh-ancestor
101674963|NCT06004947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101674964|NCT06004947|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101674965|NCT06004947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101674966|NCT06004947|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101674967|NCT06004947|Hormone Antagonists|hormone antagonists|mesh-ancestor
101674968|NCT06004947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101674969|NCT06004947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101674970|NCT06004947|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101674971|NCT06004947|Antitubercular Agents|antitubercular agents|mesh-ancestor
101674972|NCT06004947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101674973|NCT06004947|Leprostatic Agents|leprostatic agents|mesh-ancestor
101674974|NCT06004947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101674976|NCT06004947|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101674977|NCT06004947|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101674978|NCT06004947|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101674979|NCT06004947|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101674980|NCT06004947|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101674981|NCT06004882|Triamcinolone|triamcinolone|mesh-list
101674982|NCT06004882|Bupivacaine|bupivacaine|mesh-list
101674983|NCT06004882|Anesthetics, Local|anesthetics, local|mesh-ancestor
101674984|NCT06004882|Anesthetics|anesthetics|mesh-ancestor
101674985|NCT06004882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101674986|NCT06004882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674987|NCT06004882|Sensory System Agents|sensory system agents|mesh-ancestor
101674988|NCT06004882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101674989|NCT06004882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101674990|NCT06004882|Glucocorticoids|glucocorticoids|mesh-ancestor
101674992|NCT06004882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101674993|NCT06004843|Propofol|propofol|mesh-list
101674994|NCT06004843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101674995|NCT06004843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101674996|NCT06004843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101674997|NCT06004843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101674998|NCT06004843|Anesthetics, General|anesthetics, general|mesh-ancestor
101674999|NCT06004843|Anesthetics|anesthetics|mesh-ancestor
101675000|NCT06004830|Spironolactone|spironolactone|mesh-list
101675001|NCT06004830|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101675002|NCT06004830|Hormone Antagonists|hormone antagonists|mesh-ancestor
101675003|NCT06004830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101675004|NCT06004830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675005|NCT06004830|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101675006|NCT06004830|Diuretics|diuretics|mesh-ancestor
101675007|NCT06004830|Natriuretic Agents|natriuretic agents|mesh-ancestor
101675008|NCT06004765|Lenalidomide|lenalidomide|mesh-list
101675009|NCT06004765|Azacitidine|azacitidine|mesh-list
101828356|NCT05722015|Carboplatin|carboplatin|mesh-list
101828357|NCT05722015|Pembrolizumab|pembrolizumab|mesh-list
101675010|NCT06004765|Immunologic Factors|immunologic factors|mesh-ancestor
101675011|NCT06004765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675012|NCT06004765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101675013|NCT06004765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101675014|NCT06004765|Growth Substances|growth substances|mesh-ancestor
101675015|NCT06004765|Growth Inhibitors|growth inhibitors|mesh-ancestor
101675016|NCT06004765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675017|NCT06004765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101675018|NCT06004765|Antimetabolites|antimetabolites|mesh-ancestor
101675019|NCT06004765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675020|NCT06004765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101675021|NCT06004739|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101675022|NCT06004739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101675023|NCT06004739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101675024|NCT06004739|Antitubercular Agents|antitubercular agents|mesh-ancestor
101675025|NCT06004687|Acetaminophen|acetaminophen|mesh-list
101675027|NCT06004687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101675028|NCT06004687|Analgesics|analgesics|mesh-ancestor
101675029|NCT06004687|Sensory System Agents|sensory system agents|mesh-ancestor
101675030|NCT06004687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101675031|NCT06004687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675032|NCT06004687|Antipyretics|antipyretics|mesh-ancestor
101675033|NCT06004687|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101675034|NCT06004687|Diuretics|diuretics|mesh-ancestor
101675035|NCT06004687|Natriuretic Agents|natriuretic agents|mesh-ancestor
101675037|NCT06004674|Anticoagulants|anticoagulants|mesh-ancestor
101675038|NCT06004674|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101675039|NCT06004674|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101675040|NCT06004674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675041|NCT06004661|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101675042|NCT06004661|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101675043|NCT06004661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675044|NCT06004479|Carotenoids|carotenoids|mesh-list
101675045|NCT06004479|Antioxidants|antioxidants|mesh-ancestor
101675046|NCT06004479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675047|NCT06004479|Protective Agents|protective agents|mesh-ancestor
101675048|NCT06004479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675049|NCT06004401|Amoxicillin|amoxicillin|mesh-list
101675050|NCT06004401|Metronidazole|metronidazole|mesh-list
101675051|NCT06004401|Clarithromycin|clarithromycin|mesh-list
101675052|NCT06004401|Minocycline|minocycline|mesh-list
101675053|NCT06004401|Rabeprazole|rabeprazole|mesh-list
101675054|NCT06004401|Bismuth|bismuth|mesh-list
101675055|NCT06004401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101675056|NCT06004401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101675057|NCT06004401|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101675058|NCT06004401|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101675059|NCT06004401|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101675060|NCT06004401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101675061|NCT06004401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675062|NCT06004401|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101675063|NCT06004401|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101675064|NCT06004401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101675065|NCT06004401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101675066|NCT06004401|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101675067|NCT06004401|Antacids|antacids|mesh-ancestor
101675068|NCT06004336|Pembrolizumab|pembrolizumab|mesh-list
101675069|NCT06004336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101675070|NCT06004336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675071|NCT06004336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101675072|NCT06004336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675073|NCT06004115|Lorazepam|lorazepam|mesh-list
101675074|NCT06004115|Anticonvulsants|anticonvulsants|mesh-ancestor
101675075|NCT06004115|Antiemetics|antiemetics|mesh-ancestor
101675076|NCT06004115|Autonomic Agents|autonomic agents|mesh-ancestor
101675077|NCT06004115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101675078|NCT06004115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675079|NCT06004115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101675080|NCT06004115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101675081|NCT06004115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101675082|NCT06004115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101675083|NCT06004115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101675084|NCT06004115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101675085|NCT06004115|GABA Modulators|gaba modulators|mesh-ancestor
101675086|NCT06004115|GABA Agents|gaba agents|mesh-ancestor
101675087|NCT06004115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101675088|NCT06004115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675089|NCT06003998|Bevacizumab|bevacizumab|mesh-list
101675090|NCT06003998|Oxaliplatin|oxaliplatin|mesh-list
101675091|NCT06003998|Irinotecan|irinotecan|mesh-list
101675092|NCT06003998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101675093|NCT06003998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675094|NCT06003998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101675095|NCT06003998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101675096|NCT06003998|Growth Substances|growth substances|mesh-ancestor
101675097|NCT06003998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675098|NCT06003998|Growth Inhibitors|growth inhibitors|mesh-ancestor
101675099|NCT06003998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101675100|NCT06003998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101675101|NCT06003998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101675102|NCT06003998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675103|NCT06003972|Glatiramer Acetate|glatiramer acetate|mesh-list
101675105|NCT06003972|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101675106|NCT06003972|Immunologic Factors|immunologic factors|mesh-ancestor
101675107|NCT06003972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675108|NCT06003972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101675109|NCT06003972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101675110|NCT06003933|Lidocaine|lidocaine|mesh-list
101675111|NCT06003933|Bupivacaine|bupivacaine|mesh-list
101675112|NCT06003933|Anesthetics, Local|anesthetics, local|mesh-ancestor
101675113|NCT06003933|Anesthetics|anesthetics|mesh-ancestor
101675114|NCT06003933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101675115|NCT06003933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675116|NCT06003933|Sensory System Agents|sensory system agents|mesh-ancestor
101675117|NCT06003933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101675118|NCT06003933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101675119|NCT06003933|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101675120|NCT06003933|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101675121|NCT06003933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101675122|NCT06003933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675123|NCT06003829|Denatonium|denatonium|mesh-list
101675124|NCT06003829|Aversive Agents|aversive agents|mesh-ancestor
101675125|NCT06003829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675126|NCT06003829|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
101675127|NCT06003829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675128|NCT06003829|Sensory System Agents|sensory system agents|mesh-ancestor
101675129|NCT06003829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101675131|NCT06003608|Carbidopa|carbidopa|mesh-list
101675132|NCT06003608|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101675133|NCT06003608|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101675134|NCT06003608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101675135|NCT06003608|Dopamine Agents|dopamine agents|mesh-ancestor
101675136|NCT06003608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101828460|NCT05631886|Antibodies, Blocking|antibodies, blocking|mesh-list
101675137|NCT06003608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675138|NCT06003608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101828461|NCT05631886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101675139|NCT06003608|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101675140|NCT06003608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101675141|NCT06003608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101675142|NCT06003608|Immunologic Factors|immunologic factors|mesh-ancestor
101675143|NCT06003608|Dopamine Agonists|dopamine agonists|mesh-ancestor
101675144|NCT06003218|Dexmedetomidine|dexmedetomidine|mesh-list
101675145|NCT06003218|Remifentanil|remifentanil|mesh-list
101675146|NCT06003218|Oxycodone|oxycodone|mesh-list
101675147|NCT06003218|Esketamine|esketamine|mesh-list
101675148|NCT06003218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101675149|NCT06003218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101675150|NCT06003218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675151|NCT06003218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101675152|NCT06003218|Analgesics|analgesics|mesh-ancestor
101675153|NCT06003218|Sensory System Agents|sensory system agents|mesh-ancestor
101675154|NCT06003218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101675155|NCT06003218|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101675156|NCT06003218|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101675157|NCT06003218|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101675158|NCT06003218|Adrenergic Agents|adrenergic agents|mesh-ancestor
101675159|NCT06003218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101675160|NCT06003218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675161|NCT06003218|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101675162|NCT06003218|Narcotics|narcotics|mesh-ancestor
101675163|NCT06003218|Antidepressive Agents|antidepressive agents|mesh-ancestor
101675164|NCT06003218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101675165|NCT05999630|Lubricant Eye Drops|lubricant eye drops|mesh-list
101675166|NCT05999630|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101675167|NCT05999630|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101675168|NCT05999175|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101675169|NCT05999175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101675170|NCT05998317|Dexamethasone|dexamethasone|mesh-list
101675171|NCT05998317|Dexamethasone acetate|dexamethasone acetate|mesh-list
101675172|NCT05998317|BB 1101|bb 1101|mesh-list
101675173|NCT05998317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101332421|NCT00038116|Dopamine|dopamine|mesh-list
101675175|NCT05998317|Autonomic Agents|autonomic agents|mesh-ancestor
101675176|NCT05998317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101675177|NCT05998317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675178|NCT05998317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101675179|NCT05998317|Glucocorticoids|glucocorticoids|mesh-ancestor
101675180|NCT05998317|Hormones|hormones|mesh-ancestor
101675181|NCT05998317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101675182|NCT05998317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101675183|NCT05998317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675184|NCT05998317|Protease Inhibitors|protease inhibitors|mesh-ancestor
101675185|NCT05998317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101675186|NCT05998317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675187|NCT05995769|Psilocybin|psilocybin|mesh-list
101675188|NCT05995769|Hallucinogens|hallucinogens|mesh-ancestor
101675189|NCT05995769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675190|NCT05995769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101675191|NCT05994638|Niacinamide|niacinamide|mesh-list
101675192|NCT05994638|Hyaluronic Acid|hyaluronic acid|mesh-list
101675193|NCT05994638|Vitamins|vitamins|mesh-ancestor
101675194|NCT05994638|Micronutrients|micronutrients|mesh-ancestor
101675195|NCT05994638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675196|NCT05994638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101675197|NCT05994638|Immunologic Factors|immunologic factors|mesh-ancestor
101675198|NCT05994638|Viscosupplements|viscosupplements|mesh-ancestor
101675199|NCT05994638|Protective Agents|protective agents|mesh-ancestor
101675200|NCT05994638|Vitamin B Complex|vitamin b complex|mesh-ancestor
101828469|NCT05631886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101675201|NCT05969730|Azathioprine|azathioprine|mesh-list
101675202|NCT05969730|Antimetabolites|antimetabolites|mesh-ancestor
101675203|NCT05969730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675204|NCT05969730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101675205|NCT05969730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675206|NCT05969730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101675207|NCT05969730|Immunologic Factors|immunologic factors|mesh-ancestor
101675208|NCT05969730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675209|NCT05969730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101675210|NCT05966025|Antihypertensive Agents|antihypertensive agents|mesh-list
101675211|NCT05966025|Hypolipidemic Agents|hypolipidemic agents|mesh-list
101675212|NCT05966025|Antimetabolites|antimetabolites|mesh-ancestor
101675213|NCT05966025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675214|NCT05966025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101675215|NCT05949281|Colchicine|colchicine|mesh-list
101675216|NCT05949281|Gout Suppressants|gout suppressants|mesh-ancestor
101675217|NCT05949281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101675218|NCT05949281|Tubulin Modulators|tubulin modulators|mesh-ancestor
101675219|NCT05949281|Antimitotic Agents|antimitotic agents|mesh-ancestor
101675220|NCT05949281|Mitosis Modulators|mitosis modulators|mesh-ancestor
101675221|NCT05949281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675222|NCT05949281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675223|NCT05949099|Nirogacestat|nirogacestat|mesh-list
101675224|NCT05949099|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101675225|NCT05949099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101675226|NCT05949099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675227|NCT05934942|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
101675228|NCT05934942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101675229|NCT05934942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675230|NCT05933603|Oxybutynin|oxybutynin|mesh-list
101675231|NCT05933603|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101675232|NCT05933603|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101675233|NCT05933603|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101675234|NCT05933603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101675235|NCT05933603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675236|NCT05933603|Adrenergic Agents|adrenergic agents|mesh-ancestor
101675237|NCT05933603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101675238|NCT05933603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675239|NCT05933603|Parasympatholytics|parasympatholytics|mesh-ancestor
101675240|NCT05933603|Autonomic Agents|autonomic agents|mesh-ancestor
101675241|NCT05933603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101675242|NCT05933603|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101675243|NCT05933603|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101675244|NCT05933603|Cholinergic Agents|cholinergic agents|mesh-ancestor
101675245|NCT05933603|Urological Agents|urological agents|mesh-ancestor
101675246|NCT05893862|Moxifloxacin|moxifloxacin|mesh-list
101675247|NCT05893862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101675248|NCT05893862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101675249|NCT05893862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101675250|NCT05893862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101675251|NCT05893862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101675252|NCT05893862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675253|NCT05893862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675254|NCT05888233|Allopurinol|allopurinol|mesh-list
101675255|NCT05888233|Antimetabolites|antimetabolites|mesh-ancestor
101675256|NCT05888233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675257|NCT05888233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101675258|NCT05888233|Gout Suppressants|gout suppressants|mesh-ancestor
101675259|NCT05888233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101675260|NCT05888233|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101675261|NCT05888233|Antioxidants|antioxidants|mesh-ancestor
101675262|NCT05888233|Protective Agents|protective agents|mesh-ancestor
101675263|NCT05888233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675264|NCT05887882|Mitogens|mitogens|mesh-list
101675265|NCT05887882|Mitosis Modulators|mitosis modulators|mesh-ancestor
101828480|NCT05613088|Farletuzumab|farletuzumab|mesh-list
101675266|NCT05887882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675267|NCT05884528|Botulinum Toxins|botulinum toxins|mesh-list
101675268|NCT05884528|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101675269|NCT05884528|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101675270|NCT05884528|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
101675271|NCT05884528|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101675272|NCT05884528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101675273|NCT05884528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675274|NCT05884528|Cholinergic Agents|cholinergic agents|mesh-ancestor
101675275|NCT05884528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101675277|NCT05884528|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101675278|NCT05884528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101675279|NCT05874219|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101675281|NCT05874219|Neomycin|neomycin|mesh-list
101675282|NCT05874219|Bacitracin|bacitracin|mesh-list
101675283|NCT05874219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101675284|NCT05874219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101675285|NCT05874219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101675286|NCT05874219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675287|NCT05874219|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101675288|NCT05873244|Sorafenib|sorafenib|mesh-list
101675289|NCT05873244|Lenvatinib|lenvatinib|mesh-list
101675324|NCT05845814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101675325|NCT05845814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675326|NCT05845814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101675327|NCT05845814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675334|NCT05825781|Pertuzumab|pertuzumab|mesh-list
101675335|NCT05825781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101675336|NCT05825781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675337|NCT05825417|Selexipag|selexipag|mesh-list
101675338|NCT05825417|Riociguat|riociguat|mesh-list
101675339|NCT05825417|Enzyme Activators|enzyme activators|mesh-ancestor
101675340|NCT05825417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675341|NCT05825417|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101675342|NCT05808764|Risdiplam|risdiplam|mesh-list
101675343|NCT05808764|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101675344|NCT05808764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101675345|NCT05808764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675346|NCT05801835|Cytarabine|cytarabine|mesh-list
101675347|NCT05801835|Daunorubicin|daunorubicin|mesh-list
101675348|NCT05801835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101675349|NCT05801835|Antimetabolites|antimetabolites|mesh-ancestor
101540601|NCT04532736|Hormones|hormones|mesh-ancestor
101675350|NCT05801835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675351|NCT05801835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675353|NCT05801835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101675354|NCT05801835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101675355|NCT05801835|Immunologic Factors|immunologic factors|mesh-ancestor
101675356|NCT05801835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675357|NCT05801835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101675358|NCT05801835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101675359|NCT05801835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101675360|NCT05801835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101675361|NCT05795062|Warfarin|warfarin|mesh-list
101675362|NCT05795062|Apixaban|apixaban|mesh-list
101675363|NCT05795062|Anticoagulants|anticoagulants|mesh-ancestor
101675364|NCT05795062|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101675365|NCT05795062|Antithrombins|antithrombins|mesh-ancestor
101675366|NCT05795062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101675367|NCT05795062|Protease Inhibitors|protease inhibitors|mesh-ancestor
101675368|NCT05795062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101828498|NCT05601752|Nivolumab|nivolumab|mesh-list
101828499|NCT05601752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101675369|NCT05795062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675370|NCT05790044|Clonidine|clonidine|mesh-list
101675371|NCT05790044|Bupivacaine|bupivacaine|mesh-list
101675372|NCT05790044|Anesthetics, Local|anesthetics, local|mesh-ancestor
101675373|NCT05790044|Anesthetics|anesthetics|mesh-ancestor
101675374|NCT05790044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101675375|NCT05790044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675376|NCT05790044|Sensory System Agents|sensory system agents|mesh-ancestor
101675377|NCT05790044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101675378|NCT05790044|Analgesics|analgesics|mesh-ancestor
101675379|NCT05790044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101675380|NCT05790044|Sympatholytics|sympatholytics|mesh-ancestor
101675381|NCT05790044|Autonomic Agents|autonomic agents|mesh-ancestor
101675382|NCT05790044|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101675383|NCT05790044|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101675384|NCT05790044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101675385|NCT05790044|Adrenergic Agents|adrenergic agents|mesh-ancestor
101675386|NCT05790044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101675387|NCT05790044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675388|NCT05776030|Methamphetamine|methamphetamine|mesh-list
101675389|NCT05776030|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101675390|NCT05776030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675391|NCT05776030|Sympathomimetics|sympathomimetics|mesh-ancestor
101675392|NCT05776030|Autonomic Agents|autonomic agents|mesh-ancestor
101675393|NCT05776030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101675394|NCT05776030|Dopamine Agents|dopamine agents|mesh-ancestor
101675395|NCT05776030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101675396|NCT05776030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675397|NCT05776030|Adrenergic Agents|adrenergic agents|mesh-ancestor
101332644|NCT00000986|Zidovudine|zidovudine|mesh-list
101675398|NCT05776030|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101675399|NCT05776030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101675400|NCT05776030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101675401|NCT05776030|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101675402|NCT05773950|Fosaprepitant|fosaprepitant|mesh-list
101675404|NCT05773950|Antiemetics|antiemetics|mesh-ancestor
101675405|NCT05773950|Autonomic Agents|autonomic agents|mesh-ancestor
101675406|NCT05773950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101675407|NCT05773950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675408|NCT05773950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101675409|NCT05773950|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101675410|NCT05773950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101675411|NCT05773950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675412|NCT05766553|Nicotine|nicotine|mesh-list
101675413|NCT05766553|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101675414|NCT05766553|Autonomic Agents|autonomic agents|mesh-ancestor
101675415|NCT05766553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101675416|NCT05766553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675417|NCT05766553|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101675418|NCT05766553|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101675419|NCT05766553|Cholinergic Agents|cholinergic agents|mesh-ancestor
101675420|NCT05766553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101675421|NCT05766553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675423|NCT05765851|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
101675424|NCT05765851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101675425|NCT05765851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675427|NCT05765851|Immunologic Factors|immunologic factors|mesh-ancestor
101675428|NCT05765851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675429|NCT05763823|Letermovir|letermovir|mesh-list
101675430|NCT05763823|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101675431|NCT05763823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101675432|NCT05763823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675433|NCT05763823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675434|NCT05763823|Antiviral Agents|antiviral agents|mesh-ancestor
101675435|NCT05763823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101675436|NCT05741632|Moxifloxacin|moxifloxacin|mesh-list
101675437|NCT05741632|Levofloxacin|levofloxacin|mesh-list
101675438|NCT05741632|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101675439|NCT05741632|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101675440|NCT05741632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101675441|NCT05741632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101675442|NCT05741632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101675443|NCT05741632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101675444|NCT05741632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101675445|NCT05741632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675446|NCT05741632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675447|NCT05741632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101675448|NCT05741632|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101675449|NCT05741632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101675450|NCT05739981|Paclitaxel|paclitaxel|mesh-list
101675451|NCT05739981|Bevacizumab|bevacizumab|mesh-list
101675452|NCT05739981|Carboplatin|carboplatin|mesh-list
101675453|NCT05739981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101675454|NCT05739981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675455|NCT05739981|Tubulin Modulators|tubulin modulators|mesh-ancestor
101675456|NCT05739981|Antimitotic Agents|antimitotic agents|mesh-ancestor
101675457|NCT05739981|Mitosis Modulators|mitosis modulators|mesh-ancestor
101675458|NCT05739981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409639|NCT00350155|Analgesics|analgesics|mesh-ancestor
101675459|NCT05739981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101675460|NCT05739981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101675461|NCT05739981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101675462|NCT05739981|Growth Substances|growth substances|mesh-ancestor
101675463|NCT05739981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675464|NCT05739981|Growth Inhibitors|growth inhibitors|mesh-ancestor
101675465|NCT05728645|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
101675466|NCT05728645|Plasma Substitutes|plasma substitutes|mesh-ancestor
101675467|NCT05728645|Blood Substitutes|blood substitutes|mesh-ancestor
101675468|NCT05715229|Paclitaxel|paclitaxel|mesh-list
101675469|NCT05715229|Carboplatin|carboplatin|mesh-list
101675470|NCT05715229|Nivolumab|nivolumab|mesh-list
101675471|NCT05715229|Pemetrexed|pemetrexed|mesh-list
101675472|NCT05715229|Ipilimumab|ipilimumab|mesh-list
101675473|NCT05715229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101675475|NCT05715229|Tubulin Modulators|tubulin modulators|mesh-ancestor
101675476|NCT05715229|Antimitotic Agents|antimitotic agents|mesh-ancestor
101675477|NCT05715229|Mitosis Modulators|mitosis modulators|mesh-ancestor
101675478|NCT05715229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675479|NCT05715229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101675480|NCT05715229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101675481|NCT05715229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101675482|NCT05715229|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101675483|NCT05715229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101675484|NCT05690087|Lidocaine|lidocaine|mesh-list
101675485|NCT05690087|Anesthetics, Local|anesthetics, local|mesh-ancestor
101675486|NCT05690087|Anesthetics|anesthetics|mesh-ancestor
101675487|NCT05690087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101675488|NCT05690087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675489|NCT05690087|Sensory System Agents|sensory system agents|mesh-ancestor
101675490|NCT05690087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101675491|NCT05690087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101675492|NCT05690087|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101675493|NCT05690087|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101675494|NCT05690087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101675495|NCT05690087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675496|NCT05685602|Paclitaxel|paclitaxel|mesh-list
101675497|NCT05685602|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101828511|NCT05600426|Immunologic Factors|immunologic factors|mesh-ancestor
101675499|NCT05685602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101675500|NCT05685602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675501|NCT05685602|Tubulin Modulators|tubulin modulators|mesh-ancestor
101675502|NCT05685602|Antimitotic Agents|antimitotic agents|mesh-ancestor
101675503|NCT05685602|Mitosis Modulators|mitosis modulators|mesh-ancestor
101675504|NCT05685602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675505|NCT05685602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101675506|NCT05685602|Antimetabolites|antimetabolites|mesh-ancestor
101675507|NCT05685342|Acetaminophen|acetaminophen|mesh-list
101675508|NCT05685342|Ibuprofen|ibuprofen|mesh-list
101675509|NCT05685342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101675510|NCT05685342|Analgesics|analgesics|mesh-ancestor
101675511|NCT05685342|Sensory System Agents|sensory system agents|mesh-ancestor
101675512|NCT05685342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101675513|NCT05685342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675514|NCT05685342|Antipyretics|antipyretics|mesh-ancestor
101675515|NCT05685342|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101675516|NCT05685342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101675517|NCT05685342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101675518|NCT05685342|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101675519|NCT05685342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101675520|NCT05685342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675521|NCT05681312|Amoxicillin|amoxicillin|mesh-list
101675522|NCT05681312|Metronidazole|metronidazole|mesh-list
101675523|NCT05681312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101675524|NCT05681312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101675525|NCT05681312|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101675526|NCT05681312|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101675527|NCT05672251|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
101675528|NCT05672251|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101675529|NCT05672251|Immunologic Factors|immunologic factors|mesh-ancestor
101675530|NCT05672251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675531|NCT05672251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101675532|NCT05672251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675533|NCT05661708|Chitosan|chitosan|mesh-list
101675534|NCT05661708|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101675535|NCT05661708|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101675536|NCT05661708|Antimetabolites|antimetabolites|mesh-ancestor
101675537|NCT05661708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675538|NCT05661708|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101675539|NCT05661708|Chelating Agents|chelating agents|mesh-ancestor
101675540|NCT05661708|Sequestering Agents|sequestering agents|mesh-ancestor
101675541|NCT05661708|Hemostatics|hemostatics|mesh-ancestor
101675542|NCT05661708|Coagulants|coagulants|mesh-ancestor
101675543|NCT05658575|Dapansutrile|dapansutrile|mesh-list
101675544|NCT05658575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101675545|NCT05654454|Paclitaxel|paclitaxel|mesh-list
101675546|NCT05654454|Bevacizumab|bevacizumab|mesh-list
101675547|NCT05654454|Carboplatin|carboplatin|mesh-list
101675548|NCT05654454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101675549|NCT05654454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675550|NCT05654454|Tubulin Modulators|tubulin modulators|mesh-ancestor
101675551|NCT05654454|Antimitotic Agents|antimitotic agents|mesh-ancestor
101675552|NCT05654454|Mitosis Modulators|mitosis modulators|mesh-ancestor
101675553|NCT05654454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675554|NCT05654454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101675555|NCT05654454|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101675556|NCT05654454|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101675557|NCT05654454|Growth Substances|growth substances|mesh-ancestor
101675558|NCT05654454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675559|NCT05654454|Growth Inhibitors|growth inhibitors|mesh-ancestor
101675560|NCT05625503|Verapamil|verapamil|mesh-list
101675561|NCT05625503|Nicardipine|nicardipine|mesh-list
101675562|NCT05625503|Calcium Channel Blockers|calcium channel blockers|mesh-list
101828521|NCT05600426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101828523|NCT05600426|Antimetabolites|antimetabolites|mesh-ancestor
101675563|NCT05625503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101675564|NCT05625503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675565|NCT05625503|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101675566|NCT05625503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101675567|NCT05625503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675568|NCT05625503|Vasodilator Agents|vasodilator agents|mesh-ancestor
101675569|NCT05625503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101675571|NCT05600894|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
101675572|NCT05600894|Venetoclax|venetoclax|mesh-list
101675573|NCT05600894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101675574|NCT05600894|Antimetabolites|antimetabolites|mesh-ancestor
101675575|NCT05600894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675584|NCT05553834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675585|NCT05553834|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101675586|NCT05553834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101675587|NCT05553834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101675588|NCT05553834|Antimetabolites|antimetabolites|mesh-ancestor
101675589|NCT05553834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675590|NCT05553834|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101675591|NCT05553834|Protease Inhibitors|protease inhibitors|mesh-ancestor
101675592|NCT05553834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101675593|NCT05553834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101675594|NCT05537402|Bevacizumab|bevacizumab|mesh-list
101675595|NCT05537402|Atezolizumab|atezolizumab|mesh-list
101675596|NCT05537402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101675597|NCT05537402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675598|NCT05537402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101675599|NCT05537402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101675600|NCT05537402|Growth Substances|growth substances|mesh-ancestor
101675601|NCT05537402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675602|NCT05537402|Growth Inhibitors|growth inhibitors|mesh-ancestor
101675603|NCT05537402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101675604|NCT05537402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675605|NCT05529290|Acetaminophen|acetaminophen|mesh-list
101675606|NCT05529290|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
101675607|NCT05529290|Ketoprofen|ketoprofen|mesh-list
101675608|NCT05529290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101675609|NCT05529290|Analgesics|analgesics|mesh-ancestor
101675610|NCT05529290|Sensory System Agents|sensory system agents|mesh-ancestor
101675611|NCT05529290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101675612|NCT05529290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675613|NCT05529290|Antipyretics|antipyretics|mesh-ancestor
101675614|NCT05529290|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101675615|NCT05529290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101675616|NCT05529290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101675617|NCT05529290|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101675618|NCT05529290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101675619|NCT05529290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675620|NCT05514535|Insulin Glargine|insulin glargine|mesh-list
101675621|NCT05514535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101332865|NCT00015834|Cytarabine|cytarabine|mesh-list
101675622|NCT05514535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675629|NCT05502237|Paclitaxel|paclitaxel|mesh-list
101675630|NCT05502237|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101675631|NCT05502237|Carboplatin|carboplatin|mesh-list
101675632|NCT05502237|Pembrolizumab|pembrolizumab|mesh-list
101675633|NCT05502237|Pemetrexed|pemetrexed|mesh-list
101675634|NCT05502237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101675635|NCT05502237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675636|NCT05502237|Tubulin Modulators|tubulin modulators|mesh-ancestor
101675637|NCT05502237|Antimitotic Agents|antimitotic agents|mesh-ancestor
101675638|NCT05502237|Mitosis Modulators|mitosis modulators|mesh-ancestor
101675639|NCT05502237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485809|NCT00319202|Candesartan|candesartan|mesh-list
101675645|NCT05470491|Maraviroc|maraviroc|mesh-list
101675646|NCT05470491|Plerixafor|plerixafor|mesh-list
101675647|NCT05470491|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101675648|NCT05470491|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101675649|NCT05470491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675650|NCT05470491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101675651|NCT05470491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101675652|NCT05470491|Antiviral Agents|antiviral agents|mesh-ancestor
101675653|NCT05470491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101675654|NCT05470491|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101675661|NCT05461053|Lidocaine|lidocaine|mesh-list
101675662|NCT05461053|Anesthetics, Local|anesthetics, local|mesh-ancestor
101675663|NCT05461053|Anesthetics|anesthetics|mesh-ancestor
101675664|NCT05461053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101675665|NCT05461053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675666|NCT05461053|Sensory System Agents|sensory system agents|mesh-ancestor
101675667|NCT05461053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101675668|NCT05461053|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101675669|NCT05461053|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101675670|NCT05461053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101675671|NCT05461053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101675672|NCT05461053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675673|NCT05446870|Paclitaxel|paclitaxel|mesh-list
101675674|NCT05446870|Docetaxel|docetaxel|mesh-list
101675675|NCT05446870|Bevacizumab|bevacizumab|mesh-list
101675676|NCT05446870|Carboplatin|carboplatin|mesh-list
101675677|NCT05446870|Pembrolizumab|pembrolizumab|mesh-list
101675678|NCT05446870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101675679|NCT05446870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675680|NCT05446870|Tubulin Modulators|tubulin modulators|mesh-ancestor
101675681|NCT05446870|Antimitotic Agents|antimitotic agents|mesh-ancestor
101675682|NCT05446870|Mitosis Modulators|mitosis modulators|mesh-ancestor
101675683|NCT05446870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675684|NCT05446870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101675685|NCT05446870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101675686|NCT05446870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101675687|NCT05446870|Growth Substances|growth substances|mesh-ancestor
101675688|NCT05446870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675689|NCT05446870|Growth Inhibitors|growth inhibitors|mesh-ancestor
101675690|NCT05446870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101675691|NCT05435677|Insulin|insulin|mesh-list
101675692|NCT05435677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101675693|NCT05435677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675694|NCT05425940|Atezolizumab|atezolizumab|mesh-list
101675695|NCT05425940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101675696|NCT05425940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675697|NCT05425940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101675698|NCT05425940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675699|NCT05415917|Gemcitabine|gemcitabine|mesh-list
101675700|NCT05415917|Capecitabine|capecitabine|mesh-list
101675701|NCT05415917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101675702|NCT05415917|Antimetabolites|antimetabolites|mesh-ancestor
101675703|NCT05415917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675704|NCT05415917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675705|NCT05407441|Nivolumab|nivolumab|mesh-list
101675706|NCT05407441|Ipilimumab|ipilimumab|mesh-list
101675707|NCT05407441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101675708|NCT05407441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675709|NCT05407441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101675710|NCT05407441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675711|NCT05371054|Prednisone|prednisone|mesh-list
101675712|NCT05371054|Venetoclax|venetoclax|mesh-list
101675713|NCT05371054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101675714|NCT05371054|Glucocorticoids|glucocorticoids|mesh-ancestor
101675715|NCT05371054|Hormones|hormones|mesh-ancestor
101675716|NCT05371054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101675717|NCT05371054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675718|NCT05371054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101675719|NCT05371054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675720|NCT05367687|Apatinib|apatinib|mesh-list
101675721|NCT05367687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675722|NCT05367687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101675723|NCT05367687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101675724|NCT05367687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675725|NCT05366777|Acetaminophen|acetaminophen|mesh-list
101675726|NCT05366777|Ibuprofen|ibuprofen|mesh-list
101675727|NCT05366777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101675728|NCT05366777|Analgesics|analgesics|mesh-ancestor
101675729|NCT05366777|Sensory System Agents|sensory system agents|mesh-ancestor
101675730|NCT05366777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101675731|NCT05366777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675732|NCT05366777|Antipyretics|antipyretics|mesh-ancestor
101675733|NCT05366777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101675734|NCT05366777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101675735|NCT05366777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101675736|NCT05366777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101675737|NCT05366777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101675738|NCT05366777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675739|NCT05353829|Methotrexate|methotrexate|mesh-list
101675740|NCT05353829|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101675741|NCT05353829|Abortifacient Agents|abortifacient agents|mesh-ancestor
101675742|NCT05353829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101675743|NCT05353829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675744|NCT05353829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101675745|NCT05353829|Antimetabolites|antimetabolites|mesh-ancestor
101675746|NCT05353829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675747|NCT05353829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675748|NCT05353829|Dermatologic Agents|dermatologic agents|mesh-ancestor
101675749|NCT05353829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101675750|NCT05353829|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101675751|NCT05353829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101675757|NCT05352815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675759|NCT05345509|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101675760|NCT05345509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101675761|NCT05345509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675762|NCT05345509|Cholinergic Agents|cholinergic agents|mesh-ancestor
101675763|NCT05345509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101675764|NCT05345509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675765|NCT05345509|Nootropic Agents|nootropic agents|mesh-ancestor
101675772|NCT05307731|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101675773|NCT05307731|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101828581|NCT05556681|Sirolimus|sirolimus|mesh-list
101828582|NCT05556681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101828583|NCT05556681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101675774|NCT05307731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675776|NCT05307731|Immunologic Factors|immunologic factors|mesh-ancestor
101675777|NCT05307731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675778|NCT05306340|Tamoxifen|tamoxifen|mesh-list
101675779|NCT05306340|Dexamethasone|dexamethasone|mesh-list
101675780|NCT05306340|Fulvestrant|fulvestrant|mesh-list
101675781|NCT05306340|Everolimus|everolimus|mesh-list
101675782|NCT05306340|Exemestane|exemestane|mesh-list
101675783|NCT05306340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101675784|NCT05306340|Antiemetics|antiemetics|mesh-ancestor
101675785|NCT05306340|Autonomic Agents|autonomic agents|mesh-ancestor
101675786|NCT05306340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101675787|NCT05306340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675788|NCT05306340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101675789|NCT05306340|Glucocorticoids|glucocorticoids|mesh-ancestor
101675790|NCT05306340|Hormones|hormones|mesh-ancestor
101675791|NCT05306340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101675792|NCT05306340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101675793|NCT05306340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675794|NCT05306340|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101675795|NCT05306340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101675796|NCT05306340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101675797|NCT05306340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675798|NCT05306340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101675799|NCT05306340|Immunologic Factors|immunologic factors|mesh-ancestor
101675801|NCT05306340|Hormone Antagonists|hormone antagonists|mesh-ancestor
101675802|NCT05306340|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101675803|NCT05306340|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101675804|NCT05306340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101675805|NCT05306340|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101675806|NCT05306340|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101675807|NCT05306340|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101675808|NCT05297565|Nivolumab|nivolumab|mesh-list
101675809|NCT05297565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101675810|NCT05297565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675811|NCT05297565|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101675812|NCT05297565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675813|NCT05287035|Dexamethasone|dexamethasone|mesh-list
101675814|NCT05287035|Dexamethasone acetate|dexamethasone acetate|mesh-list
101675815|NCT05287035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101675816|NCT05287035|Antiemetics|antiemetics|mesh-ancestor
101675817|NCT05287035|Autonomic Agents|autonomic agents|mesh-ancestor
101675818|NCT05287035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101675819|NCT05287035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675820|NCT05287035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101675821|NCT05287035|Glucocorticoids|glucocorticoids|mesh-ancestor
101675822|NCT05287035|Hormones|hormones|mesh-ancestor
101675823|NCT05287035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101675824|NCT05287035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101675825|NCT05287035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675826|NCT05283720|Prednisone|prednisone|mesh-list
101675827|NCT05283720|Cyclophosphamide|cyclophosphamide|mesh-list
101675828|NCT05283720|Rituximab|rituximab|mesh-list
101675829|NCT05283720|Doxorubicin|doxorubicin|mesh-list
101675830|NCT05283720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101675831|NCT05283720|Lenalidomide|lenalidomide|mesh-list
101675832|NCT05283720|Venetoclax|venetoclax|mesh-list
101675833|NCT05283720|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
101675834|NCT05283720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101675835|NCT05283720|Immunologic Factors|immunologic factors|mesh-ancestor
101675836|NCT05283720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675837|NCT05283720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101675838|NCT05283720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101675839|NCT05283720|Alkylating Agents|alkylating agents|mesh-ancestor
101828584|NCT05556681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101828585|NCT05556681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101828586|NCT05556681|Antifungal Agents|antifungal agents|mesh-ancestor
101828587|NCT05556681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101828588|NCT05556681|Immunologic Factors|immunologic factors|mesh-ancestor
101675840|NCT05283720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675841|NCT05283720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675842|NCT05283720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101675843|NCT05283720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101675844|NCT05283720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101675845|NCT05283720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101333093|NCT00016224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101675846|NCT05283720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101675847|NCT05283720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101675848|NCT05283720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101675850|NCT05283720|Hormones|hormones|mesh-ancestor
101675851|NCT05283720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101675852|NCT05283720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101675853|NCT05283720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101675854|NCT05283720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101675855|NCT05283720|Growth Substances|growth substances|mesh-ancestor
101675856|NCT05283720|Growth Inhibitors|growth inhibitors|mesh-ancestor
101675857|NCT05283720|Immunoconjugates|immunoconjugates|mesh-ancestor
101675858|NCT05282069|Solifenacin Succinate|solifenacin succinate|mesh-list
101675859|NCT05282069|DA-8010|da-8010|mesh-list
101675860|NCT05282069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101675861|NCT05282069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101675862|NCT05282069|Cholinergic Agents|cholinergic agents|mesh-ancestor
101675863|NCT05282069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101675864|NCT05282069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675865|NCT05282069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675866|NCT05282069|Urological Agents|urological agents|mesh-ancestor
101675867|NCT05275426|Gemcitabine|gemcitabine|mesh-list
101675868|NCT05275426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101675869|NCT05275426|Antimetabolites|antimetabolites|mesh-ancestor
101675870|NCT05275426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675871|NCT05275426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675872|NCT05275010|Trastuzumab|trastuzumab|mesh-list
101675873|NCT05275010|Pertuzumab|pertuzumab|mesh-list
101675874|NCT05275010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101675875|NCT05275010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675877|NCT05259839|Lenalidomide|lenalidomide|mesh-list
101675878|NCT05259839|Daratumumab|daratumumab|mesh-list
101675879|NCT05259839|Pomalidomide|pomalidomide|mesh-list
101675880|NCT05259839|Nirogacestat|nirogacestat|mesh-list
101675881|NCT05259839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101675882|NCT05259839|Antiemetics|antiemetics|mesh-ancestor
101675883|NCT05259839|Autonomic Agents|autonomic agents|mesh-ancestor
101675884|NCT05259839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101675885|NCT05259839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675886|NCT05259839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101675887|NCT05259839|Glucocorticoids|glucocorticoids|mesh-ancestor
101675888|NCT05259839|Hormones|hormones|mesh-ancestor
101675889|NCT05259839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101675890|NCT05259839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101675891|NCT05259839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675892|NCT05259839|Immunologic Factors|immunologic factors|mesh-ancestor
101675893|NCT05259839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101675894|NCT05259839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101675895|NCT05259839|Growth Substances|growth substances|mesh-ancestor
101675896|NCT05259839|Growth Inhibitors|growth inhibitors|mesh-ancestor
101675897|NCT05259839|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101675898|NCT05259839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101675899|NCT05259839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675900|NCT05256225|Paclitaxel|paclitaxel|mesh-list
101675901|NCT05256225|Carboplatin|carboplatin|mesh-list
101675902|NCT05256225|Trastuzumab|trastuzumab|mesh-list
101675903|NCT05256225|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101828598|NCT05552976|Dexamethasone|dexamethasone|mesh-list
101828599|NCT05552976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101828600|NCT05552976|Antiemetics|antiemetics|mesh-ancestor
101828601|NCT05552976|Autonomic Agents|autonomic agents|mesh-ancestor
101828602|NCT05552976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101675904|NCT05256225|Pertuzumab|pertuzumab|mesh-list
101675905|NCT05256225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101675906|NCT05256225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675907|NCT05256225|Tubulin Modulators|tubulin modulators|mesh-ancestor
101675908|NCT05256225|Antimitotic Agents|antimitotic agents|mesh-ancestor
101675909|NCT05256225|Mitosis Modulators|mitosis modulators|mesh-ancestor
101675910|NCT05256225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675911|NCT05256225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101675912|NCT05251090|Factor VIII|factor viii|mesh-list
101675913|NCT05251090|Coagulants|coagulants|mesh-ancestor
101675914|NCT05249920|Edaravone|edaravone|mesh-list
101675915|NCT05249920|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101675916|NCT05249920|Antioxidants|antioxidants|mesh-ancestor
101675917|NCT05249920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675918|NCT05249920|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101675919|NCT05249920|Protective Agents|protective agents|mesh-ancestor
101675920|NCT05249920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675921|NCT05208047|Sunitinib|sunitinib|mesh-list
101675922|NCT05208047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675923|NCT05208047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101675924|NCT05208047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101675925|NCT05208047|Growth Substances|growth substances|mesh-ancestor
101675926|NCT05208047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675927|NCT05208047|Growth Inhibitors|growth inhibitors|mesh-ancestor
101675928|NCT05208047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101675929|NCT05208047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101675930|NCT05208047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675931|NCT05193071|Aspirin|aspirin|mesh-list
101675932|NCT05193071|Clopidogrel|clopidogrel|mesh-list
101675933|NCT05193071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101675934|NCT05193071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101675935|NCT05193071|Analgesics|analgesics|mesh-ancestor
101675936|NCT05193071|Sensory System Agents|sensory system agents|mesh-ancestor
101675937|NCT05193071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101675938|NCT05193071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675939|NCT05193071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101675940|NCT05193071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101675941|NCT05193071|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101675942|NCT05193071|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101675943|NCT05193071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675944|NCT05193071|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101675945|NCT05193071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101675946|NCT05193071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101675947|NCT05193071|Antipyretics|antipyretics|mesh-ancestor
101675948|NCT05193071|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101675949|NCT05193071|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101675951|NCT05193071|Purinergic Agents|purinergic agents|mesh-ancestor
101675952|NCT05193071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101675953|NCT05145010|Infigratinib|infigratinib|mesh-list
101675954|NCT05145010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675955|NCT05113940|Midazolam|midazolam|mesh-list
101675956|NCT05113940|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101675957|NCT05113940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101675958|NCT05113940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101675959|NCT05113940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675960|NCT05113940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101675961|NCT05113940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101675962|NCT05113940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101675963|NCT05113940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101675964|NCT05113940|Anesthetics, General|anesthetics, general|mesh-ancestor
101675966|NCT05113940|GABA Modulators|gaba modulators|mesh-ancestor
101675967|NCT05113940|GABA Agents|gaba agents|mesh-ancestor
101675968|NCT05113940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101675969|NCT05113940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675970|NCT05112965|Atezolizumab|atezolizumab|mesh-list
101675971|NCT05112965|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101675972|NCT05112965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828605|NCT05552976|Glucocorticoids|glucocorticoids|mesh-ancestor
101828606|NCT05552976|Hormones|hormones|mesh-ancestor
101828609|NCT05552976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675973|NCT05112965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101675974|NCT05112965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675975|NCT05111574|Nivolumab|nivolumab|mesh-list
101675976|NCT05111574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101675977|NCT05111574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101675978|NCT05111574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101675979|NCT05111574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675980|NCT05101096|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
101675981|NCT05101096|Immunoconjugates|immunoconjugates|mesh-ancestor
101675982|NCT05101096|Immunologic Factors|immunologic factors|mesh-ancestor
101675983|NCT05101096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675984|NCT05096884|Metoprolol|metoprolol|mesh-list
101675985|NCT05096884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101675986|NCT05096884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101675987|NCT05096884|Sympatholytics|sympatholytics|mesh-ancestor
101675988|NCT05096884|Autonomic Agents|autonomic agents|mesh-ancestor
101675989|NCT05096884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101675990|NCT05096884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101675991|NCT05096884|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101675992|NCT05096884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101675993|NCT05096884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101675994|NCT05096884|Adrenergic Agents|adrenergic agents|mesh-ancestor
101675995|NCT05096884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101675996|NCT05096884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101675997|NCT05082259|Pembrolizumab|pembrolizumab|mesh-list
101675998|NCT05082259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101675999|NCT05082259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676000|NCT05082259|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101676001|NCT05082259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676002|NCT05073172|Sulfadiazine|sulfadiazine|mesh-list
101676003|NCT05073172|Silver Sulfadiazine|silver sulfadiazine|mesh-list
101676004|NCT05073172|Hydrocortisone|hydrocortisone|mesh-list
101676005|NCT05073172|Petrolatum|petrolatum|mesh-list
101676006|NCT05073172|Mineral Oil|mineral oil|mesh-list
101676007|NCT05073172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101676008|NCT05073172|Emollients|emollients|mesh-ancestor
101676009|NCT05073172|Dermatologic Agents|dermatologic agents|mesh-ancestor
101676010|NCT05073172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101676011|NCT05073172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101676012|NCT05073172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101676013|NCT05073172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101676014|NCT05073172|Coccidiostats|coccidiostats|mesh-ancestor
101676015|NCT05073172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101676016|NCT05067634|Cenobamate|cenobamate|mesh-list
101676017|NCT05067634|Anticonvulsants|anticonvulsants|mesh-ancestor
101676018|NCT05065372|Metformin|metformin|mesh-list
101676019|NCT05065372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101676020|NCT05065372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676021|NCT05063565|Durvalumab|durvalumab|mesh-list
101676022|NCT05063565|Tremelimumab|tremelimumab|mesh-list
101676023|NCT05063565|Immunomodulating Agents|immunomodulating agents|mesh-list
101676024|NCT05063565|Immunologic Factors|immunologic factors|mesh-list
101676031|NCT05042505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676032|NCT05042505|Incretins|incretins|mesh-ancestor
101676033|NCT05042505|Hormones|hormones|mesh-ancestor
101676034|NCT05042505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101676035|NCT05042505|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101676036|NCT05042505|Protease Inhibitors|protease inhibitors|mesh-ancestor
101676037|NCT05042505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101676038|NCT05042505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676039|NCT05042505|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101676040|NCT05013229|Insulin|insulin|mesh-list
101676041|NCT05013229|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101676042|NCT05013229|Insulin Glargine|insulin glargine|mesh-list
101676043|NCT05013229|Insulin Aspart|insulin aspart|mesh-list
101676044|NCT05013229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101676045|NCT05013229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676046|NCT04962672|Anesthetics|anesthetics|mesh-list
101676047|NCT04962672|Propofol|propofol|mesh-list
101676048|NCT04962672|Sevoflurane|sevoflurane|mesh-list
101676049|NCT04962672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101676050|NCT04962672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676051|NCT04962672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101676052|NCT04962672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101676053|NCT04962672|Anesthetics, General|anesthetics, general|mesh-ancestor
101676054|NCT04962672|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101676055|NCT04962672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101676056|NCT04951206|Clobetasol|clobetasol|mesh-list
101676057|NCT04951206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101676058|NCT04951206|Glucocorticoids|glucocorticoids|mesh-ancestor
101676059|NCT04951206|Hormones|hormones|mesh-ancestor
101676060|NCT04951206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101676061|NCT04951206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676062|NCT04936126|Amantadine|amantadine|mesh-list
101676063|NCT04936126|Pramipexole|pramipexole|mesh-list
101676064|NCT04936126|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101676065|NCT04936126|Antidepressive Agents|antidepressive agents|mesh-ancestor
101676066|NCT04936126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101676067|NCT04936126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101676068|NCT04936126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101676069|NCT04936126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101676070|NCT04936126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676071|NCT04936126|Antioxidants|antioxidants|mesh-ancestor
101676072|NCT04936126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676073|NCT04936126|Protective Agents|protective agents|mesh-ancestor
101676074|NCT04936126|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101676075|NCT04936126|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101676076|NCT04936126|Dopamine Agonists|dopamine agonists|mesh-ancestor
101676077|NCT04936126|Dopamine Agents|dopamine agents|mesh-ancestor
101676078|NCT04936126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101676079|NCT04936126|Antiviral Agents|antiviral agents|mesh-ancestor
101676080|NCT04936126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101676081|NCT04936126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101676082|NCT04936126|Analgesics|analgesics|mesh-ancestor
101676083|NCT04936126|Sensory System Agents|sensory system agents|mesh-ancestor
101676084|NCT04936126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101409642|NCT00350155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676091|NCT04896073|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
101676092|NCT04896073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101676093|NCT04896073|Alkylating Agents|alkylating agents|mesh-ancestor
101676094|NCT04896073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676095|NCT04896073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676096|NCT04895436|Venetoclax|venetoclax|mesh-list
101676097|NCT04895436|Obinutuzumab|obinutuzumab|mesh-list
101676098|NCT04895436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676099|NCT04895436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101676100|NCT04846491|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101676101|NCT04846491|Interferon-alpha|interferon-alpha|mesh-list
101676102|NCT04846491|Antiviral Agents|antiviral agents|mesh-ancestor
101676103|NCT04846491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101676104|NCT04846491|Immunologic Factors|immunologic factors|mesh-ancestor
101676105|NCT04846491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676106|NCT04839042|Cloricromen|cloricromen|mesh-list
101676107|NCT04839042|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101676108|NCT04766723|Botulinum Toxins|botulinum toxins|mesh-list
101676109|NCT04766723|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101676110|NCT04766723|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101676111|NCT04766723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
101676112|NCT04766723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101676113|NCT04766723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101676114|NCT04766723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676115|NCT04766723|Cholinergic Agents|cholinergic agents|mesh-ancestor
101676116|NCT04766723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101676117|NCT04766723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676118|NCT04766723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101676119|NCT04766723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101676120|NCT04760288|Pralsetinib|pralsetinib|mesh-list
101676121|NCT04760288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676122|NCT04732286|Bevacizumab|bevacizumab|mesh-list
101676123|NCT04732286|Atezolizumab|atezolizumab|mesh-list
101676124|NCT04732286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101676125|NCT04732286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676126|NCT04732286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101676127|NCT04732286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101676128|NCT04732286|Growth Substances|growth substances|mesh-ancestor
101676129|NCT04732286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676130|NCT04732286|Growth Inhibitors|growth inhibitors|mesh-ancestor
101676131|NCT04732286|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101676132|NCT04732286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676133|NCT04708418|Pembrolizumab|pembrolizumab|mesh-list
101676134|NCT04708418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101676135|NCT04708418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676136|NCT04708418|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101676137|NCT04708418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676138|NCT04704661|Trastuzumab|trastuzumab|mesh-list
101676139|NCT04704661|Camptothecin|camptothecin|mesh-list
101676140|NCT04704661|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
101676141|NCT04704661|Immunoconjugates|immunoconjugates|mesh-list
101676142|NCT04704661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101676143|NCT04704661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676144|NCT04704661|Immunologic Factors|immunologic factors|mesh-ancestor
101676145|NCT04704661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676146|NCT04704661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101333399|NCT00038584|Lonafarnib|lonafarnib|mesh-list
101676147|NCT04704661|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101676148|NCT04704661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101676149|NCT04704661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101676150|NCT04704661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676151|NCT04689828|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101676152|NCT04689828|177Lu-PSMA-617|177lu-psma-617|mesh-list
101676153|NCT04689828|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101676154|NCT04689828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676155|NCT04676477|Osimertinib|osimertinib|mesh-list
101676156|NCT04676477|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
101676157|NCT04676477|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101676158|NCT04676477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676159|NCT04676477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101676160|NCT04676477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101676161|NCT04676477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676162|NCT04676477|Immunologic Factors|immunologic factors|mesh-ancestor
101676163|NCT04676477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676164|NCT04676477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101676165|NCT04664946|Neuroprotective Agents|neuroprotective agents|mesh-list
101676166|NCT04664946|Protective Agents|protective agents|mesh-ancestor
101676167|NCT04664946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676168|NCT04624243|Risperidone|risperidone|mesh-list
101676169|NCT04624243|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101676170|NCT04624243|Serotonin Agents|serotonin agents|mesh-ancestor
101676171|NCT04624243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101676172|NCT04624243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676173|NCT04624243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676174|NCT04624243|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101676175|NCT04624243|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101676176|NCT04624243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101676177|NCT04624243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101676178|NCT04624243|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101676179|NCT04624243|Dopamine Agents|dopamine agents|mesh-ancestor
101828634|NCT05501054|Nivolumab|nivolumab|mesh-list
101828635|NCT05501054|Ipilimumab|ipilimumab|mesh-list
101828636|NCT05501054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101828637|NCT05501054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676180|NCT04609904|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101676181|NCT04609904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101676182|NCT04609904|Respiratory System Agents|respiratory system agents|mesh-ancestor
101676183|NCT04586023|Teriflunomide|teriflunomide|mesh-list
101676184|NCT04586023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101676185|NCT04586023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101676186|NCT04586023|Analgesics|analgesics|mesh-ancestor
101676187|NCT04586023|Sensory System Agents|sensory system agents|mesh-ancestor
101676188|NCT04586023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101676189|NCT04586023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676190|NCT04586023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101676191|NCT04586023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101676192|NCT04586023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101676193|NCT04586023|Immunologic Factors|immunologic factors|mesh-ancestor
101676194|NCT04546009|Letrozole|letrozole|mesh-list
101676195|NCT04546009|Palbociclib|palbociclib|mesh-list
101676196|NCT04546009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676197|NCT04546009|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101676198|NCT04546009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101676199|NCT04546009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101676200|NCT04546009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676201|NCT04546009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101676202|NCT04546009|Hormone Antagonists|hormone antagonists|mesh-ancestor
101676203|NCT04546009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101676204|NCT04546009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676205|NCT04546009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101676206|NCT04541355|Sodium thiosulfate|sodium thiosulfate|mesh-list
101676207|NCT04541355|Cisplatin|cisplatin|mesh-list
101676208|NCT04541355|Antidotes|antidotes|mesh-list
101676209|NCT04541355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676210|NCT04541355|Protective Agents|protective agents|mesh-ancestor
101676211|NCT04541355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676212|NCT04541355|Antioxidants|antioxidants|mesh-ancestor
101676213|NCT04541355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676214|NCT04541355|Antitubercular Agents|antitubercular agents|mesh-ancestor
101676215|NCT04541355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101676216|NCT04541355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101676217|NCT04541355|Chelating Agents|chelating agents|mesh-ancestor
101676218|NCT04541355|Sequestering Agents|sequestering agents|mesh-ancestor
101676219|NCT04524871|Bevacizumab|bevacizumab|mesh-list
101676220|NCT04524871|Atezolizumab|atezolizumab|mesh-list
101333468|NCT00001304|Vitamin D|vitamin d|mesh-list
101676221|NCT04524871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101676222|NCT04524871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676223|NCT04524871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101676224|NCT04524871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101676225|NCT04524871|Growth Substances|growth substances|mesh-ancestor
101676226|NCT04524871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676227|NCT04524871|Growth Inhibitors|growth inhibitors|mesh-ancestor
101676228|NCT04524871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101676229|NCT04524871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676230|NCT04516915|Oseltamivir|oseltamivir|mesh-list
101676231|NCT04516915|Antiviral Agents|antiviral agents|mesh-ancestor
101676232|NCT04516915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101676233|NCT04516915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101676234|NCT04516915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676236|NCT04493853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676237|NCT04493853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101676238|NCT04493853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101676239|NCT04493853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676240|NCT04493853|Hormone Antagonists|hormone antagonists|mesh-ancestor
101828638|NCT05501054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101828640|NCT05483010|Atorvastatin|atorvastatin|mesh-list
101676241|NCT04493853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101676242|NCT04493853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676243|NCT04493853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101676244|NCT04485104|Cannabidiol|cannabidiol|mesh-list
101676245|NCT04485104|Anticonvulsants|anticonvulsants|mesh-ancestor
101676246|NCT04483466|Methotrexate|methotrexate|mesh-list
101676247|NCT04483466|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101676248|NCT04483466|Abortifacient Agents|abortifacient agents|mesh-ancestor
101676249|NCT04483466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101676250|NCT04483466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676251|NCT04483466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101676252|NCT04483466|Antimetabolites|antimetabolites|mesh-ancestor
101676253|NCT04483466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676254|NCT04483466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676255|NCT04483466|Dermatologic Agents|dermatologic agents|mesh-ancestor
101676256|NCT04483466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101676257|NCT04483466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101676258|NCT04483466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101676259|NCT04483466|Immunologic Factors|immunologic factors|mesh-ancestor
101676260|NCT04483466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101676261|NCT04483466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101676262|NCT04482244|Cannabidiol|cannabidiol|mesh-list
101676263|NCT04482244|Anticonvulsants|anticonvulsants|mesh-ancestor
101676265|NCT04458259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676266|NCT04458259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101676267|NCT04458259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101676268|NCT04458259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676269|NCT04444921|Paclitaxel|paclitaxel|mesh-list
101676270|NCT04444921|Carboplatin|carboplatin|mesh-list
101676271|NCT04444921|Nivolumab|nivolumab|mesh-list
101676272|NCT04444921|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101676273|NCT04444921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101676274|NCT04444921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676275|NCT04444921|Tubulin Modulators|tubulin modulators|mesh-ancestor
101676276|NCT04444921|Antimitotic Agents|antimitotic agents|mesh-ancestor
101676277|NCT04444921|Mitosis Modulators|mitosis modulators|mesh-ancestor
101676278|NCT04444921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676279|NCT04444921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101676280|NCT04444921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101676281|NCT04376268|Chlorhexidine|chlorhexidine|mesh-list
101676282|NCT04376268|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101676283|NCT04376268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101676284|NCT04376268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101676285|NCT04376268|Disinfectants|disinfectants|mesh-ancestor
101676286|NCT04376268|Dermatologic Agents|dermatologic agents|mesh-ancestor
101676287|NCT04365088|Deflazacort|deflazacort|mesh-list
101676288|NCT04365088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101676289|NCT04365088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101676290|NCT04365088|Immunologic Factors|immunologic factors|mesh-ancestor
101676291|NCT04365088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676292|NCT04360421|Bupivacaine|bupivacaine|mesh-list
101676293|NCT04360421|Anesthetics, Local|anesthetics, local|mesh-ancestor
101676294|NCT04360421|Anesthetics|anesthetics|mesh-ancestor
101676295|NCT04360421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101676296|NCT04360421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676297|NCT04360421|Sensory System Agents|sensory system agents|mesh-ancestor
101676298|NCT04360421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101676300|NCT04349579|Rifamycin SV|rifamycin sv|mesh-list
101676301|NCT04349579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101676302|NCT04349579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101676303|NCT04349579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101676305|NCT04313881|Magrolimab|magrolimab|mesh-list
101676306|NCT04313881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101676307|NCT04313881|Antimetabolites|antimetabolites|mesh-ancestor
101828670|NCT05368207|Pembrolizumab|pembrolizumab|mesh-list
101676308|NCT04313881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676309|NCT04313881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676310|NCT04313881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101676311|NCT04313881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101676312|NCT04310007|Paclitaxel|paclitaxel|mesh-list
101676313|NCT04310007|Docetaxel|docetaxel|mesh-list
101676314|NCT04310007|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101676315|NCT04310007|Gemcitabine|gemcitabine|mesh-list
101676316|NCT04310007|Nivolumab|nivolumab|mesh-list
101676317|NCT04310007|Ramucirumab|ramucirumab|mesh-list
101676318|NCT04310007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101676319|NCT04310007|Antibodies|antibodies|mesh-list
101676320|NCT04310007|Immunoglobulins|immunoglobulins|mesh-list
101676321|NCT04310007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101676322|NCT04310007|Lexatumumab|lexatumumab|mesh-list
101676323|NCT04310007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101676329|NCT04310007|Immunologic Factors|immunologic factors|mesh-ancestor
101676330|NCT04310007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676331|NCT04310007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101676332|NCT04310007|Antimetabolites|antimetabolites|mesh-ancestor
101676333|NCT04310007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101676334|NCT04300296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101676335|NCT04300296|Immunologic Factors|immunologic factors|mesh-ancestor
101676336|NCT04300296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676337|NCT04241185|Gemcitabine|gemcitabine|mesh-list
101676338|NCT04241185|Pembrolizumab|pembrolizumab|mesh-list
101676339|NCT04241185|Fluorouracil|fluorouracil|mesh-list
101676340|NCT04241185|Mitomycins|mitomycins|mesh-list
101676341|NCT04241185|Mitomycin|mitomycin|mesh-list
101676342|NCT04241185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676343|NCT04241185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101676344|NCT04241185|Antimetabolites|antimetabolites|mesh-ancestor
101676345|NCT04241185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676346|NCT04241185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101676347|NCT04241185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101676348|NCT04241185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101676349|NCT04241185|Immunologic Factors|immunologic factors|mesh-ancestor
101676350|NCT04241185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676351|NCT04241185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101676352|NCT04241185|Alkylating Agents|alkylating agents|mesh-ancestor
101676353|NCT04241185|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101676354|NCT04241185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101676355|NCT04223752|Tazobactam|tazobactam|mesh-list
101676356|NCT04223752|Ceftolozane|ceftolozane|mesh-list
101676357|NCT04223752|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
101676358|NCT04223752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101676359|NCT04223752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101676360|NCT04223752|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101676361|NCT04223752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101676362|NCT04223752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676363|NCT04223752|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101676364|NCT04216290|Cisplatin|cisplatin|mesh-list
101676365|NCT04216290|Gemcitabine|gemcitabine|mesh-list
101676366|NCT04216290|Fluorouracil|fluorouracil|mesh-list
101676367|NCT04216290|Durvalumab|durvalumab|mesh-list
101676368|NCT04216290|Mitomycins|mitomycins|mesh-list
101676369|NCT04216290|Mitomycin|mitomycin|mesh-list
101676370|NCT04216290|Immunoglobulins|immunoglobulins|mesh-list
101676371|NCT04216290|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101676372|NCT04216290|Immunoglobulin G|immunoglobulin g|mesh-list
101676373|NCT04216290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676374|NCT04216290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101676375|NCT04216290|Antimetabolites|antimetabolites|mesh-ancestor
101676376|NCT04216290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676377|NCT04216290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101676378|NCT04216290|Immunologic Factors|immunologic factors|mesh-ancestor
101676379|NCT04216290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676380|NCT04216290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101676381|NCT04216290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101676382|NCT04216290|Alkylating Agents|alkylating agents|mesh-ancestor
101676384|NCT04216290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101676385|NCT04214262|Atezolizumab|atezolizumab|mesh-list
101676386|NCT04214262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101676387|NCT04214262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101676388|NCT04214262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676389|NCT04214262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101676390|NCT04214262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676391|NCT04214262|Immunologic Factors|immunologic factors|mesh-ancestor
101676392|NCT04214262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676398|NCT04194203|Paclitaxel|paclitaxel|mesh-list
101676424|NCT04164082|Pembrolizumab|pembrolizumab|mesh-list
101676425|NCT04164082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101676426|NCT04164082|Antimetabolites|antimetabolites|mesh-ancestor
101676427|NCT04164082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676428|NCT04164082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676429|NCT04164082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101676430|NCT04164082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101676431|NCT04158713|Piperaquine|piperaquine|mesh-list
101676432|NCT04158713|Artenimol|artenimol|mesh-list
101676433|NCT04158713|Antimalarials|antimalarials|mesh-ancestor
101676434|NCT04158713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101676435|NCT04158713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101676436|NCT04158713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101676437|NCT04149210|Fluorometholone|fluorometholone|mesh-list
101676438|NCT04149210|Lubricant Eye Drops|lubricant eye drops|mesh-list
101676439|NCT04149210|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101676440|NCT04149210|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101676441|NCT04149210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101676442|NCT04149210|Glucocorticoids|glucocorticoids|mesh-ancestor
101676443|NCT04149210|Hormones|hormones|mesh-ancestor
101676444|NCT04149210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101676445|NCT04149210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676446|NCT04149210|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101676475|NCT04078568|Aspirin|aspirin|mesh-list
101676476|NCT04078568|Prednisolone|prednisolone|mesh-list
101676477|NCT04078568|Immunoglobulins|immunoglobulins|mesh-list
101676478|NCT04078568|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101676479|NCT04078568|gamma-Globulins|gamma-globulins|mesh-list
101676480|NCT04078568|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101676481|NCT04078568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101676482|NCT04078568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101676484|NCT04078568|Sensory System Agents|sensory system agents|mesh-ancestor
101676485|NCT04078568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101676486|NCT04078568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676487|NCT04078568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101676488|NCT04078568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101676489|NCT04078568|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101676490|NCT04078568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101676491|NCT04078568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676492|NCT04078568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101676493|NCT04078568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101676494|NCT04078568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101676495|NCT04078568|Antipyretics|antipyretics|mesh-ancestor
101676496|NCT04078568|Glucocorticoids|glucocorticoids|mesh-ancestor
101676497|NCT04078568|Hormones|hormones|mesh-ancestor
101676498|NCT04078568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101676499|NCT04078568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101676500|NCT04078568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101828680|NCT05350774|Immunoglobulins|immunoglobulins|mesh-list
101828682|NCT05350774|Antibodies|antibodies|mesh-list
101676502|NCT04076059|Androgens|androgens|mesh-list
101676503|NCT04076059|Hormones|hormones|mesh-ancestor
101676504|NCT04076059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101676505|NCT04076059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676506|NCT04053634|Benralizumab|benralizumab|mesh-list
101676507|NCT04053634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101676508|NCT04053634|Respiratory System Agents|respiratory system agents|mesh-ancestor
101676509|NCT04047836|Nicotine|nicotine|mesh-list
101676510|NCT04047836|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101676511|NCT04047836|Autonomic Agents|autonomic agents|mesh-ancestor
101676512|NCT04047836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101676513|NCT04047836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676514|NCT04047836|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101676515|NCT04047836|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101676516|NCT04047836|Cholinergic Agents|cholinergic agents|mesh-ancestor
101676517|NCT04047836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101676518|NCT04047836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676519|NCT04008797|Lenvatinib|lenvatinib|mesh-list
101676520|NCT04008797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676521|NCT04008797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101676522|NCT04008797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101333777|NCT00040690|Vitamins|vitamins|mesh-ancestor
101676523|NCT04008797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676525|NCT03994146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101676526|NCT03994146|Narcotics|narcotics|mesh-ancestor
101676527|NCT03994146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101676528|NCT03994146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676529|NCT03994146|Analgesics|analgesics|mesh-ancestor
101676530|NCT03994146|Sensory System Agents|sensory system agents|mesh-ancestor
101676531|NCT03994146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101676532|NCT03992404|Botulinum Toxins|botulinum toxins|mesh-list
101676533|NCT03992404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101676534|NCT03992404|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101676535|NCT03992404|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
101676536|NCT03992404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101676537|NCT03992404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101676538|NCT03992404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676539|NCT03992404|Cholinergic Agents|cholinergic agents|mesh-ancestor
101676540|NCT03992404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101676541|NCT03992404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676542|NCT03992404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101676543|NCT03992404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101676544|NCT03973268|Complement Factor H|complement factor h|mesh-list
101676545|NCT03973268|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101676546|NCT03973268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101676547|NCT03973268|Immunologic Factors|immunologic factors|mesh-ancestor
101676548|NCT03973268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676549|NCT03971253|Peficitinib|peficitinib|mesh-list
101676550|NCT03971253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101676551|NCT03971253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676553|NCT03971253|Immunologic Factors|immunologic factors|mesh-ancestor
101676554|NCT03971253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676555|NCT03962465|Cytarabine|cytarabine|mesh-list
101676556|NCT03962465|Prednisone|prednisone|mesh-list
101676557|NCT03962465|Methotrexate|methotrexate|mesh-list
101676558|NCT03962465|Vincristine|vincristine|mesh-list
101676559|NCT03962465|Daunorubicin|daunorubicin|mesh-list
101676560|NCT03962465|Pegaspargase|pegaspargase|mesh-list
101676561|NCT03962465|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
101676562|NCT03962465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101676563|NCT03962465|Glucocorticoids|glucocorticoids|mesh-ancestor
101676564|NCT03962465|Hormones|hormones|mesh-ancestor
101676565|NCT03962465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101676566|NCT03962465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101828693|NCT05341115|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101676567|NCT03962465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101676568|NCT03962465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676569|NCT03962465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101676570|NCT03962465|Abortifacient Agents|abortifacient agents|mesh-ancestor
101676571|NCT03962465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101676572|NCT03962465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101676573|NCT03962465|Antimetabolites|antimetabolites|mesh-ancestor
101676574|NCT03962465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676575|NCT03962465|Dermatologic Agents|dermatologic agents|mesh-ancestor
101676576|NCT03962465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101676577|NCT03962465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101676578|NCT03962465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101676579|NCT03962465|Immunologic Factors|immunologic factors|mesh-ancestor
101676580|NCT03962465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101676581|NCT03962465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101676582|NCT03962465|Antiviral Agents|antiviral agents|mesh-ancestor
101676583|NCT03962465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101676584|NCT03962465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101676585|NCT03962465|Tubulin Modulators|tubulin modulators|mesh-ancestor
101676586|NCT03962465|Antimitotic Agents|antimitotic agents|mesh-ancestor
101676587|NCT03962465|Mitosis Modulators|mitosis modulators|mesh-ancestor
101676588|NCT03962465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101676589|NCT03962465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101676590|NCT03962465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101676591|NCT03962465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101676592|NCT03962465|Immunotoxins|immunotoxins|mesh-ancestor
101676593|NCT03962465|Immunoconjugates|immunoconjugates|mesh-ancestor
101676594|NCT03952299|Mandelic Acids|mandelic acids|mesh-list
101676595|NCT03952299|Oxybutynin|oxybutynin|mesh-list
101676596|NCT03952299|Parasympatholytics|parasympatholytics|mesh-ancestor
101676597|NCT03952299|Autonomic Agents|autonomic agents|mesh-ancestor
101676598|NCT03952299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101676599|NCT03952299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676600|NCT03952299|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101676601|NCT03952299|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101676602|NCT03952299|Cholinergic Agents|cholinergic agents|mesh-ancestor
101676603|NCT03952299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101676604|NCT03952299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676605|NCT03952299|Urological Agents|urological agents|mesh-ancestor
101676606|NCT03952299|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101676607|NCT03952299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101676609|NCT03939767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101676610|NCT03939767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101676611|NCT03939767|Growth Substances|growth substances|mesh-ancestor
101676612|NCT03939767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676613|NCT03939767|Growth Inhibitors|growth inhibitors|mesh-ancestor
101676614|NCT03939767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676615|NCT03908437|Buprenorphine|buprenorphine|mesh-list
101676616|NCT03908437|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101676617|NCT03908437|Naloxone|naloxone|mesh-list
101676618|NCT03908437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101676619|NCT03908437|Narcotics|narcotics|mesh-ancestor
101676620|NCT03908437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101676621|NCT03908437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676622|NCT03908437|Analgesics|analgesics|mesh-ancestor
101676623|NCT03908437|Sensory System Agents|sensory system agents|mesh-ancestor
101676624|NCT03908437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101676625|NCT03908437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101676626|NCT03903185|Sofosbuvir|sofosbuvir|mesh-list
101676627|NCT03903185|Ledipasvir|ledipasvir|mesh-list
101676628|NCT03903185|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
101676629|NCT03903185|Antiviral Agents|antiviral agents|mesh-ancestor
101676630|NCT03903185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101676631|NCT03834948|Paclitaxel|paclitaxel|mesh-list
101676632|NCT03834948|Pembrolizumab|pembrolizumab|mesh-list
101676633|NCT03834948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101676634|NCT03834948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676635|NCT03834948|Tubulin Modulators|tubulin modulators|mesh-ancestor
101676636|NCT03834948|Antimitotic Agents|antimitotic agents|mesh-ancestor
101676637|NCT03834948|Mitosis Modulators|mitosis modulators|mesh-ancestor
101676638|NCT03834948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676639|NCT03834948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101676640|NCT03834948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101676641|NCT03811015|Cisplatin|cisplatin|mesh-list
101676642|NCT03811015|Nivolumab|nivolumab|mesh-list
101676643|NCT03811015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676644|NCT03811015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101676645|NCT03811015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101676646|NCT03811015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676647|NCT03811002|Cisplatin|cisplatin|mesh-list
101676648|NCT03811002|Carboplatin|carboplatin|mesh-list
101676649|NCT03811002|Etoposide|etoposide|mesh-list
101676650|NCT03811002|Etoposide phosphate|etoposide phosphate|mesh-list
101676651|NCT03811002|Atezolizumab|atezolizumab|mesh-list
101676652|NCT03811002|Podophyllotoxin|podophyllotoxin|mesh-list
101676653|NCT03811002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101676654|NCT03811002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101828732|NCT05328908|Antiviral Agents|antiviral agents|mesh-ancestor
101676655|NCT03811002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101676656|NCT03811002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101676657|NCT03811002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101676658|NCT03811002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101676659|NCT03811002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676660|NCT03811002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101828747|NCT05319730|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101676687|NCT03728933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676688|NCT03695250|Nivolumab|nivolumab|mesh-list
101676689|NCT03695250|Linrodostat|linrodostat|mesh-list
101676690|NCT03695250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101676691|NCT03695250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676692|NCT03695250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101676693|NCT03695250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676694|NCT03695250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101676695|NCT03678753|Cenobamate|cenobamate|mesh-list
101676696|NCT03678753|Anticonvulsants|anticonvulsants|mesh-ancestor
101676697|NCT03663543|Estrogens|estrogens|mesh-list
101676698|NCT03663543|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101676699|NCT03663543|Hormones|hormones|mesh-ancestor
101676700|NCT03663543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101676701|NCT03663543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676702|NCT03641560|Androgens|androgens|mesh-list
101676703|NCT03641560|Hormones|hormones|mesh-ancestor
101676704|NCT03641560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101676705|NCT03641560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676706|NCT03615105|Cyclophosphamide|cyclophosphamide|mesh-list
101676707|NCT03615105|Melphalan|melphalan|mesh-list
101676708|NCT03615105|Busulfan|busulfan|mesh-list
101676709|NCT03615105|Thiotepa|thiotepa|mesh-list
101676711|NCT03615105|Fludarabine|fludarabine|mesh-list
101676712|NCT03615105|Clofarabine|clofarabine|mesh-list
101676713|NCT03615105|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101676714|NCT03615105|Thymoglobulin|thymoglobulin|mesh-list
101676715|NCT03615105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101676716|NCT03615105|Immunologic Factors|immunologic factors|mesh-ancestor
101676717|NCT03615105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676718|NCT03615105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101676719|NCT03615105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101676720|NCT03615105|Alkylating Agents|alkylating agents|mesh-ancestor
101828790|NCT05280704|Sensory System Agents|sensory system agents|mesh-ancestor
101676721|NCT03615105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676722|NCT03615105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676723|NCT03615105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101676724|NCT03615105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101676725|NCT03615105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101676726|NCT03615105|Antimetabolites|antimetabolites|mesh-ancestor
101676727|NCT03603899|Xenon|xenon|mesh-list
101676728|NCT03603899|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101676729|NCT03603899|Anesthetics, General|anesthetics, general|mesh-ancestor
101676730|NCT03603899|Anesthetics|anesthetics|mesh-ancestor
101676731|NCT03603899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101676732|NCT03603899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676733|NCT03599622|Deucravacitinib|deucravacitinib|mesh-list
101676734|NCT03599622|Dermatologic Agents|dermatologic agents|mesh-ancestor
101676735|NCT03599622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101676736|NCT03599622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101676737|NCT03599622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676738|NCT03564691|Paclitaxel|paclitaxel|mesh-list
101676739|NCT03564691|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101676740|NCT03564691|Cisplatin|cisplatin|mesh-list
101676741|NCT03564691|Carboplatin|carboplatin|mesh-list
101676742|NCT03564691|Pembrolizumab|pembrolizumab|mesh-list
101676743|NCT03564691|Pemetrexed|pemetrexed|mesh-list
101676744|NCT03564691|Lenvatinib|lenvatinib|mesh-list
101676745|NCT03564691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101334000|NCT00042367|Mafosfamide|mafosfamide|mesh-list
101676746|NCT03564691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676747|NCT03564691|Tubulin Modulators|tubulin modulators|mesh-ancestor
101676748|NCT03564691|Antimitotic Agents|antimitotic agents|mesh-ancestor
101676749|NCT03564691|Mitosis Modulators|mitosis modulators|mesh-ancestor
101676750|NCT03564691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676751|NCT03564691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101676752|NCT03564691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101676754|NCT03564691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101676755|NCT03564691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101676756|NCT03564691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101676757|NCT03537014|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
101676758|NCT03537014|Hallucinogens|hallucinogens|mesh-ancestor
101676759|NCT03537014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676760|NCT03537014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101676761|NCT03537014|Serotonin Agents|serotonin agents|mesh-ancestor
101676762|NCT03537014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101676763|NCT03537014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676764|NCT03537014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101676765|NCT03537014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101676766|NCT03537014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101676767|NCT03537014|Adrenergic Agents|adrenergic agents|mesh-ancestor
101676768|NCT03526354|Antipsychotic Agents|antipsychotic agents|mesh-list
101676769|NCT03526354|Brexpiprazole|brexpiprazole|mesh-list
101676770|NCT03526354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101676771|NCT03526354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101676772|NCT03526354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676773|NCT03526354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101676774|NCT03526354|Serotonin Agents|serotonin agents|mesh-ancestor
101676775|NCT03526354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101676776|NCT03526354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676777|NCT03526354|Dopamine Agonists|dopamine agonists|mesh-ancestor
101676778|NCT03526354|Dopamine Agents|dopamine agents|mesh-ancestor
101676779|NCT03393884|Paclitaxel|paclitaxel|mesh-list
101676780|NCT03393884|Carboplatin|carboplatin|mesh-list
101676781|NCT03393884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101676782|NCT03393884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676783|NCT03393884|Tubulin Modulators|tubulin modulators|mesh-ancestor
101676784|NCT03393884|Antimitotic Agents|antimitotic agents|mesh-ancestor
101676785|NCT03393884|Mitosis Modulators|mitosis modulators|mesh-ancestor
101676786|NCT03393884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676787|NCT03383458|Nivolumab|nivolumab|mesh-list
101676788|NCT03383458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101676789|NCT03383458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676790|NCT03383458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101676791|NCT03383458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676792|NCT03382561|Cisplatin|cisplatin|mesh-list
101676793|NCT03382561|Carboplatin|carboplatin|mesh-list
101676794|NCT03382561|Nivolumab|nivolumab|mesh-list
101676795|NCT03382561|Etoposide|etoposide|mesh-list
101676796|NCT03382561|Etoposide phosphate|etoposide phosphate|mesh-list
101676797|NCT03382561|Podophyllotoxin|podophyllotoxin|mesh-list
101676798|NCT03382561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676799|NCT03382561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101676800|NCT03382561|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101676801|NCT03382561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676802|NCT03382561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101676803|NCT03382561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101676804|NCT03382561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101676805|NCT03382561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101676806|NCT03382561|Keratolytic Agents|keratolytic agents|mesh-ancestor
101676807|NCT03382561|Dermatologic Agents|dermatologic agents|mesh-ancestor
101676808|NCT03382561|Tubulin Modulators|tubulin modulators|mesh-ancestor
101676809|NCT03382561|Antimitotic Agents|antimitotic agents|mesh-ancestor
101676810|NCT03382561|Mitosis Modulators|mitosis modulators|mesh-ancestor
101676811|NCT03329378|Paclitaxel|paclitaxel|mesh-list
101676812|NCT03329378|Docetaxel|docetaxel|mesh-list
101676813|NCT03329378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101676814|NCT03329378|Cyclophosphamide|cyclophosphamide|mesh-list
101676815|NCT03329378|Carboplatin|carboplatin|mesh-list
101676816|NCT03329378|Doxorubicin|doxorubicin|mesh-list
101676817|NCT03329378|Trastuzumab|trastuzumab|mesh-list
101676818|NCT03329378|Pertuzumab|pertuzumab|mesh-list
101676819|NCT03329378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101676820|NCT03329378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676821|NCT03329378|Tubulin Modulators|tubulin modulators|mesh-ancestor
101676822|NCT03329378|Antimitotic Agents|antimitotic agents|mesh-ancestor
101676823|NCT03329378|Mitosis Modulators|mitosis modulators|mesh-ancestor
101334076|NCT00042601|Pramlintide|pramlintide|mesh-list
101676824|NCT03329378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676825|NCT03329378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101676826|NCT03329378|Immunologic Factors|immunologic factors|mesh-ancestor
101676827|NCT03329378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676828|NCT03329378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101409661|NCT00404781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101676829|NCT03329378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101676830|NCT03329378|Alkylating Agents|alkylating agents|mesh-ancestor
101676831|NCT03329378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101676832|NCT03329378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101676833|NCT03329378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101676834|NCT03329378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101676835|NCT03329378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101676836|NCT03329378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101676837|NCT03274895|Biguanides|biguanides|mesh-list
101828863|NCT05253573|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101676838|NCT03274895|Polihexanide|polihexanide|mesh-list
101676839|NCT03274895|Dibrompropamidine|dibrompropamidine|mesh-list
101676840|NCT03274895|Propamidine|propamidine|mesh-list
101676841|NCT03274895|Disinfectants|disinfectants|mesh-ancestor
101676842|NCT03274895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101676843|NCT03274895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101676844|NCT03274895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676845|NCT03274895|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101676846|NCT03274895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101676847|NCT03274895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101676848|NCT03258593|Durvalumab|durvalumab|mesh-list
101676849|NCT03258593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101676850|NCT03258593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676851|NCT03250975|Azithromycin|azithromycin|mesh-list
101676852|NCT03250975|Budesonide|budesonide|mesh-list
101676853|NCT03250975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101676854|NCT03250975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101676855|NCT03250975|Autonomic Agents|autonomic agents|mesh-ancestor
101676856|NCT03250975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101676858|NCT03250975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101676859|NCT03250975|Respiratory System Agents|respiratory system agents|mesh-ancestor
101676860|NCT03250975|Glucocorticoids|glucocorticoids|mesh-ancestor
101676861|NCT03250975|Hormones|hormones|mesh-ancestor
101676862|NCT03250975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101676863|NCT03250975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101676864|NCT03250975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101676865|NCT03233711|Nivolumab|nivolumab|mesh-list
101676866|NCT03233711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101676867|NCT03233711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676868|NCT03233711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101676869|NCT03233711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676870|NCT03193190|Leucovorin|leucovorin|mesh-list
101676871|NCT03193190|Paclitaxel|paclitaxel|mesh-list
101676872|NCT03193190|Bevacizumab|bevacizumab|mesh-list
101676873|NCT03193190|Gemcitabine|gemcitabine|mesh-list
101676874|NCT03193190|Fluorouracil|fluorouracil|mesh-list
101676875|NCT03193190|Oxaliplatin|oxaliplatin|mesh-list
101676876|NCT03193190|Atezolizumab|atezolizumab|mesh-list
101676877|NCT03193190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101676878|NCT03193190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676879|NCT03193190|Tubulin Modulators|tubulin modulators|mesh-ancestor
101676880|NCT03193190|Antimitotic Agents|antimitotic agents|mesh-ancestor
101676881|NCT03193190|Mitosis Modulators|mitosis modulators|mesh-ancestor
101676882|NCT03193190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676883|NCT03193190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101676884|NCT03193190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101676885|NCT03193190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101676886|NCT03193190|Growth Substances|growth substances|mesh-ancestor
101676887|NCT03193190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676888|NCT03193190|Growth Inhibitors|growth inhibitors|mesh-ancestor
101676889|NCT03193190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101676890|NCT03193190|Antimetabolites|antimetabolites|mesh-ancestor
101676891|NCT03193190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101676892|NCT03193190|Immunologic Factors|immunologic factors|mesh-ancestor
101676893|NCT03193190|Antidotes|antidotes|mesh-ancestor
101676894|NCT03193190|Protective Agents|protective agents|mesh-ancestor
101828872|NCT05236673|Empagliflozin|empagliflozin|mesh-list
101676895|NCT03193190|Vitamin B Complex|vitamin b complex|mesh-ancestor
101676896|NCT03193190|Vitamins|vitamins|mesh-ancestor
101676897|NCT03193190|Micronutrients|micronutrients|mesh-ancestor
101334147|NCT00042874|Vitamin B Complex|vitamin b complex|mesh-ancestor
101676898|NCT03193190|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101676913|NCT03057106|Durvalumab|durvalumab|mesh-list
101676914|NCT03057106|Tremelimumab|tremelimumab|mesh-list
101676915|NCT03057106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101676916|NCT03057106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676917|NCT03055013|Nivolumab|nivolumab|mesh-list
101676918|NCT03055013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101676919|NCT03055013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676920|NCT03055013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101676921|NCT03055013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676922|NCT03054831|Oxycodone|oxycodone|mesh-list
101676923|NCT03054831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101676924|NCT03054831|Narcotics|narcotics|mesh-ancestor
101676925|NCT03054831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101676926|NCT03054831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676927|NCT03054831|Analgesics|analgesics|mesh-ancestor
101676928|NCT03054831|Sensory System Agents|sensory system agents|mesh-ancestor
101676929|NCT03054831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101676930|NCT03049189|Everolimus|everolimus|mesh-list
101676931|NCT03049189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101676933|NCT03049189|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
101676934|NCT03049189|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101676935|NCT03049189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101676936|NCT03049189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101676937|NCT03049189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676938|NCT03049189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101676939|NCT03049189|Immunologic Factors|immunologic factors|mesh-ancestor
101676940|NCT03049189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676941|NCT03049189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676942|NCT03049189|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101676943|NCT03036098|Carboplatin|carboplatin|mesh-list
101676944|NCT03036098|Gemcitabine|gemcitabine|mesh-list
101676945|NCT03036098|Nivolumab|nivolumab|mesh-list
101676946|NCT03036098|Ipilimumab|ipilimumab|mesh-list
101676947|NCT03036098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676948|NCT03036098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101676949|NCT03036098|Antimetabolites|antimetabolites|mesh-ancestor
101676950|NCT03036098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676951|NCT03036098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101676952|NCT03036098|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101676953|NCT03025087|Hydroxychloroquine|hydroxychloroquine|mesh-list
101676954|NCT03025087|Antimalarials|antimalarials|mesh-ancestor
101676955|NCT03025087|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101676956|NCT03025087|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101676957|NCT03025087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101676958|NCT03025087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101676959|NCT03025087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676960|NCT03025087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101676961|NCT03003065|Temoporfin|temoporfin|mesh-list
101676962|NCT03003065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676963|NCT03003065|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101676964|NCT03003065|Dermatologic Agents|dermatologic agents|mesh-ancestor
101676965|NCT02906332|Dexamethasone|dexamethasone|mesh-list
101676966|NCT02906332|Pembrolizumab|pembrolizumab|mesh-list
101676967|NCT02906332|Lenalidomide|lenalidomide|mesh-list
101676968|NCT02906332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101676969|NCT02906332|Antiemetics|antiemetics|mesh-ancestor
101676970|NCT02906332|Autonomic Agents|autonomic agents|mesh-ancestor
101676971|NCT02906332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101676972|NCT02906332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101676973|NCT02906332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101676974|NCT02906332|Glucocorticoids|glucocorticoids|mesh-ancestor
101676975|NCT02906332|Hormones|hormones|mesh-ancestor
101676976|NCT02906332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101828887|NCT05220046|Psilocybin|psilocybin|mesh-list
101676977|NCT02906332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101676978|NCT02906332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676979|NCT02906332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101676980|NCT02906332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101676981|NCT02906332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101676982|NCT02906332|Immunologic Factors|immunologic factors|mesh-ancestor
101676983|NCT02906332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101676984|NCT02906332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101676985|NCT02906332|Growth Substances|growth substances|mesh-ancestor
101676986|NCT02906332|Growth Inhibitors|growth inhibitors|mesh-ancestor
101676987|NCT02870920|Durvalumab|durvalumab|mesh-list
101676988|NCT02870920|Tremelimumab|tremelimumab|mesh-list
101676989|NCT02870920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101676990|NCT02870920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101676991|NCT02827877|Copper|copper|mesh-list
101676992|NCT02827877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101676993|NCT02827877|Trastuzumab|trastuzumab|mesh-list
101676994|NCT02827877|Pertuzumab|pertuzumab|mesh-list
101676995|NCT02827877|Antibodies|antibodies|mesh-list
101676996|NCT02827877|Immunoglobulins|immunoglobulins|mesh-list
101676997|NCT02827877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101676998|NCT02827877|Immunologic Factors|immunologic factors|mesh-ancestor
101676999|NCT02827877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677000|NCT02827877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677001|NCT02827877|Trace Elements|trace elements|mesh-ancestor
101677002|NCT02827877|Micronutrients|micronutrients|mesh-ancestor
101677003|NCT02823665|Atropine|atropine|mesh-list
101677004|NCT02823665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101677005|NCT02823665|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101677006|NCT02823665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101677007|NCT02823665|Autonomic Agents|autonomic agents|mesh-ancestor
101677008|NCT02823665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101677009|NCT02823665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677011|NCT02823665|Respiratory System Agents|respiratory system agents|mesh-ancestor
101677012|NCT02823665|Mydriatics|mydriatics|mesh-ancestor
101677013|NCT02823665|Parasympatholytics|parasympatholytics|mesh-ancestor
101677014|NCT02823665|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101677015|NCT02823665|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101677016|NCT02823665|Cholinergic Agents|cholinergic agents|mesh-ancestor
101677017|NCT02823665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101677018|NCT02823665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677019|NCT02803437|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
101677020|NCT02803437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677021|NCT02755597|Dexamethasone|dexamethasone|mesh-list
101677022|NCT02755597|Bortezomib|bortezomib|mesh-list
101677023|NCT02755597|Venetoclax|venetoclax|mesh-list
101677024|NCT02755597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101677025|NCT02755597|Antiemetics|antiemetics|mesh-ancestor
101677026|NCT02755597|Autonomic Agents|autonomic agents|mesh-ancestor
101677027|NCT02755597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101677028|NCT02755597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677029|NCT02755597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101677030|NCT02755597|Glucocorticoids|glucocorticoids|mesh-ancestor
101677031|NCT02755597|Hormones|hormones|mesh-ancestor
101677032|NCT02755597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101677033|NCT02755597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101677034|NCT02755597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677035|NCT02715284|Dostarlimab|dostarlimab|mesh-list
101677036|NCT02715284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677037|NCT02705300|Leucovorin|leucovorin|mesh-list
101677038|NCT02705300|Tocotrienols|tocotrienols|mesh-list
101677039|NCT02705300|Vitamin E|vitamin e|mesh-list
101677040|NCT02705300|Tocopherols|tocopherols|mesh-list
101677041|NCT02705300|Fluorouracil|fluorouracil|mesh-list
101677042|NCT02705300|Oxaliplatin|oxaliplatin|mesh-list
101677043|NCT02705300|Irinotecan|irinotecan|mesh-list
101677044|NCT02705300|Levoleucovorin|levoleucovorin|mesh-list
101677045|NCT02705300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677046|NCT02705300|Antimetabolites|antimetabolites|mesh-ancestor
101677047|NCT02705300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334310|NCT00043771|Tolvaptan|tolvaptan|mesh-list
101677048|NCT02705300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101677049|NCT02705300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677050|NCT02705300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101677051|NCT02705300|Immunologic Factors|immunologic factors|mesh-ancestor
101677052|NCT02705300|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101677053|NCT02705300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101677054|NCT02705300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101677055|NCT02705300|Antidotes|antidotes|mesh-ancestor
101677056|NCT02705300|Protective Agents|protective agents|mesh-ancestor
101677057|NCT02705300|Vitamin B Complex|vitamin b complex|mesh-ancestor
101677058|NCT02705300|Vitamins|vitamins|mesh-ancestor
101677059|NCT02705300|Micronutrients|micronutrients|mesh-ancestor
101677060|NCT02705300|Antioxidants|antioxidants|mesh-ancestor
101677061|NCT02598557|Exemestane|exemestane|mesh-list
101677062|NCT02598557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677063|NCT02598557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101677064|NCT02598557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101677065|NCT02598557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101677066|NCT02598557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677067|NCT02598557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101677068|NCT02598557|Hormone Antagonists|hormone antagonists|mesh-ancestor
101677069|NCT02598557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101677070|NCT02598557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677071|NCT02595944|Nivolumab|nivolumab|mesh-list
101677072|NCT02595944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101677073|NCT02595944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677074|NCT02595944|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101677075|NCT02595944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677076|NCT02576574|Paclitaxel|paclitaxel|mesh-list
101677077|NCT02576574|Carboplatin|carboplatin|mesh-list
101677078|NCT02576574|Gemcitabine|gemcitabine|mesh-list
101677079|NCT02576574|Pemetrexed|pemetrexed|mesh-list
101677080|NCT02576574|Avelumab|avelumab|mesh-list
101677081|NCT02576574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101677082|NCT02576574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101677083|NCT02576574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677084|NCT02576574|Tubulin Modulators|tubulin modulators|mesh-ancestor
101677085|NCT02576574|Antimitotic Agents|antimitotic agents|mesh-ancestor
101677086|NCT02576574|Mitosis Modulators|mitosis modulators|mesh-ancestor
101677087|NCT02576574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677088|NCT02576574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101677089|NCT02576574|Antimetabolites|antimetabolites|mesh-ancestor
101677090|NCT02576574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101677091|NCT02576574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101677092|NCT02576574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101677093|NCT02576574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101677094|NCT02576574|Immunologic Factors|immunologic factors|mesh-ancestor
101677095|NCT02576574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677096|NCT02494973|Oxaliplatin|oxaliplatin|mesh-list
101677097|NCT02494973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677098|NCT02317783|Deoxyglucose|deoxyglucose|mesh-list
101677099|NCT02317783|Flutemetamol|flutemetamol|mesh-list
101677100|NCT02317783|Antimetabolites|antimetabolites|mesh-ancestor
101677101|NCT02317783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101828912|NCT05173987|Docetaxel|docetaxel|mesh-list
101677102|NCT02317783|Antiviral Agents|antiviral agents|mesh-ancestor
101677103|NCT02317783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101677104|NCT02317783|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101677105|NCT02160015|Rituximab|rituximab|mesh-list
101677106|NCT02160015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101677107|NCT02160015|Lenalidomide|lenalidomide|mesh-list
101677108|NCT02160015|Antibodies|antibodies|mesh-list
101677109|NCT02160015|Immunoglobulins|immunoglobulins|mesh-list
101677110|NCT02160015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101677111|NCT02160015|Immunologic Factors|immunologic factors|mesh-ancestor
101677112|NCT02160015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677113|NCT02160015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677114|NCT02160015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101677115|NCT02160015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101677116|NCT02160015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101677117|NCT02160015|Growth Substances|growth substances|mesh-ancestor
101677118|NCT02160015|Growth Inhibitors|growth inhibitors|mesh-ancestor
101677119|NCT02091960|Trastuzumab|trastuzumab|mesh-list
101677120|NCT02091960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101677121|NCT02091960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677122|NCT02044497|Oxycodone|oxycodone|mesh-list
101677123|NCT02044497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101677124|NCT02044497|Narcotics|narcotics|mesh-ancestor
101677125|NCT02044497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101677126|NCT02044497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677127|NCT02044497|Analgesics|analgesics|mesh-ancestor
101677128|NCT02044497|Sensory System Agents|sensory system agents|mesh-ancestor
101677129|NCT02044497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101677130|NCT02033993|Paclitaxel|paclitaxel|mesh-list
101677131|NCT02033993|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101677132|NCT02033993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101677133|NCT02033993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677134|NCT02033993|Tubulin Modulators|tubulin modulators|mesh-ancestor
101677135|NCT02033993|Antimitotic Agents|antimitotic agents|mesh-ancestor
101677136|NCT02033993|Mitosis Modulators|mitosis modulators|mesh-ancestor
101677137|NCT02033993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677139|NCT01997879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101677140|NCT01810913|Cisplatin|cisplatin|mesh-list
101677141|NCT01810913|Docetaxel|docetaxel|mesh-list
101677142|NCT01810913|Cetuximab|cetuximab|mesh-list
101677143|NCT01810913|Atezolizumab|atezolizumab|mesh-list
101677144|NCT01810913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101677145|NCT01810913|Antibodies|antibodies|mesh-list
101677146|NCT01810913|Immunoglobulins|immunoglobulins|mesh-list
101677147|NCT01810913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101677148|NCT01810913|Immunologic Factors|immunologic factors|mesh-ancestor
101677149|NCT01810913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677150|NCT01810913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677151|NCT01810913|Tubulin Modulators|tubulin modulators|mesh-ancestor
101677152|NCT01810913|Antimitotic Agents|antimitotic agents|mesh-ancestor
101677153|NCT01810913|Mitosis Modulators|mitosis modulators|mesh-ancestor
101677154|NCT01810913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677155|NCT01810913|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101677156|NCT01772472|Trastuzumab|trastuzumab|mesh-list
101677157|NCT01772472|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101677158|NCT01772472|Maytansine|maytansine|mesh-list
101677159|NCT01772472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101677160|NCT01772472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677161|NCT01772472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101677162|NCT01772472|Tubulin Modulators|tubulin modulators|mesh-ancestor
101677163|NCT01772472|Antimitotic Agents|antimitotic agents|mesh-ancestor
101677164|NCT01772472|Mitosis Modulators|mitosis modulators|mesh-ancestor
101677165|NCT01772472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677166|NCT01772472|Immunotoxins|immunotoxins|mesh-ancestor
101677167|NCT01772472|Immunoconjugates|immunoconjugates|mesh-ancestor
101677168|NCT01772472|Immunologic Factors|immunologic factors|mesh-ancestor
101677169|NCT01772472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677170|NCT01500551|Tofacitinib|tofacitinib|mesh-list
101677171|NCT01500551|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101677172|NCT01500551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101677173|NCT01500551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101677174|NCT01500551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677175|NCT01470417|Gemcitabine|gemcitabine|mesh-list
101677176|NCT01470417|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101677177|NCT01470417|Paclitaxel|paclitaxel|mesh-list
101677178|NCT01470417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101677179|NCT01470417|Antimetabolites|antimetabolites|mesh-ancestor
101677180|NCT01470417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677181|NCT01470417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677182|NCT01470417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101677183|NCT01470417|Tubulin Modulators|tubulin modulators|mesh-ancestor
101677184|NCT01470417|Antimitotic Agents|antimitotic agents|mesh-ancestor
101677185|NCT01470417|Mitosis Modulators|mitosis modulators|mesh-ancestor
101677186|NCT01463072|Paclitaxel|paclitaxel|mesh-list
101677187|NCT01463072|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101677188|NCT01463072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101677189|NCT01463072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677190|NCT01463072|Tubulin Modulators|tubulin modulators|mesh-ancestor
101677191|NCT01463072|Antimitotic Agents|antimitotic agents|mesh-ancestor
101677192|NCT01463072|Mitosis Modulators|mitosis modulators|mesh-ancestor
101677193|NCT01463072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677194|NCT01409772|Ethanol|ethanol|mesh-list
101677195|NCT01409772|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101677196|NCT01409772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101677197|NCT01409772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101677198|NCT01409772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677199|NCT01241708|Bortezomib|bortezomib|mesh-list
101677200|NCT01241708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677201|NCT01208766|Dexamethasone|dexamethasone|mesh-list
101677202|NCT01208766|Prednisone|prednisone|mesh-list
101677203|NCT01208766|Lenalidomide|lenalidomide|mesh-list
101677204|NCT01208766|Bortezomib|bortezomib|mesh-list
101334443|NCT00044434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101677205|NCT01208766|Melphalan|melphalan|mesh-list
101677206|NCT01208766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101677207|NCT01208766|Antiemetics|antiemetics|mesh-ancestor
101677208|NCT01208766|Autonomic Agents|autonomic agents|mesh-ancestor
101677209|NCT01208766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101677210|NCT01208766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677211|NCT01208766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101677212|NCT01208766|Glucocorticoids|glucocorticoids|mesh-ancestor
101677213|NCT01208766|Hormones|hormones|mesh-ancestor
101677214|NCT01208766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101677215|NCT01208766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101677216|NCT01208766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677217|NCT01208766|Immunologic Factors|immunologic factors|mesh-ancestor
101677218|NCT01208766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101677219|NCT01208766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101677220|NCT01208766|Growth Substances|growth substances|mesh-ancestor
101677221|NCT01208766|Growth Inhibitors|growth inhibitors|mesh-ancestor
101677222|NCT01208766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101677223|NCT01208766|Alkylating Agents|alkylating agents|mesh-ancestor
101677224|NCT01208766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677225|NCT01208766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101677226|NCT01208766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101677227|NCT01121588|Crizotinib|crizotinib|mesh-list
101677228|NCT01121588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677229|NCT01121588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101677230|NCT01121588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101828940|NCT05115630|Immunologic Factors|immunologic factors|mesh-ancestor
101677231|NCT01121588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677232|NCT00999336|Betrixaban|betrixaban|mesh-list
101677233|NCT00999336|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101677234|NCT00999336|Antithrombins|antithrombins|mesh-ancestor
101677235|NCT00999336|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101677236|NCT00999336|Protease Inhibitors|protease inhibitors|mesh-ancestor
101677237|NCT00999336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101677238|NCT00999336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677240|NCT00992901|Atropine|atropine|mesh-list
101677241|NCT00992901|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101677242|NCT00992901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101677243|NCT00992901|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101677244|NCT00992901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101677245|NCT00992901|Autonomic Agents|autonomic agents|mesh-ancestor
101677246|NCT00992901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101677247|NCT00992901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677248|NCT00992901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101677249|NCT00992901|Respiratory System Agents|respiratory system agents|mesh-ancestor
101677250|NCT00992901|Mydriatics|mydriatics|mesh-ancestor
101677251|NCT00992901|Parasympatholytics|parasympatholytics|mesh-ancestor
101677252|NCT00992901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101677253|NCT00992901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101677254|NCT00992901|Cholinergic Agents|cholinergic agents|mesh-ancestor
101677255|NCT00992901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101677256|NCT00992901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677257|NCT00992901|Incretins|incretins|mesh-ancestor
101677258|NCT00992901|Hormones|hormones|mesh-ancestor
101677259|NCT00992901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101677260|NCT00820248|Panitumumab|panitumumab|mesh-list
101677261|NCT00820248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677262|NCT00820248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101677263|NCT00795340|Paclitaxel|paclitaxel|mesh-list
101677264|NCT00795340|Carboplatin|carboplatin|mesh-list
101677265|NCT00795340|Cediranib|cediranib|mesh-list
101677266|NCT00795340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101677267|NCT00795340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677268|NCT00795340|Tubulin Modulators|tubulin modulators|mesh-ancestor
101677269|NCT00795340|Antimitotic Agents|antimitotic agents|mesh-ancestor
101677270|NCT00795340|Mitosis Modulators|mitosis modulators|mesh-ancestor
101677271|NCT00795340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677272|NCT00795340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101677273|NCT00795340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101677274|NCT00742157|Hormones|hormones|mesh-list
101677275|NCT00742157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101677276|NCT00742157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677277|NCT00668642|Dutasteride|dutasteride|mesh-list
101677278|NCT00668642|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101677279|NCT00668642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101677280|NCT00668642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101677281|NCT00668642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677282|NCT00668642|Hormone Antagonists|hormone antagonists|mesh-ancestor
101409677|NCT00350311|Nicotine|nicotine|mesh-list
101677283|NCT00668642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101677284|NCT00668642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677285|NCT00609791|Paclitaxel|paclitaxel|mesh-list
101677286|NCT00609791|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101677287|NCT00609791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101677288|NCT00609791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677289|NCT00609791|Tubulin Modulators|tubulin modulators|mesh-ancestor
101677290|NCT00609791|Antimitotic Agents|antimitotic agents|mesh-ancestor
101677291|NCT00609791|Mitosis Modulators|mitosis modulators|mesh-ancestor
101828949|NCT05115630|Antimetabolites|antimetabolites|mesh-ancestor
101828950|NCT05115630|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101828951|NCT05115630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101677292|NCT00609791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677293|NCT00489710|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101677294|NCT00489710|Immunomodulating Agents|immunomodulating agents|mesh-list
101677295|NCT00489710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677296|NCT00489710|Immunologic Factors|immunologic factors|mesh-ancestor
101677297|NCT00489710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677298|NCT00482677|Temozolomide|temozolomide|mesh-list
101677299|NCT00482677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101677300|NCT00482677|Alkylating Agents|alkylating agents|mesh-ancestor
101677301|NCT00482677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677302|NCT00482677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677303|NCT00314756|Imiquimod|imiquimod|mesh-list
101677304|NCT00314756|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101677305|NCT00314756|Immunologic Factors|immunologic factors|mesh-ancestor
101677306|NCT00314756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677307|NCT00314756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677308|NCT00314756|Interferon Inducers|interferon inducers|mesh-ancestor
101677309|NCT00101101|Aldesleukin|aldesleukin|mesh-list
101677310|NCT00101101|Dexamethasone|dexamethasone|mesh-list
101677311|NCT00101101|Prednisone|prednisone|mesh-list
101677312|NCT00101101|Cyclophosphamide|cyclophosphamide|mesh-list
101677313|NCT00101101|Doxorubicin|doxorubicin|mesh-list
101677314|NCT00101101|Vincristine|vincristine|mesh-list
101677315|NCT00101101|Interleukin-2|interleukin-2|mesh-list
101677316|NCT00101101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101677317|NCT00101101|Immunologic Factors|immunologic factors|mesh-ancestor
101677318|NCT00101101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677319|NCT00101101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101677320|NCT00101101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101677321|NCT00101101|Alkylating Agents|alkylating agents|mesh-ancestor
101677322|NCT00101101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677323|NCT00101101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677324|NCT00101101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101677325|NCT00101101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101677326|NCT00101101|Antiemetics|antiemetics|mesh-ancestor
101677327|NCT00101101|Autonomic Agents|autonomic agents|mesh-ancestor
101677328|NCT00101101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101677329|NCT00101101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101677330|NCT00101101|Glucocorticoids|glucocorticoids|mesh-ancestor
101677331|NCT00101101|Hormones|hormones|mesh-ancestor
101677332|NCT00101101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101677333|NCT00101101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101677334|NCT00101101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101677335|NCT00101101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101677336|NCT00101101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101677337|NCT00101101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101677338|NCT00101101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101677339|NCT00101101|Tubulin Modulators|tubulin modulators|mesh-ancestor
101677340|NCT00101101|Antimitotic Agents|antimitotic agents|mesh-ancestor
101677341|NCT00101101|Mitosis Modulators|mitosis modulators|mesh-ancestor
101677342|NCT00101101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101677343|NCT00101101|Analgesics|analgesics|mesh-ancestor
101677344|NCT00101101|Sensory System Agents|sensory system agents|mesh-ancestor
101677345|NCT00101101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101677346|NCT00101101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101677347|NCT00101101|Antiviral Agents|antiviral agents|mesh-ancestor
101677348|NCT00101101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101677349|NCT00946621|Ramipril|ramipril|mesh-list
101677350|NCT00946621|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101677351|NCT00946621|Protease Inhibitors|protease inhibitors|mesh-ancestor
101677352|NCT00946621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101828964|NCT05104047|Cholinergic Agents|cholinergic agents|mesh-ancestor
101677353|NCT00946621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677354|NCT00946621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101334598|NCT00044863|Cetuximab|cetuximab|mesh-list
101677356|NCT02600793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101677357|NCT02600793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101677358|NCT04235894|Propofol|propofol|mesh-list
101677359|NCT04235894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101677360|NCT04235894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101677361|NCT04235894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677362|NCT04235894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101677363|NCT04235894|Anesthetics, General|anesthetics, general|mesh-ancestor
101677364|NCT04235894|Anesthetics|anesthetics|mesh-ancestor
101677365|NCT04096599|Fluorides|fluorides|mesh-list
101677366|NCT04096599|Cariostatic Agents|cariostatic agents|mesh-ancestor
101677367|NCT04096599|Protective Agents|protective agents|mesh-ancestor
101677368|NCT04096599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677369|NCT00923351|Vaccines|vaccines|mesh-list
101677370|NCT00923351|Immunologic Factors|immunologic factors|mesh-ancestor
101677371|NCT00923351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677372|NCT02788292|Acetylcysteine|acetylcysteine|mesh-list
101677373|NCT02788292|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101677374|NCT02788292|Antiviral Agents|antiviral agents|mesh-ancestor
101677375|NCT02788292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101677376|NCT02788292|Expectorants|expectorants|mesh-ancestor
101677377|NCT02788292|Respiratory System Agents|respiratory system agents|mesh-ancestor
101677378|NCT02788292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101677379|NCT02788292|Antioxidants|antioxidants|mesh-ancestor
101677380|NCT02788292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677381|NCT02788292|Protective Agents|protective agents|mesh-ancestor
101677382|NCT02788292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677383|NCT02788292|Antidotes|antidotes|mesh-ancestor
101677385|NCT00944359|Trace Elements|trace elements|mesh-ancestor
101677386|NCT00944359|Micronutrients|micronutrients|mesh-ancestor
101677387|NCT00944359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677388|NCT02791256|Ribavirin|ribavirin|mesh-list
101677389|NCT02791256|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101677390|NCT02791256|Antimetabolites|antimetabolites|mesh-ancestor
101677391|NCT02791256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677392|NCT02791256|Antiviral Agents|antiviral agents|mesh-ancestor
101677393|NCT02791256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101677394|NCT04258007|Neostigmine|neostigmine|mesh-list
101677395|NCT04258007|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101677396|NCT04258007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101677397|NCT04258007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677398|NCT04258007|Cholinergic Agents|cholinergic agents|mesh-ancestor
101677399|NCT04258007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101677400|NCT04258007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677401|NCT04258007|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101677402|NCT04258007|Autonomic Agents|autonomic agents|mesh-ancestor
101677403|NCT04258007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101677404|NCT02787824|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101677405|NCT02787824|Hematinics|hematinics|mesh-ancestor
101677406|NCT02796950|Acipimox|acipimox|mesh-list
101677407|NCT02796950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101677408|NCT02796950|Antimetabolites|antimetabolites|mesh-ancestor
101677409|NCT02796950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677410|NCT02796950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101677411|NCT00755079|Adrenergic Agents|adrenergic agents|mesh-list
101677412|NCT00755079|Adrenergic Agonists|adrenergic agonists|mesh-list
101677413|NCT00755079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101677414|NCT00755079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677415|NCT00755079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677416|NCT00950209|Heparin|heparin|mesh-list
101677417|NCT00950209|Anticoagulants|anticoagulants|mesh-ancestor
101677418|NCT00950209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101828976|NCT05081479|Acetylcysteine|acetylcysteine|mesh-list
101677419|NCT00950209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101677420|NCT00950209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677421|NCT05370326|Analgesics, Opioid|analgesics, opioid|mesh-list
101677422|NCT05370326|Narcotics|narcotics|mesh-ancestor
101677423|NCT05370326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101677424|NCT05370326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677425|NCT05370326|Analgesics|analgesics|mesh-ancestor
101677426|NCT05370326|Sensory System Agents|sensory system agents|mesh-ancestor
101677427|NCT05370326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101677428|NCT00947323|Simvastatin|simvastatin|mesh-list
101677429|NCT00947323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101677430|NCT00947323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101677431|NCT00947323|Antimetabolites|antimetabolites|mesh-ancestor
101677432|NCT00947323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677433|NCT00947323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101677434|NCT00947323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101677435|NCT00947323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101677436|NCT04236050|Rocuronium|rocuronium|mesh-list
101677437|NCT04236050|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101677438|NCT04236050|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101677439|NCT04236050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101677440|NCT04236050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101677441|NCT04236050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677442|NCT02790632|Nimodipine|nimodipine|mesh-list
101677443|NCT02790632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101677444|NCT02790632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101677445|NCT02790632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101677446|NCT02790632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677447|NCT02790632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101677448|NCT02790632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677449|NCT02790632|Vasodilator Agents|vasodilator agents|mesh-ancestor
101677450|NCT03633110|Pembrolizumab|pembrolizumab|mesh-list
101677451|NCT03633110|Nivolumab|nivolumab|mesh-list
101677452|NCT03633110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101677453|NCT03633110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677454|NCT03633110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101677455|NCT03633110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677456|NCT02788136|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101677457|NCT02788136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101677458|NCT02788136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677459|NCT02788058|Gefitinib|gefitinib|mesh-list
101677460|NCT02788058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677461|NCT02788058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101677463|NCT02788058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677464|NCT04200092|Granisetron|granisetron|mesh-list
101677465|NCT04200092|Antiemetics|antiemetics|mesh-ancestor
101677466|NCT04200092|Autonomic Agents|autonomic agents|mesh-ancestor
101677467|NCT04200092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101677468|NCT04200092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677469|NCT04200092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101677470|NCT04200092|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101677471|NCT04200092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101677472|NCT04200092|Serotonin Agents|serotonin agents|mesh-ancestor
101677473|NCT04200092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101677474|NCT04200092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677475|NCT00754065|Moxifloxacin|moxifloxacin|mesh-list
101677476|NCT00754065|Dienogest|dienogest|mesh-list
101677477|NCT00754065|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101677478|NCT00754065|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101677479|NCT00754065|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101677481|NCT00754065|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101677482|NCT00754065|Estrogens|estrogens|mesh-ancestor
101677483|NCT00754065|Hormones|hormones|mesh-ancestor
101677484|NCT00754065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101677485|NCT00754065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677486|NCT00754065|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101677487|NCT00754065|Contraceptive Agents|contraceptive agents|mesh-ancestor
101677488|NCT00754065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101677489|NCT00754065|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101677490|NCT00754065|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101677491|NCT00754065|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101677492|NCT00754065|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101677493|NCT00754065|Hormone Antagonists|hormone antagonists|mesh-ancestor
101677494|NCT00754065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101677495|NCT00754065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677496|NCT00754065|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101677497|NCT00754065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101677498|NCT00754065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101677499|NCT00754065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101677500|NCT00754065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101677501|NCT00754065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101677502|NCT00754065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334745|NCT00001688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101677503|NCT02787746|Donepezil|donepezil|mesh-list
101677504|NCT02787746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101677505|NCT02787746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101677506|NCT02787746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677507|NCT02787746|Cholinergic Agents|cholinergic agents|mesh-ancestor
101677508|NCT02787746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101677509|NCT02787746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677510|NCT02787746|Nootropic Agents|nootropic agents|mesh-ancestor
101677511|NCT03254654|Apatinib|apatinib|mesh-list
101677512|NCT03254654|Vinorelbine|vinorelbine|mesh-list
101677513|NCT03254654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677514|NCT03254654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101677515|NCT03254654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101677516|NCT03254654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677517|NCT03254654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101677518|NCT03254654|Tubulin Modulators|tubulin modulators|mesh-ancestor
101677519|NCT03254654|Antimitotic Agents|antimitotic agents|mesh-ancestor
101677520|NCT03254654|Mitosis Modulators|mitosis modulators|mesh-ancestor
101677521|NCT02785718|Hemostatics|hemostatics|mesh-list
101677522|NCT02785718|Coagulants|coagulants|mesh-ancestor
101677523|NCT04094805|Calcitriol|calcitriol|mesh-list
101677524|NCT04094805|Dexamethasone|dexamethasone|mesh-list
101677525|NCT04094805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101677526|NCT04094805|Antiemetics|antiemetics|mesh-ancestor
101677527|NCT04094805|Autonomic Agents|autonomic agents|mesh-ancestor
101677528|NCT04094805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101677529|NCT04094805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677530|NCT04094805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101677531|NCT04094805|Glucocorticoids|glucocorticoids|mesh-ancestor
101677532|NCT04094805|Hormones|hormones|mesh-ancestor
101677533|NCT04094805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101677534|NCT04094805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101677535|NCT04094805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677536|NCT04094805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101677537|NCT04094805|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101829003|NCT05059626|Hormone Antagonists|hormone antagonists|mesh-ancestor
101677538|NCT04094805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101677539|NCT04094805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677540|NCT04094805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101677542|NCT04094805|Micronutrients|micronutrients|mesh-ancestor
101677543|NCT04094805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101677544|NCT04094727|Lumefantrine|lumefantrine|mesh-list
101677545|NCT04094727|Artemether|artemether|mesh-list
101677546|NCT04094727|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101677547|NCT04094727|Antimalarials|antimalarials|mesh-ancestor
101677548|NCT04094727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101677549|NCT04094727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101677550|NCT04094727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101677551|NCT00638066|Botulinum Toxins|botulinum toxins|mesh-list
101677552|NCT00638066|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101677553|NCT00638066|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101677554|NCT00638066|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101677555|NCT00638066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101677556|NCT00638066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677557|NCT00638066|Cholinergic Agents|cholinergic agents|mesh-ancestor
101677558|NCT00638066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101677559|NCT00638066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677560|NCT00638066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101677561|NCT00638066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101677562|NCT02786732|Ustekinumab|ustekinumab|mesh-list
101677563|NCT02786732|Brodalumab|brodalumab|mesh-list
101677564|NCT02786732|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101677565|NCT02786732|Dermatologic Agents|dermatologic agents|mesh-ancestor
101677566|NCT02786732|Immunologic Factors|immunologic factors|mesh-ancestor
101677567|NCT02786732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677568|NCT02785250|Cyclophosphamide|cyclophosphamide|mesh-list
101677569|NCT02785250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101677570|NCT02785250|Immunologic Factors|immunologic factors|mesh-ancestor
101677571|NCT02785250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677572|NCT02785250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101677573|NCT02785250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101677574|NCT02785250|Alkylating Agents|alkylating agents|mesh-ancestor
101677575|NCT02785250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677576|NCT02785250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677577|NCT02785250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101677578|NCT03110822|Methylprednisolone|methylprednisolone|mesh-list
101677580|NCT03110822|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101677581|NCT03110822|Prednisolone|prednisolone|mesh-list
101677582|NCT03110822|Prednisolone acetate|prednisolone acetate|mesh-list
101677583|NCT03110822|Lenalidomide|lenalidomide|mesh-list
101677584|NCT03110822|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101677585|NCT03110822|Prednisolone phosphate|prednisolone phosphate|mesh-list
101677586|NCT03110822|Immunologic Factors|immunologic factors|mesh-ancestor
101677587|NCT03110822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677588|NCT03110822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101829015|NCT04985344|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101677589|NCT03110822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101677591|NCT03110822|Growth Inhibitors|growth inhibitors|mesh-ancestor
101677592|NCT03110822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677593|NCT03110822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101677594|NCT03110822|Antiemetics|antiemetics|mesh-ancestor
101677595|NCT03110822|Autonomic Agents|autonomic agents|mesh-ancestor
101677596|NCT03110822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101677597|NCT03110822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101677598|NCT03110822|Glucocorticoids|glucocorticoids|mesh-ancestor
101677599|NCT03110822|Hormones|hormones|mesh-ancestor
101677600|NCT03110822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101677601|NCT03110822|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101677602|NCT03110822|Protective Agents|protective agents|mesh-ancestor
101677603|NCT03110822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101677604|NCT02787356|Lidocaine|lidocaine|mesh-list
101677605|NCT02787356|Anesthetics, Local|anesthetics, local|mesh-ancestor
101677606|NCT02787356|Anesthetics|anesthetics|mesh-ancestor
101677607|NCT02787356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101677608|NCT02787356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677609|NCT02787356|Sensory System Agents|sensory system agents|mesh-ancestor
101677610|NCT02787356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101677612|NCT02787356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101677613|NCT02787356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101677614|NCT02787356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101677615|NCT02787356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677616|NCT02787278|Otaplimastat|otaplimastat|mesh-list
101677617|NCT02787278|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101677618|NCT02787278|Protective Agents|protective agents|mesh-ancestor
101677619|NCT02787278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677620|NCT03083678|Afatinib|afatinib|mesh-list
101677621|NCT03083678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677622|NCT03083678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101677623|NCT03083678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101677624|NCT03083678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677625|NCT04232150|Midazolam|midazolam|mesh-list
101677626|NCT04232150|Anesthetics|anesthetics|mesh-list
101677627|NCT04232150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101677628|NCT04232150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677629|NCT04232150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101677630|NCT04232150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101677631|NCT04232150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101677632|NCT04232150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101677633|NCT04232150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101677634|NCT04232150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101677635|NCT04232150|Anesthetics, General|anesthetics, general|mesh-ancestor
101677636|NCT04232150|GABA Modulators|gaba modulators|mesh-ancestor
101677637|NCT04232150|GABA Agents|gaba agents|mesh-ancestor
101677638|NCT04232150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101677639|NCT04232150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677640|NCT04197752|Anesthetics|anesthetics|mesh-list
101677641|NCT04197752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101677642|NCT04197752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677643|NCT02336750|Aprepitant|aprepitant|mesh-list
101677644|NCT02336750|Fosaprepitant|fosaprepitant|mesh-list
101677645|NCT02336750|Mirtazapine|mirtazapine|mesh-list
101677646|NCT02336750|Antiemetics|antiemetics|mesh-ancestor
101677647|NCT02336750|Autonomic Agents|autonomic agents|mesh-ancestor
101677648|NCT02336750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101677649|NCT02336750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677650|NCT02336750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101677651|NCT02336750|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101677652|NCT02336750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101334892|NCT00001724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101829043|NCT04920695|Respiratory System Agents|respiratory system agents|mesh-ancestor
101677653|NCT02336750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677654|NCT02336750|Antidepressive Agents|antidepressive agents|mesh-ancestor
101677655|NCT02336750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101677656|NCT02336750|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101677657|NCT02336750|Histamine Antagonists|histamine antagonists|mesh-ancestor
101677658|NCT02336750|Histamine Agents|histamine agents|mesh-ancestor
101677659|NCT02336750|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101677660|NCT02336750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101677661|NCT02336750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101677662|NCT02336750|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101677663|NCT02336750|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101677664|NCT02336750|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101677665|NCT02336750|Adrenergic Agents|adrenergic agents|mesh-ancestor
101677666|NCT02336750|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101677667|NCT02336750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101677668|NCT02336750|Serotonin Agents|serotonin agents|mesh-ancestor
101677669|NCT02336750|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101677671|NCT02784392|Antiemetics|antiemetics|mesh-ancestor
101677672|NCT02784392|Autonomic Agents|autonomic agents|mesh-ancestor
101677673|NCT02784392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101677674|NCT02784392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677675|NCT02784392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101677676|NCT02784392|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101677677|NCT02784392|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101677678|NCT02784392|Dopamine Agents|dopamine agents|mesh-ancestor
101677679|NCT02784392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101677680|NCT02784392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677682|NCT00634556|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
101677683|NCT00634556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101677684|NCT00634556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101677685|NCT00634556|Dopamine Agents|dopamine agents|mesh-ancestor
101677686|NCT00634556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101677687|NCT00634556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677688|NCT00634556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677689|NCT02784080|Isoantibodies|isoantibodies|mesh-list
101677690|NCT02784080|Immunologic Factors|immunologic factors|mesh-ancestor
101677691|NCT02784080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677692|NCT02784860|Lidocaine|lidocaine|mesh-list
101677693|NCT02784860|Anesthetics, Local|anesthetics, local|mesh-ancestor
101677694|NCT02784860|Anesthetics|anesthetics|mesh-ancestor
101677695|NCT02784860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101677696|NCT02784860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677697|NCT02784860|Sensory System Agents|sensory system agents|mesh-ancestor
101677698|NCT02784860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101677699|NCT02784860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101677700|NCT02784860|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101677701|NCT02784860|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101677702|NCT02784860|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101677703|NCT02784860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677704|NCT02783924|Cholecalciferol|cholecalciferol|mesh-list
101677705|NCT02783924|Vitamin D|vitamin d|mesh-list
101677706|NCT02783924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101677707|NCT02783924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677708|NCT02783924|Vitamins|vitamins|mesh-ancestor
101677709|NCT02783924|Micronutrients|micronutrients|mesh-ancestor
101677710|NCT02783924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101677711|NCT02783846|Dexmedetomidine|dexmedetomidine|mesh-list
101677712|NCT02783846|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101829055|NCT04915612|Calicheamicins|calicheamicins|mesh-list
101677713|NCT02783846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101677714|NCT02783846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677715|NCT02783846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101677717|NCT02783846|Sensory System Agents|sensory system agents|mesh-ancestor
101677718|NCT02783846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101677719|NCT02783846|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101677720|NCT02783846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101677721|NCT02783846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101677722|NCT02783846|Adrenergic Agents|adrenergic agents|mesh-ancestor
101677723|NCT02783846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101677724|NCT02783846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677725|NCT02783378|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
101677726|NCT02783378|Antacids|antacids|mesh-ancestor
101677727|NCT02783378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677728|NCT02783378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101677729|NCT05237726|Heparin|heparin|mesh-list
101677730|NCT05237726|Enoxaparin|enoxaparin|mesh-list
101677731|NCT05237726|Calcium heparin|calcium heparin|mesh-list
101677732|NCT05237726|Enoxaparin sodium|enoxaparin sodium|mesh-list
101677733|NCT05237726|Anticoagulants|anticoagulants|mesh-ancestor
101677734|NCT05237726|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101677735|NCT05237726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101677736|NCT05237726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677737|NCT02783144|Dexamethasone|dexamethasone|mesh-list
101677738|NCT02783144|Dexamethasone acetate|dexamethasone acetate|mesh-list
101677739|NCT02783144|BB 1101|bb 1101|mesh-list
101677740|NCT02783144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101677741|NCT02783144|Antiemetics|antiemetics|mesh-ancestor
101677742|NCT02783144|Autonomic Agents|autonomic agents|mesh-ancestor
101677743|NCT02783144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101677744|NCT02783144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677745|NCT02783144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101677746|NCT02783144|Glucocorticoids|glucocorticoids|mesh-ancestor
101677747|NCT02783144|Hormones|hormones|mesh-ancestor
101677748|NCT02783144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101677749|NCT02783144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101677750|NCT02783144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677751|NCT02783144|Protease Inhibitors|protease inhibitors|mesh-ancestor
101677752|NCT02783144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101677753|NCT02783144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677754|NCT05260320|Anesthetics|anesthetics|mesh-list
101677755|NCT05260320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101677756|NCT05260320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677758|NCT02783222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101677759|NCT02783222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677760|NCT02783222|Tubulin Modulators|tubulin modulators|mesh-ancestor
101677761|NCT02783222|Antimitotic Agents|antimitotic agents|mesh-ancestor
101677762|NCT02783222|Mitosis Modulators|mitosis modulators|mesh-ancestor
101677763|NCT02783222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677764|NCT02689856|Hydrocortisone|hydrocortisone|mesh-list
101677765|NCT02689856|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101677766|NCT02689856|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101677767|NCT02689856|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101677768|NCT02689856|Lidocaine|lidocaine|mesh-list
101677769|NCT02689856|Anesthetics, Local|anesthetics, local|mesh-ancestor
101677770|NCT02689856|Anesthetics|anesthetics|mesh-ancestor
101677771|NCT02689856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101677772|NCT02689856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677773|NCT02689856|Sensory System Agents|sensory system agents|mesh-ancestor
101677774|NCT02689856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101677775|NCT02689856|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101677776|NCT02689856|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101677777|NCT02689856|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101677778|NCT02689856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101677779|NCT02689856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677780|NCT02689856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101677781|NCT02722902|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101677782|NCT02722902|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101677783|NCT02722902|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101677784|NCT02722902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101677785|NCT05206448|Letrozole|letrozole|mesh-list
101677786|NCT05206448|Clomiphene|clomiphene|mesh-list
101677787|NCT05206448|Enclomiphene|enclomiphene|mesh-list
101677788|NCT05206448|Zuclomiphene|zuclomiphene|mesh-list
101677789|NCT05206448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677790|NCT05206448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677791|NCT05206448|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101677792|NCT05206448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101677793|NCT05206448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101677794|NCT05206448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101677795|NCT05206448|Hormone Antagonists|hormone antagonists|mesh-ancestor
101326204|NCT00115726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677796|NCT05206448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101335044|NCT00046852|Carmustine|carmustine|mesh-list
101677797|NCT05206448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677798|NCT05206448|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101677799|NCT05206448|Fertility Agents|fertility agents|mesh-ancestor
101677800|NCT05206448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101677801|NCT05206448|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101677802|NCT05206448|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101677803|NCT02722746|Epinephrine|epinephrine|mesh-list
101677804|NCT02722746|Ropivacaine|ropivacaine|mesh-list
101677805|NCT02722746|Anesthetics, Local|anesthetics, local|mesh-ancestor
101677806|NCT02722746|Anesthetics|anesthetics|mesh-ancestor
101677807|NCT02722746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101677808|NCT02722746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677809|NCT02722746|Sensory System Agents|sensory system agents|mesh-ancestor
101677810|NCT02722746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101677811|NCT02722746|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101677812|NCT02722746|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101677813|NCT02722746|Adrenergic Agents|adrenergic agents|mesh-ancestor
101677814|NCT02722746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101677815|NCT02722746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677816|NCT02722746|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101677817|NCT02722746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101677818|NCT02722746|Autonomic Agents|autonomic agents|mesh-ancestor
101677819|NCT02722746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101677820|NCT02722746|Respiratory System Agents|respiratory system agents|mesh-ancestor
101677821|NCT02722746|Mydriatics|mydriatics|mesh-ancestor
101677822|NCT02722746|Sympathomimetics|sympathomimetics|mesh-ancestor
101677823|NCT02722746|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101677824|NCT02784626|Dexmedetomidine|dexmedetomidine|mesh-list
101677825|NCT02784626|Propofol|propofol|mesh-list
101677826|NCT02784626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101677827|NCT02784626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101677828|NCT02784626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677829|NCT02784626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101677830|NCT02784626|Analgesics|analgesics|mesh-ancestor
101677831|NCT02784626|Sensory System Agents|sensory system agents|mesh-ancestor
101677832|NCT02784626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101677833|NCT02784626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101677834|NCT02784626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101677835|NCT02784626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101677836|NCT02784626|Adrenergic Agents|adrenergic agents|mesh-ancestor
101677837|NCT02784626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101677838|NCT02784626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677839|NCT02784626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101677840|NCT02784626|Anesthetics, General|anesthetics, general|mesh-ancestor
101677842|NCT02782754|Cyclophosphamide|cyclophosphamide|mesh-list
101677843|NCT02782754|Carboplatin|carboplatin|mesh-list
101677844|NCT02782754|Etoposide|etoposide|mesh-list
101677845|NCT02782754|Bleomycin|bleomycin|mesh-list
101677846|NCT02782754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101677847|NCT02782754|Immunologic Factors|immunologic factors|mesh-ancestor
101677848|NCT02782754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677849|NCT02782754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101677850|NCT02782754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101677851|NCT02782754|Alkylating Agents|alkylating agents|mesh-ancestor
101677852|NCT02782754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677853|NCT02782754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677854|NCT02782754|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101677855|NCT02782754|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101677856|NCT02782754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101677857|NCT02782754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101677858|NCT02782754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101677859|NCT02782754|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101677860|NCT05341076|Oxytocin|oxytocin|mesh-list
101677861|NCT05341076|Oxytocics|oxytocics|mesh-ancestor
101677862|NCT05341076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101677863|NCT05341076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677864|NCT05133518|Midazolam|midazolam|mesh-list
101677865|NCT05133518|Ketamine|ketamine|mesh-list
101677866|NCT05133518|Analgesics|analgesics|mesh-ancestor
101677867|NCT05133518|Sensory System Agents|sensory system agents|mesh-ancestor
101677868|NCT05133518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101677869|NCT05133518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677870|NCT05133518|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101677871|NCT05133518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101677872|NCT05133518|Anesthetics, General|anesthetics, general|mesh-ancestor
101677874|NCT05133518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101677875|NCT05133518|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101677876|NCT05133518|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101677877|NCT05133518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101677878|NCT05133518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677879|NCT05133518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101677880|NCT05133518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101677881|NCT05133518|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101677882|NCT05133518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101677883|NCT05133518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101677884|NCT05133518|GABA Modulators|gaba modulators|mesh-ancestor
101677885|NCT05133518|GABA Agents|gaba agents|mesh-ancestor
101677886|NCT02714712|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101677887|NCT02714712|Antiviral Agents|antiviral agents|mesh-ancestor
101677888|NCT02714712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101677889|NCT02714166|Sunscreening Agents|sunscreening agents|mesh-list
101677890|NCT02714166|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101677891|NCT02714166|Protective Agents|protective agents|mesh-ancestor
101677892|NCT02714166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677893|NCT02714166|Dermatologic Agents|dermatologic agents|mesh-ancestor
101677894|NCT04231682|Denosumab|denosumab|mesh-list
101677895|NCT04231682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101677896|NCT04231682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677897|NCT02722356|Oxytocin|oxytocin|mesh-list
101677898|NCT02722356|Oxytocics|oxytocics|mesh-ancestor
101677899|NCT02722356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101677900|NCT02722356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677901|NCT00753675|Gemcitabine|gemcitabine|mesh-list
101677902|NCT00753675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101677903|NCT00753675|Antimetabolites|antimetabolites|mesh-ancestor
101677904|NCT00753675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677905|NCT00753675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829103|NCT04895358|Antimetabolites|antimetabolites|mesh-ancestor
101677907|NCT05131178|Anesthetics, Local|anesthetics, local|mesh-ancestor
101677908|NCT05131178|Anesthetics|anesthetics|mesh-ancestor
101677909|NCT05131178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101677910|NCT05131178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677911|NCT05131178|Sensory System Agents|sensory system agents|mesh-ancestor
101677912|NCT05131178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101677914|NCT02546934|Gemcitabine|gemcitabine|mesh-list
101677915|NCT02546934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677916|NCT02546934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101677917|NCT02546934|Antimetabolites|antimetabolites|mesh-ancestor
101677918|NCT02546934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677919|NCT00586521|Factor VIII|factor viii|mesh-list
101677920|NCT00586521|Coagulants|coagulants|mesh-ancestor
101677921|NCT02782286|Ketorolac|ketorolac|mesh-list
101677922|NCT02782286|Morphine|morphine|mesh-list
101677923|NCT02782286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101677924|NCT02782286|Narcotics|narcotics|mesh-ancestor
101677925|NCT02782286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101677926|NCT02782286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677927|NCT02782286|Analgesics|analgesics|mesh-ancestor
101677928|NCT02782286|Sensory System Agents|sensory system agents|mesh-ancestor
101677929|NCT02782286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101677930|NCT02782286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101677931|NCT02782286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101677932|NCT02782286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101677933|NCT02782286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101677934|NCT02782286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101677935|NCT02782286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101677936|NCT02782286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677937|NCT04231448|Prednisone|prednisone|mesh-list
101677938|NCT04231448|Cyclophosphamide|cyclophosphamide|mesh-list
101677939|NCT04231448|Rituximab|rituximab|mesh-list
101677940|NCT04231448|Doxorubicin|doxorubicin|mesh-list
101677941|NCT04231448|Vincristine|vincristine|mesh-list
101677942|NCT04231448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101677943|NCT04231448|Immunologic Factors|immunologic factors|mesh-ancestor
101677944|NCT04231448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677945|NCT04231448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101677946|NCT04231448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101677947|NCT04231448|Alkylating Agents|alkylating agents|mesh-ancestor
101677948|NCT04231448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677949|NCT04231448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101677950|NCT04231448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101677951|NCT04231448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101677952|NCT04231448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101677953|NCT04231448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101677954|NCT04231448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101677955|NCT04231448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101677956|NCT04231448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101677957|NCT04231448|Glucocorticoids|glucocorticoids|mesh-ancestor
101677958|NCT04231448|Hormones|hormones|mesh-ancestor
101677959|NCT04231448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101677960|NCT04231448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101677961|NCT04231448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101677962|NCT04231448|Tubulin Modulators|tubulin modulators|mesh-ancestor
101677963|NCT04231448|Antimitotic Agents|antimitotic agents|mesh-ancestor
101829122|NCT04865419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101677964|NCT04231448|Mitosis Modulators|mitosis modulators|mesh-ancestor
101677965|NCT02600247|Acetaminophen|acetaminophen|mesh-list
101677966|NCT02600247|Celecoxib|celecoxib|mesh-list
101677967|NCT02600247|Pregabalin|pregabalin|mesh-list
101677968|NCT02600247|Oxycodone|oxycodone|mesh-list
101677969|NCT02600247|Tramadol|tramadol|mesh-list
101677970|NCT02600247|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101677971|NCT02600247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101677972|NCT02600247|Analgesics|analgesics|mesh-ancestor
101677973|NCT02600247|Sensory System Agents|sensory system agents|mesh-ancestor
101677974|NCT02600247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101677975|NCT02600247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101677976|NCT02600247|Antipyretics|antipyretics|mesh-ancestor
101677977|NCT02600247|Anticonvulsants|anticonvulsants|mesh-ancestor
101677978|NCT02600247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101677979|NCT02600247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101677980|NCT02600247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101677981|NCT02600247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101677982|NCT02600247|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101677983|NCT02600247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101677984|NCT02600247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101677985|NCT02600247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101677986|NCT02600247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101677987|NCT02600247|Narcotics|narcotics|mesh-ancestor
101677988|NCT02600247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101677989|NCT02600247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101677990|NCT02600247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101677991|NCT02600247|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101677992|NCT02600247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101677993|NCT02600247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101677994|NCT02600247|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101677995|NCT02600247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101677996|NCT02600247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101677997|NCT02600247|Antidepressive Agents|antidepressive agents|mesh-ancestor
101677998|NCT02600247|Dopamine Agents|dopamine agents|mesh-ancestor
101678000|NCT05453253|Immunologic Factors|immunologic factors|mesh-ancestor
101678001|NCT05453253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678002|NCT04229498|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101678003|NCT04229498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101678004|NCT02717052|Ketamine|ketamine|mesh-list
101678005|NCT02717052|Esketamine|esketamine|mesh-list
101678006|NCT02717052|Analgesics|analgesics|mesh-ancestor
101678007|NCT02717052|Sensory System Agents|sensory system agents|mesh-ancestor
101678008|NCT02717052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101678009|NCT02717052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678010|NCT02717052|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101678011|NCT02717052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101678012|NCT02717052|Anesthetics, General|anesthetics, general|mesh-ancestor
101678013|NCT02717052|Anesthetics|anesthetics|mesh-ancestor
101678014|NCT02717052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101678015|NCT02717052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101678016|NCT02717052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101678017|NCT02717052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101678018|NCT02717052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678019|NCT02717052|Antidepressive Agents|antidepressive agents|mesh-ancestor
101678020|NCT02717052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101678021|NCT05342558|Fluticasone|fluticasone|mesh-list
101678022|NCT05342558|Xhance|xhance|mesh-list
101678023|NCT05342558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101678024|NCT05342558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101678025|NCT05342558|Autonomic Agents|autonomic agents|mesh-ancestor
101678026|NCT05342558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101678027|NCT05342558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678028|NCT05342558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101678029|NCT05342558|Respiratory System Agents|respiratory system agents|mesh-ancestor
101678030|NCT05342558|Dermatologic Agents|dermatologic agents|mesh-ancestor
101678031|NCT05342558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101678032|NCT00923273|Folic Acid|folic acid|mesh-list
101678033|NCT00923273|Vitamin B 12|vitamin b 12|mesh-list
101678034|NCT00923273|Sirolimus|sirolimus|mesh-list
101678035|NCT00923273|Dexamethasone|dexamethasone|mesh-list
101678036|NCT00923273|Pemetrexed|pemetrexed|mesh-list
101678037|NCT00923273|Vitamins|vitamins|mesh-ancestor
101678038|NCT00923273|Micronutrients|micronutrients|mesh-ancestor
101678039|NCT00923273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678040|NCT00923273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101678041|NCT00923273|Antiemetics|antiemetics|mesh-ancestor
101678042|NCT00923273|Autonomic Agents|autonomic agents|mesh-ancestor
101678043|NCT00923273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101678044|NCT00923273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101678045|NCT00923273|Glucocorticoids|glucocorticoids|mesh-ancestor
101678046|NCT00923273|Hormones|hormones|mesh-ancestor
101678047|NCT00923273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101678048|NCT00923273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101678049|NCT00923273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101678050|NCT00923273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101678051|NCT00923273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678052|NCT00923273|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101678053|NCT00923273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101678054|NCT00923273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101678055|NCT00923273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101678056|NCT00923273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101678057|NCT00923273|Antifungal Agents|antifungal agents|mesh-ancestor
101678058|NCT00923273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101678059|NCT00923273|Immunologic Factors|immunologic factors|mesh-ancestor
101678060|NCT00923273|Hematinics|hematinics|mesh-ancestor
101678061|NCT00923273|Vitamin B Complex|vitamin b complex|mesh-ancestor
101678062|NCT04231370|Lenalidomide|lenalidomide|mesh-list
101678063|NCT04231370|Immunologic Factors|immunologic factors|mesh-ancestor
101678064|NCT04231370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678065|NCT04231370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101678066|NCT04231370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101678067|NCT04231370|Growth Substances|growth substances|mesh-ancestor
101678068|NCT04231370|Growth Inhibitors|growth inhibitors|mesh-ancestor
101678069|NCT04231370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101678070|NCT05340530|Meropenem|meropenem|mesh-list
101678071|NCT05340530|Avibactam|avibactam|mesh-list
101678072|NCT05340530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101678073|NCT05340530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101678074|NCT05340530|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101678075|NCT05340530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101678076|NCT05340530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678077|NCT00634712|Candesartan|candesartan|mesh-list
101678078|NCT00634712|Candesartan cilexetil|candesartan cilexetil|mesh-list
101678079|NCT00634712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101678080|NCT00634712|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101678081|NCT00634712|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101829149|NCT04767594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101678082|NCT00634712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678083|NCT00923195|Aldesleukin|aldesleukin|mesh-list
101678085|NCT00923195|Fludarabine|fludarabine|mesh-list
101678086|NCT00923195|Interleukin-2|interleukin-2|mesh-list
101678087|NCT00923195|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101678088|NCT00923195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101678089|NCT00923195|Immunologic Factors|immunologic factors|mesh-ancestor
101678090|NCT00923195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678091|NCT00923195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101678092|NCT00923195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101678093|NCT00923195|Alkylating Agents|alkylating agents|mesh-ancestor
101678094|NCT00923195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678095|NCT00923195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101678096|NCT00923195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101678097|NCT00923195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101678098|NCT00923195|Analgesics|analgesics|mesh-ancestor
101678099|NCT00923195|Sensory System Agents|sensory system agents|mesh-ancestor
101335342|NCT00049075|Fludarabine|fludarabine|mesh-list
101678100|NCT00923195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101678101|NCT00923195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101678102|NCT00923195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101678103|NCT00923195|Antiviral Agents|antiviral agents|mesh-ancestor
101678104|NCT00923195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101678105|NCT00923195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101678106|NCT02721888|Liraglutide|liraglutide|mesh-list
101678108|NCT02721888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678109|NCT02721888|Incretins|incretins|mesh-ancestor
101678110|NCT02721888|Hormones|hormones|mesh-ancestor
101678111|NCT02721888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101678112|NCT04256057|Magnesium Sulfate|magnesium sulfate|mesh-list
101678113|NCT04256057|Analgesics|analgesics|mesh-ancestor
101678114|NCT04256057|Sensory System Agents|sensory system agents|mesh-ancestor
101678115|NCT04256057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101678116|NCT04256057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678117|NCT04256057|Anesthetics|anesthetics|mesh-ancestor
101678118|NCT04256057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101678119|NCT04256057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101678120|NCT04256057|Anticonvulsants|anticonvulsants|mesh-ancestor
101678121|NCT04256057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101678122|NCT04256057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101678123|NCT04256057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678124|NCT04256057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101678125|NCT04256057|Tocolytic Agents|tocolytic agents|mesh-ancestor
101678126|NCT04256057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101678127|NCT04189302|Pyrithione zinc|pyrithione zinc|mesh-list
101678128|NCT04189302|Keratolytic Agents|keratolytic agents|mesh-ancestor
101678129|NCT04189302|Dermatologic Agents|dermatologic agents|mesh-ancestor
101678130|NCT02714010|Gefitinib|gefitinib|mesh-list
101678131|NCT02714010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101678132|NCT02714010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101678134|NCT02714010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678135|NCT00917241|Dexamethasone|dexamethasone|mesh-list
101678136|NCT00917241|Methimazole|methimazole|mesh-list
101678137|NCT00917241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101678138|NCT00917241|Antiemetics|antiemetics|mesh-ancestor
101678139|NCT00917241|Autonomic Agents|autonomic agents|mesh-ancestor
101678140|NCT00917241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101678141|NCT00917241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678142|NCT00917241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101678143|NCT00917241|Glucocorticoids|glucocorticoids|mesh-ancestor
101678144|NCT00917241|Hormones|hormones|mesh-ancestor
101678145|NCT00917241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101678146|NCT00917241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101829176|NCT04739800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101678147|NCT00917241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101678148|NCT00917241|Antithyroid Agents|antithyroid agents|mesh-ancestor
101678149|NCT00917241|Hormone Antagonists|hormone antagonists|mesh-ancestor
101678150|NCT00919061|Gemcitabine|gemcitabine|mesh-list
101678151|NCT00919061|Sorafenib|sorafenib|mesh-list
101678152|NCT00919061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101678153|NCT00919061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101678154|NCT00919061|Antimetabolites|antimetabolites|mesh-ancestor
101678155|NCT00919061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678156|NCT00919061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101678157|NCT00919061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101678158|NCT05106296|Cyclophosphamide|cyclophosphamide|mesh-list
101678159|NCT05106296|Etoposide|etoposide|mesh-list
101678160|NCT05106296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101678161|NCT05106296|Immunologic Factors|immunologic factors|mesh-ancestor
101678162|NCT05106296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678163|NCT05106296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101678164|NCT05106296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101678165|NCT05106296|Alkylating Agents|alkylating agents|mesh-ancestor
101678166|NCT05106296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678167|NCT05106296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101678168|NCT05106296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101678169|NCT05106296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101678170|NCT05106296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101678171|NCT05106296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101678172|NCT05106296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101678173|NCT02598687|Paclitaxel|paclitaxel|mesh-list
101678174|NCT02598687|Carboplatin|carboplatin|mesh-list
101678175|NCT02598687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101335419|NCT00391911|Antidotes|antidotes|mesh-ancestor
101678176|NCT02598687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101678178|NCT02598687|Antimitotic Agents|antimitotic agents|mesh-ancestor
101678179|NCT02598687|Mitosis Modulators|mitosis modulators|mesh-ancestor
101678180|NCT02598687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678181|NCT05338190|Rituximab|rituximab|mesh-list
101678182|NCT05338190|Belimumab|belimumab|mesh-list
101678183|NCT05338190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101678184|NCT05338190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101678185|NCT05338190|Immunologic Factors|immunologic factors|mesh-ancestor
101678186|NCT05338190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678187|NCT05338190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101678188|NCT05338190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101678189|NCT04908605|Melatonin|melatonin|mesh-list
101678190|NCT04908605|Mirtazapine|mirtazapine|mesh-list
101678191|NCT04908605|Antioxidants|antioxidants|mesh-ancestor
101678192|NCT04908605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678193|NCT04908605|Protective Agents|protective agents|mesh-ancestor
101678194|NCT04908605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678195|NCT04908605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101678196|NCT04908605|Antidepressive Agents|antidepressive agents|mesh-ancestor
101678197|NCT04908605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101678198|NCT04908605|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101678199|NCT04908605|Histamine Antagonists|histamine antagonists|mesh-ancestor
101678200|NCT04908605|Histamine Agents|histamine agents|mesh-ancestor
101678201|NCT04908605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101678202|NCT04908605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101678203|NCT04908605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101678204|NCT04908605|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101678205|NCT04908605|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101678206|NCT04908605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101678207|NCT04908605|Adrenergic Agents|adrenergic agents|mesh-ancestor
101829191|NCT04700124|Cisplatin|cisplatin|mesh-list
101678209|NCT04908605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101678210|NCT04908605|Serotonin Agents|serotonin agents|mesh-ancestor
101678211|NCT04908605|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101678212|NCT02782208|Acipimox|acipimox|mesh-list
101678213|NCT02782208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101678214|NCT02782208|Antimetabolites|antimetabolites|mesh-ancestor
101678215|NCT02782208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678216|NCT02782208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101678217|NCT02598453|Ibandronic Acid|ibandronic acid|mesh-list
101678218|NCT02598453|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101678219|NCT02598453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678220|NCT00611286|Sirolimus|sirolimus|mesh-list
101678221|NCT00611286|Paclitaxel|paclitaxel|mesh-list
101678222|NCT00611286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101678223|NCT00611286|Everolimus|everolimus|mesh-list
101678224|NCT00611286|Clopidogrel|clopidogrel|mesh-list
101678225|NCT00611286|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
101678226|NCT00611286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101678227|NCT00611286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101678228|NCT00611286|Tubulin Modulators|tubulin modulators|mesh-ancestor
101678229|NCT00611286|Antimitotic Agents|antimitotic agents|mesh-ancestor
101678230|NCT00611286|Mitosis Modulators|mitosis modulators|mesh-ancestor
101678231|NCT00611286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678232|NCT00611286|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101678233|NCT00611286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101678234|NCT00611286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101678235|NCT00611286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101678236|NCT00611286|Immunologic Factors|immunologic factors|mesh-ancestor
101678237|NCT00611286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678238|NCT00611286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101326205|NCT00401869|Epoetin Alfa|epoetin alfa|mesh-list
101678239|NCT00611286|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101678240|NCT00611286|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101678241|NCT00611286|Purinergic Agents|purinergic agents|mesh-ancestor
101678242|NCT00611286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101678243|NCT00611286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101678244|NCT00611286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101678245|NCT00611286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101678246|NCT00611286|Antifungal Agents|antifungal agents|mesh-ancestor
101678248|NCT04257851|Theophylline|theophylline|mesh-list
101678249|NCT04257851|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101678250|NCT04257851|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101678251|NCT04257851|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101678252|NCT04257851|Serotonin Agents|serotonin agents|mesh-ancestor
101678253|NCT04257851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101678254|NCT04257851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678255|NCT04257851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678256|NCT04257851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101678257|NCT04257851|Autonomic Agents|autonomic agents|mesh-ancestor
101678258|NCT04257851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101678259|NCT04257851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101678260|NCT04257851|Respiratory System Agents|respiratory system agents|mesh-ancestor
101678261|NCT04257851|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101678262|NCT04257851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101678263|NCT04257851|Vasodilator Agents|vasodilator agents|mesh-ancestor
101678264|NCT04257851|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101678265|NCT04257851|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101678266|NCT04257851|Purinergic Agents|purinergic agents|mesh-ancestor
101678267|NCT02780102|Methylphenidate|methylphenidate|mesh-list
101678268|NCT02780102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101678269|NCT02780102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678270|NCT02780102|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101678271|NCT02780102|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101678272|NCT02780102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101678273|NCT02780102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678274|NCT02780102|Dopamine Agents|dopamine agents|mesh-ancestor
101678275|NCT02780102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101678276|NCT04197050|Valsartan|valsartan|mesh-list
101678277|NCT04197050|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101678278|NCT04197050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101678279|NCT04197050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101678280|NCT04197050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101678281|NCT04197050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678282|NCT04090047|Itraconazole|itraconazole|mesh-list
101678283|NCT04090047|PF-06700841|pf-06700841|mesh-list
101678284|NCT04090047|Antifungal Agents|antifungal agents|mesh-ancestor
101678285|NCT04090047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101678286|NCT04090047|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101678287|NCT04090047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101678288|NCT04090047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101678289|NCT04090047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678290|NCT04090047|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101678291|NCT04090047|Hormone Antagonists|hormone antagonists|mesh-ancestor
101678292|NCT04090047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101678293|NCT04090047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678294|NCT04090047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101678295|NCT04090047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101678296|NCT02782052|Bromides|bromides|mesh-list
101678297|NCT02782052|Albuterol|albuterol|mesh-list
101678298|NCT02782052|Ipratropium|ipratropium|mesh-list
101678299|NCT02782052|Anticonvulsants|anticonvulsants|mesh-ancestor
101678300|NCT02782052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101678301|NCT02782052|Autonomic Agents|autonomic agents|mesh-ancestor
101678302|NCT02782052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101678303|NCT02782052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678304|NCT02782052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101678305|NCT02782052|Respiratory System Agents|respiratory system agents|mesh-ancestor
101678306|NCT02782052|Tocolytic Agents|tocolytic agents|mesh-ancestor
101678307|NCT02782052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101678308|NCT02782052|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101678309|NCT02782052|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101678310|NCT02782052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101678311|NCT02782052|Adrenergic Agents|adrenergic agents|mesh-ancestor
101678312|NCT02782052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101678313|NCT02782052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678314|NCT02782052|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101678315|NCT02782052|Cholinergic Agents|cholinergic agents|mesh-ancestor
101678316|NCT02708628|Heparin|heparin|mesh-list
101678317|NCT02708628|Allantoin|allantoin|mesh-list
101678318|NCT02708628|Anticoagulants|anticoagulants|mesh-ancestor
101678319|NCT02708628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101678320|NCT02708628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101678321|NCT02708628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678322|NCT02708628|Dermatologic Agents|dermatologic agents|mesh-ancestor
101678323|NCT00746733|Amphetamine|amphetamine|mesh-list
101678324|NCT00746733|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101678325|NCT00746733|Adderall|adderall|mesh-list
101678326|NCT00746733|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101678327|NCT00746733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678328|NCT00746733|Sympathomimetics|sympathomimetics|mesh-ancestor
101678329|NCT00746733|Autonomic Agents|autonomic agents|mesh-ancestor
101678330|NCT00746733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101678331|NCT00746733|Dopamine Agents|dopamine agents|mesh-ancestor
101678332|NCT00746733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101678333|NCT00746733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678334|NCT00746733|Adrenergic Agents|adrenergic agents|mesh-ancestor
101678335|NCT00746733|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101678336|NCT00746733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101678337|NCT00746733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101678338|NCT00746733|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101678339|NCT00636870|Fexofenadine|fexofenadine|mesh-list
101678340|NCT00636870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101678341|NCT00636870|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101678342|NCT00636870|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101678343|NCT00636870|Histamine Antagonists|histamine antagonists|mesh-ancestor
101678344|NCT00636870|Histamine Agents|histamine agents|mesh-ancestor
101678345|NCT00636870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101678346|NCT00636870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678347|NCT00636870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678348|NCT00634790|Alprazolam|alprazolam|mesh-list
101678349|NCT00634790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101678350|NCT00634790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101678351|NCT00634790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678352|NCT00634790|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101678354|NCT00634790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101678355|NCT00634790|GABA Modulators|gaba modulators|mesh-ancestor
101678356|NCT00634790|GABA Agents|gaba agents|mesh-ancestor
101678357|NCT00634790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101678358|NCT00634790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678359|NCT04831151|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
101678360|NCT04831151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678361|NCT04831151|Androgen Antagonists|androgen antagonists|mesh-ancestor
101678362|NCT04831151|Hormone Antagonists|hormone antagonists|mesh-ancestor
101678363|NCT04831151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101678364|NCT00917397|Sertraline|sertraline|mesh-list
101678365|NCT00917397|Antidepressive Agents|antidepressive agents|mesh-ancestor
101678366|NCT00917397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101678367|NCT00917397|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101678368|NCT00917397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101678369|NCT00917397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101678370|NCT00917397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678371|NCT00917397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101678372|NCT00917397|Serotonin Agents|serotonin agents|mesh-ancestor
101678373|NCT00917397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678374|NCT02708160|Fluorides|fluorides|mesh-list
101678375|NCT02708160|Cariostatic Agents|cariostatic agents|mesh-ancestor
101678376|NCT02708160|Protective Agents|protective agents|mesh-ancestor
101678377|NCT02708160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678378|NCT04257461|Capecitabine|capecitabine|mesh-list
101678379|NCT04257461|Oxaliplatin|oxaliplatin|mesh-list
101678380|NCT04257461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101678381|NCT04257461|Antimetabolites|antimetabolites|mesh-ancestor
101678382|NCT04257461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678383|NCT04257461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101678384|NCT02712528|Sufentanil|sufentanil|mesh-list
101678385|NCT02712528|Remifentanil|remifentanil|mesh-list
101678386|NCT02712528|Sevoflurane|sevoflurane|mesh-list
101678387|NCT02712528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101678388|NCT02712528|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101678389|NCT02712528|Anesthetics, General|anesthetics, general|mesh-ancestor
101678390|NCT02712528|Anesthetics|anesthetics|mesh-ancestor
101678391|NCT02712528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101678392|NCT02712528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678393|NCT02712528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101678394|NCT02712528|Narcotics|narcotics|mesh-ancestor
101678395|NCT02712528|Analgesics|analgesics|mesh-ancestor
101678396|NCT02712528|Sensory System Agents|sensory system agents|mesh-ancestor
101829228|NCT04646694|Anesthetics|anesthetics|mesh-ancestor
101829229|NCT04646694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101829230|NCT04646694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101678397|NCT02712528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101678399|NCT02712528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101678401|NCT04089657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101678402|NCT04089657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101678403|NCT04089657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101678404|NCT04089657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678405|NCT02713074|Povidone-Iodine|povidone-iodine|mesh-list
101678406|NCT02713074|Povidone|povidone|mesh-list
101678407|NCT02713074|Plasma Substitutes|plasma substitutes|mesh-ancestor
101678408|NCT02713074|Blood Substitutes|blood substitutes|mesh-ancestor
101678409|NCT02713074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101678410|NCT02713074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101678411|NCT00637793|(S)-2-ethyl-8-methyl-1-thia-4,8-diazaspiro(4.5)decan-3-one|(s)-2-ethyl-8-methyl-1-thia-4,8-diazaspiro(4.5)decan-3-one|mesh-list
101678412|NCT00637793|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101678413|NCT00637793|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101678414|NCT00637793|Cholinergic Agents|cholinergic agents|mesh-ancestor
101678415|NCT00637793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101678416|NCT00637793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678417|NCT00637793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678418|NCT00745875|Pemetrexed|pemetrexed|mesh-list
101678419|NCT00745875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101678420|NCT00745875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101678421|NCT00745875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678422|NCT00745875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101678423|NCT00745875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101678424|NCT04089813|Metformin|metformin|mesh-list
101678425|NCT04089813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101678426|NCT04089813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678427|NCT00555217|Losartan|losartan|mesh-list
101678428|NCT00555217|Lisinopril|lisinopril|mesh-list
101678429|NCT00555217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101678430|NCT00555217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101678431|NCT00555217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101678432|NCT00555217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101678433|NCT00555217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678434|NCT00555217|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101678435|NCT00555217|Protease Inhibitors|protease inhibitors|mesh-ancestor
101678436|NCT00555217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101678437|NCT00555217|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101678438|NCT00555217|Protective Agents|protective agents|mesh-ancestor
101678439|NCT00555217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678440|NCT02711904|Remifentanil|remifentanil|mesh-list
101678441|NCT02711904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101678442|NCT02711904|Narcotics|narcotics|mesh-ancestor
101678443|NCT02711904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101678444|NCT02711904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678445|NCT02711904|Analgesics|analgesics|mesh-ancestor
101678446|NCT02711904|Sensory System Agents|sensory system agents|mesh-ancestor
101678447|NCT02711904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101678448|NCT05326490|Metformin|metformin|mesh-list
101678449|NCT05326490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101678450|NCT05326490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678451|NCT02693808|Hyaluronic Acid|hyaluronic acid|mesh-list
101678452|NCT02693808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101678453|NCT02693808|Immunologic Factors|immunologic factors|mesh-ancestor
101678454|NCT02693808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678455|NCT02693808|Viscosupplements|viscosupplements|mesh-ancestor
101678456|NCT02693808|Protective Agents|protective agents|mesh-ancestor
101678457|NCT02711982|Methylprednisolone|methylprednisolone|mesh-list
101678458|NCT02711982|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101678459|NCT02711982|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101678460|NCT02711982|Prednisolone|prednisolone|mesh-list
101678461|NCT02711982|Prednisolone acetate|prednisolone acetate|mesh-list
101678462|NCT02711982|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101829236|NCT04645160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101678463|NCT02711982|Prednisolone phosphate|prednisolone phosphate|mesh-list
101678464|NCT02711982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101678465|NCT02711982|Antiemetics|antiemetics|mesh-ancestor
101678466|NCT02711982|Autonomic Agents|autonomic agents|mesh-ancestor
101678467|NCT02711982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101678468|NCT02711982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678469|NCT02711982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101678470|NCT02711982|Glucocorticoids|glucocorticoids|mesh-ancestor
101678471|NCT02711982|Hormones|hormones|mesh-ancestor
101678472|NCT02711982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101678473|NCT02711982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101678474|NCT02711982|Protective Agents|protective agents|mesh-ancestor
101678475|NCT02711982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101678476|NCT02711982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101678477|NCT00745095|Neostigmine|neostigmine|mesh-list
101678478|NCT00745095|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101678479|NCT00745095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101678480|NCT00745095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678481|NCT00745095|Cholinergic Agents|cholinergic agents|mesh-ancestor
101678482|NCT00745095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101678483|NCT00745095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678484|NCT00745095|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101678485|NCT00745095|Autonomic Agents|autonomic agents|mesh-ancestor
101678486|NCT00745095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101678487|NCT05181462|Carboplatin|carboplatin|mesh-list
101678488|NCT05181462|Gemcitabine|gemcitabine|mesh-list
101678489|NCT05181462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101678490|NCT05181462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101678491|NCT05181462|Antimetabolites|antimetabolites|mesh-ancestor
101678492|NCT05181462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678493|NCT00612612|Rituximab|rituximab|mesh-list
101678494|NCT00612612|Fludarabine|fludarabine|mesh-list
101678495|NCT00612612|Fludarabine phosphate|fludarabine phosphate|mesh-list
101678496|NCT00612612|Obatoclax|obatoclax|mesh-list
101678497|NCT00612612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101678498|NCT00612612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101678499|NCT00612612|Immunologic Factors|immunologic factors|mesh-ancestor
101678500|NCT00612612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678501|NCT00612612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101678502|NCT00612612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101678503|NCT00612612|Antimetabolites|antimetabolites|mesh-ancestor
101678504|NCT00612612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678505|NCT00612612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101678506|NCT00612612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101678507|NCT00947713|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101678508|NCT00947713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101678509|NCT00947713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678510|NCT00940693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101678511|NCT00940693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101678512|NCT00940693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101678513|NCT00940693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101678514|NCT00940693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678515|NCT00940693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101678516|NCT00940693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678518|NCT00940693|Sensory System Agents|sensory system agents|mesh-ancestor
101678519|NCT00940693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101678520|NCT00940693|Antidepressive Agents|antidepressive agents|mesh-ancestor
101678521|NCT00940693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101678522|NCT00940693|Dopamine Agents|dopamine agents|mesh-ancestor
101678523|NCT02598063|Lamivudine|lamivudine|mesh-list
101678524|NCT02598063|Adefovir|adefovir|mesh-list
101678525|NCT02598063|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101678526|NCT02598063|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101678527|NCT02598063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101829245|NCT04626518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101678528|NCT02598063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101678529|NCT02598063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101678530|NCT02598063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678531|NCT02598063|Antiviral Agents|antiviral agents|mesh-ancestor
101678532|NCT02598063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101678533|NCT02598063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101678534|NCT02598063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101678535|NCT02707458|Probucol|probucol|mesh-list
101678536|NCT02707458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101678537|NCT02707458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101678538|NCT02707458|Antimetabolites|antimetabolites|mesh-ancestor
101678539|NCT02707458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678540|NCT02707458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101678541|NCT02707458|Antioxidants|antioxidants|mesh-ancestor
101678542|NCT02707458|Protective Agents|protective agents|mesh-ancestor
101678543|NCT02707458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678544|NCT00950677|Exenatide|exenatide|mesh-list
101678545|NCT00950677|Pramlintide|pramlintide|mesh-list
101335825|NCT00052468|Paclitaxel|paclitaxel|mesh-list
101678546|NCT00950677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101678547|NCT00950677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678548|NCT00950677|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101678550|NCT00950677|Hormones|hormones|mesh-ancestor
101678551|NCT00950677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101678552|NCT05174598|Calcitriol|calcitriol|mesh-list
101678553|NCT05174598|Calcipotriene|calcipotriene|mesh-list
101678554|NCT05174598|Dermatologic Agents|dermatologic agents|mesh-ancestor
101678555|NCT05174598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101678556|NCT05174598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678557|NCT05174598|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101678558|NCT05174598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101678559|NCT05174598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678560|NCT05174598|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101678561|NCT05174598|Vitamins|vitamins|mesh-ancestor
101678562|NCT05174598|Micronutrients|micronutrients|mesh-ancestor
101678563|NCT05174598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101678564|NCT05341856|Isosorbide|isosorbide|mesh-list
101678565|NCT05341856|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
101678566|NCT05341856|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
101678567|NCT05341856|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101678568|NCT05341856|Diuretics|diuretics|mesh-ancestor
101678569|NCT05341856|Natriuretic Agents|natriuretic agents|mesh-ancestor
101678570|NCT05341856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678571|NCT05341856|Vasodilator Agents|vasodilator agents|mesh-ancestor
101678572|NCT05341856|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101678573|NCT05341856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678574|NCT00951223|Interferons|interferons|mesh-list
101678575|NCT00951223|Interferon alfacon-1|interferon alfacon-1|mesh-list
101678576|NCT00951223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101678577|NCT00951223|Antiviral Agents|antiviral agents|mesh-ancestor
101678578|NCT00951223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101678579|NCT02711592|Analgesics|analgesics|mesh-list
101678580|NCT02711592|Sensory System Agents|sensory system agents|mesh-ancestor
101678581|NCT02711592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101678582|NCT02711592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678583|NCT00948103|Nitrous Oxide|nitrous oxide|mesh-list
101678584|NCT00948103|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101678585|NCT00948103|Anesthetics, General|anesthetics, general|mesh-ancestor
101678586|NCT00948103|Anesthetics|anesthetics|mesh-ancestor
101678587|NCT00948103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101678588|NCT00948103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678589|NCT00948103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101829254|NCT04626479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101678590|NCT00948103|Analgesics|analgesics|mesh-ancestor
101678591|NCT00948103|Sensory System Agents|sensory system agents|mesh-ancestor
101678592|NCT00948103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101678593|NCT02012114|Cysteamine|cysteamine|mesh-list
101678594|NCT02012114|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
101678595|NCT02012114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678596|NCT05301205|Gabapentin|gabapentin|mesh-list
101678597|NCT05301205|Analgesics|analgesics|mesh-ancestor
101678598|NCT05301205|Sensory System Agents|sensory system agents|mesh-ancestor
101678599|NCT05301205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101678600|NCT05301205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678601|NCT05301205|Anticonvulsants|anticonvulsants|mesh-ancestor
101678602|NCT05301205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101678603|NCT05301205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101678604|NCT05301205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101678605|NCT05301205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101678606|NCT05301205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101678607|NCT05301205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101678608|NCT05301205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101678609|NCT05301205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678610|NCT05301205|Antimanic Agents|antimanic agents|mesh-ancestor
101678611|NCT02707224|Candesartan|candesartan|mesh-list
101678612|NCT02707224|Candesartan cilexetil|candesartan cilexetil|mesh-list
101678613|NCT02707224|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101678614|NCT02707224|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101678615|NCT02707224|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101678616|NCT02707224|Antimetabolites|antimetabolites|mesh-ancestor
101678617|NCT02707224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678618|NCT02707224|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101678619|NCT02707224|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101678620|NCT02707224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101678621|NCT02707224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101678622|NCT02707224|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101678623|NCT02707224|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101678624|NCT04229264|Apixaban|apixaban|mesh-list
101678625|NCT04229264|Clopidogrel|clopidogrel|mesh-list
101678626|NCT04229264|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101678627|NCT04229264|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101678628|NCT04229264|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101678629|NCT04229264|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101678630|NCT04229264|Purinergic Agents|purinergic agents|mesh-ancestor
101678631|NCT04229264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101678632|NCT04229264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678633|NCT04229264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678634|NCT04229264|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101678635|NCT04229264|Antithrombins|antithrombins|mesh-ancestor
101678636|NCT04229264|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101678637|NCT04229264|Protease Inhibitors|protease inhibitors|mesh-ancestor
101678638|NCT04229264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101678639|NCT04229264|Anticoagulants|anticoagulants|mesh-ancestor
101678640|NCT02597829|Certolizumab Pegol|certolizumab pegol|mesh-list
101678641|NCT02597829|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101678642|NCT02597829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101678643|NCT02597829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101678644|NCT02597829|Immunologic Factors|immunologic factors|mesh-ancestor
101678645|NCT02597829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678646|NCT02597829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101678647|NCT02711202|Sirolimus|sirolimus|mesh-list
101678648|NCT02711202|Infliximab|infliximab|mesh-list
101678649|NCT02711202|Alemtuzumab|alemtuzumab|mesh-list
101678650|NCT02711202|Tacrolimus|tacrolimus|mesh-list
101678651|NCT02711202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101678652|NCT02711202|Immunologic Factors|immunologic factors|mesh-ancestor
101678653|NCT02711202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829266|NCT04595370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829267|NCT04595370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101829268|NCT04595370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678654|NCT02711202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101678655|NCT02711202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101678656|NCT02711202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678657|NCT02711202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101678658|NCT02711202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101678659|NCT02711202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101678660|NCT02711202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101678661|NCT02711202|Antifungal Agents|antifungal agents|mesh-ancestor
101678662|NCT02711202|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101678663|NCT02711202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101678664|NCT02711202|Dermatologic Agents|dermatologic agents|mesh-ancestor
101678665|NCT02711202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101678666|NCT02711202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101678667|NCT02711202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101678668|NCT04227938|ALPN-101|alpn-101|mesh-list
101678669|NCT04227938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101678670|NCT04227938|Immunologic Factors|immunologic factors|mesh-ancestor
101678671|NCT04227938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678672|NCT02711358|Indomethacin|indomethacin|mesh-list
101678673|NCT02711358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101678674|NCT02711358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101678675|NCT02711358|Analgesics|analgesics|mesh-ancestor
101678676|NCT02711358|Sensory System Agents|sensory system agents|mesh-ancestor
101678677|NCT02711358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101678678|NCT02711358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678679|NCT02711358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101678680|NCT02711358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101678681|NCT02711358|Gout Suppressants|gout suppressants|mesh-ancestor
101678682|NCT02711358|Tocolytic Agents|tocolytic agents|mesh-ancestor
101678683|NCT02711358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101678684|NCT02711358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101678685|NCT02711358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101678686|NCT02711358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678687|NCT04962152|Nalbuphine|nalbuphine|mesh-list
101678688|NCT04962152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101678689|NCT04962152|Narcotics|narcotics|mesh-ancestor
101678690|NCT04962152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101678691|NCT04962152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678692|NCT04962152|Analgesics|analgesics|mesh-ancestor
101678693|NCT04962152|Sensory System Agents|sensory system agents|mesh-ancestor
101678694|NCT04962152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101335977|NCT00053638|Tenofovir|tenofovir|mesh-list
101678695|NCT00744627|Vortioxetine|vortioxetine|mesh-list
101678696|NCT00744627|Antidepressive Agents|antidepressive agents|mesh-ancestor
101678697|NCT00744627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101678698|NCT00744627|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101678699|NCT00744627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101678700|NCT00744627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101678701|NCT00744627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678702|NCT00744627|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101678703|NCT00744627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101678704|NCT00744627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101678705|NCT00744627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678706|NCT00744627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101678707|NCT00744627|Serotonin Agents|serotonin agents|mesh-ancestor
101678708|NCT00744627|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101678709|NCT00744627|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101678710|NCT00744627|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101678711|NCT00744627|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101678713|NCT04942886|Antiviral Agents|antiviral agents|mesh-ancestor
101678714|NCT04942886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101678715|NCT00951847|Oxcarbazepine|oxcarbazepine|mesh-list
101829282|NCT04543942|Ethanol|ethanol|mesh-list
101829283|NCT04543942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101829284|NCT04543942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101829285|NCT04543942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101829286|NCT04543942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678716|NCT00951847|Anticonvulsants|anticonvulsants|mesh-ancestor
101678717|NCT00951847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101678718|NCT00951847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101678719|NCT00951847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101678720|NCT00951847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678721|NCT00951847|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101678722|NCT00951847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101678723|NCT02711280|Propofol|propofol|mesh-list
101678724|NCT02711280|Sevoflurane|sevoflurane|mesh-list
101678725|NCT02711280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101678726|NCT02711280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101678727|NCT02711280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678728|NCT02711280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101678729|NCT02711280|Anesthetics, General|anesthetics, general|mesh-ancestor
101678730|NCT02711280|Anesthetics|anesthetics|mesh-ancestor
101678731|NCT02711280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101678732|NCT02711280|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101678733|NCT00948493|Insulin|insulin|mesh-list
101678734|NCT00948493|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101678735|NCT00948493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101678736|NCT00948493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678737|NCT00952003|Bevacizumab|bevacizumab|mesh-list
101678738|NCT00952003|Docetaxel|docetaxel|mesh-list
101678739|NCT00952003|Oxaliplatin|oxaliplatin|mesh-list
101678740|NCT00952003|Irinotecan|irinotecan|mesh-list
101678741|NCT00952003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101678742|NCT00952003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101678743|NCT00952003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101678744|NCT00952003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101678745|NCT00952003|Growth Substances|growth substances|mesh-ancestor
101678746|NCT00952003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678747|NCT00952003|Growth Inhibitors|growth inhibitors|mesh-ancestor
101678748|NCT00952003|Tubulin Modulators|tubulin modulators|mesh-ancestor
101678749|NCT00952003|Antimitotic Agents|antimitotic agents|mesh-ancestor
101678750|NCT00952003|Mitosis Modulators|mitosis modulators|mesh-ancestor
101678751|NCT00952003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678752|NCT00952003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101678753|NCT00952003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101678754|NCT00952003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101678755|NCT00612144|Metformin|metformin|mesh-list
101678756|NCT00612144|Glimepiride|glimepiride|mesh-list
101678757|NCT00612144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101678758|NCT00612144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678759|NCT00612144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101678760|NCT00612144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101678761|NCT00612144|Immunologic Factors|immunologic factors|mesh-ancestor
101678762|NCT02597361|Irbesartan|irbesartan|mesh-list
101678763|NCT02597361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101678764|NCT02597361|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101678765|NCT02597361|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101678766|NCT02597361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678767|NCT00562627|Ketorolac|ketorolac|mesh-list
101678768|NCT00562627|Epinephrine|epinephrine|mesh-list
101678769|NCT00562627|Racepinephrine|racepinephrine|mesh-list
101678770|NCT00562627|Fentanyl|fentanyl|mesh-list
101678771|NCT00562627|Morphine|morphine|mesh-list
101678772|NCT00562627|Bupivacaine|bupivacaine|mesh-list
101678773|NCT00562627|Ropivacaine|ropivacaine|mesh-list
101678774|NCT00562627|Epinephryl borate|epinephryl borate|mesh-list
101678775|NCT00562627|Anesthetics, Local|anesthetics, local|mesh-ancestor
101829289|NCT04534153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101678776|NCT00562627|Anesthetics|anesthetics|mesh-ancestor
101678777|NCT00562627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101678778|NCT00562627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678779|NCT00562627|Sensory System Agents|sensory system agents|mesh-ancestor
101678780|NCT00562627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101678781|NCT00562627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101678782|NCT00562627|Narcotics|narcotics|mesh-ancestor
101678783|NCT00562627|Analgesics|analgesics|mesh-ancestor
101678784|NCT00562627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101678785|NCT00562627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101678786|NCT00562627|Anesthetics, General|anesthetics, general|mesh-ancestor
101678787|NCT00562627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101678788|NCT00562627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101678789|NCT00562627|Adrenergic Agents|adrenergic agents|mesh-ancestor
101678790|NCT00562627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101678791|NCT00562627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678792|NCT00562627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101678793|NCT00562627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101678794|NCT00562627|Autonomic Agents|autonomic agents|mesh-ancestor
101678795|NCT00562627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101678796|NCT00562627|Respiratory System Agents|respiratory system agents|mesh-ancestor
101678797|NCT00562627|Mydriatics|mydriatics|mesh-ancestor
101678798|NCT00562627|Sympathomimetics|sympathomimetics|mesh-ancestor
101678799|NCT00562627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101678800|NCT00562627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101678801|NCT00562627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101678802|NCT00562627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101678803|NCT00562627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101678804|NCT00562627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101678805|NCT00562627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101678806|NCT02597283|Sirolimus|sirolimus|mesh-list
101678807|NCT02597283|Temsirolimus|temsirolimus|mesh-list
101678808|NCT02597283|MTOR Inhibitors|mtor inhibitors|mesh-list
101678809|NCT02597283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101678810|NCT02597283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101678811|NCT02597283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101678812|NCT02597283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101678813|NCT02597283|Antifungal Agents|antifungal agents|mesh-ancestor
101678814|NCT02597283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101678815|NCT02597283|Immunologic Factors|immunologic factors|mesh-ancestor
101678816|NCT02597283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678817|NCT02597283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101678818|NCT02597283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101678819|NCT02597283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678820|NCT00948649|Varenicline|varenicline|mesh-list
101678821|NCT00948649|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101678822|NCT00948649|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101678823|NCT00948649|Cholinergic Agents|cholinergic agents|mesh-ancestor
101678824|NCT00948649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101678825|NCT00948649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678826|NCT00948649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678827|NCT00952159|Tramadol|tramadol|mesh-list
101678828|NCT00952159|O-demethyltramadol|o-demethyltramadol|mesh-list
101678829|NCT00952159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101678830|NCT00952159|Narcotics|narcotics|mesh-ancestor
101678831|NCT00952159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101678832|NCT00952159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678833|NCT00952159|Analgesics|analgesics|mesh-ancestor
101678834|NCT00952159|Sensory System Agents|sensory system agents|mesh-ancestor
101678835|NCT00952159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101678836|NCT00948727|Cyclosporine|cyclosporine|mesh-list
101678837|NCT00948727|Cyclosporins|cyclosporins|mesh-list
101678838|NCT00948727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101678839|NCT00948727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678840|NCT00948727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101678841|NCT00948727|Immunologic Factors|immunologic factors|mesh-ancestor
101678842|NCT00948727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678843|NCT00948727|Antifungal Agents|antifungal agents|mesh-ancestor
101678844|NCT00948727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101678845|NCT00948727|Dermatologic Agents|dermatologic agents|mesh-ancestor
101336094|NCT00054340|Antimetabolites|antimetabolites|mesh-ancestor
101678846|NCT00948727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101678847|NCT00948727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101678849|NCT02778776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101678850|NCT02778776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678851|NCT00948805|Goserelin|goserelin|mesh-list
101678852|NCT00948805|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101678853|NCT00948805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101678854|NCT00948805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101678855|NCT00948805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101678856|NCT00948805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678857|NCT02710656|Paclitaxel|paclitaxel|mesh-list
101678858|NCT02710656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101678859|NCT02710656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101678860|NCT02710656|Tubulin Modulators|tubulin modulators|mesh-ancestor
101678861|NCT02710656|Antimitotic Agents|antimitotic agents|mesh-ancestor
101678862|NCT02710656|Mitosis Modulators|mitosis modulators|mesh-ancestor
101678863|NCT02710656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678864|NCT02780882|Pasireotide|pasireotide|mesh-list
101678865|NCT02780882|Hormones|hormones|mesh-ancestor
101678866|NCT02780882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101678867|NCT02780882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678868|NCT02710266|Gabexate|gabexate|mesh-list
101678869|NCT02710266|Anticoagulants|anticoagulants|mesh-ancestor
101678870|NCT02710266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101678871|NCT02710266|Protease Inhibitors|protease inhibitors|mesh-ancestor
101678872|NCT02710266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101678873|NCT02710266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678874|NCT00562159|Fluticasone|fluticasone|mesh-list
101678875|NCT00562159|Xhance|xhance|mesh-list
101678876|NCT00562159|Mometasone Furoate|mometasone furoate|mesh-list
101678877|NCT00562159|Loratadine|loratadine|mesh-list
101678878|NCT00562159|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
101678879|NCT00562159|Prednisone|prednisone|mesh-list
101678880|NCT00562159|Albuterol|albuterol|mesh-list
101678881|NCT00562159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101678882|NCT00562159|Glucocorticoids|glucocorticoids|mesh-ancestor
101678883|NCT00562159|Hormones|hormones|mesh-ancestor
101678884|NCT00562159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101678885|NCT00562159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678886|NCT00562159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101678887|NCT00562159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101678888|NCT00562159|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101678889|NCT00562159|Autonomic Agents|autonomic agents|mesh-ancestor
101678890|NCT00562159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101678891|NCT00562159|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101678892|NCT00562159|Respiratory System Agents|respiratory system agents|mesh-ancestor
101678893|NCT00562159|Dermatologic Agents|dermatologic agents|mesh-ancestor
101678894|NCT00562159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101678895|NCT00562159|Tocolytic Agents|tocolytic agents|mesh-ancestor
101678896|NCT00562159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101678897|NCT00562159|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101678898|NCT00562159|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101678899|NCT00562159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101678900|NCT00562159|Adrenergic Agents|adrenergic agents|mesh-ancestor
101678901|NCT00562159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101678902|NCT00562159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678903|NCT00562159|Antipruritics|antipruritics|mesh-ancestor
101678904|NCT00562159|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101678905|NCT00562159|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101829317|NCT04530565|Mesna|mesna|mesh-list
101829318|NCT04530565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101678906|NCT00562159|Histamine Antagonists|histamine antagonists|mesh-ancestor
101678907|NCT00562159|Histamine Agents|histamine agents|mesh-ancestor
101678908|NCT00562159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101678909|NCT00562159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101678910|NCT00562159|Analgesics|analgesics|mesh-ancestor
101678911|NCT00562159|Sensory System Agents|sensory system agents|mesh-ancestor
101678912|NCT00562159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101678913|NCT02710110|Capsaicin|capsaicin|mesh-list
101678914|NCT02710110|Antipruritics|antipruritics|mesh-ancestor
101678915|NCT02710110|Dermatologic Agents|dermatologic agents|mesh-ancestor
101678916|NCT02710110|Sensory System Agents|sensory system agents|mesh-ancestor
101678917|NCT02710110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101678918|NCT02710110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678919|NCT00952627|Pycnogenols|pycnogenols|mesh-list
101678920|NCT00952627|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101678921|NCT00952627|Immunologic Factors|immunologic factors|mesh-ancestor
101678922|NCT00952627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678923|NCT00952627|Antioxidants|antioxidants|mesh-ancestor
101678924|NCT00952627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678925|NCT00952627|Protective Agents|protective agents|mesh-ancestor
101678926|NCT00952627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101678927|NCT00611676|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101678928|NCT00611676|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101678929|NCT00611676|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101678930|NCT00611676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101678931|NCT00611676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678932|NCT00611676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101678933|NCT00611676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678934|NCT00611676|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101678935|NCT00611676|Antidepressive Agents|antidepressive agents|mesh-ancestor
101678936|NCT00611676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101678937|NCT04848714|Antivenins|antivenins|mesh-list
101678938|NCT04848714|Immunologic Factors|immunologic factors|mesh-ancestor
101678939|NCT04848714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678940|NCT00952861|Doxycycline|doxycycline|mesh-list
101678941|NCT00952861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101678942|NCT00952861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101678943|NCT00952861|Antimalarials|antimalarials|mesh-ancestor
101678944|NCT00952861|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101678945|NCT00952861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101678946|NCT05137730|Parathyroid Hormone|parathyroid hormone|mesh-list
101678947|NCT05137730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678948|NCT05137730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101678949|NCT04889066|Durvalumab|durvalumab|mesh-list
101678950|NCT04889066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101678951|NCT04889066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101678952|NCT04223778|Islatravir|islatravir|mesh-list
101678953|NCT04223778|Antiviral Agents|antiviral agents|mesh-ancestor
101678954|NCT04223778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101678955|NCT04223778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101678956|NCT04223778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678957|NCT04223778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101678958|NCT04223778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101678959|NCT04223778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101678960|NCT05109416|Bupivacaine|bupivacaine|mesh-list
101678961|NCT05109416|Anesthetics, Local|anesthetics, local|mesh-ancestor
101678962|NCT05109416|Anesthetics|anesthetics|mesh-ancestor
101678963|NCT05109416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101678964|NCT05109416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678965|NCT05109416|Sensory System Agents|sensory system agents|mesh-ancestor
101678966|NCT05109416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101678967|NCT04074564|Apatinib|apatinib|mesh-list
101678968|NCT04074564|Antibodies|antibodies|mesh-list
101678969|NCT04074564|Immunologic Factors|immunologic factors|mesh-ancestor
101678970|NCT04074564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678971|NCT04074564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101678972|NCT04074564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101678973|NCT04074564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101678974|NCT04074564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678975|NCT02778308|Gemcitabine|gemcitabine|mesh-list
101678976|NCT02778308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101678977|NCT02778308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101678978|NCT02778308|Antimetabolites|antimetabolites|mesh-ancestor
101678979|NCT02778308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678980|NCT02776202|Mycophenolic Acid|mycophenolic acid|mesh-list
101678981|NCT02776202|Sirolimus|sirolimus|mesh-list
101678982|NCT02776202|Fludarabine|fludarabine|mesh-list
101678983|NCT02776202|Fludarabine phosphate|fludarabine phosphate|mesh-list
101678984|NCT02776202|Melphalan|melphalan|mesh-list
101678985|NCT02776202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101678986|NCT02776202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101678987|NCT02776202|Antimetabolites|antimetabolites|mesh-ancestor
101678988|NCT02776202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101678989|NCT02776202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101678990|NCT02776202|Immunologic Factors|immunologic factors|mesh-ancestor
101678991|NCT02776202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101678992|NCT02776202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101678993|NCT02776202|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101678994|NCT02776202|Antitubercular Agents|antitubercular agents|mesh-ancestor
101678995|NCT02776202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101336246|NCT00055159|Plasminogen|plasminogen|mesh-list
101678996|NCT02776202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101678997|NCT02776202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101678998|NCT02776202|Antifungal Agents|antifungal agents|mesh-ancestor
101678999|NCT02776202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101679000|NCT02776202|Alkylating Agents|alkylating agents|mesh-ancestor
101679001|NCT02776202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101679002|NCT00921557|Vitamin D|vitamin d|mesh-list
101679003|NCT00921557|Alendronate|alendronate|mesh-list
101679004|NCT00921557|Calcium Carbonate|calcium carbonate|mesh-list
101679005|NCT00921557|Calcium|calcium|mesh-list
101679006|NCT00921557|Vitamins|vitamins|mesh-ancestor
101679007|NCT00921557|Micronutrients|micronutrients|mesh-ancestor
101679008|NCT00921557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679009|NCT00921557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101679010|NCT00921557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101679011|NCT00921557|Antacids|antacids|mesh-ancestor
101679012|NCT00921557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679013|NCT00921557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101679014|NCT00611754|Fluorouracil|fluorouracil|mesh-list
101679015|NCT00611754|Oxaliplatin|oxaliplatin|mesh-list
101679016|NCT00611754|Antimetabolites|antimetabolites|mesh-ancestor
101679017|NCT00611754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679018|NCT00611754|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101679019|NCT00611754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101679020|NCT00611754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101679021|NCT00611754|Immunologic Factors|immunologic factors|mesh-ancestor
101679022|NCT00611754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679023|NCT00550615|Dasatinib|dasatinib|mesh-list
101679024|NCT00550615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101679025|NCT00550615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101679026|NCT00550615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101829339|NCT04530565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101679027|NCT00550615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679029|NCT02709720|Vinorelbine|vinorelbine|mesh-list
101679030|NCT02709720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101679031|NCT02709720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101679032|NCT02709720|Tubulin Modulators|tubulin modulators|mesh-ancestor
101679033|NCT02709720|Antimitotic Agents|antimitotic agents|mesh-ancestor
101679034|NCT02709720|Mitosis Modulators|mitosis modulators|mesh-ancestor
101679035|NCT02709720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679036|NCT02779634|Coenzyme Q10|coenzyme q10|mesh-list
101679037|NCT02779634|Micronutrients|micronutrients|mesh-ancestor
101679038|NCT02779634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679039|NCT02779634|Vitamins|vitamins|mesh-ancestor
101679040|NCT04255589|Ethanol|ethanol|mesh-list
101679041|NCT04255589|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101679042|NCT04255589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101679043|NCT04255589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101679044|NCT04255589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679045|NCT00744471|Tanezumab|tanezumab|mesh-list
101679046|NCT00744471|Analgesics|analgesics|mesh-ancestor
101679047|NCT00744471|Sensory System Agents|sensory system agents|mesh-ancestor
101679048|NCT00744471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101679049|NCT00744471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679050|NCT02776436|Dexamethasone|dexamethasone|mesh-list
101679051|NCT02776436|Prednisone|prednisone|mesh-list
101679052|NCT02776436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101679053|NCT02776436|Antiemetics|antiemetics|mesh-ancestor
101679054|NCT02776436|Autonomic Agents|autonomic agents|mesh-ancestor
101679055|NCT02776436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101679056|NCT02776436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679057|NCT02776436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101679058|NCT02776436|Glucocorticoids|glucocorticoids|mesh-ancestor
101679059|NCT02776436|Hormones|hormones|mesh-ancestor
101679060|NCT02776436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101679061|NCT02776436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101679062|NCT02776436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101679063|NCT02775968|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101679064|NCT02775968|Azithromycin|azithromycin|mesh-list
101679065|NCT02775968|Ceftriaxone|ceftriaxone|mesh-list
101679066|NCT02775968|Erythromycin|erythromycin|mesh-list
101679067|NCT02775968|Cephalosporins|cephalosporins|mesh-list
101679069|NCT02775968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101679070|NCT02775968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101679071|NCT02775968|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101336323|NCT00055822|Antidotes|antidotes|mesh-ancestor
101679072|NCT02775968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101679073|NCT02775968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679075|NCT02775734|Clomiphene|clomiphene|mesh-list
101679076|NCT02775734|Enclomiphene|enclomiphene|mesh-list
101679077|NCT02775734|Zuclomiphene|zuclomiphene|mesh-list
101679078|NCT02775734|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101679079|NCT02775734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679080|NCT02775734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101679081|NCT02775734|Hormone Antagonists|hormone antagonists|mesh-ancestor
101679082|NCT02775734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101679083|NCT02775734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679084|NCT02775734|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101679085|NCT02775734|Fertility Agents|fertility agents|mesh-ancestor
101679086|NCT02775734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101679087|NCT02775734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101679088|NCT02775734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101679089|NCT02775734|Antiviral Agents|antiviral agents|mesh-ancestor
101679090|NCT02775734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101679091|NCT02775734|Expectorants|expectorants|mesh-ancestor
101679092|NCT02775734|Respiratory System Agents|respiratory system agents|mesh-ancestor
101679093|NCT02775734|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101679094|NCT02775734|Antioxidants|antioxidants|mesh-ancestor
101679095|NCT02775734|Protective Agents|protective agents|mesh-ancestor
101679096|NCT02775734|Antidotes|antidotes|mesh-ancestor
101679097|NCT02772926|Benphothiamine|benphothiamine|mesh-list
101679098|NCT02772926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101679099|NCT02772926|Immunologic Factors|immunologic factors|mesh-ancestor
101679100|NCT02772926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679101|NCT02772926|Chelating Agents|chelating agents|mesh-ancestor
101679102|NCT02772926|Sequestering Agents|sequestering agents|mesh-ancestor
101679103|NCT02772926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679104|NCT02709564|Misoprostol|misoprostol|mesh-list
101679105|NCT02709564|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101679106|NCT02709564|Abortifacient Agents|abortifacient agents|mesh-ancestor
101679107|NCT02709564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101679108|NCT02709564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679109|NCT02709564|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101679110|NCT02709564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101679111|NCT02709564|Oxytocics|oxytocics|mesh-ancestor
101679112|NCT04688814|Morphine|morphine|mesh-list
101679113|NCT04688814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101679114|NCT04688814|Narcotics|narcotics|mesh-ancestor
101679115|NCT04688814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101679116|NCT04688814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679117|NCT04688814|Analgesics|analgesics|mesh-ancestor
101679118|NCT04688814|Sensory System Agents|sensory system agents|mesh-ancestor
101679119|NCT04688814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101679120|NCT00744237|Metoprolol|metoprolol|mesh-list
101679121|NCT00744237|Nebivolol|nebivolol|mesh-list
101679122|NCT00744237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101679123|NCT00744237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101679124|NCT00744237|Sympatholytics|sympatholytics|mesh-ancestor
101679125|NCT00744237|Autonomic Agents|autonomic agents|mesh-ancestor
101679126|NCT00744237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101679127|NCT00744237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679128|NCT00744237|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101679129|NCT00744237|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101679130|NCT00744237|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101679131|NCT00744237|Adrenergic Agents|adrenergic agents|mesh-ancestor
101679132|NCT00744237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101679133|NCT00744237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679134|NCT00744237|Vasodilator Agents|vasodilator agents|mesh-ancestor
101679135|NCT00744237|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101679136|NCT00744237|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101679137|NCT00744237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101679138|NCT04821284|Leucovorin|leucovorin|mesh-list
101679139|NCT04821284|Paclitaxel|paclitaxel|mesh-list
101679140|NCT04821284|Gemcitabine|gemcitabine|mesh-list
101679141|NCT04821284|Fluorouracil|fluorouracil|mesh-list
101679142|NCT04821284|Oxaliplatin|oxaliplatin|mesh-list
101679143|NCT04821284|Irinotecan|irinotecan|mesh-list
101679144|NCT04821284|Calcium|calcium|mesh-list
101679145|NCT04821284|Levoleucovorin|levoleucovorin|mesh-list
101679146|NCT04821284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101679147|NCT04821284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101679148|NCT04821284|Tubulin Modulators|tubulin modulators|mesh-ancestor
101679149|NCT04821284|Antimitotic Agents|antimitotic agents|mesh-ancestor
101679150|NCT04821284|Mitosis Modulators|mitosis modulators|mesh-ancestor
101679151|NCT04821284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679152|NCT04821284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101679153|NCT04821284|Antimetabolites|antimetabolites|mesh-ancestor
101679154|NCT04821284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101679155|NCT04821284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679156|NCT04821284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101679157|NCT04821284|Immunologic Factors|immunologic factors|mesh-ancestor
101679158|NCT04821284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101679159|NCT04821284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101679160|NCT04821284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101679161|NCT04821284|Antidotes|antidotes|mesh-ancestor
101679162|NCT04821284|Protective Agents|protective agents|mesh-ancestor
101679163|NCT04821284|Vitamin B Complex|vitamin b complex|mesh-ancestor
101679164|NCT04821284|Vitamins|vitamins|mesh-ancestor
101679165|NCT04821284|Micronutrients|micronutrients|mesh-ancestor
101679166|NCT05260554|Fosfomycin|fosfomycin|mesh-list
101679167|NCT05260554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101679168|NCT05260554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101679169|NCT04089345|Ustekinumab|ustekinumab|mesh-list
101679170|NCT04089345|Dermatologic Agents|dermatologic agents|mesh-ancestor
101679171|NCT02693574|Amoxicillin|amoxicillin|mesh-list
101679172|NCT02693574|Clarithromycin|clarithromycin|mesh-list
101679173|NCT02693574|Levofloxacin|levofloxacin|mesh-list
101679174|NCT02693574|Esomeprazole|esomeprazole|mesh-list
101679175|NCT02693574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101679176|NCT02693574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101679177|NCT02693574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101679178|NCT02693574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101679179|NCT02693574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101679180|NCT02693574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101679181|NCT02693574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679182|NCT02693574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101679183|NCT02693574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101679184|NCT02693574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101679185|NCT02693574|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101679186|NCT02693574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101679187|NCT02693574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101679188|NCT02693574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101679189|NCT02693574|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101679190|NCT04179266|Ketamine|ketamine|mesh-list
101679191|NCT04179266|Analgesics|analgesics|mesh-ancestor
101679192|NCT04179266|Sensory System Agents|sensory system agents|mesh-ancestor
101679193|NCT04179266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101679194|NCT04179266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679195|NCT04179266|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101679196|NCT04179266|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101679197|NCT04179266|Anesthetics, General|anesthetics, general|mesh-ancestor
101679198|NCT04179266|Anesthetics|anesthetics|mesh-ancestor
101679199|NCT04179266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101679200|NCT04179266|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101679201|NCT04179266|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101679202|NCT04179266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101679203|NCT04179266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679204|NCT00743145|Naltrexone|naltrexone|mesh-list
101679205|NCT00743145|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101679206|NCT00743145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101679207|NCT00743145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679208|NCT00743145|Sensory System Agents|sensory system agents|mesh-ancestor
101679209|NCT00743145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101679210|NCT04875728|Cefazolin|cefazolin|mesh-list
101679211|NCT04875728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101679212|NCT04875728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101679213|NCT00611910|Sirolimus|sirolimus|mesh-list
101679214|NCT00611910|Paclitaxel|paclitaxel|mesh-list
101679215|NCT00611910|Temsirolimus|temsirolimus|mesh-list
101679216|NCT00611910|MTOR Inhibitors|mtor inhibitors|mesh-list
101679217|NCT00611910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101679218|NCT00611910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101679219|NCT00611910|Tubulin Modulators|tubulin modulators|mesh-ancestor
101679220|NCT00611910|Antimitotic Agents|antimitotic agents|mesh-ancestor
101679221|NCT00611910|Mitosis Modulators|mitosis modulators|mesh-ancestor
101679222|NCT00611910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679223|NCT00611910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101679224|NCT00611910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101679225|NCT00611910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101679226|NCT00611910|Antifungal Agents|antifungal agents|mesh-ancestor
101679227|NCT00611910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101679228|NCT00611910|Immunologic Factors|immunologic factors|mesh-ancestor
101679229|NCT00611910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679230|NCT00611910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101679231|NCT00611910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101679232|NCT00920855|Bortezomib|bortezomib|mesh-list
101679233|NCT00920855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101679234|NCT00920855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101679235|NCT00920855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101679236|NCT00920855|Alkylating Agents|alkylating agents|mesh-ancestor
101679237|NCT00920855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679238|NCT04251845|Melatonin|melatonin|mesh-list
101679239|NCT04251845|Antioxidants|antioxidants|mesh-ancestor
101679240|NCT04251845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679241|NCT04251845|Protective Agents|protective agents|mesh-ancestor
101679242|NCT04251845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679243|NCT04251845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101679244|NCT05207358|Mycophenolic Acid|mycophenolic acid|mesh-list
101679245|NCT05207358|Cyclophosphamide|cyclophosphamide|mesh-list
101679246|NCT05207358|Rituximab|rituximab|mesh-list
101679247|NCT05207358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101679248|NCT05207358|Immunologic Factors|immunologic factors|mesh-ancestor
101679249|NCT05207358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679250|NCT05207358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101679251|NCT05207358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101679252|NCT05207358|Alkylating Agents|alkylating agents|mesh-ancestor
101679253|NCT05207358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679254|NCT05207358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101679255|NCT05207358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101679256|NCT05207358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101679257|NCT05207358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101679258|NCT05207358|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101679259|NCT05207358|Antitubercular Agents|antitubercular agents|mesh-ancestor
101679260|NCT05207358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101679261|NCT05207358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101679262|NCT05207358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101679263|NCT04256993|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
101679264|NCT04256993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101679266|NCT05387031|Dermatologic Agents|dermatologic agents|mesh-ancestor
101679267|NCT04570644|Cromolyn Sodium|cromolyn sodium|mesh-list
101679268|NCT04570644|Ibuprofen|ibuprofen|mesh-list
101679269|NCT04570644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101679270|NCT04570644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101679271|NCT04570644|Analgesics|analgesics|mesh-ancestor
101679272|NCT04570644|Sensory System Agents|sensory system agents|mesh-ancestor
101679273|NCT04570644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101679274|NCT04570644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679275|NCT04570644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101679276|NCT04570644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101679277|NCT04570644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101679278|NCT04570644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101679279|NCT04570644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679280|NCT04570644|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
101679281|NCT04570644|Immunologic Factors|immunologic factors|mesh-ancestor
101679282|NCT04570644|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101679283|NCT04570644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101679284|NCT04570644|Respiratory System Agents|respiratory system agents|mesh-ancestor
101679285|NCT02775110|Natalizumab|natalizumab|mesh-list
101679286|NCT02775110|Immunologic Factors|immunologic factors|mesh-ancestor
101679287|NCT02775110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679288|NCT02775266|Thioctic Acid|thioctic acid|mesh-list
101679289|NCT02775266|Antioxidants|antioxidants|mesh-ancestor
101679290|NCT02775266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679291|NCT02775266|Protective Agents|protective agents|mesh-ancestor
101679292|NCT02775266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679293|NCT02775266|Vitamin B Complex|vitamin b complex|mesh-ancestor
101679294|NCT02775266|Vitamins|vitamins|mesh-ancestor
101679295|NCT02775266|Micronutrients|micronutrients|mesh-ancestor
101679296|NCT01524926|Crizotinib|crizotinib|mesh-list
101679297|NCT01524926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101679298|NCT01524926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101679299|NCT01524926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101679300|NCT01524926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679301|NCT03738228|Cisplatin|cisplatin|mesh-list
101679302|NCT03738228|Atezolizumab|atezolizumab|mesh-list
101679303|NCT03738228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101679304|NCT03738228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101679305|NCT03738228|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101679306|NCT03738228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679307|NCT03738228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101679308|NCT03738228|Immunologic Factors|immunologic factors|mesh-ancestor
101679309|NCT03738228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679310|NCT04756232|Mecamylamine|mecamylamine|mesh-list
101679311|NCT04756232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101679312|NCT04756232|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
101679313|NCT04756232|Autonomic Agents|autonomic agents|mesh-ancestor
101679314|NCT04756232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101679315|NCT04756232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679316|NCT04756232|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101679317|NCT04756232|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101679318|NCT04756232|Cholinergic Agents|cholinergic agents|mesh-ancestor
101679319|NCT04756232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101679320|NCT04756232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679321|NCT02774876|Insulin|insulin|mesh-list
101679322|NCT02774876|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101679323|NCT02774876|Hormones|hormones|mesh-list
101679324|NCT02774876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101679325|NCT02774876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679326|NCT02774876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101679327|NCT04225364|Paclitaxel|paclitaxel|mesh-list
101679328|NCT04225364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101679329|NCT04225364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101679330|NCT04225364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101679331|NCT04225364|Tubulin Modulators|tubulin modulators|mesh-ancestor
101679332|NCT04225364|Antimitotic Agents|antimitotic agents|mesh-ancestor
101679333|NCT04225364|Mitosis Modulators|mitosis modulators|mesh-ancestor
101679334|NCT04225364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679335|NCT02771834|Vitamin D|vitamin d|mesh-list
101679336|NCT02771834|Vitamins|vitamins|mesh-ancestor
101679337|NCT02771834|Micronutrients|micronutrients|mesh-ancestor
101679338|NCT02771834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829444|NCT04336098|Gemcitabine|gemcitabine|mesh-list
101679339|NCT02771834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101679340|NCT02774564|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101679341|NCT02774564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101679342|NCT02774564|Immunologic Factors|immunologic factors|mesh-ancestor
101679343|NCT02774564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679344|NCT02774564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101679345|NCT02774564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101679346|NCT02774564|Dopamine Agonists|dopamine agonists|mesh-ancestor
101679347|NCT02774564|Dopamine Agents|dopamine agents|mesh-ancestor
101679348|NCT02774564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101679349|NCT02774564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679351|NCT00613470|Escitalopram|escitalopram|mesh-list
101679352|NCT00613470|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101679353|NCT00613470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101679354|NCT00613470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101679355|NCT00613470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679356|NCT00613470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101679357|NCT00613470|Serotonin Agents|serotonin agents|mesh-ancestor
101679358|NCT00613470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679359|NCT00613470|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101679360|NCT00613470|Antidepressive Agents|antidepressive agents|mesh-ancestor
101679361|NCT00613470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101679362|NCT02771912|Propofol|propofol|mesh-list
101679363|NCT02771912|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101679364|NCT02771912|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101679365|NCT02771912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101679366|NCT02771912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679367|NCT02771912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101679368|NCT02771912|Anesthetics, General|anesthetics, general|mesh-ancestor
101679369|NCT02771912|Anesthetics|anesthetics|mesh-ancestor
101679370|NCT02771912|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101679371|NCT02771912|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101679372|NCT02771912|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101679373|NCT00741819|Treprostinil|treprostinil|mesh-list
101679374|NCT00741819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101679375|NCT04457466|Mitogens|mitogens|mesh-list
101679376|NCT04457466|Mitosis Modulators|mitosis modulators|mesh-ancestor
101679377|NCT04457466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679378|NCT04954742|Riociguat|riociguat|mesh-list
101679379|NCT04954742|Enzyme Activators|enzyme activators|mesh-ancestor
101679380|NCT04954742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679381|NCT04193696|Immunomodulating Agents|immunomodulating agents|mesh-list
101679382|NCT04193696|Immunologic Factors|immunologic factors|mesh-ancestor
101679383|NCT04193696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679384|NCT02774096|Xenon|xenon|mesh-list
101679385|NCT02774096|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101679386|NCT02774096|Anesthetics, General|anesthetics, general|mesh-ancestor
101679387|NCT02774096|Anesthetics|anesthetics|mesh-ancestor
101679388|NCT02774096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101679389|NCT02774096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679390|NCT04181385|Bromocriptine|bromocriptine|mesh-list
101679391|NCT04181385|Olanzapine|olanzapine|mesh-list
101679392|NCT04181385|Antiemetics|antiemetics|mesh-ancestor
101679393|NCT04181385|Autonomic Agents|autonomic agents|mesh-ancestor
101679394|NCT04181385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101679395|NCT04181385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679396|NCT04181385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101679397|NCT04181385|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101679398|NCT04181385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101679399|NCT04181385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101829455|NCT04336098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101679400|NCT04181385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101679401|NCT04181385|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101679402|NCT04181385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101679403|NCT04181385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101679404|NCT04181385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679405|NCT04181385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101679406|NCT04181385|Serotonin Agents|serotonin agents|mesh-ancestor
101679407|NCT04181385|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101679408|NCT04181385|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101679409|NCT04181385|Hormone Antagonists|hormone antagonists|mesh-ancestor
101679410|NCT04181385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101679411|NCT04181385|Dopamine Agonists|dopamine agonists|mesh-ancestor
101679412|NCT04181385|Dopamine Agents|dopamine agents|mesh-ancestor
101679414|NCT00924443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101679415|NCT00924443|Antimetabolites|antimetabolites|mesh-ancestor
101679416|NCT00924443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679417|NCT00924443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101679418|NCT02677155|Rituximab|rituximab|mesh-list
101679419|NCT02677155|Pembrolizumab|pembrolizumab|mesh-list
101679420|NCT02677155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101679421|NCT02677155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101679422|NCT02677155|Immunologic Factors|immunologic factors|mesh-ancestor
101679423|NCT02677155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679424|NCT02677155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101679425|NCT02677155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101679426|NCT02677155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679427|NCT02537691|Theophylline|theophylline|mesh-list
101679428|NCT02537691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101679429|NCT02537691|Autonomic Agents|autonomic agents|mesh-ancestor
101679430|NCT02537691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101679431|NCT02537691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679432|NCT02537691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101679433|NCT02537691|Respiratory System Agents|respiratory system agents|mesh-ancestor
101679434|NCT02537691|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101679435|NCT02537691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101679436|NCT02537691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679437|NCT02537691|Vasodilator Agents|vasodilator agents|mesh-ancestor
101679438|NCT02537691|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101679439|NCT02537691|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101679440|NCT02537691|Purinergic Agents|purinergic agents|mesh-ancestor
101679441|NCT02537691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101679442|NCT04225052|Varenicline|varenicline|mesh-list
101679443|NCT04225052|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101679444|NCT04225052|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101679445|NCT04225052|Cholinergic Agents|cholinergic agents|mesh-ancestor
101679446|NCT04225052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101679447|NCT04225052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336694|NCT00058435|Abagovomab|abagovomab|mesh-list
101679448|NCT04225052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679449|NCT04255121|Lidocaine|lidocaine|mesh-list
101679450|NCT04255121|Epinephrine|epinephrine|mesh-list
101679451|NCT04255121|Racepinephrine|racepinephrine|mesh-list
101679452|NCT04255121|Epinephryl borate|epinephryl borate|mesh-list
101679453|NCT04255121|Anesthetics, Local|anesthetics, local|mesh-ancestor
101679454|NCT04255121|Anesthetics|anesthetics|mesh-ancestor
101679455|NCT04255121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101829467|NCT04310020|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101679456|NCT04255121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679457|NCT04255121|Sensory System Agents|sensory system agents|mesh-ancestor
101679458|NCT04255121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101679459|NCT04255121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101679460|NCT04255121|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101679461|NCT04255121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101679462|NCT04255121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101679463|NCT04255121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679464|NCT04255121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101679465|NCT04255121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101679466|NCT04255121|Adrenergic Agents|adrenergic agents|mesh-ancestor
101679467|NCT04255121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101679468|NCT04255121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101679469|NCT04255121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101679470|NCT04255121|Autonomic Agents|autonomic agents|mesh-ancestor
101679471|NCT04255121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101679472|NCT04255121|Respiratory System Agents|respiratory system agents|mesh-ancestor
101679473|NCT04255121|Mydriatics|mydriatics|mesh-ancestor
101679474|NCT04255121|Sympathomimetics|sympathomimetics|mesh-ancestor
101679475|NCT04255121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101679476|NCT03521232|Niclosamide|niclosamide|mesh-list
101679477|NCT03521232|Anticestodal Agents|anticestodal agents|mesh-ancestor
101679478|NCT03521232|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101679479|NCT03521232|Anthelmintics|anthelmintics|mesh-ancestor
101679480|NCT03521232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101679481|NCT03521232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101679482|NCT03521232|Antinematodal Agents|antinematodal agents|mesh-ancestor
101679483|NCT00924287|Aldesleukin|aldesleukin|mesh-list
101679484|NCT00924287|Cyclophosphamide|cyclophosphamide|mesh-list
101679485|NCT00924287|Fludarabine|fludarabine|mesh-list
101679486|NCT00924287|Interleukin-2|interleukin-2|mesh-list
101679487|NCT00924287|Mesna|mesna|mesh-list
101679488|NCT00924287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101679489|NCT00924287|Immunologic Factors|immunologic factors|mesh-ancestor
101679490|NCT00924287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679491|NCT00924287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101679492|NCT00924287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101679493|NCT00924287|Alkylating Agents|alkylating agents|mesh-ancestor
101679494|NCT00924287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679495|NCT00924287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101679496|NCT00924287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101679497|NCT00924287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101679498|NCT00924287|Analgesics|analgesics|mesh-ancestor
101679499|NCT00924287|Sensory System Agents|sensory system agents|mesh-ancestor
101679500|NCT00924287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101679501|NCT00924287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101679502|NCT00924287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101679503|NCT00924287|Antiviral Agents|antiviral agents|mesh-ancestor
101679504|NCT00924287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101679505|NCT00924287|Protective Agents|protective agents|mesh-ancestor
101679506|NCT02696954|Lumefantrine|lumefantrine|mesh-list
101679507|NCT02696954|Artemether|artemether|mesh-list
101679508|NCT02696954|Primaquine|primaquine|mesh-list
101679509|NCT02696954|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101679510|NCT02696954|Amodiaquine|amodiaquine|mesh-list
101679511|NCT02696954|Antimalarials|antimalarials|mesh-ancestor
101679512|NCT02696954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101679513|NCT02696954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101679514|NCT02696954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101679515|NCT02677077|Natalizumab|natalizumab|mesh-list
101679516|NCT02677077|Immunologic Factors|immunologic factors|mesh-ancestor
101679517|NCT02677077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829483|NCT04298567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101829484|NCT04298567|Analgesics|analgesics|mesh-ancestor
101679518|NCT02771600|Anesthetics|anesthetics|mesh-list
101679519|NCT02771600|Anesthetics, Local|anesthetics, local|mesh-list
101679520|NCT02771600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101679521|NCT02771600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336805|NCT00059800|Boron|boron|mesh-list
101679523|NCT02771600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101679524|NCT02773316|Morphine|morphine|mesh-list
101679525|NCT02773316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101679526|NCT02773316|Narcotics|narcotics|mesh-ancestor
101679527|NCT02773316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101679528|NCT02773316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679529|NCT02773316|Analgesics|analgesics|mesh-ancestor
101679530|NCT02773316|Sensory System Agents|sensory system agents|mesh-ancestor
101679531|NCT02773316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101679532|NCT00642681|Insulin|insulin|mesh-list
101679533|NCT00642681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101679534|NCT00642681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679535|NCT02773550|Prednisone|prednisone|mesh-list
101679536|NCT02773550|Bortezomib|bortezomib|mesh-list
101679537|NCT02773550|Melphalan|melphalan|mesh-list
101679538|NCT02773550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101679539|NCT02773550|Glucocorticoids|glucocorticoids|mesh-ancestor
101679540|NCT02773550|Hormones|hormones|mesh-ancestor
101679541|NCT02773550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101679542|NCT02773550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679543|NCT02773550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101679544|NCT02773550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101679545|NCT02773550|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101679546|NCT02773550|Alkylating Agents|alkylating agents|mesh-ancestor
101679547|NCT02773550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679548|NCT02773550|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101679549|NCT02773550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101679550|NCT02773550|Immunologic Factors|immunologic factors|mesh-ancestor
101679551|NCT02773472|Morphine|morphine|mesh-list
101679552|NCT02773472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101679553|NCT02773472|Narcotics|narcotics|mesh-ancestor
101679554|NCT02773472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101679555|NCT02773472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679556|NCT02773472|Analgesics|analgesics|mesh-ancestor
101679557|NCT02773472|Sensory System Agents|sensory system agents|mesh-ancestor
101679558|NCT02773472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101679560|NCT00637871|Bicalutamide|bicalutamide|mesh-list
101679561|NCT00637871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101679562|NCT00637871|Hormone Antagonists|hormone antagonists|mesh-ancestor
101679563|NCT00637871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101679564|NCT00637871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679565|NCT00637871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101679566|NCT00637871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101679567|NCT00637871|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101679568|NCT00637871|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101679569|NCT00637871|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101679570|NCT00637871|Androgen Antagonists|androgen antagonists|mesh-ancestor
101679571|NCT00635258|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101679572|NCT00635258|Ganirelix|ganirelix|mesh-list
101679573|NCT00635258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101679574|NCT00635258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679575|NCT00635258|Luteolytic Agents|luteolytic agents|mesh-ancestor
101829491|NCT04298567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101829492|NCT04298567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101829493|NCT04298567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101829494|NCT04298567|Antipyretics|antipyretics|mesh-ancestor
101486779|NCT00354081|Micronutrients|micronutrients|mesh-ancestor
101679576|NCT00635258|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101679577|NCT00635258|Contraceptive Agents|contraceptive agents|mesh-ancestor
101679578|NCT00635258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101679579|NCT00635258|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101679580|NCT00635258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101679581|NCT00635258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101679582|NCT00635258|Hormone Antagonists|hormone antagonists|mesh-ancestor
101679583|NCT00642837|Acetaminophen|acetaminophen|mesh-list
101679584|NCT00642837|Tramadol|tramadol|mesh-list
101679585|NCT00642837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101679586|NCT00642837|Analgesics|analgesics|mesh-ancestor
101679587|NCT00642837|Sensory System Agents|sensory system agents|mesh-ancestor
101679588|NCT00642837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101679589|NCT00642837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679590|NCT00642837|Antipyretics|antipyretics|mesh-ancestor
101679591|NCT00642837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101679592|NCT00642837|Narcotics|narcotics|mesh-ancestor
101679593|NCT00642837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101679594|NCT02776748|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101679595|NCT02776748|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101679596|NCT02776748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101679597|NCT02776748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101679598|NCT02776748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336841|NCT00060112|Antimetabolites|antimetabolites|mesh-ancestor
101679599|NCT02776748|Antiviral Agents|antiviral agents|mesh-ancestor
101679600|NCT02776748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101679601|NCT02776748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101679602|NCT02776748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101679603|NCT02676609|Insulin|insulin|mesh-list
101679604|NCT02676609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101679605|NCT02676609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679606|NCT00642915|Insulin Glargine|insulin glargine|mesh-list
101679607|NCT00642915|Glimepiride|glimepiride|mesh-list
101679608|NCT00642915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101679609|NCT00642915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679610|NCT00642915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101679611|NCT00642915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101679612|NCT00642915|Immunologic Factors|immunologic factors|mesh-ancestor
101679614|NCT02676297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101679615|NCT02676297|Autonomic Agents|autonomic agents|mesh-ancestor
101679616|NCT02676297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101679617|NCT02676297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679618|NCT02676297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101679619|NCT02676297|Respiratory System Agents|respiratory system agents|mesh-ancestor
101679620|NCT02676297|Parasympatholytics|parasympatholytics|mesh-ancestor
101679621|NCT02676297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101679622|NCT02676297|Cholinergic Agents|cholinergic agents|mesh-ancestor
101679623|NCT02676297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101679624|NCT02676297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679625|NCT02696720|Lidocaine|lidocaine|mesh-list
101679626|NCT02696720|Anesthetics, Local|anesthetics, local|mesh-ancestor
101679627|NCT02696720|Anesthetics|anesthetics|mesh-ancestor
101679628|NCT02696720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101544612|NCT02279576|Paclitaxel|paclitaxel|mesh-list
101679629|NCT02696720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679630|NCT02696720|Sensory System Agents|sensory system agents|mesh-ancestor
101679631|NCT02696720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101679632|NCT02696720|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101679633|NCT02696720|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101679634|NCT02696720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101679635|NCT02696720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101679636|NCT02696720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829515|NCT04253262|Rucaparib|rucaparib|mesh-list
101829516|NCT04253262|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101829517|NCT04253262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101829518|NCT04253262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829519|NCT04253262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101679638|NCT00643071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101679639|NCT00643071|Immunologic Factors|immunologic factors|mesh-ancestor
101679640|NCT00643071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679641|NCT00643071|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101679642|NCT00643071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101679643|NCT00643071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679644|NCT03728634|Vitamin A|vitamin a|mesh-list
101679645|NCT03728634|Vitamins|vitamins|mesh-ancestor
101679646|NCT03728634|Micronutrients|micronutrients|mesh-ancestor
101679647|NCT03728634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679648|NCT02767310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101679649|NCT02767310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101679650|NCT02767310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101679651|NCT02767310|Antimetabolites|antimetabolites|mesh-ancestor
101679652|NCT02767310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679653|NCT02767310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101679654|NCT02767310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101679655|NCT02767310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101679656|NCT04353414|Bupivacaine|bupivacaine|mesh-list
101679657|NCT04353414|Anesthetics, Local|anesthetics, local|mesh-ancestor
101679658|NCT04353414|Anesthetics|anesthetics|mesh-ancestor
101679659|NCT04353414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101679660|NCT04353414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679661|NCT04353414|Sensory System Agents|sensory system agents|mesh-ancestor
101679662|NCT04353414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101679663|NCT00643149|Amoxicillin|amoxicillin|mesh-list
101679664|NCT00643149|Azithromycin|azithromycin|mesh-list
101679665|NCT00643149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101679666|NCT00643149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101679667|NCT05141682|Azacitidine|azacitidine|mesh-list
101679668|NCT05141682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101679669|NCT05141682|Antimetabolites|antimetabolites|mesh-ancestor
101679670|NCT05141682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679671|NCT05141682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101679672|NCT05141682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101679673|NCT00643227|Azithromycin|azithromycin|mesh-list
101679674|NCT00643227|Clarithromycin|clarithromycin|mesh-list
101679675|NCT00643227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101679676|NCT00643227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101679677|NCT00643227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101679678|NCT00643227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101679679|NCT00643227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679680|NCT00643227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101679681|NCT00643227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101679682|NCT00613392|Antioxidants|antioxidants|mesh-list
101679683|NCT00613392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679684|NCT00613392|Protective Agents|protective agents|mesh-ancestor
101679685|NCT00613392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679686|NCT02537457|Rivaroxaban|rivaroxaban|mesh-list
101679687|NCT02537457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101679688|NCT02537457|Antithrombins|antithrombins|mesh-ancestor
101679689|NCT02537457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101679690|NCT02537457|Protease Inhibitors|protease inhibitors|mesh-ancestor
101679691|NCT02537457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101679692|NCT02537457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679693|NCT02537457|Anticoagulants|anticoagulants|mesh-ancestor
101679694|NCT02762864|Clopidogrel|clopidogrel|mesh-list
101679695|NCT02762864|Ticagrelor|ticagrelor|mesh-list
101679696|NCT02762864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829521|NCT04169737|Obinutuzumab|obinutuzumab|mesh-list
101679697|NCT02762864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679698|NCT02762864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101679699|NCT02762864|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101679700|NCT02762864|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101679701|NCT02762864|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101679702|NCT02762864|Purinergic Agents|purinergic agents|mesh-ancestor
101679703|NCT02762864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101679705|NCT02767154|Dextrans|dextrans|mesh-list
101679706|NCT02767154|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101679707|NCT02767154|Diuretics|diuretics|mesh-ancestor
101679708|NCT02767154|Natriuretic Agents|natriuretic agents|mesh-ancestor
101679709|NCT02767154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679710|NCT02767154|Anticoagulants|anticoagulants|mesh-ancestor
101679711|NCT02767154|Plasma Substitutes|plasma substitutes|mesh-ancestor
101679712|NCT02767154|Blood Substitutes|blood substitutes|mesh-ancestor
101679713|NCT02767232|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101679714|NCT02767232|Plasminogen|plasminogen|mesh-list
101679715|NCT02767232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101679716|NCT02767232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101679717|NCT02767232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679718|NCT02767076|Anesthetics|anesthetics|mesh-list
101679719|NCT02767076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101679720|NCT02767076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679721|NCT02766764|Hormones|hormones|mesh-list
101679722|NCT02766764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101679723|NCT02766764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679724|NCT04658654|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
101679725|NCT04658654|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101679726|NCT04658654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101679727|NCT04658654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679728|NCT02770508|Ritonavir|ritonavir|mesh-list
101679729|NCT02770508|Darunavir|darunavir|mesh-list
101679730|NCT02770508|Tenofovir|tenofovir|mesh-list
101679731|NCT02770508|Lamivudine|lamivudine|mesh-list
101679732|NCT02770508|Emtricitabine|emtricitabine|mesh-list
101679733|NCT02770508|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101679734|NCT02770508|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101679735|NCT02770508|Protease Inhibitors|protease inhibitors|mesh-ancestor
101679736|NCT02770508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101679737|NCT02770508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679738|NCT02770508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101679739|NCT02770508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101679740|NCT02770508|Antiviral Agents|antiviral agents|mesh-ancestor
101679741|NCT02770508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101679742|NCT02770508|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101679743|NCT02770508|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101679744|NCT02770508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101679745|NCT02770508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101336999|NCT00060931|Metoprolol|metoprolol|mesh-list
101679747|NCT02762942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101679748|NCT02762942|Abortifacient Agents|abortifacient agents|mesh-ancestor
101679749|NCT02762942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101679750|NCT02762942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679751|NCT02762942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101679752|NCT02762942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101679753|NCT02762942|Oxytocics|oxytocics|mesh-ancestor
101679754|NCT02770430|Infliximab|infliximab|mesh-list
101679755|NCT02770430|Basiliximab|basiliximab|mesh-list
101679756|NCT02770430|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101679757|NCT02770430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101679758|NCT02770430|Dermatologic Agents|dermatologic agents|mesh-ancestor
101679759|NCT02770430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101679760|NCT02770430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101679761|NCT02770430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101679762|NCT02770430|Immunologic Factors|immunologic factors|mesh-ancestor
101679763|NCT02770430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679764|NCT00918203|Paclitaxel|paclitaxel|mesh-list
101679765|NCT00918203|Carboplatin|carboplatin|mesh-list
101679766|NCT00918203|Olaratumab|olaratumab|mesh-list
101679767|NCT00918203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101679768|NCT00918203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101679769|NCT00918203|Tubulin Modulators|tubulin modulators|mesh-ancestor
101679770|NCT00918203|Antimitotic Agents|antimitotic agents|mesh-ancestor
101679771|NCT00918203|Mitosis Modulators|mitosis modulators|mesh-ancestor
101679772|NCT00918203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679773|NCT00644319|Ibuprofen|ibuprofen|mesh-list
101679774|NCT00644319|Morphine|morphine|mesh-list
101679775|NCT00644319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101679776|NCT00644319|Narcotics|narcotics|mesh-ancestor
101679777|NCT00644319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101679778|NCT00644319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679780|NCT00644319|Sensory System Agents|sensory system agents|mesh-ancestor
101679781|NCT00644319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101679782|NCT00644319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101679783|NCT00644319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101679784|NCT00644319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101679785|NCT00644319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101679786|NCT00644319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101679787|NCT00644319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101679788|NCT00644319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679789|NCT04224116|Tranexamic Acid|tranexamic acid|mesh-list
101679790|NCT04224116|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101679791|NCT04224116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101679792|NCT04224116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679793|NCT04224116|Hemostatics|hemostatics|mesh-ancestor
101679794|NCT04224116|Coagulants|coagulants|mesh-ancestor
101679795|NCT02672709|Apixaban|apixaban|mesh-list
101679796|NCT02672709|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101679797|NCT02672709|Antithrombins|antithrombins|mesh-ancestor
101679798|NCT02672709|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101679799|NCT02672709|Protease Inhibitors|protease inhibitors|mesh-ancestor
101679800|NCT02672709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101679801|NCT02672709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679802|NCT02672709|Anticoagulants|anticoagulants|mesh-ancestor
101679803|NCT02770274|Aspirin|aspirin|mesh-list
101679804|NCT02770274|Cilostazol|cilostazol|mesh-list
101679805|NCT02770274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101679806|NCT02770274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101679807|NCT02770274|Analgesics|analgesics|mesh-ancestor
101679808|NCT02770274|Sensory System Agents|sensory system agents|mesh-ancestor
101679809|NCT02770274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101679810|NCT02770274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679811|NCT02770274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101679812|NCT02770274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101679813|NCT02770274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101679814|NCT02770274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101679815|NCT02770274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679816|NCT02770274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101679817|NCT02770274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101679818|NCT02770274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101679819|NCT02770274|Antipyretics|antipyretics|mesh-ancestor
101679820|NCT02770274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101679821|NCT02770274|Autonomic Agents|autonomic agents|mesh-ancestor
101679822|NCT02770274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101679823|NCT02770274|Respiratory System Agents|respiratory system agents|mesh-ancestor
101679824|NCT02770274|Vasodilator Agents|vasodilator agents|mesh-ancestor
101679825|NCT02770274|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101679826|NCT02770274|Protective Agents|protective agents|mesh-ancestor
101679827|NCT02770274|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101679828|NCT02770274|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101679829|NCT00910221|Atorvastatin|atorvastatin|mesh-list
101679830|NCT00910221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101679831|NCT00910221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101679832|NCT00910221|Antimetabolites|antimetabolites|mesh-ancestor
101679833|NCT00910221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679834|NCT00910221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101679835|NCT00910221|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101679836|NCT00910221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101679837|NCT04657562|Tacrolimus|tacrolimus|mesh-list
101679838|NCT04657562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101679839|NCT04657562|Immunologic Factors|immunologic factors|mesh-ancestor
101679840|NCT04657562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679841|NCT04657562|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101679842|NCT04657562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101679843|NCT04657562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679844|NCT05252117|Mepivacaine|mepivacaine|mesh-list
101679845|NCT05252117|Carticaine|carticaine|mesh-list
101679846|NCT05252117|Anesthetics, Local|anesthetics, local|mesh-ancestor
101679847|NCT05252117|Anesthetics|anesthetics|mesh-ancestor
101679848|NCT05252117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101679849|NCT05252117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679850|NCT05252117|Sensory System Agents|sensory system agents|mesh-ancestor
101679851|NCT05252117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101679852|NCT04224350|Tacrolimus|tacrolimus|mesh-list
101679853|NCT04224350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101679854|NCT04224350|Immunologic Factors|immunologic factors|mesh-ancestor
101679855|NCT04224350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679856|NCT04224350|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101679857|NCT04224350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101679858|NCT04224350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679859|NCT02770716|Terlipressin|terlipressin|mesh-list
101679860|NCT02770716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101679861|NCT02770716|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101679862|NCT02672241|Temozolomide|temozolomide|mesh-list
101679863|NCT02672241|Nimotuzumab|nimotuzumab|mesh-list
101679864|NCT02672241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101679865|NCT02672241|Alkylating Agents|alkylating agents|mesh-ancestor
101679866|NCT02672241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679867|NCT02672241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101679868|NCT02672241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101679869|NCT04177875|Paclitaxel|paclitaxel|mesh-list
101679870|NCT04177875|Docetaxel|docetaxel|mesh-list
101679871|NCT04177875|Cisplatin|cisplatin|mesh-list
101679872|NCT04177875|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101679873|NCT04177875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101679874|NCT04177875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101679875|NCT04177875|Tubulin Modulators|tubulin modulators|mesh-ancestor
101679876|NCT04177875|Antimitotic Agents|antimitotic agents|mesh-ancestor
101679877|NCT04177875|Mitosis Modulators|mitosis modulators|mesh-ancestor
101679878|NCT04177875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679879|NCT00917579|Atorvastatin|atorvastatin|mesh-list
101679880|NCT00917579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101679881|NCT00917579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101829560|NCT04129515|Pembrolizumab|pembrolizumab|mesh-list
101679882|NCT00917579|Antimetabolites|antimetabolites|mesh-ancestor
101679883|NCT00917579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679885|NCT00917579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101679886|NCT00917579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101679887|NCT03808740|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101679888|NCT03808740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101679889|NCT03808740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101679890|NCT03808740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101679891|NCT03808740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679892|NCT03808740|Adrenergic Agents|adrenergic agents|mesh-ancestor
101679893|NCT03808740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101679894|NCT03808740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679895|NCT02766140|Docetaxel|docetaxel|mesh-list
101679896|NCT02766140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101679897|NCT02766140|Tubulin Modulators|tubulin modulators|mesh-ancestor
101679898|NCT02766140|Antimitotic Agents|antimitotic agents|mesh-ancestor
101679899|NCT02766140|Mitosis Modulators|mitosis modulators|mesh-ancestor
101679900|NCT02766140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679901|NCT04177641|Antioxidants|antioxidants|mesh-list
101679902|NCT04177641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679903|NCT04177641|Protective Agents|protective agents|mesh-ancestor
101679904|NCT04177641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679905|NCT04178109|Acetaminophen|acetaminophen|mesh-list
101679906|NCT04178109|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
101679907|NCT04178109|Tramadol|tramadol|mesh-list
101679908|NCT04178109|Ropivacaine|ropivacaine|mesh-list
101679909|NCT04178109|Levobupivacaine|levobupivacaine|mesh-list
101679910|NCT04178109|Anesthetics, Local|anesthetics, local|mesh-ancestor
101679911|NCT04178109|Anesthetics|anesthetics|mesh-ancestor
101679912|NCT04178109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101679913|NCT04178109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679914|NCT04178109|Sensory System Agents|sensory system agents|mesh-ancestor
101679915|NCT04178109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101679916|NCT04178109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101679917|NCT04178109|Analgesics|analgesics|mesh-ancestor
101679918|NCT04178109|Antipyretics|antipyretics|mesh-ancestor
101679919|NCT04178109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101679920|NCT04178109|Narcotics|narcotics|mesh-ancestor
101679921|NCT04178109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101679922|NCT04178109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101679923|NCT04178109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101679924|NCT00644475|Candesartan|candesartan|mesh-list
101679925|NCT00644475|Candesartan cilexetil|candesartan cilexetil|mesh-list
101679926|NCT00644475|Imidapril|imidapril|mesh-list
101679927|NCT00644475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101679928|NCT00644475|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101679929|NCT00644475|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101679930|NCT00644475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679931|NCT00644475|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101679933|NCT00644475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101679934|NCT04177719|Oxytocin|oxytocin|mesh-list
101679935|NCT04177719|Oxytocics|oxytocics|mesh-ancestor
101679936|NCT04177719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101679937|NCT04177719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679938|NCT00644553|Amoxicillin|amoxicillin|mesh-list
101679939|NCT00644553|Clarithromycin|clarithromycin|mesh-list
101679940|NCT00644553|Clavulanic Acid|clavulanic acid|mesh-list
101679941|NCT00644553|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101679942|NCT00644553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101679943|NCT00644553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101679944|NCT00644553|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101679945|NCT00644553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101679946|NCT00644553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679947|NCT00644553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101679948|NCT00644553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101829588|NCT04069052|Nitric Oxide|nitric oxide|mesh-list
101679949|NCT00644553|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101679950|NCT02762474|Paclitaxel|paclitaxel|mesh-list
101679951|NCT02762474|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101679952|NCT02762474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101679953|NCT02762474|Tubulin Modulators|tubulin modulators|mesh-ancestor
101679954|NCT02762474|Antimitotic Agents|antimitotic agents|mesh-ancestor
101679955|NCT02762474|Mitosis Modulators|mitosis modulators|mesh-ancestor
101679956|NCT02762474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679957|NCT00915473|Methylprednisolone|methylprednisolone|mesh-list
101679958|NCT00915473|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101679959|NCT00915473|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101679960|NCT00915473|Prednisolone|prednisolone|mesh-list
101679961|NCT00915473|Prednisolone acetate|prednisolone acetate|mesh-list
101679962|NCT00915473|Lidocaine|lidocaine|mesh-list
101679963|NCT00915473|Bupivacaine|bupivacaine|mesh-list
101679964|NCT00915473|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101679965|NCT00915473|Prednisolone phosphate|prednisolone phosphate|mesh-list
101679966|NCT00915473|Anesthetics, Local|anesthetics, local|mesh-ancestor
101679967|NCT00915473|Anesthetics|anesthetics|mesh-ancestor
101679968|NCT00915473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101679969|NCT00915473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679970|NCT00915473|Sensory System Agents|sensory system agents|mesh-ancestor
101679971|NCT00915473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101679972|NCT00915473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101679973|NCT00915473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101679974|NCT00915473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101679975|NCT00915473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101679976|NCT00915473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101679977|NCT00915473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101679978|NCT00915473|Antiemetics|antiemetics|mesh-ancestor
101679979|NCT00915473|Autonomic Agents|autonomic agents|mesh-ancestor
101679980|NCT00915473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101679981|NCT00915473|Glucocorticoids|glucocorticoids|mesh-ancestor
101679982|NCT00915473|Hormones|hormones|mesh-ancestor
101679983|NCT00915473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101679984|NCT00915473|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101679985|NCT00915473|Protective Agents|protective agents|mesh-ancestor
101679986|NCT00915473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101679987|NCT00915473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101679988|NCT04691726|Dipyrone|dipyrone|mesh-list
101679989|NCT04691726|Lidocaine|lidocaine|mesh-list
101679990|NCT04691726|Morphine|morphine|mesh-list
101679991|NCT04691726|Anesthetics, Local|anesthetics, local|mesh-ancestor
101679992|NCT04691726|Anesthetics|anesthetics|mesh-ancestor
101679993|NCT04691726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101679994|NCT04691726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101679995|NCT04691726|Sensory System Agents|sensory system agents|mesh-ancestor
101679996|NCT04691726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101679997|NCT04691726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101679998|NCT04691726|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101679999|NCT04691726|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101680000|NCT04691726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101680001|NCT04691726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829596|NCT04069052|Antioxidants|antioxidants|mesh-ancestor
101829597|NCT04069052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829598|NCT04069052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101829599|NCT04069052|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101829600|NCT04069052|Vasodilator Agents|vasodilator agents|mesh-ancestor
101829601|NCT04069052|Gasotransmitters|gasotransmitters|mesh-ancestor
101829602|NCT04069052|Protective Agents|protective agents|mesh-ancestor
101829603|NCT04062266|Azacitidine|azacitidine|mesh-list
101680002|NCT04691726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101680004|NCT04691726|Analgesics|analgesics|mesh-ancestor
101680005|NCT04691726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101680006|NCT04691726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101680007|NCT04691726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101680008|NCT04691726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101680009|NCT04691726|Antipyretics|antipyretics|mesh-ancestor
101680010|NCT00614328|Naltrexone|naltrexone|mesh-list
101680011|NCT00614328|Baclofen|baclofen|mesh-list
101680012|NCT00614328|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101680013|NCT00614328|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101680014|NCT00614328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680015|NCT00614328|Sensory System Agents|sensory system agents|mesh-ancestor
101680016|NCT00614328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101680017|NCT00614328|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101680018|NCT00614328|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101680019|NCT00614328|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101680020|NCT00614328|GABA Agonists|gaba agonists|mesh-ancestor
101680021|NCT00614328|GABA Agents|gaba agents|mesh-ancestor
101680022|NCT00614328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101680023|NCT00614328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680025|NCT04177173|Simvastatin|simvastatin|mesh-list
101680026|NCT04177173|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101680027|NCT04177173|Abortifacient Agents|abortifacient agents|mesh-ancestor
101680028|NCT04177173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101680029|NCT04177173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680030|NCT04177173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101680031|NCT04177173|Antimetabolites|antimetabolites|mesh-ancestor
101680032|NCT04177173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680033|NCT04177173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101680034|NCT04177173|Dermatologic Agents|dermatologic agents|mesh-ancestor
101680035|NCT04177173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101680036|NCT04177173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101680037|NCT04177173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101680038|NCT04177173|Immunologic Factors|immunologic factors|mesh-ancestor
101680039|NCT04177173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101680040|NCT04177173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101680041|NCT04177173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101680042|NCT04177173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101680043|NCT04177173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101680044|NCT04177173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101680045|NCT04224818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101680046|NCT04224818|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101680047|NCT04224818|Luteolytic Agents|luteolytic agents|mesh-ancestor
101680048|NCT04224818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101680049|NCT04224818|Contraceptive Agents|contraceptive agents|mesh-ancestor
101680050|NCT04224818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101680051|NCT04224818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680052|NCT04224818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101680053|NCT04224818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101680054|NCT04224818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101680055|NCT03651804|Acetaminophen|acetaminophen|mesh-list
101680056|NCT03651804|Diphosphonates|diphosphonates|mesh-list
101680057|NCT03651804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101680058|NCT03651804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101680059|NCT03651804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101680060|NCT03651804|Analgesics|analgesics|mesh-ancestor
101680061|NCT03651804|Sensory System Agents|sensory system agents|mesh-ancestor
101680062|NCT03651804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101680063|NCT03651804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680064|NCT03651804|Antipyretics|antipyretics|mesh-ancestor
101680065|NCT03651804|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101680066|NCT03651804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101680067|NCT00917267|Exenatide|exenatide|mesh-list
101680068|NCT00917267|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101680069|NCT00917267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680070|NCT00917267|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101829609|NCT04062266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101680071|NCT00917267|Incretins|incretins|mesh-ancestor
101680072|NCT00917267|Hormones|hormones|mesh-ancestor
101680073|NCT00917267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101680074|NCT02670759|Bupivacaine|bupivacaine|mesh-list
101680075|NCT02670759|Anesthetics, Local|anesthetics, local|mesh-ancestor
101680076|NCT02670759|Anesthetics|anesthetics|mesh-ancestor
101680077|NCT02670759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101680078|NCT02670759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680079|NCT02670759|Sensory System Agents|sensory system agents|mesh-ancestor
101680080|NCT02670759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101680081|NCT00644943|Amoxicillin|amoxicillin|mesh-list
101680082|NCT00644943|Cefdinir|cefdinir|mesh-list
101680083|NCT00644943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101680084|NCT00644943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101680085|NCT02762006|Durvalumab|durvalumab|mesh-list
101680086|NCT02762006|Tremelimumab|tremelimumab|mesh-list
101680087|NCT02762006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101680088|NCT02762006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101680089|NCT02769884|Pancrelipase|pancrelipase|mesh-list
101680090|NCT02769884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101680091|NCT05213507|Amikacin|amikacin|mesh-list
101680092|NCT05213507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101680093|NCT05213507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101680094|NCT02670603|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101680095|NCT04253873|Temozolomide|temozolomide|mesh-list
101680096|NCT04253873|Apatinib|apatinib|mesh-list
101680097|NCT04253873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101680098|NCT04253873|Alkylating Agents|alkylating agents|mesh-ancestor
101680099|NCT04253873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680100|NCT04253873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101680101|NCT04253873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101680102|NCT04253873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101680103|NCT05147727|Fluconazole|fluconazole|mesh-list
101680104|NCT05147727|Antifungal Agents|antifungal agents|mesh-ancestor
101680105|NCT05147727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101680106|NCT05147727|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101680107|NCT05147727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101680108|NCT05147727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101680109|NCT05147727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680110|NCT05147727|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101680111|NCT05147727|Hormone Antagonists|hormone antagonists|mesh-ancestor
101680112|NCT05147727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101680113|NCT05147727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680114|NCT05147727|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101680115|NCT05147727|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101680116|NCT02765594|Hydroxychloroquine|hydroxychloroquine|mesh-list
101680117|NCT02765594|Valsartan|valsartan|mesh-list
101680118|NCT02765594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101326206|NCT00401869|Hematinics|hematinics|mesh-ancestor
101680119|NCT02765594|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101680120|NCT02765594|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101680121|NCT02765594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680122|NCT02765594|Antimalarials|antimalarials|mesh-ancestor
101680123|NCT02765594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101680124|NCT02765594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101680125|NCT02765594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101680126|NCT02765594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101680127|NCT02765594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101680128|NCT00920699|Ubiquinone|ubiquinone|mesh-list
101680129|NCT00920699|Coenzyme Q10|coenzyme q10|mesh-list
101680130|NCT00920699|Micronutrients|micronutrients|mesh-ancestor
101680131|NCT00920699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680133|NCT02670135|Triclosan|triclosan|mesh-list
101680134|NCT02670135|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101680135|NCT02670135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101680136|NCT02670135|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101680137|NCT02670135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101680138|NCT02670135|Antimetabolites|antimetabolites|mesh-ancestor
101680139|NCT02670135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680140|NCT02670135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101680141|NCT02769494|Riboflavin|riboflavin|mesh-list
101680142|NCT02769494|Flavin Mononucleotide|flavin mononucleotide|mesh-list
101680143|NCT02769494|Mesalamine|mesalamine|mesh-list
101680144|NCT02769494|Vitamin B Complex|vitamin b complex|mesh-ancestor
101680145|NCT02769494|Vitamins|vitamins|mesh-ancestor
101680146|NCT02769494|Micronutrients|micronutrients|mesh-ancestor
101680147|NCT02769494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680148|NCT02769494|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101680149|NCT02769494|Dermatologic Agents|dermatologic agents|mesh-ancestor
101680150|NCT02769494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101680151|NCT02769494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101680152|NCT02769494|Analgesics|analgesics|mesh-ancestor
101680153|NCT02769494|Sensory System Agents|sensory system agents|mesh-ancestor
101680154|NCT02769494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101680155|NCT02769494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101680156|NCT02769494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101680157|NCT02769572|Diclofenac|diclofenac|mesh-list
101680158|NCT02769572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101680159|NCT02769572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101680160|NCT02769572|Analgesics|analgesics|mesh-ancestor
101680161|NCT02769572|Sensory System Agents|sensory system agents|mesh-ancestor
101680162|NCT02769572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101680163|NCT02769572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680164|NCT02769572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101680165|NCT02769572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101680166|NCT02769572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101680167|NCT02769572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101680168|NCT02769572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680169|NCT02669589|Heparin|heparin|mesh-list
101680170|NCT02669589|Anticoagulants|anticoagulants|mesh-ancestor
101680171|NCT02669589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680172|NCT02669589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101680173|NCT02669589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101680174|NCT02765204|Dapagliflozin|dapagliflozin|mesh-list
101680175|NCT02765204|Saxagliptin|saxagliptin|mesh-list
101680176|NCT02765204|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101680177|NCT02765204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680178|NCT02765204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101680179|NCT02765204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680180|NCT02765204|Incretins|incretins|mesh-ancestor
101680181|NCT02765204|Hormones|hormones|mesh-ancestor
101680182|NCT02765204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101680183|NCT02765204|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101680184|NCT02765204|Protease Inhibitors|protease inhibitors|mesh-ancestor
101680185|NCT02765204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101680186|NCT03342456|Amoxicillin|amoxicillin|mesh-list
101680187|NCT03342456|Doxycycline|doxycycline|mesh-list
101680188|NCT03342456|Furazolidone|furazolidone|mesh-list
101680189|NCT03342456|Potassium Citrate|potassium citrate|mesh-list
101680190|NCT03342456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680191|NCT03342456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101680192|NCT03342456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101680193|NCT03342456|Antimalarials|antimalarials|mesh-ancestor
101680194|NCT03342456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101680195|NCT03342456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101680196|NCT03342456|Diuretics|diuretics|mesh-ancestor
101680197|NCT03342456|Natriuretic Agents|natriuretic agents|mesh-ancestor
101680198|NCT03342456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680199|NCT03342456|Expectorants|expectorants|mesh-ancestor
101680200|NCT03342456|Respiratory System Agents|respiratory system agents|mesh-ancestor
101680201|NCT03342456|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101680202|NCT03342456|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101680203|NCT03342456|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
101680204|NCT03342456|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101680205|NCT03342456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101680206|NCT02669277|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101680207|NCT02669277|gamma-Globulins|gamma-globulins|mesh-list
101680208|NCT02669277|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101680209|NCT02669277|Immunologic Factors|immunologic factors|mesh-ancestor
101680210|NCT02669277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680212|NCT02769104|Letrozole|letrozole|mesh-list
101680213|NCT02769104|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101680214|NCT02769104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101680215|NCT02769104|Tubulin Modulators|tubulin modulators|mesh-ancestor
101680216|NCT02769104|Antimitotic Agents|antimitotic agents|mesh-ancestor
101680217|NCT02769104|Mitosis Modulators|mitosis modulators|mesh-ancestor
101680218|NCT02769104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680219|NCT02769104|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101680220|NCT02769104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101680221|NCT02769104|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101680222|NCT02769104|Hormone Antagonists|hormone antagonists|mesh-ancestor
101680223|NCT02769104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101680224|NCT02769104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680225|NCT02545842|Insulin Glargine|insulin glargine|mesh-list
101680226|NCT02545842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101680227|NCT02545842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680228|NCT00645255|Sibutramine|sibutramine|mesh-list
101680229|NCT00645255|Antidepressive Agents|antidepressive agents|mesh-ancestor
101680230|NCT00645255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101680231|NCT00645255|Appetite Depressants|appetite depressants|mesh-ancestor
101680232|NCT00645255|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101680233|NCT04679012|Prednisone|prednisone|mesh-list
101680234|NCT04679012|Cyclophosphamide|cyclophosphamide|mesh-list
101680235|NCT04679012|Rituximab|rituximab|mesh-list
101680236|NCT04679012|Doxorubicin|doxorubicin|mesh-list
101680238|NCT04679012|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101680239|NCT04679012|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
101680240|NCT04679012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101680241|NCT04679012|Immunologic Factors|immunologic factors|mesh-ancestor
101680242|NCT04679012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680243|NCT04679012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101680244|NCT04679012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101680245|NCT04679012|Alkylating Agents|alkylating agents|mesh-ancestor
101680246|NCT04679012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680247|NCT04679012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101680248|NCT04679012|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101680249|NCT04679012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101680250|NCT04679012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101680251|NCT04679012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101680252|NCT04679012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101680253|NCT04679012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101680254|NCT04679012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101680255|NCT04679012|Glucocorticoids|glucocorticoids|mesh-ancestor
101829639|NCT03953898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101680256|NCT04679012|Hormones|hormones|mesh-ancestor
101680257|NCT04679012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101680258|NCT04679012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101680259|NCT04679012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101680260|NCT04679012|Immunoconjugates|immunoconjugates|mesh-ancestor
101680262|NCT00910455|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101680263|NCT00910455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680264|NCT00910455|Natriuretic Agents|natriuretic agents|mesh-ancestor
101680265|NCT00910455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680266|NCT02765126|Vaccines|vaccines|mesh-list
101680267|NCT02765126|Immunologic Factors|immunologic factors|mesh-ancestor
101680268|NCT02765126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680269|NCT02668965|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101680270|NCT02668965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101680271|NCT02668965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680272|NCT00916721|Propranolol|propranolol|mesh-list
101680273|NCT00916721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101680274|NCT00916721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101337517|NCT00065143|Clofarabine|clofarabine|mesh-list
101680275|NCT00916721|Adrenergic Agents|adrenergic agents|mesh-ancestor
101680276|NCT00916721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101680277|NCT00916721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680278|NCT00916721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680279|NCT00916721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101680280|NCT00916721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101680281|NCT00916721|Vasodilator Agents|vasodilator agents|mesh-ancestor
101680282|NCT00613782|Methyltestosterone|methyltestosterone|mesh-list
101680283|NCT00613782|Testosterone|testosterone|mesh-list
101680284|NCT00613782|Testosterone undecanoate|testosterone undecanoate|mesh-list
101680285|NCT00613782|Testosterone enanthate|testosterone enanthate|mesh-list
101680286|NCT00613782|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101680287|NCT00613782|Androgens|androgens|mesh-ancestor
101680288|NCT00613782|Hormones|hormones|mesh-ancestor
101680289|NCT00613782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101680290|NCT00613782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680291|NCT00613782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101680292|NCT00613782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101680294|NCT02764736|Atorvastatin|atorvastatin|mesh-list
101680295|NCT02764736|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101680296|NCT02764736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101680297|NCT02764736|Antimetabolites|antimetabolites|mesh-ancestor
101680298|NCT02764736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680299|NCT02764736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101680300|NCT02764736|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101680301|NCT02764736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101680302|NCT00646737|Mycophenolic Acid|mycophenolic acid|mesh-list
101680304|NCT00646737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101680305|NCT00646737|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101680306|NCT00646737|Antitubercular Agents|antitubercular agents|mesh-ancestor
101680307|NCT00646737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101680308|NCT00646737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101680309|NCT00646737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101680310|NCT00646737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680311|NCT00646815|Hormones|hormones|mesh-list
101680312|NCT00646815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101680313|NCT00646815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680314|NCT00915005|Paclitaxel|paclitaxel|mesh-list
101829659|NCT03896269|Immunologic Factors|immunologic factors|mesh-ancestor
101680315|NCT00915005|Carboplatin|carboplatin|mesh-list
101680316|NCT00915005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101680317|NCT00915005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101680318|NCT00915005|Tubulin Modulators|tubulin modulators|mesh-ancestor
101680319|NCT00915005|Antimitotic Agents|antimitotic agents|mesh-ancestor
101680320|NCT00915005|Mitosis Modulators|mitosis modulators|mesh-ancestor
101680321|NCT00915005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680322|NCT00910533|Ceftriaxone|ceftriaxone|mesh-list
101680323|NCT00910533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101680324|NCT00910533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101680325|NCT02696642|Maytansine|maytansine|mesh-list
101680326|NCT02696642|Anetumab ravtansine|anetumab ravtansine|mesh-list
101680327|NCT02696642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101680328|NCT02696642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101680329|NCT02696642|Tubulin Modulators|tubulin modulators|mesh-ancestor
101680330|NCT02696642|Antimitotic Agents|antimitotic agents|mesh-ancestor
101680331|NCT02696642|Mitosis Modulators|mitosis modulators|mesh-ancestor
101680332|NCT02696642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680333|NCT02696642|Immunoconjugates|immunoconjugates|mesh-ancestor
101680334|NCT02696642|Immunologic Factors|immunologic factors|mesh-ancestor
101680335|NCT02696642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680336|NCT00647049|Cytarabine|cytarabine|mesh-list
101680337|NCT00647049|Rituximab|rituximab|mesh-list
101680338|NCT00647049|Methotrexate|methotrexate|mesh-list
101680339|NCT00647049|Thiotepa|thiotepa|mesh-list
101680340|NCT00647049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101680341|NCT00647049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101680342|NCT00647049|Immunologic Factors|immunologic factors|mesh-ancestor
101680343|NCT00647049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680344|NCT00647049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101680345|NCT00647049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101680346|NCT00647049|Abortifacient Agents|abortifacient agents|mesh-ancestor
101680347|NCT00647049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101680348|NCT00647049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101680349|NCT00647049|Antimetabolites|antimetabolites|mesh-ancestor
101680350|NCT00647049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680351|NCT00647049|Dermatologic Agents|dermatologic agents|mesh-ancestor
101680352|NCT00647049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101680353|NCT00647049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101680354|NCT00647049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101680355|NCT00647049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101680356|NCT00647049|Antiviral Agents|antiviral agents|mesh-ancestor
101680357|NCT00647049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101680358|NCT00647049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101680359|NCT00647049|Alkylating Agents|alkylating agents|mesh-ancestor
101680360|NCT00647049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101680362|NCT02696330|Clopidogrel|clopidogrel|mesh-list
101680363|NCT02696330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101680364|NCT02696330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101680365|NCT02696330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101680366|NCT02696330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101680367|NCT02696330|Purinergic Agents|purinergic agents|mesh-ancestor
101680368|NCT02696330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101680369|NCT02696330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680370|NCT02696330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680371|NCT02696330|Anticoagulants|anticoagulants|mesh-ancestor
101680372|NCT02696330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101680373|NCT02696330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101680374|NCT04172727|Bupivacaine|bupivacaine|mesh-list
101680375|NCT04172727|Anesthetics, Local|anesthetics, local|mesh-ancestor
101680376|NCT04172727|Anesthetics|anesthetics|mesh-ancestor
101545295|NCT02272647|Progesterone|progesterone|mesh-list
101680377|NCT04172727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101829674|NCT03829683|Vitamins|vitamins|mesh-ancestor
101829675|NCT03829683|Micronutrients|micronutrients|mesh-ancestor
101829676|NCT03829683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829677|NCT03829683|Antioxidants|antioxidants|mesh-ancestor
101829678|NCT03829683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829679|NCT03829683|Protective Agents|protective agents|mesh-ancestor
101680378|NCT04172727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680379|NCT04172727|Sensory System Agents|sensory system agents|mesh-ancestor
101680380|NCT04172727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101680381|NCT04648319|Nivolumab|nivolumab|mesh-list
101680382|NCT04648319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101680383|NCT04648319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101680384|NCT04648319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101680385|NCT04648319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680386|NCT00647127|Fentanyl|fentanyl|mesh-list
101680387|NCT00647127|Buprenorphine|buprenorphine|mesh-list
101680388|NCT00647127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101680389|NCT00647127|Narcotics|narcotics|mesh-ancestor
101680390|NCT00647127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101680391|NCT00647127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680392|NCT00647127|Analgesics|analgesics|mesh-ancestor
101680393|NCT00647127|Sensory System Agents|sensory system agents|mesh-ancestor
101680394|NCT00647127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101680395|NCT00647127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101680396|NCT00647127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101680397|NCT00647127|Anesthetics, General|anesthetics, general|mesh-ancestor
101680398|NCT00647127|Anesthetics|anesthetics|mesh-ancestor
101680399|NCT00647127|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101680400|NCT04750070|Dopamine|dopamine|mesh-list
101680401|NCT04750070|Epinephrine|epinephrine|mesh-list
101680402|NCT04750070|Racepinephrine|racepinephrine|mesh-list
101680403|NCT04750070|Epinephryl borate|epinephryl borate|mesh-list
101680404|NCT04750070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101680405|NCT04750070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101680406|NCT04750070|Adrenergic Agents|adrenergic agents|mesh-ancestor
101680407|NCT04750070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101680408|NCT04750070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680409|NCT04750070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680410|NCT04750070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101680411|NCT04750070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101680412|NCT04750070|Autonomic Agents|autonomic agents|mesh-ancestor
101680413|NCT04750070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101680414|NCT04750070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101680415|NCT04750070|Respiratory System Agents|respiratory system agents|mesh-ancestor
101680416|NCT04750070|Mydriatics|mydriatics|mesh-ancestor
101680417|NCT04750070|Sympathomimetics|sympathomimetics|mesh-ancestor
101680418|NCT04750070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101680419|NCT04750070|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101680420|NCT04750070|Dopamine Agents|dopamine agents|mesh-ancestor
101680421|NCT04750070|Protective Agents|protective agents|mesh-ancestor
101680422|NCT02763722|Emollients|emollients|mesh-list
101680423|NCT02763722|Dermatologic Agents|dermatologic agents|mesh-ancestor
101680424|NCT01143246|Terlipressin|terlipressin|mesh-list
101680425|NCT01143246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101680426|NCT01143246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101680428|NCT00647673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101680429|NCT00647673|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101680430|NCT00647673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101680431|NCT00647673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680432|NCT00647673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101680433|NCT00647673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680434|NCT00647673|Vasodilator Agents|vasodilator agents|mesh-ancestor
101680435|NCT00561925|Nevirapine|nevirapine|mesh-list
101680436|NCT00561925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101680437|NCT00561925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101680438|NCT00561925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101680439|NCT00561925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680440|NCT00561925|Antiviral Agents|antiviral agents|mesh-ancestor
101680441|NCT00561925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101680442|NCT00561925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101680443|NCT00561925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101680444|NCT00561925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101680445|NCT00561925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101680446|NCT02760992|Baclofen|baclofen|mesh-list
101680447|NCT02760992|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101680448|NCT02760992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680449|NCT02760992|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101680450|NCT02760992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101680451|NCT02760992|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101680452|NCT02760992|GABA Agonists|gaba agonists|mesh-ancestor
101680453|NCT02760992|GABA Agents|gaba agents|mesh-ancestor
101680454|NCT02760992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101680455|NCT02760992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680457|NCT04172259|Docetaxel|docetaxel|mesh-list
101680458|NCT04172259|Doxorubicin|doxorubicin|mesh-list
101680459|NCT04172259|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101680460|NCT04172259|Trastuzumab|trastuzumab|mesh-list
101680461|NCT04172259|Epirubicin|epirubicin|mesh-list
101680462|NCT04172259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101680463|NCT04172259|Immunologic Factors|immunologic factors|mesh-ancestor
101680464|NCT04172259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680465|NCT04172259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101680466|NCT04172259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101680467|NCT04172259|Alkylating Agents|alkylating agents|mesh-ancestor
101680468|NCT04172259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680469|NCT04172259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101680470|NCT04172259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101680471|NCT04172259|Tubulin Modulators|tubulin modulators|mesh-ancestor
101680472|NCT04172259|Antimitotic Agents|antimitotic agents|mesh-ancestor
101680473|NCT04172259|Mitosis Modulators|mitosis modulators|mesh-ancestor
101680474|NCT04172259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101680475|NCT04172259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101680476|NCT04172259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101680477|NCT04172259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101680478|NCT04172259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101680479|NCT00647751|Lamotrigine|lamotrigine|mesh-list
101680480|NCT00647751|Anticonvulsants|anticonvulsants|mesh-ancestor
101680481|NCT00647751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101680482|NCT00647751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101680483|NCT00647751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680484|NCT00647751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101680485|NCT00647751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680486|NCT00647751|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101680487|NCT00647751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101680488|NCT00647751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101680489|NCT00647751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101680490|NCT00647751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101680491|NCT02536989|Omeprazole|omeprazole|mesh-list
101680492|NCT02536989|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101680493|NCT02536989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101680494|NCT02536989|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101680495|NCT02536989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101680496|NCT02536989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680497|NCT00647829|Valdecoxib|valdecoxib|mesh-list
101680498|NCT00647829|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101337741|NCT00066625|Oxaliplatin|oxaliplatin|mesh-list
101680499|NCT00647829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101680500|NCT00647829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101680501|NCT00647829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680502|NCT00647829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101680503|NCT00647829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101680504|NCT00647829|Analgesics|analgesics|mesh-ancestor
101680505|NCT00647829|Sensory System Agents|sensory system agents|mesh-ancestor
101680506|NCT00647829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101680507|NCT00647829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680508|NCT00647829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101680509|NCT00647829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101680510|NCT02517918|Zoledronic Acid|zoledronic acid|mesh-list
101680511|NCT02517918|Sirolimus|sirolimus|mesh-list
101680512|NCT02517918|Methotrexate|methotrexate|mesh-list
101680513|NCT02517918|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101680514|NCT02517918|Abortifacient Agents|abortifacient agents|mesh-ancestor
101680515|NCT02517918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101680516|NCT02517918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680517|NCT02517918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101680518|NCT02517918|Antimetabolites|antimetabolites|mesh-ancestor
101680519|NCT02517918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680520|NCT02517918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101680521|NCT02517918|Dermatologic Agents|dermatologic agents|mesh-ancestor
101680522|NCT02517918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101680523|NCT02517918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101680524|NCT02517918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101680525|NCT02517918|Immunologic Factors|immunologic factors|mesh-ancestor
101680526|NCT02517918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101680527|NCT02517918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101680528|NCT02517918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101680529|NCT02517918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101680530|NCT02517918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101680531|NCT02517918|Antifungal Agents|antifungal agents|mesh-ancestor
101680532|NCT02517918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101680533|NCT00647907|Voriconazole|voriconazole|mesh-list
101680534|NCT00647907|Antifungal Agents|antifungal agents|mesh-ancestor
101680535|NCT00647907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101680536|NCT00647907|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101680537|NCT00647907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101680538|NCT00647907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101680539|NCT00647907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680540|NCT00647907|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101680541|NCT00647907|Hormone Antagonists|hormone antagonists|mesh-ancestor
101680542|NCT00647907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101680543|NCT00647907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680544|NCT00647907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101680545|NCT04017546|Venetoclax|venetoclax|mesh-list
101680546|NCT04017546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101680547|NCT04171791|Venetoclax|venetoclax|mesh-list
101680548|NCT04171791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101680549|NCT04003818|Teicoplanin|teicoplanin|mesh-list
101680550|NCT04003818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101680551|NCT04003818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101680552|NCT00949663|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
101680553|NCT00949663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101680554|NCT00949663|Incretins|incretins|mesh-ancestor
101680555|NCT00949663|Hormones|hormones|mesh-ancestor
101680556|NCT00949663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101680557|NCT00949663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680558|NCT00647985|Fexofenadine|fexofenadine|mesh-list
101680559|NCT00647985|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101680560|NCT00647985|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101680561|NCT00647985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101680562|NCT00647985|Histamine Antagonists|histamine antagonists|mesh-ancestor
101680563|NCT00647985|Histamine Agents|histamine agents|mesh-ancestor
101680564|NCT00647985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101680565|NCT00647985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680566|NCT00647985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680567|NCT02664051|Cromolyn Sodium|cromolyn sodium|mesh-list
101680568|NCT02664051|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
101680569|NCT02664051|Immunologic Factors|immunologic factors|mesh-ancestor
101680570|NCT02664051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680571|NCT02664051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101680573|NCT02664051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101680574|NCT02664051|Respiratory System Agents|respiratory system agents|mesh-ancestor
101680575|NCT00648063|Letrozole|letrozole|mesh-list
101680576|NCT00648063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101680577|NCT00648063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101680578|NCT00648063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101680579|NCT00648063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101680580|NCT00648063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680581|NCT00648063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101680582|NCT00648063|Hormone Antagonists|hormone antagonists|mesh-ancestor
101680583|NCT00648063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101680584|NCT00648063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680585|NCT00648141|Celecoxib|celecoxib|mesh-list
101680586|NCT00648141|Diclofenac|diclofenac|mesh-list
101680587|NCT00648141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101680588|NCT00648141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101680589|NCT00648141|Analgesics|analgesics|mesh-ancestor
101680590|NCT00648141|Sensory System Agents|sensory system agents|mesh-ancestor
101680591|NCT00648141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101680592|NCT00648141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680593|NCT00648141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101680594|NCT00648141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101680595|NCT00648141|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101680596|NCT00648141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101680597|NCT00648141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101680598|NCT00648141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680599|NCT00953641|Misoprostol|misoprostol|mesh-list
101680600|NCT00953641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101680601|NCT00953641|Abortifacient Agents|abortifacient agents|mesh-ancestor
101680602|NCT00953641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101680603|NCT00953641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680604|NCT00953641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101680605|NCT00953641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101680606|NCT00953641|Oxytocics|oxytocics|mesh-ancestor
101680607|NCT02763098|Remifentanil|remifentanil|mesh-list
101680608|NCT02763098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101680609|NCT02763098|Narcotics|narcotics|mesh-ancestor
101680610|NCT02763098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101680611|NCT02763098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680612|NCT02763098|Analgesics|analgesics|mesh-ancestor
101680613|NCT02763098|Sensory System Agents|sensory system agents|mesh-ancestor
101680614|NCT02763098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101680615|NCT00648219|Olmesartan|olmesartan|mesh-list
101680616|NCT00648219|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101680617|NCT00648219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101680618|NCT00648219|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101680619|NCT00648219|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101680620|NCT00648219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680621|NCT00648297|Nadolol|nadolol|mesh-list
101680622|NCT00648297|Bendroflumethiazide|bendroflumethiazide|mesh-list
101680623|NCT00648297|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101680624|NCT00648297|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101680625|NCT00648297|Adrenergic Agents|adrenergic agents|mesh-ancestor
101680626|NCT00648297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101680627|NCT00648297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680628|NCT00648297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680629|NCT00648297|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101680630|NCT00648297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101680631|NCT00648297|Sympatholytics|sympatholytics|mesh-ancestor
101680632|NCT00648297|Autonomic Agents|autonomic agents|mesh-ancestor
101680633|NCT00648297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101680634|NCT00648297|Diuretics|diuretics|mesh-ancestor
101680635|NCT00648297|Natriuretic Agents|natriuretic agents|mesh-ancestor
101680636|NCT00648297|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101680637|NCT00648297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101680638|NCT00648453|Clopidogrel|clopidogrel|mesh-list
101680639|NCT00648453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101829722|NCT03672539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680640|NCT00648453|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101680641|NCT00648453|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101680642|NCT00648453|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101680643|NCT00648453|Purinergic Agents|purinergic agents|mesh-ancestor
101680644|NCT00648453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101680645|NCT00648453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680646|NCT00648453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680647|NCT00549445|Azithromycin|azithromycin|mesh-list
101680648|NCT00549445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101680649|NCT00549445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101680650|NCT00637026|Gefitinib|gefitinib|mesh-list
101680651|NCT00637026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101680652|NCT00637026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101680653|NCT00637026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101680654|NCT00637026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680655|NCT00649155|Ciprofloxacin|ciprofloxacin|mesh-list
101680656|NCT00649155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101680657|NCT00649155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101680658|NCT00649155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101680659|NCT00649155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101680660|NCT00649155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101680661|NCT00649155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680662|NCT00649155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101680663|NCT00649155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101680664|NCT00649155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101680665|NCT02758340|Misoprostol|misoprostol|mesh-list
101680666|NCT02758340|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101680667|NCT02758340|Abortifacient Agents|abortifacient agents|mesh-ancestor
101680668|NCT02758340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101680669|NCT02758340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680670|NCT02758340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101680671|NCT02758340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101680672|NCT02758340|Oxytocics|oxytocics|mesh-ancestor
101680673|NCT02768168|Dezocine|dezocine|mesh-list
101680674|NCT02768168|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101680676|NCT02768168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101680677|NCT02768168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680678|NCT02768168|Analgesics|analgesics|mesh-ancestor
101680679|NCT02768168|Sensory System Agents|sensory system agents|mesh-ancestor
101680680|NCT02768168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101680681|NCT03739554|Venetoclax|venetoclax|mesh-list
101680682|NCT03739554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101680683|NCT02659683|Esomeprazole|esomeprazole|mesh-list
101680684|NCT02659683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101680685|NCT02659683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101680686|NCT02659683|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101680687|NCT02659683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101680688|NCT02659683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680689|NCT04701476|Pembrolizumab|pembrolizumab|mesh-list
101680690|NCT04701476|Tirapazamine|tirapazamine|mesh-list
101680691|NCT04701476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101680692|NCT04701476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101680693|NCT04701476|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101680694|NCT04701476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680695|NCT05343702|Rocuronium|rocuronium|mesh-list
101680696|NCT05343702|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101680697|NCT05343702|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101680698|NCT05343702|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101680699|NCT05343702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101680700|NCT05343702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680701|NCT02659761|Lamivudine|lamivudine|mesh-list
101680702|NCT02659761|Abacavir|abacavir|mesh-list
101680703|NCT02659761|Dolutegravir|dolutegravir|mesh-list
101680704|NCT02659761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101680705|NCT02659761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101829731|NCT03672539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101829734|NCT03672539|Immunotoxins|immunotoxins|mesh-ancestor
101680706|NCT02659761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101680707|NCT02659761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680708|NCT02659761|Antiviral Agents|antiviral agents|mesh-ancestor
101680709|NCT02659761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101680710|NCT02659761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101680711|NCT02659761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101680712|NCT02659761|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101680713|NCT02659761|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101680715|NCT05343546|Levonorgestrel|levonorgestrel|mesh-list
101680716|NCT05343546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101680717|NCT05343546|Contraceptive Agents|contraceptive agents|mesh-ancestor
101680718|NCT05343546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101680719|NCT05343546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680720|NCT05343546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101680721|NCT05343546|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101680722|NCT05343546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101680723|NCT05343546|Trace Elements|trace elements|mesh-ancestor
101680724|NCT05343546|Micronutrients|micronutrients|mesh-ancestor
101680725|NCT02659917|Methamphetamine|methamphetamine|mesh-list
101680726|NCT02659917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101680727|NCT02659917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680728|NCT02659917|Sympathomimetics|sympathomimetics|mesh-ancestor
101680729|NCT02659917|Autonomic Agents|autonomic agents|mesh-ancestor
101680730|NCT02659917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101680731|NCT02659917|Dopamine Agents|dopamine agents|mesh-ancestor
101680732|NCT02659917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101680733|NCT02659917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680734|NCT02659917|Adrenergic Agents|adrenergic agents|mesh-ancestor
101680735|NCT02659917|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101680736|NCT02659917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101680737|NCT02659917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101680738|NCT02659917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101680739|NCT00954265|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101680740|NCT00954265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101680741|NCT00954265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680742|NCT04500236|Anesthetics|anesthetics|mesh-list
101680743|NCT04500236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101680744|NCT04500236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680745|NCT02658825|Moxifloxacin|moxifloxacin|mesh-list
101829740|NCT03629171|Antimetabolites|antimetabolites|mesh-ancestor
101680746|NCT02658825|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101680747|NCT02658825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101680748|NCT02658825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101680749|NCT02658825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101680750|NCT02658825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101680751|NCT02658825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101680752|NCT02658825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680753|NCT02658825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101680754|NCT02658825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101680755|NCT02658825|Contraceptive Agents|contraceptive agents|mesh-ancestor
101680756|NCT02658825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101680757|NCT02658825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680758|NCT02658825|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101680759|NCT02658825|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101680760|NCT02658825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101680762|NCT00649233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101680763|NCT00649233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101680764|NCT00649233|Diuretics|diuretics|mesh-ancestor
101680765|NCT00649233|Natriuretic Agents|natriuretic agents|mesh-ancestor
101680766|NCT00649233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680767|NCT00649233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101680768|NCT00649233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101680769|NCT00649233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680770|NCT00649233|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101680771|NCT00649233|Sympatholytics|sympatholytics|mesh-ancestor
101680772|NCT00649233|Autonomic Agents|autonomic agents|mesh-ancestor
101680773|NCT00649233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101680774|NCT00649233|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101680775|NCT00649233|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101680776|NCT00649233|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101680777|NCT00649233|Adrenergic Agents|adrenergic agents|mesh-ancestor
101680778|NCT00649233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101680779|NCT00954811|Progesterone|progesterone|mesh-list
101680780|NCT00954811|Progestins|progestins|mesh-ancestor
101680781|NCT00954811|Hormones|hormones|mesh-ancestor
101680782|NCT00954811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101680783|NCT00954811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680784|NCT00954889|Tamsulosin|tamsulosin|mesh-list
101680785|NCT00954889|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101680786|NCT00954889|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101680787|NCT00954889|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101680788|NCT00954889|Adrenergic Agents|adrenergic agents|mesh-ancestor
101680789|NCT00954889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101680790|NCT00954889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338046|NCT00070174|Cytarabine|cytarabine|mesh-list
101680791|NCT00954889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680792|NCT00954889|Urological Agents|urological agents|mesh-ancestor
101680793|NCT03666000|Cyclophosphamide|cyclophosphamide|mesh-list
101680794|NCT03666000|Fludarabine|fludarabine|mesh-list
101680795|NCT03666000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101680796|NCT03666000|Immunologic Factors|immunologic factors|mesh-ancestor
101680797|NCT03666000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680798|NCT03666000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101680799|NCT03666000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101680800|NCT03666000|Alkylating Agents|alkylating agents|mesh-ancestor
101680801|NCT03666000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680802|NCT03666000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101680803|NCT03666000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101680804|NCT02692248|Dexamethasone|dexamethasone|mesh-list
101680805|NCT02692248|Rituximab|rituximab|mesh-list
101680806|NCT02692248|Gemcitabine|gemcitabine|mesh-list
101680807|NCT02692248|Oxaliplatin|oxaliplatin|mesh-list
101680808|NCT02692248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101829773|NCT03609580|Adrenergic Agents|adrenergic agents|mesh-ancestor
101680809|NCT02692248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101680810|NCT02692248|Immunologic Factors|immunologic factors|mesh-ancestor
101680811|NCT02692248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680812|NCT02692248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101680813|NCT02692248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101680814|NCT02692248|Antiemetics|antiemetics|mesh-ancestor
101680815|NCT02692248|Autonomic Agents|autonomic agents|mesh-ancestor
101680816|NCT02692248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101680817|NCT02692248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101680818|NCT02692248|Glucocorticoids|glucocorticoids|mesh-ancestor
101680819|NCT02692248|Hormones|hormones|mesh-ancestor
101680820|NCT02692248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101680821|NCT02692248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101680822|NCT02692248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101680824|NCT02692248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680825|NCT02851290|Anesthetics|anesthetics|mesh-list
101680826|NCT02851290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101680827|NCT02851290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680828|NCT02757404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101680829|NCT02757404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101680830|NCT02757404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101680831|NCT02757404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680832|NCT02757404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101680833|NCT02757404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101680834|NCT02757404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680835|NCT02757404|Cholinergic Agents|cholinergic agents|mesh-ancestor
101680836|NCT02757404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101680837|NCT00955045|Istradefylline|istradefylline|mesh-list
101680838|NCT00955045|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
101680839|NCT00955045|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101680840|NCT00955045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101680841|NCT00955045|Purinergic Agents|purinergic agents|mesh-ancestor
101680842|NCT00955045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101680843|NCT00955045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680844|NCT00955045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680845|NCT00601107|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
101680846|NCT00601107|Vitamins|vitamins|mesh-ancestor
101680847|NCT00601107|Micronutrients|micronutrients|mesh-ancestor
101680848|NCT00601107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680849|NCT00601107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101680850|NCT00957385|Lenalidomide|lenalidomide|mesh-list
101680851|NCT00957385|Immunologic Factors|immunologic factors|mesh-ancestor
101680852|NCT00957385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680853|NCT00957385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101680854|NCT00957385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101680855|NCT00957385|Growth Substances|growth substances|mesh-ancestor
101680856|NCT00957385|Growth Inhibitors|growth inhibitors|mesh-ancestor
101680857|NCT00957385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101680858|NCT04169841|Durvalumab|durvalumab|mesh-list
101680859|NCT04169841|Olaparib|olaparib|mesh-list
101680860|NCT04169841|Tremelimumab|tremelimumab|mesh-list
101680861|NCT04169841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101680862|NCT04169841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101680863|NCT04169841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101338117|NCT00070252|Antimetabolites|antimetabolites|mesh-ancestor
101680864|NCT04169841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101680865|NCT04169841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680867|NCT02462538|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101680868|NCT02462538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101680869|NCT02462538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101829783|NCT03605342|Analgesics|analgesics|mesh-ancestor
101680870|NCT02462538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101680871|NCT02462538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680872|NCT02462538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101680873|NCT02462538|Immunotoxins|immunotoxins|mesh-ancestor
101680874|NCT02462538|Immunoconjugates|immunoconjugates|mesh-ancestor
101680875|NCT02462538|Immunologic Factors|immunologic factors|mesh-ancestor
101680876|NCT02462538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680877|NCT02752646|Ketorolac|ketorolac|mesh-list
101680878|NCT02752646|Nepafenac|nepafenac|mesh-list
101680879|NCT02752646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101680880|NCT02752646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101680881|NCT02752646|Analgesics|analgesics|mesh-ancestor
101680882|NCT02752646|Sensory System Agents|sensory system agents|mesh-ancestor
101680883|NCT02752646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101680884|NCT02752646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680885|NCT02752646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101680886|NCT02752646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101680887|NCT02752646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101680888|NCT02752646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101680889|NCT02752646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680890|NCT04169919|Povidone-Iodine|povidone-iodine|mesh-list
101680891|NCT04169919|Povidone|povidone|mesh-list
101680892|NCT04169919|Plasma Substitutes|plasma substitutes|mesh-ancestor
101680893|NCT04169919|Blood Substitutes|blood substitutes|mesh-ancestor
101545791|NCT04396587|Sufentanil|sufentanil|mesh-list
101680894|NCT04169919|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101680895|NCT04169919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101680896|NCT02757248|Romidepsin|romidepsin|mesh-list
101680897|NCT02757248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101680898|NCT02757248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101680899|NCT02757248|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101680900|NCT02757248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101680901|NCT02757248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680902|NCT00649311|Losartan|losartan|mesh-list
101680903|NCT00649311|Eplerenone|eplerenone|mesh-list
101680904|NCT00649311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101680905|NCT00649311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101680906|NCT00649311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101680907|NCT00649311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101680908|NCT00649311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680909|NCT00649311|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101680910|NCT00649311|Hormone Antagonists|hormone antagonists|mesh-ancestor
101680911|NCT00649311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101680912|NCT00649311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680913|NCT00649311|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101680914|NCT00649311|Diuretics|diuretics|mesh-ancestor
101680915|NCT00649311|Natriuretic Agents|natriuretic agents|mesh-ancestor
101680916|NCT02704494|Losartan|losartan|mesh-list
101680917|NCT02704494|Resveratrol|resveratrol|mesh-list
101680918|NCT02704494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101680919|NCT02704494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101680920|NCT02704494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101680921|NCT02704494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101680922|NCT02704494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680923|NCT02704494|Antioxidants|antioxidants|mesh-ancestor
101680924|NCT02704494|Protective Agents|protective agents|mesh-ancestor
101680925|NCT02704494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680926|NCT02704494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101680927|NCT02704494|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101680928|NCT00649467|Topiramate|topiramate|mesh-list
101680929|NCT00649467|Anticonvulsants|anticonvulsants|mesh-ancestor
101829794|NCT03598608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101829795|NCT03598608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101829796|NCT03598608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101829797|NCT03598608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101829803|NCT03530696|Palbociclib|palbociclib|mesh-list
101680931|NCT00649467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680932|NCT00649545|Adalimumab|adalimumab|mesh-list
101680933|NCT00649545|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101680934|NCT00649545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101680935|NCT00649545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101680936|NCT00635414|Esomeprazole|esomeprazole|mesh-list
101338192|NCT00071188|Paclitaxel|paclitaxel|mesh-list
101680937|NCT00635414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101680938|NCT00635414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101680939|NCT00635414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101680940|NCT00635414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101680941|NCT00635414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680942|NCT02658435|Tafenoquine|tafenoquine|mesh-list
101680943|NCT02658435|Antimalarials|antimalarials|mesh-ancestor
101680944|NCT02658435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101680945|NCT02658435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101680946|NCT02658435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101680947|NCT02756546|Hydroxychloroquine|hydroxychloroquine|mesh-list
101680948|NCT02756546|Hydrocortisone|hydrocortisone|mesh-list
101680949|NCT02756546|Cyclophosphamide|cyclophosphamide|mesh-list
101680950|NCT02756546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101680951|NCT02756546|Immunologic Factors|immunologic factors|mesh-ancestor
101680952|NCT02756546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680953|NCT02756546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101680954|NCT02756546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101680955|NCT02756546|Alkylating Agents|alkylating agents|mesh-ancestor
101680956|NCT02756546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680957|NCT02756546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101680958|NCT02756546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101680959|NCT02756546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101680960|NCT02756546|Antimalarials|antimalarials|mesh-ancestor
101680961|NCT02756546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101680962|NCT02756546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101680963|NCT02756546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101680964|NCT02756546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101680965|NCT02759666|Fluzoparib|fluzoparib|mesh-list
101680966|NCT02759666|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101680967|NCT02759666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101680968|NCT02759666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680969|NCT02759666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101680970|NCT02752724|Ketamine|ketamine|mesh-list
101680971|NCT02752724|Methohexital|methohexital|mesh-list
101680972|NCT02752724|Analgesics|analgesics|mesh-ancestor
101680973|NCT02752724|Sensory System Agents|sensory system agents|mesh-ancestor
101680974|NCT02752724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101680975|NCT02752724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680976|NCT02752724|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101680977|NCT02752724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101680979|NCT02752724|Anesthetics|anesthetics|mesh-ancestor
101680980|NCT02752724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101680981|NCT02752724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101680982|NCT02752724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101680983|NCT02752724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101326208|NCT00008333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101680984|NCT02752724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680985|NCT00649623|Olmesartan|olmesartan|mesh-list
101680986|NCT00649623|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101680987|NCT00649623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101680988|NCT00649623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101680989|NCT00649623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101680990|NCT00649623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101680991|NCT02756312|Anesthetics|anesthetics|mesh-list
101829804|NCT03530696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101680992|NCT02756312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101680993|NCT02756312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101680994|NCT02657187|Rocuronium|rocuronium|mesh-list
101680995|NCT02657187|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101680996|NCT02657187|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101680997|NCT02657187|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101680998|NCT02657187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101680999|NCT02657187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681000|NCT00649779|Albuterol|albuterol|mesh-list
101681001|NCT00649779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101681002|NCT00649779|Autonomic Agents|autonomic agents|mesh-ancestor
101681003|NCT00649779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101681004|NCT00649779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681005|NCT00649779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101681006|NCT00649779|Respiratory System Agents|respiratory system agents|mesh-ancestor
101681007|NCT00649779|Tocolytic Agents|tocolytic agents|mesh-ancestor
101681008|NCT00649779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101681009|NCT00649779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101681010|NCT00649779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101681012|NCT00649779|Adrenergic Agents|adrenergic agents|mesh-ancestor
101681013|NCT00649779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101681014|NCT00649779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681015|NCT00615186|Temozolomide|temozolomide|mesh-list
101681016|NCT00615186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101681017|NCT00615186|Alkylating Agents|alkylating agents|mesh-ancestor
101681018|NCT00615186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681019|NCT00615186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101681020|NCT00616044|Anesthetics|anesthetics|mesh-list
101681021|NCT00616044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101681022|NCT00616044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681023|NCT02536911|Eliglustat|eliglustat|mesh-list
101681024|NCT02536911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101681025|NCT02536911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681026|NCT04221152|Empagliflozin|empagliflozin|mesh-list
101681027|NCT04221152|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101681028|NCT04221152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681029|NCT04221152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101681030|NCT04221152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681031|NCT02656563|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
101681032|NCT02656563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101681033|NCT02759510|Phenylephrine|phenylephrine|mesh-list
101681034|NCT02759510|Oxymetazoline|oxymetazoline|mesh-list
101681035|NCT02759510|Norepinephrine|norepinephrine|mesh-list
101681036|NCT02759510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101681037|NCT02759510|Mydriatics|mydriatics|mesh-ancestor
101681038|NCT02759510|Autonomic Agents|autonomic agents|mesh-ancestor
101681039|NCT02759510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101681040|NCT02759510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681041|NCT02759510|Sympathomimetics|sympathomimetics|mesh-ancestor
101681042|NCT02759510|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101681043|NCT02759510|Nasal Decongestants|nasal decongestants|mesh-ancestor
101681044|NCT02759510|Respiratory System Agents|respiratory system agents|mesh-ancestor
101681045|NCT02759510|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101681046|NCT02759510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101681048|NCT02759510|Adrenergic Agents|adrenergic agents|mesh-ancestor
101681049|NCT02759510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101681050|NCT02759510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681051|NCT02759510|Protective Agents|protective agents|mesh-ancestor
101681052|NCT04220528|Capecitabine|capecitabine|mesh-list
101681053|NCT04220528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101681054|NCT04220528|Antimetabolites|antimetabolites|mesh-ancestor
101681055|NCT04220528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681056|NCT04220528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101681057|NCT02759042|Leronlimab|leronlimab|mesh-list
101681058|NCT02759042|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101681059|NCT02759042|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101681060|NCT02759042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681061|NCT02759042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101681062|NCT02759042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101681063|NCT02759042|Antiviral Agents|antiviral agents|mesh-ancestor
101681064|NCT02759042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101681065|NCT02755532|Bupivacaine|bupivacaine|mesh-list
101681066|NCT02755532|Anesthetics, Local|anesthetics, local|mesh-ancestor
101681067|NCT02755532|Anesthetics|anesthetics|mesh-ancestor
101681068|NCT02755532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101681069|NCT02755532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681070|NCT02755532|Sensory System Agents|sensory system agents|mesh-ancestor
101681071|NCT02755532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101681072|NCT02755376|Hyaluronic Acid|hyaluronic acid|mesh-list
101681073|NCT02755376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101681074|NCT02755376|Immunologic Factors|immunologic factors|mesh-ancestor
101681075|NCT02755376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681076|NCT02755376|Viscosupplements|viscosupplements|mesh-ancestor
101681077|NCT02755376|Protective Agents|protective agents|mesh-ancestor
101681078|NCT02752334|Magnesium Sulfate|magnesium sulfate|mesh-list
101681079|NCT02752334|Bupivacaine|bupivacaine|mesh-list
101681080|NCT02752334|Anesthetics, Local|anesthetics, local|mesh-ancestor
101681081|NCT02752334|Anesthetics|anesthetics|mesh-ancestor
101681082|NCT02752334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101681083|NCT02752334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681084|NCT02752334|Sensory System Agents|sensory system agents|mesh-ancestor
101681085|NCT02752334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101681086|NCT02752334|Analgesics|analgesics|mesh-ancestor
101681087|NCT02752334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101681088|NCT02752334|Anticonvulsants|anticonvulsants|mesh-ancestor
101681089|NCT02752334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101681090|NCT02752334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101681091|NCT02752334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681092|NCT02752334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101681093|NCT02752334|Tocolytic Agents|tocolytic agents|mesh-ancestor
101681094|NCT02752334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101681095|NCT02755298|Acetazolamide|acetazolamide|mesh-list
101681096|NCT02755298|Anticonvulsants|anticonvulsants|mesh-ancestor
101681097|NCT02755298|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101681098|NCT02755298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101681099|NCT02755298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681100|NCT02755298|Diuretics|diuretics|mesh-ancestor
101681101|NCT02755298|Natriuretic Agents|natriuretic agents|mesh-ancestor
101681102|NCT02755298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681103|NCT02755142|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101681104|NCT02755142|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101681105|NCT02755142|Dermatologic Agents|dermatologic agents|mesh-ancestor
101681107|NCT02759198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101681108|NCT02759198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101681109|NCT02759198|Analgesics|analgesics|mesh-ancestor
101681110|NCT02759198|Sensory System Agents|sensory system agents|mesh-ancestor
101681111|NCT02759198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101681112|NCT02759198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681113|NCT02759198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101681114|NCT02759198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101681115|NCT02759198|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101681116|NCT02759198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101681117|NCT02759198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101681118|NCT02759198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681119|NCT04220606|Nitroglycerin|nitroglycerin|mesh-list
101681120|NCT04220606|Vasodilator Agents|vasodilator agents|mesh-ancestor
101681121|NCT02755064|Erythromycin|erythromycin|mesh-list
101681122|NCT02755064|Erythromycin Estolate|erythromycin estolate|mesh-list
101681123|NCT02755064|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101681124|NCT02755064|Erythromycin stearate|erythromycin stearate|mesh-list
101681125|NCT02755064|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
101681126|NCT02755064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101681127|NCT02755064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101681128|NCT02755064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101681129|NCT02755064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101829824|NCT03520686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101681130|NCT02755064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101681131|NCT02755064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681132|NCT02705976|Warfarin|warfarin|mesh-list
101681133|NCT02705976|Anticoagulants|anticoagulants|mesh-ancestor
101681134|NCT02752412|Insulin|insulin|mesh-list
101681135|NCT02752412|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101681136|NCT02752412|Metformin|metformin|mesh-list
101681137|NCT02752412|Insulin Glargine|insulin glargine|mesh-list
101681138|NCT02752412|Lixisenatide|lixisenatide|mesh-list
101681139|NCT02752412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101681140|NCT02752412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681141|NCT02703090|Remifentanil|remifentanil|mesh-list
101681142|NCT02703090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101681143|NCT02703090|Narcotics|narcotics|mesh-ancestor
101681144|NCT02703090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101681145|NCT02703090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681146|NCT02703090|Analgesics|analgesics|mesh-ancestor
101681147|NCT02703090|Sensory System Agents|sensory system agents|mesh-ancestor
101681148|NCT02703090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101681149|NCT02754362|Bevacizumab|bevacizumab|mesh-list
101681150|NCT02754362|Poly ICLC|poly iclc|mesh-list
101681151|NCT02754362|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
101681152|NCT02754362|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
101681153|NCT02754362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101681154|NCT02754362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101681155|NCT02754362|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101681156|NCT02754362|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101681157|NCT02754362|Growth Substances|growth substances|mesh-ancestor
101681158|NCT02754362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681159|NCT02754362|Growth Inhibitors|growth inhibitors|mesh-ancestor
101681160|NCT02754362|Interferon Inducers|interferon inducers|mesh-ancestor
101681161|NCT02754362|Immunologic Factors|immunologic factors|mesh-ancestor
101681163|NCT03373188|Ipilimumab|ipilimumab|mesh-list
101681164|NCT03373188|Antibodies|antibodies|mesh-list
101681165|NCT03373188|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101681166|NCT03373188|Immunologic Factors|immunologic factors|mesh-ancestor
101681167|NCT03373188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681168|NCT03373188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101681169|NCT03373188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101681170|NCT03373188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101681171|NCT03373188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681172|NCT02698098|Methadone|methadone|mesh-list
101681173|NCT02698098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101681174|NCT02698098|Narcotics|narcotics|mesh-ancestor
101681175|NCT02698098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101681176|NCT02698098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681177|NCT02698098|Analgesics|analgesics|mesh-ancestor
101681178|NCT02698098|Sensory System Agents|sensory system agents|mesh-ancestor
101681179|NCT02698098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101681180|NCT02698098|Antitussive Agents|antitussive agents|mesh-ancestor
101681181|NCT02698098|Respiratory System Agents|respiratory system agents|mesh-ancestor
101681182|NCT04220996|Vortioxetine|vortioxetine|mesh-list
101681183|NCT04220996|Antidepressive Agents|antidepressive agents|mesh-ancestor
101681184|NCT04220996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101681185|NCT04220996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101681186|NCT04220996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101681187|NCT04220996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101681188|NCT04220996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681189|NCT04220996|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101681190|NCT04220996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101681191|NCT04220996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101681192|NCT04220996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681193|NCT04220996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101681194|NCT04220996|Serotonin Agents|serotonin agents|mesh-ancestor
101829829|NCT03486873|Pembrolizumab|pembrolizumab|mesh-list
101681195|NCT04220996|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101681196|NCT04220996|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101681197|NCT04220996|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101681198|NCT04220996|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101681200|NCT02702700|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101681201|NCT02702700|Dermatologic Agents|dermatologic agents|mesh-ancestor
101681202|NCT02702622|Provitamins|provitamins|mesh-list
101681203|NCT02702622|Beta Carotene|beta carotene|mesh-list
101681204|NCT02702622|Vitamins|vitamins|mesh-ancestor
101681205|NCT02702622|Micronutrients|micronutrients|mesh-ancestor
101681206|NCT02702622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681207|NCT04214808|Dutasteride|dutasteride|mesh-list
101681208|NCT04214808|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101681209|NCT04214808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101681210|NCT04214808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101681211|NCT04214808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681212|NCT04214808|Hormone Antagonists|hormone antagonists|mesh-ancestor
101681213|NCT04214808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101681214|NCT04214808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681215|NCT02702778|Prednisone|prednisone|mesh-list
101681216|NCT02702778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101681217|NCT02702778|Glucocorticoids|glucocorticoids|mesh-ancestor
101681218|NCT02702778|Hormones|hormones|mesh-ancestor
101681219|NCT02702778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101681220|NCT02702778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681221|NCT02702778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101681222|NCT02702778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101681223|NCT02753738|Escitalopram|escitalopram|mesh-list
101681224|NCT02753738|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101681225|NCT02753738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101681226|NCT02753738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101681227|NCT02753738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681228|NCT02753738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101681229|NCT02753738|Serotonin Agents|serotonin agents|mesh-ancestor
101681230|NCT02753738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681231|NCT02751632|Fluoxetine|fluoxetine|mesh-list
101681232|NCT02751632|Antidepressive Agents|antidepressive agents|mesh-list
101681233|NCT02751632|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101681234|NCT02751632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101681235|NCT02751632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101681236|NCT02751632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681237|NCT02751632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101681238|NCT02751632|Serotonin Agents|serotonin agents|mesh-ancestor
101681239|NCT02751632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681240|NCT02751632|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101681241|NCT02751632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101681242|NCT02751632|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101681243|NCT02751632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101681244|NCT02751632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101681245|NCT04805268|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101681246|NCT04805268|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101681247|NCT04805268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681248|NCT02751476|Disinfectants|disinfectants|mesh-list
101681249|NCT02751476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101681251|NCT02705664|Bifonazole|bifonazole|mesh-list
101681252|NCT02705664|Antifungal Agents|antifungal agents|mesh-ancestor
101681253|NCT02705664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101681254|NCT02753426|Doxycycline|doxycycline|mesh-list
101681255|NCT02753426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101681256|NCT02753426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101829840|NCT03452332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101681257|NCT02753426|Antimalarials|antimalarials|mesh-ancestor
101681258|NCT02753426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101681259|NCT02753426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101681260|NCT04219124|Dapagliflozin|dapagliflozin|mesh-list
101681261|NCT04219124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
101681262|NCT04219124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681263|NCT04219124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101681264|NCT04219124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681265|NCT02702076|Apomorphine|apomorphine|mesh-list
101681266|NCT02702076|Emetics|emetics|mesh-ancestor
101681267|NCT02702076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681268|NCT02702076|Autonomic Agents|autonomic agents|mesh-ancestor
101681269|NCT02702076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101681270|NCT02702076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101681271|NCT02702076|Dopamine Agonists|dopamine agonists|mesh-ancestor
101681272|NCT02702076|Dopamine Agents|dopamine agents|mesh-ancestor
101681273|NCT02702076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101681274|NCT02702076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681275|NCT02751398|Dapagliflozin|dapagliflozin|mesh-list
101681276|NCT02751398|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101681277|NCT02751398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681278|NCT02751398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101681279|NCT02751398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681280|NCT02753114|Ketamine|ketamine|mesh-list
101681281|NCT02753114|Analgesics|analgesics|mesh-ancestor
101681282|NCT02753114|Sensory System Agents|sensory system agents|mesh-ancestor
101681283|NCT02753114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101681284|NCT02753114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681285|NCT02753114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101681286|NCT02753114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101681287|NCT02753114|Anesthetics, General|anesthetics, general|mesh-ancestor
101681288|NCT02753114|Anesthetics|anesthetics|mesh-ancestor
101681289|NCT02753114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101681290|NCT02753114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101681291|NCT02753114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101681292|NCT02753114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101681293|NCT02753114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681299|NCT05324748|Methylprednisolone|methylprednisolone|mesh-list
101681300|NCT05324748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101681301|NCT05324748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101681302|NCT05324748|Prednisolone|prednisolone|mesh-list
101681303|NCT05324748|Prednisolone acetate|prednisolone acetate|mesh-list
101681304|NCT05324748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101681305|NCT05324748|Prednisolone phosphate|prednisolone phosphate|mesh-list
101681306|NCT05324748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101338571|NCT02966236|Hemostatics|hemostatics|mesh-ancestor
101681307|NCT05324748|Antiemetics|antiemetics|mesh-ancestor
101681308|NCT05324748|Autonomic Agents|autonomic agents|mesh-ancestor
101681309|NCT05324748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101681310|NCT05324748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681311|NCT05324748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101681312|NCT05324748|Glucocorticoids|glucocorticoids|mesh-ancestor
101681313|NCT05324748|Hormones|hormones|mesh-ancestor
101681314|NCT05324748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101829851|NCT03450057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101829852|NCT03450057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101829854|NCT03450057|Glucocorticoids|glucocorticoids|mesh-ancestor
101681315|NCT05324748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101681316|NCT05324748|Protective Agents|protective agents|mesh-ancestor
101681317|NCT05324748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101681318|NCT05324748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101681320|NCT02705274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101681321|NCT02705274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101681322|NCT02705274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101681323|NCT02705274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101681324|NCT02705274|Growth Substances|growth substances|mesh-ancestor
101681325|NCT02705274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681326|NCT02705274|Growth Inhibitors|growth inhibitors|mesh-ancestor
101681327|NCT00914849|Plerixafor|plerixafor|mesh-list
101681328|NCT00914849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101681329|NCT00914849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101681330|NCT00914849|Antiviral Agents|antiviral agents|mesh-ancestor
101681331|NCT00914849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101681332|NCT02704962|Olanzapine|olanzapine|mesh-list
101681333|NCT02704962|Antiemetics|antiemetics|mesh-ancestor
101681334|NCT02704962|Autonomic Agents|autonomic agents|mesh-ancestor
101681335|NCT02704962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101681336|NCT02704962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681337|NCT02704962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101681338|NCT02704962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101681339|NCT02704962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101681340|NCT02704962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101681341|NCT02704962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101681342|NCT02704962|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101681343|NCT02704962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101681344|NCT02704962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101681345|NCT02704962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681346|NCT02704962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101681347|NCT02704962|Serotonin Agents|serotonin agents|mesh-ancestor
101681348|NCT00631943|Pregabalin|pregabalin|mesh-list
101681349|NCT00631943|Analgesics|analgesics|mesh-ancestor
101681350|NCT00631943|Sensory System Agents|sensory system agents|mesh-ancestor
101681351|NCT00631943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101681352|NCT00631943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681353|NCT00631943|Anticonvulsants|anticonvulsants|mesh-ancestor
101681354|NCT00631943|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101681355|NCT00631943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101681356|NCT00631943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681357|NCT00631943|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101681358|NCT00631943|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101681359|NCT00631943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101681360|NCT00631943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101681361|NCT00631943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101681362|NCT05429684|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101681363|NCT05429684|Capecitabine|capecitabine|mesh-list
101681364|NCT05429684|Trastuzumab|trastuzumab|mesh-list
101681365|NCT05429684|Everolimus|everolimus|mesh-list
101681366|NCT05429684|Letrozole|letrozole|mesh-list
101681367|NCT05429684|Palbociclib|palbociclib|mesh-list
101681368|NCT05429684|Pertuzumab|pertuzumab|mesh-list
101681369|NCT05429684|Antibodies|antibodies|mesh-list
101681370|NCT05429684|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101681371|NCT05429684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101681372|NCT05429684|Tubulin Modulators|tubulin modulators|mesh-ancestor
101681373|NCT05429684|Antimitotic Agents|antimitotic agents|mesh-ancestor
101681374|NCT05429684|Mitosis Modulators|mitosis modulators|mesh-ancestor
101681375|NCT05429684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681376|NCT05429684|Immunologic Factors|immunologic factors|mesh-ancestor
101681377|NCT05429684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681378|NCT05429684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101681379|NCT05429684|Antimetabolites|antimetabolites|mesh-ancestor
101829870|NCT03335839|Plasminogen|plasminogen|mesh-list
101681380|NCT05429684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101681381|NCT05429684|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101338644|NCT00073879|Fludarabine|fludarabine|mesh-list
101681382|NCT05429684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101681383|NCT05429684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101681384|NCT05429684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101681385|NCT05429684|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101681386|NCT05429684|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101681387|NCT05429684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101681388|NCT05429684|Hormone Antagonists|hormone antagonists|mesh-ancestor
101681389|NCT05429684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101681390|NCT05429684|Immunotoxins|immunotoxins|mesh-ancestor
101681391|NCT05429684|Immunoconjugates|immunoconjugates|mesh-ancestor
101681392|NCT05324592|Aflibercept|aflibercept|mesh-list
101681393|NCT05324592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101681394|NCT05324592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101681395|NCT05324592|Growth Substances|growth substances|mesh-ancestor
101681396|NCT05324592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681397|NCT05324592|Growth Inhibitors|growth inhibitors|mesh-ancestor
101681398|NCT05324592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101681400|NCT04433858|Hallucinogens|hallucinogens|mesh-ancestor
101681401|NCT04433858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681402|NCT04433858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101681403|NCT02750696|Acetaminophen|acetaminophen|mesh-list
101681404|NCT02750696|Tramadol|tramadol|mesh-list
101681405|NCT02750696|Codeine|codeine|mesh-list
101681406|NCT02750696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101681407|NCT02750696|Analgesics|analgesics|mesh-ancestor
101681408|NCT02750696|Sensory System Agents|sensory system agents|mesh-ancestor
101681409|NCT02750696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101681410|NCT02750696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681411|NCT02750696|Antipyretics|antipyretics|mesh-ancestor
101681412|NCT02750696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101681413|NCT02750696|Narcotics|narcotics|mesh-ancestor
101681414|NCT02750696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101681415|NCT02750696|Antitussive Agents|antitussive agents|mesh-ancestor
101681416|NCT02750696|Respiratory System Agents|respiratory system agents|mesh-ancestor
101681417|NCT02695550|Conteltinib|conteltinib|mesh-list
101681418|NCT02695550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101681419|NCT02695550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101681420|NCT02695550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681421|NCT00912743|Olaparib|olaparib|mesh-list
101681422|NCT00912743|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101681423|NCT00912743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101681424|NCT00912743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681425|NCT00912743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101681426|NCT04432610|Nebivolol|nebivolol|mesh-list
101681427|NCT04432610|Bisoprolol|bisoprolol|mesh-list
101681428|NCT04432610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101681429|NCT04432610|Vasodilator Agents|vasodilator agents|mesh-ancestor
101681430|NCT04432610|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101681431|NCT04432610|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101681432|NCT04432610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101681433|NCT04432610|Adrenergic Agents|adrenergic agents|mesh-ancestor
101681434|NCT04432610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101681435|NCT04432610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681436|NCT04432610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681437|NCT04432610|Sympatholytics|sympatholytics|mesh-ancestor
101681438|NCT04432610|Autonomic Agents|autonomic agents|mesh-ancestor
101681439|NCT04432610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101681440|NCT04432610|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101681441|NCT04432610|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101829878|NCT03317392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101681442|NCT04432610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101681443|NCT04643093|Ezetimibe|ezetimibe|mesh-list
101681444|NCT04643093|Pitavastatin|pitavastatin|mesh-list
101681445|NCT04643093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101681446|NCT04643093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101681447|NCT04643093|Antimetabolites|antimetabolites|mesh-ancestor
101681448|NCT04643093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681449|NCT04643093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101681450|NCT04643093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101681451|NCT04643093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101681452|NCT00914459|Factor VIII|factor viii|mesh-list
101681453|NCT00914459|Coagulants|coagulants|mesh-ancestor
101681455|NCT02701608|Rifampin|rifampin|mesh-list
101681456|NCT02701608|Fluoroquinolones|fluoroquinolones|mesh-list
101681457|NCT02701608|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101681458|NCT02701608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101681459|NCT02701608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101681460|NCT02701608|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101681461|NCT02701608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101681462|NCT02701608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101681463|NCT02701608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681464|NCT02701608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101681465|NCT02701608|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101681466|NCT02701608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101681467|NCT02701608|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101681468|NCT02701608|Antitubercular Agents|antitubercular agents|mesh-ancestor
101681469|NCT02701608|Leprostatic Agents|leprostatic agents|mesh-ancestor
101681470|NCT02701608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101681471|NCT02701608|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101681472|NCT02701608|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101681473|NCT02701608|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101681474|NCT02701608|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101681475|NCT02701608|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101681476|NCT02701608|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101681477|NCT00635960|Hormones|hormones|mesh-list
101681478|NCT00635960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101681479|NCT00635960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681480|NCT05429294|Paclitaxel|paclitaxel|mesh-list
101681481|NCT05429294|Trastuzumab|trastuzumab|mesh-list
101681482|NCT05429294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101681483|NCT05429294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101681484|NCT05429294|Tubulin Modulators|tubulin modulators|mesh-ancestor
101681485|NCT05429294|Antimitotic Agents|antimitotic agents|mesh-ancestor
101681486|NCT05429294|Mitosis Modulators|mitosis modulators|mesh-ancestor
101681487|NCT05429294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681488|NCT05429294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101681489|NCT04219046|Naloxegol|naloxegol|mesh-list
101681490|NCT04219046|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101681491|NCT04219046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681492|NCT04219046|Sensory System Agents|sensory system agents|mesh-ancestor
101681493|NCT04219046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101681494|NCT00912509|Riboflavin|riboflavin|mesh-list
101681495|NCT00912509|Vitamin B Complex|vitamin b complex|mesh-ancestor
101681496|NCT00912509|Vitamins|vitamins|mesh-ancestor
101681497|NCT00912509|Micronutrients|micronutrients|mesh-ancestor
101681498|NCT00912509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681499|NCT00912509|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101681500|NCT00912509|Dermatologic Agents|dermatologic agents|mesh-ancestor
101681501|NCT02873598|Paclitaxel|paclitaxel|mesh-list
101681502|NCT02873598|Gemcitabine|gemcitabine|mesh-list
101681503|NCT02873598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101681504|NCT02873598|Folfirinox|folfirinox|mesh-list
101681505|NCT02873598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101681506|NCT02873598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101681507|NCT02873598|Tubulin Modulators|tubulin modulators|mesh-ancestor
101681508|NCT02873598|Antimitotic Agents|antimitotic agents|mesh-ancestor
101681509|NCT02873598|Mitosis Modulators|mitosis modulators|mesh-ancestor
101681510|NCT02873598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681511|NCT02873598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101681512|NCT02873598|Antimetabolites|antimetabolites|mesh-ancestor
101681513|NCT02749994|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101681514|NCT02749994|Ezetimibe|ezetimibe|mesh-list
101681515|NCT02749994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101681516|NCT02749994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101681517|NCT02749994|Antimetabolites|antimetabolites|mesh-ancestor
101681518|NCT02749994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681519|NCT02749994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101681520|NCT02749994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101681521|NCT02749994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101681522|NCT04417049|Pentoxifylline|pentoxifylline|mesh-list
101681523|NCT04417049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101681524|NCT04417049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101681525|NCT04417049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681526|NCT04417049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101681527|NCT04417049|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101681528|NCT04417049|Protective Agents|protective agents|mesh-ancestor
101681529|NCT04417049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681530|NCT04417049|Vasodilator Agents|vasodilator agents|mesh-ancestor
101681531|NCT04417049|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101681532|NCT04417049|Antioxidants|antioxidants|mesh-ancestor
101681533|NCT02862210|Lithium Carbonate|lithium carbonate|mesh-list
101681534|NCT02862210|Antidepressive Agents|antidepressive agents|mesh-ancestor
101681535|NCT02862210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101681536|NCT02862210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101681537|NCT02862210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681538|NCT02862210|Antimanic Agents|antimanic agents|mesh-ancestor
101681539|NCT02862210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101681540|NCT02862210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101681541|NCT02862210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681542|NCT05323422|Ketamine|ketamine|mesh-list
101681543|NCT05323422|Analgesics|analgesics|mesh-ancestor
101681544|NCT05323422|Sensory System Agents|sensory system agents|mesh-ancestor
101681545|NCT05323422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101681546|NCT05323422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681547|NCT05323422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101681548|NCT05323422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101681549|NCT05323422|Anesthetics, General|anesthetics, general|mesh-ancestor
101681550|NCT05323422|Anesthetics|anesthetics|mesh-ancestor
101681551|NCT05323422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101681552|NCT05323422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101681553|NCT05323422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101681554|NCT05323422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101681555|NCT05323422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681556|NCT02700906|Lidocaine|lidocaine|mesh-list
101681557|NCT02700906|Anesthetics, Local|anesthetics, local|mesh-ancestor
101681558|NCT02700906|Anesthetics|anesthetics|mesh-ancestor
101681559|NCT02700906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101681560|NCT02700906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681561|NCT02700906|Sensory System Agents|sensory system agents|mesh-ancestor
101681562|NCT02700906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101681563|NCT02700906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101681564|NCT02700906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101681565|NCT02700906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101681566|NCT02700906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101681567|NCT02700906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681568|NCT00636038|Beta Carotene|beta carotene|mesh-list
101681569|NCT00636038|Carotenoids|carotenoids|mesh-list
101681570|NCT00636038|Antioxidants|antioxidants|mesh-ancestor
101681571|NCT00636038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681572|NCT00636038|Protective Agents|protective agents|mesh-ancestor
101681573|NCT00636038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681574|NCT00636038|Provitamins|provitamins|mesh-ancestor
101681575|NCT00636038|Vitamins|vitamins|mesh-ancestor
101681576|NCT00636038|Micronutrients|micronutrients|mesh-ancestor
101829896|NCT03214562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681577|NCT04213716|Calcium, Dietary|calcium, dietary|mesh-list
101681578|NCT04213716|Calcium|calcium|mesh-list
101681579|NCT04213716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101681580|NCT04213716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681581|NCT04213716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101681582|NCT04218890|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
101681583|NCT04218890|Thromboplastin|thromboplastin|mesh-list
101681584|NCT04218890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101681585|NCT04218890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101681586|NCT04218890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681587|NCT04218890|Hemostatics|hemostatics|mesh-ancestor
101681588|NCT04218890|Coagulants|coagulants|mesh-ancestor
101681589|NCT04218890|Anticoagulants|anticoagulants|mesh-ancestor
101681590|NCT04218890|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101681591|NCT04218890|Protease Inhibitors|protease inhibitors|mesh-ancestor
101681592|NCT04218890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101681593|NCT04218890|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101681594|NCT04218890|Antithrombins|antithrombins|mesh-ancestor
101681595|NCT00636116|Antivenins|antivenins|mesh-list
101681596|NCT00636116|Immunologic Factors|immunologic factors|mesh-ancestor
101681597|NCT00636116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681598|NCT04772196|Vitamin D|vitamin d|mesh-list
101681599|NCT04772196|Cholecalciferol|cholecalciferol|mesh-list
101681600|NCT04772196|Vitamins|vitamins|mesh-ancestor
101681601|NCT04772196|Micronutrients|micronutrients|mesh-ancestor
101681602|NCT04772196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681603|NCT04772196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101681604|NCT04772196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101681605|NCT05428670|Rituximab|rituximab|mesh-list
101681606|NCT05428670|Lenalidomide|lenalidomide|mesh-list
101681607|NCT05428670|Zanubrutinib|zanubrutinib|mesh-list
101681608|NCT05428670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101681609|NCT05428670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101681610|NCT05428670|Immunologic Factors|immunologic factors|mesh-ancestor
101681611|NCT05428670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681612|NCT05428670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101681613|NCT05428670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101681614|NCT05428670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101681615|NCT05428670|Growth Substances|growth substances|mesh-ancestor
101681616|NCT05428670|Growth Inhibitors|growth inhibitors|mesh-ancestor
101681617|NCT05428670|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101681618|NCT05428670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101681619|NCT05428670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681620|NCT00635726|Cisplatin|cisplatin|mesh-list
101681621|NCT00635726|Gemcitabine|gemcitabine|mesh-list
101681622|NCT00635726|Doxorubicin|doxorubicin|mesh-list
101681623|NCT00635726|Methotrexate|methotrexate|mesh-list
101681624|NCT00635726|Vinblastine|vinblastine|mesh-list
101681625|NCT00635726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101681626|NCT00635726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101681627|NCT00635726|Antimetabolites|antimetabolites|mesh-ancestor
101681628|NCT00635726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681629|NCT00635726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101681630|NCT00635726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101681631|NCT00635726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101681632|NCT00635726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101681633|NCT00635726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101681634|NCT00635726|Abortifacient Agents|abortifacient agents|mesh-ancestor
101681635|NCT00635726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101681636|NCT00635726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681637|NCT00635726|Dermatologic Agents|dermatologic agents|mesh-ancestor
101681638|NCT00635726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101681639|NCT00635726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101681640|NCT00635726|Immunologic Factors|immunologic factors|mesh-ancestor
101681641|NCT00635726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101681642|NCT00635726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101681643|NCT00635726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101681644|NCT00635726|Tubulin Modulators|tubulin modulators|mesh-ancestor
101681645|NCT00635726|Antimitotic Agents|antimitotic agents|mesh-ancestor
101681646|NCT00635726|Mitosis Modulators|mitosis modulators|mesh-ancestor
101681647|NCT04219982|Scopolamine|scopolamine|mesh-list
101681648|NCT04219982|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101681649|NCT04219982|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101681650|NCT04219982|Antiemetics|antiemetics|mesh-ancestor
101681651|NCT04219982|Autonomic Agents|autonomic agents|mesh-ancestor
101681652|NCT04219982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101681653|NCT04219982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681654|NCT04219982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101681655|NCT04219982|Mydriatics|mydriatics|mesh-ancestor
101681656|NCT04219982|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101681657|NCT04219982|Cholinergic Agents|cholinergic agents|mesh-ancestor
101681658|NCT04219982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101681659|NCT04219982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681660|NCT04219982|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101681661|NCT04219982|Parasympatholytics|parasympatholytics|mesh-ancestor
101681662|NCT02700438|Nitroglycerin|nitroglycerin|mesh-list
101681663|NCT02700438|Vasodilator Agents|vasodilator agents|mesh-ancestor
101681664|NCT04216706|Calcium Channel Blockers|calcium channel blockers|mesh-list
101681665|NCT04216706|Sympatholytics|sympatholytics|mesh-list
101681666|NCT04216706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101681667|NCT04216706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681668|NCT04216706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101681669|NCT04216706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681670|NCT04216706|Autonomic Agents|autonomic agents|mesh-ancestor
101681671|NCT04216706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101681672|NCT00913835|Doxorubicin|doxorubicin|mesh-list
101681673|NCT00913835|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101681675|NCT00913835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101681676|NCT00913835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101681677|NCT00913835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101681678|NCT00913835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101681679|NCT00913835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101681680|NCT00913835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681681|NCT05322720|Paclitaxel|paclitaxel|mesh-list
101338949|NCT03958383|Nivolumab|nivolumab|mesh-list
101681682|NCT05322720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101681683|NCT05322720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101681684|NCT05322720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101681685|NCT05322720|Tubulin Modulators|tubulin modulators|mesh-ancestor
101681686|NCT05322720|Antimitotic Agents|antimitotic agents|mesh-ancestor
101681687|NCT05322720|Mitosis Modulators|mitosis modulators|mesh-ancestor
101681688|NCT05322720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681689|NCT04213170|Bevacizumab|bevacizumab|mesh-list
101681690|NCT04213170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101681691|NCT04213170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101681692|NCT04213170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101681693|NCT04213170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101681694|NCT04213170|Growth Substances|growth substances|mesh-ancestor
101681695|NCT04213170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681696|NCT04213170|Growth Inhibitors|growth inhibitors|mesh-ancestor
101681697|NCT05322564|Opiate Alkaloids|opiate alkaloids|mesh-list
101681698|NCT05322564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101681699|NCT05322564|Narcotics|narcotics|mesh-ancestor
101681700|NCT05322564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101681701|NCT05322564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681702|NCT05322564|Analgesics|analgesics|mesh-ancestor
101681703|NCT05322564|Sensory System Agents|sensory system agents|mesh-ancestor
101681704|NCT05322564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101681705|NCT02749136|Gemcitabine|gemcitabine|mesh-list
101681706|NCT02749136|Folfirinox|folfirinox|mesh-list
101681707|NCT02749136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101681708|NCT02749136|Antimetabolites|antimetabolites|mesh-ancestor
101681709|NCT02749136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681710|NCT02749136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101681711|NCT00631631|Mifamurtide|mifamurtide|mesh-list
101681712|NCT00631631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101681713|NCT00631631|Immunologic Factors|immunologic factors|mesh-ancestor
101681714|NCT00631631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681715|NCT04238741|Anesthetics|anesthetics|mesh-list
101681716|NCT04238741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101681717|NCT04238741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681718|NCT02691858|Hydrocortisone|hydrocortisone|mesh-list
101681719|NCT02691858|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101681720|NCT02691858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101681721|NCT04218500|Niacinamide|niacinamide|mesh-list
101681723|NCT04218500|Nicotinic Acids|nicotinic acids|mesh-list
101681724|NCT04218500|Vitamin B Complex|vitamin b complex|mesh-ancestor
101681725|NCT04218500|Vitamins|vitamins|mesh-ancestor
101681726|NCT04218500|Micronutrients|micronutrients|mesh-ancestor
101681727|NCT04218500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681728|NCT04218500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101681729|NCT04218500|Antimetabolites|antimetabolites|mesh-ancestor
101681730|NCT04218500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681731|NCT04218500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101681732|NCT04218500|Vasodilator Agents|vasodilator agents|mesh-ancestor
101681733|NCT04264208|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101681734|NCT04264208|Bombesin|bombesin|mesh-list
101681735|NCT04264208|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101681736|NCT04264208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681737|NCT04264208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101681738|NCT04264208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681739|NCT05412056|Metformin|metformin|mesh-list
101681740|NCT05412056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101681741|NCT05412056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681742|NCT04453046|Pembrolizumab|pembrolizumab|mesh-list
101681743|NCT04453046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101681744|NCT04453046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101681745|NCT04453046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101681746|NCT04453046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681747|NCT04216628|Oxytocin|oxytocin|mesh-list
101681748|NCT04216628|Oxytocics|oxytocics|mesh-ancestor
101681749|NCT04216628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101681750|NCT04216628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681751|NCT04217096|Paclitaxel|paclitaxel|mesh-list
101681752|NCT04217096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101681753|NCT04217096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101681754|NCT04217096|Tubulin Modulators|tubulin modulators|mesh-ancestor
101681755|NCT04217096|Antimitotic Agents|antimitotic agents|mesh-ancestor
101681756|NCT04217096|Mitosis Modulators|mitosis modulators|mesh-ancestor
101681757|NCT04217096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681758|NCT05411978|Ubiquinone|ubiquinone|mesh-list
101681759|NCT05411978|Idebenone|idebenone|mesh-list
101681760|NCT05411978|Antioxidants|antioxidants|mesh-ancestor
101681761|NCT05411978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681762|NCT05411978|Protective Agents|protective agents|mesh-ancestor
101681763|NCT05411978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681764|NCT05411978|Micronutrients|micronutrients|mesh-ancestor
101681765|NCT00617370|Paclitaxel|paclitaxel|mesh-list
101681766|NCT00617370|Cyclophosphamide|cyclophosphamide|mesh-list
101681767|NCT00617370|Epirubicin|epirubicin|mesh-list
101681768|NCT00617370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101681769|NCT00617370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101681770|NCT00617370|Tubulin Modulators|tubulin modulators|mesh-ancestor
101681771|NCT00617370|Antimitotic Agents|antimitotic agents|mesh-ancestor
101681772|NCT00617370|Mitosis Modulators|mitosis modulators|mesh-ancestor
101829937|NCT03173950|Nivolumab|nivolumab|mesh-list
101681773|NCT00617370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681774|NCT00617370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101681775|NCT00617370|Immunologic Factors|immunologic factors|mesh-ancestor
101681776|NCT00617370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681777|NCT00617370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101681778|NCT00617370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101681779|NCT00617370|Alkylating Agents|alkylating agents|mesh-ancestor
101681780|NCT00617370|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101681781|NCT00617370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101681782|NCT00617370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101681783|NCT00617370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101681784|NCT00617370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101681785|NCT02699658|Levofloxacin|levofloxacin|mesh-list
101681786|NCT02699658|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101681787|NCT02699658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101681788|NCT02699658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101681789|NCT02699658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101681790|NCT02699658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101681791|NCT02699658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101681792|NCT02699658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681793|NCT02699658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101681794|NCT02699658|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101681795|NCT02699658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101681796|NCT04218734|Metformin|metformin|mesh-list
101681797|NCT04218734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101681798|NCT04218734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681799|NCT04066478|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101681800|NCT04066478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101681801|NCT04066478|Immunologic Factors|immunologic factors|mesh-ancestor
101681802|NCT04066478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681803|NCT04496063|Ustekinumab|ustekinumab|mesh-list
101681804|NCT04496063|Dermatologic Agents|dermatologic agents|mesh-ancestor
101681806|NCT04032626|Immunologic Factors|immunologic factors|mesh-ancestor
101681807|NCT04032626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681808|NCT04032626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101681809|NCT04032626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101681810|NCT04032626|Growth Substances|growth substances|mesh-ancestor
101681811|NCT04032626|Growth Inhibitors|growth inhibitors|mesh-ancestor
101681812|NCT04032626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101681813|NCT04214106|Thiamine|thiamine|mesh-list
101681814|NCT04214106|Vitamin B Complex|vitamin b complex|mesh-ancestor
101681815|NCT04214106|Vitamins|vitamins|mesh-ancestor
101681816|NCT04214106|Micronutrients|micronutrients|mesh-ancestor
101681817|NCT04214106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681818|NCT02747732|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101681819|NCT02747732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101681820|NCT02747732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101681821|NCT02747732|Alkylating Agents|alkylating agents|mesh-ancestor
101681822|NCT02747732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681823|NCT02695862|Terlipressin|terlipressin|mesh-list
101681824|NCT02695862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101681825|NCT02695862|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101681826|NCT00617448|Anesthetics|anesthetics|mesh-list
101681827|NCT00617448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101681828|NCT00617448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681829|NCT04308863|Chitosan|chitosan|mesh-list
101681830|NCT04308863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681831|NCT04308863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101681832|NCT04308863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101681833|NCT04308863|Antimetabolites|antimetabolites|mesh-ancestor
101681834|NCT04308863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101681835|NCT04308863|Chelating Agents|chelating agents|mesh-ancestor
101681836|NCT04308863|Sequestering Agents|sequestering agents|mesh-ancestor
101681837|NCT04308863|Hemostatics|hemostatics|mesh-ancestor
101681838|NCT04308863|Coagulants|coagulants|mesh-ancestor
101681839|NCT00615810|Efavirenz|efavirenz|mesh-list
101681840|NCT00615810|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101829938|NCT03173950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101681841|NCT00615810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101681842|NCT00615810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101681843|NCT00615810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101681844|NCT00615810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681845|NCT00615810|Antiviral Agents|antiviral agents|mesh-ancestor
101681846|NCT00615810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101681847|NCT00615810|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101681848|NCT00615810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101681849|NCT00615810|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101681850|NCT00615810|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101681851|NCT00615810|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101681852|NCT00615810|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101681853|NCT00615810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101681854|NCT00615810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101681855|NCT03355157|Tamoxifen|tamoxifen|mesh-list
101681856|NCT03355157|Paclitaxel|paclitaxel|mesh-list
101681857|NCT03355157|Vinorelbine|vinorelbine|mesh-list
101681858|NCT03355157|Capecitabine|capecitabine|mesh-list
101681859|NCT03355157|Letrozole|letrozole|mesh-list
101681860|NCT03355157|Epirubicin|epirubicin|mesh-list
101681861|NCT03355157|Fulvestrant|fulvestrant|mesh-list
101681862|NCT03355157|Palbociclib|palbociclib|mesh-list
101681863|NCT03355157|Exemestane|exemestane|mesh-list
101681864|NCT03355157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101681865|NCT03355157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101681866|NCT03355157|Tubulin Modulators|tubulin modulators|mesh-ancestor
101681867|NCT03355157|Antimitotic Agents|antimitotic agents|mesh-ancestor
101681868|NCT03355157|Mitosis Modulators|mitosis modulators|mesh-ancestor
101681869|NCT03355157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681870|NCT03355157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101681871|NCT03355157|Antimetabolites|antimetabolites|mesh-ancestor
101681872|NCT03355157|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101681873|NCT03355157|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101681874|NCT03355157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101681875|NCT03355157|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101681876|NCT03355157|Hormone Antagonists|hormone antagonists|mesh-ancestor
101681877|NCT03355157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101681878|NCT03355157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681879|NCT03355157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101681880|NCT03355157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101681881|NCT03355157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101681882|NCT03355157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101681883|NCT03355157|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101681884|NCT03355157|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101681885|NCT03355157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101681886|NCT03355157|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101681887|NCT03355157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101681889|NCT04215432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101681890|NCT02747342|Fluzoparib|fluzoparib|mesh-list
101681891|NCT02747342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101681892|NCT02747342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101681893|NCT02747342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681894|NCT02747342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101681895|NCT03324035|Tramadol|tramadol|mesh-list
101681896|NCT03324035|Amitriptyline|amitriptyline|mesh-list
101681897|NCT03324035|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101681898|NCT03324035|Narcotics|narcotics|mesh-ancestor
101681899|NCT03324035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101681900|NCT03324035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681901|NCT03324035|Analgesics|analgesics|mesh-ancestor
101681902|NCT03324035|Sensory System Agents|sensory system agents|mesh-ancestor
101681903|NCT03324035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101681904|NCT03324035|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101681905|NCT03324035|Antidepressive Agents|antidepressive agents|mesh-ancestor
101681906|NCT03324035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101339171|NCT04711213|BB 1101|bb 1101|mesh-list
101681908|NCT03324035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101681909|NCT03324035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101681910|NCT03324035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101681911|NCT03324035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681912|NCT03324035|Adrenergic Agents|adrenergic agents|mesh-ancestor
101681913|NCT03324035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101681914|NCT00616746|Ethanol|ethanol|mesh-list
101681915|NCT00616746|Nicotine|nicotine|mesh-list
101681916|NCT00616746|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101681917|NCT00616746|Autonomic Agents|autonomic agents|mesh-ancestor
101681918|NCT00616746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101681919|NCT00616746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681920|NCT00616746|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101681921|NCT00616746|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101681922|NCT00616746|Cholinergic Agents|cholinergic agents|mesh-ancestor
101681923|NCT00616746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101681924|NCT00616746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681925|NCT00616746|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101681926|NCT00616746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101681927|NCT00616746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101681928|NCT00777582|Olaparib|olaparib|mesh-list
101681929|NCT00777582|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101681930|NCT00777582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101681931|NCT00777582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681932|NCT00777582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101681933|NCT00632255|Imatinib Mesylate|imatinib mesylate|mesh-list
101681934|NCT00632255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101681935|NCT00632255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101681936|NCT00632255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101681937|NCT00632255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681938|NCT05271578|Nicotine|nicotine|mesh-list
101681939|NCT05271578|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101681940|NCT05271578|Autonomic Agents|autonomic agents|mesh-ancestor
101681941|NCT05271578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101681942|NCT05271578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681943|NCT05271578|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101681944|NCT05271578|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101681945|NCT05271578|Cholinergic Agents|cholinergic agents|mesh-ancestor
101681946|NCT05271578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101681947|NCT05271578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681948|NCT04203485|Paclitaxel|paclitaxel|mesh-list
101681949|NCT04203485|Carboplatin|carboplatin|mesh-list
101681950|NCT04203485|Pemetrexed|pemetrexed|mesh-list
101681951|NCT04203485|Apatinib|apatinib|mesh-list
101681952|NCT04203485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101681953|NCT04203485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101681954|NCT04203485|Tubulin Modulators|tubulin modulators|mesh-ancestor
101681955|NCT04203485|Antimitotic Agents|antimitotic agents|mesh-ancestor
101681956|NCT04203485|Mitosis Modulators|mitosis modulators|mesh-ancestor
101681957|NCT04203485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681958|NCT04203485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101681959|NCT04203485|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101681960|NCT04203485|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101681961|NCT04203485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101681962|NCT03851627|Methyltestosterone|methyltestosterone|mesh-list
101681963|NCT03851627|Testosterone|testosterone|mesh-list
101681964|NCT03851627|Testosterone undecanoate|testosterone undecanoate|mesh-list
101829962|NCT03137407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101681965|NCT03851627|Testosterone enanthate|testosterone enanthate|mesh-list
101681966|NCT03851627|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101681967|NCT03851627|Androgens|androgens|mesh-ancestor
101681968|NCT03851627|Hormones|hormones|mesh-ancestor
101681969|NCT03851627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101681970|NCT03851627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681971|NCT03851627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101681972|NCT03851627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101681973|NCT03851627|Anabolic Agents|anabolic agents|mesh-ancestor
101681974|NCT03116126|Guanfacine|guanfacine|mesh-list
101681975|NCT03116126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101681976|NCT03116126|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101681977|NCT03116126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101681978|NCT03116126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101681979|NCT03116126|Adrenergic Agents|adrenergic agents|mesh-ancestor
101681980|NCT03116126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101681981|NCT03116126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681982|NCT03116126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681983|NCT02983682|Lidocaine|lidocaine|mesh-list
101681984|NCT02983682|Anesthetics, Local|anesthetics, local|mesh-ancestor
101681985|NCT02983682|Anesthetics|anesthetics|mesh-ancestor
101681986|NCT02983682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101681987|NCT02983682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101681988|NCT02983682|Sensory System Agents|sensory system agents|mesh-ancestor
101681989|NCT02983682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101681990|NCT02983682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101681991|NCT02983682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101681992|NCT02983682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101681993|NCT02983682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101681994|NCT02983682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101681995|NCT00910247|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
101681996|NCT00910247|Anticonvulsants|anticonvulsants|mesh-ancestor
101681997|NCT00910247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101681998|NCT00910247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101681999|NCT00910247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101682000|NCT00910247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682001|NCT04217798|Etoposide|etoposide|mesh-list
101682002|NCT04217798|Niraparib|niraparib|mesh-list
101682003|NCT04217798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101682004|NCT04217798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101682005|NCT04217798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101682006|NCT04217798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101682007|NCT04217798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101682008|NCT04217798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682009|NCT04217798|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101682010|NCT02742038|Fluorides|fluorides|mesh-list
101682011|NCT02742038|Fluorides, Topical|fluorides, topical|mesh-list
101682012|NCT02742038|Cariostatic Agents|cariostatic agents|mesh-ancestor
101682013|NCT02742038|Protective Agents|protective agents|mesh-ancestor
101682014|NCT02742038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682015|NCT02022098|Cisplatin|cisplatin|mesh-list
101682016|NCT02022098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101682017|NCT02746250|Amitriptyline|amitriptyline|mesh-list
101682018|NCT02746250|Antidepressive Agents|antidepressive agents|mesh-list
101682019|NCT02746250|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
101682020|NCT02746250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101682021|NCT02746250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101682022|NCT02746250|Analgesics|analgesics|mesh-ancestor
101682023|NCT02746250|Sensory System Agents|sensory system agents|mesh-ancestor
101682024|NCT02746250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101682025|NCT02746250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682026|NCT02746250|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101682027|NCT02746250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101682028|NCT02746250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101682029|NCT02746250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682030|NCT02746250|Adrenergic Agents|adrenergic agents|mesh-ancestor
101682031|NCT02746250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101682032|NCT02741960|Metformin|metformin|mesh-list
101682033|NCT02741960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101682034|NCT02741960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682035|NCT00910091|Megestrol|megestrol|mesh-list
101682036|NCT00910091|Megestrol Acetate|megestrol acetate|mesh-list
101682037|NCT00910091|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101682038|NCT00910091|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101682039|NCT00910091|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101682040|NCT00910091|Contraceptive Agents|contraceptive agents|mesh-ancestor
101682041|NCT00910091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101682042|NCT00910091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682043|NCT00910091|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101682044|NCT00910091|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101682045|NCT00910091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101682046|NCT00910091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101682047|NCT00910091|Appetite Stimulants|appetite stimulants|mesh-ancestor
101682048|NCT00910091|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101682049|NCT04216550|Apatinib|apatinib|mesh-list
101682050|NCT04216550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101682051|NCT04216550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101682052|NCT04216550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101682053|NCT04216550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339324|NCT00079105|Hormones|hormones|mesh-ancestor
101682054|NCT01442792|Rivaroxaban|rivaroxaban|mesh-list
101682055|NCT01442792|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101682056|NCT01442792|Antithrombins|antithrombins|mesh-ancestor
101682057|NCT01442792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101682058|NCT01442792|Protease Inhibitors|protease inhibitors|mesh-ancestor
101682059|NCT01442792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101682060|NCT01442792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682061|NCT01442792|Anticoagulants|anticoagulants|mesh-ancestor
101682062|NCT00909857|Dienogest|dienogest|mesh-list
101682063|NCT00909857|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101682064|NCT00909857|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101682065|NCT00909857|Levonorgestrel|levonorgestrel|mesh-list
101682066|NCT00909857|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101682067|NCT00909857|Estradiol|estradiol|mesh-list
101682068|NCT00909857|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101682069|NCT00909857|Estrogens|estrogens|mesh-ancestor
101682070|NCT00909857|Hormones|hormones|mesh-ancestor
101682071|NCT00909857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101682072|NCT00909857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682073|NCT00909857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101682074|NCT00909857|Contraceptive Agents|contraceptive agents|mesh-ancestor
101682075|NCT00909857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101682076|NCT00909857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101682077|NCT00909857|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101682078|NCT00909857|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101682079|NCT00909857|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101682080|NCT00909857|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101682081|NCT00909857|Hormone Antagonists|hormone antagonists|mesh-ancestor
101682082|NCT00909857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101682083|NCT00909857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101682084|NCT00911807|Cerebrolysin|cerebrolysin|mesh-list
101682085|NCT00911807|Donepezil|donepezil|mesh-list
101829985|NCT03107182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682086|NCT00911807|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101682087|NCT00911807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101682088|NCT00911807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682089|NCT00911807|Cholinergic Agents|cholinergic agents|mesh-ancestor
101829987|NCT03107182|Glucocorticoids|glucocorticoids|mesh-ancestor
101682090|NCT00911807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101682091|NCT00911807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682093|NCT00911807|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101682094|NCT00911807|Protective Agents|protective agents|mesh-ancestor
101682095|NCT04127981|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101682096|NCT04127981|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101682097|NCT04127981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682098|NCT04117451|Propolis|propolis|mesh-list
101682099|NCT04117451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101682100|NCT03690089|Atropine|atropine|mesh-list
101682101|NCT03690089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101682102|NCT03690089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101682103|NCT03690089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101682104|NCT03690089|Autonomic Agents|autonomic agents|mesh-ancestor
101682105|NCT03690089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101682106|NCT03690089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682107|NCT03690089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101682108|NCT03690089|Respiratory System Agents|respiratory system agents|mesh-ancestor
101682109|NCT03690089|Mydriatics|mydriatics|mesh-ancestor
101682110|NCT03690089|Parasympatholytics|parasympatholytics|mesh-ancestor
101682111|NCT03690089|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101682112|NCT03690089|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101682113|NCT03690089|Cholinergic Agents|cholinergic agents|mesh-ancestor
101682114|NCT03690089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101682115|NCT03690089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682116|NCT03812588|Escitalopram|escitalopram|mesh-list
101682117|NCT03812588|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101682118|NCT03812588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101682119|NCT03812588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101682120|NCT03812588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682121|NCT03812588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101682122|NCT03812588|Serotonin Agents|serotonin agents|mesh-ancestor
101682123|NCT03812588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682124|NCT02387099|Everolimus|everolimus|mesh-list
101682125|NCT02387099|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101682126|NCT02387099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101682127|NCT02387099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101682128|NCT02387099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682129|NCT02387099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101682130|NCT02387099|Immunologic Factors|immunologic factors|mesh-ancestor
101682131|NCT02387099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682132|NCT02387099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101682134|NCT02745860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101682135|NCT04788641|Cyclosporine|cyclosporine|mesh-list
101682136|NCT04788641|Tacrolimus|tacrolimus|mesh-list
101682137|NCT04788641|Cyclosporins|cyclosporins|mesh-list
101682138|NCT04788641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101682139|NCT04788641|Immunologic Factors|immunologic factors|mesh-ancestor
101682140|NCT04788641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682141|NCT04788641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101682142|NCT04788641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101682143|NCT04788641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682144|NCT04788641|Antifungal Agents|antifungal agents|mesh-ancestor
101682145|NCT04788641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101682146|NCT04788641|Dermatologic Agents|dermatologic agents|mesh-ancestor
101682147|NCT04788641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101682148|NCT02745470|Lixisenatide|lixisenatide|mesh-list
101682149|NCT02745470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101682150|NCT02745470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682151|NCT02741414|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101682152|NCT02741414|Amoxicillin|amoxicillin|mesh-list
101682153|NCT02741414|Metronidazole|metronidazole|mesh-list
101682154|NCT02741414|Clarithromycin|clarithromycin|mesh-list
101682155|NCT02741414|Levofloxacin|levofloxacin|mesh-list
101682156|NCT02741414|Tetracycline|tetracycline|mesh-list
101682157|NCT02741414|Furazolidone|furazolidone|mesh-list
101682158|NCT02741414|Esomeprazole|esomeprazole|mesh-list
101682159|NCT02741414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101682160|NCT02741414|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101682161|NCT02741414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101682162|NCT02741414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101682163|NCT02741414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101682164|NCT02741414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101682165|NCT02741414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101682166|NCT02741414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682167|NCT02741414|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101682168|NCT02741414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101682169|NCT02741414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101682170|NCT02741414|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101682171|NCT02741414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101682172|NCT02741414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101682173|NCT02741414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101682174|NCT02741414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101682175|NCT02741414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101682176|NCT02741414|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
101682177|NCT02741414|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101682178|NCT02736500|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
101682179|NCT02736500|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101682180|NCT02736500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682181|NCT05629598|Epoetin Alfa|epoetin alfa|mesh-list
101682182|NCT05629598|Hematinics|hematinics|mesh-ancestor
101682183|NCT02736032|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101682184|NCT02736032|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101682185|NCT02736032|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101682187|NCT02736032|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101682188|NCT02736032|Progesterone|progesterone|mesh-list
101682189|NCT02736032|Estrogens|estrogens|mesh-ancestor
101682190|NCT02736032|Hormones|hormones|mesh-ancestor
101682191|NCT02736032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101682192|NCT02736032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682193|NCT02736032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101682194|NCT02736032|Contraceptive Agents|contraceptive agents|mesh-ancestor
101682195|NCT02736032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101682196|NCT02736032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101682197|NCT02736032|Progestins|progestins|mesh-ancestor
101682198|NCT02736032|Luteolytic Agents|luteolytic agents|mesh-ancestor
101682199|NCT02736032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101682200|NCT02736032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101682201|NCT02744768|Dasatinib|dasatinib|mesh-list
101682202|NCT02744768|Blinatumomab|blinatumomab|mesh-list
101682203|NCT02744768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101682204|NCT02744768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101682205|NCT02744768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101682206|NCT02744768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682207|NCT00909779|Formoterol Fumarate|formoterol fumarate|mesh-list
101682208|NCT00909779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101682209|NCT00909779|Autonomic Agents|autonomic agents|mesh-ancestor
101682210|NCT00909779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101682211|NCT00909779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682212|NCT00909779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101682213|NCT00909779|Respiratory System Agents|respiratory system agents|mesh-ancestor
101682214|NCT00909779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101682215|NCT00909779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101682216|NCT00909779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101682217|NCT00909779|Adrenergic Agents|adrenergic agents|mesh-ancestor
101682218|NCT00909779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101682219|NCT00909779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682220|NCT04096391|Analgesics|analgesics|mesh-list
101682221|NCT04096391|Sensory System Agents|sensory system agents|mesh-ancestor
101830008|NCT03107182|Dermatologic Agents|dermatologic agents|mesh-ancestor
101682222|NCT04096391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101682223|NCT04096391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682224|NCT02744378|Clobetasol|clobetasol|mesh-list
101682225|NCT02744378|Tacrolimus|tacrolimus|mesh-list
101682226|NCT02744378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101682227|NCT02744378|Immunologic Factors|immunologic factors|mesh-ancestor
101682228|NCT02744378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682229|NCT02744378|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101682230|NCT02744378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101682231|NCT02744378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682232|NCT02744378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101682233|NCT02744378|Glucocorticoids|glucocorticoids|mesh-ancestor
101682234|NCT02744378|Hormones|hormones|mesh-ancestor
101682235|NCT02744378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101682237|NCT04318730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101682238|NCT04318730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101682239|NCT04318730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101682240|NCT04318730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682241|NCT00632333|Fluorouracil|fluorouracil|mesh-list
101682242|NCT00632333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101682243|NCT00632333|Antimetabolites|antimetabolites|mesh-ancestor
101682244|NCT00632333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682245|NCT00632333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101682246|NCT00632333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101682247|NCT00632333|Immunologic Factors|immunologic factors|mesh-ancestor
101682248|NCT00632333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682249|NCT02744456|Losartan|losartan|mesh-list
101682250|NCT02744456|Amlodipine|amlodipine|mesh-list
101682251|NCT02744456|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101682252|NCT02744456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101682253|NCT02744456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101682254|NCT02744456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101682255|NCT02744456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682256|NCT02744456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101682257|NCT02744456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682258|NCT02744456|Vasodilator Agents|vasodilator agents|mesh-ancestor
101682259|NCT02744456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101682260|NCT02744456|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101682261|NCT02744456|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101682262|NCT02744456|Diuretics|diuretics|mesh-ancestor
101682263|NCT02744456|Natriuretic Agents|natriuretic agents|mesh-ancestor
101682264|NCT02744456|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101682265|NCT02744222|Interferons|interferons|mesh-list
101682266|NCT02744222|Interferon-beta|interferon-beta|mesh-list
101682267|NCT02744222|Interferon beta-1a|interferon beta-1a|mesh-list
101682268|NCT02744222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101682269|NCT02744222|Antiviral Agents|antiviral agents|mesh-ancestor
101682270|NCT02744222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101682271|NCT02744222|Immunologic Factors|immunologic factors|mesh-ancestor
101682272|NCT02744222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682273|NCT02744222|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101682274|NCT02741024|Artesunate|artesunate|mesh-list
101682275|NCT02741024|Lumefantrine|lumefantrine|mesh-list
101682276|NCT02741024|Artemether|artemether|mesh-list
101339548|NCT00080158|Bupropion|bupropion|mesh-list
101682277|NCT02741024|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101682278|NCT02741024|Amodiaquine|amodiaquine|mesh-list
101682279|NCT02741024|Antimalarials|antimalarials|mesh-ancestor
101682280|NCT02741024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101682281|NCT02741024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101682282|NCT02741024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101682283|NCT02741024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101682285|NCT02741024|Schistosomicides|schistosomicides|mesh-ancestor
101682286|NCT02741024|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101682287|NCT02741024|Anthelmintics|anthelmintics|mesh-ancestor
101682288|NCT02735876|Rituximab|rituximab|mesh-list
101682289|NCT02735876|Acalabrutinib|acalabrutinib|mesh-list
101682290|NCT02735876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101682291|NCT02735876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101682292|NCT02735876|Immunologic Factors|immunologic factors|mesh-ancestor
101682293|NCT02735876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682294|NCT02735876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101682295|NCT00910871|Bedaquiline|bedaquiline|mesh-list
101682296|NCT00910871|Antitubercular Agents|antitubercular agents|mesh-ancestor
101682297|NCT00910871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101682298|NCT00910871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101682299|NCT04230707|Melatonin|melatonin|mesh-list
101682300|NCT04230707|Antioxidants|antioxidants|mesh-ancestor
101682301|NCT04230707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682302|NCT04230707|Protective Agents|protective agents|mesh-ancestor
101682303|NCT04230707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682304|NCT04230707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101682305|NCT03943667|Paclitaxel|paclitaxel|mesh-list
101682306|NCT03943667|Gemcitabine|gemcitabine|mesh-list
101682307|NCT03943667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101682308|NCT03943667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101682309|NCT03943667|Tubulin Modulators|tubulin modulators|mesh-ancestor
101682310|NCT03943667|Antimitotic Agents|antimitotic agents|mesh-ancestor
101682311|NCT03943667|Mitosis Modulators|mitosis modulators|mesh-ancestor
101682312|NCT03943667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682313|NCT03943667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101682314|NCT03943667|Antimetabolites|antimetabolites|mesh-ancestor
101682315|NCT02735798|Trastuzumab|trastuzumab|mesh-list
101682317|NCT02735798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101682318|NCT02735798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101682319|NCT02735798|Immunoconjugates|immunoconjugates|mesh-ancestor
101682320|NCT02735798|Immunologic Factors|immunologic factors|mesh-ancestor
101682321|NCT02735798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682322|NCT03760718|Chloroprocaine|chloroprocaine|mesh-list
101682323|NCT03760718|Procaine|procaine|mesh-list
101682324|NCT03760718|Anesthetics, Local|anesthetics, local|mesh-ancestor
101682325|NCT03760718|Anesthetics|anesthetics|mesh-ancestor
101682326|NCT03760718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101682327|NCT03760718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682328|NCT03760718|Sensory System Agents|sensory system agents|mesh-ancestor
101682329|NCT03760718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101682330|NCT05590286|Amoxicillin|amoxicillin|mesh-list
101682331|NCT05590286|Esomeprazole|esomeprazole|mesh-list
101682332|NCT05590286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101682333|NCT05590286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101682334|NCT05590286|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101682335|NCT05590286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101682336|NCT05590286|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101682337|NCT05590286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101682338|NCT05590286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682339|NCT05580029|Triamcinolone|triamcinolone|mesh-list
101682340|NCT05580029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101682341|NCT05580029|Glucocorticoids|glucocorticoids|mesh-ancestor
101682342|NCT05580029|Hormones|hormones|mesh-ancestor
101682343|NCT05580029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101682344|NCT05580029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682345|NCT03724994|Paclitaxel|paclitaxel|mesh-list
101682346|NCT03724994|Gemcitabine|gemcitabine|mesh-list
101682347|NCT03724994|Fluorouracil|fluorouracil|mesh-list
101682348|NCT03724994|Folfirinox|folfirinox|mesh-list
101830054|NCT02927769|Alkylating Agents|alkylating agents|mesh-ancestor
101682349|NCT03724994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101682350|NCT03724994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101682351|NCT03724994|Tubulin Modulators|tubulin modulators|mesh-ancestor
101682352|NCT03724994|Antimitotic Agents|antimitotic agents|mesh-ancestor
101682353|NCT03724994|Mitosis Modulators|mitosis modulators|mesh-ancestor
101682354|NCT03724994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682355|NCT03724994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101682356|NCT03724994|Antimetabolites|antimetabolites|mesh-ancestor
101682358|NCT03724994|Immunologic Factors|immunologic factors|mesh-ancestor
101682359|NCT03724994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682360|NCT02735330|Ethanol|ethanol|mesh-list
101682361|NCT02735330|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101682362|NCT02735330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101682363|NCT02735330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101682364|NCT02735330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682366|NCT02631941|Formoterol Fumarate|formoterol fumarate|mesh-list
101682367|NCT02631941|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101682368|NCT02631941|Charcoal|charcoal|mesh-list
101682369|NCT02631941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101682370|NCT02631941|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101682371|NCT02631941|Autonomic Agents|autonomic agents|mesh-ancestor
101682372|NCT02631941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101682373|NCT02631941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682374|NCT02631941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101682375|NCT02631941|Respiratory System Agents|respiratory system agents|mesh-ancestor
101682376|NCT02631941|Glucocorticoids|glucocorticoids|mesh-ancestor
101682377|NCT02631941|Hormones|hormones|mesh-ancestor
101682378|NCT02631941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101682379|NCT02631941|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101682380|NCT02631941|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101682381|NCT02631941|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101682382|NCT02631941|Adrenergic Agents|adrenergic agents|mesh-ancestor
101682383|NCT02631941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101682384|NCT02631941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682385|NCT02631941|Antidotes|antidotes|mesh-ancestor
101682386|NCT02631941|Protective Agents|protective agents|mesh-ancestor
101682387|NCT02690987|Exenatide|exenatide|mesh-list
101682388|NCT02690987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101682389|NCT02690987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682390|NCT02690987|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101682391|NCT02690987|Incretins|incretins|mesh-ancestor
101682392|NCT02690987|Hormones|hormones|mesh-ancestor
101682393|NCT02690987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101682395|NCT02740166|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101682396|NCT02740166|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101682397|NCT02740166|Adrenergic Agents|adrenergic agents|mesh-ancestor
101682398|NCT02740166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101682399|NCT02740166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682400|NCT02740166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682401|NCT02740166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101682402|NCT02740166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101682403|NCT02740166|Vasodilator Agents|vasodilator agents|mesh-ancestor
101682404|NCT02735018|Epinephrine|epinephrine|mesh-list
101682405|NCT02735018|Racepinephrine|racepinephrine|mesh-list
101682406|NCT02735018|Epinephryl borate|epinephryl borate|mesh-list
101682407|NCT02735018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101682408|NCT02735018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101682409|NCT02735018|Adrenergic Agents|adrenergic agents|mesh-ancestor
101682410|NCT02735018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101682411|NCT02735018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682412|NCT02735018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682413|NCT02735018|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101682414|NCT02735018|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101682415|NCT02735018|Autonomic Agents|autonomic agents|mesh-ancestor
101682416|NCT02735018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101682417|NCT02735018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101682418|NCT02735018|Respiratory System Agents|respiratory system agents|mesh-ancestor
101682419|NCT02735018|Mydriatics|mydriatics|mesh-ancestor
101830075|NCT02873195|Bevacizumab|bevacizumab|mesh-list
101682420|NCT02735018|Sympathomimetics|sympathomimetics|mesh-ancestor
101682421|NCT02735018|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101682422|NCT00908375|Pregabalin|pregabalin|mesh-list
101682423|NCT00908375|Analgesics|analgesics|mesh-ancestor
101682424|NCT00908375|Sensory System Agents|sensory system agents|mesh-ancestor
101682425|NCT00908375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101682426|NCT00908375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682427|NCT00908375|Anticonvulsants|anticonvulsants|mesh-ancestor
101682428|NCT00908375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101682429|NCT00908375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101682430|NCT00908375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682431|NCT00908375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101682432|NCT00908375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101682433|NCT00908375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101682434|NCT00908375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101682435|NCT00908375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101682436|NCT04247867|Psyllium|psyllium|mesh-list
101682437|NCT04247867|Cathartics|cathartics|mesh-ancestor
101682438|NCT04247867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101682439|NCT02731664|Glucagon|glucagon|mesh-list
101682440|NCT02731664|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101682441|NCT02731664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101682442|NCT02731664|Hormones|hormones|mesh-ancestor
101682443|NCT02731664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101682444|NCT02731664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682445|NCT02731664|Incretins|incretins|mesh-ancestor
101682446|NCT02543255|Prednisone|prednisone|mesh-list
101682447|NCT02543255|Leuprolide|leuprolide|mesh-list
101682448|NCT02543255|Abiraterone Acetate|abiraterone acetate|mesh-list
101682449|NCT02543255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101682450|NCT02543255|Glucocorticoids|glucocorticoids|mesh-ancestor
101682451|NCT02543255|Hormones|hormones|mesh-ancestor
101682452|NCT02543255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101682453|NCT02543255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682454|NCT02543255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101682455|NCT02543255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101682456|NCT02543255|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101682457|NCT02543255|Fertility Agents|fertility agents|mesh-ancestor
101682458|NCT02543255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101682459|NCT02543255|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101682460|NCT02543255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101682461|NCT02543255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682462|NCT02543255|Hormone Antagonists|hormone antagonists|mesh-ancestor
101682463|NCT02543255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101682464|NCT02695004|Donepezil|donepezil|mesh-list
101682465|NCT02695004|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101682466|NCT02695004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101682467|NCT02695004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682468|NCT02695004|Cholinergic Agents|cholinergic agents|mesh-ancestor
101682469|NCT02695004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101682470|NCT02695004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682471|NCT02695004|Nootropic Agents|nootropic agents|mesh-ancestor
101682472|NCT00909389|Simvastatin|simvastatin|mesh-list
101682473|NCT00909389|Ezetimibe|ezetimibe|mesh-list
101682474|NCT00909389|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
101682475|NCT00909389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101682476|NCT00909389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101682477|NCT00909389|Antimetabolites|antimetabolites|mesh-ancestor
101682478|NCT00909389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682479|NCT00909389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101682480|NCT00909389|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101682481|NCT00909389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101682483|NCT00910715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101682484|NCT00910715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101682485|NCT00910715|Antimalarials|antimalarials|mesh-ancestor
101682486|NCT00910715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101682487|NCT00910715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101682488|NCT02731430|Morphine|morphine|mesh-list
101682489|NCT02731430|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101682490|NCT02731430|Narcotics|narcotics|mesh-ancestor
101682491|NCT02731430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101682492|NCT02731430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682493|NCT02731430|Analgesics|analgesics|mesh-ancestor
101682494|NCT02731430|Sensory System Agents|sensory system agents|mesh-ancestor
101682495|NCT02731430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101682496|NCT04232969|Exenatide|exenatide|mesh-list
101682497|NCT04232969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101682498|NCT04232969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682499|NCT04232969|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101682500|NCT04232969|Incretins|incretins|mesh-ancestor
101682501|NCT04232969|Hormones|hormones|mesh-ancestor
101682502|NCT04232969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101682503|NCT03364868|Insulin|insulin|mesh-list
101682504|NCT03364868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101682505|NCT03364868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682506|NCT03695510|Pembrolizumab|pembrolizumab|mesh-list
101682508|NCT03695510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101682509|NCT03695510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101682510|NCT03695510|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101682511|NCT03695510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682512|NCT03695510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101682513|NCT03695510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101682514|NCT02731040|Ibandronic Acid|ibandronic acid|mesh-list
101682515|NCT02731040|Zoledronic Acid|zoledronic acid|mesh-list
101682516|NCT02731040|Diphosphonates|diphosphonates|mesh-list
101682517|NCT02731040|Etidronic Acid|etidronic acid|mesh-list
101682518|NCT02731040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101682519|NCT02731040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682520|NCT02734160|Durvalumab|durvalumab|mesh-list
101682521|NCT02734160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101682522|NCT02734160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101682523|NCT02730572|Methylphenidate|methylphenidate|mesh-list
101682524|NCT02730572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101682525|NCT02730572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682526|NCT02730572|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101682527|NCT02730572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101682528|NCT02730572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101682529|NCT02730572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682530|NCT02730572|Dopamine Agents|dopamine agents|mesh-ancestor
101682531|NCT02730572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101682532|NCT04225988|Tacrolimus|tacrolimus|mesh-list
101682533|NCT04225988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101682534|NCT04225988|Immunologic Factors|immunologic factors|mesh-ancestor
101682535|NCT04225988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682536|NCT04225988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101682537|NCT04225988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101682538|NCT04225988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682539|NCT02730026|Ketoprofen|ketoprofen|mesh-list
101682540|NCT02730026|Omeprazole|omeprazole|mesh-list
101682541|NCT02730026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101682542|NCT02730026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101682543|NCT02730026|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101682544|NCT02730026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101682545|NCT02730026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682546|NCT02730026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101682547|NCT02730026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101682548|NCT02730026|Analgesics|analgesics|mesh-ancestor
101682549|NCT02730026|Sensory System Agents|sensory system agents|mesh-ancestor
101682550|NCT02730026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101682551|NCT02730026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682552|NCT02730026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101682553|NCT02730026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101682554|NCT02730026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101682555|NCT02738918|Abatacept|abatacept|mesh-list
101682556|NCT02738918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101682557|NCT02738918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682558|NCT02738918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101682559|NCT02738918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101682560|NCT02738918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101682561|NCT02738918|Immunologic Factors|immunologic factors|mesh-ancestor
101682562|NCT02738918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682563|NCT02738918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101682564|NCT03195374|Analgesics, Opioid|analgesics, opioid|mesh-list
101682565|NCT03195374|Narcotics|narcotics|mesh-ancestor
101682566|NCT03195374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101682567|NCT03195374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682568|NCT03195374|Analgesics|analgesics|mesh-ancestor
101682569|NCT03195374|Sensory System Agents|sensory system agents|mesh-ancestor
101682570|NCT03195374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101682571|NCT02739386|Ipilimumab|ipilimumab|mesh-list
101682572|NCT02739386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101682573|NCT02739386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101682574|NCT02739386|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101682575|NCT02739386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682576|NCT00636428|Midazolam|midazolam|mesh-list
101682577|NCT00636428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101682578|NCT00636428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101682579|NCT00636428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101682580|NCT00636428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682581|NCT00636428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101682582|NCT00636428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101682583|NCT00636428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101682584|NCT00636428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101682585|NCT00636428|Anesthetics, General|anesthetics, general|mesh-ancestor
101682586|NCT00636428|Anesthetics|anesthetics|mesh-ancestor
101682587|NCT00636428|GABA Modulators|gaba modulators|mesh-ancestor
101682588|NCT00636428|GABA Agents|gaba agents|mesh-ancestor
101682589|NCT00636428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101682590|NCT00636428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682591|NCT02729870|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101682592|NCT02729870|Laxatives|laxatives|mesh-ancestor
101682593|NCT02729870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101682594|NCT05628662|Insulin|insulin|mesh-list
101682595|NCT05628662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101682596|NCT05628662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682597|NCT02694848|Aspirin|aspirin|mesh-list
101682598|NCT02694848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101682599|NCT02694848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101682600|NCT02694848|Analgesics|analgesics|mesh-ancestor
101682601|NCT02694848|Sensory System Agents|sensory system agents|mesh-ancestor
101682602|NCT02694848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101682603|NCT02694848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682604|NCT02694848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101682605|NCT02694848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101682606|NCT02694848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101682607|NCT02694848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101682608|NCT02694848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682609|NCT02694848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101682610|NCT02694848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101682611|NCT02694848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101682612|NCT02694848|Antipyretics|antipyretics|mesh-ancestor
101682613|NCT02729324|Protective Agents|protective agents|mesh-list
101682614|NCT02729324|Radiation-Protective Agents|radiation-protective agents|mesh-list
101682615|NCT02729324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682616|NCT02733458|Dexamethasone|dexamethasone|mesh-list
101682617|NCT02733458|Gemcitabine|gemcitabine|mesh-list
101682618|NCT02733458|Etoposide|etoposide|mesh-list
101682619|NCT02733458|Pegaspargase|pegaspargase|mesh-list
101682620|NCT02733458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101682621|NCT02733458|Antiemetics|antiemetics|mesh-ancestor
101682622|NCT02733458|Autonomic Agents|autonomic agents|mesh-ancestor
101682623|NCT02733458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101682624|NCT02733458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682625|NCT02733458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101682626|NCT02733458|Glucocorticoids|glucocorticoids|mesh-ancestor
101682627|NCT02733458|Hormones|hormones|mesh-ancestor
101682628|NCT02733458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101682629|NCT02733458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101682630|NCT02733458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101682631|NCT02733458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101682632|NCT02733458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682633|NCT02733458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101682634|NCT02733458|Antimetabolites|antimetabolites|mesh-ancestor
101682635|NCT02733458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101682636|NCT02733458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101682637|NCT02733458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101682638|NCT03658772|Pembrolizumab|pembrolizumab|mesh-list
101682639|NCT03658772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101682640|NCT03658772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101682641|NCT03658772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101682642|NCT03658772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682643|NCT02729012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101682644|NCT02728856|Sunscreening Agents|sunscreening agents|mesh-list
101682645|NCT02728856|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101682646|NCT02728856|Protective Agents|protective agents|mesh-ancestor
101682647|NCT02728856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682648|NCT02728856|Dermatologic Agents|dermatologic agents|mesh-ancestor
101682649|NCT02728934|Infliximab|infliximab|mesh-list
101682650|NCT02728934|Golimumab|golimumab|mesh-list
101682651|NCT02728934|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101682652|NCT02728934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101682653|NCT02728934|Dermatologic Agents|dermatologic agents|mesh-ancestor
101682654|NCT02728934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101682655|NCT02728934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101682656|NCT02728934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101682657|NCT02728934|Immunologic Factors|immunologic factors|mesh-ancestor
101682658|NCT02728934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682659|NCT04179500|Moxifloxacin|moxifloxacin|mesh-list
101682660|NCT04179500|Pyrazinamide|pyrazinamide|mesh-list
101682661|NCT04179500|Bedaquiline|bedaquiline|mesh-list
101682662|NCT04179500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101682663|NCT04179500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101682664|NCT04179500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101682665|NCT04179500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101682666|NCT04179500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101682667|NCT04179500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682668|NCT04179500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101682669|NCT04179500|Antitubercular Agents|antitubercular agents|mesh-ancestor
101682670|NCT02728700|Mycophenolic Acid|mycophenolic acid|mesh-list
101682671|NCT02728700|Sirolimus|sirolimus|mesh-list
101682672|NCT02728700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101682673|NCT02728700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101682674|NCT02728700|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101682675|NCT02728700|Antitubercular Agents|antitubercular agents|mesh-ancestor
101682676|NCT02728700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101682677|NCT02728700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101682678|NCT02728700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101682679|NCT02728700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682680|NCT02728700|Antifungal Agents|antifungal agents|mesh-ancestor
101682681|NCT02728700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101682682|NCT02728700|Immunologic Factors|immunologic factors|mesh-ancestor
101682683|NCT02728700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682684|NCT02728622|Tamoxifen|tamoxifen|mesh-list
101682685|NCT02728622|Paclitaxel|paclitaxel|mesh-list
101682686|NCT02728622|Doxorubicin|doxorubicin|mesh-list
101830102|NCT02833701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101682687|NCT02728622|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101682688|NCT02728622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101682689|NCT02728622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101682690|NCT02728622|Tubulin Modulators|tubulin modulators|mesh-ancestor
101682692|NCT02728622|Mitosis Modulators|mitosis modulators|mesh-ancestor
101682693|NCT02728622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682694|NCT02728622|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101682695|NCT02728622|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101682696|NCT02728622|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101682697|NCT02728622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101682698|NCT02728622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101682699|NCT02728622|Hormone Antagonists|hormone antagonists|mesh-ancestor
101682700|NCT02728622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101682701|NCT02728622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682702|NCT02728622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101682703|NCT02728622|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101682704|NCT02728622|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101682705|NCT02728622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101682707|NCT02728466|Procyanidin|procyanidin|mesh-list
101682708|NCT02728466|Antioxidants|antioxidants|mesh-ancestor
101682709|NCT02728466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682710|NCT02728466|Protective Agents|protective agents|mesh-ancestor
101682711|NCT02728466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682712|NCT02728466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101682713|NCT02728466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101682714|NCT02728466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101682715|NCT02733380|Thalidomide|thalidomide|mesh-list
101682716|NCT02733380|Dexamethasone|dexamethasone|mesh-list
101682717|NCT02733380|Doxorubicin|doxorubicin|mesh-list
101682718|NCT02733380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101682719|NCT02733380|Vinorelbine|vinorelbine|mesh-list
101682720|NCT02733380|Mitoxantrone|mitoxantrone|mesh-list
101682721|NCT02733380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101682722|NCT02733380|Antiemetics|antiemetics|mesh-ancestor
101682723|NCT02733380|Autonomic Agents|autonomic agents|mesh-ancestor
101682724|NCT02733380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101682725|NCT02733380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682726|NCT02733380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101682727|NCT02733380|Glucocorticoids|glucocorticoids|mesh-ancestor
101682728|NCT02733380|Hormones|hormones|mesh-ancestor
101682729|NCT02733380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101682730|NCT02733380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101682731|NCT02733380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101682732|NCT02733380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101682733|NCT02733380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101682735|NCT02733380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101682736|NCT02733380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682737|NCT02733380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101830114|NCT02833701|Protective Agents|protective agents|mesh-ancestor
101682738|NCT02733380|Tubulin Modulators|tubulin modulators|mesh-ancestor
101682739|NCT02733380|Antimitotic Agents|antimitotic agents|mesh-ancestor
101682740|NCT02733380|Mitosis Modulators|mitosis modulators|mesh-ancestor
101682741|NCT02733380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101682742|NCT02733380|Immunologic Factors|immunologic factors|mesh-ancestor
101682743|NCT02733380|Leprostatic Agents|leprostatic agents|mesh-ancestor
101682744|NCT02733380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101682745|NCT02733380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101682746|NCT02733380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101682747|NCT02733380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101682748|NCT02733380|Growth Substances|growth substances|mesh-ancestor
101682749|NCT02733380|Growth Inhibitors|growth inhibitors|mesh-ancestor
101682750|NCT02733380|Analgesics|analgesics|mesh-ancestor
101682751|NCT02733380|Sensory System Agents|sensory system agents|mesh-ancestor
101682752|NCT02737670|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
101682753|NCT02737670|Anticoagulants|anticoagulants|mesh-ancestor
101682754|NCT02737670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101682755|NCT02737670|Antimetabolites|antimetabolites|mesh-ancestor
101682756|NCT02737670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682757|NCT02737670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101682758|NCT02737670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101682759|NCT02737670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101682760|NCT02737670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101682761|NCT02737670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682762|NCT02728310|Levobupivacaine|levobupivacaine|mesh-list
101682763|NCT02728310|Anesthetics, Local|anesthetics, local|mesh-ancestor
101682764|NCT02728310|Anesthetics|anesthetics|mesh-ancestor
101682765|NCT02728310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101682766|NCT02728310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682767|NCT02728310|Sensory System Agents|sensory system agents|mesh-ancestor
101682768|NCT02728310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101682769|NCT00636584|Nitroprusside|nitroprusside|mesh-list
101682770|NCT00636584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101682771|NCT00636584|Vasodilator Agents|vasodilator agents|mesh-ancestor
101682772|NCT00636584|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101682773|NCT00636584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682774|NCT02732756|Oxymetazoline|oxymetazoline|mesh-list
101682775|NCT02732756|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101682776|NCT02732756|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101682777|NCT02732756|Adrenergic Agents|adrenergic agents|mesh-ancestor
101682778|NCT02732756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101682779|NCT02732756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682780|NCT02732756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682781|NCT02732756|Sympathomimetics|sympathomimetics|mesh-ancestor
101682782|NCT02732756|Autonomic Agents|autonomic agents|mesh-ancestor
101682783|NCT02732756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101682784|NCT02732756|Nasal Decongestants|nasal decongestants|mesh-ancestor
101682785|NCT02732756|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101682786|NCT02732756|Respiratory System Agents|respiratory system agents|mesh-ancestor
101682787|NCT02732522|Misoprostol|misoprostol|mesh-list
101682788|NCT02732522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101682789|NCT02732522|Abortifacient Agents|abortifacient agents|mesh-ancestor
101682790|NCT02732522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101682791|NCT02732522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682793|NCT02732522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101682794|NCT02732522|Oxytocics|oxytocics|mesh-ancestor
101682795|NCT02732678|Propranolol|propranolol|mesh-list
101830137|NCT02675465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101682796|NCT02732678|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101682797|NCT02732678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101682798|NCT02732678|Adrenergic Agents|adrenergic agents|mesh-ancestor
101682799|NCT02732678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101682800|NCT02732678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682801|NCT02732678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682802|NCT02732678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101682803|NCT02732678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101682804|NCT02732678|Vasodilator Agents|vasodilator agents|mesh-ancestor
101682805|NCT02727608|Eculizumab|eculizumab|mesh-list
101682806|NCT02727608|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101682807|NCT02727608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101682808|NCT02727608|Immunologic Factors|immunologic factors|mesh-ancestor
101682809|NCT02727608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682810|NCT02727296|Propofol|propofol|mesh-list
101682811|NCT02727296|Sevoflurane|sevoflurane|mesh-list
101682812|NCT02727296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101682813|NCT02727296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101682814|NCT02727296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682815|NCT02727296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101682816|NCT02727296|Anesthetics, General|anesthetics, general|mesh-ancestor
101682817|NCT02727296|Anesthetics|anesthetics|mesh-ancestor
101682818|NCT02727296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101682819|NCT02727296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101682820|NCT02732132|Fentanyl|fentanyl|mesh-list
101682821|NCT02732132|Midazolam|midazolam|mesh-list
101682822|NCT02732132|Ketamine|ketamine|mesh-list
101682823|NCT02732132|Propofol|propofol|mesh-list
101682824|NCT02732132|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101682825|NCT02732132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101682826|NCT02732132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682827|NCT02732132|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101682828|NCT02732132|Anesthetics, General|anesthetics, general|mesh-ancestor
101682829|NCT02732132|Anesthetics|anesthetics|mesh-ancestor
101682830|NCT02732132|Analgesics|analgesics|mesh-ancestor
101682831|NCT02732132|Sensory System Agents|sensory system agents|mesh-ancestor
101682832|NCT02732132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101682833|NCT02732132|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101682834|NCT02732132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101682835|NCT02732132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101682836|NCT02732132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101682837|NCT02732132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682838|NCT02732132|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101682839|NCT02732132|Narcotics|narcotics|mesh-ancestor
101682840|NCT02732132|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101682841|NCT02732132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101682842|NCT02732132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101682843|NCT02732132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101682844|NCT02732132|GABA Modulators|gaba modulators|mesh-ancestor
101682845|NCT02732132|GABA Agents|gaba agents|mesh-ancestor
101682846|NCT02737202|Saracatinib|saracatinib|mesh-list
101682847|NCT02737202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101682848|NCT02737202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101682849|NCT02737202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682850|NCT02721368|Lidocaine|lidocaine|mesh-list
101682851|NCT02721368|Anesthetics, Local|anesthetics, local|mesh-ancestor
101682852|NCT02721368|Anesthetics|anesthetics|mesh-ancestor
101682853|NCT02721368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101682854|NCT02721368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682855|NCT02721368|Sensory System Agents|sensory system agents|mesh-ancestor
101682856|NCT02721368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101682857|NCT02721368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101682858|NCT02721368|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101682859|NCT02721368|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101682860|NCT02721368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101682861|NCT02721368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682862|NCT02737124|Acetaminophen|acetaminophen|mesh-list
101682863|NCT02737124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101682865|NCT02737124|Sensory System Agents|sensory system agents|mesh-ancestor
101682866|NCT02737124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101682867|NCT02737124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682868|NCT02737124|Antipyretics|antipyretics|mesh-ancestor
101682869|NCT02721290|Ropivacaine|ropivacaine|mesh-list
101682870|NCT02721290|Anesthetics, Local|anesthetics, local|mesh-ancestor
101682871|NCT02721290|Anesthetics|anesthetics|mesh-ancestor
101682872|NCT02721290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101682873|NCT02721290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682874|NCT02721290|Sensory System Agents|sensory system agents|mesh-ancestor
101682875|NCT02721290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101682876|NCT02720978|Oxytocin|oxytocin|mesh-list
101682877|NCT02720978|Oxytocics|oxytocics|mesh-ancestor
101682878|NCT02720978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101682879|NCT02720978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682880|NCT02726984|Listerine|listerine|mesh-list
101682881|NCT02726984|Fluorides|fluorides|mesh-list
101682882|NCT02726984|Sodium Fluoride|sodium fluoride|mesh-list
101682883|NCT02726984|Cariostatic Agents|cariostatic agents|mesh-ancestor
101682884|NCT02726984|Protective Agents|protective agents|mesh-ancestor
101682885|NCT02726984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682886|NCT02726984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101682887|NCT02726984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101682888|NCT02726828|Ketamine|ketamine|mesh-list
101682889|NCT02726828|Morphine|morphine|mesh-list
101682890|NCT02726828|Analgesics|analgesics|mesh-ancestor
101682891|NCT02726828|Sensory System Agents|sensory system agents|mesh-ancestor
101682892|NCT02726828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101682893|NCT02726828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682894|NCT02726828|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101682895|NCT02726828|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101682896|NCT02726828|Anesthetics, General|anesthetics, general|mesh-ancestor
101682897|NCT02726828|Anesthetics|anesthetics|mesh-ancestor
101682898|NCT02726828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101682899|NCT02726828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101682900|NCT02726828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101682901|NCT02726828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101682902|NCT02726828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682903|NCT02726828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101682904|NCT02726828|Narcotics|narcotics|mesh-ancestor
101682905|NCT02799134|Dexamethasone|dexamethasone|mesh-list
101682906|NCT02799134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682907|NCT02799134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101682908|NCT02799134|Antiemetics|antiemetics|mesh-ancestor
101682909|NCT02799134|Autonomic Agents|autonomic agents|mesh-ancestor
101682910|NCT02799134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101682911|NCT02799134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101682912|NCT02799134|Glucocorticoids|glucocorticoids|mesh-ancestor
101682913|NCT02799134|Hormones|hormones|mesh-ancestor
101682914|NCT02799134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101682915|NCT02799134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101682916|NCT02799134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101682917|NCT02720822|Morphine|morphine|mesh-list
101682918|NCT02720822|Laxatives|laxatives|mesh-list
101682919|NCT02720822|Cathartics|cathartics|mesh-list
101682920|NCT02720822|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101682921|NCT02720822|Narcotics|narcotics|mesh-ancestor
101682922|NCT02720822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101682923|NCT02720822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682924|NCT02720822|Analgesics|analgesics|mesh-ancestor
101682925|NCT02720822|Sensory System Agents|sensory system agents|mesh-ancestor
101682926|NCT02720822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101682927|NCT02720822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101682928|NCT02757872|Vitamin D|vitamin d|mesh-list
101682929|NCT02757872|Ergocalciferols|ergocalciferols|mesh-list
101682930|NCT02757872|Cholecalciferol|cholecalciferol|mesh-list
101682931|NCT02757872|Vitamins|vitamins|mesh-list
101682933|NCT02757872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682934|NCT02757872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101830164|NCT02658890|Nivolumab|nivolumab|mesh-list
101682935|NCT02757872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101682937|NCT02746796|Tegafur|tegafur|mesh-list
101682938|NCT02746796|Oxaliplatin|oxaliplatin|mesh-list
101682939|NCT02746796|Nivolumab|nivolumab|mesh-list
101682940|NCT02746796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101682941|NCT02746796|Antimetabolites|antimetabolites|mesh-ancestor
101682942|NCT02746796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682943|NCT02746796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101682944|NCT02746796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101682945|NCT02746796|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101682946|NCT04167176|Lidocaine|lidocaine|mesh-list
101682947|NCT04167176|Bupivacaine|bupivacaine|mesh-list
101682948|NCT04167176|Anesthetics, Local|anesthetics, local|mesh-ancestor
101682949|NCT04167176|Anesthetics|anesthetics|mesh-ancestor
101682950|NCT04167176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101682951|NCT04167176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682952|NCT04167176|Sensory System Agents|sensory system agents|mesh-ancestor
101682953|NCT04167176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101682954|NCT04167176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101682955|NCT04167176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101340222|NCT00136396|Rituximab|rituximab|mesh-list
101682956|NCT04167176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101682957|NCT04167176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101682958|NCT04167176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682959|NCT02720120|Ocrelizumab|ocrelizumab|mesh-list
101682960|NCT02720120|Immunologic Factors|immunologic factors|mesh-ancestor
101682961|NCT02720120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682962|NCT04189250|Carbon Monoxide|carbon monoxide|mesh-list
101682963|NCT04189250|Antimetabolites|antimetabolites|mesh-ancestor
101682964|NCT04189250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682965|NCT04189250|Gasotransmitters|gasotransmitters|mesh-ancestor
101682966|NCT04189250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101682967|NCT04189250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682968|NCT02726126|Fentanyl|fentanyl|mesh-list
101682969|NCT02726126|Melatonin|melatonin|mesh-list
101682970|NCT02726126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101682971|NCT02726126|Narcotics|narcotics|mesh-ancestor
101682972|NCT02726126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101682973|NCT02726126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101682974|NCT02726126|Analgesics|analgesics|mesh-ancestor
101682975|NCT02726126|Sensory System Agents|sensory system agents|mesh-ancestor
101682976|NCT02726126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101682977|NCT02726126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101682978|NCT02726126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101682979|NCT02726126|Anesthetics, General|anesthetics, general|mesh-ancestor
101682980|NCT02726126|Anesthetics|anesthetics|mesh-ancestor
101682981|NCT02726126|Antioxidants|antioxidants|mesh-ancestor
101682982|NCT02726126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682983|NCT02726126|Protective Agents|protective agents|mesh-ancestor
101682984|NCT02694458|Vancomycin|vancomycin|mesh-list
101682985|NCT02694458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101682986|NCT02694458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101682987|NCT02719808|Tenofovir|tenofovir|mesh-list
101682988|NCT02719808|Antiviral Agents|antiviral agents|mesh-ancestor
101682989|NCT02719808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101682990|NCT02719808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101682991|NCT02719808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101682992|NCT02719808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101682993|NCT02719808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101682994|NCT02719808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101682995|NCT02719808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101682996|NCT02719418|Tinzaparin|tinzaparin|mesh-list
101682997|NCT02719418|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101682999|NCT02719418|Anticoagulants|anticoagulants|mesh-ancestor
101683000|NCT02719418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101830170|NCT02658890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683001|NCT02719418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101683002|NCT02719418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683003|NCT02129348|Lithium Carbonate|lithium carbonate|mesh-list
101683004|NCT02129348|Antidepressive Agents|antidepressive agents|mesh-ancestor
101683005|NCT02129348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101683006|NCT02129348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101683007|NCT02129348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683008|NCT02129348|Antimanic Agents|antimanic agents|mesh-ancestor
101683009|NCT02129348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101683010|NCT02129348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101683011|NCT02129348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683012|NCT02725736|Nifedipine|nifedipine|mesh-list
101683013|NCT02725736|Atosiban|atosiban|mesh-list
101683014|NCT02725736|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101683015|NCT02725736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101683016|NCT02725736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683017|NCT02725736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101683018|NCT02725736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683019|NCT02725736|Vasodilator Agents|vasodilator agents|mesh-ancestor
101683020|NCT02725736|Tocolytic Agents|tocolytic agents|mesh-ancestor
101683021|NCT02725736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101683022|NCT02725736|Hormone Antagonists|hormone antagonists|mesh-ancestor
101683023|NCT02725736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101683024|NCT02716142|Misoprostol|misoprostol|mesh-list
101683025|NCT02716142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101683026|NCT02716142|Abortifacient Agents|abortifacient agents|mesh-ancestor
101683027|NCT02716142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101683028|NCT02716142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683029|NCT02716142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101683030|NCT02716142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101683031|NCT02716142|Oxytocics|oxytocics|mesh-ancestor
101683032|NCT03015974|Mycophenolic Acid|mycophenolic acid|mesh-list
101683033|NCT03015974|Prednisone|prednisone|mesh-list
101683034|NCT03015974|Prednisolone|prednisolone|mesh-list
101683035|NCT03015974|Deflazacort|deflazacort|mesh-list
101683036|NCT03015974|Cyclophosphamide|cyclophosphamide|mesh-list
101683037|NCT03015974|Dipyridamole|dipyridamole|mesh-list
101683038|NCT03015974|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101683039|NCT03015974|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
101683040|NCT03015974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101683041|NCT03015974|Immunologic Factors|immunologic factors|mesh-ancestor
101683042|NCT03015974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683043|NCT03015974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101683044|NCT03015974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101683045|NCT03015974|Alkylating Agents|alkylating agents|mesh-ancestor
101683046|NCT03015974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683047|NCT03015974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101683048|NCT03015974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101683049|NCT03015974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101683050|NCT03015974|Glucocorticoids|glucocorticoids|mesh-ancestor
101683051|NCT03015974|Hormones|hormones|mesh-ancestor
101683052|NCT03015974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101683053|NCT03015974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101683054|NCT03015974|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101683055|NCT03015974|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101830177|NCT02597062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101683057|NCT03015974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101683058|NCT03015974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101683059|NCT03015974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101683060|NCT03015974|Protease Inhibitors|protease inhibitors|mesh-ancestor
101683061|NCT03015974|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101683062|NCT03015974|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101683063|NCT03015974|Vasodilator Agents|vasodilator agents|mesh-ancestor
101683064|NCT02718950|Liraglutide|liraglutide|mesh-list
101683065|NCT02718950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101683066|NCT02718950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683067|NCT02718950|Incretins|incretins|mesh-ancestor
101683069|NCT02718950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101683070|NCT02725502|Linagliptin|linagliptin|mesh-list
101683071|NCT02725502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101683072|NCT02725502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683073|NCT02725502|Incretins|incretins|mesh-ancestor
101683074|NCT02725502|Hormones|hormones|mesh-ancestor
101683075|NCT02725502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101683076|NCT02725502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101683077|NCT02725502|Protease Inhibitors|protease inhibitors|mesh-ancestor
101683078|NCT02725502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101683079|NCT02725502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683080|NCT02718716|Rozanolixizumab|rozanolixizumab|mesh-list
101683081|NCT02718716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101683082|NCT02718716|Immunologic Factors|immunologic factors|mesh-ancestor
101683083|NCT02718716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683084|NCT01959464|Progesterone|progesterone|mesh-list
101683085|NCT01959464|Progestins|progestins|mesh-ancestor
101683086|NCT01959464|Hormones|hormones|mesh-ancestor
101683087|NCT01959464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101683088|NCT01959464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683089|NCT02718482|Gemcitabine|gemcitabine|mesh-list
101683090|NCT02718482|Docetaxel|docetaxel|mesh-list
101683091|NCT02718482|Ifosfamide|ifosfamide|mesh-list
101683092|NCT02718482|Isophosphamide mustard|isophosphamide mustard|mesh-list
101683093|NCT02718482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101683094|NCT02718482|Antimetabolites|antimetabolites|mesh-ancestor
101683095|NCT02718482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683096|NCT02718482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101683097|NCT02718482|Tubulin Modulators|tubulin modulators|mesh-ancestor
101683098|NCT02718482|Antimitotic Agents|antimitotic agents|mesh-ancestor
101683099|NCT02718482|Mitosis Modulators|mitosis modulators|mesh-ancestor
101683100|NCT02718482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101683101|NCT02718482|Alkylating Agents|alkylating agents|mesh-ancestor
101683102|NCT01921166|Leuprolide|leuprolide|mesh-list
101683103|NCT01921166|Clomiphene|clomiphene|mesh-list
101683104|NCT01921166|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101683105|NCT01921166|Fertility Agents|fertility agents|mesh-ancestor
101683106|NCT01921166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101683107|NCT01921166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683108|NCT01921166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101683109|NCT01921166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101683110|NCT01921166|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101683111|NCT01921166|Hormone Antagonists|hormone antagonists|mesh-ancestor
101683112|NCT01921166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101683113|NCT01921166|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101683114|NCT01921166|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101683115|NCT05087030|Denosumab|denosumab|mesh-list
101683116|NCT05087030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101683117|NCT05087030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683118|NCT02717858|Liraglutide|liraglutide|mesh-list
101683119|NCT02717858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101683120|NCT02717858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683121|NCT02717858|Incretins|incretins|mesh-ancestor
101683122|NCT02717858|Hormones|hormones|mesh-ancestor
101683123|NCT02717858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101683124|NCT02725112|Pregabalin|pregabalin|mesh-list
101683125|NCT02725112|Analgesics|analgesics|mesh-ancestor
101683126|NCT02725112|Sensory System Agents|sensory system agents|mesh-ancestor
101683127|NCT02725112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101683128|NCT02725112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683129|NCT02725112|Anticonvulsants|anticonvulsants|mesh-ancestor
101683130|NCT02725112|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101683131|NCT02725112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101683132|NCT02725112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683133|NCT02725112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101683134|NCT02725112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101683135|NCT02725112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101683136|NCT02725112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101683137|NCT02725112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101683139|NCT02724332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101683140|NCT02724332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101683141|NCT02724332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101683142|NCT02724332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101683143|NCT02724332|Antifungal Agents|antifungal agents|mesh-ancestor
101683144|NCT02724332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101683145|NCT02724332|Immunologic Factors|immunologic factors|mesh-ancestor
101683146|NCT02724332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683147|NCT02717780|Fentanyl|fentanyl|mesh-list
101683148|NCT02717780|Remifentanil|remifentanil|mesh-list
101683149|NCT02717780|Sevoflurane|sevoflurane|mesh-list
101683150|NCT02717780|Desflurane|desflurane|mesh-list
101683151|NCT02717780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101683152|NCT02717780|Narcotics|narcotics|mesh-ancestor
101683153|NCT02717780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101683154|NCT02717780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683155|NCT02717780|Analgesics|analgesics|mesh-ancestor
101683156|NCT02717780|Sensory System Agents|sensory system agents|mesh-ancestor
101683157|NCT02717780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101683158|NCT02717780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101683159|NCT02717780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101683160|NCT02717780|Anesthetics, General|anesthetics, general|mesh-ancestor
101683161|NCT02717780|Anesthetics|anesthetics|mesh-ancestor
101683162|NCT02717780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101683163|NCT02717780|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101683164|NCT02724098|Dexmedetomidine|dexmedetomidine|mesh-list
101683165|NCT02724098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101683166|NCT02724098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101683167|NCT02724098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683168|NCT02724098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101683169|NCT02724098|Analgesics|analgesics|mesh-ancestor
101683170|NCT02724098|Sensory System Agents|sensory system agents|mesh-ancestor
101683171|NCT02724098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101683172|NCT02724098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101683173|NCT02724098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101683174|NCT02724098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101683175|NCT02724098|Adrenergic Agents|adrenergic agents|mesh-ancestor
101683176|NCT02724098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101683177|NCT02724098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683178|NCT02723942|Immunomodulating Agents|immunomodulating agents|mesh-list
101683179|NCT02723942|Immunologic Factors|immunologic factors|mesh-ancestor
101683180|NCT02723942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683181|NCT04138316|Candesartan|candesartan|mesh-list
101683182|NCT04138316|Candesartan cilexetil|candesartan cilexetil|mesh-list
101683183|NCT04138316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101683184|NCT04138316|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101683185|NCT04138316|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101683186|NCT04138316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683187|NCT05291390|Pyronaridine|pyronaridine|mesh-list
101683188|NCT05291390|Antimalarials|antimalarials|mesh-ancestor
101683189|NCT05291390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101683190|NCT05291390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101683191|NCT05291390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101683193|NCT04189484|Alirocumab|alirocumab|mesh-list
101683194|NCT04189484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101683195|NCT04189484|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101683196|NCT04189484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101683197|NCT04189484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101683198|NCT04189484|Antimetabolites|antimetabolites|mesh-ancestor
101683199|NCT04189484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683200|NCT04189484|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101683201|NCT04189484|Protease Inhibitors|protease inhibitors|mesh-ancestor
101683202|NCT04189484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101683203|NCT04189484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101683204|NCT04189484|Immunologic Factors|immunologic factors|mesh-ancestor
101683205|NCT04189484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683206|NCT00636740|Zoledronic Acid|zoledronic acid|mesh-list
101683207|NCT00636740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101683208|NCT00636740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683209|NCT02716766|Capecitabine|capecitabine|mesh-list
101683211|NCT02716766|Sorafenib|sorafenib|mesh-list
101683212|NCT02716766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101683213|NCT02716766|Antimetabolites|antimetabolites|mesh-ancestor
101683214|NCT02716766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683215|NCT02716766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101683216|NCT02716766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101683217|NCT02716766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101683218|NCT02716610|Insulin Lispro|insulin lispro|mesh-list
101683219|NCT02716610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101683220|NCT02716610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683222|NCT02694224|Cyclophosphamide|cyclophosphamide|mesh-list
101683223|NCT02694224|Epirubicin|epirubicin|mesh-list
101683224|NCT02694224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101683225|NCT02694224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101683226|NCT02694224|Tubulin Modulators|tubulin modulators|mesh-ancestor
101683227|NCT02694224|Antimitotic Agents|antimitotic agents|mesh-ancestor
101683228|NCT02694224|Mitosis Modulators|mitosis modulators|mesh-ancestor
101683229|NCT02694224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683230|NCT02694224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101683231|NCT02694224|Immunologic Factors|immunologic factors|mesh-ancestor
101683232|NCT02694224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683233|NCT02694224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101683234|NCT02694224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101683235|NCT02694224|Alkylating Agents|alkylating agents|mesh-ancestor
101683236|NCT02694224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101683237|NCT02694224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101683238|NCT02694224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101683239|NCT02694224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101683240|NCT02694224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101683241|NCT00782288|Digitoxin|digitoxin|mesh-list
101683242|NCT00782288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101683243|NCT00782288|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101683244|NCT00782288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101683245|NCT00782288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683246|NCT00782288|Protective Agents|protective agents|mesh-ancestor
101683247|NCT00782288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683248|NCT04189094|Etoposide|etoposide|mesh-list
101683249|NCT04189094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101683250|NCT04189094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101683251|NCT04189094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101683252|NCT04189094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101683253|NCT04189094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101683254|NCT04189094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683255|NCT02712944|Testosterone|testosterone|mesh-list
101683256|NCT02712944|Androgens|androgens|mesh-ancestor
101683257|NCT02712944|Hormones|hormones|mesh-ancestor
101683258|NCT02712944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101683259|NCT02712944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683260|NCT02712866|Vedolizumab|vedolizumab|mesh-list
101683261|NCT02712866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101683262|NCT00600483|Gentamicins|gentamicins|mesh-list
101830214|NCT02451982|Nivolumab|nivolumab|mesh-list
101683263|NCT00600483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101683264|NCT00600483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101683265|NCT00600483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101683266|NCT00600483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101683267|NCT00600483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683268|NCT04132232|Carbon Monoxide|carbon monoxide|mesh-list
101683269|NCT04132232|Antimetabolites|antimetabolites|mesh-ancestor
101683270|NCT04132232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683271|NCT04132232|Gasotransmitters|gasotransmitters|mesh-ancestor
101683272|NCT04132232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101683273|NCT04132232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683274|NCT00649857|Cetirizine|cetirizine|mesh-list
101683275|NCT00649857|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101683276|NCT00649857|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101683277|NCT00649857|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101683278|NCT00649857|Histamine Antagonists|histamine antagonists|mesh-ancestor
101683279|NCT00649857|Histamine Agents|histamine agents|mesh-ancestor
101683280|NCT00649857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101326209|NCT00008333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101683281|NCT00649857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683282|NCT00649857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683284|NCT00764270|Antioxidants|antioxidants|mesh-ancestor
101683285|NCT00764270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683286|NCT00764270|Protective Agents|protective agents|mesh-ancestor
101683287|NCT00764270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683288|NCT00764270|Vitamin B Complex|vitamin b complex|mesh-ancestor
101683289|NCT00764270|Vitamins|vitamins|mesh-ancestor
101683290|NCT00764270|Micronutrients|micronutrients|mesh-ancestor
101683291|NCT00650481|Oxybutynin|oxybutynin|mesh-list
101683292|NCT00650481|Parasympatholytics|parasympatholytics|mesh-ancestor
101683294|NCT00650481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101683295|NCT00650481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683296|NCT00650481|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101683297|NCT00650481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101683298|NCT00650481|Cholinergic Agents|cholinergic agents|mesh-ancestor
101683299|NCT00650481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101683300|NCT00650481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683301|NCT00650481|Urological Agents|urological agents|mesh-ancestor
101683302|NCT02712476|Furosemide|furosemide|mesh-list
101683303|NCT02712476|Mannitol|mannitol|mesh-list
101683304|NCT02712476|Diuretics|diuretics|mesh-ancestor
101683305|NCT02712476|Natriuretic Agents|natriuretic agents|mesh-ancestor
101683306|NCT02712476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683307|NCT02712476|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101683308|NCT02712476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101683309|NCT02712476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683310|NCT02712476|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101683311|NCT02722538|Gemcitabine|gemcitabine|mesh-list
101683312|NCT02722538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101683313|NCT02722538|Antimetabolites|antimetabolites|mesh-ancestor
101683314|NCT02722538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683315|NCT02722538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101683316|NCT02651727|Paclitaxel|paclitaxel|mesh-list
101683317|NCT02651727|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101683319|NCT02651727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101683320|NCT02651727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101683321|NCT02651727|Tubulin Modulators|tubulin modulators|mesh-ancestor
101683322|NCT02651727|Antimitotic Agents|antimitotic agents|mesh-ancestor
101683323|NCT02651727|Mitosis Modulators|mitosis modulators|mesh-ancestor
101683324|NCT02651727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683325|NCT02651727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101683326|NCT02651727|Antimetabolites|antimetabolites|mesh-ancestor
101683327|NCT02650791|Tranexamic Acid|tranexamic acid|mesh-list
101683328|NCT02650791|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101683329|NCT02650791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101683330|NCT02650791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683331|NCT02650791|Hemostatics|hemostatics|mesh-ancestor
101683332|NCT02650791|Coagulants|coagulants|mesh-ancestor
101683333|NCT04035668|Remibrutinib|remibrutinib|mesh-list
101683334|NCT04035668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101683335|NCT04035668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101683336|NCT04035668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683337|NCT02650713|Atezolizumab|atezolizumab|mesh-list
101683338|NCT02650713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101683339|NCT02650713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683340|NCT02650713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101683341|NCT02650713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101683342|NCT02650635|Cyclophosphamide|cyclophosphamide|mesh-list
101683343|NCT02650635|Lenograstim|lenograstim|mesh-list
101683344|NCT02650635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101683345|NCT02650635|Immunologic Factors|immunologic factors|mesh-ancestor
101683346|NCT02650635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683347|NCT02650635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101683348|NCT02650635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101683349|NCT02650635|Alkylating Agents|alkylating agents|mesh-ancestor
101683350|NCT02650635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683351|NCT02650635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101683352|NCT02650635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101683353|NCT02650635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101683354|NCT00650637|Calcium, Dietary|calcium, dietary|mesh-list
101683355|NCT00650637|Lamivudine|lamivudine|mesh-list
101683356|NCT00650637|Zidovudine|zidovudine|mesh-list
101683357|NCT00650637|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101683358|NCT00650637|Nelfinavir|nelfinavir|mesh-list
101683359|NCT00650637|Calcium Carbonate|calcium carbonate|mesh-list
101683360|NCT00650637|Loperamide|loperamide|mesh-list
101683361|NCT00650637|Antidiarrheals|antidiarrheals|mesh-list
101683362|NCT00650637|Calcium|calcium|mesh-list
101683363|NCT00650637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101683364|NCT00650637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683365|NCT00650637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101683366|NCT00650637|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101683367|NCT00650637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101683368|NCT00650637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101683369|NCT00650637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683370|NCT00650637|Antiviral Agents|antiviral agents|mesh-ancestor
101683371|NCT00650637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101683372|NCT00650637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101683373|NCT00650637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101683374|NCT00650637|Antimetabolites|antimetabolites|mesh-ancestor
101683375|NCT00650637|Antacids|antacids|mesh-ancestor
101683376|NCT00650637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101683377|NCT00650637|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101683378|NCT00650637|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101683379|NCT00650637|Protease Inhibitors|protease inhibitors|mesh-ancestor
101683380|NCT02650479|Exenatide|exenatide|mesh-list
101683381|NCT02650479|Moxifloxacin|moxifloxacin|mesh-list
101683382|NCT02650479|Palonosetron|palonosetron|mesh-list
101683383|NCT02650479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101683384|NCT02650479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101683385|NCT02650479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101683386|NCT02650479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101683387|NCT02650479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101683388|NCT02650479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683389|NCT02650479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101683390|NCT02650479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683391|NCT02650479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101683392|NCT02650479|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101683393|NCT02650479|Incretins|incretins|mesh-ancestor
101683394|NCT02650479|Hormones|hormones|mesh-ancestor
101683395|NCT02650479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101683396|NCT02650479|Antiemetics|antiemetics|mesh-ancestor
101683397|NCT02650479|Autonomic Agents|autonomic agents|mesh-ancestor
101683398|NCT02650479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101683399|NCT02650479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101683400|NCT02650479|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101683401|NCT02650479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101683402|NCT02650479|Serotonin Agents|serotonin agents|mesh-ancestor
101683403|NCT02650479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101683404|NCT02722772|Etanercept|etanercept|mesh-list
101683405|NCT02722772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101683406|NCT02722772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101683407|NCT02722772|Analgesics|analgesics|mesh-ancestor
101683408|NCT02722772|Sensory System Agents|sensory system agents|mesh-ancestor
101683409|NCT02722772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101683410|NCT02722772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683411|NCT02722772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101683412|NCT02722772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101683413|NCT02722772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101683414|NCT02722772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101683415|NCT02722772|Immunologic Factors|immunologic factors|mesh-ancestor
101683416|NCT02650245|Lactulose|lactulose|mesh-list
101683417|NCT02650245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101683418|NCT00650793|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101683419|NCT00650793|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101683420|NCT00650793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101683421|NCT00650793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101683422|NCT00650793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683423|NCT00650793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101683424|NCT00650793|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101683425|NCT00650793|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101683426|NCT00650793|Serotonin Agents|serotonin agents|mesh-ancestor
101683427|NCT00650793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101683428|NCT00650793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683429|NCT00650793|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101683430|NCT00650793|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101683431|NCT00650793|Dopamine Agents|dopamine agents|mesh-ancestor
101683432|NCT00910767|Insulin|insulin|mesh-list
101683433|NCT00910767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101683434|NCT00910767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683435|NCT02722694|Methotrexate|methotrexate|mesh-list
101683436|NCT02722694|Abatacept|abatacept|mesh-list
101683437|NCT02722694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101683438|NCT02722694|Abortifacient Agents|abortifacient agents|mesh-ancestor
101683439|NCT02722694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101683440|NCT02722694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683441|NCT02722694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101683442|NCT02722694|Antimetabolites|antimetabolites|mesh-ancestor
101683443|NCT02722694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683445|NCT02722694|Dermatologic Agents|dermatologic agents|mesh-ancestor
101683446|NCT02722694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101683447|NCT02722694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101683448|NCT02722694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101683449|NCT02722694|Immunologic Factors|immunologic factors|mesh-ancestor
101683450|NCT02722694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101683451|NCT02722694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101683452|NCT02722694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101683453|NCT02722694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101683455|NCT00650871|Antiemetics|antiemetics|mesh-ancestor
101683456|NCT00650871|Autonomic Agents|autonomic agents|mesh-ancestor
101683457|NCT00650871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101683458|NCT00650871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683459|NCT00650871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101683460|NCT00650871|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101683461|NCT00650871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101683462|NCT00650871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683463|NCT02649621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101683464|NCT02649621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101683465|NCT02649465|Glimepiride|glimepiride|mesh-list
101683466|NCT02649465|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
101683467|NCT02649465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101683468|NCT02649465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101683469|NCT02649465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683470|NCT02649465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101683471|NCT02649465|Immunologic Factors|immunologic factors|mesh-ancestor
101683472|NCT02649465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101683473|NCT02649465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683474|NCT00651105|Vildagliptin|vildagliptin|mesh-list
101683475|NCT00651105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101683476|NCT00651105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683477|NCT00651105|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101683478|NCT00651105|Protease Inhibitors|protease inhibitors|mesh-ancestor
101683479|NCT00651105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101683480|NCT00651105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683482|NCT02694146|Viscosupplements|viscosupplements|mesh-ancestor
101683483|NCT02694146|Protective Agents|protective agents|mesh-ancestor
101683484|NCT02694146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683485|NCT04167267|Fexuprazan|fexuprazan|mesh-list
101683486|NCT04167267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101683487|NCT02649075|Immunoglobulins|immunoglobulins|mesh-list
101683488|NCT02649075|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101683490|NCT02649075|Immunologic Factors|immunologic factors|mesh-ancestor
101683491|NCT02649075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683492|NCT02644785|Protamines|protamines|mesh-list
101683493|NCT02644785|Heparin Antagonists|heparin antagonists|mesh-ancestor
101683494|NCT02644785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683495|NCT02644785|Coagulants|coagulants|mesh-ancestor
101683496|NCT02644707|Selenium|selenium|mesh-list
101683497|NCT02644707|Antioxidants|antioxidants|mesh-ancestor
101683498|NCT02644707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683499|NCT02644707|Protective Agents|protective agents|mesh-ancestor
101683500|NCT02644707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683501|NCT02644707|Trace Elements|trace elements|mesh-ancestor
101683502|NCT02644707|Micronutrients|micronutrients|mesh-ancestor
101683503|NCT02711228|Immunoglobulins|immunoglobulins|mesh-list
101683504|NCT02711228|Antibodies|antibodies|mesh-list
101683505|NCT02711228|gamma-Globulins|gamma-globulins|mesh-list
101683506|NCT02711228|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101683507|NCT02711228|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101683508|NCT02711228|Immunologic Factors|immunologic factors|mesh-ancestor
101683509|NCT02711228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683510|NCT02644863|Paclitaxel|paclitaxel|mesh-list
101683511|NCT02644863|Cisplatin|cisplatin|mesh-list
101683512|NCT02644863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101683513|NCT02644863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101683514|NCT02644863|Tubulin Modulators|tubulin modulators|mesh-ancestor
101683515|NCT02644863|Antimitotic Agents|antimitotic agents|mesh-ancestor
101683516|NCT02644863|Mitosis Modulators|mitosis modulators|mesh-ancestor
101683517|NCT02644863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683519|NCT00302744|Psilocybin|psilocybin|mesh-list
101683520|NCT00302744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101683521|NCT00302744|Antimetabolites|antimetabolites|mesh-ancestor
101683522|NCT00302744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683523|NCT00302744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101683524|NCT00302744|Vasodilator Agents|vasodilator agents|mesh-ancestor
101683525|NCT00302744|Vitamin B Complex|vitamin b complex|mesh-ancestor
101683526|NCT00302744|Vitamins|vitamins|mesh-ancestor
101683527|NCT00302744|Micronutrients|micronutrients|mesh-ancestor
101683528|NCT00302744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683529|NCT00302744|Hallucinogens|hallucinogens|mesh-ancestor
101683530|NCT00302744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101683531|NCT02644629|Ketamine|ketamine|mesh-list
101683532|NCT02644629|Analgesics|analgesics|mesh-ancestor
101683533|NCT02644629|Sensory System Agents|sensory system agents|mesh-ancestor
101683534|NCT02644629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101683535|NCT02644629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683536|NCT02644629|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101683537|NCT02644629|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101683538|NCT02644629|Anesthetics, General|anesthetics, general|mesh-ancestor
101683539|NCT02644629|Anesthetics|anesthetics|mesh-ancestor
101683540|NCT02644629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101683541|NCT02644629|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101683542|NCT02644629|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101683543|NCT02644629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101683544|NCT02644629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683545|NCT00652665|Leflunomide|leflunomide|mesh-list
101683546|NCT00652665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101683547|NCT00652665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683548|NCT00652665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101683549|NCT00652665|Immunologic Factors|immunologic factors|mesh-ancestor
101683550|NCT00652665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683551|NCT02644551|Ciclopirox|ciclopirox|mesh-list
101683552|NCT02644551|Antifungal Agents|antifungal agents|mesh-ancestor
101683553|NCT02644551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101683554|NCT02644395|Amlodipine|amlodipine|mesh-list
101340827|NCT00140101|Paclitaxel|paclitaxel|mesh-list
101683555|NCT02644395|Chlorthalidone|chlorthalidone|mesh-list
101683556|NCT02644395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101683557|NCT02644395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101683558|NCT02644395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101683559|NCT02644395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683560|NCT02644395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101683561|NCT02644395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683562|NCT02644395|Vasodilator Agents|vasodilator agents|mesh-ancestor
101683563|NCT02644395|Diuretics|diuretics|mesh-ancestor
101683564|NCT02644395|Natriuretic Agents|natriuretic agents|mesh-ancestor
101683565|NCT02644395|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101683566|NCT04166565|Dexamethasone|dexamethasone|mesh-list
101683567|NCT04166565|Cyclophosphamide|cyclophosphamide|mesh-list
101683568|NCT04166565|Bortezomib|bortezomib|mesh-list
101683569|NCT04166565|Daratumumab|daratumumab|mesh-list
101683570|NCT04166565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101683571|NCT04166565|Immunologic Factors|immunologic factors|mesh-ancestor
101683572|NCT04166565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683573|NCT04166565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101683574|NCT04166565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101683575|NCT04166565|Alkylating Agents|alkylating agents|mesh-ancestor
101683576|NCT04166565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683577|NCT04166565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101683578|NCT04166565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101683579|NCT04166565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101683580|NCT04166565|Antiemetics|antiemetics|mesh-ancestor
101683581|NCT04166565|Autonomic Agents|autonomic agents|mesh-ancestor
101683582|NCT04166565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101683583|NCT04166565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101683584|NCT04166565|Glucocorticoids|glucocorticoids|mesh-ancestor
101683585|NCT04166565|Hormones|hormones|mesh-ancestor
101683586|NCT04166565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101683587|NCT04166565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101683588|NCT02644473|Tranexamic Acid|tranexamic acid|mesh-list
101683589|NCT02644473|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101683590|NCT02644473|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101683591|NCT02644473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683592|NCT02644473|Hemostatics|hemostatics|mesh-ancestor
101683593|NCT02644473|Coagulants|coagulants|mesh-ancestor
101683594|NCT02644083|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101683595|NCT02644083|Dermatologic Agents|dermatologic agents|mesh-ancestor
101683596|NCT02644083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101683597|NCT02644083|Immunologic Factors|immunologic factors|mesh-ancestor
101683598|NCT02644083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683600|NCT04005872|Fluorides|fluorides|mesh-list
101683601|NCT04005872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101683602|NCT04005872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683603|NCT04005872|Cariostatic Agents|cariostatic agents|mesh-ancestor
101683604|NCT04005872|Protective Agents|protective agents|mesh-ancestor
101683605|NCT00652821|Tramadol|tramadol|mesh-list
101683606|NCT00652821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101683607|NCT00652821|Narcotics|narcotics|mesh-ancestor
101683608|NCT00652821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101683609|NCT00652821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683610|NCT00652821|Analgesics|analgesics|mesh-ancestor
101683611|NCT00652821|Sensory System Agents|sensory system agents|mesh-ancestor
101683612|NCT00652821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101683613|NCT02644161|Antidepressive Agents|antidepressive agents|mesh-list
101683614|NCT02644161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101683615|NCT02535975|Metformin|metformin|mesh-list
101683616|NCT02535975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101683617|NCT02535975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683618|NCT02714036|Ibudilast|ibudilast|mesh-list
101683619|NCT02714036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101683620|NCT02714036|Autonomic Agents|autonomic agents|mesh-ancestor
101683621|NCT02714036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101683622|NCT02714036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683623|NCT02714036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101683624|NCT02714036|Respiratory System Agents|respiratory system agents|mesh-ancestor
101683625|NCT02714036|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101683626|NCT02714036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101683627|NCT02714036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683628|NCT02714036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101683629|NCT02714036|Vasodilator Agents|vasodilator agents|mesh-ancestor
101683630|NCT02710448|Metformin|metformin|mesh-list
101683631|NCT02710448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101340902|NCT00140647|Ramipril|ramipril|mesh-list
101683632|NCT02710448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683633|NCT04602026|Coal Tar|coal tar|mesh-list
101683634|NCT04602026|Keratolytic Agents|keratolytic agents|mesh-ancestor
101683635|NCT04602026|Dermatologic Agents|dermatologic agents|mesh-ancestor
101683636|NCT04166253|Vitamin D|vitamin d|mesh-list
101683638|NCT04166253|Vitamins|vitamins|mesh-ancestor
101683639|NCT04166253|Micronutrients|micronutrients|mesh-ancestor
101683640|NCT04166253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683641|NCT04166253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101683642|NCT00653055|Cabergoline|cabergoline|mesh-list
101683643|NCT00653055|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101683644|NCT00653055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101683645|NCT00653055|Dopamine Agonists|dopamine agonists|mesh-ancestor
101683646|NCT00653055|Dopamine Agents|dopamine agents|mesh-ancestor
101683647|NCT00653055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101683648|NCT00653055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683649|NCT00653055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683650|NCT02643147|Furosemide|furosemide|mesh-list
101683651|NCT02643147|Diuretics|diuretics|mesh-list
101683652|NCT02643147|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
101683653|NCT02643147|Natriuretic Agents|natriuretic agents|mesh-ancestor
101683654|NCT02643147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683655|NCT02643147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101683656|NCT02643147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683657|NCT02642913|Sorafenib|sorafenib|mesh-list
101683658|NCT02642913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101683659|NCT02642913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101683660|NCT02642913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101683661|NCT02642913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683662|NCT04165629|Aspirin|aspirin|mesh-list
101683663|NCT04165629|Clopidogrel|clopidogrel|mesh-list
101683664|NCT04165629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101683665|NCT04165629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101683666|NCT04165629|Analgesics|analgesics|mesh-ancestor
101683667|NCT04165629|Sensory System Agents|sensory system agents|mesh-ancestor
101683668|NCT04165629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101683669|NCT04165629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683670|NCT04165629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101683671|NCT04165629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101683672|NCT04165629|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101683673|NCT04165629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101683674|NCT04165629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683675|NCT04165629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101683676|NCT04165629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101683677|NCT04165629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101683678|NCT04165629|Antipyretics|antipyretics|mesh-ancestor
101683679|NCT04165629|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101683680|NCT04165629|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101683681|NCT04165629|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101683682|NCT04165629|Purinergic Agents|purinergic agents|mesh-ancestor
101683683|NCT04165629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101683684|NCT02642523|Insulin|insulin|mesh-list
101683685|NCT02642523|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101683686|NCT02642523|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101683687|NCT02642523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101683688|NCT02642523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683689|NCT02642523|Natriuretic Agents|natriuretic agents|mesh-ancestor
101683690|NCT02713802|Propofol|propofol|mesh-list
101683691|NCT02713802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101683692|NCT02713802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101683693|NCT02713802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683694|NCT02713802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101683695|NCT02713802|Anesthetics, General|anesthetics, general|mesh-ancestor
101683696|NCT02713802|Anesthetics|anesthetics|mesh-ancestor
101683697|NCT02642601|Indomethacin|indomethacin|mesh-list
101830303|NCT01528852|Disinfectants|disinfectants|mesh-ancestor
101683698|NCT02642601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101683699|NCT02642601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101683700|NCT02642601|Analgesics|analgesics|mesh-ancestor
101683701|NCT02642601|Sensory System Agents|sensory system agents|mesh-ancestor
101683702|NCT02642601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101221713|NCT01509131|Cathartics|cathartics|mesh-ancestor
101683703|NCT02642601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683704|NCT02642601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101683705|NCT02642601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101683706|NCT02642601|Gout Suppressants|gout suppressants|mesh-ancestor
101683707|NCT02642601|Tocolytic Agents|tocolytic agents|mesh-ancestor
101683708|NCT02642601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101683709|NCT02642601|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101683710|NCT02642601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101683711|NCT02642601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683713|NCT02709902|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
101683714|NCT02709902|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101683715|NCT02709902|Dermatologic Agents|dermatologic agents|mesh-ancestor
101683716|NCT02709902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101683717|NCT02709902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101683718|NCT02709902|Analgesics|analgesics|mesh-ancestor
101683719|NCT02709902|Sensory System Agents|sensory system agents|mesh-ancestor
101683720|NCT02709902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101683721|NCT02709902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683722|NCT02709902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101683723|NCT02709902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101683724|NCT02710604|Tenofovir|tenofovir|mesh-list
101683725|NCT02710604|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
101683726|NCT02710604|Antiviral Agents|antiviral agents|mesh-ancestor
101683727|NCT02710604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101683728|NCT02710604|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101683729|NCT02710604|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101683730|NCT02710604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101683731|NCT02710604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683732|NCT02710604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101683733|NCT02710604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101683734|NCT02709824|Chlorhexidine|chlorhexidine|mesh-list
101683735|NCT02709824|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101683736|NCT02709824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101683737|NCT02709824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101683738|NCT02709824|Disinfectants|disinfectants|mesh-ancestor
101683739|NCT02709824|Dermatologic Agents|dermatologic agents|mesh-ancestor
101683741|NCT02642367|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101683742|NCT02642367|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101683743|NCT02642367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101683744|NCT02642367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101683745|NCT02642367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683746|NCT00653445|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101683747|NCT00653445|Ezetimibe|ezetimibe|mesh-list
101683748|NCT00653445|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101683749|NCT00653445|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101683750|NCT00653445|Antimetabolites|antimetabolites|mesh-ancestor
101683751|NCT00653445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683752|NCT00653445|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101683753|NCT00653445|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101683754|NCT00653445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101683755|NCT02641899|Acetaminophen|acetaminophen|mesh-list
101683756|NCT02641899|Exenatide|exenatide|mesh-list
101683757|NCT02641899|Digoxin|digoxin|mesh-list
101683758|NCT02641899|Lisinopril|lisinopril|mesh-list
101683759|NCT02641899|Warfarin|warfarin|mesh-list
101683760|NCT02641899|Atorvastatin|atorvastatin|mesh-list
101683761|NCT02641899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101683762|NCT02641899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101683763|NCT02641899|Antimetabolites|antimetabolites|mesh-ancestor
101683764|NCT02641899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683765|NCT02641899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101683766|NCT02641899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101683767|NCT02641899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101683768|NCT02641899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101683769|NCT02641899|Analgesics|analgesics|mesh-ancestor
101683770|NCT02641899|Sensory System Agents|sensory system agents|mesh-ancestor
101683771|NCT02641899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101683772|NCT02641899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683773|NCT02641899|Antipyretics|antipyretics|mesh-ancestor
101683774|NCT02641899|Anticoagulants|anticoagulants|mesh-ancestor
101683775|NCT02641899|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101683776|NCT02641899|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101683777|NCT02641899|Protective Agents|protective agents|mesh-ancestor
101683778|NCT02641899|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101683779|NCT02641899|Protease Inhibitors|protease inhibitors|mesh-ancestor
101683780|NCT02641899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101683781|NCT02641899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101683782|NCT02641899|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101683783|NCT02641899|Incretins|incretins|mesh-ancestor
101683785|NCT02641899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101683786|NCT02641821|Nifedipine|nifedipine|mesh-list
101683787|NCT02641821|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101683788|NCT02641821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101683789|NCT02641821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683790|NCT02641821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101683791|NCT02641821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683792|NCT02641821|Vasodilator Agents|vasodilator agents|mesh-ancestor
101683793|NCT02641821|Tocolytic Agents|tocolytic agents|mesh-ancestor
101683794|NCT02641821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101683795|NCT01320345|Fenofibrate|fenofibrate|mesh-list
101683796|NCT01320345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101683797|NCT01320345|Antimetabolites|antimetabolites|mesh-ancestor
101683798|NCT01320345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683799|NCT01320345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101683800|NCT04164615|Capecitabine|capecitabine|mesh-list
101683801|NCT04164615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101683802|NCT04164615|Antimetabolites|antimetabolites|mesh-ancestor
101683803|NCT04164615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683804|NCT04164615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101683805|NCT04164459|Latanoprost|latanoprost|mesh-list
101683806|NCT04164459|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101683807|NCT04164459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101683808|NCT04164693|Heparin|heparin|mesh-list
101683809|NCT04164693|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101683810|NCT04164693|Tinzaparin|tinzaparin|mesh-list
101683811|NCT04164693|Dalteparin|dalteparin|mesh-list
101683812|NCT04164693|Warfarin|warfarin|mesh-list
101683813|NCT04164693|Anticoagulants|anticoagulants|mesh-ancestor
101683814|NCT04164693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101683815|NCT04164693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101683816|NCT04164693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683817|NCT00655785|Gemcitabine|gemcitabine|mesh-list
101683818|NCT00655785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101683819|NCT00655785|Antimetabolites|antimetabolites|mesh-ancestor
101683820|NCT00655785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683821|NCT00655785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101683823|NCT00885495|Darunavir|darunavir|mesh-list
101683824|NCT00885495|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101683825|NCT00885495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101683826|NCT00885495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101683827|NCT00885495|Protease Inhibitors|protease inhibitors|mesh-ancestor
101683828|NCT00885495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101830318|NCT00993655|Carboplatin|carboplatin|mesh-list
101683829|NCT00885495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683830|NCT00885495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101683831|NCT00885495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101683832|NCT00885495|Antiviral Agents|antiviral agents|mesh-ancestor
101683833|NCT00885495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101683834|NCT00885495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101683835|NCT00885495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101683836|NCT00885495|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101683837|NCT00885495|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101683838|NCT00885495|Antimetabolites|antimetabolites|mesh-ancestor
101683839|NCT00885495|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101683840|NCT00885495|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101683841|NCT02637375|Paclitaxel|paclitaxel|mesh-list
101683842|NCT02637375|Cyclophosphamide|cyclophosphamide|mesh-list
101683843|NCT02637375|Doxorubicin|doxorubicin|mesh-list
101683844|NCT02637375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101683845|NCT02637375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101683846|NCT02637375|Tubulin Modulators|tubulin modulators|mesh-ancestor
101683847|NCT02637375|Antimitotic Agents|antimitotic agents|mesh-ancestor
101683848|NCT02637375|Mitosis Modulators|mitosis modulators|mesh-ancestor
101683849|NCT02637375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683850|NCT02637375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101683851|NCT02637375|Immunologic Factors|immunologic factors|mesh-ancestor
101683852|NCT02637375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683853|NCT02637375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101683854|NCT02637375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101683855|NCT02637375|Alkylating Agents|alkylating agents|mesh-ancestor
101683856|NCT02637375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101341136|NCT00142129|Bortezomib|bortezomib|mesh-list
101683857|NCT02637375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101683858|NCT02637375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101683859|NCT02637375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101683860|NCT02637375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101683861|NCT04163523|Zanubrutinib|zanubrutinib|mesh-list
101683862|NCT04163523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101683863|NCT04163523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101683864|NCT04163523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101683865|NCT04163523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683866|NCT00885105|Vaccines|vaccines|mesh-list
101683867|NCT00885105|Immunologic Factors|immunologic factors|mesh-ancestor
101683868|NCT00885105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683869|NCT02709668|Vitamin B Complex|vitamin b complex|mesh-list
101683870|NCT02709668|Vitamins|vitamins|mesh-ancestor
101683871|NCT02709668|Micronutrients|micronutrients|mesh-ancestor
101683872|NCT02709668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683873|NCT04188782|Sevoflurane|sevoflurane|mesh-list
101683874|NCT04188782|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101683875|NCT04188782|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101683876|NCT04188782|Anesthetics, General|anesthetics, general|mesh-ancestor
101683877|NCT04188782|Anesthetics|anesthetics|mesh-ancestor
101683878|NCT04188782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101683879|NCT04188782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683880|NCT02709590|Diclofenac|diclofenac|mesh-list
101683881|NCT02709590|Lidocaine|lidocaine|mesh-list
101683882|NCT02709590|Anesthetics, Local|anesthetics, local|mesh-ancestor
101683883|NCT02709590|Anesthetics|anesthetics|mesh-ancestor
101683884|NCT02709590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101683885|NCT02709590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683886|NCT02709590|Sensory System Agents|sensory system agents|mesh-ancestor
101683887|NCT02709590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101683888|NCT02709590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101683889|NCT02709590|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101683890|NCT02709590|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101683891|NCT02709590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101683892|NCT02709590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683893|NCT02709590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101683894|NCT02709590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101683895|NCT02709590|Analgesics|analgesics|mesh-ancestor
101683896|NCT02709590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101683897|NCT02709590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101683898|NCT02709590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101683899|NCT02709590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101683900|NCT02707874|Ropivacaine|ropivacaine|mesh-list
101683901|NCT02707874|Anesthetics, Local|anesthetics, local|mesh-ancestor
101683903|NCT02707874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101683904|NCT02707874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683905|NCT02707874|Sensory System Agents|sensory system agents|mesh-ancestor
101683906|NCT02707874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101683907|NCT02709200|Dexmedetomidine|dexmedetomidine|mesh-list
101683908|NCT02709200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101683909|NCT02709200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101683910|NCT02709200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683911|NCT02709200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101683912|NCT02709200|Analgesics|analgesics|mesh-ancestor
101683913|NCT02709200|Sensory System Agents|sensory system agents|mesh-ancestor
101683914|NCT02709200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101683915|NCT02709200|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101683916|NCT02709200|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101683917|NCT02709200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101683918|NCT02709200|Adrenergic Agents|adrenergic agents|mesh-ancestor
101683919|NCT02709200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101683920|NCT02709200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683921|NCT00611936|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101683922|NCT00611936|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101683923|NCT00611936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101683924|NCT00611936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101683925|NCT00611936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683926|NCT00611936|Adrenergic Agents|adrenergic agents|mesh-ancestor
101683927|NCT00611936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101683928|NCT00611936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683929|NCT02707328|Paclitaxel|paclitaxel|mesh-list
101683930|NCT02707328|Gemcitabine|gemcitabine|mesh-list
101683931|NCT02707328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101683932|NCT02707328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101683933|NCT02707328|Tubulin Modulators|tubulin modulators|mesh-ancestor
101683934|NCT02707328|Antimitotic Agents|antimitotic agents|mesh-ancestor
101683935|NCT02707328|Mitosis Modulators|mitosis modulators|mesh-ancestor
101683936|NCT02707328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683937|NCT02707328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101683939|NCT00612638|Irinotecan|irinotecan|mesh-list
101683940|NCT00612638|Temozolomide|temozolomide|mesh-list
101683941|NCT00612638|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
101683942|NCT00612638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101683943|NCT00612638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101683944|NCT00612638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101683945|NCT00612638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683946|NCT00612638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101683947|NCT00612638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101683948|NCT00612638|Alkylating Agents|alkylating agents|mesh-ancestor
101683949|NCT05151848|Adalimumab|adalimumab|mesh-list
101683950|NCT05151848|Tofacitinib|tofacitinib|mesh-list
101683951|NCT05151848|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101683952|NCT05151848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101683953|NCT05151848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101683954|NCT05151848|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101683955|NCT05151848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101683956|NCT05151848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101683957|NCT05151848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683958|NCT05134688|Magnesium Sulfate|magnesium sulfate|mesh-list
101683959|NCT05134688|Analgesics|analgesics|mesh-ancestor
101683960|NCT05134688|Sensory System Agents|sensory system agents|mesh-ancestor
101683961|NCT05134688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101683962|NCT05134688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683963|NCT05134688|Anesthetics|anesthetics|mesh-ancestor
101683964|NCT05134688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101683965|NCT05134688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101489458|NCT00444522|GABA Agents|gaba agents|mesh-ancestor
101683966|NCT05134688|Anticonvulsants|anticonvulsants|mesh-ancestor
101683967|NCT05134688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101683968|NCT05134688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101683969|NCT05134688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683970|NCT05134688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101683971|NCT05134688|Tocolytic Agents|tocolytic agents|mesh-ancestor
101683972|NCT05134688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101683973|NCT02693288|Anesthetics|anesthetics|mesh-list
101683974|NCT02693288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101683975|NCT02693288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683976|NCT02693210|Cyclophosphamide|cyclophosphamide|mesh-list
101683977|NCT02693210|Rituximab|rituximab|mesh-list
101683978|NCT02693210|Methotrexate|methotrexate|mesh-list
101683979|NCT02693210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101683980|NCT02693210|Immunologic Factors|immunologic factors|mesh-ancestor
101683981|NCT02693210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101683982|NCT02693210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101683983|NCT02693210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101683984|NCT02693210|Alkylating Agents|alkylating agents|mesh-ancestor
101683985|NCT02693210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101683986|NCT02693210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101683987|NCT02693210|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101683988|NCT02693210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101683989|NCT02693210|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101683990|NCT02693210|Abortifacient Agents|abortifacient agents|mesh-ancestor
101683991|NCT02693210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101683992|NCT02693210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101683993|NCT02693210|Antimetabolites|antimetabolites|mesh-ancestor
101683994|NCT02693210|Dermatologic Agents|dermatologic agents|mesh-ancestor
101683995|NCT02693210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101683996|NCT02693210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101683997|NCT02693210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101683998|NCT05024006|Interferons|interferons|mesh-list
101683999|NCT05024006|Ritonavir|ritonavir|mesh-list
101684000|NCT05024006|Lopinavir|lopinavir|mesh-list
101684001|NCT05024006|Interferon-beta|interferon-beta|mesh-list
101684002|NCT05024006|Interferon beta-1a|interferon beta-1a|mesh-list
101684003|NCT05024006|Remdesivir|remdesivir|mesh-list
101684004|NCT05024006|Hydroxychloroquine|hydroxychloroquine|mesh-list
101684005|NCT05024006|Acalabrutinib|acalabrutinib|mesh-list
101684006|NCT05024006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101684007|NCT05024006|Antiviral Agents|antiviral agents|mesh-ancestor
101684008|NCT05024006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101684009|NCT05024006|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101684010|NCT05024006|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101684011|NCT05024006|Protease Inhibitors|protease inhibitors|mesh-ancestor
101684012|NCT05024006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101684013|NCT05024006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684014|NCT05024006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101684015|NCT05024006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101684016|NCT05024006|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101684017|NCT05024006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101684018|NCT05024006|Antimalarials|antimalarials|mesh-ancestor
101684019|NCT05024006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101684020|NCT05024006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101684021|NCT05024006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101684022|NCT05024006|Immunologic Factors|immunologic factors|mesh-ancestor
101684023|NCT05024006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684024|NCT05024006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101684025|NCT05024006|Antimetabolites|antimetabolites|mesh-ancestor
101684026|NCT02707250|Meperidine|meperidine|mesh-list
101684027|NCT02707250|Bupivacaine|bupivacaine|mesh-list
101684028|NCT02707250|Anesthetics, Local|anesthetics, local|mesh-ancestor
101684029|NCT02707250|Anesthetics|anesthetics|mesh-ancestor
101684030|NCT02707250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101684031|NCT02707250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684032|NCT02707250|Sensory System Agents|sensory system agents|mesh-ancestor
101684033|NCT02707250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101684034|NCT02707250|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101684035|NCT02707250|Narcotics|narcotics|mesh-ancestor
101684036|NCT02707250|Analgesics|analgesics|mesh-ancestor
101684037|NCT02707250|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101684038|NCT03781544|Acetaminophen|acetaminophen|mesh-list
101684039|NCT03781544|Diclofenac|diclofenac|mesh-list
101684040|NCT03781544|Tramadol|tramadol|mesh-list
101684041|NCT03781544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101684042|NCT03781544|Analgesics|analgesics|mesh-ancestor
101684043|NCT03781544|Sensory System Agents|sensory system agents|mesh-ancestor
101684044|NCT03781544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101684045|NCT03781544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684046|NCT03781544|Antipyretics|antipyretics|mesh-ancestor
101684047|NCT03781544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101326210|NCT00008333|Tubulin Modulators|tubulin modulators|mesh-ancestor
101684048|NCT03781544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101684049|NCT03781544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101684050|NCT03781544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101684051|NCT03781544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101684052|NCT03781544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684053|NCT03781544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101684054|NCT03781544|Narcotics|narcotics|mesh-ancestor
101684055|NCT03781544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101684056|NCT02707094|Immunologic Factors|immunologic factors|mesh-list
101684057|NCT02707094|Immunomodulating Agents|immunomodulating agents|mesh-list
101684058|NCT02707094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684059|NCT02707016|Sevoflurane|sevoflurane|mesh-list
101684060|NCT02707016|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101684061|NCT02707016|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101684062|NCT02707016|Anesthetics, General|anesthetics, general|mesh-ancestor
101684063|NCT02707016|Anesthetics|anesthetics|mesh-ancestor
101684064|NCT02707016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101684065|NCT02707016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684066|NCT04956146|Carboplatin|carboplatin|mesh-list
101684067|NCT04956146|Pemetrexed|pemetrexed|mesh-list
101684068|NCT04956146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101684069|NCT04956146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101684070|NCT04956146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684071|NCT04956146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101684072|NCT04956146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101684073|NCT00612794|Exenatide|exenatide|mesh-list
101684074|NCT00612794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101684075|NCT00612794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684076|NCT00612794|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101684077|NCT00612794|Incretins|incretins|mesh-ancestor
101684078|NCT00612794|Hormones|hormones|mesh-ancestor
101684079|NCT00612794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101684080|NCT03773276|Norepinephrine|norepinephrine|mesh-list
101341349|NCT00143533|Cefpodoxime|cefpodoxime|mesh-list
101684081|NCT03773276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101684082|NCT03773276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101684083|NCT03773276|Adrenergic Agents|adrenergic agents|mesh-ancestor
101684084|NCT03773276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101684085|NCT03773276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684086|NCT03773276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684087|NCT03773276|Sympathomimetics|sympathomimetics|mesh-ancestor
101684088|NCT03773276|Autonomic Agents|autonomic agents|mesh-ancestor
101499313|NCT00502164|Cediranib|cediranib|mesh-list
101684089|NCT03773276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101499379|NCT00470678|Growth Substances|growth substances|mesh-ancestor
101684091|NCT02706860|Atorvastatin|atorvastatin|mesh-list
101684092|NCT02706860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101684093|NCT02706860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101684094|NCT02706860|Antimetabolites|antimetabolites|mesh-ancestor
101684095|NCT02706860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684096|NCT02706860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101684097|NCT02706860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101684098|NCT02706860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101684099|NCT02706470|Cyclosporine|cyclosporine|mesh-list
101684100|NCT02706470|Cyclosporins|cyclosporins|mesh-list
101684101|NCT02706470|Dydrogesterone|dydrogesterone|mesh-list
101684102|NCT02706470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101684103|NCT02706470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684104|NCT02706470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101684105|NCT02706470|Immunologic Factors|immunologic factors|mesh-ancestor
101684106|NCT02706470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684107|NCT02706470|Antifungal Agents|antifungal agents|mesh-ancestor
101684108|NCT02706470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101684109|NCT02706470|Dermatologic Agents|dermatologic agents|mesh-ancestor
101684110|NCT02706470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101326211|NCT00008333|Antimitotic Agents|antimitotic agents|mesh-ancestor
101684111|NCT02706470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101684112|NCT02706470|Progestins|progestins|mesh-ancestor
101684113|NCT02706470|Hormones|hormones|mesh-ancestor
101684114|NCT02706470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101684115|NCT03769766|Curcumin|curcumin|mesh-list
101684116|NCT03769766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101684117|NCT03769766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101684118|NCT03769766|Analgesics|analgesics|mesh-ancestor
101684119|NCT03769766|Sensory System Agents|sensory system agents|mesh-ancestor
101684120|NCT03769766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101684121|NCT03769766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684122|NCT03769766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101684123|NCT03769766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101684124|NCT03769766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101684125|NCT03769766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101684126|NCT03769766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684127|NCT03764540|Prednisone|prednisone|mesh-list
101684128|NCT03764540|Docetaxel|docetaxel|mesh-list
101684129|NCT03764540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101684130|NCT03764540|Tubulin Modulators|tubulin modulators|mesh-ancestor
101684131|NCT03764540|Antimitotic Agents|antimitotic agents|mesh-ancestor
101684132|NCT03764540|Mitosis Modulators|mitosis modulators|mesh-ancestor
101684133|NCT03764540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684134|NCT03764540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101684135|NCT03764540|Glucocorticoids|glucocorticoids|mesh-ancestor
101684136|NCT03764540|Hormones|hormones|mesh-ancestor
101684137|NCT03764540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101684138|NCT03764540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684139|NCT03764540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101684140|NCT03763370|Immunoconjugates|immunoconjugates|mesh-list
101684141|NCT03763370|Immunologic Factors|immunologic factors|mesh-ancestor
101684142|NCT03763370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684143|NCT02706236|Pancrelipase|pancrelipase|mesh-list
101684144|NCT02706236|Pancreatin|pancreatin|mesh-list
101684145|NCT02706236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101684146|NCT00613496|Irbesartan|irbesartan|mesh-list
101684147|NCT00613496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101684148|NCT00613496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101684149|NCT00613496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101684150|NCT00613496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684151|NCT00612950|Glucagon|glucagon|mesh-list
101684152|NCT00612950|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
101684153|NCT00612950|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101684154|NCT00612950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101684155|NCT00612950|Hormones|hormones|mesh-ancestor
101341434|NCT00144118|Isoflurane|isoflurane|mesh-list
101265359|NCT01773044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265360|NCT01773044|Sensory System Agents|sensory system agents|mesh-ancestor
101684156|NCT00612950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101684157|NCT00612950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684158|NCT00612950|Incretins|incretins|mesh-ancestor
101684159|NCT00884793|Ritonavir|ritonavir|mesh-list
101684160|NCT00884793|Lopinavir|lopinavir|mesh-list
101684161|NCT00884793|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101684162|NCT00884793|Fosamprenavir|fosamprenavir|mesh-list
101684163|NCT00884793|Raltegravir Potassium|raltegravir potassium|mesh-list
101684164|NCT00884793|Efavirenz|efavirenz|mesh-list
101684165|NCT00884793|Etravirine|etravirine|mesh-list
101684166|NCT00884793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101684167|NCT00884793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101684168|NCT00884793|Protease Inhibitors|protease inhibitors|mesh-ancestor
101684169|NCT00884793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101684170|NCT00884793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684171|NCT00884793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101684172|NCT00884793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101684173|NCT00884793|Antiviral Agents|antiviral agents|mesh-ancestor
101684174|NCT00884793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101684175|NCT00884793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101684176|NCT00884793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101684177|NCT00884793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101684178|NCT00884793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101684179|NCT00884793|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101684180|NCT00884793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101684181|NCT00884793|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101684182|NCT00884793|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101684183|NCT00884793|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101684185|NCT00884793|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101684186|NCT02636829|Calcium|calcium|mesh-list
101684187|NCT02636829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101684188|NCT02636829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684189|NCT00884325|Levocetirizine|levocetirizine|mesh-list
101684190|NCT00884325|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101684191|NCT00884325|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101684192|NCT00884325|Histamine Antagonists|histamine antagonists|mesh-ancestor
101684193|NCT00884325|Histamine Agents|histamine agents|mesh-ancestor
101684194|NCT00884325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101684195|NCT00884325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684196|NCT00884325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684197|NCT00656409|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101684198|NCT00656409|Immunologic Factors|immunologic factors|mesh-ancestor
101684199|NCT00656409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684200|NCT05264558|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
101684201|NCT05264558|Antiviral Agents|antiviral agents|mesh-ancestor
101684202|NCT05264558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101684203|NCT04705844|Adalimumab|adalimumab|mesh-list
101684204|NCT04705844|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101684205|NCT04705844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101684206|NCT04705844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101684207|NCT00636896|Olanzapine|olanzapine|mesh-list
101684208|NCT00636896|Modafinil|modafinil|mesh-list
101684209|NCT00636896|Antiemetics|antiemetics|mesh-ancestor
101684210|NCT00636896|Autonomic Agents|autonomic agents|mesh-ancestor
101684211|NCT00636896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101684212|NCT00636896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684213|NCT00636896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101684214|NCT00636896|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101684215|NCT00636896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101684216|NCT00636896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101684217|NCT00636896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101684218|NCT00636896|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101265368|NCT01773096|Bisacodyl|bisacodyl|mesh-list
101684219|NCT00636896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101684220|NCT00636896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101684221|NCT00636896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684222|NCT00636896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101684223|NCT00636896|Serotonin Agents|serotonin agents|mesh-ancestor
101684224|NCT00636896|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101684225|NCT00636896|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101684226|NCT00636896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101684227|NCT00636896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101684230|NCT04470674|Durvalumab|durvalumab|mesh-list
101684231|NCT04470674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101684232|NCT04470674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101684233|NCT04470674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684234|NCT04470674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101684235|NCT04470674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101684236|NCT04470674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101684237|NCT00883779|Carboplatin|carboplatin|mesh-list
101684238|NCT00883779|Gemcitabine|gemcitabine|mesh-list
101684239|NCT00883779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101684240|NCT00883779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101684241|NCT00883779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101684242|NCT00883779|Antimetabolites|antimetabolites|mesh-ancestor
101684243|NCT00883779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326212|NCT00008333|Mitosis Modulators|mitosis modulators|mesh-ancestor
101684244|NCT00883779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101684245|NCT00883779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101684246|NCT05263778|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
101684247|NCT05263778|Ezetimibe|ezetimibe|mesh-list
101684248|NCT05263778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101684249|NCT05263778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101684250|NCT05263778|Antimetabolites|antimetabolites|mesh-ancestor
101684251|NCT05263778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684252|NCT05263778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101684253|NCT05263778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101684254|NCT05263778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101684255|NCT05263778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684256|NCT02693444|Lidocaine|lidocaine|mesh-list
101684257|NCT02693444|Anesthetics, Local|anesthetics, local|mesh-ancestor
101684258|NCT02693444|Anesthetics|anesthetics|mesh-ancestor
101684259|NCT02693444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101684260|NCT02693444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684261|NCT02693444|Sensory System Agents|sensory system agents|mesh-ancestor
101684262|NCT02693444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101684263|NCT02693444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101684264|NCT02693444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101684265|NCT02693444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101684266|NCT02693444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101684267|NCT02693444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684268|NCT04162743|Trazodone|trazodone|mesh-list
101684269|NCT04162743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101684270|NCT04162743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101684271|NCT04162743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101684272|NCT04162743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684273|NCT04162743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101684274|NCT04162743|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101684275|NCT04162743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101684276|NCT04162743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101684277|NCT04162743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684278|NCT04162743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101684279|NCT04162743|Serotonin Agents|serotonin agents|mesh-ancestor
101684280|NCT04162743|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101684281|NCT04162743|Antidepressive Agents|antidepressive agents|mesh-ancestor
101684282|NCT03813992|Nitroglycerin|nitroglycerin|mesh-list
101684283|NCT03813992|Vasodilator Agents|vasodilator agents|mesh-ancestor
101684284|NCT04302896|Tenofovir|tenofovir|mesh-list
101684285|NCT04302896|Lamivudine|lamivudine|mesh-list
101684286|NCT04302896|Emtricitabine|emtricitabine|mesh-list
101684287|NCT04302896|Dolutegravir|dolutegravir|mesh-list
101684288|NCT04302896|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
101684289|NCT04302896|Antiviral Agents|antiviral agents|mesh-ancestor
101684290|NCT04302896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101684291|NCT04302896|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101684292|NCT04302896|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101684293|NCT04302896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101684294|NCT04302896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684295|NCT04302896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101684296|NCT04302896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101684297|NCT04302896|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101684298|NCT04302896|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101684299|NCT00656643|Sirolimus|sirolimus|mesh-list
101684300|NCT00656643|Temsirolimus|temsirolimus|mesh-list
101684301|NCT00656643|MTOR Inhibitors|mtor inhibitors|mesh-list
101341571|NCT05595109|Silymarin|silymarin|mesh-list
101684302|NCT00656643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101684303|NCT00656643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101684304|NCT00656643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101684305|NCT00656643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101684306|NCT00656643|Antifungal Agents|antifungal agents|mesh-ancestor
101684307|NCT00656643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101684308|NCT00656643|Immunologic Factors|immunologic factors|mesh-ancestor
101684309|NCT00656643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684310|NCT00656643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101684311|NCT00656643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101684312|NCT00656643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684314|NCT02635971|Oxaliplatin|oxaliplatin|mesh-list
101684315|NCT02635971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101684316|NCT02635971|Antimetabolites|antimetabolites|mesh-ancestor
101684317|NCT02635971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684318|NCT02635971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101684319|NCT00657423|Cisplatin|cisplatin|mesh-list
101684321|NCT00657423|Endostar protein|endostar protein|mesh-list
101684322|NCT00657423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101684323|NCT00657423|Tubulin Modulators|tubulin modulators|mesh-ancestor
101684324|NCT00657423|Antimitotic Agents|antimitotic agents|mesh-ancestor
101684325|NCT00657423|Mitosis Modulators|mitosis modulators|mesh-ancestor
101684326|NCT00657423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684327|NCT00657423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101684328|NCT00657423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101684329|NCT00657423|Growth Substances|growth substances|mesh-ancestor
101684330|NCT00657423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684331|NCT00657423|Growth Inhibitors|growth inhibitors|mesh-ancestor
101684332|NCT00911235|Fluconazole|fluconazole|mesh-list
101684333|NCT00911235|Fesoterodine|fesoterodine|mesh-list
101684334|NCT00911235|Antifungal Agents|antifungal agents|mesh-ancestor
101684335|NCT00911235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101684336|NCT00911235|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101684337|NCT00911235|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101684338|NCT00911235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101684339|NCT00911235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684340|NCT00911235|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101684341|NCT00911235|Hormone Antagonists|hormone antagonists|mesh-ancestor
101684342|NCT00911235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101684343|NCT00911235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684344|NCT00911235|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101684345|NCT00911235|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101265390|NCT01773408|Daunorubicin|daunorubicin|mesh-list
101684346|NCT00911235|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101684347|NCT00911235|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101684348|NCT00911235|Cholinergic Agents|cholinergic agents|mesh-ancestor
101684349|NCT00911235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101684350|NCT00911235|Urological Agents|urological agents|mesh-ancestor
101684351|NCT00636974|Anesthetics|anesthetics|mesh-list
101684352|NCT00636974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101684353|NCT00636974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684354|NCT02535351|Sunitinib|sunitinib|mesh-list
101684355|NCT02535351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101684356|NCT02535351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101684357|NCT02535351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101684358|NCT02535351|Growth Substances|growth substances|mesh-ancestor
101684359|NCT02535351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684360|NCT02535351|Growth Inhibitors|growth inhibitors|mesh-ancestor
101684361|NCT02535351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101684362|NCT02535351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101684363|NCT02535351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684364|NCT00613964|Diuretics|diuretics|mesh-list
101684365|NCT00613964|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
101684366|NCT00613964|Natriuretic Agents|natriuretic agents|mesh-ancestor
101684367|NCT00613964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684368|NCT00613964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101684369|NCT00613964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684370|NCT05342870|Dexmedetomidine|dexmedetomidine|mesh-list
101684371|NCT05342870|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101684372|NCT05342870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101684373|NCT05342870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684374|NCT05342870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101684375|NCT05342870|Analgesics|analgesics|mesh-ancestor
101684376|NCT05342870|Sensory System Agents|sensory system agents|mesh-ancestor
101684377|NCT05342870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101684378|NCT05342870|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101684379|NCT05342870|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101684380|NCT05342870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101684381|NCT05342870|Adrenergic Agents|adrenergic agents|mesh-ancestor
101684382|NCT05342870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101684383|NCT05342870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684384|NCT00657579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101684385|NCT00657579|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101684387|NCT05342792|Tislelizumab|tislelizumab|mesh-list
101684388|NCT05342792|Antibodies|antibodies|mesh-list
101684389|NCT05342792|Immunologic Factors|immunologic factors|mesh-ancestor
101684390|NCT05342792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684391|NCT05342792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101684392|NCT05342792|Antimetabolites|antimetabolites|mesh-ancestor
101684393|NCT05342792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684394|NCT05342792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101684395|NCT05342792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101684396|NCT00657891|Omalizumab|omalizumab|mesh-list
101684397|NCT00657891|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101684398|NCT00657891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101684399|NCT00657891|Respiratory System Agents|respiratory system agents|mesh-ancestor
101684400|NCT05162300|Botulinum Toxins|botulinum toxins|mesh-list
101684401|NCT05162300|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101684402|NCT05162300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101684403|NCT05162300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684404|NCT05162300|Cholinergic Agents|cholinergic agents|mesh-ancestor
101684405|NCT05162300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101265398|NCT01773408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101684406|NCT05162300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684407|NCT04159077|Tamsulosin|tamsulosin|mesh-list
101684408|NCT04159077|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101684409|NCT04159077|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101684410|NCT04159077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101684411|NCT04159077|Adrenergic Agents|adrenergic agents|mesh-ancestor
101684412|NCT04159077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101684413|NCT04159077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684414|NCT04159077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684415|NCT04159077|Urological Agents|urological agents|mesh-ancestor
101684416|NCT02690480|Fulvestrant|fulvestrant|mesh-list
101684417|NCT02690480|Palbociclib|palbociclib|mesh-list
101684418|NCT02690480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101684419|NCT02690480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101684420|NCT02690480|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101684421|NCT02690480|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101684422|NCT02690480|Hormone Antagonists|hormone antagonists|mesh-ancestor
101684423|NCT02690480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101684424|NCT02690480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684425|NCT02690480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101684426|NCT02690480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101684427|NCT02690480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684428|NCT00880269|Panobinostat|panobinostat|mesh-list
101684429|NCT00880269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101684430|NCT00880269|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101684431|NCT00880269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101684432|NCT00880269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684433|NCT00880191|Dexamethasone|dexamethasone|mesh-list
101684434|NCT00880191|Gabapentin|gabapentin|mesh-list
101684435|NCT00880191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101684436|NCT00880191|Antiemetics|antiemetics|mesh-ancestor
101684437|NCT00880191|Autonomic Agents|autonomic agents|mesh-ancestor
101684438|NCT00880191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101684439|NCT00880191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684440|NCT00880191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101684441|NCT00880191|Glucocorticoids|glucocorticoids|mesh-ancestor
101684442|NCT00880191|Hormones|hormones|mesh-ancestor
101684443|NCT00880191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101684444|NCT00880191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101684445|NCT00880191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101684446|NCT00880191|Analgesics|analgesics|mesh-ancestor
101684447|NCT00880191|Sensory System Agents|sensory system agents|mesh-ancestor
101684449|NCT00880191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101684450|NCT00880191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101684451|NCT00880191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101684452|NCT00880191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101684453|NCT00880191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101684454|NCT00880191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101684455|NCT00880191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101684456|NCT00880191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684457|NCT00880191|Antimanic Agents|antimanic agents|mesh-ancestor
101684458|NCT00659451|Losartan|losartan|mesh-list
101684459|NCT00659451|Amlodipine|amlodipine|mesh-list
101684460|NCT00659451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101684461|NCT00659451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101684462|NCT00659451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101684463|NCT00659451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684464|NCT00659451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101684465|NCT00659451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684466|NCT00659451|Vasodilator Agents|vasodilator agents|mesh-ancestor
101684467|NCT00659451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101684468|NCT00659451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101684469|NCT00659451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101684470|NCT00911313|Metformin|metformin|mesh-list
101684471|NCT00911313|Letrozole|letrozole|mesh-list
101684472|NCT00911313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101684473|NCT00911313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684474|NCT00911313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101684475|NCT00911313|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101684476|NCT00911313|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101684477|NCT00911313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101684478|NCT00911313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684479|NCT00911313|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101684480|NCT00911313|Hormone Antagonists|hormone antagonists|mesh-ancestor
101684481|NCT00911313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101684482|NCT00659685|Ondansetron|ondansetron|mesh-list
101684483|NCT00659685|Antiemetics|antiemetics|mesh-ancestor
101684484|NCT00659685|Autonomic Agents|autonomic agents|mesh-ancestor
101684485|NCT00659685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101684486|NCT00659685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684487|NCT00659685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101684488|NCT00659685|Antipruritics|antipruritics|mesh-ancestor
101684489|NCT00659685|Dermatologic Agents|dermatologic agents|mesh-ancestor
101684490|NCT00659685|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101684491|NCT00659685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101684492|NCT00659685|Serotonin Agents|serotonin agents|mesh-ancestor
101684493|NCT00659685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101684494|NCT00659685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684495|NCT00659841|Ciclesonide|ciclesonide|mesh-list
101684496|NCT00659841|Glucocorticoids|glucocorticoids|mesh-ancestor
101684497|NCT00659841|Hormones|hormones|mesh-ancestor
101684498|NCT00659841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101684499|NCT00659841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684500|NCT00659841|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101684501|NCT00659919|Trazodone|trazodone|mesh-list
101684502|NCT00659919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101684503|NCT00659919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101684504|NCT00659919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101684505|NCT00659919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684506|NCT00659919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101684507|NCT00659919|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101684508|NCT00659919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101684509|NCT00659919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101684510|NCT00659919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684511|NCT00659919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101684512|NCT00659919|Serotonin Agents|serotonin agents|mesh-ancestor
101684513|NCT00659919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101684514|NCT00659919|Antidepressive Agents|antidepressive agents|mesh-ancestor
101684515|NCT00659997|Albendazole|albendazole|mesh-list
101684516|NCT00659997|Levamisole|levamisole|mesh-list
101684517|NCT00659997|Anthelmintics|anthelmintics|mesh-ancestor
101684518|NCT00659997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101341800|NCT05227456|Hormones|hormones|mesh-ancestor
101684519|NCT00659997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101684520|NCT00659997|Anticestodal Agents|anticestodal agents|mesh-ancestor
101684521|NCT00659997|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101684522|NCT00659997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101684524|NCT00659997|Antimitotic Agents|antimitotic agents|mesh-ancestor
101684525|NCT00659997|Mitosis Modulators|mitosis modulators|mesh-ancestor
101684526|NCT00659997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684527|NCT00659997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101684528|NCT00659997|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101684529|NCT00659997|Immunologic Factors|immunologic factors|mesh-ancestor
101684530|NCT00659997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684531|NCT00659997|Antinematodal Agents|antinematodal agents|mesh-ancestor
101684532|NCT00659997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101684534|NCT00660153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101684535|NCT00660153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101684536|NCT00660153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684537|NCT00660231|Gemcitabine|gemcitabine|mesh-list
101684538|NCT00660231|Bexarotene|bexarotene|mesh-list
101684539|NCT00660231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101265416|NCT01773512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101684540|NCT00660231|Antimetabolites|antimetabolites|mesh-ancestor
101684541|NCT00660231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684542|NCT00660231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101684543|NCT00597519|Cyclophosphamide|cyclophosphamide|mesh-list
101684544|NCT00597519|Fludarabine|fludarabine|mesh-list
101684545|NCT00597519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101684546|NCT00597519|Immunologic Factors|immunologic factors|mesh-ancestor
101684547|NCT00597519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684548|NCT00597519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101684549|NCT00597519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101684550|NCT00597519|Alkylating Agents|alkylating agents|mesh-ancestor
101684551|NCT00597519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684552|NCT00597519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101684553|NCT00597519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101684554|NCT00660621|Bevacizumab|bevacizumab|mesh-list
101684555|NCT00660621|Temozolomide|temozolomide|mesh-list
101684556|NCT00660621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101684557|NCT00660621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101684558|NCT00660621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101684559|NCT00660621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101684560|NCT00660621|Growth Substances|growth substances|mesh-ancestor
101684561|NCT00660621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684562|NCT00660621|Growth Inhibitors|growth inhibitors|mesh-ancestor
101684563|NCT00660621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101684564|NCT00660621|Alkylating Agents|alkylating agents|mesh-ancestor
101684565|NCT00660621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684566|NCT02632305|Paclitaxel|paclitaxel|mesh-list
101684567|NCT02632305|Gemcitabine|gemcitabine|mesh-list
101684568|NCT02632305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101684569|NCT02632305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101684570|NCT02632305|Tubulin Modulators|tubulin modulators|mesh-ancestor
101684571|NCT02632305|Antimitotic Agents|antimitotic agents|mesh-ancestor
101684572|NCT02632305|Mitosis Modulators|mitosis modulators|mesh-ancestor
101684573|NCT02632305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684574|NCT02632305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101684575|NCT02632305|Antimetabolites|antimetabolites|mesh-ancestor
101684576|NCT02631993|Furocoumarins|furocoumarins|mesh-list
101684577|NCT02631993|Dermatologic Agents|dermatologic agents|mesh-ancestor
101684578|NCT02631993|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101684579|NCT00660855|Parecoxib|parecoxib|mesh-list
101684580|NCT00660855|Valdecoxib|valdecoxib|mesh-list
101684581|NCT00660855|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101684582|NCT00660855|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101684583|NCT00660855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101684584|NCT00660855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684585|NCT00660855|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101684586|NCT00660855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101684587|NCT00660855|Analgesics|analgesics|mesh-ancestor
101684588|NCT00660855|Sensory System Agents|sensory system agents|mesh-ancestor
101684589|NCT00660855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101684590|NCT00660855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684591|NCT00660855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101684592|NCT00660855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101684593|NCT00660933|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101684594|NCT00660933|Hematinics|hematinics|mesh-ancestor
101684596|NCT02632071|Ricolinostat|ricolinostat|mesh-list
101684597|NCT02632071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101684598|NCT02632071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101684599|NCT02632071|Tubulin Modulators|tubulin modulators|mesh-ancestor
101684600|NCT02632071|Antimitotic Agents|antimitotic agents|mesh-ancestor
101684601|NCT02632071|Mitosis Modulators|mitosis modulators|mesh-ancestor
101684602|NCT02632071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684603|NCT02632071|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101684604|NCT02632071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101684605|NCT00879333|Everolimus|everolimus|mesh-list
101684606|NCT00879333|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101684608|NCT00879333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101684609|NCT00879333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684610|NCT00879333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101684611|NCT00879333|Immunologic Factors|immunologic factors|mesh-ancestor
101684612|NCT00879333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684613|NCT00879333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101684614|NCT02630823|Paclitaxel|paclitaxel|mesh-list
101684615|NCT02630823|Carboplatin|carboplatin|mesh-list
101684616|NCT02630823|Pembrolizumab|pembrolizumab|mesh-list
101684617|NCT02630823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101684618|NCT02630823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101684619|NCT02630823|Tubulin Modulators|tubulin modulators|mesh-ancestor
101684620|NCT02630823|Antimitotic Agents|antimitotic agents|mesh-ancestor
101684621|NCT02630823|Mitosis Modulators|mitosis modulators|mesh-ancestor
101684622|NCT02630823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684623|NCT02630823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101684624|NCT02630823|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101684625|NCT02630511|Mannitol|mannitol|mesh-list
101684626|NCT02630511|Methacholine Chloride|methacholine chloride|mesh-list
101684627|NCT02630511|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101684628|NCT02630511|Diuretics|diuretics|mesh-ancestor
101684629|NCT02630511|Natriuretic Agents|natriuretic agents|mesh-ancestor
101684630|NCT02630511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684631|NCT02630511|Miotics|miotics|mesh-ancestor
101684632|NCT02630511|Autonomic Agents|autonomic agents|mesh-ancestor
101684633|NCT02630511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101684634|NCT02630511|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101684635|NCT02630511|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
101684636|NCT02630511|Respiratory System Agents|respiratory system agents|mesh-ancestor
101684637|NCT02630511|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101684638|NCT02630511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101684639|NCT02630511|Cholinergic Agents|cholinergic agents|mesh-ancestor
101684640|NCT02630511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101684641|NCT02630511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684642|NCT00666159|Pimecrolimus|pimecrolimus|mesh-list
101684643|NCT00666159|Tacrolimus|tacrolimus|mesh-list
101684644|NCT00666159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101684645|NCT00666159|Immunologic Factors|immunologic factors|mesh-ancestor
101684646|NCT00666159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684647|NCT00666159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101684648|NCT00666159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101684649|NCT00666159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684650|NCT00666159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101684651|NCT00666159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101684652|NCT00666159|Analgesics|analgesics|mesh-ancestor
101684653|NCT00666159|Sensory System Agents|sensory system agents|mesh-ancestor
101684654|NCT00666159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101684655|NCT00666159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101684656|NCT00666159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101684657|NCT00666159|Dermatologic Agents|dermatologic agents|mesh-ancestor
101684658|NCT00666393|Fentanyl|fentanyl|mesh-list
101684659|NCT00666393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101684660|NCT00666393|Narcotics|narcotics|mesh-ancestor
101684661|NCT00666393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101684662|NCT00666393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684663|NCT00666393|Analgesics|analgesics|mesh-ancestor
101684664|NCT00666393|Sensory System Agents|sensory system agents|mesh-ancestor
101684665|NCT00666393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101684666|NCT00666393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101684667|NCT00666393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101684668|NCT00666393|Anesthetics, General|anesthetics, general|mesh-ancestor
101265433|NCT01773616|Rituximab|rituximab|mesh-list
101684669|NCT00666393|Anesthetics|anesthetics|mesh-ancestor
101684670|NCT00666627|Alendronate|alendronate|mesh-list
101684671|NCT00666627|Risedronic Acid|risedronic acid|mesh-list
101265434|NCT01773616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101684672|NCT00666627|Ibandronic Acid|ibandronic acid|mesh-list
101684673|NCT00666627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101684674|NCT00666627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684675|NCT00666627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101684676|NCT00666627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101684677|NCT00666627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684678|NCT00666627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101684679|NCT00666783|Palonosetron|palonosetron|mesh-list
101684680|NCT00666783|Granisetron|granisetron|mesh-list
101684681|NCT00666783|Antiemetics|antiemetics|mesh-ancestor
101684682|NCT00666783|Autonomic Agents|autonomic agents|mesh-ancestor
101684683|NCT00666783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101684684|NCT00666783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684685|NCT00666783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101684686|NCT00666783|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101684687|NCT00666783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101684688|NCT00666783|Serotonin Agents|serotonin agents|mesh-ancestor
101684689|NCT00666783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101684690|NCT00666783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684691|NCT00666939|Gabapentin|gabapentin|mesh-list
101684692|NCT00666939|Analgesics|analgesics|mesh-ancestor
101684693|NCT00666939|Sensory System Agents|sensory system agents|mesh-ancestor
101684694|NCT00666939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101684695|NCT00666939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684696|NCT00666939|Anticonvulsants|anticonvulsants|mesh-ancestor
101684697|NCT00666939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101684698|NCT00666939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101684699|NCT00666939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101684700|NCT00666939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101684701|NCT00666939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101684702|NCT00666939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101684703|NCT00666939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101684704|NCT00666939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684705|NCT00666939|Antimanic Agents|antimanic agents|mesh-ancestor
101684706|NCT00667407|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101684707|NCT00667407|Albuterol|albuterol|mesh-list
101684708|NCT00667407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101684709|NCT00667407|Autonomic Agents|autonomic agents|mesh-ancestor
101684710|NCT00667407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101684711|NCT00667407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684712|NCT00667407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101684713|NCT00667407|Respiratory System Agents|respiratory system agents|mesh-ancestor
101684714|NCT00667407|Tocolytic Agents|tocolytic agents|mesh-ancestor
101684715|NCT00667407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101684716|NCT00667407|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101684717|NCT00667407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101684718|NCT00667407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101684719|NCT00667407|Adrenergic Agents|adrenergic agents|mesh-ancestor
101684720|NCT00667407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101684721|NCT00667407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684722|NCT00667485|Sirolimus|sirolimus|mesh-list
101684723|NCT00667485|Bevacizumab|bevacizumab|mesh-list
101684724|NCT00667485|Temsirolimus|temsirolimus|mesh-list
101684725|NCT00667485|MTOR Inhibitors|mtor inhibitors|mesh-list
101684726|NCT00667485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101684727|NCT00667485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101684728|NCT00667485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101684729|NCT00667485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101684730|NCT00667485|Growth Substances|growth substances|mesh-ancestor
101684731|NCT00667485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684732|NCT00667485|Growth Inhibitors|growth inhibitors|mesh-ancestor
101684733|NCT00667485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101684734|NCT00667485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101684735|NCT00667485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101684736|NCT00667485|Antifungal Agents|antifungal agents|mesh-ancestor
101265442|NCT01773616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101684737|NCT00667485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101684738|NCT00667485|Immunologic Factors|immunologic factors|mesh-ancestor
101684739|NCT00667485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101684740|NCT00667485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101684741|NCT00667485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684742|NCT00667641|Paclitaxel|paclitaxel|mesh-list
101342015|NCT01806090|Clopidogrel|clopidogrel|mesh-list
101684743|NCT00667641|Bortezomib|bortezomib|mesh-list
101684744|NCT00667641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101684745|NCT00667641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101684746|NCT00667641|Tubulin Modulators|tubulin modulators|mesh-ancestor
101684747|NCT00667641|Antimitotic Agents|antimitotic agents|mesh-ancestor
101684748|NCT00667641|Mitosis Modulators|mitosis modulators|mesh-ancestor
101684749|NCT00667641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684750|NCT00667797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101684751|NCT00667797|Albuterol|albuterol|mesh-list
101684752|NCT00667797|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101684753|NCT00667797|Autonomic Agents|autonomic agents|mesh-ancestor
101684754|NCT00667797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101684755|NCT00667797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684756|NCT00667797|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101684757|NCT00667797|Respiratory System Agents|respiratory system agents|mesh-ancestor
101684758|NCT00667797|Tocolytic Agents|tocolytic agents|mesh-ancestor
101684759|NCT00667797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101684760|NCT00667797|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101684761|NCT00667797|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101684762|NCT00667797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101684763|NCT00667797|Adrenergic Agents|adrenergic agents|mesh-ancestor
101684764|NCT00667797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101684765|NCT00667797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684766|NCT03481556|Dexamethasone|dexamethasone|mesh-list
101684767|NCT03481556|Dexamethasone acetate|dexamethasone acetate|mesh-list
101684768|NCT03481556|Bortezomib|bortezomib|mesh-list
101684769|NCT03481556|Melphalan|melphalan|mesh-list
101684770|NCT03481556|Daratumumab|daratumumab|mesh-list
101684771|NCT03481556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101684772|NCT03481556|Antiemetics|antiemetics|mesh-ancestor
101684773|NCT03481556|Autonomic Agents|autonomic agents|mesh-ancestor
101684774|NCT03481556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101684775|NCT03481556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684776|NCT03481556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101684777|NCT03481556|Glucocorticoids|glucocorticoids|mesh-ancestor
101684778|NCT03481556|Hormones|hormones|mesh-ancestor
101684779|NCT03481556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101684780|NCT03481556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101684781|NCT03481556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101684782|NCT03481556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101684783|NCT03481556|Alkylating Agents|alkylating agents|mesh-ancestor
101684784|NCT03481556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684785|NCT03481556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101684786|NCT03481556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101684787|NCT03481556|Immunologic Factors|immunologic factors|mesh-ancestor
101684788|NCT00668031|Aprotinin|aprotinin|mesh-list
101684789|NCT00668031|Hemostatics|hemostatics|mesh-ancestor
101684790|NCT00668031|Coagulants|coagulants|mesh-ancestor
101684791|NCT00668031|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101684792|NCT00668031|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101684793|NCT00668031|Protease Inhibitors|protease inhibitors|mesh-ancestor
101684794|NCT00668031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101684795|NCT00668031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684796|NCT00668109|Tadalafil|tadalafil|mesh-list
101684797|NCT00668109|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101684798|NCT00668109|Vasodilator Agents|vasodilator agents|mesh-ancestor
101684799|NCT00668109|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101265449|NCT01773616|Glucocorticoids|glucocorticoids|mesh-ancestor
101684800|NCT00668109|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101684802|NCT00668109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684803|NCT00668109|Urological Agents|urological agents|mesh-ancestor
101684804|NCT00668343|Simvastatin|simvastatin|mesh-list
101684805|NCT00668343|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101684806|NCT00668343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101684807|NCT00668343|Antimetabolites|antimetabolites|mesh-ancestor
101684808|NCT00668343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684809|NCT00668343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101684810|NCT00668343|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101684811|NCT00668343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101684812|NCT04717700|Dexamethasone|dexamethasone|mesh-list
101684813|NCT04717700|Lenalidomide|lenalidomide|mesh-list
101684814|NCT04717700|Bortezomib|bortezomib|mesh-list
101684815|NCT04717700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101684816|NCT04717700|Antiemetics|antiemetics|mesh-ancestor
101684817|NCT04717700|Autonomic Agents|autonomic agents|mesh-ancestor
101684818|NCT04717700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101684819|NCT04717700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684820|NCT04717700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101684821|NCT04717700|Glucocorticoids|glucocorticoids|mesh-ancestor
101684822|NCT04717700|Hormones|hormones|mesh-ancestor
101684823|NCT04717700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101684824|NCT04717700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101684825|NCT04717700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101684826|NCT04717700|Immunologic Factors|immunologic factors|mesh-ancestor
101684827|NCT04717700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101684828|NCT04717700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101684829|NCT04717700|Growth Substances|growth substances|mesh-ancestor
101684830|NCT04717700|Growth Inhibitors|growth inhibitors|mesh-ancestor
101684831|NCT02630277|Aflibercept|aflibercept|mesh-list
101684832|NCT02630277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101684833|NCT02630277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101684834|NCT02630277|Growth Substances|growth substances|mesh-ancestor
101684835|NCT02630277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684836|NCT02630277|Growth Inhibitors|growth inhibitors|mesh-ancestor
101684837|NCT02630277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101684838|NCT00668499|Pemetrexed|pemetrexed|mesh-list
101684839|NCT00668499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101684840|NCT00668499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101684841|NCT00668499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684842|NCT00668499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101684843|NCT00668499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101684844|NCT05201846|Insulin|insulin|mesh-list
101684845|NCT05201846|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101684846|NCT05201846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101684847|NCT05201846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684848|NCT00668967|Verapamil|verapamil|mesh-list
101684849|NCT00668967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101684850|NCT00668967|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101684851|NCT00668967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101684852|NCT00668967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684853|NCT00668967|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101684854|NCT00668967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684855|NCT00668967|Vasodilator Agents|vasodilator agents|mesh-ancestor
101684856|NCT03583658|Ambroxol|ambroxol|mesh-list
101684857|NCT03583658|Expectorants|expectorants|mesh-ancestor
101684858|NCT03583658|Respiratory System Agents|respiratory system agents|mesh-ancestor
101684859|NCT03555968|Dronabinol|dronabinol|mesh-list
101684860|NCT03555968|Hallucinogens|hallucinogens|mesh-ancestor
101684861|NCT03555968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684862|NCT03555968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101684863|NCT03555968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101684864|NCT03555968|Analgesics|analgesics|mesh-ancestor
101684865|NCT03555968|Sensory System Agents|sensory system agents|mesh-ancestor
101684866|NCT03555968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101684867|NCT03555968|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101684868|NCT03555968|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101684869|NCT03555968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101684870|NCT03555968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684871|NCT03555968|Hormones|hormones|mesh-ancestor
101684872|NCT03555968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101684873|NCT04593680|Tenofovir|tenofovir|mesh-list
101684874|NCT04593680|Emtricitabine|emtricitabine|mesh-list
101684875|NCT04593680|Antiviral Agents|antiviral agents|mesh-ancestor
101684876|NCT04593680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101684877|NCT04593680|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101684878|NCT04593680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101684879|NCT04593680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101684880|NCT04593680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684881|NCT04593680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101684882|NCT04593680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101684883|NCT00669435|Losartan|losartan|mesh-list
101684884|NCT00669435|Amlodipine|amlodipine|mesh-list
101684885|NCT00669435|Simvastatin|simvastatin|mesh-list
101684886|NCT00669435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101684887|NCT00669435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101684888|NCT00669435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101684889|NCT00669435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684890|NCT00669435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101684891|NCT00669435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342168|NCT00391157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101684892|NCT00669435|Vasodilator Agents|vasodilator agents|mesh-ancestor
101684893|NCT00669435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101684894|NCT00669435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101684895|NCT00669435|Antimetabolites|antimetabolites|mesh-ancestor
101684896|NCT00669435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101684897|NCT00669435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101684898|NCT00669435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101684899|NCT00669435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101684900|NCT00669435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101684901|NCT00669435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101684902|NCT00669591|Bavituximab|bavituximab|mesh-list
101684903|NCT00669591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101684904|NCT00669591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101684905|NCT00669747|Carboplatin|carboplatin|mesh-list
101684906|NCT00669747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101684907|NCT00596427|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
101684908|NCT00596427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101684909|NCT00596427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101684910|NCT00596427|Antimetabolites|antimetabolites|mesh-ancestor
101684911|NCT00596427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684912|NCT00596427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101684913|NCT00670215|Ciprofloxacin|ciprofloxacin|mesh-list
101684914|NCT00670215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101684915|NCT00670215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101684916|NCT00670215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101684917|NCT00670215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101265474|NCT01773798|Insulin, Long-Acting|insulin, long-acting|mesh-list
101684918|NCT00670215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101684919|NCT00670215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684920|NCT00670215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101684921|NCT00670215|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101684922|NCT00670215|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101684924|NCT00670293|Methylphenidate|methylphenidate|mesh-list
101684925|NCT00670293|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101684926|NCT00670293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684927|NCT00670293|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101684928|NCT00670293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101684929|NCT00670293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101451727|NCT00208065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101684930|NCT00670293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684932|NCT00670293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101684933|NCT00670293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101684934|NCT00670293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101684935|NCT00670293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101684936|NCT00670293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101684937|NCT00670293|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101684938|NCT00670683|Insulin Detemir|insulin detemir|mesh-list
101684939|NCT00670683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101684940|NCT00670683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684941|NCT00670761|Misoprostol|misoprostol|mesh-list
101684942|NCT00670761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101684943|NCT00670761|Abortifacient Agents|abortifacient agents|mesh-ancestor
101684944|NCT00670761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101684945|NCT00670761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684946|NCT00670761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101684947|NCT00670761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101684948|NCT00670761|Oxytocics|oxytocics|mesh-ancestor
101684949|NCT00680433|Ketamine|ketamine|mesh-list
101684950|NCT00680433|Analgesics|analgesics|mesh-ancestor
101684951|NCT00680433|Sensory System Agents|sensory system agents|mesh-ancestor
101684952|NCT00680433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101684953|NCT00680433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684954|NCT00680433|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101684955|NCT00680433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101684956|NCT00680433|Anesthetics, General|anesthetics, general|mesh-ancestor
101684957|NCT00680433|Anesthetics|anesthetics|mesh-ancestor
101684958|NCT00680433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101684959|NCT00680433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101684960|NCT00680433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101684961|NCT00680433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101684962|NCT00680433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684963|NCT03322280|Chlorotrianisene|chlorotrianisene|mesh-list
101684964|NCT03322280|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101684965|NCT03322280|Estrogens|estrogens|mesh-ancestor
101684966|NCT03322280|Hormones|hormones|mesh-ancestor
101684967|NCT03322280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101684968|NCT03322280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684969|NCT03322280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101684970|NCT03322280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101684971|NCT04150575|Paclitaxel|paclitaxel|mesh-list
101684972|NCT04150575|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101684973|NCT04150575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101684974|NCT04150575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101684975|NCT04150575|Tubulin Modulators|tubulin modulators|mesh-ancestor
101684976|NCT04150575|Antimitotic Agents|antimitotic agents|mesh-ancestor
101684977|NCT04150575|Mitosis Modulators|mitosis modulators|mesh-ancestor
101684978|NCT04150575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684979|NCT05345132|Magnesium Sulfate|magnesium sulfate|mesh-list
101684980|NCT05345132|Nifedipine|nifedipine|mesh-list
101265488|NCT01773837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101265489|NCT01773876|Micafungin|micafungin|mesh-list
101684981|NCT05345132|Analgesics|analgesics|mesh-ancestor
101684982|NCT05345132|Sensory System Agents|sensory system agents|mesh-ancestor
101684983|NCT05345132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101684984|NCT05345132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101684985|NCT05345132|Anesthetics|anesthetics|mesh-ancestor
101684986|NCT05345132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101684987|NCT05345132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101684988|NCT05345132|Anticonvulsants|anticonvulsants|mesh-ancestor
101684989|NCT05345132|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101684990|NCT05345132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101684991|NCT05345132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101684992|NCT05345132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101684993|NCT05345132|Tocolytic Agents|tocolytic agents|mesh-ancestor
101684994|NCT05345132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101684995|NCT05345132|Vasodilator Agents|vasodilator agents|mesh-ancestor
101684996|NCT04349306|Rasburicase|rasburicase|mesh-list
101684997|NCT04349306|Gout Suppressants|gout suppressants|mesh-ancestor
101684998|NCT04349306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101684999|NCT00614588|Anesthetics|anesthetics|mesh-list
101685000|NCT00614588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101685001|NCT00614588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685003|NCT02699840|Immunologic Factors|immunologic factors|mesh-ancestor
101685004|NCT02699840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685005|NCT00613808|Nitric Oxide|nitric oxide|mesh-list
101685006|NCT00613808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101685007|NCT00613808|Autonomic Agents|autonomic agents|mesh-ancestor
101685008|NCT00613808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101685009|NCT00613808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685010|NCT00613808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101685011|NCT00613808|Respiratory System Agents|respiratory system agents|mesh-ancestor
101685012|NCT00613808|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101685013|NCT00613808|Antioxidants|antioxidants|mesh-ancestor
101685014|NCT00613808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685015|NCT00613808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101685016|NCT00613808|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101685017|NCT00613808|Vasodilator Agents|vasodilator agents|mesh-ancestor
101685018|NCT00613808|Gasotransmitters|gasotransmitters|mesh-ancestor
101685019|NCT00613808|Protective Agents|protective agents|mesh-ancestor
101685020|NCT05344742|Paclitaxel|paclitaxel|mesh-list
101685021|NCT05344742|Capecitabine|capecitabine|mesh-list
101685022|NCT05344742|Mitoxantrone|mitoxantrone|mesh-list
101685023|NCT05344742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101685024|NCT05344742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101685025|NCT05344742|Tubulin Modulators|tubulin modulators|mesh-ancestor
101685026|NCT05344742|Antimitotic Agents|antimitotic agents|mesh-ancestor
101685027|NCT05344742|Mitosis Modulators|mitosis modulators|mesh-ancestor
101685028|NCT05344742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685029|NCT05344742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101685030|NCT05344742|Antimetabolites|antimetabolites|mesh-ancestor
101685031|NCT05344742|Analgesics|analgesics|mesh-ancestor
101685032|NCT05344742|Sensory System Agents|sensory system agents|mesh-ancestor
101685033|NCT05344742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101685034|NCT05344742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685035|NCT05344742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101685036|NCT05344742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101685037|NCT05344742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101685038|NCT02046434|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
101342321|NCT01466517|Ibuprofen|ibuprofen|mesh-list
101685039|NCT02046434|Glycerol|glycerol|mesh-list
101685040|NCT02046434|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101685041|NCT02046434|Protective Agents|protective agents|mesh-ancestor
101685042|NCT02046434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685043|NCT02046434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101265498|NCT01774370|Anticoagulants|anticoagulants|mesh-ancestor
101685045|NCT03930446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101685046|NCT03930446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101685047|NCT03930446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101685048|NCT03930446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685049|NCT00614666|Nikkomycin|nikkomycin|mesh-list
101685050|NCT00614666|Antifungal Agents|antifungal agents|mesh-ancestor
101685051|NCT00614666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101685052|NCT00614666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101685053|NCT00614666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685054|NCT03794336|Aspirin|aspirin|mesh-list
101685055|NCT03794336|Metformin|metformin|mesh-list
101685056|NCT03794336|Alogliptin|alogliptin|mesh-list
101685057|NCT03794336|Acarbose|acarbose|mesh-list
101685058|NCT03794336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101685059|NCT03794336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685060|NCT03794336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101685061|NCT03794336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101685062|NCT03794336|Analgesics|analgesics|mesh-ancestor
101685063|NCT03794336|Sensory System Agents|sensory system agents|mesh-ancestor
101685064|NCT03794336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101685065|NCT03794336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101685066|NCT03794336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101685067|NCT03794336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101685068|NCT03794336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101685069|NCT03794336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685070|NCT03794336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101685071|NCT03794336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101685072|NCT03794336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101685073|NCT03794336|Antipyretics|antipyretics|mesh-ancestor
101685074|NCT03794336|Incretins|incretins|mesh-ancestor
101685075|NCT03794336|Hormones|hormones|mesh-ancestor
101685076|NCT03794336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101685077|NCT03794336|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101685078|NCT03794336|Protease Inhibitors|protease inhibitors|mesh-ancestor
101685079|NCT03794336|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101685080|NCT03774914|Alemtuzumab|alemtuzumab|mesh-list
101685081|NCT03774914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101685082|NCT03774914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101685083|NCT03687554|Venglustat|venglustat|mesh-list
101685084|NCT03687554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101685085|NCT03687554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685086|NCT03681158|Valproic Acid|valproic acid|mesh-list
101685087|NCT03681158|Anticonvulsants|anticonvulsants|mesh-ancestor
101409853|NCT00112034|Methylprednisolone|methylprednisolone|mesh-list
101685088|NCT03681158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101685089|NCT03681158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685090|NCT03681158|GABA Agents|gaba agents|mesh-ancestor
101685091|NCT03681158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101685092|NCT03681158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685093|NCT03681158|Antimanic Agents|antimanic agents|mesh-ancestor
101685094|NCT03681158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101685095|NCT03681158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101685096|NCT03681158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101685097|NCT05343806|Magnesium Sulfate|magnesium sulfate|mesh-list
101685098|NCT05343806|Nifedipine|nifedipine|mesh-list
101685099|NCT05343806|Analgesics|analgesics|mesh-ancestor
101685100|NCT05343806|Sensory System Agents|sensory system agents|mesh-ancestor
101685101|NCT05343806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101685102|NCT05343806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265508|NCT01774396|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101265509|NCT01774396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101685103|NCT05343806|Anesthetics|anesthetics|mesh-ancestor
101685104|NCT05343806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101685105|NCT05343806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101685106|NCT05343806|Anticonvulsants|anticonvulsants|mesh-ancestor
101685107|NCT05343806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101685108|NCT05343806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101685109|NCT05343806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685110|NCT05343806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101342393|NCT01466205|Dihydrexidine|dihydrexidine|mesh-list
101685111|NCT05343806|Tocolytic Agents|tocolytic agents|mesh-ancestor
101685112|NCT05343806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101685113|NCT05343806|Vasodilator Agents|vasodilator agents|mesh-ancestor
101685114|NCT05343728|Hemostatics|hemostatics|mesh-list
101685115|NCT05343728|Coagulants|coagulants|mesh-ancestor
101685116|NCT00436748|Darbepoetin alfa|darbepoetin alfa|mesh-list
101685117|NCT00436748|Hematinics|hematinics|mesh-ancestor
101685118|NCT02704598|Warfarin|warfarin|mesh-list
101685119|NCT02704598|Rivaroxaban|rivaroxaban|mesh-list
101685120|NCT02704598|Anticoagulants|anticoagulants|mesh-ancestor
101685121|NCT02704598|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101685122|NCT02704598|Antithrombins|antithrombins|mesh-ancestor
101685123|NCT02704598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101685124|NCT02704598|Protease Inhibitors|protease inhibitors|mesh-ancestor
101685125|NCT02704598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101685126|NCT02704598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685127|NCT03342404|Luspatercept|luspatercept|mesh-list
101685128|NCT03342404|Hematinics|hematinics|mesh-ancestor
101685129|NCT03094052|Trastuzumab|trastuzumab|mesh-list
101685130|NCT03094052|Atropine|atropine|mesh-list
101685131|NCT03094052|Diphenoxylate|diphenoxylate|mesh-list
101685132|NCT03094052|Loperamide|loperamide|mesh-list
101685133|NCT03094052|Antidiarrheals|antidiarrheals|mesh-list
101685134|NCT03094052|Atropine sulfate-diphenoxylate hydrochloride drug combination|atropine sulfate-diphenoxylate hydrochloride drug combination|mesh-list
101685135|NCT03094052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101685136|NCT03094052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101685137|NCT03094052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101685138|NCT03094052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101685139|NCT03094052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101685140|NCT03094052|Autonomic Agents|autonomic agents|mesh-ancestor
101685141|NCT03094052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101685142|NCT03094052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685143|NCT03094052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101685144|NCT03094052|Respiratory System Agents|respiratory system agents|mesh-ancestor
101685145|NCT03094052|Mydriatics|mydriatics|mesh-ancestor
101685146|NCT03094052|Parasympatholytics|parasympatholytics|mesh-ancestor
101685147|NCT03094052|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101685148|NCT03094052|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101685149|NCT03094052|Cholinergic Agents|cholinergic agents|mesh-ancestor
101685150|NCT03094052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101685151|NCT03094052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685152|NCT03094052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101685153|NCT03094052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101685155|NCT03094052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101685156|NCT03094052|Analgesics|analgesics|mesh-ancestor
101409859|NCT00112034|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101265521|NCT01774474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101685157|NCT03094052|Sensory System Agents|sensory system agents|mesh-ancestor
101685158|NCT05343338|Sivelestat|sivelestat|mesh-list
101685159|NCT05343338|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101685160|NCT05343338|Protease Inhibitors|protease inhibitors|mesh-ancestor
101685161|NCT05343338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101685162|NCT05343338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685163|NCT02704520|Leucovorin|leucovorin|mesh-list
101685164|NCT02704520|Folic Acid|folic acid|mesh-list
101685165|NCT02704520|Fluorouracil|fluorouracil|mesh-list
101685166|NCT02704520|Capecitabine|capecitabine|mesh-list
101685167|NCT02704520|Oxaliplatin|oxaliplatin|mesh-list
101685168|NCT02704520|Levoleucovorin|levoleucovorin|mesh-list
101685169|NCT02704520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685170|NCT02704520|Antimetabolites|antimetabolites|mesh-ancestor
101685171|NCT02704520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685172|NCT02704520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101685173|NCT02704520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101685174|NCT02704520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101685175|NCT02704520|Immunologic Factors|immunologic factors|mesh-ancestor
101685176|NCT02704520|Antidotes|antidotes|mesh-ancestor
101685177|NCT02704520|Protective Agents|protective agents|mesh-ancestor
101685178|NCT02704520|Vitamin B Complex|vitamin b complex|mesh-ancestor
101685179|NCT02704520|Vitamins|vitamins|mesh-ancestor
101685180|NCT02704520|Micronutrients|micronutrients|mesh-ancestor
101685181|NCT02704520|Hematinics|hematinics|mesh-ancestor
101685182|NCT02704052|Enoxaparin|enoxaparin|mesh-list
101685183|NCT02704052|Enoxaparin sodium|enoxaparin sodium|mesh-list
101685184|NCT02704052|Anticoagulants|anticoagulants|mesh-ancestor
101685185|NCT02704052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101685186|NCT02704052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101685187|NCT02704052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685188|NCT02703896|Esomeprazole|esomeprazole|mesh-list
101685189|NCT02703896|Omeprazole|omeprazole|mesh-list
101685190|NCT02703896|Pantoprazole|pantoprazole|mesh-list
101685191|NCT02703896|Lansoprazole|lansoprazole|mesh-list
101685192|NCT02703896|Famotidine|famotidine|mesh-list
101685193|NCT02703896|Ranitidine|ranitidine|mesh-list
101685194|NCT02703896|Cimetidine|cimetidine|mesh-list
101685195|NCT02703896|Nizatidine|nizatidine|mesh-list
101685196|NCT02703896|Lafutidine|lafutidine|mesh-list
101685197|NCT02703896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101685198|NCT02703896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101685199|NCT02703896|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101685200|NCT02703896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101685201|NCT02703896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685202|NCT02703896|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101685203|NCT02703896|Histamine Antagonists|histamine antagonists|mesh-ancestor
101685204|NCT02703896|Histamine Agents|histamine agents|mesh-ancestor
101685205|NCT02703896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101685206|NCT02703896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685207|NCT02703896|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101685208|NCT02703896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101685209|NCT02737436|Oxytocin|oxytocin|mesh-list
101685210|NCT02737436|Oxytocics|oxytocics|mesh-ancestor
101685211|NCT02737436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101685212|NCT02737436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685213|NCT00614978|Temozolomide|temozolomide|mesh-list
101685214|NCT00614978|Lapatinib|lapatinib|mesh-list
101685215|NCT00614978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101685216|NCT00614978|Alkylating Agents|alkylating agents|mesh-ancestor
101685217|NCT00614978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685218|NCT00614978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101685219|NCT00614978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101685220|NCT00614978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101685222|NCT03188354|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101685223|NCT03188354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685224|NCT02703740|Lidocaine|lidocaine|mesh-list
101685225|NCT02703740|Hyaluronic Acid|hyaluronic acid|mesh-list
101685226|NCT02703740|Anesthetics, Local|anesthetics, local|mesh-ancestor
101685227|NCT02703740|Anesthetics|anesthetics|mesh-ancestor
101685228|NCT02703740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101685229|NCT02703740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685230|NCT02703740|Sensory System Agents|sensory system agents|mesh-ancestor
101685231|NCT02703740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101685232|NCT02703740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101685233|NCT02703740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101685234|NCT02703740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101685235|NCT02703740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101685236|NCT02703740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685237|NCT02703740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101685238|NCT02703740|Immunologic Factors|immunologic factors|mesh-ancestor
101685239|NCT02703740|Viscosupplements|viscosupplements|mesh-ancestor
101685240|NCT02703740|Protective Agents|protective agents|mesh-ancestor
101685241|NCT00615368|Epoetin Alfa|epoetin alfa|mesh-list
101685242|NCT00615368|Hematinics|hematinics|mesh-ancestor
101685243|NCT00615446|Gemcitabine|gemcitabine|mesh-list
101685244|NCT00615446|Sunitinib|sunitinib|mesh-list
101685245|NCT00615446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101685246|NCT00615446|Antimetabolites|antimetabolites|mesh-ancestor
101685247|NCT00615446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685248|NCT00615446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101685249|NCT00615446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101685250|NCT00615446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101685251|NCT00615446|Growth Substances|growth substances|mesh-ancestor
101685252|NCT00615446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685253|NCT00615446|Growth Inhibitors|growth inhibitors|mesh-ancestor
101685254|NCT00615446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101685255|NCT00615446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101685256|NCT02703272|Dexamethasone|dexamethasone|mesh-list
101685257|NCT02703272|Rituximab|rituximab|mesh-list
101685258|NCT02703272|Carboplatin|carboplatin|mesh-list
101685259|NCT02703272|Etoposide|etoposide|mesh-list
101685260|NCT02703272|Vincristine|vincristine|mesh-list
101685261|NCT02703272|Ifosfamide|ifosfamide|mesh-list
101685262|NCT02703272|Idarubicin|idarubicin|mesh-list
101685263|NCT02703272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101685264|NCT02703272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101685265|NCT02703272|Immunologic Factors|immunologic factors|mesh-ancestor
101685266|NCT02703272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685267|NCT02703272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101685268|NCT02703272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101685269|NCT02703272|Antiemetics|antiemetics|mesh-ancestor
101685270|NCT02703272|Autonomic Agents|autonomic agents|mesh-ancestor
101685271|NCT02703272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101685272|NCT02703272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101685273|NCT02703272|Glucocorticoids|glucocorticoids|mesh-ancestor
101685274|NCT02703272|Hormones|hormones|mesh-ancestor
101685275|NCT02703272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101685276|NCT02703272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101685277|NCT02703272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101265571|NCT01774864|Udenafil|udenafil|mesh-list
101685278|NCT02703272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101685279|NCT02703272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101685280|NCT02703272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101685281|NCT02703272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685282|NCT02703272|Tubulin Modulators|tubulin modulators|mesh-ancestor
101685283|NCT02703272|Antimitotic Agents|antimitotic agents|mesh-ancestor
101685284|NCT02703272|Mitosis Modulators|mitosis modulators|mesh-ancestor
101685285|NCT02703272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101685286|NCT02703272|Alkylating Agents|alkylating agents|mesh-ancestor
101685287|NCT02703272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101685290|NCT02703194|Leflunomide|leflunomide|mesh-list
101685291|NCT02703194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101685292|NCT02703194|Glucocorticoids|glucocorticoids|mesh-ancestor
101685293|NCT02703194|Hormones|hormones|mesh-ancestor
101685294|NCT02703194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101685295|NCT02703194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685296|NCT02703194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101685297|NCT02703194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101685298|NCT02703194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101685299|NCT02703194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685300|NCT02703194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101685301|NCT02703194|Immunologic Factors|immunologic factors|mesh-ancestor
101685302|NCT02402660|Vitamin A|vitamin a|mesh-list
101685303|NCT02402660|Retinol acetate|retinol acetate|mesh-list
101685304|NCT02402660|Vitamins|vitamins|mesh-ancestor
101685305|NCT02402660|Micronutrients|micronutrients|mesh-ancestor
101685306|NCT02402660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685307|NCT02402660|Protective Agents|protective agents|mesh-ancestor
101685308|NCT02402660|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101685309|NCT02402660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101685310|NCT02402660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101685311|NCT02402660|Immunologic Factors|immunologic factors|mesh-ancestor
101685313|NCT02702960|Prednisone|prednisone|mesh-list
101685314|NCT02702960|Cyclophosphamide|cyclophosphamide|mesh-list
101685315|NCT02702960|Fludarabine|fludarabine|mesh-list
101685316|NCT02702960|Tacrolimus|tacrolimus|mesh-list
101685317|NCT02702960|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101685318|NCT02702960|Mesna|mesna|mesh-list
101685319|NCT02702960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101685320|NCT02702960|Immunologic Factors|immunologic factors|mesh-ancestor
101685321|NCT02702960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685322|NCT02702960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101685323|NCT02702960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101685324|NCT02702960|Alkylating Agents|alkylating agents|mesh-ancestor
101685325|NCT02702960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685326|NCT02702960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101685327|NCT02702960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101685328|NCT02702960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101685329|NCT02702960|Glucocorticoids|glucocorticoids|mesh-ancestor
101685330|NCT02702960|Hormones|hormones|mesh-ancestor
101685331|NCT02702960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101685332|NCT02702960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101685333|NCT02702960|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101685334|NCT02702960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101685335|NCT02702960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101685336|NCT02702960|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101685337|NCT02702960|Antitubercular Agents|antitubercular agents|mesh-ancestor
101685338|NCT02702960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101685339|NCT02702960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101685340|NCT02702960|Protective Agents|protective agents|mesh-ancestor
101685341|NCT02699528|Methylphenidate|methylphenidate|mesh-list
101685342|NCT02699528|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101265577|NCT01774877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101265580|NCT01774877|Immunologic Factors|immunologic factors|mesh-ancestor
101685343|NCT02699528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685344|NCT02699528|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101685345|NCT02699528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101685346|NCT02699528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101685347|NCT02699528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685348|NCT02699528|Dopamine Agents|dopamine agents|mesh-ancestor
101685349|NCT02699528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101685351|NCT04215770|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101685352|NCT04215770|Penicillin G|penicillin g|mesh-list
101685353|NCT04215770|Penicillin G Benzathine|penicillin g benzathine|mesh-list
101685354|NCT04215770|Penicillin G Procaine|penicillin g procaine|mesh-list
101685355|NCT04215770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101685356|NCT04215770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101685357|NCT04215770|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101685358|NCT04215770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101685359|NCT04215770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685360|NCT02702882|Fenugreek seed meal|fenugreek seed meal|mesh-list
101685361|NCT02702882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101685362|NCT02702882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685363|NCT02699138|Trazodone|trazodone|mesh-list
101685364|NCT02699138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101685365|NCT02699138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101685366|NCT02699138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101685367|NCT02699138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685368|NCT02699138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101685369|NCT02699138|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101685370|NCT02699138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101685371|NCT02699138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101685372|NCT02699138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685373|NCT02699138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101685374|NCT02699138|Serotonin Agents|serotonin agents|mesh-ancestor
101685375|NCT02699138|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101685376|NCT02699138|Antidepressive Agents|antidepressive agents|mesh-ancestor
101685377|NCT00615134|Enfuvirtide|enfuvirtide|mesh-list
101685378|NCT00615134|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101685379|NCT00615134|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101685380|NCT00615134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685381|NCT00615134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101685382|NCT00615134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101685383|NCT00615134|Antiviral Agents|antiviral agents|mesh-ancestor
101685384|NCT00615134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101685385|NCT01831076|Tamoxifen|tamoxifen|mesh-list
101685386|NCT01831076|Exemestane|exemestane|mesh-list
101685387|NCT01831076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101685388|NCT01831076|Hormone Antagonists|hormone antagonists|mesh-ancestor
101685389|NCT01831076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101685390|NCT01831076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685391|NCT01831076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101685392|NCT01831076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101685393|NCT01831076|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101685394|NCT01831076|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101685395|NCT01831076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101685396|NCT01831076|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101685397|NCT01831076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101685398|NCT01831076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101685399|NCT01831076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685400|NCT02698982|Anesthetics|anesthetics|mesh-list
101685401|NCT02698982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101685402|NCT02698982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685403|NCT00615524|Exemestane|exemestane|mesh-list
101685404|NCT00615524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101685405|NCT00615524|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101685406|NCT00615524|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101685407|NCT00615524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101685408|NCT00615524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685409|NCT00615524|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101685410|NCT00615524|Hormone Antagonists|hormone antagonists|mesh-ancestor
101685411|NCT00615524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101685412|NCT00615524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685413|NCT00908141|Sargramostim|sargramostim|mesh-list
101685414|NCT00908141|Immunologic Factors|immunologic factors|mesh-ancestor
101685415|NCT00908141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685416|NCT01246310|Inositol|inositol|mesh-list
101685417|NCT01246310|Vitamin B Complex|vitamin b complex|mesh-ancestor
101685418|NCT01246310|Vitamins|vitamins|mesh-ancestor
101685420|NCT01246310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685421|NCT00700076|Ketamine|ketamine|mesh-list
101685422|NCT00700076|Analgesics|analgesics|mesh-ancestor
101685423|NCT00700076|Sensory System Agents|sensory system agents|mesh-ancestor
101685424|NCT00700076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101685425|NCT00700076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685426|NCT00700076|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101685427|NCT00700076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101685428|NCT00700076|Anesthetics, General|anesthetics, general|mesh-ancestor
101685429|NCT00700076|Anesthetics|anesthetics|mesh-ancestor
101685430|NCT00700076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101685431|NCT00700076|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101685432|NCT00700076|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101685433|NCT00700076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101685434|NCT00700076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685435|NCT02698514|Sevoflurane|sevoflurane|mesh-list
101685436|NCT02698514|Desflurane|desflurane|mesh-list
101685437|NCT02698514|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101685438|NCT02698514|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101685439|NCT02698514|Anesthetics, General|anesthetics, general|mesh-ancestor
101685440|NCT02698514|Anesthetics|anesthetics|mesh-ancestor
101685441|NCT02698514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101685442|NCT02698514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685443|NCT02706158|Vitamin D|vitamin d|mesh-list
101685444|NCT02706158|Calcium|calcium|mesh-list
101685445|NCT02706158|Vitamins|vitamins|mesh-ancestor
101685446|NCT02706158|Micronutrients|micronutrients|mesh-ancestor
101685447|NCT02706158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685448|NCT02706158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101685449|NCT02706158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101685450|NCT03739853|Sulfasalazine|sulfasalazine|mesh-list
101685451|NCT03739853|Adalimumab|adalimumab|mesh-list
101685452|NCT03739853|Methotrexate|methotrexate|mesh-list
101685453|NCT03739853|Leflunomide|leflunomide|mesh-list
101409866|NCT00112034|Antimetabolites|antimetabolites|mesh-ancestor
101685454|NCT03739853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101685455|NCT03739853|Abortifacient Agents|abortifacient agents|mesh-ancestor
101685456|NCT03739853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101685457|NCT03739853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685458|NCT03739853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101685460|NCT03739853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685461|NCT03739853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101685462|NCT03739853|Dermatologic Agents|dermatologic agents|mesh-ancestor
101685463|NCT03739853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101265599|NCT01775540|Dexamethasone|dexamethasone|mesh-list
101685464|NCT03739853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101685465|NCT03739853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101685466|NCT03739853|Immunologic Factors|immunologic factors|mesh-ancestor
101685467|NCT03739853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101685468|NCT03739853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101685469|NCT03739853|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101685470|NCT03739853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101685471|NCT03739853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101685472|NCT03739853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101685473|NCT03739853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101685474|NCT03739853|Analgesics|analgesics|mesh-ancestor
101685475|NCT03739853|Sensory System Agents|sensory system agents|mesh-ancestor
101685476|NCT03739853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101685477|NCT03739853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101685478|NCT00615602|Cyclophosphamide|cyclophosphamide|mesh-list
101685479|NCT00615602|Docetaxel|docetaxel|mesh-list
101685480|NCT00615602|Trastuzumab|trastuzumab|mesh-list
101685481|NCT00615602|Epirubicin|epirubicin|mesh-list
101685482|NCT00615602|Fluorouracil|fluorouracil|mesh-list
101685484|NCT00615602|Mitogens|mitogens|mesh-list
101685485|NCT00615602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101685486|NCT00615602|Immunologic Factors|immunologic factors|mesh-ancestor
101685487|NCT00615602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685488|NCT00615602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101685489|NCT00615602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101685490|NCT00615602|Alkylating Agents|alkylating agents|mesh-ancestor
101685491|NCT00615602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685492|NCT00615602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101685493|NCT00615602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101685494|NCT00615602|Tubulin Modulators|tubulin modulators|mesh-ancestor
101685495|NCT00615602|Antimitotic Agents|antimitotic agents|mesh-ancestor
101685496|NCT00615602|Mitosis Modulators|mitosis modulators|mesh-ancestor
101685497|NCT00615602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101685498|NCT00615602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101685499|NCT00615602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101685500|NCT00615602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101685501|NCT00615602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101685502|NCT00615602|Antimetabolites|antimetabolites|mesh-ancestor
101685503|NCT00615602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101685504|NCT00615602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101685505|NCT02698748|Chloroquine|chloroquine|mesh-list
101685506|NCT02698748|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
101685507|NCT02698748|Amebicides|amebicides|mesh-ancestor
101685508|NCT02698748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101685509|NCT02698748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101685510|NCT02698748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101685511|NCT02698748|Antimalarials|antimalarials|mesh-ancestor
101685512|NCT02698748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101685513|NCT02698748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101685514|NCT02698748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101685515|NCT02698748|Analgesics|analgesics|mesh-ancestor
101685516|NCT02698748|Sensory System Agents|sensory system agents|mesh-ancestor
101685517|NCT02698748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101685518|NCT02698748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685519|NCT02698748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101685520|NCT02698748|Filaricides|filaricides|mesh-ancestor
101685521|NCT02698748|Antinematodal Agents|antinematodal agents|mesh-ancestor
101685522|NCT02698748|Anthelmintics|anthelmintics|mesh-ancestor
101685523|NCT04750343|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101685524|NCT04214990|Aspirin|aspirin|mesh-list
101685525|NCT04214990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101685526|NCT04214990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101685527|NCT04214990|Analgesics|analgesics|mesh-ancestor
101685528|NCT04214990|Sensory System Agents|sensory system agents|mesh-ancestor
101685529|NCT04214990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101265620|NCT01775579|Antimetabolites|antimetabolites|mesh-ancestor
101685530|NCT04214990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685531|NCT04214990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101685532|NCT04214990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101685533|NCT04214990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101685534|NCT04214990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101685535|NCT04214990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304189|NCT02011750|GABA Agents|gaba agents|mesh-ancestor
101685536|NCT04214990|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101685537|NCT04214990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101685538|NCT04214990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101504592|NCT02274974|Lidocaine|lidocaine|mesh-list
101685539|NCT04214990|Antipyretics|antipyretics|mesh-ancestor
101685540|NCT00615212|Rosiglitazone|rosiglitazone|mesh-list
101685541|NCT00615212|Flurbiprofen|flurbiprofen|mesh-list
101685542|NCT00615212|Midazolam|midazolam|mesh-list
101685543|NCT00615212|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101685544|NCT00615212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101685545|NCT00615212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101685546|NCT00615212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685547|NCT00615212|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101685548|NCT00615212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101685549|NCT00615212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101685550|NCT00615212|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101685551|NCT00615212|Anesthetics, General|anesthetics, general|mesh-ancestor
101685552|NCT00615212|Anesthetics|anesthetics|mesh-ancestor
101685553|NCT00615212|GABA Modulators|gaba modulators|mesh-ancestor
101685554|NCT00615212|GABA Agents|gaba agents|mesh-ancestor
101685555|NCT00615212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101685556|NCT00615212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685557|NCT00615212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101685558|NCT00615212|Analgesics|analgesics|mesh-ancestor
101685559|NCT00615212|Sensory System Agents|sensory system agents|mesh-ancestor
101685560|NCT00615212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101685561|NCT00615212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101685562|NCT00615212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101685563|NCT00615212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101685564|NCT00615212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101685565|NCT00615212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101685567|NCT02701478|Nitrous Oxide|nitrous oxide|mesh-list
101685568|NCT02701478|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101685569|NCT02701478|Anesthetics, General|anesthetics, general|mesh-ancestor
101685570|NCT02701478|Anesthetics|anesthetics|mesh-ancestor
101685571|NCT02701478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101685572|NCT02701478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685573|NCT02701478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101685574|NCT02701478|Analgesics|analgesics|mesh-ancestor
101685575|NCT02701478|Sensory System Agents|sensory system agents|mesh-ancestor
101685576|NCT02701478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101685577|NCT03314363|Trace Elements|trace elements|mesh-list
101685578|NCT03314363|Micronutrients|micronutrients|mesh-list
101685579|NCT03314363|Citric Acid|citric acid|mesh-list
101685580|NCT03314363|Sodium Citrate|sodium citrate|mesh-list
101685581|NCT03314363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685582|NCT03314363|Anticoagulants|anticoagulants|mesh-ancestor
101685583|NCT03314363|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101685584|NCT03314363|Chelating Agents|chelating agents|mesh-ancestor
101685585|NCT03314363|Sequestering Agents|sequestering agents|mesh-ancestor
101685586|NCT03314363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685587|NCT00906347|Misoprostol|misoprostol|mesh-list
101685588|NCT00906347|Oxytocin|oxytocin|mesh-list
101685589|NCT00906347|Oxytocics|oxytocics|mesh-ancestor
101685590|NCT00906347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101685591|NCT00906347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685592|NCT00906347|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101685593|NCT00906347|Abortifacient Agents|abortifacient agents|mesh-ancestor
101685594|NCT00906347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101685595|NCT00906347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101685596|NCT02705768|Carbamazepine|carbamazepine|mesh-list
101685597|NCT02705768|Oxcarbazepine|oxcarbazepine|mesh-list
101685598|NCT02705768|Anticonvulsants|anticonvulsants|mesh-ancestor
101505025|NCT00502541|Hormones|hormones|mesh-ancestor
101685599|NCT02705768|Antimanic Agents|antimanic agents|mesh-ancestor
101685600|NCT02705768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101505065|NCT00504062|Autonomic Agents|autonomic agents|mesh-ancestor
101685601|NCT02705768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101685602|NCT02705768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685603|NCT02705768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101685604|NCT02705768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101265645|NCT01775839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101685605|NCT02705768|Analgesics|analgesics|mesh-ancestor
101685606|NCT02705768|Sensory System Agents|sensory system agents|mesh-ancestor
101685607|NCT02705768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101685608|NCT02705768|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101685609|NCT02705768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101685610|NCT02705768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685611|NCT02705768|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101685612|NCT02705768|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101685613|NCT02705768|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101685614|NCT00616070|Difluprednate|difluprednate|mesh-list
101685615|NCT00616070|Glucocorticoids|glucocorticoids|mesh-ancestor
101685617|NCT00616070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101685618|NCT00616070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685619|NCT03153527|Prednisone|prednisone|mesh-list
101685620|NCT03153527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101685621|NCT03153527|Glucocorticoids|glucocorticoids|mesh-ancestor
101685622|NCT03153527|Hormones|hormones|mesh-ancestor
101505421|NCT00512928|Vitamin K|vitamin k|mesh-list
101685623|NCT03153527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101685624|NCT03153527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505501|NCT01245140|Alitretinoin|alitretinoin|mesh-list
101685625|NCT03153527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101685627|NCT02705534|Ribavirin|ribavirin|mesh-list
101685628|NCT02705534|Sofosbuvir|sofosbuvir|mesh-list
101685629|NCT02705534|Ledipasvir|ledipasvir|mesh-list
101685630|NCT02705534|Antimetabolites|antimetabolites|mesh-ancestor
101685631|NCT02705534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685632|NCT02705534|Antiviral Agents|antiviral agents|mesh-ancestor
101685633|NCT02705534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101685634|NCT02701166|Bezafibrate|bezafibrate|mesh-list
101685635|NCT02701166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101685636|NCT02701166|Antimetabolites|antimetabolites|mesh-ancestor
101265696|NCT01776203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101685637|NCT02701166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685638|NCT02701166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101685639|NCT03141203|Romidepsin|romidepsin|mesh-list
101685640|NCT03141203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101685641|NCT03141203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101685642|NCT03141203|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101685643|NCT03141203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101685644|NCT03141203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265744|NCT01776684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101685645|NCT05320991|Ketamine|ketamine|mesh-list
101685646|NCT05320991|Analgesics|analgesics|mesh-ancestor
101685647|NCT05320991|Sensory System Agents|sensory system agents|mesh-ancestor
101685648|NCT05320991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101685649|NCT05320991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685650|NCT05320991|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101685651|NCT05320991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101685652|NCT05320991|Anesthetics, General|anesthetics, general|mesh-ancestor
101685654|NCT05320991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101685655|NCT05320991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101685656|NCT05320991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101685657|NCT05320991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101506132|NCT00516750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101685658|NCT05320991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685659|NCT04215614|Lidocaine|lidocaine|mesh-list
101685660|NCT04215614|Bupivacaine|bupivacaine|mesh-list
101506218|NCT00517062|Hormones|hormones|mesh-list
101265812|NCT01777685|Sulpiride|sulpiride|mesh-list
101685661|NCT04215614|Anesthetics, Local|anesthetics, local|mesh-ancestor
101685662|NCT04215614|Anesthetics|anesthetics|mesh-ancestor
101685663|NCT04215614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101685664|NCT04215614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506282|NCT00517725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101506353|NCT01242930|Growth Substances|growth substances|mesh-ancestor
101685665|NCT04215614|Sensory System Agents|sensory system agents|mesh-ancestor
101685666|NCT04215614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101685667|NCT04215614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101685668|NCT04215614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101685669|NCT04215614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101685670|NCT04215614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101685671|NCT04215614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685672|NCT00906035|Aspirin|aspirin|mesh-list
101685673|NCT00906035|Dipyridamole|dipyridamole|mesh-list
101685674|NCT00906035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101685675|NCT00906035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101685676|NCT00906035|Analgesics|analgesics|mesh-ancestor
101685677|NCT00906035|Sensory System Agents|sensory system agents|mesh-ancestor
101685678|NCT00906035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101685679|NCT00906035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685680|NCT00906035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101685681|NCT00906035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101685682|NCT00906035|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101685683|NCT00906035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101685684|NCT00906035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685685|NCT00906035|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101685686|NCT00906035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101685687|NCT00906035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101265866|NCT01778075|Narcotics|narcotics|mesh-ancestor
101685689|NCT00906035|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101685690|NCT00906035|Vasodilator Agents|vasodilator agents|mesh-ancestor
101685691|NCT02698280|Bevacizumab|bevacizumab|mesh-list
101685693|NCT02698280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101685694|NCT02698280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101685695|NCT02698280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101685696|NCT02698280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101685697|NCT02698280|Growth Substances|growth substances|mesh-ancestor
101685698|NCT02698280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685699|NCT02698280|Growth Inhibitors|growth inhibitors|mesh-ancestor
101685700|NCT03087773|Empagliflozin|empagliflozin|mesh-list
101685701|NCT03087773|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101685702|NCT03087773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685703|NCT03087773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101685704|NCT03087773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685706|NCT02705612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101685707|NCT02705612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101685708|NCT05333159|Dapagliflozin|dapagliflozin|mesh-list
101685709|NCT05333159|Empagliflozin|empagliflozin|mesh-list
101685710|NCT05333159|Canagliflozin|canagliflozin|mesh-list
101685711|NCT05333159|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
101685712|NCT05333159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685713|NCT05333159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101506690|NCT00520650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101685714|NCT05333159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685715|NCT02698124|Decitabine|decitabine|mesh-list
101685716|NCT02698124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101265980|NCT01779232|Danazol|danazol|mesh-list
101685718|NCT02698124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506738|NCT00520806|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101685720|NCT02698124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101685721|NCT00905489|Nevirapine|nevirapine|mesh-list
101685722|NCT00905489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101506809|NCT00505817|Hormone Antagonists|hormone antagonists|mesh-ancestor
101685723|NCT00905489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101685724|NCT00905489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101685725|NCT00905489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685726|NCT00905489|Antiviral Agents|antiviral agents|mesh-ancestor
101685727|NCT00905489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101685728|NCT00905489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101685729|NCT00905489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101685730|NCT00905489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101685731|NCT00905489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101685732|NCT02705378|Naloxegol|naloxegol|mesh-list
101266094|NCT01779687|Atorvastatin|atorvastatin|mesh-list
101685733|NCT02705378|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101507168|NCT05148143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101685734|NCT02705378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685735|NCT02705378|Sensory System Agents|sensory system agents|mesh-ancestor
101685736|NCT02705378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101685738|NCT03059147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101507312|NCT02947932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101685739|NCT03059147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101685740|NCT03059147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101266169|NCT01780233|Citric Acid|citric acid|mesh-list
101685741|NCT03059147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685744|NCT03356834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101685745|NCT03356834|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101685746|NCT03356834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101685747|NCT03356834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101685748|NCT03356834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685749|NCT03356834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101685750|NCT03356834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101685751|NCT02705066|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
101685752|NCT02705066|Nootropic Agents|nootropic agents|mesh-ancestor
101685753|NCT00615758|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101685754|NCT00615758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101685755|NCT00615758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101685757|NCT00615758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685758|NCT02704988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101685759|NCT02704754|Suvorexant|suvorexant|mesh-list
101685760|NCT02704754|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101685761|NCT02704754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101685762|NCT02704754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101685763|NCT02704754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685764|NCT02704754|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
101685765|NCT02704754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101685766|NCT02704754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685767|NCT05182658|Empagliflozin|empagliflozin|mesh-list
101685768|NCT05182658|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101266371|NCT01781507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101507878|NCT00508898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101685769|NCT05182658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685770|NCT05182658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101685771|NCT05182658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685773|NCT04214054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101685774|NCT04214054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685775|NCT02909036|Melphalan|melphalan|mesh-list
101685776|NCT02909036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101508105|NCT00510965|Ranibizumab|ranibizumab|mesh-list
101685778|NCT02909036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685779|NCT02909036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101685781|NCT02909036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101685782|NCT02909036|Immunologic Factors|immunologic factors|mesh-ancestor
101685783|NCT02909036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685785|NCT04213898|Epirubicin|epirubicin|mesh-list
101685786|NCT04213898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101685787|NCT04213898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101685788|NCT04213898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101685789|NCT04213898|Tubulin Modulators|tubulin modulators|mesh-ancestor
101685790|NCT04213898|Antimitotic Agents|antimitotic agents|mesh-ancestor
101685791|NCT04213898|Mitosis Modulators|mitosis modulators|mesh-ancestor
101508457|NCT00513188|Antimitotic Agents|antimitotic agents|mesh-ancestor
101685792|NCT04213898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685793|NCT04213898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101685794|NCT04213898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101685797|NCT03170882|Dexamethasone|dexamethasone|mesh-list
101685798|NCT03170882|Pomalidomide|pomalidomide|mesh-list
101685799|NCT03170882|Ixazomib|ixazomib|mesh-list
101685800|NCT03170882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101685801|NCT03170882|Antiemetics|antiemetics|mesh-ancestor
101685802|NCT03170882|Autonomic Agents|autonomic agents|mesh-ancestor
101266568|NCT01783106|Hydroxychloroquine|hydroxychloroquine|mesh-list
101685803|NCT03170882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101685804|NCT03170882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685805|NCT03170882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101685806|NCT03170882|Glucocorticoids|glucocorticoids|mesh-ancestor
101685807|NCT03170882|Hormones|hormones|mesh-ancestor
101685808|NCT03170882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101685809|NCT03170882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101685810|NCT03170882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101685811|NCT03170882|Immunologic Factors|immunologic factors|mesh-ancestor
101685812|NCT03170882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101266634|NCT01783834|Pemetrexed|pemetrexed|mesh-list
101685813|NCT03170882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101685814|NCT03170882|Growth Substances|growth substances|mesh-ancestor
101685815|NCT03170882|Growth Inhibitors|growth inhibitors|mesh-ancestor
101685816|NCT03170882|Protease Inhibitors|protease inhibitors|mesh-ancestor
101685817|NCT03170882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101685818|NCT03170882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685819|NCT00616850|Lidocaine|lidocaine|mesh-list
101685820|NCT00616850|Anesthetics, Local|anesthetics, local|mesh-ancestor
101685821|NCT00616850|Anesthetics|anesthetics|mesh-ancestor
101508954|NCT00515255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101685822|NCT00616850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101685823|NCT00616850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685825|NCT00616850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101685826|NCT00616850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101685828|NCT00616850|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101685829|NCT00616850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101685830|NCT00616850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685832|NCT00618644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101685833|NCT00618644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101685834|NCT00618644|Growth Substances|growth substances|mesh-ancestor
101685835|NCT00618644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685836|NCT00618644|Growth Inhibitors|growth inhibitors|mesh-ancestor
101266762|NCT01784549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101685837|NCT00618644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101685838|NCT05324774|Aflibercept|aflibercept|mesh-list
101685839|NCT05324774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101685840|NCT05324774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101509544|NCT04691076|Anesthetics|anesthetics|mesh-ancestor
101685841|NCT05324774|Growth Substances|growth substances|mesh-ancestor
101685842|NCT05324774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685843|NCT05324774|Growth Inhibitors|growth inhibitors|mesh-ancestor
101685844|NCT05324774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101685845|NCT05324618|Hydrocortisone|hydrocortisone|mesh-list
101685846|NCT05324618|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101685847|NCT05324618|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101685848|NCT05324618|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101685849|NCT05324618|Tacrolimus|tacrolimus|mesh-list
101266824|NCT01785043|Liraglutide|liraglutide|mesh-list
101685850|NCT05324618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101685851|NCT05324618|Immunologic Factors|immunologic factors|mesh-ancestor
101685852|NCT05324618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685853|NCT05324618|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101685854|NCT05324618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101685855|NCT05324618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685856|NCT05324618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101685857|NCT03654989|Treprostinil|treprostinil|mesh-list
101685858|NCT03654989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101685859|NCT05300594|Vitamins|vitamins|mesh-list
101685860|NCT05300594|Micronutrients|micronutrients|mesh-ancestor
101685861|NCT05300594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510115|NCT02947880|Bumetanide|bumetanide|mesh-list
101510185|NCT00524069|Bevacizumab|bevacizumab|mesh-list
101685863|NCT00907517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101685864|NCT00907517|Antimetabolites|antimetabolites|mesh-ancestor
101510336|NCT02947178|Anesthetics, Local|anesthetics, local|mesh-ancestor
101685865|NCT00907517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685866|NCT00907517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101685867|NCT00907517|Antiviral Agents|antiviral agents|mesh-ancestor
101685868|NCT00907517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101685869|NCT00907517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101685870|NCT00907517|Immunologic Factors|immunologic factors|mesh-ancestor
101685871|NCT00907517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685872|NCT03043547|Leucovorin|leucovorin|mesh-list
101685873|NCT03043547|Antidotes|antidotes|mesh-ancestor
101685874|NCT03043547|Protective Agents|protective agents|mesh-ancestor
101685875|NCT03043547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685876|NCT03043547|Vitamin B Complex|vitamin b complex|mesh-ancestor
101685877|NCT03043547|Vitamins|vitamins|mesh-ancestor
101685878|NCT03043547|Micronutrients|micronutrients|mesh-ancestor
101685879|NCT00905255|Lixisenatide|lixisenatide|mesh-list
101685880|NCT00905255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101685881|NCT00905255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685883|NCT00905021|Exemestane|exemestane|mesh-list
101685884|NCT00905021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101685885|NCT00905021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101685886|NCT00905021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101685887|NCT00905021|Growth Substances|growth substances|mesh-ancestor
101685888|NCT00905021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510696|NCT00526409|Hormones|hormones|mesh-ancestor
101267089|NCT01786382|Anesthetics|anesthetics|mesh-ancestor
101685889|NCT00905021|Growth Inhibitors|growth inhibitors|mesh-ancestor
101685890|NCT00905021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101685891|NCT00905021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101685892|NCT00905021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685893|NCT00905021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101685894|NCT00905021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101685895|NCT00905021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101685896|NCT00905021|Hormone Antagonists|hormone antagonists|mesh-ancestor
101685897|NCT00905021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101685898|NCT03537131|Dapagliflozin|dapagliflozin|mesh-list
101685899|NCT03537131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101510762|NCT00526760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101510823|NCT00527033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101685900|NCT03537131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685901|NCT03537131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101510899|NCT00528281|Pemetrexed|pemetrexed|mesh-list
101685902|NCT03537131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685903|NCT02677805|Botulinum Toxins|botulinum toxins|mesh-list
101685904|NCT02677805|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101685905|NCT02677805|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101685906|NCT02677805|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101685907|NCT02677805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101685908|NCT02677805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685909|NCT02677805|Cholinergic Agents|cholinergic agents|mesh-ancestor
101685910|NCT02677805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101685911|NCT02677805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685912|NCT02677805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101685913|NCT02677805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101685914|NCT04202861|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101685915|NCT04202861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101267151|NCT01786655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101685916|NCT04202471|Chlorhexidine|chlorhexidine|mesh-list
101685917|NCT04202471|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101685918|NCT04202471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101685919|NCT04202471|Disinfectants|disinfectants|mesh-ancestor
101685920|NCT02395601|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
101685921|NCT02395601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101685922|NCT02395601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685924|NCT00632645|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
101685925|NCT00632645|Tetrabenazine|tetrabenazine|mesh-list
101685926|NCT00632645|Antiemetics|antiemetics|mesh-ancestor
101685927|NCT00632645|Autonomic Agents|autonomic agents|mesh-ancestor
101511544|NCT03403569|Contraceptive Agents|contraceptive agents|mesh-ancestor
101685928|NCT00632645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101685929|NCT00632645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511630|NCT02942810|Cefepime|cefepime|mesh-list
101685930|NCT00632645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101511692|NCT02941562|Leucovorin|leucovorin|mesh-list
101685931|NCT00632645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101685932|NCT00632645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101685933|NCT00632645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101685934|NCT00632645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101511769|NCT02941016|Evolocumab|evolocumab|mesh-list
101685935|NCT00632645|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101685936|NCT00632645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101685937|NCT00632645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101685938|NCT00632645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343218|NCT00845910|Antimetabolites|antimetabolites|mesh-ancestor
101685939|NCT00632645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101685940|NCT00632645|Serotonin Agents|serotonin agents|mesh-ancestor
101685941|NCT00632645|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101685943|NCT00632645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101685944|NCT00632645|Dopamine Agents|dopamine agents|mesh-ancestor
101685946|NCT02849873|Dermatologic Agents|dermatologic agents|mesh-ancestor
101685947|NCT02849873|Keratolytic Agents|keratolytic agents|mesh-ancestor
101685949|NCT02304809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101685950|NCT02304809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101685951|NCT02304809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101512337|NCT02909751|Alkylating Agents|alkylating agents|mesh-ancestor
101512410|NCT04688346|Adrenergic Agents|adrenergic agents|mesh-ancestor
101685952|NCT02304809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685953|NCT02849483|Ramosetron|ramosetron|mesh-list
101685954|NCT02849483|Antiemetics|antiemetics|mesh-ancestor
101685955|NCT02849483|Autonomic Agents|autonomic agents|mesh-ancestor
101685956|NCT02849483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101267319|NCT01788384|Clindamycin palmitate|clindamycin palmitate|mesh-list
101267321|NCT01788384|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101685957|NCT02849483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685958|NCT02849483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101685959|NCT02849483|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101685960|NCT02849483|Serotonin Agents|serotonin agents|mesh-ancestor
101685961|NCT02849483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101512630|NCT02935959|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101685962|NCT02849483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685964|NCT05116007|Etoposide|etoposide|mesh-list
101685965|NCT05116007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101685966|NCT05116007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101685967|NCT05116007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101685968|NCT05116007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101685969|NCT05116007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101685970|NCT05116007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685972|NCT02849327|Immunologic Factors|immunologic factors|mesh-ancestor
101685973|NCT02849327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685974|NCT00618696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101685976|NCT00618696|Immunoglobulins|immunoglobulins|mesh-list
101685977|NCT00618696|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101685978|NCT00618696|Immunologic Factors|immunologic factors|mesh-ancestor
101685979|NCT00618696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685980|NCT00618696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101685981|NCT00618852|Furosemide|furosemide|mesh-list
101685982|NCT00618852|Diuretics|diuretics|mesh-ancestor
101685983|NCT00618852|Natriuretic Agents|natriuretic agents|mesh-ancestor
101685984|NCT00618852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685985|NCT00618852|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101685986|NCT00618852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101513122|NCT02923583|Abatacept|abatacept|mesh-list
101685987|NCT00618852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101685988|NCT02073474|Nabiximols|nabiximols|mesh-list
101685989|NCT02073474|Analgesics|analgesics|mesh-ancestor
101685990|NCT02073474|Sensory System Agents|sensory system agents|mesh-ancestor
101267378|NCT01788722|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101685991|NCT02073474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101685992|NCT02073474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685993|NCT00637104|Chromium|chromium|mesh-list
101685994|NCT00637104|Trace Elements|trace elements|mesh-ancestor
101685995|NCT00637104|Micronutrients|micronutrients|mesh-ancestor
101513198|NCT02834559|Fluorouracil|fluorouracil|mesh-list
101685996|NCT00637104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101685997|NCT00617760|Vaccines|vaccines|mesh-list
101685998|NCT00617760|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101685999|NCT00617760|Immunologic Factors|immunologic factors|mesh-ancestor
101686000|NCT00617760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686001|NCT00620490|Ropivacaine|ropivacaine|mesh-list
101686002|NCT00620490|Anesthetics, Local|anesthetics, local|mesh-ancestor
101686003|NCT00620490|Anesthetics|anesthetics|mesh-ancestor
101686004|NCT00620490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101686005|NCT00620490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686006|NCT00620490|Sensory System Agents|sensory system agents|mesh-ancestor
101686007|NCT00620490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101686008|NCT04212078|Levofloxacin|levofloxacin|mesh-list
101686009|NCT04212078|Cefuroxime|cefuroxime|mesh-list
101686010|NCT04212078|Cefuroxime axetil|cefuroxime axetil|mesh-list
101686011|NCT04212078|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101686012|NCT04212078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101686013|NCT04212078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101267495|NCT01789437|Hormones|hormones|mesh-ancestor
101686014|NCT04212078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101686015|NCT04212078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101686016|NCT04212078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686017|NCT04212078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686018|NCT04212078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101686019|NCT04212078|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101686020|NCT04212078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101267540|NCT01789827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101686023|NCT01898520|Sensory System Agents|sensory system agents|mesh-ancestor
101513535|NCT00623857|Zinc|zinc|mesh-list
101686024|NCT01898520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101686025|NCT01898520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686028|NCT00903617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101686029|NCT00903617|Antimetabolites|antimetabolites|mesh-ancestor
101686030|NCT00903617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686031|NCT00903617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101686032|NCT00903617|Vasodilator Agents|vasodilator agents|mesh-ancestor
101686033|NCT00903617|Vitamin B Complex|vitamin b complex|mesh-ancestor
101686035|NCT00903617|Micronutrients|micronutrients|mesh-ancestor
101686036|NCT00903617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686037|NCT02848937|Citric Acid|citric acid|mesh-list
101686038|NCT02848937|Sodium Citrate|sodium citrate|mesh-list
101686039|NCT02848937|Anticoagulants|anticoagulants|mesh-ancestor
101686040|NCT02848937|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101686041|NCT02848937|Chelating Agents|chelating agents|mesh-ancestor
101686042|NCT02848937|Sequestering Agents|sequestering agents|mesh-ancestor
101686043|NCT02848937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686044|NCT00343824|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101686045|NCT00343824|Laxatives|laxatives|mesh-ancestor
101686046|NCT00343824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101686047|NCT02849015|Immunomodulating Agents|immunomodulating agents|mesh-list
101686048|NCT02849015|Immunologic Factors|immunologic factors|mesh-ancestor
101686049|NCT02849015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686050|NCT01428089|Progesterone|progesterone|mesh-list
101686051|NCT01428089|Progestins|progestins|mesh-ancestor
101686052|NCT01428089|Hormones|hormones|mesh-ancestor
101686053|NCT01428089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101267663|NCT01794208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686054|NCT01428089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686055|NCT04212000|Ketoconazole|ketoconazole|mesh-list
101686056|NCT04212000|Antifungal Agents|antifungal agents|mesh-ancestor
101686057|NCT04212000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101686058|NCT04212000|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101686059|NCT04212000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101686060|NCT04212000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686061|NCT04212000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686062|NCT04212000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101686063|NCT04212000|Hormone Antagonists|hormone antagonists|mesh-ancestor
101686064|NCT04212000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101686065|NCT04212000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686066|NCT04212000|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101686067|NCT00619398|Tacrolimus|tacrolimus|mesh-list
101686068|NCT00619398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101686069|NCT00619398|Immunologic Factors|immunologic factors|mesh-ancestor
101686070|NCT00619398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686071|NCT00619398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101686072|NCT00619398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686073|NCT00619398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686074|NCT00620646|Aspirin|aspirin|mesh-list
101686075|NCT00620646|Cilostazol|cilostazol|mesh-list
101686076|NCT00620646|Clopidogrel|clopidogrel|mesh-list
101686077|NCT00620646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101686078|NCT00620646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101686079|NCT00620646|Analgesics|analgesics|mesh-ancestor
101686080|NCT00620646|Sensory System Agents|sensory system agents|mesh-ancestor
101686081|NCT00620646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101686082|NCT00620646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686083|NCT00620646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101513581|NCT01280656|Ribavirin|ribavirin|mesh-list
101686085|NCT00620646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101267868|NCT01800019|Nicotine|nicotine|mesh-list
101686087|NCT00620646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686088|NCT00620646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101686089|NCT00620646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101686091|NCT00620646|Antipyretics|antipyretics|mesh-ancestor
101686092|NCT00620646|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101686093|NCT00620646|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101686094|NCT00620646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101686095|NCT00620646|Purinergic Agents|purinergic agents|mesh-ancestor
101686096|NCT00620646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101686097|NCT00620646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101686098|NCT00620646|Autonomic Agents|autonomic agents|mesh-ancestor
101686100|NCT00620646|Respiratory System Agents|respiratory system agents|mesh-ancestor
101686101|NCT00620646|Vasodilator Agents|vasodilator agents|mesh-ancestor
101686102|NCT00620646|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101686103|NCT00620646|Protective Agents|protective agents|mesh-ancestor
101686104|NCT00620646|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101686105|NCT00620646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101686106|NCT00810017|Trastuzumab|trastuzumab|mesh-list
101686107|NCT00810017|Etoposide|etoposide|mesh-list
101686108|NCT00810017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101686109|NCT00810017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101686110|NCT00810017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101686111|NCT00810017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101686112|NCT00810017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101686113|NCT00810017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686114|NCT00810017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101267919|NCT01800357|Immunologic Factors|immunologic factors|mesh-ancestor
101686115|NCT00620724|Nifedipine|nifedipine|mesh-list
101686116|NCT00620724|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101686117|NCT00620724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101686118|NCT00620724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513771|NCT02918825|Antiemetics|antiemetics|mesh-ancestor
101686119|NCT00620724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101686120|NCT00620724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101267966|NCT01800643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101513830|NCT02918591|Empagliflozin|empagliflozin|mesh-list
101686121|NCT00620724|Vasodilator Agents|vasodilator agents|mesh-ancestor
101686122|NCT00620724|Tocolytic Agents|tocolytic agents|mesh-ancestor
101686123|NCT00620724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101686125|NCT04209426|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101686126|NCT04209426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686127|NCT04209426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513974|NCT04484610|Analgesics|analgesics|mesh-ancestor
101686129|NCT04209426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101686130|NCT04209426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686131|NCT04209426|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101686132|NCT04209426|Autonomic Agents|autonomic agents|mesh-ancestor
101686133|NCT04209426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101686134|NCT04209426|Nootropic Agents|nootropic agents|mesh-ancestor
101686135|NCT00620802|Clopidogrel|clopidogrel|mesh-list
101686136|NCT00620802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101686137|NCT00620802|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101268100|NCT01802255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101268101|NCT01802255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101686138|NCT00620802|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101686139|NCT00620802|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101686140|NCT00620802|Purinergic Agents|purinergic agents|mesh-ancestor
101686141|NCT00620802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101686142|NCT00620802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686143|NCT00620802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686144|NCT02848157|Dexmedetomidine|dexmedetomidine|mesh-list
101686145|NCT02848157|Ropivacaine|ropivacaine|mesh-list
101686146|NCT02848157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101686147|NCT02848157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101514247|NCT00534456|Darbepoetin alfa|darbepoetin alfa|mesh-list
101686148|NCT02848157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686149|NCT02848157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101686151|NCT02848157|Sensory System Agents|sensory system agents|mesh-ancestor
101686152|NCT02848157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101686153|NCT02848157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101686154|NCT02848157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101686155|NCT02848157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101686156|NCT02848157|Adrenergic Agents|adrenergic agents|mesh-ancestor
101686157|NCT02848157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101686158|NCT02848157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686159|NCT02848157|Anesthetics, Local|anesthetics, local|mesh-ancestor
101686160|NCT02848157|Anesthetics|anesthetics|mesh-ancestor
101686161|NCT04211844|Sofosbuvir|sofosbuvir|mesh-list
101686162|NCT04211844|Ledipasvir|ledipasvir|mesh-list
101686163|NCT04211844|Antiviral Agents|antiviral agents|mesh-ancestor
101686164|NCT04211844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101686165|NCT00619710|Meropenem|meropenem|mesh-list
101686166|NCT00619710|Imipenem|imipenem|mesh-list
101686167|NCT00619710|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
101686169|NCT00619710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101686170|NCT00619710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101686171|NCT00619710|Protease Inhibitors|protease inhibitors|mesh-ancestor
101686172|NCT00619710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686173|NCT00619710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686174|NCT03929627|Hydrocortisone|hydrocortisone|mesh-list
101686175|NCT03929627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101686177|NCT04019015|Hemostatics|hemostatics|mesh-ancestor
101686178|NCT04019015|Coagulants|coagulants|mesh-ancestor
101514789|NCT05471427|Taxane|taxane|mesh-list
101686179|NCT02846909|Progesterone|progesterone|mesh-list
101686180|NCT02846909|Progestins|progestins|mesh-ancestor
101686181|NCT02846909|Hormones|hormones|mesh-ancestor
101514825|NCT00595543|Ketorolac|ketorolac|mesh-list
101686182|NCT02846909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101686183|NCT02846909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686184|NCT00632723|Gefitinib|gefitinib|mesh-list
101686185|NCT00632723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101686186|NCT00632723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101686187|NCT00632723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101515041|NCT00597064|Glucocorticoids|glucocorticoids|mesh-ancestor
101686188|NCT00632723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686190|NCT02847143|Oxytocics|oxytocics|mesh-ancestor
101686191|NCT02847143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101686192|NCT02847143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686193|NCT02847455|Rabeprazole|rabeprazole|mesh-list
101686194|NCT02847455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101686195|NCT02847455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101686196|NCT02847455|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101515337|NCT05469750|Capecitabine|capecitabine|mesh-list
101686198|NCT02847455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686199|NCT03897335|Aminophylline|aminophylline|mesh-list
101686200|NCT03897335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101686201|NCT03897335|Autonomic Agents|autonomic agents|mesh-ancestor
101686202|NCT03897335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101686203|NCT03897335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686204|NCT03897335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101686205|NCT03897335|Respiratory System Agents|respiratory system agents|mesh-ancestor
101686206|NCT03897335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101686207|NCT03897335|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101268408|NCT01804361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101686208|NCT03897335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686209|NCT03897335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101268409|NCT01804374|Everolimus|everolimus|mesh-list
101515617|NCT04543682|Iloprost|iloprost|mesh-list
101686210|NCT03897335|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101409893|NCT00114387|Protective Agents|protective agents|mesh-ancestor
101686211|NCT03897335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101686212|NCT03897335|Purinergic Agents|purinergic agents|mesh-ancestor
101686214|NCT03897335|Protective Agents|protective agents|mesh-ancestor
101686216|NCT01617096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101686217|NCT01617096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101686218|NCT01617096|Antiviral Agents|antiviral agents|mesh-ancestor
101686219|NCT01617096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101515904|NCT03534284|Trazodone|trazodone|mesh-list
101686220|NCT00619944|Ritonavir|ritonavir|mesh-list
101686221|NCT00619944|Lopinavir|lopinavir|mesh-list
101268474|NCT01804985|Dasatinib|dasatinib|mesh-list
101686222|NCT00619944|Lumefantrine|lumefantrine|mesh-list
101686223|NCT00619944|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101515987|NCT04320589|Anesthetics|anesthetics|mesh-list
101686224|NCT00619944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101686225|NCT00619944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101686226|NCT00619944|Protease Inhibitors|protease inhibitors|mesh-ancestor
101686227|NCT00619944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686228|NCT00619944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686229|NCT00619944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101686230|NCT00619944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101686232|NCT00619944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101686233|NCT00619944|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101268532|NCT01807767|Mycophenolic Acid|mycophenolic acid|mesh-list
101268533|NCT01807767|Everolimus|everolimus|mesh-list
101268534|NCT01807767|Tacrolimus|tacrolimus|mesh-list
101686234|NCT00619944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101686235|NCT00619944|Antimalarials|antimalarials|mesh-ancestor
101343518|NCT00276003|Gemcitabine|gemcitabine|mesh-list
101686236|NCT00619944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101686237|NCT00619944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101686238|NCT00621036|Methotrexate|methotrexate|mesh-list
101686239|NCT00621036|Thiotepa|thiotepa|mesh-list
101686240|NCT00621036|Immunoglobulins|immunoglobulins|mesh-list
101686241|NCT00621036|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101686242|NCT00621036|Antibodies|antibodies|mesh-list
101516268|NCT05264142|Omeprazole|omeprazole|mesh-list
101686244|NCT00621036|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
101686245|NCT00621036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101686246|NCT00621036|Abortifacient Agents|abortifacient agents|mesh-ancestor
101686247|NCT00621036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101686248|NCT00621036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686249|NCT00621036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101686250|NCT00621036|Antimetabolites|antimetabolites|mesh-ancestor
101686251|NCT00621036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686252|NCT00621036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101686253|NCT00621036|Dermatologic Agents|dermatologic agents|mesh-ancestor
101268594|NCT01808300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686254|NCT00621036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686255|NCT00621036|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101686256|NCT00621036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101686257|NCT00621036|Immunologic Factors|immunologic factors|mesh-ancestor
101686258|NCT00621036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101686259|NCT00621036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101686260|NCT00621036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101686261|NCT00621036|Alkylating Agents|alkylating agents|mesh-ancestor
101686262|NCT00621036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101686263|NCT02846831|Insulin|insulin|mesh-list
101686264|NCT02846831|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101686265|NCT02846831|Hormones|hormones|mesh-list
101686266|NCT02846831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101516397|NCT03778931|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101686267|NCT02846831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686268|NCT02846831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101686269|NCT01497509|Epinephrine|epinephrine|mesh-list
101686270|NCT01497509|Racepinephrine|racepinephrine|mesh-list
101686271|NCT01497509|Fentanyl|fentanyl|mesh-list
101268654|NCT01808638|Gemcitabine|gemcitabine|mesh-list
101686272|NCT01497509|Bupivacaine|bupivacaine|mesh-list
101686273|NCT01497509|Epinephryl borate|epinephryl borate|mesh-list
101686274|NCT01497509|Anesthetics, Local|anesthetics, local|mesh-ancestor
101686275|NCT01497509|Anesthetics|anesthetics|mesh-ancestor
101686276|NCT01497509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101686277|NCT01497509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686278|NCT01497509|Sensory System Agents|sensory system agents|mesh-ancestor
101516670|NCT01264939|Promethazine|promethazine|mesh-list
101686279|NCT01497509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101686280|NCT01497509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101686281|NCT01497509|Narcotics|narcotics|mesh-ancestor
101686282|NCT01497509|Analgesics|analgesics|mesh-ancestor
101686283|NCT01497509|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101686284|NCT01497509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101268707|NCT01809301|Vasodilator Agents|vasodilator agents|mesh-ancestor
101686286|NCT01497509|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101686287|NCT01497509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101686288|NCT01497509|Adrenergic Agents|adrenergic agents|mesh-ancestor
101686289|NCT01497509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101516958|NCT00546936|Growth Inhibitors|growth inhibitors|mesh-ancestor
101686290|NCT01497509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686291|NCT01497509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101686292|NCT01497509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101686293|NCT01497509|Autonomic Agents|autonomic agents|mesh-ancestor
101686294|NCT01497509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101686295|NCT01497509|Respiratory System Agents|respiratory system agents|mesh-ancestor
101686297|NCT01497509|Sympathomimetics|sympathomimetics|mesh-ancestor
101686298|NCT01497509|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101686299|NCT02844881|Apatinib|apatinib|mesh-list
101686300|NCT02844881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101686301|NCT02844881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101686302|NCT02844881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686303|NCT02844881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686305|NCT02846519|Esketamine|esketamine|mesh-list
101686306|NCT02846519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101686307|NCT02846519|Antitubercular Agents|antitubercular agents|mesh-ancestor
101686308|NCT02846519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101686309|NCT02846519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101517475|NCT04043494|Hormones|hormones|mesh-ancestor
101686310|NCT02846519|Leprostatic Agents|leprostatic agents|mesh-ancestor
101686311|NCT02846519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101686312|NCT02846519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101517613|NCT01262287|Dutasteride|dutasteride|mesh-list
101686313|NCT02846519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686314|NCT02846519|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101686315|NCT02846519|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101686316|NCT02846519|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101686317|NCT02846519|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101686318|NCT02846519|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101686319|NCT02846519|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101686320|NCT02846519|Antidepressive Agents|antidepressive agents|mesh-ancestor
101517685|NCT04321642|Anesthetics|anesthetics|mesh-ancestor
101268906|NCT01810848|Immunologic Factors|immunologic factors|mesh-ancestor
101268908|NCT01810848|Viscosupplements|viscosupplements|mesh-ancestor
101686321|NCT02846519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101686323|NCT00618228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101686324|NCT00618228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101686325|NCT00618228|Analgesics|analgesics|mesh-ancestor
101686327|NCT00618228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101686328|NCT00618228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686329|NCT00618228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101517963|NCT00550563|Vitamin D|vitamin d|mesh-list
101686330|NCT00618228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101686331|NCT00618228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101686333|NCT03711305|Etoposide|etoposide|mesh-list
101686334|NCT03711305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101268962|NCT01811056|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101686335|NCT03711305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101686337|NCT03711305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101686339|NCT03711305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686340|NCT00618384|Sorafenib|sorafenib|mesh-list
101686341|NCT00618384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101686342|NCT00618384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101686343|NCT00618384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686344|NCT00618384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686345|NCT03608657|Apremilast|apremilast|mesh-list
101686346|NCT03608657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101686347|NCT03608657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101686348|NCT03608657|Analgesics|analgesics|mesh-ancestor
101686349|NCT03608657|Sensory System Agents|sensory system agents|mesh-ancestor
101686350|NCT03608657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101686351|NCT03608657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686352|NCT03608657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101686353|NCT03608657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101686354|NCT03608657|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101686355|NCT03608657|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101269092|NCT01812200|Phenprocoumon|phenprocoumon|mesh-list
101686356|NCT03608657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686357|NCT03608657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686358|NCT05000658|Dexamethasone|dexamethasone|mesh-list
101686359|NCT05000658|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101686360|NCT05000658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101686361|NCT05000658|Antiemetics|antiemetics|mesh-ancestor
101686363|NCT05000658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101686364|NCT05000658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686365|NCT05000658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101686366|NCT05000658|Glucocorticoids|glucocorticoids|mesh-ancestor
101686367|NCT05000658|Hormones|hormones|mesh-ancestor
101775309|NCT00936195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686368|NCT05000658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101686369|NCT05000658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101686370|NCT05000658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101686372|NCT02844803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101686373|NCT02844803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686374|NCT04211298|Dexmedetomidine|dexmedetomidine|mesh-list
101686375|NCT04211298|Propofol|propofol|mesh-list
101269158|NCT01812538|Diclofenac|diclofenac|mesh-list
101686376|NCT04211298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101686377|NCT04211298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101686378|NCT04211298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686379|NCT04211298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101686380|NCT04211298|Analgesics|analgesics|mesh-ancestor
101686381|NCT04211298|Sensory System Agents|sensory system agents|mesh-ancestor
101686382|NCT04211298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101686383|NCT04211298|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101269210|NCT01812954|Methotrexate|methotrexate|mesh-list
101518966|NCT02529852|Prednisone|prednisone|mesh-list
101686386|NCT04211298|Adrenergic Agents|adrenergic agents|mesh-ancestor
101686387|NCT04211298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101686388|NCT04211298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686389|NCT04211298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101686390|NCT04211298|Anesthetics, General|anesthetics, general|mesh-ancestor
101686391|NCT04211298|Anesthetics|anesthetics|mesh-ancestor
101686392|NCT04212702|Everolimus|everolimus|mesh-list
101686393|NCT04212702|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101686394|NCT04212702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101686395|NCT04212702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686396|NCT04212702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686397|NCT04212702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101686398|NCT04212702|Immunologic Factors|immunologic factors|mesh-ancestor
101686399|NCT04212702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686400|NCT04212702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101686401|NCT02691780|Sorafenib|sorafenib|mesh-list
101269348|NCT01813617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686402|NCT02691780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101686403|NCT02691780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101686404|NCT02691780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686405|NCT02691780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686406|NCT02845661|Dexmedetomidine|dexmedetomidine|mesh-list
101686407|NCT02845661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101686408|NCT02845661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101686409|NCT02845661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686410|NCT02845661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101519319|NCT04664894|Ribavirin|ribavirin|mesh-list
101686412|NCT02845661|Sensory System Agents|sensory system agents|mesh-ancestor
101686413|NCT02845661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101519388|NCT04351737|Antiemetics|antiemetics|mesh-ancestor
101686414|NCT02845661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101686415|NCT02845661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101686416|NCT02845661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101269410|NCT01813955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686418|NCT02845661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101686419|NCT02845661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686420|NCT02844335|Immunomodulating Agents|immunomodulating agents|mesh-list
101686421|NCT02844335|Immunologic Factors|immunologic factors|mesh-ancestor
101686422|NCT02844335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686424|NCT00880074|Antiviral Agents|antiviral agents|mesh-ancestor
101686425|NCT00880074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101686426|NCT04375787|Atorvastatin|atorvastatin|mesh-list
101686427|NCT04375787|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101686429|NCT04375787|Antimetabolites|antimetabolites|mesh-ancestor
101775310|NCT00936195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101775311|NCT00936195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101686430|NCT04375787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775312|NCT00936195|Antiviral Agents|antiviral agents|mesh-ancestor
101686432|NCT04375787|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101686433|NCT04375787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686434|NCT00825630|Esomeprazole|esomeprazole|mesh-list
101686435|NCT00825630|Pantoprazole|pantoprazole|mesh-list
101686436|NCT00825630|Lansoprazole|lansoprazole|mesh-list
101686437|NCT00825630|Dexlansoprazole|dexlansoprazole|mesh-list
101686439|NCT00825630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101686440|NCT00825630|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101520040|NCT02546583|Furosemide|furosemide|mesh-list
101686441|NCT00825630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686442|NCT00825630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686444|NCT00620100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101686445|NCT00620100|Tubulin Modulators|tubulin modulators|mesh-ancestor
101686446|NCT00620100|Antimitotic Agents|antimitotic agents|mesh-ancestor
101686447|NCT00620100|Mitosis Modulators|mitosis modulators|mesh-ancestor
101686448|NCT00620100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686449|NCT02845349|Vortioxetine|vortioxetine|mesh-list
101686450|NCT02845349|Antidepressive Agents|antidepressive agents|mesh-ancestor
101686451|NCT02845349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101686452|NCT02845349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101686453|NCT02845349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101686454|NCT02845349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101520398|NCT00543933|Nitric Oxide|nitric oxide|mesh-list
101686455|NCT02845349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686456|NCT02845349|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101686457|NCT02845349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101686458|NCT02845349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101520617|NCT01237951|Antiemetics|antiemetics|mesh-ancestor
101686459|NCT02845349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686460|NCT02845349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101520692|NCT00544596|Acetic Acid|acetic acid|mesh-list
101269663|NCT01814930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686462|NCT02845349|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101686463|NCT02845349|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101520761|NCT01237678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686464|NCT02845349|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101686466|NCT03852251|Capecitabine|capecitabine|mesh-list
101686467|NCT03852251|Oxaliplatin|oxaliplatin|mesh-list
101686468|NCT03852251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101686469|NCT03852251|Antimetabolites|antimetabolites|mesh-ancestor
101686470|NCT03852251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686472|NCT00620178|Losartan|losartan|mesh-list
101686473|NCT00620178|Candesartan|candesartan|mesh-list
101686474|NCT00620178|Candesartan cilexetil|candesartan cilexetil|mesh-list
101686475|NCT00620178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101686476|NCT00620178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101686477|NCT00620178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101686478|NCT00620178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101686479|NCT00620178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686480|NCT04349982|Fibrin fragment D|fibrin fragment d|mesh-list
101521125|NCT02904759|Coagulants|coagulants|mesh-ancestor
101521193|NCT02898012|Growth Substances|growth substances|mesh-ancestor
101686481|NCT04349982|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101686482|NCT04349982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101686483|NCT04349982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686485|NCT04349982|Coagulants|coagulants|mesh-ancestor
101686486|NCT04315350|Prednisolone|prednisolone|mesh-list
101269790|NCT01816321|Ganirelix|ganirelix|mesh-list
101686488|NCT04315350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101686490|NCT04315350|Hormones|hormones|mesh-ancestor
101521490|NCT00553722|Diuretics|diuretics|mesh-ancestor
101409907|NCT00351403|Ribavirin|ribavirin|mesh-list
101686491|NCT04315350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101686492|NCT04315350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686493|NCT04315350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101686494|NCT04315350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101686495|NCT04315350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101686496|NCT04315350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101269846|NCT01816555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686497|NCT04315350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101686498|NCT04315350|Analgesics|analgesics|mesh-ancestor
101686499|NCT04315350|Sensory System Agents|sensory system agents|mesh-ancestor
101686500|NCT04315350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101686501|NCT04315350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686502|NCT04315350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686503|NCT04288206|Cefazolin|cefazolin|mesh-list
101686504|NCT04288206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101686505|NCT04288206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101686506|NCT04958772|Lenograstim|lenograstim|mesh-list
101522161|NCT00447239|Insulin|insulin|mesh-list
101686508|NCT04958772|Immunologic Factors|immunologic factors|mesh-ancestor
101686509|NCT04958772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686510|NCT02771249|Pyridoxine|pyridoxine|mesh-list
101686511|NCT02771249|Isoniazid|isoniazid|mesh-list
101686512|NCT02771249|Darunavir|darunavir|mesh-list
101686513|NCT02771249|Cobicistat|cobicistat|mesh-list
101686514|NCT02771249|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
101686515|NCT02771249|Antitubercular Agents|antitubercular agents|mesh-ancestor
101522292|NCT03276689|Dopamine Agents|dopamine agents|mesh-ancestor
101686516|NCT02771249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101522439|NCT05468359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101686517|NCT02771249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101686518|NCT02771249|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101686519|NCT02771249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101686520|NCT02771249|Antimetabolites|antimetabolites|mesh-ancestor
101269976|NCT01817322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101775314|NCT00936195|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101686521|NCT02771249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686522|NCT02771249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101686523|NCT02771249|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101522582|NCT00449774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101686524|NCT02771249|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101686525|NCT02771249|Protease Inhibitors|protease inhibitors|mesh-ancestor
101686526|NCT02771249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686527|NCT02771249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101522725|NCT04699097|Azithromycin|azithromycin|mesh-list
101686528|NCT02771249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101522805|NCT02900157|Durvalumab|durvalumab|mesh-list
101686530|NCT02771249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101686531|NCT02771249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101686532|NCT02771249|Vitamin B Complex|vitamin b complex|mesh-ancestor
101686535|NCT02771249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686545|NCT04048278|Anesthetics, Local|anesthetics, local|mesh-ancestor
101686546|NCT04048278|Anesthetics|anesthetics|mesh-ancestor
101686547|NCT04048278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101686548|NCT04048278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686549|NCT04048278|Sensory System Agents|sensory system agents|mesh-ancestor
101686550|NCT04048278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101686551|NCT04048278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101270096|NCT01818648|Exenatide|exenatide|mesh-list
101686552|NCT04048278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101686553|NCT04048278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101686554|NCT04048278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101686555|NCT04048278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686557|NCT02697318|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101686558|NCT02697318|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101775315|NCT00936195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101523438|NCT01699464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101409913|NCT05595096|Anesthetics|anesthetics|mesh-list
101775316|NCT00936195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101523591|NCT01632228|Bevacizumab|bevacizumab|mesh-list
101270158|NCT01818908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101686559|NCT02697318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686560|NCT02697318|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101686561|NCT02697318|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101686562|NCT02697318|Adrenergic Agents|adrenergic agents|mesh-ancestor
101686563|NCT02697318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101686564|NCT02697318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686565|NCT02697318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101686566|NCT02697318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101686567|NCT05242133|Interferons|interferons|mesh-list
101686568|NCT05242133|Interferon-beta|interferon-beta|mesh-list
101686569|NCT05242133|Interferon beta-1a|interferon beta-1a|mesh-list
101686570|NCT05242133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101686571|NCT05242133|Antiviral Agents|antiviral agents|mesh-ancestor
101270221|NCT01819285|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101270222|NCT01819285|Hormones|hormones|mesh-ancestor
101270225|NCT01819389|Imatinib Mesylate|imatinib mesylate|mesh-list
101686572|NCT05242133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101686573|NCT05242133|Immunologic Factors|immunologic factors|mesh-ancestor
101686574|NCT05242133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686575|NCT05242133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101686576|NCT00621816|Nitroprusside|nitroprusside|mesh-list
101686577|NCT00621816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101686578|NCT00621816|Vasodilator Agents|vasodilator agents|mesh-ancestor
101686579|NCT00621816|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101686580|NCT00621816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686581|NCT05368974|Antiviral Agents|antiviral agents|mesh-list
101686582|NCT05368974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101523805|NCT02912702|Protective Agents|protective agents|mesh-ancestor
101686584|NCT04186026|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101686585|NCT04186026|Incretins|incretins|mesh-ancestor
101686586|NCT04186026|Hormones|hormones|mesh-ancestor
101686587|NCT04186026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101686588|NCT04186026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686589|NCT04186026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101686590|NCT00900731|Tiotropium Bromide|tiotropium bromide|mesh-list
101270342|NCT01820143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101686591|NCT00900731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101686592|NCT00900731|Autonomic Agents|autonomic agents|mesh-ancestor
101686593|NCT00900731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101686594|NCT00900731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686595|NCT00900731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101686596|NCT00900731|Respiratory System Agents|respiratory system agents|mesh-ancestor
101686597|NCT00900731|Parasympatholytics|parasympatholytics|mesh-ancestor
101270410|NCT01820624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101270411|NCT01820624|Keratolytic Agents|keratolytic agents|mesh-ancestor
101686598|NCT00900731|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101686599|NCT00900731|Cholinergic Agents|cholinergic agents|mesh-ancestor
101686600|NCT00900731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101686601|NCT00900731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686602|NCT02687490|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101686603|NCT02687490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101686604|NCT05241821|Fibrinolytic Agents|fibrinolytic agents|mesh-list
101686605|NCT05241821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101686606|NCT05241821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686607|NCT00650819|Simvastatin|simvastatin|mesh-list
101686609|NCT00650819|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101686610|NCT00650819|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101343896|NCT00016016|Analgesics|analgesics|mesh-ancestor
101686611|NCT00650819|Antimetabolites|antimetabolites|mesh-ancestor
101686612|NCT00650819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686613|NCT00650819|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101686614|NCT00650819|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101686615|NCT00650819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686616|NCT05662410|Aflibercept|aflibercept|mesh-list
101686617|NCT05662410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101686618|NCT05662410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101686619|NCT05662410|Growth Substances|growth substances|mesh-ancestor
101270537|NCT01821261|Fluorides|fluorides|mesh-list
101686620|NCT05662410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686622|NCT05662410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101686623|NCT02689362|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101686624|NCT02689362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101686625|NCT02689362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686628|NCT02689362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101686629|NCT02689362|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101686630|NCT02689362|Protease Inhibitors|protease inhibitors|mesh-ancestor
101686631|NCT02689362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686632|NCT02689362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686633|NCT02687256|Heparin|heparin|mesh-list
101686634|NCT02687256|Anticoagulants|anticoagulants|mesh-ancestor
101686635|NCT02687256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101686636|NCT02687256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101686637|NCT02687256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686638|NCT00622206|Ritonavir|ritonavir|mesh-list
101686639|NCT00622206|Saquinavir|saquinavir|mesh-list
101686640|NCT00622206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101686641|NCT00622206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101686642|NCT00622206|Protease Inhibitors|protease inhibitors|mesh-ancestor
101686643|NCT00622206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686644|NCT00622206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686645|NCT00622206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101270667|NCT01822405|Tocopherols|tocopherols|mesh-list
101686646|NCT00622206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101686648|NCT00622206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101686649|NCT00622206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101686650|NCT00622206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101686651|NCT03582293|Tranexamic Acid|tranexamic acid|mesh-list
101686652|NCT03582293|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101686653|NCT03582293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101686654|NCT03582293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686655|NCT03582293|Hemostatics|hemostatics|mesh-ancestor
101686656|NCT03582293|Coagulants|coagulants|mesh-ancestor
101270727|NCT01822639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101686658|NCT03574337|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101686659|NCT03574337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775317|NCT00936195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101775318|NCT00936195|Antimetabolites|antimetabolites|mesh-ancestor
101686660|NCT03574337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686662|NCT03574337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101686663|NCT03574337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686664|NCT03574337|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101686665|NCT03574337|Autonomic Agents|autonomic agents|mesh-ancestor
101686666|NCT03574337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101686667|NCT02689596|Oxytocin|oxytocin|mesh-list
101686668|NCT02689596|Oxytocics|oxytocics|mesh-ancestor
101686669|NCT02689596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101686670|NCT02689596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686671|NCT04574856|Temozolomide|temozolomide|mesh-list
101686672|NCT04574856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101686673|NCT04574856|Alkylating Agents|alkylating agents|mesh-ancestor
101686674|NCT04574856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686675|NCT04574856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101686676|NCT00423995|Loratadine|loratadine|mesh-list
101686677|NCT00423995|Montelukast|montelukast|mesh-list
101686678|NCT00423995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101686679|NCT00423995|Respiratory System Agents|respiratory system agents|mesh-ancestor
101686680|NCT00423995|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101686681|NCT00423995|Hormone Antagonists|hormone antagonists|mesh-ancestor
101686682|NCT00423995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101686683|NCT00423995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343973|NCT00394368|Xhance|xhance|mesh-list
101686684|NCT00423995|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101686685|NCT00423995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101686686|NCT00423995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686687|NCT00423995|Antipruritics|antipruritics|mesh-ancestor
101686688|NCT00423995|Dermatologic Agents|dermatologic agents|mesh-ancestor
101686689|NCT00423995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101686690|NCT00423995|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101686691|NCT00423995|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101524164|NCT01959282|Niacinamide|niacinamide|mesh-list
101686692|NCT00423995|Histamine Antagonists|histamine antagonists|mesh-ancestor
101686693|NCT00423995|Histamine Agents|histamine agents|mesh-ancestor
101270908|NCT01824238|Oxazolidinones|oxazolidinones|mesh-list
101686694|NCT00423995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101686696|NCT00380627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101686697|NCT00380627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101686698|NCT00380627|Analgesics|analgesics|mesh-ancestor
101686699|NCT00380627|Sensory System Agents|sensory system agents|mesh-ancestor
101686700|NCT00380627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101686701|NCT00380627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686702|NCT00380627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101270971|NCT01824524|Narcotics|narcotics|mesh-ancestor
101270974|NCT01824524|Analgesics|analgesics|mesh-ancestor
101686703|NCT00380627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101686704|NCT00380627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101686705|NCT00380627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101686706|NCT00380627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686707|NCT00380627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686709|NCT00212771|Asenapine|asenapine|mesh-list
101686710|NCT00212771|Antiemetics|antiemetics|mesh-ancestor
101686711|NCT00212771|Autonomic Agents|autonomic agents|mesh-ancestor
101686712|NCT00212771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101686713|NCT00212771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686714|NCT00212771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101686715|NCT00212771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101686716|NCT00212771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101271036|NCT01825031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101686717|NCT00212771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101686718|NCT00212771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101686719|NCT00212771|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101686720|NCT00212771|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101686721|NCT00212771|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101686722|NCT00212771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686723|NCT00212771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101686724|NCT00212771|Serotonin Agents|serotonin agents|mesh-ancestor
101686725|NCT03842436|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101686726|NCT03842436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101686727|NCT03842436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101686728|NCT03842436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686729|NCT03842436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686730|NCT03842436|Antiviral Agents|antiviral agents|mesh-ancestor
101686731|NCT03842436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101686732|NCT03842436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101686733|NCT03842436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101686734|NCT03829722|Paclitaxel|paclitaxel|mesh-list
101686735|NCT03829722|Carboplatin|carboplatin|mesh-list
101686736|NCT03829722|Nivolumab|nivolumab|mesh-list
101271167|NCT01825850|Irbesartan|irbesartan|mesh-list
101686737|NCT03829722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101686738|NCT03829722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101686739|NCT03829722|Tubulin Modulators|tubulin modulators|mesh-ancestor
101686740|NCT03829722|Antimitotic Agents|antimitotic agents|mesh-ancestor
101686741|NCT03829722|Mitosis Modulators|mitosis modulators|mesh-ancestor
101686742|NCT03829722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524310|NCT01904409|Rifaximin|rifaximin|mesh-list
101686743|NCT03829722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101686744|NCT03829722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101686745|NCT03822312|Tobramycin|tobramycin|mesh-list
101686746|NCT03822312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101686747|NCT03822312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101686748|NCT02687178|Canrenone|canrenone|mesh-list
101271225|NCT01826253|Plasma Substitutes|plasma substitutes|mesh-ancestor
101686749|NCT02687178|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101686750|NCT02687178|Hormone Antagonists|hormone antagonists|mesh-ancestor
101686751|NCT02687178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101686752|NCT02687178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686753|NCT02687178|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101686754|NCT02687178|Diuretics|diuretics|mesh-ancestor
101686755|NCT02687178|Natriuretic Agents|natriuretic agents|mesh-ancestor
101686756|NCT03711318|Buprenorphine|buprenorphine|mesh-list
101686757|NCT03711318|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101686759|NCT03711318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101271290|NCT01827059|Bosentan|bosentan|mesh-list
101686760|NCT03711318|Narcotics|narcotics|mesh-ancestor
101686761|NCT03711318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101686762|NCT03711318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686763|NCT03711318|Analgesics|analgesics|mesh-ancestor
101686764|NCT03711318|Sensory System Agents|sensory system agents|mesh-ancestor
101524375|NCT00556023|Tremelimumab|tremelimumab|mesh-list
101686765|NCT03711318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101686766|NCT03711318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101686767|NCT03535116|Ketorolac|ketorolac|mesh-list
101686768|NCT03535116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101271350|NCT01827293|Histamine Agents|histamine agents|mesh-ancestor
101686769|NCT03535116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101686771|NCT03535116|Sensory System Agents|sensory system agents|mesh-ancestor
101686772|NCT03535116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101686773|NCT03535116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686774|NCT03535116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101686775|NCT03535116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101686776|NCT03535116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101271426|NCT01827865|Etodolac|etodolac|mesh-list
101686777|NCT03535116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686778|NCT03535116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686779|NCT03704298|Cyclophosphamide|cyclophosphamide|mesh-list
101686780|NCT03704298|Fludarabine|fludarabine|mesh-list
101686781|NCT03704298|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
101686782|NCT03704298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101686783|NCT03704298|Immunologic Factors|immunologic factors|mesh-ancestor
101686784|NCT03704298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686785|NCT03704298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101686786|NCT03704298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101686787|NCT03704298|Alkylating Agents|alkylating agents|mesh-ancestor
101686788|NCT03704298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686789|NCT03704298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101686790|NCT03704298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101686791|NCT03704298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101686792|NCT02687100|Beclomethasone|beclomethasone|mesh-list
101686793|NCT02687100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101686794|NCT02687100|Glucocorticoids|glucocorticoids|mesh-ancestor
101686795|NCT02687100|Hormones|hormones|mesh-ancestor
101271550|NCT01828606|Sodium Ionophores|sodium ionophores|mesh-ancestor
101686796|NCT02687100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101524438|NCT01825980|Ritonavir|ritonavir|mesh-list
101686797|NCT02687100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686798|NCT02687100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101686799|NCT02687100|Respiratory System Agents|respiratory system agents|mesh-ancestor
101686800|NCT05662098|Hydroxyurea|hydroxyurea|mesh-list
101686801|NCT05662098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101686802|NCT05662098|Antisickling Agents|antisickling agents|mesh-ancestor
101686803|NCT05662098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686804|NCT05662098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686805|NCT05662098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101686806|NCT02153645|Amantadine|amantadine|mesh-list
101686807|NCT02153645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101686808|NCT02153645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101686809|NCT02153645|Antiviral Agents|antiviral agents|mesh-ancestor
101686810|NCT02153645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101686811|NCT02153645|Dopamine Agents|dopamine agents|mesh-ancestor
101686812|NCT02153645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101686813|NCT02153645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409934|NCT00351715|Antitussive Agents|antitussive agents|mesh-ancestor
101686814|NCT02153645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686815|NCT02153645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101686816|NCT02153645|Analgesics|analgesics|mesh-ancestor
101686817|NCT02153645|Sensory System Agents|sensory system agents|mesh-ancestor
101686818|NCT02153645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101686819|NCT02688738|Doxycycline|doxycycline|mesh-list
101686820|NCT02688738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101686821|NCT02688738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101686822|NCT02688738|Antimalarials|antimalarials|mesh-ancestor
101686823|NCT02688738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101271619|NCT01829659|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101686824|NCT02688738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101686825|NCT00639366|Trastuzumab|trastuzumab|mesh-list
101686826|NCT00639366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101686827|NCT00639366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101686828|NCT02686788|Tarenflurbil|tarenflurbil|mesh-list
101686829|NCT02686788|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101686830|NCT02686788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101524484|NCT01818921|CKD732|ckd732|mesh-list
101686831|NCT02686788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271671|NCT01829893|Tamsulosin|tamsulosin|mesh-list
101686834|NCT02686710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101686835|NCT02686710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101686836|NCT02686710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686837|NCT02686710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101686838|NCT02686710|Anesthetics, General|anesthetics, general|mesh-ancestor
101686839|NCT02686710|Anesthetics|anesthetics|mesh-ancestor
101686840|NCT02686710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101686841|NCT02686710|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101686842|NCT01818167|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101686843|NCT01818167|Dermatologic Agents|dermatologic agents|mesh-ancestor
101686844|NCT01773083|Heparin|heparin|mesh-list
101686845|NCT01773083|Calcium heparin|calcium heparin|mesh-list
101686846|NCT01773083|Anticoagulants|anticoagulants|mesh-ancestor
101686847|NCT01773083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101686848|NCT01773083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101686849|NCT01773083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686850|NCT02354898|Sorafenib|sorafenib|mesh-list
101686851|NCT02354898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101686852|NCT02354898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101686853|NCT02354898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686854|NCT02354898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686855|NCT00110435|Atorvastatin|atorvastatin|mesh-list
101686856|NCT00110435|Simvastatin|simvastatin|mesh-list
101686857|NCT00110435|Ezetimibe|ezetimibe|mesh-list
101686858|NCT00110435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101686859|NCT00110435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101686860|NCT00110435|Antimetabolites|antimetabolites|mesh-ancestor
101686861|NCT00110435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686862|NCT00110435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101686863|NCT00110435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101686864|NCT00110435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686865|NCT00093899|Simvastatin|simvastatin|mesh-list
101686866|NCT00093899|Ezetimibe|ezetimibe|mesh-list
101271728|NCT01830907|Micronutrients|micronutrients|mesh-ancestor
101686867|NCT00093899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101686868|NCT00093899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101686869|NCT00093899|Antimetabolites|antimetabolites|mesh-ancestor
101686870|NCT00093899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686872|NCT00093899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101686873|NCT00093899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686874|NCT00092807|Ezetimibe|ezetimibe|mesh-list
101524702|NCT01712451|Fluticasone|fluticasone|mesh-list
101686876|NCT00092807|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101686877|NCT00092807|Antimetabolites|antimetabolites|mesh-ancestor
101686878|NCT00092807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686879|NCT00092807|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101686880|NCT00092729|Naproxen|naproxen|mesh-list
101686881|NCT00092729|Etoricoxib|etoricoxib|mesh-list
101686882|NCT00092729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101686883|NCT00092729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101686884|NCT00092729|Analgesics|analgesics|mesh-ancestor
101686885|NCT00092729|Sensory System Agents|sensory system agents|mesh-ancestor
101686886|NCT00092729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101686887|NCT00092729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686888|NCT00092729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101686889|NCT00092729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101686890|NCT00092729|Gout Suppressants|gout suppressants|mesh-ancestor
101686891|NCT00092729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101686892|NCT00092729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686893|NCT00092729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686894|NCT00092729|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101686895|NCT02686476|Empagliflozin|empagliflozin|mesh-list
101686896|NCT02686476|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101686897|NCT02686476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686898|NCT02686476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101686899|NCT02686476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686900|NCT04972175|Insulin Lispro|insulin lispro|mesh-list
101686901|NCT04972175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101686902|NCT04972175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686903|NCT00616382|Indomethacin|indomethacin|mesh-list
101686904|NCT00616382|Pentoxifylline|pentoxifylline|mesh-list
101686905|NCT00616382|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101686906|NCT00616382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686907|NCT00616382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686908|NCT00616382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101686909|NCT00616382|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101686910|NCT00616382|Protective Agents|protective agents|mesh-ancestor
101686911|NCT00616382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686912|NCT00616382|Vasodilator Agents|vasodilator agents|mesh-ancestor
101686913|NCT00616382|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101686914|NCT00616382|Antioxidants|antioxidants|mesh-ancestor
101686915|NCT00616382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101686916|NCT00616382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101271770|NCT01832350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101271771|NCT01832350|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101686917|NCT00616382|Analgesics|analgesics|mesh-ancestor
101271772|NCT01832350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101686918|NCT00616382|Sensory System Agents|sensory system agents|mesh-ancestor
101686919|NCT00616382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101686920|NCT00616382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101686921|NCT00616382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101686922|NCT00616382|Gout Suppressants|gout suppressants|mesh-ancestor
101686923|NCT00616382|Tocolytic Agents|tocolytic agents|mesh-ancestor
101686924|NCT00616382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101686925|NCT00616382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101686926|NCT01864746|Palbociclib|palbociclib|mesh-list
101686927|NCT01864746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101686928|NCT01864746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101686929|NCT01864746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686930|NCT01864746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686931|NCT04967573|Rivaroxaban|rivaroxaban|mesh-list
101686932|NCT04967573|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101686933|NCT04967573|Antithrombins|antithrombins|mesh-ancestor
101686934|NCT04967573|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101686935|NCT04967573|Protease Inhibitors|protease inhibitors|mesh-ancestor
101686936|NCT04967573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686937|NCT04967573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524901|NCT04547153|Docetaxel|docetaxel|mesh-list
101686938|NCT04967573|Anticoagulants|anticoagulants|mesh-ancestor
101686940|NCT04212650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101686941|NCT04212650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101686942|NCT04212650|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101686943|NCT04212650|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101686944|NCT04212650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686945|NCT02574728|Sirolimus|sirolimus|mesh-list
101686946|NCT02574728|Celecoxib|celecoxib|mesh-list
101686947|NCT02574728|Cyclophosphamide|cyclophosphamide|mesh-list
101686948|NCT02574728|Etoposide|etoposide|mesh-list
101686949|NCT02574728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101686950|NCT02574728|Immunologic Factors|immunologic factors|mesh-ancestor
101686951|NCT02574728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686952|NCT02574728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101686953|NCT02574728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101524934|NCT04658355|Povidone|povidone|mesh-list
101686954|NCT02574728|Alkylating Agents|alkylating agents|mesh-ancestor
101686955|NCT02574728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686956|NCT02574728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101686957|NCT02574728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101686958|NCT02574728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101686959|NCT02574728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101686960|NCT02574728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101686961|NCT02574728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686962|NCT02574728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101686963|NCT02574728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101686964|NCT02574728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101686965|NCT02574728|Antifungal Agents|antifungal agents|mesh-ancestor
101686966|NCT02574728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101686967|NCT02574728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101686968|NCT02574728|Analgesics|analgesics|mesh-ancestor
101686969|NCT02574728|Sensory System Agents|sensory system agents|mesh-ancestor
101686970|NCT02574728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101686971|NCT02574728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101271790|NCT01834820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101271791|NCT01834820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686972|NCT02574728|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101686973|NCT02574728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101686974|NCT00617474|Epoetin Alfa|epoetin alfa|mesh-list
101686975|NCT00617474|Hematinics|hematinics|mesh-ancestor
101686976|NCT00619034|Diclofenac|diclofenac|mesh-list
101686977|NCT00619034|Dorzolamide|dorzolamide|mesh-list
101686978|NCT00619034|Latanoprost|latanoprost|mesh-list
101686979|NCT00619034|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101686980|NCT00619034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101686981|NCT00619034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101686983|NCT00619034|Sensory System Agents|sensory system agents|mesh-ancestor
101686984|NCT00619034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101686985|NCT00619034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686986|NCT00619034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101686987|NCT00619034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101686988|NCT00619034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101686989|NCT00619034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101686990|NCT00619034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101686991|NCT00619034|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101686992|NCT00619034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101686993|NCT00619034|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101686994|NCT01614912|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
101686995|NCT01614912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101686996|NCT01614912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101686997|NCT01614912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101686998|NCT01614912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101686999|NCT01614912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101687000|NCT01614912|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101687001|NCT01614912|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101687002|NCT01614912|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101687003|NCT01614912|Adrenergic Agents|adrenergic agents|mesh-ancestor
101687004|NCT01614912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101687005|NCT01614912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687006|NCT01614912|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101687007|NCT01614912|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101687008|NCT01614912|Serotonin Agents|serotonin agents|mesh-ancestor
101687009|NCT01614912|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101687010|NCT01614912|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101687011|NCT01614912|Dopamine Agents|dopamine agents|mesh-ancestor
101687012|NCT00638742|Latanoprost|latanoprost|mesh-list
101687013|NCT00638742|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101687014|NCT00638742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101687015|NCT03512418|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101525097|NCT03813875|Anesthetics|anesthetics|mesh-ancestor
101687017|NCT03512418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101687018|NCT03512418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101687019|NCT03512418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687020|NCT03512418|Antiviral Agents|antiviral agents|mesh-ancestor
101687021|NCT03512418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101687022|NCT03512418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101687023|NCT03512418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101687024|NCT02686242|Anesthetics|anesthetics|mesh-list
101687025|NCT02686242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101687026|NCT02686242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271805|NCT01834820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101687027|NCT05661786|Antiviral Agents|antiviral agents|mesh-list
101687028|NCT05661786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101687029|NCT00639522|Paclitaxel|paclitaxel|mesh-list
101271806|NCT01834820|Respiratory System Agents|respiratory system agents|mesh-ancestor
101271808|NCT01834820|Sympathomimetics|sympathomimetics|mesh-ancestor
101271809|NCT01834820|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101271814|NCT01835418|Amlodipine|amlodipine|mesh-list
101687031|NCT00639522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101687032|NCT00639522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101687033|NCT00639522|Tubulin Modulators|tubulin modulators|mesh-ancestor
101687034|NCT00639522|Antimitotic Agents|antimitotic agents|mesh-ancestor
101687035|NCT00639522|Mitosis Modulators|mitosis modulators|mesh-ancestor
101687036|NCT00639522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687037|NCT00639522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101687038|NCT00639522|Antimetabolites|antimetabolites|mesh-ancestor
101687039|NCT00411138|Paclitaxel|paclitaxel|mesh-list
101687040|NCT00411138|Carboplatin|carboplatin|mesh-list
101687041|NCT00411138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101687042|NCT00411138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101687043|NCT00411138|Tubulin Modulators|tubulin modulators|mesh-ancestor
101687044|NCT00411138|Antimitotic Agents|antimitotic agents|mesh-ancestor
101687045|NCT00411138|Mitosis Modulators|mitosis modulators|mesh-ancestor
101687046|NCT00411138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687047|NCT02686086|Albuterol|albuterol|mesh-list
101687048|NCT02686086|Ipratropium|ipratropium|mesh-list
101687049|NCT02686086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101687050|NCT02686086|Autonomic Agents|autonomic agents|mesh-ancestor
101687051|NCT02686086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101687052|NCT02686086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687053|NCT02686086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101525156|NCT03580148|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101687054|NCT02686086|Respiratory System Agents|respiratory system agents|mesh-ancestor
101687055|NCT02686086|Tocolytic Agents|tocolytic agents|mesh-ancestor
101687056|NCT02686086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101687057|NCT02686086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101687058|NCT02686086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101687059|NCT02686086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101687060|NCT02686086|Adrenergic Agents|adrenergic agents|mesh-ancestor
101687061|NCT02686086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101687062|NCT02686086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687063|NCT02686086|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101687064|NCT02686086|Cholinergic Agents|cholinergic agents|mesh-ancestor
101687065|NCT03460158|Hyaluronic Acid|hyaluronic acid|mesh-list
101687066|NCT03460158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101687067|NCT03460158|Immunologic Factors|immunologic factors|mesh-ancestor
101687068|NCT03460158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687069|NCT03460158|Viscosupplements|viscosupplements|mesh-ancestor
101687070|NCT03460158|Protective Agents|protective agents|mesh-ancestor
101687071|NCT02697630|Pembrolizumab|pembrolizumab|mesh-list
101687072|NCT02697630|Entinostat|entinostat|mesh-list
101525192|NCT03527576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101687073|NCT02697630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101687074|NCT02697630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101687075|NCT02697630|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101687076|NCT02697630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687077|NCT02697630|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101687078|NCT02697630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101687079|NCT02685852|Exenatide|exenatide|mesh-list
101687080|NCT02685852|Acarbose|acarbose|mesh-list
101687081|NCT02685852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101687082|NCT02685852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687083|NCT02685852|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101687084|NCT02685852|Incretins|incretins|mesh-ancestor
101687085|NCT02685852|Hormones|hormones|mesh-ancestor
101687086|NCT02685852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101687087|NCT02685852|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101271819|NCT01835418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101687088|NCT02685852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101271821|NCT01835418|Vasodilator Agents|vasodilator agents|mesh-ancestor
101687089|NCT02685852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687090|NCT02697162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
101687092|NCT02697162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101687093|NCT02685930|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101409945|NCT00351871|Antimetabolites|antimetabolites|mesh-ancestor
101687094|NCT02685930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101687095|NCT02685930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101687096|NCT02685930|Antitubercular Agents|antitubercular agents|mesh-ancestor
101687098|NCT00622674|Bortezomib|bortezomib|mesh-list
101687099|NCT00622674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101687100|NCT00622674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101687101|NCT02687724|Golimumab|golimumab|mesh-list
101687102|NCT02687724|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101687103|NCT02687724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101687104|NCT02687724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101687105|NCT02687724|Immunologic Factors|immunologic factors|mesh-ancestor
101687106|NCT02687724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687107|NCT02685774|Metformin|metformin|mesh-list
101687108|NCT02685774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101687109|NCT02685774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687110|NCT00638976|Eptifibatide|eptifibatide|mesh-list
101687111|NCT00638976|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101687112|NCT00639756|Allopurinol|allopurinol|mesh-list
101687113|NCT00639756|Antimetabolites|antimetabolites|mesh-ancestor
101687114|NCT00639756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687115|NCT00639756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101687116|NCT00639756|Gout Suppressants|gout suppressants|mesh-ancestor
101687117|NCT00639756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101687118|NCT00639756|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101687119|NCT00639756|Antioxidants|antioxidants|mesh-ancestor
101687120|NCT00639756|Protective Agents|protective agents|mesh-ancestor
101687121|NCT00639756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687122|NCT00622752|Nicotine|nicotine|mesh-list
101687123|NCT00622752|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101687124|NCT00622752|Autonomic Agents|autonomic agents|mesh-ancestor
101687125|NCT00622752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101687126|NCT00622752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344429|NCT00128700|Temozolomide|temozolomide|mesh-list
101687127|NCT00622752|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101687128|NCT00622752|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101271831|NCT01835678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687129|NCT00622752|Cholinergic Agents|cholinergic agents|mesh-ancestor
101687130|NCT00622752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101687131|NCT00622752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687132|NCT03451578|alpha-MSH|alpha-msh|mesh-list
101687133|NCT03451578|Hormones|hormones|mesh-ancestor
101687134|NCT03451578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101687135|NCT03451578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687137|NCT02686008|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101687138|NCT02686008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101687139|NCT02686008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687140|NCT02686008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101687141|NCT02685618|Iloprost|iloprost|mesh-list
101687142|NCT02685618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101687143|NCT02685618|Vasodilator Agents|vasodilator agents|mesh-ancestor
101687144|NCT00602472|Linagliptin|linagliptin|mesh-list
101687145|NCT00602472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101687146|NCT00602472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687147|NCT00602472|Incretins|incretins|mesh-ancestor
101687148|NCT00602472|Hormones|hormones|mesh-ancestor
101687149|NCT00602472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101687150|NCT00602472|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101687151|NCT00602472|Protease Inhibitors|protease inhibitors|mesh-ancestor
101687152|NCT00602472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101687153|NCT00602472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687154|NCT03384654|Cytarabine|cytarabine|mesh-list
101687155|NCT03384654|Prednisone|prednisone|mesh-list
101687156|NCT03384654|Cyclophosphamide|cyclophosphamide|mesh-list
101687157|NCT03384654|Doxorubicin|doxorubicin|mesh-list
101687159|NCT03384654|Vincristine|vincristine|mesh-list
101687160|NCT03384654|Asparaginase|asparaginase|mesh-list
101687161|NCT03384654|Mercaptopurine|mercaptopurine|mesh-list
101687162|NCT03384654|Daratumumab|daratumumab|mesh-list
101687163|NCT03384654|Pegaspargase|pegaspargase|mesh-list
101687164|NCT03384654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101687165|NCT03384654|Immunologic Factors|immunologic factors|mesh-ancestor
101687166|NCT03384654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687167|NCT03384654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101687168|NCT03384654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101687169|NCT03384654|Alkylating Agents|alkylating agents|mesh-ancestor
101687170|NCT03384654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687171|NCT03384654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101687172|NCT03384654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101687173|NCT03384654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101687174|NCT03384654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101687175|NCT03384654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101687176|NCT03384654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101687177|NCT03384654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101687178|NCT03384654|Glucocorticoids|glucocorticoids|mesh-ancestor
101687179|NCT03384654|Hormones|hormones|mesh-ancestor
101775319|NCT00936195|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101687180|NCT03384654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101687181|NCT03384654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101687182|NCT03384654|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101687183|NCT03384654|Abortifacient Agents|abortifacient agents|mesh-ancestor
101687184|NCT03384654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101271860|NCT01837290|Sensory System Agents|sensory system agents|mesh-ancestor
101271861|NCT01837290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101687185|NCT03384654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101687186|NCT03384654|Antimetabolites|antimetabolites|mesh-ancestor
101687187|NCT03384654|Dermatologic Agents|dermatologic agents|mesh-ancestor
101687188|NCT03384654|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101687189|NCT03384654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101687190|NCT03384654|Antiviral Agents|antiviral agents|mesh-ancestor
101687191|NCT03384654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101687192|NCT03384654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101687193|NCT03384654|Tubulin Modulators|tubulin modulators|mesh-ancestor
101687194|NCT03384654|Antimitotic Agents|antimitotic agents|mesh-ancestor
101687195|NCT03384654|Mitosis Modulators|mitosis modulators|mesh-ancestor
101687196|NCT02685462|Digoxin|digoxin|mesh-list
101687197|NCT02685462|Caffeine|caffeine|mesh-list
101687198|NCT02685462|Atorvastatin|atorvastatin|mesh-list
101687199|NCT02685462|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101687200|NCT02685462|Simvastatin|simvastatin|mesh-list
101687201|NCT02685462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101687202|NCT02685462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101687203|NCT02685462|Antimetabolites|antimetabolites|mesh-ancestor
101687204|NCT02685462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344506|NCT00017654|Antiemetics|antiemetics|mesh-ancestor
101687205|NCT02685462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101687206|NCT02685462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101687207|NCT02685462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101687208|NCT02685462|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101525722|NCT00538811|Dopamine Agents|dopamine agents|mesh-ancestor
101687209|NCT02685462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687210|NCT02685462|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101687211|NCT02685462|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101687212|NCT02685462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101687213|NCT02685462|Purinergic Agents|purinergic agents|mesh-ancestor
101687214|NCT02685462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101687215|NCT02685462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101687216|NCT02685462|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101687217|NCT02685462|Protective Agents|protective agents|mesh-ancestor
101687219|NCT02685306|Taxane|taxane|mesh-list
101687220|NCT02685306|Bavituximab|bavituximab|mesh-list
101687221|NCT02685306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101687222|NCT02685306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101687223|NCT02685306|Tubulin Modulators|tubulin modulators|mesh-ancestor
101687224|NCT02685306|Antimitotic Agents|antimitotic agents|mesh-ancestor
101687225|NCT02685306|Mitosis Modulators|mitosis modulators|mesh-ancestor
101687226|NCT02685306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687227|NCT02685306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101687228|NCT02680938|Oxytocin|oxytocin|mesh-list
101687229|NCT02680938|Oxytocics|oxytocics|mesh-ancestor
101687230|NCT02680938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101687231|NCT02680938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687232|NCT05663892|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101687233|NCT05663892|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101687234|NCT05663892|Estradiol|estradiol|mesh-list
101687235|NCT05663892|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101687236|NCT05663892|Estrogens|estrogens|mesh-ancestor
101687237|NCT05663892|Hormones|hormones|mesh-ancestor
101687238|NCT05663892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101687239|NCT05663892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687240|NCT05663892|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101687241|NCT05663892|Contraceptive Agents|contraceptive agents|mesh-ancestor
101687242|NCT05663892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101271883|NCT01837433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101687243|NCT05663892|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101687244|NCT02685228|Gemcitabine|gemcitabine|mesh-list
101687245|NCT02685228|Decitabine|decitabine|mesh-list
101687246|NCT02685228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101687247|NCT02685228|Antimetabolites|antimetabolites|mesh-ancestor
101687248|NCT02685228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687249|NCT02685228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101687250|NCT02685228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101687251|NCT00616460|Bivalirudin|bivalirudin|mesh-list
101687252|NCT00616460|Antithrombins|antithrombins|mesh-ancestor
101687253|NCT00616460|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101687254|NCT00616460|Protease Inhibitors|protease inhibitors|mesh-ancestor
101687255|NCT00616460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101687256|NCT00616460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687257|NCT00616460|Anticoagulants|anticoagulants|mesh-ancestor
101687258|NCT00616538|Fluticasone|fluticasone|mesh-list
101687259|NCT00616538|Xhance|xhance|mesh-list
101687260|NCT00616538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101687261|NCT00616538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101687262|NCT00616538|Autonomic Agents|autonomic agents|mesh-ancestor
101687263|NCT00616538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101687264|NCT00616538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687265|NCT00616538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101687266|NCT00616538|Respiratory System Agents|respiratory system agents|mesh-ancestor
101687267|NCT00616538|Dermatologic Agents|dermatologic agents|mesh-ancestor
101687268|NCT00616538|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101687269|NCT02680548|Methylprednisolone|methylprednisolone|mesh-list
101687270|NCT02680548|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101687271|NCT02680548|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101687272|NCT02680548|Prednisolone|prednisolone|mesh-list
101687273|NCT02680548|Prednisolone acetate|prednisolone acetate|mesh-list
101687274|NCT02680548|Bupivacaine|bupivacaine|mesh-list
101687275|NCT02680548|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101687276|NCT02680548|Prednisolone phosphate|prednisolone phosphate|mesh-list
101687277|NCT02680548|Anesthetics, Local|anesthetics, local|mesh-ancestor
101344576|NCT00018642|Antiemetics|antiemetics|mesh-ancestor
101687278|NCT02680548|Anesthetics|anesthetics|mesh-ancestor
101687279|NCT02680548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101687280|NCT02680548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687281|NCT02680548|Sensory System Agents|sensory system agents|mesh-ancestor
101687282|NCT02680548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101687283|NCT02680548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101687285|NCT02680548|Autonomic Agents|autonomic agents|mesh-ancestor
101687286|NCT02680548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101687287|NCT02680548|Glucocorticoids|glucocorticoids|mesh-ancestor
101687288|NCT02680548|Hormones|hormones|mesh-ancestor
101687289|NCT02680548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101687290|NCT02680548|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101687291|NCT02680548|Protective Agents|protective agents|mesh-ancestor
101687292|NCT02680548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101687293|NCT02680548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101687294|NCT05663736|Glimepiride|glimepiride|mesh-list
101687295|NCT05663736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101687296|NCT05663736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101687297|NCT05663736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687298|NCT05663736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101687299|NCT05663736|Immunologic Factors|immunologic factors|mesh-ancestor
101687300|NCT02685150|Omeprazole|omeprazole|mesh-list
101687301|NCT02685150|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101687302|NCT02685150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101271898|NCT01837446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101687303|NCT02685150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101687304|NCT02685150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101271899|NCT01837446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101271904|NCT01837446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101687305|NCT02685150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687306|NCT02682186|Ropivacaine|ropivacaine|mesh-list
101687307|NCT02682186|Anesthetics, Local|anesthetics, local|mesh-ancestor
101687308|NCT02682186|Anesthetics|anesthetics|mesh-ancestor
101525994|NCT04659525|Ezetimibe|ezetimibe|mesh-list
101687309|NCT02682186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101687310|NCT02682186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687311|NCT02682186|Sensory System Agents|sensory system agents|mesh-ancestor
101687312|NCT02682186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101687314|NCT00619268|Interferon-alpha|interferon-alpha|mesh-list
101687315|NCT00619268|Interferon alpha-2|interferon alpha-2|mesh-list
101687316|NCT00619268|Sirolimus|sirolimus|mesh-list
101687317|NCT00619268|Bevacizumab|bevacizumab|mesh-list
101687318|NCT00619268|Sunitinib|sunitinib|mesh-list
101687319|NCT00619268|Temsirolimus|temsirolimus|mesh-list
101687320|NCT00619268|MTOR Inhibitors|mtor inhibitors|mesh-list
101687321|NCT00619268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101687322|NCT00619268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101687323|NCT00619268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101687324|NCT00619268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101687325|NCT00619268|Growth Substances|growth substances|mesh-ancestor
101687326|NCT00619268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687327|NCT00619268|Growth Inhibitors|growth inhibitors|mesh-ancestor
101687328|NCT00619268|Antiviral Agents|antiviral agents|mesh-ancestor
101687329|NCT00619268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101687330|NCT00619268|Immunologic Factors|immunologic factors|mesh-ancestor
101687331|NCT00619268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101687332|NCT00619268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101687333|NCT00619268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687334|NCT00619268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101687335|NCT00619268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101687336|NCT00619268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101687337|NCT00619268|Antifungal Agents|antifungal agents|mesh-ancestor
101687338|NCT00619346|Pafuramidine|pafuramidine|mesh-list
101687339|NCT00619346|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101687340|NCT00619346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101687341|NCT00619346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101687342|NCT00619346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101687343|NCT04182828|Lidocaine|lidocaine|mesh-list
101687344|NCT04182828|Anesthetics, Local|anesthetics, local|mesh-ancestor
101687345|NCT04182828|Anesthetics|anesthetics|mesh-ancestor
101687346|NCT04182828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101687347|NCT04182828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687348|NCT04182828|Sensory System Agents|sensory system agents|mesh-ancestor
101687349|NCT04182828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101687350|NCT04182828|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101687351|NCT04182828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101687352|NCT04182828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101687353|NCT04182828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101687354|NCT04182828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687355|NCT00619424|Pemetrexed|pemetrexed|mesh-list
101687356|NCT00619424|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101687357|NCT00619424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101687358|NCT00619424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101687359|NCT00619424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687360|NCT00619424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101687361|NCT00619424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101687362|NCT00619424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101687363|NCT00641004|Esomeprazole|esomeprazole|mesh-list
101687364|NCT00641004|Rebamipide|rebamipide|mesh-list
101687365|NCT00641004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101687366|NCT00641004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101687367|NCT00641004|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101687368|NCT00641004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101271911|NCT01837446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101687369|NCT00641004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687370|NCT00641004|Antioxidants|antioxidants|mesh-ancestor
101687371|NCT00641004|Protective Agents|protective agents|mesh-ancestor
101687372|NCT00641004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687373|NCT02680080|Moxifloxacin|moxifloxacin|mesh-list
101687374|NCT02680080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101687375|NCT02680080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101687376|NCT02680080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101526142|NCT00542555|Naproxen|naproxen|mesh-list
101687377|NCT02680080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101687378|NCT02680080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101687379|NCT02680080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687381|NCT01009788|Temozolomide|temozolomide|mesh-list
101687382|NCT01009788|Veliparib|veliparib|mesh-list
101687383|NCT01009788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101687384|NCT01009788|Alkylating Agents|alkylating agents|mesh-ancestor
101687385|NCT01009788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687386|NCT01009788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101687387|NCT01009788|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101687388|NCT01009788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101687389|NCT04183608|Adalimumab|adalimumab|mesh-list
101687390|NCT04183608|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101687391|NCT04183608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101687392|NCT04183608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101687393|NCT00641082|Adefovir|adefovir|mesh-list
101687394|NCT00641082|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101687395|NCT00641082|Clevudine|clevudine|mesh-list
101687396|NCT00641082|Antiviral Agents|antiviral agents|mesh-ancestor
101687397|NCT00641082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101687398|NCT00641082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101687399|NCT00641082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101687400|NCT00641082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101687401|NCT00641082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687402|NCT00641160|Vinorelbine|vinorelbine|mesh-list
101687403|NCT00641160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101687404|NCT00641160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101687405|NCT00641160|Tubulin Modulators|tubulin modulators|mesh-ancestor
101687406|NCT00641160|Antimitotic Agents|antimitotic agents|mesh-ancestor
101687407|NCT00641160|Mitosis Modulators|mitosis modulators|mesh-ancestor
101687408|NCT00641160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687409|NCT02679924|Hyaluronic Acid|hyaluronic acid|mesh-list
101687410|NCT02679924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101687411|NCT02679924|Immunologic Factors|immunologic factors|mesh-ancestor
101687412|NCT02679924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687413|NCT02679924|Viscosupplements|viscosupplements|mesh-ancestor
101687414|NCT02679924|Protective Agents|protective agents|mesh-ancestor
101687415|NCT00618176|Lamivudine|lamivudine|mesh-list
101687416|NCT00618176|Zidovudine|zidovudine|mesh-list
101687417|NCT00618176|Nevirapine|nevirapine|mesh-list
101687418|NCT00618176|Didanosine|didanosine|mesh-list
101687419|NCT00618176|Stavudine|stavudine|mesh-list
101687420|NCT00618176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101687421|NCT00618176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101687422|NCT00618176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101687423|NCT00618176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687425|NCT00618176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101687426|NCT00618176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101687427|NCT00618176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101687428|NCT00618176|Antimetabolites|antimetabolites|mesh-ancestor
101687429|NCT00618176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101687430|NCT00618176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101687431|NCT04211558|Ozanimod|ozanimod|mesh-list
101687432|NCT04211558|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101687433|NCT04211558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687435|NCT04211558|Immunologic Factors|immunologic factors|mesh-ancestor
101687436|NCT04211558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101271921|NCT01837446|Antacids|antacids|mesh-ancestor
101687437|NCT05048498|Azacitidine|azacitidine|mesh-list
101687438|NCT05048498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101687439|NCT05048498|Antimetabolites|antimetabolites|mesh-ancestor
101687440|NCT05048498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687441|NCT05048498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101687442|NCT05048498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101687443|NCT00901901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101687444|NCT00901901|Sorafenib|sorafenib|mesh-list
101687445|NCT00901901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101687446|NCT00901901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101687447|NCT00901901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101687448|NCT00901901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687449|NCT00618254|Granisetron|granisetron|mesh-list
101687450|NCT00618254|Antiemetics|antiemetics|mesh-ancestor
101687451|NCT00618254|Autonomic Agents|autonomic agents|mesh-ancestor
101687452|NCT00618254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101687453|NCT00618254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687454|NCT00618254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101687455|NCT00618254|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101687456|NCT00618254|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101687457|NCT00618254|Serotonin Agents|serotonin agents|mesh-ancestor
101687458|NCT00618254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101687459|NCT00618254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687460|NCT04184466|Insulin|insulin|mesh-list
101687461|NCT04184466|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101687462|NCT04184466|Insulin Aspart|insulin aspart|mesh-list
101687463|NCT04184466|Insulin, Long-Acting|insulin, long-acting|mesh-list
101687464|NCT04184466|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101687465|NCT04184466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101687466|NCT04184466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687467|NCT04201769|Dexamethasone|dexamethasone|mesh-list
101687468|NCT04201769|Palonosetron|palonosetron|mesh-list
101687469|NCT04201769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101687470|NCT04201769|Antiemetics|antiemetics|mesh-ancestor
101687471|NCT04201769|Autonomic Agents|autonomic agents|mesh-ancestor
101687472|NCT04201769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101687473|NCT04201769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687474|NCT04201769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101687475|NCT04201769|Glucocorticoids|glucocorticoids|mesh-ancestor
101687476|NCT04201769|Hormones|hormones|mesh-ancestor
101687477|NCT04201769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101687478|NCT04201769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101687479|NCT04201769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101687480|NCT04201769|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101687481|NCT04201769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101687482|NCT04201769|Serotonin Agents|serotonin agents|mesh-ancestor
101687483|NCT04201769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101687484|NCT04201769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687485|NCT05336825|Lidocaine|lidocaine|mesh-list
101687486|NCT05336825|Anesthetics, Local|anesthetics, local|mesh-ancestor
101687487|NCT05336825|Anesthetics|anesthetics|mesh-ancestor
101687488|NCT05336825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101687489|NCT05336825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687490|NCT05336825|Sensory System Agents|sensory system agents|mesh-ancestor
101687491|NCT05336825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101687492|NCT05336825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101271931|NCT01839344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101271932|NCT01839344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101687493|NCT05336825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101687494|NCT05336825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101687495|NCT05336825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101687496|NCT05336825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687498|NCT04748783|Chlorhexidine|chlorhexidine|mesh-list
101687499|NCT04748783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101687500|NCT04748783|Hydrogen Peroxide|hydrogen peroxide|mesh-list
101687501|NCT04748783|Sodium Fluoride|sodium fluoride|mesh-list
101687502|NCT04748783|Cariostatic Agents|cariostatic agents|mesh-ancestor
101687503|NCT04748783|Protective Agents|protective agents|mesh-ancestor
101687504|NCT04748783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687505|NCT04748783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101687506|NCT04748783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101687507|NCT04748783|Disinfectants|disinfectants|mesh-ancestor
101687508|NCT04748783|Dermatologic Agents|dermatologic agents|mesh-ancestor
101687509|NCT02777580|Tenecteplase|tenecteplase|mesh-list
101687510|NCT02777580|Clopidogrel|clopidogrel|mesh-list
101687511|NCT02777580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101687512|NCT02777580|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101687513|NCT02777580|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101687514|NCT02777580|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101526475|NCT00544505|Antimetabolites|antimetabolites|mesh-ancestor
101687516|NCT02777580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101687517|NCT02777580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687518|NCT02777580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687519|NCT02777580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101687520|NCT02777580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101687521|NCT04628663|Dexmedetomidine|dexmedetomidine|mesh-list
101687522|NCT04628663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101687523|NCT04628663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101687524|NCT04628663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687525|NCT04628663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101687526|NCT04628663|Analgesics|analgesics|mesh-ancestor
101687527|NCT04628663|Sensory System Agents|sensory system agents|mesh-ancestor
101687528|NCT04628663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101687529|NCT04628663|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101687530|NCT04628663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101409947|NCT00351871|Antiviral Agents|antiviral agents|mesh-ancestor
101687531|NCT04628663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101687532|NCT04628663|Adrenergic Agents|adrenergic agents|mesh-ancestor
101687533|NCT04628663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101271947|NCT01840189|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101271948|NCT01840189|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101687534|NCT04628663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687535|NCT05663268|Infliximab|infliximab|mesh-list
101687536|NCT05663268|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101687537|NCT05663268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101687538|NCT05663268|Dermatologic Agents|dermatologic agents|mesh-ancestor
101687539|NCT05663268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101687540|NCT05663268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101687541|NCT02822027|gamma-Globulins|gamma-globulins|mesh-list
101687542|NCT02822027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101687543|NCT02822027|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101687544|NCT02822027|Immunologic Factors|immunologic factors|mesh-ancestor
101687545|NCT02822027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687546|NCT00642096|Metoprolol|metoprolol|mesh-list
101687547|NCT00642096|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101271977|NCT01840423|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101271978|NCT01840423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101687548|NCT00642096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101687549|NCT00642096|Diuretics|diuretics|mesh-ancestor
101687550|NCT00642096|Natriuretic Agents|natriuretic agents|mesh-ancestor
101687551|NCT00642096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687552|NCT00642096|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101687553|NCT00642096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101526574|NCT05822713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101687554|NCT00642096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687555|NCT00642096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101687556|NCT00642096|Sympatholytics|sympatholytics|mesh-ancestor
101687557|NCT00642096|Autonomic Agents|autonomic agents|mesh-ancestor
101687558|NCT00642096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101687559|NCT00642096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101687560|NCT00642096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101687561|NCT00642096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101687562|NCT00642096|Adrenergic Agents|adrenergic agents|mesh-ancestor
101687563|NCT00642096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101687564|NCT05336513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101687565|NCT02679456|Fluconazole|fluconazole|mesh-list
101687566|NCT02679456|Ibrexafungerp|ibrexafungerp|mesh-list
101687568|NCT02679456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101687569|NCT02679456|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101687570|NCT02679456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101687571|NCT02679456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101687572|NCT02679456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687573|NCT02679456|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101687574|NCT02679456|Hormone Antagonists|hormone antagonists|mesh-ancestor
101687575|NCT02679456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101687576|NCT02679456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687577|NCT02679456|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101687578|NCT02679456|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101687579|NCT00640458|Sildenafil Citrate|sildenafil citrate|mesh-list
101687580|NCT00640458|Vasodilator Agents|vasodilator agents|mesh-ancestor
101272165|NCT01841775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101687581|NCT00640458|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101687582|NCT00640458|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101687583|NCT00640458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101687584|NCT00640458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687585|NCT00640458|Urological Agents|urological agents|mesh-ancestor
101687586|NCT00909948|Fludarabine|fludarabine|mesh-list
101687587|NCT00909948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101687588|NCT02681562|Olaparib|olaparib|mesh-list
101687589|NCT02681562|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101272225|NCT01842230|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101687590|NCT02681562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101687591|NCT02681562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526638|NCT05780567|Hormone Antagonists|hormone antagonists|mesh-ancestor
101687592|NCT02681562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101687593|NCT00633035|Esomeprazole|esomeprazole|mesh-list
101687594|NCT00633035|Famotidine|famotidine|mesh-list
101687595|NCT00633035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101687596|NCT00633035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101526671|NCT05728294|Ropivacaine|ropivacaine|mesh-list
101687597|NCT00633035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101687598|NCT00633035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775320|NCT00936195|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101272283|NCT01842373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101687599|NCT00633035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687600|NCT00633035|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101687601|NCT00633035|Histamine Antagonists|histamine antagonists|mesh-ancestor
101687602|NCT00633035|Histamine Agents|histamine agents|mesh-ancestor
101687603|NCT00633035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101687604|NCT00633035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687607|NCT02511132|Irinotecan|irinotecan|mesh-list
101687608|NCT02511132|Temozolomide|temozolomide|mesh-list
101272352|NCT01843127|Hormones|hormones|mesh-ancestor
101687609|NCT02511132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101687610|NCT02511132|Antimetabolites|antimetabolites|mesh-ancestor
101687611|NCT02511132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687612|NCT02511132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101687613|NCT02511132|Tubulin Modulators|tubulin modulators|mesh-ancestor
101687614|NCT02511132|Antimitotic Agents|antimitotic agents|mesh-ancestor
101687615|NCT02511132|Mitosis Modulators|mitosis modulators|mesh-ancestor
101687616|NCT02511132|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101687617|NCT02511132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101687618|NCT02511132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101687619|NCT02511132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101687620|NCT02511132|Alkylating Agents|alkylating agents|mesh-ancestor
101687622|NCT02678520|Bicalutamide|bicalutamide|mesh-list
101527101|NCT04293562|Cytarabine|cytarabine|mesh-list
101687623|NCT02678520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101687624|NCT02678520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687625|NCT02678520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101687626|NCT02678520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101687627|NCT02678520|Androgen Antagonists|androgen antagonists|mesh-ancestor
101687629|NCT00642252|Fluorides|fluorides|mesh-list
101687630|NCT00642252|Cariostatic Agents|cariostatic agents|mesh-ancestor
101272480|NCT01843829|Antimitotic Agents|antimitotic agents|mesh-ancestor
101272485|NCT01843868|Prednisolone|prednisolone|mesh-list
101687631|NCT00642252|Protective Agents|protective agents|mesh-ancestor
101687632|NCT00642252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687633|NCT00642330|Ibuprofen|ibuprofen|mesh-list
101687634|NCT00642330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101687635|NCT00642330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101687636|NCT00642330|Analgesics|analgesics|mesh-ancestor
101687637|NCT00642330|Sensory System Agents|sensory system agents|mesh-ancestor
101687638|NCT00642330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101687639|NCT00642330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687640|NCT00642330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101527467|NCT00521222|Xhance|xhance|mesh-list
101687641|NCT00642330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101687642|NCT00642330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101687643|NCT00642330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101687644|NCT00642330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687645|NCT02681796|Bupivacaine|bupivacaine|mesh-list
101687646|NCT02681796|Anesthetics, Local|anesthetics, local|mesh-ancestor
101687647|NCT02681796|Anesthetics|anesthetics|mesh-ancestor
101687648|NCT02681796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101687649|NCT02681796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687650|NCT02681796|Sensory System Agents|sensory system agents|mesh-ancestor
101687651|NCT02681796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101527615|NCT04645914|Nicotine|nicotine|mesh-list
101687653|NCT02842931|Cyclophosphamide|cyclophosphamide|mesh-list
101687654|NCT02842931|Doxorubicin|doxorubicin|mesh-list
101687655|NCT02842931|Etoposide|etoposide|mesh-list
101687656|NCT02842931|Vincristine|vincristine|mesh-list
101687657|NCT02842931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101687658|NCT02842931|Immunologic Factors|immunologic factors|mesh-ancestor
101687659|NCT02842931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687661|NCT02842931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101687662|NCT02842931|Alkylating Agents|alkylating agents|mesh-ancestor
101527825|NCT00548561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687663|NCT02842931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687664|NCT02842931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101687665|NCT02842931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101272548|NCT01843998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101687666|NCT02842931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101272557|NCT01844024|Misoprostol|misoprostol|mesh-list
101687667|NCT02842931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101687668|NCT02842931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101687669|NCT02842931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101687670|NCT02842931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101687671|NCT02842931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101687672|NCT02842931|Glucocorticoids|glucocorticoids|mesh-ancestor
101687673|NCT02842931|Hormones|hormones|mesh-ancestor
101687674|NCT02842931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101687675|NCT02842931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101687676|NCT02842931|Tubulin Modulators|tubulin modulators|mesh-ancestor
101687677|NCT02842931|Antimitotic Agents|antimitotic agents|mesh-ancestor
101687678|NCT02842931|Mitosis Modulators|mitosis modulators|mesh-ancestor
101687679|NCT04183296|Propofol|propofol|mesh-list
101687681|NCT04183296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101687682|NCT04183296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101687683|NCT04183296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687684|NCT04183296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101687685|NCT04183296|Anesthetics, General|anesthetics, general|mesh-ancestor
101687686|NCT04183296|Anesthetics|anesthetics|mesh-ancestor
101223396|NCT01518101|Metformin|metformin|mesh-list
101687687|NCT04183296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101687688|NCT04183296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101687689|NCT00642408|Micronutrients|micronutrients|mesh-list
101687690|NCT00642408|Trace Elements|trace elements|mesh-list
101687691|NCT00642408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687692|NCT02678598|Micafungin|micafungin|mesh-list
101687693|NCT02678598|Antifungal Agents|antifungal agents|mesh-ancestor
101687694|NCT02678598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101687695|NCT02359019|Pembrolizumab|pembrolizumab|mesh-list
101687696|NCT02359019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101223761|NCT01520103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101687697|NCT02359019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101687698|NCT02359019|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101687699|NCT02359019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687700|NCT02678364|Vitamin D|vitamin d|mesh-list
101687701|NCT02678364|Cholecalciferol|cholecalciferol|mesh-list
101687702|NCT02678364|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
101687703|NCT02678364|Calcifediol|calcifediol|mesh-list
101687704|NCT02678364|Vitamins|vitamins|mesh-ancestor
101687705|NCT02678364|Micronutrients|micronutrients|mesh-ancestor
101687706|NCT02678364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687707|NCT02678364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101687708|NCT02678364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101687709|NCT02678208|Tranexamic Acid|tranexamic acid|mesh-list
101687710|NCT02678208|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101687711|NCT02678208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101224045|NCT01521975|Adefovir|adefovir|mesh-list
101687712|NCT02678208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687713|NCT02678208|Hemostatics|hemostatics|mesh-ancestor
101687715|NCT05551182|Nicergoline|nicergoline|mesh-list
101687716|NCT05551182|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101687717|NCT05551182|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101687718|NCT05551182|Adrenergic Agents|adrenergic agents|mesh-ancestor
101687719|NCT05551182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101687720|NCT05551182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687721|NCT05551182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687722|NCT05551182|Vasodilator Agents|vasodilator agents|mesh-ancestor
101272586|NCT01844401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687723|NCT05551182|Nootropic Agents|nootropic agents|mesh-ancestor
101687724|NCT02677584|Caffeine|caffeine|mesh-list
101687725|NCT02677584|Caffeine citrate|caffeine citrate|mesh-list
101687726|NCT02677584|Citric Acid|citric acid|mesh-list
101687727|NCT02677584|Sodium Citrate|sodium citrate|mesh-list
101272587|NCT01844401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101687728|NCT02677584|Anticoagulants|anticoagulants|mesh-ancestor
101345021|NCT00020943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101224550|NCT01524497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101687729|NCT02677584|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101687730|NCT02677584|Chelating Agents|chelating agents|mesh-ancestor
101687731|NCT02677584|Sequestering Agents|sequestering agents|mesh-ancestor
101687732|NCT02677584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687733|NCT02677584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101687734|NCT02677584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687735|NCT02677584|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101687736|NCT02677584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101687737|NCT02677584|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101687738|NCT02677584|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101687739|NCT02677584|Purinergic Agents|purinergic agents|mesh-ancestor
101224628|NCT01524757|Pantoprazole|pantoprazole|mesh-list
101687740|NCT02677584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101687741|NCT05662956|Azacitidine|azacitidine|mesh-list
101687742|NCT05662956|Venetoclax|venetoclax|mesh-list
101687743|NCT05662956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101687744|NCT05662956|Antimetabolites|antimetabolites|mesh-ancestor
101687745|NCT05662956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687746|NCT05662956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101224692|NCT01525537|Sufentanil|sufentanil|mesh-list
101687747|NCT05662956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101687749|NCT02838173|Anesthetics, Local|anesthetics, local|mesh-ancestor
101687750|NCT02838173|Anesthetics|anesthetics|mesh-ancestor
101687751|NCT02838173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101224838|NCT01526278|Alendronate|alendronate|mesh-list
101687752|NCT02838173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687753|NCT02838173|Sensory System Agents|sensory system agents|mesh-ancestor
101687754|NCT02838173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101687755|NCT00641472|Budesonide|budesonide|mesh-list
101687756|NCT00641472|Montelukast|montelukast|mesh-list
101687758|NCT00641472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101687759|NCT00641472|Autonomic Agents|autonomic agents|mesh-ancestor
101687760|NCT00641472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101687761|NCT00641472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687762|NCT00641472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101687763|NCT00641472|Respiratory System Agents|respiratory system agents|mesh-ancestor
101687764|NCT00641472|Glucocorticoids|glucocorticoids|mesh-ancestor
101687765|NCT00641472|Hormones|hormones|mesh-ancestor
101775321|NCT00936195|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101687766|NCT00641472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101687768|NCT00641472|Hormone Antagonists|hormone antagonists|mesh-ancestor
101687769|NCT00641472|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101687770|NCT00641472|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101687771|NCT00641472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687772|NCT00896051|Ritonavir|ritonavir|mesh-list
101687773|NCT00896051|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101687774|NCT00896051|Tenofovir|tenofovir|mesh-list
101687775|NCT00896051|Etravirine|etravirine|mesh-list
101687776|NCT00896051|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
101687777|NCT00896051|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101687778|NCT00896051|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101687779|NCT00896051|Protease Inhibitors|protease inhibitors|mesh-ancestor
101687780|NCT00896051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775322|NCT00936195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101687781|NCT00896051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687782|NCT00896051|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101687783|NCT00896051|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101687784|NCT00896051|Antiviral Agents|antiviral agents|mesh-ancestor
101687785|NCT00896051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101272598|NCT01844427|Memantine|memantine|mesh-list
101272599|NCT01844427|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101272600|NCT01844427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101687786|NCT00896051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101687787|NCT00896051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101687788|NCT00896051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101687789|NCT02673606|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101687790|NCT02673606|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101687792|NCT02673606|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101687794|NCT02673606|Hormones|hormones|mesh-ancestor
101687795|NCT02673606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101687796|NCT02673606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687797|NCT02673606|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101687798|NCT02673606|Contraceptive Agents|contraceptive agents|mesh-ancestor
101687799|NCT02673606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101687800|NCT02673606|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101687801|NCT02675400|Methylphenidate|methylphenidate|mesh-list
101226054|NCT01532297|Dialysis Solutions|dialysis solutions|mesh-list
101687802|NCT02675400|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101687803|NCT02675400|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101687804|NCT02675400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226133|NCT01532895|Hydromorphone|hydromorphone|mesh-list
101687805|NCT02675400|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101687806|NCT02675400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101687807|NCT02675400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101687808|NCT02675400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687809|NCT02675400|Dopamine Agents|dopamine agents|mesh-ancestor
101687810|NCT02675400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101687812|NCT00894647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101687813|NCT00894647|Immunologic Factors|immunologic factors|mesh-ancestor
101687814|NCT00894647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687815|NCT00894647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101687816|NCT00894647|Interferon Inducers|interferon inducers|mesh-ancestor
101687818|NCT02839421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101687819|NCT02839421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101226498|NCT01534949|Rituximab|rituximab|mesh-list
101687820|NCT02839421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101687821|NCT02839421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101687822|NCT02839421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101687823|NCT02839421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687824|NCT02839421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101687826|NCT02841839|Tin Fluorides|tin fluorides|mesh-list
101687827|NCT02841839|Cariostatic Agents|cariostatic agents|mesh-ancestor
101687828|NCT02841839|Protective Agents|protective agents|mesh-ancestor
101687829|NCT02841839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687830|NCT04179942|Nitric Oxide|nitric oxide|mesh-list
101687831|NCT04179942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101687832|NCT04179942|Autonomic Agents|autonomic agents|mesh-ancestor
101687833|NCT04179942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101687834|NCT04179942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687835|NCT04179942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101687836|NCT04179942|Respiratory System Agents|respiratory system agents|mesh-ancestor
101687837|NCT04179942|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101687838|NCT04179942|Antioxidants|antioxidants|mesh-ancestor
101687839|NCT04179942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687840|NCT04179942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101687841|NCT04179942|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101687842|NCT04179942|Vasodilator Agents|vasodilator agents|mesh-ancestor
101687843|NCT04179942|Gasotransmitters|gasotransmitters|mesh-ancestor
101687844|NCT04179942|Protective Agents|protective agents|mesh-ancestor
101687846|NCT04250831|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
101687847|NCT04250831|Trace Elements|trace elements|mesh-ancestor
101687848|NCT04250831|Micronutrients|micronutrients|mesh-ancestor
101272617|NCT01844635|Thymoglobulin|thymoglobulin|mesh-list
101687849|NCT04250831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687850|NCT04250831|Cathartics|cathartics|mesh-ancestor
101687851|NCT04250831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101687852|NCT00633191|Immunomodulating Agents|immunomodulating agents|mesh-list
101687853|NCT00633191|Immunologic Factors|immunologic factors|mesh-ancestor
101687854|NCT00633191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687855|NCT00643500|Levetiracetam|levetiracetam|mesh-list
101687856|NCT00643500|Anticonvulsants|anticonvulsants|mesh-ancestor
101687857|NCT00643500|Nootropic Agents|nootropic agents|mesh-ancestor
101687858|NCT02837081|Anti-Infective Agents|anti-infective agents|mesh-list
101687860|NCT00633269|Olaparib|olaparib|mesh-list
101227202|NCT01538875|Adrenergic Agents|adrenergic agents|mesh-ancestor
101687861|NCT00633269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101775323|NCT00936195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101687863|NCT00633269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687864|NCT00633269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101687865|NCT04181346|Pregabalin|pregabalin|mesh-list
101687866|NCT04181346|Analgesics|analgesics|mesh-ancestor
101687867|NCT04181346|Sensory System Agents|sensory system agents|mesh-ancestor
101687868|NCT04181346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101687869|NCT04181346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687870|NCT04181346|Anticonvulsants|anticonvulsants|mesh-ancestor
101687871|NCT04181346|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101687872|NCT04181346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101227499|NCT01540526|Axitinib|axitinib|mesh-list
101687873|NCT04181346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687874|NCT04181346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101687875|NCT04181346|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101687876|NCT04181346|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101227748|NCT01541670|Antibodies|antibodies|mesh-list
101687877|NCT04181346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101687878|NCT04181346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101687879|NCT00642798|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101687880|NCT00642798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101687881|NCT00642798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687882|NCT00642798|Incretins|incretins|mesh-ancestor
101687883|NCT00642798|Hormones|hormones|mesh-ancestor
101775324|NCT00680186|Warfarin|warfarin|mesh-list
101775326|NCT00680186|Anticoagulants|anticoagulants|mesh-ancestor
101687884|NCT00642798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101687885|NCT00642798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101687886|NCT00642798|Protease Inhibitors|protease inhibitors|mesh-ancestor
101687887|NCT00642798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101687888|NCT00642798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687889|NCT05364996|Dimercaprol|dimercaprol|mesh-list
101687890|NCT05364996|Chelating Agents|chelating agents|mesh-ancestor
101687891|NCT05364996|Sequestering Agents|sequestering agents|mesh-ancestor
101687892|NCT05364996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687893|NCT00643734|Azithromycin|azithromycin|mesh-list
101687894|NCT00643734|Levofloxacin|levofloxacin|mesh-list
101687895|NCT00643734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101687896|NCT00643734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101687897|NCT00643734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101687898|NCT00643734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101687899|NCT00643734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101687900|NCT00643734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775327|NCT00680186|Antithrombins|antithrombins|mesh-ancestor
101687901|NCT00643734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687902|NCT00643734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101687903|NCT00643734|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101228274|NCT01544894|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101687904|NCT00643734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101687905|NCT02674308|Vedolizumab|vedolizumab|mesh-list
101687906|NCT02674308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101687907|NCT04179006|Antidepressive Agents|antidepressive agents|mesh-list
101687908|NCT04179006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101272621|NCT01844648|Tropicamide|tropicamide|mesh-list
101687909|NCT02672592|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101687910|NCT02672592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101687911|NCT04178850|Folic Acid|folic acid|mesh-list
101687912|NCT04178850|Vitamin B Complex|vitamin b complex|mesh-list
101687913|NCT04178850|Infliximab|infliximab|mesh-list
101687914|NCT04178850|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101687915|NCT04178850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101687916|NCT04178850|Dermatologic Agents|dermatologic agents|mesh-ancestor
101687917|NCT04178850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101687918|NCT04178850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101687920|NCT04178850|Vitamins|vitamins|mesh-ancestor
101687921|NCT04178850|Micronutrients|micronutrients|mesh-ancestor
101687922|NCT04178850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687923|NCT02676336|Iodine|iodine|mesh-list
101687924|NCT02676336|Cadexomer iodine|cadexomer iodine|mesh-list
101228479|NCT01546701|Sensory System Agents|sensory system agents|mesh-ancestor
101687925|NCT02676336|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101687926|NCT02676336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101687927|NCT02676336|Trace Elements|trace elements|mesh-ancestor
101687928|NCT02676336|Micronutrients|micronutrients|mesh-ancestor
101687929|NCT02676336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687931|NCT02672358|Dabrafenib|dabrafenib|mesh-list
101687932|NCT02672358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101687933|NCT02672358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101687934|NCT02672358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101687935|NCT02672358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687936|NCT02675868|Phenylephrine|phenylephrine|mesh-list
101687937|NCT02675868|Vasopressins|vasopressins|mesh-list
101687938|NCT02675868|Arginine Vasopressin|arginine vasopressin|mesh-list
101272630|NCT01844648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687939|NCT02675868|Oxymetazoline|oxymetazoline|mesh-list
101687940|NCT02675868|Norepinephrine|norepinephrine|mesh-list
101687941|NCT02675868|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101687942|NCT02675868|Mydriatics|mydriatics|mesh-ancestor
101687943|NCT02675868|Autonomic Agents|autonomic agents|mesh-ancestor
101687944|NCT02675868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101687945|NCT02675868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687946|NCT02675868|Sympathomimetics|sympathomimetics|mesh-ancestor
101687947|NCT02675868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101687948|NCT02675868|Nasal Decongestants|nasal decongestants|mesh-ancestor
101687949|NCT02675868|Respiratory System Agents|respiratory system agents|mesh-ancestor
101687950|NCT02675868|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101687951|NCT02675868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101687952|NCT02675868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101228778|NCT01548521|Oxytocin|oxytocin|mesh-list
101687953|NCT02675868|Adrenergic Agents|adrenergic agents|mesh-ancestor
101687954|NCT02675868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101687955|NCT02675868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101272746|NCT01845194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101687956|NCT02675868|Protective Agents|protective agents|mesh-ancestor
101687957|NCT02675868|Hemostatics|hemostatics|mesh-ancestor
101687958|NCT02675868|Coagulants|coagulants|mesh-ancestor
101687959|NCT02675868|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101687960|NCT02675868|Natriuretic Agents|natriuretic agents|mesh-ancestor
101687962|NCT05279742|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101687963|NCT05279742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101687964|NCT05279742|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101687965|NCT05279742|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101687966|NCT05279742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687968|NCT02673840|Antipruritics|antipruritics|mesh-ancestor
101687969|NCT02673840|Dermatologic Agents|dermatologic agents|mesh-ancestor
101687970|NCT02673840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101687971|NCT02673840|Histamine Antagonists|histamine antagonists|mesh-ancestor
101687972|NCT02673840|Histamine Agents|histamine agents|mesh-ancestor
101687973|NCT02673840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101687974|NCT02673840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687975|NCT02673840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687976|NCT02673840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101687977|NCT00644124|Aflibercept|aflibercept|mesh-list
101687978|NCT00644124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101687979|NCT00644124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101687980|NCT00644124|Growth Substances|growth substances|mesh-ancestor
101687981|NCT00644124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687982|NCT00644124|Growth Inhibitors|growth inhibitors|mesh-ancestor
101687983|NCT00644124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101687985|NCT02670954|Dexmedetomidine|dexmedetomidine|mesh-list
101687986|NCT02670954|Tramadol|tramadol|mesh-list
101229248|NCT01551511|Hormones|hormones|mesh-ancestor
101687987|NCT02670954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101687988|NCT02670954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101687989|NCT02670954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101687990|NCT02670954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101687991|NCT02670954|Analgesics|analgesics|mesh-ancestor
101687992|NCT02670954|Sensory System Agents|sensory system agents|mesh-ancestor
101687993|NCT02670954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101687994|NCT02670954|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101272939|NCT01846650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101687995|NCT02670954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101687997|NCT02670954|Adrenergic Agents|adrenergic agents|mesh-ancestor
101687998|NCT02670954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101687999|NCT02670954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688000|NCT02670954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101688001|NCT02670954|Narcotics|narcotics|mesh-ancestor
101688002|NCT02670954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101688004|NCT02670954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101688005|NCT02670954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101688006|NCT02670954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101688007|NCT00644904|Vitamin D|vitamin d|mesh-list
101688008|NCT00644904|Ergocalciferols|ergocalciferols|mesh-list
101688009|NCT00644904|Cholecalciferol|cholecalciferol|mesh-list
101688010|NCT00644904|Vitamins|vitamins|mesh-list
101688011|NCT00644904|Micronutrients|micronutrients|mesh-ancestor
101688012|NCT00644904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688013|NCT00644904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101688014|NCT00644904|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101688015|NCT02670564|Busulfan|busulfan|mesh-list
101688016|NCT02670564|Alkylating Agents|alkylating agents|mesh-ancestor
101775328|NCT00680186|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101688017|NCT02670564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688018|NCT02670564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101688019|NCT02670564|Immunologic Factors|immunologic factors|mesh-ancestor
101688020|NCT02670564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688021|NCT02670564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101688022|NCT02670564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101688023|NCT02670564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101688024|NCT02672202|Pregabalin|pregabalin|mesh-list
101688025|NCT02672202|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101688026|NCT02672202|Analgesics|analgesics|mesh-ancestor
101688027|NCT02672202|Sensory System Agents|sensory system agents|mesh-ancestor
101688028|NCT02672202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101688029|NCT02672202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688030|NCT02672202|Anticonvulsants|anticonvulsants|mesh-ancestor
101345334|NCT00022230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101688031|NCT02672202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101688032|NCT02672202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101688033|NCT02672202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688034|NCT02672202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101688035|NCT02672202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101688036|NCT02672202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101688037|NCT02672202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101688038|NCT02672202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101273125|NCT01848132|Rituximab|rituximab|mesh-list
101273126|NCT01848132|Doxorubicin|doxorubicin|mesh-list
101688039|NCT02672202|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101688040|NCT02672202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101688041|NCT02672202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101688042|NCT02672202|Antidepressive Agents|antidepressive agents|mesh-ancestor
101688044|NCT02671578|Nitrous Oxide|nitrous oxide|mesh-list
101688045|NCT02671578|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101688046|NCT02671578|Anesthetics, General|anesthetics, general|mesh-ancestor
101688047|NCT02671578|Anesthetics|anesthetics|mesh-ancestor
101273184|NCT01848340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101688048|NCT02671578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101688049|NCT02671578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688050|NCT02671578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101688052|NCT02671578|Sensory System Agents|sensory system agents|mesh-ancestor
101688053|NCT02671578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101688054|NCT00644982|Sertraline|sertraline|mesh-list
101688055|NCT00644982|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101688056|NCT00644982|Antidepressive Agents|antidepressive agents|mesh-ancestor
101688057|NCT00644982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101688058|NCT00644982|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101688059|NCT00644982|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101688060|NCT00644982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101688061|NCT00644982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688062|NCT00644982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101273249|NCT01848769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101688064|NCT00644982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230402|NCT05458102|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101688065|NCT00644982|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101688066|NCT00644982|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101688067|NCT02670642|Esomeprazole|esomeprazole|mesh-list
101688068|NCT02670642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101688069|NCT02670642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101688070|NCT02670642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101688071|NCT02670642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101688072|NCT02670642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101273307|NCT01849406|Autonomic Agents|autonomic agents|mesh-ancestor
101688073|NCT04175496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101688074|NCT02670018|Metformin|metformin|mesh-list
101688075|NCT02670018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101688076|NCT02670018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688077|NCT02670096|Acetazolamide|acetazolamide|mesh-list
101688078|NCT02670096|Anticonvulsants|anticonvulsants|mesh-ancestor
101688079|NCT02670096|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101230531|NCT05040282|Etonogestrel|etonogestrel|mesh-list
101688080|NCT02670096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101688081|NCT02670096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688082|NCT02670096|Diuretics|diuretics|mesh-ancestor
101688083|NCT02670096|Natriuretic Agents|natriuretic agents|mesh-ancestor
101688084|NCT02670096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688086|NCT00645060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101688087|NCT00645060|Immunologic Factors|immunologic factors|mesh-ancestor
101688088|NCT00645060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688089|NCT04176978|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101688090|NCT04176978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101688091|NCT04176978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101688092|NCT04176978|Antimetabolites|antimetabolites|mesh-ancestor
101688093|NCT04176978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688094|NCT04176978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101688095|NCT04176978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101688096|NCT04176978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101688097|NCT00644670|Atorvastatin|atorvastatin|mesh-list
101688098|NCT00644670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101688099|NCT00644670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101688100|NCT00644670|Antimetabolites|antimetabolites|mesh-ancestor
101688101|NCT00644670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345398|NCT00022737|Leucovorin|leucovorin|mesh-list
101273574|NCT01851473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101688102|NCT00644670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101688103|NCT00644670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101688104|NCT00644670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101688105|NCT02669706|Pentamidine|pentamidine|mesh-list
101688106|NCT02669706|Antifungal Agents|antifungal agents|mesh-ancestor
101688107|NCT02669706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101688108|NCT02669706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101688109|NCT02669706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101688110|NCT02669706|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101688111|NCT00645138|Anesthetics|anesthetics|mesh-list
101688112|NCT00645138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101688113|NCT00645138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688115|NCT00895895|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101688116|NCT00895895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101688117|NCT00895895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688118|NCT00895895|Cholinergic Agents|cholinergic agents|mesh-ancestor
101688119|NCT00895895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101688120|NCT00895895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688121|NCT00895895|Nootropic Agents|nootropic agents|mesh-ancestor
101273639|NCT01851759|Cinepazide|cinepazide|mesh-list
101688123|NCT00644748|Analgesics|analgesics|mesh-ancestor
101688124|NCT00644748|Sensory System Agents|sensory system agents|mesh-ancestor
101688125|NCT00644748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101688126|NCT00644748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688127|NCT00644748|Anticonvulsants|anticonvulsants|mesh-ancestor
101688128|NCT00644748|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101688129|NCT00644748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101688130|NCT00644748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101273694|NCT01851993|Dermatologic Agents|dermatologic agents|mesh-ancestor
101688131|NCT00644748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101688132|NCT00644748|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101688133|NCT00644748|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101688134|NCT00644748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101688135|NCT00644748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688136|NCT00644748|Antimanic Agents|antimanic agents|mesh-ancestor
101688137|NCT00910416|Remifentanil|remifentanil|mesh-list
101688138|NCT00910416|Propofol|propofol|mesh-list
101688139|NCT00910416|Sevoflurane|sevoflurane|mesh-list
101688141|NCT00910416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101688142|NCT00910416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101688143|NCT00910416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688144|NCT00910416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101688145|NCT00910416|Anesthetics, General|anesthetics, general|mesh-ancestor
101688146|NCT00910416|Anesthetics|anesthetics|mesh-ancestor
101688147|NCT00910416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101688148|NCT00910416|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101688149|NCT00910416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101688150|NCT00910416|Narcotics|narcotics|mesh-ancestor
101688152|NCT00910416|Sensory System Agents|sensory system agents|mesh-ancestor
101688153|NCT00910416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101688154|NCT00910416|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101688155|NCT00910416|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101688156|NCT00910416|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101688157|NCT00910416|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101688158|NCT00910416|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101688159|NCT00910416|Cholinergic Agents|cholinergic agents|mesh-ancestor
101688160|NCT00910416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101688161|NCT00910416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688162|NCT02669238|Etonogestrel|etonogestrel|mesh-list
101775329|NCT00680186|Protease Inhibitors|protease inhibitors|mesh-ancestor
101688163|NCT02669238|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101688165|NCT02669238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101688166|NCT02669238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688167|NCT02669238|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101688168|NCT02669004|Morphine|morphine|mesh-list
101273961|NCT01854463|Vitamin D|vitamin d|mesh-list
101688169|NCT02669004|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101688170|NCT02669004|Narcotics|narcotics|mesh-ancestor
101688171|NCT02669004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101688173|NCT02669004|Analgesics|analgesics|mesh-ancestor
101688174|NCT02669004|Sensory System Agents|sensory system agents|mesh-ancestor
101688175|NCT02669004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101688176|NCT00895661|Rituximab|rituximab|mesh-list
101688177|NCT00895661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101688178|NCT00895661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101688179|NCT00895661|Immunologic Factors|immunologic factors|mesh-ancestor
101274025|NCT01854606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101274042|NCT01854749|Cisplatin|cisplatin|mesh-list
101688180|NCT00895661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688181|NCT00895661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101688182|NCT00645294|Adefovir|adefovir|mesh-list
101688183|NCT00645294|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101688184|NCT00645294|Antiviral Agents|antiviral agents|mesh-ancestor
101688185|NCT00645294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101688186|NCT00645294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101688187|NCT00645294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101688188|NCT00645294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101688189|NCT00645294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688190|NCT02837003|Aspirin|aspirin|mesh-list
101688191|NCT02837003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101688192|NCT02837003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101688193|NCT02837003|Analgesics|analgesics|mesh-ancestor
101688194|NCT02837003|Sensory System Agents|sensory system agents|mesh-ancestor
101688195|NCT02837003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101274094|NCT01855100|Rivaroxaban|rivaroxaban|mesh-list
101688196|NCT02837003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688197|NCT02837003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101688199|NCT02837003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101688200|NCT02837003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101688201|NCT02837003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688202|NCT02837003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101688203|NCT02837003|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101688204|NCT02837003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101688205|NCT02837003|Antipyretics|antipyretics|mesh-ancestor
101688206|NCT02668926|Amphetamine|amphetamine|mesh-list
101688207|NCT02668926|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101688208|NCT02668926|Dextroamphetamine|dextroamphetamine|mesh-list
101688209|NCT02668926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101688210|NCT02668926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688211|NCT02668926|Sympathomimetics|sympathomimetics|mesh-ancestor
101688212|NCT02668926|Autonomic Agents|autonomic agents|mesh-ancestor
101688213|NCT02668926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101688214|NCT02668926|Dopamine Agents|dopamine agents|mesh-ancestor
101274152|NCT01855529|Anesthetics|anesthetics|mesh-ancestor
101688215|NCT02668926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101688216|NCT02668926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688217|NCT02668926|Adrenergic Agents|adrenergic agents|mesh-ancestor
101688218|NCT02668926|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101688219|NCT02668926|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101688220|NCT02668926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101688221|NCT02668926|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101688222|NCT02668536|Sunscreening Agents|sunscreening agents|mesh-list
101688223|NCT02668536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101688224|NCT02668536|Protective Agents|protective agents|mesh-ancestor
101688225|NCT02668536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688226|NCT02668536|Dermatologic Agents|dermatologic agents|mesh-ancestor
101688227|NCT00645372|Risperidone|risperidone|mesh-list
101688229|NCT00645372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101688230|NCT00645372|Serotonin Agents|serotonin agents|mesh-ancestor
101688231|NCT00645372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101688232|NCT00645372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688233|NCT00645372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688234|NCT00645372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101688235|NCT00645372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101688236|NCT00645372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101688237|NCT00645372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101274272|NCT01856062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101688238|NCT00645372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101688239|NCT00645372|Dopamine Agents|dopamine agents|mesh-ancestor
101688240|NCT00645918|Clopidogrel|clopidogrel|mesh-list
101688241|NCT00645918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101688243|NCT00645918|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101274343|NCT01856413|Immunoglobulins|immunoglobulins|mesh-list
101688244|NCT00645918|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101688245|NCT00645918|Purinergic Agents|purinergic agents|mesh-ancestor
101688246|NCT00645918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101688247|NCT00645918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688248|NCT00645918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688249|NCT00646854|Cyclophosphamide|cyclophosphamide|mesh-list
101688250|NCT00646854|Alemtuzumab|alemtuzumab|mesh-list
101688251|NCT00646854|Doxorubicin|doxorubicin|mesh-list
101688253|NCT00646854|Vincristine|vincristine|mesh-list
101688254|NCT00646854|Lenograstim|lenograstim|mesh-list
101688255|NCT00646854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101688256|NCT00646854|Immunologic Factors|immunologic factors|mesh-ancestor
101688257|NCT00646854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688258|NCT00646854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101688259|NCT00646854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101688260|NCT00646854|Alkylating Agents|alkylating agents|mesh-ancestor
101688261|NCT00646854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688262|NCT00646854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101688263|NCT00646854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101688264|NCT00646854|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101688265|NCT00646854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101688266|NCT00646854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101688267|NCT00646854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101688268|NCT00646854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101688269|NCT00646854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101688270|NCT00646854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101688271|NCT00646854|Tubulin Modulators|tubulin modulators|mesh-ancestor
101688272|NCT00646854|Antimitotic Agents|antimitotic agents|mesh-ancestor
101688273|NCT00646854|Mitosis Modulators|mitosis modulators|mesh-ancestor
101688275|NCT04173858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101688276|NCT04173858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688277|NCT04173858|Sensory System Agents|sensory system agents|mesh-ancestor
101274609|NCT01857817|Etodolac|etodolac|mesh-list
101688278|NCT04173858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101688279|NCT00646932|Ergocalciferols|ergocalciferols|mesh-list
101688280|NCT00646932|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101688281|NCT00646932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688284|NCT00646932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101688285|NCT00646152|Poly ICLC|poly iclc|mesh-list
101688286|NCT00646152|Interferon Inducers|interferon inducers|mesh-ancestor
101274681|NCT01858025|Mitomycins|mitomycins|mesh-list
101688287|NCT00646152|Immunologic Factors|immunologic factors|mesh-ancestor
101688288|NCT00646152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688289|NCT00647166|Azathioprine|azathioprine|mesh-list
101688290|NCT00647166|Antimetabolites|antimetabolites|mesh-ancestor
101688291|NCT00647166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688292|NCT00647166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101688293|NCT00647166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101688294|NCT00647166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101688295|NCT00647166|Immunologic Factors|immunologic factors|mesh-ancestor
101688296|NCT00647166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688297|NCT00647166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101688298|NCT00647244|Tenofovir|tenofovir|mesh-list
101688299|NCT00647244|Abacavir|abacavir|mesh-list
101688300|NCT00647244|Antiviral Agents|antiviral agents|mesh-ancestor
101688301|NCT00647244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101688302|NCT00647244|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101688303|NCT00647244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101688304|NCT00647244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775330|NCT00680186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101688305|NCT00647244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688306|NCT00647244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101688307|NCT00647244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101688308|NCT00895583|Sirolimus|sirolimus|mesh-list
101688309|NCT00895583|Tacrolimus|tacrolimus|mesh-list
101688310|NCT00895583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101688311|NCT00895583|Immunologic Factors|immunologic factors|mesh-ancestor
101688312|NCT00895583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688313|NCT00895583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101688314|NCT00895583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101688315|NCT00895583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688316|NCT00895583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101688317|NCT00895583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101274878|NCT01858649|Irinotecan|irinotecan|mesh-list
101688318|NCT00895583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101688319|NCT00895583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101688320|NCT00895583|Antifungal Agents|antifungal agents|mesh-ancestor
101688322|NCT04174872|Midazolam|midazolam|mesh-list
101688323|NCT04174872|Dexmedetomidine|dexmedetomidine|mesh-list
101688324|NCT04174872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101688325|NCT04174872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101688326|NCT04174872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688327|NCT04174872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101688328|NCT04174872|Analgesics|analgesics|mesh-ancestor
101688329|NCT04174872|Sensory System Agents|sensory system agents|mesh-ancestor
101688330|NCT04174872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101688331|NCT04174872|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101688332|NCT04174872|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101688333|NCT04174872|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101688334|NCT04174872|Adrenergic Agents|adrenergic agents|mesh-ancestor
101688335|NCT04174872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101688336|NCT04174872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688337|NCT04174872|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101688338|NCT04174872|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101688339|NCT04174872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101688340|NCT04174872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101688341|NCT04174872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101688342|NCT04174872|Anesthetics, General|anesthetics, general|mesh-ancestor
101688343|NCT04174872|Anesthetics|anesthetics|mesh-ancestor
101688344|NCT04174872|GABA Modulators|gaba modulators|mesh-ancestor
101688345|NCT04174872|GABA Agents|gaba agents|mesh-ancestor
101688346|NCT02841137|Progesterone|progesterone|mesh-list
101688348|NCT02841137|Hormones|hormones|mesh-ancestor
101688349|NCT02841137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101688350|NCT02841137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688351|NCT00645606|Rituximab|rituximab|mesh-list
101688352|NCT00645606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101688353|NCT00645606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101688354|NCT00645606|Immunologic Factors|immunologic factors|mesh-ancestor
101688355|NCT00645606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688356|NCT00645606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101688357|NCT02836847|Trastuzumab|trastuzumab|mesh-list
101688359|NCT02836847|Everolimus|everolimus|mesh-list
101688360|NCT02836847|Sorafenib|sorafenib|mesh-list
101688361|NCT02836847|Lapatinib|lapatinib|mesh-list
101688362|NCT02836847|Gefitinib|gefitinib|mesh-list
101688363|NCT02836847|Crizotinib|crizotinib|mesh-list
101688364|NCT02836847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101688365|NCT02836847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101274950|NCT01859377|Ibuprofen|ibuprofen|mesh-list
101688367|NCT02836847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101688368|NCT02836847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101688369|NCT02836847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688370|NCT02836847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101688371|NCT02836847|Immunologic Factors|immunologic factors|mesh-ancestor
101688372|NCT02836847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688373|NCT02666040|Anesthetics|anesthetics|mesh-list
101688374|NCT02666040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101688375|NCT02666040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688376|NCT00894413|Tadalafil|tadalafil|mesh-list
101688377|NCT00894413|Vasodilator Agents|vasodilator agents|mesh-ancestor
101688378|NCT00894413|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101688379|NCT00894413|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101688380|NCT00894413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101688381|NCT00894413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688382|NCT00894413|Urological Agents|urological agents|mesh-ancestor
101688383|NCT04250519|Sodium Hypochlorite|sodium hypochlorite|mesh-list
101688384|NCT04250519|Eusol|eusol|mesh-list
101688385|NCT04250519|Disinfectants|disinfectants|mesh-ancestor
101688386|NCT04250519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101688387|NCT04172220|Midazolam|midazolam|mesh-list
101688388|NCT04172220|Anesthetics|anesthetics|mesh-list
101232096|NCT01557712|Anesthetics|anesthetics|mesh-ancestor
101688389|NCT04172220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101688390|NCT04172220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688391|NCT04172220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101688392|NCT04172220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101688393|NCT04172220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101688394|NCT04172220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101688395|NCT04172220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101688396|NCT04172220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101688397|NCT04172220|Anesthetics, General|anesthetics, general|mesh-ancestor
101688398|NCT04172220|GABA Modulators|gaba modulators|mesh-ancestor
101688399|NCT04172220|GABA Agents|gaba agents|mesh-ancestor
101688400|NCT04172220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101688401|NCT04172220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688402|NCT02665806|Fluticasone|fluticasone|mesh-list
101688403|NCT02665806|Ciclesonide|ciclesonide|mesh-list
101232320|NCT01559272|Serotonin Agents|serotonin agents|mesh-ancestor
101688404|NCT02665806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101688405|NCT02665806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101688406|NCT02665806|Autonomic Agents|autonomic agents|mesh-ancestor
101688407|NCT02665806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101688408|NCT02665806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688409|NCT02665806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101688410|NCT02665806|Respiratory System Agents|respiratory system agents|mesh-ancestor
101232512|NCT05564741|Autonomic Agents|autonomic agents|mesh-ancestor
101688411|NCT02665806|Dermatologic Agents|dermatologic agents|mesh-ancestor
101688412|NCT02665806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101688414|NCT02665806|Hormones|hormones|mesh-ancestor
101232656|NCT04424511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101688415|NCT02665806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101688416|NCT00646386|Adalimumab|adalimumab|mesh-list
101232731|NCT04182672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101688417|NCT00646386|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101688418|NCT00646386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101688419|NCT00646386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101688420|NCT00647634|Alprazolam|alprazolam|mesh-list
101274975|NCT01859468|Antacids|antacids|mesh-ancestor
101688421|NCT00647634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101688422|NCT00647634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101688423|NCT00647634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232949|NCT02546492|beta-Endorphin|beta-endorphin|mesh-list
101688424|NCT00647634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101688425|NCT00647634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101688426|NCT00647634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101688427|NCT00647634|GABA Modulators|gaba modulators|mesh-ancestor
101688429|NCT00647634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101688430|NCT00647634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688431|NCT04172064|Dobutamine|dobutamine|mesh-list
101233159|NCT01569685|Serotonin Agents|serotonin agents|mesh-ancestor
101688432|NCT04172064|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101688434|NCT04172064|Autonomic Agents|autonomic agents|mesh-ancestor
101688435|NCT04172064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101688436|NCT04172064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688437|NCT04172064|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101688438|NCT04172064|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101688439|NCT04172064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101688441|NCT04172064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101688442|NCT04172064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688443|NCT04172064|Protective Agents|protective agents|mesh-ancestor
101688444|NCT00647712|Valproic Acid|valproic acid|mesh-list
101688445|NCT00647712|Anticonvulsants|anticonvulsants|mesh-ancestor
101688446|NCT00647712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101688447|NCT00647712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688448|NCT00647712|GABA Agents|gaba agents|mesh-ancestor
101688449|NCT00647712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101688450|NCT00647712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688451|NCT00647712|Antimanic Agents|antimanic agents|mesh-ancestor
101688452|NCT00647712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101688453|NCT00647712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101688454|NCT00647712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101688455|NCT04173390|Pregabalin|pregabalin|mesh-list
101688456|NCT04173390|Analgesics|analgesics|mesh-ancestor
101688458|NCT04173390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101688459|NCT04173390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688460|NCT04173390|Anticonvulsants|anticonvulsants|mesh-ancestor
101688461|NCT04173390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101688462|NCT04173390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101688463|NCT04173390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688464|NCT04173390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101688465|NCT04173390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101688466|NCT04173390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101688467|NCT04173390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101688468|NCT04173390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101688475|NCT02665650|Pembrolizumab|pembrolizumab|mesh-list
101688476|NCT02665650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101688477|NCT02665650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101688478|NCT02665650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101688479|NCT02665650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688480|NCT00647868|Testosterone|testosterone|mesh-list
101688481|NCT00647868|Androgens|androgens|mesh-ancestor
101688483|NCT00647868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101688484|NCT00647868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688486|NCT00647946|Abacavir|abacavir|mesh-list
101688487|NCT00647946|Antiviral Agents|antiviral agents|mesh-ancestor
101274989|NCT01859585|Sensory System Agents|sensory system agents|mesh-ancestor
101274992|NCT01859585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101688488|NCT00647946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101688489|NCT00647946|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101688490|NCT00647946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101688492|NCT00647946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688493|NCT00647946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101688494|NCT00647946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101688495|NCT00648024|Anagrelide|anagrelide|mesh-list
101688496|NCT00648024|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101688497|NCT00648024|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101688498|NCT00648024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688499|NCT00648024|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101688500|NCT02665416|Bevacizumab|bevacizumab|mesh-list
101688501|NCT02665416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101688502|NCT02665416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101688503|NCT02665416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101688504|NCT02665416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101688505|NCT02665416|Growth Substances|growth substances|mesh-ancestor
101688506|NCT02665416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688507|NCT02665416|Growth Inhibitors|growth inhibitors|mesh-ancestor
101688508|NCT00646620|Fluticasone|fluticasone|mesh-list
101688509|NCT00646620|Budesonide|budesonide|mesh-list
101688510|NCT00646620|Albuterol|albuterol|mesh-list
101688511|NCT00646620|Formoterol Fumarate|formoterol fumarate|mesh-list
101688512|NCT00646620|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101688513|NCT00646620|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101688514|NCT00646620|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101688516|NCT00646620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101688517|NCT00646620|Autonomic Agents|autonomic agents|mesh-ancestor
101688518|NCT00646620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101688519|NCT00646620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688520|NCT00646620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101688521|NCT00646620|Respiratory System Agents|respiratory system agents|mesh-ancestor
101688522|NCT00646620|Dermatologic Agents|dermatologic agents|mesh-ancestor
101688523|NCT00646620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101688524|NCT00646620|Glucocorticoids|glucocorticoids|mesh-ancestor
101688526|NCT00646620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101688527|NCT00646620|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101688528|NCT00646620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101688529|NCT00646620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101688530|NCT00646620|Adrenergic Agents|adrenergic agents|mesh-ancestor
101688531|NCT00646620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101688532|NCT00646620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688533|NCT00646620|Tocolytic Agents|tocolytic agents|mesh-ancestor
101688534|NCT00646620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101688535|NCT00646620|Sympathomimetics|sympathomimetics|mesh-ancestor
101688536|NCT00648180|Doxycycline|doxycycline|mesh-list
101688537|NCT00648180|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101688538|NCT00648180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101688539|NCT00648180|Antimalarials|antimalarials|mesh-ancestor
101688540|NCT00648180|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101688541|NCT00648180|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101688542|NCT02664168|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101688543|NCT02664168|Laxatives|laxatives|mesh-ancestor
101688544|NCT02664168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101688546|NCT00648492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101688547|NCT00648492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688548|NCT00648570|Dexetimide|dexetimide|mesh-list
101688550|NCT00648570|Escitalopram|escitalopram|mesh-list
101688551|NCT00648570|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101234682|NCT01579539|Esomeprazole|esomeprazole|mesh-list
101688552|NCT00648570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101275015|NCT01859728|Irinotecan|irinotecan|mesh-list
101688553|NCT00648570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101688554|NCT00648570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688555|NCT00648570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101688556|NCT00648570|Serotonin Agents|serotonin agents|mesh-ancestor
101688557|NCT00648570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688558|NCT00648570|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101688559|NCT00648570|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101688560|NCT00648570|Parasympatholytics|parasympatholytics|mesh-ancestor
101688561|NCT00648570|Autonomic Agents|autonomic agents|mesh-ancestor
101688562|NCT00648570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101688563|NCT00648570|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101688564|NCT00648570|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101688565|NCT00648570|Cholinergic Agents|cholinergic agents|mesh-ancestor
101688566|NCT00648570|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101688567|NCT00648570|Antidepressive Agents|antidepressive agents|mesh-ancestor
101688568|NCT00648570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101235015|NCT01590537|Copper|copper|mesh-list
101688571|NCT00648258|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101688572|NCT00648258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101688573|NCT00648258|Analgesics|analgesics|mesh-ancestor
101688574|NCT00648258|Sensory System Agents|sensory system agents|mesh-ancestor
101688575|NCT00648258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101688576|NCT00648258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688577|NCT00648258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101688579|NCT00648258|Gout Suppressants|gout suppressants|mesh-ancestor
101688580|NCT00648258|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101688582|NCT00648258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688583|NCT00648258|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101235401|NCT01592981|Fludarabine|fludarabine|mesh-list
101235475|NCT01593280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688586|NCT00648336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688587|NCT00648336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101688588|NCT00648336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101688589|NCT00648336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101688590|NCT00648336|Immunologic Factors|immunologic factors|mesh-ancestor
101688591|NCT00648336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235844|NCT01595022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101688592|NCT00648336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101688593|NCT00648336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101688594|NCT04650984|Doxorubicin|doxorubicin|mesh-list
101688595|NCT04650984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101688596|NCT04650984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101688597|NCT04650984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101688598|NCT04650984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101688599|NCT04650984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101688600|NCT04650984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688601|NCT00648414|Fentanyl|fentanyl|mesh-list
101688602|NCT00648414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101688603|NCT00648414|Narcotics|narcotics|mesh-ancestor
101688604|NCT00648414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101688605|NCT00648414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688606|NCT00648414|Analgesics|analgesics|mesh-ancestor
101275019|NCT01859728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275020|NCT01859728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101275023|NCT01859754|gamma-Globulins|gamma-globulins|mesh-list
101688607|NCT00648414|Sensory System Agents|sensory system agents|mesh-ancestor
101688608|NCT00648414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101688609|NCT00648414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101688610|NCT00648414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101688611|NCT00648414|Anesthetics, General|anesthetics, general|mesh-ancestor
101688612|NCT00648414|Anesthetics|anesthetics|mesh-ancestor
101688614|NCT02663700|Antimalarials|antimalarials|mesh-ancestor
101688615|NCT02663700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101688616|NCT02663700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101688617|NCT02663700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101688618|NCT02663700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101688619|NCT02663700|Antiviral Agents|antiviral agents|mesh-ancestor
101688620|NCT02663700|Schistosomicides|schistosomicides|mesh-ancestor
101688621|NCT02663700|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101688622|NCT02663700|Anthelmintics|anthelmintics|mesh-ancestor
101688623|NCT00648726|Azithromycin|azithromycin|mesh-list
101688624|NCT00648726|Erythromycin|erythromycin|mesh-list
101236138|NCT01596634|Lactoferrin|lactoferrin|mesh-list
101688625|NCT00648726|Erythromycin Estolate|erythromycin estolate|mesh-list
101688626|NCT00648726|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101688627|NCT00648726|Erythromycin stearate|erythromycin stearate|mesh-list
101688629|NCT00648726|Cefuroxime axetil|cefuroxime axetil|mesh-list
101688630|NCT00648726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101688632|NCT00648726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101688633|NCT00648726|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101688634|NCT00648726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101688635|NCT00648726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688636|NCT04171674|Ceftobiprole|ceftobiprole|mesh-list
101688637|NCT04171674|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
101688638|NCT04171674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101688639|NCT04171674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101688640|NCT00648804|Ondansetron|ondansetron|mesh-list
101688641|NCT00648804|Antiemetics|antiemetics|mesh-ancestor
101688642|NCT00648804|Autonomic Agents|autonomic agents|mesh-ancestor
101688643|NCT00648804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101688644|NCT00648804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688645|NCT00648804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101688646|NCT00648804|Antipruritics|antipruritics|mesh-ancestor
101688647|NCT00648804|Dermatologic Agents|dermatologic agents|mesh-ancestor
101688648|NCT00648804|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101688649|NCT00648804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101688650|NCT00648804|Serotonin Agents|serotonin agents|mesh-ancestor
101688651|NCT00648804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101688652|NCT00648804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688653|NCT02664012|Menthol|menthol|mesh-list
101688654|NCT02664012|Nicotine|nicotine|mesh-list
101688655|NCT02664012|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101688656|NCT02664012|Autonomic Agents|autonomic agents|mesh-ancestor
101236317|NCT01597167|Anticonvulsants|anticonvulsants|mesh-ancestor
101688657|NCT02664012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101688658|NCT02664012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688659|NCT02664012|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101688660|NCT02664012|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101688661|NCT02664012|Cholinergic Agents|cholinergic agents|mesh-ancestor
101688662|NCT02664012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101688663|NCT02664012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688664|NCT02664012|Antipruritics|antipruritics|mesh-ancestor
101688665|NCT02664012|Dermatologic Agents|dermatologic agents|mesh-ancestor
101688666|NCT00895037|Factor VIII|factor viii|mesh-list
101275036|NCT01859858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101688667|NCT00895037|Coagulants|coagulants|mesh-ancestor
101688668|NCT04170504|Methotrexate|methotrexate|mesh-list
101688669|NCT04170504|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101688670|NCT04170504|Abortifacient Agents|abortifacient agents|mesh-ancestor
101688671|NCT04170504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101236636|NCT01598623|Oxytocin|oxytocin|mesh-list
101688672|NCT04170504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688673|NCT04170504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101688674|NCT04170504|Antimetabolites|antimetabolites|mesh-ancestor
101236755|NCT05691088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688675|NCT04170504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688676|NCT04170504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101688677|NCT04170504|Dermatologic Agents|dermatologic agents|mesh-ancestor
101688678|NCT04170504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101688679|NCT04170504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101688680|NCT04170504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101236901|NCT05540184|Antioxidants|antioxidants|mesh-ancestor
101688681|NCT04170504|Immunologic Factors|immunologic factors|mesh-ancestor
101688682|NCT04170504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101688683|NCT04170504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101688684|NCT04170270|Omeprazole|omeprazole|mesh-list
101688685|NCT04170270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101237049|NCT04753216|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101688686|NCT04170270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101688687|NCT04170270|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101688688|NCT04170270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101688689|NCT04170270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688690|NCT00633347|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101688691|NCT00633347|Cetrorelix|cetrorelix|mesh-list
101688692|NCT00633347|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101688693|NCT00633347|Hormones|hormones|mesh-ancestor
101237120|NCT04563494|Glucocorticoids|glucocorticoids|mesh-ancestor
101688694|NCT00633347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101688695|NCT00633347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688696|NCT00633347|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101688697|NCT00633347|Fertility Agents|fertility agents|mesh-ancestor
101688698|NCT00633347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101688699|NCT00633347|Hormone Antagonists|hormone antagonists|mesh-ancestor
101688700|NCT00633347|Luteolytic Agents|luteolytic agents|mesh-ancestor
101688701|NCT00633347|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101688702|NCT00633347|Contraceptive Agents|contraceptive agents|mesh-ancestor
101688703|NCT00633347|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101688704|NCT00633347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101688705|NCT00633347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101688707|NCT02838719|Dexamethasone acetate|dexamethasone acetate|mesh-list
101688709|NCT02838719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101688710|NCT02838719|Antiemetics|antiemetics|mesh-ancestor
101688711|NCT02838719|Autonomic Agents|autonomic agents|mesh-ancestor
101237543|NCT04558892|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101688712|NCT02838719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101688713|NCT02838719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688714|NCT02838719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101688716|NCT02838719|Hormones|hormones|mesh-ancestor
101688717|NCT02838719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101237689|NCT03780829|Antitubercular Agents|antitubercular agents|mesh-ancestor
101688718|NCT02838719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101688719|NCT02838719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101688720|NCT02838719|Protease Inhibitors|protease inhibitors|mesh-ancestor
101688721|NCT02838719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101688722|NCT02838719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275053|NCT01860066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101688724|NCT02659488|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101688725|NCT02659488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688726|NCT02659488|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101688727|NCT02659488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101688728|NCT02659488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101688729|NCT02659488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688731|NCT02659488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101688732|NCT00649194|Rabeprazole|rabeprazole|mesh-list
101688733|NCT00649194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101688734|NCT00649194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101688735|NCT00649194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101688736|NCT00649194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101237833|NCT02938442|Paclitaxel|paclitaxel|mesh-list
101688737|NCT00649194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688738|NCT02659254|Sirolimus|sirolimus|mesh-list
101237889|NCT02398773|Hormones|hormones|mesh-ancestor
101688739|NCT02659254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101688740|NCT02659254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101688741|NCT02659254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101688742|NCT02659254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101688743|NCT02659254|Antifungal Agents|antifungal agents|mesh-ancestor
101688744|NCT02659254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101688745|NCT02659254|Immunologic Factors|immunologic factors|mesh-ancestor
101238031|NCT03161353|Tubulin Modulators|tubulin modulators|mesh-ancestor
101688746|NCT02659254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688748|NCT02658864|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101688749|NCT02658864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101688750|NCT02658864|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101688751|NCT02658864|Histamine Antagonists|histamine antagonists|mesh-ancestor
101688752|NCT02658864|Histamine Agents|histamine agents|mesh-ancestor
101238176|NCT02652455|Nivolumab|nivolumab|mesh-list
101688753|NCT02658864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101688754|NCT02658864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688755|NCT02658864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688756|NCT02835833|Bevacizumab|bevacizumab|mesh-list
101688757|NCT02835833|Nintedanib|nintedanib|mesh-list
101688758|NCT02835833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101688759|NCT02835833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101238390|NCT01602029|Antimetabolites|antimetabolites|mesh-ancestor
101688760|NCT02835833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101688761|NCT02835833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101688762|NCT02835833|Growth Substances|growth substances|mesh-ancestor
101688763|NCT02835833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688764|NCT02835833|Growth Inhibitors|growth inhibitors|mesh-ancestor
101688765|NCT02835833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101688766|NCT02835833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101688767|NCT02835833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688769|NCT04171284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101688770|NCT04171284|Tubulin Modulators|tubulin modulators|mesh-ancestor
101688771|NCT04171284|Antimitotic Agents|antimitotic agents|mesh-ancestor
101688772|NCT04171284|Mitosis Modulators|mitosis modulators|mesh-ancestor
101688773|NCT04171284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688774|NCT02838329|Ropivacaine|ropivacaine|mesh-list
101688775|NCT02838329|Anesthetics, Local|anesthetics, local|mesh-ancestor
101688776|NCT02838329|Anesthetics|anesthetics|mesh-ancestor
101688777|NCT02838329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101688778|NCT02838329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688779|NCT02838329|Sensory System Agents|sensory system agents|mesh-ancestor
101688780|NCT02838329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101275065|NCT01860066|Glucocorticoids|glucocorticoids|mesh-ancestor
101688782|NCT02662530|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101688784|NCT02662530|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101688785|NCT02662530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101688786|NCT02662530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688787|NCT02662530|Cholinergic Agents|cholinergic agents|mesh-ancestor
101688788|NCT02662530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101688789|NCT02662530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688790|NCT02662530|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101688791|NCT02662530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101688792|NCT02835521|Triamcinolone|triamcinolone|mesh-list
101688793|NCT02835521|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101688794|NCT02835521|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101688795|NCT02835521|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101688796|NCT02835521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101688797|NCT02835521|Glucocorticoids|glucocorticoids|mesh-ancestor
101688798|NCT02835521|Hormones|hormones|mesh-ancestor
101688799|NCT02835521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101688800|NCT02835521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688801|NCT02835521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101688802|NCT02835521|Immunologic Factors|immunologic factors|mesh-ancestor
101688803|NCT02835521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101688804|NCT02835521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688806|NCT00649272|Parasympatholytics|parasympatholytics|mesh-ancestor
101688807|NCT00649272|Autonomic Agents|autonomic agents|mesh-ancestor
101688808|NCT00649272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101688809|NCT00649272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688810|NCT00649272|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101688811|NCT00649272|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101688812|NCT00649272|Cholinergic Agents|cholinergic agents|mesh-ancestor
101688813|NCT00649272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101688814|NCT00649272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688815|NCT00649272|Urological Agents|urological agents|mesh-ancestor
101688816|NCT02666898|Cyclophosphamide|cyclophosphamide|mesh-list
101688817|NCT02666898|Fludarabine|fludarabine|mesh-list
101688818|NCT02666898|Obinutuzumab|obinutuzumab|mesh-list
101688819|NCT02666898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101688820|NCT02666898|Immunologic Factors|immunologic factors|mesh-ancestor
101688821|NCT02666898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688822|NCT02666898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101688823|NCT02666898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101688824|NCT02666898|Alkylating Agents|alkylating agents|mesh-ancestor
101688825|NCT02666898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688826|NCT02666898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101688827|NCT02666898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101688828|NCT02666898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101688829|NCT00633425|Glimepiride|glimepiride|mesh-list
101688830|NCT00633425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101688831|NCT00633425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101688832|NCT00633425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688833|NCT00633425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101688834|NCT00633425|Immunologic Factors|immunologic factors|mesh-ancestor
101688835|NCT02840279|BPN14770|bpn14770|mesh-list
101688836|NCT02840279|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101688837|NCT02840279|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101688838|NCT02840279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101688839|NCT02840279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688840|NCT00648960|Clarithromycin|clarithromycin|mesh-list
101688841|NCT00648960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101688842|NCT00648960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101688843|NCT00648960|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101688844|NCT00648960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101239074|NCT01613820|Antiemetics|antiemetics|mesh-ancestor
101688845|NCT00648960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688846|NCT00648960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101688847|NCT00648960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101688848|NCT04437329|Cisplatin|cisplatin|mesh-list
101688849|NCT04437329|Docetaxel|docetaxel|mesh-list
101688850|NCT04437329|Fluorouracil|fluorouracil|mesh-list
101688852|NCT04437329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101688853|NCT04437329|Tubulin Modulators|tubulin modulators|mesh-ancestor
101688854|NCT04437329|Antimitotic Agents|antimitotic agents|mesh-ancestor
101688855|NCT04437329|Mitosis Modulators|mitosis modulators|mesh-ancestor
101239274|NCT01613729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101688856|NCT04437329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688857|NCT04437329|Antimetabolites|antimetabolites|mesh-ancestor
101688858|NCT04437329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101688859|NCT04437329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101688860|NCT04437329|Immunologic Factors|immunologic factors|mesh-ancestor
101688861|NCT04437329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688862|NCT02834507|Levodopa|levodopa|mesh-list
101688863|NCT02834507|Carbidopa|carbidopa|mesh-list
101688864|NCT02834507|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101688865|NCT02834507|Entacapone|entacapone|mesh-list
101688866|NCT02834507|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101688867|NCT02834507|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101688868|NCT02834507|Dopamine Agents|dopamine agents|mesh-ancestor
101688869|NCT02834507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101688870|NCT02834507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688871|NCT02834507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688872|NCT02834507|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101688873|NCT02834507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101688874|NCT02834507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101688875|NCT02834507|Immunologic Factors|immunologic factors|mesh-ancestor
101688876|NCT02834507|Dopamine Agonists|dopamine agonists|mesh-ancestor
101688877|NCT02834507|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101688878|NCT02831543|Mosapride|mosapride|mesh-list
101688879|NCT02831543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688880|NCT02831543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101688881|NCT02831543|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101688882|NCT02831543|Serotonin Agents|serotonin agents|mesh-ancestor
101688883|NCT02831543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101688884|NCT02831543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688885|NCT02840591|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
101688886|NCT02840591|Nootropic Agents|nootropic agents|mesh-ancestor
101688887|NCT02667054|Anesthetics|anesthetics|mesh-list
101688888|NCT02667054|Anesthetics, Local|anesthetics, local|mesh-list
101688889|NCT02667054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101688890|NCT02667054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688891|NCT02667054|Sensory System Agents|sensory system agents|mesh-ancestor
101688892|NCT02667054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101688893|NCT02662296|Idelalisib|idelalisib|mesh-list
101688894|NCT02662296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101688895|NCT02662296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101688896|NCT02662296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688897|NCT02662374|Nystatin|nystatin|mesh-list
101688898|NCT02662374|Calcium|calcium|mesh-list
101688899|NCT02662374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101688900|NCT02662374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688901|NCT02662374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101275091|NCT01860183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101275092|NCT01860183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101688902|NCT02662374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101688903|NCT02662374|Antifungal Agents|antifungal agents|mesh-ancestor
101688904|NCT02662374|Ionophores|ionophores|mesh-ancestor
101688905|NCT02662374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101688906|NCT02662374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688907|NCT05334251|Anesthetics|anesthetics|mesh-list
101688908|NCT05334251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101688909|NCT05334251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688911|NCT00649350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101239586|NCT01616966|Sevoflurane|sevoflurane|mesh-list
101688912|NCT00649350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688913|NCT00649506|Nitrofurantoin|nitrofurantoin|mesh-list
101688914|NCT00649506|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101688915|NCT00649506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101239658|NCT01617226|Antimetabolites|antimetabolites|mesh-ancestor
101688916|NCT00649506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101688917|NCT00649038|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101688919|NCT00649038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101688920|NCT00649038|Diuretics|diuretics|mesh-ancestor
101688921|NCT00649038|Natriuretic Agents|natriuretic agents|mesh-ancestor
101688922|NCT00649038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688923|NCT00649038|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101688924|NCT00649038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101688925|NCT00649038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346232|NCT00395382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688926|NCT00649038|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101688928|NCT00649038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101688929|NCT04169256|Bupivacaine|bupivacaine|mesh-list
101240015|NCT01619176|Methotrexate|methotrexate|mesh-list
101240083|NCT01619566|Dopamine Agents|dopamine agents|mesh-ancestor
101688930|NCT04169256|Anesthetics, Local|anesthetics, local|mesh-ancestor
101688932|NCT04169256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101688933|NCT04169256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688934|NCT04169256|Sensory System Agents|sensory system agents|mesh-ancestor
101688935|NCT04169256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101688936|NCT02658396|Bortezomib|bortezomib|mesh-list
101688937|NCT02658396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101688938|NCT02661438|Ciprofloxacin|ciprofloxacin|mesh-list
101688939|NCT02661438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101688940|NCT02661438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101688941|NCT02661438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101688942|NCT02661438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101688943|NCT02661438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101275100|NCT01860196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101275101|NCT01860196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688944|NCT02661438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688945|NCT02661438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101688946|NCT02661438|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101688947|NCT02661438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101688949|NCT00894803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101688950|NCT00601458|Naproxen|naproxen|mesh-list
101688951|NCT00601458|Pregabalin|pregabalin|mesh-list
101688952|NCT00601458|Analgesics|analgesics|mesh-ancestor
101688953|NCT00601458|Sensory System Agents|sensory system agents|mesh-ancestor
101688954|NCT00601458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101240227|NCT01620437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101688955|NCT00601458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688956|NCT00601458|Anticonvulsants|anticonvulsants|mesh-ancestor
101688957|NCT00601458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101688958|NCT00601458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101688959|NCT00601458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688960|NCT00601458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101688962|NCT00601458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101688963|NCT00601458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101688964|NCT00601458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101688965|NCT00601458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101688966|NCT00601458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101688967|NCT00601458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101688968|NCT00601458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101240643|NCT01622946|Hemostatics|hemostatics|mesh-ancestor
101688969|NCT00601458|Gout Suppressants|gout suppressants|mesh-ancestor
101688970|NCT00601458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101688971|NCT00601458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101688972|NCT02660736|rGLP-1 protein|rglp-1 protein|mesh-list
101688973|NCT02660736|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101688974|NCT02660736|Incretins|incretins|mesh-ancestor
101688975|NCT02660736|Hormones|hormones|mesh-ancestor
101688976|NCT02660736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101688977|NCT02660736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688978|NCT00649584|Gemcitabine|gemcitabine|mesh-list
101688979|NCT00649584|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101688980|NCT00649584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101688981|NCT00649584|Antimetabolites|antimetabolites|mesh-ancestor
101688982|NCT00649584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688983|NCT00649584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101688984|NCT00649584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101688985|NCT00649584|Immunotoxins|immunotoxins|mesh-ancestor
101688986|NCT00649584|Immunoconjugates|immunoconjugates|mesh-ancestor
101688987|NCT00649584|Immunologic Factors|immunologic factors|mesh-ancestor
101688988|NCT00649584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688989|NCT02141282|Venetoclax|venetoclax|mesh-list
101688990|NCT02141282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101688991|NCT02657616|Vitamin K|vitamin k|mesh-list
101688992|NCT02657616|Anticoagulants|anticoagulants|mesh-list
101688993|NCT02657616|Vitamins|vitamins|mesh-ancestor
101688994|NCT02657616|Micronutrients|micronutrients|mesh-ancestor
101688995|NCT02657616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101688996|NCT02657616|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101688997|NCT02657616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101240718|NCT01623570|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101688998|NCT02657616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101688999|NCT02657616|Hemostatics|hemostatics|mesh-ancestor
101689000|NCT02657616|Coagulants|coagulants|mesh-ancestor
101689001|NCT02657694|Sofosbuvir|sofosbuvir|mesh-list
101240873|NCT01624441|Epirubicin|epirubicin|mesh-list
101689002|NCT02657694|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
101689003|NCT02657694|Ledipasvir|ledipasvir|mesh-list
101689004|NCT02657694|Velpatasvir|velpatasvir|mesh-list
101689005|NCT02657694|Antiviral Agents|antiviral agents|mesh-ancestor
101689006|NCT02657694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101689007|NCT02657460|Cisplatin|cisplatin|mesh-list
101689008|NCT02657460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101689009|NCT00649896|Estradiol|estradiol|mesh-list
101689010|NCT00649896|Estrogens|estrogens|mesh-ancestor
101689011|NCT00649896|Hormones|hormones|mesh-ancestor
101241127|NCT01626911|Heparin|heparin|mesh-list
101689012|NCT00649896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101689013|NCT00649896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689015|NCT00649662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101689016|NCT00649662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101689017|NCT00649662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101689018|NCT00649662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101689019|NCT00649662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101689020|NCT00649662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689021|NCT00649662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101689022|NCT00649662|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101689023|NCT00649662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101689024|NCT04188158|Capecitabine|capecitabine|mesh-list
101241337|NCT01627717|Maraviroc|maraviroc|mesh-list
101689025|NCT04188158|Oxaliplatin|oxaliplatin|mesh-list
101689026|NCT04188158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101241475|NCT01628952|Curare|curare|mesh-list
101689027|NCT04188158|Antimetabolites|antimetabolites|mesh-ancestor
101241483|NCT01628952|Cholinergic Agents|cholinergic agents|mesh-ancestor
101689028|NCT04188158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689029|NCT04188158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101689030|NCT02831231|Xanomeline|xanomeline|mesh-list
101689031|NCT02831231|Trospium chloride|trospium chloride|mesh-list
101689032|NCT02831231|Parasympatholytics|parasympatholytics|mesh-ancestor
101689033|NCT02831231|Autonomic Agents|autonomic agents|mesh-ancestor
101689034|NCT02831231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101689035|NCT02831231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689036|NCT02831231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101689037|NCT02831231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101689038|NCT02831231|Cholinergic Agents|cholinergic agents|mesh-ancestor
101689039|NCT02831231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101689040|NCT02831231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689041|NCT02831231|Urological Agents|urological agents|mesh-ancestor
101689042|NCT02831231|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101689043|NCT02831231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101689044|NCT02831231|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101689045|NCT02831231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101689047|NCT05234606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101689048|NCT05234606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101689049|NCT05234606|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101689050|NCT05234606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689051|NCT00649740|Topiramate|topiramate|mesh-list
101689052|NCT00649740|Anticonvulsants|anticonvulsants|mesh-ancestor
101689053|NCT00649740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101689054|NCT00649740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689055|NCT04209920|Chromium|chromium|mesh-list
101689057|NCT04209920|Trace Elements|trace elements|mesh-ancestor
101689058|NCT04209920|Micronutrients|micronutrients|mesh-ancestor
101689059|NCT04209920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689060|NCT00616694|Risedronic Acid|risedronic acid|mesh-list
101689061|NCT00616694|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101689062|NCT00616694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101241610|NCT01629628|Immunologic Factors|immunologic factors|mesh-ancestor
101241745|NCT01630655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101689063|NCT00616694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689064|NCT00616694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101689065|NCT00616694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241893|NCT01631409|Autonomic Agents|autonomic agents|mesh-ancestor
101689066|NCT00616694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101689067|NCT02660658|Dexmedetomidine|dexmedetomidine|mesh-list
101689068|NCT02660658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101689069|NCT02660658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101242041|NCT01632605|Sirolimus|sirolimus|mesh-list
101689070|NCT02660658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689071|NCT02660658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101689072|NCT02660658|Analgesics|analgesics|mesh-ancestor
101689073|NCT02660658|Sensory System Agents|sensory system agents|mesh-ancestor
101689074|NCT02660658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101689075|NCT02660658|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101689076|NCT02660658|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101689077|NCT02660658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101275178|NCT01860690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101689078|NCT02660658|Adrenergic Agents|adrenergic agents|mesh-ancestor
101275179|NCT01860690|Dermatologic Agents|dermatologic agents|mesh-ancestor
101689079|NCT02660658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101689080|NCT02660658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689082|NCT02660502|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101689083|NCT02660502|Insulin Lispro|insulin lispro|mesh-list
101689084|NCT02660502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101689085|NCT02660502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689086|NCT02660346|Vancomycin|vancomycin|mesh-list
101689087|NCT02660346|Daptomycin|daptomycin|mesh-list
101689088|NCT02660346|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
101689089|NCT02660346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101689090|NCT02660346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101689091|NCT00620438|Efavirenz|efavirenz|mesh-list
101689092|NCT00620438|Nevirapine|nevirapine|mesh-list
101689093|NCT00620438|Rifampin|rifampin|mesh-list
101689094|NCT00620438|Lumefantrine|lumefantrine|mesh-list
101689095|NCT00620438|Artemether|artemether|mesh-list
101689096|NCT00620438|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101689097|NCT00620438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101689098|NCT00620438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101689099|NCT00620438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101689100|NCT00620438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689101|NCT00620438|Antiviral Agents|antiviral agents|mesh-ancestor
101689102|NCT00620438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101689103|NCT00620438|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101689104|NCT00620438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101689105|NCT00620438|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101689106|NCT00620438|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101689107|NCT00620438|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101689108|NCT00620438|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101205398|NCT02010385|Octreotide|octreotide|mesh-list
101689109|NCT00620438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101689110|NCT00620438|Antitubercular Agents|antitubercular agents|mesh-ancestor
101275224|NCT01860833|Celecoxib|celecoxib|mesh-list
101689111|NCT00620438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101689112|NCT00620438|Leprostatic Agents|leprostatic agents|mesh-ancestor
101689113|NCT00620438|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101689114|NCT00620438|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101689115|NCT00620438|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101689116|NCT00620438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101242370|NCT01634906|Antimetabolites|antimetabolites|mesh-ancestor
101689118|NCT00620438|Antimalarials|antimalarials|mesh-ancestor
101689119|NCT00620438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101689120|NCT00620438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101689122|NCT00891839|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101242518|NCT01635946|Isavuconazole|isavuconazole|mesh-list
101689123|NCT00891839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101689124|NCT00891839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101689125|NCT00891839|Immunologic Factors|immunologic factors|mesh-ancestor
101689126|NCT00891839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689127|NCT00891839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101689128|NCT00891839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101689129|NCT00891839|Alkylating Agents|alkylating agents|mesh-ancestor
101689130|NCT00891839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689131|NCT00600756|Risperidone|risperidone|mesh-list
101689132|NCT00600756|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101689133|NCT00600756|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101689134|NCT00600756|Serotonin Agents|serotonin agents|mesh-ancestor
101242908|NCT01637545|Ramosetron|ramosetron|mesh-list
101689135|NCT00600756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101689136|NCT00600756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242959|NCT01637636|Antifungal Agents|antifungal agents|mesh-ancestor
101689137|NCT00600756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689139|NCT00600756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101689140|NCT00600756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101689141|NCT00600756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101689142|NCT00600756|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101689143|NCT00600756|Dopamine Agents|dopamine agents|mesh-ancestor
101689144|NCT00600756|Antidepressive Agents|antidepressive agents|mesh-ancestor
101243255|NCT01638988|Metformin|metformin|mesh-list
101689145|NCT02657148|Contraceptive Agents|contraceptive agents|mesh-list
101689146|NCT02657148|Etonogestrel|etonogestrel|mesh-list
101689147|NCT02657148|Desogestrel|desogestrel|mesh-list
101689148|NCT02657148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101689149|NCT02657148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689150|NCT02657148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101689151|NCT02657148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101243474|NCT01642979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101689152|NCT02657148|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101689153|NCT02657148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101689154|NCT02657148|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101206834|NCT01434069|Leucovorin|leucovorin|mesh-list
101275247|NCT01861015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101689155|NCT02657148|Progestins|progestins|mesh-ancestor
101689156|NCT02657148|Hormones|hormones|mesh-ancestor
101275248|NCT01861015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689157|NCT02657148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101689158|NCT04247087|Vitamin K|vitamin k|mesh-list
101689159|NCT04247087|Vitamin K 1|vitamin k 1|mesh-list
101689160|NCT04247087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101689161|NCT04247087|Vitamins|vitamins|mesh-ancestor
101689162|NCT04247087|Micronutrients|micronutrients|mesh-ancestor
101689163|NCT04247087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689164|NCT04247087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101689165|NCT04247087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101243908|NCT01651520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101689166|NCT04247087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689168|NCT04247087|Coagulants|coagulants|mesh-ancestor
101689169|NCT00649116|Metoprolol|metoprolol|mesh-list
101244065|NCT01652339|Amlodipine|amlodipine|mesh-list
101689170|NCT00649116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101689171|NCT00649116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101689172|NCT00649116|Sympatholytics|sympatholytics|mesh-ancestor
101689173|NCT00649116|Autonomic Agents|autonomic agents|mesh-ancestor
101689174|NCT00649116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101689175|NCT00649116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689176|NCT00649116|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101689177|NCT00649116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101689178|NCT00649116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101689179|NCT00649116|Adrenergic Agents|adrenergic agents|mesh-ancestor
101689180|NCT00649116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101689181|NCT00649116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689182|NCT02652234|Endostar protein|endostar protein|mesh-list
101689183|NCT02652234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101689184|NCT02652234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101689186|NCT02652234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689187|NCT02652234|Growth Inhibitors|growth inhibitors|mesh-ancestor
101689188|NCT02652234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101689190|NCT04211012|Cisplatin|cisplatin|mesh-list
101689191|NCT04211012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101689192|NCT04211012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101689193|NCT04211012|Tubulin Modulators|tubulin modulators|mesh-ancestor
101689194|NCT04211012|Antimitotic Agents|antimitotic agents|mesh-ancestor
101689195|NCT04211012|Mitosis Modulators|mitosis modulators|mesh-ancestor
101689196|NCT04211012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689197|NCT00649974|Valacyclovir|valacyclovir|mesh-list
101689198|NCT00649974|Antiviral Agents|antiviral agents|mesh-ancestor
101689199|NCT00649974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101689200|NCT02536872|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101689201|NCT02536872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101689202|NCT00620594|Dactolisib|dactolisib|mesh-list
101689203|NCT00620594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101689204|NCT02655822|Atezolizumab|atezolizumab|mesh-list
101275271|NCT01861145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101689205|NCT02655822|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101689206|NCT02655822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275272|NCT01861145|Dermatologic Agents|dermatologic agents|mesh-ancestor
101275273|NCT01861145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101689207|NCT02655822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101689208|NCT02655822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101689209|NCT00650442|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101689210|NCT00650442|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101689212|NCT00650442|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101244542|NCT01655056|Darexaban|darexaban|mesh-list
101689213|NCT00650442|Estrogens|estrogens|mesh-ancestor
101689214|NCT00650442|Hormones|hormones|mesh-ancestor
101689215|NCT00650442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101689216|NCT00650442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689217|NCT00650442|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101689218|NCT00650442|Contraceptive Agents|contraceptive agents|mesh-ancestor
101689219|NCT00650442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101689220|NCT00650442|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101689221|NCT00890825|Docetaxel|docetaxel|mesh-list
101689222|NCT00890825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101689223|NCT00890825|Tubulin Modulators|tubulin modulators|mesh-ancestor
101689224|NCT00890825|Antimitotic Agents|antimitotic agents|mesh-ancestor
101689225|NCT00890825|Mitosis Modulators|mitosis modulators|mesh-ancestor
101689226|NCT00890825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689227|NCT04760132|Vaccines|vaccines|mesh-list
101689228|NCT04760132|Immunologic Factors|immunologic factors|mesh-ancestor
101689229|NCT04760132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689230|NCT04248101|Silver Nitrate|silver nitrate|mesh-list
101689231|NCT04248101|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101689232|NCT04248101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101689234|NCT00649818|Anticonvulsants|anticonvulsants|mesh-ancestor
101689235|NCT00649818|Antiemetics|antiemetics|mesh-ancestor
101689236|NCT00649818|Autonomic Agents|autonomic agents|mesh-ancestor
101689237|NCT00649818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101689238|NCT00649818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689239|NCT00649818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101689240|NCT00649818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101689241|NCT00649818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101208393|NCT01440062|Vitamin D|vitamin d|mesh-list
101275294|NCT01861340|Immunologic Factors|immunologic factors|mesh-ancestor
101275295|NCT01861340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101689242|NCT00649818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101275296|NCT01861340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101689243|NCT00649818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101689244|NCT00649818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101689246|NCT00649818|GABA Agents|gaba agents|mesh-ancestor
101689247|NCT00649818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101689248|NCT00649818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689249|NCT02830139|Capecitabine|capecitabine|mesh-list
101245476|NCT01659359|Anesthetics|anesthetics|mesh-ancestor
101689251|NCT02830139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101689252|NCT02830139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101689254|NCT02830139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689255|NCT02833025|Thrombin|thrombin|mesh-list
101689256|NCT02833025|Hemostatics|hemostatics|mesh-ancestor
101689257|NCT02833025|Coagulants|coagulants|mesh-ancestor
101689258|NCT02651610|Paclitaxel|paclitaxel|mesh-list
101689260|NCT02651610|Taxane|taxane|mesh-list
101245761|NCT01660997|Ixazomib|ixazomib|mesh-list
101689261|NCT02651610|Bavituximab|bavituximab|mesh-list
101689262|NCT02651610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101689263|NCT02651610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101689264|NCT02651610|Tubulin Modulators|tubulin modulators|mesh-ancestor
101689265|NCT02651610|Antimitotic Agents|antimitotic agents|mesh-ancestor
101689266|NCT02651610|Mitosis Modulators|mitosis modulators|mesh-ancestor
101689267|NCT02651610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689268|NCT02651610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101689269|NCT04208594|Propranolol|propranolol|mesh-list
101689271|NCT04208594|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101689272|NCT04208594|Adrenergic Agents|adrenergic agents|mesh-ancestor
101689273|NCT04208594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101689274|NCT04208594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689275|NCT04208594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689276|NCT04208594|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101689277|NCT04208594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101689278|NCT04208594|Vasodilator Agents|vasodilator agents|mesh-ancestor
101689279|NCT04733144|Dexamethasone|dexamethasone|mesh-list
101689280|NCT04733144|Prednisolone|prednisolone|mesh-list
101689281|NCT04733144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101689282|NCT04733144|Antiemetics|antiemetics|mesh-ancestor
101689283|NCT04733144|Autonomic Agents|autonomic agents|mesh-ancestor
101689284|NCT04733144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101689285|NCT04733144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689286|NCT04733144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101689287|NCT04733144|Glucocorticoids|glucocorticoids|mesh-ancestor
101689288|NCT04733144|Hormones|hormones|mesh-ancestor
101689289|NCT04733144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101689290|NCT04733144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101275338|NCT01862003|Leucovorin|leucovorin|mesh-list
101689291|NCT04733144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101689292|NCT04724720|Famotidine|famotidine|mesh-list
101689293|NCT04724720|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101689294|NCT04724720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101689295|NCT04724720|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101689296|NCT04724720|Histamine Antagonists|histamine antagonists|mesh-ancestor
101689298|NCT04724720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101689299|NCT04724720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689300|NCT04724720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689302|NCT02833103|Bromides|bromides|mesh-list
101689303|NCT02833103|Anticonvulsants|anticonvulsants|mesh-ancestor
101689304|NCT02833103|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101689305|NCT02833103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101689306|NCT02833103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246471|NCT01666236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101689307|NCT02833103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101689308|NCT02833103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689309|NCT02833103|Parasympatholytics|parasympatholytics|mesh-ancestor
101689310|NCT02833103|Autonomic Agents|autonomic agents|mesh-ancestor
101689311|NCT02833103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101689312|NCT02648490|Acetaminophen|acetaminophen|mesh-list
101689313|NCT02648490|Diphenhydramine|diphenhydramine|mesh-list
101689314|NCT02648490|Promethazine|promethazine|mesh-list
101689315|NCT02648490|Dexamethasone|dexamethasone|mesh-list
101689316|NCT02648490|Ondansetron|ondansetron|mesh-list
101689317|NCT02648490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101689318|NCT02648490|Antiemetics|antiemetics|mesh-ancestor
101689319|NCT02648490|Autonomic Agents|autonomic agents|mesh-ancestor
101689320|NCT02648490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101689321|NCT02648490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689322|NCT02648490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101689323|NCT02648490|Glucocorticoids|glucocorticoids|mesh-ancestor
101246919|NCT01669226|Taxane|taxane|mesh-list
101689324|NCT02648490|Hormones|hormones|mesh-ancestor
101689325|NCT02648490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101689326|NCT02648490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101689327|NCT02648490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101689328|NCT02648490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101689329|NCT02648490|Analgesics|analgesics|mesh-ancestor
101247056|NCT01670552|Pantoprazole|pantoprazole|mesh-list
101689330|NCT02648490|Sensory System Agents|sensory system agents|mesh-ancestor
101689332|NCT02648490|Antipruritics|antipruritics|mesh-ancestor
101689333|NCT02648490|Dermatologic Agents|dermatologic agents|mesh-ancestor
101689334|NCT02648490|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101689335|NCT02648490|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101689336|NCT02648490|Serotonin Agents|serotonin agents|mesh-ancestor
101275362|NCT01862081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101689337|NCT02648490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101689338|NCT02648490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689339|NCT02648490|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101275363|NCT01862081|Tubulin Modulators|tubulin modulators|mesh-ancestor
101689340|NCT02648490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101689341|NCT02648490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101689342|NCT02648490|Anesthetics, Local|anesthetics, local|mesh-ancestor
101689343|NCT02648490|Anesthetics|anesthetics|mesh-ancestor
101689344|NCT02648490|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101689345|NCT02648490|Histamine Antagonists|histamine antagonists|mesh-ancestor
101247571|NCT05226923|Meropenem|meropenem|mesh-list
101689346|NCT02648490|Histamine Agents|histamine agents|mesh-ancestor
101689347|NCT02648490|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101689348|NCT04965272|Cariprazine|cariprazine|mesh-list
101689349|NCT04965272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101689350|NCT04965272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101689351|NCT04965272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101689352|NCT04965272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689353|NCT04965272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101689355|NCT02648412|Analgesics|analgesics|mesh-ancestor
101689356|NCT02648412|Sensory System Agents|sensory system agents|mesh-ancestor
101689357|NCT02648412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101689358|NCT02648412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689359|NCT02648412|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101689360|NCT02648412|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101248161|NCT05838729|Pembrolizumab|pembrolizumab|mesh-list
101689362|NCT02648412|Anesthetics|anesthetics|mesh-ancestor
101689363|NCT02648412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101689364|NCT02648412|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101689365|NCT02648412|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101248372|NCT05650996|Protease Inhibitors|protease inhibitors|mesh-ancestor
101689366|NCT02648412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101689367|NCT02648412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689368|NCT00650520|Bromocriptine|bromocriptine|mesh-list
101689370|NCT00650520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101689372|NCT00650520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101689373|NCT00650520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689374|NCT00650520|Dopamine Agonists|dopamine agonists|mesh-ancestor
101689376|NCT00650520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101248678|NCT04257448|Antimetabolites|antimetabolites|mesh-ancestor
101689377|NCT00650520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689378|NCT04244981|Thrombin|thrombin|mesh-list
101346689|NCT00029328|Etanercept|etanercept|mesh-list
101689379|NCT04244981|Hemostatics|hemostatics|mesh-ancestor
101689380|NCT04244981|Coagulants|coagulants|mesh-ancestor
101689381|NCT00621218|Tretinoin|tretinoin|mesh-list
101689382|NCT00621218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101689383|NCT00621218|Keratolytic Agents|keratolytic agents|mesh-ancestor
101689384|NCT00621218|Dermatologic Agents|dermatologic agents|mesh-ancestor
101689385|NCT02655276|Glycine|glycine|mesh-list
101689386|NCT02655276|Glycine Agents|glycine agents|mesh-ancestor
101689387|NCT02655276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101689388|NCT02655276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275386|NCT01862302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275387|NCT01862302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101689389|NCT02655276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689390|NCT02832947|Rivaroxaban|rivaroxaban|mesh-list
101689391|NCT02832947|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101689392|NCT02832947|Antithrombins|antithrombins|mesh-ancestor
101689393|NCT02832947|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101689394|NCT02832947|Protease Inhibitors|protease inhibitors|mesh-ancestor
101689395|NCT02832947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101248803|NCT03069326|Thalidomide|thalidomide|mesh-list
101689396|NCT02832947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689397|NCT02832947|Anticoagulants|anticoagulants|mesh-ancestor
101689398|NCT00651300|Parecoxib|parecoxib|mesh-list
101689399|NCT00651300|Valdecoxib|valdecoxib|mesh-list
101689400|NCT00651300|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101248964|NCT01684982|Sirolimus|sirolimus|mesh-list
101689401|NCT00651300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101689402|NCT00651300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101689403|NCT00651300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689404|NCT00651300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101689405|NCT00651300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101689407|NCT00651300|Sensory System Agents|sensory system agents|mesh-ancestor
101689408|NCT00651300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101689409|NCT00651300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689410|NCT00651300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101689411|NCT00651300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101689412|NCT02828033|Rilonacept|rilonacept|mesh-list
101689413|NCT02828033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101689414|NCT00621998|Olanzapine|olanzapine|mesh-list
101689415|NCT00621998|Risperidone|risperidone|mesh-list
101689416|NCT00621998|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101689417|NCT00621998|Serotonin Agents|serotonin agents|mesh-ancestor
101689418|NCT00621998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101689419|NCT00621998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689420|NCT00621998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689421|NCT00621998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101689422|NCT00621998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101689423|NCT00621998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101689424|NCT00621998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101689425|NCT00621998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101689426|NCT00621998|Dopamine Agents|dopamine agents|mesh-ancestor
101689428|NCT00621998|Autonomic Agents|autonomic agents|mesh-ancestor
101689429|NCT00621998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101249660|NCT01693679|Antiviral Agents|antiviral agents|mesh-ancestor
101689430|NCT00621998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101689431|NCT00621998|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101689432|NCT00621998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101689433|NCT00621998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101689434|NCT02655198|Fenfluramine|fenfluramine|mesh-list
101689435|NCT02655198|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101689436|NCT02655198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101689437|NCT02655198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101275414|NCT01862497|Vasodilator Agents|vasodilator agents|mesh-ancestor
101689438|NCT02655198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689439|NCT02655198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101689440|NCT02655198|Serotonin Agents|serotonin agents|mesh-ancestor
101689441|NCT02655198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689443|NCT00650052|Anticonvulsants|anticonvulsants|mesh-ancestor
101689444|NCT00650052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101689445|NCT00650052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101689446|NCT00650052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250318|NCT05238506|Anesthetics, Local|anesthetics, local|mesh-ancestor
101689447|NCT00650052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101689448|NCT00650052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250394|NCT05189444|Bismuth|bismuth|mesh-list
101689450|NCT00891527|Imatinib Mesylate|imatinib mesylate|mesh-list
101689451|NCT00891527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101689452|NCT00891527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346758|NCT00395772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101689453|NCT00891527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101250534|NCT04950868|Antidepressive Agents|antidepressive agents|mesh-ancestor
101689454|NCT00891527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101689455|NCT00891527|Growth Substances|growth substances|mesh-ancestor
101689456|NCT00891527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250684|NCT04640818|Rituximab|rituximab|mesh-list
101689457|NCT00891527|Growth Inhibitors|growth inhibitors|mesh-ancestor
101689458|NCT00891527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101250760|NCT04490707|Lenalidomide|lenalidomide|mesh-list
101689459|NCT00891527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101689460|NCT00891527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689461|NCT03861078|Nicotine|nicotine|mesh-list
101689462|NCT03861078|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101689463|NCT03861078|Autonomic Agents|autonomic agents|mesh-ancestor
101689464|NCT03861078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101689465|NCT03861078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689466|NCT03861078|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101689467|NCT03861078|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101275438|NCT01862887|Moxifloxacin|moxifloxacin|mesh-list
101275439|NCT01862887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101275440|NCT01862887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101689469|NCT03861078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101251055|NCT03993249|Nivolumab|nivolumab|mesh-list
101689470|NCT03861078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689471|NCT02829359|Entecavir|entecavir|mesh-list
101689472|NCT02829359|Antiviral Agents|antiviral agents|mesh-ancestor
101251118|NCT05802303|Estrogens|estrogens|mesh-ancestor
101689473|NCT02829359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101689474|NCT02650752|Capecitabine|capecitabine|mesh-list
101689475|NCT02650752|Lapatinib|lapatinib|mesh-list
101689476|NCT02650752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101689477|NCT02650752|Antimetabolites|antimetabolites|mesh-ancestor
101689478|NCT02650752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251345|NCT05785689|Analgesics|analgesics|mesh-ancestor
101689479|NCT02650752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101689480|NCT02650752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101689481|NCT02650752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101689482|NCT02832713|Botulinum Toxins|botulinum toxins|mesh-list
101689483|NCT02832713|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101689484|NCT02832713|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101689485|NCT02832713|Hyaluronic Acid|hyaluronic acid|mesh-list
101689486|NCT02832713|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101251479|NCT05521984|Alkylating Agents|alkylating agents|mesh-ancestor
101689487|NCT02832713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101689488|NCT02832713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689489|NCT02832713|Cholinergic Agents|cholinergic agents|mesh-ancestor
101689490|NCT02832713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101689491|NCT02832713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689492|NCT02832713|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101689493|NCT02832713|Immunologic Factors|immunologic factors|mesh-ancestor
101689494|NCT02832713|Viscosupplements|viscosupplements|mesh-ancestor
101689495|NCT02832713|Protective Agents|protective agents|mesh-ancestor
101689496|NCT02832713|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101689497|NCT02832713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101689498|NCT02832635|Temozolomide|temozolomide|mesh-list
101689499|NCT02832635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101689500|NCT02832635|Alkylating Agents|alkylating agents|mesh-ancestor
101689501|NCT02832635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689502|NCT02832635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101689503|NCT00650598|Diclofenac|diclofenac|mesh-list
101689504|NCT00650598|Valdecoxib|valdecoxib|mesh-list
101689505|NCT00650598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101275477|NCT01863147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101689506|NCT00650598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101275478|NCT01863147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275479|NCT01863147|Incretins|incretins|mesh-ancestor
101689507|NCT00650598|Analgesics|analgesics|mesh-ancestor
101275480|NCT01863147|Hormones|hormones|mesh-ancestor
101689508|NCT00650598|Sensory System Agents|sensory system agents|mesh-ancestor
101689509|NCT00650598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101689510|NCT00650598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689511|NCT00650598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101689513|NCT00650598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101689514|NCT00650598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101689515|NCT00650598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252053|NCT03253289|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101689516|NCT00650598|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101252132|NCT02682511|Ifetroban|ifetroban|mesh-list
101689518|NCT00620204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101689519|NCT00620204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101689520|NCT00620204|Antimetabolites|antimetabolites|mesh-ancestor
101689521|NCT00620204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689522|NCT00620204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101689523|NCT00620204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101689524|NCT00620204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101689525|NCT02650596|Liraglutide|liraglutide|mesh-list
101689526|NCT02650596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101689527|NCT02650596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689529|NCT02650596|Hormones|hormones|mesh-ancestor
101252489|NCT03649802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101689530|NCT02650596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101689531|NCT02650518|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101252560|NCT03546556|Antiviral Agents|antiviral agents|mesh-ancestor
101689532|NCT02650518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101689533|NCT02832089|Carvedilol|carvedilol|mesh-list
101689534|NCT02832089|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101689535|NCT02832089|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101689537|NCT02832089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101689538|NCT02832089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689539|NCT02832089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252779|NCT05357859|Vitamins|vitamins|mesh-ancestor
101689540|NCT02832089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101689542|NCT02832089|Protective Agents|protective agents|mesh-ancestor
101689543|NCT02832089|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101689544|NCT02832089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101689545|NCT02832089|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101689546|NCT02832089|Vasodilator Agents|vasodilator agents|mesh-ancestor
101689547|NCT02832089|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101689548|NCT02832089|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101689550|NCT04247633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101689551|NCT04247633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101253147|NCT02692651|Fidaxomicin|fidaxomicin|mesh-list
101689553|NCT04247633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689554|NCT00891371|Lanreotide|lanreotide|mesh-list
101689555|NCT00891371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101689556|NCT04324229|Liraglutide|liraglutide|mesh-list
101253219|NCT02499367|Doxorubicin|doxorubicin|mesh-list
101689558|NCT04324229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689559|NCT04324229|Incretins|incretins|mesh-ancestor
101689560|NCT04324229|Hormones|hormones|mesh-ancestor
101253365|NCT02283281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101689561|NCT04324229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101689563|NCT04430894|Lenalidomide|lenalidomide|mesh-list
101689564|NCT04430894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101689565|NCT04430894|Antiemetics|antiemetics|mesh-ancestor
101689566|NCT04430894|Autonomic Agents|autonomic agents|mesh-ancestor
101253508|NCT01913730|Dexamethasone|dexamethasone|mesh-list
101275507|NCT01863225|Atorvastatin|atorvastatin|mesh-list
101689567|NCT04430894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101689568|NCT04430894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689569|NCT04430894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101689572|NCT04430894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101689573|NCT04430894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101253664|NCT01187433|Vaccines|vaccines|mesh-list
101689574|NCT04430894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101689575|NCT04430894|Immunologic Factors|immunologic factors|mesh-ancestor
101689576|NCT04430894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101689577|NCT04430894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101253803|NCT01694134|Lidocaine|lidocaine|mesh-list
101689578|NCT04430894|Growth Substances|growth substances|mesh-ancestor
101689579|NCT04430894|Growth Inhibitors|growth inhibitors|mesh-ancestor
101689581|NCT02829281|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101689582|NCT02829281|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101689584|NCT02829281|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101689585|NCT02829281|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101689586|NCT02829281|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101689587|NCT02829281|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101689588|NCT02829281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101689589|NCT02829281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689590|NCT02829281|Cholinergic Agents|cholinergic agents|mesh-ancestor
101689591|NCT02829281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101689592|NCT02829281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689593|NCT02829281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101689594|NCT02829281|Glucocorticoids|glucocorticoids|mesh-ancestor
101689595|NCT02829281|Hormones|hormones|mesh-ancestor
101689596|NCT02829281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101689598|NCT02829281|Immunologic Factors|immunologic factors|mesh-ancestor
101689599|NCT02829281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101689600|NCT02829281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101689601|NCT02829281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101689602|NCT04210544|Caseins|caseins|mesh-list
101689603|NCT04210544|Chelating Agents|chelating agents|mesh-ancestor
101689604|NCT04210544|Sequestering Agents|sequestering agents|mesh-ancestor
101689605|NCT04210544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689606|NCT04168944|Lenvatinib|lenvatinib|mesh-list
101689607|NCT04168944|Immunosuppressive Agents|immunosuppressive agents|mesh-list
101689608|NCT04168944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101689609|NCT04168944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101254173|NCT01697046|Antiviral Agents|antiviral agents|mesh-ancestor
101410043|NCT00112658|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101689611|NCT04168944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101275520|NCT01863251|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101689612|NCT04168944|Immunologic Factors|immunologic factors|mesh-ancestor
101689613|NCT04168944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689614|NCT02697032|Bicalutamide|bicalutamide|mesh-list
101689615|NCT02697032|Androgen Antagonists|androgen antagonists|mesh-ancestor
101689616|NCT02697032|Hormone Antagonists|hormone antagonists|mesh-ancestor
101689617|NCT02697032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101254442|NCT01698749|Dexamethasone|dexamethasone|mesh-list
101689618|NCT02697032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689619|NCT02697032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101689620|NCT04409834|Heparin|heparin|mesh-list
101689621|NCT04409834|Calcium heparin|calcium heparin|mesh-list
101689622|NCT04409834|Enoxaparin|enoxaparin|mesh-list
101689623|NCT04409834|Enoxaparin sodium|enoxaparin sodium|mesh-list
101689624|NCT04409834|Clopidogrel|clopidogrel|mesh-list
101689625|NCT04409834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101689626|NCT04409834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101689627|NCT04409834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101689628|NCT04409834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101689629|NCT04409834|Purinergic Agents|purinergic agents|mesh-ancestor
101689630|NCT04409834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101689631|NCT04409834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689632|NCT04409834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689633|NCT04409834|Anticoagulants|anticoagulants|mesh-ancestor
101689634|NCT04409834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101689635|NCT04409834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101689636|NCT02647632|Ribavirin|ribavirin|mesh-list
101689637|NCT02647632|Sofosbuvir|sofosbuvir|mesh-list
101689638|NCT02647632|Grazoprevir|grazoprevir|mesh-list
101689639|NCT02647632|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
101689640|NCT02647632|Antimetabolites|antimetabolites|mesh-ancestor
101254798|NCT01701076|Lenalidomide|lenalidomide|mesh-list
101689641|NCT02647632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689642|NCT02647632|Antiviral Agents|antiviral agents|mesh-ancestor
101254946|NCT01701778|Anesthetics|anesthetics|mesh-ancestor
101689643|NCT02647632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101689645|NCT00621452|Cyclophosphamide|cyclophosphamide|mesh-list
101689646|NCT00621452|Interleukin-2|interleukin-2|mesh-list
101689647|NCT00621452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101689648|NCT00621452|Immunologic Factors|immunologic factors|mesh-ancestor
101689649|NCT00621452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689650|NCT00621452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101689651|NCT00621452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101689652|NCT00621452|Alkylating Agents|alkylating agents|mesh-ancestor
101689653|NCT00621452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689654|NCT00621452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101275546|NCT01863407|Metronidazole|metronidazole|mesh-list
101275547|NCT01863407|Dexamethasone|dexamethasone|mesh-list
101689655|NCT00621452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101255104|NCT01702714|Paclitaxel|paclitaxel|mesh-list
101689656|NCT00621452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101689657|NCT00621452|Analgesics|analgesics|mesh-ancestor
101689658|NCT00621452|Sensory System Agents|sensory system agents|mesh-ancestor
101689659|NCT00621452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101689660|NCT00621452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101689661|NCT00621452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101689662|NCT00621452|Antiviral Agents|antiviral agents|mesh-ancestor
101255308|NCT01704092|Analgesics|analgesics|mesh-ancestor
101689663|NCT00621452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101689664|NCT04336748|Hydroxychloroquine|hydroxychloroquine|mesh-list
101689665|NCT04336748|Antimalarials|antimalarials|mesh-ancestor
101689666|NCT04336748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101689667|NCT04336748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101689668|NCT04336748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101689669|NCT04336748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101689670|NCT04336748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689671|NCT04336748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101689672|NCT00651612|Timolol|timolol|mesh-list
101689673|NCT00651612|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101689674|NCT00651612|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101689675|NCT00651612|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101689676|NCT00651612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101255392|NCT01704690|Paclitaxel|paclitaxel|mesh-list
101689677|NCT00651612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101689678|NCT00651612|Adrenergic Agents|adrenergic agents|mesh-ancestor
101689679|NCT00651612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101689680|NCT00651612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255518|NCT01705340|Trastuzumab|trastuzumab|mesh-list
101689681|NCT00651612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689682|NCT00651612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101689683|NCT00651612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101255590|NCT01705743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689684|NCT00651612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101689685|NCT00651612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101689686|NCT00651612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101689688|NCT00650754|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101255736|NCT01707082|Anesthetics|anesthetics|mesh-ancestor
101689690|NCT00650754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689691|NCT02831933|Valacyclovir|valacyclovir|mesh-list
101689692|NCT02831933|Nivolumab|nivolumab|mesh-list
101689693|NCT02831933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101689694|NCT02831933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101689695|NCT02831933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101689696|NCT02831933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689698|NCT02831933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101689699|NCT02650206|Liraglutide|liraglutide|mesh-list
101689700|NCT02650206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101689701|NCT02650206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689702|NCT02650206|Incretins|incretins|mesh-ancestor
101256235|NCT01710163|Serotonin Agents|serotonin agents|mesh-ancestor
101775331|NCT00680186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689704|NCT02650206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101689706|NCT05368766|Natriuretic Agents|natriuretic agents|mesh-ancestor
101689707|NCT05368766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689708|NCT00891293|Fenofibrate|fenofibrate|mesh-list
101689709|NCT00891293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101689710|NCT00891293|Antimetabolites|antimetabolites|mesh-ancestor
101689711|NCT00891293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689712|NCT00891293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101689713|NCT05368142|Cell Wall Skeleton|cell wall skeleton|mesh-list
101689714|NCT05368142|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101689715|NCT05368142|Immunologic Factors|immunologic factors|mesh-ancestor
101689716|NCT05368142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689717|NCT00889421|Apremilast|apremilast|mesh-list
101689718|NCT00889421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101689719|NCT00889421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101689720|NCT00889421|Analgesics|analgesics|mesh-ancestor
101689721|NCT00889421|Sensory System Agents|sensory system agents|mesh-ancestor
101689722|NCT00889421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101689723|NCT00889421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689724|NCT00889421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101689725|NCT00889421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101689726|NCT00889421|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101689727|NCT00889421|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101689728|NCT00889421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101689729|NCT00889421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689730|NCT02827643|Vitamin D|vitamin d|mesh-list
101689731|NCT02827643|Ergocalciferols|ergocalciferols|mesh-list
101689732|NCT02827643|Lamivudine|lamivudine|mesh-list
101689734|NCT02827643|Vitamins|vitamins|mesh-ancestor
101689735|NCT02827643|Micronutrients|micronutrients|mesh-ancestor
101689736|NCT02827643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689737|NCT02827643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101689738|NCT02827643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101256810|NCT01713049|Alovudine|alovudine|mesh-list
101689739|NCT02827643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101689740|NCT02827643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101689741|NCT02827643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101689742|NCT02827643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689743|NCT02827643|Antiviral Agents|antiviral agents|mesh-ancestor
101689744|NCT02827643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101689745|NCT02827643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101689746|NCT02827643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101689748|NCT02646774|Antifungal Agents|antifungal agents|mesh-ancestor
101257118|NCT01714427|Hormones|hormones|mesh-ancestor
101689749|NCT02646774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101689750|NCT02647086|Metoprolol|metoprolol|mesh-list
101689751|NCT02647086|Midazolam|midazolam|mesh-list
101689752|NCT02647086|Caffeine|caffeine|mesh-list
101689753|NCT02647086|Omeprazole|omeprazole|mesh-list
101689754|NCT02647086|Warfarin|warfarin|mesh-list
101689755|NCT02647086|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101689756|NCT02647086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101689757|NCT02647086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101689758|NCT02647086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689759|NCT02647086|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101689760|NCT02647086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101689761|NCT02647086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101689762|NCT02647086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101689763|NCT02647086|Anesthetics, General|anesthetics, general|mesh-ancestor
101689765|NCT02647086|GABA Modulators|gaba modulators|mesh-ancestor
101257311|NCT01715597|Vitamins|vitamins|mesh-ancestor
101689766|NCT02647086|GABA Agents|gaba agents|mesh-ancestor
101689767|NCT02647086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101689768|NCT02647086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689769|NCT02647086|Anticoagulants|anticoagulants|mesh-ancestor
101689770|NCT02647086|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101689771|NCT02647086|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101689772|NCT02647086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101689773|NCT02647086|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101689774|NCT02647086|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101689775|NCT02647086|Purinergic Agents|purinergic agents|mesh-ancestor
101689776|NCT02647086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101275643|NCT01863810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275644|NCT01863810|Anticonvulsants|anticonvulsants|mesh-ancestor
101689777|NCT02647086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101689778|NCT02647086|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101689779|NCT02647086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101689780|NCT02647086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101689781|NCT02647086|Sympatholytics|sympatholytics|mesh-ancestor
101689782|NCT02647086|Autonomic Agents|autonomic agents|mesh-ancestor
101689783|NCT02647086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101257448|NCT01716637|Etanercept|etanercept|mesh-list
101689784|NCT02647086|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101689785|NCT02647086|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101689786|NCT02647086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101689787|NCT02647086|Adrenergic Agents|adrenergic agents|mesh-ancestor
101257588|NCT01717690|Chlorhexidine|chlorhexidine|mesh-list
101689788|NCT00651690|Botulinum Toxins|botulinum toxins|mesh-list
101775332|NCT00936429|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101689789|NCT00651690|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101689790|NCT00651690|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101689791|NCT00651690|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101689792|NCT00651690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101689793|NCT00651690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689794|NCT00651690|Cholinergic Agents|cholinergic agents|mesh-ancestor
101689795|NCT00651690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101689796|NCT00651690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689797|NCT00651690|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101689798|NCT00651690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101689799|NCT00651768|Budesonide|budesonide|mesh-list
101689800|NCT00651768|Formoterol Fumarate|formoterol fumarate|mesh-list
101689801|NCT00651768|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101689802|NCT00651768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101258093|NCT01720459|Resveratrol|resveratrol|mesh-list
101689803|NCT00651768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101689804|NCT00651768|Autonomic Agents|autonomic agents|mesh-ancestor
101689805|NCT00651768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101689806|NCT00651768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689807|NCT00651768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101258313|NCT01730495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101689808|NCT00651768|Respiratory System Agents|respiratory system agents|mesh-ancestor
101689809|NCT00651768|Glucocorticoids|glucocorticoids|mesh-ancestor
101689810|NCT00651768|Hormones|hormones|mesh-ancestor
101689811|NCT00651768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101689812|NCT00651768|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101689813|NCT00651768|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101689814|NCT00651768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101689815|NCT00651768|Adrenergic Agents|adrenergic agents|mesh-ancestor
101689816|NCT00651768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101689817|NCT00651768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689818|NCT00651846|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
101689819|NCT00651846|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
101689820|NCT00651846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101689821|NCT00651846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689822|NCT00651846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101689823|NCT00651846|Contraceptive Agents|contraceptive agents|mesh-ancestor
101689824|NCT00651846|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101347139|NCT00031395|Clonidine|clonidine|mesh-list
101689825|NCT00651846|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101689826|NCT00651846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101689827|NCT00651846|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101689828|NCT00651846|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101689829|NCT00651846|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
101689830|NCT00651846|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101689831|NCT00651846|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101689832|NCT04167306|Bupropion|bupropion|mesh-list
101689833|NCT04167306|Varenicline|varenicline|mesh-list
101689834|NCT04167306|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101689835|NCT04167306|Antidepressive Agents|antidepressive agents|mesh-ancestor
101275705|NCT01864083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101275706|NCT01864096|Metformin|metformin|mesh-list
101689836|NCT04167306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101689837|NCT04167306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101689838|NCT04167306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101689839|NCT04167306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101689840|NCT04167306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689842|NCT04167306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101259104|NCT01736020|Ketamine|ketamine|mesh-list
101689843|NCT04167306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689844|NCT04167306|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101689845|NCT04167306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101689846|NCT04167306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101689847|NCT04167306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101689848|NCT04167306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101689849|NCT04167306|Cholinergic Agents|cholinergic agents|mesh-ancestor
101689850|NCT04244591|Methylprednisolone|methylprednisolone|mesh-list
101259176|NCT01736449|Growth Substances|growth substances|mesh-ancestor
101689851|NCT04244591|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101689852|NCT04244591|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101689853|NCT04244591|Prednisolone|prednisolone|mesh-list
101689854|NCT04244591|Prednisolone acetate|prednisolone acetate|mesh-list
101689855|NCT04244591|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101689856|NCT04244591|Prednisolone phosphate|prednisolone phosphate|mesh-list
101689857|NCT04244591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101689858|NCT04244591|Antiemetics|antiemetics|mesh-ancestor
101689859|NCT04244591|Autonomic Agents|autonomic agents|mesh-ancestor
101689860|NCT04244591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101689861|NCT04244591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689864|NCT04244591|Hormones|hormones|mesh-ancestor
101689865|NCT04244591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101689866|NCT04244591|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101689867|NCT04244591|Protective Agents|protective agents|mesh-ancestor
101689868|NCT04244591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101689869|NCT04244591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101689871|NCT02649582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101259670|NCT01739855|Antacids|antacids|mesh-ancestor
101689872|NCT02649582|Alkylating Agents|alkylating agents|mesh-ancestor
101775333|NCT00936429|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101775334|NCT00936429|Immunologic Factors|immunologic factors|mesh-ancestor
101689873|NCT02649582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689874|NCT02649582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101689875|NCT04167696|Cyclophosphamide|cyclophosphamide|mesh-list
101689877|NCT04167696|Fludarabine phosphate|fludarabine phosphate|mesh-list
101689878|NCT04167696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101689879|NCT04167696|Immunologic Factors|immunologic factors|mesh-ancestor
101689880|NCT04167696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689881|NCT04167696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101689882|NCT04167696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101260038|NCT01742429|Antacids|antacids|mesh-ancestor
101260110|NCT01742702|Bisoprolol|bisoprolol|mesh-list
101689884|NCT04167696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689885|NCT04167696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101689886|NCT04167696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101689887|NCT04167696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101689888|NCT04167696|Antimetabolites|antimetabolites|mesh-ancestor
101689889|NCT02827487|Celecoxib|celecoxib|mesh-list
101689890|NCT02827487|Tramadol|tramadol|mesh-list
101689891|NCT02827487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101689892|NCT02827487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101689893|NCT02827487|Analgesics|analgesics|mesh-ancestor
101689894|NCT02827487|Sensory System Agents|sensory system agents|mesh-ancestor
101689895|NCT02827487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101689896|NCT02827487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689897|NCT02827487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101689898|NCT02827487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101689899|NCT02827487|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101689900|NCT02827487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101689901|NCT02827487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101689902|NCT02827487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689903|NCT02827487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101689904|NCT02827487|Narcotics|narcotics|mesh-ancestor
101689905|NCT02827487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101314511|NCT00001030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101276005|NCT01866605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101689906|NCT02649504|Mycophenolic Acid|mycophenolic acid|mesh-list
101689908|NCT02649504|Rituximab|rituximab|mesh-list
101689909|NCT02649504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101689910|NCT02649504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101689911|NCT02649504|Immunologic Factors|immunologic factors|mesh-ancestor
101689912|NCT02649504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689913|NCT02649504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101689914|NCT02649504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101689915|NCT02649504|Antiemetics|antiemetics|mesh-ancestor
101689916|NCT02649504|Autonomic Agents|autonomic agents|mesh-ancestor
101689917|NCT02649504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101260679|NCT01745770|Mesalamine|mesalamine|mesh-list
101260759|NCT01746680|Tacrolimus|tacrolimus|mesh-list
101689919|NCT02649504|Glucocorticoids|glucocorticoids|mesh-ancestor
101689920|NCT02649504|Hormones|hormones|mesh-ancestor
101775335|NCT00936429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689921|NCT02649504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101689922|NCT02649504|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101689923|NCT02649504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101689924|NCT02649504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101689925|NCT02649504|Antitubercular Agents|antitubercular agents|mesh-ancestor
101689926|NCT02649504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101689927|NCT02649504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101689928|NCT02649504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101689929|NCT02649504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101276122|NCT01867775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689930|NCT03703856|Memantine|memantine|mesh-list
101689931|NCT03703856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101689932|NCT03703856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101689933|NCT03703856|Dopamine Agents|dopamine agents|mesh-ancestor
101689934|NCT03703856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101261264|NCT01749098|Anesthetics|anesthetics|mesh-ancestor
101689935|NCT03703856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689936|NCT03703856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689937|NCT03703856|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101689938|NCT03703856|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101689940|NCT00650910|Digoxin|digoxin|mesh-list
101689941|NCT00650910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101689942|NCT00650910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101689943|NCT00650910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101689944|NCT00650910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689945|NCT00650910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101689946|NCT00650910|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101689947|NCT00650910|Protective Agents|protective agents|mesh-ancestor
101689948|NCT00650910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689949|NCT02654730|Primaquine|primaquine|mesh-list
101689950|NCT02654730|Piperaquine|piperaquine|mesh-list
101689951|NCT02654730|Artenimol|artenimol|mesh-list
101689952|NCT02654730|Artemisinins|artemisinins|mesh-list
101689953|NCT02654730|Antimalarials|antimalarials|mesh-ancestor
101689954|NCT02654730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101410049|NCT00112658|Vitamins|vitamins|mesh-ancestor
101689955|NCT02654730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101689956|NCT02654730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101689957|NCT00888329|Aprepitant|aprepitant|mesh-list
101689958|NCT00888329|Antiemetics|antiemetics|mesh-ancestor
101276196|NCT01868438|Artesunate|artesunate|mesh-list
101689959|NCT00888329|Autonomic Agents|autonomic agents|mesh-ancestor
101689960|NCT00888329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101689961|NCT00888329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689962|NCT00888329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101689963|NCT00888329|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101689964|NCT00888329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101276240|NCT01868750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101689965|NCT00888329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689967|NCT00652002|Formoterol Fumarate|formoterol fumarate|mesh-list
101689968|NCT00652002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101689969|NCT00652002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101689970|NCT00652002|Autonomic Agents|autonomic agents|mesh-ancestor
101689971|NCT00652002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101689972|NCT00652002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689973|NCT00652002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101347287|NCT00031902|Prednisolone|prednisolone|mesh-list
101689974|NCT00652002|Respiratory System Agents|respiratory system agents|mesh-ancestor
101689975|NCT00652002|Glucocorticoids|glucocorticoids|mesh-ancestor
101689976|NCT00652002|Hormones|hormones|mesh-ancestor
101689977|NCT00652002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101689978|NCT00652002|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101689979|NCT00652002|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101689980|NCT00652002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101689981|NCT00652002|Adrenergic Agents|adrenergic agents|mesh-ancestor
101689982|NCT00652002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101689983|NCT00652002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689984|NCT02646540|Metolazone|metolazone|mesh-list
101689985|NCT02646540|Furosemide|furosemide|mesh-list
101689986|NCT02646540|Tolvaptan|tolvaptan|mesh-list
101689987|NCT02646540|Diuretics|diuretics|mesh-list
101689988|NCT02646540|Natriuretic Agents|natriuretic agents|mesh-ancestor
101689989|NCT02646540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101689990|NCT02646540|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101689991|NCT02646540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101689992|NCT02646540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101689993|NCT02646540|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101689994|NCT02646540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101689995|NCT02646540|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101276305|NCT01869036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101689996|NCT00651066|Ritonavir|ritonavir|mesh-list
101689997|NCT00651066|Lopinavir|lopinavir|mesh-list
101689998|NCT00651066|Rifabutin|rifabutin|mesh-list
101689999|NCT00651066|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101690000|NCT00651066|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101690001|NCT00651066|Protease Inhibitors|protease inhibitors|mesh-ancestor
101690002|NCT00651066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101690003|NCT00651066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690004|NCT00651066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101690005|NCT00651066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101690006|NCT00651066|Antiviral Agents|antiviral agents|mesh-ancestor
101690007|NCT00651066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101690008|NCT00651066|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101690009|NCT00651066|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101690010|NCT00651066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101690011|NCT00651066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101690012|NCT00651066|Antitubercular Agents|antitubercular agents|mesh-ancestor
101690013|NCT02646072|Ketorolac|ketorolac|mesh-list
101690014|NCT02646072|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101690015|NCT02646072|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101690016|NCT02646072|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101690017|NCT02646072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101690018|NCT02646072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101690019|NCT02646072|Analgesics|analgesics|mesh-ancestor
101690020|NCT02646072|Sensory System Agents|sensory system agents|mesh-ancestor
101690021|NCT02646072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101690022|NCT02646072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276345|NCT01869556|Abortifacient Agents|abortifacient agents|mesh-ancestor
101276346|NCT01869569|Pregabalin|pregabalin|mesh-list
101690023|NCT02646072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101690024|NCT02646072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101690025|NCT02646072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101690026|NCT02646072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101690027|NCT02646072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690028|NCT02654106|Temozolomide|temozolomide|mesh-list
101690029|NCT02654106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101690030|NCT02654106|Alkylating Agents|alkylating agents|mesh-ancestor
101690031|NCT02654106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690032|NCT02654106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101690033|NCT04243733|Pemetrexed|pemetrexed|mesh-list
101690034|NCT04243733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101690035|NCT04243733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101690036|NCT04243733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690037|NCT04243733|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101690038|NCT04243733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101690039|NCT03434366|Dexmedetomidine|dexmedetomidine|mesh-list
101690040|NCT03434366|Ketamine|ketamine|mesh-list
101690041|NCT03434366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101276393|NCT01869907|Minocycline|minocycline|mesh-list
101690042|NCT03434366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101690043|NCT03434366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690044|NCT03434366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101690045|NCT03434366|Analgesics|analgesics|mesh-ancestor
101690046|NCT03434366|Sensory System Agents|sensory system agents|mesh-ancestor
101347366|NCT00032019|Glucocorticoids|glucocorticoids|mesh-ancestor
101690047|NCT03434366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101690048|NCT03434366|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101690049|NCT03434366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101690050|NCT03434366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101690051|NCT03434366|Adrenergic Agents|adrenergic agents|mesh-ancestor
101690052|NCT03434366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101690053|NCT03434366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690054|NCT03434366|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101276449|NCT01870050|Antimalarials|antimalarials|mesh-ancestor
101690055|NCT03434366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101690056|NCT03434366|Anesthetics, General|anesthetics, general|mesh-ancestor
101690058|NCT03434366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101690059|NCT03434366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101690060|NCT04167228|Ceftazidime|ceftazidime|mesh-list
101690061|NCT04167228|Avibactam|avibactam|mesh-list
101276508|NCT01870167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101690062|NCT04167228|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
101690063|NCT04167228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101690064|NCT04167228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101690065|NCT04167228|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101690066|NCT04167228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101690067|NCT04167228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690068|NCT02687438|Mometasone Furoate|mometasone furoate|mesh-list
101690069|NCT02687438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101690070|NCT02687438|Dermatologic Agents|dermatologic agents|mesh-ancestor
101690071|NCT02687438|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101276575|NCT01870466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101276576|NCT01870466|Antimetabolites|antimetabolites|mesh-ancestor
101690072|NCT02537834|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
101690073|NCT02537834|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101690074|NCT02537834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690075|NCT02537834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101690076|NCT02537834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690077|NCT02648958|Dexmedetomidine|dexmedetomidine|mesh-list
101690078|NCT02648958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101276637|NCT01870804|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101690079|NCT02648958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101690080|NCT02648958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690081|NCT02648958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101690083|NCT02648958|Sensory System Agents|sensory system agents|mesh-ancestor
101690084|NCT02648958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101690085|NCT02648958|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101690086|NCT02648958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101690087|NCT02648958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101690088|NCT02648958|Adrenergic Agents|adrenergic agents|mesh-ancestor
101690089|NCT02648958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101690090|NCT02648958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690091|NCT00887549|Pemetrexed|pemetrexed|mesh-list
101690092|NCT00887549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101690093|NCT00887549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101690094|NCT00887549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690095|NCT00887549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101690096|NCT00887549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101690097|NCT04243811|Anesthetics|anesthetics|mesh-list
101690098|NCT04243811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101690099|NCT04243811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690100|NCT00638300|Dialysis Solutions|dialysis solutions|mesh-list
101690101|NCT00638300|Calcium|calcium|mesh-list
101690102|NCT00638300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101690103|NCT00638300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690104|NCT00638300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101690105|NCT00887315|Cisplatin|cisplatin|mesh-list
101690106|NCT00887315|Docetaxel|docetaxel|mesh-list
101690107|NCT00887315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101276769|NCT01871701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101690108|NCT00887315|Tubulin Modulators|tubulin modulators|mesh-ancestor
101276771|NCT01871701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101690109|NCT00887315|Antimitotic Agents|antimitotic agents|mesh-ancestor
101690110|NCT00887315|Mitosis Modulators|mitosis modulators|mesh-ancestor
101690111|NCT00887315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690112|NCT02645994|Anesthetics|anesthetics|mesh-list
101690113|NCT02645994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101690114|NCT02645994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690115|NCT03014648|Atezolizumab|atezolizumab|mesh-list
101690116|NCT03014648|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101347428|NCT00032175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101690117|NCT03014648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690118|NCT03014648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101690119|NCT03014648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101276822|NCT01871844|Somatostatin|somatostatin|mesh-list
101276826|NCT01871844|Hormones|hormones|mesh-ancestor
101690121|NCT02645058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690122|NCT02645058|Sensory System Agents|sensory system agents|mesh-ancestor
101690123|NCT02645058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101690124|NCT02644980|Anesthetics|anesthetics|mesh-list
101690125|NCT02644980|Propofol|propofol|mesh-list
101690126|NCT02644980|Etomidate|etomidate|mesh-list
101690127|NCT02644980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101690128|NCT02644980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101276906|NCT01872013|ASP7991|asp7991|mesh-list
101690129|NCT02644980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101690130|NCT02644980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101690131|NCT02644980|Anesthetics, General|anesthetics, general|mesh-ancestor
101690132|NCT04187456|Midazolam|midazolam|mesh-list
101690133|NCT04187456|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101690134|NCT04187456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101690135|NCT04187456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101690136|NCT04187456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690137|NCT04187456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101690138|NCT04187456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101690139|NCT04187456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101690140|NCT04187456|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101690141|NCT04187456|Anesthetics, General|anesthetics, general|mesh-ancestor
101690142|NCT04187456|Anesthetics|anesthetics|mesh-ancestor
101690143|NCT04187456|GABA Modulators|gaba modulators|mesh-ancestor
101690144|NCT04187456|GABA Agents|gaba agents|mesh-ancestor
101690145|NCT04187456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101276949|NCT01872416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101690146|NCT04187456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690147|NCT02827331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
101690148|NCT02827331|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
101690149|NCT02827331|Antidepressive Agents|antidepressive agents|mesh-list
101690150|NCT02827331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101690151|NCT02827331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101690153|NCT02827331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101690155|NCT02687204|Enoxaparin sodium|enoxaparin sodium|mesh-list
101690156|NCT02687204|Anticoagulants|anticoagulants|mesh-ancestor
101690157|NCT02687204|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101690158|NCT02687204|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101690159|NCT02687204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690160|NCT00650208|Lamotrigine|lamotrigine|mesh-list
101690161|NCT00650208|Anticonvulsants|anticonvulsants|mesh-ancestor
101690163|NCT00650208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101690164|NCT00650208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690165|NCT00650208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101690166|NCT00650208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690167|NCT00650208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101690168|NCT00650208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101690169|NCT00650208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101690170|NCT00650208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101690171|NCT00650208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101690172|NCT02645370|Topiramate|topiramate|mesh-list
101690173|NCT02645370|Anticonvulsants|anticonvulsants|mesh-ancestor
101690174|NCT02645370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101690175|NCT02645370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690176|NCT00652392|Budesonide|budesonide|mesh-list
101690177|NCT00652392|Formoterol Fumarate|formoterol fumarate|mesh-list
101690178|NCT00652392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101690179|NCT00652392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101690180|NCT00652392|Autonomic Agents|autonomic agents|mesh-ancestor
101690181|NCT00652392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101690182|NCT00652392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690183|NCT00652392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101690184|NCT00652392|Respiratory System Agents|respiratory system agents|mesh-ancestor
101690185|NCT00652392|Glucocorticoids|glucocorticoids|mesh-ancestor
101690186|NCT00652392|Hormones|hormones|mesh-ancestor
101690187|NCT00652392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101690188|NCT00652392|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101690189|NCT00652392|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101690190|NCT00652392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101347503|NCT00032955|Analgesics|analgesics|mesh-ancestor
101277202|NCT05855070|Viscosupplements|viscosupplements|mesh-ancestor
101277210|NCT05855018|Atropine|atropine|mesh-list
101690192|NCT00652392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101690193|NCT00652392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690194|NCT02645214|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
101690195|NCT02645214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101690196|NCT02653638|Indomethacin|indomethacin|mesh-list
101690197|NCT02653638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101690198|NCT02653638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101690199|NCT02653638|Analgesics|analgesics|mesh-ancestor
101690200|NCT02653638|Sensory System Agents|sensory system agents|mesh-ancestor
101690201|NCT02653638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101690202|NCT02653638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690203|NCT02653638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101690204|NCT02653638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101690205|NCT02653638|Gout Suppressants|gout suppressants|mesh-ancestor
101690206|NCT02653638|Tocolytic Agents|tocolytic agents|mesh-ancestor
101690207|NCT02653638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101690208|NCT02653638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101690209|NCT02653638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101690210|NCT02653638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690211|NCT02644590|Melatonin|melatonin|mesh-list
101690212|NCT02644590|Antioxidants|antioxidants|mesh-ancestor
101690213|NCT02644590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690214|NCT02644590|Protective Agents|protective agents|mesh-ancestor
101690215|NCT02644590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690216|NCT02644590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101690217|NCT00910806|Nevirapine|nevirapine|mesh-list
101690218|NCT00910806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101690219|NCT00910806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101690220|NCT00910806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101690221|NCT00910806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690222|NCT00910806|Antiviral Agents|antiviral agents|mesh-ancestor
101690223|NCT00910806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101690224|NCT00910806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101690225|NCT00910806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101690226|NCT00910806|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101690227|NCT00910806|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101690228|NCT00652704|Doxycycline|doxycycline|mesh-list
101690229|NCT00652704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101690230|NCT00652704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101690231|NCT00652704|Antimalarials|antimalarials|mesh-ancestor
101690232|NCT00652704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101690233|NCT00652704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101690235|NCT00652782|Diuretics|diuretics|mesh-ancestor
101690236|NCT00652782|Natriuretic Agents|natriuretic agents|mesh-ancestor
101690237|NCT00652782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690238|NCT00653562|Zolpidem|zolpidem|mesh-list
101690239|NCT00653562|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101690240|NCT00653562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101690241|NCT00653562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101690242|NCT00653562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690243|NCT00653562|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101690244|NCT00653562|GABA Agonists|gaba agonists|mesh-ancestor
101690245|NCT00653562|GABA Agents|gaba agents|mesh-ancestor
101690246|NCT00653562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101690247|NCT00653562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690248|NCT00887159|Cisplatin|cisplatin|mesh-list
101690249|NCT00887159|Etoposide|etoposide|mesh-list
101690250|NCT00887159|Etoposide phosphate|etoposide phosphate|mesh-list
101690251|NCT00887159|Podophyllotoxin|podophyllotoxin|mesh-list
101690252|NCT00887159|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101690253|NCT00887159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101690254|NCT00887159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101690255|NCT00887159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101690256|NCT00887159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101690257|NCT00887159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101690258|NCT00887159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690259|NCT00887159|Keratolytic Agents|keratolytic agents|mesh-ancestor
101690260|NCT00887159|Dermatologic Agents|dermatologic agents|mesh-ancestor
101690261|NCT00887159|Tubulin Modulators|tubulin modulators|mesh-ancestor
101690262|NCT00887159|Antimitotic Agents|antimitotic agents|mesh-ancestor
101277581|NCT05458375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690263|NCT00887159|Mitosis Modulators|mitosis modulators|mesh-ancestor
101690264|NCT00887159|Immunologic Factors|immunologic factors|mesh-ancestor
101690265|NCT00887159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690267|NCT00650286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101690268|NCT00650286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690269|NCT00650286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101277652|NCT05302999|Gabapentin|gabapentin|mesh-list
101690270|NCT00650286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101690271|NCT00650286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101690272|NCT00650286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690273|NCT02640846|Simendan|simendan|mesh-list
101690274|NCT02640846|Milrinone|milrinone|mesh-list
101690275|NCT02640846|Norepinephrine|norepinephrine|mesh-list
101690276|NCT02640846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101690277|NCT02640846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101690278|NCT02640846|Adrenergic Agents|adrenergic agents|mesh-ancestor
101690279|NCT02640846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101277708|NCT05232227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101690280|NCT02640846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690281|NCT02640846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690282|NCT02640846|Sympathomimetics|sympathomimetics|mesh-ancestor
101690283|NCT02640846|Autonomic Agents|autonomic agents|mesh-ancestor
101690284|NCT02640846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101690285|NCT02640846|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101690286|NCT02640846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101690287|NCT02640846|Vasodilator Agents|vasodilator agents|mesh-ancestor
101277775|NCT05073822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101690288|NCT02640846|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101690289|NCT02640846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101690290|NCT02640846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101690291|NCT02640846|Protective Agents|protective agents|mesh-ancestor
101690292|NCT02640846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101690293|NCT02644044|Methotrexate|methotrexate|mesh-list
101690294|NCT02644044|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101690295|NCT02644044|Abortifacient Agents|abortifacient agents|mesh-ancestor
101690296|NCT02644044|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101690297|NCT02644044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101277841|NCT04893525|Analgesics|analgesics|mesh-ancestor
101690298|NCT02644044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101690299|NCT02644044|Antimetabolites|antimetabolites|mesh-ancestor
101690300|NCT02644044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690301|NCT02644044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101690302|NCT02644044|Dermatologic Agents|dermatologic agents|mesh-ancestor
101690303|NCT02644044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101277905|NCT04757584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101690304|NCT02644044|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101690305|NCT02644044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101690306|NCT02644044|Immunologic Factors|immunologic factors|mesh-ancestor
101690307|NCT02644044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101690308|NCT02644044|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101690310|NCT00652860|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101690311|NCT00652860|Ifosfamide|ifosfamide|mesh-list
101690312|NCT00652860|Molgramostim|molgramostim|mesh-list
101690313|NCT00652860|Mitomycins|mitomycins|mesh-list
101690314|NCT00652860|Mitomycin|mitomycin|mesh-list
101690315|NCT00652860|Sargramostim|sargramostim|mesh-list
101690316|NCT00652860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101690317|NCT00652860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101690318|NCT00652860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101690319|NCT00652860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101690320|NCT00652860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101690321|NCT00652860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101277969|NCT04708054|Immunologic Factors|immunologic factors|mesh-ancestor
101690322|NCT00652860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101690323|NCT00652860|Alkylating Agents|alkylating agents|mesh-ancestor
101690324|NCT00652860|Immunologic Factors|immunologic factors|mesh-ancestor
101690325|NCT00652860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690326|NCT00652860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101690327|NCT02536014|Dexmedetomidine|dexmedetomidine|mesh-list
101690328|NCT02536014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101690329|NCT02536014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101690330|NCT02536014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690331|NCT02536014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101690332|NCT02536014|Analgesics|analgesics|mesh-ancestor
101690333|NCT02536014|Sensory System Agents|sensory system agents|mesh-ancestor
101690334|NCT02536014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101690335|NCT02536014|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101690336|NCT02536014|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101690337|NCT02536014|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101278032|NCT04255160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101690338|NCT02536014|Adrenergic Agents|adrenergic agents|mesh-ancestor
101690339|NCT02536014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101690340|NCT02536014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690341|NCT02653014|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
101690342|NCT02653014|Mineralocorticoids|mineralocorticoids|mesh-list
101690343|NCT02653014|Hormone Antagonists|hormone antagonists|mesh-ancestor
101690344|NCT02653014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101690345|NCT02653014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690346|NCT02653014|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101690347|NCT02653014|Diuretics|diuretics|mesh-ancestor
101690348|NCT02653014|Natriuretic Agents|natriuretic agents|mesh-ancestor
101690349|NCT02653014|Hormones|hormones|mesh-ancestor
101690350|NCT00886613|Vaccines|vaccines|mesh-list
101690351|NCT00886613|Immunologic Factors|immunologic factors|mesh-ancestor
101690352|NCT00886613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690353|NCT00653016|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101690354|NCT00653016|Norelgestromin|norelgestromin|mesh-list
101690355|NCT00653016|Estradiol|estradiol|mesh-list
101690356|NCT00653016|Estrogens|estrogens|mesh-ancestor
101690357|NCT00653016|Hormones|hormones|mesh-ancestor
101278091|NCT04062656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101690358|NCT00653016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101690359|NCT00653016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690360|NCT00653016|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101690361|NCT00653016|Contraceptive Agents|contraceptive agents|mesh-ancestor
101690362|NCT00653016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101690363|NCT00653016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101690364|NCT00653016|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101690365|NCT00653016|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101690366|NCT00886379|Vitamin D|vitamin d|mesh-list
101690367|NCT00886379|Ergocalciferols|ergocalciferols|mesh-list
101690368|NCT00886379|Cholecalciferol|cholecalciferol|mesh-list
101690369|NCT00886379|Vitamins|vitamins|mesh-list
101690370|NCT00886379|Micronutrients|micronutrients|mesh-ancestor
101690371|NCT00886379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690372|NCT00886379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101278157|NCT03879694|Octreotide|octreotide|mesh-list
101775336|NCT00936429|Antacids|antacids|mesh-ancestor
101690373|NCT00886379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101690374|NCT00633581|Ascorbic Acid|ascorbic acid|mesh-list
101690375|NCT00633581|Vitamins|vitamins|mesh-ancestor
101690376|NCT00633581|Micronutrients|micronutrients|mesh-ancestor
101690377|NCT00633581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690378|NCT00633581|Antioxidants|antioxidants|mesh-ancestor
101690379|NCT00633581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690380|NCT00633581|Protective Agents|protective agents|mesh-ancestor
101690381|NCT02825147|Dexamethasone|dexamethasone|mesh-list
101690382|NCT02825147|Methotrexate|methotrexate|mesh-list
101690383|NCT02825147|Etoposide|etoposide|mesh-list
101690384|NCT02825147|Pegaspargase|pegaspargase|mesh-list
101690385|NCT02825147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101690386|NCT02825147|Antiemetics|antiemetics|mesh-ancestor
101690387|NCT02825147|Autonomic Agents|autonomic agents|mesh-ancestor
101690388|NCT02825147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101690389|NCT02825147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690390|NCT02825147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101278206|NCT03770338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101278207|NCT03770338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690391|NCT02825147|Glucocorticoids|glucocorticoids|mesh-ancestor
101690392|NCT02825147|Hormones|hormones|mesh-ancestor
101690393|NCT02825147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101278208|NCT03770338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101690394|NCT02825147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101690395|NCT02825147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101690396|NCT02825147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101690397|NCT02825147|Abortifacient Agents|abortifacient agents|mesh-ancestor
101690398|NCT02825147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101690399|NCT02825147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101690400|NCT02825147|Antimetabolites|antimetabolites|mesh-ancestor
101690401|NCT02825147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690402|NCT02825147|Dermatologic Agents|dermatologic agents|mesh-ancestor
101690403|NCT02825147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101690404|NCT02825147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101690405|NCT02825147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101690406|NCT02825147|Immunologic Factors|immunologic factors|mesh-ancestor
101690407|NCT02825147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101690408|NCT02825147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101690409|NCT02825147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101690410|NCT02825147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101690411|NCT02825147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101690412|NCT02825225|Anesthetics|anesthetics|mesh-list
101690413|NCT02825225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101690414|NCT02825225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690415|NCT00637949|Rofecoxib|rofecoxib|mesh-list
101690416|NCT00637949|Lumiracoxib|lumiracoxib|mesh-list
101690417|NCT00637949|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101690418|NCT00637949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101690419|NCT00637949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101690420|NCT00637949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690421|NCT00637949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101690422|NCT00637949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101690423|NCT00637949|Analgesics|analgesics|mesh-ancestor
101690424|NCT00637949|Sensory System Agents|sensory system agents|mesh-ancestor
101690425|NCT00637949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101690426|NCT00637949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690427|NCT00637949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101690428|NCT00637949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101690429|NCT04242017|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101690430|NCT04242017|Luteolytic Agents|luteolytic agents|mesh-ancestor
101690431|NCT04242017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101690432|NCT04242017|Contraceptive Agents|contraceptive agents|mesh-ancestor
101690433|NCT04242017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101690434|NCT04242017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690435|NCT04242017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101690436|NCT04242017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101278527|NCT00408005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690437|NCT04242017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101690439|NCT00599196|Dopamine Agonists|dopamine agonists|mesh-ancestor
101690440|NCT00599196|Dopamine Agents|dopamine agents|mesh-ancestor
101690441|NCT00599196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101690442|NCT00599196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690443|NCT00599196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690444|NCT04201145|Pembrolizumab|pembrolizumab|mesh-list
101690445|NCT04201145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101690446|NCT04201145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101690447|NCT04201145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101690448|NCT04201145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690450|NCT02824601|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101690451|NCT02824601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690452|NCT02643732|Methylphenidate|methylphenidate|mesh-list
101690453|NCT02643732|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101690454|NCT02643732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690455|NCT02643732|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101690456|NCT02643732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101690457|NCT02643732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101278651|NCT01873339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101690458|NCT02643732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690460|NCT02643732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101690461|NCT04876937|Dexmedetomidine|dexmedetomidine|mesh-list
101690462|NCT04876937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101690463|NCT04876937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101690464|NCT04876937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690465|NCT04876937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101690466|NCT04876937|Analgesics|analgesics|mesh-ancestor
101690467|NCT04876937|Sensory System Agents|sensory system agents|mesh-ancestor
101690468|NCT04876937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101690469|NCT04876937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101690470|NCT04876937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101690471|NCT04876937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101690472|NCT04876937|Adrenergic Agents|adrenergic agents|mesh-ancestor
101690473|NCT04876937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101690474|NCT04876937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690475|NCT04165590|Immunomodulating Agents|immunomodulating agents|mesh-list
101690476|NCT04165590|Immunologic Factors|immunologic factors|mesh-ancestor
101690477|NCT04165590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690478|NCT05660993|Nivolumab|nivolumab|mesh-list
101690479|NCT05660993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101690480|NCT05660993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101690481|NCT05660993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101690482|NCT05660993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690483|NCT00633659|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
101690484|NCT00633659|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101690485|NCT00633659|Plasma Substitutes|plasma substitutes|mesh-ancestor
101690486|NCT00633659|Blood Substitutes|blood substitutes|mesh-ancestor
101690487|NCT04241705|Lumefantrine|lumefantrine|mesh-list
101690489|NCT04241705|Primaquine|primaquine|mesh-list
101690490|NCT04241705|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101690491|NCT04241705|Antimalarials|antimalarials|mesh-ancestor
101690492|NCT04241705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101690493|NCT04241705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101690494|NCT04241705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101690495|NCT04243109|Dexamethasone|dexamethasone|mesh-list
101690496|NCT04243109|Cyclophosphamide|cyclophosphamide|mesh-list
101690498|NCT04243109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101278861|NCT01874847|Melatonin|melatonin|mesh-list
101690499|NCT04243109|Immunologic Factors|immunologic factors|mesh-ancestor
101690500|NCT04243109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690501|NCT04243109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101690502|NCT04243109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101690503|NCT04243109|Alkylating Agents|alkylating agents|mesh-ancestor
101690504|NCT04243109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690505|NCT04243109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101690506|NCT04243109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101690507|NCT04243109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101690508|NCT04243109|Antiemetics|antiemetics|mesh-ancestor
101690509|NCT04243109|Autonomic Agents|autonomic agents|mesh-ancestor
101690510|NCT04243109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101690511|NCT04243109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101690512|NCT04243109|Glucocorticoids|glucocorticoids|mesh-ancestor
101690513|NCT04243109|Hormones|hormones|mesh-ancestor
101690514|NCT04243109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101278902|NCT01875185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101278909|NCT01875185|Antipyretics|antipyretics|mesh-ancestor
101690515|NCT04243109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101690516|NCT04243109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101690517|NCT04243109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101690518|NCT04243109|Growth Substances|growth substances|mesh-ancestor
101690519|NCT04243109|Growth Inhibitors|growth inhibitors|mesh-ancestor
101690520|NCT04861181|Niraparib|niraparib|mesh-list
101690521|NCT04861181|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101690522|NCT04861181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101690523|NCT04861181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690524|NCT04861181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101690525|NCT00603512|Tofacitinib|tofacitinib|mesh-list
101690526|NCT00603512|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101690527|NCT00603512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101279029|NCT01876121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101690528|NCT00603512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101690529|NCT00603512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690530|NCT04167774|Paclitaxel|paclitaxel|mesh-list
101690531|NCT04167774|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101690532|NCT04167774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101690533|NCT04167774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101690534|NCT04167774|Tubulin Modulators|tubulin modulators|mesh-ancestor
101690535|NCT04167774|Antimitotic Agents|antimitotic agents|mesh-ancestor
101690536|NCT04167774|Mitosis Modulators|mitosis modulators|mesh-ancestor
101279095|NCT01876615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101279102|NCT01876641|Decitabine|decitabine|mesh-list
101690537|NCT04167774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690538|NCT02640300|Clozapine|clozapine|mesh-list
101690539|NCT02640300|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101690540|NCT02640300|Serotonin Agents|serotonin agents|mesh-ancestor
101690541|NCT02640300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101690542|NCT02640300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690543|NCT02640300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690544|NCT02640300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101690545|NCT02640300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101690546|NCT02640300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101690547|NCT02640300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101690548|NCT02640300|GABA Antagonists|gaba antagonists|mesh-ancestor
101690550|NCT02640144|Hyaluronic Acid|hyaluronic acid|mesh-list
101690551|NCT02640144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101690552|NCT02640144|Immunologic Factors|immunologic factors|mesh-ancestor
101690553|NCT02640144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690554|NCT02640144|Viscosupplements|viscosupplements|mesh-ancestor
101690555|NCT02640144|Protective Agents|protective agents|mesh-ancestor
101690556|NCT02643186|Misoprostol|misoprostol|mesh-list
101690557|NCT02643186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101690558|NCT02643186|Abortifacient Agents|abortifacient agents|mesh-ancestor
101690559|NCT02643186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101690560|NCT02643186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347874|NCT00034710|Sensory System Agents|sensory system agents|mesh-ancestor
101690561|NCT02643186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101690562|NCT02643186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101690563|NCT02643186|Oxytocics|oxytocics|mesh-ancestor
101690564|NCT02652312|Diclofenac|diclofenac|mesh-list
101690565|NCT02652312|Fentanyl|fentanyl|mesh-list
101690566|NCT02652312|Dexmedetomidine|dexmedetomidine|mesh-list
101690567|NCT02652312|Ondansetron|ondansetron|mesh-list
101690568|NCT02652312|Propofol|propofol|mesh-list
101690570|NCT02652312|Atracurium|atracurium|mesh-list
101690571|NCT02652312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101690572|NCT02652312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101690573|NCT02652312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690574|NCT02652312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101690575|NCT02652312|Analgesics|analgesics|mesh-ancestor
101690576|NCT02652312|Sensory System Agents|sensory system agents|mesh-ancestor
101690577|NCT02652312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101690578|NCT02652312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101690579|NCT02652312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101690580|NCT02652312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101690581|NCT02652312|Adrenergic Agents|adrenergic agents|mesh-ancestor
101279447|NCT01879514|Hormones|hormones|mesh-ancestor
101690582|NCT02652312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101690583|NCT02652312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690584|NCT02652312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101690585|NCT02652312|Anesthetics, General|anesthetics, general|mesh-ancestor
101690586|NCT02652312|Anesthetics|anesthetics|mesh-ancestor
101690587|NCT02652312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101690588|NCT02652312|Narcotics|narcotics|mesh-ancestor
101690589|NCT02652312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101690590|NCT02652312|Antiemetics|antiemetics|mesh-ancestor
101690591|NCT02652312|Autonomic Agents|autonomic agents|mesh-ancestor
101690592|NCT02652312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101690593|NCT02652312|Antipruritics|antipruritics|mesh-ancestor
101690594|NCT02652312|Dermatologic Agents|dermatologic agents|mesh-ancestor
101690595|NCT02652312|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101690596|NCT02652312|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101690597|NCT02652312|Serotonin Agents|serotonin agents|mesh-ancestor
101690598|NCT02652312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101690599|NCT02652312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101279565|NCT01880385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101690600|NCT02652312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101690601|NCT02652312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101690602|NCT02652312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101690603|NCT02652312|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101690604|NCT02652312|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101690605|NCT02652312|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101690606|NCT02652312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101690607|NCT02652312|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101690608|NCT02652312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101690609|NCT02652312|Cholinergic Agents|cholinergic agents|mesh-ancestor
101690610|NCT04165512|Triamcinolone|triamcinolone|mesh-list
101279628|NCT01880931|Remifentanil|remifentanil|mesh-list
101690612|NCT04165512|Bupivacaine|bupivacaine|mesh-list
101690613|NCT04165512|Anesthetics, Local|anesthetics, local|mesh-ancestor
101690614|NCT04165512|Anesthetics|anesthetics|mesh-ancestor
101690615|NCT04165512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101690616|NCT04165512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690617|NCT04165512|Sensory System Agents|sensory system agents|mesh-ancestor
101690618|NCT04165512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101690619|NCT04165512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101690620|NCT04165512|Glucocorticoids|glucocorticoids|mesh-ancestor
101279691|NCT01881997|Narcotics|narcotics|mesh-ancestor
101279694|NCT01881997|Analgesics|analgesics|mesh-ancestor
101690622|NCT04165512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101690623|NCT04165512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101690624|NCT04165512|Immunologic Factors|immunologic factors|mesh-ancestor
101690625|NCT02642874|Methocarbamol|methocarbamol|mesh-list
101690626|NCT02642874|Calcium Carbonate|calcium carbonate|mesh-list
101690627|NCT02642874|Calcium|calcium|mesh-list
101690628|NCT02642874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101690629|NCT02642874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690630|NCT02642874|Antacids|antacids|mesh-ancestor
101279755|NCT01882387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101690631|NCT02642874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690632|NCT02642874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101690633|NCT02642874|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101690634|NCT02642874|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101690635|NCT02642874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101690636|NCT00653874|Bilirubin|bilirubin|mesh-list
101690637|NCT00653874|Antioxidants|antioxidants|mesh-ancestor
101690638|NCT00653874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690639|NCT00653874|Protective Agents|protective agents|mesh-ancestor
101690640|NCT00653874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690641|NCT04224701|Vaccines|vaccines|mesh-list
101690642|NCT04224701|Immunologic Factors|immunologic factors|mesh-ancestor
101690643|NCT04224701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690644|NCT00653952|Paclitaxel|paclitaxel|mesh-list
101279822|NCT01883232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101690645|NCT00653952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101690646|NCT00653952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101690647|NCT00653952|Tubulin Modulators|tubulin modulators|mesh-ancestor
101690648|NCT00653952|Antimitotic Agents|antimitotic agents|mesh-ancestor
101690649|NCT00653952|Mitosis Modulators|mitosis modulators|mesh-ancestor
101690650|NCT00653952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690651|NCT00650364|Midodrine|midodrine|mesh-list
101690652|NCT00650364|Sympathomimetics|sympathomimetics|mesh-ancestor
101690653|NCT00650364|Autonomic Agents|autonomic agents|mesh-ancestor
101279882|NCT01883869|Ticagrelor|ticagrelor|mesh-list
101690654|NCT00650364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101690655|NCT00650364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690656|NCT00650364|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101690657|NCT00650364|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101690658|NCT00650364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101690659|NCT00650364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101690660|NCT00650364|Adrenergic Agents|adrenergic agents|mesh-ancestor
101690661|NCT00650364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101690662|NCT00650364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690663|NCT04909697|Sivelestat|sivelestat|mesh-list
101279946|NCT01884298|Lidocaine|lidocaine|mesh-list
101279947|NCT01884298|Remifentanil|remifentanil|mesh-list
101690664|NCT04909697|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101690665|NCT04909697|Protease Inhibitors|protease inhibitors|mesh-ancestor
101690666|NCT04909697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101690667|NCT04909697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690668|NCT00654108|Ascorbic Acid|ascorbic acid|mesh-list
101690669|NCT00654108|Ciprofloxacin|ciprofloxacin|mesh-list
101690670|NCT00654108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101690671|NCT00654108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101690672|NCT00654108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101280010|NCT01884467|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101280013|NCT01884506|Iron|iron|mesh-list
101690673|NCT00654108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101690674|NCT00654108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101690675|NCT00654108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690676|NCT00654108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101690677|NCT00654108|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101690678|NCT00654108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101690679|NCT00654108|Antioxidants|antioxidants|mesh-ancestor
101690680|NCT00654108|Protective Agents|protective agents|mesh-ancestor
101690681|NCT00654108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690682|NCT00654108|Vitamins|vitamins|mesh-ancestor
101690683|NCT00654108|Micronutrients|micronutrients|mesh-ancestor
101690684|NCT04165902|Hyaluronic Acid|hyaluronic acid|mesh-list
101690685|NCT04165902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101690686|NCT04165902|Immunologic Factors|immunologic factors|mesh-ancestor
101690687|NCT04165902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690688|NCT04165902|Viscosupplements|viscosupplements|mesh-ancestor
101690689|NCT04165902|Protective Agents|protective agents|mesh-ancestor
101690691|NCT02639598|Flunarizine|flunarizine|mesh-list
101690692|NCT02639598|Anticonvulsants|anticonvulsants|mesh-ancestor
101690693|NCT02639598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101690694|NCT02639598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690695|NCT02639598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101690696|NCT02639598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101690697|NCT02639598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690698|NCT02639598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101690699|NCT02639598|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101690700|NCT02639598|Histamine Antagonists|histamine antagonists|mesh-ancestor
101690701|NCT02639598|Histamine Agents|histamine agents|mesh-ancestor
101690702|NCT02639598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101690703|NCT02639598|Vasodilator Agents|vasodilator agents|mesh-ancestor
101690704|NCT04907279|Aripiprazole|aripiprazole|mesh-list
101690705|NCT04907279|Antidepressive Agents|antidepressive agents|mesh-ancestor
101690706|NCT04907279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101690707|NCT04907279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101690708|NCT04907279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101690709|NCT04907279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101690710|NCT04907279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690711|NCT04907279|Dopamine Agonists|dopamine agonists|mesh-ancestor
101690712|NCT04907279|Dopamine Agents|dopamine agents|mesh-ancestor
101690713|NCT04907279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101690714|NCT04907279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280133|NCT01885338|Expectorants|expectorants|mesh-ancestor
101690715|NCT04907279|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101690716|NCT04907279|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101690717|NCT04907279|Serotonin Agents|serotonin agents|mesh-ancestor
101690718|NCT04907279|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101690719|NCT04907279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101690720|NCT04907279|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101690721|NCT04907279|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101690722|NCT02642718|Ketorolac|ketorolac|mesh-list
101280183|NCT01885481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101690723|NCT02642718|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101690724|NCT02642718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101690725|NCT02642718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101690726|NCT02642718|Analgesics|analgesics|mesh-ancestor
101690727|NCT02642718|Sensory System Agents|sensory system agents|mesh-ancestor
101690728|NCT02642718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101690729|NCT02642718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690730|NCT02642718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101690731|NCT02642718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101690732|NCT02642718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101690733|NCT02642718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101690734|NCT02642718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280250|NCT01886079|Adrenergic Agents|adrenergic agents|mesh-ancestor
101280253|NCT01886196|Ibuprofen|ibuprofen|mesh-list
101690735|NCT02642484|Gabapentin|gabapentin|mesh-list
101690736|NCT02642484|Calcium Carbonate|calcium carbonate|mesh-list
101690737|NCT02642484|Calcium|calcium|mesh-list
101690738|NCT02642484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101690739|NCT02642484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690740|NCT02642484|Analgesics|analgesics|mesh-ancestor
101690741|NCT02642484|Sensory System Agents|sensory system agents|mesh-ancestor
101690742|NCT02642484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101690743|NCT02642484|Anticonvulsants|anticonvulsants|mesh-ancestor
101690744|NCT02642484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101690745|NCT02642484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101690746|NCT02642484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101690747|NCT02642484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101690748|NCT02642484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101690749|NCT02642484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101690750|NCT02642484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101690751|NCT02642484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690752|NCT02642484|Antimanic Agents|antimanic agents|mesh-ancestor
101690754|NCT02642484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101690755|NCT00639392|Zoledronic Acid|zoledronic acid|mesh-list
101690756|NCT00639392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101690757|NCT00639392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690758|NCT04185350|Exenatide|exenatide|mesh-list
101690759|NCT04185350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101690760|NCT04185350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690761|NCT04185350|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101690762|NCT04185350|Incretins|incretins|mesh-ancestor
101690763|NCT04185350|Hormones|hormones|mesh-ancestor
101690764|NCT04185350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101690765|NCT00653172|Streptogramin A|streptogramin a|mesh-list
101690766|NCT00653172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101690767|NCT00653172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101690768|NCT02639520|Fosfomycin|fosfomycin|mesh-list
101690769|NCT02639520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101690770|NCT02639520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101690771|NCT02822729|Timolol|timolol|mesh-list
101690772|NCT02822729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101690773|NCT02822729|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101690774|NCT02822729|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101690775|NCT02822729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101690776|NCT02822729|Adrenergic Agents|adrenergic agents|mesh-ancestor
101690777|NCT02822729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101690778|NCT02822729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690779|NCT02822729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690780|NCT02822729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101690781|NCT02822729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101690782|NCT02642250|Metronidazole|metronidazole|mesh-list
101690783|NCT02642250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101690784|NCT02642250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101280439|NCT01887249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101280440|NCT01887249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101348096|NCT01805726|Alfentanil|alfentanil|mesh-list
101690785|NCT02642250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101690786|NCT02642250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101690787|NCT00653250|Celecoxib|celecoxib|mesh-list
101690788|NCT00653250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101690789|NCT00653250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101280441|NCT01887249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101690791|NCT00653250|Sensory System Agents|sensory system agents|mesh-ancestor
101690792|NCT00653250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101690793|NCT00653250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690794|NCT00653250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101690795|NCT00653250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101690796|NCT00653250|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101690797|NCT00653250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101690798|NCT00653250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101690799|NCT00653250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690800|NCT00638534|Telithromycin|telithromycin|mesh-list
101690801|NCT00638534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101690802|NCT00638534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101690803|NCT04240535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101690804|NCT04240535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101690805|NCT04240535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101690806|NCT04240535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101690807|NCT04240535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690808|NCT04240535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101690809|NCT04240535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101690810|NCT04240535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690811|NCT04240535|Cholinergic Agents|cholinergic agents|mesh-ancestor
101690812|NCT04240535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101690813|NCT02638896|Sulfasalazine|sulfasalazine|mesh-list
101690814|NCT02638896|Celecoxib|celecoxib|mesh-list
101690815|NCT02638896|Etanercept|etanercept|mesh-list
101280545|NCT01887704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101690817|NCT02638896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101690819|NCT02638896|Sensory System Agents|sensory system agents|mesh-ancestor
101690820|NCT02638896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101690821|NCT02638896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690822|NCT02638896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101690823|NCT02638896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101690824|NCT02638896|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101690825|NCT02638896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101690826|NCT02638896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101690827|NCT02638896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690828|NCT02638896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101280605|NCT01887873|Viscosupplements|viscosupplements|mesh-ancestor
101280607|NCT01887951|Tramadol|tramadol|mesh-list
101690829|NCT02638896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101690830|NCT02638896|Immunologic Factors|immunologic factors|mesh-ancestor
101690831|NCT02638896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101690832|NCT04240223|Brilacidin|brilacidin|mesh-list
101690833|NCT04240223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101690834|NCT00653406|Risperidone|risperidone|mesh-list
101690835|NCT00653406|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101690836|NCT00653406|Serotonin Agents|serotonin agents|mesh-ancestor
101690837|NCT00653406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101280669|NCT01888263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101690838|NCT00653406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690839|NCT00653406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690840|NCT00653406|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101690841|NCT00653406|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101690842|NCT00653406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101690843|NCT00653406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101690844|NCT00653406|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101690845|NCT00653406|Dopamine Agents|dopamine agents|mesh-ancestor
101690846|NCT00655200|Insulin Detemir|insulin detemir|mesh-list
101690847|NCT00655200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101690848|NCT00655200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690849|NCT04239755|Doxycycline|doxycycline|mesh-list
101690850|NCT04239755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101690851|NCT04239755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101690852|NCT04239755|Antimalarials|antimalarials|mesh-ancestor
101690853|NCT04239755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101690854|NCT04239755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101690855|NCT04185194|Lidocaine|lidocaine|mesh-list
101690856|NCT04185194|Anesthetics, Local|anesthetics, local|mesh-ancestor
101690857|NCT04185194|Anesthetics|anesthetics|mesh-ancestor
101690858|NCT04185194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101348172|NCT01805531|Rivaroxaban|rivaroxaban|mesh-list
101690859|NCT04185194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690860|NCT04185194|Sensory System Agents|sensory system agents|mesh-ancestor
101690861|NCT04185194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101690862|NCT04185194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101690863|NCT04185194|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101690864|NCT04185194|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101690865|NCT04185194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101690866|NCT04185194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690867|NCT00876447|Botulinum Toxins|botulinum toxins|mesh-list
101690868|NCT00876447|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101690869|NCT00876447|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101690870|NCT00876447|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101690871|NCT00876447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101690872|NCT00876447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280859|NCT01888978|Immunologic Factors|immunologic factors|mesh-ancestor
101690873|NCT00876447|Cholinergic Agents|cholinergic agents|mesh-ancestor
101690874|NCT00876447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101280860|NCT01888978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690875|NCT00876447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690876|NCT00876447|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101690877|NCT00876447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101690879|NCT04239833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101690880|NCT04239833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101690881|NCT04239833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101690882|NCT04239833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690884|NCT03513770|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101690885|NCT03513770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101690886|NCT03513770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101690887|NCT03513770|Analgesics|analgesics|mesh-ancestor
101690888|NCT03513770|Sensory System Agents|sensory system agents|mesh-ancestor
101690889|NCT03513770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101690890|NCT03513770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690891|NCT03513770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101280914|NCT01889290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101690892|NCT03513770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101690893|NCT03513770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101690894|NCT03513770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101690895|NCT03513770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690896|NCT02638740|Mechlorethamine|mechlorethamine|mesh-list
101690897|NCT02638740|Alkylating Agents|alkylating agents|mesh-ancestor
101690898|NCT02638740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101280973|NCT01889758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101690899|NCT02638740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101690900|NCT02638740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101690902|NCT02823977|Ketamine|ketamine|mesh-list
101690903|NCT02823977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101690904|NCT02823977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101690905|NCT02823977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101281042|NCT01891981|Immunotoxin HA22|immunotoxin ha22|mesh-list
101690906|NCT02823977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101690908|NCT02823977|Sensory System Agents|sensory system agents|mesh-ancestor
101690909|NCT02823977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101690910|NCT02823977|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101690911|NCT02823977|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101690912|NCT02823977|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101690913|NCT02823977|Adrenergic Agents|adrenergic agents|mesh-ancestor
101690914|NCT02823977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101690915|NCT02823977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690916|NCT02823977|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101690917|NCT02823977|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101690918|NCT02823977|Anesthetics, General|anesthetics, general|mesh-ancestor
101690919|NCT02823977|Anesthetics|anesthetics|mesh-ancestor
101690920|NCT02823977|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101690921|NCT02823977|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101690922|NCT00680511|Methamphetamine|methamphetamine|mesh-list
101690923|NCT00680511|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101690924|NCT00680511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690925|NCT00680511|Sympathomimetics|sympathomimetics|mesh-ancestor
101690926|NCT00680511|Autonomic Agents|autonomic agents|mesh-ancestor
101690927|NCT00680511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101690928|NCT00680511|Dopamine Agents|dopamine agents|mesh-ancestor
101690929|NCT00680511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101690930|NCT00680511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690931|NCT00680511|Adrenergic Agents|adrenergic agents|mesh-ancestor
101690932|NCT00680511|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101690933|NCT00680511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101690934|NCT00680511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101690935|NCT00680511|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101690937|NCT00654576|Chlorpromazine|chlorpromazine|mesh-list
101690938|NCT00654576|Risperidone|risperidone|mesh-list
101690939|NCT00654576|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101690940|NCT00654576|Clozapine|clozapine|mesh-list
101690941|NCT00654576|Sulpiride|sulpiride|mesh-list
101281179|NCT01897740|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101690942|NCT00654576|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101690943|NCT00654576|Serotonin Agents|serotonin agents|mesh-ancestor
101690944|NCT00654576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101690945|NCT00654576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690946|NCT00654576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690947|NCT00654576|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101690948|NCT00654576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101281218|NCT01900015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101690949|NCT00654576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101690950|NCT00654576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101690951|NCT00654576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101690952|NCT00654576|Dopamine Agents|dopamine agents|mesh-ancestor
101690954|NCT00654576|Autonomic Agents|autonomic agents|mesh-ancestor
101690955|NCT00654576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101690956|NCT00654576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101690957|NCT00654576|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101690958|NCT00654576|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101690959|NCT00654576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101690960|NCT00654576|Antidepressive Agents|antidepressive agents|mesh-ancestor
101690961|NCT00654576|GABA Antagonists|gaba antagonists|mesh-ancestor
101690962|NCT00654576|GABA Agents|gaba agents|mesh-ancestor
101281290|NCT01900327|Gemcitabine|gemcitabine|mesh-list
101690963|NCT00654576|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101690965|NCT00622622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101690966|NCT00622622|Antimetabolites|antimetabolites|mesh-ancestor
101690967|NCT00622622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690968|NCT00622622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101690969|NCT00598650|Donepezil|donepezil|mesh-list
101690970|NCT00598650|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101281351|NCT01900587|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101690971|NCT00598650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101690972|NCT00598650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101690973|NCT00598650|Cholinergic Agents|cholinergic agents|mesh-ancestor
101690974|NCT00598650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101690975|NCT00598650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690976|NCT00598650|Nootropic Agents|nootropic agents|mesh-ancestor
101690977|NCT04150731|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101690978|NCT04150731|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101690979|NCT04150731|Estradiol|estradiol|mesh-list
101690980|NCT04150731|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101690981|NCT04150731|Estrogens|estrogens|mesh-ancestor
101690982|NCT04150731|Hormones|hormones|mesh-ancestor
101690983|NCT04150731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101690984|NCT04150731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690985|NCT04150731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101690986|NCT04150731|Contraceptive Agents|contraceptive agents|mesh-ancestor
101690987|NCT04150731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101690988|NCT04150731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101690989|NCT02641938|Dexmedetomidine|dexmedetomidine|mesh-list
101690990|NCT02641938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101690991|NCT02641938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101690992|NCT02641938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101690993|NCT02641938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101690994|NCT02641938|Analgesics|analgesics|mesh-ancestor
101690995|NCT02641938|Sensory System Agents|sensory system agents|mesh-ancestor
101690996|NCT02641938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101690997|NCT02641938|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101690998|NCT02641938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101690999|NCT02641938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101691000|NCT02641938|Adrenergic Agents|adrenergic agents|mesh-ancestor
101691001|NCT02641938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101691002|NCT02641938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691003|NCT04249076|Clobetasol|clobetasol|mesh-list
101691004|NCT04249076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101281622|NCT01902186|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101691005|NCT04249076|Glucocorticoids|glucocorticoids|mesh-ancestor
101691006|NCT04249076|Hormones|hormones|mesh-ancestor
101691007|NCT04249076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101691008|NCT04249076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691010|NCT00681135|Cariostatic Agents|cariostatic agents|mesh-ancestor
101691011|NCT00681135|Protective Agents|protective agents|mesh-ancestor
101691012|NCT00681135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691013|NCT02821559|Bevacizumab|bevacizumab|mesh-list
101691014|NCT02821559|Oxaliplatin|oxaliplatin|mesh-list
101691015|NCT02821559|Raltitrexed|raltitrexed|mesh-list
101691016|NCT02821559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101691017|NCT02821559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101691018|NCT02821559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101691019|NCT02821559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101691020|NCT02821559|Growth Substances|growth substances|mesh-ancestor
101691021|NCT02821559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691022|NCT02821559|Growth Inhibitors|growth inhibitors|mesh-ancestor
101691023|NCT02821559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101691024|NCT02821559|Antimetabolites|antimetabolites|mesh-ancestor
101691025|NCT02821559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101281684|NCT01902511|Lenograstim|lenograstim|mesh-list
101691026|NCT02821559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101691027|NCT02821559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101691028|NCT00681213|Sirolimus|sirolimus|mesh-list
101691029|NCT00681213|Temsirolimus|temsirolimus|mesh-list
101691030|NCT00681213|MTOR Inhibitors|mtor inhibitors|mesh-list
101691031|NCT00681213|Tacrolimus|tacrolimus|mesh-list
101691032|NCT00681213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101691033|NCT00681213|Immunologic Factors|immunologic factors|mesh-ancestor
101691034|NCT00681213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691036|NCT00681213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101691037|NCT00681213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691038|NCT00681213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101691039|NCT00681213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101691040|NCT00681213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101691041|NCT00681213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101691042|NCT00681213|Antifungal Agents|antifungal agents|mesh-ancestor
101691043|NCT00681213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101691044|NCT02638506|Fentanyl|fentanyl|mesh-list
101691045|NCT02638506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101691046|NCT02638506|Narcotics|narcotics|mesh-ancestor
101691047|NCT02638506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101691048|NCT02638506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691049|NCT02638506|Analgesics|analgesics|mesh-ancestor
101691050|NCT02638506|Sensory System Agents|sensory system agents|mesh-ancestor
101691051|NCT02638506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101691052|NCT02638506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101691053|NCT02638506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101691054|NCT02638506|Anesthetics, General|anesthetics, general|mesh-ancestor
101691055|NCT02638506|Anesthetics|anesthetics|mesh-ancestor
101281738|NCT01902810|Propranolol|propranolol|mesh-list
101691056|NCT04745975|Paclitaxel|paclitaxel|mesh-list
101691057|NCT04745975|Vinorelbine|vinorelbine|mesh-list
101691058|NCT04745975|Gemcitabine|gemcitabine|mesh-list
101691059|NCT04745975|Capecitabine|capecitabine|mesh-list
101691060|NCT04745975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101691061|NCT04745975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101691062|NCT04745975|Tubulin Modulators|tubulin modulators|mesh-ancestor
101691063|NCT04745975|Antimitotic Agents|antimitotic agents|mesh-ancestor
101691064|NCT04745975|Mitosis Modulators|mitosis modulators|mesh-ancestor
101691065|NCT04745975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691066|NCT04745975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101691067|NCT04745975|Antimetabolites|antimetabolites|mesh-ancestor
101691068|NCT04150107|Insulin|insulin|mesh-list
101691069|NCT04150107|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101691070|NCT04150107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101691071|NCT04150107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691072|NCT02638428|Cytarabine|cytarabine|mesh-list
101691073|NCT02638428|Carboplatin|carboplatin|mesh-list
101691074|NCT02638428|Trastuzumab|trastuzumab|mesh-list
101691075|NCT02638428|Fludarabine|fludarabine|mesh-list
101691076|NCT02638428|Etoposide|etoposide|mesh-list
101691077|NCT02638428|Everolimus|everolimus|mesh-list
101691078|NCT02638428|Sorafenib|sorafenib|mesh-list
101691079|NCT02638428|Dasatinib|dasatinib|mesh-list
101691080|NCT02638428|Ifosfamide|ifosfamide|mesh-list
101691081|NCT02638428|Axitinib|axitinib|mesh-list
101691082|NCT02638428|Vemurafenib|vemurafenib|mesh-list
101691084|NCT02638428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101691085|NCT02638428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101691086|NCT02638428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101691087|NCT02638428|Antimetabolites|antimetabolites|mesh-ancestor
101691088|NCT02638428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691089|NCT02638428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101691090|NCT02638428|Immunologic Factors|immunologic factors|mesh-ancestor
101691091|NCT02638428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691092|NCT02638428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101691093|NCT02638428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101691094|NCT02638428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101691095|NCT02638428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101691096|NCT02638428|Antiviral Agents|antiviral agents|mesh-ancestor
101691097|NCT02638428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101691098|NCT02638428|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101691099|NCT02638428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101691100|NCT02638428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101281913|NCT01904110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101691102|NCT01003964|Cisplatin|cisplatin|mesh-list
101691103|NCT01003964|Gemcitabine|gemcitabine|mesh-list
101691104|NCT01003964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101691105|NCT01003964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101691106|NCT01003964|Antimetabolites|antimetabolites|mesh-ancestor
101691107|NCT01003964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691108|NCT02823743|Aspirin|aspirin|mesh-list
101691109|NCT02823743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101691110|NCT02823743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101691111|NCT02823743|Analgesics|analgesics|mesh-ancestor
101691112|NCT02823743|Sensory System Agents|sensory system agents|mesh-ancestor
101691113|NCT02823743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101691114|NCT02823743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691115|NCT02823743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101691116|NCT02823743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101691117|NCT02823743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101691118|NCT02823743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101691119|NCT02823743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282037|NCT01904981|Atenolol|atenolol|mesh-list
101691120|NCT02823743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101691121|NCT02823743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101691122|NCT02823743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101691123|NCT02823743|Antipyretics|antipyretics|mesh-ancestor
101691124|NCT00654888|Mitomycins|mitomycins|mesh-list
101691125|NCT00654888|Mitomycin|mitomycin|mesh-list
101691126|NCT00654888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101691127|NCT00654888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101691128|NCT00654888|Alkylating Agents|alkylating agents|mesh-ancestor
101691129|NCT00654888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282100|NCT01905150|Tubulin Modulators|tubulin modulators|mesh-ancestor
101282101|NCT01905150|Antimitotic Agents|antimitotic agents|mesh-ancestor
101282102|NCT01905150|Mitosis Modulators|mitosis modulators|mesh-ancestor
101691130|NCT00654888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101691131|NCT00654888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101691133|NCT05299203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101691134|NCT05299203|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101691135|NCT05299203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101691136|NCT05299203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101282165|NCT01905696|Protective Agents|protective agents|mesh-ancestor
101282167|NCT01905696|Antidotes|antidotes|mesh-ancestor
101691137|NCT05299203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101691138|NCT05299203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691139|NCT05299203|Vasodilator Agents|vasodilator agents|mesh-ancestor
101691140|NCT02638584|Rabeprazole|rabeprazole|mesh-list
101691141|NCT02638584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101691142|NCT02638584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101691143|NCT02638584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101691144|NCT02638584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101691145|NCT02638584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691146|NCT04208516|Dexamethasone|dexamethasone|mesh-list
101691148|NCT04208516|Dexmedetomidine|dexmedetomidine|mesh-list
101691149|NCT04208516|Ropivacaine|ropivacaine|mesh-list
101691150|NCT04208516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101691151|NCT04208516|Antiemetics|antiemetics|mesh-ancestor
101691152|NCT04208516|Autonomic Agents|autonomic agents|mesh-ancestor
101691153|NCT04208516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101691154|NCT04208516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691155|NCT04208516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101691156|NCT04208516|Glucocorticoids|glucocorticoids|mesh-ancestor
101691157|NCT04208516|Hormones|hormones|mesh-ancestor
101691158|NCT04208516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101691159|NCT04208516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101282307|NCT01907061|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101691160|NCT04208516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101282310|NCT01907061|Expectorants|expectorants|mesh-ancestor
101691161|NCT04208516|Anesthetics, Local|anesthetics, local|mesh-ancestor
101691163|NCT04208516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101691164|NCT04208516|Sensory System Agents|sensory system agents|mesh-ancestor
101691165|NCT04208516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101691166|NCT04208516|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101691167|NCT04208516|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101691168|NCT04208516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101691169|NCT04208516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691170|NCT04208516|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101691171|NCT04208516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101691172|NCT04208516|Analgesics|analgesics|mesh-ancestor
101691174|NCT04208516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101691175|NCT04208516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101691176|NCT04208516|Adrenergic Agents|adrenergic agents|mesh-ancestor
101691177|NCT04208516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101691178|NCT02821169|Ropivacaine|ropivacaine|mesh-list
101691179|NCT02821169|Anesthetics, Local|anesthetics, local|mesh-ancestor
101691180|NCT02821169|Anesthetics|anesthetics|mesh-ancestor
101691181|NCT02821169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101691182|NCT02821169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691183|NCT02821169|Sensory System Agents|sensory system agents|mesh-ancestor
101691184|NCT02821169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101691185|NCT02820935|Itraconazole|itraconazole|mesh-list
101691186|NCT02820935|Rifampin|rifampin|mesh-list
101691187|NCT02820935|Antifungal Agents|antifungal agents|mesh-ancestor
101691188|NCT02820935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101691189|NCT02820935|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101691190|NCT02820935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101691191|NCT02820935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101691192|NCT02820935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691193|NCT02820935|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101691194|NCT02820935|Hormone Antagonists|hormone antagonists|mesh-ancestor
101691195|NCT02820935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101691196|NCT02820935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101282568|NCT01908387|Azacitidine|azacitidine|mesh-list
101691197|NCT02820935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101691199|NCT02820935|Antitubercular Agents|antitubercular agents|mesh-ancestor
101691200|NCT02820935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101691201|NCT02820935|Leprostatic Agents|leprostatic agents|mesh-ancestor
101691202|NCT02820935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101691203|NCT02820935|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101691204|NCT02820935|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101691205|NCT02820935|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101691206|NCT02820935|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101282631|NCT01909063|Vitamin E|vitamin e|mesh-list
101282632|NCT01909063|Vitamin A|vitamin a|mesh-list
101282640|NCT01909115|Vitamin D|vitamin d|mesh-list
101691207|NCT02820935|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101691208|NCT02820935|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101691210|NCT02626845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101691211|NCT02626845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101691212|NCT02626845|Immunologic Factors|immunologic factors|mesh-ancestor
101691213|NCT02626845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691214|NCT02626845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101691215|NCT02821247|Aflibercept|aflibercept|mesh-list
101691217|NCT02821247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101282696|NCT01909856|Dexamethasone|dexamethasone|mesh-list
101282697|NCT01909856|Palonosetron|palonosetron|mesh-list
101410070|NCT00352378|Docetaxel|docetaxel|mesh-list
101691218|NCT02821247|Growth Substances|growth substances|mesh-ancestor
101691219|NCT02821247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691220|NCT02821247|Growth Inhibitors|growth inhibitors|mesh-ancestor
101691221|NCT02821247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101691222|NCT00681525|Atorvastatin|atorvastatin|mesh-list
101691223|NCT00681525|Ezetimibe|ezetimibe|mesh-list
101691224|NCT00681525|Fenofibric acid|fenofibric acid|mesh-list
101691225|NCT00681525|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101691226|NCT00681525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101691227|NCT00681525|Antimetabolites|antimetabolites|mesh-ancestor
101282776|NCT01910246|Metformin|metformin|mesh-list
101691228|NCT00681525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691229|NCT00681525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101691230|NCT00681525|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101691232|NCT00681603|Bevacizumab|bevacizumab|mesh-list
101691233|NCT00681603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101691234|NCT00681603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101691235|NCT00681603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101691236|NCT00681603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101691237|NCT00681603|Growth Substances|growth substances|mesh-ancestor
101691238|NCT00681603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691239|NCT00681603|Growth Inhibitors|growth inhibitors|mesh-ancestor
101691240|NCT04239443|Apatinib|apatinib|mesh-list
101691241|NCT04239443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101282827|NCT01910363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101691242|NCT04239443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101691243|NCT04239443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101691244|NCT04239443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101691245|NCT04239443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691246|NCT04239443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101691248|NCT04200599|Oxytocics|oxytocics|mesh-ancestor
101691249|NCT04200599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101691250|NCT04200599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691251|NCT02820077|Hemostatics|hemostatics|mesh-list
101282893|NCT01910766|Ubiquinone|ubiquinone|mesh-list
101691252|NCT02820077|Coagulants|coagulants|mesh-ancestor
101691253|NCT00681993|Cyclophosphamide|cyclophosphamide|mesh-list
101691254|NCT00681993|Carboplatin|carboplatin|mesh-list
101691256|NCT00681993|Trastuzumab|trastuzumab|mesh-list
101691257|NCT00681993|Doxorubicin|doxorubicin|mesh-list
101691258|NCT00681993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101691259|NCT00681993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101691260|NCT00681993|Immunologic Factors|immunologic factors|mesh-ancestor
101691261|NCT00681993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691262|NCT00681993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101691263|NCT00681993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101691264|NCT00681993|Alkylating Agents|alkylating agents|mesh-ancestor
101691265|NCT00681993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691266|NCT00681993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101691267|NCT00681993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101691268|NCT00681993|Tubulin Modulators|tubulin modulators|mesh-ancestor
101691269|NCT00681993|Antimitotic Agents|antimitotic agents|mesh-ancestor
101691270|NCT00681993|Mitosis Modulators|mitosis modulators|mesh-ancestor
101691271|NCT00681993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101691272|NCT00681993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101691273|NCT00681993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101691274|NCT00681993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101691275|NCT00681993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101691276|NCT02819999|Etoposide|etoposide|mesh-list
101691277|NCT02819999|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
101691278|NCT02819999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101691279|NCT02819999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101691280|NCT02819999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101691281|NCT02819999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101691282|NCT02819999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101691283|NCT02819999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691284|NCT02819999|Immunoconjugates|immunoconjugates|mesh-ancestor
101691285|NCT02819999|Immunologic Factors|immunologic factors|mesh-ancestor
101691286|NCT02819999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691287|NCT04173494|Danazol|danazol|mesh-list
101691288|NCT04173494|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
101691289|NCT04173494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101691290|NCT04173494|Hormone Antagonists|hormone antagonists|mesh-ancestor
101691291|NCT04173494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101691292|NCT04173494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691293|NCT04173494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101691294|NCT04173494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101283014|NCT01911455|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101283015|NCT01911468|Metformin|metformin|mesh-list
101283016|NCT01911468|Liraglutide|liraglutide|mesh-list
101283017|NCT01911468|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101691295|NCT04173494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691296|NCT02819921|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101691297|NCT02819921|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101691298|NCT02819921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101691299|NCT02819921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101691300|NCT02819921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691301|NCT02819921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101691302|NCT02819921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691303|NCT02819921|Antidepressive Agents|antidepressive agents|mesh-ancestor
101691304|NCT02819921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101691305|NCT00875979|Trastuzumab|trastuzumab|mesh-list
101691306|NCT00875979|Pertuzumab|pertuzumab|mesh-list
101691307|NCT00875979|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101691308|NCT00875979|Maytansine|maytansine|mesh-list
101691309|NCT00875979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101691310|NCT00875979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101691311|NCT00875979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101691312|NCT00875979|Tubulin Modulators|tubulin modulators|mesh-ancestor
101691313|NCT00875979|Antimitotic Agents|antimitotic agents|mesh-ancestor
101691314|NCT00875979|Mitosis Modulators|mitosis modulators|mesh-ancestor
101691315|NCT00875979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691316|NCT00875979|Immunotoxins|immunotoxins|mesh-ancestor
101691317|NCT00875979|Immunoconjugates|immunoconjugates|mesh-ancestor
101691318|NCT00875979|Immunologic Factors|immunologic factors|mesh-ancestor
101691319|NCT00875979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691320|NCT02818751|Escitalopram|escitalopram|mesh-list
101691321|NCT02818751|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101691322|NCT02818751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101691323|NCT02818751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101691324|NCT02818751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691325|NCT02818751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101691326|NCT02818751|Serotonin Agents|serotonin agents|mesh-ancestor
101691327|NCT02818751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691328|NCT04238975|Vaccines|vaccines|mesh-list
101283120|NCT01911975|Lacosamide|lacosamide|mesh-list
101691329|NCT04238975|Immunologic Factors|immunologic factors|mesh-ancestor
101691330|NCT04238975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691332|NCT00602420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101691333|NCT00602420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101691334|NCT00602420|Analgesics|analgesics|mesh-ancestor
101691335|NCT00602420|Sensory System Agents|sensory system agents|mesh-ancestor
101691336|NCT00602420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101691337|NCT00602420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691338|NCT00602420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101691339|NCT00602420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101691340|NCT00602420|Gout Suppressants|gout suppressants|mesh-ancestor
101691341|NCT00602420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101691342|NCT00602420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101283174|NCT01912391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101691343|NCT00602420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691344|NCT04635605|Methylene Blue|methylene blue|mesh-list
101691345|NCT04635605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101691346|NCT04635605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691348|NCT02688374|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101691349|NCT02688374|Autonomic Agents|autonomic agents|mesh-ancestor
101691350|NCT02688374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101691351|NCT02688374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691352|NCT02688374|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101691353|NCT02688374|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101535535|NCT02883478|Riboflavin|riboflavin|mesh-list
101691354|NCT02688374|Cholinergic Agents|cholinergic agents|mesh-ancestor
101691355|NCT02688374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101691356|NCT02688374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691357|NCT02819375|Ketamine|ketamine|mesh-list
101691358|NCT02819375|Remifentanil|remifentanil|mesh-list
101691359|NCT02819375|Propofol|propofol|mesh-list
101691360|NCT02819375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101691361|NCT02819375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101283234|NCT01912677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101691362|NCT02819375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691363|NCT02819375|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101691364|NCT02819375|Anesthetics, General|anesthetics, general|mesh-ancestor
101691365|NCT02819375|Anesthetics|anesthetics|mesh-ancestor
101691366|NCT02819375|Analgesics|analgesics|mesh-ancestor
101691367|NCT02819375|Sensory System Agents|sensory system agents|mesh-ancestor
101691368|NCT02819375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101691369|NCT02819375|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101691370|NCT02819375|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101691371|NCT02819375|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101691372|NCT02819375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101691373|NCT02819375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691374|NCT02819375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101691375|NCT02819375|Narcotics|narcotics|mesh-ancestor
101691376|NCT02818985|Dexamethasone|dexamethasone|mesh-list
101691377|NCT02818985|Dexmedetomidine|dexmedetomidine|mesh-list
101691378|NCT02818985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101691379|NCT02818985|Antiemetics|antiemetics|mesh-ancestor
101691380|NCT02818985|Autonomic Agents|autonomic agents|mesh-ancestor
101691381|NCT02818985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101691382|NCT02818985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691383|NCT02818985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101691384|NCT02818985|Glucocorticoids|glucocorticoids|mesh-ancestor
101691385|NCT02818985|Hormones|hormones|mesh-ancestor
101283287|NCT01913002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101691386|NCT02818985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101691387|NCT02818985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101691388|NCT02818985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101691389|NCT02818985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101691390|NCT02818985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101691391|NCT02818985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101691392|NCT02818985|Analgesics|analgesics|mesh-ancestor
101691393|NCT02818985|Sensory System Agents|sensory system agents|mesh-ancestor
101691394|NCT02818985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101691395|NCT02818985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101691396|NCT02818985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101691397|NCT02818985|Adrenergic Agents|adrenergic agents|mesh-ancestor
101691398|NCT02818985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101691399|NCT02818985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691400|NCT03362060|Pembrolizumab|pembrolizumab|mesh-list
101691401|NCT03362060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101691402|NCT03362060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101261341|NCT01749371|Micronutrients|micronutrients|mesh-ancestor
101691403|NCT03362060|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101691404|NCT03362060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691405|NCT02815787|Glyburide|glyburide|mesh-list
101691406|NCT02815787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101283333|NCT01913379|Hormone Antagonists|hormone antagonists|mesh-ancestor
101691407|NCT02815787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691408|NCT00639938|Nevirapine|nevirapine|mesh-list
101691409|NCT00639938|Immunoglobulins|immunoglobulins|mesh-list
101691410|NCT00639938|Antibodies|antibodies|mesh-list
101691411|NCT00639938|gamma-Globulins|gamma-globulins|mesh-list
101691412|NCT00639938|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101691413|NCT00639938|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101691414|NCT00639938|Immunologic Factors|immunologic factors|mesh-ancestor
101691415|NCT00639938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691416|NCT00639938|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101691417|NCT00639938|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101691418|NCT00639938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101691419|NCT00639938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691420|NCT00639938|Antiviral Agents|antiviral agents|mesh-ancestor
101283394|NCT01913990|Hormones|hormones|mesh-ancestor
101691421|NCT00639938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101691422|NCT00639938|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101691423|NCT00639938|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101691424|NCT00639938|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101691425|NCT00639938|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101691426|NCT02815319|Dexamethasone|dexamethasone|mesh-list
101691427|NCT02815319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101691428|NCT02815319|Antiemetics|antiemetics|mesh-ancestor
101691429|NCT02815319|Autonomic Agents|autonomic agents|mesh-ancestor
101691430|NCT02815319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101691431|NCT02815319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691432|NCT02815319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101691433|NCT02815319|Glucocorticoids|glucocorticoids|mesh-ancestor
101691435|NCT02815319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101691436|NCT02815319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101283450|NCT01914250|Analgesics|analgesics|mesh-list
101691437|NCT02815319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101691438|NCT02815475|Curcumin|curcumin|mesh-list
101691439|NCT02815475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101691440|NCT02815475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101691441|NCT02815475|Analgesics|analgesics|mesh-ancestor
101283451|NCT01914250|Tetracaine|tetracaine|mesh-list
101283456|NCT01914250|Anesthetics|anesthetics|mesh-ancestor
101691442|NCT02815475|Sensory System Agents|sensory system agents|mesh-ancestor
101691443|NCT02815475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101691444|NCT02815475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691445|NCT02815475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101691446|NCT02815475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101691447|NCT02815475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101691448|NCT02815475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101691449|NCT02815475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691450|NCT00640796|Aldesleukin|aldesleukin|mesh-list
101691451|NCT00640796|Cyclophosphamide|cyclophosphamide|mesh-list
101691452|NCT00640796|Fludarabine|fludarabine|mesh-list
101691453|NCT00640796|Interleukin-2|interleukin-2|mesh-list
101691454|NCT00640796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101691455|NCT00640796|Immunologic Factors|immunologic factors|mesh-ancestor
101691456|NCT00640796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691457|NCT00640796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101691458|NCT00640796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101691459|NCT00640796|Alkylating Agents|alkylating agents|mesh-ancestor
101691460|NCT00640796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691461|NCT00640796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101691462|NCT00640796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101691463|NCT00640796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101691464|NCT00640796|Analgesics|analgesics|mesh-ancestor
101691465|NCT00640796|Sensory System Agents|sensory system agents|mesh-ancestor
101691466|NCT00640796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101691467|NCT00640796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101691468|NCT00640796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101691469|NCT00640796|Antiviral Agents|antiviral agents|mesh-ancestor
101691470|NCT00640796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101691471|NCT02687984|Risperidone|risperidone|mesh-list
101691472|NCT02687984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101691473|NCT02687984|Serotonin Agents|serotonin agents|mesh-ancestor
101691474|NCT02687984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101691475|NCT02687984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691476|NCT02687984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691477|NCT02687984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101691478|NCT02687984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101691479|NCT02687984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101691480|NCT02687984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101691481|NCT02687984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101691483|NCT02683148|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101691484|NCT02683148|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101691485|NCT02683148|Immunologic Factors|immunologic factors|mesh-ancestor
101691486|NCT02683148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691487|NCT02684786|Lidocaine|lidocaine|mesh-list
101691488|NCT02684786|Reserpine|reserpine|mesh-list
101691489|NCT02684786|Anesthetics, Local|anesthetics, local|mesh-ancestor
101691490|NCT02684786|Anesthetics|anesthetics|mesh-ancestor
101691491|NCT02684786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101691492|NCT02684786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691494|NCT02684786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101691495|NCT02684786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101691496|NCT02684786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101691497|NCT02684786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101691498|NCT02684786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101691499|NCT02684786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691500|NCT02684786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101691501|NCT02684786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101691502|NCT02684786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101691503|NCT02684786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101691504|NCT02684786|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101691505|NCT02684786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101691506|NCT02684786|Adrenergic Agents|adrenergic agents|mesh-ancestor
101691507|NCT02684786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101691508|NCT02683070|Tramadol|tramadol|mesh-list
101691509|NCT02683070|Ropivacaine|ropivacaine|mesh-list
101691510|NCT02683070|Anesthetics, Local|anesthetics, local|mesh-ancestor
101691511|NCT02683070|Anesthetics|anesthetics|mesh-ancestor
101691512|NCT02683070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101691513|NCT02683070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691514|NCT02683070|Sensory System Agents|sensory system agents|mesh-ancestor
101691515|NCT02683070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101691516|NCT02683070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101283608|NCT01915277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101691517|NCT02683070|Narcotics|narcotics|mesh-ancestor
101691518|NCT02683070|Analgesics|analgesics|mesh-ancestor
101691519|NCT02685176|Charcoal|charcoal|mesh-list
101691520|NCT02685176|Antidotes|antidotes|mesh-ancestor
101691521|NCT02685176|Protective Agents|protective agents|mesh-ancestor
101691522|NCT02685176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691524|NCT05664074|Indomethacin|indomethacin|mesh-list
101691525|NCT05664074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101691526|NCT05664074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101691527|NCT05664074|Analgesics|analgesics|mesh-ancestor
101691528|NCT05664074|Sensory System Agents|sensory system agents|mesh-ancestor
101691529|NCT05664074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101691530|NCT05664074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691531|NCT05664074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101283650|NCT01915550|Metformin|metformin|mesh-list
101691532|NCT05664074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101691533|NCT05664074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101691534|NCT05664074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101691535|NCT05664074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691536|NCT05664074|Gout Suppressants|gout suppressants|mesh-ancestor
101691537|NCT05664074|Tocolytic Agents|tocolytic agents|mesh-ancestor
101691538|NCT05664074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101691539|NCT00634205|Doxorubicin|doxorubicin|mesh-list
101691540|NCT00634205|Valproic Acid|valproic acid|mesh-list
101691541|NCT00634205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101691542|NCT00634205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101691543|NCT00634205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101691544|NCT00634205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101691545|NCT00634205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101691546|NCT00634205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691547|NCT00634205|Anticonvulsants|anticonvulsants|mesh-ancestor
101691548|NCT00634205|GABA Agents|gaba agents|mesh-ancestor
101691549|NCT00634205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101691550|NCT00634205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691551|NCT00634205|Antimanic Agents|antimanic agents|mesh-ancestor
101691552|NCT00634205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101691553|NCT00634205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101283715|NCT01916200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101283717|NCT01916200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101691554|NCT00634205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101691555|NCT04238195|Moxifloxacin|moxifloxacin|mesh-list
101691556|NCT04238195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101691557|NCT04238195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101691558|NCT04238195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101691559|NCT04238195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101691560|NCT04238195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101691561|NCT04238195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691562|NCT04238195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101691563|NCT02818049|Dimercaprol|dimercaprol|mesh-list
101691564|NCT02818049|Chelating Agents|chelating agents|mesh-ancestor
101691565|NCT02818049|Sequestering Agents|sequestering agents|mesh-ancestor
101691566|NCT02818049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691568|NCT02684708|Cyclophosphamide|cyclophosphamide|mesh-list
101691569|NCT02684708|Dacarbazine|dacarbazine|mesh-list
101691570|NCT02684708|Vincristine|vincristine|mesh-list
101691571|NCT02684708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101691572|NCT02684708|Immunologic Factors|immunologic factors|mesh-ancestor
101691573|NCT02684708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691574|NCT02684708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101691575|NCT02684708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101691576|NCT02684708|Alkylating Agents|alkylating agents|mesh-ancestor
101691577|NCT02684708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691578|NCT02684708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101691579|NCT02684708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101691580|NCT02684708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101691581|NCT02684708|Glucocorticoids|glucocorticoids|mesh-ancestor
101691582|NCT02684708|Hormones|hormones|mesh-ancestor
101691583|NCT02684708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101283766|NCT01916265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691584|NCT02684708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101691585|NCT02684708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101691586|NCT02684708|Tubulin Modulators|tubulin modulators|mesh-ancestor
101691587|NCT02684708|Antimitotic Agents|antimitotic agents|mesh-ancestor
101691588|NCT02684708|Mitosis Modulators|mitosis modulators|mesh-ancestor
101691589|NCT02817503|Folic Acid|folic acid|mesh-list
101691590|NCT02817503|Vitamin B Complex|vitamin b complex|mesh-list
101691591|NCT02817503|Amlodipine|amlodipine|mesh-list
101283810|NCT01916642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101691592|NCT02817503|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101691593|NCT02817503|Enalapril|enalapril|mesh-list
101691594|NCT02817503|Enalaprilat|enalaprilat|mesh-list
101691595|NCT02817503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101691596|NCT02817503|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101691597|NCT02817503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101691598|NCT02817503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691599|NCT02817503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101691600|NCT02817503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691601|NCT02817503|Vasodilator Agents|vasodilator agents|mesh-ancestor
101691602|NCT02817503|Hematinics|hematinics|mesh-ancestor
101348918|NCT00276809|Etoposide|etoposide|mesh-list
101691603|NCT02817503|Vitamins|vitamins|mesh-ancestor
101691604|NCT02817503|Micronutrients|micronutrients|mesh-ancestor
101691605|NCT02817503|Diuretics|diuretics|mesh-ancestor
101691606|NCT02817503|Natriuretic Agents|natriuretic agents|mesh-ancestor
101691607|NCT02817503|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101691608|NCT02817503|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101691609|NCT02817503|Protease Inhibitors|protease inhibitors|mesh-ancestor
101691610|NCT02817503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101691611|NCT02814461|Axitinib|axitinib|mesh-list
101691612|NCT02814461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101691613|NCT02814461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101691614|NCT02814461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101691615|NCT02814461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691616|NCT00875667|Fludarabine|fludarabine|mesh-list
101691617|NCT00875667|Fludarabine phosphate|fludarabine phosphate|mesh-list
101691618|NCT00875667|Lenalidomide|lenalidomide|mesh-list
101691619|NCT00875667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101691620|NCT00875667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101691621|NCT00875667|Antimetabolites|antimetabolites|mesh-ancestor
101691622|NCT00875667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691623|NCT00875667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101691624|NCT00875667|Immunologic Factors|immunologic factors|mesh-ancestor
101283895|NCT01917045|Dsuvia|dsuvia|mesh-list
101691625|NCT00875667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691626|NCT00875667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101691627|NCT00875667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101691628|NCT00875667|Growth Substances|growth substances|mesh-ancestor
101691629|NCT00875667|Growth Inhibitors|growth inhibitors|mesh-ancestor
101691630|NCT02811185|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101691631|NCT02811185|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101691632|NCT02811185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691633|NCT02811341|Scopolamine|scopolamine|mesh-list
101691634|NCT02811341|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101691635|NCT02811341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101691636|NCT02811341|Antiemetics|antiemetics|mesh-ancestor
101691637|NCT02811341|Autonomic Agents|autonomic agents|mesh-ancestor
101691638|NCT02811341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101283916|NCT01917097|Dexmedetomidine|dexmedetomidine|mesh-list
101691639|NCT02811341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691640|NCT02811341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101691642|NCT02811341|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101691643|NCT02811341|Cholinergic Agents|cholinergic agents|mesh-ancestor
101283986|NCT01917331|Hormones|hormones|mesh-ancestor
101691644|NCT02811341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101691645|NCT02811341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691646|NCT02811341|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101691647|NCT02811341|Parasympatholytics|parasympatholytics|mesh-ancestor
101691648|NCT00682383|Docetaxel|docetaxel|mesh-list
101691649|NCT00682383|Etoposide|etoposide|mesh-list
101691650|NCT00682383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101691651|NCT00682383|Tubulin Modulators|tubulin modulators|mesh-ancestor
101691653|NCT00682383|Mitosis Modulators|mitosis modulators|mesh-ancestor
101691654|NCT00682383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691655|NCT00682383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101691656|NCT00682383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101691657|NCT00682383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101691658|NCT00682383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101691659|NCT04237493|Insulin|insulin|mesh-list
101691660|NCT04237493|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101691661|NCT04237493|Metformin|metformin|mesh-list
101691662|NCT04237493|Insulin Glargine|insulin glargine|mesh-list
101691663|NCT04237493|Glimepiride|glimepiride|mesh-list
101691664|NCT04237493|Vildagliptin|vildagliptin|mesh-list
101691666|NCT04237493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691667|NCT04237493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101691668|NCT04237493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101284183|NCT01918514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101691669|NCT04237493|Immunologic Factors|immunologic factors|mesh-ancestor
101691670|NCT04237493|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101691671|NCT04237493|Protease Inhibitors|protease inhibitors|mesh-ancestor
101284185|NCT01918514|Anesthetics|anesthetics|mesh-ancestor
101691672|NCT04237493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101691673|NCT04237493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691674|NCT00683319|Cyclophosphamide|cyclophosphamide|mesh-list
101691675|NCT00683319|Carboplatin|carboplatin|mesh-list
101691676|NCT00683319|Methotrexate|methotrexate|mesh-list
101691677|NCT00683319|Vincristine|vincristine|mesh-list
101691678|NCT00683319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101691679|NCT00683319|Immunologic Factors|immunologic factors|mesh-ancestor
101691680|NCT00683319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691682|NCT00683319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101691683|NCT00683319|Alkylating Agents|alkylating agents|mesh-ancestor
101691684|NCT00683319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691685|NCT00683319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101691686|NCT00683319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101691687|NCT00683319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101691688|NCT00683319|Abortifacient Agents|abortifacient agents|mesh-ancestor
101691689|NCT00683319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101691690|NCT00683319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101691691|NCT00683319|Antimetabolites|antimetabolites|mesh-ancestor
101691692|NCT00683319|Dermatologic Agents|dermatologic agents|mesh-ancestor
101691693|NCT00683319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101691694|NCT00683319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101691695|NCT00683319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101691696|NCT00683319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101691697|NCT00683319|Tubulin Modulators|tubulin modulators|mesh-ancestor
101691698|NCT00683319|Antimitotic Agents|antimitotic agents|mesh-ancestor
101691699|NCT00683319|Mitosis Modulators|mitosis modulators|mesh-ancestor
101691700|NCT00634361|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
101691701|NCT00634361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101691702|NCT00634361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101284460|NCT01921374|Antiviral Agents|antiviral agents|mesh-ancestor
101691703|NCT02810483|Topiramate|topiramate|mesh-list
101691704|NCT02810483|Anticonvulsants|anticonvulsants|mesh-ancestor
101691705|NCT02810483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101284528|NCT01924676|Oxycodone|oxycodone|mesh-list
101691706|NCT02810483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691707|NCT00683865|Moxifloxacin|moxifloxacin|mesh-list
101691708|NCT00683865|Ofloxacin|ofloxacin|mesh-list
101691709|NCT00683865|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101691710|NCT00683865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101691711|NCT00683865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101691712|NCT00683865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101691713|NCT00683865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101691714|NCT00683865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101691715|NCT00683865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691716|NCT00683865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101691717|NCT00683865|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101691718|NCT00683865|Contraceptive Agents|contraceptive agents|mesh-ancestor
101691719|NCT00683865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101284600|NCT01930019|Anticonvulsants|anticonvulsants|mesh-ancestor
101284601|NCT01930019|GABA Modulators|gaba modulators|mesh-ancestor
101691720|NCT00683865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691721|NCT00683865|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101691722|NCT00683865|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101691723|NCT00683865|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101691724|NCT00683865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101691725|NCT00683865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101691726|NCT00683865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101691727|NCT02813369|Naloxegol|naloxegol|mesh-list
101691728|NCT02813369|Laxatives|laxatives|mesh-list
101691729|NCT02813369|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101691730|NCT02813369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691731|NCT02813369|Sensory System Agents|sensory system agents|mesh-ancestor
101691732|NCT02813369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101691733|NCT02813369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101691734|NCT00683943|Lithium Carbonate|lithium carbonate|mesh-list
101691735|NCT00683943|Antidepressive Agents|antidepressive agents|mesh-ancestor
101691736|NCT00683943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101691737|NCT00683943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101691738|NCT00683943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691739|NCT00683943|Antimanic Agents|antimanic agents|mesh-ancestor
101691740|NCT00683943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101691741|NCT00683943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101691742|NCT00683943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691743|NCT02810015|Botulinum Toxins|botulinum toxins|mesh-list
101691744|NCT02810015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101691745|NCT02810015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101691746|NCT02810015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101284663|NCT01930552|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101284664|NCT01930552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101691747|NCT02810015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101691748|NCT02810015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691750|NCT02810015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101691751|NCT02810015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691752|NCT02810015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101284708|NCT01930734|Sympathomimetics|sympathomimetics|mesh-ancestor
101691753|NCT02810015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101691755|NCT02809781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101691756|NCT02809781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101691757|NCT02809781|Analgesics|analgesics|mesh-ancestor
101691758|NCT02809781|Sensory System Agents|sensory system agents|mesh-ancestor
101691759|NCT02809781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101691760|NCT02809781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691761|NCT02809781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101691762|NCT02809781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101691763|NCT02809781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101691764|NCT02809781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101691765|NCT02809781|Immunologic Factors|immunologic factors|mesh-ancestor
101691766|NCT02809937|Dexmedetomidine|dexmedetomidine|mesh-list
101691767|NCT02809937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101691768|NCT02809937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101691769|NCT02809937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691770|NCT02809937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101691772|NCT02809937|Sensory System Agents|sensory system agents|mesh-ancestor
101691773|NCT02809937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101691774|NCT02809937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101691775|NCT02809937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101691776|NCT02809937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101691777|NCT02809937|Adrenergic Agents|adrenergic agents|mesh-ancestor
101691778|NCT02809937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101691779|NCT02809937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691780|NCT02812979|Albuterol|albuterol|mesh-list
101691781|NCT02812979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101691782|NCT02812979|Autonomic Agents|autonomic agents|mesh-ancestor
101691783|NCT02812979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101691784|NCT02812979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691785|NCT02812979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101691786|NCT02812979|Respiratory System Agents|respiratory system agents|mesh-ancestor
101691787|NCT02812979|Tocolytic Agents|tocolytic agents|mesh-ancestor
101691788|NCT02812979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101691789|NCT02812979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101691790|NCT02812979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101691791|NCT02812979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101691792|NCT02812979|Adrenergic Agents|adrenergic agents|mesh-ancestor
101691793|NCT02812979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101691794|NCT02812979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691795|NCT02809469|Apixaban|apixaban|mesh-list
101691796|NCT02809469|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101691797|NCT02809469|Antithrombins|antithrombins|mesh-ancestor
101691798|NCT02809469|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101691799|NCT02809469|Protease Inhibitors|protease inhibitors|mesh-ancestor
101691800|NCT02809469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101691801|NCT02809469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691802|NCT02809469|Anticoagulants|anticoagulants|mesh-ancestor
101691803|NCT02809079|Mycophenolic Acid|mycophenolic acid|mesh-list
101691804|NCT02809079|Prednisone|prednisone|mesh-list
101691805|NCT02809079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101691806|NCT02809079|Glucocorticoids|glucocorticoids|mesh-ancestor
101691807|NCT02809079|Hormones|hormones|mesh-ancestor
101285025|NCT01932450|Antihypertensive Agents|antihypertensive agents|mesh-list
101285026|NCT01932502|Clobazam|clobazam|mesh-list
101691808|NCT02809079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101691809|NCT02809079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691810|NCT02809079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101691811|NCT02809079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101691812|NCT02809079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101691813|NCT02809079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101691814|NCT02809079|Antitubercular Agents|antitubercular agents|mesh-ancestor
101691815|NCT02809079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101691816|NCT02809079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101691817|NCT02809079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101691818|NCT02809079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691819|NCT02812199|Lidocaine|lidocaine|mesh-list
101691820|NCT02812199|Epinephrine|epinephrine|mesh-list
101691821|NCT02812199|Racepinephrine|racepinephrine|mesh-list
101691822|NCT02812199|Epinephryl borate|epinephryl borate|mesh-list
101691823|NCT02812199|Anesthetics, Local|anesthetics, local|mesh-ancestor
101691824|NCT02812199|Anesthetics|anesthetics|mesh-ancestor
101691825|NCT02812199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101285092|NCT01932580|Immunologic Factors|immunologic factors|mesh-ancestor
101691826|NCT02812199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691827|NCT02812199|Sensory System Agents|sensory system agents|mesh-ancestor
101691828|NCT02812199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101691829|NCT02812199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101691830|NCT02812199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101691831|NCT02812199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101691832|NCT02812199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101691833|NCT02812199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691834|NCT02812199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101691835|NCT02812199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101691836|NCT02812199|Adrenergic Agents|adrenergic agents|mesh-ancestor
101691837|NCT02812199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101691838|NCT02812199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101691839|NCT02812199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101691840|NCT02812199|Autonomic Agents|autonomic agents|mesh-ancestor
101691841|NCT02812199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101691842|NCT02812199|Respiratory System Agents|respiratory system agents|mesh-ancestor
101691844|NCT02812199|Sympathomimetics|sympathomimetics|mesh-ancestor
101691846|NCT02812043|Amorolfine|amorolfine|mesh-list
101691847|NCT02812043|Antifungal Agents|antifungal agents|mesh-ancestor
101691848|NCT02812043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101691849|NCT02808767|Ticagrelor|ticagrelor|mesh-list
101691850|NCT02808767|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101691851|NCT02808767|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101691852|NCT02808767|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101691853|NCT02808767|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101691854|NCT02808767|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101691855|NCT02808767|Purinergic Agents|purinergic agents|mesh-ancestor
101691856|NCT02808767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101691857|NCT02808767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691858|NCT02808767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691859|NCT02812355|Heparin|heparin|mesh-list
101691860|NCT02812355|Anticoagulants|anticoagulants|mesh-ancestor
101691861|NCT02812355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101691862|NCT02812355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101691863|NCT02812355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691864|NCT02811731|Amlodipine|amlodipine|mesh-list
101285276|NCT01934569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101691865|NCT02811731|Candesartan|candesartan|mesh-list
101691866|NCT02811731|Candesartan cilexetil|candesartan cilexetil|mesh-list
101691867|NCT02811731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101691868|NCT02811731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101691869|NCT02811731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101691870|NCT02811731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691871|NCT02811731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101285340|NCT01934816|Hormones|hormones|mesh-ancestor
101691872|NCT02811731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691873|NCT02811731|Vasodilator Agents|vasodilator agents|mesh-ancestor
101691874|NCT02811731|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101691875|NCT02811731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101691876|NCT02811809|Leuprolide|leuprolide|mesh-list
101691877|NCT02811809|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101691878|NCT02811809|Fertility Agents|fertility agents|mesh-ancestor
101691879|NCT02811809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101691880|NCT02811809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691881|NCT02811809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101285405|NCT01935193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101691882|NCT02811809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101691884|NCT05569421|Formoterol Fumarate|formoterol fumarate|mesh-list
101691885|NCT05569421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101691886|NCT05569421|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101691887|NCT05569421|Autonomic Agents|autonomic agents|mesh-ancestor
101691888|NCT05569421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101691889|NCT05569421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691890|NCT05569421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101691891|NCT05569421|Respiratory System Agents|respiratory system agents|mesh-ancestor
101691892|NCT05569421|Glucocorticoids|glucocorticoids|mesh-ancestor
101691893|NCT05569421|Hormones|hormones|mesh-ancestor
101691894|NCT05569421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101691895|NCT05569421|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101691896|NCT05569421|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101691897|NCT05569421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101691898|NCT05569421|Adrenergic Agents|adrenergic agents|mesh-ancestor
101691899|NCT05569421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101285470|NCT01935518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101349213|NCT00275093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101285474|NCT01935518|Vasodilator Agents|vasodilator agents|mesh-ancestor
101691900|NCT05569421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691901|NCT02808611|Propranolol|propranolol|mesh-list
101691902|NCT02808611|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101691903|NCT02808611|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101691904|NCT02808611|Adrenergic Agents|adrenergic agents|mesh-ancestor
101691905|NCT02808611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101691906|NCT02808611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691907|NCT02808611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691908|NCT02808611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101691909|NCT02808611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101691910|NCT02808611|Vasodilator Agents|vasodilator agents|mesh-ancestor
101691912|NCT02808533|Anticonvulsants|anticonvulsants|mesh-ancestor
101691913|NCT02808533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101691914|NCT02808533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691915|NCT02811497|Azacitidine|azacitidine|mesh-list
101691916|NCT02811497|Durvalumab|durvalumab|mesh-list
101691917|NCT02811497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101691918|NCT02811497|Antimetabolites|antimetabolites|mesh-ancestor
101691919|NCT02811497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691920|NCT02811497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101691921|NCT02811497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101691922|NCT02811497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101285592|NCT01935882|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101285593|NCT01935882|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101691923|NCT00634439|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101285595|NCT01935908|Levetiracetam|levetiracetam|mesh-list
101691924|NCT00634439|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101691925|NCT00634439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101691926|NCT00634439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101691927|NCT00634439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691928|NCT00634439|Adrenergic Agents|adrenergic agents|mesh-ancestor
101691929|NCT00634439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101691930|NCT00634439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691931|NCT02807909|Itraconazole|itraconazole|mesh-list
101691933|NCT02807909|Antifungal Agents|antifungal agents|mesh-ancestor
101691934|NCT02807909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101691935|NCT02807909|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101691936|NCT02807909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101691937|NCT02807909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101691938|NCT02807909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691939|NCT02807909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101691940|NCT02807909|Hormone Antagonists|hormone antagonists|mesh-ancestor
101691941|NCT02807909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101691942|NCT02807909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691943|NCT02807909|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101691944|NCT02807909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101691945|NCT02807909|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101691946|NCT02807909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101285717|NCT01936545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101691947|NCT02807909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101691948|NCT02807909|Vasodilator Agents|vasodilator agents|mesh-ancestor
101691949|NCT02808065|Mycophenolic Acid|mycophenolic acid|mesh-list
101691950|NCT02808065|Tacrolimus|tacrolimus|mesh-list
101691951|NCT02808065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101691952|NCT02808065|Immunologic Factors|immunologic factors|mesh-ancestor
101691953|NCT02808065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691954|NCT02808065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101691955|NCT02808065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101691956|NCT02808065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691957|NCT02808065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101691958|NCT02808065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101691959|NCT02808065|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101691960|NCT02808065|Antitubercular Agents|antitubercular agents|mesh-ancestor
101285777|NCT01937182|Citalopram|citalopram|mesh-list
101691961|NCT02808065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101691962|NCT02808065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101691963|NCT00602030|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101691964|NCT00602030|Entinostat|entinostat|mesh-list
101691965|NCT00602030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101691966|NCT00602030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101691967|NCT00602030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101691968|NCT00602030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285833|NCT01937611|Midazolam|midazolam|mesh-list
101691969|NCT00602030|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101691970|NCT02804711|Vaccines|vaccines|mesh-list
101691971|NCT02804711|Immunologic Factors|immunologic factors|mesh-ancestor
101691972|NCT02804711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691974|NCT00640094|Antioxidants|antioxidants|mesh-ancestor
101691975|NCT00640094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101285902|NCT01937767|Analgesics|analgesics|mesh-ancestor
101691976|NCT00640094|Protective Agents|protective agents|mesh-ancestor
101691977|NCT00640094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691978|NCT00640094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101691980|NCT04183634|Dopamine Agonists|dopamine agonists|mesh-ancestor
101691981|NCT04183634|Dopamine Agents|dopamine agents|mesh-ancestor
101410090|NCT00352378|Antimetabolites|antimetabolites|mesh-ancestor
101691982|NCT04183634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101691983|NCT04183634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101691984|NCT04183634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691985|NCT02804633|Acetaminophen|acetaminophen|mesh-list
101691986|NCT02804633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101691987|NCT02804633|Analgesics|analgesics|mesh-ancestor
101691988|NCT02804633|Sensory System Agents|sensory system agents|mesh-ancestor
101691989|NCT02804633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101691990|NCT02804633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691991|NCT02804633|Antipyretics|antipyretics|mesh-ancestor
101691992|NCT02807441|Aspirin|aspirin|mesh-list
101691993|NCT02807441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101691994|NCT02807441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101691995|NCT02807441|Analgesics|analgesics|mesh-ancestor
101691996|NCT02807441|Sensory System Agents|sensory system agents|mesh-ancestor
101691997|NCT02807441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101286044|NCT01938859|Antidepressive Agents|antidepressive agents|mesh-ancestor
101691998|NCT02807441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101691999|NCT02807441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101692000|NCT02807441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101692001|NCT02807441|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101692002|NCT02807441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101692003|NCT02807441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692004|NCT02807441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101692005|NCT02807441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101692006|NCT02807441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101692007|NCT02807441|Antipyretics|antipyretics|mesh-ancestor
101692008|NCT02807285|Ocrelizumab|ocrelizumab|mesh-list
101692009|NCT02807285|Immunologic Factors|immunologic factors|mesh-ancestor
101692010|NCT02807285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692011|NCT02682680|Ezetimibe|ezetimibe|mesh-list
101286104|NCT01939093|Histamine Agents|histamine agents|mesh-ancestor
101692012|NCT02682680|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
101692013|NCT02682680|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101692014|NCT02682680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101692015|NCT02682680|Antimetabolites|antimetabolites|mesh-ancestor
101286165|NCT01939483|Camptothecin|camptothecin|mesh-list
101692016|NCT02682680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692017|NCT02682680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101692018|NCT02807207|Moxifloxacin|moxifloxacin|mesh-list
101692019|NCT02807207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101692020|NCT02807207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101692021|NCT02807207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101692022|NCT02807207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101692023|NCT02807207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101692024|NCT02807207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692025|NCT02807207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101692026|NCT02682758|Xenon|xenon|mesh-list
101692027|NCT02682758|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101692028|NCT02682758|Anesthetics, General|anesthetics, general|mesh-ancestor
101692029|NCT02682758|Anesthetics|anesthetics|mesh-ancestor
101692030|NCT02682758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101692031|NCT02682758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692032|NCT02682524|Aceclofenac|aceclofenac|mesh-list
101692033|NCT02682524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101692034|NCT02682524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101692035|NCT02682524|Analgesics|analgesics|mesh-ancestor
101692037|NCT02682524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101692038|NCT02682524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692039|NCT02682524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101692040|NCT02682524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101692041|NCT04183556|Naproxen|naproxen|mesh-list
101692042|NCT04183556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101692043|NCT04183556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101692044|NCT04183556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101692045|NCT04183556|Analgesics|analgesics|mesh-ancestor
101692046|NCT04183556|Sensory System Agents|sensory system agents|mesh-ancestor
101692047|NCT04183556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101692048|NCT04183556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692049|NCT04183556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101692050|NCT04183556|Gout Suppressants|gout suppressants|mesh-ancestor
101692051|NCT04183556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101692052|NCT04183556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101692053|NCT04183556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692054|NCT00640952|Acamprosate|acamprosate|mesh-list
101692055|NCT00640952|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101692056|NCT02684240|Nitazoxanide|nitazoxanide|mesh-list
101286366|NCT01940419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101286379|NCT01940627|Ubiquinone|ubiquinone|mesh-list
101692057|NCT02684240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101692058|NCT02684240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101692059|NCT02807051|Clarithromycin|clarithromycin|mesh-list
101692060|NCT02807051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101692061|NCT02807051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101692062|NCT02807051|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101692063|NCT02807051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101692064|NCT02807051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692065|NCT02807051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101692066|NCT02807051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101692067|NCT02684084|Dexamethasone|dexamethasone|mesh-list
101692068|NCT02684084|Ranibizumab|ranibizumab|mesh-list
101692069|NCT02684084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101692070|NCT02684084|Antiemetics|antiemetics|mesh-ancestor
101692071|NCT02684084|Autonomic Agents|autonomic agents|mesh-ancestor
101692072|NCT02684084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101692073|NCT02684084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692074|NCT02684084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101692075|NCT02684084|Glucocorticoids|glucocorticoids|mesh-ancestor
101692076|NCT02684084|Hormones|hormones|mesh-ancestor
101692077|NCT02684084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101286423|NCT01940952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692078|NCT02684084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101692079|NCT02684084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101692080|NCT02684084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101692081|NCT02684084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101692082|NCT02684084|Growth Substances|growth substances|mesh-ancestor
101692083|NCT02684084|Growth Inhibitors|growth inhibitors|mesh-ancestor
101692085|NCT02684318|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101692086|NCT02684318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101692087|NCT02684318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692088|NCT02684318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101692089|NCT02806817|Bevacizumab|bevacizumab|mesh-list
101692090|NCT02806817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101692091|NCT02806817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101692092|NCT02806817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101692093|NCT02806817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101692094|NCT02806817|Growth Substances|growth substances|mesh-ancestor
101286555|NCT01941758|Vaccines|vaccines|mesh-list
101692095|NCT02806817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692097|NCT04182854|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101692098|NCT04182854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101692100|NCT04182854|Natriuretic Agents|natriuretic agents|mesh-ancestor
101692101|NCT04182854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692102|NCT04182854|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101692103|NCT04182854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101692104|NCT04182854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692105|NCT02680808|Olorofim|olorofim|mesh-list
101692106|NCT02680808|Midazolam|midazolam|mesh-list
101286611|NCT01941966|Mitomycin|mitomycin|mesh-list
101286621|NCT01941979|Capecitabine|capecitabine|mesh-list
101692107|NCT02680808|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101692108|NCT02680808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101692109|NCT02680808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101692110|NCT02680808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692111|NCT02680808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101692112|NCT02680808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101692113|NCT02680808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101692114|NCT02680808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101692115|NCT02680808|Anesthetics, General|anesthetics, general|mesh-ancestor
101692116|NCT02680808|Anesthetics|anesthetics|mesh-ancestor
101692117|NCT02680808|GABA Modulators|gaba modulators|mesh-ancestor
101692118|NCT02680808|GABA Agents|gaba agents|mesh-ancestor
101692119|NCT02680808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101692120|NCT02680808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349445|NCT00129155|Treosulfan|treosulfan|mesh-list
101692122|NCT02680808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101692123|NCT05663684|Proxymetacaine|proxymetacaine|mesh-list
101692124|NCT05663684|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101692125|NCT05663684|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101692126|NCT05663684|Anesthetics, Local|anesthetics, local|mesh-ancestor
101692127|NCT05663684|Anesthetics|anesthetics|mesh-ancestor
101692128|NCT05663684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101692129|NCT05663684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692130|NCT05663684|Sensory System Agents|sensory system agents|mesh-ancestor
101692131|NCT05663684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101692132|NCT04004819|Rituximab|rituximab|mesh-list
101692133|NCT04004819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101692134|NCT04004819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101692135|NCT04004819|Immunologic Factors|immunologic factors|mesh-ancestor
101692136|NCT04004819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692137|NCT04004819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101692138|NCT00641654|Interferons|interferons|mesh-list
101692139|NCT00641654|Ribavirin|ribavirin|mesh-list
101692140|NCT00641654|Interferon-alpha|interferon-alpha|mesh-list
101692141|NCT00641654|Interferon alpha-2|interferon alpha-2|mesh-list
101692142|NCT00641654|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101692143|NCT00641654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101692144|NCT00641654|Antiviral Agents|antiviral agents|mesh-ancestor
101692145|NCT00641654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101692146|NCT00641654|Antimetabolites|antimetabolites|mesh-ancestor
101692147|NCT00641654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692148|NCT00641654|Immunologic Factors|immunologic factors|mesh-ancestor
101692149|NCT00641654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692150|NCT02826434|Durvalumab|durvalumab|mesh-list
101692151|NCT02826434|Poly ICLC|poly iclc|mesh-list
101692152|NCT02826434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101692153|NCT02826434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101692154|NCT02826434|Interferon Inducers|interferon inducers|mesh-ancestor
101692155|NCT02826434|Immunologic Factors|immunologic factors|mesh-ancestor
101692156|NCT02826434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692157|NCT00549601|Rivastigmine|rivastigmine|mesh-list
101692158|NCT00549601|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101692159|NCT00549601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101286796|NCT01943058|Levonorgestrel|levonorgestrel|mesh-list
101692160|NCT00549601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692161|NCT00549601|Cholinergic Agents|cholinergic agents|mesh-ancestor
101692162|NCT00549601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101692163|NCT00549601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692164|NCT00549601|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101692165|NCT00549601|Protective Agents|protective agents|mesh-ancestor
101692166|NCT02806349|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
101692168|NCT02806349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101692169|NCT04184492|Insulin|insulin|mesh-list
101692170|NCT04184492|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101692171|NCT04184492|Insulin Aspart|insulin aspart|mesh-list
101692172|NCT04184492|Insulin, Long-Acting|insulin, long-acting|mesh-list
101692173|NCT04184492|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101692174|NCT04184492|Biphasic Insulins|biphasic insulins|mesh-list
101692175|NCT04184492|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101692176|NCT04184492|Insulin, Isophane|insulin, isophane|mesh-list
101692177|NCT04184492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101692178|NCT04184492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692180|NCT02806115|Retinol acetate|retinol acetate|mesh-list
101692181|NCT02806115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101692182|NCT02806115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101692183|NCT02806115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101692184|NCT02806115|Immunologic Factors|immunologic factors|mesh-ancestor
101692185|NCT02806115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692186|NCT02806115|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101692187|NCT02806115|Protective Agents|protective agents|mesh-ancestor
101286992|NCT01944410|Mitogens|mitogens|mesh-list
101692188|NCT02806115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101692189|NCT02682134|Dexamethasone|dexamethasone|mesh-list
101692190|NCT02682134|Dexamethasone acetate|dexamethasone acetate|mesh-list
101692191|NCT02682134|Lidocaine|lidocaine|mesh-list
101692192|NCT02682134|BB 1101|bb 1101|mesh-list
101692193|NCT02682134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101692194|NCT02682134|Antiemetics|antiemetics|mesh-ancestor
101692195|NCT02682134|Autonomic Agents|autonomic agents|mesh-ancestor
101692196|NCT02682134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101692197|NCT02682134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692198|NCT02682134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101692200|NCT02682134|Hormones|hormones|mesh-ancestor
101692201|NCT02682134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101692202|NCT02682134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101692203|NCT02682134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101692204|NCT02682134|Protease Inhibitors|protease inhibitors|mesh-ancestor
101692205|NCT02682134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101692206|NCT02682134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692207|NCT02682134|Anesthetics, Local|anesthetics, local|mesh-ancestor
101692208|NCT02682134|Anesthetics|anesthetics|mesh-ancestor
101692209|NCT02682134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101692210|NCT02682134|Sensory System Agents|sensory system agents|mesh-ancestor
101692211|NCT02682134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101692212|NCT02682134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101692213|NCT02682134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101692214|NCT02682134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101692215|NCT04236323|Remifentanil|remifentanil|mesh-list
101692216|NCT04236323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101692217|NCT04236323|Narcotics|narcotics|mesh-ancestor
101692218|NCT04236323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101692219|NCT04236323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692221|NCT04236323|Sensory System Agents|sensory system agents|mesh-ancestor
101692222|NCT04236323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101692223|NCT04206163|Edotreotide|edotreotide|mesh-list
101692224|NCT04206163|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101692225|NCT04206163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692226|NCT00909974|Micronutrients|micronutrients|mesh-list
101692227|NCT00909974|Trace Elements|trace elements|mesh-list
101692228|NCT00909974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692229|NCT05300347|Adenosine|adenosine|mesh-list
101692230|NCT05300347|Analgesics|analgesics|mesh-ancestor
101692231|NCT05300347|Sensory System Agents|sensory system agents|mesh-ancestor
101692232|NCT05300347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101287042|NCT01945021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101287043|NCT01945021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101692233|NCT05300347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692234|NCT05300347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101692235|NCT05300347|Vasodilator Agents|vasodilator agents|mesh-ancestor
101692236|NCT05300347|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101692237|NCT05300347|Purinergic Agonists|purinergic agonists|mesh-ancestor
101692238|NCT05300347|Purinergic Agents|purinergic agents|mesh-ancestor
101692239|NCT05300347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101692240|NCT05300347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692241|NCT04011241|Itraconazole|itraconazole|mesh-list
101692242|NCT04011241|Antifungal Agents|antifungal agents|mesh-ancestor
101692243|NCT04011241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101692244|NCT04011241|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101692245|NCT04011241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101692246|NCT04011241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101692247|NCT04011241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692248|NCT04011241|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101692249|NCT04011241|Hormone Antagonists|hormone antagonists|mesh-ancestor
101692250|NCT04011241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101692251|NCT04011241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692252|NCT04011241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101692253|NCT00956059|Prednisone|prednisone|mesh-list
101692254|NCT00956059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101692255|NCT00956059|Glucocorticoids|glucocorticoids|mesh-ancestor
101692256|NCT00956059|Hormones|hormones|mesh-ancestor
101692257|NCT00956059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101692258|NCT00956059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692259|NCT00956059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101287126|NCT01945554|Anesthetics, Local|anesthetics, local|mesh-ancestor
101692260|NCT00956059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101692262|NCT04010929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101692263|NCT04010929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101692264|NCT04010929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692265|NCT04010929|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101692266|NCT04010929|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101692267|NCT00956215|Aprepitant|aprepitant|mesh-list
101692268|NCT00956215|Fosaprepitant|fosaprepitant|mesh-list
101692269|NCT00956215|Antiemetics|antiemetics|mesh-ancestor
101692270|NCT00956215|Autonomic Agents|autonomic agents|mesh-ancestor
101692271|NCT00956215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101287188|NCT05410314|Vitamin B Complex|vitamin b complex|mesh-ancestor
101692272|NCT00956215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692273|NCT00956215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101692274|NCT00956215|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101692276|NCT00956215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692277|NCT00640640|Bevacizumab|bevacizumab|mesh-list
101692278|NCT00640640|Ranibizumab|ranibizumab|mesh-list
101692279|NCT00640640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101692280|NCT00640640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101692281|NCT00640640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101692282|NCT00640640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101692283|NCT00640640|Growth Substances|growth substances|mesh-ancestor
101692284|NCT00640640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692285|NCT00640640|Growth Inhibitors|growth inhibitors|mesh-ancestor
101692287|NCT03973177|Methylprednisolone|methylprednisolone|mesh-list
101692288|NCT03973177|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101692289|NCT03973177|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101692290|NCT03973177|Prednisolone|prednisolone|mesh-list
101692291|NCT03973177|Prednisolone acetate|prednisolone acetate|mesh-list
101692293|NCT03973177|Prednisolone phosphate|prednisolone phosphate|mesh-list
101692294|NCT03973177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101692295|NCT03973177|Antiemetics|antiemetics|mesh-ancestor
101692296|NCT03973177|Autonomic Agents|autonomic agents|mesh-ancestor
101692297|NCT03973177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101692298|NCT03973177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692299|NCT03973177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101692300|NCT03973177|Glucocorticoids|glucocorticoids|mesh-ancestor
101692301|NCT03973177|Hormones|hormones|mesh-ancestor
101692302|NCT03973177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101692303|NCT03973177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101692304|NCT03973177|Protective Agents|protective agents|mesh-ancestor
101692305|NCT03973177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101692306|NCT03973177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101692307|NCT03973177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101692308|NCT03973177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101692310|NCT03973177|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
101692311|NCT03973177|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101692312|NCT03951493|Zoledronic Acid|zoledronic acid|mesh-list
101692313|NCT03951493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101692314|NCT03951493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692315|NCT00961909|Metformin|metformin|mesh-list
101692316|NCT00961909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101692317|NCT00961909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692318|NCT04115189|Sunitinib|sunitinib|mesh-list
101692319|NCT04115189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101692320|NCT04115189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101692321|NCT04115189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101692322|NCT04115189|Growth Substances|growth substances|mesh-ancestor
101692323|NCT04115189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692324|NCT04115189|Growth Inhibitors|growth inhibitors|mesh-ancestor
101287378|NCT04411940|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101692325|NCT04115189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101287397|NCT04030429|Crizotinib|crizotinib|mesh-list
101692326|NCT04115189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101692327|NCT04115189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692328|NCT03940729|Chlorhexidine|chlorhexidine|mesh-list
101692329|NCT03940729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101692330|NCT03940729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101692331|NCT03940729|Disinfectants|disinfectants|mesh-ancestor
101692332|NCT02678234|Acetaminophen|acetaminophen|mesh-list
101692333|NCT02678234|Phenylephrine|phenylephrine|mesh-list
101692334|NCT02678234|Oxymetazoline|oxymetazoline|mesh-list
101692335|NCT02678234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287430|NCT03714880|Luteolytic Agents|luteolytic agents|mesh-ancestor
101692336|NCT02678234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101692337|NCT02678234|Analgesics|analgesics|mesh-ancestor
101692338|NCT02678234|Sensory System Agents|sensory system agents|mesh-ancestor
101692339|NCT02678234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101692340|NCT02678234|Antipyretics|antipyretics|mesh-ancestor
101410106|NCT00112697|Antimetabolites|antimetabolites|mesh-ancestor
101692341|NCT02678234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692342|NCT02678234|Protective Agents|protective agents|mesh-ancestor
101692343|NCT02678234|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101692344|NCT02678234|Mydriatics|mydriatics|mesh-ancestor
101692345|NCT02678234|Autonomic Agents|autonomic agents|mesh-ancestor
101349666|NCT05769049|Vaccines|vaccines|mesh-list
101287494|NCT03073694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101287509|NCT02862548|Antiviral Agents|antiviral agents|mesh-list
101692346|NCT02678234|Sympathomimetics|sympathomimetics|mesh-ancestor
101692347|NCT02678234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101692348|NCT02678234|Nasal Decongestants|nasal decongestants|mesh-ancestor
101692349|NCT02678234|Respiratory System Agents|respiratory system agents|mesh-ancestor
101692350|NCT02678234|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101692351|NCT02678234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101692352|NCT02678234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101692353|NCT02678234|Adrenergic Agents|adrenergic agents|mesh-ancestor
101692354|NCT02678234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101692356|NCT00601640|Diclofenac|diclofenac|mesh-list
101692357|NCT00601640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101287561|NCT05412589|Apatinib|apatinib|mesh-list
101692359|NCT00601640|Analgesics|analgesics|mesh-ancestor
101692360|NCT00601640|Sensory System Agents|sensory system agents|mesh-ancestor
101692361|NCT00601640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101692362|NCT00601640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692363|NCT00601640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101692364|NCT00601640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101692365|NCT00601640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101692366|NCT00601640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101287623|NCT05384951|Vitamin D|vitamin d|mesh-list
101692367|NCT00601640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692368|NCT00601640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101692369|NCT00601640|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101692370|NCT00601640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101692371|NCT00601640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101692372|NCT00601640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101692373|NCT00601640|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
101692374|NCT02805725|Cyclophosphamide|cyclophosphamide|mesh-list
101692375|NCT02805725|Trabectedin|trabectedin|mesh-list
101692376|NCT02805725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101692377|NCT02805725|Immunologic Factors|immunologic factors|mesh-ancestor
101692378|NCT02805725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692379|NCT02805725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101692380|NCT02805725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101692382|NCT02805725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692383|NCT02805725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101692384|NCT02805725|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101692385|NCT05300191|Dialysis Solutions|dialysis solutions|mesh-list
101692386|NCT05300191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101692387|NCT03549715|Durvalumab|durvalumab|mesh-list
101692388|NCT03549715|Tremelimumab|tremelimumab|mesh-list
101692389|NCT03549715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101692390|NCT03549715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101692391|NCT02803385|Analgesics, Opioid|analgesics, opioid|mesh-list
101692392|NCT02803385|Anesthetics|anesthetics|mesh-list
101692393|NCT02803385|Anesthetics, Local|anesthetics, local|mesh-list
101692394|NCT02803385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101692395|NCT02803385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692396|NCT02803385|Narcotics|narcotics|mesh-ancestor
101692397|NCT02803385|Analgesics|analgesics|mesh-ancestor
101692398|NCT02803385|Sensory System Agents|sensory system agents|mesh-ancestor
101287749|NCT04321551|Letrozole|letrozole|mesh-list
101692399|NCT02803385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101692400|NCT00958321|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101692401|NCT00958321|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101692402|NCT00958321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692403|NCT00642434|Metoprolol|metoprolol|mesh-list
101692404|NCT00642434|Carvedilol|carvedilol|mesh-list
101692405|NCT00642434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101692406|NCT00642434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101692407|NCT00642434|Sympatholytics|sympatholytics|mesh-ancestor
101692408|NCT00642434|Autonomic Agents|autonomic agents|mesh-ancestor
101692409|NCT00642434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101692410|NCT00642434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101287810|NCT03539055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101692411|NCT00642434|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101692412|NCT00642434|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101692413|NCT00642434|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101692414|NCT00642434|Adrenergic Agents|adrenergic agents|mesh-ancestor
101692415|NCT00642434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101692416|NCT00642434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692417|NCT00642434|Antioxidants|antioxidants|mesh-ancestor
101692418|NCT00642434|Protective Agents|protective agents|mesh-ancestor
101692419|NCT00642434|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101692420|NCT00642434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101692421|NCT00642434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101692422|NCT00642434|Vasodilator Agents|vasodilator agents|mesh-ancestor
101692423|NCT00642434|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101692424|NCT00642434|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101692425|NCT05352373|Calcium|calcium|mesh-list
101287938|NCT02257346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101692426|NCT05352373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101692427|NCT05352373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692429|NCT02677532|Sufentanil|sufentanil|mesh-list
101692430|NCT02677532|Morphine|morphine|mesh-list
101692431|NCT02677532|Dsuvia|dsuvia|mesh-list
101692432|NCT02677532|Levobupivacaine|levobupivacaine|mesh-list
101692433|NCT02677532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101692434|NCT02677532|Narcotics|narcotics|mesh-ancestor
101692435|NCT02677532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101288009|NCT05414149|Growth Substances|growth substances|mesh-ancestor
101288011|NCT05414149|Growth Inhibitors|growth inhibitors|mesh-ancestor
101692436|NCT02677532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692437|NCT02677532|Analgesics|analgesics|mesh-ancestor
101692438|NCT02677532|Sensory System Agents|sensory system agents|mesh-ancestor
101692439|NCT02677532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101692440|NCT02677532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101692441|NCT02677532|Antipyretics|antipyretics|mesh-ancestor
101692442|NCT02677532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101692444|NCT02677532|Anesthetics, General|anesthetics, general|mesh-ancestor
101692445|NCT02677532|Anesthetics|anesthetics|mesh-ancestor
101692446|NCT02677532|Anesthetics, Local|anesthetics, local|mesh-ancestor
101692447|NCT00641810|Caffeine|caffeine|mesh-list
101692448|NCT00641810|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101692449|NCT00641810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692450|NCT00641810|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101692451|NCT00641810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101692452|NCT00641810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692453|NCT00641810|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101692454|NCT00641810|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101692455|NCT00641810|Purinergic Agents|purinergic agents|mesh-ancestor
101692456|NCT00641810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101692457|NCT02802995|Thrombin|thrombin|mesh-list
101692458|NCT02802995|Hemostatics|hemostatics|mesh-ancestor
101692459|NCT02802995|Coagulants|coagulants|mesh-ancestor
101692460|NCT00910052|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101692461|NCT00910052|Hemostatics|hemostatics|mesh-ancestor
101692462|NCT00910052|Coagulants|coagulants|mesh-ancestor
101692463|NCT02677376|Listerine|listerine|mesh-list
101692464|NCT02677376|Fluorides|fluorides|mesh-list
101692465|NCT02677376|Sodium Fluoride|sodium fluoride|mesh-list
101692466|NCT02677376|Cariostatic Agents|cariostatic agents|mesh-ancestor
101692467|NCT02677376|Protective Agents|protective agents|mesh-ancestor
101692468|NCT02677376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692469|NCT02677376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101692470|NCT02677376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101692471|NCT02800889|Pixantrone|pixantrone|mesh-list
101692472|NCT02800889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101692473|NCT02800889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101692474|NCT02800889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101692475|NCT02800889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692476|NCT02800889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101692477|NCT02803073|Methyltestosterone|methyltestosterone|mesh-list
101692478|NCT02803073|Testosterone|testosterone|mesh-list
101692479|NCT02803073|Testosterone undecanoate|testosterone undecanoate|mesh-list
101692480|NCT02803073|Testosterone enanthate|testosterone enanthate|mesh-list
101692481|NCT02803073|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101692482|NCT02803073|Androgens|androgens|mesh-ancestor
101692483|NCT02803073|Hormones|hormones|mesh-ancestor
101288210|NCT04222283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101692484|NCT02803073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101692485|NCT02803073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692486|NCT02803073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101692487|NCT02803073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101692488|NCT02803073|Anabolic Agents|anabolic agents|mesh-ancestor
101692489|NCT00922532|Nitric Oxide|nitric oxide|mesh-list
101692490|NCT00922532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101692491|NCT00922532|Autonomic Agents|autonomic agents|mesh-ancestor
101692492|NCT00922532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101692493|NCT00922532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692494|NCT00922532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101288264|NCT03626922|Hormones|hormones|mesh-ancestor
101692495|NCT00922532|Respiratory System Agents|respiratory system agents|mesh-ancestor
101692496|NCT00922532|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101692498|NCT00922532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692500|NCT00922532|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101692501|NCT00922532|Vasodilator Agents|vasodilator agents|mesh-ancestor
101692502|NCT00922532|Gasotransmitters|gasotransmitters|mesh-ancestor
101692503|NCT00922532|Protective Agents|protective agents|mesh-ancestor
101692504|NCT05662904|Gemtuzumab|gemtuzumab|mesh-list
101692505|NCT05662904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101692506|NCT05662904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101692507|NCT05662904|Immunotoxins|immunotoxins|mesh-ancestor
101692508|NCT05662904|Immunoconjugates|immunoconjugates|mesh-ancestor
101692509|NCT05662904|Immunologic Factors|immunologic factors|mesh-ancestor
101692510|NCT05662904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692511|NCT00642512|Dronabinol|dronabinol|mesh-list
101692512|NCT00642512|Ondansetron|ondansetron|mesh-list
101692513|NCT00642512|Antiemetics|antiemetics|mesh-ancestor
101692514|NCT00642512|Autonomic Agents|autonomic agents|mesh-ancestor
101692515|NCT00642512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101692516|NCT00642512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692517|NCT00642512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101692518|NCT00642512|Antipruritics|antipruritics|mesh-ancestor
101692519|NCT00642512|Dermatologic Agents|dermatologic agents|mesh-ancestor
101692520|NCT00642512|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101692521|NCT00642512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101692522|NCT00642512|Serotonin Agents|serotonin agents|mesh-ancestor
101692523|NCT00642512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101692524|NCT00642512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692525|NCT00642512|Hallucinogens|hallucinogens|mesh-ancestor
101692526|NCT00642512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101692527|NCT00642512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101692528|NCT00642512|Analgesics|analgesics|mesh-ancestor
101692529|NCT00642512|Sensory System Agents|sensory system agents|mesh-ancestor
101692530|NCT00642512|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101692531|NCT00642512|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101692532|NCT00642512|Hormones|hormones|mesh-ancestor
101692533|NCT00642512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101692534|NCT02802683|Phenylephrine|phenylephrine|mesh-list
101692535|NCT02802683|Oxymetazoline|oxymetazoline|mesh-list
101692536|NCT02802683|Bupivacaine|bupivacaine|mesh-list
101692537|NCT02802683|Levobupivacaine|levobupivacaine|mesh-list
101692538|NCT02802683|Anesthetics, Local|anesthetics, local|mesh-ancestor
101692539|NCT02802683|Anesthetics|anesthetics|mesh-ancestor
101692540|NCT02802683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101692541|NCT02802683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692542|NCT02802683|Sensory System Agents|sensory system agents|mesh-ancestor
101692543|NCT02802683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101692545|NCT02802683|Mydriatics|mydriatics|mesh-ancestor
101692546|NCT02802683|Autonomic Agents|autonomic agents|mesh-ancestor
101692547|NCT02802683|Sympathomimetics|sympathomimetics|mesh-ancestor
101692548|NCT02802683|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101692549|NCT02802683|Nasal Decongestants|nasal decongestants|mesh-ancestor
101692550|NCT02802683|Respiratory System Agents|respiratory system agents|mesh-ancestor
101692551|NCT02802683|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101692552|NCT02802683|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101692553|NCT02802683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101692554|NCT02802683|Adrenergic Agents|adrenergic agents|mesh-ancestor
101692555|NCT02802683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101692556|NCT02802683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692557|NCT02802683|Protective Agents|protective agents|mesh-ancestor
101692558|NCT00641264|Omeprazole|omeprazole|mesh-list
101692559|NCT00641264|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101692560|NCT00641264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101692561|NCT00641264|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101692563|NCT00641264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692564|NCT05484167|Methyltestosterone|methyltestosterone|mesh-list
101692565|NCT05484167|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101692566|NCT05484167|Testosterone|testosterone|mesh-list
101692567|NCT05484167|Testosterone undecanoate|testosterone undecanoate|mesh-list
101692568|NCT05484167|Testosterone enanthate|testosterone enanthate|mesh-list
101288486|NCT01945983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692569|NCT05484167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101692570|NCT05484167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101692571|NCT05484167|Anabolic Agents|anabolic agents|mesh-ancestor
101349886|NCT05453955|Anesthetics|anesthetics|mesh-ancestor
101692573|NCT05484167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101692574|NCT05484167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692575|NCT05484167|Androgens|androgens|mesh-ancestor
101692576|NCT04183322|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101692577|NCT04183322|Immunologic Factors|immunologic factors|mesh-ancestor
101692578|NCT04183322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692579|NCT04180982|Febuxostat|febuxostat|mesh-list
101692580|NCT04180982|Gout Suppressants|gout suppressants|mesh-ancestor
101692581|NCT04180982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101692582|NCT02802605|Bemiparin|bemiparin|mesh-list
101692583|NCT02802605|Anticoagulants|anticoagulants|mesh-ancestor
101692584|NCT02800265|Sulforaphane|sulforaphane|mesh-list
101692585|NCT02800265|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101692586|NCT02800265|Protective Agents|protective agents|mesh-ancestor
101692587|NCT02800265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692588|NCT02800265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101692590|NCT02676986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101692591|NCT02676986|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101692592|NCT02676986|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101692593|NCT02676986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101692594|NCT02676986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692595|NCT02676986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101692596|NCT02676986|Hormone Antagonists|hormone antagonists|mesh-ancestor
101288687|NCT01947205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101288688|NCT01947205|Antipyretics|antipyretics|mesh-ancestor
101692597|NCT02676986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101692598|NCT02676986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692600|NCT02802215|Metformin|metformin|mesh-list
101692601|NCT02802215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101692602|NCT02802215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692603|NCT02802215|Hematinics|hematinics|mesh-ancestor
101692604|NCT02802215|Vitamin B Complex|vitamin b complex|mesh-ancestor
101692605|NCT02802215|Vitamins|vitamins|mesh-ancestor
101692606|NCT02802215|Micronutrients|micronutrients|mesh-ancestor
101692607|NCT02799797|Sufentanil|sufentanil|mesh-list
101692608|NCT02799797|Dsuvia|dsuvia|mesh-list
101692609|NCT02799797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101692610|NCT02799797|Narcotics|narcotics|mesh-ancestor
101692611|NCT02799797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101288747|NCT01947803|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101692612|NCT02799797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692614|NCT02799797|Sensory System Agents|sensory system agents|mesh-ancestor
101692615|NCT02799797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101692616|NCT02799797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101692617|NCT02799797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101692618|NCT02799797|Anesthetics, General|anesthetics, general|mesh-ancestor
101692619|NCT02799797|Anesthetics|anesthetics|mesh-ancestor
101692620|NCT05663372|Eplerenone|eplerenone|mesh-list
101692621|NCT05663372|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101692622|NCT05663372|Hormone Antagonists|hormone antagonists|mesh-ancestor
101692623|NCT05663372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101692624|NCT05663372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692625|NCT05663372|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101692626|NCT05663372|Diuretics|diuretics|mesh-ancestor
101692627|NCT05663372|Natriuretic Agents|natriuretic agents|mesh-ancestor
101692628|NCT05663372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101692629|NCT02802137|Timolol|timolol|mesh-list
101692630|NCT02802137|Dorzolamide|dorzolamide|mesh-list
101692631|NCT02802137|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101692632|NCT02802137|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101692633|NCT02802137|Adrenergic Agents|adrenergic agents|mesh-ancestor
101288873|NCT01948648|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
101410112|NCT02959606|Clopidogrel|clopidogrel|mesh-list
101692635|NCT02802137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692636|NCT02802137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692637|NCT02802137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101692638|NCT02802137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101692639|NCT02802137|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101692640|NCT02802137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101692641|NCT04033562|Lidocaine|lidocaine|mesh-list
101692642|NCT04033562|Bupivacaine|bupivacaine|mesh-list
101692643|NCT04033562|Anesthetics, Local|anesthetics, local|mesh-ancestor
101692644|NCT04033562|Anesthetics|anesthetics|mesh-ancestor
101692645|NCT04033562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101692646|NCT04033562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692647|NCT04033562|Sensory System Agents|sensory system agents|mesh-ancestor
101692648|NCT04033562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101692649|NCT04033562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101692650|NCT04033562|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101692651|NCT04033562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101692652|NCT04033562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101692653|NCT04033562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692654|NCT04032834|Budesonide|budesonide|mesh-list
101692655|NCT04032834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101692656|NCT04032834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101692657|NCT04032834|Autonomic Agents|autonomic agents|mesh-ancestor
101692658|NCT04032834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101692659|NCT04032834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692660|NCT04032834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101692661|NCT04032834|Respiratory System Agents|respiratory system agents|mesh-ancestor
101692662|NCT04032834|Glucocorticoids|glucocorticoids|mesh-ancestor
101692663|NCT04032834|Hormones|hormones|mesh-ancestor
101289141|NCT01950182|Mitosis Modulators|mitosis modulators|mesh-ancestor
101692664|NCT04032834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101692665|NCT02817191|Tobramycin|tobramycin|mesh-list
101692666|NCT02817191|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
101692667|NCT02817191|Dexamethasone|dexamethasone|mesh-list
101692668|NCT02817191|Dexamethasone acetate|dexamethasone acetate|mesh-list
101692669|NCT02817191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101692671|NCT02817191|Dipivefrin|dipivefrin|mesh-list
101692672|NCT02817191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101692673|NCT02817191|Antiemetics|antiemetics|mesh-ancestor
101692674|NCT02817191|Autonomic Agents|autonomic agents|mesh-ancestor
101692675|NCT02817191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101692676|NCT02817191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692677|NCT02817191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101692678|NCT02817191|Glucocorticoids|glucocorticoids|mesh-ancestor
101692679|NCT02817191|Hormones|hormones|mesh-ancestor
101692680|NCT02817191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101692681|NCT02817191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101692682|NCT02817191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101692683|NCT02817191|Protease Inhibitors|protease inhibitors|mesh-ancestor
101692684|NCT02817191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101289274|NCT01951079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692685|NCT02817191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692686|NCT02817191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101692687|NCT02817191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101692688|NCT02817191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101692689|NCT02817191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101692690|NCT02817191|Adrenergic Agents|adrenergic agents|mesh-ancestor
101692691|NCT02817191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101692692|NCT02636010|Pembrolizumab|pembrolizumab|mesh-list
101692693|NCT02636010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101692694|NCT02636010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101692695|NCT02636010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101692696|NCT02636010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692697|NCT05474027|Antihypertensive Agents|antihypertensive agents|mesh-list
101692698|NCT05474027|Tranexamic Acid|tranexamic acid|mesh-list
101692699|NCT05474027|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101692700|NCT05474027|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101692701|NCT05474027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692702|NCT05474027|Hemostatics|hemostatics|mesh-ancestor
101692703|NCT05474027|Coagulants|coagulants|mesh-ancestor
101692704|NCT00642824|Bevacizumab|bevacizumab|mesh-list
101289405|NCT01951872|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101692705|NCT00642824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101692706|NCT00642824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101692707|NCT00642824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101692708|NCT00642824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101692709|NCT00642824|Growth Substances|growth substances|mesh-ancestor
101692710|NCT00642824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692711|NCT00642824|Growth Inhibitors|growth inhibitors|mesh-ancestor
101692712|NCT02679014|Petesicatib|petesicatib|mesh-list
101692713|NCT02679014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101692714|NCT02679014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692715|NCT02801357|Lofexidine|lofexidine|mesh-list
101692716|NCT02801357|Buprenorphine|buprenorphine|mesh-list
101692717|NCT02801357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101692718|NCT02801357|Narcotics|narcotics|mesh-ancestor
101692719|NCT02801357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101692720|NCT02801357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692721|NCT02801357|Analgesics|analgesics|mesh-ancestor
101692722|NCT02801357|Sensory System Agents|sensory system agents|mesh-ancestor
101692723|NCT02801357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101692724|NCT02801357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101692725|NCT02801357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101692726|NCT02801357|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101692727|NCT02801357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101692728|NCT02801357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101692729|NCT02801357|Adrenergic Agents|adrenergic agents|mesh-ancestor
101692730|NCT02801357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101692731|NCT02801357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692732|NCT02676674|Vitamin D|vitamin d|mesh-list
101692733|NCT02676674|Cholecalciferol|cholecalciferol|mesh-list
101692734|NCT02676674|Vitamins|vitamins|mesh-ancestor
101692735|NCT02676674|Micronutrients|micronutrients|mesh-ancestor
101692736|NCT02676674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692737|NCT02676674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101692738|NCT02676674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101692739|NCT00962299|Beclomethasone|beclomethasone|mesh-list
101692740|NCT00962299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101692741|NCT00962299|Glucocorticoids|glucocorticoids|mesh-ancestor
101692742|NCT00962299|Hormones|hormones|mesh-ancestor
101692743|NCT00962299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101692744|NCT00962299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692746|NCT00962299|Respiratory System Agents|respiratory system agents|mesh-ancestor
101692747|NCT02679092|Misoprostol|misoprostol|mesh-list
101692748|NCT02679092|Mifepristone|mifepristone|mesh-list
101692749|NCT02679092|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101692750|NCT02679092|Abortifacient Agents|abortifacient agents|mesh-ancestor
101692751|NCT02679092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101289589|NCT05875675|Pioglitazone|pioglitazone|mesh-list
101289590|NCT05875675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101692753|NCT02679092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101692754|NCT02679092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101692755|NCT02679092|Oxytocics|oxytocics|mesh-ancestor
101692756|NCT02679092|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101692757|NCT02679092|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101692758|NCT02679092|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101692759|NCT02679092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101692760|NCT02679092|Contraceptive Agents|contraceptive agents|mesh-ancestor
101692761|NCT02679092|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101692762|NCT02679092|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101692763|NCT02679092|Hormone Antagonists|hormone antagonists|mesh-ancestor
101692764|NCT02679092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101692765|NCT02679092|Luteolytic Agents|luteolytic agents|mesh-ancestor
101692766|NCT02679092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101692767|NCT02679092|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101692769|NCT04183088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101692770|NCT04183088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101692771|NCT00642122|Budesonide|budesonide|mesh-list
101692772|NCT00642122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101692773|NCT00642122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101692774|NCT00642122|Autonomic Agents|autonomic agents|mesh-ancestor
101692775|NCT00642122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101692776|NCT00642122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692777|NCT00642122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101692778|NCT00642122|Respiratory System Agents|respiratory system agents|mesh-ancestor
101692779|NCT00642122|Glucocorticoids|glucocorticoids|mesh-ancestor
101692780|NCT00642122|Hormones|hormones|mesh-ancestor
101692781|NCT00642122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101692782|NCT00546871|Immunoglobulins|immunoglobulins|mesh-list
101692783|NCT00546871|Antibodies|antibodies|mesh-list
101692784|NCT00546871|gamma-Globulins|gamma-globulins|mesh-list
101692785|NCT00546871|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101692786|NCT00546871|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101692787|NCT00546871|Immunologic Factors|immunologic factors|mesh-ancestor
101692788|NCT00546871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692789|NCT02817113|Fluorouracil|fluorouracil|mesh-list
101692790|NCT02817113|Cetuximab|cetuximab|mesh-list
101692791|NCT02817113|Antimetabolites|antimetabolites|mesh-ancestor
101692792|NCT02817113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692793|NCT02817113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101692794|NCT02817113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101692795|NCT02817113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101692796|NCT02817113|Immunologic Factors|immunologic factors|mesh-ancestor
101692797|NCT02817113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692798|NCT02817113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101692799|NCT02801201|Midazolam|midazolam|mesh-list
101692800|NCT02801201|Bupivacaine|bupivacaine|mesh-list
101692801|NCT02801201|Anesthetics, Local|anesthetics, local|mesh-ancestor
101692802|NCT02801201|Anesthetics|anesthetics|mesh-ancestor
101692803|NCT02801201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101692804|NCT02801201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692805|NCT02801201|Sensory System Agents|sensory system agents|mesh-ancestor
101692806|NCT02801201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101289844|NCT05872412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101692807|NCT02801201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101289847|NCT05864144|Cemiplimab|cemiplimab|mesh-list
101692808|NCT02801201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101692809|NCT02801201|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101692810|NCT02801201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101692811|NCT02801201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101692812|NCT02801201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101692813|NCT02801201|Anesthetics, General|anesthetics, general|mesh-ancestor
101692814|NCT02801201|GABA Modulators|gaba modulators|mesh-ancestor
101692815|NCT02801201|GABA Agents|gaba agents|mesh-ancestor
101692816|NCT02801201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101692817|NCT02801201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692819|NCT04182932|Immunologic Factors|immunologic factors|mesh-ancestor
101692820|NCT04182932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692821|NCT03951805|Insulin|insulin|mesh-list
101692822|NCT03951805|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101692823|NCT03951805|Insulin Glargine|insulin glargine|mesh-list
101692824|NCT03951805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101692825|NCT03951805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692826|NCT02681198|Lofexidine|lofexidine|mesh-list
101692827|NCT02681198|Paroxetine|paroxetine|mesh-list
101692828|NCT02681198|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101692829|NCT02681198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101692830|NCT02681198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101692831|NCT02681198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692832|NCT02681198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101692833|NCT02681198|Serotonin Agents|serotonin agents|mesh-ancestor
101692834|NCT02681198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692835|NCT02681198|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101692836|NCT02681198|Antidepressive Agents|antidepressive agents|mesh-ancestor
101692837|NCT02681198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101692838|NCT02681198|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101692839|NCT02681198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101692840|NCT02681198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101692841|NCT02681198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101692842|NCT02681198|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101692843|NCT02681198|Sensory System Agents|sensory system agents|mesh-ancestor
101692844|NCT02681198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101289893|NCT05874869|Piperaquine|piperaquine|mesh-list
101692845|NCT02681198|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101692846|NCT02681198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101692848|NCT02681198|Adrenergic Agents|adrenergic agents|mesh-ancestor
101692849|NCT05597306|Venetoclax|venetoclax|mesh-list
101692850|NCT05597306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101692851|NCT00962533|Telbivudine|telbivudine|mesh-list
101692852|NCT00962533|Antiviral Agents|antiviral agents|mesh-ancestor
101692853|NCT00962533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101692854|NCT00962533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101692855|NCT00962533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101692856|NCT00962533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692857|NCT00642980|Clindamycin|clindamycin|mesh-list
101692858|NCT00642980|Clindamycin palmitate|clindamycin palmitate|mesh-list
101692859|NCT00642980|Clindamycin phosphate|clindamycin phosphate|mesh-list
101692860|NCT00642980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101692861|NCT00642980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101692862|NCT00642980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101692863|NCT00642980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101289929|NCT05790161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101289930|NCT05786040|Rituximab|rituximab|mesh-list
101692864|NCT00642980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692865|NCT02798159|Sildenafil Citrate|sildenafil citrate|mesh-list
101692866|NCT02798159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692867|NCT02798159|Vasodilator Agents|vasodilator agents|mesh-ancestor
101692868|NCT02798159|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101692869|NCT02798159|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101692870|NCT02798159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101692871|NCT02798159|Urological Agents|urological agents|mesh-ancestor
101692872|NCT00962767|Gemtuzumab|gemtuzumab|mesh-list
101692873|NCT00962767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101692874|NCT00962767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101692875|NCT00962767|Immunotoxins|immunotoxins|mesh-ancestor
101692876|NCT00962767|Immunoconjugates|immunoconjugates|mesh-ancestor
101692877|NCT00962767|Immunologic Factors|immunologic factors|mesh-ancestor
101692878|NCT00962767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692879|NCT02678780|Lenvatinib|lenvatinib|mesh-list
101692880|NCT02678780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101692881|NCT02678780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101692882|NCT02678780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101692883|NCT02678780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692884|NCT00963001|Treprostinil|treprostinil|mesh-list
101692885|NCT00963001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101692886|NCT00643136|Pregabalin|pregabalin|mesh-list
101692887|NCT00643136|Analgesics|analgesics|mesh-ancestor
101692888|NCT00643136|Sensory System Agents|sensory system agents|mesh-ancestor
101692889|NCT00643136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101692890|NCT00643136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692891|NCT00643136|Anticonvulsants|anticonvulsants|mesh-ancestor
101692892|NCT00643136|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101692893|NCT00643136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101692894|NCT00643136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692895|NCT00643136|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101692896|NCT00643136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101692897|NCT00643136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101692898|NCT00643136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101692899|NCT00643136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101289984|NCT05698407|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101289985|NCT05698407|Narcotics|narcotics|mesh-ancestor
101289986|NCT05698407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101692900|NCT01563367|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
101692901|NCT01563367|Hematinics|hematinics|mesh-ancestor
101692903|NCT00963313|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101692904|NCT00963313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101692905|NCT00963313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101692906|NCT02797145|Digoxin|digoxin|mesh-list
101692907|NCT02797145|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101692908|NCT02797145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101692909|NCT02797145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101692910|NCT02797145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692911|NCT02797145|Protective Agents|protective agents|mesh-ancestor
101692912|NCT02797145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692913|NCT02690129|Progesterone|progesterone|mesh-list
101692914|NCT02690129|Progestins|progestins|mesh-ancestor
101692915|NCT02690129|Hormones|hormones|mesh-ancestor
101692916|NCT02690129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101692917|NCT02690129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692918|NCT00883116|Paclitaxel|paclitaxel|mesh-list
101692919|NCT00883116|Doxorubicin|doxorubicin|mesh-list
101410117|NCT02959606|Purinergic Agents|purinergic agents|mesh-ancestor
101692920|NCT00883116|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101692921|NCT00883116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101290076|NCT05327530|Avelumab|avelumab|mesh-list
101290146|NCT05044962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692941|NCT00643292|Amoxicillin|amoxicillin|mesh-list
101692942|NCT00643292|Azithromycin|azithromycin|mesh-list
101692943|NCT00643292|Clavulanic Acid|clavulanic acid|mesh-list
101692944|NCT00643292|Clavulanic Acids|clavulanic acids|mesh-list
101692945|NCT00643292|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101692946|NCT00643292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101692947|NCT00643292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101692948|NCT00643292|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101350263|NCT04598815|Immunologic Factors|immunologic factors|mesh-ancestor
101692949|NCT00643292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101692950|NCT00643292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692951|NCT02797067|Indomethacin|indomethacin|mesh-list
101290201|NCT04985760|Vaccines|vaccines|mesh-list
101290202|NCT04985760|Aluminum sulfate|aluminum sulfate|mesh-list
101692953|NCT02797067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101692954|NCT02797067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101692955|NCT02797067|Analgesics|analgesics|mesh-ancestor
101692956|NCT02797067|Sensory System Agents|sensory system agents|mesh-ancestor
101692957|NCT02797067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101692958|NCT02797067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692959|NCT02797067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101692960|NCT02797067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101692961|NCT02797067|Gout Suppressants|gout suppressants|mesh-ancestor
101692962|NCT02797067|Tocolytic Agents|tocolytic agents|mesh-ancestor
101692963|NCT02797067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101692964|NCT02797067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101692966|NCT02797067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692967|NCT02797067|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101692968|NCT02797067|Protective Agents|protective agents|mesh-ancestor
101692969|NCT00655044|Insulin Detemir|insulin detemir|mesh-list
101692970|NCT00655044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101692971|NCT00655044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692972|NCT00963703|Rituximab|rituximab|mesh-list
101692973|NCT00963703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101692974|NCT00963703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101692975|NCT00963703|Immunologic Factors|immunologic factors|mesh-ancestor
101692976|NCT00963703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692977|NCT00963703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101692978|NCT00655122|Dalteparin|dalteparin|mesh-list
101692979|NCT00655122|Tinzaparin|tinzaparin|mesh-list
101692980|NCT00655122|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101692981|NCT00655122|Anticoagulants|anticoagulants|mesh-ancestor
101692982|NCT00655122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101290262|NCT04756401|Glucocorticoids|glucocorticoids|mesh-ancestor
101692983|NCT00655122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101692984|NCT00655122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692985|NCT02638116|Omeprazole|omeprazole|mesh-list
101692986|NCT02638116|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101692987|NCT02638116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101692988|NCT02638116|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101692989|NCT02638116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101692990|NCT02638116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101692991|NCT04164264|Propofol|propofol|mesh-list
101692992|NCT04164264|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101692993|NCT04164264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101692994|NCT04164264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101692995|NCT04164264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101692996|NCT04164264|Anesthetics, General|anesthetics, general|mesh-ancestor
101692997|NCT04164264|Anesthetics|anesthetics|mesh-ancestor
101692998|NCT02795039|Fulvestrant|fulvestrant|mesh-list
101692999|NCT02795039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101693000|NCT02795039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101693001|NCT02795039|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101693002|NCT02795039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101693003|NCT02795039|Hormone Antagonists|hormone antagonists|mesh-ancestor
101693004|NCT02795039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101693005|NCT02795039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693006|NCT02796833|SMOFlipid|smoflipid|mesh-list
101693007|NCT02796833|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101410121|NCT02959606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101693008|NCT02796833|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101693009|NCT02796833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101693010|NCT04009603|Metformin|metformin|mesh-list
101693011|NCT04009603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101693012|NCT04009603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693014|NCT02635230|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101693015|NCT02635230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101693016|NCT02635230|Analgesics|analgesics|mesh-ancestor
101693017|NCT02635230|Sensory System Agents|sensory system agents|mesh-ancestor
101290310|NCT04507217|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101290311|NCT04507217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101290312|NCT04507217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101290313|NCT04495452|Fentanyl|fentanyl|mesh-list
101290314|NCT04495452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101290315|NCT04495452|Narcotics|narcotics|mesh-ancestor
101290316|NCT04495452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101290317|NCT04495452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101290318|NCT04495452|Analgesics|analgesics|mesh-ancestor
101290319|NCT04495452|Sensory System Agents|sensory system agents|mesh-ancestor
101290320|NCT04495452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101290321|NCT04495452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101290322|NCT04495452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101290323|NCT04495452|Anesthetics, General|anesthetics, general|mesh-ancestor
101693018|NCT02635230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101693019|NCT02635230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693020|NCT02635230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101693021|NCT02635230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101693022|NCT02635230|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101693023|NCT02635230|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101693024|NCT02635230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693025|NCT02635230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101693026|NCT02635230|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101693027|NCT02635230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101693028|NCT02635230|Antipyretics|antipyretics|mesh-ancestor
101693029|NCT00964015|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
101693030|NCT00964015|Plasma Substitutes|plasma substitutes|mesh-ancestor
101693031|NCT00964015|Blood Substitutes|blood substitutes|mesh-ancestor
101693032|NCT02673632|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101693033|NCT02673632|Luteolytic Agents|luteolytic agents|mesh-ancestor
101693034|NCT02673632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101693035|NCT02673632|Contraceptive Agents|contraceptive agents|mesh-ancestor
101693036|NCT02673632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101693037|NCT02673632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693038|NCT02673632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101693039|NCT02673632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101693040|NCT02673632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101693041|NCT04009525|Cyclosporine|cyclosporine|mesh-list
101693042|NCT04009525|Mycophenolic Acid|mycophenolic acid|mesh-list
101693043|NCT04009525|Cyclophosphamide|cyclophosphamide|mesh-list
101693044|NCT04009525|Busulfan|busulfan|mesh-list
101693045|NCT04009525|Methotrexate|methotrexate|mesh-list
101693046|NCT04009525|Fludarabine|fludarabine|mesh-list
101693047|NCT04009525|Tacrolimus|tacrolimus|mesh-list
101693048|NCT04009525|Cyclosporins|cyclosporins|mesh-list
101693049|NCT04009525|Thymoglobulin|thymoglobulin|mesh-list
101693050|NCT04009525|Basiliximab|basiliximab|mesh-list
101693051|NCT04009525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101290411|NCT04166331|Sympathomimetics|sympathomimetics|mesh-ancestor
101693052|NCT04009525|Immunologic Factors|immunologic factors|mesh-ancestor
101693053|NCT04009525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693054|NCT04009525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101693055|NCT04009525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101693056|NCT04009525|Alkylating Agents|alkylating agents|mesh-ancestor
101693057|NCT04009525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693058|NCT04009525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101693059|NCT04009525|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101693060|NCT04009525|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101693061|NCT04009525|Abortifacient Agents|abortifacient agents|mesh-ancestor
101693062|NCT04009525|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101693063|NCT04009525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101693064|NCT04009525|Antimetabolites|antimetabolites|mesh-ancestor
101693065|NCT04009525|Dermatologic Agents|dermatologic agents|mesh-ancestor
101693066|NCT04009525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101693067|NCT04009525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101693068|NCT04009525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101693069|NCT04009525|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101693070|NCT04009525|Antifungal Agents|antifungal agents|mesh-ancestor
101693071|NCT04009525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101693072|NCT04009525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101693073|NCT04009525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101693074|NCT04009525|Antitubercular Agents|antitubercular agents|mesh-ancestor
101693075|NCT04009525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101693076|NCT04032366|Nitric Oxide|nitric oxide|mesh-list
101693077|NCT04032366|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101693078|NCT04032366|Autonomic Agents|autonomic agents|mesh-ancestor
101693079|NCT04032366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101693080|NCT04032366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693081|NCT04032366|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101693082|NCT04032366|Respiratory System Agents|respiratory system agents|mesh-ancestor
101693083|NCT04032366|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101693084|NCT04032366|Antioxidants|antioxidants|mesh-ancestor
101693085|NCT04032366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693086|NCT04032366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101693087|NCT04032366|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101693088|NCT04032366|Vasodilator Agents|vasodilator agents|mesh-ancestor
101693089|NCT04032366|Gasotransmitters|gasotransmitters|mesh-ancestor
101693090|NCT04032366|Protective Agents|protective agents|mesh-ancestor
101290468|NCT03883880|Protective Agents|protective agents|mesh-ancestor
101290469|NCT03883880|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101693091|NCT02537600|Vemurafenib|vemurafenib|mesh-list
101693092|NCT02537600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101693093|NCT02537600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101693095|NCT02537600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693096|NCT00684099|Docetaxel|docetaxel|mesh-list
101693097|NCT00684099|Pemetrexed|pemetrexed|mesh-list
101693098|NCT00684099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101693099|NCT00684099|Tubulin Modulators|tubulin modulators|mesh-ancestor
101693100|NCT00684099|Antimitotic Agents|antimitotic agents|mesh-ancestor
101693101|NCT00684099|Mitosis Modulators|mitosis modulators|mesh-ancestor
101693102|NCT00684099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693103|NCT00684099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101693104|NCT00684099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101693105|NCT00684099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101693106|NCT04159896|Nivolumab|nivolumab|mesh-list
101693107|NCT04159896|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101693108|NCT04159896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101693109|NCT04159896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101693110|NCT04159896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101693111|NCT04159896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693112|NCT04159896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101693113|NCT04159896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101693114|NCT02635074|Cytarabine|cytarabine|mesh-list
101693115|NCT02635074|Idarubicin|idarubicin|mesh-list
101693116|NCT02635074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101693117|NCT02635074|Antimetabolites|antimetabolites|mesh-ancestor
101693118|NCT02635074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693119|NCT02635074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101693120|NCT02635074|Antiviral Agents|antiviral agents|mesh-ancestor
101693121|NCT02635074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101693122|NCT02635074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101693123|NCT02635074|Immunologic Factors|immunologic factors|mesh-ancestor
101693124|NCT02635074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693125|NCT02635074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101693126|NCT02635074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101693127|NCT02635074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101693128|NCT02635074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101693129|NCT02537366|Dexmedetomidine|dexmedetomidine|mesh-list
101693130|NCT02537366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101693131|NCT02537366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101693132|NCT02537366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693133|NCT02537366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101693134|NCT02537366|Analgesics|analgesics|mesh-ancestor
101693135|NCT02537366|Sensory System Agents|sensory system agents|mesh-ancestor
101693136|NCT02537366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101290539|NCT03434275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101693138|NCT02537366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101693139|NCT02537366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101693140|NCT02537366|Adrenergic Agents|adrenergic agents|mesh-ancestor
101693141|NCT02537366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101693142|NCT02537366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693143|NCT00690417|Vitamin D|vitamin d|mesh-list
101693144|NCT00690417|Cholecalciferol|cholecalciferol|mesh-list
101693145|NCT00690417|Vitamins|vitamins|mesh-ancestor
101693146|NCT00690417|Micronutrients|micronutrients|mesh-ancestor
101693147|NCT00690417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693148|NCT00690417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101693149|NCT00690417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101693150|NCT05434559|Insulin|insulin|mesh-list
101693151|NCT05434559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101693152|NCT05434559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693154|NCT00546637|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101693155|NCT00546637|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101693156|NCT00546637|Cholinergic Agents|cholinergic agents|mesh-ancestor
101693157|NCT00546637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101693158|NCT00546637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693159|NCT00546637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693160|NCT00546637|Urological Agents|urological agents|mesh-ancestor
101693161|NCT00690885|Interferons|interferons|mesh-list
101693162|NCT00690885|Interferon-alpha|interferon-alpha|mesh-list
101693163|NCT00690885|Interferon alpha-2|interferon alpha-2|mesh-list
101693164|NCT00690885|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
101693165|NCT00690885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101693166|NCT00690885|Antiviral Agents|antiviral agents|mesh-ancestor
101693167|NCT00690885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101693168|NCT00690885|Immunologic Factors|immunologic factors|mesh-ancestor
101693169|NCT00690885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693170|NCT04138719|Paclitaxel|paclitaxel|mesh-list
101693171|NCT04138719|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101693172|NCT04138719|Carboplatin|carboplatin|mesh-list
101693173|NCT04138719|Epirubicin|epirubicin|mesh-list
101693174|NCT04138719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101693175|NCT04138719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101693176|NCT04138719|Tubulin Modulators|tubulin modulators|mesh-ancestor
101693177|NCT04138719|Antimitotic Agents|antimitotic agents|mesh-ancestor
101693178|NCT04138719|Mitosis Modulators|mitosis modulators|mesh-ancestor
101693179|NCT04138719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693180|NCT04138719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101693181|NCT04138719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101693182|NCT04138719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101693183|NCT04138719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101693184|NCT02790203|Celecoxib|celecoxib|mesh-list
101693185|NCT02790203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101693186|NCT02790203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101693187|NCT02790203|Analgesics|analgesics|mesh-ancestor
101693188|NCT02790203|Sensory System Agents|sensory system agents|mesh-ancestor
101693189|NCT02790203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101693190|NCT02790203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693191|NCT02790203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101693192|NCT02790203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101693193|NCT02790203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101693194|NCT02790203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101693195|NCT02790203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101693196|NCT02790203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693197|NCT02816567|Sufentanil|sufentanil|mesh-list
101693198|NCT02816567|Propofol|propofol|mesh-list
101693199|NCT02816567|Cisatracurium|cisatracurium|mesh-list
101693200|NCT02816567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101693201|NCT02816567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101693202|NCT02816567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693203|NCT02816567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101693204|NCT02816567|Anesthetics, General|anesthetics, general|mesh-ancestor
101693205|NCT02816567|Anesthetics|anesthetics|mesh-ancestor
101693206|NCT02816567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101693207|NCT02816567|Narcotics|narcotics|mesh-ancestor
101693208|NCT02816567|Analgesics|analgesics|mesh-ancestor
101693209|NCT02816567|Sensory System Agents|sensory system agents|mesh-ancestor
101693210|NCT02816567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101693211|NCT02816567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101693212|NCT02816567|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101693213|NCT02816567|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101693214|NCT00657774|Prednisone|prednisone|mesh-list
101693215|NCT00657774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101693216|NCT00657774|Glucocorticoids|glucocorticoids|mesh-ancestor
101693218|NCT00657774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101693219|NCT00657774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693220|NCT00657774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101693221|NCT00657774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101693222|NCT04138485|Immunoglobulins|immunoglobulins|mesh-list
101693223|NCT04138485|Immunologic Factors|immunologic factors|mesh-ancestor
101693224|NCT04138485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693226|NCT02789969|Hydromorphone|hydromorphone|mesh-list
101693227|NCT02789969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101693228|NCT02789969|Narcotics|narcotics|mesh-ancestor
101693229|NCT02789969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101693230|NCT02789969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693231|NCT02789969|Analgesics|analgesics|mesh-ancestor
101290992|NCT01952886|Antipruritics|antipruritics|mesh-ancestor
101693232|NCT02789969|Sensory System Agents|sensory system agents|mesh-ancestor
101693233|NCT02789969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101693235|NCT02789969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101693236|NCT02789969|Anesthetics, General|anesthetics, general|mesh-ancestor
101693237|NCT02789969|Anesthetics|anesthetics|mesh-ancestor
101693238|NCT00657852|Pamidronate|pamidronate|mesh-list
101693239|NCT00657852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101693240|NCT00657852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693241|NCT00691275|Ondansetron|ondansetron|mesh-list
101693242|NCT00691275|Antiemetics|antiemetics|mesh-ancestor
101693243|NCT00691275|Autonomic Agents|autonomic agents|mesh-ancestor
101693244|NCT00691275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101693245|NCT00691275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693246|NCT00691275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101693247|NCT00691275|Antipruritics|antipruritics|mesh-ancestor
101291050|NCT01953445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693248|NCT00691275|Dermatologic Agents|dermatologic agents|mesh-ancestor
101693249|NCT00691275|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101693250|NCT00691275|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101693251|NCT00691275|Serotonin Agents|serotonin agents|mesh-ancestor
101693252|NCT00691275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101693253|NCT00691275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693254|NCT00657930|Insulin Detemir|insulin detemir|mesh-list
101693255|NCT00657930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101693256|NCT00657930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693257|NCT00655512|Clobetasol|clobetasol|mesh-list
101693258|NCT00655512|Pimecrolimus|pimecrolimus|mesh-list
101693259|NCT00655512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101693260|NCT00655512|Glucocorticoids|glucocorticoids|mesh-ancestor
101693261|NCT00655512|Hormones|hormones|mesh-ancestor
101693262|NCT00655512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101693263|NCT00655512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693264|NCT00655512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101693265|NCT00655512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101291109|NCT01953757|Micronutrients|micronutrients|mesh-ancestor
101693267|NCT00655512|Sensory System Agents|sensory system agents|mesh-ancestor
101693268|NCT00655512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101693269|NCT00655512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101693270|NCT00655512|Dermatologic Agents|dermatologic agents|mesh-ancestor
101693271|NCT00655512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101693272|NCT00655512|Immunologic Factors|immunologic factors|mesh-ancestor
101693273|NCT00655512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101693274|NCT00655512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101693275|NCT00655512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693276|NCT00644306|Thalidomide|thalidomide|mesh-list
101693278|NCT00644306|Melphalan|melphalan|mesh-list
101693279|NCT00644306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101693280|NCT00644306|Glucocorticoids|glucocorticoids|mesh-ancestor
101693281|NCT00644306|Hormones|hormones|mesh-ancestor
101693282|NCT00644306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101693283|NCT00644306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101291175|NCT01953887|Tamsulosin|tamsulosin|mesh-list
101693284|NCT00644306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101693285|NCT00644306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101693286|NCT00644306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101693287|NCT00644306|Alkylating Agents|alkylating agents|mesh-ancestor
101693288|NCT00644306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693289|NCT00644306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101693290|NCT00644306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101693291|NCT00644306|Immunologic Factors|immunologic factors|mesh-ancestor
101693292|NCT00644306|Leprostatic Agents|leprostatic agents|mesh-ancestor
101693293|NCT00644306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101693294|NCT00644306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101291224|NCT01954030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693295|NCT00644306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101693296|NCT00644306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101693297|NCT00644306|Growth Substances|growth substances|mesh-ancestor
101693298|NCT00644306|Growth Inhibitors|growth inhibitors|mesh-ancestor
101693300|NCT02634528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101693302|NCT02634528|Isophane Insulin, Human|isophane insulin, human|mesh-list
101693303|NCT02634528|Isophane insulin, beef|isophane insulin, beef|mesh-list
101693304|NCT02634528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101291285|NCT01954368|Sufentanil|sufentanil|mesh-list
101291286|NCT01954368|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101693305|NCT02634528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693306|NCT02816411|Caseins|caseins|mesh-list
101693307|NCT02816411|Chelating Agents|chelating agents|mesh-ancestor
101693308|NCT02816411|Sequestering Agents|sequestering agents|mesh-ancestor
101693309|NCT02816411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693310|NCT00655590|Sildenafil Citrate|sildenafil citrate|mesh-list
101693311|NCT00655590|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101693312|NCT00655590|Vasodilator Agents|vasodilator agents|mesh-ancestor
101693313|NCT00655590|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101291353|NCT01955057|Gasotransmitters|gasotransmitters|mesh-ancestor
101693314|NCT00655590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101693315|NCT00655590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101693316|NCT00655590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693317|NCT00655590|Urological Agents|urological agents|mesh-ancestor
101693318|NCT02794025|Esmolol|esmolol|mesh-list
101693319|NCT02794025|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101693320|NCT02794025|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101693321|NCT02794025|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101291415|NCT01955187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101693322|NCT02794025|Adrenergic Agents|adrenergic agents|mesh-ancestor
101693323|NCT02794025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101291419|NCT01955187|Antiemetics|antiemetics|mesh-ancestor
101693324|NCT02794025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350661|NCT03255473|Prednisone|prednisone|mesh-list
101693325|NCT02794025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693327|NCT00546481|Hematinics|hematinics|mesh-ancestor
101693328|NCT02789813|Valproic Acid|valproic acid|mesh-list
101693329|NCT02789813|Anticonvulsants|anticonvulsants|mesh-ancestor
101693330|NCT02789813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101693331|NCT02789813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693332|NCT02789813|GABA Agents|gaba agents|mesh-ancestor
101693333|NCT02789813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101693334|NCT02789813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693335|NCT02789813|Antimanic Agents|antimanic agents|mesh-ancestor
101693336|NCT02789813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101693337|NCT02789813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101693338|NCT02789813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101693339|NCT02632578|Vaccines|vaccines|mesh-list
101693340|NCT02632578|Immunologic Factors|immunologic factors|mesh-ancestor
101693341|NCT02632578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693342|NCT04138251|Empagliflozin|empagliflozin|mesh-list
101693343|NCT04138251|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101693344|NCT04138251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693345|NCT04138251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101693346|NCT04138251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693347|NCT00964171|Efavirenz|efavirenz|mesh-list
101693348|NCT00964171|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101693349|NCT00964171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101693350|NCT00964171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101693351|NCT00964171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693352|NCT00964171|Antiviral Agents|antiviral agents|mesh-ancestor
101693353|NCT00964171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101693354|NCT00964171|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101693355|NCT00964171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101693356|NCT00964171|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101693357|NCT00964171|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101693358|NCT00964171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101291605|NCT01956591|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101693359|NCT00964171|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101693361|NCT04016246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101693362|NCT04016246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101693363|NCT04016246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693364|NCT04016246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101693365|NCT04016246|Anesthetics, General|anesthetics, general|mesh-ancestor
101693366|NCT04016246|Anesthetics|anesthetics|mesh-ancestor
101693367|NCT02789501|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101693368|NCT04178876|Ethanol|ethanol|mesh-list
101693369|NCT04178876|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101693370|NCT04178876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101693371|NCT04178876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101291663|NCT01956955|Anticoagulants|anticoagulants|mesh-ancestor
101693372|NCT04178876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693373|NCT02789579|Levofloxacin|levofloxacin|mesh-list
101693374|NCT02789579|Nitrofurantoin|nitrofurantoin|mesh-list
101693375|NCT02789579|Cefuroxime|cefuroxime|mesh-list
101693376|NCT02789579|Cefuroxime axetil|cefuroxime axetil|mesh-list
101693377|NCT02789579|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101693378|NCT02789579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101693379|NCT02789579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101693380|NCT02789579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101693381|NCT02789579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101693382|NCT02789579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101693383|NCT02789579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693384|NCT02789579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101693385|NCT02789579|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101693386|NCT02789579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101693387|NCT04233203|Insulin|insulin|mesh-list
101693388|NCT04233203|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101693389|NCT04233203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101693390|NCT04233203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693391|NCT00959101|Metformin|metformin|mesh-list
101693392|NCT00959101|Repaglinide|repaglinide|mesh-list
101693393|NCT00959101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101693394|NCT00959101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693395|NCT04233359|Anesthetics|anesthetics|mesh-list
101693396|NCT04233359|Anesthetics, Local|anesthetics, local|mesh-list
101693397|NCT04233359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101693398|NCT04233359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693399|NCT04233359|Sensory System Agents|sensory system agents|mesh-ancestor
101693400|NCT04233359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101693401|NCT00964327|Darunavir|darunavir|mesh-list
101693402|NCT00964327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101693403|NCT00964327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101693404|NCT00964327|Protease Inhibitors|protease inhibitors|mesh-ancestor
101693405|NCT00964327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101693406|NCT00964327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101291725|NCT01957293|Adrenergic Agents|adrenergic agents|mesh-ancestor
101693407|NCT00964327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101693408|NCT00964327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101693409|NCT00964327|Antiviral Agents|antiviral agents|mesh-ancestor
101693410|NCT00964327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101693411|NCT05252546|Loperamide|loperamide|mesh-list
101693412|NCT05252546|Antidiarrheals|antidiarrheals|mesh-list
101693413|NCT05252546|Bentonite|bentonite|mesh-list
101693414|NCT05252546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101693415|NCT05252546|Antidotes|antidotes|mesh-ancestor
101693416|NCT05252546|Protective Agents|protective agents|mesh-ancestor
101291766|NCT01957449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101693417|NCT05252546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693418|NCT00644384|Acitretin|acitretin|mesh-list
101693419|NCT00644384|Keratolytic Agents|keratolytic agents|mesh-ancestor
101693420|NCT00644384|Dermatologic Agents|dermatologic agents|mesh-ancestor
101693421|NCT02637648|Sodium Oxybate|sodium oxybate|mesh-list
101693422|NCT02637648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101693423|NCT02637648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101693424|NCT02637648|Anesthetics, General|anesthetics, general|mesh-ancestor
101693425|NCT02637648|Anesthetics|anesthetics|mesh-ancestor
101693426|NCT02637648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101693427|NCT02637648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693428|NCT02815865|Oxytocin|oxytocin|mesh-list
101693429|NCT02815865|Dinoprostone|dinoprostone|mesh-list
101693430|NCT02815865|Oxytocics|oxytocics|mesh-ancestor
101693431|NCT02815865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101693432|NCT02815865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693434|NCT02673866|DS-1971a|ds-1971a|mesh-list
101693435|NCT02673866|Analgesics|analgesics|mesh-ancestor
101693436|NCT02673866|Sensory System Agents|sensory system agents|mesh-ancestor
101693437|NCT02673866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101291827|NCT01958138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101693438|NCT02673866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693439|NCT02673866|Anticonvulsants|anticonvulsants|mesh-ancestor
101693440|NCT02673866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101693441|NCT02673866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101693442|NCT02673866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693443|NCT02673866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101693444|NCT02673866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101693445|NCT02673866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101693446|NCT02673866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101693447|NCT02673866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101693448|NCT02673866|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101693449|NCT02673866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101693450|NCT00964561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101693452|NCT00964561|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101693453|NCT00964561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101693454|NCT00964561|Antitubercular Agents|antitubercular agents|mesh-ancestor
101693455|NCT00964561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101693456|NCT00964561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101693457|NCT00964561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101693458|NCT00964561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693459|NCT00964561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101693460|NCT00964561|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101693461|NCT00964561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101693462|NCT02793323|Anesthetics|anesthetics|mesh-list
101693463|NCT02793323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101693464|NCT02793323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693465|NCT00964639|Ropivacaine|ropivacaine|mesh-list
101693466|NCT00964639|Anesthetics, Local|anesthetics, local|mesh-ancestor
101693467|NCT00964639|Anesthetics|anesthetics|mesh-ancestor
101693468|NCT00964639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101693469|NCT00964639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693470|NCT00964639|Sensory System Agents|sensory system agents|mesh-ancestor
101350798|NCT02471430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693471|NCT00964639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101693472|NCT00880620|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101693474|NCT00880620|Levodopa|levodopa|mesh-list
101693475|NCT00880620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101693476|NCT00880620|Immunologic Factors|immunologic factors|mesh-ancestor
101693477|NCT00880620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693478|NCT00880620|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101693479|NCT00880620|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101693480|NCT00880620|Dopamine Agonists|dopamine agonists|mesh-ancestor
101693481|NCT00880620|Dopamine Agents|dopamine agents|mesh-ancestor
101693482|NCT00880620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101693483|NCT00880620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693484|NCT00880620|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101693485|NCT00880620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101693486|NCT00959335|Bicalutamide|bicalutamide|mesh-list
101693487|NCT00959335|Androgen Antagonists|androgen antagonists|mesh-ancestor
101693488|NCT00959335|Hormone Antagonists|hormone antagonists|mesh-ancestor
101291930|NCT01959022|Adrenergic Agents|adrenergic agents|mesh-ancestor
101291934|NCT01959061|Oxaliplatin|oxaliplatin|mesh-list
101693489|NCT00959335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101693490|NCT00959335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693491|NCT00959335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101693492|NCT00644618|Gemcitabine|gemcitabine|mesh-list
101693493|NCT00644618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101693494|NCT00644618|Antimetabolites|antimetabolites|mesh-ancestor
101693495|NCT00644618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693496|NCT00644618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101693497|NCT03967847|Ketorolac|ketorolac|mesh-list
101693498|NCT03967847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101693499|NCT03967847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101693500|NCT03967847|Analgesics|analgesics|mesh-ancestor
101693501|NCT03967847|Sensory System Agents|sensory system agents|mesh-ancestor
101693502|NCT03967847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101693503|NCT03967847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693504|NCT03967847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101693505|NCT03967847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101693506|NCT03967847|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101693507|NCT03967847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101693508|NCT03967847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693509|NCT04175990|Dydrogesterone|dydrogesterone|mesh-list
101291987|NCT01959191|Antipyretics|antipyretics|mesh-ancestor
101693510|NCT04175990|Progestins|progestins|mesh-ancestor
101693511|NCT04175990|Hormones|hormones|mesh-ancestor
101693512|NCT04175990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101693513|NCT04175990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693514|NCT00959569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101693515|NCT00959569|Esmolol|esmolol|mesh-list
101693516|NCT00959569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101693517|NCT00959569|Adrenergic Agents|adrenergic agents|mesh-ancestor
101693518|NCT00959569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101693519|NCT00959569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101292034|NCT01959477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101693520|NCT00959569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693521|NCT00959569|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101693523|NCT00881868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101693524|NCT00881868|Glucocorticoids|glucocorticoids|mesh-ancestor
101693525|NCT00881868|Hormones|hormones|mesh-ancestor
101693526|NCT00881868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101693527|NCT00881868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693528|NCT04176068|Calcium|calcium|mesh-list
101693529|NCT04176068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101693530|NCT04176068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693531|NCT00959725|Infliximab|infliximab|mesh-list
101693532|NCT00959725|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101693533|NCT00959725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101693534|NCT00959725|Dermatologic Agents|dermatologic agents|mesh-ancestor
101693535|NCT00959725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101693536|NCT00959725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101693537|NCT02789189|Gemcitabine|gemcitabine|mesh-list
101693538|NCT02789189|Nedaplatin|nedaplatin|mesh-list
101693539|NCT02789189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101693540|NCT02789189|Antimetabolites|antimetabolites|mesh-ancestor
101693541|NCT02789189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693542|NCT02789189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101693543|NCT04234607|Carboplatin|carboplatin|mesh-list
101693544|NCT04234607|Etoposide|etoposide|mesh-list
101693545|NCT04234607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101693546|NCT04234607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101350872|NCT01885949|Tivozanib|tivozanib|mesh-list
101693547|NCT04234607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101693548|NCT04234607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101693549|NCT04234607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101693550|NCT04234607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693551|NCT03955471|Niraparib|niraparib|mesh-list
101693552|NCT03955471|Dostarlimab|dostarlimab|mesh-list
101693553|NCT03955471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101693554|NCT03955471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101261353|NCT01749384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101410135|NCT00352651|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101693555|NCT03955471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693556|NCT03955471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101693557|NCT02637726|Remifentanil|remifentanil|mesh-list
101693558|NCT02637726|Propofol|propofol|mesh-list
101693559|NCT02637726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101693560|NCT02637726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101693561|NCT02637726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693562|NCT02637726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101693563|NCT02637726|Anesthetics, General|anesthetics, general|mesh-ancestor
101693565|NCT02637726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101693566|NCT02637726|Narcotics|narcotics|mesh-ancestor
101693567|NCT02637726|Analgesics|analgesics|mesh-ancestor
101693568|NCT02637726|Sensory System Agents|sensory system agents|mesh-ancestor
101693569|NCT02637726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101693570|NCT04161768|Norfloxacin|norfloxacin|mesh-list
101693571|NCT04161768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101693572|NCT04161768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101693573|NCT04161768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101693574|NCT04161768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101693575|NCT04161768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101693576|NCT04161768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693577|NCT04161768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101292348|NCT01962376|Antimetabolites|antimetabolites|mesh-ancestor
101693578|NCT04161768|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101693579|NCT04161768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101693581|NCT05300282|Atezolizumab|atezolizumab|mesh-list
101693582|NCT05300282|Vinorelbine|vinorelbine|mesh-list
101693583|NCT05300282|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101693584|NCT05300282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101693585|NCT05300282|Antimetabolites|antimetabolites|mesh-ancestor
101292417|NCT01963442|Lactams|lactams|mesh-list
101292418|NCT01963442|beta-Lactams|beta-lactams|mesh-list
101292438|NCT01963559|Lidocaine|lidocaine|mesh-list
101693586|NCT05300282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693587|NCT05300282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101693588|NCT05300282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101693589|NCT05300282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101693590|NCT05300282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101693591|NCT05300282|Tubulin Modulators|tubulin modulators|mesh-ancestor
101693592|NCT05300282|Antimitotic Agents|antimitotic agents|mesh-ancestor
101693593|NCT05300282|Mitosis Modulators|mitosis modulators|mesh-ancestor
101292485|NCT01963754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101693594|NCT05300282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101693595|NCT05300282|Alkylating Agents|alkylating agents|mesh-ancestor
101693596|NCT02793011|Dexamethasone|dexamethasone|mesh-list
101693597|NCT02793011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101693598|NCT02793011|Antiemetics|antiemetics|mesh-ancestor
101693599|NCT02793011|Autonomic Agents|autonomic agents|mesh-ancestor
101693600|NCT02793011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101693601|NCT02793011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292552|NCT01964040|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101292553|NCT01964040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101693602|NCT02793011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101693603|NCT02793011|Glucocorticoids|glucocorticoids|mesh-ancestor
101693605|NCT02793011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101693606|NCT02793011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101693607|NCT02793011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101693608|NCT00965107|Thiopental|thiopental|mesh-list
101693609|NCT00965107|Propofol|propofol|mesh-list
101693610|NCT00965107|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101693611|NCT00965107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101693612|NCT00965107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101292617|NCT01964287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101292618|NCT01964287|Tubulin Modulators|tubulin modulators|mesh-ancestor
101693613|NCT00965107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101693614|NCT00965107|Anesthetics, General|anesthetics, general|mesh-ancestor
101693615|NCT00965107|Anesthetics|anesthetics|mesh-ancestor
101693616|NCT00965107|Anticonvulsants|anticonvulsants|mesh-ancestor
101693617|NCT00965107|GABA Modulators|gaba modulators|mesh-ancestor
101693618|NCT00965107|GABA Agents|gaba agents|mesh-ancestor
101693619|NCT00965107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101693620|NCT00965107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693621|NCT02788877|Aflibercept|aflibercept|mesh-list
101350965|NCT05772676|Aprepitant|aprepitant|mesh-list
101693622|NCT02788877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101693623|NCT02788877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101292681|NCT01964534|Antimetabolites|antimetabolites|mesh-ancestor
101693624|NCT02788877|Growth Substances|growth substances|mesh-ancestor
101693625|NCT02788877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693626|NCT02788877|Growth Inhibitors|growth inhibitors|mesh-ancestor
101693627|NCT02788877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101693629|NCT00959881|Begacestat|begacestat|mesh-list
101693630|NCT00959881|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101693631|NCT00959881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101693632|NCT00959881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693633|NCT00959881|Cholinergic Agents|cholinergic agents|mesh-ancestor
101693634|NCT00959881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101693635|NCT00959881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693636|NCT00959881|Nootropic Agents|nootropic agents|mesh-ancestor
101693637|NCT00959881|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101292741|NCT01964781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101292742|NCT01964781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101693638|NCT00959959|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
101693639|NCT00959959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101693640|NCT00959959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693642|NCT03651011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101693643|NCT03651011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101693644|NCT03651011|Growth Substances|growth substances|mesh-ancestor
101693645|NCT03651011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693646|NCT03651011|Growth Inhibitors|growth inhibitors|mesh-ancestor
101693647|NCT03651011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101693648|NCT00880542|Sorafenib|sorafenib|mesh-list
101693649|NCT00880542|Ifosfamide|ifosfamide|mesh-list
101693650|NCT00880542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101693651|NCT00880542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101693652|NCT00880542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101693653|NCT00880542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693654|NCT00880542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101693655|NCT00880542|Alkylating Agents|alkylating agents|mesh-ancestor
101693656|NCT00960037|Vitamin D|vitamin d|mesh-list
101693657|NCT00960037|Cholecalciferol|cholecalciferol|mesh-list
101693658|NCT00960037|Vitamins|vitamins|mesh-ancestor
101693659|NCT00960037|Micronutrients|micronutrients|mesh-ancestor
101693660|NCT00960037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693661|NCT00960037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101292887|NCT01965405|Bupropion|bupropion|mesh-list
101693662|NCT00960037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101693663|NCT04161690|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
101693664|NCT04161690|Ropivacaine|ropivacaine|mesh-list
101693665|NCT04161690|Anesthetics, Local|anesthetics, local|mesh-ancestor
101693666|NCT04161690|Anesthetics|anesthetics|mesh-ancestor
101693667|NCT04161690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101693668|NCT04161690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693669|NCT04161690|Sensory System Agents|sensory system agents|mesh-ancestor
101693670|NCT04161690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101693671|NCT04161690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101693672|NCT04161690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101693673|NCT04161690|Analgesics|analgesics|mesh-ancestor
101693674|NCT04161690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101693675|NCT04161690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101693676|NCT00885534|Temozolomide|temozolomide|mesh-list
101693677|NCT00885534|Vinblastine|vinblastine|mesh-list
101693678|NCT00885534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101693679|NCT00885534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101693680|NCT00885534|Alkylating Agents|alkylating agents|mesh-ancestor
101693681|NCT00885534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693682|NCT00885534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101693683|NCT00885534|Tubulin Modulators|tubulin modulators|mesh-ancestor
101693684|NCT00885534|Antimitotic Agents|antimitotic agents|mesh-ancestor
101693685|NCT00885534|Mitosis Modulators|mitosis modulators|mesh-ancestor
101693687|NCT05277038|Zopiclone|zopiclone|mesh-list
101693688|NCT05277038|Analgesics|analgesics|mesh-ancestor
101693689|NCT05277038|Sensory System Agents|sensory system agents|mesh-ancestor
101693690|NCT05277038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101693691|NCT05277038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693692|NCT05277038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101693693|NCT05277038|Sympatholytics|sympatholytics|mesh-ancestor
101693694|NCT05277038|Autonomic Agents|autonomic agents|mesh-ancestor
101693695|NCT05277038|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101693696|NCT05277038|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101693697|NCT05277038|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101693698|NCT05277038|Adrenergic Agents|adrenergic agents|mesh-ancestor
101693699|NCT05277038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101693700|NCT05277038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693701|NCT05277038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101693702|NCT05277038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101693704|NCT00960349|Capecitabine|capecitabine|mesh-list
101693706|NCT00960349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101693707|NCT00960349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101693708|NCT00960349|Antimetabolites|antimetabolites|mesh-ancestor
101693709|NCT00960349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693710|NCT00960349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101693711|NCT00960349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101693713|NCT02670434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101693714|NCT02670434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101693715|NCT02670434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101693716|NCT02670434|Antimetabolites|antimetabolites|mesh-ancestor
101693717|NCT02670434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693718|NCT02670434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101693719|NCT02670434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101693720|NCT00965653|Folic Acid|folic acid|mesh-list
101693721|NCT00965653|Methotrexate|methotrexate|mesh-list
101693722|NCT00965653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101693723|NCT00965653|Abortifacient Agents|abortifacient agents|mesh-ancestor
101693724|NCT00965653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101693725|NCT00965653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693726|NCT00965653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101693727|NCT00965653|Antimetabolites|antimetabolites|mesh-ancestor
101693728|NCT00965653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693729|NCT00965653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101693730|NCT00965653|Dermatologic Agents|dermatologic agents|mesh-ancestor
101293049|NCT01966822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101293062|NCT01967017|Lidocaine|lidocaine|mesh-list
101693731|NCT00965653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101693732|NCT00965653|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101693733|NCT00965653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101693734|NCT00965653|Immunologic Factors|immunologic factors|mesh-ancestor
101693735|NCT00965653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101693736|NCT00965653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101693737|NCT00965653|Hematinics|hematinics|mesh-ancestor
101693738|NCT00965653|Vitamin B Complex|vitamin b complex|mesh-ancestor
101693739|NCT00965653|Vitamins|vitamins|mesh-ancestor
101693740|NCT00965653|Micronutrients|micronutrients|mesh-ancestor
101693741|NCT00644696|Cefixime|cefixime|mesh-list
101693742|NCT00644696|Cefpodoxime|cefpodoxime|mesh-list
101293088|NCT01967199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101693743|NCT00644696|Irinotecan|irinotecan|mesh-list
101693744|NCT00644696|Bortezomib|bortezomib|mesh-list
101293089|NCT01967199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101693745|NCT00644696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101693746|NCT00644696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101693747|NCT00644696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101693748|NCT00644696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693749|NCT00644696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101693750|NCT00644696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101693751|NCT00644696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101693753|NCT00960739|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
101693754|NCT00960739|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101693755|NCT00960739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101693756|NCT00960739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101693757|NCT00960739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693758|NCT00960739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101693759|NCT00960739|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101693760|NCT00659022|Bevacizumab|bevacizumab|mesh-list
101693761|NCT00659022|Capecitabine|capecitabine|mesh-list
101693762|NCT00659022|Oxaliplatin|oxaliplatin|mesh-list
101693763|NCT00659022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101693764|NCT00659022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101693765|NCT00659022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101693766|NCT00659022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101693767|NCT00659022|Growth Substances|growth substances|mesh-ancestor
101693768|NCT00659022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693769|NCT00659022|Growth Inhibitors|growth inhibitors|mesh-ancestor
101693770|NCT00659022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101693771|NCT00659022|Antimetabolites|antimetabolites|mesh-ancestor
101693772|NCT00659022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693773|NCT02788643|Dimercaprol|dimercaprol|mesh-list
101693774|NCT02788643|Chelating Agents|chelating agents|mesh-ancestor
101693775|NCT02788643|Sequestering Agents|sequestering agents|mesh-ancestor
101693776|NCT02788643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693777|NCT04175522|Immunoglobulins|immunoglobulins|mesh-list
101693778|NCT04175522|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101693779|NCT04175522|Antibodies|antibodies|mesh-list
101693781|NCT04175522|Immunologic Factors|immunologic factors|mesh-ancestor
101693782|NCT04175522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693783|NCT00960817|Aspirin|aspirin|mesh-list
101693784|NCT00960817|Dipyridamole|dipyridamole|mesh-list
101693785|NCT00960817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101693786|NCT00960817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101693787|NCT00960817|Analgesics|analgesics|mesh-ancestor
101693788|NCT00960817|Sensory System Agents|sensory system agents|mesh-ancestor
101693789|NCT00960817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101693790|NCT00960817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693791|NCT00960817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101693792|NCT00960817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101693793|NCT00960817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101693794|NCT00960817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101693795|NCT00960817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693796|NCT00960817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101693797|NCT00960817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101693798|NCT00960817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101693799|NCT00960817|Antipyretics|antipyretics|mesh-ancestor
101693800|NCT00960817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101693801|NCT00960817|Vasodilator Agents|vasodilator agents|mesh-ancestor
101693802|NCT00965809|Dronabinol|dronabinol|mesh-list
101693803|NCT00965809|Hallucinogens|hallucinogens|mesh-ancestor
101693804|NCT00965809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693805|NCT00965809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101693806|NCT00965809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101693807|NCT00965809|Analgesics|analgesics|mesh-ancestor
101293263|NCT01968018|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101293264|NCT01968018|Narcotics|narcotics|mesh-ancestor
101293265|NCT01968018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101293270|NCT01968044|Hormones|hormones|mesh-ancestor
101693808|NCT00965809|Sensory System Agents|sensory system agents|mesh-ancestor
101693809|NCT00965809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101693810|NCT00965809|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101693811|NCT00965809|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101693812|NCT00965809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101693813|NCT00965809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693814|NCT00965809|Hormones|hormones|mesh-ancestor
101410155|NCT00352768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101693815|NCT00965809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101693817|NCT00885378|Saxagliptin|saxagliptin|mesh-list
101693818|NCT00885378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101693819|NCT00885378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693820|NCT00885378|Incretins|incretins|mesh-ancestor
101693821|NCT00885378|Hormones|hormones|mesh-ancestor
101693822|NCT00885378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101693823|NCT00885378|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101693824|NCT00885378|Protease Inhibitors|protease inhibitors|mesh-ancestor
101693825|NCT00885378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101693826|NCT00885378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693827|NCT04095494|Nitrous Oxide|nitrous oxide|mesh-list
101693828|NCT04095494|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101693829|NCT04095494|Anesthetics, General|anesthetics, general|mesh-ancestor
101693830|NCT04095494|Anesthetics|anesthetics|mesh-ancestor
101693831|NCT04095494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101693832|NCT04095494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693833|NCT04095494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101693834|NCT04095494|Analgesics|analgesics|mesh-ancestor
101693835|NCT04095494|Sensory System Agents|sensory system agents|mesh-ancestor
101693836|NCT04095494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101693837|NCT02537210|Mesalamine|mesalamine|mesh-list
101693838|NCT02537210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101693839|NCT02537210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101693840|NCT02537210|Analgesics|analgesics|mesh-ancestor
101693841|NCT02537210|Sensory System Agents|sensory system agents|mesh-ancestor
101693842|NCT02537210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101693843|NCT02537210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693844|NCT02537210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101693845|NCT02537210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101693846|NCT01563289|Ibuprofen|ibuprofen|mesh-list
101693847|NCT01563289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101693848|NCT01563289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101693850|NCT01563289|Sensory System Agents|sensory system agents|mesh-ancestor
101693851|NCT01563289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101693852|NCT01563289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693853|NCT01563289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101693854|NCT01563289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101693855|NCT01563289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101693856|NCT01563289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101693857|NCT01563289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693858|NCT00960973|Menatetrenone|menatetrenone|mesh-list
101693859|NCT00960973|Hemostatics|hemostatics|mesh-ancestor
101693860|NCT00960973|Coagulants|coagulants|mesh-ancestor
101693862|NCT04099849|Trace Elements|trace elements|mesh-ancestor
101693863|NCT04099849|Micronutrients|micronutrients|mesh-ancestor
101693864|NCT04099849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693865|NCT00659100|Gabapentin|gabapentin|mesh-list
101693866|NCT00659100|Analgesics|analgesics|mesh-ancestor
101693867|NCT00659100|Sensory System Agents|sensory system agents|mesh-ancestor
101693868|NCT00659100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101693869|NCT00659100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693870|NCT00659100|Anticonvulsants|anticonvulsants|mesh-ancestor
101693871|NCT00659100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101693872|NCT00659100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101693873|NCT00659100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101693874|NCT00659100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101693875|NCT00659100|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101293567|NCT01970059|Carvedilol|carvedilol|mesh-list
101293568|NCT01970059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101293603|NCT01970202|Enoxaparin|enoxaparin|mesh-list
101693876|NCT00659100|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101693877|NCT00659100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101693878|NCT00659100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693879|NCT00659100|Antimanic Agents|antimanic agents|mesh-ancestor
101693880|NCT00659178|Doxorubicin|doxorubicin|mesh-list
101693881|NCT00659178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101693882|NCT00659178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101693883|NCT00659178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101693884|NCT00659178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101693885|NCT00659178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101693886|NCT00659178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101693887|NCT00659178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693888|NCT02792621|Acipimox|acipimox|mesh-list
101693889|NCT02792621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101693890|NCT02792621|Antimetabolites|antimetabolites|mesh-ancestor
101693891|NCT02792621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693892|NCT02792621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101693893|NCT04009759|Ketamine|ketamine|mesh-list
101693894|NCT04009759|Morphine|morphine|mesh-list
101693895|NCT04009759|Analgesics|analgesics|mesh-ancestor
101693896|NCT04009759|Sensory System Agents|sensory system agents|mesh-ancestor
101693897|NCT04009759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101693898|NCT04009759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693899|NCT04009759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101693900|NCT04009759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101693901|NCT04009759|Anesthetics, General|anesthetics, general|mesh-ancestor
101693902|NCT04009759|Anesthetics|anesthetics|mesh-ancestor
101693903|NCT04009759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101693904|NCT04009759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101693905|NCT04009759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101693906|NCT04009759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101693907|NCT04009759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693908|NCT04009759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101693909|NCT04009759|Narcotics|narcotics|mesh-ancestor
101693910|NCT00645086|Clarithromycin|clarithromycin|mesh-list
101693911|NCT00645086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101693912|NCT00645086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101693913|NCT00645086|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101693914|NCT00645086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101693915|NCT00645086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693916|NCT00645086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101693917|NCT00645086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101693918|NCT05238649|Vaccines|vaccines|mesh-list
101293674|NCT01971047|Insulin Lispro|insulin lispro|mesh-list
101693920|NCT05238649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693921|NCT02792153|Estradiol|estradiol|mesh-list
101693922|NCT02792153|Estrogens|estrogens|mesh-ancestor
101693923|NCT02792153|Hormones|hormones|mesh-ancestor
101693924|NCT02792153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101693925|NCT02792153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693926|NCT00644540|Vaccines|vaccines|mesh-list
101693927|NCT00644540|Immunologic Factors|immunologic factors|mesh-ancestor
101693928|NCT00644540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693929|NCT02669732|Firuglipel|firuglipel|mesh-list
101693930|NCT02669732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101693931|NCT02669732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693932|NCT05003245|Ranibizumab|ranibizumab|mesh-list
101693933|NCT05003245|Antibodies|antibodies|mesh-list
101693934|NCT05003245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101693935|NCT05003245|Mitogens|mitogens|mesh-list
101693936|NCT05003245|Endothelial Growth Factors|endothelial growth factors|mesh-list
101693937|NCT05003245|Immunologic Factors|immunologic factors|mesh-ancestor
101293788|NCT01971658|Growth Substances|growth substances|mesh-ancestor
101693938|NCT05003245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101293789|NCT01971658|Growth Inhibitors|growth inhibitors|mesh-ancestor
101693939|NCT05003245|Mitosis Modulators|mitosis modulators|mesh-ancestor
101693940|NCT05003245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693941|NCT05003245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101693942|NCT05003245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101693943|NCT05003245|Growth Substances|growth substances|mesh-ancestor
101693944|NCT05003245|Growth Inhibitors|growth inhibitors|mesh-ancestor
101693945|NCT05003245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101693947|NCT05367089|Antifungal Agents|antifungal agents|mesh-ancestor
101693948|NCT05367089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101693949|NCT05367089|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101693950|NCT05367089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101693951|NCT05367089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101693952|NCT05367089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693953|NCT05367089|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101410174|NCT00112853|Tipifarnib|tipifarnib|mesh-list
101693954|NCT05367089|Hormone Antagonists|hormone antagonists|mesh-ancestor
101293854|NCT01972269|Anesthetics, Local|anesthetics, local|mesh-ancestor
101693955|NCT05367089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101693956|NCT05367089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693957|NCT05367089|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101693958|NCT05367089|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101693959|NCT02671058|Hydrocortisone|hydrocortisone|mesh-list
101693960|NCT02671058|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101693961|NCT02671058|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101693962|NCT02671058|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101693963|NCT02671058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101693965|NCT02791919|Fludarabine|fludarabine|mesh-list
101693966|NCT02791919|Fludarabine phosphate|fludarabine phosphate|mesh-list
101693967|NCT02791919|Lenograstim|lenograstim|mesh-list
101693968|NCT02791919|Adavosertib|adavosertib|mesh-list
101693969|NCT02791919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101693970|NCT02791919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101693971|NCT02791919|Antimetabolites|antimetabolites|mesh-ancestor
101693972|NCT02791919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693973|NCT02791919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101693974|NCT02791919|Immunologic Factors|immunologic factors|mesh-ancestor
101693975|NCT02791919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693976|NCT02791919|Antiviral Agents|antiviral agents|mesh-ancestor
101693977|NCT02791919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101693978|NCT02791919|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101693979|NCT02791919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101693980|NCT00966121|Propranolol|propranolol|mesh-list
101693981|NCT00966121|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101693982|NCT00966121|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101693983|NCT00966121|Adrenergic Agents|adrenergic agents|mesh-ancestor
101693984|NCT00966121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101693985|NCT00966121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693986|NCT00966121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101693987|NCT00966121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101693988|NCT00966121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101693989|NCT00966121|Vasodilator Agents|vasodilator agents|mesh-ancestor
101693990|NCT02537288|Moxifloxacin|moxifloxacin|mesh-list
101693991|NCT02537288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101693992|NCT02537288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101693993|NCT02537288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101693994|NCT02537288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101693995|NCT02537288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101351369|NCT04752163|Mesna|mesna|mesh-list
101693996|NCT02537288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101693997|NCT02537288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101694000|NCT00659412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101694001|NCT00659412|Abortifacient Agents|abortifacient agents|mesh-ancestor
101694002|NCT00659412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101694003|NCT00659412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694004|NCT00659412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101694005|NCT00659412|Antimetabolites|antimetabolites|mesh-ancestor
101694006|NCT00659412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694007|NCT00659412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101694008|NCT00659412|Dermatologic Agents|dermatologic agents|mesh-ancestor
101694009|NCT00659412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101694010|NCT00659412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101694011|NCT00659412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101694012|NCT00659412|Immunologic Factors|immunologic factors|mesh-ancestor
101694013|NCT00659412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101694014|NCT00659412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101694015|NCT04176224|Edaravone|edaravone|mesh-list
101294105|NCT01974024|Prednisolone|prednisolone|mesh-list
101694016|NCT04176224|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101694017|NCT04176224|Antioxidants|antioxidants|mesh-ancestor
101694018|NCT04176224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694019|NCT04176224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101694020|NCT04176224|Protective Agents|protective agents|mesh-ancestor
101294153|NCT01974375|Micafungin|micafungin|mesh-list
101694021|NCT04176224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694022|NCT00966199|Antihypertensive Agents|antihypertensive agents|mesh-list
101694024|NCT04158102|Anesthetics, Local|anesthetics, local|mesh-ancestor
101694025|NCT04158102|Anesthetics|anesthetics|mesh-ancestor
101694026|NCT04158102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101694027|NCT04158102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694028|NCT04158102|Sensory System Agents|sensory system agents|mesh-ancestor
101694029|NCT04158102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101694030|NCT02689895|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101694031|NCT02689895|Antiviral Agents|antiviral agents|mesh-ancestor
101694032|NCT02689895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101694033|NCT00961363|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101294220|NCT01975012|Antiviral Agents|antiviral agents|mesh-ancestor
101694034|NCT00961363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101694035|NCT00961363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694036|NCT00961363|Incretins|incretins|mesh-ancestor
101694037|NCT00961363|Hormones|hormones|mesh-ancestor
101694038|NCT00961363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101694039|NCT00961363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101694040|NCT00961363|Protease Inhibitors|protease inhibitors|mesh-ancestor
101694041|NCT00961363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101694042|NCT00961363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694043|NCT02633202|Cisplatin|cisplatin|mesh-list
101694044|NCT02633202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101694045|NCT00645242|Fluconazole|fluconazole|mesh-list
101694046|NCT00645242|Antifungal Agents|antifungal agents|mesh-ancestor
101694047|NCT00645242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101694048|NCT00645242|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101694049|NCT00645242|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101694050|NCT00645242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101694051|NCT00645242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694052|NCT00645242|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101694053|NCT00645242|Hormone Antagonists|hormone antagonists|mesh-ancestor
101451728|NCT00208065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694054|NCT00645242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101694055|NCT00645242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694056|NCT00645242|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101694057|NCT00645242|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101694059|NCT00659568|Sirolimus|sirolimus|mesh-list
101694060|NCT00659568|Temsirolimus|temsirolimus|mesh-list
101694061|NCT00659568|MTOR Inhibitors|mtor inhibitors|mesh-list
101694062|NCT00659568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101694063|NCT00659568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694064|NCT00659568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101694065|NCT00659568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101294412|NCT01976195|Dexamethasone|dexamethasone|mesh-list
101694066|NCT00659568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694067|NCT00659568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101694068|NCT00659568|Immunologic Factors|immunologic factors|mesh-ancestor
101694069|NCT00659568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101694070|NCT00659568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101694071|NCT00659568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101694072|NCT00659568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101694073|NCT00659568|Antifungal Agents|antifungal agents|mesh-ancestor
101694075|NCT00961753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101694076|NCT00961753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101694078|NCT00961753|Sensory System Agents|sensory system agents|mesh-ancestor
101694079|NCT00961753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101694080|NCT00961753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694081|NCT00961753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101694082|NCT00961753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101694083|NCT00961753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101694084|NCT00961753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101694085|NCT00961753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694086|NCT04232813|Estradiol|estradiol|mesh-list
101694087|NCT04232813|Estrogens|estrogens|mesh-ancestor
101694088|NCT04232813|Hormones|hormones|mesh-ancestor
101694089|NCT04232813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101694090|NCT04232813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694091|NCT00659958|Zonisamide|zonisamide|mesh-list
101694092|NCT00659958|Anticonvulsants|anticonvulsants|mesh-ancestor
101694093|NCT00659958|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101694094|NCT00659958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101694095|NCT00659958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694096|NCT00659958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101694097|NCT00659958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694098|NCT00644774|Azithromycin|azithromycin|mesh-list
101294608|NCT01978301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694099|NCT00644774|Cefdinir|cefdinir|mesh-list
101694100|NCT00644774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101694101|NCT00644774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101694102|NCT00545779|Ibandronic Acid|ibandronic acid|mesh-list
101694103|NCT00545779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101694104|NCT00545779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694105|NCT00910442|Acetylcysteine|acetylcysteine|mesh-list
101694106|NCT00910442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101694107|NCT00910442|Antiviral Agents|antiviral agents|mesh-ancestor
101694108|NCT00910442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101694109|NCT00910442|Expectorants|expectorants|mesh-ancestor
101694110|NCT00910442|Respiratory System Agents|respiratory system agents|mesh-ancestor
101694111|NCT00910442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101294668|NCT01978665|Glucocorticoids|glucocorticoids|mesh-ancestor
101294669|NCT01978665|Hormones|hormones|mesh-ancestor
101694112|NCT00910442|Antioxidants|antioxidants|mesh-ancestor
101694113|NCT00910442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694114|NCT00910442|Protective Agents|protective agents|mesh-ancestor
101694115|NCT00910442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694116|NCT00910442|Antidotes|antidotes|mesh-ancestor
101694117|NCT00660036|Etoposide|etoposide|mesh-list
101694118|NCT00660036|Mitoxantrone|mitoxantrone|mesh-list
101694119|NCT00660036|Gemtuzumab|gemtuzumab|mesh-list
101694120|NCT00660036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101694121|NCT00660036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101694122|NCT00660036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101694123|NCT00660036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101694124|NCT00660036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101694125|NCT00660036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101294729|NCT01979341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101294730|NCT01979341|Luteolytic Agents|luteolytic agents|mesh-ancestor
101694127|NCT00660036|Sensory System Agents|sensory system agents|mesh-ancestor
101694128|NCT00660036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101694129|NCT00660036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694130|NCT00660036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101694131|NCT00660036|Immunotoxins|immunotoxins|mesh-ancestor
101694132|NCT00660036|Immunoconjugates|immunoconjugates|mesh-ancestor
101694133|NCT00660036|Immunologic Factors|immunologic factors|mesh-ancestor
101694134|NCT02791373|Gemcitabine|gemcitabine|mesh-list
101694135|NCT02791373|Vinorelbine|vinorelbine|mesh-list
101694136|NCT02791373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101694137|NCT02791373|Antimetabolites|antimetabolites|mesh-ancestor
101694138|NCT02791373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694139|NCT02791373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101694140|NCT02791373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101694141|NCT02791373|Tubulin Modulators|tubulin modulators|mesh-ancestor
101351479|NCT04641702|Autonomic Agents|autonomic agents|mesh-ancestor
101694142|NCT02791373|Antimitotic Agents|antimitotic agents|mesh-ancestor
101694143|NCT02791373|Mitosis Modulators|mitosis modulators|mesh-ancestor
101694145|NCT03102047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101294859|NCT01980407|Leucovorin|leucovorin|mesh-list
101694146|NCT03102047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101694148|NCT00966745|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101694149|NCT00966745|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101694150|NCT00966745|Vasodilator Agents|vasodilator agents|mesh-ancestor
101694151|NCT00966745|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101694152|NCT00966745|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101694153|NCT00966745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101294922|NCT01980745|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101294924|NCT01980745|Antimalarials|antimalarials|mesh-ancestor
101694154|NCT00966745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694156|NCT00966745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694158|NCT02669030|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101694159|NCT02669030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101694160|NCT02669030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101694161|NCT02669030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694162|NCT02669030|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
101694163|NCT02669030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101694164|NCT02669030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694165|NCT02668796|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101694166|NCT02668796|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101694168|NCT02668796|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101694169|NCT02668796|Estrogens|estrogens|mesh-ancestor
101694170|NCT02668796|Hormones|hormones|mesh-ancestor
101694171|NCT02668796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101694172|NCT02668796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694173|NCT02668796|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101694174|NCT02668796|Contraceptive Agents|contraceptive agents|mesh-ancestor
101694175|NCT02668796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101694176|NCT02668796|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101694177|NCT00645320|Ziprasidone|ziprasidone|mesh-list
101694178|NCT00645320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101694179|NCT00645320|Serotonin Agents|serotonin agents|mesh-ancestor
101694180|NCT00645320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101295124|NCT01982578|Hormones|hormones|mesh-ancestor
101694181|NCT00645320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694182|NCT00645320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694183|NCT00645320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101694184|NCT00645320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101694185|NCT00645320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101694186|NCT00645320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101694187|NCT00645320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101694188|NCT00645320|Dopamine Agents|dopamine agents|mesh-ancestor
101694189|NCT03938857|Fentanyl|fentanyl|mesh-list
101694190|NCT03938857|Dexmedetomidine|dexmedetomidine|mesh-list
101694191|NCT03938857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101694192|NCT03938857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101694193|NCT03938857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694194|NCT03938857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101694195|NCT03938857|Analgesics|analgesics|mesh-ancestor
101295186|NCT01982929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101694196|NCT03938857|Sensory System Agents|sensory system agents|mesh-ancestor
101694197|NCT03938857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101694198|NCT03938857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101694199|NCT03938857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101694200|NCT03938857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101694201|NCT03938857|Adrenergic Agents|adrenergic agents|mesh-ancestor
101694202|NCT03938857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101694203|NCT03938857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694204|NCT03938857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101694205|NCT03938857|Narcotics|narcotics|mesh-ancestor
101694206|NCT03938857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101694207|NCT03938857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101694208|NCT03938857|Anesthetics, General|anesthetics, general|mesh-ancestor
101694209|NCT03938857|Anesthetics|anesthetics|mesh-ancestor
101694210|NCT04160598|Fentanyl|fentanyl|mesh-list
101694211|NCT04160598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101694212|NCT04160598|Narcotics|narcotics|mesh-ancestor
101694213|NCT04160598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101694214|NCT04160598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694215|NCT04160598|Analgesics|analgesics|mesh-ancestor
101694216|NCT04160598|Sensory System Agents|sensory system agents|mesh-ancestor
101694217|NCT04160598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101295314|NCT01983761|Antitubercular Agents|antitubercular agents|mesh-ancestor
101694218|NCT04160598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101694219|NCT04160598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101694221|NCT04160598|Anesthetics|anesthetics|mesh-ancestor
101694222|NCT00967837|Insulin|insulin|mesh-list
101694223|NCT00967837|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101694224|NCT00967837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101694225|NCT00967837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694226|NCT02668016|Atorvastatin|atorvastatin|mesh-list
101694227|NCT02668016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
101694228|NCT02668016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101694229|NCT02668016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101694230|NCT02668016|Antimetabolites|antimetabolites|mesh-ancestor
101694231|NCT02668016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694232|NCT02668016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101694233|NCT02668016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101694234|NCT00966901|Nicotine|nicotine|mesh-list
101694235|NCT00966901|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101295380|NCT01984086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101694237|NCT00966901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101694238|NCT00966901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694239|NCT00966901|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101694240|NCT00966901|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101694241|NCT00966901|Cholinergic Agents|cholinergic agents|mesh-ancestor
101694242|NCT00966901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101694243|NCT00966901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694244|NCT02668172|Pasireotide|pasireotide|mesh-list
101694245|NCT02668172|Hormones|hormones|mesh-ancestor
101694246|NCT02668172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101694247|NCT02668172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694248|NCT00660270|Interferons|interferons|mesh-list
101295438|NCT01984567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694249|NCT00660270|Interferon-alpha|interferon-alpha|mesh-list
101694250|NCT00660270|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
101694251|NCT00660270|Gemcitabine|gemcitabine|mesh-list
101694252|NCT00660270|Fluorouracil|fluorouracil|mesh-list
101694253|NCT00660270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101694254|NCT00660270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101694255|NCT00660270|Antimetabolites|antimetabolites|mesh-ancestor
101694256|NCT00660270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694257|NCT00660270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101295501|NCT01985061|Alkylating Agents|alkylating agents|mesh-ancestor
101317128|NCT00009061|Abacavir|abacavir|mesh-list
101694258|NCT00660270|Immunologic Factors|immunologic factors|mesh-ancestor
101694259|NCT00660270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694260|NCT00660270|Antiviral Agents|antiviral agents|mesh-ancestor
101694261|NCT00660270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101694262|NCT04032132|Curcumin|curcumin|mesh-list
101694263|NCT04032132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101694264|NCT04032132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101694265|NCT04032132|Analgesics|analgesics|mesh-ancestor
101694266|NCT04032132|Sensory System Agents|sensory system agents|mesh-ancestor
101694267|NCT04032132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101694268|NCT04032132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694269|NCT04032132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101295569|NCT01985594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694270|NCT04032132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101694271|NCT04032132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101694272|NCT04032132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101694273|NCT04032132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694274|NCT00967057|Dexamethasone|dexamethasone|mesh-list
101694275|NCT00967057|Methotrexate|methotrexate|mesh-list
101694276|NCT00967057|Vincristine|vincristine|mesh-list
101694277|NCT00967057|Asparaginase|asparaginase|mesh-list
101694278|NCT00967057|Mitoxantrone|mitoxantrone|mesh-list
101694279|NCT00967057|Idarubicin|idarubicin|mesh-list
101694280|NCT00967057|Pegaspargase|pegaspargase|mesh-list
101694281|NCT00967057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101694282|NCT00967057|Antiemetics|antiemetics|mesh-ancestor
101694283|NCT00967057|Autonomic Agents|autonomic agents|mesh-ancestor
101694284|NCT00967057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101694285|NCT00967057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694286|NCT00967057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101694287|NCT00967057|Glucocorticoids|glucocorticoids|mesh-ancestor
101694288|NCT00967057|Hormones|hormones|mesh-ancestor
101694289|NCT00967057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101694290|NCT00967057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101694291|NCT00967057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101295700|NCT01986192|Warfarin|warfarin|mesh-list
101351625|NCT04332341|Niacinamide|niacinamide|mesh-list
101694292|NCT00967057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101295701|NCT01986192|Rivaroxaban|rivaroxaban|mesh-list
101295709|NCT01986218|BMS-986115|bms-986115|mesh-list
101694293|NCT00967057|Abortifacient Agents|abortifacient agents|mesh-ancestor
101261361|NCT01749397|Floxuridine|floxuridine|mesh-list
101694294|NCT00967057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101694295|NCT00967057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101694297|NCT00967057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694298|NCT00967057|Dermatologic Agents|dermatologic agents|mesh-ancestor
101694299|NCT00967057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101694300|NCT00967057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101694301|NCT00967057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101694302|NCT00967057|Immunologic Factors|immunologic factors|mesh-ancestor
101694303|NCT00967057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101694304|NCT00967057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101694305|NCT00967057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101694306|NCT00967057|Tubulin Modulators|tubulin modulators|mesh-ancestor
101694307|NCT00967057|Antimitotic Agents|antimitotic agents|mesh-ancestor
101694308|NCT00967057|Mitosis Modulators|mitosis modulators|mesh-ancestor
101694310|NCT00967057|Sensory System Agents|sensory system agents|mesh-ancestor
101295760|NCT01986465|Autonomic Agents|autonomic agents|mesh-ancestor
101694311|NCT00967057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101694312|NCT00967057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101694313|NCT00967057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101694314|NCT02633514|Etoposide|etoposide|mesh-list
101694315|NCT02633514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101694316|NCT02633514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101694317|NCT02633514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101694318|NCT02633514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101694319|NCT02633514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101694320|NCT02633514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694321|NCT00656214|Lycopene|lycopene|mesh-list
101694322|NCT00656214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101694323|NCT00656214|Antioxidants|antioxidants|mesh-ancestor
101694324|NCT00656214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694325|NCT00656214|Protective Agents|protective agents|mesh-ancestor
101694326|NCT00656214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694327|NCT00656214|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101694328|NCT00656214|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101694329|NCT00656214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101694330|NCT02790671|Firuglipel|firuglipel|mesh-list
101694331|NCT02790671|Itraconazole|itraconazole|mesh-list
101694332|NCT02790671|Antifungal Agents|antifungal agents|mesh-ancestor
101694333|NCT02790671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101694334|NCT02790671|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101694335|NCT02790671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101295819|NCT01986764|Estradiol|estradiol|mesh-list
101694336|NCT02790671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101694337|NCT02790671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694338|NCT02790671|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101694339|NCT02790671|Hormone Antagonists|hormone antagonists|mesh-ancestor
101694340|NCT02790671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101694341|NCT02790671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694342|NCT02790671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101694343|NCT02790671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101295865|NCT01986998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101694344|NCT02668094|Lidocaine|lidocaine|mesh-list
101694345|NCT02668094|Pregabalin|pregabalin|mesh-list
101694346|NCT02668094|Propofol|propofol|mesh-list
101694347|NCT02668094|Anesthetics, Local|anesthetics, local|mesh-ancestor
101694348|NCT02668094|Anesthetics|anesthetics|mesh-ancestor
101694349|NCT02668094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101694350|NCT02668094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694351|NCT02668094|Sensory System Agents|sensory system agents|mesh-ancestor
101694352|NCT02668094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101295933|NCT01987375|Cetuximab|cetuximab|mesh-list
101694353|NCT02668094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101694354|NCT02668094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101694355|NCT02668094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101694356|NCT02668094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101694357|NCT02668094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694358|NCT02668094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101694359|NCT02668094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101694360|NCT02668094|Anesthetics, General|anesthetics, general|mesh-ancestor
101694361|NCT02668094|Analgesics|analgesics|mesh-ancestor
101694362|NCT02668094|Anticonvulsants|anticonvulsants|mesh-ancestor
101296003|NCT01988545|Exenatide|exenatide|mesh-list
101694363|NCT02668094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101694364|NCT02668094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101694365|NCT02668094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101694366|NCT02668094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101261363|NCT01749397|Deoxyuridine|deoxyuridine|mesh-list
101694367|NCT02668094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101694369|NCT00967135|Analgesics|analgesics|mesh-ancestor
101694370|NCT00967135|Sensory System Agents|sensory system agents|mesh-ancestor
101296061|NCT01989052|Lomustine|lomustine|mesh-list
101296071|NCT01989078|Losartan|losartan|mesh-list
101694371|NCT00967135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101694372|NCT00967135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694373|NCT00967135|Anticonvulsants|anticonvulsants|mesh-ancestor
101694374|NCT00967135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101694375|NCT00967135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101694376|NCT00967135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694377|NCT00967135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101694378|NCT00967135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101694379|NCT00967135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101694380|NCT00967135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101694381|NCT00967135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101694382|NCT02666768|Interferons|interferons|mesh-list
101694383|NCT02666768|Interferon-gamma|interferon-gamma|mesh-list
101694384|NCT02666768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101694385|NCT02666768|Antiviral Agents|antiviral agents|mesh-ancestor
101694386|NCT02666768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101694387|NCT00967213|Ranibizumab|ranibizumab|mesh-list
101694388|NCT00967213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101694389|NCT00967213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101694390|NCT00967213|Growth Substances|growth substances|mesh-ancestor
101694391|NCT00967213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694392|NCT00967213|Growth Inhibitors|growth inhibitors|mesh-ancestor
101694393|NCT00967213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101694394|NCT04160676|Ascorbic Acid|ascorbic acid|mesh-list
101694395|NCT04160676|Thiamine|thiamine|mesh-list
101694396|NCT04160676|Hydrocortisone|hydrocortisone|mesh-list
101694397|NCT04160676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101694398|NCT04160676|Antioxidants|antioxidants|mesh-ancestor
101694399|NCT04160676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694400|NCT04160676|Protective Agents|protective agents|mesh-ancestor
101694401|NCT04160676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101296326|NCT01990807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694402|NCT04160676|Vitamins|vitamins|mesh-ancestor
101694403|NCT04160676|Micronutrients|micronutrients|mesh-ancestor
101694404|NCT04160676|Vitamin B Complex|vitamin b complex|mesh-ancestor
101694405|NCT00660426|Gemcitabine|gemcitabine|mesh-list
101694406|NCT00660426|Capecitabine|capecitabine|mesh-list
101694407|NCT00660426|Oxaliplatin|oxaliplatin|mesh-list
101694408|NCT00660426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101694409|NCT00660426|Antimetabolites|antimetabolites|mesh-ancestor
101296380|NCT01991158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101694410|NCT00660426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694411|NCT00660426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101694412|NCT00967291|Ifosfamide|ifosfamide|mesh-list
101694413|NCT00967291|Mitomycins|mitomycins|mesh-list
101694414|NCT00967291|Mitomycin|mitomycin|mesh-list
101694415|NCT00967291|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101694416|NCT00967291|Alkylating Agents|alkylating agents|mesh-ancestor
101694417|NCT00967291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694418|NCT00967291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101694419|NCT00967291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101694420|NCT00967291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101694421|NCT00967291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101694422|NCT00645398|Pregabalin|pregabalin|mesh-list
101694423|NCT00645398|Analgesics|analgesics|mesh-ancestor
101694424|NCT00645398|Sensory System Agents|sensory system agents|mesh-ancestor
101694425|NCT00645398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101694427|NCT00645398|Anticonvulsants|anticonvulsants|mesh-ancestor
101694428|NCT00645398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101694429|NCT00645398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101694430|NCT00645398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694431|NCT00645398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101694432|NCT00645398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101694433|NCT00645398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101694434|NCT00645398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101694435|NCT00645398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101694436|NCT00884832|Clonidine|clonidine|mesh-list
101694437|NCT00884832|Analgesics|analgesics|mesh-ancestor
101694438|NCT00884832|Sensory System Agents|sensory system agents|mesh-ancestor
101694439|NCT00884832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101694440|NCT00884832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694441|NCT00884832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101694442|NCT00884832|Sympatholytics|sympatholytics|mesh-ancestor
101296665|NCT01993472|Antimetabolites|antimetabolites|mesh-ancestor
101296671|NCT01993472|Analgesics|analgesics|mesh-ancestor
101694444|NCT00884832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101694445|NCT00884832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101694446|NCT00884832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101694447|NCT00884832|Adrenergic Agents|adrenergic agents|mesh-ancestor
101694448|NCT00884832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101694449|NCT00884832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694451|NCT00660582|Folic Acid|folic acid|mesh-list
101694452|NCT00660582|Fluorouracil|fluorouracil|mesh-list
101694453|NCT00660582|Oxaliplatin|oxaliplatin|mesh-list
101694454|NCT00660582|Cetuximab|cetuximab|mesh-list
101694455|NCT00660582|Levoleucovorin|levoleucovorin|mesh-list
101694456|NCT00660582|Antimetabolites|antimetabolites|mesh-ancestor
101694457|NCT00660582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694458|NCT00660582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101694459|NCT00660582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101694460|NCT00660582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101694461|NCT00660582|Immunologic Factors|immunologic factors|mesh-ancestor
101694462|NCT00660582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694463|NCT00660582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101694464|NCT00660582|Antidotes|antidotes|mesh-ancestor
101694465|NCT00660582|Protective Agents|protective agents|mesh-ancestor
101694466|NCT00660582|Vitamin B Complex|vitamin b complex|mesh-ancestor
101694467|NCT00660582|Vitamins|vitamins|mesh-ancestor
101694468|NCT00660582|Micronutrients|micronutrients|mesh-ancestor
101694469|NCT00660582|Hematinics|hematinics|mesh-ancestor
101694470|NCT00646802|Progesterone|progesterone|mesh-list
101694471|NCT00646802|Progestins|progestins|mesh-ancestor
101694472|NCT00646802|Hormones|hormones|mesh-ancestor
101694473|NCT00646802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101694474|NCT00646802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694475|NCT00968383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
101694476|NCT00968383|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101694477|NCT00968383|Adrenergic Agents|adrenergic agents|mesh-list
101694478|NCT00968383|Adrenergic Antagonists|adrenergic antagonists|mesh-list
101694479|NCT00968383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101694480|NCT00968383|Protease Inhibitors|protease inhibitors|mesh-ancestor
101694481|NCT00968383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101694482|NCT00968383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694483|NCT00968383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101694484|NCT00968383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694485|NCT00657228|Heparin|heparin|mesh-list
101694486|NCT00657228|Anticoagulants|anticoagulants|mesh-ancestor
101694487|NCT00657228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101694488|NCT00657228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101694489|NCT00657228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694490|NCT02666534|Lidocaine|lidocaine|mesh-list
101694491|NCT02666534|Prilocaine|prilocaine|mesh-list
101694492|NCT02666534|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
101694493|NCT02666534|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101694494|NCT02666534|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
101694495|NCT02666534|Anesthetics, Local|anesthetics, local|mesh-ancestor
101694496|NCT02666534|Anesthetics|anesthetics|mesh-ancestor
101694497|NCT02666534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101694498|NCT02666534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694499|NCT02666534|Sensory System Agents|sensory system agents|mesh-ancestor
101694500|NCT02666534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101694501|NCT02666534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101296775|NCT01994642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101694502|NCT02666534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101694503|NCT02666534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101694504|NCT02666534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101694505|NCT02666534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694506|NCT02666534|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101694507|NCT02666534|Dermatologic Agents|dermatologic agents|mesh-ancestor
101694508|NCT02666534|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
101694509|NCT02787473|Docetaxel|docetaxel|mesh-list
101694510|NCT02787473|Pemetrexed|pemetrexed|mesh-list
101694511|NCT02787473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101694512|NCT02787473|Tubulin Modulators|tubulin modulators|mesh-ancestor
101694513|NCT02787473|Antimitotic Agents|antimitotic agents|mesh-ancestor
101694514|NCT02787473|Mitosis Modulators|mitosis modulators|mesh-ancestor
101694515|NCT02787473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694516|NCT02787473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101694517|NCT02787473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101694518|NCT02787473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101694520|NCT00657306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101694522|NCT00967603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101694523|NCT00967603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101694524|NCT00967603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101694525|NCT00967603|Growth Substances|growth substances|mesh-ancestor
101694526|NCT00967603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694527|NCT00967603|Growth Inhibitors|growth inhibitors|mesh-ancestor
101694528|NCT00967603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101694529|NCT00967603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101694530|NCT00967603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694531|NCT00657384|Tranexamic Acid|tranexamic acid|mesh-list
101694532|NCT00657384|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101694533|NCT00657384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101694534|NCT00657384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101296819|NCT01994759|Hormones|hormones|mesh-ancestor
101694536|NCT00657384|Coagulants|coagulants|mesh-ancestor
101694537|NCT00973453|Immunomodulating Agents|immunomodulating agents|mesh-list
101694538|NCT00973453|Immunologic Factors|immunologic factors|mesh-list
101694539|NCT00973453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694540|NCT00646880|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101694541|NCT00646880|Propiverine|propiverine|mesh-list
101296875|NCT01995019|Hormones|hormones|mesh-ancestor
101694543|NCT00646880|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101694544|NCT00646880|Cholinergic Agents|cholinergic agents|mesh-ancestor
101694545|NCT00646880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101694546|NCT00646880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694547|NCT00646880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694548|NCT00646880|Urological Agents|urological agents|mesh-ancestor
101694549|NCT00646880|Parasympatholytics|parasympatholytics|mesh-ancestor
101694550|NCT00646880|Autonomic Agents|autonomic agents|mesh-ancestor
101296926|NCT01995331|Cyclosporine|cyclosporine|mesh-list
101694551|NCT00646880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101694552|NCT00910598|Glatiramer Acetate|glatiramer acetate|mesh-list
101694553|NCT00910598|(T,G)-A-L|(t,g)-a-l|mesh-list
101694554|NCT00910598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101694555|NCT00910598|Immunologic Factors|immunologic factors|mesh-ancestor
101694556|NCT00910598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694557|NCT00910598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101694558|NCT00910598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101296999|NCT01996085|Lisinopril|lisinopril|mesh-list
101694559|NCT00968461|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
101694560|NCT00968461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101694561|NCT00968461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694562|NCT00968461|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101694563|NCT00968461|Protective Agents|protective agents|mesh-ancestor
101694564|NCT00968461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694565|NCT00968461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101694566|NCT04157010|Methotrexate|methotrexate|mesh-list
101694567|NCT04157010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101694568|NCT04157010|Abortifacient Agents|abortifacient agents|mesh-ancestor
101694569|NCT04157010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101694570|NCT04157010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694571|NCT04157010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101694572|NCT04157010|Antimetabolites|antimetabolites|mesh-ancestor
101694573|NCT04157010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694574|NCT04157010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101297066|NCT01996384|Anesthetics|anesthetics|mesh-ancestor
101694575|NCT04157010|Dermatologic Agents|dermatologic agents|mesh-ancestor
101694576|NCT04157010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101694577|NCT04157010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101694578|NCT04157010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101694579|NCT04157010|Immunologic Factors|immunologic factors|mesh-ancestor
101694580|NCT04157010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101694581|NCT04157010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101694582|NCT02632032|Insulin|insulin|mesh-list
101694583|NCT02632032|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101694584|NCT02632032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101694585|NCT02632032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694586|NCT00973609|Folic Acid|folic acid|mesh-list
101694587|NCT00973609|Vitamin B Complex|vitamin b complex|mesh-list
101694588|NCT00973609|Bevacizumab|bevacizumab|mesh-list
101694589|NCT00973609|Fluorouracil|fluorouracil|mesh-list
101297118|NCT01996475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101297119|NCT01996475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101694590|NCT00973609|Capecitabine|capecitabine|mesh-list
101694591|NCT00973609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101694592|NCT00973609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101694594|NCT00973609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101694595|NCT00973609|Growth Substances|growth substances|mesh-ancestor
101694596|NCT00973609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694597|NCT00973609|Growth Inhibitors|growth inhibitors|mesh-ancestor
101694598|NCT00973609|Antimetabolites|antimetabolites|mesh-ancestor
101694599|NCT00973609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694600|NCT00973609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101694601|NCT00973609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101694602|NCT00973609|Immunologic Factors|immunologic factors|mesh-ancestor
101694603|NCT00973609|Hematinics|hematinics|mesh-ancestor
101694604|NCT00973609|Vitamins|vitamins|mesh-ancestor
101694605|NCT00973609|Micronutrients|micronutrients|mesh-ancestor
101694606|NCT02537054|Aflibercept|aflibercept|mesh-list
101694607|NCT02537054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101694608|NCT02537054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101694609|NCT02537054|Growth Substances|growth substances|mesh-ancestor
101694610|NCT02537054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694611|NCT02537054|Growth Inhibitors|growth inhibitors|mesh-ancestor
101694612|NCT02537054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101694614|NCT00973687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101694615|NCT00973687|Antiemetics|antiemetics|mesh-ancestor
101694616|NCT00973687|Autonomic Agents|autonomic agents|mesh-ancestor
101694617|NCT00973687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101694618|NCT00973687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694619|NCT00973687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101694620|NCT00973687|Glucocorticoids|glucocorticoids|mesh-ancestor
101694621|NCT00973687|Hormones|hormones|mesh-ancestor
101694622|NCT00973687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101694623|NCT00973687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101694624|NCT00973687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101694625|NCT02785757|Thrombin|thrombin|mesh-list
101694626|NCT02785757|Hemostatics|hemostatics|mesh-ancestor
101694627|NCT02785757|Coagulants|coagulants|mesh-ancestor
101694628|NCT00645554|Galantamine|galantamine|mesh-list
101694629|NCT00645554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101694630|NCT00645554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101694631|NCT00645554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694632|NCT00645554|Cholinergic Agents|cholinergic agents|mesh-ancestor
101297295|NCT01997658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101694633|NCT00645554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101694634|NCT00645554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694635|NCT00645554|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101694636|NCT00645554|Autonomic Agents|autonomic agents|mesh-ancestor
101694637|NCT00645554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101694638|NCT00645554|Nootropic Agents|nootropic agents|mesh-ancestor
101694640|NCT02785601|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101694641|NCT02785601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101297393|NCT01998295|Artemether|artemether|mesh-list
101694642|NCT02785601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101694643|NCT02785601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694645|NCT02785601|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101694646|NCT02785601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101694647|NCT02785601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101694648|NCT02785601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694649|NCT02785601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101694650|NCT02785601|Serotonin Agents|serotonin agents|mesh-ancestor
101694651|NCT02785601|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101694652|NCT02785601|Antidepressive Agents|antidepressive agents|mesh-ancestor
101694653|NCT05299567|Azithromycin|azithromycin|mesh-list
101694654|NCT05299567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101694655|NCT05299567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101694656|NCT00660894|Leucovorin|leucovorin|mesh-list
101694657|NCT00660894|Tegafur|tegafur|mesh-list
101694658|NCT00660894|Calcium|calcium|mesh-list
101694659|NCT00660894|Levoleucovorin|levoleucovorin|mesh-list
101694660|NCT00660894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101694661|NCT00660894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694662|NCT00660894|Antidotes|antidotes|mesh-ancestor
101694663|NCT00660894|Protective Agents|protective agents|mesh-ancestor
101694664|NCT00660894|Vitamin B Complex|vitamin b complex|mesh-ancestor
101694665|NCT00660894|Vitamins|vitamins|mesh-ancestor
101297492|NCT01998698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101297493|NCT01998763|Vitamin D|vitamin d|mesh-list
101694667|NCT00660894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101694668|NCT00660894|Antimetabolites|antimetabolites|mesh-ancestor
101694669|NCT00660894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694670|NCT00660894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101694671|NCT00660972|Tenofovir|tenofovir|mesh-list
101694672|NCT00660972|Emtricitabine|emtricitabine|mesh-list
101694673|NCT00660972|Raltegravir Potassium|raltegravir potassium|mesh-list
101694674|NCT00660972|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101694675|NCT00660972|Antiviral Agents|antiviral agents|mesh-ancestor
101694676|NCT00660972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101694677|NCT00660972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101694678|NCT00660972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101694679|NCT00660972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101694680|NCT00660972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694681|NCT00660972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101694682|NCT00660972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101694683|NCT00660972|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101694684|NCT00660972|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101694685|NCT02667470|Solifenacin Succinate|solifenacin succinate|mesh-list
101694686|NCT02667470|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101694687|NCT02667470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101694688|NCT02667470|Cholinergic Agents|cholinergic agents|mesh-ancestor
101694689|NCT02667470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101694690|NCT02667470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297628|NCT02000193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101694691|NCT02667470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694692|NCT02667470|Urological Agents|urological agents|mesh-ancestor
101694693|NCT05327699|Ketamine|ketamine|mesh-list
101694694|NCT05327699|Analgesics|analgesics|mesh-ancestor
101694695|NCT05327699|Sensory System Agents|sensory system agents|mesh-ancestor
101694696|NCT05327699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101694697|NCT05327699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694698|NCT05327699|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101694699|NCT05327699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101694700|NCT05327699|Anesthetics, General|anesthetics, general|mesh-ancestor
101694701|NCT05327699|Anesthetics|anesthetics|mesh-ancestor
101694702|NCT05327699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101694703|NCT05327699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101694704|NCT05327699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101694705|NCT05327699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101694706|NCT05327699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694707|NCT04157478|Temozolomide|temozolomide|mesh-list
101694708|NCT04157478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101694709|NCT04157478|Alkylating Agents|alkylating agents|mesh-ancestor
101694710|NCT04157478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694711|NCT04157478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101694712|NCT00647192|Eplerenone|eplerenone|mesh-list
101694713|NCT00647192|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101694714|NCT00647192|Hormone Antagonists|hormone antagonists|mesh-ancestor
101694715|NCT00647192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101297682|NCT02000401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101297689|NCT02000414|Daptomycin|daptomycin|mesh-list
101694716|NCT00647192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694717|NCT00647192|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101694718|NCT00647192|Diuretics|diuretics|mesh-ancestor
101694719|NCT00647192|Natriuretic Agents|natriuretic agents|mesh-ancestor
101694720|NCT00647192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101694721|NCT00661206|Clopidogrel|clopidogrel|mesh-list
101694722|NCT00661206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101694723|NCT00661206|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101694724|NCT00661206|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101694725|NCT00661206|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101694726|NCT00661206|Purinergic Agents|purinergic agents|mesh-ancestor
101694727|NCT00661206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101694728|NCT00661206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694729|NCT00661206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694730|NCT05276960|Cholecalciferol|cholecalciferol|mesh-list
101694731|NCT05276960|Vitamin D|vitamin d|mesh-list
101694732|NCT05276960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101694733|NCT05276960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694734|NCT05276960|Vitamins|vitamins|mesh-ancestor
101694735|NCT05276960|Micronutrients|micronutrients|mesh-ancestor
101694736|NCT05276960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101694737|NCT02787317|Heparin|heparin|mesh-list
101694738|NCT02787317|Bivalirudin|bivalirudin|mesh-list
101694739|NCT02787317|Anticoagulants|anticoagulants|mesh-ancestor
101694740|NCT02787317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101694741|NCT02787317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101694742|NCT02787317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352078|NCT02573909|Narcotics|narcotics|mesh-ancestor
101694745|NCT02787317|Protease Inhibitors|protease inhibitors|mesh-ancestor
101694746|NCT02787317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101694747|NCT00645632|Doxorubicin|doxorubicin|mesh-list
101694748|NCT00645632|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101694749|NCT00645632|Methotrexate|methotrexate|mesh-list
101694750|NCT00645632|Ifosfamide|ifosfamide|mesh-list
101694751|NCT00645632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101694752|NCT00645632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101694753|NCT00645632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101694754|NCT00645632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101694755|NCT00645632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101694756|NCT00645632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694757|NCT00645632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101694758|NCT00645632|Abortifacient Agents|abortifacient agents|mesh-ancestor
101694759|NCT00645632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101694760|NCT00645632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694761|NCT00645632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101694763|NCT00645632|Dermatologic Agents|dermatologic agents|mesh-ancestor
101694764|NCT00645632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101694765|NCT00645632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101694766|NCT00645632|Immunologic Factors|immunologic factors|mesh-ancestor
101694767|NCT00645632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101694768|NCT00645632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101694769|NCT00645632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101694770|NCT00645632|Alkylating Agents|alkylating agents|mesh-ancestor
101694771|NCT04156464|Lorazepam|lorazepam|mesh-list
101694772|NCT04156464|Phenobarbital|phenobarbital|mesh-list
101694773|NCT04156464|Anticonvulsants|anticonvulsants|mesh-ancestor
101694774|NCT04156464|Antiemetics|antiemetics|mesh-ancestor
101694775|NCT04156464|Autonomic Agents|autonomic agents|mesh-ancestor
101694776|NCT04156464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101694777|NCT04156464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694778|NCT04156464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101694779|NCT04156464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101694780|NCT04156464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101694781|NCT04156464|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101694782|NCT04156464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101694783|NCT04156464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101694784|NCT04156464|GABA Modulators|gaba modulators|mesh-ancestor
101694785|NCT04156464|GABA Agents|gaba agents|mesh-ancestor
101694786|NCT04156464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101694787|NCT04156464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694788|NCT04156464|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101694789|NCT04156464|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101694790|NCT04156464|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101694791|NCT04156464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101694792|NCT04156464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101694793|NCT02607215|Vinorelbine|vinorelbine|mesh-list
101694794|NCT02607215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101694795|NCT02607215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101694796|NCT02607215|Tubulin Modulators|tubulin modulators|mesh-ancestor
101694797|NCT02607215|Antimitotic Agents|antimitotic agents|mesh-ancestor
101694798|NCT02607215|Mitosis Modulators|mitosis modulators|mesh-ancestor
101694799|NCT02607215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694800|NCT00973999|Botulinum Toxins|botulinum toxins|mesh-list
101694801|NCT00973999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101694802|NCT00973999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101694803|NCT00973999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694804|NCT00973999|Cholinergic Agents|cholinergic agents|mesh-ancestor
101694805|NCT00973999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101694806|NCT00973999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694807|NCT00968929|Streptokinase|streptokinase|mesh-list
101694808|NCT00968929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101694809|NCT00968929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101694810|NCT00968929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694811|NCT00661596|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101694812|NCT00661596|Vasodilator Agents|vasodilator agents|mesh-ancestor
101694813|NCT00661596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101694814|NCT00661596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101352154|NCT00038844|Cyclophosphamide|cyclophosphamide|mesh-list
101297891|NCT02001740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101297892|NCT02001857|Hemostatics|hemostatics|mesh-list
101297893|NCT02001857|Coagulants|coagulants|mesh-ancestor
101694816|NCT00661596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694817|NCT00661596|Urological Agents|urological agents|mesh-ancestor
101694818|NCT00969085|Curcumin|curcumin|mesh-list
101694820|NCT00969085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101694821|NCT00969085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101694822|NCT00969085|Analgesics|analgesics|mesh-ancestor
101694823|NCT00969085|Sensory System Agents|sensory system agents|mesh-ancestor
101694824|NCT00969085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101694825|NCT00969085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694826|NCT00969085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101694827|NCT00969085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101694828|NCT00969085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101694829|NCT00969085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101694830|NCT00969085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694831|NCT00969085|Antioxidants|antioxidants|mesh-ancestor
101694832|NCT00969085|Protective Agents|protective agents|mesh-ancestor
101694833|NCT00974155|Dexetimide|dexetimide|mesh-list
101694834|NCT00974155|Citalopram|citalopram|mesh-list
101694835|NCT00974155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101694836|NCT00974155|Escitalopram|escitalopram|mesh-list
101694837|NCT00974155|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101694838|NCT00974155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101694839|NCT00974155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101297929|NCT02001935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101297936|NCT02001948|Morphine|morphine|mesh-list
101694840|NCT00974155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694841|NCT00974155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101694842|NCT00974155|Serotonin Agents|serotonin agents|mesh-ancestor
101694843|NCT00974155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694844|NCT00974155|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101694845|NCT00974155|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101694846|NCT00974155|Parasympatholytics|parasympatholytics|mesh-ancestor
101694847|NCT00974155|Autonomic Agents|autonomic agents|mesh-ancestor
101694848|NCT00974155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101694849|NCT00974155|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101694850|NCT00974155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101694851|NCT00974155|Cholinergic Agents|cholinergic agents|mesh-ancestor
101694852|NCT00974155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101694853|NCT00974155|Antidepressive Agents|antidepressive agents|mesh-ancestor
101694854|NCT00974155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101694855|NCT00974155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101297982|NCT02002078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101694857|NCT00879996|Methadone|methadone|mesh-list
101694858|NCT00879996|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101694859|NCT00879996|Naloxone|naloxone|mesh-list
101694860|NCT00879996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101694861|NCT00879996|Narcotics|narcotics|mesh-ancestor
101694862|NCT00879996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101694863|NCT00879996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694864|NCT00879996|Analgesics|analgesics|mesh-ancestor
101694865|NCT00879996|Sensory System Agents|sensory system agents|mesh-ancestor
101694866|NCT00879996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101694867|NCT00879996|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101694868|NCT00879996|Antitussive Agents|antitussive agents|mesh-ancestor
101694869|NCT00879996|Respiratory System Agents|respiratory system agents|mesh-ancestor
101694870|NCT00969163|Testosterone|testosterone|mesh-list
101694871|NCT00969163|Androgens|androgens|mesh-ancestor
101694872|NCT00969163|Hormones|hormones|mesh-ancestor
101694873|NCT00969163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101694874|NCT00969163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694875|NCT00873093|Leucovorin|leucovorin|mesh-list
101694876|NCT00873093|Cytarabine|cytarabine|mesh-list
101694877|NCT00873093|Prednisone|prednisone|mesh-list
101694878|NCT00873093|Hydrocortisone|hydrocortisone|mesh-list
101694879|NCT00873093|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101694880|NCT00873093|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101694881|NCT00873093|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101694882|NCT00873093|Cyclophosphamide|cyclophosphamide|mesh-list
101694883|NCT00873093|Doxorubicin|doxorubicin|mesh-list
101694884|NCT00873093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101694885|NCT00873093|Methotrexate|methotrexate|mesh-list
101694886|NCT00873093|Etoposide|etoposide|mesh-list
101298108|NCT02002663|Narcotics|narcotics|mesh-ancestor
101694887|NCT00873093|Vincristine|vincristine|mesh-list
101694888|NCT00873093|Bortezomib|bortezomib|mesh-list
101694889|NCT00873093|Asparaginase|asparaginase|mesh-list
101298111|NCT02002663|Analgesics|analgesics|mesh-ancestor
101694890|NCT00873093|Pegaspargase|pegaspargase|mesh-list
101694892|NCT00873093|Levoleucovorin|levoleucovorin|mesh-list
101694893|NCT00873093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101694894|NCT00873093|Immunologic Factors|immunologic factors|mesh-ancestor
101694895|NCT00873093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694896|NCT00873093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101694897|NCT00873093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101694898|NCT00873093|Alkylating Agents|alkylating agents|mesh-ancestor
101694899|NCT00873093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694900|NCT00873093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101694901|NCT00873093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101694902|NCT00873093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101694903|NCT00873093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101694904|NCT00873093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101694905|NCT00873093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101694906|NCT00873093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101694907|NCT00873093|Glucocorticoids|glucocorticoids|mesh-ancestor
101694908|NCT00873093|Hormones|hormones|mesh-ancestor
101694909|NCT00873093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101694910|NCT00873093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101694911|NCT00873093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101694912|NCT00873093|Abortifacient Agents|abortifacient agents|mesh-ancestor
101298224|NCT02003677|Insulin|insulin|mesh-list
101298225|NCT02003677|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101694913|NCT00873093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101694914|NCT00873093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101694915|NCT00873093|Antimetabolites|antimetabolites|mesh-ancestor
101694916|NCT00873093|Dermatologic Agents|dermatologic agents|mesh-ancestor
101694917|NCT00873093|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101694918|NCT00873093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101694919|NCT00873093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101694920|NCT00873093|Antiviral Agents|antiviral agents|mesh-ancestor
101694921|NCT00873093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101694922|NCT00873093|Antidotes|antidotes|mesh-ancestor
101694923|NCT00873093|Protective Agents|protective agents|mesh-ancestor
101694924|NCT00873093|Vitamin B Complex|vitamin b complex|mesh-ancestor
101694925|NCT00873093|Vitamins|vitamins|mesh-ancestor
101694926|NCT00873093|Micronutrients|micronutrients|mesh-ancestor
101694927|NCT00873093|Tubulin Modulators|tubulin modulators|mesh-ancestor
101694928|NCT00873093|Antimitotic Agents|antimitotic agents|mesh-ancestor
101694929|NCT00873093|Mitosis Modulators|mitosis modulators|mesh-ancestor
101694930|NCT00969319|Factor VIII|factor viii|mesh-list
101694931|NCT00969319|Coagulants|coagulants|mesh-ancestor
101694932|NCT02784899|Iloprost|iloprost|mesh-list
101694933|NCT02784899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101694934|NCT02784899|Vasodilator Agents|vasodilator agents|mesh-ancestor
101694935|NCT00974389|Bevacizumab|bevacizumab|mesh-list
101694936|NCT00974389|Tegafur|tegafur|mesh-list
101694937|NCT00974389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101694938|NCT00974389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101694939|NCT00974389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101694940|NCT00974389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101694941|NCT00974389|Growth Substances|growth substances|mesh-ancestor
101694942|NCT00974389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694943|NCT00974389|Growth Inhibitors|growth inhibitors|mesh-ancestor
101694944|NCT00974389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101694945|NCT00974389|Antimetabolites|antimetabolites|mesh-ancestor
101694946|NCT00974389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694947|NCT00969397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
101694948|NCT00969397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101694949|NCT00969397|Growth Substances|growth substances|mesh-ancestor
101694950|NCT00969397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694951|NCT00969397|Growth Inhibitors|growth inhibitors|mesh-ancestor
101694952|NCT00969397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101694953|NCT02783885|Immunomodulating Agents|immunomodulating agents|mesh-list
101694954|NCT02783885|Immunologic Factors|immunologic factors|mesh-ancestor
101694955|NCT02783885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694956|NCT00647660|Nadolol|nadolol|mesh-list
101694957|NCT00647660|Bendroflumethiazide|bendroflumethiazide|mesh-list
101694958|NCT00647660|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101694959|NCT00647660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101694960|NCT00647660|Adrenergic Agents|adrenergic agents|mesh-ancestor
101694961|NCT00647660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101694962|NCT00647660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298288|NCT02004197|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101694963|NCT00647660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694964|NCT00647660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101694967|NCT00647660|Autonomic Agents|autonomic agents|mesh-ancestor
101694968|NCT00647660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101694970|NCT00647660|Natriuretic Agents|natriuretic agents|mesh-ancestor
101694971|NCT00647660|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101694972|NCT00647660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101694973|NCT00634595|Paclitaxel|paclitaxel|mesh-list
101694974|NCT00634595|Cisplatin|cisplatin|mesh-list
101694975|NCT00634595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101694976|NCT00634595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101694977|NCT00634595|Tubulin Modulators|tubulin modulators|mesh-ancestor
101298320|NCT02004509|Anticoagulants|anticoagulants|mesh-list
101694978|NCT00634595|Antimitotic Agents|antimitotic agents|mesh-ancestor
101694979|NCT00634595|Mitosis Modulators|mitosis modulators|mesh-ancestor
101694980|NCT00634595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694981|NCT00647738|Baclofen|baclofen|mesh-list
101694982|NCT00647738|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101694983|NCT00647738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101694984|NCT00647738|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101694985|NCT00647738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101694986|NCT00647738|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101694987|NCT00647738|GABA Agonists|gaba agonists|mesh-ancestor
101694988|NCT00647738|GABA Agents|gaba agents|mesh-ancestor
101694989|NCT00647738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101694990|NCT00647738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694991|NCT04008511|Capecitabine|capecitabine|mesh-list
101694992|NCT04008511|Oxaliplatin|oxaliplatin|mesh-list
101694993|NCT04008511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101694994|NCT04008511|Antimetabolites|antimetabolites|mesh-ancestor
101694995|NCT04008511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101694996|NCT04008511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101694997|NCT00979537|Nisoldipine|nisoldipine|mesh-list
101694998|NCT00979537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101694999|NCT00979537|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101695000|NCT00979537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101695001|NCT00979537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695002|NCT00979537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101695003|NCT00979537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695004|NCT00979537|Vasodilator Agents|vasodilator agents|mesh-ancestor
101695005|NCT00692055|Naproxen|naproxen|mesh-list
101695006|NCT00692055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101695007|NCT00692055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101695008|NCT00692055|Analgesics|analgesics|mesh-ancestor
101695009|NCT00692055|Sensory System Agents|sensory system agents|mesh-ancestor
101695010|NCT00692055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101695011|NCT00692055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695012|NCT00692055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101695013|NCT00692055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101695014|NCT00692055|Gout Suppressants|gout suppressants|mesh-ancestor
101695015|NCT00692055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101695016|NCT00692055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101695017|NCT00692055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101298423|NCT02005419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101695018|NCT04033250|Bisacodyl|bisacodyl|mesh-list
101695019|NCT04033250|Picosulfate sodium|picosulfate sodium|mesh-list
101695020|NCT04033250|Magnesium Oxide|magnesium oxide|mesh-list
101695021|NCT04033250|Sodium Citrate|sodium citrate|mesh-list
101695022|NCT04033250|Citric Acid|citric acid|mesh-list
101695023|NCT04033250|Cathartics|cathartics|mesh-ancestor
101695024|NCT04033250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101695025|NCT04033250|Laxatives|laxatives|mesh-ancestor
101695026|NCT04033250|Anticoagulants|anticoagulants|mesh-ancestor
101695027|NCT04033250|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101695028|NCT04033250|Chelating Agents|chelating agents|mesh-ancestor
101695029|NCT04033250|Sequestering Agents|sequestering agents|mesh-ancestor
101695030|NCT04033250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695031|NCT04033250|Antacids|antacids|mesh-ancestor
101695032|NCT02624973|Tamoxifen|tamoxifen|mesh-list
101695033|NCT02624973|Cyclophosphamide|cyclophosphamide|mesh-list
101695034|NCT02624973|Docetaxel|docetaxel|mesh-list
101695036|NCT02624973|Letrozole|letrozole|mesh-list
101695037|NCT02624973|Epirubicin|epirubicin|mesh-list
101695038|NCT02624973|Olaparib|olaparib|mesh-list
101695039|NCT02624973|Palbociclib|palbociclib|mesh-list
101695040|NCT02624973|Pertuzumab|pertuzumab|mesh-list
101695041|NCT02624973|Goserelin|goserelin|mesh-list
101695042|NCT02624973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101352379|NCT00019487|Freund's Adjuvant|freund's adjuvant|mesh-list
101695044|NCT02624973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298486|NCT02005718|Vitamins|vitamins|mesh-ancestor
101695045|NCT02624973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101695046|NCT02624973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101695047|NCT02624973|Alkylating Agents|alkylating agents|mesh-ancestor
101695048|NCT02624973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695049|NCT02624973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101695050|NCT02624973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101695051|NCT02624973|Tubulin Modulators|tubulin modulators|mesh-ancestor
101695052|NCT02624973|Antimitotic Agents|antimitotic agents|mesh-ancestor
101695053|NCT02624973|Mitosis Modulators|mitosis modulators|mesh-ancestor
101695054|NCT02624973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101695055|NCT02624973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101695056|NCT02624973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101695057|NCT02624973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101695058|NCT02624973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101695059|NCT02624973|Hormone Antagonists|hormone antagonists|mesh-ancestor
101695060|NCT02624973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101695061|NCT02624973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101695062|NCT02624973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101695063|NCT02624973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101695064|NCT02624973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101695065|NCT02624973|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101695066|NCT02624973|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101695067|NCT02624973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101695068|NCT02624973|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101695069|NCT02624973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101695071|NCT00647816|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101695072|NCT00647816|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101695073|NCT00647816|Adrenergic Agents|adrenergic agents|mesh-ancestor
101695074|NCT00647816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101222568|NCT01513603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101695075|NCT00647816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695076|NCT00647816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695077|NCT00647816|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101695078|NCT00647816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101695079|NCT00647816|Vasodilator Agents|vasodilator agents|mesh-ancestor
101695080|NCT00647894|Alprazolam|alprazolam|mesh-list
101695081|NCT00647894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101695082|NCT00647894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101695083|NCT00647894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695084|NCT00647894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101298598|NCT05970887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101298599|NCT05970822|Azacitidine|azacitidine|mesh-list
101695085|NCT00647894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101695086|NCT00647894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101695087|NCT00647894|GABA Modulators|gaba modulators|mesh-ancestor
101695088|NCT00647894|GABA Agents|gaba agents|mesh-ancestor
101695089|NCT00647894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101695090|NCT00647894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695091|NCT02782559|Sildenafil Citrate|sildenafil citrate|mesh-list
101695092|NCT02782559|Vasodilator Agents|vasodilator agents|mesh-ancestor
101695093|NCT02782559|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101695094|NCT02782559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101695095|NCT02782559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101695096|NCT02782559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695097|NCT02782559|Urological Agents|urological agents|mesh-ancestor
101695098|NCT00647972|Olanzapine|olanzapine|mesh-list
101695099|NCT00647972|Antiemetics|antiemetics|mesh-ancestor
101695100|NCT00647972|Autonomic Agents|autonomic agents|mesh-ancestor
101695101|NCT00647972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101695102|NCT00647972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695103|NCT00647972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101695104|NCT00647972|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101695105|NCT00647972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101695106|NCT00647972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101695107|NCT00647972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101695108|NCT00647972|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101695109|NCT00647972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101695110|NCT00647972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101695111|NCT00647972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695112|NCT00647972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101695114|NCT02782403|Axitinib|axitinib|mesh-list
101298716|NCT05969847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101695115|NCT02782403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352459|NCT00039468|Immunologic Factors|immunologic factors|mesh-ancestor
101695116|NCT02782403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101695117|NCT02782403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101695118|NCT02782403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695119|NCT00646178|Adalimumab|adalimumab|mesh-list
101695120|NCT00646178|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101695121|NCT00646178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101695122|NCT00646178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101695123|NCT02624817|Glyburide|glyburide|mesh-list
101695124|NCT02624817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101695125|NCT02624817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695126|NCT02664116|Diclofenac|diclofenac|mesh-list
101695127|NCT02664116|Ketorolac|ketorolac|mesh-list
101695128|NCT02664116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101695129|NCT02664116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101695130|NCT02664116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101695131|NCT02664116|Analgesics|analgesics|mesh-ancestor
101695132|NCT02664116|Sensory System Agents|sensory system agents|mesh-ancestor
101695133|NCT02664116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101695134|NCT02664116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695135|NCT02664116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101695136|NCT02664116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101695137|NCT02664116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101695138|NCT02664116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101695139|NCT02664116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695140|NCT00692601|Capsaicin|capsaicin|mesh-list
101695141|NCT00692601|Antipruritics|antipruritics|mesh-ancestor
101695142|NCT00692601|Dermatologic Agents|dermatologic agents|mesh-ancestor
101695143|NCT00692601|Sensory System Agents|sensory system agents|mesh-ancestor
101695144|NCT00692601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101298820|NCT05968885|Mirabegron|mirabegron|mesh-list
101695145|NCT00692601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695146|NCT02785055|Hydromorphone|hydromorphone|mesh-list
101695147|NCT02785055|Bupivacaine|bupivacaine|mesh-list
101695148|NCT02785055|Anesthetics, Local|anesthetics, local|mesh-ancestor
101695149|NCT02785055|Anesthetics|anesthetics|mesh-ancestor
101695150|NCT02785055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101695151|NCT02785055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695152|NCT02785055|Sensory System Agents|sensory system agents|mesh-ancestor
101695153|NCT02785055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101298881|NCT05967936|Bupivacaine|bupivacaine|mesh-list
101298883|NCT05967936|Anesthetics|anesthetics|mesh-ancestor
101695154|NCT02785055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101695155|NCT02785055|Narcotics|narcotics|mesh-ancestor
101695156|NCT02785055|Analgesics|analgesics|mesh-ancestor
101695157|NCT02624661|Glycerol|glycerol|mesh-list
101695158|NCT02624661|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101695159|NCT02624661|Protective Agents|protective agents|mesh-ancestor
101695160|NCT02624661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695161|NCT00648050|Verapamil|verapamil|mesh-list
101695162|NCT00648050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101695163|NCT00648050|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101695164|NCT00648050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101695165|NCT00648050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695166|NCT00648050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101695167|NCT00648050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695168|NCT00648050|Vasodilator Agents|vasodilator agents|mesh-ancestor
101695169|NCT00692757|Povidone-Iodine|povidone-iodine|mesh-list
101695170|NCT00692757|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101695171|NCT00692757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101695174|NCT02624505|Autonomic Agents|autonomic agents|mesh-ancestor
101695175|NCT02624505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101695176|NCT02624505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695177|NCT02624505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101695178|NCT02624505|Respiratory System Agents|respiratory system agents|mesh-ancestor
101695179|NCT02624505|Tocolytic Agents|tocolytic agents|mesh-ancestor
101695180|NCT02624505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101695181|NCT02624505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101695182|NCT02624505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101695183|NCT02624505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101695184|NCT02624505|Adrenergic Agents|adrenergic agents|mesh-ancestor
101695185|NCT02624505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101695186|NCT02624505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695188|NCT00969631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101695189|NCT00969631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352540|NCT00020150|Temozolomide|temozolomide|mesh-list
101695190|NCT02782481|Levodopa|levodopa|mesh-list
101695192|NCT02782481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101695193|NCT02782481|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101695194|NCT02782481|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101410238|NCT05594784|Prednisone|prednisone|mesh-list
101695195|NCT02782481|Dopamine Agents|dopamine agents|mesh-ancestor
101695196|NCT02782481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101695197|NCT02782481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299163|NCT05917340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101299164|NCT05917340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101299165|NCT05917340|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101299166|NCT05917340|Antitubercular Agents|antitubercular agents|mesh-ancestor
101695198|NCT02782481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695199|NCT02782481|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101695200|NCT02782481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101695201|NCT00648128|Clarithromycin|clarithromycin|mesh-list
101695202|NCT00648128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101695203|NCT00648128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101695204|NCT00648128|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101695205|NCT00648128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101695206|NCT00648128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695207|NCT00648128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101695208|NCT00648128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101695209|NCT05342597|Edaravone|edaravone|mesh-list
101695210|NCT05342597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101695211|NCT05342597|Antioxidants|antioxidants|mesh-ancestor
101695212|NCT05342597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695213|NCT05342597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101695214|NCT05342597|Protective Agents|protective agents|mesh-ancestor
101695215|NCT05342597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299227|NCT05882214|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101299228|NCT05882214|Antimetabolites|antimetabolites|mesh-ancestor
101299229|NCT05882214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299230|NCT05882214|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101299231|NCT05882214|Vasodilator Agents|vasodilator agents|mesh-ancestor
101299232|NCT05878639|Lactulose|lactulose|mesh-list
101299233|NCT05878639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101299234|NCT05876858|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101299235|NCT05876858|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101299236|NCT05876858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299237|NCT05871684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101299238|NCT05871684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101299240|NCT05871684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101695216|NCT02784821|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101695218|NCT02784821|Ampicillin|ampicillin|mesh-list
101695219|NCT02784821|Cefotaxime|cefotaxime|mesh-list
101695220|NCT02784821|Cefoxitin|cefoxitin|mesh-list
101695221|NCT02784821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101695222|NCT02784821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101695223|NCT02784821|Antitubercular Agents|antitubercular agents|mesh-ancestor
101695224|NCT02784821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101695225|NCT02784821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101695226|NCT02784821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695227|NCT00693069|Clopidogrel|clopidogrel|mesh-list
101695228|NCT00693069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101695229|NCT00693069|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101695230|NCT00693069|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101695231|NCT00693069|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101695232|NCT00693069|Purinergic Agents|purinergic agents|mesh-ancestor
101695233|NCT00693069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101695234|NCT00693069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695235|NCT00693069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695236|NCT04949282|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
101695237|NCT04949282|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101695238|NCT04949282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695239|NCT00974935|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101695240|NCT00974935|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101695241|NCT00974935|Immunologic Factors|immunologic factors|mesh-ancestor
101695242|NCT00974935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695243|NCT00974935|Antacids|antacids|mesh-ancestor
101695244|NCT00974935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695245|NCT00974935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101299353|NCT05834777|Icatibant|icatibant|mesh-list
101695246|NCT00665808|Insulin|insulin|mesh-list
101695247|NCT00665808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101695248|NCT00665808|Insulin Detemir|insulin detemir|mesh-list
101695249|NCT00665808|Isophane Insulin, Human|isophane insulin, human|mesh-list
101695250|NCT00665808|Insulin, Isophane|insulin, isophane|mesh-list
101695251|NCT00665808|Isophane insulin, beef|isophane insulin, beef|mesh-list
101695252|NCT00665808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101695253|NCT00665808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695254|NCT04230083|Dienogest|dienogest|mesh-list
101695255|NCT04230083|Nandrolone|nandrolone|mesh-list
101695256|NCT04230083|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101695257|NCT04230083|Contraceptive Agents|contraceptive agents|mesh-ancestor
101695258|NCT04230083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101695259|NCT04230083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101299425|NCT05741502|Ziprasidone|ziprasidone|mesh-list
101299426|NCT05741502|Antipsychotic Agents|antipsychotic agents|mesh-list
101695260|NCT04230083|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101695262|NCT04230083|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101695263|NCT04230083|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101695264|NCT04230083|Hormone Antagonists|hormone antagonists|mesh-ancestor
101695265|NCT04230083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101695266|NCT04230083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101695267|NCT04230083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101695268|NCT04230083|Androgens|androgens|mesh-ancestor
101695269|NCT04230083|Hormones|hormones|mesh-ancestor
101695270|NCT04230083|Anabolic Agents|anabolic agents|mesh-ancestor
101695271|NCT00645866|Docetaxel|docetaxel|mesh-list
101695272|NCT00645866|Capecitabine|capecitabine|mesh-list
101695273|NCT00645866|Epirubicin|epirubicin|mesh-list
101695274|NCT00645866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101695275|NCT00645866|Tubulin Modulators|tubulin modulators|mesh-ancestor
101695276|NCT00645866|Antimitotic Agents|antimitotic agents|mesh-ancestor
101695277|NCT00645866|Mitosis Modulators|mitosis modulators|mesh-ancestor
101695278|NCT00645866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695279|NCT00645866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101695281|NCT00645866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101695282|NCT00645866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101695283|NCT00645866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101695284|NCT00645866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101695285|NCT05221151|Pregabalin|pregabalin|mesh-list
101695286|NCT05221151|Ondansetron|ondansetron|mesh-list
101695287|NCT05221151|Melatonin|melatonin|mesh-list
101695289|NCT05221151|Sensory System Agents|sensory system agents|mesh-ancestor
101695290|NCT05221151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101695291|NCT05221151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695292|NCT05221151|Anticonvulsants|anticonvulsants|mesh-ancestor
101695293|NCT05221151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101695294|NCT05221151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101695295|NCT05221151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695296|NCT05221151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101695297|NCT05221151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101695298|NCT05221151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101695299|NCT05221151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101695300|NCT05221151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101695301|NCT05221151|Antioxidants|antioxidants|mesh-ancestor
101695302|NCT05221151|Protective Agents|protective agents|mesh-ancestor
101695303|NCT05221151|Antiemetics|antiemetics|mesh-ancestor
101695304|NCT05221151|Autonomic Agents|autonomic agents|mesh-ancestor
101695305|NCT05221151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101695306|NCT05221151|Antipruritics|antipruritics|mesh-ancestor
101695307|NCT05221151|Dermatologic Agents|dermatologic agents|mesh-ancestor
101695308|NCT05221151|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101695309|NCT05221151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101695310|NCT05221151|Serotonin Agents|serotonin agents|mesh-ancestor
101695311|NCT05221151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101695312|NCT04008043|Acetaminophen|acetaminophen|mesh-list
101695313|NCT04008043|Dexamethasone|dexamethasone|mesh-list
101695314|NCT04008043|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
101695315|NCT04008043|Hydrocodone|hydrocodone|mesh-list
101695316|NCT04008043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101695317|NCT04008043|Antiemetics|antiemetics|mesh-ancestor
101695318|NCT04008043|Autonomic Agents|autonomic agents|mesh-ancestor
101299678|NCT05558124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101695319|NCT04008043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101695320|NCT04008043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695321|NCT04008043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101695322|NCT04008043|Glucocorticoids|glucocorticoids|mesh-ancestor
101695323|NCT04008043|Hormones|hormones|mesh-ancestor
101695324|NCT04008043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101695325|NCT04008043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101695326|NCT04008043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101695327|NCT04008043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101695328|NCT04008043|Analgesics|analgesics|mesh-ancestor
101695329|NCT04008043|Sensory System Agents|sensory system agents|mesh-ancestor
101695330|NCT04008043|Antipyretics|antipyretics|mesh-ancestor
101695331|NCT04008043|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101695332|NCT04008043|Narcotics|narcotics|mesh-ancestor
101695333|NCT04008043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101695334|NCT04008043|Antitussive Agents|antitussive agents|mesh-ancestor
101695335|NCT04008043|Respiratory System Agents|respiratory system agents|mesh-ancestor
101695336|NCT04008043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101695337|NCT04008043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101695338|NCT02783183|Pregabalin|pregabalin|mesh-list
101695339|NCT02783183|Analgesics|analgesics|mesh-ancestor
101695340|NCT02783183|Sensory System Agents|sensory system agents|mesh-ancestor
101299804|NCT05469893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101299805|NCT05469893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101299806|NCT05469893|Immunologic Factors|immunologic factors|mesh-ancestor
101695341|NCT02783183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101695342|NCT02783183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695344|NCT02783183|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101695345|NCT02783183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101695346|NCT02783183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695347|NCT02783183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101695348|NCT02783183|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101695349|NCT02783183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101695350|NCT02783183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101695351|NCT02783183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101695352|NCT00693381|Mycophenolic Acid|mycophenolic acid|mesh-list
101299869|NCT05413343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101695353|NCT00693381|Prednisone|prednisone|mesh-list
101695354|NCT00693381|Methylprednisolone|methylprednisolone|mesh-list
101695355|NCT00693381|Tacrolimus|tacrolimus|mesh-list
101695356|NCT00693381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101695357|NCT00693381|Glucocorticoids|glucocorticoids|mesh-ancestor
101695358|NCT00693381|Hormones|hormones|mesh-ancestor
101695359|NCT00693381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101695360|NCT00693381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695361|NCT00693381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101695362|NCT00693381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101695363|NCT00693381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101695364|NCT00693381|Immunologic Factors|immunologic factors|mesh-ancestor
101695365|NCT00693381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101695366|NCT00693381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101695367|NCT00693381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695368|NCT00693381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101695369|NCT00693381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101300002|NCT05274269|Ivacaftor|ivacaftor|mesh-list
101695370|NCT00693381|Antitubercular Agents|antitubercular agents|mesh-ancestor
101695371|NCT00693381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101695372|NCT00693381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101695374|NCT00693381|Autonomic Agents|autonomic agents|mesh-ancestor
101695375|NCT00693381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101695376|NCT00693381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101695377|NCT00693381|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101695378|NCT00693381|Protective Agents|protective agents|mesh-ancestor
101695379|NCT05285891|Ocrelizumab|ocrelizumab|mesh-list
101695380|NCT05285891|Immunologic Factors|immunologic factors|mesh-ancestor
101695381|NCT05285891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695382|NCT00693615|Vaccines|vaccines|mesh-list
101695383|NCT00693615|Immunologic Factors|immunologic factors|mesh-ancestor
101695384|NCT00693615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695386|NCT02663960|Sodium Citrate|sodium citrate|mesh-list
101695387|NCT02663960|Anticoagulants|anticoagulants|mesh-ancestor
101695388|NCT02663960|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101695390|NCT02663960|Sequestering Agents|sequestering agents|mesh-ancestor
101695391|NCT02663960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695392|NCT00693771|Insulin Glargine|insulin glargine|mesh-list
101695393|NCT00693771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101695394|NCT00693771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695395|NCT00693849|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101695396|NCT00693849|Sertraline|sertraline|mesh-list
101695397|NCT00693849|Escitalopram|escitalopram|mesh-list
101695398|NCT00693849|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101300137|NCT05113251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101300138|NCT05113251|Immunoconjugates|immunoconjugates|mesh-ancestor
101300139|NCT05095376|Temozolomide|temozolomide|mesh-list
101300140|NCT05095376|Lomustine|lomustine|mesh-list
101300141|NCT05095376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101300142|NCT05095376|Alkylating Agents|alkylating agents|mesh-ancestor
101300143|NCT05095376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101300144|NCT05095376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101300145|NCT05077683|Rivaroxaban|rivaroxaban|mesh-list
101300146|NCT05077683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101300147|NCT05077683|Antithrombins|antithrombins|mesh-ancestor
101300149|NCT05077683|Protease Inhibitors|protease inhibitors|mesh-ancestor
101695399|NCT00693849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101695400|NCT00693849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101695401|NCT00693849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695402|NCT00693849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101695403|NCT00693849|Serotonin Agents|serotonin agents|mesh-ancestor
101695404|NCT00693849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300217|NCT05010538|Sarecycline|sarecycline|mesh-list
101695405|NCT00693849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101695406|NCT00693849|Antidepressive Agents|antidepressive agents|mesh-ancestor
101695407|NCT00693849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101695408|NCT00693849|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101695410|NCT00693927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101695411|NCT00648362|Glimepiride|glimepiride|mesh-list
101695412|NCT00648362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101695413|NCT00648362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101695414|NCT00648362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695415|NCT00648362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101352768|NCT00020774|Gemcitabine|gemcitabine|mesh-list
101695417|NCT00648440|Midodrine|midodrine|mesh-list
101695418|NCT00648440|Sympathomimetics|sympathomimetics|mesh-ancestor
101695419|NCT00648440|Autonomic Agents|autonomic agents|mesh-ancestor
101695420|NCT00648440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101695421|NCT00648440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695422|NCT00648440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101695423|NCT00648440|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101695424|NCT00648440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101695425|NCT00648440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101695426|NCT00648440|Adrenergic Agents|adrenergic agents|mesh-ancestor
101695427|NCT00648440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101695428|NCT00648440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695429|NCT00694005|Sirolimus|sirolimus|mesh-list
101695430|NCT00694005|Paclitaxel|paclitaxel|mesh-list
101695431|NCT00694005|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101695432|NCT00694005|Everolimus|everolimus|mesh-list
101695433|NCT00694005|Temsirolimus|temsirolimus|mesh-list
101695434|NCT00694005|MTOR Inhibitors|mtor inhibitors|mesh-list
101695435|NCT00694005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101695436|NCT00694005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101695437|NCT00694005|Tubulin Modulators|tubulin modulators|mesh-ancestor
101695438|NCT00694005|Antimitotic Agents|antimitotic agents|mesh-ancestor
101695439|NCT00694005|Mitosis Modulators|mitosis modulators|mesh-ancestor
101695440|NCT00694005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695441|NCT00694005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101695442|NCT00694005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101695443|NCT00694005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101695444|NCT00694005|Immunologic Factors|immunologic factors|mesh-ancestor
101695445|NCT00694005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695446|NCT00694005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101695447|NCT00694005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101695448|NCT00694005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101695449|NCT00694005|Antifungal Agents|antifungal agents|mesh-ancestor
101695450|NCT00975325|Yohimbine|yohimbine|mesh-list
101695451|NCT00975325|Mydriatics|mydriatics|mesh-ancestor
101300470|NCT04743804|Immunologic Factors|immunologic factors|mesh-ancestor
101695452|NCT00975325|Autonomic Agents|autonomic agents|mesh-ancestor
101695453|NCT00975325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101695454|NCT00975325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695455|NCT00975325|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101695456|NCT00975325|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101695457|NCT00975325|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101695458|NCT00975325|Adrenergic Agents|adrenergic agents|mesh-ancestor
101300558|NCT04734080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695459|NCT00975325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101695460|NCT00975325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695461|NCT00975325|Urological Agents|urological agents|mesh-ancestor
101695462|NCT00910676|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101695463|NCT00910676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101695465|NCT00648518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101695466|NCT00648518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695467|NCT00648596|Sildenafil Citrate|sildenafil citrate|mesh-list
101695468|NCT00648596|Vasodilator Agents|vasodilator agents|mesh-ancestor
101695469|NCT00648596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101695470|NCT00648596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101695471|NCT00648596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101695472|NCT00648596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695473|NCT00648596|Urological Agents|urological agents|mesh-ancestor
101695474|NCT03921151|Mirtazapine|mirtazapine|mesh-list
101695475|NCT03921151|Antidepressive Agents|antidepressive agents|mesh-ancestor
101695476|NCT03921151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101695477|NCT03921151|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101695478|NCT03921151|Histamine Antagonists|histamine antagonists|mesh-ancestor
101695479|NCT03921151|Histamine Agents|histamine agents|mesh-ancestor
101695480|NCT03921151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101695481|NCT03921151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695482|NCT03921151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695483|NCT03921151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101695484|NCT03921151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101300714|NCT04477772|Antibodies|antibodies|mesh-list
101695485|NCT03921151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101695486|NCT03921151|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101695487|NCT03921151|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101695488|NCT03921151|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101695489|NCT03921151|Adrenergic Agents|adrenergic agents|mesh-ancestor
101695490|NCT03921151|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101695491|NCT03921151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101695493|NCT03921151|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101695494|NCT04570436|Diazepam|diazepam|mesh-list
101695495|NCT04570436|Gabapentin|gabapentin|mesh-list
101695496|NCT04570436|Analgesics|analgesics|mesh-ancestor
101695497|NCT04570436|Sensory System Agents|sensory system agents|mesh-ancestor
101695498|NCT04570436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101695499|NCT04570436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695500|NCT04570436|Anticonvulsants|anticonvulsants|mesh-ancestor
101300767|NCT04394624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695501|NCT04570436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101695502|NCT04570436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101695503|NCT04570436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101695504|NCT04570436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101695505|NCT04570436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101695506|NCT04570436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101695507|NCT04570436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101300826|NCT04321408|Analgesics|analgesics|mesh-ancestor
101695508|NCT04570436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695510|NCT04570436|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101695511|NCT04570436|Antiemetics|antiemetics|mesh-ancestor
101695512|NCT04570436|Autonomic Agents|autonomic agents|mesh-ancestor
101695513|NCT04570436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101695514|NCT04570436|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101695515|NCT04570436|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101695516|NCT04570436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101695517|NCT04570436|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101695518|NCT04570436|Anesthetics, General|anesthetics, general|mesh-ancestor
101695519|NCT04570436|Anesthetics|anesthetics|mesh-ancestor
101695520|NCT04570436|GABA Modulators|gaba modulators|mesh-ancestor
101695521|NCT04570436|GABA Agents|gaba agents|mesh-ancestor
101695523|NCT05195645|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101695524|NCT05195645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695525|NCT05195645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101695526|NCT05195645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101695527|NCT05195645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101695528|NCT05195645|Immunologic Factors|immunologic factors|mesh-ancestor
101695529|NCT05195645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695530|NCT05195645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101695531|NCT04171388|Micronutrients|micronutrients|mesh-list
101695532|NCT04171388|Trace Elements|trace elements|mesh-list
101695533|NCT04171388|Azithromycin|azithromycin|mesh-list
101695534|NCT04171388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101695535|NCT04171388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101695536|NCT04171388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695537|NCT00970411|Tivozanib|tivozanib|mesh-list
101695538|NCT00970411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101695539|NCT00970411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101695540|NCT00970411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695541|NCT05341193|Bevacizumab|bevacizumab|mesh-list
101695542|NCT05341193|Gemcitabine|gemcitabine|mesh-list
101695543|NCT05341193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101695544|NCT05341193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101695545|NCT05341193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101695546|NCT05341193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101695547|NCT05341193|Growth Substances|growth substances|mesh-ancestor
101695548|NCT05341193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101300949|NCT04209296|Anesthetics|anesthetics|mesh-ancestor
101695549|NCT05341193|Growth Inhibitors|growth inhibitors|mesh-ancestor
101695550|NCT05341193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101695551|NCT05341193|Antimetabolites|antimetabolites|mesh-ancestor
101695552|NCT05341193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695553|NCT04229459|Nivolumab|nivolumab|mesh-list
101695554|NCT04229459|Cetuximab|cetuximab|mesh-list
101695555|NCT04229459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101695556|NCT04229459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101695557|NCT04229459|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101261369|NCT01749397|Immunologic Factors|immunologic factors|mesh-ancestor
101695558|NCT04229459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695559|NCT00980239|Bevacizumab|bevacizumab|mesh-list
101695560|NCT00980239|Cetuximab|cetuximab|mesh-list
101695561|NCT00980239|Oxaliplatin|oxaliplatin|mesh-list
101695562|NCT00980239|Irinotecan|irinotecan|mesh-list
101301081|NCT04042558|Pemetrexed|pemetrexed|mesh-list
101695563|NCT00980239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101695564|NCT00980239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101695565|NCT00980239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101695568|NCT00980239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695569|NCT00980239|Growth Inhibitors|growth inhibitors|mesh-ancestor
101695570|NCT00980239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101695571|NCT00980239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101695572|NCT00980239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101695573|NCT00980239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695574|NCT02665832|Amlodipine|amlodipine|mesh-list
101695575|NCT02665832|Olmesartan|olmesartan|mesh-list
101695576|NCT02665832|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101695577|NCT02665832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101695578|NCT02665832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101695579|NCT02665832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101301222|NCT03941860|Ixazomib|ixazomib|mesh-list
101695580|NCT02665832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695581|NCT02665832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101695582|NCT02665832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695583|NCT02665832|Vasodilator Agents|vasodilator agents|mesh-ancestor
101695584|NCT02665832|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101695585|NCT02665832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101695586|NCT02665832|Antimetabolites|antimetabolites|mesh-ancestor
101695587|NCT02665832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101695588|NCT02665832|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101695589|NCT02665832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101695590|NCT02665832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101695591|NCT02665832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101695592|NCT02781467|Cyclophosphamide|cyclophosphamide|mesh-list
101695593|NCT02781467|Fludarabine|fludarabine|mesh-list
101695594|NCT02781467|Interleukin-2|interleukin-2|mesh-list
101695595|NCT02781467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101695596|NCT02781467|Immunologic Factors|immunologic factors|mesh-ancestor
101695599|NCT02781467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101695600|NCT02781467|Alkylating Agents|alkylating agents|mesh-ancestor
101695601|NCT02781467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695602|NCT02781467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101695603|NCT02781467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101695604|NCT02781467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101695605|NCT02781467|Analgesics|analgesics|mesh-ancestor
101695606|NCT02781467|Sensory System Agents|sensory system agents|mesh-ancestor
101301349|NCT03725761|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
101301350|NCT03725761|Immunoconjugates|immunoconjugates|mesh-ancestor
101301351|NCT03725761|Immunologic Factors|immunologic factors|mesh-ancestor
101301352|NCT03725761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301361|NCT03707951|Acetylcysteine|acetylcysteine|mesh-list
101301362|NCT03707951|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101301363|NCT03707951|Antiviral Agents|antiviral agents|mesh-ancestor
101301364|NCT03707951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101301365|NCT03707951|Expectorants|expectorants|mesh-ancestor
101301366|NCT03707951|Respiratory System Agents|respiratory system agents|mesh-ancestor
101301367|NCT03707951|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101301368|NCT03707951|Antioxidants|antioxidants|mesh-ancestor
101301369|NCT03707951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301370|NCT03707951|Protective Agents|protective agents|mesh-ancestor
101695607|NCT02781467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101695608|NCT00648830|Clarithromycin|clarithromycin|mesh-list
101695609|NCT00648830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101695610|NCT00648830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101695611|NCT00648830|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101695612|NCT00648830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101695613|NCT00648830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695614|NCT00648830|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101695615|NCT00648830|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101301419|NCT03637400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101695616|NCT00970567|Insulin|insulin|mesh-list
101695617|NCT00970567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101695618|NCT00970567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695619|NCT05341817|Letrozole|letrozole|mesh-list
101695620|NCT05341817|Mifepristone|mifepristone|mesh-list
101695621|NCT05341817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101695622|NCT05341817|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101695623|NCT05341817|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101695624|NCT05341817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101695625|NCT05341817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695626|NCT05341817|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101695627|NCT05341817|Hormone Antagonists|hormone antagonists|mesh-ancestor
101695628|NCT05341817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101695629|NCT05341817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695630|NCT05341817|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101695631|NCT05341817|Abortifacient Agents|abortifacient agents|mesh-ancestor
101301482|NCT03520842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101695632|NCT05341817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101695633|NCT05341817|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101695634|NCT05341817|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101695635|NCT05341817|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101695636|NCT05341817|Contraceptive Agents|contraceptive agents|mesh-ancestor
101352991|NCT00021671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101695637|NCT05341817|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101695638|NCT05341817|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101695639|NCT05341817|Luteolytic Agents|luteolytic agents|mesh-ancestor
101695640|NCT05341817|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101695641|NCT05341817|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101695643|NCT02663570|Antioxidants|antioxidants|mesh-ancestor
101695644|NCT02663570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101301539|NCT03301857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101301544|NCT03277482|Durvalumab|durvalumab|mesh-list
101695645|NCT02663570|Protective Agents|protective agents|mesh-ancestor
101695646|NCT02663570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695647|NCT02663570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101695648|NCT00980473|Timolol|timolol|mesh-list
101695649|NCT00980473|Travoprost|travoprost|mesh-list
101695650|NCT00980473|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101695651|NCT00980473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101695652|NCT00980473|Adrenergic Agents|adrenergic agents|mesh-ancestor
101695653|NCT00980473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101695654|NCT00980473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695655|NCT00980473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695656|NCT00980473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101301606|NCT03077542|Sirolimus|sirolimus|mesh-list
101695657|NCT00980473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101301607|NCT03077542|Cyclophosphamide|cyclophosphamide|mesh-list
101695658|NCT02784743|Ivermectin|ivermectin|mesh-list
101695659|NCT02784743|Albendazole|albendazole|mesh-list
101695660|NCT02784743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101695661|NCT02784743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101695662|NCT02784743|Anthelmintics|anthelmintics|mesh-ancestor
101695663|NCT02784743|Anticestodal Agents|anticestodal agents|mesh-ancestor
101695664|NCT02784743|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101695665|NCT02784743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101695666|NCT02784743|Tubulin Modulators|tubulin modulators|mesh-ancestor
101695667|NCT02784743|Antimitotic Agents|antimitotic agents|mesh-ancestor
101695668|NCT02784743|Mitosis Modulators|mitosis modulators|mesh-ancestor
101695669|NCT02784743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695670|NCT02784743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101301667|NCT02965963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101301669|NCT02965963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101695672|NCT00980551|Vincristine|vincristine|mesh-list
101695673|NCT00980551|Topotecan|topotecan|mesh-list
101695674|NCT00980551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101695675|NCT00980551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101695676|NCT00980551|Tubulin Modulators|tubulin modulators|mesh-ancestor
101695677|NCT00980551|Antimitotic Agents|antimitotic agents|mesh-ancestor
101695678|NCT00980551|Mitosis Modulators|mitosis modulators|mesh-ancestor
101695679|NCT00980551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695680|NCT00980551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101301751|NCT02913196|Abiraterone Acetate|abiraterone acetate|mesh-list
101695681|NCT00980551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101695682|NCT00980551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101695683|NCT02660060|Pramipexole|pramipexole|mesh-list
101695684|NCT02660060|Antioxidants|antioxidants|mesh-ancestor
101695685|NCT02660060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695686|NCT02660060|Protective Agents|protective agents|mesh-ancestor
101695687|NCT02660060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695688|NCT02660060|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101695689|NCT02660060|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101695690|NCT02660060|Dopamine Agonists|dopamine agonists|mesh-ancestor
101695691|NCT02660060|Dopamine Agents|dopamine agents|mesh-ancestor
101695692|NCT02660060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101695693|NCT04008979|Aspirin|aspirin|mesh-list
101695694|NCT04008979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101695695|NCT04008979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101695696|NCT04008979|Analgesics|analgesics|mesh-ancestor
101695697|NCT04008979|Sensory System Agents|sensory system agents|mesh-ancestor
101695698|NCT04008979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101301901|NCT02744690|Mitomycin|mitomycin|mesh-list
101695699|NCT04008979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695700|NCT04008979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101695701|NCT04008979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101695702|NCT04008979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101695703|NCT04008979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101695704|NCT04008979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695705|NCT04008979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101695706|NCT04008979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101695707|NCT04008979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101695708|NCT04008979|Antipyretics|antipyretics|mesh-ancestor
101301953|NCT02582775|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101695709|NCT05263583|Bromides|bromides|mesh-list
101695710|NCT05263583|Anticonvulsants|anticonvulsants|mesh-ancestor
101301959|NCT02506517|Afatinib|afatinib|mesh-list
101695711|NCT00970879|Mefloquine|mefloquine|mesh-list
101695712|NCT00970879|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101695713|NCT00970879|Antimalarials|antimalarials|mesh-ancestor
101695714|NCT00970879|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101695715|NCT00970879|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101695716|NCT00970879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101695717|NCT00970879|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101695718|NCT00970879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101695719|NCT05340803|Magnesium Sulfate|magnesium sulfate|mesh-list
101695720|NCT05340803|Midazolam|midazolam|mesh-list
101695721|NCT05340803|Dexmedetomidine|dexmedetomidine|mesh-list
101695722|NCT05340803|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101695723|NCT05340803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101695724|NCT05340803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695725|NCT05340803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101695726|NCT05340803|Analgesics|analgesics|mesh-ancestor
101695727|NCT05340803|Sensory System Agents|sensory system agents|mesh-ancestor
101695728|NCT05340803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101695729|NCT05340803|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101695730|NCT05340803|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101695731|NCT05340803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101695732|NCT05340803|Adrenergic Agents|adrenergic agents|mesh-ancestor
101695733|NCT05340803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101695734|NCT05340803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695735|NCT05340803|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101695737|NCT05340803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101695738|NCT05340803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101695739|NCT05340803|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101695740|NCT05340803|Anesthetics, General|anesthetics, general|mesh-ancestor
101302085|NCT02169089|Spironolactone|spironolactone|mesh-list
101695742|NCT05340803|GABA Modulators|gaba modulators|mesh-ancestor
101695743|NCT05340803|GABA Agents|gaba agents|mesh-ancestor
101695744|NCT05340803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101695745|NCT05340803|Anticonvulsants|anticonvulsants|mesh-ancestor
101695746|NCT05340803|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101695747|NCT05340803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101695748|NCT05340803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101695749|NCT05340803|Tocolytic Agents|tocolytic agents|mesh-ancestor
101695750|NCT05340803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101695751|NCT02663258|Pembrolizumab|pembrolizumab|mesh-list
101695752|NCT02663258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101695753|NCT02663258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101695754|NCT02663258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101695755|NCT02663258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695757|NCT04033172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101695758|NCT04033172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101695759|NCT04033172|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101695760|NCT04033172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101695761|NCT04033172|Hormone Antagonists|hormone antagonists|mesh-ancestor
101695762|NCT04033172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101695763|NCT04033172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695764|NCT00980707|Fluticasone|fluticasone|mesh-list
101695766|NCT00980707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101695767|NCT00980707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101695768|NCT00980707|Autonomic Agents|autonomic agents|mesh-ancestor
101695769|NCT00980707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101695770|NCT00980707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695771|NCT00980707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101695772|NCT00980707|Respiratory System Agents|respiratory system agents|mesh-ancestor
101695773|NCT00980707|Dermatologic Agents|dermatologic agents|mesh-ancestor
101695774|NCT00980707|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101695775|NCT05340725|Dexmedetomidine|dexmedetomidine|mesh-list
101695776|NCT05340725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101695777|NCT05340725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101695778|NCT05340725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695779|NCT05340725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101695780|NCT05340725|Analgesics|analgesics|mesh-ancestor
101695781|NCT05340725|Sensory System Agents|sensory system agents|mesh-ancestor
101695782|NCT05340725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101695783|NCT05340725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101695784|NCT05340725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101695785|NCT05340725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101695786|NCT05340725|Adrenergic Agents|adrenergic agents|mesh-ancestor
101695787|NCT05340725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101695788|NCT05340725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695789|NCT00970957|Bevacizumab|bevacizumab|mesh-list
101695790|NCT00970957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101695791|NCT00970957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101695792|NCT00970957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101695793|NCT00970957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101695794|NCT00970957|Growth Substances|growth substances|mesh-ancestor
101695795|NCT00970957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695796|NCT00970957|Growth Inhibitors|growth inhibitors|mesh-ancestor
101695798|NCT00976105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
101695799|NCT00976105|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101695800|NCT00976105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101695801|NCT00976105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695802|NCT00976105|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101695803|NCT00976105|GABA Agonists|gaba agonists|mesh-ancestor
101695804|NCT00976105|GABA Agents|gaba agents|mesh-ancestor
101695805|NCT00976105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101695806|NCT00976105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695807|NCT00976261|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101695808|NCT00976261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101695809|NCT00976261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695810|NCT00976261|Incretins|incretins|mesh-ancestor
101695811|NCT00976261|Hormones|hormones|mesh-ancestor
101695812|NCT00976261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101695813|NCT00976261|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101695814|NCT00976261|Protease Inhibitors|protease inhibitors|mesh-ancestor
101695815|NCT00976261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101695816|NCT00976261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695817|NCT02662712|JNJ-56136379|jnj-56136379|mesh-list
101695818|NCT02662712|Antiviral Agents|antiviral agents|mesh-ancestor
101695819|NCT02662712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101695820|NCT00976651|Menotropins|menotropins|mesh-list
101695821|NCT00976651|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101695822|NCT00976651|Fertility Agents|fertility agents|mesh-ancestor
101695823|NCT00976651|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101695824|NCT00976651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695825|NCT00971581|Ketoprofen|ketoprofen|mesh-list
101695826|NCT00971581|Omeprazole|omeprazole|mesh-list
101695827|NCT00971581|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101695828|NCT00971581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101695829|NCT00971581|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101695830|NCT00971581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101695831|NCT00971581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695832|NCT00971581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101695833|NCT00971581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101695834|NCT00971581|Analgesics|analgesics|mesh-ancestor
101695835|NCT00971581|Sensory System Agents|sensory system agents|mesh-ancestor
101695836|NCT00971581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101695837|NCT00971581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695838|NCT00971581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101695839|NCT00971581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101695840|NCT00971581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101695841|NCT02662322|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
101695842|NCT02662322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101695843|NCT02662322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695844|NCT00971659|Insulin|insulin|mesh-list
101695845|NCT00971659|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101302441|NCT00769379|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
101302442|NCT00769379|Antibodies|antibodies|mesh-list
101302443|NCT00769379|Immunoglobulins|immunoglobulins|mesh-list
101302444|NCT00769379|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101302445|NCT00769379|Immunologic Factors|immunologic factors|mesh-ancestor
101302446|NCT00769379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695846|NCT00971659|Metformin|metformin|mesh-list
101695847|NCT00971659|Insulin Glargine|insulin glargine|mesh-list
101695848|NCT00971659|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101695849|NCT00971659|Exenatide|exenatide|mesh-list
101695850|NCT00971659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101695851|NCT00971659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695852|NCT00971659|Incretins|incretins|mesh-ancestor
101695853|NCT00971659|Hormones|hormones|mesh-ancestor
101695854|NCT00971659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101695855|NCT00971659|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101695856|NCT00971659|Protease Inhibitors|protease inhibitors|mesh-ancestor
101695857|NCT00971659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101695858|NCT00971659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695859|NCT00971659|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101695860|NCT00648986|Tazarotene|tazarotene|mesh-list
101695861|NCT00648986|Dermatologic Agents|dermatologic agents|mesh-ancestor
101353236|NCT00049608|Gemcitabine|gemcitabine|mesh-list
101695862|NCT00648986|Keratolytic Agents|keratolytic agents|mesh-ancestor
101695864|NCT00971815|Citalopram|citalopram|mesh-list
101695865|NCT00971815|Escitalopram|escitalopram|mesh-list
101695866|NCT00971815|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101695867|NCT00971815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101695868|NCT00971815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101695869|NCT00971815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695870|NCT00971815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101695871|NCT00971815|Serotonin Agents|serotonin agents|mesh-ancestor
101695872|NCT00971815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695873|NCT00971815|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101695874|NCT00971815|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101695875|NCT00971815|Parasympatholytics|parasympatholytics|mesh-ancestor
101695876|NCT00971815|Autonomic Agents|autonomic agents|mesh-ancestor
101695877|NCT00971815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101695878|NCT00971815|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101695879|NCT00971815|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101695880|NCT00971815|Cholinergic Agents|cholinergic agents|mesh-ancestor
101695881|NCT00971815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101695882|NCT00971815|Antidepressive Agents|antidepressive agents|mesh-ancestor
101695883|NCT00971815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101695884|NCT00981487|Ondansetron|ondansetron|mesh-list
101302509|NCT00433511|Paclitaxel|paclitaxel|mesh-list
101302510|NCT00433511|Cyclophosphamide|cyclophosphamide|mesh-list
101302511|NCT00433511|Bevacizumab|bevacizumab|mesh-list
101302512|NCT00433511|Doxorubicin|doxorubicin|mesh-list
101302513|NCT00433511|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101302514|NCT00433511|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101302515|NCT00433511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101302516|NCT00433511|Antibodies|antibodies|mesh-list
101302517|NCT00433511|Immunoglobulins|immunoglobulins|mesh-list
101302518|NCT00433511|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101302519|NCT00433511|Immunoglobulin G|immunoglobulin g|mesh-list
101302520|NCT00433511|Endothelial Growth Factors|endothelial growth factors|mesh-list
101302521|NCT00433511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101302522|NCT00433511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302523|NCT00433511|Tubulin Modulators|tubulin modulators|mesh-ancestor
101302524|NCT00433511|Antimitotic Agents|antimitotic agents|mesh-ancestor
101302525|NCT00433511|Mitosis Modulators|mitosis modulators|mesh-ancestor
101695885|NCT00981487|Antiemetics|antiemetics|mesh-ancestor
101695886|NCT00981487|Autonomic Agents|autonomic agents|mesh-ancestor
101695887|NCT00981487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101695888|NCT00981487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695889|NCT00981487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101695890|NCT00981487|Antipruritics|antipruritics|mesh-ancestor
101695891|NCT00981487|Dermatologic Agents|dermatologic agents|mesh-ancestor
101695892|NCT00981487|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101695893|NCT00981487|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101695894|NCT00981487|Serotonin Agents|serotonin agents|mesh-ancestor
101695895|NCT00981487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101695896|NCT00981487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695897|NCT00646568|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101695898|NCT00646568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101695899|NCT00646568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695900|NCT00971893|Methylprednisolone|methylprednisolone|mesh-list
101695901|NCT00971893|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101695902|NCT00971893|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101695903|NCT00971893|Prednisolone|prednisolone|mesh-list
101695904|NCT00971893|Prednisolone acetate|prednisolone acetate|mesh-list
101695905|NCT00971893|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101695906|NCT00971893|Prednisolone phosphate|prednisolone phosphate|mesh-list
101695907|NCT00971893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101695908|NCT00971893|Antiemetics|antiemetics|mesh-ancestor
101695909|NCT00971893|Autonomic Agents|autonomic agents|mesh-ancestor
101695910|NCT00971893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101695911|NCT00971893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695912|NCT00971893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101695913|NCT00971893|Glucocorticoids|glucocorticoids|mesh-ancestor
101695914|NCT00971893|Hormones|hormones|mesh-ancestor
101695915|NCT00971893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101695916|NCT00971893|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101695917|NCT00971893|Protective Agents|protective agents|mesh-ancestor
101695918|NCT00971893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101302530|NCT00433511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101302531|NCT00433511|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101695919|NCT00971893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101695921|NCT02665208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101695922|NCT02665208|Autonomic Agents|autonomic agents|mesh-ancestor
101695923|NCT02665208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101695924|NCT02665208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695925|NCT02665208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101695926|NCT02665208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101695927|NCT02665208|Cholinergic Agents|cholinergic agents|mesh-ancestor
101695928|NCT02665208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101695929|NCT02665208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695931|NCT00977353|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101695932|NCT00977353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101695933|NCT00977353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101695934|NCT00977353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353298|NCT00022451|Tipifarnib|tipifarnib|mesh-list
101695935|NCT00977353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101695936|NCT00977353|Serotonin Agents|serotonin agents|mesh-ancestor
101695937|NCT00977353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695938|NCT00977353|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101695939|NCT00977353|Antidepressive Agents|antidepressive agents|mesh-ancestor
101695940|NCT00977353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101695941|NCT00871923|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101695942|NCT00871923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101695943|NCT00871923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101695944|NCT00871923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101302637|NCT02006745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695945|NCT00871923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695946|NCT04170530|Oxaliplatin|oxaliplatin|mesh-list
101695947|NCT04170530|Irinotecan|irinotecan|mesh-list
101695948|NCT04170530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101695949|NCT04170530|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101695950|NCT04170530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101695951|NCT04170530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101695952|NCT04170530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695953|NCT02617017|Buspirone|buspirone|mesh-list
101695954|NCT02617017|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101302691|NCT02007161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695955|NCT02617017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101695956|NCT02617017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101695957|NCT02617017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695958|NCT02617017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101695959|NCT02617017|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101695960|NCT02617017|Serotonin Agents|serotonin agents|mesh-ancestor
101695961|NCT02617017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101695962|NCT02617017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695963|NCT02616861|Praliciguat|praliciguat|mesh-list
101695964|NCT02616861|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
101695965|NCT02616861|Enzyme Activators|enzyme activators|mesh-ancestor
101695966|NCT02616861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695967|NCT02616861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101695968|NCT00981721|Cediranib|cediranib|mesh-list
101695969|NCT00981721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101695970|NCT00981721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101695971|NCT00981721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101695972|NCT00981721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695973|NCT04133337|Apatinib|apatinib|mesh-list
101695974|NCT04133337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101695975|NCT04133337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101695976|NCT04133337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101695977|NCT04133337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695978|NCT04133259|Tenofovir|tenofovir|mesh-list
101695979|NCT04133259|Entecavir|entecavir|mesh-list
101695980|NCT04133259|Antibodies|antibodies|mesh-list
101695981|NCT04133259|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101695982|NCT04133259|Immunologic Factors|immunologic factors|mesh-ancestor
101695983|NCT04133259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695984|NCT04133259|Antiviral Agents|antiviral agents|mesh-ancestor
101695985|NCT04133259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101695986|NCT04133259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101695987|NCT04133259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101695988|NCT04133259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101695989|NCT04133259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101695990|NCT04133259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101695991|NCT04133259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101695992|NCT02616315|Naltrexone|naltrexone|mesh-list
101695993|NCT02616315|Bupropion|bupropion|mesh-list
101695994|NCT02616315|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101695995|NCT02616315|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101695996|NCT02616315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101695997|NCT02616315|Sensory System Agents|sensory system agents|mesh-ancestor
101695998|NCT02616315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101695999|NCT02616315|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101696001|NCT02616315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101696002|NCT02616315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101696003|NCT02616315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101696004|NCT02616315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101696005|NCT02616315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696006|NCT02616315|Dopamine Agents|dopamine agents|mesh-ancestor
101696007|NCT02616315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101696008|NCT02616315|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101696009|NCT02616315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101696010|NCT02616315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101696011|NCT02779283|Calcium, Dietary|calcium, dietary|mesh-list
101696012|NCT02779283|Leucovorin|leucovorin|mesh-list
101696013|NCT02779283|Folic Acid|folic acid|mesh-list
101696014|NCT02779283|Cytarabine|cytarabine|mesh-list
101696015|NCT02779283|Dexamethasone|dexamethasone|mesh-list
101696016|NCT02779283|Methylprednisolone|methylprednisolone|mesh-list
101696017|NCT02779283|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101696018|NCT02779283|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101696019|NCT02779283|Prednisolone|prednisolone|mesh-list
101696020|NCT02779283|Prednisolone acetate|prednisolone acetate|mesh-list
101696021|NCT02779283|Dexamethasone acetate|dexamethasone acetate|mesh-list
101696022|NCT02779283|Cyclophosphamide|cyclophosphamide|mesh-list
101696023|NCT02779283|Rituximab|rituximab|mesh-list
101696024|NCT02779283|Doxorubicin|doxorubicin|mesh-list
101696025|NCT02779283|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101696026|NCT02779283|Methotrexate|methotrexate|mesh-list
101302787|NCT02007928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101696027|NCT02779283|Vincristine|vincristine|mesh-list
101696028|NCT02779283|Sorafenib|sorafenib|mesh-list
101696029|NCT02779283|Sunitinib|sunitinib|mesh-list
101696030|NCT02779283|Dasatinib|dasatinib|mesh-list
101696031|NCT02779283|Idarubicin|idarubicin|mesh-list
101696032|NCT02779283|Ponatinib|ponatinib|mesh-list
101696033|NCT02779283|Idelalisib|idelalisib|mesh-list
101696034|NCT02779283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101696035|NCT02779283|Antibodies|antibodies|mesh-list
101696036|NCT02779283|Immunoglobulins|immunoglobulins|mesh-list
101696037|NCT02779283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101696038|NCT02779283|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101696039|NCT02779283|Prednisolone phosphate|prednisolone phosphate|mesh-list
101696040|NCT02779283|BB 1101|bb 1101|mesh-list
101696041|NCT02779283|Calcium|calcium|mesh-list
101696042|NCT02779283|Levoleucovorin|levoleucovorin|mesh-list
101696043|NCT02779283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101696044|NCT02779283|Immunologic Factors|immunologic factors|mesh-ancestor
101696045|NCT02779283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696046|NCT02779283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101696047|NCT02779283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101696048|NCT02779283|Alkylating Agents|alkylating agents|mesh-ancestor
101302830|NCT02008006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101696049|NCT02779283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696050|NCT02779283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101696051|NCT02779283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101696052|NCT02779283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101696053|NCT02779283|Antiemetics|antiemetics|mesh-ancestor
101302831|NCT02008019|Everolimus|everolimus|mesh-list
101696054|NCT02779283|Autonomic Agents|autonomic agents|mesh-ancestor
101696055|NCT02779283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101696056|NCT02779283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101696057|NCT02779283|Glucocorticoids|glucocorticoids|mesh-ancestor
101696058|NCT02779283|Hormones|hormones|mesh-ancestor
101696059|NCT02779283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101696060|NCT02779283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101696061|NCT02779283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101696062|NCT02779283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101696063|NCT02779283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101696064|NCT02779283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101696065|NCT02779283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101696066|NCT02779283|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101696067|NCT02779283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101696068|NCT02779283|Abortifacient Agents|abortifacient agents|mesh-ancestor
101696069|NCT02779283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101696070|NCT02779283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101696071|NCT02779283|Antimetabolites|antimetabolites|mesh-ancestor
101302881|NCT02008214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101302890|NCT02008214|Antioxidants|antioxidants|mesh-ancestor
101696072|NCT02779283|Dermatologic Agents|dermatologic agents|mesh-ancestor
101696073|NCT02779283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101696074|NCT02779283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101696075|NCT02779283|Antiviral Agents|antiviral agents|mesh-ancestor
101696076|NCT02779283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101696077|NCT02779283|Antidotes|antidotes|mesh-ancestor
101696078|NCT02779283|Protective Agents|protective agents|mesh-ancestor
101696079|NCT02779283|Vitamin B Complex|vitamin b complex|mesh-ancestor
101696080|NCT02779283|Vitamins|vitamins|mesh-ancestor
101696081|NCT02779283|Micronutrients|micronutrients|mesh-ancestor
101696082|NCT02779283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101696083|NCT02779283|Tubulin Modulators|tubulin modulators|mesh-ancestor
101696084|NCT02779283|Antimitotic Agents|antimitotic agents|mesh-ancestor
101696085|NCT02779283|Mitosis Modulators|mitosis modulators|mesh-ancestor
101696086|NCT02779283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101696087|NCT02779283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101696088|NCT02779283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101302935|NCT02008747|Anticonvulsants|anticonvulsants|mesh-ancestor
101302936|NCT02008747|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101696089|NCT02779283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101696090|NCT02779283|Growth Substances|growth substances|mesh-ancestor
101696091|NCT02779283|Growth Inhibitors|growth inhibitors|mesh-ancestor
101696092|NCT02779283|Hematinics|hematinics|mesh-ancestor
101696093|NCT02779283|Protease Inhibitors|protease inhibitors|mesh-ancestor
101696094|NCT02616003|Liraglutide|liraglutide|mesh-list
101696095|NCT02616003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101696096|NCT02616003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696097|NCT02616003|Incretins|incretins|mesh-ancestor
101696098|NCT02616003|Hormones|hormones|mesh-ancestor
101696099|NCT02616003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101696100|NCT02661152|Nimorazole|nimorazole|mesh-list
101696101|NCT02661152|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
101696102|NCT02661152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101302994|NCT02009007|Respiratory System Agents|respiratory system agents|mesh-ancestor
101696103|NCT02661152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101696104|NCT02661152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101696105|NCT00697671|Cyclophosphamide|cyclophosphamide|mesh-list
101696107|NCT00697671|Interleukin-2|interleukin-2|mesh-list
101696108|NCT00697671|Clofarabine|clofarabine|mesh-list
101696109|NCT00697671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101696110|NCT00697671|Immunologic Factors|immunologic factors|mesh-ancestor
101696111|NCT00697671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696112|NCT00697671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101696113|NCT00697671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101696114|NCT00697671|Alkylating Agents|alkylating agents|mesh-ancestor
101696115|NCT00697671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696116|NCT00697671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101696117|NCT00697671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101696118|NCT00697671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101696119|NCT00697671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101696120|NCT00697671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101696121|NCT00697671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101696122|NCT00697671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101696123|NCT00697671|Analgesics|analgesics|mesh-ancestor
101696124|NCT00697671|Sensory System Agents|sensory system agents|mesh-ancestor
101696125|NCT00697671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101696126|NCT00697671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101696127|NCT00697671|Antimetabolites|antimetabolites|mesh-ancestor
101696128|NCT03922945|Topiramate|topiramate|mesh-list
101696129|NCT03922945|Phentermine|phentermine|mesh-list
101696130|NCT03922945|Anticonvulsants|anticonvulsants|mesh-ancestor
101696131|NCT03922945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101303124|NCT05777369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101696132|NCT03922945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696133|NCT03922945|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101696134|NCT03922945|Appetite Depressants|appetite depressants|mesh-ancestor
101696135|NCT03922945|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101696136|NCT03922945|Sympathomimetics|sympathomimetics|mesh-ancestor
101303125|NCT05777278|Docetaxel|docetaxel|mesh-list
101696137|NCT03922945|Autonomic Agents|autonomic agents|mesh-ancestor
101696138|NCT03922945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101696139|NCT03922945|Adrenergic Agents|adrenergic agents|mesh-ancestor
101696140|NCT03922945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101696141|NCT03922945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696142|NCT04973345|Terbutaline|terbutaline|mesh-list
101696143|NCT04973345|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101696144|NCT04973345|Autonomic Agents|autonomic agents|mesh-ancestor
101696145|NCT04973345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101696146|NCT04973345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696147|NCT04973345|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101696148|NCT04973345|Respiratory System Agents|respiratory system agents|mesh-ancestor
101303172|NCT05548270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101303173|NCT05548270|Mydriatics|mydriatics|mesh-ancestor
101303174|NCT05548270|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101303175|NCT05548270|Cholinergic Agents|cholinergic agents|mesh-ancestor
101303176|NCT05548270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101303177|NCT05548270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303180|NCT05534620|Treosulfan|treosulfan|mesh-list
101696149|NCT04973345|Sympathomimetics|sympathomimetics|mesh-ancestor
101696150|NCT04973345|Tocolytic Agents|tocolytic agents|mesh-ancestor
101696151|NCT04973345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101696152|NCT04973345|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101696153|NCT04973345|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101696154|NCT04973345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101696155|NCT04973345|Adrenergic Agents|adrenergic agents|mesh-ancestor
101696156|NCT04973345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101696157|NCT04973345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696158|NCT05236985|Oxytocin|oxytocin|mesh-list
101696159|NCT05236985|Oxytocics|oxytocics|mesh-ancestor
101696160|NCT05236985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101696161|NCT05236985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696162|NCT03922477|Atezolizumab|atezolizumab|mesh-list
101353521|NCT00023426|Rifapentine|rifapentine|mesh-list
101696163|NCT03922477|Magrolimab|magrolimab|mesh-list
101696164|NCT03922477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101696165|NCT03922477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696166|NCT03922477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101696167|NCT03922477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101696168|NCT00978211|Octreotide|octreotide|mesh-list
101696169|NCT00978211|Somatostatin|somatostatin|mesh-list
101696170|NCT00978211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101696171|NCT00978211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101303295|NCT04983589|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101696172|NCT00978211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101696174|NCT00978211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101696175|NCT00978211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696176|NCT00867165|Ezetimibe|ezetimibe|mesh-list
101696177|NCT00867165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101696178|NCT00867165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101696179|NCT00867165|Antimetabolites|antimetabolites|mesh-ancestor
101696180|NCT00867165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696181|NCT00867165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101696182|NCT00981955|Caffeine|caffeine|mesh-list
101696183|NCT00981955|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101696184|NCT00981955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696185|NCT00981955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101696186|NCT00981955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101696187|NCT00981955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696188|NCT00981955|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101696189|NCT00981955|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101303357|NCT04567420|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101696190|NCT00981955|Purinergic Agents|purinergic agents|mesh-ancestor
101696191|NCT00981955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101696192|NCT00972829|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101696193|NCT00972829|Ezetimibe|ezetimibe|mesh-list
101696194|NCT00972829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101696195|NCT00972829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101696196|NCT00972829|Antimetabolites|antimetabolites|mesh-ancestor
101696197|NCT00972829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696198|NCT00972829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101696199|NCT00972829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101696200|NCT00972829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101696201|NCT05037617|Oxytocin|oxytocin|mesh-list
101696202|NCT05037617|Oxytocics|oxytocics|mesh-ancestor
101696203|NCT05037617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101696204|NCT05037617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696205|NCT00972907|Nifedipine|nifedipine|mesh-list
101696206|NCT00972907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101696207|NCT00972907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101696208|NCT00972907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696209|NCT00972907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101696210|NCT00972907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696211|NCT00972907|Vasodilator Agents|vasodilator agents|mesh-ancestor
101696212|NCT00972907|Tocolytic Agents|tocolytic agents|mesh-ancestor
101303414|NCT04278833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101696213|NCT00972907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101696214|NCT04008433|Lidocaine|lidocaine|mesh-list
101696215|NCT04008433|Anesthetics, Local|anesthetics, local|mesh-ancestor
101696216|NCT04008433|Anesthetics|anesthetics|mesh-ancestor
101696217|NCT04008433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101696218|NCT04008433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696219|NCT04008433|Sensory System Agents|sensory system agents|mesh-ancestor
101696220|NCT04008433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101696221|NCT04008433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101696222|NCT04008433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101696223|NCT04008433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101696224|NCT04008433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101696225|NCT04008433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696226|NCT04132479|Amoxicillin|amoxicillin|mesh-list
101696227|NCT04132479|Clarithromycin|clarithromycin|mesh-list
101696228|NCT04132479|Tinidazole|tinidazole|mesh-list
101696229|NCT04132479|Rabeprazole|rabeprazole|mesh-list
101696230|NCT04132479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101696231|NCT04132479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101696232|NCT04132479|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101696233|NCT04132479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101696234|NCT04132479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696235|NCT04132479|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101696236|NCT04132479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101696237|NCT04132479|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101696238|NCT04132479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101696239|NCT04132479|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101696240|NCT04132479|Alkylating Agents|alkylating agents|mesh-ancestor
101696241|NCT04132479|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
101696242|NCT04132479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101696243|NCT04132479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101696244|NCT00972985|Lorazepam|lorazepam|mesh-list
101303526|NCT03994731|Protective Agents|protective agents|mesh-ancestor
101696245|NCT00972985|Methylphenidate|methylphenidate|mesh-list
101696247|NCT00972985|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101696248|NCT00972985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696249|NCT00972985|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101696250|NCT00972985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101696251|NCT00972985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101696252|NCT00972985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696253|NCT00972985|Dopamine Agents|dopamine agents|mesh-ancestor
101696254|NCT00972985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101696255|NCT00972985|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101696256|NCT00972985|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101696257|NCT00972985|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101696258|NCT00972985|Anticonvulsants|anticonvulsants|mesh-ancestor
101696259|NCT00972985|Antiemetics|antiemetics|mesh-ancestor
101696260|NCT00972985|Autonomic Agents|autonomic agents|mesh-ancestor
101696261|NCT00972985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101696262|NCT00972985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101696263|NCT00972985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101696264|NCT00972985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101696265|NCT00972985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101696266|NCT00972985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101303594|NCT03556202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101696267|NCT00972985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101696268|NCT00972985|GABA Modulators|gaba modulators|mesh-ancestor
101696269|NCT00972985|GABA Agents|gaba agents|mesh-ancestor
101696271|NCT00867087|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
101696272|NCT00867087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101696273|NCT00867087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101696274|NCT00867087|Immunologic Factors|immunologic factors|mesh-ancestor
101696275|NCT00867087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696276|NCT00867087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101696277|NCT00867087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101696278|NCT00867087|Immunotoxins|immunotoxins|mesh-ancestor
101696279|NCT00867087|Immunoconjugates|immunoconjugates|mesh-ancestor
101696280|NCT02778425|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101696281|NCT02778425|Somatostatin|somatostatin|mesh-list
101696282|NCT02778425|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101696283|NCT02778425|Adrenergic Agents|adrenergic agents|mesh-ancestor
101696284|NCT02778425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101696285|NCT02778425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696286|NCT02778425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696288|NCT02778425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101696289|NCT04228757|Phytoestrogens|phytoestrogens|mesh-list
101696290|NCT04228757|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101696291|NCT04228757|Estrogens|estrogens|mesh-ancestor
101696292|NCT04228757|Hormones|hormones|mesh-ancestor
101696293|NCT04228757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101303716|NCT02649998|Furosemide|furosemide|mesh-list
101303717|NCT02649998|Isosorbide|isosorbide|mesh-list
101303718|NCT02649998|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
101303720|NCT02649998|Diuretics|diuretics|mesh-ancestor
101696294|NCT04228757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696295|NCT04227431|Insulin|insulin|mesh-list
101696296|NCT04227431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101696297|NCT04227431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696298|NCT04227041|Capecitabine|capecitabine|mesh-list
101696299|NCT04227041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101696301|NCT04227041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696302|NCT04227041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101696303|NCT04226963|Ketamine|ketamine|mesh-list
101696304|NCT04226963|Analgesics|analgesics|mesh-ancestor
101696305|NCT04226963|Sensory System Agents|sensory system agents|mesh-ancestor
101696306|NCT04226963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101696308|NCT04226963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101696309|NCT04226963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101696310|NCT04226963|Anesthetics, General|anesthetics, general|mesh-ancestor
101696311|NCT04226963|Anesthetics|anesthetics|mesh-ancestor
101303768|NCT02336087|Antimetabolites|antimetabolites|mesh-ancestor
101696312|NCT04226963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101353674|NCT00023933|Antibodies|antibodies|mesh-list
101696313|NCT04226963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101696314|NCT04226963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101696315|NCT04226963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101696316|NCT04226963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696318|NCT00545233|Ribavirin|ribavirin|mesh-list
101696319|NCT00545233|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101696320|NCT00545233|Antimetabolites|antimetabolites|mesh-ancestor
101696321|NCT00545233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696322|NCT00545233|Antiviral Agents|antiviral agents|mesh-ancestor
101303834|NCT01332097|Prednisone|prednisone|mesh-list
101696323|NCT00545233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101696324|NCT00545233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101696325|NCT00545233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696326|NCT02393248|Gemcitabine|gemcitabine|mesh-list
101696327|NCT02393248|Docetaxel|docetaxel|mesh-list
101696328|NCT02393248|Pembrolizumab|pembrolizumab|mesh-list
101696329|NCT02393248|Trastuzumab|trastuzumab|mesh-list
101696330|NCT02393248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101696331|NCT02393248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101696332|NCT02393248|Antimetabolites|antimetabolites|mesh-ancestor
101696333|NCT02393248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696334|NCT02393248|Tubulin Modulators|tubulin modulators|mesh-ancestor
101696335|NCT02393248|Antimitotic Agents|antimitotic agents|mesh-ancestor
101696336|NCT02393248|Mitosis Modulators|mitosis modulators|mesh-ancestor
101696337|NCT02393248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101303900|NCT00538031|Analgesics|analgesics|mesh-ancestor
101696338|NCT02393248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101696339|NCT00601484|Tanezumab|tanezumab|mesh-list
101696340|NCT00601484|Analgesics|analgesics|mesh-ancestor
101696341|NCT00601484|Sensory System Agents|sensory system agents|mesh-ancestor
101696342|NCT00601484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101696343|NCT00601484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696344|NCT04228601|Fluzoparib|fluzoparib|mesh-list
101696345|NCT04228601|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101696346|NCT04228601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101696347|NCT04228601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696348|NCT04228601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101696349|NCT00978601|Analgesics|analgesics|mesh-list
101696350|NCT00978601|Sensory System Agents|sensory system agents|mesh-ancestor
101696351|NCT00978601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101696352|NCT00978601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696353|NCT00883896|Fezakinumab|fezakinumab|mesh-list
101696354|NCT00883896|Dermatologic Agents|dermatologic agents|mesh-ancestor
101696355|NCT02778191|Carboplatin|carboplatin|mesh-list
101696356|NCT02778191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101696357|NCT05170685|Nivolumab|nivolumab|mesh-list
101696358|NCT05170685|Relatlimab|relatlimab|mesh-list
101696359|NCT05170685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101696360|NCT05170685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101696361|NCT05170685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101696362|NCT05170685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696363|NCT02778893|Thalidomide|thalidomide|mesh-list
101696364|NCT02778893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101696365|NCT02778893|Immunologic Factors|immunologic factors|mesh-ancestor
101696366|NCT02778893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696367|NCT02778893|Leprostatic Agents|leprostatic agents|mesh-ancestor
101696368|NCT02778893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101696369|NCT02778893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101696370|NCT02778893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101696371|NCT02778893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101696372|NCT02778893|Growth Substances|growth substances|mesh-ancestor
101696373|NCT02778893|Growth Inhibitors|growth inhibitors|mesh-ancestor
101696374|NCT02778893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101696386|NCT00867009|Cetuximab|cetuximab|mesh-list
101353744|NCT00051831|Enfuvirtide|enfuvirtide|mesh-list
101696387|NCT00867009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101696388|NCT00867009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101696389|NCT00867009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696390|NCT00867009|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101696391|NCT00867009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101696392|NCT00867009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101696393|NCT00666042|Moxifloxacin|moxifloxacin|mesh-list
101696394|NCT00666042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101696395|NCT00666042|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101696396|NCT00666042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101696397|NCT00666042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101696398|NCT00666042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101696399|NCT00666042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101696400|NCT00666042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101696401|NCT00666042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101696402|NCT00666042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696403|NCT00666042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101696404|NCT00666042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101696405|NCT00666042|Contraceptive Agents|contraceptive agents|mesh-ancestor
101696406|NCT00666042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101696407|NCT00666042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696408|NCT00666042|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101696409|NCT00666042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101696410|NCT00666042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101696411|NCT02660840|Flupenthixol|flupenthixol|mesh-list
101696412|NCT02660840|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
101696413|NCT02660840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101696414|NCT02660840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101696415|NCT02660840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101696416|NCT02660840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696417|NCT02660840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101696418|NCT02660840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101696419|NCT02660840|Dopamine Agents|dopamine agents|mesh-ancestor
101696420|NCT02660840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101696421|NCT02660840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696422|NCT02777801|Entecavir|entecavir|mesh-list
101696423|NCT02777801|Antiviral Agents|antiviral agents|mesh-ancestor
101696424|NCT02777801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101696425|NCT00649064|Ziprasidone|ziprasidone|mesh-list
101696426|NCT00649064|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101696427|NCT00649064|Serotonin Agents|serotonin agents|mesh-ancestor
101696428|NCT00649064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101696429|NCT00649064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696430|NCT00649064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696431|NCT00649064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101696432|NCT00649064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101696433|NCT00649064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101696434|NCT00649064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101696435|NCT00649064|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101696436|NCT00649064|Dopamine Agents|dopamine agents|mesh-ancestor
101696437|NCT04132713|Capecitabine|capecitabine|mesh-list
101696438|NCT04132713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101696440|NCT04132713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696441|NCT04132713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101696442|NCT04007341|Dexmedetomidine|dexmedetomidine|mesh-list
101696443|NCT04007341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101304127|NCT02011347|Sensory System Agents|sensory system agents|mesh-ancestor
101304128|NCT02011347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101304129|NCT02011347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696444|NCT04007341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101696445|NCT04007341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696446|NCT04007341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101696447|NCT04007341|Analgesics|analgesics|mesh-ancestor
101696448|NCT04007341|Sensory System Agents|sensory system agents|mesh-ancestor
101696449|NCT04007341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101696450|NCT04007341|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101696451|NCT04007341|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101696452|NCT04007341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101696453|NCT04007341|Adrenergic Agents|adrenergic agents|mesh-ancestor
101696454|NCT04007341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101696455|NCT04007341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696456|NCT02656082|Etanercept|etanercept|mesh-list
101696457|NCT02656082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101696458|NCT02656082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101696459|NCT02656082|Analgesics|analgesics|mesh-ancestor
101696460|NCT02656082|Sensory System Agents|sensory system agents|mesh-ancestor
101696461|NCT02656082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101696462|NCT02656082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696463|NCT02656082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101696464|NCT02656082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101304161|NCT02011633|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101696465|NCT02656082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101696466|NCT02656082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101696467|NCT02656082|Immunologic Factors|immunologic factors|mesh-ancestor
101696468|NCT04132635|Mitogens|mitogens|mesh-list
101696469|NCT04132635|Mitosis Modulators|mitosis modulators|mesh-ancestor
101696470|NCT04132635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696471|NCT02623504|Carbamazepine|carbamazepine|mesh-list
101696472|NCT02623504|Anticonvulsants|anticonvulsants|mesh-ancestor
101696473|NCT02623504|Antimanic Agents|antimanic agents|mesh-ancestor
101696474|NCT02623504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101696475|NCT02623504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101696476|NCT02623504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696478|NCT02623504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101696479|NCT02623504|Analgesics|analgesics|mesh-ancestor
101696480|NCT02623504|Sensory System Agents|sensory system agents|mesh-ancestor
101696481|NCT02623504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101696482|NCT02623504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101696483|NCT02623504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101696484|NCT02623504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696485|NCT02623504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101696486|NCT02623504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101696487|NCT02777723|Hyaluronic Acid|hyaluronic acid|mesh-list
101696488|NCT02777723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101696489|NCT02777723|Immunologic Factors|immunologic factors|mesh-ancestor
101696490|NCT02777723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696491|NCT02777723|Viscosupplements|viscosupplements|mesh-ancestor
101696492|NCT02777723|Protective Agents|protective agents|mesh-ancestor
101535651|NCT00195663|Adalimumab|adalimumab|mesh-list
101696493|NCT00601250|Linagliptin|linagliptin|mesh-list
101696494|NCT00601250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101696495|NCT00601250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696496|NCT00601250|Incretins|incretins|mesh-ancestor
101696497|NCT00601250|Hormones|hormones|mesh-ancestor
101696498|NCT00601250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101696499|NCT00601250|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101696500|NCT00601250|Protease Inhibitors|protease inhibitors|mesh-ancestor
101696501|NCT00601250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101696502|NCT00601250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696503|NCT04226885|Fentanyl|fentanyl|mesh-list
101696504|NCT04226885|Midazolam|midazolam|mesh-list
101696505|NCT04226885|Dexmedetomidine|dexmedetomidine|mesh-list
101696506|NCT04226885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101696507|NCT04226885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101696508|NCT04226885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696509|NCT04226885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101696510|NCT04226885|Analgesics|analgesics|mesh-ancestor
101696511|NCT04226885|Sensory System Agents|sensory system agents|mesh-ancestor
101696512|NCT04226885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101696513|NCT04226885|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101696514|NCT04226885|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101696515|NCT04226885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101696516|NCT04226885|Adrenergic Agents|adrenergic agents|mesh-ancestor
101696517|NCT04226885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101696518|NCT04226885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696519|NCT04226885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101696520|NCT04226885|Narcotics|narcotics|mesh-ancestor
101696521|NCT04226885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101696523|NCT04226885|Anesthetics, General|anesthetics, general|mesh-ancestor
101696524|NCT04226885|Anesthetics|anesthetics|mesh-ancestor
101696525|NCT04226885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101696526|NCT04226885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101696527|NCT04226885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101696528|NCT04226885|GABA Modulators|gaba modulators|mesh-ancestor
101696529|NCT04226885|GABA Agents|gaba agents|mesh-ancestor
101696530|NCT00866775|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
101696531|NCT00866775|Anticonvulsants|anticonvulsants|mesh-ancestor
101696532|NCT00866775|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101696533|NCT00866775|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101696534|NCT00866775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101696535|NCT00866775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696537|NCT02777411|Immunologic Factors|immunologic factors|mesh-ancestor
101696538|NCT02777411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696539|NCT02777489|Perindopril|perindopril|mesh-list
101696540|NCT02777489|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101696541|NCT02777489|Protease Inhibitors|protease inhibitors|mesh-ancestor
101696542|NCT02777489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101696543|NCT02777489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696544|NCT02777489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101696545|NCT02660762|Cytarabine|cytarabine|mesh-list
101696546|NCT02660762|Dexamethasone|dexamethasone|mesh-list
101696547|NCT02660762|Dexamethasone acetate|dexamethasone acetate|mesh-list
101696548|NCT02660762|Prednisone|prednisone|mesh-list
101696549|NCT02660762|Cyclophosphamide|cyclophosphamide|mesh-list
101696550|NCT02660762|Methotrexate|methotrexate|mesh-list
101696551|NCT02660762|Etoposide|etoposide|mesh-list
101696552|NCT02660762|Vincristine|vincristine|mesh-list
101696553|NCT02660762|Daunorubicin|daunorubicin|mesh-list
101696554|NCT02660762|Mercaptopurine|mercaptopurine|mesh-list
101696555|NCT02660762|Pegaspargase|pegaspargase|mesh-list
101304235|NCT02012036|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101696556|NCT02660762|Thioguanine|thioguanine|mesh-list
101696557|NCT02660762|BB 1101|bb 1101|mesh-list
101696558|NCT02660762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101696559|NCT02660762|Immunologic Factors|immunologic factors|mesh-ancestor
101696560|NCT02660762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696561|NCT02660762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101696562|NCT02660762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101696563|NCT02660762|Alkylating Agents|alkylating agents|mesh-ancestor
101696564|NCT02660762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696565|NCT02660762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101696566|NCT02660762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101696567|NCT02660762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101696568|NCT02660762|Antiemetics|antiemetics|mesh-ancestor
101696569|NCT02660762|Autonomic Agents|autonomic agents|mesh-ancestor
101696570|NCT02660762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101696571|NCT02660762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101696572|NCT02660762|Glucocorticoids|glucocorticoids|mesh-ancestor
101696573|NCT02660762|Hormones|hormones|mesh-ancestor
101696574|NCT02660762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101696575|NCT02660762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101696576|NCT02660762|Protease Inhibitors|protease inhibitors|mesh-ancestor
101696577|NCT02660762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101696578|NCT02660762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101696579|NCT02660762|Abortifacient Agents|abortifacient agents|mesh-ancestor
101696580|NCT02660762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101696581|NCT02660762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101696582|NCT02660762|Antimetabolites|antimetabolites|mesh-ancestor
101696583|NCT02660762|Dermatologic Agents|dermatologic agents|mesh-ancestor
101696584|NCT02660762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101696585|NCT02660762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101696586|NCT02660762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101696587|NCT02660762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101696588|NCT02660762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101696589|NCT02660762|Antiviral Agents|antiviral agents|mesh-ancestor
101696590|NCT02660762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101696591|NCT02660762|Tubulin Modulators|tubulin modulators|mesh-ancestor
101696592|NCT02660762|Antimitotic Agents|antimitotic agents|mesh-ancestor
101696593|NCT02660762|Mitosis Modulators|mitosis modulators|mesh-ancestor
101696594|NCT02660762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101696595|NCT02660684|Cyclosporine|cyclosporine|mesh-list
101696596|NCT02660684|Methotrexate|methotrexate|mesh-list
101696597|NCT02660684|Tacrolimus|tacrolimus|mesh-list
101696598|NCT02660684|Cyclosporins|cyclosporins|mesh-list
101696599|NCT02660684|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101696601|NCT02660684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101696602|NCT02660684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696603|NCT02660684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101696604|NCT02660684|Antimetabolites|antimetabolites|mesh-ancestor
101696605|NCT02660684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696606|NCT02660684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101696607|NCT02660684|Dermatologic Agents|dermatologic agents|mesh-ancestor
101504667|NCT02953275|Pentoxifylline|pentoxifylline|mesh-list
101696608|NCT02660684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101696609|NCT02660684|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101696610|NCT02660684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101696611|NCT02660684|Immunologic Factors|immunologic factors|mesh-ancestor
101696612|NCT02660684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101696613|NCT02660684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101696614|NCT02660684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101696615|NCT02660684|Antifungal Agents|antifungal agents|mesh-ancestor
101696616|NCT02660684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101696618|NCT00982891|Hydromorphone|hydromorphone|mesh-list
101696619|NCT00982891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101696620|NCT00982891|Narcotics|narcotics|mesh-ancestor
101696621|NCT00982891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101696622|NCT00982891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696623|NCT00982891|Analgesics|analgesics|mesh-ancestor
101696624|NCT00982891|Sensory System Agents|sensory system agents|mesh-ancestor
101696625|NCT00982891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101696626|NCT02615223|Bicalutamide|bicalutamide|mesh-list
101696627|NCT02615223|Hormones|hormones|mesh-list
101696628|NCT02615223|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101696629|NCT02615223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101696630|NCT02615223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696631|NCT02615223|Androgen Antagonists|androgen antagonists|mesh-ancestor
101696632|NCT02615223|Hormone Antagonists|hormone antagonists|mesh-ancestor
101696633|NCT02615223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101504730|NCT00501566|Natriuretic Agents|natriuretic agents|mesh-ancestor
101696634|NCT04132557|Methylphenidate|methylphenidate|mesh-list
101696635|NCT04132557|Amphetamine|amphetamine|mesh-list
101696636|NCT04132557|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101696637|NCT04132557|Dextroamphetamine|dextroamphetamine|mesh-list
101696638|NCT04132557|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101696639|NCT04132557|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101696640|NCT04132557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696641|NCT04132557|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101696642|NCT04132557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101696643|NCT04132557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101696644|NCT04132557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696645|NCT04132557|Dopamine Agents|dopamine agents|mesh-ancestor
101696646|NCT04132557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101696647|NCT04132557|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101696648|NCT04132557|Adrenergic Agents|adrenergic agents|mesh-ancestor
101696649|NCT04132557|Sympathomimetics|sympathomimetics|mesh-ancestor
101696650|NCT04132557|Autonomic Agents|autonomic agents|mesh-ancestor
101696651|NCT04132557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101696652|NCT00978913|Cyclophosphamide|cyclophosphamide|mesh-list
101696653|NCT00978913|Vaccines|vaccines|mesh-list
101696654|NCT00978913|Immunologic Factors|immunologic factors|mesh-ancestor
101696655|NCT00978913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696656|NCT00978913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101696657|NCT00978913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101696658|NCT00978913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101696659|NCT00978913|Alkylating Agents|alkylating agents|mesh-ancestor
101504776|NCT01248611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696660|NCT00978913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696661|NCT00978913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101696662|NCT00978913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101696663|NCT04227509|Pembrolizumab|pembrolizumab|mesh-list
101696664|NCT04227509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101696665|NCT04227509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101696666|NCT04227509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101696667|NCT04227509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696668|NCT02778659|Zolpidem|zolpidem|mesh-list
101696669|NCT02778659|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101696670|NCT02778659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101696671|NCT02778659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101696672|NCT02778659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696674|NCT02778659|GABA Agonists|gaba agonists|mesh-ancestor
101696675|NCT02778659|GABA Agents|gaba agents|mesh-ancestor
101696676|NCT02778659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101696677|NCT02778659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696678|NCT04072900|Imiquimod|imiquimod|mesh-list
101696679|NCT04072900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101696680|NCT04072900|Immunologic Factors|immunologic factors|mesh-ancestor
101696681|NCT04072900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696682|NCT04072900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101696683|NCT04072900|Interferon Inducers|interferon inducers|mesh-ancestor
101696684|NCT00984763|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101696685|NCT00984763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101354052|NCT00052923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101696686|NCT00984763|Immunologic Factors|immunologic factors|mesh-ancestor
101696687|NCT00984763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696688|NCT00984763|Antacids|antacids|mesh-ancestor
101696689|NCT00984763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696690|NCT00984763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101696691|NCT02578108|Lidocaine|lidocaine|mesh-list
101696692|NCT02578108|Anesthetics, Local|anesthetics, local|mesh-list
101696693|NCT02578108|Anesthetics|anesthetics|mesh-list
101696694|NCT02578108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101696695|NCT02578108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696696|NCT02578108|Sensory System Agents|sensory system agents|mesh-ancestor
101696697|NCT02578108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101504825|NCT00501878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101696698|NCT02578108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101696699|NCT02578108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101696700|NCT02578108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101696701|NCT02578108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101696702|NCT02578108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696703|NCT02776163|Docetaxel|docetaxel|mesh-list
101696704|NCT02776163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101696705|NCT02776163|Tubulin Modulators|tubulin modulators|mesh-ancestor
101696706|NCT02776163|Antimitotic Agents|antimitotic agents|mesh-ancestor
101696707|NCT02776163|Mitosis Modulators|mitosis modulators|mesh-ancestor
101696708|NCT02776163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696709|NCT05325346|Argatroban|argatroban|mesh-list
101696710|NCT05325346|Antithrombins|antithrombins|mesh-ancestor
101696711|NCT05325346|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101696712|NCT05325346|Protease Inhibitors|protease inhibitors|mesh-ancestor
101696713|NCT05325346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101696714|NCT05325346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696715|NCT05325346|Anticoagulants|anticoagulants|mesh-ancestor
101696716|NCT05325346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101696717|NCT00984997|Etoposide|etoposide|mesh-list
101696718|NCT00984997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101696719|NCT00984997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101696720|NCT00984997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101696721|NCT00984997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101696723|NCT00984997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696724|NCT00973219|Interferons|interferons|mesh-list
101696725|NCT00973219|Tenofovir|tenofovir|mesh-list
101504862|NCT00502034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101696727|NCT00973219|Interferon alpha-2|interferon alpha-2|mesh-list
101696728|NCT00973219|Adefovir|adefovir|mesh-list
101696729|NCT00973219|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101696730|NCT00973219|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101696731|NCT00973219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101696732|NCT00973219|Antiviral Agents|antiviral agents|mesh-ancestor
101696733|NCT00973219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101696734|NCT00973219|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101696735|NCT00973219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101696736|NCT00973219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101696737|NCT00973219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696738|NCT00973219|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101696739|NCT00973219|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101696740|NCT00973219|Immunologic Factors|immunologic factors|mesh-ancestor
101696741|NCT00973219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696742|NCT04194125|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
101696743|NCT04194125|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101696744|NCT04194125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696745|NCT04973891|Metformin|metformin|mesh-list
101696746|NCT04973891|Canagliflozin|canagliflozin|mesh-list
101696747|NCT04973891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101696748|NCT04973891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696749|NCT04973891|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101696750|NCT04973891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696751|NCT00983047|Docetaxel|docetaxel|mesh-list
101696752|NCT00983047|Nimotuzumab|nimotuzumab|mesh-list
101696753|NCT00983047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101696754|NCT00983047|Tubulin Modulators|tubulin modulators|mesh-ancestor
101696755|NCT00983047|Antimitotic Agents|antimitotic agents|mesh-ancestor
101504909|NCT01248923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101504910|NCT01248923|Glucocorticoids|glucocorticoids|mesh-ancestor
101696756|NCT00983047|Mitosis Modulators|mitosis modulators|mesh-ancestor
101696757|NCT00983047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696758|NCT00983047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101696759|NCT00983125|Clonidine|clonidine|mesh-list
101696760|NCT00983125|Analgesics|analgesics|mesh-ancestor
101696761|NCT00983125|Sensory System Agents|sensory system agents|mesh-ancestor
101696762|NCT00983125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101696763|NCT00983125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696764|NCT00983125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101696765|NCT00983125|Sympatholytics|sympatholytics|mesh-ancestor
101696766|NCT00983125|Autonomic Agents|autonomic agents|mesh-ancestor
101696767|NCT00983125|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101696768|NCT00983125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101696769|NCT00983125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101696770|NCT00983125|Adrenergic Agents|adrenergic agents|mesh-ancestor
101696771|NCT00983125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101696772|NCT00983125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696773|NCT00988039|Raltegravir Potassium|raltegravir potassium|mesh-list
101696774|NCT00988039|Lopinavir|lopinavir|mesh-list
101696775|NCT00988039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101696776|NCT00988039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101696777|NCT00988039|Antiviral Agents|antiviral agents|mesh-ancestor
101696778|NCT00988039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101696779|NCT00988039|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101696780|NCT00988039|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101696781|NCT00988039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101696782|NCT00988039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696783|NCT00988039|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101696784|NCT00988039|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101696785|NCT00988039|Protease Inhibitors|protease inhibitors|mesh-ancestor
101696786|NCT00988039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101696787|NCT00988039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101696788|NCT04855513|Metformin|metformin|mesh-list
101696789|NCT04855513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101696790|NCT04855513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696791|NCT02775773|Tranexamic Acid|tranexamic acid|mesh-list
101696792|NCT02775773|Oxytocin|oxytocin|mesh-list
101696793|NCT02775773|Oxytocics|oxytocics|mesh-ancestor
101696794|NCT02775773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101696795|NCT02775773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696796|NCT02775773|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101696797|NCT02775773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101696798|NCT02775773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696799|NCT02775773|Hemostatics|hemostatics|mesh-ancestor
101696800|NCT02775773|Coagulants|coagulants|mesh-ancestor
101696801|NCT00983203|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101696802|NCT00983203|Lubricant Eye Drops|lubricant eye drops|mesh-list
101696803|NCT00983203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101696804|NCT00988195|Doxorubicin|doxorubicin|mesh-list
101696805|NCT00988195|BCT-100|bct-100|mesh-list
101696806|NCT00988195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101696807|NCT00988195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101696808|NCT00988195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101696809|NCT00988195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101696810|NCT00988195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101696811|NCT00988195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696812|NCT00634985|Eletriptan|eletriptan|mesh-list
101696813|NCT00634985|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101696814|NCT00634985|Serotonin Agents|serotonin agents|mesh-ancestor
101696815|NCT00634985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101696816|NCT00634985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696817|NCT00634985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505012|NCT03459417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101696818|NCT00985387|Solifenacin Succinate|solifenacin succinate|mesh-list
101696819|NCT00985387|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101696820|NCT00985387|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101696822|NCT00985387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101696823|NCT00985387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696824|NCT00985387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696825|NCT00985387|Urological Agents|urological agents|mesh-ancestor
101696827|NCT02776943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101696828|NCT02776943|Immunologic Factors|immunologic factors|mesh-ancestor
101696829|NCT02776943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696830|NCT02776943|Viscosupplements|viscosupplements|mesh-ancestor
101696831|NCT02776943|Protective Agents|protective agents|mesh-ancestor
101696832|NCT04005781|Hydroxychloroquine|hydroxychloroquine|mesh-list
101505042|NCT01249430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101188768|NCT00003120|Paclitaxel|paclitaxel|mesh-list
101696833|NCT04005781|Antimalarials|antimalarials|mesh-ancestor
101696834|NCT04005781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101696835|NCT04005781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101354202|NCT00053196|Tacrolimus|tacrolimus|mesh-list
101696836|NCT04005781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101696837|NCT04005781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101696838|NCT04005781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696839|NCT04005781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101696840|NCT04654351|Icatibant|icatibant|mesh-list
101696841|NCT04654351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101696842|NCT04654351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101696843|NCT04654351|Analgesics|analgesics|mesh-ancestor
101696844|NCT04654351|Sensory System Agents|sensory system agents|mesh-ancestor
101696845|NCT04654351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101505106|NCT00511212|Antibodies|antibodies|mesh-list
101696846|NCT04654351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696847|NCT04654351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101696848|NCT04654351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101696849|NCT04654351|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
101696850|NCT04654351|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
101410279|NCT00354094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101696851|NCT04654351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696852|NCT04654351|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101696853|NCT04654351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101696854|NCT04654351|Immunologic Factors|immunologic factors|mesh-ancestor
101696855|NCT00582556|Zoledronic Acid|zoledronic acid|mesh-list
101696857|NCT00582556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101696858|NCT00582556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696859|NCT00582556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101696860|NCT00582556|Fertility Agents|fertility agents|mesh-ancestor
101505164|NCT00511446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101696861|NCT00582556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101696862|NCT00582556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101696864|NCT02776397|Vitamin E|vitamin e|mesh-list
101696865|NCT02776397|Tocopherols|tocopherols|mesh-list
101696866|NCT02776397|alpha-Tocopherol|alpha-tocopherol|mesh-list
101696867|NCT02776397|Vitamins|vitamins|mesh-ancestor
101696868|NCT02776397|Micronutrients|micronutrients|mesh-ancestor
101696869|NCT02776397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696870|NCT02776397|Antioxidants|antioxidants|mesh-ancestor
101696871|NCT02776397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696872|NCT02776397|Protective Agents|protective agents|mesh-ancestor
101696873|NCT00985777|Vitamin E|vitamin e|mesh-list
101696874|NCT00985777|Tocopherols|tocopherols|mesh-list
101696875|NCT00985777|Tocotrienols|tocotrienols|mesh-list
101696876|NCT00985777|Vitamins|vitamins|mesh-ancestor
101696877|NCT00985777|Micronutrients|micronutrients|mesh-ancestor
101505224|NCT00504413|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101696878|NCT00985777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696879|NCT00985777|Antioxidants|antioxidants|mesh-ancestor
101696880|NCT00985777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696881|NCT00985777|Protective Agents|protective agents|mesh-ancestor
101696882|NCT01563601|Carboplatin|carboplatin|mesh-list
101696883|NCT01563601|Etoposide|etoposide|mesh-list
101696884|NCT01563601|Etoposide phosphate|etoposide phosphate|mesh-list
101696885|NCT01563601|Obatoclax|obatoclax|mesh-list
101696886|NCT01563601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101505285|NCT00512265|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101505286|NCT00512265|Antiviral Agents|antiviral agents|mesh-ancestor
101696887|NCT01563601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101696888|NCT01563601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101696889|NCT01563601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101696890|NCT01563601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101696891|NCT01563601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696892|NCT00988507|Artesunate|artesunate|mesh-list
101696893|NCT00988507|Ferroquine|ferroquine|mesh-list
101696894|NCT00988507|Antimalarials|antimalarials|mesh-ancestor
101696895|NCT00988507|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101696896|NCT00988507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101696897|NCT00988507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101696898|NCT00988507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101696899|NCT00988507|Antiviral Agents|antiviral agents|mesh-ancestor
101696900|NCT00988507|Schistosomicides|schistosomicides|mesh-ancestor
101696901|NCT00988507|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101696902|NCT00988507|Anthelmintics|anthelmintics|mesh-ancestor
101696904|NCT00985855|Cetuximab|cetuximab|mesh-list
101696905|NCT00985855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101696906|NCT00985855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101696907|NCT00985855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101696908|NCT00985855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101696909|NCT00985855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101696910|NCT00985855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696911|NCT00985855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101354280|NCT00053430|Leprostatic Agents|leprostatic agents|mesh-ancestor
101696912|NCT04226105|Insulin|insulin|mesh-list
101696913|NCT04226105|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101696914|NCT04226105|Insulin Aspart|insulin aspart|mesh-list
101696915|NCT04226105|Insulin, Long-Acting|insulin, long-acting|mesh-list
101696916|NCT04226105|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101696917|NCT04226105|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101696918|NCT04226105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101696919|NCT04226105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696920|NCT02776865|Lidocaine|lidocaine|mesh-list
101696921|NCT02776865|Anesthetics, Local|anesthetics, local|mesh-ancestor
101696922|NCT02776865|Anesthetics|anesthetics|mesh-ancestor
101696923|NCT02776865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101696924|NCT02776865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696925|NCT02776865|Sensory System Agents|sensory system agents|mesh-ancestor
101696926|NCT02776865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101696927|NCT02776865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101696928|NCT02776865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101696929|NCT02776865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101696930|NCT02776865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101696931|NCT02776865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696932|NCT02772653|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101696933|NCT02772653|Natriuretic Agents|natriuretic agents|mesh-ancestor
101696934|NCT02772653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696935|NCT00542269|Amlodipine|amlodipine|mesh-list
101696936|NCT00542269|Ramipril|ramipril|mesh-list
101696937|NCT00542269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101696938|NCT00542269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101505413|NCT01248884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505414|NCT00512850|Folic Acid|folic acid|mesh-list
101505415|NCT00512850|Hematinics|hematinics|mesh-ancestor
101505416|NCT00512850|Vitamin B Complex|vitamin b complex|mesh-ancestor
101696939|NCT00542269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101696940|NCT00542269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696941|NCT00542269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101696942|NCT00542269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696943|NCT00542269|Vasodilator Agents|vasodilator agents|mesh-ancestor
101696944|NCT00542269|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101696945|NCT00542269|Protease Inhibitors|protease inhibitors|mesh-ancestor
101696946|NCT00542269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101696947|NCT02579434|Midazolam|midazolam|mesh-list
101696948|NCT02579434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101696949|NCT02579434|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101696950|NCT02579434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101696951|NCT02579434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696952|NCT02579434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101696953|NCT02579434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101696954|NCT02579434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101696955|NCT02579434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101696956|NCT02579434|Anesthetics, General|anesthetics, general|mesh-ancestor
101696957|NCT02579434|Anesthetics|anesthetics|mesh-ancestor
101696958|NCT02579434|GABA Modulators|gaba modulators|mesh-ancestor
101696959|NCT02579434|GABA Agents|gaba agents|mesh-ancestor
101696960|NCT02579434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101696961|NCT02579434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696962|NCT00542191|Paclitaxel|paclitaxel|mesh-list
101696963|NCT00542191|Cyclophosphamide|cyclophosphamide|mesh-list
101696964|NCT00542191|Carboplatin|carboplatin|mesh-list
101696965|NCT00542191|Doxorubicin|doxorubicin|mesh-list
101696966|NCT00542191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101696967|NCT00542191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101696968|NCT00542191|Tubulin Modulators|tubulin modulators|mesh-ancestor
101696969|NCT00542191|Antimitotic Agents|antimitotic agents|mesh-ancestor
101696970|NCT00542191|Mitosis Modulators|mitosis modulators|mesh-ancestor
101696971|NCT00542191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696972|NCT00542191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101696973|NCT00542191|Immunologic Factors|immunologic factors|mesh-ancestor
101696974|NCT00542191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696975|NCT00542191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101696976|NCT00542191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101696977|NCT00542191|Alkylating Agents|alkylating agents|mesh-ancestor
101696978|NCT00542191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101696979|NCT00542191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101696980|NCT00542191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101696981|NCT00542191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101696982|NCT00542191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101696984|NCT00600938|Deferoxamine|deferoxamine|mesh-list
101696985|NCT00600938|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101696986|NCT00600938|Chelating Agents|chelating agents|mesh-ancestor
101696987|NCT00600938|Sequestering Agents|sequestering agents|mesh-ancestor
101696988|NCT00600938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101696989|NCT00600938|Siderophores|siderophores|mesh-ancestor
101696990|NCT03061474|Niacinamide|niacinamide|mesh-list
101696991|NCT03061474|Niacin|niacin|mesh-list
101696992|NCT03061474|Nicotinic Acids|nicotinic acids|mesh-list
101696993|NCT03061474|Vitamin B Complex|vitamin b complex|mesh-ancestor
101696994|NCT03061474|Vitamins|vitamins|mesh-ancestor
101696995|NCT03061474|Micronutrients|micronutrients|mesh-ancestor
101696996|NCT03061474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101696997|NCT03061474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101696998|NCT03061474|Antimetabolites|antimetabolites|mesh-ancestor
101696999|NCT03061474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697000|NCT03061474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101697001|NCT03061474|Vasodilator Agents|vasodilator agents|mesh-ancestor
101697002|NCT00988663|Memantine|memantine|mesh-list
101697003|NCT00988663|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101697004|NCT00988663|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101697005|NCT00988663|Dopamine Agents|dopamine agents|mesh-ancestor
101697006|NCT00988663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101697007|NCT00988663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505505|NCT02951637|Pemetrexed|pemetrexed|mesh-list
101697008|NCT00988663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697009|NCT00988663|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101697010|NCT00988663|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101697011|NCT04072198|Leucovorin|leucovorin|mesh-list
101697012|NCT04072198|Bevacizumab|bevacizumab|mesh-list
101697013|NCT04072198|Nivolumab|nivolumab|mesh-list
101697014|NCT04072198|Oxaliplatin|oxaliplatin|mesh-list
101697015|NCT04072198|Irinotecan|irinotecan|mesh-list
101697016|NCT04072198|Fluorouracil|fluorouracil|mesh-list
101697017|NCT04072198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101697018|NCT04072198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101697019|NCT04072198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101697020|NCT04072198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101697021|NCT04072198|Growth Substances|growth substances|mesh-ancestor
101697022|NCT04072198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697023|NCT04072198|Growth Inhibitors|growth inhibitors|mesh-ancestor
101697024|NCT04072198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101697025|NCT04072198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697026|NCT04072198|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101697027|NCT04072198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101697028|NCT04072198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101697029|NCT04072198|Antidotes|antidotes|mesh-ancestor
101697030|NCT04072198|Protective Agents|protective agents|mesh-ancestor
101697031|NCT04072198|Vitamin B Complex|vitamin b complex|mesh-ancestor
101697032|NCT04072198|Vitamins|vitamins|mesh-ancestor
101697033|NCT04072198|Micronutrients|micronutrients|mesh-ancestor
101697034|NCT04072198|Antimetabolites|antimetabolites|mesh-ancestor
101697035|NCT04072198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101697036|NCT04072198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101697037|NCT04072198|Immunologic Factors|immunologic factors|mesh-ancestor
101697038|NCT02772419|Benralizumab|benralizumab|mesh-list
101697039|NCT02772419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101697040|NCT02772419|Respiratory System Agents|respiratory system agents|mesh-ancestor
101697041|NCT00543439|Factor VIII|factor viii|mesh-list
101697042|NCT00543439|Coagulants|coagulants|mesh-ancestor
101697043|NCT02772497|Aflibercept|aflibercept|mesh-list
101505532|NCT01244984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101505533|NCT01244984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697044|NCT02772497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101697045|NCT02772497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101697046|NCT02772497|Growth Substances|growth substances|mesh-ancestor
101697047|NCT02772497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697048|NCT02772497|Growth Inhibitors|growth inhibitors|mesh-ancestor
101697049|NCT02772497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101697050|NCT00582166|Rituximab|rituximab|mesh-list
101697051|NCT00582166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101697052|NCT00582166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101697053|NCT00582166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101697054|NCT00582166|Immunologic Factors|immunologic factors|mesh-ancestor
101697055|NCT00582166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697056|NCT00582166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101697057|NCT02775539|Mirabegron|mirabegron|mesh-list
101697058|NCT02775539|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101697059|NCT02775539|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101697060|NCT02775539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101697061|NCT02775539|Adrenergic Agents|adrenergic agents|mesh-ancestor
101697062|NCT02775539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101505572|NCT00514293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101697063|NCT02775539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697064|NCT02775539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697065|NCT02775539|Urological Agents|urological agents|mesh-ancestor
101697066|NCT04840459|Bamlanivimab|bamlanivimab|mesh-list
101697067|NCT04840459|Antiviral Agents|antiviral agents|mesh-ancestor
101697068|NCT04840459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101697069|NCT04666961|Tamoxifen|tamoxifen|mesh-list
101697070|NCT04666961|Anastrozole|anastrozole|mesh-list
101697071|NCT04666961|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101697072|NCT04666961|Hormone Antagonists|hormone antagonists|mesh-ancestor
101697073|NCT04666961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101697074|NCT04666961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697075|NCT04666961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101697076|NCT04666961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101697077|NCT04666961|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101697078|NCT04666961|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101697079|NCT04666961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101697080|NCT04666961|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101697081|NCT04666961|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101697082|NCT04666961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101697083|NCT04666961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697084|NCT04006639|Analgesics|analgesics|mesh-list
101505627|NCT01241786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101697085|NCT04006639|Sensory System Agents|sensory system agents|mesh-ancestor
101697086|NCT04006639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101697087|NCT04006639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697088|NCT00601172|Dexamethasone|dexamethasone|mesh-list
101697089|NCT00601172|Ondansetron|ondansetron|mesh-list
101697090|NCT00601172|Casopitant|casopitant|mesh-list
101697091|NCT00601172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101697092|NCT00601172|Antiemetics|antiemetics|mesh-ancestor
101697093|NCT00601172|Autonomic Agents|autonomic agents|mesh-ancestor
101697094|NCT00601172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101697095|NCT00601172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697096|NCT00601172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101697097|NCT00601172|Glucocorticoids|glucocorticoids|mesh-ancestor
101697098|NCT00601172|Hormones|hormones|mesh-ancestor
101697099|NCT00601172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101697100|NCT00601172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101697101|NCT00601172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101697102|NCT00601172|Antipruritics|antipruritics|mesh-ancestor
101697103|NCT00601172|Dermatologic Agents|dermatologic agents|mesh-ancestor
101697104|NCT00601172|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101505680|NCT00516009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697105|NCT00601172|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101697106|NCT00601172|Serotonin Agents|serotonin agents|mesh-ancestor
101697107|NCT00601172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101697108|NCT00601172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697109|NCT00601172|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101697110|NCT02772107|Temozolomide|temozolomide|mesh-list
101697111|NCT02772107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101697112|NCT02772107|Alkylating Agents|alkylating agents|mesh-ancestor
101697113|NCT02772107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697114|NCT02772107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101697115|NCT00986167|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101697116|NCT00986167|Antidepressive Agents|antidepressive agents|mesh-ancestor
101697117|NCT00986167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101697118|NCT00986167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101697119|NCT00986167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101697120|NCT00986167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101697121|NCT00986167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697122|NCT00988897|Leucovorin|leucovorin|mesh-list
101697123|NCT00988897|Bevacizumab|bevacizumab|mesh-list
101697124|NCT00988897|Fluorouracil|fluorouracil|mesh-list
101505736|NCT00504192|Gemcitabine|gemcitabine|mesh-list
101505737|NCT00504192|Oxaliplatin|oxaliplatin|mesh-list
101505739|NCT00504192|Antimetabolites|antimetabolites|mesh-ancestor
101697125|NCT00988897|Oxaliplatin|oxaliplatin|mesh-list
101697126|NCT00988897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101697127|NCT00988897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101697128|NCT00988897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101697129|NCT00988897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101697130|NCT00988897|Growth Substances|growth substances|mesh-ancestor
101697131|NCT00988897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697132|NCT00988897|Growth Inhibitors|growth inhibitors|mesh-ancestor
101697133|NCT00988897|Antimetabolites|antimetabolites|mesh-ancestor
101697134|NCT00988897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697135|NCT00988897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101697136|NCT00988897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101354509|NCT00026273|Immunologic Factors|immunologic factors|mesh-ancestor
101697138|NCT00988897|Antidotes|antidotes|mesh-ancestor
101697139|NCT00988897|Protective Agents|protective agents|mesh-ancestor
101697140|NCT00988897|Vitamin B Complex|vitamin b complex|mesh-ancestor
101697142|NCT00988897|Micronutrients|micronutrients|mesh-ancestor
101697143|NCT02775227|Hydrocortisone|hydrocortisone|mesh-list
101697144|NCT02775227|Pasireotide|pasireotide|mesh-list
101697145|NCT02775227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101697146|NCT02775227|Hormones|hormones|mesh-ancestor
101697147|NCT02775227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101697148|NCT02775227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697149|NCT02875132|Pembrolizumab|pembrolizumab|mesh-list
101505789|NCT01249521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101505790|NCT01249521|Growth Substances|growth substances|mesh-ancestor
101697150|NCT02875132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101697151|NCT02875132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101697152|NCT02875132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101697153|NCT02875132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697154|NCT00984217|Panitumumab|panitumumab|mesh-list
101697155|NCT00984217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101697156|NCT00984217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101697157|NCT00989053|Escitalopram|escitalopram|mesh-list
101697158|NCT00989053|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101697159|NCT00989053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101697160|NCT00989053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101697161|NCT00989053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697162|NCT00989053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101697163|NCT00989053|Serotonin Agents|serotonin agents|mesh-ancestor
101697164|NCT00989053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697165|NCT04614493|Temozolomide|temozolomide|mesh-list
101697166|NCT04614493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101697167|NCT04614493|Alkylating Agents|alkylating agents|mesh-ancestor
101697168|NCT04614493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697169|NCT04614493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101505837|NCT01244256|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101697170|NCT02841748|Pembrolizumab|pembrolizumab|mesh-list
101697171|NCT02841748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101697172|NCT02841748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101697173|NCT02841748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101697174|NCT02841748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697175|NCT04033094|Morphine|morphine|mesh-list
101697176|NCT04033094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101697177|NCT04033094|Narcotics|narcotics|mesh-ancestor
101697178|NCT04033094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101697179|NCT04033094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697180|NCT04033094|Analgesics|analgesics|mesh-ancestor
101505886|NCT00506051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101697181|NCT04033094|Sensory System Agents|sensory system agents|mesh-ancestor
101697182|NCT04033094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101505887|NCT00506051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101505889|NCT00506051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101697183|NCT04073758|Dexmedetomidine|dexmedetomidine|mesh-list
101697184|NCT04073758|Remifentanil|remifentanil|mesh-list
101697185|NCT04073758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101697186|NCT04073758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101697187|NCT04073758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697188|NCT04073758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101697189|NCT04073758|Analgesics|analgesics|mesh-ancestor
101697190|NCT04073758|Sensory System Agents|sensory system agents|mesh-ancestor
101697191|NCT04073758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101697192|NCT04073758|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101697193|NCT04073758|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101697194|NCT04073758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101697195|NCT04073758|Adrenergic Agents|adrenergic agents|mesh-ancestor
101697196|NCT04073758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101697197|NCT04073758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697198|NCT04073758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101697199|NCT04073758|Narcotics|narcotics|mesh-ancestor
101697200|NCT02660606|Analgesics, Opioid|analgesics, opioid|mesh-list
101697201|NCT02660606|Narcotics|narcotics|mesh-ancestor
101697202|NCT02660606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101697203|NCT02660606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697204|NCT02660606|Analgesics|analgesics|mesh-ancestor
101697205|NCT02660606|Sensory System Agents|sensory system agents|mesh-ancestor
101697206|NCT02660606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101697207|NCT00582010|Nitric Oxide|nitric oxide|mesh-list
101697208|NCT00582010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101697209|NCT00582010|Autonomic Agents|autonomic agents|mesh-ancestor
101354590|NCT00054522|Vitamins|vitamins|mesh-ancestor
101697210|NCT00582010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101697211|NCT00582010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697212|NCT00582010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101697213|NCT00582010|Respiratory System Agents|respiratory system agents|mesh-ancestor
101697214|NCT00582010|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101697215|NCT00582010|Antioxidants|antioxidants|mesh-ancestor
101697216|NCT00582010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697217|NCT00582010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101505991|NCT02275299|Methotrexate|methotrexate|mesh-list
101697218|NCT00582010|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101697219|NCT00582010|Vasodilator Agents|vasodilator agents|mesh-ancestor
101697220|NCT00582010|Gasotransmitters|gasotransmitters|mesh-ancestor
101697221|NCT00582010|Protective Agents|protective agents|mesh-ancestor
101697222|NCT00989209|Botulinum Toxins|botulinum toxins|mesh-list
101697223|NCT00989209|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101697224|NCT00989209|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101697225|NCT00989209|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101697226|NCT00989209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101697227|NCT00989209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697228|NCT00989209|Cholinergic Agents|cholinergic agents|mesh-ancestor
101697229|NCT00989209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101697230|NCT00989209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697231|NCT00989209|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101697232|NCT00989209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101697234|NCT00649922|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101697235|NCT00649922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101697236|NCT00649922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101697237|NCT00986557|Ganciclovir|ganciclovir|mesh-list
101697238|NCT00986557|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101697239|NCT00986557|Foscarnet|foscarnet|mesh-list
101697240|NCT00986557|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
101697241|NCT00986557|Alemtuzumab|alemtuzumab|mesh-list
101506121|NCT00516750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101697242|NCT00986557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101697244|NCT00986557|Antiviral Agents|antiviral agents|mesh-ancestor
101697245|NCT00986557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101697246|NCT00986557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101697247|NCT00986557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101697248|NCT00986557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697249|NCT00986557|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101697250|NCT00910754|Prednisone|prednisone|mesh-list
101697251|NCT00910754|Abiraterone Acetate|abiraterone acetate|mesh-list
101697252|NCT00910754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101697253|NCT00910754|Glucocorticoids|glucocorticoids|mesh-ancestor
101697254|NCT00910754|Hormones|hormones|mesh-ancestor
101506184|NCT04510337|Anticonvulsants|anticonvulsants|mesh-ancestor
101506185|NCT04510337|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101697255|NCT00910754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101697256|NCT00910754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697257|NCT00910754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101697258|NCT00910754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101697259|NCT00910754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101697260|NCT00910754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101697261|NCT00910754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697262|NCT00910754|Hormone Antagonists|hormone antagonists|mesh-ancestor
101697263|NCT00910754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101697264|NCT00649376|Fexofenadine|fexofenadine|mesh-list
101697265|NCT00649376|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101697266|NCT00649376|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101697267|NCT00649376|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101697268|NCT00649376|Histamine Antagonists|histamine antagonists|mesh-ancestor
101697269|NCT00649376|Histamine Agents|histamine agents|mesh-ancestor
101697270|NCT00649376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101697271|NCT00649376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697272|NCT00649376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697273|NCT02340676|Interleukin-2|interleukin-2|mesh-list
101697274|NCT02340676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101697275|NCT02340676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101697276|NCT02340676|Analgesics|analgesics|mesh-ancestor
101697277|NCT02340676|Sensory System Agents|sensory system agents|mesh-ancestor
101697278|NCT02340676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101697279|NCT02340676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697281|NCT00649454|Glipizide|glipizide|mesh-list
101697282|NCT00649454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101506378|NCT01240629|Doxorubicin|doxorubicin|mesh-list
101697283|NCT00649454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697284|NCT03920215|Varenicline|varenicline|mesh-list
101697285|NCT03920215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101697286|NCT03920215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101697287|NCT03920215|Cholinergic Agents|cholinergic agents|mesh-ancestor
101697288|NCT03920215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101697289|NCT03920215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697290|NCT03920215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697291|NCT02655770|Liraglutide|liraglutide|mesh-list
101697292|NCT02655770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101697293|NCT02655770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697294|NCT02655770|Incretins|incretins|mesh-ancestor
101697295|NCT02655770|Hormones|hormones|mesh-ancestor
101697296|NCT02655770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101697297|NCT00986713|Amphotericin B|amphotericin b|mesh-list
101697298|NCT00986713|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101697299|NCT00986713|Amebicides|amebicides|mesh-ancestor
101506523|NCT02955251|Nivolumab|nivolumab|mesh-list
101697300|NCT00986713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101697301|NCT00986713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101697302|NCT00986713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101697303|NCT00986713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101697304|NCT00986713|Antifungal Agents|antifungal agents|mesh-ancestor
101697305|NCT02651870|Amlodipine|amlodipine|mesh-list
101697306|NCT02651870|Candesartan|candesartan|mesh-list
101697307|NCT02651870|Candesartan cilexetil|candesartan cilexetil|mesh-list
101697308|NCT02651870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101697309|NCT02651870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101697310|NCT02651870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101697311|NCT02651870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697312|NCT02651870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101697313|NCT02651870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697314|NCT02651870|Vasodilator Agents|vasodilator agents|mesh-ancestor
101506580|NCT00520338|Sensory System Agents|sensory system agents|mesh-ancestor
101697315|NCT02651870|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101506581|NCT00520338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101506589|NCT02594072|Goserelin|goserelin|mesh-list
101697316|NCT02651870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101697317|NCT02766803|Resveratrol|resveratrol|mesh-list
101697318|NCT02766803|Simvastatin|simvastatin|mesh-list
101697319|NCT02766803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101697320|NCT02766803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101697321|NCT02766803|Antimetabolites|antimetabolites|mesh-ancestor
101697322|NCT02766803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697323|NCT02766803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101697324|NCT02766803|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101697325|NCT02766803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101697326|NCT02766803|Antioxidants|antioxidants|mesh-ancestor
101506633|NCT00520455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101261385|NCT01749475|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101697328|NCT02766803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697329|NCT02766803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101697331|NCT00650468|Prednisone|prednisone|mesh-list
101697332|NCT00650468|Tacrolimus|tacrolimus|mesh-list
101697333|NCT00650468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101697334|NCT00650468|Glucocorticoids|glucocorticoids|mesh-ancestor
101697335|NCT00650468|Hormones|hormones|mesh-ancestor
101697336|NCT00650468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101697337|NCT00650468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697338|NCT00650468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101697339|NCT00650468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101697340|NCT00650468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101697341|NCT00650468|Immunologic Factors|immunologic factors|mesh-ancestor
101697342|NCT00650468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101697343|NCT00650468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101697344|NCT00650468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697345|NCT00650468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101697346|NCT00650468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101697347|NCT00650468|Antitubercular Agents|antitubercular agents|mesh-ancestor
101697348|NCT00650468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101697349|NCT00650468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101697350|NCT02576080|Imatinib Mesylate|imatinib mesylate|mesh-list
101697351|NCT02576080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101697352|NCT02576080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101697353|NCT02576080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101697354|NCT02576080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697355|NCT04006483|Fluorides|fluorides|mesh-list
101697356|NCT04006483|Tin Fluorides|tin fluorides|mesh-list
101697357|NCT04006483|Cariostatic Agents|cariostatic agents|mesh-ancestor
101697358|NCT04006483|Protective Agents|protective agents|mesh-ancestor
101697359|NCT04006483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697360|NCT02651792|Meperidine|meperidine|mesh-list
101697361|NCT02651792|Ketamine|ketamine|mesh-list
101697362|NCT02651792|Propofol|propofol|mesh-list
101697363|NCT02651792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101697364|NCT02651792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101697365|NCT02651792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697366|NCT02651792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101697367|NCT02651792|Anesthetics, General|anesthetics, general|mesh-ancestor
101697368|NCT02651792|Anesthetics|anesthetics|mesh-ancestor
101697369|NCT02651792|Analgesics|analgesics|mesh-ancestor
101697370|NCT02651792|Sensory System Agents|sensory system agents|mesh-ancestor
101697371|NCT02651792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101697372|NCT02651792|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101697373|NCT02651792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101697374|NCT02651792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101697375|NCT02651792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101697376|NCT02651792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697377|NCT02651792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101506746|NCT00505739|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101697378|NCT02651792|Narcotics|narcotics|mesh-ancestor
101697379|NCT02651792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101354818|NCT00027677|Halofuginone|halofuginone|mesh-list
101697381|NCT04754815|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101697382|NCT04754815|Pembrolizumab|pembrolizumab|mesh-list
101697383|NCT04754815|Pemetrexed|pemetrexed|mesh-list
101697384|NCT04754815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101697385|NCT04754815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101697386|NCT04754815|Tubulin Modulators|tubulin modulators|mesh-ancestor
101697387|NCT04754815|Antimitotic Agents|antimitotic agents|mesh-ancestor
101697388|NCT04754815|Mitosis Modulators|mitosis modulators|mesh-ancestor
101697389|NCT04754815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697390|NCT04754815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101697391|NCT04754815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101697392|NCT04754815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101697393|NCT04754815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101697394|NCT04754815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101697395|NCT00649532|Ondansetron|ondansetron|mesh-list
101697396|NCT00649532|Antiemetics|antiemetics|mesh-ancestor
101697397|NCT00649532|Autonomic Agents|autonomic agents|mesh-ancestor
101697398|NCT00649532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101697399|NCT00649532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697400|NCT00649532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101697401|NCT00649532|Antipruritics|antipruritics|mesh-ancestor
101697402|NCT00649532|Dermatologic Agents|dermatologic agents|mesh-ancestor
101697403|NCT00649532|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101697405|NCT00649532|Serotonin Agents|serotonin agents|mesh-ancestor
101506789|NCT04513379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101506790|NCT04513379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101697406|NCT00649532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101506795|NCT00521157|Naltrexone|naltrexone|mesh-list
101697407|NCT00649532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697409|NCT02655614|Caffeine|caffeine|mesh-list
101697410|NCT02655614|Rabeprazole|rabeprazole|mesh-list
101697411|NCT02655614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101697412|NCT02655614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101697413|NCT02655614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101697414|NCT02655614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697415|NCT02655614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101697416|NCT02655614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101697417|NCT02655614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101697418|NCT02655614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101697419|NCT02655614|Anesthetics, General|anesthetics, general|mesh-ancestor
101697420|NCT02655614|Anesthetics|anesthetics|mesh-ancestor
101697421|NCT02655614|GABA Modulators|gaba modulators|mesh-ancestor
101697422|NCT02655614|GABA Agents|gaba agents|mesh-ancestor
101697423|NCT02655614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101697424|NCT02655614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697425|NCT02655614|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101697426|NCT02655614|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101697427|NCT02655614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101697428|NCT02655614|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101697429|NCT02655614|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101697431|NCT02655614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101697432|NCT02655614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101697433|NCT02655614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101697434|NCT02772029|Apatinib|apatinib|mesh-list
101697435|NCT02772029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101697436|NCT02772029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101697437|NCT02772029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101697438|NCT02772029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697439|NCT02766725|Sildenafil Citrate|sildenafil citrate|mesh-list
101506891|NCT00505700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101697440|NCT02766725|Vasodilator Agents|vasodilator agents|mesh-ancestor
101697441|NCT02766725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101697442|NCT02766725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101697443|NCT02766725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101697444|NCT02766725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697445|NCT02766725|Urological Agents|urological agents|mesh-ancestor
101697446|NCT02658422|Montelukast|montelukast|mesh-list
101697447|NCT02658422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101697448|NCT02658422|Respiratory System Agents|respiratory system agents|mesh-ancestor
101697449|NCT02658422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101697450|NCT02658422|Hormone Antagonists|hormone antagonists|mesh-ancestor
101697451|NCT02658422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101697452|NCT02658422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697453|NCT02658422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101697454|NCT02658422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101697455|NCT02658422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697456|NCT02771795|Trastuzumab|trastuzumab|mesh-list
101697457|NCT02771795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101697458|NCT02771795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101697459|NCT02655536|Bevacizumab|bevacizumab|mesh-list
101697460|NCT02655536|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101697461|NCT02655536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101697462|NCT02655536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101697463|NCT02655536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101697464|NCT02655536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101697465|NCT02655536|Growth Substances|growth substances|mesh-ancestor
101697466|NCT02655536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697467|NCT02655536|Growth Inhibitors|growth inhibitors|mesh-ancestor
101697468|NCT02655536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101697469|NCT02655536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101697470|NCT02655536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697471|NCT02766647|Lenograstim|lenograstim|mesh-list
101697472|NCT02766647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101697474|NCT02766647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697475|NCT02651636|Folic Acid|folic acid|mesh-list
101506956|NCT00521703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697476|NCT02651636|Thioctic Acid|thioctic acid|mesh-list
101697477|NCT02651636|Inositol|inositol|mesh-list
101697478|NCT02651636|Hematinics|hematinics|mesh-ancestor
101697479|NCT02651636|Vitamin B Complex|vitamin b complex|mesh-ancestor
101697480|NCT02651636|Vitamins|vitamins|mesh-ancestor
101697481|NCT02651636|Micronutrients|micronutrients|mesh-ancestor
101697482|NCT02651636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697483|NCT02651636|Antioxidants|antioxidants|mesh-ancestor
101697484|NCT02651636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697485|NCT02651636|Protective Agents|protective agents|mesh-ancestor
101697486|NCT02774993|Doxycycline|doxycycline|mesh-list
101697487|NCT02774993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101697488|NCT02774993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101697489|NCT02774993|Antimalarials|antimalarials|mesh-ancestor
101697490|NCT02774993|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101697491|NCT02774993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101697492|NCT02774837|Tenofovir|tenofovir|mesh-list
101697493|NCT02774837|Telbivudine|telbivudine|mesh-list
101697494|NCT02774837|Antiviral Agents|antiviral agents|mesh-ancestor
101697495|NCT02774837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101697496|NCT02774837|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101697497|NCT02774837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101697498|NCT02774837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101697499|NCT02774837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697500|NCT02774837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101697501|NCT02774837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101697502|NCT02658188|Gabapentin|gabapentin|mesh-list
101697503|NCT02658188|Analgesics|analgesics|mesh-ancestor
101697504|NCT02658188|Sensory System Agents|sensory system agents|mesh-ancestor
101697505|NCT02658188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101697506|NCT02658188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697507|NCT02658188|Anticonvulsants|anticonvulsants|mesh-ancestor
101697508|NCT02658188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101697509|NCT02658188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101697510|NCT02658188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101697511|NCT02658188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101697512|NCT02658188|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101697513|NCT02658188|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101697514|NCT02658188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101697515|NCT02658188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697516|NCT02658188|Antimanic Agents|antimanic agents|mesh-ancestor
101697517|NCT02771717|Budesonide|budesonide|mesh-list
101506994|NCT00521859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101697518|NCT02771717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101697519|NCT02771717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101697520|NCT02771717|Autonomic Agents|autonomic agents|mesh-ancestor
101697521|NCT02771717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101697522|NCT02771717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697523|NCT02771717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101697524|NCT02771717|Respiratory System Agents|respiratory system agents|mesh-ancestor
101697525|NCT02771717|Glucocorticoids|glucocorticoids|mesh-ancestor
101697526|NCT02771717|Hormones|hormones|mesh-ancestor
101697527|NCT02771717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101354960|NCT04730973|Antimetabolites|antimetabolites|mesh-ancestor
101697528|NCT02655380|Ketamine|ketamine|mesh-list
101697529|NCT02655380|Remifentanil|remifentanil|mesh-list
101697530|NCT02655380|Analgesics|analgesics|mesh-ancestor
101697531|NCT02655380|Sensory System Agents|sensory system agents|mesh-ancestor
101697532|NCT02655380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101697533|NCT02655380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697534|NCT02655380|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101697535|NCT02655380|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101697536|NCT02655380|Anesthetics, General|anesthetics, general|mesh-ancestor
101697537|NCT02655380|Anesthetics|anesthetics|mesh-ancestor
101697538|NCT02655380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101697539|NCT02655380|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101697540|NCT02655380|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101697541|NCT02655380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101507029|NCT00523458|Antiviral Agents|antiviral agents|mesh-ancestor
101697542|NCT02655380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697543|NCT02655380|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101697544|NCT02655380|Narcotics|narcotics|mesh-ancestor
101697545|NCT00580840|Certolizumab Pegol|certolizumab pegol|mesh-list
101697546|NCT00580840|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101697547|NCT00580840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101697548|NCT00580840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101507078|NCT00522249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101697549|NCT00580840|Immunologic Factors|immunologic factors|mesh-ancestor
101697550|NCT00580840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697551|NCT00580840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101697553|NCT00987103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101697554|NCT00987103|Immunologic Factors|immunologic factors|mesh-ancestor
101697555|NCT00987103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697556|NCT00987103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101697557|NCT00987103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101697558|NCT00987103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697559|NCT02655458|Lenalidomide|lenalidomide|mesh-list
101697560|NCT02655458|Elotuzumab|elotuzumab|mesh-list
101697561|NCT02655458|Immunologic Factors|immunologic factors|mesh-ancestor
101697562|NCT02655458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697563|NCT02655458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101697564|NCT02655458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101697565|NCT02655458|Growth Substances|growth substances|mesh-ancestor
101697566|NCT02655458|Growth Inhibitors|growth inhibitors|mesh-ancestor
101697567|NCT02655458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101697568|NCT04006093|Apixaban|apixaban|mesh-list
101697569|NCT04006093|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101697570|NCT04006093|Antithrombins|antithrombins|mesh-ancestor
101697571|NCT04006093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101697572|NCT04006093|Protease Inhibitors|protease inhibitors|mesh-ancestor
101697573|NCT04006093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101697574|NCT04006093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697575|NCT04006093|Anticoagulants|anticoagulants|mesh-ancestor
101697576|NCT02766257|Anesthetics|anesthetics|mesh-list
101697577|NCT02766257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101697578|NCT02766257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697579|NCT04005469|Treprostinil|treprostinil|mesh-list
101697580|NCT04005469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101697581|NCT02651324|Ketamine|ketamine|mesh-list
101697582|NCT02651324|Analgesics|analgesics|mesh-ancestor
101697583|NCT02651324|Sensory System Agents|sensory system agents|mesh-ancestor
101697584|NCT02651324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101697585|NCT02651324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697586|NCT02651324|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101697587|NCT02651324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101697588|NCT02651324|Anesthetics, General|anesthetics, general|mesh-ancestor
101697589|NCT02651324|Anesthetics|anesthetics|mesh-ancestor
101697590|NCT02651324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101697591|NCT02651324|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101697592|NCT02651324|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101507143|NCT05148689|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101697593|NCT02651324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101697594|NCT02651324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697595|NCT00662220|Ribavirin|ribavirin|mesh-list
101697596|NCT00662220|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101697597|NCT00662220|Interferon-alpha|interferon-alpha|mesh-list
101697598|NCT00662220|Antimetabolites|antimetabolites|mesh-ancestor
101697599|NCT00662220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697600|NCT00662220|Antiviral Agents|antiviral agents|mesh-ancestor
101697601|NCT00662220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101697602|NCT00662220|Immunologic Factors|immunologic factors|mesh-ancestor
101697603|NCT00662220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697604|NCT02575924|Imidacloprid|imidacloprid|mesh-list
101697605|NCT02575924|Cholinergic Agents|cholinergic agents|mesh-ancestor
101697606|NCT02575924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101697607|NCT02575924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697608|NCT02575924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697609|NCT02651168|Aflibercept|aflibercept|mesh-list
101697610|NCT02651168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101697611|NCT02651168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101697612|NCT02651168|Growth Substances|growth substances|mesh-ancestor
101697613|NCT02651168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697614|NCT02651168|Growth Inhibitors|growth inhibitors|mesh-ancestor
101697615|NCT02651168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101697616|NCT04073602|Trastuzumab|trastuzumab|mesh-list
101697617|NCT04073602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101697618|NCT04073602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101697619|NCT00650000|Modafinil|modafinil|mesh-list
101507177|NCT00523887|Sensory System Agents|sensory system agents|mesh-ancestor
101507178|NCT00523887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101507182|NCT00523887|Anesthetics|anesthetics|mesh-ancestor
101697620|NCT00650000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101697621|NCT00650000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697622|NCT00650000|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101697623|NCT00650000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101697624|NCT00650000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101697625|NCT00650000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697627|NCT02630862|Dipyridamole|dipyridamole|mesh-list
101697628|NCT02630862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101697629|NCT02630862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101697630|NCT02630862|Analgesics|analgesics|mesh-ancestor
101697631|NCT02630862|Sensory System Agents|sensory system agents|mesh-ancestor
101697632|NCT02630862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101697633|NCT02630862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697634|NCT02630862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101697635|NCT02630862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101697636|NCT02630862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101697637|NCT02630862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101697638|NCT02630862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697639|NCT02630862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101697640|NCT02630862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101697641|NCT02630862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101697642|NCT02630862|Antipyretics|antipyretics|mesh-ancestor
101697643|NCT02630862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101507296|NCT00524433|Tezosentan|tezosentan|mesh-list
101697644|NCT02630862|Vasodilator Agents|vasodilator agents|mesh-ancestor
101697645|NCT02536430|Ketorolac|ketorolac|mesh-list
101697646|NCT02536430|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101697647|NCT02536430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101697648|NCT02536430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101697649|NCT02536430|Analgesics|analgesics|mesh-ancestor
101697650|NCT02536430|Sensory System Agents|sensory system agents|mesh-ancestor
101697651|NCT02536430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101697652|NCT02536430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697653|NCT02536430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101697654|NCT02536430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101697655|NCT02536430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101697656|NCT02536430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101697657|NCT02536430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697658|NCT02631174|Antithrombins|antithrombins|mesh-list
101697659|NCT02631174|Antithrombin III|antithrombin iii|mesh-list
101697660|NCT02631174|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101697661|NCT02631174|Protease Inhibitors|protease inhibitors|mesh-ancestor
101697662|NCT02631174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101697663|NCT02631174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697664|NCT02631174|Anticoagulants|anticoagulants|mesh-ancestor
101697665|NCT04686929|Abatacept|abatacept|mesh-list
101697666|NCT04686929|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101697667|NCT04686929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697668|NCT04686929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101697669|NCT04686929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101507352|NCT00507143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507353|NCT00507143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101697670|NCT04686929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101697671|NCT04686929|Immunologic Factors|immunologic factors|mesh-ancestor
101697672|NCT04686929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697673|NCT04686929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101697674|NCT02765633|Cangrelor|cangrelor|mesh-list
101697675|NCT02765633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101697676|NCT02765633|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101697677|NCT02765633|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101697678|NCT02765633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101507398|NCT00507221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101697680|NCT02765633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101697681|NCT02765633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697682|NCT02765633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697683|NCT00581776|Dexamethasone|dexamethasone|mesh-list
101697684|NCT00581776|Cyclophosphamide|cyclophosphamide|mesh-list
101697686|NCT00581776|Doxorubicin|doxorubicin|mesh-list
101697687|NCT00581776|Vincristine|vincristine|mesh-list
101697688|NCT00581776|Bortezomib|bortezomib|mesh-list
101697689|NCT00581776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101697690|NCT00581776|Immunologic Factors|immunologic factors|mesh-ancestor
101697691|NCT00581776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697692|NCT00581776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101697693|NCT00581776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101697694|NCT00581776|Alkylating Agents|alkylating agents|mesh-ancestor
101697695|NCT00581776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697696|NCT00581776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101697697|NCT00581776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101697698|NCT00581776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101697699|NCT00581776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101697700|NCT00581776|Antiemetics|antiemetics|mesh-ancestor
101507525|NCT02947113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697701|NCT00581776|Autonomic Agents|autonomic agents|mesh-ancestor
101697702|NCT00581776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101697703|NCT00581776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101697704|NCT00581776|Glucocorticoids|glucocorticoids|mesh-ancestor
101697706|NCT00581776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101507593|NCT05147753|Moxonidine|moxonidine|mesh-list
101697707|NCT00581776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101697708|NCT00581776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101697709|NCT00581776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101697710|NCT00581776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101697711|NCT00581776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101697712|NCT00581776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101697713|NCT00581776|Tubulin Modulators|tubulin modulators|mesh-ancestor
101697714|NCT00581776|Antimitotic Agents|antimitotic agents|mesh-ancestor
101697715|NCT00581776|Mitosis Modulators|mitosis modulators|mesh-ancestor
101697716|NCT00662454|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101697717|NCT00662454|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101697719|NCT00662454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101697720|NCT00662454|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
101697721|NCT00662454|Estradiol|estradiol|mesh-list
101697722|NCT00662454|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101697723|NCT00662454|Estrogens|estrogens|mesh-ancestor
101697724|NCT00662454|Hormones|hormones|mesh-ancestor
101507660|NCT00525642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101697725|NCT00662454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101697726|NCT00662454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697727|NCT00662454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101697728|NCT00662454|Contraceptive Agents|contraceptive agents|mesh-ancestor
101697729|NCT00662454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101697730|NCT00662454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101697731|NCT00662454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101697732|NCT00662454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101697733|NCT00662454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101697734|NCT00662454|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101697735|NCT04156152|Listerine|listerine|mesh-list
101697737|NCT04156152|Sodium Fluoride|sodium fluoride|mesh-list
101697738|NCT04156152|Cariostatic Agents|cariostatic agents|mesh-ancestor
101697739|NCT04156152|Protective Agents|protective agents|mesh-ancestor
101697740|NCT04156152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697741|NCT04156152|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101697742|NCT04156152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101697743|NCT00662610|Naproxen|naproxen|mesh-list
101697744|NCT00662610|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
101697745|NCT00662610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101697746|NCT00662610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101697747|NCT00662610|Analgesics|analgesics|mesh-ancestor
101697748|NCT00662610|Sensory System Agents|sensory system agents|mesh-ancestor
101697749|NCT00662610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101697750|NCT00662610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697751|NCT00662610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101355185|NCT00423540|Analgesics|analgesics|mesh-ancestor
101697752|NCT00662610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101697753|NCT00662610|Gout Suppressants|gout suppressants|mesh-ancestor
101697754|NCT00662610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101697755|NCT00662610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101507717|NCT02954276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101507718|NCT02954276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697756|NCT00662610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697757|NCT00662610|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101697759|NCT04225325|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
101697760|NCT04225325|Emtricitabine|emtricitabine|mesh-list
101697761|NCT04225325|Darunavir|darunavir|mesh-list
101697762|NCT04225325|Cobicistat|cobicistat|mesh-list
101697763|NCT04225325|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101697764|NCT04225325|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101697765|NCT04225325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101697766|NCT04225325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697767|NCT04225325|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101697768|NCT04225325|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101697770|NCT04225325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101697771|NCT04225325|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101697772|NCT04225325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101697773|NCT04225325|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101697774|NCT04225325|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101697775|NCT04225325|Protease Inhibitors|protease inhibitors|mesh-ancestor
101507829|NCT02953847|Antitubercular Agents|antitubercular agents|mesh-ancestor
101697776|NCT04225325|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101697777|NCT04225325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101697778|NCT00649610|Diclofenac|diclofenac|mesh-list
101697779|NCT00649610|Valdecoxib|valdecoxib|mesh-list
101697780|NCT00649610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101697781|NCT00649610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101697782|NCT00649610|Analgesics|analgesics|mesh-ancestor
101697783|NCT00649610|Sensory System Agents|sensory system agents|mesh-ancestor
101697784|NCT00649610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101697785|NCT00649610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697786|NCT00649610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101697787|NCT00649610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101697788|NCT00649610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101697789|NCT00649610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101697790|NCT00649610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697791|NCT00649610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101697792|NCT02655146|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101697793|NCT02655146|Progesterone|progesterone|mesh-list
101697794|NCT02655146|Estradiol|estradiol|mesh-list
101697795|NCT02655146|Progestins|progestins|mesh-ancestor
101697796|NCT02655146|Hormones|hormones|mesh-ancestor
101697797|NCT02655146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101697798|NCT02655146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697799|NCT02655146|Luteolytic Agents|luteolytic agents|mesh-ancestor
101697800|NCT02655146|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101697801|NCT02655146|Contraceptive Agents|contraceptive agents|mesh-ancestor
101697802|NCT02655146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101697803|NCT02655146|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101697804|NCT02655146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101697805|NCT02655146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101697806|NCT02655146|Estrogens|estrogens|mesh-ancestor
101697807|NCT02774525|Ethanol|ethanol|mesh-list
101697808|NCT02774525|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101697809|NCT02774525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101697810|NCT02774525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101697811|NCT02774525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697813|NCT04167566|Artemisinin|artemisinin|mesh-list
101697814|NCT04167566|Antimalarials|antimalarials|mesh-ancestor
101697815|NCT04167566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101697816|NCT04167566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101697817|NCT04167566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101697818|NCT00650624|Valdecoxib|valdecoxib|mesh-list
101697819|NCT00650624|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101507943|NCT00508976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101507944|NCT00508976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101507945|NCT00508976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101697820|NCT00650624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101697822|NCT00650624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697823|NCT00650624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101697824|NCT00650624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101697825|NCT00650624|Analgesics|analgesics|mesh-ancestor
101697826|NCT00650624|Sensory System Agents|sensory system agents|mesh-ancestor
101697827|NCT00650624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101697828|NCT00650624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507992|NCT00528060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101697829|NCT00650624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101697830|NCT00650624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101697831|NCT00666354|Methotrexate|methotrexate|mesh-list
101697832|NCT00666354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101697833|NCT00666354|Abortifacient Agents|abortifacient agents|mesh-ancestor
101697834|NCT00666354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101697835|NCT00666354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697836|NCT00666354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101697837|NCT00666354|Antimetabolites|antimetabolites|mesh-ancestor
101697838|NCT00666354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508060|NCT02953106|Dermatologic Agents|dermatologic agents|mesh-ancestor
101697839|NCT00666354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101697840|NCT00666354|Dermatologic Agents|dermatologic agents|mesh-ancestor
101697841|NCT00666354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101697842|NCT00666354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101697843|NCT00666354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101697844|NCT00666354|Immunologic Factors|immunologic factors|mesh-ancestor
101697845|NCT00666354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101697846|NCT00666354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101697848|NCT02536352|Fluorides|fluorides|mesh-list
101697849|NCT02536352|Micronutrients|micronutrients|mesh-ancestor
101697850|NCT02536352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697851|NCT02536352|Cariostatic Agents|cariostatic agents|mesh-ancestor
101697852|NCT02536352|Protective Agents|protective agents|mesh-ancestor
101697853|NCT02773979|Chloroquine|chloroquine|mesh-list
101697854|NCT02773979|Amebicides|amebicides|mesh-ancestor
101697855|NCT02773979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101697856|NCT02773979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101697857|NCT02773979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101697858|NCT02773979|Antimalarials|antimalarials|mesh-ancestor
101697859|NCT02773979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101697861|NCT00662844|Cholecalciferol|cholecalciferol|mesh-list
101697862|NCT00662844|Vitamins|vitamins|mesh-ancestor
101697863|NCT00662844|Micronutrients|micronutrients|mesh-ancestor
101697864|NCT00662844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697865|NCT00662844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101697866|NCT00662844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101697867|NCT02650544|Mirtazapine|mirtazapine|mesh-list
101508330|NCT00529620|Piperaquine|piperaquine|mesh-list
101697868|NCT02650544|Antidepressive Agents|antidepressive agents|mesh-ancestor
101697869|NCT02650544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101697870|NCT02650544|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101697871|NCT02650544|Histamine Antagonists|histamine antagonists|mesh-ancestor
101697872|NCT02650544|Histamine Agents|histamine agents|mesh-ancestor
101697873|NCT02650544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101697874|NCT02650544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697875|NCT02650544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697876|NCT02650544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101697877|NCT02650544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101697878|NCT02650544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101697879|NCT02650544|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101697880|NCT02650544|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101508483|NCT00513266|Antidotes|antidotes|mesh-ancestor
101697881|NCT02650544|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101697882|NCT02650544|Adrenergic Agents|adrenergic agents|mesh-ancestor
101697883|NCT02650544|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101697884|NCT02650544|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101697885|NCT02650544|Serotonin Agents|serotonin agents|mesh-ancestor
101697886|NCT02650544|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101697887|NCT02650388|Chrysarobin|chrysarobin|mesh-list
101697888|NCT02650388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101697889|NCT02650388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101697890|NCT02650388|Analgesics|analgesics|mesh-ancestor
101697891|NCT02650388|Sensory System Agents|sensory system agents|mesh-ancestor
101508538|NCT00530127|Deferiprone|deferiprone|mesh-list
101697893|NCT02650388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697894|NCT02650388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101697895|NCT02650388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101697896|NCT00883740|Pregabalin|pregabalin|mesh-list
101697897|NCT00883740|Analgesics|analgesics|mesh-ancestor
101697898|NCT00883740|Sensory System Agents|sensory system agents|mesh-ancestor
101697899|NCT00883740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101697900|NCT00883740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697902|NCT00883740|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101697904|NCT00883740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697905|NCT00883740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101697906|NCT00883740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101697907|NCT00883740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101697908|NCT00883740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101697909|NCT00883740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101697910|NCT04183712|Gemcitabine|gemcitabine|mesh-list
101697911|NCT04183712|Oxaliplatin|oxaliplatin|mesh-list
101697912|NCT04183712|Afatinib|afatinib|mesh-list
101697913|NCT04183712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101697914|NCT04183712|Antimetabolites|antimetabolites|mesh-ancestor
101697915|NCT04183712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697916|NCT04183712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101697917|NCT04183712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101697918|NCT04183712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101697920|NCT02773199|Anesthetics, Local|anesthetics, local|mesh-ancestor
101697921|NCT02773199|Anesthetics|anesthetics|mesh-ancestor
101697922|NCT02773199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101697923|NCT02773199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697924|NCT02773199|Sensory System Agents|sensory system agents|mesh-ancestor
101697925|NCT02773199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101697926|NCT02654834|Nitrous Oxide|nitrous oxide|mesh-list
101697927|NCT02654834|Anesthetics|anesthetics|mesh-list
101697928|NCT02654834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101697929|NCT02654834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697930|NCT02654834|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101697931|NCT02654834|Anesthetics, General|anesthetics, general|mesh-ancestor
101697932|NCT02654834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101697933|NCT02654834|Analgesics|analgesics|mesh-ancestor
101697934|NCT02654834|Sensory System Agents|sensory system agents|mesh-ancestor
101697935|NCT02654834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101508787|NCT02943369|Purinergic Agents|purinergic agents|mesh-ancestor
101697937|NCT00656526|Anesthetics, Local|anesthetics, local|mesh-ancestor
101697938|NCT00656526|Anesthetics|anesthetics|mesh-ancestor
101697939|NCT00656526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101697940|NCT00656526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697941|NCT00656526|Sensory System Agents|sensory system agents|mesh-ancestor
101697942|NCT00656526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101697943|NCT00656526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101697944|NCT00656526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101697945|NCT00656526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101697946|NCT00656526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101697947|NCT00656526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697948|NCT02765009|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101697949|NCT02765009|Furosemide|furosemide|mesh-list
101697950|NCT02765009|Bumetanide|bumetanide|mesh-list
101697951|NCT02765009|Diuretics|diuretics|mesh-list
101697952|NCT02765009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101697953|NCT02765009|Natriuretic Agents|natriuretic agents|mesh-ancestor
101697954|NCT02765009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697955|NCT02765009|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101697956|NCT02765009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101508989|NCT00516152|Tacrolimus|tacrolimus|mesh-list
101697957|NCT02765009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697958|NCT02765009|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101697960|NCT02649920|Oxytocics|oxytocics|mesh-ancestor
101697961|NCT02649920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101697962|NCT02649920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697963|NCT00649688|Metoprolol|metoprolol|mesh-list
101697964|NCT00649688|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101697965|NCT00649688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101697966|NCT00649688|Diuretics|diuretics|mesh-ancestor
101697967|NCT00649688|Natriuretic Agents|natriuretic agents|mesh-ancestor
101697968|NCT00649688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697969|NCT00649688|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101509058|NCT02941731|Oseltamivir|oseltamivir|mesh-list
101697970|NCT00649688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101697971|NCT00649688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697972|NCT00649688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101697974|NCT00649688|Autonomic Agents|autonomic agents|mesh-ancestor
101697975|NCT00649688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101697976|NCT00649688|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101697977|NCT00649688|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101697978|NCT00649688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101697979|NCT00649688|Adrenergic Agents|adrenergic agents|mesh-ancestor
101697980|NCT00649688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101697981|NCT00667056|Tacrolimus|tacrolimus|mesh-list
101697982|NCT00667056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101697983|NCT00667056|Immunologic Factors|immunologic factors|mesh-ancestor
101697984|NCT00667056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697985|NCT00667056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101697986|NCT00667056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101697987|NCT00667056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101697988|NCT02764619|Spironolactone|spironolactone|mesh-list
101697989|NCT02764619|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101697990|NCT02764619|Hormone Antagonists|hormone antagonists|mesh-ancestor
101697991|NCT02764619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101697992|NCT02764619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101697993|NCT02764619|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101697994|NCT02764619|Diuretics|diuretics|mesh-ancestor
101697995|NCT02764619|Natriuretic Agents|natriuretic agents|mesh-ancestor
101697996|NCT04032210|Zinc|zinc|mesh-list
101697997|NCT04032210|Fluorides|fluorides|mesh-list
101697998|NCT04032210|Cariostatic Agents|cariostatic agents|mesh-ancestor
101697999|NCT04032210|Protective Agents|protective agents|mesh-ancestor
101698000|NCT04032210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698001|NCT04032210|Trace Elements|trace elements|mesh-ancestor
101698002|NCT04032210|Micronutrients|micronutrients|mesh-ancestor
101698003|NCT04223219|Magnesium Sulfate|magnesium sulfate|mesh-list
101698004|NCT04223219|Fentanyl|fentanyl|mesh-list
101698005|NCT04223219|Dexmedetomidine|dexmedetomidine|mesh-list
101698006|NCT04223219|Ketamine|ketamine|mesh-list
101698007|NCT04223219|Propofol|propofol|mesh-list
101698008|NCT04223219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101698009|NCT04223219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101698010|NCT04223219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698011|NCT04223219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101698013|NCT04223219|Sensory System Agents|sensory system agents|mesh-ancestor
101698014|NCT04223219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101698015|NCT04223219|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101698016|NCT04223219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101698018|NCT04223219|Adrenergic Agents|adrenergic agents|mesh-ancestor
101698019|NCT04223219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101698020|NCT04223219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509381|NCT02941068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101698021|NCT04223219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101698022|NCT04223219|Anesthetics, General|anesthetics, general|mesh-ancestor
101698023|NCT04223219|Anesthetics|anesthetics|mesh-ancestor
101698024|NCT04223219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101698025|NCT04223219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101698026|NCT04223219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101698027|NCT04223219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101698028|NCT04223219|Narcotics|narcotics|mesh-ancestor
101698029|NCT04223219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101698030|NCT04223219|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101698031|NCT04223219|Anticonvulsants|anticonvulsants|mesh-ancestor
101698032|NCT04223219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101698033|NCT04223219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101698034|NCT04223219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101698035|NCT04223219|Tocolytic Agents|tocolytic agents|mesh-ancestor
101698036|NCT04223219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101698037|NCT02631252|Hydroxychloroquine|hydroxychloroquine|mesh-list
101698038|NCT02631252|Etoposide|etoposide|mesh-list
101698039|NCT02631252|Mitoxantrone|mitoxantrone|mesh-list
101698040|NCT02631252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101698041|NCT02631252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101698042|NCT02631252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101698043|NCT02631252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101698044|NCT02631252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101698045|NCT02631252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698046|NCT02631252|Antimalarials|antimalarials|mesh-ancestor
101698047|NCT02631252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101698048|NCT02631252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101698049|NCT02631252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101698050|NCT02631252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101355485|NCT00057798|Antimetabolites|antimetabolites|mesh-ancestor
101698051|NCT02631252|Analgesics|analgesics|mesh-ancestor
101698052|NCT02631252|Sensory System Agents|sensory system agents|mesh-ancestor
101698053|NCT02631252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101698054|NCT02631252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698055|NCT02631408|Vancomycin|vancomycin|mesh-list
101698056|NCT02631408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101698057|NCT02631408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101509517|NCT00519701|Hydroxyurea|hydroxyurea|mesh-list
101509518|NCT00519701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101509519|NCT00519701|Antisickling Agents|antisickling agents|mesh-ancestor
101509520|NCT00519701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101698058|NCT02630394|Azithromycin|azithromycin|mesh-list
101698059|NCT02630394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101698060|NCT02630394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101698061|NCT02771405|Ribavirin|ribavirin|mesh-list
101698062|NCT02771405|Sofosbuvir|sofosbuvir|mesh-list
101698063|NCT02771405|Simeprevir|simeprevir|mesh-list
101698064|NCT02771405|Ledipasvir|ledipasvir|mesh-list
101698065|NCT02771405|Antimetabolites|antimetabolites|mesh-ancestor
101261394|NCT01749475|Anesthetics|anesthetics|mesh-ancestor
101698066|NCT02771405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698067|NCT02771405|Antiviral Agents|antiviral agents|mesh-ancestor
101698068|NCT02771405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101698069|NCT02771405|Protease Inhibitors|protease inhibitors|mesh-ancestor
101698070|NCT02771405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101698071|NCT00667758|Cetrorelix|cetrorelix|mesh-list
101698072|NCT00667758|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101698073|NCT00667758|Fertility Agents|fertility agents|mesh-ancestor
101698074|NCT00667758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101698075|NCT00667758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698076|NCT00667758|Hormone Antagonists|hormone antagonists|mesh-ancestor
101698077|NCT00667758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101698078|NCT00542815|Sevelamer|sevelamer|mesh-list
101698079|NCT00542815|Chelating Agents|chelating agents|mesh-ancestor
101698080|NCT00542815|Sequestering Agents|sequestering agents|mesh-ancestor
101698081|NCT00542815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698082|NCT02762591|Pimavanserin|pimavanserin|mesh-list
101698083|NCT02762591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101698084|NCT02762591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101698085|NCT02762591|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101698086|NCT02762591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101698087|NCT02762591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101698088|NCT02762591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698089|NCT02762591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101698090|NCT02762591|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101698091|NCT02762591|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101698093|NCT02762591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101698094|NCT02762591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698095|NCT02696369|Lidocaine|lidocaine|mesh-list
101698096|NCT02696369|Epinephrine|epinephrine|mesh-list
101698097|NCT02696369|Racepinephrine|racepinephrine|mesh-list
101698098|NCT02696369|Epinephryl borate|epinephryl borate|mesh-list
101698099|NCT02696369|Anesthetics, Local|anesthetics, local|mesh-ancestor
101698100|NCT02696369|Anesthetics|anesthetics|mesh-ancestor
101698101|NCT02696369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101698102|NCT02696369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698103|NCT02696369|Sensory System Agents|sensory system agents|mesh-ancestor
101698104|NCT02696369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101698105|NCT02696369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101698106|NCT02696369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101698107|NCT02696369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101509819|NCT00521300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101509820|NCT00521690|Insulin Detemir|insulin detemir|mesh-list
101698108|NCT02696369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101698109|NCT02696369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698110|NCT02696369|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101698111|NCT02696369|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101698112|NCT02696369|Adrenergic Agents|adrenergic agents|mesh-ancestor
101698113|NCT02696369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101698114|NCT02696369|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101698115|NCT02696369|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101698116|NCT02696369|Autonomic Agents|autonomic agents|mesh-ancestor
101698117|NCT02696369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101698118|NCT02696369|Respiratory System Agents|respiratory system agents|mesh-ancestor
101698119|NCT02696369|Mydriatics|mydriatics|mesh-ancestor
101698120|NCT02696369|Sympathomimetics|sympathomimetics|mesh-ancestor
101698121|NCT02696369|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101698122|NCT00663312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
101698123|NCT00663312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101698124|NCT00663312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698125|NCT02636088|Cetuximab|cetuximab|mesh-list
101698126|NCT02636088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101698127|NCT02636088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101509887|NCT02948348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101509888|NCT04693910|Hormones|hormones|mesh-list
101698128|NCT02630160|Epinephrine|epinephrine|mesh-list
101509890|NCT04693910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698129|NCT02630160|Bupivacaine|bupivacaine|mesh-list
101698130|NCT02630160|Anesthetics, Local|anesthetics, local|mesh-ancestor
101698131|NCT02630160|Anesthetics|anesthetics|mesh-ancestor
101698132|NCT02630160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101698133|NCT02630160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698134|NCT02630160|Sensory System Agents|sensory system agents|mesh-ancestor
101698135|NCT02630160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101698136|NCT02630160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101698137|NCT02630160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101698138|NCT02630160|Adrenergic Agents|adrenergic agents|mesh-ancestor
101698139|NCT02630160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101698140|NCT02630160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698141|NCT02630160|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101698142|NCT02630160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101698143|NCT02630160|Autonomic Agents|autonomic agents|mesh-ancestor
101698144|NCT02630160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101698145|NCT02630160|Respiratory System Agents|respiratory system agents|mesh-ancestor
101510008|NCT04694105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101698147|NCT02630160|Sympathomimetics|sympathomimetics|mesh-ancestor
101698148|NCT02630160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101698149|NCT00668304|Moxifloxacin|moxifloxacin|mesh-list
101698150|NCT00668304|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101698151|NCT00668304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101698152|NCT00668304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101698154|NCT00668304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101698155|NCT00668304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101698156|NCT00668304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698157|NCT00668304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101698158|NCT00668304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101698159|NCT00668304|Contraceptive Agents|contraceptive agents|mesh-ancestor
101698160|NCT00668304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101698161|NCT00668304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698162|NCT00668304|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101698163|NCT00668304|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101698164|NCT00668304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101698165|NCT00542425|Teriparatide|teriparatide|mesh-list
101698166|NCT00542425|Abaloparatide|abaloparatide|mesh-list
101698167|NCT00542425|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
101698168|NCT00542425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101698169|NCT00542425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698170|NCT00542425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101698171|NCT00668538|Miconazole|miconazole|mesh-list
101698172|NCT00668538|Clotrimazole|clotrimazole|mesh-list
101698173|NCT00668538|Antifungal Agents|antifungal agents|mesh-ancestor
101698174|NCT00668538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101698175|NCT00668538|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101698176|NCT00668538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101698177|NCT00668538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101698178|NCT00668538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698179|NCT00668538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101698180|NCT00668538|Hormone Antagonists|hormone antagonists|mesh-ancestor
101698181|NCT00668538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101510348|NCT00525239|Lopinavir|lopinavir|mesh-list
101510349|NCT00525239|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101698182|NCT00668538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698183|NCT00668538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101698184|NCT00668538|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101698185|NCT00668538|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101698186|NCT00668616|Paclitaxel|paclitaxel|mesh-list
101698187|NCT00668616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101698188|NCT00668616|Cyclophosphamide|cyclophosphamide|mesh-list
101698189|NCT00668616|Epirubicin|epirubicin|mesh-list
101698190|NCT00668616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101698191|NCT00668616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101698192|NCT00668616|Tubulin Modulators|tubulin modulators|mesh-ancestor
101698193|NCT00668616|Antimitotic Agents|antimitotic agents|mesh-ancestor
101698194|NCT00668616|Mitosis Modulators|mitosis modulators|mesh-ancestor
101698195|NCT00668616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698196|NCT00668616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101698197|NCT00668616|Immunologic Factors|immunologic factors|mesh-ancestor
101698198|NCT00668616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698199|NCT00668616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101698200|NCT00668616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101698201|NCT00668616|Alkylating Agents|alkylating agents|mesh-ancestor
101698202|NCT00668616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101698203|NCT00668616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101698204|NCT00668616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101698205|NCT00668616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101698206|NCT00668616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101698208|NCT02763761|Methylprednisolone|methylprednisolone|mesh-list
101698209|NCT02763761|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101698210|NCT02763761|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101698211|NCT02763761|Prednisolone|prednisolone|mesh-list
101698212|NCT02763761|Prednisolone acetate|prednisolone acetate|mesh-list
101698214|NCT02763761|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101698215|NCT02763761|Prednisolone phosphate|prednisolone phosphate|mesh-list
101698216|NCT02763761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101698217|NCT02763761|Glucocorticoids|glucocorticoids|mesh-ancestor
101698218|NCT02763761|Hormones|hormones|mesh-ancestor
101698219|NCT02763761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101698220|NCT02763761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698221|NCT02763761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101698222|NCT02763761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101698223|NCT02763761|Antiemetics|antiemetics|mesh-ancestor
101698224|NCT02763761|Autonomic Agents|autonomic agents|mesh-ancestor
101698225|NCT02763761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101698226|NCT02763761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101698227|NCT02763761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101698228|NCT02763761|Protective Agents|protective agents|mesh-ancestor
101698229|NCT02763761|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101698230|NCT02763761|Dermatologic Agents|dermatologic agents|mesh-ancestor
101698231|NCT02763761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101698232|NCT04155918|Allopurinol|allopurinol|mesh-list
101698233|NCT04155918|Febuxostat|febuxostat|mesh-list
101698234|NCT04155918|Antimetabolites|antimetabolites|mesh-ancestor
101302555|NCT00324805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101698235|NCT04155918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698236|NCT04155918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101698237|NCT04155918|Gout Suppressants|gout suppressants|mesh-ancestor
101698238|NCT04155918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101698239|NCT04155918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101698240|NCT04155918|Antioxidants|antioxidants|mesh-ancestor
101698241|NCT04155918|Protective Agents|protective agents|mesh-ancestor
101698242|NCT04155918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698243|NCT02763839|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101698244|NCT02763839|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101698245|NCT02763839|Immunologic Factors|immunologic factors|mesh-ancestor
101698246|NCT02763839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698247|NCT02763839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101698248|NCT02763839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101698249|NCT02763839|Dopamine Agonists|dopamine agonists|mesh-ancestor
101698250|NCT02763839|Dopamine Agents|dopamine agents|mesh-ancestor
101698251|NCT02763839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101698252|NCT02763839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698254|NCT00541099|Docetaxel|docetaxel|mesh-list
101698255|NCT00541099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101698256|NCT00541099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101698257|NCT00541099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101698258|NCT00541099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101698259|NCT00541099|Growth Substances|growth substances|mesh-ancestor
101698260|NCT00541099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698261|NCT00541099|Growth Inhibitors|growth inhibitors|mesh-ancestor
101698262|NCT00541099|Tubulin Modulators|tubulin modulators|mesh-ancestor
101698263|NCT00541099|Antimitotic Agents|antimitotic agents|mesh-ancestor
101698264|NCT00541099|Mitosis Modulators|mitosis modulators|mesh-ancestor
101698265|NCT00541099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698267|NCT00580606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101698268|NCT00580606|Protective Agents|protective agents|mesh-ancestor
101510798|NCT00526877|Risperidone|risperidone|mesh-list
101698269|NCT00580606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698271|NCT02575768|Analgesics|analgesics|mesh-ancestor
101698272|NCT02575768|Sensory System Agents|sensory system agents|mesh-ancestor
101698273|NCT02575768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101698274|NCT02575768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698275|NCT02575768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101698277|NCT02575768|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101698278|NCT02575768|Purinergic Agonists|purinergic agonists|mesh-ancestor
101698279|NCT02575768|Purinergic Agents|purinergic agents|mesh-ancestor
101698280|NCT02575768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101698281|NCT02575768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698282|NCT00987493|Rituximab|rituximab|mesh-list
101698283|NCT00987493|Lenalidomide|lenalidomide|mesh-list
101698284|NCT00987493|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101698285|NCT00987493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101698287|NCT00987493|Immunologic Factors|immunologic factors|mesh-ancestor
101510991|NCT00528515|Propofol|propofol|mesh-list
101698288|NCT00987493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698289|NCT00987493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101511074|NCT00527540|Ribavirin|ribavirin|mesh-list
101698290|NCT00987493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101698291|NCT00987493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101698292|NCT00987493|Growth Substances|growth substances|mesh-ancestor
101698293|NCT00987493|Growth Inhibitors|growth inhibitors|mesh-ancestor
101698294|NCT00987493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101511130|NCT00529022|Antimetabolites|antimetabolites|mesh-ancestor
101698295|NCT00987493|Alkylating Agents|alkylating agents|mesh-ancestor
101698296|NCT00987493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698297|NCT02579356|Telmisartan|telmisartan|mesh-list
101698298|NCT02579356|Atorvastatin|atorvastatin|mesh-list
101698299|NCT02579356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101698300|NCT02579356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101698301|NCT02579356|Antimetabolites|antimetabolites|mesh-ancestor
101698302|NCT02579356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698303|NCT02579356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101698304|NCT02579356|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101698305|NCT02579356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101698306|NCT02579356|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101410315|NCT00114933|Ritonavir|ritonavir|mesh-list
101698307|NCT02579356|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101698308|NCT02579356|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101698309|NCT03914170|Cetuximab|cetuximab|mesh-list
101698310|NCT03914170|Folfirinox|folfirinox|mesh-list
101698311|NCT03914170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101698312|NCT03914170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101698313|NCT00663624|Insulin Aspart|insulin aspart|mesh-list
101698314|NCT00663624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101698315|NCT00663624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698316|NCT02577250|Ketamine|ketamine|mesh-list
101698317|NCT02577250|Analgesics|analgesics|mesh-ancestor
101194991|NCT05767723|Aspirin|aspirin|mesh-list
101698318|NCT02577250|Sensory System Agents|sensory system agents|mesh-ancestor
101698319|NCT02577250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101698320|NCT02577250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698321|NCT02577250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101698322|NCT02577250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101698324|NCT02577250|Anesthetics|anesthetics|mesh-ancestor
101698325|NCT02577250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101698326|NCT02577250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101698327|NCT02577250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101698328|NCT02577250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101698329|NCT02577250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698330|NCT00668850|Insulin|insulin|mesh-list
101698331|NCT00668850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101698332|NCT00668850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101698333|NCT00668850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698334|NCT02762123|Flurbiprofen|flurbiprofen|mesh-list
101698335|NCT02762123|Digoxin|digoxin|mesh-list
101698336|NCT02762123|Midazolam|midazolam|mesh-list
101698337|NCT02762123|Omeprazole|omeprazole|mesh-list
101698338|NCT02762123|Montelukast|montelukast|mesh-list
101698339|NCT02762123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101698340|NCT02762123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101698341|NCT02762123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101698342|NCT02762123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698343|NCT02762123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101698344|NCT02762123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101698345|NCT02762123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101698346|NCT02762123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101698347|NCT02762123|Anesthetics, General|anesthetics, general|mesh-ancestor
101511467|NCT00531596|Selegiline|selegiline|mesh-list
101698348|NCT02762123|Anesthetics|anesthetics|mesh-ancestor
101698349|NCT02762123|GABA Modulators|gaba modulators|mesh-ancestor
101698350|NCT02762123|GABA Agents|gaba agents|mesh-ancestor
101698351|NCT02762123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101698352|NCT02762123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698353|NCT02762123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101698354|NCT02762123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101511522|NCT02917512|Immunologic Factors|immunologic factors|mesh-ancestor
101698355|NCT02762123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101698356|NCT02762123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101698357|NCT02762123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101698358|NCT02762123|Respiratory System Agents|respiratory system agents|mesh-ancestor
101698359|NCT02762123|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101698360|NCT02762123|Hormone Antagonists|hormone antagonists|mesh-ancestor
101698361|NCT02762123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101698362|NCT02762123|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101511591|NCT02920905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101698363|NCT02762123|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101698364|NCT02762123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101698365|NCT02762123|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101698366|NCT02762123|Protective Agents|protective agents|mesh-ancestor
101698368|NCT02762123|Sensory System Agents|sensory system agents|mesh-ancestor
101698369|NCT02762123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101698370|NCT02762123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101698371|NCT02762123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101698372|NCT02762123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101698373|NCT02762123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101698374|NCT02762123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101698376|NCT04153734|Carboplatin|carboplatin|mesh-list
101698377|NCT04153734|Pembrolizumab|pembrolizumab|mesh-list
101698379|NCT04153734|Cisplatin|cisplatin|mesh-list
101698380|NCT04153734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101511662|NCT02942732|Cholecalciferol|cholecalciferol|mesh-list
101698381|NCT04153734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101698382|NCT04153734|Tubulin Modulators|tubulin modulators|mesh-ancestor
101698383|NCT04153734|Antimitotic Agents|antimitotic agents|mesh-ancestor
101698384|NCT04153734|Mitosis Modulators|mitosis modulators|mesh-ancestor
101698385|NCT04153734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698386|NCT04153734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101511727|NCT02916420|Glucocorticoids|glucocorticoids|mesh-ancestor
101698387|NCT04153734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101698388|NCT04153734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101698389|NCT04153734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101698390|NCT04153734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101698391|NCT04073680|Canagliflozin|canagliflozin|mesh-list
101698392|NCT04073680|Serabelisib|serabelisib|mesh-list
101698393|NCT04073680|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101698394|NCT04073680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698395|NCT04073680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101698396|NCT04073680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698397|NCT04073680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101698398|NCT02761577|Acetylcysteine|acetylcysteine|mesh-list
101698399|NCT02761577|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101698400|NCT02761577|Antiviral Agents|antiviral agents|mesh-ancestor
101698401|NCT02761577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101698402|NCT02761577|Expectorants|expectorants|mesh-ancestor
101698403|NCT02761577|Respiratory System Agents|respiratory system agents|mesh-ancestor
101511862|NCT03153150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101511864|NCT02916147|Propofol|propofol|mesh-list
101698404|NCT02761577|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101698405|NCT02761577|Antioxidants|antioxidants|mesh-ancestor
101698406|NCT02761577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698407|NCT02761577|Protective Agents|protective agents|mesh-ancestor
101698408|NCT02761577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698409|NCT02761577|Antidotes|antidotes|mesh-ancestor
101698410|NCT00579982|Lamotrigine|lamotrigine|mesh-list
101698411|NCT00579982|Anticonvulsants|anticonvulsants|mesh-ancestor
101698412|NCT00579982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101698413|NCT00579982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101698414|NCT00579982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698415|NCT00579982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101511999|NCT02915055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101698417|NCT00579982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101698418|NCT00579982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101698419|NCT00579982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101512065|NCT02914626|Ranibizumab|ranibizumab|mesh-list
101698420|NCT00579982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101698421|NCT00579982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101698422|NCT00596466|Pregabalin|pregabalin|mesh-list
101698423|NCT00596466|Analgesics|analgesics|mesh-ancestor
101698424|NCT00596466|Sensory System Agents|sensory system agents|mesh-ancestor
101698425|NCT00596466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101698426|NCT00596466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698427|NCT00596466|Anticonvulsants|anticonvulsants|mesh-ancestor
101698428|NCT00596466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101698429|NCT00596466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101512135|NCT02910141|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101698430|NCT00596466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698431|NCT00596466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101698432|NCT00596466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101698433|NCT00596466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101698434|NCT00596466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101698435|NCT00596466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101698437|NCT02763059|Dexamethasone|dexamethasone|mesh-list
101698438|NCT02763059|Ibuprofen|ibuprofen|mesh-list
101698439|NCT02763059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101698440|NCT02763059|Antiemetics|antiemetics|mesh-ancestor
101698441|NCT02763059|Autonomic Agents|autonomic agents|mesh-ancestor
101698442|NCT02763059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101698443|NCT02763059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512178|NCT02938286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101698444|NCT02763059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101698445|NCT02763059|Glucocorticoids|glucocorticoids|mesh-ancestor
101698446|NCT02763059|Hormones|hormones|mesh-ancestor
101698447|NCT02763059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101698448|NCT02763059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101698449|NCT02763059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101698450|NCT02763059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101698451|NCT02763059|Analgesics|analgesics|mesh-ancestor
101698452|NCT02763059|Sensory System Agents|sensory system agents|mesh-ancestor
101698454|NCT02763059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101698455|NCT02763059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101698456|NCT02763059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101698457|NCT02763059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101698458|NCT02763059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698459|NCT04222517|Hemostatics|hemostatics|mesh-list
101698460|NCT04222517|Coagulants|coagulants|mesh-ancestor
101698461|NCT00671112|Everolimus|everolimus|mesh-list
101698462|NCT00671112|Bortezomib|bortezomib|mesh-list
101698463|NCT00671112|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101698464|NCT00671112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101698465|NCT00671112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101698466|NCT00671112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698467|NCT00671112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101698468|NCT00671112|Immunologic Factors|immunologic factors|mesh-ancestor
101698469|NCT00671112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698470|NCT00671112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101698471|NCT04857385|Hemostatics|hemostatics|mesh-list
101698472|NCT04857385|Coagulants|coagulants|mesh-ancestor
101698473|NCT00664014|Tolvaptan|tolvaptan|mesh-list
101512454|NCT01289782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101698474|NCT00664014|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101698475|NCT00664014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698476|NCT00664014|Natriuretic Agents|natriuretic agents|mesh-ancestor
101698477|NCT00664014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698478|NCT02696915|Fentanyl|fentanyl|mesh-list
101698479|NCT02696915|Bupivacaine|bupivacaine|mesh-list
101698480|NCT02696915|Anesthetics, Local|anesthetics, local|mesh-ancestor
101698481|NCT02696915|Anesthetics|anesthetics|mesh-ancestor
101512595|NCT02912676|Immunologic Factors|immunologic factors|mesh-ancestor
101698483|NCT02696915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698484|NCT02696915|Sensory System Agents|sensory system agents|mesh-ancestor
101698485|NCT02696915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101698486|NCT02696915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101698487|NCT02696915|Narcotics|narcotics|mesh-ancestor
101698488|NCT02696915|Analgesics|analgesics|mesh-ancestor
101698489|NCT02696915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101698490|NCT02696915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101698491|NCT02696915|Anesthetics, General|anesthetics, general|mesh-ancestor
101698492|NCT00911664|Vitamin D|vitamin d|mesh-list
101698493|NCT00911664|Ergocalciferols|ergocalciferols|mesh-list
101698494|NCT00911664|Cholecalciferol|cholecalciferol|mesh-list
101698495|NCT00911664|Vitamins|vitamins|mesh-list
101698496|NCT00911664|Micronutrients|micronutrients|mesh-ancestor
101698497|NCT00911664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698498|NCT00911664|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101512737|NCT02934035|Dopamine Agents|dopamine agents|mesh-ancestor
101698499|NCT00911664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101698500|NCT00664170|Docetaxel|docetaxel|mesh-list
101698501|NCT00664170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101698502|NCT00664170|Tubulin Modulators|tubulin modulators|mesh-ancestor
101698503|NCT00664170|Antimitotic Agents|antimitotic agents|mesh-ancestor
101698504|NCT00664170|Mitosis Modulators|mitosis modulators|mesh-ancestor
101698505|NCT00664170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698508|NCT02758067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101698509|NCT02758067|Serotonin Agents|serotonin agents|mesh-ancestor
101698510|NCT02758067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101698511|NCT02758067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698512|NCT02758067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698513|NCT02758067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101698514|NCT02758067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101698515|NCT02758067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101512806|NCT02933645|Insulin|insulin|mesh-list
101698516|NCT02758067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101698517|NCT02758067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101698518|NCT02758067|Dopamine Agents|dopamine agents|mesh-ancestor
101698519|NCT02758067|Dopamine Agonists|dopamine agonists|mesh-ancestor
101698520|NCT00664248|Clindamycin|clindamycin|mesh-list
101698521|NCT00664248|Clindamycin palmitate|clindamycin palmitate|mesh-list
101698522|NCT00664248|Clindamycin phosphate|clindamycin phosphate|mesh-list
101698523|NCT00664248|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101698524|NCT00664248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101512864|NCT02933099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101698525|NCT00664248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101698526|NCT00664248|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101698527|NCT00664248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101698528|NCT00664248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698529|NCT00664248|Dermatologic Agents|dermatologic agents|mesh-ancestor
101698530|NCT00579670|Ziprasidone|ziprasidone|mesh-list
101698531|NCT00579670|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101698532|NCT00579670|Serotonin Agents|serotonin agents|mesh-ancestor
101698533|NCT00579670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101698534|NCT00579670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698535|NCT00579670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698536|NCT00579670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101698537|NCT00579670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101698538|NCT00579670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101698539|NCT00579670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101698540|NCT00579670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101698541|NCT00579670|Dopamine Agents|dopamine agents|mesh-ancestor
101698542|NCT00669786|Menotropins|menotropins|mesh-list
101698543|NCT00669786|Hormones|hormones|mesh-list
101698544|NCT00669786|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101698545|NCT00669786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101698546|NCT00669786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698547|NCT00669786|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101698548|NCT00669786|Fertility Agents|fertility agents|mesh-ancestor
101698549|NCT00669786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101698550|NCT02760953|Epirubicin|epirubicin|mesh-list
101698551|NCT02760953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101698552|NCT02760953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101698553|NCT02760953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101698554|NCT02760953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101698555|NCT02760953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101698556|NCT02760953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698557|NCT02630004|Melatonin|melatonin|mesh-list
101698558|NCT02630004|Antioxidants|antioxidants|mesh-ancestor
101698559|NCT02630004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698560|NCT02630004|Protective Agents|protective agents|mesh-ancestor
101698561|NCT02630004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698562|NCT02630004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101698563|NCT00129922|Paclitaxel|paclitaxel|mesh-list
101698564|NCT00129922|Cyclophosphamide|cyclophosphamide|mesh-list
101698565|NCT00129922|Fluorouracil|fluorouracil|mesh-list
101698566|NCT00129922|Epirubicin|epirubicin|mesh-list
101698567|NCT00129922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101698568|NCT00129922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101698569|NCT00129922|Tubulin Modulators|tubulin modulators|mesh-ancestor
101698570|NCT00129922|Antimitotic Agents|antimitotic agents|mesh-ancestor
101698571|NCT00129922|Mitosis Modulators|mitosis modulators|mesh-ancestor
101698572|NCT00129922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698573|NCT00129922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101698574|NCT00129922|Immunologic Factors|immunologic factors|mesh-ancestor
101698575|NCT00129922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698576|NCT00129922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101356015|NCT00032396|Hormones|hormones|mesh-ancestor
101698577|NCT00129922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101698578|NCT00129922|Alkylating Agents|alkylating agents|mesh-ancestor
101698579|NCT00129922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101698580|NCT00129922|Antimetabolites|antimetabolites|mesh-ancestor
101698581|NCT00129922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101698582|NCT00129922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101698583|NCT00129922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101698584|NCT00129922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101698585|NCT00129922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101698586|NCT03909295|Valsartan|valsartan|mesh-list
101698587|NCT03909295|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101698588|NCT03909295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101698589|NCT03909295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101698590|NCT03909295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101698591|NCT03909295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698592|NCT04153968|Retinol acetate|retinol acetate|mesh-list
101698593|NCT04153968|Protective Agents|protective agents|mesh-ancestor
101698594|NCT04153968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698595|NCT04153968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101698596|NCT04153968|Immunologic Factors|immunologic factors|mesh-ancestor
101698597|NCT04153968|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101698598|NCT04153968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101698599|NCT00671424|Remogliflozin etabonate|remogliflozin etabonate|mesh-list
101698600|NCT00671424|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101698601|NCT00671424|Furosemide|furosemide|mesh-list
101698602|NCT00671424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101698603|NCT00671424|Diuretics|diuretics|mesh-ancestor
101698604|NCT00671424|Natriuretic Agents|natriuretic agents|mesh-ancestor
101698605|NCT00671424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698606|NCT00671424|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101513236|NCT02921984|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101513238|NCT01285609|Paclitaxel|paclitaxel|mesh-list
101698607|NCT00671424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101698608|NCT00671424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698609|NCT00671424|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101698610|NCT00671424|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101698612|NCT00599924|Leucovorin|leucovorin|mesh-list
101698613|NCT00599924|Sunitinib|sunitinib|mesh-list
101698614|NCT00599924|Fluorouracil|fluorouracil|mesh-list
101698615|NCT00599924|Oxaliplatin|oxaliplatin|mesh-list
101698616|NCT00599924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101698617|NCT00599924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101698618|NCT00599924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101698619|NCT00599924|Growth Substances|growth substances|mesh-ancestor
101698620|NCT00599924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698621|NCT00599924|Growth Inhibitors|growth inhibitors|mesh-ancestor
101698622|NCT00599924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101698623|NCT00599924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101698624|NCT00599924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698625|NCT00599924|Antimetabolites|antimetabolites|mesh-ancestor
101698626|NCT00599924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101513365|NCT02932488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101513368|NCT02921165|Aspirin|aspirin|mesh-list
101698627|NCT00599924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101698628|NCT00599924|Immunologic Factors|immunologic factors|mesh-ancestor
101698629|NCT00599924|Antidotes|antidotes|mesh-ancestor
101698630|NCT00599924|Protective Agents|protective agents|mesh-ancestor
101698631|NCT00599924|Vitamin B Complex|vitamin b complex|mesh-ancestor
101698632|NCT00599924|Vitamins|vitamins|mesh-ancestor
101698633|NCT00599924|Micronutrients|micronutrients|mesh-ancestor
101698634|NCT02757209|Fluticasone|fluticasone|mesh-list
101698636|NCT02757209|Budesonide|budesonide|mesh-list
101698637|NCT02757209|Formoterol Fumarate|formoterol fumarate|mesh-list
101698638|NCT02757209|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101698639|NCT02757209|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101698640|NCT02757209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101698641|NCT02757209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101698642|NCT02757209|Autonomic Agents|autonomic agents|mesh-ancestor
101698643|NCT02757209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101698644|NCT02757209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698645|NCT02757209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101698646|NCT02757209|Respiratory System Agents|respiratory system agents|mesh-ancestor
101698647|NCT02757209|Dermatologic Agents|dermatologic agents|mesh-ancestor
101698648|NCT02757209|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101698649|NCT02757209|Glucocorticoids|glucocorticoids|mesh-ancestor
101698650|NCT02757209|Hormones|hormones|mesh-ancestor
101698651|NCT02757209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101698652|NCT02757209|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101698653|NCT02757209|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101698654|NCT02757209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101513487|NCT05466708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101698656|NCT02757209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101698657|NCT02757209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698658|NCT00670254|Hydrocortisone|hydrocortisone|mesh-list
101698659|NCT00670254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101513574|NCT02932020|Hormones|hormones|mesh-ancestor
101698660|NCT00581542|Moxifloxacin|moxifloxacin|mesh-list
101698661|NCT00581542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101698662|NCT00581542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101698663|NCT00581542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101698664|NCT00581542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101698665|NCT00581542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101698666|NCT00581542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698667|NCT00581542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101698669|NCT05338801|Antipruritics|antipruritics|mesh-ancestor
101698670|NCT05338801|Dermatologic Agents|dermatologic agents|mesh-ancestor
101698671|NCT02757287|Desogestrel|desogestrel|mesh-list
101513693|NCT03673787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101698672|NCT02757287|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101698673|NCT02757287|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101698674|NCT02757287|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101698675|NCT02757287|Contraceptive Agents|contraceptive agents|mesh-ancestor
101698676|NCT02757287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101698677|NCT02757287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698678|NCT02757287|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101698679|NCT02757287|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101698680|NCT02757287|Progestins|progestins|mesh-ancestor
101698681|NCT02757287|Hormones|hormones|mesh-ancestor
101698682|NCT02757287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101698683|NCT02757365|Aspirin|aspirin|mesh-list
101698684|NCT02757365|Levofloxacin|levofloxacin|mesh-list
101513763|NCT04727775|Remdesivir|remdesivir|mesh-list
101513826|NCT02918747|Mitosis Modulators|mitosis modulators|mesh-ancestor
101698685|NCT02757365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101698686|NCT02757365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101698688|NCT02757365|Sensory System Agents|sensory system agents|mesh-ancestor
101698689|NCT02757365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101698690|NCT02757365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698691|NCT02757365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101698692|NCT02757365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101698693|NCT02757365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101698694|NCT02757365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101698695|NCT02757365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698696|NCT02757365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101698697|NCT02757365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101698699|NCT02757365|Antipyretics|antipyretics|mesh-ancestor
101698700|NCT02757365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101698701|NCT02757365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101698702|NCT02757365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101698703|NCT02757365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101698704|NCT02757365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101698705|NCT02757365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101513957|NCT00533676|Nasal Decongestants|nasal decongestants|mesh-ancestor
101698706|NCT02757365|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101698707|NCT02757365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101698708|NCT02649530|LGK974|lgk974|mesh-list
101698709|NCT02649530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101698710|NCT02649530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698711|NCT02575534|Procainamide|procainamide|mesh-list
101698712|NCT02575534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101698713|NCT02575534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101698714|NCT02575534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101698715|NCT02575534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101698716|NCT02575534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698717|NCT02757443|Phosphocreatine|phosphocreatine|mesh-list
101698718|NCT02757443|Anesthetics|anesthetics|mesh-list
101514027|NCT01275625|Antiviral Agents|antiviral agents|mesh-ancestor
101698719|NCT02757443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101698720|NCT02757443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698722|NCT02757443|Protective Agents|protective agents|mesh-ancestor
101698723|NCT04071262|Prednisolone|prednisolone|mesh-list
101698724|NCT04071262|Abiraterone Acetate|abiraterone acetate|mesh-list
101698725|NCT04071262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101698726|NCT04071262|Glucocorticoids|glucocorticoids|mesh-ancestor
101698727|NCT04071262|Hormones|hormones|mesh-ancestor
101698728|NCT04071262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101261399|NCT01749514|Luspatercept|luspatercept|mesh-list
101698729|NCT04071262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698730|NCT04071262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101698731|NCT04071262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101698732|NCT04071262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101698733|NCT04071262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101698734|NCT04071262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698735|NCT04071262|Hormone Antagonists|hormone antagonists|mesh-ancestor
101698736|NCT04071262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101698738|NCT04154748|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101698739|NCT04154748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101698740|NCT04154748|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101698741|NCT04154748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101698742|NCT04154748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698744|NCT02657096|Dental Disinfectants|dental disinfectants|mesh-ancestor
101698745|NCT02657096|Disinfectants|disinfectants|mesh-ancestor
101698746|NCT02657096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101698747|NCT02536742|Fulvestrant|fulvestrant|mesh-list
101514223|NCT00534378|Midazolam|midazolam|mesh-list
101698749|NCT02536742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101698750|NCT02536742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101698751|NCT02536742|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101698752|NCT02536742|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101698753|NCT02536742|Hormone Antagonists|hormone antagonists|mesh-ancestor
101698754|NCT02536742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101698755|NCT02536742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698756|NCT02536742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101698757|NCT02536742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101698758|NCT02536742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698759|NCT00670410|Fludarabine|fludarabine|mesh-list
101698760|NCT00670410|Busulfan|busulfan|mesh-list
101698761|NCT00670410|Thymoglobulin|thymoglobulin|mesh-list
101698762|NCT00670410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101698763|NCT00670410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698764|NCT00670410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101698765|NCT00670410|Immunologic Factors|immunologic factors|mesh-ancestor
101698766|NCT00670410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698767|NCT00670410|Alkylating Agents|alkylating agents|mesh-ancestor
101698768|NCT00670410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101698769|NCT00670410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101698770|NCT02756663|Dexamethasone|dexamethasone|mesh-list
101698771|NCT02756663|Panobinostat|panobinostat|mesh-list
101514345|NCT04942730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101698772|NCT02756663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101698774|NCT02756663|Autonomic Agents|autonomic agents|mesh-ancestor
101698775|NCT02756663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101698776|NCT02756663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698777|NCT02756663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101698778|NCT02756663|Glucocorticoids|glucocorticoids|mesh-ancestor
101698779|NCT02756663|Hormones|hormones|mesh-ancestor
101698780|NCT02756663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101698781|NCT02756663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101698782|NCT02756663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101698783|NCT02756663|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101698784|NCT02756663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101698785|NCT02756663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698786|NCT02654678|Enalapril|enalapril|mesh-list
101698787|NCT02654678|Enalaprilat|enalaprilat|mesh-list
101698788|NCT02654678|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101698789|NCT02654678|Protease Inhibitors|protease inhibitors|mesh-ancestor
101698790|NCT02654678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101514493|NCT05471063|Amebicides|amebicides|mesh-ancestor
101698792|NCT02654678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101698793|NCT00670566|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101698794|NCT00670566|Irbesartan|irbesartan|mesh-list
101698795|NCT00670566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101698796|NCT00670566|Diuretics|diuretics|mesh-ancestor
101698797|NCT00670566|Natriuretic Agents|natriuretic agents|mesh-ancestor
101514546|NCT01606384|Arginine Vasopressin|arginine vasopressin|mesh-list
101698798|NCT00670566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698799|NCT00670566|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101698800|NCT00670566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101698801|NCT00670566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698802|NCT00670566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101698803|NCT00670566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101698804|NCT02629848|Paclitaxel|paclitaxel|mesh-list
101698805|NCT02629848|Carboplatin|carboplatin|mesh-list
101698806|NCT02629848|Motesanib diphosphate|motesanib diphosphate|mesh-list
101514615|NCT00594217|Progestins|progestins|mesh-ancestor
101698807|NCT02629848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101698808|NCT02629848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101698809|NCT02629848|Tubulin Modulators|tubulin modulators|mesh-ancestor
101698810|NCT02629848|Antimitotic Agents|antimitotic agents|mesh-ancestor
101698811|NCT02629848|Mitosis Modulators|mitosis modulators|mesh-ancestor
101698812|NCT02629848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698813|NCT02629848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101698814|NCT02629848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101698816|NCT03912337|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
101698817|NCT03912337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698818|NCT03912337|Analgesics|analgesics|mesh-ancestor
101698819|NCT03912337|Sensory System Agents|sensory system agents|mesh-ancestor
101698820|NCT03912337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101698821|NCT03912337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698822|NCT00650156|Adalimumab|adalimumab|mesh-list
101698823|NCT00650156|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101698824|NCT00650156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101698825|NCT00650156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101698826|NCT02576782|Dexamethasone|dexamethasone|mesh-list
101698827|NCT02576782|Dexamethasone acetate|dexamethasone acetate|mesh-list
101698828|NCT02576782|Bupivacaine|bupivacaine|mesh-list
101698829|NCT02576782|BB 1101|bb 1101|mesh-list
101698830|NCT02576782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101698831|NCT02576782|Antiemetics|antiemetics|mesh-ancestor
101698832|NCT02576782|Autonomic Agents|autonomic agents|mesh-ancestor
101698833|NCT02576782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101698834|NCT02576782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698835|NCT02576782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101514683|NCT05470166|Lidocaine|lidocaine|mesh-list
101698836|NCT02576782|Glucocorticoids|glucocorticoids|mesh-ancestor
101698837|NCT02576782|Hormones|hormones|mesh-ancestor
101698838|NCT02576782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101698839|NCT02576782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101698840|NCT02576782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101698841|NCT02576782|Protease Inhibitors|protease inhibitors|mesh-ancestor
101698842|NCT02576782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101698843|NCT02576782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698844|NCT02576782|Anesthetics, Local|anesthetics, local|mesh-ancestor
101698845|NCT02576782|Anesthetics|anesthetics|mesh-ancestor
101698846|NCT02576782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101698847|NCT02576782|Sensory System Agents|sensory system agents|mesh-ancestor
101698848|NCT02629770|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101698849|NCT02629770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101698850|NCT02577094|Fludarabine|fludarabine|mesh-list
101698851|NCT02577094|Busulfan|busulfan|mesh-list
101698852|NCT02577094|Epratuzumab|epratuzumab|mesh-list
101698853|NCT02577094|Thymoglobulin|thymoglobulin|mesh-list
101698854|NCT02577094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101698855|NCT02577094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698856|NCT02577094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101698857|NCT02577094|Immunologic Factors|immunologic factors|mesh-ancestor
101698858|NCT02577094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698859|NCT02577094|Alkylating Agents|alkylating agents|mesh-ancestor
101698860|NCT02577094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101698861|NCT02577094|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101698862|NCT02577094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101698863|NCT00649844|Ziprasidone|ziprasidone|mesh-list
101698864|NCT00649844|Clozapine|clozapine|mesh-list
101698865|NCT00649844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101698866|NCT00649844|Serotonin Agents|serotonin agents|mesh-ancestor
101698867|NCT00649844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101698868|NCT00649844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514724|NCT05469386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101698869|NCT00649844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698870|NCT00649844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101698871|NCT00649844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101698872|NCT00649844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101698873|NCT00649844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101698874|NCT00649844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101698875|NCT00649844|Dopamine Agents|dopamine agents|mesh-ancestor
101698876|NCT00649844|GABA Antagonists|gaba antagonists|mesh-ancestor
101698877|NCT00649844|GABA Agents|gaba agents|mesh-ancestor
101698879|NCT03912259|Dermatologic Agents|dermatologic agents|mesh-ancestor
101698880|NCT02656472|Tranexamic Acid|tranexamic acid|mesh-list
101698881|NCT02656472|Aminocaproic Acid|aminocaproic acid|mesh-list
101698882|NCT02656472|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101698883|NCT02656472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101698884|NCT02656472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698885|NCT02656472|Hemostatics|hemostatics|mesh-ancestor
101698886|NCT02656472|Coagulants|coagulants|mesh-ancestor
101698887|NCT00665340|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101698888|NCT00665340|Vasodilator Agents|vasodilator agents|mesh-ancestor
101698889|NCT00665340|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101698890|NCT00665340|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101698891|NCT00665340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101698892|NCT00665340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698893|NCT00665340|Urological Agents|urological agents|mesh-ancestor
101698894|NCT00665418|Sevoflurane|sevoflurane|mesh-list
101698895|NCT00665418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101698896|NCT00665418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101698897|NCT00665418|Anesthetics, General|anesthetics, general|mesh-ancestor
101514823|NCT00536393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698898|NCT00665418|Anesthetics|anesthetics|mesh-ancestor
101698899|NCT00665418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101698900|NCT00665418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698901|NCT04058990|Paclitaxel|paclitaxel|mesh-list
101698902|NCT04058990|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101698903|NCT04058990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101698904|NCT04058990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101698905|NCT04058990|Tubulin Modulators|tubulin modulators|mesh-ancestor
101698906|NCT04058990|Antimitotic Agents|antimitotic agents|mesh-ancestor
101698907|NCT04058990|Mitosis Modulators|mitosis modulators|mesh-ancestor
101698908|NCT04058990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698909|NCT00595920|Vaccines|vaccines|mesh-list
101698910|NCT00595920|Immunologic Factors|immunologic factors|mesh-ancestor
101698911|NCT00595920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698912|NCT02654288|Gemcitabine|gemcitabine|mesh-list
101698913|NCT02654288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101698914|NCT02654288|Antimetabolites|antimetabolites|mesh-ancestor
101698915|NCT02654288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698916|NCT02654288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101698917|NCT02649140|Acetic Acid|acetic acid|mesh-list
101698918|NCT02649140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101698919|NCT02649140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101698920|NCT00665496|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101698921|NCT00665496|Vasodilator Agents|vasodilator agents|mesh-ancestor
101698922|NCT00665496|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101698923|NCT00665496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101698924|NCT00665496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101698925|NCT00665496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698926|NCT00665496|Urological Agents|urological agents|mesh-ancestor
101698927|NCT02653898|Artesunate|artesunate|mesh-list
101698928|NCT02653898|Primaquine|primaquine|mesh-list
101698929|NCT02653898|Piperaquine|piperaquine|mesh-list
101698930|NCT02653898|Artenimol|artenimol|mesh-list
101698931|NCT02653898|Mefloquine|mefloquine|mesh-list
101698932|NCT02653898|Permethrin|permethrin|mesh-list
101698933|NCT02653898|Antimalarials|antimalarials|mesh-ancestor
101698934|NCT02653898|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101698935|NCT02653898|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101698936|NCT02653898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101698937|NCT02653898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101698938|NCT02653898|Antiviral Agents|antiviral agents|mesh-ancestor
101698939|NCT02653898|Schistosomicides|schistosomicides|mesh-ancestor
101698940|NCT02653898|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101698941|NCT02653898|Anthelmintics|anthelmintics|mesh-ancestor
101698942|NCT02653898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101698943|NCT02653898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698944|NCT02629536|Acetylcysteine|acetylcysteine|mesh-list
101698945|NCT02629536|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101515020|NCT04326790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101698946|NCT02629536|Antiviral Agents|antiviral agents|mesh-ancestor
101698947|NCT02629536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101698948|NCT02629536|Expectorants|expectorants|mesh-ancestor
101698949|NCT02629536|Respiratory System Agents|respiratory system agents|mesh-ancestor
101515039|NCT00597064|Prednisone|prednisone|mesh-list
101698950|NCT02629536|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101698952|NCT02629536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698953|NCT02629536|Protective Agents|protective agents|mesh-ancestor
101698954|NCT02629536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698955|NCT02629536|Antidotes|antidotes|mesh-ancestor
101698956|NCT04071106|Betamethasone|betamethasone|mesh-list
101698957|NCT04071106|Calcipotriene|calcipotriene|mesh-list
101698958|NCT04071106|Petrolatum|petrolatum|mesh-list
101698959|NCT04071106|Turmeric extract|turmeric extract|mesh-list
101515068|NCT05470764|Vasodilator Agents|vasodilator agents|mesh-ancestor
101698960|NCT04071106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101698961|NCT04071106|Glucocorticoids|glucocorticoids|mesh-ancestor
101698962|NCT04071106|Hormones|hormones|mesh-ancestor
101698963|NCT04071106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101698964|NCT04071106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698965|NCT04071106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101698966|NCT04071106|Respiratory System Agents|respiratory system agents|mesh-ancestor
101698967|NCT04071106|Dermatologic Agents|dermatologic agents|mesh-ancestor
101698968|NCT04071106|Antioxidants|antioxidants|mesh-ancestor
101515133|NCT00598195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101698969|NCT04071106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698970|NCT04071106|Protective Agents|protective agents|mesh-ancestor
101698971|NCT04071106|Emollients|emollients|mesh-ancestor
101698972|NCT00670722|Insulin|insulin|mesh-list
101698973|NCT00670722|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101698974|NCT00670722|Insulin Aspart|insulin aspart|mesh-list
101698975|NCT00670722|Insulin, Long-Acting|insulin, long-acting|mesh-list
101698976|NCT00670722|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101698977|NCT00670722|Insulin Detemir|insulin detemir|mesh-list
101698978|NCT00670722|Biphasic Insulins|biphasic insulins|mesh-list
101515198|NCT02909478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101698979|NCT00670722|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101698980|NCT00670722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101698981|NCT00670722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698982|NCT02648906|Choline|choline|mesh-list
101698983|NCT02648906|Lipotropic Agents|lipotropic agents|mesh-ancestor
101698984|NCT02648906|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101698985|NCT02648906|Antimetabolites|antimetabolites|mesh-ancestor
101698986|NCT02648906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698987|NCT02648906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101698988|NCT02648906|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101698989|NCT02648906|Nootropic Agents|nootropic agents|mesh-ancestor
101698990|NCT00670878|Gemcitabine|gemcitabine|mesh-list
101698991|NCT00670878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101515256|NCT00536783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101698992|NCT00670878|Antimetabolites|antimetabolites|mesh-ancestor
101698993|NCT00670878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101698994|NCT00670878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101698995|NCT02760095|Vitamin A|vitamin a|mesh-list
101698996|NCT02760095|Acetic Acid|acetic acid|mesh-list
101698997|NCT02760095|Retinol acetate|retinol acetate|mesh-list
101698998|NCT02760095|Zinc Sulfate|zinc sulfate|mesh-list
101698999|NCT02760095|Vitamins|vitamins|mesh-ancestor
101699000|NCT02760095|Micronutrients|micronutrients|mesh-ancestor
101699001|NCT02760095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699002|NCT02760095|Protective Agents|protective agents|mesh-ancestor
101699003|NCT02760095|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101699004|NCT02760095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101699005|NCT02760095|Astringents|astringents|mesh-ancestor
101699006|NCT02760095|Dermatologic Agents|dermatologic agents|mesh-ancestor
101515321|NCT00537173|Growth Substances|growth substances|mesh-ancestor
101699007|NCT02760095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101699008|NCT02760095|Immunologic Factors|immunologic factors|mesh-ancestor
101699009|NCT02760095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101699010|NCT02760095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101699011|NCT04418167|Dabrafenib|dabrafenib|mesh-list
101699012|NCT04418167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101699013|NCT04418167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101699014|NCT04418167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101699015|NCT04418167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699016|NCT02576626|Glycopyrrolate|glycopyrrolate|mesh-list
101699017|NCT02576626|Albuterol|albuterol|mesh-list
101699018|NCT02576626|Ipratropium|ipratropium|mesh-list
101699019|NCT02576626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101699020|NCT02576626|Autonomic Agents|autonomic agents|mesh-ancestor
101699021|NCT02576626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101699022|NCT02576626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699023|NCT02576626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101699024|NCT02576626|Respiratory System Agents|respiratory system agents|mesh-ancestor
101699025|NCT02576626|Tocolytic Agents|tocolytic agents|mesh-ancestor
101699026|NCT02576626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101699027|NCT02576626|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101699028|NCT02576626|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101699029|NCT02576626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101699030|NCT02576626|Adrenergic Agents|adrenergic agents|mesh-ancestor
101515383|NCT05469165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699031|NCT02576626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101699032|NCT02576626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699034|NCT02576626|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101699035|NCT02576626|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101699036|NCT02576626|Cholinergic Agents|cholinergic agents|mesh-ancestor
101699038|NCT00877890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101699039|NCT00877890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699040|NCT00877890|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101699041|NCT00877890|Incretins|incretins|mesh-ancestor
101699042|NCT00877890|Hormones|hormones|mesh-ancestor
101699043|NCT00877890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101699044|NCT02648672|BPN14770|bpn14770|mesh-list
101699045|NCT02648672|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101699046|NCT02648672|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101699047|NCT02648672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101699048|NCT02648672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699049|NCT04221971|Cyclophosphamide|cyclophosphamide|mesh-list
101699050|NCT04221971|Fludarabine|fludarabine|mesh-list
101699051|NCT04221971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101699052|NCT04221971|Immunologic Factors|immunologic factors|mesh-ancestor
101699053|NCT04221971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699054|NCT04221971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101699055|NCT04221971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101699056|NCT04221971|Alkylating Agents|alkylating agents|mesh-ancestor
101699057|NCT04221971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699058|NCT04221971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101699059|NCT04221971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101699060|NCT02644694|Dexamethasone|dexamethasone|mesh-list
101699061|NCT02644694|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101699062|NCT02644694|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101699063|NCT02644694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101699065|NCT02644694|Autonomic Agents|autonomic agents|mesh-ancestor
101699066|NCT02644694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101699067|NCT02644694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699068|NCT02644694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101699069|NCT02644694|Glucocorticoids|glucocorticoids|mesh-ancestor
101699070|NCT02644694|Hormones|hormones|mesh-ancestor
101699071|NCT02644694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101699072|NCT02644694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101699073|NCT02644694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101699074|NCT02644694|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101699075|NCT02653742|Ketorolac|ketorolac|mesh-list
101699076|NCT02653742|Fentanyl|fentanyl|mesh-list
101515482|NCT00551564|Rosiglitazone|rosiglitazone|mesh-list
101699077|NCT02653742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101699078|NCT02653742|Narcotics|narcotics|mesh-ancestor
101699079|NCT02653742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101515483|NCT00551564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101515485|NCT05105061|Ketamine|ketamine|mesh-list
101699080|NCT02653742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699082|NCT02653742|Sensory System Agents|sensory system agents|mesh-ancestor
101699083|NCT02653742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101699084|NCT02653742|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101699085|NCT02653742|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101699086|NCT02653742|Anesthetics, General|anesthetics, general|mesh-ancestor
101699087|NCT02653742|Anesthetics|anesthetics|mesh-ancestor
101699088|NCT02653742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101699089|NCT02653742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101699090|NCT02653742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101699091|NCT02653742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101699092|NCT02653742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101699093|NCT02653742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101699094|NCT02653742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699095|NCT02755259|Acetazolamide|acetazolamide|mesh-list
101699096|NCT02755259|Anticonvulsants|anticonvulsants|mesh-ancestor
101699097|NCT02755259|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101699098|NCT02755259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101699099|NCT02755259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699100|NCT02755259|Diuretics|diuretics|mesh-ancestor
101699101|NCT02755259|Natriuretic Agents|natriuretic agents|mesh-ancestor
101356537|NCT00034502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101699102|NCT02755259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699103|NCT02575222|Nivolumab|nivolumab|mesh-list
101261402|NCT01749540|Hematinics|hematinics|mesh-ancestor
101699104|NCT02575222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101699106|NCT02575222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101699107|NCT02575222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699108|NCT00680394|Misoprostol|misoprostol|mesh-list
101699109|NCT00680394|Mifepristone|mifepristone|mesh-list
101699110|NCT00680394|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101699111|NCT00680394|Abortifacient Agents|abortifacient agents|mesh-ancestor
101699112|NCT00680394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101699113|NCT00680394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699114|NCT00680394|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101699115|NCT00680394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101699116|NCT00680394|Oxytocics|oxytocics|mesh-ancestor
101699117|NCT00680394|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101699118|NCT00680394|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101699119|NCT00680394|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101699120|NCT00680394|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101699121|NCT00680394|Contraceptive Agents|contraceptive agents|mesh-ancestor
101699122|NCT00680394|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101699123|NCT00680394|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101699124|NCT00680394|Hormone Antagonists|hormone antagonists|mesh-ancestor
101699125|NCT00680394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101699126|NCT00680394|Luteolytic Agents|luteolytic agents|mesh-ancestor
101699127|NCT00680394|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101699128|NCT00680394|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101515533|NCT00552227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699129|NCT04724044|Moxifloxacin|moxifloxacin|mesh-list
101699130|NCT04724044|Clarithromycin|clarithromycin|mesh-list
101699131|NCT04724044|Ceftriaxone|ceftriaxone|mesh-list
101699132|NCT04724044|Lactams|lactams|mesh-list
101699133|NCT04724044|beta-Lactams|beta-lactams|mesh-list
101699134|NCT04724044|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101699135|NCT04724044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101699136|NCT04724044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101699137|NCT04724044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101699138|NCT04724044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101699139|NCT04724044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101699140|NCT04724044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699141|NCT04724044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101699142|NCT04724044|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101699143|NCT04724044|Contraceptive Agents|contraceptive agents|mesh-ancestor
101699144|NCT04724044|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101699145|NCT04724044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699146|NCT04724044|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101699147|NCT04724044|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101699148|NCT04724044|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101699149|NCT04724044|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101699150|NCT04724044|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101699151|NCT04724044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101699152|NCT02768519|OTS167|ots167|mesh-list
101699153|NCT02768519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101515550|NCT04943757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101699154|NCT02768519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101699155|NCT02768519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699156|NCT00671814|Linezolid|linezolid|mesh-list
101699157|NCT00671814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101699158|NCT00671814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101699159|NCT00671814|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101699160|NCT00671814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101699161|NCT00671814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699162|NCT02627430|Talazoparib|talazoparib|mesh-list
101515602|NCT01824537|Vaccines|vaccines|mesh-list
101699163|NCT02627430|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101699164|NCT02627430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101699165|NCT02627430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699166|NCT02627430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101699167|NCT02759393|Lansoprazole|lansoprazole|mesh-list
101699168|NCT02759393|Dexlansoprazole|dexlansoprazole|mesh-list
101699169|NCT02759393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101699170|NCT02759393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101699171|NCT02759393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101699172|NCT02759393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101699173|NCT02759393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699176|NCT02576548|Immunologic Factors|immunologic factors|mesh-ancestor
101699177|NCT02576548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699178|NCT02758925|Cytarabine|cytarabine|mesh-list
101699179|NCT02758925|Rituximab|rituximab|mesh-list
101699180|NCT02758925|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101699181|NCT02758925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101699182|NCT02758925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101699183|NCT02758925|Immunologic Factors|immunologic factors|mesh-ancestor
101515798|NCT01255423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101699184|NCT02758925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699185|NCT02758925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101699186|NCT02758925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101699187|NCT02758925|Antimetabolites|antimetabolites|mesh-ancestor
101515800|NCT01255423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101699188|NCT02758925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699189|NCT02758925|Antiviral Agents|antiviral agents|mesh-ancestor
101699190|NCT02758925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101699191|NCT02758925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101699192|NCT02758925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101699193|NCT02758925|Alkylating Agents|alkylating agents|mesh-ancestor
101699194|NCT00676260|Pioglitazone|pioglitazone|mesh-list
101699195|NCT00676260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101699196|NCT00676260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699197|NCT00652652|Furosemide|furosemide|mesh-list
101699198|NCT00652652|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101699199|NCT00652652|Diuretics|diuretics|mesh-ancestor
101699200|NCT00652652|Natriuretic Agents|natriuretic agents|mesh-ancestor
101699201|NCT00652652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699202|NCT00652652|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101699203|NCT00652652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101699204|NCT00652652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699205|NCT02768441|Dextroamphetamine|dextroamphetamine|mesh-list
101699206|NCT02768441|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101699207|NCT02768441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699208|NCT02768441|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101515924|NCT01254292|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101515925|NCT01254292|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101699209|NCT02768441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101699210|NCT02768441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101699211|NCT02768441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699212|NCT02768441|Dopamine Agents|dopamine agents|mesh-ancestor
101699213|NCT02768441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101699214|NCT02644616|Torsemide|torsemide|mesh-list
101699215|NCT02644616|Tolvaptan|tolvaptan|mesh-list
101699216|NCT02644616|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101699217|NCT02644616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699218|NCT02644616|Natriuretic Agents|natriuretic agents|mesh-ancestor
101699219|NCT02644616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699220|NCT02644616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101699221|NCT02644616|Diuretics|diuretics|mesh-ancestor
101699222|NCT02644616|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101699223|NCT02644616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101699225|NCT02648048|Analgesics|analgesics|mesh-ancestor
101699226|NCT02648048|Sensory System Agents|sensory system agents|mesh-ancestor
101699227|NCT02648048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101699228|NCT02648048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699229|NCT02648048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101699230|NCT02648048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101699231|NCT02648048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101699232|NCT02648048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101699233|NCT02648048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101699234|NCT00676416|Propofol|propofol|mesh-list
101516131|NCT03910998|Rocuronium|rocuronium|mesh-list
101699235|NCT00676416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101699236|NCT00676416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101699237|NCT00676416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699238|NCT00676416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101699239|NCT00676416|Anesthetics, General|anesthetics, general|mesh-ancestor
101699240|NCT00676416|Anesthetics|anesthetics|mesh-ancestor
101699241|NCT04150536|Lidocaine|lidocaine|mesh-list
101699242|NCT04150536|Anesthetics, Local|anesthetics, local|mesh-ancestor
101699243|NCT04150536|Anesthetics|anesthetics|mesh-ancestor
101699244|NCT04150536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101699245|NCT04150536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699246|NCT04150536|Sensory System Agents|sensory system agents|mesh-ancestor
101356686|NCT00034853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101699247|NCT04150536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101699248|NCT04150536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101302556|NCT00324805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101699249|NCT04150536|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101699250|NCT04150536|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101699251|NCT04150536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101699252|NCT04150536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699253|NCT05167123|Calcium|calcium|mesh-list
101699254|NCT05167123|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101699255|NCT05167123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699256|NCT02644538|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101516319|NCT00544986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101699257|NCT02644538|Antiviral Agents|antiviral agents|mesh-ancestor
101699258|NCT02644538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101699260|NCT02576314|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
101699261|NCT02576314|Ledipasvir|ledipasvir|mesh-list
101699262|NCT02576314|Antiviral Agents|antiviral agents|mesh-ancestor
101699263|NCT02576314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101699264|NCT00650234|Metformin|metformin|mesh-list
101699265|NCT00650234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101699266|NCT00650234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699267|NCT00680940|Paclitaxel|paclitaxel|mesh-list
101699268|NCT00680940|Cisplatin|cisplatin|mesh-list
101699269|NCT00680940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101699270|NCT00680940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516384|NCT01267201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101699271|NCT00680940|Tubulin Modulators|tubulin modulators|mesh-ancestor
101699272|NCT00680940|Antimitotic Agents|antimitotic agents|mesh-ancestor
101699273|NCT00680940|Mitosis Modulators|mitosis modulators|mesh-ancestor
101699274|NCT00680940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699275|NCT03472885|Eculizumab|eculizumab|mesh-list
101699276|NCT03472885|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101699277|NCT03472885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101699278|NCT03472885|Immunologic Factors|immunologic factors|mesh-ancestor
101699279|NCT03472885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699280|NCT02644304|Cabergoline|cabergoline|mesh-list
101699281|NCT02644304|Clomiphene|clomiphene|mesh-list
101699282|NCT02644304|Enclomiphene|enclomiphene|mesh-list
101699283|NCT02644304|Zuclomiphene|zuclomiphene|mesh-list
101699284|NCT02644304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699285|NCT02644304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101699286|NCT02644304|Hormone Antagonists|hormone antagonists|mesh-ancestor
101699287|NCT02644304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101699288|NCT02644304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699289|NCT02644304|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101699290|NCT02644304|Fertility Agents|fertility agents|mesh-ancestor
101699291|NCT02644304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101699292|NCT02644304|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101699293|NCT02644304|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101699294|NCT02644304|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101699295|NCT02644304|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101699296|NCT02644304|Dopamine Agonists|dopamine agonists|mesh-ancestor
101699297|NCT02644304|Dopamine Agents|dopamine agents|mesh-ancestor
101699298|NCT02644304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101699299|NCT00681174|Acetaminophen|acetaminophen|mesh-list
101699300|NCT00681174|Morphine|morphine|mesh-list
101699301|NCT00681174|Remifentanil|remifentanil|mesh-list
101699302|NCT00681174|Oxycodone|oxycodone|mesh-list
101699303|NCT00681174|Propofol|propofol|mesh-list
101699304|NCT00681174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101699305|NCT00681174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101699306|NCT00681174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699307|NCT00681174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101699308|NCT00681174|Anesthetics, General|anesthetics, general|mesh-ancestor
101699309|NCT00681174|Anesthetics|anesthetics|mesh-ancestor
101699310|NCT00681174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101699311|NCT00681174|Narcotics|narcotics|mesh-ancestor
101516509|NCT00545493|Immunoglobulins|immunoglobulins|mesh-list
101516510|NCT00545493|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101699312|NCT00681174|Analgesics|analgesics|mesh-ancestor
101516511|NCT00545493|Antibodies|antibodies|mesh-list
101699313|NCT00681174|Sensory System Agents|sensory system agents|mesh-ancestor
101699314|NCT00681174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101699315|NCT00681174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101699316|NCT00681174|Antipyretics|antipyretics|mesh-ancestor
101699317|NCT02758769|Abatacept|abatacept|mesh-list
101699318|NCT02758769|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101699319|NCT02758769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699320|NCT02758769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101699321|NCT02758769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101699322|NCT02758769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101356761|NCT00062322|Irinotecan|irinotecan|mesh-list
101699324|NCT02758769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699325|NCT02758769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101699326|NCT04150146|Rebamipide|rebamipide|mesh-list
101699327|NCT04150146|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101699328|NCT04150146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101699329|NCT04150146|Antioxidants|antioxidants|mesh-ancestor
101516558|NCT03268382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101516559|NCT03268382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699330|NCT04150146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516560|NCT01266148|Cyclosporine|cyclosporine|mesh-list
101699331|NCT04150146|Protective Agents|protective agents|mesh-ancestor
101699332|NCT04150146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699333|NCT04150146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101699335|NCT00652730|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101699336|NCT00652730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101699337|NCT00652730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101516622|NCT01265563|Acetylcysteine|acetylcysteine|mesh-list
101699338|NCT00652730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699339|NCT00652730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101699340|NCT00652730|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101699341|NCT00652730|Serotonin Agents|serotonin agents|mesh-ancestor
101699342|NCT00652730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101699343|NCT00652730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699345|NCT00652808|Valdecoxib|valdecoxib|mesh-list
101699346|NCT00652808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101699347|NCT00652808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101699348|NCT00652808|Analgesics|analgesics|mesh-ancestor
101699349|NCT00652808|Sensory System Agents|sensory system agents|mesh-ancestor
101699350|NCT00652808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101699351|NCT00652808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699352|NCT00652808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101699353|NCT00652808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101699354|NCT00652808|Gout Suppressants|gout suppressants|mesh-ancestor
101699355|NCT00652808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101699356|NCT00652808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101699357|NCT00652808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699358|NCT00652808|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101699360|NCT00635531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101699361|NCT00635531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101699362|NCT00635531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699363|NCT00635531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101699364|NCT00635531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101699365|NCT00635531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101699366|NCT00635531|GABA Modulators|gaba modulators|mesh-ancestor
101699367|NCT00635531|GABA Agents|gaba agents|mesh-ancestor
101699368|NCT00635531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101699369|NCT00635531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699370|NCT02535156|Risperidone|risperidone|mesh-list
101699371|NCT02535156|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101699372|NCT02535156|Serotonin Agents|serotonin agents|mesh-ancestor
101699373|NCT02535156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101699374|NCT02535156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699375|NCT02535156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699376|NCT02535156|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101699377|NCT02535156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101699378|NCT02535156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101516741|NCT04323631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101516754|NCT01263769|Axitinib|axitinib|mesh-list
101699379|NCT02535156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101699380|NCT02535156|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101699381|NCT02535156|Dopamine Agents|dopamine agents|mesh-ancestor
101699382|NCT03417895|Apatinib|apatinib|mesh-list
101699383|NCT03417895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101699384|NCT03417895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101699385|NCT03417895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101699386|NCT03417895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516788|NCT02236013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101516789|NCT02236013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101516796|NCT00539409|Insulin|insulin|mesh-list
101699387|NCT05299164|Rituximab|rituximab|mesh-list
101699388|NCT05299164|Gemcitabine|gemcitabine|mesh-list
101699389|NCT05299164|Vinorelbine|vinorelbine|mesh-list
101699390|NCT05299164|Mitoxantrone|mitoxantrone|mesh-list
101699391|NCT05299164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101699392|NCT05299164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101699393|NCT05299164|Immunologic Factors|immunologic factors|mesh-ancestor
101699394|NCT05299164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699395|NCT05299164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101699396|NCT05299164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101699397|NCT05299164|Antimetabolites|antimetabolites|mesh-ancestor
101699398|NCT05299164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699399|NCT05299164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101516853|NCT01310192|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101699400|NCT05299164|Tubulin Modulators|tubulin modulators|mesh-ancestor
101699401|NCT05299164|Antimitotic Agents|antimitotic agents|mesh-ancestor
101699402|NCT05299164|Mitosis Modulators|mitosis modulators|mesh-ancestor
101699403|NCT05299164|Analgesics|analgesics|mesh-ancestor
101699404|NCT05299164|Sensory System Agents|sensory system agents|mesh-ancestor
101699405|NCT05299164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101699406|NCT05299164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101699407|NCT05299164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101699408|NCT05299164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101699410|NCT01563835|Bupivacaine|bupivacaine|mesh-list
101699411|NCT01563835|Citric Acid|citric acid|mesh-list
101699412|NCT01563835|Sodium Citrate|sodium citrate|mesh-list
101699413|NCT01563835|Anesthetics, Local|anesthetics, local|mesh-ancestor
101699414|NCT01563835|Anesthetics|anesthetics|mesh-ancestor
101699415|NCT01563835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101699416|NCT01563835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699417|NCT01563835|Sensory System Agents|sensory system agents|mesh-ancestor
101699418|NCT01563835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101699419|NCT01563835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101699420|NCT01563835|Narcotics|narcotics|mesh-ancestor
101699421|NCT01563835|Analgesics|analgesics|mesh-ancestor
101699422|NCT01563835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101517057|NCT00547209|Nitrous Oxide|nitrous oxide|mesh-list
101699423|NCT01563835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101699424|NCT01563835|Anesthetics, General|anesthetics, general|mesh-ancestor
101699425|NCT01563835|Anticoagulants|anticoagulants|mesh-ancestor
101699426|NCT01563835|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101699427|NCT01563835|Chelating Agents|chelating agents|mesh-ancestor
101699428|NCT01563835|Sequestering Agents|sequestering agents|mesh-ancestor
101302557|NCT00324805|Growth Substances|growth substances|mesh-ancestor
101699429|NCT01563835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699431|NCT02768207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101699432|NCT02768207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101699433|NCT02768207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101699434|NCT02768207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699435|NCT02653196|Cyclosporine|cyclosporine|mesh-list
101699436|NCT02653196|Mycophenolic Acid|mycophenolic acid|mesh-list
101699437|NCT02653196|Fludarabine|fludarabine|mesh-list
101517192|NCT00534807|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101699438|NCT02653196|Etoposide|etoposide|mesh-list
101517206|NCT00534846|Toremifene|toremifene|mesh-list
101699440|NCT02653196|Alemtuzumab|alemtuzumab|mesh-list
101699441|NCT02653196|Thiotepa|thiotepa|mesh-list
101699442|NCT02653196|Tacrolimus|tacrolimus|mesh-list
101699443|NCT02653196|Cyclosporins|cyclosporins|mesh-list
101699444|NCT02653196|Mitogens|mitogens|mesh-list
101699445|NCT02653196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101699446|NCT02653196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699447|NCT02653196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101517253|NCT02907593|Budesonide|budesonide|mesh-list
101699448|NCT02653196|Immunologic Factors|immunologic factors|mesh-ancestor
101699449|NCT02653196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699450|NCT02653196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101699451|NCT02653196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101699452|NCT02653196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101699453|NCT02653196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101517318|NCT04682132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517319|NCT02907554|Cyclosporine|cyclosporine|mesh-list
101699454|NCT02653196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101699455|NCT02653196|Antifungal Agents|antifungal agents|mesh-ancestor
101699456|NCT02653196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101699457|NCT02653196|Dermatologic Agents|dermatologic agents|mesh-ancestor
101517320|NCT02907554|Cyclosporins|cyclosporins|mesh-list
101699458|NCT02653196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101517321|NCT02907554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101699459|NCT02653196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101699460|NCT02653196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101699461|NCT02653196|Antitubercular Agents|antitubercular agents|mesh-ancestor
101699462|NCT02653196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101699463|NCT02653196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101699464|NCT02653196|Alkylating Agents|alkylating agents|mesh-ancestor
101699465|NCT02653196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101699466|NCT02653196|Mitosis Modulators|mitosis modulators|mesh-ancestor
101699467|NCT02653196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101699468|NCT05135845|Spartalizumab|spartalizumab|mesh-list
101699469|NCT05135845|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101699470|NCT05135845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699471|NCT05135845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101699472|NCT05135845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101699473|NCT04479436|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
101356910|NCT00062946|Fallypride|fallypride|mesh-list
101699474|NCT04479436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101699475|NCT04479436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101699476|NCT00677118|Cisplatin|cisplatin|mesh-list
101699477|NCT00677118|Fluorouracil|fluorouracil|mesh-list
101699478|NCT00677118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101517377|NCT02899364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699479|NCT00677118|Antimetabolites|antimetabolites|mesh-ancestor
101699480|NCT00677118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517381|NCT02899364|Chelating Agents|chelating agents|mesh-ancestor
101699481|NCT00677118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101699482|NCT00677118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101699483|NCT00677118|Immunologic Factors|immunologic factors|mesh-ancestor
101699484|NCT00677118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699485|NCT02644226|Sevoflurane|sevoflurane|mesh-list
101699486|NCT02644226|Desflurane|desflurane|mesh-list
101699487|NCT02644226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101699488|NCT02644226|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101699489|NCT02644226|Anesthetics, General|anesthetics, general|mesh-ancestor
101699490|NCT02644226|Anesthetics|anesthetics|mesh-ancestor
101699491|NCT02644226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101699492|NCT02644226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699493|NCT02753855|Telavancin|telavancin|mesh-list
101699494|NCT02753855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101699495|NCT02753855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101517427|NCT03436992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101699496|NCT02758691|Insulin|insulin|mesh-list
101699497|NCT02758691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101699498|NCT02758691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699499|NCT00714376|Docetaxel|docetaxel|mesh-list
101699500|NCT00714376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101699501|NCT00714376|Tubulin Modulators|tubulin modulators|mesh-ancestor
101699502|NCT00714376|Antimitotic Agents|antimitotic agents|mesh-ancestor
101699503|NCT00714376|Mitosis Modulators|mitosis modulators|mesh-ancestor
101517496|NCT02899286|BCT-100|bct-100|mesh-list
101699504|NCT00714376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699505|NCT04068766|Bupivacaine|bupivacaine|mesh-list
101699506|NCT04068766|Anesthetics, Local|anesthetics, local|mesh-ancestor
101699507|NCT04068766|Anesthetics|anesthetics|mesh-ancestor
101699508|NCT04068766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101699509|NCT04068766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699510|NCT04068766|Sensory System Agents|sensory system agents|mesh-ancestor
101699511|NCT04068766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101699512|NCT03267199|Fibrinolytic Agents|fibrinolytic agents|mesh-list
101699513|NCT03267199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101699514|NCT03267199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699515|NCT04725695|Lidocaine|lidocaine|mesh-list
101699516|NCT04725695|Anesthetics, Local|anesthetics, local|mesh-ancestor
101699517|NCT04725695|Anesthetics|anesthetics|mesh-ancestor
101517622|NCT01262092|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101699518|NCT04725695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101699519|NCT04725695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699520|NCT04725695|Sensory System Agents|sensory system agents|mesh-ancestor
101699521|NCT04725695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101699522|NCT04725695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101699523|NCT04725695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101699524|NCT04725695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101699525|NCT04725695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101699526|NCT04725695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699527|NCT04151472|Ubiquinone|ubiquinone|mesh-list
101699528|NCT04151472|Idebenone|idebenone|mesh-list
101699529|NCT04151472|Antioxidants|antioxidants|mesh-ancestor
101699530|NCT04151472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699531|NCT04151472|Protective Agents|protective agents|mesh-ancestor
101699532|NCT04151472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699533|NCT04151472|Micronutrients|micronutrients|mesh-ancestor
101699534|NCT04070794|Metformin|metformin|mesh-list
101699535|NCT04070794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101699536|NCT04070794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699537|NCT02695901|Chlorhexidine|chlorhexidine|mesh-list
101699538|NCT02695901|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101699539|NCT02695901|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101699540|NCT02695901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101699541|NCT02695901|Disinfectants|disinfectants|mesh-ancestor
101699542|NCT02695901|Dermatologic Agents|dermatologic agents|mesh-ancestor
101699543|NCT00677664|Glatiramer Acetate|glatiramer acetate|mesh-list
101699544|NCT00677664|Mannitol|mannitol|mesh-list
101699545|NCT00677664|(T,G)-A-L|(t,g)-a-l|mesh-list
101699546|NCT00677664|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101699547|NCT00677664|Diuretics|diuretics|mesh-ancestor
101699548|NCT00677664|Natriuretic Agents|natriuretic agents|mesh-ancestor
101699549|NCT00677664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699550|NCT00677664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101699551|NCT00677664|Immunologic Factors|immunologic factors|mesh-ancestor
101517819|NCT03482479|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101517824|NCT00553709|Nicotine|nicotine|mesh-list
101699552|NCT00677664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101699553|NCT00677664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101699554|NCT02572492|Dexamethasone|dexamethasone|mesh-list
101699555|NCT02572492|Dexamethasone acetate|dexamethasone acetate|mesh-list
101699556|NCT02572492|Melphalan|melphalan|mesh-list
101699557|NCT02572492|BB 1101|bb 1101|mesh-list
101699558|NCT02572492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101699559|NCT02572492|Antiemetics|antiemetics|mesh-ancestor
101699560|NCT02572492|Autonomic Agents|autonomic agents|mesh-ancestor
101699561|NCT02572492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101699562|NCT02572492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517877|NCT00551889|Immunologic Factors|immunologic factors|mesh-ancestor
101699563|NCT02572492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101699564|NCT02572492|Glucocorticoids|glucocorticoids|mesh-ancestor
101699566|NCT02572492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101699567|NCT02572492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101699568|NCT02572492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101699569|NCT02572492|Protease Inhibitors|protease inhibitors|mesh-ancestor
101699570|NCT02572492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101699571|NCT02572492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699572|NCT02572492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101699573|NCT02572492|Alkylating Agents|alkylating agents|mesh-ancestor
101699574|NCT02572492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101699575|NCT02572492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101699576|NCT02572492|Immunologic Factors|immunologic factors|mesh-ancestor
101699577|NCT02753387|Chlorhexidine|chlorhexidine|mesh-list
101699578|NCT02753387|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101699579|NCT02753387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101699580|NCT02753387|Disinfectants|disinfectants|mesh-ancestor
101699581|NCT00672282|Bicalutamide|bicalutamide|mesh-list
101699582|NCT00672282|Androgen Antagonists|androgen antagonists|mesh-ancestor
101699583|NCT00672282|Hormone Antagonists|hormone antagonists|mesh-ancestor
101699584|NCT00672282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101699585|NCT00672282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699586|NCT00672282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101699587|NCT02753309|Sirolimus|sirolimus|mesh-list
101699588|NCT02753309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101699589|NCT02753309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101699590|NCT02753309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101518004|NCT00552630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699591|NCT02753309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101699592|NCT02753309|Antifungal Agents|antifungal agents|mesh-ancestor
101699593|NCT02753309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101699594|NCT02753309|Immunologic Factors|immunologic factors|mesh-ancestor
101699595|NCT02753309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699596|NCT04147728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
101699597|NCT04147728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101699598|NCT04147728|Growth Substances|growth substances|mesh-ancestor
101699599|NCT04147728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699600|NCT04147728|Growth Inhibitors|growth inhibitors|mesh-ancestor
101699601|NCT04147728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101699602|NCT04330690|Artesunate|artesunate|mesh-list
101699603|NCT04330690|Dexamethasone|dexamethasone|mesh-list
101699605|NCT04330690|Imatinib Mesylate|imatinib mesylate|mesh-list
101699606|NCT04330690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101699607|NCT04330690|Antiemetics|antiemetics|mesh-ancestor
101699608|NCT04330690|Autonomic Agents|autonomic agents|mesh-ancestor
101699609|NCT04330690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101699610|NCT04330690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699612|NCT04330690|Glucocorticoids|glucocorticoids|mesh-ancestor
101699613|NCT04330690|Hormones|hormones|mesh-ancestor
101699614|NCT04330690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101699615|NCT04330690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101699616|NCT04330690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101699617|NCT04330690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101699618|NCT04330690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101699619|NCT04330690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699620|NCT04330690|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101699621|NCT04330690|Dermatologic Agents|dermatologic agents|mesh-ancestor
101518274|NCT01212094|Rituximab|rituximab|mesh-list
101699622|NCT04330690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101699623|NCT04330690|Antimalarials|antimalarials|mesh-ancestor
101699624|NCT04330690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101699625|NCT04330690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101518338|NCT04335305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699626|NCT04330690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101699627|NCT04330690|Antiviral Agents|antiviral agents|mesh-ancestor
101699628|NCT04330690|Schistosomicides|schistosomicides|mesh-ancestor
101699629|NCT04330690|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101699630|NCT04330690|Anthelmintics|anthelmintics|mesh-ancestor
101699631|NCT03083041|Apatinib|apatinib|mesh-list
101699632|NCT03083041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101518344|NCT04152980|Pentoxifylline|pentoxifylline|mesh-list
101518345|NCT04152980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101518346|NCT04152980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101518347|NCT04152980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699633|NCT03083041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101699634|NCT03083041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101699635|NCT03083041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699637|NCT00672360|Hematinics|hematinics|mesh-ancestor
101699638|NCT00672360|Vitamin B Complex|vitamin b complex|mesh-ancestor
101699639|NCT00672360|Vitamins|vitamins|mesh-ancestor
101699640|NCT00672360|Micronutrients|micronutrients|mesh-ancestor
101699641|NCT00672360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699642|NCT02628522|Lidocaine|lidocaine|mesh-list
101699643|NCT02628522|Epinephrine|epinephrine|mesh-list
101699644|NCT02628522|Anesthetics, Local|anesthetics, local|mesh-ancestor
101699645|NCT02628522|Anesthetics|anesthetics|mesh-ancestor
101699646|NCT02628522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101699647|NCT02628522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699648|NCT02628522|Sensory System Agents|sensory system agents|mesh-ancestor
101699649|NCT02628522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101699650|NCT02628522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101699651|NCT02628522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101699652|NCT02628522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101699653|NCT02628522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101699654|NCT02628522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699655|NCT02628522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101518458|NCT03911336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101699656|NCT02628522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101699657|NCT02628522|Adrenergic Agents|adrenergic agents|mesh-ancestor
101699658|NCT02628522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101699659|NCT02628522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101699660|NCT02628522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101699661|NCT02628522|Autonomic Agents|autonomic agents|mesh-ancestor
101699662|NCT02628522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101699663|NCT02628522|Respiratory System Agents|respiratory system agents|mesh-ancestor
101699664|NCT02628522|Mydriatics|mydriatics|mesh-ancestor
101699665|NCT02628522|Sympathomimetics|sympathomimetics|mesh-ancestor
101699666|NCT02628522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101699667|NCT02572336|Plasminogen|plasminogen|mesh-list
101699668|NCT02572336|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101699669|NCT02572336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101699670|NCT02572336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101699671|NCT02572336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699672|NCT02750969|Lidocaine|lidocaine|mesh-list
101699673|NCT02750969|Anesthetics, Local|anesthetics, local|mesh-ancestor
101699674|NCT02750969|Anesthetics|anesthetics|mesh-ancestor
101699675|NCT02750969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101699676|NCT02750969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699677|NCT02750969|Sensory System Agents|sensory system agents|mesh-ancestor
101699678|NCT02750969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101699679|NCT02750969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101699680|NCT02750969|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101699681|NCT02750969|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101699682|NCT02750969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101699683|NCT02750969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699684|NCT04067011|Doxycycline|doxycycline|mesh-list
101699685|NCT04067011|Ciprofloxacin|ciprofloxacin|mesh-list
101699686|NCT04067011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101699687|NCT04067011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101699688|NCT04067011|Antimalarials|antimalarials|mesh-ancestor
101518585|NCT02964884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101699689|NCT04067011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101699690|NCT04067011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101699691|NCT04067011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101699692|NCT04067011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101699693|NCT04067011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101699694|NCT04067011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699695|NCT04067011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101699696|NCT04067011|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101699697|NCT04067011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101699698|NCT00719056|Ciprofloxacin|ciprofloxacin|mesh-list
101699699|NCT00719056|Lactams|lactams|mesh-list
101699700|NCT00719056|Cephalosporins|cephalosporins|mesh-list
101699701|NCT00719056|Teicoplanin|teicoplanin|mesh-list
101699702|NCT00719056|beta-Lactams|beta-lactams|mesh-list
101518644|NCT02623751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101699703|NCT00719056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101699704|NCT00719056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101699705|NCT00719056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101699706|NCT00719056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101699707|NCT00719056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101518645|NCT02623751|Hormone Antagonists|hormone antagonists|mesh-ancestor
101518647|NCT02623751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699708|NCT00719056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699709|NCT00719056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101699710|NCT00719056|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101699711|NCT00719056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101699713|NCT04469699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101699714|NCT04469699|Dermatologic Agents|dermatologic agents|mesh-ancestor
101699715|NCT03475004|Bevacizumab|bevacizumab|mesh-list
101699716|NCT03475004|Pembrolizumab|pembrolizumab|mesh-list
101699717|NCT03475004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101699718|NCT03475004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101699719|NCT03475004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101699720|NCT03475004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101699721|NCT03475004|Growth Substances|growth substances|mesh-ancestor
101699722|NCT03475004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699723|NCT03475004|Growth Inhibitors|growth inhibitors|mesh-ancestor
101699724|NCT03475004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101699725|NCT03475004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699726|NCT02695745|Celecoxib|celecoxib|mesh-list
101699727|NCT02695745|Capsaicin|capsaicin|mesh-list
101699728|NCT02695745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101699729|NCT02695745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101699730|NCT02695745|Analgesics|analgesics|mesh-ancestor
101699731|NCT02695745|Sensory System Agents|sensory system agents|mesh-ancestor
101699732|NCT02695745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101699733|NCT02695745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699734|NCT02695745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101699735|NCT02695745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101699736|NCT02695745|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101699737|NCT02695745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101699738|NCT02695745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101699739|NCT02695745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699740|NCT02695745|Antipruritics|antipruritics|mesh-ancestor
101518826|NCT00554528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101699742|NCT00990067|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101699743|NCT00990067|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
101699744|NCT00990067|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101699745|NCT00990067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101699746|NCT00990067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101699747|NCT00990067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699748|NCT00990067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101699749|NCT00990067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518886|NCT02324309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518887|NCT02306291|Cytarabine|cytarabine|mesh-list
101699751|NCT00990067|Sensory System Agents|sensory system agents|mesh-ancestor
101699752|NCT00990067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101699753|NCT00990067|Antidepressive Agents|antidepressive agents|mesh-ancestor
101699754|NCT00990067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101699755|NCT00990067|Dopamine Agents|dopamine agents|mesh-ancestor
101699756|NCT00990067|Hallucinogens|hallucinogens|mesh-ancestor
101699757|NCT00990067|Serotonin Agents|serotonin agents|mesh-ancestor
101699758|NCT00990067|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101518948|NCT04857645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518950|NCT02224235|Aspirin|aspirin|mesh-list
101699759|NCT00990067|Adrenergic Agents|adrenergic agents|mesh-ancestor
101699760|NCT00719290|Hyaluronic Acid|hyaluronic acid|mesh-list
101699761|NCT00719290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101699762|NCT00719290|Immunologic Factors|immunologic factors|mesh-ancestor
101699763|NCT00719290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699764|NCT00719290|Viscosupplements|viscosupplements|mesh-ancestor
101699765|NCT00719290|Protective Agents|protective agents|mesh-ancestor
101699766|NCT00635921|Ziprasidone|ziprasidone|mesh-list
101699767|NCT00635921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101699768|NCT00635921|Serotonin Agents|serotonin agents|mesh-ancestor
101699769|NCT00635921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101699770|NCT00635921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699771|NCT00635921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699772|NCT00635921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101699773|NCT00635921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101699774|NCT00635921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101699776|NCT00635921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101699777|NCT00635921|Dopamine Agents|dopamine agents|mesh-ancestor
101699778|NCT04166006|Interleukin-2|interleukin-2|mesh-list
101699779|NCT04166006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101699780|NCT04166006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101699781|NCT04166006|Analgesics|analgesics|mesh-ancestor
101699782|NCT04166006|Sensory System Agents|sensory system agents|mesh-ancestor
101699783|NCT04166006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101699784|NCT04166006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699785|NCT04069858|Entecavir|entecavir|mesh-list
101699786|NCT04069858|Antiviral Agents|antiviral agents|mesh-ancestor
101699787|NCT04069858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101699788|NCT00710086|Remifentanil|remifentanil|mesh-list
101699789|NCT00710086|Hydromorphone|hydromorphone|mesh-list
101699790|NCT00710086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101699791|NCT00710086|Narcotics|narcotics|mesh-ancestor
101699792|NCT00710086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101519076|NCT04831593|Anesthetics|anesthetics|mesh-list
101519079|NCT04667897|Ranibizumab|ranibizumab|mesh-list
101699793|NCT00710086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699794|NCT00710086|Analgesics|analgesics|mesh-ancestor
101699795|NCT00710086|Sensory System Agents|sensory system agents|mesh-ancestor
101699796|NCT00710086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101699797|NCT00652886|Oxandrolone|oxandrolone|mesh-list
101699798|NCT00652886|Androgens|androgens|mesh-ancestor
101699799|NCT00652886|Hormones|hormones|mesh-ancestor
101699800|NCT00652886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101699801|NCT00652886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699802|NCT00652886|Anabolic Agents|anabolic agents|mesh-ancestor
101699803|NCT00539305|Methyltestosterone|methyltestosterone|mesh-list
101699804|NCT00539305|Testosterone|testosterone|mesh-list
101519132|NCT01230892|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101699805|NCT00539305|Testosterone undecanoate|testosterone undecanoate|mesh-list
101699806|NCT00539305|Testosterone enanthate|testosterone enanthate|mesh-list
101699807|NCT00539305|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101699809|NCT00539305|Hormones|hormones|mesh-ancestor
101699810|NCT00539305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101699811|NCT00539305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699812|NCT00539305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101699813|NCT00539305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101699814|NCT00539305|Anabolic Agents|anabolic agents|mesh-ancestor
101699815|NCT02643914|Nicotine|nicotine|mesh-list
101699816|NCT02643914|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101699817|NCT02643914|Autonomic Agents|autonomic agents|mesh-ancestor
101699818|NCT02643914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101699819|NCT02643914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699820|NCT02643914|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101699821|NCT02643914|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101699822|NCT02643914|Cholinergic Agents|cholinergic agents|mesh-ancestor
101699823|NCT02643914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101699824|NCT02643914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699825|NCT00715702|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
101699826|NCT00715702|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101699827|NCT00715702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699828|NCT00715702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101699829|NCT00715702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101699830|NCT00715702|Antiviral Agents|antiviral agents|mesh-ancestor
101699831|NCT00715702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101699833|NCT00990223|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101699834|NCT00990223|Hormone Antagonists|hormone antagonists|mesh-ancestor
101699835|NCT00990223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101699836|NCT00990223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519252|NCT04721457|Plasma Substitutes|plasma substitutes|mesh-ancestor
101699837|NCT00990223|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101699838|NCT00990223|Diuretics|diuretics|mesh-ancestor
101699839|NCT00990223|Natriuretic Agents|natriuretic agents|mesh-ancestor
101699840|NCT00990223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101699841|NCT00715780|Insulin|insulin|mesh-list
101699842|NCT00715780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101699843|NCT00715780|Insulin Aspart|insulin aspart|mesh-list
101699844|NCT00715780|Insulin, Long-Acting|insulin, long-acting|mesh-list
101699845|NCT00715780|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101699846|NCT00715780|Insulin Detemir|insulin detemir|mesh-list
101699847|NCT00715780|Biphasic Insulins|biphasic insulins|mesh-list
101699848|NCT00715780|Isophane Insulin, Human|isophane insulin, human|mesh-list
101357285|NCT00065169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101699849|NCT00715780|Insulin, Isophane|insulin, isophane|mesh-list
101699850|NCT00715780|Isophane insulin, beef|isophane insulin, beef|mesh-list
101699851|NCT00715780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101699852|NCT00715780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699853|NCT02652884|Betamethasone|betamethasone|mesh-list
101699854|NCT02652884|Betamethasone acetate|betamethasone acetate|mesh-list
101699855|NCT02652884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101699856|NCT02652884|Glucocorticoids|glucocorticoids|mesh-ancestor
101699857|NCT02652884|Hormones|hormones|mesh-ancestor
101699858|NCT02652884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101699859|NCT02652884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699860|NCT02652884|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101699861|NCT02652884|Respiratory System Agents|respiratory system agents|mesh-ancestor
101699862|NCT00990301|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101699864|NCT00990301|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101699865|NCT00990301|Diuretics|diuretics|mesh-ancestor
101699866|NCT00990301|Natriuretic Agents|natriuretic agents|mesh-ancestor
101699867|NCT00990301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699868|NCT00990301|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101699869|NCT00990301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101699870|NCT00990301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699871|NCT00990301|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101699872|NCT00990301|Protease Inhibitors|protease inhibitors|mesh-ancestor
101699873|NCT00990301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101699875|NCT00715858|Rifampin|rifampin|mesh-list
101699876|NCT00715858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101699877|NCT00715858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101699878|NCT00715858|Antimalarials|antimalarials|mesh-ancestor
101699879|NCT00715858|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101699880|NCT00715858|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101699881|NCT00715858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101699882|NCT00715858|Antitubercular Agents|antitubercular agents|mesh-ancestor
101699883|NCT00715858|Leprostatic Agents|leprostatic agents|mesh-ancestor
101699884|NCT00715858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101699885|NCT00715858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101519431|NCT04662476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519434|NCT03986424|Memantine|memantine|mesh-list
101699886|NCT00715858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699887|NCT00715858|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101699888|NCT00715858|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101699889|NCT00715858|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101699890|NCT00715858|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101699891|NCT00715858|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101699892|NCT00715858|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101699894|NCT02643680|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101699895|NCT02643680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101699896|NCT02643680|Disinfectants|disinfectants|mesh-ancestor
101519488|NCT00557180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519489|NCT00557180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101699897|NCT04696445|Morphine|morphine|mesh-list
101699898|NCT04696445|Oxycodone|oxycodone|mesh-list
101699899|NCT04696445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101699900|NCT04696445|Narcotics|narcotics|mesh-ancestor
101699901|NCT04696445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101699902|NCT04696445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699903|NCT04696445|Analgesics|analgesics|mesh-ancestor
101699904|NCT04696445|Sensory System Agents|sensory system agents|mesh-ancestor
101699905|NCT04696445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101699906|NCT05360953|Clonidine|clonidine|mesh-list
101699907|NCT05360953|Doxazosin|doxazosin|mesh-list
101699908|NCT05360953|Analgesics|analgesics|mesh-ancestor
101699909|NCT05360953|Sensory System Agents|sensory system agents|mesh-ancestor
101699910|NCT05360953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101519568|NCT04660916|Isotretinoin|isotretinoin|mesh-list
101699911|NCT05360953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699912|NCT05360953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101519569|NCT04660916|Dermatologic Agents|dermatologic agents|mesh-ancestor
101519570|NCT00540150|Immunomodulating Agents|immunomodulating agents|mesh-list
101519571|NCT00540150|Immunologic Factors|immunologic factors|mesh-ancestor
101519572|NCT00540150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519573|NCT01208233|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1H)-one|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1h)-one|mesh-list
101519574|NCT01208233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101519575|NCT01208233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101519576|NCT01208233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101519577|NCT01208233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519578|NCT04660565|Prednisone|prednisone|mesh-list
101519579|NCT04660565|Belimumab|belimumab|mesh-list
101519580|NCT04660565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101519581|NCT04660565|Glucocorticoids|glucocorticoids|mesh-ancestor
101699913|NCT05360953|Sympatholytics|sympatholytics|mesh-ancestor
101699914|NCT05360953|Autonomic Agents|autonomic agents|mesh-ancestor
101699915|NCT05360953|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101699916|NCT05360953|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101699917|NCT05360953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101699918|NCT05360953|Adrenergic Agents|adrenergic agents|mesh-ancestor
101699919|NCT05360953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101261407|NCT01749566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101699920|NCT05360953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699921|NCT05360953|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101699922|NCT05360953|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101699923|NCT05360953|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101357360|NCT00398697|Antimetabolites|antimetabolites|mesh-ancestor
101699926|NCT02647424|Enclomiphene|enclomiphene|mesh-list
101699927|NCT02647424|Zuclomiphene|zuclomiphene|mesh-list
101519612|NCT04659785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101699928|NCT02647424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101699929|NCT02647424|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101699930|NCT02647424|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101699931|NCT02647424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101699932|NCT02647424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699933|NCT02647424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101699934|NCT02647424|Hormone Antagonists|hormone antagonists|mesh-ancestor
101699935|NCT02647424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101699936|NCT02647424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699937|NCT02647424|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101699938|NCT02647424|Fertility Agents|fertility agents|mesh-ancestor
101699939|NCT02647424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101699940|NCT02647424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101699941|NCT02647424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101519680|NCT04659551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101699942|NCT02574754|Warfarin|warfarin|mesh-list
101699943|NCT02574754|Anticoagulants|anticoagulants|mesh-ancestor
101699944|NCT00719602|Ritonavir|ritonavir|mesh-list
101699945|NCT00719602|Lopinavir|lopinavir|mesh-list
101699946|NCT00719602|Lamivudine|lamivudine|mesh-list
101699947|NCT00719602|Zidovudine|zidovudine|mesh-list
101699948|NCT00719602|Nevirapine|nevirapine|mesh-list
101699949|NCT00719602|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101699950|NCT00719602|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101699951|NCT00719602|Protease Inhibitors|protease inhibitors|mesh-ancestor
101699952|NCT00719602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101699953|NCT00719602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699954|NCT00719602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101699955|NCT00719602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101699956|NCT00719602|Antiviral Agents|antiviral agents|mesh-ancestor
101699957|NCT00719602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101699958|NCT00719602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101699959|NCT00719602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101699960|NCT00719602|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101699961|NCT00719602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101699962|NCT00719602|Antimetabolites|antimetabolites|mesh-ancestor
101699963|NCT00719602|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101699964|NCT00719602|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101699965|NCT02652650|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101699966|NCT02652650|Norethindrone|norethindrone|mesh-list
101699967|NCT02652650|Norethindrone Acetate|norethindrone acetate|mesh-list
101699968|NCT02652650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101699969|NCT02652650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101699970|NCT02652650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101699971|NCT02652650|Contraceptive Agents|contraceptive agents|mesh-ancestor
101519732|NCT04658732|Alprazolam|alprazolam|mesh-list
101519733|NCT04658732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101699972|NCT02652650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101699973|NCT02652650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519734|NCT04658732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101699974|NCT02652650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101699975|NCT02652650|Estrogens|estrogens|mesh-ancestor
101699976|NCT02652650|Hormones|hormones|mesh-ancestor
101699977|NCT02652650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101699978|NCT02652650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101699979|NCT02643602|Theophylline|theophylline|mesh-list
101699980|NCT02643602|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101699981|NCT02643602|Autonomic Agents|autonomic agents|mesh-ancestor
101699982|NCT02643602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101699983|NCT02643602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699984|NCT02643602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101699985|NCT02643602|Respiratory System Agents|respiratory system agents|mesh-ancestor
101699986|NCT02643602|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101699987|NCT02643602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101699988|NCT02643602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101699989|NCT02643602|Vasodilator Agents|vasodilator agents|mesh-ancestor
101699990|NCT02643602|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101699991|NCT02643602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101699992|NCT02643602|Purinergic Agents|purinergic agents|mesh-ancestor
101699994|NCT00710320|Anesthetics|anesthetics|mesh-list
101699995|NCT00710320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101699996|NCT00710320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101699997|NCT00716170|Glucagon|glucagon|mesh-list
101357434|NCT00069888|Docetaxel|docetaxel|mesh-list
101699998|NCT00716170|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
101699999|NCT00716170|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101700000|NCT00716170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101700001|NCT00716170|Hormones|hormones|mesh-ancestor
101700002|NCT00716170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101700003|NCT00716170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700004|NCT00716170|Incretins|incretins|mesh-ancestor
101700005|NCT02652806|Epoetin Alfa|epoetin alfa|mesh-list
101700006|NCT02652806|Hematinics|hematinics|mesh-ancestor
101700007|NCT04529135|Dexmedetomidine|dexmedetomidine|mesh-list
101700008|NCT04529135|Remifentanil|remifentanil|mesh-list
101700009|NCT04529135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101700010|NCT04529135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101700011|NCT04529135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700012|NCT04529135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101700013|NCT04529135|Analgesics|analgesics|mesh-ancestor
101700014|NCT04529135|Sensory System Agents|sensory system agents|mesh-ancestor
101700015|NCT04529135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101700016|NCT04529135|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101700017|NCT04529135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101700018|NCT04529135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101700019|NCT04529135|Adrenergic Agents|adrenergic agents|mesh-ancestor
101700020|NCT04529135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101700021|NCT04529135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700022|NCT04529135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101700023|NCT04529135|Narcotics|narcotics|mesh-ancestor
101700024|NCT02647190|Asparaginase|asparaginase|mesh-list
101700025|NCT02647190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101700026|NCT00653042|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101700027|NCT00653042|Natriuretic Agents|natriuretic agents|mesh-ancestor
101700028|NCT00653042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700029|NCT04165850|Ciprofloxacin|ciprofloxacin|mesh-list
101700030|NCT04165850|Celecoxib|celecoxib|mesh-list
101700031|NCT04165850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101700032|NCT04165850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101700033|NCT04165850|Analgesics|analgesics|mesh-ancestor
101700034|NCT04165850|Sensory System Agents|sensory system agents|mesh-ancestor
101519773|NCT00540891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101519774|NCT00540891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101700035|NCT04165850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101700036|NCT04165850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700037|NCT04165850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101700038|NCT04165850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101700039|NCT04165850|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101700040|NCT04165850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101700041|NCT04165850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101700042|NCT04165850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700043|NCT04165850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101700044|NCT04165850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101700045|NCT04165850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101700046|NCT04165850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101700047|NCT04165850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101700048|NCT04165850|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101700049|NCT04165850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101700050|NCT00719758|Beraprost|beraprost|mesh-list
101700051|NCT00719758|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101700052|NCT00719758|Vasodilator Agents|vasodilator agents|mesh-ancestor
101700053|NCT02647268|Magnesium Sulfate|magnesium sulfate|mesh-list
101700054|NCT02647268|Oxytocin|oxytocin|mesh-list
101700055|NCT02647268|Oxytocics|oxytocics|mesh-ancestor
101700056|NCT02647268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101700057|NCT02647268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700058|NCT02647268|Analgesics|analgesics|mesh-ancestor
101700059|NCT02647268|Sensory System Agents|sensory system agents|mesh-ancestor
101700060|NCT02647268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101700061|NCT02647268|Anesthetics|anesthetics|mesh-ancestor
101700062|NCT02647268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101700063|NCT02647268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101700064|NCT02647268|Anticonvulsants|anticonvulsants|mesh-ancestor
101519785|NCT00540930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101700065|NCT02647268|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101700066|NCT02647268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101700067|NCT02647268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700068|NCT02647268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101700070|NCT04218149|Bupivacaine|bupivacaine|mesh-list
101700071|NCT04218149|Anesthetics, Local|anesthetics, local|mesh-ancestor
101357512|NCT00396734|Topiramate|topiramate|mesh-list
101700072|NCT04218149|Anesthetics|anesthetics|mesh-ancestor
101700073|NCT04218149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101700074|NCT04218149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700075|NCT04218149|Sensory System Agents|sensory system agents|mesh-ancestor
101700076|NCT04218149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101700077|NCT04032860|Tenofovir|tenofovir|mesh-list
101700078|NCT04032860|Entecavir|entecavir|mesh-list
101519827|NCT00541086|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101519828|NCT00541086|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101700079|NCT04032860|Antiviral Agents|antiviral agents|mesh-ancestor
101700080|NCT04032860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101700081|NCT04032860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101700082|NCT04032860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101700083|NCT04032860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101700084|NCT04032860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700085|NCT04032860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101700086|NCT04032860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101519890|NCT00541281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101700087|NCT00716248|Bucillamine|bucillamine|mesh-list
101700088|NCT00716248|Methotrexate|methotrexate|mesh-list
101700089|NCT00716248|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101700090|NCT00716248|Abortifacient Agents|abortifacient agents|mesh-ancestor
101700091|NCT00716248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101700092|NCT00716248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700093|NCT00716248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101700094|NCT00716248|Antimetabolites|antimetabolites|mesh-ancestor
101700095|NCT00716248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700096|NCT00716248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101700097|NCT00716248|Dermatologic Agents|dermatologic agents|mesh-ancestor
101700098|NCT00716248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101700099|NCT00716248|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101700100|NCT00716248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101700101|NCT00716248|Immunologic Factors|immunologic factors|mesh-ancestor
101700102|NCT00716248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101520017|NCT00541905|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
101520018|NCT00541905|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101700103|NCT00716248|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101700104|NCT00716248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101700105|NCT00716248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101700106|NCT00716248|Analgesics|analgesics|mesh-ancestor
101700107|NCT00716248|Sensory System Agents|sensory system agents|mesh-ancestor
101700108|NCT00716248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101700109|NCT00716248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101700110|NCT00716248|Antioxidants|antioxidants|mesh-ancestor
101700111|NCT00716248|Protective Agents|protective agents|mesh-ancestor
101700112|NCT02643212|Rivaroxaban|rivaroxaban|mesh-list
101700113|NCT02643212|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101700114|NCT02643212|Antithrombins|antithrombins|mesh-ancestor
101700115|NCT02643212|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101700116|NCT02643212|Protease Inhibitors|protease inhibitors|mesh-ancestor
101700117|NCT02643212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101700118|NCT02643212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700119|NCT02643212|Anticoagulants|anticoagulants|mesh-ancestor
101700121|NCT02642900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101700122|NCT02642900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101700123|NCT02642900|Antifungal Agents|antifungal agents|mesh-ancestor
101700124|NCT02642900|Ionophores|ionophores|mesh-ancestor
101700125|NCT02642900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101700126|NCT02642900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700127|NCT02652728|Enalapril|enalapril|mesh-list
101700128|NCT02652728|Enalaprilat|enalaprilat|mesh-list
101700129|NCT02652728|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101700130|NCT02652728|Protease Inhibitors|protease inhibitors|mesh-ancestor
101700131|NCT02652728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101700132|NCT02652728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700133|NCT02652728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101700134|NCT00720148|Bortezomib|bortezomib|mesh-list
101700135|NCT00720148|Sunitinib|sunitinib|mesh-list
101700136|NCT00720148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101700137|NCT00720148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101700138|NCT00720148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101700139|NCT00720148|Growth Substances|growth substances|mesh-ancestor
101700140|NCT00720148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700141|NCT00720148|Growth Inhibitors|growth inhibitors|mesh-ancestor
101700142|NCT00720148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101700143|NCT00720148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101700144|NCT00720148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700145|NCT00710788|Calcium Carbonate|calcium carbonate|mesh-list
101700146|NCT00710788|Calcium|calcium|mesh-list
101700147|NCT00710788|Sevelamer|sevelamer|mesh-list
101700148|NCT00710788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101700149|NCT00710788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700150|NCT00710788|Antacids|antacids|mesh-ancestor
101700151|NCT00710788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700152|NCT00710788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101700153|NCT00710788|Chelating Agents|chelating agents|mesh-ancestor
101700154|NCT00710788|Sequestering Agents|sequestering agents|mesh-ancestor
101700159|NCT02646800|Antifungal Agents|antifungal agents|mesh-ancestor
101700160|NCT02646800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101700161|NCT02749409|Parecoxib|parecoxib|mesh-list
101700162|NCT02749409|Morphine|morphine|mesh-list
101700163|NCT02749409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101700164|NCT02749409|Narcotics|narcotics|mesh-ancestor
101700165|NCT02749409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101700166|NCT02749409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520132|NCT04685031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700167|NCT02749409|Analgesics|analgesics|mesh-ancestor
101520133|NCT00542763|Mycophenolic Acid|mycophenolic acid|mesh-list
101700168|NCT02749409|Sensory System Agents|sensory system agents|mesh-ancestor
101700169|NCT02749409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101700170|NCT02749409|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101700171|NCT02749409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101535716|NCT00195507|Analgesics|analgesics|mesh-ancestor
101700172|NCT02749409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101700173|NCT02749409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700174|NCT02749409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101700175|NCT02749409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101700176|NCT02749409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101700177|NCT02749409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101700178|NCT03449459|Amikacin|amikacin|mesh-list
101700179|NCT03449459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101700180|NCT03449459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101700181|NCT00653120|Propranolol|propranolol|mesh-list
101700182|NCT00653120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101700183|NCT00653120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101700184|NCT00653120|Adrenergic Agents|adrenergic agents|mesh-ancestor
101700185|NCT00653120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101700186|NCT00653120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700187|NCT00653120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700188|NCT00653120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101700189|NCT00653120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101700190|NCT00653120|Vasodilator Agents|vasodilator agents|mesh-ancestor
101700191|NCT00678132|Gemcitabine|gemcitabine|mesh-list
101700192|NCT00678132|Olaparib|olaparib|mesh-list
101700193|NCT00678132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101700194|NCT00678132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101700195|NCT00678132|Antimetabolites|antimetabolites|mesh-ancestor
101700196|NCT00678132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700197|NCT00678132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101700198|NCT00678132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101700199|NCT02789345|Osimertinib|osimertinib|mesh-list
101700200|NCT02789345|Ramucirumab|ramucirumab|mesh-list
101700201|NCT02789345|Necitumumab|necitumumab|mesh-list
101700202|NCT02789345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101700203|NCT02789345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101700204|NCT02789345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101700205|NCT02789345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700206|NCT02789345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101700207|NCT02772965|Methotrexate|methotrexate|mesh-list
101700208|NCT02772965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101700209|NCT02772965|Abortifacient Agents|abortifacient agents|mesh-ancestor
101700210|NCT02772965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101700211|NCT02772965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700212|NCT02772965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101700213|NCT02772965|Antimetabolites|antimetabolites|mesh-ancestor
101700214|NCT02772965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700215|NCT02772965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101700216|NCT02772965|Dermatologic Agents|dermatologic agents|mesh-ancestor
101700217|NCT02772965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101700218|NCT02772965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101700219|NCT02772965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101700220|NCT02772965|Immunologic Factors|immunologic factors|mesh-ancestor
101700221|NCT02772965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101357664|NCT00066417|Cyclosporine|cyclosporine|mesh-list
101700222|NCT02772965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101700223|NCT00681720|Flumazenil|flumazenil|mesh-list
101700224|NCT00681720|Antidotes|antidotes|mesh-ancestor
101700225|NCT00681720|Protective Agents|protective agents|mesh-ancestor
101700226|NCT00681720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700227|NCT00681720|GABA Modulators|gaba modulators|mesh-ancestor
101700228|NCT00681720|GABA Agents|gaba agents|mesh-ancestor
101700229|NCT00681720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101700230|NCT00681720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700231|NCT00650312|Metformin|metformin|mesh-list
101700232|NCT00650312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101700233|NCT00650312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700234|NCT00538681|Pemetrexed|pemetrexed|mesh-list
101700235|NCT00538681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101700236|NCT00538681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101700237|NCT00538681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700238|NCT00538681|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101700239|NCT00538681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101700240|NCT00650390|Adalimumab|adalimumab|mesh-list
101700241|NCT00650390|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101700242|NCT00650390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101700243|NCT00650390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101700244|NCT00681876|Bevacizumab|bevacizumab|mesh-list
101700245|NCT00681876|Cetuximab|cetuximab|mesh-list
101700246|NCT00681876|Irinotecan|irinotecan|mesh-list
101700247|NCT00681876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101700248|NCT00681876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101700249|NCT00681876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101700250|NCT00681876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101700251|NCT00681876|Growth Substances|growth substances|mesh-ancestor
101700252|NCT00681876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520226|NCT00543231|Oblimersen|oblimersen|mesh-list
101700253|NCT00681876|Growth Inhibitors|growth inhibitors|mesh-ancestor
101700254|NCT00681876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101700255|NCT00681876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101700256|NCT00681876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101700257|NCT00681876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700258|NCT02226367|Prazosin|prazosin|mesh-list
101700259|NCT02226367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101700260|NCT02226367|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101700261|NCT02226367|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101700262|NCT02226367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101700263|NCT02226367|Adrenergic Agents|adrenergic agents|mesh-ancestor
101700264|NCT02226367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101700265|NCT02226367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700266|NCT02226367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700267|NCT03885934|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101700268|NCT03885934|Immunologic Factors|immunologic factors|mesh-ancestor
101700269|NCT03885934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700270|NCT02159989|Aflibercept|aflibercept|mesh-list
101700271|NCT02159989|Endothelial Growth Factors|endothelial growth factors|mesh-list
101700272|NCT02159989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101700273|NCT02159989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101700274|NCT02159989|Growth Substances|growth substances|mesh-ancestor
101700275|NCT02159989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700276|NCT02159989|Growth Inhibitors|growth inhibitors|mesh-ancestor
101700277|NCT02159989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101700278|NCT02628132|Paclitaxel|paclitaxel|mesh-list
101700279|NCT02628132|Durvalumab|durvalumab|mesh-list
101700280|NCT02628132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101700281|NCT02628132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101700282|NCT02628132|Tubulin Modulators|tubulin modulators|mesh-ancestor
101700283|NCT02628132|Antimitotic Agents|antimitotic agents|mesh-ancestor
101700284|NCT02628132|Mitosis Modulators|mitosis modulators|mesh-ancestor
101700285|NCT02628132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700286|NCT02628132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101700287|NCT02695355|Methylphenidate|methylphenidate|mesh-list
101700288|NCT02695355|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101700289|NCT02695355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700290|NCT02695355|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101700291|NCT02695355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101700292|NCT02695355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101700293|NCT02695355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700294|NCT02695355|Dopamine Agents|dopamine agents|mesh-ancestor
101700295|NCT02695355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101700297|NCT02573038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101700298|NCT02573038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101700299|NCT02573038|Growth Substances|growth substances|mesh-ancestor
101700300|NCT02573038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700301|NCT02573038|Growth Inhibitors|growth inhibitors|mesh-ancestor
101520238|NCT04651556|Bupivacaine|bupivacaine|mesh-list
101700302|NCT02573038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101700303|NCT02159755|Palbociclib|palbociclib|mesh-list
101700304|NCT02159755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101700305|NCT02159755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101700306|NCT02159755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101700307|NCT02159755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700309|NCT01822015|Sirolimus|sirolimus|mesh-list
101700310|NCT01822015|Idarubicin|idarubicin|mesh-list
101700311|NCT01822015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101700312|NCT01822015|Antimetabolites|antimetabolites|mesh-ancestor
101700313|NCT01822015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700314|NCT01822015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101700315|NCT01822015|Antiviral Agents|antiviral agents|mesh-ancestor
101700316|NCT01822015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101700317|NCT01822015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101700318|NCT01822015|Immunologic Factors|immunologic factors|mesh-ancestor
101700319|NCT01822015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700320|NCT01822015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101700321|NCT01822015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101700322|NCT01822015|Antifungal Agents|antifungal agents|mesh-ancestor
101700323|NCT01822015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101700324|NCT01822015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101700325|NCT01822015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101700326|NCT00990535|Octreotide|octreotide|mesh-list
101700327|NCT00990535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101700328|NCT00990535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101700329|NCT00990535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101700330|NCT05590897|Anti-Infective Agents|anti-infective agents|mesh-list
101700331|NCT05590897|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101700332|NCT00720304|Docetaxel|docetaxel|mesh-list
101700333|NCT00720304|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101700334|NCT00720304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101700335|NCT00720304|Tubulin Modulators|tubulin modulators|mesh-ancestor
101700336|NCT00720304|Antimitotic Agents|antimitotic agents|mesh-ancestor
101700337|NCT00720304|Mitosis Modulators|mitosis modulators|mesh-ancestor
101700338|NCT00720304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700339|NCT00720304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101700340|NCT00720304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101700341|NCT00682344|Levobupivacaine|levobupivacaine|mesh-list
101700342|NCT00682344|Anesthetics, Local|anesthetics, local|mesh-ancestor
101700343|NCT00682344|Anesthetics|anesthetics|mesh-ancestor
101520261|NCT04651049|Propranolol|propranolol|mesh-list
101520262|NCT04651049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101700344|NCT00682344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101700345|NCT00682344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700346|NCT00682344|Sensory System Agents|sensory system agents|mesh-ancestor
101700347|NCT00682344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101700348|NCT00990691|Desipramine|desipramine|mesh-list
101700349|NCT00990691|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101700350|NCT00990691|Antidepressive Agents|antidepressive agents|mesh-ancestor
101700351|NCT00990691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101700352|NCT00990691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101700353|NCT00990691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700354|NCT00990691|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101700355|NCT00990691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101700356|NCT00990691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101700357|NCT00990691|Adrenergic Agents|adrenergic agents|mesh-ancestor
101700358|NCT00990691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101700359|NCT00990691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700360|NCT00678522|Atorvastatin|atorvastatin|mesh-list
101700361|NCT00678522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101700362|NCT00678522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101700363|NCT00678522|Antimetabolites|antimetabolites|mesh-ancestor
101700364|NCT00678522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700365|NCT00678522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101700366|NCT00678522|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101700367|NCT00678522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101700368|NCT04391855|Dexmedetomidine|dexmedetomidine|mesh-list
101700369|NCT04391855|Tramadol|tramadol|mesh-list
101700370|NCT04391855|Ropivacaine|ropivacaine|mesh-list
101700371|NCT04391855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101700372|NCT04391855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101700373|NCT04391855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700374|NCT04391855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101700376|NCT04391855|Sensory System Agents|sensory system agents|mesh-ancestor
101700377|NCT04391855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101700378|NCT04391855|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101700379|NCT04391855|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101700380|NCT04391855|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101700381|NCT04391855|Adrenergic Agents|adrenergic agents|mesh-ancestor
101700382|NCT04391855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101700383|NCT04391855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700384|NCT04391855|Anesthetics, Local|anesthetics, local|mesh-ancestor
101700385|NCT04391855|Anesthetics|anesthetics|mesh-ancestor
101700386|NCT04391855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101700387|NCT04391855|Narcotics|narcotics|mesh-ancestor
101700388|NCT00716950|Losartan|losartan|mesh-list
101700389|NCT00716950|Valsartan|valsartan|mesh-list
101700390|NCT00716950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101700391|NCT00716950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101700392|NCT00716950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101700393|NCT00716950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700394|NCT00716950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101700395|NCT00711178|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101700396|NCT00711178|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
101700397|NCT00711178|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101520294|NCT00557921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101520295|NCT00557921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101520310|NCT02352558|Dexamethasone|dexamethasone|mesh-list
101700398|NCT00711178|Dermatologic Agents|dermatologic agents|mesh-ancestor
101700400|NCT00678756|Antifungal Agents|antifungal agents|mesh-ancestor
101700401|NCT00678756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101700402|NCT00678756|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101700403|NCT00678756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101700404|NCT00678756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101700405|NCT00678756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700406|NCT00678756|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101700407|NCT00678756|Hormone Antagonists|hormone antagonists|mesh-ancestor
101700408|NCT00678756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101700409|NCT00678756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700410|NCT00678756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101700411|NCT02748395|Triamcinolone|triamcinolone|mesh-list
101700412|NCT02748395|Lidocaine|lidocaine|mesh-list
101700413|NCT02748395|Anesthetics, Local|anesthetics, local|mesh-ancestor
101700414|NCT02748395|Anesthetics|anesthetics|mesh-ancestor
101700415|NCT02748395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101700416|NCT02748395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700417|NCT02748395|Sensory System Agents|sensory system agents|mesh-ancestor
101700418|NCT02748395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101700419|NCT02748395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101700420|NCT02748395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101700421|NCT02748395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101700422|NCT02748395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101700423|NCT02748395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700424|NCT02748395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101700425|NCT02748395|Glucocorticoids|glucocorticoids|mesh-ancestor
101700426|NCT02748395|Hormones|hormones|mesh-ancestor
101700427|NCT02748395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101700428|NCT02629224|Gabapentin|gabapentin|mesh-list
101700429|NCT02629224|Analgesics|analgesics|mesh-ancestor
101700430|NCT02629224|Sensory System Agents|sensory system agents|mesh-ancestor
101700431|NCT02629224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101700432|NCT02629224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700433|NCT02629224|Anticonvulsants|anticonvulsants|mesh-ancestor
101700434|NCT02629224|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101700435|NCT02629224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101700436|NCT02629224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101700437|NCT02629224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101700438|NCT02629224|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101700439|NCT02629224|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101700440|NCT02629224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101700441|NCT02629224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700442|NCT02629224|Antimanic Agents|antimanic agents|mesh-ancestor
101700443|NCT00711256|Sunscreening Agents|sunscreening agents|mesh-list
101700444|NCT00711256|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101700445|NCT00711256|Protective Agents|protective agents|mesh-ancestor
101700446|NCT00711256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700447|NCT00711256|Dermatologic Agents|dermatologic agents|mesh-ancestor
101700448|NCT04069234|Clopidogrel|clopidogrel|mesh-list
101700449|NCT04069234|Ticagrelor|ticagrelor|mesh-list
101700450|NCT04069234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101700451|NCT04069234|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101700452|NCT04069234|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101700453|NCT04069234|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101700454|NCT04069234|Purinergic Agents|purinergic agents|mesh-ancestor
101700455|NCT04069234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101700456|NCT04069234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700457|NCT04069234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520313|NCT02352558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101520314|NCT02352558|Antiemetics|antiemetics|mesh-ancestor
101700458|NCT04374773|Dronabinol|dronabinol|mesh-list
101700459|NCT04374773|Hallucinogens|hallucinogens|mesh-ancestor
101700460|NCT04374773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700461|NCT04374773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101700462|NCT04374773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101700463|NCT04374773|Analgesics|analgesics|mesh-ancestor
101700464|NCT04374773|Sensory System Agents|sensory system agents|mesh-ancestor
101700465|NCT04374773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101700466|NCT04374773|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101700467|NCT04374773|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101700468|NCT04374773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101700469|NCT04374773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700470|NCT04374773|Hormones|hormones|mesh-ancestor
101700471|NCT04374773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101700472|NCT00720538|Thalidomide|thalidomide|mesh-list
101700473|NCT00720538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101700474|NCT00720538|Immunologic Factors|immunologic factors|mesh-ancestor
101700475|NCT00720538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700476|NCT00720538|Leprostatic Agents|leprostatic agents|mesh-ancestor
101700477|NCT00720538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101700478|NCT00720538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101700479|NCT00720538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101700480|NCT00720538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101700481|NCT00720538|Growth Substances|growth substances|mesh-ancestor
101700482|NCT00720538|Growth Inhibitors|growth inhibitors|mesh-ancestor
101700483|NCT00720538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101700484|NCT00678990|Heparin|heparin|mesh-list
101700485|NCT00678990|Anticoagulants|anticoagulants|mesh-ancestor
101700486|NCT00678990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101700487|NCT00678990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101700488|NCT00678990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700489|NCT00679068|Bosentan|bosentan|mesh-list
101700490|NCT00679068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101700491|NCT00679068|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101700492|NCT00679068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700493|NCT00679146|Ketoprofen|ketoprofen|mesh-list
101700494|NCT00679146|Colchicine|colchicine|mesh-list
101700495|NCT00679146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101700496|NCT00679146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101700497|NCT00679146|Analgesics|analgesics|mesh-ancestor
101700498|NCT00679146|Sensory System Agents|sensory system agents|mesh-ancestor
101700499|NCT00679146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101700500|NCT00679146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700501|NCT00679146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101700502|NCT00679146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101700503|NCT00679146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101700504|NCT00679146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101700505|NCT00679146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700506|NCT00679146|Gout Suppressants|gout suppressants|mesh-ancestor
101700507|NCT00679146|Tubulin Modulators|tubulin modulators|mesh-ancestor
101700508|NCT00679146|Antimitotic Agents|antimitotic agents|mesh-ancestor
101700509|NCT00679146|Mitosis Modulators|mitosis modulators|mesh-ancestor
101700510|NCT00679146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101700511|NCT00679224|Ambrisentan|ambrisentan|mesh-list
101700512|NCT00679224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101700513|NCT02748005|Fenugreek seed meal|fenugreek seed meal|mesh-list
101700514|NCT02748005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101700515|NCT02748005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357992|NCT00067509|Estrogens|estrogens|mesh-list
101700517|NCT00990847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101700518|NCT00990847|Autonomic Agents|autonomic agents|mesh-ancestor
101700519|NCT00990847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101700520|NCT00990847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700521|NCT00990847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101520323|NCT02352558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101520324|NCT02352558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101520325|NCT02352558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101700522|NCT00990847|Respiratory System Agents|respiratory system agents|mesh-ancestor
101700523|NCT00990847|Sympathomimetics|sympathomimetics|mesh-ancestor
101700524|NCT00990847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101700525|NCT00990847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101700526|NCT00990847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101700527|NCT00990847|Adrenergic Agents|adrenergic agents|mesh-ancestor
101700528|NCT00990847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101700529|NCT00990847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700530|NCT00594516|Tapentadol|tapentadol|mesh-list
101700531|NCT00594516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101700532|NCT00594516|Narcotics|narcotics|mesh-ancestor
101700533|NCT00594516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101700534|NCT00594516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700535|NCT00594516|Analgesics|analgesics|mesh-ancestor
101700536|NCT00594516|Sensory System Agents|sensory system agents|mesh-ancestor
101700537|NCT00594516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101700538|NCT00594516|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101700539|NCT00594516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101700540|NCT00594516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101700541|NCT00594516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700542|NCT00594516|Adrenergic Agents|adrenergic agents|mesh-ancestor
101700543|NCT00594516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101700544|NCT00682500|Calfactant|calfactant|mesh-list
101700545|NCT00682500|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
101700546|NCT00682500|Respiratory System Agents|respiratory system agents|mesh-ancestor
101700547|NCT00538291|Capecitabine|capecitabine|mesh-list
101700548|NCT00538291|Cetuximab|cetuximab|mesh-list
101700549|NCT00538291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101700550|NCT00538291|Antimetabolites|antimetabolites|mesh-ancestor
101700551|NCT00538291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700552|NCT00538291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101700553|NCT00538291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101700554|NCT00682578|Artesunate|artesunate|mesh-list
101700555|NCT00682578|Chloroquine|chloroquine|mesh-list
101700556|NCT00682578|Pyrimethamine|pyrimethamine|mesh-list
101700557|NCT00682578|Piperaquine|piperaquine|mesh-list
101700558|NCT00682578|Artenimol|artenimol|mesh-list
101700559|NCT00682578|Antimalarials|antimalarials|mesh-ancestor
101700560|NCT00682578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101700561|NCT00682578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101700562|NCT00682578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101700563|NCT00682578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101700564|NCT00682578|Antiviral Agents|antiviral agents|mesh-ancestor
101700565|NCT00682578|Schistosomicides|schistosomicides|mesh-ancestor
101700566|NCT00682578|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101700567|NCT00682578|Anthelmintics|anthelmintics|mesh-ancestor
101700568|NCT00682578|Amebicides|amebicides|mesh-ancestor
101700569|NCT00682578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101700570|NCT00682578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101700571|NCT00682578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101700572|NCT00682578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700573|NCT00594906|Teriparatide|teriparatide|mesh-list
101700574|NCT00594906|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101700575|NCT00594906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700576|NCT00594906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101700577|NCT02745431|Oxytocin|oxytocin|mesh-list
101700578|NCT02745431|Oxytocics|oxytocics|mesh-ancestor
101700579|NCT02745431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101700580|NCT02745431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700581|NCT00682656|Azithromycin|azithromycin|mesh-list
101700583|NCT00682656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101520331|NCT02324283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520332|NCT02324283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101520333|NCT02324283|Anesthetics, General|anesthetics, general|mesh-ancestor
101520334|NCT02324283|Anesthetics|anesthetics|mesh-ancestor
101520335|NCT02324283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101520336|NCT00557960|Amphetamine|amphetamine|mesh-list
101700584|NCT00682656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101700585|NCT00682656|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101700586|NCT00682656|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101700588|NCT05590117|Fluorouracil|fluorouracil|mesh-list
101700589|NCT05590117|Oxaliplatin|oxaliplatin|mesh-list
101700590|NCT05590117|Pentoxifylline|pentoxifylline|mesh-list
101700591|NCT05590117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700592|NCT05590117|Antimetabolites|antimetabolites|mesh-ancestor
101700593|NCT05590117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700594|NCT05590117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101700595|NCT05590117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101700596|NCT05590117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101700598|NCT05590117|Antidotes|antidotes|mesh-ancestor
101700599|NCT05590117|Protective Agents|protective agents|mesh-ancestor
101700600|NCT05590117|Vitamin B Complex|vitamin b complex|mesh-ancestor
101700601|NCT05590117|Vitamins|vitamins|mesh-ancestor
101700602|NCT05590117|Micronutrients|micronutrients|mesh-ancestor
101700603|NCT05590117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101700604|NCT05590117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101700605|NCT05590117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101700606|NCT05590117|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101700607|NCT05590117|Vasodilator Agents|vasodilator agents|mesh-ancestor
101700608|NCT05590117|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101700609|NCT05590117|Antioxidants|antioxidants|mesh-ancestor
101700610|NCT00636311|Gemcitabine|gemcitabine|mesh-list
101700611|NCT00636311|Bortezomib|bortezomib|mesh-list
101700612|NCT00636311|Vinorelbine|vinorelbine|mesh-list
101700613|NCT00636311|Ifosfamide|ifosfamide|mesh-list
101700614|NCT00636311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101700615|NCT00636311|Antimetabolites|antimetabolites|mesh-ancestor
101700616|NCT00636311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700617|NCT00636311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101700618|NCT00636311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101700619|NCT00636311|Tubulin Modulators|tubulin modulators|mesh-ancestor
101700620|NCT00636311|Antimitotic Agents|antimitotic agents|mesh-ancestor
101700621|NCT00636311|Mitosis Modulators|mitosis modulators|mesh-ancestor
101700622|NCT00636311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101700623|NCT00636311|Alkylating Agents|alkylating agents|mesh-ancestor
101700624|NCT00679458|Buprenorphine|buprenorphine|mesh-list
101700625|NCT00679458|Naloxone|naloxone|mesh-list
101700626|NCT00679458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101700627|NCT00679458|Narcotics|narcotics|mesh-ancestor
101700628|NCT00679458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101700629|NCT00679458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700630|NCT00679458|Analgesics|analgesics|mesh-ancestor
101700631|NCT00679458|Sensory System Agents|sensory system agents|mesh-ancestor
101700632|NCT00679458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101700633|NCT00679458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101700634|NCT04216511|Autoantibodies|autoantibodies|mesh-list
101700635|NCT04216511|Immunologic Factors|immunologic factors|mesh-ancestor
101700636|NCT04216511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700637|NCT02747537|Irinotecan|irinotecan|mesh-list
101700638|NCT02747537|Sorafenib|sorafenib|mesh-list
101700639|NCT02747537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101700640|NCT02747537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101700641|NCT02747537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101700642|NCT02747537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700643|NCT02747537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101700644|NCT02747537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101700645|NCT02747381|Alfacalcidol|alfacalcidol|mesh-list
101700646|NCT02747381|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
101700647|NCT02747381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101700648|NCT02747381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700649|NCT02747381|Vitamins|vitamins|mesh-ancestor
101520341|NCT00557960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101520343|NCT00557960|Adrenergic Agents|adrenergic agents|mesh-ancestor
101700650|NCT02747381|Micronutrients|micronutrients|mesh-ancestor
101700651|NCT00673218|Omalizumab|omalizumab|mesh-list
101700652|NCT00673218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101700653|NCT00673218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101700654|NCT00673218|Respiratory System Agents|respiratory system agents|mesh-ancestor
101700655|NCT00673296|Bevacizumab|bevacizumab|mesh-list
101700656|NCT00673296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101700657|NCT00673296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101700658|NCT00673296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101700659|NCT00673296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101700660|NCT00673296|Growth Substances|growth substances|mesh-ancestor
101700661|NCT00673296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700662|NCT00673296|Growth Inhibitors|growth inhibitors|mesh-ancestor
101700664|NCT04216355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101700665|NCT04216355|Antimetabolites|antimetabolites|mesh-ancestor
101700666|NCT04216355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700667|NCT04216355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101700668|NCT04216355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101700669|NCT00683124|Losartan|losartan|mesh-list
101700670|NCT00683124|Nebivolol|nebivolol|mesh-list
101700671|NCT00683124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101700672|NCT00683124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101700673|NCT00683124|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101700674|NCT00683124|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101700675|NCT00683124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700676|NCT00683124|Vasodilator Agents|vasodilator agents|mesh-ancestor
101700677|NCT00683124|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101700678|NCT00683124|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101700679|NCT00683124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101700680|NCT00683124|Adrenergic Agents|adrenergic agents|mesh-ancestor
101700681|NCT00683124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101700682|NCT00683124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700683|NCT02744729|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
101700684|NCT02744729|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101700685|NCT02744729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700686|NCT00683202|Aspirin|aspirin|mesh-list
101700687|NCT00683202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101700688|NCT00683202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101700690|NCT00683202|Sensory System Agents|sensory system agents|mesh-ancestor
101700691|NCT00683202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101700692|NCT00683202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700693|NCT00683202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101700694|NCT00683202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101700695|NCT00683202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101700696|NCT00683202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101700697|NCT00683202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700698|NCT00683202|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101700699|NCT00683202|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101700700|NCT00683202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101700701|NCT00683202|Antipyretics|antipyretics|mesh-ancestor
101700702|NCT00679536|Fludarabine|fludarabine|mesh-list
101700703|NCT00679536|Busulfan|busulfan|mesh-list
101700704|NCT00679536|Thymoglobulin|thymoglobulin|mesh-list
101700705|NCT00679536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101700706|NCT00679536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700707|NCT00679536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101700708|NCT00679536|Immunologic Factors|immunologic factors|mesh-ancestor
101520349|NCT00557960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101520350|NCT00557960|Dopamine Agents|dopamine agents|mesh-ancestor
101520351|NCT00557960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101520352|NCT00558077|Metformin|metformin|mesh-list
101520353|NCT00558077|Clomiphene|clomiphene|mesh-list
101700709|NCT00679536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700710|NCT00679536|Alkylating Agents|alkylating agents|mesh-ancestor
101700711|NCT00679536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101700712|NCT00679536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101700713|NCT00537979|Ergocalciferols|ergocalciferols|mesh-list
101700714|NCT00537979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101700715|NCT00537979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700716|NCT00537979|Vitamins|vitamins|mesh-ancestor
101700717|NCT00537979|Micronutrients|micronutrients|mesh-ancestor
101700718|NCT00537979|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101700719|NCT00679614|Acetaminophen|acetaminophen|mesh-list
101700720|NCT00679614|Tramadol|tramadol|mesh-list
101700721|NCT00679614|Naloxone|naloxone|mesh-list
101700722|NCT00679614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101700723|NCT00679614|Analgesics|analgesics|mesh-ancestor
101700724|NCT00679614|Sensory System Agents|sensory system agents|mesh-ancestor
101700725|NCT00679614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101700726|NCT00679614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700727|NCT00679614|Antipyretics|antipyretics|mesh-ancestor
101700728|NCT00679614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101700729|NCT00679614|Narcotics|narcotics|mesh-ancestor
101700730|NCT00679614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101700731|NCT00679614|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101700732|NCT02744417|Bupropion|bupropion|mesh-list
101700733|NCT02744417|Nicotine|nicotine|mesh-list
101700734|NCT02744417|Varenicline|varenicline|mesh-list
101700735|NCT02744417|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101700737|NCT02744417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101700738|NCT02744417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700739|NCT02744417|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101700740|NCT02744417|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101700741|NCT02744417|Cholinergic Agents|cholinergic agents|mesh-ancestor
101700742|NCT02744417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101700743|NCT02744417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700744|NCT02744417|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101700745|NCT02744417|Antidepressive Agents|antidepressive agents|mesh-ancestor
101700746|NCT02744417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101700747|NCT02744417|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101700748|NCT02744417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101700749|NCT02744417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101700750|NCT02744417|Dopamine Agents|dopamine agents|mesh-ancestor
101700751|NCT02744417|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101700752|NCT02744417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101700753|NCT02744417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101700754|NCT02629146|Fentanyl|fentanyl|mesh-list
101700755|NCT02629146|Midazolam|midazolam|mesh-list
101700756|NCT02629146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101700757|NCT02629146|Narcotics|narcotics|mesh-ancestor
101700758|NCT02629146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101700759|NCT02629146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700760|NCT02629146|Analgesics|analgesics|mesh-ancestor
101700761|NCT02629146|Sensory System Agents|sensory system agents|mesh-ancestor
101700762|NCT02629146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101700763|NCT02629146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101700764|NCT02629146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101700765|NCT02629146|Anesthetics, General|anesthetics, general|mesh-ancestor
101700766|NCT02629146|Anesthetics|anesthetics|mesh-ancestor
101700767|NCT02629146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101700768|NCT02629146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101700769|NCT02629146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101700770|NCT02629146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101700771|NCT02629146|GABA Modulators|gaba modulators|mesh-ancestor
101520364|NCT00558077|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101520365|NCT00558077|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101700772|NCT02629146|GABA Agents|gaba agents|mesh-ancestor
101700773|NCT02629146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101700774|NCT02629146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700776|NCT02744339|Enzyme Activators|enzyme activators|mesh-ancestor
101700777|NCT02744339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700778|NCT00991159|Bococizumab|bococizumab|mesh-list
101700779|NCT00991159|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101700780|NCT00991159|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101700781|NCT00991159|Antimetabolites|antimetabolites|mesh-ancestor
101700782|NCT00991159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700783|NCT00991159|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101700784|NCT00679770|Tavaborole|tavaborole|mesh-list
101700785|NCT00679770|Antifungal Agents|antifungal agents|mesh-ancestor
101700786|NCT00679770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101700787|NCT02744495|Betamethasone|betamethasone|mesh-list
101700788|NCT02744495|Droperidol|droperidol|mesh-list
101700789|NCT02744495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101700790|NCT02744495|Glucocorticoids|glucocorticoids|mesh-ancestor
101700791|NCT02744495|Hormones|hormones|mesh-ancestor
101700792|NCT02744495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101700793|NCT02744495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700794|NCT02744495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101700795|NCT02744495|Respiratory System Agents|respiratory system agents|mesh-ancestor
101700796|NCT02744495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101700797|NCT02744495|Antiemetics|antiemetics|mesh-ancestor
101700798|NCT02744495|Autonomic Agents|autonomic agents|mesh-ancestor
101700799|NCT02744495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101700800|NCT02744495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101700801|NCT02744495|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101700802|NCT02744495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101700803|NCT02744495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101700804|NCT02744495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101700805|NCT02744495|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101700806|NCT02744495|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101700807|NCT02744495|Dopamine Agents|dopamine agents|mesh-ancestor
101700808|NCT02744495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101700809|NCT02744495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700810|NCT00683358|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101700811|NCT00683358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101700812|NCT00683358|Immunologic Factors|immunologic factors|mesh-ancestor
101700813|NCT00683358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700814|NCT00683436|Adipiplon|adipiplon|mesh-list
101700815|NCT00683436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101700816|NCT00683436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700817|NCT00683436|GABA Agonists|gaba agonists|mesh-ancestor
101700818|NCT00683436|GABA Agents|gaba agents|mesh-ancestor
101700819|NCT00683436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101700820|NCT00683436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700821|NCT00683436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101700822|NCT00683436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101700823|NCT00683436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101700824|NCT00989443|Cidofovir|cidofovir|mesh-list
101700825|NCT00989443|Antiviral Agents|antiviral agents|mesh-ancestor
101700826|NCT00989443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101700827|NCT00989443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101700828|NCT00989443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700829|NCT00683514|Cisplatin|cisplatin|mesh-list
101700830|NCT00683514|Vinorelbine|vinorelbine|mesh-list
101700832|NCT00683514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101700833|NCT00683514|Tubulin Modulators|tubulin modulators|mesh-ancestor
101700834|NCT00683514|Antimitotic Agents|antimitotic agents|mesh-ancestor
101700835|NCT00683514|Mitosis Modulators|mitosis modulators|mesh-ancestor
101700836|NCT00683514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700837|NCT00683670|Cyclophosphamide|cyclophosphamide|mesh-list
101700838|NCT00683670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101700839|NCT00683670|Immunologic Factors|immunologic factors|mesh-ancestor
101520374|NCT05077254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700840|NCT00683670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700841|NCT00683670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101700842|NCT00683670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101700843|NCT00683670|Alkylating Agents|alkylating agents|mesh-ancestor
101700844|NCT00683670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700845|NCT00683670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101700846|NCT00683670|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101700847|NCT05629325|Buspirone|buspirone|mesh-list
101700848|NCT05629325|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101700849|NCT05629325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101700850|NCT05629325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101700851|NCT05629325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700852|NCT05629325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101700853|NCT05629325|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101700854|NCT05629325|Serotonin Agents|serotonin agents|mesh-ancestor
101700855|NCT05629325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101700856|NCT05629325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700857|NCT02629380|Hyaluronic Acid|hyaluronic acid|mesh-list
101700858|NCT02629380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101700859|NCT02629380|Immunologic Factors|immunologic factors|mesh-ancestor
101700860|NCT02629380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700861|NCT02629380|Viscosupplements|viscosupplements|mesh-ancestor
101700862|NCT02629380|Protective Agents|protective agents|mesh-ancestor
101700863|NCT02743247|Mycophenolic Acid|mycophenolic acid|mesh-list
101700864|NCT02743247|Tacrolimus|tacrolimus|mesh-list
101700865|NCT02743247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101700866|NCT02743247|Immunologic Factors|immunologic factors|mesh-ancestor
101700867|NCT02743247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700868|NCT02743247|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101700869|NCT02743247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101700870|NCT02743247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700871|NCT02743247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101700872|NCT02743247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101700873|NCT02743247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101700874|NCT02743247|Antitubercular Agents|antitubercular agents|mesh-ancestor
101700875|NCT02743247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101700876|NCT02743247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101700877|NCT00680160|Tavaborole|tavaborole|mesh-list
101700878|NCT00680160|Antifungal Agents|antifungal agents|mesh-ancestor
101700879|NCT00680160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101700880|NCT00683982|Nitazoxanide|nitazoxanide|mesh-list
101700881|NCT00683982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101700882|NCT00683982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101700883|NCT02742623|Rivaroxaban|rivaroxaban|mesh-list
101700884|NCT02742623|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101700885|NCT02742623|Antithrombins|antithrombins|mesh-ancestor
101700886|NCT02742623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101700887|NCT02742623|Protease Inhibitors|protease inhibitors|mesh-ancestor
101700888|NCT02742623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101700889|NCT02742623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700891|NCT00537823|Leucovorin|leucovorin|mesh-list
101700892|NCT00537823|Bevacizumab|bevacizumab|mesh-list
101700893|NCT00537823|Cetuximab|cetuximab|mesh-list
101700894|NCT00537823|Fluorouracil|fluorouracil|mesh-list
101700895|NCT00537823|Oxaliplatin|oxaliplatin|mesh-list
101700896|NCT00537823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101700897|NCT00537823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358346|NCT00203281|Tacrolimus|tacrolimus|mesh-list
101700898|NCT00537823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101700899|NCT00537823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101700900|NCT00537823|Growth Substances|growth substances|mesh-ancestor
101700901|NCT00537823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700902|NCT00537823|Growth Inhibitors|growth inhibitors|mesh-ancestor
101700903|NCT00537823|Antimetabolites|antimetabolites|mesh-ancestor
101700904|NCT00537823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700905|NCT00537823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101700906|NCT00537823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101520381|NCT00543504|Bevacizumab|bevacizumab|mesh-list
101520382|NCT00543504|Trastuzumab|trastuzumab|mesh-list
101700907|NCT00537823|Immunologic Factors|immunologic factors|mesh-ancestor
101700908|NCT00537823|Antidotes|antidotes|mesh-ancestor
101700909|NCT00537823|Protective Agents|protective agents|mesh-ancestor
101700910|NCT00537823|Vitamin B Complex|vitamin b complex|mesh-ancestor
101700912|NCT00537823|Micronutrients|micronutrients|mesh-ancestor
101700913|NCT04139928|Magnesium citrate|magnesium citrate|mesh-list
101700914|NCT04139928|Magnesium Oxide|magnesium oxide|mesh-list
101700915|NCT04139928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700916|NCT04139928|Cathartics|cathartics|mesh-ancestor
101700917|NCT04139928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101700918|NCT04139928|Antacids|antacids|mesh-ancestor
101700919|NCT05589025|Eugenol|eugenol|mesh-list
101700920|NCT05589025|Zinc Oxide|zinc oxide|mesh-list
101700921|NCT05589025|Dermatologic Agents|dermatologic agents|mesh-ancestor
101700922|NCT05589025|Sunscreening Agents|sunscreening agents|mesh-ancestor
101700923|NCT05589025|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101700924|NCT05589025|Protective Agents|protective agents|mesh-ancestor
101700925|NCT05589025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700926|NCT05589025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101700927|NCT02742233|Saxagliptin|saxagliptin|mesh-list
101700928|NCT02742233|Incretins|incretins|mesh-ancestor
101700929|NCT02742233|Hormones|hormones|mesh-ancestor
101700930|NCT02742233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101700931|NCT02742233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700932|NCT02742233|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101700933|NCT02742233|Protease Inhibitors|protease inhibitors|mesh-ancestor
101700934|NCT02742233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101700935|NCT02742233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700936|NCT02742233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101700937|NCT00673608|Deferasirox|deferasirox|mesh-list
101700938|NCT00673608|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101700939|NCT00673608|Chelating Agents|chelating agents|mesh-ancestor
101700940|NCT00673608|Sequestering Agents|sequestering agents|mesh-ancestor
101700941|NCT00673608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700942|NCT00537277|Insulin Aspart|insulin aspart|mesh-list
101700943|NCT00537277|Biphasic Insulins|biphasic insulins|mesh-list
101700944|NCT00537277|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101700945|NCT00537277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101700946|NCT00537277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700947|NCT02742467|Amlodipine|amlodipine|mesh-list
101700948|NCT02742467|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101700949|NCT02742467|Perindopril|perindopril|mesh-list
101700950|NCT02742467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101700951|NCT02742467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101700952|NCT02742467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101700953|NCT02742467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700954|NCT02742467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101700955|NCT02742467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700956|NCT02742467|Vasodilator Agents|vasodilator agents|mesh-ancestor
101700957|NCT02742467|Diuretics|diuretics|mesh-ancestor
101700958|NCT02742467|Natriuretic Agents|natriuretic agents|mesh-ancestor
101700959|NCT02742467|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101700960|NCT02742467|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101700961|NCT02742467|Protease Inhibitors|protease inhibitors|mesh-ancestor
101700962|NCT02742467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101700963|NCT00684216|Tamoxifen|tamoxifen|mesh-list
101700964|NCT00684216|Capecitabine|capecitabine|mesh-list
101700965|NCT00684216|Letrozole|letrozole|mesh-list
101520390|NCT00543504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101700967|NCT00684216|Exemestane|exemestane|mesh-list
101700968|NCT00684216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101700969|NCT00684216|Antimetabolites|antimetabolites|mesh-ancestor
101700970|NCT00684216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700971|NCT00684216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101700972|NCT00684216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101700973|NCT00684216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101700974|NCT00684216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101700975|NCT00684216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101700976|NCT00684216|Hormone Antagonists|hormone antagonists|mesh-ancestor
101700977|NCT00684216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101700978|NCT00684216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700979|NCT00684216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101700980|NCT00684216|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101700981|NCT00684216|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101700982|NCT00684216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101700983|NCT00684450|Protamines|protamines|mesh-list
101700984|NCT00684450|Heparin Antagonists|heparin antagonists|mesh-ancestor
101700985|NCT00684450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700986|NCT00684450|Coagulants|coagulants|mesh-ancestor
101700987|NCT00684528|Metformin|metformin|mesh-list
101700988|NCT00684528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101700989|NCT00684528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700990|NCT00684606|Oxytocin|oxytocin|mesh-list
101700991|NCT00684606|Oxytocics|oxytocics|mesh-ancestor
101700992|NCT00684606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101700993|NCT00684606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101700994|NCT00684372|Leflunomide|leflunomide|mesh-list
101700995|NCT00684372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101700996|NCT00684372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101700997|NCT00684372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101700998|NCT00684372|Immunologic Factors|immunologic factors|mesh-ancestor
101700999|NCT00684372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701000|NCT00673686|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
101701001|NCT00673686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101701002|NCT00673686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701003|NCT04334915|Cenicriviroc|cenicriviroc|mesh-list
101701004|NCT04334915|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101701005|NCT04334915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701006|NCT04334915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101701007|NCT04334915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101701008|NCT04334915|Antiviral Agents|antiviral agents|mesh-ancestor
101701009|NCT04334915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101701010|NCT00991627|Atropine|atropine|mesh-list
101701011|NCT00991627|Ephedrine|ephedrine|mesh-list
101701012|NCT00991627|Pseudoephedrine|pseudoephedrine|mesh-list
101701013|NCT00991627|Morphine|morphine|mesh-list
101701014|NCT00991627|Bupivacaine|bupivacaine|mesh-list
101701015|NCT00991627|Anesthetics, Local|anesthetics, local|mesh-list
101701016|NCT00991627|Anesthetics|anesthetics|mesh-list
101701017|NCT00991627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101701018|NCT00991627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701019|NCT00991627|Sensory System Agents|sensory system agents|mesh-ancestor
101701020|NCT00991627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101701021|NCT00991627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101701022|NCT00991627|Narcotics|narcotics|mesh-ancestor
101701023|NCT00991627|Analgesics|analgesics|mesh-ancestor
101701024|NCT00991627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101701025|NCT00991627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101701026|NCT00991627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101701027|NCT00991627|Autonomic Agents|autonomic agents|mesh-ancestor
101701028|NCT00991627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101701029|NCT00991627|Respiratory System Agents|respiratory system agents|mesh-ancestor
101701030|NCT00991627|Mydriatics|mydriatics|mesh-ancestor
101701031|NCT00991627|Parasympatholytics|parasympatholytics|mesh-ancestor
101701032|NCT00991627|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101701033|NCT00991627|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101701034|NCT00991627|Cholinergic Agents|cholinergic agents|mesh-ancestor
101701035|NCT00991627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101701036|NCT00991627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701037|NCT00991627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101701038|NCT00991627|Sympathomimetics|sympathomimetics|mesh-ancestor
101701039|NCT00991627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101701040|NCT00991627|Adrenergic Agents|adrenergic agents|mesh-ancestor
101701041|NCT00991627|Nasal Decongestants|nasal decongestants|mesh-ancestor
101701042|NCT03562871|Carboplatin|carboplatin|mesh-list
101701043|NCT03562871|Pembrolizumab|pembrolizumab|mesh-list
101701044|NCT03562871|Pemetrexed|pemetrexed|mesh-list
101701045|NCT03562871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101701046|NCT03562871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101701047|NCT03562871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101701048|NCT03562871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701049|NCT03562871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101701050|NCT03562871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101701051|NCT03562871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101701052|NCT00690222|Mydriatics|mydriatics|mesh-list
101701053|NCT00690222|Autonomic Agents|autonomic agents|mesh-ancestor
101701054|NCT00690222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101701055|NCT00690222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701056|NCT02736071|Celecoxib|celecoxib|mesh-list
101701057|NCT02736071|Tramadol|tramadol|mesh-list
101701058|NCT02736071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101701059|NCT02736071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101701060|NCT02736071|Analgesics|analgesics|mesh-ancestor
101701061|NCT02736071|Sensory System Agents|sensory system agents|mesh-ancestor
101701062|NCT02736071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101701063|NCT02736071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701064|NCT02736071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101701065|NCT02736071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101520435|NCT04649723|Rifampin|rifampin|mesh-list
101520436|NCT04649723|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101701066|NCT02736071|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101701067|NCT02736071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101701068|NCT02736071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101701069|NCT02736071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701070|NCT02736071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101701071|NCT02736071|Narcotics|narcotics|mesh-ancestor
101701072|NCT02736071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101701073|NCT00690300|Docetaxel|docetaxel|mesh-list
101701074|NCT00690300|Oxaliplatin|oxaliplatin|mesh-list
101701075|NCT00690300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101701076|NCT00690300|Tubulin Modulators|tubulin modulators|mesh-ancestor
101701077|NCT00690300|Antimitotic Agents|antimitotic agents|mesh-ancestor
101701078|NCT00690300|Mitosis Modulators|mitosis modulators|mesh-ancestor
101701079|NCT00690300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701080|NCT02741219|Sufentanil|sufentanil|mesh-list
101701081|NCT02741219|Dexmedetomidine|dexmedetomidine|mesh-list
101701082|NCT02741219|Dsuvia|dsuvia|mesh-list
101701083|NCT02741219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101701084|NCT02741219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101701085|NCT02741219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701086|NCT02741219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101701087|NCT02741219|Analgesics|analgesics|mesh-ancestor
101701088|NCT02741219|Sensory System Agents|sensory system agents|mesh-ancestor
101701089|NCT02741219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101701090|NCT02741219|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101701091|NCT02741219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101701092|NCT02741219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101701093|NCT02741219|Adrenergic Agents|adrenergic agents|mesh-ancestor
101701094|NCT02741219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101701095|NCT02741219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520456|NCT02909088|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101520457|NCT02909088|Dopamine Agents|dopamine agents|mesh-ancestor
101701096|NCT02741219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101701098|NCT02741219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101701099|NCT02741219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101701100|NCT02741219|Anesthetics, General|anesthetics, general|mesh-ancestor
101701101|NCT02741219|Anesthetics|anesthetics|mesh-ancestor
101701102|NCT00690534|Insulin|insulin|mesh-list
101701103|NCT00690534|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101701104|NCT00690534|Nitroprusside|nitroprusside|mesh-list
101701105|NCT00690534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101701106|NCT00690534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701107|NCT00690534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101701108|NCT00690534|Vasodilator Agents|vasodilator agents|mesh-ancestor
101701109|NCT00690534|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101701110|NCT00690534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701111|NCT00991705|Atorvastatin|atorvastatin|mesh-list
101701112|NCT00991705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101701113|NCT00991705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101701114|NCT00991705|Antimetabolites|antimetabolites|mesh-ancestor
101520500|NCT05476432|Protective Agents|protective agents|mesh-ancestor
101701115|NCT00991705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701116|NCT00991705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101701117|NCT00991705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101701118|NCT00991705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101701119|NCT02735837|Doxycycline|doxycycline|mesh-list
101701120|NCT02735837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101701121|NCT02735837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101701122|NCT02735837|Antimalarials|antimalarials|mesh-ancestor
101701123|NCT02735837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101358582|NCT00072150|Bortezomib|bortezomib|mesh-list
101701124|NCT02735837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101701125|NCT02625558|Riociguat|riociguat|mesh-list
101701126|NCT02625558|Enzyme Activators|enzyme activators|mesh-ancestor
101701127|NCT02625558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701128|NCT00685230|Antivenins|antivenins|mesh-list
101701129|NCT00685230|Immunologic Factors|immunologic factors|mesh-ancestor
101701130|NCT00685230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701131|NCT05455879|Pulmonary Surfactants|pulmonary surfactants|mesh-list
101701132|NCT05455879|Respiratory System Agents|respiratory system agents|mesh-ancestor
101701134|NCT00991783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101701135|NCT00991783|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101701136|NCT00991783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101701137|NCT00991783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701138|NCT00991783|Protective Agents|protective agents|mesh-ancestor
101701139|NCT00991783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701140|NCT00690768|Bevacizumab|bevacizumab|mesh-list
101701141|NCT00690768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101701142|NCT00690768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101701143|NCT00690768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101701144|NCT00690768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101701145|NCT00690768|Growth Substances|growth substances|mesh-ancestor
101701146|NCT00690768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701147|NCT00690768|Growth Inhibitors|growth inhibitors|mesh-ancestor
101701148|NCT00690846|Adalimumab|adalimumab|mesh-list
101701149|NCT00690846|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101701150|NCT00690846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101701151|NCT00690846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101701152|NCT04683679|Pembrolizumab|pembrolizumab|mesh-list
101701153|NCT04683679|Olaparib|olaparib|mesh-list
101701154|NCT04683679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101701155|NCT04683679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101701156|NCT04683679|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101701157|NCT04683679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701158|NCT04683679|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101701159|NCT04683679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101701160|NCT00685464|Abciximab|abciximab|mesh-list
101701161|NCT00685464|Anticoagulants|anticoagulants|mesh-ancestor
101701162|NCT00685464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101701163|NCT02740829|Glucagon|glucagon|mesh-list
101701164|NCT02740829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101701165|NCT02740829|Hormones|hormones|mesh-ancestor
101701166|NCT02740829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101701167|NCT02740829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520672|NCT04648358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101520673|NCT04648358|Sensory System Agents|sensory system agents|mesh-ancestor
101520674|NCT00544518|Metformin|metformin|mesh-list
101520675|NCT00544518|Benfluorex|benfluorex|mesh-list
101701168|NCT00685542|Diacerein|diacerein|mesh-list
101701169|NCT00685542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101701170|NCT02741063|Oxytocin|oxytocin|mesh-list
101701171|NCT02741063|Oxytocics|oxytocics|mesh-ancestor
101701172|NCT02741063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101701173|NCT02741063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701174|NCT04138836|Itraconazole|itraconazole|mesh-list
101701175|NCT04138836|Midazolam|midazolam|mesh-list
101701176|NCT04138836|Esomeprazole|esomeprazole|mesh-list
101701177|NCT04138836|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101701178|NCT04138836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101701179|NCT04138836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101701180|NCT04138836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520727|NCT02908191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101701181|NCT04138836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101701182|NCT04138836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101701183|NCT04138836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101701184|NCT04138836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101701185|NCT04138836|Anesthetics, General|anesthetics, general|mesh-ancestor
101701186|NCT04138836|Anesthetics|anesthetics|mesh-ancestor
101701187|NCT04138836|GABA Modulators|gaba modulators|mesh-ancestor
101701188|NCT04138836|GABA Agents|gaba agents|mesh-ancestor
101701189|NCT04138836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101701190|NCT04138836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701191|NCT04138836|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101701192|NCT04138836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101701193|NCT04138836|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101701194|NCT04138836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101701195|NCT04138836|Antifungal Agents|antifungal agents|mesh-ancestor
101701196|NCT04138836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101701197|NCT04138836|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101520790|NCT01237327|Megestrol Acetate|megestrol acetate|mesh-list
101701198|NCT04138836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101701199|NCT04138836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101701200|NCT04138836|Hormone Antagonists|hormone antagonists|mesh-ancestor
101701201|NCT04138836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101701202|NCT04138836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101701203|NCT00922584|Sorafenib|sorafenib|mesh-list
101701204|NCT00922584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101701205|NCT00922584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101701206|NCT00922584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101701207|NCT00922584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701208|NCT02735603|Moxifloxacin|moxifloxacin|mesh-list
101701209|NCT02735603|Naltrexone|naltrexone|mesh-list
101701210|NCT02735603|Bupropion|bupropion|mesh-list
101701211|NCT02735603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101520845|NCT02906748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520846|NCT02907957|Anesthetics|anesthetics|mesh-list
101701212|NCT02735603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101701213|NCT02735603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101701214|NCT02735603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101701215|NCT02735603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101701216|NCT02735603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701217|NCT02735603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101701218|NCT02735603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701219|NCT02735603|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101701220|NCT02735603|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101701221|NCT02735603|Sensory System Agents|sensory system agents|mesh-ancestor
101701222|NCT02735603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101701223|NCT02735603|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101520904|NCT04646135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101701224|NCT02735603|Antidepressive Agents|antidepressive agents|mesh-ancestor
101701225|NCT02735603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101701226|NCT02735603|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101701227|NCT02735603|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101701228|NCT02735603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101701229|NCT02735603|Dopamine Agents|dopamine agents|mesh-ancestor
101701230|NCT02735603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101701231|NCT02735603|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101701232|NCT02735603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101701234|NCT00685776|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101701235|NCT00685776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101701236|NCT00685776|Antimetabolites|antimetabolites|mesh-ancestor
101520966|NCT00558662|Sodium Ionophores|sodium ionophores|mesh-ancestor
101701237|NCT00685776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701238|NCT00685776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101701239|NCT00685854|Ranibizumab|ranibizumab|mesh-list
101701240|NCT00685854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101701241|NCT00685854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101701242|NCT00685854|Growth Substances|growth substances|mesh-ancestor
101701243|NCT00685854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701244|NCT00685854|Growth Inhibitors|growth inhibitors|mesh-ancestor
101701245|NCT00685854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101701246|NCT04138368|Psychotropic Drugs|psychotropic drugs|mesh-list
101521030|NCT02905734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101521033|NCT04644185|Paraproteins|paraproteins|mesh-list
101701247|NCT04138290|Antidepressive Agents|antidepressive agents|mesh-list
101701248|NCT04138290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101701250|NCT04003207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101701251|NCT04003207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701252|NCT04582435|Insulin|insulin|mesh-list
101701253|NCT04582435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101701254|NCT04582435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701255|NCT05295355|Bromides|bromides|mesh-list
101701256|NCT05295355|Tiotropium Bromide|tiotropium bromide|mesh-list
101701257|NCT05295355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101701258|NCT05295355|Autonomic Agents|autonomic agents|mesh-ancestor
101701259|NCT05295355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101701260|NCT05295355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701261|NCT05295355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101701262|NCT05295355|Respiratory System Agents|respiratory system agents|mesh-ancestor
101701263|NCT05295355|Parasympatholytics|parasympatholytics|mesh-ancestor
101701264|NCT05295355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101521094|NCT04643132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101521095|NCT04643132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521096|NCT04643132|Antidepressive Agents|antidepressive agents|mesh-ancestor
101701265|NCT05295355|Cholinergic Agents|cholinergic agents|mesh-ancestor
101701266|NCT05295355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101701267|NCT05295355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701268|NCT05295355|Anticonvulsants|anticonvulsants|mesh-ancestor
101701269|NCT01564303|Acetylcysteine|acetylcysteine|mesh-list
101701270|NCT01564303|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101701271|NCT01564303|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
101701272|NCT01564303|Antiviral Agents|antiviral agents|mesh-ancestor
101701273|NCT01564303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101358720|NCT00205738|Serotonin Agents|serotonin agents|mesh-ancestor
101701274|NCT01564303|Expectorants|expectorants|mesh-ancestor
101701275|NCT01564303|Respiratory System Agents|respiratory system agents|mesh-ancestor
101521149|NCT04642001|Listerine|listerine|mesh-list
101521150|NCT04642001|Sodium Fluoride|sodium fluoride|mesh-list
101701276|NCT01564303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101701277|NCT01564303|Antioxidants|antioxidants|mesh-ancestor
101701278|NCT01564303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701279|NCT01564303|Protective Agents|protective agents|mesh-ancestor
101701280|NCT01564303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701281|NCT01564303|Antidotes|antidotes|mesh-ancestor
101701282|NCT01564303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101701283|NCT01564303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101701284|NCT00674232|Misoprostol|misoprostol|mesh-list
101701285|NCT00674232|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101701286|NCT00674232|Abortifacient Agents|abortifacient agents|mesh-ancestor
101701287|NCT00674232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101701288|NCT00674232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701289|NCT00674232|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101701290|NCT00674232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101701291|NCT00674232|Oxytocics|oxytocics|mesh-ancestor
101701293|NCT00674310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101701294|NCT00674310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101521224|NCT00559481|Ketoconazole|ketoconazole|mesh-list
101701295|NCT00674310|Dopamine Agonists|dopamine agonists|mesh-ancestor
101701296|NCT00674310|Dopamine Agents|dopamine agents|mesh-ancestor
101701297|NCT00674310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101701298|NCT00674310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701299|NCT00674310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701301|NCT00686010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101701302|NCT00686010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101701303|NCT00686010|Antimetabolites|antimetabolites|mesh-ancestor
101701304|NCT00686010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701305|NCT00686010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101701306|NCT05265247|Esomeprazole|esomeprazole|mesh-list
101521270|NCT04206631|Antimalarials|antimalarials|mesh-ancestor
101701307|NCT05265247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101701308|NCT05265247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101701309|NCT05265247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101701310|NCT05265247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101701311|NCT05265247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701314|NCT03823300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101701315|NCT03823300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101701316|NCT03823300|Growth Substances|growth substances|mesh-ancestor
101701317|NCT03823300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701318|NCT03823300|Growth Inhibitors|growth inhibitors|mesh-ancestor
101701319|NCT03823300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101701320|NCT00537745|Naltrexone|naltrexone|mesh-list
101701321|NCT00537745|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101701322|NCT00537745|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101701323|NCT00537745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701324|NCT00537745|Sensory System Agents|sensory system agents|mesh-ancestor
101521331|NCT01235728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101701325|NCT00537745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101701326|NCT00686322|Paclitaxel|paclitaxel|mesh-list
101701327|NCT00686322|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101701328|NCT00686322|Cisplatin|cisplatin|mesh-list
101701329|NCT00686322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101701330|NCT00686322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101701331|NCT00686322|Tubulin Modulators|tubulin modulators|mesh-ancestor
101701332|NCT00686322|Antimitotic Agents|antimitotic agents|mesh-ancestor
101701333|NCT00686322|Mitosis Modulators|mitosis modulators|mesh-ancestor
101701334|NCT00686322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701336|NCT02734511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101701337|NCT02734511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101701338|NCT02734511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701339|NCT02734511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101701340|NCT02734511|Anesthetics, General|anesthetics, general|mesh-ancestor
101701341|NCT02734511|Anesthetics|anesthetics|mesh-ancestor
101521392|NCT01235689|Hormones|hormones|mesh-ancestor
101701342|NCT04003441|Fexuprazan|fexuprazan|mesh-list
101701343|NCT04003441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101701344|NCT02739815|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101701345|NCT02739815|Tranexamic Acid|tranexamic acid|mesh-list
101701346|NCT02739815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101701347|NCT02739815|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101701348|NCT02739815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101701349|NCT02739815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701350|NCT02739815|Hemostatics|hemostatics|mesh-ancestor
101701351|NCT02739815|Coagulants|coagulants|mesh-ancestor
101701352|NCT00720616|Insulin|insulin|mesh-list
101701353|NCT00720616|Hormones|hormones|mesh-list
101701354|NCT00720616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101701355|NCT00720616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701356|NCT00720616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101701357|NCT00720772|Sodium thiosulfate|sodium thiosulfate|mesh-list
101521451|NCT00553683|Cyclophosphamide|cyclophosphamide|mesh-list
101701358|NCT00720772|Antidotes|antidotes|mesh-ancestor
101521452|NCT00553683|Poly ICLC|poly iclc|mesh-list
101701359|NCT00720772|Protective Agents|protective agents|mesh-ancestor
101701360|NCT00720772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701361|NCT00720772|Antioxidants|antioxidants|mesh-ancestor
101701362|NCT00720772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701363|NCT00720772|Antitubercular Agents|antitubercular agents|mesh-ancestor
101701364|NCT00720772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101701365|NCT00720772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101701366|NCT00720772|Chelating Agents|chelating agents|mesh-ancestor
101701367|NCT00720772|Sequestering Agents|sequestering agents|mesh-ancestor
101701368|NCT00720850|Lenalidomide|lenalidomide|mesh-list
101701369|NCT00720850|Immunologic Factors|immunologic factors|mesh-ancestor
101701370|NCT00720850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521506|NCT01235338|Dopamine Agents|dopamine agents|mesh-ancestor
101701371|NCT00720850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101701372|NCT00720850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101701373|NCT00720850|Growth Substances|growth substances|mesh-ancestor
101701375|NCT00720850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101701376|NCT03785158|Melatonin|melatonin|mesh-list
101701377|NCT03785158|Antioxidants|antioxidants|mesh-ancestor
101701378|NCT03785158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701379|NCT03785158|Protective Agents|protective agents|mesh-ancestor
101701380|NCT03785158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701381|NCT03785158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101701382|NCT02739581|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101701383|NCT02739581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101701384|NCT02739581|Adrenergic Agents|adrenergic agents|mesh-ancestor
101701385|NCT02739581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101701386|NCT02739581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701387|NCT02739581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701388|NCT02733809|Sorafenib|sorafenib|mesh-list
101701389|NCT02733809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101701390|NCT02733809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101701391|NCT02733809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101701392|NCT02733809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701393|NCT00717340|Paclitaxel|paclitaxel|mesh-list
101701394|NCT00717340|Tivozanib|tivozanib|mesh-list
101701395|NCT00717340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101701396|NCT00717340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101701397|NCT00717340|Tubulin Modulators|tubulin modulators|mesh-ancestor
101701398|NCT00717340|Antimitotic Agents|antimitotic agents|mesh-ancestor
101701399|NCT00717340|Mitosis Modulators|mitosis modulators|mesh-ancestor
101521633|NCT02904369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101701400|NCT00717340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701401|NCT00717340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101701402|NCT00717340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101701403|NCT02733887|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101701404|NCT02733887|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101701405|NCT02733887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701406|NCT00874848|Paclitaxel|paclitaxel|mesh-list
101701407|NCT00874848|Carboplatin|carboplatin|mesh-list
101701408|NCT00874848|Cetuximab|cetuximab|mesh-list
101701409|NCT00874848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101701410|NCT00874848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101701411|NCT00874848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101701412|NCT00874848|Tubulin Modulators|tubulin modulators|mesh-ancestor
101701413|NCT00874848|Antimitotic Agents|antimitotic agents|mesh-ancestor
101701414|NCT00874848|Mitosis Modulators|mitosis modulators|mesh-ancestor
101701415|NCT00874848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701416|NCT00874848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101701417|NCT00691236|Zoledronic Acid|zoledronic acid|mesh-list
101701418|NCT00691236|Doxorubicin|doxorubicin|mesh-list
101701419|NCT00691236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101701420|NCT00691236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101701421|NCT00691236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101701422|NCT00691236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101701423|NCT00691236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101701424|NCT00691236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701425|NCT00691236|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101701426|NCT00691236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701427|NCT04137978|Potassium Citrate|potassium citrate|mesh-list
101701429|NCT04137978|Natriuretic Agents|natriuretic agents|mesh-ancestor
101701430|NCT04137978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701431|NCT04137978|Expectorants|expectorants|mesh-ancestor
101701432|NCT04137978|Respiratory System Agents|respiratory system agents|mesh-ancestor
101701433|NCT00691392|Linezolid|linezolid|mesh-list
101701434|NCT00691392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101701435|NCT00691392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101521755|NCT05655130|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101701436|NCT00691392|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101701437|NCT00691392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101701438|NCT00691392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701439|NCT02625168|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101701440|NCT02625168|Afatinib|afatinib|mesh-list
101701441|NCT02625168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101701442|NCT02625168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101701443|NCT02625168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101701444|NCT02625168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701445|NCT00717730|Vitamins|vitamins|mesh-list
101701446|NCT00717730|Folic Acid|folic acid|mesh-list
101521808|NCT05427903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101701447|NCT00717730|Hydroxocobalamin|hydroxocobalamin|mesh-list
101701448|NCT00717730|Vitamin B 12|vitamin b 12|mesh-list
101701449|NCT00717730|Vitamin B Complex|vitamin b complex|mesh-list
101701450|NCT00717730|Micronutrients|micronutrients|mesh-ancestor
101701451|NCT00717730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701452|NCT00717730|Hematinics|hematinics|mesh-ancestor
101701453|NCT00691470|Warfarin|warfarin|mesh-list
101701454|NCT00691470|Anticoagulants|anticoagulants|mesh-ancestor
101701455|NCT05407597|Icatibant|icatibant|mesh-list
101701456|NCT05407597|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101701457|NCT05407597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101701458|NCT05407597|Analgesics|analgesics|mesh-ancestor
101701459|NCT05407597|Sensory System Agents|sensory system agents|mesh-ancestor
101701460|NCT05407597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101701461|NCT05407597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701462|NCT05407597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101701463|NCT05407597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101701464|NCT05407597|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
101701465|NCT05407597|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
101701466|NCT05407597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701467|NCT05407597|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101521938|NCT00446303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101701468|NCT05407597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101701469|NCT05407597|Immunologic Factors|immunologic factors|mesh-ancestor
101701470|NCT05407207|Immunologic Factors|immunologic factors|mesh-list
101701471|NCT05407207|Immunomodulating Agents|immunomodulating agents|mesh-list
101701472|NCT05407207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701473|NCT05493995|Paclitaxel|paclitaxel|mesh-list
101701474|NCT05493995|Gemcitabine|gemcitabine|mesh-list
101701475|NCT05493995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101522003|NCT01223365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101701476|NCT05493995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101701477|NCT05493995|Tubulin Modulators|tubulin modulators|mesh-ancestor
101701478|NCT05493995|Antimitotic Agents|antimitotic agents|mesh-ancestor
101701479|NCT05493995|Mitosis Modulators|mitosis modulators|mesh-ancestor
101701480|NCT05493995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701481|NCT05493995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101701482|NCT05493995|Antimetabolites|antimetabolites|mesh-ancestor
101701483|NCT00717808|Tranilast|tranilast|mesh-list
101701484|NCT00717808|Anthranilic acid|anthranilic acid|mesh-list
101701485|NCT00717808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101701486|NCT00717808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101701487|NCT00717808|Analgesics|analgesics|mesh-ancestor
101701488|NCT00717808|Sensory System Agents|sensory system agents|mesh-ancestor
101701489|NCT00717808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101701490|NCT00717808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701491|NCT00717808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101701492|NCT00717808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101701493|NCT00717808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101701494|NCT00717808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101701495|NCT00717808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701496|NCT00717808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101522131|NCT05426499|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101522141|NCT00446810|Benphothiamine|benphothiamine|mesh-list
101701497|NCT00717808|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101701498|NCT00717808|Histamine Antagonists|histamine antagonists|mesh-ancestor
101701499|NCT00717808|Histamine Agents|histamine agents|mesh-ancestor
101701500|NCT00717808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101701501|NCT00717808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101701502|NCT00717808|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101701504|NCT02738177|Isosorbide|isosorbide|mesh-list
101701505|NCT02738177|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
101701506|NCT02738177|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
101701507|NCT02738177|Misoprostol|misoprostol|mesh-list
101410397|NCT00115128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101701508|NCT02738177|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101701509|NCT02738177|Abortifacient Agents|abortifacient agents|mesh-ancestor
101701510|NCT02738177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101701511|NCT02738177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701512|NCT02738177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101701513|NCT02738177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101701514|NCT02738177|Oxytocics|oxytocics|mesh-ancestor
101701515|NCT02738177|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101701516|NCT02738177|Diuretics|diuretics|mesh-ancestor
101701517|NCT02738177|Natriuretic Agents|natriuretic agents|mesh-ancestor
101701518|NCT02738177|Vasodilator Agents|vasodilator agents|mesh-ancestor
101701519|NCT02738177|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101701520|NCT02738177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701521|NCT04043806|Ivacaftor|ivacaftor|mesh-list
101701522|NCT04043806|Elexacaftor|elexacaftor|mesh-list
101701523|NCT04043806|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101701524|NCT04043806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101701525|NCT04043806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701526|NCT02737943|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101701527|NCT02737943|Analgesics|analgesics|mesh-list
101701528|NCT02737943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101701529|NCT02737943|Sensory System Agents|sensory system agents|mesh-ancestor
101701530|NCT02737943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101522195|NCT00447473|Hormone Antagonists|hormone antagonists|mesh-ancestor
101522198|NCT00553488|Insulin|insulin|mesh-list
101701531|NCT02737943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701532|NCT05290753|Erythromycin|erythromycin|mesh-list
101701533|NCT05290753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101701534|NCT05290753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101701535|NCT05290753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101701536|NCT05290753|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101701537|NCT05290753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101701538|NCT05290753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701541|NCT02737709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101701542|NCT02737709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101701543|NCT02737709|Tubulin Modulators|tubulin modulators|mesh-ancestor
101701544|NCT02737709|Antimitotic Agents|antimitotic agents|mesh-ancestor
101701545|NCT02737709|Mitosis Modulators|mitosis modulators|mesh-ancestor
101701546|NCT02737709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701547|NCT02572960|Vitamin D|vitamin d|mesh-list
101701548|NCT02572960|Cholecalciferol|cholecalciferol|mesh-list
101701549|NCT02572960|Valsartan|valsartan|mesh-list
101701550|NCT02572960|Vitamins|vitamins|mesh-ancestor
101701551|NCT02572960|Micronutrients|micronutrients|mesh-ancestor
101701552|NCT02572960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522304|NCT01220128|Tubulin Modulators|tubulin modulators|mesh-ancestor
101701553|NCT02572960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101701554|NCT02572960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101701555|NCT02572960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101701556|NCT02572960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101701557|NCT02572960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101701558|NCT02572960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701559|NCT04001959|Fluorides|fluorides|mesh-list
101701560|NCT04001959|Cariostatic Agents|cariostatic agents|mesh-ancestor
101701561|NCT04001959|Protective Agents|protective agents|mesh-ancestor
101522367|NCT02901288|Antimetabolites|antimetabolites|mesh-ancestor
101701562|NCT04001959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701564|NCT00721240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101701565|NCT00721240|Respiratory System Agents|respiratory system agents|mesh-ancestor
101701566|NCT00721240|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101701567|NCT00721240|Hormone Antagonists|hormone antagonists|mesh-ancestor
101410405|NCT00115245|Antiviral Agents|antiviral agents|mesh-ancestor
101701568|NCT00721240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101701569|NCT00721240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701570|NCT00721240|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101701571|NCT00721240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101701572|NCT00721240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701573|NCT02737319|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101701574|NCT02737319|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101701575|NCT02737319|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101701576|NCT02737319|Antimetabolites|antimetabolites|mesh-ancestor
101522431|NCT05368441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522432|NCT05468359|Cyclophosphamide|cyclophosphamide|mesh-list
101522433|NCT05468359|Bevacizumab|bevacizumab|mesh-list
101701577|NCT02737319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701578|NCT02737319|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101701579|NCT02737319|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101701580|NCT02737319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101701581|NCT00721552|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101701582|NCT00721552|Prednisolone|prednisolone|mesh-list
101701583|NCT00721552|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101701584|NCT00721552|Methylprednisolone|methylprednisolone|mesh-list
101701585|NCT00721552|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101701586|NCT00721552|Prednisolone acetate|prednisolone acetate|mesh-list
101701587|NCT00721552|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101701588|NCT00721552|Prednisolone phosphate|prednisolone phosphate|mesh-list
101701590|NCT00721552|Glucocorticoids|glucocorticoids|mesh-ancestor
101701591|NCT00721552|Hormones|hormones|mesh-ancestor
101701592|NCT00721552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101522557|NCT04318444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101701593|NCT00721552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701594|NCT00721552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101701595|NCT00721552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101701596|NCT00721552|Antiemetics|antiemetics|mesh-ancestor
101701597|NCT00721552|Autonomic Agents|autonomic agents|mesh-ancestor
101701598|NCT00721552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101701599|NCT00721552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101701600|NCT00721552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101701601|NCT00721552|Protective Agents|protective agents|mesh-ancestor
101701602|NCT00721552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101701603|NCT00721552|Incretins|incretins|mesh-ancestor
101522622|NCT00450008|Tubulin Modulators|tubulin modulators|mesh-ancestor
101701604|NCT00721552|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101701605|NCT00721552|Protease Inhibitors|protease inhibitors|mesh-ancestor
101701606|NCT00721552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101701607|NCT00721552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701608|NCT04069078|Scopolamine|scopolamine|mesh-list
101701609|NCT04069078|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101701610|NCT04069078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101701611|NCT04069078|Antiemetics|antiemetics|mesh-ancestor
101701612|NCT04069078|Autonomic Agents|autonomic agents|mesh-ancestor
101701613|NCT04069078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101701614|NCT04069078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701615|NCT04069078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101522685|NCT00450164|Sympatholytics|sympatholytics|mesh-ancestor
101701616|NCT04069078|Mydriatics|mydriatics|mesh-ancestor
101522686|NCT00450164|Autonomic Agents|autonomic agents|mesh-ancestor
101701617|NCT04069078|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101701618|NCT04069078|Cholinergic Agents|cholinergic agents|mesh-ancestor
101701619|NCT04069078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101701620|NCT04069078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701621|NCT04069078|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101701622|NCT04069078|Parasympatholytics|parasympatholytics|mesh-ancestor
101701623|NCT02732249|Metronidazole|metronidazole|mesh-list
101701624|NCT02732249|Clarithromycin|clarithromycin|mesh-list
101701625|NCT02732249|Potassium Citrate|potassium citrate|mesh-list
101701626|NCT02732249|Esomeprazole|esomeprazole|mesh-list
101701627|NCT02732249|Bismuth|bismuth|mesh-list
101701628|NCT02732249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701629|NCT02732249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101701630|NCT02732249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101701632|NCT02732249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101701633|NCT02732249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101701634|NCT02732249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101701635|NCT02732249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101701636|NCT02732249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101701637|NCT02732249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101701638|NCT02732249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101522746|NCT00450398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701639|NCT02732249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101701640|NCT02732249|Antacids|antacids|mesh-ancestor
101701641|NCT02732249|Diuretics|diuretics|mesh-ancestor
101701642|NCT02732249|Natriuretic Agents|natriuretic agents|mesh-ancestor
101701643|NCT02732249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701644|NCT02732249|Expectorants|expectorants|mesh-ancestor
101701645|NCT02732249|Respiratory System Agents|respiratory system agents|mesh-ancestor
101701646|NCT04561063|Sofosbuvir|sofosbuvir|mesh-list
101701647|NCT04561063|Nitazoxanide|nitazoxanide|mesh-list
101701648|NCT04561063|Antiviral Agents|antiviral agents|mesh-ancestor
101701649|NCT04561063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101701650|NCT04561063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101701651|NCT02732093|Lidocaine|lidocaine|mesh-list
101701652|NCT02732093|Anesthetics, Local|anesthetics, local|mesh-ancestor
101701653|NCT02732093|Anesthetics|anesthetics|mesh-ancestor
101701654|NCT02732093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101701655|NCT02732093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701656|NCT02732093|Sensory System Agents|sensory system agents|mesh-ancestor
101701657|NCT02732093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101701659|NCT02732093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101701660|NCT02732093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101701661|NCT02732093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101701662|NCT02732093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701664|NCT00718276|Cholecalciferol|cholecalciferol|mesh-list
101701665|NCT00718276|Vitamins|vitamins|mesh-ancestor
101701666|NCT00718276|Micronutrients|micronutrients|mesh-ancestor
101701667|NCT00718276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701668|NCT00718276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101522859|NCT01186939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101701669|NCT00718276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101701671|NCT00718354|Carboplatin|carboplatin|mesh-list
101701672|NCT00718354|Fluorouracil|fluorouracil|mesh-list
101701673|NCT00718354|Capecitabine|capecitabine|mesh-list
101701674|NCT00718354|Oxaliplatin|oxaliplatin|mesh-list
101701675|NCT00718354|Epirubicin|epirubicin|mesh-list
101701676|NCT00718354|Enoxaparin|enoxaparin|mesh-list
101701677|NCT00718354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101701678|NCT00718354|Antimetabolites|antimetabolites|mesh-ancestor
101701679|NCT00718354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701680|NCT00718354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101701681|NCT00718354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101701682|NCT00718354|Immunologic Factors|immunologic factors|mesh-ancestor
101701683|NCT00718354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701684|NCT00718354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101701685|NCT00718354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101701686|NCT00718354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101701687|NCT00718354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101701688|NCT00718354|Anticoagulants|anticoagulants|mesh-ancestor
101701689|NCT00718354|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101701690|NCT00718354|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101701691|NCT00536809|Capecitabine|capecitabine|mesh-list
101701692|NCT00536809|Oxaliplatin|oxaliplatin|mesh-list
101701693|NCT00536809|Lapatinib|lapatinib|mesh-list
101701694|NCT00536809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101701695|NCT00536809|Antimetabolites|antimetabolites|mesh-ancestor
101522980|NCT02929394|Alkylating Agents|alkylating agents|mesh-ancestor
101410420|NCT00444340|Etanercept|etanercept|mesh-list
101701696|NCT00536809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701697|NCT00536809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101701698|NCT00536809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101701699|NCT00536809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101701700|NCT04189601|Complement System Proteins|complement system proteins|mesh-list
101701701|NCT04189601|Immunologic Factors|immunologic factors|mesh-ancestor
101701702|NCT04189601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701704|NCT04067986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101701705|NCT04067986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101701706|NCT04067986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101701707|NCT04067986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523045|NCT02927951|Analgesics|analgesics|mesh-ancestor
101523058|NCT02927405|Gabapentin|gabapentin|mesh-list
101701708|NCT00536731|Budesonide|budesonide|mesh-list
101701709|NCT00536731|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101701710|NCT00536731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101701711|NCT00536731|Respiratory System Agents|respiratory system agents|mesh-ancestor
101701712|NCT00536731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101701713|NCT00536731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101701714|NCT00536731|Autonomic Agents|autonomic agents|mesh-ancestor
101701715|NCT00536731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101701716|NCT00536731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701717|NCT00536731|Glucocorticoids|glucocorticoids|mesh-ancestor
101701718|NCT00536731|Hormones|hormones|mesh-ancestor
101701719|NCT00536731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101701720|NCT02571712|Timolol|timolol|mesh-list
101701721|NCT02571712|Bimatoprost|bimatoprost|mesh-list
101523106|NCT02926976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101701722|NCT02571712|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101523107|NCT02926976|GABA Agents|gaba agents|mesh-ancestor
101701723|NCT02571712|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101701724|NCT02571712|Adrenergic Agents|adrenergic agents|mesh-ancestor
101701725|NCT02571712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101701726|NCT02571712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701727|NCT02571712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701728|NCT02571712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101701729|NCT02571712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101701730|NCT02730845|Dexmedetomidine|dexmedetomidine|mesh-list
101701731|NCT02730845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101701732|NCT02730845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101701733|NCT02730845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701734|NCT02730845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101701735|NCT02730845|Analgesics|analgesics|mesh-ancestor
101701736|NCT02730845|Sensory System Agents|sensory system agents|mesh-ancestor
101523168|NCT02925299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701738|NCT02730845|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101701739|NCT02730845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101701740|NCT02730845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101701741|NCT02730845|Adrenergic Agents|adrenergic agents|mesh-ancestor
101701742|NCT02730845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101701743|NCT02730845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701744|NCT02730689|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101701746|NCT02730689|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101701747|NCT02730689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101701748|NCT02730689|Antimetabolites|antimetabolites|mesh-ancestor
101523231|NCT02200380|Plerixafor|plerixafor|mesh-list
101701749|NCT02730689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701750|NCT02730689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101701751|NCT02730689|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101701752|NCT02730689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101701754|NCT03579316|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
101701755|NCT03579316|Adavosertib|adavosertib|mesh-list
101701756|NCT03579316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101701757|NCT03579316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701758|NCT03579316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101701760|NCT02730533|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101701761|NCT02730533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101701762|NCT02730533|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101535754|NCT04609748|Nimesulide|nimesulide|mesh-list
101701763|NCT02730533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101701764|NCT02730533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701765|NCT00536575|Bortezomib|bortezomib|mesh-list
101701766|NCT00536575|Sorafenib|sorafenib|mesh-list
101701767|NCT00536575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101701768|NCT00536575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101701769|NCT00536575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101701770|NCT00536575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701771|NCT00712114|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101701772|NCT00712114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101701773|NCT00712114|Immunologic Factors|immunologic factors|mesh-ancestor
101701774|NCT00712114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701776|NCT03214250|Gemcitabine|gemcitabine|mesh-list
101701777|NCT03214250|Nivolumab|nivolumab|mesh-list
101701778|NCT03214250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101701780|NCT03214250|Tubulin Modulators|tubulin modulators|mesh-ancestor
101701781|NCT03214250|Antimitotic Agents|antimitotic agents|mesh-ancestor
101701782|NCT03214250|Mitosis Modulators|mitosis modulators|mesh-ancestor
101701783|NCT03214250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701784|NCT03214250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101701785|NCT03214250|Antimetabolites|antimetabolites|mesh-ancestor
101701786|NCT03214250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101701787|NCT03214250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101701788|NCT00722098|Cyclophosphamide|cyclophosphamide|mesh-list
101701789|NCT00722098|Vaccines|vaccines|mesh-list
101701790|NCT00722098|Immunologic Factors|immunologic factors|mesh-ancestor
101701791|NCT00722098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701792|NCT00722098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101523420|NCT04688723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101701793|NCT00722098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101701794|NCT00722098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101701795|NCT00722098|Alkylating Agents|alkylating agents|mesh-ancestor
101701796|NCT00722098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701797|NCT00722098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101701798|NCT00722098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101701799|NCT04186871|Abatacept|abatacept|mesh-list
101701800|NCT04186871|Branebrutinib|branebrutinib|mesh-list
101701801|NCT04186871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101701802|NCT04186871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701803|NCT04186871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101701804|NCT04186871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101701805|NCT04186871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101701806|NCT04186871|Immunologic Factors|immunologic factors|mesh-ancestor
101701807|NCT04186871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701808|NCT04186871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101701809|NCT04186871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101701810|NCT04186871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101701811|NCT05245591|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
101701812|NCT05245591|Anticoagulants|anticoagulants|mesh-ancestor
101701813|NCT00992095|Buprenorphine|buprenorphine|mesh-list
101701814|NCT00992095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101701815|NCT00992095|Narcotics|narcotics|mesh-ancestor
101701816|NCT00992095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101701817|NCT00992095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701818|NCT00992095|Analgesics|analgesics|mesh-ancestor
101701819|NCT00992095|Sensory System Agents|sensory system agents|mesh-ancestor
101523542|NCT02914886|Insulin|insulin|mesh-list
101701820|NCT00992095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101701821|NCT00992095|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101701823|NCT00653354|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101701824|NCT00653354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101701825|NCT00653354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101701826|NCT00653354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701827|NCT00653354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101701828|NCT00653354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101701829|NCT00653354|Analgesics|analgesics|mesh-ancestor
101701830|NCT00653354|Sensory System Agents|sensory system agents|mesh-ancestor
101701831|NCT00653354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101701832|NCT00653354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523595|NCT01632228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101701834|NCT00653354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101701835|NCT00712504|Docetaxel|docetaxel|mesh-list
101701836|NCT00712504|Sunitinib|sunitinib|mesh-list
101701837|NCT00712504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101701838|NCT00712504|Tubulin Modulators|tubulin modulators|mesh-ancestor
101701839|NCT00712504|Antimitotic Agents|antimitotic agents|mesh-ancestor
101701840|NCT00712504|Mitosis Modulators|mitosis modulators|mesh-ancestor
101701841|NCT00712504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701842|NCT00712504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101701843|NCT00712504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101701844|NCT00712504|Growth Substances|growth substances|mesh-ancestor
101701845|NCT00712504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701846|NCT00712504|Growth Inhibitors|growth inhibitors|mesh-ancestor
101701847|NCT00712504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101523659|NCT00585507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101701848|NCT00712504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101701849|NCT00653510|Insulin|insulin|mesh-list
101523666|NCT02063685|Prednisone|prednisone|mesh-list
101701850|NCT00653510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101701851|NCT00653510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101701853|NCT02694653|Acetaminophen|acetaminophen|mesh-list
101701854|NCT02694653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101701855|NCT02694653|Analgesics|analgesics|mesh-ancestor
101701856|NCT02694653|Sensory System Agents|sensory system agents|mesh-ancestor
101701857|NCT02694653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101701858|NCT02694653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701860|NCT00722956|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
101701861|NCT00722956|Atorvastatin|atorvastatin|mesh-list
101701862|NCT00722956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101701863|NCT00722956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101701864|NCT00722956|Antimetabolites|antimetabolites|mesh-ancestor
101523784|NCT02912702|Etoposide|etoposide|mesh-list
101701865|NCT00722956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701867|NCT00722956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101701868|NCT00722956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101701869|NCT00722956|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101701870|NCT00722956|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101701871|NCT00722956|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101701872|NCT00722956|Antiviral Agents|antiviral agents|mesh-ancestor
101701873|NCT00722956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101701874|NCT00992173|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
101523851|NCT02912234|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101701875|NCT00992173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101701876|NCT00992173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101701877|NCT00992173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701878|NCT00992173|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101701879|NCT02729285|Ketorolac|ketorolac|mesh-list
101701880|NCT02729285|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101701881|NCT02729285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101701882|NCT02729285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101701883|NCT02729285|Analgesics|analgesics|mesh-ancestor
101701884|NCT02729285|Sensory System Agents|sensory system agents|mesh-ancestor
101701885|NCT02729285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101701886|NCT02729285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701887|NCT02729285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101701888|NCT02729285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101701889|NCT02729285|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101701890|NCT02729285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101701891|NCT02729285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701892|NCT00722176|Risperidone|risperidone|mesh-list
101701893|NCT00722176|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101701894|NCT00722176|Serotonin Agents|serotonin agents|mesh-ancestor
101701895|NCT00722176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101701896|NCT00722176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701897|NCT00722176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701898|NCT00722176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101701899|NCT00722176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101701900|NCT00722176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101701901|NCT00722176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101701902|NCT00722176|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101701903|NCT00722176|Dopamine Agents|dopamine agents|mesh-ancestor
101701905|NCT02729441|Perindopril|perindopril|mesh-list
101701906|NCT02729441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101701907|NCT02729441|Protease Inhibitors|protease inhibitors|mesh-ancestor
101701908|NCT02729441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101701909|NCT02729441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523976|NCT02910518|Glucagon|glucagon|mesh-list
101701910|NCT02729441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101701911|NCT04181333|Trastuzumab|trastuzumab|mesh-list
101701912|NCT04181333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101701913|NCT04181333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101701914|NCT00712660|Antipsychotic Agents|antipsychotic agents|mesh-list
101701915|NCT00712660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101701916|NCT00712660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101701917|NCT00712660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701918|NCT00712660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101701919|NCT00636545|Oblimersen|oblimersen|mesh-list
101701920|NCT00636545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101701921|NCT00722488|Pevonedistat|pevonedistat|mesh-list
101701922|NCT00722488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101701923|NCT00722488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524032|NCT04316377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101701924|NCT00652106|Timolol|timolol|mesh-list
101701925|NCT00652106|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101701926|NCT00652106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101701927|NCT00652106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101701928|NCT00652106|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101701929|NCT00652106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101701930|NCT00652106|Adrenergic Agents|adrenergic agents|mesh-ancestor
101701931|NCT00652106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101701932|NCT00652106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701933|NCT00652106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701934|NCT00652106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101701935|NCT00652106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101701936|NCT00652106|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101524092|NCT02909972|Cytarabine|cytarabine|mesh-list
101524093|NCT02909972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101701937|NCT00652106|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101701938|NCT00652106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101701939|NCT00723268|Prednisolone|prednisolone|mesh-list
101701940|NCT00723268|Colchicine|colchicine|mesh-list
101701941|NCT00723268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101701942|NCT00723268|Glucocorticoids|glucocorticoids|mesh-ancestor
101701943|NCT00723268|Hormones|hormones|mesh-ancestor
101701944|NCT00723268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101701945|NCT00723268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701946|NCT00723268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101701947|NCT00723268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101701948|NCT00723268|Gout Suppressants|gout suppressants|mesh-ancestor
101701949|NCT00723268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101701950|NCT00723268|Tubulin Modulators|tubulin modulators|mesh-ancestor
101701951|NCT00723268|Antimitotic Agents|antimitotic agents|mesh-ancestor
101524153|NCT02910245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101524154|NCT02910245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101524155|NCT01185340|Serotonin|serotonin|mesh-list
101701952|NCT00723268|Mitosis Modulators|mitosis modulators|mesh-ancestor
101524158|NCT01185340|Serotonin Agents|serotonin agents|mesh-ancestor
101701953|NCT00723268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701955|NCT00874770|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101701956|NCT00874770|Antimetabolites|antimetabolites|mesh-ancestor
101701957|NCT00874770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701958|NCT00874770|Antiviral Agents|antiviral agents|mesh-ancestor
101701959|NCT00874770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101701960|NCT00536263|Interferons|interferons|mesh-list
101701961|NCT00536263|Interferon-alpha|interferon-alpha|mesh-list
101701962|NCT00536263|Interferon alpha-2|interferon alpha-2|mesh-list
101701963|NCT00536263|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101701964|NCT00536263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101701965|NCT00536263|Antiviral Agents|antiviral agents|mesh-ancestor
101701966|NCT00536263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101701967|NCT00536263|Immunologic Factors|immunologic factors|mesh-ancestor
101701968|NCT00536263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701969|NCT00578344|Cyclophosphamide|cyclophosphamide|mesh-list
101701970|NCT00578344|Busulfan|busulfan|mesh-list
101701971|NCT00578344|Alemtuzumab|alemtuzumab|mesh-list
101701972|NCT00578344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101701973|NCT00578344|Immunologic Factors|immunologic factors|mesh-ancestor
101524270|NCT00555867|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101524271|NCT00555867|Hormone Antagonists|hormone antagonists|mesh-ancestor
101701974|NCT00578344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701976|NCT00578344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101701977|NCT00578344|Alkylating Agents|alkylating agents|mesh-ancestor
101701978|NCT00578344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701979|NCT00578344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101701980|NCT00578344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101701981|NCT00578344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101701982|NCT00653588|Atorvastatin|atorvastatin|mesh-list
101701983|NCT00653588|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101524336|NCT05189717|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101524338|NCT05189717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101701984|NCT00653588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101701985|NCT00653588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101701986|NCT00653588|Antimetabolites|antimetabolites|mesh-ancestor
101701987|NCT00653588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101701988|NCT00653588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101701989|NCT00653588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101701990|NCT00653588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101701991|NCT00723346|Asparaginase|asparaginase|mesh-list
101701992|NCT00723346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101701993|NCT02571400|Analgesics, Opioid|analgesics, opioid|mesh-list
101701994|NCT02571400|Analgesics|analgesics|mesh-list
101701995|NCT02571400|Narcotics|narcotics|mesh-ancestor
101701996|NCT02571400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101701997|NCT02571400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101701998|NCT02571400|Sensory System Agents|sensory system agents|mesh-ancestor
101701999|NCT02571400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101702000|NCT02641652|Sertraline|sertraline|mesh-list
101702001|NCT02641652|Antidepressive Agents|antidepressive agents|mesh-ancestor
101702002|NCT02641652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101702003|NCT02641652|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101702004|NCT02641652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101702005|NCT02641652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101702006|NCT02641652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702007|NCT02641652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101702008|NCT02641652|Serotonin Agents|serotonin agents|mesh-ancestor
101702009|NCT02641652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702010|NCT02626104|Lactoferrin|lactoferrin|mesh-list
101702011|NCT02626104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101702012|NCT02571166|Valacyclovir|valacyclovir|mesh-list
101702013|NCT02571166|Antiviral Agents|antiviral agents|mesh-ancestor
101524469|NCT01655225|Anesthetics|anesthetics|mesh-ancestor
101702014|NCT02571166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101702015|NCT00686478|Interferons|interferons|mesh-list
101702016|NCT00686478|Interferon-alpha|interferon-alpha|mesh-list
101702017|NCT00686478|Interferon alpha-2|interferon alpha-2|mesh-list
101702018|NCT00686478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702019|NCT00686478|Antiviral Agents|antiviral agents|mesh-ancestor
101702020|NCT00686478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101702021|NCT00686478|Immunologic Factors|immunologic factors|mesh-ancestor
101702022|NCT00686478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702023|NCT00723424|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
101702025|NCT00723424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101702026|NCT00723424|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101702027|NCT00723424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101702028|NCT00723424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524526|NCT01782729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101702029|NCT00723424|Protective Agents|protective agents|mesh-ancestor
101702030|NCT00723424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702031|NCT00723424|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101702032|NCT00723424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101702033|NCT00723424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101702034|NCT00723424|Antiviral Agents|antiviral agents|mesh-ancestor
101702035|NCT00723424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101702036|NCT02641340|Fentanyl|fentanyl|mesh-list
101702037|NCT02641340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101702038|NCT02641340|Narcotics|narcotics|mesh-ancestor
101702039|NCT02641340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101702040|NCT02641340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702041|NCT02641340|Analgesics|analgesics|mesh-ancestor
101702042|NCT02641340|Sensory System Agents|sensory system agents|mesh-ancestor
101702043|NCT02641340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101702044|NCT02641340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101702045|NCT02641340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101702046|NCT02641340|Anesthetics, General|anesthetics, general|mesh-ancestor
101702047|NCT02641340|Anesthetics|anesthetics|mesh-ancestor
101702048|NCT02625948|Tranexamic Acid|tranexamic acid|mesh-list
101702049|NCT02625948|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101702050|NCT02625948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101702051|NCT02625948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702052|NCT02625948|Hemostatics|hemostatics|mesh-ancestor
101702053|NCT02625948|Coagulants|coagulants|mesh-ancestor
101524753|NCT00533312|Niacin|niacin|mesh-list
101702054|NCT02571556|Dexamethasone|dexamethasone|mesh-list
101702055|NCT02571556|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101702056|NCT02571556|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101702057|NCT02571556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101702058|NCT02571556|Antiemetics|antiemetics|mesh-ancestor
101702059|NCT02571556|Autonomic Agents|autonomic agents|mesh-ancestor
101702060|NCT02571556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101702061|NCT02571556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702062|NCT02571556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101702063|NCT02571556|Glucocorticoids|glucocorticoids|mesh-ancestor
101702064|NCT02571556|Hormones|hormones|mesh-ancestor
101702065|NCT02571556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101702066|NCT02571556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101702067|NCT02571556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702068|NCT02571556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101702069|NCT03752216|Niraparib|niraparib|mesh-list
101702070|NCT03752216|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101702071|NCT03752216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101702072|NCT03752216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702073|NCT03752216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702075|NCT00691548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101702076|NCT00691548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702077|NCT00712738|Nifedipine|nifedipine|mesh-list
101702078|NCT00712738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101702079|NCT00712738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101702080|NCT00712738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702081|NCT00712738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101702082|NCT00712738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702083|NCT00712738|Vasodilator Agents|vasodilator agents|mesh-ancestor
101702084|NCT00712738|Tocolytic Agents|tocolytic agents|mesh-ancestor
101702085|NCT00712738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101524911|NCT04547153|Immunologic Factors|immunologic factors|mesh-ancestor
101702086|NCT00686556|Cyclosporine|cyclosporine|mesh-list
101702087|NCT00686556|Mycophenolic Acid|mycophenolic acid|mesh-list
101702088|NCT00686556|Cyclophosphamide|cyclophosphamide|mesh-list
101702089|NCT00686556|Fludarabine|fludarabine|mesh-list
101702090|NCT00686556|Cyclosporins|cyclosporins|mesh-list
101702091|NCT00686556|Lenograstim|lenograstim|mesh-list
101702092|NCT00686556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101702093|NCT00686556|Immunologic Factors|immunologic factors|mesh-ancestor
101702094|NCT00686556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359552|NCT00209716|Antimetabolites|antimetabolites|mesh-ancestor
101702096|NCT00686556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101702097|NCT00686556|Alkylating Agents|alkylating agents|mesh-ancestor
101702098|NCT00686556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702099|NCT00686556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702100|NCT00686556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101702101|NCT00686556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101702102|NCT00686556|Antifungal Agents|antifungal agents|mesh-ancestor
101702103|NCT00686556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101702104|NCT00686556|Dermatologic Agents|dermatologic agents|mesh-ancestor
101702105|NCT00686556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101702106|NCT00686556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101702107|NCT00686556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101702108|NCT00686556|Antitubercular Agents|antitubercular agents|mesh-ancestor
101702109|NCT00686556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101525046|NCT01215721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702110|NCT00686556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101702112|NCT04070482|Antiviral Agents|antiviral agents|mesh-ancestor
101702113|NCT04070482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101702114|NCT04070482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101702115|NCT04070482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101702116|NCT04070482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101702117|NCT04070482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702118|NCT04070482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101702119|NCT04070482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101702120|NCT04166786|Ethanol|ethanol|mesh-list
101702121|NCT04166786|Methyltestosterone|methyltestosterone|mesh-list
101525106|NCT03813875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101702122|NCT04166786|Petrolatum|petrolatum|mesh-list
101702123|NCT04166786|Testosterone|testosterone|mesh-list
101702124|NCT04166786|Testosterone undecanoate|testosterone undecanoate|mesh-list
101702125|NCT04166786|Testosterone enanthate|testosterone enanthate|mesh-list
101702126|NCT04166786|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101702127|NCT04166786|Androgens|androgens|mesh-ancestor
101702128|NCT04166786|Hormones|hormones|mesh-ancestor
101702129|NCT04166786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101702130|NCT04166786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702131|NCT04166786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101702132|NCT04166786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702133|NCT04166786|Anabolic Agents|anabolic agents|mesh-ancestor
101702134|NCT04166786|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101702135|NCT04166786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101702136|NCT04166786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101702137|NCT04166786|Emollients|emollients|mesh-ancestor
101702138|NCT04166786|Dermatologic Agents|dermatologic agents|mesh-ancestor
101702139|NCT02727647|Factor VIII|factor viii|mesh-list
101702140|NCT02727647|Coagulants|coagulants|mesh-ancestor
101702141|NCT00723502|Amoxicillin|amoxicillin|mesh-list
101702142|NCT00723502|Finafloxacin|finafloxacin|mesh-list
101702143|NCT00723502|Fluoroquinolones|fluoroquinolones|mesh-list
101525171|NCT01215097|Linagliptin|linagliptin|mesh-list
101702145|NCT00723502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101702146|NCT00723502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101702147|NCT00723502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101702148|NCT00723502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101261419|NCT01749579|Anesthetics, General|anesthetics, general|mesh-ancestor
101702149|NCT00723502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101702150|NCT00723502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101702151|NCT00723502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702152|NCT00723502|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101702153|NCT00723502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101702154|NCT00723502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101702155|NCT00723502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702156|NCT00723502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101702157|NCT02727881|Squalamine|squalamine|mesh-list
101702158|NCT02727881|Ranibizumab|ranibizumab|mesh-list
101702159|NCT02727881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101702160|NCT02727881|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101702161|NCT02727881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101702162|NCT02727881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101702163|NCT02727881|Growth Substances|growth substances|mesh-ancestor
101702164|NCT02727881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702165|NCT02727881|Growth Inhibitors|growth inhibitors|mesh-ancestor
101702166|NCT02727881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702167|NCT02727881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101702168|NCT02727881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101702169|NCT02727881|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101702170|NCT02727881|Protective Agents|protective agents|mesh-ancestor
101702171|NCT01564381|Resveratrol|resveratrol|mesh-list
101702172|NCT01564381|Antioxidants|antioxidants|mesh-ancestor
101702173|NCT01564381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702174|NCT01564381|Protective Agents|protective agents|mesh-ancestor
101702175|NCT01564381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702176|NCT01564381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101702177|NCT01564381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101702178|NCT04164524|Gentamicins|gentamicins|mesh-list
101702179|NCT04164524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101702180|NCT04164524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101702181|NCT04164524|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101702182|NCT04164524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101702183|NCT04164524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702184|NCT00723658|Cytarabine|cytarabine|mesh-list
101702185|NCT00723658|Thalidomide|thalidomide|mesh-list
101702186|NCT00723658|Dexamethasone|dexamethasone|mesh-list
101702187|NCT00723658|Cyclophosphamide|cyclophosphamide|mesh-list
101702188|NCT00723658|Melphalan|melphalan|mesh-list
101702189|NCT00723658|Carmustine|carmustine|mesh-list
101702190|NCT00723658|Rituximab|rituximab|mesh-list
101702191|NCT00723658|Doxorubicin|doxorubicin|mesh-list
101702192|NCT00723658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101702193|NCT00723658|Etoposide|etoposide|mesh-list
101702194|NCT00723658|Bortezomib|bortezomib|mesh-list
101702195|NCT00723658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101702196|NCT00723658|Immunologic Factors|immunologic factors|mesh-ancestor
101702197|NCT00723658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702198|NCT00723658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101702199|NCT00723658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101702200|NCT00723658|Alkylating Agents|alkylating agents|mesh-ancestor
101702201|NCT00723658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702202|NCT00723658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702203|NCT00723658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101702204|NCT00723658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101702205|NCT00723658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101702206|NCT00723658|Antiemetics|antiemetics|mesh-ancestor
101702207|NCT00723658|Autonomic Agents|autonomic agents|mesh-ancestor
101702208|NCT00723658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101702209|NCT00723658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101702210|NCT00723658|Glucocorticoids|glucocorticoids|mesh-ancestor
101702211|NCT00723658|Hormones|hormones|mesh-ancestor
101525408|NCT01183390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101525409|NCT01183390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101702212|NCT00723658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101702213|NCT00723658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101702214|NCT00723658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101525416|NCT02887807|Cyclosporine|cyclosporine|mesh-list
101702215|NCT00723658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101702216|NCT00723658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101702217|NCT00723658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101702218|NCT00723658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101702219|NCT00723658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101702220|NCT00723658|Antimetabolites|antimetabolites|mesh-ancestor
101702221|NCT00723658|Antiviral Agents|antiviral agents|mesh-ancestor
101702222|NCT00723658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101702223|NCT00723658|Leprostatic Agents|leprostatic agents|mesh-ancestor
101702224|NCT00723658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101702225|NCT00723658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101702226|NCT00723658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101702227|NCT00723658|Growth Substances|growth substances|mesh-ancestor
101702228|NCT00723658|Growth Inhibitors|growth inhibitors|mesh-ancestor
101702229|NCT04139850|Antiviral Agents|antiviral agents|mesh-list
101702230|NCT04139850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101702231|NCT02638142|Furosemide|furosemide|mesh-list
101702232|NCT02638142|Diuretics|diuretics|mesh-ancestor
101702233|NCT02638142|Natriuretic Agents|natriuretic agents|mesh-ancestor
101702234|NCT02638142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702235|NCT02638142|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101702236|NCT02638142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101702237|NCT02638142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702238|NCT02727491|Dextromethorphan|dextromethorphan|mesh-list
101702239|NCT02727491|Antitussive Agents|antitussive agents|mesh-ancestor
101702240|NCT02727491|Respiratory System Agents|respiratory system agents|mesh-ancestor
101525512|NCT04661670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101702241|NCT02727491|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101702242|NCT02727491|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101702243|NCT02727491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101702244|NCT02727491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702245|NCT02727491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702246|NCT03562195|Albuterol|albuterol|mesh-list
101702247|NCT03562195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101702248|NCT03562195|Autonomic Agents|autonomic agents|mesh-ancestor
101702249|NCT03562195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101702250|NCT03562195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702251|NCT03562195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101702252|NCT03562195|Respiratory System Agents|respiratory system agents|mesh-ancestor
101702253|NCT03562195|Tocolytic Agents|tocolytic agents|mesh-ancestor
101702254|NCT03562195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101525579|NCT00538265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525581|NCT00538265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101702255|NCT03562195|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101702256|NCT03562195|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101702257|NCT03562195|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101702258|NCT03562195|Adrenergic Agents|adrenergic agents|mesh-ancestor
101702259|NCT03562195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101702260|NCT03562195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702261|NCT00686868|Ofatumumab|ofatumumab|mesh-list
101702262|NCT00686868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702263|NCT00992329|Ciprofloxacin|ciprofloxacin|mesh-list
101702264|NCT00992329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101702265|NCT00992329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101702266|NCT00992329|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101702267|NCT00992329|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101702268|NCT00992329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101525706|NCT02436096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101302558|NCT00324805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702269|NCT00992329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702270|NCT00992329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702271|NCT00992329|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101702272|NCT00992329|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101702274|NCT02645864|Apatinib|apatinib|mesh-list
101702275|NCT02645864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101702276|NCT02645864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101702277|NCT02645864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101702278|NCT02645864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702279|NCT02645864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702280|NCT02645864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101702281|NCT00674856|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
101702282|NCT00674856|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101702283|NCT00674856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702285|NCT02574130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101702286|NCT02574130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101702287|NCT00652184|Valacyclovir|valacyclovir|mesh-list
101702288|NCT00652184|Sorivudine|sorivudine|mesh-list
101702289|NCT00652184|Antiviral Agents|antiviral agents|mesh-ancestor
101702290|NCT00652184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101702291|NCT00652184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101702292|NCT00652184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702293|NCT02726867|Lacosamide|lacosamide|mesh-list
101702294|NCT02726867|Ketamine|ketamine|mesh-list
101702295|NCT02726867|Levetiracetam|levetiracetam|mesh-list
101702296|NCT02726867|Phenobarbital|phenobarbital|mesh-list
101702297|NCT02726867|Analgesics|analgesics|mesh-ancestor
101702298|NCT02726867|Sensory System Agents|sensory system agents|mesh-ancestor
101702299|NCT02726867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101702300|NCT02726867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702301|NCT02726867|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101702302|NCT02726867|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101702305|NCT02726867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101702306|NCT02726867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101702307|NCT02726867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101702308|NCT02726867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101702309|NCT02726867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702310|NCT02726867|Anticonvulsants|anticonvulsants|mesh-ancestor
101702311|NCT02726867|Nootropic Agents|nootropic agents|mesh-ancestor
101702312|NCT02726867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101702313|NCT02726867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101525894|NCT00540410|Antiviral Agents|antiviral agents|mesh-ancestor
101702314|NCT02726867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101702315|NCT02726867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101702316|NCT02726867|GABA Modulators|gaba modulators|mesh-ancestor
101702317|NCT02726867|GABA Agents|gaba agents|mesh-ancestor
101702318|NCT02726867|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101702319|NCT02726867|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101702320|NCT02726867|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101702321|NCT00723970|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101525948|NCT00540800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101702322|NCT00723970|Antidepressive Agents|antidepressive agents|mesh-ancestor
101702323|NCT00723970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101702324|NCT00723970|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101702325|NCT00723970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101702326|NCT00723970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101702327|NCT00723970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702328|NCT00873366|Tamoxifen|tamoxifen|mesh-list
101702329|NCT00873366|Dextromethorphan|dextromethorphan|mesh-list
101702330|NCT00873366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702331|NCT00873366|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101702332|NCT00873366|Hormone Antagonists|hormone antagonists|mesh-ancestor
101702333|NCT00873366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101702334|NCT00873366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702335|NCT00873366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101702336|NCT00873366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702337|NCT00873366|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101702338|NCT00873366|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101702339|NCT00873366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101702340|NCT00873366|Antitussive Agents|antitussive agents|mesh-ancestor
101702341|NCT00873366|Respiratory System Agents|respiratory system agents|mesh-ancestor
101702342|NCT00873366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101702343|NCT00873366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101702344|NCT00873366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101702345|NCT00712894|Verapamil|verapamil|mesh-list
101702346|NCT00712894|Diltiazem|diltiazem|mesh-list
101702347|NCT00712894|Nitroglycerin|nitroglycerin|mesh-list
101702348|NCT00712894|Vasodilator Agents|vasodilator agents|mesh-ancestor
101702349|NCT00712894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101702350|NCT00712894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101702351|NCT00712894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101702352|NCT00712894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702353|NCT00712894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101702354|NCT00712894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702355|NCT00712894|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101702356|NCT04164368|Lenalidomide|lenalidomide|mesh-list
101702357|NCT04164368|Immunologic Factors|immunologic factors|mesh-ancestor
101702358|NCT04164368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702359|NCT04164368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101702360|NCT04164368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101526075|NCT00541853|Candesartan|candesartan|mesh-list
101702361|NCT04164368|Growth Substances|growth substances|mesh-ancestor
101702362|NCT04164368|Growth Inhibitors|growth inhibitors|mesh-ancestor
101702363|NCT04164368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702364|NCT02726555|Atorvastatin|atorvastatin|mesh-list
101702365|NCT02726555|Red yeast rice|red yeast rice|mesh-list
101702366|NCT02726555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101702367|NCT02726555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101702368|NCT02726555|Antimetabolites|antimetabolites|mesh-ancestor
101702369|NCT02726555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702370|NCT02726555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101702371|NCT02726555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101702372|NCT02726555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101702373|NCT00536107|Docetaxel|docetaxel|mesh-list
101702374|NCT00536107|Gefitinib|gefitinib|mesh-list
101702375|NCT00536107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702376|NCT00536107|Tubulin Modulators|tubulin modulators|mesh-ancestor
101702377|NCT00536107|Antimitotic Agents|antimitotic agents|mesh-ancestor
101702378|NCT00536107|Mitosis Modulators|mitosis modulators|mesh-ancestor
101702379|NCT00536107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526128|NCT00542165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410437|NCT00444379|Efavirenz|efavirenz|mesh-list
101702380|NCT00536107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101702381|NCT00536107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101702382|NCT01022138|Cyclophosphamide|cyclophosphamide|mesh-list
101702383|NCT01022138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101702384|NCT01022138|Immunologic Factors|immunologic factors|mesh-ancestor
101702385|NCT01022138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702386|NCT01022138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101702387|NCT01022138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101702388|NCT01022138|Alkylating Agents|alkylating agents|mesh-ancestor
101702389|NCT01022138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702390|NCT01022138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702391|NCT01022138|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101702392|NCT00724360|Trastuzumab|trastuzumab|mesh-list
101702393|NCT00724360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101702394|NCT00724360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702395|NCT02637830|Fluorides|fluorides|mesh-list
101702396|NCT02637830|Fluorides, Topical|fluorides, topical|mesh-list
101702397|NCT02637830|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
101702398|NCT02637830|Cariostatic Agents|cariostatic agents|mesh-ancestor
101702399|NCT02637830|Protective Agents|protective agents|mesh-ancestor
101702400|NCT02637830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702401|NCT00687258|Vitamin E|vitamin e|mesh-list
101702402|NCT00687258|Vitamins|vitamins|mesh-ancestor
101702403|NCT00687258|Micronutrients|micronutrients|mesh-ancestor
101702404|NCT00687258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702405|NCT00687258|Antioxidants|antioxidants|mesh-ancestor
101702406|NCT00687258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702407|NCT00687258|Protective Agents|protective agents|mesh-ancestor
101702408|NCT04001569|Paclitaxel|paclitaxel|mesh-list
101702409|NCT04001569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101702410|NCT04001569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702411|NCT04001569|Tubulin Modulators|tubulin modulators|mesh-ancestor
101702412|NCT04001569|Antimitotic Agents|antimitotic agents|mesh-ancestor
101702413|NCT04001569|Mitosis Modulators|mitosis modulators|mesh-ancestor
101702414|NCT04001569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702415|NCT00692016|Naproxen|naproxen|mesh-list
101702416|NCT00692016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101702417|NCT00692016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101702418|NCT00692016|Analgesics|analgesics|mesh-ancestor
101702419|NCT00692016|Sensory System Agents|sensory system agents|mesh-ancestor
101526180|NCT02257983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526181|NCT00543023|Teriparatide|teriparatide|mesh-list
101526182|NCT00543023|Calcitonin|calcitonin|mesh-list
101702420|NCT00692016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101702421|NCT00692016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702422|NCT00692016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101702423|NCT00692016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101702424|NCT00692016|Gout Suppressants|gout suppressants|mesh-ancestor
101702425|NCT00692016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101702426|NCT00692016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101702427|NCT00692016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702428|NCT03295981|Zoledronic Acid|zoledronic acid|mesh-list
101702429|NCT03295981|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101702430|NCT03295981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702431|NCT02733107|Etoposide|etoposide|mesh-list
101526215|NCT03456752|Dexamethasone|dexamethasone|mesh-list
101702432|NCT02733107|Apatinib|apatinib|mesh-list
101526217|NCT03456752|Antiemetics|antiemetics|mesh-ancestor
101702433|NCT02733107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101702434|NCT02733107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702435|NCT02733107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101702436|NCT02733107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101702437|NCT02733107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101702438|NCT02733107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702439|NCT02733107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101702440|NCT00675012|Capecitabine|capecitabine|mesh-list
101702441|NCT00675012|Oxaliplatin|oxaliplatin|mesh-list
101702442|NCT00675012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101702443|NCT00675012|Antimetabolites|antimetabolites|mesh-ancestor
101702444|NCT00675012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702445|NCT00675012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702446|NCT00652262|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101702447|NCT00652262|Vasodilator Agents|vasodilator agents|mesh-ancestor
101702448|NCT00652262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101702449|NCT00652262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101702450|NCT00652262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101702451|NCT00652262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702452|NCT00652262|Urological Agents|urological agents|mesh-ancestor
101702453|NCT02640794|Aspirin|aspirin|mesh-list
101702454|NCT02640794|Clopidogrel|clopidogrel|mesh-list
101702455|NCT02640794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101702456|NCT02640794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101702457|NCT02640794|Analgesics|analgesics|mesh-ancestor
101702458|NCT02640794|Sensory System Agents|sensory system agents|mesh-ancestor
101702459|NCT02640794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101702460|NCT02640794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702461|NCT02640794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101702462|NCT02640794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101702463|NCT02640794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101702464|NCT02640794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101702465|NCT02640794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702466|NCT02640794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101702467|NCT02640794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101702468|NCT02640794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101702469|NCT02640794|Antipyretics|antipyretics|mesh-ancestor
101526331|NCT00543842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101702470|NCT02640794|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101702471|NCT02640794|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101702472|NCT02640794|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101702473|NCT02640794|Purinergic Agents|purinergic agents|mesh-ancestor
101702474|NCT02640794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101702475|NCT00724672|Adalimumab|adalimumab|mesh-list
101702476|NCT00724672|Infliximab|infliximab|mesh-list
101702477|NCT00724672|Etanercept|etanercept|mesh-list
101702478|NCT00724672|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101702479|NCT00724672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101702480|NCT00724672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101702481|NCT00724672|Dermatologic Agents|dermatologic agents|mesh-ancestor
101526392|NCT00544232|Paclitaxel|paclitaxel|mesh-list
101702482|NCT00724672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101702483|NCT00724672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101702484|NCT00724672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101702485|NCT00724672|Analgesics|analgesics|mesh-ancestor
101702486|NCT00724672|Sensory System Agents|sensory system agents|mesh-ancestor
101702487|NCT00724672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101702488|NCT00724672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702489|NCT00724672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101702490|NCT00724672|Immunologic Factors|immunologic factors|mesh-ancestor
101702491|NCT02624856|Dexamethasone|dexamethasone|mesh-list
101702492|NCT02624856|Bupivacaine|bupivacaine|mesh-list
101702493|NCT02624856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101702494|NCT02624856|Antiemetics|antiemetics|mesh-ancestor
101702495|NCT02624856|Autonomic Agents|autonomic agents|mesh-ancestor
101702496|NCT02624856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101702497|NCT02624856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702498|NCT02624856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101702499|NCT02624856|Glucocorticoids|glucocorticoids|mesh-ancestor
101702501|NCT02624856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101702502|NCT02624856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101526451|NCT00544349|Micronutrients|micronutrients|mesh-ancestor
101702503|NCT02624856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702504|NCT02624856|Anesthetics, Local|anesthetics, local|mesh-ancestor
101702505|NCT02624856|Anesthetics|anesthetics|mesh-ancestor
101702506|NCT02624856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101702507|NCT02624856|Sensory System Agents|sensory system agents|mesh-ancestor
101702508|NCT02646020|Loratadine|loratadine|mesh-list
101702509|NCT02646020|Aprepitant|aprepitant|mesh-list
101702510|NCT02646020|Fosaprepitant|fosaprepitant|mesh-list
101702511|NCT02646020|Desloratadine|desloratadine|mesh-list
101702512|NCT02646020|Antiemetics|antiemetics|mesh-ancestor
101702513|NCT02646020|Autonomic Agents|autonomic agents|mesh-ancestor
101702514|NCT02646020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101526504|NCT05824455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101702515|NCT02646020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702516|NCT02646020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101702517|NCT02646020|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101702518|NCT02646020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101702519|NCT02646020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702520|NCT02646020|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101261947|NCT01754285|Octreotide|octreotide|mesh-list
101262093|NCT01755338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101262322|NCT01756443|Sensory System Agents|sensory system agents|mesh-ancestor
101262543|NCT01757587|Insulin|insulin|mesh-list
101702522|NCT02646020|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101702523|NCT02646020|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101702524|NCT02646020|Histamine Antagonists|histamine antagonists|mesh-ancestor
101702525|NCT02646020|Histamine Agents|histamine agents|mesh-ancestor
101702526|NCT02646020|Antipruritics|antipruritics|mesh-ancestor
101702527|NCT02646020|Dermatologic Agents|dermatologic agents|mesh-ancestor
101702528|NCT02646020|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101702529|NCT02733419|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101702530|NCT02733419|Enfuvirtide|enfuvirtide|mesh-list
101702531|NCT02733419|Antiviral Agents|antiviral agents|mesh-ancestor
101526564|NCT05823155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101702532|NCT02733419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101702533|NCT02733419|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101702534|NCT02733419|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101702535|NCT02733419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702536|NCT02733419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101702537|NCT00992797|Vitamin D|vitamin d|mesh-list
101702538|NCT00992797|Cholecalciferol|cholecalciferol|mesh-list
101702539|NCT00992797|Vitamins|vitamins|mesh-ancestor
101702540|NCT00992797|Micronutrients|micronutrients|mesh-ancestor
101702541|NCT00992797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262700|NCT01758263|Metoprolol|metoprolol|mesh-list
101702542|NCT00992797|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101702543|NCT00992797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101702544|NCT02725541|Trastuzumab|trastuzumab|mesh-list
101702545|NCT02725541|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101702546|NCT02725541|Maytansine|maytansine|mesh-list
101702547|NCT02725541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101702548|NCT02725541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702549|NCT02725541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101702550|NCT02725541|Tubulin Modulators|tubulin modulators|mesh-ancestor
101526617|NCT05824338|Sensory System Agents|sensory system agents|mesh-ancestor
101702551|NCT02725541|Antimitotic Agents|antimitotic agents|mesh-ancestor
101702552|NCT02725541|Mitosis Modulators|mitosis modulators|mesh-ancestor
101702553|NCT02725541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702555|NCT02725541|Immunoconjugates|immunoconjugates|mesh-ancestor
101702556|NCT02725541|Immunologic Factors|immunologic factors|mesh-ancestor
101702557|NCT02725541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702558|NCT00911066|Azacitidine|azacitidine|mesh-list
101702559|NCT00911066|Pevonedistat|pevonedistat|mesh-list
101702560|NCT00911066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101702561|NCT00911066|Antimetabolites|antimetabolites|mesh-ancestor
101702562|NCT00911066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702563|NCT00911066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702564|NCT00911066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101702565|NCT02733341|Ticagrelor|ticagrelor|mesh-list
101702566|NCT02733341|Cangrelor|cangrelor|mesh-list
101702567|NCT02733341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101702568|NCT02733341|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101702569|NCT02733341|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101702570|NCT02733341|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101702571|NCT02733341|Purinergic Agents|purinergic agents|mesh-ancestor
101702572|NCT02733341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101702573|NCT02733341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302559|NCT00324805|Growth Inhibitors|growth inhibitors|mesh-ancestor
101702574|NCT02733341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702575|NCT00692172|Alefacept|alefacept|mesh-list
101702576|NCT00692172|Dermatologic Agents|dermatologic agents|mesh-ancestor
101702577|NCT00692172|Immunologic Factors|immunologic factors|mesh-ancestor
101702578|NCT00692172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702579|NCT00692250|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
101702580|NCT00692250|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101702581|NCT00692250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101702582|NCT00692250|Antimetabolites|antimetabolites|mesh-ancestor
101702583|NCT00692250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702584|NCT00692250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101702585|NCT03675139|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101702586|NCT03675139|Medroxyprogesterone|medroxyprogesterone|mesh-list
101702587|NCT03675139|Dydrogesterone|dydrogesterone|mesh-list
101702588|NCT03675139|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101702589|NCT03675139|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101702590|NCT03675139|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101702591|NCT03675139|Contraceptive Agents|contraceptive agents|mesh-ancestor
101702592|NCT03675139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101702593|NCT03675139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702594|NCT03675139|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101702595|NCT03675139|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101526724|NCT05564221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101702596|NCT03675139|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101702597|NCT03675139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101702598|NCT03675139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702599|NCT03675139|Progestins|progestins|mesh-ancestor
101702600|NCT03675139|Hormones|hormones|mesh-ancestor
101702601|NCT03675139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101702602|NCT02645552|Tranexamic Acid|tranexamic acid|mesh-list
101702603|NCT02645552|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101702604|NCT02645552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101702605|NCT02645552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702606|NCT02645552|Hemostatics|hemostatics|mesh-ancestor
101702607|NCT02645552|Coagulants|coagulants|mesh-ancestor
101702608|NCT00692328|Levodopa|levodopa|mesh-list
101702609|NCT00692328|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101702610|NCT00692328|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101526779|NCT05065294|Psilocybin|psilocybin|mesh-list
101702611|NCT00692328|Dopamine Agents|dopamine agents|mesh-ancestor
101702612|NCT00692328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101702613|NCT00692328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702614|NCT00692328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702615|NCT03415828|Ethanol|ethanol|mesh-list
101702616|NCT03415828|Prednisolone|prednisolone|mesh-list
101702617|NCT03415828|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101702618|NCT03415828|Methylprednisolone|methylprednisolone|mesh-list
101702619|NCT03415828|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101526837|NCT04943198|Vemurafenib|vemurafenib|mesh-list
101702620|NCT03415828|Prednisolone acetate|prednisolone acetate|mesh-list
101702621|NCT03415828|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101702622|NCT03415828|Prednisolone phosphate|prednisolone phosphate|mesh-list
101702623|NCT03415828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101702624|NCT03415828|Glucocorticoids|glucocorticoids|mesh-ancestor
101702625|NCT03415828|Hormones|hormones|mesh-ancestor
101702626|NCT03415828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101702627|NCT03415828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702628|NCT03415828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101526903|NCT04803747|Tranexamic Acid|tranexamic acid|mesh-list
101702630|NCT03415828|Antiemetics|antiemetics|mesh-ancestor
101702631|NCT03415828|Autonomic Agents|autonomic agents|mesh-ancestor
101702632|NCT03415828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101702633|NCT03415828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101702634|NCT03415828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101702635|NCT03415828|Protective Agents|protective agents|mesh-ancestor
101702636|NCT03415828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101702637|NCT03415828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101702638|NCT03415828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101702639|NCT00687648|Prednisolone|prednisolone|mesh-list
101702640|NCT00687648|Cyclophosphamide|cyclophosphamide|mesh-list
101702641|NCT00687648|Methotrexate|methotrexate|mesh-list
101702642|NCT00687648|Letrozole|letrozole|mesh-list
101702643|NCT00687648|Anastrozole|anastrozole|mesh-list
101702644|NCT00687648|Exemestane|exemestane|mesh-list
101702645|NCT00687648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101535809|NCT00193479|Prednisone|prednisone|mesh-list
101702646|NCT00687648|Immunologic Factors|immunologic factors|mesh-ancestor
101702647|NCT00687648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702648|NCT00687648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101302560|NCT00324805|Immunologic Factors|immunologic factors|mesh-ancestor
101702649|NCT00687648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101702650|NCT00687648|Alkylating Agents|alkylating agents|mesh-ancestor
101702651|NCT00687648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702652|NCT00687648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702653|NCT00687648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101702654|NCT00687648|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101702655|NCT00687648|Abortifacient Agents|abortifacient agents|mesh-ancestor
101702656|NCT00687648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101702657|NCT00687648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101702658|NCT00687648|Antimetabolites|antimetabolites|mesh-ancestor
101702659|NCT00687648|Dermatologic Agents|dermatologic agents|mesh-ancestor
101702660|NCT00687648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101702661|NCT00687648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101702662|NCT00687648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101702663|NCT00687648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101702664|NCT00687648|Glucocorticoids|glucocorticoids|mesh-ancestor
101702665|NCT00687648|Hormones|hormones|mesh-ancestor
101702666|NCT00687648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101702667|NCT00687648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101702668|NCT00687648|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101702669|NCT00687648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101702670|NCT00687648|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101702671|NCT00687648|Hormone Antagonists|hormone antagonists|mesh-ancestor
101702672|NCT00725218|Flurbiprofen|flurbiprofen|mesh-list
101702673|NCT00725218|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
101702674|NCT00725218|Analgesics|analgesics|mesh-ancestor
101702675|NCT00725218|Sensory System Agents|sensory system agents|mesh-ancestor
101702676|NCT00725218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101702677|NCT00725218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702678|NCT00725218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101527029|NCT04562090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101702679|NCT00725218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101702680|NCT00725218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101702681|NCT00725218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101702682|NCT00725218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101702683|NCT00725218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101702684|NCT00725218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702685|NCT02732795|Morphine|morphine|mesh-list
101702686|NCT02732795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101702687|NCT02732795|Narcotics|narcotics|mesh-ancestor
101702688|NCT02732795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101702689|NCT02732795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702691|NCT02732795|Sensory System Agents|sensory system agents|mesh-ancestor
101702692|NCT02732795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101702693|NCT05373004|Empagliflozin|empagliflozin|mesh-list
101702694|NCT05373004|Enalapril|enalapril|mesh-list
101702696|NCT05373004|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101702697|NCT05373004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702698|NCT05373004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101702699|NCT05373004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702700|NCT05373004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101527070|NCT04442919|Anesthetics, General|anesthetics, general|mesh-ancestor
101527084|NCT04415060|Isoflurane|isoflurane|mesh-list
101702701|NCT05373004|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101702702|NCT05373004|Protease Inhibitors|protease inhibitors|mesh-ancestor
101702703|NCT05373004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101702704|NCT00655616|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101702705|NCT00655616|Montelukast|montelukast|mesh-list
101702706|NCT00655616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101702707|NCT00655616|Autonomic Agents|autonomic agents|mesh-ancestor
101702708|NCT00655616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101702709|NCT00655616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702710|NCT00655616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101702711|NCT00655616|Respiratory System Agents|respiratory system agents|mesh-ancestor
101702712|NCT00655616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101527126|NCT04293562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702713|NCT00655616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101702715|NCT00655616|Adrenergic Agents|adrenergic agents|mesh-ancestor
101702716|NCT00655616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101702717|NCT00655616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702718|NCT00655616|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101702719|NCT00655616|Hormone Antagonists|hormone antagonists|mesh-ancestor
101702720|NCT00655616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101702721|NCT00655616|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101702722|NCT00655616|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101702723|NCT00713440|Acetaminophen|acetaminophen|mesh-list
101702724|NCT00713440|Prednisolone|prednisolone|mesh-list
101702725|NCT00713440|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101702726|NCT00713440|Methylprednisolone|methylprednisolone|mesh-list
101702727|NCT00713440|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101702728|NCT00713440|Prednisolone acetate|prednisolone acetate|mesh-list
101702729|NCT00713440|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101702730|NCT00713440|Prednisolone phosphate|prednisolone phosphate|mesh-list
101702731|NCT00713440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101702732|NCT00713440|Glucocorticoids|glucocorticoids|mesh-ancestor
101702733|NCT00713440|Hormones|hormones|mesh-ancestor
101702734|NCT00713440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101702735|NCT00713440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702736|NCT00713440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101702737|NCT00713440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702738|NCT00713440|Antiemetics|antiemetics|mesh-ancestor
101702739|NCT00713440|Autonomic Agents|autonomic agents|mesh-ancestor
101702740|NCT00713440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101702741|NCT00713440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101702742|NCT00713440|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101702743|NCT00713440|Protective Agents|protective agents|mesh-ancestor
101702744|NCT00713440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101702745|NCT00713440|Analgesics|analgesics|mesh-ancestor
101702746|NCT00713440|Sensory System Agents|sensory system agents|mesh-ancestor
101702747|NCT00713440|Antipyretics|antipyretics|mesh-ancestor
101702748|NCT00993109|Valsartan|valsartan|mesh-list
101702749|NCT00993109|Nifedipine|nifedipine|mesh-list
101702750|NCT00993109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101702751|NCT00993109|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101702752|NCT00993109|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101527187|NCT04003285|Anesthetics|anesthetics|mesh-ancestor
101527190|NCT04000555|Vancomycin|vancomycin|mesh-list
101702753|NCT00993109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702754|NCT00993109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101702755|NCT00993109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101702756|NCT00993109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101702757|NCT00993109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702758|NCT00993109|Vasodilator Agents|vasodilator agents|mesh-ancestor
101702759|NCT00993109|Tocolytic Agents|tocolytic agents|mesh-ancestor
101702760|NCT00993109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101702761|NCT02725229|Levobupivacaine|levobupivacaine|mesh-list
101702762|NCT02725229|Anesthetics, Local|anesthetics, local|mesh-ancestor
101702763|NCT02725229|Anesthetics|anesthetics|mesh-ancestor
101702764|NCT02725229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101702765|NCT02725229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702766|NCT02725229|Sensory System Agents|sensory system agents|mesh-ancestor
101702767|NCT02725229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101702768|NCT00655772|Chlorine dioxide|chlorine dioxide|mesh-list
101702769|NCT00655772|Dental Disinfectants|dental disinfectants|mesh-ancestor
101702770|NCT00655772|Disinfectants|disinfectants|mesh-ancestor
101702771|NCT00655772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101702772|NCT00675246|Betamethasone|betamethasone|mesh-list
101702773|NCT00675246|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
101702774|NCT00675246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101702775|NCT00675246|Glucocorticoids|glucocorticoids|mesh-ancestor
101702777|NCT00675246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101527285|NCT03251859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101702778|NCT00675246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702779|NCT00675246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101702780|NCT00675246|Respiratory System Agents|respiratory system agents|mesh-ancestor
101702781|NCT00675246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101702782|NCT00675246|Autonomic Agents|autonomic agents|mesh-ancestor
101702783|NCT00675246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101702784|NCT02732405|Grazoprevir|grazoprevir|mesh-list
101702785|NCT02732405|Antiviral Agents|antiviral agents|mesh-ancestor
101702786|NCT02732405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101702787|NCT04001725|Metformin|metformin|mesh-list
101702788|NCT04001725|Dexamethasone|dexamethasone|mesh-list
101702789|NCT04001725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101702790|NCT04001725|Antiemetics|antiemetics|mesh-ancestor
101527345|NCT02259621|Paclitaxel|paclitaxel|mesh-list
101527346|NCT02259621|Carboplatin|carboplatin|mesh-list
101702791|NCT04001725|Autonomic Agents|autonomic agents|mesh-ancestor
101702792|NCT04001725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101702793|NCT04001725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702794|NCT04001725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101702795|NCT04001725|Glucocorticoids|glucocorticoids|mesh-ancestor
101702796|NCT04001725|Hormones|hormones|mesh-ancestor
101702797|NCT04001725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101702798|NCT04001725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101702799|NCT04001725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702800|NCT04001725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101702801|NCT00713674|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101702802|NCT00713674|Mupirocin|mupirocin|mesh-list
101702803|NCT00713674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101702804|NCT00713674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101702805|NCT00713674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101702806|NCT00713674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702807|NCT00885482|Ritonavir|ritonavir|mesh-list
101702808|NCT00885482|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101702809|NCT00885482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101702810|NCT00885482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101702811|NCT00885482|Protease Inhibitors|protease inhibitors|mesh-ancestor
101702812|NCT00885482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101527474|NCT00521222|Autonomic Agents|autonomic agents|mesh-ancestor
101527479|NCT00521222|Dermatologic Agents|dermatologic agents|mesh-ancestor
101702813|NCT00885482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702815|NCT00885482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101702816|NCT00885482|Antiviral Agents|antiviral agents|mesh-ancestor
101702817|NCT00885482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101702818|NCT00885482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101702819|NCT00885482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101702820|NCT04139226|CC-11050|cc-11050|mesh-list
101702821|NCT04139226|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101702822|NCT04139226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101702823|NCT04139226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101702824|NCT04139226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702825|NCT05366062|Cyclophosphamide|cyclophosphamide|mesh-list
101702826|NCT05366062|Pembrolizumab|pembrolizumab|mesh-list
101702827|NCT05366062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101702828|NCT05366062|Immunologic Factors|immunologic factors|mesh-ancestor
101702829|NCT05366062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702830|NCT05366062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101702831|NCT05366062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101702832|NCT05366062|Alkylating Agents|alkylating agents|mesh-ancestor
101702833|NCT05366062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702834|NCT05366062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702835|NCT05366062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101702836|NCT05366062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101702837|NCT05366062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101702838|NCT02645240|Heparin|heparin|mesh-list
101702840|NCT02645240|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101702841|NCT02645240|Tinzaparin|tinzaparin|mesh-list
101360301|NCT00215176|Modafinil|modafinil|mesh-list
101702842|NCT02645240|Dalteparin|dalteparin|mesh-list
101702843|NCT02645240|Anticoagulants|anticoagulants|mesh-ancestor
101702844|NCT02645240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101702845|NCT02645240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101702846|NCT02645240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702847|NCT00688194|Letrozole|letrozole|mesh-list
101702848|NCT00688194|Fulvestrant|fulvestrant|mesh-list
101702849|NCT00688194|Lapatinib|lapatinib|mesh-list
101702850|NCT00688194|Anastrozole|anastrozole|mesh-list
101702851|NCT00688194|Exemestane|exemestane|mesh-list
101702852|NCT00688194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702853|NCT00688194|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101702854|NCT00688194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101702855|NCT00688194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101527551|NCT00545558|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101702856|NCT00688194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702857|NCT00688194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101702858|NCT00688194|Hormone Antagonists|hormone antagonists|mesh-ancestor
101702859|NCT00688194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101702860|NCT00688194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702861|NCT00688194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101702862|NCT00688194|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101702863|NCT00688194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101702864|NCT00653744|Atorvastatin|atorvastatin|mesh-list
101702865|NCT00653744|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101702866|NCT00653744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101702867|NCT00653744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101702868|NCT00653744|Antimetabolites|antimetabolites|mesh-ancestor
101702869|NCT00653744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702870|NCT00653744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101702871|NCT00653744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101702872|NCT00653744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101702873|NCT03322267|Cisplatin|cisplatin|mesh-list
101702874|NCT03322267|Pembrolizumab|pembrolizumab|mesh-list
101702875|NCT03322267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702876|NCT03322267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101702877|NCT03322267|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101702878|NCT03322267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702879|NCT00652496|Bimatoprost|bimatoprost|mesh-list
101702880|NCT00652496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101702881|NCT00652496|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101527575|NCT04684667|Vasodilator Agents|vasodilator agents|mesh-ancestor
101702882|NCT00652496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101702883|NCT00688272|Ciprofloxacin|ciprofloxacin|mesh-list
101702884|NCT00688272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101702885|NCT00688272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101702886|NCT00688272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101702887|NCT00688272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101702888|NCT00688272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101702889|NCT00688272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702890|NCT00688272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702891|NCT00688272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101702892|NCT00688272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101702893|NCT00993343|Cyclosporine|cyclosporine|mesh-list
101702894|NCT00993343|Sirolimus|sirolimus|mesh-list
101702895|NCT00993343|Methotrexate|methotrexate|mesh-list
101702896|NCT00993343|Tacrolimus|tacrolimus|mesh-list
101702897|NCT00993343|Cyclosporins|cyclosporins|mesh-list
101702898|NCT00993343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101702899|NCT00993343|Abortifacient Agents|abortifacient agents|mesh-ancestor
101702900|NCT00993343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101702901|NCT00993343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702902|NCT00993343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101702903|NCT00993343|Antimetabolites|antimetabolites|mesh-ancestor
101702904|NCT00993343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702905|NCT00993343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702906|NCT00993343|Dermatologic Agents|dermatologic agents|mesh-ancestor
101702907|NCT00993343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101702908|NCT00993343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101702909|NCT00993343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101702910|NCT00993343|Immunologic Factors|immunologic factors|mesh-ancestor
101702911|NCT00993343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101702912|NCT00993343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101702913|NCT00993343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101527628|NCT00546065|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101702914|NCT00993343|Antifungal Agents|antifungal agents|mesh-ancestor
101702915|NCT00993343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101702916|NCT00993343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101702917|NCT00993343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101702919|NCT02974049|Albendazole|albendazole|mesh-list
101702920|NCT02974049|Diethylcarbamazine|diethylcarbamazine|mesh-list
101702921|NCT02974049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101702922|NCT02974049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101702923|NCT02974049|Anthelmintics|anthelmintics|mesh-ancestor
101702924|NCT02974049|Anticestodal Agents|anticestodal agents|mesh-ancestor
101702925|NCT02974049|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101702926|NCT02974049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101702927|NCT02974049|Tubulin Modulators|tubulin modulators|mesh-ancestor
101702928|NCT02974049|Antimitotic Agents|antimitotic agents|mesh-ancestor
101702929|NCT02974049|Mitosis Modulators|mitosis modulators|mesh-ancestor
101702930|NCT02974049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702931|NCT02974049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702932|NCT02974049|Filaricides|filaricides|mesh-ancestor
101702933|NCT02974049|Antinematodal Agents|antinematodal agents|mesh-ancestor
101702934|NCT02974049|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101702935|NCT02974049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101702937|NCT02637284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101702938|NCT02637284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101702939|NCT04138992|Bevacizumab|bevacizumab|mesh-list
101702940|NCT04138992|Cisplatin|cisplatin|mesh-list
101702941|NCT04138992|Docetaxel|docetaxel|mesh-list
101702942|NCT04138992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101702943|NCT04138992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702944|NCT04138992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101702945|NCT04138992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101702946|NCT04138992|Growth Substances|growth substances|mesh-ancestor
101702947|NCT04138992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702948|NCT04138992|Growth Inhibitors|growth inhibitors|mesh-ancestor
101702949|NCT04138992|Tubulin Modulators|tubulin modulators|mesh-ancestor
101702950|NCT04138992|Antimitotic Agents|antimitotic agents|mesh-ancestor
101702951|NCT04138992|Mitosis Modulators|mitosis modulators|mesh-ancestor
101702952|NCT04138992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702953|NCT04137588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101702954|NCT04137588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
101702955|NCT04137588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101702956|NCT04137588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101527721|NCT00547508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101702957|NCT04137588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702958|NCT04137588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101702959|NCT04137588|Growth Substances|growth substances|mesh-ancestor
101702960|NCT04137588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702961|NCT04137588|Growth Inhibitors|growth inhibitors|mesh-ancestor
101702962|NCT02721329|Acetaminophen|acetaminophen|mesh-list
101702963|NCT02721329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101702964|NCT02721329|Analgesics|analgesics|mesh-ancestor
101702965|NCT02721329|Sensory System Agents|sensory system agents|mesh-ancestor
101702966|NCT02721329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101702967|NCT02721329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702968|NCT02721329|Antipyretics|antipyretics|mesh-ancestor
101702969|NCT02637128|Artesunate|artesunate|mesh-list
101702970|NCT02637128|Lumefantrine|lumefantrine|mesh-list
101702971|NCT02637128|Artemether|artemether|mesh-list
101702972|NCT02637128|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101702973|NCT02637128|Amodiaquine|amodiaquine|mesh-list
101702974|NCT02637128|Antimalarials|antimalarials|mesh-ancestor
101702975|NCT02637128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101702976|NCT02637128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101702977|NCT02637128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101702978|NCT02637128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702979|NCT02637128|Antiviral Agents|antiviral agents|mesh-ancestor
101702980|NCT02637128|Schistosomicides|schistosomicides|mesh-ancestor
101702981|NCT02637128|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101702982|NCT02637128|Anthelmintics|anthelmintics|mesh-ancestor
101702984|NCT02624622|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101702985|NCT02624622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101702986|NCT02624622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101535833|NCT00193479|Analgesics|analgesics|mesh-ancestor
101702987|NCT02624622|Disinfectants|disinfectants|mesh-ancestor
101702988|NCT02624622|Dermatologic Agents|dermatologic agents|mesh-ancestor
101702989|NCT00585247|Imiquimod|imiquimod|mesh-list
101702990|NCT00585247|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101702991|NCT00585247|Immunologic Factors|immunologic factors|mesh-ancestor
101527777|NCT04636242|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101527778|NCT04636242|Dermatologic Agents|dermatologic agents|mesh-ancestor
101527779|NCT00548288|Pamidronate|pamidronate|mesh-list
101702992|NCT00585247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101702993|NCT00585247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101702994|NCT00585247|Interferon Inducers|interferon inducers|mesh-ancestor
101702996|NCT04002349|Levocabastine|levocabastine|mesh-list
101702997|NCT04002349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101702998|NCT04002349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101702999|NCT04002349|Autonomic Agents|autonomic agents|mesh-ancestor
101703000|NCT04002349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101703001|NCT04002349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703002|NCT04002349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101703003|NCT04002349|Respiratory System Agents|respiratory system agents|mesh-ancestor
101703004|NCT04002349|Glucocorticoids|glucocorticoids|mesh-ancestor
101703005|NCT04002349|Hormones|hormones|mesh-ancestor
101703006|NCT04002349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101703007|NCT04002349|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101703008|NCT04002349|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101703009|NCT04002349|Histamine Antagonists|histamine antagonists|mesh-ancestor
101703010|NCT04002349|Histamine Agents|histamine agents|mesh-ancestor
101703011|NCT04002349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101703012|NCT04002349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703013|NCT00688428|Aspirin|aspirin|mesh-list
101703014|NCT00688428|Esomeprazole|esomeprazole|mesh-list
101703015|NCT00688428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101703016|NCT00688428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101703017|NCT00688428|Analgesics|analgesics|mesh-ancestor
101703018|NCT00688428|Sensory System Agents|sensory system agents|mesh-ancestor
101703019|NCT00688428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101703020|NCT00688428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703021|NCT00688428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101703022|NCT00688428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101703023|NCT00688428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101703024|NCT00688428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101703025|NCT00688428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703026|NCT00688428|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101703027|NCT00688428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101703028|NCT00688428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101703029|NCT00688428|Antipyretics|antipyretics|mesh-ancestor
101703030|NCT00688428|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101703031|NCT00688428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101703032|NCT00688428|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101703033|NCT02724761|Epinephrine|epinephrine|mesh-list
101703034|NCT02724761|Racepinephrine|racepinephrine|mesh-list
101703035|NCT02724761|Epinephryl borate|epinephryl borate|mesh-list
101703036|NCT02724761|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101703037|NCT02724761|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101703038|NCT02724761|Adrenergic Agents|adrenergic agents|mesh-ancestor
101527817|NCT00548561|Razoxane|razoxane|mesh-list
101703040|NCT02724761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703041|NCT02724761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703042|NCT02724761|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101703043|NCT02724761|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101703044|NCT02724761|Autonomic Agents|autonomic agents|mesh-ancestor
101703045|NCT02724761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101703046|NCT02724761|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101703047|NCT02724761|Respiratory System Agents|respiratory system agents|mesh-ancestor
101703048|NCT02724761|Mydriatics|mydriatics|mesh-ancestor
101703049|NCT02724761|Sympathomimetics|sympathomimetics|mesh-ancestor
101703050|NCT02724761|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101703051|NCT04350190|Apatinib|apatinib|mesh-list
101703052|NCT04350190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101703053|NCT04350190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101703054|NCT04350190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101703055|NCT04350190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703056|NCT02721173|Clindamycin|clindamycin|mesh-list
101703057|NCT02721173|Clindamycin palmitate|clindamycin palmitate|mesh-list
101703058|NCT02721173|Clindamycin phosphate|clindamycin phosphate|mesh-list
101703059|NCT02721173|Adapalene|adapalene|mesh-list
101703060|NCT02721173|Tazarotene|tazarotene|mesh-list
101703061|NCT02721173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101703062|NCT02721173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101703063|NCT02721173|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101703064|NCT02721173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101703065|NCT02721173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703066|NCT02721173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101703067|NCT02721173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101703068|NCT02721173|Analgesics|analgesics|mesh-ancestor
101703069|NCT02721173|Sensory System Agents|sensory system agents|mesh-ancestor
101703070|NCT02721173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101703071|NCT02721173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703072|NCT02721173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101527847|NCT00548678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101703075|NCT02721173|Keratolytic Agents|keratolytic agents|mesh-ancestor
101703076|NCT00713986|Tin Fluorides|tin fluorides|mesh-list
101703077|NCT00713986|Cariostatic Agents|cariostatic agents|mesh-ancestor
101703078|NCT00713986|Protective Agents|protective agents|mesh-ancestor
101703079|NCT00713986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703080|NCT00993733|Dialysis Solutions|dialysis solutions|mesh-list
101703081|NCT00993733|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101703082|NCT00692640|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101703083|NCT00692640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101703084|NCT00692640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101703085|NCT00692640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101703086|NCT00692640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703088|NCT04137432|Oxytocics|oxytocics|mesh-ancestor
101703089|NCT04137432|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101703090|NCT04137432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703091|NCT00885170|Vitamin D|vitamin d|mesh-list
101703092|NCT00885170|Cholecalciferol|cholecalciferol|mesh-list
101703093|NCT00885170|Calcium|calcium|mesh-list
101703094|NCT00885170|Vitamins|vitamins|mesh-ancestor
101703095|NCT00885170|Micronutrients|micronutrients|mesh-ancestor
101703096|NCT00885170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703097|NCT00885170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101703098|NCT00885170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101703099|NCT05342467|Dinoprostone|dinoprostone|mesh-list
101703100|NCT05342467|Gemeprost|gemeprost|mesh-list
101703101|NCT05342467|Oxytocics|oxytocics|mesh-ancestor
101703102|NCT05342467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101703103|NCT05342467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703104|NCT05342467|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101703105|NCT05342467|Abortifacient Agents|abortifacient agents|mesh-ancestor
101703106|NCT02720783|Econazole|econazole|mesh-list
101703107|NCT02720783|Benzydamine|benzydamine|mesh-list
101703108|NCT02720783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101703109|NCT02720783|Antifungal Agents|antifungal agents|mesh-ancestor
101703110|NCT02720783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101703111|NCT02720783|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101703112|NCT02720783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101703113|NCT02720783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101703114|NCT02720783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703115|NCT02720783|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101703116|NCT02720783|Hormone Antagonists|hormone antagonists|mesh-ancestor
101703117|NCT02720783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101703118|NCT02720783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703119|NCT00714064|Edetic Acid|edetic acid|mesh-list
101703120|NCT00714064|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101703121|NCT00714064|Pentetic Acid|pentetic acid|mesh-list
101703122|NCT00714064|Immunologic Factors|immunologic factors|mesh-ancestor
101703123|NCT00714064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527887|NCT00549107|Vasodilator Agents|vasodilator agents|mesh-ancestor
101703125|NCT00714064|Protective Agents|protective agents|mesh-ancestor
101703126|NCT00714064|Chelating Agents|chelating agents|mesh-ancestor
101703127|NCT00714064|Sequestering Agents|sequestering agents|mesh-ancestor
101703128|NCT00714064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703129|NCT00714064|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101703130|NCT00714064|Anticoagulants|anticoagulants|mesh-ancestor
101703131|NCT00714064|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101703132|NCT02720705|Dexmedetomidine|dexmedetomidine|mesh-list
101703133|NCT02720705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101703134|NCT02720705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101703135|NCT02720705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703136|NCT02720705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101703137|NCT02720705|Analgesics|analgesics|mesh-ancestor
101527911|NCT00549146|Adrenergic Agents|adrenergic agents|mesh-ancestor
101703138|NCT02720705|Sensory System Agents|sensory system agents|mesh-ancestor
101703139|NCT02720705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101262752|NCT01758640|Phenindione|phenindione|mesh-list
101703140|NCT02720705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101703141|NCT02720705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101703142|NCT02720705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101703143|NCT02720705|Adrenergic Agents|adrenergic agents|mesh-ancestor
101527912|NCT00549146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101703144|NCT02720705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101703145|NCT02720705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703146|NCT02720471|Anesthetics|anesthetics|mesh-list
101703147|NCT02720471|Anesthetics, Local|anesthetics, local|mesh-list
101703148|NCT02720471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101703149|NCT02720471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703151|NCT02720471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101703152|NCT00688818|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101703153|NCT00688818|Antidepressive Agents|antidepressive agents|mesh-ancestor
101703154|NCT00688818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101703155|NCT00688818|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101703156|NCT00688818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101703157|NCT00688818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101703158|NCT00688818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703159|NCT00656006|Ribavirin|ribavirin|mesh-list
101703160|NCT00656006|Antimetabolites|antimetabolites|mesh-ancestor
101703161|NCT00656006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703162|NCT00656006|Antiviral Agents|antiviral agents|mesh-ancestor
101703163|NCT00656006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101703164|NCT00688896|Pravastatin|pravastatin|mesh-list
101703165|NCT00688896|Dalcetrapib|dalcetrapib|mesh-list
101703166|NCT00688896|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101703167|NCT00688896|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101703168|NCT00688896|Antimetabolites|antimetabolites|mesh-ancestor
101703169|NCT00688896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703170|NCT00688896|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101703171|NCT00688896|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101703172|NCT00688896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101703173|NCT02724293|Pregabalin|pregabalin|mesh-list
101703174|NCT02724293|Analgesics|analgesics|mesh-ancestor
101703175|NCT02724293|Sensory System Agents|sensory system agents|mesh-ancestor
101703176|NCT02724293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101703177|NCT02724293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703178|NCT02724293|Anticonvulsants|anticonvulsants|mesh-ancestor
101703179|NCT02724293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101703180|NCT02724293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101703181|NCT02724293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703182|NCT02724293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101703183|NCT02724293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101703184|NCT02724293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101703185|NCT02724293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101703186|NCT02724293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101703187|NCT05092828|Morphine|morphine|mesh-list
101703188|NCT05092828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101703189|NCT05092828|Narcotics|narcotics|mesh-ancestor
101703190|NCT05092828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101703191|NCT05092828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703192|NCT05092828|Analgesics|analgesics|mesh-ancestor
101703193|NCT05092828|Sensory System Agents|sensory system agents|mesh-ancestor
101703194|NCT05092828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101703195|NCT04137198|Sufentanil|sufentanil|mesh-list
101703196|NCT04137198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101527962|NCT00549536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101703197|NCT04137198|Narcotics|narcotics|mesh-ancestor
101703198|NCT04137198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101703199|NCT04137198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703200|NCT04137198|Analgesics|analgesics|mesh-ancestor
101703201|NCT04137198|Sensory System Agents|sensory system agents|mesh-ancestor
101703202|NCT04137198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101703203|NCT04137198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101703204|NCT04137198|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101703205|NCT04137198|Anesthetics, General|anesthetics, general|mesh-ancestor
101703206|NCT04137198|Anesthetics|anesthetics|mesh-ancestor
101703207|NCT00995293|Docetaxel|docetaxel|mesh-list
101703208|NCT00995293|Fluorouracil|fluorouracil|mesh-list
101703209|NCT00995293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101703210|NCT00995293|Tubulin Modulators|tubulin modulators|mesh-ancestor
101703211|NCT00995293|Antimitotic Agents|antimitotic agents|mesh-ancestor
101703212|NCT00995293|Mitosis Modulators|mitosis modulators|mesh-ancestor
101703213|NCT00995293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703214|NCT00995293|Antimetabolites|antimetabolites|mesh-ancestor
101527982|NCT00549926|Antimetabolites|antimetabolites|mesh-ancestor
101703215|NCT00995293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101703216|NCT00995293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101703217|NCT00995293|Immunologic Factors|immunologic factors|mesh-ancestor
101703218|NCT00995293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703219|NCT00692952|Benzalkonium Compounds|benzalkonium compounds|mesh-list
101703220|NCT00692952|Contraceptive Agents|contraceptive agents|mesh-list
101703221|NCT00692952|Nonoxynol|nonoxynol|mesh-list
101703222|NCT00692952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101703223|NCT00692952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703224|NCT00692952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101703225|NCT00692952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101703226|NCT00692952|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
101703227|NCT00692952|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
101703228|NCT00692952|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101703229|NCT00692952|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101703231|NCT02639858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101703232|NCT02639858|Tubulin Modulators|tubulin modulators|mesh-ancestor
101528039|NCT00550433|Hormone Antagonists|hormone antagonists|mesh-ancestor
101528041|NCT04642989|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101703233|NCT02639858|Antimitotic Agents|antimitotic agents|mesh-ancestor
101703234|NCT02639858|Mitosis Modulators|mitosis modulators|mesh-ancestor
101703235|NCT02639858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703236|NCT00689208|Atropine|atropine|mesh-list
101703237|NCT00689208|Physostigmine|physostigmine|mesh-list
101703238|NCT00689208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101703239|NCT00689208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101703240|NCT00689208|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101703241|NCT00689208|Autonomic Agents|autonomic agents|mesh-ancestor
101703242|NCT00689208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101703243|NCT00689208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703244|NCT00689208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101703245|NCT00689208|Respiratory System Agents|respiratory system agents|mesh-ancestor
101703246|NCT00689208|Mydriatics|mydriatics|mesh-ancestor
101703247|NCT00689208|Parasympatholytics|parasympatholytics|mesh-ancestor
101703248|NCT00689208|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101703249|NCT00689208|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101703250|NCT00689208|Cholinergic Agents|cholinergic agents|mesh-ancestor
101703251|NCT00689208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101703252|NCT00689208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703253|NCT00689208|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101703254|NCT00689208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101703255|NCT00689208|Miotics|miotics|mesh-ancestor
101703256|NCT00726466|Ranibizumab|ranibizumab|mesh-list
101703257|NCT00726466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101703258|NCT00726466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101703259|NCT00726466|Growth Substances|growth substances|mesh-ancestor
101703260|NCT00726466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703261|NCT00726466|Growth Inhibitors|growth inhibitors|mesh-ancestor
101703262|NCT00726466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101703263|NCT02694263|Pioglitazone|pioglitazone|mesh-list
101703264|NCT02694263|Glimepiride|glimepiride|mesh-list
101703265|NCT02694263|Canagliflozin|canagliflozin|mesh-list
101703266|NCT02694263|Repaglinide|repaglinide|mesh-list
101703267|NCT02694263|Gliclazide|gliclazide|mesh-list
101703268|NCT02694263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101703269|NCT02694263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703270|NCT02694263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101703271|NCT02694263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101703272|NCT02694263|Immunologic Factors|immunologic factors|mesh-ancestor
101703273|NCT02694263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101703274|NCT02694263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703275|NCT04139070|Bleomycin|bleomycin|mesh-list
101703276|NCT04139070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101703277|NCT04139070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101703278|NCT00693030|Sirolimus|sirolimus|mesh-list
101703279|NCT00693030|Paclitaxel|paclitaxel|mesh-list
101703280|NCT00693030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101703281|NCT00693030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101703282|NCT00693030|Tubulin Modulators|tubulin modulators|mesh-ancestor
101703283|NCT00693030|Antimitotic Agents|antimitotic agents|mesh-ancestor
101703284|NCT00693030|Mitosis Modulators|mitosis modulators|mesh-ancestor
101703285|NCT00693030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703286|NCT00693030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101703287|NCT00693030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101703288|NCT00693030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101703289|NCT00693030|Antifungal Agents|antifungal agents|mesh-ancestor
101703290|NCT00693030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101703291|NCT00693030|Immunologic Factors|immunologic factors|mesh-ancestor
101703292|NCT00693030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703293|NCT00653822|Alefacept|alefacept|mesh-list
101703295|NCT00653822|Immunologic Factors|immunologic factors|mesh-ancestor
101703296|NCT00653822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703297|NCT04137276|Vitamins|vitamins|mesh-list
101703298|NCT04137276|Thiamine|thiamine|mesh-list
101703299|NCT04137276|Vitamin B Complex|vitamin b complex|mesh-list
101703300|NCT04137276|Micronutrients|micronutrients|mesh-ancestor
101703301|NCT04137276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703302|NCT02723981|Vitamins|vitamins|mesh-list
101703303|NCT02723981|Vitamin K|vitamin k|mesh-list
101703304|NCT02723981|Rivaroxaban|rivaroxaban|mesh-list
101703305|NCT02723981|Dabigatran|dabigatran|mesh-list
101703306|NCT02723981|Anticoagulants|anticoagulants|mesh-list
101703307|NCT02723981|Clopidogrel|clopidogrel|mesh-list
101703308|NCT02723981|Micronutrients|micronutrients|mesh-ancestor
101703309|NCT02723981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703310|NCT02723981|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101703311|NCT02723981|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101703312|NCT02723981|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101703313|NCT02723981|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101703314|NCT02723981|Purinergic Agents|purinergic agents|mesh-ancestor
101703315|NCT02723981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101528193|NCT00559455|Antidotes|antidotes|mesh-ancestor
101703316|NCT02723981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703317|NCT02723981|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101703319|NCT02723981|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101703320|NCT02723981|Protease Inhibitors|protease inhibitors|mesh-ancestor
101703321|NCT02723981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101703322|NCT02723981|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101703323|NCT02723981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101703324|NCT02723981|Hemostatics|hemostatics|mesh-ancestor
101703325|NCT02723981|Coagulants|coagulants|mesh-ancestor
101703326|NCT00912444|Cyclophosphamide|cyclophosphamide|mesh-list
101703327|NCT00912444|Docetaxel|docetaxel|mesh-list
101703328|NCT00912444|Doxorubicin|doxorubicin|mesh-list
101703329|NCT00912444|Epirubicin|epirubicin|mesh-list
101703330|NCT00912444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101703331|NCT00912444|Immunologic Factors|immunologic factors|mesh-ancestor
101703332|NCT00912444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703333|NCT00912444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101703334|NCT00912444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101703335|NCT00912444|Alkylating Agents|alkylating agents|mesh-ancestor
101703336|NCT00912444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703337|NCT00912444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101703338|NCT00912444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101703339|NCT00912444|Tubulin Modulators|tubulin modulators|mesh-ancestor
101703340|NCT00912444|Antimitotic Agents|antimitotic agents|mesh-ancestor
101703341|NCT00912444|Mitosis Modulators|mitosis modulators|mesh-ancestor
101703342|NCT00912444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101703343|NCT00912444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101528247|NCT05186675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101703344|NCT00912444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101703345|NCT00912444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101703346|NCT02644525|Imatinib Mesylate|imatinib mesylate|mesh-list
101703347|NCT02644525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101703348|NCT02644525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101703349|NCT02644525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101703350|NCT02644525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703351|NCT00726700|Prednisone|prednisone|mesh-list
101703352|NCT00726700|Cyclophosphamide|cyclophosphamide|mesh-list
101703353|NCT00726700|Rituximab|rituximab|mesh-list
101703354|NCT00726700|Doxorubicin|doxorubicin|mesh-list
101703355|NCT00726700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101703356|NCT00726700|Vincristine|vincristine|mesh-list
101703357|NCT00726700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101703358|NCT00726700|Immunologic Factors|immunologic factors|mesh-ancestor
101703359|NCT00726700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703361|NCT00726700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101703362|NCT00726700|Alkylating Agents|alkylating agents|mesh-ancestor
101703363|NCT00726700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703364|NCT00726700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101703365|NCT00726700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101703366|NCT00726700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101703367|NCT00726700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101703368|NCT00726700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101703369|NCT00726700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101262754|NCT01758666|Leucovorin|leucovorin|mesh-list
101703371|NCT00726700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101703372|NCT00726700|Glucocorticoids|glucocorticoids|mesh-ancestor
101703373|NCT00726700|Hormones|hormones|mesh-ancestor
101703374|NCT00726700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101703375|NCT00726700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101703376|NCT00726700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101703377|NCT00726700|Tubulin Modulators|tubulin modulators|mesh-ancestor
101703378|NCT00726700|Antimitotic Agents|antimitotic agents|mesh-ancestor
101703379|NCT00726700|Mitosis Modulators|mitosis modulators|mesh-ancestor
101703381|NCT02723903|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101703382|NCT02723903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101703383|NCT02723903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101703384|NCT02723903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223275|NCT01517399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101223300|NCT01517490|Insulin|insulin|mesh-list
101703385|NCT02723903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101703386|NCT02723903|Serotonin Agents|serotonin agents|mesh-ancestor
101703387|NCT02723903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703388|NCT02723903|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101703389|NCT02723903|Antidepressive Agents|antidepressive agents|mesh-ancestor
101703390|NCT02723903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101703391|NCT02723903|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101703392|NCT02723903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101703393|NCT02723903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101703394|NCT00675714|Nandrolone Decanoate|nandrolone decanoate|mesh-list
101703395|NCT00675714|Itraconazole|itraconazole|mesh-list
101703396|NCT00675714|Fluconazole|fluconazole|mesh-list
101703397|NCT00675714|Ketoconazole|ketoconazole|mesh-list
101703398|NCT00675714|Methyltestosterone|methyltestosterone|mesh-list
101703399|NCT00675714|Propranolol|propranolol|mesh-list
101703400|NCT00675714|Metoprolol|metoprolol|mesh-list
101703401|NCT00675714|Hormones|hormones|mesh-list
101703402|NCT00675714|Testosterone|testosterone|mesh-list
101703403|NCT00675714|Testosterone undecanoate|testosterone undecanoate|mesh-list
101703404|NCT00675714|Testosterone enanthate|testosterone enanthate|mesh-list
101703405|NCT00675714|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101703406|NCT00675714|Oxandrolone|oxandrolone|mesh-list
101703407|NCT00675714|Nandrolone|nandrolone|mesh-list
101703408|NCT00675714|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
101703409|NCT00675714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101703410|NCT00675714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703411|NCT00675714|Androgens|androgens|mesh-ancestor
101703412|NCT00675714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101703413|NCT00675714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101703414|NCT00675714|Anabolic Agents|anabolic agents|mesh-ancestor
101703415|NCT00675714|Antifungal Agents|antifungal agents|mesh-ancestor
101703416|NCT00675714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101703417|NCT00675714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101703418|NCT00675714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101703419|NCT00675714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101703420|NCT00675714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703421|NCT00675714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101703422|NCT00675714|Hormone Antagonists|hormone antagonists|mesh-ancestor
101703423|NCT00675714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101703424|NCT00675714|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101703425|NCT00675714|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101703426|NCT00675714|Adrenergic Agents|adrenergic agents|mesh-ancestor
101703427|NCT00675714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101703428|NCT00675714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101703429|NCT00675714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101703430|NCT00675714|Vasodilator Agents|vasodilator agents|mesh-ancestor
101703431|NCT00675714|Sympatholytics|sympatholytics|mesh-ancestor
101703432|NCT00675714|Autonomic Agents|autonomic agents|mesh-ancestor
101703433|NCT00675714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101703434|NCT00675714|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101703435|NCT00675714|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101703436|NCT00675714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101703437|NCT00675714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101703438|NCT00656240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101703439|NCT00656240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101703440|NCT00729976|Ibuprofen|ibuprofen|mesh-list
101703441|NCT00729976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101223368|NCT01517854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101223369|NCT01517854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703442|NCT00729976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101703443|NCT00729976|Analgesics|analgesics|mesh-ancestor
101703445|NCT00729976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101703446|NCT00729976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703447|NCT00729976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101703448|NCT00729976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101703449|NCT00729976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101703450|NCT00729976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101703451|NCT00729976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703452|NCT00656318|Contraceptive Agents|contraceptive agents|mesh-list
101703453|NCT00656318|Contraceptives, Oral|contraceptives, oral|mesh-list
101703454|NCT00656318|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
101703455|NCT00656318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101703456|NCT00656318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703457|NCT00656318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101703458|NCT02451553|Capecitabine|capecitabine|mesh-list
101703459|NCT02451553|Afatinib|afatinib|mesh-list
101703460|NCT02451553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101703461|NCT02451553|Antimetabolites|antimetabolites|mesh-ancestor
101703462|NCT02451553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703463|NCT02451553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101703464|NCT02451553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101703465|NCT02451553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101703467|NCT02636816|Oxytocics|oxytocics|mesh-ancestor
101703468|NCT02636816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101703469|NCT02636816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703470|NCT00730054|Clonidine|clonidine|mesh-list
101703471|NCT00730054|Remifentanil|remifentanil|mesh-list
101703472|NCT00730054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101703473|NCT00730054|Narcotics|narcotics|mesh-ancestor
101703474|NCT00730054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101703475|NCT00730054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703476|NCT00730054|Analgesics|analgesics|mesh-ancestor
101703477|NCT00730054|Sensory System Agents|sensory system agents|mesh-ancestor
101703478|NCT00730054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101703479|NCT00730054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101703480|NCT00730054|Sympatholytics|sympatholytics|mesh-ancestor
101703481|NCT00730054|Autonomic Agents|autonomic agents|mesh-ancestor
101703482|NCT00730054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101703483|NCT00730054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101703484|NCT00730054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101703485|NCT00730054|Adrenergic Agents|adrenergic agents|mesh-ancestor
101703486|NCT00730054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101703487|NCT00730054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703488|NCT00866619|Vaccines|vaccines|mesh-list
101703489|NCT00866619|Immunologic Factors|immunologic factors|mesh-ancestor
101703490|NCT00866619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703491|NCT00693108|Testosterone|testosterone|mesh-list
101703492|NCT00693108|Androgens|androgens|mesh-ancestor
101703493|NCT00693108|Hormones|hormones|mesh-ancestor
101703494|NCT00693108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101703495|NCT00693108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703496|NCT00884390|Factor VIII|factor viii|mesh-list
101703497|NCT00884390|Coagulants|coagulants|mesh-ancestor
101703498|NCT02723669|Acetylcysteine|acetylcysteine|mesh-list
101703499|NCT02723669|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101703500|NCT02723669|Antiviral Agents|antiviral agents|mesh-ancestor
101703501|NCT02723669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101703502|NCT02723669|Expectorants|expectorants|mesh-ancestor
101703503|NCT02723669|Respiratory System Agents|respiratory system agents|mesh-ancestor
101703504|NCT02723669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101703505|NCT02723669|Antioxidants|antioxidants|mesh-ancestor
101703506|NCT02723669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703507|NCT02723669|Protective Agents|protective agents|mesh-ancestor
101703508|NCT02723669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703509|NCT02723669|Antidotes|antidotes|mesh-ancestor
101703510|NCT02719379|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101703511|NCT02719379|Immunologic Factors|immunologic factors|mesh-ancestor
101223521|NCT01518608|Anesthetics, General|anesthetics, general|mesh-ancestor
101703512|NCT02719379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703513|NCT00689442|Atorvastatin|atorvastatin|mesh-list
101703514|NCT00689442|Dalcetrapib|dalcetrapib|mesh-list
101703515|NCT00689442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101703516|NCT00689442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101703517|NCT00689442|Antimetabolites|antimetabolites|mesh-ancestor
101703518|NCT00689442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703520|NCT00689442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101703521|NCT00689442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101703523|NCT02625636|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101703524|NCT02625636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101703525|NCT02625636|Hormones|hormones|mesh-ancestor
101703526|NCT02625636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101703527|NCT02625636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703529|NCT03012100|Cyclophosphamide|cyclophosphamide|mesh-list
101703530|NCT03012100|Vaccines|vaccines|mesh-list
101703531|NCT03012100|Sargramostim|sargramostim|mesh-list
101703532|NCT03012100|Immunologic Factors|immunologic factors|mesh-ancestor
101223563|NCT01518855|Vasodilator Agents|vasodilator agents|mesh-ancestor
101703533|NCT03012100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703534|NCT03012100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101703535|NCT03012100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101703536|NCT03012100|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101703537|NCT03012100|Alkylating Agents|alkylating agents|mesh-ancestor
101703538|NCT03012100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703539|NCT03012100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101703540|NCT03012100|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101703541|NCT02379247|Paclitaxel|paclitaxel|mesh-list
101703542|NCT02379247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101703543|NCT02379247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101703544|NCT02379247|Tubulin Modulators|tubulin modulators|mesh-ancestor
101703545|NCT02379247|Antimitotic Agents|antimitotic agents|mesh-ancestor
101703546|NCT02379247|Mitosis Modulators|mitosis modulators|mesh-ancestor
101703547|NCT02379247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703548|NCT00689520|Vitamin K|vitamin k|mesh-list
101703549|NCT00689520|Tinzaparin|tinzaparin|mesh-list
101703550|NCT00689520|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101703551|NCT00689520|Dalteparin|dalteparin|mesh-list
101703552|NCT00689520|Acenocoumarol|acenocoumarol|mesh-list
101703553|NCT00689520|Vitamins|vitamins|mesh-ancestor
101703554|NCT00689520|Micronutrients|micronutrients|mesh-ancestor
101703555|NCT00689520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703556|NCT00689520|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101703557|NCT00689520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101703558|NCT00689520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703559|NCT00689520|Hemostatics|hemostatics|mesh-ancestor
101223624|NCT01519154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101703560|NCT00689520|Coagulants|coagulants|mesh-ancestor
101703561|NCT00689520|Anticoagulants|anticoagulants|mesh-ancestor
101703562|NCT00689520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101703563|NCT02723279|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101703564|NCT02723279|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101703565|NCT02723279|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101703566|NCT02723279|Cholinergic Agents|cholinergic agents|mesh-ancestor
101703567|NCT02723279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101703568|NCT02723279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703569|NCT02723279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703570|NCT02723279|Urological Agents|urological agents|mesh-ancestor
101703571|NCT02615301|Vitamin D|vitamin d|mesh-list
101703572|NCT02615301|Ergocalciferols|ergocalciferols|mesh-list
101703573|NCT02615301|Cholecalciferol|cholecalciferol|mesh-list
101703574|NCT02615301|Vitamins|vitamins|mesh-list
101703575|NCT02615301|Micronutrients|micronutrients|mesh-ancestor
101703576|NCT02615301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703577|NCT02615301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101703578|NCT02615301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101223670|NCT01519401|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101703579|NCT02570230|Ketamine|ketamine|mesh-list
101703580|NCT02570230|Analgesics|analgesics|mesh-ancestor
101703581|NCT02570230|Sensory System Agents|sensory system agents|mesh-ancestor
101703582|NCT02570230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101703583|NCT02570230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703584|NCT02570230|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101703585|NCT02570230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101703586|NCT02570230|Anesthetics, General|anesthetics, general|mesh-ancestor
101703587|NCT02570230|Anesthetics|anesthetics|mesh-ancestor
101703588|NCT02570230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101703589|NCT02570230|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101703590|NCT02570230|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101703591|NCT02570230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101223728|NCT01519856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101223729|NCT01519856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101703592|NCT02570230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703594|NCT00693342|Immunologic Factors|immunologic factors|mesh-ancestor
101703596|NCT02718911|Durvalumab|durvalumab|mesh-list
101703597|NCT02718911|Tremelimumab|tremelimumab|mesh-list
101703598|NCT02718911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101703599|NCT02718911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101703600|NCT00697905|Carboplatin|carboplatin|mesh-list
101703601|NCT00697905|Gemcitabine|gemcitabine|mesh-list
101703602|NCT00697905|Fluorouracil|fluorouracil|mesh-list
101361050|NCT00220480|Serotonin Agents|serotonin agents|mesh-ancestor
101703603|NCT00697905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101703604|NCT00697905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101703605|NCT00697905|Antimetabolites|antimetabolites|mesh-ancestor
101703606|NCT00697905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703607|NCT00697905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101703608|NCT00697905|Immunologic Factors|immunologic factors|mesh-ancestor
101703609|NCT00697905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703610|NCT02718755|Cytarabine|cytarabine|mesh-list
101703611|NCT02718755|Fludarabine|fludarabine|mesh-list
101223788|NCT01520285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101703612|NCT02718755|Fludarabine phosphate|fludarabine phosphate|mesh-list
101703613|NCT02718755|Asparaginase|asparaginase|mesh-list
101703614|NCT02718755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101703615|NCT02718755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101703616|NCT02718755|Antimetabolites|antimetabolites|mesh-ancestor
101703617|NCT02718755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703618|NCT02718755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101703619|NCT02718755|Immunologic Factors|immunologic factors|mesh-ancestor
101703620|NCT02718755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703621|NCT02718755|Antiviral Agents|antiviral agents|mesh-ancestor
101703622|NCT02718755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101703623|NCT00730210|Parathyroid Hormone|parathyroid hormone|mesh-list
101703624|NCT00730210|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101703625|NCT00730210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703626|NCT00730288|Vaccines|vaccines|mesh-list
101703627|NCT00730288|Immunologic Factors|immunologic factors|mesh-ancestor
101703628|NCT00730288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703629|NCT00872898|Memantine|memantine|mesh-list
101703630|NCT00872898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101703631|NCT00872898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101703632|NCT00872898|Dopamine Agents|dopamine agents|mesh-ancestor
101703633|NCT00872898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101703634|NCT00872898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703635|NCT00872898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703636|NCT00872898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101703637|NCT00872898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101703639|NCT02723435|Staurosporine|staurosporine|mesh-list
101703640|NCT02723435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101703641|NCT02723435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101703642|NCT02723435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101703643|NCT02723435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703644|NCT02718677|Factor VIII|factor viii|mesh-list
101703645|NCT02718677|Coagulants|coagulants|mesh-ancestor
101703646|NCT04132011|Morphine|morphine|mesh-list
101703647|NCT04132011|Oxycodone|oxycodone|mesh-list
101703648|NCT04132011|Analgesics, Opioid|analgesics, opioid|mesh-list
101703649|NCT04132011|Hydromorphone|hydromorphone|mesh-list
101703650|NCT04132011|Narcotics|narcotics|mesh-ancestor
101703651|NCT04132011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101703652|NCT04132011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703653|NCT04132011|Analgesics|analgesics|mesh-ancestor
101703654|NCT04132011|Sensory System Agents|sensory system agents|mesh-ancestor
101703655|NCT04132011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101223893|NCT01520818|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101703656|NCT00693576|Simvastatin|simvastatin|mesh-list
101703657|NCT00693576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101703658|NCT00693576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101703659|NCT00693576|Antimetabolites|antimetabolites|mesh-ancestor
101703660|NCT00693576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703661|NCT00693576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101703662|NCT00693576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101703663|NCT00693576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101703665|NCT04116047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101703666|NCT04116047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101703667|NCT00693732|Escitalopram|escitalopram|mesh-list
101703668|NCT00693732|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101223943|NCT01521312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101703669|NCT00693732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101703670|NCT00693732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101703671|NCT00693732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703672|NCT00693732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101703674|NCT00693732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703675|NCT00689598|Spironolactone|spironolactone|mesh-list
101703676|NCT00689598|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101703677|NCT00689598|Hormone Antagonists|hormone antagonists|mesh-ancestor
101703678|NCT00689598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101703679|NCT00689598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703681|NCT00689598|Diuretics|diuretics|mesh-ancestor
101703682|NCT00689598|Natriuretic Agents|natriuretic agents|mesh-ancestor
101703683|NCT04163354|Listerine|listerine|mesh-list
101703684|NCT04163354|Fluorides|fluorides|mesh-list
101703685|NCT04163354|Sodium Fluoride|sodium fluoride|mesh-list
101703686|NCT04163354|Fluorides, Topical|fluorides, topical|mesh-list
101703687|NCT04163354|Cariostatic Agents|cariostatic agents|mesh-ancestor
101703688|NCT04163354|Protective Agents|protective agents|mesh-ancestor
101703689|NCT04163354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410481|NCT00444808|Calcitonin|calcitonin|mesh-list
101703690|NCT04163354|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101703691|NCT04163354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101224003|NCT01521689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703692|NCT04131621|Nivolumab|nivolumab|mesh-list
101703693|NCT04131621|Ipilimumab|ipilimumab|mesh-list
101703694|NCT04131621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101703695|NCT04131621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101703696|NCT04131621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101703697|NCT04131621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703698|NCT00689832|Fluticasone|fluticasone|mesh-list
101703699|NCT00689832|Tacrolimus|tacrolimus|mesh-list
101703700|NCT00689832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101703701|NCT00689832|Immunologic Factors|immunologic factors|mesh-ancestor
101703702|NCT00689832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703703|NCT00689832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101703704|NCT00689832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101703705|NCT00689832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703706|NCT00689832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101703707|NCT00689832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101703708|NCT00689832|Autonomic Agents|autonomic agents|mesh-ancestor
101703709|NCT00689832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101703710|NCT00689832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101703711|NCT00689832|Respiratory System Agents|respiratory system agents|mesh-ancestor
101703712|NCT00689832|Dermatologic Agents|dermatologic agents|mesh-ancestor
101703713|NCT00689832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101703714|NCT02718521|Isosorbide|isosorbide|mesh-list
101703715|NCT02718521|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
101703716|NCT02718521|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
101703717|NCT02718521|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101703718|NCT02718521|Diuretics|diuretics|mesh-ancestor
101703719|NCT02718521|Natriuretic Agents|natriuretic agents|mesh-ancestor
101703720|NCT02718521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703721|NCT02718521|Vasodilator Agents|vasodilator agents|mesh-ancestor
101703722|NCT02718521|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101703723|NCT02718521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703724|NCT02718599|Terlipressin|terlipressin|mesh-list
101703725|NCT02718599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101703726|NCT02718599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101703727|NCT00693966|Vaccines|vaccines|mesh-list
101703728|NCT00693966|Immunologic Factors|immunologic factors|mesh-ancestor
101703729|NCT00693966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703730|NCT00694044|Varenicline|varenicline|mesh-list
101703731|NCT00694044|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101703732|NCT00694044|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101703733|NCT00694044|Cholinergic Agents|cholinergic agents|mesh-ancestor
101703734|NCT00694044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101703735|NCT00694044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703736|NCT00694044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703737|NCT02722811|Etanercept|etanercept|mesh-list
101703738|NCT02722811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101703739|NCT02722811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101703740|NCT02722811|Analgesics|analgesics|mesh-ancestor
101703741|NCT02722811|Sensory System Agents|sensory system agents|mesh-ancestor
101703742|NCT02722811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101703743|NCT02722811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189435|NCT00003786|Irofulven|irofulven|mesh-list
101703744|NCT02722811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101703745|NCT02722811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101703746|NCT02722811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101703747|NCT02722811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101703748|NCT02722811|Immunologic Factors|immunologic factors|mesh-ancestor
101703750|NCT04136886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101703751|NCT04103645|Vactosertib|vactosertib|mesh-list
101703752|NCT04103645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101703753|NCT04103645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101703754|NCT04103645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703755|NCT00534313|Abatacept|abatacept|mesh-list
101703756|NCT00534313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101703757|NCT00534313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703758|NCT00534313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101703759|NCT00534313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101703760|NCT00534313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101703761|NCT00534313|Immunologic Factors|immunologic factors|mesh-ancestor
101224163|NCT01522729|Anesthetics|anesthetics|mesh-ancestor
101224164|NCT01522820|Sirolimus|sirolimus|mesh-list
101703762|NCT00534313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703763|NCT00534313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101703764|NCT00694200|Bevacizumab|bevacizumab|mesh-list
101703765|NCT00694200|Vinorelbine|vinorelbine|mesh-list
101703766|NCT00694200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101703767|NCT00694200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101703768|NCT00694200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101703769|NCT00694200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101703770|NCT00694200|Growth Substances|growth substances|mesh-ancestor
101703771|NCT00694200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703772|NCT00694200|Growth Inhibitors|growth inhibitors|mesh-ancestor
101703773|NCT00694200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101703774|NCT00694200|Tubulin Modulators|tubulin modulators|mesh-ancestor
101703775|NCT00694200|Antimitotic Agents|antimitotic agents|mesh-ancestor
101703776|NCT00694200|Mitosis Modulators|mitosis modulators|mesh-ancestor
101703777|NCT00694200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703778|NCT02722733|Cytarabine|cytarabine|mesh-list
101703780|NCT02722733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101703781|NCT02722733|Immunologic Factors|immunologic factors|mesh-ancestor
101703782|NCT02722733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703783|NCT02722733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101703784|NCT02722733|Antimetabolites|antimetabolites|mesh-ancestor
101703785|NCT02722733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703786|NCT02722733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101703787|NCT02722733|Antiviral Agents|antiviral agents|mesh-ancestor
101703788|NCT02722733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101224210|NCT01522989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101224217|NCT01523002|Artesunate|artesunate|mesh-list
101703789|NCT02722733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101703790|NCT02722421|Efavirenz|efavirenz|mesh-list
101703791|NCT02722421|Levonorgestrel|levonorgestrel|mesh-list
101703792|NCT02722421|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101703793|NCT02722421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101703794|NCT02722421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101703795|NCT02722421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703796|NCT02722421|Antiviral Agents|antiviral agents|mesh-ancestor
101703797|NCT02722421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101703798|NCT02722421|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101703799|NCT02722421|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101703800|NCT02722421|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101703801|NCT02722421|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101703802|NCT02722421|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101703803|NCT02722421|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101703804|NCT02722421|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101703805|NCT02722421|Contraceptive Agents|contraceptive agents|mesh-ancestor
101703806|NCT02722421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101703807|NCT02722421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703808|NCT02722421|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101224258|NCT01523041|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101703809|NCT02722421|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101703811|NCT02617290|Clopidogrel|clopidogrel|mesh-list
101703812|NCT02617290|Ticagrelor|ticagrelor|mesh-list
101703813|NCT02617290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101703814|NCT02617290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101703815|NCT02617290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101189540|NCT00003870|Antibodies|antibodies|mesh-list
101703816|NCT02617290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101703817|NCT02617290|Purinergic Agents|purinergic agents|mesh-ancestor
101703818|NCT02617290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101703819|NCT02617290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703820|NCT02617290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703822|NCT02717819|Vitamins|vitamins|mesh-ancestor
101703823|NCT02717819|Micronutrients|micronutrients|mesh-ancestor
101703824|NCT02717819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703825|NCT02717819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101703826|NCT02007655|Apixaban|apixaban|mesh-list
101703827|NCT02007655|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101703828|NCT02007655|Antithrombins|antithrombins|mesh-ancestor
101703829|NCT02007655|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101703830|NCT02007655|Protease Inhibitors|protease inhibitors|mesh-ancestor
101703831|NCT02007655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101703832|NCT02007655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703833|NCT02007655|Anticoagulants|anticoagulants|mesh-ancestor
101703834|NCT05298462|Antibodies|antibodies|mesh-list
101703835|NCT05298462|Immunologic Factors|immunologic factors|mesh-ancestor
101703836|NCT05298462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703837|NCT00730366|Chloroquine|chloroquine|mesh-list
101703838|NCT00730366|Pyrimethamine|pyrimethamine|mesh-list
101703839|NCT00730366|Sulfadoxine|sulfadoxine|mesh-list
101703840|NCT00730366|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101703841|NCT00730366|Amebicides|amebicides|mesh-ancestor
101703842|NCT00730366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101703843|NCT00730366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101703844|NCT00730366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101703845|NCT00730366|Antimalarials|antimalarials|mesh-ancestor
101703846|NCT00730366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101703847|NCT00730366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101703848|NCT00730366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101703849|NCT00730366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703850|NCT00730366|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101703851|NCT02722343|Tenofovir|tenofovir|mesh-list
101703852|NCT02722343|Emtricitabine|emtricitabine|mesh-list
101703853|NCT02722343|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101703854|NCT02722343|Antiviral Agents|antiviral agents|mesh-ancestor
101703855|NCT02722343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101703856|NCT02722343|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101703857|NCT02722343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101703858|NCT02722343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101703859|NCT02722343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703860|NCT02722343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101703861|NCT02722343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101703862|NCT00694590|Plerixafor|plerixafor|mesh-list
101703863|NCT00694590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101703864|NCT00694590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101703865|NCT00694590|Antiviral Agents|antiviral agents|mesh-ancestor
101703866|NCT00694590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101703867|NCT00730444|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
101703868|NCT00730444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101224358|NCT01523418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224359|NCT01523418|Anticoagulants|anticoagulants|mesh-ancestor
101703869|NCT00730444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101703870|NCT00730444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703871|NCT00730444|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101703873|NCT03903406|Lenalidomide|lenalidomide|mesh-list
101703874|NCT03903406|Ixazomib|ixazomib|mesh-list
101703875|NCT03903406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101703876|NCT03903406|Antiemetics|antiemetics|mesh-ancestor
101703877|NCT03903406|Autonomic Agents|autonomic agents|mesh-ancestor
101703878|NCT03903406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101703879|NCT03903406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703880|NCT03903406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101703881|NCT03903406|Glucocorticoids|glucocorticoids|mesh-ancestor
101703882|NCT03903406|Hormones|hormones|mesh-ancestor
101703883|NCT03903406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101703884|NCT03903406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101703885|NCT03903406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101703886|NCT03903406|Immunologic Factors|immunologic factors|mesh-ancestor
101703887|NCT03903406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101703888|NCT03903406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101703889|NCT03903406|Growth Substances|growth substances|mesh-ancestor
101703890|NCT03903406|Growth Inhibitors|growth inhibitors|mesh-ancestor
101703891|NCT03903406|Protease Inhibitors|protease inhibitors|mesh-ancestor
101703893|NCT03903406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703894|NCT00594204|Varenicline|varenicline|mesh-list
101703895|NCT00594204|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101224402|NCT01523574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101703896|NCT00594204|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101703897|NCT00594204|Cholinergic Agents|cholinergic agents|mesh-ancestor
101703898|NCT00594204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101703899|NCT00594204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703900|NCT00594204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703901|NCT00999271|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
101703902|NCT00999271|Hormones|hormones|mesh-list
101703903|NCT00999271|Incretins|incretins|mesh-list
101535864|NCT00193050|Mitosis Modulators|mitosis modulators|mesh-ancestor
101703904|NCT00999271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101703905|NCT00999271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703906|NCT00999271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101703907|NCT02716961|Gemcitabine|gemcitabine|mesh-list
101703908|NCT02716961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101703909|NCT02716961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101703910|NCT02716961|Antimetabolites|antimetabolites|mesh-ancestor
101703911|NCT02716961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703912|NCT02704156|Gemcitabine|gemcitabine|mesh-list
101703913|NCT02704156|Pembrolizumab|pembrolizumab|mesh-list
101703914|NCT02704156|Trametinib|trametinib|mesh-list
101703915|NCT02704156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101703916|NCT02704156|Antimetabolites|antimetabolites|mesh-ancestor
101703917|NCT02704156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703918|NCT02704156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101703919|NCT02704156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101224450|NCT01524068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101224451|NCT01524068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101703920|NCT02704156|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101703921|NCT02704156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101703923|NCT00912678|Mycophenolic Acid|mycophenolic acid|mesh-list
101703924|NCT00912678|Tacrolimus|tacrolimus|mesh-list
101703925|NCT00912678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101703926|NCT00912678|Immunologic Factors|immunologic factors|mesh-ancestor
101703927|NCT00912678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703928|NCT00912678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101703929|NCT00912678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101703930|NCT00912678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703931|NCT00912678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101703932|NCT00912678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101703933|NCT00912678|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101703934|NCT00912678|Antitubercular Agents|antitubercular agents|mesh-ancestor
101703935|NCT00912678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101703936|NCT00912678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101703937|NCT00995839|Terlipressin|terlipressin|mesh-list
101703938|NCT00995839|Vasopressins|vasopressins|mesh-list
101703939|NCT00995839|Arginine Vasopressin|arginine vasopressin|mesh-list
101703940|NCT00995839|Hemostatics|hemostatics|mesh-ancestor
101224498|NCT01524237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101703941|NCT00995839|Coagulants|coagulants|mesh-ancestor
101703942|NCT00995839|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101703943|NCT00995839|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101224499|NCT01524237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703944|NCT00995839|Natriuretic Agents|natriuretic agents|mesh-ancestor
101703945|NCT00995839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703946|NCT00995839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101703947|NCT00994513|Thioctic Acid|thioctic acid|mesh-list
101703948|NCT00994513|Antioxidants|antioxidants|mesh-ancestor
101703949|NCT00994513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703950|NCT00994513|Protective Agents|protective agents|mesh-ancestor
101703951|NCT00994513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703952|NCT00994513|Vitamin B Complex|vitamin b complex|mesh-ancestor
101703953|NCT00994513|Vitamins|vitamins|mesh-ancestor
101703954|NCT00994513|Micronutrients|micronutrients|mesh-ancestor
101703955|NCT02616744|Ibandronic Acid|ibandronic acid|mesh-list
101703956|NCT02616744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101703957|NCT02616744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703958|NCT00995917|Vitamin K|vitamin k|mesh-list
101703959|NCT00995917|Vitamins|vitamins|mesh-ancestor
101703960|NCT00995917|Micronutrients|micronutrients|mesh-ancestor
101703961|NCT00995917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703962|NCT00995917|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101703963|NCT00995917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101703964|NCT00995917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703965|NCT00995917|Hemostatics|hemostatics|mesh-ancestor
101703966|NCT00995917|Coagulants|coagulants|mesh-ancestor
101703968|NCT02616822|Antioxidants|antioxidants|mesh-ancestor
101703969|NCT02616822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703970|NCT02616822|Protective Agents|protective agents|mesh-ancestor
101703971|NCT02616822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703972|NCT02616822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101703973|NCT02616822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101703974|NCT00912756|Cilostazol|cilostazol|mesh-list
101703975|NCT00912756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101703976|NCT00912756|Autonomic Agents|autonomic agents|mesh-ancestor
101703977|NCT00912756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101224545|NCT01524432|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101703978|NCT00912756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703979|NCT00912756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101224546|NCT01524445|Bortezomib|bortezomib|mesh-list
101703980|NCT00912756|Respiratory System Agents|respiratory system agents|mesh-ancestor
101703982|NCT00912756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101703983|NCT00912756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703984|NCT00912756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101703985|NCT00912756|Vasodilator Agents|vasodilator agents|mesh-ancestor
101703986|NCT00912756|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101703987|NCT00912756|Protective Agents|protective agents|mesh-ancestor
101703988|NCT00912756|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101703989|NCT00912756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101703990|NCT00912756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101703991|NCT04426240|Cyclosporine|cyclosporine|mesh-list
101703993|NCT04426240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101703994|NCT04426240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101703995|NCT04426240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101703996|NCT04426240|Immunologic Factors|immunologic factors|mesh-ancestor
101703997|NCT04426240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101703998|NCT04426240|Antifungal Agents|antifungal agents|mesh-ancestor
101703999|NCT04426240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101704000|NCT04426240|Dermatologic Agents|dermatologic agents|mesh-ancestor
101704001|NCT04426240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101704002|NCT04426240|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101704003|NCT00995995|Rosiglitazone|rosiglitazone|mesh-list
101704004|NCT00995995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101704005|NCT00995995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704006|NCT00999349|Silymarin|silymarin|mesh-list
101704007|NCT00999349|Antioxidants|antioxidants|mesh-ancestor
101224582|NCT01524653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101224583|NCT01524653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101704008|NCT00999349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704009|NCT00999349|Protective Agents|protective agents|mesh-ancestor
101704010|NCT00999349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704011|NCT02621112|Imiquimod|imiquimod|mesh-list
101704012|NCT02621112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101704013|NCT02621112|Immunologic Factors|immunologic factors|mesh-ancestor
101704014|NCT02621112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704015|NCT02621112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101704016|NCT02621112|Interferon Inducers|interferon inducers|mesh-ancestor
101704017|NCT04000789|Vitamins|vitamins|mesh-list
101704018|NCT04000789|Vitamin E|vitamin e|mesh-list
101704019|NCT04000789|Vitamin A|vitamin a|mesh-list
101704020|NCT04000789|Hyaluronic Acid|hyaluronic acid|mesh-list
101704021|NCT04000789|Micronutrients|micronutrients|mesh-ancestor
101704022|NCT04000789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704023|NCT04000789|Antioxidants|antioxidants|mesh-ancestor
101704024|NCT04000789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704025|NCT04000789|Protective Agents|protective agents|mesh-ancestor
101704026|NCT04000789|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101704027|NCT04000789|Immunologic Factors|immunologic factors|mesh-ancestor
101704028|NCT04000789|Viscosupplements|viscosupplements|mesh-ancestor
101704029|NCT00697554|Vaccines|vaccines|mesh-list
101704030|NCT00697554|Immunologic Factors|immunologic factors|mesh-ancestor
101704031|NCT00697554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704032|NCT00731068|Mitogens|mitogens|mesh-list
101704033|NCT00731068|Mitosis Modulators|mitosis modulators|mesh-ancestor
101704034|NCT00731068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704035|NCT00866307|Cytarabine|cytarabine|mesh-list
101704036|NCT00866307|Dexamethasone|dexamethasone|mesh-list
101704037|NCT00866307|Dexamethasone acetate|dexamethasone acetate|mesh-list
101704038|NCT00866307|Prednisone|prednisone|mesh-list
101224631|NCT01524757|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101704039|NCT00866307|Cortisone|cortisone|mesh-list
101704040|NCT00866307|Cyclophosphamide|cyclophosphamide|mesh-list
101704041|NCT00866307|Doxorubicin|doxorubicin|mesh-list
101704042|NCT00866307|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101704043|NCT00866307|Methotrexate|methotrexate|mesh-list
101704044|NCT00866307|Vincristine|vincristine|mesh-list
101704045|NCT00866307|Daunorubicin|daunorubicin|mesh-list
101704046|NCT00866307|Asparaginase|asparaginase|mesh-list
101704047|NCT00866307|Mercaptopurine|mercaptopurine|mesh-list
101704048|NCT00866307|Pegaspargase|pegaspargase|mesh-list
101704049|NCT00866307|Thioguanine|thioguanine|mesh-list
101704050|NCT00866307|BB 1101|bb 1101|mesh-list
101704051|NCT00866307|2-Aminopurine|2-aminopurine|mesh-list
101704052|NCT00866307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101704053|NCT00866307|Immunologic Factors|immunologic factors|mesh-ancestor
101704054|NCT00866307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704055|NCT00866307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101704056|NCT00866307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101704057|NCT00866307|Alkylating Agents|alkylating agents|mesh-ancestor
101704058|NCT00866307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704060|NCT00866307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101704061|NCT00866307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101704062|NCT00866307|Antiemetics|antiemetics|mesh-ancestor
101704063|NCT00866307|Autonomic Agents|autonomic agents|mesh-ancestor
101224675|NCT01525043|Naproxen|naproxen|mesh-list
101704064|NCT00866307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101704065|NCT00866307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101704066|NCT00866307|Glucocorticoids|glucocorticoids|mesh-ancestor
101224678|NCT01525043|Analgesics|analgesics|mesh-ancestor
101704067|NCT00866307|Hormones|hormones|mesh-ancestor
101704068|NCT00866307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101704069|NCT00866307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101704070|NCT00866307|Protease Inhibitors|protease inhibitors|mesh-ancestor
101704071|NCT00866307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101704072|NCT00866307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101704073|NCT00866307|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101704074|NCT00866307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101704075|NCT00866307|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101704076|NCT00866307|Abortifacient Agents|abortifacient agents|mesh-ancestor
101704077|NCT00866307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101704078|NCT00866307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101704079|NCT00866307|Antimetabolites|antimetabolites|mesh-ancestor
101704080|NCT00866307|Dermatologic Agents|dermatologic agents|mesh-ancestor
101704081|NCT00866307|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101704082|NCT00866307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101704083|NCT00866307|Antiviral Agents|antiviral agents|mesh-ancestor
101704084|NCT00866307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101704085|NCT00866307|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101704086|NCT00866307|Tubulin Modulators|tubulin modulators|mesh-ancestor
101704087|NCT00866307|Antimitotic Agents|antimitotic agents|mesh-ancestor
101704088|NCT00866307|Mitosis Modulators|mitosis modulators|mesh-ancestor
101704089|NCT00731146|Anesthetics|anesthetics|mesh-list
101704090|NCT00731146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101704091|NCT00731146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704092|NCT02716415|Menthol|menthol|mesh-list
101704093|NCT02716415|Petrolatum|petrolatum|mesh-list
101704094|NCT02716415|Zinc Oxide|zinc oxide|mesh-list
101704095|NCT02716415|Antipruritics|antipruritics|mesh-ancestor
101704096|NCT02716415|Dermatologic Agents|dermatologic agents|mesh-ancestor
101704097|NCT02716415|Emollients|emollients|mesh-ancestor
101704098|NCT02716415|Sunscreening Agents|sunscreening agents|mesh-ancestor
101224726|NCT01525719|Immunologic Factors|immunologic factors|mesh-ancestor
101224727|NCT01525719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224728|NCT01525719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101704099|NCT02716415|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101704101|NCT02716415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704102|NCT02616354|Imipenem|imipenem|mesh-list
101704103|NCT02616354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101704104|NCT02616354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101704105|NCT00731224|Rivastigmine|rivastigmine|mesh-list
101704106|NCT00731224|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101704107|NCT00731224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101704108|NCT00731224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704109|NCT00731224|Cholinergic Agents|cholinergic agents|mesh-ancestor
101704110|NCT00731224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101704111|NCT00731224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704112|NCT00731224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101704113|NCT00731224|Protective Agents|protective agents|mesh-ancestor
101704114|NCT00531427|Buprenorphine|buprenorphine|mesh-list
101704115|NCT00531427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101704116|NCT00531427|Narcotics|narcotics|mesh-ancestor
101704117|NCT00531427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101704118|NCT00531427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704119|NCT00531427|Analgesics|analgesics|mesh-ancestor
101704120|NCT00531427|Sensory System Agents|sensory system agents|mesh-ancestor
101704121|NCT00531427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101704122|NCT00531427|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101704123|NCT00731302|Aspirin|aspirin|mesh-list
101224767|NCT01526005|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101704124|NCT00731302|Meloxicam|meloxicam|mesh-list
101224768|NCT01526005|Cholinergic Agents|cholinergic agents|mesh-ancestor
101704125|NCT00731302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101704126|NCT00731302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101704127|NCT00731302|Analgesics|analgesics|mesh-ancestor
101704128|NCT00731302|Sensory System Agents|sensory system agents|mesh-ancestor
101704129|NCT00731302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101704130|NCT00731302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704131|NCT00731302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101704132|NCT00731302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101704133|NCT00731302|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101704134|NCT00731302|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101704135|NCT00731302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704136|NCT00731302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101704137|NCT00731302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101704138|NCT00731302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101704139|NCT00731302|Antipyretics|antipyretics|mesh-ancestor
101704140|NCT00731302|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101704141|NCT00871728|Itraconazole|itraconazole|mesh-list
101224815|NCT01526161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101704142|NCT00871728|Antifungal Agents|antifungal agents|mesh-ancestor
101224816|NCT01526161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704143|NCT00871728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101704144|NCT00871728|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101704145|NCT00871728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101704146|NCT00871728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101704147|NCT00871728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704148|NCT00871728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101704149|NCT00871728|Hormone Antagonists|hormone antagonists|mesh-ancestor
101704150|NCT00871728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101704151|NCT00871728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704152|NCT00871728|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101704153|NCT00731380|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101704154|NCT00731380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101704155|NCT00999427|Povidone-Iodine|povidone-iodine|mesh-list
101704156|NCT00999427|Povidone|povidone|mesh-list
101704157|NCT00999427|Plasma Substitutes|plasma substitutes|mesh-ancestor
101704158|NCT00999427|Blood Substitutes|blood substitutes|mesh-ancestor
101704159|NCT00999427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101704160|NCT00999427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101704161|NCT04189211|Trastuzumab|trastuzumab|mesh-list
101704162|NCT04189211|Maytansine|maytansine|mesh-list
101704163|NCT04189211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101704164|NCT04189211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101704165|NCT04189211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101704166|NCT04189211|Tubulin Modulators|tubulin modulators|mesh-ancestor
101704167|NCT04189211|Antimitotic Agents|antimitotic agents|mesh-ancestor
101704168|NCT04189211|Mitosis Modulators|mitosis modulators|mesh-ancestor
101704169|NCT04189211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704170|NCT00364780|XL647|xl647|mesh-list
101704171|NCT00364780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101704172|NCT00364780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101704173|NCT00364780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101704174|NCT00364780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704175|NCT00868998|Gemcitabine|gemcitabine|mesh-list
101704176|NCT00868998|Capecitabine|capecitabine|mesh-list
101704177|NCT00868998|Docetaxel|docetaxel|mesh-list
101704178|NCT00868998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101704179|NCT00868998|Antimetabolites|antimetabolites|mesh-ancestor
101704180|NCT00868998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704181|NCT00868998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101704182|NCT00868998|Tubulin Modulators|tubulin modulators|mesh-ancestor
101704183|NCT00868998|Antimitotic Agents|antimitotic agents|mesh-ancestor
101704184|NCT00868998|Mitosis Modulators|mitosis modulators|mesh-ancestor
101704185|NCT00996151|Testosterone|testosterone|mesh-list
101704186|NCT00996151|Androgens|androgens|mesh-ancestor
101704187|NCT00996151|Hormones|hormones|mesh-ancestor
101704188|NCT00996151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101704189|NCT00996151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704190|NCT04131231|Aldesleukin|aldesleukin|mesh-list
101704191|NCT04131231|Methotrexate|methotrexate|mesh-list
101704192|NCT04131231|Interleukin-2|interleukin-2|mesh-list
101704193|NCT04131231|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101704194|NCT04131231|Abortifacient Agents|abortifacient agents|mesh-ancestor
101704195|NCT04131231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101704196|NCT04131231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704197|NCT04131231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101704198|NCT04131231|Antimetabolites|antimetabolites|mesh-ancestor
101704199|NCT04131231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704200|NCT04131231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101704201|NCT04131231|Dermatologic Agents|dermatologic agents|mesh-ancestor
101704202|NCT04131231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101704203|NCT04131231|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101704204|NCT04131231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101704205|NCT04131231|Immunologic Factors|immunologic factors|mesh-ancestor
101224966|NCT01526694|Leprostatic Agents|leprostatic agents|mesh-ancestor
101704206|NCT04131231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101704207|NCT04131231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101361642|NCT00078000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101704208|NCT04131231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101704209|NCT04131231|Analgesics|analgesics|mesh-ancestor
101704210|NCT04131231|Sensory System Agents|sensory system agents|mesh-ancestor
101704211|NCT04131231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101704212|NCT04131231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101704213|NCT04131231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101704214|NCT04131231|Antiviral Agents|antiviral agents|mesh-ancestor
101704215|NCT04131231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101704217|NCT02716259|Sodium Fluoride|sodium fluoride|mesh-list
101704218|NCT02716259|Cariostatic Agents|cariostatic agents|mesh-ancestor
101704219|NCT02716259|Protective Agents|protective agents|mesh-ancestor
101704220|NCT02716259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704221|NCT00996229|Resveratrol|resveratrol|mesh-list
101704222|NCT00996229|Antioxidants|antioxidants|mesh-ancestor
101704223|NCT00996229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704224|NCT00996229|Protective Agents|protective agents|mesh-ancestor
101704225|NCT00996229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704226|NCT00996229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101704227|NCT00996229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101704228|NCT02712671|Interferons|interferons|mesh-list
101704229|NCT02712671|Interferon-gamma|interferon-gamma|mesh-list
101225028|NCT01527019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101704230|NCT02712671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101704231|NCT02712671|Antiviral Agents|antiviral agents|mesh-ancestor
101704232|NCT02712671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101704233|NCT02614833|Paclitaxel|paclitaxel|mesh-list
101704234|NCT02614833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101704235|NCT02614833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101704236|NCT02614833|Tubulin Modulators|tubulin modulators|mesh-ancestor
101704237|NCT02614833|Antimitotic Agents|antimitotic agents|mesh-ancestor
101704238|NCT02614833|Mitosis Modulators|mitosis modulators|mesh-ancestor
101704239|NCT02614833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704240|NCT05260957|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
101704241|NCT05260957|Immunoconjugates|immunoconjugates|mesh-ancestor
101704242|NCT05260957|Immunologic Factors|immunologic factors|mesh-ancestor
101704243|NCT05260957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704244|NCT00999505|Amantadine|amantadine|mesh-list
101704245|NCT00999505|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101704246|NCT00999505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101704247|NCT00999505|Antiviral Agents|antiviral agents|mesh-ancestor
101704248|NCT00999505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101704249|NCT00999505|Dopamine Agents|dopamine agents|mesh-ancestor
101704250|NCT00999505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101704251|NCT00999505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704252|NCT00999505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704253|NCT00999505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101704254|NCT00999505|Analgesics|analgesics|mesh-ancestor
101704255|NCT00999505|Sensory System Agents|sensory system agents|mesh-ancestor
101704256|NCT00999505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101704258|NCT00996385|Bortezomib|bortezomib|mesh-list
101704259|NCT00996385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101704260|NCT00533845|Bupivacaine|bupivacaine|mesh-list
101704261|NCT00533845|Anesthetics, Local|anesthetics, local|mesh-ancestor
101704262|NCT00533845|Anesthetics|anesthetics|mesh-ancestor
101704263|NCT00533845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101704264|NCT00533845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704265|NCT00533845|Sensory System Agents|sensory system agents|mesh-ancestor
101704266|NCT00533845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101704267|NCT02752763|Dextrans|dextrans|mesh-list
101704268|NCT02752763|Povidone|povidone|mesh-list
101704269|NCT02752763|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101704270|NCT02752763|Lubricant Eye Drops|lubricant eye drops|mesh-list
101704271|NCT02752763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101225119|NCT01527422|Tubulin Modulators|tubulin modulators|mesh-ancestor
101704272|NCT02752763|Plasma Substitutes|plasma substitutes|mesh-ancestor
101704273|NCT02752763|Blood Substitutes|blood substitutes|mesh-ancestor
101704274|NCT02752763|Anticoagulants|anticoagulants|mesh-ancestor
101704275|NCT00857649|Memantine|memantine|mesh-list
101704276|NCT00857649|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101704277|NCT00857649|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101704278|NCT00857649|Dopamine Agents|dopamine agents|mesh-ancestor
101704279|NCT00857649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101704280|NCT00857649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704281|NCT00857649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704282|NCT00857649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101704283|NCT00857649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101704284|NCT02752841|Vitamin D|vitamin d|mesh-list
101704285|NCT02752841|Vitamins|vitamins|mesh-ancestor
101704287|NCT02752841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704288|NCT02752841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101704289|NCT03971669|Vaccines|vaccines|mesh-list
101704290|NCT03971669|Immunologic Factors|immunologic factors|mesh-ancestor
101704291|NCT03971669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704292|NCT02715869|Sevoflurane|sevoflurane|mesh-list
101704293|NCT02715869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101704294|NCT02715869|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101704295|NCT02715869|Anesthetics, General|anesthetics, general|mesh-ancestor
101704296|NCT02715869|Anesthetics|anesthetics|mesh-ancestor
101704297|NCT02715869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101704298|NCT02715869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704299|NCT00532441|Docetaxel|docetaxel|mesh-list
101704300|NCT00532441|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101704301|NCT00532441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101704302|NCT00532441|Tubulin Modulators|tubulin modulators|mesh-ancestor
101704303|NCT00532441|Antimitotic Agents|antimitotic agents|mesh-ancestor
101704304|NCT00532441|Mitosis Modulators|mitosis modulators|mesh-ancestor
101704305|NCT00532441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704306|NCT00532441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101704307|NCT00532441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101225241|NCT01527994|Aprepitant|aprepitant|mesh-list
101704308|NCT00999739|Vaccines|vaccines|mesh-list
101704309|NCT00999739|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101704310|NCT00999739|Immunologic Factors|immunologic factors|mesh-ancestor
101704311|NCT00999739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704312|NCT00996463|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
101704313|NCT00996463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101704314|NCT00996463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101704315|NCT00996463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101704316|NCT00996463|Schistosomicides|schistosomicides|mesh-ancestor
101704317|NCT00996463|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101225299|NCT01528501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101704318|NCT00996463|Anthelmintics|anthelmintics|mesh-ancestor
101704319|NCT00999817|Dextromethorphan|dextromethorphan|mesh-list
101704320|NCT00999817|Antitussive Agents|antitussive agents|mesh-ancestor
101704321|NCT00999817|Respiratory System Agents|respiratory system agents|mesh-ancestor
101704322|NCT00999817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101704323|NCT00999817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101704324|NCT00999817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101704325|NCT00999817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704326|NCT00999817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704327|NCT00857259|Everolimus|everolimus|mesh-list
101704328|NCT00857259|Ranibizumab|ranibizumab|mesh-list
101704329|NCT00857259|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101704330|NCT00857259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101704331|NCT00857259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101704332|NCT00857259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704334|NCT00857259|Immunologic Factors|immunologic factors|mesh-ancestor
101704335|NCT00857259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704336|NCT00857259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101704337|NCT00857259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101704338|NCT00857259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101704339|NCT00857259|Growth Substances|growth substances|mesh-ancestor
101704340|NCT00857259|Growth Inhibitors|growth inhibitors|mesh-ancestor
101704341|NCT00868608|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
101704342|NCT00868608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101704343|NCT00868608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101704344|NCT00868608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101704345|NCT00868608|Immunotoxins|immunotoxins|mesh-ancestor
101704346|NCT00868608|Immunoconjugates|immunoconjugates|mesh-ancestor
101704347|NCT00868608|Immunologic Factors|immunologic factors|mesh-ancestor
101704348|NCT00868608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704349|NCT04000633|Lidocaine|lidocaine|mesh-list
101704350|NCT04000633|Anesthetics, Local|anesthetics, local|mesh-ancestor
101704351|NCT04000633|Anesthetics|anesthetics|mesh-ancestor
101704352|NCT04000633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101704353|NCT04000633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704354|NCT04000633|Sensory System Agents|sensory system agents|mesh-ancestor
101704355|NCT04000633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101704356|NCT04000633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101704357|NCT04000633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101704358|NCT04000633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101704359|NCT04000633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101704360|NCT04000633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704361|NCT00994825|Simendan|simendan|mesh-list
101704362|NCT00994825|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101704363|NCT00994825|Vasodilator Agents|vasodilator agents|mesh-ancestor
101704364|NCT00994825|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101704365|NCT00994825|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101704366|NCT00994825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101704367|NCT00994825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704368|NCT00994825|Protective Agents|protective agents|mesh-ancestor
101704369|NCT00994825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704370|NCT02752529|Tacrolimus|tacrolimus|mesh-list
101704371|NCT02752529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101704372|NCT02752529|Immunologic Factors|immunologic factors|mesh-ancestor
101704373|NCT02752529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704374|NCT02752529|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101704375|NCT02752529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101704376|NCT02752529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704377|NCT00856635|Glatiramer Acetate|glatiramer acetate|mesh-list
101704378|NCT00856635|(T,G)-A-L|(t,g)-a-l|mesh-list
101704379|NCT00856635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101704380|NCT00856635|Immunologic Factors|immunologic factors|mesh-ancestor
101704381|NCT00856635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704382|NCT00856635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101704383|NCT00856635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101704384|NCT02620800|Leucovorin|leucovorin|mesh-list
101225485|NCT01529229|Hormones|hormones|mesh-ancestor
101225506|NCT01529242|Hormones|hormones|mesh-ancestor
101704386|NCT02620800|Bevacizumab|bevacizumab|mesh-list
101704387|NCT02620800|Oxaliplatin|oxaliplatin|mesh-list
101704388|NCT02620800|Calcium|calcium|mesh-list
101704389|NCT02620800|Levoleucovorin|levoleucovorin|mesh-list
101704390|NCT02620800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101704391|NCT02620800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101704392|NCT02620800|Tubulin Modulators|tubulin modulators|mesh-ancestor
101704393|NCT02620800|Antimitotic Agents|antimitotic agents|mesh-ancestor
101704394|NCT02620800|Mitosis Modulators|mitosis modulators|mesh-ancestor
101704395|NCT02620800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704396|NCT02620800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101704397|NCT02620800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101704398|NCT02620800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101704399|NCT02620800|Growth Substances|growth substances|mesh-ancestor
101704400|NCT02620800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704401|NCT02620800|Growth Inhibitors|growth inhibitors|mesh-ancestor
101704402|NCT02620800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101704403|NCT02620800|Antidotes|antidotes|mesh-ancestor
101704404|NCT02620800|Protective Agents|protective agents|mesh-ancestor
101704405|NCT02620800|Vitamin B Complex|vitamin b complex|mesh-ancestor
101704406|NCT02620800|Vitamins|vitamins|mesh-ancestor
101704407|NCT02620800|Micronutrients|micronutrients|mesh-ancestor
101704408|NCT04135014|Midazolam|midazolam|mesh-list
101704409|NCT04135014|Dexmedetomidine|dexmedetomidine|mesh-list
101704410|NCT04135014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101704411|NCT04135014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101704412|NCT04135014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704413|NCT04135014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101704414|NCT04135014|Analgesics|analgesics|mesh-ancestor
101704415|NCT04135014|Sensory System Agents|sensory system agents|mesh-ancestor
101704416|NCT04135014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101704417|NCT04135014|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101704418|NCT04135014|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101704419|NCT04135014|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101704420|NCT04135014|Adrenergic Agents|adrenergic agents|mesh-ancestor
101704421|NCT04135014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101704422|NCT04135014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704423|NCT04135014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101704424|NCT04135014|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101225529|NCT01529294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101704425|NCT04135014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101704426|NCT04135014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101704427|NCT04135014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101704428|NCT04135014|Anesthetics, General|anesthetics, general|mesh-ancestor
101704429|NCT04135014|Anesthetics|anesthetics|mesh-ancestor
101704430|NCT04135014|GABA Modulators|gaba modulators|mesh-ancestor
101225530|NCT01529294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101225531|NCT01529294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704432|NCT00996697|Budesonide|budesonide|mesh-list
101704433|NCT00996697|Formoterol Fumarate|formoterol fumarate|mesh-list
101704434|NCT00996697|Tiotropium Bromide|tiotropium bromide|mesh-list
101704435|NCT00996697|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101704436|NCT00996697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101704437|NCT00996697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101704439|NCT00996697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101704440|NCT00996697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704441|NCT00996697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101704442|NCT00996697|Respiratory System Agents|respiratory system agents|mesh-ancestor
101704443|NCT00996697|Glucocorticoids|glucocorticoids|mesh-ancestor
101704444|NCT00996697|Hormones|hormones|mesh-ancestor
101704445|NCT00996697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101704446|NCT00996697|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101704447|NCT00996697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101704448|NCT00996697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101704449|NCT00996697|Adrenergic Agents|adrenergic agents|mesh-ancestor
101704450|NCT00996697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101704451|NCT00996697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704452|NCT00996697|Parasympatholytics|parasympatholytics|mesh-ancestor
101704453|NCT00996697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101704454|NCT00996697|Cholinergic Agents|cholinergic agents|mesh-ancestor
101225556|NCT01529437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704455|NCT00999973|Mitomycins|mitomycins|mesh-list
101704456|NCT00999973|Mitomycin|mitomycin|mesh-list
101704457|NCT00999973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101704458|NCT00999973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101704459|NCT00999973|Alkylating Agents|alkylating agents|mesh-ancestor
101704460|NCT00999973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704461|NCT00999973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101704462|NCT00999973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101704463|NCT02715947|Methotrexate|methotrexate|mesh-list
101704464|NCT02715947|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101704465|NCT02715947|Abortifacient Agents|abortifacient agents|mesh-ancestor
101704466|NCT02715947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101704467|NCT02715947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704468|NCT02715947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101704469|NCT02715947|Antimetabolites|antimetabolites|mesh-ancestor
101704470|NCT02715947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704471|NCT02715947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101704472|NCT02715947|Dermatologic Agents|dermatologic agents|mesh-ancestor
101704473|NCT02715947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101704474|NCT02715947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101704475|NCT02715947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101704476|NCT02715947|Immunologic Factors|immunologic factors|mesh-ancestor
101704477|NCT02715947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101704478|NCT02715947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101704479|NCT00856323|Tenofovir|tenofovir|mesh-list
101704480|NCT00856323|Emtricitabine|emtricitabine|mesh-list
101704481|NCT00856323|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101704482|NCT00856323|Antiviral Agents|antiviral agents|mesh-ancestor
101704483|NCT00856323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101704484|NCT00856323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101704485|NCT00856323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101704486|NCT00856323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101704487|NCT00856323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704488|NCT00856323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101704489|NCT00856323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101704490|NCT00856245|Rituximab|rituximab|mesh-list
101704491|NCT00856245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101704492|NCT00856245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101704493|NCT00856245|Immunologic Factors|immunologic factors|mesh-ancestor
101704494|NCT00856245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704495|NCT00856245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101704496|NCT00855933|Cetylpyridinium|cetylpyridinium|mesh-list
101704497|NCT00855933|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101704498|NCT00855933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101704499|NCT00994903|Simvastatin|simvastatin|mesh-list
101225662|NCT01530126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704501|NCT00994903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101704502|NCT00994903|Antimetabolites|antimetabolites|mesh-ancestor
101704503|NCT00994903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704504|NCT00994903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101704505|NCT00994903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101704506|NCT00994903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101704507|NCT00699777|Risedronic Acid|risedronic acid|mesh-list
101704508|NCT00699777|Etidronic Acid|etidronic acid|mesh-list
101704509|NCT00699777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101704510|NCT00699777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101704511|NCT00699777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704512|NCT00699777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101704513|NCT00699777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704514|NCT00699777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101704516|NCT00997009|Carboplatin|carboplatin|mesh-list
101704517|NCT00997009|Cetuximab|cetuximab|mesh-list
101225709|NCT01530308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101225710|NCT01530308|Dopamine Agents|dopamine agents|mesh-ancestor
101704518|NCT00997009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101704519|NCT00997009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101704520|NCT00997009|Tubulin Modulators|tubulin modulators|mesh-ancestor
101704521|NCT00997009|Antimitotic Agents|antimitotic agents|mesh-ancestor
101704522|NCT00997009|Mitosis Modulators|mitosis modulators|mesh-ancestor
101704523|NCT00997009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704524|NCT00997009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101704525|NCT02712125|Isosorbide|isosorbide|mesh-list
101704526|NCT02712125|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
101704527|NCT02712125|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
101704528|NCT02712125|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101704529|NCT02712125|Diuretics|diuretics|mesh-ancestor
101704530|NCT02712125|Natriuretic Agents|natriuretic agents|mesh-ancestor
101704531|NCT02712125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704532|NCT02712125|Vasodilator Agents|vasodilator agents|mesh-ancestor
101704533|NCT02712125|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101704534|NCT02712125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704535|NCT00994981|Magnesium Sulfate|magnesium sulfate|mesh-list
101704536|NCT00994981|Analgesics|analgesics|mesh-ancestor
101704537|NCT00994981|Sensory System Agents|sensory system agents|mesh-ancestor
101704538|NCT00994981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101704539|NCT00994981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704541|NCT00994981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101704542|NCT00994981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101704543|NCT00994981|Anticonvulsants|anticonvulsants|mesh-ancestor
101704544|NCT00994981|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101704545|NCT00994981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101704546|NCT00994981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704547|NCT00994981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101704548|NCT00994981|Tocolytic Agents|tocolytic agents|mesh-ancestor
101704549|NCT00994981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101704550|NCT02715479|Dolutegravir|dolutegravir|mesh-list
101704551|NCT02715479|BMS-955176|bms-955176|mesh-list
101704552|NCT02715479|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101704553|NCT02715479|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101704554|NCT02715479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101704555|NCT02715479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704556|NCT02715479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101704557|NCT02715479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101704558|NCT02715479|Antiviral Agents|antiviral agents|mesh-ancestor
101704559|NCT02715479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101704560|NCT01000441|Adalimumab|adalimumab|mesh-list
101704561|NCT01000441|Infliximab|infliximab|mesh-list
101704562|NCT01000441|Etanercept|etanercept|mesh-list
101704563|NCT01000441|Rituximab|rituximab|mesh-list
101704564|NCT01000441|Abatacept|abatacept|mesh-list
101704565|NCT01000441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101704566|NCT01000441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101704567|NCT01000441|Immunologic Factors|immunologic factors|mesh-ancestor
101225877|NCT01531192|Ionophores|ionophores|mesh-ancestor
101704568|NCT01000441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225880|NCT01531218|Azithromycin|azithromycin|mesh-list
101704570|NCT01000441|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101704571|NCT01000441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101704572|NCT01000441|Dermatologic Agents|dermatologic agents|mesh-ancestor
101704573|NCT01000441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101704574|NCT01000441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101704575|NCT01000441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101704576|NCT01000441|Analgesics|analgesics|mesh-ancestor
101704577|NCT01000441|Sensory System Agents|sensory system agents|mesh-ancestor
101704578|NCT01000441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101704579|NCT01000441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101704580|NCT01000441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101704581|NCT01000441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704582|NCT00997087|Flumazenil|flumazenil|mesh-list
101704583|NCT00997087|Antidotes|antidotes|mesh-ancestor
101704584|NCT00997087|Protective Agents|protective agents|mesh-ancestor
101704585|NCT00997087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704586|NCT00997087|GABA Modulators|gaba modulators|mesh-ancestor
101704587|NCT00997087|GABA Agents|gaba agents|mesh-ancestor
101225953|NCT01531647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101704588|NCT00997087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101704589|NCT00997087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704590|NCT01000597|Fluticasone|fluticasone|mesh-list
101704591|NCT01000597|Xhance|xhance|mesh-list
101704592|NCT01000597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101704593|NCT01000597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101704594|NCT01000597|Autonomic Agents|autonomic agents|mesh-ancestor
101704595|NCT01000597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101704596|NCT01000597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704597|NCT01000597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101704598|NCT01000597|Respiratory System Agents|respiratory system agents|mesh-ancestor
101704599|NCT01000597|Dermatologic Agents|dermatologic agents|mesh-ancestor
101704600|NCT01000597|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101704601|NCT02751593|Dexamethasone|dexamethasone|mesh-list
101704602|NCT02751593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101704603|NCT02751593|Antiemetics|antiemetics|mesh-ancestor
101704604|NCT02751593|Autonomic Agents|autonomic agents|mesh-ancestor
101704605|NCT02751593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101704606|NCT02751593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704607|NCT02751593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101704608|NCT02751593|Glucocorticoids|glucocorticoids|mesh-ancestor
101704609|NCT02751593|Hormones|hormones|mesh-ancestor
101704610|NCT02751593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101704611|NCT02751593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101704612|NCT02751593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101704613|NCT00997399|Panobinostat|panobinostat|mesh-list
101704614|NCT00997399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101704615|NCT00997399|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101704616|NCT00997399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101704617|NCT00997399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704618|NCT00997477|Budesonide|budesonide|mesh-list
101704619|NCT00997477|Formoterol Fumarate|formoterol fumarate|mesh-list
101704620|NCT00997477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101704621|NCT00997477|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101704622|NCT00997477|Autonomic Agents|autonomic agents|mesh-ancestor
101704623|NCT00997477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101704624|NCT00997477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226058|NCT01532466|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101226059|NCT01532466|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101704625|NCT00997477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101704626|NCT00997477|Respiratory System Agents|respiratory system agents|mesh-ancestor
101704627|NCT00997477|Glucocorticoids|glucocorticoids|mesh-ancestor
101704629|NCT00997477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101704630|NCT00997477|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101704631|NCT00997477|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101704632|NCT00997477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101704633|NCT00997477|Adrenergic Agents|adrenergic agents|mesh-ancestor
101704634|NCT00997477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101704635|NCT00997477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704636|NCT01000831|Vaccines|vaccines|mesh-list
101704637|NCT01000831|Immunologic Factors|immunologic factors|mesh-ancestor
101704638|NCT01000831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704639|NCT05170789|Dexamethasone|dexamethasone|mesh-list
101704640|NCT05170789|Elotuzumab|elotuzumab|mesh-list
101704641|NCT05170789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101704642|NCT05170789|Antiemetics|antiemetics|mesh-ancestor
101704643|NCT05170789|Autonomic Agents|autonomic agents|mesh-ancestor
101704644|NCT05170789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101704645|NCT05170789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704646|NCT05170789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101704647|NCT05170789|Glucocorticoids|glucocorticoids|mesh-ancestor
101704648|NCT05170789|Hormones|hormones|mesh-ancestor
101226113|NCT01532856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101226114|NCT01532856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101704649|NCT05170789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101704650|NCT05170789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101704651|NCT05170789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101704652|NCT02693951|Cefotiam|cefotiam|mesh-list
101704653|NCT02693951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101704654|NCT02693951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101704655|NCT00997711|Sirolimus|sirolimus|mesh-list
101704656|NCT00997711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101704657|NCT00997711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101535913|NCT00191646|Paclitaxel|paclitaxel|mesh-list
101704658|NCT00997711|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101226170|NCT01533155|Antimalarials|antimalarials|mesh-ancestor
101704659|NCT00997711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101704660|NCT00997711|Antifungal Agents|antifungal agents|mesh-ancestor
101704661|NCT00997711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101704662|NCT00997711|Immunologic Factors|immunologic factors|mesh-ancestor
101704663|NCT00997711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704665|NCT01001143|Bexarotene|bexarotene|mesh-list
101704666|NCT01001143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101704667|NCT01001143|Antimetabolites|antimetabolites|mesh-ancestor
101704668|NCT01001143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704669|NCT01001143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101704670|NCT01001143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101704671|NCT02715167|Budesonide|budesonide|mesh-list
101704672|NCT02715167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101704673|NCT02715167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101704674|NCT02715167|Autonomic Agents|autonomic agents|mesh-ancestor
101704675|NCT02715167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101704676|NCT02715167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704677|NCT02715167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101704678|NCT02715167|Respiratory System Agents|respiratory system agents|mesh-ancestor
101226232|NCT01533376|Adrenergic Agents|adrenergic agents|mesh-ancestor
101226240|NCT01533389|Silodosin|silodosin|mesh-list
101704679|NCT02715167|Glucocorticoids|glucocorticoids|mesh-ancestor
101704680|NCT02715167|Hormones|hormones|mesh-ancestor
101704681|NCT02715167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101704682|NCT03885661|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
101704683|NCT03885661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101704684|NCT03885661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101704685|NCT02620566|Bupivacaine|bupivacaine|mesh-list
101704686|NCT02620566|Anesthetics, Local|anesthetics, local|mesh-ancestor
101704687|NCT02620566|Anesthetics|anesthetics|mesh-ancestor
101704688|NCT02620566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101704689|NCT02620566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704690|NCT02620566|Sensory System Agents|sensory system agents|mesh-ancestor
101704691|NCT02620566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101704692|NCT00855465|Riociguat|riociguat|mesh-list
101704693|NCT00855465|Enzyme Activators|enzyme activators|mesh-ancestor
101704694|NCT00855465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704695|NCT02714699|Diclofenac|diclofenac|mesh-list
101704696|NCT02714699|Scopolamine|scopolamine|mesh-list
101704697|NCT02714699|Bromides|bromides|mesh-list
101704698|NCT02714699|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101704699|NCT02714699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101704700|NCT02714699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101704701|NCT02714699|Analgesics|analgesics|mesh-ancestor
101704702|NCT02714699|Sensory System Agents|sensory system agents|mesh-ancestor
101190393|NCT00004728|Antipyretics|antipyretics|mesh-ancestor
101704703|NCT02714699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101704704|NCT02714699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704705|NCT02714699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101704706|NCT02714699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101704707|NCT02714699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101704708|NCT02714699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101704709|NCT02714699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704710|NCT02714699|Anticonvulsants|anticonvulsants|mesh-ancestor
101704711|NCT02714699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101704712|NCT02714699|Antiemetics|antiemetics|mesh-ancestor
101226352|NCT01533870|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101704713|NCT02714699|Autonomic Agents|autonomic agents|mesh-ancestor
101704714|NCT02714699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101704715|NCT02714699|Mydriatics|mydriatics|mesh-ancestor
101704716|NCT02714699|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101704717|NCT02714699|Cholinergic Agents|cholinergic agents|mesh-ancestor
101704718|NCT02714699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101704719|NCT02714699|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101704720|NCT02714699|Parasympatholytics|parasympatholytics|mesh-ancestor
101704721|NCT01004419|Fulvestrant|fulvestrant|mesh-list
101704722|NCT01004419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101704723|NCT01004419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101704724|NCT01004419|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101704725|NCT01004419|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101704726|NCT01004419|Hormone Antagonists|hormone antagonists|mesh-ancestor
101704727|NCT01004419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101704728|NCT01004419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704729|NCT02714855|Apixaban|apixaban|mesh-list
101704730|NCT02714855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101704731|NCT02714855|Antithrombins|antithrombins|mesh-ancestor
101704732|NCT02714855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101704733|NCT02714855|Protease Inhibitors|protease inhibitors|mesh-ancestor
101704734|NCT02714855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101704735|NCT02714855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704736|NCT02714855|Anticoagulants|anticoagulants|mesh-ancestor
101704737|NCT02712203|Vaccines|vaccines|mesh-list
101704738|NCT02712203|Immunologic Factors|immunologic factors|mesh-ancestor
101704739|NCT02712203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704740|NCT00696930|Edotreotide|edotreotide|mesh-list
101704741|NCT00696930|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101704742|NCT00696930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704743|NCT00598442|Darbepoetin alfa|darbepoetin alfa|mesh-list
101704744|NCT00598442|Hematinics|hematinics|mesh-ancestor
101704745|NCT02714543|Hydrocortisone|hydrocortisone|mesh-list
101704746|NCT02714543|Hyaluronic Acid|hyaluronic acid|mesh-list
101704747|NCT02714543|Antioxidants|antioxidants|mesh-list
101704748|NCT02714543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101704749|NCT02714543|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101704750|NCT02714543|Immunologic Factors|immunologic factors|mesh-ancestor
101704751|NCT02714543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704752|NCT02714543|Viscosupplements|viscosupplements|mesh-ancestor
101704753|NCT02714543|Protective Agents|protective agents|mesh-ancestor
101704754|NCT02714543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704755|NCT02714231|Diclofenac|diclofenac|mesh-list
101704756|NCT02714231|Scopolamine|scopolamine|mesh-list
101704757|NCT02714231|Bromides|bromides|mesh-list
101704758|NCT02714231|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101704759|NCT02714231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101704760|NCT02714231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101704761|NCT02714231|Analgesics|analgesics|mesh-ancestor
101704762|NCT02714231|Sensory System Agents|sensory system agents|mesh-ancestor
101704763|NCT02714231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101704764|NCT02714231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704765|NCT02714231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101704766|NCT02714231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101704767|NCT02714231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101704768|NCT02714231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101704769|NCT02714231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704770|NCT02714231|Anticonvulsants|anticonvulsants|mesh-ancestor
101226448|NCT01534702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101226449|NCT01534702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101226450|NCT01534702|Immunologic Factors|immunologic factors|mesh-ancestor
101226451|NCT01534702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226452|NCT01534702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101226453|NCT01534702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101704771|NCT02714231|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101226454|NCT01534702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101704773|NCT02714231|Autonomic Agents|autonomic agents|mesh-ancestor
101704774|NCT02714231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101704775|NCT02714231|Mydriatics|mydriatics|mesh-ancestor
101704776|NCT02714231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101704777|NCT02714231|Cholinergic Agents|cholinergic agents|mesh-ancestor
101704778|NCT02714231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101704779|NCT02714231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101704780|NCT02714231|Parasympatholytics|parasympatholytics|mesh-ancestor
101704781|NCT00855309|Acyclovir|acyclovir|mesh-list
101704782|NCT00855309|Antiviral Agents|antiviral agents|mesh-ancestor
101704783|NCT00855309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101704784|NCT00532129|Rituximab|rituximab|mesh-list
101704785|NCT00532129|Chlorambucil|chlorambucil|mesh-list
101704786|NCT00532129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101704787|NCT00532129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101704788|NCT00532129|Immunologic Factors|immunologic factors|mesh-ancestor
101704789|NCT00532129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704790|NCT00532129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101226488|NCT01534858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410517|NCT05594121|Analgesics|analgesics|mesh-ancestor
101704791|NCT00532129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101704792|NCT00532129|Alkylating Agents|alkylating agents|mesh-ancestor
101704793|NCT00532129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704794|NCT04163276|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101704795|NCT04163276|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101704796|NCT04163276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704797|NCT04163588|Metolazone|metolazone|mesh-list
101704798|NCT04163588|Diuretics|diuretics|mesh-list
101704799|NCT04163588|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
101704800|NCT04163588|Natriuretic Agents|natriuretic agents|mesh-ancestor
101704801|NCT04163588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704802|NCT04163588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101226551|NCT01535183|Irinotecan|irinotecan|mesh-list
101704803|NCT04163588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704804|NCT04163588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101704805|NCT04163588|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101704807|NCT05167513|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101704808|NCT05167513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101704809|NCT05167513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704810|NCT05167513|Incretins|incretins|mesh-ancestor
101704811|NCT05167513|Hormones|hormones|mesh-ancestor
101704812|NCT05167513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101704813|NCT05167513|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101704814|NCT05167513|Protease Inhibitors|protease inhibitors|mesh-ancestor
101704815|NCT05167513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101704816|NCT05167513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704817|NCT00654056|Insulin|insulin|mesh-list
101704818|NCT00654056|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101704819|NCT00654056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101704820|NCT00654056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704821|NCT00854373|Hormones|hormones|mesh-list
101226603|NCT01535612|Insulin|insulin|mesh-list
101704822|NCT00854373|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101704823|NCT00854373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101704824|NCT00854373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704825|NCT00611507|Fluorouracil|fluorouracil|mesh-list
101704826|NCT00611507|Oxaliplatin|oxaliplatin|mesh-list
101704827|NCT00611507|Antimetabolites|antimetabolites|mesh-ancestor
101704828|NCT00611507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704829|NCT00611507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101704830|NCT00611507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101704831|NCT00611507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101704832|NCT00611507|Immunologic Factors|immunologic factors|mesh-ancestor
101704833|NCT00611507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704834|NCT01001845|Vitamin E|vitamin e|mesh-list
101704835|NCT01001845|alpha-Tocopherol|alpha-tocopherol|mesh-list
101704836|NCT01001845|Tocopherols|tocopherols|mesh-list
101704837|NCT01001845|Antioxidants|antioxidants|mesh-ancestor
101704838|NCT01001845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704839|NCT01001845|Protective Agents|protective agents|mesh-ancestor
101704840|NCT01001845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704841|NCT01001845|Vitamins|vitamins|mesh-ancestor
101226657|NCT01535989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101704842|NCT01001845|Micronutrients|micronutrients|mesh-ancestor
101704843|NCT02635334|Montelukast|montelukast|mesh-list
101704844|NCT02635334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101704845|NCT02635334|Respiratory System Agents|respiratory system agents|mesh-ancestor
101704846|NCT02635334|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101704847|NCT02635334|Hormone Antagonists|hormone antagonists|mesh-ancestor
101704848|NCT02635334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101704849|NCT02635334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704850|NCT02635334|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101704851|NCT02635334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101704852|NCT02635334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704853|NCT00853905|Triamcinolone|triamcinolone|mesh-list
101704854|NCT00853905|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101704855|NCT00853905|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101704856|NCT00853905|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101704857|NCT00853905|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101704858|NCT00853905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101704860|NCT00853905|Hormones|hormones|mesh-ancestor
101704861|NCT00853905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101704862|NCT00853905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704863|NCT00853905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101704864|NCT00853905|Immunologic Factors|immunologic factors|mesh-ancestor
101704865|NCT00853905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101226711|NCT01536158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101704866|NCT00853905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704868|NCT00998101|Cetuximab|cetuximab|mesh-list
101704869|NCT00998101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101704870|NCT00998101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101704871|NCT04234217|Niacin|niacin|mesh-list
101704872|NCT04234217|Niacinamide|niacinamide|mesh-list
101704873|NCT04234217|Nicotinic Acids|nicotinic acids|mesh-list
101704874|NCT04234217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101704875|NCT04234217|Antimetabolites|antimetabolites|mesh-ancestor
101704876|NCT04234217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704877|NCT04234217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101704878|NCT04234217|Vasodilator Agents|vasodilator agents|mesh-ancestor
101704879|NCT04234217|Vitamin B Complex|vitamin b complex|mesh-ancestor
101704880|NCT04234217|Vitamins|vitamins|mesh-ancestor
101704881|NCT04234217|Micronutrients|micronutrients|mesh-ancestor
101704882|NCT04234217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704883|NCT01002079|Rifampin|rifampin|mesh-list
101704884|NCT01002079|BMS 708163|bms 708163|mesh-list
101704885|NCT01002079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101704886|NCT01002079|Antitubercular Agents|antitubercular agents|mesh-ancestor
101704887|NCT01002079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101704888|NCT01002079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101704889|NCT01002079|Leprostatic Agents|leprostatic agents|mesh-ancestor
101704890|NCT01002079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101704891|NCT01002079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101704892|NCT01002079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704893|NCT01002079|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101226762|NCT01536314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101704894|NCT01002079|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101704895|NCT01002079|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101704896|NCT01002079|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101704897|NCT01002079|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101704898|NCT01002079|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101704899|NCT01002079|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101704900|NCT02639624|Dialysis Solutions|dialysis solutions|mesh-list
101704901|NCT02639624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101704902|NCT05429567|Fentanyl|fentanyl|mesh-list
101704903|NCT05429567|Bupivacaine|bupivacaine|mesh-list
101704904|NCT05429567|Anesthetics, Local|anesthetics, local|mesh-ancestor
101704905|NCT05429567|Anesthetics|anesthetics|mesh-ancestor
101704906|NCT05429567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101704907|NCT05429567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704908|NCT05429567|Sensory System Agents|sensory system agents|mesh-ancestor
101704909|NCT05429567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101704910|NCT05429567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101226763|NCT01536314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704911|NCT05429567|Narcotics|narcotics|mesh-ancestor
101704912|NCT05429567|Analgesics|analgesics|mesh-ancestor
101704913|NCT05429567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101704914|NCT05429567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101704915|NCT05429567|Anesthetics, General|anesthetics, general|mesh-ancestor
101704916|NCT00868296|Pantoprazole|pantoprazole|mesh-list
101704917|NCT00868296|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101704918|NCT00868296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101704919|NCT00868296|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101704920|NCT00868296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101704921|NCT00868296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704922|NCT01002157|Vitamin K|vitamin k|mesh-list
101704923|NCT01002157|Vitamin K 2|vitamin k 2|mesh-list
101704924|NCT01002157|Menaquinone 7|menaquinone 7|mesh-list
101704925|NCT01002157|Vitamins|vitamins|mesh-ancestor
101704926|NCT01002157|Micronutrients|micronutrients|mesh-ancestor
101704927|NCT01002157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704928|NCT01002157|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101704929|NCT01002157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101302561|NCT00324805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101704930|NCT01002157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704932|NCT01002157|Coagulants|coagulants|mesh-ancestor
101704933|NCT01004497|Cytarabine|cytarabine|mesh-list
101704934|NCT01004497|Dexamethasone|dexamethasone|mesh-list
101704935|NCT01004497|Dexamethasone acetate|dexamethasone acetate|mesh-list
101704936|NCT01004497|Cyclophosphamide|cyclophosphamide|mesh-list
101704937|NCT01004497|Vincristine|vincristine|mesh-list
101704938|NCT01004497|Daunorubicin|daunorubicin|mesh-list
101704939|NCT01004497|Dasatinib|dasatinib|mesh-list
101704940|NCT01004497|Mitoxantrone|mitoxantrone|mesh-list
101704941|NCT01004497|BB 1101|bb 1101|mesh-list
101704942|NCT01004497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101704943|NCT01004497|Immunologic Factors|immunologic factors|mesh-ancestor
101704944|NCT01004497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704945|NCT01004497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101704946|NCT01004497|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101704947|NCT01004497|Alkylating Agents|alkylating agents|mesh-ancestor
101704948|NCT01004497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704949|NCT01004497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101704950|NCT01004497|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101226845|NCT01536873|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101226855|NCT01537055|Ofloxacin|ofloxacin|mesh-list
101704951|NCT01004497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101704952|NCT01004497|Antiemetics|antiemetics|mesh-ancestor
101704953|NCT01004497|Autonomic Agents|autonomic agents|mesh-ancestor
101704954|NCT01004497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101704955|NCT01004497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101704956|NCT01004497|Glucocorticoids|glucocorticoids|mesh-ancestor
101704957|NCT01004497|Hormones|hormones|mesh-ancestor
101704958|NCT01004497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101704959|NCT01004497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101704960|NCT01004497|Protease Inhibitors|protease inhibitors|mesh-ancestor
101704961|NCT01004497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101704962|NCT01004497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101704963|NCT01004497|Antimetabolites|antimetabolites|mesh-ancestor
101704964|NCT01004497|Antiviral Agents|antiviral agents|mesh-ancestor
101704965|NCT01004497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101704966|NCT01004497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101704967|NCT01004497|Tubulin Modulators|tubulin modulators|mesh-ancestor
101704968|NCT01004497|Antimitotic Agents|antimitotic agents|mesh-ancestor
101704969|NCT01004497|Mitosis Modulators|mitosis modulators|mesh-ancestor
101704970|NCT01004497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101704971|NCT01004497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101704972|NCT01004497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101704973|NCT01004497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101704974|NCT01004497|Analgesics|analgesics|mesh-ancestor
101704975|NCT01004497|Sensory System Agents|sensory system agents|mesh-ancestor
101704976|NCT02713841|Insulin|insulin|mesh-list
101704977|NCT02713841|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101704978|NCT02713841|Insulin Lispro|insulin lispro|mesh-list
101704979|NCT02713841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101704980|NCT02713841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704982|NCT01004575|Chromium|chromium|mesh-list
101704983|NCT01004575|Trace Elements|trace elements|mesh-ancestor
101704984|NCT01004575|Micronutrients|micronutrients|mesh-ancestor
101704985|NCT01004575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101704986|NCT02615730|Paclitaxel|paclitaxel|mesh-list
101704987|NCT02615730|GSK2636771|gsk2636771|mesh-list
101704988|NCT02615730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101704989|NCT02615730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101704990|NCT02615730|Tubulin Modulators|tubulin modulators|mesh-ancestor
101704991|NCT02615730|Antimitotic Agents|antimitotic agents|mesh-ancestor
101704992|NCT02615730|Mitosis Modulators|mitosis modulators|mesh-ancestor
101704993|NCT02615730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101704994|NCT02615730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101704995|NCT02615730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101704996|NCT02711891|Loperamide|loperamide|mesh-list
101704997|NCT02711891|Antidiarrheals|antidiarrheals|mesh-list
101704998|NCT02711891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101704999|NCT02615496|Aflibercept|aflibercept|mesh-list
101705000|NCT02615496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101705001|NCT02615496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101705002|NCT02615496|Growth Substances|growth substances|mesh-ancestor
101705003|NCT02615496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705004|NCT02615496|Growth Inhibitors|growth inhibitors|mesh-ancestor
101705005|NCT02615496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101705006|NCT02714075|Zinc|zinc|mesh-list
101226963|NCT01537809|Vitamin D|vitamin d|mesh-list
101705007|NCT02714075|Iron|iron|mesh-list
101705008|NCT02714075|Zinc Sulfate|zinc sulfate|mesh-list
101705009|NCT02714075|Zinc Oxide|zinc oxide|mesh-list
101705011|NCT02714075|Sodium Citrate|sodium citrate|mesh-list
101705012|NCT02714075|Anticoagulants|anticoagulants|mesh-ancestor
101705013|NCT02714075|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101705014|NCT02714075|Chelating Agents|chelating agents|mesh-ancestor
101705015|NCT02714075|Sequestering Agents|sequestering agents|mesh-ancestor
101705016|NCT02714075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705017|NCT02714075|Trace Elements|trace elements|mesh-ancestor
101705018|NCT02714075|Micronutrients|micronutrients|mesh-ancestor
101705019|NCT02714075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705020|NCT02714075|Astringents|astringents|mesh-ancestor
101705021|NCT02714075|Dermatologic Agents|dermatologic agents|mesh-ancestor
101705022|NCT02714075|Sunscreening Agents|sunscreening agents|mesh-ancestor
101705023|NCT02714075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101705024|NCT02714075|Protective Agents|protective agents|mesh-ancestor
101705025|NCT02636426|Sorafenib|sorafenib|mesh-list
101705026|NCT02636426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101705027|NCT02636426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101705028|NCT02636426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101705029|NCT02636426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705030|NCT02713763|Sunitinib|sunitinib|mesh-list
101705031|NCT02713763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101705032|NCT02713763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101705033|NCT02713763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101705034|NCT02713763|Growth Substances|growth substances|mesh-ancestor
101705035|NCT02713763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705036|NCT02713763|Growth Inhibitors|growth inhibitors|mesh-ancestor
101362470|NCT00074841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101705037|NCT02713763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101705038|NCT02713763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101705039|NCT02713763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705040|NCT00867360|Mifepristone|mifepristone|mesh-list
101705041|NCT00867360|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101705042|NCT00867360|Abortifacient Agents|abortifacient agents|mesh-ancestor
101705043|NCT00867360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101705044|NCT00867360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705045|NCT00867360|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101705046|NCT00867360|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101705047|NCT00867360|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101226996|NCT01537861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101705048|NCT00867360|Contraceptive Agents|contraceptive agents|mesh-ancestor
101705049|NCT00867360|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101705050|NCT00867360|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101705051|NCT00867360|Hormone Antagonists|hormone antagonists|mesh-ancestor
101705052|NCT00867360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101705053|NCT00867360|Luteolytic Agents|luteolytic agents|mesh-ancestor
101705054|NCT00867360|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101705055|NCT00867360|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101705056|NCT00656552|Escitalopram|escitalopram|mesh-list
101705057|NCT00656552|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101705058|NCT00656552|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101705059|NCT00656552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101705060|NCT00656552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705061|NCT00656552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101705062|NCT00656552|Serotonin Agents|serotonin agents|mesh-ancestor
101705063|NCT00656552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705064|NCT01004809|Dutasteride|dutasteride|mesh-list
101705065|NCT01004809|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101705066|NCT01004809|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101705067|NCT01004809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101705068|NCT01004809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705069|NCT01004809|Hormone Antagonists|hormone antagonists|mesh-ancestor
101705070|NCT01004809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101705071|NCT01004809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705072|NCT00883688|Bevacizumab|bevacizumab|mesh-list
101705073|NCT00883688|Lapatinib|lapatinib|mesh-list
101705074|NCT00883688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101705075|NCT00883688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101705076|NCT00883688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101705077|NCT00883688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101705078|NCT00883688|Growth Substances|growth substances|mesh-ancestor
101302562|NCT00324805|Antimetabolites|antimetabolites|mesh-ancestor
101227032|NCT01538316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101705079|NCT00883688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705081|NCT00883688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101705082|NCT00883688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101705083|NCT00883688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705084|NCT04191863|Valproic Acid|valproic acid|mesh-list
101705085|NCT04191863|Anticonvulsants|anticonvulsants|mesh-ancestor
101705086|NCT04191863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101705087|NCT04191863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705088|NCT04191863|GABA Agents|gaba agents|mesh-ancestor
101705089|NCT04191863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101705090|NCT04191863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705091|NCT04191863|Antimanic Agents|antimanic agents|mesh-ancestor
101705092|NCT04191863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101705093|NCT04191863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101705094|NCT04191863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101705096|NCT02636348|Calcium|calcium|mesh-list
101705097|NCT02636348|Vitamins|vitamins|mesh-ancestor
101705098|NCT02636348|Micronutrients|micronutrients|mesh-ancestor
101705099|NCT02636348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705100|NCT02636348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101705101|NCT02636348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101705102|NCT04219865|Edaravone|edaravone|mesh-list
101705103|NCT04219865|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101705104|NCT04219865|Antioxidants|antioxidants|mesh-ancestor
101705105|NCT04219865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705106|NCT04219865|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101705107|NCT04219865|Protective Agents|protective agents|mesh-ancestor
101705108|NCT04219865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705109|NCT01002703|Prednisone|prednisone|mesh-list
101705110|NCT01002703|Lenalidomide|lenalidomide|mesh-list
101705111|NCT01002703|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101705112|NCT01002703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101705113|NCT01002703|Glucocorticoids|glucocorticoids|mesh-ancestor
101362542|NCT00044915|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101227072|NCT01538446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101227077|NCT01538459|Dexamethasone|dexamethasone|mesh-list
101705115|NCT01002703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101705116|NCT01002703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705117|NCT01002703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101705118|NCT01002703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101705119|NCT01002703|Immunologic Factors|immunologic factors|mesh-ancestor
101705120|NCT01002703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101705121|NCT01002703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101705122|NCT01002703|Growth Substances|growth substances|mesh-ancestor
101705123|NCT01002703|Growth Inhibitors|growth inhibitors|mesh-ancestor
101705124|NCT01002703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101705125|NCT01002703|Alkylating Agents|alkylating agents|mesh-ancestor
101705126|NCT01002703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705127|NCT02639234|Nivolumab|nivolumab|mesh-list
101705128|NCT02639234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101705129|NCT02639234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101705130|NCT02639234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101705131|NCT02639234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705132|NCT00654290|Propranolol|propranolol|mesh-list
101705133|NCT00654290|Amiodarone|amiodarone|mesh-list
101705134|NCT00654290|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101705135|NCT00654290|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101705136|NCT00654290|Adrenergic Agents|adrenergic agents|mesh-ancestor
101705137|NCT00654290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101705138|NCT00654290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705139|NCT00654290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705140|NCT00654290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101705141|NCT00654290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101227111|NCT01538537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101705142|NCT00654290|Vasodilator Agents|vasodilator agents|mesh-ancestor
101705143|NCT00654290|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101705144|NCT00654290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101705145|NCT00654290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101705146|NCT00654290|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101705147|NCT00654290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101705148|NCT00654290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101705149|NCT00654290|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101705150|NCT00654290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101705151|NCT00654290|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101705152|NCT02713139|Metronidazole|metronidazole|mesh-list
101705153|NCT02713139|Clotrimazole|clotrimazole|mesh-list
101705154|NCT02713139|Miconazole|miconazole|mesh-list
101705155|NCT02713139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101705156|NCT02713139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101705157|NCT02713139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101705158|NCT02713139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101705159|NCT02713139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101705160|NCT02713139|Antifungal Agents|antifungal agents|mesh-ancestor
101705161|NCT02713139|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101705162|NCT02713139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101705163|NCT02713139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101227158|NCT01538693|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101227159|NCT01538693|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101705164|NCT02713139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705165|NCT02713139|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101705167|NCT02713139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101705168|NCT02713139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705169|NCT02713139|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101705170|NCT02713139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101705171|NCT01005121|Colchicine|colchicine|mesh-list
101705172|NCT01005121|Gout Suppressants|gout suppressants|mesh-ancestor
101705173|NCT01005121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101705174|NCT01005121|Tubulin Modulators|tubulin modulators|mesh-ancestor
101227210|NCT01538875|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101705175|NCT01005121|Antimitotic Agents|antimitotic agents|mesh-ancestor
101705176|NCT01005121|Mitosis Modulators|mitosis modulators|mesh-ancestor
101705177|NCT01005121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705178|NCT01005121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101705179|NCT02711579|Celecoxib|celecoxib|mesh-list
101705180|NCT02711579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101705181|NCT02711579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101705182|NCT02711579|Analgesics|analgesics|mesh-ancestor
101705183|NCT02711579|Sensory System Agents|sensory system agents|mesh-ancestor
101705184|NCT02711579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101705185|NCT02711579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705186|NCT02711579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101705187|NCT02711579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101705188|NCT02711579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101705189|NCT02711579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101705190|NCT02711579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101705191|NCT02711579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227274|NCT01539174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101705192|NCT00611195|Remifentanil|remifentanil|mesh-list
101705193|NCT00611195|Propofol|propofol|mesh-list
101705194|NCT00611195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101705195|NCT00611195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101705196|NCT00611195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705197|NCT00611195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101705198|NCT00611195|Anesthetics, General|anesthetics, general|mesh-ancestor
101705199|NCT00611195|Anesthetics|anesthetics|mesh-ancestor
101705200|NCT00611195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101705201|NCT00611195|Narcotics|narcotics|mesh-ancestor
101705202|NCT00611195|Analgesics|analgesics|mesh-ancestor
101705203|NCT00611195|Sensory System Agents|sensory system agents|mesh-ancestor
101705204|NCT00611195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101705205|NCT01008709|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101705206|NCT01008709|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
101705208|NCT01008709|Hormones|hormones|mesh-ancestor
101705209|NCT01008709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101705210|NCT01008709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705211|NCT01008709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101705212|NCT01008709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227330|NCT01539473|Adrenergic Agents|adrenergic agents|mesh-ancestor
101705213|NCT02615574|Interferons|interferons|mesh-list
101705214|NCT02615574|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
101705215|NCT02615574|Celecoxib|celecoxib|mesh-list
101705216|NCT02615574|Vaccines|vaccines|mesh-list
101705217|NCT02615574|Immunologic Factors|immunologic factors|mesh-ancestor
101705218|NCT02615574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705219|NCT02615574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101705220|NCT02615574|Antiviral Agents|antiviral agents|mesh-ancestor
101705221|NCT02615574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101705222|NCT02615574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101705223|NCT02615574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101705224|NCT02615574|Analgesics|analgesics|mesh-ancestor
101705225|NCT02615574|Sensory System Agents|sensory system agents|mesh-ancestor
101705226|NCT02615574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101705227|NCT02615574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101705228|NCT02615574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101705229|NCT02615574|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101705230|NCT02615574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101227387|NCT01539720|Levonorgestrel|levonorgestrel|mesh-list
101705231|NCT02615574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101705232|NCT02615574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705233|NCT02708693|Triamcinolone|triamcinolone|mesh-list
101705234|NCT02708693|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101705235|NCT02708693|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101705236|NCT02708693|Lidocaine|lidocaine|mesh-list
101705237|NCT02708693|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101705238|NCT02708693|Anesthetics, Local|anesthetics, local|mesh-ancestor
101705239|NCT02708693|Anesthetics|anesthetics|mesh-ancestor
101705240|NCT02708693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101705241|NCT02708693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705242|NCT02708693|Sensory System Agents|sensory system agents|mesh-ancestor
101705243|NCT02708693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101705244|NCT02708693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101705245|NCT02708693|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101705246|NCT02708693|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101705247|NCT02708693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101705248|NCT02708693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705249|NCT02708693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101705250|NCT02708693|Glucocorticoids|glucocorticoids|mesh-ancestor
101705252|NCT02708693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101705253|NCT02708693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101705254|NCT02708693|Immunologic Factors|immunologic factors|mesh-ancestor
101705255|NCT02708693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101705256|NCT02638922|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101705257|NCT02638922|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101705258|NCT02638922|Trisequens|trisequens|mesh-list
101362706|NCT03928366|Propofol|propofol|mesh-list
101705260|NCT02638922|Estradiol|estradiol|mesh-list
101705261|NCT02638922|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101705262|NCT02638922|Estrogens|estrogens|mesh-ancestor
101705263|NCT02638922|Hormones|hormones|mesh-ancestor
101705264|NCT02638922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101705265|NCT02638922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705266|NCT02638922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101705267|NCT02638922|Contraceptive Agents|contraceptive agents|mesh-ancestor
101705268|NCT02638922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101705269|NCT02638922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101227435|NCT01540032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101227446|NCT01540084|Anesthetics|anesthetics|mesh-ancestor
101705270|NCT02638922|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101705271|NCT02638922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101705272|NCT02638922|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101705273|NCT01005199|Everolimus|everolimus|mesh-list
101705274|NCT01005199|Sorafenib|sorafenib|mesh-list
101705275|NCT01005199|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101705276|NCT01005199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101705277|NCT01005199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101705278|NCT01005199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705279|NCT01005199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101705280|NCT01005199|Immunologic Factors|immunologic factors|mesh-ancestor
101705281|NCT01005199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705282|NCT01005199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101705283|NCT02711189|Oxytocin|oxytocin|mesh-list
101705284|NCT02711189|Oxytocics|oxytocics|mesh-ancestor
101705285|NCT02711189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101705286|NCT02711189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705287|NCT02635802|Lidocaine|lidocaine|mesh-list
101705288|NCT02635802|Midazolam|midazolam|mesh-list
101705289|NCT02635802|Remifentanil|remifentanil|mesh-list
101705290|NCT02635802|Anesthetics, Local|anesthetics, local|mesh-ancestor
101705291|NCT02635802|Anesthetics|anesthetics|mesh-ancestor
101705292|NCT02635802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101705293|NCT02635802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705294|NCT02635802|Sensory System Agents|sensory system agents|mesh-ancestor
101705295|NCT02635802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101705296|NCT02635802|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101705297|NCT02635802|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101705298|NCT02635802|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101705299|NCT02635802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101705300|NCT02635802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227475|NCT01540435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101705301|NCT02635802|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101705302|NCT02635802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101705303|NCT02635802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101705304|NCT02635802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101705305|NCT02635802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101705306|NCT02635802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101705307|NCT02635802|Anesthetics, General|anesthetics, general|mesh-ancestor
101705308|NCT02635802|GABA Modulators|gaba modulators|mesh-ancestor
101705310|NCT02635802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101227515|NCT01540708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705311|NCT02635802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101705312|NCT02635802|Narcotics|narcotics|mesh-ancestor
101705313|NCT02635802|Analgesics|analgesics|mesh-ancestor
101705314|NCT00853749|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101705315|NCT00853749|Immunologic Factors|immunologic factors|mesh-ancestor
101705316|NCT00853749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705317|NCT00657410|Dexamethasone|dexamethasone|mesh-list
101705318|NCT00657410|Prednisone|prednisone|mesh-list
101705319|NCT00657410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101705320|NCT00657410|Antiemetics|antiemetics|mesh-ancestor
101705321|NCT00657410|Autonomic Agents|autonomic agents|mesh-ancestor
101227585|NCT01540812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101705322|NCT00657410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101705323|NCT00657410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705324|NCT00657410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101705325|NCT00657410|Glucocorticoids|glucocorticoids|mesh-ancestor
101705327|NCT00657410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101705328|NCT00657410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101705329|NCT00657410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101705330|NCT01009021|Diclofenac|diclofenac|mesh-list
101705331|NCT01009021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101705332|NCT01009021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101705333|NCT01009021|Analgesics|analgesics|mesh-ancestor
101705334|NCT01009021|Sensory System Agents|sensory system agents|mesh-ancestor
101705335|NCT01009021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101705336|NCT01009021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705337|NCT01009021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101705338|NCT01009021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101705339|NCT01009021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101705340|NCT01009021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101705341|NCT01009021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705342|NCT01005433|Dexmedetomidine|dexmedetomidine|mesh-list
101705343|NCT01005433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101227645|NCT01541267|Telmisartan|telmisartan|mesh-list
101227646|NCT01541267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101705344|NCT01005433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101705345|NCT01005433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705346|NCT01005433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101705348|NCT01005433|Sensory System Agents|sensory system agents|mesh-ancestor
101705349|NCT01005433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101705350|NCT01005433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101705351|NCT01005433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101705352|NCT01005433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101705353|NCT01005433|Adrenergic Agents|adrenergic agents|mesh-ancestor
101705354|NCT01005433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101705355|NCT01005433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705356|NCT00654446|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101705358|NCT00654446|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101705359|NCT00654446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101705360|NCT00654446|Antimetabolites|antimetabolites|mesh-ancestor
101705361|NCT00654446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705362|NCT00654446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101227697|NCT01541436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101227698|NCT01541436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705363|NCT00654446|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101705364|NCT00654446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101705365|NCT01003483|Orlistat|orlistat|mesh-list
101705366|NCT01003483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101705367|NCT01003483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705368|NCT01003483|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101705369|NCT01003483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101705370|NCT00592839|Estrogens|estrogens|mesh-list
101705371|NCT00592839|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101227754|NCT01541085|Ritonavir|ritonavir|mesh-list
101705372|NCT00592839|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
101705373|NCT00592839|Estrogens, conjugated synthetic B|estrogens, conjugated synthetic b|mesh-list
101705374|NCT00592839|Hormones|hormones|mesh-ancestor
101705375|NCT00592839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101705376|NCT00592839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705377|NCT01009177|Bosentan|bosentan|mesh-list
101705378|NCT01009177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101705379|NCT01009177|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101227817|NCT01542138|Micronutrients|micronutrients|mesh-ancestor
101705380|NCT01009177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705381|NCT00598832|Adapalene|adapalene|mesh-list
101705382|NCT00598832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101705383|NCT00598832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101705384|NCT00598832|Analgesics|analgesics|mesh-ancestor
101705385|NCT00598832|Sensory System Agents|sensory system agents|mesh-ancestor
101705386|NCT00598832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101705387|NCT00598832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705388|NCT00598832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101705389|NCT00598832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101705390|NCT00598832|Dermatologic Agents|dermatologic agents|mesh-ancestor
101705391|NCT01003561|Anesthetics|anesthetics|mesh-list
101705392|NCT01003561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101705393|NCT01003561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705394|NCT02711267|Acyclovir|acyclovir|mesh-list
101705395|NCT02711267|Antiviral Agents|antiviral agents|mesh-ancestor
101705396|NCT02711267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101705397|NCT04219553|Anti-Infective Agents|anti-infective agents|mesh-list
101705398|NCT04219553|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101705399|NCT04459871|Thrombin|thrombin|mesh-list
101227884|NCT01542489|Insulin|insulin|mesh-list
101705401|NCT04459871|Coagulants|coagulants|mesh-ancestor
101705402|NCT02708459|Morphine|morphine|mesh-list
101705403|NCT02708459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101705404|NCT02708459|Narcotics|narcotics|mesh-ancestor
101705405|NCT02708459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101705406|NCT02708459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705407|NCT02708459|Analgesics|analgesics|mesh-ancestor
101227937|NCT01542827|Analgesics|analgesics|mesh-list
101705408|NCT02708459|Sensory System Agents|sensory system agents|mesh-ancestor
101705409|NCT02708459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101705410|NCT01005979|Cyclophosphamide|cyclophosphamide|mesh-list
101227941|NCT01542918|Rituximab|rituximab|mesh-list
101705412|NCT01005979|Lenalidomide|lenalidomide|mesh-list
101705413|NCT01005979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101705414|NCT01005979|Immunologic Factors|immunologic factors|mesh-ancestor
101705415|NCT01005979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705416|NCT01005979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101705417|NCT01005979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101705418|NCT01005979|Alkylating Agents|alkylating agents|mesh-ancestor
101705419|NCT01005979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705420|NCT01005979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101705421|NCT01005979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101705422|NCT01005979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101705423|NCT01005979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101705424|NCT01005979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101705425|NCT01005979|Growth Substances|growth substances|mesh-ancestor
101705426|NCT01005979|Growth Inhibitors|growth inhibitors|mesh-ancestor
101705428|NCT00913029|Latanoprost|latanoprost|mesh-list
101705429|NCT00913029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101705430|NCT00913029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101705431|NCT00913029|Adrenergic Agents|adrenergic agents|mesh-ancestor
101228009|NCT01543399|Tibolone|tibolone|mesh-list
101705432|NCT00913029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101705433|NCT00913029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705435|NCT00913029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101705436|NCT00913029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101705437|NCT00913029|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101705438|NCT00913029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101705440|NCT01006057|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101705441|NCT01006057|Insulin, Long-Acting|insulin, long-acting|mesh-list
101705442|NCT01006057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101705443|NCT01006057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705444|NCT00853125|Sunitinib|sunitinib|mesh-list
101705445|NCT00853125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101705446|NCT00853125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101705447|NCT00853125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101705448|NCT00853125|Growth Substances|growth substances|mesh-ancestor
101228124|NCT01544192|Antioxidants|antioxidants|mesh-list
101228125|NCT01544192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705449|NCT00853125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705450|NCT00853125|Growth Inhibitors|growth inhibitors|mesh-ancestor
101705451|NCT00853125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101705452|NCT00853125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101705453|NCT00853125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705454|NCT02707913|Amlodipine|amlodipine|mesh-list
101228191|NCT01544634|Beclomethasone|beclomethasone|mesh-list
101705455|NCT02707913|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101705456|NCT02707913|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101705457|NCT02707913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101705458|NCT02707913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705459|NCT02707913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101705460|NCT02707913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705461|NCT02707913|Vasodilator Agents|vasodilator agents|mesh-ancestor
101705462|NCT02710877|Sufentanil|sufentanil|mesh-list
101705463|NCT02710877|Dsuvia|dsuvia|mesh-list
101705464|NCT02710877|Levobupivacaine|levobupivacaine|mesh-list
101705465|NCT02710877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101705466|NCT02710877|Narcotics|narcotics|mesh-ancestor
101705467|NCT02710877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101705468|NCT02710877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705469|NCT02710877|Analgesics|analgesics|mesh-ancestor
101705470|NCT02710877|Sensory System Agents|sensory system agents|mesh-ancestor
101228262|NCT01544842|Hormones|hormones|mesh-ancestor
101705471|NCT02710877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101705472|NCT02710877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101705473|NCT02710877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101705474|NCT02710877|Anesthetics, General|anesthetics, general|mesh-ancestor
101705476|NCT02710877|Anesthetics, Local|anesthetics, local|mesh-ancestor
101705477|NCT00530023|Insulin|insulin|mesh-list
101705478|NCT00530023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101705479|NCT00530023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705480|NCT02707445|Clopidogrel|clopidogrel|mesh-list
101705481|NCT02707445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101705482|NCT02707445|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101705483|NCT02707445|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101705484|NCT02707445|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101705485|NCT02707445|Purinergic Agents|purinergic agents|mesh-ancestor
101705486|NCT02707445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101705487|NCT02707445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705488|NCT02707445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705489|NCT03999775|Calcium, Dietary|calcium, dietary|mesh-list
101705490|NCT03999775|Vitamin D|vitamin d|mesh-list
101705491|NCT03999775|Ergocalciferols|ergocalciferols|mesh-list
101705492|NCT03999775|Cholecalciferol|cholecalciferol|mesh-list
101705493|NCT03999775|Vitamins|vitamins|mesh-list
101705494|NCT03999775|Calcium|calcium|mesh-list
101705495|NCT03999775|Micronutrients|micronutrients|mesh-ancestor
101705496|NCT03999775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705497|NCT03999775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101705498|NCT03999775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101705499|NCT02706977|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101705500|NCT02706977|Carbidopa|carbidopa|mesh-list
101705501|NCT02706977|Levodopa|levodopa|mesh-list
101705502|NCT02706977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101705503|NCT02706977|Immunologic Factors|immunologic factors|mesh-ancestor
101705504|NCT02706977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705505|NCT02706977|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101705506|NCT02706977|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101705507|NCT02706977|Dopamine Agonists|dopamine agonists|mesh-ancestor
101705508|NCT02706977|Dopamine Agents|dopamine agents|mesh-ancestor
101228311|NCT01544972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101228315|NCT01544972|Antipyretics|antipyretics|mesh-ancestor
101705509|NCT02706977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101705510|NCT02706977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705511|NCT02706977|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101705512|NCT02706977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101705513|NCT02707211|Antibodies|antibodies|mesh-list
101705514|NCT02707211|Immunoglobulin M|immunoglobulin m|mesh-list
101705515|NCT02707211|Immunologic Factors|immunologic factors|mesh-ancestor
101705516|NCT02707211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705517|NCT01006525|Zolpidem|zolpidem|mesh-list
101705518|NCT01006525|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101228358|NCT01545479|Captopril|captopril|mesh-list
101705519|NCT01006525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101705520|NCT01006525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101705521|NCT01006525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705522|NCT01006525|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101705523|NCT01006525|GABA Agonists|gaba agonists|mesh-ancestor
101705524|NCT01006525|GABA Agents|gaba agents|mesh-ancestor
101705525|NCT01006525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101705526|NCT01006525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705527|NCT01006681|Vaccines|vaccines|mesh-list
101705528|NCT01006681|MF59 oil emulsion|mf59 oil emulsion|mesh-list
101705529|NCT01006681|Immunologic Factors|immunologic factors|mesh-ancestor
101705530|NCT01006681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705531|NCT01006681|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101705532|NCT05733403|Norepinephrine|norepinephrine|mesh-list
101705533|NCT05733403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101705534|NCT05733403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101705535|NCT05733403|Adrenergic Agents|adrenergic agents|mesh-ancestor
101705536|NCT05733403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101705537|NCT05733403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705538|NCT05733403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705539|NCT05733403|Sympathomimetics|sympathomimetics|mesh-ancestor
101705540|NCT05733403|Autonomic Agents|autonomic agents|mesh-ancestor
101705541|NCT05733403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101705542|NCT05733403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101705543|NCT03893903|Avelumab|avelumab|mesh-list
101705544|NCT03893903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101705545|NCT03893903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101705546|NCT02706509|Tramadol|tramadol|mesh-list
101228412|NCT01545947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101705547|NCT02706509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101705548|NCT02706509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705549|NCT02706509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101705550|NCT02706509|Narcotics|narcotics|mesh-ancestor
101705551|NCT02706509|Analgesics|analgesics|mesh-ancestor
101705552|NCT02706509|Sensory System Agents|sensory system agents|mesh-ancestor
101705553|NCT02706509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101705554|NCT02710409|Vaccines|vaccines|mesh-list
101705555|NCT02710409|Immunologic Factors|immunologic factors|mesh-ancestor
101705556|NCT02710409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705557|NCT00529087|Bromides|bromides|mesh-list
101705558|NCT00529087|Methylnaltrexone|methylnaltrexone|mesh-list
101228458|NCT01546558|Metformin|metformin|mesh-list
101705559|NCT00529087|Anticonvulsants|anticonvulsants|mesh-ancestor
101705560|NCT00529087|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101228459|NCT01546558|Ranolazine|ranolazine|mesh-list
101705561|NCT00529087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705562|NCT00529087|Sensory System Agents|sensory system agents|mesh-ancestor
101705563|NCT00529087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101705565|NCT04318210|Emtricitabine|emtricitabine|mesh-list
101705566|NCT04318210|Antiviral Agents|antiviral agents|mesh-ancestor
101705567|NCT04318210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101705568|NCT04318210|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101705569|NCT04318210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101705570|NCT04318210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101228521|NCT01547104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101705571|NCT04318210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705572|NCT04318210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101705573|NCT04318210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101705574|NCT00611663|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101705575|NCT00611663|Immunologic Factors|immunologic factors|mesh-ancestor
101705576|NCT00611663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705577|NCT00870870|Carboplatin|carboplatin|mesh-list
101228587|NCT01547377|Zinc|zinc|mesh-list
101228588|NCT01547377|Selenium|selenium|mesh-list
101705579|NCT00870870|Cetuximab|cetuximab|mesh-list
101705580|NCT00870870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101705581|NCT00870870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101705582|NCT00870870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101705583|NCT00870870|Antimetabolites|antimetabolites|mesh-ancestor
101705584|NCT00870870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705585|NCT00870870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101705587|NCT00870870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705588|NCT04120636|Celecoxib|celecoxib|mesh-list
101705589|NCT04120636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101705590|NCT04120636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101705591|NCT04120636|Analgesics|analgesics|mesh-ancestor
101705592|NCT04120636|Sensory System Agents|sensory system agents|mesh-ancestor
101705593|NCT04120636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101228656|NCT01548001|Immunologic Factors|immunologic factors|mesh-ancestor
101228657|NCT01548001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101228658|NCT01548001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101228659|NCT01548027|Anesthetics|anesthetics|mesh-list
101228660|NCT01548027|Anesthetics, Local|anesthetics, local|mesh-list
101228661|NCT01548027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101228662|NCT01548027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228663|NCT01548027|Sensory System Agents|sensory system agents|mesh-ancestor
101228665|NCT01548066|Valproic Acid|valproic acid|mesh-list
101705594|NCT04120636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705595|NCT04120636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101705597|NCT04120636|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101705598|NCT04120636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101705599|NCT04120636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101705600|NCT04120636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705601|NCT00731926|Vitamins|vitamins|mesh-list
101705602|NCT00731926|Vitamin E|vitamin e|mesh-list
101705603|NCT00731926|Micronutrients|micronutrients|mesh-ancestor
101705604|NCT00731926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705605|NCT00731926|Antioxidants|antioxidants|mesh-ancestor
101705606|NCT00731926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705607|NCT00731926|Protective Agents|protective agents|mesh-ancestor
101705608|NCT00732082|Gemcitabine|gemcitabine|mesh-list
101228775|NCT01548482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101705609|NCT00732082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101705610|NCT00732082|Antimetabolites|antimetabolites|mesh-ancestor
101705611|NCT00732082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705612|NCT00732082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101705613|NCT00611741|Furosemide|furosemide|mesh-list
101705614|NCT00611741|Diuretics|diuretics|mesh-ancestor
101705615|NCT00611741|Natriuretic Agents|natriuretic agents|mesh-ancestor
101705616|NCT00611741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705617|NCT00611741|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101705618|NCT00611741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101705619|NCT00611741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705620|NCT04134468|Gemcitabine|gemcitabine|mesh-list
101705621|NCT04134468|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101705622|NCT04134468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101705623|NCT04134468|Antimetabolites|antimetabolites|mesh-ancestor
101705624|NCT04134468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705625|NCT04134468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101705626|NCT02709863|Propofol|propofol|mesh-list
101705627|NCT02709863|Sevoflurane|sevoflurane|mesh-list
101705628|NCT02709863|Desflurane|desflurane|mesh-list
101705629|NCT02709863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101705630|NCT02709863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101228840|NCT01548859|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101705631|NCT02709863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705632|NCT02709863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101705633|NCT02709863|Anesthetics, General|anesthetics, general|mesh-ancestor
101705635|NCT02709863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101705636|NCT02709863|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101705637|NCT03877237|Dapagliflozin|dapagliflozin|mesh-list
101705638|NCT03877237|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101705639|NCT03877237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228894|NCT01549236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101705641|NCT03877237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705642|NCT02619786|Colistin|colistin|mesh-list
101705643|NCT02619786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101705644|NCT02619786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101705645|NCT00697086|Dronedarone|dronedarone|mesh-list
101705646|NCT00697086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101705647|NCT04066660|Fucoidan|fucoidan|mesh-list
101705648|NCT04066660|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101705649|NCT04066660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101705650|NCT04066660|Anticoagulants|anticoagulants|mesh-ancestor
101705651|NCT04066660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101705652|NCT00697164|Epoetin Alfa|epoetin alfa|mesh-list
101228958|NCT01549574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101705653|NCT00697164|Hematinics|hematinics|mesh-ancestor
101228959|NCT01549574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101705654|NCT00694980|Etrolizumab|etrolizumab|mesh-list
101705655|NCT00694980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101705656|NCT00694980|Immunologic Factors|immunologic factors|mesh-ancestor
101705657|NCT00694980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705658|NCT00612755|Ribavirin|ribavirin|mesh-list
101705659|NCT00612755|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101705660|NCT00612755|Antimetabolites|antimetabolites|mesh-ancestor
101705661|NCT00612755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705662|NCT00612755|Antiviral Agents|antiviral agents|mesh-ancestor
101705663|NCT00612755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101705664|NCT04132674|Tenofovir|tenofovir|mesh-list
101705665|NCT04132674|Emtricitabine|emtricitabine|mesh-list
101229021|NCT01549990|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101705666|NCT04132674|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
101705667|NCT04132674|Antiviral Agents|antiviral agents|mesh-ancestor
101705668|NCT04132674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101705669|NCT04132674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101705670|NCT04132674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101705671|NCT04132674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101705672|NCT04132674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705673|NCT04132674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101705674|NCT04132674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101705675|NCT00612287|Buprenorphine|buprenorphine|mesh-list
101705676|NCT00612287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101705677|NCT00612287|Narcotics|narcotics|mesh-ancestor
101705678|NCT00612287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101229086|NCT01550419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101229087|NCT01550419|Antimetabolites|antimetabolites|mesh-ancestor
101705679|NCT00612287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705680|NCT00612287|Analgesics|analgesics|mesh-ancestor
101705681|NCT00612287|Sensory System Agents|sensory system agents|mesh-ancestor
101705682|NCT00612287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101705683|NCT00612287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101705684|NCT00732784|Imatinib Mesylate|imatinib mesylate|mesh-list
101705685|NCT00732784|Calcium Carbonate|calcium carbonate|mesh-list
101705686|NCT00732784|Calcium|calcium|mesh-list
101705687|NCT00732784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101705688|NCT00732784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229146|NCT01550458|Mibefradil|mibefradil|mesh-list
101705689|NCT00732784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101705690|NCT00732784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101705691|NCT00732784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101705692|NCT00732784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705693|NCT00732784|Antacids|antacids|mesh-ancestor
101705694|NCT00732784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101705695|NCT04496219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101705696|NCT04496219|BCG Vaccine|bcg vaccine|mesh-list
101705697|NCT04496219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101705698|NCT04496219|Immunologic Factors|immunologic factors|mesh-ancestor
101705699|NCT04496219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705700|NCT02947126|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
101705701|NCT02947126|Pentetic Acid|pentetic acid|mesh-list
101705702|NCT02947126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101705703|NCT02947126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705704|NCT02947126|Antidotes|antidotes|mesh-ancestor
101705705|NCT02947126|Protective Agents|protective agents|mesh-ancestor
101705706|NCT02947126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705707|NCT02947126|Chelating Agents|chelating agents|mesh-ancestor
101705708|NCT02947126|Sequestering Agents|sequestering agents|mesh-ancestor
101705709|NCT02947126|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101363147|NCT00046358|Ibuprofen|ibuprofen|mesh-list
101705710|NCT04492553|Testosterone|testosterone|mesh-list
101705711|NCT04492553|Androgens|androgens|mesh-ancestor
101705712|NCT04492553|Hormones|hormones|mesh-ancestor
101705713|NCT04492553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101705714|NCT04492553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705715|NCT00871494|Azithromycin|azithromycin|mesh-list
101705716|NCT00871494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101705717|NCT00871494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101705718|NCT01007539|Choline|choline|mesh-list
101705719|NCT01007539|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
101705720|NCT01007539|Lipotropic Agents|lipotropic agents|mesh-ancestor
101705721|NCT01007539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101705722|NCT01007539|Antimetabolites|antimetabolites|mesh-ancestor
101705723|NCT01007539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705724|NCT01007539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101705725|NCT01007539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101705726|NCT01007539|Nootropic Agents|nootropic agents|mesh-ancestor
101229343|NCT01552122|Alendronate|alendronate|mesh-list
101705727|NCT04951817|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101705728|NCT04951817|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101705729|NCT04951817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705730|NCT04137185|Hormones|hormones|mesh-list
101705731|NCT04137185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101705732|NCT04137185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705733|NCT00733174|Rosiglitazone|rosiglitazone|mesh-list
101705734|NCT00733174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101705735|NCT00733174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705736|NCT00529789|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101705737|NCT00529789|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101705738|NCT00529789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101229395|NCT01552668|Fidaxomicin|fidaxomicin|mesh-list
101705739|NCT00529789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101705740|NCT00529789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705741|NCT00529789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101705742|NCT00529789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705743|NCT00529789|Analgesics|analgesics|mesh-ancestor
101705744|NCT00529789|Sensory System Agents|sensory system agents|mesh-ancestor
101705745|NCT00529789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101705746|NCT00529789|Antidepressive Agents|antidepressive agents|mesh-ancestor
101705747|NCT00529789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101705748|NCT00529789|Dopamine Agents|dopamine agents|mesh-ancestor
101705749|NCT04136028|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101705750|NCT04136028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101705751|NCT00611819|Interferons|interferons|mesh-list
101705752|NCT00611819|Ribavirin|ribavirin|mesh-list
101705753|NCT00611819|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101705754|NCT00611819|Interferon-alpha|interferon-alpha|mesh-list
101705755|NCT00611819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101229457|NCT01553019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101705756|NCT00611819|Antiviral Agents|antiviral agents|mesh-ancestor
101705757|NCT00611819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101705758|NCT00611819|Antimetabolites|antimetabolites|mesh-ancestor
101705759|NCT00611819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705760|NCT00611819|Immunologic Factors|immunologic factors|mesh-ancestor
101705761|NCT00611819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705762|NCT00577642|Zoledronic Acid|zoledronic acid|mesh-list
101705763|NCT00577642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101705764|NCT00577642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705765|NCT02619162|Letrozole|letrozole|mesh-list
101705766|NCT02619162|Nintedanib|nintedanib|mesh-list
101705767|NCT02619162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101705768|NCT02619162|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101705769|NCT02619162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101705770|NCT02619162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101705771|NCT02619162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705772|NCT02619162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101705773|NCT02619162|Hormone Antagonists|hormone antagonists|mesh-ancestor
101705774|NCT02619162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101705775|NCT02619162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705776|NCT02619162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101705777|NCT04018690|Triamcinolone|triamcinolone|mesh-list
101705778|NCT04018690|Ropivacaine|ropivacaine|mesh-list
101705779|NCT04018690|Anesthetics, Local|anesthetics, local|mesh-ancestor
101705780|NCT04018690|Anesthetics|anesthetics|mesh-ancestor
101705781|NCT04018690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101229646|NCT01554930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101705782|NCT04018690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705783|NCT04018690|Sensory System Agents|sensory system agents|mesh-ancestor
101705784|NCT04018690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101705785|NCT04018690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101705786|NCT04018690|Glucocorticoids|glucocorticoids|mesh-ancestor
101705787|NCT04018690|Hormones|hormones|mesh-ancestor
101705788|NCT04018690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101705789|NCT00697866|Vaccines|vaccines|mesh-list
101705790|NCT00697866|Immunologic Factors|immunologic factors|mesh-ancestor
101705791|NCT00697866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705792|NCT00733564|Lidocaine|lidocaine|mesh-list
101705793|NCT00733564|Propofol|propofol|mesh-list
101705794|NCT00733564|Sevoflurane|sevoflurane|mesh-list
101705795|NCT00733564|Anesthetics, Local|anesthetics, local|mesh-ancestor
101705796|NCT00733564|Anesthetics|anesthetics|mesh-ancestor
101705797|NCT00733564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101705798|NCT00733564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705799|NCT00733564|Sensory System Agents|sensory system agents|mesh-ancestor
101705800|NCT00733564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101229700|NCT01555112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101705801|NCT00733564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101705802|NCT00733564|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101705803|NCT00733564|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101535932|NCT00191334|Gemcitabine|gemcitabine|mesh-list
101705804|NCT00733564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101705805|NCT00733564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705806|NCT00733564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101705807|NCT00733564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101705808|NCT00733564|Anesthetics, General|anesthetics, general|mesh-ancestor
101229776|NCT01555866|Isavuconazole|isavuconazole|mesh-list
101705809|NCT00733564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101705812|NCT00727870|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101705813|NCT00727870|Protective Agents|protective agents|mesh-ancestor
101705814|NCT00727870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705815|NCT01007695|Valproic Acid|valproic acid|mesh-list
101705816|NCT01007695|Anticonvulsants|anticonvulsants|mesh-ancestor
101229835|NCT01556334|Erythromycin|erythromycin|mesh-list
101229836|NCT01556334|Erythromycin Estolate|erythromycin estolate|mesh-list
101705817|NCT01007695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101229837|NCT01556334|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101705818|NCT01007695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705819|NCT01007695|GABA Agents|gaba agents|mesh-ancestor
101705820|NCT01007695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101705821|NCT01007695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705822|NCT01007695|Antimanic Agents|antimanic agents|mesh-ancestor
101705823|NCT01007695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101705824|NCT01007695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101705825|NCT01007695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101705826|NCT02709473|Remifentanil|remifentanil|mesh-list
101705827|NCT02709473|Propofol|propofol|mesh-list
101705828|NCT02709473|Rocuronium|rocuronium|mesh-list
101229907|NCT05847257|Vitamins|vitamins|mesh-ancestor
101705829|NCT02709473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101705830|NCT02709473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101705831|NCT02709473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705832|NCT02709473|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101705833|NCT02709473|Anesthetics, General|anesthetics, general|mesh-ancestor
101705834|NCT02709473|Anesthetics|anesthetics|mesh-ancestor
101705835|NCT02709473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101705836|NCT02709473|Narcotics|narcotics|mesh-ancestor
101705837|NCT02709473|Analgesics|analgesics|mesh-ancestor
101705838|NCT02709473|Sensory System Agents|sensory system agents|mesh-ancestor
101229972|NCT05846867|Antidotes|antidotes|mesh-ancestor
101705839|NCT02709473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101705840|NCT02709473|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101705841|NCT02709473|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101705842|NCT02709473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101705843|NCT00866658|Lixisenatide|lixisenatide|mesh-list
101705844|NCT00866658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101705845|NCT00866658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705846|NCT04942067|Dexamethasone|dexamethasone|mesh-list
101705847|NCT04942067|Dexamethasone acetate|dexamethasone acetate|mesh-list
101705848|NCT04942067|Lenalidomide|lenalidomide|mesh-list
101705849|NCT04942067|Daratumumab|daratumumab|mesh-list
101705850|NCT04942067|Pomalidomide|pomalidomide|mesh-list
101705851|NCT04942067|BB 1101|bb 1101|mesh-list
101705852|NCT04942067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101705853|NCT04942067|Antiemetics|antiemetics|mesh-ancestor
101705854|NCT04942067|Autonomic Agents|autonomic agents|mesh-ancestor
101705855|NCT04942067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101705856|NCT04942067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705857|NCT04942067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101363295|NCT00080145|Risperidone|risperidone|mesh-list
101705858|NCT04942067|Glucocorticoids|glucocorticoids|mesh-ancestor
101705859|NCT04942067|Hormones|hormones|mesh-ancestor
101705860|NCT04942067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101705861|NCT04942067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101705862|NCT04942067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101705863|NCT04942067|Protease Inhibitors|protease inhibitors|mesh-ancestor
101705864|NCT04942067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101705865|NCT04942067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705866|NCT04942067|Immunologic Factors|immunologic factors|mesh-ancestor
101705868|NCT04942067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101705869|NCT04942067|Growth Substances|growth substances|mesh-ancestor
101705870|NCT04942067|Growth Inhibitors|growth inhibitors|mesh-ancestor
101705871|NCT01007773|Fentanyl|fentanyl|mesh-list
101705872|NCT01007773|Dexmedetomidine|dexmedetomidine|mesh-list
101705873|NCT01007773|Propofol|propofol|mesh-list
101230155|NCT05839509|Hallucinogens|hallucinogens|mesh-ancestor
101705875|NCT01007773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101705876|NCT01007773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705877|NCT01007773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101705878|NCT01007773|Analgesics|analgesics|mesh-ancestor
101705879|NCT01007773|Sensory System Agents|sensory system agents|mesh-ancestor
101705880|NCT01007773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101705881|NCT01007773|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101705882|NCT01007773|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101705883|NCT01007773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101705884|NCT01007773|Adrenergic Agents|adrenergic agents|mesh-ancestor
101705886|NCT01007773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705887|NCT01007773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101705888|NCT01007773|Anesthetics, General|anesthetics, general|mesh-ancestor
101705889|NCT01007773|Anesthetics|anesthetics|mesh-ancestor
101705890|NCT01007773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101705891|NCT01007773|Narcotics|narcotics|mesh-ancestor
101705892|NCT01007773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101705893|NCT02615340|Melatonin|melatonin|mesh-list
101705894|NCT02615340|Antioxidants|antioxidants|mesh-ancestor
101705895|NCT02615340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705896|NCT02615340|Protective Agents|protective agents|mesh-ancestor
101705897|NCT02615340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705898|NCT02615340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101705899|NCT04899791|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
101705900|NCT04899791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101705901|NCT04899791|Antioxidants|antioxidants|mesh-ancestor
101705902|NCT04899791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705903|NCT04899791|Protective Agents|protective agents|mesh-ancestor
101705904|NCT04899791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230354|NCT05585112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705905|NCT04899791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101705906|NCT02615106|Endostar protein|endostar protein|mesh-list
101705907|NCT02615106|Endostatins|endostatins|mesh-list
101705908|NCT02615106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101705909|NCT02615106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101705910|NCT02615106|Growth Substances|growth substances|mesh-ancestor
101705911|NCT02615106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705912|NCT02615106|Growth Inhibitors|growth inhibitors|mesh-ancestor
101705913|NCT02615106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101705914|NCT04930237|Methylnaltrexone|methylnaltrexone|mesh-list
101705915|NCT04930237|Bisacodyl|bisacodyl|mesh-list
101705916|NCT04930237|Magnesium citrate|magnesium citrate|mesh-list
101705917|NCT04930237|Magnesium Oxide|magnesium oxide|mesh-list
101705918|NCT04930237|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
101705919|NCT04930237|Magnesium Hydroxide|magnesium hydroxide|mesh-list
101705920|NCT04930237|Calcium|calcium|mesh-list
101705921|NCT04930237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101705922|NCT04930237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705923|NCT04930237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705924|NCT04930237|Cathartics|cathartics|mesh-ancestor
101705925|NCT04930237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101705926|NCT04930237|Laxatives|laxatives|mesh-ancestor
101705927|NCT04930237|Antacids|antacids|mesh-ancestor
101705928|NCT04930237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101705929|NCT04930237|Sensory System Agents|sensory system agents|mesh-ancestor
101705930|NCT04930237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101230492|NCT05095259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101705931|NCT04930237|Antidiarrheals|antidiarrheals|mesh-ancestor
101705933|NCT02615262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101705934|NCT02615262|Antiemetics|antiemetics|mesh-ancestor
101705935|NCT02615262|Autonomic Agents|autonomic agents|mesh-ancestor
101705936|NCT02615262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101705937|NCT02615262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705938|NCT02615262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101705939|NCT02615262|Glucocorticoids|glucocorticoids|mesh-ancestor
101705940|NCT02615262|Hormones|hormones|mesh-ancestor
101230557|NCT04953754|Protective Agents|protective agents|mesh-ancestor
101705941|NCT02615262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101705942|NCT02615262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101705944|NCT00733720|Naltrexone|naltrexone|mesh-list
101705945|NCT00733720|Buprenorphine|buprenorphine|mesh-list
101705946|NCT00733720|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101705947|NCT00733720|Naloxone|naloxone|mesh-list
101705948|NCT00733720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101705949|NCT00733720|Narcotics|narcotics|mesh-ancestor
101705950|NCT00733720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101705951|NCT00733720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705952|NCT00733720|Analgesics|analgesics|mesh-ancestor
101705953|NCT00733720|Sensory System Agents|sensory system agents|mesh-ancestor
101705954|NCT00733720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101705955|NCT00733720|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101705956|NCT00733720|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101230688|NCT04699604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230689|NCT04699604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705957|NCT04134312|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
101705958|NCT04134312|Antiviral Agents|antiviral agents|mesh-ancestor
101705959|NCT04134312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101705961|NCT02624388|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101705962|NCT02624388|Protective Agents|protective agents|mesh-ancestor
101230757|NCT04559880|Tranexamic Acid|tranexamic acid|mesh-list
101705963|NCT02624388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705964|NCT02624388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101705965|NCT02624388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101705966|NCT02624388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101705967|NCT02624388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705968|NCT02624388|Phytoestrogens|phytoestrogens|mesh-ancestor
101705969|NCT02624388|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101705971|NCT02624388|Hormones|hormones|mesh-ancestor
101705972|NCT02624388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101705973|NCT00727948|Aspirin|aspirin|mesh-list
101705974|NCT00727948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101705975|NCT00727948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101705977|NCT00727948|Sensory System Agents|sensory system agents|mesh-ancestor
101705978|NCT00727948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101705979|NCT00727948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705980|NCT00727948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101705981|NCT00727948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101705982|NCT00727948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101705983|NCT00727948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101230960|NCT04175262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101230968|NCT04149899|Timolol|timolol|mesh-list
101705984|NCT00727948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101705985|NCT00727948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101705986|NCT00727948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101705987|NCT00727948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101705988|NCT00727948|Antipyretics|antipyretics|mesh-ancestor
101705989|NCT01007851|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101705990|NCT01007851|Luteolytic Agents|luteolytic agents|mesh-ancestor
101705991|NCT01007851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101705992|NCT01007851|Contraceptive Agents|contraceptive agents|mesh-ancestor
101705993|NCT01007851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101705994|NCT01007851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101705995|NCT01007851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101705996|NCT01007851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101705997|NCT01007851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101705998|NCT05580016|Plasminogen|plasminogen|mesh-list
101705999|NCT05580016|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101706000|NCT05580016|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101706001|NCT05580016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706002|NCT05730673|Leronlimab|leronlimab|mesh-list
101231099|NCT03776864|Pembrolizumab|pembrolizumab|mesh-list
101706003|NCT05730673|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101706004|NCT05730673|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101706005|NCT05730673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706006|NCT05730673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101231155|NCT03652870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101706007|NCT05730673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101706008|NCT05730673|Antiviral Agents|antiviral agents|mesh-ancestor
101706009|NCT05730673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101706010|NCT04134078|Nitric Oxide|nitric oxide|mesh-list
101231156|NCT03652870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101706011|NCT04134078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101706012|NCT04134078|Autonomic Agents|autonomic agents|mesh-ancestor
101706013|NCT04134078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101706014|NCT04134078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706015|NCT04134078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101706016|NCT04134078|Respiratory System Agents|respiratory system agents|mesh-ancestor
101706017|NCT04134078|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101706018|NCT04134078|Antioxidants|antioxidants|mesh-ancestor
101231221|NCT03625986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101231223|NCT03604289|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
101706019|NCT04134078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706020|NCT04134078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101706021|NCT04134078|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101706022|NCT04134078|Vasodilator Agents|vasodilator agents|mesh-ancestor
101706023|NCT04134078|Gasotransmitters|gasotransmitters|mesh-ancestor
101706024|NCT04134078|Protective Agents|protective agents|mesh-ancestor
101706025|NCT03871829|Dexamethasone|dexamethasone|mesh-list
101706026|NCT03871829|Dexamethasone acetate|dexamethasone acetate|mesh-list
101706027|NCT03871829|BB 1101|bb 1101|mesh-list
101706028|NCT03871829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101706029|NCT03871829|Antiemetics|antiemetics|mesh-ancestor
101706030|NCT03871829|Autonomic Agents|autonomic agents|mesh-ancestor
101706031|NCT03871829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101706032|NCT03871829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706033|NCT03871829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101706034|NCT03871829|Glucocorticoids|glucocorticoids|mesh-ancestor
101706035|NCT03871829|Hormones|hormones|mesh-ancestor
101706036|NCT03871829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101706037|NCT03871829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101706038|NCT03871829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101706039|NCT03871829|Protease Inhibitors|protease inhibitors|mesh-ancestor
101706040|NCT03871829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101706041|NCT03871829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706042|NCT00738556|Sirolimus|sirolimus|mesh-list
101706043|NCT00738556|Paclitaxel|paclitaxel|mesh-list
101706044|NCT00738556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101706045|NCT00738556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101231283|NCT03523156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101706046|NCT00738556|Tubulin Modulators|tubulin modulators|mesh-ancestor
101706047|NCT00738556|Antimitotic Agents|antimitotic agents|mesh-ancestor
101706048|NCT00738556|Mitosis Modulators|mitosis modulators|mesh-ancestor
101706049|NCT00738556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706050|NCT00738556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101706051|NCT00738556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101706052|NCT00738556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101706053|NCT00738556|Antifungal Agents|antifungal agents|mesh-ancestor
101706054|NCT00738556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101706055|NCT00738556|Immunologic Factors|immunologic factors|mesh-ancestor
101706056|NCT00738556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706057|NCT00597584|Epoetin Alfa|epoetin alfa|mesh-list
101706058|NCT00597584|Hematinics|hematinics|mesh-ancestor
101706059|NCT00529633|Thalidomide|thalidomide|mesh-list
101706060|NCT00529633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101706061|NCT00529633|Immunologic Factors|immunologic factors|mesh-ancestor
101706062|NCT00529633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706063|NCT00529633|Leprostatic Agents|leprostatic agents|mesh-ancestor
101706064|NCT00529633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101706065|NCT00529633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101706066|NCT00529633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101231396|NCT03344419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101706067|NCT00529633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101706068|NCT00529633|Growth Substances|growth substances|mesh-ancestor
101706069|NCT00529633|Growth Inhibitors|growth inhibitors|mesh-ancestor
101706070|NCT00529633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101706071|NCT01366144|Paclitaxel|paclitaxel|mesh-list
101706072|NCT01366144|Carboplatin|carboplatin|mesh-list
101706073|NCT01366144|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101706074|NCT01366144|Veliparib|veliparib|mesh-list
101706075|NCT01366144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101706076|NCT01366144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101706077|NCT01366144|Tubulin Modulators|tubulin modulators|mesh-ancestor
101706078|NCT01366144|Antimitotic Agents|antimitotic agents|mesh-ancestor
101706079|NCT01366144|Mitosis Modulators|mitosis modulators|mesh-ancestor
101706080|NCT01366144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706082|NCT01366144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101706083|NCT00697944|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101706084|NCT00697944|Antifungal Agents|antifungal agents|mesh-ancestor
101706085|NCT00697944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101706086|NCT00697944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101706087|NCT00697944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101706088|NCT00657488|Thalidomide|thalidomide|mesh-list
101706089|NCT00657488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101706090|NCT00657488|Immunologic Factors|immunologic factors|mesh-ancestor
101231602|NCT03020030|Tubulin Modulators|tubulin modulators|mesh-ancestor
101706091|NCT00657488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706092|NCT00657488|Leprostatic Agents|leprostatic agents|mesh-ancestor
101706093|NCT00657488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101706094|NCT00657488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101706095|NCT00657488|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101706096|NCT00657488|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101706097|NCT00657488|Growth Substances|growth substances|mesh-ancestor
101706098|NCT00657488|Growth Inhibitors|growth inhibitors|mesh-ancestor
101706099|NCT00657488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101706100|NCT00530335|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101706101|NCT00530335|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101706102|NCT00530335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101706103|NCT00530335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101706104|NCT00530335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706105|NCT00530335|Adrenergic Agents|adrenergic agents|mesh-ancestor
101706106|NCT00530335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101706107|NCT00530335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706108|NCT00712270|Risperidone|risperidone|mesh-list
101706111|NCT00712270|Serotonin Agents|serotonin agents|mesh-ancestor
101706112|NCT00712270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101706113|NCT00712270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706114|NCT00712270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706115|NCT00712270|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101706116|NCT00712270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101706117|NCT00712270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101706118|NCT00712270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101706119|NCT00712270|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101706120|NCT00712270|Dopamine Agents|dopamine agents|mesh-ancestor
101706121|NCT00712270|Antidepressive Agents|antidepressive agents|mesh-ancestor
101706122|NCT00712270|Dopamine Agonists|dopamine agonists|mesh-ancestor
101706123|NCT00712270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101706124|NCT00712270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101706125|NCT00712270|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101706126|NCT00712270|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101706127|NCT03860597|Memantine|memantine|mesh-list
101706128|NCT03860597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101706129|NCT03860597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101706130|NCT03860597|Dopamine Agents|dopamine agents|mesh-ancestor
101706131|NCT03860597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101706132|NCT03860597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706133|NCT03860597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706134|NCT03860597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101231870|NCT00713193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101706136|NCT02614872|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
101706137|NCT02614872|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101706138|NCT02614872|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101706139|NCT02614872|Protease Inhibitors|protease inhibitors|mesh-ancestor
101706140|NCT02614872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101706141|NCT02614872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706142|NCT00695604|Fluticasone|fluticasone|mesh-list
101706143|NCT00695604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101706144|NCT00695604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101706145|NCT00695604|Autonomic Agents|autonomic agents|mesh-ancestor
101706146|NCT00695604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101706147|NCT00695604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706148|NCT00695604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101706149|NCT00695604|Respiratory System Agents|respiratory system agents|mesh-ancestor
101706150|NCT00695604|Dermatologic Agents|dermatologic agents|mesh-ancestor
101706151|NCT00695604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101706152|NCT00654524|Vitamin D|vitamin d|mesh-list
101706153|NCT00654524|Goserelin|goserelin|mesh-list
101706154|NCT00654524|Hormones|hormones|mesh-list
101706155|NCT00654524|Vitamins|vitamins|mesh-ancestor
101706156|NCT00654524|Micronutrients|micronutrients|mesh-ancestor
101410567|NCT00445159|Treprostinil|treprostinil|mesh-list
101706157|NCT00654524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706158|NCT00654524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101231998|NCT01557153|Amlodipine|amlodipine|mesh-list
101706159|NCT00654524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101706160|NCT00654524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101706161|NCT00654524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101706163|NCT05260619|Immunologic Factors|immunologic factors|mesh-ancestor
101706164|NCT05260619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706165|NCT05260619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101232055|NCT01557335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101232056|NCT01557335|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101232057|NCT01557374|Abatacept|abatacept|mesh-list
101706166|NCT05260619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101706167|NCT05260619|Growth Substances|growth substances|mesh-ancestor
101706168|NCT05260619|Growth Inhibitors|growth inhibitors|mesh-ancestor
101706169|NCT05260619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101706171|NCT00695682|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101706172|NCT00695682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101706173|NCT00695682|Dermatologic Agents|dermatologic agents|mesh-ancestor
101706174|NCT00695682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101706175|NCT00695682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101706176|NCT00657566|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101706177|NCT00657566|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101706178|NCT00657566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101706179|NCT00657566|Antitubercular Agents|antitubercular agents|mesh-ancestor
101706181|NCT03828773|Posaconazole|posaconazole|mesh-list
101706182|NCT03828773|Antifungal Agents|antifungal agents|mesh-ancestor
101706183|NCT03828773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101232119|NCT01557816|Naproxen|naproxen|mesh-list
101232120|NCT01557816|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101706184|NCT03828773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101706185|NCT03828773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101706186|NCT03828773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101706187|NCT03828773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706188|NCT03828773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101232212|NCT01558622|Ketoprofen|ketoprofen|mesh-list
101706189|NCT03828773|Hormone Antagonists|hormone antagonists|mesh-ancestor
101706190|NCT03828773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101706191|NCT03828773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706192|NCT03828773|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101706193|NCT03828773|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101706194|NCT03828773|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101232250|NCT01558830|Ranolazine|ranolazine|mesh-list
101706195|NCT03828773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101706196|NCT03828773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101706197|NCT00530257|Methylphenidate|methylphenidate|mesh-list
101706198|NCT00530257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101706199|NCT00530257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706200|NCT00530257|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101706201|NCT00530257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101706202|NCT00530257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101706203|NCT00530257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706204|NCT00530257|Dopamine Agents|dopamine agents|mesh-ancestor
101706205|NCT00530257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101232317|NCT01559272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101706206|NCT00738868|Cetuximab|cetuximab|mesh-list
101706207|NCT00738868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101706208|NCT00738868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101706209|NCT00657644|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101706210|NCT00657644|Vasodilator Agents|vasodilator agents|mesh-ancestor
101706211|NCT00657644|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101706212|NCT00657644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101706213|NCT00657644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101706214|NCT00657644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706215|NCT00657644|Urological Agents|urological agents|mesh-ancestor
101706217|NCT00869778|Immunologic Factors|immunologic factors|mesh-ancestor
101706218|NCT00869778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410572|NCT00113984|Ipilimumab|ipilimumab|mesh-list
101706220|NCT04159610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101706221|NCT04159610|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101706222|NCT04159610|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101706223|NCT04159610|Cholinergic Agents|cholinergic agents|mesh-ancestor
101706224|NCT04159610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101706225|NCT04159610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706226|NCT04159610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706227|NCT04162028|Ketamine|ketamine|mesh-list
101706228|NCT04162028|Analgesics|analgesics|mesh-ancestor
101706229|NCT04162028|Sensory System Agents|sensory system agents|mesh-ancestor
101706230|NCT04162028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101706231|NCT04162028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706232|NCT04162028|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101706233|NCT04162028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101706234|NCT04162028|Anesthetics, General|anesthetics, general|mesh-ancestor
101706235|NCT04162028|Anesthetics|anesthetics|mesh-ancestor
101706236|NCT04162028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101232654|NCT04424511|Azithromycin|azithromycin|mesh-list
101706238|NCT04162028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101706239|NCT04162028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101706240|NCT04162028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706241|NCT00656786|Vitamin K 3|vitamin k 3|mesh-list
101706242|NCT00656786|Vitamin K|vitamin k|mesh-list
101706243|NCT00656786|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101232728|NCT04182672|Hormones|hormones|mesh-ancestor
101706244|NCT00656786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101706245|NCT00656786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706247|NCT00656786|Coagulants|coagulants|mesh-ancestor
101706248|NCT00656786|Vitamins|vitamins|mesh-ancestor
101706249|NCT00656786|Micronutrients|micronutrients|mesh-ancestor
101706250|NCT00656786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706251|NCT01008631|Sodium thiosulfate|sodium thiosulfate|mesh-list
101706252|NCT01008631|Antidotes|antidotes|mesh-ancestor
101706253|NCT01008631|Protective Agents|protective agents|mesh-ancestor
101706254|NCT01008631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706255|NCT01008631|Antioxidants|antioxidants|mesh-ancestor
101706256|NCT01008631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706257|NCT01008631|Antitubercular Agents|antitubercular agents|mesh-ancestor
101706258|NCT01008631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101706259|NCT01008631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101706261|NCT01008631|Sequestering Agents|sequestering agents|mesh-ancestor
101706262|NCT00734890|Bevacizumab|bevacizumab|mesh-list
101706263|NCT00734890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101232860|NCT03104374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101706265|NCT00734890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101706266|NCT00734890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101706267|NCT00734890|Growth Substances|growth substances|mesh-ancestor
101706268|NCT00734890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232925|NCT02658487|Cytarabine|cytarabine|mesh-list
101706269|NCT00734890|Growth Inhibitors|growth inhibitors|mesh-ancestor
101706270|NCT05325190|Granisetron|granisetron|mesh-list
101706271|NCT05325190|Antiemetics|antiemetics|mesh-ancestor
101706272|NCT05325190|Autonomic Agents|autonomic agents|mesh-ancestor
101706273|NCT05325190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101706274|NCT05325190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706275|NCT05325190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101706276|NCT05325190|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101706277|NCT05325190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101706278|NCT05325190|Serotonin Agents|serotonin agents|mesh-ancestor
101706279|NCT05325190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101706280|NCT05325190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706281|NCT02624310|Droxidopa|droxidopa|mesh-list
101706282|NCT02624310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101535953|NCT00564512|Cyclophosphamide|cyclophosphamide|mesh-list
101706283|NCT02624310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101706284|NCT00612521|Adenosine|adenosine|mesh-list
101706285|NCT00612521|Analgesics|analgesics|mesh-ancestor
101706286|NCT00612521|Sensory System Agents|sensory system agents|mesh-ancestor
101233128|NCT01568645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101706287|NCT00612521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101706288|NCT00612521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706289|NCT00612521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101706290|NCT00612521|Vasodilator Agents|vasodilator agents|mesh-ancestor
101706291|NCT00612521|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101706292|NCT00612521|Purinergic Agonists|purinergic agonists|mesh-ancestor
101706293|NCT00612521|Purinergic Agents|purinergic agents|mesh-ancestor
101706294|NCT00612521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101706295|NCT00612521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233196|NCT01570569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101706296|NCT00735124|Gabapentin|gabapentin|mesh-list
101706297|NCT00735124|Analgesics|analgesics|mesh-ancestor
101706298|NCT00735124|Sensory System Agents|sensory system agents|mesh-ancestor
101706299|NCT00735124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101706300|NCT00735124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706301|NCT00735124|Anticonvulsants|anticonvulsants|mesh-ancestor
101706302|NCT00735124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101706303|NCT00735124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101706304|NCT00735124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101233303|NCT01571024|Leucovorin|leucovorin|mesh-list
101706305|NCT00735124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101706306|NCT00735124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101706307|NCT00735124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101706308|NCT00735124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101706309|NCT00735124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706310|NCT00735124|Antimanic Agents|antimanic agents|mesh-ancestor
101706311|NCT04131348|Botulinum Toxins|botulinum toxins|mesh-list
101706312|NCT04131348|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101706313|NCT04131348|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101706314|NCT04131348|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101233327|NCT01571037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706315|NCT04131348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101706316|NCT04131348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706317|NCT04131348|Cholinergic Agents|cholinergic agents|mesh-ancestor
101706318|NCT04131348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101706319|NCT04131348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706320|NCT04131348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101706321|NCT04131348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101706322|NCT04246541|Acetaminophen|acetaminophen|mesh-list
101706324|NCT04246541|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
101706325|NCT04246541|Oxycodone|oxycodone|mesh-list
101706326|NCT04246541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101706327|NCT04246541|Analgesics|analgesics|mesh-ancestor
101706328|NCT04246541|Sensory System Agents|sensory system agents|mesh-ancestor
101706329|NCT04246541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101262805|NCT01758978|Hydrocodone|hydrocodone|mesh-list
101706330|NCT04246541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706331|NCT04246541|Antipyretics|antipyretics|mesh-ancestor
101706332|NCT04246541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101706333|NCT04246541|Narcotics|narcotics|mesh-ancestor
101233390|NCT01571414|Antitubercular Agents|antitubercular agents|mesh-ancestor
101706334|NCT04246541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101706335|NCT04246541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101706336|NCT04246541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101706337|NCT04246541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101706338|NCT04246541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101706339|NCT04246541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101706340|NCT04246541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706341|NCT04902859|Clonidine|clonidine|mesh-list
101706342|NCT04902859|Analgesics|analgesics|mesh-ancestor
101706343|NCT04902859|Sensory System Agents|sensory system agents|mesh-ancestor
101706344|NCT04902859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101706345|NCT04902859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706346|NCT04902859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101706347|NCT04902859|Sympatholytics|sympatholytics|mesh-ancestor
101706348|NCT04902859|Autonomic Agents|autonomic agents|mesh-ancestor
101706349|NCT04902859|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101706350|NCT04902859|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101706351|NCT04902859|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101706352|NCT04902859|Adrenergic Agents|adrenergic agents|mesh-ancestor
101706353|NCT04902859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101706354|NCT04902859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706355|NCT05227313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101706356|NCT00711958|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101706357|NCT04180943|Bupivacaine|bupivacaine|mesh-list
101706358|NCT04180943|Anesthetics, Local|anesthetics, local|mesh-ancestor
101706359|NCT04180943|Anesthetics|anesthetics|mesh-ancestor
101706360|NCT04180943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101706361|NCT04180943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706362|NCT04180943|Sensory System Agents|sensory system agents|mesh-ancestor
101706363|NCT04180943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101706364|NCT05011357|Phenylephrine|phenylephrine|mesh-list
101706365|NCT05011357|Oxymetazoline|oxymetazoline|mesh-list
101706366|NCT05011357|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101706367|NCT05011357|Mydriatics|mydriatics|mesh-ancestor
101233575|NCT01572285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233576|NCT01572285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101233577|NCT01572285|Glucocorticoids|glucocorticoids|mesh-ancestor
101706368|NCT05011357|Autonomic Agents|autonomic agents|mesh-ancestor
101706369|NCT05011357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101706370|NCT05011357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233632|NCT01572454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706372|NCT05011357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101706373|NCT05011357|Nasal Decongestants|nasal decongestants|mesh-ancestor
101706374|NCT05011357|Respiratory System Agents|respiratory system agents|mesh-ancestor
101706375|NCT05011357|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101706376|NCT05011357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101706377|NCT05011357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101706378|NCT05011357|Adrenergic Agents|adrenergic agents|mesh-ancestor
101706379|NCT05011357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101706380|NCT05011357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706381|NCT05011357|Protective Agents|protective agents|mesh-ancestor
101706382|NCT00711880|Nabiximols|nabiximols|mesh-list
101706383|NCT00711880|Analgesics|analgesics|mesh-ancestor
101233633|NCT01572454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101706384|NCT00711880|Sensory System Agents|sensory system agents|mesh-ancestor
101706385|NCT00711880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101706386|NCT00711880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706387|NCT02693483|Povidone-Iodine|povidone-iodine|mesh-list
101706388|NCT02693483|Povidone|povidone|mesh-list
101706389|NCT02693483|Plasma Substitutes|plasma substitutes|mesh-ancestor
101706390|NCT02693483|Blood Substitutes|blood substitutes|mesh-ancestor
101706391|NCT02693483|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101706392|NCT02693483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101706393|NCT04873063|Beclomethasone|beclomethasone|mesh-list
101706394|NCT04873063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101706395|NCT04873063|Glucocorticoids|glucocorticoids|mesh-ancestor
101706396|NCT04873063|Hormones|hormones|mesh-ancestor
101706397|NCT04873063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101706398|NCT04873063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706399|NCT04873063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101706400|NCT04873063|Respiratory System Agents|respiratory system agents|mesh-ancestor
101706401|NCT00739414|Panobinostat|panobinostat|mesh-list
101706402|NCT00739414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101233690|NCT01572623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101233742|NCT01573013|Iron|iron|mesh-list
101706403|NCT00739414|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101706404|NCT00739414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101706405|NCT00739414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706407|NCT00612599|Biphasic Insulins|biphasic insulins|mesh-list
101706408|NCT00612599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101706409|NCT00612599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706411|NCT00735280|Calcium heparin|calcium heparin|mesh-list
101706412|NCT00735280|Anticoagulants|anticoagulants|mesh-ancestor
101233744|NCT01573013|Micronutrients|micronutrients|mesh-ancestor
101706413|NCT00735280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101706414|NCT00735280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101706415|NCT00735280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706416|NCT00612989|Temozolomide|temozolomide|mesh-list
101706417|NCT00612989|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
101706418|NCT00612989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101706419|NCT00612989|Alkylating Agents|alkylating agents|mesh-ancestor
101706420|NCT00612989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233807|NCT01573637|Hormone Antagonists|hormone antagonists|mesh-ancestor
101706421|NCT00612989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101706422|NCT00612989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101706423|NCT04929067|Immunomodulating Agents|immunomodulating agents|mesh-list
101706424|NCT04929067|Immunologic Factors|immunologic factors|mesh-ancestor
101706425|NCT04929067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706426|NCT05215405|Venetoclax|venetoclax|mesh-list
101706427|NCT05215405|Navitoclax|navitoclax|mesh-list
101706428|NCT05215405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101706429|NCT00613067|Escitalopram|escitalopram|mesh-list
101706430|NCT00613067|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101706431|NCT00613067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101233871|NCT01574027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101706432|NCT00613067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101706433|NCT00613067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706434|NCT00613067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101706435|NCT00613067|Serotonin Agents|serotonin agents|mesh-ancestor
101706436|NCT00613067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706437|NCT04649489|Bevacizumab|bevacizumab|mesh-list
101706438|NCT04649489|Atezolizumab|atezolizumab|mesh-list
101706439|NCT04649489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101233936|NCT01575158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101706440|NCT04649489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101706441|NCT04649489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101706442|NCT04649489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101706443|NCT04649489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101706444|NCT04649489|Growth Substances|growth substances|mesh-ancestor
101706445|NCT04649489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706447|NCT04649489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101706448|NCT04649489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706449|NCT04649489|Immunologic Factors|immunologic factors|mesh-ancestor
101706450|NCT00613145|Capecitabine|capecitabine|mesh-list
101706452|NCT00613145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101706453|NCT00613145|Antimetabolites|antimetabolites|mesh-ancestor
101706454|NCT00613145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363901|NCT00047255|Carboplatin|carboplatin|mesh-list
101706455|NCT00613145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101706456|NCT00613145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101234073|NCT01576263|Anesthetics, Local|anesthetics, local|mesh-ancestor
101234074|NCT01576263|Anesthetics|anesthetics|mesh-ancestor
101706457|NCT00613145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101706458|NCT04570085|Caffeine|caffeine|mesh-list
101706459|NCT04570085|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101706460|NCT04570085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706461|NCT04570085|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101706462|NCT04570085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101706463|NCT04570085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706464|NCT04570085|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101706465|NCT04570085|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101706466|NCT04570085|Purinergic Agents|purinergic agents|mesh-ancestor
101706467|NCT04570085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101706468|NCT00529399|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101706469|NCT00529399|Aluminum sulfate|aluminum sulfate|mesh-list
101706470|NCT00529399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101706471|NCT00529399|Immunologic Factors|immunologic factors|mesh-ancestor
101706472|NCT00529399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706473|NCT00529399|Antacids|antacids|mesh-ancestor
101706474|NCT00529399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706475|NCT00529399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101706476|NCT05268419|Ethanol|ethanol|mesh-list
101706477|NCT05268419|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101706478|NCT05268419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101706479|NCT05268419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101706480|NCT05268419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706481|NCT00852969|Niacin|niacin|mesh-list
101706482|NCT00852969|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101706483|NCT00852969|Antimetabolites|antimetabolites|mesh-ancestor
101706484|NCT00852969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234202|NCT01577121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101234203|NCT01577121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101234204|NCT01577121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706485|NCT00852969|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101706486|NCT00852969|Vasodilator Agents|vasodilator agents|mesh-ancestor
101706487|NCT00852969|Vitamin B Complex|vitamin b complex|mesh-ancestor
101706488|NCT00852969|Vitamins|vitamins|mesh-ancestor
101706489|NCT00852969|Micronutrients|micronutrients|mesh-ancestor
101706490|NCT00852969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706491|NCT00613457|Cytarabine|cytarabine|mesh-list
101706492|NCT00613457|Dexamethasone|dexamethasone|mesh-list
101706494|NCT00613457|Cyclophosphamide|cyclophosphamide|mesh-list
101706495|NCT00613457|Ifosfamide|ifosfamide|mesh-list
101706496|NCT00613457|Doxorubicin|doxorubicin|mesh-list
101706497|NCT00613457|Methotrexate|methotrexate|mesh-list
101706498|NCT00613457|Etoposide|etoposide|mesh-list
101706500|NCT00613457|Daunorubicin|daunorubicin|mesh-list
101706501|NCT00613457|Asparaginase|asparaginase|mesh-list
101706502|NCT00613457|Mercaptopurine|mercaptopurine|mesh-list
101706503|NCT00613457|Thioguanine|thioguanine|mesh-list
101706504|NCT00613457|Vindesine|vindesine|mesh-list
101706505|NCT00613457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101706506|NCT00613457|Immunologic Factors|immunologic factors|mesh-ancestor
101706507|NCT00613457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706508|NCT00613457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101706509|NCT00613457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101706510|NCT00613457|Alkylating Agents|alkylating agents|mesh-ancestor
101706511|NCT00613457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706512|NCT00613457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101706513|NCT00613457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101706514|NCT00613457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101706515|NCT00613457|Antiemetics|antiemetics|mesh-ancestor
101706516|NCT00613457|Autonomic Agents|autonomic agents|mesh-ancestor
101706517|NCT00613457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101706518|NCT00613457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101706519|NCT00613457|Glucocorticoids|glucocorticoids|mesh-ancestor
101706520|NCT00613457|Hormones|hormones|mesh-ancestor
101706521|NCT00613457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101706522|NCT00613457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101706523|NCT00613457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101706524|NCT00613457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101706525|NCT00613457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101706526|NCT00613457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101706527|NCT00613457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101706528|NCT00613457|Abortifacient Agents|abortifacient agents|mesh-ancestor
101706529|NCT00613457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101706530|NCT00613457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101706531|NCT00613457|Antimetabolites|antimetabolites|mesh-ancestor
101706532|NCT00613457|Dermatologic Agents|dermatologic agents|mesh-ancestor
101706534|NCT00613457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101706535|NCT00613457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101706536|NCT00613457|Antiviral Agents|antiviral agents|mesh-ancestor
101706537|NCT00613457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101706538|NCT00613457|Tubulin Modulators|tubulin modulators|mesh-ancestor
101706539|NCT00613457|Antimitotic Agents|antimitotic agents|mesh-ancestor
101706540|NCT00613457|Mitosis Modulators|mitosis modulators|mesh-ancestor
101706541|NCT04131582|Metformin|metformin|mesh-list
101706542|NCT04131582|Empagliflozin|empagliflozin|mesh-list
101706544|NCT04131582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101706545|NCT04131582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706546|NCT04131582|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101706547|NCT04131582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706548|NCT04131582|Incretins|incretins|mesh-ancestor
101706549|NCT04131582|Hormones|hormones|mesh-ancestor
101706550|NCT04131582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101706551|NCT04131582|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101706552|NCT04131582|Protease Inhibitors|protease inhibitors|mesh-ancestor
101706553|NCT04131582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101706554|NCT00521365|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101706555|NCT00521365|Antidepressive Agents|antidepressive agents|mesh-ancestor
101706556|NCT00521365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101706557|NCT00521365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101706558|NCT00521365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101706559|NCT00521365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101706560|NCT00521365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706561|NCT00695994|Carboplatin|carboplatin|mesh-list
101706562|NCT00695994|Gemcitabine|gemcitabine|mesh-list
101706563|NCT00695994|Docetaxel|docetaxel|mesh-list
101706564|NCT00695994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101706565|NCT00695994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101706566|NCT00695994|Antimetabolites|antimetabolites|mesh-ancestor
101706567|NCT00695994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234790|NCT01581476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101706568|NCT00695994|Tubulin Modulators|tubulin modulators|mesh-ancestor
101706569|NCT00695994|Antimitotic Agents|antimitotic agents|mesh-ancestor
101706570|NCT00695994|Mitosis Modulators|mitosis modulators|mesh-ancestor
101706571|NCT00711802|Daptomycin|daptomycin|mesh-list
101706572|NCT00711802|Cloxacillin|cloxacillin|mesh-list
101706573|NCT00711802|Oxacillin|oxacillin|mesh-list
101706574|NCT00711802|Nafcillin|nafcillin|mesh-list
101706575|NCT00711802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101706576|NCT00711802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101706577|NCT00851877|Paclitaxel|paclitaxel|mesh-list
101706578|NCT00851877|Cetuximab|cetuximab|mesh-list
101706579|NCT00851877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101706580|NCT00851877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101706581|NCT00851877|Tubulin Modulators|tubulin modulators|mesh-ancestor
101706582|NCT00851877|Antimitotic Agents|antimitotic agents|mesh-ancestor
101706583|NCT00851877|Mitosis Modulators|mitosis modulators|mesh-ancestor
101706584|NCT00851877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706585|NCT00851877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101706586|NCT00613223|Etoposide|etoposide|mesh-list
101706587|NCT00613223|Etoposide phosphate|etoposide phosphate|mesh-list
101706588|NCT00613223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101706589|NCT00613223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101706590|NCT00613223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101234988|NCT01590199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101234989|NCT01590199|Immunologic Factors|immunologic factors|mesh-ancestor
101706591|NCT00613223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101706592|NCT00613223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101706593|NCT00613223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706595|NCT00882908|Simeprevir|simeprevir|mesh-list
101706596|NCT00882908|Antimetabolites|antimetabolites|mesh-ancestor
101706597|NCT00882908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706598|NCT00882908|Antiviral Agents|antiviral agents|mesh-ancestor
101706599|NCT00882908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101706600|NCT00882908|Protease Inhibitors|protease inhibitors|mesh-ancestor
101706601|NCT00882908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101235054|NCT01590732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101706603|NCT03580967|Antidepressive Agents|antidepressive agents|mesh-ancestor
101706604|NCT03580967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101706605|NCT03580967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101706606|NCT03580967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101706607|NCT03580967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101706608|NCT03580967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706609|NCT03580967|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101706610|NCT03580967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101235119|NCT01591070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101706611|NCT03580967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101706612|NCT03580967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706613|NCT03580967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101706614|NCT03580967|Serotonin Agents|serotonin agents|mesh-ancestor
101706615|NCT03580967|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101706616|NCT03580967|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101706617|NCT03580967|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101706618|NCT03580967|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101235185|NCT01591551|Immunologic Factors|immunologic factors|mesh-ancestor
101706619|NCT00851799|Ritonavir|ritonavir|mesh-list
101706620|NCT00851799|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101706621|NCT00851799|Darunavir|darunavir|mesh-list
101706622|NCT00851799|Tenofovir|tenofovir|mesh-list
101706623|NCT00851799|Emtricitabine|emtricitabine|mesh-list
101706624|NCT00851799|Raltegravir Potassium|raltegravir potassium|mesh-list
101706625|NCT00851799|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101706626|NCT00851799|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101706627|NCT00851799|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101706628|NCT00851799|Protease Inhibitors|protease inhibitors|mesh-ancestor
101706629|NCT00851799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101706630|NCT00851799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706631|NCT00851799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101706632|NCT00851799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101706634|NCT00851799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101706635|NCT00851799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101706636|NCT00851799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101706637|NCT00851799|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101706638|NCT00851799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101706639|NCT00851799|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101706640|NCT00851799|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101235318|NCT01592201|Dopamine Agonists|dopamine agonists|mesh-ancestor
101706641|NCT00853047|Octreotide|octreotide|mesh-list
101706642|NCT00853047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101706643|NCT00853047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101706644|NCT00853047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101706645|NCT04117191|Tryptophan|tryptophan|mesh-list
101706646|NCT04117191|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101706647|NCT04117191|Antidepressive Agents|antidepressive agents|mesh-ancestor
101706648|NCT04117191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101706649|NCT00520975|Paclitaxel|paclitaxel|mesh-list
101706650|NCT00520975|Bevacizumab|bevacizumab|mesh-list
101706651|NCT00520975|Carboplatin|carboplatin|mesh-list
101235382|NCT01592526|Nicotine|nicotine|mesh-list
101706653|NCT00520975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101706654|NCT00520975|Antibodies|antibodies|mesh-list
101706655|NCT00520975|Immunoglobulins|immunoglobulins|mesh-list
101706656|NCT00520975|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101706657|NCT00520975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101706658|NCT00520975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101706659|NCT00520975|Tubulin Modulators|tubulin modulators|mesh-ancestor
101706660|NCT00520975|Antimitotic Agents|antimitotic agents|mesh-ancestor
101706661|NCT00520975|Mitosis Modulators|mitosis modulators|mesh-ancestor
101706662|NCT00520975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706663|NCT00520975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101706664|NCT00520975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101706665|NCT00520975|Growth Substances|growth substances|mesh-ancestor
101706666|NCT00520975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706667|NCT00520975|Growth Inhibitors|growth inhibitors|mesh-ancestor
101706668|NCT00520975|Immunologic Factors|immunologic factors|mesh-ancestor
101706669|NCT00614159|Ketamine|ketamine|mesh-list
101706670|NCT00614159|Propofol|propofol|mesh-list
101706671|NCT00614159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101706672|NCT00614159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101706673|NCT00614159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706674|NCT00614159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101706675|NCT00614159|Anesthetics, General|anesthetics, general|mesh-ancestor
101706676|NCT00614159|Anesthetics|anesthetics|mesh-ancestor
101706677|NCT00614159|Analgesics|analgesics|mesh-ancestor
101706679|NCT00614159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101706680|NCT00614159|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101706681|NCT00614159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101706682|NCT00614159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101706683|NCT00614159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101706684|NCT00614159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706686|NCT05042531|Dasatinib|dasatinib|mesh-list
101706687|NCT05042531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101706688|NCT05042531|Antimetabolites|antimetabolites|mesh-ancestor
101706689|NCT05042531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706690|NCT05042531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101235648|NCT01594060|Insulin|insulin|mesh-list
101235654|NCT01594099|Paclitaxel|paclitaxel|mesh-list
101706691|NCT05042531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101706692|NCT05042531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101706693|NCT00851721|Factor VIII|factor viii|mesh-list
101706694|NCT00851721|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
101706695|NCT00851721|Coagulants|coagulants|mesh-ancestor
101706697|NCT04071119|Oxytocics|oxytocics|mesh-ancestor
101706698|NCT04071119|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101235711|NCT01594268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706699|NCT04071119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706701|NCT02634476|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101706702|NCT02634476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101706703|NCT02634476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101706704|NCT02634476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706705|NCT04385303|Lorecivivint|lorecivivint|mesh-list
101706706|NCT04385303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101706707|NCT00654602|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101235779|NCT01594866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101706708|NCT00654602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101706709|NCT00654602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101706710|NCT00654602|Antimetabolites|antimetabolites|mesh-ancestor
101706711|NCT00654602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706712|NCT00654602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101235782|NCT01594866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101706713|NCT00654602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101706714|NCT00654602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101706716|NCT00740194|Estrogens|estrogens|mesh-ancestor
101706717|NCT00740194|Hormones|hormones|mesh-ancestor
101706718|NCT00740194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101706719|NCT00740194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706720|NCT04159142|Paclitaxel|paclitaxel|mesh-list
101706721|NCT04159142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101706722|NCT04159142|Carboplatin|carboplatin|mesh-list
101706723|NCT04159142|Capecitabine|capecitabine|mesh-list
101706724|NCT04159142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101706725|NCT04159142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101706726|NCT04159142|Tubulin Modulators|tubulin modulators|mesh-ancestor
101706727|NCT04159142|Antimitotic Agents|antimitotic agents|mesh-ancestor
101235921|NCT01595737|Simendan|simendan|mesh-list
101706728|NCT04159142|Mitosis Modulators|mitosis modulators|mesh-ancestor
101706729|NCT04159142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706730|NCT04159142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101706731|NCT04159142|Antimetabolites|antimetabolites|mesh-ancestor
101706732|NCT00654680|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101706733|NCT00654680|Vasodilator Agents|vasodilator agents|mesh-ancestor
101706734|NCT00654680|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101706735|NCT00654680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101706736|NCT00654680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101235975|NCT01595893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706737|NCT00654680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706738|NCT00654680|Urological Agents|urological agents|mesh-ancestor
101706739|NCT00520741|Lacosamide|lacosamide|mesh-list
101706740|NCT00520741|Anticonvulsants|anticonvulsants|mesh-ancestor
101706741|NCT00520741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101706742|NCT00520741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101706743|NCT00520741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101706744|NCT00520741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706745|NCT03682289|Durvalumab|durvalumab|mesh-list
101706746|NCT03682289|Olaparib|olaparib|mesh-list
101706747|NCT03682289|Adenosine|adenosine|mesh-list
101706748|NCT03682289|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101706749|NCT03682289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101706750|NCT03682289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101706751|NCT03682289|Immunologic Factors|immunologic factors|mesh-ancestor
101706752|NCT03682289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706753|NCT03682289|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101706754|NCT03682289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101706755|NCT03682289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706756|NCT03682289|Analgesics|analgesics|mesh-ancestor
101535974|NCT00190983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101706757|NCT03682289|Sensory System Agents|sensory system agents|mesh-ancestor
101706758|NCT03682289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101706759|NCT03682289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101706760|NCT03682289|Vasodilator Agents|vasodilator agents|mesh-ancestor
101236175|NCT01596660|Bupivacaine|bupivacaine|mesh-list
101706761|NCT03682289|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101706762|NCT03682289|Purinergic Agonists|purinergic agonists|mesh-ancestor
101706763|NCT03682289|Purinergic Agents|purinergic agents|mesh-ancestor
101706764|NCT03682289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101706765|NCT00729118|Lenalidomide|lenalidomide|mesh-list
101706766|NCT00729118|Vorinostat|vorinostat|mesh-list
101706767|NCT00729118|Immunologic Factors|immunologic factors|mesh-ancestor
101706768|NCT00729118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706769|NCT00729118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101236248|NCT01596868|Docetaxel|docetaxel|mesh-list
101236251|NCT01596868|Antimetabolites|antimetabolites|mesh-ancestor
101706770|NCT00729118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101706771|NCT00729118|Growth Substances|growth substances|mesh-ancestor
101706772|NCT00729118|Growth Inhibitors|growth inhibitors|mesh-ancestor
101706773|NCT00729118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101706774|NCT00729118|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101706775|NCT00729118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101236316|NCT01597167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101706776|NCT00729118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706777|NCT04064632|Darunavir|darunavir|mesh-list
101706778|NCT04064632|Cobicistat|cobicistat|mesh-list
101706779|NCT04064632|Rilpivirine|rilpivirine|mesh-list
101706780|NCT04064632|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
101706781|NCT04064632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101706782|NCT04064632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101706783|NCT04064632|Protease Inhibitors|protease inhibitors|mesh-ancestor
101706784|NCT04064632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101706785|NCT04064632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706786|NCT04064632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101706787|NCT04064632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101706788|NCT04064632|Antiviral Agents|antiviral agents|mesh-ancestor
101706789|NCT04064632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101236455|NCT01597765|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101706790|NCT04064632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101706791|NCT04064632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101706792|NCT04064632|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101706793|NCT04064632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101706794|NCT00882518|Chlorpromazine|chlorpromazine|mesh-list
101706795|NCT00882518|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101706796|NCT00882518|Antidepressive Agents|antidepressive agents|mesh-ancestor
101706797|NCT00882518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101706798|NCT00882518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101706799|NCT00882518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101706800|NCT00882518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101706801|NCT00882518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706802|NCT00882518|Antiemetics|antiemetics|mesh-ancestor
101706803|NCT00882518|Autonomic Agents|autonomic agents|mesh-ancestor
101706804|NCT00882518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101706805|NCT00882518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101706806|NCT00882518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101706807|NCT00882518|Dopamine Agents|dopamine agents|mesh-ancestor
101706808|NCT00882518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101706809|NCT00882518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706810|NCT00882362|Aripiprazole|aripiprazole|mesh-list
101706811|NCT00882362|Antidepressive Agents|antidepressive agents|mesh-ancestor
101706812|NCT00882362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101706813|NCT00882362|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101706814|NCT00882362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101706815|NCT00882362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101706816|NCT00882362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706817|NCT00882362|Dopamine Agonists|dopamine agonists|mesh-ancestor
101706818|NCT00882362|Dopamine Agents|dopamine agents|mesh-ancestor
101706819|NCT00882362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101706820|NCT00882362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706821|NCT00882362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101706822|NCT00882362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101706823|NCT00882362|Serotonin Agents|serotonin agents|mesh-ancestor
101706824|NCT00882362|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101706825|NCT00882362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101706826|NCT00882362|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101706827|NCT00882362|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101706828|NCT00529243|Raltegravir Potassium|raltegravir potassium|mesh-list
101706829|NCT00529243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101706830|NCT00529243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101706831|NCT00529243|Antiviral Agents|antiviral agents|mesh-ancestor
101706832|NCT00529243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101706833|NCT00529243|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101706834|NCT00529243|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101706835|NCT00529243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101706836|NCT00529243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706837|NCT00636935|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101706838|NCT00636935|Clindamycin|clindamycin|mesh-list
101706839|NCT00636935|Clindamycin palmitate|clindamycin palmitate|mesh-list
101706840|NCT00636935|Clindamycin phosphate|clindamycin phosphate|mesh-list
101706842|NCT00636935|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101706843|NCT00636935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101706844|NCT00636935|Primaquine|primaquine|mesh-list
101706845|NCT00636935|Trimethoprim|trimethoprim|mesh-list
101236724|NCT01599338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101706846|NCT00636935|Atovaquone|atovaquone|mesh-list
101706847|NCT00636935|Pentamidine|pentamidine|mesh-list
101706848|NCT00636935|Prednisone|prednisone|mesh-list
101706849|NCT00636935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101706850|NCT00636935|Glucocorticoids|glucocorticoids|mesh-ancestor
101706851|NCT00636935|Hormones|hormones|mesh-ancestor
101706852|NCT00636935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101236777|NCT05690321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101706853|NCT00636935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706854|NCT00636935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101706855|NCT00636935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101706856|NCT00636935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101192562|NCT01271166|Leucovorin|leucovorin|mesh-list
101706857|NCT00636935|Antitubercular Agents|antitubercular agents|mesh-ancestor
101706858|NCT00636935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101706859|NCT00636935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101706860|NCT00636935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706861|NCT00636935|Antimalarials|antimalarials|mesh-ancestor
101236845|NCT05689619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706862|NCT00636935|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101706863|NCT00636935|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101706864|NCT00636935|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101706865|NCT00636935|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101706866|NCT00636935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101706867|NCT00636935|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101236909|NCT05473195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101236910|NCT05473195|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101236911|NCT05473195|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101236912|NCT05473195|Antimetabolites|antimetabolites|mesh-ancestor
101236913|NCT05473195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236914|NCT05473195|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101236921|NCT05422053|Insulin|insulin|mesh-list
101236922|NCT05422053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101236923|NCT05422053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236924|NCT05344911|Remifentanil|remifentanil|mesh-list
101236925|NCT05344911|Alfentanil|alfentanil|mesh-list
101706868|NCT00636935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101706869|NCT00636935|Leprostatic Agents|leprostatic agents|mesh-ancestor
101706870|NCT00636935|Antifungal Agents|antifungal agents|mesh-ancestor
101706871|NCT00636935|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101706872|NCT00654758|Paclitaxel|paclitaxel|mesh-list
101706873|NCT00654758|Carboplatin|carboplatin|mesh-list
101706874|NCT00654758|Volociximab|volociximab|mesh-list
101706875|NCT00654758|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101706876|NCT00654758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101706877|NCT00654758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101706878|NCT00654758|Tubulin Modulators|tubulin modulators|mesh-ancestor
101706879|NCT00654758|Antimitotic Agents|antimitotic agents|mesh-ancestor
101706880|NCT00654758|Mitosis Modulators|mitosis modulators|mesh-ancestor
101706881|NCT00654758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706882|NCT00654758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101706883|NCT00654758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101706884|NCT00654758|Growth Substances|growth substances|mesh-ancestor
101706885|NCT00654758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706886|NCT00654758|Growth Inhibitors|growth inhibitors|mesh-ancestor
101706887|NCT00654758|Immunologic Factors|immunologic factors|mesh-ancestor
101706888|NCT00656864|Pioglitazone|pioglitazone|mesh-list
101706889|NCT00656864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101706890|NCT00656864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706891|NCT00658268|Clodronic Acid|clodronic acid|mesh-list
101706892|NCT00658268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101706893|NCT00658268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706894|NCT00613613|Fenofibrate|fenofibrate|mesh-list
101706895|NCT00613613|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101706896|NCT00613613|Antimetabolites|antimetabolites|mesh-ancestor
101706897|NCT00613613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706898|NCT00613613|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101706899|NCT04298099|Ropivacaine|ropivacaine|mesh-list
101706900|NCT04298099|Anesthetics, Local|anesthetics, local|mesh-ancestor
101706901|NCT04298099|Anesthetics|anesthetics|mesh-ancestor
101706902|NCT04298099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101706903|NCT04298099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706904|NCT04298099|Sensory System Agents|sensory system agents|mesh-ancestor
101706905|NCT04298099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101706906|NCT02613195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101706907|NCT00850395|Maraviroc|maraviroc|mesh-list
101706908|NCT00850395|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101706909|NCT00850395|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101706910|NCT00850395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706911|NCT00850395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101706912|NCT00850395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101706913|NCT00850395|Antiviral Agents|antiviral agents|mesh-ancestor
101706914|NCT00850395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101706915|NCT00850395|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101706916|NCT04188431|Dexamethasone|dexamethasone|mesh-list
101706917|NCT04188431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101706918|NCT04188431|Antiemetics|antiemetics|mesh-ancestor
101706919|NCT04188431|Autonomic Agents|autonomic agents|mesh-ancestor
101706920|NCT04188431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101706921|NCT04188431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706922|NCT04188431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101706923|NCT04188431|Glucocorticoids|glucocorticoids|mesh-ancestor
101706924|NCT04188431|Hormones|hormones|mesh-ancestor
101706925|NCT04188431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101706926|NCT04188431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101237090|NCT04689945|Narcotics|narcotics|mesh-ancestor
101706927|NCT04188431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101706928|NCT03630809|Vaccines|vaccines|mesh-list
101706929|NCT03630809|Immunologic Factors|immunologic factors|mesh-ancestor
101706930|NCT03630809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706931|NCT00577720|Risedronic Acid|risedronic acid|mesh-list
101706932|NCT00577720|Etidronic Acid|etidronic acid|mesh-list
101706933|NCT00577720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101706934|NCT00577720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101706935|NCT00577720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706936|NCT00577720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101706937|NCT00577720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706938|NCT00577720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101706940|NCT00736294|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101706941|NCT00736294|Protease Inhibitors|protease inhibitors|mesh-ancestor
101706942|NCT00736294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101706943|NCT00736294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706944|NCT00736294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101706945|NCT00512707|Sildenafil Citrate|sildenafil citrate|mesh-list
101706946|NCT00512707|Testosterone|testosterone|mesh-list
101706947|NCT00512707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706948|NCT00512707|Androgens|androgens|mesh-ancestor
101706949|NCT00512707|Hormones|hormones|mesh-ancestor
101706950|NCT00512707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101706951|NCT00512707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706952|NCT00512707|Vasodilator Agents|vasodilator agents|mesh-ancestor
101237153|NCT04456296|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101237155|NCT04456296|Hormones|hormones|mesh-ancestor
101706953|NCT00512707|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101706954|NCT00512707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101706955|NCT00512707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101706956|NCT00512707|Urological Agents|urological agents|mesh-ancestor
101706957|NCT00729274|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101706958|NCT03471767|Dextromethorphan|dextromethorphan|mesh-list
101706959|NCT03471767|Bupropion|bupropion|mesh-list
101706960|NCT03471767|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101706961|NCT03471767|Antidepressive Agents|antidepressive agents|mesh-ancestor
101706962|NCT03471767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101706963|NCT03471767|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101706964|NCT03471767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101706965|NCT03471767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101706966|NCT03471767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706967|NCT03471767|Dopamine Agents|dopamine agents|mesh-ancestor
101706968|NCT03471767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101706969|NCT03471767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237200|NCT04182334|Antioxidants|antioxidants|mesh-ancestor
101237201|NCT04182334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706970|NCT03471767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101706971|NCT03471767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101706972|NCT03471767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101706973|NCT03471767|Antitussive Agents|antitussive agents|mesh-ancestor
101706974|NCT03471767|Respiratory System Agents|respiratory system agents|mesh-ancestor
101706975|NCT03471767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101706976|NCT03471767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101706977|NCT00849693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101706979|NCT00849693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101706980|NCT00849693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101706981|NCT00849693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101706982|NCT00849693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101706983|NCT00849693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101706984|NCT00849693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101706985|NCT00849693|Analgesics|analgesics|mesh-ancestor
101706986|NCT00849693|Sensory System Agents|sensory system agents|mesh-ancestor
101706987|NCT00849693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101706989|NCT00849693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101706990|NCT00849693|Dopamine Agents|dopamine agents|mesh-ancestor
101706991|NCT00849693|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101706992|NCT00849693|Serotonin Agents|serotonin agents|mesh-ancestor
101706993|NCT00849693|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101706994|NCT00849693|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101706995|NCT00849693|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101706996|NCT00849693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101706997|NCT00736606|Simvastatin|simvastatin|mesh-list
101706998|NCT00736606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101706999|NCT00736606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101707000|NCT00736606|Antimetabolites|antimetabolites|mesh-ancestor
101707001|NCT00736606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707002|NCT00736606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101707003|NCT00736606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101707004|NCT00736606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101707005|NCT00527605|Dutasteride|dutasteride|mesh-list
101707006|NCT00527605|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101707007|NCT00527605|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101707008|NCT00527605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101707009|NCT00527605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707010|NCT00527605|Hormone Antagonists|hormone antagonists|mesh-ancestor
101707011|NCT00527605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101707012|NCT00527605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707014|NCT04865939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101707015|NCT04865939|Antimetabolites|antimetabolites|mesh-ancestor
101707016|NCT04865939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707017|NCT04865939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101707018|NCT00741052|Azithromycin|azithromycin|mesh-list
101707019|NCT00741052|Ciprofloxacin|ciprofloxacin|mesh-list
101707020|NCT00741052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101707021|NCT00741052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101707022|NCT00741052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101707023|NCT00741052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101707024|NCT00741052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101707025|NCT00741052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707026|NCT00741052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101707027|NCT00741052|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101707028|NCT00741052|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101707029|NCT04116411|Valganciclovir|valganciclovir|mesh-list
101707030|NCT04116411|Temozolomide|temozolomide|mesh-list
101707031|NCT04116411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101707032|NCT04116411|Alkylating Agents|alkylating agents|mesh-ancestor
101707033|NCT04116411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707034|NCT04116411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101707035|NCT04116411|Antiviral Agents|antiviral agents|mesh-ancestor
101707036|NCT04116411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101707037|NCT00706953|Doxorubicin|doxorubicin|mesh-list
101707038|NCT00706953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101707039|NCT00706953|Bortezomib|bortezomib|mesh-list
101237287|NCT03462251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101707040|NCT00706953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101707042|NCT00706953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101707043|NCT00706953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101707044|NCT00706953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101707045|NCT00706953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707046|NCT03462017|Sildenafil Citrate|sildenafil citrate|mesh-list
101707047|NCT03462017|Acetylcholine|acetylcholine|mesh-list
101707048|NCT03462017|Vasodilator Agents|vasodilator agents|mesh-ancestor
101707049|NCT03462017|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101707050|NCT03462017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101707051|NCT03462017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101237330|NCT03272334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101237335|NCT03258281|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101707052|NCT03462017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707054|NCT03462017|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101707055|NCT03462017|Cholinergic Agents|cholinergic agents|mesh-ancestor
101707056|NCT03462017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101707057|NCT03462017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707058|NCT00913419|Amitriptyline|amitriptyline|mesh-list
101707059|NCT00913419|Cyclobenzaprine|cyclobenzaprine|mesh-list
101707060|NCT00913419|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101707061|NCT00913419|Antidepressive Agents|antidepressive agents|mesh-ancestor
101707062|NCT00913419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101707063|NCT00913419|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101707064|NCT00913419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707065|NCT00913419|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101707066|NCT00913419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101707067|NCT00913419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101707068|NCT00913419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101707069|NCT00913419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101707070|NCT00913419|Analgesics|analgesics|mesh-ancestor
101707071|NCT00913419|Sensory System Agents|sensory system agents|mesh-ancestor
101707072|NCT00913419|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101707073|NCT00913419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101707074|NCT00913419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101707075|NCT00913419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707076|NCT00913419|Adrenergic Agents|adrenergic agents|mesh-ancestor
101707077|NCT00913419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101707078|NCT00711412|Capecitabine|capecitabine|mesh-list
101707079|NCT00711412|Oxaliplatin|oxaliplatin|mesh-list
101707080|NCT00711412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101707081|NCT00711412|Antimetabolites|antimetabolites|mesh-ancestor
101707082|NCT00711412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237401|NCT05703984|Metformin|metformin|mesh-list
101707083|NCT00711412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101707084|NCT01840007|Metformin|metformin|mesh-list
101707085|NCT01840007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101707086|NCT01840007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707087|NCT03746951|Ropivacaine|ropivacaine|mesh-list
101707088|NCT03746951|Anesthetics, Local|anesthetics, local|mesh-ancestor
101707089|NCT03746951|Anesthetics|anesthetics|mesh-ancestor
101707090|NCT03746951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101237434|NCT05645380|Carboplatin|carboplatin|mesh-list
101707091|NCT03746951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707092|NCT03746951|Sensory System Agents|sensory system agents|mesh-ancestor
101707093|NCT03746951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101707095|NCT00577408|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101707096|NCT00577408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101707097|NCT00577408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707098|NCT00577408|Sensory System Agents|sensory system agents|mesh-ancestor
101707099|NCT00577408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101707100|NCT03391193|Vaccines|vaccines|mesh-list
101707101|NCT03391193|Immunologic Factors|immunologic factors|mesh-ancestor
101707102|NCT03391193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707103|NCT00741364|Vitamin D|vitamin d|mesh-list
101707104|NCT00741364|Cholecalciferol|cholecalciferol|mesh-list
101707105|NCT00741364|Vitamins|vitamins|mesh-ancestor
101707106|NCT00741364|Micronutrients|micronutrients|mesh-ancestor
101707107|NCT00741364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707108|NCT00741364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101707109|NCT00741364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101707110|NCT03332303|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101707111|NCT03332303|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101707112|NCT03332303|Estradiol|estradiol|mesh-list
101707113|NCT03332303|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101707114|NCT03332303|Estrogens|estrogens|mesh-ancestor
101707115|NCT03332303|Hormones|hormones|mesh-ancestor
101707116|NCT03332303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101707117|NCT03332303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707118|NCT03332303|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101707119|NCT03332303|Contraceptive Agents|contraceptive agents|mesh-ancestor
101707120|NCT03332303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101707121|NCT03332303|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101707122|NCT00614471|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101707123|NCT00614471|Interferon-alpha|interferon-alpha|mesh-list
101707124|NCT00614471|Entecavir|entecavir|mesh-list
101237503|NCT05184803|Mitosis Modulators|mitosis modulators|mesh-ancestor
101237505|NCT05030506|Pembrolizumab|pembrolizumab|mesh-list
101707125|NCT00614471|Antiviral Agents|antiviral agents|mesh-ancestor
101707126|NCT00614471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101707127|NCT00614471|Immunologic Factors|immunologic factors|mesh-ancestor
101707128|NCT00614471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707129|NCT05742256|Sufentanil|sufentanil|mesh-list
101707130|NCT05742256|Oxycodone|oxycodone|mesh-list
101707131|NCT05742256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101707132|NCT05742256|Narcotics|narcotics|mesh-ancestor
101707133|NCT05742256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101707134|NCT05742256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707135|NCT05742256|Analgesics|analgesics|mesh-ancestor
101707136|NCT05742256|Sensory System Agents|sensory system agents|mesh-ancestor
101707137|NCT05742256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101707138|NCT05742256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101707139|NCT05742256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101707140|NCT05742256|Anesthetics, General|anesthetics, general|mesh-ancestor
101707141|NCT05742256|Anesthetics|anesthetics|mesh-ancestor
101707142|NCT00713596|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101707144|NCT00713596|Coagulants|coagulants|mesh-ancestor
101707145|NCT00729664|Atezolizumab|atezolizumab|mesh-list
101707146|NCT00729664|BMS-936559|bms-936559|mesh-list
101707147|NCT00729664|Antibodies|antibodies|mesh-list
101707148|NCT00729664|Immunoglobulins|immunoglobulins|mesh-list
101707149|NCT00729664|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101707150|NCT00729664|Immunologic Factors|immunologic factors|mesh-ancestor
101707151|NCT00729664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707152|NCT00729664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101707153|NCT00729664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707154|NCT00729664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101707155|NCT00729664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101707156|NCT04229615|Apatinib|apatinib|mesh-list
101707157|NCT04229615|Fluzoparib|fluzoparib|mesh-list
101707158|NCT04229615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101707159|NCT04229615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101237549|NCT04551885|Avelumab|avelumab|mesh-list
101707160|NCT04229615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101707161|NCT04229615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707162|NCT04229615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101707163|NCT00881894|Rotigotine|rotigotine|mesh-list
101707164|NCT00881894|Dopamine Agonists|dopamine agonists|mesh-ancestor
101707165|NCT00881894|Dopamine Agents|dopamine agents|mesh-ancestor
101707166|NCT00881894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101707167|NCT00881894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707168|NCT00881894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707169|NCT02638376|Riboflavin|riboflavin|mesh-list
101707170|NCT02638376|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101707171|NCT02638376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101707172|NCT02638376|Vitamin B Complex|vitamin b complex|mesh-ancestor
101707173|NCT02638376|Vitamins|vitamins|mesh-ancestor
101707174|NCT02638376|Micronutrients|micronutrients|mesh-ancestor
101707175|NCT02638376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707176|NCT02638376|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101707177|NCT02638376|Dermatologic Agents|dermatologic agents|mesh-ancestor
101707178|NCT00827931|Tranexamic Acid|tranexamic acid|mesh-list
101707179|NCT00827931|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101707180|NCT00827931|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101237587|NCT04166435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707181|NCT00827931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707182|NCT00827931|Hemostatics|hemostatics|mesh-ancestor
101707183|NCT00827931|Coagulants|coagulants|mesh-ancestor
101707184|NCT04158674|Simendan|simendan|mesh-list
101707185|NCT04158674|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101707186|NCT04158674|Vasodilator Agents|vasodilator agents|mesh-ancestor
101707187|NCT04158674|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101707188|NCT04158674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101707189|NCT04158674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101707190|NCT04158674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707191|NCT04158674|Protective Agents|protective agents|mesh-ancestor
101707192|NCT04158674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707193|NCT00526669|Capecitabine|capecitabine|mesh-list
101707194|NCT00526669|Lapatinib|lapatinib|mesh-list
101707195|NCT00526669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101707196|NCT00526669|Antimetabolites|antimetabolites|mesh-ancestor
101707197|NCT00526669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707198|NCT00526669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101707200|NCT00526669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101707201|NCT03640949|Methylprednisolone|methylprednisolone|mesh-list
101707202|NCT03640949|Vasopressins|vasopressins|mesh-list
101707203|NCT03640949|Arginine Vasopressin|arginine vasopressin|mesh-list
101364657|NCT02957851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101707204|NCT03640949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101707205|NCT03640949|Antiemetics|antiemetics|mesh-ancestor
101707206|NCT03640949|Autonomic Agents|autonomic agents|mesh-ancestor
101707207|NCT03640949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101707208|NCT03640949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707210|NCT03640949|Glucocorticoids|glucocorticoids|mesh-ancestor
101707211|NCT03640949|Hormones|hormones|mesh-ancestor
101707212|NCT03640949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101707213|NCT03640949|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101707214|NCT03640949|Protective Agents|protective agents|mesh-ancestor
101707215|NCT03640949|Hemostatics|hemostatics|mesh-ancestor
101707217|NCT03640949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101707218|NCT03640949|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101707219|NCT03640949|Natriuretic Agents|natriuretic agents|mesh-ancestor
101707220|NCT00827775|Carvedilol|carvedilol|mesh-list
101707221|NCT00827775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101707222|NCT00827775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101707223|NCT00827775|Adrenergic Agents|adrenergic agents|mesh-ancestor
101707224|NCT00827775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101707225|NCT00827775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707226|NCT00827775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707227|NCT00827775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101237757|NCT03476642|Mydriatics|mydriatics|mesh-ancestor
101237758|NCT03476642|Sympathomimetics|sympathomimetics|mesh-ancestor
101237759|NCT03476642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101237760|NCT03430700|Pembrolizumab|pembrolizumab|mesh-list
101237761|NCT03430700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101237762|NCT03430700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237763|NCT03430700|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101237764|NCT03430700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237775|NCT03171025|Nivolumab|nivolumab|mesh-list
101707228|NCT00827775|Antioxidants|antioxidants|mesh-ancestor
101707229|NCT00827775|Protective Agents|protective agents|mesh-ancestor
101707230|NCT00827775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101707231|NCT00827775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101707232|NCT00827775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101707233|NCT00827775|Vasodilator Agents|vasodilator agents|mesh-ancestor
101707234|NCT00827775|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101237821|NCT02965703|Sensory System Agents|sensory system agents|mesh-ancestor
101707236|NCT02544308|Dexamethasone|dexamethasone|mesh-list
101707237|NCT02544308|Lenalidomide|lenalidomide|mesh-list
101707238|NCT02544308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101707239|NCT02544308|Antiemetics|antiemetics|mesh-ancestor
101707240|NCT02544308|Autonomic Agents|autonomic agents|mesh-ancestor
101237892|NCT02229084|Paclitaxel|paclitaxel|mesh-list
101707241|NCT02544308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101707242|NCT02544308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707243|NCT02544308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101707244|NCT02544308|Glucocorticoids|glucocorticoids|mesh-ancestor
101707245|NCT02544308|Hormones|hormones|mesh-ancestor
101707246|NCT02544308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101707247|NCT02544308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101707248|NCT02544308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101707249|NCT02544308|Immunologic Factors|immunologic factors|mesh-ancestor
101707250|NCT02544308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101707251|NCT02544308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101707252|NCT02544308|Growth Substances|growth substances|mesh-ancestor
101237962|NCT01746173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101707253|NCT02544308|Growth Inhibitors|growth inhibitors|mesh-ancestor
101707254|NCT00707187|Tadalafil|tadalafil|mesh-list
101707255|NCT00707187|Vasodilator Agents|vasodilator agents|mesh-ancestor
101707256|NCT00707187|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101707257|NCT00707187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101707258|NCT00707187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101707259|NCT00707187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707260|NCT00707187|Urological Agents|urological agents|mesh-ancestor
101707261|NCT03998761|Progesterone|progesterone|mesh-list
101707262|NCT03998761|Dydrogesterone|dydrogesterone|mesh-list
101707263|NCT03998761|Progestins|progestins|mesh-ancestor
101707264|NCT03998761|Hormones|hormones|mesh-ancestor
101707265|NCT03998761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101707266|NCT03998761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707267|NCT00658580|Etoposide|etoposide|mesh-list
101707268|NCT00658580|Etoposide phosphate|etoposide phosphate|mesh-list
101707269|NCT00658580|Epirubicin|epirubicin|mesh-list
101707270|NCT00658580|Ifosfamide|ifosfamide|mesh-list
101707271|NCT00658580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101707272|NCT00658580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101707273|NCT00658580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101707274|NCT00658580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101707275|NCT00658580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101364735|NCT00405808|Rimonabant|rimonabant|mesh-list
101707276|NCT00658580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707277|NCT00658580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101707278|NCT00658580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101707279|NCT00658580|Alkylating Agents|alkylating agents|mesh-ancestor
101707280|NCT00729742|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101238090|NCT02876107|Mitosis Modulators|mitosis modulators|mesh-ancestor
101707281|NCT00729742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101707282|NCT00729742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101707283|NCT00729742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101707284|NCT00729742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707286|NCT03435107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101707287|NCT03435107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101707288|NCT03612791|Atezolizumab|atezolizumab|mesh-list
101707289|NCT03612791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101707290|NCT03612791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101707291|NCT03612791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707292|NCT03612791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101707293|NCT00827541|Tigecycline|tigecycline|mesh-list
101707294|NCT00827541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101707295|NCT00827541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101707296|NCT00827541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101707297|NCT00827541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101238145|NCT02727803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101707298|NCT00827541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707299|NCT03916601|Insulin|insulin|mesh-list
101707300|NCT03916601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101238206|NCT02491983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101707301|NCT03916601|Insulin Aspart|insulin aspart|mesh-list
101707302|NCT03916601|Insulin, Long-Acting|insulin, long-acting|mesh-list
101707303|NCT03916601|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101707304|NCT03916601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101707305|NCT03916601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707306|NCT00518323|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101707307|NCT00518323|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101238216|NCT02467478|Linagliptin|linagliptin|mesh-list
101707308|NCT00518323|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101707309|NCT00518323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101707311|NCT00518323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101707312|NCT00518323|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101707313|NCT00518323|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101707314|NCT00518323|Serotonin Agents|serotonin agents|mesh-ancestor
101707315|NCT00518323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101238265|NCT01953926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707316|NCT00518323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707317|NCT00518323|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101707318|NCT00518323|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101707319|NCT00518323|Dopamine Agents|dopamine agents|mesh-ancestor
101707320|NCT00707421|Fluorometholone|fluorometholone|mesh-list
101707322|NCT00707421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101707323|NCT00707421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101707324|NCT00707421|Analgesics|analgesics|mesh-ancestor
101707325|NCT00707421|Sensory System Agents|sensory system agents|mesh-ancestor
101238332|NCT01599884|Respiratory System Agents|respiratory system agents|mesh-ancestor
101707326|NCT00707421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101707327|NCT00707421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707328|NCT00707421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101707329|NCT00707421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101238400|NCT01602029|Antipruritics|antipruritics|mesh-ancestor
101707330|NCT00707421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101707331|NCT00707421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101707332|NCT00707421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707333|NCT00707421|Glucocorticoids|glucocorticoids|mesh-ancestor
101707334|NCT00707421|Hormones|hormones|mesh-ancestor
101707335|NCT00707421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101707336|NCT00707421|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101707337|NCT03570437|Paclitaxel|paclitaxel|mesh-list
101707338|NCT03570437|Olaparib|olaparib|mesh-list
101707339|NCT03570437|Cediranib|cediranib|mesh-list
101707340|NCT03570437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101707341|NCT03570437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101707342|NCT03570437|Tubulin Modulators|tubulin modulators|mesh-ancestor
101707343|NCT03570437|Antimitotic Agents|antimitotic agents|mesh-ancestor
101707344|NCT03570437|Mitosis Modulators|mitosis modulators|mesh-ancestor
101707345|NCT03570437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707346|NCT03570437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101707347|NCT03570437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101707348|NCT03570437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101707349|NCT00826449|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101707350|NCT00826449|Dasatinib|dasatinib|mesh-list
101707351|NCT00826449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101707352|NCT00826449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101707353|NCT00826449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101707354|NCT00826449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238603|NCT01610921|Vasodilator Agents|vasodilator agents|mesh-ancestor
101707356|NCT03632213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101707357|NCT03632213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101707358|NCT03632213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101707359|NCT03632213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101707360|NCT03632213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707362|NCT00825825|Escitalopram|escitalopram|mesh-list
101707363|NCT00825825|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101707364|NCT00825825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101707365|NCT00825825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101707366|NCT00825825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707367|NCT00825825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101707368|NCT00825825|Serotonin Agents|serotonin agents|mesh-ancestor
101238671|NCT01611324|Adrenergic Agents|adrenergic agents|mesh-ancestor
101238672|NCT01611324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101238673|NCT01611324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238674|NCT01611324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238675|NCT01611324|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101238676|NCT01611324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101238677|NCT01611324|Autonomic Agents|autonomic agents|mesh-ancestor
101707369|NCT00825825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707370|NCT00825825|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101707371|NCT00825825|Antidepressive Agents|antidepressive agents|mesh-ancestor
101707372|NCT00825825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101707373|NCT03802487|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
101707375|NCT03802487|Antidotes|antidotes|mesh-ancestor
101707376|NCT03802487|Protective Agents|protective agents|mesh-ancestor
101707377|NCT03802487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707378|NCT03802487|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101707379|NCT03802487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707380|NCT03802487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101707381|NCT00880334|Docetaxel|docetaxel|mesh-list
101707382|NCT00880334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101707383|NCT00880334|Tubulin Modulators|tubulin modulators|mesh-ancestor
101707384|NCT00880334|Antimitotic Agents|antimitotic agents|mesh-ancestor
101707385|NCT00880334|Mitosis Modulators|mitosis modulators|mesh-ancestor
101707386|NCT00880334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707387|NCT01033565|Melatonin|melatonin|mesh-list
101707388|NCT01033565|Antioxidants|antioxidants|mesh-ancestor
101707389|NCT01033565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707390|NCT01033565|Protective Agents|protective agents|mesh-ancestor
101707391|NCT01033565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707392|NCT01033565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101707393|NCT00658892|Antibodies|antibodies|mesh-list
101707394|NCT00658892|Immunologic Factors|immunologic factors|mesh-ancestor
101707395|NCT00658892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238792|NCT01612247|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101707396|NCT00654914|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101707397|NCT00654914|Vasodilator Agents|vasodilator agents|mesh-ancestor
101707398|NCT00654914|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101707399|NCT00654914|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101707400|NCT00654914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101707401|NCT00654914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707402|NCT00654914|Urological Agents|urological agents|mesh-ancestor
101707403|NCT00865566|Vaccines|vaccines|mesh-list
101238844|NCT01612403|Zinc Sulfate|zinc sulfate|mesh-list
101238845|NCT01612403|Astringents|astringents|mesh-ancestor
101707404|NCT00865566|Immunologic Factors|immunologic factors|mesh-ancestor
101707405|NCT00865566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707407|NCT00658970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101707408|NCT00658970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707409|NCT00659048|Ciclesonide|ciclesonide|mesh-list
101707410|NCT00659048|Glucocorticoids|glucocorticoids|mesh-ancestor
101707411|NCT00659048|Hormones|hormones|mesh-ancestor
101707412|NCT00659048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101707413|NCT00659048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707414|NCT00659048|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101707415|NCT02623920|Rituximab|rituximab|mesh-list
101707416|NCT02623920|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101707417|NCT02623920|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101707418|NCT02623920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101707419|NCT02623920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101707420|NCT02623920|Immunologic Factors|immunologic factors|mesh-ancestor
101707421|NCT02623920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707422|NCT02623920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101707423|NCT02623920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101707424|NCT02623920|Alkylating Agents|alkylating agents|mesh-ancestor
101707425|NCT02623920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707427|NCT02623920|Immunoconjugates|immunoconjugates|mesh-ancestor
101707428|NCT00525499|Androgens|androgens|mesh-list
101707429|NCT00525499|Hormones|hormones|mesh-ancestor
101707430|NCT00525499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101707431|NCT00525499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707432|NCT04576546|Inositol|inositol|mesh-list
101707433|NCT04576546|Vitamin B Complex|vitamin b complex|mesh-ancestor
101707434|NCT04576546|Vitamins|vitamins|mesh-ancestor
101707435|NCT04576546|Micronutrients|micronutrients|mesh-ancestor
101707436|NCT04576546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707437|NCT02617680|Nitric Oxide|nitric oxide|mesh-list
101707438|NCT02617680|Desflurane|desflurane|mesh-list
101707439|NCT02617680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101707440|NCT02617680|Autonomic Agents|autonomic agents|mesh-ancestor
101707441|NCT02617680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101239033|NCT01613755|Metformin|metformin|mesh-list
101707443|NCT02617680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101707444|NCT02617680|Respiratory System Agents|respiratory system agents|mesh-ancestor
101707445|NCT02617680|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101707446|NCT02617680|Antioxidants|antioxidants|mesh-ancestor
101707447|NCT02617680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707448|NCT02617680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101707449|NCT02617680|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101707450|NCT02617680|Vasodilator Agents|vasodilator agents|mesh-ancestor
101707451|NCT02617680|Gasotransmitters|gasotransmitters|mesh-ancestor
101707452|NCT02617680|Protective Agents|protective agents|mesh-ancestor
101707453|NCT02617680|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101707454|NCT02617680|Anesthetics, General|anesthetics, general|mesh-ancestor
101707456|NCT02617680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101707457|NCT02568280|Insulin|insulin|mesh-list
101707458|NCT02568280|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101707459|NCT02568280|Insulin Aspart|insulin aspart|mesh-list
101707460|NCT02568280|Insulin, Long-Acting|insulin, long-acting|mesh-list
101707461|NCT02568280|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101707462|NCT02568280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101707463|NCT02568280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707464|NCT00525265|Tolvaptan|tolvaptan|mesh-list
101707465|NCT00525265|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101707466|NCT00525265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707467|NCT00525265|Natriuretic Agents|natriuretic agents|mesh-ancestor
101707468|NCT00525265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707469|NCT04158830|Aspirin|aspirin|mesh-list
101707470|NCT04158830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101707471|NCT04158830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101707472|NCT04158830|Analgesics|analgesics|mesh-ancestor
101707473|NCT04158830|Sensory System Agents|sensory system agents|mesh-ancestor
101707474|NCT04158830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101707475|NCT04158830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707476|NCT04158830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101707477|NCT04158830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101707478|NCT04158830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101707479|NCT04158830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101707480|NCT04158830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707481|NCT04158830|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101707482|NCT04158830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101707483|NCT04158830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101707485|NCT00659282|Insulin Aspart|insulin aspart|mesh-list
101707486|NCT00659282|Biphasic Insulins|biphasic insulins|mesh-list
101302563|NCT00324805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707487|NCT00659282|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101707488|NCT00659282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101707489|NCT00659282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707491|NCT02617758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101707492|NCT02617758|Narcotics|narcotics|mesh-ancestor
101707493|NCT02617758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101707494|NCT02617758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707495|NCT02617758|Analgesics|analgesics|mesh-ancestor
101302564|NCT00324805|Tubulin Modulators|tubulin modulators|mesh-ancestor
101707496|NCT02617758|Sensory System Agents|sensory system agents|mesh-ancestor
101707497|NCT02617758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101707498|NCT02617758|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101707499|NCT02617758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101707501|NCT02617758|Anesthetics|anesthetics|mesh-ancestor
101707502|NCT00737542|Lidocaine|lidocaine|mesh-list
101707503|NCT00737542|Anesthetics, Local|anesthetics, local|mesh-ancestor
101707505|NCT00737542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101707506|NCT00737542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707507|NCT00737542|Sensory System Agents|sensory system agents|mesh-ancestor
101707508|NCT00737542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101707509|NCT00737542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101707510|NCT00737542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101707511|NCT00737542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101707512|NCT00737542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101707513|NCT00737542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707514|NCT00865098|Cetuximab|cetuximab|mesh-list
101707515|NCT00865098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101707516|NCT00865098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101707517|NCT00880100|Pancrelipase|pancrelipase|mesh-list
101707518|NCT00880100|Pancreatin|pancreatin|mesh-list
101707519|NCT00880100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101707520|NCT00729898|Insulin Aspart|insulin aspart|mesh-list
101707521|NCT00729898|Biphasic Insulins|biphasic insulins|mesh-list
101707522|NCT00729898|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101707523|NCT00729898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101707524|NCT00729898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707525|NCT00659594|Ciclesonide|ciclesonide|mesh-list
101707526|NCT00659594|Glucocorticoids|glucocorticoids|mesh-ancestor
101707527|NCT00659594|Hormones|hormones|mesh-ancestor
101707528|NCT00659594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101707529|NCT00659594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707530|NCT00659594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101707531|NCT05541016|Cisplatin|cisplatin|mesh-list
101707532|NCT05541016|Docetaxel|docetaxel|mesh-list
101707533|NCT05541016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101707534|NCT05541016|Tubulin Modulators|tubulin modulators|mesh-ancestor
101707535|NCT05541016|Antimitotic Agents|antimitotic agents|mesh-ancestor
101707536|NCT05541016|Mitosis Modulators|mitosis modulators|mesh-ancestor
101707537|NCT05541016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707538|NCT04158050|Omalizumab|omalizumab|mesh-list
101707539|NCT04158050|Antibodies|antibodies|mesh-list
101707540|NCT04158050|Immunologic Factors|immunologic factors|mesh-ancestor
101707541|NCT04158050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707542|NCT04158050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101707543|NCT04158050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101707544|NCT04158050|Respiratory System Agents|respiratory system agents|mesh-ancestor
101707545|NCT00659750|Ciclesonide|ciclesonide|mesh-list
101707546|NCT00659750|Glucocorticoids|glucocorticoids|mesh-ancestor
101707547|NCT00659750|Hormones|hormones|mesh-ancestor
101239469|NCT01616069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101239497|NCT01616355|Eusol|eusol|mesh-list
101707548|NCT00659750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101707549|NCT00659750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707550|NCT00659750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101707551|NCT00697476|Topotecan|topotecan|mesh-list
101707552|NCT00697476|Vorinostat|vorinostat|mesh-list
101707553|NCT00697476|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101707554|NCT00697476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101707555|NCT00697476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101707556|NCT00697476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239515|NCT01616407|Dopamine Agents|dopamine agents|mesh-ancestor
101707557|NCT00697476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101707558|NCT00697476|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101707559|NCT00660062|Dexetimide|dexetimide|mesh-list
101707560|NCT00660062|Citalopram|citalopram|mesh-list
101707561|NCT00660062|Nortriptyline|nortriptyline|mesh-list
101707562|NCT00660062|Escitalopram|escitalopram|mesh-list
101302565|NCT00324805|Antimitotic Agents|antimitotic agents|mesh-ancestor
101707563|NCT00660062|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101707564|NCT00660062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101707565|NCT00660062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101707566|NCT00660062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707567|NCT00660062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101707568|NCT00660062|Serotonin Agents|serotonin agents|mesh-ancestor
101707569|NCT00660062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707570|NCT00660062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101707571|NCT00660062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101707572|NCT00660062|Parasympatholytics|parasympatholytics|mesh-ancestor
101707573|NCT00660062|Autonomic Agents|autonomic agents|mesh-ancestor
101707574|NCT00660062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101707575|NCT00660062|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101707576|NCT00660062|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101707577|NCT00660062|Cholinergic Agents|cholinergic agents|mesh-ancestor
101707578|NCT00660062|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101707579|NCT00660062|Antidepressive Agents|antidepressive agents|mesh-ancestor
101707580|NCT00660062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101707581|NCT00660062|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101707582|NCT00660062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101707583|NCT00660062|Adrenergic Agents|adrenergic agents|mesh-ancestor
101707585|NCT04063540|Diuretics|diuretics|mesh-ancestor
101707586|NCT04063540|Natriuretic Agents|natriuretic agents|mesh-ancestor
101707587|NCT04063540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707588|NCT04063540|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
101707589|NCT04063540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101707590|NCT04063540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101707591|NCT04063540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707592|NCT04063540|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101707593|NCT04063540|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101707595|NCT04161560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101707596|NCT04161560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101707597|NCT00518011|Gemcitabine|gemcitabine|mesh-list
101239777|NCT01617824|Linagliptin|linagliptin|mesh-list
101707598|NCT00518011|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101707599|NCT00518011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101707600|NCT00518011|Antimetabolites|antimetabolites|mesh-ancestor
101707601|NCT00518011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707602|NCT00518011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101707603|NCT00518011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101239844|NCT01618448|Tolvaptan|tolvaptan|mesh-list
101707604|NCT00518011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101707605|NCT00737776|Insulin Aspart|insulin aspart|mesh-list
101707606|NCT00737776|Biphasic Insulins|biphasic insulins|mesh-list
101707607|NCT00737776|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101707608|NCT00737776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101707609|NCT00737776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707610|NCT02633930|Amoxicillin|amoxicillin|mesh-list
101707611|NCT02633930|Clarithromycin|clarithromycin|mesh-list
101707612|NCT02633930|Lansoprazole|lansoprazole|mesh-list
101707613|NCT02633930|Dexlansoprazole|dexlansoprazole|mesh-list
101707615|NCT02633930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101239909|NCT01618773|Dermatologic Agents|dermatologic agents|mesh-ancestor
101707616|NCT02633930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101707617|NCT02633930|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101707618|NCT02633930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101707619|NCT02633930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707620|NCT02633930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101707621|NCT02633930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101707622|NCT02633930|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101707623|NCT02633930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101707624|NCT02633930|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101707625|NCT02633930|Antacids|antacids|mesh-ancestor
101707626|NCT00698334|Rifampin|rifampin|mesh-list
101707627|NCT00698334|Pyrazinamide|pyrazinamide|mesh-list
101707628|NCT00698334|Ethambutol|ethambutol|mesh-list
101707629|NCT00698334|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101707630|NCT00698334|Antitubercular Agents|antitubercular agents|mesh-ancestor
101707631|NCT00698334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101707632|NCT00698334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101707633|NCT00698334|Leprostatic Agents|leprostatic agents|mesh-ancestor
101707634|NCT00698334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101707635|NCT00698334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101707636|NCT00698334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707637|NCT00698334|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101707638|NCT00698334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101707639|NCT00698334|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101707640|NCT00698334|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101707641|NCT00698334|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101707642|NCT00698334|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101707643|NCT04161482|Furosemide|furosemide|mesh-list
101707644|NCT04161482|Diuretics|diuretics|mesh-ancestor
101707645|NCT04161482|Natriuretic Agents|natriuretic agents|mesh-ancestor
101707646|NCT04161482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707647|NCT04161482|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101707648|NCT04161482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101707649|NCT04161482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707651|NCT02623452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101707652|NCT02623452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707653|NCT02633696|Silybin|silybin|mesh-list
101707654|NCT02633696|Silymarin|silymarin|mesh-list
101707655|NCT02633696|Antioxidants|antioxidants|mesh-ancestor
101302566|NCT00324805|Mitosis Modulators|mitosis modulators|mesh-ancestor
101707656|NCT02633696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707657|NCT02633696|Protective Agents|protective agents|mesh-ancestor
101707658|NCT02633696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707659|NCT02633696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101707660|NCT02633696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101707661|NCT02633852|Aflibercept|aflibercept|mesh-list
101707662|NCT02633852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101707663|NCT02633852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101707664|NCT02633852|Growth Substances|growth substances|mesh-ancestor
101707665|NCT02633852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707666|NCT02633852|Growth Inhibitors|growth inhibitors|mesh-ancestor
101707667|NCT02633852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101707668|NCT02633774|Propafenone|propafenone|mesh-list
101707670|NCT02633774|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101707671|NCT02633774|Antithrombins|antithrombins|mesh-ancestor
101707672|NCT02633774|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101707673|NCT02633774|Protease Inhibitors|protease inhibitors|mesh-ancestor
101707674|NCT02633774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101707675|NCT02633774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707676|NCT02633774|Anticoagulants|anticoagulants|mesh-ancestor
101707677|NCT02633774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101707678|NCT02633774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101707679|NCT02633774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101707680|NCT02633774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101707681|NCT02633618|Neurotropin|neurotropin|mesh-list
101707682|NCT02633618|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101707683|NCT02633618|Immunologic Factors|immunologic factors|mesh-ancestor
101707684|NCT02633618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707685|NCT02633618|Analgesics|analgesics|mesh-ancestor
101707686|NCT02633618|Sensory System Agents|sensory system agents|mesh-ancestor
101707687|NCT02633618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101707688|NCT02633618|Anticonvulsants|anticonvulsants|mesh-ancestor
101707689|NCT00865020|Telmisartan|telmisartan|mesh-list
101707690|NCT00865020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101240285|NCT01620944|Antiviral Agents|antiviral agents|mesh-ancestor
101707691|NCT00865020|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101707692|NCT00865020|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101707693|NCT00865020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707694|NCT00517933|Sildenafil Citrate|sildenafil citrate|mesh-list
101707695|NCT00517933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707696|NCT00517933|Vasodilator Agents|vasodilator agents|mesh-ancestor
101707697|NCT00517933|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101707698|NCT00517933|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101707699|NCT00517933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101240347|NCT01621217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240348|NCT01621217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101707701|NCT02633384|Sorbitol|sorbitol|mesh-list
101707702|NCT02633384|SMOFlipid|smoflipid|mesh-list
101707703|NCT02633384|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101707704|NCT02633384|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101707705|NCT02633384|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101707706|NCT02633384|Cathartics|cathartics|mesh-ancestor
101707707|NCT02633384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101707708|NCT02633462|Inositol|inositol|mesh-list
101707709|NCT02633462|Vitamin B Complex|vitamin b complex|mesh-ancestor
101707710|NCT02633462|Vitamins|vitamins|mesh-ancestor
101240408|NCT01621386|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101707711|NCT02633462|Micronutrients|micronutrients|mesh-ancestor
101707712|NCT02633462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707713|NCT02638064|Surgiflo|surgiflo|mesh-list
101707714|NCT02638064|Hemostatics|hemostatics|mesh-ancestor
101707715|NCT02638064|Coagulants|coagulants|mesh-ancestor
101707716|NCT00655148|Vaccines|vaccines|mesh-list
101707717|NCT00655148|Immunologic Factors|immunologic factors|mesh-ancestor
101707718|NCT00655148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707719|NCT00857766|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101707720|NCT00857766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101707721|NCT00857766|Autonomic Agents|autonomic agents|mesh-ancestor
101707722|NCT00857766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101707723|NCT00857766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365210|NCT00082446|Vaccines|vaccines|mesh-list
101707724|NCT00857766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101707725|NCT00857766|Respiratory System Agents|respiratory system agents|mesh-ancestor
101707726|NCT00857766|Glucocorticoids|glucocorticoids|mesh-ancestor
101707728|NCT00857766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101707729|NCT00857766|Sympathomimetics|sympathomimetics|mesh-ancestor
101707730|NCT04161404|Metformin|metformin|mesh-list
101707731|NCT04161404|Andrographolide|andrographolide|mesh-list
101240478|NCT01621763|Clopidogrel|clopidogrel|mesh-list
101707733|NCT04161404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707734|NCT04161404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101707735|NCT04161404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101707736|NCT04161404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101707737|NCT04161404|Analgesics|analgesics|mesh-ancestor
101707738|NCT04161404|Sensory System Agents|sensory system agents|mesh-ancestor
101707739|NCT04161404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101707740|NCT04161404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101707741|NCT04161404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101707742|NCT04161404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101707743|NCT04161404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101707745|NCT04161404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101707746|NCT00517699|Cytarabine|cytarabine|mesh-list
101707748|NCT00517699|Methotrexate|methotrexate|mesh-list
101707749|NCT00517699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101707750|NCT00517699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101707751|NCT00517699|Immunologic Factors|immunologic factors|mesh-ancestor
101707752|NCT00517699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707753|NCT00517699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101240592|NCT01622556|Fludarabine|fludarabine|mesh-list
101707754|NCT00517699|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101707755|NCT00517699|Abortifacient Agents|abortifacient agents|mesh-ancestor
101707756|NCT00517699|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101707757|NCT00517699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101707758|NCT00517699|Antimetabolites|antimetabolites|mesh-ancestor
101707759|NCT00517699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707760|NCT00517699|Dermatologic Agents|dermatologic agents|mesh-ancestor
101707761|NCT00517699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101707762|NCT00517699|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101707763|NCT00517699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101707764|NCT00517699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101707765|NCT00517699|Antiviral Agents|antiviral agents|mesh-ancestor
101707766|NCT00517699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101707771|NCT04161014|Nintedanib|nintedanib|mesh-list
101707772|NCT04161014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101707773|NCT04161014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101707774|NCT04161014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101410607|NCT00445900|Immunologic Factors|immunologic factors|mesh-ancestor
101707775|NCT04161014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707776|NCT04491643|Megestrol|megestrol|mesh-list
101707777|NCT04491643|Megestrol Acetate|megestrol acetate|mesh-list
101707778|NCT04491643|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101707779|NCT04491643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101707780|NCT04491643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101707781|NCT04491643|Antimetabolites|antimetabolites|mesh-ancestor
101707782|NCT04491643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707783|NCT04491643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101707784|NCT04491643|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101707785|NCT04491643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101707786|NCT04491643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101707787|NCT04491643|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101707788|NCT04491643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101707789|NCT04491643|Contraceptive Agents|contraceptive agents|mesh-ancestor
101707790|NCT04491643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101707791|NCT04491643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707792|NCT04491643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101707793|NCT04491643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101707794|NCT04491643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101707795|NCT04491643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101707796|NCT04491643|Appetite Stimulants|appetite stimulants|mesh-ancestor
101707797|NCT04491643|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101365254|NCT00049556|Gefitinib|gefitinib|mesh-list
101707799|NCT00699504|Cangrelor|cangrelor|mesh-list
101707800|NCT00699504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101707801|NCT00699504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101707802|NCT00699504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101707803|NCT00699504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101707804|NCT00699504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101707805|NCT00699504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707806|NCT00699504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101707807|NCT00699504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707808|NCT00699504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101707809|NCT00699504|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101240694|NCT01623375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101240697|NCT01623401|Tedizolid|tedizolid|mesh-list
101707810|NCT00699504|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101707811|NCT00699504|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101707812|NCT00699504|Purinergic Agents|purinergic agents|mesh-ancestor
101707813|NCT00699504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101707814|NCT02997605|Prednisone|prednisone|mesh-list
101707815|NCT02997605|Hydrocortisone|hydrocortisone|mesh-list
101707816|NCT02997605|Glucocorticoids|glucocorticoids|mesh-list
101707817|NCT02997605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101707819|NCT02997605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101707820|NCT02997605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707821|NCT02997605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101707822|NCT02997605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101707823|NCT03767543|Insulin Glargine|insulin glargine|mesh-list
101707824|NCT03767543|Lixisenatide|lixisenatide|mesh-list
101707825|NCT03767543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101707826|NCT03767543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240823|NCT01624116|Metformin|metformin|mesh-list
101707827|NCT00857454|Testosterone|testosterone|mesh-list
101707828|NCT00857454|Androgens|androgens|mesh-ancestor
101707830|NCT00857454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101707831|NCT00857454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707832|NCT00660140|Carboplatin|carboplatin|mesh-list
101707833|NCT00660140|Gemcitabine|gemcitabine|mesh-list
101707834|NCT00660140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101707835|NCT00660140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101707836|NCT00660140|Antimetabolites|antimetabolites|mesh-ancestor
101707837|NCT00660140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707838|NCT03760991|Insulin Glargine|insulin glargine|mesh-list
101707839|NCT03760991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101240887|NCT01624649|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101240888|NCT01624649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101707840|NCT03760991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707841|NCT00525031|Interferons|interferons|mesh-list
101707842|NCT00525031|Interferon-alpha|interferon-alpha|mesh-list
101707843|NCT00525031|Interferon alpha-2|interferon alpha-2|mesh-list
101707844|NCT00525031|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101707845|NCT00525031|Temozolomide|temozolomide|mesh-list
101707846|NCT00525031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101707847|NCT00525031|Antiviral Agents|antiviral agents|mesh-ancestor
101707848|NCT00525031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101707849|NCT00525031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101707850|NCT00525031|Alkylating Agents|alkylating agents|mesh-ancestor
101707851|NCT00525031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707852|NCT00525031|Immunologic Factors|immunologic factors|mesh-ancestor
101707853|NCT00525031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707854|NCT00660374|Isophane Insulin, Human|isophane insulin, human|mesh-list
101707855|NCT00660374|Insulin, Isophane|insulin, isophane|mesh-list
101707856|NCT00660374|Isophane insulin, beef|isophane insulin, beef|mesh-list
101707857|NCT00660374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101707858|NCT00660374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707859|NCT00524485|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101707860|NCT00524485|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101707861|NCT00524485|Dermatologic Agents|dermatologic agents|mesh-ancestor
101707862|NCT00857220|Eszopiclone|eszopiclone|mesh-list
101707863|NCT00857220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101707864|NCT00857220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101707865|NCT00857220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707866|NCT00524173|Tenofovir|tenofovir|mesh-list
101707867|NCT00524173|Emtricitabine|emtricitabine|mesh-list
101707868|NCT00524173|Antiviral Agents|antiviral agents|mesh-ancestor
101707869|NCT00524173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101707870|NCT00524173|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101707871|NCT00524173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101707872|NCT00524173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101707873|NCT00524173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707875|NCT00524173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101707876|NCT02704481|Misoprostol|misoprostol|mesh-list
101707877|NCT02704481|Mifepristone|mifepristone|mesh-list
101707878|NCT02704481|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101707879|NCT02704481|Abortifacient Agents|abortifacient agents|mesh-ancestor
101707880|NCT02704481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101707881|NCT02704481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707882|NCT02704481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101707883|NCT02704481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101707884|NCT02704481|Oxytocics|oxytocics|mesh-ancestor
101707885|NCT02704481|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101707886|NCT02704481|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101707887|NCT02704481|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101707888|NCT02704481|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101707889|NCT02704481|Contraceptive Agents|contraceptive agents|mesh-ancestor
101707890|NCT02704481|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101707891|NCT02704481|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101707892|NCT02704481|Hormone Antagonists|hormone antagonists|mesh-ancestor
101707893|NCT02704481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101707894|NCT02704481|Luteolytic Agents|luteolytic agents|mesh-ancestor
101707895|NCT02704481|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101707896|NCT02704481|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101707897|NCT02614482|Fesoterodine|fesoterodine|mesh-list
101707898|NCT02614482|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101707899|NCT02614482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101707900|NCT02614482|Cholinergic Agents|cholinergic agents|mesh-ancestor
101707901|NCT02614482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101707902|NCT02614482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707903|NCT02614482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707904|NCT02614482|Urological Agents|urological agents|mesh-ancestor
101707905|NCT04713709|Naloxone|naloxone|mesh-list
101707906|NCT04713709|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101707907|NCT04713709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241135|NCT01627041|Cytarabine|cytarabine|mesh-list
101707908|NCT04713709|Sensory System Agents|sensory system agents|mesh-ancestor
101707909|NCT04713709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101707910|NCT00879710|Simvastatin|simvastatin|mesh-list
101707911|NCT00879710|Ezetimibe|ezetimibe|mesh-list
101707912|NCT00879710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101707913|NCT00879710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101707914|NCT00879710|Antimetabolites|antimetabolites|mesh-ancestor
101707915|NCT00879710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707916|NCT00879710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101707917|NCT00879710|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101707918|NCT00879710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101707919|NCT02703857|Cefoxitin|cefoxitin|mesh-list
101707920|NCT02703857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101707921|NCT02703857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101707922|NCT02623062|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
101707923|NCT02623062|Antacids|antacids|mesh-ancestor
101707924|NCT02623062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707925|NCT02623062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101707926|NCT00597506|Bevacizumab|bevacizumab|mesh-list
101707927|NCT00597506|Everolimus|everolimus|mesh-list
101707928|NCT00597506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101707929|NCT00597506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101707930|NCT00597506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101707931|NCT00597506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101707932|NCT00597506|Growth Substances|growth substances|mesh-ancestor
101707933|NCT00597506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707934|NCT00597506|Growth Inhibitors|growth inhibitors|mesh-ancestor
101707935|NCT00597506|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101707936|NCT00597506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101707937|NCT00597506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101707938|NCT00597506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707939|NCT00597506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101707940|NCT00597506|Immunologic Factors|immunologic factors|mesh-ancestor
101707941|NCT03393611|Cytarabine|cytarabine|mesh-list
101707943|NCT03393611|Melphalan|melphalan|mesh-list
101707944|NCT03393611|Daunorubicin|daunorubicin|mesh-list
101707945|NCT03393611|Thymoglobulin|thymoglobulin|mesh-list
101707947|NCT03393611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101707948|NCT03393611|Antimetabolites|antimetabolites|mesh-ancestor
101707949|NCT03393611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707950|NCT03393611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101707951|NCT03393611|Immunologic Factors|immunologic factors|mesh-ancestor
101707952|NCT03393611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707953|NCT03393611|Antiviral Agents|antiviral agents|mesh-ancestor
101707954|NCT03393611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101707955|NCT03393611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101707956|NCT03393611|Alkylating Agents|alkylating agents|mesh-ancestor
101707957|NCT03393611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101707958|NCT03393611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101707959|NCT03393611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101707960|NCT03393611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101707961|NCT03393611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101707962|NCT04032548|Chlorhexidine|chlorhexidine|mesh-list
101707963|NCT04032548|Propolis|propolis|mesh-list
101707964|NCT04032548|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101707965|NCT04032548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101241528|NCT01629251|Insulin|insulin|mesh-list
101707966|NCT04032548|Disinfectants|disinfectants|mesh-ancestor
101707967|NCT04032236|Caffeine|caffeine|mesh-list
101707968|NCT04032236|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101707969|NCT04032236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707970|NCT04032236|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101707971|NCT04032236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101707972|NCT04032236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707973|NCT04032236|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101707974|NCT04032236|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101707975|NCT04032236|Purinergic Agents|purinergic agents|mesh-ancestor
101707976|NCT04032236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101707978|NCT02313389|Methotrexate|methotrexate|mesh-list
101707979|NCT02313389|Temozolomide|temozolomide|mesh-list
101707980|NCT02313389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101707981|NCT02313389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101707982|NCT02313389|Immunologic Factors|immunologic factors|mesh-ancestor
101707983|NCT02313389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101707984|NCT02313389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101707985|NCT02313389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101707986|NCT02313389|Abortifacient Agents|abortifacient agents|mesh-ancestor
101707987|NCT02313389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101707988|NCT02313389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101707989|NCT02313389|Antimetabolites|antimetabolites|mesh-ancestor
101707990|NCT02313389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101707991|NCT02313389|Dermatologic Agents|dermatologic agents|mesh-ancestor
101707992|NCT02313389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101707993|NCT02313389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101707994|NCT02313389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101707995|NCT02313389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101707996|NCT02313389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101707997|NCT02313389|Alkylating Agents|alkylating agents|mesh-ancestor
101707998|NCT00708682|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101707999|NCT00708682|Immunologic Factors|immunologic factors|mesh-ancestor
101241642|NCT01630018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101241643|NCT01630018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708000|NCT00708682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708002|NCT02632916|Denosumab|denosumab|mesh-list
101708003|NCT02632916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101708004|NCT02632916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708005|NCT00881504|Bevacizumab|bevacizumab|mesh-list
101708006|NCT00881504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101708007|NCT00881504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101708008|NCT00881504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101708009|NCT00881504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101708010|NCT00881504|Growth Substances|growth substances|mesh-ancestor
101708011|NCT00881504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708012|NCT00881504|Growth Inhibitors|growth inhibitors|mesh-ancestor
101708013|NCT00660764|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101708014|NCT00660764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101708015|NCT00660764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101708016|NCT00660764|Antimetabolites|antimetabolites|mesh-ancestor
101708017|NCT00660764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708018|NCT00660764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101365475|NCT00082563|Amebicides|amebicides|mesh-ancestor
101708019|NCT00660764|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101708020|NCT00660764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708022|NCT02131493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101708023|NCT02131493|Antimetabolites|antimetabolites|mesh-ancestor
101708024|NCT02131493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708025|NCT02131493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101708026|NCT02096159|Trimethoprim|trimethoprim|mesh-list
101708027|NCT02096159|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101708028|NCT02096159|Sulfamethoxazole|sulfamethoxazole|mesh-list
101708029|NCT02096159|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101708030|NCT02096159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101708031|NCT02096159|Antimalarials|antimalarials|mesh-ancestor
101708032|NCT02096159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101708033|NCT02096159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101708034|NCT02096159|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101708035|NCT02096159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708036|NCT02096159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708037|NCT02096159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101708038|NCT02096159|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101708039|NCT02096159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101241887|NCT01631409|Antipyretics|antipyretics|mesh-ancestor
101708040|NCT02096159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101708042|NCT02632136|Anesthetics, Local|anesthetics, local|mesh-ancestor
101708043|NCT02632136|Anesthetics|anesthetics|mesh-ancestor
101708044|NCT02632136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101708045|NCT02632136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708046|NCT02632136|Sensory System Agents|sensory system agents|mesh-ancestor
101708047|NCT02632136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101708049|NCT00660920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101708050|NCT00660920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101708051|NCT00660920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708052|NCT00660920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708053|NCT01936831|Vitamin B 6|vitamin b 6|mesh-list
101708054|NCT01936831|Pyridoxal|pyridoxal|mesh-list
101708055|NCT01936831|Pyridoxine|pyridoxine|mesh-list
101708056|NCT01936831|Isoniazid|isoniazid|mesh-list
101708057|NCT01936831|Vitamins|vitamins|mesh-ancestor
101708058|NCT01936831|Micronutrients|micronutrients|mesh-ancestor
101708059|NCT01936831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708060|NCT01936831|Vitamin B Complex|vitamin b complex|mesh-ancestor
101708061|NCT01936831|Antitubercular Agents|antitubercular agents|mesh-ancestor
101242087|NCT01633086|Gasotransmitters|gasotransmitters|mesh-ancestor
101708062|NCT01936831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101708063|NCT01936831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101708064|NCT01936831|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101708065|NCT01936831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101708066|NCT01936831|Antimetabolites|antimetabolites|mesh-ancestor
101708067|NCT01936831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708068|NCT01936831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101708069|NCT00615173|Cyclophosphamide|cyclophosphamide|mesh-list
101708070|NCT00615173|Azathioprine|azathioprine|mesh-list
101708071|NCT00615173|Tacrolimus|tacrolimus|mesh-list
101708072|NCT00615173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101708073|NCT00615173|Immunologic Factors|immunologic factors|mesh-ancestor
101708074|NCT00615173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708075|NCT00615173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101708076|NCT00615173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101708077|NCT00615173|Alkylating Agents|alkylating agents|mesh-ancestor
101708078|NCT00615173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708079|NCT00615173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101708080|NCT00615173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101708081|NCT00615173|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101708082|NCT00615173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708083|NCT00615173|Antimetabolites|antimetabolites|mesh-ancestor
101708084|NCT00615173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101708085|NCT00660998|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101708086|NCT00660998|Vasodilator Agents|vasodilator agents|mesh-ancestor
101708087|NCT00660998|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101708088|NCT00660998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101708089|NCT00660998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708090|NCT00660998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708091|NCT00660998|Urological Agents|urological agents|mesh-ancestor
101708092|NCT00657254|Sorafenib|sorafenib|mesh-list
101708093|NCT00657254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101242161|NCT01633970|Leucovorin|leucovorin|mesh-list
101708094|NCT00657254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101708095|NCT00657254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708096|NCT00657254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708097|NCT01455389|Diphenhydramine|diphenhydramine|mesh-list
101708098|NCT01455389|Promethazine|promethazine|mesh-list
101708099|NCT01455389|Dexamethasone|dexamethasone|mesh-list
101708100|NCT01455389|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101708101|NCT01455389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101708102|NCT01455389|Antiemetics|antiemetics|mesh-ancestor
101708103|NCT01455389|Autonomic Agents|autonomic agents|mesh-ancestor
101708104|NCT01455389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101708105|NCT01455389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708106|NCT01455389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101708107|NCT01455389|Glucocorticoids|glucocorticoids|mesh-ancestor
101708108|NCT01455389|Hormones|hormones|mesh-ancestor
101708109|NCT01455389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101708110|NCT01455389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101708111|NCT01455389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101708112|NCT01455389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101708113|NCT01455389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708114|NCT01455389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708115|NCT01455389|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101708116|NCT01455389|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101708117|NCT01455389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101708118|NCT01455389|Anesthetics, Local|anesthetics, local|mesh-ancestor
101708119|NCT01455389|Anesthetics|anesthetics|mesh-ancestor
101708120|NCT01455389|Sensory System Agents|sensory system agents|mesh-ancestor
101708121|NCT01455389|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101708122|NCT01455389|Histamine Antagonists|histamine antagonists|mesh-ancestor
101708123|NCT01455389|Histamine Agents|histamine agents|mesh-ancestor
101708124|NCT01455389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101708125|NCT01455389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101708126|NCT01455389|Antipruritics|antipruritics|mesh-ancestor
101708127|NCT01455389|Dermatologic Agents|dermatologic agents|mesh-ancestor
101708128|NCT00661076|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101708129|NCT00661076|Adefovir|adefovir|mesh-list
101708130|NCT00661076|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101708131|NCT00661076|Antiviral Agents|antiviral agents|mesh-ancestor
101708132|NCT00661076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101708133|NCT00661076|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101708134|NCT00661076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101242203|NCT01633983|Immunologic Factors|immunologic factors|mesh-ancestor
101708136|NCT00661076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708137|NCT04215965|Dialysis Solutions|dialysis solutions|mesh-list
101708138|NCT04215965|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101708139|NCT00661700|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101708140|NCT00661700|Vasodilator Agents|vasodilator agents|mesh-ancestor
101708141|NCT00661700|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101708142|NCT00661700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101708143|NCT00661700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708144|NCT00661700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708145|NCT00661700|Urological Agents|urological agents|mesh-ancestor
101708146|NCT00613769|Metronidazole|metronidazole|mesh-list
101708147|NCT00613769|Trimethoprim|trimethoprim|mesh-list
101708148|NCT00613769|Sulfamethoxazole|sulfamethoxazole|mesh-list
101708149|NCT00613769|Cefuroxime|cefuroxime|mesh-list
101708150|NCT00613769|Cefuroxime axetil|cefuroxime axetil|mesh-list
101708151|NCT00613769|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101708152|NCT00613769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101708153|NCT00613769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101708154|NCT00613769|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101708155|NCT00613769|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101708156|NCT00613769|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101708157|NCT00613769|Antimalarials|antimalarials|mesh-ancestor
101708158|NCT00613769|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101708159|NCT00613769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708160|NCT00613769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708161|NCT00613769|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101708162|NCT00613769|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101708163|NCT00613769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101708164|NCT00661154|Bevacizumab|bevacizumab|mesh-list
101708165|NCT00661154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101365626|NCT00152191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101242305|NCT01634594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101242306|NCT01634594|Adrenergic Agents|adrenergic agents|mesh-ancestor
101708166|NCT00661154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101708167|NCT00661154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101708168|NCT00661154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101708169|NCT00661154|Growth Substances|growth substances|mesh-ancestor
101708170|NCT00661154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708171|NCT00661154|Growth Inhibitors|growth inhibitors|mesh-ancestor
101708172|NCT00523705|Escitalopram|escitalopram|mesh-list
101708173|NCT00523705|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101708174|NCT00523705|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101708175|NCT00523705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101708176|NCT00523705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708177|NCT00523705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101708178|NCT00523705|Serotonin Agents|serotonin agents|mesh-ancestor
101242352|NCT01634880|Panitumumab|panitumumab|mesh-list
101708179|NCT00523705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708180|NCT00193427|Carboplatin|carboplatin|mesh-list
101708181|NCT00193427|Gemcitabine|gemcitabine|mesh-list
101708182|NCT00193427|Docetaxel|docetaxel|mesh-list
101708183|NCT00193427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101708184|NCT00193427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101708185|NCT00193427|Antimetabolites|antimetabolites|mesh-ancestor
101708186|NCT00193427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708187|NCT00193427|Tubulin Modulators|tubulin modulators|mesh-ancestor
101708188|NCT00193427|Antimitotic Agents|antimitotic agents|mesh-ancestor
101708189|NCT00193427|Mitosis Modulators|mitosis modulators|mesh-ancestor
101708190|NCT00665678|Paroxetine|paroxetine|mesh-list
101708191|NCT00665678|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101708192|NCT00665678|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101708193|NCT00665678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101708194|NCT00665678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708195|NCT00665678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101708196|NCT00665678|Serotonin Agents|serotonin agents|mesh-ancestor
101708197|NCT00665678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708198|NCT00665678|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101708199|NCT00665678|Antidepressive Agents|antidepressive agents|mesh-ancestor
101708200|NCT00665678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101708201|NCT00665678|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101536032|NCT04607525|Dexmedetomidine|dexmedetomidine|mesh-list
101708202|NCT00665678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101708203|NCT00665678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708204|NCT00523549|Amlodipine|amlodipine|mesh-list
101708205|NCT00523549|Valsartan|valsartan|mesh-list
101708206|NCT00523549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101708207|NCT00523549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101708208|NCT00523549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101708209|NCT00523549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708210|NCT00523549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101708211|NCT00523549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708212|NCT00523549|Vasodilator Agents|vasodilator agents|mesh-ancestor
101708213|NCT00523549|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101708214|NCT00523549|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101708215|NCT04215653|Rabeprazole|rabeprazole|mesh-list
101708216|NCT04215653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101708217|NCT04215653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101708218|NCT04215653|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101708219|NCT04215653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708220|NCT04215653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708221|NCT02706119|Insulin|insulin|mesh-list
101708222|NCT02706119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101708223|NCT02706119|Insulin Glargine|insulin glargine|mesh-list
101708224|NCT02706119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101708225|NCT02706119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708226|NCT02631668|Ferrous succinate|ferrous succinate|mesh-list
101708228|NCT00665756|Mitomycins|mitomycins|mesh-list
101708229|NCT00665756|Mitomycin|mitomycin|mesh-list
101708230|NCT00665756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101708231|NCT00665756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101708232|NCT00665756|Alkylating Agents|alkylating agents|mesh-ancestor
101708233|NCT00665756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708234|NCT00665756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101708235|NCT00665756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708236|NCT00661856|Genistein|genistein|mesh-list
101708237|NCT00661856|Daidzein|daidzein|mesh-list
101708238|NCT00661856|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101708239|NCT00661856|Protective Agents|protective agents|mesh-ancestor
101708240|NCT00661856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708241|NCT00661856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101708242|NCT00661856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101708243|NCT00661856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708244|NCT00661856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708245|NCT00661856|Phytoestrogens|phytoestrogens|mesh-ancestor
101708246|NCT00661856|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101708247|NCT00661856|Estrogens|estrogens|mesh-ancestor
101708248|NCT00661856|Hormones|hormones|mesh-ancestor
101708249|NCT00661856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101708250|NCT04215731|Leucovorin|leucovorin|mesh-list
101708251|NCT04215731|Bevacizumab|bevacizumab|mesh-list
101708252|NCT04215731|Fluorouracil|fluorouracil|mesh-list
101708253|NCT04215731|Oxaliplatin|oxaliplatin|mesh-list
101708254|NCT04215731|Irinotecan|irinotecan|mesh-list
101708255|NCT04215731|Levoleucovorin|levoleucovorin|mesh-list
101708256|NCT04215731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101708257|NCT04215731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101708258|NCT04215731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101708259|NCT04215731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101708260|NCT04215731|Growth Substances|growth substances|mesh-ancestor
101708261|NCT04215731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242587|NCT01636180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101708262|NCT04215731|Growth Inhibitors|growth inhibitors|mesh-ancestor
101708263|NCT04215731|Antimetabolites|antimetabolites|mesh-ancestor
101708264|NCT04215731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708265|NCT04215731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101708266|NCT04215731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101708267|NCT04215731|Immunologic Factors|immunologic factors|mesh-ancestor
101708268|NCT04215731|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101708269|NCT04215731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101708270|NCT04215731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708271|NCT04215731|Antidotes|antidotes|mesh-ancestor
101708272|NCT04215731|Protective Agents|protective agents|mesh-ancestor
101708273|NCT04215731|Vitamin B Complex|vitamin b complex|mesh-ancestor
101708274|NCT04215731|Vitamins|vitamins|mesh-ancestor
101708275|NCT04215731|Micronutrients|micronutrients|mesh-ancestor
101708276|NCT00665834|Atorvastatin|atorvastatin|mesh-list
101708277|NCT00665834|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101708278|NCT00665834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101708279|NCT00665834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101708280|NCT00665834|Antimetabolites|antimetabolites|mesh-ancestor
101708281|NCT00665834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708282|NCT00665834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101708283|NCT00665834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101708284|NCT00665834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708285|NCT02704013|Oxybutynin|oxybutynin|mesh-list
101708286|NCT02704013|Parasympatholytics|parasympatholytics|mesh-ancestor
101708287|NCT02704013|Autonomic Agents|autonomic agents|mesh-ancestor
101242629|NCT01636336|Hormones|hormones|mesh-ancestor
101708288|NCT02704013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101708289|NCT02704013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708290|NCT02704013|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101708291|NCT02704013|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101708292|NCT02704013|Cholinergic Agents|cholinergic agents|mesh-ancestor
101708293|NCT02704013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101708294|NCT02704013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708295|NCT02704013|Urological Agents|urological agents|mesh-ancestor
101708296|NCT00665990|Cyclophosphamide|cyclophosphamide|mesh-list
101708297|NCT00665990|Bevacizumab|bevacizumab|mesh-list
101708298|NCT00665990|Sorafenib|sorafenib|mesh-list
101708299|NCT00665990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101708300|NCT00665990|Immunologic Factors|immunologic factors|mesh-ancestor
101242754|NCT01636895|Pyrimethamine|pyrimethamine|mesh-list
101708301|NCT00665990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708302|NCT00665990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101708303|NCT00665990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101708304|NCT00665990|Alkylating Agents|alkylating agents|mesh-ancestor
101708305|NCT00665990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708306|NCT00665990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101708307|NCT00665990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101708308|NCT00665990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101708309|NCT00665990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101708310|NCT00665990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101708311|NCT00665990|Growth Substances|growth substances|mesh-ancestor
101708312|NCT00665990|Growth Inhibitors|growth inhibitors|mesh-ancestor
101708313|NCT00665990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101708314|NCT00665990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101242824|NCT01637233|Tenofovir|tenofovir|mesh-list
101708315|NCT00666068|Hormones|hormones|mesh-list
101708316|NCT00666068|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101708317|NCT00666068|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
101708318|NCT00666068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101708319|NCT00666068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708320|NCT00700102|Bevacizumab|bevacizumab|mesh-list
101708321|NCT00700102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101708322|NCT00700102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302567|NCT00324805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101242890|NCT01637454|Sympathomimetics|sympathomimetics|mesh-ancestor
101708323|NCT00700102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101708324|NCT00700102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101708325|NCT00700102|Growth Substances|growth substances|mesh-ancestor
101708326|NCT00700102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708327|NCT00700102|Growth Inhibitors|growth inhibitors|mesh-ancestor
101708328|NCT02705729|Methamphetamine|methamphetamine|mesh-list
101708329|NCT02705729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101708330|NCT02705729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243024|NCT01637883|Benzydamine|benzydamine|mesh-list
101708333|NCT02705729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101708334|NCT02705729|Dopamine Agents|dopamine agents|mesh-ancestor
101708335|NCT02705729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101708336|NCT02705729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708337|NCT02705729|Adrenergic Agents|adrenergic agents|mesh-ancestor
101708338|NCT02705729|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101708339|NCT02705729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101708340|NCT02705729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101708341|NCT02705729|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101708342|NCT02705573|Mannitol|mannitol|mesh-list
101708343|NCT02705573|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101708344|NCT02705573|Diuretics|diuretics|mesh-ancestor
101708345|NCT02705573|Natriuretic Agents|natriuretic agents|mesh-ancestor
101708346|NCT02705573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708347|NCT00613847|Trastuzumab|trastuzumab|mesh-list
101243095|NCT01638273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708348|NCT00613847|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
101708349|NCT00613847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101708350|NCT00613847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101708351|NCT00613847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708352|NCT00516295|Cyclophosphamide|cyclophosphamide|mesh-list
101708353|NCT00516295|Bevacizumab|bevacizumab|mesh-list
101708354|NCT00516295|Vincristine|vincristine|mesh-list
101708355|NCT00516295|Topotecan|topotecan|mesh-list
101243152|NCT01638650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708356|NCT00516295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101708357|NCT00516295|Antibodies|antibodies|mesh-list
101708358|NCT00516295|Immunoglobulins|immunoglobulins|mesh-list
101708359|NCT00516295|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101708360|NCT00516295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101708361|NCT00516295|Immunologic Factors|immunologic factors|mesh-ancestor
101708362|NCT00516295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708363|NCT00516295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101708364|NCT00516295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101708365|NCT00516295|Alkylating Agents|alkylating agents|mesh-ancestor
101243213|NCT01638858|Growth Substances|growth substances|mesh-ancestor
101708366|NCT00516295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708367|NCT00516295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101708368|NCT00516295|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101708369|NCT00516295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101708370|NCT00516295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101708371|NCT00516295|Growth Substances|growth substances|mesh-ancestor
101708372|NCT00516295|Growth Inhibitors|growth inhibitors|mesh-ancestor
101708373|NCT00516295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101708374|NCT00516295|Tubulin Modulators|tubulin modulators|mesh-ancestor
101708375|NCT00516295|Antimitotic Agents|antimitotic agents|mesh-ancestor
101708376|NCT00516295|Mitosis Modulators|mitosis modulators|mesh-ancestor
101708377|NCT00516295|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101708378|NCT00516295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101708379|NCT00516295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708380|NCT03362099|Bupropion|bupropion|mesh-list
101708381|NCT03362099|Varenicline|varenicline|mesh-list
101708382|NCT03362099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101708383|NCT03362099|Antidepressive Agents|antidepressive agents|mesh-ancestor
101708384|NCT03362099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101708386|NCT03362099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101243353|NCT01639547|Antimetabolites|antimetabolites|mesh-ancestor
101708387|NCT03362099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101243418|NCT01640743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101708388|NCT03362099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708389|NCT03362099|Dopamine Agents|dopamine agents|mesh-ancestor
101708390|NCT03362099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101708391|NCT03362099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708392|NCT03362099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101708393|NCT03362099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101708394|NCT03362099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708395|NCT03362099|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101708396|NCT03362099|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101708397|NCT03362099|Cholinergic Agents|cholinergic agents|mesh-ancestor
101708398|NCT03861559|Mometasone Furoate|mometasone furoate|mesh-list
101708399|NCT03861559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101708400|NCT03861559|Dermatologic Agents|dermatologic agents|mesh-ancestor
101708401|NCT03861559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101243419|NCT01640743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101708402|NCT02705651|Somatostatin|somatostatin|mesh-list
101708403|NCT02705651|Hormones|hormones|mesh-ancestor
101708404|NCT02705651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101708405|NCT02705651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708406|NCT00738088|Gliclazide|gliclazide|mesh-list
101708408|NCT00738088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708409|NCT02703233|Nitrous Oxide|nitrous oxide|mesh-list
101708410|NCT02703233|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101708411|NCT02703233|Anesthetics, General|anesthetics, general|mesh-ancestor
101708412|NCT02703233|Anesthetics|anesthetics|mesh-ancestor
101708413|NCT02703233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101708414|NCT02703233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708415|NCT02703233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101708416|NCT02703233|Analgesics|analgesics|mesh-ancestor
101708417|NCT02703233|Sensory System Agents|sensory system agents|mesh-ancestor
101243547|NCT01646437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101708418|NCT02703233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101708420|NCT04152941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101708421|NCT04152941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708422|NCT04152941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708423|NCT04152941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101708424|NCT04062760|Diuretics|diuretics|mesh-list
101708425|NCT04062760|Natriuretic Agents|natriuretic agents|mesh-ancestor
101243618|NCT01650012|Eplerenone|eplerenone|mesh-list
101708426|NCT04062760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708427|NCT02702843|Xenon|xenon|mesh-list
101708428|NCT02702843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101708429|NCT02702843|Anesthetics, General|anesthetics, general|mesh-ancestor
101708430|NCT02702843|Anesthetics|anesthetics|mesh-ancestor
101708431|NCT02702843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101708432|NCT02702843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708433|NCT00516139|Lamotrigine|lamotrigine|mesh-list
101708434|NCT00516139|Anticonvulsants|anticonvulsants|mesh-ancestor
101708435|NCT00516139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101708436|NCT00516139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101708437|NCT00516139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708438|NCT00516139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101708439|NCT00516139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243744|NCT01650662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101708440|NCT00516139|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101708441|NCT00516139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101708442|NCT00516139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101708443|NCT00516139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101708444|NCT00516139|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101243745|NCT01650662|Immunologic Factors|immunologic factors|mesh-ancestor
101708446|NCT02704715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101708447|NCT02704715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708448|NCT00515827|Raltegravir Potassium|raltegravir potassium|mesh-list
101708449|NCT00515827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101708450|NCT00515827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101708451|NCT00515827|Antiviral Agents|antiviral agents|mesh-ancestor
101708452|NCT00515827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101708453|NCT00515827|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101708454|NCT00515827|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101708455|NCT00515827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708456|NCT00515827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708457|NCT00615875|Naproxen|naproxen|mesh-list
101194172|NCT02241564|Sirolimus|sirolimus|mesh-list
101708459|NCT00615875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101708460|NCT00615875|Analgesics|analgesics|mesh-ancestor
101708461|NCT00615875|Sensory System Agents|sensory system agents|mesh-ancestor
101708462|NCT00615875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101708463|NCT00615875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708464|NCT00615875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101708465|NCT00615875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101708466|NCT00615875|Gout Suppressants|gout suppressants|mesh-ancestor
101708467|NCT00615875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101708468|NCT00615875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708469|NCT00615875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708470|NCT02630888|Memantine|memantine|mesh-list
101708471|NCT02630888|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101708472|NCT02630888|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101708473|NCT02630888|Dopamine Agents|dopamine agents|mesh-ancestor
101708474|NCT02630888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101708475|NCT02630888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708476|NCT02630888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708477|NCT02630888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101708478|NCT02630888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101708479|NCT00666302|Pimecrolimus|pimecrolimus|mesh-list
101708480|NCT00666302|Tacrolimus|tacrolimus|mesh-list
101708481|NCT00666302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101708482|NCT00666302|Immunologic Factors|immunologic factors|mesh-ancestor
101708483|NCT00666302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708484|NCT00666302|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101708485|NCT00666302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101243875|NCT01651416|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101243877|NCT01651416|Artenimol|artenimol|mesh-list
101708486|NCT00666302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708487|NCT00666302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101708488|NCT00666302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101708490|NCT00666302|Sensory System Agents|sensory system agents|mesh-ancestor
101708491|NCT00666302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101708492|NCT00666302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101708493|NCT00666302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101708494|NCT00666302|Dermatologic Agents|dermatologic agents|mesh-ancestor
101243922|NCT01651715|Antibodies|antibodies|mesh-list
101708495|NCT00671372|Bevacizumab|bevacizumab|mesh-list
101708496|NCT00671372|Cetuximab|cetuximab|mesh-list
101708497|NCT00671372|Irinotecan|irinotecan|mesh-list
101708498|NCT00671372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101708499|NCT00671372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101708500|NCT00671372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101708501|NCT00671372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101708502|NCT00671372|Growth Substances|growth substances|mesh-ancestor
101708503|NCT00671372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243982|NCT01652014|Alkylating Agents|alkylating agents|mesh-ancestor
101708504|NCT00671372|Growth Inhibitors|growth inhibitors|mesh-ancestor
101708505|NCT00671372|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101708506|NCT00671372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101708507|NCT00671372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708508|NCT00671372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708510|NCT00856986|Liraglutide|liraglutide|mesh-list
101708511|NCT00856986|Insulin Detemir|insulin detemir|mesh-list
101708512|NCT00856986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101708513|NCT00856986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708515|NCT00856986|Hormones|hormones|mesh-ancestor
101708516|NCT00856986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101708517|NCT00666692|Paclitaxel|paclitaxel|mesh-list
101708518|NCT00666692|Bevacizumab|bevacizumab|mesh-list
101708519|NCT00666692|Carboplatin|carboplatin|mesh-list
101708520|NCT00666692|Volociximab|volociximab|mesh-list
101708521|NCT00666692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101708522|NCT00666692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101708523|NCT00666692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101708524|NCT00666692|Tubulin Modulators|tubulin modulators|mesh-ancestor
101708525|NCT00666692|Antimitotic Agents|antimitotic agents|mesh-ancestor
101708526|NCT00666692|Mitosis Modulators|mitosis modulators|mesh-ancestor
101708527|NCT00666692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708528|NCT00666692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101708529|NCT00666692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101708530|NCT00666692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101708531|NCT00666692|Growth Substances|growth substances|mesh-ancestor
101708532|NCT00666692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244262|NCT01653067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101708533|NCT00666692|Growth Inhibitors|growth inhibitors|mesh-ancestor
101244283|NCT01653171|Acetylcysteine|acetylcysteine|mesh-list
101708534|NCT00666692|Immunologic Factors|immunologic factors|mesh-ancestor
101708536|NCT00707746|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101708537|NCT00707746|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101708538|NCT00707746|Antimetabolites|antimetabolites|mesh-ancestor
101302568|NCT00324805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101708539|NCT00707746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708540|NCT00707746|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101708541|NCT00666770|Gabapentin|gabapentin|mesh-list
101708542|NCT00666770|Analgesics|analgesics|mesh-ancestor
101708543|NCT00666770|Sensory System Agents|sensory system agents|mesh-ancestor
101708544|NCT00666770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101708545|NCT00666770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708547|NCT00666770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101708548|NCT00666770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101708549|NCT00666770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101244317|NCT01653457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101708550|NCT00666770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101708551|NCT00666770|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101708552|NCT00666770|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101708553|NCT00666770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101708554|NCT00666770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708555|NCT00666770|Antimanic Agents|antimanic agents|mesh-ancestor
101708556|NCT04188353|Mannitol|mannitol|mesh-list
101708557|NCT04188353|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101708558|NCT04188353|Diuretics|diuretics|mesh-ancestor
101708559|NCT04188353|Natriuretic Agents|natriuretic agents|mesh-ancestor
101708560|NCT04188353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708561|NCT03583697|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
101708562|NCT03583697|Natriuretic Agents|natriuretic agents|mesh-ancestor
101708563|NCT03583697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708564|NCT02630420|Cetuximab|cetuximab|mesh-list
101708565|NCT02630420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101708566|NCT02630420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101708567|NCT00667082|Vorinostat|vorinostat|mesh-list
101708568|NCT00667082|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
101708569|NCT00667082|Proteasome Inhibitors|proteasome inhibitors|mesh-list
101708570|NCT00667082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101708571|NCT00667082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708572|NCT00667082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708573|NCT00667082|Protease Inhibitors|protease inhibitors|mesh-ancestor
101244382|NCT01653990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708575|NCT05343299|Ropivacaine|ropivacaine|mesh-list
101708576|NCT05343299|Anesthetics|anesthetics|mesh-list
101708577|NCT05343299|Anesthetics, Local|anesthetics, local|mesh-ancestor
101708578|NCT05343299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101708579|NCT05343299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708580|NCT05343299|Sensory System Agents|sensory system agents|mesh-ancestor
101708581|NCT05343299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101708582|NCT05343299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101708583|NCT05343299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101708584|NCT05343299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101708585|NCT05343299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101708586|NCT05343299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708587|NCT00667160|Pimecrolimus|pimecrolimus|mesh-list
101708588|NCT00667160|Tacrolimus|tacrolimus|mesh-list
101708589|NCT00667160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101708590|NCT00667160|Immunologic Factors|immunologic factors|mesh-ancestor
101708591|NCT00667160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708592|NCT00667160|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101708593|NCT00667160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708594|NCT00667160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708595|NCT00667160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101708596|NCT00667160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101708597|NCT00667160|Analgesics|analgesics|mesh-ancestor
101708598|NCT00667160|Sensory System Agents|sensory system agents|mesh-ancestor
101708599|NCT00667160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101708600|NCT00667160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101708601|NCT00667160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101708602|NCT00667160|Dermatologic Agents|dermatologic agents|mesh-ancestor
101708603|NCT02701673|Pyridoxine|pyridoxine|mesh-list
101708604|NCT02701673|Gemcitabine|gemcitabine|mesh-list
101244567|NCT01655095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101244570|NCT01655095|Cathartics|cathartics|mesh-ancestor
101708606|NCT02701673|Melphalan|melphalan|mesh-list
101708607|NCT02701673|Busulfan|busulfan|mesh-list
101708608|NCT02701673|Belinostat|belinostat|mesh-list
101708609|NCT02701673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101708610|NCT02701673|Antimetabolites|antimetabolites|mesh-ancestor
101708611|NCT02701673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708612|NCT02701673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101708613|NCT02701673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708614|NCT02701673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101708616|NCT02701673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101708617|NCT02701673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101708618|NCT02701673|Immunologic Factors|immunologic factors|mesh-ancestor
101708619|NCT02701673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708620|NCT02701673|Vitamin B Complex|vitamin b complex|mesh-ancestor
101708621|NCT02701673|Vitamins|vitamins|mesh-ancestor
101708622|NCT02701673|Micronutrients|micronutrients|mesh-ancestor
101708623|NCT02701673|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101708624|NCT00522379|Rotigotine|rotigotine|mesh-list
101708625|NCT00522379|Dopamine Agonists|dopamine agonists|mesh-ancestor
101708626|NCT00522379|Dopamine Agents|dopamine agents|mesh-ancestor
101708627|NCT00522379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101708628|NCT00522379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708629|NCT00522379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708630|NCT00856830|Carboplatin|carboplatin|mesh-list
101708631|NCT00856830|Irinotecan|irinotecan|mesh-list
101708632|NCT00856830|Etoposide|etoposide|mesh-list
101708633|NCT00856830|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101708634|NCT00856830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101708635|NCT00856830|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101708636|NCT00856830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101708637|NCT00856830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708638|NCT00856830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708639|NCT00856830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101708640|NCT00856830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101708641|NCT00856830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101708642|NCT00856830|Alkylating Agents|alkylating agents|mesh-ancestor
101708643|NCT02614404|Piperaquine|piperaquine|mesh-list
101708644|NCT02614404|Artenimol|artenimol|mesh-list
101708645|NCT02614404|Imatinib Mesylate|imatinib mesylate|mesh-list
101708646|NCT02614404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101208010|NCT03098355|Analgesics|analgesics|mesh-ancestor
101708647|NCT02614404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101708648|NCT02614404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708649|NCT02614404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708650|NCT02614404|Antimalarials|antimalarials|mesh-ancestor
101708651|NCT02614404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101708652|NCT02614404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101708653|NCT02614404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101708654|NCT00522301|Sorafenib|sorafenib|mesh-list
101708655|NCT00522301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101708656|NCT00522301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101708657|NCT00522301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708658|NCT00522301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244950|NCT01656811|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101708660|NCT00662636|Lapatinib|lapatinib|mesh-list
101708661|NCT00662636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101708662|NCT00662636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101708663|NCT00662636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708664|NCT00662636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708665|NCT00506389|Mirtazapine|mirtazapine|mesh-list
101708666|NCT00506389|Antidepressive Agents|antidepressive agents|mesh-ancestor
101708667|NCT00506389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101708668|NCT00506389|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101708669|NCT00506389|Histamine Antagonists|histamine antagonists|mesh-ancestor
101708671|NCT00506389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101708672|NCT00506389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245011|NCT01657201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101708673|NCT00506389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708674|NCT00506389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101708675|NCT00506389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101708676|NCT00506389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101708677|NCT00506389|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101708678|NCT00506389|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101708679|NCT00506389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101708680|NCT00506389|Adrenergic Agents|adrenergic agents|mesh-ancestor
101708681|NCT00506389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101708682|NCT00506389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101708683|NCT00506389|Serotonin Agents|serotonin agents|mesh-ancestor
101708684|NCT00506389|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101708686|NCT00667472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101245140|NCT01657838|Antifungal Agents|antifungal agents|mesh-ancestor
101708687|NCT00667472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101708688|NCT00667472|Growth Substances|growth substances|mesh-ancestor
101708689|NCT00667472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708690|NCT00667472|Growth Inhibitors|growth inhibitors|mesh-ancestor
101708691|NCT00667472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101708692|NCT00662714|Insulin|insulin|mesh-list
101708693|NCT00662714|Repaglinide|repaglinide|mesh-list
101708695|NCT00662714|Insulin, Short-Acting|insulin, short-acting|mesh-list
101708696|NCT00662714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101708697|NCT00662714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708698|NCT00668018|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101708699|NCT00668018|Vasodilator Agents|vasodilator agents|mesh-ancestor
101708700|NCT00668018|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101708701|NCT00668018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101708702|NCT00668018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708703|NCT00668018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708704|NCT00668018|Urological Agents|urological agents|mesh-ancestor
101708705|NCT00871338|Vaccines|vaccines|mesh-list
101708706|NCT00871338|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101708707|NCT00871338|Immunologic Factors|immunologic factors|mesh-ancestor
101708708|NCT00871338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708709|NCT04130100|Hyaluronic Acid|hyaluronic acid|mesh-list
101708710|NCT04130100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101708711|NCT04130100|Immunologic Factors|immunologic factors|mesh-ancestor
101245339|NCT01658774|Tubulin Modulators|tubulin modulators|mesh-ancestor
101245343|NCT01658852|Metronidazole|metronidazole|mesh-list
101708712|NCT04130100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708713|NCT04130100|Viscosupplements|viscosupplements|mesh-ancestor
101708714|NCT04130100|Protective Agents|protective agents|mesh-ancestor
101708715|NCT00597116|Vinorelbine|vinorelbine|mesh-list
101708716|NCT00597116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101708717|NCT00597116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101708718|NCT00597116|Tubulin Modulators|tubulin modulators|mesh-ancestor
101708719|NCT00597116|Antimitotic Agents|antimitotic agents|mesh-ancestor
101708720|NCT00597116|Mitosis Modulators|mitosis modulators|mesh-ancestor
101708721|NCT00597116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708723|NCT00668096|Vasodilator Agents|vasodilator agents|mesh-ancestor
101708724|NCT00668096|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101708725|NCT00668096|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101708726|NCT00668096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101245479|NCT01659359|Sensory System Agents|sensory system agents|mesh-ancestor
101708727|NCT00668096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708729|NCT00514735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
101708730|NCT03252587|Deucravacitinib|deucravacitinib|mesh-list
101245545|NCT01659788|Vitamins|vitamins|mesh-ancestor
101708731|NCT03252587|Dermatologic Agents|dermatologic agents|mesh-ancestor
101708732|NCT03252587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101708733|NCT03252587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708734|NCT03252587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708735|NCT02630264|Paclitaxel|paclitaxel|mesh-list
101708736|NCT02630264|Endostatins|endostatins|mesh-list
101708737|NCT02630264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101708738|NCT02630264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101708739|NCT02630264|Tubulin Modulators|tubulin modulators|mesh-ancestor
101708740|NCT02630264|Antimitotic Agents|antimitotic agents|mesh-ancestor
101708741|NCT02630264|Mitosis Modulators|mitosis modulators|mesh-ancestor
101708742|NCT02630264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708743|NCT02630264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101708744|NCT02630264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101708745|NCT02630264|Growth Substances|growth substances|mesh-ancestor
101708746|NCT02630264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708747|NCT02630264|Growth Inhibitors|growth inhibitors|mesh-ancestor
101708748|NCT00668330|Calcium, Dietary|calcium, dietary|mesh-list
101708749|NCT00668330|Ibandronic Acid|ibandronic acid|mesh-list
101708750|NCT00668330|Alfacalcidol|alfacalcidol|mesh-list
101708751|NCT00668330|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
101708752|NCT00668330|Calcium|calcium|mesh-list
101708753|NCT00668330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101708754|NCT00668330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708755|NCT00668330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101708756|NCT00668330|Vitamins|vitamins|mesh-ancestor
101708757|NCT00668330|Micronutrients|micronutrients|mesh-ancestor
101708758|NCT01012687|Perindopril|perindopril|mesh-list
101194462|NCT02249130|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101245816|NCT01661322|Analgesics|analgesics|mesh-ancestor
101708759|NCT01012687|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101708760|NCT01012687|Protease Inhibitors|protease inhibitors|mesh-ancestor
101708761|NCT01012687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708762|NCT01012687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708763|NCT01012687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101708764|NCT00662948|Rituximab|rituximab|mesh-list
101708765|NCT00662948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101708766|NCT00662948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101708767|NCT00662948|Immunologic Factors|immunologic factors|mesh-ancestor
101708769|NCT00662948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101708770|NCT00511147|Immunoglobulins|immunoglobulins|mesh-list
101708771|NCT00511147|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101708772|NCT00511147|gamma-Globulins|gamma-globulins|mesh-list
101708773|NCT00511147|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101245890|NCT01661556|Antioxidants|antioxidants|mesh-ancestor
101708774|NCT00511147|Immunologic Factors|immunologic factors|mesh-ancestor
101708775|NCT00511147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708776|NCT00672464|Metformin|metformin|mesh-list
101708777|NCT00672464|Olanzapine|olanzapine|mesh-list
101708778|NCT00672464|Simvastatin|simvastatin|mesh-list
101708779|NCT00672464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101708780|NCT00672464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708781|NCT00672464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101708782|NCT00672464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101708783|NCT00672464|Antimetabolites|antimetabolites|mesh-ancestor
101302569|NCT00324805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101245945|NCT01662193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101245946|NCT01662193|Antacids|antacids|mesh-ancestor
101708784|NCT00672464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708785|NCT00672464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101708786|NCT00672464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101708787|NCT00672464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708788|NCT00672464|Antiemetics|antiemetics|mesh-ancestor
101708789|NCT00672464|Autonomic Agents|autonomic agents|mesh-ancestor
101708790|NCT00672464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101708791|NCT00672464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101708792|NCT00672464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101708793|NCT00672464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101708794|NCT00672464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101708795|NCT00672464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101708796|NCT00672464|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101708797|NCT00672464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101708798|NCT00672464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101708799|NCT00672464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101708800|NCT00672464|Serotonin Agents|serotonin agents|mesh-ancestor
101708801|NCT02701595|Amoxicillin|amoxicillin|mesh-list
101708802|NCT02701595|Vancomycin|vancomycin|mesh-list
101708803|NCT02701595|Gentamicins|gentamicins|mesh-list
101708804|NCT02701595|Ceftriaxone|ceftriaxone|mesh-list
101708805|NCT02701595|Penicillins|penicillins|mesh-list
101708806|NCT02701595|Penicillin G|penicillin g|mesh-list
101708807|NCT02701595|Penicillin G Benzathine|penicillin g benzathine|mesh-list
101246150|NCT01664013|Cholinergic Agents|cholinergic agents|mesh-ancestor
101708808|NCT02701595|Penicillin G Procaine|penicillin g procaine|mesh-list
101708809|NCT02701595|Netilmicin|netilmicin|mesh-list
101708810|NCT02701595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101708811|NCT02701595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101708812|NCT02701595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101708813|NCT02701595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708814|NCT02701595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708815|NCT02698553|Bupropion|bupropion|mesh-list
101708816|NCT02698553|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101708817|NCT02698553|Antidepressive Agents|antidepressive agents|mesh-ancestor
101708818|NCT02698553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101708819|NCT02698553|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101708820|NCT02698553|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101708821|NCT02698553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101246212|NCT01664728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708822|NCT02698553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708823|NCT02698553|Dopamine Agents|dopamine agents|mesh-ancestor
101708824|NCT02698553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101708825|NCT02698553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708826|NCT02698553|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101708827|NCT02698553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101708828|NCT02698553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708829|NCT00663182|Entecavir|entecavir|mesh-list
101708830|NCT00663182|Antiviral Agents|antiviral agents|mesh-ancestor
101708831|NCT00663182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101708832|NCT00616031|Paclitaxel|paclitaxel|mesh-list
101708833|NCT00616031|Carboplatin|carboplatin|mesh-list
101708834|NCT00616031|Nitroglycerin|nitroglycerin|mesh-list
101708835|NCT00616031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101708837|NCT00616031|Tubulin Modulators|tubulin modulators|mesh-ancestor
101708838|NCT00616031|Antimitotic Agents|antimitotic agents|mesh-ancestor
101708839|NCT00616031|Mitosis Modulators|mitosis modulators|mesh-ancestor
101708840|NCT00616031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708841|NCT00616031|Vasodilator Agents|vasodilator agents|mesh-ancestor
101708842|NCT04213937|Paclitaxel|paclitaxel|mesh-list
101708843|NCT04213937|Topotecan|topotecan|mesh-list
101708844|NCT04213937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101708845|NCT04213937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101708846|NCT04213937|Tubulin Modulators|tubulin modulators|mesh-ancestor
101708847|NCT04213937|Antimitotic Agents|antimitotic agents|mesh-ancestor
101708848|NCT04213937|Mitosis Modulators|mitosis modulators|mesh-ancestor
101708849|NCT04213937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708850|NCT04213937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101708851|NCT04213937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101708852|NCT04213937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708853|NCT02701517|Cyclosporine|cyclosporine|mesh-list
101708854|NCT02701517|Methotrexate|methotrexate|mesh-list
101708855|NCT02701517|Alemtuzumab|alemtuzumab|mesh-list
101708856|NCT02701517|Cyclosporins|cyclosporins|mesh-list
101708857|NCT02701517|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101708858|NCT02701517|Abortifacient Agents|abortifacient agents|mesh-ancestor
101708859|NCT02701517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101708860|NCT02701517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308458|NCT02047292|Nootropic Agents|nootropic agents|mesh-ancestor
101708861|NCT02701517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101708863|NCT02701517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708864|NCT02701517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101708865|NCT02701517|Dermatologic Agents|dermatologic agents|mesh-ancestor
101708866|NCT02701517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708867|NCT02701517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101708868|NCT02701517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101708869|NCT02701517|Immunologic Factors|immunologic factors|mesh-ancestor
101708870|NCT02701517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101708871|NCT02701517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101308471|NCT00005823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708872|NCT02701517|Antifungal Agents|antifungal agents|mesh-ancestor
101708873|NCT02701517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101708874|NCT02701517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101708875|NCT02701517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101708876|NCT02630108|Epirubicin|epirubicin|mesh-list
101708877|NCT02630108|Ethiodized Oil|ethiodized oil|mesh-list
101708878|NCT02630108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101708879|NCT02630108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101708880|NCT02630108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101708881|NCT02630108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101708882|NCT02630108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708883|NCT02630108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708884|NCT00505921|Cytarabine|cytarabine|mesh-list
101708885|NCT00505921|Cyclophosphamide|cyclophosphamide|mesh-list
101708886|NCT00505921|Melphalan|melphalan|mesh-list
101708887|NCT00505921|Carmustine|carmustine|mesh-list
101708888|NCT00505921|Fludarabine|fludarabine|mesh-list
101708889|NCT00505921|Fludarabine phosphate|fludarabine phosphate|mesh-list
101708890|NCT00505921|Etoposide|etoposide|mesh-list
101708891|NCT00505921|Etoposide phosphate|etoposide phosphate|mesh-list
101708892|NCT00505921|Molgramostim|molgramostim|mesh-list
101708893|NCT00505921|Alemtuzumab|alemtuzumab|mesh-list
101708894|NCT00505921|Sargramostim|sargramostim|mesh-list
101708895|NCT00505921|Lenograstim|lenograstim|mesh-list
101708896|NCT00505921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101708898|NCT00505921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708899|NCT00505921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101708900|NCT00505921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101708901|NCT00505921|Alkylating Agents|alkylating agents|mesh-ancestor
101708902|NCT00505921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708903|NCT00505921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101708904|NCT00505921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101708905|NCT00505921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101708906|NCT00505921|Antimetabolites|antimetabolites|mesh-ancestor
101708907|NCT00505921|Antiviral Agents|antiviral agents|mesh-ancestor
101452032|NCT00226551|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101452047|NCT00196859|Capecitabine|capecitabine|mesh-list
101708908|NCT00505921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101452099|NCT00226707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101708909|NCT00505921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101708910|NCT00505921|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101708911|NCT00505921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101708913|NCT00505921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101410631|NCT00115479|Anesthetics, Local|anesthetics, local|mesh-ancestor
101708914|NCT00505921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101708916|NCT04729205|Mitomycin|mitomycin|mesh-list
101708917|NCT04729205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101708918|NCT04729205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101708919|NCT04729205|Alkylating Agents|alkylating agents|mesh-ancestor
101708920|NCT04729205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708921|NCT04729205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101708922|NCT04729205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708923|NCT00669344|Rivastigmine|rivastigmine|mesh-list
101708924|NCT00669344|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101708925|NCT00669344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101708926|NCT00669344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708927|NCT00669344|Cholinergic Agents|cholinergic agents|mesh-ancestor
101708928|NCT00669344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101708929|NCT00669344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708930|NCT00669344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101708931|NCT00669344|Protective Agents|protective agents|mesh-ancestor
101708932|NCT02701127|Niacinamide|niacinamide|mesh-list
101708933|NCT02701127|Niacin|niacin|mesh-list
101708934|NCT02701127|Nicotinic Acids|nicotinic acids|mesh-list
101708935|NCT02701127|Vitamin B Complex|vitamin b complex|mesh-ancestor
101708936|NCT02701127|Vitamins|vitamins|mesh-ancestor
101708937|NCT02701127|Micronutrients|micronutrients|mesh-ancestor
101708938|NCT02701127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708939|NCT02701127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101452322|NCT00197483|Pergolide|pergolide|mesh-list
101708940|NCT02701127|Antimetabolites|antimetabolites|mesh-ancestor
101708941|NCT02701127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708942|NCT02701127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101708943|NCT02701127|Vasodilator Agents|vasodilator agents|mesh-ancestor
101708944|NCT02700893|Atropine|atropine|mesh-list
101708945|NCT02700893|Sufentanil|sufentanil|mesh-list
101708946|NCT02700893|Propofol|propofol|mesh-list
101708947|NCT02700893|Atracurium|atracurium|mesh-list
101708948|NCT02700893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101708949|NCT02700893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101708950|NCT02700893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708951|NCT02700893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101452386|NCT00227448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708952|NCT02700893|Anesthetics, General|anesthetics, general|mesh-ancestor
101708953|NCT02700893|Anesthetics|anesthetics|mesh-ancestor
101708954|NCT02700893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101708955|NCT02700893|Narcotics|narcotics|mesh-ancestor
101708956|NCT02700893|Analgesics|analgesics|mesh-ancestor
101708957|NCT02700893|Sensory System Agents|sensory system agents|mesh-ancestor
101452458|NCT00227682|Ascorbic Acid|ascorbic acid|mesh-list
101708958|NCT02700893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101708959|NCT02700893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101708960|NCT02700893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101708961|NCT02700893|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101708963|NCT02700893|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101708964|NCT02700893|Respiratory System Agents|respiratory system agents|mesh-ancestor
101708965|NCT02700893|Mydriatics|mydriatics|mesh-ancestor
101708966|NCT02700893|Parasympatholytics|parasympatholytics|mesh-ancestor
101452521|NCT00197912|Immunologic Factors|immunologic factors|mesh-ancestor
101452522|NCT00197912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708967|NCT02700893|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101708968|NCT02700893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101708969|NCT02700893|Cholinergic Agents|cholinergic agents|mesh-ancestor
101708970|NCT02700893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101708971|NCT02700893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708972|NCT02700893|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101708973|NCT02700893|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101452612|NCT00230997|Autonomic Agents|autonomic agents|mesh-ancestor
101708974|NCT02700893|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101708975|NCT02700893|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101708976|NCT04213781|Sufentanil|sufentanil|mesh-list
101708977|NCT04213781|Propofol|propofol|mesh-list
101708978|NCT04213781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101708979|NCT04213781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101708980|NCT04213781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708981|NCT04213781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101708982|NCT04213781|Anesthetics, General|anesthetics, general|mesh-ancestor
101708983|NCT04213781|Anesthetics|anesthetics|mesh-ancestor
101452679|NCT00228267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101708984|NCT04213781|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101708985|NCT04213781|Narcotics|narcotics|mesh-ancestor
101452685|NCT00231348|Nefazodone|nefazodone|mesh-list
101708987|NCT04213781|Sensory System Agents|sensory system agents|mesh-ancestor
101708988|NCT04213781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101708989|NCT04213781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101708991|NCT00505687|Dopamine Agonists|dopamine agonists|mesh-ancestor
101708992|NCT00505687|Dopamine Agents|dopamine agents|mesh-ancestor
101708993|NCT00505687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101302570|NCT00324805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101452779|NCT00228540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101708994|NCT00505687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101708995|NCT00505687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101708996|NCT00669656|Vitamin D|vitamin d|mesh-list
101708997|NCT00669656|Cholecalciferol|cholecalciferol|mesh-list
101708998|NCT00669656|Vitamins|vitamins|mesh-list
101708999|NCT00669656|Vitamin E|vitamin e|mesh-list
101709000|NCT00669656|Tocopherols|tocopherols|mesh-list
101709001|NCT00669656|alpha-Tocopherol|alpha-tocopherol|mesh-list
101709002|NCT00669656|Selenium|selenium|mesh-list
101709003|NCT00669656|Lycopene|lycopene|mesh-list
101709004|NCT00669656|Daidzein|daidzein|mesh-list
101709005|NCT00669656|Micronutrients|micronutrients|mesh-ancestor
101709006|NCT00669656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709007|NCT00669656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101709008|NCT00669656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101709009|NCT00669656|Antioxidants|antioxidants|mesh-ancestor
101709010|NCT00669656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709011|NCT00669656|Protective Agents|protective agents|mesh-ancestor
101709012|NCT00669656|Trace Elements|trace elements|mesh-ancestor
101709013|NCT00669656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101452987|NCT00232011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101709014|NCT00669656|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101709015|NCT00669656|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101709016|NCT00669656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101709017|NCT00669656|Phytoestrogens|phytoestrogens|mesh-ancestor
101709018|NCT00669656|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101709020|NCT00669656|Hormones|hormones|mesh-ancestor
101709021|NCT00669656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101709022|NCT00672776|Paroxetine|paroxetine|mesh-list
101709023|NCT00672776|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101709024|NCT00672776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101709025|NCT00672776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101302571|NCT00310180|Tamoxifen|tamoxifen|mesh-list
101453049|NCT00205283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101302572|NCT00310180|Letrozole|letrozole|mesh-list
101709026|NCT00672776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709027|NCT00672776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101709028|NCT00672776|Serotonin Agents|serotonin agents|mesh-ancestor
101709029|NCT00672776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709030|NCT00672776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101709031|NCT00672776|Antidepressive Agents|antidepressive agents|mesh-ancestor
101709032|NCT00672776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101453106|NCT00205634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101709033|NCT00672776|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101709034|NCT00672776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101709035|NCT00672776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101709036|NCT00616187|Interferons|interferons|mesh-list
101709037|NCT00616187|Interferon-beta|interferon-beta|mesh-list
101709038|NCT00616187|Atorvastatin|atorvastatin|mesh-list
101709039|NCT00616187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101709040|NCT00616187|Antiviral Agents|antiviral agents|mesh-ancestor
101709041|NCT00616187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101709042|NCT00616187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101453182|NCT00229515|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101453183|NCT00229515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101709043|NCT00616187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101709044|NCT00616187|Antimetabolites|antimetabolites|mesh-ancestor
101709045|NCT00616187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709046|NCT00616187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101709047|NCT00616187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101709048|NCT00616187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101709049|NCT00616187|Immunologic Factors|immunologic factors|mesh-ancestor
101709050|NCT00616187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709051|NCT00663338|Rotigotine|rotigotine|mesh-list
101709052|NCT00663338|Dopamine Agonists|dopamine agonists|mesh-ancestor
101709053|NCT00663338|Dopamine Agents|dopamine agents|mesh-ancestor
101709054|NCT00663338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101709055|NCT00663338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709056|NCT00663338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709057|NCT02992015|Gemcitabine|gemcitabine|mesh-list
101709058|NCT02992015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101709059|NCT02992015|Antimetabolites|antimetabolites|mesh-ancestor
101709060|NCT02992015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709061|NCT02992015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101709063|NCT01009567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101709064|NCT01009567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101709065|NCT01009567|Dopamine Agonists|dopamine agonists|mesh-ancestor
101709067|NCT01009567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101709068|NCT01009567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709069|NCT01009567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709070|NCT00669812|Cytarabine|cytarabine|mesh-list
101709072|NCT00669812|Cyclophosphamide|cyclophosphamide|mesh-list
101709073|NCT00669812|Melphalan|melphalan|mesh-list
101709074|NCT00669812|Ifosfamide|ifosfamide|mesh-list
101709075|NCT00669812|Carmustine|carmustine|mesh-list
101709076|NCT00669812|Doxorubicin|doxorubicin|mesh-list
101709077|NCT00669812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101709078|NCT00669812|Methotrexate|methotrexate|mesh-list
101709079|NCT00669812|Etoposide|etoposide|mesh-list
101709080|NCT00669812|Vincristine|vincristine|mesh-list
101709081|NCT00669812|Epirubicin|epirubicin|mesh-list
101709082|NCT00669812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101709083|NCT00669812|Immunologic Factors|immunologic factors|mesh-ancestor
101709084|NCT00669812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709085|NCT00669812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101709086|NCT00669812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101709087|NCT00669812|Alkylating Agents|alkylating agents|mesh-ancestor
101709088|NCT00669812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709089|NCT00669812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101709090|NCT00669812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101709091|NCT00669812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101709092|NCT00669812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101709093|NCT00669812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101709094|NCT00669812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101453665|NCT00233610|Tamoxifen|tamoxifen|mesh-list
101709095|NCT00669812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101709096|NCT00669812|Abortifacient Agents|abortifacient agents|mesh-ancestor
101709097|NCT00669812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101709098|NCT00669812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101709099|NCT00669812|Antimetabolites|antimetabolites|mesh-ancestor
101709100|NCT00669812|Dermatologic Agents|dermatologic agents|mesh-ancestor
101709101|NCT00669812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101302573|NCT00310180|Anastrozole|anastrozole|mesh-list
101709102|NCT00669812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101709103|NCT00669812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101709104|NCT00669812|Antiviral Agents|antiviral agents|mesh-ancestor
101709105|NCT00669812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101709106|NCT00669812|Tubulin Modulators|tubulin modulators|mesh-ancestor
101709107|NCT00669812|Antimitotic Agents|antimitotic agents|mesh-ancestor
101709108|NCT00669812|Mitosis Modulators|mitosis modulators|mesh-ancestor
101709109|NCT00669812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101709110|NCT00669812|Glucocorticoids|glucocorticoids|mesh-ancestor
101709111|NCT00669812|Hormones|hormones|mesh-ancestor
101453721|NCT00208208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709112|NCT00669812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101709113|NCT00669812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101709115|NCT02697851|Cobicistat|cobicistat|mesh-list
101709116|NCT02697851|Levonorgestrel|levonorgestrel|mesh-list
101709117|NCT02697851|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101709118|NCT02697851|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
101302574|NCT00310180|Exemestane|exemestane|mesh-list
101709119|NCT02697851|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
101709120|NCT02697851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101709121|NCT02697851|Contraceptive Agents|contraceptive agents|mesh-ancestor
101709122|NCT02697851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101709123|NCT02697851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453860|NCT00208715|Modafinil|modafinil|mesh-list
101709124|NCT02697851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101709125|NCT02697851|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101709126|NCT02697851|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101709127|NCT02697851|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101709128|NCT02697851|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101709129|NCT02697851|Protease Inhibitors|protease inhibitors|mesh-ancestor
101709130|NCT02697851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101709131|NCT02697851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709132|NCT02697851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101709133|NCT02697851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101709134|NCT02697851|Antiviral Agents|antiviral agents|mesh-ancestor
101709135|NCT02697851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101709136|NCT02697851|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101709137|NCT02697851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101709138|NCT02697851|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101709139|NCT02697851|Estrogens|estrogens|mesh-ancestor
101709140|NCT02697851|Hormones|hormones|mesh-ancestor
101709141|NCT02697851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101709142|NCT02697851|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101709143|NCT02697851|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
101709144|NCT02697851|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101709145|NCT02697851|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101709146|NCT01012843|Amoxicillin|amoxicillin|mesh-list
101709147|NCT01012843|Clavulanic Acid|clavulanic acid|mesh-list
101454059|NCT00209495|Autonomic Agents|autonomic agents|mesh-ancestor
101454063|NCT00209495|Glucocorticoids|glucocorticoids|mesh-ancestor
101709148|NCT01012843|Clavulanic Acids|clavulanic acids|mesh-list
101709149|NCT01012843|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101709150|NCT01012843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101709151|NCT01012843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101709152|NCT01012843|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101709153|NCT01012843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101709154|NCT01012843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709156|NCT00669890|Cyclophosphamide|cyclophosphamide|mesh-list
101454190|NCT01080625|Mydriatics|mydriatics|mesh-ancestor
101709157|NCT00669890|Busulfan|busulfan|mesh-list
101709158|NCT00669890|Methotrexate|methotrexate|mesh-list
101709159|NCT00669890|Gemtuzumab|gemtuzumab|mesh-list
101709160|NCT00669890|Tacrolimus|tacrolimus|mesh-list
101709161|NCT00669890|Thymoglobulin|thymoglobulin|mesh-list
101709162|NCT00669890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101709163|NCT00669890|Immunologic Factors|immunologic factors|mesh-ancestor
101709164|NCT00669890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709165|NCT00669890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101454197|NCT00209729|Docetaxel|docetaxel|mesh-list
101709166|NCT00669890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101709167|NCT00669890|Alkylating Agents|alkylating agents|mesh-ancestor
101709168|NCT00669890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709169|NCT00669890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101709170|NCT00669890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101709171|NCT00669890|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101709172|NCT00669890|Abortifacient Agents|abortifacient agents|mesh-ancestor
101709173|NCT00669890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101709174|NCT00669890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101709175|NCT00669890|Antimetabolites|antimetabolites|mesh-ancestor
101709176|NCT00669890|Dermatologic Agents|dermatologic agents|mesh-ancestor
101709177|NCT00669890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101709178|NCT00669890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101709179|NCT00669890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101709180|NCT00669890|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101709181|NCT00669890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101709182|NCT00669890|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101709183|NCT00669890|Antitubercular Agents|antitubercular agents|mesh-ancestor
101709184|NCT00669890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101709185|NCT00669890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101709186|NCT00669890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101709188|NCT00669890|Immunoconjugates|immunoconjugates|mesh-ancestor
101709189|NCT02697929|Neostigmine|neostigmine|mesh-list
101709190|NCT02697929|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101709191|NCT02697929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101709192|NCT02697929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709193|NCT02697929|Cholinergic Agents|cholinergic agents|mesh-ancestor
101709194|NCT02697929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101709195|NCT02697929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709197|NCT02697929|Autonomic Agents|autonomic agents|mesh-ancestor
101709198|NCT02697929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101709199|NCT00505375|Abatacept|abatacept|mesh-list
101709200|NCT00505375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101709201|NCT00505375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709202|NCT00505375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101709203|NCT00505375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101454594|NCT00234858|Losartan|losartan|mesh-list
101709204|NCT00505375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101709205|NCT00505375|Immunologic Factors|immunologic factors|mesh-ancestor
101709206|NCT00505375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709207|NCT00505375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101709208|NCT02700347|Pyrazinamide|pyrazinamide|mesh-list
101709209|NCT02700347|Allopurinol|allopurinol|mesh-list
101709210|NCT02700347|Antimetabolites|antimetabolites|mesh-ancestor
101194905|NCT05768464|Axitinib|axitinib|mesh-list
101709211|NCT02700347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709212|NCT02700347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101709213|NCT02700347|Gout Suppressants|gout suppressants|mesh-ancestor
101709214|NCT02700347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101709216|NCT02700347|Antioxidants|antioxidants|mesh-ancestor
101709217|NCT02700347|Protective Agents|protective agents|mesh-ancestor
101709218|NCT02700347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709219|NCT02700347|Antitubercular Agents|antitubercular agents|mesh-ancestor
101709220|NCT02700347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101709221|NCT02700347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101709222|NCT00594932|Mycophenolic Acid|mycophenolic acid|mesh-list
101709223|NCT00594932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101709224|NCT00594932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101709225|NCT00594932|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101709226|NCT00594932|Antitubercular Agents|antitubercular agents|mesh-ancestor
101709227|NCT00594932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101709228|NCT00594932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101709229|NCT00594932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101709230|NCT00594932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709231|NCT00616889|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101709232|NCT00616889|Antidepressive Agents|antidepressive agents|mesh-ancestor
101709233|NCT00616889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101709234|NCT00616889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101709235|NCT00616889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101709236|NCT00616889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101709237|NCT00616889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709239|NCT00673088|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101709240|NCT00673088|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101709241|NCT00673088|Dopamine Agonists|dopamine agonists|mesh-ancestor
101709242|NCT00673088|Dopamine Agents|dopamine agents|mesh-ancestor
101709243|NCT00673088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101709244|NCT00673088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709245|NCT00673088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709246|NCT00504829|Atorvastatin|atorvastatin|mesh-list
101709247|NCT00504829|Fenofibrate|fenofibrate|mesh-list
101709248|NCT00504829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101709249|NCT00504829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101709250|NCT00504829|Antimetabolites|antimetabolites|mesh-ancestor
101455026|NCT00211562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709251|NCT00504829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709253|NCT00504829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101709254|NCT00504829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101709255|NCT02701205|Etanercept|etanercept|mesh-list
101709256|NCT02701205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101709257|NCT02701205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101709258|NCT02701205|Analgesics|analgesics|mesh-ancestor
101709259|NCT02701205|Sensory System Agents|sensory system agents|mesh-ancestor
101709260|NCT02701205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101709261|NCT02701205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709262|NCT02701205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101709263|NCT02701205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101709264|NCT02701205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101709265|NCT02701205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101709266|NCT02701205|Immunologic Factors|immunologic factors|mesh-ancestor
101709267|NCT00670436|Paclitaxel|paclitaxel|mesh-list
101709268|NCT00670436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101308699|NCT00005922|Hormones|hormones|mesh-ancestor
101709269|NCT00670436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101709270|NCT00670436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101709271|NCT00670436|Tubulin Modulators|tubulin modulators|mesh-ancestor
101709272|NCT00670436|Antimitotic Agents|antimitotic agents|mesh-ancestor
101709273|NCT00670436|Mitosis Modulators|mitosis modulators|mesh-ancestor
101709274|NCT00670436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709275|NCT02699879|Pirfenidone|pirfenidone|mesh-list
101709276|NCT02699879|Analgesics|analgesics|mesh-ancestor
101709277|NCT02699879|Sensory System Agents|sensory system agents|mesh-ancestor
101455345|NCT00239109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101709278|NCT02699879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101709279|NCT02699879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709280|NCT02699879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101709281|NCT02699879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101709282|NCT02699879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101709283|NCT02699879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101709284|NCT02699879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101709285|NCT02699723|Itraconazole|itraconazole|mesh-list
101709286|NCT02699723|Arsenic Trioxide|arsenic trioxide|mesh-list
101709287|NCT02699723|Antifungal Agents|antifungal agents|mesh-ancestor
101709288|NCT02699723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101709289|NCT02699723|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101709290|NCT02699723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101709291|NCT02699723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101709292|NCT02699723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709293|NCT02699723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101709294|NCT02699723|Hormone Antagonists|hormone antagonists|mesh-ancestor
101709295|NCT02699723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101709296|NCT02699723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455536|NCT00239538|Telmisartan|telmisartan|mesh-list
101709297|NCT02699723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101709298|NCT02699723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101709299|NCT02699645|Amlodipine|amlodipine|mesh-list
101709300|NCT02699645|Telmisartan|telmisartan|mesh-list
101709301|NCT02699645|Indapamide|indapamide|mesh-list
101709302|NCT02699645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101709303|NCT02699645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101455586|NCT00239889|Calcitonin|calcitonin|mesh-list
101709304|NCT02699645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101709305|NCT02699645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709306|NCT02699645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101709307|NCT02699645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455661|NCT00243711|Glycerol|glycerol|mesh-list
101709308|NCT02699645|Vasodilator Agents|vasodilator agents|mesh-ancestor
101709309|NCT02699645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101709310|NCT02699645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101709312|NCT02699645|Natriuretic Agents|natriuretic agents|mesh-ancestor
101709313|NCT02699645|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101709315|NCT04152434|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
101709316|NCT04152434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709317|NCT04152434|Analgesics|analgesics|mesh-ancestor
101709318|NCT04152434|Sensory System Agents|sensory system agents|mesh-ancestor
101709319|NCT04152434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101709320|NCT04152434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709321|NCT00615797|Penicillins|penicillins|mesh-list
101709322|NCT00615797|Penicillin V|penicillin v|mesh-list
101709323|NCT00615797|Haloperidol|haloperidol|mesh-list
101709324|NCT00615797|Haloperidol decanoate|haloperidol decanoate|mesh-list
101709325|NCT00615797|Immunoglobulins|immunoglobulins|mesh-list
101709326|NCT00615797|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101709327|NCT00615797|Antibodies|antibodies|mesh-list
101709328|NCT00615797|gamma-Globulins|gamma-globulins|mesh-list
101709329|NCT00615797|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101709330|NCT00615797|Immunologic Factors|immunologic factors|mesh-ancestor
101709331|NCT00615797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709332|NCT00615797|Antiemetics|antiemetics|mesh-ancestor
101308832|NCT00005964|Etoposide|etoposide|mesh-list
101308833|NCT00005964|Vincristine|vincristine|mesh-list
101709333|NCT00615797|Autonomic Agents|autonomic agents|mesh-ancestor
101709334|NCT00615797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101709335|NCT00615797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101709336|NCT00615797|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101709337|NCT00615797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101709338|NCT00615797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101709339|NCT00615797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101709340|NCT00615797|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101709341|NCT00615797|Dopamine Agents|dopamine agents|mesh-ancestor
101709342|NCT00615797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101709343|NCT00615797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709344|NCT00615797|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101709345|NCT00615797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101709346|NCT00615797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101709347|NCT00705016|Fluorouracil|fluorouracil|mesh-list
101709348|NCT00705016|Cetuximab|cetuximab|mesh-list
101308839|NCT00005964|Alkylating Agents|alkylating agents|mesh-ancestor
101709349|NCT00705016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101709350|NCT00705016|Antimetabolites|antimetabolites|mesh-ancestor
101709351|NCT00705016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709352|NCT00705016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101709353|NCT00705016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101709354|NCT00705016|Immunologic Factors|immunologic factors|mesh-ancestor
101709355|NCT00705016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709356|NCT00705016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101709357|NCT00595868|Varenicline|varenicline|mesh-list
101709359|NCT00595868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101709360|NCT00595868|Cholinergic Agents|cholinergic agents|mesh-ancestor
101709361|NCT00595868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101709362|NCT00595868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709363|NCT00595868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709364|NCT02699801|Dexmedetomidine|dexmedetomidine|mesh-list
101709365|NCT02699801|Propofol|propofol|mesh-list
101709366|NCT02699801|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101456228|NCT00215774|Flecainide|flecainide|mesh-list
101308847|NCT00005964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101308849|NCT00005964|Hormones|hormones|mesh-ancestor
101709367|NCT02699801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101709368|NCT02699801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709369|NCT02699801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101709370|NCT02699801|Analgesics|analgesics|mesh-ancestor
101366830|NCT00159133|Lorazepam|lorazepam|mesh-list
101709371|NCT02699801|Sensory System Agents|sensory system agents|mesh-ancestor
101709372|NCT02699801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101709373|NCT02699801|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101709374|NCT02699801|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101709375|NCT02699801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101709376|NCT02699801|Adrenergic Agents|adrenergic agents|mesh-ancestor
101709377|NCT02699801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101709378|NCT02699801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709379|NCT02699801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101709380|NCT02699801|Anesthetics, General|anesthetics, general|mesh-ancestor
101709381|NCT02699801|Anesthetics|anesthetics|mesh-ancestor
101709382|NCT02727907|Interferons|interferons|mesh-list
101709383|NCT02727907|Interferon-beta|interferon-beta|mesh-list
101709384|NCT02727907|Interferon beta-1a|interferon beta-1a|mesh-list
101709385|NCT02727907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101709386|NCT02727907|Antiviral Agents|antiviral agents|mesh-ancestor
101709387|NCT02727907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101709388|NCT02727907|Immunologic Factors|immunologic factors|mesh-ancestor
101308856|NCT00005967|Tipifarnib|tipifarnib|mesh-list
101709389|NCT02727907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709390|NCT02727907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101709391|NCT00663728|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101709392|NCT00663728|Vasodilator Agents|vasodilator agents|mesh-ancestor
101709393|NCT00663728|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101709394|NCT00663728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101709395|NCT00663728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101709396|NCT00663728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709397|NCT00663728|Urological Agents|urological agents|mesh-ancestor
101709399|NCT01009801|Everolimus|everolimus|mesh-list
101709400|NCT01009801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101709401|NCT01009801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101709402|NCT01009801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101709403|NCT01009801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101709404|NCT01009801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101709405|NCT01009801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709406|NCT01009801|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101709407|NCT01009801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101709408|NCT01009801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101709409|NCT01009801|Immunologic Factors|immunologic factors|mesh-ancestor
101709410|NCT01009801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709411|NCT00617045|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101709412|NCT00617045|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101709413|NCT00617045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101709414|NCT00617045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101709415|NCT00617045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709416|NCT00617045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101709417|NCT00617045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709418|NCT00617045|Analgesics|analgesics|mesh-ancestor
101709419|NCT00617045|Sensory System Agents|sensory system agents|mesh-ancestor
101775463|NCT00676520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101709420|NCT00617045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101709421|NCT00617045|Antidepressive Agents|antidepressive agents|mesh-ancestor
101709422|NCT00617045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101775555|NCT00655980|Vitamins|vitamins|mesh-ancestor
101709423|NCT00617045|Dopamine Agents|dopamine agents|mesh-ancestor
101709424|NCT02629718|Paclitaxel|paclitaxel|mesh-list
101709425|NCT02629718|Carboplatin|carboplatin|mesh-list
101709426|NCT02629718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101709427|NCT02629718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101709428|NCT02629718|Tubulin Modulators|tubulin modulators|mesh-ancestor
101775620|NCT00676130|Cephalexin|cephalexin|mesh-list
101709429|NCT02629718|Antimitotic Agents|antimitotic agents|mesh-ancestor
101709430|NCT02629718|Mitosis Modulators|mitosis modulators|mesh-ancestor
101709431|NCT02629718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709432|NCT01009879|Etanercept|etanercept|mesh-list
101709433|NCT01009879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101709434|NCT01009879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101709435|NCT01009879|Analgesics|analgesics|mesh-ancestor
101709436|NCT01009879|Sensory System Agents|sensory system agents|mesh-ancestor
101709437|NCT01009879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101709438|NCT01009879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709439|NCT01009879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101709440|NCT01009879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101709441|NCT01009879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101709442|NCT01009879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101709443|NCT01009879|Immunologic Factors|immunologic factors|mesh-ancestor
101366905|NCT00159718|Amlodipine|amlodipine|mesh-list
101709445|NCT01009957|MTOR Inhibitors|mtor inhibitors|mesh-list
101709446|NCT01009957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101709448|NCT01009957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709449|NCT01009957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101709450|NCT01009957|Immunologic Factors|immunologic factors|mesh-ancestor
101709451|NCT01009957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709452|NCT01009957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101709453|NCT04062370|Ranibizumab|ranibizumab|mesh-list
101709454|NCT04062370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101709455|NCT04062370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101709456|NCT04062370|Growth Substances|growth substances|mesh-ancestor
101709457|NCT04062370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709458|NCT04062370|Growth Inhibitors|growth inhibitors|mesh-ancestor
101709459|NCT04062370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101709460|NCT01015183|Zinc Sulfate|zinc sulfate|mesh-list
101709461|NCT01015183|Astringents|astringents|mesh-ancestor
101775874|NCT00759122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101775884|NCT02558816|Venetoclax|venetoclax|mesh-list
101709462|NCT01015183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709463|NCT01015183|Dermatologic Agents|dermatologic agents|mesh-ancestor
101709464|NCT00856284|Metformin|metformin|mesh-list
101709465|NCT00856284|Alogliptin|alogliptin|mesh-list
101709466|NCT00856284|Glipizide|glipizide|mesh-list
101709467|NCT00856284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101709468|NCT00856284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709469|NCT00856284|Incretins|incretins|mesh-ancestor
101709470|NCT00856284|Hormones|hormones|mesh-ancestor
101709471|NCT00856284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101709472|NCT00856284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101709473|NCT00856284|Protease Inhibitors|protease inhibitors|mesh-ancestor
101709474|NCT00856284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101709475|NCT00856284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709476|NCT00510289|Sorafenib|sorafenib|mesh-list
101709477|NCT00510289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101709479|NCT00510289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101709480|NCT00510289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709481|NCT01013155|Perindopril|perindopril|mesh-list
101709482|NCT01013155|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101709483|NCT01013155|Protease Inhibitors|protease inhibitors|mesh-ancestor
101709484|NCT01013155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101709485|NCT01013155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709486|NCT01013155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101709487|NCT00663806|Ciprofloxacin|ciprofloxacin|mesh-list
101709488|NCT00663806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101709489|NCT00663806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101709490|NCT00663806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101709491|NCT00663806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101709492|NCT00663806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101709493|NCT00663806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709494|NCT00663806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101709495|NCT00663806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101709496|NCT00663806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101709497|NCT01015339|Paclitaxel|paclitaxel|mesh-list
101709499|NCT01015339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101709500|NCT01015339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101709502|NCT01015339|Antimitotic Agents|antimitotic agents|mesh-ancestor
101709503|NCT01015339|Mitosis Modulators|mitosis modulators|mesh-ancestor
101709504|NCT01015339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776209|NCT00950391|Tacrolimus|tacrolimus|mesh-list
101709505|NCT01015339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101709506|NCT01015339|Antimetabolites|antimetabolites|mesh-ancestor
101709507|NCT05110313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101776286|NCT00946335|Veliparib|veliparib|mesh-list
101709509|NCT05110313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709510|NCT02622906|Pasireotide|pasireotide|mesh-list
101709511|NCT02622906|Hormones|hormones|mesh-ancestor
101709512|NCT02622906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101709513|NCT02622906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709514|NCT00673556|Alefacept|alefacept|mesh-list
101709515|NCT00673556|Dermatologic Agents|dermatologic agents|mesh-ancestor
101709516|NCT00673556|Immunologic Factors|immunologic factors|mesh-ancestor
101709517|NCT00673556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366979|NCT00407017|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101709518|NCT00675896|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101709519|NCT00675896|Antidepressive Agents|antidepressive agents|mesh-ancestor
101709520|NCT00675896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101709521|NCT00675896|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101709522|NCT00675896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101709523|NCT00675896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101709524|NCT00675896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709525|NCT01015417|Amoxicillin|amoxicillin|mesh-list
101776479|NCT00764972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101709526|NCT01015417|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101709527|NCT01015417|Clavulanic Acids|clavulanic acids|mesh-list
101709528|NCT01015417|Clavulanic Acid|clavulanic acid|mesh-list
101709529|NCT01015417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101709530|NCT01015417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101709531|NCT01015417|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101709532|NCT01015417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101709533|NCT01015417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709534|NCT04061824|Olmesartan|olmesartan|mesh-list
101709535|NCT04061824|Angiotensin II|angiotensin ii|mesh-list
101709536|NCT04061824|Giapreza|giapreza|mesh-list
101709537|NCT04061824|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101709538|NCT04061824|Angiotensinogen|angiotensinogen|mesh-list
101709539|NCT04061824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
101709540|NCT04061824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101709541|NCT04061824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101709542|NCT04061824|Antimetabolites|antimetabolites|mesh-ancestor
101776684|NCT00655668|Growth Substances|growth substances|mesh-ancestor
101709543|NCT04061824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709545|NCT04061824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101709546|NCT04061824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101709547|NCT04061824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101709548|NCT04061824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101709549|NCT04061824|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101709550|NCT04061824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101709551|NCT04061824|Protease Inhibitors|protease inhibitors|mesh-ancestor
101709553|NCT04212533|Vitamins|vitamins|mesh-ancestor
101709554|NCT04212533|Micronutrients|micronutrients|mesh-ancestor
101709556|NCT04212533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101709557|NCT04155554|Tenofovir|tenofovir|mesh-list
101709558|NCT04155554|Lamivudine|lamivudine|mesh-list
101709559|NCT04155554|Emtricitabine|emtricitabine|mesh-list
101709560|NCT04155554|Dolutegravir|dolutegravir|mesh-list
101709561|NCT04155554|Abacavir|abacavir|mesh-list
101709562|NCT04155554|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
101709563|NCT04155554|Antiviral Agents|antiviral agents|mesh-ancestor
101709564|NCT04155554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101709565|NCT04155554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101709566|NCT04155554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101709567|NCT04155554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101709568|NCT04155554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709569|NCT04155554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101709570|NCT04155554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101709571|NCT04155554|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101709572|NCT04155554|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101709573|NCT00663884|Voglibose|voglibose|mesh-list
101709574|NCT00663884|Mitiglinide|mitiglinide|mesh-list
101709575|NCT00663884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101709576|NCT00663884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709577|NCT00663884|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101709578|NCT00663884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101709579|NCT00663884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709580|NCT00856206|Rilonacept|rilonacept|mesh-list
101777099|NCT05355610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101709581|NCT00856206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101709583|NCT03997279|Metronidazole|metronidazole|mesh-list
101709584|NCT03997279|Clarithromycin|clarithromycin|mesh-list
101709585|NCT03997279|Rabeprazole|rabeprazole|mesh-list
101709586|NCT03997279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101709587|NCT03997279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101777244|NCT00952029|Antimetabolites|antimetabolites|mesh-ancestor
101709588|NCT03997279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101709589|NCT03997279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101709590|NCT03997279|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101709591|NCT03997279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101709592|NCT03997279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709593|NCT03997279|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101536060|NCT00588003|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101709594|NCT03997279|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101709596|NCT03997279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101709597|NCT03997279|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101709598|NCT00920998|Z 338|z 338|mesh-list
101709599|NCT00920998|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101709600|NCT00920998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101777309|NCT00535132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101709601|NCT00920998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709602|NCT00920998|Cholinergic Agents|cholinergic agents|mesh-ancestor
101709603|NCT00920998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101709604|NCT00920998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709605|NCT00920998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101709606|NCT00593112|Methylphenidate|methylphenidate|mesh-list
101709607|NCT00593112|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101709608|NCT00593112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709609|NCT00593112|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101709610|NCT00593112|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101709611|NCT00593112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101709612|NCT00593112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709613|NCT00593112|Dopamine Agents|dopamine agents|mesh-ancestor
101709614|NCT00593112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101709615|NCT05323565|Dexamethasone|dexamethasone|mesh-list
101709617|NCT05323565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101709618|NCT05323565|Antiemetics|antiemetics|mesh-ancestor
101709619|NCT05323565|Autonomic Agents|autonomic agents|mesh-ancestor
101709620|NCT05323565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101709621|NCT05323565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709622|NCT05323565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101709623|NCT05323565|Glucocorticoids|glucocorticoids|mesh-ancestor
101709624|NCT05323565|Hormones|hormones|mesh-ancestor
101709625|NCT05323565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101709626|NCT05323565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101709627|NCT05323565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101777573|NCT00808002|Emtricitabine|emtricitabine|mesh-list
101709628|NCT05323565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709629|NCT05323565|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101709630|NCT05323565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101709631|NCT05323565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101709633|NCT05323565|Sensory System Agents|sensory system agents|mesh-ancestor
101709634|NCT05323565|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101709635|NCT05323565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101709636|NCT05323565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101709637|NCT05323565|Adrenergic Agents|adrenergic agents|mesh-ancestor
101709638|NCT05323565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101709639|NCT01015495|Ranibizumab|ranibizumab|mesh-list
101709640|NCT01015495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101709641|NCT01015495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101709642|NCT01015495|Growth Substances|growth substances|mesh-ancestor
101709643|NCT01015495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709644|NCT01015495|Growth Inhibitors|growth inhibitors|mesh-ancestor
101709645|NCT01015495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101709646|NCT00676286|Choline|choline|mesh-list
101777673|NCT03979105|Ketamine|ketamine|mesh-list
101709648|NCT00676286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101709649|NCT00676286|Antimetabolites|antimetabolites|mesh-ancestor
101709650|NCT00676286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709651|NCT00676286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101709652|NCT00676286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101709653|NCT00676286|Nootropic Agents|nootropic agents|mesh-ancestor
101709654|NCT00699894|Ondansetron|ondansetron|mesh-list
101709655|NCT00699894|Aprepitant|aprepitant|mesh-list
101709656|NCT00699894|Antiemetics|antiemetics|mesh-ancestor
101709657|NCT00699894|Autonomic Agents|autonomic agents|mesh-ancestor
101709658|NCT00699894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101709659|NCT00699894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709660|NCT00699894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101709661|NCT00699894|Antipruritics|antipruritics|mesh-ancestor
101709662|NCT00699894|Dermatologic Agents|dermatologic agents|mesh-ancestor
101709663|NCT00699894|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101709664|NCT00699894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101709666|NCT00699894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101367131|NCT00052559|Growth Substances|growth substances|mesh-ancestor
101777758|NCT00321685|Hematinics|hematinics|mesh-ancestor
101709667|NCT00699894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709668|NCT00699894|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101709670|NCT00664196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101709671|NCT00664196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709673|NCT00616499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101709674|NCT00616499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101709675|NCT00616499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101709676|NCT00616499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709677|NCT05317936|Venetoclax|venetoclax|mesh-list
101709678|NCT05317936|Pirtobrutinib|pirtobrutinib|mesh-list
101709679|NCT05317936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101709680|NCT05317936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101709681|NCT05317936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101709682|NCT05317936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709683|NCT02614248|Protective Agents|protective agents|mesh-list
101709684|NCT02614248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709685|NCT00491179|Interferons|interferons|mesh-list
101709686|NCT00491179|Ribavirin|ribavirin|mesh-list
101709687|NCT00491179|Interferon-alpha|interferon-alpha|mesh-list
101709688|NCT00491179|Interferon alpha-2|interferon alpha-2|mesh-list
101709689|NCT00491179|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101709690|NCT00491179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101709692|NCT00491179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101709693|NCT00491179|Antimetabolites|antimetabolites|mesh-ancestor
101709694|NCT00491179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709695|NCT00491179|Immunologic Factors|immunologic factors|mesh-ancestor
101709696|NCT00491179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709697|NCT04155476|Nitroglycerin|nitroglycerin|mesh-list
101709698|NCT04155476|Vasodilator Agents|vasodilator agents|mesh-ancestor
101709699|NCT04502095|Levofloxacin|levofloxacin|mesh-list
101709700|NCT04502095|Ofloxacin|ofloxacin|mesh-list
101709701|NCT04502095|Trimethoprim|trimethoprim|mesh-list
101709702|NCT04502095|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101709703|NCT04502095|Nitrofurantoin|nitrofurantoin|mesh-list
101709704|NCT04502095|Clindamycin|clindamycin|mesh-list
101709705|NCT04502095|Ertapenem|ertapenem|mesh-list
101709706|NCT04502095|Sulfamethoxazole|sulfamethoxazole|mesh-list
101709707|NCT04502095|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101709708|NCT04502095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101709709|NCT04502095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101709710|NCT04502095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101709711|NCT04502095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101709712|NCT04502095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101709713|NCT04502095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709714|NCT04502095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101709715|NCT04502095|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101778392|NCT00780650|Adrenergic Agents|adrenergic agents|mesh-ancestor
101709716|NCT04502095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101709717|NCT04502095|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101709718|NCT04502095|Antimalarials|antimalarials|mesh-ancestor
101709719|NCT04502095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101709720|NCT04502095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101709721|NCT04502095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101709722|NCT04502095|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101709723|NCT04502095|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101709724|NCT00674102|Vadimezan|vadimezan|mesh-list
101709725|NCT00674102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101709727|NCT00503581|Megestrol Acetate|megestrol acetate|mesh-list
101709728|NCT00503581|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101709729|NCT00503581|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101709730|NCT00503581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101709731|NCT00503581|Contraceptive Agents|contraceptive agents|mesh-ancestor
101709732|NCT00503581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101709733|NCT00503581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709734|NCT00503581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101709735|NCT00503581|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101778592|NCT00642018|Prednisone|prednisone|mesh-list
101709736|NCT00503581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101709738|NCT00503581|Appetite Stimulants|appetite stimulants|mesh-ancestor
101709739|NCT00503581|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101709740|NCT00677144|Capecitabine|capecitabine|mesh-list
101709741|NCT00677144|Oxaliplatin|oxaliplatin|mesh-list
101709742|NCT00677144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101709743|NCT00677144|Antimetabolites|antimetabolites|mesh-ancestor
101709744|NCT00677144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709745|NCT00677144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101709746|NCT00703534|Lesogaberan|lesogaberan|mesh-list
101778782|NCT00995800|Xhance|xhance|mesh-list
101709747|NCT00703534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101709748|NCT00703534|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101709749|NCT00703534|GABA Agonists|gaba agonists|mesh-ancestor
101709750|NCT00703534|GABA Agents|gaba agents|mesh-ancestor
101709751|NCT00703534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101709752|NCT00703534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709753|NCT00703534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709754|NCT00503425|Rituximab|rituximab|mesh-list
101778801|NCT00821652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101709755|NCT00503425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101709756|NCT00503425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101709757|NCT00503425|Immunologic Factors|immunologic factors|mesh-ancestor
101709758|NCT00503425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709759|NCT00503425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101709760|NCT00863772|Tanezumab|tanezumab|mesh-list
101709761|NCT00863772|Analgesics|analgesics|mesh-ancestor
101709762|NCT00863772|Sensory System Agents|sensory system agents|mesh-ancestor
101778939|NCT00640224|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101709763|NCT00863772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101709764|NCT00863772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709765|NCT01010425|Hormones|hormones|mesh-list
101709766|NCT01010425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101709767|NCT01010425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709768|NCT00677300|Ritonavir|ritonavir|mesh-list
101709769|NCT00677300|Darunavir|darunavir|mesh-list
101709770|NCT00677300|Tenofovir|tenofovir|mesh-list
101709772|NCT00677300|Raltegravir Potassium|raltegravir potassium|mesh-list
101709773|NCT00677300|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101709774|NCT00677300|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101709775|NCT00677300|Protease Inhibitors|protease inhibitors|mesh-ancestor
101709776|NCT00677300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101709777|NCT00677300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709778|NCT00677300|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101709779|NCT00677300|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101709780|NCT00677300|Antiviral Agents|antiviral agents|mesh-ancestor
101709781|NCT00677300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101709782|NCT00677300|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101709783|NCT00677300|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101709784|NCT00677300|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101709785|NCT00677300|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101709786|NCT00677300|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101709787|NCT00677300|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101709788|NCT02628392|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101709790|NCT02628392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101779146|NCT01008982|Belimumab|belimumab|mesh-list
101709791|NCT02628392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709792|NCT02628392|Incretins|incretins|mesh-ancestor
101709793|NCT02628392|Hormones|hormones|mesh-ancestor
101709794|NCT02628392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101709795|NCT02628392|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101709796|NCT02628392|Protease Inhibitors|protease inhibitors|mesh-ancestor
101709797|NCT02628392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101709798|NCT02628392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709799|NCT00664586|Masoprocol|masoprocol|mesh-list
101709800|NCT00664586|Antioxidants|antioxidants|mesh-ancestor
101709801|NCT00664586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779223|NCT00530842|Hormones|hormones|mesh-ancestor
101709802|NCT00664586|Protective Agents|protective agents|mesh-ancestor
101709803|NCT00664586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709804|NCT00664586|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101709805|NCT00664586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101709806|NCT00664586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101709807|NCT00664586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101709808|NCT00664586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101709809|NCT00664586|Analgesics|analgesics|mesh-ancestor
101709810|NCT00664586|Sensory System Agents|sensory system agents|mesh-ancestor
101709811|NCT00664586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101709812|NCT00664586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101709813|NCT00664586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101709814|NCT00502801|Doripenem|doripenem|mesh-list
101709815|NCT00502801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101709816|NCT00502801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101709817|NCT04154852|Folic Acid|folic acid|mesh-list
101709818|NCT04154852|Adalimumab|adalimumab|mesh-list
101779342|NCT00819000|Interferon beta-1b|interferon beta-1b|mesh-list
101709819|NCT04154852|Methotrexate|methotrexate|mesh-list
101709820|NCT04154852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101709821|NCT04154852|Abortifacient Agents|abortifacient agents|mesh-ancestor
101709822|NCT04154852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101709823|NCT04154852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709824|NCT04154852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101709825|NCT04154852|Antimetabolites|antimetabolites|mesh-ancestor
101709826|NCT04154852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709827|NCT04154852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101709828|NCT04154852|Dermatologic Agents|dermatologic agents|mesh-ancestor
101709829|NCT04154852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101779411|NCT00303667|Vidarabine|vidarabine|mesh-list
101709830|NCT04154852|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101709831|NCT04154852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101709832|NCT04154852|Immunologic Factors|immunologic factors|mesh-ancestor
101709833|NCT04154852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101709834|NCT04154852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101709835|NCT04154852|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101709836|NCT04154852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101709837|NCT04154852|Hematinics|hematinics|mesh-ancestor
101436885|NCT00324922|Vancomycin|vancomycin|mesh-list
101709838|NCT04154852|Vitamin B Complex|vitamin b complex|mesh-ancestor
101709839|NCT04154852|Vitamins|vitamins|mesh-ancestor
101709840|NCT04154852|Micronutrients|micronutrients|mesh-ancestor
101709841|NCT00921154|Ivermectin|ivermectin|mesh-list
101709842|NCT00921154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101709843|NCT00921154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101709844|NCT01015651|Remifentanil|remifentanil|mesh-list
101709845|NCT01015651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101709846|NCT01015651|Narcotics|narcotics|mesh-ancestor
101709847|NCT01015651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101709848|NCT01015651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709849|NCT01015651|Analgesics|analgesics|mesh-ancestor
101709850|NCT01015651|Sensory System Agents|sensory system agents|mesh-ancestor
101709851|NCT01015651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101709852|NCT00674414|Trastuzumab|trastuzumab|mesh-list
101709853|NCT00674414|Everolimus|everolimus|mesh-list
101709854|NCT00674414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101709855|NCT00674414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101709856|NCT00674414|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101709857|NCT00674414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101709858|NCT00674414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101709859|NCT00674414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709860|NCT00674414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101709861|NCT00674414|Immunologic Factors|immunologic factors|mesh-ancestor
101709862|NCT00674414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709863|NCT05570422|Cisplatin|cisplatin|mesh-list
101709864|NCT05570422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101709865|NCT05272930|Dienogest|dienogest|mesh-list
101709866|NCT05272930|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101709867|NCT05272930|Contraceptive Agents|contraceptive agents|mesh-ancestor
101709868|NCT05272930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101709869|NCT05272930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709870|NCT05272930|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101709871|NCT05272930|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101709872|NCT05272930|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101709873|NCT05272930|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101779738|NCT05667883|Immunologic Factors|immunologic factors|mesh-ancestor
101779739|NCT05667883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779740|NCT05667883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101779741|NCT05667883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101709874|NCT05272930|Hormone Antagonists|hormone antagonists|mesh-ancestor
101709875|NCT05272930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101709876|NCT05272930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101709877|NCT05272930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101709878|NCT00855894|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101709880|NCT00855894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101709881|NCT00855894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101709882|NCT00855894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101779804|NCT05543642|Vaccines|vaccines|mesh-list
101779805|NCT05543642|Immunologic Factors|immunologic factors|mesh-ancestor
101779812|NCT05476770|Cytarabine|cytarabine|mesh-list
101709883|NCT00855894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709884|NCT00855894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101709885|NCT02566096|Morphine|morphine|mesh-list
101709886|NCT02566096|Bupivacaine|bupivacaine|mesh-list
101709887|NCT02566096|Anesthetics, Local|anesthetics, local|mesh-list
101709888|NCT02566096|Anesthetics|anesthetics|mesh-list
101709889|NCT02566096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101709890|NCT02566096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709891|NCT02566096|Sensory System Agents|sensory system agents|mesh-ancestor
101367362|NCT00162409|Folic Acid|folic acid|mesh-list
101709892|NCT02566096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101709893|NCT02566096|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101709894|NCT02566096|Narcotics|narcotics|mesh-ancestor
101709895|NCT02566096|Analgesics|analgesics|mesh-ancestor
101709896|NCT02622594|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101709897|NCT02622594|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101709898|NCT02622594|Dermatologic Agents|dermatologic agents|mesh-ancestor
101709899|NCT02628860|Ferric Compounds|ferric compounds|mesh-list
101709900|NCT02628860|Hematinics|hematinics|mesh-ancestor
101709901|NCT00708357|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
101709902|NCT00708357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101709903|NCT00708357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709904|NCT00855738|Topiramate|topiramate|mesh-list
101709905|NCT00855738|Pregabalin|pregabalin|mesh-list
101709906|NCT00855738|Lamotrigine|lamotrigine|mesh-list
101709907|NCT00855738|Zonisamide|zonisamide|mesh-list
101709908|NCT00855738|Gabapentin|gabapentin|mesh-list
101709909|NCT00855738|Levetiracetam|levetiracetam|mesh-list
101709910|NCT00855738|Tiagabine|tiagabine|mesh-list
101780001|NCT05005741|Glucagon|glucagon|mesh-list
101709912|NCT00855738|Sensory System Agents|sensory system agents|mesh-ancestor
101709913|NCT00855738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101709914|NCT00855738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709915|NCT00855738|Anticonvulsants|anticonvulsants|mesh-ancestor
101709916|NCT00855738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101709917|NCT00855738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101780069|NCT04877288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101709918|NCT00855738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709919|NCT00855738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101709920|NCT00855738|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101709921|NCT00855738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101709922|NCT00855738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101709923|NCT00855738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101709924|NCT00855738|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101709925|NCT00855738|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101709926|NCT00855738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101709927|NCT00855738|Antimanic Agents|antimanic agents|mesh-ancestor
101709928|NCT00855738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101709929|NCT00855738|Nootropic Agents|nootropic agents|mesh-ancestor
101709930|NCT00855738|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101709931|NCT00855738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101709932|NCT00855738|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
101709933|NCT00855738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101709934|NCT00855738|GABA Agents|gaba agents|mesh-ancestor
101709935|NCT02628002|Regadenoson|regadenoson|mesh-list
101709936|NCT02628002|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
101709937|NCT02628002|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101709938|NCT02628002|Purinergic Agonists|purinergic agonists|mesh-ancestor
101709939|NCT02628002|Purinergic Agents|purinergic agents|mesh-ancestor
101709940|NCT02628002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101709941|NCT02628002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709942|NCT02628002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709943|NCT00665054|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101709944|NCT00665054|Vasodilator Agents|vasodilator agents|mesh-ancestor
101709945|NCT00665054|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101709946|NCT00665054|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101709947|NCT00665054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101709948|NCT00665054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709949|NCT00665054|Urological Agents|urological agents|mesh-ancestor
101709951|NCT02622672|Micronutrients|micronutrients|mesh-ancestor
101709952|NCT02622672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780138|NCT04632069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101709953|NCT02622672|Vitamins|vitamins|mesh-ancestor
101709954|NCT04152356|Sorafenib|sorafenib|mesh-list
101709955|NCT04152356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101709956|NCT04152356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101709957|NCT04152356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101709958|NCT04152356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709959|NCT04271956|Tislelizumab|tislelizumab|mesh-list
101709960|NCT04271956|Zanubrutinib|zanubrutinib|mesh-list
101709961|NCT04271956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101709962|NCT04271956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101709963|NCT04271956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101709964|NCT04271956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101709965|NCT04271956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709966|NCT02628080|Atovaquone|atovaquone|mesh-list
101709967|NCT02628080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101709968|NCT02628080|Antimalarials|antimalarials|mesh-ancestor
101709969|NCT02628080|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101709970|NCT02628080|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101709971|NCT02628080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101709972|NCT02628080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709973|NCT00678236|Gentamicins|gentamicins|mesh-list
101709975|NCT00678236|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101709976|NCT00678236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101709977|NCT00678236|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101780254|NCT04118010|Vitamin D|vitamin d|mesh-list
101709979|NCT00678236|Histamine Agents|histamine agents|mesh-ancestor
101709980|NCT00678236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101709981|NCT00678236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101709982|NCT00678236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709983|NCT00678236|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101709984|NCT00678236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101709985|NCT00678236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101709986|NCT00678236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101709987|NCT00678236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101709988|NCT00678236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101709989|NCT00678314|Ropivacaine|ropivacaine|mesh-list
101709990|NCT00678314|Anesthetics, Local|anesthetics, local|mesh-ancestor
101709991|NCT00678314|Anesthetics|anesthetics|mesh-ancestor
101709992|NCT00678314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101709993|NCT00678314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101709994|NCT00678314|Sensory System Agents|sensory system agents|mesh-ancestor
101709995|NCT00678314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101709996|NCT02566720|Amantadine|amantadine|mesh-list
101709997|NCT02566720|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101709998|NCT02566720|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101709999|NCT02566720|Antiviral Agents|antiviral agents|mesh-ancestor
101710000|NCT02566720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101710001|NCT02566720|Dopamine Agents|dopamine agents|mesh-ancestor
101710002|NCT02566720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101710003|NCT02566720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710004|NCT02566720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710005|NCT02566720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101710006|NCT02566720|Analgesics|analgesics|mesh-ancestor
101710007|NCT02566720|Sensory System Agents|sensory system agents|mesh-ancestor
101710008|NCT02566720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101710009|NCT00675194|Capecitabine|capecitabine|mesh-list
101710010|NCT00675194|Irinotecan|irinotecan|mesh-list
101710011|NCT00675194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101710012|NCT00675194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101710013|NCT00675194|Antimetabolites|antimetabolites|mesh-ancestor
101710014|NCT00675194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710015|NCT00675194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101780504|NCT03418649|Eplerenone|eplerenone|mesh-list
101710016|NCT00675194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101710017|NCT00675194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101710018|NCT00665522|Fentanyl|fentanyl|mesh-list
101710019|NCT00665522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101710020|NCT00665522|Narcotics|narcotics|mesh-ancestor
101710021|NCT00665522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101710022|NCT00665522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710023|NCT00665522|Analgesics|analgesics|mesh-ancestor
101710024|NCT00665522|Sensory System Agents|sensory system agents|mesh-ancestor
101710025|NCT00665522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101710026|NCT00665522|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101710027|NCT00665522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101780566|NCT02944578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101710040|NCT00678704|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101710041|NCT00678704|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101780639|NCT02374242|Nivolumab|nivolumab|mesh-list
101780640|NCT02374242|Ipilimumab|ipilimumab|mesh-list
101780641|NCT02374242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101780642|NCT02374242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780643|NCT02374242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101710042|NCT00678704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101710043|NCT00678704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710044|NCT00678704|Urological Agents|urological agents|mesh-ancestor
101710045|NCT00678782|Etanercept|etanercept|mesh-list
101710046|NCT00678782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101710047|NCT00678782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101710048|NCT00678782|Analgesics|analgesics|mesh-ancestor
101710049|NCT00678782|Sensory System Agents|sensory system agents|mesh-ancestor
101710050|NCT00678782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101710051|NCT00678782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710052|NCT00678782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101710053|NCT00678782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101710054|NCT00678782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101710055|NCT00678782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101710056|NCT00678782|Immunologic Factors|immunologic factors|mesh-ancestor
101710057|NCT04707352|Dapagliflozin|dapagliflozin|mesh-list
101710058|NCT04707352|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101710059|NCT04707352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710060|NCT04707352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101710061|NCT04707352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710062|NCT04061200|Empagliflozin|empagliflozin|mesh-list
101710063|NCT04061200|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101710064|NCT04061200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710065|NCT04061200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101710066|NCT04061200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710067|NCT00675350|Homoharringtonine|homoharringtonine|mesh-list
101710068|NCT00675350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101710069|NCT00675350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101710070|NCT00675350|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101710071|NCT00675350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101710072|NCT00675350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710073|NCT02565862|Metformin|metformin|mesh-list
101710074|NCT02565862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101710075|NCT02565862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710076|NCT04060888|Ustekinumab|ustekinumab|mesh-list
101710077|NCT04060888|Dermatologic Agents|dermatologic agents|mesh-ancestor
101710078|NCT00879398|Fesoterodine|fesoterodine|mesh-list
101710079|NCT00879398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101710080|NCT00879398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101710081|NCT00879398|Cholinergic Agents|cholinergic agents|mesh-ancestor
101710082|NCT00879398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101710083|NCT00879398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710084|NCT00879398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710085|NCT00879398|Urological Agents|urological agents|mesh-ancestor
101710087|NCT00679250|Levocetirizine|levocetirizine|mesh-list
101710088|NCT00679250|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101710090|NCT00679250|Histamine Antagonists|histamine antagonists|mesh-ancestor
101710091|NCT00679250|Histamine Agents|histamine agents|mesh-ancestor
101710092|NCT00679250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101710093|NCT00679250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710094|NCT00679250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710095|NCT00679250|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101710096|NCT00696436|Valsartan|valsartan|mesh-list
101710097|NCT00696436|Olmesartan|olmesartan|mesh-list
101780943|NCT00816894|Serotonin Agents|serotonin agents|mesh-ancestor
101710098|NCT00696436|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
101710099|NCT00696436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101710100|NCT00696436|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101710101|NCT00696436|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101710102|NCT00696436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710103|NCT00878072|Famciclovir|famciclovir|mesh-list
101710104|NCT00878072|Antiviral Agents|antiviral agents|mesh-ancestor
101710105|NCT00878072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101781004|NCT00293059|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101710106|NCT00878072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101710107|NCT00878072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101710108|NCT00878072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710109|NCT00675740|Rosiglitazone|rosiglitazone|mesh-list
101710110|NCT00675740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101781070|NCT01067677|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101710111|NCT00675740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710112|NCT03045341|Naltrexone|naltrexone|mesh-list
101710113|NCT03045341|Bupropion|bupropion|mesh-list
101710114|NCT03045341|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101710115|NCT03045341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101710116|NCT03045341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710117|NCT03045341|Sensory System Agents|sensory system agents|mesh-ancestor
101710118|NCT03045341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101710120|NCT03045341|Antidepressive Agents|antidepressive agents|mesh-ancestor
101710121|NCT03045341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101710122|NCT03045341|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101710123|NCT03045341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101710124|NCT03045341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101710125|NCT03045341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710126|NCT03045341|Dopamine Agents|dopamine agents|mesh-ancestor
101710127|NCT03045341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101781212|NCT00633594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101710128|NCT03045341|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101710129|NCT03045341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101710130|NCT03045341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101710131|NCT00679484|Candesartan|candesartan|mesh-list
101710132|NCT00679484|Candesartan cilexetil|candesartan cilexetil|mesh-list
101710133|NCT00679484|Olmesartan|olmesartan|mesh-list
101710134|NCT00679484|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101710135|NCT00679484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101710136|NCT00679484|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101710137|NCT00679484|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101710138|NCT00679484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710139|NCT00679640|Candesartan|candesartan|mesh-list
101710140|NCT00679640|Candesartan cilexetil|candesartan cilexetil|mesh-list
101710141|NCT00679640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101710142|NCT00679640|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101710143|NCT00679640|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101710144|NCT00679640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710145|NCT00921388|Varenicline|varenicline|mesh-list
101710146|NCT00921388|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101710147|NCT00921388|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101710148|NCT00921388|Cholinergic Agents|cholinergic agents|mesh-ancestor
101710149|NCT00921388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101710150|NCT00921388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710151|NCT00921388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781337|NCT00825864|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101710152|NCT04212065|Buprenorphine|buprenorphine|mesh-list
101710153|NCT04212065|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101710154|NCT04212065|Narcotics|narcotics|mesh-ancestor
101710155|NCT04212065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101710156|NCT04212065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710157|NCT04212065|Analgesics|analgesics|mesh-ancestor
101710158|NCT04212065|Sensory System Agents|sensory system agents|mesh-ancestor
101710159|NCT04212065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101710160|NCT04212065|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101781399|NCT00820326|Serotonin Agents|serotonin agents|mesh-ancestor
101710161|NCT02627534|Anti-Infective Agents|anti-infective agents|mesh-list
101710162|NCT02627534|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101710163|NCT02627456|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101710165|NCT02627456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101710166|NCT02627456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101710167|NCT02627456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101710168|NCT00617513|Prucalopride|prucalopride|mesh-list
101710169|NCT00617513|Laxatives|laxatives|mesh-ancestor
101710170|NCT00617513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101710171|NCT00617513|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101710172|NCT00617513|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101710173|NCT00617513|Serotonin Agents|serotonin agents|mesh-ancestor
101710174|NCT00617513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101781529|NCT00826644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101710175|NCT00617513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710176|NCT00617513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710178|NCT02627222|Provitamins|provitamins|mesh-list
101710179|NCT02627222|Vitamins|vitamins|mesh-ancestor
101710180|NCT02627222|Micronutrients|micronutrients|mesh-ancestor
101710181|NCT02627222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710182|NCT00684476|Immunomodulating Agents|immunomodulating agents|mesh-list
101710183|NCT00684476|Immunologic Factors|immunologic factors|mesh-ancestor
101710184|NCT00684476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710185|NCT00594854|Diclofenac|diclofenac|mesh-list
101710186|NCT00594854|Arthrotec|arthrotec|mesh-list
101710187|NCT00594854|Misoprostol|misoprostol|mesh-list
101710188|NCT00594854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101710189|NCT00594854|Abortifacient Agents|abortifacient agents|mesh-ancestor
101710190|NCT00594854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101710191|NCT00594854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710192|NCT00594854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101710193|NCT00594854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101710194|NCT00594854|Oxytocics|oxytocics|mesh-ancestor
101710195|NCT00594854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101710196|NCT00594854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101710197|NCT00594854|Analgesics|analgesics|mesh-ancestor
101710198|NCT00594854|Sensory System Agents|sensory system agents|mesh-ancestor
101710199|NCT00594854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101781675|NCT00830856|Antimetabolites|antimetabolites|mesh-ancestor
101710200|NCT00594854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101710201|NCT00594854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101710202|NCT00594854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101710203|NCT00594854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101710204|NCT00594854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710205|NCT00679718|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101710206|NCT00679718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101710207|NCT00684632|Fentanyl|fentanyl|mesh-list
101710208|NCT00684632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101710209|NCT00684632|Narcotics|narcotics|mesh-ancestor
101710210|NCT00684632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101710211|NCT00684632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710212|NCT00684632|Analgesics|analgesics|mesh-ancestor
101710213|NCT00684632|Sensory System Agents|sensory system agents|mesh-ancestor
101710214|NCT00684632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101710215|NCT00684632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101710216|NCT00684632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101710217|NCT00684632|Anesthetics, General|anesthetics, general|mesh-ancestor
101710218|NCT00684632|Anesthetics|anesthetics|mesh-ancestor
101710219|NCT00855582|Tadalafil|tadalafil|mesh-list
101781788|NCT00523978|Sotalol|sotalol|mesh-list
101710220|NCT00855582|Vasodilator Agents|vasodilator agents|mesh-ancestor
101710221|NCT00855582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101710222|NCT00855582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101710223|NCT00855582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101710224|NCT00855582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710225|NCT00855582|Urological Agents|urological agents|mesh-ancestor
101710228|NCT00619541|Antimetabolites|antimetabolites|mesh-ancestor
101710229|NCT00619541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710230|NCT00619541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101781847|NCT00523744|Diuretics|diuretics|mesh-ancestor
101781848|NCT00523744|Natriuretic Agents|natriuretic agents|mesh-ancestor
101710231|NCT00619541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101710232|NCT00619541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101710233|NCT00619541|Immunologic Factors|immunologic factors|mesh-ancestor
101710234|NCT00619541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710235|NCT00619541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101710236|NCT00619541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101710237|NCT00680498|Ranibizumab|ranibizumab|mesh-list
101781979|NCT00296491|Xhance|xhance|mesh-list
101710238|NCT00680498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101710239|NCT00680498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101710240|NCT00680498|Growth Substances|growth substances|mesh-ancestor
101710241|NCT00680498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710242|NCT00680498|Growth Inhibitors|growth inhibitors|mesh-ancestor
101710243|NCT00680498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101710244|NCT00684866|Albuterol|albuterol|mesh-list
101710245|NCT00684866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101710246|NCT00684866|Autonomic Agents|autonomic agents|mesh-ancestor
101781981|NCT00296491|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101710247|NCT00684866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101710248|NCT00684866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710249|NCT00684866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101710250|NCT00684866|Respiratory System Agents|respiratory system agents|mesh-ancestor
101710251|NCT00684866|Tocolytic Agents|tocolytic agents|mesh-ancestor
101710252|NCT00684866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101710253|NCT00684866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101710254|NCT00684866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101782048|NCT01065961|BB 1101|bb 1101|mesh-list
101710256|NCT00684866|Adrenergic Agents|adrenergic agents|mesh-ancestor
101710257|NCT00684866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101710258|NCT00684866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710259|NCT00854724|Puerarin|puerarin|mesh-list
101710260|NCT00854724|Vasodilator Agents|vasodilator agents|mesh-ancestor
101710261|NCT00619697|Insulin|insulin|mesh-list
101710262|NCT00619697|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101710263|NCT00619697|Metformin|metformin|mesh-list
101710264|NCT00619697|Insulin Glargine|insulin glargine|mesh-list
101710265|NCT00619697|Insulin Aspart|insulin aspart|mesh-list
101710266|NCT00619697|Glimepiride|glimepiride|mesh-list
101710267|NCT00619697|Biphasic Insulins|biphasic insulins|mesh-list
101367727|NCT00164359|Antiviral Agents|antiviral agents|mesh-ancestor
101302575|NCT00310180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710268|NCT00619697|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101710269|NCT00619697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101710270|NCT00619697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710271|NCT00619697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101710272|NCT00619697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101710273|NCT00619697|Immunologic Factors|immunologic factors|mesh-ancestor
101710275|NCT00680654|Enzyme Activators|enzyme activators|mesh-ancestor
101710276|NCT00680654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710277|NCT00680108|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101710278|NCT00680108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101710279|NCT00680732|Folic Acid|folic acid|mesh-list
101710280|NCT00680732|Micronutrients|micronutrients|mesh-list
101710281|NCT00680732|Trace Elements|trace elements|mesh-list
101710282|NCT00680732|Chloroquine|chloroquine|mesh-list
101710283|NCT00680732|Pyrimethamine|pyrimethamine|mesh-list
101782322|NCT00827814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101710284|NCT00680732|Hematinics|hematinics|mesh-ancestor
101710285|NCT00680732|Vitamin B Complex|vitamin b complex|mesh-ancestor
101710287|NCT00680732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710288|NCT00680732|Amebicides|amebicides|mesh-ancestor
101710289|NCT00680732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101710290|NCT00680732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101710291|NCT00680732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101710292|NCT00680732|Antimalarials|antimalarials|mesh-ancestor
101710293|NCT00680732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101710294|NCT00680732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101710295|NCT00680732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101710296|NCT00680732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710298|NCT00698932|Incretins|incretins|mesh-ancestor
101710299|NCT00698932|Hormones|hormones|mesh-ancestor
101710300|NCT00698932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101710301|NCT00698932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782450|NCT02549430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101710302|NCT00698932|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101710303|NCT00698932|Protease Inhibitors|protease inhibitors|mesh-ancestor
101710304|NCT00698932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101710305|NCT00698932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710306|NCT00698932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101710307|NCT02566252|Cromolyn Sodium|cromolyn sodium|mesh-list
101710308|NCT02566252|Albuterol|albuterol|mesh-list
101710309|NCT02566252|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
101710310|NCT02566252|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101710311|NCT02566252|Autonomic Agents|autonomic agents|mesh-ancestor
101710312|NCT02566252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101782584|NCT00947895|Hormones|hormones|mesh-ancestor
101710313|NCT02566252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710314|NCT02566252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101710315|NCT02566252|Respiratory System Agents|respiratory system agents|mesh-ancestor
101710316|NCT02566252|Tocolytic Agents|tocolytic agents|mesh-ancestor
101710317|NCT02566252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101710318|NCT02566252|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101710319|NCT02566252|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101710320|NCT02566252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101710321|NCT02566252|Adrenergic Agents|adrenergic agents|mesh-ancestor
101710322|NCT02566252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101710323|NCT02566252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710324|NCT02566252|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
101710325|NCT02566252|Immunologic Factors|immunologic factors|mesh-ancestor
101710326|NCT02566252|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101710327|NCT02566252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101782653|NCT00954135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101710329|NCT00823719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101710330|NCT00823719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101710331|NCT00823719|Immunologic Factors|immunologic factors|mesh-ancestor
101710332|NCT00823719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710333|NCT03953170|Teduglutide|teduglutide|mesh-list
101710334|NCT03953170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101710335|NCT03953170|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101710336|NCT03953170|Protective Agents|protective agents|mesh-ancestor
101782711|NCT00828594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101710337|NCT03953170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710338|NCT00708591|Sirolimus|sirolimus|mesh-list
101710339|NCT00708591|Ketoconazole|ketoconazole|mesh-list
101710340|NCT00708591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101710341|NCT00708591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101710342|NCT00708591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101710343|NCT00708591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101710344|NCT00708591|Antifungal Agents|antifungal agents|mesh-ancestor
101710345|NCT00708591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101710346|NCT00708591|Immunologic Factors|immunologic factors|mesh-ancestor
101710347|NCT00708591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710348|NCT00708591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101782777|NCT00531934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101710349|NCT00708591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710350|NCT00708591|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101710351|NCT00708591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101710352|NCT00708591|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101710353|NCT00708591|Hormone Antagonists|hormone antagonists|mesh-ancestor
101710354|NCT00708591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101710355|NCT00708591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101710357|NCT04595266|Bevacizumab|bevacizumab|mesh-list
101710358|NCT04595266|Fluorouracil|fluorouracil|mesh-list
101710359|NCT04595266|Oxaliplatin|oxaliplatin|mesh-list
101710360|NCT04595266|Irinotecan|irinotecan|mesh-list
101710361|NCT04595266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101710362|NCT04595266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101710363|NCT04595266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101710364|NCT04595266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101710365|NCT04595266|Growth Substances|growth substances|mesh-ancestor
101710366|NCT04595266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710367|NCT04595266|Growth Inhibitors|growth inhibitors|mesh-ancestor
101710368|NCT04595266|Antimetabolites|antimetabolites|mesh-ancestor
101710369|NCT04595266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710370|NCT04595266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101710371|NCT04595266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101710372|NCT04595266|Immunologic Factors|immunologic factors|mesh-ancestor
101710373|NCT04595266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101710374|NCT04595266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101710375|NCT04595266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101710376|NCT04595266|Antidotes|antidotes|mesh-ancestor
101710377|NCT04595266|Protective Agents|protective agents|mesh-ancestor
101710378|NCT04595266|Vitamin B Complex|vitamin b complex|mesh-ancestor
101710379|NCT04595266|Vitamins|vitamins|mesh-ancestor
101710380|NCT04595266|Micronutrients|micronutrients|mesh-ancestor
101710381|NCT00708747|Immunoglobulins|immunoglobulins|mesh-list
101710382|NCT00708747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101710383|NCT00708747|Antibodies|antibodies|mesh-list
101710384|NCT00708747|Immunologic Factors|immunologic factors|mesh-ancestor
101710385|NCT00708747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710387|NCT00685022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101710388|NCT00685022|Autonomic Agents|autonomic agents|mesh-ancestor
101710389|NCT00685022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101710390|NCT00685022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710391|NCT00685022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101710392|NCT00685022|Respiratory System Agents|respiratory system agents|mesh-ancestor
101710393|NCT00685022|Tocolytic Agents|tocolytic agents|mesh-ancestor
101710394|NCT00685022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101710395|NCT00685022|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101710396|NCT00685022|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101710397|NCT00685022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101782975|NCT04010955|Antithrombins|antithrombins|mesh-ancestor
101782980|NCT04010955|Anticoagulants|anticoagulants|mesh-ancestor
101710398|NCT00685022|Adrenergic Agents|adrenergic agents|mesh-ancestor
101710399|NCT00685022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101710400|NCT00685022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710401|NCT03787264|Venetoclax|venetoclax|mesh-list
101710402|NCT03787264|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101710403|NCT03787264|Obinutuzumab|obinutuzumab|mesh-list
101710404|NCT03787264|Acalabrutinib|acalabrutinib|mesh-list
101710405|NCT03787264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101710406|NCT03787264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101710407|NCT03787264|Alkylating Agents|alkylating agents|mesh-ancestor
101710408|NCT03787264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710409|NCT03787264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101710411|NCT00822237|Immunologic Factors|immunologic factors|mesh-ancestor
101710412|NCT00822237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710413|NCT00617747|Zolmitriptan|zolmitriptan|mesh-list
101710414|NCT00617747|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101710415|NCT00617747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101710416|NCT00617747|Serotonin Agents|serotonin agents|mesh-ancestor
101710417|NCT00617747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101710418|NCT00617747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710419|NCT00617747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710421|NCT00685100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101710422|NCT00685100|Glucocorticoids|glucocorticoids|mesh-ancestor
101710423|NCT00685100|Hormones|hormones|mesh-ancestor
101710424|NCT00685100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101710425|NCT00685100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710426|NCT00708903|Moxifloxacin|moxifloxacin|mesh-list
101710427|NCT00708903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101710428|NCT00708903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101710429|NCT00708903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101710430|NCT00708903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101710431|NCT00708903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101710432|NCT00708903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710433|NCT00708903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101710434|NCT00637091|Irinotecan|irinotecan|mesh-list
101710435|NCT00637091|Cetuximab|cetuximab|mesh-list
101710436|NCT00637091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101710437|NCT00637091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101710438|NCT00637091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101710439|NCT00637091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710440|NCT00637091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101710441|NCT00637091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101710442|NCT04213391|Sulforaphane|sulforaphane|mesh-list
101710443|NCT04213391|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101710444|NCT04213391|Protective Agents|protective agents|mesh-ancestor
101710445|NCT04213391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710446|NCT04213391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101710447|NCT00709137|Amiloride|amiloride|mesh-list
101710448|NCT00709137|Spironolactone|spironolactone|mesh-list
101710449|NCT00709137|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101783217|NCT00956163|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101710450|NCT00709137|Hormone Antagonists|hormone antagonists|mesh-ancestor
101710451|NCT00709137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101710452|NCT00709137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710453|NCT00709137|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101710454|NCT00709137|Diuretics|diuretics|mesh-ancestor
101710455|NCT00709137|Natriuretic Agents|natriuretic agents|mesh-ancestor
101710456|NCT00709137|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
101710457|NCT00709137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101710458|NCT00709137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101302576|NCT00310180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101710459|NCT00709137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710460|NCT00709137|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101710462|NCT04150172|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101710463|NCT04150172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101710464|NCT04150172|Antioxidants|antioxidants|mesh-ancestor
101710465|NCT04150172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710466|NCT04150172|Protective Agents|protective agents|mesh-ancestor
101710467|NCT04150172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710468|NCT04150172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101710469|NCT02325011|Fluconazole|fluconazole|mesh-list
101710470|NCT02325011|Nabiximols|nabiximols|mesh-list
101710471|NCT02325011|Dronabinol|dronabinol|mesh-list
101710472|NCT02325011|Cannabidiol|cannabidiol|mesh-list
101710473|NCT02325011|Antifungal Agents|antifungal agents|mesh-ancestor
101710474|NCT02325011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101710475|NCT02325011|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101710476|NCT02325011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101710477|NCT02325011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101710478|NCT02325011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710479|NCT02325011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101783466|NCT00963573|Histamine Antagonists|histamine antagonists|mesh-ancestor
101710480|NCT02325011|Hormone Antagonists|hormone antagonists|mesh-ancestor
101710481|NCT02325011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101710482|NCT02325011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302577|NCT00310180|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101710483|NCT02325011|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101710484|NCT02325011|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101710486|NCT02325011|Sensory System Agents|sensory system agents|mesh-ancestor
101710487|NCT02325011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101710488|NCT02325011|Anticonvulsants|anticonvulsants|mesh-ancestor
101710489|NCT02325011|Hallucinogens|hallucinogens|mesh-ancestor
101710490|NCT02325011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101710491|NCT02325011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101710492|NCT02325011|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101710493|NCT02325011|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101710494|NCT02325011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101710496|NCT00577096|Thalidomide|thalidomide|mesh-list
101710497|NCT00577096|Dexamethasone|dexamethasone|mesh-list
101710498|NCT00577096|Cyclophosphamide|cyclophosphamide|mesh-list
101710499|NCT00577096|Melphalan|melphalan|mesh-list
101710500|NCT00577096|Cisplatin|cisplatin|mesh-list
101710501|NCT00577096|Doxorubicin|doxorubicin|mesh-list
101710503|NCT00577096|Vincristine|vincristine|mesh-list
101710504|NCT00577096|Heparin|heparin|mesh-list
101710505|NCT00577096|Calcium heparin|calcium heparin|mesh-list
101710506|NCT00577096|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101710507|NCT00577096|Tinzaparin|tinzaparin|mesh-list
101710508|NCT00577096|Dalteparin|dalteparin|mesh-list
101710509|NCT00577096|Epoetin Alfa|epoetin alfa|mesh-list
101710510|NCT00577096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101710511|NCT00577096|Immunologic Factors|immunologic factors|mesh-ancestor
101710512|NCT00577096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710513|NCT00577096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101710514|NCT00577096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101710515|NCT00577096|Alkylating Agents|alkylating agents|mesh-ancestor
101783668|NCT00840918|Lidocaine|lidocaine|mesh-list
101710516|NCT00577096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710517|NCT00577096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101710518|NCT00577096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101710519|NCT00577096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101710521|NCT00577096|Autonomic Agents|autonomic agents|mesh-ancestor
101710522|NCT00577096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101710523|NCT00577096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101783726|NCT00967707|Antidepressive Agents|antidepressive agents|mesh-ancestor
101710524|NCT00577096|Glucocorticoids|glucocorticoids|mesh-ancestor
101710525|NCT00577096|Hormones|hormones|mesh-ancestor
101710526|NCT00577096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101710527|NCT00577096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101710528|NCT00577096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101710529|NCT00577096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101710530|NCT00577096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101710531|NCT00577096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101783792|NCT00968331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101710532|NCT00577096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101710533|NCT00577096|Tubulin Modulators|tubulin modulators|mesh-ancestor
101710534|NCT00577096|Antimitotic Agents|antimitotic agents|mesh-ancestor
101710535|NCT00577096|Mitosis Modulators|mitosis modulators|mesh-ancestor
101710536|NCT00577096|Anticoagulants|anticoagulants|mesh-ancestor
101710537|NCT00577096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101710538|NCT00577096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101710539|NCT00577096|Hematinics|hematinics|mesh-ancestor
101710540|NCT00577096|Leprostatic Agents|leprostatic agents|mesh-ancestor
101710541|NCT00577096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101710542|NCT00577096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101710543|NCT00577096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101710544|NCT00577096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101783931|NCT00849030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710545|NCT00577096|Growth Substances|growth substances|mesh-ancestor
101710546|NCT00577096|Growth Inhibitors|growth inhibitors|mesh-ancestor
101710549|NCT02625506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101710550|NCT02625506|Narcotics|narcotics|mesh-ancestor
101710551|NCT02625506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101710552|NCT02625506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710553|NCT02625506|Analgesics|analgesics|mesh-ancestor
101710554|NCT02625506|Sensory System Agents|sensory system agents|mesh-ancestor
101710555|NCT02625506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101710556|NCT02625506|Anesthetics, Local|anesthetics, local|mesh-ancestor
101710557|NCT02625506|Anesthetics|anesthetics|mesh-ancestor
101710558|NCT04209959|Nifekalant|nifekalant|mesh-list
101710559|NCT04209959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101710561|NCT04209803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101710562|NCT04209803|Vasodilator Agents|vasodilator agents|mesh-ancestor
101710563|NCT02567032|Oxytocin|oxytocin|mesh-list
101710564|NCT02567032|Oxytocics|oxytocics|mesh-ancestor
101710565|NCT02567032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101710566|NCT02567032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710567|NCT00618059|Pilocarpine|pilocarpine|mesh-list
101710568|NCT00618059|Miotics|miotics|mesh-ancestor
101710569|NCT00618059|Autonomic Agents|autonomic agents|mesh-ancestor
101710570|NCT00618059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101784145|NCT00969033|Irinotecan|irinotecan|mesh-list
101710571|NCT00618059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710573|NCT00618059|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101710574|NCT00618059|Cholinergic Agents|cholinergic agents|mesh-ancestor
101710575|NCT00618059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101710576|NCT00618059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710577|NCT00863304|Naproxen|naproxen|mesh-list
101710578|NCT00863304|Tanezumab|tanezumab|mesh-list
101710579|NCT00863304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101710580|NCT00863304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101710581|NCT00863304|Analgesics|analgesics|mesh-ancestor
101710582|NCT00863304|Sensory System Agents|sensory system agents|mesh-ancestor
101710583|NCT00863304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101710584|NCT00863304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784266|NCT00855972|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101710585|NCT00863304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101710586|NCT00863304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101710587|NCT00863304|Gout Suppressants|gout suppressants|mesh-ancestor
101710588|NCT00863304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101710589|NCT00863304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101710590|NCT00863304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710591|NCT00695110|Methyltestosterone|methyltestosterone|mesh-list
101710592|NCT00695110|Testosterone|testosterone|mesh-list
101710593|NCT00695110|Testosterone undecanoate|testosterone undecanoate|mesh-list
101710594|NCT00695110|Testosterone enanthate|testosterone enanthate|mesh-list
101710595|NCT00695110|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101710596|NCT00695110|Androgens|androgens|mesh-ancestor
101710597|NCT00695110|Hormones|hormones|mesh-ancestor
101710598|NCT00695110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101710599|NCT00695110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710600|NCT00695110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101710601|NCT00695110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101784403|NCT00970905|Antiemetics|antiemetics|mesh-ancestor
101710603|NCT03374332|Gemtuzumab|gemtuzumab|mesh-list
101710604|NCT03374332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101710605|NCT03374332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101710606|NCT03374332|Immunotoxins|immunotoxins|mesh-ancestor
101710607|NCT03374332|Immunoconjugates|immunoconjugates|mesh-ancestor
101710608|NCT03374332|Immunologic Factors|immunologic factors|mesh-ancestor
101710609|NCT03374332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710610|NCT03264352|Amlodipine|amlodipine|mesh-list
101784472|NCT00959439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101710611|NCT03264352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101710612|NCT03264352|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101710613|NCT03264352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101710614|NCT03264352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710615|NCT03264352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101710616|NCT03264352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710618|NCT04897919|Lumefantrine|lumefantrine|mesh-list
101710619|NCT04897919|Artemether|artemether|mesh-list
101710620|NCT04897919|Piperaquine|piperaquine|mesh-list
101710621|NCT04897919|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101710622|NCT04897919|Artenimol|artenimol|mesh-list
101710623|NCT04897919|Antimalarials|antimalarials|mesh-ancestor
101710624|NCT04897919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101710625|NCT04897919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101710626|NCT04897919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101710627|NCT00594386|Rotigotine|rotigotine|mesh-list
101710628|NCT00594386|Dopamine Agonists|dopamine agonists|mesh-ancestor
101710629|NCT00594386|Dopamine Agents|dopamine agents|mesh-ancestor
101710630|NCT00594386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101710631|NCT00594386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710632|NCT00594386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710633|NCT04857671|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101710634|NCT04857671|Botulinum Toxins|botulinum toxins|mesh-list
101710635|NCT04857671|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101710636|NCT04857671|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101710637|NCT04857671|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101710638|NCT04857671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101784672|NCT00974805|Glucocorticoids|glucocorticoids|mesh-ancestor
101710639|NCT04857671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710640|NCT04857671|Cholinergic Agents|cholinergic agents|mesh-ancestor
101710641|NCT04857671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101710642|NCT04857671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710643|NCT04857671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101710644|NCT04857671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101710645|NCT03466450|Temozolomide|temozolomide|mesh-list
101368111|NCT00166465|Vitamins|vitamins|mesh-ancestor
101710646|NCT03466450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101710647|NCT03466450|Alkylating Agents|alkylating agents|mesh-ancestor
101710648|NCT03466450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710649|NCT03466450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101710650|NCT00690560|Prednisone|prednisone|mesh-list
101710651|NCT00690560|Cyclophosphamide|cyclophosphamide|mesh-list
101710652|NCT00690560|Rituximab|rituximab|mesh-list
101710653|NCT00690560|Doxorubicin|doxorubicin|mesh-list
101710654|NCT00690560|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101710655|NCT00690560|Vincristine|vincristine|mesh-list
101710656|NCT00690560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101710657|NCT00690560|Immunologic Factors|immunologic factors|mesh-ancestor
101710658|NCT00690560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710659|NCT00690560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101710660|NCT00690560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101710661|NCT00690560|Alkylating Agents|alkylating agents|mesh-ancestor
101710662|NCT00690560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710663|NCT00690560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101710664|NCT00690560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101710665|NCT00690560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101710666|NCT00690560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101710667|NCT00690560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101710669|NCT00690560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101710670|NCT00690560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101710671|NCT00690560|Glucocorticoids|glucocorticoids|mesh-ancestor
101710672|NCT00690560|Hormones|hormones|mesh-ancestor
101710673|NCT00690560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101784932|NCT00858624|Ketamine|ketamine|mesh-list
101710674|NCT00690560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101710675|NCT00690560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101710676|NCT00690560|Tubulin Modulators|tubulin modulators|mesh-ancestor
101710677|NCT00690560|Antimitotic Agents|antimitotic agents|mesh-ancestor
101710678|NCT00690560|Mitosis Modulators|mitosis modulators|mesh-ancestor
101710679|NCT00742690|Terlipressin|terlipressin|mesh-list
101710680|NCT00742690|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101710681|NCT00742690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101710682|NCT00742768|Vitamins|vitamins|mesh-list
101710683|NCT00742768|Vitamin K|vitamin k|mesh-list
101710684|NCT00742768|Vitamin K 2|vitamin k 2|mesh-list
101710685|NCT00742768|Micronutrients|micronutrients|mesh-ancestor
101710686|NCT00742768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710687|NCT00742768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101710689|NCT00742768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710690|NCT00742768|Hemostatics|hemostatics|mesh-ancestor
101710691|NCT00742768|Coagulants|coagulants|mesh-ancestor
101710692|NCT00862992|Cariprazine|cariprazine|mesh-list
101710693|NCT00862992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101710694|NCT00862992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101710695|NCT00862992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101710696|NCT00862992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710697|NCT00862992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101710698|NCT02565316|Sertraline|sertraline|mesh-list
101710699|NCT02565316|Antidepressive Agents|antidepressive agents|mesh-ancestor
101710700|NCT02565316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101710701|NCT02565316|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101710702|NCT02565316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101710703|NCT02565316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101710704|NCT02565316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710705|NCT02565316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101710706|NCT02565316|Serotonin Agents|serotonin agents|mesh-ancestor
101710707|NCT02565316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710708|NCT00742846|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101710709|NCT00742846|Triamcinolone|triamcinolone|mesh-list
101710710|NCT00742846|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101710711|NCT00742846|Lidocaine|lidocaine|mesh-list
101710712|NCT00742846|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101710713|NCT00742846|Anesthetics, Local|anesthetics, local|mesh-ancestor
101710714|NCT00742846|Anesthetics|anesthetics|mesh-ancestor
101710715|NCT00742846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101710716|NCT00742846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710717|NCT00742846|Sensory System Agents|sensory system agents|mesh-ancestor
101710718|NCT00742846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101785231|NCT00960921|Iron|iron|mesh-list
101710719|NCT00742846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101710720|NCT00742846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101710721|NCT00742846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101710722|NCT00742846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101710723|NCT00742846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710724|NCT00742846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101710726|NCT00742846|Hormones|hormones|mesh-ancestor
101710727|NCT00742846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101710728|NCT00742846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101710729|NCT00742846|Immunologic Factors|immunologic factors|mesh-ancestor
101710730|NCT00742846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101710731|NCT00690872|Carboplatin|carboplatin|mesh-list
101710732|NCT00690872|Gemcitabine|gemcitabine|mesh-list
101710733|NCT00690872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101710734|NCT00690872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101710735|NCT00690872|Antimetabolites|antimetabolites|mesh-ancestor
101710736|NCT00690872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710737|NCT00694096|Sunitinib|sunitinib|mesh-list
101710738|NCT00694096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101710739|NCT00694096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101710740|NCT00694096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101710741|NCT00694096|Growth Substances|growth substances|mesh-ancestor
101710742|NCT00694096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710743|NCT00694096|Growth Inhibitors|growth inhibitors|mesh-ancestor
101710744|NCT00694096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101710745|NCT00694096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101710746|NCT00694096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710747|NCT04808531|Oxycodone|oxycodone|mesh-list
101710748|NCT04808531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101710749|NCT04808531|Narcotics|narcotics|mesh-ancestor
101710750|NCT04808531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101710751|NCT04808531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710752|NCT04808531|Analgesics|analgesics|mesh-ancestor
101710753|NCT04808531|Sensory System Agents|sensory system agents|mesh-ancestor
101710754|NCT04808531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101710755|NCT00690950|Dutasteride|dutasteride|mesh-list
101710756|NCT00690950|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101710757|NCT00690950|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101710758|NCT00690950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101710759|NCT00690950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710760|NCT00690950|Hormone Antagonists|hormone antagonists|mesh-ancestor
101785524|NCT00973401|Insulin|insulin|mesh-list
101710761|NCT00690950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101710762|NCT00690950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710764|NCT02622126|Ephedrine|ephedrine|mesh-list
101785593|NCT00745901|Contraceptive Agents|contraceptive agents|mesh-ancestor
101785594|NCT00745901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101710765|NCT02622126|Morphine|morphine|mesh-list
101710766|NCT02622126|Bupivacaine|bupivacaine|mesh-list
101710767|NCT02622126|Anesthetics, Local|anesthetics, local|mesh-ancestor
101710768|NCT02622126|Anesthetics|anesthetics|mesh-ancestor
101710769|NCT02622126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101710770|NCT02622126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710771|NCT02622126|Sensory System Agents|sensory system agents|mesh-ancestor
101710772|NCT02622126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101710773|NCT02622126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101710774|NCT02622126|Narcotics|narcotics|mesh-ancestor
101710775|NCT02622126|Analgesics|analgesics|mesh-ancestor
101710776|NCT02622126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101785683|NCT00860496|Tacrolimus|tacrolimus|mesh-list
101710777|NCT02622126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101710778|NCT02622126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101710779|NCT02622126|Autonomic Agents|autonomic agents|mesh-ancestor
101710780|NCT02622126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101710781|NCT02622126|Respiratory System Agents|respiratory system agents|mesh-ancestor
101710782|NCT02622126|Mydriatics|mydriatics|mesh-ancestor
101710783|NCT02622126|Parasympatholytics|parasympatholytics|mesh-ancestor
101710784|NCT02622126|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101710785|NCT02622126|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101710786|NCT02622126|Cholinergic Agents|cholinergic agents|mesh-ancestor
101710787|NCT02622126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101710788|NCT02622126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710789|NCT02622126|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101710790|NCT02622126|Sympathomimetics|sympathomimetics|mesh-ancestor
101710791|NCT02622126|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101710792|NCT02622126|Adrenergic Agents|adrenergic agents|mesh-ancestor
101710793|NCT04140188|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
101710794|NCT04140188|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101785798|NCT00961467|Hormones|hormones|mesh-ancestor
101710795|NCT04140188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710796|NCT00685568|Celecoxib|celecoxib|mesh-list
101710797|NCT00685568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101710798|NCT00685568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101710800|NCT00685568|Sensory System Agents|sensory system agents|mesh-ancestor
101710801|NCT00685568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101710802|NCT00685568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710803|NCT00685568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101710804|NCT00685568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101785930|NCT00984789|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101710805|NCT00685568|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101710806|NCT00685568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101710807|NCT00685568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101710808|NCT00685568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710809|NCT02626208|ST 1435|st 1435|mesh-list
101710811|NCT02626208|Estradiol|estradiol|mesh-list
101710812|NCT02626208|Estrogens|estrogens|mesh-ancestor
101710813|NCT02626208|Hormones|hormones|mesh-ancestor
101710814|NCT02626208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101710815|NCT02626208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710816|NCT02626208|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101710817|NCT02626208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101710818|NCT02626208|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101710819|NCT04210739|Betamethasone|betamethasone|mesh-list
101710820|NCT04210739|Betamethasone Valerate|betamethasone valerate|mesh-list
101710821|NCT04210739|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101710822|NCT04210739|Betamethasone benzoate|betamethasone benzoate|mesh-list
101710823|NCT04210739|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101710824|NCT04210739|Glucocorticoids|glucocorticoids|mesh-ancestor
101710825|NCT04210739|Hormones|hormones|mesh-ancestor
101302578|NCT00310180|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101786139|NCT00801866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710826|NCT04210739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101710827|NCT04210739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710828|NCT04210739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101710829|NCT04210739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101710830|NCT04210739|Respiratory System Agents|respiratory system agents|mesh-ancestor
101710832|NCT00696540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101710833|NCT00696540|Autonomic Agents|autonomic agents|mesh-ancestor
101710834|NCT00696540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101710835|NCT00696540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710836|NCT00696540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101710837|NCT00696540|Respiratory System Agents|respiratory system agents|mesh-ancestor
101710838|NCT00696540|Tocolytic Agents|tocolytic agents|mesh-ancestor
101710839|NCT00696540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101710840|NCT00696540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101710841|NCT00696540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101710842|NCT00696540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101710843|NCT00696540|Adrenergic Agents|adrenergic agents|mesh-ancestor
101710844|NCT00696540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101302579|NCT00310180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101786208|NCT00868764|Serotonin Agents|serotonin agents|mesh-ancestor
101710845|NCT00696540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710847|NCT04212845|Bupivacaine|bupivacaine|mesh-list
101710848|NCT04212845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101710849|NCT04212845|Antiemetics|antiemetics|mesh-ancestor
101710850|NCT04212845|Autonomic Agents|autonomic agents|mesh-ancestor
101710851|NCT04212845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101710852|NCT04212845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710853|NCT04212845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101786255|NCT00742079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786256|NCT04730362|Propofol|propofol|mesh-list
101710854|NCT04212845|Glucocorticoids|glucocorticoids|mesh-ancestor
101710855|NCT04212845|Hormones|hormones|mesh-ancestor
101710856|NCT04212845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101710857|NCT04212845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101710858|NCT04212845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101710859|NCT04212845|Anesthetics, Local|anesthetics, local|mesh-ancestor
101710860|NCT04212845|Anesthetics|anesthetics|mesh-ancestor
101710861|NCT04212845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101710862|NCT04212845|Sensory System Agents|sensory system agents|mesh-ancestor
101710863|NCT00620165|Levetiracetam|levetiracetam|mesh-list
101710864|NCT00620165|Anticonvulsants|anticonvulsants|mesh-ancestor
101710865|NCT00620165|Nootropic Agents|nootropic agents|mesh-ancestor
101710866|NCT00685646|Zoledronic Acid|zoledronic acid|mesh-list
101710867|NCT00685646|Androgen Antagonists|androgen antagonists|mesh-list
101710868|NCT00685646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101710869|NCT00685646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710870|NCT00685646|Hormone Antagonists|hormone antagonists|mesh-ancestor
101710871|NCT00685646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101710872|NCT00685958|Enoxaparin|enoxaparin|mesh-list
101710873|NCT00685958|Anticoagulants|anticoagulants|mesh-ancestor
101786460|NCT00802568|Fludarabine|fludarabine|mesh-list
101710874|NCT00685958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101710875|NCT00685958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101710876|NCT00685958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710878|NCT04138472|Fentanyl|fentanyl|mesh-list
101710879|NCT04138472|Dexmedetomidine|dexmedetomidine|mesh-list
101710880|NCT04138472|Anesthetics, Local|anesthetics, local|mesh-ancestor
101710882|NCT04138472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101710883|NCT04138472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710884|NCT04138472|Sensory System Agents|sensory system agents|mesh-ancestor
101710885|NCT04138472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101710886|NCT04138472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101710887|NCT04138472|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101786608|NCT00803192|Famotidine|famotidine|mesh-list
101710888|NCT04138472|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101710889|NCT04138472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101710890|NCT04138472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710891|NCT04138472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101710892|NCT04138472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101710893|NCT04138472|Analgesics|analgesics|mesh-ancestor
101710894|NCT04138472|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101710895|NCT04138472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101710896|NCT04138472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101786661|NCT00789386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101786718|NCT02553824|Topiramate|topiramate|mesh-list
101710897|NCT04138472|Adrenergic Agents|adrenergic agents|mesh-ancestor
101710898|NCT04138472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101710899|NCT04138472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101710900|NCT04138472|Narcotics|narcotics|mesh-ancestor
101710901|NCT04138472|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101710902|NCT04138472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101710903|NCT04138472|Anesthetics, General|anesthetics, general|mesh-ancestor
101710905|NCT00620789|Citalopram|citalopram|mesh-list
101710906|NCT00620789|Antidepressive Agents|antidepressive agents|mesh-list
101710907|NCT00620789|Escitalopram|escitalopram|mesh-list
101710908|NCT00620789|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101710909|NCT00620789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101710910|NCT00620789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101710911|NCT00620789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710912|NCT00620789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101710914|NCT00620789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710915|NCT00620789|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101710916|NCT00620789|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101710917|NCT00620789|Parasympatholytics|parasympatholytics|mesh-ancestor
101786732|NCT04039854|Propofol|propofol|mesh-list
101710919|NCT00620789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101786783|NCT00977301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101710920|NCT00620789|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101710921|NCT00620789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101710922|NCT00620789|Cholinergic Agents|cholinergic agents|mesh-ancestor
101710923|NCT00620789|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101710924|NCT00620789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101710925|NCT00691184|Terbinafine|terbinafine|mesh-list
101710926|NCT00691184|Antifungal Agents|antifungal agents|mesh-ancestor
101710927|NCT00691184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101710928|NCT00691184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101710929|NCT00691184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710930|NCT00854100|Cariprazine|cariprazine|mesh-list
101710931|NCT00854100|Antidepressive Agents|antidepressive agents|mesh-list
101710932|NCT00854100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101710933|NCT00854100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101710934|NCT00854100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101710935|NCT00854100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101710936|NCT00854100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710937|NCT00691262|Tacrolimus|tacrolimus|mesh-list
101710938|NCT00691262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101710939|NCT00691262|Immunologic Factors|immunologic factors|mesh-ancestor
101710940|NCT00691262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710941|NCT00691262|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101710942|NCT00691262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101710943|NCT00691262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710944|NCT00620867|Ibuprofen|ibuprofen|mesh-list
101710945|NCT00620867|Celecoxib|celecoxib|mesh-list
101710946|NCT00620867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101710948|NCT00620867|Analgesics|analgesics|mesh-ancestor
101710949|NCT00620867|Sensory System Agents|sensory system agents|mesh-ancestor
101710950|NCT00620867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101786921|NCT05279391|Anticoagulants|anticoagulants|mesh-ancestor
101710951|NCT00620867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710952|NCT00620867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101710953|NCT00620867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101710954|NCT00620867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101710955|NCT00620867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101710956|NCT00620867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786971|NCT00797420|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101786973|NCT00981513|Immunologic Factors|immunologic factors|mesh-ancestor
101710957|NCT00620867|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101710958|NCT04271917|Acetaminophen|acetaminophen|mesh-list
101710960|NCT04271917|Cannabidiol|cannabidiol|mesh-list
101710961|NCT04271917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101710962|NCT04271917|Analgesics|analgesics|mesh-ancestor
101710963|NCT04271917|Sensory System Agents|sensory system agents|mesh-ancestor
101710964|NCT04271917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101710965|NCT04271917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710966|NCT04271917|Antipyretics|antipyretics|mesh-ancestor
101710967|NCT04271917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101710968|NCT04271917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101787034|NCT00981591|Iloprost|iloprost|mesh-list
101787035|NCT00981591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101787036|NCT00981591|Vasodilator Agents|vasodilator agents|mesh-ancestor
101787037|NCT00978159|Esomeprazole|esomeprazole|mesh-list
101787038|NCT00978159|Famotidine|famotidine|mesh-list
101787039|NCT00978159|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101710969|NCT04271917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101710970|NCT04271917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101710971|NCT04271917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101710972|NCT04271917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710974|NCT04122222|Vaccines|vaccines|mesh-list
101710975|NCT04122222|Immunologic Factors|immunologic factors|mesh-ancestor
101710976|NCT04122222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101710978|NCT00686114|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101710979|NCT00686114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101710980|NCT00686114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101710982|NCT00686114|Antimitotic Agents|antimitotic agents|mesh-ancestor
101710983|NCT00686114|Mitosis Modulators|mitosis modulators|mesh-ancestor
101710984|NCT00686114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710985|NCT00686114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101710986|NCT00686114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101710987|NCT01015729|Esomeprazole|esomeprazole|mesh-list
101710988|NCT01015729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101710989|NCT01015729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101710990|NCT01015729|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101710991|NCT01015729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101710992|NCT01015729|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101710993|NCT00698724|Prednisolone acetate|prednisolone acetate|mesh-list
101710994|NCT00698724|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101710995|NCT00698724|Methylprednisolone|methylprednisolone|mesh-list
101710996|NCT00698724|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101710997|NCT00698724|Prednisolone|prednisolone|mesh-list
101710998|NCT00698724|Bromfenac|bromfenac|mesh-list
101710999|NCT00698724|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101711000|NCT00698724|Prednisolone phosphate|prednisolone phosphate|mesh-list
101711001|NCT00698724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101711003|NCT00698724|Autonomic Agents|autonomic agents|mesh-ancestor
101711004|NCT00698724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101711005|NCT00698724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711006|NCT00698724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101711007|NCT00698724|Glucocorticoids|glucocorticoids|mesh-ancestor
101711008|NCT00698724|Hormones|hormones|mesh-ancestor
101302580|NCT00310180|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101787373|NCT00805064|Growth Substances|growth substances|mesh-ancestor
101711009|NCT00698724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101711010|NCT00698724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101711011|NCT00698724|Protective Agents|protective agents|mesh-ancestor
101711012|NCT00698724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101711013|NCT00698724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101711014|NCT00698724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101711015|NCT00698724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101787435|NCT00805298|Epinephrine|epinephrine|mesh-list
101711016|NCT00698724|Analgesics|analgesics|mesh-ancestor
101711017|NCT00698724|Sensory System Agents|sensory system agents|mesh-ancestor
101711018|NCT00698724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101711019|NCT00686192|Calcium Carbonate|calcium carbonate|mesh-list
101711020|NCT00686192|Calcium|calcium|mesh-list
101711021|NCT00686192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101711022|NCT00686192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711023|NCT00686192|Antacids|antacids|mesh-ancestor
101711024|NCT00686192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711025|NCT00686192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101711026|NCT04117776|Chlorhexidine|chlorhexidine|mesh-list
101711027|NCT04117776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101711028|NCT04117776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101711029|NCT04117776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101711030|NCT04117776|Disinfectants|disinfectants|mesh-ancestor
101711031|NCT04117776|Dermatologic Agents|dermatologic agents|mesh-ancestor
101711032|NCT00922610|Epoetin Alfa|epoetin alfa|mesh-list
101711033|NCT00922610|Hematinics|hematinics|mesh-ancestor
101711034|NCT04117698|Ethambutol|ethambutol|mesh-list
101302581|NCT00310180|Hormone Antagonists|hormone antagonists|mesh-ancestor
101711035|NCT04117698|Antitubercular Agents|antitubercular agents|mesh-ancestor
101711036|NCT04117698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101711037|NCT04117698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101711038|NCT04118322|Peppermint oil|peppermint oil|mesh-list
101711039|NCT04118322|Antiemetics|antiemetics|mesh-ancestor
101711040|NCT04118322|Autonomic Agents|autonomic agents|mesh-ancestor
101711041|NCT04118322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101711042|NCT04118322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711043|NCT04118322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101711044|NCT04118322|Parasympatholytics|parasympatholytics|mesh-ancestor
101711045|NCT00698802|Insulin|insulin|mesh-list
101711046|NCT00698802|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101711047|NCT00698802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101711048|NCT00698802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711049|NCT00621647|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101711050|NCT00621647|Antidepressive Agents|antidepressive agents|mesh-ancestor
101711051|NCT00621647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101711052|NCT00621647|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101711053|NCT00621647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101711054|NCT00621647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101711055|NCT00621647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711056|NCT02621970|Cisplatin|cisplatin|mesh-list
101711057|NCT02621970|Docetaxel|docetaxel|mesh-list
101711058|NCT02621970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101711059|NCT02621970|Tubulin Modulators|tubulin modulators|mesh-ancestor
101711060|NCT02621970|Antimitotic Agents|antimitotic agents|mesh-ancestor
101711061|NCT02621970|Mitosis Modulators|mitosis modulators|mesh-ancestor
101711062|NCT02621970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711063|NCT00820755|Cetuximab|cetuximab|mesh-list
101711064|NCT00820755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101711065|NCT00820755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101711066|NCT00700128|Frovatriptan|frovatriptan|mesh-list
101711067|NCT00700128|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101711068|NCT00700128|Serotonin Agents|serotonin agents|mesh-ancestor
101711069|NCT00700128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101711070|NCT00700128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711071|NCT00700128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711072|NCT04662515|Warfarin|warfarin|mesh-list
101711073|NCT04662515|Rivaroxaban|rivaroxaban|mesh-list
101711074|NCT04662515|Dabigatran|dabigatran|mesh-list
101711075|NCT04662515|Apixaban|apixaban|mesh-list
101711076|NCT04662515|Edoxaban|edoxaban|mesh-list
101711077|NCT04662515|Anticoagulants|anticoagulants|mesh-ancestor
101711078|NCT04662515|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101711079|NCT04662515|Antithrombins|antithrombins|mesh-ancestor
101711080|NCT04662515|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101711081|NCT04662515|Protease Inhibitors|protease inhibitors|mesh-ancestor
101711082|NCT04662515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101711083|NCT04662515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711084|NCT04660097|Etoposide|etoposide|mesh-list
101711085|NCT04660097|Etoposide phosphate|etoposide phosphate|mesh-list
101711086|NCT04660097|Durvalumab|durvalumab|mesh-list
101711087|NCT04660097|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101711088|NCT04660097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101711089|NCT04660097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101711090|NCT04660097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101711091|NCT04660097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101711092|NCT04660097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101711093|NCT04660097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711094|NCT04660097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101711095|NCT04660097|Immunologic Factors|immunologic factors|mesh-ancestor
101711096|NCT04660097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711098|NCT00621101|Temsirolimus|temsirolimus|mesh-list
101711099|NCT00621101|MTOR Inhibitors|mtor inhibitors|mesh-list
101711101|NCT00621101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101711102|NCT00621101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101711103|NCT00621101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101711104|NCT00621101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101711105|NCT00621101|Antifungal Agents|antifungal agents|mesh-ancestor
101711106|NCT00621101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101788027|NCT00882024|Analgesics|analgesics|mesh-ancestor
101788044|NCT00799760|Zanamivir|zanamivir|mesh-list
101711107|NCT00621101|Immunologic Factors|immunologic factors|mesh-ancestor
101711108|NCT00621101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711109|NCT00621101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101711110|NCT00621101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101711111|NCT00621101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711112|NCT00621101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101711113|NCT00621101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101711114|NCT00621101|Antimetabolites|antimetabolites|mesh-ancestor
101711115|NCT00621101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101711116|NCT00709215|Cordycepin|cordycepin|mesh-list
101711117|NCT00709215|Pentostatin|pentostatin|mesh-list
101711118|NCT00709215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101711119|NCT00709215|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
101711120|NCT00709215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101711121|NCT00709215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711122|NCT00709215|Antifungal Agents|antifungal agents|mesh-ancestor
101711123|NCT00709215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101711124|NCT00699036|Metformin|metformin|mesh-list
101711125|NCT00699036|Rosiglitazone|rosiglitazone|mesh-list
101711126|NCT00699036|Losartan|losartan|mesh-list
101711127|NCT00699036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101711128|NCT00699036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711129|NCT00699036|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101711130|NCT00699036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101711131|NCT00699036|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101788304|NCT00236899|Antimetabolites|antimetabolites|mesh-ancestor
101711132|NCT00699036|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101711133|NCT00699036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711134|NCT00709293|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101711135|NCT00709293|Immunologic Factors|immunologic factors|mesh-ancestor
101711136|NCT00709293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711137|NCT00709293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101711138|NCT00913497|Insulin|insulin|mesh-list
101711139|NCT00913497|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101711140|NCT00913497|Insulin Aspart|insulin aspart|mesh-list
101711141|NCT00913497|Insulin glulisine|insulin glulisine|mesh-list
101711142|NCT00913497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101711143|NCT00913497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788371|NCT02541708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788372|NCT03973567|Norepinephrine|norepinephrine|mesh-list
101711144|NCT00819741|Metformin|metformin|mesh-list
101711145|NCT00819741|Repaglinide|repaglinide|mesh-list
101711146|NCT00819741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101711147|NCT00819741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711148|NCT04208555|Terconazole|terconazole|mesh-list
101711149|NCT04208555|Antifungal Agents|antifungal agents|mesh-ancestor
101788441|NCT00886002|Fentanyl|fentanyl|mesh-list
101711150|NCT04208555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101711151|NCT00621725|Cediranib|cediranib|mesh-list
101711152|NCT00621725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101711153|NCT00621725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101711154|NCT00621725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101711155|NCT00621725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711156|NCT00862134|Docetaxel|docetaxel|mesh-list
101711157|NCT00862134|Lenograstim|lenograstim|mesh-list
101711158|NCT00862134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101711159|NCT00862134|Tubulin Modulators|tubulin modulators|mesh-ancestor
101711160|NCT00862134|Antimitotic Agents|antimitotic agents|mesh-ancestor
101711161|NCT00862134|Mitosis Modulators|mitosis modulators|mesh-ancestor
101711162|NCT00862134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711163|NCT00862134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101711164|NCT00862134|Immunologic Factors|immunologic factors|mesh-ancestor
101711165|NCT00862134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711167|NCT00700284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101310025|NCT00006249|Antiviral Agents|antiviral agents|mesh-ancestor
101711168|NCT00700284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101711169|NCT00700284|Antiviral Agents|antiviral agents|mesh-ancestor
101711170|NCT00700284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101711171|NCT00618527|Interferons|interferons|mesh-list
101711172|NCT00618527|Interferon-beta|interferon-beta|mesh-list
101711173|NCT00618527|Interferon beta-1a|interferon beta-1a|mesh-list
101711174|NCT00618527|Mycophenolic Acid|mycophenolic acid|mesh-list
101711175|NCT00618527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101711176|NCT00618527|Antiviral Agents|antiviral agents|mesh-ancestor
101711177|NCT00618527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101711178|NCT00618527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101788643|NCT00884442|Nifedipine|nifedipine|mesh-list
101711179|NCT00618527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101711180|NCT00618527|Antitubercular Agents|antitubercular agents|mesh-ancestor
101711181|NCT00618527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101711182|NCT00618527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101711183|NCT00618527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711184|NCT00618527|Immunologic Factors|immunologic factors|mesh-ancestor
101711185|NCT00618527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711186|NCT00618527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101711187|NCT02691533|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101711188|NCT02691533|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101711189|NCT02691533|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101711190|NCT02691533|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101711191|NCT00621881|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
101711192|NCT00621881|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101711193|NCT00621881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711194|NCT04115982|Cholecalciferol|cholecalciferol|mesh-list
101711195|NCT04115982|Vitamin D|vitamin d|mesh-list
101711196|NCT04115982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101711197|NCT04115982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711198|NCT04115982|Vitamins|vitamins|mesh-ancestor
101711199|NCT04115982|Micronutrients|micronutrients|mesh-ancestor
101788765|NCT00800462|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101711200|NCT04115982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101711201|NCT00622037|Lubricant Eye Drops|lubricant eye drops|mesh-list
101711202|NCT00622037|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101711203|NCT00622037|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101711204|NCT01010581|Folic Acid|folic acid|mesh-list
101711205|NCT01010581|Methotrexate|methotrexate|mesh-list
101711206|NCT01010581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101711207|NCT01010581|Abortifacient Agents|abortifacient agents|mesh-ancestor
101711208|NCT01010581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101711209|NCT01010581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711210|NCT01010581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101711212|NCT01010581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711213|NCT01010581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101711214|NCT01010581|Dermatologic Agents|dermatologic agents|mesh-ancestor
101711215|NCT01010581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101711216|NCT01010581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101711217|NCT01010581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101711218|NCT01010581|Immunologic Factors|immunologic factors|mesh-ancestor
101711219|NCT01010581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101788902|NCT00812864|Capecitabine|capecitabine|mesh-list
101788964|NCT00813332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101711220|NCT01010581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101711221|NCT01010581|Hematinics|hematinics|mesh-ancestor
101711222|NCT01010581|Vitamin B Complex|vitamin b complex|mesh-ancestor
101711223|NCT01010581|Vitamins|vitamins|mesh-ancestor
101711224|NCT01010581|Micronutrients|micronutrients|mesh-ancestor
101711225|NCT04382885|Cariprazine|cariprazine|mesh-list
101711226|NCT04382885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101711227|NCT04382885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101711228|NCT04382885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101711229|NCT04382885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711230|NCT04382885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101711231|NCT04208945|Colistin|colistin|mesh-list
101711232|NCT04208945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101711233|NCT04208945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101711234|NCT01016041|Paclitaxel|paclitaxel|mesh-list
101711236|NCT01016041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101711237|NCT01016041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101711238|NCT01016041|Tubulin Modulators|tubulin modulators|mesh-ancestor
101711239|NCT01016041|Antimitotic Agents|antimitotic agents|mesh-ancestor
101711240|NCT01016041|Mitosis Modulators|mitosis modulators|mesh-ancestor
101711241|NCT01016041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711242|NCT01016041|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101711243|NCT01016041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101711244|NCT01016041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101789047|NCT00817622|Vitamin E|vitamin e|mesh-list
101711245|NCT01016041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101711246|NCT01016041|Immunologic Factors|immunologic factors|mesh-ancestor
101711247|NCT01016041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711248|NCT00622115|Enoxaparin|enoxaparin|mesh-list
101711249|NCT00622115|Anticoagulants|anticoagulants|mesh-ancestor
101711250|NCT00622115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101368712|NCT00170404|Vitamins|vitamins|mesh-list
101711251|NCT00622115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101711252|NCT00622115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711254|NCT02696837|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101711255|NCT02696837|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101711257|NCT02696837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101711258|NCT02696837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711259|NCT00490555|Methyltestosterone|methyltestosterone|mesh-list
101711260|NCT00490555|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101711261|NCT00490555|Medroxyprogesterone|medroxyprogesterone|mesh-list
101711262|NCT00490555|Testosterone|testosterone|mesh-list
101711263|NCT00490555|Testosterone undecanoate|testosterone undecanoate|mesh-list
101711264|NCT00490555|Testosterone enanthate|testosterone enanthate|mesh-list
101711265|NCT00490555|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101711266|NCT00490555|Dutasteride|dutasteride|mesh-list
101711267|NCT00490555|Androgens|androgens|mesh-ancestor
101711268|NCT00490555|Hormones|hormones|mesh-ancestor
101711269|NCT00490555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101711270|NCT00490555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711271|NCT00490555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101711272|NCT00490555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101711273|NCT00490555|Anabolic Agents|anabolic agents|mesh-ancestor
101711274|NCT00490555|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101711275|NCT00490555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101711276|NCT00490555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101711277|NCT00490555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711278|NCT00490555|Hormone Antagonists|hormone antagonists|mesh-ancestor
101789225|NCT00723125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101711279|NCT00490555|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101711280|NCT00490555|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101711281|NCT00490555|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101711282|NCT00490555|Contraceptive Agents|contraceptive agents|mesh-ancestor
101711283|NCT00490555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101711284|NCT00490555|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101711285|NCT00490555|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101711286|NCT00490555|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101711287|NCT01014247|Moxifloxacin|moxifloxacin|mesh-list
101711288|NCT01014247|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101711289|NCT01014247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101711290|NCT01014247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101711291|NCT01014247|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101711292|NCT01014247|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101711293|NCT01014247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101789348|NCT00275821|Growth Inhibitors|growth inhibitors|mesh-ancestor
101711294|NCT01014247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711295|NCT01014247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101711296|NCT01014247|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101711297|NCT01014247|Contraceptive Agents|contraceptive agents|mesh-ancestor
101711298|NCT01014247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101711299|NCT01014247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711300|NCT01014247|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101711302|NCT01014247|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101711303|NCT00049595|Prednisone|prednisone|mesh-list
101711304|NCT00049595|Cyclophosphamide|cyclophosphamide|mesh-list
101711305|NCT00049595|Dacarbazine|dacarbazine|mesh-list
101711306|NCT00049595|Doxorubicin|doxorubicin|mesh-list
101711307|NCT00049595|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101711308|NCT00049595|Etoposide|etoposide|mesh-list
101711309|NCT00049595|Vincristine|vincristine|mesh-list
101711310|NCT00049595|Bleomycin|bleomycin|mesh-list
101789484|NCT00884676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101789485|NCT00884676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789486|NCT00884676|Tubulin Modulators|tubulin modulators|mesh-ancestor
101789487|NCT00884676|Antimitotic Agents|antimitotic agents|mesh-ancestor
101789488|NCT00884676|Mitosis Modulators|mitosis modulators|mesh-ancestor
101711311|NCT00049595|Vinblastine|vinblastine|mesh-list
101711312|NCT00049595|Procarbazine|procarbazine|mesh-list
101711313|NCT00049595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101711314|NCT00049595|Immunologic Factors|immunologic factors|mesh-ancestor
101711315|NCT00049595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711316|NCT00049595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101711317|NCT00049595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101711318|NCT00049595|Alkylating Agents|alkylating agents|mesh-ancestor
101711319|NCT00049595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711320|NCT00049595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101711321|NCT00049595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101711322|NCT00049595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101711323|NCT00049595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101711324|NCT00049595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101711325|NCT00049595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101711326|NCT00049595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101711327|NCT00049595|Glucocorticoids|glucocorticoids|mesh-ancestor
101711328|NCT00049595|Hormones|hormones|mesh-ancestor
101711329|NCT00049595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101789544|NCT04397406|Anesthetics|anesthetics|mesh-ancestor
101711330|NCT00049595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101789545|NCT04397406|Anesthetics, Local|anesthetics, local|mesh-ancestor
101711331|NCT00049595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101711332|NCT00049595|Tubulin Modulators|tubulin modulators|mesh-ancestor
101711333|NCT00049595|Antimitotic Agents|antimitotic agents|mesh-ancestor
101711334|NCT00049595|Mitosis Modulators|mitosis modulators|mesh-ancestor
101711335|NCT00873860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101711336|NCT00873860|Immunologic Factors|immunologic factors|mesh-ancestor
101711337|NCT00873860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711339|NCT03854227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101711340|NCT03854227|Tubulin Modulators|tubulin modulators|mesh-ancestor
101711342|NCT03854227|Mitosis Modulators|mitosis modulators|mesh-ancestor
101711343|NCT03854227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711344|NCT05368961|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
101711345|NCT05368961|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101711346|NCT05368961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101711347|NCT05368961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711348|NCT05368961|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101711349|NCT02626754|Sunitinib|sunitinib|mesh-list
101711350|NCT02626754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101711351|NCT02626754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101711352|NCT02626754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101711353|NCT02626754|Growth Substances|growth substances|mesh-ancestor
101711354|NCT02626754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711355|NCT02626754|Growth Inhibitors|growth inhibitors|mesh-ancestor
101711356|NCT02626754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101711357|NCT02626754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101711358|NCT02626754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711360|NCT00691886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101711361|NCT00691886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101711362|NCT00691886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711363|NCT00691886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101711364|NCT00691886|Analgesics|analgesics|mesh-ancestor
101711365|NCT00691886|Sensory System Agents|sensory system agents|mesh-ancestor
101711366|NCT00691886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101711367|NCT00691886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101711368|NCT00691886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101711369|NCT00691886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101711370|NCT00691886|Adrenergic Agents|adrenergic agents|mesh-ancestor
101711371|NCT00691886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101789728|NCT02541786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101711372|NCT00691886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711373|NCT04138004|Lubiprostone|lubiprostone|mesh-list
101711374|NCT04138004|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101711375|NCT04138004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101711376|NCT04138004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711377|NCT00621491|Warfarin|warfarin|mesh-list
101711378|NCT00621491|Anticoagulants|anticoagulants|mesh-list
101711379|NCT00622349|Cisplatin|cisplatin|mesh-list
101711380|NCT00622349|Gemcitabine|gemcitabine|mesh-list
101711381|NCT00622349|Docetaxel|docetaxel|mesh-list
101789780|NCT00608322|Antioxidants|antioxidants|mesh-ancestor
101711382|NCT00622349|Ifosfamide|ifosfamide|mesh-list
101711383|NCT00622349|Isophosphamide mustard|isophosphamide mustard|mesh-list
101711384|NCT00622349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101711385|NCT00622349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101711386|NCT00622349|Antimetabolites|antimetabolites|mesh-ancestor
101711387|NCT00622349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711388|NCT00622349|Tubulin Modulators|tubulin modulators|mesh-ancestor
101711389|NCT00622349|Antimitotic Agents|antimitotic agents|mesh-ancestor
101711390|NCT00622349|Mitosis Modulators|mitosis modulators|mesh-ancestor
101711391|NCT00622349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101711392|NCT00622349|Alkylating Agents|alkylating agents|mesh-ancestor
101711393|NCT00686816|Sucrose polyester|sucrose polyester|mesh-list
101711394|NCT00686816|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101711395|NCT00686816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101711396|NCT00686816|Antimetabolites|antimetabolites|mesh-ancestor
101789893|NCT00893724|Niacin|niacin|mesh-list
101711397|NCT00686816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711398|NCT00686816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101711399|NCT05368181|Methylprednisolone|methylprednisolone|mesh-list
101711400|NCT05368181|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101711401|NCT05368181|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101711402|NCT05368181|Prednisolone|prednisolone|mesh-list
101711403|NCT05368181|Prednisolone acetate|prednisolone acetate|mesh-list
101711404|NCT05368181|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101711405|NCT05368181|Prednisolone phosphate|prednisolone phosphate|mesh-list
101711406|NCT05368181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101711407|NCT05368181|Antiemetics|antiemetics|mesh-ancestor
101711408|NCT05368181|Autonomic Agents|autonomic agents|mesh-ancestor
101711409|NCT05368181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101711410|NCT05368181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711411|NCT05368181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101711412|NCT05368181|Glucocorticoids|glucocorticoids|mesh-ancestor
101711413|NCT05368181|Hormones|hormones|mesh-ancestor
101711414|NCT05368181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101711415|NCT05368181|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101711416|NCT05368181|Protective Agents|protective agents|mesh-ancestor
101711417|NCT05368181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101711418|NCT05368181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101711419|NCT05662163|Anesthetics|anesthetics|mesh-list
101711420|NCT05662163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101711421|NCT05662163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711422|NCT02666105|Exemestane|exemestane|mesh-list
101789972|NCT03455556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101711423|NCT02666105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101711424|NCT02666105|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101711425|NCT02666105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101711426|NCT02666105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101711427|NCT02666105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711428|NCT02666105|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101711429|NCT02666105|Hormone Antagonists|hormone antagonists|mesh-ancestor
101711430|NCT02666105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101789985|NCT04017624|Nicotine|nicotine|mesh-list
101711431|NCT02666105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711433|NCT04138238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101711434|NCT04138238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101711435|NCT04138238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101711436|NCT04138238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101711437|NCT04138238|Antifungal Agents|antifungal agents|mesh-ancestor
101711438|NCT04138238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101711439|NCT04138238|Immunologic Factors|immunologic factors|mesh-ancestor
101711440|NCT04138238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711441|NCT00622817|Epinephrine|epinephrine|mesh-list
101711442|NCT00622817|Xylometazoline|xylometazoline|mesh-list
101711443|NCT00622817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101711444|NCT00622817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101711445|NCT00622817|Adrenergic Agents|adrenergic agents|mesh-ancestor
101711446|NCT00622817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101711447|NCT00622817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711448|NCT00622817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711449|NCT00622817|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101790021|NCT00635570|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101711450|NCT00622817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101711451|NCT00622817|Autonomic Agents|autonomic agents|mesh-ancestor
101711452|NCT00622817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101711453|NCT00622817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101711454|NCT00622817|Respiratory System Agents|respiratory system agents|mesh-ancestor
101711455|NCT00622817|Mydriatics|mydriatics|mesh-ancestor
101711456|NCT00622817|Sympathomimetics|sympathomimetics|mesh-ancestor
101711457|NCT00622817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101711458|NCT00622817|Nasal Decongestants|nasal decongestants|mesh-ancestor
101711459|NCT02432417|Chloroquine|chloroquine|mesh-list
101711460|NCT02432417|Amebicides|amebicides|mesh-ancestor
101711461|NCT02432417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101711462|NCT02432417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101711463|NCT02432417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101711464|NCT02432417|Antimalarials|antimalarials|mesh-ancestor
101711465|NCT02432417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101711468|NCT00692120|Cholecalciferol|cholecalciferol|mesh-list
101711469|NCT00692120|Vitamins|vitamins|mesh-list
101711470|NCT00692120|Micronutrients|micronutrients|mesh-ancestor
101711471|NCT00692120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711472|NCT00692120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101711473|NCT00692120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101711474|NCT00819585|Colchicine|colchicine|mesh-list
101711475|NCT00819585|Allopurinol|allopurinol|mesh-list
101711476|NCT00819585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101711477|NCT00819585|Gout Suppressants|gout suppressants|mesh-ancestor
101711478|NCT00819585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101711479|NCT00819585|Tubulin Modulators|tubulin modulators|mesh-ancestor
101711480|NCT00819585|Antimitotic Agents|antimitotic agents|mesh-ancestor
101711481|NCT00819585|Mitosis Modulators|mitosis modulators|mesh-ancestor
101711482|NCT00819585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711483|NCT00819585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101711484|NCT00819585|Antimetabolites|antimetabolites|mesh-ancestor
101711485|NCT00819585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101711486|NCT00819585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101711487|NCT00819585|Antioxidants|antioxidants|mesh-ancestor
101711488|NCT00819585|Protective Agents|protective agents|mesh-ancestor
101790199|NCT00903084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101711489|NCT00819585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711491|NCT00687206|Valsartan|valsartan|mesh-list
101711492|NCT00687206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101711493|NCT00687206|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101711494|NCT00687206|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101711495|NCT00687206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711497|NCT00687284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101711498|NCT00687284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711500|NCT02358395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101711501|NCT02358395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101711502|NCT02358395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101711503|NCT02358395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711504|NCT00692354|Tosedostat|tosedostat|mesh-list
101711505|NCT00692354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101790407|NCT00904176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101711506|NCT00692354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790476|NCT00906048|Levofloxacin|levofloxacin|mesh-list
101711507|NCT03928847|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
101711509|NCT03928847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711510|NCT03928847|Protective Agents|protective agents|mesh-ancestor
101711511|NCT03928847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711512|NCT03928847|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101711513|NCT03928847|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101711514|NCT03928847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101711515|NCT03928847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101790544|NCT00906360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101711517|NCT02624726|Fluorouracil|fluorouracil|mesh-list
101711518|NCT02624726|Irinotecan|irinotecan|mesh-list
101711519|NCT02624726|Aflibercept|aflibercept|mesh-list
101711520|NCT02624726|Levoleucovorin|levoleucovorin|mesh-list
101711521|NCT02624726|Antimetabolites|antimetabolites|mesh-ancestor
101711522|NCT02624726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790614|NCT00905190|Antipruritics|antipruritics|mesh-ancestor
101711523|NCT02624726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101711524|NCT02624726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101711525|NCT02624726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101711526|NCT02624726|Immunologic Factors|immunologic factors|mesh-ancestor
101711527|NCT02624726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711528|NCT02624726|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101711529|NCT02624726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101711530|NCT02624726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101711531|NCT02624726|Antidotes|antidotes|mesh-ancestor
101790682|NCT00819806|Alkylating Agents|alkylating agents|mesh-ancestor
101711532|NCT02624726|Protective Agents|protective agents|mesh-ancestor
101711533|NCT02624726|Vitamin B Complex|vitamin b complex|mesh-ancestor
101711534|NCT02624726|Vitamins|vitamins|mesh-ancestor
101711535|NCT02624726|Micronutrients|micronutrients|mesh-ancestor
101711536|NCT02624726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101711537|NCT02624726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101711538|NCT02624726|Growth Substances|growth substances|mesh-ancestor
101711539|NCT02624726|Growth Inhibitors|growth inhibitors|mesh-ancestor
101711541|NCT00681746|Antidotes|antidotes|mesh-ancestor
101711542|NCT00681746|Protective Agents|protective agents|mesh-ancestor
101711543|NCT00681746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711544|NCT00681746|GABA Modulators|gaba modulators|mesh-ancestor
101711545|NCT00681746|GABA Agents|gaba agents|mesh-ancestor
101711546|NCT00681746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101711547|NCT00681746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711548|NCT04265911|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101711549|NCT04265911|Immunologic Factors|immunologic factors|mesh-ancestor
101711550|NCT04265911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711552|NCT00819039|Aprepitant|aprepitant|mesh-list
101369012|NCT00055718|Silymarin|silymarin|mesh-list
101711553|NCT00819039|Antiemetics|antiemetics|mesh-ancestor
101711554|NCT00819039|Autonomic Agents|autonomic agents|mesh-ancestor
101711555|NCT00819039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101711556|NCT00819039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711557|NCT00819039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101711558|NCT00819039|Antipruritics|antipruritics|mesh-ancestor
101711559|NCT00819039|Dermatologic Agents|dermatologic agents|mesh-ancestor
101711560|NCT00819039|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101711561|NCT00819039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101711562|NCT00819039|Serotonin Agents|serotonin agents|mesh-ancestor
101711563|NCT00819039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101711564|NCT00819039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711565|NCT00819039|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101711566|NCT00692510|Rosiglitazone|rosiglitazone|mesh-list
101711568|NCT00692510|Caffeine|caffeine|mesh-list
101711569|NCT00692510|Bupropion|bupropion|mesh-list
101711570|NCT00692510|Omeprazole|omeprazole|mesh-list
101790944|NCT05420727|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101711571|NCT00692510|Bilirubin|bilirubin|mesh-list
101711572|NCT00692510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101711573|NCT00692510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101711574|NCT00692510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101711575|NCT00692510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711576|NCT00692510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101711577|NCT00692510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101711578|NCT00692510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101711579|NCT00692510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101711580|NCT00692510|Anesthetics, General|anesthetics, general|mesh-ancestor
101711581|NCT00692510|Anesthetics|anesthetics|mesh-ancestor
101711582|NCT00692510|GABA Modulators|gaba modulators|mesh-ancestor
101711583|NCT00692510|GABA Agents|gaba agents|mesh-ancestor
101711584|NCT00692510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101711585|NCT00692510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791080|NCT04085393|Autonomic Agents|autonomic agents|mesh-ancestor
101791086|NCT04085393|Serotonin Agents|serotonin agents|mesh-ancestor
101711586|NCT00692510|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101711588|NCT00692510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101711589|NCT00692510|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101711590|NCT00692510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101711591|NCT00692510|Purinergic Agents|purinergic agents|mesh-ancestor
101711592|NCT00692510|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101711593|NCT00692510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101791143|NCT03947099|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101711594|NCT00692510|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101711595|NCT00692510|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101711596|NCT00692510|Antidepressive Agents|antidepressive agents|mesh-ancestor
101711597|NCT00692510|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101711598|NCT00692510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101711599|NCT00692510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101711600|NCT00692510|Dopamine Agents|dopamine agents|mesh-ancestor
101791210|NCT05315271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101711601|NCT00692510|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101711602|NCT00692510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101711603|NCT00692510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101711604|NCT00692510|Antioxidants|antioxidants|mesh-ancestor
101711605|NCT00692510|Protective Agents|protective agents|mesh-ancestor
101711607|NCT00500539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101711608|NCT00500539|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101711609|NCT00500539|Respiratory System Agents|respiratory system agents|mesh-ancestor
101711610|NCT00687518|Epoetin Alfa|epoetin alfa|mesh-list
101711611|NCT00687518|Hematinics|hematinics|mesh-ancestor
101711612|NCT02303795|Warfarin|warfarin|mesh-list
101711613|NCT02303795|Rivaroxaban|rivaroxaban|mesh-list
101711614|NCT02303795|Anticoagulants|anticoagulants|mesh-ancestor
101711616|NCT02303795|Antithrombins|antithrombins|mesh-ancestor
101711617|NCT02303795|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101711618|NCT02303795|Protease Inhibitors|protease inhibitors|mesh-ancestor
101711619|NCT02303795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101711620|NCT02303795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711621|NCT04187417|Tetracaine|tetracaine|mesh-list
101711622|NCT04187417|Anesthetics, Local|anesthetics, local|mesh-ancestor
101711623|NCT04187417|Anesthetics|anesthetics|mesh-ancestor
101711624|NCT04187417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101711625|NCT04187417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711626|NCT04187417|Sensory System Agents|sensory system agents|mesh-ancestor
101711627|NCT04187417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101711628|NCT00818883|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101711629|NCT00818883|Chlorthalidone|chlorthalidone|mesh-list
101711630|NCT00818883|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
101791407|NCT00826826|Amiodarone|amiodarone|mesh-list
101711631|NCT00818883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101711633|NCT00818883|Natriuretic Agents|natriuretic agents|mesh-ancestor
101711634|NCT00818883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711635|NCT00818883|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101711636|NCT00818883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101711637|NCT00818883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711638|NCT00818883|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101711639|NCT00818883|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101711640|NCT01014481|Tenofovir|tenofovir|mesh-list
101711641|NCT01014481|Lamivudine|lamivudine|mesh-list
101711642|NCT01014481|Efavirenz|efavirenz|mesh-list
101711643|NCT01014481|Antiviral Agents|antiviral agents|mesh-ancestor
101711644|NCT01014481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101711645|NCT01014481|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101711646|NCT01014481|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101711647|NCT01014481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101711648|NCT01014481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711649|NCT01014481|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101711651|NCT01014481|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101711652|NCT01014481|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101711653|NCT01014481|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101711654|NCT01014481|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101711655|NCT01014481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101711656|NCT01014481|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101711657|NCT02167763|Copper|copper|mesh-list
101711658|NCT02167763|Contraceptive Agents|contraceptive agents|mesh-list
101711659|NCT02167763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101711660|NCT02167763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711661|NCT02167763|Trace Elements|trace elements|mesh-ancestor
101711662|NCT02167763|Micronutrients|micronutrients|mesh-ancestor
101711663|NCT00508027|Simvastatin|simvastatin|mesh-list
101711664|NCT00508027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101711665|NCT00508027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101711666|NCT00508027|Antimetabolites|antimetabolites|mesh-ancestor
101711667|NCT00508027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711669|NCT00508027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101711670|NCT00508027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101711671|NCT01986101|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
101711672|NCT01986101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101711673|NCT01986101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101711674|NCT01986101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101711675|NCT01986101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711676|NCT01986101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101711677|NCT01986101|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101711678|NCT01986101|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101711679|NCT01986101|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101711680|NCT01986101|Adrenergic Agents|adrenergic agents|mesh-ancestor
101711681|NCT01986101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101791656|NCT00827684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101711682|NCT01986101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711683|NCT01986101|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101711684|NCT01986101|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101711685|NCT01986101|Serotonin Agents|serotonin agents|mesh-ancestor
101711686|NCT01986101|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101711687|NCT01986101|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101711688|NCT01986101|Dopamine Agents|dopamine agents|mesh-ancestor
101711689|NCT00500149|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101711690|NCT00500149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101711691|NCT00500149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711692|NCT00500149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101791794|NCT00931008|Docetaxel|docetaxel|mesh-list
101711693|NCT00500149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101711694|NCT00500149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101711695|NCT00500149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711696|NCT00500149|Dopamine Agents|dopamine agents|mesh-ancestor
101711697|NCT00500149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101711699|NCT00681902|Anesthetics, Local|anesthetics, local|mesh-ancestor
101369166|NCT00173875|Gefitinib|gefitinib|mesh-list
101711700|NCT00681902|Anesthetics|anesthetics|mesh-ancestor
101711701|NCT00681902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101711702|NCT00681902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711703|NCT00681902|Sensory System Agents|sensory system agents|mesh-ancestor
101711704|NCT00681902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101711705|NCT00681902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101711706|NCT00681902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101711707|NCT00681902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101711708|NCT00681902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101791989|NCT03742947|Hemostatics|hemostatics|mesh-list
101711709|NCT00681902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711710|NCT04185857|Olmesartan|olmesartan|mesh-list
101711711|NCT04185857|Canrenone|canrenone|mesh-list
101711712|NCT04185857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101711713|NCT04185857|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101711714|NCT04185857|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101711715|NCT04185857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711716|NCT04185857|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101711717|NCT04185857|Hormone Antagonists|hormone antagonists|mesh-ancestor
101711718|NCT04185857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101711719|NCT04185857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711720|NCT04185857|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101711721|NCT04185857|Diuretics|diuretics|mesh-ancestor
101711722|NCT04185857|Natriuretic Agents|natriuretic agents|mesh-ancestor
101711723|NCT01016509|Insulin|insulin|mesh-list
101711724|NCT01016509|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101711725|NCT01016509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101711726|NCT01016509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711727|NCT00639119|Ropinirole|ropinirole|mesh-list
101711728|NCT00639119|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101711729|NCT00639119|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101711730|NCT00639119|Dopamine Agonists|dopamine agonists|mesh-ancestor
101711731|NCT00639119|Dopamine Agents|dopamine agents|mesh-ancestor
101711732|NCT00639119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101711733|NCT00639119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711734|NCT00639119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711735|NCT01010893|Vaccines|vaccines|mesh-list
101711736|NCT01010893|Immunologic Factors|immunologic factors|mesh-ancestor
101711737|NCT01010893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711738|NCT01011127|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101711739|NCT01011127|Pravastatin|pravastatin|mesh-list
101711740|NCT01011127|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101711741|NCT01011127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101711742|NCT01011127|Antimetabolites|antimetabolites|mesh-ancestor
101711743|NCT01011127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711744|NCT01011127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101711745|NCT01011127|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101792336|NCT00833378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310226|NCT00005830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101792337|NCT00833378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792339|NCT00833378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101792340|NCT00833378|Antiviral Agents|antiviral agents|mesh-ancestor
101792341|NCT00833378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101792342|NCT00833378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101792343|NCT00833378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101792344|NCT05359341|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101711746|NCT01011127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101711747|NCT00912548|Tamoxifen|tamoxifen|mesh-list
101711748|NCT00912548|Goserelin|goserelin|mesh-list
101711749|NCT00912548|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101711750|NCT00912548|Hormone Antagonists|hormone antagonists|mesh-ancestor
101711751|NCT00912548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101711752|NCT00912548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711753|NCT00912548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101711754|NCT00912548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101711755|NCT00912548|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101711756|NCT00912548|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101711757|NCT00912548|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101711759|NCT01016665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101792460|NCT00839462|Vitamins|vitamins|mesh-ancestor
101711760|NCT01016665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101711761|NCT01016665|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101711762|NCT01016665|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101711763|NCT01016665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101711764|NCT01016665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792526|NCT00625742|Analgesics|analgesics|mesh-ancestor
101711765|NCT01016665|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101711766|NCT01016665|Hormone Antagonists|hormone antagonists|mesh-ancestor
101711767|NCT01016665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101711768|NCT01016665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711770|NCT00681980|Anticonvulsants|anticonvulsants|mesh-ancestor
101711771|NCT00681980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101711772|NCT00681980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711773|NCT00681980|GABA Agents|gaba agents|mesh-ancestor
101711774|NCT00681980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101711775|NCT00681980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711776|NCT00681980|Antimanic Agents|antimanic agents|mesh-ancestor
101711777|NCT00681980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101711778|NCT00681980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101711779|NCT00681980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101711780|NCT00692900|Docetaxel|docetaxel|mesh-list
101711781|NCT00692900|Oxaliplatin|oxaliplatin|mesh-list
101711782|NCT00692900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101711783|NCT00692900|Tubulin Modulators|tubulin modulators|mesh-ancestor
101711784|NCT00692900|Antimitotic Agents|antimitotic agents|mesh-ancestor
101711785|NCT00692900|Mitosis Modulators|mitosis modulators|mesh-ancestor
101711786|NCT00692900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711787|NCT03800381|Rifampin|rifampin|mesh-list
101711788|NCT03800381|Isoniazid|isoniazid|mesh-list
101711789|NCT03800381|Pyrazinamide|pyrazinamide|mesh-list
101792654|NCT00840242|Nicotine|nicotine|mesh-list
101711790|NCT03800381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101711791|NCT03800381|Antitubercular Agents|antitubercular agents|mesh-ancestor
101711792|NCT03800381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101711793|NCT03800381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101711794|NCT03800381|Leprostatic Agents|leprostatic agents|mesh-ancestor
101711795|NCT03800381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101711796|NCT03800381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101711797|NCT03800381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711798|NCT03800381|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101711799|NCT03800381|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101711800|NCT03800381|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101711801|NCT03800381|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101711802|NCT03800381|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101711803|NCT03800381|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101711804|NCT03800381|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101711806|NCT03800381|Antimetabolites|antimetabolites|mesh-ancestor
101711807|NCT03800381|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101711809|NCT00489853|Formoterol Fumarate|formoterol fumarate|mesh-list
101792725|NCT04696575|Antiviral Agents|antiviral agents|mesh-ancestor
101711811|NCT00489853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101711812|NCT00489853|Autonomic Agents|autonomic agents|mesh-ancestor
101711813|NCT00489853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101711814|NCT00489853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711815|NCT00489853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101711816|NCT00489853|Respiratory System Agents|respiratory system agents|mesh-ancestor
101711818|NCT00489853|Hormones|hormones|mesh-ancestor
101711819|NCT00489853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101711820|NCT00489853|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101711821|NCT00489853|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101711822|NCT00489853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101711823|NCT00489853|Adrenergic Agents|adrenergic agents|mesh-ancestor
101711824|NCT00489853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101711825|NCT00489853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711826|NCT00682136|Ropivacaine|ropivacaine|mesh-list
101711827|NCT00682136|Anesthetics, Local|anesthetics, local|mesh-ancestor
101711828|NCT00682136|Anesthetics|anesthetics|mesh-ancestor
101711829|NCT00682136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101711830|NCT00682136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711831|NCT00682136|Sensory System Agents|sensory system agents|mesh-ancestor
101711832|NCT00682136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101711833|NCT00693056|beta-Lactams|beta-lactams|mesh-list
101792843|NCT00989625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101711834|NCT00693056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101711835|NCT00693056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101711837|NCT04137302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101711838|NCT04145336|Indomethacin|indomethacin|mesh-list
101711839|NCT04145336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101711840|NCT04145336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101711841|NCT04145336|Analgesics|analgesics|mesh-ancestor
101711842|NCT04145336|Sensory System Agents|sensory system agents|mesh-ancestor
101711843|NCT04145336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101711844|NCT04145336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369321|NCT00174733|Hormones|hormones|mesh-ancestor
101711845|NCT04145336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101711846|NCT04145336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101711847|NCT04145336|Gout Suppressants|gout suppressants|mesh-ancestor
101711848|NCT04145336|Tocolytic Agents|tocolytic agents|mesh-ancestor
101711849|NCT04145336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101711850|NCT04145336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101711851|NCT04145336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101711852|NCT04145336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711853|NCT00499681|Letrozole|letrozole|mesh-list
101711854|NCT00499681|Lapatinib|lapatinib|mesh-list
101711855|NCT00499681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101711856|NCT00499681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101711857|NCT00499681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101711858|NCT00499681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101711859|NCT00499681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711860|NCT00499681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101711861|NCT00499681|Hormone Antagonists|hormone antagonists|mesh-ancestor
101711862|NCT00499681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101711863|NCT00499681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711864|NCT00499681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101711865|NCT02687009|Niclosamide|niclosamide|mesh-list
101711866|NCT02687009|Anticestodal Agents|anticestodal agents|mesh-ancestor
101711867|NCT02687009|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101711868|NCT02687009|Anthelmintics|anthelmintics|mesh-ancestor
101711869|NCT02687009|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101711870|NCT02687009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101711871|NCT02687009|Antinematodal Agents|antinematodal agents|mesh-ancestor
101711872|NCT00693212|Methylphenidate|methylphenidate|mesh-list
101711873|NCT00693212|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101711874|NCT00693212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711875|NCT00693212|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101711876|NCT00693212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101792929|NCT00841724|Immunologic Factors|immunologic factors|mesh-ancestor
101711877|NCT00693212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101711878|NCT00693212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711880|NCT00693212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101711882|NCT00688298|Cholinergic Agents|cholinergic agents|mesh-ancestor
101711883|NCT00688298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101793000|NCT00842114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101711884|NCT00688298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711885|NCT00688298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711886|NCT00499603|Paclitaxel|paclitaxel|mesh-list
101711887|NCT00499603|Cyclophosphamide|cyclophosphamide|mesh-list
101711888|NCT00499603|Fluorouracil|fluorouracil|mesh-list
101711889|NCT00499603|Epirubicin|epirubicin|mesh-list
101711890|NCT00499603|Everolimus|everolimus|mesh-list
101711891|NCT00499603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101711892|NCT00499603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101711893|NCT00499603|Tubulin Modulators|tubulin modulators|mesh-ancestor
101711894|NCT00499603|Antimitotic Agents|antimitotic agents|mesh-ancestor
101711895|NCT00499603|Mitosis Modulators|mitosis modulators|mesh-ancestor
101793137|NCT00836576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101793138|NCT00836654|Catumaxomab|catumaxomab|mesh-list
101711896|NCT00499603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711897|NCT00499603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101711898|NCT00499603|Immunologic Factors|immunologic factors|mesh-ancestor
101711899|NCT00499603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711900|NCT00499603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101711901|NCT00499603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101711902|NCT00499603|Alkylating Agents|alkylating agents|mesh-ancestor
101711903|NCT00499603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101711904|NCT00499603|Antimetabolites|antimetabolites|mesh-ancestor
101711905|NCT00499603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101711907|NCT00499603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101711908|NCT00499603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101711909|NCT00499603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101711910|NCT00499603|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101711911|NCT00499603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101711912|NCT01946711|Budesonide|budesonide|mesh-list
101711913|NCT01946711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101711914|NCT01946711|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101711915|NCT01946711|Autonomic Agents|autonomic agents|mesh-ancestor
101711916|NCT01946711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101711917|NCT01946711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711918|NCT01946711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101711919|NCT01946711|Respiratory System Agents|respiratory system agents|mesh-ancestor
101711920|NCT01946711|Glucocorticoids|glucocorticoids|mesh-ancestor
101711921|NCT01946711|Hormones|hormones|mesh-ancestor
101711922|NCT01946711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101711923|NCT00693446|Sirolimus|sirolimus|mesh-list
101711924|NCT00693446|Tacrolimus|tacrolimus|mesh-list
101711925|NCT00693446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101711926|NCT00693446|Immunologic Factors|immunologic factors|mesh-ancestor
101711927|NCT00693446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711928|NCT00693446|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101711929|NCT00693446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101711930|NCT00693446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711931|NCT00693446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101711932|NCT00693446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101711933|NCT00693446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101711934|NCT00693446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101711935|NCT00693446|Antifungal Agents|antifungal agents|mesh-ancestor
101711936|NCT00693524|Mycophenolic Acid|mycophenolic acid|mesh-list
101711937|NCT00693524|Prednisone|prednisone|mesh-list
101711938|NCT00693524|Tacrolimus|tacrolimus|mesh-list
101711939|NCT00693524|Daclizumab|daclizumab|mesh-list
101711940|NCT00693524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101711941|NCT00693524|Glucocorticoids|glucocorticoids|mesh-ancestor
101711942|NCT00693524|Hormones|hormones|mesh-ancestor
101711943|NCT00693524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101711944|NCT00693524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711945|NCT00693524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101793684|NCT00853190|Chlorpheniramine|chlorpheniramine|mesh-list
101711946|NCT00693524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101711947|NCT00693524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101711948|NCT00693524|Immunologic Factors|immunologic factors|mesh-ancestor
101711950|NCT00693524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101711951|NCT00693524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711952|NCT00693524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101711953|NCT00693524|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101711955|NCT00693524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101711956|NCT00693524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101711957|NCT00693602|Asparaginase|asparaginase|mesh-list
101711958|NCT00693602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101711959|NCT00682214|Vitamin D|vitamin d|mesh-list
101711960|NCT00682214|Cholecalciferol|cholecalciferol|mesh-list
101711961|NCT00682214|Vitamins|vitamins|mesh-ancestor
101711962|NCT00682214|Micronutrients|micronutrients|mesh-ancestor
101711963|NCT00682214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711964|NCT00682214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101711965|NCT00682214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101711966|NCT04137380|Mirikizumab|mirikizumab|mesh-list
101711967|NCT04137380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101711968|NCT04137380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101711969|NCT04137380|Analgesics|analgesics|mesh-ancestor
101711970|NCT04137380|Sensory System Agents|sensory system agents|mesh-ancestor
101711971|NCT04137380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101711972|NCT04137380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711973|NCT04137380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101711974|NCT04137380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101711975|NCT04137380|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101711976|NCT04137380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101711977|NCT00693680|Imipramine|imipramine|mesh-list
101794030|NCT00862472|Timolol|timolol|mesh-list
101711978|NCT00693680|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101711979|NCT00693680|Antidepressive Agents|antidepressive agents|mesh-ancestor
101711980|NCT00693680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101711981|NCT00693680|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101711982|NCT00693680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101711983|NCT00693680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101711984|NCT00693680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101711985|NCT00693680|Adrenergic Agents|adrenergic agents|mesh-ancestor
101711986|NCT00693680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101711987|NCT00693680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711988|NCT00682292|Thymoglobulin|thymoglobulin|mesh-list
101711989|NCT00682292|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101711990|NCT00682292|Daclizumab|daclizumab|mesh-list
101711991|NCT00682292|Immunologic Factors|immunologic factors|mesh-ancestor
101369457|NCT00056537|Naptumomab estafenatox|naptumomab estafenatox|mesh-list
101711992|NCT00682292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101711993|NCT00682292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101711994|NCT00810069|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101711996|NCT00810069|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101711997|NCT00810069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101711998|NCT00810069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101711999|NCT00810069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712000|NCT00810069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101712001|NCT00810069|Serotonin Agents|serotonin agents|mesh-ancestor
101712002|NCT00810069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712003|NCT00810069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101712004|NCT00810069|Antidepressive Agents|antidepressive agents|mesh-ancestor
101712005|NCT00810069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101712006|NCT00810069|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101712007|NCT00810069|Analgesics|analgesics|mesh-ancestor
101712008|NCT00810069|Sensory System Agents|sensory system agents|mesh-ancestor
101712009|NCT00810069|Dopamine Agents|dopamine agents|mesh-ancestor
101712010|NCT00693758|Adenosine|adenosine|mesh-list
101712011|NCT00693758|Analgesics|analgesics|mesh-ancestor
101712012|NCT00693758|Sensory System Agents|sensory system agents|mesh-ancestor
101712013|NCT00693758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101712014|NCT00693758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712015|NCT00693758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101712016|NCT00693758|Vasodilator Agents|vasodilator agents|mesh-ancestor
101712017|NCT00693758|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101712018|NCT00693758|Purinergic Agonists|purinergic agonists|mesh-ancestor
101712019|NCT00693758|Purinergic Agents|purinergic agents|mesh-ancestor
101712020|NCT00693758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101712021|NCT00693758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712023|NCT02625740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101712024|NCT02625740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101712025|NCT02625740|Tubulin Modulators|tubulin modulators|mesh-ancestor
101712026|NCT02625740|Antimitotic Agents|antimitotic agents|mesh-ancestor
101712027|NCT02625740|Mitosis Modulators|mitosis modulators|mesh-ancestor
101712028|NCT02625740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712029|NCT00688922|Pravastatin|pravastatin|mesh-list
101794433|NCT05238233|Anesthetics, Local|anesthetics, local|mesh-ancestor
101712031|NCT00688922|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101712032|NCT00688922|Antimetabolites|antimetabolites|mesh-ancestor
101712033|NCT00688922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712034|NCT00688922|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101712035|NCT00688922|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101712037|NCT00694148|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
101712038|NCT00694148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101712039|NCT00694148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101712040|NCT00694148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712041|NCT00694148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101712042|NCT00694148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101712043|NCT00694148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712044|NCT00694148|Cholinergic Agents|cholinergic agents|mesh-ancestor
101712045|NCT00694148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101712046|NCT02626364|Crenolanib|crenolanib|mesh-list
101712047|NCT02626364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101712049|NCT00694460|Immunologic Factors|immunologic factors|mesh-ancestor
101712050|NCT00694460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712051|NCT04776525|Doxorubicin|doxorubicin|mesh-list
101712052|NCT04776525|Ifosfamide|ifosfamide|mesh-list
101712053|NCT04776525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101712054|NCT04776525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101712055|NCT04776525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101712056|NCT04776525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101712057|NCT04776525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101712058|NCT04776525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712059|NCT04776525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101712060|NCT04776525|Alkylating Agents|alkylating agents|mesh-ancestor
101712061|NCT00689000|Tosedostat|tosedostat|mesh-list
101712062|NCT00689000|Glycine|glycine|mesh-list
101712063|NCT00689000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101712064|NCT00689000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794674|NCT00871910|Aprepitant|aprepitant|mesh-list
101712066|NCT00689000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101712067|NCT00689000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712069|NCT00489541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101712070|NCT00489541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101712071|NCT00489541|Tubulin Modulators|tubulin modulators|mesh-ancestor
101712072|NCT00489541|Antimitotic Agents|antimitotic agents|mesh-ancestor
101712073|NCT00489541|Mitosis Modulators|mitosis modulators|mesh-ancestor
101712074|NCT00489541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712075|NCT00689156|Cyclophosphamide|cyclophosphamide|mesh-list
101712076|NCT00689156|Docetaxel|docetaxel|mesh-list
101712077|NCT00689156|Epirubicin|epirubicin|mesh-list
101712078|NCT00689156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101712079|NCT00689156|Immunologic Factors|immunologic factors|mesh-ancestor
101712080|NCT00689156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712081|NCT00689156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101794761|NCT00513604|Fludarabine|fludarabine|mesh-list
101712082|NCT00689156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101712083|NCT00689156|Alkylating Agents|alkylating agents|mesh-ancestor
101712084|NCT00689156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712085|NCT00689156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101712086|NCT00689156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101712087|NCT00689156|Tubulin Modulators|tubulin modulators|mesh-ancestor
101712088|NCT00689156|Antimitotic Agents|antimitotic agents|mesh-ancestor
101712090|NCT00689156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101712091|NCT00689156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101712092|NCT00689156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101794897|NCT02588417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101712094|NCT04773873|Lithium Carbonate|lithium carbonate|mesh-list
101712095|NCT04773873|Antidepressive Agents|antidepressive agents|mesh-ancestor
101712096|NCT04773873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101712097|NCT04773873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101712098|NCT04773873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712099|NCT04773873|Antimanic Agents|antimanic agents|mesh-ancestor
101712100|NCT04773873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101712101|NCT04773873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101712102|NCT04773873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712105|NCT01016821|Narcotics|narcotics|mesh-ancestor
101712106|NCT01016821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101712107|NCT01016821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712108|NCT01016821|Analgesics|analgesics|mesh-ancestor
101712109|NCT01016821|Sensory System Agents|sensory system agents|mesh-ancestor
101794959|NCT00994617|Natriuretic Agents|natriuretic agents|mesh-ancestor
101712110|NCT01016821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101712111|NCT01011205|Mycophenolic Acid|mycophenolic acid|mesh-list
101712112|NCT01011205|Methylprednisolone|methylprednisolone|mesh-list
101712114|NCT01011205|Basiliximab|basiliximab|mesh-list
101712115|NCT01011205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101712116|NCT01011205|Immunologic Factors|immunologic factors|mesh-ancestor
101712117|NCT01011205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712118|NCT01011205|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101712119|NCT01011205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101712120|NCT01011205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795091|NCT00491764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101712121|NCT01011205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101712122|NCT01011205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101712123|NCT01011205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101712124|NCT01011205|Antitubercular Agents|antitubercular agents|mesh-ancestor
101712125|NCT01011205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101712126|NCT01011205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101712127|NCT01011205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101712129|NCT01011205|Autonomic Agents|autonomic agents|mesh-ancestor
101712130|NCT01011205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101712132|NCT01011205|Glucocorticoids|glucocorticoids|mesh-ancestor
101712133|NCT01011205|Hormones|hormones|mesh-ancestor
101712134|NCT01011205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101712135|NCT01011205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101712137|NCT00809835|Galantamine|galantamine|mesh-list
101712138|NCT00809835|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101712139|NCT00809835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101712140|NCT00809835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712141|NCT00809835|Cholinergic Agents|cholinergic agents|mesh-ancestor
101712142|NCT00809835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101712143|NCT00809835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712144|NCT00809835|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101712145|NCT00809835|Autonomic Agents|autonomic agents|mesh-ancestor
101712146|NCT00809835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101712148|NCT01014559|Oxycodone|oxycodone|mesh-list
101712149|NCT01014559|Naloxone|naloxone|mesh-list
101712150|NCT01014559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101712151|NCT01014559|Narcotics|narcotics|mesh-ancestor
101795437|NCT04081805|Estradiol|estradiol|mesh-list
101712152|NCT01014559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101712153|NCT01014559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712154|NCT01014559|Analgesics|analgesics|mesh-ancestor
101712155|NCT01014559|Sensory System Agents|sensory system agents|mesh-ancestor
101712156|NCT01014559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101712157|NCT01014559|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101712158|NCT00853242|Sevelamer|sevelamer|mesh-list
101712159|NCT00853242|Chelating Agents|chelating agents|mesh-ancestor
101712161|NCT00853242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712162|NCT02609061|Alendronate|alendronate|mesh-list
101712163|NCT02609061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101712164|NCT02609061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795580|NCT00996099|Insulin|insulin|mesh-list
101712165|NCT00848250|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101712166|NCT00848250|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101795642|NCT04079933|Nicotine|nicotine|mesh-list
101712167|NCT00848250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712169|NCT00694694|Azithromycin|azithromycin|mesh-list
101712170|NCT00694694|Artesunate|artesunate|mesh-list
101712171|NCT00694694|Lumefantrine|lumefantrine|mesh-list
101712172|NCT00694694|Artemether|artemether|mesh-list
101712173|NCT00694694|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101712174|NCT00694694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101712175|NCT00694694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101712176|NCT00694694|Antimalarials|antimalarials|mesh-ancestor
101712177|NCT00694694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101712178|NCT00694694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101712179|NCT00694694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101712180|NCT00694694|Antiviral Agents|antiviral agents|mesh-ancestor
101712181|NCT00694694|Schistosomicides|schistosomicides|mesh-ancestor
101795781|NCT02582177|Ketoconazole|ketoconazole|mesh-list
101712182|NCT00694694|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101712183|NCT00694694|Anthelmintics|anthelmintics|mesh-ancestor
101712184|NCT00700362|Insulin|insulin|mesh-list
101712185|NCT00700362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101712186|NCT00700362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712187|NCT04136600|Antibodies|antibodies|mesh-list
101712188|NCT04136600|Immunologic Factors|immunologic factors|mesh-ancestor
101712189|NCT04136600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712190|NCT00809757|Albuterol|albuterol|mesh-list
101712191|NCT00809757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101712192|NCT00809757|Autonomic Agents|autonomic agents|mesh-ancestor
101712193|NCT00809757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101712194|NCT00809757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101712195|NCT00809757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101712196|NCT00809757|Respiratory System Agents|respiratory system agents|mesh-ancestor
101712198|NCT00809757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101712199|NCT00809757|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101712200|NCT00809757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101712201|NCT00809757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101712202|NCT00809757|Adrenergic Agents|adrenergic agents|mesh-ancestor
101712203|NCT00809757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101712204|NCT00809757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101712206|NCT00594464|Dopamine Agonists|dopamine agonists|mesh-ancestor
101248620|NCT04505878|Vitamins|vitamins|mesh-ancestor
101248621|NCT04505878|Micronutrients|micronutrients|mesh-ancestor
101248622|NCT04505878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248623|NCT04505878|Antioxidants|antioxidants|mesh-ancestor
101248624|NCT04505878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248626|NCT04505189|Psilocybin|psilocybin|mesh-list
101248692|NCT04075136|Ranibizumab|ranibizumab|mesh-list
101248693|NCT04075136|Verteporfin|verteporfin|mesh-list
101248694|NCT04075136|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101248695|NCT04075136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101248696|NCT04075136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101248697|NCT04075136|Growth Substances|growth substances|mesh-ancestor
101248698|NCT04075136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248699|NCT04075136|Growth Inhibitors|growth inhibitors|mesh-ancestor
101248700|NCT04075136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101248701|NCT04075136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101248702|NCT04075136|Glucocorticoids|glucocorticoids|mesh-ancestor
101248703|NCT04075136|Hormones|hormones|mesh-ancestor
101248704|NCT04075136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101248705|NCT04075136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101248706|NCT04075136|Immunologic Factors|immunologic factors|mesh-ancestor
101248707|NCT04075136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101248708|NCT04075136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248709|NCT04075136|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101248711|NCT03959566|Moxifloxacin|moxifloxacin|mesh-list
101248748|NCT03909529|Protective Agents|protective agents|mesh-ancestor
101248749|NCT03875755|Inositol|inositol|mesh-list
101248750|NCT03875755|Vitamin B Complex|vitamin b complex|mesh-ancestor
101248751|NCT03875755|Vitamins|vitamins|mesh-ancestor
101248752|NCT03875755|Micronutrients|micronutrients|mesh-ancestor
101248753|NCT03875755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248754|NCT03519997|Pembrolizumab|pembrolizumab|mesh-list
101248755|NCT03519997|Bavituximab|bavituximab|mesh-list
101248756|NCT03519997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101248816|NCT03015740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101248817|NCT03015740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101248818|NCT03015740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101248819|NCT03015740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248820|NCT02881242|Trametinib|trametinib|mesh-list
101248887|NCT02098512|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101248888|NCT02098512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101248889|NCT02098512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101248890|NCT02098512|Immunotoxins|immunotoxins|mesh-ancestor
101248891|NCT02098512|Immunoconjugates|immunoconjugates|mesh-ancestor
101248892|NCT02098512|Immunologic Factors|immunologic factors|mesh-ancestor
101248893|NCT02098512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248952|NCT01683760|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101248953|NCT01683760|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101248954|NCT01684813|Clopidogrel|clopidogrel|mesh-list
101249024|NCT01687517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249026|NCT01687751|Dexmedetomidine|dexmedetomidine|mesh-list
101249027|NCT01687751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101249028|NCT01687751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101249094|NCT01690104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101249095|NCT01690104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101249096|NCT01690104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249097|NCT01690104|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101249161|NCT01690338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249162|NCT01690338|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101249163|NCT01690338|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101249164|NCT01690338|Cholinergic Agents|cholinergic agents|mesh-ancestor
101249230|NCT01690559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101249231|NCT01690572|Paclitaxel|paclitaxel|mesh-list
101249232|NCT01690572|Hyaluronic Acid|hyaluronic acid|mesh-list
101249233|NCT01690572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101249234|NCT01690572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101249235|NCT01690572|Tubulin Modulators|tubulin modulators|mesh-ancestor
101249299|NCT01690780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101249300|NCT01690780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101249301|NCT01690780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101249302|NCT01690780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101249303|NCT01690780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101249304|NCT01690780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101323574|NCT00098878|Carboplatin|carboplatin|mesh-list
101249305|NCT01690780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249364|NCT01691365|Vitamin B Complex|vitamin b complex|mesh-list
101249365|NCT01691365|Antioxidants|antioxidants|mesh-list
101249366|NCT01691365|Micronutrients|micronutrients|mesh-ancestor
101249367|NCT01691365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249368|NCT01691365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249369|NCT01691365|Protective Agents|protective agents|mesh-ancestor
101249371|NCT01691404|Antioxidants|antioxidants|mesh-ancestor
101249372|NCT01691404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249373|NCT01691404|Protective Agents|protective agents|mesh-ancestor
101249374|NCT01691404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249375|NCT01691456|Montelukast|montelukast|mesh-list
101249376|NCT01691456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101249377|NCT01691456|Respiratory System Agents|respiratory system agents|mesh-ancestor
101249378|NCT01691456|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101249422|NCT01691677|Glucocorticoids|glucocorticoids|mesh-ancestor
101249424|NCT01691677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101249494|NCT01692483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249495|NCT01692483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101249496|NCT01692483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101249497|NCT01692483|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101249498|NCT01692483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101249499|NCT01692483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249500|NCT01692483|Hormone Antagonists|hormone antagonists|mesh-ancestor
101249502|NCT01692652|Loteprednol Etabonate|loteprednol etabonate|mesh-list
101249561|NCT01693081|Dopamine Agents|dopamine agents|mesh-ancestor
101249562|NCT01693081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101249563|NCT01693081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249564|NCT01693159|Ethyl 2-cyanoacrylate|ethyl 2-cyanoacrylate|mesh-list
101249565|NCT01693159|Hemostatics|hemostatics|mesh-ancestor
101249566|NCT01693159|Coagulants|coagulants|mesh-ancestor
101249567|NCT01693276|Paclitaxel|paclitaxel|mesh-list
101249568|NCT01693276|Gemcitabine|gemcitabine|mesh-list
101249569|NCT01693276|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101249570|NCT01693276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101249571|NCT01693276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101249572|NCT01693276|Tubulin Modulators|tubulin modulators|mesh-ancestor
101249573|NCT01693276|Antimitotic Agents|antimitotic agents|mesh-ancestor
101249625|NCT01693419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101249626|NCT01693432|Docetaxel|docetaxel|mesh-list
101249627|NCT01693432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101249628|NCT01693432|Tubulin Modulators|tubulin modulators|mesh-ancestor
101249629|NCT01693432|Antimitotic Agents|antimitotic agents|mesh-ancestor
101249630|NCT01693432|Mitosis Modulators|mitosis modulators|mesh-ancestor
101249631|NCT01693432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249632|NCT01693445|Oxaliplatin|oxaliplatin|mesh-list
101249692|NCT01694017|Zidovudine|zidovudine|mesh-list
101249693|NCT01694017|Antiviral Agents|antiviral agents|mesh-ancestor
101249694|NCT01694017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101249695|NCT01694017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101249696|NCT01694017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101249761|NCT05288179|Analgesics|analgesics|mesh-ancestor
101249762|NCT05288179|Sensory System Agents|sensory system agents|mesh-ancestor
101249763|NCT05288179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101249764|NCT05288179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249765|NCT05288179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101249766|NCT05288179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101249767|NCT05288179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101249768|NCT05288179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101249769|NCT05288179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101249827|NCT05290948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101249828|NCT05290948|Growth Substances|growth substances|mesh-ancestor
101249829|NCT05290948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249830|NCT05290948|Growth Inhibitors|growth inhibitors|mesh-ancestor
101249831|NCT05290948|Anticonvulsants|anticonvulsants|mesh-ancestor
101249832|NCT05290948|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101249833|NCT05290948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101249896|NCT05291910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101249897|NCT05291910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101249898|NCT05291910|Tubulin Modulators|tubulin modulators|mesh-ancestor
101249967|NCT05294744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249969|NCT05294679|Propofol|propofol|mesh-list
101249970|NCT05294679|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101249975|NCT05294679|Anesthetics|anesthetics|mesh-ancestor
101250042|NCT05294393|Analgesics|analgesics|mesh-ancestor
101250043|NCT05294393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101250044|NCT05294393|Anticonvulsants|anticonvulsants|mesh-ancestor
101250045|NCT05294393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101250046|NCT05294393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101250049|NCT05294393|Tocolytic Agents|tocolytic agents|mesh-ancestor
101250110|NCT05296863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101250111|NCT05296863|Vasodilator Agents|vasodilator agents|mesh-ancestor
101250112|NCT05296564|Aldesleukin|aldesleukin|mesh-list
101250113|NCT05296564|Cyclophosphamide|cyclophosphamide|mesh-list
101250114|NCT05296564|Interleukin-2|interleukin-2|mesh-list
101250125|NCT05296564|Analgesics|analgesics|mesh-ancestor
101250185|NCT05294900|Mitosis Modulators|mitosis modulators|mesh-ancestor
101250187|NCT05275647|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101250257|NCT05267431|Antioxidants|antioxidants|mesh-ancestor
101250260|NCT05266248|Caffeine|caffeine|mesh-list
101250335|NCT05225402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101250336|NCT05225402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101250337|NCT05225402|Adrenergic Agents|adrenergic agents|mesh-ancestor
101250338|NCT05225402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101250339|NCT05225402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250340|NCT05225402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250404|NCT05189444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101250405|NCT05189444|Antacids|antacids|mesh-ancestor
101250406|NCT05189444|Diuretics|diuretics|mesh-ancestor
101250407|NCT05189444|Natriuretic Agents|natriuretic agents|mesh-ancestor
101250408|NCT05189444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250409|NCT05189444|Expectorants|expectorants|mesh-ancestor
101250410|NCT05189444|Respiratory System Agents|respiratory system agents|mesh-ancestor
101250473|NCT05030025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101250474|NCT05030025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101250475|NCT05030025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101250476|NCT05030025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250478|NCT05030025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101250611|NCT04767503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101250612|NCT04767503|Anesthetics, General|anesthetics, general|mesh-ancestor
101250613|NCT04767503|Anesthetics|anesthetics|mesh-ancestor
101250614|NCT04767503|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101250615|NCT04750967|Lidocaine|lidocaine|mesh-list
101250616|NCT04750967|Amitriptyline|amitriptyline|mesh-list
101250617|NCT04750967|Anesthetics, Local|anesthetics, local|mesh-ancestor
101250618|NCT04750967|Anesthetics|anesthetics|mesh-ancestor
101250619|NCT04750967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101250679|NCT04658823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250680|NCT04658823|Protective Agents|protective agents|mesh-ancestor
101250681|NCT04648241|Vaccines|vaccines|mesh-list
101250682|NCT04648241|Immunologic Factors|immunologic factors|mesh-ancestor
101250683|NCT04648241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250685|NCT04640818|Cladribine|cladribine|mesh-list
101250752|NCT04523428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101250753|NCT04508504|Ropivacaine|ropivacaine|mesh-list
101250754|NCT04508504|Anesthetics, Local|anesthetics, local|mesh-ancestor
101250755|NCT04508504|Anesthetics|anesthetics|mesh-ancestor
101250756|NCT04508504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101250757|NCT04508504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250758|NCT04508504|Sensory System Agents|sensory system agents|mesh-ancestor
101250759|NCT04508504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101250761|NCT04490707|Azacitidine|azacitidine|mesh-list
101250816|NCT04391179|Dipyridamole|dipyridamole|mesh-list
101250817|NCT04391179|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101250818|NCT04391179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101250819|NCT04391179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250820|NCT04391179|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101250821|NCT04391179|Vasodilator Agents|vasodilator agents|mesh-ancestor
101250890|NCT04238091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101250891|NCT04233801|Empagliflozin|empagliflozin|mesh-list
101250892|NCT04233801|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101250893|NCT04233801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250894|NCT04233801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101250895|NCT04233801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250903|NCT04180085|Abatacept|abatacept|mesh-list
101250912|NCT04169451|Letrozole|letrozole|mesh-list
101250964|NCT04136262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250965|NCT04136262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101250966|NCT04136262|Dermatologic Agents|dermatologic agents|mesh-ancestor
101250967|NCT04136262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101250968|NCT04136262|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101250969|NCT04136262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101250970|NCT04136262|Immunologic Factors|immunologic factors|mesh-ancestor
101250971|NCT04136262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101250972|NCT04136262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101250973|NCT04133922|Insulin|insulin|mesh-list
101250974|NCT04133922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101250975|NCT04133922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250976|NCT04115059|Dasatinib|dasatinib|mesh-list
101250977|NCT04115059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101250978|NCT04115059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101250979|NCT04115059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101250980|NCT04115059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250981|NCT04114890|Tenofovir|tenofovir|mesh-list
101250982|NCT04114890|Antiviral Agents|antiviral agents|mesh-ancestor
101251023|NCT04012177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101251024|NCT04012177|Antimetabolites|antimetabolites|mesh-ancestor
101251025|NCT04012177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251026|NCT04012177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101251027|NCT04012177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101251028|NCT04012177|Nootropic Agents|nootropic agents|mesh-ancestor
101251029|NCT04012177|Vitamin B Complex|vitamin b complex|mesh-ancestor
101251030|NCT04012177|Vitamins|vitamins|mesh-ancestor
101251031|NCT04012177|Micronutrients|micronutrients|mesh-ancestor
101251032|NCT04012177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251033|NCT04012177|Vasodilator Agents|vasodilator agents|mesh-ancestor
101251034|NCT04007289|Apixaban|apixaban|mesh-list
101251035|NCT04007289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101251036|NCT04007289|Antithrombins|antithrombins|mesh-ancestor
101251037|NCT04007289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101251038|NCT04007289|Protease Inhibitors|protease inhibitors|mesh-ancestor
101251083|NCT03926091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251084|NCT03926091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101251085|NCT03926091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101251156|NCT05801900|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101251157|NCT05801900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101410746|NCT00446680|Mannitol|mannitol|mesh-list
101251228|NCT05801133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101251229|NCT05801133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101251230|NCT05801068|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
101251231|NCT05801068|Antithrombins|antithrombins|mesh-ancestor
101251232|NCT05801068|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101251233|NCT05801068|Protease Inhibitors|protease inhibitors|mesh-ancestor
101251234|NCT05801068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101251235|NCT05801068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251236|NCT05801068|Anticoagulants|anticoagulants|mesh-ancestor
101251237|NCT05801029|Osimertinib|osimertinib|mesh-list
101251238|NCT05801029|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
101251239|NCT05801029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101251240|NCT05801029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101251289|NCT05800197|Anastrozole|anastrozole|mesh-list
101251290|NCT05800197|Goserelin|goserelin|mesh-list
101251292|NCT05800197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101251293|NCT05800197|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101251294|NCT05800197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101251295|NCT05800197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101251296|NCT05800197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251297|NCT05800197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101251355|NCT05759156|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101251356|NCT05759156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101251357|NCT05759156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251358|NCT05759156|Hemostatics|hemostatics|mesh-ancestor
101251359|NCT05759156|Coagulants|coagulants|mesh-ancestor
101251360|NCT05753644|Ropivacaine|ropivacaine|mesh-list
101251367|NCT05752201|Vaccines|vaccines|mesh-list
101251424|NCT05622812|Sensory System Agents|sensory system agents|mesh-ancestor
101251501|NCT05371886|Midazolam|midazolam|mesh-list
101251502|NCT05371886|Morphine|morphine|mesh-list
101251503|NCT05371886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101251504|NCT05371886|Narcotics|narcotics|mesh-ancestor
101251505|NCT05371886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101251506|NCT05371886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251507|NCT05371886|Analgesics|analgesics|mesh-ancestor
101251508|NCT05371886|Sensory System Agents|sensory system agents|mesh-ancestor
101251509|NCT05371886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101251510|NCT05371886|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101251512|NCT05371886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101251569|NCT05219799|Respiratory System Agents|respiratory system agents|mesh-ancestor
101251571|NCT05219799|Protective Agents|protective agents|mesh-ancestor
101251573|NCT05215951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101251574|NCT05215951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101251575|NCT05215951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101251640|NCT04991480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251641|NCT04991480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101251643|NCT04892043|Ipilimumab|ipilimumab|mesh-list
101251644|NCT04892043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101251645|NCT04892043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101251646|NCT04892043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101251647|NCT04892043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251648|NCT04880278|Nabilone|nabilone|mesh-list
101251649|NCT04880278|Antiemetics|antiemetics|mesh-ancestor
101251708|NCT04824092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101251709|NCT04824092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101251710|NCT04824092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101251712|NCT04824092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101251782|NCT04594187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251783|NCT04559230|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
101251784|NCT04559230|Immunoconjugates|immunoconjugates|mesh-ancestor
101251785|NCT04559230|Immunologic Factors|immunologic factors|mesh-ancestor
101251786|NCT04559230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251787|NCT04549792|Ustekinumab|ustekinumab|mesh-list
101251788|NCT04549792|Dermatologic Agents|dermatologic agents|mesh-ancestor
101251846|NCT04323046|Nivolumab|nivolumab|mesh-list
101251847|NCT04323046|Ipilimumab|ipilimumab|mesh-list
101251848|NCT04323046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101251849|NCT04323046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101251850|NCT04323046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101251851|NCT04323046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251913|NCT03961360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101251914|NCT03961360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101251915|NCT03961360|Antipyretics|antipyretics|mesh-ancestor
101251916|NCT03924401|Abatacept|abatacept|mesh-list
101251917|NCT03924401|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101251920|NCT03924401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101251984|NCT03632330|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101251985|NCT03632330|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101251986|NCT03632330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101251987|NCT03632330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101251988|NCT03632330|GABA Modulators|gaba modulators|mesh-ancestor
101251989|NCT03632330|GABA Agents|gaba agents|mesh-ancestor
101251990|NCT03575949|Deoxyglucose|deoxyglucose|mesh-list
101251991|NCT03575949|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101252055|NCT03253289|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101252056|NCT03227705|Progesterone|progesterone|mesh-list
101252128|NCT02777385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252129|NCT02701699|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
101252200|NCT01892371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252201|NCT01892371|Antiviral Agents|antiviral agents|mesh-ancestor
101252202|NCT01892371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101252203|NCT01892371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101252204|NCT01892371|Immunologic Factors|immunologic factors|mesh-ancestor
101252205|NCT01892371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252206|NCT01892371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101252207|NCT01819064|Atropine|atropine|mesh-list
101252223|NCT01817751|Sorafenib|sorafenib|mesh-list
101252267|NCT00812669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101252268|NCT00812669|Antimetabolites|antimetabolites|mesh-ancestor
101252269|NCT00188539|Anesthetics|anesthetics|mesh-list
101252270|NCT00188539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101252271|NCT00188539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252272|NCT03889314|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101324107|NCT00102310|Z 338|z 338|mesh-list
101252337|NCT03785106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101252338|NCT03785106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101252339|NCT03785106|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101252340|NCT03785106|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101252341|NCT03785106|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101252407|NCT03727750|Gemtuzumab|gemtuzumab|mesh-list
101252408|NCT03727750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101252409|NCT03727750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252410|NCT03727750|Immunotoxins|immunotoxins|mesh-ancestor
101252411|NCT03727750|Immunoconjugates|immunoconjugates|mesh-ancestor
101252478|NCT03651102|Antisickling Agents|antisickling agents|mesh-ancestor
101252479|NCT03651102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101252480|NCT03651102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252481|NCT03651102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101252482|NCT03649802|Vitamin D|vitamin d|mesh-list
101252483|NCT03649802|Ergocalciferols|ergocalciferols|mesh-list
101252484|NCT03649802|Cholecalciferol|cholecalciferol|mesh-list
101252485|NCT03649802|Vitamins|vitamins|mesh-list
101252486|NCT03649802|Micronutrients|micronutrients|mesh-ancestor
101252487|NCT03649802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252488|NCT03649802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101252490|NCT03643198|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101252491|NCT03643198|Metronidazole|metronidazole|mesh-list
101252492|NCT03643198|Ciprofloxacin|ciprofloxacin|mesh-list
101252493|NCT03643198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101215640|NCT01476124|Analgesics|analgesics|mesh-ancestor
101252494|NCT03643198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101252495|NCT03643198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101252496|NCT03643198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101252497|NCT03643198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101252498|NCT03643198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101252499|NCT03643198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252521|NCT03576417|Nivolumab|nivolumab|mesh-list
101252548|NCT03569475|Antidepressive Agents|antidepressive agents|mesh-ancestor
101252549|NCT03569475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101252550|NCT03569475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101252551|NCT03569475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101252619|NCT03435185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101252620|NCT03435185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252621|NCT03426293|Heparin|heparin|mesh-list
101252622|NCT03426293|Anticoagulants|anticoagulants|mesh-ancestor
101252623|NCT03426293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101252624|NCT03426293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101252626|NCT03383380|Sirolimus|sirolimus|mesh-list
101252689|NCT05438108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252690|NCT05438108|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101252691|NCT05438108|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101252760|NCT05436964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101252761|NCT05436964|Analgesics|analgesics|mesh-ancestor
101252762|NCT05436964|Sensory System Agents|sensory system agents|mesh-ancestor
101252763|NCT05436964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101252764|NCT05436964|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101252830|NCT04312009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101252831|NCT04312009|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101252832|NCT04312009|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101252833|NCT04312009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252834|NCT04100096|Brexpiprazole|brexpiprazole|mesh-list
101252900|NCT02333292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101252901|NCT02333292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101252902|NCT02203773|Posaconazole|posaconazole|mesh-list
101252903|NCT02203773|Azacitidine|azacitidine|mesh-list
101252922|NCT02175030|Copper|copper|mesh-list
101252972|NCT00496795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101252973|NCT00496795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101252974|NCT03164889|Entecavir|entecavir|mesh-list
101252975|NCT03164889|Molgramostim|molgramostim|mesh-list
101252976|NCT03164889|Sargramostim|sargramostim|mesh-list
101252977|NCT03164889|Antiviral Agents|antiviral agents|mesh-ancestor
101252978|NCT03164889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101252979|NCT03164889|Immunologic Factors|immunologic factors|mesh-ancestor
101253042|NCT03012815|Anticonvulsants|anticonvulsants|mesh-ancestor
101253043|NCT03012815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101253044|NCT03012815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101253045|NCT03012815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101253046|NCT03012815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101253047|NCT03012815|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101253048|NCT03012815|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101253051|NCT03012815|Antimanic Agents|antimanic agents|mesh-ancestor
101253112|NCT02886286|Sensory System Agents|sensory system agents|mesh-ancestor
101253113|NCT02886286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101253114|NCT02886286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101253115|NCT02886286|Narcotics|narcotics|mesh-ancestor
101253116|NCT02886286|Analgesics|analgesics|mesh-ancestor
101253117|NCT02886286|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101253118|NCT02886286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101253119|NCT02886286|Anesthetics, General|anesthetics, general|mesh-ancestor
101253181|NCT02608684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101253182|NCT02608684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101253183|NCT02608684|Antimetabolites|antimetabolites|mesh-ancestor
101253184|NCT02608684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253185|NCT02608684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101253186|NCT02608684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101253251|NCT02491333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253252|NCT02469987|Bevacizumab|bevacizumab|mesh-list
101253253|NCT02469987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101253254|NCT02469987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101253255|NCT02469987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101253256|NCT02469987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101253257|NCT02469987|Growth Substances|growth substances|mesh-ancestor
101253258|NCT02469987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253259|NCT02469987|Growth Inhibitors|growth inhibitors|mesh-ancestor
101253261|NCT02439307|Rifaximin|rifaximin|mesh-list
101253318|NCT02363998|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101253319|NCT02363998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253320|NCT02363998|Sensory System Agents|sensory system agents|mesh-ancestor
101253321|NCT02363998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101253322|NCT02363998|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101253323|NCT02363998|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101253324|NCT02363998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101253385|NCT02162563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101253386|NCT02162563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101253387|NCT02162563|Growth Substances|growth substances|mesh-ancestor
101253389|NCT02162563|Growth Inhibitors|growth inhibitors|mesh-ancestor
101253457|NCT02040857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101253458|NCT02040857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253459|NCT02040857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101253460|NCT02040857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101253461|NCT02040857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101253526|NCT01863186|Sensory System Agents|sensory system agents|mesh-ancestor
101253527|NCT01863186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101253528|NCT01863186|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101253529|NCT01863186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101253530|NCT01863186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101253531|NCT01863186|Adrenergic Agents|adrenergic agents|mesh-ancestor
101253532|NCT01863186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101325162|NCT00110071|Iodine|iodine|mesh-list
101253596|NCT01436396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253672|NCT01150045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253673|NCT01150045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101253674|NCT01150045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101253675|NCT01150045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101253676|NCT01150045|Immunologic Factors|immunologic factors|mesh-ancestor
101253677|NCT01150045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253679|NCT01150045|Protective Agents|protective agents|mesh-ancestor
101253680|NCT01150045|Vitamin B Complex|vitamin b complex|mesh-ancestor
101253739|NCT00579527|Mycophenolic Acid|mycophenolic acid|mesh-list
101253740|NCT00579527|Methylprednisolone|methylprednisolone|mesh-list
101253741|NCT00579527|Prednisolone|prednisolone|mesh-list
101253742|NCT00579527|Tacrolimus|tacrolimus|mesh-list
101253743|NCT00579527|Cyclosporins|cyclosporins|mesh-list
101253744|NCT00579527|Thymoglobulin|thymoglobulin|mesh-list
101253745|NCT00579527|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101253746|NCT00579527|Daclizumab|daclizumab|mesh-list
101253747|NCT00579527|Parathyroid Hormone|parathyroid hormone|mesh-list
101253748|NCT00579527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101253749|NCT00579527|Immunologic Factors|immunologic factors|mesh-ancestor
101253810|NCT01694134|Sensory System Agents|sensory system agents|mesh-ancestor
101253811|NCT01694134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101253812|NCT01694134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101253813|NCT01694134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101253814|NCT01694134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101253815|NCT01694134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101253817|NCT01694134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101253876|NCT01694498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253878|NCT01694576|Nedaplatin|nedaplatin|mesh-list
101253947|NCT01695122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101253948|NCT01695122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101253949|NCT01695122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101253950|NCT01695148|Carotenoids|carotenoids|mesh-list
101254021|NCT01696110|Anticoagulants|anticoagulants|mesh-ancestor
101254022|NCT01696110|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101254023|NCT01696110|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101254024|NCT01696110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254025|NCT01696110|Antithrombins|antithrombins|mesh-ancestor
101254026|NCT01696110|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101254027|NCT01696110|Protease Inhibitors|protease inhibitors|mesh-ancestor
101254028|NCT01696110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101254030|NCT01696240|Udenafil|udenafil|mesh-list
101254090|NCT01696552|Histamine Agents|histamine agents|mesh-ancestor
101254091|NCT01696552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101325853|NCT00114205|Docetaxel|docetaxel|mesh-list
101254163|NCT01697020|Immunologic Factors|immunologic factors|mesh-ancestor
101254164|NCT01697020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254165|NCT01697020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101254166|NCT01697020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101254168|NCT01697046|Raltegravir Potassium|raltegravir potassium|mesh-list
101254233|NCT01697293|Mitosis Modulators|mitosis modulators|mesh-ancestor
101254234|NCT01697293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254235|NCT01697293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101254236|NCT01697293|Immunologic Factors|immunologic factors|mesh-ancestor
101254238|NCT01697293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101254304|NCT01697722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101254305|NCT01697722|Glucocorticoids|glucocorticoids|mesh-ancestor
101254306|NCT01697722|Hormones|hormones|mesh-ancestor
101254307|NCT01697722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101254308|NCT01697722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254309|NCT01697722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101254373|NCT01698203|Anesthetics|anesthetics|mesh-ancestor
101254374|NCT01698203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101254375|NCT01698203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254376|NCT01698203|Sensory System Agents|sensory system agents|mesh-ancestor
101254377|NCT01698203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101254378|NCT01698476|Vitamin D|vitamin d|mesh-list
101217506|NCT01487421|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101254443|NCT01698749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101326105|NCT00115492|Hormones|hormones|mesh-ancestor
101254444|NCT01698749|Antiemetics|antiemetics|mesh-ancestor
101254445|NCT01698749|Autonomic Agents|autonomic agents|mesh-ancestor
101254446|NCT01698749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101254447|NCT01698749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254448|NCT01698749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101254449|NCT01698749|Glucocorticoids|glucocorticoids|mesh-ancestor
101254450|NCT01698749|Hormones|hormones|mesh-ancestor
101254512|NCT01699360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101254513|NCT01699360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101254514|NCT01699360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254515|NCT01699360|Antifungal Agents|antifungal agents|mesh-ancestor
101254516|NCT01699360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101254517|NCT01699360|Dermatologic Agents|dermatologic agents|mesh-ancestor
101254518|NCT01699360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101254519|NCT01699360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101254579|NCT01699659|Immunomodulating Agents|immunomodulating agents|mesh-list
101254580|NCT01699659|Immunologic Factors|immunologic factors|mesh-ancestor
101254581|NCT01699659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254582|NCT01699711|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
101254583|NCT01699711|Antioxidants|antioxidants|mesh-ancestor
101254584|NCT01699711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254585|NCT01699711|Protective Agents|protective agents|mesh-ancestor
101254586|NCT01699711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254587|NCT01699711|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101254588|NCT01699711|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101254642|NCT01699932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254643|NCT01699932|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101254644|NCT01699932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101254645|NCT01699932|Immunologic Factors|immunologic factors|mesh-ancestor
101254646|NCT01699997|Oxytocin|oxytocin|mesh-list
101254647|NCT01699997|Oxytocics|oxytocics|mesh-ancestor
101254648|NCT01699997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101254649|NCT01699997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254650|NCT01700010|Paclitaxel|paclitaxel|mesh-list
101254651|NCT01700010|Lapatinib|lapatinib|mesh-list
101254706|NCT01700400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101254707|NCT01700400|Immunologic Factors|immunologic factors|mesh-ancestor
101254708|NCT01700413|Idarubicin|idarubicin|mesh-list
101254709|NCT01700413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101254710|NCT01700413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101254780|NCT01700803|Cadexomer iodine|cadexomer iodine|mesh-list
101254781|NCT01700803|Povidone-Iodine|povidone-iodine|mesh-list
101254782|NCT01700803|Povidone|povidone|mesh-list
101254783|NCT01700803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101254784|NCT01700803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101254785|NCT01700803|Trace Elements|trace elements|mesh-ancestor
101254786|NCT01700803|Micronutrients|micronutrients|mesh-ancestor
101254787|NCT01700803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254849|NCT01701297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101254850|NCT01701323|Cytarabine|cytarabine|mesh-list
101254851|NCT01701323|Fludarabine|fludarabine|mesh-list
101254852|NCT01701323|Fludarabine phosphate|fludarabine phosphate|mesh-list
101254853|NCT01701323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101254854|NCT01701323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101254855|NCT01701323|Antimetabolites|antimetabolites|mesh-ancestor
101254856|NCT01701323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254919|NCT01701583|Respiratory System Agents|respiratory system agents|mesh-ancestor
101254920|NCT01701739|Digoxin|digoxin|mesh-list
101254921|NCT01701739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101254922|NCT01701739|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101254991|NCT01702038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101254992|NCT01702038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101254993|NCT01702038|Immunologic Factors|immunologic factors|mesh-ancestor
101254994|NCT01702038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254995|NCT01702038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101254996|NCT01702090|Ritonavir|ritonavir|mesh-list
101254997|NCT01702090|Darunavir|darunavir|mesh-list
101255059|NCT01702610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101255060|NCT01702610|Alkylating Agents|alkylating agents|mesh-ancestor
101255061|NCT01702610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255062|NCT01702610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101255063|NCT01702623|Oxcarbazepine|oxcarbazepine|mesh-list
101255064|NCT01702623|Anticonvulsants|anticonvulsants|mesh-ancestor
101255127|NCT01702857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101255129|NCT01702974|Cholecalciferol|cholecalciferol|mesh-list
101255130|NCT01702974|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
101255132|NCT01702974|Micronutrients|micronutrients|mesh-ancestor
101255133|NCT01702974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255134|NCT01702974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101255135|NCT01702974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101255198|NCT01703390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101255199|NCT01703455|Sorafenib|sorafenib|mesh-list
101255200|NCT01703455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101255273|NCT01703910|Topotecan|topotecan|mesh-list
101255274|NCT01703910|Dasatinib|dasatinib|mesh-list
101255275|NCT01703910|Mitomycins|mitomycins|mesh-list
101255276|NCT01703910|Mitomycin|mitomycin|mesh-list
101255277|NCT01703910|Raltitrexed|raltitrexed|mesh-list
101255278|NCT01703910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101255279|NCT01703910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101255345|NCT01704482|Respiratory System Agents|respiratory system agents|mesh-ancestor
101326627|NCT00118690|Fluticasone|fluticasone|mesh-list
101255346|NCT01704482|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101255347|NCT01704482|Antioxidants|antioxidants|mesh-ancestor
101255348|NCT01704482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255349|NCT01704482|Protective Agents|protective agents|mesh-ancestor
101255350|NCT01704482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255351|NCT01704482|Antidotes|antidotes|mesh-ancestor
101255415|NCT01704716|Doxorubicin|doxorubicin|mesh-list
101255416|NCT01704716|Etoposide|etoposide|mesh-list
101255417|NCT01704716|Vincristine|vincristine|mesh-list
101255418|NCT01704716|Interleukin-2|interleukin-2|mesh-list
101255419|NCT01704716|Dinutuximab|dinutuximab|mesh-list
101255420|NCT01704716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101255421|NCT01704716|Immunologic Factors|immunologic factors|mesh-ancestor
101255422|NCT01704716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255445|NCT01704794|Folic Acid|folic acid|mesh-list
101255484|NCT01705002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255485|NCT01705041|Liver Extracts|liver extracts|mesh-list
101255486|NCT01705041|Hematinics|hematinics|mesh-ancestor
101255487|NCT01705158|Carboplatin|carboplatin|mesh-list
101255488|NCT01705158|Doxorubicin|doxorubicin|mesh-list
101255489|NCT01705158|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101255490|NCT01705158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101255554|NCT01705457|Vitamins|vitamins|mesh-ancestor
101255555|NCT01705457|Micronutrients|micronutrients|mesh-ancestor
101255556|NCT01705457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255557|NCT01705457|Antioxidants|antioxidants|mesh-ancestor
101255627|NCT01706055|Antiviral Agents|antiviral agents|mesh-ancestor
101255628|NCT01706055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101255629|NCT01706055|Immunologic Factors|immunologic factors|mesh-ancestor
101255630|NCT01706055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255631|NCT01706055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101255633|NCT01706172|Anesthetics, Local|anesthetics, local|mesh-ancestor
101255634|NCT01706172|Anesthetics|anesthetics|mesh-ancestor
101255635|NCT01706172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101255636|NCT01706172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255637|NCT01706172|Sensory System Agents|sensory system agents|mesh-ancestor
101255638|NCT01706172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101255639|NCT01706172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101255640|NCT01706172|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101255641|NCT01706172|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101255642|NCT01706172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101255644|NCT01706211|Rosiglitazone|rosiglitazone|mesh-list
101255686|NCT01706510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255687|NCT01706562|Itraconazole|itraconazole|mesh-list
101255688|NCT01706562|Antifungal Agents|antifungal agents|mesh-ancestor
101255689|NCT01706562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101255690|NCT01706562|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101255691|NCT01706562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101255754|NCT01707160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101255755|NCT01707160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255757|NCT01707199|Pyrimethamine|pyrimethamine|mesh-list
101255758|NCT01707199|Sulfadoxine|sulfadoxine|mesh-list
101255759|NCT01707199|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101255760|NCT01707199|Antimalarials|antimalarials|mesh-ancestor
101255822|NCT01707407|Hormone Antagonists|hormone antagonists|mesh-ancestor
101255823|NCT01707407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101255824|NCT01707407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101255825|NCT01707407|Anticonvulsants|anticonvulsants|mesh-ancestor
101255826|NCT01707407|Antimanic Agents|antimanic agents|mesh-ancestor
101255827|NCT01707407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101255828|NCT01707407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101255888|NCT01707849|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101255889|NCT01707849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101255890|NCT01707849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101255891|NCT01707849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255892|NCT01707849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101255893|NCT01707849|Immunologic Factors|immunologic factors|mesh-ancestor
101255894|NCT01707849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255952|NCT01708369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101255953|NCT01708369|Analgesics|analgesics|mesh-ancestor
101255954|NCT01708369|Sensory System Agents|sensory system agents|mesh-ancestor
101255955|NCT01708369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101255956|NCT01708369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255957|NCT01708369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101256021|NCT01708707|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101256022|NCT01708720|Vaccines|vaccines|mesh-list
101256023|NCT01708720|Immunologic Factors|immunologic factors|mesh-ancestor
101256024|NCT01708720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256025|NCT01708798|Eplerenone|eplerenone|mesh-list
101256026|NCT01708798|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101256027|NCT01708798|Hormone Antagonists|hormone antagonists|mesh-ancestor
101256028|NCT01708798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101256029|NCT01708798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256089|NCT01709370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101256090|NCT01709370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101256091|NCT01709370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256092|NCT01709370|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101256093|NCT01709370|Hormone Antagonists|hormone antagonists|mesh-ancestor
101256094|NCT01709370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101256095|NCT01709370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256155|NCT01709760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101256157|NCT01709760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256158|NCT01709760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101256159|NCT01709760|Dermatologic Agents|dermatologic agents|mesh-ancestor
101256160|NCT01709760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101256161|NCT01709760|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101256162|NCT01709760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101256163|NCT01709760|Immunologic Factors|immunologic factors|mesh-ancestor
101256220|NCT01710072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101256221|NCT01710072|Antipyretics|antipyretics|mesh-ancestor
101256222|NCT01710163|Aripiprazole|aripiprazole|mesh-list
101256223|NCT01710163|Antidepressive Agents|antidepressive agents|mesh-ancestor
101256224|NCT01710163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101256225|NCT01710163|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101256226|NCT01710163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101256289|NCT01710488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101256290|NCT01710488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101256291|NCT01710488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101256292|NCT01710488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256293|NCT01710488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101256294|NCT01710488|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101256295|NCT01710488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101256356|NCT01710722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256357|NCT01710722|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101256358|NCT01710722|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101256359|NCT01710722|Purinergic Agents|purinergic agents|mesh-ancestor
101256426|NCT01711125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256427|NCT01711125|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101256428|NCT01711125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101256429|NCT01711125|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101256430|NCT01711125|GABA Agonists|gaba agonists|mesh-ancestor
101256499|NCT01711515|Cisplatin|cisplatin|mesh-list
101256500|NCT01711515|Ipilimumab|ipilimumab|mesh-list
101256501|NCT01711515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101256502|NCT01711515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101256503|NCT01711515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101256504|NCT01711515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256505|NCT01711528|Dexamethasone|dexamethasone|mesh-list
101256506|NCT01711528|Dexamethasone acetate|dexamethasone acetate|mesh-list
101256507|NCT01711528|Bortezomib|bortezomib|mesh-list
101256567|NCT01711723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101256568|NCT01711723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256569|NCT01711749|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101256637|NCT01712126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256638|NCT01712126|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101256639|NCT01712126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101256640|NCT01712126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256641|NCT01712126|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101256642|NCT01712126|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101256643|NCT01712139|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101256644|NCT01712139|Irbesartan|irbesartan|mesh-list
101256645|NCT01712139|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101256646|NCT01712139|Diuretics|diuretics|mesh-ancestor
101256647|NCT01712139|Natriuretic Agents|natriuretic agents|mesh-ancestor
101256648|NCT01712139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256649|NCT01712139|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101256650|NCT01712139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101256654|NCT01712295|Salicylic Acid|salicylic acid|mesh-list
101256692|NCT01712464|Oxytocics|oxytocics|mesh-ancestor
101256693|NCT01712464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101256694|NCT01712464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256766|NCT01712828|Histamine Antagonists|histamine antagonists|mesh-ancestor
101256767|NCT01712828|Histamine Agents|histamine agents|mesh-ancestor
101256768|NCT01712828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101256769|NCT01712828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101256770|NCT01712828|Antipruritics|antipruritics|mesh-ancestor
101256771|NCT01712828|Dermatologic Agents|dermatologic agents|mesh-ancestor
101256772|NCT01712828|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101256773|NCT01712828|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101256774|NCT01712828|Adrenergic Agents|adrenergic agents|mesh-ancestor
101256835|NCT01713127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101256836|NCT01713153|Misoprostol|misoprostol|mesh-list
101256837|NCT01713153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101256838|NCT01713153|Abortifacient Agents|abortifacient agents|mesh-ancestor
101256839|NCT01713153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101256840|NCT01713153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256841|NCT01713153|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101256842|NCT01713153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101256843|NCT01713153|Oxytocics|oxytocics|mesh-ancestor
101256844|NCT01713166|Plasma-lyte 148|plasma-lyte 148|mesh-list
101256845|NCT01713166|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101256846|NCT01713166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101256847|NCT01713179|Ambroxol|ambroxol|mesh-list
101256848|NCT01713179|Expectorants|expectorants|mesh-ancestor
101256849|NCT01713179|Respiratory System Agents|respiratory system agents|mesh-ancestor
101256850|NCT01713218|Gemcitabine|gemcitabine|mesh-list
101256851|NCT01713218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101256852|NCT01713218|Antimetabolites|antimetabolites|mesh-ancestor
101256853|NCT01713218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256854|NCT01713218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101256855|NCT01713231|Vitamin D|vitamin d|mesh-list
101256856|NCT01713231|Ergocalciferols|ergocalciferols|mesh-list
101256888|NCT01713426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101256889|NCT01713426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101256890|NCT01713426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101256891|NCT01713426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101256892|NCT01713426|Antipruritics|antipruritics|mesh-ancestor
101256893|NCT01713426|Dermatologic Agents|dermatologic agents|mesh-ancestor
101256957|NCT01714011|Antidepressive Agents|antidepressive agents|mesh-ancestor
101256958|NCT01714011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101256959|NCT01714011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101256960|NCT01714011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101256961|NCT01714011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101256962|NCT01714011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256963|NCT01714011|Dopamine Agonists|dopamine agonists|mesh-ancestor
101256964|NCT01714011|Dopamine Agents|dopamine agents|mesh-ancestor
101256965|NCT01714011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101256966|NCT01714011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257024|NCT01714128|Hormones|hormones|mesh-ancestor
101257025|NCT01714128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101257026|NCT01714128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257027|NCT01714128|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101257028|NCT01714128|Contraceptive Agents|contraceptive agents|mesh-ancestor
101257029|NCT01714128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101257030|NCT01714128|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101257031|NCT01714154|Ritonavir|ritonavir|mesh-list
101257032|NCT01714154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101257033|NCT01714154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101257034|NCT01714154|Protease Inhibitors|protease inhibitors|mesh-ancestor
101257035|NCT01714154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101257036|NCT01714154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257037|NCT01714154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101257038|NCT01714154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101257039|NCT01714154|Antiviral Agents|antiviral agents|mesh-ancestor
101257040|NCT01714154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101257041|NCT01714154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101257042|NCT01714154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101257043|NCT01714193|Canagliflozin|canagliflozin|mesh-list
101257044|NCT01714193|Contraceptive Agents|contraceptive agents|mesh-list
101257045|NCT01714193|Contraceptives, Oral|contraceptives, oral|mesh-list
101257046|NCT01714193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101257047|NCT01714193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257048|NCT01714193|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101257049|NCT01714193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257050|NCT01714193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101257052|NCT01714206|Canagliflozin|canagliflozin|mesh-list
101257069|NCT01714388|Remifentanil|remifentanil|mesh-list
101257070|NCT01714388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101257071|NCT01714388|Narcotics|narcotics|mesh-ancestor
101257072|NCT01714388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101257073|NCT01714388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257074|NCT01714388|Analgesics|analgesics|mesh-ancestor
101257075|NCT01714388|Sensory System Agents|sensory system agents|mesh-ancestor
101257138|NCT01714570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257140|NCT01714596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101257141|NCT01714648|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101257142|NCT01714648|Luteolytic Agents|luteolytic agents|mesh-ancestor
101257143|NCT01714648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101257144|NCT01714648|Contraceptive Agents|contraceptive agents|mesh-ancestor
101257145|NCT01714648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101257146|NCT01714648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257150|NCT01714765|Everolimus|everolimus|mesh-list
101257201|NCT01714908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101257202|NCT01714908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101257203|NCT01714908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101257204|NCT01714908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101257205|NCT01714908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101257206|NCT01714908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257207|NCT01714908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101257267|NCT01715363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257268|NCT01715363|Vitamin B Complex|vitamin b complex|mesh-ancestor
101257270|NCT01715363|Micronutrients|micronutrients|mesh-ancestor
101257339|NCT01715688|Sensory System Agents|sensory system agents|mesh-ancestor
101257340|NCT01715688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101257341|NCT01715688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101257342|NCT01715688|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101257343|NCT01715688|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101257344|NCT01715688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101257345|NCT01715688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257404|NCT01716377|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101257405|NCT01716377|Antidepressive Agents|antidepressive agents|mesh-ancestor
101257406|NCT01716377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101257476|NCT01716689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257551|NCT01717300|Antimetabolites|antimetabolites|mesh-ancestor
101257557|NCT01717404|Mexiletine|mexiletine|mesh-list
101257626|NCT01717911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257627|NCT01717911|Incretins|incretins|mesh-ancestor
101257628|NCT01717911|Hormones|hormones|mesh-ancestor
101327838|NCT00020761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101536076|NCT00564590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101257629|NCT01717911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101257630|NCT01717911|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101257695|NCT01718288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101257696|NCT01718288|Analgesics|analgesics|mesh-ancestor
101257697|NCT01718288|Sensory System Agents|sensory system agents|mesh-ancestor
101257698|NCT01718288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101257699|NCT01718288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257700|NCT01718288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101257701|NCT01718288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101257710|NCT01718301|Ribavirin|ribavirin|mesh-list
101257763|NCT01718366|Sequestering Agents|sequestering agents|mesh-ancestor
101257764|NCT01718379|Lenalidomide|lenalidomide|mesh-list
101257765|NCT01718379|Immunologic Factors|immunologic factors|mesh-ancestor
101257766|NCT01718379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257767|NCT01718379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101257768|NCT01718379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101257769|NCT01718379|Growth Substances|growth substances|mesh-ancestor
101257770|NCT01718379|Growth Inhibitors|growth inhibitors|mesh-ancestor
101257771|NCT01718379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101257830|NCT01718678|Protective Agents|protective agents|mesh-ancestor
101257831|NCT01718678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257832|NCT01718678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101257833|NCT01718717|Morphine|morphine|mesh-list
101257835|NCT01718717|Narcotics|narcotics|mesh-ancestor
101257836|NCT01718717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101257837|NCT01718717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257838|NCT01718717|Analgesics|analgesics|mesh-ancestor
101257839|NCT01718717|Sensory System Agents|sensory system agents|mesh-ancestor
101257840|NCT01718717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101257841|NCT01718808|Capecitabine|capecitabine|mesh-list
101257842|NCT01718808|Cetuximab|cetuximab|mesh-list
101257843|NCT01718808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101257844|NCT01718808|Antimetabolites|antimetabolites|mesh-ancestor
101257845|NCT01718808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257846|NCT01718808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101257847|NCT01718808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101257848|NCT01718834|Vaccines|vaccines|mesh-list
101317403|NCT00010231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101317404|NCT00010270|Immunotoxins|immunotoxins|mesh-list
101317405|NCT00010270|Immunoconjugates|immunoconjugates|mesh-ancestor
101317406|NCT00010270|Immunologic Factors|immunologic factors|mesh-ancestor
101317407|NCT00010270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317408|NCT00010387|Cyclophosphamide|cyclophosphamide|mesh-list
101317409|NCT00010387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101317410|NCT00010387|Immunologic Factors|immunologic factors|mesh-ancestor
101317411|NCT00010387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317412|NCT00010387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101317413|NCT00010387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101317414|NCT00010387|Alkylating Agents|alkylating agents|mesh-ancestor
101317415|NCT00010387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317422|NCT00386516|Antimetabolites|antimetabolites|mesh-ancestor
101317423|NCT00386516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528355|NCT04628676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317424|NCT00386516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101317425|NCT00386516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317426|NCT00386516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101317427|NCT00386516|Immunologic Factors|immunologic factors|mesh-ancestor
101317428|NCT00386516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317430|NCT00010699|Vitamins|vitamins|mesh-ancestor
101317431|NCT00010699|Micronutrients|micronutrients|mesh-ancestor
101317432|NCT00010699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317433|NCT00010699|Antioxidants|antioxidants|mesh-ancestor
101317434|NCT00010699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317435|NCT00010699|Protective Agents|protective agents|mesh-ancestor
101317436|NCT00386555|Docetaxel|docetaxel|mesh-list
101317437|NCT00386555|Axitinib|axitinib|mesh-list
101317438|NCT00386555|Crenolanib|crenolanib|mesh-list
101317439|NCT00386555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317441|NCT00386555|Antimitotic Agents|antimitotic agents|mesh-ancestor
101317442|NCT00386555|Mitosis Modulators|mitosis modulators|mesh-ancestor
101317443|NCT00386555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317444|NCT00386555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101317445|NCT00386555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317446|NCT00010855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
101257849|NCT01718834|Immunologic Factors|immunologic factors|mesh-ancestor
101257850|NCT01718834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257851|NCT01718899|Lenalidomide|lenalidomide|mesh-list
101257852|NCT01718899|Immunologic Factors|immunologic factors|mesh-ancestor
101257853|NCT01718899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257854|NCT01718899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101257855|NCT01718899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101257856|NCT01718899|Growth Substances|growth substances|mesh-ancestor
101257857|NCT01718899|Growth Inhibitors|growth inhibitors|mesh-ancestor
101257858|NCT01718899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101257859|NCT01718912|Metronidazole|metronidazole|mesh-list
101257860|NCT01718912|Nystatin|nystatin|mesh-list
101257861|NCT01718912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101257862|NCT01718912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101257863|NCT01718912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101257864|NCT01718912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101257865|NCT01718912|Antifungal Agents|antifungal agents|mesh-ancestor
101257866|NCT01718912|Ionophores|ionophores|mesh-ancestor
101257867|NCT01718912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101257868|NCT01718912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257869|NCT01718951|Pamidronate|pamidronate|mesh-list
101257870|NCT01718951|Golimumab|golimumab|mesh-list
101317447|NCT00010855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101317448|NCT00010855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317449|NCT00001191|Omeprazole|omeprazole|mesh-list
101317450|NCT00001191|Pantoprazole|pantoprazole|mesh-list
101317451|NCT00001191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101317452|NCT00001191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101317453|NCT00001191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101317454|NCT00001191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317455|NCT00001191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317457|NCT00011089|Antiviral Agents|antiviral agents|mesh-ancestor
101317458|NCT00011089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101317459|NCT00011089|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101317460|NCT00011089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101317461|NCT00011089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317462|NCT00011089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317463|NCT00011089|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101317464|NCT00011089|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101317465|NCT00011128|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101317466|NCT00011128|Antiviral Agents|antiviral agents|mesh-ancestor
101317467|NCT00011128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101317468|NCT00005921|Caspofungin|caspofungin|mesh-list
101317469|NCT00005921|Antifungal Agents|antifungal agents|mesh-ancestor
101317470|NCT00005921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101317471|NCT00005921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317475|NCT00011362|BB 1101|bb 1101|mesh-list
101317476|NCT00011362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101317477|NCT00011362|Antiemetics|antiemetics|mesh-ancestor
101317478|NCT00011362|Autonomic Agents|autonomic agents|mesh-ancestor
101317479|NCT00011362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101317480|NCT00011362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317481|NCT00011362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101317484|NCT00011362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101317485|NCT00011362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101257871|NCT01718951|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101257872|NCT01718951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101257873|NCT01718951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101257874|NCT01718951|Immunologic Factors|immunologic factors|mesh-ancestor
101257875|NCT01718951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257876|NCT01718951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101257877|NCT01718964|Hydrocortisone|hydrocortisone|mesh-list
101257878|NCT01718964|Mannitol|mannitol|mesh-list
101257879|NCT01718964|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101257880|NCT01718964|Diuretics|diuretics|mesh-ancestor
101257881|NCT01718964|Natriuretic Agents|natriuretic agents|mesh-ancestor
101257882|NCT01718964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257883|NCT01718964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101257884|NCT01719042|Ondansetron|ondansetron|mesh-list
101257935|NCT01719419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101257936|NCT01719419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257937|NCT01719419|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101257938|NCT01719419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101257940|NCT01719588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101257941|NCT01719588|Narcotics|narcotics|mesh-ancestor
101257942|NCT01719588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101257943|NCT01719588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257944|NCT01719588|Analgesics|analgesics|mesh-ancestor
101257945|NCT01719588|Sensory System Agents|sensory system agents|mesh-ancestor
101257946|NCT01719588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101257947|NCT01719588|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101257948|NCT01719588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101257949|NCT01719588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101257950|NCT01719588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257951|NCT01719588|Adrenergic Agents|adrenergic agents|mesh-ancestor
101257952|NCT01719588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101257953|NCT01719601|Tapentadol|tapentadol|mesh-list
101257988|NCT01719692|Rituximab|rituximab|mesh-list
101257989|NCT01719692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101257990|NCT01719692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101257991|NCT01719692|Immunologic Factors|immunologic factors|mesh-ancestor
101257992|NCT01719692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257993|NCT01719692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101257994|NCT01719705|Pregabalin|pregabalin|mesh-list
101257995|NCT01719705|Analgesics|analgesics|mesh-ancestor
101257996|NCT01719705|Sensory System Agents|sensory system agents|mesh-ancestor
101257997|NCT01719705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101257998|NCT01719705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257999|NCT01719705|Anticonvulsants|anticonvulsants|mesh-ancestor
101258000|NCT01719705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101258001|NCT01719705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101258002|NCT01719705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258003|NCT01719705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101258004|NCT01719705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101258005|NCT01719705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101258006|NCT01719705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101258007|NCT01719705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101258043|NCT01719835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101258044|NCT01719835|Glucocorticoids|glucocorticoids|mesh-ancestor
101258045|NCT01719835|Hormones|hormones|mesh-ancestor
101258046|NCT01719835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101258047|NCT01719835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101258048|NCT01719835|Protective Agents|protective agents|mesh-ancestor
101258049|NCT01719835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101258050|NCT01719926|Indomethacin|indomethacin|mesh-list
101258051|NCT01719926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101258052|NCT01719926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101258053|NCT01719926|Analgesics|analgesics|mesh-ancestor
101258054|NCT01719926|Sensory System Agents|sensory system agents|mesh-ancestor
101258105|NCT01720537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258106|NCT01720537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101258107|NCT01720537|Immunologic Factors|immunologic factors|mesh-ancestor
101258108|NCT01720537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258109|NCT01720719|Vitamin E|vitamin e|mesh-list
101258110|NCT01720719|Atorvastatin|atorvastatin|mesh-list
101258111|NCT01720719|Vitamins|vitamins|mesh-ancestor
101258112|NCT01720719|Micronutrients|micronutrients|mesh-ancestor
101258113|NCT01720719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258114|NCT01720719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101258115|NCT01720719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101258116|NCT01720719|Antimetabolites|antimetabolites|mesh-ancestor
101258117|NCT01720719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258118|NCT01720719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101258119|NCT01720719|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101258120|NCT01720719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101258121|NCT01720719|Antioxidants|antioxidants|mesh-ancestor
101258122|NCT01720719|Protective Agents|protective agents|mesh-ancestor
101258123|NCT01722214|Adalimumab|adalimumab|mesh-list
101258124|NCT01722214|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101258125|NCT01722214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101258126|NCT01722214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101258127|NCT01722578|N-Methylaspartate|n-methylaspartate|mesh-list
101258128|NCT01722578|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
101258129|NCT01722578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101258130|NCT01722578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101258153|NCT01724229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258154|NCT01724229|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101258155|NCT01724229|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101258156|NCT01724450|Carvedilol|carvedilol|mesh-list
101258157|NCT01724450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101258158|NCT01724450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101258159|NCT01724450|Adrenergic Agents|adrenergic agents|mesh-ancestor
101258160|NCT01724450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101258161|NCT01724450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258162|NCT01724450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258163|NCT01724450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101258164|NCT01724450|Antioxidants|antioxidants|mesh-ancestor
101258165|NCT01724450|Protective Agents|protective agents|mesh-ancestor
101258166|NCT01724450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101258167|NCT01724450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101327899|NCT00020917|Antimetabolites|antimetabolites|mesh-ancestor
101258168|NCT01724450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101258169|NCT01724450|Vasodilator Agents|vasodilator agents|mesh-ancestor
101258170|NCT01724450|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101258171|NCT01724450|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101258172|NCT01724723|Entecavir|entecavir|mesh-list
101258173|NCT01724723|Antiviral Agents|antiviral agents|mesh-ancestor
101258174|NCT01724723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101258175|NCT01724892|Loteprednol Etabonate|loteprednol etabonate|mesh-list
101258176|NCT01724892|Dexamethasone|dexamethasone|mesh-list
101258177|NCT01724892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101258178|NCT01724892|Antiemetics|antiemetics|mesh-ancestor
101258179|NCT01724892|Autonomic Agents|autonomic agents|mesh-ancestor
101258180|NCT01724892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101258181|NCT01724892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258182|NCT01724892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101258183|NCT01724892|Glucocorticoids|glucocorticoids|mesh-ancestor
101258184|NCT01724892|Hormones|hormones|mesh-ancestor
101258185|NCT01724892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101258186|NCT01724892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101258191|NCT01727427|Vitamin K|vitamin k|mesh-list
101258192|NCT01727427|Heparin|heparin|mesh-list
101258193|NCT01727427|Enoxaparin|enoxaparin|mesh-list
101258194|NCT01727427|Dalteparin|dalteparin|mesh-list
101258195|NCT01727427|Tinzaparin|tinzaparin|mesh-list
101258196|NCT01727427|PENTA|penta|mesh-list
101258197|NCT01727427|Nadroparin|nadroparin|mesh-list
101258198|NCT01727427|Warfarin|warfarin|mesh-list
101258199|NCT01727427|Rivaroxaban|rivaroxaban|mesh-list
101258200|NCT01727427|Dabigatran|dabigatran|mesh-list
101258201|NCT01727427|Apixaban|apixaban|mesh-list
101258202|NCT01727427|Fondaparinux|fondaparinux|mesh-list
101258203|NCT01727427|Acenocoumarol|acenocoumarol|mesh-list
101258204|NCT01727427|Phenprocoumon|phenprocoumon|mesh-list
101258205|NCT01727427|Bemiparin|bemiparin|mesh-list
101258206|NCT01727427|Vitamins|vitamins|mesh-ancestor
101258207|NCT01727427|Micronutrients|micronutrients|mesh-ancestor
101258208|NCT01727427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258209|NCT01727427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101258256|NCT01730157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101258257|NCT01730157|Immunologic Factors|immunologic factors|mesh-ancestor
101258258|NCT01730157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258259|NCT01730157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101258260|NCT01730157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101258261|NCT01730157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258262|NCT01730209|Everolimus|everolimus|mesh-list
101258263|NCT01730209|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101258264|NCT01730209|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101258265|NCT01730209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101258266|NCT01730209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258267|NCT01730209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101258268|NCT01730209|Immunologic Factors|immunologic factors|mesh-ancestor
101258269|NCT01730209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258270|NCT01730209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101258271|NCT01730222|Paclitaxel|paclitaxel|mesh-list
101258272|NCT01730222|Gemcitabine|gemcitabine|mesh-list
101258273|NCT01730222|Capecitabine|capecitabine|mesh-list
101258274|NCT01730222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101258275|NCT01730222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101258276|NCT01730222|Tubulin Modulators|tubulin modulators|mesh-ancestor
101258277|NCT01730222|Antimitotic Agents|antimitotic agents|mesh-ancestor
101258278|NCT01730222|Mitosis Modulators|mitosis modulators|mesh-ancestor
101258279|NCT01730222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258280|NCT01730222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101258281|NCT01730222|Antimetabolites|antimetabolites|mesh-ancestor
101258282|NCT01730287|Calcium, Dietary|calcium, dietary|mesh-list
101258283|NCT01730287|Calcium|calcium|mesh-list
101258284|NCT01730287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101258285|NCT01730287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258286|NCT01730287|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101258287|NCT01730326|Acetaminophen|acetaminophen|mesh-list
101258288|NCT01730326|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
101258289|NCT01730326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101258290|NCT01730326|Analgesics|analgesics|mesh-ancestor
101258291|NCT01730326|Sensory System Agents|sensory system agents|mesh-ancestor
101258296|NCT01730326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101258297|NCT01730326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101258298|NCT01730417|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
101258299|NCT01730417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101258300|NCT01730417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101327906|NCT00020917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101258301|NCT01730417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258302|NCT01730417|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101258303|NCT01730495|Etanercept|etanercept|mesh-list
101258304|NCT01730495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101258305|NCT01730495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101258306|NCT01730495|Analgesics|analgesics|mesh-ancestor
101258307|NCT01730495|Sensory System Agents|sensory system agents|mesh-ancestor
101258308|NCT01730495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101258309|NCT01730495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258310|NCT01730495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101258311|NCT01730495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101258312|NCT01730495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101258314|NCT01730495|Immunologic Factors|immunologic factors|mesh-ancestor
101258315|NCT01730508|Interferons|interferons|mesh-list
101258316|NCT01730508|Interferon-alpha|interferon-alpha|mesh-list
101258317|NCT01730508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101258318|NCT01730508|Antiviral Agents|antiviral agents|mesh-ancestor
101258319|NCT01730508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101258320|NCT01730508|Immunologic Factors|immunologic factors|mesh-ancestor
101258321|NCT01730508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258322|NCT01726400|Interferons|interferons|mesh-list
101258323|NCT01726400|Ribavirin|ribavirin|mesh-list
101258324|NCT01726400|Interferon-alpha|interferon-alpha|mesh-list
101258325|NCT01726400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101258326|NCT01726400|Antiviral Agents|antiviral agents|mesh-ancestor
101258327|NCT01726400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101317486|NCT00011362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317487|NCT00011362|Protease Inhibitors|protease inhibitors|mesh-ancestor
101317488|NCT00011362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317489|NCT00011362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317491|NCT00001212|Prednisone|prednisone|mesh-list
101317492|NCT00001212|Cyclophosphamide|cyclophosphamide|mesh-list
101317493|NCT00001212|Cyclosporins|cyclosporins|mesh-list
101317494|NCT00001212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101317495|NCT00001212|Immunologic Factors|immunologic factors|mesh-ancestor
101317496|NCT00001212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317497|NCT00001212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101317498|NCT00001212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101258328|NCT01726400|Antimetabolites|antimetabolites|mesh-ancestor
101258329|NCT01726400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258330|NCT01726400|Immunologic Factors|immunologic factors|mesh-ancestor
101258331|NCT01726400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258332|NCT01730612|Histamine|histamine|mesh-list
101258333|NCT01730612|Glycine|glycine|mesh-list
101258334|NCT01730612|Histamine Agonists|histamine agonists|mesh-ancestor
101258335|NCT01730612|Histamine Agents|histamine agents|mesh-ancestor
101258336|NCT01730612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101258337|NCT01730612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258338|NCT01730612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258339|NCT01730612|Glycine Agents|glycine agents|mesh-ancestor
101258340|NCT01730664|Ertapenem|ertapenem|mesh-list
101258341|NCT01730664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101258342|NCT01730664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101258343|NCT01730677|Vinorelbine|vinorelbine|mesh-list
101258344|NCT01730677|Lapatinib|lapatinib|mesh-list
101258345|NCT01730677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101258346|NCT01730677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101258347|NCT01730677|Tubulin Modulators|tubulin modulators|mesh-ancestor
101258348|NCT01730677|Antimitotic Agents|antimitotic agents|mesh-ancestor
101258349|NCT01730677|Mitosis Modulators|mitosis modulators|mesh-ancestor
101258350|NCT01730677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258351|NCT01730677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101258352|NCT01730677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101258353|NCT01730976|Vitamin D|vitamin d|mesh-list
101258354|NCT01730976|Vitamins|vitamins|mesh-list
101258355|NCT01730976|Micronutrients|micronutrients|mesh-ancestor
101258356|NCT01730976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258357|NCT01730976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101258358|NCT01731067|Fexofenadine|fexofenadine|mesh-list
101258359|NCT01731067|Flurbiprofen|flurbiprofen|mesh-list
101258360|NCT01731067|Midazolam|midazolam|mesh-list
101258361|NCT01731067|Dextromethorphan|dextromethorphan|mesh-list
101258362|NCT01731067|Caffeine|caffeine|mesh-list
101258363|NCT01731067|Bupropion|bupropion|mesh-list
101317500|NCT00001212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317501|NCT00001212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317502|NCT00001212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101317503|NCT00001212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101317504|NCT00001212|Glucocorticoids|glucocorticoids|mesh-ancestor
101317505|NCT00001212|Hormones|hormones|mesh-ancestor
101317506|NCT00001212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101258365|NCT01731067|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101221482|NCT01507974|Antimalarials|antimalarials|mesh-ancestor
101258366|NCT01731067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101258367|NCT01731067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101258368|NCT01731067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258369|NCT01731067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101258370|NCT01731067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101258371|NCT01731067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101327928|NCT00021073|Antimetabolites|antimetabolites|mesh-ancestor
101317507|NCT00001212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101317508|NCT00001212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317509|NCT00001212|Antifungal Agents|antifungal agents|mesh-ancestor
101317510|NCT00001212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101317511|NCT00001212|Dermatologic Agents|dermatologic agents|mesh-ancestor
101317512|NCT00001212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101317513|NCT00011479|Abacavir|abacavir|mesh-list
101317514|NCT00011479|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101317515|NCT00011479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101317518|NCT00011479|Antiviral Agents|antiviral agents|mesh-ancestor
101317519|NCT00011479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101317520|NCT00011479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101317521|NCT00011479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101317522|NCT00011635|Silymarin|silymarin|mesh-list
101317523|NCT00011635|Antioxidants|antioxidants|mesh-ancestor
101317524|NCT00011635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317525|NCT00011635|Protective Agents|protective agents|mesh-ancestor
101317526|NCT00011635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317527|NCT00001221|Hormones|hormones|mesh-list
101317528|NCT00001221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101317529|NCT00001221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317530|NCT00391417|Estradiol|estradiol|mesh-list
101317531|NCT00391417|Estrogens|estrogens|mesh-ancestor
101317532|NCT00391417|Hormones|hormones|mesh-ancestor
101317533|NCT00391417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101317534|NCT00391417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317535|NCT00011908|Epratuzumab|epratuzumab|mesh-list
101317536|NCT00011908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101317537|NCT00011908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317538|NCT00012025|Fulvestrant|fulvestrant|mesh-list
101317539|NCT00012025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101317540|NCT00012025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317541|NCT00012025|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101317542|NCT00012025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101317543|NCT00012025|Hormone Antagonists|hormone antagonists|mesh-ancestor
101329819|NCT00000482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101317544|NCT00012025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101317545|NCT00012025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317546|NCT00005942|Daunorubicin|daunorubicin|mesh-list
101317547|NCT00005942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317548|NCT00005942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101317549|NCT00005942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317550|NCT00005942|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101317551|NCT00005942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101317552|NCT00005942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317553|NCT00012103|Dimercaprol|dimercaprol|mesh-list
101317554|NCT00012103|Chelating Agents|chelating agents|mesh-ancestor
101317555|NCT00012103|Sequestering Agents|sequestering agents|mesh-ancestor
101317556|NCT00012103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317558|NCT00001251|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101317559|NCT00001251|Immunologic Factors|immunologic factors|mesh-ancestor
101317560|NCT00001251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317561|NCT00001251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101258372|NCT01731067|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101258373|NCT01731067|Anesthetics, General|anesthetics, general|mesh-ancestor
101258375|NCT01731067|GABA Modulators|gaba modulators|mesh-ancestor
101258376|NCT01731067|GABA Agents|gaba agents|mesh-ancestor
101258377|NCT01731067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101258378|NCT01731067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258379|NCT01731067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101258380|NCT01731067|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101258381|NCT01731067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101258382|NCT01731067|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101258383|NCT01731067|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101258384|NCT01731067|Purinergic Agents|purinergic agents|mesh-ancestor
101317562|NCT00012142|Sirolimus|sirolimus|mesh-list
101317563|NCT00012142|Temsirolimus|temsirolimus|mesh-list
101317565|NCT00012142|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101317566|NCT00012142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317567|NCT00012142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317568|NCT00012142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101317569|NCT00012142|Immunologic Factors|immunologic factors|mesh-ancestor
101317570|NCT00012142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317571|NCT00012142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317572|NCT00012142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101317573|NCT00012142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101317580|NCT00012181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317581|NCT00012181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101317583|NCT00012181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317584|NCT00005945|Cytarabine|cytarabine|mesh-list
101317585|NCT00005945|Dexamethasone|dexamethasone|mesh-list
101317586|NCT00005945|Cyclophosphamide|cyclophosphamide|mesh-list
101317587|NCT00005945|Doxorubicin|doxorubicin|mesh-list
101317588|NCT00005945|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101317589|NCT00005945|Methotrexate|methotrexate|mesh-list
101317590|NCT00005945|Vincristine|vincristine|mesh-list
101317591|NCT00005945|Daunorubicin|daunorubicin|mesh-list
101317592|NCT00005945|Asparaginase|asparaginase|mesh-list
101317593|NCT00005945|Mercaptopurine|mercaptopurine|mesh-list
101317594|NCT00005945|Pegaspargase|pegaspargase|mesh-list
101317595|NCT00005945|Thioguanine|thioguanine|mesh-list
101317596|NCT00005945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101317597|NCT00005945|Immunologic Factors|immunologic factors|mesh-ancestor
101317598|NCT00005945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317599|NCT00005945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101317600|NCT00005945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101317601|NCT00005945|Alkylating Agents|alkylating agents|mesh-ancestor
101317602|NCT00005945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317603|NCT00005945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317604|NCT00005945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101317605|NCT00005945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101317606|NCT00005945|Antiemetics|antiemetics|mesh-ancestor
101317607|NCT00005945|Autonomic Agents|autonomic agents|mesh-ancestor
101317608|NCT00005945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101317609|NCT00005945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101317610|NCT00005945|Glucocorticoids|glucocorticoids|mesh-ancestor
101317611|NCT00005945|Hormones|hormones|mesh-ancestor
101329825|NCT00000482|Vitamins|vitamins|mesh-ancestor
101317612|NCT00005945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101317613|NCT00005945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101317614|NCT00005945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101317615|NCT00005945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101317616|NCT00005945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101317617|NCT00005945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317618|NCT00005945|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101317619|NCT00005945|Abortifacient Agents|abortifacient agents|mesh-ancestor
101317620|NCT00005945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101258385|NCT01731067|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101258386|NCT01731067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101258387|NCT01731067|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101258388|NCT01731067|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101258389|NCT01731067|Antidepressive Agents|antidepressive agents|mesh-ancestor
101258390|NCT01731067|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101258391|NCT01731067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101258392|NCT01731067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101258393|NCT01731067|Dopamine Agents|dopamine agents|mesh-ancestor
101258394|NCT01731067|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101258395|NCT01731067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101258396|NCT01731067|Antitussive Agents|antitussive agents|mesh-ancestor
101258397|NCT01731067|Respiratory System Agents|respiratory system agents|mesh-ancestor
101258398|NCT01731067|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101258399|NCT01731067|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101258400|NCT01731067|Analgesics|analgesics|mesh-ancestor
101258444|NCT01731184|Midazolam|midazolam|mesh-list
101258445|NCT01731184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101258446|NCT01731184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101258447|NCT01731184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101258449|NCT01731184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101258513|NCT01731574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101258514|NCT01731574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258515|NCT01731574|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101258516|NCT01731574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101258517|NCT01731587|Cyclophosphamide|cyclophosphamide|mesh-list
101258518|NCT01731587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101258519|NCT01731587|Immunologic Factors|immunologic factors|mesh-ancestor
101258520|NCT01731587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258521|NCT01731587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101258522|NCT01731587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101258523|NCT01731587|Alkylating Agents|alkylating agents|mesh-ancestor
101258524|NCT01731587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258525|NCT01731587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101258572|NCT01731899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258573|NCT01731925|Sunitinib|sunitinib|mesh-list
101258574|NCT01731925|Lanreotide|lanreotide|mesh-list
101258575|NCT01731925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101258609|NCT01732224|Tenofovir|tenofovir|mesh-list
101258645|NCT01732367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101258646|NCT01732380|Oxaliplatin|oxaliplatin|mesh-list
101258647|NCT01732380|Raltitrexed|raltitrexed|mesh-list
101327950|NCT00021112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101258648|NCT01732380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101258649|NCT01732380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101258650|NCT01732380|Antimetabolites|antimetabolites|mesh-ancestor
101258651|NCT01732380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258652|NCT01732380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101258653|NCT01732380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101258654|NCT01732393|Quercetin|quercetin|mesh-list
101258655|NCT01732393|Antioxidants|antioxidants|mesh-ancestor
101258656|NCT01732393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258657|NCT01732393|Protective Agents|protective agents|mesh-ancestor
101258658|NCT01732393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258659|NCT01732666|Remifentanil|remifentanil|mesh-list
101258705|NCT01733043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258706|NCT01733043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101258707|NCT01733043|Analgesics|analgesics|mesh-ancestor
101258708|NCT01733043|Sensory System Agents|sensory system agents|mesh-ancestor
101258709|NCT01733043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101258710|NCT01733043|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101258771|NCT01733485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101258772|NCT01733485|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101258773|NCT01733485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101258774|NCT01733485|Antipyretics|antipyretics|mesh-ancestor
101258775|NCT01733485|Gout Suppressants|gout suppressants|mesh-ancestor
101258776|NCT01733485|Tocolytic Agents|tocolytic agents|mesh-ancestor
101258777|NCT01733485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101258778|NCT01733589|Etoposide|etoposide|mesh-list
101258779|NCT01733589|Cisplatin|cisplatin|mesh-list
101258780|NCT01733589|Endostatins|endostatins|mesh-list
101258781|NCT01733589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101258782|NCT01733589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101258783|NCT01733589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101258784|NCT01733589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101258785|NCT01733589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101258786|NCT01733589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258787|NCT01733589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101258788|NCT01733589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101258789|NCT01733589|Growth Substances|growth substances|mesh-ancestor
101258790|NCT01733589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258791|NCT01733589|Growth Inhibitors|growth inhibitors|mesh-ancestor
101258792|NCT01733706|Nicotine|nicotine|mesh-list
101258793|NCT01733706|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101258794|NCT01733706|Autonomic Agents|autonomic agents|mesh-ancestor
101258795|NCT01733706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101258821|NCT01733966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101258822|NCT01733966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101258823|NCT01733966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101258824|NCT01733966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101258825|NCT01733966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101258891|NCT01734408|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101258892|NCT01734408|Aluminum sulfate|aluminum sulfate|mesh-list
101258893|NCT01734408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101258894|NCT01734408|Immunologic Factors|immunologic factors|mesh-ancestor
101258895|NCT01734408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258896|NCT01734408|Antacids|antacids|mesh-ancestor
101258899|NCT01734473|Caseins|caseins|mesh-list
101258963|NCT01735071|Bevacizumab|bevacizumab|mesh-list
101258964|NCT01735071|Carboplatin|carboplatin|mesh-list
101258965|NCT01735071|Trabectedin|trabectedin|mesh-list
101258966|NCT01735071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101258967|NCT01735071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101258968|NCT01735071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101258969|NCT01735071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101258970|NCT01735071|Growth Substances|growth substances|mesh-ancestor
101258971|NCT01735071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258972|NCT01735071|Growth Inhibitors|growth inhibitors|mesh-ancestor
101258973|NCT01735071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101258974|NCT01735071|Alkylating Agents|alkylating agents|mesh-ancestor
101258975|NCT01735071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258976|NCT01735084|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101258977|NCT01735084|Immunologic Factors|immunologic factors|mesh-ancestor
101259021|NCT01735344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101259022|NCT01735344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259023|NCT01735344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101259024|NCT01735344|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101259025|NCT01735344|Protective Agents|protective agents|mesh-ancestor
101259026|NCT01735344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259027|NCT01735370|Etodolac|etodolac|mesh-list
101259028|NCT01735370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101259029|NCT01735370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101259030|NCT01735370|Analgesics|analgesics|mesh-ancestor
101259031|NCT01735370|Sensory System Agents|sensory system agents|mesh-ancestor
101259032|NCT01735370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101259033|NCT01735370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259034|NCT01735370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101259035|NCT01735370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101259036|NCT01735370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101259037|NCT01735370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101259038|NCT01735370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101259039|NCT01735370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259040|NCT01735383|Etodolac|etodolac|mesh-list
101259041|NCT01735383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101259042|NCT01735383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101259043|NCT01735383|Analgesics|analgesics|mesh-ancestor
101259070|NCT01735669|Sensory System Agents|sensory system agents|mesh-ancestor
101259071|NCT01735669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101259144|NCT01736150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259145|NCT01736163|Hormones|hormones|mesh-list
101259146|NCT01736163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101259147|NCT01736163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259148|NCT01736371|Propofol|propofol|mesh-list
101259149|NCT01736371|Sevoflurane|sevoflurane|mesh-list
101259212|NCT01736670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101259214|NCT01736670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101259215|NCT01736670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259216|NCT01736761|Ritonavir|ritonavir|mesh-list
101259217|NCT01736761|Darunavir|darunavir|mesh-list
101259218|NCT01736761|Rilpivirine|rilpivirine|mesh-list
101259221|NCT01736761|Protease Inhibitors|protease inhibitors|mesh-ancestor
101259282|NCT01737177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101259352|NCT01737541|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101259353|NCT01737541|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101259354|NCT01737541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101259356|NCT01737671|Methotrexate|methotrexate|mesh-list
101259357|NCT01737671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101259358|NCT01737671|Abortifacient Agents|abortifacient agents|mesh-ancestor
101259359|NCT01737671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101259360|NCT01737671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259361|NCT01737671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101259362|NCT01737671|Antimetabolites|antimetabolites|mesh-ancestor
101259363|NCT01737671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259364|NCT01737671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101259365|NCT01737671|Dermatologic Agents|dermatologic agents|mesh-ancestor
101259366|NCT01737671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101259367|NCT01737671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101259368|NCT01737671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101259369|NCT01737671|Immunologic Factors|immunologic factors|mesh-ancestor
101259370|NCT01737671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101259371|NCT01737671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101259372|NCT01737671|Antidotes|antidotes|mesh-ancestor
101259373|NCT01737671|Protective Agents|protective agents|mesh-ancestor
101259374|NCT01737671|Vitamin B Complex|vitamin b complex|mesh-ancestor
101259375|NCT01737671|Vitamins|vitamins|mesh-ancestor
101259376|NCT01737671|Micronutrients|micronutrients|mesh-ancestor
101259402|NCT01738087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101259403|NCT01738087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259404|NCT01738087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101259405|NCT01738087|Respiratory System Agents|respiratory system agents|mesh-ancestor
101259406|NCT01738087|Dermatologic Agents|dermatologic agents|mesh-ancestor
101259407|NCT01738087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101259408|NCT01738087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101259409|NCT01738087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101259410|NCT01738087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101259411|NCT01738087|Adrenergic Agents|adrenergic agents|mesh-ancestor
101259412|NCT01738087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101259413|NCT01738087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259414|NCT01738100|Morphine|morphine|mesh-list
101259415|NCT01738100|Clopidogrel|clopidogrel|mesh-list
101259416|NCT01738100|Ticagrelor|ticagrelor|mesh-list
101259417|NCT01738100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101259418|NCT01738100|Narcotics|narcotics|mesh-ancestor
101259419|NCT01738100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101259420|NCT01738100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259455|NCT01738282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101259456|NCT01738282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259457|NCT01738295|Donepezil|donepezil|mesh-list
101259458|NCT01738295|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101259459|NCT01738295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101259460|NCT01738295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259461|NCT01738295|Cholinergic Agents|cholinergic agents|mesh-ancestor
101259462|NCT01738295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101259463|NCT01738295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259464|NCT01738295|Nootropic Agents|nootropic agents|mesh-ancestor
101259465|NCT01738360|Arsenic Trioxide|arsenic trioxide|mesh-list
101259466|NCT01738360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101259467|NCT01738373|Plerixafor|plerixafor|mesh-list
101259468|NCT01738373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101259469|NCT01738373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101259470|NCT01738373|Antiviral Agents|antiviral agents|mesh-ancestor
101259471|NCT01738373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101259472|NCT01738425|Hydrogen Sulfide|hydrogen sulfide|mesh-list
101259473|NCT01738425|Gasotransmitters|gasotransmitters|mesh-ancestor
101259474|NCT01738425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101259475|NCT01738425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259476|NCT01738425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259506|NCT01738763|Vitamins|vitamins|mesh-ancestor
101259507|NCT01738763|Micronutrients|micronutrients|mesh-ancestor
101259508|NCT01738763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259509|NCT01738802|Micronutrients|micronutrients|mesh-list
101259510|NCT01738802|Trace Elements|trace elements|mesh-list
101259511|NCT01738802|Antioxidants|antioxidants|mesh-list
101259512|NCT01738802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259513|NCT01738802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259514|NCT01738802|Protective Agents|protective agents|mesh-ancestor
101259515|NCT01738815|Valproic Acid|valproic acid|mesh-list
101259516|NCT01738815|Anticonvulsants|anticonvulsants|mesh-ancestor
101259517|NCT01738815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101259518|NCT01738815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259519|NCT01738815|GABA Agents|gaba agents|mesh-ancestor
101259520|NCT01738815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101259526|NCT01738867|Naltrexone|naltrexone|mesh-list
101259566|NCT01739127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101259567|NCT01739127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259568|NCT01739127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259569|NCT01739127|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101259570|NCT01739127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101259571|NCT01739127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101259572|NCT01739127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101259573|NCT01739127|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101259574|NCT01739127|Dopamine Agents|dopamine agents|mesh-ancestor
101259575|NCT01739127|Antidepressive Agents|antidepressive agents|mesh-ancestor
101259576|NCT01739127|Dopamine Agonists|dopamine agonists|mesh-ancestor
101259577|NCT01739127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101259578|NCT01739127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101259579|NCT01739127|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101259580|NCT01739127|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101259582|NCT01739192|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101259583|NCT01739192|Antidepressive Agents|antidepressive agents|mesh-ancestor
101259584|NCT01739192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101259585|NCT01739192|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101259586|NCT01739192|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101259587|NCT01739192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101259588|NCT01739192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259589|NCT01739192|Dopamine Agents|dopamine agents|mesh-ancestor
101259590|NCT01739192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101259614|NCT01739439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101259615|NCT01739439|Antimetabolites|antimetabolites|mesh-ancestor
101259616|NCT01739439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259617|NCT01739439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101259618|NCT01739504|Anesthetics|anesthetics|mesh-list
101259619|NCT01739504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101259620|NCT01739504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259621|NCT01739556|Aspirin|aspirin|mesh-list
101259622|NCT01739556|Ticagrelor|ticagrelor|mesh-list
101259623|NCT01739556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101259624|NCT01739556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101259625|NCT01739556|Analgesics|analgesics|mesh-ancestor
101259626|NCT01739556|Sensory System Agents|sensory system agents|mesh-ancestor
101259627|NCT01739556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101259675|NCT01739855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101259676|NCT01739894|Paclitaxel|paclitaxel|mesh-list
101259677|NCT01739894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101259678|NCT01739894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101259679|NCT01739894|Tubulin Modulators|tubulin modulators|mesh-ancestor
101259680|NCT01739894|Antimitotic Agents|antimitotic agents|mesh-ancestor
101259681|NCT01739894|Mitosis Modulators|mitosis modulators|mesh-ancestor
101259682|NCT01739894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259683|NCT01739907|Vitamin D|vitamin d|mesh-list
101259684|NCT01739907|Vitamins|vitamins|mesh-ancestor
101259685|NCT01739907|Micronutrients|micronutrients|mesh-ancestor
101259686|NCT01739907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259687|NCT01739907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101259688|NCT01739920|Povidone-Iodine|povidone-iodine|mesh-list
101259739|NCT01740271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101259740|NCT01740271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101259741|NCT01740271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259742|NCT01740336|Paclitaxel|paclitaxel|mesh-list
101259743|NCT01740336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101259744|NCT01740336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101259745|NCT01740336|Tubulin Modulators|tubulin modulators|mesh-ancestor
101259746|NCT01740336|Antimitotic Agents|antimitotic agents|mesh-ancestor
101259747|NCT01740336|Mitosis Modulators|mitosis modulators|mesh-ancestor
101259748|NCT01740336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259749|NCT01740453|Ropivacaine|ropivacaine|mesh-list
101259750|NCT01740453|Anesthetics, Local|anesthetics, local|mesh-ancestor
101259751|NCT01740453|Anesthetics|anesthetics|mesh-ancestor
101259752|NCT01740453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101259753|NCT01740453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259754|NCT01740453|Sensory System Agents|sensory system agents|mesh-ancestor
101259800|NCT01740960|Sensory System Agents|sensory system agents|mesh-ancestor
101259801|NCT01740960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101259802|NCT01740960|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101259803|NCT01740960|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101259806|NCT01740960|Hormones|hormones|mesh-ancestor
101259869|NCT01741493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101259870|NCT01741493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101259871|NCT01741493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259872|NCT01741493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101259874|NCT01741506|Tinzaparin|tinzaparin|mesh-list
101259875|NCT01741506|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101259876|NCT01741506|Anticoagulants|anticoagulants|mesh-ancestor
101259877|NCT01741506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101259878|NCT01741506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101259879|NCT01741506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259880|NCT01741519|Landiolol|landiolol|mesh-list
101259881|NCT01741519|Esmolol|esmolol|mesh-list
101259882|NCT01741519|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101259883|NCT01741519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101259884|NCT01741519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101259885|NCT01741519|Adrenergic Agents|adrenergic agents|mesh-ancestor
101259886|NCT01741519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101259887|NCT01741519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259888|NCT01741519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259889|NCT01741519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101259890|NCT01741558|Riboflavin|riboflavin|mesh-list
101259891|NCT01741558|Methotrexate|methotrexate|mesh-list
101259892|NCT01741558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101259893|NCT01741558|Abortifacient Agents|abortifacient agents|mesh-ancestor
101259894|NCT01741558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101259911|NCT01741623|Bisoprolol|bisoprolol|mesh-list
101259917|NCT01741623|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101259918|NCT01741623|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101259919|NCT01741623|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101259920|NCT01741623|Adrenergic Agents|adrenergic agents|mesh-ancestor
101259921|NCT01741623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101259989|NCT01742338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101259990|NCT01742338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259991|NCT01742338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101259992|NCT01742338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101259993|NCT01742338|Antiemetics|antiemetics|mesh-ancestor
101259994|NCT01742338|Autonomic Agents|autonomic agents|mesh-ancestor
101259995|NCT01742338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101259996|NCT01742338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101259997|NCT01742338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101259998|NCT01742338|Protective Agents|protective agents|mesh-ancestor
101259999|NCT01742390|Risperidone|risperidone|mesh-list
101260000|NCT01742390|Aripiprazole|aripiprazole|mesh-list
101260001|NCT01742390|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101260002|NCT01742390|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101260003|NCT01742390|Serotonin Agents|serotonin agents|mesh-ancestor
101260004|NCT01742390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101260005|NCT01742390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260006|NCT01742390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260045|NCT01742624|Mycophenolic Acid|mycophenolic acid|mesh-list
101260046|NCT01742624|Tacrolimus|tacrolimus|mesh-list
101260047|NCT01742624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101260048|NCT01742624|Immunologic Factors|immunologic factors|mesh-ancestor
101260049|NCT01742624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260050|NCT01742624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101260059|NCT01742637|Adapalene|adapalene|mesh-list
101260116|NCT01742702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101260117|NCT01742702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260118|NCT01742702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101260119|NCT01742702|Respiratory System Agents|respiratory system agents|mesh-ancestor
101260186|NCT01743066|Vitamins|vitamins|mesh-ancestor
101260187|NCT01743066|Micronutrients|micronutrients|mesh-ancestor
101260188|NCT01743066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260189|NCT01743066|Antioxidants|antioxidants|mesh-ancestor
101260190|NCT01743066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260256|NCT01743300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101260257|NCT01743300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101260327|NCT01743794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260328|NCT01743794|Sensory System Agents|sensory system agents|mesh-ancestor
101260329|NCT01743794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101260330|NCT01743820|Piperaquine|piperaquine|mesh-list
101260331|NCT01743820|Primaquine|primaquine|mesh-list
101260332|NCT01743820|Artenimol|artenimol|mesh-list
101260333|NCT01743820|Antimalarials|antimalarials|mesh-ancestor
101260334|NCT01743820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101260335|NCT01743820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101260336|NCT01743820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101260337|NCT01743885|Propranolol|propranolol|mesh-list
101260338|NCT01743885|Acebutolol|acebutolol|mesh-list
101260339|NCT01743885|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101260340|NCT01743885|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101260341|NCT01743885|Adrenergic Agents|adrenergic agents|mesh-ancestor
101260342|NCT01743885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101260343|NCT01743885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260387|NCT01744184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101260388|NCT01744184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260389|NCT01744184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101260390|NCT01744184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101260391|NCT01744184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101260392|NCT01744184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101260393|NCT01744184|Anesthetics, General|anesthetics, general|mesh-ancestor
101260394|NCT01744184|Anesthetics|anesthetics|mesh-ancestor
101260395|NCT01744184|GABA Modulators|gaba modulators|mesh-ancestor
101260396|NCT01744184|GABA Agents|gaba agents|mesh-ancestor
101260397|NCT01744184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101260398|NCT01744184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260399|NCT01744184|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101260400|NCT01744184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101260401|NCT01744184|Analgesics|analgesics|mesh-ancestor
101260402|NCT01744184|Sensory System Agents|sensory system agents|mesh-ancestor
101260403|NCT01744184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101260404|NCT01744184|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
101260405|NCT01744236|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101260406|NCT01744236|Liraglutide|liraglutide|mesh-list
101260407|NCT01744236|Exenatide|exenatide|mesh-list
101260408|NCT01744236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101260438|NCT01744314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101260439|NCT01744314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101260440|NCT01744314|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101260441|NCT01744314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101260442|NCT01744314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260443|NCT01744314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101260444|NCT01744314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101260446|NCT01744314|Sensory System Agents|sensory system agents|mesh-ancestor
101260447|NCT01744314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101260448|NCT01744314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260449|NCT01744314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101260450|NCT01744314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101260451|NCT01744314|Gout Suppressants|gout suppressants|mesh-ancestor
101260452|NCT01744314|Tocolytic Agents|tocolytic agents|mesh-ancestor
101260453|NCT01744314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101260454|NCT01744314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101260495|NCT01744587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101260496|NCT01744587|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101260497|NCT01744262|Anesthetics|anesthetics|mesh-list
101260568|NCT01745328|Levofloxacin|levofloxacin|mesh-list
101260569|NCT01745328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101260570|NCT01745328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101260571|NCT01745328|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101260572|NCT01745328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101260573|NCT01745328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101260574|NCT01745328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101260575|NCT01745328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260576|NCT01745328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101260577|NCT01745328|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101260578|NCT01745328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101260579|NCT01745549|Insulin|insulin|mesh-list
101260580|NCT01745549|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101260581|NCT01745549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101260582|NCT01745549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260583|NCT01745562|Alprazolam|alprazolam|mesh-list
101260584|NCT01745562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101260585|NCT01745562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101260586|NCT01745562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260587|NCT01745562|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101260588|NCT01745562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101260589|NCT01745562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101260590|NCT01745562|GABA Modulators|gaba modulators|mesh-ancestor
101260591|NCT01745562|GABA Agents|gaba agents|mesh-ancestor
101260592|NCT01745562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101260593|NCT01745562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260594|NCT01745575|Alprazolam|alprazolam|mesh-list
101260595|NCT01745575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101260596|NCT01745575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101260597|NCT01745575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260598|NCT01745575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101260599|NCT01745575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101260612|NCT01745601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101260613|NCT01745601|Serotonin Agents|serotonin agents|mesh-ancestor
101260614|NCT01745601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260685|NCT01745770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260686|NCT01745770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101260687|NCT01745770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101260688|NCT01745809|Dimercaprol|dimercaprol|mesh-list
101260689|NCT01745809|Chelating Agents|chelating agents|mesh-ancestor
101260690|NCT01745809|Sequestering Agents|sequestering agents|mesh-ancestor
101260691|NCT01745809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260692|NCT01745835|Bisacodyl|bisacodyl|mesh-list
101260693|NCT01745835|Cathartics|cathartics|mesh-ancestor
101260694|NCT01745835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101260695|NCT01745835|Laxatives|laxatives|mesh-ancestor
101260696|NCT01746199|Pyrimethamine|pyrimethamine|mesh-list
101260697|NCT01746199|Sulfadoxine|sulfadoxine|mesh-list
101260698|NCT01746199|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101260699|NCT01746199|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101260700|NCT01746199|Sulfamethoxazole|sulfamethoxazole|mesh-list
101260701|NCT01746199|Antimalarials|antimalarials|mesh-ancestor
101260710|NCT01746251|Afatinib|afatinib|mesh-list
101260744|NCT01746602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101260745|NCT01746641|Remifentanil|remifentanil|mesh-list
101260746|NCT01746641|Propofol|propofol|mesh-list
101260747|NCT01746641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101260748|NCT01746641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101260749|NCT01746641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260750|NCT01746641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101260751|NCT01746641|Anesthetics, General|anesthetics, general|mesh-ancestor
101260752|NCT01746641|Anesthetics|anesthetics|mesh-ancestor
101260753|NCT01746641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101260754|NCT01746641|Narcotics|narcotics|mesh-ancestor
101260755|NCT01746641|Analgesics|analgesics|mesh-ancestor
101260756|NCT01746641|Sensory System Agents|sensory system agents|mesh-ancestor
101260757|NCT01746641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101260758|NCT01746680|Methotrexate|methotrexate|mesh-list
101260806|NCT01746823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101260807|NCT01746823|Dermatologic Agents|dermatologic agents|mesh-ancestor
101260808|NCT01746823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101260809|NCT01746823|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101260810|NCT01746875|Aflibercept|aflibercept|mesh-list
101260811|NCT01746875|Verteporfin|verteporfin|mesh-list
101260812|NCT01746875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101260813|NCT01746875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101260814|NCT01746875|Growth Substances|growth substances|mesh-ancestor
101260815|NCT01746875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260816|NCT01746875|Growth Inhibitors|growth inhibitors|mesh-ancestor
101260817|NCT01746875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101260818|NCT01746875|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101260819|NCT01746875|Dermatologic Agents|dermatologic agents|mesh-ancestor
101260820|NCT01746992|Prednisone|prednisone|mesh-list
101260821|NCT01746992|Cyclophosphamide|cyclophosphamide|mesh-list
101260822|NCT01746992|Ifosfamide|ifosfamide|mesh-list
101260823|NCT01746992|Doxorubicin|doxorubicin|mesh-list
101260824|NCT01746992|Methotrexate|methotrexate|mesh-list
101260825|NCT01746992|Etoposide|etoposide|mesh-list
101260826|NCT01746992|Vincristine|vincristine|mesh-list
101260827|NCT01746992|Etoposide phosphate|etoposide phosphate|mesh-list
101260828|NCT01746992|Pirarubicin|pirarubicin|mesh-list
101260844|NCT01746992|Hormones|hormones|mesh-ancestor
101260857|NCT01746992|Antimitotic Agents|antimitotic agents|mesh-ancestor
101260858|NCT01746992|Mitosis Modulators|mitosis modulators|mesh-ancestor
101260859|NCT01747044|Milnacipran|milnacipran|mesh-list
101260860|NCT01747044|Levomilnacipran|levomilnacipran|mesh-list
101260861|NCT01747044|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101260862|NCT01747044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101260863|NCT01747044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101260864|NCT01747044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260865|NCT01747044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101260866|NCT01747044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260867|NCT01747044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101260868|NCT01747044|Analgesics|analgesics|mesh-ancestor
101260869|NCT01747044|Sensory System Agents|sensory system agents|mesh-ancestor
101260870|NCT01747044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101260871|NCT01747044|Antidepressive Agents|antidepressive agents|mesh-ancestor
101260872|NCT01747044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101260873|NCT01747083|Metformin|metformin|mesh-list
101260874|NCT01747083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101260912|NCT01747252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260913|NCT01747252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101260914|NCT01747252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101260915|NCT01747278|Trimethoprim|trimethoprim|mesh-list
101260916|NCT01747278|Sulfamethoxazole|sulfamethoxazole|mesh-list
101260917|NCT01747278|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101260918|NCT01747278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101260919|NCT01747278|Antimalarials|antimalarials|mesh-ancestor
101260920|NCT01747278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101260921|NCT01747278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101260922|NCT01747278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101260923|NCT01747278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101260924|NCT01747278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260925|NCT01747278|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101260972|NCT01747616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260973|NCT01747616|Antidotes|antidotes|mesh-ancestor
101260974|NCT01747616|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101260975|NCT01747616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101260976|NCT01747616|Antimetabolites|antimetabolites|mesh-ancestor
101260977|NCT01747616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101260978|NCT01747616|Chelating Agents|chelating agents|mesh-ancestor
101261043|NCT01748123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101261045|NCT01748123|Natriuretic Agents|natriuretic agents|mesh-ancestor
101261046|NCT01748123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261047|NCT01748123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101261048|NCT01748123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101261049|NCT01748123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261108|NCT01748396|Calcium|calcium|mesh-list
101261109|NCT01748396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101261110|NCT01748396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261111|NCT01748396|Antacids|antacids|mesh-ancestor
101261112|NCT01748396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261113|NCT01748396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101261114|NCT01748396|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101261115|NCT01748396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101261116|NCT01748396|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101261117|NCT01748396|Vitamins|vitamins|mesh-ancestor
101261118|NCT01748396|Micronutrients|micronutrients|mesh-ancestor
101261120|NCT01748422|Capsaicin|capsaicin|mesh-list
101261171|NCT01748630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101261172|NCT01748630|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101261173|NCT01748630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101261174|NCT01748630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101261175|NCT01748630|Adrenergic Agents|adrenergic agents|mesh-ancestor
101261176|NCT01748630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101261177|NCT01748630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261178|NCT01748630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101261179|NCT01748630|Narcotics|narcotics|mesh-ancestor
101261180|NCT01748630|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101261181|NCT01748630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101261235|NCT01749072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101261236|NCT01749072|Tubulin Modulators|tubulin modulators|mesh-ancestor
101261237|NCT01749072|Antimitotic Agents|antimitotic agents|mesh-ancestor
101261238|NCT01749072|Mitosis Modulators|mitosis modulators|mesh-ancestor
101261239|NCT01749072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261240|NCT01749072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101261241|NCT01749072|Alkylating Agents|alkylating agents|mesh-ancestor
101261242|NCT01749072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101261243|NCT01749072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101261244|NCT01749085|Ketoconazole|ketoconazole|mesh-list
101261245|NCT01749085|Antifungal Agents|antifungal agents|mesh-ancestor
101261298|NCT01749150|Protease Inhibitors|protease inhibitors|mesh-ancestor
101261299|NCT01749150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101261300|NCT01749150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261301|NCT01749150|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101261302|NCT01749150|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101261303|NCT01749150|Antiviral Agents|antiviral agents|mesh-ancestor
101261304|NCT01749150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101261305|NCT01749150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101261306|NCT01749150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101261307|NCT01749150|Antimetabolites|antimetabolites|mesh-ancestor
101261308|NCT01749150|Immunologic Factors|immunologic factors|mesh-ancestor
101261309|NCT01749150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261310|NCT01749150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101261311|NCT01749228|Etodolac|etodolac|mesh-list
101261312|NCT01749228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101261313|NCT01749228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101261314|NCT01749228|Analgesics|analgesics|mesh-ancestor
101261315|NCT01749228|Sensory System Agents|sensory system agents|mesh-ancestor
101261316|NCT01749228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101261317|NCT01749228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261318|NCT01749228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101261319|NCT01749228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101261347|NCT01749384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101261398|NCT01749475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261400|NCT01749514|Hematinics|hematinics|mesh-ancestor
101261401|NCT01749540|Luspatercept|luspatercept|mesh-list
101261403|NCT01749566|Maraviroc|maraviroc|mesh-list
101261460|NCT01750099|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101261461|NCT01750099|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101261462|NCT01750099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101261463|NCT01750099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261464|NCT01750099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101261482|NCT01750359|Curcumin|curcumin|mesh-list
101261530|NCT01750541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101261531|NCT01750541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261532|NCT01750541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101261533|NCT01750541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101261534|NCT01750541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101261535|NCT01750541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101261536|NCT01750541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101261537|NCT01750541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101261538|NCT01750541|Dopamine Agents|dopamine agents|mesh-ancestor
101261539|NCT01750541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101261540|NCT01750541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261541|NCT01750541|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101261542|NCT01750541|Anticonvulsants|anticonvulsants|mesh-ancestor
101261543|NCT01750541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101261544|NCT01750541|GABA Agents|gaba agents|mesh-ancestor
101261545|NCT01750541|Antimanic Agents|antimanic agents|mesh-ancestor
101261546|NCT01750580|Ipilimumab|ipilimumab|mesh-list
101261547|NCT01750580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101261548|NCT01750580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101261549|NCT01750580|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101261550|NCT01750580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261581|NCT01750788|Anticoagulants|anticoagulants|mesh-ancestor
101261582|NCT01750801|Chlorhexidine|chlorhexidine|mesh-list
101261584|NCT01750801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101261585|NCT01750801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101261586|NCT01750801|Disinfectants|disinfectants|mesh-ancestor
101261587|NCT01750866|Prednisone|prednisone|mesh-list
101261588|NCT01750866|Lenograstim|lenograstim|mesh-list
101261589|NCT01750866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101261590|NCT01750866|Glucocorticoids|glucocorticoids|mesh-ancestor
101261591|NCT01750866|Hormones|hormones|mesh-ancestor
101261592|NCT01750866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101261593|NCT01750866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261594|NCT01750866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101261595|NCT01750866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101261596|NCT01750866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101261597|NCT01750866|Immunologic Factors|immunologic factors|mesh-ancestor
101261598|NCT01750983|Lenalidomide|lenalidomide|mesh-list
101261599|NCT01750983|Ipilimumab|ipilimumab|mesh-list
101261600|NCT01750983|Immunologic Factors|immunologic factors|mesh-ancestor
101261610|NCT01751009|Vitamins|vitamins|mesh-list
101261640|NCT01751295|Atorvastatin|atorvastatin|mesh-list
101261641|NCT01751295|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101261642|NCT01751295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101261643|NCT01751295|Antimetabolites|antimetabolites|mesh-ancestor
101261644|NCT01751295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261645|NCT01751295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101261646|NCT01751295|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101261647|NCT01751295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101261648|NCT01751321|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101261649|NCT01751321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101261650|NCT01751321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261652|NCT01751321|Hormones|hormones|mesh-ancestor
101261653|NCT01751321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101261654|NCT01751321|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101261698|NCT01751854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101261699|NCT01751854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101261700|NCT01751854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261701|NCT01751854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101261702|NCT01751854|Serotonin Agents|serotonin agents|mesh-ancestor
101261703|NCT01751854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261704|NCT01751919|Imatinib Mesylate|imatinib mesylate|mesh-list
101261705|NCT01751919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101261706|NCT01751919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101261707|NCT01751919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101261708|NCT01751919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261760|NCT01752322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101328169|NCT00022126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101261761|NCT01752322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261762|NCT01752322|Sensory System Agents|sensory system agents|mesh-ancestor
101261763|NCT01752322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101261764|NCT01752322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101261765|NCT01752322|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101261766|NCT01752322|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101261767|NCT01752322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101261768|NCT01752322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261769|NCT01752517|Vinorelbine|vinorelbine|mesh-list
101261770|NCT01752517|Ifosfamide|ifosfamide|mesh-list
101261771|NCT01752517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101261772|NCT01752517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101261773|NCT01752517|Tubulin Modulators|tubulin modulators|mesh-ancestor
101261774|NCT01752517|Antimitotic Agents|antimitotic agents|mesh-ancestor
101261775|NCT01752517|Mitosis Modulators|mitosis modulators|mesh-ancestor
101261776|NCT01752517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261777|NCT01752517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101261778|NCT01752517|Alkylating Agents|alkylating agents|mesh-ancestor
101261779|NCT01752543|Conivaptan|conivaptan|mesh-list
101261780|NCT01752543|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101261781|NCT01752543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261782|NCT01752543|Natriuretic Agents|natriuretic agents|mesh-ancestor
101261783|NCT01752543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261784|NCT01752686|Carboplatin|carboplatin|mesh-list
101261785|NCT01752686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101261786|NCT01752699|Methadone|methadone|mesh-list
101261802|NCT01752790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101261803|NCT01752790|Immunologic Factors|immunologic factors|mesh-ancestor
101261804|NCT01752790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261805|NCT01752881|Vaccines|vaccines|mesh-list
101261806|NCT01752881|Immunologic Factors|immunologic factors|mesh-ancestor
101261873|NCT01753453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261874|NCT01753453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101261875|NCT01753453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101261876|NCT01753453|Antiviral Agents|antiviral agents|mesh-ancestor
101261877|NCT01753453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101261945|NCT01754220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101261946|NCT01754220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261948|NCT01754285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101261949|NCT01754285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101261950|NCT01754285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101261952|NCT01754324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101262014|NCT01754883|Lithium Carbonate|lithium carbonate|mesh-list
101262015|NCT01754883|Antidepressive Agents|antidepressive agents|mesh-ancestor
101262016|NCT01754883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101262017|NCT01754883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101262018|NCT01754883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262019|NCT01754883|Antimanic Agents|antimanic agents|mesh-ancestor
101262023|NCT01754961|Vitamin D|vitamin d|mesh-list
101262083|NCT01755338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101262084|NCT01755338|Prednisolone|prednisolone|mesh-list
101262085|NCT01755338|Prednisolone acetate|prednisolone acetate|mesh-list
101262086|NCT01755338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101262087|NCT01755338|Prednisolone phosphate|prednisolone phosphate|mesh-list
101262088|NCT01755338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101262089|NCT01755338|Antiemetics|antiemetics|mesh-ancestor
101262090|NCT01755338|Autonomic Agents|autonomic agents|mesh-ancestor
101262091|NCT01755338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101262092|NCT01755338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262094|NCT01755338|Glucocorticoids|glucocorticoids|mesh-ancestor
101262096|NCT01755338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101262097|NCT01755338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101262098|NCT01755338|Protective Agents|protective agents|mesh-ancestor
101262099|NCT01755338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101262100|NCT01755338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101262101|NCT01755377|Benzonidazole|benzonidazole|mesh-list
101262102|NCT01755377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101262103|NCT01755377|Immunologic Factors|immunologic factors|mesh-ancestor
101262141|NCT01755520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101262142|NCT01755520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262143|NCT01755520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101262144|NCT01755520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101262145|NCT01755520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101262146|NCT01755520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101262147|NCT01755520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262148|NCT01755520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101262149|NCT01755520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101262150|NCT01755520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101262151|NCT01755520|Antipyretics|antipyretics|mesh-ancestor
101262152|NCT01755520|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101262153|NCT01755520|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101262154|NCT01755520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101262155|NCT01755520|Purinergic Agents|purinergic agents|mesh-ancestor
101262156|NCT01755520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101262202|NCT01755676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262203|NCT01755676|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101262204|NCT01755676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101262205|NCT01755728|Acetaminophen|acetaminophen|mesh-list
101262206|NCT01755728|Ibuprofen|ibuprofen|mesh-list
101262207|NCT01755728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101262208|NCT01755728|Analgesics|analgesics|mesh-ancestor
101262209|NCT01755728|Sensory System Agents|sensory system agents|mesh-ancestor
101262210|NCT01755728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101262211|NCT01755728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262212|NCT01755728|Antipyretics|antipyretics|mesh-ancestor
101262213|NCT01755728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101262214|NCT01755728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101262215|NCT01755728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101262216|NCT01755728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101262217|NCT01755728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101262218|NCT01755728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262219|NCT01755845|Paclitaxel|paclitaxel|mesh-list
101262220|NCT01755845|Cisplatin|cisplatin|mesh-list
101262221|NCT01755845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101262222|NCT01755845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101262223|NCT01755845|Tubulin Modulators|tubulin modulators|mesh-ancestor
101262224|NCT01755845|Antimitotic Agents|antimitotic agents|mesh-ancestor
101262225|NCT01755845|Mitosis Modulators|mitosis modulators|mesh-ancestor
101262254|NCT01756105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262255|NCT01756131|Cabotegravir|cabotegravir|mesh-list
101262256|NCT01756131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101262257|NCT01756131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101262258|NCT01756131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101262259|NCT01756131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262260|NCT01756131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101262261|NCT01756131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101262262|NCT01756131|Antiviral Agents|antiviral agents|mesh-ancestor
101262263|NCT01756131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101262264|NCT01756170|Paclitaxel|paclitaxel|mesh-list
101262265|NCT01756170|Cisplatin|cisplatin|mesh-list
101262266|NCT01756170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101262267|NCT01756170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101262315|NCT01756443|Racepinephrine|racepinephrine|mesh-list
101262316|NCT01756443|Bupivacaine|bupivacaine|mesh-list
101262317|NCT01756443|Epinephryl borate|epinephryl borate|mesh-list
101262318|NCT01756443|Anesthetics, Local|anesthetics, local|mesh-ancestor
101262319|NCT01756443|Anesthetics|anesthetics|mesh-ancestor
101262320|NCT01756443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101262321|NCT01756443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262323|NCT01756443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101262324|NCT01756443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101262325|NCT01756443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101262326|NCT01756443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101262327|NCT01756443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101262328|NCT01756443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262329|NCT01756443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101262375|NCT01756547|Respiratory System Agents|respiratory system agents|mesh-ancestor
101262376|NCT01756612|Epoetin Alfa|epoetin alfa|mesh-list
101262377|NCT01756612|Hematinics|hematinics|mesh-ancestor
101262378|NCT01756638|Prednisolone|prednisolone|mesh-list
101262379|NCT01756638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101262380|NCT01756638|Glucocorticoids|glucocorticoids|mesh-ancestor
101262381|NCT01756638|Hormones|hormones|mesh-ancestor
101262382|NCT01756638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101262383|NCT01756638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262384|NCT01756638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101262385|NCT01756638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101262386|NCT01756651|Fentanyl|fentanyl|mesh-list
101262387|NCT01756651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101262388|NCT01756651|Narcotics|narcotics|mesh-ancestor
101262389|NCT01756651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101262390|NCT01756651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262391|NCT01756651|Analgesics|analgesics|mesh-ancestor
101262392|NCT01756651|Sensory System Agents|sensory system agents|mesh-ancestor
101262436|NCT01756989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101262437|NCT01756989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101262438|NCT01756989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262439|NCT01756989|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101262440|NCT01756989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101262441|NCT01756989|Analgesics|analgesics|mesh-ancestor
101262442|NCT01756989|Sensory System Agents|sensory system agents|mesh-ancestor
101262443|NCT01756989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101262444|NCT01756989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262445|NCT01756989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101262446|NCT01756989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101262447|NCT01756989|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101262448|NCT01756989|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101262449|NCT01756989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101262495|NCT01757236|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101262496|NCT01757236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101262497|NCT01757236|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101262566|NCT01757756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101262567|NCT01757756|Anesthetics, General|anesthetics, general|mesh-ancestor
101262568|NCT01757756|Anesthetics|anesthetics|mesh-ancestor
101262569|NCT01757756|GABA Modulators|gaba modulators|mesh-ancestor
101262570|NCT01757756|GABA Agents|gaba agents|mesh-ancestor
101262571|NCT01757756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101262572|NCT01757756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262573|NCT01757769|Silodosin|silodosin|mesh-list
101262574|NCT01757769|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101262575|NCT01757769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101262576|NCT01757769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101262577|NCT01757769|Adrenergic Agents|adrenergic agents|mesh-ancestor
101262578|NCT01757769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101262579|NCT01757769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262625|NCT01758029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101262626|NCT01758029|Anabolic Agents|anabolic agents|mesh-ancestor
101262627|NCT01758094|Testosterone|testosterone|mesh-list
101262628|NCT01758094|Androgens|androgens|mesh-ancestor
101262695|NCT01758198|Immunologic Factors|immunologic factors|mesh-ancestor
101262696|NCT01758198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101262697|NCT01758198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101262698|NCT01758198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101262699|NCT01758198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101262702|NCT01758263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101262703|NCT01758263|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101262704|NCT01758263|Sympatholytics|sympatholytics|mesh-ancestor
101262705|NCT01758263|Autonomic Agents|autonomic agents|mesh-ancestor
101262706|NCT01758263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101262707|NCT01758263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262708|NCT01758263|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101262709|NCT01758263|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101262710|NCT01758263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101262711|NCT01758263|Adrenergic Agents|adrenergic agents|mesh-ancestor
101262712|NCT01758263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101262713|NCT01758263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262714|NCT01758263|Vasodilator Agents|vasodilator agents|mesh-ancestor
101262715|NCT01758263|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101262716|NCT01758263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101262717|NCT01758263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101262718|NCT01758367|Decitabine|decitabine|mesh-list
101262719|NCT01758367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101262720|NCT01758367|Antimetabolites|antimetabolites|mesh-ancestor
101262747|NCT01758471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262749|NCT01758627|Dialysis Solutions|dialysis solutions|mesh-ancestor
101262750|NCT01758627|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101188462|NCT00002880|Etoposide|etoposide|mesh-list
101188535|NCT00002964|Trioxsalen|trioxsalen|mesh-list
101262751|NCT01758640|Warfarin|warfarin|mesh-list
101188793|NCT00003144|Amifostine|amifostine|mesh-list
101262753|NCT01758640|Anticoagulants|anticoagulants|mesh-ancestor
101189064|NCT00003390|Irofulven|irofulven|mesh-list
101262755|NCT01758666|Methotrexate|methotrexate|mesh-list
101189296|NCT00003624|Paclitaxel|paclitaxel|mesh-list
101189586|NCT00003894|Growth Substances|growth substances|mesh-ancestor
101189669|NCT00003960|Busulfan|busulfan|mesh-list
101189738|NCT00004002|Bortezomib|bortezomib|mesh-list
101262758|NCT01758666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101262759|NCT01758666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262760|NCT01758666|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101262761|NCT01758666|Abortifacient Agents|abortifacient agents|mesh-ancestor
101262777|NCT01758666|Vitamins|vitamins|mesh-ancestor
101262800|NCT01758913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101262801|NCT01758913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101262802|NCT01758913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101191204|NCT00360048|Oxytocin|oxytocin|mesh-list
101262803|NCT01758913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101191579|NCT00370188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101191653|NCT00371124|Autonomic Agents|autonomic agents|mesh-ancestor
101191801|NCT00376584|Niacin|niacin|mesh-list
101262804|NCT01758913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195644|NCT04131309|Dexamethasone|dexamethasone|mesh-list
101262850|NCT01759524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101195796|NCT03654833|Growth Substances|growth substances|mesh-ancestor
101195871|NCT03273413|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101262851|NCT01759524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101195951|NCT02817360|Spirapril|spirapril|mesh-list
101196022|NCT02659384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101196553|NCT01386372|Tolvaptan|tolvaptan|mesh-list
101202111|NCT01408095|Glimepiride|glimepiride|mesh-list
101202253|NCT01408927|Aspirin|aspirin|mesh-list
101262887|NCT01759706|Anesthetics|anesthetics|mesh-list
101262888|NCT01759706|Ropivacaine|ropivacaine|mesh-list
101262889|NCT01759706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101262890|NCT01759706|Antiemetics|antiemetics|mesh-ancestor
101262891|NCT01759706|Autonomic Agents|autonomic agents|mesh-ancestor
101262892|NCT01759706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101202327|NCT01409174|Alkylating Agents|alkylating agents|mesh-ancestor
101262936|NCT01759732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101262937|NCT01759732|Alkylating Agents|alkylating agents|mesh-ancestor
101304270|NCT02012075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101262938|NCT01759732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262939|NCT01759732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101262940|NCT01759732|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101262942|NCT01759771|Cholecalciferol|cholecalciferol|mesh-list
101262943|NCT01759771|Vitamins|vitamins|mesh-ancestor
101262944|NCT01759771|Micronutrients|micronutrients|mesh-ancestor
101262945|NCT01759771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262946|NCT01759771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101262947|NCT01759771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101262948|NCT01759810|Vaccines|vaccines|mesh-list
101262949|NCT01759810|Immunologic Factors|immunologic factors|mesh-ancestor
101262987|NCT01760096|Levamisole|levamisole|mesh-list
101262988|NCT01760096|Cyclosporins|cyclosporins|mesh-list
101262989|NCT01760096|Glucocorticoids|glucocorticoids|mesh-list
101262990|NCT01760096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101262991|NCT01760096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262992|NCT01760096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101262993|NCT01760096|Immunologic Factors|immunologic factors|mesh-ancestor
101262994|NCT01760096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262995|NCT01760096|Antifungal Agents|antifungal agents|mesh-ancestor
101263055|NCT01760226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263056|NCT01760226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101263057|NCT01760226|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101263058|NCT01760226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101263059|NCT01760226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101263115|NCT01760421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101263117|NCT01760460|Anacetrapib|anacetrapib|mesh-list
101263118|NCT01760460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101263121|NCT01760460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263122|NCT01760460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101263123|NCT01760460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101263124|NCT01760460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101263125|NCT01760460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101263126|NCT01760564|Miglustat|miglustat|mesh-list
101263127|NCT01760564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101263128|NCT01760564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263129|NCT01760564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101263130|NCT01760564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101263131|NCT01760564|Antiviral Agents|antiviral agents|mesh-ancestor
101263132|NCT01760564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101263133|NCT01760564|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101263134|NCT01760564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101263135|NCT01760564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263136|NCT01760577|Botulinum Toxins|botulinum toxins|mesh-list
101263137|NCT01760577|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101263138|NCT01760577|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101263139|NCT01760577|Hyaluronic Acid|hyaluronic acid|mesh-list
101263140|NCT01760577|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101263141|NCT01760577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101317621|NCT00005945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101317622|NCT00005945|Antimetabolites|antimetabolites|mesh-ancestor
101317623|NCT00005945|Dermatologic Agents|dermatologic agents|mesh-ancestor
101317624|NCT00005945|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101317625|NCT00005945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101317626|NCT00005945|Antiviral Agents|antiviral agents|mesh-ancestor
101317627|NCT00005945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101317628|NCT00005945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101317629|NCT00005945|Tubulin Modulators|tubulin modulators|mesh-ancestor
101317630|NCT00005945|Antimitotic Agents|antimitotic agents|mesh-ancestor
101317633|NCT01929811|Docetaxel|docetaxel|mesh-list
101263142|NCT01760577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263143|NCT01760577|Cholinergic Agents|cholinergic agents|mesh-ancestor
101263144|NCT01760577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101328266|NCT00010686|Estrogens|estrogens|mesh-ancestor
101317634|NCT01929811|Epirubicin|epirubicin|mesh-list
101317635|NCT01929811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101317636|NCT01929811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317637|NCT01929811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317638|NCT01929811|Tubulin Modulators|tubulin modulators|mesh-ancestor
101317639|NCT01929811|Antimitotic Agents|antimitotic agents|mesh-ancestor
101317640|NCT01929811|Mitosis Modulators|mitosis modulators|mesh-ancestor
101317641|NCT01929811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317642|NCT01929811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101317643|NCT01929811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101317644|NCT01929811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101317645|NCT01929811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317646|NCT00012220|Gemcitabine|gemcitabine|mesh-list
101317647|NCT00012220|Docetaxel|docetaxel|mesh-list
101317648|NCT00012220|Irinotecan|irinotecan|mesh-list
101317649|NCT00012220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317650|NCT00012220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101317651|NCT00012220|Antimetabolites|antimetabolites|mesh-ancestor
101317652|NCT00012220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317653|NCT00012220|Tubulin Modulators|tubulin modulators|mesh-ancestor
101317654|NCT00012220|Antimitotic Agents|antimitotic agents|mesh-ancestor
101317655|NCT00012220|Mitosis Modulators|mitosis modulators|mesh-ancestor
101317656|NCT00012220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101317657|NCT00012220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101317658|NCT00012220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317659|NCT00012259|Troxacitabine|troxacitabine|mesh-list
101317660|NCT00012259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317661|NCT00012259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101317662|NCT00012259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101317663|NCT00012259|Antiviral Agents|antiviral agents|mesh-ancestor
101317664|NCT00012259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101317665|NCT00012337|Gefitinib|gefitinib|mesh-list
101317666|NCT00012337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317667|NCT00012337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101317668|NCT00012337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317669|NCT00012337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317670|NCT00012376|Bryostatin 1|bryostatin 1|mesh-list
101317671|NCT00012376|Sargramostim|sargramostim|mesh-list
101317672|NCT00012376|Immunologic Factors|immunologic factors|mesh-ancestor
101317673|NCT00012376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317674|NCT00012376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317675|NCT00012376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101317677|NCT00001266|Antinematodal Agents|antinematodal agents|mesh-ancestor
101317678|NCT00001266|Anthelmintics|anthelmintics|mesh-ancestor
101317679|NCT00001266|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101317681|NCT00001266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317682|NCT00001266|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101317683|NCT00001266|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101317684|NCT00005948|Interferons|interferons|mesh-list
101317685|NCT00005948|Interferon-alpha|interferon-alpha|mesh-list
101317686|NCT00005948|Aldesleukin|aldesleukin|mesh-list
101317687|NCT00005948|Busulfan|busulfan|mesh-list
101317688|NCT00005948|Sargramostim|sargramostim|mesh-list
101317689|NCT00005948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317690|NCT00005948|Antiviral Agents|antiviral agents|mesh-ancestor
101317691|NCT00005948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101317692|NCT00005948|Immunologic Factors|immunologic factors|mesh-ancestor
101317694|NCT00005948|Alkylating Agents|alkylating agents|mesh-ancestor
101317695|NCT00005948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317696|NCT00005948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101263145|NCT01760577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263147|NCT01760577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101263148|NCT01760577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101263149|NCT01760577|Immunologic Factors|immunologic factors|mesh-ancestor
101263150|NCT01760577|Viscosupplements|viscosupplements|mesh-ancestor
101263151|NCT01760577|Protective Agents|protective agents|mesh-ancestor
101263152|NCT01760642|Rifampin|rifampin|mesh-list
101317697|NCT00005948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101317698|NCT00005948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101317699|NCT00005948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101317700|NCT00005948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101317701|NCT00012688|Chlorhexidine|chlorhexidine|mesh-list
101317702|NCT00012688|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101317703|NCT00012688|Doxycycline|doxycycline|mesh-list
101317704|NCT00012688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101317705|NCT00012688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101317706|NCT00012688|Disinfectants|disinfectants|mesh-ancestor
101317707|NCT00012688|Dermatologic Agents|dermatologic agents|mesh-ancestor
101317708|NCT00012688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101317709|NCT00012688|Antimalarials|antimalarials|mesh-ancestor
101317710|NCT00012688|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101317711|NCT00012688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101317712|NCT00005951|Irinotecan|irinotecan|mesh-list
101317713|NCT00005951|Temozolomide|temozolomide|mesh-list
101317714|NCT00005951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101317715|NCT00005951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101317716|NCT00005951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317717|NCT00005951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317718|NCT00005951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317719|NCT00005951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101317720|NCT00005951|Alkylating Agents|alkylating agents|mesh-ancestor
101317721|NCT00001287|Immunoglobulins|immunoglobulins|mesh-list
101317722|NCT00001287|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101317723|NCT00001287|Antibodies|antibodies|mesh-list
101317724|NCT00001287|gamma-Globulins|gamma-globulins|mesh-list
101317725|NCT00001287|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101317726|NCT00001287|Immunologic Factors|immunologic factors|mesh-ancestor
101317727|NCT00001287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317728|NCT00005954|Temozolomide|temozolomide|mesh-list
101317729|NCT00005954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101317730|NCT00005954|Alkylating Agents|alkylating agents|mesh-ancestor
101317731|NCT00005954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317732|NCT00005954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317733|NCT00005960|Cyclophosphamide|cyclophosphamide|mesh-list
101317734|NCT00005960|Docetaxel|docetaxel|mesh-list
101317735|NCT00005960|Doxorubicin|doxorubicin|mesh-list
101317736|NCT00005960|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101317737|NCT00005960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101317738|NCT00005960|Immunologic Factors|immunologic factors|mesh-ancestor
101317739|NCT00005960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317740|NCT00005960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101317741|NCT00005960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101317742|NCT00005960|Alkylating Agents|alkylating agents|mesh-ancestor
101317743|NCT00005960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317744|NCT00005960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317745|NCT00005960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101317746|NCT00005960|Tubulin Modulators|tubulin modulators|mesh-ancestor
101317747|NCT00005960|Antimitotic Agents|antimitotic agents|mesh-ancestor
101317748|NCT00005960|Mitosis Modulators|mitosis modulators|mesh-ancestor
101317749|NCT00005960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101317750|NCT00005960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101317751|NCT00005960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101317752|NCT00005960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317754|NCT00005963|Docetaxel|docetaxel|mesh-list
101317755|NCT00005963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317756|NCT00005963|Tubulin Modulators|tubulin modulators|mesh-ancestor
101317758|NCT00005963|Mitosis Modulators|mitosis modulators|mesh-ancestor
101317759|NCT00005963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317760|NCT00013585|Selegiline|selegiline|mesh-list
101317761|NCT00013585|Antidepressive Agents|antidepressive agents|mesh-ancestor
101263154|NCT01760642|Midazolam|midazolam|mesh-list
101263155|NCT01760642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101263156|NCT01760642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101317762|NCT00013585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101317763|NCT00013585|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101317764|NCT00013585|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101317765|NCT00013585|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101317766|NCT00013585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317767|NCT00013585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317768|NCT00013585|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101317769|NCT00013585|Protective Agents|protective agents|mesh-ancestor
101317770|NCT00013585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317771|NCT00013624|Levodopa|levodopa|mesh-list
101317772|NCT00013624|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101317773|NCT00013624|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101317774|NCT00013624|Dopamine Agents|dopamine agents|mesh-ancestor
101317775|NCT00013624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101317776|NCT00013624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317777|NCT00013624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317778|NCT00013663|Aldesleukin|aldesleukin|mesh-list
101317779|NCT00013663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317780|NCT00013663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101317781|NCT00013663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101317782|NCT00013663|Antiviral Agents|antiviral agents|mesh-ancestor
101317783|NCT00013663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101317785|NCT00013702|Antiviral Agents|antiviral agents|mesh-ancestor
101317786|NCT00013702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101317787|NCT00013702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101317788|NCT00013702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101317789|NCT00013702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317790|NCT00013702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317791|NCT00005966|Interferons|interferons|mesh-list
101317792|NCT00005966|Interferon-alpha|interferon-alpha|mesh-list
101317793|NCT00005966|Thalidomide|thalidomide|mesh-list
101317794|NCT00005966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317795|NCT00005966|Antiviral Agents|antiviral agents|mesh-ancestor
101317796|NCT00005966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101317797|NCT00005966|Immunologic Factors|immunologic factors|mesh-ancestor
101317798|NCT00005966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317799|NCT00005966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101317800|NCT00005966|Leprostatic Agents|leprostatic agents|mesh-ancestor
101317801|NCT00005966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101317802|NCT00005966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101317803|NCT00005966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101317804|NCT00005966|Growth Substances|growth substances|mesh-ancestor
101317805|NCT00005966|Growth Inhibitors|growth inhibitors|mesh-ancestor
101317810|NCT00014014|Lamivudine|lamivudine|mesh-list
101317811|NCT00014014|Zidovudine|zidovudine|mesh-list
101317812|NCT00014014|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101317813|NCT00014014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101317814|NCT00014014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101317815|NCT00014014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317816|NCT00014014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317817|NCT00014014|Antiviral Agents|antiviral agents|mesh-ancestor
101317818|NCT00014014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101317819|NCT00014014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101317820|NCT00014014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101317821|NCT00014014|Antimetabolites|antimetabolites|mesh-ancestor
101317822|NCT00014092|Interferons|interferons|mesh-list
101317823|NCT00014092|Interferon-alpha|interferon-alpha|mesh-list
101317825|NCT00014092|Temozolomide|temozolomide|mesh-list
101317826|NCT00014092|Sargramostim|sargramostim|mesh-list
101317827|NCT00014092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317828|NCT00014092|Antiviral Agents|antiviral agents|mesh-ancestor
101317829|NCT00014092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101317830|NCT00014092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101317831|NCT00014092|Alkylating Agents|alkylating agents|mesh-ancestor
101317832|NCT00014092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317833|NCT00014092|Immunologic Factors|immunologic factors|mesh-ancestor
101317834|NCT00014092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317835|NCT00014092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101317836|NCT00014092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101263157|NCT01760642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101263158|NCT01760642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263160|NCT01760642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101263161|NCT01760642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101263162|NCT01760642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101317837|NCT00005972|Gemcitabine|gemcitabine|mesh-list
101317838|NCT00005972|Irinotecan|irinotecan|mesh-list
101317839|NCT00005972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101317841|NCT00005972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317842|NCT00005972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317843|NCT00005972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101317844|NCT00005972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101317845|NCT00005972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317846|NCT00014170|Gefitinib|gefitinib|mesh-list
101317847|NCT00014170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317848|NCT00014170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101317850|NCT00014170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317851|NCT00014209|Dexamethasone|dexamethasone|mesh-list
101317852|NCT00014209|Gemcitabine|gemcitabine|mesh-list
101317853|NCT00014209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101317854|NCT00014209|Antiemetics|antiemetics|mesh-ancestor
101317855|NCT00014209|Autonomic Agents|autonomic agents|mesh-ancestor
101317856|NCT00014209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101317857|NCT00014209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317858|NCT00014209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101317859|NCT00014209|Glucocorticoids|glucocorticoids|mesh-ancestor
101317860|NCT00014209|Hormones|hormones|mesh-ancestor
101317861|NCT00014209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101317862|NCT00014209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101317863|NCT00014209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317864|NCT00014209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101317865|NCT00014209|Antimetabolites|antimetabolites|mesh-ancestor
101317869|NCT00014248|Sensory System Agents|sensory system agents|mesh-ancestor
101317870|NCT00014248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101317871|NCT00014248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317872|NCT00014248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101317874|NCT00014248|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101317875|NCT00014248|Purinergic Agonists|purinergic agonists|mesh-ancestor
101317876|NCT00014248|Purinergic Agents|purinergic agents|mesh-ancestor
101317877|NCT00014248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101317878|NCT00014248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317879|NCT00005975|Megestrol|megestrol|mesh-list
101317880|NCT00005975|Megestrol Acetate|megestrol acetate|mesh-list
101317881|NCT00005975|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101317882|NCT00005975|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101317883|NCT00005975|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101317884|NCT00005975|Contraceptive Agents|contraceptive agents|mesh-ancestor
101317885|NCT00005975|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101410775|NCT00446836|Antimitotic Agents|antimitotic agents|mesh-ancestor
101317887|NCT00005975|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101317888|NCT00005975|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101329850|NCT00028327|Protease Inhibitors|protease inhibitors|mesh-ancestor
101317889|NCT00005975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101317890|NCT00005975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317892|NCT00005975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101317893|NCT00014287|Gemcitabine|gemcitabine|mesh-list
101317894|NCT00014287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101317895|NCT00014287|Antimetabolites|antimetabolites|mesh-ancestor
101317896|NCT00014287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317897|NCT00014287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317898|NCT02971930|Factor VIII|factor viii|mesh-list
101317899|NCT02971930|Coagulants|coagulants|mesh-ancestor
101317900|NCT00005978|Carboplatin|carboplatin|mesh-list
101317901|NCT00005978|Etoposide|etoposide|mesh-list
101317902|NCT00005978|Melphalan|melphalan|mesh-list
101317903|NCT00005978|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
101263163|NCT01760642|Anesthetics, General|anesthetics, general|mesh-ancestor
101263164|NCT01760642|Anesthetics|anesthetics|mesh-ancestor
101263165|NCT01760642|GABA Modulators|gaba modulators|mesh-ancestor
101263166|NCT01760642|GABA Agents|gaba agents|mesh-ancestor
101263167|NCT01760642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101263168|NCT01760642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263169|NCT01760642|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101317904|NCT00005978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317905|NCT00005978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101317906|NCT00005978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101317907|NCT00005978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101317908|NCT00005978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317909|NCT00005978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317910|NCT00005978|Immunologic Factors|immunologic factors|mesh-ancestor
101317911|NCT00005978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317912|NCT00005978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101317913|NCT00005978|Alkylating Agents|alkylating agents|mesh-ancestor
101317914|NCT00005978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101317915|NCT00005978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101317916|NCT00005978|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101317918|NCT00014404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101317919|NCT00014404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101317920|NCT00014404|Analgesics|analgesics|mesh-ancestor
101317921|NCT00014404|Sensory System Agents|sensory system agents|mesh-ancestor
101317922|NCT00014404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101317923|NCT00014404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317924|NCT00014404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101317927|NCT00014404|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101317928|NCT00014404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317929|NCT00014404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317931|NCT00001332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317932|NCT00014599|Paclitaxel|paclitaxel|mesh-list
101317933|NCT00014599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101317934|NCT00014599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317935|NCT00014599|Tubulin Modulators|tubulin modulators|mesh-ancestor
101317936|NCT00014599|Antimitotic Agents|antimitotic agents|mesh-ancestor
101317938|NCT00014599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317939|NCT00005981|Carmustine|carmustine|mesh-list
101317940|NCT00005981|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
101317941|NCT00005981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101317942|NCT00005981|Alkylating Agents|alkylating agents|mesh-ancestor
101317943|NCT00005981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317944|NCT00005981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317945|NCT00005981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317946|NCT00014638|Letrozole|letrozole|mesh-list
101317947|NCT00014638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317948|NCT00014638|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101317949|NCT00014638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101317950|NCT00014638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317951|NCT00014638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317952|NCT00014638|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101317953|NCT00014638|Hormone Antagonists|hormone antagonists|mesh-ancestor
101317954|NCT00014638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101317955|NCT00014638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317956|NCT00001341|Raltitrexed|raltitrexed|mesh-list
101317957|NCT00001341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101317958|NCT00001341|Antimetabolites|antimetabolites|mesh-ancestor
101329856|NCT00028366|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101317959|NCT00001341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317960|NCT00001341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317961|NCT00001341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101317962|NCT00001341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317963|NCT00014677|Interleukin-4|interleukin-4|mesh-list
101317964|NCT00014677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101317965|NCT00014677|Immunologic Factors|immunologic factors|mesh-ancestor
101263170|NCT01760642|Antitubercular Agents|antitubercular agents|mesh-ancestor
101263171|NCT01760642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101263172|NCT01760642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101263173|NCT01760642|Leprostatic Agents|leprostatic agents|mesh-ancestor
101263174|NCT01760642|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101263175|NCT01760642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317966|NCT00014677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317967|NCT00014677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317968|NCT00014677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101317969|NCT00391534|Oxcarbazepine|oxcarbazepine|mesh-list
101317970|NCT00391534|Anticonvulsants|anticonvulsants|mesh-ancestor
101317971|NCT00391534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101317972|NCT00391534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101317973|NCT00391534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101317975|NCT00391534|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101317976|NCT00391534|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101317978|NCT00005984|Interferon-alpha|interferon-alpha|mesh-list
101317979|NCT00005984|Cyclophosphamide|cyclophosphamide|mesh-list
101317980|NCT00005984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101317981|NCT00005984|Immunologic Factors|immunologic factors|mesh-ancestor
101317982|NCT00005984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317983|NCT00005984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101317984|NCT00005984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101317985|NCT00005984|Alkylating Agents|alkylating agents|mesh-ancestor
101317986|NCT00005984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317987|NCT00005984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317988|NCT00005984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101317989|NCT00005984|Antiviral Agents|antiviral agents|mesh-ancestor
101317990|NCT00005984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101317991|NCT00391651|Nitrofurantoin|nitrofurantoin|mesh-list
101317992|NCT00391651|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101317993|NCT00391651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101317994|NCT00391651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101317995|NCT00391690|Zoledronic Acid|zoledronic acid|mesh-list
101317996|NCT00391690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101317997|NCT00391690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317998|NCT00005987|Interferons|interferons|mesh-list
101317999|NCT00005987|Interferon-alpha|interferon-alpha|mesh-list
101318000|NCT00005987|Dexamethasone|dexamethasone|mesh-list
101318001|NCT00005987|Cyclophosphamide|cyclophosphamide|mesh-list
101318003|NCT00005987|Etoposide|etoposide|mesh-list
101318004|NCT00005987|Mitoxantrone|mitoxantrone|mesh-list
101318005|NCT00005987|Sargramostim|sargramostim|mesh-list
101318006|NCT00005987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101318007|NCT00005987|Immunologic Factors|immunologic factors|mesh-ancestor
101318008|NCT00005987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318009|NCT00005987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101318010|NCT00005987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101318011|NCT00005987|Alkylating Agents|alkylating agents|mesh-ancestor
101318012|NCT00005987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318013|NCT00005987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318014|NCT00005987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101318015|NCT00005987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101318016|NCT00005987|Antiemetics|antiemetics|mesh-ancestor
101318017|NCT00005987|Autonomic Agents|autonomic agents|mesh-ancestor
101318018|NCT00005987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101318019|NCT00005987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101318020|NCT00005987|Glucocorticoids|glucocorticoids|mesh-ancestor
101318021|NCT00005987|Hormones|hormones|mesh-ancestor
101318022|NCT00005987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101318023|NCT00005987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101318024|NCT00005987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101318025|NCT00005987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101318026|NCT00005987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101318027|NCT00005987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101318028|NCT00005987|Antiviral Agents|antiviral agents|mesh-ancestor
101318029|NCT00005987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101263176|NCT01760642|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101263177|NCT01760642|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101263178|NCT01760642|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101263179|NCT01760642|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101318030|NCT00005987|Analgesics|analgesics|mesh-ancestor
101318031|NCT00005987|Sensory System Agents|sensory system agents|mesh-ancestor
101318032|NCT00014755|Prednisone|prednisone|mesh-list
101318033|NCT00014755|Cyclophosphamide|cyclophosphamide|mesh-list
101318034|NCT00014755|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101318039|NCT00014755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101318040|NCT00014755|Alkylating Agents|alkylating agents|mesh-ancestor
101318041|NCT00014755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318043|NCT00014755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101318044|NCT00014755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101318045|NCT00014755|Glucocorticoids|glucocorticoids|mesh-ancestor
101318047|NCT00014755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101318048|NCT00014755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101318049|NCT00005990|Topotecan|topotecan|mesh-list
101318050|NCT00005990|Tipifarnib|tipifarnib|mesh-list
101318051|NCT00005990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101318052|NCT00005990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101318053|NCT00005990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101318054|NCT00005990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318055|NCT00005990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318056|NCT00001344|Dextromethorphan|dextromethorphan|mesh-list
101318057|NCT00001344|Antitussive Agents|antitussive agents|mesh-ancestor
101318058|NCT00001344|Respiratory System Agents|respiratory system agents|mesh-ancestor
101318059|NCT00001344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101318060|NCT00001344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101318061|NCT00001344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101318062|NCT00001344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318063|NCT00001344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318064|NCT00014989|Magnesium Sulfate|magnesium sulfate|mesh-list
101318065|NCT00014989|Analgesics|analgesics|mesh-ancestor
101318067|NCT00014989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101318068|NCT00014989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318070|NCT00014989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101318071|NCT00014989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101318072|NCT00014989|Anticonvulsants|anticonvulsants|mesh-ancestor
101318073|NCT00014989|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101318074|NCT00014989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101318075|NCT00014989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318076|NCT00014989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101318077|NCT00014989|Tocolytic Agents|tocolytic agents|mesh-ancestor
101318078|NCT00014989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101318079|NCT00005993|Aldesleukin|aldesleukin|mesh-list
101318080|NCT00005993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318081|NCT00005993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101318082|NCT00005993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101318083|NCT00005993|Antiviral Agents|antiviral agents|mesh-ancestor
101318084|NCT00005993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101318086|NCT00015028|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101318087|NCT00015028|Naloxone|naloxone|mesh-list
101318088|NCT00015028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101318089|NCT00015028|Narcotics|narcotics|mesh-ancestor
101318090|NCT00015028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101318091|NCT00015028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318092|NCT00015028|Analgesics|analgesics|mesh-ancestor
101318093|NCT00015028|Sensory System Agents|sensory system agents|mesh-ancestor
101318094|NCT00015028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101318095|NCT00015028|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101318097|NCT00015067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101318098|NCT00015067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318099|NCT00015067|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101318100|NCT00015067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101263180|NCT01760642|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101263181|NCT01760642|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101263183|NCT01760642|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101263184|NCT01760642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101318101|NCT00015067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101318102|NCT00015067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318104|NCT00015067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101318105|NCT00015106|Lamotrigine|lamotrigine|mesh-list
101318106|NCT00015106|Anticonvulsants|anticonvulsants|mesh-ancestor
101318107|NCT00015106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101318108|NCT00015106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101318109|NCT00015106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318110|NCT00015106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101318111|NCT00015106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318112|NCT00015106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101318113|NCT00015106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101318114|NCT00015106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101318115|NCT00015106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101318116|NCT00015106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101318117|NCT00005996|Gemcitabine|gemcitabine|mesh-list
101318118|NCT00005996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318119|NCT00005996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101318120|NCT00005996|Antimetabolites|antimetabolites|mesh-ancestor
101318121|NCT00005996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318122|NCT00001359|Penicillins|penicillins|mesh-list
101318123|NCT00001359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101318124|NCT00001359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101318125|NCT00015223|Methylphenidate|methylphenidate|mesh-list
101318126|NCT00015223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101318127|NCT00015223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318128|NCT00015223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101318129|NCT00015223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101318130|NCT00015223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101318131|NCT00015223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318132|NCT00015223|Dopamine Agents|dopamine agents|mesh-ancestor
101318133|NCT00015223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101318134|NCT00015301|Methylphenidate|methylphenidate|mesh-list
101318135|NCT00015301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101318136|NCT00015301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318137|NCT00015301|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101318138|NCT00015301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101318139|NCT00015301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101318140|NCT00015301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318142|NCT00015301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101318143|NCT00015340|Buprenorphine|buprenorphine|mesh-list
101318145|NCT00015340|Naloxone|naloxone|mesh-list
101318146|NCT00015340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101318147|NCT00015340|Narcotics|narcotics|mesh-ancestor
101318148|NCT00015340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101318149|NCT00015340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318150|NCT00015340|Analgesics|analgesics|mesh-ancestor
101318151|NCT00015340|Sensory System Agents|sensory system agents|mesh-ancestor
101318152|NCT00015340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101318153|NCT00015340|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101318156|NCT00015652|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101318157|NCT00015652|Antimetabolites|antimetabolites|mesh-ancestor
101318158|NCT00015652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318159|NCT00015652|Antiviral Agents|antiviral agents|mesh-ancestor
101318160|NCT00015652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101318161|NCT00015652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318162|NCT00015652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101318163|NCT00015652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101318164|NCT00005999|Arsenic Trioxide|arsenic trioxide|mesh-list
101263185|NCT01760642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101263186|NCT01760642|Hormone Antagonists|hormone antagonists|mesh-ancestor
101263187|NCT01760642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101263188|NCT01760642|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101263189|NCT01760694|Leucovorin|leucovorin|mesh-list
101263190|NCT01760694|Oxaliplatin|oxaliplatin|mesh-list
101263191|NCT01760694|Irinotecan|irinotecan|mesh-list
101263192|NCT01760694|Folfirinox|folfirinox|mesh-list
101318165|NCT00005999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318166|NCT00015691|Metformin|metformin|mesh-list
101318167|NCT00015691|Rosiglitazone|rosiglitazone|mesh-list
101318168|NCT00015691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101318169|NCT00015691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318170|NCT00015769|Levetiracetam|levetiracetam|mesh-list
101318171|NCT00015769|Anticonvulsants|anticonvulsants|mesh-ancestor
101318172|NCT00015769|Nootropic Agents|nootropic agents|mesh-ancestor
101318173|NCT00015808|Idebenone|idebenone|mesh-list
101318174|NCT00015808|Antioxidants|antioxidants|mesh-ancestor
101318175|NCT00015808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318176|NCT00015808|Protective Agents|protective agents|mesh-ancestor
101318177|NCT00015808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318178|NCT00015886|Docetaxel|docetaxel|mesh-list
101318179|NCT00015886|Fluorouracil|fluorouracil|mesh-list
101318180|NCT00015886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318181|NCT00015886|Tubulin Modulators|tubulin modulators|mesh-ancestor
101318182|NCT00015886|Antimitotic Agents|antimitotic agents|mesh-ancestor
101318183|NCT00015886|Mitosis Modulators|mitosis modulators|mesh-ancestor
101318184|NCT00015886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318185|NCT00015886|Antimetabolites|antimetabolites|mesh-ancestor
101318186|NCT00015886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101318187|NCT00015886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101318188|NCT00015886|Immunologic Factors|immunologic factors|mesh-ancestor
101318189|NCT00015886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318190|NCT00006002|Dexamethasone|dexamethasone|mesh-list
101318191|NCT00006002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101318192|NCT00006002|Antiemetics|antiemetics|mesh-ancestor
101318193|NCT00006002|Autonomic Agents|autonomic agents|mesh-ancestor
101318194|NCT00006002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101318195|NCT00006002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318196|NCT00006002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101318197|NCT00006002|Glucocorticoids|glucocorticoids|mesh-ancestor
101318199|NCT00006002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101318200|NCT00006002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101318201|NCT00006002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318202|NCT00001365|Dextromethorphan|dextromethorphan|mesh-list
101318203|NCT00001365|Antitussive Agents|antitussive agents|mesh-ancestor
101318204|NCT00001365|Respiratory System Agents|respiratory system agents|mesh-ancestor
101318205|NCT00001365|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101318206|NCT00001365|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101318207|NCT00001365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101318208|NCT00001365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318209|NCT00001365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318210|NCT00015925|Entinostat|entinostat|mesh-list
101318211|NCT00015925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318212|NCT00015925|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101318213|NCT00015925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101318215|NCT00006005|Thalidomide|thalidomide|mesh-list
101318216|NCT00006005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101318217|NCT00006005|Immunologic Factors|immunologic factors|mesh-ancestor
101318218|NCT00006005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318219|NCT00006005|Leprostatic Agents|leprostatic agents|mesh-ancestor
101318220|NCT00006005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101318221|NCT00006005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101318222|NCT00006005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101318223|NCT00006005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101318224|NCT00006005|Growth Substances|growth substances|mesh-ancestor
101263193|NCT01760694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101263194|NCT01760694|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101263195|NCT01760694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101263196|NCT01760694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101318225|NCT00006005|Growth Inhibitors|growth inhibitors|mesh-ancestor
101318226|NCT00006005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318228|NCT00015964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318229|NCT00015964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101318230|NCT00015964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101318231|NCT00015964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318232|NCT01630213|Vitamin D|vitamin d|mesh-list
101318233|NCT01630213|Ergocalciferols|ergocalciferols|mesh-list
101318234|NCT01630213|Cholecalciferol|cholecalciferol|mesh-list
101318235|NCT01630213|Vitamins|vitamins|mesh-list
101318236|NCT01630213|Micronutrients|micronutrients|mesh-ancestor
101318237|NCT01630213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318238|NCT01630213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101318239|NCT01630213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101318240|NCT00006008|Arsenic Trioxide|arsenic trioxide|mesh-list
101318241|NCT00006008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318243|NCT00016042|Interferon-alpha|interferon-alpha|mesh-list
101318244|NCT00016042|Fluorouracil|fluorouracil|mesh-list
101318245|NCT00016042|Sargramostim|sargramostim|mesh-list
101318246|NCT00016042|Antimetabolites|antimetabolites|mesh-ancestor
101318247|NCT00016042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318248|NCT00016042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101318249|NCT00016042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318250|NCT00016042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101318251|NCT00016042|Immunologic Factors|immunologic factors|mesh-ancestor
101318252|NCT00016042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318253|NCT00016042|Antiviral Agents|antiviral agents|mesh-ancestor
101318254|NCT00016042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101318255|NCT00016081|Ribavirin|ribavirin|mesh-list
101318256|NCT00016081|Antimetabolites|antimetabolites|mesh-ancestor
101318257|NCT00016081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318258|NCT00016081|Antiviral Agents|antiviral agents|mesh-ancestor
101318259|NCT00016081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101318260|NCT00016159|Idarubicin|idarubicin|mesh-list
101318261|NCT00016159|Arsenic Trioxide|arsenic trioxide|mesh-list
101318262|NCT00016159|Tretinoin|tretinoin|mesh-list
101318263|NCT00016159|Lintuzumab|lintuzumab|mesh-list
101318264|NCT00016159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101318265|NCT00016159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318266|NCT00016159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101318267|NCT00016159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101318268|NCT00016159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101318269|NCT00016159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318271|NCT00016159|Dermatologic Agents|dermatologic agents|mesh-ancestor
101318272|NCT00016159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101318274|NCT00016198|Fluorouracil|fluorouracil|mesh-list
101318275|NCT00016198|Oxaliplatin|oxaliplatin|mesh-list
101318276|NCT00016198|Calcium|calcium|mesh-list
101318277|NCT00016198|Levoleucovorin|levoleucovorin|mesh-list
101318278|NCT00016198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101318279|NCT00016198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318280|NCT00016198|Antimetabolites|antimetabolites|mesh-ancestor
101318281|NCT00016198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318282|NCT00016198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101318283|NCT00016198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318284|NCT00016198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101318285|NCT00016198|Immunologic Factors|immunologic factors|mesh-ancestor
101318286|NCT00016198|Antidotes|antidotes|mesh-ancestor
101318287|NCT00016198|Protective Agents|protective agents|mesh-ancestor
101318288|NCT00016198|Vitamin B Complex|vitamin b complex|mesh-ancestor
101318289|NCT00016198|Vitamins|vitamins|mesh-ancestor
101318290|NCT00016198|Micronutrients|micronutrients|mesh-ancestor
101318291|NCT00016276|Tamoxifen|tamoxifen|mesh-list
101318292|NCT00016276|Paclitaxel|paclitaxel|mesh-list
101318293|NCT00016276|Razoxane|razoxane|mesh-list
101318294|NCT00016276|Cyclophosphamide|cyclophosphamide|mesh-list
101318295|NCT00016276|Doxorubicin|doxorubicin|mesh-list
101263197|NCT01760694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263198|NCT01760694|Antidotes|antidotes|mesh-ancestor
101263199|NCT01760694|Protective Agents|protective agents|mesh-ancestor
101328281|NCT00000146|Prednisone|prednisone|mesh-list
101263200|NCT01760694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318296|NCT00016276|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101318297|NCT00016276|Trastuzumab|trastuzumab|mesh-list
101318298|NCT00016276|Dexrazoxane|dexrazoxane|mesh-list
101318299|NCT00016276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101318300|NCT00016276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318301|NCT00016276|Tubulin Modulators|tubulin modulators|mesh-ancestor
101318302|NCT00016276|Antimitotic Agents|antimitotic agents|mesh-ancestor
101318303|NCT00016276|Mitosis Modulators|mitosis modulators|mesh-ancestor
101318304|NCT00016276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318305|NCT00016276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101318306|NCT00016276|Immunologic Factors|immunologic factors|mesh-ancestor
101318307|NCT00016276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318308|NCT00016276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101318309|NCT00016276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101318310|NCT00016276|Alkylating Agents|alkylating agents|mesh-ancestor
101318311|NCT00016276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101318312|NCT00016276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101318313|NCT00016276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101318314|NCT00016276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101318315|NCT00016276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101318316|NCT00016276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101318317|NCT00016276|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101318318|NCT00016276|Hormone Antagonists|hormone antagonists|mesh-ancestor
101318319|NCT00016276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101318320|NCT00016276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101318321|NCT00016276|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101318322|NCT00016276|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101318323|NCT00016276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101318324|NCT00016276|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101318325|NCT00016276|Protective Agents|protective agents|mesh-ancestor
101318326|NCT00016315|Paclitaxel|paclitaxel|mesh-list
101318327|NCT00016315|Carboplatin|carboplatin|mesh-list
101318328|NCT00016315|Gemcitabine|gemcitabine|mesh-list
101318334|NCT00016315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318335|NCT00016315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101318338|NCT00006014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101318339|NCT00006014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101318340|NCT00006014|Growth Substances|growth substances|mesh-ancestor
101318341|NCT00006014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318342|NCT00006014|Growth Inhibitors|growth inhibitors|mesh-ancestor
101318343|NCT00006014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318344|NCT00006014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101318345|NCT00006014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101318346|NCT00006014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318348|NCT00016432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318349|NCT00016432|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101318350|NCT00016432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101318351|NCT00016432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101318352|NCT00016432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318353|NCT00016432|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101318354|NCT00016432|Hormone Antagonists|hormone antagonists|mesh-ancestor
101318355|NCT00016432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101318356|NCT00016432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318357|NCT00389376|Silymarin|silymarin|mesh-list
101318358|NCT00389376|Antioxidants|antioxidants|mesh-ancestor
101263201|NCT01760694|Vitamin B Complex|vitamin b complex|mesh-ancestor
101263203|NCT01760694|Micronutrients|micronutrients|mesh-ancestor
101263204|NCT01760746|Bevacizumab|bevacizumab|mesh-list
101263205|NCT01760746|Ranibizumab|ranibizumab|mesh-list
101318359|NCT00389376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318360|NCT00389376|Protective Agents|protective agents|mesh-ancestor
101318361|NCT00389376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318362|NCT00016549|Bevacizumab|bevacizumab|mesh-list
101318363|NCT00016549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101318364|NCT00016549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318365|NCT00016549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101318366|NCT00016549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101318367|NCT00016549|Growth Substances|growth substances|mesh-ancestor
101318368|NCT00016549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318369|NCT00016549|Growth Inhibitors|growth inhibitors|mesh-ancestor
101318370|NCT00006023|Capecitabine|capecitabine|mesh-list
101318371|NCT00006023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101318372|NCT00006023|Antimetabolites|antimetabolites|mesh-ancestor
101318373|NCT00006023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318374|NCT00006023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318375|NCT00016588|Tenofovir|tenofovir|mesh-list
101318376|NCT00016588|Antiviral Agents|antiviral agents|mesh-ancestor
101318377|NCT00016588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101318378|NCT00016588|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101318379|NCT00016588|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101318381|NCT00016588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318382|NCT00016588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101318383|NCT00016588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101318385|NCT00006026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318386|NCT00006026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101318387|NCT00006026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101318388|NCT00006026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101318389|NCT00006026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318391|NCT00016666|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101318392|NCT00016666|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101318393|NCT00016666|Adrenergic Agents|adrenergic agents|mesh-ancestor
101318394|NCT00016666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101318395|NCT00016666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318396|NCT00016666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318397|NCT00016666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101318398|NCT00016666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101318399|NCT00016666|Vasodilator Agents|vasodilator agents|mesh-ancestor
101318400|NCT00016744|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
101318401|NCT00016744|Genistein|genistein|mesh-list
101318402|NCT00016744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318403|NCT00016744|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101318405|NCT00016744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318406|NCT00016744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101318407|NCT00016744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101318408|NCT00016744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318409|NCT00016744|Phytoestrogens|phytoestrogens|mesh-ancestor
101318410|NCT00016744|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101318411|NCT00016744|Estrogens|estrogens|mesh-ancestor
101318412|NCT00016744|Hormones|hormones|mesh-ancestor
101318413|NCT00016744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101318414|NCT00016861|Irinotecan|irinotecan|mesh-list
101318415|NCT00016861|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101318416|NCT00016861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101318418|NCT00016861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318419|NCT00016861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318421|NCT00016900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101318422|NCT00016900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318423|NCT00016900|Tubulin Modulators|tubulin modulators|mesh-ancestor
101318424|NCT00016900|Antimitotic Agents|antimitotic agents|mesh-ancestor
101318425|NCT00016900|Mitosis Modulators|mitosis modulators|mesh-ancestor
101318426|NCT00016900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318427|NCT00016939|Alvocidib|alvocidib|mesh-list
101318428|NCT00016939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318430|NCT00016939|Growth Substances|growth substances|mesh-ancestor
101318431|NCT00016939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263206|NCT01760746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101263207|NCT01760746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101263208|NCT01760746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101263209|NCT01760746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101263210|NCT01760746|Growth Substances|growth substances|mesh-ancestor
101318432|NCT00016939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101318434|NCT00016939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318435|NCT00386672|Calcium, Dietary|calcium, dietary|mesh-list
101318437|NCT00386672|Ergocalciferols|ergocalciferols|mesh-list
101318438|NCT00386672|Cholecalciferol|cholecalciferol|mesh-list
101318439|NCT00386672|Vitamins|vitamins|mesh-list
101318440|NCT00386672|Calcium|calcium|mesh-list
101318441|NCT00386672|Micronutrients|micronutrients|mesh-ancestor
101318442|NCT00386672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318443|NCT00386672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101318444|NCT00386672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101318445|NCT00016978|Leucovorin|leucovorin|mesh-list
101318447|NCT00016978|Oxaliplatin|oxaliplatin|mesh-list
101318448|NCT00016978|Calcium|calcium|mesh-list
101318449|NCT00016978|Levoleucovorin|levoleucovorin|mesh-list
101318450|NCT00016978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101318451|NCT00016978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318452|NCT00016978|Antimetabolites|antimetabolites|mesh-ancestor
101318453|NCT00016978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329887|NCT00012207|Hormones|hormones|mesh-ancestor
101318454|NCT00016978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101318455|NCT00016978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318456|NCT00016978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101318457|NCT00016978|Immunologic Factors|immunologic factors|mesh-ancestor
101318458|NCT00016978|Antidotes|antidotes|mesh-ancestor
101318459|NCT00016978|Protective Agents|protective agents|mesh-ancestor
101318460|NCT00016978|Vitamin B Complex|vitamin b complex|mesh-ancestor
101318461|NCT00016978|Vitamins|vitamins|mesh-ancestor
101318462|NCT00016978|Micronutrients|micronutrients|mesh-ancestor
101318463|NCT00017017|Paclitaxel|paclitaxel|mesh-list
101318464|NCT00017017|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
101318465|NCT00017017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101318466|NCT00017017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318467|NCT00017017|Tubulin Modulators|tubulin modulators|mesh-ancestor
101318468|NCT00017017|Antimitotic Agents|antimitotic agents|mesh-ancestor
101318469|NCT00017017|Mitosis Modulators|mitosis modulators|mesh-ancestor
101318470|NCT00017017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318471|NCT00017095|Cyclophosphamide|cyclophosphamide|mesh-list
101318472|NCT00017095|Docetaxel|docetaxel|mesh-list
101318473|NCT00017095|Fluorouracil|fluorouracil|mesh-list
101318474|NCT00017095|Epirubicin|epirubicin|mesh-list
101318475|NCT00017095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101318476|NCT00017095|Immunologic Factors|immunologic factors|mesh-ancestor
101318477|NCT00017095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318478|NCT00017095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101318479|NCT00017095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101318480|NCT00017095|Alkylating Agents|alkylating agents|mesh-ancestor
101318481|NCT00017095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318482|NCT00017095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318483|NCT00017095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101318484|NCT00017095|Tubulin Modulators|tubulin modulators|mesh-ancestor
101318485|NCT00017095|Antimitotic Agents|antimitotic agents|mesh-ancestor
101318486|NCT00017095|Mitosis Modulators|mitosis modulators|mesh-ancestor
101318487|NCT00017095|Antimetabolites|antimetabolites|mesh-ancestor
101318488|NCT00017095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101318489|NCT00017095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101318490|NCT00017095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101318491|NCT00017095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101318492|NCT00017095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101318493|NCT00006029|Gemcitabine|gemcitabine|mesh-list
101318495|NCT00006029|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101318496|NCT00006029|Vinorelbine|vinorelbine|mesh-list
101318497|NCT00006029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101263211|NCT01760746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263212|NCT01760746|Growth Inhibitors|growth inhibitors|mesh-ancestor
101263213|NCT01760798|Teriparatide|teriparatide|mesh-list
101263214|NCT01760798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101263215|NCT01760798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263216|NCT01760798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101263217|NCT01760811|Cetuximab|cetuximab|mesh-list
101263218|NCT01760811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101263219|NCT01760811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101263220|NCT01760824|Amoxicillin|amoxicillin|mesh-list
101263221|NCT01760824|Metronidazole|metronidazole|mesh-list
101263222|NCT01760824|Clarithromycin|clarithromycin|mesh-list
101263223|NCT01760824|Tetracycline|tetracycline|mesh-list
101263224|NCT01760824|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
101263225|NCT01760824|Esomeprazole|esomeprazole|mesh-list
101263226|NCT01760824|Bismuth|bismuth|mesh-list
101263227|NCT01760824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101263228|NCT01760824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101263229|NCT01760824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101263230|NCT01760824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101318498|NCT00006029|Antimetabolites|antimetabolites|mesh-ancestor
101318499|NCT00006029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318500|NCT00006029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318501|NCT00006029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101318502|NCT00006029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101318503|NCT00006029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101318504|NCT00006029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101318505|NCT00006029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101318506|NCT00006029|Tubulin Modulators|tubulin modulators|mesh-ancestor
101318507|NCT00006029|Antimitotic Agents|antimitotic agents|mesh-ancestor
101318508|NCT00006029|Mitosis Modulators|mitosis modulators|mesh-ancestor
101318510|NCT00371059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101318512|NCT00371059|Dopamine Agents|dopamine agents|mesh-ancestor
101318513|NCT00371059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101318514|NCT00371059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318515|NCT00371059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318516|NCT00371059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101318517|NCT00371059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101318518|NCT00001482|Lamotrigine|lamotrigine|mesh-list
101318519|NCT00001482|Gabapentin|gabapentin|mesh-list
101318520|NCT00001482|Analgesics|analgesics|mesh-ancestor
101318521|NCT00001482|Sensory System Agents|sensory system agents|mesh-ancestor
101318522|NCT00001482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101318523|NCT00001482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318524|NCT00001482|Anticonvulsants|anticonvulsants|mesh-ancestor
101318525|NCT00001482|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101318526|NCT00001482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101318527|NCT00001482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101329894|NCT00012207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101318528|NCT00001482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101318529|NCT00001482|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101318530|NCT00001482|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101318531|NCT00001482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101318532|NCT00001482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318533|NCT00001482|Antimanic Agents|antimanic agents|mesh-ancestor
101263231|NCT01760824|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101263232|NCT01760824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101263233|NCT01760824|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101263234|NCT01760824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101318534|NCT00001482|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101318535|NCT00001482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101318536|NCT00001482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101318537|NCT00001482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101318538|NCT00001482|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101318539|NCT00017134|Fenretinide|fenretinide|mesh-list
101318540|NCT00017134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318541|NCT00017134|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101318542|NCT00017134|Protective Agents|protective agents|mesh-ancestor
101318543|NCT00017134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318544|NCT04734418|Dexmedetomidine|dexmedetomidine|mesh-list
101318545|NCT04734418|Remifentanil|remifentanil|mesh-list
101318546|NCT04734418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101318547|NCT04734418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101318548|NCT04734418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318549|NCT04734418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101318550|NCT04734418|Analgesics|analgesics|mesh-ancestor
101318551|NCT04734418|Sensory System Agents|sensory system agents|mesh-ancestor
101318552|NCT04734418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101318553|NCT04734418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101318554|NCT04734418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101318555|NCT04734418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101318556|NCT04734418|Adrenergic Agents|adrenergic agents|mesh-ancestor
101318557|NCT04734418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101318558|NCT04734418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318559|NCT04734418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101318560|NCT04734418|Narcotics|narcotics|mesh-ancestor
101318561|NCT00006032|Etoposide|etoposide|mesh-list
101318564|NCT00006032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101318565|NCT00006032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318566|NCT00006032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101318567|NCT00006032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101318568|NCT00006032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101318569|NCT00006032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318570|NCT00006032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101318571|NCT00006032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101318572|NCT00006032|Alkylating Agents|alkylating agents|mesh-ancestor
101318573|NCT00017173|Cisplatin|cisplatin|mesh-list
101318574|NCT00017173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318575|NCT00001509|Tretinoin|tretinoin|mesh-list
101318576|NCT00001509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318577|NCT00001509|Keratolytic Agents|keratolytic agents|mesh-ancestor
101318578|NCT00001509|Dermatologic Agents|dermatologic agents|mesh-ancestor
101318580|NCT00006035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101318581|NCT00006035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318582|NCT00017212|Exatecan|exatecan|mesh-list
101318583|NCT00017212|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101318584|NCT00017212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101318585|NCT00017212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101318586|NCT00017212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318587|NCT00017212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318588|NCT00017251|Carboplatin|carboplatin|mesh-list
101318589|NCT00017251|Etoposide|etoposide|mesh-list
101318590|NCT00017251|Etoposide phosphate|etoposide phosphate|mesh-list
101318591|NCT00017251|Oblimersen|oblimersen|mesh-list
101318592|NCT00017251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318593|NCT00017251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101318594|NCT00017251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101318595|NCT00017251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101318596|NCT00017251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101329898|NCT00028483|Docetaxel|docetaxel|mesh-list
101318597|NCT00017251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318598|NCT00006038|Leucovorin|leucovorin|mesh-list
101318599|NCT00006038|Docetaxel|docetaxel|mesh-list
101318600|NCT00006038|Fluorouracil|fluorouracil|mesh-list
101318601|NCT00006038|Floxuridine|floxuridine|mesh-list
101318602|NCT00006038|Calcium|calcium|mesh-list
101263235|NCT01760824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263236|NCT01760824|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101263237|NCT01760824|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101263238|NCT01760824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101263239|NCT01760824|Antacids|antacids|mesh-ancestor
101263240|NCT01760863|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101263241|NCT01760863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101263242|NCT01760967|Dexmedetomidine|dexmedetomidine|mesh-list
101263243|NCT01760967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101263244|NCT01760967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101263245|NCT01760967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318603|NCT00006038|Levoleucovorin|levoleucovorin|mesh-list
101318604|NCT00006038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318605|NCT00006038|Tubulin Modulators|tubulin modulators|mesh-ancestor
101318606|NCT00006038|Antimitotic Agents|antimitotic agents|mesh-ancestor
101318607|NCT00006038|Mitosis Modulators|mitosis modulators|mesh-ancestor
101318608|NCT00006038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318609|NCT00006038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101318610|NCT00006038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318611|NCT00006038|Antimetabolites|antimetabolites|mesh-ancestor
101318612|NCT00006038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101318613|NCT00006038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101318614|NCT00006038|Immunologic Factors|immunologic factors|mesh-ancestor
101318615|NCT00006038|Antidotes|antidotes|mesh-ancestor
101318616|NCT00006038|Protective Agents|protective agents|mesh-ancestor
101318617|NCT00006038|Vitamin B Complex|vitamin b complex|mesh-ancestor
101318618|NCT00006038|Vitamins|vitamins|mesh-ancestor
101318619|NCT00006038|Micronutrients|micronutrients|mesh-ancestor
101318620|NCT00017290|Prednisone|prednisone|mesh-list
101318621|NCT00017290|Cyclophosphamide|cyclophosphamide|mesh-list
101318622|NCT00017290|Vincristine|vincristine|mesh-list
101318623|NCT00017290|Immunoglobulins|immunoglobulins|mesh-list
101318624|NCT00017290|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101318625|NCT00017290|Antibodies|antibodies|mesh-list
101318626|NCT00017290|Sargramostim|sargramostim|mesh-list
101318627|NCT00017290|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
101318628|NCT00017290|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
101318629|NCT00017290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101318631|NCT00017290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318632|NCT00017290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101318635|NCT00017290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318637|NCT00017290|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101318638|NCT00017290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101318639|NCT00017290|Glucocorticoids|glucocorticoids|mesh-ancestor
101318640|NCT00017290|Hormones|hormones|mesh-ancestor
101318641|NCT00017290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101318642|NCT00017290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101318643|NCT00017290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101318644|NCT00017290|Tubulin Modulators|tubulin modulators|mesh-ancestor
101318645|NCT00017290|Antimitotic Agents|antimitotic agents|mesh-ancestor
101318646|NCT00017290|Mitosis Modulators|mitosis modulators|mesh-ancestor
101318647|NCT00017290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101318649|NCT00017329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318650|NCT00017368|Cyclophosphamide|cyclophosphamide|mesh-list
101318652|NCT00017368|Ifosfamide|ifosfamide|mesh-list
101318653|NCT00017368|Thiotepa|thiotepa|mesh-list
101318654|NCT00017368|Carboplatin|carboplatin|mesh-list
101318655|NCT00017368|Doxorubicin|doxorubicin|mesh-list
101318656|NCT00017368|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101318657|NCT00017368|Etoposide|etoposide|mesh-list
101318658|NCT00017368|Etoposide phosphate|etoposide phosphate|mesh-list
101318659|NCT00017368|Vincristine|vincristine|mesh-list
101318660|NCT00017368|Isotretinoin|isotretinoin|mesh-list
101318662|NCT00017368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101263246|NCT01760967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101263248|NCT01760967|Sensory System Agents|sensory system agents|mesh-ancestor
101263249|NCT01760967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101263250|NCT01760967|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101263251|NCT01760967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101263252|NCT01760967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101263253|NCT01760967|Adrenergic Agents|adrenergic agents|mesh-ancestor
101318663|NCT00017368|Immunologic Factors|immunologic factors|mesh-ancestor
101318664|NCT00017368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318665|NCT00017368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101318666|NCT00017368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101318667|NCT00017368|Alkylating Agents|alkylating agents|mesh-ancestor
101318668|NCT00017368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318669|NCT00017368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318670|NCT00017368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101318671|NCT00017368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101318672|NCT00017368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101318673|NCT00017368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101318674|NCT00017368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101318675|NCT00017368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101318677|NCT00017368|Antimitotic Agents|antimitotic agents|mesh-ancestor
101318678|NCT00017368|Mitosis Modulators|mitosis modulators|mesh-ancestor
101318679|NCT00017368|Dermatologic Agents|dermatologic agents|mesh-ancestor
101318680|NCT00001524|Thalidomide|thalidomide|mesh-list
101318681|NCT00001524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101318682|NCT00001524|Immunologic Factors|immunologic factors|mesh-ancestor
101318683|NCT00001524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318684|NCT00001524|Leprostatic Agents|leprostatic agents|mesh-ancestor
101318685|NCT00001524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101318686|NCT00001524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101318687|NCT00001524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101318688|NCT00001524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101318689|NCT00001524|Growth Substances|growth substances|mesh-ancestor
101318690|NCT00001524|Growth Inhibitors|growth inhibitors|mesh-ancestor
101318691|NCT00001524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318693|NCT00006041|Saponin QA-21V1|saponin qa-21v1|mesh-list
101318694|NCT00006041|Immunologic Factors|immunologic factors|mesh-ancestor
101318699|NCT00017602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101318700|NCT00017602|Antiemetics|antiemetics|mesh-ancestor
101318701|NCT00017602|Autonomic Agents|autonomic agents|mesh-ancestor
101318702|NCT00017602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101318703|NCT00017602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318704|NCT00017602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101318706|NCT00017602|Hormones|hormones|mesh-ancestor
101318707|NCT00017602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101318708|NCT00017602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101318710|NCT00001533|Cyclosporine|cyclosporine|mesh-list
101318712|NCT00001533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101318713|NCT00001533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318714|NCT00001533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101318716|NCT00001533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318717|NCT00001533|Antifungal Agents|antifungal agents|mesh-ancestor
101318718|NCT00001533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101318719|NCT00001533|Dermatologic Agents|dermatologic agents|mesh-ancestor
101318720|NCT00001533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101318721|NCT00001533|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101318722|NCT00017641|Cyclophosphamide|cyclophosphamide|mesh-list
101318723|NCT00017641|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101318724|NCT00017641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101318726|NCT00017641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318728|NCT00017641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101318729|NCT00017641|Alkylating Agents|alkylating agents|mesh-ancestor
101263254|NCT01760967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101263255|NCT01760967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318730|NCT00017641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318731|NCT00017641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318732|NCT00017641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101318734|NCT00017680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101318735|NCT00017680|Alkylating Agents|alkylating agents|mesh-ancestor
101318736|NCT00017680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318737|NCT00017680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318738|NCT00017680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101318739|NCT00017680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101318741|NCT00017680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318743|NCT00017719|Zidovudine|zidovudine|mesh-list
101318744|NCT00017719|Nevirapine|nevirapine|mesh-list
101318745|NCT00017719|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101318746|NCT00017719|Nelfinavir|nelfinavir|mesh-list
101318747|NCT00017719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101410789|NCT00446953|Hormones|hormones|mesh-ancestor
101318748|NCT00017719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101318749|NCT00017719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101318750|NCT00017719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318751|NCT00017719|Antiviral Agents|antiviral agents|mesh-ancestor
101318752|NCT00017719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101318753|NCT00017719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101318754|NCT00017719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101318755|NCT00017719|Antimetabolites|antimetabolites|mesh-ancestor
101318756|NCT00017719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101318757|NCT00017719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101318761|NCT00001542|Fluconazole|fluconazole|mesh-list
101318762|NCT00001542|Antifungal Agents|antifungal agents|mesh-ancestor
101318763|NCT00001542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101318764|NCT00001542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101318765|NCT00001542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101318766|NCT00001542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101318767|NCT00001542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318768|NCT00001542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101318769|NCT00001542|Hormone Antagonists|hormone antagonists|mesh-ancestor
101318770|NCT00001542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101318771|NCT00001542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318772|NCT00001542|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101318773|NCT00001542|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101318774|NCT00017758|Efavirenz|efavirenz|mesh-list
101318775|NCT00017758|Nelfinavir|nelfinavir|mesh-list
101318777|NCT00017758|Simvastatin|simvastatin|mesh-list
101318778|NCT00017758|Pravastatin|pravastatin|mesh-list
101318779|NCT00017758|Calcium|calcium|mesh-list
101318780|NCT00017758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101318781|NCT00017758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318782|NCT00017758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101318783|NCT00017758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101318784|NCT00017758|Antimetabolites|antimetabolites|mesh-ancestor
101318785|NCT00017758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318786|NCT00017758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101318787|NCT00017758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101318788|NCT00017758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101318789|NCT00017758|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101318790|NCT00017758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101318791|NCT00017758|Antiviral Agents|antiviral agents|mesh-ancestor
101318792|NCT00017758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101318793|NCT00017758|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101318794|NCT00017758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101318795|NCT00017758|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101318796|NCT00017758|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101318797|NCT00017758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101318798|NCT00017758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101263257|NCT01760980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101263258|NCT01760980|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101263259|NCT01760980|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101263260|NCT01760980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101263261|NCT01760980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318799|NCT00017758|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101318800|NCT00017758|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101318801|NCT00017758|Protease Inhibitors|protease inhibitors|mesh-ancestor
101318802|NCT00017758|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101318803|NCT00017758|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101318806|NCT00017992|Emtricitabine|emtricitabine|mesh-list
101318807|NCT00017992|Stavudine|stavudine|mesh-list
101318809|NCT00017992|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101318810|NCT00017992|Protease Inhibitors|protease inhibitors|mesh-ancestor
101318811|NCT00017992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101318812|NCT00017992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318813|NCT00017992|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101318814|NCT00017992|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101318815|NCT00017992|Antiviral Agents|antiviral agents|mesh-ancestor
101318816|NCT00017992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101318817|NCT00017992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101318821|NCT00017992|Antimetabolites|antimetabolites|mesh-ancestor
101318822|NCT04734067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101318823|NCT04734067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318824|NCT04734067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101318825|NCT04734067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318827|NCT00018148|Nicotine|nicotine|mesh-list
101318828|NCT00018148|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101318829|NCT00018148|Autonomic Agents|autonomic agents|mesh-ancestor
101318830|NCT00018148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101318831|NCT00018148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318833|NCT00018148|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101318834|NCT00018148|Cholinergic Agents|cholinergic agents|mesh-ancestor
101318835|NCT00018148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101318836|NCT00018148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318837|NCT00018148|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101318838|NCT00018148|Antidepressive Agents|antidepressive agents|mesh-ancestor
101318839|NCT00018148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101318840|NCT00018148|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101318841|NCT00018148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101318842|NCT00018148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101318843|NCT00018148|Adrenergic Agents|adrenergic agents|mesh-ancestor
101318844|NCT00001563|Rituximab|rituximab|mesh-list
101318845|NCT00001563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101318846|NCT00001563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318847|NCT00001563|Immunologic Factors|immunologic factors|mesh-ancestor
101318848|NCT00001563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318849|NCT00001563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101318850|NCT00018187|Mecamylamine|mecamylamine|mesh-list
101318851|NCT00018187|Bupropion|bupropion|mesh-list
101318852|NCT00018187|Nicotine|nicotine|mesh-list
101318853|NCT00018187|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101318854|NCT00018187|Autonomic Agents|autonomic agents|mesh-ancestor
101318855|NCT00018187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101318856|NCT00018187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318857|NCT00018187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101318858|NCT00018187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101318859|NCT00018187|Cholinergic Agents|cholinergic agents|mesh-ancestor
101318860|NCT00018187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101318861|NCT00018187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318862|NCT00018187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101318863|NCT00018187|Antidepressive Agents|antidepressive agents|mesh-ancestor
101318864|NCT00018187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101318865|NCT00018187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101318867|NCT00018187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101318868|NCT00018187|Dopamine Agents|dopamine agents|mesh-ancestor
101318869|NCT00018187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101263262|NCT01760980|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101263263|NCT01760980|Hormone Antagonists|hormone antagonists|mesh-ancestor
101263264|NCT01760980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101263265|NCT01760980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263266|NCT01761071|Diclofenac|diclofenac|mesh-list
101263267|NCT01761071|Ketorolac|ketorolac|mesh-list
101263268|NCT01761071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101318870|NCT00018187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101318872|NCT00018187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101318873|NCT00018187|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
101318874|NCT00018187|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101318875|NCT00018187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101318877|NCT00018343|Hormones|hormones|mesh-ancestor
101318878|NCT00018343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101318879|NCT00018343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318880|NCT00001566|Indinavir|indinavir|mesh-list
101318881|NCT00001566|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101318882|NCT00001566|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101318883|NCT00001566|Protease Inhibitors|protease inhibitors|mesh-ancestor
101318884|NCT00001566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101318885|NCT00001566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318886|NCT00001566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101318887|NCT00001566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101318888|NCT00001566|Antiviral Agents|antiviral agents|mesh-ancestor
101329913|NCT00000485|Diuretics|diuretics|mesh-list
101318889|NCT00001566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101318890|NCT00018382|Rosiglitazone|rosiglitazone|mesh-list
101318892|NCT00018382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318894|NCT00018460|Vitamin B Complex|vitamin b complex|mesh-list
101318895|NCT00018460|Micronutrients|micronutrients|mesh-ancestor
101318896|NCT00018460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318897|NCT00386750|Lumefantrine|lumefantrine|mesh-list
101318898|NCT00386750|Artemether|artemether|mesh-list
101318899|NCT00386750|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101318900|NCT00386750|Antimalarials|antimalarials|mesh-ancestor
101318901|NCT00386750|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101318902|NCT00386750|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101318903|NCT00386750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101318904|NCT00001575|Edetic Acid|edetic acid|mesh-list
101318905|NCT00001575|Calcium|calcium|mesh-list
101318906|NCT00001575|Pentetic Acid|pentetic acid|mesh-list
101318907|NCT00001575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101318908|NCT00001575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318909|NCT00001575|Antidotes|antidotes|mesh-ancestor
101318910|NCT00001575|Protective Agents|protective agents|mesh-ancestor
101318912|NCT00001575|Sequestering Agents|sequestering agents|mesh-ancestor
101318913|NCT00001575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318914|NCT00001575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101318915|NCT00001575|Anticoagulants|anticoagulants|mesh-ancestor
101318916|NCT00001575|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101318917|NCT00001596|Pirfenidone|pirfenidone|mesh-list
101318918|NCT00001596|Analgesics|analgesics|mesh-ancestor
101318919|NCT00001596|Sensory System Agents|sensory system agents|mesh-ancestor
101318920|NCT00001596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101318921|NCT00001596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318922|NCT00001596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101318923|NCT00001596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101318924|NCT00001596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101318925|NCT00001596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101318926|NCT00001596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318927|NCT05576194|Hydrogen Peroxide|hydrogen peroxide|mesh-list
101318928|NCT05576194|Taurolidine|taurolidine|mesh-list
101318929|NCT05576194|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101318930|NCT05576194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101263269|NCT01761071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101263270|NCT01761071|Analgesics|analgesics|mesh-ancestor
101263271|NCT01761071|Sensory System Agents|sensory system agents|mesh-ancestor
101263272|NCT01761071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101263273|NCT01761071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263274|NCT01761071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101318931|NCT05576194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318932|NCT00391885|Anesthetics|anesthetics|mesh-list
101528356|NCT04628676|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101318933|NCT00391885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101318934|NCT00391885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318935|NCT00391924|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101318936|NCT00391924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101318937|NCT00391924|Immunologic Factors|immunologic factors|mesh-ancestor
101318938|NCT00391924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318940|NCT00392002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101318941|NCT00392002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101318942|NCT00392002|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101318943|NCT00392002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101318944|NCT00392002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318946|NCT00392080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101318947|NCT00392080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101318948|NCT00392080|Analgesics|analgesics|mesh-ancestor
101318949|NCT00392080|Sensory System Agents|sensory system agents|mesh-ancestor
101318950|NCT00392080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101318951|NCT00392080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318952|NCT00392080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101318953|NCT00392080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101318954|NCT00392080|Gout Suppressants|gout suppressants|mesh-ancestor
101318955|NCT00392080|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101318956|NCT00392080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101318957|NCT00392080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318958|NCT00001644|Lamivudine|lamivudine|mesh-list
101318959|NCT00001644|Zidovudine|zidovudine|mesh-list
101318961|NCT00001644|Indinavir|indinavir|mesh-list
101318962|NCT00001644|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101318963|NCT00001644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101318964|NCT00001644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101318965|NCT00001644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318966|NCT00001644|Antiviral Agents|antiviral agents|mesh-ancestor
101318967|NCT00001644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101318968|NCT00001644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101318969|NCT00001644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101318970|NCT00001644|Antimetabolites|antimetabolites|mesh-ancestor
101318971|NCT00001644|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101318972|NCT00001644|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101318973|NCT00001644|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101318974|NCT00001644|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101318975|NCT00001644|Protease Inhibitors|protease inhibitors|mesh-ancestor
101318976|NCT05573386|Lenograstim|lenograstim|mesh-list
101318977|NCT05573386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101318978|NCT05573386|Immunologic Factors|immunologic factors|mesh-ancestor
101318979|NCT05573386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318980|NCT00001656|Olanzapine|olanzapine|mesh-list
101318981|NCT00001656|Clozapine|clozapine|mesh-list
101318983|NCT00001656|Autonomic Agents|autonomic agents|mesh-ancestor
101318984|NCT00001656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101318985|NCT00001656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318986|NCT00001656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101318987|NCT00001656|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101318988|NCT00001656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101318989|NCT00001656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101318990|NCT00001656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101318991|NCT00001656|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101318992|NCT00001656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101318993|NCT00001656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101263276|NCT01761071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101263277|NCT01761071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101263278|NCT01761071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263279|NCT01761110|Buprenorphine|buprenorphine|mesh-list
101318994|NCT00001656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318995|NCT00001656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101318996|NCT00001656|Serotonin Agents|serotonin agents|mesh-ancestor
101318997|NCT00001656|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101318998|NCT00001656|GABA Antagonists|gaba antagonists|mesh-ancestor
101318999|NCT00001656|GABA Agents|gaba agents|mesh-ancestor
101319000|NCT05573191|Lidocaine|lidocaine|mesh-list
101319001|NCT05573191|Anesthetics, Local|anesthetics, local|mesh-ancestor
101319002|NCT05573191|Anesthetics|anesthetics|mesh-ancestor
101319003|NCT05573191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101319004|NCT05573191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319005|NCT05573191|Sensory System Agents|sensory system agents|mesh-ancestor
101319006|NCT05573191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101319007|NCT05573191|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101319008|NCT05573191|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101319009|NCT05573191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101319010|NCT05573191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101319011|NCT05573191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319012|NCT05679830|Cannabidiol|cannabidiol|mesh-list
101319013|NCT05679830|Anticonvulsants|anticonvulsants|mesh-ancestor
101319014|NCT05572996|Treprostinil|treprostinil|mesh-list
101319015|NCT05572996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101319016|NCT05572723|Dexmedetomidine|dexmedetomidine|mesh-list
101319017|NCT05572723|Remifentanil|remifentanil|mesh-list
101319018|NCT05572723|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101319019|NCT05572723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101319020|NCT05572723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319021|NCT05572723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101319022|NCT05572723|Analgesics|analgesics|mesh-ancestor
101319023|NCT05572723|Sensory System Agents|sensory system agents|mesh-ancestor
101319024|NCT05572723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101319025|NCT05572723|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101319026|NCT05572723|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101319027|NCT05572723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101319028|NCT05572723|Adrenergic Agents|adrenergic agents|mesh-ancestor
101319029|NCT05572723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101319030|NCT05572723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319032|NCT05572723|Narcotics|narcotics|mesh-ancestor
101319033|NCT05563753|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101319034|NCT05563753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101319035|NCT00389415|Vildagliptin|vildagliptin|mesh-list
101319036|NCT00389415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101319037|NCT00389415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319038|NCT00389415|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101319039|NCT00389415|Protease Inhibitors|protease inhibitors|mesh-ancestor
101319040|NCT00389415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101319041|NCT00389415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319042|NCT05419921|Lidocaine|lidocaine|mesh-list
101319043|NCT05419921|Anesthetics, Local|anesthetics, local|mesh-ancestor
101319044|NCT05419921|Anesthetics|anesthetics|mesh-ancestor
101319045|NCT05419921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101319046|NCT05419921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319047|NCT05419921|Sensory System Agents|sensory system agents|mesh-ancestor
101319048|NCT05419921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101319049|NCT05419921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101319050|NCT05419921|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101319051|NCT05419921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101319052|NCT05419921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101319053|NCT05419921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319054|NCT00386828|Bevacizumab|bevacizumab|mesh-list
101319055|NCT00386828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101263280|NCT01761110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101263281|NCT01761110|Narcotics|narcotics|mesh-ancestor
101263282|NCT01761110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101263283|NCT01761110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263284|NCT01761110|Analgesics|analgesics|mesh-ancestor
101263285|NCT01761110|Sensory System Agents|sensory system agents|mesh-ancestor
101263286|NCT01761110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101263287|NCT01761110|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101263289|NCT01761149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101263290|NCT01761149|Narcotics|narcotics|mesh-ancestor
101263291|NCT01761149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101263292|NCT01761149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263293|NCT01761149|Analgesics|analgesics|mesh-ancestor
101263294|NCT01761149|Sensory System Agents|sensory system agents|mesh-ancestor
101263295|NCT01761149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101263296|NCT01761201|Levofloxacin|levofloxacin|mesh-list
101263298|NCT01761201|Isoniazid|isoniazid|mesh-list
101263300|NCT01761201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101319056|NCT00386828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101319057|NCT00386828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101319058|NCT00386828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101319059|NCT00386828|Growth Substances|growth substances|mesh-ancestor
101319060|NCT00386828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319061|NCT00386828|Growth Inhibitors|growth inhibitors|mesh-ancestor
101319062|NCT05367271|Dexamethasone|dexamethasone|mesh-list
101319063|NCT05367271|Cortisone|cortisone|mesh-list
101319064|NCT05367271|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101319065|NCT05367271|Botulinum Toxins|botulinum toxins|mesh-list
101319066|NCT05367271|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101319067|NCT05367271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101319068|NCT05367271|Antiemetics|antiemetics|mesh-ancestor
101319069|NCT05367271|Autonomic Agents|autonomic agents|mesh-ancestor
101319070|NCT05367271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101319071|NCT05367271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319072|NCT05367271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101319073|NCT05367271|Glucocorticoids|glucocorticoids|mesh-ancestor
101319074|NCT05367271|Hormones|hormones|mesh-ancestor
101319075|NCT05367271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101319076|NCT05367271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101319077|NCT05367271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101319078|NCT05367271|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101319079|NCT05367271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101528357|NCT04628676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101319080|NCT05367271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319081|NCT05367271|Cholinergic Agents|cholinergic agents|mesh-ancestor
101319082|NCT05367271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101319083|NCT05367271|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101319084|NCT00001725|Dextromethorphan|dextromethorphan|mesh-list
101319085|NCT00001725|Antitussive Agents|antitussive agents|mesh-ancestor
101319086|NCT00001725|Respiratory System Agents|respiratory system agents|mesh-ancestor
101319087|NCT00001725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101319088|NCT00001725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101319089|NCT00001725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101263301|NCT01761201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101263302|NCT01761201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101263303|NCT01761201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101263304|NCT01761201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101319090|NCT00001725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319091|NCT00001725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319092|NCT05311618|Pembrolizumab|pembrolizumab|mesh-list
101319093|NCT05311618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101319094|NCT05311618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101319095|NCT05311618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101319096|NCT05311618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319097|NCT00001728|Alendronate|alendronate|mesh-list
101319098|NCT00001728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101319099|NCT00001728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319100|NCT05673629|Docetaxel|docetaxel|mesh-list
101319101|NCT05673629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101319102|NCT05673629|Tubulin Modulators|tubulin modulators|mesh-ancestor
101319103|NCT05673629|Antimitotic Agents|antimitotic agents|mesh-ancestor
101319104|NCT05673629|Mitosis Modulators|mitosis modulators|mesh-ancestor
101319105|NCT05673629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319106|NCT00001731|Cyclosporine|cyclosporine|mesh-list
101319107|NCT00001731|Cyclosporins|cyclosporins|mesh-list
101319108|NCT00001731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101319109|NCT00001731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319110|NCT00001731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101319111|NCT00001731|Immunologic Factors|immunologic factors|mesh-ancestor
101319112|NCT00001731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319113|NCT00001731|Antifungal Agents|antifungal agents|mesh-ancestor
101319114|NCT00001731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101319115|NCT00001731|Dermatologic Agents|dermatologic agents|mesh-ancestor
101319116|NCT00001731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101319117|NCT00001731|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101319118|NCT00392158|Anesthetics|anesthetics|mesh-list
101319119|NCT00392158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101319120|NCT00392158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319121|NCT00392275|Ciprofloxacin|ciprofloxacin|mesh-list
101319122|NCT00392275|Levofloxacin|levofloxacin|mesh-list
101319124|NCT00392275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101319125|NCT00392275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101319126|NCT00392275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101319127|NCT00392275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101319128|NCT00392275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101319129|NCT00392275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319130|NCT00392275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101319131|NCT00392275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101319132|NCT00392275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101319133|NCT00392275|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101319134|NCT00001749|Cyclosporine|cyclosporine|mesh-list
101319135|NCT00001749|Cyclosporins|cyclosporins|mesh-list
101319136|NCT00001749|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101319137|NCT00001749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101319138|NCT00001749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319139|NCT00001749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101319140|NCT00001749|Immunologic Factors|immunologic factors|mesh-ancestor
101319141|NCT00001749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319142|NCT00001749|Antifungal Agents|antifungal agents|mesh-ancestor
101319143|NCT00001749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101319144|NCT00001749|Dermatologic Agents|dermatologic agents|mesh-ancestor
101319145|NCT00001749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101319146|NCT00001749|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101319147|NCT00001752|Estrogens|estrogens|mesh-list
101319148|NCT00001752|Hormones|hormones|mesh-ancestor
101319149|NCT00001752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101319150|NCT00001752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263305|NCT01761201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319152|NCT05171179|Bupivacaine|bupivacaine|mesh-list
101319153|NCT05171179|Anesthetics, Local|anesthetics, local|mesh-ancestor
101319154|NCT05171179|Anesthetics|anesthetics|mesh-ancestor
101319155|NCT05171179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101319156|NCT05171179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319157|NCT05171179|Sensory System Agents|sensory system agents|mesh-ancestor
101319158|NCT05171179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101319159|NCT05171179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101319160|NCT05171179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101319161|NCT05171179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101319162|NCT05171179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101319163|NCT05171179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319164|NCT05156905|Docetaxel|docetaxel|mesh-list
101319165|NCT05156905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101319168|NCT05156905|Mitosis Modulators|mitosis modulators|mesh-ancestor
101319169|NCT05156905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319171|NCT00001758|Abacavir|abacavir|mesh-list
101319172|NCT00001758|Amprenavir|amprenavir|mesh-list
101319173|NCT00001758|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101319174|NCT00001758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101319175|NCT00001758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101319176|NCT00001758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319177|NCT00001758|Antiviral Agents|antiviral agents|mesh-ancestor
101319178|NCT00001758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101319179|NCT00001758|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101319180|NCT00001758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101319181|NCT00001758|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101319182|NCT00001758|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101319183|NCT00001758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101319184|NCT00001758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101319185|NCT00001758|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101319186|NCT00001758|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101319187|NCT00001758|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101319188|NCT00001758|Antitubercular Agents|antitubercular agents|mesh-ancestor
101319189|NCT00001758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101319190|NCT00001758|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101319191|NCT00001758|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101319192|NCT00001758|Protease Inhibitors|protease inhibitors|mesh-ancestor
101319193|NCT00001764|Mycophenolic Acid|mycophenolic acid|mesh-list
101319194|NCT00001764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101319195|NCT00001764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101319196|NCT00001764|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101319197|NCT00001764|Antitubercular Agents|antitubercular agents|mesh-ancestor
101319198|NCT00001764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101319199|NCT00001764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101319200|NCT00001764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101319201|NCT00001764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319203|NCT04983901|Meropenem|meropenem|mesh-list
101319204|NCT04983901|Tazobactam|tazobactam|mesh-list
101319205|NCT04983901|Linezolid|linezolid|mesh-list
101319206|NCT04983901|Piperacillin|piperacillin|mesh-list
101319207|NCT04983901|Daptomycin|daptomycin|mesh-list
101319208|NCT04983901|Imipenem|imipenem|mesh-list
101319210|NCT04983901|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101319211|NCT04983901|Relebactam|relebactam|mesh-list
101319212|NCT04983901|Cilastatin|cilastatin|mesh-list
101319213|NCT04983901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101319214|NCT04983901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101319215|NCT04983901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101319216|NCT04983901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101319217|NCT04983901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319218|NCT04983901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101319219|NCT04983901|Protease Inhibitors|protease inhibitors|mesh-ancestor
101319220|NCT04971343|Antibodies|antibodies|mesh-list
101319221|NCT04971343|Immunoglobulins|immunoglobulins|mesh-list
101319222|NCT04971343|Immunologic Factors|immunologic factors|mesh-ancestor
101319223|NCT04971343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319224|NCT04951804|Bupivacaine|bupivacaine|mesh-list
101263306|NCT01761201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101263307|NCT01761201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101263308|NCT01761201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101263309|NCT01761201|Antitubercular Agents|antitubercular agents|mesh-ancestor
101263310|NCT01761201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101263311|NCT01761201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101263312|NCT01761201|Antimetabolites|antimetabolites|mesh-ancestor
101263313|NCT01761201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101263314|NCT01761214|Amoxicillin|amoxicillin|mesh-list
101263315|NCT01761214|Moxifloxacin|moxifloxacin|mesh-list
101263316|NCT01761214|Ciprofloxacin|ciprofloxacin|mesh-list
101263317|NCT01761214|Clavulanic Acid|clavulanic acid|mesh-list
101328288|NCT00000146|Prednisolone phosphate|prednisolone phosphate|mesh-list
101263318|NCT01761214|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101319225|NCT04951804|Anesthetics, Local|anesthetics, local|mesh-ancestor
101319226|NCT04951804|Anesthetics|anesthetics|mesh-ancestor
101319227|NCT04951804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101319228|NCT04951804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319229|NCT04951804|Sensory System Agents|sensory system agents|mesh-ancestor
101319230|NCT04951804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101319232|NCT05620628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101319233|NCT05620628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101319234|NCT04905121|Psilocybin|psilocybin|mesh-list
101319235|NCT04905121|Hallucinogens|hallucinogens|mesh-ancestor
101319236|NCT04905121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319237|NCT04905121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101319238|NCT00001818|Hydroxyurea|hydroxyurea|mesh-list
101319239|NCT00001818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101319243|NCT00001818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101319244|NCT04887805|Pembrolizumab|pembrolizumab|mesh-list
101319245|NCT04887805|Lenvatinib|lenvatinib|mesh-list
101319246|NCT04887805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101319247|NCT04887805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101319248|NCT04887805|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101319249|NCT04887805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319250|NCT04887805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101319251|NCT04887805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101319252|NCT00392314|Deoxyglucose|deoxyglucose|mesh-list
101319253|NCT00392314|Antimetabolites|antimetabolites|mesh-ancestor
101319254|NCT00392314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319255|NCT00392314|Antiviral Agents|antiviral agents|mesh-ancestor
101319256|NCT00392314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101319257|NCT00000102|Nifedipine|nifedipine|mesh-list
101319258|NCT00000102|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101319259|NCT00000102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101319260|NCT00000102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319261|NCT00000102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101319262|NCT00000102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319264|NCT00000102|Tocolytic Agents|tocolytic agents|mesh-ancestor
101319265|NCT00000102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101319266|NCT05641623|3-(3-(methylsulfonyl)phenyl)-1-propylpiperidine|3-(3-(methylsulfonyl)phenyl)-1-propylpiperidine|mesh-list
101319267|NCT05641623|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101319268|NCT05641623|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101319269|NCT05641623|Dopamine Agents|dopamine agents|mesh-ancestor
101319270|NCT05641623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101263319|NCT01761214|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
101263320|NCT01761214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101263321|NCT01761214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101319271|NCT05641623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319272|NCT05641623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319274|NCT05641506|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101319275|NCT05641506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101319276|NCT05641506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319278|NCT00386867|Misoprostol|misoprostol|mesh-list
101319279|NCT00386867|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101319280|NCT00386867|Abortifacient Agents|abortifacient agents|mesh-ancestor
101319281|NCT00386867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101319282|NCT00386867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319283|NCT00386867|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101319284|NCT00386867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101319285|NCT00386867|Oxytocics|oxytocics|mesh-ancestor
101319286|NCT04526119|Z 338|z 338|mesh-list
101319287|NCT04526119|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101319288|NCT04526119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101319289|NCT04526119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319290|NCT04526119|Cholinergic Agents|cholinergic agents|mesh-ancestor
101319291|NCT04526119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101319292|NCT04526119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319293|NCT04526119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101319294|NCT00392431|Amiodarone|amiodarone|mesh-list
101319295|NCT00392431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101319296|NCT00392431|Vasodilator Agents|vasodilator agents|mesh-ancestor
101319297|NCT00392431|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101319298|NCT00392431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101319299|NCT00392431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329940|NCT00028600|Abortifacient Agents|abortifacient agents|mesh-ancestor
101319304|NCT00392431|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101319305|NCT00392431|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101319306|NCT00392431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101319308|NCT05495204|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101319310|NCT05495204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101319311|NCT05495204|Antiviral Agents|antiviral agents|mesh-ancestor
101319312|NCT05495204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101319313|NCT05495204|Immunologic Factors|immunologic factors|mesh-ancestor
101319314|NCT05495204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319315|NCT00392470|Irinotecan|irinotecan|mesh-list
101319316|NCT00392470|Cetuximab|cetuximab|mesh-list
101319317|NCT00392470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101319318|NCT00392470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101319319|NCT00392470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101319320|NCT00392470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319321|NCT00392470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101319322|NCT00392470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101319326|NCT03960151|Dexamethasone|dexamethasone|mesh-list
101319327|NCT03960151|Olanzapine|olanzapine|mesh-list
101319328|NCT03960151|Palonosetron|palonosetron|mesh-list
101319329|NCT03960151|Rolapitant|rolapitant|mesh-list
101319330|NCT03960151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101319331|NCT03960151|Antiemetics|antiemetics|mesh-ancestor
101319332|NCT03960151|Autonomic Agents|autonomic agents|mesh-ancestor
101319333|NCT03960151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101319334|NCT03960151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319335|NCT03960151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101319337|NCT03960151|Hormones|hormones|mesh-ancestor
101319338|NCT03960151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101319339|NCT03960151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101319340|NCT03960151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101319341|NCT03960151|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101319342|NCT03960151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101319343|NCT03960151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101319344|NCT03960151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101302582|NCT00310180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101302583|NCT00310180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302584|NCT00310180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101302585|NCT00310180|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101302586|NCT00310180|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101302587|NCT00310180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101302588|NCT00098475|Thalidomide|thalidomide|mesh-list
101302589|NCT00098475|Dexamethasone|dexamethasone|mesh-list
101302590|NCT00098475|Dexamethasone acetate|dexamethasone acetate|mesh-list
101302591|NCT00098475|Lenalidomide|lenalidomide|mesh-list
101302592|NCT00098475|Ichthammol|ichthammol|mesh-list
101302593|NCT00098475|BB 1101|bb 1101|mesh-list
101302594|NCT00098475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101302595|NCT00098475|Antiemetics|antiemetics|mesh-ancestor
101302596|NCT00098475|Autonomic Agents|autonomic agents|mesh-ancestor
101302597|NCT00098475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101302598|NCT00098475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302599|NCT00098475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101302600|NCT00098475|Glucocorticoids|glucocorticoids|mesh-ancestor
101302601|NCT00098475|Hormones|hormones|mesh-ancestor
101302602|NCT00098475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101302603|NCT00098475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101302604|NCT00098475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302605|NCT00098475|Protease Inhibitors|protease inhibitors|mesh-ancestor
101302606|NCT00098475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101302607|NCT00098475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302608|NCT00098475|Immunologic Factors|immunologic factors|mesh-ancestor
101302609|NCT00098475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101302610|NCT00098475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101302611|NCT00098475|Growth Substances|growth substances|mesh-ancestor
101302612|NCT00098475|Growth Inhibitors|growth inhibitors|mesh-ancestor
101302613|NCT00098475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101302614|NCT00098475|Leprostatic Agents|leprostatic agents|mesh-ancestor
101302615|NCT00098475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101302616|NCT00098475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101302617|NCT00098475|Dermatologic Agents|dermatologic agents|mesh-ancestor
101302618|NCT02006498|Silymarin|silymarin|mesh-list
101302619|NCT02006498|Antioxidants|antioxidants|mesh-ancestor
101302620|NCT02006498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302621|NCT02006498|Protective Agents|protective agents|mesh-ancestor
101302622|NCT02006498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302623|NCT02006589|Candesartan|candesartan|mesh-list
101302624|NCT02006589|Candesartan cilexetil|candesartan cilexetil|mesh-list
101302625|NCT02006589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101302626|NCT02006589|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101302627|NCT02006589|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101302628|NCT02006589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302629|NCT02006602|Candesartan|candesartan|mesh-list
101302630|NCT02006602|Candesartan cilexetil|candesartan cilexetil|mesh-list
101302631|NCT02006602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101302632|NCT02006602|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101302633|NCT02006602|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101302634|NCT02006602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302635|NCT02006745|Ribavirin|ribavirin|mesh-list
101302636|NCT02006745|Antimetabolites|antimetabolites|mesh-ancestor
101302638|NCT02006745|Antiviral Agents|antiviral agents|mesh-ancestor
101302639|NCT02006745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101302640|NCT02006849|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101302641|NCT02006849|Hormones|hormones|mesh-ancestor
101302642|NCT02006849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101302643|NCT02006849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302644|NCT02006914|Chromium|chromium|mesh-list
101302645|NCT02006914|Picolinic acid|picolinic acid|mesh-list
101302646|NCT02006914|Trace Elements|trace elements|mesh-ancestor
101302647|NCT02006914|Micronutrients|micronutrients|mesh-ancestor
101302648|NCT02006914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263322|NCT01761214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101263323|NCT01761214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101263326|NCT01761214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302649|NCT02006914|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101302650|NCT02006914|Chelating Agents|chelating agents|mesh-ancestor
101302651|NCT02006914|Sequestering Agents|sequestering agents|mesh-ancestor
101302652|NCT02006914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302653|NCT02006966|Lidocaine|lidocaine|mesh-list
101302654|NCT02006966|Anesthetics, Local|anesthetics, local|mesh-ancestor
101302655|NCT02006966|Anesthetics|anesthetics|mesh-ancestor
101302656|NCT02006966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101302657|NCT02006966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302658|NCT02006966|Sensory System Agents|sensory system agents|mesh-ancestor
101302659|NCT02006966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101302660|NCT02006966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101302661|NCT02006966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101302662|NCT02006966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101302663|NCT02006966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101302664|NCT02006966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302665|NCT02007005|Viscum album peptide|viscum album peptide|mesh-list
101302666|NCT02007005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302667|NCT02007005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101302668|NCT02007005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101302669|NCT02007005|Antiviral Agents|antiviral agents|mesh-ancestor
101302670|NCT02007005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101302671|NCT02007148|Docetaxel|docetaxel|mesh-list
101302672|NCT02007148|Capecitabine|capecitabine|mesh-list
101302673|NCT02007148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302674|NCT02007148|Tubulin Modulators|tubulin modulators|mesh-ancestor
101302675|NCT02007148|Antimitotic Agents|antimitotic agents|mesh-ancestor
101302676|NCT02007148|Mitosis Modulators|mitosis modulators|mesh-ancestor
101302677|NCT02007148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302678|NCT02007148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101302679|NCT02007148|Antimetabolites|antimetabolites|mesh-ancestor
101302680|NCT02007161|Diclofenac|diclofenac|mesh-list
101302681|NCT02007161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101302682|NCT02007161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101302684|NCT02007161|Sensory System Agents|sensory system agents|mesh-ancestor
101302685|NCT02007161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101302686|NCT02007161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302687|NCT02007161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101302688|NCT02007161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101302689|NCT02007161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101302690|NCT02007161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101302692|NCT02007174|Bevacizumab|bevacizumab|mesh-list
101302693|NCT02007174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101302694|NCT02007174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302695|NCT02007174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101302696|NCT02007174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101302698|NCT02007174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302699|NCT02007174|Growth Inhibitors|growth inhibitors|mesh-ancestor
101302700|NCT02007330|Lidocaine|lidocaine|mesh-list
101302701|NCT02007330|Anesthetics, Local|anesthetics, local|mesh-ancestor
101302702|NCT02007330|Anesthetics|anesthetics|mesh-ancestor
101302703|NCT02007330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101302704|NCT02007330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302705|NCT02007330|Sensory System Agents|sensory system agents|mesh-ancestor
101302706|NCT02007330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101302707|NCT02007330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101302708|NCT02007330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101302709|NCT02007330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101302710|NCT02007330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101302711|NCT02007330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302712|NCT02007408|Lidocaine|lidocaine|mesh-list
101302713|NCT02007408|Anesthetics, Local|anesthetics, local|mesh-ancestor
101302714|NCT02007408|Anesthetics|anesthetics|mesh-ancestor
101302715|NCT02007408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101302716|NCT02007408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302717|NCT02007408|Sensory System Agents|sensory system agents|mesh-ancestor
101302718|NCT02007408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101302719|NCT02007408|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101302720|NCT02007408|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101302721|NCT02007408|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101302722|NCT02007408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101302723|NCT02007408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302724|NCT02007447|Oxytocin|oxytocin|mesh-list
101302725|NCT02007447|Oxytocics|oxytocics|mesh-ancestor
101302726|NCT02007447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101302727|NCT02007447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302728|NCT02007603|Amoxicillin|amoxicillin|mesh-list
101302729|NCT02007603|Clavulanic Acids|clavulanic acids|mesh-list
101302730|NCT02007603|Clavulanic Acid|clavulanic acid|mesh-list
101302731|NCT02007603|Ampicillin|ampicillin|mesh-list
101302732|NCT02007603|Sulbactam|sulbactam|mesh-list
101302733|NCT02007603|Sultamicillin|sultamicillin|mesh-list
101302734|NCT02007603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101302735|NCT02007603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101302736|NCT02007603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101302737|NCT02007603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302738|NCT02007603|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101302739|NCT02007629|Riociguat|riociguat|mesh-list
101302740|NCT02007629|Enzyme Activators|enzyme activators|mesh-ancestor
101302741|NCT02007629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302742|NCT02007746|Liver Extracts|liver extracts|mesh-list
101302743|NCT02007746|Hematinics|hematinics|mesh-ancestor
101302744|NCT02007798|Dexmedetomidine|dexmedetomidine|mesh-list
101302745|NCT02007798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101302746|NCT02007798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101302747|NCT02007798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302748|NCT02007798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101302749|NCT02007798|Analgesics|analgesics|mesh-ancestor
101302750|NCT02007798|Sensory System Agents|sensory system agents|mesh-ancestor
101302751|NCT02007798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101302752|NCT02007798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101302753|NCT02007798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101302754|NCT02007798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101302755|NCT02007798|Adrenergic Agents|adrenergic agents|mesh-ancestor
101302756|NCT02007798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101302757|NCT02007798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302758|NCT02007837|Aspirin|aspirin|mesh-list
101302759|NCT02007837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101302760|NCT02007837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101302761|NCT02007837|Analgesics|analgesics|mesh-ancestor
101302762|NCT02007837|Sensory System Agents|sensory system agents|mesh-ancestor
101302763|NCT02007837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101317557|NCT00001251|Mafosfamide|mafosfamide|mesh-list
101302764|NCT02007837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302765|NCT02007837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101302766|NCT02007837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101302767|NCT02007837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101302768|NCT02007837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101302769|NCT02007837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302770|NCT02007837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101302771|NCT02007837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101302772|NCT02007837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101302773|NCT02007837|Antipyretics|antipyretics|mesh-ancestor
101302774|NCT02007850|Ropivacaine|ropivacaine|mesh-list
101302775|NCT02007850|Anesthetics, Local|anesthetics, local|mesh-ancestor
101302776|NCT02007850|Anesthetics|anesthetics|mesh-ancestor
101302777|NCT02007850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101302778|NCT02007850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302779|NCT02007850|Sensory System Agents|sensory system agents|mesh-ancestor
101302780|NCT02007850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101302781|NCT02007915|Pamidronate|pamidronate|mesh-list
101302782|NCT02007915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101302783|NCT02007915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302784|NCT02007928|Olanzapine|olanzapine|mesh-list
101302785|NCT02007928|Risperidone|risperidone|mesh-list
101302786|NCT02007928|Aripiprazole|aripiprazole|mesh-list
101302788|NCT02007928|Serotonin Agents|serotonin agents|mesh-ancestor
101302789|NCT02007928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101302790|NCT02007928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302791|NCT02007928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302792|NCT02007928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101302793|NCT02007928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101302794|NCT02007928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101302795|NCT02007928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101302796|NCT02007928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101302797|NCT02007928|Dopamine Agents|dopamine agents|mesh-ancestor
101302798|NCT02007928|Antiemetics|antiemetics|mesh-ancestor
101302799|NCT02007928|Autonomic Agents|autonomic agents|mesh-ancestor
101302800|NCT02007928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101302801|NCT02007928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101302802|NCT02007928|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101302803|NCT02007928|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101302804|NCT02007928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101302805|NCT02007928|Antidepressive Agents|antidepressive agents|mesh-ancestor
101302806|NCT02007928|Dopamine Agonists|dopamine agonists|mesh-ancestor
101302807|NCT02007928|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101302808|NCT02007928|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101302809|NCT02007928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101302810|NCT02007928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101302811|NCT02008006|Cytarabine|cytarabine|mesh-list
101302812|NCT02008006|Etoposide|etoposide|mesh-list
101302813|NCT02008006|Melphalan|melphalan|mesh-list
101302814|NCT02008006|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101302815|NCT02008006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101302816|NCT02008006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302817|NCT02008006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101302818|NCT02008006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101302819|NCT02008006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101302820|NCT02008006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302821|NCT02008006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101302822|NCT02008006|Antimetabolites|antimetabolites|mesh-ancestor
101302823|NCT02008006|Antiviral Agents|antiviral agents|mesh-ancestor
101302824|NCT02008006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101302825|NCT02008006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101302826|NCT02008006|Immunologic Factors|immunologic factors|mesh-ancestor
101302827|NCT02008006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302828|NCT02008006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101302829|NCT02008006|Alkylating Agents|alkylating agents|mesh-ancestor
101302832|NCT02008019|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101302833|NCT02008019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101302834|NCT02008019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101302835|NCT02008019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302836|NCT02008019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101302838|NCT02008019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302839|NCT02008019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302840|NCT02008123|Primidone|primidone|mesh-list
101302841|NCT02008123|Anticonvulsants|anticonvulsants|mesh-ancestor
101302842|NCT02008123|GABA Modulators|gaba modulators|mesh-ancestor
101302843|NCT02008123|GABA Agents|gaba agents|mesh-ancestor
101302844|NCT02008123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101302845|NCT02008123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302846|NCT02008123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302847|NCT02008136|Botulinum Toxins|botulinum toxins|mesh-list
101302848|NCT02008136|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101302849|NCT02008136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101302850|NCT02008136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302851|NCT02008136|Cholinergic Agents|cholinergic agents|mesh-ancestor
101302852|NCT02008136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101302853|NCT02008136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302854|NCT02008162|Bromides|bromides|mesh-list
101302855|NCT02008162|Albuterol|albuterol|mesh-list
101302856|NCT02008162|Tiotropium Bromide|tiotropium bromide|mesh-list
101302857|NCT02008162|Bronchodilator Agents|bronchodilator agents|mesh-list
101304271|NCT02012075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101304272|NCT02012075|Vasodilator Agents|vasodilator agents|mesh-ancestor
101304273|NCT02012075|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101263335|NCT01761344|Hydrocortisone|hydrocortisone|mesh-list
101302858|NCT02008162|Autonomic Agents|autonomic agents|mesh-ancestor
101302859|NCT02008162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101302860|NCT02008162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302861|NCT02008162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101302862|NCT02008162|Respiratory System Agents|respiratory system agents|mesh-ancestor
101302863|NCT02008162|Parasympatholytics|parasympatholytics|mesh-ancestor
101302864|NCT02008162|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101302865|NCT02008162|Cholinergic Agents|cholinergic agents|mesh-ancestor
101302866|NCT02008162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101302867|NCT02008162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302868|NCT02008162|Anticonvulsants|anticonvulsants|mesh-ancestor
101302869|NCT02008162|Tocolytic Agents|tocolytic agents|mesh-ancestor
101302870|NCT02008162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101302871|NCT02008162|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101302872|NCT02008162|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101302873|NCT02008162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101302874|NCT02008162|Adrenergic Agents|adrenergic agents|mesh-ancestor
101302875|NCT02008201|Vitamin D|vitamin d|mesh-list
101302876|NCT02008201|Vitamins|vitamins|mesh-ancestor
101302877|NCT02008201|Micronutrients|micronutrients|mesh-ancestor
101302878|NCT02008201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302879|NCT02008201|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101302880|NCT02008214|Pentoxifylline|pentoxifylline|mesh-list
101302882|NCT02008214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101302883|NCT02008214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302884|NCT02008214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101302885|NCT02008214|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101302886|NCT02008214|Protective Agents|protective agents|mesh-ancestor
101302887|NCT02008214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302888|NCT02008214|Vasodilator Agents|vasodilator agents|mesh-ancestor
101302889|NCT02008214|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101302891|NCT02008383|Panitumumab|panitumumab|mesh-list
101302892|NCT02008383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101302893|NCT02008383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302894|NCT02008422|Oxaliplatin|oxaliplatin|mesh-list
101302895|NCT02008422|Tegafur|tegafur|mesh-list
101302896|NCT02008422|Endostar protein|endostar protein|mesh-list
101302897|NCT02008422|Endostatins|endostatins|mesh-list
101302898|NCT02008422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302899|NCT02008422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101302900|NCT02008422|Antimetabolites|antimetabolites|mesh-ancestor
101302901|NCT02008422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302902|NCT02008422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101302903|NCT02008422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101302904|NCT02008422|Growth Substances|growth substances|mesh-ancestor
101302905|NCT02008422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302906|NCT02008422|Growth Inhibitors|growth inhibitors|mesh-ancestor
101302907|NCT02008461|Botulinum Toxins|botulinum toxins|mesh-list
101302908|NCT02008461|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101317564|NCT00012142|MTOR Inhibitors|mtor inhibitors|mesh-list
101302909|NCT02008461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101302910|NCT02008461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302912|NCT02008461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101302913|NCT02008461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302914|NCT02008578|Immunoglobulins|immunoglobulins|mesh-list
101302915|NCT02008578|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101302916|NCT02008578|Antibodies|antibodies|mesh-list
101302917|NCT02008578|Immunologic Factors|immunologic factors|mesh-ancestor
101302918|NCT02008578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302919|NCT02008721|Neuroprotective Agents|neuroprotective agents|mesh-list
101302920|NCT02008721|Protective Agents|protective agents|mesh-ancestor
101302921|NCT02008721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302922|NCT02008734|Palbociclib|palbociclib|mesh-list
101302923|NCT02008734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101302924|NCT02008734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101302925|NCT02008734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101302926|NCT02008734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302927|NCT02008747|Magnesium Sulfate|magnesium sulfate|mesh-list
101302928|NCT02008747|Analgesics|analgesics|mesh-ancestor
101302929|NCT02008747|Sensory System Agents|sensory system agents|mesh-ancestor
101302930|NCT02008747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101302931|NCT02008747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302932|NCT02008747|Anesthetics|anesthetics|mesh-ancestor
101302933|NCT02008747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101302934|NCT02008747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101302937|NCT02008747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101302938|NCT02008747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302939|NCT02008747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101302940|NCT02008747|Tocolytic Agents|tocolytic agents|mesh-ancestor
101302941|NCT02008747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101302942|NCT02008786|Ramipril|ramipril|mesh-list
101302943|NCT02008786|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101302944|NCT02008786|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101302945|NCT02008786|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101302946|NCT02008786|Antimetabolites|antimetabolites|mesh-ancestor
101302947|NCT02008786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302948|NCT02008786|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101302949|NCT02008786|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101302950|NCT02008786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101302951|NCT02008786|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101302952|NCT02008786|Protease Inhibitors|protease inhibitors|mesh-ancestor
101302953|NCT02008786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101302954|NCT02008968|Allopurinol|allopurinol|mesh-list
101302955|NCT02008968|Antimetabolites|antimetabolites|mesh-ancestor
101302956|NCT02008968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302957|NCT02008968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101302958|NCT02008968|Gout Suppressants|gout suppressants|mesh-ancestor
101302959|NCT02008968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101302960|NCT02008968|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101302961|NCT02008968|Antioxidants|antioxidants|mesh-ancestor
101302962|NCT02008968|Protective Agents|protective agents|mesh-ancestor
101302963|NCT02008968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302964|NCT02008981|Aspirin|aspirin|mesh-list
101302965|NCT02008981|Turmeric extract|turmeric extract|mesh-list
101302966|NCT02008981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101302967|NCT02008981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101302968|NCT02008981|Analgesics|analgesics|mesh-ancestor
101302969|NCT02008981|Sensory System Agents|sensory system agents|mesh-ancestor
101302970|NCT02008981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101302971|NCT02008981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302972|NCT02008981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101302973|NCT02008981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101302974|NCT02008981|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101302975|NCT02008981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101302976|NCT02008981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101302977|NCT02008981|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101302978|NCT02008981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101302979|NCT02008981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101302980|NCT02008981|Antipyretics|antipyretics|mesh-ancestor
101302981|NCT02008981|Antioxidants|antioxidants|mesh-ancestor
101302982|NCT02008981|Protective Agents|protective agents|mesh-ancestor
101302983|NCT02009007|Phenylephrine|phenylephrine|mesh-list
101302985|NCT02009007|Oxymetazoline|oxymetazoline|mesh-list
101302986|NCT02009007|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101302987|NCT02009007|Mydriatics|mydriatics|mesh-ancestor
101302988|NCT02009007|Autonomic Agents|autonomic agents|mesh-ancestor
101302989|NCT02009007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101302990|NCT02009007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101302992|NCT02009007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101302993|NCT02009007|Nasal Decongestants|nasal decongestants|mesh-ancestor
101302995|NCT02009007|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101302996|NCT02009007|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101302997|NCT02009007|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101302998|NCT02009007|Adrenergic Agents|adrenergic agents|mesh-ancestor
101302999|NCT02009007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101303000|NCT02009007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303001|NCT02009007|Protective Agents|protective agents|mesh-ancestor
101303002|NCT02009007|Dopamine Agents|dopamine agents|mesh-ancestor
101303003|NCT02009098|Cefuroxime|cefuroxime|mesh-list
101303004|NCT02009098|Cefuroxime axetil|cefuroxime axetil|mesh-list
101263345|NCT01761487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101303005|NCT02009098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101303006|NCT02009098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101303008|NCT02009189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101303009|NCT02009189|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101303010|NCT02009189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303011|NCT02009202|Picosulfate sodium|picosulfate sodium|mesh-list
101303012|NCT02009202|Cathartics|cathartics|mesh-ancestor
101303013|NCT02009202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101303014|NCT02009215|Piperaquine|piperaquine|mesh-list
101303015|NCT02009215|Artenimol|artenimol|mesh-list
101303016|NCT02009215|Antimalarials|antimalarials|mesh-ancestor
101303017|NCT02009215|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101303018|NCT02009215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101303019|NCT02009215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101303020|NCT05778825|Minoxidil|minoxidil|mesh-list
101303021|NCT05778825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101303022|NCT05778825|Vasodilator Agents|vasodilator agents|mesh-ancestor
101303023|NCT05778461|N-Methylaspartate|n-methylaspartate|mesh-list
101303024|NCT05778461|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
101303025|NCT05778461|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101303026|NCT05778461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101303027|NCT05778461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303028|NCT05778461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303029|NCT05778305|Dexmedetomidine|dexmedetomidine|mesh-list
101303030|NCT05778305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101303031|NCT05778305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101303032|NCT05778305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303033|NCT05778305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101303034|NCT05778305|Analgesics|analgesics|mesh-ancestor
101303035|NCT05778305|Sensory System Agents|sensory system agents|mesh-ancestor
101303036|NCT05778305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101303037|NCT05778305|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101303038|NCT05778305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101303039|NCT05778305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101303040|NCT05778305|Adrenergic Agents|adrenergic agents|mesh-ancestor
101303041|NCT05778305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101303042|NCT05778305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303043|NCT05778227|Etidronic Acid|etidronic acid|mesh-list
101303044|NCT05778227|Sodium Hypochlorite|sodium hypochlorite|mesh-list
101303045|NCT05778227|Eusol|eusol|mesh-list
101303046|NCT05778227|Acetic Acid|acetic acid|mesh-list
101303047|NCT05778227|Retinol acetate|retinol acetate|mesh-list
101303048|NCT05778227|Ethylene|ethylene|mesh-list
101303049|NCT05778227|Maleic acid|maleic acid|mesh-list
101303050|NCT05778227|Disinfectants|disinfectants|mesh-ancestor
101303051|NCT05778227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101303052|NCT05778227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101303053|NCT05778227|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101303054|NCT05778227|Immunologic Factors|immunologic factors|mesh-ancestor
101303055|NCT05778227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303056|NCT05778227|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101303057|NCT05778227|Protective Agents|protective agents|mesh-ancestor
101303058|NCT05778227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303059|NCT05778227|Plant Growth Regulators|plant growth regulators|mesh-ancestor
101303060|NCT05778227|Growth Substances|growth substances|mesh-ancestor
101303061|NCT05778227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101303062|NCT05778227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303063|NCT05778227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101303064|NCT05778097|Androgens|androgens|mesh-list
101303065|NCT05778097|Hormones|hormones|mesh-ancestor
101303066|NCT05778097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101303067|NCT05778097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303068|NCT05778084|Empagliflozin|empagliflozin|mesh-list
101303069|NCT05778084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101303070|NCT05778084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303071|NCT05778084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101303072|NCT05778084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303074|NCT05777902|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101263347|NCT01761513|Esomeprazole|esomeprazole|mesh-list
101263348|NCT01761513|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101303075|NCT05777902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303076|NCT05777902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101303077|NCT05777902|Immunologic Factors|immunologic factors|mesh-ancestor
101303078|NCT05777902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303079|NCT05777824|Antibodies|antibodies|mesh-list
101303080|NCT05777824|Immunologic Factors|immunologic factors|mesh-ancestor
101303081|NCT05777824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303082|NCT05777707|Paclitaxel|paclitaxel|mesh-list
101303083|NCT05777707|Carboplatin|carboplatin|mesh-list
101303084|NCT05777707|Nedaplatin|nedaplatin|mesh-list
101303085|NCT05777707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101303086|NCT05777707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303087|NCT05777707|Tubulin Modulators|tubulin modulators|mesh-ancestor
101303088|NCT05777707|Antimitotic Agents|antimitotic agents|mesh-ancestor
101303089|NCT05777707|Mitosis Modulators|mitosis modulators|mesh-ancestor
101303090|NCT05777707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303091|NCT05777694|Anesthetics|anesthetics|mesh-list
101303092|NCT05777694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101303093|NCT05777694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303094|NCT05777369|Prednisone|prednisone|mesh-list
101303095|NCT05777369|Cyclophosphamide|cyclophosphamide|mesh-list
101303096|NCT05777369|Rituximab|rituximab|mesh-list
101303097|NCT05777369|Vincristine|vincristine|mesh-list
101303098|NCT05777369|Mitoxantrone|mitoxantrone|mesh-list
101303099|NCT05777369|Vindesine|vindesine|mesh-list
101303100|NCT05777369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101303101|NCT05777369|Immunologic Factors|immunologic factors|mesh-ancestor
101303102|NCT05777369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303103|NCT05777369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101303104|NCT05777369|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101303105|NCT05777369|Alkylating Agents|alkylating agents|mesh-ancestor
101303106|NCT05777369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303107|NCT05777369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303108|NCT05777369|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101303109|NCT05777369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101303110|NCT05777369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101303111|NCT05777369|Glucocorticoids|glucocorticoids|mesh-ancestor
101303112|NCT05777369|Hormones|hormones|mesh-ancestor
101303113|NCT05777369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101303114|NCT05777369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101303115|NCT05777369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101303116|NCT05777369|Tubulin Modulators|tubulin modulators|mesh-ancestor
101303117|NCT05777369|Antimitotic Agents|antimitotic agents|mesh-ancestor
101303118|NCT05777369|Mitosis Modulators|mitosis modulators|mesh-ancestor
101303119|NCT05777369|Analgesics|analgesics|mesh-ancestor
101303120|NCT05777369|Sensory System Agents|sensory system agents|mesh-ancestor
101303121|NCT05777369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101303122|NCT05777369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101303123|NCT05777369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101303126|NCT05777278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303127|NCT05777278|Tubulin Modulators|tubulin modulators|mesh-ancestor
101303128|NCT05777278|Antimitotic Agents|antimitotic agents|mesh-ancestor
101303129|NCT05777278|Mitosis Modulators|mitosis modulators|mesh-ancestor
101303130|NCT05777278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303132|NCT05777122|Anesthetics, Local|anesthetics, local|mesh-ancestor
101303133|NCT05777122|Anesthetics|anesthetics|mesh-ancestor
101303134|NCT05777122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101303135|NCT05777122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303136|NCT05777122|Sensory System Agents|sensory system agents|mesh-ancestor
101303137|NCT05777122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101303138|NCT05777122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101303139|NCT05777122|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101303141|NCT05777122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101303142|NCT05777122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263351|NCT01761513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101304274|NCT02012075|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101303143|NCT05753306|Cisplatin|cisplatin|mesh-list
101303144|NCT05753306|Docetaxel|docetaxel|mesh-list
101303145|NCT05753306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303146|NCT05753306|Tubulin Modulators|tubulin modulators|mesh-ancestor
101303147|NCT05753306|Antimitotic Agents|antimitotic agents|mesh-ancestor
101303148|NCT05753306|Mitosis Modulators|mitosis modulators|mesh-ancestor
101303149|NCT05753306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303150|NCT05616390|Bevacizumab|bevacizumab|mesh-list
101303151|NCT05616390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101303152|NCT05616390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303153|NCT05616390|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101303154|NCT05616390|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101303155|NCT05616390|Growth Substances|growth substances|mesh-ancestor
101303156|NCT05616390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303157|NCT05616390|Growth Inhibitors|growth inhibitors|mesh-ancestor
101303158|NCT05613413|Pembrolizumab|pembrolizumab|mesh-list
101303159|NCT05613413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101303160|NCT05613413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303161|NCT05613413|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101303162|NCT05613413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303163|NCT05597150|Magnesium citrate|magnesium citrate|mesh-list
101303164|NCT05597150|Cathartics|cathartics|mesh-ancestor
101303165|NCT05597150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101303166|NCT05548270|Scopolamine|scopolamine|mesh-list
101303167|NCT05548270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101303168|NCT05548270|Antiemetics|antiemetics|mesh-ancestor
101303169|NCT05548270|Autonomic Agents|autonomic agents|mesh-ancestor
101303170|NCT05548270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101303171|NCT05548270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303178|NCT05548270|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101303179|NCT05534620|Fludarabine|fludarabine|mesh-list
101303181|NCT05534620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303182|NCT05534620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303183|NCT05534620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101303184|NCT05534620|Alkylating Agents|alkylating agents|mesh-ancestor
101303192|NCT05499052|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101303193|NCT05499052|Hormones|hormones|mesh-ancestor
101303194|NCT05499052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101303195|NCT05499052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303196|NCT05493735|Lidocaine|lidocaine|mesh-list
101303197|NCT05493735|Anesthetics, Local|anesthetics, local|mesh-ancestor
101303198|NCT05493735|Anesthetics|anesthetics|mesh-ancestor
101303199|NCT05493735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101303200|NCT05493735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303201|NCT05493735|Sensory System Agents|sensory system agents|mesh-ancestor
101303202|NCT05493735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101303203|NCT05493735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101303204|NCT05493735|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101303205|NCT05493735|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101303206|NCT05493735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101303207|NCT05493735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303210|NCT05410158|Sensory System Agents|sensory system agents|mesh-ancestor
101303211|NCT05410158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101303212|NCT05410158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303213|NCT05410158|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101303214|NCT05410158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101303215|NCT05410158|Anesthetics, General|anesthetics, general|mesh-ancestor
101303216|NCT05410158|Anesthetics|anesthetics|mesh-ancestor
101303217|NCT05410158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101303218|NCT05410158|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101303219|NCT05410158|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101303220|NCT05410158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101303221|NCT05410158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303223|NCT05291403|Erythromycin Estolate|erythromycin estolate|mesh-list
101303224|NCT05291403|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101303225|NCT05291403|Erythromycin stearate|erythromycin stearate|mesh-list
101303226|NCT05291403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101303227|NCT05291403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101303228|NCT05291403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101303229|NCT05291403|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101303230|NCT05291403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101303231|NCT05291403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303232|NCT05279690|Colchicine|colchicine|mesh-list
101303233|NCT05279690|Gout Suppressants|gout suppressants|mesh-ancestor
101303234|NCT05279690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101303235|NCT05279690|Tubulin Modulators|tubulin modulators|mesh-ancestor
101303236|NCT05279690|Antimitotic Agents|antimitotic agents|mesh-ancestor
101303237|NCT05279690|Mitosis Modulators|mitosis modulators|mesh-ancestor
101303238|NCT05279690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303239|NCT05279690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303240|NCT05255302|Pembrolizumab|pembrolizumab|mesh-list
101303241|NCT05255302|Pemetrexed|pemetrexed|mesh-list
101303242|NCT05255302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101303243|NCT05255302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303244|NCT05255302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101303245|NCT05255302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303246|NCT05255302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101303247|NCT05255302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101303248|NCT05255302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101303249|NCT05138068|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
101303250|NCT05138068|Hallucinogens|hallucinogens|mesh-ancestor
101303251|NCT05138068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303252|NCT05138068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101303253|NCT05138068|Serotonin Agents|serotonin agents|mesh-ancestor
101303254|NCT05138068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101303255|NCT05138068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303256|NCT05138068|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101303257|NCT05138068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101303258|NCT05138068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101303259|NCT05138068|Adrenergic Agents|adrenergic agents|mesh-ancestor
101303260|NCT05121168|Bupivacaine|bupivacaine|mesh-list
101303261|NCT05121168|Anesthetics, Local|anesthetics, local|mesh-ancestor
101303262|NCT05121168|Anesthetics|anesthetics|mesh-ancestor
101303263|NCT05121168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101303264|NCT05121168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303265|NCT05121168|Sensory System Agents|sensory system agents|mesh-ancestor
101303266|NCT05121168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101303267|NCT05091905|Ropivacaine|ropivacaine|mesh-list
101303268|NCT05091905|Anesthetics, Local|anesthetics, local|mesh-list
101303270|NCT05091905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101303271|NCT05091905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303272|NCT05091905|Sensory System Agents|sensory system agents|mesh-ancestor
101303273|NCT05091905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101303274|NCT05085873|Midazolam|midazolam|mesh-list
101303275|NCT05085873|Sodium Oxybate|sodium oxybate|mesh-list
101303276|NCT05085873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101303277|NCT05085873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101303278|NCT05085873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101303279|NCT05085873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303280|NCT05085873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101303281|NCT05085873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101303282|NCT05085873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101303283|NCT05085873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101303284|NCT05085873|Anesthetics, General|anesthetics, general|mesh-ancestor
101303285|NCT05085873|Anesthetics|anesthetics|mesh-ancestor
101303286|NCT05085873|GABA Modulators|gaba modulators|mesh-ancestor
101303287|NCT05085873|GABA Agents|gaba agents|mesh-ancestor
101303288|NCT05085873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101303289|NCT05085873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263366|NCT01761552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303290|NCT04983589|Pilocarpine|pilocarpine|mesh-list
101303291|NCT04983589|Miotics|miotics|mesh-ancestor
101303292|NCT04983589|Autonomic Agents|autonomic agents|mesh-ancestor
101303293|NCT04983589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101303294|NCT04983589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303296|NCT04983589|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101303297|NCT04983589|Cholinergic Agents|cholinergic agents|mesh-ancestor
101303298|NCT04983589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101303299|NCT04983589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303300|NCT04961580|Ceftazidime|ceftazidime|mesh-list
101303301|NCT04961580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101303302|NCT04961580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101303303|NCT04886154|Vaccines|vaccines|mesh-list
101303304|NCT04886154|Immunologic Factors|immunologic factors|mesh-ancestor
101303305|NCT04886154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303306|NCT04861922|Heparin|heparin|mesh-list
101303307|NCT04861922|Calcium heparin|calcium heparin|mesh-list
101303308|NCT04861922|Anticoagulants|anticoagulants|mesh-ancestor
101303309|NCT04861922|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101303310|NCT04861922|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101303311|NCT04861922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303312|NCT04840472|Panitumumab|panitumumab|mesh-list
101303313|NCT04840472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101303314|NCT04840472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303315|NCT04794517|Dapagliflozin|dapagliflozin|mesh-list
101303316|NCT04794517|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101303317|NCT04794517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303318|NCT04794517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101303319|NCT04794517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303320|NCT04782830|Midodrine|midodrine|mesh-list
101303321|NCT04782830|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101303322|NCT04782830|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101303323|NCT04782830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101303324|NCT04782830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101303325|NCT04782830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303326|NCT04782830|Adrenergic Agents|adrenergic agents|mesh-ancestor
101303327|NCT04782830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101303328|NCT04782830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303329|NCT04782830|Sympathomimetics|sympathomimetics|mesh-ancestor
101303330|NCT04782830|Autonomic Agents|autonomic agents|mesh-ancestor
101303331|NCT04782830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101303332|NCT04782830|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101303333|NCT04782830|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101303334|NCT04782830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101303335|NCT04782830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101303336|NCT04771000|Ambrisentan|ambrisentan|mesh-list
101303337|NCT04771000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101303341|NCT04620382|Midodrine|midodrine|mesh-list
101303342|NCT04620382|Sympathomimetics|sympathomimetics|mesh-ancestor
101303343|NCT04620382|Autonomic Agents|autonomic agents|mesh-ancestor
101303344|NCT04620382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101303345|NCT04620382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303346|NCT04620382|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101303347|NCT04620382|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101303348|NCT04620382|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101303349|NCT04620382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101303350|NCT04620382|Adrenergic Agents|adrenergic agents|mesh-ancestor
101303351|NCT04620382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101303352|NCT04620382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303353|NCT04567420|Fulvestrant|fulvestrant|mesh-list
101303355|NCT04567420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101303356|NCT04567420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303358|NCT04567420|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101303359|NCT04567420|Hormone Antagonists|hormone antagonists|mesh-ancestor
101303360|NCT04567420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101303361|NCT04567420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303362|NCT04567420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101263372|NCT01761552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101303363|NCT04567420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101303364|NCT04567420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303365|NCT04565483|Benralizumab|benralizumab|mesh-list
101303366|NCT04565483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101303367|NCT04565483|Respiratory System Agents|respiratory system agents|mesh-ancestor
101303369|NCT04495855|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101303370|NCT04495855|Contraceptive Agents|contraceptive agents|mesh-ancestor
101303371|NCT04495855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101303372|NCT04495855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303373|NCT04495855|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101303374|NCT04495855|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101303375|NCT04495855|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101303376|NCT04495855|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101303377|NCT04495855|Hormone Antagonists|hormone antagonists|mesh-ancestor
101303378|NCT04495855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101303379|NCT04495855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101303380|NCT04495855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303381|NCT04461587|Pirfenidone|pirfenidone|mesh-list
101303382|NCT04461587|Analgesics|analgesics|mesh-ancestor
101303383|NCT04461587|Sensory System Agents|sensory system agents|mesh-ancestor
101303384|NCT04461587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101303385|NCT04461587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303386|NCT04461587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101303387|NCT04461587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101303388|NCT04461587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101303389|NCT04461587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101303390|NCT04461587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303391|NCT04371107|Azithromycin|azithromycin|mesh-list
101303392|NCT04371107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101303393|NCT04371107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101303394|NCT04364984|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101303395|NCT04364984|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101303396|NCT04364984|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
101303397|NCT04364984|Renin Inhibitors|renin inhibitors|mesh-list
101303398|NCT04364984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303399|NCT04364984|Protease Inhibitors|protease inhibitors|mesh-ancestor
101303400|NCT04278833|Dexamethasone|dexamethasone|mesh-list
101303401|NCT04278833|Triamcinolone|triamcinolone|mesh-list
101303402|NCT04278833|Betamethasone|betamethasone|mesh-list
101303403|NCT04278833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101303404|NCT04278833|Antiemetics|antiemetics|mesh-ancestor
101303405|NCT04278833|Autonomic Agents|autonomic agents|mesh-ancestor
101303406|NCT04278833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101303407|NCT04278833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303408|NCT04278833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101303409|NCT04278833|Glucocorticoids|glucocorticoids|mesh-ancestor
101303411|NCT04278833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101303412|NCT04278833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101303413|NCT04278833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303415|NCT04278833|Respiratory System Agents|respiratory system agents|mesh-ancestor
101303416|NCT04225065|Chlorhexidine|chlorhexidine|mesh-list
101303417|NCT04225065|Povidone-Iodine|povidone-iodine|mesh-list
101303418|NCT04225065|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101303419|NCT04225065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101303420|NCT04225065|Disinfectants|disinfectants|mesh-ancestor
101303421|NCT04221087|Dexamethasone|dexamethasone|mesh-list
101303422|NCT04221087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101303423|NCT04221087|Antiemetics|antiemetics|mesh-ancestor
101303424|NCT04221087|Autonomic Agents|autonomic agents|mesh-ancestor
101303425|NCT04221087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101303426|NCT04221087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263375|NCT01761552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303427|NCT04221087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101303428|NCT04221087|Glucocorticoids|glucocorticoids|mesh-ancestor
101303430|NCT04221087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101303431|NCT04221087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101303432|NCT04221087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303434|NCT04200911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101303435|NCT04200911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101303436|NCT04200911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101303437|NCT04200911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303438|NCT04200911|Antifungal Agents|antifungal agents|mesh-ancestor
101303439|NCT04200911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101303440|NCT04200911|Immunologic Factors|immunologic factors|mesh-ancestor
101303441|NCT04200911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303442|NCT04112641|Niacinamide|niacinamide|mesh-list
101303443|NCT04112641|Niacin|niacin|mesh-list
101303444|NCT04112641|Nicotinic Acids|nicotinic acids|mesh-list
101303445|NCT04112641|Vitamin B Complex|vitamin b complex|mesh-ancestor
101303446|NCT04112641|Vitamins|vitamins|mesh-ancestor
101303447|NCT04112641|Micronutrients|micronutrients|mesh-ancestor
101303448|NCT04112641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303449|NCT04112641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101303450|NCT04112641|Antimetabolites|antimetabolites|mesh-ancestor
101303451|NCT04112641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303452|NCT04112641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101303453|NCT04112641|Vasodilator Agents|vasodilator agents|mesh-ancestor
101303454|NCT04062591|Piroxicam|piroxicam|mesh-list
101303455|NCT04062591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101303456|NCT04062591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101303457|NCT04062591|Analgesics|analgesics|mesh-ancestor
101303458|NCT04062591|Sensory System Agents|sensory system agents|mesh-ancestor
101303459|NCT04062591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101303460|NCT04062591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303461|NCT04062591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101303462|NCT04062591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101303463|NCT04062591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101303464|NCT04062591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101303465|NCT04062591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303466|NCT04059770|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101303467|NCT04059770|Amphotericin B|amphotericin b|mesh-list
101303468|NCT04059770|Antifungal Agents|antifungal agents|mesh-ancestor
101303469|NCT04059770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101303470|NCT04059770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101303471|NCT04059770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101303472|NCT04059770|Amebicides|amebicides|mesh-ancestor
101303473|NCT04059770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101303474|NCT04050280|Cytarabine|cytarabine|mesh-list
101303475|NCT04050280|Cladribine|cladribine|mesh-list
101303476|NCT04050280|Gemtuzumab|gemtuzumab|mesh-list
101303477|NCT04050280|Lenograstim|lenograstim|mesh-list
101303478|NCT04050280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101303479|NCT04050280|Antimetabolites|antimetabolites|mesh-ancestor
101303480|NCT04050280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303481|NCT04050280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303482|NCT04050280|Antiviral Agents|antiviral agents|mesh-ancestor
101303483|NCT04050280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101303484|NCT04050280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101303485|NCT04050280|Immunologic Factors|immunologic factors|mesh-ancestor
101303486|NCT04050280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303487|NCT04050280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101303488|NCT04050280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101303489|NCT04050280|Immunotoxins|immunotoxins|mesh-ancestor
101303490|NCT04050280|Immunoconjugates|immunoconjugates|mesh-ancestor
101303491|NCT04018755|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101303492|NCT04018755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101303493|NCT03994731|Acetaminophen|acetaminophen|mesh-list
101303494|NCT03994731|Folic Acid|folic acid|mesh-list
101303495|NCT03994731|Fexofenadine|fexofenadine|mesh-list
101303496|NCT03994731|Methylprednisolone|methylprednisolone|mesh-list
101303497|NCT03994731|Methotrexate|methotrexate|mesh-list
101303498|NCT03994731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101303499|NCT03994731|Abortifacient Agents|abortifacient agents|mesh-ancestor
101263384|NCT01761656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101263386|NCT01761656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101303500|NCT03994731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101303501|NCT03994731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303502|NCT03994731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101303503|NCT03994731|Antimetabolites|antimetabolites|mesh-ancestor
101303504|NCT03994731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303505|NCT03994731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303506|NCT03994731|Dermatologic Agents|dermatologic agents|mesh-ancestor
101303507|NCT03994731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101303508|NCT03994731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101303509|NCT03994731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101303510|NCT03994731|Immunologic Factors|immunologic factors|mesh-ancestor
101303511|NCT03994731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101303512|NCT03994731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101303513|NCT03994731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101303514|NCT03994731|Analgesics|analgesics|mesh-ancestor
101303515|NCT03994731|Sensory System Agents|sensory system agents|mesh-ancestor
101303516|NCT03994731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101303517|NCT03994731|Antipyretics|antipyretics|mesh-ancestor
101303518|NCT03994731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101303519|NCT03994731|Antiemetics|antiemetics|mesh-ancestor
101303520|NCT03994731|Autonomic Agents|autonomic agents|mesh-ancestor
101303521|NCT03994731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101303522|NCT03994731|Glucocorticoids|glucocorticoids|mesh-ancestor
101303523|NCT03994731|Hormones|hormones|mesh-ancestor
101303524|NCT03994731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101303525|NCT03994731|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101303527|NCT03994731|Hematinics|hematinics|mesh-ancestor
101303528|NCT03994731|Vitamin B Complex|vitamin b complex|mesh-ancestor
101303529|NCT03994731|Vitamins|vitamins|mesh-ancestor
101303530|NCT03994731|Micronutrients|micronutrients|mesh-ancestor
101303531|NCT03994731|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101303532|NCT03994731|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101303533|NCT03994731|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101303534|NCT03994731|Histamine Antagonists|histamine antagonists|mesh-ancestor
101303535|NCT03994731|Histamine Agents|histamine agents|mesh-ancestor
101303536|NCT03994731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101303537|NCT03984357|Gemcitabine|gemcitabine|mesh-list
101303538|NCT03984357|Antibodies|antibodies|mesh-list
101303539|NCT03984357|Antibodies, Blocking|antibodies, blocking|mesh-list
101303540|NCT03984357|Immunologic Factors|immunologic factors|mesh-ancestor
101303541|NCT03984357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303542|NCT03984357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303543|NCT03984357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101303544|NCT03984357|Antimetabolites|antimetabolites|mesh-ancestor
101303545|NCT03984357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303553|NCT03824522|BAX 855|bax 855|mesh-list
101303554|NCT03824522|Coagulants|coagulants|mesh-ancestor
101303555|NCT03812991|Calcitonin|calcitonin|mesh-list
101303556|NCT03812991|Salmon calcitonin|salmon calcitonin|mesh-list
101303557|NCT03812991|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
101303558|NCT03812991|Katacalcin|katacalcin|mesh-list
101303559|NCT03812991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101303560|NCT03812991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303561|NCT03812991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101303562|NCT03812991|Vasodilator Agents|vasodilator agents|mesh-ancestor
101303563|NCT03737968|Durvalumab|durvalumab|mesh-list
101303564|NCT03737968|Tremelimumab|tremelimumab|mesh-list
101303565|NCT03737968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101303566|NCT03737968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101303567|NCT03737968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303568|NCT03737968|Immunologic Factors|immunologic factors|mesh-ancestor
101303569|NCT03737968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303570|NCT03652753|Acetylcysteine|acetylcysteine|mesh-list
101303571|NCT03652753|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101303572|NCT03652753|Antiviral Agents|antiviral agents|mesh-ancestor
101303573|NCT03652753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101303574|NCT03652753|Expectorants|expectorants|mesh-ancestor
101303575|NCT03652753|Respiratory System Agents|respiratory system agents|mesh-ancestor
101303576|NCT03652753|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101303577|NCT03652753|Antioxidants|antioxidants|mesh-ancestor
101263390|NCT01761669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303578|NCT03652753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303579|NCT03652753|Protective Agents|protective agents|mesh-ancestor
101303580|NCT03652753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303581|NCT03652753|Antidotes|antidotes|mesh-ancestor
101303582|NCT03581877|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101303584|NCT03581877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101303585|NCT03581877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303586|NCT03556202|Mirikizumab|mirikizumab|mesh-list
101303587|NCT03556202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101303588|NCT03556202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101303589|NCT03556202|Analgesics|analgesics|mesh-ancestor
101303590|NCT03556202|Sensory System Agents|sensory system agents|mesh-ancestor
101303591|NCT03556202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101303592|NCT03556202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303593|NCT03556202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101303595|NCT03556202|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101303596|NCT03556202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101303597|NCT03480438|Blinatumomab|blinatumomab|mesh-list
101303598|NCT03480438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303599|NCT03463876|Apatinib|apatinib|mesh-list
101303600|NCT03463876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303601|NCT03463876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101303602|NCT03463876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101303603|NCT03463876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303604|NCT03461120|Anesthetics|anesthetics|mesh-list
101303605|NCT03461120|Anesthetics, Local|anesthetics, local|mesh-list
101303606|NCT03461120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101303607|NCT03461120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303608|NCT03461120|Sensory System Agents|sensory system agents|mesh-ancestor
101303609|NCT03461120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101303610|NCT03396588|Clonidine|clonidine|mesh-list
101303611|NCT03396588|Morphine|morphine|mesh-list
101303612|NCT03396588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101303613|NCT03396588|Narcotics|narcotics|mesh-ancestor
101303614|NCT03396588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101303615|NCT03396588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303616|NCT03396588|Analgesics|analgesics|mesh-ancestor
101303617|NCT03396588|Sensory System Agents|sensory system agents|mesh-ancestor
101303618|NCT03396588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101303619|NCT03396588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101303620|NCT03396588|Sympatholytics|sympatholytics|mesh-ancestor
101303621|NCT03396588|Autonomic Agents|autonomic agents|mesh-ancestor
101303622|NCT03396588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101303623|NCT03396588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101303624|NCT03396588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101303625|NCT03396588|Adrenergic Agents|adrenergic agents|mesh-ancestor
101303626|NCT03396588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101303627|NCT03396588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303628|NCT03361852|Rituximab|rituximab|mesh-list
101303629|NCT03361852|Pembrolizumab|pembrolizumab|mesh-list
101303630|NCT03361852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101303631|NCT03361852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303632|NCT03361852|Immunologic Factors|immunologic factors|mesh-ancestor
101303633|NCT03361852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303634|NCT03361852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101303635|NCT03361852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101303636|NCT03361852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303638|NCT03350516|Calcium Carbonate|calcium carbonate|mesh-list
101303639|NCT03350516|Calcium|calcium|mesh-list
101303640|NCT03350516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101303641|NCT03350516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303642|NCT03350516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101303643|NCT03350516|Antacids|antacids|mesh-ancestor
101303644|NCT03350516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303645|NCT03350516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101303646|NCT03350451|Lumasiran|lumasiran|mesh-list
101303647|NCT03350451|Renal Agents|renal agents|mesh-ancestor
101303648|NCT03329508|Pramipexole|pramipexole|mesh-list
101303649|NCT03329508|Rasagiline|rasagiline|mesh-list
101263396|NCT01761916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101303651|NCT03329508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303652|NCT03329508|Protective Agents|protective agents|mesh-ancestor
101303653|NCT03329508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303654|NCT03329508|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101303655|NCT03329508|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101303656|NCT03329508|Dopamine Agonists|dopamine agonists|mesh-ancestor
101303657|NCT03329508|Dopamine Agents|dopamine agents|mesh-ancestor
101303658|NCT03329508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101303659|NCT03329508|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101303660|NCT03329508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101303661|NCT03329508|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101303662|NCT03289039|Fulvestrant|fulvestrant|mesh-list
101303663|NCT03289039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101303664|NCT03289039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303665|NCT03289039|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101303666|NCT03289039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101303667|NCT03289039|Hormone Antagonists|hormone antagonists|mesh-ancestor
101303668|NCT03289039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101303669|NCT03289039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303670|NCT03281304|Tofacitinib|tofacitinib|mesh-list
101303671|NCT03281304|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101303672|NCT03281304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101303673|NCT03281304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101303674|NCT03281304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303675|NCT03153319|Adalimumab|adalimumab|mesh-list
101303676|NCT03153319|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101303677|NCT03153319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101303678|NCT03153319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101303679|NCT03145272|Oxycodone|oxycodone|mesh-list
101303680|NCT03145272|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101303681|NCT03145272|Narcotics|narcotics|mesh-ancestor
101303682|NCT03145272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101303683|NCT03145272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303684|NCT03145272|Analgesics|analgesics|mesh-ancestor
101303685|NCT03145272|Sensory System Agents|sensory system agents|mesh-ancestor
101303686|NCT03145272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101303687|NCT03127007|Atezolizumab|atezolizumab|mesh-list
101303688|NCT03127007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101303689|NCT03127007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303690|NCT03127007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101303691|NCT03127007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303692|NCT03109093|Blinatumomab|blinatumomab|mesh-list
101303693|NCT03109093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303694|NCT02726711|Trimethaphan|trimethaphan|mesh-list
101303695|NCT02726711|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
101303696|NCT02726711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101303697|NCT02726711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101303698|NCT02726711|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
101303699|NCT02726711|Autonomic Agents|autonomic agents|mesh-ancestor
101303700|NCT02726711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101303701|NCT02726711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303702|NCT02726711|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101303703|NCT02726711|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101303704|NCT02726711|Cholinergic Agents|cholinergic agents|mesh-ancestor
101303705|NCT02726711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101303706|NCT02726711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303707|NCT02726711|Vasodilator Agents|vasodilator agents|mesh-ancestor
101303708|NCT02691065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
101303709|NCT02691065|Integrase Inhibitors|integrase inhibitors|mesh-list
101303710|NCT02691065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101303711|NCT02691065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303712|NCT02691065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101303713|NCT02691065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101303714|NCT02691065|Antiviral Agents|antiviral agents|mesh-ancestor
101303715|NCT02691065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101303719|NCT02649998|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
101303721|NCT02649998|Natriuretic Agents|natriuretic agents|mesh-ancestor
101303722|NCT02649998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303723|NCT02649998|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101303724|NCT02649998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101303725|NCT02649998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303726|NCT02649998|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101303727|NCT02649998|Vasodilator Agents|vasodilator agents|mesh-ancestor
101303728|NCT02649998|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101303729|NCT02503358|Paclitaxel|paclitaxel|mesh-list
101303730|NCT02503358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101303731|NCT02503358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101303732|NCT02503358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303733|NCT02503358|Tubulin Modulators|tubulin modulators|mesh-ancestor
101303734|NCT02503358|Antimitotic Agents|antimitotic agents|mesh-ancestor
101303735|NCT02503358|Mitosis Modulators|mitosis modulators|mesh-ancestor
101303736|NCT02503358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303737|NCT02432963|Pembrolizumab|pembrolizumab|mesh-list
101303738|NCT02432963|Vaccines|vaccines|mesh-list
101303739|NCT02432963|Immunologic Factors|immunologic factors|mesh-ancestor
101303740|NCT02432963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303741|NCT02432963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101303742|NCT02432963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303743|NCT02432963|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101303744|NCT02432963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303745|NCT02358538|Ganaxolone|ganaxolone|mesh-list
101303746|NCT02358538|Neurosteroids|neurosteroids|mesh-ancestor
101303747|NCT02358538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101303748|NCT02358538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303749|NCT02358538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303750|NCT02358538|GABA Modulators|gaba modulators|mesh-ancestor
101303751|NCT02358538|GABA Agents|gaba agents|mesh-ancestor
101303752|NCT02349906|Treosulfan|treosulfan|mesh-list
101303753|NCT02349906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101303754|NCT02349906|Alkylating Agents|alkylating agents|mesh-ancestor
101303755|NCT02349906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303756|NCT02349906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303757|NCT02336087|Metformin|metformin|mesh-list
101303758|NCT02336087|Paclitaxel|paclitaxel|mesh-list
101303759|NCT02336087|Gemcitabine|gemcitabine|mesh-list
101303760|NCT02336087|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101303761|NCT02336087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101303762|NCT02336087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303763|NCT02336087|Tubulin Modulators|tubulin modulators|mesh-ancestor
101303764|NCT02336087|Antimitotic Agents|antimitotic agents|mesh-ancestor
101303765|NCT02336087|Mitosis Modulators|mitosis modulators|mesh-ancestor
101303766|NCT02336087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303767|NCT02336087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101303769|NCT02336087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101303770|NCT02336087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303771|NCT02332980|Pembrolizumab|pembrolizumab|mesh-list
101303772|NCT02332980|Idelalisib|idelalisib|mesh-list
101303773|NCT02332980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101303774|NCT02332980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303775|NCT02332980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101303776|NCT02332980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303777|NCT02332980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101303778|NCT02087826|Metformin|metformin|mesh-list
101303779|NCT02087826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101303780|NCT02087826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303781|NCT02048150|Antibodies|antibodies|mesh-list
101303782|NCT02048150|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101303783|NCT02048150|Immunologic Factors|immunologic factors|mesh-ancestor
101263409|NCT01761916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101263410|NCT01761968|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
101263411|NCT01761968|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101263412|NCT01761968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101303784|NCT02048150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303785|NCT02038452|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101303786|NCT02038452|Methylprednisolone|methylprednisolone|mesh-list
101303787|NCT02038452|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101303788|NCT02038452|Prednisolone|prednisolone|mesh-list
101303789|NCT02038452|Prednisolone acetate|prednisolone acetate|mesh-list
101303790|NCT02038452|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101303791|NCT02038452|Prednisolone phosphate|prednisolone phosphate|mesh-list
101303792|NCT02038452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101303793|NCT02038452|Antiemetics|antiemetics|mesh-ancestor
101303794|NCT02038452|Autonomic Agents|autonomic agents|mesh-ancestor
101303795|NCT02038452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101303796|NCT02038452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303797|NCT02038452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101303798|NCT02038452|Glucocorticoids|glucocorticoids|mesh-ancestor
101303799|NCT02038452|Hormones|hormones|mesh-ancestor
101303800|NCT02038452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101303801|NCT02038452|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101303802|NCT02038452|Protective Agents|protective agents|mesh-ancestor
101303803|NCT02038452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101303804|NCT02038452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303805|NCT01748448|Vitamin D|vitamin d|mesh-list
101303807|NCT01748448|Vitamins|vitamins|mesh-ancestor
101303808|NCT01748448|Micronutrients|micronutrients|mesh-ancestor
101303809|NCT01748448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303810|NCT01748448|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101303811|NCT01748448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101303812|NCT01476839|Cytarabine|cytarabine|mesh-list
101303813|NCT01476839|Etoposide|etoposide|mesh-list
101303814|NCT01476839|Etoposide phosphate|etoposide phosphate|mesh-list
101303815|NCT01476839|Melphalan|melphalan|mesh-list
101303816|NCT01476839|Carmustine|carmustine|mesh-list
101303817|NCT01476839|Basiliximab|basiliximab|mesh-list
101303818|NCT01476839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101303819|NCT01476839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303820|NCT01476839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101303821|NCT01476839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101303822|NCT01476839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101303823|NCT01476839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303824|NCT01476839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101303825|NCT01476839|Antimetabolites|antimetabolites|mesh-ancestor
101303826|NCT01476839|Antiviral Agents|antiviral agents|mesh-ancestor
101303827|NCT01476839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101303828|NCT01476839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101303829|NCT01476839|Immunologic Factors|immunologic factors|mesh-ancestor
101303830|NCT01476839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303831|NCT01476839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101303832|NCT01476839|Alkylating Agents|alkylating agents|mesh-ancestor
101303833|NCT01476839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101303835|NCT01332097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101303836|NCT01332097|Glucocorticoids|glucocorticoids|mesh-ancestor
101303837|NCT01332097|Hormones|hormones|mesh-ancestor
101303838|NCT01332097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101303839|NCT01332097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303840|NCT01332097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101303841|NCT01332097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303842|NCT01163357|Sirolimus|sirolimus|mesh-list
101303843|NCT01163357|Fludarabine|fludarabine|mesh-list
101303844|NCT01163357|Fludarabine phosphate|fludarabine phosphate|mesh-list
101303845|NCT01163357|Bortezomib|bortezomib|mesh-list
101263416|NCT01761994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101303846|NCT01163357|Melphalan|melphalan|mesh-list
101303847|NCT01163357|Tacrolimus|tacrolimus|mesh-list
101303848|NCT01163357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303849|NCT01163357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101303850|NCT01163357|Antimetabolites|antimetabolites|mesh-ancestor
101303851|NCT01163357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303852|NCT01163357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101303853|NCT01163357|Immunologic Factors|immunologic factors|mesh-ancestor
101303854|NCT01163357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303855|NCT01163357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101303856|NCT01163357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101303857|NCT01163357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101303858|NCT01163357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101303859|NCT01163357|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101303860|NCT01163357|Antifungal Agents|antifungal agents|mesh-ancestor
101303861|NCT01163357|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101303862|NCT01163357|Alkylating Agents|alkylating agents|mesh-ancestor
101303863|NCT01163357|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101303864|NCT00967005|Acetylcysteine|acetylcysteine|mesh-list
101303865|NCT00967005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101303866|NCT00967005|Antiviral Agents|antiviral agents|mesh-ancestor
101303867|NCT00967005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101303868|NCT00967005|Expectorants|expectorants|mesh-ancestor
101303869|NCT00967005|Respiratory System Agents|respiratory system agents|mesh-ancestor
101303870|NCT00967005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101303871|NCT00967005|Antioxidants|antioxidants|mesh-ancestor
101303872|NCT00967005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303873|NCT00967005|Protective Agents|protective agents|mesh-ancestor
101303874|NCT00967005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303875|NCT00967005|Antidotes|antidotes|mesh-ancestor
101303876|NCT00863369|Rituximab|rituximab|mesh-list
101303877|NCT00863369|Gemcitabine|gemcitabine|mesh-list
101303878|NCT00863369|Bortezomib|bortezomib|mesh-list
101303879|NCT00863369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101303880|NCT00863369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303881|NCT00863369|Immunologic Factors|immunologic factors|mesh-ancestor
101303882|NCT00863369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303883|NCT00863369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101303884|NCT00863369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101303885|NCT00863369|Antimetabolites|antimetabolites|mesh-ancestor
101303886|NCT00863369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303887|NCT00538031|Celecoxib|celecoxib|mesh-list
101303888|NCT00538031|Cyclophosphamide|cyclophosphamide|mesh-list
101303889|NCT00538031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101303890|NCT00538031|Immunologic Factors|immunologic factors|mesh-ancestor
101303891|NCT00538031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303892|NCT00538031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101303893|NCT00538031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101303894|NCT00538031|Alkylating Agents|alkylating agents|mesh-ancestor
101303895|NCT00538031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303896|NCT00538031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303897|NCT00538031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101303898|NCT00538031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101303899|NCT00538031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101303901|NCT00538031|Sensory System Agents|sensory system agents|mesh-ancestor
101303902|NCT00538031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101303903|NCT00538031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101303904|NCT00538031|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101303905|NCT00538031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101303906|NCT00538031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101303907|NCT00203996|Pioglitazone|pioglitazone|mesh-list
101303908|NCT00203996|Leuprolide|leuprolide|mesh-list
101303909|NCT00203996|Estrogens|estrogens|mesh-list
101303910|NCT00203996|Progestins|progestins|mesh-list
101303911|NCT00203996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101303912|NCT00203996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303913|NCT00203996|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101303914|NCT00203996|Fertility Agents|fertility agents|mesh-ancestor
101303915|NCT00203996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101303916|NCT00203996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101303917|NCT00203996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303918|NCT00203996|Hormones|hormones|mesh-ancestor
101303919|NCT00203996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101303920|NCT02009280|Anesthetics|anesthetics|mesh-list
101303921|NCT02009280|Propofol|propofol|mesh-list
101263428|NCT01761994|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101303923|NCT02009280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101303924|NCT02009280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303926|NCT02009280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101303927|NCT02009280|Anesthetics, General|anesthetics, general|mesh-ancestor
101303928|NCT02009280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101303929|NCT02009280|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101303930|NCT02009306|Fentanyl|fentanyl|mesh-list
101303931|NCT02009306|Midazolam|midazolam|mesh-list
101303932|NCT02009306|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101303933|NCT02009306|Narcotics|narcotics|mesh-ancestor
101303934|NCT02009306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101303935|NCT02009306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303936|NCT02009306|Analgesics|analgesics|mesh-ancestor
101303937|NCT02009306|Sensory System Agents|sensory system agents|mesh-ancestor
101303938|NCT02009306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101303939|NCT02009306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101303940|NCT02009306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101303941|NCT02009306|Anesthetics, General|anesthetics, general|mesh-ancestor
101303942|NCT02009306|Anesthetics|anesthetics|mesh-ancestor
101303943|NCT02009306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101303944|NCT02009306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101303945|NCT02009306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101303946|NCT02009306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101303947|NCT02009306|GABA Modulators|gaba modulators|mesh-ancestor
101303948|NCT02009306|GABA Agents|gaba agents|mesh-ancestor
101303949|NCT02009306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101303950|NCT02009306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303951|NCT02009410|Pancrelipase|pancrelipase|mesh-list
101303952|NCT02009410|Pancreatin|pancreatin|mesh-list
101303953|NCT02009410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101303954|NCT02009436|Azacitidine|azacitidine|mesh-list
101303955|NCT02009436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101303956|NCT02009436|Antimetabolites|antimetabolites|mesh-ancestor
101303957|NCT02009436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303959|NCT02009436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101303960|NCT02009462|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
101303961|NCT02009462|Vasodilator Agents|vasodilator agents|mesh-ancestor
101303962|NCT02009462|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101303963|NCT02009462|Protective Agents|protective agents|mesh-ancestor
101303964|NCT02009462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303965|NCT02009488|Canagliflozin|canagliflozin|mesh-list
101303966|NCT02009488|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101303967|NCT02009488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303968|NCT02009488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101303969|NCT02009488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303970|NCT02009514|Dialysis Solutions|dialysis solutions|mesh-list
101303971|NCT02009514|Hemodialysis Solutions|hemodialysis solutions|mesh-list
101303972|NCT02009514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101303973|NCT02009540|Botulinum Toxins|botulinum toxins|mesh-list
101303974|NCT02009540|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101303975|NCT02009540|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101303976|NCT02009540|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101303977|NCT02009540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101303978|NCT02009540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303979|NCT02009540|Cholinergic Agents|cholinergic agents|mesh-ancestor
101303980|NCT02009540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101303981|NCT02009540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101303982|NCT02009540|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101303983|NCT02009540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101303984|NCT02009592|Rifaximin|rifaximin|mesh-list
101303985|NCT02009592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101303986|NCT02009592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101263432|NCT01762046|Metformin|metformin|mesh-list
101303987|NCT02009592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101303988|NCT02009618|Rifaximin|rifaximin|mesh-list
101303989|NCT02009618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101303990|NCT02009618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101303991|NCT02009618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101303992|NCT02009631|Veliparib|veliparib|mesh-list
101303993|NCT02009631|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101303994|NCT02009631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101303995|NCT02009631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101303996|NCT02009631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101303997|NCT02009709|Riboflavin|riboflavin|mesh-list
101303998|NCT02009709|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101303999|NCT02009709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101304000|NCT02009709|Vitamin B Complex|vitamin b complex|mesh-ancestor
101304002|NCT02009709|Micronutrients|micronutrients|mesh-ancestor
101304003|NCT02009709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304004|NCT02009709|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101304005|NCT02009709|Dermatologic Agents|dermatologic agents|mesh-ancestor
101304006|NCT02009748|Vitamin D|vitamin d|mesh-list
101304007|NCT02009748|Vitamins|vitamins|mesh-ancestor
101304008|NCT02009748|Micronutrients|micronutrients|mesh-ancestor
101304009|NCT02009748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304010|NCT02009748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101304011|NCT02009787|Vitamin D|vitamin d|mesh-list
101304012|NCT02009787|Cholecalciferol|cholecalciferol|mesh-list
101304013|NCT02009787|Vitamins|vitamins|mesh-ancestor
101304014|NCT02009787|Micronutrients|micronutrients|mesh-ancestor
101304015|NCT02009787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304016|NCT02009787|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101304017|NCT02009787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101304018|NCT02009943|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101304019|NCT02009943|Hematinics|hematinics|mesh-ancestor
101304020|NCT02010164|Ubiquinone|ubiquinone|mesh-list
101304021|NCT02010164|Coenzyme Q10|coenzyme q10|mesh-list
101304022|NCT02010164|Micronutrients|micronutrients|mesh-ancestor
101304023|NCT02010164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304024|NCT02010164|Vitamins|vitamins|mesh-ancestor
101304025|NCT02010411|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
101304026|NCT02010411|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101304027|NCT02010411|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101304028|NCT02010411|Protease Inhibitors|protease inhibitors|mesh-ancestor
101304029|NCT02010411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101304030|NCT02010411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304031|NCT02010437|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
101304032|NCT02010437|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
101304033|NCT02010437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101304035|NCT02010723|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
101304036|NCT02010723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101304037|NCT02010762|Vitamin D|vitamin d|mesh-list
101304038|NCT02010762|Vitamins|vitamins|mesh-ancestor
101304040|NCT02010762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304041|NCT02010762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101304042|NCT02010788|Botulinum Toxins|botulinum toxins|mesh-list
101304043|NCT02010788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101304044|NCT02010788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101304045|NCT02010788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101304046|NCT02010788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101304047|NCT02010788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304048|NCT02010788|Cholinergic Agents|cholinergic agents|mesh-ancestor
101304049|NCT02010788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101304050|NCT02010788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304051|NCT02010788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101304052|NCT02010788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101304053|NCT02010827|Glucagon|glucagon|mesh-list
101304054|NCT02010827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101304055|NCT02010827|Hormones|hormones|mesh-ancestor
101304056|NCT02010827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101304057|NCT02010827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304058|NCT02010905|Losartan|losartan|mesh-list
101304059|NCT02010905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101263440|NCT01762150|Antimetabolites|antimetabolites|mesh-ancestor
101304060|NCT02010905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101304061|NCT02010905|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101304062|NCT02010905|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101304063|NCT02010905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304064|NCT02010944|Solifenacin Succinate|solifenacin succinate|mesh-list
101304065|NCT02010944|Mirabegron|mirabegron|mesh-list
101304066|NCT02010944|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101304067|NCT02010944|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101304068|NCT02010944|Cholinergic Agents|cholinergic agents|mesh-ancestor
101304069|NCT02010944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101304070|NCT02010944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304071|NCT02010944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304072|NCT02010944|Urological Agents|urological agents|mesh-ancestor
101304073|NCT02010944|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101304074|NCT02010944|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101304075|NCT02010944|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101304076|NCT02010944|Adrenergic Agents|adrenergic agents|mesh-ancestor
101304077|NCT02010957|Etomidate|etomidate|mesh-list
101304078|NCT02010957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101304079|NCT02010957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101304080|NCT02010957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304081|NCT02010957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101304082|NCT02010957|Anesthetics, General|anesthetics, general|mesh-ancestor
101304083|NCT02010957|Anesthetics|anesthetics|mesh-ancestor
101304084|NCT02010970|Itraconazole|itraconazole|mesh-list
101304085|NCT02010970|Diltiazem|diltiazem|mesh-list
101304086|NCT02010970|Calcium Channel Blockers|calcium channel blockers|mesh-list
101304087|NCT02010970|Midazolam|midazolam|mesh-list
101304088|NCT02010970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101304089|NCT02010970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304090|NCT02010970|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101304091|NCT02010970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101304092|NCT02010970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101304093|NCT02010970|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101304094|NCT02010970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101304095|NCT02010970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101304096|NCT02010970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101304097|NCT02010970|Anesthetics, General|anesthetics, general|mesh-ancestor
101304098|NCT02010970|Anesthetics|anesthetics|mesh-ancestor
101304099|NCT02010970|GABA Modulators|gaba modulators|mesh-ancestor
101304100|NCT02010970|GABA Agents|gaba agents|mesh-ancestor
101304101|NCT02010970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101304102|NCT02010970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304103|NCT02010970|Antifungal Agents|antifungal agents|mesh-ancestor
101304104|NCT02010970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101304105|NCT02010970|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101304106|NCT02010970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101304107|NCT02010970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101304108|NCT02010970|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101304109|NCT02010970|Hormone Antagonists|hormone antagonists|mesh-ancestor
101304110|NCT02010970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101304111|NCT02010970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101304112|NCT02010970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101304113|NCT02010970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101304114|NCT02010970|Vasodilator Agents|vasodilator agents|mesh-ancestor
101304116|NCT02011126|Motesanib diphosphate|motesanib diphosphate|mesh-list
101304117|NCT02011126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101304118|NCT02011126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304119|NCT02011126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101304121|NCT02011191|Vitamin B Complex|vitamin b complex|mesh-ancestor
101304122|NCT02011191|Vitamins|vitamins|mesh-ancestor
101304123|NCT02011191|Micronutrients|micronutrients|mesh-ancestor
101304124|NCT02011191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304126|NCT02011347|Analgesics|analgesics|mesh-ancestor
101304130|NCT02011347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101304131|NCT02011347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101304132|NCT02011347|Anesthetics, General|anesthetics, general|mesh-ancestor
101304133|NCT02011347|Anesthetics|anesthetics|mesh-ancestor
101304134|NCT02011347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101304135|NCT02011347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101304136|NCT02011347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101304137|NCT02011347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101304138|NCT02011347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304139|NCT02011594|Nimotuzumab|nimotuzumab|mesh-list
101304140|NCT02011594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101304141|NCT02011594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101304142|NCT02011620|Isosorbide|isosorbide|mesh-list
101304143|NCT02011620|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
101304144|NCT02011620|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
101304145|NCT02011620|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101304146|NCT02011620|Diuretics|diuretics|mesh-ancestor
101304147|NCT02011620|Natriuretic Agents|natriuretic agents|mesh-ancestor
101304148|NCT02011620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304149|NCT02011620|Vasodilator Agents|vasodilator agents|mesh-ancestor
101304150|NCT02011620|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101304151|NCT02011620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304152|NCT02011633|Metformin|metformin|mesh-list
101304153|NCT02011633|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101304154|NCT02011633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101304155|NCT02011633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304156|NCT02011633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101304157|NCT02011633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101304158|NCT02011633|Antimetabolites|antimetabolites|mesh-ancestor
101304159|NCT02011633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304160|NCT02011633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101304162|NCT02011633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101304163|NCT02011659|Ramosetron|ramosetron|mesh-list
101304164|NCT02011659|Antiemetics|antiemetics|mesh-ancestor
101304165|NCT02011659|Autonomic Agents|autonomic agents|mesh-ancestor
101304166|NCT02011659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101304167|NCT02011659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304168|NCT02011659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101304169|NCT02011659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101304170|NCT02011659|Serotonin Agents|serotonin agents|mesh-ancestor
101304171|NCT02011659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101304172|NCT02011659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304173|NCT02011737|Naftopidil|naftopidil|mesh-list
101304174|NCT02011737|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101304175|NCT02011737|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101304176|NCT02011737|Adrenergic Agents|adrenergic agents|mesh-ancestor
101304177|NCT02011737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101304178|NCT02011737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304179|NCT02011737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529347|NCT05424692|Vitamin B Complex|vitamin b complex|mesh-ancestor
101529419|NCT01165996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101529644|NCT04617171|Benralizumab|benralizumab|mesh-list
101529724|NCT04649892|Naltrexone|naltrexone|mesh-list
101531211|NCT00565968|Sorafenib|sorafenib|mesh-list
101531351|NCT01160770|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101531507|NCT04631315|Hormones|hormones|mesh-ancestor
101532024|NCT00562055|Reboxetine|reboxetine|mesh-list
101532247|NCT04622891|Azithromycin|azithromycin|mesh-list
101532753|NCT02940002|Clobetasol|clobetasol|mesh-list
101533043|NCT00571740|Antimetabolites|antimetabolites|mesh-ancestor
101533343|NCT01149421|Dulaglutide|dulaglutide|mesh-list
101304180|NCT02011737|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101533637|NCT00574353|Misonidazole|misonidazole|mesh-list
101534227|NCT04586543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101534298|NCT04585412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101534500|NCT00568217|Diclofenac|diclofenac|mesh-list
101534529|NCT00590928|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101304181|NCT02011737|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101304182|NCT02011737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101304183|NCT02011737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101304184|NCT02011737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101304185|NCT02011750|Valproic Acid|valproic acid|mesh-list
101304186|NCT02011750|Anticonvulsants|anticonvulsants|mesh-ancestor
101534606|NCT04575675|Protective Agents|protective agents|mesh-ancestor
101534630|NCT00568412|Immunologic Factors|immunologic factors|mesh-ancestor
101534775|NCT00570440|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101534778|NCT00570479|Anecortave|anecortave|mesh-list
101535066|NCT01140880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101535491|NCT03454919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101535517|NCT05181436|Analgesics|analgesics|mesh-ancestor
101535523|NCT01137292|Voriconazole|voriconazole|mesh-list
101535528|NCT01137292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101535574|NCT00197106|Autonomic Agents|autonomic agents|mesh-ancestor
101263457|NCT01762163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101535695|NCT04610567|Dermatologic Agents|dermatologic agents|mesh-ancestor
101535832|NCT00193479|Mitosis Modulators|mitosis modulators|mesh-ancestor
101535922|NCT00191646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101536095|NCT04605770|Pemetrexed|pemetrexed|mesh-list
101536115|NCT00589134|Hormone Antagonists|hormone antagonists|mesh-ancestor
101536177|NCT04604756|Losartan|losartan|mesh-list
101536290|NCT00474903|Antipyretics|antipyretics|mesh-ancestor
101536361|NCT02277600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101536591|NCT01133626|Prednisone|prednisone|mesh-list
101536982|NCT04312204|Carboplatin|carboplatin|mesh-list
101537056|NCT04575389|Uric Acid|uric acid|mesh-list
101537202|NCT00589082|Daunorubicin|daunorubicin|mesh-list
101537212|NCT00589238|Doxorubicin|doxorubicin|mesh-list
101537213|NCT00589238|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101537218|NCT00589238|Mitosis Modulators|mitosis modulators|mesh-ancestor
101537246|NCT04568304|Carboplatin|carboplatin|mesh-list
101537261|NCT00589862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101537263|NCT00589862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537412|NCT00590915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101537437|NCT01083615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101537459|NCT01081782|Ceralifimod|ceralifimod|mesh-list
101537463|NCT01081782|Immunologic Factors|immunologic factors|mesh-ancestor
101537486|NCT02210754|Autonomic Agents|autonomic agents|mesh-ancestor
101537501|NCT04574141|Protective Agents|protective agents|mesh-ancestor
101537546|NCT04991103|Immunologic Factors|immunologic factors|mesh-ancestor
101537551|NCT04572620|Rituximab|rituximab|mesh-list
101537561|NCT03451019|Sevelamer|sevelamer|mesh-list
101537596|NCT04565496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101537667|NCT03456791|Protease Inhibitors|protease inhibitors|mesh-list
101537674|NCT04564638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101537990|NCT00198107|Antimetabolites|antimetabolites|mesh-ancestor
101538255|NCT00479336|Tolvaptan|tolvaptan|mesh-list
101538314|NCT00477386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101539022|NCT01080716|Vaccines|vaccines|mesh-list
101539032|NCT04571489|Tegafur|tegafur|mesh-list
101539314|NCT00477672|Pimavanserin|pimavanserin|mesh-list
101540179|NCT01122862|Disinfectants|disinfectants|mesh-ancestor
101540258|NCT00578201|Cetuximab|cetuximab|mesh-list
101541096|NCT02219100|Abortifacient Agents|abortifacient agents|mesh-ancestor
101541485|NCT04529226|Haloperidol|haloperidol|mesh-list
101541767|NCT01641549|Fibrinolytic Agents|fibrinolytic agents|mesh-list
101542091|NCT01646853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101542375|NCT01202227|Pregabalin|pregabalin|mesh-list
101542721|NCT04531748|Toremifene|toremifene|mesh-list
101543450|NCT02219906|Protective Agents|protective agents|mesh-ancestor
101543607|NCT01177540|Decitabine|decitabine|mesh-list
101543671|NCT01642472|Contraceptive Agents|contraceptive agents|mesh-ancestor
101543817|NCT01643603|Dasatinib|dasatinib|mesh-list
101544756|NCT01606878|Cyclophosphamide|cyclophosphamide|mesh-list
101544827|NCT01609881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101545507|NCT01332630|Anesthetics|anesthetics|mesh-ancestor
101546164|NCT04374123|Antibodies|antibodies|mesh-list
101546943|NCT01605734|Hormones|hormones|mesh-ancestor
101547363|NCT02273258|Insulin|insulin|mesh-list
101547413|NCT01107925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547487|NCT01335698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101547758|NCT01371851|Doxazosin|doxazosin|mesh-list
101547829|NCT01348763|Antiviral Agents|antiviral agents|mesh-ancestor
101548430|NCT00596336|Imiquimod|imiquimod|mesh-list
101548854|NCT00600639|Hormones|hormones|mesh-ancestor
101548992|NCT05344963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101549913|NCT04325061|Protease Inhibitors|protease inhibitors|mesh-ancestor
101304188|NCT02011750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304190|NCT02011750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101304191|NCT02011750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304192|NCT02011750|Antimanic Agents|antimanic agents|mesh-ancestor
101304193|NCT02011750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101304194|NCT02011750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101304195|NCT02011750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101304196|NCT02011828|Ergocalciferols|ergocalciferols|mesh-list
101304197|NCT02011828|Vitamin D|vitamin d|mesh-list
101304198|NCT02011828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101304199|NCT02011828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304200|NCT02011828|Vitamins|vitamins|mesh-ancestor
101304201|NCT02011828|Micronutrients|micronutrients|mesh-ancestor
101208458|NCT01440439|Insulin Glargine|insulin glargine|mesh-list
101304202|NCT02011828|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101304203|NCT02011841|Ciprofloxacin|ciprofloxacin|mesh-list
101304204|NCT02011841|Rifaximin|rifaximin|mesh-list
101304205|NCT02011841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101304206|NCT02011841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101304207|NCT02011841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101304208|NCT02011841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101304209|NCT02011841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101304210|NCT02011841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304211|NCT02011841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101304212|NCT02011841|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101304213|NCT02011841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101304214|NCT02011841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101304215|NCT02011906|Vitamins|vitamins|mesh-list
101304216|NCT02011906|Vitamin E|vitamin e|mesh-list
101304217|NCT02011906|Tocopherols|tocopherols|mesh-list
101304218|NCT02011906|Tocotrienols|tocotrienols|mesh-list
101304219|NCT02011906|alpha-Tocopherol|alpha-tocopherol|mesh-list
101304220|NCT02011906|Micronutrients|micronutrients|mesh-ancestor
101304221|NCT02011906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304222|NCT02011906|Antioxidants|antioxidants|mesh-ancestor
101304223|NCT02011906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304224|NCT02011906|Protective Agents|protective agents|mesh-ancestor
101304225|NCT02011958|Amphotericin B|amphotericin b|mesh-list
101304226|NCT02011958|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101304227|NCT02011958|Miltefosine|miltefosine|mesh-list
101304228|NCT02011958|Amebicides|amebicides|mesh-ancestor
101304229|NCT02011958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101304230|NCT02011958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101304231|NCT02011958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101304232|NCT02011958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101304233|NCT02011958|Antifungal Agents|antifungal agents|mesh-ancestor
101304234|NCT02011958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101304236|NCT02012036|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101304237|NCT02012036|Dermatologic Agents|dermatologic agents|mesh-ancestor
101304238|NCT02012049|Risperidone|risperidone|mesh-list
101304239|NCT02012049|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101304240|NCT02012049|Serotonin Agents|serotonin agents|mesh-ancestor
101304241|NCT02012049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101304242|NCT02012049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304243|NCT02012049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304244|NCT02012049|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101304245|NCT02012049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101304246|NCT02012049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101304247|NCT02012049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101304248|NCT02012049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101304249|NCT02012049|Dopamine Agents|dopamine agents|mesh-ancestor
101304250|NCT02012062|Nimotuzumab|nimotuzumab|mesh-list
101304251|NCT02012062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101304252|NCT02012062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101304253|NCT02012075|Metoprolol|metoprolol|mesh-list
101304254|NCT02012075|Carvedilol|carvedilol|mesh-list
101304255|NCT02012075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101304256|NCT02012075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101304257|NCT02012075|Sympatholytics|sympatholytics|mesh-ancestor
101304258|NCT02012075|Autonomic Agents|autonomic agents|mesh-ancestor
101304259|NCT02012075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101304260|NCT02012075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304261|NCT02012075|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101504520|NCT01246037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101504521|NCT01246037|Sympatholytics|sympatholytics|mesh-ancestor
101504522|NCT01246037|Autonomic Agents|autonomic agents|mesh-ancestor
101504523|NCT01246037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101504524|NCT01246037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504525|NCT01246037|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101504526|NCT01246037|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101504527|NCT01246037|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101504528|NCT01246037|Adrenergic Agents|adrenergic agents|mesh-ancestor
101504529|NCT01246037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101504530|NCT01246037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263472|NCT01762306|Folic Acid|folic acid|mesh-list
101208678|NCT01441531|Anticonvulsants|anticonvulsants|mesh-ancestor
101263473|NCT01762306|Diclofenac|diclofenac|mesh-list
101504531|NCT00501215|Parathyroid Hormone|parathyroid hormone|mesh-list
101504532|NCT00501215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101504533|NCT00501215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504535|NCT00509184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101504536|NCT00509184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101504537|NCT00509184|Immunologic Factors|immunologic factors|mesh-ancestor
101504538|NCT00509184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504539|NCT00509184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101504540|NCT00501254|Aspirin|aspirin|mesh-list
101504541|NCT00501254|Salicylic Acid|salicylic acid|mesh-list
101504542|NCT00501254|Salicylates|salicylates|mesh-list
101504543|NCT00501254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101504544|NCT00501254|Antifungal Agents|antifungal agents|mesh-ancestor
101504545|NCT00501254|Keratolytic Agents|keratolytic agents|mesh-ancestor
101504546|NCT00501254|Dermatologic Agents|dermatologic agents|mesh-ancestor
101504547|NCT00501254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101504548|NCT00501254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101504549|NCT00501254|Analgesics|analgesics|mesh-ancestor
101504550|NCT00501254|Sensory System Agents|sensory system agents|mesh-ancestor
101504551|NCT00501254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101504552|NCT00501254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504553|NCT00501254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101504554|NCT00501254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101504555|NCT00501254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101504556|NCT00501254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101504557|NCT00501254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504558|NCT00501254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101504559|NCT00501254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101504560|NCT00501254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101504561|NCT00501254|Antipyretics|antipyretics|mesh-ancestor
101504562|NCT01248338|Metoprolol|metoprolol|mesh-list
101504563|NCT01248338|Nebivolol|nebivolol|mesh-list
101504564|NCT01248338|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101504565|NCT01248338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101504566|NCT01248338|Sympatholytics|sympatholytics|mesh-ancestor
101504567|NCT01248338|Autonomic Agents|autonomic agents|mesh-ancestor
101504568|NCT01248338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101504569|NCT01248338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504570|NCT01248338|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101504571|NCT01248338|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101504572|NCT01248338|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101504573|NCT01248338|Adrenergic Agents|adrenergic agents|mesh-ancestor
101504574|NCT01248338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101504575|NCT01248338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504576|NCT01248338|Vasodilator Agents|vasodilator agents|mesh-ancestor
101504577|NCT01248338|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101504578|NCT01248338|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101504579|NCT01248338|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101504580|NCT02953743|Lenvatinib|lenvatinib|mesh-list
101504581|NCT02953743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101504582|NCT02953743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101504583|NCT02953743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101504584|NCT02953743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504585|NCT00509379|Rituximab|rituximab|mesh-list
101504586|NCT00509379|Bortezomib|bortezomib|mesh-list
101504587|NCT00509379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101504588|NCT00509379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101504589|NCT00509379|Immunologic Factors|immunologic factors|mesh-ancestor
101504590|NCT00509379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504591|NCT00509379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101504593|NCT02274974|Epinephrine|epinephrine|mesh-list
101504594|NCT02274974|Anesthetics, Local|anesthetics, local|mesh-list
101504595|NCT02274974|Anesthetics|anesthetics|mesh-list
101504596|NCT02274974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101504597|NCT02274974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504598|NCT02274974|Sensory System Agents|sensory system agents|mesh-ancestor
101504599|NCT02274974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101504600|NCT02274974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101504601|NCT02274974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101504602|NCT02274974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101504603|NCT02274974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101504604|NCT02274974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263476|NCT01762306|Analgesics|analgesics|mesh-ancestor
101504605|NCT02274974|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101504606|NCT02274974|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101504607|NCT02274974|Adrenergic Agents|adrenergic agents|mesh-ancestor
101504608|NCT02274974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101504609|NCT02274974|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101504610|NCT02274974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101504611|NCT02274974|Autonomic Agents|autonomic agents|mesh-ancestor
101504612|NCT02274974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101504613|NCT02274974|Respiratory System Agents|respiratory system agents|mesh-ancestor
101504614|NCT02274974|Mydriatics|mydriatics|mesh-ancestor
101504615|NCT02274974|Sympathomimetics|sympathomimetics|mesh-ancestor
101504616|NCT02274974|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101504617|NCT02274545|Vaccines|vaccines|mesh-list
101504618|NCT02274545|Immunologic Factors|immunologic factors|mesh-ancestor
101504619|NCT02274545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504620|NCT02275013|Simendan|simendan|mesh-list
101504621|NCT02275013|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101504622|NCT02275013|Vasodilator Agents|vasodilator agents|mesh-ancestor
101504623|NCT02275013|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101504624|NCT02275013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101504625|NCT02275013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101504626|NCT02275013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504627|NCT02275013|Protective Agents|protective agents|mesh-ancestor
101504628|NCT02275013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504629|NCT02274623|Calcifediol|calcifediol|mesh-list
101504630|NCT02274623|Vitamins|vitamins|mesh-ancestor
101504631|NCT02274623|Micronutrients|micronutrients|mesh-ancestor
101504632|NCT02274623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504633|NCT02274623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101504634|NCT00509613|Sirolimus|sirolimus|mesh-list
101504635|NCT00509613|Sorafenib|sorafenib|mesh-list
101504636|NCT00509613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101504637|NCT00509613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101504638|NCT00509613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101504639|NCT00509613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504640|NCT00509613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101504641|NCT00509613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101504642|NCT00509613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101504643|NCT00509613|Antifungal Agents|antifungal agents|mesh-ancestor
101504644|NCT00509613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101504645|NCT00509613|Immunologic Factors|immunologic factors|mesh-ancestor
101504646|NCT00509613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504647|NCT00501410|Leucovorin|leucovorin|mesh-list
101504648|NCT00501410|Fluorouracil|fluorouracil|mesh-list
101504649|NCT00501410|Oxaliplatin|oxaliplatin|mesh-list
101504650|NCT00501410|Cetuximab|cetuximab|mesh-list
101504651|NCT00501410|Dasatinib|dasatinib|mesh-list
101504652|NCT00501410|Antimetabolites|antimetabolites|mesh-ancestor
101504653|NCT00501410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504654|NCT00501410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101504655|NCT00501410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101504656|NCT00501410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101504657|NCT00501410|Immunologic Factors|immunologic factors|mesh-ancestor
101504658|NCT00501410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504659|NCT00501410|Antidotes|antidotes|mesh-ancestor
101504660|NCT00501410|Protective Agents|protective agents|mesh-ancestor
101504661|NCT00501410|Vitamin B Complex|vitamin b complex|mesh-ancestor
101504662|NCT00501410|Vitamins|vitamins|mesh-ancestor
101504663|NCT00501410|Micronutrients|micronutrients|mesh-ancestor
101504664|NCT00501410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101504665|NCT00501410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101504666|NCT00501410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101504668|NCT02953275|Vedolizumab|vedolizumab|mesh-list
101504669|NCT02953275|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101188378|NCT00002802|Cyclophosphamide|cyclophosphamide|mesh-list
101504670|NCT02953275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101504671|NCT02953275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504672|NCT02953275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101504673|NCT02953275|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101504674|NCT02953275|Protective Agents|protective agents|mesh-ancestor
101504675|NCT02953275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504676|NCT02953275|Vasodilator Agents|vasodilator agents|mesh-ancestor
101504677|NCT02953275|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101504678|NCT02953275|Antioxidants|antioxidants|mesh-ancestor
101504679|NCT02953275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101504680|NCT00501488|Rosiglitazone|rosiglitazone|mesh-list
101504681|NCT00501488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101504682|NCT00501488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504683|NCT00508911|Contraceptive Agents|contraceptive agents|mesh-list
101504684|NCT00508911|Contraceptives, Oral|contraceptives, oral|mesh-list
101504685|NCT00508911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101504686|NCT00508911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504687|NCT00508911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101504688|NCT02955719|Sertraline|sertraline|mesh-list
101504689|NCT02955719|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101504690|NCT02955719|Antidepressive Agents|antidepressive agents|mesh-ancestor
101504691|NCT02955719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101504692|NCT02955719|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101504693|NCT02955719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101504694|NCT02955719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101504695|NCT02955719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504696|NCT02955719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101504697|NCT02955719|Serotonin Agents|serotonin agents|mesh-ancestor
101504698|NCT02955719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504699|NCT02955719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101504700|NCT02955719|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101504701|NCT00501527|Immunomodulating Agents|immunomodulating agents|mesh-list
101504702|NCT00501527|Immunologic Factors|immunologic factors|mesh-ancestor
101504703|NCT00501527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504704|NCT02955524|Lidocaine|lidocaine|mesh-list
101504705|NCT02955524|Tetracaine|tetracaine|mesh-list
101504706|NCT02955524|Anesthetics, Local|anesthetics, local|mesh-ancestor
101504707|NCT02955524|Anesthetics|anesthetics|mesh-ancestor
101504708|NCT02955524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101504709|NCT02955524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504710|NCT02955524|Sensory System Agents|sensory system agents|mesh-ancestor
101504711|NCT02955524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101504712|NCT02955524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101504713|NCT02955524|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101504714|NCT02955524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101504715|NCT02955524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101504716|NCT02955524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504717|NCT02953041|Glycopyrrolate|glycopyrrolate|mesh-list
101504718|NCT02953041|Bromides|bromides|mesh-list
101504719|NCT02953041|Anticonvulsants|anticonvulsants|mesh-ancestor
101504720|NCT02953041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101504721|NCT02953041|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101504722|NCT02953041|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101504723|NCT02953041|Cholinergic Agents|cholinergic agents|mesh-ancestor
101504724|NCT02953041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101504725|NCT02953041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504726|NCT02953041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504727|NCT00501566|Satavaptan|satavaptan|mesh-list
101504728|NCT00501566|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101504729|NCT00501566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504731|NCT00501566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504732|NCT00501605|Cediranib|cediranib|mesh-list
101504733|NCT00501605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101504734|NCT00501605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101504735|NCT00501605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101504736|NCT00501605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504737|NCT00509847|Lactoferrin|lactoferrin|mesh-list
101504738|NCT00509847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101504739|NCT01248494|Letrozole|letrozole|mesh-list
101504740|NCT01248494|Dactolisib|dactolisib|mesh-list
101504741|NCT01248494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101504742|NCT01248494|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101504743|NCT01248494|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101504744|NCT01248494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101263483|NCT01762306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101504745|NCT01248494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504746|NCT01248494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101504747|NCT01248494|Hormone Antagonists|hormone antagonists|mesh-ancestor
101504748|NCT01248494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101504749|NCT01248494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504751|NCT02952573|Dexamethasone acetate|dexamethasone acetate|mesh-list
101504753|NCT02952573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101504754|NCT02952573|Antiemetics|antiemetics|mesh-ancestor
101504755|NCT02952573|Autonomic Agents|autonomic agents|mesh-ancestor
101504756|NCT02952573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101504757|NCT02952573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504758|NCT02952573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101504759|NCT02952573|Glucocorticoids|glucocorticoids|mesh-ancestor
101504760|NCT02952573|Hormones|hormones|mesh-ancestor
101504761|NCT02952573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101504762|NCT02952573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101504763|NCT02952573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101504764|NCT02952573|Protease Inhibitors|protease inhibitors|mesh-ancestor
101504765|NCT02952573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101504766|NCT02952573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504767|NCT00501722|Satavaptan|satavaptan|mesh-list
101504768|NCT00501722|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101504769|NCT00501722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504770|NCT00501722|Natriuretic Agents|natriuretic agents|mesh-ancestor
101504771|NCT00501722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504772|NCT01248611|Fentanyl|fentanyl|mesh-list
101504773|NCT01248611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101504774|NCT01248611|Narcotics|narcotics|mesh-ancestor
101504775|NCT01248611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101504777|NCT01248611|Analgesics|analgesics|mesh-ancestor
101504778|NCT01248611|Sensory System Agents|sensory system agents|mesh-ancestor
101504779|NCT01248611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101504780|NCT01248611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101504781|NCT01248611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101504782|NCT01248611|Anesthetics, General|anesthetics, general|mesh-ancestor
101504783|NCT01248611|Anesthetics|anesthetics|mesh-ancestor
101504784|NCT00509964|Irinotecan|irinotecan|mesh-list
101504785|NCT00509964|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101504786|NCT00509964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101504787|NCT00509964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101504788|NCT00509964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504789|NCT00509964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101504790|NCT00510471|Immunoglobulins|immunoglobulins|mesh-list
101504791|NCT00510471|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101504792|NCT00510471|Antibodies|antibodies|mesh-list
101504793|NCT00510471|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
101504794|NCT00510471|Immunologic Factors|immunologic factors|mesh-ancestor
101504795|NCT00510471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504796|NCT00501839|Clomiphene|clomiphene|mesh-list
101504797|NCT00501839|Enclomiphene|enclomiphene|mesh-list
101504798|NCT00501839|Zuclomiphene|zuclomiphene|mesh-list
101504799|NCT00501839|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101504800|NCT00501839|Hormone Antagonists|hormone antagonists|mesh-ancestor
101504801|NCT00501839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101504802|NCT00501839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504803|NCT00501839|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101504804|NCT00501839|Fertility Agents|fertility agents|mesh-ancestor
101504805|NCT00501839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101504806|NCT00501839|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101317676|NCT00001266|Suramin|suramin|mesh-list
101504808|NCT00510003|Pimecrolimus|pimecrolimus|mesh-list
101504809|NCT00510003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101504810|NCT00510003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101504811|NCT00510003|Analgesics|analgesics|mesh-ancestor
101504812|NCT00510003|Sensory System Agents|sensory system agents|mesh-ancestor
101504813|NCT00510003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101504814|NCT00510003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504815|NCT00510003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101504816|NCT00510003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101504817|NCT00510003|Dermatologic Agents|dermatologic agents|mesh-ancestor
101504818|NCT00510003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101504819|NCT00510003|Immunologic Factors|immunologic factors|mesh-ancestor
101504820|NCT00510003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101504821|NCT00510003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101504822|NCT00510003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504823|NCT00501878|Phenylephrine|phenylephrine|mesh-list
101504824|NCT00501878|Oxymetazoline|oxymetazoline|mesh-list
101504826|NCT00501878|Mydriatics|mydriatics|mesh-ancestor
101504827|NCT00501878|Autonomic Agents|autonomic agents|mesh-ancestor
101504828|NCT00501878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101504829|NCT00501878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504830|NCT00501878|Sympathomimetics|sympathomimetics|mesh-ancestor
101504831|NCT00501878|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101504832|NCT00501878|Nasal Decongestants|nasal decongestants|mesh-ancestor
101504833|NCT00501878|Respiratory System Agents|respiratory system agents|mesh-ancestor
101504834|NCT00501878|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101504835|NCT00501878|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101504836|NCT00501878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101504837|NCT00501878|Adrenergic Agents|adrenergic agents|mesh-ancestor
101504838|NCT00501878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101504839|NCT00501878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504840|NCT00501878|Protective Agents|protective agents|mesh-ancestor
101504841|NCT00501917|Darbepoetin alfa|darbepoetin alfa|mesh-list
101504842|NCT00501917|Hematinics|hematinics|mesh-ancestor
101504843|NCT00510588|Metformin|metformin|mesh-list
101504844|NCT00510588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101504845|NCT00510588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504846|NCT00510627|Oxaliplatin|oxaliplatin|mesh-list
101504847|NCT00510627|Irinotecan|irinotecan|mesh-list
101504848|NCT00510627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101504849|NCT00510627|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101504850|NCT00510627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101504851|NCT00510627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101504852|NCT00510627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504853|NCT00502034|Interferons|interferons|mesh-list
101504854|NCT00502034|Interferon-alpha|interferon-alpha|mesh-list
101504855|NCT00502034|Interferon alpha-2|interferon alpha-2|mesh-list
101504856|NCT00502034|Interleukin-2|interleukin-2|mesh-list
101504857|NCT00502034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101504858|NCT00502034|Antiviral Agents|antiviral agents|mesh-ancestor
101504859|NCT00502034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101504860|NCT00502034|Immunologic Factors|immunologic factors|mesh-ancestor
101504861|NCT00502034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504863|NCT00502034|Analgesics|analgesics|mesh-ancestor
101504864|NCT00502034|Sensory System Agents|sensory system agents|mesh-ancestor
101504865|NCT00502034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101504866|NCT00510666|Tramadol|tramadol|mesh-list
101504867|NCT00510666|Butorphanol|butorphanol|mesh-list
101504868|NCT00510666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101504869|NCT00510666|Narcotics|narcotics|mesh-ancestor
101504870|NCT00510666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101504871|NCT00510666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504872|NCT00510666|Analgesics|analgesics|mesh-ancestor
101504873|NCT00510666|Sensory System Agents|sensory system agents|mesh-ancestor
101504874|NCT00510666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101504875|NCT00510666|Antitussive Agents|antitussive agents|mesh-ancestor
101504876|NCT00510666|Respiratory System Agents|respiratory system agents|mesh-ancestor
101504877|NCT00510666|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101504878|NCT00508092|Anesthetics|anesthetics|mesh-list
101504879|NCT00508092|Anesthetics, Local|anesthetics, local|mesh-list
101504880|NCT00508092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101504881|NCT00508092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504882|NCT00508092|Sensory System Agents|sensory system agents|mesh-ancestor
101504883|NCT00508092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101504885|NCT00510705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101504886|NCT00510705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504887|NCT00502073|Cyclosporine|cyclosporine|mesh-list
101504888|NCT00502073|Cyclosporins|cyclosporins|mesh-list
101504889|NCT00502073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101263492|NCT01762319|Misoprostol|misoprostol|mesh-list
101504890|NCT00502073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504891|NCT00502073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101504892|NCT00502073|Immunologic Factors|immunologic factors|mesh-ancestor
101504893|NCT00502073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504894|NCT00502073|Antifungal Agents|antifungal agents|mesh-ancestor
101504895|NCT00502073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101504896|NCT00502073|Dermatologic Agents|dermatologic agents|mesh-ancestor
101504897|NCT00502073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101504898|NCT00502073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101504899|NCT01248923|Dexamethasone|dexamethasone|mesh-list
101504900|NCT01248923|Bortezomib|bortezomib|mesh-list
101504901|NCT01248923|Filanesib|filanesib|mesh-list
101504902|NCT01248923|Lenograstim|lenograstim|mesh-list
101504903|NCT01248923|Proteasome Inhibitors|proteasome inhibitors|mesh-list
101504904|NCT01248923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101504905|NCT01248923|Antiemetics|antiemetics|mesh-ancestor
101504906|NCT01248923|Autonomic Agents|autonomic agents|mesh-ancestor
101504907|NCT01248923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101504908|NCT01248923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504911|NCT01248923|Hormones|hormones|mesh-ancestor
101504912|NCT01248923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101504913|NCT01248923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101504914|NCT01248923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101504915|NCT01248923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101504916|NCT01248923|Immunologic Factors|immunologic factors|mesh-ancestor
101504917|NCT01248923|Protease Inhibitors|protease inhibitors|mesh-ancestor
101504918|NCT01248923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101504919|NCT01248923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504920|NCT01248923|Antimitotic Agents|antimitotic agents|mesh-ancestor
101504921|NCT01248923|Mitosis Modulators|mitosis modulators|mesh-ancestor
101504922|NCT01249001|Aprepitant|aprepitant|mesh-list
101504923|NCT01249001|Fosaprepitant|fosaprepitant|mesh-list
101504924|NCT01249001|Antiemetics|antiemetics|mesh-ancestor
101504925|NCT01249001|Autonomic Agents|autonomic agents|mesh-ancestor
101504926|NCT01249001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101504927|NCT01249001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504928|NCT01249001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101504929|NCT01249001|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101504930|NCT01249001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101504931|NCT01249001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504932|NCT00502112|Lenalidomide|lenalidomide|mesh-list
101504933|NCT00502112|Lintuzumab|lintuzumab|mesh-list
101504934|NCT00502112|Immunologic Factors|immunologic factors|mesh-ancestor
101504935|NCT00502112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504936|NCT00502112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101504937|NCT00502112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101504939|NCT00502112|Growth Inhibitors|growth inhibitors|mesh-ancestor
101504940|NCT00502112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101504941|NCT00502112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101504942|NCT00502190|Silicon|silicon|mesh-list
101504943|NCT00502190|Trace Elements|trace elements|mesh-ancestor
101504944|NCT00502190|Micronutrients|micronutrients|mesh-ancestor
101504945|NCT00502190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504946|NCT00502229|Metformin|metformin|mesh-list
101504947|NCT00502229|Clomiphene|clomiphene|mesh-list
101504948|NCT00502229|Enclomiphene|enclomiphene|mesh-list
101504949|NCT00502229|Zuclomiphene|zuclomiphene|mesh-list
101504950|NCT00502229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101504951|NCT00502229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263496|NCT01762319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101263497|NCT01762319|Abortifacient Agents|abortifacient agents|mesh-ancestor
101504952|NCT00502229|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101504953|NCT00502229|Hormone Antagonists|hormone antagonists|mesh-ancestor
101504954|NCT00502229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101504955|NCT00502229|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101504956|NCT00502229|Fertility Agents|fertility agents|mesh-ancestor
101504957|NCT00502229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101504958|NCT00502229|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101504959|NCT00502229|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101504960|NCT00502268|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
101504961|NCT00502268|Ergocalciferols|ergocalciferols|mesh-list
101504962|NCT00502268|Vitamins|vitamins|mesh-ancestor
101504963|NCT00502268|Micronutrients|micronutrients|mesh-ancestor
101504964|NCT00502268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504965|NCT00502268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101504966|NCT00502268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101504967|NCT00510081|Calcium|calcium|mesh-list
101504968|NCT00510081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101504969|NCT00510081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504970|NCT00502385|Cediranib|cediranib|mesh-list
101504971|NCT00502385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101504972|NCT00502385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101504973|NCT00502385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101504974|NCT00502385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504975|NCT00510159|Artesunate|artesunate|mesh-list
101504976|NCT00510159|Sulfalene|sulfalene|mesh-list
101504977|NCT00510159|Praziquantel|praziquantel|mesh-list
101504978|NCT00510159|Antimalarials|antimalarials|mesh-ancestor
101504979|NCT00510159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101504980|NCT00510159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101504981|NCT00510159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101504982|NCT00510159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101504983|NCT00510159|Antiviral Agents|antiviral agents|mesh-ancestor
101504984|NCT00510159|Schistosomicides|schistosomicides|mesh-ancestor
101504985|NCT00510159|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101504986|NCT00510159|Anthelmintics|anthelmintics|mesh-ancestor
101504987|NCT00510159|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101504988|NCT00502463|Immunomodulating Agents|immunomodulating agents|mesh-list
101504989|NCT00502463|Immunologic Factors|immunologic factors|mesh-ancestor
101504990|NCT00502463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504991|NCT02952807|Misoprostol|misoprostol|mesh-list
101504992|NCT02952807|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101504993|NCT02952807|Abortifacient Agents|abortifacient agents|mesh-ancestor
101504994|NCT02952807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101504995|NCT02952807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504996|NCT02952807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101504997|NCT02952807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101504998|NCT02952807|Oxytocics|oxytocics|mesh-ancestor
101504999|NCT02275130|Calcium, Dietary|calcium, dietary|mesh-list
101505000|NCT02275130|Calcium|calcium|mesh-list
101505001|NCT02275130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101505002|NCT02275130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505003|NCT02275130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101505004|NCT03459417|Morphine|morphine|mesh-list
101505005|NCT03459417|Sulpiride|sulpiride|mesh-list
101505006|NCT03459417|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101505007|NCT03459417|Narcotics|narcotics|mesh-ancestor
101505008|NCT03459417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101505009|NCT03459417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505010|NCT03459417|Analgesics|analgesics|mesh-ancestor
101505011|NCT03459417|Sensory System Agents|sensory system agents|mesh-ancestor
101505013|NCT03459417|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101505014|NCT03459417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101505015|NCT03459417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101505016|NCT03459417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101505017|NCT03459417|Dopamine Agents|dopamine agents|mesh-ancestor
101505018|NCT03459417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101505019|NCT03459417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505020|NCT03459417|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101505021|NCT03459417|Antidepressive Agents|antidepressive agents|mesh-ancestor
101505022|NCT00502541|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
101505023|NCT00502541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101263508|NCT01762332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505024|NCT00502541|Glucocorticoids|glucocorticoids|mesh-ancestor
101505026|NCT00502541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101505027|NCT00502541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505028|NCT01249430|Cytarabine|cytarabine|mesh-list
101505029|NCT01249430|Etoposide|etoposide|mesh-list
101505030|NCT01249430|Mitoxantrone|mitoxantrone|mesh-list
101505031|NCT01249430|Azacitidine|azacitidine|mesh-list
101505032|NCT01249430|Etoposide phosphate|etoposide phosphate|mesh-list
101505033|NCT01249430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101505034|NCT01249430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101505035|NCT01249430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101505036|NCT01249430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101505037|NCT01249430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101505038|NCT01249430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505039|NCT01249430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101505040|NCT01249430|Antimetabolites|antimetabolites|mesh-ancestor
101505041|NCT01249430|Antiviral Agents|antiviral agents|mesh-ancestor
101505043|NCT01249430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101505044|NCT01249430|Immunologic Factors|immunologic factors|mesh-ancestor
101505045|NCT01249430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505046|NCT01249430|Analgesics|analgesics|mesh-ancestor
101505047|NCT01249430|Sensory System Agents|sensory system agents|mesh-ancestor
101505048|NCT01249430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101505049|NCT02952963|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
101505050|NCT02952963|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
101505051|NCT02952963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101505052|NCT02952963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101505053|NCT02952963|Antimetabolites|antimetabolites|mesh-ancestor
101505054|NCT02952963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505055|NCT02952963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101505056|NCT02952963|Cathartics|cathartics|mesh-ancestor
101505057|NCT02952963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101505058|NCT00510939|Bortezomib|bortezomib|mesh-list
101505059|NCT00510939|Tipifarnib|tipifarnib|mesh-list
101505060|NCT00510939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101505061|NCT00504062|Fluticasone|fluticasone|mesh-list
101505062|NCT00504062|Budesonide|budesonide|mesh-list
101505063|NCT00504062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101505064|NCT00504062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101410855|NCT00447577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101505066|NCT00504062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101505067|NCT00504062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505068|NCT00504062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101505069|NCT00504062|Respiratory System Agents|respiratory system agents|mesh-ancestor
101505070|NCT00504062|Dermatologic Agents|dermatologic agents|mesh-ancestor
101505071|NCT00504062|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101505072|NCT00504062|Glucocorticoids|glucocorticoids|mesh-ancestor
101505073|NCT00504062|Hormones|hormones|mesh-ancestor
101505074|NCT00504062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101505075|NCT00504101|Bortezomib|bortezomib|mesh-list
101505076|NCT00504101|Melphalan|melphalan|mesh-list
101505077|NCT00504101|Arsenic Trioxide|arsenic trioxide|mesh-list
101505078|NCT00504101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101505079|NCT00504101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101505080|NCT00504101|Alkylating Agents|alkylating agents|mesh-ancestor
101505081|NCT00504101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505082|NCT00504101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101505083|NCT00504101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101505084|NCT00504101|Immunologic Factors|immunologic factors|mesh-ancestor
101505085|NCT00504101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505086|NCT00504140|Interferons|interferons|mesh-list
101505087|NCT00504140|Interferon-alpha|interferon-alpha|mesh-list
101505088|NCT00504140|Etoposide|etoposide|mesh-list
101505089|NCT00504140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101505090|NCT00504140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101505091|NCT00504140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101505092|NCT00504140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101505093|NCT00504140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101263513|NCT01762332|Adrenergic Agents|adrenergic agents|mesh-ancestor
101505094|NCT00504140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505095|NCT00504140|Antiviral Agents|antiviral agents|mesh-ancestor
101505096|NCT00504140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101505097|NCT00504140|Immunologic Factors|immunologic factors|mesh-ancestor
101505098|NCT00504140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505099|NCT00511017|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
101505100|NCT00511017|Vitamins|vitamins|mesh-ancestor
101505101|NCT00511017|Micronutrients|micronutrients|mesh-ancestor
101505102|NCT00511017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505103|NCT00511017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101505104|NCT00511212|Immunoglobulins|immunoglobulins|mesh-list
101505105|NCT00511212|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101505107|NCT00511212|gamma-Globulins|gamma-globulins|mesh-list
101505108|NCT00511212|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101505109|NCT00511212|Immunologic Factors|immunologic factors|mesh-ancestor
101505110|NCT00511212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505111|NCT00510354|Imatinib Mesylate|imatinib mesylate|mesh-list
101505112|NCT00510354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101505113|NCT00510354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101505114|NCT00510354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101505115|NCT00510354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505116|NCT01241006|Dexamethasone|dexamethasone|mesh-list
101505117|NCT01241006|Prednisone|prednisone|mesh-list
101505118|NCT01241006|Glucocorticoids|glucocorticoids|mesh-list
101505119|NCT01241006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101505120|NCT01241006|Antiemetics|antiemetics|mesh-ancestor
101505121|NCT01241006|Autonomic Agents|autonomic agents|mesh-ancestor
101505122|NCT01241006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101511601|NCT02917200|Moxifloxacin|moxifloxacin|mesh-list
101188836|NCT00003174|Cladribine|cladribine|mesh-list
101505123|NCT01241006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505124|NCT01241006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101505126|NCT01241006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101505127|NCT01241006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101505128|NCT01241006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101505129|NCT00510393|Everolimus|everolimus|mesh-list
101505130|NCT00510393|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101505131|NCT00510393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101505132|NCT00510393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101505133|NCT00510393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505134|NCT00510393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101505135|NCT00510393|Immunologic Factors|immunologic factors|mesh-ancestor
101505136|NCT00510393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505137|NCT00510393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101505138|NCT01249547|Axitinib|axitinib|mesh-list
101505139|NCT01249547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101505140|NCT01249547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101505141|NCT01249547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101505142|NCT01249547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505143|NCT00511719|Insulin|insulin|mesh-list
101505144|NCT00511719|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101505145|NCT00511719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101505146|NCT00511719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505147|NCT01246232|Amisulpride|amisulpride|mesh-list
101505148|NCT01246232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101505149|NCT01246232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101505150|NCT01246232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101505151|NCT01246232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505152|NCT01246232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101505153|NCT01246232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101505154|NCT01246232|Dopamine Agents|dopamine agents|mesh-ancestor
101505155|NCT01246232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101505156|NCT01246232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505157|NCT01246232|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101505158|NCT01246232|Antidepressive Agents|antidepressive agents|mesh-ancestor
101505159|NCT01248962|Carboplatin|carboplatin|mesh-list
101505160|NCT01248962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101505161|NCT00511446|Docetaxel|docetaxel|mesh-list
101505162|NCT00511446|Capecitabine|capecitabine|mesh-list
101505163|NCT00511446|Oxaliplatin|oxaliplatin|mesh-list
101505165|NCT00511446|Tubulin Modulators|tubulin modulators|mesh-ancestor
101505166|NCT00511446|Antimitotic Agents|antimitotic agents|mesh-ancestor
101263520|NCT01762436|Sympatholytics|sympatholytics|mesh-ancestor
101505167|NCT00511446|Mitosis Modulators|mitosis modulators|mesh-ancestor
101505168|NCT00511446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505169|NCT00511446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101505170|NCT00511446|Antimetabolites|antimetabolites|mesh-ancestor
101505171|NCT02955446|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
101505172|NCT02955446|Nirogacestat|nirogacestat|mesh-list
101505173|NCT02955446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101505174|NCT02955446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505175|NCT00511602|Insulin|insulin|mesh-list
101505176|NCT00511602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101505177|NCT00511602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505178|NCT00511953|Gabapentin|gabapentin|mesh-list
101505179|NCT00511953|Analgesics|analgesics|mesh-ancestor
101505180|NCT00511953|Sensory System Agents|sensory system agents|mesh-ancestor
101505181|NCT00511953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101505182|NCT00511953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505183|NCT00511953|Anticonvulsants|anticonvulsants|mesh-ancestor
101505184|NCT00511953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101505185|NCT00511953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101505186|NCT00511953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101505187|NCT00511953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101505188|NCT00511953|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101317753|NCT00005963|Carboplatin|carboplatin|mesh-list
101505189|NCT00511953|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101505190|NCT00511953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101505191|NCT00511953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505192|NCT00511953|Antimanic Agents|antimanic agents|mesh-ancestor
101505193|NCT01249820|Anidulafungin|anidulafungin|mesh-list
101505194|NCT01249820|Antifungal Agents|antifungal agents|mesh-ancestor
101505195|NCT01249820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101505196|NCT01247090|Vasopressins|vasopressins|mesh-list
101188915|NCT00003216|Gemcitabine|gemcitabine|mesh-list
101505197|NCT01247090|Arginine Vasopressin|arginine vasopressin|mesh-list
101505198|NCT01247090|Hemostatics|hemostatics|mesh-ancestor
101505199|NCT01247090|Coagulants|coagulants|mesh-ancestor
101505200|NCT01247090|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101505201|NCT01247090|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101505202|NCT01247090|Natriuretic Agents|natriuretic agents|mesh-ancestor
101505203|NCT01247090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505204|NCT00504764|Arsenic Trioxide|arsenic trioxide|mesh-list
101505205|NCT00504764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101505206|NCT02951754|Methylphenidate|methylphenidate|mesh-list
101505207|NCT02951754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101505208|NCT02951754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505209|NCT02951754|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101505210|NCT02951754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101505211|NCT02951754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101505212|NCT02951754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505213|NCT02951754|Dopamine Agents|dopamine agents|mesh-ancestor
101505214|NCT02951754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101505215|NCT00504413|Digoxin|digoxin|mesh-list
101505216|NCT00504413|Midazolam|midazolam|mesh-list
101505217|NCT00504413|Methadone|methadone|mesh-list
101505218|NCT00504413|Bupropion|bupropion|mesh-list
101505219|NCT00504413|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101505220|NCT00504413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101505221|NCT00504413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101505222|NCT00504413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505223|NCT00504413|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101505225|NCT00504413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101505226|NCT00504413|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101505227|NCT00504413|Anesthetics, General|anesthetics, general|mesh-ancestor
101505228|NCT00504413|Anesthetics|anesthetics|mesh-ancestor
101505229|NCT00504413|GABA Modulators|gaba modulators|mesh-ancestor
101505230|NCT00504413|GABA Agents|gaba agents|mesh-ancestor
101505231|NCT00504413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101505232|NCT00504413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505233|NCT00504413|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101505234|NCT00504413|Antidepressive Agents|antidepressive agents|mesh-ancestor
101263526|NCT01762436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101505236|NCT00504413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101505237|NCT00504413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101505238|NCT00504413|Dopamine Agents|dopamine agents|mesh-ancestor
101505239|NCT00504413|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101505240|NCT00504413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101505241|NCT00504413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101505242|NCT00504413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101505243|NCT00504413|Narcotics|narcotics|mesh-ancestor
101505244|NCT00504413|Analgesics|analgesics|mesh-ancestor
101505245|NCT00504413|Sensory System Agents|sensory system agents|mesh-ancestor
101505246|NCT00504413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101505247|NCT00504413|Antitussive Agents|antitussive agents|mesh-ancestor
101505248|NCT00504413|Respiratory System Agents|respiratory system agents|mesh-ancestor
101505249|NCT00504413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101505250|NCT00504413|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101505251|NCT00504413|Protective Agents|protective agents|mesh-ancestor
101505252|NCT02951793|Psychotropic Drugs|psychotropic drugs|mesh-list
101505253|NCT01243658|Oxytocin|oxytocin|mesh-list
101505254|NCT01243658|Oxytocics|oxytocics|mesh-ancestor
101505255|NCT01243658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101505256|NCT01243658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505257|NCT01249664|Aflibercept|aflibercept|mesh-list
101505258|NCT01249664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101505259|NCT01249664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101505260|NCT01249664|Growth Substances|growth substances|mesh-ancestor
101505261|NCT01249664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505262|NCT01249664|Growth Inhibitors|growth inhibitors|mesh-ancestor
101505263|NCT01249664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101505264|NCT00513162|Etoposide|etoposide|mesh-list
101505265|NCT00513162|Valproic Acid|valproic acid|mesh-list
101505266|NCT00513162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101505267|NCT00513162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101505268|NCT00513162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101505269|NCT00513162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101505270|NCT00513162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101505271|NCT00513162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505272|NCT00513162|Anticonvulsants|anticonvulsants|mesh-ancestor
101505273|NCT00513162|GABA Agents|gaba agents|mesh-ancestor
101505274|NCT00513162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101505275|NCT00513162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505276|NCT00513162|Antimanic Agents|antimanic agents|mesh-ancestor
101505277|NCT00513162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101505278|NCT00513162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101505279|NCT00513162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101505281|NCT00513201|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101505282|NCT00513201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101505283|NCT00513201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505284|NCT00512265|Acetylcysteine|acetylcysteine|mesh-list
101505287|NCT00512265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101505288|NCT00512265|Expectorants|expectorants|mesh-ancestor
101505289|NCT00512265|Respiratory System Agents|respiratory system agents|mesh-ancestor
101505290|NCT00512265|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101505291|NCT00512265|Antioxidants|antioxidants|mesh-ancestor
101505292|NCT00512265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505293|NCT00512265|Protective Agents|protective agents|mesh-ancestor
101505294|NCT00512265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505295|NCT00512265|Antidotes|antidotes|mesh-ancestor
101505296|NCT00513396|Isoniazid|isoniazid|mesh-list
101505297|NCT00513396|Antitubercular Agents|antitubercular agents|mesh-ancestor
101505298|NCT00513396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101505299|NCT00513396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101505300|NCT00513396|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101505301|NCT00513396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101505302|NCT00513396|Antimetabolites|antimetabolites|mesh-ancestor
101505303|NCT00513396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505304|NCT00513396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101505305|NCT01249274|Progesterone|progesterone|mesh-list
101505306|NCT01249274|Progestins|progestins|mesh-ancestor
101505307|NCT01249274|Hormones|hormones|mesh-ancestor
101505308|NCT01249274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101505309|NCT01249274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263528|NCT01762436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101505310|NCT00513513|Ritonavir|ritonavir|mesh-list
101505311|NCT00513513|Darunavir|darunavir|mesh-list
101505312|NCT00513513|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101505313|NCT00513513|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101505314|NCT00513513|Protease Inhibitors|protease inhibitors|mesh-ancestor
101505315|NCT00513513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101505316|NCT00513513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505317|NCT00513513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101505318|NCT00513513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101505319|NCT00513513|Antiviral Agents|antiviral agents|mesh-ancestor
101505320|NCT00513513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101505321|NCT00513513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101505322|NCT00513513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101505323|NCT00504959|Ranibizumab|ranibizumab|mesh-list
101505324|NCT00504959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101505325|NCT00504959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101505326|NCT00504959|Growth Substances|growth substances|mesh-ancestor
101505327|NCT00504959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505328|NCT00504959|Growth Inhibitors|growth inhibitors|mesh-ancestor
101505329|NCT00504959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101505331|NCT00512616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101505332|NCT00512616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101505333|NCT00505037|Sevelamer|sevelamer|mesh-list
101505334|NCT00505037|Chelating Agents|chelating agents|mesh-ancestor
101505335|NCT00505037|Sequestering Agents|sequestering agents|mesh-ancestor
101505336|NCT00505037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505337|NCT00513552|Clarithromycin|clarithromycin|mesh-list
101505338|NCT00513552|Rifabutin|rifabutin|mesh-list
101505339|NCT00513552|Clofazimine|clofazimine|mesh-list
101505340|NCT00513552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101505341|NCT00513552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101505342|NCT00513552|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101505343|NCT00513552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101505344|NCT00513552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505345|NCT00513552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101505346|NCT00513552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101505347|NCT00513552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101505348|NCT00513552|Antitubercular Agents|antitubercular agents|mesh-ancestor
101505349|NCT00513552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101505350|NCT00513552|Leprostatic Agents|leprostatic agents|mesh-ancestor
101505351|NCT00513630|Metformin|metformin|mesh-list
101505352|NCT00513630|Glipizide|glipizide|mesh-list
101505353|NCT00513630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101505354|NCT00513630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505355|NCT02275247|Ropivacaine|ropivacaine|mesh-list
101505356|NCT02275247|Anesthetics, Local|anesthetics, local|mesh-ancestor
101505357|NCT02275247|Anesthetics|anesthetics|mesh-ancestor
101505358|NCT02275247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101505359|NCT02275247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505360|NCT02275247|Sensory System Agents|sensory system agents|mesh-ancestor
101505361|NCT02275247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101505362|NCT04515719|Belimumab|belimumab|mesh-list
101505363|NCT04515719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101505364|NCT04515719|Immunologic Factors|immunologic factors|mesh-ancestor
101505365|NCT04515719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505366|NCT00513786|Paclitaxel|paclitaxel|mesh-list
101505367|NCT00513786|Bevacizumab|bevacizumab|mesh-list
101505368|NCT00513786|Carboplatin|carboplatin|mesh-list
101505369|NCT00513786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101505370|NCT00513786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101505371|NCT00513786|Tubulin Modulators|tubulin modulators|mesh-ancestor
101505372|NCT00513786|Antimitotic Agents|antimitotic agents|mesh-ancestor
101505373|NCT00513786|Mitosis Modulators|mitosis modulators|mesh-ancestor
101505374|NCT00513786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505375|NCT00513786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101505376|NCT00513786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101505377|NCT00513786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101505378|NCT00513786|Growth Substances|growth substances|mesh-ancestor
101505379|NCT00513786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505381|NCT00504491|Rituximab|rituximab|mesh-list
101505382|NCT00504491|Alemtuzumab|alemtuzumab|mesh-list
101505383|NCT00504491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101505384|NCT00504491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101505385|NCT00504491|Immunologic Factors|immunologic factors|mesh-ancestor
101505386|NCT00504491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505387|NCT00504491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101505388|NCT00512811|Furosemide|furosemide|mesh-list
101505389|NCT00512811|Diuretics|diuretics|mesh-ancestor
101505390|NCT00512811|Natriuretic Agents|natriuretic agents|mesh-ancestor
101505391|NCT00512811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505392|NCT00512811|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101505393|NCT00512811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101505394|NCT00512811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505395|NCT00513864|Morphine|morphine|mesh-list
101505396|NCT00513864|Codeine|codeine|mesh-list
101505397|NCT00513864|Dextromethorphan|dextromethorphan|mesh-list
101505398|NCT00513864|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101505399|NCT00513864|Narcotics|narcotics|mesh-ancestor
101505400|NCT00513864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101505401|NCT00513864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505403|NCT00513864|Sensory System Agents|sensory system agents|mesh-ancestor
101505404|NCT00513864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101505405|NCT00513864|Antitussive Agents|antitussive agents|mesh-ancestor
101505406|NCT00513864|Respiratory System Agents|respiratory system agents|mesh-ancestor
101505407|NCT00513864|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101505408|NCT00513864|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101505409|NCT00513864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101505410|NCT00513864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505411|NCT01248884|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101505412|NCT01248884|Immunologic Factors|immunologic factors|mesh-ancestor
101505417|NCT00512850|Vitamins|vitamins|mesh-ancestor
101505418|NCT00512850|Micronutrients|micronutrients|mesh-ancestor
101505419|NCT00512850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505420|NCT00512928|Vitamin K 2|vitamin k 2|mesh-list
101505422|NCT00512928|Acenocoumarol|acenocoumarol|mesh-list
101505423|NCT00512928|Menaquinone 7|menaquinone 7|mesh-list
101505424|NCT00512928|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101505425|NCT00512928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101505426|NCT00512928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505427|NCT00512928|Hemostatics|hemostatics|mesh-ancestor
101505428|NCT00512928|Coagulants|coagulants|mesh-ancestor
101505429|NCT00512928|Vitamins|vitamins|mesh-ancestor
101505430|NCT00512928|Micronutrients|micronutrients|mesh-ancestor
101505431|NCT00512928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505432|NCT00512928|Anticoagulants|anticoagulants|mesh-ancestor
101505433|NCT00505154|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101505434|NCT00505154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101505435|NCT00505154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101505436|NCT00505154|Antimetabolites|antimetabolites|mesh-ancestor
101505437|NCT00505154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505438|NCT00505154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101505439|NCT00505154|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101505440|NCT00505154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101505441|NCT01246973|Curcumin|curcumin|mesh-list
101505442|NCT01246973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101505443|NCT01246973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101505444|NCT01246973|Analgesics|analgesics|mesh-ancestor
101505445|NCT01246973|Sensory System Agents|sensory system agents|mesh-ancestor
101505446|NCT01246973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101505447|NCT01246973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505448|NCT01246973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101505449|NCT01246973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101505450|NCT01246973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101304283|NCT02012088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101505451|NCT01246973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101505452|NCT01246973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505453|NCT00514605|Antibodies|antibodies|mesh-list
101505454|NCT00514605|Immunoglobulins|immunoglobulins|mesh-list
101505455|NCT00514605|Immunologic Factors|immunologic factors|mesh-ancestor
101505456|NCT00514605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505457|NCT00513981|Leucovorin|leucovorin|mesh-list
101505458|NCT00513981|Methotrexate|methotrexate|mesh-list
101505459|NCT00513981|Calcium|calcium|mesh-list
101505460|NCT00513981|Levoleucovorin|levoleucovorin|mesh-list
101505461|NCT00513981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101505462|NCT00513981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505463|NCT00513981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101505464|NCT00513981|Abortifacient Agents|abortifacient agents|mesh-ancestor
101505465|NCT00513981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101505466|NCT00513981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101505467|NCT00513981|Antimetabolites|antimetabolites|mesh-ancestor
101505468|NCT00513981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505469|NCT00513981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101505470|NCT00513981|Dermatologic Agents|dermatologic agents|mesh-ancestor
101505471|NCT00513981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317784|NCT00013702|Adefovir|adefovir|mesh-list
101505472|NCT00513981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101505473|NCT00513981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101505474|NCT00513981|Immunologic Factors|immunologic factors|mesh-ancestor
101505475|NCT00513981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101505476|NCT00513981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101505477|NCT00513981|Antidotes|antidotes|mesh-ancestor
101505478|NCT00513981|Protective Agents|protective agents|mesh-ancestor
101505479|NCT00513981|Vitamin B Complex|vitamin b complex|mesh-ancestor
101505480|NCT00513981|Vitamins|vitamins|mesh-ancestor
101505481|NCT00513981|Micronutrients|micronutrients|mesh-ancestor
101505482|NCT00505232|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101505483|NCT00505232|Immunologic Factors|immunologic factors|mesh-ancestor
101505484|NCT00505232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505485|NCT00514761|Capecitabine|capecitabine|mesh-list
101505486|NCT00514761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101505487|NCT00514761|Antimetabolites|antimetabolites|mesh-ancestor
101505488|NCT00514761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505489|NCT00514761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101505490|NCT04695600|Botulinum Toxins|botulinum toxins|mesh-list
101505491|NCT04695600|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101505492|NCT04695600|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101505493|NCT04695600|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101505494|NCT04695600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101505495|NCT04695600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505496|NCT04695600|Cholinergic Agents|cholinergic agents|mesh-ancestor
101505497|NCT04695600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101505498|NCT04695600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505499|NCT04695600|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101505500|NCT04695600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101505502|NCT01245140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101505503|NCT01245140|Dermatologic Agents|dermatologic agents|mesh-ancestor
101505504|NCT02951637|Carboplatin|carboplatin|mesh-list
101505506|NCT02951637|Gefitinib|gefitinib|mesh-list
101505507|NCT02951637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101505508|NCT02951637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101505509|NCT02951637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505510|NCT02951637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101505511|NCT02951637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101505512|NCT02951637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101505513|NCT01245101|Raltegravir Potassium|raltegravir potassium|mesh-list
101505514|NCT01245101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101505515|NCT01245101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101505516|NCT01245101|Antiviral Agents|antiviral agents|mesh-ancestor
101263545|NCT01762540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505517|NCT01245101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101505518|NCT01245101|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101505519|NCT01245101|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101505520|NCT01245101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101505521|NCT01245101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505522|NCT01245062|Trametinib|trametinib|mesh-list
101505523|NCT01245062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101505524|NCT01245062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101505525|NCT01245062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101505526|NCT01245062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505527|NCT01244984|Fluticasone|fluticasone|mesh-list
101505528|NCT01244984|Xhance|xhance|mesh-list
101505529|NCT01244984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101505530|NCT01244984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101505531|NCT01244984|Autonomic Agents|autonomic agents|mesh-ancestor
101505534|NCT01244984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101505535|NCT01244984|Respiratory System Agents|respiratory system agents|mesh-ancestor
101505536|NCT01244984|Dermatologic Agents|dermatologic agents|mesh-ancestor
101505537|NCT01244984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101505538|NCT04695483|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101505539|NCT04695483|Hormones|hormones|mesh-ancestor
101505540|NCT04695483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101505541|NCT04695483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505542|NCT01244126|Fentanyl|fentanyl|mesh-list
101505543|NCT01244126|Morphine|morphine|mesh-list
101505544|NCT01244126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101505546|NCT01244126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101505547|NCT01244126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505548|NCT01244126|Analgesics|analgesics|mesh-ancestor
101505549|NCT01244126|Sensory System Agents|sensory system agents|mesh-ancestor
101505550|NCT01244126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101505551|NCT01244126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101505552|NCT01244126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101505553|NCT01244126|Anesthetics, General|anesthetics, general|mesh-ancestor
101505554|NCT01244126|Anesthetics|anesthetics|mesh-ancestor
101505555|NCT01243775|Docetaxel|docetaxel|mesh-list
101505556|NCT01243775|Oxaliplatin|oxaliplatin|mesh-list
101505557|NCT01243775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101505558|NCT01243775|Tubulin Modulators|tubulin modulators|mesh-ancestor
101505559|NCT01243775|Antimitotic Agents|antimitotic agents|mesh-ancestor
101505560|NCT01243775|Mitosis Modulators|mitosis modulators|mesh-ancestor
101505561|NCT01243775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505562|NCT00514293|Carboplatin|carboplatin|mesh-list
101505563|NCT00514293|Docetaxel|docetaxel|mesh-list
101505564|NCT00514293|Capecitabine|capecitabine|mesh-list
101505565|NCT00514293|Tretinoin|tretinoin|mesh-list
101505566|NCT00514293|Bexarotene|bexarotene|mesh-list
101505567|NCT00514293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101505568|NCT00514293|Tubulin Modulators|tubulin modulators|mesh-ancestor
101505569|NCT00514293|Antimitotic Agents|antimitotic agents|mesh-ancestor
101505570|NCT00514293|Mitosis Modulators|mitosis modulators|mesh-ancestor
101505571|NCT00514293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505573|NCT00514293|Antimetabolites|antimetabolites|mesh-ancestor
101505574|NCT00514293|Keratolytic Agents|keratolytic agents|mesh-ancestor
101505575|NCT00514293|Dermatologic Agents|dermatologic agents|mesh-ancestor
101505576|NCT02955641|Dexamethasone|dexamethasone|mesh-list
101505577|NCT02955641|Nepafenac|nepafenac|mesh-list
101505578|NCT02955641|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101505579|NCT02955641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101505580|NCT02955641|Antiemetics|antiemetics|mesh-ancestor
101505581|NCT02955641|Autonomic Agents|autonomic agents|mesh-ancestor
101505582|NCT02955641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101505583|NCT02955641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505584|NCT02955641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101505585|NCT02955641|Glucocorticoids|glucocorticoids|mesh-ancestor
101505586|NCT02955641|Hormones|hormones|mesh-ancestor
101505587|NCT02955641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101505588|NCT02955641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101505589|NCT02955641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101505590|NCT02955641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101505591|NCT02955641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101505592|NCT02955641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101505593|NCT02955641|Analgesics|analgesics|mesh-ancestor
101263551|NCT01762644|Cyclosporine|cyclosporine|mesh-list
101505594|NCT02955641|Sensory System Agents|sensory system agents|mesh-ancestor
101263552|NCT01762644|Omeprazole|omeprazole|mesh-list
101505595|NCT02955641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101505596|NCT01243268|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
101505597|NCT01243268|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101505598|NCT01243268|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101505599|NCT01243268|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101505600|NCT01243268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505601|NCT00514995|Sodium Oxybate|sodium oxybate|mesh-list
101505602|NCT00514995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101505603|NCT00514995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101505604|NCT00514995|Anesthetics, General|anesthetics, general|mesh-ancestor
101505605|NCT00514995|Anesthetics|anesthetics|mesh-ancestor
101505606|NCT00514995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101505607|NCT00514995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505608|NCT01242176|Empagliflozin|empagliflozin|mesh-list
101505609|NCT01242176|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101505610|NCT01242176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505611|NCT01242176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101505612|NCT01242176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505614|NCT00515151|Octenidine|octenidine|mesh-list
101505615|NCT00515151|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101505616|NCT00515151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101505617|NCT00515151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101505618|NCT00515151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505619|NCT01241786|Lenalidomide|lenalidomide|mesh-list
101505620|NCT01241786|Azacitidine|azacitidine|mesh-list
101505621|NCT01241786|Immunologic Factors|immunologic factors|mesh-ancestor
101505622|NCT01241786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505623|NCT01241786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101505624|NCT01241786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101505625|NCT01241786|Growth Substances|growth substances|mesh-ancestor
101505626|NCT01241786|Growth Inhibitors|growth inhibitors|mesh-ancestor
101505628|NCT01241786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101505629|NCT01241786|Antimetabolites|antimetabolites|mesh-ancestor
101505630|NCT01241786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505631|NCT01241786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101505632|NCT00514410|Folic Acid|folic acid|mesh-list
101505633|NCT00514410|Hematinics|hematinics|mesh-ancestor
101505634|NCT00514410|Vitamin B Complex|vitamin b complex|mesh-ancestor
101505635|NCT00514410|Vitamins|vitamins|mesh-ancestor
101505636|NCT00514410|Micronutrients|micronutrients|mesh-ancestor
101505637|NCT00514410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505638|NCT01241318|Chlorhexidine|chlorhexidine|mesh-list
101505639|NCT01241318|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101505640|NCT01241318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101505641|NCT01241318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101505642|NCT01241318|Disinfectants|disinfectants|mesh-ancestor
101505643|NCT01241318|Dermatologic Agents|dermatologic agents|mesh-ancestor
101505644|NCT00514488|Imatinib Mesylate|imatinib mesylate|mesh-list
101505645|NCT00514488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101505646|NCT00514488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101505647|NCT00514488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101505648|NCT00514488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505649|NCT00514527|Oritavancin|oritavancin|mesh-list
101505650|NCT00514527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101505651|NCT00514527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101505652|NCT01241240|Timolol|timolol|mesh-list
101505653|NCT01241240|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101189389|NCT00003714|NSC 366140|nsc 366140|mesh-list
101505654|NCT01241240|Bimatoprost|bimatoprost|mesh-list
101505655|NCT01241240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101505656|NCT01241240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101505657|NCT01241240|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101505658|NCT01241240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101505659|NCT01241240|Adrenergic Agents|adrenergic agents|mesh-ancestor
101505660|NCT01241240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101505661|NCT01241240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505662|NCT01241240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263556|NCT01762644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101505663|NCT01241240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101505664|NCT01241240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101505665|NCT01241240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101505666|NCT01241240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101505667|NCT01241240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101505668|NCT02950623|Titanium dioxide|titanium dioxide|mesh-list
101505669|NCT02950623|Sunscreening Agents|sunscreening agents|mesh-ancestor
101505670|NCT02950623|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101505671|NCT02950623|Protective Agents|protective agents|mesh-ancestor
101505672|NCT02950623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505673|NCT02950623|Dermatologic Agents|dermatologic agents|mesh-ancestor
101505674|NCT02950623|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101505675|NCT00516009|Dexamethasone|dexamethasone|mesh-list
101505676|NCT00516009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101505677|NCT00516009|Antiemetics|antiemetics|mesh-ancestor
101505678|NCT00516009|Autonomic Agents|autonomic agents|mesh-ancestor
101505679|NCT00516009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101505681|NCT00516009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101505682|NCT00516009|Glucocorticoids|glucocorticoids|mesh-ancestor
101505683|NCT00516009|Hormones|hormones|mesh-ancestor
101505684|NCT00516009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101505685|NCT00516009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101505686|NCT00516009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101505687|NCT02950584|Titanium dioxide|titanium dioxide|mesh-list
101505688|NCT02950584|Sunscreening Agents|sunscreening agents|mesh-ancestor
101505689|NCT02950584|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101505690|NCT02950584|Protective Agents|protective agents|mesh-ancestor
101505691|NCT02950584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505692|NCT02950584|Dermatologic Agents|dermatologic agents|mesh-ancestor
101505693|NCT02950584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101505695|NCT01240811|Levonorgestrel|levonorgestrel|mesh-list
101505696|NCT01240811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101505697|NCT01240811|Contraceptive Agents|contraceptive agents|mesh-ancestor
101505698|NCT01240811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101505699|NCT01240811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505700|NCT01240811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101505701|NCT01240811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101505702|NCT01240811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101505703|NCT01240811|Trace Elements|trace elements|mesh-ancestor
101505704|NCT01240811|Micronutrients|micronutrients|mesh-ancestor
101505705|NCT03459144|Ranibizumab|ranibizumab|mesh-list
101505706|NCT03459144|Verteporfin|verteporfin|mesh-list
101505707|NCT03459144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101505708|NCT03459144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101505709|NCT03459144|Growth Substances|growth substances|mesh-ancestor
101505710|NCT03459144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505711|NCT03459144|Growth Inhibitors|growth inhibitors|mesh-ancestor
101505712|NCT03459144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101505713|NCT03459144|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101505714|NCT03459144|Dermatologic Agents|dermatologic agents|mesh-ancestor
101505715|NCT03459105|Bupivacaine|bupivacaine|mesh-list
101505716|NCT03459105|Anesthetics|anesthetics|mesh-list
101505717|NCT03459105|Anesthetics, Local|anesthetics, local|mesh-ancestor
101505718|NCT03459105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101505719|NCT03459105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505720|NCT03459105|Sensory System Agents|sensory system agents|mesh-ancestor
101505721|NCT03459105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101505722|NCT01240382|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101505723|NCT01240382|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101505724|NCT01240382|Hyaluronic Acid|hyaluronic acid|mesh-list
101505725|NCT01240382|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101505726|NCT01240382|Immunologic Factors|immunologic factors|mesh-ancestor
101505727|NCT01240382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505728|NCT01240382|Viscosupplements|viscosupplements|mesh-ancestor
101263562|NCT01762644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101214044|NCT01463215|Ambroxol|ambroxol|mesh-list
101505729|NCT01240382|Protective Agents|protective agents|mesh-ancestor
101505730|NCT01244828|Asenapine|asenapine|mesh-list
101505731|NCT01244828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101505732|NCT01244828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101505733|NCT01244828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101505734|NCT01244828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505735|NCT01244828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101505738|NCT00504192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101505740|NCT00504192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505741|NCT00504192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101505742|NCT01243346|Crenolanib|crenolanib|mesh-list
101505743|NCT01243346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101505744|NCT01249443|Paclitaxel|paclitaxel|mesh-list
101505745|NCT01249443|Carboplatin|carboplatin|mesh-list
101505746|NCT01249443|Vorinostat|vorinostat|mesh-list
101505747|NCT01249443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101505748|NCT01249443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101505749|NCT01249443|Tubulin Modulators|tubulin modulators|mesh-ancestor
101505750|NCT01249443|Antimitotic Agents|antimitotic agents|mesh-ancestor
101505751|NCT01249443|Mitosis Modulators|mitosis modulators|mesh-ancestor
101505752|NCT01249443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505753|NCT01249443|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101505754|NCT01249443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101505755|NCT01243073|Imetelstat|imetelstat|mesh-list
101505756|NCT01243073|Motesanib diphosphate|motesanib diphosphate|mesh-list
101505757|NCT01243073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101505758|NCT01243073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505759|NCT01243073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101505760|NCT00516243|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
101505761|NCT00516243|Antioxidants|antioxidants|mesh-ancestor
101505762|NCT00516243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505763|NCT00516243|Protective Agents|protective agents|mesh-ancestor
101505764|NCT00516243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505765|NCT00516243|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101505766|NCT00516243|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101505767|NCT00516243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101505768|NCT00516243|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101505769|NCT01240889|Fluticasone|fluticasone|mesh-list
101505770|NCT01240889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101505771|NCT01240889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101505772|NCT01240889|Autonomic Agents|autonomic agents|mesh-ancestor
101505773|NCT01240889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101505774|NCT01240889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505775|NCT01240889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101505776|NCT01240889|Respiratory System Agents|respiratory system agents|mesh-ancestor
101505777|NCT01240889|Dermatologic Agents|dermatologic agents|mesh-ancestor
101505778|NCT01240889|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101505779|NCT00516282|Temozolomide|temozolomide|mesh-list
101505780|NCT00516282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101505781|NCT00516282|Alkylating Agents|alkylating agents|mesh-ancestor
101505782|NCT00516282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505783|NCT00516282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101505784|NCT01249521|Bevacizumab|bevacizumab|mesh-list
101505785|NCT01249521|Trebananib|trebananib|mesh-list
101505786|NCT01249521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101505787|NCT01249521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101505788|NCT01249521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101505791|NCT01249521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505792|NCT01249521|Growth Inhibitors|growth inhibitors|mesh-ancestor
101505793|NCT01249677|Insulin Glargine|insulin glargine|mesh-list
101505794|NCT01249677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101505795|NCT01249677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505796|NCT04511975|Azacitidine|azacitidine|mesh-list
101317840|NCT00005972|Antimetabolites|antimetabolites|mesh-ancestor
101505798|NCT04511975|Antimetabolites|antimetabolites|mesh-ancestor
101505799|NCT04511975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505800|NCT04511975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101505801|NCT04511975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101505802|NCT04511897|Expectorants|expectorants|mesh-list
101505803|NCT04511897|Respiratory System Agents|respiratory system agents|mesh-ancestor
101505804|NCT04519463|Lidocaine|lidocaine|mesh-list
101505805|NCT04519463|Anesthetics, Local|anesthetics, local|mesh-ancestor
101189528|NCT00003858|Mitoxantrone|mitoxantrone|mesh-list
101505807|NCT04519463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101505808|NCT04519463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505809|NCT04519463|Sensory System Agents|sensory system agents|mesh-ancestor
101505810|NCT04519463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101505811|NCT04519463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101505812|NCT04519463|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101505813|NCT04519463|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101505814|NCT04519463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101410872|NCT00114569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101505815|NCT04519463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505816|NCT04696848|Durvalumab|durvalumab|mesh-list
101505817|NCT04696848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101505818|NCT04696848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101505819|NCT01244256|Gentamicins|gentamicins|mesh-list
101505820|NCT01244256|Clotrimazole|clotrimazole|mesh-list
101505821|NCT01244256|Miconazole|miconazole|mesh-list
101505822|NCT01244256|Beclomethasone|beclomethasone|mesh-list
101505823|NCT01244256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101505824|NCT01244256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101505825|NCT01244256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101505826|NCT01244256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101505827|NCT01244256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505828|NCT01244256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101505829|NCT01244256|Glucocorticoids|glucocorticoids|mesh-ancestor
101505830|NCT01244256|Hormones|hormones|mesh-ancestor
101505831|NCT01244256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101505832|NCT01244256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505833|NCT01244256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101505834|NCT01244256|Respiratory System Agents|respiratory system agents|mesh-ancestor
101505835|NCT01244256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101505836|NCT01244256|Antifungal Agents|antifungal agents|mesh-ancestor
101505838|NCT01244256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101505839|NCT01244256|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101505840|NCT01244256|Hormone Antagonists|hormone antagonists|mesh-ancestor
101505841|NCT01244256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101505842|NCT01244256|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101505843|NCT01249833|Oseltamivir|oseltamivir|mesh-list
101505844|NCT01249833|Antiviral Agents|antiviral agents|mesh-ancestor
101505845|NCT01249833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101505846|NCT01249833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101505847|NCT01249833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505848|NCT02950233|N-Methylaspartate|n-methylaspartate|mesh-list
101505849|NCT02950233|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
101505850|NCT02950233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101505851|NCT02950233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101505852|NCT02950233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505853|NCT02950233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505854|NCT01249404|Botulinum Toxins|botulinum toxins|mesh-list
101505855|NCT01249404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101505856|NCT01249404|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101505857|NCT01249404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101505858|NCT01249404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101505859|NCT01249404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505860|NCT01249404|Cholinergic Agents|cholinergic agents|mesh-ancestor
101505861|NCT01249404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101505862|NCT01249404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505863|NCT01249404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101505864|NCT01249404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101505865|NCT04511000|Atorvastatin|atorvastatin|mesh-list
101505866|NCT04511000|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101505867|NCT04511000|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101505868|NCT04511000|Antimetabolites|antimetabolites|mesh-ancestor
101505869|NCT04511000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505870|NCT04511000|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101505871|NCT04511000|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101505872|NCT04511000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101505873|NCT04519385|Dexamethasone|dexamethasone|mesh-list
101505874|NCT04519385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101505875|NCT04519385|Antiemetics|antiemetics|mesh-ancestor
101505876|NCT04519385|Autonomic Agents|autonomic agents|mesh-ancestor
101189599|NCT00003906|Tamoxifen|tamoxifen|mesh-list
101505877|NCT04519385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101505878|NCT04519385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505879|NCT04519385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101505880|NCT04519385|Glucocorticoids|glucocorticoids|mesh-ancestor
101505881|NCT04519385|Hormones|hormones|mesh-ancestor
101505882|NCT04519385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101505883|NCT04519385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101505884|NCT04519385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101505885|NCT00506051|Pemetrexed|pemetrexed|mesh-list
101505888|NCT00506051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505890|NCT00506051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101505891|NCT00504465|Dinoprostone|dinoprostone|mesh-list
101505892|NCT00504465|Oxytocics|oxytocics|mesh-ancestor
101505893|NCT00504465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101505894|NCT00504465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505895|NCT00516360|Chlorhexidine|chlorhexidine|mesh-list
101505896|NCT00516360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
101505897|NCT00516360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101505898|NCT00516360|Disinfectants|disinfectants|mesh-ancestor
101505899|NCT04510649|Rifampin|rifampin|mesh-list
101505900|NCT04510649|Rabeprazole|rabeprazole|mesh-list
101505901|NCT04510649|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101505902|NCT04510649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101505903|NCT04510649|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101505904|NCT04510649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101505905|NCT04510649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505906|NCT04510649|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101505907|NCT04510649|Antitubercular Agents|antitubercular agents|mesh-ancestor
101505908|NCT04510649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101505909|NCT04510649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101505910|NCT04510649|Leprostatic Agents|leprostatic agents|mesh-ancestor
101505911|NCT04510649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101505912|NCT04510649|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101505913|NCT04510649|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101505914|NCT04510649|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101505915|NCT04510649|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101505916|NCT04510649|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101505917|NCT04510649|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101505918|NCT01249092|Pentoxifylline|pentoxifylline|mesh-list
101505919|NCT01249092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101505920|NCT01249092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101505921|NCT01249092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505922|NCT01249092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101505923|NCT01249092|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101505924|NCT01249092|Protective Agents|protective agents|mesh-ancestor
101505925|NCT01249092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505926|NCT01249092|Vasodilator Agents|vasodilator agents|mesh-ancestor
101505927|NCT01249092|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101505928|NCT01249092|Antioxidants|antioxidants|mesh-ancestor
101505929|NCT02275182|Dexmedetomidine|dexmedetomidine|mesh-list
101505930|NCT02275182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101505931|NCT02275182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101505932|NCT02275182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505933|NCT02275182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101505934|NCT02275182|Analgesics|analgesics|mesh-ancestor
101505935|NCT02275182|Sensory System Agents|sensory system agents|mesh-ancestor
101505936|NCT02275182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101505937|NCT02275182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101505938|NCT02275182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101505939|NCT02275182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101505940|NCT02275182|Adrenergic Agents|adrenergic agents|mesh-ancestor
101505941|NCT02275182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101505942|NCT02275182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263579|NCT01762657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101505943|NCT01248780|Golimumab|golimumab|mesh-list
101505944|NCT01248780|Methotrexate|methotrexate|mesh-list
101505945|NCT01248780|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101505946|NCT01248780|Abortifacient Agents|abortifacient agents|mesh-ancestor
101505947|NCT01248780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101505948|NCT01248780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505949|NCT01248780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101505950|NCT01248780|Antimetabolites|antimetabolites|mesh-ancestor
101505951|NCT01248780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505952|NCT01248780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101505953|NCT01248780|Dermatologic Agents|dermatologic agents|mesh-ancestor
101505954|NCT01248780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101505955|NCT01248780|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101505956|NCT01248780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101505957|NCT01248780|Immunologic Factors|immunologic factors|mesh-ancestor
101505958|NCT01248780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101505959|NCT01248780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101505960|NCT01248780|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101505961|NCT01248780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101505963|NCT01248468|Acetaminophen|acetaminophen|mesh-list
101505964|NCT01248468|Sumatriptan|sumatriptan|mesh-list
101505965|NCT01248468|Caffeine|caffeine|mesh-list
101505966|NCT01248468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101505967|NCT01248468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101505968|NCT01248468|Analgesics|analgesics|mesh-ancestor
101505969|NCT01248468|Sensory System Agents|sensory system agents|mesh-ancestor
101505970|NCT01248468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101505971|NCT01248468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505972|NCT01248468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101505973|NCT01248468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101505974|NCT01248468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101505975|NCT01248468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101505976|NCT01248468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101505977|NCT01248468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101505978|NCT01248468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101505979|NCT01248468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101505980|NCT01248468|Antipyretics|antipyretics|mesh-ancestor
101505981|NCT01248468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101505982|NCT01248468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101505983|NCT01248468|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101505984|NCT01248468|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101505985|NCT01248468|Purinergic Agents|purinergic agents|mesh-ancestor
101505986|NCT01248468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101505987|NCT01248468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101505988|NCT01248468|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101505989|NCT01248468|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101505990|NCT01248468|Serotonin Agents|serotonin agents|mesh-ancestor
101505992|NCT02275299|Leflunomide|leflunomide|mesh-list
101505993|NCT02275299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101505994|NCT02275299|Abortifacient Agents|abortifacient agents|mesh-ancestor
101505995|NCT02275299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101505996|NCT02275299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101505997|NCT02275299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101505998|NCT02275299|Antimetabolites|antimetabolites|mesh-ancestor
101505999|NCT02275299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506000|NCT02275299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506001|NCT02275299|Dermatologic Agents|dermatologic agents|mesh-ancestor
101506002|NCT02275299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317849|NCT00014170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101506003|NCT02275299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101506004|NCT02275299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101506005|NCT02275299|Immunologic Factors|immunologic factors|mesh-ancestor
101506006|NCT02275299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101506007|NCT02275299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101506008|NCT01247922|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101506009|NCT01247922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506010|NCT01247922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101506011|NCT01247922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101506012|NCT01247922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506013|NCT01246206|Tacrolimus|tacrolimus|mesh-list
101506015|NCT01246206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101506016|NCT01246206|Immunologic Factors|immunologic factors|mesh-ancestor
101506017|NCT01246206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506018|NCT01246206|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101506019|NCT01246206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101506020|NCT01246206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506021|NCT04510610|Decitabine|decitabine|mesh-list
101506022|NCT04510610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101506023|NCT04510610|Antimetabolites|antimetabolites|mesh-ancestor
101506024|NCT04510610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506025|NCT04510610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506026|NCT04510610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101506027|NCT01246011|Warfarin|warfarin|mesh-list
101506028|NCT01246011|Argatroban|argatroban|mesh-list
101506029|NCT01246011|Anticoagulants|anticoagulants|mesh-ancestor
101506030|NCT01246011|Antithrombins|antithrombins|mesh-ancestor
101506031|NCT01246011|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101506032|NCT01246011|Protease Inhibitors|protease inhibitors|mesh-ancestor
101506033|NCT01246011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101506034|NCT01246011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506035|NCT01246011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101506036|NCT01244490|Guanfacine|guanfacine|mesh-list
101506037|NCT01244490|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101506038|NCT01244490|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101506039|NCT01244490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101506040|NCT01244490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101506041|NCT01244490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506042|NCT01244490|Adrenergic Agents|adrenergic agents|mesh-ancestor
101506043|NCT01244490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101506044|NCT01244490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506045|NCT01244490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101506046|NCT01244490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101506047|NCT01244490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101506048|NCT01244490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101506049|NCT01243944|Lenalidomide|lenalidomide|mesh-list
101506050|NCT01243944|Pomalidomide|pomalidomide|mesh-list
101506051|NCT01243944|Hydroxyurea|hydroxyurea|mesh-list
101506052|NCT01243944|Pipobroman|pipobroman|mesh-list
101506053|NCT01243944|Anagrelide|anagrelide|mesh-list
101506054|NCT01243944|Immunologic Factors|immunologic factors|mesh-ancestor
101506055|NCT01243944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506056|NCT01243944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101506057|NCT01243944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101506058|NCT01243944|Growth Substances|growth substances|mesh-ancestor
101506059|NCT01243944|Growth Inhibitors|growth inhibitors|mesh-ancestor
101506060|NCT01243944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506061|NCT01243944|Antisickling Agents|antisickling agents|mesh-ancestor
101506062|NCT01243944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101506063|NCT01243944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506064|NCT01243944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101506065|NCT01243944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101506066|NCT01243944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101506067|NCT01243944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101506068|NCT01243944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101506069|NCT01243944|Alkylating Agents|alkylating agents|mesh-ancestor
101506070|NCT00516399|Povidone-Iodine|povidone-iodine|mesh-list
101506072|NCT00516399|Povidone|povidone|mesh-list
101506073|NCT00516399|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101506074|NCT00516399|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101506075|NCT00516399|Plasma Substitutes|plasma substitutes|mesh-ancestor
101506076|NCT00516399|Blood Substitutes|blood substitutes|mesh-ancestor
101506077|NCT00516399|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101506078|NCT00516399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101506079|NCT00516399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101506080|NCT00516399|Antifungal Agents|antifungal agents|mesh-ancestor
101506081|NCT00516438|Topotecan|topotecan|mesh-list
101506082|NCT00516438|Olaparib|olaparib|mesh-list
101506083|NCT00516438|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
101506084|NCT00516438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101506085|NCT00516438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101506086|NCT00516438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101506087|NCT00516438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506088|NCT00516438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506089|NCT02275988|Clarithromycin|clarithromycin|mesh-list
101506090|NCT02275988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101506091|NCT02275988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101506092|NCT02275988|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101506093|NCT02275988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101506094|NCT02275988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506095|NCT02275988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101506096|NCT02275988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101506097|NCT02950155|Rituximab|rituximab|mesh-list
101506098|NCT02950155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101506100|NCT02950155|Immunologic Factors|immunologic factors|mesh-ancestor
101506101|NCT02950155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506102|NCT02950155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101506103|NCT00516672|Lapatinib|lapatinib|mesh-list
101506104|NCT00516672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506105|NCT00516672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101506106|NCT00516672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101506107|NCT00516672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506108|NCT00516711|Sevoflurane|sevoflurane|mesh-list
101506109|NCT00516711|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101506110|NCT00516711|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101506111|NCT00516711|Anesthetics, General|anesthetics, general|mesh-ancestor
101506112|NCT00516711|Anesthetics|anesthetics|mesh-ancestor
101506113|NCT00516711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101506114|NCT00516711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506115|NCT00516750|Doxorubicin|doxorubicin|mesh-list
101506116|NCT00516750|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101506117|NCT00516750|Methotrexate|methotrexate|mesh-list
101506118|NCT00516750|Vinblastine|vinblastine|mesh-list
101506119|NCT00516750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506120|NCT00516750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101506122|NCT00516750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101506123|NCT00516750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101506124|NCT00516750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506125|NCT00516750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101506126|NCT00516750|Abortifacient Agents|abortifacient agents|mesh-ancestor
101506127|NCT00516750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101506128|NCT00516750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506129|NCT00516750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101506130|NCT00516750|Antimetabolites|antimetabolites|mesh-ancestor
101506131|NCT00516750|Dermatologic Agents|dermatologic agents|mesh-ancestor
101506133|NCT00516750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101506134|NCT00516750|Immunologic Factors|immunologic factors|mesh-ancestor
101506135|NCT00516750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101506136|NCT00516750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101506137|NCT00516750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101506138|NCT00516750|Tubulin Modulators|tubulin modulators|mesh-ancestor
101506139|NCT00516750|Antimitotic Agents|antimitotic agents|mesh-ancestor
101506140|NCT00516750|Mitosis Modulators|mitosis modulators|mesh-ancestor
101506141|NCT00505427|Thioctic Acid|thioctic acid|mesh-list
101506142|NCT00505427|Antioxidants|antioxidants|mesh-ancestor
101506143|NCT00505427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506144|NCT00505427|Protective Agents|protective agents|mesh-ancestor
101506145|NCT00505427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506146|NCT00505427|Vitamin B Complex|vitamin b complex|mesh-ancestor
101506147|NCT00505427|Vitamins|vitamins|mesh-ancestor
101506148|NCT00505427|Micronutrients|micronutrients|mesh-ancestor
101506149|NCT00506168|Capecitabine|capecitabine|mesh-list
101506150|NCT00506168|Irinotecan|irinotecan|mesh-list
101506151|NCT00506168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101506152|NCT00506168|Antimetabolites|antimetabolites|mesh-ancestor
101263600|NCT01762787|Analgesics|analgesics|mesh-ancestor
101506153|NCT00506168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506154|NCT00506168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506155|NCT00506168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101506156|NCT00506168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101506157|NCT00506168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101506158|NCT02950038|Nivolumab|nivolumab|mesh-list
101506159|NCT02950038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101506160|NCT02950038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506161|NCT02950038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101506162|NCT02950038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506163|NCT04510220|Ofatumumab|ofatumumab|mesh-list
101506164|NCT04510220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506165|NCT02949648|Nicotine|nicotine|mesh-list
101506166|NCT02949648|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101506167|NCT02949648|Autonomic Agents|autonomic agents|mesh-ancestor
101506168|NCT02949648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101506169|NCT02949648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506170|NCT02949648|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101506171|NCT02949648|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101506172|NCT02949648|Cholinergic Agents|cholinergic agents|mesh-ancestor
101506173|NCT02949648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101506174|NCT02949648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506175|NCT04510337|Magnesium Sulfate|magnesium sulfate|mesh-list
101506176|NCT04510337|Rocuronium|rocuronium|mesh-list
101506177|NCT04510337|Analgesics|analgesics|mesh-ancestor
101506178|NCT04510337|Sensory System Agents|sensory system agents|mesh-ancestor
101506179|NCT04510337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101506180|NCT04510337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506181|NCT04510337|Anesthetics|anesthetics|mesh-ancestor
101506182|NCT04510337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101506183|NCT04510337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101506186|NCT04510337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101506187|NCT04510337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506188|NCT04510337|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101506189|NCT04510337|Tocolytic Agents|tocolytic agents|mesh-ancestor
101506190|NCT04510337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101506191|NCT04510337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101506192|NCT04510337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101506193|NCT04510337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101506194|NCT02949765|Iron|iron|mesh-list
101506195|NCT02949765|Trace Elements|trace elements|mesh-ancestor
101506196|NCT02949765|Micronutrients|micronutrients|mesh-ancestor
101506197|NCT02949765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506198|NCT04518176|Oxytocin|oxytocin|mesh-list
101506199|NCT04518176|Oxytocics|oxytocics|mesh-ancestor
101506200|NCT04518176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101506201|NCT04518176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506202|NCT00516945|Lamivudine|lamivudine|mesh-list
101506203|NCT00516945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101506204|NCT00516945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101506205|NCT00516945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101506206|NCT00516945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506207|NCT00516945|Antiviral Agents|antiviral agents|mesh-ancestor
101506208|NCT00516945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101506209|NCT00516945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101506210|NCT00516945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101506211|NCT02275598|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101506212|NCT02275598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101506213|NCT02275598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506214|NCT02275598|Immunotoxins|immunotoxins|mesh-ancestor
101506215|NCT02275598|Immunoconjugates|immunoconjugates|mesh-ancestor
101506216|NCT02275598|Immunologic Factors|immunologic factors|mesh-ancestor
101506217|NCT02275598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506219|NCT00517062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101506220|NCT00517062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506221|NCT00517179|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101506222|NCT00517179|Vasodilator Agents|vasodilator agents|mesh-ancestor
101506223|NCT00517179|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101506224|NCT00517179|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101506225|NCT00517179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101506226|NCT00517179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506227|NCT00517179|Urological Agents|urological agents|mesh-ancestor
101506229|NCT00517218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506230|NCT00506207|Oxaliplatin|oxaliplatin|mesh-list
101506231|NCT00506207|Irinotecan|irinotecan|mesh-list
101506232|NCT00506207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506233|NCT00506207|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101506234|NCT00506207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101506235|NCT00506207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101506236|NCT00506207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506237|NCT00517257|Atorvastatin|atorvastatin|mesh-list
101506238|NCT00517257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101506239|NCT00517257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101506240|NCT00517257|Antimetabolites|antimetabolites|mesh-ancestor
101506241|NCT00517257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506242|NCT00517257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101506243|NCT00517257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101506244|NCT00517257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101506245|NCT00506246|Propofol|propofol|mesh-list
101506246|NCT00506246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101506247|NCT00506246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101506248|NCT00506246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506249|NCT00506246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101506250|NCT00506246|Anesthetics, General|anesthetics, general|mesh-ancestor
101506251|NCT00506246|Anesthetics|anesthetics|mesh-ancestor
101506252|NCT01243242|Metadoxine|metadoxine|mesh-list
101506253|NCT01243242|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101506254|NCT00517491|Lanreotide|lanreotide|mesh-list
101506255|NCT00517491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506256|NCT04517201|Insulin|insulin|mesh-list
101506257|NCT04517201|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101506258|NCT04517201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101506259|NCT04517201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506260|NCT01241292|Elotuzumab|elotuzumab|mesh-list
101506261|NCT01241292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506262|NCT00517725|Carvedilol|carvedilol|mesh-list
101506263|NCT00517725|Nebivolol|nebivolol|mesh-list
101506264|NCT00517725|Bisoprolol|bisoprolol|mesh-list
101506265|NCT00517725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101506266|NCT00517725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101506267|NCT00517725|Adrenergic Agents|adrenergic agents|mesh-ancestor
101506268|NCT00517725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101506269|NCT00517725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506270|NCT00517725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506271|NCT00517725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101506272|NCT00517725|Antioxidants|antioxidants|mesh-ancestor
101506273|NCT00517725|Protective Agents|protective agents|mesh-ancestor
101506274|NCT00517725|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101506275|NCT00517725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101506276|NCT00517725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101506277|NCT00517725|Vasodilator Agents|vasodilator agents|mesh-ancestor
101506278|NCT00517725|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101506279|NCT00517725|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101506280|NCT00517725|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101506281|NCT00517725|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101506283|NCT00517725|Sympatholytics|sympatholytics|mesh-ancestor
101506284|NCT00517725|Autonomic Agents|autonomic agents|mesh-ancestor
101506285|NCT00517725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101506286|NCT00517725|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101506287|NCT01240863|Hydrocodone|hydrocodone|mesh-list
101506288|NCT01240863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101506289|NCT01240863|Narcotics|narcotics|mesh-ancestor
101506290|NCT01240863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101506291|NCT01240863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506292|NCT01240863|Analgesics|analgesics|mesh-ancestor
101506293|NCT01240863|Sensory System Agents|sensory system agents|mesh-ancestor
101506294|NCT01240863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101506295|NCT01240863|Antitussive Agents|antitussive agents|mesh-ancestor
101506296|NCT01240863|Respiratory System Agents|respiratory system agents|mesh-ancestor
101506297|NCT01240746|Vaccines|vaccines|mesh-list
101506298|NCT01240746|Immunologic Factors|immunologic factors|mesh-ancestor
101506299|NCT01240746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506300|NCT01240590|Cisplatin|cisplatin|mesh-list
101506301|NCT01240590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506302|NCT01240200|Insulin Glargine|insulin glargine|mesh-list
101506303|NCT01240200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101506304|NCT01240200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506305|NCT00504543|Everolimus|everolimus|mesh-list
101506306|NCT00504543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101506307|NCT00504543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506308|NCT00504543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101506309|NCT00504543|Immunologic Factors|immunologic factors|mesh-ancestor
101506310|NCT00504543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506311|NCT00504543|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101506312|NCT00504543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101506313|NCT00504543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506314|NCT02949843|Pembrolizumab|pembrolizumab|mesh-list
101506315|NCT02949843|Nivolumab|nivolumab|mesh-list
101506316|NCT02949843|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101506317|NCT02949843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101506318|NCT02949843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506319|NCT02949843|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101506320|NCT02949843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506321|NCT02949843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101506322|NCT02949843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101506323|NCT00517764|Citalopram|citalopram|mesh-list
101506324|NCT00517764|Escitalopram|escitalopram|mesh-list
101506325|NCT00517764|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101506326|NCT00517764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101506327|NCT00517764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101506328|NCT00517764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506330|NCT00517764|Serotonin Agents|serotonin agents|mesh-ancestor
101506331|NCT00517764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506332|NCT00517764|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101506333|NCT00517764|Antidepressive Agents|antidepressive agents|mesh-ancestor
101506334|NCT00517764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101506335|NCT00517803|Micronutrients|micronutrients|mesh-list
101506336|NCT00517803|Trace Elements|trace elements|mesh-list
101506337|NCT00517803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506338|NCT04516304|Equol|equol|mesh-list
101506339|NCT04516304|Phytoestrogens|phytoestrogens|mesh-ancestor
101506340|NCT04516304|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101506341|NCT04516304|Estrogens|estrogens|mesh-ancestor
101506342|NCT04516304|Hormones|hormones|mesh-ancestor
101506343|NCT04516304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101506344|NCT04516304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506345|NCT01242930|Niacinamide|niacinamide|mesh-list
101506346|NCT01242930|Lenalidomide|lenalidomide|mesh-list
101506347|NCT01242930|Imetelstat|imetelstat|mesh-list
101506348|NCT01242930|Motesanib diphosphate|motesanib diphosphate|mesh-list
101506349|NCT01242930|Immunologic Factors|immunologic factors|mesh-ancestor
101506350|NCT01242930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506351|NCT01242930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101506352|NCT01242930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101506354|NCT01242930|Growth Inhibitors|growth inhibitors|mesh-ancestor
101506355|NCT01242930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506356|NCT01242930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101506357|NCT01242930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506358|NCT01242930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101506359|NCT01242930|Vitamin B Complex|vitamin b complex|mesh-ancestor
101506360|NCT01242930|Vitamins|vitamins|mesh-ancestor
101263623|NCT01762826|Inositol|inositol|mesh-list
101506361|NCT01242930|Micronutrients|micronutrients|mesh-ancestor
101506362|NCT01241214|Cetirizine|cetirizine|mesh-list
101506363|NCT01241214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101506364|NCT01241214|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101506365|NCT01241214|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101506366|NCT01241214|Histamine Antagonists|histamine antagonists|mesh-ancestor
101506367|NCT01241214|Histamine Agents|histamine agents|mesh-ancestor
101506368|NCT01241214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101506369|NCT01241214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506370|NCT01241214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506371|NCT01240512|Vitamin D|vitamin d|mesh-list
101506372|NCT01240512|Cholecalciferol|cholecalciferol|mesh-list
101506373|NCT01240512|Vitamins|vitamins|mesh-ancestor
101506374|NCT01240512|Micronutrients|micronutrients|mesh-ancestor
101506375|NCT01240512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506376|NCT01240512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101506377|NCT01240512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101506379|NCT01240629|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101506380|NCT01240629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101506381|NCT01240629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506382|NCT01240629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101506383|NCT01240629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101506384|NCT01240629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101506385|NCT01240629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506386|NCT00518232|Methylphenidate|methylphenidate|mesh-list
101506387|NCT00518232|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101506388|NCT00518232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506389|NCT00518232|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101506390|NCT00518232|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101506391|NCT00518232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101506392|NCT00518232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506393|NCT00518232|Dopamine Agents|dopamine agents|mesh-ancestor
101506394|NCT00518232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101506395|NCT00505505|Insulin|insulin|mesh-list
101506396|NCT00505505|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101506397|NCT00505505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101190137|NCT00004278|Ganciclovir|ganciclovir|mesh-list
101506398|NCT00505505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506399|NCT00518271|Sirolimus|sirolimus|mesh-list
101506400|NCT00518271|Tacrolimus|tacrolimus|mesh-list
101506401|NCT00518271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101506402|NCT00518271|Immunologic Factors|immunologic factors|mesh-ancestor
101506403|NCT00518271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506404|NCT00518271|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101506405|NCT00518271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101506406|NCT00518271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506407|NCT00518271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101506408|NCT00518271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101506409|NCT00518271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101506410|NCT00518271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506411|NCT00518271|Antifungal Agents|antifungal agents|mesh-ancestor
101506412|NCT00518193|Cetuximab|cetuximab|mesh-list
101506413|NCT00518193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101506414|NCT00518193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506415|NCT00518427|Insulin Glargine|insulin glargine|mesh-list
101506416|NCT00518427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101506417|NCT00518427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506418|NCT00518466|Topiramate|topiramate|mesh-list
101506419|NCT00518466|Phentermine|phentermine|mesh-list
101506420|NCT00518466|Anticonvulsants|anticonvulsants|mesh-ancestor
101506421|NCT00518466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101506422|NCT00518466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506423|NCT00518466|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101506424|NCT00518466|Appetite Depressants|appetite depressants|mesh-ancestor
101506425|NCT00518466|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101506426|NCT00518466|Sympathomimetics|sympathomimetics|mesh-ancestor
101506427|NCT00518466|Autonomic Agents|autonomic agents|mesh-ancestor
101506428|NCT00518466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101506429|NCT00518466|Adrenergic Agents|adrenergic agents|mesh-ancestor
101506430|NCT00518466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101506431|NCT00518466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506433|NCT00518583|Doxorubicin|doxorubicin|mesh-list
101263628|NCT01762839|Moxifloxacin|moxifloxacin|mesh-list
101506434|NCT00518583|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101506435|NCT00518583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101506436|NCT00518583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506437|NCT00518583|Tubulin Modulators|tubulin modulators|mesh-ancestor
101506438|NCT00518583|Antimitotic Agents|antimitotic agents|mesh-ancestor
101506439|NCT00518583|Mitosis Modulators|mitosis modulators|mesh-ancestor
101506440|NCT00518583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506441|NCT00518583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101506442|NCT00518583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101506443|NCT00518583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101506444|NCT00518583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101506445|NCT00519753|Timolol|timolol|mesh-list
101506446|NCT00519753|Travoprost|travoprost|mesh-list
101506447|NCT00519753|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101506448|NCT00519753|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101506449|NCT00519753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506450|NCT00519753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101506451|NCT00519753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101506452|NCT00519753|Adrenergic Agents|adrenergic agents|mesh-ancestor
101506453|NCT00519753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101506454|NCT00519753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506455|NCT00519753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101506456|NCT00519753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101506457|NCT00519870|Losartan|losartan|mesh-list
101506458|NCT00519870|Nifedipine|nifedipine|mesh-list
101506459|NCT00519870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101506460|NCT00519870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101506461|NCT00519870|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101506462|NCT00519870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101506463|NCT00519870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506464|NCT00519870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101506465|NCT00519870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101506466|NCT00519870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101506467|NCT00519870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506468|NCT00519870|Vasodilator Agents|vasodilator agents|mesh-ancestor
101506469|NCT00519870|Tocolytic Agents|tocolytic agents|mesh-ancestor
101506470|NCT00519870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101506471|NCT00519909|Calcium|calcium|mesh-list
101506472|NCT00519909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101506473|NCT00519909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506474|NCT02949492|Interleukin-2|interleukin-2|mesh-list
101506475|NCT02949492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506476|NCT02949492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101506477|NCT02949492|Analgesics|analgesics|mesh-ancestor
101506478|NCT02949492|Sensory System Agents|sensory system agents|mesh-ancestor
101506479|NCT02949492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101506480|NCT02949492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506490|NCT04514588|Caffeine|caffeine|mesh-list
101506491|NCT04514588|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101506492|NCT04514588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506493|NCT04514588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101506494|NCT04514588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317886|NCT00005975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506495|NCT04514588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506496|NCT04514588|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101506497|NCT04514588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101506498|NCT04514588|Purinergic Agents|purinergic agents|mesh-ancestor
101263630|NCT01762839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101216234|NCT01479361|Atovaquone|atovaquone|mesh-list
101506499|NCT04514588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101506501|NCT02276300|Imiquimod|imiquimod|mesh-list
101506502|NCT02276300|Sargramostim|sargramostim|mesh-list
101506503|NCT02276300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101506504|NCT02276300|Immunologic Factors|immunologic factors|mesh-ancestor
101506505|NCT02276300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506506|NCT02276300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101506507|NCT02276300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101506508|NCT02276300|Alkylating Agents|alkylating agents|mesh-ancestor
101506509|NCT02276300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506510|NCT02276300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506511|NCT02276300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101506512|NCT02276300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101506513|NCT02276300|Interferon Inducers|interferon inducers|mesh-ancestor
101506514|NCT00520026|Lithium Carbonate|lithium carbonate|mesh-list
101506515|NCT00520026|Antidepressive Agents|antidepressive agents|mesh-ancestor
101506516|NCT00520026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101506517|NCT00520026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101506518|NCT00520026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506519|NCT00520026|Antimanic Agents|antimanic agents|mesh-ancestor
101506520|NCT00520026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101506521|NCT00520026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101506522|NCT00520026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506524|NCT02955251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101506525|NCT02955251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506526|NCT02955251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101506527|NCT02955251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506528|NCT00518895|Dacarbazine|dacarbazine|mesh-list
101506529|NCT00518895|Oblimersen|oblimersen|mesh-list
101506530|NCT00518895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101506531|NCT00518895|Alkylating Agents|alkylating agents|mesh-ancestor
101506532|NCT00518895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506533|NCT00518895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506534|NCT00520104|Ketamine|ketamine|mesh-list
101506535|NCT00520104|Analgesics|analgesics|mesh-ancestor
101506536|NCT00520104|Sensory System Agents|sensory system agents|mesh-ancestor
101506537|NCT00520104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101506538|NCT00520104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506539|NCT00520104|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101506540|NCT00520104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101506541|NCT00520104|Anesthetics, General|anesthetics, general|mesh-ancestor
101506542|NCT00520104|Anesthetics|anesthetics|mesh-ancestor
101506543|NCT00520104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101506544|NCT00520104|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101506545|NCT00520104|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101190279|NCT00004482|Antiemetics|antiemetics|mesh-ancestor
101506546|NCT00520104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101506547|NCT00520104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506548|NCT00519012|Sertraline|sertraline|mesh-list
101506549|NCT00519012|Paroxetine|paroxetine|mesh-list
101506550|NCT00519012|Antidepressive Agents|antidepressive agents|mesh-ancestor
101506551|NCT00519012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101506552|NCT00519012|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101506553|NCT00519012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101506554|NCT00519012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101506555|NCT00519012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506556|NCT00519012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101506557|NCT00519012|Serotonin Agents|serotonin agents|mesh-ancestor
101506558|NCT00519012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506559|NCT00519012|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101506560|NCT00519012|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101506561|NCT00519012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101506562|NCT00519012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101506563|NCT00520260|Ketorolac|ketorolac|mesh-list
101506564|NCT00520260|Bromfenac|bromfenac|mesh-list
101506565|NCT00520260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101506566|NCT00520260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101506567|NCT00520260|Analgesics|analgesics|mesh-ancestor
101506568|NCT00520260|Sensory System Agents|sensory system agents|mesh-ancestor
101216530|NCT01481233|Colchicine|colchicine|mesh-list
101506569|NCT00520260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101506570|NCT00520260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506571|NCT00520260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101506572|NCT00520260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101506573|NCT00520260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101506574|NCT00520260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101506575|NCT00520260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506576|NCT00520338|Celecoxib|celecoxib|mesh-list
101506577|NCT00520338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101506578|NCT00520338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101506579|NCT00520338|Analgesics|analgesics|mesh-ancestor
101506582|NCT00520338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506583|NCT00520338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101506584|NCT00520338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101506585|NCT00520338|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101506586|NCT00520338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101506587|NCT00520338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101506588|NCT00520338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506590|NCT02594072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101506591|NCT02594072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506592|NCT00519051|Fluoxetine|fluoxetine|mesh-list
101506593|NCT00519051|Antidepressive Agents|antidepressive agents|mesh-list
101506594|NCT00519051|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101506595|NCT00519051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101506596|NCT00519051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101506597|NCT00519051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506598|NCT00519051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101506599|NCT00519051|Serotonin Agents|serotonin agents|mesh-ancestor
101506600|NCT00519051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506601|NCT00519051|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101506602|NCT00519051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101506603|NCT00519051|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101506604|NCT00519051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101506605|NCT00519051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101506606|NCT02275832|Minoxidil|minoxidil|mesh-list
101506607|NCT02275832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101506608|NCT02275832|Vasodilator Agents|vasodilator agents|mesh-ancestor
101506609|NCT00519207|Lidocaine|lidocaine|mesh-list
101506610|NCT00519207|Anesthetics, Local|anesthetics, local|mesh-ancestor
101506611|NCT00519207|Anesthetics|anesthetics|mesh-ancestor
101506612|NCT00519207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101506613|NCT00519207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506614|NCT00519207|Sensory System Agents|sensory system agents|mesh-ancestor
101506615|NCT00519207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101506616|NCT00519207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101506617|NCT00519207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101506618|NCT00519207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101506619|NCT00519207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101506620|NCT00519207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506621|NCT02590094|Bevacizumab|bevacizumab|mesh-list
101506622|NCT02590094|Aflibercept|aflibercept|mesh-list
101506623|NCT02590094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101506624|NCT02590094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506625|NCT02590094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101506626|NCT02590094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101506627|NCT02590094|Growth Substances|growth substances|mesh-ancestor
101506628|NCT02590094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506629|NCT02590094|Growth Inhibitors|growth inhibitors|mesh-ancestor
101506630|NCT00520455|Levonorgestrel|levonorgestrel|mesh-list
101506631|NCT00520455|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101506632|NCT00520455|Contraceptive Agents|contraceptive agents|mesh-ancestor
101317891|NCT00005975|Appetite Stimulants|appetite stimulants|mesh-ancestor
101506634|NCT00520455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506635|NCT00520455|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101506636|NCT00520455|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101216589|NCT01481519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101506637|NCT00520455|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101506640|NCT02949258|Epirubicin|epirubicin|mesh-list
101506641|NCT02949258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506642|NCT02949258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101506643|NCT02949258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101506644|NCT02949258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101506645|NCT02949258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101506646|NCT02949258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506647|NCT02949258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101506648|NCT04514081|Decitabine|decitabine|mesh-list
101506649|NCT04514081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101506650|NCT04514081|Antimetabolites|antimetabolites|mesh-ancestor
101506651|NCT04514081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506652|NCT04514081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506653|NCT04514081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101506654|NCT00519246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101506655|NCT00519246|Analgesics, Opioid|analgesics, opioid|mesh-list
101506656|NCT00519246|Narcotics|narcotics|mesh-ancestor
101506657|NCT00519246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101506658|NCT00519246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506659|NCT00519246|Analgesics|analgesics|mesh-ancestor
101506660|NCT00519246|Sensory System Agents|sensory system agents|mesh-ancestor
101506661|NCT00519246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101506662|NCT00519246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101506663|NCT00519246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101506664|NCT00519246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101506665|NCT00519987|Ketamine|ketamine|mesh-list
101506666|NCT00519987|Analgesics|analgesics|mesh-ancestor
101506667|NCT00519987|Sensory System Agents|sensory system agents|mesh-ancestor
101506668|NCT00519987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101506669|NCT00519987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506670|NCT00519987|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101506671|NCT00519987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101506672|NCT00519987|Anesthetics, General|anesthetics, general|mesh-ancestor
101506673|NCT00519987|Anesthetics|anesthetics|mesh-ancestor
101506674|NCT00519987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101506675|NCT00519987|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101506676|NCT00519987|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101506677|NCT00519987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101506678|NCT00519987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506679|NCT00519324|Everolimus|everolimus|mesh-list
101506680|NCT00519324|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101506681|NCT00519324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101506682|NCT00519324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101506683|NCT00519324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506684|NCT00519324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101506685|NCT00519324|Immunologic Factors|immunologic factors|mesh-ancestor
101506686|NCT00519324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506687|NCT00519324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506688|NCT00520650|Aripiprazole|aripiprazole|mesh-list
101506689|NCT00520650|Antidepressive Agents|antidepressive agents|mesh-ancestor
101506691|NCT00520650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101506692|NCT00520650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101506693|NCT00520650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101506694|NCT00520650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506695|NCT00520650|Dopamine Agonists|dopamine agonists|mesh-ancestor
101506696|NCT00520650|Dopamine Agents|dopamine agents|mesh-ancestor
101506697|NCT00520650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101506698|NCT00520650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506699|NCT00520650|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101506700|NCT00520650|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101506701|NCT00520650|Serotonin Agents|serotonin agents|mesh-ancestor
101506702|NCT00520650|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101506703|NCT00520650|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101506704|NCT00520650|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101506705|NCT00520650|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101506706|NCT00519363|Atorvastatin|atorvastatin|mesh-list
101506707|NCT00519363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101506709|NCT00519363|Antimetabolites|antimetabolites|mesh-ancestor
101506710|NCT00519363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506711|NCT00519363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101506712|NCT00519363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101506713|NCT00519363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101506714|NCT00519480|Metformin|metformin|mesh-list
101506715|NCT00519480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101506716|NCT00519480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506717|NCT02955056|Teriparatide|teriparatide|mesh-list
101506718|NCT02955056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506719|NCT02955056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101506720|NCT02955056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101506721|NCT02954939|Prednisone|prednisone|mesh-list
101506722|NCT02954939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101506723|NCT02954939|Glucocorticoids|glucocorticoids|mesh-ancestor
101506724|NCT02954939|Hormones|hormones|mesh-ancestor
101506725|NCT02954939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101506726|NCT02954939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506727|NCT02954939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101506728|NCT02954939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506729|NCT00519519|Omeprazole|omeprazole|mesh-list
101506730|NCT00519519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101506731|NCT00519519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101506732|NCT00519519|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101506733|NCT00519519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101506734|NCT00519519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506735|NCT00520806|Methocarbamol|methocarbamol|mesh-list
101506736|NCT00520806|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101506737|NCT00520806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506739|NCT00520806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101506740|NCT00505739|Mifepristone|mifepristone|mesh-list
101506741|NCT00505739|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101506742|NCT00505739|Abortifacient Agents|abortifacient agents|mesh-ancestor
101506743|NCT00505739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101506744|NCT00505739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506745|NCT00505739|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101506747|NCT00505739|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101506748|NCT00505739|Contraceptive Agents|contraceptive agents|mesh-ancestor
101506749|NCT00505739|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101506750|NCT00505739|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101506751|NCT00505739|Hormone Antagonists|hormone antagonists|mesh-ancestor
101506752|NCT00505739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101506753|NCT00505739|Luteolytic Agents|luteolytic agents|mesh-ancestor
101506754|NCT00505739|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101506755|NCT00505739|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101506756|NCT02948985|Cetuximab|cetuximab|mesh-list
101506757|NCT02948985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101506758|NCT02948985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506759|NCT04513457|Liver Extracts|liver extracts|mesh-list
101506760|NCT04513457|Hematinics|hematinics|mesh-ancestor
101506761|NCT00521040|Levocetirizine|levocetirizine|mesh-list
101506762|NCT00521040|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101506763|NCT00521040|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101506764|NCT00521040|Histamine Antagonists|histamine antagonists|mesh-ancestor
101506765|NCT00521040|Histamine Agents|histamine agents|mesh-ancestor
101506766|NCT00521040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101506767|NCT00521040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506768|NCT00521040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506769|NCT04513340|Levodopa|levodopa|mesh-list
101506770|NCT04513340|Carbidopa|carbidopa|mesh-list
101217182|NCT01485744|Oxaliplatin|oxaliplatin|mesh-list
101263655|NCT01762891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101506771|NCT04513340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101506772|NCT04513340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101506773|NCT04513340|Dopamine Agents|dopamine agents|mesh-ancestor
101506774|NCT04513340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101506775|NCT04513340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506776|NCT04513340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506777|NCT04513340|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101506778|NCT04513340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101506779|NCT05144945|Vaccines|vaccines|mesh-list
101506780|NCT05144945|Immunologic Factors|immunologic factors|mesh-ancestor
101506781|NCT05144945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506782|NCT04513379|Efavirenz|efavirenz|mesh-list
101506783|NCT04513379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101506784|NCT04513379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101506785|NCT04513379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101506786|NCT04513379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506787|NCT04513379|Antiviral Agents|antiviral agents|mesh-ancestor
101506788|NCT04513379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101506791|NCT04513379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101506792|NCT04513379|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101506793|NCT04513379|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101506794|NCT04513379|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101506796|NCT00521157|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101506797|NCT00521157|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101506798|NCT00521157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506799|NCT00521157|Sensory System Agents|sensory system agents|mesh-ancestor
101506800|NCT00521157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101506801|NCT00505817|Leuprolide|leuprolide|mesh-list
101506802|NCT00505817|Cetrorelix|cetrorelix|mesh-list
101506803|NCT00505817|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101506804|NCT00505817|Fertility Agents|fertility agents|mesh-ancestor
101506805|NCT00505817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101506806|NCT00505817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506807|NCT00505817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101506808|NCT00505817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506810|NCT00505817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101506812|NCT00521430|Methylprednisolone|methylprednisolone|mesh-list
101506813|NCT00521430|Methotrexate|methotrexate|mesh-list
101506814|NCT00521430|Fludarabine phosphate|fludarabine phosphate|mesh-list
101506815|NCT00521430|Fludarabine|fludarabine|mesh-list
101506816|NCT00521430|Busulfan|busulfan|mesh-list
101506817|NCT00521430|Cyclosporins|cyclosporins|mesh-list
101506818|NCT00521430|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101506819|NCT00521430|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101506820|NCT00521430|Abortifacient Agents|abortifacient agents|mesh-ancestor
101506821|NCT00521430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101506822|NCT00521430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506823|NCT00521430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101506824|NCT00521430|Antimetabolites|antimetabolites|mesh-ancestor
101506825|NCT00521430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506826|NCT00521430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506827|NCT00521430|Dermatologic Agents|dermatologic agents|mesh-ancestor
101506828|NCT00521430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101506829|NCT00521430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101506830|NCT00521430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101506831|NCT00521430|Immunologic Factors|immunologic factors|mesh-ancestor
101506832|NCT00521430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101506833|NCT00521430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101506834|NCT00521430|Antifungal Agents|antifungal agents|mesh-ancestor
101506835|NCT00521430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101506836|NCT00521430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101506837|NCT00521430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101506838|NCT00521430|Antiemetics|antiemetics|mesh-ancestor
101190583|NCT00004992|Metformin|metformin|mesh-list
101506839|NCT00521430|Autonomic Agents|autonomic agents|mesh-ancestor
101506840|NCT00521430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101263664|NCT01762995|Calcium|calcium|mesh-list
101263665|NCT01762995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101506841|NCT00521430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101506842|NCT00521430|Glucocorticoids|glucocorticoids|mesh-ancestor
101506843|NCT00521430|Hormones|hormones|mesh-ancestor
101506844|NCT00521430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101506845|NCT00521430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101506846|NCT00521430|Protective Agents|protective agents|mesh-ancestor
101506847|NCT00521430|Alkylating Agents|alkylating agents|mesh-ancestor
101506848|NCT00521430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101506849|NCT00521430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101506850|NCT00521274|Docetaxel|docetaxel|mesh-list
101506851|NCT00521274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506852|NCT00521274|Tubulin Modulators|tubulin modulators|mesh-ancestor
101506853|NCT00521274|Antimitotic Agents|antimitotic agents|mesh-ancestor
101506854|NCT00521274|Mitosis Modulators|mitosis modulators|mesh-ancestor
101506855|NCT00521274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506856|NCT05146778|Lidocaine|lidocaine|mesh-list
101506857|NCT05146778|Fentanyl|fentanyl|mesh-list
101506858|NCT05146778|Dexmedetomidine|dexmedetomidine|mesh-list
101506859|NCT05146778|Analgesics, Opioid|analgesics, opioid|mesh-list
101506860|NCT05146778|Anesthetics|anesthetics|mesh-list
101506861|NCT05146778|Anesthetics, Local|anesthetics, local|mesh-ancestor
101506862|NCT05146778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101506863|NCT05146778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506864|NCT05146778|Sensory System Agents|sensory system agents|mesh-ancestor
101506865|NCT05146778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101506866|NCT05146778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101506867|NCT05146778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101506868|NCT05146778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101506869|NCT05146778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101506870|NCT05146778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506871|NCT05146778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101506872|NCT05146778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101506873|NCT05146778|Analgesics|analgesics|mesh-ancestor
101506874|NCT05146778|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101506875|NCT05146778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101506877|NCT05146778|Adrenergic Agents|adrenergic agents|mesh-ancestor
101506878|NCT05146778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101506879|NCT05146778|Narcotics|narcotics|mesh-ancestor
101317937|NCT00014599|Mitosis Modulators|mitosis modulators|mesh-ancestor
101506880|NCT05146778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101506881|NCT05146778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101506882|NCT05146778|Anesthetics, General|anesthetics, general|mesh-ancestor
101506883|NCT00505700|Cytarabine|cytarabine|mesh-list
101506884|NCT00505700|Bortezomib|bortezomib|mesh-list
101506885|NCT00505700|Idarubicin|idarubicin|mesh-list
101506886|NCT00505700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101506887|NCT00505700|Antimetabolites|antimetabolites|mesh-ancestor
101506888|NCT00505700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506889|NCT00505700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506890|NCT00505700|Antiviral Agents|antiviral agents|mesh-ancestor
101506892|NCT00505700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101506893|NCT00505700|Immunologic Factors|immunologic factors|mesh-ancestor
101506894|NCT00505700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506895|NCT00505700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101506896|NCT00505700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101506897|NCT00505700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101506898|NCT00505700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101506899|NCT02948283|Metformin|metformin|mesh-list
101506900|NCT02948283|Ritonavir|ritonavir|mesh-list
101506901|NCT02948283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101506902|NCT02948283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506903|NCT02948283|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101506904|NCT02948283|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101506905|NCT02948283|Protease Inhibitors|protease inhibitors|mesh-ancestor
101506906|NCT02948283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101506907|NCT02948283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506908|NCT02948283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101506909|NCT02948283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101506910|NCT02948283|Antiviral Agents|antiviral agents|mesh-ancestor
101506911|NCT02948283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101506912|NCT02948283|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101506913|NCT02948283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101506914|NCT04512872|Denosumab|denosumab|mesh-list
101506915|NCT04512872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101506916|NCT04512872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506917|NCT00523185|Diazepam|diazepam|mesh-list
101506918|NCT00523185|Lorazepam|lorazepam|mesh-list
101506919|NCT00523185|Anticonvulsants|anticonvulsants|mesh-ancestor
101506920|NCT00523185|Antiemetics|antiemetics|mesh-ancestor
101506921|NCT00523185|Autonomic Agents|autonomic agents|mesh-ancestor
101506922|NCT00523185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101506923|NCT00523185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506924|NCT00523185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101506925|NCT00523185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101506926|NCT00523185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101506927|NCT00523185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101506928|NCT00523185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101506929|NCT00523185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101506930|NCT00523185|GABA Modulators|gaba modulators|mesh-ancestor
101506931|NCT00523185|GABA Agents|gaba agents|mesh-ancestor
101506932|NCT00523185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101506933|NCT00523185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506934|NCT00523185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101506935|NCT00523185|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101506936|NCT00523185|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101506937|NCT00523185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101506938|NCT00523185|Anesthetics, General|anesthetics, general|mesh-ancestor
101506939|NCT00523185|Anesthetics|anesthetics|mesh-ancestor
101506940|NCT04512404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
101506941|NCT04512404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101506942|NCT04512404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101506943|NCT04512404|Antimetabolites|antimetabolites|mesh-ancestor
101506944|NCT04512404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506945|NCT04512404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101506946|NCT04512404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101506947|NCT04693962|Mitogens|mitogens|mesh-list
101506948|NCT04693962|Mitosis Modulators|mitosis modulators|mesh-ancestor
101506949|NCT04693962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506950|NCT05144399|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101506951|NCT05144399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101506953|NCT00521703|Anesthetics, Local|anesthetics, local|mesh-ancestor
101506954|NCT00521703|Anesthetics|anesthetics|mesh-ancestor
101506955|NCT00521703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101506957|NCT00521703|Sensory System Agents|sensory system agents|mesh-ancestor
101506958|NCT00521703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101506959|NCT00521703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101506960|NCT00521703|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101506961|NCT00521703|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101506962|NCT00521703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101506963|NCT00521703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506964|NCT00521742|Pioglitazone|pioglitazone|mesh-list
101506965|NCT00521742|Glyburide|glyburide|mesh-list
101506966|NCT00521742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101506967|NCT00521742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506968|NCT00521781|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101506969|NCT00521781|Leuprolide|leuprolide|mesh-list
101506970|NCT00521781|Bicalutamide|bicalutamide|mesh-list
101506971|NCT00521781|Androgens|androgens|mesh-list
101506972|NCT00521781|Androgen Antagonists|androgen antagonists|mesh-list
101506973|NCT00521781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506974|NCT00521781|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101506975|NCT00521781|Fertility Agents|fertility agents|mesh-ancestor
101506976|NCT00521781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101506977|NCT00521781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506978|NCT00521781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101506979|NCT00521781|Hormones|hormones|mesh-ancestor
101506980|NCT00521781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101506981|NCT00521781|Hormone Antagonists|hormone antagonists|mesh-ancestor
101506982|NCT00521820|Pioglitazone|pioglitazone|mesh-list
101506983|NCT00521820|Glyburide|glyburide|mesh-list
101506984|NCT00521820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101506985|NCT00521820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101506986|NCT00523263|Heparin|heparin|mesh-list
101506987|NCT00523263|Anticoagulants|anticoagulants|mesh-ancestor
101506988|NCT00523263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101506989|NCT00523263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101506990|NCT00523263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506991|NCT00521859|Fludarabine|fludarabine|mesh-list
101506992|NCT00521859|Fludarabine phosphate|fludarabine phosphate|mesh-list
101506993|NCT00521859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101506995|NCT00521859|Antimetabolites|antimetabolites|mesh-ancestor
101506996|NCT00521859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101506997|NCT00521859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101506998|NCT00521859|Immunologic Factors|immunologic factors|mesh-ancestor
101506999|NCT00521859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507000|NCT02954822|Glimepiride|glimepiride|mesh-list
101507001|NCT02954822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101507002|NCT02954822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101507003|NCT02954822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507004|NCT02954822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101507005|NCT02954822|Immunologic Factors|immunologic factors|mesh-ancestor
101507006|NCT00522015|Rivastigmine|rivastigmine|mesh-list
101507007|NCT00522015|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101507008|NCT00522015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101507009|NCT00522015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507010|NCT00522015|Cholinergic Agents|cholinergic agents|mesh-ancestor
101507011|NCT00522015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101507012|NCT00522015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507013|NCT00522015|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101507014|NCT00522015|Protective Agents|protective agents|mesh-ancestor
101507016|NCT00523380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101507017|NCT00523380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101507018|NCT00523380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101507019|NCT00523380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101507020|NCT00523380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101507021|NCT00523380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101507022|NCT00523380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507023|NCT00523458|Efavirenz|efavirenz|mesh-list
101507024|NCT00523458|Nevirapine|nevirapine|mesh-list
101507025|NCT00523458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101507026|NCT00523458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101507027|NCT00523458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101507028|NCT00523458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507030|NCT00523458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101507031|NCT00523458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101507032|NCT00523458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101507033|NCT00523458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101507034|NCT00523458|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101507035|NCT00523458|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101507036|NCT00523458|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101507037|NCT00523458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101507038|NCT00523458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101507039|NCT00507065|Amphetamine|amphetamine|mesh-list
101507040|NCT00507065|Adderall|adderall|mesh-list
101507041|NCT00507065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101507042|NCT00507065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507043|NCT00507065|Sympathomimetics|sympathomimetics|mesh-ancestor
101507044|NCT00507065|Autonomic Agents|autonomic agents|mesh-ancestor
101507045|NCT00507065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101507046|NCT00507065|Dopamine Agents|dopamine agents|mesh-ancestor
101507047|NCT00507065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101507048|NCT00507065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507049|NCT00507065|Adrenergic Agents|adrenergic agents|mesh-ancestor
101507050|NCT00507065|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101507051|NCT00507065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101507052|NCT00507065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101507053|NCT00507065|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101507054|NCT00522132|Artesunate|artesunate|mesh-list
101507055|NCT00522132|Antimalarials|antimalarials|mesh-ancestor
101507056|NCT00522132|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101507057|NCT00522132|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101507058|NCT00522132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101507059|NCT00522132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101507060|NCT00522132|Antiviral Agents|antiviral agents|mesh-ancestor
101507061|NCT00522132|Schistosomicides|schistosomicides|mesh-ancestor
101507062|NCT00522132|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101507063|NCT00522132|Anthelmintics|anthelmintics|mesh-ancestor
101507064|NCT00522210|Insulin|insulin|mesh-list
101507065|NCT00522210|Isophane Insulin, Human|isophane insulin, human|mesh-list
101507066|NCT00522210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101507067|NCT00522210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507068|NCT00522249|Interferons|interferons|mesh-list
101507069|NCT00522249|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101507070|NCT00522249|Interferon-alpha|interferon-alpha|mesh-list
101507071|NCT00522249|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
101507072|NCT00522249|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101507073|NCT00522249|Sunitinib|sunitinib|mesh-list
101507074|NCT00522249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101507075|NCT00522249|Antiviral Agents|antiviral agents|mesh-ancestor
101507076|NCT00522249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101507077|NCT00522249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101507079|NCT00522249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507080|NCT00522249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101507081|NCT00522249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101507082|NCT00522249|Growth Substances|growth substances|mesh-ancestor
101507083|NCT00522249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507084|NCT00522249|Growth Inhibitors|growth inhibitors|mesh-ancestor
101507085|NCT00522249|Immunologic Factors|immunologic factors|mesh-ancestor
101507086|NCT05148767|Irinotecan|irinotecan|mesh-list
101507087|NCT05148767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101507088|NCT05148767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101507089|NCT05148767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101507090|NCT05148767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507091|NCT05148767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101507092|NCT00523692|Etanercept|etanercept|mesh-list
101507093|NCT00523692|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101507094|NCT00523692|Methylprednisolone|methylprednisolone|mesh-list
101507095|NCT00523692|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101507096|NCT00523692|Prednisolone|prednisolone|mesh-list
101507097|NCT00523692|Prednisolone acetate|prednisolone acetate|mesh-list
101507098|NCT00523692|Methotrexate|methotrexate|mesh-list
101507099|NCT00523692|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101507100|NCT00523692|Prednisolone phosphate|prednisolone phosphate|mesh-list
101507101|NCT00523692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101507102|NCT00523692|Abortifacient Agents|abortifacient agents|mesh-ancestor
101507103|NCT00523692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101219255|NCT01497522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101507104|NCT00523692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219479|NCT01499004|Tofacitinib|tofacitinib|mesh-list
101507105|NCT00523692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101507107|NCT00523692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507108|NCT00523692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101507109|NCT00523692|Dermatologic Agents|dermatologic agents|mesh-ancestor
101507110|NCT00523692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101507111|NCT00523692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101507112|NCT00523692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101507113|NCT00523692|Immunologic Factors|immunologic factors|mesh-ancestor
101507114|NCT00523692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101507115|NCT00523692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101507116|NCT00523692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101507117|NCT00523692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101507118|NCT00523692|Analgesics|analgesics|mesh-ancestor
101507119|NCT00523692|Sensory System Agents|sensory system agents|mesh-ancestor
101507120|NCT00523692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101507121|NCT00523692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101507122|NCT00523692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101507123|NCT00523692|Antiemetics|antiemetics|mesh-ancestor
101507124|NCT00523692|Autonomic Agents|autonomic agents|mesh-ancestor
101507125|NCT00523692|Glucocorticoids|glucocorticoids|mesh-ancestor
101507126|NCT00523692|Hormones|hormones|mesh-ancestor
101507127|NCT00523692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101507128|NCT00523692|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101507129|NCT00523692|Protective Agents|protective agents|mesh-ancestor
101507130|NCT00523692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101507131|NCT05148689|Phenylephrine|phenylephrine|mesh-list
101507132|NCT05148689|Oxymetazoline|oxymetazoline|mesh-list
101507133|NCT05148689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101507134|NCT05148689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101507135|NCT05148689|Adrenergic Agents|adrenergic agents|mesh-ancestor
101507136|NCT05148689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101507137|NCT05148689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507138|NCT05148689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507139|NCT05148689|Sympathomimetics|sympathomimetics|mesh-ancestor
101507140|NCT05148689|Autonomic Agents|autonomic agents|mesh-ancestor
101507141|NCT05148689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101507144|NCT05148689|Respiratory System Agents|respiratory system agents|mesh-ancestor
101507145|NCT05148689|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101507146|NCT05148689|Mydriatics|mydriatics|mesh-ancestor
101507147|NCT05148689|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101507148|NCT05148689|Protective Agents|protective agents|mesh-ancestor
101263700|NCT01763385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101507149|NCT00522444|Magnesium Sulfate|magnesium sulfate|mesh-list
101507150|NCT00522444|Analgesics|analgesics|mesh-ancestor
101507151|NCT00522444|Sensory System Agents|sensory system agents|mesh-ancestor
101507152|NCT00522444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101507153|NCT00522444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507154|NCT00522444|Anesthetics|anesthetics|mesh-ancestor
101507155|NCT00522444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101507156|NCT00522444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101507157|NCT00522444|Anticonvulsants|anticonvulsants|mesh-ancestor
101507158|NCT00522444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101507159|NCT00522444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101507160|NCT00522444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507161|NCT00522444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101507162|NCT00522444|Tocolytic Agents|tocolytic agents|mesh-ancestor
101507163|NCT00522444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101507164|NCT05148143|Raltitrexed|raltitrexed|mesh-list
101507165|NCT05148143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101507166|NCT05148143|Antimetabolites|antimetabolites|mesh-ancestor
101304262|NCT02012075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101507167|NCT05148143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507169|NCT05148143|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101507170|NCT05148143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101507171|NCT00523887|Fentanyl|fentanyl|mesh-list
101507172|NCT00523887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101507173|NCT00523887|Narcotics|narcotics|mesh-ancestor
101507174|NCT00523887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101507175|NCT00523887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507176|NCT00523887|Analgesics|analgesics|mesh-ancestor
101507179|NCT00523887|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101507180|NCT00523887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101507181|NCT00523887|Anesthetics, General|anesthetics, general|mesh-ancestor
101507183|NCT05145218|Paclitaxel|paclitaxel|mesh-list
101507184|NCT05145218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101507185|NCT05145218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101507186|NCT05145218|Tubulin Modulators|tubulin modulators|mesh-ancestor
101507187|NCT05145218|Antimitotic Agents|antimitotic agents|mesh-ancestor
101507188|NCT05145218|Mitosis Modulators|mitosis modulators|mesh-ancestor
101507189|NCT05145218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507190|NCT00523926|Bedaquiline|bedaquiline|mesh-list
101507191|NCT00523926|Antitubercular Agents|antitubercular agents|mesh-ancestor
101507192|NCT00523926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101507193|NCT00523926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101507194|NCT05146271|Anesthetics|anesthetics|mesh-list
101507195|NCT05146271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101507196|NCT05146271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507197|NCT00522639|Deoxyglucose|deoxyglucose|mesh-list
101507198|NCT00522639|Antimetabolites|antimetabolites|mesh-ancestor
101507199|NCT00522639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507200|NCT00522639|Antiviral Agents|antiviral agents|mesh-ancestor
101507201|NCT00522639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101507202|NCT05142098|Dexamethasone|dexamethasone|mesh-list
101507203|NCT05142098|Etoricoxib|etoricoxib|mesh-list
101507204|NCT05142098|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
101507205|NCT05142098|Glucocorticoids|glucocorticoids|mesh-list
101507206|NCT05142098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101507207|NCT05142098|Antiemetics|antiemetics|mesh-ancestor
101507208|NCT05142098|Autonomic Agents|autonomic agents|mesh-ancestor
101507209|NCT05142098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101507210|NCT05142098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507211|NCT05142098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101507212|NCT05142098|Hormones|hormones|mesh-ancestor
101507213|NCT05142098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101507214|NCT05142098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101507215|NCT05142098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190953|NCT00356226|Sympatholytics|sympatholytics|mesh-ancestor
101507216|NCT05142098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101507218|NCT05142098|Analgesics|analgesics|mesh-ancestor
101507219|NCT05142098|Sensory System Agents|sensory system agents|mesh-ancestor
101507220|NCT05142098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101507221|NCT05142098|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101507222|NCT05142098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101507223|NCT05142098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507224|NCT00523965|Amphotericin B|amphotericin b|mesh-list
101507225|NCT00523965|Paromomycin|paromomycin|mesh-list
101507226|NCT00523965|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101507227|NCT00523965|Miltefosine|miltefosine|mesh-list
101507228|NCT00523965|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
101507229|NCT00523965|Deoxycholic Acid|deoxycholic acid|mesh-list
101507230|NCT00523965|Amebicides|amebicides|mesh-ancestor
101507231|NCT00523965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101507232|NCT00523965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101507233|NCT00523965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101507234|NCT00523965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101507235|NCT00523965|Antifungal Agents|antifungal agents|mesh-ancestor
101507236|NCT00523965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101507237|NCT00523965|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101507238|NCT00523965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101507239|NCT05141669|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101507240|NCT05141669|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101507241|NCT05141669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507242|NCT05141669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101507243|NCT05141669|Immunologic Factors|immunologic factors|mesh-ancestor
101507244|NCT05141669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507245|NCT05141240|Palbociclib|palbociclib|mesh-list
101507246|NCT05141240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101507247|NCT05141240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101507248|NCT05141240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101507249|NCT05141240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507250|NCT00524004|Immunoglobulin G|immunoglobulin g|mesh-list
101507251|NCT00524004|Immunologic Factors|immunologic factors|mesh-ancestor
101507252|NCT00524004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507253|NCT05148377|Heparin|heparin|mesh-list
101507254|NCT05148377|Anticoagulants|anticoagulants|mesh-ancestor
101507255|NCT05148377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101507256|NCT05148377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101507257|NCT05148377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507258|NCT00524160|Fentanyl|fentanyl|mesh-list
101507259|NCT00524160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101507260|NCT00524160|Narcotics|narcotics|mesh-ancestor
101507261|NCT00524160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101507262|NCT00524160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507263|NCT00524160|Analgesics|analgesics|mesh-ancestor
101507264|NCT00524160|Sensory System Agents|sensory system agents|mesh-ancestor
101507265|NCT00524160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101507266|NCT00524160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101507267|NCT00524160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101507268|NCT00524160|Anesthetics, General|anesthetics, general|mesh-ancestor
101507269|NCT00524160|Anesthetics|anesthetics|mesh-ancestor
101507270|NCT00524199|Mesna|mesna|mesh-list
101507271|NCT00524199|Protective Agents|protective agents|mesh-ancestor
101507272|NCT00524199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507273|NCT00523068|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101507274|NCT00523068|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101507275|NCT00523068|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101507276|NCT00523068|Cholinergic Agents|cholinergic agents|mesh-ancestor
101507277|NCT00523068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101507278|NCT00523068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507279|NCT00523068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507280|NCT00523068|Urological Agents|urological agents|mesh-ancestor
101507281|NCT02276378|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101507282|NCT02276378|Telmisartan|telmisartan|mesh-list
101507283|NCT02276378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101507284|NCT02276378|Diuretics|diuretics|mesh-ancestor
101507285|NCT02276378|Natriuretic Agents|natriuretic agents|mesh-ancestor
101263734|NCT01763463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101507286|NCT02276378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507287|NCT02276378|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101507288|NCT02276378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101507289|NCT02276378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507291|NCT02276378|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101507292|NCT04696250|Antineoplastic Agents|antineoplastic agents|mesh-list
101507293|NCT04696250|Immunomodulating Agents|immunomodulating agents|mesh-list
101507294|NCT04696250|Immunologic Factors|immunologic factors|mesh-ancestor
101507295|NCT04696250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507297|NCT00524433|Vasodilator Agents|vasodilator agents|mesh-ancestor
101507298|NCT02947932|Indomethacin|indomethacin|mesh-list
101507299|NCT02947932|Resveratrol|resveratrol|mesh-list
101507300|NCT02947932|Antioxidants|antioxidants|mesh-ancestor
101507301|NCT02947932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507302|NCT02947932|Protective Agents|protective agents|mesh-ancestor
101507303|NCT02947932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507304|NCT02947932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101507305|NCT02947932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101507306|NCT02947932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101507307|NCT02947932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101507308|NCT02947932|Analgesics|analgesics|mesh-ancestor
101507309|NCT02947932|Sensory System Agents|sensory system agents|mesh-ancestor
101507310|NCT02947932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101507311|NCT02947932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101507313|NCT02947932|Gout Suppressants|gout suppressants|mesh-ancestor
101507314|NCT02947932|Tocolytic Agents|tocolytic agents|mesh-ancestor
101507315|NCT02947932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101507316|NCT02947932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101507317|NCT05146154|Imipenem|imipenem|mesh-list
101507318|NCT05146154|Relebactam|relebactam|mesh-list
101507319|NCT05146154|Cilastatin|cilastatin|mesh-list
101507320|NCT05146154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101507321|NCT05146154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101507322|NCT05146154|Protease Inhibitors|protease inhibitors|mesh-ancestor
101507323|NCT05146154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101507324|NCT05146154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507325|NCT05146154|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101507326|NCT00524667|Fludarabine|fludarabine|mesh-list
101507327|NCT00524667|Valproic Acid|valproic acid|mesh-list
101507328|NCT00524667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101507329|NCT00524667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507330|NCT00524667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507331|NCT00524667|Anticonvulsants|anticonvulsants|mesh-ancestor
101507332|NCT00524667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101507333|NCT00524667|GABA Agents|gaba agents|mesh-ancestor
101507334|NCT00524667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101507335|NCT00524667|Antimanic Agents|antimanic agents|mesh-ancestor
101507336|NCT00524667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101507337|NCT00524667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101507338|NCT00524667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101507339|NCT00524706|Leucovorin|leucovorin|mesh-list
101507340|NCT00524706|Oxaliplatin|oxaliplatin|mesh-list
101507341|NCT00524706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101507342|NCT00524706|Antidotes|antidotes|mesh-ancestor
101507343|NCT00524706|Protective Agents|protective agents|mesh-ancestor
101507344|NCT00524706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507345|NCT00524706|Vitamin B Complex|vitamin b complex|mesh-ancestor
101507346|NCT00524706|Vitamins|vitamins|mesh-ancestor
101507347|NCT00524706|Micronutrients|micronutrients|mesh-ancestor
101507348|NCT00507143|Irinotecan|irinotecan|mesh-list
101507349|NCT00507143|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101507350|NCT00507143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101507351|NCT00507143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101507354|NCT00525993|Etoricoxib|etoricoxib|mesh-list
101507355|NCT00525993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101507356|NCT00525993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101507357|NCT00525993|Analgesics|analgesics|mesh-ancestor
101507358|NCT00525993|Sensory System Agents|sensory system agents|mesh-ancestor
101507359|NCT00525993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101507360|NCT00525993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507361|NCT00525993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101507362|NCT00525993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101507363|NCT00525993|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101507364|NCT00525993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101507365|NCT00525993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101511602|NCT02917200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101507366|NCT00525993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507367|NCT02947854|Photosensitizing Agents|photosensitizing agents|mesh-list
101507368|NCT02947854|Poly ICLC|poly iclc|mesh-list
101507369|NCT02947854|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
101507370|NCT02947854|Interferon Inducers|interferon inducers|mesh-ancestor
101507371|NCT02947854|Immunologic Factors|immunologic factors|mesh-ancestor
101507372|NCT02947854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507373|NCT02947854|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101507374|NCT02947854|Dermatologic Agents|dermatologic agents|mesh-ancestor
101507375|NCT02947815|Botulinum Toxins|botulinum toxins|mesh-list
101507376|NCT02947815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101507377|NCT02947815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101507378|NCT02947815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101507379|NCT02947815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101507380|NCT02947815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507381|NCT02947815|Cholinergic Agents|cholinergic agents|mesh-ancestor
101507382|NCT02947815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101507383|NCT02947815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507384|NCT02947815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101507385|NCT02947815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101507386|NCT00507221|Albendazole|albendazole|mesh-list
101507387|NCT00507221|Praziquantel|praziquantel|mesh-list
101507388|NCT00507221|Anthelmintics|anthelmintics|mesh-ancestor
101507389|NCT00507221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101507390|NCT00507221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101507391|NCT00507221|Anticestodal Agents|anticestodal agents|mesh-ancestor
101507392|NCT00507221|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101507393|NCT00507221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101507394|NCT00507221|Tubulin Modulators|tubulin modulators|mesh-ancestor
101507395|NCT00507221|Antimitotic Agents|antimitotic agents|mesh-ancestor
101507396|NCT00507221|Mitosis Modulators|mitosis modulators|mesh-ancestor
101507397|NCT00507221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507399|NCT02947737|Gentamicins|gentamicins|mesh-list
101507400|NCT02947737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101507401|NCT02947737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101507402|NCT02947737|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101507403|NCT02947737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101507404|NCT02947737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507405|NCT05146895|Imiquimod|imiquimod|mesh-list
101507406|NCT05146895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101507407|NCT05146895|Immunologic Factors|immunologic factors|mesh-ancestor
101507408|NCT05146895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507409|NCT05146895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101507410|NCT05146895|Interferon Inducers|interferon inducers|mesh-ancestor
101507411|NCT05143073|Ethanol|ethanol|mesh-list
101507412|NCT05143073|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101507413|NCT05143073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101507414|NCT05143073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101507415|NCT05143073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507416|NCT00524901|Epoetin Alfa|epoetin alfa|mesh-list
101507417|NCT00524901|Hematinics|hematinics|mesh-ancestor
101507418|NCT02954588|Pyridoxamine|pyridoxamine|mesh-list
101507419|NCT02954588|Vitamin B Complex|vitamin b complex|mesh-ancestor
101507420|NCT02954588|Vitamins|vitamins|mesh-ancestor
101507421|NCT02954588|Micronutrients|micronutrients|mesh-ancestor
101507422|NCT02954588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507423|NCT02954549|Vitamin D|vitamin d|mesh-list
101507424|NCT02954549|Cholecalciferol|cholecalciferol|mesh-list
101507425|NCT02954549|Vitamins|vitamins|mesh-ancestor
101507426|NCT02954549|Micronutrients|micronutrients|mesh-ancestor
101507427|NCT02954549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507428|NCT02954549|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101507429|NCT02954549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101507430|NCT05145608|Lamotrigine|lamotrigine|mesh-list
101507431|NCT05145608|Anticonvulsants|anticonvulsants|mesh-list
101507432|NCT05145608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101507433|NCT05145608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101507434|NCT05145608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507435|NCT05145608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101507436|NCT05145608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507437|NCT05145608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101507438|NCT05145608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101507439|NCT05145608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101507440|NCT05145608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101191179|NCT00359658|Hormones|hormones|mesh-ancestor
101507441|NCT05145608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101507442|NCT02946294|Epinephrine|epinephrine|mesh-list
101507443|NCT02946294|Racepinephrine|racepinephrine|mesh-list
101507444|NCT02946294|Bupivacaine|bupivacaine|mesh-list
101507445|NCT02946294|Epinephryl borate|epinephryl borate|mesh-list
101507446|NCT02946294|Anesthetics, Local|anesthetics, local|mesh-ancestor
101507447|NCT02946294|Anesthetics|anesthetics|mesh-ancestor
101507448|NCT02946294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101507449|NCT02946294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507450|NCT02946294|Sensory System Agents|sensory system agents|mesh-ancestor
101507451|NCT02946294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101507452|NCT02946294|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101507453|NCT02946294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101507454|NCT02946294|Adrenergic Agents|adrenergic agents|mesh-ancestor
101507455|NCT02946294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101507456|NCT02946294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507457|NCT02946294|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101507458|NCT02946294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101507459|NCT02946294|Autonomic Agents|autonomic agents|mesh-ancestor
101507460|NCT02946294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101507461|NCT02946294|Respiratory System Agents|respiratory system agents|mesh-ancestor
101507462|NCT02946294|Mydriatics|mydriatics|mesh-ancestor
101507463|NCT02946294|Sympathomimetics|sympathomimetics|mesh-ancestor
101507464|NCT02946294|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101507465|NCT05146232|Anesthetics|anesthetics|mesh-list
101507466|NCT05146232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101507467|NCT05146232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507468|NCT00525096|Celecoxib|celecoxib|mesh-list
101507469|NCT00525096|Exemestane|exemestane|mesh-list
101507470|NCT00525096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101507471|NCT00525096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101507472|NCT00525096|Analgesics|analgesics|mesh-ancestor
101507473|NCT00525096|Sensory System Agents|sensory system agents|mesh-ancestor
101507474|NCT00525096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101507475|NCT00525096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507476|NCT00525096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101507477|NCT00525096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101507478|NCT00525096|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101507479|NCT00525096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101507480|NCT00525096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101507481|NCT00525096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507482|NCT00525096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101507483|NCT00525096|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101507484|NCT00525096|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101507485|NCT00525096|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101507486|NCT00525096|Hormone Antagonists|hormone antagonists|mesh-ancestor
101507487|NCT00525096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101507489|NCT04693026|Antimetabolites|antimetabolites|mesh-ancestor
101263748|NCT01763541|Leuprolide|leuprolide|mesh-list
101507490|NCT04693026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507491|NCT04693026|Antiviral Agents|antiviral agents|mesh-ancestor
101507492|NCT04693026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101507493|NCT02276859|Insulin|insulin|mesh-list
101507494|NCT02276859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101507495|NCT02276859|Insulin Aspart|insulin aspart|mesh-list
101507496|NCT02276859|Insulin Lispro|insulin lispro|mesh-list
101507497|NCT02276859|Insulin glulisine|insulin glulisine|mesh-list
101507498|NCT02276859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101507499|NCT02276859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507500|NCT05143970|Trastuzumab|trastuzumab|mesh-list
101507501|NCT05143970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101507502|NCT05143970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101507503|NCT05147090|Empagliflozin|empagliflozin|mesh-list
101507504|NCT05147090|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101507505|NCT05147090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507506|NCT05147090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101507507|NCT05147090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507508|NCT00525252|Baclofen|baclofen|mesh-list
101507509|NCT00525252|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101507510|NCT00525252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507511|NCT00525252|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101507512|NCT00525252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101507513|NCT00525252|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101507514|NCT00525252|GABA Agonists|gaba agonists|mesh-ancestor
101507515|NCT00525252|GABA Agents|gaba agents|mesh-ancestor
101191256|NCT00361452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101507516|NCT00525252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101507517|NCT00525252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507518|NCT02947113|Etoposide|etoposide|mesh-list
101507519|NCT02947113|Pemetrexed|pemetrexed|mesh-list
101507520|NCT02947113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101507521|NCT02947113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101507522|NCT02947113|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101507523|NCT02947113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101507524|NCT02947113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101507526|NCT02947113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101507527|NCT02947113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101507528|NCT05149274|Fexuprazan|fexuprazan|mesh-list
101507529|NCT05149274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101507530|NCT02276690|Hepcidins|hepcidins|mesh-list
101507531|NCT02276690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101507532|NCT02947269|Prucalopride|prucalopride|mesh-list
101507533|NCT02947269|Laxatives|laxatives|mesh-ancestor
101507534|NCT02947269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101507535|NCT02947269|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101507536|NCT02947269|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101507537|NCT02947269|Serotonin Agents|serotonin agents|mesh-ancestor
101507538|NCT02947269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101507539|NCT02947269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507540|NCT02947269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507541|NCT00526305|Cytarabine|cytarabine|mesh-list
101507542|NCT00526305|Dexamethasone|dexamethasone|mesh-list
101507543|NCT00526305|Prednisone|prednisone|mesh-list
101507544|NCT00526305|Hydrocortisone|hydrocortisone|mesh-list
101507545|NCT00526305|Cyclophosphamide|cyclophosphamide|mesh-list
101507546|NCT00526305|Vincristine|vincristine|mesh-list
101507547|NCT00526305|Daunorubicin|daunorubicin|mesh-list
101507548|NCT00526305|Asparaginase|asparaginase|mesh-list
101507549|NCT00526305|Mitoxantrone|mitoxantrone|mesh-list
101263755|NCT01763541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101507550|NCT00526305|Mercaptopurine|mercaptopurine|mesh-list
101263762|NCT01763658|Dexamethasone|dexamethasone|mesh-list
101507551|NCT00526305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101507552|NCT00526305|Immunologic Factors|immunologic factors|mesh-ancestor
101507553|NCT00526305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507554|NCT00526305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101507555|NCT00526305|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101507556|NCT00526305|Alkylating Agents|alkylating agents|mesh-ancestor
101507557|NCT00526305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507558|NCT00526305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101507559|NCT00526305|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101507560|NCT00526305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101507561|NCT00526305|Antiemetics|antiemetics|mesh-ancestor
101507562|NCT00526305|Autonomic Agents|autonomic agents|mesh-ancestor
101507563|NCT00526305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101507564|NCT00526305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101507565|NCT00526305|Glucocorticoids|glucocorticoids|mesh-ancestor
101507566|NCT00526305|Hormones|hormones|mesh-ancestor
101507567|NCT00526305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101507568|NCT00526305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101507569|NCT00526305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101507570|NCT00526305|Tubulin Modulators|tubulin modulators|mesh-ancestor
101507571|NCT00526305|Antimitotic Agents|antimitotic agents|mesh-ancestor
101507572|NCT00526305|Mitosis Modulators|mitosis modulators|mesh-ancestor
101507573|NCT00526305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101507574|NCT00526305|Antimetabolites|antimetabolites|mesh-ancestor
101507575|NCT00526305|Antiviral Agents|antiviral agents|mesh-ancestor
101507576|NCT00526305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101507577|NCT00526305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101507578|NCT00526305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101507579|NCT00526305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101507580|NCT00526305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101507581|NCT00526305|Analgesics|analgesics|mesh-ancestor
101507582|NCT00526305|Sensory System Agents|sensory system agents|mesh-ancestor
101507583|NCT00526305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101507584|NCT02276768|Trimebutine|trimebutine|mesh-list
101507585|NCT02276768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101507586|NCT02276768|Parasympatholytics|parasympatholytics|mesh-ancestor
101507587|NCT02276768|Autonomic Agents|autonomic agents|mesh-ancestor
101507588|NCT02276768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101507589|NCT02276768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507590|NCT00526383|Antidepressive Agents|antidepressive agents|mesh-list
101507591|NCT00526383|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
101507592|NCT00526383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101507594|NCT05147753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101507595|NCT00525408|Docetaxel|docetaxel|mesh-list
101507596|NCT00525408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101507597|NCT00525408|Tubulin Modulators|tubulin modulators|mesh-ancestor
101507598|NCT00525408|Antimitotic Agents|antimitotic agents|mesh-ancestor
101507599|NCT00525408|Mitosis Modulators|mitosis modulators|mesh-ancestor
101507600|NCT00525408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507601|NCT00525447|Dexamethasone|dexamethasone|mesh-list
101507602|NCT00525447|Lenalidomide|lenalidomide|mesh-list
101507603|NCT00525447|Dacetuzumab|dacetuzumab|mesh-list
101507604|NCT00525447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101507605|NCT00525447|Antiemetics|antiemetics|mesh-ancestor
101507606|NCT00525447|Autonomic Agents|autonomic agents|mesh-ancestor
101507607|NCT00525447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101507608|NCT00525447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507609|NCT00525447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101507610|NCT00525447|Glucocorticoids|glucocorticoids|mesh-ancestor
101507611|NCT00525447|Hormones|hormones|mesh-ancestor
101507612|NCT00525447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101507613|NCT00525447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101507614|NCT00525447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101507615|NCT00525447|Immunologic Factors|immunologic factors|mesh-ancestor
101507616|NCT00525447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101263769|NCT01763658|Antioxidants|antioxidants|mesh-list
101507617|NCT00525447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101507619|NCT00525447|Growth Inhibitors|growth inhibitors|mesh-ancestor
101507620|NCT00525447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101507622|NCT00525486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101507623|NCT00525486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101507624|NCT00525486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507625|NCT00525486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101507626|NCT00525486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507627|NCT00525486|Vasodilator Agents|vasodilator agents|mesh-ancestor
101507628|NCT00525486|Tocolytic Agents|tocolytic agents|mesh-ancestor
101507629|NCT00525486|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101507630|NCT05145101|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101507631|NCT05145101|Immunologic Factors|immunologic factors|mesh-ancestor
101507632|NCT05145101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507633|NCT02946060|TEMPO|tempo|mesh-list
101507634|NCT02946060|Antioxidants|antioxidants|mesh-ancestor
101507635|NCT02946060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507636|NCT02946060|Protective Agents|protective agents|mesh-ancestor
101507637|NCT02946060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507638|NCT00525564|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101507639|NCT00525564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101507640|NCT00525564|Autonomic Agents|autonomic agents|mesh-ancestor
101507641|NCT00525564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101507642|NCT00525564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507643|NCT00525564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101507644|NCT00525564|Respiratory System Agents|respiratory system agents|mesh-ancestor
101507645|NCT00525564|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101507646|NCT00525564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101507647|NCT00525564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101507648|NCT00525564|Adrenergic Agents|adrenergic agents|mesh-ancestor
101507649|NCT00525564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101507650|NCT00525564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507651|NCT00525642|Cyclophosphamide|cyclophosphamide|mesh-list
101507652|NCT00525642|Docetaxel|docetaxel|mesh-list
101507653|NCT00525642|Doxorubicin|doxorubicin|mesh-list
101507654|NCT00525642|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101507655|NCT00525642|Epirubicin|epirubicin|mesh-list
101507656|NCT00525642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101507657|NCT00525642|Immunologic Factors|immunologic factors|mesh-ancestor
101507658|NCT00525642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507659|NCT00525642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101507661|NCT00525642|Alkylating Agents|alkylating agents|mesh-ancestor
101507662|NCT00525642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507663|NCT00525642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101507664|NCT00525642|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101507665|NCT00525642|Tubulin Modulators|tubulin modulators|mesh-ancestor
101507666|NCT00525642|Antimitotic Agents|antimitotic agents|mesh-ancestor
101191406|NCT00365742|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101507667|NCT00525642|Mitosis Modulators|mitosis modulators|mesh-ancestor
101507668|NCT00525642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101507669|NCT00525642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101507670|NCT00525642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101507671|NCT00525642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101507672|NCT00525681|Cyclosporine|cyclosporine|mesh-list
101507673|NCT00525681|Tacrolimus|tacrolimus|mesh-list
101507674|NCT00525681|Cyclosporins|cyclosporins|mesh-list
101507675|NCT00525681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101507676|NCT00525681|Immunologic Factors|immunologic factors|mesh-ancestor
101507677|NCT00525681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507678|NCT00525681|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101507679|NCT00525681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101507680|NCT00525681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507681|NCT00525681|Antifungal Agents|antifungal agents|mesh-ancestor
101507682|NCT00525681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101507683|NCT00525681|Dermatologic Agents|dermatologic agents|mesh-ancestor
101507684|NCT00525681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101507685|NCT03456635|Anti-Infective Agents|anti-infective agents|mesh-list
101507686|NCT03456635|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101507689|NCT02945982|Antiviral Agents|antiviral agents|mesh-ancestor
101507690|NCT02945982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101507691|NCT02945982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101507692|NCT02945982|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101507693|NCT02945982|Adrenergic Agents|adrenergic agents|mesh-ancestor
101507694|NCT02945982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101507695|NCT02945982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507696|NCT02945982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507697|NCT02945982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101507698|NCT02945982|Antioxidants|antioxidants|mesh-ancestor
101507699|NCT02945982|Protective Agents|protective agents|mesh-ancestor
101507700|NCT02945982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101507701|NCT02945982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101507702|NCT02945982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101507703|NCT02945982|Vasodilator Agents|vasodilator agents|mesh-ancestor
101507704|NCT02945982|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101507705|NCT02945982|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101507706|NCT02954393|Amoxicillin|amoxicillin|mesh-list
101507707|NCT02954393|Metronidazole|metronidazole|mesh-list
101507708|NCT02954393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101507709|NCT02954393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101507710|NCT02954393|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101507711|NCT02954393|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101507712|NCT02954276|Sumatriptan|sumatriptan|mesh-list
101507713|NCT02954276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101507714|NCT02954276|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101507715|NCT02954276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101507716|NCT02954276|Serotonin Agents|serotonin agents|mesh-ancestor
101507719|NCT02954276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507720|NCT00507494|Pioglitazone|pioglitazone|mesh-list
101507721|NCT00507494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101507722|NCT00507494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507723|NCT00526617|Temozolomide|temozolomide|mesh-list
101507724|NCT00526617|Veliparib|veliparib|mesh-list
101507725|NCT00526617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101507726|NCT00526617|Alkylating Agents|alkylating agents|mesh-ancestor
101507727|NCT00526617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507728|NCT00526617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101507729|NCT00526617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101507730|NCT00526617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101507731|NCT00507845|Felodipine|felodipine|mesh-list
101507732|NCT00507845|Ramipril|ramipril|mesh-list
101507733|NCT00507845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101507734|NCT00507845|Protease Inhibitors|protease inhibitors|mesh-ancestor
101507735|NCT00507845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101507736|NCT00507845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507737|NCT00507845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101507738|NCT00507845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101507739|NCT00507845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101507740|NCT00507845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101507741|NCT00507845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101507742|NCT00507845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507743|NCT00507845|Vasodilator Agents|vasodilator agents|mesh-ancestor
101507744|NCT00525759|Zoledronic Acid|zoledronic acid|mesh-list
101507745|NCT00525759|Cyclophosphamide|cyclophosphamide|mesh-list
101507746|NCT00525759|Docetaxel|docetaxel|mesh-list
101507747|NCT00525759|Fluorouracil|fluorouracil|mesh-list
101507748|NCT00525759|Epirubicin|epirubicin|mesh-list
101507749|NCT00525759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101507750|NCT00525759|Immunologic Factors|immunologic factors|mesh-ancestor
101507751|NCT00525759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507752|NCT00525759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101507753|NCT00525759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101507754|NCT00525759|Alkylating Agents|alkylating agents|mesh-ancestor
101507755|NCT00525759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507756|NCT00525759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101507757|NCT00525759|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101507759|NCT00525759|Antimitotic Agents|antimitotic agents|mesh-ancestor
101507760|NCT00525759|Mitosis Modulators|mitosis modulators|mesh-ancestor
101507761|NCT00525759|Antimetabolites|antimetabolites|mesh-ancestor
101507762|NCT00525759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101507763|NCT00525759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101507764|NCT00525759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101507765|NCT00525759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101507766|NCT00525759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101507767|NCT00525759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101507768|NCT00507962|Cisplatin|cisplatin|mesh-list
101507769|NCT00507962|Doxorubicin|doxorubicin|mesh-list
101507770|NCT00507962|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101507771|NCT00507962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101507772|NCT00507962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101507773|NCT00507962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101507774|NCT00507962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101507775|NCT00507962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101507776|NCT00507962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507777|NCT00508040|Interferons|interferons|mesh-list
101507778|NCT00508040|Interferon-alpha|interferon-alpha|mesh-list
101507779|NCT00508040|Interferon alpha-2|interferon alpha-2|mesh-list
101507780|NCT00508040|Prednisone|prednisone|mesh-list
101507781|NCT00508040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101507782|NCT00508040|Glucocorticoids|glucocorticoids|mesh-ancestor
101507783|NCT00508040|Hormones|hormones|mesh-ancestor
101507784|NCT00508040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101507785|NCT00508040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507786|NCT00508040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101507787|NCT00508040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101507788|NCT00508040|Antiviral Agents|antiviral agents|mesh-ancestor
101507789|NCT00508040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101507790|NCT00508040|Immunologic Factors|immunologic factors|mesh-ancestor
101507791|NCT00508664|Docetaxel|docetaxel|mesh-list
101507792|NCT00508664|Fluorouracil|fluorouracil|mesh-list
101507793|NCT00508664|Cetuximab|cetuximab|mesh-list
101507794|NCT00508664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101507795|NCT00508664|Tubulin Modulators|tubulin modulators|mesh-ancestor
101507796|NCT00508664|Antimitotic Agents|antimitotic agents|mesh-ancestor
101507797|NCT00508664|Mitosis Modulators|mitosis modulators|mesh-ancestor
101507798|NCT00508664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507799|NCT00508664|Antimetabolites|antimetabolites|mesh-ancestor
101507800|NCT00508664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101507801|NCT00508664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101507802|NCT00508664|Immunologic Factors|immunologic factors|mesh-ancestor
101507803|NCT00508664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507804|NCT00508664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101507805|NCT02946684|Letrozole|letrozole|mesh-list
101507806|NCT02946684|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101507808|NCT02946684|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101507809|NCT02946684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101507810|NCT02946684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507811|NCT02946684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101507812|NCT02946684|Hormone Antagonists|hormone antagonists|mesh-ancestor
101507813|NCT02946684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101507814|NCT02946684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507815|NCT02953379|Mometasone Furoate|mometasone furoate|mesh-list
101507816|NCT02953379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101507817|NCT02953379|Dermatologic Agents|dermatologic agents|mesh-ancestor
101507818|NCT02953379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101507819|NCT02946801|Listerine|listerine|mesh-list
101507820|NCT02946801|Sodium Fluoride|sodium fluoride|mesh-list
101507821|NCT02946801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101507822|NCT02946801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101507823|NCT02946801|Cariostatic Agents|cariostatic agents|mesh-ancestor
101507824|NCT02946801|Protective Agents|protective agents|mesh-ancestor
101507825|NCT02946801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507826|NCT02953847|Rifampin|rifampin|mesh-list
101507827|NCT02953847|Isoniazid|isoniazid|mesh-list
101507828|NCT02953847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101507830|NCT02953847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101507831|NCT02953847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101507832|NCT02953847|Leprostatic Agents|leprostatic agents|mesh-ancestor
101507833|NCT02953847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101507834|NCT02953847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101507835|NCT02953847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507836|NCT02953847|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101507837|NCT02953847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101507838|NCT02953847|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101507839|NCT02953847|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101507840|NCT02953847|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101507841|NCT02953847|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101507842|NCT02953847|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101507843|NCT02953847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101507844|NCT02953847|Antimetabolites|antimetabolites|mesh-ancestor
101507845|NCT02953847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101507846|NCT00526695|Sevoflurane|sevoflurane|mesh-list
101507847|NCT00526695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101507848|NCT00526695|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101507849|NCT00526695|Anesthetics, General|anesthetics, general|mesh-ancestor
101507850|NCT00526695|Anesthetics|anesthetics|mesh-ancestor
101507851|NCT00526695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101507852|NCT00526695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507853|NCT00526929|Darbepoetin alfa|darbepoetin alfa|mesh-list
101507854|NCT00526929|Hematinics|hematinics|mesh-ancestor
101507855|NCT02953535|Sofosbuvir|sofosbuvir|mesh-list
101507856|NCT02953535|Antiviral Agents|antiviral agents|mesh-ancestor
101507857|NCT02953535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101507858|NCT00526734|Melphalan|melphalan|mesh-list
101507859|NCT00526734|Immunologic Factors|immunologic factors|mesh-ancestor
101507860|NCT00526734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507861|NCT00526734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101507862|NCT00526734|Alkylating Agents|alkylating agents|mesh-ancestor
101507863|NCT00526734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507864|NCT00526734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101507865|NCT00526734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101507866|NCT00526734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101507867|NCT00508859|Sertraline|sertraline|mesh-list
101507868|NCT00508859|Antidepressive Agents|antidepressive agents|mesh-ancestor
101507869|NCT00508859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101507870|NCT00508859|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101507871|NCT00508859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101507872|NCT00508859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101507873|NCT00508859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507874|NCT00508859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101507875|NCT00508859|Serotonin Agents|serotonin agents|mesh-ancestor
101507876|NCT00508859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507877|NCT00508898|Calcitriol|calcitriol|mesh-list
101507879|NCT00508898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507880|NCT00508898|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101507881|NCT00508898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101507882|NCT00508898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318046|NCT00014755|Hormones|hormones|mesh-ancestor
101507883|NCT00508898|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101507884|NCT00508898|Vitamins|vitamins|mesh-ancestor
101507885|NCT00508898|Micronutrients|micronutrients|mesh-ancestor
101263805|NCT01763788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101507886|NCT00508898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101507887|NCT04692558|Hyaluronic Acid|hyaluronic acid|mesh-list
101507888|NCT04692558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101507889|NCT04692558|Immunologic Factors|immunologic factors|mesh-ancestor
101507890|NCT04692558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191631|NCT00370656|Adrenergic Agents|adrenergic agents|mesh-ancestor
101507891|NCT04692558|Viscosupplements|viscosupplements|mesh-ancestor
101507892|NCT04692558|Protective Agents|protective agents|mesh-ancestor
101507894|NCT02952599|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101507895|NCT02952599|Antithrombins|antithrombins|mesh-ancestor
101507896|NCT02952599|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101507897|NCT02952599|Protease Inhibitors|protease inhibitors|mesh-ancestor
101507898|NCT02952599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101507899|NCT02952599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507900|NCT02952599|Anticoagulants|anticoagulants|mesh-ancestor
101507901|NCT00510419|Sumatriptan|sumatriptan|mesh-list
101507902|NCT00510419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101507903|NCT00510419|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101507904|NCT00510419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101507905|NCT00510419|Serotonin Agents|serotonin agents|mesh-ancestor
101507906|NCT00510419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101507907|NCT00510419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507908|NCT00510419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507909|NCT00510536|Acetaminophen|acetaminophen|mesh-list
101507910|NCT00510536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101507911|NCT00510536|Analgesics|analgesics|mesh-ancestor
101507912|NCT00510536|Sensory System Agents|sensory system agents|mesh-ancestor
101507913|NCT00510536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101507914|NCT00510536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507915|NCT00510536|Antipyretics|antipyretics|mesh-ancestor
101507916|NCT03458715|Empagliflozin|empagliflozin|mesh-list
101507917|NCT03458715|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
101507918|NCT03458715|Linagliptin|linagliptin|mesh-list
101507919|NCT03458715|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
101507920|NCT03458715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507921|NCT03458715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101507922|NCT03458715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507923|NCT03458715|Incretins|incretins|mesh-ancestor
101507924|NCT03458715|Hormones|hormones|mesh-ancestor
101507925|NCT03458715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101507926|NCT03458715|Protease Inhibitors|protease inhibitors|mesh-ancestor
101507927|NCT03458715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101507928|NCT00510614|Tinidazole|tinidazole|mesh-list
101507929|NCT00510614|Alkylating Agents|alkylating agents|mesh-ancestor
101507930|NCT00510614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507931|NCT00510614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101507932|NCT00510614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101507933|NCT00510614|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
101507934|NCT00510614|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101507935|NCT00510614|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101507936|NCT00508976|Lidocaine|lidocaine|mesh-list
101507937|NCT00508976|Bupivacaine|bupivacaine|mesh-list
101507938|NCT00508976|Anesthetics, Local|anesthetics, local|mesh-ancestor
101507939|NCT00508976|Anesthetics|anesthetics|mesh-ancestor
101507940|NCT00508976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101507941|NCT00508976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507942|NCT00508976|Sensory System Agents|sensory system agents|mesh-ancestor
101507946|NCT00508976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101507947|NCT00508976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101507948|NCT00508976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507949|NCT04692285|Zolpidem|zolpidem|mesh-list
101507950|NCT04692285|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101507951|NCT04692285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101507952|NCT04692285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101507953|NCT04692285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507954|NCT04692285|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101507955|NCT04692285|GABA Agonists|gaba agonists|mesh-ancestor
101318066|NCT00014989|Sensory System Agents|sensory system agents|mesh-ancestor
101507957|NCT04692285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101507958|NCT04692285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507960|NCT00509015|Pyrimethamine|pyrimethamine|mesh-list
101507961|NCT00509015|Primaquine|primaquine|mesh-list
101507962|NCT00509015|Sulfadoxine|sulfadoxine|mesh-list
101507963|NCT00509015|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101507964|NCT00509015|Antimalarials|antimalarials|mesh-ancestor
101507965|NCT00509015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101507966|NCT00509015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101507967|NCT00509015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101507968|NCT00509015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101507969|NCT00509015|Antiviral Agents|antiviral agents|mesh-ancestor
101507970|NCT00509015|Schistosomicides|schistosomicides|mesh-ancestor
101507971|NCT00509015|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101507972|NCT00509015|Anthelmintics|anthelmintics|mesh-ancestor
101507973|NCT00509015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101507974|NCT00509015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101507975|NCT00509015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507976|NCT00509015|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101507977|NCT00528060|Ritonavir|ritonavir|mesh-list
101507978|NCT00528060|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101507979|NCT00528060|Tenofovir|tenofovir|mesh-list
101507980|NCT00528060|Emtricitabine|emtricitabine|mesh-list
101507981|NCT00528060|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101507982|NCT00528060|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101507983|NCT00528060|Protease Inhibitors|protease inhibitors|mesh-ancestor
101507984|NCT00528060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101507985|NCT00528060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101507986|NCT00528060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101507987|NCT00528060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101507988|NCT00528060|Antiviral Agents|antiviral agents|mesh-ancestor
101507989|NCT00528060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101507990|NCT00528060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101507991|NCT00528060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101507993|NCT00528060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101507994|NCT00527085|Cinacalcet|cinacalcet|mesh-list
101507995|NCT00527085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101507996|NCT00527085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101507997|NCT00527085|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101507998|NCT00527085|Hormone Antagonists|hormone antagonists|mesh-ancestor
101507999|NCT00527085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101508000|NCT00509327|Bisacodyl|bisacodyl|mesh-list
101508001|NCT00509327|Cathartics|cathartics|mesh-ancestor
101508002|NCT00509327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101508003|NCT00509327|Laxatives|laxatives|mesh-ancestor
101508004|NCT00509405|Potassium Citrate|potassium citrate|mesh-list
101508005|NCT00509405|Diuretics|diuretics|mesh-ancestor
101508006|NCT00509405|Natriuretic Agents|natriuretic agents|mesh-ancestor
101508007|NCT00509405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508008|NCT00509405|Expectorants|expectorants|mesh-ancestor
101508009|NCT00509405|Respiratory System Agents|respiratory system agents|mesh-ancestor
101508010|NCT00509561|Capecitabine|capecitabine|mesh-list
101508011|NCT00509561|Cetuximab|cetuximab|mesh-list
101508012|NCT00509561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101508013|NCT00509561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101508014|NCT00509561|Antimetabolites|antimetabolites|mesh-ancestor
101508015|NCT00509561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508016|NCT00509561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101508017|NCT00509639|Metronidazole|metronidazole|mesh-list
101508018|NCT00509639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101508019|NCT00509639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101508020|NCT00509639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101508021|NCT00509639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101508022|NCT00528177|Morphine|morphine|mesh-list
101508023|NCT00528177|Oxycodone|oxycodone|mesh-list
101508024|NCT00528177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101508025|NCT00528177|Narcotics|narcotics|mesh-ancestor
101263818|NCT01764126|Vaccines|vaccines|mesh-list
101508026|NCT00528177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101508027|NCT00528177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508029|NCT00528177|Sensory System Agents|sensory system agents|mesh-ancestor
101508030|NCT00528177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101508032|NCT00509678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101508033|NCT00509678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101508034|NCT00509678|Immunologic Factors|immunologic factors|mesh-ancestor
101508035|NCT00509678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508036|NCT00509678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101508037|NCT00528216|Capsaicin|capsaicin|mesh-list
101508038|NCT00528216|Antipruritics|antipruritics|mesh-ancestor
101508039|NCT00528216|Dermatologic Agents|dermatologic agents|mesh-ancestor
101508040|NCT00528216|Sensory System Agents|sensory system agents|mesh-ancestor
101508041|NCT00528216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101508042|NCT00528216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508043|NCT00528255|Misoprostol|misoprostol|mesh-list
101508044|NCT00528255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101508045|NCT00528255|Abortifacient Agents|abortifacient agents|mesh-ancestor
101508046|NCT00528255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101508047|NCT00528255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508048|NCT00528255|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101508049|NCT00528255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101508050|NCT00528255|Oxytocics|oxytocics|mesh-ancestor
101508051|NCT02953106|Fluticasone|fluticasone|mesh-list
101508052|NCT02953106|Azelastine|azelastine|mesh-list
101508053|NCT02953106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101508054|NCT02953106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101508055|NCT02953106|Autonomic Agents|autonomic agents|mesh-ancestor
101508056|NCT02953106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101508057|NCT02953106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508058|NCT02953106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101508059|NCT02953106|Respiratory System Agents|respiratory system agents|mesh-ancestor
101508061|NCT02953106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101508062|NCT02953106|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101508063|NCT02953106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101508064|NCT02953106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508065|NCT02953106|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101508066|NCT02953106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101508067|NCT02953106|Histamine Antagonists|histamine antagonists|mesh-ancestor
101508068|NCT02953106|Histamine Agents|histamine agents|mesh-ancestor
101508069|NCT02953106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101508070|NCT02952989|Pembrolizumab|pembrolizumab|mesh-list
101508071|NCT02952989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101508072|NCT02952989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101508073|NCT02952989|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101508074|NCT02952989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508075|NCT00510926|Imatinib Mesylate|imatinib mesylate|mesh-list
101508076|NCT00510926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101508077|NCT00510926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101508078|NCT00510926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101508079|NCT00510926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508080|NCT00509834|Lactoferrin|lactoferrin|mesh-list
101508081|NCT00509834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101508082|NCT03459404|Sufentanil|sufentanil|mesh-list
101508083|NCT03459404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101508084|NCT03459404|Narcotics|narcotics|mesh-ancestor
101508085|NCT03459404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101508086|NCT03459404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508087|NCT03459404|Analgesics|analgesics|mesh-ancestor
101508088|NCT03459404|Sensory System Agents|sensory system agents|mesh-ancestor
101508089|NCT03459404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101508090|NCT03459404|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101508091|NCT03459404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101508092|NCT03459404|Anesthetics, General|anesthetics, general|mesh-ancestor
101508093|NCT03459404|Anesthetics|anesthetics|mesh-ancestor
101508094|NCT00527202|Botulinum Toxins|botulinum toxins|mesh-list
101508095|NCT00527202|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101508096|NCT00527202|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101508097|NCT00527202|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101508098|NCT00527202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101508099|NCT00527202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508100|NCT00527202|Cholinergic Agents|cholinergic agents|mesh-ancestor
101508101|NCT00527202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101508102|NCT00527202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508103|NCT00527202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101508104|NCT00527202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101508106|NCT00510965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101508107|NCT00510965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101508108|NCT00510965|Growth Substances|growth substances|mesh-ancestor
101508109|NCT00510965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508110|NCT00510965|Growth Inhibitors|growth inhibitors|mesh-ancestor
101508111|NCT00510965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101508112|NCT00509990|Pimecrolimus|pimecrolimus|mesh-list
101508113|NCT00509990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101508114|NCT00509990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101508115|NCT00509990|Analgesics|analgesics|mesh-ancestor
101508116|NCT00509990|Sensory System Agents|sensory system agents|mesh-ancestor
101508117|NCT00509990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101508118|NCT00509990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508119|NCT00509990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101508120|NCT00509990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101508121|NCT00509990|Dermatologic Agents|dermatologic agents|mesh-ancestor
101508122|NCT00509990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101508123|NCT00509990|Immunologic Factors|immunologic factors|mesh-ancestor
101508124|NCT00509990|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101508125|NCT00509990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101508126|NCT00509990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508128|NCT03459911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101508129|NCT03459911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101508130|NCT03459911|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101508131|NCT03459911|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101508132|NCT03459911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508133|NCT03459833|Hyaluronic Acid|hyaluronic acid|mesh-list
101508134|NCT03459833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101508135|NCT03459833|Immunologic Factors|immunologic factors|mesh-ancestor
101508136|NCT03459833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508137|NCT03459833|Viscosupplements|viscosupplements|mesh-ancestor
101508138|NCT03459833|Protective Agents|protective agents|mesh-ancestor
101508139|NCT05648487|Antibodies|antibodies|mesh-list
101508140|NCT05648487|Immunologic Factors|immunologic factors|mesh-ancestor
101508141|NCT05648487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508142|NCT00511121|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101508143|NCT00511121|Imatinib Mesylate|imatinib mesylate|mesh-list
101508144|NCT00511121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101508145|NCT00511121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101508146|NCT00511121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101508147|NCT00511121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508148|NCT00511121|Antiviral Agents|antiviral agents|mesh-ancestor
101508149|NCT00511121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101508150|NCT04692051|Paclitaxel|paclitaxel|mesh-list
101508151|NCT04692051|Cisplatin|cisplatin|mesh-list
101508152|NCT04692051|Gemcitabine|gemcitabine|mesh-list
101508153|NCT04692051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101508154|NCT04692051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101508155|NCT04692051|Tubulin Modulators|tubulin modulators|mesh-ancestor
101508156|NCT04692051|Antimitotic Agents|antimitotic agents|mesh-ancestor
101508157|NCT04692051|Mitosis Modulators|mitosis modulators|mesh-ancestor
101508158|NCT04692051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508159|NCT04692051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101508160|NCT04692051|Antimetabolites|antimetabolites|mesh-ancestor
101508161|NCT00528723|Albuterol|albuterol|mesh-list
101508162|NCT00528723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101328351|NCT00000152|Micronutrients|micronutrients|mesh-ancestor
101508163|NCT00528723|Autonomic Agents|autonomic agents|mesh-ancestor
101508164|NCT00528723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101508165|NCT00528723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508166|NCT00528723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101508167|NCT00528723|Respiratory System Agents|respiratory system agents|mesh-ancestor
101508168|NCT00528723|Tocolytic Agents|tocolytic agents|mesh-ancestor
101508169|NCT00528723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101508170|NCT00528723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101508171|NCT00528723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101508172|NCT00528723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101508173|NCT00528723|Adrenergic Agents|adrenergic agents|mesh-ancestor
101508174|NCT00528723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101508175|NCT00528723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508176|NCT00510107|Oxaliplatin|oxaliplatin|mesh-list
101508177|NCT00510107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101508179|NCT01580514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101508180|NCT01580514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508181|NCT01580514|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101508182|NCT01580514|Incretins|incretins|mesh-ancestor
101508183|NCT01580514|Hormones|hormones|mesh-ancestor
101508184|NCT01580514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101508185|NCT00528918|Insulin glulisine|insulin glulisine|mesh-list
101508186|NCT00528918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101508187|NCT00528918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508188|NCT00515190|Oxaliplatin|oxaliplatin|mesh-list
101508189|NCT00515190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101508190|NCT00511277|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101508191|NCT00511277|Antidepressive Agents|antidepressive agents|mesh-ancestor
101508192|NCT00511277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101508193|NCT00511277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101508194|NCT00511277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101508195|NCT00511277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101508196|NCT00511277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508197|NCT02953184|Vitamins|vitamins|mesh-list
101508198|NCT02953184|Vitamin B Complex|vitamin b complex|mesh-list
101508199|NCT02953184|Cyclophosphamide|cyclophosphamide|mesh-list
101508200|NCT02953184|Docetaxel|docetaxel|mesh-list
101508201|NCT02953184|Doxorubicin|doxorubicin|mesh-list
101508202|NCT02953184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101508203|NCT02953184|Dexrazoxane|dexrazoxane|mesh-list
101508204|NCT02953184|Razoxane|razoxane|mesh-list
101508205|NCT02953184|Pirarubicin|pirarubicin|mesh-list
101508206|NCT02953184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101508207|NCT02953184|Immunologic Factors|immunologic factors|mesh-ancestor
101508208|NCT02953184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508209|NCT02953184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101508210|NCT02953184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101508211|NCT02953184|Alkylating Agents|alkylating agents|mesh-ancestor
101508212|NCT02953184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508213|NCT02953184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101508214|NCT02953184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101508215|NCT02953184|Micronutrients|micronutrients|mesh-ancestor
101508216|NCT02953184|Tubulin Modulators|tubulin modulators|mesh-ancestor
101508217|NCT02953184|Antimitotic Agents|antimitotic agents|mesh-ancestor
101508218|NCT02953184|Mitosis Modulators|mitosis modulators|mesh-ancestor
101508219|NCT02953184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101508220|NCT02953184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101508221|NCT02953184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101508222|NCT02953184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101508223|NCT02953184|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101508224|NCT02953184|Protective Agents|protective agents|mesh-ancestor
101508225|NCT00515229|Amitriptyline|amitriptyline|mesh-list
101508226|NCT00515229|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101508227|NCT00515229|Antidepressive Agents|antidepressive agents|mesh-ancestor
101508228|NCT00515229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101508229|NCT00515229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101508230|NCT00515229|Analgesics|analgesics|mesh-ancestor
101508231|NCT00515229|Sensory System Agents|sensory system agents|mesh-ancestor
101508232|NCT00515229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101508233|NCT00515229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508234|NCT00515229|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101508235|NCT00515229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101508236|NCT00515229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101508237|NCT00515229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508238|NCT00515229|Adrenergic Agents|adrenergic agents|mesh-ancestor
101508239|NCT00515229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101508240|NCT00511316|Montelukast|montelukast|mesh-list
101508241|NCT00511316|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101508242|NCT00511316|Respiratory System Agents|respiratory system agents|mesh-ancestor
101508243|NCT00511316|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101508244|NCT00511316|Hormone Antagonists|hormone antagonists|mesh-ancestor
101508245|NCT00511316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101508246|NCT00511316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508247|NCT00511316|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101508248|NCT00511316|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101508249|NCT00511316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508250|NCT00529269|Mycophenolic Acid|mycophenolic acid|mesh-list
101508251|NCT00529269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101508252|NCT00529269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101508253|NCT00529269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101508254|NCT00529269|Antitubercular Agents|antitubercular agents|mesh-ancestor
101508255|NCT00529269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101508256|NCT00529269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101508257|NCT00529269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101508258|NCT00529269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508259|NCT00515268|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
101508260|NCT00515268|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101508261|NCT00515268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101508262|NCT00515268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101508263|NCT00515268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508264|NCT01356966|Folic Acid|folic acid|mesh-list
101508265|NCT01356966|Hematinics|hematinics|mesh-ancestor
101192005|NCT00381732|Tadalafil|tadalafil|mesh-list
101508266|NCT01356966|Vitamin B Complex|vitamin b complex|mesh-ancestor
101508267|NCT01356966|Vitamins|vitamins|mesh-ancestor
101508268|NCT01356966|Micronutrients|micronutrients|mesh-ancestor
101508269|NCT01356966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508270|NCT02944734|Amlodipine|amlodipine|mesh-list
101508271|NCT02944734|Candesartan|candesartan|mesh-list
101508272|NCT02944734|Candesartan cilexetil|candesartan cilexetil|mesh-list
101508273|NCT02944734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101508274|NCT02944734|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101508275|NCT02944734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101508276|NCT02944734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508277|NCT02944734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101508278|NCT02944734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508279|NCT02944734|Vasodilator Agents|vasodilator agents|mesh-ancestor
101508280|NCT02944734|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101508281|NCT02944734|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101508282|NCT00510263|Valacyclovir|valacyclovir|mesh-list
101508283|NCT00510263|Prednisolone|prednisolone|mesh-list
101508284|NCT00510263|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101508285|NCT00510263|Methylprednisolone|methylprednisolone|mesh-list
101508286|NCT00510263|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101508287|NCT00510263|Prednisolone acetate|prednisolone acetate|mesh-list
101508288|NCT00510263|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101508289|NCT00510263|Prednisolone phosphate|prednisolone phosphate|mesh-list
101508290|NCT00510263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101508291|NCT00510263|Glucocorticoids|glucocorticoids|mesh-ancestor
101508292|NCT00510263|Hormones|hormones|mesh-ancestor
101508293|NCT00510263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101508294|NCT00510263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508295|NCT00510263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101508296|NCT00510263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101508297|NCT00510263|Antiemetics|antiemetics|mesh-ancestor
101508298|NCT00510263|Autonomic Agents|autonomic agents|mesh-ancestor
101508299|NCT00510263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101508300|NCT00510263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101508301|NCT00510263|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101508302|NCT00510263|Protective Agents|protective agents|mesh-ancestor
101508303|NCT00510263|Antiviral Agents|antiviral agents|mesh-ancestor
101508304|NCT00510263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101508305|NCT00511628|Risperidone|risperidone|mesh-list
101508306|NCT00511628|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101508307|NCT00511628|Serotonin Agents|serotonin agents|mesh-ancestor
101508308|NCT00511628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101508309|NCT00511628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508310|NCT00511628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508311|NCT00511628|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101508312|NCT00511628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101508313|NCT00511628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101508314|NCT00511628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101508315|NCT00511628|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101508316|NCT00511628|Dopamine Agents|dopamine agents|mesh-ancestor
101508317|NCT00529425|Ropivacaine|ropivacaine|mesh-list
101508318|NCT00529425|Anesthetics, Local|anesthetics, local|mesh-ancestor
101508319|NCT00529425|Anesthetics|anesthetics|mesh-ancestor
101508320|NCT00529425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101508321|NCT00529425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508322|NCT00529425|Sensory System Agents|sensory system agents|mesh-ancestor
101508323|NCT00529425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101508324|NCT02950935|Progesterone|progesterone|mesh-list
101508325|NCT02950935|Progestins|progestins|mesh-ancestor
101508326|NCT02950935|Hormones|hormones|mesh-ancestor
101508327|NCT02950935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101508328|NCT02950935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508329|NCT00529620|Pyrimethamine|pyrimethamine|mesh-list
101508331|NCT00529620|Sulfadoxine|sulfadoxine|mesh-list
101508332|NCT00529620|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101508333|NCT00529620|Amodiaquine|amodiaquine|mesh-list
101508334|NCT00529620|Artenimol|artenimol|mesh-list
101508335|NCT00529620|Sulfalene|sulfalene|mesh-list
101508336|NCT00529620|Antimalarials|antimalarials|mesh-ancestor
101508337|NCT00529620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101508338|NCT00529620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101508339|NCT00529620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101508340|NCT00529620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101508341|NCT00529620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101511603|NCT02917200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101508342|NCT00529620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508343|NCT00529620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101508344|NCT00512993|Zoledronic Acid|zoledronic acid|mesh-list
101508345|NCT00512993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101508346|NCT00512993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508347|NCT00513032|Methylene Blue|methylene blue|mesh-list
101508348|NCT00513032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101508349|NCT00513032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508351|NCT00513110|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101508352|NCT00513110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508353|NCT00513110|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101508354|NCT00513110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101508355|NCT00513110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263852|NCT01764295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508356|NCT00513110|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101508357|NCT00513110|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101508358|NCT00513110|Purinergic Agents|purinergic agents|mesh-ancestor
101508359|NCT00513110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101508360|NCT02951897|Pemetrexed|pemetrexed|mesh-list
101508361|NCT02951897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101508362|NCT02951897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101508363|NCT02951897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508364|NCT02951897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101508365|NCT02951897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101508366|NCT00511823|Rosiglitazone|rosiglitazone|mesh-list
101508367|NCT00511823|Granisetron|granisetron|mesh-list
101508368|NCT00511823|Casopitant|casopitant|mesh-list
101508369|NCT00511823|Dolasetron|dolasetron|mesh-list
101508370|NCT00511823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101508371|NCT00511823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508372|NCT00511823|Antiemetics|antiemetics|mesh-ancestor
101508373|NCT00511823|Autonomic Agents|autonomic agents|mesh-ancestor
101508374|NCT00511823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101508375|NCT00511823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101508376|NCT00511823|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101508377|NCT00511823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101508378|NCT00511823|Serotonin Agents|serotonin agents|mesh-ancestor
101508379|NCT00511823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101508380|NCT00511823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318085|NCT00015028|Buprenorphine|buprenorphine|mesh-list
101508381|NCT00511823|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101508383|NCT00515736|Vitamin E|vitamin e|mesh-list
101508384|NCT00515736|Thiamine|thiamine|mesh-list
101508385|NCT00515736|Zinc|zinc|mesh-list
101508386|NCT00515736|Selenium|selenium|mesh-list
101508387|NCT00515736|Micronutrients|micronutrients|mesh-ancestor
101508388|NCT00515736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508389|NCT00515736|Trace Elements|trace elements|mesh-ancestor
101508390|NCT00515736|Antioxidants|antioxidants|mesh-ancestor
101508391|NCT00515736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508392|NCT00515736|Protective Agents|protective agents|mesh-ancestor
101508393|NCT00515736|Vitamin B Complex|vitamin b complex|mesh-ancestor
101508394|NCT00511940|Acamprosate|acamprosate|mesh-list
101508395|NCT00511940|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101508396|NCT00513149|Clopidogrel|clopidogrel|mesh-list
101508397|NCT00513149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101508398|NCT00513149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101508399|NCT00513149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101508400|NCT00513149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101508401|NCT00513149|Purinergic Agents|purinergic agents|mesh-ancestor
101508402|NCT00513149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101508403|NCT00513149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508404|NCT00513149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508405|NCT02944227|Ranibizumab|ranibizumab|mesh-list
101508406|NCT02944227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101508407|NCT02944227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101508408|NCT02944227|Growth Substances|growth substances|mesh-ancestor
101508409|NCT02944227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508410|NCT02944227|Growth Inhibitors|growth inhibitors|mesh-ancestor
101508411|NCT02944227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101508412|NCT00513188|Leucovorin|leucovorin|mesh-list
101508413|NCT00513188|Cytarabine|cytarabine|mesh-list
101263860|NCT01764451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101263861|NCT01764451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101508414|NCT00513188|Prednisone|prednisone|mesh-list
101508415|NCT00513188|Cyclophosphamide|cyclophosphamide|mesh-list
101508416|NCT00513188|Doxorubicin|doxorubicin|mesh-list
101192152|NCT00385710|Valproic Acid|valproic acid|mesh-list
101508417|NCT00513188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101508418|NCT00513188|Methotrexate|methotrexate|mesh-list
101508419|NCT00513188|Vincristine|vincristine|mesh-list
101508420|NCT00513188|Denileukin diftitox|denileukin diftitox|mesh-list
101508421|NCT00513188|Levoleucovorin|levoleucovorin|mesh-list
101508422|NCT00513188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101508423|NCT00513188|Immunologic Factors|immunologic factors|mesh-ancestor
101508424|NCT00513188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508425|NCT00513188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101508426|NCT00513188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101508427|NCT00513188|Alkylating Agents|alkylating agents|mesh-ancestor
101508428|NCT00513188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508429|NCT00513188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101508430|NCT00513188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101508431|NCT00513188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101508432|NCT00513188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101508433|NCT00513188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101508434|NCT00513188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101508435|NCT00513188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101508436|NCT00513188|Glucocorticoids|glucocorticoids|mesh-ancestor
101508437|NCT00513188|Hormones|hormones|mesh-ancestor
101508438|NCT00513188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101508439|NCT00513188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101508440|NCT00513188|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101508441|NCT00513188|Abortifacient Agents|abortifacient agents|mesh-ancestor
101508442|NCT00513188|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101508443|NCT00513188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101508444|NCT00513188|Antimetabolites|antimetabolites|mesh-ancestor
101508445|NCT00513188|Dermatologic Agents|dermatologic agents|mesh-ancestor
101508446|NCT00513188|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101508447|NCT00513188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101508448|NCT00513188|Antiviral Agents|antiviral agents|mesh-ancestor
101508449|NCT00513188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101508450|NCT00513188|Antidotes|antidotes|mesh-ancestor
101508451|NCT00513188|Protective Agents|protective agents|mesh-ancestor
101508452|NCT00513188|Vitamin B Complex|vitamin b complex|mesh-ancestor
101508454|NCT00513188|Micronutrients|micronutrients|mesh-ancestor
101508455|NCT00513188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101508456|NCT00513188|Tubulin Modulators|tubulin modulators|mesh-ancestor
101508458|NCT00513188|Mitosis Modulators|mitosis modulators|mesh-ancestor
101508459|NCT00513266|Leucovorin|leucovorin|mesh-list
101508460|NCT00513266|Bevacizumab|bevacizumab|mesh-list
101508461|NCT00513266|Cetuximab|cetuximab|mesh-list
101508462|NCT00513266|Fluorouracil|fluorouracil|mesh-list
101508463|NCT00513266|Oxaliplatin|oxaliplatin|mesh-list
101508464|NCT00513266|Irinotecan|irinotecan|mesh-list
101508465|NCT00513266|Calcium|calcium|mesh-list
101508466|NCT00513266|Levoleucovorin|levoleucovorin|mesh-list
101508467|NCT00513266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101508468|NCT00513266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101508469|NCT00513266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101508470|NCT00513266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101508471|NCT00513266|Growth Substances|growth substances|mesh-ancestor
101508472|NCT00513266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508473|NCT00513266|Growth Inhibitors|growth inhibitors|mesh-ancestor
101508474|NCT00513266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101508475|NCT00513266|Antimetabolites|antimetabolites|mesh-ancestor
101508476|NCT00513266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508477|NCT00513266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101508478|NCT00513266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101263878|NCT01763424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508479|NCT00513266|Immunologic Factors|immunologic factors|mesh-ancestor
101508480|NCT00513266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101508481|NCT00513266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101508482|NCT00513266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101508484|NCT00513266|Protective Agents|protective agents|mesh-ancestor
101508485|NCT00513266|Vitamin B Complex|vitamin b complex|mesh-ancestor
101508486|NCT00513266|Vitamins|vitamins|mesh-ancestor
101508487|NCT00513266|Micronutrients|micronutrients|mesh-ancestor
101508488|NCT00513383|Paclitaxel|paclitaxel|mesh-list
101508489|NCT00513383|Docetaxel|docetaxel|mesh-list
101508490|NCT00513383|Carboplatin|carboplatin|mesh-list
101508491|NCT00513383|Fluorouracil|fluorouracil|mesh-list
101508492|NCT00513383|Panitumumab|panitumumab|mesh-list
101508493|NCT00513383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101508494|NCT00513383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101508495|NCT00513383|Tubulin Modulators|tubulin modulators|mesh-ancestor
101508496|NCT00513383|Antimitotic Agents|antimitotic agents|mesh-ancestor
101508497|NCT00513383|Mitosis Modulators|mitosis modulators|mesh-ancestor
101508498|NCT00513383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508499|NCT00513383|Antimetabolites|antimetabolites|mesh-ancestor
101508500|NCT00513383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101508501|NCT00513383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101508502|NCT00513383|Immunologic Factors|immunologic factors|mesh-ancestor
101508503|NCT00513383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508504|NCT00513383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101508505|NCT00515892|Immunotoxin HA22|immunotoxin ha22|mesh-list
101508506|NCT00515892|Antibodies|antibodies|mesh-list
101508507|NCT00515892|Immunoglobulins|immunoglobulins|mesh-list
101508508|NCT00515892|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101508509|NCT00515892|Immunotoxins|immunotoxins|mesh-list
101508510|NCT00515892|Immunologic Factors|immunologic factors|mesh-ancestor
101508511|NCT00515892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508512|NCT00515892|Immunoconjugates|immunoconjugates|mesh-ancestor
101508513|NCT00515892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101508514|NCT00513539|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
101508515|NCT00513539|Trioxsalen|trioxsalen|mesh-list
101508516|NCT00513539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101508517|NCT00513539|Dermatologic Agents|dermatologic agents|mesh-ancestor
101508518|NCT00513539|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101508519|NCT00511979|Insulin|insulin|mesh-list
101508520|NCT00511979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101508521|NCT00511979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101508522|NCT00511979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508523|NCT00513578|Sargramostim|sargramostim|mesh-list
101508524|NCT00513578|Freund's Adjuvant|freund's adjuvant|mesh-list
101508525|NCT00513578|Immunologic Factors|immunologic factors|mesh-ancestor
101508526|NCT00513578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508527|NCT00513578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101508528|NCT00513656|Oxycodone|oxycodone|mesh-list
101508529|NCT00513656|Naloxone|naloxone|mesh-list
101508530|NCT00513656|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101508531|NCT00513656|Narcotics|narcotics|mesh-ancestor
101508532|NCT00513656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101508533|NCT00513656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508534|NCT00513656|Analgesics|analgesics|mesh-ancestor
101508535|NCT00513656|Sensory System Agents|sensory system agents|mesh-ancestor
101508536|NCT00513656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101508537|NCT00513656|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101508539|NCT00530127|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101508540|NCT00530127|Chelating Agents|chelating agents|mesh-ancestor
101508541|NCT00530127|Sequestering Agents|sequestering agents|mesh-ancestor
101508542|NCT00530127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508543|NCT04691934|Anesthetics|anesthetics|mesh-list
101508544|NCT04691934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101508545|NCT04691934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508546|NCT00512057|Allopurinol|allopurinol|mesh-list
101508547|NCT00512057|Antimetabolites|antimetabolites|mesh-ancestor
101508548|NCT00512057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508549|NCT00512057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101508550|NCT00512057|Gout Suppressants|gout suppressants|mesh-ancestor
101508551|NCT00512057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101508552|NCT00512057|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101508553|NCT00512057|Antioxidants|antioxidants|mesh-ancestor
101508554|NCT00512057|Protective Agents|protective agents|mesh-ancestor
101508555|NCT00512057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508556|NCT00513929|Zinc Sulfate|zinc sulfate|mesh-list
101508557|NCT00513929|Astringents|astringents|mesh-ancestor
101508558|NCT00513929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508559|NCT00513929|Dermatologic Agents|dermatologic agents|mesh-ancestor
101508561|NCT00513968|Antiviral Agents|antiviral agents|mesh-ancestor
101508562|NCT00513968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101508563|NCT00513968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101508564|NCT00513968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101508565|NCT00513968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101508566|NCT00513968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508567|NCT03459248|Anesthetics|anesthetics|mesh-list
101508568|NCT03459248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101508569|NCT03459248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508571|NCT00512291|Fluoxetine|fluoxetine|mesh-list
101508572|NCT00512291|Antiemetics|antiemetics|mesh-ancestor
101508573|NCT00512291|Autonomic Agents|autonomic agents|mesh-ancestor
101508574|NCT00512291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101508575|NCT00512291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508576|NCT00512291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101508577|NCT00512291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101508578|NCT00512291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101508579|NCT00512291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101508580|NCT00512291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101508581|NCT00512291|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101508582|NCT00512291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101508583|NCT00512291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101508584|NCT00512291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508585|NCT00512291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101508586|NCT00512291|Serotonin Agents|serotonin agents|mesh-ancestor
101508587|NCT00512291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101508588|NCT00512291|Antidepressive Agents|antidepressive agents|mesh-ancestor
101508589|NCT00512291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101508590|NCT00512291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101508591|NCT00512291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101508592|NCT00514163|Gemcitabine|gemcitabine|mesh-list
101508593|NCT00514163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101508594|NCT00514163|Antimetabolites|antimetabolites|mesh-ancestor
101508595|NCT00514163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508596|NCT00514163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101508597|NCT00514202|Dextroamphetamine|dextroamphetamine|mesh-list
101508598|NCT00514202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101508599|NCT00514202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508600|NCT00514202|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101508601|NCT00514202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101508602|NCT00514202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101508603|NCT00514202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508604|NCT00514202|Dopamine Agents|dopamine agents|mesh-ancestor
101508605|NCT00514202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101508606|NCT00530361|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101508608|NCT00530361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508609|NCT00512408|Testosterone|testosterone|mesh-list
101508610|NCT00512408|Androgens|androgens|mesh-ancestor
101508611|NCT00512408|Hormones|hormones|mesh-ancestor
101508612|NCT00512408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101508613|NCT00512408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508614|NCT00530400|Cefuroxime|cefuroxime|mesh-list
101508615|NCT00530400|Cefuroxime axetil|cefuroxime axetil|mesh-list
101508616|NCT00530400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101508617|NCT00530400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101508618|NCT00531336|Bevacizumab|bevacizumab|mesh-list
101508619|NCT00531336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101508620|NCT00531336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101508621|NCT00531336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101263890|NCT01764555|Sensory System Agents|sensory system agents|mesh-ancestor
101263894|NCT01764581|Tacrolimus|tacrolimus|mesh-list
101508622|NCT00531336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101508623|NCT00531336|Growth Substances|growth substances|mesh-ancestor
101508624|NCT00531336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508625|NCT00531336|Growth Inhibitors|growth inhibitors|mesh-ancestor
101508627|NCT00530478|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101508628|NCT00530478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101508629|NCT00530478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508630|NCT00530478|Cholinergic Agents|cholinergic agents|mesh-ancestor
101318141|NCT00015301|Dopamine Agents|dopamine agents|mesh-ancestor
101508631|NCT00530478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101508632|NCT00530478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508633|NCT00530478|Nootropic Agents|nootropic agents|mesh-ancestor
101508634|NCT00530556|Zolpidem|zolpidem|mesh-list
101508635|NCT00530556|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101508636|NCT00530556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101508637|NCT00530556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101508638|NCT00530556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508639|NCT00530556|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101508640|NCT00530556|GABA Agonists|gaba agonists|mesh-ancestor
101508641|NCT00530556|GABA Agents|gaba agents|mesh-ancestor
101508642|NCT00530556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101508643|NCT00530556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508644|NCT00512486|Benralizumab|benralizumab|mesh-list
101508645|NCT00512486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101508646|NCT00512486|Respiratory System Agents|respiratory system agents|mesh-ancestor
101508647|NCT00530595|Losartan|losartan|mesh-list
101508648|NCT00530595|Valsartan|valsartan|mesh-list
101508649|NCT00530595|Candesartan|candesartan|mesh-list
101508650|NCT00530595|Candesartan cilexetil|candesartan cilexetil|mesh-list
101508651|NCT00530595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101508652|NCT00530595|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101508653|NCT00530595|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101508654|NCT00530595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508655|NCT00530595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101508656|NCT02943759|Chlorhexidine|chlorhexidine|mesh-list
101508657|NCT02943759|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101508658|NCT02943759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101508659|NCT02943759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101508660|NCT02943759|Disinfectants|disinfectants|mesh-ancestor
101508661|NCT02943759|Dermatologic Agents|dermatologic agents|mesh-ancestor
101508662|NCT02944110|Glucagon|glucagon|mesh-list
101508663|NCT02944110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101508664|NCT02944110|Hormones|hormones|mesh-ancestor
101508665|NCT02944110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101508666|NCT02944110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508667|NCT02951975|Dexamethasone|dexamethasone|mesh-list
101508668|NCT02951975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101508669|NCT02951975|Antiemetics|antiemetics|mesh-ancestor
101508670|NCT02951975|Autonomic Agents|autonomic agents|mesh-ancestor
101508671|NCT02951975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101508672|NCT02951975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508673|NCT02951975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101508674|NCT02951975|Glucocorticoids|glucocorticoids|mesh-ancestor
101508675|NCT02951975|Hormones|hormones|mesh-ancestor
101318144|NCT00015340|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101508676|NCT02951975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101508677|NCT02951975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101508678|NCT02951975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101508679|NCT00514397|Temozolomide|temozolomide|mesh-list
101508680|NCT00514397|Motexafin gadolinium|motexafin gadolinium|mesh-list
101508681|NCT00514397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101508682|NCT00514397|Alkylating Agents|alkylating agents|mesh-ancestor
101508683|NCT00514397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508684|NCT00514397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101508685|NCT00514397|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101508686|NCT00514397|Dermatologic Agents|dermatologic agents|mesh-ancestor
101508687|NCT02943603|Pembrolizumab|pembrolizumab|mesh-list
101508688|NCT02943603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101508689|NCT02943603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101508690|NCT02943603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101508691|NCT02943603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508692|NCT00531687|Paclitaxel|paclitaxel|mesh-list
101508693|NCT00531687|Gemcitabine|gemcitabine|mesh-list
101508694|NCT00531687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101508695|NCT00531687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101508696|NCT00531687|Tubulin Modulators|tubulin modulators|mesh-ancestor
101508697|NCT00531687|Antimitotic Agents|antimitotic agents|mesh-ancestor
101508698|NCT00531687|Mitosis Modulators|mitosis modulators|mesh-ancestor
101508699|NCT00531687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508700|NCT00531687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101508701|NCT00531687|Antimetabolites|antimetabolites|mesh-ancestor
101508702|NCT00514475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101508703|NCT00514475|Immunologic Factors|immunologic factors|mesh-ancestor
101508704|NCT00514475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508705|NCT00512681|Oxaliplatin|oxaliplatin|mesh-list
101508706|NCT00512681|Irinotecan|irinotecan|mesh-list
101508707|NCT00512681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101508708|NCT00512681|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101508709|NCT00512681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101508710|NCT00512681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101508711|NCT00512681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508712|NCT00530868|Bevacizumab|bevacizumab|mesh-list
101508713|NCT00530868|Letrozole|letrozole|mesh-list
101508714|NCT00530868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101508715|NCT00530868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101508716|NCT00530868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101508717|NCT00530868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101508718|NCT00530868|Growth Substances|growth substances|mesh-ancestor
101508719|NCT00530868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508720|NCT00530868|Growth Inhibitors|growth inhibitors|mesh-ancestor
101508721|NCT00530868|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101508722|NCT00530868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101508723|NCT00530868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101508724|NCT00530868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508725|NCT00530868|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101508726|NCT00530868|Hormone Antagonists|hormone antagonists|mesh-ancestor
101508727|NCT00530868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101508729|NCT00530907|Valproic Acid|valproic acid|mesh-list
101508730|NCT00530907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101508731|NCT00530907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101508732|NCT00530907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101508733|NCT00530907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101508734|NCT00530907|Growth Substances|growth substances|mesh-ancestor
101508735|NCT00530907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508736|NCT00530907|Growth Inhibitors|growth inhibitors|mesh-ancestor
101508737|NCT00530907|Anticonvulsants|anticonvulsants|mesh-ancestor
101508738|NCT00530907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101508739|NCT00530907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508740|NCT00530907|GABA Agents|gaba agents|mesh-ancestor
101508741|NCT00530907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101508742|NCT00530907|Antimanic Agents|antimanic agents|mesh-ancestor
101508743|NCT00530907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101508744|NCT00530907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101508745|NCT00530907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101508746|NCT00531024|Bevacizumab|bevacizumab|mesh-list
101508747|NCT00531024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101508748|NCT00531024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101508749|NCT00531024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101508750|NCT00531024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101508751|NCT00531024|Growth Substances|growth substances|mesh-ancestor
101263903|NCT01764672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508752|NCT00531024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508753|NCT00531024|Growth Inhibitors|growth inhibitors|mesh-ancestor
101508754|NCT00512759|Nitroglycerin|nitroglycerin|mesh-list
101508755|NCT00512759|Vasodilator Agents|vasodilator agents|mesh-ancestor
101508756|NCT00514670|Hand Sanitizers|hand sanitizers|mesh-list
101508757|NCT00514670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101508758|NCT00514670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101508759|NCT00514670|Disinfectants|disinfectants|mesh-ancestor
101508760|NCT00531063|Everolimus|everolimus|mesh-list
101508761|NCT00531063|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101508762|NCT00531063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101508763|NCT00531063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101508764|NCT00531063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508765|NCT00531063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101508766|NCT00531063|Immunologic Factors|immunologic factors|mesh-ancestor
101508767|NCT00531063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508768|NCT00531063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101508770|NCT02943798|Etoposide|etoposide|mesh-list
101508771|NCT02943798|Carboplatin|carboplatin|mesh-list
101508772|NCT02943798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101508773|NCT02943798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101508774|NCT02943798|Tubulin Modulators|tubulin modulators|mesh-ancestor
101508775|NCT02943798|Antimitotic Agents|antimitotic agents|mesh-ancestor
101508776|NCT02943798|Mitosis Modulators|mitosis modulators|mesh-ancestor
101508777|NCT02943798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508778|NCT02943798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101508779|NCT02943798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101508780|NCT02943798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101508781|NCT02943369|Ticagrelor|ticagrelor|mesh-list
101508782|NCT02943369|Cangrelor|cangrelor|mesh-list
101508783|NCT02943369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101508784|NCT02943369|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101508785|NCT02943369|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101508786|NCT02943369|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101508788|NCT02943369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101508789|NCT02943369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508790|NCT02943369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508791|NCT00514748|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
101508792|NCT00514748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101508793|NCT00514748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101508794|NCT00514748|Analgesics|analgesics|mesh-ancestor
101508795|NCT00514748|Sensory System Agents|sensory system agents|mesh-ancestor
101508796|NCT00514748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101508797|NCT00514748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508798|NCT00514748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101508799|NCT00514748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101508800|NCT00515957|Antibodies|antibodies|mesh-list
101508801|NCT00515957|Immunologic Factors|immunologic factors|mesh-ancestor
101508802|NCT00515957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508803|NCT02943642|Vorinostat|vorinostat|mesh-list
101508804|NCT02943642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101508805|NCT02943642|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101508806|NCT02943642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101508807|NCT02943642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508808|NCT04695509|Propofol|propofol|mesh-list
101508809|NCT04695509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101508810|NCT04695509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101508811|NCT04695509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508812|NCT04695509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101508813|NCT04695509|Anesthetics, General|anesthetics, general|mesh-ancestor
101508814|NCT04695509|Anesthetics|anesthetics|mesh-ancestor
101508815|NCT02943135|Lidocaine|lidocaine|mesh-list
101508816|NCT02943135|Anesthetics, Local|anesthetics, local|mesh-ancestor
101508817|NCT02943135|Anesthetics|anesthetics|mesh-ancestor
101508818|NCT02943135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101508819|NCT02943135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508820|NCT02943135|Sensory System Agents|sensory system agents|mesh-ancestor
101508821|NCT02943135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101508822|NCT02943135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101508823|NCT02943135|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101263910|NCT01764750|Vancomycin|vancomycin|mesh-list
101508825|NCT02943135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101508826|NCT02943135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508827|NCT02951234|Aspirin|aspirin|mesh-list
101508828|NCT02951234|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101508829|NCT02951234|gamma-Globulins|gamma-globulins|mesh-list
101508830|NCT02951234|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101508831|NCT02951234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101508832|NCT02951234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101508833|NCT02951234|Analgesics|analgesics|mesh-ancestor
101508834|NCT02951234|Sensory System Agents|sensory system agents|mesh-ancestor
101508835|NCT02951234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101508836|NCT02951234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508837|NCT02951234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101508838|NCT02951234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101508839|NCT02951234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101508840|NCT02951234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101508841|NCT02951234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508842|NCT02951234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101508843|NCT02951234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101508844|NCT02951234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101508845|NCT02951234|Antipyretics|antipyretics|mesh-ancestor
101508846|NCT02951234|Immunologic Factors|immunologic factors|mesh-ancestor
101508847|NCT02943252|Apatinib|apatinib|mesh-list
101508848|NCT02943252|Tegafur|tegafur|mesh-list
101508849|NCT02943252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101508850|NCT02943252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101508851|NCT02943252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101508852|NCT02943252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508853|NCT02943252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101508854|NCT02943252|Antimetabolites|antimetabolites|mesh-ancestor
101508855|NCT00514982|Adalimumab|adalimumab|mesh-list
101508856|NCT00514982|Infliximab|infliximab|mesh-list
101508857|NCT00514982|Mesalamine|mesalamine|mesh-list
101508858|NCT00514982|Mercaptopurine|mercaptopurine|mesh-list
101508859|NCT00514982|Tacrolimus|tacrolimus|mesh-list
101508860|NCT00514982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101508861|NCT00514982|Immunologic Factors|immunologic factors|mesh-ancestor
101508862|NCT00514982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508863|NCT00514982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101508864|NCT00514982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101508865|NCT00514982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508866|NCT00514982|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101508867|NCT00514982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101508868|NCT00514982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101508869|NCT00514982|Dermatologic Agents|dermatologic agents|mesh-ancestor
101192618|NCT01273506|Tapentadol|tapentadol|mesh-list
101508870|NCT00514982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101508871|NCT00514982|Antimetabolites|antimetabolites|mesh-ancestor
101508872|NCT00514982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101508873|NCT00514982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101508874|NCT00514982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101508875|NCT00514982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101508876|NCT00514982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101508877|NCT00514982|Analgesics|analgesics|mesh-ancestor
101508878|NCT00514982|Sensory System Agents|sensory system agents|mesh-ancestor
101508879|NCT00514982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101508880|NCT00531999|Ritonavir|ritonavir|mesh-list
101508881|NCT00531999|Lopinavir|lopinavir|mesh-list
101508882|NCT00531999|Raltegravir Potassium|raltegravir potassium|mesh-list
101508883|NCT00531999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101508884|NCT00531999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101508885|NCT00531999|Protease Inhibitors|protease inhibitors|mesh-ancestor
101508886|NCT00531999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101508887|NCT00531999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508888|NCT00531999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101508889|NCT00531999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101508890|NCT00531999|Antiviral Agents|antiviral agents|mesh-ancestor
101508891|NCT00531999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101508892|NCT00531999|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101508893|NCT00531999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101508894|NCT00531999|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101508895|NCT00531999|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101508896|NCT05319912|Molybdenum|molybdenum|mesh-list
101508897|NCT05319912|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
101508898|NCT05319912|Choline|choline|mesh-list
101508899|NCT05319912|Omeprazole|omeprazole|mesh-list
101508900|NCT05319912|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101508901|NCT05319912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101508902|NCT05319912|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101508903|NCT05319912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101318242|NCT00016042|Interferons|interferons|mesh-list
101508904|NCT05319912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508905|NCT05319912|Lipotropic Agents|lipotropic agents|mesh-ancestor
101508906|NCT05319912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101508907|NCT05319912|Antimetabolites|antimetabolites|mesh-ancestor
101508908|NCT05319912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101508909|NCT05319912|Nootropic Agents|nootropic agents|mesh-ancestor
101508910|NCT05319912|Chelating Agents|chelating agents|mesh-ancestor
101508911|NCT05319912|Sequestering Agents|sequestering agents|mesh-ancestor
101508912|NCT05319912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101508913|NCT05319912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101508914|NCT05319912|Growth Substances|growth substances|mesh-ancestor
101508915|NCT05319912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508916|NCT05319912|Growth Inhibitors|growth inhibitors|mesh-ancestor
101508917|NCT05319912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101508918|NCT05319912|Trace Elements|trace elements|mesh-ancestor
101508919|NCT05319912|Micronutrients|micronutrients|mesh-ancestor
101508920|NCT00515138|Rituximab|rituximab|mesh-list
101508921|NCT00515138|Carboplatin|carboplatin|mesh-list
101508922|NCT00515138|Etoposide|etoposide|mesh-list
101508923|NCT00515138|Bortezomib|bortezomib|mesh-list
101508924|NCT00515138|Ifosfamide|ifosfamide|mesh-list
101508925|NCT00515138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101508926|NCT00515138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101508927|NCT00515138|Immunologic Factors|immunologic factors|mesh-ancestor
101508928|NCT00515138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508929|NCT00515138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101508930|NCT00515138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101508931|NCT00515138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101508932|NCT00515138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101508933|NCT00515138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101508934|NCT00515138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508935|NCT00515138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101508936|NCT00515138|Alkylating Agents|alkylating agents|mesh-ancestor
101508937|NCT05319834|Aspirin|aspirin|mesh-list
101508938|NCT05319834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101508939|NCT05319834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101508940|NCT05319834|Analgesics|analgesics|mesh-ancestor
101508941|NCT05319834|Sensory System Agents|sensory system agents|mesh-ancestor
101508942|NCT05319834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101508943|NCT05319834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508944|NCT05319834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101508945|NCT05319834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101508946|NCT05319834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101508947|NCT05319834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101508948|NCT05319834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508949|NCT05319834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101508950|NCT05319834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101508951|NCT05319834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101508952|NCT05319834|Antipyretics|antipyretics|mesh-ancestor
101508953|NCT00515255|Minocycline|minocycline|mesh-list
101508955|NCT00515255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101508956|NCT00516113|Paroxetine|paroxetine|mesh-list
101508957|NCT00516113|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101508958|NCT00516113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101508959|NCT00516113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101508960|NCT00516113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508961|NCT00516113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101508962|NCT00516113|Serotonin Agents|serotonin agents|mesh-ancestor
101508963|NCT00516113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263915|NCT01764828|Antimetabolites|antimetabolites|mesh-ancestor
101508964|NCT00516113|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101508965|NCT00516113|Antidepressive Agents|antidepressive agents|mesh-ancestor
101508966|NCT00516113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101508967|NCT00516113|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101508968|NCT00516113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101508969|NCT00516113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101508970|NCT04695197|Artesunate|artesunate|mesh-list
101508971|NCT04695197|Lumefantrine|lumefantrine|mesh-list
101508972|NCT04695197|Artemether|artemether|mesh-list
101508973|NCT04695197|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101508974|NCT04695197|Pyronaridine|pyronaridine|mesh-list
101508975|NCT04695197|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
101508976|NCT04695197|Antimalarials|antimalarials|mesh-ancestor
101508977|NCT04695197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101508978|NCT04695197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101508979|NCT04695197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101508980|NCT04695197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101508981|NCT04695197|Antiviral Agents|antiviral agents|mesh-ancestor
101508982|NCT04695197|Schistosomicides|schistosomicides|mesh-ancestor
101508983|NCT04695197|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101508984|NCT04695197|Anthelmintics|anthelmintics|mesh-ancestor
101508985|NCT00516152|Methotrexate|methotrexate|mesh-list
101508986|NCT00516152|Fludarabine phosphate|fludarabine phosphate|mesh-list
101508987|NCT00516152|Fludarabine|fludarabine|mesh-list
101508988|NCT00516152|Busulfan|busulfan|mesh-list
101508990|NCT00516152|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101508991|NCT00516152|Abortifacient Agents|abortifacient agents|mesh-ancestor
101508992|NCT00516152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101508993|NCT00516152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101508994|NCT00516152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101508995|NCT00516152|Antimetabolites|antimetabolites|mesh-ancestor
101508996|NCT00516152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101508997|NCT00516152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101508998|NCT00516152|Dermatologic Agents|dermatologic agents|mesh-ancestor
101508999|NCT00516152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101509000|NCT00516152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101509001|NCT00516152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101509002|NCT00516152|Immunologic Factors|immunologic factors|mesh-ancestor
101509003|NCT00516152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101509004|NCT00516152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101509005|NCT00516152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101509006|NCT00516152|Alkylating Agents|alkylating agents|mesh-ancestor
101509007|NCT00516152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101509008|NCT00516152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101509009|NCT00516191|Doxorubicin|doxorubicin|mesh-list
101509010|NCT00516191|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101509011|NCT00516191|Bortezomib|bortezomib|mesh-list
101509012|NCT00516191|Melphalan|melphalan|mesh-list
101509013|NCT00516191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101509014|NCT00516191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101509015|NCT00516191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101509016|NCT00516191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101509017|NCT00516191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101509018|NCT00516191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509019|NCT00516191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101509020|NCT00516191|Alkylating Agents|alkylating agents|mesh-ancestor
101509021|NCT00516191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101509022|NCT00516191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101509023|NCT00516191|Immunologic Factors|immunologic factors|mesh-ancestor
101509024|NCT00516191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509025|NCT00515450|Immunoglobulins|immunoglobulins|mesh-list
101509026|NCT00515450|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101509028|NCT00515450|gamma-Globulins|gamma-globulins|mesh-list
101509029|NCT00515450|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101509030|NCT00515450|Immunologic Factors|immunologic factors|mesh-ancestor
101509031|NCT00515450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509032|NCT00515489|Risperidone|risperidone|mesh-list
101509033|NCT00515489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101263922|NCT01764867|Trazodone|trazodone|mesh-list
101509034|NCT00515489|Serotonin Agents|serotonin agents|mesh-ancestor
101509035|NCT00515489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101509036|NCT00515489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509037|NCT00515489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509039|NCT00515489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101509040|NCT00515489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101509041|NCT00515489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101509042|NCT00515489|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101509043|NCT00515489|Dopamine Agents|dopamine agents|mesh-ancestor
101509044|NCT02941575|Methamphetamine|methamphetamine|mesh-list
101509045|NCT02941575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101509046|NCT02941575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509047|NCT02941575|Sympathomimetics|sympathomimetics|mesh-ancestor
101509048|NCT02941575|Autonomic Agents|autonomic agents|mesh-ancestor
101509049|NCT02941575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101509050|NCT02941575|Dopamine Agents|dopamine agents|mesh-ancestor
101509051|NCT02941575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101509052|NCT02941575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509053|NCT02941575|Adrenergic Agents|adrenergic agents|mesh-ancestor
101509054|NCT02941575|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101509055|NCT02941575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101509056|NCT02941575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101509057|NCT02941575|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101509059|NCT02941731|Antiviral Agents|antiviral agents|mesh-ancestor
101509060|NCT02941731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101509061|NCT02941731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101509062|NCT02941731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509064|NCT02951039|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101509065|NCT02951039|Antithrombins|antithrombins|mesh-ancestor
101509066|NCT02951039|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101509067|NCT02951039|Protease Inhibitors|protease inhibitors|mesh-ancestor
101509068|NCT02951039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101509069|NCT02951039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509070|NCT02951039|Anticoagulants|anticoagulants|mesh-ancestor
101509071|NCT02951117|Dexamethasone|dexamethasone|mesh-list
101509072|NCT02951117|Venetoclax|venetoclax|mesh-list
101509073|NCT02951117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101509074|NCT02951117|Antiemetics|antiemetics|mesh-ancestor
101509075|NCT02951117|Autonomic Agents|autonomic agents|mesh-ancestor
101509076|NCT02951117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101509077|NCT02951117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509078|NCT02951117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101509079|NCT02951117|Glucocorticoids|glucocorticoids|mesh-ancestor
101509080|NCT02951117|Hormones|hormones|mesh-ancestor
101509081|NCT02951117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101509082|NCT02951117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101509083|NCT02951117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101509084|NCT02950220|Pembrolizumab|pembrolizumab|mesh-list
101509085|NCT02950220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101509086|NCT02950220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101509087|NCT02950220|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101509088|NCT02950220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509089|NCT00515684|Bevacizumab|bevacizumab|mesh-list
101509090|NCT00515684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101509091|NCT00515684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101509092|NCT00515684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101509093|NCT00515684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101509094|NCT00515684|Growth Substances|growth substances|mesh-ancestor
101509095|NCT00515684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192833|NCT01274988|Analgesics|analgesics|mesh-ancestor
101509096|NCT00515684|Growth Inhibitors|growth inhibitors|mesh-ancestor
101509098|NCT05317767|Immunologic Factors|immunologic factors|mesh-ancestor
101509099|NCT05317767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509100|NCT00515801|Glyburide|glyburide|mesh-list
101509101|NCT00515801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101509102|NCT00515801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509103|NCT05317611|Ondansetron|ondansetron|mesh-list
101509104|NCT05317611|Bupivacaine|bupivacaine|mesh-list
101509105|NCT05317611|Anesthetics, Local|anesthetics, local|mesh-ancestor
101509106|NCT05317611|Anesthetics|anesthetics|mesh-ancestor
101509107|NCT05317611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101509108|NCT05317611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509109|NCT05317611|Sensory System Agents|sensory system agents|mesh-ancestor
101509110|NCT05317611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101509111|NCT05317611|Antiemetics|antiemetics|mesh-ancestor
101509112|NCT05317611|Autonomic Agents|autonomic agents|mesh-ancestor
101509113|NCT05317611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101509114|NCT05317611|Antipruritics|antipruritics|mesh-ancestor
101509115|NCT05317611|Dermatologic Agents|dermatologic agents|mesh-ancestor
101509116|NCT05317611|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101509117|NCT05317611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101509118|NCT05317611|Serotonin Agents|serotonin agents|mesh-ancestor
101509119|NCT05317611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101509120|NCT05317611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509121|NCT05317572|Morphine|morphine|mesh-list
101509122|NCT05317572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101509123|NCT05317572|Narcotics|narcotics|mesh-ancestor
101509124|NCT05317572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101509125|NCT05317572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509126|NCT05317572|Analgesics|analgesics|mesh-ancestor
101509127|NCT05317572|Sensory System Agents|sensory system agents|mesh-ancestor
101509128|NCT05317572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101509129|NCT00516425|Cyclophosphamide|cyclophosphamide|mesh-list
101509130|NCT00516425|Doxorubicin|doxorubicin|mesh-list
101509131|NCT00516425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101509132|NCT00516425|Epirubicin|epirubicin|mesh-list
101509133|NCT00516425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101509134|NCT00516425|Immunologic Factors|immunologic factors|mesh-ancestor
101509135|NCT00516425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509136|NCT00516425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101509137|NCT00516425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101509138|NCT00516425|Alkylating Agents|alkylating agents|mesh-ancestor
101509139|NCT00516425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509140|NCT00516425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101509141|NCT00516425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101509142|NCT00516425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101509143|NCT00516425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101509144|NCT00516425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101509145|NCT00516425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101509146|NCT02942706|Cetuximab|cetuximab|mesh-list
101509147|NCT02942706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101509148|NCT02942706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101509149|NCT00516464|Ranibizumab|ranibizumab|mesh-list
101509150|NCT00516464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101509151|NCT00516464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101509152|NCT00516464|Growth Substances|growth substances|mesh-ancestor
101509153|NCT00516464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509154|NCT00516464|Growth Inhibitors|growth inhibitors|mesh-ancestor
101509155|NCT00516464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101509156|NCT00516542|Letrozole|letrozole|mesh-list
101509157|NCT00516542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101509158|NCT00516542|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101509159|NCT00516542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101509160|NCT00516542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101509161|NCT00516542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509162|NCT00516542|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101509163|NCT00516542|Hormone Antagonists|hormone antagonists|mesh-ancestor
101509164|NCT00516542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101509165|NCT00516542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509166|NCT03458481|Sofosbuvir|sofosbuvir|mesh-list
101509167|NCT03458481|Yimitasvir|yimitasvir|mesh-list
101509168|NCT03458481|Antiviral Agents|antiviral agents|mesh-ancestor
101509169|NCT03458481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101509170|NCT02949752|Aripiprazole|aripiprazole|mesh-list
101509171|NCT02949752|Antidepressive Agents|antidepressive agents|mesh-ancestor
101509172|NCT02949752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101509173|NCT02949752|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101509174|NCT02949752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101509175|NCT02949752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101509176|NCT02949752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509177|NCT02949752|Dopamine Agonists|dopamine agonists|mesh-ancestor
101509178|NCT02949752|Dopamine Agents|dopamine agents|mesh-ancestor
101509179|NCT02949752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101318270|NCT00016159|Keratolytic Agents|keratolytic agents|mesh-ancestor
101509180|NCT02949752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509181|NCT02949752|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101509182|NCT02949752|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101509183|NCT02949752|Serotonin Agents|serotonin agents|mesh-ancestor
101509184|NCT02949752|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101509185|NCT02949752|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101509186|NCT02949752|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101509187|NCT02949752|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101509188|NCT02942550|Bromides|bromides|mesh-list
101509189|NCT02942550|Methylnaltrexone|methylnaltrexone|mesh-list
101509190|NCT02942550|Anticonvulsants|anticonvulsants|mesh-ancestor
101509191|NCT02942550|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101509192|NCT02942550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509193|NCT02942550|Sensory System Agents|sensory system agents|mesh-ancestor
101509194|NCT02942550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101509195|NCT04694612|Remdesivir|remdesivir|mesh-list
101509196|NCT04694612|Favipiravir|favipiravir|mesh-list
101509197|NCT04694612|Antimetabolites|antimetabolites|mesh-ancestor
101509198|NCT04694612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509199|NCT04694612|Antiviral Agents|antiviral agents|mesh-ancestor
101509200|NCT04694612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101509201|NCT02941224|Sirolimus|sirolimus|mesh-list
101509202|NCT02941224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101509203|NCT02941224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101509204|NCT02941224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101509205|NCT02941224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101509206|NCT02941224|Antifungal Agents|antifungal agents|mesh-ancestor
101509207|NCT02941224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101509208|NCT02941224|Immunologic Factors|immunologic factors|mesh-ancestor
101509209|NCT02941224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509210|NCT00516854|Chlordiazepoxide|chlordiazepoxide|mesh-list
101509211|NCT00516854|Clidinium|clidinium|mesh-list
101509212|NCT00516854|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101509213|NCT00516854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101509214|NCT00516854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101509215|NCT00516854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509216|NCT00516854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101509217|NCT00516854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101509218|NCT00516854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101509219|NCT00516854|GABA Modulators|gaba modulators|mesh-ancestor
101509220|NCT00516854|GABA Agents|gaba agents|mesh-ancestor
101509221|NCT00516854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101509222|NCT00516854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509223|NCT00516854|Parasympatholytics|parasympatholytics|mesh-ancestor
101509224|NCT00516854|Autonomic Agents|autonomic agents|mesh-ancestor
101509225|NCT00516854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101509226|NCT02940990|Paclitaxel|paclitaxel|mesh-list
101509227|NCT02940990|Etoposide|etoposide|mesh-list
101509228|NCT02940990|Vinorelbine|vinorelbine|mesh-list
101509229|NCT02940990|Docetaxel|docetaxel|mesh-list
101509230|NCT02940990|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101509231|NCT02940990|Carboplatin|carboplatin|mesh-list
101509232|NCT02940990|Gemcitabine|gemcitabine|mesh-list
101509233|NCT02940990|Pemetrexed|pemetrexed|mesh-list
101509234|NCT02940990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101318273|NCT00016198|Leucovorin|leucovorin|mesh-list
101509235|NCT02940990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101509236|NCT02940990|Tubulin Modulators|tubulin modulators|mesh-ancestor
101509237|NCT02940990|Antimitotic Agents|antimitotic agents|mesh-ancestor
101509238|NCT02940990|Mitosis Modulators|mitosis modulators|mesh-ancestor
101509239|NCT02940990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509240|NCT02940990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101509242|NCT02940990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101509243|NCT02940990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101192979|NCT03804372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101509244|NCT02940990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101509245|NCT02940990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101509246|NCT02940990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101509247|NCT00518297|Raltegravir Potassium|raltegravir potassium|mesh-list
101509248|NCT00518297|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101509249|NCT00518297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101509250|NCT00518297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101509251|NCT00518297|Antiviral Agents|antiviral agents|mesh-ancestor
101509252|NCT00518297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101509253|NCT00518297|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101509254|NCT00518297|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101509255|NCT00518297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101509256|NCT00518297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509257|NCT00518297|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101509258|NCT00518297|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101509259|NCT00518297|Protease Inhibitors|protease inhibitors|mesh-ancestor
101509260|NCT00518375|Cyclosporine|cyclosporine|mesh-list
101509261|NCT00518375|Sirolimus|sirolimus|mesh-list
101509262|NCT00518375|Cyclosporins|cyclosporins|mesh-list
101509263|NCT00518375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101509264|NCT00518375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509265|NCT00518375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101509266|NCT00518375|Immunologic Factors|immunologic factors|mesh-ancestor
101509267|NCT00518375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509268|NCT00518375|Antifungal Agents|antifungal agents|mesh-ancestor
101509269|NCT00518375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101509270|NCT00518375|Dermatologic Agents|dermatologic agents|mesh-ancestor
101509271|NCT00518375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101509272|NCT00518375|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101509273|NCT00518375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101509274|NCT00518375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101509275|NCT00518375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101509276|NCT02942043|Bevacizumab|bevacizumab|mesh-list
101509277|NCT02942043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101509278|NCT02942043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101509279|NCT02942043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101509280|NCT02942043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101509281|NCT02942043|Growth Substances|growth substances|mesh-ancestor
101509282|NCT02942043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509283|NCT02942043|Growth Inhibitors|growth inhibitors|mesh-ancestor
101509284|NCT00516971|Esomeprazole|esomeprazole|mesh-list
101509285|NCT00516971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101509286|NCT00516971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101509287|NCT00516971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101509288|NCT00516971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101509289|NCT00516971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509290|NCT00518570|Levetiracetam|levetiracetam|mesh-list
101509291|NCT00518570|Anticonvulsants|anticonvulsants|mesh-ancestor
101509292|NCT00518570|Nootropic Agents|nootropic agents|mesh-ancestor
101509293|NCT03458208|Metformin|metformin|mesh-list
101509294|NCT03458208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101509295|NCT03458208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509296|NCT00517283|Exenatide|exenatide|mesh-list
101509297|NCT00517283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101509298|NCT00517283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509299|NCT00517283|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101509300|NCT00517283|Incretins|incretins|mesh-ancestor
101509301|NCT00517283|Hormones|hormones|mesh-ancestor
101509302|NCT00517283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101509303|NCT02940912|Apomorphine|apomorphine|mesh-list
101509304|NCT02940912|Emetics|emetics|mesh-ancestor
101509305|NCT02940912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509306|NCT02940912|Autonomic Agents|autonomic agents|mesh-ancestor
101509307|NCT02940912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101509308|NCT02940912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101509309|NCT02940912|Dopamine Agonists|dopamine agonists|mesh-ancestor
101509310|NCT02940912|Dopamine Agents|dopamine agents|mesh-ancestor
101509311|NCT02940912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101509312|NCT02940912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509313|NCT00517322|Ramipril|ramipril|mesh-list
101509314|NCT00517322|Irbesartan|irbesartan|mesh-list
101509315|NCT00517322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101509316|NCT00517322|Protease Inhibitors|protease inhibitors|mesh-ancestor
101509317|NCT00517322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101509318|NCT00517322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509319|NCT00517322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101509320|NCT00517322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101509321|NCT00517322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101509322|NCT02939430|Atropine|atropine|mesh-list
101509323|NCT02939430|Neostigmine|neostigmine|mesh-list
101509324|NCT02939430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101509325|NCT02939430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101509326|NCT02939430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101509327|NCT02939430|Autonomic Agents|autonomic agents|mesh-ancestor
101509328|NCT02939430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101509329|NCT02939430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509330|NCT02939430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101509331|NCT02939430|Respiratory System Agents|respiratory system agents|mesh-ancestor
101509332|NCT02939430|Mydriatics|mydriatics|mesh-ancestor
101509333|NCT02939430|Parasympatholytics|parasympatholytics|mesh-ancestor
101509334|NCT02939430|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101509335|NCT02939430|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101509336|NCT02939430|Cholinergic Agents|cholinergic agents|mesh-ancestor
101509337|NCT02939430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101509338|NCT02939430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509339|NCT02939430|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101509340|NCT02939430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101509341|NCT02939430|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101509342|NCT02940717|Lithium Carbonate|lithium carbonate|mesh-list
101509343|NCT02940717|Antidepressive Agents|antidepressive agents|mesh-ancestor
101509344|NCT02940717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101509345|NCT02940717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101509346|NCT02940717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509347|NCT02940717|Antimanic Agents|antimanic agents|mesh-ancestor
101509348|NCT02940717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101509349|NCT02940717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101509350|NCT02940717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509351|NCT00517517|Hemagglutinins|hemagglutinins|mesh-list
101509352|NCT00517517|Agglutinins|agglutinins|mesh-ancestor
101509353|NCT00517517|Immunologic Factors|immunologic factors|mesh-ancestor
101509354|NCT00517517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509355|NCT00517517|Coagulants|coagulants|mesh-ancestor
101509356|NCT02940756|Artesunate|artesunate|mesh-list
101509357|NCT02940756|Lumefantrine|lumefantrine|mesh-list
101509358|NCT02940756|Artemether|artemether|mesh-list
101509359|NCT02940756|Piperaquine|piperaquine|mesh-list
101509360|NCT02940756|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101509361|NCT02940756|Amodiaquine|amodiaquine|mesh-list
101509362|NCT02940756|Artenimol|artenimol|mesh-list
101509363|NCT02940756|Antimalarials|antimalarials|mesh-ancestor
101509364|NCT02940756|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101509365|NCT02940756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101509366|NCT02940756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101509367|NCT02940756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101509368|NCT02940756|Antiviral Agents|antiviral agents|mesh-ancestor
101509369|NCT02940756|Schistosomicides|schistosomicides|mesh-ancestor
101509370|NCT02940756|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101509371|NCT02940756|Anthelmintics|anthelmintics|mesh-ancestor
101509372|NCT02939547|Betadex|betadex|mesh-list
101509373|NCT02939547|Sequestering Agents|sequestering agents|mesh-ancestor
101509374|NCT02939547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509375|NCT02941068|Fluconazole|fluconazole|mesh-list
101509376|NCT02941068|Caspofungin|caspofungin|mesh-list
101509377|NCT02941068|Antifungal Agents|antifungal agents|mesh-ancestor
101509378|NCT02941068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101509379|NCT02941068|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101509380|NCT02941068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101509382|NCT02941068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509383|NCT02941068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101509384|NCT02941068|Hormone Antagonists|hormone antagonists|mesh-ancestor
101509385|NCT02941068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101509386|NCT02941068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509387|NCT02941068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101509388|NCT02941068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101509389|NCT00517712|Arsenic Trioxide|arsenic trioxide|mesh-list
101509390|NCT00517712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101509391|NCT02939274|Verteporfin|verteporfin|mesh-list
101509392|NCT02939274|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101509393|NCT02939274|Dermatologic Agents|dermatologic agents|mesh-ancestor
101509394|NCT04694183|Paclitaxel|paclitaxel|mesh-list
101509395|NCT04694183|Antibodies|antibodies|mesh-list
101509396|NCT04694183|Immunoglobulins|immunoglobulins|mesh-list
101509397|NCT04694183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101509398|NCT04694183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101509399|NCT04694183|Tubulin Modulators|tubulin modulators|mesh-ancestor
101509400|NCT04694183|Antimitotic Agents|antimitotic agents|mesh-ancestor
101509401|NCT04694183|Mitosis Modulators|mitosis modulators|mesh-ancestor
101511604|NCT02917200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101509402|NCT04694183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509403|NCT04694183|Immunologic Factors|immunologic factors|mesh-ancestor
101509404|NCT04694183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509405|NCT00517946|Cetirizine|cetirizine|mesh-list
101509406|NCT00517946|Pseudoephedrine|pseudoephedrine|mesh-list
101509407|NCT00517946|Ephedrine|ephedrine|mesh-list
101509408|NCT00517946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101509409|NCT00517946|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101509410|NCT00517946|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101509411|NCT00517946|Histamine Antagonists|histamine antagonists|mesh-ancestor
101509412|NCT00517946|Histamine Agents|histamine agents|mesh-ancestor
101509413|NCT00517946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101509414|NCT00517946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263999|NCT01765023|Antimetabolites|antimetabolites|mesh-ancestor
101509415|NCT00517946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509416|NCT00517946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101509418|NCT00517946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101509419|NCT00517946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101509420|NCT00517946|Respiratory System Agents|respiratory system agents|mesh-ancestor
101509421|NCT00517946|Nasal Decongestants|nasal decongestants|mesh-ancestor
101509422|NCT00517946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101509423|NCT00517946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101509424|NCT00517946|Sympathomimetics|sympathomimetics|mesh-ancestor
101509425|NCT00517946|Adrenergic Agents|adrenergic agents|mesh-ancestor
101509426|NCT04988685|Sirolimus|sirolimus|mesh-list
101509427|NCT04988685|Paclitaxel|paclitaxel|mesh-list
101509428|NCT04988685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101509429|NCT04988685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101509430|NCT04988685|Tubulin Modulators|tubulin modulators|mesh-ancestor
101509431|NCT04988685|Antimitotic Agents|antimitotic agents|mesh-ancestor
101509432|NCT04988685|Mitosis Modulators|mitosis modulators|mesh-ancestor
101509433|NCT04988685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509434|NCT04988685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101509435|NCT04988685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101509436|NCT04988685|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101509437|NCT04988685|Antifungal Agents|antifungal agents|mesh-ancestor
101509438|NCT04988685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101509439|NCT04988685|Immunologic Factors|immunologic factors|mesh-ancestor
101509440|NCT04988685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509441|NCT00517985|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101509442|NCT00517985|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101509443|NCT00517985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101509444|NCT00517985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101509445|NCT00517985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509446|NCT00517985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101509447|NCT00517985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509449|NCT00517985|Sensory System Agents|sensory system agents|mesh-ancestor
101509450|NCT00517985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101509451|NCT00517985|Antidepressive Agents|antidepressive agents|mesh-ancestor
101509452|NCT00517985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101509453|NCT00517985|Dopamine Agents|dopamine agents|mesh-ancestor
101509454|NCT04690920|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101509455|NCT04690920|Remdesivir|remdesivir|mesh-list
101509456|NCT04690920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101509457|NCT04690920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509458|NCT04690920|Antimetabolites|antimetabolites|mesh-ancestor
101509459|NCT04690920|Antiviral Agents|antiviral agents|mesh-ancestor
101509460|NCT00518102|Becaplermin|becaplermin|mesh-list
101509461|NCT00518102|Anticoagulants|anticoagulants|mesh-ancestor
101509462|NCT00518102|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
101509463|NCT00518102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101509464|NCT00518102|Growth Substances|growth substances|mesh-ancestor
101509465|NCT00518102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509466|NCT02939235|Morphine|morphine|mesh-list
101509467|NCT02939235|Metoclopramide|metoclopramide|mesh-list
101509468|NCT02939235|Ticagrelor|ticagrelor|mesh-list
101509469|NCT02939235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101509470|NCT02939235|Narcotics|narcotics|mesh-ancestor
101509471|NCT02939235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101509472|NCT02939235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509473|NCT02939235|Analgesics|analgesics|mesh-ancestor
101509474|NCT02939235|Sensory System Agents|sensory system agents|mesh-ancestor
101509475|NCT02939235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101509476|NCT02939235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101509477|NCT02939235|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101509478|NCT02939235|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101509479|NCT02939235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101509480|NCT02939235|Purinergic Agents|purinergic agents|mesh-ancestor
101509481|NCT02939235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101509482|NCT02939235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509483|NCT02939235|Antiemetics|antiemetics|mesh-ancestor
101509484|NCT02939235|Autonomic Agents|autonomic agents|mesh-ancestor
101509485|NCT02939235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101509486|NCT02939235|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101509487|NCT02939235|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101509488|NCT02939235|Dopamine Agents|dopamine agents|mesh-ancestor
101509489|NCT00518141|Aspirin|aspirin|mesh-list
101509490|NCT00518141|Salicylic Acid|salicylic acid|mesh-list
101509491|NCT00518141|Salicylates|salicylates|mesh-list
101509492|NCT00518141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101509493|NCT00518141|Antifungal Agents|antifungal agents|mesh-ancestor
101509494|NCT00518141|Keratolytic Agents|keratolytic agents|mesh-ancestor
101509495|NCT00518141|Dermatologic Agents|dermatologic agents|mesh-ancestor
101509496|NCT00518141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101509497|NCT00518141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101509498|NCT00518141|Analgesics|analgesics|mesh-ancestor
101509499|NCT00518141|Sensory System Agents|sensory system agents|mesh-ancestor
101509500|NCT00518141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101509501|NCT00518141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509502|NCT00518141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101509503|NCT00518141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101509504|NCT00518141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101509505|NCT00518141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101509506|NCT00518141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509507|NCT00518141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101509508|NCT00518141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101509509|NCT00518141|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101509510|NCT00518141|Antipyretics|antipyretics|mesh-ancestor
101509511|NCT02938962|Tranexamic Acid|tranexamic acid|mesh-list
101509512|NCT02938962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101509513|NCT02938962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101509514|NCT02938962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509515|NCT02938962|Hemostatics|hemostatics|mesh-ancestor
101509516|NCT02938962|Coagulants|coagulants|mesh-ancestor
101509521|NCT00519701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509522|NCT00519701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101509523|NCT00519116|Sirolimus|sirolimus|mesh-list
101509524|NCT00519116|Tacrolimus|tacrolimus|mesh-list
101509525|NCT00519116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101509526|NCT00519116|Immunologic Factors|immunologic factors|mesh-ancestor
101509527|NCT00519116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509528|NCT00519116|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101509529|NCT00519116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101509530|NCT00519116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509531|NCT00519116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101509532|NCT00519116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101509533|NCT00519116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101509534|NCT00519116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101509535|NCT00519116|Antifungal Agents|antifungal agents|mesh-ancestor
101509536|NCT04691076|Fentanyl|fentanyl|mesh-list
101509537|NCT04691076|Propofol|propofol|mesh-list
101509538|NCT04691076|Esketamine|esketamine|mesh-list
101509539|NCT04691076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101509540|NCT04691076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101509541|NCT04691076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509542|NCT04691076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101509543|NCT04691076|Anesthetics, General|anesthetics, general|mesh-ancestor
101509545|NCT04691076|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101509546|NCT04691076|Narcotics|narcotics|mesh-ancestor
101509547|NCT04691076|Analgesics|analgesics|mesh-ancestor
101193291|NCT03211728|Pregabalin|pregabalin|mesh-list
101509548|NCT04691076|Sensory System Agents|sensory system agents|mesh-ancestor
101509549|NCT04691076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101509550|NCT04691076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101509551|NCT04691076|Antidepressive Agents|antidepressive agents|mesh-ancestor
101509552|NCT04691076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101509553|NCT02949206|Thrombin|thrombin|mesh-list
101509554|NCT02949206|Hemostatics|hemostatics|mesh-ancestor
101509555|NCT02949206|Coagulants|coagulants|mesh-ancestor
101509556|NCT05108454|Micronutrients|micronutrients|mesh-list
101509557|NCT05108454|Trace Elements|trace elements|mesh-list
101509558|NCT05108454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509559|NCT02940561|Methotrexate|methotrexate|mesh-list
101509560|NCT02940561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101509561|NCT02940561|Abortifacient Agents|abortifacient agents|mesh-ancestor
101509562|NCT02940561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101410952|NCT00448552|Capecitabine|capecitabine|mesh-list
101509563|NCT02940561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509564|NCT02940561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101509565|NCT02940561|Antimetabolites|antimetabolites|mesh-ancestor
101509566|NCT02940561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509567|NCT02940561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101509568|NCT02940561|Dermatologic Agents|dermatologic agents|mesh-ancestor
101509569|NCT02940561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101509570|NCT02940561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101509571|NCT02940561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101509572|NCT02940561|Immunologic Factors|immunologic factors|mesh-ancestor
101509573|NCT02940561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101509574|NCT02940561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101509575|NCT02940366|Atorvastatin|atorvastatin|mesh-list
101509576|NCT02940366|Pitavastatin|pitavastatin|mesh-list
101509577|NCT02940366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101509578|NCT02940366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101509579|NCT02940366|Antimetabolites|antimetabolites|mesh-ancestor
101509580|NCT02940366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509581|NCT02940366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101509582|NCT02940366|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101509583|NCT02940366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101509584|NCT02940405|Ketorolac|ketorolac|mesh-list
101509585|NCT02940405|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101509586|NCT02940405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101509587|NCT02940405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101509588|NCT02940405|Analgesics|analgesics|mesh-ancestor
101509589|NCT02940405|Sensory System Agents|sensory system agents|mesh-ancestor
101509590|NCT02940405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101509591|NCT02940405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509592|NCT02940405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101509593|NCT02940405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101509594|NCT02940405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101509595|NCT02940405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101509596|NCT02940405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509597|NCT02940444|Heparin|heparin|mesh-list
101509598|NCT02940444|Anticoagulants|anticoagulants|mesh-ancestor
101509599|NCT02940444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101509600|NCT02940444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101509601|NCT02940444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509602|NCT00520052|Zoledronic Acid|zoledronic acid|mesh-list
101509603|NCT00520052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101509604|NCT00520052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509605|NCT04690647|Dexamethasone|dexamethasone|mesh-list
101509606|NCT04690647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
101509607|NCT04690647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101509608|NCT04690647|Antiemetics|antiemetics|mesh-ancestor
101509609|NCT04690647|Autonomic Agents|autonomic agents|mesh-ancestor
101509610|NCT04690647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101509611|NCT04690647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509612|NCT04690647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101509613|NCT04690647|Glucocorticoids|glucocorticoids|mesh-ancestor
101509614|NCT04690647|Hormones|hormones|mesh-ancestor
101509615|NCT04690647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101509616|NCT04690647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101509617|NCT04690647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101509618|NCT04690647|Analgesics|analgesics|mesh-ancestor
101509619|NCT04690647|Sensory System Agents|sensory system agents|mesh-ancestor
101509620|NCT00519467|Artesunate|artesunate|mesh-list
101509621|NCT00519467|Dapsone|dapsone|mesh-list
101509622|NCT00519467|Chlorproguanil|chlorproguanil|mesh-list
101509623|NCT00519467|Antimalarials|antimalarials|mesh-ancestor
101509624|NCT00519467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101509625|NCT00519467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101193377|NCT01831674|Metformin|metformin|mesh-list
101509626|NCT00519467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101509627|NCT00519467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101509628|NCT00519467|Antiviral Agents|antiviral agents|mesh-ancestor
101509629|NCT00519467|Schistosomicides|schistosomicides|mesh-ancestor
101509630|NCT00519467|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101264008|NCT01765088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101509631|NCT00519467|Anthelmintics|anthelmintics|mesh-ancestor
101509632|NCT00519467|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101509633|NCT00519467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101509634|NCT00519467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509635|NCT00519467|Leprostatic Agents|leprostatic agents|mesh-ancestor
101509636|NCT00519467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101509637|NCT02940483|Azacitidine|azacitidine|mesh-list
101509638|NCT02940483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101509639|NCT02940483|Antimetabolites|antimetabolites|mesh-ancestor
101509640|NCT02940483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509641|NCT02940483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101509642|NCT02940483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101509643|NCT04974684|Apixaban|apixaban|mesh-list
101509644|NCT04974684|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101509645|NCT04974684|Antithrombins|antithrombins|mesh-ancestor
101509646|NCT04974684|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101509647|NCT04974684|Protease Inhibitors|protease inhibitors|mesh-ancestor
101509648|NCT04974684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101509649|NCT04974684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509650|NCT04974684|Anticoagulants|anticoagulants|mesh-ancestor
101509651|NCT00520091|Celecoxib|celecoxib|mesh-list
101509652|NCT00520091|Irinotecan|irinotecan|mesh-list
101509653|NCT00520091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101509654|NCT00520091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101509655|NCT00520091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101509656|NCT00520091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101509657|NCT00520091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509658|NCT00520091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101509659|NCT00520091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101509660|NCT00520091|Analgesics|analgesics|mesh-ancestor
101509661|NCT00520091|Sensory System Agents|sensory system agents|mesh-ancestor
101509662|NCT00520091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101509663|NCT00520091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509664|NCT00520091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101509665|NCT00520091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101509666|NCT00520091|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101509667|NCT00520091|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101509668|NCT00520169|Ketamine|ketamine|mesh-list
101509669|NCT00520169|Analgesics|analgesics|mesh-ancestor
101509670|NCT00520169|Sensory System Agents|sensory system agents|mesh-ancestor
101509671|NCT00520169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101509672|NCT00520169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509673|NCT00520169|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101509674|NCT00520169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101509675|NCT00520169|Anesthetics, General|anesthetics, general|mesh-ancestor
101509676|NCT00520169|Anesthetics|anesthetics|mesh-ancestor
101509677|NCT00520169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101509678|NCT00520169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101509679|NCT00520169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101509680|NCT00520169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101509681|NCT00520169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509682|NCT00520247|Folic Acid|folic acid|mesh-list
101509683|NCT00520247|Enalapril|enalapril|mesh-list
101509684|NCT00520247|Hematinics|hematinics|mesh-ancestor
101509685|NCT00520247|Vitamin B Complex|vitamin b complex|mesh-ancestor
101509686|NCT00520247|Vitamins|vitamins|mesh-ancestor
101509687|NCT00520247|Micronutrients|micronutrients|mesh-ancestor
101509688|NCT00520247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509689|NCT00520247|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101509690|NCT00520247|Protease Inhibitors|protease inhibitors|mesh-ancestor
101509691|NCT00520247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101509692|NCT00520247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509693|NCT00520247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101509694|NCT02949050|Immunomodulating Agents|immunomodulating agents|mesh-list
101509695|NCT02949050|Immunologic Factors|immunologic factors|mesh-ancestor
101509696|NCT02949050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509697|NCT00520325|Lectins|lectins|mesh-list
101509698|NCT00520325|Agglutinins|agglutinins|mesh-ancestor
101509699|NCT00520325|Immunologic Factors|immunologic factors|mesh-ancestor
101509700|NCT00520325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509701|NCT00520325|Coagulants|coagulants|mesh-ancestor
101509702|NCT00520442|Ibuprofen|ibuprofen|mesh-list
101509703|NCT00520442|Codeine|codeine|mesh-list
101509704|NCT00520442|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101509705|NCT00520442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101509706|NCT00520442|Analgesics|analgesics|mesh-ancestor
101509707|NCT00520442|Sensory System Agents|sensory system agents|mesh-ancestor
101509708|NCT00520442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101509709|NCT00520442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509710|NCT00520442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101509711|NCT00520442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101509712|NCT00520442|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101509713|NCT00520442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101509714|NCT00520442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509715|NCT00520442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101509716|NCT00520442|Narcotics|narcotics|mesh-ancestor
101509717|NCT00520442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101509718|NCT00520442|Antitussive Agents|antitussive agents|mesh-ancestor
101509719|NCT00520442|Respiratory System Agents|respiratory system agents|mesh-ancestor
101509720|NCT02938572|Insulin Aspart|insulin aspart|mesh-list
101509721|NCT02938572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101509722|NCT02938572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509723|NCT02939898|Letrozole|letrozole|mesh-list
101509724|NCT02939898|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101509725|NCT02939898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101509726|NCT02939898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101509727|NCT02939898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101509728|NCT02939898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509729|NCT02939898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101509730|NCT02939898|Hormone Antagonists|hormone antagonists|mesh-ancestor
101509731|NCT02939898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101509732|NCT02939898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509733|NCT00520754|Levocetirizine|levocetirizine|mesh-list
101509734|NCT00520754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101509735|NCT00520754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101509736|NCT00520754|Histamine Antagonists|histamine antagonists|mesh-ancestor
101509737|NCT00520754|Histamine Agents|histamine agents|mesh-ancestor
101509738|NCT00520754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101509739|NCT00520754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509740|NCT00520754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509741|NCT02277132|Sildenafil Citrate|sildenafil citrate|mesh-list
101509742|NCT02277132|Vasodilator Agents|vasodilator agents|mesh-ancestor
101509743|NCT02277132|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101509744|NCT02277132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101509745|NCT02277132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101509746|NCT02277132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509747|NCT02277132|Urological Agents|urological agents|mesh-ancestor
101509748|NCT00520949|Amoxicillin|amoxicillin|mesh-list
101509749|NCT00520949|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101509750|NCT00520949|Furazolidone|furazolidone|mesh-list
101509751|NCT00520949|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
101509752|NCT00520949|Esomeprazole|esomeprazole|mesh-list
101509754|NCT00520949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101509755|NCT00520949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101509756|NCT00520949|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101509757|NCT00520949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101509758|NCT00520949|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101509759|NCT00520949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101509760|NCT00520949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509761|NCT00520949|Antacids|antacids|mesh-ancestor
101509762|NCT00520949|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101509763|NCT00520949|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101509764|NCT00520949|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101509765|NCT00520949|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
101509766|NCT00520949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101509767|NCT00520949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101509768|NCT00520949|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101509769|NCT02938260|Metoprolol|metoprolol|mesh-list
101509770|NCT02938260|Diltiazem|diltiazem|mesh-list
101509771|NCT02938260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101509772|NCT02938260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101509773|NCT02938260|Sympatholytics|sympatholytics|mesh-ancestor
101509774|NCT02938260|Autonomic Agents|autonomic agents|mesh-ancestor
101509775|NCT02938260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101509776|NCT02938260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509777|NCT02938260|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101509778|NCT02938260|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101509779|NCT02938260|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101509780|NCT02938260|Adrenergic Agents|adrenergic agents|mesh-ancestor
101509781|NCT02938260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101509782|NCT02938260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509783|NCT02938260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101509784|NCT02938260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101509785|NCT02938260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101509786|NCT02938260|Vasodilator Agents|vasodilator agents|mesh-ancestor
101509788|NCT02938182|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101509789|NCT02938182|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101509790|NCT02938182|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101509791|NCT02938182|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101509792|NCT02938182|Purinergic Agents|purinergic agents|mesh-ancestor
101509793|NCT02938182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101509794|NCT02938182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509795|NCT02938182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509796|NCT00521183|Tetrahydrouridine|tetrahydrouridine|mesh-list
101509797|NCT00521183|Antimetabolites|antimetabolites|mesh-ancestor
101509798|NCT00521183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509799|NCT00521612|Sevoflurane|sevoflurane|mesh-list
101509800|NCT00521612|Isoflurane|isoflurane|mesh-list
101509801|NCT00521612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101509802|NCT00521612|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101509803|NCT00521612|Anesthetics, General|anesthetics, general|mesh-ancestor
101509804|NCT00521612|Anesthetics|anesthetics|mesh-ancestor
101509805|NCT00521612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101509806|NCT00521612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509807|NCT00521261|Antibodies|antibodies|mesh-list
101509808|NCT00521261|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101509809|NCT00521261|Immunologic Factors|immunologic factors|mesh-ancestor
101509810|NCT00521261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509811|NCT02931591|Metformin|metformin|mesh-list
101509812|NCT02931591|Hormones|hormones|mesh-list
101509813|NCT02931591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101509814|NCT02931591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509815|NCT02931591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101509816|NCT00521300|Octreotide|octreotide|mesh-list
101509817|NCT00521300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101509818|NCT00521300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101509821|NCT00521690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101509822|NCT00521690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509823|NCT00523133|Naltrexone|naltrexone|mesh-list
101509824|NCT00523133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101509825|NCT00523133|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101509826|NCT00523133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509827|NCT00523133|Sensory System Agents|sensory system agents|mesh-ancestor
101509828|NCT00523133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101509829|NCT02937792|Bupivacaine|bupivacaine|mesh-list
101509830|NCT02937792|Anesthetics, Local|anesthetics, local|mesh-ancestor
101509831|NCT02937792|Anesthetics|anesthetics|mesh-ancestor
101509832|NCT02937792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101509833|NCT02937792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509834|NCT02937792|Sensory System Agents|sensory system agents|mesh-ancestor
101509835|NCT02937792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101509836|NCT02931474|Tesamorelin|tesamorelin|mesh-list
101509837|NCT02931474|Growth Substances|growth substances|mesh-ancestor
101264023|NCT01765309|Cholinergic Agents|cholinergic agents|mesh-ancestor
101509838|NCT02931474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509839|NCT02931357|Cetylpyridinium|cetylpyridinium|mesh-list
101509840|NCT02931357|Lidocaine|lidocaine|mesh-list
101509841|NCT02931357|Hyaluronic Acid|hyaluronic acid|mesh-list
101509842|NCT02931357|Anesthetics, Local|anesthetics, local|mesh-ancestor
101509843|NCT02931357|Anesthetics|anesthetics|mesh-ancestor
101509844|NCT02931357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101509845|NCT02931357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509846|NCT02931357|Sensory System Agents|sensory system agents|mesh-ancestor
101509847|NCT02931357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101509848|NCT02931357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101509849|NCT02931357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101509850|NCT02931357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101509851|NCT02931357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101193575|NCT01836432|Gemcitabine|gemcitabine|mesh-list
101509852|NCT02931357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509854|NCT02931357|Immunologic Factors|immunologic factors|mesh-ancestor
101509855|NCT02931357|Viscosupplements|viscosupplements|mesh-ancestor
101509856|NCT02931357|Protective Agents|protective agents|mesh-ancestor
101509857|NCT02931357|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101509858|NCT02931357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101509859|NCT02937519|Cisplatin|cisplatin|mesh-list
101509860|NCT02937519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101509861|NCT00521963|Infliximab|infliximab|mesh-list
101509862|NCT00521963|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101509863|NCT00521963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101509864|NCT00521963|Dermatologic Agents|dermatologic agents|mesh-ancestor
101509865|NCT00521963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101509866|NCT00521963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101509867|NCT02937402|Dimercaprol|dimercaprol|mesh-list
101509868|NCT02937402|Chelating Agents|chelating agents|mesh-ancestor
101509869|NCT02937402|Sequestering Agents|sequestering agents|mesh-ancestor
101509870|NCT02937402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509871|NCT02937363|Thioctic Acid|thioctic acid|mesh-list
101509873|NCT02937363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509874|NCT02937363|Protective Agents|protective agents|mesh-ancestor
101509875|NCT02937363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509876|NCT02937363|Vitamin B Complex|vitamin b complex|mesh-ancestor
101509877|NCT02937363|Vitamins|vitamins|mesh-ancestor
101509878|NCT02937363|Micronutrients|micronutrients|mesh-ancestor
101509879|NCT02948348|Capecitabine|capecitabine|mesh-list
101509880|NCT02948348|Nivolumab|nivolumab|mesh-list
101509881|NCT02948348|Ipilimumab|ipilimumab|mesh-list
101509882|NCT02948348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101509883|NCT02948348|Antimetabolites|antimetabolites|mesh-ancestor
101509884|NCT02948348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509885|NCT02948348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101509886|NCT02948348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101509889|NCT04693910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101509891|NCT00522158|Atorvastatin|atorvastatin|mesh-list
101509892|NCT00522158|Simvastatin|simvastatin|mesh-list
101509893|NCT00522158|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101509894|NCT00522158|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101509895|NCT00522158|Antimetabolites|antimetabolites|mesh-ancestor
101509896|NCT00522158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509897|NCT00522158|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101304263|NCT02012075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101509898|NCT00522158|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101509899|NCT00522158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101509900|NCT02931123|Rifaximin|rifaximin|mesh-list
101509901|NCT02931123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101509902|NCT02931123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101509903|NCT02931123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101509904|NCT02936934|Morphine|morphine|mesh-list
101509905|NCT02936934|Oxycodone|oxycodone|mesh-list
101509906|NCT02936934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101509907|NCT02936934|Narcotics|narcotics|mesh-ancestor
101509908|NCT02936934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101264030|NCT01765374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509909|NCT02936934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509910|NCT02936934|Analgesics|analgesics|mesh-ancestor
101509911|NCT02936934|Sensory System Agents|sensory system agents|mesh-ancestor
101509912|NCT02936934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101509913|NCT00522470|Rosiglitazone|rosiglitazone|mesh-list
101509914|NCT00522470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101509915|NCT00522470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509916|NCT00522509|Floxuridine|floxuridine|mesh-list
101509917|NCT00522509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101509918|NCT00522509|Antimetabolites|antimetabolites|mesh-ancestor
101509919|NCT00522509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509920|NCT00522509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101509921|NCT00522587|Remifentanil|remifentanil|mesh-list
101509922|NCT00522587|Sevoflurane|sevoflurane|mesh-list
101509923|NCT00522587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101509924|NCT00522587|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101509925|NCT00522587|Anesthetics, General|anesthetics, general|mesh-ancestor
101509926|NCT00522587|Anesthetics|anesthetics|mesh-ancestor
101509927|NCT00522587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101509928|NCT00522587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509929|NCT00522587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101509930|NCT00522587|Narcotics|narcotics|mesh-ancestor
101509931|NCT00522587|Analgesics|analgesics|mesh-ancestor
101509932|NCT00522587|Sensory System Agents|sensory system agents|mesh-ancestor
101509933|NCT00522587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101509934|NCT00522665|Irinotecan|irinotecan|mesh-list
101509935|NCT00522665|Cetuximab|cetuximab|mesh-list
101509936|NCT00522665|Everolimus|everolimus|mesh-list
101509937|NCT00522665|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101509938|NCT00522665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101509939|NCT00522665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101509940|NCT00522665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509941|NCT00522665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101509942|NCT00522665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101509943|NCT00522665|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101509944|NCT00522665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101509945|NCT00522665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101509946|NCT00522665|Immunologic Factors|immunologic factors|mesh-ancestor
101509947|NCT00522665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509949|NCT00522743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101509950|NCT00522743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509951|NCT02937012|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101509952|NCT02937012|Bezafibrate|bezafibrate|mesh-list
101509953|NCT02937012|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101509954|NCT02937012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101509955|NCT02937012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101509956|NCT02937012|Antimetabolites|antimetabolites|mesh-ancestor
101509957|NCT02937012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509958|NCT02937012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101509959|NCT00522782|Budesonide|budesonide|mesh-list
101509960|NCT00522782|Nitric Oxide|nitric oxide|mesh-list
101509961|NCT00522782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101509962|NCT00522782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101509963|NCT00522782|Autonomic Agents|autonomic agents|mesh-ancestor
101509964|NCT00522782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101509965|NCT00522782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509966|NCT00522782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101509967|NCT00522782|Respiratory System Agents|respiratory system agents|mesh-ancestor
101509968|NCT00522782|Glucocorticoids|glucocorticoids|mesh-ancestor
101509969|NCT00522782|Hormones|hormones|mesh-ancestor
101509970|NCT00522782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101509971|NCT00522782|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101509972|NCT00522782|Antioxidants|antioxidants|mesh-ancestor
101264036|NCT01765452|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101509973|NCT00522782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101509974|NCT00522782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101509975|NCT00522782|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101509976|NCT00522782|Vasodilator Agents|vasodilator agents|mesh-ancestor
101509977|NCT00522782|Gasotransmitters|gasotransmitters|mesh-ancestor
101509978|NCT00522782|Protective Agents|protective agents|mesh-ancestor
101509979|NCT00522821|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101509980|NCT00522821|Immunoglobulins|immunoglobulins|mesh-list
101509981|NCT00522821|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101509983|NCT00522821|gamma-Globulins|gamma-globulins|mesh-list
101509984|NCT00522821|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101509985|NCT00522821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101509986|NCT00522821|Immunologic Factors|immunologic factors|mesh-ancestor
101509987|NCT00522821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509988|NCT02936895|Vitamin D|vitamin d|mesh-list
101509989|NCT02936895|Cholecalciferol|cholecalciferol|mesh-list
101509990|NCT02936895|Vitamins|vitamins|mesh-ancestor
101509991|NCT02936895|Micronutrients|micronutrients|mesh-ancestor
101509992|NCT02936895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101509993|NCT02936895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101509994|NCT02936895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101509995|NCT00522938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101509996|NCT00522938|Tosedostat|tosedostat|mesh-list
101509997|NCT00522938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101509998|NCT00522938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101509999|NCT00522938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101510000|NCT00522938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510001|NCT04694105|Dexamethasone|dexamethasone|mesh-list
101510002|NCT04694105|Dexmedetomidine|dexmedetomidine|mesh-list
101510003|NCT04694105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101510004|NCT04694105|Antiemetics|antiemetics|mesh-ancestor
101510005|NCT04694105|Autonomic Agents|autonomic agents|mesh-ancestor
101510006|NCT04694105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101510007|NCT04694105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510009|NCT04694105|Glucocorticoids|glucocorticoids|mesh-ancestor
101510010|NCT04694105|Hormones|hormones|mesh-ancestor
101510011|NCT04694105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101510012|NCT04694105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101510013|NCT04694105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101510014|NCT04694105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101510015|NCT04694105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101510016|NCT04694105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101510017|NCT04694105|Analgesics|analgesics|mesh-ancestor
101510018|NCT04694105|Sensory System Agents|sensory system agents|mesh-ancestor
101510019|NCT04694105|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101510020|NCT04694105|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101510021|NCT04694105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101510022|NCT04694105|Adrenergic Agents|adrenergic agents|mesh-ancestor
101510023|NCT04694105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101510024|NCT04694105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510025|NCT02930733|Bupivacaine|bupivacaine|mesh-list
101510026|NCT02930733|Anesthetics, Local|anesthetics, local|mesh-ancestor
101510027|NCT02930733|Anesthetics|anesthetics|mesh-ancestor
101510028|NCT02930733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101510029|NCT02930733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510030|NCT02930733|Sensory System Agents|sensory system agents|mesh-ancestor
101510031|NCT02930733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101510032|NCT00523055|Lidocaine|lidocaine|mesh-list
101510033|NCT00523055|Anesthetics, Local|anesthetics, local|mesh-ancestor
101510034|NCT00523055|Anesthetics|anesthetics|mesh-ancestor
101510035|NCT00523055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101510036|NCT00523055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510037|NCT00523055|Sensory System Agents|sensory system agents|mesh-ancestor
101510038|NCT00523055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101510039|NCT00523055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101510040|NCT00523055|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101510041|NCT00523055|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101510042|NCT00523055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101510043|NCT00523055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510044|NCT00523289|Bupivacaine|bupivacaine|mesh-list
101510045|NCT00523289|Ropivacaine|ropivacaine|mesh-list
101510046|NCT00523289|Anesthetics, Local|anesthetics, local|mesh-ancestor
101510047|NCT00523289|Anesthetics|anesthetics|mesh-ancestor
101510048|NCT00523289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101510049|NCT00523289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510050|NCT00523289|Sensory System Agents|sensory system agents|mesh-ancestor
101510051|NCT00523289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101510052|NCT00524381|Etanercept|etanercept|mesh-list
101510053|NCT00524381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101510054|NCT00524381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101510055|NCT00524381|Analgesics|analgesics|mesh-ancestor
101510056|NCT00524381|Sensory System Agents|sensory system agents|mesh-ancestor
101510057|NCT00524381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101510058|NCT00524381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510059|NCT00524381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101510060|NCT00524381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101510061|NCT00524381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101510062|NCT00524381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101510063|NCT00524381|Immunologic Factors|immunologic factors|mesh-ancestor
101510064|NCT04502667|Vitamin D|vitamin d|mesh-list
101510065|NCT04502667|Cholecalciferol|cholecalciferol|mesh-list
101510066|NCT04502667|Vitamins|vitamins|mesh-ancestor
101510067|NCT04502667|Micronutrients|micronutrients|mesh-ancestor
101510068|NCT04502667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510069|NCT04502667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101510070|NCT04502667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101510071|NCT00524498|Cisplatin|cisplatin|mesh-list
101510072|NCT00524498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101510073|NCT00523406|Triamcinolone|triamcinolone|mesh-list
101510074|NCT00523406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101510075|NCT00523406|Glucocorticoids|glucocorticoids|mesh-ancestor
101510076|NCT00523406|Hormones|hormones|mesh-ancestor
101510077|NCT00523406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101193797|NCT01726686|Anesthetics|anesthetics|mesh-ancestor
101510078|NCT00523406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510080|NCT00524615|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101510081|NCT00524615|Hormone Antagonists|hormone antagonists|mesh-ancestor
101510082|NCT00524615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101510083|NCT00524615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510084|NCT00524615|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101510085|NCT00524615|Diuretics|diuretics|mesh-ancestor
101510086|NCT00524615|Natriuretic Agents|natriuretic agents|mesh-ancestor
101510087|NCT00523445|Varenicline|varenicline|mesh-list
101510088|NCT00523445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101510089|NCT00523445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101510090|NCT00523445|Cholinergic Agents|cholinergic agents|mesh-ancestor
101510091|NCT00523445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101510092|NCT00523445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510093|NCT00523445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510094|NCT02936661|Tranexamic Acid|tranexamic acid|mesh-list
101510095|NCT02936661|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101510096|NCT02936661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101510097|NCT02936661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510098|NCT02936661|Hemostatics|hemostatics|mesh-ancestor
101264049|NCT01765556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101510099|NCT02936661|Coagulants|coagulants|mesh-ancestor
101510100|NCT02948075|Paclitaxel|paclitaxel|mesh-list
101510101|NCT02948075|Carboplatin|carboplatin|mesh-list
101510102|NCT02948075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101510103|NCT02948075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101510104|NCT02948075|Tubulin Modulators|tubulin modulators|mesh-ancestor
101510105|NCT02948075|Antimitotic Agents|antimitotic agents|mesh-ancestor
101510106|NCT02948075|Mitosis Modulators|mitosis modulators|mesh-ancestor
101510107|NCT02948075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510108|NCT02930811|Sildenafil Citrate|sildenafil citrate|mesh-list
101510109|NCT02930811|Vasodilator Agents|vasodilator agents|mesh-ancestor
101510110|NCT02930811|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101510111|NCT02930811|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101510112|NCT02930811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101510113|NCT02930811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510114|NCT02930811|Urological Agents|urological agents|mesh-ancestor
101510116|NCT02947880|Diuretics|diuretics|mesh-ancestor
101510117|NCT02947880|Natriuretic Agents|natriuretic agents|mesh-ancestor
101510118|NCT02947880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510119|NCT02947880|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101510120|NCT02947880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101510121|NCT02947880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510122|NCT00523757|Spironolactone|spironolactone|mesh-list
101510123|NCT00523757|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101510124|NCT00523757|Hormone Antagonists|hormone antagonists|mesh-ancestor
101510125|NCT00523757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101510126|NCT00523757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510127|NCT00523757|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101510128|NCT00523757|Diuretics|diuretics|mesh-ancestor
101510129|NCT00523757|Natriuretic Agents|natriuretic agents|mesh-ancestor
101510130|NCT00524693|Montelukast|montelukast|mesh-list
101510131|NCT00524693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101510132|NCT00524693|Respiratory System Agents|respiratory system agents|mesh-ancestor
101510133|NCT00524693|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101510134|NCT00524693|Hormone Antagonists|hormone antagonists|mesh-ancestor
101510135|NCT00524693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101510136|NCT00524693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510137|NCT00524693|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101510138|NCT00524693|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101510139|NCT00524693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510140|NCT02931201|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101510141|NCT02931201|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101510142|NCT02931201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510143|NCT02936427|Dexamethasone|dexamethasone|mesh-list
101510144|NCT02936427|Dexamethasone acetate|dexamethasone acetate|mesh-list
101510145|NCT02936427|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101510146|NCT02936427|BB 1101|bb 1101|mesh-list
101510147|NCT02936427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101510148|NCT02936427|Antiemetics|antiemetics|mesh-ancestor
101510149|NCT02936427|Autonomic Agents|autonomic agents|mesh-ancestor
101510150|NCT02936427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101510151|NCT02936427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510152|NCT02936427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101510153|NCT02936427|Glucocorticoids|glucocorticoids|mesh-ancestor
101510154|NCT02936427|Hormones|hormones|mesh-ancestor
101510155|NCT02936427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101510156|NCT02936427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101510157|NCT02936427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101510158|NCT02936427|Protease Inhibitors|protease inhibitors|mesh-ancestor
101510159|NCT02936427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101510160|NCT02936427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510161|NCT00523913|Rosiglitazone|rosiglitazone|mesh-list
101510162|NCT00523913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101510163|NCT00523913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510164|NCT02947763|Metronidazole|metronidazole|mesh-list
101510165|NCT02947763|Ciprofloxacin|ciprofloxacin|mesh-list
101510166|NCT02947763|Minocycline|minocycline|mesh-list
101510167|NCT02947763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101510168|NCT02947763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101510169|NCT02947763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101510170|NCT02947763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101510171|NCT02947763|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101510172|NCT02947763|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101510173|NCT02947763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101510174|NCT02947763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510175|NCT02947763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101510176|NCT02947763|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101510177|NCT02947763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101510178|NCT00523952|Tacrolimus|tacrolimus|mesh-list
101510179|NCT00523952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101510180|NCT00523952|Immunologic Factors|immunologic factors|mesh-ancestor
101510181|NCT00523952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510182|NCT00523952|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101510183|NCT00523952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101510184|NCT00523952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510186|NCT00524069|Gemcitabine|gemcitabine|mesh-list
101510187|NCT00524069|Capecitabine|capecitabine|mesh-list
101510188|NCT00524069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101510189|NCT00524069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101510190|NCT00524069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101510191|NCT00524069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101510192|NCT00524069|Growth Substances|growth substances|mesh-ancestor
101510193|NCT00524069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510194|NCT00524069|Growth Inhibitors|growth inhibitors|mesh-ancestor
101510195|NCT00524069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101510196|NCT00524069|Antimetabolites|antimetabolites|mesh-ancestor
101510197|NCT00524069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510198|NCT00524810|Docetaxel|docetaxel|mesh-list
101510199|NCT00524810|Doxorubicin|doxorubicin|mesh-list
101510200|NCT00524810|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101510201|NCT00524810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101510202|NCT00524810|Tubulin Modulators|tubulin modulators|mesh-ancestor
101510203|NCT00524810|Antimitotic Agents|antimitotic agents|mesh-ancestor
101510204|NCT00524810|Mitosis Modulators|mitosis modulators|mesh-ancestor
101510205|NCT00524810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510206|NCT00524810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101510207|NCT00524810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101510208|NCT00524810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101510209|NCT00524810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101510210|NCT00524849|Zoledronic Acid|zoledronic acid|mesh-list
101510211|NCT00524849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101510212|NCT00524849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510213|NCT00524927|Methoxyflurane|methoxyflurane|mesh-list
101510214|NCT00524927|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101510215|NCT00524927|Anesthetics, General|anesthetics, general|mesh-ancestor
101510216|NCT00524927|Anesthetics|anesthetics|mesh-ancestor
101510217|NCT00524927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101510218|NCT00524927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510219|NCT00524966|Hemostatics|hemostatics|mesh-list
101510220|NCT00524966|Coagulants|coagulants|mesh-ancestor
101510221|NCT02276846|Paclitaxel|paclitaxel|mesh-list
101510222|NCT02276846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101193947|NCT01046682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101510223|NCT02276846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101510224|NCT02276846|Tubulin Modulators|tubulin modulators|mesh-ancestor
101510225|NCT02276846|Antimitotic Agents|antimitotic agents|mesh-ancestor
101510226|NCT02276846|Mitosis Modulators|mitosis modulators|mesh-ancestor
101510227|NCT02276846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510228|NCT02935725|Ketamine|ketamine|mesh-list
101510229|NCT02935725|Analgesics|analgesics|mesh-ancestor
101318347|NCT00016432|Exemestane|exemestane|mesh-list
101510230|NCT02935725|Sensory System Agents|sensory system agents|mesh-ancestor
101510231|NCT02935725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101510232|NCT02935725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510233|NCT02935725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101510234|NCT02935725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101510235|NCT02935725|Anesthetics, General|anesthetics, general|mesh-ancestor
101510236|NCT02935725|Anesthetics|anesthetics|mesh-ancestor
101510237|NCT02935725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101264065|NCT01765738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101510238|NCT02935725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101510239|NCT02935725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101510240|NCT02935725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101510241|NCT02935725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510243|NCT02935764|Fluorouracil|fluorouracil|mesh-list
101510244|NCT02935764|Irinotecan|irinotecan|mesh-list
101510245|NCT02935764|Antimetabolites|antimetabolites|mesh-ancestor
101510246|NCT02935764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510247|NCT02935764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101510248|NCT02935764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101510249|NCT02935764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101510250|NCT02935764|Immunologic Factors|immunologic factors|mesh-ancestor
101510251|NCT02935764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510252|NCT02935764|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101510253|NCT02935764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101510254|NCT02935764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101510255|NCT02935764|Antidotes|antidotes|mesh-ancestor
101510256|NCT02935764|Protective Agents|protective agents|mesh-ancestor
101510257|NCT02935764|Vitamin B Complex|vitamin b complex|mesh-ancestor
101510258|NCT02935764|Vitamins|vitamins|mesh-ancestor
101510259|NCT02935764|Micronutrients|micronutrients|mesh-ancestor
101510260|NCT02935998|Ziprasidone|ziprasidone|mesh-list
101510261|NCT02935998|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101510262|NCT02935998|Serotonin Agents|serotonin agents|mesh-ancestor
101510263|NCT02935998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101510264|NCT02935998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510265|NCT02935998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510266|NCT02935998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101510267|NCT02935998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101510268|NCT02935998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101510269|NCT02935998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101510270|NCT02935998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101510271|NCT02935998|Dopamine Agents|dopamine agents|mesh-ancestor
101510272|NCT02930109|Cytarabine|cytarabine|mesh-list
101510273|NCT02930109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101510274|NCT02930109|Antimetabolites|antimetabolites|mesh-ancestor
101510275|NCT02930109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510276|NCT02930109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101510277|NCT02930109|Antiviral Agents|antiviral agents|mesh-ancestor
101510278|NCT02930109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101510279|NCT02930109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101510280|NCT02930109|Immunologic Factors|immunologic factors|mesh-ancestor
101510281|NCT02930109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510282|NCT00524186|Leucovorin|leucovorin|mesh-list
101510283|NCT00524186|Fluorouracil|fluorouracil|mesh-list
101510284|NCT00524186|Irinotecan|irinotecan|mesh-list
101510285|NCT00524186|Sunitinib|sunitinib|mesh-list
101510286|NCT00524186|Calcium|calcium|mesh-list
101510287|NCT00524186|Levoleucovorin|levoleucovorin|mesh-list
101510288|NCT00524186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101510289|NCT00524186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510290|NCT00524186|Antimetabolites|antimetabolites|mesh-ancestor
101510291|NCT00524186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510292|NCT00524186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101510293|NCT00524186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101510294|NCT00524186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101510295|NCT00524186|Immunologic Factors|immunologic factors|mesh-ancestor
101510296|NCT00524186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101510297|NCT00524186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101510298|NCT00524186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101510299|NCT00524186|Antidotes|antidotes|mesh-ancestor
101510300|NCT00524186|Protective Agents|protective agents|mesh-ancestor
101510301|NCT00524186|Vitamin B Complex|vitamin b complex|mesh-ancestor
101510303|NCT00524186|Micronutrients|micronutrients|mesh-ancestor
101510304|NCT00524186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101510305|NCT00524186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101510306|NCT00524186|Growth Substances|growth substances|mesh-ancestor
101510307|NCT00524186|Growth Inhibitors|growth inhibitors|mesh-ancestor
101510308|NCT00524186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101510309|NCT00525005|Docetaxel|docetaxel|mesh-list
101510311|NCT00525005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101510312|NCT00525005|Tubulin Modulators|tubulin modulators|mesh-ancestor
101510313|NCT00525005|Antimitotic Agents|antimitotic agents|mesh-ancestor
101510314|NCT00525005|Mitosis Modulators|mitosis modulators|mesh-ancestor
101510315|NCT00525005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510316|NCT00525200|Docetaxel|docetaxel|mesh-list
101510317|NCT00525200|Cisplatin|cisplatin|mesh-list
101510318|NCT00525200|Fluorouracil|fluorouracil|mesh-list
101510319|NCT00525200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101510320|NCT00525200|Tubulin Modulators|tubulin modulators|mesh-ancestor
101510321|NCT00525200|Antimitotic Agents|antimitotic agents|mesh-ancestor
101510322|NCT00525200|Mitosis Modulators|mitosis modulators|mesh-ancestor
101510323|NCT00525200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510324|NCT00525200|Antimetabolites|antimetabolites|mesh-ancestor
101510325|NCT00525200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101510326|NCT00525200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101510327|NCT00525200|Immunologic Factors|immunologic factors|mesh-ancestor
101510328|NCT00525200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510329|NCT02930265|Liraglutide|liraglutide|mesh-list
101510330|NCT02930265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101510331|NCT02930265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510332|NCT02930265|Incretins|incretins|mesh-ancestor
101510333|NCT02930265|Hormones|hormones|mesh-ancestor
101510334|NCT02930265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101510335|NCT02947178|Bupivacaine|bupivacaine|mesh-list
101510337|NCT02947178|Anesthetics|anesthetics|mesh-ancestor
101510338|NCT02947178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101510339|NCT02947178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510340|NCT02947178|Sensory System Agents|sensory system agents|mesh-ancestor
101510341|NCT02947178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101510342|NCT02929797|Gemcitabine|gemcitabine|mesh-list
101510343|NCT02929797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101510344|NCT02929797|Antimetabolites|antimetabolites|mesh-ancestor
101510345|NCT02929797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510346|NCT02929797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101510347|NCT00525239|Ritonavir|ritonavir|mesh-list
101510350|NCT00525239|Efavirenz|efavirenz|mesh-list
101510351|NCT00525239|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101510352|NCT00525239|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101510353|NCT00525239|Protease Inhibitors|protease inhibitors|mesh-ancestor
101510354|NCT00525239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101510355|NCT00525239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510356|NCT00525239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101510357|NCT00525239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101510358|NCT00525239|Antiviral Agents|antiviral agents|mesh-ancestor
101510359|NCT00525239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101510360|NCT00525239|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101510361|NCT00525239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101510362|NCT00525239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101510363|NCT00525239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101510364|NCT00525239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101510365|NCT00525239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101510366|NCT00525239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101510367|NCT00525239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101510368|NCT00525239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101510369|NCT02929914|Anti-Infective Agents|anti-infective agents|mesh-list
101510370|NCT02929914|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101510371|NCT02947334|Bococizumab|bococizumab|mesh-list
101510372|NCT02947334|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101510373|NCT02947334|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101510374|NCT02947334|Antimetabolites|antimetabolites|mesh-ancestor
101510375|NCT02947334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510376|NCT02947334|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101510377|NCT00525278|Levocetirizine|levocetirizine|mesh-list
101510378|NCT00525278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101510379|NCT00525278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101510380|NCT00525278|Histamine Antagonists|histamine antagonists|mesh-ancestor
101510381|NCT00525278|Histamine Agents|histamine agents|mesh-ancestor
101510382|NCT00525278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101510383|NCT00525278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510384|NCT00525278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510385|NCT02929719|Dapsone|dapsone|mesh-list
101510386|NCT02929719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101510387|NCT02929719|Antimalarials|antimalarials|mesh-ancestor
101510388|NCT02929719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101510389|NCT02929719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101510390|NCT02929719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101510391|NCT02929719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101510392|NCT02929719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510393|NCT02929719|Leprostatic Agents|leprostatic agents|mesh-ancestor
101510394|NCT02929719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101510395|NCT04325685|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
101510396|NCT04325685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101510397|NCT02929524|Ketamine|ketamine|mesh-list
101510398|NCT02929524|Analgesics|analgesics|mesh-ancestor
101510399|NCT02929524|Sensory System Agents|sensory system agents|mesh-ancestor
101510400|NCT02929524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101510401|NCT02929524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510402|NCT02929524|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101510403|NCT02929524|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101510404|NCT02929524|Anesthetics, General|anesthetics, general|mesh-ancestor
101510405|NCT02929524|Anesthetics|anesthetics|mesh-ancestor
101510406|NCT02929524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101510407|NCT02929524|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101510408|NCT02929524|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101510409|NCT02929524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101510410|NCT02929524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510411|NCT00525473|Azathioprine|azathioprine|mesh-list
101510412|NCT00525473|Antimetabolites|antimetabolites|mesh-ancestor
101510413|NCT00525473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510414|NCT00525473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101510415|NCT00525473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101510416|NCT00525473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101510417|NCT00525473|Immunologic Factors|immunologic factors|mesh-ancestor
101510418|NCT00525473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510419|NCT00525473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101510420|NCT00526175|Cytarabine|cytarabine|mesh-list
101510421|NCT00526175|Prednisone|prednisone|mesh-list
101510422|NCT00526175|Cyclophosphamide|cyclophosphamide|mesh-list
101510423|NCT00526175|Methotrexate|methotrexate|mesh-list
101510424|NCT00526175|Vincristine|vincristine|mesh-list
101510425|NCT00526175|Daunorubicin|daunorubicin|mesh-list
101510426|NCT00526175|Asparaginase|asparaginase|mesh-list
101510427|NCT00526175|Mercaptopurine|mercaptopurine|mesh-list
101510428|NCT00526175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101510429|NCT00526175|Immunologic Factors|immunologic factors|mesh-ancestor
101510430|NCT00526175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510431|NCT00526175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101510432|NCT00526175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101510433|NCT00526175|Alkylating Agents|alkylating agents|mesh-ancestor
101510434|NCT00526175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510435|NCT00526175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101510436|NCT00526175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101510437|NCT00526175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101510438|NCT00526175|Glucocorticoids|glucocorticoids|mesh-ancestor
101510439|NCT00526175|Hormones|hormones|mesh-ancestor
101510440|NCT00526175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101510441|NCT00526175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101510442|NCT00526175|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101264084|NCT01765829|Haloperidol|haloperidol|mesh-list
101510443|NCT00526175|Abortifacient Agents|abortifacient agents|mesh-ancestor
101510444|NCT00526175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101510445|NCT00526175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101510446|NCT00526175|Antimetabolites|antimetabolites|mesh-ancestor
101510447|NCT00526175|Dermatologic Agents|dermatologic agents|mesh-ancestor
101510448|NCT00526175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101510449|NCT00526175|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101510450|NCT00526175|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101194169|NCT02241174|Eusol|eusol|mesh-list
101510451|NCT00526175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101510452|NCT00526175|Tubulin Modulators|tubulin modulators|mesh-ancestor
101510453|NCT00526175|Antimitotic Agents|antimitotic agents|mesh-ancestor
101510454|NCT00526175|Mitosis Modulators|mitosis modulators|mesh-ancestor
101510455|NCT00526175|Antiviral Agents|antiviral agents|mesh-ancestor
101510456|NCT00526175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101510457|NCT00526175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101510458|NCT00526175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101510459|NCT00526175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101510460|NCT02930031|Acetylcysteine|acetylcysteine|mesh-list
101510461|NCT02930031|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101510462|NCT02930031|Antiviral Agents|antiviral agents|mesh-ancestor
101510463|NCT02930031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101510464|NCT02930031|Expectorants|expectorants|mesh-ancestor
101510465|NCT02930031|Respiratory System Agents|respiratory system agents|mesh-ancestor
101510466|NCT02930031|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101510467|NCT02930031|Antioxidants|antioxidants|mesh-ancestor
101510468|NCT02930031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510469|NCT02930031|Protective Agents|protective agents|mesh-ancestor
101304264|NCT02012075|Adrenergic Agents|adrenergic agents|mesh-ancestor
101510470|NCT02930031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510471|NCT02930031|Antidotes|antidotes|mesh-ancestor
101510472|NCT02929563|Pantoprazole|pantoprazole|mesh-list
101510473|NCT02929563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101510474|NCT02929563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101510475|NCT02929563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101510476|NCT02929563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101510477|NCT02929563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510478|NCT00525551|Acetylcysteine|acetylcysteine|mesh-list
101510479|NCT00525551|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101510480|NCT00525551|Antiviral Agents|antiviral agents|mesh-ancestor
101510481|NCT00525551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101510482|NCT00525551|Expectorants|expectorants|mesh-ancestor
101510483|NCT00525551|Respiratory System Agents|respiratory system agents|mesh-ancestor
101510484|NCT00525551|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101510485|NCT00525551|Antioxidants|antioxidants|mesh-ancestor
101510486|NCT00525551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510487|NCT00525551|Protective Agents|protective agents|mesh-ancestor
101510488|NCT00525551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510489|NCT00525551|Antidotes|antidotes|mesh-ancestor
101510490|NCT04288323|Diethylenetriamine|diethylenetriamine|mesh-list
101510491|NCT04288323|Edetic Acid|edetic acid|mesh-list
101510492|NCT04288323|Pentetic Acid|pentetic acid|mesh-list
101510493|NCT04288323|Antidotes|antidotes|mesh-ancestor
101510494|NCT04288323|Protective Agents|protective agents|mesh-ancestor
101510495|NCT04288323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510496|NCT04288323|Chelating Agents|chelating agents|mesh-ancestor
101510497|NCT04288323|Sequestering Agents|sequestering agents|mesh-ancestor
101510498|NCT04288323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510499|NCT04288323|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101510500|NCT04288323|Anticoagulants|anticoagulants|mesh-ancestor
101510501|NCT04288323|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101510502|NCT04288323|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101510503|NCT02946359|Bevacizumab|bevacizumab|mesh-list
101510504|NCT02946359|Crizotinib|crizotinib|mesh-list
101510505|NCT02946359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101510506|NCT02946359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101510507|NCT02946359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101510508|NCT02946359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101510509|NCT02946359|Growth Substances|growth substances|mesh-ancestor
101510510|NCT02946359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510511|NCT02946359|Growth Inhibitors|growth inhibitors|mesh-ancestor
101510512|NCT02946359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101510513|NCT02946359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101510514|NCT02946359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510515|NCT02946437|Midazolam|midazolam|mesh-list
101510516|NCT02946437|Propofol|propofol|mesh-list
101510517|NCT02946437|Sevoflurane|sevoflurane|mesh-list
101510518|NCT02946437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101510519|NCT02946437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101510520|NCT02946437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510521|NCT02946437|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101510522|NCT02946437|Anesthetics, General|anesthetics, general|mesh-ancestor
101510523|NCT02946437|Anesthetics|anesthetics|mesh-ancestor
101510524|NCT02946437|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101510525|NCT02946437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101510526|NCT02946437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101510527|NCT02946437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101510528|NCT02946437|GABA Modulators|gaba modulators|mesh-ancestor
101510529|NCT02946437|GABA Agents|gaba agents|mesh-ancestor
101510530|NCT02946437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101510531|NCT02946437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510532|NCT02946437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101510533|NCT02946437|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101510534|NCT02946632|Metformin|metformin|mesh-list
101510535|NCT02946632|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101510536|NCT02946632|Dapagliflozin|dapagliflozin|mesh-list
101510537|NCT02946632|Glimepiride|glimepiride|mesh-list
101510538|NCT02946632|Saxagliptin|saxagliptin|mesh-list
101510539|NCT02946632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101510540|NCT02946632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510541|NCT02946632|Incretins|incretins|mesh-ancestor
101510542|NCT02946632|Hormones|hormones|mesh-ancestor
101510543|NCT02946632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101510544|NCT02946632|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101510545|NCT02946632|Protease Inhibitors|protease inhibitors|mesh-ancestor
101510546|NCT02946632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101510547|NCT02946632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510548|NCT02946632|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101510549|NCT02946632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101510550|NCT02946632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101510551|NCT02946632|Immunologic Factors|immunologic factors|mesh-ancestor
101510552|NCT02929134|Doxycycline|doxycycline|mesh-list
101510553|NCT02929134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101510554|NCT02929134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101510555|NCT02929134|Antimalarials|antimalarials|mesh-ancestor
101510556|NCT02929134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101510557|NCT02929134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101510558|NCT02929212|Acetaminophen|acetaminophen|mesh-list
101510559|NCT02929212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101510560|NCT02929212|Analgesics|analgesics|mesh-ancestor
101510561|NCT02929212|Sensory System Agents|sensory system agents|mesh-ancestor
101510562|NCT02929212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101510563|NCT02929212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510564|NCT02929212|Antipyretics|antipyretics|mesh-ancestor
101510565|NCT02929251|Adalimumab|adalimumab|mesh-list
101510566|NCT02929251|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101510567|NCT02929251|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101510568|NCT02929251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101510569|NCT02929251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101510570|NCT02929095|Midazolam|midazolam|mesh-list
101510571|NCT02929095|Dexmedetomidine|dexmedetomidine|mesh-list
101510572|NCT02929095|Remifentanil|remifentanil|mesh-list
101510573|NCT02929095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101510574|NCT02929095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101510575|NCT02929095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510576|NCT02929095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101510577|NCT02929095|Analgesics|analgesics|mesh-ancestor
101510578|NCT02929095|Sensory System Agents|sensory system agents|mesh-ancestor
101264100|NCT01765829|Sulpiride|sulpiride|mesh-list
101510579|NCT02929095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101510580|NCT02929095|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101264101|NCT01765829|Clopenthixol|clopenthixol|mesh-list
101510581|NCT02929095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101510582|NCT02929095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101510583|NCT02929095|Adrenergic Agents|adrenergic agents|mesh-ancestor
101510584|NCT02929095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101510585|NCT02929095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510586|NCT02929095|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101510587|NCT02929095|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101510588|NCT02929095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101510589|NCT02929095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101510590|NCT02929095|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101510591|NCT02929095|Anesthetics, General|anesthetics, general|mesh-ancestor
101510592|NCT02929095|Anesthetics|anesthetics|mesh-ancestor
101510593|NCT02929095|GABA Modulators|gaba modulators|mesh-ancestor
101510594|NCT02929095|GABA Agents|gaba agents|mesh-ancestor
101510595|NCT02929095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101510596|NCT02929095|Narcotics|narcotics|mesh-ancestor
101510597|NCT02928861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101510598|NCT02928861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101510599|NCT02928861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510600|NCT00525668|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
101510601|NCT00525668|Antioxidants|antioxidants|mesh-ancestor
101510602|NCT00525668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510603|NCT00525668|Protective Agents|protective agents|mesh-ancestor
101510604|NCT00525668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510605|NCT00525668|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101510606|NCT00525668|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101510607|NCT00525668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101510608|NCT00525668|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101510609|NCT00525707|Tezosentan|tezosentan|mesh-list
101510610|NCT00525707|Vasodilator Agents|vasodilator agents|mesh-ancestor
101510611|NCT00526214|Celecoxib|celecoxib|mesh-list
101510612|NCT00526214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101510613|NCT00526214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101510614|NCT00526214|Analgesics|analgesics|mesh-ancestor
101510615|NCT00526214|Sensory System Agents|sensory system agents|mesh-ancestor
101510616|NCT00526214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101510617|NCT00526214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510618|NCT00526214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101510619|NCT00526214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101510620|NCT00526214|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101510621|NCT00526214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101510622|NCT00526214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101510623|NCT00526214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510624|NCT02928510|Idelalisib|idelalisib|mesh-list
101510625|NCT02928510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101510626|NCT02928510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101510627|NCT02928510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510628|NCT02946944|Sildenafil Citrate|sildenafil citrate|mesh-list
101510629|NCT02946944|Apixaban|apixaban|mesh-list
101510630|NCT02946944|Vasodilator Agents|vasodilator agents|mesh-ancestor
101510631|NCT02946944|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101510632|NCT02946944|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101510633|NCT02946944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101510634|NCT02946944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510635|NCT02946944|Urological Agents|urological agents|mesh-ancestor
101510636|NCT02946944|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101510637|NCT02946944|Antithrombins|antithrombins|mesh-ancestor
101510638|NCT02946944|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101510639|NCT02946944|Protease Inhibitors|protease inhibitors|mesh-ancestor
101510640|NCT02946944|Anticoagulants|anticoagulants|mesh-ancestor
101510641|NCT02947061|Docetaxel|docetaxel|mesh-list
101510642|NCT02947061|Capecitabine|capecitabine|mesh-list
101510643|NCT02947061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101510644|NCT02947061|Tubulin Modulators|tubulin modulators|mesh-ancestor
101510645|NCT02947061|Antimitotic Agents|antimitotic agents|mesh-ancestor
101510646|NCT02947061|Mitosis Modulators|mitosis modulators|mesh-ancestor
101510647|NCT02947061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510648|NCT02947061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101510649|NCT02947061|Antimetabolites|antimetabolites|mesh-ancestor
101510650|NCT02928315|Magnesium Sulfate|magnesium sulfate|mesh-list
101510651|NCT02928315|Analgesics|analgesics|mesh-ancestor
101264112|NCT01765829|Dopamine Agents|dopamine agents|mesh-ancestor
101510652|NCT02928315|Sensory System Agents|sensory system agents|mesh-ancestor
101510653|NCT02928315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101510654|NCT02928315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510655|NCT02928315|Anesthetics|anesthetics|mesh-ancestor
101510656|NCT02928315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101510657|NCT02928315|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101510658|NCT02928315|Anticonvulsants|anticonvulsants|mesh-ancestor
101510659|NCT02928315|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101510660|NCT02928315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101510661|NCT02928315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510662|NCT02928315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101510663|NCT02928315|Tocolytic Agents|tocolytic agents|mesh-ancestor
101510664|NCT02928315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101510665|NCT00526409|Cytarabine|cytarabine|mesh-list
101510666|NCT00526409|Prednisolone|prednisolone|mesh-list
101510667|NCT00526409|Cyclophosphamide|cyclophosphamide|mesh-list
101510668|NCT00526409|Methotrexate|methotrexate|mesh-list
101510669|NCT00526409|Vincristine|vincristine|mesh-list
101510670|NCT00526409|Daunorubicin|daunorubicin|mesh-list
101510671|NCT00526409|Asparaginase|asparaginase|mesh-list
101510672|NCT00526409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101510673|NCT00526409|Immunologic Factors|immunologic factors|mesh-ancestor
101510674|NCT00526409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510675|NCT00526409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101510676|NCT00526409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101510677|NCT00526409|Alkylating Agents|alkylating agents|mesh-ancestor
101510678|NCT00526409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510679|NCT00526409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101510680|NCT00526409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101510681|NCT00526409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101510682|NCT00526409|Abortifacient Agents|abortifacient agents|mesh-ancestor
101510683|NCT00526409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101510684|NCT00526409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101510685|NCT00526409|Antimetabolites|antimetabolites|mesh-ancestor
101510686|NCT00526409|Dermatologic Agents|dermatologic agents|mesh-ancestor
101510687|NCT00526409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101510688|NCT00526409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101510689|NCT00526409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101510690|NCT00526409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101510691|NCT00526409|Tubulin Modulators|tubulin modulators|mesh-ancestor
101510692|NCT00526409|Antimitotic Agents|antimitotic agents|mesh-ancestor
101510693|NCT00526409|Mitosis Modulators|mitosis modulators|mesh-ancestor
101510694|NCT00526409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101510695|NCT00526409|Glucocorticoids|glucocorticoids|mesh-ancestor
101510697|NCT00526409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101510698|NCT00526409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101510699|NCT00526409|Antiviral Agents|antiviral agents|mesh-ancestor
101510700|NCT00526409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101510701|NCT00526409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101510702|NCT00526409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101510703|NCT00526409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101510704|NCT00526448|Ribavirin|ribavirin|mesh-list
101510705|NCT00526448|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101510706|NCT00526448|Antimetabolites|antimetabolites|mesh-ancestor
101510707|NCT00526448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510708|NCT00526448|Antiviral Agents|antiviral agents|mesh-ancestor
101510709|NCT00526448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101510710|NCT02946671|Nivolumab|nivolumab|mesh-list
101510711|NCT02946671|Mogamulizumab|mogamulizumab|mesh-list
101510712|NCT02946671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101510713|NCT02946671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101510714|NCT02946671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101510715|NCT02946671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510716|NCT02927886|Botulinum Toxins|botulinum toxins|mesh-list
101510717|NCT02927886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101264113|NCT01765829|Antiemetics|antiemetics|mesh-ancestor
101510718|NCT02927886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101510719|NCT02927886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510720|NCT02927886|Cholinergic Agents|cholinergic agents|mesh-ancestor
101510721|NCT02927886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101510722|NCT02927886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510723|NCT02945280|Apixaban|apixaban|mesh-list
101510724|NCT02945280|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101510725|NCT02945280|Antithrombins|antithrombins|mesh-ancestor
101510726|NCT02945280|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101510727|NCT02945280|Protease Inhibitors|protease inhibitors|mesh-ancestor
101510728|NCT02945280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101510729|NCT02945280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510730|NCT02945280|Anticoagulants|anticoagulants|mesh-ancestor
101510732|NCT02945241|Cystatins|cystatins|mesh-list
101510733|NCT02945241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101510734|NCT02945241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101410973|NCT00448786|Vitamin B Complex|vitamin b complex|mesh-ancestor
101510735|NCT02945241|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
101510736|NCT02945241|Protease Inhibitors|protease inhibitors|mesh-ancestor
101510737|NCT02945241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101510738|NCT02945241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510739|NCT00526643|Gemcitabine|gemcitabine|mesh-list
101510740|NCT00526643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101510741|NCT00526643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101510742|NCT00526643|Antimetabolites|antimetabolites|mesh-ancestor
101510743|NCT00526643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510744|NCT02945163|Tenofovir|tenofovir|mesh-list
101510745|NCT02945163|Lamivudine|lamivudine|mesh-list
101510746|NCT02945163|Efavirenz|efavirenz|mesh-list
101510747|NCT02945163|Antiviral Agents|antiviral agents|mesh-ancestor
101510748|NCT02945163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101510749|NCT02945163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101510750|NCT02945163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101510751|NCT02945163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101510752|NCT02945163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510753|NCT02945163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101510754|NCT02945163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101194471|NCT02249364|Propofol|propofol|mesh-list
101510755|NCT02945163|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101510756|NCT02945163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101510757|NCT02945163|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101510758|NCT02945163|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101510759|NCT02945163|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101510760|NCT02945163|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101510763|NCT00526760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101510764|NCT00526760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510765|NCT00526760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101510766|NCT00526760|Analgesics|analgesics|mesh-ancestor
101510767|NCT00526760|Sensory System Agents|sensory system agents|mesh-ancestor
101510768|NCT00526760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101510769|NCT00526760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101510770|NCT00526760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101510771|NCT00526760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101510772|NCT00526760|Adrenergic Agents|adrenergic agents|mesh-ancestor
101510773|NCT00526760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101510774|NCT00526760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510775|NCT02927379|Dexmedetomidine|dexmedetomidine|mesh-list
101510776|NCT02927379|Ketamine|ketamine|mesh-list
101510777|NCT02927379|Bupivacaine|bupivacaine|mesh-list
101510778|NCT02927379|Anesthetics, Local|anesthetics, local|mesh-ancestor
101510779|NCT02927379|Anesthetics|anesthetics|mesh-ancestor
101510780|NCT02927379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101510781|NCT02927379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510782|NCT02927379|Sensory System Agents|sensory system agents|mesh-ancestor
101510783|NCT02927379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101510784|NCT02927379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101264121|NCT01765829|Dopamine Agonists|dopamine agonists|mesh-ancestor
101510785|NCT02927379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101510786|NCT02927379|Analgesics|analgesics|mesh-ancestor
101510787|NCT02927379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101510788|NCT02927379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101510789|NCT02927379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101510790|NCT02927379|Adrenergic Agents|adrenergic agents|mesh-ancestor
101510791|NCT02927379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101510792|NCT02927379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510793|NCT02927379|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101510794|NCT02927379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101510795|NCT02927379|Anesthetics, General|anesthetics, general|mesh-ancestor
101510796|NCT02927379|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101510797|NCT02927379|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101510799|NCT00526877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101510800|NCT00526877|Serotonin Agents|serotonin agents|mesh-ancestor
101510801|NCT00526877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101510802|NCT00526877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510803|NCT00526877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510804|NCT00526877|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101510805|NCT00526877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101510806|NCT00526877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101510807|NCT00526877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101510808|NCT00526877|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101510809|NCT00526877|Dopamine Agents|dopamine agents|mesh-ancestor
101510810|NCT02927496|Doxycycline|doxycycline|mesh-list
101510811|NCT02927496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101510812|NCT02927496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101510813|NCT02927496|Antimalarials|antimalarials|mesh-ancestor
101510814|NCT02927496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101510815|NCT02927496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101510816|NCT02927535|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
101510817|NCT02927535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101510818|NCT00527033|Mirabegron|mirabegron|mesh-list
101510819|NCT00527033|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101510820|NCT00527033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101510821|NCT00527033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101510822|NCT00527033|Adrenergic Agents|adrenergic agents|mesh-ancestor
101510824|NCT00527033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510825|NCT00527033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510826|NCT00527033|Urological Agents|urological agents|mesh-ancestor
101510827|NCT02945072|Sevoflurane|sevoflurane|mesh-list
101510828|NCT02945072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101510829|NCT02945072|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101510830|NCT02945072|Anesthetics, General|anesthetics, general|mesh-ancestor
101510831|NCT02945072|Anesthetics|anesthetics|mesh-ancestor
101510832|NCT02945072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101510833|NCT02945072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510835|NCT02924922|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101510836|NCT02924922|Diuretics|diuretics|mesh-ancestor
101510837|NCT02924922|Natriuretic Agents|natriuretic agents|mesh-ancestor
101510838|NCT02924922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510839|NCT04692896|Lidocaine|lidocaine|mesh-list
101510840|NCT04692896|Anesthetics, Local|anesthetics, local|mesh-ancestor
101510841|NCT04692896|Anesthetics|anesthetics|mesh-ancestor
101510842|NCT04692896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101510843|NCT04692896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510844|NCT04692896|Sensory System Agents|sensory system agents|mesh-ancestor
101510845|NCT04692896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101510846|NCT04692896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101510847|NCT04692896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101510848|NCT04692896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101510849|NCT04692896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101510850|NCT04692896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318384|NCT00006026|Rubitecan|rubitecan|mesh-list
101510851|NCT00528008|Chlorhexidine|chlorhexidine|mesh-list
101510852|NCT00528008|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101264128|NCT01765829|GABA Agents|gaba agents|mesh-ancestor
101510853|NCT00528008|Povidone-Iodine|povidone-iodine|mesh-list
101510854|NCT00528008|Povidone|povidone|mesh-list
101510855|NCT00528008|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101510856|NCT00528008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101510857|NCT00528008|Disinfectants|disinfectants|mesh-ancestor
101510858|NCT00528008|Dermatologic Agents|dermatologic agents|mesh-ancestor
101510859|NCT00528008|Plasma Substitutes|plasma substitutes|mesh-ancestor
101510860|NCT00528008|Blood Substitutes|blood substitutes|mesh-ancestor
101510861|NCT04692740|Chlorambucil|chlorambucil|mesh-list
101510862|NCT04692740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101510863|NCT04692740|Alkylating Agents|alkylating agents|mesh-ancestor
101510864|NCT04692740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510865|NCT04692740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101510866|NCT02925000|Vinorelbine|vinorelbine|mesh-list
101510867|NCT02925000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101510868|NCT02925000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101510869|NCT02925000|Tubulin Modulators|tubulin modulators|mesh-ancestor
101510870|NCT02925000|Antimitotic Agents|antimitotic agents|mesh-ancestor
101510871|NCT02925000|Mitosis Modulators|mitosis modulators|mesh-ancestor
101510872|NCT02925000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510873|NCT02926989|Plasma-lyte 148|plasma-lyte 148|mesh-list
101510874|NCT02926989|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101510875|NCT02926989|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101510876|NCT02945696|Ropivacaine|ropivacaine|mesh-list
101510877|NCT02945696|Anesthetics, Local|anesthetics, local|mesh-ancestor
101510878|NCT02945696|Anesthetics|anesthetics|mesh-ancestor
101510879|NCT02945696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101510880|NCT02945696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510881|NCT02945696|Sensory System Agents|sensory system agents|mesh-ancestor
101510882|NCT02945696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101510883|NCT02924766|Prednisone|prednisone|mesh-list
101510884|NCT02924766|Abiraterone Acetate|abiraterone acetate|mesh-list
101510885|NCT02924766|Niraparib|niraparib|mesh-list
101510886|NCT02924766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101510887|NCT02924766|Glucocorticoids|glucocorticoids|mesh-ancestor
101510888|NCT02924766|Hormones|hormones|mesh-ancestor
101510889|NCT02924766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101510890|NCT02924766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510891|NCT02924766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101510892|NCT02924766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101510893|NCT02924766|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101510894|NCT02924766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101510895|NCT02924766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510896|NCT02924766|Hormone Antagonists|hormone antagonists|mesh-ancestor
101510897|NCT02924766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101510898|NCT02924766|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101510900|NCT00528281|Lapatinib|lapatinib|mesh-list
101510901|NCT00528281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101510902|NCT00528281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101510903|NCT00528281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510904|NCT00528281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101510905|NCT00528281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101510906|NCT00528281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101510907|NCT01580501|Sildenafil Citrate|sildenafil citrate|mesh-list
101510909|NCT01580501|Vasodilator Agents|vasodilator agents|mesh-ancestor
101510910|NCT01580501|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101510911|NCT01580501|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101510912|NCT01580501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101318404|NCT00016744|Protective Agents|protective agents|mesh-ancestor
101510913|NCT01580501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510914|NCT01580501|Urological Agents|urological agents|mesh-ancestor
101510915|NCT02924532|Hormones|hormones|mesh-list
101510916|NCT02924532|Parathyroid Hormone|parathyroid hormone|mesh-list
101510917|NCT02924532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101510918|NCT02924532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510919|NCT02924532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101510920|NCT00528359|Olanzapine|olanzapine|mesh-list
101510921|NCT00528359|Risperidone|risperidone|mesh-list
101510922|NCT00528359|Aripiprazole|aripiprazole|mesh-list
101510923|NCT00528359|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101510924|NCT00528359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101510925|NCT00528359|Serotonin Agents|serotonin agents|mesh-ancestor
101510926|NCT00528359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101510927|NCT00528359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510928|NCT00528359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510929|NCT00528359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101510930|NCT00528359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101510931|NCT00528359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101510932|NCT00528359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101510933|NCT00528359|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101510934|NCT00528359|Dopamine Agents|dopamine agents|mesh-ancestor
101510935|NCT00528359|Antiemetics|antiemetics|mesh-ancestor
101510936|NCT00528359|Autonomic Agents|autonomic agents|mesh-ancestor
101510937|NCT00528359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101510938|NCT00528359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101510939|NCT00528359|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101510940|NCT00528359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101510941|NCT00528359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101510942|NCT00528359|Antidepressive Agents|antidepressive agents|mesh-ancestor
101510943|NCT00528359|Dopamine Agonists|dopamine agonists|mesh-ancestor
101510944|NCT00528359|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101510945|NCT00528359|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101510946|NCT00528359|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101510947|NCT00528359|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101510948|NCT00527150|Varenicline|varenicline|mesh-list
101510949|NCT00527150|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101510950|NCT00527150|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101510951|NCT00527150|Cholinergic Agents|cholinergic agents|mesh-ancestor
101510952|NCT00527150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101510953|NCT00527150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510954|NCT00527150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510955|NCT00527228|Deflazacort|deflazacort|mesh-list
101510956|NCT00527228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101510957|NCT00527228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101510958|NCT00527228|Immunologic Factors|immunologic factors|mesh-ancestor
101510959|NCT00527228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510960|NCT00527267|Cinacalcet|cinacalcet|mesh-list
101510961|NCT00527267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101510962|NCT00527267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510963|NCT00527267|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101510964|NCT00527267|Hormone Antagonists|hormone antagonists|mesh-ancestor
101510965|NCT00527267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101510966|NCT02924454|Metoprolol|metoprolol|mesh-list
101510967|NCT02924454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101510968|NCT02924454|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101510969|NCT02924454|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
101510970|NCT02924454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101510971|NCT02924454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101510972|NCT02924454|Sympatholytics|sympatholytics|mesh-ancestor
101510973|NCT02924454|Autonomic Agents|autonomic agents|mesh-ancestor
101510974|NCT02924454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101194697|NCT00552708|Lisinopril|lisinopril|mesh-list
101510976|NCT02924454|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101510977|NCT02924454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101510978|NCT02924454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101510979|NCT02924454|Adrenergic Agents|adrenergic agents|mesh-ancestor
101510980|NCT02924454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101510981|NCT02924454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318417|NCT00016861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101510982|NCT02924454|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101510984|NCT02924337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101510985|NCT02924337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101510986|NCT02924337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101510987|NCT02924337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101510988|NCT02924337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101510989|NCT02924337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101510990|NCT02924337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101510992|NCT00528515|Desflurane|desflurane|mesh-list
101510993|NCT00528515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101510994|NCT00528515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101510995|NCT00528515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101510996|NCT00528515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101510997|NCT00528515|Anesthetics, General|anesthetics, general|mesh-ancestor
101510998|NCT00528515|Anesthetics|anesthetics|mesh-ancestor
101510999|NCT00528515|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101511000|NCT02923986|Dasatinib|dasatinib|mesh-list
101511001|NCT02923986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101511002|NCT02923986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101511003|NCT02923986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101511004|NCT02923986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511005|NCT02926248|Colchicine|colchicine|mesh-list
101511006|NCT02926248|Gout Suppressants|gout suppressants|mesh-ancestor
101511007|NCT02926248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101511008|NCT02926248|Tubulin Modulators|tubulin modulators|mesh-ancestor
101511009|NCT02926248|Antimitotic Agents|antimitotic agents|mesh-ancestor
101511010|NCT02926248|Mitosis Modulators|mitosis modulators|mesh-ancestor
101511011|NCT02926248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511012|NCT02926248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101511013|NCT00528593|Epoetin Alfa|epoetin alfa|mesh-list
101511014|NCT00528593|Hematinics|hematinics|mesh-ancestor
101511015|NCT02926326|Azithromycin|azithromycin|mesh-list
101511016|NCT02926326|Acumapimod|acumapimod|mesh-list
101511017|NCT02926326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101511018|NCT02926326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101511019|NCT02926326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101511020|NCT02926326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101511021|NCT02926326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511022|NCT00528671|Phenprocoumon|phenprocoumon|mesh-list
101511023|NCT00528671|Anticoagulants|anticoagulants|mesh-ancestor
101511024|NCT00528827|Nicardipine|nicardipine|mesh-list
101511025|NCT00528827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101511026|NCT00528827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101511027|NCT00528827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101511028|NCT00528827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511029|NCT00528827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101511030|NCT00528827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511031|NCT00528827|Vasodilator Agents|vasodilator agents|mesh-ancestor
101511032|NCT02926170|Rivaroxaban|rivaroxaban|mesh-list
101511033|NCT02926170|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101511034|NCT02926170|Antithrombins|antithrombins|mesh-ancestor
101511035|NCT02926170|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101511036|NCT02926170|Protease Inhibitors|protease inhibitors|mesh-ancestor
101511037|NCT02926170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101511038|NCT02926170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511039|NCT02926170|Anticoagulants|anticoagulants|mesh-ancestor
101511040|NCT04691765|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101511041|NCT04691765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101511042|NCT04691687|Furosemide|furosemide|mesh-list
101511043|NCT04691687|Diuretics|diuretics|mesh-ancestor
101511044|NCT04691687|Natriuretic Agents|natriuretic agents|mesh-ancestor
101511045|NCT04691687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511046|NCT04691687|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101511047|NCT04691687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101194769|NCT03839550|Apatinib|apatinib|mesh-list
101511048|NCT04691687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511049|NCT04107675|Cyclosporine|cyclosporine|mesh-list
101511050|NCT04107675|Cyclosporins|cyclosporins|mesh-list
101511051|NCT04107675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101511052|NCT04107675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318420|NCT00016900|Paclitaxel|paclitaxel|mesh-list
101511053|NCT04107675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101511054|NCT04107675|Immunologic Factors|immunologic factors|mesh-ancestor
101511055|NCT04107675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511056|NCT04107675|Antifungal Agents|antifungal agents|mesh-ancestor
101511057|NCT04107675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101511058|NCT04107675|Dermatologic Agents|dermatologic agents|mesh-ancestor
101511059|NCT04107675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101511060|NCT04107675|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101511061|NCT02923869|Bupivacaine|bupivacaine|mesh-list
101511062|NCT02923869|Levobupivacaine|levobupivacaine|mesh-list
101511063|NCT02923869|Anesthetics, Local|anesthetics, local|mesh-ancestor
101511064|NCT02923869|Anesthetics|anesthetics|mesh-ancestor
101511065|NCT02923869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101511066|NCT02923869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511067|NCT02923869|Sensory System Agents|sensory system agents|mesh-ancestor
101511068|NCT02923869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101511069|NCT02923791|Lenograstim|lenograstim|mesh-list
101511070|NCT02923791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101511071|NCT02923791|Immunologic Factors|immunologic factors|mesh-ancestor
101511072|NCT02923791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511073|NCT00527540|Interferons|interferons|mesh-list
101511075|NCT00527540|Interferon-alpha|interferon-alpha|mesh-list
101511076|NCT00527540|Interferon alpha-2|interferon alpha-2|mesh-list
101511077|NCT00527540|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101511078|NCT00527540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101511079|NCT00527540|Antiviral Agents|antiviral agents|mesh-ancestor
101511080|NCT00527540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101511081|NCT00527540|Antimetabolites|antimetabolites|mesh-ancestor
101511082|NCT00527540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511083|NCT00527540|Immunologic Factors|immunologic factors|mesh-ancestor
101511084|NCT00527540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511085|NCT02926053|Cyclophosphamide|cyclophosphamide|mesh-list
101511086|NCT02926053|Fludarabine|fludarabine|mesh-list
101511087|NCT02926053|Interleukin-2|interleukin-2|mesh-list
101511088|NCT02926053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101511089|NCT02926053|Immunologic Factors|immunologic factors|mesh-ancestor
101511090|NCT02926053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511091|NCT02926053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101511092|NCT02926053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101511093|NCT02926053|Alkylating Agents|alkylating agents|mesh-ancestor
101511094|NCT02926053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511095|NCT02926053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101511096|NCT02926053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101511097|NCT02926053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101511098|NCT02926053|Analgesics|analgesics|mesh-ancestor
101511099|NCT02926053|Sensory System Agents|sensory system agents|mesh-ancestor
101511100|NCT02926053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101511101|NCT00527657|Thalidomide|thalidomide|mesh-list
101511102|NCT00527657|Temozolomide|temozolomide|mesh-list
101511103|NCT00527657|Lomustine|lomustine|mesh-list
101511104|NCT00527657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101511105|NCT00527657|Alkylating Agents|alkylating agents|mesh-ancestor
101511106|NCT00527657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511107|NCT00527657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101511108|NCT00527657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101511109|NCT00527657|Immunologic Factors|immunologic factors|mesh-ancestor
101511110|NCT00527657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511111|NCT00527657|Leprostatic Agents|leprostatic agents|mesh-ancestor
101511112|NCT00527657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101511113|NCT00527657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101511114|NCT00527657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101511115|NCT00527657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101511116|NCT00527657|Growth Substances|growth substances|mesh-ancestor
101511117|NCT00527657|Growth Inhibitors|growth inhibitors|mesh-ancestor
101511118|NCT00528983|Azacitidine|azacitidine|mesh-list
101511120|NCT00528983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101194869|NCT05440578|Olaparib|olaparib|mesh-list
101264159|NCT01766089|Remifentanil|remifentanil|mesh-list
101511122|NCT00528983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511123|NCT00528983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101511124|NCT00528983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101511125|NCT00529022|Carboplatin|carboplatin|mesh-list
101511126|NCT00529022|Azacitidine|azacitidine|mesh-list
101511127|NCT00529022|Valproic Acid|valproic acid|mesh-list
101511128|NCT00529022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101511129|NCT00529022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101511131|NCT00529022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511132|NCT00529022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101511133|NCT00529022|Anticonvulsants|anticonvulsants|mesh-ancestor
101511134|NCT00529022|GABA Agents|gaba agents|mesh-ancestor
101511135|NCT00529022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101511136|NCT00529022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511137|NCT00529022|Antimanic Agents|antimanic agents|mesh-ancestor
101511138|NCT00529022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101511139|NCT00529022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101511140|NCT00529022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101511141|NCT02923557|Pirarubicin|pirarubicin|mesh-list
101511142|NCT02923557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101511143|NCT02925975|Carvedilol|carvedilol|mesh-list
101511144|NCT02925975|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101511145|NCT02925975|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101511146|NCT02925975|Adrenergic Agents|adrenergic agents|mesh-ancestor
101511147|NCT02925975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101511148|NCT02925975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511149|NCT02925975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511150|NCT02925975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101511151|NCT02925975|Antioxidants|antioxidants|mesh-ancestor
101511152|NCT02925975|Protective Agents|protective agents|mesh-ancestor
101511153|NCT02925975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101511154|NCT02925975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101511155|NCT02925975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101511156|NCT02925975|Vasodilator Agents|vasodilator agents|mesh-ancestor
101511157|NCT02925975|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101511158|NCT02925975|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101511159|NCT02945033|Aspirin|aspirin|mesh-list
101511160|NCT02945033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101511161|NCT02945033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101511162|NCT02945033|Analgesics|analgesics|mesh-ancestor
101511163|NCT02945033|Sensory System Agents|sensory system agents|mesh-ancestor
101511164|NCT02945033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101511165|NCT02945033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511166|NCT02945033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101511167|NCT02945033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101511168|NCT02945033|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101511169|NCT02945033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101511170|NCT02945033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511171|NCT02945033|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101511172|NCT02945033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101511173|NCT02945033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101511174|NCT02945033|Antipyretics|antipyretics|mesh-ancestor
101511175|NCT04231968|Ziresovir|ziresovir|mesh-list
101511176|NCT04231968|Antiviral Agents|antiviral agents|mesh-ancestor
101264168|NCT01766089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101511177|NCT04231968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101511178|NCT00529295|Misoprostol|misoprostol|mesh-list
101511179|NCT00529295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101511180|NCT00529295|Abortifacient Agents|abortifacient agents|mesh-ancestor
101511181|NCT00529295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101511182|NCT00529295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511183|NCT00529295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101511184|NCT00529295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101511185|NCT00529295|Oxytocics|oxytocics|mesh-ancestor
101511186|NCT02922933|Entinostat|entinostat|mesh-list
101511187|NCT02922933|Omeprazole|omeprazole|mesh-list
101511188|NCT02922933|Famotidine|famotidine|mesh-list
101511189|NCT02922933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101511190|NCT02922933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101511191|NCT02922933|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101511192|NCT02922933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101511193|NCT02922933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318429|NCT00016939|Growth Inhibitors|growth inhibitors|mesh-ancestor
101511194|NCT02922933|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101511195|NCT02922933|Histamine Antagonists|histamine antagonists|mesh-ancestor
101511196|NCT02922933|Histamine Agents|histamine agents|mesh-ancestor
101511197|NCT02922933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101511198|NCT02922933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511199|NCT02922933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101511200|NCT02922933|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101511201|NCT02945267|Tegafur|tegafur|mesh-list
101511202|NCT02945267|Nimotuzumab|nimotuzumab|mesh-list
101511203|NCT02945267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101511204|NCT02945267|Antimetabolites|antimetabolites|mesh-ancestor
101511205|NCT02945267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511206|NCT02945267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101511207|NCT02945267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101511208|NCT00529646|APD791|apd791|mesh-list
101511209|NCT00529646|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101511210|NCT00529646|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101511211|NCT00529646|Serotonin Agents|serotonin agents|mesh-ancestor
101511212|NCT00529646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101511213|NCT00529646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511214|NCT00529646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511215|NCT00527930|Oxaliplatin|oxaliplatin|mesh-list
101511216|NCT00527930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101511217|NCT00529841|Hydrocortisone|hydrocortisone|mesh-list
101511218|NCT00529841|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101511219|NCT00529841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101511220|NCT00529880|Cytarabine|cytarabine|mesh-list
101511221|NCT00529880|Fludarabine|fludarabine|mesh-list
101511222|NCT00529880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101511223|NCT00529880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101511224|NCT00529880|Antimetabolites|antimetabolites|mesh-ancestor
101511225|NCT00529880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511226|NCT00529880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101511227|NCT00529880|Immunologic Factors|immunologic factors|mesh-ancestor
101511228|NCT00529880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511229|NCT00529880|Antiviral Agents|antiviral agents|mesh-ancestor
101511230|NCT00529880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101511231|NCT02925702|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
101511232|NCT02925702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101511233|NCT00531089|Rituximab|rituximab|mesh-list
101511234|NCT00531089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101511235|NCT00531089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101511236|NCT00531089|Immunologic Factors|immunologic factors|mesh-ancestor
101264184|NCT01766180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511237|NCT00531089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511238|NCT00531089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101511239|NCT02922699|Omeprazole|omeprazole|mesh-list
101511240|NCT02922699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101511241|NCT02922699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101511242|NCT02922699|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101511243|NCT02922699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101511244|NCT02922699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511245|NCT02922660|Remifentanil|remifentanil|mesh-list
101511246|NCT02922660|Anesthetics|anesthetics|mesh-list
101511247|NCT02922660|Propofol|propofol|mesh-list
101511248|NCT02922660|Desflurane|desflurane|mesh-list
101511249|NCT02922660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101511250|NCT02922660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511251|NCT02922660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101511252|NCT02922660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101511253|NCT02922660|Anesthetics, General|anesthetics, general|mesh-ancestor
101511254|NCT02922660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101511255|NCT02922660|Narcotics|narcotics|mesh-ancestor
101511256|NCT02922660|Analgesics|analgesics|mesh-ancestor
101511257|NCT02922660|Sensory System Agents|sensory system agents|mesh-ancestor
101511258|NCT02922660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101511259|NCT02922660|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101511260|NCT02922465|Clopidogrel|clopidogrel|mesh-list
101318433|NCT00016939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101511261|NCT02922465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101511262|NCT02922465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101511263|NCT02922465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101511264|NCT02922465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101511265|NCT02922465|Purinergic Agents|purinergic agents|mesh-ancestor
101511266|NCT02922465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101511267|NCT02922465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511268|NCT02922465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511270|NCT02944292|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101511271|NCT02944292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101511272|NCT02944292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511273|NCT02944292|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101511274|NCT02944292|Anesthetics, General|anesthetics, general|mesh-ancestor
101511275|NCT02944292|Anesthetics|anesthetics|mesh-ancestor
101511276|NCT02922426|Olanzapine|olanzapine|mesh-list
101511277|NCT02922426|Antiemetics|antiemetics|mesh-ancestor
101511278|NCT02922426|Autonomic Agents|autonomic agents|mesh-ancestor
101511279|NCT02922426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101511280|NCT02922426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511281|NCT02922426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101511282|NCT02922426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101511283|NCT02922426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101511284|NCT02922426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101511285|NCT02922426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101511286|NCT02922426|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101511287|NCT02922426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101511288|NCT02922426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101511289|NCT02922426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511290|NCT02922426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101511291|NCT02922426|Serotonin Agents|serotonin agents|mesh-ancestor
101511292|NCT00531128|Gamma-sitosterol|gamma-sitosterol|mesh-list
101511293|NCT00531128|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101511294|NCT00531128|Antimetabolites|antimetabolites|mesh-ancestor
101511295|NCT00531128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511296|NCT00531128|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101511297|NCT02925351|Clofarabine|clofarabine|mesh-list
101511298|NCT02925351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101511299|NCT02925351|Antimetabolites|antimetabolites|mesh-ancestor
101511300|NCT02925351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511301|NCT02925351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101511302|NCT00531167|Lamivudine|lamivudine|mesh-list
101511303|NCT00531167|Adefovir|adefovir|mesh-list
101511304|NCT00531167|Entecavir|entecavir|mesh-list
101511305|NCT00531167|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101511306|NCT00531167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101511307|NCT00531167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101511308|NCT00531167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511309|NCT00531167|Antiviral Agents|antiviral agents|mesh-ancestor
101511310|NCT00531167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101511311|NCT00531167|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101511312|NCT00531167|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101511313|NCT02944214|Febuxostat|febuxostat|mesh-list
101511314|NCT02944214|Benzbromarone|benzbromarone|mesh-list
101511315|NCT02944214|Gout Suppressants|gout suppressants|mesh-ancestor
101511316|NCT02944214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101511317|NCT02944214|Uricosuric Agents|uricosuric agents|mesh-ancestor
101511318|NCT02922075|Amoxicillin|amoxicillin|mesh-list
101511319|NCT02922075|Chlorhexidine|chlorhexidine|mesh-list
101511320|NCT02922075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101511321|NCT02922075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101511322|NCT02922075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101511323|NCT02922075|Disinfectants|disinfectants|mesh-ancestor
101511324|NCT00531245|Oxaliplatin|oxaliplatin|mesh-list
101511325|NCT00531245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101511326|NCT02922348|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101511327|NCT02922348|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101511328|NCT02922348|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101511329|NCT02922348|Medroxyprogesterone|medroxyprogesterone|mesh-list
101511330|NCT02922348|Norgestimate|norgestimate|mesh-list
101511331|NCT02922348|Contraceptive Agents|contraceptive agents|mesh-list
101511332|NCT02922348|Contraceptives, Oral|contraceptives, oral|mesh-list
101511333|NCT02922348|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
101511334|NCT02922348|Hormones|hormones|mesh-list
101511335|NCT02922348|Estradiol|estradiol|mesh-list
101511336|NCT02922348|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101511337|NCT02922348|Progestins|progestins|mesh-list
101511338|NCT02922348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101511339|NCT02922348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511340|NCT02922348|Estrogens|estrogens|mesh-ancestor
101511341|NCT02922348|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101511342|NCT02922348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101511343|NCT02922348|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101511344|NCT02922348|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101511345|NCT02922348|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101511346|NCT00527501|Travoprost|travoprost|mesh-list
101511347|NCT00527501|Brinzolamide|brinzolamide|mesh-list
101511348|NCT00527501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101511349|NCT00527501|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101511350|NCT00527501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101511351|NCT00527501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511353|NCT02922387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101511354|NCT02922387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101511355|NCT02922387|Cholinergic Agents|cholinergic agents|mesh-ancestor
101511356|NCT02922387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101511357|NCT02922387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511358|NCT02922387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511359|NCT00531323|Etravirine|etravirine|mesh-list
101511360|NCT00531323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101511361|NCT00531323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101511362|NCT00531323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101511363|NCT00531323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511364|NCT00531323|Antiviral Agents|antiviral agents|mesh-ancestor
101511365|NCT00531323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101511366|NCT00531362|Aspirin|aspirin|mesh-list
101511367|NCT00531362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101511368|NCT00531362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101511369|NCT00531362|Analgesics|analgesics|mesh-ancestor
101511370|NCT00531362|Sensory System Agents|sensory system agents|mesh-ancestor
101511371|NCT00531362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101511372|NCT00531362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264200|NCT01766323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101511373|NCT00531362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101511374|NCT00531362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101511375|NCT00531362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101511376|NCT00531362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101511377|NCT00531362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511378|NCT00531362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101511379|NCT00531362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101511380|NCT00531362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101511381|NCT00531362|Antipyretics|antipyretics|mesh-ancestor
101511382|NCT00531401|Farnesylthiosalicylic acid|farnesylthiosalicylic acid|mesh-list
101511383|NCT00531401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101511384|NCT00531401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101511385|NCT00531401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511387|NCT00531440|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101511388|NCT00531440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101511389|NCT00531440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101511390|NCT00531440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511391|NCT00531440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101511392|NCT00531440|Immunologic Factors|immunologic factors|mesh-ancestor
101511393|NCT00531440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511394|NCT00531440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101511395|NCT02944526|Ropivacaine|ropivacaine|mesh-list
101511396|NCT02944526|Anesthetics, Local|anesthetics, local|mesh-ancestor
101511397|NCT02944526|Anesthetics|anesthetics|mesh-ancestor
101511398|NCT02944526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101511399|NCT02944526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511400|NCT02944526|Sensory System Agents|sensory system agents|mesh-ancestor
101511401|NCT02944526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101511402|NCT04000854|Calcium|calcium|mesh-list
101511403|NCT04000854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101511404|NCT04000854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511405|NCT00530387|Ibuprofen|ibuprofen|mesh-list
101511406|NCT00530387|Diclofenac|diclofenac|mesh-list
101511407|NCT00530387|Ketoprofen|ketoprofen|mesh-list
101511408|NCT00530387|Piroxicam|piroxicam|mesh-list
101511409|NCT00530387|Salicylates|salicylates|mesh-list
101511410|NCT00530387|Etofenamate|etofenamate|mesh-list
101511411|NCT00530387|Sunscreening Agents|sunscreening agents|mesh-list
101511412|NCT00530387|Homosalate|homosalate|mesh-list
101511413|NCT00530387|Octylmethoxycinnamate|octylmethoxycinnamate|mesh-list
101511414|NCT00530387|Benzophenone|benzophenone|mesh-list
101511415|NCT00530387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101511416|NCT00530387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101511417|NCT00530387|Analgesics|analgesics|mesh-ancestor
101511418|NCT00530387|Sensory System Agents|sensory system agents|mesh-ancestor
101511419|NCT00530387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101511420|NCT00530387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511421|NCT00530387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101511422|NCT00530387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101511423|NCT00530387|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101511424|NCT00530387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101511425|NCT00530387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195139|NCT05604599|Cisatracurium|cisatracurium|mesh-list
101511426|NCT00530387|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101511427|NCT00530387|Protective Agents|protective agents|mesh-ancestor
101511428|NCT00530387|Dermatologic Agents|dermatologic agents|mesh-ancestor
101511429|NCT00530387|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101511430|NCT04689165|Vaccines|vaccines|mesh-list
101511431|NCT04689165|Immunologic Factors|immunologic factors|mesh-ancestor
101511432|NCT04689165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511433|NCT00530582|Progesterone|progesterone|mesh-list
101511434|NCT00530582|Progestins|progestins|mesh-ancestor
101511435|NCT00530582|Hormones|hormones|mesh-ancestor
101511436|NCT00530582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101511437|NCT00530582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264207|NCT01766375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101511438|NCT02944175|Neostigmine|neostigmine|mesh-list
101511439|NCT02944175|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101511440|NCT02944175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101511441|NCT02944175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511442|NCT02944175|Cholinergic Agents|cholinergic agents|mesh-ancestor
101511443|NCT02944175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101511444|NCT02944175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511445|NCT02944175|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101511446|NCT02944175|Autonomic Agents|autonomic agents|mesh-ancestor
101511447|NCT02944175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101511448|NCT02917746|Imiquimod|imiquimod|mesh-list
101511449|NCT02917746|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101511450|NCT02917746|Immunologic Factors|immunologic factors|mesh-ancestor
101511451|NCT02917746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511452|NCT02917746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101511453|NCT02917746|Interferon Inducers|interferon inducers|mesh-ancestor
101511454|NCT00531557|Ritonavir|ritonavir|mesh-list
101511455|NCT00531557|Darunavir|darunavir|mesh-list
101511456|NCT00531557|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101511457|NCT00531557|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101511458|NCT00531557|Protease Inhibitors|protease inhibitors|mesh-ancestor
101511459|NCT00531557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101511460|NCT00531557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511461|NCT00531557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101511462|NCT00531557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101511463|NCT00531557|Antiviral Agents|antiviral agents|mesh-ancestor
101511464|NCT00531557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101511465|NCT00531557|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101511466|NCT00531557|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101511468|NCT00531596|Antidepressive Agents|antidepressive agents|mesh-ancestor
101511469|NCT00531596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101511470|NCT00531596|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101511471|NCT00531596|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101511472|NCT00531596|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101511473|NCT00531596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101511474|NCT00531596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511475|NCT00531596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101410985|NCT00448825|Topiramate|topiramate|mesh-list
101511476|NCT00531596|Protective Agents|protective agents|mesh-ancestor
101511477|NCT00531596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511478|NCT02943707|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101511479|NCT02943707|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101511480|NCT02943707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101511481|NCT00531635|Mycophenolic Acid|mycophenolic acid|mesh-list
101511482|NCT00531635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101511483|NCT00531635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101511484|NCT00531635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101511485|NCT00531635|Antitubercular Agents|antitubercular agents|mesh-ancestor
101511486|NCT00531635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101511487|NCT00531635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101511488|NCT00531635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101511489|NCT00531635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511490|NCT02917551|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101511491|NCT02917551|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101511492|NCT02917551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101511493|NCT02917551|Antitubercular Agents|antitubercular agents|mesh-ancestor
101511494|NCT00531674|Tocopherols|tocopherols|mesh-list
101511495|NCT00531674|Antioxidants|antioxidants|mesh-ancestor
101511496|NCT00531674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511497|NCT00531674|Protective Agents|protective agents|mesh-ancestor
101511498|NCT00531674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511499|NCT00531674|Vitamins|vitamins|mesh-ancestor
101511500|NCT00531674|Micronutrients|micronutrients|mesh-ancestor
101511501|NCT00530972|Ribavirin|ribavirin|mesh-list
101511502|NCT00530972|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101511503|NCT00530972|Antimetabolites|antimetabolites|mesh-ancestor
101511504|NCT00530972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511505|NCT00530972|Antiviral Agents|antiviral agents|mesh-ancestor
101511506|NCT00530972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101511507|NCT02943317|Avelumab|avelumab|mesh-list
101511508|NCT02943317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101511510|NCT02943356|Tadalafil|tadalafil|mesh-list
101511511|NCT02943356|Vasodilator Agents|vasodilator agents|mesh-ancestor
101511512|NCT02943356|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101511513|NCT02943356|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101511514|NCT02943356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101511515|NCT02943356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511516|NCT02943356|Urological Agents|urological agents|mesh-ancestor
101511517|NCT02917512|Cyclosporine|cyclosporine|mesh-list
101511518|NCT02917512|Cyclosporins|cyclosporins|mesh-list
101511519|NCT02917512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101511520|NCT02917512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511521|NCT02917512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101511523|NCT02917512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511524|NCT02917512|Antifungal Agents|antifungal agents|mesh-ancestor
101511525|NCT02917512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101511526|NCT02917512|Dermatologic Agents|dermatologic agents|mesh-ancestor
101511527|NCT02917512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101511528|NCT02917512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101511529|NCT02943902|Vaccines|vaccines|mesh-list
101511530|NCT02943902|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101511531|NCT02943902|Immunologic Factors|immunologic factors|mesh-ancestor
101511532|NCT02943902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511533|NCT00531908|Furosemide|furosemide|mesh-list
101511534|NCT00531908|Diuretics|diuretics|mesh-ancestor
101511535|NCT00531908|Natriuretic Agents|natriuretic agents|mesh-ancestor
101511536|NCT00531908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511537|NCT00531908|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101511538|NCT00531908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101511539|NCT00531908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511540|NCT03403569|Triptolide|triptolide|mesh-list
101511541|NCT03403569|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
101511542|NCT03403569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511543|NCT03403569|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101511545|NCT03403569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101511546|NCT03403569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101511547|NCT03403569|Immunologic Factors|immunologic factors|mesh-ancestor
101511548|NCT03403569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101511549|NCT03403569|Alkylating Agents|alkylating agents|mesh-ancestor
101511550|NCT03403569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511551|NCT03403569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101511552|NCT00531791|Prednisone|prednisone|mesh-list
101511553|NCT00531791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101511554|NCT00531791|Glucocorticoids|glucocorticoids|mesh-ancestor
101511555|NCT00531791|Hormones|hormones|mesh-ancestor
101511556|NCT00531791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101511557|NCT00531791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511558|NCT00531791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101511559|NCT00531791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101511560|NCT02921178|Omalizumab|omalizumab|mesh-list
101511561|NCT02921178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101511562|NCT02921178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101511563|NCT02921178|Respiratory System Agents|respiratory system agents|mesh-ancestor
101511564|NCT00531986|Lopinavir|lopinavir|mesh-list
101511565|NCT00531986|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101511566|NCT00531986|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101511567|NCT00531986|Protease Inhibitors|protease inhibitors|mesh-ancestor
101511568|NCT00531986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101511569|NCT00531986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511570|NCT00531986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101511571|NCT00531986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101511572|NCT00531986|Antiviral Agents|antiviral agents|mesh-ancestor
101511573|NCT00531986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101511574|NCT00531986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101511575|NCT00531986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101511576|NCT02920827|Dapivirine|dapivirine|mesh-list
101511577|NCT02920827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101511578|NCT02920827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101511580|NCT02920827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101511581|NCT02920905|Lidocaine|lidocaine|mesh-list
101511582|NCT02920905|Atracurium|atracurium|mesh-list
101511583|NCT02920905|Anesthetics, Local|anesthetics, local|mesh-ancestor
101511584|NCT02920905|Anesthetics|anesthetics|mesh-ancestor
101511585|NCT02920905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101511586|NCT02920905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511587|NCT02920905|Sensory System Agents|sensory system agents|mesh-ancestor
101511588|NCT02920905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101511589|NCT02920905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101511590|NCT02920905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101511592|NCT02920905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101511593|NCT02920905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511594|NCT02920905|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101511595|NCT02920905|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101511596|NCT02920905|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101511597|NCT02920905|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101511598|NCT02920905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101511599|NCT02920905|Cholinergic Agents|cholinergic agents|mesh-ancestor
101511600|NCT02920905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101511605|NCT02917200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101511606|NCT02917200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101511607|NCT02917200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511608|NCT02917200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101511609|NCT02920515|Leuprolide|leuprolide|mesh-list
101511610|NCT02920515|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101511611|NCT02920515|Fertility Agents|fertility agents|mesh-ancestor
101511612|NCT02920515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101511613|NCT02920515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511614|NCT02920515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101511615|NCT02920515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101511616|NCT02917005|Palbociclib|palbociclib|mesh-list
101511617|NCT02917005|Exemestane|exemestane|mesh-list
101511618|NCT02917005|Goserelin|goserelin|mesh-list
101511619|NCT02917005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101511620|NCT02917005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101511621|NCT02917005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101511622|NCT02917005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511623|NCT02917005|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101511624|NCT02917005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101511625|NCT02917005|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101511626|NCT02917005|Hormone Antagonists|hormone antagonists|mesh-ancestor
101511627|NCT02917005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101511628|NCT02917005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511629|NCT02917005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101511631|NCT02942810|Cefepime-zidebactam|cefepime-zidebactam|mesh-list
101511632|NCT02942810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101511633|NCT02942810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101511634|NCT02920710|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101511636|NCT02920710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101511637|NCT02920710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511638|NCT02941913|Palonosetron|palonosetron|mesh-list
101511639|NCT02941913|Antiemetics|antiemetics|mesh-ancestor
101511640|NCT02941913|Autonomic Agents|autonomic agents|mesh-ancestor
101511641|NCT02941913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101511642|NCT02941913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511643|NCT02941913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101511644|NCT02941913|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101511645|NCT02941913|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101511646|NCT02941913|Serotonin Agents|serotonin agents|mesh-ancestor
101511647|NCT02941913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101511648|NCT02941913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511649|NCT02942693|Apatinib|apatinib|mesh-list
101511650|NCT02942693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101511651|NCT02942693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101511652|NCT02942693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101511653|NCT02942693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511654|NCT02920593|Vitamin D|vitamin d|mesh-list
101511655|NCT02920593|Ergocalciferols|ergocalciferols|mesh-list
101511656|NCT02920593|Cholecalciferol|cholecalciferol|mesh-list
101511657|NCT02920593|Vitamins|vitamins|mesh-list
101511658|NCT02920593|Micronutrients|micronutrients|mesh-ancestor
101511659|NCT02920593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511660|NCT02920593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101511661|NCT02920593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101511663|NCT02942732|Vitamin D|vitamin d|mesh-list
101511664|NCT02942732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101511665|NCT02942732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511666|NCT02942732|Vitamins|vitamins|mesh-ancestor
101511667|NCT02942732|Micronutrients|micronutrients|mesh-ancestor
101511668|NCT02942732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101511669|NCT02942420|Bucillamine|bucillamine|mesh-list
101511670|NCT02942420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101511671|NCT02942420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101511672|NCT02942420|Analgesics|analgesics|mesh-ancestor
101511673|NCT02942420|Sensory System Agents|sensory system agents|mesh-ancestor
101511674|NCT02942420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101511675|NCT02942420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511676|NCT02942420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101511677|NCT02942420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101511678|NCT02942420|Antioxidants|antioxidants|mesh-ancestor
101511679|NCT02942420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511680|NCT02942420|Protective Agents|protective agents|mesh-ancestor
101511681|NCT02920359|Leuprolide|leuprolide|mesh-list
101511682|NCT02920359|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101511683|NCT02920359|Fertility Agents|fertility agents|mesh-ancestor
101511684|NCT02920359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101511685|NCT02920359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511686|NCT02920359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101511687|NCT02920359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101511688|NCT02916654|Iron|iron|mesh-list
101511689|NCT02916654|Trace Elements|trace elements|mesh-ancestor
101511690|NCT02916654|Micronutrients|micronutrients|mesh-ancestor
101511691|NCT02916654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511693|NCT02941562|Fluorouracil|fluorouracil|mesh-list
101511694|NCT02941562|Oxaliplatin|oxaliplatin|mesh-list
101511695|NCT02941562|Antimetabolites|antimetabolites|mesh-ancestor
101511696|NCT02941562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511697|NCT02941562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101511698|NCT02941562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101511699|NCT02941562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101511700|NCT02941562|Immunologic Factors|immunologic factors|mesh-ancestor
101511701|NCT02941562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511702|NCT02941562|Antidotes|antidotes|mesh-ancestor
101511703|NCT02941562|Protective Agents|protective agents|mesh-ancestor
101511704|NCT02941562|Vitamin B Complex|vitamin b complex|mesh-ancestor
101511705|NCT02941562|Vitamins|vitamins|mesh-ancestor
101511706|NCT02941562|Micronutrients|micronutrients|mesh-ancestor
101511707|NCT02942888|Niacinamide|niacinamide|mesh-list
101511708|NCT02942888|Niacin|niacin|mesh-list
101511709|NCT02942888|Nicotinic Acids|nicotinic acids|mesh-list
101511710|NCT02942888|Vitamin B Complex|vitamin b complex|mesh-ancestor
101511711|NCT02942888|Vitamins|vitamins|mesh-ancestor
101511712|NCT02942888|Micronutrients|micronutrients|mesh-ancestor
101511713|NCT02942888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511714|NCT02942888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101511715|NCT02942888|Antimetabolites|antimetabolites|mesh-ancestor
101511716|NCT02942888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511717|NCT02942888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101511718|NCT02942888|Vasodilator Agents|vasodilator agents|mesh-ancestor
101511719|NCT02916420|Dexamethasone|dexamethasone|mesh-list
101511720|NCT02916420|Pomalidomide|pomalidomide|mesh-list
101511721|NCT02916420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101511722|NCT02916420|Antiemetics|antiemetics|mesh-ancestor
101511723|NCT02916420|Autonomic Agents|autonomic agents|mesh-ancestor
101511724|NCT02916420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101511725|NCT02916420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511726|NCT02916420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101511728|NCT02916420|Hormones|hormones|mesh-ancestor
101264221|NCT01766375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101511729|NCT02916420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101511730|NCT02916420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101511732|NCT02916420|Immunologic Factors|immunologic factors|mesh-ancestor
101511733|NCT02916420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101511734|NCT02916420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101511735|NCT02916420|Growth Substances|growth substances|mesh-ancestor
101511736|NCT02916420|Growth Inhibitors|growth inhibitors|mesh-ancestor
101511737|NCT02942381|Hydroxychloroquine|hydroxychloroquine|mesh-list
101511738|NCT02942381|Antimalarials|antimalarials|mesh-ancestor
101511739|NCT02942381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101511740|NCT02942381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101511741|NCT02942381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101511742|NCT02942381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101511743|NCT02942381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511744|NCT02942381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101511745|NCT03458468|Tranexamic Acid|tranexamic acid|mesh-list
101511746|NCT03458468|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101511747|NCT03458468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101511748|NCT03458468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511749|NCT03458468|Hemostatics|hemostatics|mesh-ancestor
101511750|NCT03458468|Coagulants|coagulants|mesh-ancestor
101511751|NCT02942303|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101511752|NCT02942303|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101511753|NCT02942303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101511754|NCT02942303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511755|NCT02942303|Cholinergic Agents|cholinergic agents|mesh-ancestor
101511756|NCT02942303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101511757|NCT02942303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511758|NCT02916381|Anesthetics|anesthetics|mesh-list
101511759|NCT02916381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101511760|NCT02916381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511761|NCT02920047|Amlodipine|amlodipine|mesh-list
101511762|NCT02920047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101511763|NCT02920047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101511764|NCT02920047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101511765|NCT02920047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511766|NCT02920047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101511767|NCT02920047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511770|NCT02941016|Alirocumab|alirocumab|mesh-list
101511771|NCT02941016|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101511772|NCT02941016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101511773|NCT02941016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101511774|NCT02941016|Antimetabolites|antimetabolites|mesh-ancestor
101511775|NCT02941016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511776|NCT02941016|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101511777|NCT02941016|Protease Inhibitors|protease inhibitors|mesh-ancestor
101511778|NCT02941016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101511779|NCT02941016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101511780|NCT03200379|Antiviral Agents|antiviral agents|mesh-list
101511781|NCT03200379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101511782|NCT02919735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101511783|NCT02941445|Metformin|metformin|mesh-list
101511784|NCT02941445|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101511785|NCT02941445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101511786|NCT02941445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511787|NCT02941445|Incretins|incretins|mesh-ancestor
101511788|NCT02941445|Hormones|hormones|mesh-ancestor
101511789|NCT02941445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101511790|NCT02941445|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101511791|NCT02941445|Protease Inhibitors|protease inhibitors|mesh-ancestor
101511792|NCT02941445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101511793|NCT02941445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511794|NCT02919501|Vortioxetine|vortioxetine|mesh-list
101511795|NCT02919501|Antidepressive Agents|antidepressive agents|mesh-ancestor
101511796|NCT02919501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101511797|NCT02919501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101511798|NCT02919501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101511799|NCT02919501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101511800|NCT02919501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511801|NCT02919501|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101511802|NCT02919501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101511803|NCT02919501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101511804|NCT02919501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511805|NCT02919501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101511806|NCT02919501|Serotonin Agents|serotonin agents|mesh-ancestor
101511807|NCT02919501|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101511808|NCT02919501|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101511809|NCT02919501|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101511810|NCT02919501|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101511812|NCT02919579|Antidepressive Agents|antidepressive agents|mesh-ancestor
101511813|NCT02919579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101511814|NCT02940821|Hydrogen Peroxide|hydrogen peroxide|mesh-list
101511815|NCT02940821|Fluorides|fluorides|mesh-list
101511816|NCT02940821|Tin Fluorides|tin fluorides|mesh-list
101511817|NCT02940821|Fluorophosphate|fluorophosphate|mesh-list
101511818|NCT02940821|Cariostatic Agents|cariostatic agents|mesh-ancestor
101511819|NCT02940821|Protective Agents|protective agents|mesh-ancestor
101511820|NCT02940821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511821|NCT02940821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101511822|NCT02940821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101511823|NCT02941601|Carboplatin|carboplatin|mesh-list
101511824|NCT02941601|Gemcitabine|gemcitabine|mesh-list
101511825|NCT02941601|Necitumumab|necitumumab|mesh-list
101511826|NCT02941601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101511827|NCT02941601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101511828|NCT02941601|Antimetabolites|antimetabolites|mesh-ancestor
101511829|NCT02941601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511830|NCT02941601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101511831|NCT03160638|Azithromycin|azithromycin|mesh-list
101511832|NCT03160638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101511833|NCT03160638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101511834|NCT02919462|Cisplatin|cisplatin|mesh-list
101511835|NCT02919462|Pemetrexed|pemetrexed|mesh-list
101511836|NCT02919462|Vinorelbine|vinorelbine|mesh-list
101511837|NCT02919462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101511838|NCT02919462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101511839|NCT02919462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511840|NCT02919462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101511841|NCT02919462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101511842|NCT02919462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101511843|NCT02919462|Tubulin Modulators|tubulin modulators|mesh-ancestor
101511844|NCT02919462|Antimitotic Agents|antimitotic agents|mesh-ancestor
101511845|NCT02919462|Mitosis Modulators|mitosis modulators|mesh-ancestor
101511846|NCT02941367|Metformin|metformin|mesh-list
101511847|NCT02941367|Lixisenatide|lixisenatide|mesh-list
101511848|NCT02941367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101511849|NCT02941367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511850|NCT03153150|Warfarin|warfarin|mesh-list
101511851|NCT03153150|Rivaroxaban|rivaroxaban|mesh-list
101511852|NCT03153150|Dabigatran|dabigatran|mesh-list
101511853|NCT03153150|Apixaban|apixaban|mesh-list
101511854|NCT03153150|Edoxaban|edoxaban|mesh-list
101511855|NCT03153150|Acenocoumarol|acenocoumarol|mesh-list
101511856|NCT03153150|Phenindione|phenindione|mesh-list
101511857|NCT03153150|Anticoagulants|anticoagulants|mesh-ancestor
101511858|NCT03153150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101511859|NCT03153150|Antithrombins|antithrombins|mesh-ancestor
101511860|NCT03153150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101511861|NCT03153150|Protease Inhibitors|protease inhibitors|mesh-ancestor
101511863|NCT03153150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511865|NCT02916147|Sevoflurane|sevoflurane|mesh-list
101511866|NCT02916147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101511867|NCT02916147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101511868|NCT02916147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511869|NCT02916147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101511870|NCT02916147|Anesthetics, General|anesthetics, general|mesh-ancestor
101511871|NCT02916147|Anesthetics|anesthetics|mesh-ancestor
101511872|NCT02916147|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101511873|NCT02916147|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101511874|NCT05302388|Diphenhydramine|diphenhydramine|mesh-list
101511875|NCT05302388|Promethazine|promethazine|mesh-list
101511876|NCT05302388|Dexamethasone|dexamethasone|mesh-list
101511877|NCT05302388|Prednisolone|prednisolone|mesh-list
101511878|NCT05302388|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101511879|NCT05302388|Methylprednisolone|methylprednisolone|mesh-list
101511880|NCT05302388|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101511881|NCT05302388|Prednisolone acetate|prednisolone acetate|mesh-list
101511882|NCT05302388|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101511883|NCT05302388|Prednisolone phosphate|prednisolone phosphate|mesh-list
101511884|NCT05302388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101511885|NCT05302388|Antiemetics|antiemetics|mesh-ancestor
101511886|NCT05302388|Autonomic Agents|autonomic agents|mesh-ancestor
101511887|NCT05302388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101511888|NCT05302388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511889|NCT05302388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101511890|NCT05302388|Glucocorticoids|glucocorticoids|mesh-ancestor
101511891|NCT05302388|Hormones|hormones|mesh-ancestor
101511892|NCT05302388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101511893|NCT05302388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101511894|NCT05302388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101511895|NCT05302388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101511896|NCT05302388|Protective Agents|protective agents|mesh-ancestor
101511897|NCT05302388|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101511898|NCT05302388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101511899|NCT05302388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101511900|NCT05302388|Anesthetics, Local|anesthetics, local|mesh-ancestor
101511901|NCT05302388|Anesthetics|anesthetics|mesh-ancestor
101511902|NCT05302388|Sensory System Agents|sensory system agents|mesh-ancestor
101511903|NCT05302388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101511904|NCT05302388|Histamine Antagonists|histamine antagonists|mesh-ancestor
101511905|NCT05302388|Histamine Agents|histamine agents|mesh-ancestor
101511906|NCT05302388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101511907|NCT05302388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511908|NCT05302388|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101511909|NCT05302388|Antipruritics|antipruritics|mesh-ancestor
101511910|NCT05302388|Dermatologic Agents|dermatologic agents|mesh-ancestor
101511911|NCT02919072|Ropivacaine|ropivacaine|mesh-list
101511912|NCT02919072|Chloroprocaine|chloroprocaine|mesh-list
101511913|NCT02919072|Anesthetics, Local|anesthetics, local|mesh-ancestor
101511914|NCT02919072|Anesthetics|anesthetics|mesh-ancestor
101511915|NCT02919072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101511916|NCT02919072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511917|NCT02919072|Sensory System Agents|sensory system agents|mesh-ancestor
101511918|NCT02919072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101511919|NCT02941328|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
101511920|NCT02941328|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101511921|NCT02941328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101511922|NCT02941328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511923|NCT02941328|Cholinergic Agents|cholinergic agents|mesh-ancestor
101511924|NCT02941328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101511925|NCT02941328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511926|NCT02915796|Lenograstim|lenograstim|mesh-list
101511927|NCT02915796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101511928|NCT02915796|Immunologic Factors|immunologic factors|mesh-ancestor
101511929|NCT02915796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511930|NCT02915250|Insulin Lispro|insulin lispro|mesh-list
101511931|NCT02915250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101511932|NCT02915250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511933|NCT02277041|Misoprostol|misoprostol|mesh-list
101511934|NCT02277041|Carbetocin|carbetocin|mesh-list
101511935|NCT02277041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101511936|NCT02277041|Abortifacient Agents|abortifacient agents|mesh-ancestor
101511937|NCT02277041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101511938|NCT02277041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511939|NCT02277041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101410989|NCT00448903|Bemiparin|bemiparin|mesh-list
101511940|NCT02277041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101511941|NCT02277041|Oxytocics|oxytocics|mesh-ancestor
101511942|NCT02915289|Chlorhexidine|chlorhexidine|mesh-list
101511943|NCT02915289|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101511944|NCT02915289|Povidone-Iodine|povidone-iodine|mesh-list
101511945|NCT02915289|Povidone|povidone|mesh-list
101511946|NCT02915289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101511947|NCT02915289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101511948|NCT02915289|Disinfectants|disinfectants|mesh-ancestor
101511949|NCT02915289|Dermatologic Agents|dermatologic agents|mesh-ancestor
101511950|NCT02915289|Plasma Substitutes|plasma substitutes|mesh-ancestor
101511951|NCT02915289|Blood Substitutes|blood substitutes|mesh-ancestor
101511952|NCT02939417|Grape Seed Extract|grape seed extract|mesh-list
101511953|NCT02939417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101511954|NCT02939417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101511955|NCT02939417|Antioxidants|antioxidants|mesh-ancestor
101511956|NCT02939417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511957|NCT02939417|Protective Agents|protective agents|mesh-ancestor
101511958|NCT02939417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511959|NCT05034536|Infliximab|infliximab|mesh-list
101511960|NCT05034536|Pembrolizumab|pembrolizumab|mesh-list
101511961|NCT05034536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101511962|NCT05034536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101511963|NCT05034536|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101511964|NCT05034536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511965|NCT05034536|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101511966|NCT05034536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101511967|NCT05034536|Dermatologic Agents|dermatologic agents|mesh-ancestor
101511968|NCT05034536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101511969|NCT05034536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101511970|NCT02915094|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101511971|NCT02915094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101511972|NCT02915172|Capecitabine|capecitabine|mesh-list
101511973|NCT02915172|Lenvatinib|lenvatinib|mesh-list
101511974|NCT02915172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101511975|NCT02915172|Antimetabolites|antimetabolites|mesh-ancestor
101511976|NCT02915172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511977|NCT02915172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101511978|NCT02915172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101511979|NCT02915172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101511980|NCT02938988|Anti-Infective Agents|anti-infective agents|mesh-list
101511981|NCT02938988|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101511982|NCT02938988|Methylene Blue|methylene blue|mesh-list
101511983|NCT02938988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101511984|NCT02938988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101511985|NCT02915055|Acetaminophen|acetaminophen|mesh-list
101511986|NCT02915055|Ibuprofen|ibuprofen|mesh-list
101511987|NCT02915055|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
101511988|NCT02915055|Oxycodone|oxycodone|mesh-list
101511989|NCT02915055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101511990|NCT02915055|Analgesics|analgesics|mesh-ancestor
101511991|NCT02915055|Sensory System Agents|sensory system agents|mesh-ancestor
101511992|NCT02915055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101511993|NCT02915055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101511994|NCT02915055|Antipyretics|antipyretics|mesh-ancestor
101511995|NCT02915055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101511996|NCT02915055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101511997|NCT02915055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101511998|NCT02915055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101512000|NCT02915055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512001|NCT02915055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101512002|NCT02915055|Narcotics|narcotics|mesh-ancestor
101512003|NCT02915055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101512004|NCT01295827|Pembrolizumab|pembrolizumab|mesh-list
101512005|NCT01295827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101512006|NCT01295827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101512007|NCT01295827|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101512008|NCT01295827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512009|NCT02918760|Gabapentin|gabapentin|mesh-list
101512010|NCT02918760|Analgesics|analgesics|mesh-ancestor
101512011|NCT02918760|Sensory System Agents|sensory system agents|mesh-ancestor
101512012|NCT02918760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101512013|NCT02918760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512014|NCT02918760|Anticonvulsants|anticonvulsants|mesh-ancestor
101512015|NCT02918760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101512016|NCT02918760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101512017|NCT02918760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101512018|NCT02918760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101264236|NCT01766518|Mycophenolic Acid|mycophenolic acid|mesh-list
101512019|NCT02918760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101512020|NCT02918760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101512021|NCT02918760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101512022|NCT02918760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512023|NCT02918760|Antimanic Agents|antimanic agents|mesh-ancestor
101512024|NCT04690751|Cenobamate|cenobamate|mesh-list
101512025|NCT04690751|Anticonvulsants|anticonvulsants|mesh-ancestor
101512026|NCT03458078|Magnesium Sulfate|magnesium sulfate|mesh-list
101512027|NCT03458078|Midazolam|midazolam|mesh-list
101512028|NCT03458078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101512029|NCT03458078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101512030|NCT03458078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101512031|NCT03458078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512032|NCT03458078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101512033|NCT03458078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101512034|NCT03458078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101512035|NCT03458078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101512036|NCT03458078|Anesthetics, General|anesthetics, general|mesh-ancestor
101195741|NCT03786783|Podophyllotoxin|podophyllotoxin|mesh-list
101512037|NCT03458078|Anesthetics|anesthetics|mesh-ancestor
101512038|NCT03458078|GABA Modulators|gaba modulators|mesh-ancestor
101512039|NCT03458078|GABA Agents|gaba agents|mesh-ancestor
101512040|NCT03458078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101512041|NCT03458078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512042|NCT03458078|Analgesics|analgesics|mesh-ancestor
101512043|NCT03458078|Sensory System Agents|sensory system agents|mesh-ancestor
101512044|NCT03458078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101512045|NCT03458078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101512046|NCT03458078|Anticonvulsants|anticonvulsants|mesh-ancestor
101512047|NCT03458078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101512048|NCT03458078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101512049|NCT03458078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101512050|NCT03458078|Tocolytic Agents|tocolytic agents|mesh-ancestor
101512051|NCT03458078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101512052|NCT04690556|Ranibizumab|ranibizumab|mesh-list
101512053|NCT04690556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101512054|NCT04690556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101512055|NCT04690556|Growth Substances|growth substances|mesh-ancestor
101512056|NCT04690556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512057|NCT04690556|Growth Inhibitors|growth inhibitors|mesh-ancestor
101512058|NCT04690556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101512059|NCT01294579|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101512060|NCT01294579|Ofatumumab|ofatumumab|mesh-list
101512061|NCT01294579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101512062|NCT01294579|Alkylating Agents|alkylating agents|mesh-ancestor
101512063|NCT01294579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512064|NCT01294579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101512066|NCT02914626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101512067|NCT02914626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101512068|NCT02914626|Growth Substances|growth substances|mesh-ancestor
101512069|NCT02914626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512070|NCT02914626|Growth Inhibitors|growth inhibitors|mesh-ancestor
101512071|NCT02914626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101512072|NCT02918331|Dexamethasone|dexamethasone|mesh-list
101512073|NCT02918331|Lenalidomide|lenalidomide|mesh-list
101512074|NCT02918331|Daratumumab|daratumumab|mesh-list
101512075|NCT02918331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101512076|NCT02918331|Antiemetics|antiemetics|mesh-ancestor
101512077|NCT02918331|Autonomic Agents|autonomic agents|mesh-ancestor
101512078|NCT02918331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101512079|NCT02918331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512080|NCT02918331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101512081|NCT02918331|Glucocorticoids|glucocorticoids|mesh-ancestor
101512082|NCT02918331|Hormones|hormones|mesh-ancestor
101512083|NCT02918331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101512084|NCT02918331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101512085|NCT02918331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101512086|NCT02918331|Immunologic Factors|immunologic factors|mesh-ancestor
101512087|NCT02918331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101264245|NCT01766583|Lenalidomide|lenalidomide|mesh-list
101512088|NCT02918331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101512089|NCT02918331|Growth Substances|growth substances|mesh-ancestor
101512090|NCT02918331|Growth Inhibitors|growth inhibitors|mesh-ancestor
101512091|NCT02918136|Cortisone|cortisone|mesh-list
101512092|NCT02918136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101512093|NCT01294462|Aspirin|aspirin|mesh-list
101512094|NCT01294462|Clopidogrel|clopidogrel|mesh-list
101512095|NCT01294462|Ticagrelor|ticagrelor|mesh-list
101512096|NCT01294462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101512097|NCT01294462|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101512098|NCT01294462|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101512099|NCT01294462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101512100|NCT01294462|Purinergic Agents|purinergic agents|mesh-ancestor
101512101|NCT01294462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101512102|NCT01294462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512103|NCT01294462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512104|NCT01294462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101512105|NCT01294462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101512106|NCT01294462|Analgesics|analgesics|mesh-ancestor
101512107|NCT01294462|Sensory System Agents|sensory system agents|mesh-ancestor
101512108|NCT01294462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101512109|NCT01294462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101512110|NCT01294462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101512111|NCT01294462|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101195821|NCT03634839|Nicotine|nicotine|mesh-list
101512112|NCT01294462|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101512113|NCT01294462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101512114|NCT01294462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101512115|NCT01294462|Antipyretics|antipyretics|mesh-ancestor
101512116|NCT01294423|Dapagliflozin|dapagliflozin|mesh-list
101512117|NCT01294423|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101512118|NCT01294423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512119|NCT01294423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101512120|NCT01294423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512122|NCT02910570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101512123|NCT02910570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512124|NCT02910570|Incretins|incretins|mesh-ancestor
101512125|NCT02910570|Hormones|hormones|mesh-ancestor
101512126|NCT02910570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101512127|NCT03077685|Paclitaxel|paclitaxel|mesh-list
101512128|NCT03077685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101512129|NCT03077685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101512130|NCT03077685|Tubulin Modulators|tubulin modulators|mesh-ancestor
101512131|NCT03077685|Antimitotic Agents|antimitotic agents|mesh-ancestor
101512132|NCT03077685|Mitosis Modulators|mitosis modulators|mesh-ancestor
101512133|NCT03077685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512134|NCT02910141|Insulin|insulin|mesh-list
101512136|NCT02910141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101512137|NCT02910141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512138|NCT04817033|Midazolam|midazolam|mesh-list
101512139|NCT04817033|Dexmedetomidine|dexmedetomidine|mesh-list
101512140|NCT04817033|Anesthetics|anesthetics|mesh-list
101512141|NCT04817033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101512142|NCT04817033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512143|NCT04817033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101512144|NCT04817033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101512145|NCT04817033|Analgesics|analgesics|mesh-ancestor
101512146|NCT04817033|Sensory System Agents|sensory system agents|mesh-ancestor
101512147|NCT04817033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101512148|NCT04817033|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101512149|NCT04817033|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101512150|NCT04817033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101512151|NCT04817033|Adrenergic Agents|adrenergic agents|mesh-ancestor
101512152|NCT04817033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101512153|NCT04817033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512154|NCT04817033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101512155|NCT04817033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101512156|NCT04817033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101264247|NCT01766583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512157|NCT04817033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101512158|NCT04817033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101512159|NCT04817033|Anesthetics, General|anesthetics, general|mesh-ancestor
101512160|NCT04817033|GABA Modulators|gaba modulators|mesh-ancestor
101512161|NCT04817033|GABA Agents|gaba agents|mesh-ancestor
101512162|NCT01292473|Omalizumab|omalizumab|mesh-list
101512163|NCT01292473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101512164|NCT01292473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101512165|NCT01292473|Respiratory System Agents|respiratory system agents|mesh-ancestor
101528442|NCT04657107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101528443|NCT04657107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528444|NCT04657107|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101528445|NCT04657107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101528446|NCT04657107|Anesthetics, General|anesthetics, general|mesh-ancestor
101528447|NCT04657107|Anesthetics|anesthetics|mesh-ancestor
101528448|NCT04657107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101528449|NCT04657107|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101528450|NCT04657107|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101528451|NCT04657107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101528452|NCT04657107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528453|NCT04657107|Antidepressive Agents|antidepressive agents|mesh-ancestor
101528454|NCT04657107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101528455|NCT00561717|Cetirizine|cetirizine|mesh-list
101528456|NCT00561717|Loratadine|loratadine|mesh-list
101528457|NCT00561717|Azelastine|azelastine|mesh-list
101528458|NCT00561717|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101528459|NCT00561717|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101528460|NCT00561717|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101528461|NCT00561717|Histamine Antagonists|histamine antagonists|mesh-ancestor
101528462|NCT00561717|Histamine Agents|histamine agents|mesh-ancestor
101528463|NCT00561717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101512167|NCT02938286|Carticaine|carticaine|mesh-list
101512168|NCT02938286|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101512169|NCT02938286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101512170|NCT02938286|Adrenergic Agents|adrenergic agents|mesh-ancestor
101512171|NCT02938286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101512172|NCT02938286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318494|NCT00006029|Doxorubicin|doxorubicin|mesh-list
101512173|NCT02938286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512174|NCT02938286|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101512175|NCT02938286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101512176|NCT02938286|Autonomic Agents|autonomic agents|mesh-ancestor
101512177|NCT02938286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101512179|NCT02938286|Respiratory System Agents|respiratory system agents|mesh-ancestor
101512180|NCT02938286|Mydriatics|mydriatics|mesh-ancestor
101512181|NCT02938286|Sympathomimetics|sympathomimetics|mesh-ancestor
101512182|NCT02938286|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101512183|NCT02938286|Anesthetics, Local|anesthetics, local|mesh-ancestor
101512184|NCT02938286|Anesthetics|anesthetics|mesh-ancestor
101512185|NCT02938286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101512186|NCT02938286|Sensory System Agents|sensory system agents|mesh-ancestor
101512187|NCT01292239|Ribavirin|ribavirin|mesh-list
101512188|NCT01292239|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101512189|NCT01292239|Simeprevir|simeprevir|mesh-list
101512190|NCT01292239|Antimetabolites|antimetabolites|mesh-ancestor
101512191|NCT01292239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512192|NCT01292239|Antiviral Agents|antiviral agents|mesh-ancestor
101512193|NCT01292239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101512194|NCT01292239|Protease Inhibitors|protease inhibitors|mesh-ancestor
101512195|NCT01292239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101512196|NCT05600179|Dexamethasone|dexamethasone|mesh-list
101512197|NCT05600179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101512198|NCT05600179|Antiemetics|antiemetics|mesh-ancestor
101512199|NCT05600179|Autonomic Agents|autonomic agents|mesh-ancestor
101512200|NCT05600179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101512201|NCT05600179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512202|NCT05600179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101512203|NCT05600179|Glucocorticoids|glucocorticoids|mesh-ancestor
101512204|NCT05600179|Hormones|hormones|mesh-ancestor
101264252|NCT01766583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101512205|NCT05600179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101512206|NCT05600179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101512207|NCT05600179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101512208|NCT02937662|Cytarabine|cytarabine|mesh-list
101512209|NCT02937662|Cyclophosphamide|cyclophosphamide|mesh-list
101512210|NCT02937662|Idarubicin|idarubicin|mesh-list
101512211|NCT02937662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101512212|NCT02937662|Immunologic Factors|immunologic factors|mesh-ancestor
101512213|NCT02937662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512214|NCT02937662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101512215|NCT02937662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101512216|NCT02937662|Alkylating Agents|alkylating agents|mesh-ancestor
101512217|NCT02937662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512218|NCT02937662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101512219|NCT02937662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101512220|NCT02937662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101512221|NCT02937662|Antimetabolites|antimetabolites|mesh-ancestor
101512222|NCT02937662|Antiviral Agents|antiviral agents|mesh-ancestor
101512223|NCT02937662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101512224|NCT02937662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101512225|NCT02937662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101512226|NCT02937662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101512227|NCT02937662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101512228|NCT01290757|Dabigatran|dabigatran|mesh-list
101512229|NCT01290757|Antithrombins|antithrombins|mesh-ancestor
101512230|NCT01290757|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101512231|NCT01290757|Protease Inhibitors|protease inhibitors|mesh-ancestor
101512232|NCT01290757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101512233|NCT01290757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512234|NCT01290757|Anticoagulants|anticoagulants|mesh-ancestor
101512235|NCT02937857|Antipyretics|antipyretics|mesh-list
101512236|NCT02937857|Expectorants|expectorants|mesh-list
101512237|NCT02937857|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-list
101512238|NCT02937857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512239|NCT02937857|Respiratory System Agents|respiratory system agents|mesh-ancestor
101512240|NCT04324060|Danazol|danazol|mesh-list
101512241|NCT04324060|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101512242|NCT04324060|Hormone Antagonists|hormone antagonists|mesh-ancestor
101512243|NCT04324060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101512244|NCT04324060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512245|NCT01290718|Capecitabine|capecitabine|mesh-list
101512247|NCT01290718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101512248|NCT01290718|Antimetabolites|antimetabolites|mesh-ancestor
101512249|NCT01290718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512250|NCT01290718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101512251|NCT01290718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101512252|NCT04324294|Pancrelipase|pancrelipase|mesh-list
101512253|NCT04324294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101512254|NCT02937896|Ketorolac|ketorolac|mesh-list
101512255|NCT02937896|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101512256|NCT02937896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101512257|NCT02937896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101512258|NCT02937896|Analgesics|analgesics|mesh-ancestor
101512259|NCT02937896|Sensory System Agents|sensory system agents|mesh-ancestor
101512260|NCT02937896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101512261|NCT02937896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512262|NCT02937896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101512263|NCT02937896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101512264|NCT02937896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101512265|NCT02937896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101512266|NCT02937896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512267|NCT02937896|Hemostatics|hemostatics|mesh-ancestor
101512268|NCT02937896|Coagulants|coagulants|mesh-ancestor
101512269|NCT02937896|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101512270|NCT02937896|Natriuretic Agents|natriuretic agents|mesh-ancestor
101512271|NCT04688151|Rituximab|rituximab|mesh-list
101512272|NCT04688151|Durvalumab|durvalumab|mesh-list
101512273|NCT04688151|Acalabrutinib|acalabrutinib|mesh-list
101512274|NCT04688151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101512275|NCT04688151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101512276|NCT04688151|Immunologic Factors|immunologic factors|mesh-ancestor
101512277|NCT04688151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512278|NCT04688151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101512279|NCT02937779|Tenofovir|tenofovir|mesh-list
101512280|NCT02937779|Antiviral Agents|antiviral agents|mesh-ancestor
101512281|NCT02937779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101512282|NCT02937779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101512283|NCT02937779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101512284|NCT02937779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101512285|NCT02937779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512286|NCT02937779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101512287|NCT02937779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101512288|NCT01290679|Ribavirin|ribavirin|mesh-list
101512289|NCT01290679|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101512290|NCT01290679|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101512291|NCT01290679|Simeprevir|simeprevir|mesh-list
101512292|NCT01290679|Antimetabolites|antimetabolites|mesh-ancestor
101512293|NCT01290679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512294|NCT01290679|Antiviral Agents|antiviral agents|mesh-ancestor
101512295|NCT01290679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101512296|NCT01290679|Protease Inhibitors|protease inhibitors|mesh-ancestor
101512297|NCT01290679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101512298|NCT03457389|Cabergoline|cabergoline|mesh-list
101512299|NCT03457389|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101512300|NCT03457389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101512301|NCT03457389|Dopamine Agonists|dopamine agonists|mesh-ancestor
101512302|NCT03457389|Dopamine Agents|dopamine agents|mesh-ancestor
101512303|NCT03457389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101512304|NCT03457389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512305|NCT03457389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512306|NCT02890186|Remifentanil|remifentanil|mesh-list
101512307|NCT02890186|Propofol|propofol|mesh-list
101512308|NCT02890186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101512309|NCT02890186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101512310|NCT02890186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512311|NCT02890186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101512312|NCT02890186|Anesthetics, General|anesthetics, general|mesh-ancestor
101512313|NCT02890186|Anesthetics|anesthetics|mesh-ancestor
101512314|NCT02890186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101512315|NCT02890186|Narcotics|narcotics|mesh-ancestor
101512316|NCT02890186|Analgesics|analgesics|mesh-ancestor
101512317|NCT02890186|Sensory System Agents|sensory system agents|mesh-ancestor
101512318|NCT02890186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101512319|NCT02909751|Tocotrienols|tocotrienols|mesh-list
101512321|NCT02909751|Tocopherols|tocopherols|mesh-list
101512322|NCT02909751|Docetaxel|docetaxel|mesh-list
101512323|NCT02909751|Cyclophosphamide|cyclophosphamide|mesh-list
101512324|NCT02909751|Trastuzumab|trastuzumab|mesh-list
101512325|NCT02909751|Epirubicin|epirubicin|mesh-list
101512326|NCT02909751|Pertuzumab|pertuzumab|mesh-list
101512327|NCT02909751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101512328|NCT02909751|Tubulin Modulators|tubulin modulators|mesh-ancestor
101512329|NCT02909751|Antimitotic Agents|antimitotic agents|mesh-ancestor
101512330|NCT02909751|Mitosis Modulators|mitosis modulators|mesh-ancestor
101512331|NCT02909751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512332|NCT02909751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101512333|NCT02909751|Immunologic Factors|immunologic factors|mesh-ancestor
101512334|NCT02909751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512335|NCT02909751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101512336|NCT02909751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101512338|NCT02909751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101512339|NCT02909751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101512340|NCT02909751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101512341|NCT02909751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101512342|NCT02909751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101512343|NCT02909751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101512344|NCT02909751|Antioxidants|antioxidants|mesh-ancestor
101512345|NCT02909751|Protective Agents|protective agents|mesh-ancestor
101512346|NCT02909751|Vitamins|vitamins|mesh-ancestor
101512347|NCT02909751|Micronutrients|micronutrients|mesh-ancestor
101512348|NCT02909712|Pyrimethamine|pyrimethamine|mesh-list
101512349|NCT02909712|Piperaquine|piperaquine|mesh-list
101512350|NCT02909712|Sulfadoxine|sulfadoxine|mesh-list
101512351|NCT02909712|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101512352|NCT02909712|Artenimol|artenimol|mesh-list
101512353|NCT02909712|Antimalarials|antimalarials|mesh-ancestor
101512354|NCT02909712|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101512355|NCT02909712|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101512356|NCT02909712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101512357|NCT02909712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101512358|NCT02909712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101512359|NCT02909712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512360|NCT02909712|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101512361|NCT02913885|Fluorides|fluorides|mesh-list
101512362|NCT02913885|Fluorides, Topical|fluorides, topical|mesh-list
101512363|NCT02913885|Cariostatic Agents|cariostatic agents|mesh-ancestor
101512364|NCT02913885|Protective Agents|protective agents|mesh-ancestor
101512365|NCT02913885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512366|NCT01290601|Chloroquine|chloroquine|mesh-list
101512367|NCT01290601|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
101512368|NCT01290601|Primaquine|primaquine|mesh-list
101512369|NCT01290601|Tafenoquine|tafenoquine|mesh-list
101512370|NCT01290601|Amebicides|amebicides|mesh-ancestor
101512371|NCT01290601|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101512372|NCT01290601|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101512373|NCT01290601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101512374|NCT01290601|Antimalarials|antimalarials|mesh-ancestor
101512375|NCT01290601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101318511|NCT00371059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101512376|NCT01290601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101512377|NCT01290601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101512378|NCT01290601|Analgesics|analgesics|mesh-ancestor
101512379|NCT01290601|Sensory System Agents|sensory system agents|mesh-ancestor
101512380|NCT01290601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101512381|NCT01290601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512382|NCT01290601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101512383|NCT01290601|Filaricides|filaricides|mesh-ancestor
101512384|NCT01290601|Antinematodal Agents|antinematodal agents|mesh-ancestor
101512385|NCT01290601|Anthelmintics|anthelmintics|mesh-ancestor
101512386|NCT02978391|Epinephrine|epinephrine|mesh-list
101512387|NCT02978391|Hemostatics|hemostatics|mesh-list
101512388|NCT02978391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101512389|NCT02978391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101512390|NCT02978391|Adrenergic Agents|adrenergic agents|mesh-ancestor
101512391|NCT02978391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101512392|NCT02978391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512393|NCT02978391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512394|NCT02978391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101196138|NCT01992653|Hormones|hormones|mesh-ancestor
101512395|NCT02978391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101512396|NCT02978391|Autonomic Agents|autonomic agents|mesh-ancestor
101512397|NCT02978391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101512398|NCT02978391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101512399|NCT02978391|Respiratory System Agents|respiratory system agents|mesh-ancestor
101512400|NCT02978391|Mydriatics|mydriatics|mesh-ancestor
101512401|NCT02978391|Sympathomimetics|sympathomimetics|mesh-ancestor
101512402|NCT02978391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101512403|NCT02978391|Coagulants|coagulants|mesh-ancestor
101512404|NCT01290094|Ibandronic Acid|ibandronic acid|mesh-list
101512405|NCT01290094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101512406|NCT01290094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512407|NCT04688346|Epinephrine|epinephrine|mesh-list
101512408|NCT04688346|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101512409|NCT04688346|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101512411|NCT04688346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101512412|NCT04688346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512413|NCT04688346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512414|NCT04688346|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101512415|NCT04688346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101512416|NCT04688346|Autonomic Agents|autonomic agents|mesh-ancestor
101512417|NCT04688346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101512418|NCT04688346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101264267|NCT01766830|Immunoglobulin M|immunoglobulin m|mesh-list
101512419|NCT04688346|Respiratory System Agents|respiratory system agents|mesh-ancestor
101512420|NCT04688346|Mydriatics|mydriatics|mesh-ancestor
101512421|NCT04688346|Sympathomimetics|sympathomimetics|mesh-ancestor
101512422|NCT04688346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101512423|NCT01289821|Leucovorin|leucovorin|mesh-list
101512424|NCT01289821|Folic Acid|folic acid|mesh-list
101512425|NCT01289821|Oxaliplatin|oxaliplatin|mesh-list
101512426|NCT01289821|Levoleucovorin|levoleucovorin|mesh-list
101512427|NCT01289821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101512428|NCT01289821|Antidotes|antidotes|mesh-ancestor
101512429|NCT01289821|Protective Agents|protective agents|mesh-ancestor
101512430|NCT01289821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512431|NCT01289821|Vitamin B Complex|vitamin b complex|mesh-ancestor
101512432|NCT01289821|Vitamins|vitamins|mesh-ancestor
101512433|NCT01289821|Micronutrients|micronutrients|mesh-ancestor
101512434|NCT01289821|Hematinics|hematinics|mesh-ancestor
101512435|NCT02913768|Ondansetron|ondansetron|mesh-list
101512436|NCT02913768|Antiemetics|antiemetics|mesh-ancestor
101512437|NCT02913768|Autonomic Agents|autonomic agents|mesh-ancestor
101512438|NCT02913768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101512439|NCT02913768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512440|NCT02913768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101512441|NCT02913768|Antipruritics|antipruritics|mesh-ancestor
101512442|NCT02913768|Dermatologic Agents|dermatologic agents|mesh-ancestor
101512443|NCT02913768|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101512444|NCT02913768|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101512445|NCT02913768|Serotonin Agents|serotonin agents|mesh-ancestor
101512446|NCT02913768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101512447|NCT02913768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512448|NCT01289782|Ribavirin|ribavirin|mesh-list
101512449|NCT01289782|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101512451|NCT01289782|Antimetabolites|antimetabolites|mesh-ancestor
101512452|NCT01289782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512453|NCT01289782|Antiviral Agents|antiviral agents|mesh-ancestor
101512455|NCT01289782|Protease Inhibitors|protease inhibitors|mesh-ancestor
101512456|NCT01289782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101512457|NCT02913417|Nivolumab|nivolumab|mesh-list
101512458|NCT02913417|Ipilimumab|ipilimumab|mesh-list
101512459|NCT02913417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101512460|NCT02913417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101512461|NCT02913417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101512462|NCT02913417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512463|NCT02936492|Clobetasol|clobetasol|mesh-list
101512464|NCT02936492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101512465|NCT02936492|Glucocorticoids|glucocorticoids|mesh-ancestor
101512466|NCT02936492|Hormones|hormones|mesh-ancestor
101512467|NCT02936492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101512468|NCT02936492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512469|NCT02913573|Bupivacaine|bupivacaine|mesh-list
101512470|NCT02913573|Anesthetics, Local|anesthetics, local|mesh-ancestor
101512471|NCT02913573|Anesthetics|anesthetics|mesh-ancestor
101512472|NCT02913573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101512473|NCT02913573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512474|NCT02913573|Sensory System Agents|sensory system agents|mesh-ancestor
101512475|NCT02913573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101512476|NCT01289353|Carboplatin|carboplatin|mesh-list
101512477|NCT01289353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101512478|NCT02913300|Lidocaine|lidocaine|mesh-list
101512479|NCT02913300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101512480|NCT02913300|Anesthetics, Local|anesthetics, local|mesh-ancestor
101512481|NCT02913300|Anesthetics|anesthetics|mesh-ancestor
101512482|NCT02913300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101512483|NCT02913300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512484|NCT02913300|Sensory System Agents|sensory system agents|mesh-ancestor
101512485|NCT02913300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101512486|NCT02913300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101512487|NCT02913300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101512488|NCT02913300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101512489|NCT02913300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101512490|NCT02913300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512491|NCT02936375|Cyclophosphamide|cyclophosphamide|mesh-list
101264274|NCT01766843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101512492|NCT02936375|Azathioprine|azathioprine|mesh-list
101512493|NCT02936375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101512494|NCT02936375|Immunologic Factors|immunologic factors|mesh-ancestor
101512495|NCT02936375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512496|NCT02936375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101512497|NCT02936375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101512498|NCT02936375|Alkylating Agents|alkylating agents|mesh-ancestor
101512499|NCT02936375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512500|NCT02936375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101512501|NCT02936375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101512502|NCT02936375|Antimetabolites|antimetabolites|mesh-ancestor
101512503|NCT02936375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101512504|NCT02913690|Vitamin E|vitamin e|mesh-list
101512505|NCT02913690|Vitamins|vitamins|mesh-ancestor
101512506|NCT02913690|Micronutrients|micronutrients|mesh-ancestor
101512507|NCT02913690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512508|NCT02913690|Antioxidants|antioxidants|mesh-ancestor
101512509|NCT02913690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512510|NCT02913690|Protective Agents|protective agents|mesh-ancestor
101512511|NCT01289119|Metformin|metformin|mesh-list
101512512|NCT01289119|Pioglitazone|pioglitazone|mesh-list
101512513|NCT01289119|Alogliptin|alogliptin|mesh-list
101512514|NCT01289119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101512515|NCT01289119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512516|NCT01289119|Incretins|incretins|mesh-ancestor
101512517|NCT01289119|Hormones|hormones|mesh-ancestor
101512518|NCT01289119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101512519|NCT01289119|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101512520|NCT01289119|Protease Inhibitors|protease inhibitors|mesh-ancestor
101512521|NCT01289119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101512522|NCT01289119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512523|NCT01287832|Vancomycin|vancomycin|mesh-list
101512524|NCT01287832|Daptomycin|daptomycin|mesh-list
101512525|NCT01287832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101512526|NCT01287832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101512527|NCT02913066|Cisplatin|cisplatin|mesh-list
101512528|NCT02913066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101512529|NCT01287754|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101512530|NCT01287754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101512531|NCT01287754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101512532|NCT01287754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101512533|NCT01287754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512534|NCT02912793|Betadex|betadex|mesh-list
101512535|NCT02912793|Sequestering Agents|sequestering agents|mesh-ancestor
101512536|NCT02912793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512537|NCT02935751|Apixaban|apixaban|mesh-list
101512538|NCT02935751|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101512539|NCT02935751|Antithrombins|antithrombins|mesh-ancestor
101512540|NCT02935751|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101512541|NCT02935751|Protease Inhibitors|protease inhibitors|mesh-ancestor
101512542|NCT02935751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101512543|NCT02935751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512544|NCT02935751|Anticoagulants|anticoagulants|mesh-ancestor
101512545|NCT02935790|Nivolumab|nivolumab|mesh-list
101512546|NCT02935790|Ipilimumab|ipilimumab|mesh-list
101512547|NCT02935790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101512548|NCT02935790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101512549|NCT02935790|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101512550|NCT02935790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512552|NCT02912637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101512553|NCT02912637|Anesthetics, General|anesthetics, general|mesh-ancestor
101512554|NCT02912637|Anesthetics|anesthetics|mesh-ancestor
101512555|NCT02912637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101512556|NCT02912637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512557|NCT02912910|Labetalol|labetalol|mesh-list
101512558|NCT02912910|Nifedipine|nifedipine|mesh-list
101512559|NCT02912910|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101512560|NCT02912910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101512561|NCT02912910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264279|NCT01766843|Hormones|hormones|mesh-ancestor
101512562|NCT02912910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101512563|NCT02912910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512564|NCT02912910|Vasodilator Agents|vasodilator agents|mesh-ancestor
101512565|NCT02912910|Tocolytic Agents|tocolytic agents|mesh-ancestor
101512566|NCT02912910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101512567|NCT02912910|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101512568|NCT02912910|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101512569|NCT02912910|Adrenergic Agents|adrenergic agents|mesh-ancestor
101512570|NCT02912910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101512571|NCT02912910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101512572|NCT02912910|Sympathomimetics|sympathomimetics|mesh-ancestor
101512573|NCT02912910|Autonomic Agents|autonomic agents|mesh-ancestor
101512574|NCT02912910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101512575|NCT02912910|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101512576|NCT02912910|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101512577|NCT02935829|Locust bean gum|locust bean gum|mesh-list
101512578|NCT02935829|Antidiarrheals|antidiarrheals|mesh-ancestor
101512579|NCT02935829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101512580|NCT02912676|Methotrexate|methotrexate|mesh-list
101512581|NCT02912676|Mercaptopurine|mercaptopurine|mesh-list
101512582|NCT02912676|Thioguanine|thioguanine|mesh-list
101512583|NCT02912676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101512584|NCT02912676|Abortifacient Agents|abortifacient agents|mesh-ancestor
101512585|NCT02912676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101512586|NCT02912676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512587|NCT02912676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101512588|NCT02912676|Antimetabolites|antimetabolites|mesh-ancestor
101512589|NCT02912676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512590|NCT02912676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101512591|NCT02912676|Dermatologic Agents|dermatologic agents|mesh-ancestor
101512592|NCT02912676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101512593|NCT02912676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101512594|NCT02912676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101512596|NCT02912676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101512597|NCT02912676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101512598|NCT02935985|Fibrin fragment D|fibrin fragment d|mesh-list
101512599|NCT02935985|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101512600|NCT02935985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101512601|NCT02935985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512602|NCT02935985|Hemostatics|hemostatics|mesh-ancestor
101512603|NCT02935985|Coagulants|coagulants|mesh-ancestor
101512604|NCT02912169|Anesthetics|anesthetics|mesh-list
101512605|NCT02912169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101512606|NCT02912169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512607|NCT02912520|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101512608|NCT02912520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101512609|NCT02935959|Midazolam|midazolam|mesh-list
101512610|NCT02935959|Dexmedetomidine|dexmedetomidine|mesh-list
101512611|NCT02935959|Ketamine|ketamine|mesh-list
101512612|NCT02935959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101512613|NCT02935959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101512614|NCT02935959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512615|NCT02935959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101512616|NCT02935959|Analgesics|analgesics|mesh-ancestor
101512617|NCT02935959|Sensory System Agents|sensory system agents|mesh-ancestor
101512618|NCT02935959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101512619|NCT02935959|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101512620|NCT02935959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101512621|NCT02935959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101512622|NCT02935959|Adrenergic Agents|adrenergic agents|mesh-ancestor
101512623|NCT02935959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101512624|NCT02935959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512625|NCT02935959|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101512626|NCT02935959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101512627|NCT02935959|Anesthetics, General|anesthetics, general|mesh-ancestor
101512628|NCT02935959|Anesthetics|anesthetics|mesh-ancestor
101512629|NCT02935959|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101512631|NCT02935959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101512632|NCT02935959|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101512633|NCT02935959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101264282|NCT01766843|Antidotes|antidotes|mesh-ancestor
101512634|NCT02935959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101512635|NCT02935959|GABA Modulators|gaba modulators|mesh-ancestor
101512636|NCT02935959|GABA Agents|gaba agents|mesh-ancestor
101512637|NCT02935322|Chlorhexidine|chlorhexidine|mesh-list
101512638|NCT02935322|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101512639|NCT02935322|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101512640|NCT02935322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101512641|NCT02935322|Disinfectants|disinfectants|mesh-ancestor
101512642|NCT02935322|Dermatologic Agents|dermatologic agents|mesh-ancestor
101512643|NCT02935647|Propofol|propofol|mesh-list
101512644|NCT02935647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101512645|NCT02935647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101512646|NCT02935647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512647|NCT02935647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101512648|NCT02935647|Anesthetics, General|anesthetics, general|mesh-ancestor
101512649|NCT02935647|Anesthetics|anesthetics|mesh-ancestor
101512650|NCT02912247|Adalimumab|adalimumab|mesh-list
101512651|NCT02912247|Antibodies|antibodies|mesh-list
101512652|NCT02912247|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101512653|NCT02912247|Immunologic Factors|immunologic factors|mesh-ancestor
101512654|NCT02912247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512655|NCT02912247|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101512656|NCT02912247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101512657|NCT02912247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101512658|NCT02935010|Amoxicillin|amoxicillin|mesh-list
101512659|NCT02935010|Metronidazole|metronidazole|mesh-list
101512660|NCT02935010|Clarithromycin|clarithromycin|mesh-list
101512661|NCT02935010|Levofloxacin|levofloxacin|mesh-list
101512662|NCT02935010|Potassium Citrate|potassium citrate|mesh-list
101512663|NCT02935010|Esomeprazole|esomeprazole|mesh-list
101512664|NCT02935010|Bismuth|bismuth|mesh-list
101512665|NCT02935010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512666|NCT02935010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101512667|NCT02935010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101512668|NCT02935010|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101512669|NCT02935010|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101512670|NCT02935010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101512671|NCT02935010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101512672|NCT02935010|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101512673|NCT02935010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101512674|NCT02935010|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101512675|NCT02935010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101512676|NCT02935010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101512677|NCT02935010|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101512678|NCT02935010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101512679|NCT02935010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101512680|NCT02935010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101512681|NCT02935010|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101512682|NCT02935010|Antacids|antacids|mesh-ancestor
101512683|NCT02935010|Diuretics|diuretics|mesh-ancestor
101512684|NCT02935010|Natriuretic Agents|natriuretic agents|mesh-ancestor
101512685|NCT02935010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512686|NCT02935010|Expectorants|expectorants|mesh-ancestor
101512687|NCT02935010|Respiratory System Agents|respiratory system agents|mesh-ancestor
101512688|NCT02935530|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101512689|NCT02935530|Tinzaparin|tinzaparin|mesh-list
101512690|NCT02935530|Dalteparin|dalteparin|mesh-list
101512691|NCT02935530|Argatroban|argatroban|mesh-list
101512692|NCT02935530|Anticoagulants|anticoagulants|mesh-ancestor
101512693|NCT02935530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101512694|NCT02935530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101512695|NCT02935530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512696|NCT02935530|Antithrombins|antithrombins|mesh-ancestor
101512697|NCT02935530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101512698|NCT02935530|Protease Inhibitors|protease inhibitors|mesh-ancestor
101512699|NCT02935530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101512700|NCT02935530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101512701|NCT02934464|Leucovorin|leucovorin|mesh-list
101196426|NCT01385735|Rasagiline|rasagiline|mesh-list
101512702|NCT02934464|Paclitaxel|paclitaxel|mesh-list
101512703|NCT02934464|Ramucirumab|ramucirumab|mesh-list
101512704|NCT02934464|Oxaliplatin|oxaliplatin|mesh-list
101512705|NCT02934464|Levoleucovorin|levoleucovorin|mesh-list
101512706|NCT02934464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101512707|NCT02934464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101512708|NCT02934464|Tubulin Modulators|tubulin modulators|mesh-ancestor
101512709|NCT02934464|Antimitotic Agents|antimitotic agents|mesh-ancestor
101512710|NCT02934464|Mitosis Modulators|mitosis modulators|mesh-ancestor
101512711|NCT02934464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512712|NCT02934464|Antidotes|antidotes|mesh-ancestor
101512713|NCT02934464|Protective Agents|protective agents|mesh-ancestor
101512714|NCT02934464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512715|NCT02934464|Vitamin B Complex|vitamin b complex|mesh-ancestor
101512716|NCT02934464|Vitamins|vitamins|mesh-ancestor
101512717|NCT02934464|Micronutrients|micronutrients|mesh-ancestor
101512718|NCT02934035|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101512719|NCT02934035|Fluoxetine|fluoxetine|mesh-list
101512720|NCT02934035|Paroxetine|paroxetine|mesh-list
101512721|NCT02934035|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101512722|NCT02934035|Antidepressive Agents|antidepressive agents|mesh-list
101512723|NCT02934035|Escitalopram|escitalopram|mesh-list
101512724|NCT02934035|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101512725|NCT02934035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101512726|NCT02934035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101512727|NCT02934035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512728|NCT02934035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101512729|NCT02934035|Serotonin Agents|serotonin agents|mesh-ancestor
101512730|NCT02934035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512731|NCT02934035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101512732|NCT02934035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101512733|NCT02934035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101512734|NCT02934035|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101512735|NCT02934035|Analgesics|analgesics|mesh-ancestor
101512736|NCT02934035|Sensory System Agents|sensory system agents|mesh-ancestor
101512738|NCT02934035|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101512739|NCT02934035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101512740|NCT02934035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101512741|NCT02934152|Amoxicillin|amoxicillin|mesh-list
101512742|NCT02934152|Clarithromycin|clarithromycin|mesh-list
101512743|NCT02934152|Rabeprazole|rabeprazole|mesh-list
101512744|NCT02934152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101512745|NCT02934152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101512746|NCT02934152|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101512747|NCT02934152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101512748|NCT02934152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512749|NCT02934152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101512750|NCT02934152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101512751|NCT02934152|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101512752|NCT02934152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101512753|NCT02934152|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101512754|NCT02935335|Menotropins|menotropins|mesh-list
101512755|NCT02935335|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101512756|NCT02935335|Fertility Agents|fertility agents|mesh-ancestor
101512757|NCT02935335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101512758|NCT02935335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264301|NCT01767090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101512759|NCT02911662|Cephalexin|cephalexin|mesh-list
101512760|NCT02911662|Nitrofurantoin|nitrofurantoin|mesh-list
101512761|NCT02911662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101512762|NCT02911662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101512763|NCT02911662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101512764|NCT02935101|Prednisolone|prednisolone|mesh-list
101512765|NCT02935101|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101512766|NCT02935101|Methylprednisolone|methylprednisolone|mesh-list
101512767|NCT02935101|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101512768|NCT02935101|Prednisolone acetate|prednisolone acetate|mesh-list
101512769|NCT02935101|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101512770|NCT02935101|Prednisolone phosphate|prednisolone phosphate|mesh-list
101512771|NCT02935101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101512772|NCT02935101|Glucocorticoids|glucocorticoids|mesh-ancestor
101512773|NCT02935101|Hormones|hormones|mesh-ancestor
101512774|NCT02935101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101512775|NCT02935101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512776|NCT02935101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101512777|NCT02935101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101512778|NCT02935101|Antiemetics|antiemetics|mesh-ancestor
101512779|NCT02935101|Autonomic Agents|autonomic agents|mesh-ancestor
101512780|NCT02935101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101512781|NCT02935101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101512782|NCT02935101|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101512783|NCT02935101|Protective Agents|protective agents|mesh-ancestor
101512785|NCT04689971|Vitamin B Complex|vitamin b complex|mesh-list
101512786|NCT04689971|Micronutrients|micronutrients|mesh-ancestor
101512787|NCT04689971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512788|NCT02934945|Budesonide|budesonide|mesh-list
101512789|NCT02934945|Formoterol Fumarate|formoterol fumarate|mesh-list
101512790|NCT02934945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101512791|NCT02934945|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101512792|NCT02934945|Autonomic Agents|autonomic agents|mesh-ancestor
101512793|NCT02934945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101512794|NCT02934945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512795|NCT02934945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101512796|NCT02934945|Respiratory System Agents|respiratory system agents|mesh-ancestor
101512797|NCT02934945|Glucocorticoids|glucocorticoids|mesh-ancestor
101512798|NCT02934945|Hormones|hormones|mesh-ancestor
101512799|NCT02934945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101512800|NCT02934945|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101512801|NCT02934945|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101512802|NCT02934945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101512803|NCT02934945|Adrenergic Agents|adrenergic agents|mesh-ancestor
101512804|NCT02934945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101512805|NCT02934945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512807|NCT02933645|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101512808|NCT02933645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101512809|NCT02933645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512810|NCT02933684|Cycloserine|cycloserine|mesh-list
101512811|NCT02933684|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101512812|NCT02933684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101512813|NCT02933684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101512814|NCT02933684|Antitubercular Agents|antitubercular agents|mesh-ancestor
101512815|NCT02933684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101512816|NCT02933684|Antimetabolites|antimetabolites|mesh-ancestor
101512817|NCT02933684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512818|NCT02933333|Molgramostim|molgramostim|mesh-list
101512819|NCT02933333|Lenograstim|lenograstim|mesh-list
101512820|NCT02933333|Sargramostim|sargramostim|mesh-list
101512821|NCT02933333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101264314|NCT01767272|Fexofenadine|fexofenadine|mesh-list
101512822|NCT02933333|Immunologic Factors|immunologic factors|mesh-ancestor
101512823|NCT02933333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512824|NCT02933333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101512825|NCT02670252|Cyclophosphamide|cyclophosphamide|mesh-list
101512826|NCT02670252|Busulfan|busulfan|mesh-list
101512827|NCT02670252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101512828|NCT02670252|Immunologic Factors|immunologic factors|mesh-ancestor
101512829|NCT02670252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512830|NCT02670252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101512831|NCT02670252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101512832|NCT02670252|Alkylating Agents|alkylating agents|mesh-ancestor
101512833|NCT02670252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512834|NCT02670252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101512835|NCT02670252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101512836|NCT02934789|Contraceptive Agents|contraceptive agents|mesh-list
101512837|NCT02934789|Contraceptives, Oral|contraceptives, oral|mesh-list
101512838|NCT02934789|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
101512839|NCT02934789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101512840|NCT02934789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512841|NCT02934789|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101512842|NCT02933099|Dexamethasone|dexamethasone|mesh-list
101512843|NCT02933099|Dexamethasone acetate|dexamethasone acetate|mesh-list
101512844|NCT02933099|Aprepitant|aprepitant|mesh-list
101512845|NCT02933099|Palonosetron|palonosetron|mesh-list
101512846|NCT02933099|BB 1101|bb 1101|mesh-list
101512847|NCT02933099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101512848|NCT02933099|Antiemetics|antiemetics|mesh-ancestor
101512849|NCT02933099|Autonomic Agents|autonomic agents|mesh-ancestor
101512850|NCT02933099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101512851|NCT02933099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512852|NCT02933099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101512853|NCT02933099|Glucocorticoids|glucocorticoids|mesh-ancestor
101512854|NCT02933099|Hormones|hormones|mesh-ancestor
101512855|NCT02933099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101512856|NCT02933099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101512857|NCT02933099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101512858|NCT02933099|Protease Inhibitors|protease inhibitors|mesh-ancestor
101512859|NCT02933099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101512860|NCT02933099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512861|NCT02933099|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101512862|NCT02933099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101512863|NCT02933099|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101512865|NCT02933099|Serotonin Agents|serotonin agents|mesh-ancestor
101512866|NCT02934906|Immunoglobulins|immunoglobulins|mesh-list
101512867|NCT02934906|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101512868|NCT02934906|Antibodies|antibodies|mesh-list
101512869|NCT02934906|gamma-Globulins|gamma-globulins|mesh-list
101512870|NCT02934906|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101512871|NCT02934906|Immunologic Factors|immunologic factors|mesh-ancestor
101512872|NCT02934906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512873|NCT02911350|Paclitaxel|paclitaxel|mesh-list
101512874|NCT02911350|Hormones|hormones|mesh-list
101512875|NCT02911350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101512876|NCT02911350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101512877|NCT02911350|Tubulin Modulators|tubulin modulators|mesh-ancestor
101512878|NCT02911350|Antimitotic Agents|antimitotic agents|mesh-ancestor
101512879|NCT02911350|Mitosis Modulators|mitosis modulators|mesh-ancestor
101512880|NCT02911350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512881|NCT02911350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101512882|NCT02911350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512884|NCT02932397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101512885|NCT02932397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101512886|NCT02932397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512887|NCT02932397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101512888|NCT02932397|Anesthetics, General|anesthetics, general|mesh-ancestor
101512889|NCT02932397|Anesthetics|anesthetics|mesh-ancestor
101512890|NCT02911272|Oxytocin|oxytocin|mesh-list
101512891|NCT02911272|Oxytocics|oxytocics|mesh-ancestor
101512892|NCT02911272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101512893|NCT02911272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512894|NCT02932436|Empagliflozin|empagliflozin|mesh-list
101512895|NCT02932436|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101512896|NCT02932436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512897|NCT02932436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101512898|NCT02932436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512899|NCT02932007|Chloroquine|chloroquine|mesh-list
101512900|NCT02932007|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
101512901|NCT02932007|Amebicides|amebicides|mesh-ancestor
101512902|NCT02932007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101512903|NCT02932007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101512904|NCT02932007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101512905|NCT02932007|Antimalarials|antimalarials|mesh-ancestor
101512906|NCT02932007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101512907|NCT02932007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101512908|NCT02932007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101512909|NCT02932007|Analgesics|analgesics|mesh-ancestor
101512910|NCT02932007|Sensory System Agents|sensory system agents|mesh-ancestor
101512911|NCT02932007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101512912|NCT02932007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512913|NCT02932007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101512914|NCT02932007|Filaricides|filaricides|mesh-ancestor
101512915|NCT02932007|Antinematodal Agents|antinematodal agents|mesh-ancestor
101512916|NCT02932007|Anthelmintics|anthelmintics|mesh-ancestor
101512917|NCT02910882|Gemcitabine|gemcitabine|mesh-list
101512918|NCT02910882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101512919|NCT02910882|Antimetabolites|antimetabolites|mesh-ancestor
101512920|NCT02910882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512921|NCT02910882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101512922|NCT02910765|Methylene Blue|methylene blue|mesh-list
101512923|NCT02910765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101512924|NCT02910765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512925|NCT02925026|Lactoferrin|lactoferrin|mesh-list
101512926|NCT02925026|Muramidase|muramidase|mesh-list
101512927|NCT02925026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101512928|NCT02924987|Aflibercept|aflibercept|mesh-list
101512929|NCT02924987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101512930|NCT02924987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101512931|NCT02924987|Growth Substances|growth substances|mesh-ancestor
101512932|NCT02924987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512933|NCT02924987|Growth Inhibitors|growth inhibitors|mesh-ancestor
101512934|NCT02924987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101512936|NCT02924909|Carboplatin|carboplatin|mesh-list
101512937|NCT02924909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101512938|NCT02924909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101512939|NCT02924909|Tubulin Modulators|tubulin modulators|mesh-ancestor
101512940|NCT02924909|Antimitotic Agents|antimitotic agents|mesh-ancestor
101512941|NCT02924909|Mitosis Modulators|mitosis modulators|mesh-ancestor
101512942|NCT02924909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512943|NCT02934321|Erythritol|erythritol|mesh-list
101264333|NCT01767298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101512944|NCT02934321|Vasodilator Agents|vasodilator agents|mesh-ancestor
101512945|NCT02924753|Cyclophosphamide|cyclophosphamide|mesh-list
101512946|NCT02924753|Fludarabine|fludarabine|mesh-list
101512947|NCT02924753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101512948|NCT02924753|Immunologic Factors|immunologic factors|mesh-ancestor
101512949|NCT02924753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512950|NCT02924753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101512951|NCT02924753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101512952|NCT02924753|Alkylating Agents|alkylating agents|mesh-ancestor
101512953|NCT02924753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512954|NCT02924753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101512955|NCT02924753|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101512956|NCT02924675|Pregabalin|pregabalin|mesh-list
101512957|NCT02924675|Analgesics|analgesics|mesh-ancestor
101512958|NCT02924675|Sensory System Agents|sensory system agents|mesh-ancestor
101512959|NCT02924675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101512960|NCT02924675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101512961|NCT02924675|Anticonvulsants|anticonvulsants|mesh-ancestor
101512962|NCT02924675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101512963|NCT02924675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101512964|NCT02924675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512965|NCT02924675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101512966|NCT02924675|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101512967|NCT02924675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101512968|NCT02924675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101512969|NCT02924675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101512970|NCT03847545|4-Aminopyridine|4-aminopyridine|mesh-list
101512971|NCT03847545|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101512972|NCT03847545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101512973|NCT03847545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512974|NCT02924285|Amiodarone|amiodarone|mesh-list
101512975|NCT02924285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101512976|NCT02924285|Vasodilator Agents|vasodilator agents|mesh-ancestor
101512977|NCT02924285|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101512978|NCT02924285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101512979|NCT02924285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512980|NCT02924285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101512981|NCT02924285|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101512982|NCT02924285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101512983|NCT02924285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101512984|NCT02924285|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101512985|NCT02924285|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101512986|NCT02924285|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101512987|NCT01287520|Carboplatin|carboplatin|mesh-list
101512988|NCT01287520|Pemetrexed|pemetrexed|mesh-list
101512989|NCT01287520|Ranitidine|ranitidine|mesh-list
101512990|NCT01287520|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
101512991|NCT01287520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101512992|NCT01287520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101512993|NCT01287520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101512994|NCT01287520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101512995|NCT01287520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101512996|NCT01287520|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101512997|NCT01287520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101512998|NCT01287520|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101512999|NCT01287520|Histamine Antagonists|histamine antagonists|mesh-ancestor
101513000|NCT01287520|Histamine Agents|histamine agents|mesh-ancestor
101513001|NCT01287520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101513002|NCT01287520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513003|NCT00623740|Hydrocortisone|hydrocortisone|mesh-list
101513004|NCT00623740|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101513005|NCT00623740|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101513006|NCT00623740|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101513007|NCT00623740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101513008|NCT01287364|Mometasone Furoate|mometasone furoate|mesh-list
101513009|NCT01287364|Ciclesonide|ciclesonide|mesh-list
101513010|NCT01287364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101513011|NCT01287364|Dermatologic Agents|dermatologic agents|mesh-ancestor
101513012|NCT01287364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101513013|NCT01287364|Glucocorticoids|glucocorticoids|mesh-ancestor
101513015|NCT01287364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101264346|NCT01767389|Protease Inhibitors|protease inhibitors|mesh-ancestor
101513016|NCT01287364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513017|NCT02889835|Chlorhexidine|chlorhexidine|mesh-list
101513018|NCT02889835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101513019|NCT02889835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101513021|NCT02924090|Ketamine|ketamine|mesh-list
101513022|NCT02924090|Etomidate|etomidate|mesh-list
101513023|NCT02924090|Analgesics|analgesics|mesh-ancestor
101513024|NCT02924090|Sensory System Agents|sensory system agents|mesh-ancestor
101513025|NCT02924090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101513026|NCT02924090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513027|NCT02924090|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101513028|NCT02924090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101513029|NCT02924090|Anesthetics, General|anesthetics, general|mesh-ancestor
101513030|NCT02924090|Anesthetics|anesthetics|mesh-ancestor
101513031|NCT02924090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101513032|NCT02924090|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101513033|NCT02924090|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101513034|NCT02924090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101513035|NCT02924090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536118|NCT00589251|Penicillins|penicillins|mesh-list
101513036|NCT02924090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101513037|NCT04137770|Ketorolac|ketorolac|mesh-list
101513038|NCT04137770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101513039|NCT04137770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101513040|NCT04137770|Analgesics|analgesics|mesh-ancestor
101513041|NCT04137770|Sensory System Agents|sensory system agents|mesh-ancestor
101513042|NCT04137770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101513043|NCT04137770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513044|NCT04137770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101513045|NCT04137770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101513046|NCT04137770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101513047|NCT04137770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101513048|NCT04137770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513049|NCT01286740|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
101513050|NCT01286740|Antiviral Agents|antiviral agents|mesh-ancestor
101513051|NCT01286740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101513052|NCT01286740|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101513053|NCT01286740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101513054|NCT01286740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101513055|NCT01286740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513056|NCT01286740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101513057|NCT01286740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101513058|NCT02923856|Clarithromycin|clarithromycin|mesh-list
101513059|NCT02923856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101513060|NCT02923856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101513061|NCT02923856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101513062|NCT02923856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101513063|NCT02923856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513064|NCT02923856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101513065|NCT02923856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101513066|NCT02934204|Methotrexate|methotrexate|mesh-list
101513067|NCT02934204|Temozolomide|temozolomide|mesh-list
101513068|NCT02934204|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101513069|NCT02934204|Abortifacient Agents|abortifacient agents|mesh-ancestor
101513070|NCT02934204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101513071|NCT02934204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513072|NCT02934204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101513073|NCT02934204|Antimetabolites|antimetabolites|mesh-ancestor
101513074|NCT02934204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513075|NCT02934204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101513076|NCT02934204|Dermatologic Agents|dermatologic agents|mesh-ancestor
101513077|NCT02934204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101513078|NCT02934204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101196798|NCT01388023|Disinfectants|disinfectants|mesh-ancestor
101513080|NCT02934204|Immunologic Factors|immunologic factors|mesh-ancestor
101513081|NCT02934204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101513082|NCT02934204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101513083|NCT02934204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101513084|NCT02934204|Alkylating Agents|alkylating agents|mesh-ancestor
101513086|NCT01286077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101513087|NCT05590936|Ondansetron|ondansetron|mesh-list
101513088|NCT05590936|Dimenhydrinate|dimenhydrinate|mesh-list
101513089|NCT05590936|Antiemetics|antiemetics|mesh-ancestor
101513090|NCT05590936|Autonomic Agents|autonomic agents|mesh-ancestor
101513091|NCT05590936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101513092|NCT05590936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513093|NCT05590936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101513094|NCT05590936|Antipruritics|antipruritics|mesh-ancestor
101513095|NCT05590936|Dermatologic Agents|dermatologic agents|mesh-ancestor
101513096|NCT05590936|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101513097|NCT05590936|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101513098|NCT05590936|Serotonin Agents|serotonin agents|mesh-ancestor
101513099|NCT05590936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101513100|NCT05590936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513101|NCT05590936|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101513102|NCT05590936|Histamine Antagonists|histamine antagonists|mesh-ancestor
101513103|NCT05590936|Histamine Agents|histamine agents|mesh-ancestor
101513104|NCT02933814|Bupivacaine|bupivacaine|mesh-list
101513105|NCT02933814|Anesthetics, Local|anesthetics, local|mesh-ancestor
101513106|NCT02933814|Anesthetics|anesthetics|mesh-ancestor
101513107|NCT02933814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101513108|NCT02933814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513109|NCT02933814|Sensory System Agents|sensory system agents|mesh-ancestor
101513110|NCT02933814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101513111|NCT02933775|Cyclophosphamide|cyclophosphamide|mesh-list
101513112|NCT02933775|Fludarabine|fludarabine|mesh-list
101513113|NCT02933775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101513114|NCT02933775|Immunologic Factors|immunologic factors|mesh-ancestor
101513115|NCT02933775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513116|NCT02933775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101513117|NCT02933775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101513118|NCT02933775|Alkylating Agents|alkylating agents|mesh-ancestor
101513119|NCT02933775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513120|NCT02933775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101513121|NCT02933775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101513123|NCT02923583|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101513124|NCT02923583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513125|NCT02923583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101513126|NCT02923583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101513127|NCT02923583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101513128|NCT02923583|Immunologic Factors|immunologic factors|mesh-ancestor
101513129|NCT02923583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513130|NCT02923583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101513131|NCT02933580|JNJ-56136379|jnj-56136379|mesh-list
101513132|NCT02933580|Antiviral Agents|antiviral agents|mesh-ancestor
101513133|NCT02933580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101513134|NCT02923388|Vitamins|vitamins|mesh-list
101513135|NCT02923388|Vitamin B 12|vitamin b 12|mesh-list
101513136|NCT02923388|Pyridoxine|pyridoxine|mesh-list
101513137|NCT02923388|Vitamin B 6|vitamin b 6|mesh-list
101513138|NCT02923388|Vitamin B Complex|vitamin b complex|mesh-list
101513139|NCT02923388|Micronutrients|micronutrients|mesh-ancestor
101513140|NCT02923388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513141|NCT02933658|Amlodipine|amlodipine|mesh-list
101513142|NCT02933658|Telmisartan|telmisartan|mesh-list
101513143|NCT02933658|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101264362|NCT01767454|Trametinib|trametinib|mesh-list
101264363|NCT01767454|Dabrafenib|dabrafenib|mesh-list
101513144|NCT02933658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101513145|NCT02933658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101513146|NCT02933658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101513147|NCT02933658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513148|NCT02933658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101513149|NCT02933658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513150|NCT02933658|Vasodilator Agents|vasodilator agents|mesh-ancestor
101513151|NCT02933658|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101513152|NCT02933658|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101513153|NCT02933658|Antimetabolites|antimetabolites|mesh-ancestor
101513154|NCT02933658|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101513155|NCT02933658|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101513156|NCT02933658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101513157|NCT02933658|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101513158|NCT02933658|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101513160|NCT02933853|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101513161|NCT02933853|Insulin Aspart|insulin aspart|mesh-list
101513162|NCT02933853|Insulin, Long-Acting|insulin, long-acting|mesh-list
101513163|NCT02933853|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101513164|NCT02933853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101513165|NCT02933853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513166|NCT00532194|Cediranib|cediranib|mesh-list
101513167|NCT00532194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101513168|NCT00532194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101513169|NCT00532194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101513170|NCT00532194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513171|NCT02665143|Nintedanib|nintedanib|mesh-list
101513172|NCT02665143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101513173|NCT02665143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101513174|NCT02665143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101513175|NCT02665143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513176|NCT00532272|Letrozole|letrozole|mesh-list
101513177|NCT00532272|Goserelin|goserelin|mesh-list
101513178|NCT00532272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101513179|NCT00532272|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101513180|NCT00532272|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101513181|NCT00532272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101513182|NCT00532272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513183|NCT00532272|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101513184|NCT00532272|Hormone Antagonists|hormone antagonists|mesh-ancestor
101513185|NCT00532272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101513186|NCT00532272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513187|NCT00532272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101513188|NCT02922803|Calcium, Dietary|calcium, dietary|mesh-list
101513189|NCT02922803|Vitamin D|vitamin d|mesh-list
101513190|NCT02922803|Ergocalciferols|ergocalciferols|mesh-list
101513191|NCT02922803|Cholecalciferol|cholecalciferol|mesh-list
101513192|NCT02922803|Vitamins|vitamins|mesh-list
101513193|NCT02922803|Calcium|calcium|mesh-list
101513194|NCT02922803|Micronutrients|micronutrients|mesh-ancestor
101513195|NCT02922803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513196|NCT02922803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101513197|NCT02922803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101513199|NCT02834559|Heparin|heparin|mesh-list
101513200|NCT02834559|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101513201|NCT02834559|Tinzaparin|tinzaparin|mesh-list
101513202|NCT02834559|Dalteparin|dalteparin|mesh-list
101513203|NCT02834559|Antimetabolites|antimetabolites|mesh-ancestor
101513204|NCT02834559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513205|NCT02834559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101513206|NCT02834559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101513207|NCT02834559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101513208|NCT02834559|Immunologic Factors|immunologic factors|mesh-ancestor
101513209|NCT02834559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513210|NCT02834559|Anticoagulants|anticoagulants|mesh-ancestor
101513211|NCT02834559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101513212|NCT02834559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101513213|NCT02922686|Floxacillin|floxacillin|mesh-list
101513214|NCT02922686|Penicillin V|penicillin v|mesh-list
101513215|NCT02922686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101513216|NCT02922686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101513217|NCT02922491|Vitamin E|vitamin e|mesh-list
101513218|NCT02922491|Vitamins|vitamins|mesh-ancestor
101318579|NCT00006035|Bleomycin|bleomycin|mesh-list
101513219|NCT02922491|Micronutrients|micronutrients|mesh-ancestor
101513220|NCT02922491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513221|NCT02922491|Antioxidants|antioxidants|mesh-ancestor
101513222|NCT02922491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513223|NCT02922491|Protective Agents|protective agents|mesh-ancestor
101513224|NCT02922179|Insulin|insulin|mesh-list
101513225|NCT02922179|Insulin Detemir|insulin detemir|mesh-list
101513226|NCT02922179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101513227|NCT02922179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513228|NCT02921984|Docetaxel|docetaxel|mesh-list
101513229|NCT02921984|Pemetrexed|pemetrexed|mesh-list
101513230|NCT02921984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101513231|NCT02921984|Tubulin Modulators|tubulin modulators|mesh-ancestor
101513232|NCT02921984|Antimitotic Agents|antimitotic agents|mesh-ancestor
101513233|NCT02921984|Mitosis Modulators|mitosis modulators|mesh-ancestor
101513234|NCT02921984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513235|NCT02921984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101513237|NCT02921984|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101513239|NCT01285609|Carboplatin|carboplatin|mesh-list
101513240|NCT01285609|Ipilimumab|ipilimumab|mesh-list
101513241|NCT01285609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101513242|NCT01285609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101513243|NCT01285609|Tubulin Modulators|tubulin modulators|mesh-ancestor
101513244|NCT01285609|Antimitotic Agents|antimitotic agents|mesh-ancestor
101513245|NCT01285609|Mitosis Modulators|mitosis modulators|mesh-ancestor
101513246|NCT01285609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513247|NCT01285609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101513248|NCT01285609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101513249|NCT03981341|Bazedoxifene|bazedoxifene|mesh-list
101513250|NCT03981341|Estrogens|estrogens|mesh-list
101513251|NCT03981341|Hormones|hormones|mesh-ancestor
101513252|NCT03981341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101513253|NCT03981341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513254|NCT03981341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101513255|NCT03981341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101513256|NCT03981341|Hormone Antagonists|hormone antagonists|mesh-ancestor
101513257|NCT03981341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101513258|NCT03924440|Nonoxynol|nonoxynol|mesh-list
101513259|NCT03924440|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
101513260|NCT03924440|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
101513261|NCT03924440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513262|NCT03924440|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101513263|NCT03924440|Contraceptive Agents|contraceptive agents|mesh-ancestor
101513264|NCT03924440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101513265|NCT03924440|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101513266|NCT01285492|Tiotropium Bromide|tiotropium bromide|mesh-list
101513267|NCT01285492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101513268|NCT01285492|Autonomic Agents|autonomic agents|mesh-ancestor
101513269|NCT01285492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101513270|NCT01285492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513271|NCT01285492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101513272|NCT01285492|Respiratory System Agents|respiratory system agents|mesh-ancestor
101513273|NCT01285492|Parasympatholytics|parasympatholytics|mesh-ancestor
101513274|NCT01285492|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101513275|NCT01285492|Cholinergic Agents|cholinergic agents|mesh-ancestor
101513276|NCT01285492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101513277|NCT01285492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513278|NCT04615143|Tislelizumab|tislelizumab|mesh-list
101513279|NCT04615143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101513280|NCT04615143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101513281|NCT01284634|Cannabidiol|cannabidiol|mesh-list
101513282|NCT01284634|Anticonvulsants|anticonvulsants|mesh-ancestor
101513283|NCT02932722|Anesthetics|anesthetics|mesh-list
101513284|NCT02932722|Propofol|propofol|mesh-list
101513285|NCT02932722|Sevoflurane|sevoflurane|mesh-list
101513286|NCT02932722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101513287|NCT02932722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513288|NCT02932722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101513289|NCT02932722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101513290|NCT02932722|Anesthetics, General|anesthetics, general|mesh-ancestor
101513291|NCT02932722|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101513292|NCT02932722|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101513294|NCT02932761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101513295|NCT02932761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101513296|NCT01283971|Adalimumab|adalimumab|mesh-list
101513297|NCT01283971|Methotrexate|methotrexate|mesh-list
101513298|NCT01283971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101513299|NCT01283971|Abortifacient Agents|abortifacient agents|mesh-ancestor
101513300|NCT01283971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101513301|NCT01283971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513302|NCT01283971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101513303|NCT01283971|Antimetabolites|antimetabolites|mesh-ancestor
101513304|NCT01283971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513305|NCT01283971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101513306|NCT01283971|Dermatologic Agents|dermatologic agents|mesh-ancestor
101513307|NCT01283971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101513308|NCT01283971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101513309|NCT01283971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101513310|NCT01283971|Immunologic Factors|immunologic factors|mesh-ancestor
101513311|NCT01283971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101513312|NCT01283971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101513313|NCT01283971|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101513314|NCT01283971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101513315|NCT02921282|Dopamine|dopamine|mesh-list
101513316|NCT02921282|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101513317|NCT02921282|Sympathomimetics|sympathomimetics|mesh-ancestor
101513318|NCT02921282|Autonomic Agents|autonomic agents|mesh-ancestor
101513319|NCT02921282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101513320|NCT02921282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513321|NCT02921282|Dopamine Agents|dopamine agents|mesh-ancestor
101513322|NCT02921282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101513323|NCT02921282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513324|NCT02921282|Protective Agents|protective agents|mesh-ancestor
101513325|NCT02921360|Aspirin|aspirin|mesh-list
101513326|NCT02921360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101513327|NCT02921360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101513328|NCT02921360|Analgesics|analgesics|mesh-ancestor
101513329|NCT02921360|Sensory System Agents|sensory system agents|mesh-ancestor
101513330|NCT02921360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101513331|NCT02921360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513332|NCT02921360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101513333|NCT02921360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101513334|NCT02921360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101513335|NCT02921360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101513336|NCT02921360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513337|NCT02921360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101513338|NCT02921360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101513339|NCT02921360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101513340|NCT02921360|Antipyretics|antipyretics|mesh-ancestor
101513341|NCT02932605|Cannabidiol|cannabidiol|mesh-list
101513342|NCT02932605|Anticonvulsants|anticonvulsants|mesh-ancestor
101513343|NCT02921204|Vitamin D|vitamin d|mesh-list
101513344|NCT02921204|Vitamins|vitamins|mesh-ancestor
101513345|NCT02921204|Micronutrients|micronutrients|mesh-ancestor
101513346|NCT02921204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513347|NCT02921204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101513348|NCT01283581|Vancomycin|vancomycin|mesh-list
101513349|NCT01283581|Linezolid|linezolid|mesh-list
101513350|NCT01283581|Delafloxacin|delafloxacin|mesh-list
101513351|NCT01283581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101513352|NCT01283581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101513353|NCT01283581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101513354|NCT01283581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101513355|NCT01283581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513356|NCT01283542|Pasireotide|pasireotide|mesh-list
101513358|NCT01283542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101513359|NCT01283542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513360|NCT02932488|Sumatriptan|sumatriptan|mesh-list
101513361|NCT02932488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101513362|NCT02932488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101513363|NCT02932488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101513364|NCT02932488|Serotonin Agents|serotonin agents|mesh-ancestor
101513366|NCT02932488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513367|NCT02932488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513369|NCT02921165|Analgesics|analgesics|mesh-list
101513370|NCT02921165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101513371|NCT02921165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101513372|NCT02921165|Sensory System Agents|sensory system agents|mesh-ancestor
101513373|NCT02921165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101513374|NCT02921165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513375|NCT02921165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101513376|NCT02921165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101513377|NCT02921165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101513378|NCT02921165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101513379|NCT02921165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513380|NCT02921165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101197095|NCT01389505|Growth Inhibitors|growth inhibitors|mesh-ancestor
101513381|NCT02921165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101513382|NCT02921165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101513383|NCT02921165|Antipyretics|antipyretics|mesh-ancestor
101513384|NCT01283386|Cyclophosphamide|cyclophosphamide|mesh-list
101513385|NCT01283386|Chlorambucil|chlorambucil|mesh-list
101513387|NCT01283386|Fludarabine|fludarabine|mesh-list
101513388|NCT01283386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101513389|NCT01283386|Immunologic Factors|immunologic factors|mesh-ancestor
101513390|NCT01283386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513391|NCT01283386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101513392|NCT01283386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101513393|NCT01283386|Alkylating Agents|alkylating agents|mesh-ancestor
101513394|NCT01283386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513395|NCT01283386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101513396|NCT01283386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101513397|NCT01283386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101513398|NCT02920931|Tenofovir|tenofovir|mesh-list
101513399|NCT02920931|Antiviral Agents|antiviral agents|mesh-ancestor
101513400|NCT02920931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101513401|NCT02920931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101513402|NCT02920931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101513403|NCT02920931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101513404|NCT02920931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513405|NCT02920931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101513406|NCT02920931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101513407|NCT01283152|Lactulose|lactulose|mesh-list
101513408|NCT01283152|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101513409|NCT01283152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101513410|NCT01283152|Laxatives|laxatives|mesh-ancestor
101513411|NCT01283464|Vitamin A|vitamin a|mesh-list
101513412|NCT01283464|Tretinoin|tretinoin|mesh-list
101513413|NCT01283464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101513414|NCT01283464|Keratolytic Agents|keratolytic agents|mesh-ancestor
101513415|NCT01283464|Dermatologic Agents|dermatologic agents|mesh-ancestor
101513416|NCT01283464|Vitamins|vitamins|mesh-ancestor
101513417|NCT01283464|Micronutrients|micronutrients|mesh-ancestor
101513418|NCT01283464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513419|NCT01282801|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101513420|NCT01282801|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101513421|NCT01282801|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101513422|NCT01282801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101513423|NCT01282801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513424|NCT01282801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101513425|NCT01282801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513426|NCT01282801|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101513427|NCT01282801|Antidepressive Agents|antidepressive agents|mesh-ancestor
101513428|NCT01282801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101513429|NCT00532350|Tiotropium Bromide|tiotropium bromide|mesh-list
101513430|NCT00532350|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101513431|NCT00532350|Autonomic Agents|autonomic agents|mesh-ancestor
101513432|NCT00532350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101513433|NCT00532350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513434|NCT00532350|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101513435|NCT00532350|Respiratory System Agents|respiratory system agents|mesh-ancestor
101513436|NCT00532350|Parasympatholytics|parasympatholytics|mesh-ancestor
101513437|NCT00532350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101513438|NCT00532350|Cholinergic Agents|cholinergic agents|mesh-ancestor
101513439|NCT00532350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101513440|NCT00532350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513441|NCT02932566|Pirfenidone|pirfenidone|mesh-list
101513442|NCT02932566|Analgesics|analgesics|mesh-ancestor
101513443|NCT02932566|Sensory System Agents|sensory system agents|mesh-ancestor
101513444|NCT02932566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101513445|NCT02932566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513446|NCT02932566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101513447|NCT02932566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101513448|NCT02932566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101513449|NCT02932566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101513450|NCT02932566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101513451|NCT00532389|Panobinostat|panobinostat|mesh-list
101513452|NCT00532389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101513453|NCT00532389|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101513454|NCT00532389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101197175|NCT01389908|Olanzapine|olanzapine|mesh-list
101513455|NCT00532389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513457|NCT02932644|Ergocalciferols|ergocalciferols|mesh-list
101513458|NCT02932644|Cholecalciferol|cholecalciferol|mesh-list
101513459|NCT02932644|Vitamins|vitamins|mesh-list
101513460|NCT02932644|Micronutrients|micronutrients|mesh-ancestor
101513461|NCT02932644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513462|NCT02932644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101513463|NCT02932644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101513464|NCT05466708|Dexmedetomidine|dexmedetomidine|mesh-list
101513465|NCT05466708|Ketamine|ketamine|mesh-list
101513466|NCT05466708|Esketamine|esketamine|mesh-list
101513467|NCT05466708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101513468|NCT05466708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101513469|NCT05466708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513470|NCT05466708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101513471|NCT05466708|Analgesics|analgesics|mesh-ancestor
101513472|NCT05466708|Sensory System Agents|sensory system agents|mesh-ancestor
101513473|NCT05466708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101513474|NCT05466708|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101513475|NCT05466708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101513476|NCT05466708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101513477|NCT05466708|Adrenergic Agents|adrenergic agents|mesh-ancestor
101513478|NCT05466708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101513479|NCT05466708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513480|NCT05466708|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101513481|NCT05466708|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101513482|NCT05466708|Anesthetics, General|anesthetics, general|mesh-ancestor
101513483|NCT05466708|Anesthetics|anesthetics|mesh-ancestor
101513484|NCT05466708|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101513485|NCT05466708|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101513486|NCT05466708|Antidepressive Agents|antidepressive agents|mesh-ancestor
101513488|NCT02920502|Cholecalciferol|cholecalciferol|mesh-list
101513489|NCT02920502|Vitamin D|vitamin d|mesh-list
101513490|NCT02920502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101513491|NCT02920502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513492|NCT02920502|Vitamins|vitamins|mesh-ancestor
101513493|NCT02920502|Micronutrients|micronutrients|mesh-ancestor
101513494|NCT02920502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101513495|NCT01282216|Vaccines|vaccines|mesh-list
101513496|NCT01282216|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101513497|NCT01282216|Immunologic Factors|immunologic factors|mesh-ancestor
101513498|NCT01282216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513500|NCT01281865|Imatinib Mesylate|imatinib mesylate|mesh-list
101513501|NCT01281865|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101513502|NCT01281865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101513503|NCT01281865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101513504|NCT01281865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513505|NCT01281865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101513506|NCT01281865|Immunologic Factors|immunologic factors|mesh-ancestor
101513507|NCT01281865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513508|NCT01281865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101513510|NCT02920658|Betamethasone Valerate|betamethasone valerate|mesh-list
101513511|NCT02920658|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101513512|NCT02920658|Betamethasone benzoate|betamethasone benzoate|mesh-list
101513513|NCT02920658|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101513514|NCT02920658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101513515|NCT02920658|Glucocorticoids|glucocorticoids|mesh-ancestor
101513516|NCT02920658|Hormones|hormones|mesh-ancestor
101513517|NCT02920658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101513518|NCT02920658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513519|NCT02920658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101513520|NCT02920658|Respiratory System Agents|respiratory system agents|mesh-ancestor
101513521|NCT01281202|Vigabatrin|vigabatrin|mesh-list
101513522|NCT01281202|Anticonvulsants|anticonvulsants|mesh-ancestor
101513523|NCT01281202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101513524|NCT01281202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513525|NCT01281202|GABA Agents|gaba agents|mesh-ancestor
101513526|NCT01281202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101513527|NCT01281202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513528|NCT01281124|Azacitidine|azacitidine|mesh-list
101513529|NCT01281124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101513530|NCT01281124|Antimetabolites|antimetabolites|mesh-ancestor
101513531|NCT01281124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513532|NCT01281124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101513533|NCT01281124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101513534|NCT00623857|Vitamins|vitamins|mesh-list
101513536|NCT00623857|Micronutrients|micronutrients|mesh-ancestor
101513537|NCT00623857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513538|NCT00623857|Trace Elements|trace elements|mesh-ancestor
101513539|NCT01280968|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101513540|NCT01280968|Vaccines|vaccines|mesh-list
101513541|NCT01280968|Nicotine|nicotine|mesh-list
101513542|NCT01280968|Immunologic Factors|immunologic factors|mesh-ancestor
101513543|NCT01280968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513544|NCT01280968|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101513545|NCT01280968|Autonomic Agents|autonomic agents|mesh-ancestor
101513546|NCT01280968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101513547|NCT01280968|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101513548|NCT01280968|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101513549|NCT01280968|Cholinergic Agents|cholinergic agents|mesh-ancestor
101513550|NCT01280968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101513551|NCT01280968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513552|NCT01280968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101513553|NCT01280968|Antacids|antacids|mesh-ancestor
101513554|NCT01280968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101513555|NCT02932020|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101513556|NCT02932020|Methylprednisolone|methylprednisolone|mesh-list
101513557|NCT02932020|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101513558|NCT02932020|Prednisolone|prednisolone|mesh-list
101513559|NCT02932020|Prednisolone acetate|prednisolone acetate|mesh-list
101513560|NCT02932020|Bupivacaine|bupivacaine|mesh-list
101513561|NCT02932020|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101513562|NCT02932020|Prednisolone phosphate|prednisolone phosphate|mesh-list
101513563|NCT02932020|Anesthetics, Local|anesthetics, local|mesh-ancestor
101264403|NCT01767714|Lenograstim|lenograstim|mesh-list
101264405|NCT01767714|Immunologic Factors|immunologic factors|mesh-ancestor
101513564|NCT02932020|Anesthetics|anesthetics|mesh-ancestor
101513565|NCT02932020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101513566|NCT02932020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513567|NCT02932020|Sensory System Agents|sensory system agents|mesh-ancestor
101513568|NCT02932020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101513569|NCT02932020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101513570|NCT02932020|Antiemetics|antiemetics|mesh-ancestor
101513571|NCT02932020|Autonomic Agents|autonomic agents|mesh-ancestor
101513572|NCT02932020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101513573|NCT02932020|Glucocorticoids|glucocorticoids|mesh-ancestor
101513575|NCT02932020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101513576|NCT02932020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101513577|NCT02932020|Protective Agents|protective agents|mesh-ancestor
101513578|NCT02932020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101513579|NCT02932020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101513580|NCT01280656|Interferons|interferons|mesh-list
101513582|NCT01280656|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101513583|NCT01280656|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101513584|NCT01280656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101513585|NCT01280656|Antiviral Agents|antiviral agents|mesh-ancestor
101513586|NCT01280656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101513587|NCT01280656|Antimetabolites|antimetabolites|mesh-ancestor
101513588|NCT01280656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513589|NCT03741530|Glyburide|glyburide|mesh-list
101513590|NCT03741530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101513591|NCT03741530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513592|NCT01280617|Thymoglobulin|thymoglobulin|mesh-list
101513593|NCT01280617|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101513594|NCT01280617|Immunologic Factors|immunologic factors|mesh-ancestor
101513595|NCT01280617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513596|NCT01280617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101513597|NCT02932137|Interleukin-2|interleukin-2|mesh-list
101513598|NCT02932137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101513599|NCT02932137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101513600|NCT02932137|Analgesics|analgesics|mesh-ancestor
101513601|NCT02932137|Sensory System Agents|sensory system agents|mesh-ancestor
101513602|NCT02932137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101197320|NCT01390883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101513603|NCT02932137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513604|NCT01280266|Amlodipine|amlodipine|mesh-list
101513605|NCT01280266|Udenafil|udenafil|mesh-list
101513606|NCT01280266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101513607|NCT01280266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101513608|NCT01280266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101513609|NCT01280266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513610|NCT01280266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101513611|NCT01280266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513612|NCT01280266|Vasodilator Agents|vasodilator agents|mesh-ancestor
101513613|NCT01280266|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101513614|NCT01280266|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101513615|NCT01280266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101513616|NCT01279447|Bupivacaine|bupivacaine|mesh-list
101513617|NCT01279447|Anesthetics, Local|anesthetics, local|mesh-ancestor
101513618|NCT01279447|Anesthetics|anesthetics|mesh-ancestor
101513619|NCT01279447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101513620|NCT01279447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513621|NCT01279447|Sensory System Agents|sensory system agents|mesh-ancestor
101513622|NCT01279447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101513623|NCT02932254|Magnesium Sulfate|magnesium sulfate|mesh-list
101513624|NCT02932254|Analgesics|analgesics|mesh-ancestor
101513625|NCT02932254|Sensory System Agents|sensory system agents|mesh-ancestor
101513626|NCT02932254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101513627|NCT02932254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513628|NCT02932254|Anesthetics|anesthetics|mesh-ancestor
101513629|NCT02932254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101513630|NCT02932254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101513631|NCT02932254|Anticonvulsants|anticonvulsants|mesh-ancestor
101513632|NCT02932254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101513633|NCT02932254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101513634|NCT02932254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513635|NCT02932254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101513636|NCT02932254|Tocolytic Agents|tocolytic agents|mesh-ancestor
101513637|NCT02932254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101513638|NCT02920190|Liraglutide|liraglutide|mesh-list
101513639|NCT02920190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101513640|NCT02920190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513641|NCT02920190|Incretins|incretins|mesh-ancestor
101513642|NCT02920190|Hormones|hormones|mesh-ancestor
101513643|NCT02920190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101513644|NCT02919878|Gemcitabine|gemcitabine|mesh-list
101513645|NCT02919878|Capecitabine|capecitabine|mesh-list
101513646|NCT02919878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101513647|NCT02919878|Antimetabolites|antimetabolites|mesh-ancestor
101513648|NCT02919878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513649|NCT02919878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101513650|NCT02931786|Ketamine|ketamine|mesh-list
101513651|NCT02931786|Propofol|propofol|mesh-list
101513652|NCT02931786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101513653|NCT02931786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101513654|NCT02931786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513655|NCT02931786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101513656|NCT02931786|Anesthetics, General|anesthetics, general|mesh-ancestor
101513657|NCT02931786|Anesthetics|anesthetics|mesh-ancestor
101513658|NCT02931786|Analgesics|analgesics|mesh-ancestor
101513659|NCT02931786|Sensory System Agents|sensory system agents|mesh-ancestor
101513660|NCT02931786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101513661|NCT02931786|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101513662|NCT02931786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101513663|NCT02931786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101513664|NCT02931786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101513665|NCT02931786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513666|NCT02919605|Pentamidine|pentamidine|mesh-list
101513667|NCT02919605|Antifungal Agents|antifungal agents|mesh-ancestor
101513668|NCT02919605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101513669|NCT02919605|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101513670|NCT02919605|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101513671|NCT02919605|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101513672|NCT00532428|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101513673|NCT00532428|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101513674|NCT00532428|Hormone Antagonists|hormone antagonists|mesh-ancestor
101513675|NCT00532428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101513676|NCT00532428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513677|NCT00532428|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101513678|NCT00532428|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101513679|NCT00532428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101513680|NCT05465733|Pemetrexed|pemetrexed|mesh-list
101513681|NCT05465733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101513682|NCT05465733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101513683|NCT05465733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513684|NCT05465733|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101513685|NCT05465733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101513686|NCT03673787|Atezolizumab|atezolizumab|mesh-list
101513687|NCT03673787|Ipatasertib|ipatasertib|mesh-list
101513688|NCT03673787|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101513689|NCT03673787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513690|NCT03673787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101513691|NCT03673787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101513692|NCT03673787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101513694|NCT03571802|Simvastatin|simvastatin|mesh-list
101513695|NCT03571802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101513696|NCT03571802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101513697|NCT03571802|Antimetabolites|antimetabolites|mesh-ancestor
101513698|NCT03571802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513699|NCT03571802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101264423|NCT01767610|Antimetabolites|antimetabolites|mesh-ancestor
101513700|NCT03571802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101513701|NCT03571802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101513702|NCT02919332|Deoxyglucose|deoxyglucose|mesh-list
101513703|NCT02919332|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101513704|NCT02919332|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101513705|NCT02919332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513706|NCT02919332|Antimetabolites|antimetabolites|mesh-ancestor
101513707|NCT02919332|Antiviral Agents|antiviral agents|mesh-ancestor
101513708|NCT02919332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101513709|NCT02919293|Vaccines|vaccines|mesh-list
101513710|NCT02919293|Immunologic Factors|immunologic factors|mesh-ancestor
101513711|NCT02919293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513712|NCT02919371|Bevacizumab|bevacizumab|mesh-list
101513713|NCT02919371|Sunitinib|sunitinib|mesh-list
101513714|NCT02919371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101513716|NCT02919371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101513717|NCT02919371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101513718|NCT02919371|Growth Substances|growth substances|mesh-ancestor
101513719|NCT02919371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513720|NCT02919371|Growth Inhibitors|growth inhibitors|mesh-ancestor
101513721|NCT02919371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101513722|NCT02919371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101513723|NCT02919371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513724|NCT04736901|Enoxaparin|enoxaparin|mesh-list
101513725|NCT04736901|Rivaroxaban|rivaroxaban|mesh-list
101513726|NCT04736901|Apixaban|apixaban|mesh-list
101513727|NCT04736901|Enoxaparin sodium|enoxaparin sodium|mesh-list
101513728|NCT04736901|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101513729|NCT04736901|Antithrombins|antithrombins|mesh-ancestor
101513730|NCT04736901|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101513731|NCT04736901|Protease Inhibitors|protease inhibitors|mesh-ancestor
101513732|NCT04736901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101513733|NCT04736901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513734|NCT04736901|Anticoagulants|anticoagulants|mesh-ancestor
101513735|NCT04736901|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101513736|NCT04736901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101513737|NCT02919176|Pioglitazone|pioglitazone|mesh-list
101513738|NCT02919176|Mirabegron|mirabegron|mesh-list
101513739|NCT02919176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101513740|NCT02919176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513741|NCT02919176|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101513742|NCT02919176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101513743|NCT02919176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101513744|NCT02919176|Adrenergic Agents|adrenergic agents|mesh-ancestor
101513745|NCT02919176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101513746|NCT02919176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513747|NCT02919176|Urological Agents|urological agents|mesh-ancestor
101513748|NCT04734678|Infliximab|infliximab|mesh-list
101513749|NCT04734678|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101513750|NCT04734678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101513751|NCT04734678|Dermatologic Agents|dermatologic agents|mesh-ancestor
101513752|NCT04734678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101513753|NCT04734678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101513754|NCT02919059|Dapagliflozin|dapagliflozin|mesh-list
101513755|NCT02919059|Glimepiride|glimepiride|mesh-list
101513756|NCT02919059|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101513757|NCT02919059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513758|NCT02919059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101513759|NCT02919059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513760|NCT02919059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101513761|NCT02919059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101513762|NCT02919059|Immunologic Factors|immunologic factors|mesh-ancestor
101513764|NCT04727775|Favipiravir|favipiravir|mesh-list
101513765|NCT04727775|Antimetabolites|antimetabolites|mesh-ancestor
101513766|NCT04727775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513767|NCT04727775|Antiviral Agents|antiviral agents|mesh-ancestor
101513768|NCT04727775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101513769|NCT02918825|Olanzapine|olanzapine|mesh-list
101513770|NCT02918825|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101513773|NCT02918825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101513774|NCT02918825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513775|NCT02918825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101513776|NCT02918825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101513777|NCT02918825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101513778|NCT02918825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101513779|NCT02918825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101513780|NCT02918825|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101513781|NCT02918825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101513782|NCT02918825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101513783|NCT02918825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513784|NCT02918825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101513785|NCT02918825|Serotonin Agents|serotonin agents|mesh-ancestor
101513786|NCT02918825|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101513787|NCT02918825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101513788|NCT02918825|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101513789|NCT02918825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101513790|NCT02918825|Dopamine Agents|dopamine agents|mesh-ancestor
101513791|NCT02918747|Dexamethasone|dexamethasone|mesh-list
101513792|NCT02918747|Prednisone|prednisone|mesh-list
101513793|NCT02918747|Cyclophosphamide|cyclophosphamide|mesh-list
101513794|NCT02918747|Gemcitabine|gemcitabine|mesh-list
101513795|NCT02918747|Doxorubicin|doxorubicin|mesh-list
101513796|NCT02918747|Oxaliplatin|oxaliplatin|mesh-list
101513797|NCT02918747|Vincristine|vincristine|mesh-list
101513798|NCT02918747|Pegaspargase|pegaspargase|mesh-list
101513799|NCT02918747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101513800|NCT02918747|Immunologic Factors|immunologic factors|mesh-ancestor
101513801|NCT02918747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513802|NCT02918747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101513803|NCT02918747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101513804|NCT02918747|Alkylating Agents|alkylating agents|mesh-ancestor
101513805|NCT02918747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513806|NCT02918747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101513807|NCT02918747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101513808|NCT02918747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101513809|NCT02918747|Antiemetics|antiemetics|mesh-ancestor
101513810|NCT02918747|Autonomic Agents|autonomic agents|mesh-ancestor
101513811|NCT02918747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101513812|NCT02918747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101513813|NCT02918747|Glucocorticoids|glucocorticoids|mesh-ancestor
101513814|NCT02918747|Hormones|hormones|mesh-ancestor
101513815|NCT02918747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101513816|NCT02918747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101513817|NCT02918747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101513818|NCT02918747|Antimetabolites|antimetabolites|mesh-ancestor
101513819|NCT02918747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101513820|NCT02918747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101513821|NCT02918747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101513822|NCT02918747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101513823|NCT02918747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101513824|NCT02918747|Tubulin Modulators|tubulin modulators|mesh-ancestor
101513825|NCT02918747|Antimitotic Agents|antimitotic agents|mesh-ancestor
101513827|NCT02918708|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101513828|NCT02918708|Immunologic Factors|immunologic factors|mesh-ancestor
101513829|NCT02918708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513831|NCT02918591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101513832|NCT02918591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513833|NCT02918591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101513834|NCT02918591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513835|NCT02918045|Cellulose, Oxidized|cellulose, oxidized|mesh-list
101513836|NCT02918045|Hemostatics|hemostatics|mesh-ancestor
101513837|NCT02918045|Coagulants|coagulants|mesh-ancestor
101513838|NCT00532545|Teriparatide|teriparatide|mesh-list
101513839|NCT00532545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101513840|NCT00532545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513841|NCT00532545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101513842|NCT00533520|Ranibizumab|ranibizumab|mesh-list
101513843|NCT00533520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101513844|NCT00533520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101513845|NCT00533520|Growth Substances|growth substances|mesh-ancestor
101513846|NCT00533520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513847|NCT00533520|Growth Inhibitors|growth inhibitors|mesh-ancestor
101513848|NCT00533520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318630|NCT00017290|Immunologic Factors|immunologic factors|mesh-ancestor
101513863|NCT05356104|Exenatide|exenatide|mesh-list
101513864|NCT05356104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101513865|NCT05356104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513866|NCT05356104|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101513867|NCT05356104|Incretins|incretins|mesh-ancestor
101513868|NCT05356104|Hormones|hormones|mesh-ancestor
101513869|NCT05356104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101513870|NCT00533559|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
101513871|NCT00533559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101513872|NCT03685253|Niacinamide|niacinamide|mesh-list
101513873|NCT03685253|Vitamin B Complex|vitamin b complex|mesh-ancestor
101513874|NCT03685253|Vitamins|vitamins|mesh-ancestor
101513875|NCT03685253|Micronutrients|micronutrients|mesh-ancestor
101513876|NCT03685253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513877|NCT00532220|Ibandronic Acid|ibandronic acid|mesh-list
101513878|NCT00532220|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101513879|NCT00532220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513880|NCT00532584|Beclomethasone|beclomethasone|mesh-list
101513881|NCT00532584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101513882|NCT00532584|Glucocorticoids|glucocorticoids|mesh-ancestor
101513883|NCT00532584|Hormones|hormones|mesh-ancestor
101513884|NCT00532584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101513885|NCT00532584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513886|NCT00532584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101513887|NCT00532584|Respiratory System Agents|respiratory system agents|mesh-ancestor
101513888|NCT04687332|Tryptophan|tryptophan|mesh-list
101513889|NCT04687332|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101513890|NCT04687332|Antidepressive Agents|antidepressive agents|mesh-ancestor
101513891|NCT04687332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101513892|NCT05467709|Midazolam|midazolam|mesh-list
101513893|NCT05467709|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101513894|NCT05467709|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101513895|NCT05467709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101513896|NCT05467709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513897|NCT05467709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101513898|NCT05467709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101513899|NCT05467709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101513900|NCT05467709|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101513901|NCT05467709|Anesthetics, General|anesthetics, general|mesh-ancestor
101513902|NCT05467709|Anesthetics|anesthetics|mesh-ancestor
101513903|NCT05467709|GABA Modulators|gaba modulators|mesh-ancestor
101513904|NCT05467709|GABA Agents|gaba agents|mesh-ancestor
101513905|NCT05467709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101513906|NCT05467709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513907|NCT00532623|Gemcitabine|gemcitabine|mesh-list
101513908|NCT00532623|Vinorelbine|vinorelbine|mesh-list
101513909|NCT00532623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101513910|NCT00532623|Antimetabolites|antimetabolites|mesh-ancestor
101513911|NCT00532623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513912|NCT00532623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101513913|NCT00532623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101513914|NCT00532623|Tubulin Modulators|tubulin modulators|mesh-ancestor
101513915|NCT00532623|Antimitotic Agents|antimitotic agents|mesh-ancestor
101513916|NCT00532623|Mitosis Modulators|mitosis modulators|mesh-ancestor
101513917|NCT00532662|Ketamine|ketamine|mesh-list
101513918|NCT00532662|Analgesics|analgesics|mesh-ancestor
101513919|NCT00532662|Sensory System Agents|sensory system agents|mesh-ancestor
101513920|NCT00532662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101513921|NCT00532662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513922|NCT00532662|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101513923|NCT00532662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101513924|NCT00532662|Anesthetics, General|anesthetics, general|mesh-ancestor
101513925|NCT00532662|Anesthetics|anesthetics|mesh-ancestor
101513926|NCT00532662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101513927|NCT00532662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101513928|NCT00532662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101513929|NCT00532662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101513930|NCT00532662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513931|NCT05467436|Analgesics|analgesics|mesh-list
101513932|NCT05467436|Anesthetics|anesthetics|mesh-list
101513933|NCT05467436|Anesthetics, Local|anesthetics, local|mesh-list
101513934|NCT05467436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101513935|NCT05467436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513936|NCT05467436|Sensory System Agents|sensory system agents|mesh-ancestor
101536121|NCT00564824|Caffeine|caffeine|mesh-list
101513937|NCT05467436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101513938|NCT00533637|Cetirizine|cetirizine|mesh-list
101513939|NCT00533637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101513940|NCT00533637|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101513941|NCT00533637|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101513942|NCT00533637|Histamine Antagonists|histamine antagonists|mesh-ancestor
101513943|NCT00533637|Histamine Agents|histamine agents|mesh-ancestor
101513944|NCT00533637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101513945|NCT00533637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513946|NCT00533637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513947|NCT00533676|Oxymetazoline|oxymetazoline|mesh-list
101513948|NCT00533676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101513949|NCT00533676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101513950|NCT00533676|Adrenergic Agents|adrenergic agents|mesh-ancestor
101513951|NCT00533676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101513952|NCT00533676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513953|NCT00533676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513954|NCT00533676|Sympathomimetics|sympathomimetics|mesh-ancestor
101513955|NCT00533676|Autonomic Agents|autonomic agents|mesh-ancestor
101513956|NCT00533676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101513958|NCT00533676|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101513959|NCT00533676|Respiratory System Agents|respiratory system agents|mesh-ancestor
101513960|NCT05467319|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
101513961|NCT05467319|Hematinics|hematinics|mesh-ancestor
101513962|NCT05466695|Sildenafil Citrate|sildenafil citrate|mesh-list
101513963|NCT05466695|Tadalafil|tadalafil|mesh-list
101513964|NCT05466695|Vasodilator Agents|vasodilator agents|mesh-ancestor
101513965|NCT05466695|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101513966|NCT05466695|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101513967|NCT05466695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101513968|NCT05466695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513969|NCT05466695|Urological Agents|urological agents|mesh-ancestor
101513970|NCT04484610|Analgesics, Opioid|analgesics, opioid|mesh-list
101513971|NCT04484610|Narcotics|narcotics|mesh-ancestor
101513972|NCT04484610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101513973|NCT04484610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513975|NCT04484610|Sensory System Agents|sensory system agents|mesh-ancestor
101513976|NCT04484610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101513978|NCT05321316|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101513979|NCT05321316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513980|NCT05466149|Aflutinib|aflutinib|mesh-list
101513981|NCT05466149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101197709|NCT01393145|Hormones|hormones|mesh-ancestor
101513983|NCT05466149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513984|NCT00532701|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101513985|NCT00532701|Interferon-alpha|interferon-alpha|mesh-list
101513986|NCT00532701|Ribavirin|ribavirin|mesh-list
101513987|NCT00532701|Antiviral Agents|antiviral agents|mesh-ancestor
101513988|NCT00532701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101513989|NCT00532701|Immunologic Factors|immunologic factors|mesh-ancestor
101513990|NCT00532701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101513991|NCT00532701|Antimetabolites|antimetabolites|mesh-ancestor
101513992|NCT00532701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513993|NCT01276639|Tofacitinib|tofacitinib|mesh-list
101513994|NCT01276639|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101513995|NCT01276639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101513996|NCT01276639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101513997|NCT01276639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101513998|NCT00532415|Triamcinolone|triamcinolone|mesh-list
101513999|NCT00532415|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101514000|NCT00532415|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101514001|NCT00532415|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101514002|NCT00532415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101514003|NCT00532415|Glucocorticoids|glucocorticoids|mesh-ancestor
101514004|NCT00532415|Hormones|hormones|mesh-ancestor
101514005|NCT00532415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101514006|NCT00532415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514007|NCT00532415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101514008|NCT00532415|Immunologic Factors|immunologic factors|mesh-ancestor
101514009|NCT00532415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101514010|NCT00532415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514011|NCT00532454|Tamoxifen|tamoxifen|mesh-list
101514012|NCT00532454|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101514013|NCT00532454|Hormone Antagonists|hormone antagonists|mesh-ancestor
101514014|NCT00532454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101514015|NCT00532454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514016|NCT00532454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101514017|NCT00532454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101514018|NCT00532454|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101514019|NCT00532454|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101514020|NCT00532454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101514021|NCT01275625|Maraviroc|maraviroc|mesh-list
101514022|NCT01275625|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101514023|NCT01275625|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101514024|NCT01275625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514025|NCT01275625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101514026|NCT01275625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101514028|NCT01275625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101514029|NCT01275625|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101514030|NCT05459792|Lidocaine|lidocaine|mesh-list
101514031|NCT05459792|Bupivacaine|bupivacaine|mesh-list
101514032|NCT05459792|Anesthetics, Local|anesthetics, local|mesh-ancestor
101514033|NCT05459792|Anesthetics|anesthetics|mesh-ancestor
101514034|NCT05459792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101514035|NCT05459792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514036|NCT05459792|Sensory System Agents|sensory system agents|mesh-ancestor
101514037|NCT05459792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101514038|NCT05459792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101304265|NCT02012075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101514039|NCT05459792|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101514040|NCT05459792|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101514041|NCT05459792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101514042|NCT05459792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514043|NCT04686825|DA-8010|da-8010|mesh-list
101514044|NCT04686825|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101514045|NCT04686825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101514046|NCT04686825|Cholinergic Agents|cholinergic agents|mesh-ancestor
101514047|NCT04686825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101514048|NCT04686825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514049|NCT04686825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514050|NCT00533988|Anti-Infective Agents|anti-infective agents|mesh-list
101514051|NCT00533988|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101514052|NCT05281185|Factor VIII|factor viii|mesh-list
101514053|NCT05281185|Coagulants|coagulants|mesh-ancestor
101514054|NCT00532532|Tolperisone|tolperisone|mesh-list
101514055|NCT00532532|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101514056|NCT00532532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514057|NCT00532532|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101514058|NCT00532532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101514059|NCT00532571|Coenzyme Q10|coenzyme q10|mesh-list
101514060|NCT00532571|Vitamins|vitamins|mesh-ancestor
101514061|NCT00532571|Micronutrients|micronutrients|mesh-ancestor
101514062|NCT00532571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514063|NCT04322565|Colchicine|colchicine|mesh-list
101514064|NCT04322565|Gout Suppressants|gout suppressants|mesh-ancestor
101514065|NCT04322565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101514066|NCT04322565|Tubulin Modulators|tubulin modulators|mesh-ancestor
101514067|NCT04322565|Antimitotic Agents|antimitotic agents|mesh-ancestor
101514068|NCT04322565|Mitosis Modulators|mitosis modulators|mesh-ancestor
101514069|NCT04322565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514070|NCT04322565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101514071|NCT00532688|Acetylcysteine|acetylcysteine|mesh-list
101514072|NCT00532688|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101514073|NCT00532688|Antiviral Agents|antiviral agents|mesh-ancestor
101514074|NCT00532688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101514075|NCT00532688|Expectorants|expectorants|mesh-ancestor
101514076|NCT00532688|Respiratory System Agents|respiratory system agents|mesh-ancestor
101514077|NCT00532688|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101514078|NCT00532688|Antioxidants|antioxidants|mesh-ancestor
101514079|NCT00532688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514080|NCT00532688|Protective Agents|protective agents|mesh-ancestor
101514081|NCT00532688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514082|NCT00532688|Antidotes|antidotes|mesh-ancestor
101514083|NCT00534144|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101514084|NCT00534144|Ferric gluconate|ferric gluconate|mesh-list
101514085|NCT00534144|Hematinics|hematinics|mesh-ancestor
101514086|NCT00534183|Haloperidol|haloperidol|mesh-list
101514087|NCT00534183|Olanzapine|olanzapine|mesh-list
101514088|NCT00534183|Risperidone|risperidone|mesh-list
101514089|NCT00534183|Haloperidol decanoate|haloperidol decanoate|mesh-list
101514090|NCT00534183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101514091|NCT00534183|Serotonin Agents|serotonin agents|mesh-ancestor
101514092|NCT00534183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101514093|NCT00534183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514094|NCT00534183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514095|NCT00534183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101514096|NCT00534183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101514097|NCT00534183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101514098|NCT00534183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101514099|NCT00534183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101514100|NCT00534183|Dopamine Agents|dopamine agents|mesh-ancestor
101514101|NCT00534183|Antiemetics|antiemetics|mesh-ancestor
101514102|NCT00534183|Autonomic Agents|autonomic agents|mesh-ancestor
101514103|NCT00534183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101514104|NCT00534183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101514105|NCT00534183|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101514106|NCT00534183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101514107|NCT00534183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101514108|NCT00534183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101514109|NCT00532727|Carboplatin|carboplatin|mesh-list
101514110|NCT00532727|Docetaxel|docetaxel|mesh-list
101514111|NCT00532727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101514112|NCT00532727|Tubulin Modulators|tubulin modulators|mesh-ancestor
101514113|NCT00532727|Antimitotic Agents|antimitotic agents|mesh-ancestor
101514114|NCT00532727|Mitosis Modulators|mitosis modulators|mesh-ancestor
101514115|NCT00532727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514116|NCT04261218|Paclitaxel|paclitaxel|mesh-list
101514117|NCT04261218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101514118|NCT04261218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101514119|NCT04261218|Tubulin Modulators|tubulin modulators|mesh-ancestor
101514120|NCT04261218|Antimitotic Agents|antimitotic agents|mesh-ancestor
101514121|NCT04261218|Mitosis Modulators|mitosis modulators|mesh-ancestor
101514122|NCT04261218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514123|NCT04687449|Curcumin|curcumin|mesh-list
101514124|NCT04687449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101514125|NCT04687449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101514126|NCT04687449|Analgesics|analgesics|mesh-ancestor
101514127|NCT04687449|Sensory System Agents|sensory system agents|mesh-ancestor
101514128|NCT04687449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101197855|NCT01394224|Levetiracetam|levetiracetam|mesh-list
101514129|NCT04687449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514130|NCT04687449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101514131|NCT04687449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101514132|NCT04687449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101514133|NCT04687449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101514134|NCT04687449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514135|NCT05258279|Carboplatin|carboplatin|mesh-list
101514136|NCT05258279|Pembrolizumab|pembrolizumab|mesh-list
101514137|NCT05258279|Pemetrexed|pemetrexed|mesh-list
101514138|NCT05258279|Lenvatinib|lenvatinib|mesh-list
101514139|NCT05258279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101514140|NCT05258279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101514141|NCT05258279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101514142|NCT05258279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514143|NCT05258279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101514144|NCT05258279|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101514145|NCT05258279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101514146|NCT05258279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101514148|NCT00532818|Valproic Acid|valproic acid|mesh-list
101514149|NCT00532818|Anticonvulsants|anticonvulsants|mesh-ancestor
101514150|NCT00532818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101514151|NCT00532818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514152|NCT00532818|GABA Agents|gaba agents|mesh-ancestor
101514153|NCT00532818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101514154|NCT00532818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514155|NCT00532818|Antimanic Agents|antimanic agents|mesh-ancestor
101514156|NCT00532818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101514157|NCT00532818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101514158|NCT00532818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101514159|NCT00532818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101514160|NCT00532818|Vasodilator Agents|vasodilator agents|mesh-ancestor
101514161|NCT05209035|Trazodone|trazodone|mesh-list
101514162|NCT05209035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101514163|NCT05209035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101514164|NCT05209035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101514165|NCT05209035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514166|NCT05209035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101514167|NCT05209035|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101514168|NCT05209035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101514169|NCT05209035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101514170|NCT05209035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514171|NCT05209035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101514172|NCT05209035|Serotonin Agents|serotonin agents|mesh-ancestor
101514173|NCT05209035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101514174|NCT05209035|Antidepressive Agents|antidepressive agents|mesh-ancestor
101514175|NCT00534261|Interferons|interferons|mesh-list
101514176|NCT00534261|Interferon-beta|interferon-beta|mesh-list
101514177|NCT00534261|Interferon beta-1a|interferon beta-1a|mesh-list
101514178|NCT00534261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101514179|NCT00534261|Antiviral Agents|antiviral agents|mesh-ancestor
101514180|NCT00534261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101514181|NCT00534261|Immunologic Factors|immunologic factors|mesh-ancestor
101514182|NCT00534261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514183|NCT00534261|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101514185|NCT00532857|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101514186|NCT00532857|Gemcitabine|gemcitabine|mesh-list
101514187|NCT00532857|Trastuzumab|trastuzumab|mesh-list
101514188|NCT00532857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101514189|NCT00532857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101514190|NCT00532857|Tubulin Modulators|tubulin modulators|mesh-ancestor
101514191|NCT00532857|Antimitotic Agents|antimitotic agents|mesh-ancestor
101514192|NCT00532857|Mitosis Modulators|mitosis modulators|mesh-ancestor
101514193|NCT00532857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514194|NCT00532857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101514195|NCT00532857|Antimetabolites|antimetabolites|mesh-ancestor
101514196|NCT00532857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101514197|NCT05152004|Amoxicillin|amoxicillin|mesh-list
101514198|NCT05152004|Metronidazole|metronidazole|mesh-list
101514199|NCT05152004|Clarithromycin|clarithromycin|mesh-list
101514200|NCT05152004|Rabeprazole|rabeprazole|mesh-list
101514201|NCT05152004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101514202|NCT05152004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101514203|NCT05152004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101514204|NCT05152004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101514205|NCT05152004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101514206|NCT05152004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101514207|NCT05152004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514208|NCT05152004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101514209|NCT05152004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101514210|NCT05152004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101514211|NCT05152004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101514212|NCT05152004|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101514213|NCT05132153|Milrinone|milrinone|mesh-list
101514214|NCT05132153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101514215|NCT05132153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101514216|NCT05132153|Vasodilator Agents|vasodilator agents|mesh-ancestor
101514217|NCT05132153|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101514218|NCT05132153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101514219|NCT05132153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101514220|NCT05132153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514221|NCT05132153|Protective Agents|protective agents|mesh-ancestor
101514222|NCT05132153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514224|NCT00534378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101514225|NCT00534378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101514226|NCT00534378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101514227|NCT00534378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514228|NCT00534378|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101514229|NCT00534378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101514230|NCT00534378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101514231|NCT00534378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101514232|NCT00534378|Anesthetics, General|anesthetics, general|mesh-ancestor
101514233|NCT00534378|Anesthetics|anesthetics|mesh-ancestor
101514234|NCT00534378|GABA Modulators|gaba modulators|mesh-ancestor
101514235|NCT00534378|GABA Agents|gaba agents|mesh-ancestor
101514236|NCT00534378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101514237|NCT00534378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514238|NCT05131997|Atorvastatin|atorvastatin|mesh-list
101514239|NCT05131997|Ezetimibe|ezetimibe|mesh-list
101514240|NCT05131997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101514241|NCT05131997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101514242|NCT05131997|Antimetabolites|antimetabolites|mesh-ancestor
101514243|NCT05131997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514244|NCT05131997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101514245|NCT05131997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101514246|NCT05131997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101514248|NCT00534456|Hematinics|hematinics|mesh-ancestor
101514249|NCT05104229|Aspirin|aspirin|mesh-list
101514250|NCT05104229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101514251|NCT05104229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101514252|NCT05104229|Analgesics|analgesics|mesh-ancestor
101514253|NCT05104229|Sensory System Agents|sensory system agents|mesh-ancestor
101514254|NCT05104229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101514255|NCT05104229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514256|NCT05104229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101514257|NCT05104229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101514258|NCT05104229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101514259|NCT05104229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101514260|NCT05104229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514261|NCT05104229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101514262|NCT05104229|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101514263|NCT05104229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101514264|NCT05104229|Antipyretics|antipyretics|mesh-ancestor
101514265|NCT00532961|Loteprednol Etabonate|loteprednol etabonate|mesh-list
101514266|NCT00532961|Tobramycin|tobramycin|mesh-list
101514267|NCT00532961|Dexamethasone|dexamethasone|mesh-list
101514268|NCT00532961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101514269|NCT00532961|Antiemetics|antiemetics|mesh-ancestor
101514270|NCT00532961|Autonomic Agents|autonomic agents|mesh-ancestor
101514271|NCT00532961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101514272|NCT00532961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514273|NCT00532961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101514274|NCT00532961|Glucocorticoids|glucocorticoids|mesh-ancestor
101514275|NCT00532961|Hormones|hormones|mesh-ancestor
101514276|NCT00532961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101514277|NCT00532961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101514278|NCT00532961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101514279|NCT00532961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101514280|NCT00532961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101514281|NCT00532961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101514283|NCT00534573|Moclobemide|moclobemide|mesh-list
101514284|NCT00534573|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101514285|NCT00534573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101514286|NCT00534573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101514287|NCT00534573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514288|NCT00534573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101514289|NCT00534573|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101514290|NCT00534573|Dopamine Agents|dopamine agents|mesh-ancestor
101514291|NCT00534573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101318648|NCT00017329|Bortezomib|bortezomib|mesh-list
101514292|NCT00534573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514293|NCT00534573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101514294|NCT00534573|Antidepressive Agents|antidepressive agents|mesh-ancestor
101514295|NCT00534573|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101514296|NCT00534573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101514297|NCT04686890|Acetaminophen|acetaminophen|mesh-list
101514298|NCT04686890|Tramadol|tramadol|mesh-list
101514299|NCT04686890|Analgesics|analgesics|mesh-list
101514300|NCT04686890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101514301|NCT04686890|Sensory System Agents|sensory system agents|mesh-ancestor
101514302|NCT04686890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101514303|NCT04686890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514304|NCT04686890|Antipyretics|antipyretics|mesh-ancestor
101514305|NCT04686890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101514306|NCT04686890|Narcotics|narcotics|mesh-ancestor
101514307|NCT04686890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101514308|NCT00533039|Varespladib methyl|varespladib methyl|mesh-list
101514309|NCT00533039|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
101514310|NCT00533039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101514311|NCT00533039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514312|NCT05103306|Empagliflozin|empagliflozin|mesh-list
101514313|NCT05103306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101514314|NCT05103306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514315|NCT05103306|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101514316|NCT05103306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514317|NCT00534651|Acetaminophen|acetaminophen|mesh-list
101514318|NCT00534651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101514319|NCT00534651|Analgesics|analgesics|mesh-ancestor
101514320|NCT00534651|Sensory System Agents|sensory system agents|mesh-ancestor
101514321|NCT00534651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101514322|NCT00534651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514323|NCT00534651|Antipyretics|antipyretics|mesh-ancestor
101514324|NCT05080959|Ropivacaine|ropivacaine|mesh-list
101514325|NCT05080959|Anesthetics, Local|anesthetics, local|mesh-ancestor
101264475|NCT01768260|Analgesics|analgesics|mesh-ancestor
101514326|NCT05080959|Anesthetics|anesthetics|mesh-ancestor
101514327|NCT05080959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101514328|NCT05080959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514329|NCT05080959|Sensory System Agents|sensory system agents|mesh-ancestor
101514330|NCT05080959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101514331|NCT04942730|Mycophenolic Acid|mycophenolic acid|mesh-list
101514332|NCT04942730|Cyclophosphamide|cyclophosphamide|mesh-list
101514333|NCT04942730|Busulfan|busulfan|mesh-list
101514334|NCT04942730|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101514335|NCT04942730|Fludarabine|fludarabine|mesh-list
101514336|NCT04942730|Tacrolimus|tacrolimus|mesh-list
101514337|NCT04942730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101514338|NCT04942730|Immunologic Factors|immunologic factors|mesh-ancestor
101514339|NCT04942730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514340|NCT04942730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101514341|NCT04942730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101514342|NCT04942730|Alkylating Agents|alkylating agents|mesh-ancestor
101514343|NCT04942730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514344|NCT04942730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101514346|NCT04942730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101514347|NCT04942730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101514348|NCT04942730|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101514349|NCT04942730|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101514350|NCT04942730|Antitubercular Agents|antitubercular agents|mesh-ancestor
101514351|NCT04942730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101514352|NCT04942730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101198070|NCT01395069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101514354|NCT01272193|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101514355|NCT01272193|Insulin Glargine|insulin glargine|mesh-list
101514356|NCT01272193|Insulin Aspart|insulin aspart|mesh-list
101514357|NCT01272193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101514358|NCT01272193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514359|NCT04899206|Antidepressive Agents|antidepressive agents|mesh-list
101514360|NCT04899206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101514361|NCT04687163|Oxaliplatin|oxaliplatin|mesh-list
101514362|NCT04687163|Fluorouracil|fluorouracil|mesh-list
101514363|NCT04687163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101514364|NCT04687163|Antimetabolites|antimetabolites|mesh-ancestor
101318651|NCT00017368|Melphalan|melphalan|mesh-list
101514365|NCT04687163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514366|NCT04687163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101514367|NCT04687163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101514368|NCT04687163|Immunologic Factors|immunologic factors|mesh-ancestor
101514369|NCT04687163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514370|NCT01270828|Pregabalin|pregabalin|mesh-list
101514371|NCT01270828|Analgesics|analgesics|mesh-ancestor
101514372|NCT01270828|Sensory System Agents|sensory system agents|mesh-ancestor
101514373|NCT01270828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101514374|NCT01270828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514375|NCT01270828|Anticonvulsants|anticonvulsants|mesh-ancestor
101514376|NCT01270828|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101514377|NCT01270828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101514378|NCT01270828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514379|NCT01270828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101514380|NCT01270828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101514381|NCT01270828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101514382|NCT01270828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101514383|NCT01270828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101514384|NCT00533195|5-Methoxypsoralen|5-methoxypsoralen|mesh-list
101514385|NCT00533195|Methoxsalen|methoxsalen|mesh-list
101514386|NCT00533195|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101514387|NCT00533195|Dermatologic Agents|dermatologic agents|mesh-ancestor
101514388|NCT00533195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101514389|NCT03982407|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101514390|NCT03982407|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101514391|NCT03982407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514392|NCT01269385|Rituximab|rituximab|mesh-list
101514393|NCT01269385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101514394|NCT01269385|Alemtuzumab|alemtuzumab|mesh-list
101514395|NCT01269385|Antibodies|antibodies|mesh-list
101514396|NCT01269385|Immunoglobulins|immunoglobulins|mesh-list
101514397|NCT01269385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101514398|NCT01269385|Immunologic Factors|immunologic factors|mesh-ancestor
101514399|NCT01269385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514400|NCT01269385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101514401|NCT01269385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101514402|NCT02071862|Paclitaxel|paclitaxel|mesh-list
101514403|NCT02071862|Docetaxel|docetaxel|mesh-list
101514404|NCT02071862|Everolimus|everolimus|mesh-list
101514405|NCT02071862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101514406|NCT02071862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101514407|NCT02071862|Tubulin Modulators|tubulin modulators|mesh-ancestor
101514408|NCT02071862|Antimitotic Agents|antimitotic agents|mesh-ancestor
101514409|NCT02071862|Mitosis Modulators|mitosis modulators|mesh-ancestor
101514410|NCT02071862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514411|NCT02071862|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101514412|NCT02071862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101514413|NCT02071862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101514414|NCT02071862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101514415|NCT02071862|Immunologic Factors|immunologic factors|mesh-ancestor
101514416|NCT02071862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514417|NCT00535691|Tacrolimus|tacrolimus|mesh-list
101514418|NCT00535691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101514419|NCT00535691|Immunologic Factors|immunologic factors|mesh-ancestor
101514420|NCT00535691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514421|NCT00535691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101514422|NCT00535691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101514423|NCT00535691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514424|NCT01268683|Glyburide|glyburide|mesh-list
101514425|NCT01268683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101514426|NCT01268683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514427|NCT02021474|Phenol|phenol|mesh-list
101514428|NCT02021474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101514429|NCT02021474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101514430|NCT02021474|Disinfectants|disinfectants|mesh-ancestor
101514431|NCT02021474|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
101514432|NCT02021474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101514433|NCT04959825|Melatonin|melatonin|mesh-list
101514434|NCT04959825|Antioxidants|antioxidants|mesh-ancestor
101514435|NCT04959825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514436|NCT04959825|Protective Agents|protective agents|mesh-ancestor
101514437|NCT04959825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514438|NCT04959825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101514440|NCT05471453|Vitamin E|vitamin e|mesh-list
101514441|NCT05471453|Tocopherols|tocopherols|mesh-list
101514442|NCT05471453|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101514443|NCT05471453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101514444|NCT05471453|Immunologic Factors|immunologic factors|mesh-ancestor
101514445|NCT05471453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514446|NCT05471453|Antioxidants|antioxidants|mesh-ancestor
101514447|NCT05471453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514448|NCT05471453|Protective Agents|protective agents|mesh-ancestor
101514449|NCT05471453|Vitamins|vitamins|mesh-ancestor
101514450|NCT05471453|Micronutrients|micronutrients|mesh-ancestor
101514451|NCT03457233|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101514452|NCT03457233|Cetrorelix|cetrorelix|mesh-list
101514453|NCT03457233|Menotropins|menotropins|mesh-list
101514454|NCT03457233|Progesterone|progesterone|mesh-list
101514455|NCT03457233|Progestins|progestins|mesh-ancestor
101514456|NCT03457233|Hormones|hormones|mesh-ancestor
101514457|NCT03457233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101514458|NCT03457233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514459|NCT03457233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101514460|NCT03457233|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101514461|NCT03457233|Fertility Agents|fertility agents|mesh-ancestor
101514462|NCT03457233|Hormone Antagonists|hormone antagonists|mesh-ancestor
101514463|NCT00535808|Nitroprusside|nitroprusside|mesh-list
101514464|NCT00535808|Nitroglycerin|nitroglycerin|mesh-list
101514465|NCT00535808|Sevoflurane|sevoflurane|mesh-list
101514466|NCT00535808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101514467|NCT00535808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101514468|NCT00535808|Anesthetics, General|anesthetics, general|mesh-ancestor
101514469|NCT00535808|Anesthetics|anesthetics|mesh-ancestor
101514470|NCT00535808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101514471|NCT00535808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514472|NCT00535808|Vasodilator Agents|vasodilator agents|mesh-ancestor
101514473|NCT00535808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101514474|NCT00535808|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101514475|NCT00535808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514477|NCT05471063|Amphotericin B|amphotericin b|mesh-list
101514478|NCT05471063|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101514479|NCT05471063|Flucytosine|flucytosine|mesh-list
101514480|NCT05471063|Cholesteryl sulfate|cholesteryl sulfate|mesh-list
101514481|NCT05471063|Antifungal Agents|antifungal agents|mesh-ancestor
101514482|NCT05471063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101514483|NCT05471063|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101514484|NCT05471063|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101514485|NCT05471063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101514486|NCT05471063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514487|NCT05471063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101514488|NCT05471063|Hormone Antagonists|hormone antagonists|mesh-ancestor
101514489|NCT05471063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101514490|NCT05471063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514491|NCT05471063|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101514492|NCT05471063|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101514494|NCT05471063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101514495|NCT05471063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101514496|NCT05471063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101514497|NCT05471063|Antimetabolites|antimetabolites|mesh-ancestor
101514498|NCT05471063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101514499|NCT05471063|Protease Inhibitors|protease inhibitors|mesh-ancestor
101514500|NCT05471063|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101514501|NCT05471063|Protective Agents|protective agents|mesh-ancestor
101514502|NCT05471063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101514503|NCT04910100|Timolol|timolol|mesh-list
101514504|NCT04910100|Nebivolol|nebivolol|mesh-list
101514505|NCT04910100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101514506|NCT04910100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101514507|NCT04910100|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101514508|NCT04910100|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101514509|NCT04910100|Adrenergic Agents|adrenergic agents|mesh-ancestor
101514510|NCT04910100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101514511|NCT04910100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514512|NCT04910100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514513|NCT04910100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101514514|NCT04910100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101514515|NCT04910100|Vasodilator Agents|vasodilator agents|mesh-ancestor
101514516|NCT04910100|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101514517|NCT04910100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101514518|NCT04910100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101514519|NCT01268059|Paclitaxel|paclitaxel|mesh-list
101514520|NCT01268059|Carboplatin|carboplatin|mesh-list
101514521|NCT01268059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101514522|NCT01268059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101514523|NCT01268059|Tubulin Modulators|tubulin modulators|mesh-ancestor
101514524|NCT01268059|Antimitotic Agents|antimitotic agents|mesh-ancestor
101514525|NCT01268059|Mitosis Modulators|mitosis modulators|mesh-ancestor
101514526|NCT01268059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514527|NCT01267825|Bupivacaine|bupivacaine|mesh-list
101514528|NCT01267825|Anesthetics, Local|anesthetics, local|mesh-ancestor
101514529|NCT01267825|Anesthetics|anesthetics|mesh-ancestor
101514530|NCT01267825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101514531|NCT01267825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514532|NCT01267825|Sensory System Agents|sensory system agents|mesh-ancestor
101514533|NCT01267825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101514534|NCT00536003|Progesterone|progesterone|mesh-list
101514535|NCT00536003|Progestins|progestins|mesh-ancestor
101514536|NCT00536003|Hormones|hormones|mesh-ancestor
101514537|NCT00536003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101514538|NCT00536003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514539|NCT00533091|Sifalimumab|sifalimumab|mesh-list
101514540|NCT00533091|Immunologic Factors|immunologic factors|mesh-ancestor
101514541|NCT00533091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514542|NCT00536042|Minocycline|minocycline|mesh-list
101514543|NCT00536042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101514544|NCT00536042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101514545|NCT01606384|Vasopressins|vasopressins|mesh-list
101514547|NCT01606384|Hemostatics|hemostatics|mesh-ancestor
101514548|NCT01606384|Coagulants|coagulants|mesh-ancestor
101514549|NCT01606384|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101514550|NCT01606384|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101514551|NCT01606384|Natriuretic Agents|natriuretic agents|mesh-ancestor
101514552|NCT01606384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514553|NCT01606462|Oxytocin|oxytocin|mesh-list
101514554|NCT01606462|Oxytocics|oxytocics|mesh-ancestor
101514555|NCT01606462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101514556|NCT01606462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514557|NCT05470595|Atezolizumab|atezolizumab|mesh-list
101514558|NCT05470595|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101514559|NCT05470595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514560|NCT05470595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101514561|NCT05470595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101514562|NCT01606540|Ibuprofen|ibuprofen|mesh-list
101514563|NCT01606540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101514564|NCT01606540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101514565|NCT01606540|Analgesics|analgesics|mesh-ancestor
101514566|NCT01606540|Sensory System Agents|sensory system agents|mesh-ancestor
101514567|NCT01606540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101514568|NCT01606540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514569|NCT01606540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101514570|NCT01606540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101514571|NCT01606540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101514572|NCT01606540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101514573|NCT01606540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514574|NCT00533169|Tretinoin|tretinoin|mesh-list
101514575|NCT00533169|Isotretinoin|isotretinoin|mesh-list
101514576|NCT00533169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101514577|NCT00533169|Keratolytic Agents|keratolytic agents|mesh-ancestor
101514578|NCT00533169|Dermatologic Agents|dermatologic agents|mesh-ancestor
101514579|NCT00593710|Losartan|losartan|mesh-list
101514580|NCT00593710|Atenolol|atenolol|mesh-list
101514581|NCT00593710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101514582|NCT00593710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101514583|NCT00593710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101318661|NCT00017368|Sargramostim|sargramostim|mesh-list
101514584|NCT00593710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101514585|NCT00593710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514587|NCT00593710|Autonomic Agents|autonomic agents|mesh-ancestor
101514588|NCT00593710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101514589|NCT00593710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514590|NCT00593710|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101514591|NCT00593710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101514592|NCT00593710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101514593|NCT00593710|Adrenergic Agents|adrenergic agents|mesh-ancestor
101514594|NCT00593710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101514595|NCT04885686|Formaldehyde|formaldehyde|mesh-list
101514597|NCT04885686|Dexamethasone|dexamethasone|mesh-list
101514598|NCT04885686|Hydrocortisone|hydrocortisone|mesh-list
101514599|NCT04885686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101514600|NCT04885686|Antiemetics|antiemetics|mesh-ancestor
101514601|NCT04885686|Autonomic Agents|autonomic agents|mesh-ancestor
101514602|NCT04885686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101514603|NCT04885686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514604|NCT04885686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101514605|NCT04885686|Glucocorticoids|glucocorticoids|mesh-ancestor
101514606|NCT04885686|Hormones|hormones|mesh-ancestor
101514607|NCT04885686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101514608|NCT04885686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101264503|NCT01768299|Misoprostol|misoprostol|mesh-list
101514610|NCT04885686|Disinfectants|disinfectants|mesh-ancestor
101514611|NCT04885686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101514612|NCT04885686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101514613|NCT04885686|Antifungal Agents|antifungal agents|mesh-ancestor
101514614|NCT00594217|Progesterone|progesterone|mesh-list
101514616|NCT00594217|Hormones|hormones|mesh-ancestor
101514617|NCT00594217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101514618|NCT00594217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514619|NCT00536237|Niacin|niacin|mesh-list
101514620|NCT00536237|Niacinamide|niacinamide|mesh-list
101514621|NCT00536237|Nicotinic Acids|nicotinic acids|mesh-list
101514622|NCT00536237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514623|NCT00536237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514624|NCT00536237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101514625|NCT00536237|Antimetabolites|antimetabolites|mesh-ancestor
101514626|NCT00536237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101514627|NCT00536237|Vasodilator Agents|vasodilator agents|mesh-ancestor
101514628|NCT00536237|Vitamin B Complex|vitamin b complex|mesh-ancestor
101514629|NCT00536237|Vitamins|vitamins|mesh-ancestor
101514630|NCT00536237|Micronutrients|micronutrients|mesh-ancestor
101514631|NCT00533247|Celecoxib|celecoxib|mesh-list
101514632|NCT00533247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101514633|NCT00533247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101514634|NCT00533247|Analgesics|analgesics|mesh-ancestor
101514635|NCT00533247|Sensory System Agents|sensory system agents|mesh-ancestor
101514636|NCT00533247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101514637|NCT00533247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514638|NCT00533247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101514639|NCT00533247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101514640|NCT00533247|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101514641|NCT00533247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101514642|NCT00533247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101514643|NCT00533247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514644|NCT01260181|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101514645|NCT01260181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101514646|NCT01260181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101514647|NCT01260181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101514648|NCT01260181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514649|NCT00536276|Vitamin D|vitamin d|mesh-list
101514650|NCT00536276|Ergocalciferols|ergocalciferols|mesh-list
101514651|NCT00536276|Cholecalciferol|cholecalciferol|mesh-list
101514652|NCT00536276|Vitamins|vitamins|mesh-list
101514653|NCT00536276|Micronutrients|micronutrients|mesh-ancestor
101514654|NCT00536276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514655|NCT00536276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101514656|NCT00536276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101514657|NCT02690064|Vitamins|vitamins|mesh-list
101514658|NCT02690064|Ascorbic Acid|ascorbic acid|mesh-list
101514659|NCT02690064|Vitamin E|vitamin e|mesh-list
101514660|NCT02690064|Tocopherols|tocopherols|mesh-list
101514661|NCT02690064|Tocotrienols|tocotrienols|mesh-list
101514662|NCT02690064|alpha-Tocopherol|alpha-tocopherol|mesh-list
101514663|NCT02690064|Thioctic Acid|thioctic acid|mesh-list
101514664|NCT02690064|Ubiquinone|ubiquinone|mesh-list
101514665|NCT02690064|Resveratrol|resveratrol|mesh-list
101514666|NCT02690064|Antioxidants|antioxidants|mesh-list
101514667|NCT02690064|Micronutrients|micronutrients|mesh-ancestor
101514668|NCT02690064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514669|NCT02690064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514670|NCT02690064|Protective Agents|protective agents|mesh-ancestor
101514671|NCT02690064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101514672|NCT02690064|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101514673|NCT02690064|Vitamin B Complex|vitamin b complex|mesh-ancestor
101514674|NCT00594373|Tenofovir|tenofovir|mesh-list
101514675|NCT00594373|Antiviral Agents|antiviral agents|mesh-ancestor
101514676|NCT00594373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101514677|NCT00594373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101514678|NCT00594373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101514679|NCT00594373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101514680|NCT00594373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514681|NCT00594373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101514682|NCT00594373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101514684|NCT05470166|Anesthetics, Local|anesthetics, local|mesh-ancestor
101514686|NCT05470166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101514687|NCT05470166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514688|NCT05470166|Sensory System Agents|sensory system agents|mesh-ancestor
101514689|NCT05470166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101514690|NCT05470166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101514691|NCT05470166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101514692|NCT05470166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101514693|NCT05470166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101514694|NCT05470166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514695|NCT01260142|Propofol|propofol|mesh-list
101514696|NCT01260142|Fospropofol|fospropofol|mesh-list
101514697|NCT01260142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101514698|NCT01260142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101514699|NCT01260142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514700|NCT01260142|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101514701|NCT01260142|Anesthetics, General|anesthetics, general|mesh-ancestor
101514702|NCT01260142|Anesthetics|anesthetics|mesh-ancestor
101514703|NCT02116335|Bosentan|bosentan|mesh-list
101514704|NCT02116335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101514705|NCT02116335|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101514706|NCT02116335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514707|NCT05469659|Metformin|metformin|mesh-list
101514708|NCT05469659|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
101514709|NCT05469659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101514710|NCT05469659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514711|NCT05469659|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101514712|NCT05469659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514713|NCT01808820|Imiquimod|imiquimod|mesh-list
101514714|NCT01808820|Vaccines|vaccines|mesh-list
101514715|NCT01808820|Immunologic Factors|immunologic factors|mesh-ancestor
101514716|NCT01808820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514717|NCT01808820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101514718|NCT01808820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101514719|NCT01808820|Interferon Inducers|interferon inducers|mesh-ancestor
101514720|NCT05469386|Methylphenidate|methylphenidate|mesh-list
101514721|NCT05469386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101514722|NCT05469386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514723|NCT05469386|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101514725|NCT05469386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101514726|NCT05469386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514727|NCT05469386|Dopamine Agents|dopamine agents|mesh-ancestor
101514728|NCT05469386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101514729|NCT05469347|Alirocumab|alirocumab|mesh-list
101514730|NCT05469347|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101514731|NCT05469347|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101514732|NCT05469347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101514733|NCT05469347|Antimetabolites|antimetabolites|mesh-ancestor
101514734|NCT05469347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514735|NCT05469347|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101514736|NCT05469347|Protease Inhibitors|protease inhibitors|mesh-ancestor
101514737|NCT05469347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101514738|NCT05469347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101514739|NCT01462890|Paclitaxel|paclitaxel|mesh-list
101514740|NCT01462890|Bevacizumab|bevacizumab|mesh-list
101514741|NCT01462890|Carboplatin|carboplatin|mesh-list
101514742|NCT01462890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101514743|NCT01462890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101514744|NCT01462890|Tubulin Modulators|tubulin modulators|mesh-ancestor
101514745|NCT01462890|Antimitotic Agents|antimitotic agents|mesh-ancestor
101514746|NCT01462890|Mitosis Modulators|mitosis modulators|mesh-ancestor
101514747|NCT01462890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514748|NCT01462890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101514749|NCT01462890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101514750|NCT01462890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101514751|NCT01462890|Growth Substances|growth substances|mesh-ancestor
101514752|NCT01462890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514753|NCT01462890|Growth Inhibitors|growth inhibitors|mesh-ancestor
101514755|NCT05469113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101514756|NCT05469113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514757|NCT01259713|Amphotericin B|amphotericin b|mesh-list
101514758|NCT01259713|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101514759|NCT01259713|Amebicides|amebicides|mesh-ancestor
101514760|NCT01259713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101514761|NCT01259713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101514762|NCT01259713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101514763|NCT01259713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101514764|NCT01259713|Antifungal Agents|antifungal agents|mesh-ancestor
101514765|NCT05469035|Heparin|heparin|mesh-list
101514766|NCT05469035|Calcium heparin|calcium heparin|mesh-list
101514767|NCT05469035|Anticoagulants|anticoagulants|mesh-ancestor
101514768|NCT05469035|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101514769|NCT05469035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101514770|NCT05469035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514771|NCT05582590|Cyclophosphamide|cyclophosphamide|mesh-list
101514772|NCT05582590|Fludarabine|fludarabine|mesh-list
101514773|NCT05582590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101514774|NCT05582590|Immunologic Factors|immunologic factors|mesh-ancestor
101514775|NCT05582590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514776|NCT05582590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101514777|NCT05582590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101514778|NCT05582590|Alkylating Agents|alkylating agents|mesh-ancestor
101514779|NCT05582590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514780|NCT05582590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101514781|NCT05582590|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101514782|NCT05468879|Glimepiride|glimepiride|mesh-list
101514783|NCT05468879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101514784|NCT05468879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101514785|NCT05468879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514786|NCT05468879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101514787|NCT05468879|Immunologic Factors|immunologic factors|mesh-ancestor
101514788|NCT05471427|Docetaxel|docetaxel|mesh-list
101514790|NCT05471427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101514791|NCT05471427|Tubulin Modulators|tubulin modulators|mesh-ancestor
101514792|NCT05471427|Antimitotic Agents|antimitotic agents|mesh-ancestor
101514793|NCT05471427|Mitosis Modulators|mitosis modulators|mesh-ancestor
101514794|NCT05471427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514795|NCT05558449|Midazolam|midazolam|mesh-list
101514796|NCT05558449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101514797|NCT05558449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101514798|NCT05558449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101514799|NCT05558449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514801|NCT05558449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101514802|NCT05558449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101514803|NCT05558449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101514804|NCT05558449|Anesthetics, General|anesthetics, general|mesh-ancestor
101514805|NCT05558449|Anesthetics|anesthetics|mesh-ancestor
101514806|NCT05558449|GABA Modulators|gaba modulators|mesh-ancestor
101514807|NCT05558449|GABA Agents|gaba agents|mesh-ancestor
101514808|NCT05558449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101514809|NCT05558449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514810|NCT04326985|Hyaluronic Acid|hyaluronic acid|mesh-list
101514811|NCT04326985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101514812|NCT04326985|Immunologic Factors|immunologic factors|mesh-ancestor
101514813|NCT04326985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514814|NCT04326985|Viscosupplements|viscosupplements|mesh-ancestor
101514815|NCT04326985|Protective Agents|protective agents|mesh-ancestor
101514816|NCT00536393|Doxorubicin|doxorubicin|mesh-list
101514817|NCT00536393|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101514818|NCT00536393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101514819|NCT00536393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101514820|NCT00536393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101514821|NCT00536393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101514822|NCT00536393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101514826|NCT00595543|Bromfenac|bromfenac|mesh-list
101514827|NCT00595543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101514828|NCT00595543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101514829|NCT00595543|Analgesics|analgesics|mesh-ancestor
101514830|NCT00595543|Sensory System Agents|sensory system agents|mesh-ancestor
101514831|NCT00595543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101514832|NCT00595543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514833|NCT00595543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101514834|NCT00595543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101514835|NCT00595543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101514836|NCT00595543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101514837|NCT00595543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514838|NCT04326868|Albendazole|albendazole|mesh-list
101514839|NCT04326868|Mebendazole|mebendazole|mesh-list
101514840|NCT04326868|Benzimidazole|benzimidazole|mesh-list
101514841|NCT04326868|Pyrantel|pyrantel|mesh-list
101514842|NCT04326868|Anthelmintics|anthelmintics|mesh-list
101514843|NCT04326868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101514844|NCT04326868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101514845|NCT04326868|Anticestodal Agents|anticestodal agents|mesh-ancestor
101514846|NCT04326868|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101514847|NCT04326868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101514848|NCT04326868|Tubulin Modulators|tubulin modulators|mesh-ancestor
101514849|NCT04326868|Antimitotic Agents|antimitotic agents|mesh-ancestor
101514850|NCT04326868|Mitosis Modulators|mitosis modulators|mesh-ancestor
101514851|NCT04326868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514852|NCT04326868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101514853|NCT04326868|Antinematodal Agents|antinematodal agents|mesh-ancestor
101514854|NCT04326868|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
101514855|NCT04326868|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101514856|NCT04326868|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101514857|NCT04326868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101514858|NCT04326868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514859|NCT00595972|Endostar protein|endostar protein|mesh-list
101514860|NCT00595972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101514861|NCT00595972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101514862|NCT00595972|Growth Substances|growth substances|mesh-ancestor
101514863|NCT00595972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514864|NCT00595972|Growth Inhibitors|growth inhibitors|mesh-ancestor
101514865|NCT00595972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101514866|NCT00596050|Lidocaine|lidocaine|mesh-list
101514867|NCT00596050|Fentanyl|fentanyl|mesh-list
101514868|NCT00596050|Midazolam|midazolam|mesh-list
101514869|NCT00596050|Ketamine|ketamine|mesh-list
101514870|NCT00596050|Etomidate|etomidate|mesh-list
101514871|NCT00596050|Anesthetics, Local|anesthetics, local|mesh-ancestor
101514872|NCT00596050|Anesthetics|anesthetics|mesh-ancestor
101318676|NCT00017368|Tubulin Modulators|tubulin modulators|mesh-ancestor
101514873|NCT00596050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101514874|NCT00596050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514875|NCT00596050|Sensory System Agents|sensory system agents|mesh-ancestor
101514876|NCT00596050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101514877|NCT00596050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101514878|NCT00596050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101514879|NCT00596050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101514880|NCT00596050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101514881|NCT00596050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514882|NCT00596050|Analgesics|analgesics|mesh-ancestor
101514883|NCT00596050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101514884|NCT00596050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101514885|NCT00596050|Anesthetics, General|anesthetics, general|mesh-ancestor
101514886|NCT00596050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101514887|NCT00596050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101514888|NCT00596050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101514889|NCT00596050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101514890|NCT00596050|Narcotics|narcotics|mesh-ancestor
101514891|NCT00596050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101264524|NCT01768312|Cyclosporine|cyclosporine|mesh-list
101514892|NCT00596050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101514893|NCT00596050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101514894|NCT00596050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101514895|NCT00596050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101514896|NCT00596050|GABA Modulators|gaba modulators|mesh-ancestor
101514897|NCT00596050|GABA Agents|gaba agents|mesh-ancestor
101514899|NCT02888899|Antidiarrheals|antidiarrheals|mesh-list
101514900|NCT02888899|Calcium polycarbophil|calcium polycarbophil|mesh-list
101514902|NCT02888899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101514903|NCT02888899|Cathartics|cathartics|mesh-ancestor
101514904|NCT05468645|Hemay005|hemay005|mesh-list
101514905|NCT05468645|Dermatologic Agents|dermatologic agents|mesh-ancestor
101514906|NCT05468645|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101514907|NCT05468645|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101514908|NCT05468645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101514909|NCT05468645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514910|NCT00596128|Insulin|insulin|mesh-list
101514911|NCT00596128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101514912|NCT00596128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514913|NCT00596206|Leflunomide|leflunomide|mesh-list
101514914|NCT00596206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101514915|NCT00596206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514916|NCT00596206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101514917|NCT00596206|Immunologic Factors|immunologic factors|mesh-ancestor
101514918|NCT00596206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514919|NCT00624130|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
101514920|NCT00624130|Dacuronium|dacuronium|mesh-list
101514921|NCT00624130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101514922|NCT00624130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514923|NCT00624130|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101514924|NCT00624130|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101514925|NCT00624130|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101514926|NCT00624130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101514927|NCT05468450|Polidocanol|polidocanol|mesh-list
101514928|NCT05468450|Sclerosing Solutions|sclerosing solutions|mesh-list
101514929|NCT05468450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101514930|NCT00535860|Teriparatide|teriparatide|mesh-list
101514931|NCT00535860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101514932|NCT00535860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514933|NCT00535860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101514934|NCT00596479|Lenograstim|lenograstim|mesh-list
101514935|NCT00596479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101514936|NCT00596479|Immunologic Factors|immunologic factors|mesh-ancestor
101514937|NCT00596479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514938|NCT05468372|Amphotericin B|amphotericin b|mesh-list
101514939|NCT05468372|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101514940|NCT05468372|Posaconazole|posaconazole|mesh-list
101514941|NCT05468372|Amebicides|amebicides|mesh-ancestor
101514942|NCT05468372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101514943|NCT05468372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101514944|NCT05468372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101514945|NCT05468372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101514946|NCT05468372|Antifungal Agents|antifungal agents|mesh-ancestor
101514947|NCT05468372|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101514948|NCT05468372|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101514949|NCT05468372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101514950|NCT05468372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101514951|NCT05468372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514952|NCT05468372|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101514953|NCT05468372|Hormone Antagonists|hormone antagonists|mesh-ancestor
101514954|NCT05468372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101514955|NCT05468372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514956|NCT04207957|Olorofim|olorofim|mesh-list
101514957|NCT04207957|Antifungal Agents|antifungal agents|mesh-ancestor
101514958|NCT04207957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101514959|NCT00596557|Everolimus|everolimus|mesh-list
101514960|NCT00596557|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101514961|NCT00596557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101514962|NCT00596557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101198669|NCT02499666|Clopidogrel|clopidogrel|mesh-list
101264530|NCT01768312|Immunologic Factors|immunologic factors|mesh-ancestor
101514963|NCT00596557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514964|NCT00596557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101514965|NCT00596557|Immunologic Factors|immunologic factors|mesh-ancestor
101514966|NCT00596557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514967|NCT00596557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101514968|NCT00596596|Prucalopride|prucalopride|mesh-list
101514969|NCT00596596|Laxatives|laxatives|mesh-ancestor
101514970|NCT00596596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101514971|NCT00596596|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101514972|NCT00596596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101514973|NCT00596596|Serotonin Agents|serotonin agents|mesh-ancestor
101514974|NCT00596596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101514975|NCT00596596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514976|NCT00596596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514977|NCT05468294|Nivolumab|nivolumab|mesh-list
101514978|NCT05468294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101514979|NCT05468294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101514980|NCT05468294|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101514981|NCT05468294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101514982|NCT05312866|Acetaminophen|acetaminophen|mesh-list
101514983|NCT05312866|Dexamethasone|dexamethasone|mesh-list
101514984|NCT05312866|Magnesium Sulfate|magnesium sulfate|mesh-list
101514985|NCT05312866|Fentanyl|fentanyl|mesh-list
101514986|NCT05312866|Bupivacaine|bupivacaine|mesh-list
101514987|NCT05312866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101514988|NCT05312866|Antiemetics|antiemetics|mesh-ancestor
101514989|NCT05312866|Autonomic Agents|autonomic agents|mesh-ancestor
101514990|NCT05312866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101514991|NCT05312866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101514992|NCT05312866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101514993|NCT05312866|Glucocorticoids|glucocorticoids|mesh-ancestor
101514994|NCT05312866|Hormones|hormones|mesh-ancestor
101514995|NCT05312866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101514996|NCT05312866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101514997|NCT05312866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101514998|NCT05312866|Anesthetics, Local|anesthetics, local|mesh-ancestor
101514999|NCT05312866|Anesthetics|anesthetics|mesh-ancestor
101515000|NCT05312866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101515001|NCT05312866|Sensory System Agents|sensory system agents|mesh-ancestor
101515002|NCT05312866|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101515003|NCT05312866|Narcotics|narcotics|mesh-ancestor
101515004|NCT05312866|Analgesics|analgesics|mesh-ancestor
101515005|NCT05312866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101515006|NCT05312866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101515007|NCT05312866|Anesthetics, General|anesthetics, general|mesh-ancestor
101515008|NCT05312866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101515009|NCT05312866|Antipyretics|antipyretics|mesh-ancestor
101515010|NCT05312866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101515011|NCT05312866|Anticonvulsants|anticonvulsants|mesh-ancestor
101515012|NCT05312866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101515013|NCT05312866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101515014|NCT05312866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515015|NCT05312866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101515016|NCT05312866|Tocolytic Agents|tocolytic agents|mesh-ancestor
101515017|NCT05312866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101515018|NCT04326790|Colchicine|colchicine|mesh-list
101515019|NCT04326790|Gout Suppressants|gout suppressants|mesh-ancestor
101515021|NCT04326790|Tubulin Modulators|tubulin modulators|mesh-ancestor
101515022|NCT04326790|Antimitotic Agents|antimitotic agents|mesh-ancestor
101515023|NCT04326790|Mitosis Modulators|mitosis modulators|mesh-ancestor
101515024|NCT04326790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515025|NCT04326790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101515026|NCT00596986|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101515027|NCT00596986|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101515028|NCT00596986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101515029|NCT00596986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101515030|NCT00596986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515031|NCT00596986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101515032|NCT00596986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515033|NCT00596986|Analgesics|analgesics|mesh-ancestor
101515034|NCT00596986|Sensory System Agents|sensory system agents|mesh-ancestor
101515035|NCT00596986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101515036|NCT00596986|Antidepressive Agents|antidepressive agents|mesh-ancestor
101515037|NCT00596986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101515038|NCT00596986|Dopamine Agents|dopamine agents|mesh-ancestor
101515040|NCT00597064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101515042|NCT00597064|Hormones|hormones|mesh-ancestor
101515043|NCT00597064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101515044|NCT00597064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515045|NCT00597064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101515046|NCT00597064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101515047|NCT00597181|Mitomycins|mitomycins|mesh-list
101515048|NCT00597181|Mitomycin|mitomycin|mesh-list
101515049|NCT00597181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101515050|NCT00597181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101515051|NCT00597181|Alkylating Agents|alkylating agents|mesh-ancestor
101515052|NCT00597181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515053|NCT00597181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101515054|NCT00597181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101515055|NCT00597259|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101515056|NCT00597259|Entecavir|entecavir|mesh-list
101515057|NCT00597259|Antiviral Agents|antiviral agents|mesh-ancestor
101515058|NCT00597259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101515059|NCT05470764|Amlodipine|amlodipine|mesh-list
101515060|NCT05470764|Perindopril|perindopril|mesh-list
101515061|NCT05470764|Indapamide|indapamide|mesh-list
101515062|NCT05470764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101515063|NCT05470764|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101515064|NCT05470764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101515065|NCT05470764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515066|NCT05470764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101515067|NCT05470764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515069|NCT05470764|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101515070|NCT05470764|Protease Inhibitors|protease inhibitors|mesh-ancestor
101515071|NCT05470764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101515072|NCT05470764|Diuretics|diuretics|mesh-ancestor
101515073|NCT05470764|Natriuretic Agents|natriuretic agents|mesh-ancestor
101515074|NCT05470764|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101515075|NCT00597415|Celecoxib|celecoxib|mesh-list
101515076|NCT00597415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101515077|NCT00597415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101515078|NCT00597415|Analgesics|analgesics|mesh-ancestor
101515079|NCT00597415|Sensory System Agents|sensory system agents|mesh-ancestor
101515080|NCT00597415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101515081|NCT00597415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515082|NCT00597415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101515083|NCT00597415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101515084|NCT00597415|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101515085|NCT00597415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101515086|NCT00597415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101515087|NCT00597415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515088|NCT00597688|Chlorhexidine|chlorhexidine|mesh-list
101515089|NCT00597688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101515090|NCT00597688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101515091|NCT00597688|Disinfectants|disinfectants|mesh-ancestor
101515092|NCT05470530|Dexamethasone|dexamethasone|mesh-list
101515093|NCT05470530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101515094|NCT05470530|Antiemetics|antiemetics|mesh-ancestor
101515095|NCT05470530|Autonomic Agents|autonomic agents|mesh-ancestor
101515096|NCT05470530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101515097|NCT05470530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515098|NCT05470530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101515099|NCT05470530|Glucocorticoids|glucocorticoids|mesh-ancestor
101515100|NCT05470530|Hormones|hormones|mesh-ancestor
101515101|NCT05470530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101515102|NCT05470530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101515103|NCT05470530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101515104|NCT02891980|Vaccines|vaccines|mesh-list
101515105|NCT02891980|Immunologic Factors|immunologic factors|mesh-ancestor
101515106|NCT02891980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515107|NCT05467826|Ribavirin|ribavirin|mesh-list
101515108|NCT05467826|Sofosbuvir|sofosbuvir|mesh-list
101515109|NCT05467826|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
101515110|NCT05467826|Velpatasvir|velpatasvir|mesh-list
101515111|NCT05467826|Antimetabolites|antimetabolites|mesh-ancestor
101515112|NCT05467826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515113|NCT05467826|Antiviral Agents|antiviral agents|mesh-ancestor
101515114|NCT05467826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101515115|NCT00598156|Bevacizumab|bevacizumab|mesh-list
101515116|NCT00598156|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101515117|NCT00598156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101515118|NCT00598156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101515119|NCT00598156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101515120|NCT00598156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101515121|NCT00598156|Growth Substances|growth substances|mesh-ancestor
101515122|NCT00598156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515123|NCT00598156|Growth Inhibitors|growth inhibitors|mesh-ancestor
101515124|NCT00598156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101515125|NCT00598156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101515126|NCT00598156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515127|NCT00598195|Ketamine|ketamine|mesh-list
101515128|NCT00598195|Analgesics|analgesics|mesh-ancestor
101515129|NCT00598195|Sensory System Agents|sensory system agents|mesh-ancestor
101515130|NCT00598195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101515131|NCT00598195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515132|NCT00598195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101515134|NCT00598195|Anesthetics, General|anesthetics, general|mesh-ancestor
101515135|NCT00598195|Anesthetics|anesthetics|mesh-ancestor
101515136|NCT00598195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101515137|NCT00598195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101515138|NCT00598195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101515139|NCT00598195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101515140|NCT00598195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515141|NCT00598234|Celecoxib|celecoxib|mesh-list
101515142|NCT00598234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101515143|NCT00598234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101515144|NCT00598234|Analgesics|analgesics|mesh-ancestor
101515145|NCT00598234|Sensory System Agents|sensory system agents|mesh-ancestor
101515146|NCT00598234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101515147|NCT00598234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515148|NCT00598234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101515149|NCT00598234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101515150|NCT00598234|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101515151|NCT00598234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101515152|NCT00598234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101515153|NCT00598234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318692|NCT00006041|Vaccines|vaccines|mesh-list
101515155|NCT00598429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101515156|NCT00598429|Vasodilator Agents|vasodilator agents|mesh-ancestor
101515157|NCT00598429|Urological Agents|urological agents|mesh-ancestor
101515158|NCT00598624|Treosulfan|treosulfan|mesh-list
101515159|NCT00598624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101515160|NCT00598624|Alkylating Agents|alkylating agents|mesh-ancestor
101515161|NCT00598624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515162|NCT00598624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101515163|NCT02891785|Antipain|antipain|mesh-list
101515164|NCT02891785|Protease Inhibitors|protease inhibitors|mesh-ancestor
101515165|NCT02891785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101515166|NCT02891785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515167|NCT00598858|Prednisone|prednisone|mesh-list
101515168|NCT00598858|Cortisone|cortisone|mesh-list
101515169|NCT00598858|Docetaxel|docetaxel|mesh-list
101515170|NCT00598858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101515171|NCT00598858|Tubulin Modulators|tubulin modulators|mesh-ancestor
101515172|NCT00598858|Antimitotic Agents|antimitotic agents|mesh-ancestor
101515173|NCT00598858|Mitosis Modulators|mitosis modulators|mesh-ancestor
101515174|NCT00598858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515175|NCT00598858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101515176|NCT00598858|Glucocorticoids|glucocorticoids|mesh-ancestor
101515178|NCT00598858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101515179|NCT00598858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515180|NCT00598858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101515181|NCT05466305|Cobalt|cobalt|mesh-list
101515182|NCT05466305|Trace Elements|trace elements|mesh-ancestor
101515183|NCT05466305|Micronutrients|micronutrients|mesh-ancestor
101515184|NCT05466305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515185|NCT04207684|Testosterone|testosterone|mesh-list
101515186|NCT04207684|Androgens|androgens|mesh-ancestor
101515187|NCT04207684|Hormones|hormones|mesh-ancestor
101515188|NCT04207684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101515189|NCT04207684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515190|NCT02909400|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
101515191|NCT02909400|Antioxidants|antioxidants|mesh-ancestor
101515192|NCT02909400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515193|NCT02909400|Protective Agents|protective agents|mesh-ancestor
101515194|NCT02909400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515195|NCT02909478|Dexamethasone|dexamethasone|mesh-list
101515196|NCT02909478|Aprepitant|aprepitant|mesh-list
101515197|NCT02909478|Tropisetron|tropisetron|mesh-list
101515199|NCT02909478|Antiemetics|antiemetics|mesh-ancestor
101515200|NCT02909478|Autonomic Agents|autonomic agents|mesh-ancestor
101515201|NCT02909478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101515202|NCT02909478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515203|NCT02909478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101515204|NCT02909478|Glucocorticoids|glucocorticoids|mesh-ancestor
101515205|NCT02909478|Hormones|hormones|mesh-ancestor
101411081|NCT00449449|Anesthetics, Local|anesthetics, local|mesh-ancestor
101515206|NCT02909478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101515207|NCT02909478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101515208|NCT02909478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101515209|NCT02909478|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101515210|NCT02909478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101264547|NCT01768351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101515211|NCT02909478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515212|NCT02909478|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101515214|NCT02909478|Serotonin Agents|serotonin agents|mesh-ancestor
101515215|NCT00536211|Metformin|metformin|mesh-list
101515216|NCT00536211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101515217|NCT00536211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515218|NCT00536705|Montelukast|montelukast|mesh-list
101515219|NCT00536705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101515220|NCT00536705|Respiratory System Agents|respiratory system agents|mesh-ancestor
101515221|NCT00536705|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101515222|NCT00536705|Hormone Antagonists|hormone antagonists|mesh-ancestor
101515223|NCT00536705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101515224|NCT00536705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515225|NCT00536705|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101515226|NCT00536705|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101515227|NCT00536705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515229|NCT00624208|Ondansetron|ondansetron|mesh-list
101515230|NCT00624208|Antiemetics|antiemetics|mesh-ancestor
101515231|NCT00624208|Autonomic Agents|autonomic agents|mesh-ancestor
101515232|NCT00624208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101515233|NCT00624208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515234|NCT00624208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101515235|NCT00624208|Antipruritics|antipruritics|mesh-ancestor
101515236|NCT00624208|Dermatologic Agents|dermatologic agents|mesh-ancestor
101515237|NCT00624208|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101515238|NCT00624208|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101515239|NCT00624208|Serotonin Agents|serotonin agents|mesh-ancestor
101515240|NCT00624208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101515241|NCT00624208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515242|NCT00624208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101515243|NCT00624208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101515244|NCT00624208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101515245|NCT00624208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101515246|NCT00624208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101515247|NCT00624208|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101515248|NCT00624208|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101515249|NCT00624208|Dopamine Agents|dopamine agents|mesh-ancestor
101515250|NCT00536783|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101515251|NCT00536783|Antidepressive Agents|antidepressive agents|mesh-ancestor
101515252|NCT00536783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101515253|NCT00536783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101515254|NCT00536783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101515255|NCT00536783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101515257|NCT04685642|Aspirin|aspirin|mesh-list
101515258|NCT04685642|Atorvastatin|atorvastatin|mesh-list
101515259|NCT04685642|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101515260|NCT04685642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101515261|NCT04685642|Analgesics|analgesics|mesh-ancestor
101515262|NCT04685642|Sensory System Agents|sensory system agents|mesh-ancestor
101515263|NCT04685642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101515264|NCT04685642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515265|NCT04685642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101515266|NCT04685642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101515267|NCT04685642|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101515268|NCT04685642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101515269|NCT04685642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515270|NCT04685642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101515271|NCT04685642|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101515272|NCT04685642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101515273|NCT04685642|Antipyretics|antipyretics|mesh-ancestor
101515274|NCT04685642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101515275|NCT04685642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101515276|NCT04685642|Antimetabolites|antimetabolites|mesh-ancestor
101515277|NCT04685642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101515278|NCT04685642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101515279|NCT05312346|Hydroxocobalamin|hydroxocobalamin|mesh-list
101515280|NCT05312346|Vitamin B 12|vitamin b 12|mesh-list
101515281|NCT05312346|Hematinics|hematinics|mesh-ancestor
101515282|NCT05312346|Vitamin B Complex|vitamin b complex|mesh-ancestor
101515283|NCT05312346|Vitamins|vitamins|mesh-ancestor
101515284|NCT05312346|Micronutrients|micronutrients|mesh-ancestor
101515285|NCT05312346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515286|NCT05568563|Ethyl Chloride|ethyl chloride|mesh-list
101515287|NCT05568563|Anesthetics, Local|anesthetics, local|mesh-ancestor
101515288|NCT05568563|Anesthetics|anesthetics|mesh-ancestor
101515289|NCT05568563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101515290|NCT05568563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318705|NCT00017602|Glucocorticoids|glucocorticoids|mesh-ancestor
101515291|NCT05568563|Sensory System Agents|sensory system agents|mesh-ancestor
101515292|NCT05568563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101515293|NCT00536861|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101515294|NCT00536861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101515295|NCT00536861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101515296|NCT00536861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101515297|NCT00536861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515300|NCT05469984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101515301|NCT05469984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101515302|NCT05469984|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101515303|NCT05469984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101515304|NCT05469984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515305|NCT05312190|Progesterone|progesterone|mesh-list
101515306|NCT05312190|Progestins|progestins|mesh-ancestor
101515307|NCT05312190|Hormones|hormones|mesh-ancestor
101515308|NCT05312190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101515309|NCT05312190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515310|NCT00537173|Paclitaxel|paclitaxel|mesh-list
101515311|NCT00537173|Bevacizumab|bevacizumab|mesh-list
101515312|NCT00537173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101515313|NCT00537173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101515314|NCT00537173|Tubulin Modulators|tubulin modulators|mesh-ancestor
101515315|NCT00537173|Antimitotic Agents|antimitotic agents|mesh-ancestor
101515316|NCT00537173|Mitosis Modulators|mitosis modulators|mesh-ancestor
101515317|NCT00537173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515318|NCT00537173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101515319|NCT00537173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101515320|NCT00537173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101515322|NCT00537173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515323|NCT00537173|Growth Inhibitors|growth inhibitors|mesh-ancestor
101515324|NCT02503839|Etoricoxib|etoricoxib|mesh-list
101515325|NCT02503839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101515326|NCT02503839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101515327|NCT02503839|Analgesics|analgesics|mesh-ancestor
101515328|NCT02503839|Sensory System Agents|sensory system agents|mesh-ancestor
101515329|NCT02503839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101515330|NCT02503839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515331|NCT02503839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101515332|NCT02503839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101515333|NCT02503839|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101515334|NCT02503839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101515335|NCT02503839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101515336|NCT02503839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515338|NCT05469750|Letrozole|letrozole|mesh-list
101515339|NCT05469750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101515340|NCT05469750|Antimetabolites|antimetabolites|mesh-ancestor
101515341|NCT05469750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515342|NCT05469750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101515343|NCT05469750|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101515344|NCT05469750|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101515345|NCT05469750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101515346|NCT05469750|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101515347|NCT05469750|Hormone Antagonists|hormone antagonists|mesh-ancestor
101515348|NCT05469750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101515349|NCT05469750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515350|NCT02143830|Cyclophosphamide|cyclophosphamide|mesh-list
101515351|NCT02143830|Busulfan|busulfan|mesh-list
101515352|NCT02143830|Fludarabine|fludarabine|mesh-list
101515353|NCT02143830|Thymoglobulin|thymoglobulin|mesh-list
101515354|NCT02143830|Lenograstim|lenograstim|mesh-list
101515355|NCT02143830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101515356|NCT02143830|Immunologic Factors|immunologic factors|mesh-ancestor
101515357|NCT02143830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515358|NCT02143830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101515359|NCT02143830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101515360|NCT02143830|Alkylating Agents|alkylating agents|mesh-ancestor
101318709|NCT00017602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101515361|NCT02143830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515362|NCT02143830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101515363|NCT02143830|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101515364|NCT02143830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101515366|NCT00537251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101515367|NCT00537251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515368|NCT03457194|Vaccines|vaccines|mesh-list
101515369|NCT03457194|Immunologic Factors|immunologic factors|mesh-ancestor
101515370|NCT03457194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515371|NCT05478707|Dulaglutide|dulaglutide|mesh-list
101515372|NCT05478707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101515373|NCT05478707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515374|NCT05469165|Cyproheptadine|cyproheptadine|mesh-list
101515375|NCT05469165|Antipruritics|antipruritics|mesh-ancestor
101515376|NCT05469165|Dermatologic Agents|dermatologic agents|mesh-ancestor
101515377|NCT05469165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101515378|NCT05469165|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101515379|NCT05469165|Histamine Antagonists|histamine antagonists|mesh-ancestor
101515380|NCT05469165|Histamine Agents|histamine agents|mesh-ancestor
101515381|NCT05469165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101515382|NCT05469165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515384|NCT05469165|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101515385|NCT05469165|Serotonin Agents|serotonin agents|mesh-ancestor
101515386|NCT05469165|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101515387|NCT04319926|Lidocaine|lidocaine|mesh-list
101515388|NCT04319926|Anesthetics, Local|anesthetics, local|mesh-ancestor
101515389|NCT04319926|Anesthetics|anesthetics|mesh-ancestor
101515390|NCT04319926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101515391|NCT04319926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515392|NCT04319926|Sensory System Agents|sensory system agents|mesh-ancestor
101515393|NCT04319926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101515394|NCT04319926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101515395|NCT04319926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101515396|NCT04319926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101515397|NCT04319926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101515398|NCT04319926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515399|NCT01313923|Sirolimus|sirolimus|mesh-list
101515400|NCT01313923|Temsirolimus|temsirolimus|mesh-list
101515401|NCT01313923|MTOR Inhibitors|mtor inhibitors|mesh-list
101515402|NCT01313923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101515403|NCT01313923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101515404|NCT01313923|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101515405|NCT01313923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101515406|NCT01313923|Antifungal Agents|antifungal agents|mesh-ancestor
101515407|NCT01313923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101515408|NCT01313923|Immunologic Factors|immunologic factors|mesh-ancestor
101515409|NCT01313923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515410|NCT01313923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101515411|NCT01313923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101515412|NCT01313923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515413|NCT01313884|Cyclophosphamide|cyclophosphamide|mesh-list
101515414|NCT01313884|Temozolomide|temozolomide|mesh-list
101515415|NCT01313884|Doxorubicin|doxorubicin|mesh-list
101515417|NCT01313884|Vincristine|vincristine|mesh-list
101515418|NCT01313884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101515419|NCT01313884|Immunologic Factors|immunologic factors|mesh-ancestor
101515420|NCT01313884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515421|NCT01313884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101515422|NCT01313884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101515423|NCT01313884|Alkylating Agents|alkylating agents|mesh-ancestor
101515424|NCT01313884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515425|NCT01313884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101515426|NCT01313884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101515427|NCT01313884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101515428|NCT01313884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101515429|NCT01313884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101515430|NCT01313884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101515431|NCT01313884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101515432|NCT01313884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101515433|NCT01313884|Tubulin Modulators|tubulin modulators|mesh-ancestor
101515434|NCT01313884|Antimitotic Agents|antimitotic agents|mesh-ancestor
101515435|NCT01313884|Mitosis Modulators|mitosis modulators|mesh-ancestor
101515437|NCT00537524|Immunologic Factors|immunologic factors|mesh-ancestor
101515438|NCT00537524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515439|NCT00537563|Telithromycin|telithromycin|mesh-list
101515440|NCT00537563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101515441|NCT00537563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101515442|NCT00537602|Miglustat|miglustat|mesh-list
101515443|NCT00537602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101515444|NCT00537602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515445|NCT00537602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101515446|NCT00537602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101515447|NCT00537602|Antiviral Agents|antiviral agents|mesh-ancestor
101515448|NCT00537602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101515449|NCT00537602|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101515450|NCT00537602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101515451|NCT00537602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515452|NCT01259284|Atorvastatin|atorvastatin|mesh-list
101515453|NCT01259284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101515454|NCT01259284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101515455|NCT01259284|Antimetabolites|antimetabolites|mesh-ancestor
101515456|NCT01259284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515457|NCT01259284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101515458|NCT01259284|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101515459|NCT01259284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101515460|NCT03457025|Antiviral Agents|antiviral agents|mesh-list
101515461|NCT03457025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101515462|NCT00537836|Estradiol|estradiol|mesh-list
101515463|NCT00537836|Estrogens|estrogens|mesh-ancestor
101515464|NCT00537836|Hormones|hormones|mesh-ancestor
101515465|NCT00537836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101515466|NCT00537836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515467|NCT02277171|Nitric Oxide|nitric oxide|mesh-list
101515468|NCT02277171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101515469|NCT02277171|Autonomic Agents|autonomic agents|mesh-ancestor
101515470|NCT02277171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101515471|NCT02277171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515472|NCT02277171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101515473|NCT02277171|Respiratory System Agents|respiratory system agents|mesh-ancestor
101515474|NCT02277171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101515475|NCT02277171|Antioxidants|antioxidants|mesh-ancestor
101515476|NCT02277171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515477|NCT02277171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101515478|NCT02277171|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101515479|NCT02277171|Vasodilator Agents|vasodilator agents|mesh-ancestor
101515480|NCT02277171|Gasotransmitters|gasotransmitters|mesh-ancestor
101515481|NCT02277171|Protective Agents|protective agents|mesh-ancestor
101515484|NCT00551564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515486|NCT05105061|Analgesics|analgesics|mesh-ancestor
101515487|NCT05105061|Sensory System Agents|sensory system agents|mesh-ancestor
101515488|NCT05105061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101199197|NCT04961801|Tacrolimus|tacrolimus|mesh-list
101515490|NCT05105061|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101515491|NCT05105061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101515492|NCT05105061|Anesthetics, General|anesthetics, general|mesh-ancestor
101515493|NCT05105061|Anesthetics|anesthetics|mesh-ancestor
101515494|NCT05105061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101515495|NCT05105061|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101515496|NCT05105061|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101515497|NCT05105061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101515498|NCT05105061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515499|NCT05056584|Glucagon|glucagon|mesh-list
101515500|NCT05056584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101515501|NCT05056584|Hormones|hormones|mesh-ancestor
101515502|NCT05056584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101264650|NCT01768780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101515503|NCT05056584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515504|NCT00551954|Acarbose|acarbose|mesh-list
101318715|NCT00001533|Immunologic Factors|immunologic factors|mesh-ancestor
101515505|NCT00551954|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101515506|NCT00551954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101515507|NCT00551954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515508|NCT00551954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101515509|NCT00551954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515510|NCT00552149|Cetuximab|cetuximab|mesh-list
101515511|NCT00552149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101515512|NCT00552149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101515513|NCT05467878|Anesthetics|anesthetics|mesh-list
101515514|NCT05467878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101515515|NCT05467878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515516|NCT00536640|Bevacizumab|bevacizumab|mesh-list
101515517|NCT00536640|Gemcitabine|gemcitabine|mesh-list
101515518|NCT00536640|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101515519|NCT00536640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101515520|NCT00536640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101515521|NCT00536640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101515522|NCT00536640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101515523|NCT00536640|Growth Substances|growth substances|mesh-ancestor
101515524|NCT00536640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515525|NCT00536640|Growth Inhibitors|growth inhibitors|mesh-ancestor
101515526|NCT00536640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101515527|NCT00536640|Antimetabolites|antimetabolites|mesh-ancestor
101515528|NCT00536640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515529|NCT00536640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101515530|NCT00536640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101515531|NCT00552227|Ruboxistaurin|ruboxistaurin|mesh-list
101515532|NCT00552227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101515534|NCT01259089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101515535|NCT01259089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101264657|NCT01768884|Autonomic Agents|autonomic agents|mesh-ancestor
101515536|NCT01259089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101515537|NCT01259089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101515538|NCT01259089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515539|NCT00552266|Methylphenidate|methylphenidate|mesh-list
101515540|NCT00552266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101515541|NCT00552266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515542|NCT00552266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101515543|NCT00552266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101515544|NCT00552266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101515545|NCT00552266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515546|NCT00552266|Dopamine Agents|dopamine agents|mesh-ancestor
101515547|NCT00552266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101515548|NCT04943757|Cyclophosphamide|cyclophosphamide|mesh-list
101515549|NCT04943757|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101515551|NCT04943757|Immunologic Factors|immunologic factors|mesh-ancestor
101515552|NCT04943757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515553|NCT04943757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101515554|NCT04943757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101515555|NCT04943757|Alkylating Agents|alkylating agents|mesh-ancestor
101515556|NCT04943757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515557|NCT04943757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101515558|NCT04943757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101515559|NCT00552461|Rituximab|rituximab|mesh-list
101515560|NCT00552461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101515561|NCT00552461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101515562|NCT00552461|Immunologic Factors|immunologic factors|mesh-ancestor
101515563|NCT00552461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515564|NCT00552461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101515565|NCT00552500|Valproic Acid|valproic acid|mesh-list
101515566|NCT00552500|Anticonvulsants|anticonvulsants|mesh-ancestor
101515567|NCT00552500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101515568|NCT00552500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515569|NCT00552500|GABA Agents|gaba agents|mesh-ancestor
101515570|NCT00552500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101515571|NCT00552500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515572|NCT00552500|Antimanic Agents|antimanic agents|mesh-ancestor
101515573|NCT00552500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101515574|NCT00552500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101515575|NCT00552500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101515576|NCT01258738|Etanercept|etanercept|mesh-list
101515577|NCT01258738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101515578|NCT01258738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101515579|NCT01258738|Analgesics|analgesics|mesh-ancestor
101515580|NCT01258738|Sensory System Agents|sensory system agents|mesh-ancestor
101515581|NCT01258738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101515582|NCT01258738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515583|NCT01258738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101515584|NCT01258738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101515585|NCT01258738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101515586|NCT01258738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101515587|NCT01258738|Immunologic Factors|immunologic factors|mesh-ancestor
101515588|NCT00552656|Sirolimus|sirolimus|mesh-list
101515589|NCT00552656|Temsirolimus|temsirolimus|mesh-list
101515590|NCT00552656|MTOR Inhibitors|mtor inhibitors|mesh-list
101515591|NCT00552656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101515592|NCT00552656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101515593|NCT00552656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101515594|NCT00552656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101515595|NCT00552656|Antifungal Agents|antifungal agents|mesh-ancestor
101515596|NCT00552656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101515597|NCT00552656|Immunologic Factors|immunologic factors|mesh-ancestor
101515598|NCT00552656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515599|NCT00552656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101515600|NCT00552656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101515601|NCT00552656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515603|NCT01824537|Immunologic Factors|immunologic factors|mesh-ancestor
101515604|NCT01824537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515605|NCT04863339|Tranexamic Acid|tranexamic acid|mesh-list
101515606|NCT04863339|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101515607|NCT04863339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101515608|NCT04863339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515609|NCT04863339|Hemostatics|hemostatics|mesh-ancestor
101515610|NCT04863339|Coagulants|coagulants|mesh-ancestor
101515611|NCT04684277|Antidepressive Agents|antidepressive agents|mesh-list
101515612|NCT04684277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101515613|NCT00552734|Insulin|insulin|mesh-list
101515614|NCT00552734|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101515615|NCT00552734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101515616|NCT00552734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515618|NCT04543682|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101515619|NCT04543682|Vasodilator Agents|vasodilator agents|mesh-ancestor
101515620|NCT04802616|Broncho-Vaxom|broncho-vaxom|mesh-list
101515621|NCT04802616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101515622|NCT04802616|Immunologic Factors|immunologic factors|mesh-ancestor
101515623|NCT04802616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264717|NCT01769066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101515624|NCT01258660|Folic Acid|folic acid|mesh-list
101264719|NCT01769079|Isosorbide|isosorbide|mesh-list
101515625|NCT01258660|Vitamin B Complex|vitamin b complex|mesh-list
101515626|NCT01258660|Drospirenone|drospirenone|mesh-list
101515627|NCT01258660|Hematinics|hematinics|mesh-ancestor
101515628|NCT01258660|Vitamins|vitamins|mesh-ancestor
101515629|NCT01258660|Micronutrients|micronutrients|mesh-ancestor
101515630|NCT01258660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515631|NCT01258660|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101515632|NCT01258660|Hormone Antagonists|hormone antagonists|mesh-ancestor
101515633|NCT01258660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101515634|NCT01258660|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101515635|NCT01258660|Diuretics|diuretics|mesh-ancestor
101515636|NCT01258660|Natriuretic Agents|natriuretic agents|mesh-ancestor
101515637|NCT04772274|Ustekinumab|ustekinumab|mesh-list
101515638|NCT04772274|Dermatologic Agents|dermatologic agents|mesh-ancestor
101515639|NCT04362527|Milrinone|milrinone|mesh-list
101515640|NCT04362527|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101515641|NCT04362527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101515642|NCT04362527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101515643|NCT04362527|Vasodilator Agents|vasodilator agents|mesh-ancestor
101318725|NCT00017641|Immunologic Factors|immunologic factors|mesh-ancestor
101515644|NCT04362527|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101515645|NCT04362527|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101515646|NCT04362527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101515647|NCT04362527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515648|NCT04362527|Protective Agents|protective agents|mesh-ancestor
101515649|NCT04362527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515650|NCT04758975|Rituximab|rituximab|mesh-list
101515651|NCT04758975|Venetoclax|venetoclax|mesh-list
101515652|NCT04758975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101515653|NCT04758975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101515654|NCT04758975|Immunologic Factors|immunologic factors|mesh-ancestor
101515655|NCT04758975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515656|NCT04758975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101515657|NCT01614171|Hormones|hormones|mesh-list
101515658|NCT01614171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101515659|NCT01614171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515660|NCT05567367|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101515661|NCT05567367|Vasodilator Agents|vasodilator agents|mesh-ancestor
101515662|NCT05567367|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101515663|NCT05567367|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101515664|NCT05567367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101515665|NCT05567367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515666|NCT05567367|Urological Agents|urological agents|mesh-ancestor
101515667|NCT04656951|Daratumumab|daratumumab|mesh-list
101515668|NCT04656951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101515669|NCT04173533|Azacitidine|azacitidine|mesh-list
101515670|NCT04173533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101515671|NCT04173533|Antimetabolites|antimetabolites|mesh-ancestor
101515672|NCT04173533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515673|NCT04173533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101515674|NCT04173533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101515675|NCT01258348|Sunitinib|sunitinib|mesh-list
101515676|NCT01258348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101515677|NCT01258348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101515678|NCT01258348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101515679|NCT01258348|Growth Substances|growth substances|mesh-ancestor
101515680|NCT01258348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515681|NCT01258348|Growth Inhibitors|growth inhibitors|mesh-ancestor
101515682|NCT01258348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101264752|NCT01769235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101515683|NCT01258348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101515684|NCT01258348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515685|NCT05136898|Mitomycins|mitomycins|mesh-list
101515686|NCT05136898|Mitomycin|mitomycin|mesh-list
101515687|NCT05136898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101515688|NCT05136898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101515689|NCT05136898|Alkylating Agents|alkylating agents|mesh-ancestor
101515690|NCT05136898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515691|NCT05136898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101515692|NCT05136898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101515693|NCT01258075|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
101515694|NCT01258075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101515695|NCT01258075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101515696|NCT01258075|Antimetabolites|antimetabolites|mesh-ancestor
101515697|NCT01258075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515698|NCT01258075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101515699|NCT04687878|Insulin|insulin|mesh-list
101515700|NCT04687878|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101515701|NCT04687878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101515702|NCT04687878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515703|NCT05116774|Eculizumab|eculizumab|mesh-list
101515704|NCT05116774|Ravulizumab|ravulizumab|mesh-list
101515705|NCT05116774|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101515706|NCT05116774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101515707|NCT05116774|Immunologic Factors|immunologic factors|mesh-ancestor
101515708|NCT05116774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515709|NCT01256671|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101515710|NCT01256671|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101199424|NCT04186663|Protective Agents|protective agents|mesh-ancestor
101515711|NCT01256671|Immunologic Factors|immunologic factors|mesh-ancestor
101515712|NCT01256671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515714|NCT04687566|Dextromethorphan|dextromethorphan|mesh-list
101318727|NCT00017641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101515715|NCT04687566|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101515716|NCT04687566|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101515717|NCT04687566|Dopamine Agents|dopamine agents|mesh-ancestor
101515718|NCT04687566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101515719|NCT04687566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515720|NCT04687566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515721|NCT04687566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101515722|NCT04687566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101515723|NCT04687566|Antitussive Agents|antitussive agents|mesh-ancestor
101515724|NCT04687566|Respiratory System Agents|respiratory system agents|mesh-ancestor
101515725|NCT01256593|Pregabalin|pregabalin|mesh-list
101515726|NCT01256593|Analgesics|analgesics|mesh-ancestor
101515727|NCT01256593|Sensory System Agents|sensory system agents|mesh-ancestor
101515728|NCT01256593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101515729|NCT01256593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515730|NCT01256593|Anticonvulsants|anticonvulsants|mesh-ancestor
101515731|NCT01256593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101515732|NCT01256593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101515733|NCT01256593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515734|NCT01256593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101515735|NCT01256593|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101515736|NCT01256593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101515737|NCT01256593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101515738|NCT01256593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101515739|NCT01256476|Pravastatin|pravastatin|mesh-list
101515740|NCT01256476|Pitavastatin|pitavastatin|mesh-list
101515741|NCT01256476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101515742|NCT01256476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101515743|NCT01256476|Antimetabolites|antimetabolites|mesh-ancestor
101515744|NCT01256476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515745|NCT01256476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101515746|NCT01256476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101515747|NCT01256476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101515748|NCT05507892|Canagliflozin|canagliflozin|mesh-list
101515749|NCT05507892|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101515750|NCT05507892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515751|NCT05507892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101515752|NCT05507892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515753|NCT04106999|Dexmedetomidine|dexmedetomidine|mesh-list
101515754|NCT04106999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101515755|NCT04106999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101515756|NCT04106999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515757|NCT04106999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101515758|NCT04106999|Analgesics|analgesics|mesh-ancestor
101515759|NCT04106999|Sensory System Agents|sensory system agents|mesh-ancestor
101515760|NCT04106999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101515761|NCT04106999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101515762|NCT04106999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101515763|NCT04106999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101515764|NCT04106999|Adrenergic Agents|adrenergic agents|mesh-ancestor
101515765|NCT04106999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101264796|NCT01769664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101515766|NCT04106999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515767|NCT05478720|Diazooxonorleucine|diazooxonorleucine|mesh-list
101515768|NCT05478720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101515769|NCT05478720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101515770|NCT05478720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101515771|NCT05478720|Antimetabolites|antimetabolites|mesh-ancestor
101515772|NCT05478720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515773|NCT05003089|Prednisolone|prednisolone|mesh-list
101515774|NCT05003089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101515775|NCT05003089|Glucocorticoids|glucocorticoids|mesh-ancestor
101515776|NCT05003089|Hormones|hormones|mesh-ancestor
101515777|NCT05003089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101515778|NCT05003089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515779|NCT05003089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101515780|NCT05003089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101515781|NCT04207021|Curcumin|curcumin|mesh-list
101515782|NCT04207021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101515783|NCT04207021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101515784|NCT04207021|Analgesics|analgesics|mesh-ancestor
101515785|NCT04207021|Sensory System Agents|sensory system agents|mesh-ancestor
101515786|NCT04207021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101515787|NCT04207021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515788|NCT04207021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101515789|NCT04207021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101515790|NCT04207021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101515791|NCT04207021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101515792|NCT04207021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515793|NCT01255423|Diclofenac|diclofenac|mesh-list
101515794|NCT01255423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101515795|NCT01255423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101515796|NCT01255423|Analgesics|analgesics|mesh-ancestor
101515797|NCT01255423|Sensory System Agents|sensory system agents|mesh-ancestor
101515799|NCT01255423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515801|NCT01255423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101515802|NCT01255423|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101515803|NCT01255423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101515804|NCT01255423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515805|NCT01255306|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101515806|NCT01255306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101515807|NCT01255306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101515808|NCT01255306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101515809|NCT01255306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101515810|NCT01255306|Adrenergic Agents|adrenergic agents|mesh-ancestor
101515811|NCT01255306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101515812|NCT01255306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515813|NCT01255306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515814|NCT01254721|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101515815|NCT01254721|Antidepressive Agents|antidepressive agents|mesh-ancestor
101515816|NCT01254721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101515817|NCT01254721|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101264827|NCT01769768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101515818|NCT01254721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101515819|NCT01254721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101515820|NCT01254721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515821|NCT04003805|Nicotine|nicotine|mesh-list
101515822|NCT04003805|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101515823|NCT04003805|Autonomic Agents|autonomic agents|mesh-ancestor
101515824|NCT04003805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101515825|NCT04003805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515826|NCT04003805|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101515827|NCT04003805|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101515828|NCT04003805|Cholinergic Agents|cholinergic agents|mesh-ancestor
101515829|NCT04003805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101515830|NCT04003805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515831|NCT04842604|Azacitidine|azacitidine|mesh-list
101515832|NCT04842604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101515833|NCT04842604|Antimetabolites|antimetabolites|mesh-ancestor
101515834|NCT04842604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515835|NCT04842604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101515836|NCT04842604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101515837|NCT01254604|Timolol|timolol|mesh-list
101515838|NCT01254604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515839|NCT01254604|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101515840|NCT01254604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101515841|NCT01254604|Adrenergic Agents|adrenergic agents|mesh-ancestor
101515842|NCT01254604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101515843|NCT01254604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515844|NCT01254604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101515845|NCT01254604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101515846|NCT04390698|Analgesics, Opioid|analgesics, opioid|mesh-list
101515847|NCT04390698|Anesthetics|anesthetics|mesh-list
101515848|NCT04390698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101515849|NCT04390698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515850|NCT04390698|Narcotics|narcotics|mesh-ancestor
101515851|NCT04390698|Analgesics|analgesics|mesh-ancestor
101515852|NCT04390698|Sensory System Agents|sensory system agents|mesh-ancestor
101515853|NCT04390698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101318733|NCT00017680|Melphalan|melphalan|mesh-list
101515855|NCT03795701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101515856|NCT03795701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515857|NCT03795701|Incretins|incretins|mesh-ancestor
101515858|NCT03795701|Hormones|hormones|mesh-ancestor
101515859|NCT03795701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101515860|NCT04673578|Celecoxib|celecoxib|mesh-list
101515861|NCT04673578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101515862|NCT04673578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101515863|NCT04673578|Analgesics|analgesics|mesh-ancestor
101515864|NCT04673578|Sensory System Agents|sensory system agents|mesh-ancestor
101515865|NCT04673578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101515866|NCT04673578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515867|NCT04673578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101515868|NCT04673578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101515869|NCT04673578|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101515870|NCT04673578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101515871|NCT04673578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101515872|NCT04673578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515873|NCT05414058|Methylphenidate|methylphenidate|mesh-list
101515874|NCT05414058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101515875|NCT05414058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515876|NCT05414058|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101515877|NCT05414058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101515878|NCT05414058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101515879|NCT05414058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515880|NCT05414058|Dopamine Agents|dopamine agents|mesh-ancestor
101515881|NCT05414058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101515882|NCT03757403|Mebendazole|mebendazole|mesh-list
101515883|NCT03757403|Piperazine|piperazine|mesh-list
101515884|NCT03757403|Piperazine citrate|piperazine citrate|mesh-list
101515885|NCT03757403|DMP 777|dmp 777|mesh-list
101515886|NCT03757403|Antinematodal Agents|antinematodal agents|mesh-ancestor
101515887|NCT03757403|Anthelmintics|anthelmintics|mesh-ancestor
101515888|NCT03757403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101515889|NCT03757403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101515890|NCT03757403|Tubulin Modulators|tubulin modulators|mesh-ancestor
101515891|NCT03757403|Antimitotic Agents|antimitotic agents|mesh-ancestor
101515892|NCT03757403|Mitosis Modulators|mitosis modulators|mesh-ancestor
101515893|NCT03757403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515894|NCT03757403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101515895|NCT03757403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101515896|NCT00537342|Immunomodulating Agents|immunomodulating agents|mesh-list
101515897|NCT00537342|Immunologic Factors|immunologic factors|mesh-ancestor
101515898|NCT00537342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515899|NCT00537420|Sibutramine|sibutramine|mesh-list
101515900|NCT00537420|Antidepressive Agents|antidepressive agents|mesh-ancestor
101515901|NCT00537420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101515902|NCT00537420|Appetite Depressants|appetite depressants|mesh-ancestor
101515903|NCT00537420|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101515905|NCT03534284|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101515906|NCT03534284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101515907|NCT03534284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101515908|NCT03534284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515909|NCT03534284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101515910|NCT03534284|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101515911|NCT03534284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101515912|NCT03534284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101515913|NCT03534284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515914|NCT03534284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101515915|NCT03534284|Serotonin Agents|serotonin agents|mesh-ancestor
101515916|NCT03534284|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101515917|NCT03534284|Antidepressive Agents|antidepressive agents|mesh-ancestor
101515918|NCT01254292|Levonorgestrel|levonorgestrel|mesh-list
101515919|NCT01254292|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101515920|NCT01254292|Contraceptive Agents|contraceptive agents|mesh-ancestor
101515921|NCT01254292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101515922|NCT01254292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515923|NCT01254292|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101515926|NCT04683458|Paclitaxel|paclitaxel|mesh-list
101515927|NCT04683458|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101515928|NCT04683458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101515929|NCT04683458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101515930|NCT04683458|Tubulin Modulators|tubulin modulators|mesh-ancestor
101515931|NCT04683458|Antimitotic Agents|antimitotic agents|mesh-ancestor
101515932|NCT04683458|Mitosis Modulators|mitosis modulators|mesh-ancestor
101515933|NCT04683458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515934|NCT01253317|Mecasermin|mecasermin|mesh-list
101515935|NCT01253317|Growth Substances|growth substances|mesh-ancestor
101515936|NCT01253317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515937|NCT00537537|Telbivudine|telbivudine|mesh-list
101515938|NCT00537537|Antiviral Agents|antiviral agents|mesh-ancestor
101515939|NCT00537537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101515940|NCT00537537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101515941|NCT00537537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101515942|NCT00537537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515943|NCT04319770|Hyaluronic Acid|hyaluronic acid|mesh-list
101515944|NCT04319770|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101515945|NCT04319770|Immunologic Factors|immunologic factors|mesh-ancestor
101515946|NCT04319770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515947|NCT04319770|Viscosupplements|viscosupplements|mesh-ancestor
101515948|NCT04319770|Protective Agents|protective agents|mesh-ancestor
101515949|NCT02722616|Pancrelipase|pancrelipase|mesh-list
101515950|NCT02722616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101515951|NCT01253200|Acifluorfen|acifluorfen|mesh-list
101515952|NCT01253200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101515953|NCT01253200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264854|NCT01769820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101515954|NCT04515901|Lidocaine|lidocaine|mesh-list
101515955|NCT04515901|Anesthetics, Local|anesthetics, local|mesh-ancestor
101515956|NCT04515901|Anesthetics|anesthetics|mesh-ancestor
101515957|NCT04515901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101515958|NCT04515901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515959|NCT04515901|Sensory System Agents|sensory system agents|mesh-ancestor
101515960|NCT04515901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101515961|NCT04515901|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101515962|NCT04515901|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101515963|NCT04515901|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101515964|NCT04515901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101515965|NCT04515901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515966|NCT02605421|Cyclophosphamide|cyclophosphamide|mesh-list
101515967|NCT02605421|Melphalan|melphalan|mesh-list
101515968|NCT02605421|Thiotepa|thiotepa|mesh-list
101515969|NCT02605421|Carboplatin|carboplatin|mesh-list
101515970|NCT02605421|Etoposide|etoposide|mesh-list
101515971|NCT02605421|Lenograstim|lenograstim|mesh-list
101515972|NCT02605421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101515973|NCT02605421|Immunologic Factors|immunologic factors|mesh-ancestor
101515974|NCT02605421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515975|NCT02605421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101515976|NCT02605421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101515977|NCT02605421|Alkylating Agents|alkylating agents|mesh-ancestor
101515978|NCT02605421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101515979|NCT02605421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101515980|NCT02605421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101515981|NCT02605421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101515982|NCT02605421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101515983|NCT02605421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101515984|NCT02605421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101515985|NCT02605421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101515986|NCT04320589|Dexmedetomidine|dexmedetomidine|mesh-list
101515988|NCT04320589|Anesthetics, General|anesthetics, general|mesh-list
101515989|NCT04320589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101515990|NCT04320589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101515991|NCT04320589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101515992|NCT04320589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101515993|NCT04320589|Analgesics|analgesics|mesh-ancestor
101515994|NCT04320589|Sensory System Agents|sensory system agents|mesh-ancestor
101515995|NCT04320589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101318740|NCT00017680|Immunologic Factors|immunologic factors|mesh-ancestor
101515996|NCT04320589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101515997|NCT04320589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101515998|NCT04320589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101515999|NCT04320589|Adrenergic Agents|adrenergic agents|mesh-ancestor
101516000|NCT04320589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101516001|NCT04320589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516002|NCT04397692|Nitric Oxide|nitric oxide|mesh-list
101516003|NCT04397692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101516004|NCT04397692|Autonomic Agents|autonomic agents|mesh-ancestor
101516005|NCT04397692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101516006|NCT04397692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516007|NCT04397692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101516008|NCT04397692|Respiratory System Agents|respiratory system agents|mesh-ancestor
101516009|NCT04397692|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101516011|NCT04397692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516012|NCT04397692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101516013|NCT04397692|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101516014|NCT04397692|Vasodilator Agents|vasodilator agents|mesh-ancestor
101516015|NCT04397692|Gasotransmitters|gasotransmitters|mesh-ancestor
101516016|NCT04397692|Protective Agents|protective agents|mesh-ancestor
101516017|NCT02203643|Dexamethasone|dexamethasone|mesh-list
101516018|NCT02203643|Cyclophosphamide|cyclophosphamide|mesh-list
101516019|NCT02203643|Lenalidomide|lenalidomide|mesh-list
101516020|NCT02203643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101516021|NCT02203643|Immunologic Factors|immunologic factors|mesh-ancestor
101516022|NCT02203643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516023|NCT02203643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101516024|NCT02203643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101264861|NCT01769833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101516025|NCT02203643|Alkylating Agents|alkylating agents|mesh-ancestor
101516026|NCT02203643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516027|NCT02203643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516028|NCT02203643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101516029|NCT02203643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101516030|NCT02203643|Antiemetics|antiemetics|mesh-ancestor
101516031|NCT02203643|Autonomic Agents|autonomic agents|mesh-ancestor
101516032|NCT02203643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101516033|NCT02203643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101516034|NCT02203643|Glucocorticoids|glucocorticoids|mesh-ancestor
101516035|NCT02203643|Hormones|hormones|mesh-ancestor
101516036|NCT02203643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101516037|NCT02203643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101516038|NCT02203643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101516039|NCT02203643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101516040|NCT02203643|Growth Substances|growth substances|mesh-ancestor
101516041|NCT02203643|Growth Inhibitors|growth inhibitors|mesh-ancestor
101516042|NCT01252186|Contraceptive Agents|contraceptive agents|mesh-list
101516043|NCT01252186|Levonorgestrel|levonorgestrel|mesh-list
101516044|NCT01252186|Desogestrel|desogestrel|mesh-list
101516045|NCT01252186|Contraceptives, Oral|contraceptives, oral|mesh-list
101516046|NCT01252186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101516047|NCT01252186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516048|NCT01252186|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101516049|NCT01252186|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101516050|NCT01252186|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101516051|NCT01252186|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101516052|NCT01252186|Progestins|progestins|mesh-ancestor
101516053|NCT01252186|Hormones|hormones|mesh-ancestor
101516054|NCT01252186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101516055|NCT01731782|Bupivacaine|bupivacaine|mesh-list
101516056|NCT01731782|Anesthetics, Local|anesthetics, local|mesh-ancestor
101516057|NCT01731782|Anesthetics|anesthetics|mesh-ancestor
101516058|NCT01731782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101516059|NCT01731782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516060|NCT01731782|Sensory System Agents|sensory system agents|mesh-ancestor
101516061|NCT01731782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101516062|NCT01251952|Denileukin diftitox|denileukin diftitox|mesh-list
101516063|NCT01251952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516064|NCT04356430|Prednisone|prednisone|mesh-list
101516065|NCT04356430|Goserelin|goserelin|mesh-list
101318742|NCT00017719|Lamivudine|lamivudine|mesh-list
101516066|NCT04356430|Abiraterone Acetate|abiraterone acetate|mesh-list
101516067|NCT04356430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101516068|NCT04356430|Glucocorticoids|glucocorticoids|mesh-ancestor
101516069|NCT04356430|Hormones|hormones|mesh-ancestor
101516070|NCT04356430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101516071|NCT04356430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516072|NCT04356430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101516073|NCT04356430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516074|NCT04356430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101516075|NCT04356430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101516076|NCT04356430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516077|NCT04356430|Hormone Antagonists|hormone antagonists|mesh-ancestor
101516078|NCT04356430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101516079|NCT03974139|Metformin|metformin|mesh-list
101516080|NCT03974139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101516081|NCT03974139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516082|NCT04320238|Interferons|interferons|mesh-list
101264866|NCT01769898|Formoterol Fumarate|formoterol fumarate|mesh-list
101264867|NCT01769898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101516083|NCT04320238|Interferon-alpha|interferon-alpha|mesh-list
101516084|NCT04320238|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
101516085|NCT04320238|Thymalfasin|thymalfasin|mesh-list
101516086|NCT04320238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516087|NCT04320238|Antiviral Agents|antiviral agents|mesh-ancestor
101516088|NCT04320238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101516089|NCT04320238|Immunologic Factors|immunologic factors|mesh-ancestor
101516090|NCT04320238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516091|NCT04320238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101516092|NCT01229072|Heparin|heparin|mesh-list
101516093|NCT01229072|Calcium heparin|calcium heparin|mesh-list
101516094|NCT01229072|Anticoagulants|anticoagulants|mesh-ancestor
101516095|NCT01229072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101516096|NCT01229072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101516097|NCT01229072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516098|NCT01199978|Losartan|losartan|mesh-list
101516099|NCT01199978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101516100|NCT01199978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101516101|NCT01199978|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101516102|NCT01199978|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101516103|NCT01199978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516104|NCT00532116|Selegiline|selegiline|mesh-list
101516105|NCT00532116|Antidepressive Agents|antidepressive agents|mesh-ancestor
101516106|NCT00532116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101516107|NCT00532116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101516108|NCT00532116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101516109|NCT00532116|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101516110|NCT00532116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101516111|NCT00532116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516112|NCT00532116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101516113|NCT00532116|Protective Agents|protective agents|mesh-ancestor
101516114|NCT00532116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516115|NCT04283513|Ribavirin|ribavirin|mesh-list
101516116|NCT04283513|Antimetabolites|antimetabolites|mesh-ancestor
101516117|NCT04283513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516118|NCT04283513|Antiviral Agents|antiviral agents|mesh-ancestor
101516119|NCT04283513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101516120|NCT01251367|Botulinum Toxins|botulinum toxins|mesh-list
101516121|NCT01251367|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101516122|NCT01251367|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101516123|NCT01251367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101516124|NCT01251367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101516125|NCT01251367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516126|NCT01251367|Cholinergic Agents|cholinergic agents|mesh-ancestor
101516127|NCT01251367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101516128|NCT01251367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516129|NCT01251367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101516130|NCT01251367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101516132|NCT03910998|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101516133|NCT03910998|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101516134|NCT03910998|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101516135|NCT03910998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101516136|NCT03910998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516137|NCT04685148|Estradiol|estradiol|mesh-list
101516138|NCT04685148|Estrogens|estrogens|mesh-ancestor
101516139|NCT04685148|Hormones|hormones|mesh-ancestor
101516140|NCT04685148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101516141|NCT04685148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516142|NCT02888548|Botulinum Toxins|botulinum toxins|mesh-list
101516143|NCT02888548|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101516144|NCT02888548|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101516145|NCT02888548|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101516146|NCT02888548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101516147|NCT02888548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516148|NCT02888548|Cholinergic Agents|cholinergic agents|mesh-ancestor
101516149|NCT02888548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101516150|NCT02888548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516151|NCT02888548|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101516152|NCT02888548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101516153|NCT04246684|Leucovorin|leucovorin|mesh-list
101199890|NCT02745535|Sofosbuvir|sofosbuvir|mesh-list
101516154|NCT04246684|Folic Acid|folic acid|mesh-list
101516155|NCT04246684|Capecitabine|capecitabine|mesh-list
101516156|NCT04246684|Fluorouracil|fluorouracil|mesh-list
101516157|NCT04246684|Oxaliplatin|oxaliplatin|mesh-list
101516158|NCT04246684|Levoleucovorin|levoleucovorin|mesh-list
101516159|NCT04246684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101516160|NCT04246684|Antimetabolites|antimetabolites|mesh-ancestor
101516161|NCT04246684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516162|NCT04246684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516163|NCT04246684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101516164|NCT04246684|Immunologic Factors|immunologic factors|mesh-ancestor
101516165|NCT04246684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516166|NCT04246684|Antidotes|antidotes|mesh-ancestor
101516167|NCT04246684|Protective Agents|protective agents|mesh-ancestor
101516168|NCT04246684|Vitamin B Complex|vitamin b complex|mesh-ancestor
101516169|NCT04246684|Vitamins|vitamins|mesh-ancestor
101516170|NCT04246684|Micronutrients|micronutrients|mesh-ancestor
101516171|NCT04246684|Hematinics|hematinics|mesh-ancestor
101516172|NCT03883893|Acetaminophen|acetaminophen|mesh-list
101516173|NCT03883893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101516174|NCT03883893|Analgesics|analgesics|mesh-ancestor
101516175|NCT03883893|Sensory System Agents|sensory system agents|mesh-ancestor
101516176|NCT03883893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101516177|NCT03883893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516178|NCT03883893|Antipyretics|antipyretics|mesh-ancestor
101516179|NCT00537732|Omeprazole|omeprazole|mesh-list
101516180|NCT00537732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101516181|NCT00537732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101516182|NCT00537732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101516183|NCT00537732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101516184|NCT00537732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516185|NCT04180436|Rivaroxaban|rivaroxaban|mesh-list
101516186|NCT04180436|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101516187|NCT04180436|Antithrombins|antithrombins|mesh-ancestor
101516188|NCT04180436|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101516189|NCT04180436|Protease Inhibitors|protease inhibitors|mesh-ancestor
101516190|NCT04180436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101516191|NCT04180436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516193|NCT01250119|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101516194|NCT01250119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516195|NCT01250119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101516196|NCT01250119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101516197|NCT01250119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516198|NCT04320277|Ritonavir|ritonavir|mesh-list
101516199|NCT04320277|Lopinavir|lopinavir|mesh-list
101516200|NCT04320277|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101516201|NCT04320277|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101516202|NCT04320277|Protease Inhibitors|protease inhibitors|mesh-ancestor
101516203|NCT04320277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101516204|NCT04320277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516205|NCT04320277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101516206|NCT04320277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101516207|NCT04320277|Antiviral Agents|antiviral agents|mesh-ancestor
101516208|NCT04320277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101516209|NCT04320277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101516210|NCT04320277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101516211|NCT01250002|Lidocaine|lidocaine|mesh-list
101516212|NCT01250002|Anesthetics, Local|anesthetics, local|mesh-ancestor
101516213|NCT01250002|Anesthetics|anesthetics|mesh-ancestor
101516214|NCT01250002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101516215|NCT01250002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516216|NCT01250002|Sensory System Agents|sensory system agents|mesh-ancestor
101516217|NCT01250002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101516218|NCT01250002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101516219|NCT01250002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101516220|NCT01250002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101516221|NCT01250002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101516222|NCT01250002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516223|NCT04157153|Sirolimus|sirolimus|mesh-list
101516224|NCT04157153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101516225|NCT04157153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101516226|NCT04157153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101516227|NCT04157153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516228|NCT04157153|Antifungal Agents|antifungal agents|mesh-ancestor
101516229|NCT04157153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101516230|NCT04157153|Immunologic Factors|immunologic factors|mesh-ancestor
101516231|NCT04157153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516233|NCT05329116|Pentoxifylline|pentoxifylline|mesh-list
101516234|NCT05329116|Anesthetics, Local|anesthetics, local|mesh-ancestor
101516235|NCT05329116|Anesthetics|anesthetics|mesh-ancestor
101516236|NCT05329116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101516237|NCT05329116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516238|NCT05329116|Sensory System Agents|sensory system agents|mesh-ancestor
101516239|NCT05329116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101516240|NCT05329116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101516241|NCT05329116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101516242|NCT05329116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101411094|NCT00115115|Sympathomimetics|sympathomimetics|mesh-ancestor
101516243|NCT05329116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101516244|NCT05329116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516245|NCT05329116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101516246|NCT05329116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101516247|NCT05329116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101516248|NCT05329116|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101516249|NCT05329116|Protective Agents|protective agents|mesh-ancestor
101516250|NCT05329116|Vasodilator Agents|vasodilator agents|mesh-ancestor
101516251|NCT05329116|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101516252|NCT05329116|Antioxidants|antioxidants|mesh-ancestor
101516253|NCT00537888|Fluconazole|fluconazole|mesh-list
101516254|NCT00537888|Antifungal Agents|antifungal agents|mesh-ancestor
101516255|NCT00537888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101516256|NCT00537888|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101516257|NCT00537888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101516259|NCT00537888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516260|NCT00537888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101516261|NCT00537888|Hormone Antagonists|hormone antagonists|mesh-ancestor
101516262|NCT00537888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101516263|NCT00537888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516264|NCT00537888|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101516265|NCT00537888|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101516266|NCT05264142|Voriconazole|voriconazole|mesh-list
101516267|NCT05264142|Fluvoxamine|fluvoxamine|mesh-list
101516269|NCT05264142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101516270|NCT05264142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101516271|NCT05264142|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101516272|NCT05264142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101516273|NCT05264142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264893|NCT01769911|Carmustine|carmustine|mesh-list
101264894|NCT01769911|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
101516274|NCT05264142|Antifungal Agents|antifungal agents|mesh-ancestor
101516275|NCT05264142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101516276|NCT05264142|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101516277|NCT05264142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101516278|NCT05264142|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101516279|NCT05264142|Hormone Antagonists|hormone antagonists|mesh-ancestor
101516280|NCT05264142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101516281|NCT05264142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516282|NCT05264142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101516283|NCT05264142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101516284|NCT05264142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101516285|NCT05264142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101516286|NCT05264142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101516287|NCT05264142|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101516288|NCT05264142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101516289|NCT05264142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101516290|NCT05264142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101516291|NCT05264142|Serotonin Agents|serotonin agents|mesh-ancestor
101516292|NCT05264142|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101516293|NCT05264142|Antidepressive Agents|antidepressive agents|mesh-ancestor
101516294|NCT05264142|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101516295|NCT05264142|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101516296|NCT01246960|Leucovorin|leucovorin|mesh-list
101516297|NCT01246960|Fluorouracil|fluorouracil|mesh-list
101516298|NCT01246960|Oxaliplatin|oxaliplatin|mesh-list
101516299|NCT01246960|Ramucirumab|ramucirumab|mesh-list
101516300|NCT01246960|Antimetabolites|antimetabolites|mesh-ancestor
101516301|NCT01246960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516302|NCT01246960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101516303|NCT01246960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516304|NCT01246960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101516305|NCT01246960|Immunologic Factors|immunologic factors|mesh-ancestor
101516306|NCT01246960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516307|NCT01246960|Antidotes|antidotes|mesh-ancestor
101516308|NCT01246960|Protective Agents|protective agents|mesh-ancestor
101516309|NCT01246960|Vitamin B Complex|vitamin b complex|mesh-ancestor
101516310|NCT01246960|Vitamins|vitamins|mesh-ancestor
101516311|NCT01246960|Micronutrients|micronutrients|mesh-ancestor
101516312|NCT00544986|Anastrozole|anastrozole|mesh-list
101516313|NCT00544986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101516314|NCT00544986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516315|NCT00544986|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101516316|NCT00544986|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101516317|NCT00544986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101516318|NCT00544986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516320|NCT00544986|Hormone Antagonists|hormone antagonists|mesh-ancestor
101516321|NCT00544986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101516322|NCT00544986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516323|NCT03851588|Dolutegravir|dolutegravir|mesh-list
101516324|NCT03851588|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101516325|NCT03851588|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101516326|NCT03851588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101318776|NCT00017758|Atorvastatin|atorvastatin|mesh-list
101516327|NCT03851588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516328|NCT03851588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101516329|NCT03851588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101516330|NCT03851588|Antiviral Agents|antiviral agents|mesh-ancestor
101516331|NCT03851588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101516332|NCT01244620|Sildenafil Citrate|sildenafil citrate|mesh-list
101516334|NCT01244620|Sitaxsentan|sitaxsentan|mesh-list
101516335|NCT01244620|Vasodilator Agents|vasodilator agents|mesh-ancestor
101516336|NCT01244620|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101516337|NCT01244620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101264904|NCT01769911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101516339|NCT01244620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516340|NCT01244620|Urological Agents|urological agents|mesh-ancestor
101516341|NCT01244620|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101516342|NCT04319692|Acetic Acid|acetic acid|mesh-list
101516343|NCT04319692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101516344|NCT04319692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101516345|NCT00545142|Valproic Acid|valproic acid|mesh-list
101516346|NCT00545142|Aripiprazole|aripiprazole|mesh-list
101516347|NCT00545142|Antidepressive Agents|antidepressive agents|mesh-ancestor
101516348|NCT00545142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101516349|NCT00545142|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101516350|NCT00545142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101516351|NCT00545142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101516352|NCT00545142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516353|NCT00545142|Dopamine Agonists|dopamine agonists|mesh-ancestor
101516354|NCT00545142|Dopamine Agents|dopamine agents|mesh-ancestor
101516355|NCT00545142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101516356|NCT00545142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516357|NCT00545142|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101516358|NCT00545142|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101516359|NCT00545142|Serotonin Agents|serotonin agents|mesh-ancestor
101516360|NCT00545142|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101516361|NCT00545142|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101516362|NCT00545142|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101516363|NCT00545142|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101516364|NCT00545142|Anticonvulsants|anticonvulsants|mesh-ancestor
101516365|NCT00545142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101516366|NCT00545142|GABA Agents|gaba agents|mesh-ancestor
101516367|NCT00545142|Antimanic Agents|antimanic agents|mesh-ancestor
101516368|NCT01267201|Methylprednisolone|methylprednisolone|mesh-list
101516369|NCT01267201|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101516370|NCT01267201|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101516371|NCT01267201|Prednisolone|prednisolone|mesh-list
101516372|NCT01267201|Prednisolone acetate|prednisolone acetate|mesh-list
101516373|NCT01267201|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101516374|NCT01267201|Prednisolone phosphate|prednisolone phosphate|mesh-list
101516375|NCT01267201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101200115|NCT02293109|Hormones|hormones|mesh-ancestor
101516376|NCT01267201|Antiemetics|antiemetics|mesh-ancestor
101516377|NCT01267201|Autonomic Agents|autonomic agents|mesh-ancestor
101516378|NCT01267201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101516379|NCT01267201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516380|NCT01267201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101516381|NCT01267201|Glucocorticoids|glucocorticoids|mesh-ancestor
101516382|NCT01267201|Hormones|hormones|mesh-ancestor
101516383|NCT01267201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101516385|NCT01267201|Protective Agents|protective agents|mesh-ancestor
101516386|NCT01267201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101516387|NCT01267201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516388|NCT03778931|Fulvestrant|fulvestrant|mesh-list
101516389|NCT03778931|Anastrozole|anastrozole|mesh-list
101516390|NCT03778931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101516391|NCT03778931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516392|NCT03778931|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101516393|NCT03778931|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101516394|NCT03778931|Hormone Antagonists|hormone antagonists|mesh-ancestor
101516395|NCT03778931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101516396|NCT03778931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516398|NCT03778931|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101516399|NCT03778931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101516400|NCT03778931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516401|NCT03736616|Cytarabine|cytarabine|mesh-list
101516402|NCT03736616|Rituximab|rituximab|mesh-list
101264912|NCT01769950|Lipotropic Agents|lipotropic agents|mesh-ancestor
101516404|NCT03736616|Etoposide|etoposide|mesh-list
101516405|NCT03736616|Melphalan|melphalan|mesh-list
101516406|NCT03736616|Ifosfamide|ifosfamide|mesh-list
101516407|NCT03736616|Carmustine|carmustine|mesh-list
101516408|NCT03736616|Acalabrutinib|acalabrutinib|mesh-list
101516409|NCT03736616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101516410|NCT03736616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516411|NCT03736616|Immunologic Factors|immunologic factors|mesh-ancestor
101516412|NCT03736616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516413|NCT03736616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101516414|NCT03736616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101516415|NCT03736616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101516416|NCT03736616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101516417|NCT03736616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101516418|NCT03736616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516419|NCT03736616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101516420|NCT03736616|Antimetabolites|antimetabolites|mesh-ancestor
101516421|NCT03736616|Antiviral Agents|antiviral agents|mesh-ancestor
101516422|NCT03736616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101516423|NCT03736616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101516424|NCT03736616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101516425|NCT03736616|Alkylating Agents|alkylating agents|mesh-ancestor
101516426|NCT03736616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101516427|NCT03718403|Theophylline|theophylline|mesh-list
101516428|NCT03718403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101516429|NCT03718403|Autonomic Agents|autonomic agents|mesh-ancestor
101516430|NCT03718403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101516431|NCT03718403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516432|NCT03718403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101516433|NCT03718403|Respiratory System Agents|respiratory system agents|mesh-ancestor
101516434|NCT03718403|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101516435|NCT03718403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101516436|NCT03718403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516437|NCT03718403|Vasodilator Agents|vasodilator agents|mesh-ancestor
101516438|NCT03718403|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101516439|NCT03718403|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101516440|NCT03718403|Purinergic Agents|purinergic agents|mesh-ancestor
101516441|NCT03718403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101516442|NCT00537966|Ritonavir|ritonavir|mesh-list
101516443|NCT00537966|Darunavir|darunavir|mesh-list
101516444|NCT00537966|Tenofovir|tenofovir|mesh-list
101516445|NCT00537966|Lamivudine|lamivudine|mesh-list
101516446|NCT00537966|Emtricitabine|emtricitabine|mesh-list
101516447|NCT00537966|Raltegravir Potassium|raltegravir potassium|mesh-list
101516448|NCT00537966|Dolutegravir|dolutegravir|mesh-list
101516449|NCT00537966|Abacavir|abacavir|mesh-list
101516450|NCT00537966|Cobicistat|cobicistat|mesh-list
101200188|NCT01740297|Ipilimumab|ipilimumab|mesh-list
101516452|NCT00537966|Elvitegravir|elvitegravir|mesh-list
101516453|NCT00537966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101516454|NCT00537966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101516455|NCT00537966|Protease Inhibitors|protease inhibitors|mesh-ancestor
101516456|NCT00537966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101516457|NCT00537966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516458|NCT00537966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101516459|NCT00537966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101516460|NCT00537966|Antiviral Agents|antiviral agents|mesh-ancestor
101516461|NCT00537966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101516462|NCT00537966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101516463|NCT00537966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101516464|NCT00537966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101516465|NCT00537966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101516466|NCT00537966|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101516467|NCT00537966|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101516468|NCT01266967|Dabrafenib|dabrafenib|mesh-list
101516469|NCT01266967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516470|NCT01266967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101516471|NCT01266967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101516472|NCT01266967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516473|NCT03615326|Pembrolizumab|pembrolizumab|mesh-list
101516474|NCT03615326|Capecitabine|capecitabine|mesh-list
101516475|NCT03615326|Oxaliplatin|oxaliplatin|mesh-list
101516476|NCT03615326|Trastuzumab|trastuzumab|mesh-list
101516477|NCT03615326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516478|NCT03615326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101516479|NCT03615326|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101516480|NCT03615326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516481|NCT03615326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101516482|NCT03615326|Antimetabolites|antimetabolites|mesh-ancestor
101516483|NCT00538005|Bevacizumab|bevacizumab|mesh-list
101516484|NCT00538005|Oxaliplatin|oxaliplatin|mesh-list
101516485|NCT00538005|Sorafenib|sorafenib|mesh-list
101516486|NCT00538005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101516487|NCT00538005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516488|NCT00538005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101516489|NCT00538005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101516490|NCT00538005|Growth Substances|growth substances|mesh-ancestor
101516491|NCT00538005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516492|NCT00538005|Growth Inhibitors|growth inhibitors|mesh-ancestor
101516493|NCT00538005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101516494|NCT00538005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101516495|NCT00538005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516496|NCT03610412|Magnesium Oxide|magnesium oxide|mesh-list
101516497|NCT03610412|Antacids|antacids|mesh-ancestor
101516498|NCT03610412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516499|NCT03610412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101516500|NCT00538044|Simvastatin|simvastatin|mesh-list
101516501|NCT00538044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101516502|NCT00538044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101516503|NCT00538044|Antimetabolites|antimetabolites|mesh-ancestor
101516504|NCT00538044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516505|NCT00538044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101516506|NCT00538044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101516507|NCT00538044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101516508|NCT00545493|Tacrolimus|tacrolimus|mesh-list
101516512|NCT00545493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101516513|NCT00545493|Immunologic Factors|immunologic factors|mesh-ancestor
101516514|NCT00545493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264941|NCT01770132|Trioxsalen|trioxsalen|mesh-list
101516515|NCT00545493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101516516|NCT00545493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101516517|NCT00545493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516518|NCT01266460|Vaccines|vaccines|mesh-list
101516519|NCT01266460|Immunologic Factors|immunologic factors|mesh-ancestor
101516520|NCT01266460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516521|NCT05119257|Antibodies|antibodies|mesh-list
101516522|NCT05119257|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101516523|NCT05119257|Immunologic Factors|immunologic factors|mesh-ancestor
101516524|NCT05119257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516525|NCT01266265|Treprostinil|treprostinil|mesh-list
101516526|NCT01266265|Bosentan|bosentan|mesh-list
101516528|NCT01266265|Epoprostenol|epoprostenol|mesh-list
101516529|NCT01266265|Sildenafil Citrate|sildenafil citrate|mesh-list
101516530|NCT01266265|Tadalafil|tadalafil|mesh-list
101516531|NCT01266265|Iloprost|iloprost|mesh-list
101516532|NCT01266265|Tezosentan|tezosentan|mesh-list
101516533|NCT01266265|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
101516534|NCT01266265|Vasodilator Agents|vasodilator agents|mesh-ancestor
101516535|NCT01266265|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101516536|NCT01266265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101516537|NCT01266265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516538|NCT01266265|Urological Agents|urological agents|mesh-ancestor
101516539|NCT01266265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101516540|NCT01266265|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101516541|NCT01266265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101516542|NCT03338387|Acipimox|acipimox|mesh-list
101516543|NCT03338387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101516544|NCT03338387|Antimetabolites|antimetabolites|mesh-ancestor
101516545|NCT03338387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516546|NCT03338387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101516547|NCT05112549|Nivolumab|nivolumab|mesh-list
101516548|NCT05112549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101516549|NCT05112549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516550|NCT05112549|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101516551|NCT05112549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516552|NCT03268382|Doxorubicin|doxorubicin|mesh-list
101516553|NCT03268382|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101516554|NCT03268382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101516555|NCT03268382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516556|NCT03268382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101516557|NCT03268382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101516561|NCT01266148|Mycophenolic Acid|mycophenolic acid|mesh-list
101516562|NCT01266148|Everolimus|everolimus|mesh-list
101516563|NCT01266148|Cyclosporins|cyclosporins|mesh-list
101516564|NCT01266148|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101516565|NCT01266148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101516566|NCT01266148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516567|NCT01266148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101264961|NCT01770171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516568|NCT01266148|Immunologic Factors|immunologic factors|mesh-ancestor
101516569|NCT01266148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264962|NCT01770171|Growth Inhibitors|growth inhibitors|mesh-ancestor
101516570|NCT01266148|Antifungal Agents|antifungal agents|mesh-ancestor
101516571|NCT01266148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101516572|NCT01266148|Dermatologic Agents|dermatologic agents|mesh-ancestor
101516573|NCT01266148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101516574|NCT01266148|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101516575|NCT01266148|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101516576|NCT01266148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101516577|NCT01266148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516578|NCT01266148|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101516579|NCT01266148|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101516580|NCT01266148|Antitubercular Agents|antitubercular agents|mesh-ancestor
101516581|NCT01266148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101516582|NCT00538239|Sirolimus|sirolimus|mesh-list
101516583|NCT00538239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101516584|NCT00538239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101516585|NCT00538239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101516586|NCT00538239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516587|NCT00538239|Antifungal Agents|antifungal agents|mesh-ancestor
101516588|NCT00538239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101516589|NCT00538239|Immunologic Factors|immunologic factors|mesh-ancestor
101516590|NCT00538239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516591|NCT00538317|Tirofiban|tirofiban|mesh-list
101516592|NCT00538317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101516593|NCT00538317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101516594|NCT00538317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516595|NCT00538317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101516596|NCT01265953|Sulforaphane|sulforaphane|mesh-list
101516597|NCT01265953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101516598|NCT01265953|Protective Agents|protective agents|mesh-ancestor
101318808|NCT00017992|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101516599|NCT01265953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516600|NCT01265953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516601|NCT01265875|Secretin|secretin|mesh-list
101516602|NCT01265875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101516603|NCT01265875|Hormones|hormones|mesh-ancestor
101516604|NCT01265875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101516605|NCT01265875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516606|NCT00538395|Cyclophosphamide|cyclophosphamide|mesh-list
101516607|NCT00538395|Doxorubicin|doxorubicin|mesh-list
101516608|NCT00538395|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101516609|NCT00538395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101516610|NCT00538395|Immunologic Factors|immunologic factors|mesh-ancestor
101516611|NCT00538395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516612|NCT00538395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101516613|NCT00538395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101516614|NCT00538395|Alkylating Agents|alkylating agents|mesh-ancestor
101516615|NCT00538395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411102|NCT00449488|Epoetin Alfa|epoetin alfa|mesh-list
101516616|NCT00538395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516617|NCT00538395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101516618|NCT00538395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101516619|NCT00538395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101516620|NCT00538395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101516621|NCT00538395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101516623|NCT01265563|Silybin|silybin|mesh-list
101516624|NCT01265563|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101516625|NCT01265563|Antiviral Agents|antiviral agents|mesh-ancestor
101516626|NCT01265563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101516627|NCT01265563|Expectorants|expectorants|mesh-ancestor
101516628|NCT01265563|Respiratory System Agents|respiratory system agents|mesh-ancestor
101516629|NCT01265563|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101516630|NCT01265563|Antioxidants|antioxidants|mesh-ancestor
101516631|NCT01265563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516632|NCT01265563|Protective Agents|protective agents|mesh-ancestor
101516633|NCT01265563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516634|NCT01265563|Antidotes|antidotes|mesh-ancestor
101516635|NCT01265563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101516636|NCT01265563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516637|NCT01265056|Gabapentin|gabapentin|mesh-list
101516638|NCT01265056|Analgesics|analgesics|mesh-ancestor
101516639|NCT01265056|Sensory System Agents|sensory system agents|mesh-ancestor
101516640|NCT01265056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101516641|NCT01265056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516642|NCT01265056|Anticonvulsants|anticonvulsants|mesh-ancestor
101516643|NCT01265056|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101516644|NCT01265056|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101516645|NCT01265056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101516646|NCT01265056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101516647|NCT01265056|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101516648|NCT01265056|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101516649|NCT01265056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101516650|NCT01265056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516651|NCT01265056|Antimanic Agents|antimanic agents|mesh-ancestor
101516652|NCT02942498|Vitamins|vitamins|mesh-list
101516653|NCT02942498|Vitamin E|vitamin e|mesh-list
101516654|NCT02942498|Micronutrients|micronutrients|mesh-ancestor
101516655|NCT02942498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516656|NCT02942498|Antioxidants|antioxidants|mesh-ancestor
101516657|NCT02942498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516658|NCT02942498|Protective Agents|protective agents|mesh-ancestor
101516659|NCT00545961|Amoxicillin|amoxicillin|mesh-list
101516660|NCT00545961|Clavulanic Acid|clavulanic acid|mesh-list
101516661|NCT00545961|Clavulanic Acids|clavulanic acids|mesh-list
101516662|NCT00545961|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101516663|NCT00545961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101516664|NCT00545961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101516665|NCT00545961|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101516666|NCT00545961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101516667|NCT00545961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516668|NCT01264939|Omalizumab|omalizumab|mesh-list
101516669|NCT01264939|Diphenhydramine|diphenhydramine|mesh-list
101516671|NCT01264939|Leukotriene Antagonists|leukotriene antagonists|mesh-list
101516672|NCT01264939|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
101516673|NCT01264939|Histamine Antagonists|histamine antagonists|mesh-list
101516674|NCT01264939|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101516675|NCT01264939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101516676|NCT01264939|Respiratory System Agents|respiratory system agents|mesh-ancestor
101516677|NCT01264939|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101516678|NCT01264939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101516679|NCT01264939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101516680|NCT01264939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516681|NCT01264939|Anesthetics, Local|anesthetics, local|mesh-ancestor
101516682|NCT01264939|Anesthetics|anesthetics|mesh-ancestor
101516683|NCT01264939|Sensory System Agents|sensory system agents|mesh-ancestor
101516684|NCT01264939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101516685|NCT01264939|Antiemetics|antiemetics|mesh-ancestor
101516686|NCT01264939|Autonomic Agents|autonomic agents|mesh-ancestor
101516687|NCT01264939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101516688|NCT01264939|Histamine Agents|histamine agents|mesh-ancestor
101516689|NCT01264939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101516690|NCT01264939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516691|NCT01264939|Antipruritics|antipruritics|mesh-ancestor
101516692|NCT01264939|Dermatologic Agents|dermatologic agents|mesh-ancestor
101516693|NCT01264939|Hormone Antagonists|hormone antagonists|mesh-ancestor
101516694|NCT01264939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101516695|NCT02889367|Odalasvir|odalasvir|mesh-list
101516696|NCT02889367|Antiviral Agents|antiviral agents|mesh-ancestor
101516697|NCT02889367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101516698|NCT00546039|Genistein|genistein|mesh-list
101516699|NCT00546039|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101516700|NCT00546039|Protective Agents|protective agents|mesh-ancestor
101516701|NCT00546039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516702|NCT00546039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516703|NCT00546039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101516704|NCT00546039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101516705|NCT00546039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516706|NCT00546039|Phytoestrogens|phytoestrogens|mesh-ancestor
101516707|NCT00546039|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101516708|NCT00546039|Estrogens|estrogens|mesh-ancestor
101516709|NCT00546039|Hormones|hormones|mesh-ancestor
101516710|NCT00546039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101516711|NCT01264081|Lapatinib|lapatinib|mesh-list
101516712|NCT01264081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516713|NCT01264081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101516714|NCT01264081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101516715|NCT01264081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516716|NCT02711969|Apatinib|apatinib|mesh-list
101516717|NCT02711969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516718|NCT02711969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101516719|NCT02711969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101516720|NCT02711969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516721|NCT01263925|Pentoxifylline|pentoxifylline|mesh-list
101516722|NCT01263925|Alprostadil|alprostadil|mesh-list
101516723|NCT01263925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101516724|NCT01263925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101516725|NCT01263925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516726|NCT01263925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101516727|NCT01263925|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101516728|NCT01263925|Protective Agents|protective agents|mesh-ancestor
101516729|NCT01263925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516730|NCT01263925|Vasodilator Agents|vasodilator agents|mesh-ancestor
101516731|NCT01263925|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101516732|NCT01263925|Antioxidants|antioxidants|mesh-ancestor
101516733|NCT01263925|Urological Agents|urological agents|mesh-ancestor
101318820|NCT00017992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101516734|NCT04323631|Hydroxychloroquine|hydroxychloroquine|mesh-list
101516735|NCT04323631|Antimalarials|antimalarials|mesh-ancestor
101516736|NCT04323631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101516737|NCT04323631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101516738|NCT04323631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101516739|NCT04323631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101516740|NCT04323631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516742|NCT00546234|Tiotropium Bromide|tiotropium bromide|mesh-list
101516743|NCT00546234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101516744|NCT00546234|Autonomic Agents|autonomic agents|mesh-ancestor
101516745|NCT00546234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101516746|NCT00546234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516747|NCT00546234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101516748|NCT00546234|Respiratory System Agents|respiratory system agents|mesh-ancestor
101516749|NCT00546234|Parasympatholytics|parasympatholytics|mesh-ancestor
101516750|NCT00546234|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101516751|NCT00546234|Cholinergic Agents|cholinergic agents|mesh-ancestor
101516752|NCT00546234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101516753|NCT00546234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516755|NCT01263769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516756|NCT01263769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101516757|NCT01263769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101516758|NCT01263769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516759|NCT02623439|Cyclophosphamide|cyclophosphamide|mesh-list
101516760|NCT02623439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101516761|NCT02623439|Immunologic Factors|immunologic factors|mesh-ancestor
101516762|NCT02623439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516763|NCT02623439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101516764|NCT02623439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101516765|NCT02623439|Alkylating Agents|alkylating agents|mesh-ancestor
101516766|NCT02623439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516767|NCT02623439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516768|NCT02623439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101516770|NCT00539331|Carboplatin|carboplatin|mesh-list
101516771|NCT00539331|Cediranib|cediranib|mesh-list
101516772|NCT00539331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101516773|NCT00539331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516774|NCT00539331|Tubulin Modulators|tubulin modulators|mesh-ancestor
101516775|NCT00539331|Antimitotic Agents|antimitotic agents|mesh-ancestor
101516776|NCT00539331|Mitosis Modulators|mitosis modulators|mesh-ancestor
101516777|NCT00539331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516778|NCT00539331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101516779|NCT00539331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101516780|NCT02236013|Cytarabine|cytarabine|mesh-list
101516781|NCT02236013|Daunorubicin|daunorubicin|mesh-list
101516782|NCT02236013|Idarubicin|idarubicin|mesh-list
101516783|NCT02236013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101516784|NCT02236013|Antimetabolites|antimetabolites|mesh-ancestor
101516785|NCT02236013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516786|NCT02236013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516787|NCT02236013|Antiviral Agents|antiviral agents|mesh-ancestor
101516790|NCT02236013|Immunologic Factors|immunologic factors|mesh-ancestor
101516791|NCT02236013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516792|NCT02236013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101516793|NCT02236013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101516794|NCT02236013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101516795|NCT02236013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101516797|NCT00539409|Insulin Aspart|insulin aspart|mesh-list
101516798|NCT00539409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101516799|NCT00539409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101516800|NCT00539409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516801|NCT01263691|Vaccines|vaccines|mesh-list
101516802|NCT01263691|Immunologic Factors|immunologic factors|mesh-ancestor
101516803|NCT01263691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516804|NCT02178410|Vitamin D|vitamin d|mesh-list
101516805|NCT02178410|Ergocalciferols|ergocalciferols|mesh-list
101318826|NCT00018148|Nortriptyline|nortriptyline|mesh-list
101516806|NCT02178410|Cholecalciferol|cholecalciferol|mesh-list
101516807|NCT02178410|Vitamins|vitamins|mesh-list
101516808|NCT02178410|Micronutrients|micronutrients|mesh-ancestor
101516809|NCT02178410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516810|NCT02178410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101516811|NCT02178410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101516812|NCT00539448|Insulin|insulin|mesh-list
101516813|NCT00539448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101516814|NCT00539448|Insulin Glargine|insulin glargine|mesh-list
101516815|NCT00539448|Insulin glulisine|insulin glulisine|mesh-list
101516816|NCT00539448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101516817|NCT00539448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516818|NCT05541484|Dapagliflozin|dapagliflozin|mesh-list
101516819|NCT05541484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
101516820|NCT05541484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516821|NCT05541484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101516822|NCT05541484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516823|NCT01808456|Vaccines|vaccines|mesh-list
101516824|NCT01808456|Immunologic Factors|immunologic factors|mesh-ancestor
101516825|NCT01808456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516826|NCT01715714|Atorvastatin|atorvastatin|mesh-list
101516827|NCT01715714|Simvastatin|simvastatin|mesh-list
101516828|NCT01715714|Pravastatin|pravastatin|mesh-list
101516829|NCT01715714|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101516830|NCT01715714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101200559|NCT01398371|Digoxin|digoxin|mesh-list
101516831|NCT01715714|Antimetabolites|antimetabolites|mesh-ancestor
101516832|NCT01715714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516833|NCT01715714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101516834|NCT01715714|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101264998|NCT01770301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101516835|NCT01715714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101516836|NCT01540253|Docetaxel|docetaxel|mesh-list
101516837|NCT01540253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516838|NCT01540253|Tubulin Modulators|tubulin modulators|mesh-ancestor
101516839|NCT01540253|Antimitotic Agents|antimitotic agents|mesh-ancestor
101516840|NCT01540253|Mitosis Modulators|mitosis modulators|mesh-ancestor
101516841|NCT01540253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516842|NCT01497392|Gemcitabine|gemcitabine|mesh-list
101516843|NCT01497392|Capecitabine|capecitabine|mesh-list
101516844|NCT01497392|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101516845|NCT01497392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101516846|NCT01497392|Antimetabolites|antimetabolites|mesh-ancestor
101516847|NCT01497392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516848|NCT01497392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516849|NCT01497392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101516850|NCT01497392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101516851|NCT01310192|Choline|choline|mesh-list
101516852|NCT01310192|Lipotropic Agents|lipotropic agents|mesh-ancestor
101516854|NCT01310192|Antimetabolites|antimetabolites|mesh-ancestor
101516855|NCT01310192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516856|NCT01310192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101516857|NCT01310192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101516858|NCT01310192|Nootropic Agents|nootropic agents|mesh-ancestor
101516859|NCT00539565|Prednisolone|prednisolone|mesh-list
101516860|NCT00539565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101516861|NCT00539565|Glucocorticoids|glucocorticoids|mesh-ancestor
101516862|NCT00539565|Hormones|hormones|mesh-ancestor
101516863|NCT00539565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101516864|NCT00539565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516865|NCT00539565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101516866|NCT00539565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516867|NCT00539799|Prednisolone|prednisolone|mesh-list
101516868|NCT00539799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101516869|NCT00539799|Glucocorticoids|glucocorticoids|mesh-ancestor
101516870|NCT00539799|Hormones|hormones|mesh-ancestor
101516871|NCT00539799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101516872|NCT00539799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516873|NCT00539799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101516874|NCT00539799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516875|NCT00945152|Vancomycin|vancomycin|mesh-list
101516876|NCT00945152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101516878|NCT00546507|Celecoxib|celecoxib|mesh-list
101516879|NCT00546507|Diclofenac|diclofenac|mesh-list
101516880|NCT00546507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101516881|NCT00546507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101516882|NCT00546507|Analgesics|analgesics|mesh-ancestor
101516883|NCT00546507|Sensory System Agents|sensory system agents|mesh-ancestor
101516884|NCT00546507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101516885|NCT00546507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516886|NCT00546507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101516887|NCT00546507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101516888|NCT00546507|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101516889|NCT00546507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101516890|NCT00546507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101516891|NCT00546507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516893|NCT00546546|Azathioprine|azathioprine|mesh-list
101516894|NCT00546546|Immunosuppressive Agents|immunosuppressive agents|mesh-list
101516895|NCT00546546|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101516896|NCT00546546|Abortifacient Agents|abortifacient agents|mesh-ancestor
101516897|NCT00546546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101516898|NCT00546546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265010|NCT01770444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101516899|NCT00546546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101516900|NCT00546546|Antimetabolites|antimetabolites|mesh-ancestor
101516901|NCT00546546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516902|NCT00546546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516903|NCT00546546|Dermatologic Agents|dermatologic agents|mesh-ancestor
101516904|NCT00546546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101516905|NCT00546546|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101516906|NCT00546546|Immunologic Factors|immunologic factors|mesh-ancestor
101516907|NCT00546546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101516908|NCT00546546|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101516909|NCT00659711|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101516910|NCT00659711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101516911|NCT00659711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516912|NCT00659711|Incretins|incretins|mesh-ancestor
101516913|NCT00659711|Hormones|hormones|mesh-ancestor
101516914|NCT00659711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101516915|NCT00659711|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101516916|NCT00659711|Protease Inhibitors|protease inhibitors|mesh-ancestor
101516917|NCT00659711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101516918|NCT00659711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516919|NCT02581007|Cyclophosphamide|cyclophosphamide|mesh-list
101516920|NCT02581007|Melphalan|melphalan|mesh-list
101516921|NCT02581007|Fludarabine|fludarabine|mesh-list
101516922|NCT02581007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101516923|NCT02581007|Immunologic Factors|immunologic factors|mesh-ancestor
101516924|NCT02581007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516925|NCT02581007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101516926|NCT02581007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101516927|NCT02581007|Alkylating Agents|alkylating agents|mesh-ancestor
101516928|NCT02581007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516929|NCT02581007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516930|NCT02581007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101516931|NCT00546741|Metformin|metformin|mesh-list
101516932|NCT00546741|Dapagliflozin|dapagliflozin|mesh-list
101516933|NCT00546741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101516934|NCT00546741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516935|NCT00546741|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101516936|NCT00546741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516937|NCT02540330|Fulvestrant|fulvestrant|mesh-list
101516938|NCT02540330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101516939|NCT02540330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516940|NCT02540330|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101516941|NCT02540330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101516942|NCT02540330|Hormone Antagonists|hormone antagonists|mesh-ancestor
101516943|NCT02540330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101516944|NCT02540330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516945|NCT02467361|Pembrolizumab|pembrolizumab|mesh-list
101516946|NCT02467361|Nivolumab|nivolumab|mesh-list
101516947|NCT02467361|Ipilimumab|ipilimumab|mesh-list
101516948|NCT02467361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101318832|NCT00018148|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101516949|NCT02467361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516950|NCT02467361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101516951|NCT02467361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516952|NCT00546936|Ranibizumab|ranibizumab|mesh-list
101516953|NCT00546936|Verteporfin|verteporfin|mesh-list
101516954|NCT00546936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101516955|NCT00546936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101516956|NCT00546936|Growth Substances|growth substances|mesh-ancestor
101516957|NCT00546936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516959|NCT00546936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516960|NCT00546936|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101516961|NCT00546936|Dermatologic Agents|dermatologic agents|mesh-ancestor
101516962|NCT02231723|Leucovorin|leucovorin|mesh-list
101516963|NCT02231723|Paclitaxel|paclitaxel|mesh-list
101516964|NCT02231723|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101516965|NCT02231723|Gemcitabine|gemcitabine|mesh-list
101516966|NCT02231723|Fluorouracil|fluorouracil|mesh-list
101516967|NCT02231723|Oxaliplatin|oxaliplatin|mesh-list
101516968|NCT02231723|Irinotecan|irinotecan|mesh-list
101516969|NCT02231723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101516970|NCT02231723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101516971|NCT02231723|Tubulin Modulators|tubulin modulators|mesh-ancestor
101516972|NCT02231723|Antimitotic Agents|antimitotic agents|mesh-ancestor
101516973|NCT02231723|Mitosis Modulators|mitosis modulators|mesh-ancestor
101516974|NCT02231723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516975|NCT02231723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101516976|NCT02231723|Antimetabolites|antimetabolites|mesh-ancestor
101516977|NCT02231723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101516978|NCT02231723|Immunologic Factors|immunologic factors|mesh-ancestor
101516979|NCT02231723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516980|NCT02231723|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101516981|NCT02231723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101516982|NCT02231723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101516983|NCT02231723|Antidotes|antidotes|mesh-ancestor
101516984|NCT02231723|Protective Agents|protective agents|mesh-ancestor
101516985|NCT02231723|Vitamin B Complex|vitamin b complex|mesh-ancestor
101516986|NCT02231723|Vitamins|vitamins|mesh-ancestor
101516987|NCT02231723|Micronutrients|micronutrients|mesh-ancestor
101516988|NCT01263496|Alogliptin|alogliptin|mesh-list
101516989|NCT01263496|Voglibose|voglibose|mesh-list
101516990|NCT01263496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101516991|NCT01263496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101516992|NCT01263496|Incretins|incretins|mesh-ancestor
101516993|NCT01263496|Hormones|hormones|mesh-ancestor
101516994|NCT01263496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101516995|NCT01263496|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101516996|NCT01263496|Protease Inhibitors|protease inhibitors|mesh-ancestor
101516997|NCT01263496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101516998|NCT01263496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101516999|NCT01263496|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101517000|NCT04681937|Methylprednisolone|methylprednisolone|mesh-list
101517001|NCT04681937|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101517002|NCT04681937|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101517003|NCT04681937|Prednisolone|prednisolone|mesh-list
101517004|NCT04681937|Prednisolone acetate|prednisolone acetate|mesh-list
101517005|NCT04681937|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101517006|NCT04681937|Prednisolone phosphate|prednisolone phosphate|mesh-list
101517007|NCT04681937|Hyaluronic Acid|hyaluronic acid|mesh-list
101517008|NCT04681937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101517009|NCT04681937|Antiemetics|antiemetics|mesh-ancestor
101517010|NCT04681937|Autonomic Agents|autonomic agents|mesh-ancestor
101517011|NCT04681937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101517012|NCT04681937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517013|NCT04681937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101517014|NCT04681937|Glucocorticoids|glucocorticoids|mesh-ancestor
101517015|NCT04681937|Hormones|hormones|mesh-ancestor
101517016|NCT04681937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101265037|NCT01770769|Dalteparin|dalteparin|mesh-list
101265038|NCT01770769|Tinzaparin|tinzaparin|mesh-list
101265039|NCT01770769|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101265040|NCT01770769|Anticoagulants|anticoagulants|mesh-ancestor
101265041|NCT01770769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101265042|NCT01770769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101265043|NCT01770769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517017|NCT04681937|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101517018|NCT04681937|Protective Agents|protective agents|mesh-ancestor
101517019|NCT04681937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101517020|NCT04681937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101517021|NCT04681937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101517022|NCT04681937|Immunologic Factors|immunologic factors|mesh-ancestor
101517023|NCT04681937|Viscosupplements|viscosupplements|mesh-ancestor
101517025|NCT00547053|Diuretics|diuretics|mesh-ancestor
101517026|NCT00547053|Natriuretic Agents|natriuretic agents|mesh-ancestor
101517027|NCT00547053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517028|NCT00547053|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
101517029|NCT00547053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101517030|NCT00547053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101517031|NCT00547053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517032|NCT00547053|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101517033|NCT00547053|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101517034|NCT00547092|Sildenafil Citrate|sildenafil citrate|mesh-list
101517035|NCT00547092|Tadalafil|tadalafil|mesh-list
101517036|NCT00547092|Vasodilator Agents|vasodilator agents|mesh-ancestor
101517037|NCT00547092|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101517038|NCT00547092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101517039|NCT00547092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101517040|NCT00547092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517041|NCT00547092|Urological Agents|urological agents|mesh-ancestor
101517042|NCT00547131|Temozolomide|temozolomide|mesh-list
101517043|NCT00547131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101517044|NCT00547131|Alkylating Agents|alkylating agents|mesh-ancestor
101517045|NCT00547131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517046|NCT00547131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101517047|NCT01964495|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101517048|NCT01964495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101517049|NCT01964495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101517050|NCT01964495|Antitubercular Agents|antitubercular agents|mesh-ancestor
101517051|NCT00547170|Doxycycline|doxycycline|mesh-list
101517052|NCT00547170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101517053|NCT00547170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101517054|NCT00547170|Antimalarials|antimalarials|mesh-ancestor
101517055|NCT00547170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101517056|NCT00547170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101517058|NCT00547209|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101517059|NCT00547209|Anesthetics, General|anesthetics, general|mesh-ancestor
101517061|NCT00547209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101517062|NCT00547209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517063|NCT00547209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101517064|NCT00547209|Analgesics|analgesics|mesh-ancestor
101517065|NCT00547209|Sensory System Agents|sensory system agents|mesh-ancestor
101517066|NCT00547209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101517067|NCT00547287|Sildenafil Citrate|sildenafil citrate|mesh-list
101517068|NCT00547287|Tadalafil|tadalafil|mesh-list
101517069|NCT00547287|Vasodilator Agents|vasodilator agents|mesh-ancestor
101517070|NCT00547287|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101517071|NCT00547287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101517072|NCT00547287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101517073|NCT00547287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517074|NCT00547287|Urological Agents|urological agents|mesh-ancestor
101517075|NCT01263106|Theophylline|theophylline|mesh-list
101517076|NCT01263106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101517077|NCT01263106|Autonomic Agents|autonomic agents|mesh-ancestor
101517078|NCT01263106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101517079|NCT01263106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517080|NCT01263106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101517081|NCT01263106|Respiratory System Agents|respiratory system agents|mesh-ancestor
101517082|NCT01263106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101517083|NCT01263106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101265046|NCT01770795|Gemcitabine|gemcitabine|mesh-list
101265047|NCT01770795|genexol-PM|genexol-pm|mesh-list
101265049|NCT01770795|Antimetabolites|antimetabolites|mesh-ancestor
101517084|NCT01263106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517085|NCT01263106|Vasodilator Agents|vasodilator agents|mesh-ancestor
101517086|NCT01263106|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101517087|NCT01263106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101517088|NCT01263106|Purinergic Agents|purinergic agents|mesh-ancestor
101517089|NCT01263106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101517090|NCT01263028|Ergocalciferols|ergocalciferols|mesh-list
101517091|NCT01263028|Vitamin D|vitamin d|mesh-list
101517092|NCT01263028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101517093|NCT01263028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517094|NCT01263028|Vitamins|vitamins|mesh-ancestor
101517095|NCT01263028|Micronutrients|micronutrients|mesh-ancestor
101517096|NCT01263028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101517097|NCT00547443|Paclitaxel|paclitaxel|mesh-list
101517098|NCT00547443|Carboplatin|carboplatin|mesh-list
101517099|NCT00547443|Sorafenib|sorafenib|mesh-list
101517100|NCT00547443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101517101|NCT00547443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101517102|NCT00547443|Tubulin Modulators|tubulin modulators|mesh-ancestor
101517103|NCT00547443|Antimitotic Agents|antimitotic agents|mesh-ancestor
101517104|NCT00547443|Mitosis Modulators|mitosis modulators|mesh-ancestor
101517105|NCT00547443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517106|NCT00547443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101517107|NCT00547443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101517108|NCT00547560|Begacestat|begacestat|mesh-list
101517109|NCT00547560|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101517110|NCT00547560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101517111|NCT00547560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517112|NCT00547599|Tadalafil|tadalafil|mesh-list
101517113|NCT00547599|Vasodilator Agents|vasodilator agents|mesh-ancestor
101517114|NCT00547599|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101517115|NCT00547599|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101517116|NCT00547599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101517117|NCT00547599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517118|NCT00547599|Urological Agents|urological agents|mesh-ancestor
101517119|NCT02908763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101517120|NCT02908763|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101517121|NCT02908763|Antiviral Agents|antiviral agents|mesh-ancestor
101517122|NCT02908763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101517123|NCT02908412|Bupivacaine|bupivacaine|mesh-list
101517124|NCT02908412|Anesthetics, Local|anesthetics, local|mesh-ancestor
101517125|NCT02908412|Anesthetics|anesthetics|mesh-ancestor
101517126|NCT02908412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101517127|NCT02908412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517128|NCT02908412|Sensory System Agents|sensory system agents|mesh-ancestor
101517129|NCT02908412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101517130|NCT02908295|Misoprostol|misoprostol|mesh-list
101517131|NCT02908295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101517132|NCT02908295|Abortifacient Agents|abortifacient agents|mesh-ancestor
101200864|NCT01400750|Tobramycin|tobramycin|mesh-list
101517133|NCT02908295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101517134|NCT02908295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517135|NCT02908295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101517136|NCT02908295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101517137|NCT02908295|Oxytocics|oxytocics|mesh-ancestor
101517138|NCT03809442|Dexamethasone|dexamethasone|mesh-list
101517139|NCT03809442|Midazolam|midazolam|mesh-list
101517140|NCT03809442|Dexmedetomidine|dexmedetomidine|mesh-list
101517141|NCT03809442|Ketamine|ketamine|mesh-list
101517142|NCT03809442|Tramadol|tramadol|mesh-list
101517143|NCT03809442|Ropivacaine|ropivacaine|mesh-list
101517144|NCT03809442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101517145|NCT03809442|Antiemetics|antiemetics|mesh-ancestor
101517146|NCT03809442|Autonomic Agents|autonomic agents|mesh-ancestor
101517147|NCT03809442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101517148|NCT03809442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517149|NCT03809442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101517150|NCT03809442|Glucocorticoids|glucocorticoids|mesh-ancestor
101517151|NCT03809442|Hormones|hormones|mesh-ancestor
101517152|NCT03809442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101517153|NCT03809442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101517154|NCT03809442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101517155|NCT03809442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101517156|NCT03809442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101517157|NCT03809442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101517158|NCT03809442|Analgesics|analgesics|mesh-ancestor
101517159|NCT03809442|Sensory System Agents|sensory system agents|mesh-ancestor
101517160|NCT03809442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101517161|NCT03809442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101517162|NCT03809442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101517163|NCT03809442|Adrenergic Agents|adrenergic agents|mesh-ancestor
101517164|NCT03809442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101517165|NCT03809442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517166|NCT03809442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101517167|NCT03809442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101517168|NCT03809442|Anesthetics, General|anesthetics, general|mesh-ancestor
101517169|NCT03809442|Anesthetics|anesthetics|mesh-ancestor
101517170|NCT03809442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101517171|NCT03809442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101517172|NCT03809442|Anesthetics, Local|anesthetics, local|mesh-ancestor
101517173|NCT03809442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101517174|NCT03809442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101517175|NCT03809442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101517176|NCT03809442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101517177|NCT03809442|GABA Modulators|gaba modulators|mesh-ancestor
101517178|NCT03809442|GABA Agents|gaba agents|mesh-ancestor
101517179|NCT03809442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101517180|NCT03809442|Narcotics|narcotics|mesh-ancestor
101517181|NCT00534729|Carboplatin|carboplatin|mesh-list
101517182|NCT00534729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101517183|NCT00547989|Bupivacaine|bupivacaine|mesh-list
101517184|NCT00547989|Ropivacaine|ropivacaine|mesh-list
101517185|NCT00547989|Anesthetics, Local|anesthetics, local|mesh-ancestor
101517186|NCT00547989|Anesthetics|anesthetics|mesh-ancestor
101517187|NCT00547989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101517188|NCT00547989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517189|NCT00547989|Sensory System Agents|sensory system agents|mesh-ancestor
101517190|NCT00547989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101517191|NCT00534807|Rifampin|rifampin|mesh-list
101517193|NCT00534807|Antitubercular Agents|antitubercular agents|mesh-ancestor
101517194|NCT00534807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101517195|NCT00534807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101517196|NCT00534807|Leprostatic Agents|leprostatic agents|mesh-ancestor
101517197|NCT00534807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101517198|NCT00534807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101517199|NCT00534807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517200|NCT00534807|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101517201|NCT00534807|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101517202|NCT00534807|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101265072|NCT01770964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101265074|NCT01770964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101517203|NCT00534807|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101517204|NCT00534807|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101200937|NCT01401179|Erythromycin stearate|erythromycin stearate|mesh-list
101517205|NCT00534807|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101517207|NCT00534846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101517208|NCT00534846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101517209|NCT00534846|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101517210|NCT00534846|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101517211|NCT00534846|Hormone Antagonists|hormone antagonists|mesh-ancestor
101517212|NCT00534846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101517213|NCT00534846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517214|NCT00534846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101517215|NCT00548067|Amlodipine|amlodipine|mesh-list
101517216|NCT00548067|Valsartan|valsartan|mesh-list
101517217|NCT00548067|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101517218|NCT00548067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101517219|NCT00548067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101517220|NCT00548067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101517221|NCT00548067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517222|NCT00548067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101517223|NCT00548067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517224|NCT00548067|Vasodilator Agents|vasodilator agents|mesh-ancestor
101517225|NCT00548067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101517226|NCT00548067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101517227|NCT00548067|Diuretics|diuretics|mesh-ancestor
101517228|NCT00548067|Natriuretic Agents|natriuretic agents|mesh-ancestor
101517229|NCT00548067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101517230|NCT02907749|Carvedilol|carvedilol|mesh-list
101517231|NCT02907749|Spironolactone|spironolactone|mesh-list
101517232|NCT02907749|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101517233|NCT02907749|Hormone Antagonists|hormone antagonists|mesh-ancestor
101517234|NCT02907749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101517235|NCT02907749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517236|NCT02907749|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101517237|NCT02907749|Diuretics|diuretics|mesh-ancestor
101517238|NCT02907749|Natriuretic Agents|natriuretic agents|mesh-ancestor
101517239|NCT02907749|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101517240|NCT02907749|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101517241|NCT02907749|Adrenergic Agents|adrenergic agents|mesh-ancestor
101517242|NCT02907749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101517243|NCT02907749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517244|NCT02907749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101517245|NCT02907749|Antioxidants|antioxidants|mesh-ancestor
101517246|NCT02907749|Protective Agents|protective agents|mesh-ancestor
101517247|NCT02907749|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101517248|NCT02907749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101517249|NCT02907749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101517250|NCT02907749|Vasodilator Agents|vasodilator agents|mesh-ancestor
101517251|NCT02907749|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101517252|NCT02907749|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101517254|NCT02907593|Calfactant|calfactant|mesh-list
101517255|NCT02907593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101265084|NCT01771081|Growth Inhibitors|growth inhibitors|mesh-ancestor
101517256|NCT02907593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101517257|NCT02907593|Autonomic Agents|autonomic agents|mesh-ancestor
101517258|NCT02907593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101517259|NCT02907593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517260|NCT02907593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101517261|NCT02907593|Respiratory System Agents|respiratory system agents|mesh-ancestor
101517262|NCT02907593|Glucocorticoids|glucocorticoids|mesh-ancestor
101517263|NCT02907593|Hormones|hormones|mesh-ancestor
101517264|NCT02907593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101517265|NCT02907593|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
101517266|NCT00548301|Cyclosporine|cyclosporine|mesh-list
101517267|NCT00548301|Cyclosporins|cyclosporins|mesh-list
101517268|NCT00548301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101517269|NCT00548301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517270|NCT00548301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101517271|NCT00548301|Immunologic Factors|immunologic factors|mesh-ancestor
101517272|NCT00548301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517273|NCT00548301|Antifungal Agents|antifungal agents|mesh-ancestor
101517274|NCT00548301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101517275|NCT00548301|Dermatologic Agents|dermatologic agents|mesh-ancestor
101517276|NCT00548301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101517277|NCT00548301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101517278|NCT02907710|Endostar protein|endostar protein|mesh-list
101517279|NCT02907710|Endostatins|endostatins|mesh-list
101517280|NCT02907710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101517281|NCT02907710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101517282|NCT02907710|Growth Substances|growth substances|mesh-ancestor
101517283|NCT02907710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517284|NCT02907710|Growth Inhibitors|growth inhibitors|mesh-ancestor
101517285|NCT02907710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101517286|NCT03781362|Capecitabine|capecitabine|mesh-list
101517287|NCT03781362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101517288|NCT03781362|Antimetabolites|antimetabolites|mesh-ancestor
101517289|NCT03781362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517290|NCT03781362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101517291|NCT04682249|Apatinib|apatinib|mesh-list
101517292|NCT04682249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101517293|NCT04682249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101517294|NCT04682249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101517295|NCT04682249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517296|NCT00548379|Vitamin D|vitamin d|mesh-list
101517297|NCT00548379|Vitamins|vitamins|mesh-ancestor
101517298|NCT00548379|Micronutrients|micronutrients|mesh-ancestor
101517299|NCT00548379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517300|NCT00548379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101517301|NCT04972617|Furosemide|furosemide|mesh-list
101517302|NCT04972617|Diuretics|diuretics|mesh-ancestor
101517303|NCT04972617|Natriuretic Agents|natriuretic agents|mesh-ancestor
101517304|NCT04972617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517305|NCT04972617|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101517306|NCT04972617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101517307|NCT04972617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517308|NCT04682210|Bevacizumab|bevacizumab|mesh-list
101517309|NCT04682210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101517310|NCT04682210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101517311|NCT04682210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101517312|NCT04682210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101517313|NCT04682210|Growth Substances|growth substances|mesh-ancestor
101517314|NCT04682210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517315|NCT04682210|Growth Inhibitors|growth inhibitors|mesh-ancestor
101517316|NCT04682132|Antibodies|antibodies|mesh-list
101517317|NCT04682132|Immunologic Factors|immunologic factors|mesh-ancestor
101517322|NCT02907554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517323|NCT02907554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101517324|NCT02907554|Immunologic Factors|immunologic factors|mesh-ancestor
101517325|NCT02907554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517326|NCT02907554|Antifungal Agents|antifungal agents|mesh-ancestor
101517327|NCT02907554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101517328|NCT02907554|Dermatologic Agents|dermatologic agents|mesh-ancestor
101517329|NCT02907554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101517330|NCT02907554|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101517332|NCT02907632|Antiemetics|antiemetics|mesh-ancestor
101517333|NCT02907632|Autonomic Agents|autonomic agents|mesh-ancestor
101517334|NCT02907632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101517335|NCT02907632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517336|NCT02907632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101517337|NCT02907632|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101517338|NCT02907632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101517339|NCT02907632|Dopamine Agents|dopamine agents|mesh-ancestor
101517340|NCT02907632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101517341|NCT02907632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517342|NCT02907437|Minocycline|minocycline|mesh-list
101517343|NCT02907437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101517344|NCT02907437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101517345|NCT01262872|Vaccines|vaccines|mesh-list
101517346|NCT01262872|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101517347|NCT01262872|Immunologic Factors|immunologic factors|mesh-ancestor
101517348|NCT01262872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517349|NCT00548574|Mesalamine|mesalamine|mesh-list
101517350|NCT00548574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101517351|NCT00548574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101517352|NCT00548574|Analgesics|analgesics|mesh-ancestor
101517353|NCT00548574|Sensory System Agents|sensory system agents|mesh-ancestor
101517354|NCT00548574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101318871|NCT00018187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101517355|NCT00548574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517356|NCT00548574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101517357|NCT00548574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101517359|NCT01262677|Analgesics|analgesics|mesh-ancestor
101517360|NCT01262677|Sensory System Agents|sensory system agents|mesh-ancestor
101517361|NCT01262677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101517362|NCT01262677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517363|NCT01262677|Anticonvulsants|anticonvulsants|mesh-ancestor
101517364|NCT01262677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101517365|NCT01262677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101517366|NCT01262677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517367|NCT01262677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101517368|NCT01262677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101517369|NCT01262677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101517370|NCT01262677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101517371|NCT01262677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101517372|NCT02899364|Sodium thiosulfate|sodium thiosulfate|mesh-list
101517373|NCT02899364|Antidotes|antidotes|mesh-ancestor
101517374|NCT02899364|Protective Agents|protective agents|mesh-ancestor
101517375|NCT02899364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517376|NCT02899364|Antioxidants|antioxidants|mesh-ancestor
101517378|NCT02899364|Antitubercular Agents|antitubercular agents|mesh-ancestor
101517379|NCT02899364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101517380|NCT02899364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101517382|NCT02899364|Sequestering Agents|sequestering agents|mesh-ancestor
101517383|NCT04206865|Valsartan|valsartan|mesh-list
101517384|NCT04206865|Vasodilator Agents|vasodilator agents|mesh-list
101517385|NCT04206865|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101517386|NCT04206865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101517387|NCT04206865|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101517388|NCT04206865|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101517389|NCT04206865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517390|NCT00535080|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
101517391|NCT00535080|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101517392|NCT00535080|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101517393|NCT00535080|Dermatologic Agents|dermatologic agents|mesh-ancestor
101517394|NCT01262638|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
101517395|NCT01262638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101517396|NCT01262638|Antimetabolites|antimetabolites|mesh-ancestor
101517397|NCT01262638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517398|NCT01262638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101517399|NCT01262638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101517400|NCT01262638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101517401|NCT01262638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517402|NCT00535119|Paclitaxel|paclitaxel|mesh-list
101517403|NCT00535119|Carboplatin|carboplatin|mesh-list
101517404|NCT00535119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101517405|NCT00535119|Veliparib|veliparib|mesh-list
101517406|NCT00535119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101517407|NCT00535119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101517408|NCT00535119|Tubulin Modulators|tubulin modulators|mesh-ancestor
101517409|NCT00535119|Antimitotic Agents|antimitotic agents|mesh-ancestor
101517410|NCT00535119|Mitosis Modulators|mitosis modulators|mesh-ancestor
101517411|NCT00535119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517412|NCT00535119|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101517413|NCT00535119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101517415|NCT00535158|Ergocalciferols|ergocalciferols|mesh-list
101517416|NCT00535158|Vitamins|vitamins|mesh-ancestor
101517417|NCT00535158|Micronutrients|micronutrients|mesh-ancestor
101517418|NCT00535158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517419|NCT00535158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101517420|NCT00535158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101517421|NCT03436992|Resveratrol|resveratrol|mesh-list
101517422|NCT03436992|Antioxidants|antioxidants|mesh-list
101517423|NCT03436992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517424|NCT03436992|Protective Agents|protective agents|mesh-ancestor
101517425|NCT03436992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517426|NCT03436992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101517428|NCT04083118|Listerine|listerine|mesh-list
101517429|NCT04083118|Fluorides|fluorides|mesh-list
101517431|NCT04083118|Cariostatic Agents|cariostatic agents|mesh-ancestor
101517432|NCT04083118|Protective Agents|protective agents|mesh-ancestor
101517433|NCT04083118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517434|NCT04083118|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101517435|NCT04083118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101517436|NCT04207450|Glutaral|glutaral|mesh-list
101517437|NCT04207450|Disinfectants|disinfectants|mesh-ancestor
101517438|NCT04207450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101517439|NCT04070443|Imatinib Mesylate|imatinib mesylate|mesh-list
101517440|NCT04070443|Ponatinib|ponatinib|mesh-list
101517441|NCT04070443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101517442|NCT04070443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101517443|NCT04070443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101517444|NCT04070443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517445|NCT04043494|Cytarabine|cytarabine|mesh-list
101517446|NCT04043494|Dexamethasone|dexamethasone|mesh-list
101517447|NCT04043494|Prednisone|prednisone|mesh-list
101517448|NCT04043494|Prednisolone|prednisolone|mesh-list
101517449|NCT04043494|Cyclophosphamide|cyclophosphamide|mesh-list
101517450|NCT04043494|Ifosfamide|ifosfamide|mesh-list
101517451|NCT04043494|Doxorubicin|doxorubicin|mesh-list
101517452|NCT04043494|Methotrexate|methotrexate|mesh-list
101517453|NCT04043494|Vincristine|vincristine|mesh-list
101517454|NCT04043494|Daunorubicin|daunorubicin|mesh-list
101517455|NCT04043494|Asparaginase|asparaginase|mesh-list
101517456|NCT04043494|Mercaptopurine|mercaptopurine|mesh-list
101517457|NCT04043494|Thioguanine|thioguanine|mesh-list
101517458|NCT04043494|Pegaspargase|pegaspargase|mesh-list
101265118|NCT01771328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101265120|NCT01771406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101265121|NCT01771406|Vasodilator Agents|vasodilator agents|mesh-ancestor
101265122|NCT01771406|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101265123|NCT01771406|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101517459|NCT04043494|Vindesine|vindesine|mesh-list
101517460|NCT04043494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101517461|NCT04043494|Immunologic Factors|immunologic factors|mesh-ancestor
101517462|NCT04043494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517463|NCT04043494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101517464|NCT04043494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101517465|NCT04043494|Alkylating Agents|alkylating agents|mesh-ancestor
101517466|NCT04043494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517467|NCT04043494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101517468|NCT04043494|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101517469|NCT04043494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101517470|NCT04043494|Antiemetics|antiemetics|mesh-ancestor
101517471|NCT04043494|Autonomic Agents|autonomic agents|mesh-ancestor
101318891|NCT00018382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101517472|NCT04043494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101517473|NCT04043494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101517474|NCT04043494|Glucocorticoids|glucocorticoids|mesh-ancestor
101318911|NCT00001575|Chelating Agents|chelating agents|mesh-ancestor
101517476|NCT04043494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101517477|NCT04043494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101517478|NCT04043494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101517479|NCT04043494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101517480|NCT04043494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101517481|NCT04043494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101517482|NCT04043494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101517483|NCT04043494|Abortifacient Agents|abortifacient agents|mesh-ancestor
101517484|NCT04043494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101517485|NCT04043494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101517486|NCT04043494|Antimetabolites|antimetabolites|mesh-ancestor
101517487|NCT04043494|Dermatologic Agents|dermatologic agents|mesh-ancestor
101517488|NCT04043494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101517489|NCT04043494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101517490|NCT04043494|Antiviral Agents|antiviral agents|mesh-ancestor
101517491|NCT04043494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101517492|NCT04043494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101517493|NCT04043494|Tubulin Modulators|tubulin modulators|mesh-ancestor
101517494|NCT04043494|Antimitotic Agents|antimitotic agents|mesh-ancestor
101517495|NCT04043494|Mitosis Modulators|mitosis modulators|mesh-ancestor
101517497|NCT02899286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101517498|NCT04322422|Montelukast|montelukast|mesh-list
101318982|NCT00001656|Antiemetics|antiemetics|mesh-ancestor
101517499|NCT04322422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101517500|NCT04322422|Respiratory System Agents|respiratory system agents|mesh-ancestor
101517501|NCT04322422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101517502|NCT04322422|Hormone Antagonists|hormone antagonists|mesh-ancestor
101517503|NCT04322422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101517504|NCT04322422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517505|NCT04322422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101517506|NCT04322422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101517507|NCT04322422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517509|NCT02899169|Hydroxyurea|hydroxyurea|mesh-list
101517510|NCT02899169|Arsenic Trioxide|arsenic trioxide|mesh-list
101517511|NCT02899169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101517512|NCT02899169|Keratolytic Agents|keratolytic agents|mesh-ancestor
101517513|NCT02899169|Dermatologic Agents|dermatologic agents|mesh-ancestor
101517514|NCT02899169|Antisickling Agents|antisickling agents|mesh-ancestor
101517515|NCT02899169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101517516|NCT02899169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517517|NCT02899169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101517518|NCT00548964|Ketamine|ketamine|mesh-list
101517519|NCT00548964|Lithium Carbonate|lithium carbonate|mesh-list
101517520|NCT00548964|Analgesics|analgesics|mesh-ancestor
101319031|NCT05572723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101517521|NCT00548964|Sensory System Agents|sensory system agents|mesh-ancestor
101517522|NCT00548964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101517523|NCT00548964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517524|NCT00548964|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101517525|NCT00548964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101517526|NCT00548964|Anesthetics, General|anesthetics, general|mesh-ancestor
101517527|NCT00548964|Anesthetics|anesthetics|mesh-ancestor
101517528|NCT00548964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101517529|NCT00548964|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101265129|NCT01771432|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101517530|NCT00548964|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101517531|NCT00548964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101517532|NCT00548964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517533|NCT00548964|Antidepressive Agents|antidepressive agents|mesh-ancestor
101517534|NCT00548964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101517535|NCT00548964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101517537|NCT00548964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101517538|NCT02898779|Primaquine|primaquine|mesh-list
101517539|NCT02898779|Antimalarials|antimalarials|mesh-ancestor
101517540|NCT02898779|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101517541|NCT02898779|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101517542|NCT02898779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101517543|NCT00549120|Propranolol|propranolol|mesh-list
101517544|NCT00549120|Albuterol|albuterol|mesh-list
101517545|NCT00549120|Ipratropium|ipratropium|mesh-list
101517546|NCT00549120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101517547|NCT00549120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101517548|NCT00549120|Adrenergic Agents|adrenergic agents|mesh-ancestor
101517549|NCT00549120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101517550|NCT00549120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517551|NCT00549120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517552|NCT00549120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101517553|NCT00549120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101517554|NCT00549120|Vasodilator Agents|vasodilator agents|mesh-ancestor
101517555|NCT00549120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101517556|NCT00549120|Autonomic Agents|autonomic agents|mesh-ancestor
101517557|NCT00549120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101517558|NCT00549120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101517559|NCT00549120|Respiratory System Agents|respiratory system agents|mesh-ancestor
101517560|NCT00549120|Tocolytic Agents|tocolytic agents|mesh-ancestor
101517561|NCT00549120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101517562|NCT00549120|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101517563|NCT00549120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101517564|NCT00549120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101517565|NCT00549120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101517566|NCT00549120|Cholinergic Agents|cholinergic agents|mesh-ancestor
101517567|NCT04680884|Antifungal Agents|antifungal agents|mesh-list
101517568|NCT04680884|Clotrimazole|clotrimazole|mesh-list
101517569|NCT04680884|Miconazole|miconazole|mesh-list
101517570|NCT04680884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101517571|NCT04680884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101517572|NCT04680884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101517573|NCT04680884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101517574|NCT04680884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101319209|NCT04983901|Cefepime|cefepime|mesh-list
101517575|NCT04680884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517576|NCT04680884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101517577|NCT04680884|Hormone Antagonists|hormone antagonists|mesh-ancestor
101517578|NCT04680884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101517579|NCT04680884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517580|NCT04680884|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101517581|NCT04680884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101517582|NCT00535470|Mechlorethamine|mechlorethamine|mesh-list
101517583|NCT00535470|Alkylating Agents|alkylating agents|mesh-ancestor
101517584|NCT00535470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517585|NCT00535470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101517586|NCT00535470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101517587|NCT00535509|Cisplatin|cisplatin|mesh-list
101517588|NCT00535509|Docetaxel|docetaxel|mesh-list
101517589|NCT00535509|Trastuzumab|trastuzumab|mesh-list
101517590|NCT00535509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101517591|NCT00535509|Tubulin Modulators|tubulin modulators|mesh-ancestor
101517592|NCT00535509|Antimitotic Agents|antimitotic agents|mesh-ancestor
101517593|NCT00535509|Mitosis Modulators|mitosis modulators|mesh-ancestor
101517594|NCT00535509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517595|NCT00535509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101517596|NCT01262365|Epratuzumab|epratuzumab|mesh-list
101517597|NCT01262365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101517598|NCT01262365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101517599|NCT03244176|Avelumab|avelumab|mesh-list
101517600|NCT03244176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101517601|NCT03244176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101517602|NCT00535665|Vaccines|vaccines|mesh-list
101517603|NCT00535665|Immunologic Factors|immunologic factors|mesh-ancestor
101517604|NCT00535665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517605|NCT03971110|Goserelin|goserelin|mesh-list
101517606|NCT03971110|Bicalutamide|bicalutamide|mesh-list
101517607|NCT03971110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101517608|NCT03971110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101517609|NCT03971110|Androgen Antagonists|androgen antagonists|mesh-ancestor
101517610|NCT03971110|Hormone Antagonists|hormone antagonists|mesh-ancestor
101517611|NCT03971110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101517612|NCT03971110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517614|NCT01262287|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101517615|NCT01262287|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101517616|NCT01262287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101517617|NCT01262287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517618|NCT01262287|Hormone Antagonists|hormone antagonists|mesh-ancestor
101517619|NCT01262287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101517620|NCT01262287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517621|NCT01262092|Buprenorphine|buprenorphine|mesh-list
101517623|NCT01262092|Narcotics|narcotics|mesh-ancestor
101517624|NCT01262092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101517625|NCT01262092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517626|NCT01262092|Analgesics|analgesics|mesh-ancestor
101517627|NCT01262092|Sensory System Agents|sensory system agents|mesh-ancestor
101517628|NCT01262092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101517629|NCT01262092|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101517630|NCT03898180|Pembrolizumab|pembrolizumab|mesh-list
101517631|NCT03898180|Lenvatinib|lenvatinib|mesh-list
101517632|NCT03898180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101517633|NCT03898180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101517634|NCT03898180|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101517635|NCT03898180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517636|NCT03898180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101517637|NCT03898180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101517638|NCT04680962|Rituximab|rituximab|mesh-list
101517639|NCT04680962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101517640|NCT04680962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101517641|NCT04680962|Immunologic Factors|immunologic factors|mesh-ancestor
101517642|NCT04680962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517643|NCT04680962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101517644|NCT00549471|Botulinum Toxins|botulinum toxins|mesh-list
101517645|NCT00549471|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101517646|NCT00549471|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101517647|NCT00549471|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101517648|NCT00549471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101517649|NCT00549471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517650|NCT00549471|Cholinergic Agents|cholinergic agents|mesh-ancestor
101517651|NCT00549471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101517652|NCT00549471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517653|NCT00549471|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101517654|NCT00549471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101517655|NCT03088410|Zidovudine|zidovudine|mesh-list
101517656|NCT03088410|Nevirapine|nevirapine|mesh-list
101517657|NCT03088410|Antimetabolites|antimetabolites|mesh-ancestor
101517658|NCT03088410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517659|NCT03088410|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101517660|NCT03088410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101517661|NCT03088410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101517662|NCT03088410|Antiviral Agents|antiviral agents|mesh-ancestor
101517663|NCT03088410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101517664|NCT03088410|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101265136|NCT01771458|Sorafenib|sorafenib|mesh-list
101265137|NCT01771458|Letrozole|letrozole|mesh-list
101517665|NCT03088410|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101517666|NCT03088410|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101517667|NCT03088410|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101517669|NCT02897765|Poly ICLC|poly iclc|mesh-list
101517670|NCT02897765|Immunologic Factors|immunologic factors|mesh-ancestor
101517671|NCT02897765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517672|NCT02897765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101517673|NCT02897765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101517674|NCT02897765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101517675|NCT02897765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517676|NCT02897765|Interferon Inducers|interferon inducers|mesh-ancestor
101517677|NCT00549588|Sunscreening Agents|sunscreening agents|mesh-list
101517678|NCT00549588|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101517679|NCT00549588|Protective Agents|protective agents|mesh-ancestor
101517680|NCT00549588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517681|NCT00549588|Dermatologic Agents|dermatologic agents|mesh-ancestor
101517682|NCT04321642|Nitrous Oxide|nitrous oxide|mesh-list
101517683|NCT04321642|Entonox|entonox|mesh-list
101517684|NCT04321642|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
101517686|NCT04321642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101517687|NCT04321642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517688|NCT04321642|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101517689|NCT04321642|Anesthetics, General|anesthetics, general|mesh-ancestor
101517690|NCT04321642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101517691|NCT04321642|Analgesics|analgesics|mesh-ancestor
101517692|NCT04321642|Sensory System Agents|sensory system agents|mesh-ancestor
101517693|NCT04321642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101517694|NCT02897219|Ipragliflozin|ipragliflozin|mesh-list
101517695|NCT02897219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101517696|NCT02897219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517697|NCT02897219|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101517698|NCT02897219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517699|NCT04321720|Mechlorethamine|mechlorethamine|mesh-list
101517700|NCT04321720|Alkylating Agents|alkylating agents|mesh-ancestor
101517701|NCT04321720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319263|NCT00000102|Vasodilator Agents|vasodilator agents|mesh-ancestor
101517702|NCT04321720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101517703|NCT04321720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101517705|NCT04321837|Cholecalciferol|cholecalciferol|mesh-list
101517706|NCT04321837|Ibandronic Acid|ibandronic acid|mesh-list
101517707|NCT04321837|Vitamins|vitamins|mesh-ancestor
101517708|NCT04321837|Micronutrients|micronutrients|mesh-ancestor
101517709|NCT04321837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517710|NCT04321837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101517711|NCT04321837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101517712|NCT02896829|Imatinib Mesylate|imatinib mesylate|mesh-list
101517713|NCT02896829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101517714|NCT02896829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101517715|NCT02896829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101517716|NCT02896829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517717|NCT00549666|Moxifloxacin|moxifloxacin|mesh-list
101517718|NCT00549666|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
101517719|NCT00549666|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101517720|NCT00549666|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101517721|NCT00549666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101517722|NCT00549666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101517723|NCT00549666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517724|NCT00549666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101517725|NCT00549666|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101517726|NCT00549666|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101517727|NCT00549666|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101517728|NCT00549666|Adrenergic Agents|adrenergic agents|mesh-ancestor
101517729|NCT00549666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101517730|NCT00549666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517731|NCT00549666|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101265145|NCT01771458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101517732|NCT00549666|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101517733|NCT00549666|Serotonin Agents|serotonin agents|mesh-ancestor
101517734|NCT00549666|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101517735|NCT00549666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101517736|NCT00549666|Dopamine Agents|dopamine agents|mesh-ancestor
101517737|NCT00549666|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101517738|NCT00549666|Contraceptive Agents|contraceptive agents|mesh-ancestor
101517739|NCT00549666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101517740|NCT00549666|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101517741|NCT00549666|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101517742|NCT00549666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101517743|NCT00549666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101517744|NCT00549666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101517745|NCT00549666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101517746|NCT00549666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101517747|NCT00549666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101517748|NCT00549666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101517749|NCT04680923|Bupivacaine|bupivacaine|mesh-list
101517750|NCT04680923|Anesthetics, Local|anesthetics, local|mesh-ancestor
101517751|NCT04680923|Anesthetics|anesthetics|mesh-ancestor
101517752|NCT04680923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101517753|NCT04680923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517754|NCT04680923|Sensory System Agents|sensory system agents|mesh-ancestor
101517755|NCT04680923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101517756|NCT00551538|Insulin Glargine|insulin glargine|mesh-list
101517757|NCT00551538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101517758|NCT00551538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517759|NCT03694522|Bemarituzumab|bemarituzumab|mesh-list
101517760|NCT03694522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101517761|NCT03694522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101517762|NCT04891419|Lidocaine|lidocaine|mesh-list
101517763|NCT04891419|Anesthetics, Local|anesthetics, local|mesh-ancestor
101517764|NCT04891419|Anesthetics|anesthetics|mesh-ancestor
101517765|NCT04891419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101517766|NCT04891419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517767|NCT04891419|Sensory System Agents|sensory system agents|mesh-ancestor
101517768|NCT04891419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101517769|NCT04891419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101517770|NCT04891419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101517771|NCT04891419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101517772|NCT04891419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101517773|NCT04891419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517774|NCT00551577|Carboplatin|carboplatin|mesh-list
101517775|NCT00551577|Docetaxel|docetaxel|mesh-list
101517776|NCT00551577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101517777|NCT00551577|Tubulin Modulators|tubulin modulators|mesh-ancestor
101517778|NCT00551577|Antimitotic Agents|antimitotic agents|mesh-ancestor
101517779|NCT00551577|Mitosis Modulators|mitosis modulators|mesh-ancestor
101517780|NCT00551577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517781|NCT04207723|Paroxetine|paroxetine|mesh-list
101517782|NCT04207723|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101517783|NCT04207723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101517784|NCT04207723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101517785|NCT04207723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517786|NCT04207723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101517787|NCT04207723|Serotonin Agents|serotonin agents|mesh-ancestor
101517788|NCT04207723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517789|NCT04207723|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101517790|NCT04207723|Antidepressive Agents|antidepressive agents|mesh-ancestor
101517791|NCT04207723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101517792|NCT04207723|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101517793|NCT04207723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101517794|NCT04207723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101517795|NCT04321096|Camostat|camostat|mesh-list
101517796|NCT04321096|Protease Inhibitors|protease inhibitors|mesh-ancestor
101517797|NCT04321096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101517798|NCT04321096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517799|NCT04321096|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101265150|NCT01771458|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101517800|NCT04321096|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101517802|NCT03556696|Propofol|propofol|mesh-list
101517803|NCT03556696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101517804|NCT03556696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101517805|NCT03556696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517806|NCT03556696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101517807|NCT03556696|Anesthetics, General|anesthetics, general|mesh-ancestor
101517808|NCT03556696|Anesthetics|anesthetics|mesh-ancestor
101517809|NCT03556696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101517810|NCT03556696|Narcotics|narcotics|mesh-ancestor
101517811|NCT03556696|Analgesics|analgesics|mesh-ancestor
101517812|NCT03556696|Sensory System Agents|sensory system agents|mesh-ancestor
101517813|NCT03556696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101517814|NCT04320706|Oxytocin|oxytocin|mesh-list
101517815|NCT04320706|Oxytocics|oxytocics|mesh-ancestor
101517816|NCT04320706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101517817|NCT04320706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517818|NCT03482479|Naltrexone|naltrexone|mesh-list
101517820|NCT03482479|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101517821|NCT03482479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517822|NCT03482479|Sensory System Agents|sensory system agents|mesh-ancestor
101517823|NCT03482479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101517825|NCT00553709|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101517826|NCT00553709|Autonomic Agents|autonomic agents|mesh-ancestor
101517827|NCT00553709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101517828|NCT00553709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517829|NCT00553709|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101517830|NCT00553709|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101517831|NCT00553709|Cholinergic Agents|cholinergic agents|mesh-ancestor
101517832|NCT00553709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101517833|NCT00553709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517834|NCT00551733|Paclitaxel|paclitaxel|mesh-list
101517835|NCT00551733|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101517836|NCT00551733|Carboplatin|carboplatin|mesh-list
101517837|NCT00551733|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
101517838|NCT00551733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101517839|NCT00551733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101517840|NCT00551733|Tubulin Modulators|tubulin modulators|mesh-ancestor
101517841|NCT00551733|Antimitotic Agents|antimitotic agents|mesh-ancestor
101319273|NCT05641506|Niraparib|niraparib|mesh-list
101517842|NCT00551733|Mitosis Modulators|mitosis modulators|mesh-ancestor
101517843|NCT00551733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517844|NCT02896205|Mycophenolic Acid|mycophenolic acid|mesh-list
101517845|NCT02896205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101517846|NCT02896205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101517847|NCT02896205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101517848|NCT02896205|Antitubercular Agents|antitubercular agents|mesh-ancestor
101517849|NCT02896205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101517850|NCT02896205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101517851|NCT02896205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101517852|NCT02896205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517853|NCT04922424|Atorvastatin|atorvastatin|mesh-list
101517854|NCT04922424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101517855|NCT04922424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101517856|NCT04922424|Antimetabolites|antimetabolites|mesh-ancestor
101517857|NCT04922424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517858|NCT04922424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101517859|NCT04922424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101517860|NCT04922424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101517861|NCT00553748|Alovudine|alovudine|mesh-list
101517862|NCT00553748|Antiviral Agents|antiviral agents|mesh-ancestor
101517863|NCT00553748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101517864|NCT00551850|MP 412|mp 412|mesh-list
101517865|NCT00551850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101517866|NCT00551850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101517867|NCT00551850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101517868|NCT00551850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517869|NCT00550095|Valsartan|valsartan|mesh-list
101517870|NCT00550095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101517871|NCT00550095|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101517872|NCT00550095|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101517873|NCT00550095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517875|NCT00551889|Cyclophosphamide|cyclophosphamide|mesh-list
101517876|NCT00551889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101517878|NCT00551889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517879|NCT00551889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101517880|NCT00551889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101517881|NCT00551889|Alkylating Agents|alkylating agents|mesh-ancestor
101517882|NCT00551889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517883|NCT00551889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101517884|NCT00551889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101517885|NCT00551889|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101517886|NCT00551889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101517887|NCT00551889|Analgesics|analgesics|mesh-ancestor
101517888|NCT00551889|Sensory System Agents|sensory system agents|mesh-ancestor
101517889|NCT00551889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101517890|NCT00551889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101517891|NCT00551889|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101517892|NCT00551889|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101517893|NCT00551889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101517895|NCT03455764|Dabrafenib|dabrafenib|mesh-list
101517896|NCT03455764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101517897|NCT03455764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101517898|NCT03455764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101517899|NCT03455764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517900|NCT04902495|Pemetrexed|pemetrexed|mesh-list
101517901|NCT04902495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101517902|NCT04902495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101517903|NCT04902495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517904|NCT04902495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101517905|NCT04902495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101517906|NCT03433183|Sirolimus|sirolimus|mesh-list
101517907|NCT03433183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101517908|NCT03433183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101517909|NCT03433183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101517910|NCT03433183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101517911|NCT03433183|Antifungal Agents|antifungal agents|mesh-ancestor
101517912|NCT03433183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101517913|NCT03433183|Immunologic Factors|immunologic factors|mesh-ancestor
101517914|NCT03433183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517915|NCT02895659|Norepinephrine|norepinephrine|mesh-list
101517916|NCT02895659|Epinephrine|epinephrine|mesh-list
101517917|NCT02895659|Racepinephrine|racepinephrine|mesh-list
101517918|NCT02895659|Epinephryl borate|epinephryl borate|mesh-list
101517919|NCT02895659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101517920|NCT02895659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101517921|NCT02895659|Adrenergic Agents|adrenergic agents|mesh-ancestor
101517922|NCT02895659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101517923|NCT02895659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517924|NCT02895659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517925|NCT02895659|Sympathomimetics|sympathomimetics|mesh-ancestor
101517926|NCT02895659|Autonomic Agents|autonomic agents|mesh-ancestor
101517927|NCT02895659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101517928|NCT02895659|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101517929|NCT02895659|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101517930|NCT02895659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101517931|NCT02895659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101517932|NCT02895659|Respiratory System Agents|respiratory system agents|mesh-ancestor
101517933|NCT02895659|Mydriatics|mydriatics|mesh-ancestor
101517934|NCT00552201|Tacrolimus|tacrolimus|mesh-list
101517935|NCT00552201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101517936|NCT00552201|Immunologic Factors|immunologic factors|mesh-ancestor
101517937|NCT00552201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517938|NCT00552201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101517939|NCT00552201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101265156|NCT01771458|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101517940|NCT00552201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517941|NCT03391882|Apomorphine|apomorphine|mesh-list
101517942|NCT03391882|Emetics|emetics|mesh-ancestor
101517943|NCT03391882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517944|NCT03391882|Autonomic Agents|autonomic agents|mesh-ancestor
101517945|NCT03391882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101517946|NCT03391882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101517947|NCT03391882|Dopamine Agonists|dopamine agonists|mesh-ancestor
101517948|NCT03391882|Dopamine Agents|dopamine agents|mesh-ancestor
101517949|NCT03391882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101517950|NCT03391882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517951|NCT00550329|Glipizide|glipizide|mesh-list
101517952|NCT00550329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101517953|NCT00550329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517954|NCT00550485|Escitalopram|escitalopram|mesh-list
101517955|NCT00550485|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101517956|NCT00550485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101517957|NCT00550485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101517958|NCT00550485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517959|NCT00550485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101517960|NCT00550485|Serotonin Agents|serotonin agents|mesh-ancestor
101517961|NCT00550485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517962|NCT00550563|Cholecalciferol|cholecalciferol|mesh-list
101517964|NCT00550563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101517965|NCT00550563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517966|NCT00550563|Vitamins|vitamins|mesh-ancestor
101517967|NCT00550563|Micronutrients|micronutrients|mesh-ancestor
101517968|NCT00550563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101517969|NCT02895191|Urinastatin|urinastatin|mesh-list
101517970|NCT02895191|Trypsin Inhibitors|trypsin inhibitors|mesh-list
101517971|NCT02895191|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101517972|NCT02895191|Protease Inhibitors|protease inhibitors|mesh-ancestor
101517973|NCT02895191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101517974|NCT02895191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517975|NCT04680650|Anesthetics|anesthetics|mesh-list
101517976|NCT04680650|Propofol|propofol|mesh-list
101517977|NCT04680650|Sevoflurane|sevoflurane|mesh-list
101517978|NCT04680650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101517979|NCT04680650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517980|NCT04680650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101517981|NCT04680650|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101517982|NCT04680650|Anesthetics, General|anesthetics, general|mesh-ancestor
101319277|NCT05641506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101517983|NCT04680650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101517984|NCT04680650|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101517986|NCT02895113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101517987|NCT02895113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101517988|NCT02895113|Analgesics|analgesics|mesh-ancestor
101517989|NCT02895113|Sensory System Agents|sensory system agents|mesh-ancestor
101517990|NCT02895113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101517991|NCT02895113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101517992|NCT02895113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101517993|NCT02895113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101517994|NCT02895113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101265167|NCT01771783|Protease Inhibitors|protease inhibitors|mesh-ancestor
101517995|NCT02895113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101517996|NCT02895113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101517997|NCT02895113|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101517998|NCT02895113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101517999|NCT02895113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101518000|NCT02895113|Antipyretics|antipyretics|mesh-ancestor
101518001|NCT00552630|Penicillamine|penicillamine|mesh-list
101518002|NCT00552630|Antidotes|antidotes|mesh-ancestor
101518003|NCT00552630|Protective Agents|protective agents|mesh-ancestor
101518005|NCT00552630|Chelating Agents|chelating agents|mesh-ancestor
101518006|NCT00552630|Sequestering Agents|sequestering agents|mesh-ancestor
101518007|NCT00552630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518008|NCT00552630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101518009|NCT02894957|Varenicline|varenicline|mesh-list
101518010|NCT02894957|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101518011|NCT02894957|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101518012|NCT02894957|Cholinergic Agents|cholinergic agents|mesh-ancestor
101518013|NCT02894957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101518014|NCT02894957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518015|NCT02894957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518016|NCT00550992|Leucovorin|leucovorin|mesh-list
101518017|NCT00550992|Cytarabine|cytarabine|mesh-list
101518018|NCT00550992|Cyclosporine|cyclosporine|mesh-list
101518019|NCT00550992|Prednisone|prednisone|mesh-list
101518020|NCT00550992|Prednisolone|prednisolone|mesh-list
101518021|NCT00550992|Hydrocortisone|hydrocortisone|mesh-list
101518022|NCT00550992|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101518023|NCT00550992|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101518024|NCT00550992|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101518025|NCT00550992|Cyclophosphamide|cyclophosphamide|mesh-list
101518026|NCT00550992|Melphalan|melphalan|mesh-list
101518027|NCT00550992|Busulfan|busulfan|mesh-list
101518028|NCT00550992|Methotrexate|methotrexate|mesh-list
101518029|NCT00550992|Etoposide|etoposide|mesh-list
101518030|NCT00550992|Vincristine|vincristine|mesh-list
101518031|NCT00550992|Daunorubicin|daunorubicin|mesh-list
101265234|NCT01772290|Itraconazole|itraconazole|mesh-list
101518032|NCT00550992|Asparaginase|asparaginase|mesh-list
101518033|NCT00550992|Mitoxantrone|mitoxantrone|mesh-list
101518034|NCT00550992|Mercaptopurine|mercaptopurine|mesh-list
101265235|NCT01772290|Fluconazole|fluconazole|mesh-list
101518035|NCT00550992|Pegaspargase|pegaspargase|mesh-list
101518036|NCT00550992|Thioguanine|thioguanine|mesh-list
101518037|NCT00550992|Cyclosporins|cyclosporins|mesh-list
101518038|NCT00550992|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101518039|NCT00550992|Levoleucovorin|levoleucovorin|mesh-list
101518040|NCT00550992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101518041|NCT00550992|Immunologic Factors|immunologic factors|mesh-ancestor
101518042|NCT00550992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518043|NCT00550992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101518044|NCT00550992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101518045|NCT00550992|Alkylating Agents|alkylating agents|mesh-ancestor
101518046|NCT00550992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518047|NCT00550992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101518048|NCT00550992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101518049|NCT00550992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101518050|NCT00550992|Glucocorticoids|glucocorticoids|mesh-ancestor
101518051|NCT00550992|Hormones|hormones|mesh-ancestor
101518052|NCT00550992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101518053|NCT00550992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101518054|NCT00550992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101518055|NCT00550992|Abortifacient Agents|abortifacient agents|mesh-ancestor
101518056|NCT00550992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101518057|NCT00550992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101518058|NCT00550992|Antimetabolites|antimetabolites|mesh-ancestor
101518059|NCT00550992|Dermatologic Agents|dermatologic agents|mesh-ancestor
101518060|NCT00550992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101518061|NCT00550992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101518062|NCT00550992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101518063|NCT00550992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101265341|NCT01773005|Acetaminophen|acetaminophen|mesh-list
101265342|NCT01773005|Ibuprofen|ibuprofen|mesh-list
101518064|NCT00550992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101518065|NCT00550992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101518067|NCT00550992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101518069|NCT00550992|Protective Agents|protective agents|mesh-ancestor
101518070|NCT00550992|Vitamin B Complex|vitamin b complex|mesh-ancestor
101518071|NCT00550992|Vitamins|vitamins|mesh-ancestor
101518072|NCT00550992|Micronutrients|micronutrients|mesh-ancestor
101518073|NCT00550992|Tubulin Modulators|tubulin modulators|mesh-ancestor
101518074|NCT00550992|Antimitotic Agents|antimitotic agents|mesh-ancestor
101518075|NCT00550992|Mitosis Modulators|mitosis modulators|mesh-ancestor
101518076|NCT00550992|Antifungal Agents|antifungal agents|mesh-ancestor
101518077|NCT00550992|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101308918|NCT00005979|Vitamins|vitamins|mesh-ancestor
101308920|NCT00005985|Cytarabine|cytarabine|mesh-list
101308923|NCT00005985|Carmustine|carmustine|mesh-list
101518078|NCT00550992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101518079|NCT00550992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101518081|NCT00550992|Sensory System Agents|sensory system agents|mesh-ancestor
101518082|NCT02895074|Proxymetacaine|proxymetacaine|mesh-list
101518083|NCT02895074|Tropicamide|tropicamide|mesh-list
101518084|NCT02895074|Mydriatics|mydriatics|mesh-ancestor
101518085|NCT02895074|Autonomic Agents|autonomic agents|mesh-ancestor
101518086|NCT02895074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101518087|NCT02895074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518088|NCT02895074|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101518089|NCT02895074|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101518090|NCT02895074|Cholinergic Agents|cholinergic agents|mesh-ancestor
101518091|NCT02895074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101518092|NCT02895074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518093|NCT02895074|Anesthetics, Local|anesthetics, local|mesh-ancestor
101308983|NCT00005988|Micronutrients|micronutrients|mesh-ancestor
101308984|NCT00005988|Antifungal Agents|antifungal agents|mesh-ancestor
101308986|NCT00005988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101308987|NCT00005988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101308988|NCT00005988|Antiemetics|antiemetics|mesh-ancestor
101518094|NCT02895074|Anesthetics|anesthetics|mesh-ancestor
101518095|NCT02895074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101518096|NCT02895074|Sensory System Agents|sensory system agents|mesh-ancestor
101518097|NCT02894918|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101518098|NCT02894918|Antiviral Agents|antiviral agents|mesh-ancestor
101518099|NCT02894918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101518100|NCT00551109|SA 4503|sa 4503|mesh-list
101518101|NCT00551109|Nootropic Agents|nootropic agents|mesh-ancestor
101518102|NCT00551265|Cyclophosphamide|cyclophosphamide|mesh-list
101518103|NCT00551265|Oregovomab|oregovomab|mesh-list
101518104|NCT00551265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101518105|NCT00551265|Antibodies|antibodies|mesh-list
101518106|NCT00551265|Immunoglobulins|immunoglobulins|mesh-list
101518107|NCT00551265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101518108|NCT00551265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101518109|NCT00551265|Immunologic Factors|immunologic factors|mesh-ancestor
101518110|NCT00551265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309043|NCT00006006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309044|NCT00006006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101309045|NCT00006006|Leprostatic Agents|leprostatic agents|mesh-ancestor
101309046|NCT00006006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101518111|NCT00551265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101518112|NCT00551265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101518113|NCT00551265|Alkylating Agents|alkylating agents|mesh-ancestor
101518114|NCT00551265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518115|NCT00551265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101518116|NCT00551265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101518118|NCT02894606|Basiliximab|basiliximab|mesh-list
101518119|NCT02894606|Immunologic Factors|immunologic factors|mesh-ancestor
101518120|NCT02894606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518121|NCT02894606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101518122|NCT00551343|Exenatide|exenatide|mesh-list
101518123|NCT00551343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101518124|NCT00551343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518125|NCT00551343|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101309102|NCT00006021|Protective Agents|protective agents|mesh-ancestor
101309103|NCT00006021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309104|NCT00006021|Vitamins|vitamins|mesh-ancestor
101518126|NCT00551343|Incretins|incretins|mesh-ancestor
101518127|NCT00551343|Hormones|hormones|mesh-ancestor
101518128|NCT00551343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101518129|NCT00551382|Montelukast|montelukast|mesh-list
101518130|NCT00551382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101518131|NCT00551382|Respiratory System Agents|respiratory system agents|mesh-ancestor
101518132|NCT00551382|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101518133|NCT00551382|Hormone Antagonists|hormone antagonists|mesh-ancestor
101518134|NCT00551382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101518135|NCT00551382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518136|NCT00551382|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101518137|NCT00551382|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101518138|NCT00551382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518139|NCT02894684|Aztreonam|aztreonam|mesh-list
101518140|NCT02894684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101518141|NCT02894684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101518142|NCT02894645|Cytarabine|cytarabine|mesh-list
101518143|NCT02894645|Dexamethasone|dexamethasone|mesh-list
101518144|NCT02894645|Prednisolone|prednisolone|mesh-list
101518145|NCT02894645|Cyclophosphamide|cyclophosphamide|mesh-list
101518146|NCT02894645|Doxorubicin|doxorubicin|mesh-list
101518147|NCT02894645|Methotrexate|methotrexate|mesh-list
101518148|NCT02894645|Fludarabine|fludarabine|mesh-list
101518149|NCT02894645|Vincristine|vincristine|mesh-list
101518150|NCT02894645|Daunorubicin|daunorubicin|mesh-list
101518151|NCT02894645|Asparaginase|asparaginase|mesh-list
101518152|NCT02894645|Mercaptopurine|mercaptopurine|mesh-list
101518153|NCT02894645|Thioguanine|thioguanine|mesh-list
101518154|NCT02894645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101518155|NCT02894645|Immunologic Factors|immunologic factors|mesh-ancestor
101518156|NCT02894645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518157|NCT02894645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101518158|NCT02894645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101518159|NCT02894645|Alkylating Agents|alkylating agents|mesh-ancestor
101518160|NCT02894645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518161|NCT02894645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101518162|NCT02894645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101518163|NCT02894645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101518164|NCT02894645|Antiemetics|antiemetics|mesh-ancestor
101518165|NCT02894645|Autonomic Agents|autonomic agents|mesh-ancestor
101518166|NCT02894645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101518167|NCT02894645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101518168|NCT02894645|Glucocorticoids|glucocorticoids|mesh-ancestor
101518169|NCT02894645|Hormones|hormones|mesh-ancestor
101518170|NCT02894645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101518171|NCT02894645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101518172|NCT02894645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101518173|NCT02894645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101518174|NCT02894645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101518175|NCT02894645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101518176|NCT02894645|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101518177|NCT02894645|Abortifacient Agents|abortifacient agents|mesh-ancestor
101518178|NCT02894645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101518179|NCT02894645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101518180|NCT02894645|Antimetabolites|antimetabolites|mesh-ancestor
101518181|NCT02894645|Dermatologic Agents|dermatologic agents|mesh-ancestor
101518182|NCT02894645|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101518183|NCT02894645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101518184|NCT02894645|Antiviral Agents|antiviral agents|mesh-ancestor
101518185|NCT02894645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101518186|NCT02894645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101518187|NCT02894645|Tubulin Modulators|tubulin modulators|mesh-ancestor
101518188|NCT02894645|Antimitotic Agents|antimitotic agents|mesh-ancestor
101518189|NCT02894645|Mitosis Modulators|mitosis modulators|mesh-ancestor
101309225|NCT00386802|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101518191|NCT00552747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101518192|NCT00552747|Antimetabolites|antimetabolites|mesh-ancestor
101518193|NCT00552747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518194|NCT00552747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101518195|NCT05427617|Fulvestrant|fulvestrant|mesh-list
101518196|NCT05427617|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
101518197|NCT05427617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101518198|NCT05427617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101518199|NCT05427617|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101518200|NCT05427617|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101518201|NCT05427617|Hormone Antagonists|hormone antagonists|mesh-ancestor
101518202|NCT05427617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101518203|NCT05427617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518204|NCT05427617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101518205|NCT05427617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518206|NCT05427500|Bupivacaine|bupivacaine|mesh-list
101518207|NCT05427500|Anesthetics, Local|anesthetics, local|mesh-ancestor
101518208|NCT05427500|Anesthetics|anesthetics|mesh-ancestor
101518209|NCT05427500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101518210|NCT05427500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518211|NCT05427500|Sensory System Agents|sensory system agents|mesh-ancestor
101518212|NCT05427500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101518213|NCT05427383|Paclitaxel|paclitaxel|mesh-list
101518214|NCT05427383|Docetaxel|docetaxel|mesh-list
101518215|NCT05427383|Irinotecan|irinotecan|mesh-list
101518216|NCT05427383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101518217|NCT05427383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101518218|NCT05427383|Tubulin Modulators|tubulin modulators|mesh-ancestor
101518219|NCT05427383|Antimitotic Agents|antimitotic agents|mesh-ancestor
101518220|NCT05427383|Mitosis Modulators|mitosis modulators|mesh-ancestor
101518221|NCT05427383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518222|NCT05427383|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101518223|NCT05427383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101518224|NCT05427383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101518225|NCT05427305|Bevacizumab|bevacizumab|mesh-list
101518226|NCT05427305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101518227|NCT05427305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101518228|NCT05427305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101518229|NCT05427305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101411129|NCT00449527|Hormones|hormones|mesh-ancestor
101518230|NCT05427305|Growth Substances|growth substances|mesh-ancestor
101518231|NCT05427305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518232|NCT05427305|Growth Inhibitors|growth inhibitors|mesh-ancestor
101518233|NCT01099449|Oxaliplatin|oxaliplatin|mesh-list
101518234|NCT01099449|Magnesium Sulfate|magnesium sulfate|mesh-list
101518235|NCT01099449|Calcium|calcium|mesh-list
101518236|NCT01099449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101518237|NCT01099449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518238|NCT01099449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101518239|NCT01099449|Analgesics|analgesics|mesh-ancestor
101518240|NCT01099449|Sensory System Agents|sensory system agents|mesh-ancestor
101518241|NCT01099449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101518242|NCT01099449|Anesthetics|anesthetics|mesh-ancestor
101518243|NCT01099449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101518244|NCT01099449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101518245|NCT01099449|Anticonvulsants|anticonvulsants|mesh-ancestor
101518246|NCT01099449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101518247|NCT01099449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101518248|NCT01099449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309247|NCT05679453|Analgesics|analgesics|mesh-ancestor
101309248|NCT05679453|Sensory System Agents|sensory system agents|mesh-ancestor
101309257|NCT05679375|Ketamine|ketamine|mesh-list
101518249|NCT01099449|Tocolytic Agents|tocolytic agents|mesh-ancestor
101518250|NCT01099449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101518251|NCT04680143|Epoetin Alfa|epoetin alfa|mesh-list
101518252|NCT04680143|Hematinics|hematinics|mesh-ancestor
101518253|NCT05426798|Azacitidine|azacitidine|mesh-list
101518254|NCT05426798|Decitabine|decitabine|mesh-list
101518255|NCT05426798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101518256|NCT05426798|Antimetabolites|antimetabolites|mesh-ancestor
101518257|NCT05426798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518258|NCT05426798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101518259|NCT05426798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101518260|NCT01234402|Capecitabine|capecitabine|mesh-list
101518261|NCT01234402|Ramucirumab|ramucirumab|mesh-list
101518262|NCT01234402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101518263|NCT01234402|Antimetabolites|antimetabolites|mesh-ancestor
101518264|NCT01234402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518265|NCT01234402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101518267|NCT01260922|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101518268|NCT01260922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101309260|NCT05679375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101328624|NCT00023842|Mitomycins|mitomycins|mesh-list
101518269|NCT01260922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518271|NCT01260922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101518272|NCT01260922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518273|NCT01260922|Nootropic Agents|nootropic agents|mesh-ancestor
101518275|NCT01212094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101518276|NCT01212094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101518277|NCT01212094|Immunologic Factors|immunologic factors|mesh-ancestor
101518278|NCT01212094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518279|NCT01212094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101518280|NCT04369794|BCG Vaccine|bcg vaccine|mesh-list
101518281|NCT04369794|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101518282|NCT04369794|Immunologic Factors|immunologic factors|mesh-ancestor
101518283|NCT04369794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518284|NCT05409885|Anesthetics|anesthetics|mesh-list
101518285|NCT05409885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101518286|NCT05409885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518287|NCT00552864|Ropivacaine|ropivacaine|mesh-list
101518288|NCT00552864|Levobupivacaine|levobupivacaine|mesh-list
101518289|NCT00552864|Anesthetics, Local|anesthetics, local|mesh-ancestor
101518290|NCT00552864|Anesthetics|anesthetics|mesh-ancestor
101518291|NCT00552864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101518292|NCT00552864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518293|NCT00552864|Sensory System Agents|sensory system agents|mesh-ancestor
101518294|NCT00552864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101518295|NCT01211665|Methylprednisolone|methylprednisolone|mesh-list
101518296|NCT01211665|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101518297|NCT01211665|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101518298|NCT01211665|Prednisolone|prednisolone|mesh-list
101518299|NCT01211665|Prednisolone acetate|prednisolone acetate|mesh-list
101518300|NCT01211665|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101518301|NCT01211665|Prednisolone phosphate|prednisolone phosphate|mesh-list
101518302|NCT01211665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101518303|NCT01211665|Antiemetics|antiemetics|mesh-ancestor
101518304|NCT01211665|Autonomic Agents|autonomic agents|mesh-ancestor
101518305|NCT01211665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101518306|NCT01211665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518307|NCT01211665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101518308|NCT01211665|Glucocorticoids|glucocorticoids|mesh-ancestor
101518309|NCT01211665|Hormones|hormones|mesh-ancestor
101518310|NCT01211665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101518311|NCT01211665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101518312|NCT01211665|Protective Agents|protective agents|mesh-ancestor
101518313|NCT01211665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101518314|NCT01211665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101518315|NCT04401176|Lidocaine|lidocaine|mesh-list
101518316|NCT04401176|Heparin|heparin|mesh-list
101309314|NCT00386958|Povidone|povidone|mesh-list
101518317|NCT04401176|Anesthetics, Local|anesthetics, local|mesh-ancestor
101518318|NCT04401176|Anesthetics|anesthetics|mesh-ancestor
101518319|NCT04401176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101518320|NCT04401176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518321|NCT04401176|Sensory System Agents|sensory system agents|mesh-ancestor
101518322|NCT04401176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101518323|NCT04401176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101518324|NCT04401176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101518325|NCT04401176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101518326|NCT04401176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101518327|NCT04401176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518328|NCT04401176|Anticoagulants|anticoagulants|mesh-ancestor
101518329|NCT04401176|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101518330|NCT04401176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101518331|NCT01232491|Insulin Detemir|insulin detemir|mesh-list
101518332|NCT01232491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101518333|NCT01232491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202017|NCT01407237|Angiotensinogen|angiotensinogen|mesh-list
101518335|NCT04335305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101518336|NCT04335305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101518337|NCT04335305|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101518348|NCT04152980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101518349|NCT04152980|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101518350|NCT04152980|Protective Agents|protective agents|mesh-ancestor
101518351|NCT04152980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518352|NCT04152980|Vasodilator Agents|vasodilator agents|mesh-ancestor
101518353|NCT04152980|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101518354|NCT04152980|Antioxidants|antioxidants|mesh-ancestor
101518355|NCT01232452|Pemetrexed|pemetrexed|mesh-list
101518356|NCT01232452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101518357|NCT01232452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101518358|NCT01232452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518359|NCT01232452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101309342|NCT00387309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101309344|NCT04921722|Temsirolimus|temsirolimus|mesh-list
101309345|NCT04921722|MTOR Inhibitors|mtor inhibitors|mesh-list
101309350|NCT04921722|Antifungal Agents|antifungal agents|mesh-ancestor
101518360|NCT01232452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101518361|NCT01211197|Metformin|metformin|mesh-list
101518362|NCT01211197|Empagliflozin|empagliflozin|mesh-list
101518363|NCT01211197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101518364|NCT01211197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518365|NCT01211197|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101518366|NCT01211197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518367|NCT00553137|Fluconazole|fluconazole|mesh-list
101518368|NCT00553137|Antifungal Agents|antifungal agents|mesh-ancestor
101518369|NCT00553137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101518370|NCT00553137|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101518371|NCT00553137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101518372|NCT00553137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101518373|NCT00553137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518374|NCT00553137|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101518375|NCT00553137|Hormone Antagonists|hormone antagonists|mesh-ancestor
101518376|NCT00553137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101518377|NCT00553137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518378|NCT00553137|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101518379|NCT00553137|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101518380|NCT04090775|Cyclophosphamide|cyclophosphamide|mesh-list
101518381|NCT04090775|Nivolumab|nivolumab|mesh-list
101518382|NCT04090775|Ipilimumab|ipilimumab|mesh-list
101518383|NCT04090775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101518384|NCT04090775|Immunologic Factors|immunologic factors|mesh-ancestor
101518385|NCT04090775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518386|NCT04090775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101518387|NCT04090775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101518388|NCT04090775|Alkylating Agents|alkylating agents|mesh-ancestor
101518389|NCT04090775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518390|NCT04090775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101518391|NCT04090775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101518392|NCT04090775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101518393|NCT04090775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101518394|NCT01232296|Sorafenib|sorafenib|mesh-list
101518395|NCT01232296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101518396|NCT01232296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101518397|NCT01232296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101518398|NCT01232296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518399|NCT04041011|Fluzoparib|fluzoparib|mesh-list
101518400|NCT04041011|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101518401|NCT04041011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101319307|NCT05495204|Ibalizumab|ibalizumab|mesh-list
101518402|NCT04041011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518403|NCT04041011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101518404|NCT00554138|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101518405|NCT00554138|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101518406|NCT00554138|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101518407|NCT00554138|Antimetabolites|antimetabolites|mesh-ancestor
101309381|NCT03834909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101518408|NCT00554138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518409|NCT00554138|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101518410|NCT00554138|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101518411|NCT00554138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101518412|NCT01231555|Efavirenz|efavirenz|mesh-list
101518413|NCT01231555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101518414|NCT01231555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101518415|NCT01231555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101518416|NCT01231555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518417|NCT01231555|Antiviral Agents|antiviral agents|mesh-ancestor
101518418|NCT01231555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101518419|NCT01231555|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101518420|NCT01231555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101518421|NCT01231555|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101518422|NCT01231555|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101518423|NCT01231555|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101518424|NCT01231555|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101518425|NCT04116528|Ketamine|ketamine|mesh-list
101518426|NCT04116528|Buprenorphine|buprenorphine|mesh-list
101518427|NCT04116528|Analgesics|analgesics|mesh-ancestor
101518428|NCT04116528|Sensory System Agents|sensory system agents|mesh-ancestor
101518429|NCT04116528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101518430|NCT04116528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518431|NCT04116528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101518432|NCT04116528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101518433|NCT04116528|Anesthetics, General|anesthetics, general|mesh-ancestor
101518434|NCT04116528|Anesthetics|anesthetics|mesh-ancestor
101518435|NCT04116528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101518436|NCT04116528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101518437|NCT04116528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101518438|NCT04116528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101309404|NCT04360473|Anticonvulsants|anticonvulsants|mesh-ancestor
101309405|NCT04360473|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101518439|NCT04116528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518440|NCT04116528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101518441|NCT04116528|Narcotics|narcotics|mesh-ancestor
101518442|NCT04116528|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101518443|NCT05288907|Lidocaine|lidocaine|mesh-list
101518444|NCT05288907|Anesthetics, Local|anesthetics, local|mesh-ancestor
101518445|NCT05288907|Anesthetics|anesthetics|mesh-ancestor
101518446|NCT05288907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101518447|NCT05288907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518448|NCT05288907|Sensory System Agents|sensory system agents|mesh-ancestor
101518449|NCT05288907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101518450|NCT05288907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101518451|NCT05288907|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101518452|NCT05288907|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101518453|NCT05288907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101518454|NCT05288907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518455|NCT03911336|Acetaminophen|acetaminophen|mesh-list
101518456|NCT03911336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101518457|NCT03911336|Ketoprofen|ketoprofen|mesh-list
101518459|NCT03911336|Analgesics|analgesics|mesh-ancestor
101518460|NCT03911336|Sensory System Agents|sensory system agents|mesh-ancestor
101518461|NCT03911336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101309445|NCT03869736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101309446|NCT03786081|Bevacizumab|bevacizumab|mesh-list
101518462|NCT03911336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518464|NCT03911336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101518465|NCT03911336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101518466|NCT03911336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101518467|NCT03911336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101518468|NCT03911336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518469|NCT03850535|Cytarabine|cytarabine|mesh-list
101518470|NCT03850535|Daunorubicin|daunorubicin|mesh-list
101518471|NCT03850535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101518472|NCT03850535|Antimetabolites|antimetabolites|mesh-ancestor
101518473|NCT03850535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518474|NCT03850535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101518475|NCT03850535|Antiviral Agents|antiviral agents|mesh-ancestor
101518476|NCT03850535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101309496|NCT03000387|Cholinergic Agents|cholinergic agents|mesh-ancestor
101309497|NCT03000387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101518477|NCT03850535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101518478|NCT03850535|Immunologic Factors|immunologic factors|mesh-ancestor
101518479|NCT03850535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518480|NCT03850535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101518481|NCT03850535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101518482|NCT03850535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101518483|NCT03850535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101518485|NCT03850301|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101518486|NCT03850301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101518487|NCT03850301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101518488|NCT03850301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518489|NCT03850301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101518490|NCT05255367|Phenol|phenol|mesh-list
101518491|NCT05255367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101518492|NCT05255367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101518493|NCT05255367|Disinfectants|disinfectants|mesh-ancestor
101518494|NCT05255367|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
101518495|NCT05255367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101518496|NCT04017936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101518497|NCT04017936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101518498|NCT03653000|Anesthetics|anesthetics|mesh-list
101309558|NCT02373813|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101518499|NCT03653000|Anesthetics, Local|anesthetics, local|mesh-list
101518500|NCT03653000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101309559|NCT02373813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101309572|NCT02373813|Vitamins|vitamins|mesh-ancestor
101518501|NCT03653000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518502|NCT03653000|Sensory System Agents|sensory system agents|mesh-ancestor
101518503|NCT03653000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101518504|NCT03639389|Morphine|morphine|mesh-list
101518505|NCT03639389|Analgesics|analgesics|mesh-list
101518506|NCT03639389|Bupivacaine|bupivacaine|mesh-list
101518507|NCT03639389|Anesthetics, Local|anesthetics, local|mesh-ancestor
101518508|NCT03639389|Anesthetics|anesthetics|mesh-ancestor
101518509|NCT03639389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101518510|NCT03639389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518511|NCT03639389|Sensory System Agents|sensory system agents|mesh-ancestor
101518512|NCT03639389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101518513|NCT03639389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101518514|NCT03639389|Narcotics|narcotics|mesh-ancestor
101518515|NCT05172531|Cisatracurium|cisatracurium|mesh-list
101518516|NCT05172531|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101518517|NCT05172531|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101518518|NCT05172531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101518519|NCT05172531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518520|NCT03570983|Cytarabine|cytarabine|mesh-list
101518521|NCT03570983|Etoposide|etoposide|mesh-list
101518522|NCT03570983|Melphalan|melphalan|mesh-list
101518523|NCT03570983|Carmustine|carmustine|mesh-list
101518524|NCT03570983|Allopurinol|allopurinol|mesh-list
101518525|NCT03570983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101518526|NCT03570983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101518527|NCT03570983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101518528|NCT03570983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101518529|NCT03570983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101518530|NCT03570983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518531|NCT03570983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101518532|NCT03570983|Antimetabolites|antimetabolites|mesh-ancestor
101518533|NCT03570983|Antiviral Agents|antiviral agents|mesh-ancestor
101518534|NCT03570983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101518535|NCT03570983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101518536|NCT03570983|Immunologic Factors|immunologic factors|mesh-ancestor
101518537|NCT03570983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518538|NCT03570983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101518539|NCT03570983|Alkylating Agents|alkylating agents|mesh-ancestor
101518540|NCT03570983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101518541|NCT03570983|Gout Suppressants|gout suppressants|mesh-ancestor
101518542|NCT03570983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101518543|NCT03570983|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101518544|NCT03570983|Antioxidants|antioxidants|mesh-ancestor
101518545|NCT03570983|Protective Agents|protective agents|mesh-ancestor
101518547|NCT03540758|Nicotinic Acids|nicotinic acids|mesh-list
101518548|NCT03540758|Niacinamide|niacinamide|mesh-list
101518549|NCT03540758|Diazoxide|diazoxide|mesh-list
101518550|NCT03540758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101309613|NCT00006045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518551|NCT03540758|Antimetabolites|antimetabolites|mesh-ancestor
101518552|NCT03540758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518553|NCT03540758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101518554|NCT03540758|Vasodilator Agents|vasodilator agents|mesh-ancestor
101518555|NCT03540758|Vitamin B Complex|vitamin b complex|mesh-ancestor
101518556|NCT03540758|Vitamins|vitamins|mesh-ancestor
101518557|NCT03540758|Micronutrients|micronutrients|mesh-ancestor
101518558|NCT03540758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518559|NCT03540758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101518560|NCT03187379|Bupivacaine|bupivacaine|mesh-list
101518561|NCT03187379|Anesthetics, Local|anesthetics, local|mesh-ancestor
101518562|NCT03187379|Anesthetics|anesthetics|mesh-ancestor
101518563|NCT03187379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101518564|NCT03187379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309637|NCT00006054|Cyclophosphamide|cyclophosphamide|mesh-list
101309638|NCT00006054|Busulfan|busulfan|mesh-list
101309640|NCT00006054|Etoposide|etoposide|mesh-list
101309654|NCT00006054|Hormones|hormones|mesh-ancestor
101518565|NCT03187379|Sensory System Agents|sensory system agents|mesh-ancestor
101518566|NCT03187379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101518567|NCT03182231|Exenatide|exenatide|mesh-list
101518568|NCT03182231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101518569|NCT03182231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518570|NCT03182231|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101518571|NCT03182231|Incretins|incretins|mesh-ancestor
101518572|NCT03182231|Hormones|hormones|mesh-ancestor
101518573|NCT03182231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101518574|NCT03182192|Exenatide|exenatide|mesh-list
101518575|NCT03182192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101518576|NCT03182192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518577|NCT03182192|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101518578|NCT03182192|Incretins|incretins|mesh-ancestor
101309702|NCT00006078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309703|NCT00006078|Protective Agents|protective agents|mesh-ancestor
101309708|NCT00006081|Paclitaxel|paclitaxel|mesh-list
101518579|NCT03182192|Hormones|hormones|mesh-ancestor
101518580|NCT03182192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101518581|NCT02964884|Lovastatin|lovastatin|mesh-list
101518582|NCT02964884|L 647318|l 647318|mesh-list
101518583|NCT02964884|Dihydromevinolin|dihydromevinolin|mesh-list
101518584|NCT02964884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101518586|NCT02964884|Antimetabolites|antimetabolites|mesh-ancestor
101518587|NCT02964884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518588|NCT02964884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101518589|NCT02964884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101518590|NCT02964884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101518591|NCT02837042|Pembrolizumab|pembrolizumab|mesh-list
101518592|NCT02837042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101518593|NCT02837042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101518594|NCT02837042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101518595|NCT02837042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518596|NCT05098470|Metformin|metformin|mesh-list
101518597|NCT05098470|Insulin Glargine|insulin glargine|mesh-list
101518598|NCT05098470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101518599|NCT05098470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518600|NCT02710643|Ofatumumab|ofatumumab|mesh-list
101518601|NCT02710643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101518602|NCT05093205|Midazolam|midazolam|mesh-list
101518603|NCT05093205|Atorvastatin|atorvastatin|mesh-list
101309765|NCT00006114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101309766|NCT00006114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309767|NCT00006114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101309768|NCT00006114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101518604|NCT05093205|Levonorgestrel|levonorgestrel|mesh-list
101518605|NCT05093205|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101518606|NCT05093205|Estradiol|estradiol|mesh-list
101518607|NCT05093205|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101518608|NCT05093205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101518609|NCT05093205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101518610|NCT05093205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518611|NCT05093205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101518612|NCT05093205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101518613|NCT05093205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101518614|NCT05093205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101518615|NCT05093205|Anesthetics, General|anesthetics, general|mesh-ancestor
101518616|NCT05093205|Anesthetics|anesthetics|mesh-ancestor
101309816|NCT00006126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101518617|NCT05093205|GABA Modulators|gaba modulators|mesh-ancestor
101518619|NCT05093205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101309817|NCT00006126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101309819|NCT00006129|Testosterone|testosterone|mesh-list
101309820|NCT00006129|Androgens|androgens|mesh-ancestor
101309821|NCT00006129|Hormones|hormones|mesh-ancestor
101518620|NCT05093205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518621|NCT05093205|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101518622|NCT05093205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101518624|NCT05093205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101518625|NCT05093205|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101518626|NCT05093205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101518627|NCT05093205|Estrogens|estrogens|mesh-ancestor
101518628|NCT05093205|Hormones|hormones|mesh-ancestor
101518629|NCT05093205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101518630|NCT05093205|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101518631|NCT05093205|Contraceptive Agents|contraceptive agents|mesh-ancestor
101518632|NCT05093205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101518633|NCT05093205|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101518634|NCT05093205|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101518635|NCT05093205|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101518636|NCT05093205|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101518637|NCT02623751|Exemestane|exemestane|mesh-list
101518638|NCT02623751|Entinostat|entinostat|mesh-list
101518639|NCT02623751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101518640|NCT02623751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101518641|NCT02623751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101518642|NCT02623751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101518643|NCT02623751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518646|NCT02623751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101309875|NCT00006180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101309876|NCT00006180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309877|NCT00006195|Olanzapine|olanzapine|mesh-list
101518648|NCT02623751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101518650|NCT02469155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101518651|NCT02469155|Serotonin Agents|serotonin agents|mesh-ancestor
101518652|NCT02469155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101518653|NCT02469155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518654|NCT02469155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518655|NCT02469155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101518656|NCT02469155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101518657|NCT02469155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101518658|NCT02469155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101518659|NCT02469155|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101518660|NCT02469155|Dopamine Agents|dopamine agents|mesh-ancestor
101518661|NCT02465606|Triamcinolone|triamcinolone|mesh-list
101309921|NCT00006204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101309922|NCT00006204|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101309923|NCT00006204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101518662|NCT02465606|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101518663|NCT02465606|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101518664|NCT02465606|Hydrocortisone|hydrocortisone|mesh-list
101518665|NCT02465606|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101518666|NCT02465606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101518667|NCT02465606|Glucocorticoids|glucocorticoids|mesh-ancestor
101518668|NCT02465606|Hormones|hormones|mesh-ancestor
101518669|NCT02465606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101518670|NCT02465606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518671|NCT02465606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101518672|NCT02465606|Immunologic Factors|immunologic factors|mesh-ancestor
101518673|NCT02465606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101518674|NCT02465606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518675|NCT05080530|Vitamin D|vitamin d|mesh-list
101518676|NCT05080530|Cholecalciferol|cholecalciferol|mesh-list
101518677|NCT05080530|Vitamins|vitamins|mesh-ancestor
101518678|NCT05080530|Micronutrients|micronutrients|mesh-ancestor
101518679|NCT05080530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518680|NCT05080530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101518681|NCT05080530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101518682|NCT00554177|Mifepristone|mifepristone|mesh-list
101518683|NCT00554177|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101518684|NCT00554177|Abortifacient Agents|abortifacient agents|mesh-ancestor
101518686|NCT00554177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518687|NCT00554177|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101518688|NCT00554177|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101518689|NCT00554177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101518690|NCT00554177|Contraceptive Agents|contraceptive agents|mesh-ancestor
101518691|NCT00554177|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101518692|NCT00554177|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101518693|NCT00554177|Hormone Antagonists|hormone antagonists|mesh-ancestor
101309980|NCT03751800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101309987|NCT03751800|Hormone Antagonists|hormone antagonists|mesh-ancestor
101518694|NCT00554177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101518695|NCT00554177|Luteolytic Agents|luteolytic agents|mesh-ancestor
101518696|NCT00554177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101518697|NCT00554177|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101518698|NCT03425565|Pembrolizumab|pembrolizumab|mesh-list
101518699|NCT03425565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101518700|NCT03425565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101518701|NCT03425565|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101518702|NCT03425565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518703|NCT05073627|Dicloxacillin|dicloxacillin|mesh-list
101518704|NCT05073627|Dabigatran|dabigatran|mesh-list
101518705|NCT05073627|Antithrombins|antithrombins|mesh-ancestor
101518706|NCT05073627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101518707|NCT05073627|Protease Inhibitors|protease inhibitors|mesh-ancestor
101518708|NCT05073627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101518709|NCT05073627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518710|NCT05073627|Anticoagulants|anticoagulants|mesh-ancestor
101310026|NCT00006249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101310027|NCT00006249|Immunologic Factors|immunologic factors|mesh-ancestor
101310028|NCT00006249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310029|NCT00006252|Cyclophosphamide|cyclophosphamide|mesh-list
101310030|NCT00006252|Fludarabine|fludarabine|mesh-list
101518711|NCT05073627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101518712|NCT05073627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101518713|NCT04678739|Remdesivir|remdesivir|mesh-list
101518714|NCT04678739|Antimetabolites|antimetabolites|mesh-ancestor
101518715|NCT04678739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518716|NCT04678739|Antiviral Agents|antiviral agents|mesh-ancestor
101518717|NCT04678739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101518718|NCT03368196|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
101518719|NCT03368196|Immunoconjugates|immunoconjugates|mesh-ancestor
101518720|NCT03368196|Immunologic Factors|immunologic factors|mesh-ancestor
101518721|NCT03368196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518722|NCT03230565|Ropivacaine|ropivacaine|mesh-list
101518723|NCT03230565|Anesthetics, Local|anesthetics, local|mesh-ancestor
101518724|NCT03230565|Anesthetics|anesthetics|mesh-ancestor
101518725|NCT03230565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101518726|NCT03230565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518727|NCT03230565|Sensory System Agents|sensory system agents|mesh-ancestor
101310082|NCT00006261|Alkylating Agents|alkylating agents|mesh-ancestor
101310083|NCT00006261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310084|NCT00006261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310085|NCT00006261|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101310086|NCT00006261|Tubulin Modulators|tubulin modulators|mesh-ancestor
101518728|NCT03230565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101518729|NCT02389985|Paclitaxel|paclitaxel|mesh-list
101518730|NCT02389985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101518731|NCT02389985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101518732|NCT02389985|Tubulin Modulators|tubulin modulators|mesh-ancestor
101518733|NCT02389985|Antimitotic Agents|antimitotic agents|mesh-ancestor
101518734|NCT02389985|Mitosis Modulators|mitosis modulators|mesh-ancestor
101518735|NCT02389985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518736|NCT03147612|Cytarabine|cytarabine|mesh-list
101518737|NCT03147612|Cyclophosphamide|cyclophosphamide|mesh-list
101518738|NCT03147612|Rituximab|rituximab|mesh-list
101518739|NCT03147612|Methotrexate|methotrexate|mesh-list
101518740|NCT03147612|Vincristine|vincristine|mesh-list
101518741|NCT03147612|Blinatumomab|blinatumomab|mesh-list
101518742|NCT03147612|Ponatinib|ponatinib|mesh-list
101310135|NCT00006279|Antiviral Agents|antiviral agents|mesh-ancestor
101310136|NCT00006279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101518743|NCT03147612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101518744|NCT03147612|Muromonab-CD3|muromonab-cd3|mesh-list
101518745|NCT03147612|Antibodies|antibodies|mesh-list
101518746|NCT03147612|Immunoglobulins|immunoglobulins|mesh-list
101518747|NCT03147612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101518748|NCT03147612|Lenograstim|lenograstim|mesh-list
101518749|NCT03147612|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101518750|NCT03147612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101518751|NCT03147612|Immunologic Factors|immunologic factors|mesh-ancestor
101518752|NCT03147612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518753|NCT03147612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101518754|NCT03147612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101518755|NCT03147612|Alkylating Agents|alkylating agents|mesh-ancestor
101518756|NCT03147612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518757|NCT03147612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310195|NCT00006324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101518759|NCT03147612|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101518760|NCT03147612|Abortifacient Agents|abortifacient agents|mesh-ancestor
101518761|NCT03147612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101518762|NCT03147612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101518763|NCT03147612|Antimetabolites|antimetabolites|mesh-ancestor
101518764|NCT03147612|Dermatologic Agents|dermatologic agents|mesh-ancestor
101518765|NCT03147612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101518766|NCT03147612|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101518767|NCT03147612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101518768|NCT03147612|Antiviral Agents|antiviral agents|mesh-ancestor
101518769|NCT03147612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101518770|NCT03147612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101518771|NCT03147612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101310256|NCT00005851|Mycophenolic Acid|mycophenolic acid|mesh-list
101310257|NCT00005851|Fludarabine|fludarabine|mesh-list
101310258|NCT00005851|Fludarabine phosphate|fludarabine phosphate|mesh-list
101518772|NCT03147612|Tubulin Modulators|tubulin modulators|mesh-ancestor
101518773|NCT03147612|Antimitotic Agents|antimitotic agents|mesh-ancestor
101518774|NCT03147612|Mitosis Modulators|mitosis modulators|mesh-ancestor
101518775|NCT03147612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101518776|NCT02377895|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101518778|NCT03455075|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101518779|NCT03455075|Contraceptive Agents|contraceptive agents|mesh-ancestor
101518780|NCT03455075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101518781|NCT03455075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518782|NCT03455075|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101518783|NCT03455075|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101518784|NCT03455075|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101518785|NCT05007132|Trifluridine|trifluridine|mesh-list
101310317|NCT00005860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101518786|NCT05007132|Bevacizumab|bevacizumab|mesh-list
101518787|NCT05007132|Panitumumab|panitumumab|mesh-list
101518788|NCT05007132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101518789|NCT05007132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101518790|NCT05007132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101518791|NCT05007132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101518792|NCT05007132|Growth Substances|growth substances|mesh-ancestor
101518793|NCT05007132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518794|NCT05007132|Growth Inhibitors|growth inhibitors|mesh-ancestor
101518795|NCT05007132|Antimetabolites|antimetabolites|mesh-ancestor
101518796|NCT05007132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518797|NCT05007132|Antiviral Agents|antiviral agents|mesh-ancestor
101518798|NCT05007132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101518799|NCT04684017|Carboplatin|carboplatin|mesh-list
101518800|NCT04684017|Etoposide|etoposide|mesh-list
101518801|NCT04684017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101518802|NCT04684017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101518803|NCT04684017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101518804|NCT04684017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101518805|NCT04684017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310379|NCT00005869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310380|NCT00005869|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101310381|NCT00005869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101518806|NCT04684017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518807|NCT00554450|Dapagliflozin|dapagliflozin|mesh-list
101518808|NCT00554450|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101518809|NCT00554450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518810|NCT00554450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101518811|NCT00554450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518812|NCT00553020|Insulin Glargine|insulin glargine|mesh-list
101518813|NCT00553020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101518814|NCT00553020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518815|NCT00554528|Meloxicam|meloxicam|mesh-list
101518816|NCT00554528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101518817|NCT00554528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101518818|NCT00554528|Analgesics|analgesics|mesh-ancestor
101518819|NCT00554528|Sensory System Agents|sensory system agents|mesh-ancestor
101518820|NCT00554528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101319336|NCT03960151|Glucocorticoids|glucocorticoids|mesh-ancestor
101518821|NCT00554528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518822|NCT00554528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101518823|NCT00554528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101518824|NCT00554528|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101518825|NCT00554528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101518827|NCT00554528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518828|NCT04683198|Carboplatin|carboplatin|mesh-list
101518829|NCT04683198|Etoposide|etoposide|mesh-list
101518830|NCT04683198|Apatinib|apatinib|mesh-list
101518831|NCT04683198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101518832|NCT04683198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101518833|NCT04683198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101518834|NCT04683198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101518835|NCT04683198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101518836|NCT04683198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518837|NCT04683198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101518838|NCT03075423|Nivolumab|nivolumab|mesh-list
101518839|NCT03075423|Ipilimumab|ipilimumab|mesh-list
101518840|NCT03075423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101518841|NCT03075423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101518842|NCT03075423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101518843|NCT03075423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518844|NCT02342249|Oseltamivir|oseltamivir|mesh-list
101518845|NCT02342249|Antiviral Agents|antiviral agents|mesh-ancestor
101518846|NCT02342249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101518847|NCT02342249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310435|NCT00006339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310438|NCT00006339|Antimetabolites|antimetabolites|mesh-ancestor
101518848|NCT02342249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518849|NCT02339129|Ibuprofen|ibuprofen|mesh-list
101518850|NCT02339129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101518851|NCT02339129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101310468|NCT00386503|Schistosomicides|schistosomicides|mesh-ancestor
101518852|NCT02339129|Analgesics|analgesics|mesh-ancestor
101518853|NCT02339129|Sensory System Agents|sensory system agents|mesh-ancestor
101518854|NCT02339129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101518855|NCT02339129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518856|NCT02339129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101518857|NCT02339129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101202548|NCT01411072|Antimetabolites|antimetabolites|mesh-ancestor
101518858|NCT02339129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101518859|NCT02339129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101518860|NCT02339129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518861|NCT02884206|Valsartan|valsartan|mesh-list
101518862|NCT02884206|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101518863|NCT02884206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101310469|NCT00386503|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101310470|NCT00386503|Anthelmintics|anthelmintics|mesh-ancestor
101310471|NCT00386581|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101310482|NCT00006345|Antiemetics|antiemetics|mesh-ancestor
101518872|NCT02326454|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101518873|NCT02326454|Dermatologic Agents|dermatologic agents|mesh-ancestor
101310521|NCT00005935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101310522|NCT00006348|Ondansetron|ondansetron|mesh-list
101310523|NCT00006348|Antiemetics|antiemetics|mesh-ancestor
101518888|NCT02306291|Etoposide|etoposide|mesh-list
101518889|NCT02306291|Mitoxantrone|mitoxantrone|mesh-list
101518890|NCT02306291|Idarubicin|idarubicin|mesh-list
101518891|NCT02306291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101518892|NCT02306291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101518893|NCT02306291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101518894|NCT02306291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101518895|NCT02306291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101518896|NCT02306291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518897|NCT02306291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101518898|NCT02306291|Antimetabolites|antimetabolites|mesh-ancestor
101518899|NCT02306291|Antiviral Agents|antiviral agents|mesh-ancestor
101518900|NCT02306291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101518901|NCT02306291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101518902|NCT02306291|Immunologic Factors|immunologic factors|mesh-ancestor
101518903|NCT02306291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518904|NCT02306291|Analgesics|analgesics|mesh-ancestor
101518905|NCT02306291|Sensory System Agents|sensory system agents|mesh-ancestor
101518906|NCT02306291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101518907|NCT02306291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101518908|NCT02302079|Ranibizumab|ranibizumab|mesh-list
101518909|NCT02302079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101518910|NCT02302079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101518911|NCT02302079|Growth Substances|growth substances|mesh-ancestor
101518912|NCT02302079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518913|NCT02302079|Growth Inhibitors|growth inhibitors|mesh-ancestor
101518914|NCT02302079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101518915|NCT01210495|Axitinib|axitinib|mesh-list
101518916|NCT01210495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101518917|NCT01210495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101518918|NCT01210495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101518919|NCT01210495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518920|NCT02289716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101518921|NCT02289716|Immunologic Factors|immunologic factors|mesh-ancestor
101518922|NCT02289716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518923|NCT04678076|Ketoprofen|ketoprofen|mesh-list
101518924|NCT04678076|Ketoprofen lysine|ketoprofen lysine|mesh-list
101518925|NCT04678076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101518926|NCT04678076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101518927|NCT04678076|Analgesics|analgesics|mesh-ancestor
101518928|NCT04678076|Sensory System Agents|sensory system agents|mesh-ancestor
101518929|NCT04678076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101518930|NCT04678076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518931|NCT04678076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101518932|NCT04678076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101518933|NCT04678076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101518934|NCT04678076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101518935|NCT04678076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518936|NCT02257619|Docetaxel|docetaxel|mesh-list
101518937|NCT02257619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101518938|NCT02257619|Tubulin Modulators|tubulin modulators|mesh-ancestor
101518939|NCT02257619|Antimitotic Agents|antimitotic agents|mesh-ancestor
101518940|NCT02257619|Mitosis Modulators|mitosis modulators|mesh-ancestor
101518941|NCT02257619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518942|NCT04891302|Clevudine|clevudine|mesh-list
101518943|NCT04891302|Antiviral Agents|antiviral agents|mesh-ancestor
101518944|NCT04891302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101310576|NCT00005944|Immunologic Factors|immunologic factors|mesh-ancestor
101310577|NCT00005944|Antidotes|antidotes|mesh-ancestor
101310578|NCT00005944|Protective Agents|protective agents|mesh-ancestor
101518945|NCT04857645|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
101518946|NCT04857645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101518949|NCT04857645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101518951|NCT02224235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101518952|NCT02224235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101518953|NCT02224235|Analgesics|analgesics|mesh-ancestor
101518954|NCT02224235|Sensory System Agents|sensory system agents|mesh-ancestor
101518955|NCT02224235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101518956|NCT02224235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518957|NCT02224235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101518958|NCT02224235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101518959|NCT02224235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101518960|NCT02224235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101518961|NCT02224235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518962|NCT02224235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101310589|NCT00387699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310590|NCT00387699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101310591|NCT00387699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101310592|NCT00387699|Growth Substances|growth substances|mesh-ancestor
101310593|NCT00387699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518963|NCT02224235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101518964|NCT02224235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101518967|NCT02529852|Cyclophosphamide|cyclophosphamide|mesh-list
101518968|NCT02529852|Doxorubicin|doxorubicin|mesh-list
101518969|NCT02529852|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101518970|NCT02529852|Vincristine|vincristine|mesh-list
101518971|NCT02529852|Lenalidomide|lenalidomide|mesh-list
101518972|NCT02529852|Obinutuzumab|obinutuzumab|mesh-list
101518973|NCT02529852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101518974|NCT02529852|Immunologic Factors|immunologic factors|mesh-ancestor
101310642|NCT00005968|Alkylating Agents|alkylating agents|mesh-ancestor
101310644|NCT00005968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101518975|NCT02529852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518976|NCT02529852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101518977|NCT02529852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101518978|NCT02529852|Alkylating Agents|alkylating agents|mesh-ancestor
101518979|NCT02529852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101518980|NCT02529852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101518981|NCT02529852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101518982|NCT02529852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101518983|NCT02529852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101518984|NCT02529852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101518985|NCT02529852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101518986|NCT02529852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101518987|NCT02529852|Glucocorticoids|glucocorticoids|mesh-ancestor
101518988|NCT02529852|Hormones|hormones|mesh-ancestor
101310708|NCT00005977|Antimetabolites|antimetabolites|mesh-ancestor
101310709|NCT00005977|Dermatologic Agents|dermatologic agents|mesh-ancestor
101411164|NCT00449839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101518989|NCT02529852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101518990|NCT02529852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101518991|NCT02529852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101518992|NCT02529852|Tubulin Modulators|tubulin modulators|mesh-ancestor
101518993|NCT02529852|Antimitotic Agents|antimitotic agents|mesh-ancestor
101518994|NCT02529852|Mitosis Modulators|mitosis modulators|mesh-ancestor
101518995|NCT02529852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101518996|NCT02529852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101518997|NCT02529852|Growth Substances|growth substances|mesh-ancestor
101518998|NCT02529852|Growth Inhibitors|growth inhibitors|mesh-ancestor
101310772|NCT00005998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101518999|NCT02529852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101519000|NCT02221232|Ethanol|ethanol|mesh-list
101519001|NCT02221232|Chlorhexidine|chlorhexidine|mesh-list
101519002|NCT02221232|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101519003|NCT02221232|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101519004|NCT02221232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101519005|NCT02221232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101519006|NCT02221232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519007|NCT02221232|Disinfectants|disinfectants|mesh-ancestor
101519008|NCT02221232|Dermatologic Agents|dermatologic agents|mesh-ancestor
101519009|NCT02206100|Enoxaparin|enoxaparin|mesh-list
101519010|NCT02206100|Anticoagulants|anticoagulants|mesh-ancestor
101519011|NCT02206100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101519012|NCT02206100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101519013|NCT02206100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519014|NCT01231516|Raltegravir Potassium|raltegravir potassium|mesh-list
101519015|NCT01231516|Dolutegravir|dolutegravir|mesh-list
101519016|NCT01231516|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101519017|NCT01231516|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101519018|NCT01231516|Antiviral Agents|antiviral agents|mesh-ancestor
101519019|NCT01231516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101519020|NCT01231516|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101519021|NCT01231516|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101519022|NCT01231516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101519023|NCT01231516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519024|NCT01962636|Cyclosporine|cyclosporine|mesh-list
101519025|NCT01962636|Cyclophosphamide|cyclophosphamide|mesh-list
101519026|NCT01962636|Fludarabine|fludarabine|mesh-list
101519027|NCT01962636|Cyclosporins|cyclosporins|mesh-list
101519028|NCT01962636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101319354|NCT04733326|Ketorolac|ketorolac|mesh-list
101519029|NCT01962636|Immunologic Factors|immunologic factors|mesh-ancestor
101519030|NCT01962636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519031|NCT01962636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101519032|NCT01962636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101519033|NCT01962636|Alkylating Agents|alkylating agents|mesh-ancestor
101519034|NCT01962636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519035|NCT01962636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101519036|NCT01962636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101519037|NCT01962636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101519038|NCT01962636|Antifungal Agents|antifungal agents|mesh-ancestor
101310891|NCT00386659|Antiviral Agents|antiviral agents|mesh-ancestor
101310903|NCT00006028|Gemcitabine|gemcitabine|mesh-list
101519039|NCT01962636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101519040|NCT01962636|Dermatologic Agents|dermatologic agents|mesh-ancestor
101519041|NCT01962636|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101519042|NCT01231321|Adalimumab|adalimumab|mesh-list
101519043|NCT01231321|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101519044|NCT01231321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101519045|NCT01231321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101519046|NCT01722240|Liraglutide|liraglutide|mesh-list
101519047|NCT01722240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101519048|NCT01722240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519049|NCT01722240|Incretins|incretins|mesh-ancestor
101519050|NCT01722240|Hormones|hormones|mesh-ancestor
101519051|NCT01722240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101519052|NCT01210222|Trebananib|trebananib|mesh-list
101519053|NCT01210222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101519054|NCT01210222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101519055|NCT01210222|Growth Substances|growth substances|mesh-ancestor
101519056|NCT01210222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519057|NCT01210222|Growth Inhibitors|growth inhibitors|mesh-ancestor
101519058|NCT01210222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101519059|NCT01210144|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101310943|NCT00006040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101519060|NCT01210144|Hormones|hormones|mesh-list
101310944|NCT00006040|Immunologic Factors|immunologic factors|mesh-ancestor
101519061|NCT01210144|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101519062|NCT01210144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101519063|NCT01210144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519064|NCT01210144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101519065|NCT01209949|Adapalene|adapalene|mesh-list
101519066|NCT01209949|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101519067|NCT01209949|Dermatologic Agents|dermatologic agents|mesh-ancestor
101519068|NCT01209949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101519069|NCT01209949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101519070|NCT01209949|Analgesics|analgesics|mesh-ancestor
101519071|NCT01209949|Sensory System Agents|sensory system agents|mesh-ancestor
101519072|NCT01209949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101519073|NCT01209949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519074|NCT01209949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101519075|NCT01209949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101519077|NCT04831593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101519078|NCT04831593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310997|NCT00006366|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101310998|NCT00006366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101310999|NCT00006366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101311000|NCT05680792|Ritonavir|ritonavir|mesh-list
101311001|NCT05680792|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101519080|NCT04667897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101519081|NCT04667897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101519082|NCT04667897|Growth Substances|growth substances|mesh-ancestor
101519083|NCT04667897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519084|NCT04667897|Growth Inhibitors|growth inhibitors|mesh-ancestor
101519085|NCT04667897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101519086|NCT01209832|Midazolam|midazolam|mesh-list
101519087|NCT01209832|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101519088|NCT01209832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101519089|NCT01209832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101519090|NCT01209832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519091|NCT01209832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101519092|NCT01209832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101519093|NCT01209832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101519094|NCT01209832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101519095|NCT01209832|Anesthetics, General|anesthetics, general|mesh-ancestor
101519096|NCT01209832|Anesthetics|anesthetics|mesh-ancestor
101519097|NCT01209832|GABA Modulators|gaba modulators|mesh-ancestor
101311053|NCT00006381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101311054|NCT00006381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311056|NCT00006384|Interferon-alpha|interferon-alpha|mesh-list
101311057|NCT00006384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101519099|NCT01209832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101519100|NCT01209832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519101|NCT04667819|Hyaluronic Acid|hyaluronic acid|mesh-list
101519102|NCT04667819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101519103|NCT04667819|Immunologic Factors|immunologic factors|mesh-ancestor
101519104|NCT04667819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519105|NCT04667819|Viscosupplements|viscosupplements|mesh-ancestor
101519106|NCT04667819|Protective Agents|protective agents|mesh-ancestor
101519107|NCT04683159|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101519108|NCT04683159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101519109|NCT04683159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101519110|NCT04683159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101519111|NCT04683159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101519112|NCT04683159|Adrenergic Agents|adrenergic agents|mesh-ancestor
101519113|NCT04683159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101519114|NCT04683159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311107|NCT00006396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101311108|NCT00006396|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101311109|NCT00006396|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101311111|NCT03996148|Remifentanil|remifentanil|mesh-list
101519116|NCT01230892|Atenolol|atenolol|mesh-list
101519117|NCT01230892|Nebivolol|nebivolol|mesh-list
101519118|NCT01230892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101519119|NCT01230892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101519120|NCT01230892|Sympatholytics|sympatholytics|mesh-ancestor
101519121|NCT01230892|Autonomic Agents|autonomic agents|mesh-ancestor
101519122|NCT01230892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101519123|NCT01230892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519124|NCT01230892|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101519125|NCT01230892|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101519126|NCT01230892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101519127|NCT01230892|Adrenergic Agents|adrenergic agents|mesh-ancestor
101519128|NCT01230892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101519129|NCT01230892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519130|NCT01230892|Vasodilator Agents|vasodilator agents|mesh-ancestor
101519131|NCT01230892|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101519133|NCT01230892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101519134|NCT04667624|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
101519135|NCT04667624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101519136|NCT04667624|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101519137|NCT04667624|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101311162|NCT05552404|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101311163|NCT05552404|Purinergic Agents|purinergic agents|mesh-ancestor
101519138|NCT04667624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519140|NCT04667351|Antimetabolites|antimetabolites|mesh-ancestor
101519141|NCT04667351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519142|NCT04667351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101519143|NCT04667351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101519144|NCT04667351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101519145|NCT04667351|Immunologic Factors|immunologic factors|mesh-ancestor
101519146|NCT04667351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519147|NCT01230814|Metronidazole|metronidazole|mesh-list
101519148|NCT01230814|Miconazole|miconazole|mesh-list
101519149|NCT01230814|Clotrimazole|clotrimazole|mesh-list
101519150|NCT01230814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101519151|NCT01230814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101519152|NCT01230814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101519153|NCT01230814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101519154|NCT01230814|Antifungal Agents|antifungal agents|mesh-ancestor
101519155|NCT01230814|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101519156|NCT01230814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101519157|NCT01230814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101202852|NCT01413022|Vitamins|vitamins|mesh-ancestor
101311215|NCT05431543|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101311216|NCT05431543|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101311217|NCT05431543|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101311218|NCT05431543|Aceclidine|aceclidine|mesh-list
101311219|NCT05431543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101519158|NCT01230814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519159|NCT01230814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101519160|NCT01230814|Hormone Antagonists|hormone antagonists|mesh-ancestor
101519161|NCT01230814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101519162|NCT01230814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519163|NCT01230814|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101519164|NCT01230814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101519165|NCT01230814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101519166|NCT01230307|Vitamin D|vitamin d|mesh-list
101519167|NCT01230307|Cholecalciferol|cholecalciferol|mesh-list
101519168|NCT01230307|Vitamins|vitamins|mesh-ancestor
101519169|NCT01230307|Micronutrients|micronutrients|mesh-ancestor
101519170|NCT01230307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519171|NCT01230307|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101519172|NCT01230307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101519173|NCT01209598|Palbociclib|palbociclib|mesh-list
101519174|NCT01209598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101519175|NCT01209598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101519176|NCT01209598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101519177|NCT01209598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519178|NCT00556634|Efavirenz|efavirenz|mesh-list
101519179|NCT00556634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101519180|NCT00556634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101519181|NCT00556634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101519182|NCT00556634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519183|NCT00556634|Antiviral Agents|antiviral agents|mesh-ancestor
101519184|NCT00556634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101519185|NCT00556634|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101311263|NCT05247970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101311264|NCT05247970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101311265|NCT05247970|Anesthetics, General|anesthetics, general|mesh-ancestor
101311266|NCT05247970|Anesthetics|anesthetics|mesh-ancestor
101519186|NCT00556634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101519187|NCT00556634|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101519188|NCT00556634|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101519189|NCT00556634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101519190|NCT00556634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101519192|NCT01209520|Vinorelbine|vinorelbine|mesh-list
101519193|NCT01209520|Docetaxel|docetaxel|mesh-list
101519194|NCT01209520|Cisplatin|cisplatin|mesh-list
101519195|NCT01209520|Carboplatin|carboplatin|mesh-list
101519196|NCT01209520|Pemetrexed|pemetrexed|mesh-list
101519197|NCT01209520|Azacitidine|azacitidine|mesh-list
101519198|NCT01209520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101519199|NCT01209520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101519200|NCT01209520|Tubulin Modulators|tubulin modulators|mesh-ancestor
101519201|NCT01209520|Antimitotic Agents|antimitotic agents|mesh-ancestor
101519202|NCT01209520|Mitosis Modulators|mitosis modulators|mesh-ancestor
101519203|NCT01209520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519204|NCT01209520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101519205|NCT01209520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101519206|NCT01209520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101519207|NCT01209520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101519208|NCT01209520|Antimetabolites|antimetabolites|mesh-ancestor
101519209|NCT04805541|Tropicamide|tropicamide|mesh-list
101311308|NCT00006453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101519210|NCT04805541|Mydriatics|mydriatics|mesh-list
101519211|NCT04805541|Autonomic Agents|autonomic agents|mesh-ancestor
101311309|NCT00006453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101311310|NCT00006453|Antimetabolites|antimetabolites|mesh-ancestor
101311311|NCT00006453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311312|NCT00387322|Pemetrexed|pemetrexed|mesh-list
101519212|NCT04805541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101519213|NCT04805541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519214|NCT04805541|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101519215|NCT04805541|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101519216|NCT04805541|Cholinergic Agents|cholinergic agents|mesh-ancestor
101519217|NCT04805541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101519218|NCT04805541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519220|NCT04784754|Antioxidants|antioxidants|mesh-ancestor
101519221|NCT04784754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519222|NCT04784754|Protective Agents|protective agents|mesh-ancestor
101519223|NCT04784754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519224|NCT04784754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101519225|NCT04666805|Tamoxifen|tamoxifen|mesh-list
101519226|NCT04666805|Toremifene|toremifene|mesh-list
101519227|NCT04666805|Letrozole|letrozole|mesh-list
101519228|NCT04666805|Anastrozole|anastrozole|mesh-list
101519229|NCT04666805|Exemestane|exemestane|mesh-list
101519230|NCT04666805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101519231|NCT04666805|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101519232|NCT04666805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101519233|NCT04666805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101519234|NCT04666805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311356|NCT00388128|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101311357|NCT00388128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519235|NCT04666805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101519236|NCT04666805|Hormone Antagonists|hormone antagonists|mesh-ancestor
101519237|NCT04666805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101519238|NCT04666805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519239|NCT04666805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101519240|NCT04666805|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101519241|NCT04666805|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101519242|NCT04666805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101519243|NCT04721457|Povidone-Iodine|povidone-iodine|mesh-list
101519244|NCT04721457|Listerine|listerine|mesh-list
101519245|NCT04721457|Hydrogen Peroxide|hydrogen peroxide|mesh-list
101519246|NCT04721457|Cetylpyridinium|cetylpyridinium|mesh-list
101519247|NCT04721457|Sodium Hypochlorite|sodium hypochlorite|mesh-list
101519249|NCT04721457|Povidone|povidone|mesh-list
101519250|NCT04721457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101519251|NCT04721457|Sodium Fluoride|sodium fluoride|mesh-list
101519253|NCT04721457|Blood Substitutes|blood substitutes|mesh-ancestor
101311435|NCT03771157|Vaccines|vaccines|mesh-list
101519254|NCT04721457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101519255|NCT04721457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101519256|NCT04721457|Cariostatic Agents|cariostatic agents|mesh-ancestor
101519257|NCT04721457|Protective Agents|protective agents|mesh-ancestor
101519258|NCT04721457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519259|NCT04721457|Disinfectants|disinfectants|mesh-ancestor
101519261|NCT04665986|Vinorelbine|vinorelbine|mesh-list
101519262|NCT04665986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101519263|NCT04665986|Tubulin Modulators|tubulin modulators|mesh-ancestor
101519264|NCT04665986|Antimitotic Agents|antimitotic agents|mesh-ancestor
101519265|NCT04665986|Mitosis Modulators|mitosis modulators|mesh-ancestor
101519266|NCT04665986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519267|NCT04665986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101519268|NCT04638309|Azacitidine|azacitidine|mesh-list
101519269|NCT04638309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101519270|NCT04638309|Antimetabolites|antimetabolites|mesh-ancestor
101519271|NCT04638309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519272|NCT04638309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101519273|NCT04638309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101519274|NCT04665830|Evolocumab|evolocumab|mesh-list
101519275|NCT04665830|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101519276|NCT04665830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101519277|NCT04665830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101519278|NCT04665830|Antimetabolites|antimetabolites|mesh-ancestor
101519279|NCT04665830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519280|NCT04665830|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101519281|NCT04665830|Protease Inhibitors|protease inhibitors|mesh-ancestor
101519282|NCT04665830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101519283|NCT04665830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101519284|NCT04683237|Liraglutide|liraglutide|mesh-list
101519285|NCT04683237|Megestrol|megestrol|mesh-list
101519286|NCT04683237|Megestrol Acetate|megestrol acetate|mesh-list
101519287|NCT04683237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101519288|NCT04683237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519289|NCT04683237|Incretins|incretins|mesh-ancestor
101519290|NCT04683237|Hormones|hormones|mesh-ancestor
101519291|NCT04683237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101519292|NCT04683237|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101519293|NCT04683237|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101519294|NCT04683237|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101519295|NCT04683237|Contraceptive Agents|contraceptive agents|mesh-ancestor
101519296|NCT04683237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101519297|NCT04683237|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101519298|NCT04683237|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101519299|NCT04683237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101519300|NCT04683237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101519301|NCT04683237|Appetite Stimulants|appetite stimulants|mesh-ancestor
101519302|NCT04683237|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101519303|NCT04665362|Apatinib|apatinib|mesh-list
101519304|NCT04665362|Antibodies|antibodies|mesh-list
101519305|NCT04665362|Immunologic Factors|immunologic factors|mesh-ancestor
101519306|NCT04665362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519307|NCT04665362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101519308|NCT04665362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101519309|NCT04665362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101519310|NCT04665362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519312|NCT04665284|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101519313|NCT04665284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311511|NCT02890069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101519314|NCT04665284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101519315|NCT04665284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519317|NCT04432974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101519318|NCT04432974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519320|NCT04664894|Sofosbuvir|sofosbuvir|mesh-list
101519321|NCT04664894|Velpatasvir|velpatasvir|mesh-list
101519322|NCT04664894|Antimetabolites|antimetabolites|mesh-ancestor
101519323|NCT04664894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519324|NCT04664894|Antiviral Agents|antiviral agents|mesh-ancestor
101519325|NCT04664894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101519326|NCT00557102|Leucovorin|leucovorin|mesh-list
101519327|NCT00557102|Fluorouracil|fluorouracil|mesh-list
101519328|NCT00557102|Irinotecan|irinotecan|mesh-list
101519329|NCT00557102|Cetuximab|cetuximab|mesh-list
101519330|NCT00557102|Calcium|calcium|mesh-list
101519331|NCT00557102|Levoleucovorin|levoleucovorin|mesh-list
101311556|NCT00006519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311557|NCT00006519|Antiviral Agents|antiviral agents|mesh-ancestor
101519332|NCT00557102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101519333|NCT00557102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519334|NCT00557102|Antimetabolites|antimetabolites|mesh-ancestor
101519335|NCT00557102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519336|NCT00557102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101519337|NCT00557102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101519338|NCT00557102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101519339|NCT00557102|Immunologic Factors|immunologic factors|mesh-ancestor
101519340|NCT00557102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101519341|NCT00557102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101519342|NCT00557102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101519343|NCT00557102|Antidotes|antidotes|mesh-ancestor
101519344|NCT00557102|Protective Agents|protective agents|mesh-ancestor
101519345|NCT00557102|Vitamin B Complex|vitamin b complex|mesh-ancestor
101519346|NCT00557102|Vitamins|vitamins|mesh-ancestor
101519347|NCT00557102|Micronutrients|micronutrients|mesh-ancestor
101519348|NCT00557102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101519349|NCT04682691|Erythromycin|erythromycin|mesh-list
101519350|NCT04682691|Erythromycin Estolate|erythromycin estolate|mesh-list
101519351|NCT04682691|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101519352|NCT04682691|Erythromycin stearate|erythromycin stearate|mesh-list
101519353|NCT04682691|Metoclopramide|metoclopramide|mesh-list
101519354|NCT04682691|Antiemetics|antiemetics|mesh-ancestor
101519355|NCT04682691|Autonomic Agents|autonomic agents|mesh-ancestor
101519356|NCT04682691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101311616|NCT00006708|Carboplatin|carboplatin|mesh-list
101519357|NCT04682691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519358|NCT04682691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101519359|NCT04682691|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101519360|NCT04682691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101519361|NCT04682691|Dopamine Agents|dopamine agents|mesh-ancestor
101519362|NCT04682691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101519363|NCT04682691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519364|NCT04682691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101519365|NCT04682691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101519366|NCT04682691|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101519367|NCT04682691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101519368|NCT01209286|Blinatumomab|blinatumomab|mesh-list
101519369|NCT01209286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101519370|NCT04663763|Capecitabine|capecitabine|mesh-list
101519371|NCT04663763|Oxaliplatin|oxaliplatin|mesh-list
101519372|NCT04663763|Antibodies|antibodies|mesh-list
101519373|NCT04663763|Immunologic Factors|immunologic factors|mesh-ancestor
101519374|NCT04663763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519375|NCT04663763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101519376|NCT04663763|Antimetabolites|antimetabolites|mesh-ancestor
101519377|NCT04663763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519378|NCT04663763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311669|NCT00006786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311670|NCT00006786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101519379|NCT04351737|Dexamethasone|dexamethasone|mesh-list
101519380|NCT04351737|Prednisolone|prednisolone|mesh-list
101519381|NCT04351737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101519382|NCT04351737|Methylprednisolone|methylprednisolone|mesh-list
101519383|NCT04351737|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101519384|NCT04351737|Prednisolone acetate|prednisolone acetate|mesh-list
101319372|NCT00386984|Hormones|hormones|mesh-ancestor
101519385|NCT04351737|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101519386|NCT04351737|Prednisolone phosphate|prednisolone phosphate|mesh-list
101519387|NCT04351737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101519389|NCT04351737|Autonomic Agents|autonomic agents|mesh-ancestor
101519390|NCT04351737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101519391|NCT04351737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519392|NCT04351737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101519393|NCT04351737|Glucocorticoids|glucocorticoids|mesh-ancestor
101311721|NCT00007059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101519394|NCT04351737|Hormones|hormones|mesh-ancestor
101519395|NCT04351737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101519396|NCT04351737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101519397|NCT04351737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101519398|NCT04351737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101519399|NCT04351737|Protective Agents|protective agents|mesh-ancestor
101519400|NCT04347915|Clevudine|clevudine|mesh-list
101519401|NCT04347915|Antiviral Agents|antiviral agents|mesh-ancestor
101519402|NCT04347915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101519403|NCT04185051|Aticaprant|aticaprant|mesh-list
101519404|NCT04185051|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101519405|NCT04185051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519406|NCT04185051|Sensory System Agents|sensory system agents|mesh-ancestor
101519407|NCT04185051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101519408|NCT04662788|Antibodies|antibodies|mesh-list
101519409|NCT04662788|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101519410|NCT04662788|Immunologic Factors|immunologic factors|mesh-ancestor
101519411|NCT04662788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519412|NCT04662866|Metformin|metformin|mesh-list
101519413|NCT04662866|Pioglitazone|pioglitazone|mesh-list
101519414|NCT04662866|Empagliflozin|empagliflozin|mesh-list
101519415|NCT04662866|Linagliptin|linagliptin|mesh-list
101519416|NCT04662866|Biguanides|biguanides|mesh-list
101519417|NCT04662866|Protease Inhibitors|protease inhibitors|mesh-list
101519418|NCT04662866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101519419|NCT04662866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311782|NCT00006055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101519420|NCT04662866|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101519421|NCT04662866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311783|NCT00006055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101311785|NCT00006055|Glucocorticoids|glucocorticoids|mesh-ancestor
101519422|NCT04662866|Incretins|incretins|mesh-ancestor
101519423|NCT04662866|Hormones|hormones|mesh-ancestor
101519424|NCT04662866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101519425|NCT04662866|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101519426|NCT04662866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101519427|NCT04662476|Vitamin D|vitamin d|mesh-list
101519428|NCT04662476|Cholecalciferol|cholecalciferol|mesh-list
101519429|NCT04662476|Vitamins|vitamins|mesh-ancestor
101519430|NCT04662476|Micronutrients|micronutrients|mesh-ancestor
101519432|NCT04662476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101519433|NCT04662476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101519435|NCT03986424|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101519436|NCT03986424|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101519437|NCT03986424|Dopamine Agents|dopamine agents|mesh-ancestor
101519438|NCT03986424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101519439|NCT03986424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519440|NCT03986424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519441|NCT03986424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101519442|NCT03986424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101519443|NCT03918252|Nivolumab|nivolumab|mesh-list
101519444|NCT03918252|Ipilimumab|ipilimumab|mesh-list
101519445|NCT03918252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101519446|NCT03918252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101519447|NCT03918252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101519448|NCT03918252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519449|NCT04662125|Acetaminophen|acetaminophen|mesh-list
101519450|NCT04662125|Prednisolone|prednisolone|mesh-list
101519451|NCT04662125|Pregabalin|pregabalin|mesh-list
101519452|NCT04662125|Caffeine|caffeine|mesh-list
101311829|NCT00006088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311830|NCT00006088|Tubulin Modulators|tubulin modulators|mesh-ancestor
101311831|NCT00006088|Antimitotic Agents|antimitotic agents|mesh-ancestor
101519453|NCT04662125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101519454|NCT04662125|Glucocorticoids|glucocorticoids|mesh-ancestor
101519456|NCT04662125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101519457|NCT04662125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519458|NCT04662125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101519459|NCT04662125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101519460|NCT04662125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101519461|NCT04662125|Analgesics|analgesics|mesh-ancestor
101519462|NCT04662125|Sensory System Agents|sensory system agents|mesh-ancestor
101519463|NCT04662125|Anticonvulsants|anticonvulsants|mesh-ancestor
101519464|NCT04662125|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101519465|NCT04662125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101519466|NCT04662125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519467|NCT04662125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101519468|NCT04662125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101519469|NCT04662125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101519470|NCT04662125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101519471|NCT04662125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101519472|NCT04662125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101519474|NCT04662125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101519475|NCT04662125|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101519476|NCT04662125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101519477|NCT04662125|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101519478|NCT04662125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101519479|NCT04662125|Purinergic Agents|purinergic agents|mesh-ancestor
101519480|NCT04662125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101519481|NCT00557180|Beclomethasone|beclomethasone|mesh-list
101519482|NCT00557180|Bromides|bromides|mesh-list
101519483|NCT00557180|Tiotropium Bromide|tiotropium bromide|mesh-list
101311936|NCT00006118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101519484|NCT00557180|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101519485|NCT00557180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101519486|NCT00557180|Autonomic Agents|autonomic agents|mesh-ancestor
101519487|NCT00557180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101519490|NCT00557180|Respiratory System Agents|respiratory system agents|mesh-ancestor
101519491|NCT00557180|Parasympatholytics|parasympatholytics|mesh-ancestor
101519492|NCT00557180|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101519493|NCT00557180|Cholinergic Agents|cholinergic agents|mesh-ancestor
101519494|NCT00557180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101519495|NCT00557180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519496|NCT00557180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101519497|NCT00557180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101519498|NCT00557180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101519499|NCT00557180|Adrenergic Agents|adrenergic agents|mesh-ancestor
101519500|NCT00557180|Anticonvulsants|anticonvulsants|mesh-ancestor
101519501|NCT00557180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101519502|NCT00557180|Glucocorticoids|glucocorticoids|mesh-ancestor
101519504|NCT00557180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101519505|NCT00557219|Fenoldopam|fenoldopam|mesh-list
101519506|NCT00557219|Ketanserin|ketanserin|mesh-list
101519507|NCT00557219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101519508|NCT00557219|Vasodilator Agents|vasodilator agents|mesh-ancestor
101519509|NCT00557219|Dopamine Agonists|dopamine agonists|mesh-ancestor
101519510|NCT00557219|Dopamine Agents|dopamine agents|mesh-ancestor
101519511|NCT00557219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101528352|NCT04628676|Antidepressive Agents|antidepressive agents|mesh-ancestor
101312004|NCT00006154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312005|NCT00006154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101312006|NCT00006154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101519512|NCT00557219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519513|NCT00557219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519514|NCT00557219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101519515|NCT00557219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101519516|NCT00557219|Serotonin Agents|serotonin agents|mesh-ancestor
101519517|NCT00539877|Irinotecan|irinotecan|mesh-list
101519518|NCT00539877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101519519|NCT00539877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101519520|NCT00539877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312049|NCT00006190|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101329283|NCT00026260|Semaxinib|semaxinib|mesh-list
101312050|NCT00006190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101312055|NCT00006196|Vitamins|vitamins|mesh-ancestor
101519521|NCT00539877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519522|NCT00539877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101519523|NCT03798405|Analgesics|analgesics|mesh-list
101519524|NCT03798405|Narcotics|narcotics|mesh-list
101519525|NCT03798405|Sensory System Agents|sensory system agents|mesh-ancestor
101519526|NCT03798405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101519527|NCT03798405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519528|NCT03798405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101519529|NCT04661696|Paclitaxel|paclitaxel|mesh-list
101519530|NCT04661696|Carboplatin|carboplatin|mesh-list
101519531|NCT04661696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101519532|NCT04661696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101519533|NCT04661696|Tubulin Modulators|tubulin modulators|mesh-ancestor
101519534|NCT04661696|Antimitotic Agents|antimitotic agents|mesh-ancestor
101519535|NCT04661696|Mitosis Modulators|mitosis modulators|mesh-ancestor
101519536|NCT04661696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312115|NCT00006214|Androgen Antagonists|androgen antagonists|mesh-ancestor
101312116|NCT00006214|Hormone Antagonists|hormone antagonists|mesh-ancestor
101312117|NCT00006214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101312118|NCT00006214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312119|NCT00006214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101519537|NCT03776136|Pembrolizumab|pembrolizumab|mesh-list
101519539|NCT03776136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101519540|NCT03776136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101519541|NCT03776136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101519542|NCT03776136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519543|NCT03776136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101519544|NCT03776136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101519545|NCT04661345|Coagulase|coagulase|mesh-list
101519546|NCT04661345|Coagulants|coagulants|mesh-ancestor
101519547|NCT00540072|Daptomycin|daptomycin|mesh-list
101519548|NCT00540072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101519549|NCT00540072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101519582|NCT04660565|Hormones|hormones|mesh-ancestor
101519583|NCT04660565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101519584|NCT04660565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519585|NCT04660565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101519586|NCT04660565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101519587|NCT04660565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101519588|NCT04660565|Immunologic Factors|immunologic factors|mesh-ancestor
101519589|NCT04319341|Autoantibodies|autoantibodies|mesh-list
101519590|NCT04319341|Immunologic Factors|immunologic factors|mesh-ancestor
101519591|NCT04319341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519592|NCT05420935|Immunoglobulin G|immunoglobulin g|mesh-list
101519593|NCT05420935|Immunoglobulin E|immunoglobulin e|mesh-list
101519594|NCT05420935|Immunologic Factors|immunologic factors|mesh-ancestor
101319386|NCT03959332|Baloxavir|baloxavir|mesh-list
101519595|NCT05420935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312169|NCT00006232|Tubulin Modulators|tubulin modulators|mesh-ancestor
101312170|NCT00006232|Antimitotic Agents|antimitotic agents|mesh-ancestor
101312171|NCT00006232|Mitosis Modulators|mitosis modulators|mesh-ancestor
101312172|NCT00006235|Carboplatin|carboplatin|mesh-list
101312173|NCT00006235|Doxorubicin|doxorubicin|mesh-list
101519597|NCT01208038|Testosterone|testosterone|mesh-list
101519598|NCT01208038|Testosterone undecanoate|testosterone undecanoate|mesh-list
101519599|NCT01208038|Testosterone enanthate|testosterone enanthate|mesh-list
101519600|NCT01208038|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101519601|NCT01208038|Androgens|androgens|mesh-ancestor
101519603|NCT01208038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101519604|NCT01208038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519605|NCT01208038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101519606|NCT01208038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101519607|NCT01208038|Anabolic Agents|anabolic agents|mesh-ancestor
101519608|NCT04659785|Apatinib|apatinib|mesh-list
101519609|NCT04659785|Fluzoparib|fluzoparib|mesh-list
101519610|NCT04659785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101519611|NCT04659785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101519613|NCT04659785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519614|NCT04659785|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101519615|NCT01207687|Bevacizumab|bevacizumab|mesh-list
101312216|NCT00006250|Analgesics|analgesics|mesh-ancestor
101312217|NCT00006250|Sensory System Agents|sensory system agents|mesh-ancestor
101312218|NCT00006250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101519616|NCT01207687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101519617|NCT01207687|Antibodies|antibodies|mesh-list
101519618|NCT01207687|Immunoglobulins|immunoglobulins|mesh-list
101519619|NCT01207687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101519620|NCT01207687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101519621|NCT01207687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101519622|NCT01207687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101519623|NCT01207687|Growth Substances|growth substances|mesh-ancestor
101519624|NCT01207687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519625|NCT01207687|Growth Inhibitors|growth inhibitors|mesh-ancestor
101519626|NCT01207687|Immunologic Factors|immunologic factors|mesh-ancestor
101519627|NCT01207453|Milnacipran|milnacipran|mesh-list
101519628|NCT01207453|Levomilnacipran|levomilnacipran|mesh-list
101519629|NCT01207453|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101519630|NCT01207453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101312275|NCT00007605|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101312276|NCT00007605|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101312277|NCT00007605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101312292|NCT03709888|Pregabalin|pregabalin|mesh-list
101519631|NCT01207453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101519632|NCT01207453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519633|NCT01207453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101519634|NCT01207453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519635|NCT01207453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101519636|NCT01207453|Analgesics|analgesics|mesh-ancestor
101519637|NCT01207453|Sensory System Agents|sensory system agents|mesh-ancestor
101519638|NCT01207453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101519639|NCT01207453|Antidepressive Agents|antidepressive agents|mesh-ancestor
101519640|NCT01207453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101519641|NCT00540345|Interferons|interferons|mesh-list
101519642|NCT00540345|Ribavirin|ribavirin|mesh-list
101312330|NCT00007683|Antipyretics|antipyretics|mesh-ancestor
101519643|NCT00540345|Interferon-alpha|interferon-alpha|mesh-list
101312331|NCT00007683|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101312332|NCT00007683|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101312333|NCT00007683|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101312334|NCT00007683|Purinergic Agents|purinergic agents|mesh-ancestor
101519645|NCT00540345|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101519646|NCT00540345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101519647|NCT00540345|Antiviral Agents|antiviral agents|mesh-ancestor
101519648|NCT00540345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101519649|NCT00540345|Antimetabolites|antimetabolites|mesh-ancestor
101519650|NCT00540345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519651|NCT00540345|Immunologic Factors|immunologic factors|mesh-ancestor
101519652|NCT00540345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519653|NCT01207414|Iloperidone|iloperidone|mesh-list
101519654|NCT01207414|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101519655|NCT01207414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101519656|NCT01207414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101519657|NCT01207414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519658|NCT01207414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101519659|NCT00540384|Darbepoetin alfa|darbepoetin alfa|mesh-list
101519660|NCT00540384|Hematinics|hematinics|mesh-ancestor
101519661|NCT04659551|Cyclophosphamide|cyclophosphamide|mesh-list
101519662|NCT04659551|Nivolumab|nivolumab|mesh-list
101519663|NCT04659551|Epirubicin|epirubicin|mesh-list
101519664|NCT04659551|Exemestane|exemestane|mesh-list
101519665|NCT04659551|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101519666|NCT04659551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101519667|NCT04659551|Immunologic Factors|immunologic factors|mesh-ancestor
101319391|NCT04733521|Cisplatin|cisplatin|mesh-list
101519668|NCT04659551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519669|NCT04659551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101519670|NCT04659551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101519671|NCT04659551|Alkylating Agents|alkylating agents|mesh-ancestor
101519672|NCT04659551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519673|NCT04659551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101519674|NCT04659551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101519675|NCT04659551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101519676|NCT04659551|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101519677|NCT04659551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101519678|NCT04659551|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101519679|NCT04659551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101312390|NCT00387868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312391|NCT03616717|Modafinil|modafinil|mesh-list
101312393|NCT03616717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519681|NCT04659551|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101411188|NCT00450736|Celecoxib|celecoxib|mesh-list
101519682|NCT04659551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101519683|NCT04659551|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101519684|NCT04659551|Hormone Antagonists|hormone antagonists|mesh-ancestor
101519685|NCT04659551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101519686|NCT04659551|Luteolytic Agents|luteolytic agents|mesh-ancestor
101519687|NCT04659551|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101519688|NCT04659551|Contraceptive Agents|contraceptive agents|mesh-ancestor
101519689|NCT04659551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101519690|NCT04659551|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101519691|NCT04659551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101519693|NCT01206517|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101519694|NCT01206517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101519695|NCT01206517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101519696|NCT01206517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519697|NCT01206517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101519699|NCT01206439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101312428|NCT00007878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101312429|NCT00007878|Immunologic Factors|immunologic factors|mesh-ancestor
101312433|NCT00007878|Vitamins|vitamins|mesh-ancestor
101519700|NCT01206439|Vasodilator Agents|vasodilator agents|mesh-ancestor
101519701|NCT01206439|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101519702|NCT01206439|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101519703|NCT01206439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101519704|NCT01206439|Adrenergic Agents|adrenergic agents|mesh-ancestor
101519705|NCT01206439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101519706|NCT01206439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519707|NCT01206439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519709|NCT01206322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101519710|NCT01206322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519711|NCT00540501|Oseltamivir|oseltamivir|mesh-list
101312485|NCT00006367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519712|NCT00540501|Zanamivir|zanamivir|mesh-list
101519713|NCT00540501|Antiviral Agents|antiviral agents|mesh-ancestor
101519714|NCT00540501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101519715|NCT00540501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101519716|NCT00540501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519717|NCT00557453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101519718|NCT00557453|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101519719|NCT00557453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101519720|NCT00557453|Antitubercular Agents|antitubercular agents|mesh-ancestor
101519721|NCT01207102|Paclitaxel|paclitaxel|mesh-list
101519722|NCT01207102|Carboplatin|carboplatin|mesh-list
101519723|NCT01207102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101519724|NCT01207102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101519725|NCT01207102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101519726|NCT01207102|Tubulin Modulators|tubulin modulators|mesh-ancestor
101519727|NCT01207102|Antimitotic Agents|antimitotic agents|mesh-ancestor
101519728|NCT01207102|Mitosis Modulators|mitosis modulators|mesh-ancestor
101519729|NCT01207102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519731|NCT04658732|Gabapentin|gabapentin|mesh-list
101519735|NCT04658732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519736|NCT04658732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101519737|NCT04658732|Analgesics|analgesics|mesh-ancestor
101519738|NCT04658732|Sensory System Agents|sensory system agents|mesh-ancestor
101312620|NCT00006397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101519739|NCT04658732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101519740|NCT04658732|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101519741|NCT04658732|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101519742|NCT04658732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101519743|NCT04658732|Adrenergic Agents|adrenergic agents|mesh-ancestor
101519744|NCT04658732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101519745|NCT04658732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519746|NCT04658732|Anticonvulsants|anticonvulsants|mesh-ancestor
101519747|NCT04658732|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101519748|NCT04658732|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101519749|NCT04658732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101519750|NCT04658732|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101519751|NCT04658732|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101519752|NCT04658732|Antimanic Agents|antimanic agents|mesh-ancestor
101519753|NCT04658732|GABA Modulators|gaba modulators|mesh-ancestor
101519754|NCT04658732|GABA Agents|gaba agents|mesh-ancestor
101519755|NCT00540696|Darbepoetin alfa|darbepoetin alfa|mesh-list
101519756|NCT00540696|Hematinics|hematinics|mesh-ancestor
101519758|NCT04658420|Analgesics|analgesics|mesh-ancestor
101519759|NCT04658420|Sensory System Agents|sensory system agents|mesh-ancestor
101519760|NCT04658420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101519761|NCT04658420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312680|NCT00008151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101312681|NCT00008151|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101519762|NCT04658420|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101519763|NCT04658420|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101519764|NCT04658420|Anesthetics, General|anesthetics, general|mesh-ancestor
101519765|NCT04658420|Anesthetics|anesthetics|mesh-ancestor
101519766|NCT04658420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101519767|NCT04658420|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101519768|NCT04658420|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101519769|NCT04658420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101519770|NCT04658420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519771|NCT00540891|Alfuzosin|alfuzosin|mesh-list
101519772|NCT00540891|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101519775|NCT00540891|Adrenergic Agents|adrenergic agents|mesh-ancestor
101519776|NCT00540891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101519777|NCT00540891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519778|NCT00540891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519779|NCT00540891|Urological Agents|urological agents|mesh-ancestor
101519780|NCT04658225|Chlorhexidine|chlorhexidine|mesh-list
101519781|NCT04658225|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101519782|NCT04658225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101519783|NCT04658225|Disinfectants|disinfectants|mesh-ancestor
101519784|NCT00540930|Ranibizumab|ranibizumab|mesh-list
101519786|NCT00540930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101312733|NCT00006451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101312734|NCT00006451|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101312735|NCT00006451|Abortifacient Agents|abortifacient agents|mesh-ancestor
101519787|NCT00540930|Growth Substances|growth substances|mesh-ancestor
101519788|NCT00540930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519789|NCT00540930|Growth Inhibitors|growth inhibitors|mesh-ancestor
101519790|NCT00540930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101519792|NCT00541008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101519793|NCT00541008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101519794|NCT00541008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101519795|NCT00541008|Growth Substances|growth substances|mesh-ancestor
101519796|NCT00541008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519797|NCT00541008|Growth Inhibitors|growth inhibitors|mesh-ancestor
101312783|NCT00006457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101312784|NCT00006457|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101519798|NCT00541008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101519799|NCT00541008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101519800|NCT00541008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519802|NCT00541047|Goserelin|goserelin|mesh-list
101519803|NCT00541047|Bicalutamide|bicalutamide|mesh-list
101519804|NCT00541047|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101519805|NCT00541047|Fertility Agents|fertility agents|mesh-ancestor
101519806|NCT00541047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101519807|NCT00541047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519808|NCT00541047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101519809|NCT00541047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101519810|NCT00541047|Androgen Antagonists|androgen antagonists|mesh-ancestor
101519811|NCT00541047|Hormone Antagonists|hormone antagonists|mesh-ancestor
101519812|NCT00541047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101519813|NCT00541086|Tamoxifen|tamoxifen|mesh-list
101519814|NCT00541086|Letrozole|letrozole|mesh-list
101519815|NCT00541086|Anastrozole|anastrozole|mesh-list
101519816|NCT00541086|Exemestane|exemestane|mesh-list
101519817|NCT00541086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519818|NCT00541086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101519819|NCT00541086|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101519820|NCT00541086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101519821|NCT00541086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101519822|NCT00541086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101519823|NCT00541086|Hormone Antagonists|hormone antagonists|mesh-ancestor
101519824|NCT00541086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101519825|NCT00541086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519826|NCT00541086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101519829|NCT00541086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101519830|NCT04657484|Prednisolone|prednisolone|mesh-list
101519831|NCT04657484|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101519832|NCT04657484|Methylprednisolone|methylprednisolone|mesh-list
101519833|NCT04657484|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101519834|NCT04657484|Prednisolone acetate|prednisolone acetate|mesh-list
101519835|NCT04657484|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101519836|NCT04657484|Prednisolone phosphate|prednisolone phosphate|mesh-list
101203523|NCT01417923|Vitamins|vitamins|mesh-ancestor
101519837|NCT04657484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101312847|NCT00006469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101519838|NCT04657484|Glucocorticoids|glucocorticoids|mesh-ancestor
101519840|NCT04657484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101519841|NCT04657484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519842|NCT04657484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101519843|NCT04657484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101519844|NCT04657484|Antiemetics|antiemetics|mesh-ancestor
101519845|NCT04657484|Autonomic Agents|autonomic agents|mesh-ancestor
101519846|NCT04657484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101519847|NCT04657484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101519848|NCT04657484|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101519849|NCT04657484|Protective Agents|protective agents|mesh-ancestor
101519850|NCT00541125|Leucovorin|leucovorin|mesh-list
101519851|NCT00541125|Bevacizumab|bevacizumab|mesh-list
101519852|NCT00541125|Fluorouracil|fluorouracil|mesh-list
101519853|NCT00541125|Irinotecan|irinotecan|mesh-list
101519854|NCT00541125|Calcium|calcium|mesh-list
101519855|NCT00541125|Levoleucovorin|levoleucovorin|mesh-list
101519856|NCT00541125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101519857|NCT00541125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101519858|NCT00541125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101519859|NCT00541125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101519860|NCT00541125|Growth Substances|growth substances|mesh-ancestor
101519861|NCT00541125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519862|NCT00541125|Growth Inhibitors|growth inhibitors|mesh-ancestor
101519863|NCT00541125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101519864|NCT00541125|Antimetabolites|antimetabolites|mesh-ancestor
101519865|NCT00541125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519866|NCT00541125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101312883|NCT00006484|Antimitotic Agents|antimitotic agents|mesh-ancestor
101519868|NCT00541125|Immunologic Factors|immunologic factors|mesh-ancestor
101519869|NCT00541125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101519870|NCT00541125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101519871|NCT00541125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101519872|NCT00541125|Antidotes|antidotes|mesh-ancestor
101519873|NCT00541125|Protective Agents|protective agents|mesh-ancestor
101519874|NCT00541125|Vitamin B Complex|vitamin b complex|mesh-ancestor
101519875|NCT00541125|Vitamins|vitamins|mesh-ancestor
101519876|NCT00541125|Micronutrients|micronutrients|mesh-ancestor
101519877|NCT00541164|Ubiquinone|ubiquinone|mesh-list
101519878|NCT00541164|Coenzyme Q10|coenzyme q10|mesh-list
101519879|NCT00541164|Micronutrients|micronutrients|mesh-ancestor
101519880|NCT00541164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519881|NCT00541164|Vitamins|vitamins|mesh-ancestor
101519882|NCT00541281|Prednisone|prednisone|mesh-list
101519883|NCT00541281|Docetaxel|docetaxel|mesh-list
101519884|NCT00541281|Estramustine|estramustine|mesh-list
101519885|NCT00541281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101519886|NCT00541281|Tubulin Modulators|tubulin modulators|mesh-ancestor
101519887|NCT00541281|Antimitotic Agents|antimitotic agents|mesh-ancestor
101312929|NCT00006760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519888|NCT00541281|Mitosis Modulators|mitosis modulators|mesh-ancestor
101519889|NCT00541281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519891|NCT00541281|Glucocorticoids|glucocorticoids|mesh-ancestor
101519892|NCT00541281|Hormones|hormones|mesh-ancestor
101519893|NCT00541281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101519894|NCT00541281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519895|NCT00541281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101519896|NCT00541281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101519897|NCT00541281|Alkylating Agents|alkylating agents|mesh-ancestor
101312983|NCT00007189|Analgesics|analgesics|mesh-ancestor
101312984|NCT00007189|Sensory System Agents|sensory system agents|mesh-ancestor
101312985|NCT00007189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101312986|NCT00007189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312987|NCT00007189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101312994|NCT00388219|Buprenorphine|buprenorphine|mesh-list
101519898|NCT00541320|2-(5-chlorothien-2-yl)-N-(1-(1-methyl-2-(morpholin-4-yl)-2-oxoethyl)-2-oxopyrrolidin-3-yl)ethenesulfonamide|2-(5-chlorothien-2-yl)-n-(1-(1-methyl-2-(morpholin-4-yl)-2-oxoethyl)-2-oxopyrrolidin-3-yl)ethenesulfonamide|mesh-list
101519899|NCT00541320|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101519900|NCT00541320|Antithrombins|antithrombins|mesh-ancestor
101519901|NCT00541320|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101519902|NCT00541320|Protease Inhibitors|protease inhibitors|mesh-ancestor
101519903|NCT00541320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101519904|NCT00541320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519905|NCT00541320|Anticoagulants|anticoagulants|mesh-ancestor
101519906|NCT04657172|Pilocarpine|pilocarpine|mesh-list
101313044|NCT00007774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519907|NCT04657172|Miotics|miotics|mesh-ancestor
101519908|NCT04657172|Autonomic Agents|autonomic agents|mesh-ancestor
101203607|NCT01418417|Pantoprazole|pantoprazole|mesh-list
101519909|NCT04657172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101519910|NCT04657172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519911|NCT04657172|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101519912|NCT04657172|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101519913|NCT04657172|Cholinergic Agents|cholinergic agents|mesh-ancestor
101519914|NCT04657172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101519915|NCT04657172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519916|NCT03199794|Factor VIII|factor viii|mesh-list
101519917|NCT03199794|Coagulants|coagulants|mesh-ancestor
101519918|NCT00541359|Bortezomib|bortezomib|mesh-list
101519919|NCT00541359|Topotecan|topotecan|mesh-list
101519920|NCT00541359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101519921|NCT00541359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101519922|NCT00541359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101519923|NCT00541359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101519924|NCT00541359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519925|NCT03096249|Oxytocin|oxytocin|mesh-list
101519926|NCT03096249|Oxytocics|oxytocics|mesh-ancestor
101519927|NCT03096249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101519928|NCT03096249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519929|NCT04656665|Aspirin|aspirin|mesh-list
101519930|NCT04656665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101519931|NCT04656665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101519932|NCT04656665|Analgesics|analgesics|mesh-ancestor
101519933|NCT04656665|Sensory System Agents|sensory system agents|mesh-ancestor
101519934|NCT04656665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101313109|NCT00008008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101313111|NCT00008008|Alkylating Agents|alkylating agents|mesh-ancestor
101519935|NCT04656665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519936|NCT04656665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101519937|NCT04656665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101519938|NCT04656665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101519939|NCT04656665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101519940|NCT04656665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519941|NCT04656665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101519942|NCT04656665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101519943|NCT04656665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101519944|NCT04656665|Antipyretics|antipyretics|mesh-ancestor
101519945|NCT03014622|Botulinum Toxins|botulinum toxins|mesh-list
101519946|NCT03014622|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101519947|NCT03014622|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101519948|NCT03014622|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101519949|NCT03014622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101519950|NCT03014622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313157|NCT00008203|Cyclosporine|cyclosporine|mesh-list
101313159|NCT00008203|Thiotepa|thiotepa|mesh-list
101313160|NCT00008203|Carboplatin|carboplatin|mesh-list
101313161|NCT00008203|Cyclosporins|cyclosporins|mesh-list
101313162|NCT00008203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101519951|NCT03014622|Cholinergic Agents|cholinergic agents|mesh-ancestor
101519952|NCT03014622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101519953|NCT03014622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519954|NCT03014622|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101519955|NCT03014622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101519956|NCT04655807|Adalimumab|adalimumab|mesh-list
101519957|NCT04655807|Ustekinumab|ustekinumab|mesh-list
101519958|NCT04655807|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101519959|NCT04655807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101519960|NCT04655807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101519961|NCT04655807|Dermatologic Agents|dermatologic agents|mesh-ancestor
101519962|NCT04655417|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
101519963|NCT04655417|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
101519964|NCT04655417|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101519965|NCT00541515|Insulin|insulin|mesh-list
101519966|NCT00541515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101519967|NCT00541515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519968|NCT04655729|Infliximab|infliximab|mesh-list
101519969|NCT04655729|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101519970|NCT04655729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101519971|NCT04655729|Dermatologic Agents|dermatologic agents|mesh-ancestor
101519972|NCT04655729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101519973|NCT04655729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101519974|NCT00541554|Aripiprazole|aripiprazole|mesh-list
101519975|NCT00541554|Antidepressive Agents|antidepressive agents|mesh-ancestor
101519976|NCT00541554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101519977|NCT00541554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101519978|NCT00541554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101519979|NCT00541554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101519980|NCT00541554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101519981|NCT00541554|Dopamine Agonists|dopamine agonists|mesh-ancestor
101519982|NCT00541554|Dopamine Agents|dopamine agents|mesh-ancestor
101519983|NCT00541554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101519984|NCT00541554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519985|NCT00541554|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101519986|NCT00541554|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101519987|NCT00541554|Serotonin Agents|serotonin agents|mesh-ancestor
101519988|NCT00541554|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101519989|NCT00541554|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101519990|NCT00541554|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101519991|NCT00541554|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101519992|NCT04655183|Niraparib|niraparib|mesh-list
101519993|NCT04655183|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101519994|NCT04655183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101519995|NCT04655183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101519996|NCT04655183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101519997|NCT00541710|Genistein|genistein|mesh-list
101519998|NCT00541710|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101519999|NCT00541710|Protective Agents|protective agents|mesh-ancestor
101520000|NCT00541710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520001|NCT00541710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101520002|NCT00541710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101520003|NCT00541710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101520004|NCT00541710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520005|NCT00541710|Phytoestrogens|phytoestrogens|mesh-ancestor
101520006|NCT00541710|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101520007|NCT00541710|Estrogens|estrogens|mesh-ancestor
101520008|NCT00541710|Hormones|hormones|mesh-ancestor
101520009|NCT00541710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101520010|NCT04654676|Vildagliptin|vildagliptin|mesh-list
101520011|NCT04654676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101520012|NCT04654676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520013|NCT04654676|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101520014|NCT04654676|Protease Inhibitors|protease inhibitors|mesh-ancestor
101520015|NCT04654676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101520016|NCT04654676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520019|NCT00541905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101520020|NCT00541905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520021|NCT00541905|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101520022|NCT00541905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101520023|NCT00541905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520024|NCT00541905|Cholinergic Agents|cholinergic agents|mesh-ancestor
101520025|NCT00541905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101520026|NCT00542022|Oxymetazoline|oxymetazoline|mesh-list
101313234|NCT00008359|Antifungal Agents|antifungal agents|mesh-ancestor
101313237|NCT00008398|Sargramostim|sargramostim|mesh-list
101520027|NCT00542022|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101520028|NCT00542022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101520029|NCT00542022|Adrenergic Agents|adrenergic agents|mesh-ancestor
101520030|NCT00542022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101520031|NCT00542022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520032|NCT00542022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520033|NCT00542022|Sympathomimetics|sympathomimetics|mesh-ancestor
101520034|NCT00542022|Autonomic Agents|autonomic agents|mesh-ancestor
101520035|NCT00542022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101520036|NCT00542022|Nasal Decongestants|nasal decongestants|mesh-ancestor
101520037|NCT00542022|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101520038|NCT00542022|Respiratory System Agents|respiratory system agents|mesh-ancestor
101520039|NCT02546583|Chlorothiazide|chlorothiazide|mesh-list
101313294|NCT05637073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101520041|NCT02546583|Bumetanide|bumetanide|mesh-list
101313295|NCT05637073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520043|NCT02546583|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
101520044|NCT02546583|Natriuretic Agents|natriuretic agents|mesh-ancestor
101520045|NCT02546583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520046|NCT02546583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101520047|NCT02546583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520048|NCT02546583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101520049|NCT02546583|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101520050|NCT01205581|Vaccines|vaccines|mesh-list
101520051|NCT01205581|Immunologic Factors|immunologic factors|mesh-ancestor
101520052|NCT01205581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520053|NCT00542139|Betamethasone|betamethasone|mesh-list
101520054|NCT00542139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101520055|NCT00542139|Glucocorticoids|glucocorticoids|mesh-ancestor
101520056|NCT00542139|Hormones|hormones|mesh-ancestor
101520057|NCT00542139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101520058|NCT00542139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520059|NCT00542139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101520060|NCT00542139|Respiratory System Agents|respiratory system agents|mesh-ancestor
101520061|NCT00542295|Mebeverine|mebeverine|mesh-list
101520062|NCT00542295|Alverine|alverine|mesh-list
101520063|NCT00542295|Parasympatholytics|parasympatholytics|mesh-ancestor
101520064|NCT00542295|Autonomic Agents|autonomic agents|mesh-ancestor
101520065|NCT00542295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101520066|NCT00542295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520067|NCT00542295|Anticonvulsants|anticonvulsants|mesh-ancestor
101520068|NCT03454841|Ticagrelor|ticagrelor|mesh-list
101520069|NCT03454841|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101520070|NCT03454841|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101520071|NCT03454841|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101520072|NCT03454841|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101520073|NCT03454841|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101520074|NCT03454841|Purinergic Agents|purinergic agents|mesh-ancestor
101520075|NCT03454841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101520076|NCT03454841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313355|NCT05638984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101313356|NCT05638984|Antimetabolites|antimetabolites|mesh-ancestor
101520077|NCT03454841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520079|NCT02293980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101520080|NCT02293980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101520081|NCT02293980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101520082|NCT02293980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520083|NCT04653506|Acetaminophen|acetaminophen|mesh-list
101520084|NCT04653506|Ibuprofen|ibuprofen|mesh-list
101520085|NCT04653506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101520086|NCT04653506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101520088|NCT04653506|Sensory System Agents|sensory system agents|mesh-ancestor
101520089|NCT04653506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101520090|NCT04653506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520091|NCT04653506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101520092|NCT04653506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101313394|NCT00000136|Foscarnet|foscarnet|mesh-list
101313395|NCT00000136|Antiviral Agents|antiviral agents|mesh-ancestor
101313396|NCT00000136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101313397|NCT00000136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101520093|NCT04653506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101520094|NCT04653506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101520095|NCT04653506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520097|NCT00542412|Riluzole|riluzole|mesh-list
101520098|NCT00542412|Anticonvulsants|anticonvulsants|mesh-ancestor
101520099|NCT00542412|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101520100|NCT00542412|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101520101|NCT00542412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101520102|NCT00542412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520103|NCT00542412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520104|NCT00542412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101520105|NCT00542412|Protective Agents|protective agents|mesh-ancestor
101520106|NCT04653623|Tranexamic Acid|tranexamic acid|mesh-list
101313452|NCT00000172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101313453|NCT00000172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101313455|NCT00000172|Cholinergic Agents|cholinergic agents|mesh-ancestor
101520107|NCT04653623|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101520108|NCT04653623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101520109|NCT04653623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520110|NCT04653623|Hemostatics|hemostatics|mesh-ancestor
101520111|NCT04653623|Coagulants|coagulants|mesh-ancestor
101520112|NCT00542568|Epoetin Alfa|epoetin alfa|mesh-list
101520113|NCT00542568|Hematinics|hematinics|mesh-ancestor
101520114|NCT04653779|Metformin|metformin|mesh-list
101520115|NCT04653779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101520116|NCT04653779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520117|NCT00542607|Levocetirizine|levocetirizine|mesh-list
101520118|NCT00542607|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101313512|NCT00000256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101313513|NCT00000256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520119|NCT00542607|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101520120|NCT00542607|Histamine Antagonists|histamine antagonists|mesh-ancestor
101520121|NCT00542607|Histamine Agents|histamine agents|mesh-ancestor
101520122|NCT00542607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101520123|NCT00542607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520124|NCT00542607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520125|NCT04685031|Clobetasol|clobetasol|mesh-list
101520126|NCT04685031|Nitroglycerin|nitroglycerin|mesh-list
101520127|NCT04685031|Vasodilator Agents|vasodilator agents|mesh-ancestor
101520128|NCT04685031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101520129|NCT04685031|Glucocorticoids|glucocorticoids|mesh-ancestor
101520130|NCT04685031|Hormones|hormones|mesh-ancestor
101520131|NCT04685031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101313571|NCT00000466|Progestins|progestins|mesh-ancestor
101313572|NCT00000466|Hormones|hormones|mesh-ancestor
101520134|NCT00542763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101203822|NCT01419691|Auranofin|auranofin|mesh-list
101520135|NCT00542763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101520136|NCT00542763|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101520137|NCT00542763|Antitubercular Agents|antitubercular agents|mesh-ancestor
101520138|NCT00542763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101520139|NCT00542763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101520140|NCT00542763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101520141|NCT00542763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520143|NCT01854684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101520144|NCT01854684|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101520145|NCT01854684|Dermatologic Agents|dermatologic agents|mesh-ancestor
101520146|NCT00542802|Carbamazepine|carbamazepine|mesh-list
101520147|NCT00542802|Levetiracetam|levetiracetam|mesh-list
101520148|NCT00542802|Anticonvulsants|anticonvulsants|mesh-ancestor
101520149|NCT00542802|Nootropic Agents|nootropic agents|mesh-ancestor
101520150|NCT00542802|Antimanic Agents|antimanic agents|mesh-ancestor
101520151|NCT00542802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101520152|NCT00542802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101520153|NCT00542802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520154|NCT00542802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101313633|NCT00388882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101313635|NCT00388882|Anticonvulsants|anticonvulsants|mesh-ancestor
101520155|NCT00542802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101520157|NCT00542802|Sensory System Agents|sensory system agents|mesh-ancestor
101520158|NCT00542802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101520159|NCT00542802|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101520160|NCT00542802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101520161|NCT00542802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520162|NCT00542802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101520163|NCT00542802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101520165|NCT04652648|Antimalarials|antimalarials|mesh-ancestor
101520166|NCT04652648|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101520167|NCT04652648|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101520168|NCT04652648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101520169|NCT04652648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101313686|NCT00000499|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101313687|NCT00000499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101313689|NCT00000514|Chlorthalidone|chlorthalidone|mesh-list
101520170|NCT04652648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520171|NCT04652648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101520172|NCT00542841|Hydrocortisone|hydrocortisone|mesh-list
101520173|NCT00542841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101520174|NCT04652765|Bicalutamide|bicalutamide|mesh-list
101520176|NCT04652765|Androgen Antagonists|androgen antagonists|mesh-ancestor
101520177|NCT04652765|Hormone Antagonists|hormone antagonists|mesh-ancestor
101520178|NCT04652765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101520179|NCT04652765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520180|NCT04652765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101520181|NCT04652765|Protease Inhibitors|protease inhibitors|mesh-ancestor
101313745|NCT00000526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101520182|NCT04652765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101520183|NCT04652765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520184|NCT04652765|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101520185|NCT04652765|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101520186|NCT04652492|Tislelizumab|tislelizumab|mesh-list
101520187|NCT04652492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101520188|NCT04652492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101520189|NCT00543075|Oblimersen|oblimersen|mesh-list
101520190|NCT00543075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101520191|NCT00543114|Rituximab|rituximab|mesh-list
101520192|NCT00543114|Fludarabine|fludarabine|mesh-list
101520193|NCT00543114|Lenalidomide|lenalidomide|mesh-list
101520194|NCT00543114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101520195|NCT00543114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101520196|NCT00543114|Immunologic Factors|immunologic factors|mesh-ancestor
101520197|NCT00543114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520198|NCT00543114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101520199|NCT00543114|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101520200|NCT00543114|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101520201|NCT00543114|Growth Substances|growth substances|mesh-ancestor
101520202|NCT00543114|Growth Inhibitors|growth inhibitors|mesh-ancestor
101520203|NCT03454724|Sirolimus|sirolimus|mesh-list
101520204|NCT03454724|Everolimus|everolimus|mesh-list
101520205|NCT03454724|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101520206|NCT03454724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101520207|NCT03454724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101520208|NCT03454724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520209|NCT03454724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101203900|NCT01420406|Vitamin A|vitamin a|mesh-list
101520210|NCT03454724|Immunologic Factors|immunologic factors|mesh-ancestor
101520211|NCT03454724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520212|NCT03454724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101520213|NCT03454724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101520214|NCT03454724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101520215|NCT03454724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101520216|NCT03454724|Antifungal Agents|antifungal agents|mesh-ancestor
101520217|NCT01014546|Vitamins|vitamins|mesh-list
101520218|NCT01014546|Ascorbic Acid|ascorbic acid|mesh-list
101520219|NCT01014546|Arsenic Trioxide|arsenic trioxide|mesh-list
101520220|NCT01014546|Micronutrients|micronutrients|mesh-ancestor
101520221|NCT01014546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520222|NCT01014546|Antioxidants|antioxidants|mesh-ancestor
101520223|NCT01014546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520224|NCT01014546|Protective Agents|protective agents|mesh-ancestor
101520225|NCT01014546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101520227|NCT00543231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101520228|NCT00557843|Bupivacaine|bupivacaine|mesh-list
101520229|NCT00557843|Anesthetics, Local|anesthetics, local|mesh-ancestor
101520230|NCT00557843|Anesthetics|anesthetics|mesh-ancestor
101520231|NCT00557843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101520232|NCT00557843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520233|NCT00557843|Sensory System Agents|sensory system agents|mesh-ancestor
101520234|NCT00557843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101520235|NCT04651556|Acetaminophen|acetaminophen|mesh-list
101520236|NCT04651556|Ketorolac|ketorolac|mesh-list
101520237|NCT04651556|Magnesium Sulfate|magnesium sulfate|mesh-list
101520239|NCT04651556|Anesthetics, Local|anesthetics, local|mesh-ancestor
101520240|NCT04651556|Anesthetics|anesthetics|mesh-ancestor
101520241|NCT04651556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101520242|NCT04651556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520243|NCT04651556|Sensory System Agents|sensory system agents|mesh-ancestor
101520244|NCT04651556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101520245|NCT04651556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101520246|NCT04651556|Analgesics|analgesics|mesh-ancestor
101520247|NCT04651556|Antipyretics|antipyretics|mesh-ancestor
101520248|NCT04651556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101520249|NCT04651556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101313868|NCT00000625|Zalcitabine|zalcitabine|mesh-list
101520250|NCT04651556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101520251|NCT04651556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101520252|NCT04651556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101520253|NCT04651556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520254|NCT04651556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101520255|NCT04651556|Anticonvulsants|anticonvulsants|mesh-ancestor
101520256|NCT04651556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101520257|NCT04651556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101520258|NCT04651556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101520259|NCT04651556|Tocolytic Agents|tocolytic agents|mesh-ancestor
101520260|NCT04651556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101520263|NCT04651049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101520264|NCT04651049|Adrenergic Agents|adrenergic agents|mesh-ancestor
101520265|NCT04651049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101313896|NCT00000640|Sulfamethoxazole|sulfamethoxazole|mesh-list
101313897|NCT00000640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101313898|NCT00000640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101313899|NCT00000640|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101313937|NCT00000652|Zidovudine|zidovudine|mesh-list
101520266|NCT04651049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520267|NCT04651049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520268|NCT04651049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101520269|NCT04651049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101520270|NCT04651049|Vasodilator Agents|vasodilator agents|mesh-ancestor
101520271|NCT04651205|Thiamine|thiamine|mesh-list
101520272|NCT04651205|Vitamins|vitamins|mesh-ancestor
101520273|NCT04651205|Micronutrients|micronutrients|mesh-ancestor
101520274|NCT04651205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520275|NCT04651205|Vitamin B Complex|vitamin b complex|mesh-ancestor
101520276|NCT03456648|Apixaban|apixaban|mesh-list
101520277|NCT03456648|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101520278|NCT03456648|Antithrombins|antithrombins|mesh-ancestor
101520279|NCT03456648|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101520280|NCT03456648|Protease Inhibitors|protease inhibitors|mesh-ancestor
101520281|NCT03456648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101520282|NCT03456648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520283|NCT03456648|Anticoagulants|anticoagulants|mesh-ancestor
101520284|NCT00557921|Aspirin|aspirin|mesh-list
101520285|NCT00557921|Omeprazole|omeprazole|mesh-list
101203972|NCT01420822|Dermatologic Agents|dermatologic agents|mesh-ancestor
101520286|NCT00557921|Clopidogrel|clopidogrel|mesh-list
101520287|NCT00557921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101520288|NCT00557921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101520289|NCT00557921|Analgesics|analgesics|mesh-ancestor
101520290|NCT00557921|Sensory System Agents|sensory system agents|mesh-ancestor
101520291|NCT00557921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101520292|NCT00557921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520293|NCT00557921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101520296|NCT00557921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101520297|NCT00557921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520298|NCT00557921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101520299|NCT00557921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101520300|NCT00557921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101520302|NCT00557921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101520303|NCT00557921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101520304|NCT00557921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101520305|NCT00557921|Purinergic Agents|purinergic agents|mesh-ancestor
101520306|NCT00557921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101520307|NCT00557921|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101520308|NCT00557921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101520309|NCT00557921|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101520311|NCT02352558|Bortezomib|bortezomib|mesh-list
101520312|NCT02352558|Imatinib Mesylate|imatinib mesylate|mesh-list
101520315|NCT02352558|Autonomic Agents|autonomic agents|mesh-ancestor
101520316|NCT02352558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101520317|NCT02352558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520318|NCT02352558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101520319|NCT02352558|Glucocorticoids|glucocorticoids|mesh-ancestor
101520320|NCT02352558|Hormones|hormones|mesh-ancestor
101520321|NCT02352558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101520322|NCT02352558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101313952|NCT00000676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101520326|NCT02352558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313953|NCT00000676|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101520328|NCT02324283|Desflurane|desflurane|mesh-list
101520329|NCT02324283|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101520330|NCT02324283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101520337|NCT00557960|Adderall|adderall|mesh-list
101520338|NCT00557960|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101520339|NCT00557960|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101520340|NCT00557960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101520342|NCT00557960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520344|NCT00557960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101520345|NCT00557960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520346|NCT00557960|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101520347|NCT00557960|Sympathomimetics|sympathomimetics|mesh-ancestor
101520348|NCT00557960|Autonomic Agents|autonomic agents|mesh-ancestor
101520354|NCT00558077|Enclomiphene|enclomiphene|mesh-list
101520355|NCT00558077|Zuclomiphene|zuclomiphene|mesh-list
101520356|NCT00558077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101520357|NCT00558077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520358|NCT00558077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101520359|NCT00558077|Hormone Antagonists|hormone antagonists|mesh-ancestor
101520360|NCT00558077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101520361|NCT00558077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101520362|NCT00558077|Fertility Agents|fertility agents|mesh-ancestor
101520363|NCT00558077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101520366|NCT05077254|Mycophenolic Acid|mycophenolic acid|mesh-list
101520368|NCT05077254|Tacrolimus|tacrolimus|mesh-list
101520369|NCT05077254|Immunologic Factors|immunologic factors|mesh-ancestor
101520370|NCT05077254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520371|NCT05077254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101520372|NCT05077254|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101520373|NCT05077254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101520375|NCT05077254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101520376|NCT05077254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101520377|NCT05077254|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101520378|NCT05077254|Antitubercular Agents|antitubercular agents|mesh-ancestor
101520379|NCT05077254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101520380|NCT05077254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101520383|NCT00543504|Cetuximab|cetuximab|mesh-list
101520384|NCT00543504|Sunitinib|sunitinib|mesh-list
101520385|NCT00543504|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101520386|NCT00543504|Sorafenib|sorafenib|mesh-list
101520387|NCT00543504|Lapatinib|lapatinib|mesh-list
101520388|NCT00543504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101520389|NCT00543504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101520391|NCT00543504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101520392|NCT00543504|Growth Substances|growth substances|mesh-ancestor
101520393|NCT00543504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520394|NCT00543504|Growth Inhibitors|growth inhibitors|mesh-ancestor
101520395|NCT00543504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101520396|NCT00543504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101520397|NCT00543504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520399|NCT00543933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101520400|NCT00543933|Autonomic Agents|autonomic agents|mesh-ancestor
101520401|NCT00543933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101520402|NCT00543933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520403|NCT00543933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101520404|NCT00543933|Respiratory System Agents|respiratory system agents|mesh-ancestor
101520405|NCT00543933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101520406|NCT00543933|Antioxidants|antioxidants|mesh-ancestor
101520407|NCT00543933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520408|NCT00543933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101520409|NCT00543933|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101520410|NCT00543933|Vasodilator Agents|vasodilator agents|mesh-ancestor
101520411|NCT00543933|Gasotransmitters|gasotransmitters|mesh-ancestor
101520412|NCT00543933|Protective Agents|protective agents|mesh-ancestor
101520413|NCT00544011|Bevacizumab|bevacizumab|mesh-list
101520414|NCT00544011|Fluorouracil|fluorouracil|mesh-list
101520415|NCT00544011|Capecitabine|capecitabine|mesh-list
101520416|NCT00544011|Irinotecan|irinotecan|mesh-list
101520417|NCT00544011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101520418|NCT00544011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101520419|NCT00544011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101314033|NCT00000718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101314034|NCT00000739|Dapsone|dapsone|mesh-list
101520420|NCT00544011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101520422|NCT00544011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520423|NCT00544011|Growth Inhibitors|growth inhibitors|mesh-ancestor
101520424|NCT00544011|Antimetabolites|antimetabolites|mesh-ancestor
101520425|NCT00544011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520426|NCT00544011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101520427|NCT00544011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101520428|NCT00544011|Immunologic Factors|immunologic factors|mesh-ancestor
101520429|NCT00544011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101520430|NCT00544011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101520431|NCT00544011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101520432|NCT00544050|Levetiracetam|levetiracetam|mesh-list
101520433|NCT00544050|Anticonvulsants|anticonvulsants|mesh-ancestor
101520434|NCT00544050|Nootropic Agents|nootropic agents|mesh-ancestor
101520437|NCT04649723|Antitubercular Agents|antitubercular agents|mesh-ancestor
101314052|NCT00000742|Antiviral Agents|antiviral agents|mesh-ancestor
101520439|NCT04649723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101520440|NCT04649723|Leprostatic Agents|leprostatic agents|mesh-ancestor
101520441|NCT04649723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101520442|NCT04649723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101520443|NCT04649723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520444|NCT04649723|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101520445|NCT04649723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101520446|NCT04649723|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101520447|NCT04649723|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101520448|NCT04649723|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101520449|NCT04649723|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101520450|NCT02909088|Ecopipam|ecopipam|mesh-list
101520451|NCT02909088|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101520452|NCT02909088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101520453|NCT02909088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101520454|NCT02909088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520455|NCT02909088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101520458|NCT02909088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101520459|NCT02909088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520460|NCT04649645|Nicotine|nicotine|mesh-list
101520461|NCT04649645|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101314111|NCT00000760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101314112|NCT00000760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314117|NCT00000790|Thalidomide|thalidomide|mesh-list
101520462|NCT04649645|Autonomic Agents|autonomic agents|mesh-ancestor
101520463|NCT04649645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101520464|NCT04649645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520465|NCT04649645|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101520466|NCT04649645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101520467|NCT04649645|Cholinergic Agents|cholinergic agents|mesh-ancestor
101520468|NCT04649645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101520469|NCT04649645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520471|NCT00544128|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101520472|NCT00544128|Tenofovir|tenofovir|mesh-list
101520473|NCT00544128|Lamivudine|lamivudine|mesh-list
101520474|NCT00544128|Emtricitabine|emtricitabine|mesh-list
101520475|NCT00544128|Abacavir|abacavir|mesh-list
101520476|NCT00544128|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101520477|NCT00544128|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101520478|NCT00544128|Protease Inhibitors|protease inhibitors|mesh-ancestor
101520479|NCT00544128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101520480|NCT00544128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520481|NCT00544128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101520482|NCT00544128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101520483|NCT00544128|Antiviral Agents|antiviral agents|mesh-ancestor
101314163|NCT00000799|Antiviral Agents|antiviral agents|mesh-ancestor
101314164|NCT00000799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314165|NCT00000799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314166|NCT00000799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520484|NCT00544128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101520485|NCT00544128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101520486|NCT00544128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101520487|NCT00544128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101520488|NCT00544128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101520489|NCT05476432|Leucovorin|leucovorin|mesh-list
101520490|NCT05476432|Fluorouracil|fluorouracil|mesh-list
101520491|NCT05476432|Oxaliplatin|oxaliplatin|mesh-list
101520492|NCT05476432|Antimetabolites|antimetabolites|mesh-ancestor
101520493|NCT05476432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520494|NCT05476432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101520495|NCT05476432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101314212|NCT00000826|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101314213|NCT00000826|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101314214|NCT00000826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101314215|NCT00000826|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101314216|NCT00000826|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101520496|NCT05476432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101520497|NCT05476432|Immunologic Factors|immunologic factors|mesh-ancestor
101520498|NCT05476432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520499|NCT05476432|Antidotes|antidotes|mesh-ancestor
101520501|NCT05476432|Vitamin B Complex|vitamin b complex|mesh-ancestor
101520502|NCT05476432|Vitamins|vitamins|mesh-ancestor
101520503|NCT05476432|Micronutrients|micronutrients|mesh-ancestor
101520504|NCT01239745|Exemestane|exemestane|mesh-list
101520505|NCT01239745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101520506|NCT01239745|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101520507|NCT01239745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101520508|NCT01239745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101520509|NCT01239745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520510|NCT01239745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101520511|NCT01239745|Hormone Antagonists|hormone antagonists|mesh-ancestor
101314277|NCT00000895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101520512|NCT01239745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101520513|NCT01239745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520514|NCT01239472|Everolimus|everolimus|mesh-list
101520515|NCT01239472|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101520516|NCT01239472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101520517|NCT01239472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101520518|NCT01239472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520519|NCT01239472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101520520|NCT01239472|Immunologic Factors|immunologic factors|mesh-ancestor
101520521|NCT01239472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520522|NCT01239472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101520523|NCT00544284|Temozolomide|temozolomide|mesh-list
101520524|NCT00544284|Bortezomib|bortezomib|mesh-list
101520525|NCT00544284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101520526|NCT00544284|Alkylating Agents|alkylating agents|mesh-ancestor
101520527|NCT00544284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520528|NCT00544284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101520529|NCT02888275|Dexmedetomidine|dexmedetomidine|mesh-list
101520530|NCT02888275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101520531|NCT02888275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101520532|NCT02888275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520533|NCT02888275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101520534|NCT02888275|Analgesics|analgesics|mesh-ancestor
101520535|NCT02888275|Sensory System Agents|sensory system agents|mesh-ancestor
101520536|NCT02888275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101520537|NCT02888275|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101520538|NCT02888275|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101520539|NCT02888275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101520540|NCT02888275|Adrenergic Agents|adrenergic agents|mesh-ancestor
101520541|NCT02888275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101314339|NCT00000919|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101520542|NCT02888275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520543|NCT03456531|Aspirin|aspirin|mesh-list
101520544|NCT03456531|Analgesics|analgesics|mesh-list
101520545|NCT03456531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101520546|NCT03456531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101520547|NCT03456531|Sensory System Agents|sensory system agents|mesh-ancestor
101520548|NCT03456531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101520549|NCT03456531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520550|NCT03456531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101520551|NCT03456531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101520552|NCT03456531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101411199|NCT00450736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101520553|NCT03456531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101520554|NCT03456531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520555|NCT03456531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101520556|NCT03456531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101314384|NCT00000940|Ritonavir|ritonavir|mesh-list
101520557|NCT03456531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101520558|NCT03456531|Antipyretics|antipyretics|mesh-ancestor
101520559|NCT02909049|Midazolam|midazolam|mesh-list
101520560|NCT02909049|Ketamine|ketamine|mesh-list
101520561|NCT02909049|Mepivacaine|mepivacaine|mesh-list
101520562|NCT02909049|Analgesics|analgesics|mesh-ancestor
101520563|NCT02909049|Sensory System Agents|sensory system agents|mesh-ancestor
101520564|NCT02909049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101520565|NCT02909049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520566|NCT02909049|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101520567|NCT02909049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101520568|NCT02909049|Anesthetics, General|anesthetics, general|mesh-ancestor
101520569|NCT02909049|Anesthetics|anesthetics|mesh-ancestor
101520570|NCT02909049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101520571|NCT02909049|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101520572|NCT02909049|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101520573|NCT02909049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101520574|NCT02909049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520575|NCT02909049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101520576|NCT02909049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101520577|NCT02909049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101314447|NCT00000970|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
101314448|NCT00000970|Antiviral Agents|antiviral agents|mesh-ancestor
101314454|NCT00000973|Leucovorin|leucovorin|mesh-list
101520578|NCT02909049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101520579|NCT02909049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101520580|NCT02909049|GABA Modulators|gaba modulators|mesh-ancestor
101520581|NCT02909049|GABA Agents|gaba agents|mesh-ancestor
101520582|NCT02909049|Anesthetics, Local|anesthetics, local|mesh-ancestor
101520583|NCT01229449|Acetaminophen|acetaminophen|mesh-list
101520585|NCT01229449|Codeine|codeine|mesh-list
101520586|NCT01229449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101520587|NCT01229449|Analgesics|analgesics|mesh-ancestor
101520588|NCT01229449|Sensory System Agents|sensory system agents|mesh-ancestor
101520589|NCT01229449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101520590|NCT01229449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314505|NCT00001003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101520591|NCT01229449|Antipyretics|antipyretics|mesh-ancestor
101520592|NCT01229449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101520593|NCT01229449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101520594|NCT01229449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101520595|NCT01229449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101520596|NCT01229449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101520597|NCT01229449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520598|NCT01229449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101520599|NCT01229449|Narcotics|narcotics|mesh-ancestor
101520600|NCT01229449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101520601|NCT01229449|Antitussive Agents|antitussive agents|mesh-ancestor
101520602|NCT01229449|Respiratory System Agents|respiratory system agents|mesh-ancestor
101520603|NCT01238575|Guanfacine|guanfacine|mesh-list
101314570|NCT00001036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314572|NCT00001036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314583|NCT00001045|Nevirapine|nevirapine|mesh-list
101520604|NCT01238575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101520605|NCT01238575|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101520606|NCT01238575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101520607|NCT01238575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101520608|NCT01238575|Adrenergic Agents|adrenergic agents|mesh-ancestor
101520609|NCT01238575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101520610|NCT01238575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520611|NCT01238575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520612|NCT01237951|Dexamethasone|dexamethasone|mesh-list
101520613|NCT01237951|Gemcitabine|gemcitabine|mesh-list
101520614|NCT01237951|Melphalan|melphalan|mesh-list
101520615|NCT01237951|Busulfan|busulfan|mesh-list
101520616|NCT01237951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101520618|NCT01237951|Autonomic Agents|autonomic agents|mesh-ancestor
101520619|NCT01237951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101520620|NCT01237951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520621|NCT01237951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101520622|NCT01237951|Glucocorticoids|glucocorticoids|mesh-ancestor
101520623|NCT01237951|Hormones|hormones|mesh-ancestor
101520624|NCT01237951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101314634|NCT00001075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101314643|NCT00001084|Lamivudine|lamivudine|mesh-list
101520625|NCT01237951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101520626|NCT01237951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101520627|NCT01237951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101520628|NCT01237951|Antimetabolites|antimetabolites|mesh-ancestor
101520629|NCT01237951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520630|NCT01237951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101520631|NCT01237951|Alkylating Agents|alkylating agents|mesh-ancestor
101520632|NCT01237951|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101520633|NCT01237951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101520634|NCT01237951|Immunologic Factors|immunologic factors|mesh-ancestor
101520636|NCT02908581|Vitamin B Complex|vitamin b complex|mesh-list
101520637|NCT02908581|Hematinics|hematinics|mesh-ancestor
101520638|NCT02908581|Vitamins|vitamins|mesh-ancestor
101520639|NCT02908581|Micronutrients|micronutrients|mesh-ancestor
101520640|NCT02908581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520641|NCT00544362|Fluorouracil|fluorouracil|mesh-list
101520642|NCT00544362|Cetuximab|cetuximab|mesh-list
101520643|NCT00544362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101520644|NCT00544362|Antimetabolites|antimetabolites|mesh-ancestor
101520645|NCT00544362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520646|NCT00544362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101520647|NCT00544362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101520648|NCT00544362|Immunologic Factors|immunologic factors|mesh-ancestor
101520649|NCT00544362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520650|NCT00544362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101520651|NCT01239394|Ofatumumab|ofatumumab|mesh-list
101520652|NCT01239394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101520653|NCT00553293|Hormones|hormones|mesh-list
101520654|NCT00553293|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101520655|NCT00553293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101520656|NCT00553293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520657|NCT04648358|Dexamethasone|dexamethasone|mesh-list
101520658|NCT04648358|Bupivacaine|bupivacaine|mesh-list
101520659|NCT04648358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101520660|NCT04648358|Antiemetics|antiemetics|mesh-ancestor
101520661|NCT04648358|Autonomic Agents|autonomic agents|mesh-ancestor
101520662|NCT04648358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101520663|NCT04648358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520664|NCT04648358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101520665|NCT04648358|Glucocorticoids|glucocorticoids|mesh-ancestor
101520666|NCT04648358|Hormones|hormones|mesh-ancestor
101314692|NCT00001105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520667|NCT04648358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101520668|NCT04648358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101520669|NCT04648358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101520670|NCT04648358|Anesthetics, Local|anesthetics, local|mesh-ancestor
101520671|NCT04648358|Anesthetics|anesthetics|mesh-ancestor
101520676|NCT00544518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101520677|NCT00544518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520678|NCT00544518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101520679|NCT00544518|Antimetabolites|antimetabolites|mesh-ancestor
101520680|NCT00544518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520681|NCT00544518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101520682|NCT00544518|Appetite Depressants|appetite depressants|mesh-ancestor
101520683|NCT00544518|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101520684|NCT02908698|Prednisone|prednisone|mesh-list
101520685|NCT02908698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101520686|NCT02908698|Glucocorticoids|glucocorticoids|mesh-ancestor
101520687|NCT02908698|Hormones|hormones|mesh-ancestor
101314724|NCT00001165|Fluorouracil|fluorouracil|mesh-list
101520688|NCT02908698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101520689|NCT02908698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520690|NCT02908698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101520691|NCT02908698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101520693|NCT00544596|Etoposide|etoposide|mesh-list
101520694|NCT00544596|Etoposide phosphate|etoposide phosphate|mesh-list
101520695|NCT00544596|Retinol acetate|retinol acetate|mesh-list
101520696|NCT00544596|Gossypol acetic acid|gossypol acetic acid|mesh-list
101520697|NCT00544596|Gossypol|gossypol|mesh-list
101520698|NCT00544596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101520699|NCT00544596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101520700|NCT00544596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101314785|NCT00001267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101520701|NCT00544596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101520702|NCT00544596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101520703|NCT00544596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520704|NCT00544596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101520705|NCT00544596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101520706|NCT00544596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101520707|NCT00544596|Immunologic Factors|immunologic factors|mesh-ancestor
101520708|NCT00544596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520709|NCT00544596|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101520710|NCT00544596|Protective Agents|protective agents|mesh-ancestor
101520711|NCT00544596|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101520712|NCT00544596|Contraceptive Agents|contraceptive agents|mesh-ancestor
101520713|NCT00544596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101314845|NCT00388557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520714|NCT00544596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101520715|NCT00544596|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
101520716|NCT00544596|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
101520717|NCT02908191|Tenofovir|tenofovir|mesh-list
101520718|NCT02908191|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101520719|NCT02908191|Entecavir|entecavir|mesh-list
101520720|NCT02908191|Antiviral Agents|antiviral agents|mesh-ancestor
101520721|NCT02908191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101520722|NCT02908191|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101520723|NCT02908191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101520724|NCT02908191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101520725|NCT02908191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520726|NCT02908191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101520728|NCT00544791|Melatonin|melatonin|mesh-list
101520729|NCT00544791|Antioxidants|antioxidants|mesh-ancestor
101520730|NCT00544791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520731|NCT00544791|Protective Agents|protective agents|mesh-ancestor
101520732|NCT00544791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314901|NCT00001507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101314906|NCT00001576|Leucovorin|leucovorin|mesh-list
101520733|NCT00544791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101520734|NCT04647773|Pregabalin|pregabalin|mesh-list
101520735|NCT04647773|Analgesics|analgesics|mesh-ancestor
101520736|NCT04647773|Sensory System Agents|sensory system agents|mesh-ancestor
101520737|NCT04647773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101520738|NCT04647773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520739|NCT04647773|Anticonvulsants|anticonvulsants|mesh-ancestor
101520740|NCT04647773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101520741|NCT04647773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101520742|NCT04647773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520743|NCT04647773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101520745|NCT04647773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101520746|NCT04647773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101520747|NCT04647773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101520748|NCT01237678|Carboplatin|carboplatin|mesh-list
101520749|NCT01237678|Etoposide|etoposide|mesh-list
101520750|NCT01237678|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
101314961|NCT00001666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101314962|NCT00001669|Mecasermin|mecasermin|mesh-list
101520752|NCT01237678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101520753|NCT01237678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101520754|NCT01237678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101520755|NCT01237678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101520756|NCT01237678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520757|NCT01237678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101520758|NCT01237678|Immunotoxins|immunotoxins|mesh-ancestor
101520759|NCT01237678|Immunoconjugates|immunoconjugates|mesh-ancestor
101520760|NCT01237678|Immunologic Factors|immunologic factors|mesh-ancestor
101520762|NCT04647461|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101520763|NCT04647461|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101520764|NCT04647461|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101520765|NCT04647461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101520766|NCT04647461|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101520767|NCT04647461|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101520768|NCT04647461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101520769|NCT04647461|Adrenergic Agents|adrenergic agents|mesh-ancestor
101520770|NCT04647461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101520771|NCT04647461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520772|NCT04647461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520773|NCT01229371|Vaccines|vaccines|mesh-list
101520774|NCT01229371|Immunologic Factors|immunologic factors|mesh-ancestor
101520775|NCT01229371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520776|NCT02908152|Curcumin|curcumin|mesh-list
101520777|NCT02908152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101520778|NCT02908152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101520779|NCT02908152|Analgesics|analgesics|mesh-ancestor
101520780|NCT02908152|Sensory System Agents|sensory system agents|mesh-ancestor
101315018|NCT00001729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101315019|NCT00001741|Losartan|losartan|mesh-list
101315020|NCT00001741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101520781|NCT02908152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101520782|NCT02908152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520783|NCT02908152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101520784|NCT02908152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101520785|NCT02908152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101520786|NCT02908152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101520787|NCT02908152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520788|NCT01237327|Exemestane|exemestane|mesh-list
101520789|NCT01237327|Megestrol|megestrol|mesh-list
101520791|NCT01237327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101520792|NCT01237327|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101520793|NCT01237327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101520794|NCT01237327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101520795|NCT01237327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520796|NCT01237327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101520797|NCT01237327|Hormone Antagonists|hormone antagonists|mesh-ancestor
101520798|NCT01237327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101315057|NCT00000216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315062|NCT00000252|Nitrous Oxide|nitrous oxide|mesh-list
101520800|NCT01237327|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101520801|NCT01237327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101520802|NCT01237327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101520803|NCT01237327|Contraceptive Agents|contraceptive agents|mesh-ancestor
101520804|NCT01237327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101520805|NCT01237327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101520806|NCT01237327|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101520807|NCT01237327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101520808|NCT01237327|Appetite Stimulants|appetite stimulants|mesh-ancestor
101520809|NCT01237327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101520810|NCT02907021|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101520811|NCT02907021|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101520812|NCT02907021|Adrenergic Agents|adrenergic agents|mesh-ancestor
101520813|NCT02907021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101520814|NCT02907021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520815|NCT02907021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520816|NCT01237054|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101520817|NCT01237054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101520818|NCT01237054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520819|NCT04647695|Interferons|interferons|mesh-list
101520820|NCT04647695|Interferon-beta|interferon-beta|mesh-list
101520821|NCT04647695|Remdesivir|remdesivir|mesh-list
101520822|NCT04647695|Interferon beta-1b|interferon beta-1b|mesh-list
101520823|NCT04647695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101520824|NCT04647695|Antiviral Agents|antiviral agents|mesh-ancestor
101520825|NCT04647695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101315114|NCT00389506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101315115|NCT00389506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101315117|NCT00389506|Antimetabolites|antimetabolites|mesh-ancestor
101520827|NCT04647695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520828|NCT04647695|Antimetabolites|antimetabolites|mesh-ancestor
101520829|NCT04647695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520830|NCT04647695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101520831|NCT04647344|Paclitaxel|paclitaxel|mesh-list
101520832|NCT04647344|Carboplatin|carboplatin|mesh-list
101520833|NCT04647344|Pemetrexed|pemetrexed|mesh-list
101520834|NCT04647344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101520835|NCT04647344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101520836|NCT04647344|Tubulin Modulators|tubulin modulators|mesh-ancestor
101520837|NCT04647344|Antimitotic Agents|antimitotic agents|mesh-ancestor
101520838|NCT04647344|Mitosis Modulators|mitosis modulators|mesh-ancestor
101520839|NCT04647344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520840|NCT04647344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101520841|NCT04647344|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101520842|NCT04647344|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101520843|NCT02906748|Parathyroid Hormone|parathyroid hormone|mesh-list
101520844|NCT02906748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101520847|NCT02907957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101520848|NCT02907957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520849|NCT04646876|Magnesium Sulfate|magnesium sulfate|mesh-list
101520850|NCT04646876|Analgesics|analgesics|mesh-ancestor
101520851|NCT04646876|Sensory System Agents|sensory system agents|mesh-ancestor
101520852|NCT04646876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101520853|NCT04646876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520854|NCT04646876|Anesthetics|anesthetics|mesh-ancestor
101520855|NCT04646876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101520856|NCT04646876|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101520857|NCT04646876|Anticonvulsants|anticonvulsants|mesh-ancestor
101520858|NCT04646876|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101520859|NCT04646876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101520860|NCT04646876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315160|NCT00000375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101315161|NCT00000375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520861|NCT04646876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101520862|NCT04646876|Tocolytic Agents|tocolytic agents|mesh-ancestor
101520863|NCT04646876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101520864|NCT02908035|Sirolimus|sirolimus|mesh-list
101520865|NCT02908035|Temsirolimus|temsirolimus|mesh-list
101520866|NCT02908035|MTOR Inhibitors|mtor inhibitors|mesh-list
101520867|NCT02908035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101520868|NCT02908035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101520869|NCT02908035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520870|NCT02908035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101520871|NCT02908035|Immunologic Factors|immunologic factors|mesh-ancestor
101520872|NCT02908035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520873|NCT02908035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101520874|NCT02908035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101520875|NCT02908035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101520876|NCT02908035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101520877|NCT02908035|Antifungal Agents|antifungal agents|mesh-ancestor
101520878|NCT04646759|Capecitabine|capecitabine|mesh-list
101520879|NCT04646759|Fulvestrant|fulvestrant|mesh-list
101520880|NCT04646759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101520881|NCT04646759|Antimetabolites|antimetabolites|mesh-ancestor
101520882|NCT04646759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520883|NCT04646759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101520884|NCT04646759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101520885|NCT04646759|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101520886|NCT04646759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101520887|NCT04646759|Hormone Antagonists|hormone antagonists|mesh-ancestor
101520888|NCT04646759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101520889|NCT04646759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520890|NCT02906514|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
101520892|NCT02906514|Blood Substitutes|blood substitutes|mesh-ancestor
101520893|NCT04646135|Lorazepam|lorazepam|mesh-list
101520894|NCT04646135|Anticonvulsants|anticonvulsants|mesh-ancestor
101520895|NCT04646135|Antiemetics|antiemetics|mesh-ancestor
101520896|NCT04646135|Autonomic Agents|autonomic agents|mesh-ancestor
101520897|NCT04646135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101520898|NCT04646135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520899|NCT04646135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101520900|NCT04646135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101520901|NCT04646135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101520902|NCT04646135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101520903|NCT04646135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101520905|NCT04646135|GABA Modulators|gaba modulators|mesh-ancestor
101520906|NCT04646135|GABA Agents|gaba agents|mesh-ancestor
101520907|NCT04646135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101520908|NCT04646135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520909|NCT02906553|Nitroglycerin|nitroglycerin|mesh-list
101520910|NCT02906553|Vasodilator Agents|vasodilator agents|mesh-ancestor
101520911|NCT04682184|Propranolol|propranolol|mesh-list
101520912|NCT04682184|Pseudoephedrine|pseudoephedrine|mesh-list
101520913|NCT04682184|Ephedrine|ephedrine|mesh-list
101520914|NCT04682184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101520915|NCT04682184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101520916|NCT04682184|Adrenergic Agents|adrenergic agents|mesh-ancestor
101520917|NCT04682184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101520918|NCT04682184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315235|NCT05631925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315236|NCT05631925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101520919|NCT04682184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520920|NCT04682184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101520921|NCT04682184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101520922|NCT04682184|Vasodilator Agents|vasodilator agents|mesh-ancestor
101520923|NCT04682184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101520924|NCT04682184|Autonomic Agents|autonomic agents|mesh-ancestor
101520925|NCT04682184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101520926|NCT04682184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101520927|NCT04682184|Respiratory System Agents|respiratory system agents|mesh-ancestor
101520928|NCT04682184|Nasal Decongestants|nasal decongestants|mesh-ancestor
101520929|NCT04682184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101520930|NCT04682184|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101520931|NCT04682184|Sympathomimetics|sympathomimetics|mesh-ancestor
101520932|NCT04645940|Rabeprazole|rabeprazole|mesh-list
101520933|NCT04645940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101520934|NCT04645940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101520935|NCT04645940|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101520936|NCT04645940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101520937|NCT04645940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520938|NCT00558506|Abatacept|abatacept|mesh-list
101520939|NCT00558506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101520940|NCT00558506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520941|NCT00558506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101520942|NCT00558506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101520943|NCT00558506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101520944|NCT00558506|Immunologic Factors|immunologic factors|mesh-ancestor
101520945|NCT00558506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520946|NCT00558506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101520947|NCT00558623|Calcium Carbonate|calcium carbonate|mesh-list
101520948|NCT00558623|Calcium|calcium|mesh-list
101520949|NCT00558623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101520950|NCT00558623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520951|NCT00558623|Antacids|antacids|mesh-ancestor
101520952|NCT00558623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520953|NCT00558623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101520954|NCT00558662|Monensin|monensin|mesh-list
101520955|NCT00558662|Antifungal Agents|antifungal agents|mesh-ancestor
101520956|NCT00558662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101520957|NCT00558662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101520958|NCT00558662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101520959|NCT00558662|Coccidiostats|coccidiostats|mesh-ancestor
101520960|NCT00558662|Proton Ionophores|proton ionophores|mesh-ancestor
101520961|NCT00558662|Uncoupling Agents|uncoupling agents|mesh-ancestor
101315292|NCT05442268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101315293|NCT05442268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101315295|NCT05442268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101520962|NCT00558662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101520963|NCT00558662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520964|NCT00558662|Ionophores|ionophores|mesh-ancestor
101520965|NCT00558662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101520967|NCT02905890|Norethindrone|norethindrone|mesh-list
101520968|NCT02905890|Norethindrone enanthate|norethindrone enanthate|mesh-list
101520969|NCT02905890|Norethindrone Acetate|norethindrone acetate|mesh-list
101520970|NCT02905890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101520971|NCT02905890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101520972|NCT02905890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101520973|NCT02905890|Contraceptive Agents|contraceptive agents|mesh-ancestor
101520974|NCT02905890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101520975|NCT02905890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520976|NCT02905890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101520977|NCT02905890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101520978|NCT02906163|Gefitinib|gefitinib|mesh-list
101520979|NCT02906163|Afatinib|afatinib|mesh-list
101520980|NCT02906163|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101520981|NCT02906163|Thymalfasin|thymalfasin|mesh-list
101520982|NCT02906163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101520983|NCT02906163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101520984|NCT02906163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101520985|NCT02906163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101520986|NCT02906163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101520987|NCT02906163|Immunologic Factors|immunologic factors|mesh-ancestor
101520988|NCT02906163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520989|NCT04645745|Folic Acid|folic acid|mesh-list
101520990|NCT04645745|Inositol|inositol|mesh-list
101520991|NCT04645745|Hematinics|hematinics|mesh-ancestor
101520992|NCT04645745|Vitamin B Complex|vitamin b complex|mesh-ancestor
101520993|NCT04645745|Vitamins|vitamins|mesh-ancestor
101520994|NCT04645745|Micronutrients|micronutrients|mesh-ancestor
101520995|NCT04645745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101520996|NCT02905695|Levobupivacaine|levobupivacaine|mesh-list
101520997|NCT02905695|Anesthetics, Local|anesthetics, local|mesh-ancestor
101520998|NCT02905695|Anesthetics|anesthetics|mesh-ancestor
101520999|NCT02905695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101521000|NCT02905695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521001|NCT02905695|Sensory System Agents|sensory system agents|mesh-ancestor
101521002|NCT02905695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101521003|NCT00558818|Clevudine|clevudine|mesh-list
101521004|NCT00558818|Antiviral Agents|antiviral agents|mesh-ancestor
101315321|NCT02972476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101315322|NCT02972476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521005|NCT00558818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101521006|NCT04644341|Respiratory System Agents|respiratory system agents|mesh-list
101521008|NCT04681911|Vinorelbine|vinorelbine|mesh-list
101521009|NCT04681911|Carboplatin|carboplatin|mesh-list
101521010|NCT04681911|Gemcitabine|gemcitabine|mesh-list
101521011|NCT04681911|Capecitabine|capecitabine|mesh-list
101521012|NCT04681911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101521013|NCT04681911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101521014|NCT04681911|Tubulin Modulators|tubulin modulators|mesh-ancestor
101521015|NCT04681911|Antimitotic Agents|antimitotic agents|mesh-ancestor
101521016|NCT04681911|Mitosis Modulators|mitosis modulators|mesh-ancestor
101521017|NCT04681911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521018|NCT04681911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101521019|NCT04681911|Antimetabolites|antimetabolites|mesh-ancestor
101521020|NCT02905539|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
101521021|NCT02905539|Hematinics|hematinics|mesh-ancestor
101521022|NCT02905734|Nicotine|nicotine|mesh-list
101521023|NCT02905734|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101521024|NCT02905734|Autonomic Agents|autonomic agents|mesh-ancestor
101521025|NCT02905734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101521026|NCT02905734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521027|NCT02905734|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101521028|NCT02905734|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101315353|NCT05349838|Dolutegravir|dolutegravir|mesh-list
101521029|NCT02905734|Cholinergic Agents|cholinergic agents|mesh-ancestor
101521031|NCT02905734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315354|NCT05349838|Rilpivirine|rilpivirine|mesh-list
101521032|NCT04644185|Myeloma Proteins|myeloma proteins|mesh-list
101521034|NCT04644185|Immunologic Factors|immunologic factors|mesh-ancestor
101521035|NCT04644185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521036|NCT02905461|Contraceptive Agents|contraceptive agents|mesh-list
101521037|NCT02905461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101521038|NCT02905461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521040|NCT02905305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101521041|NCT02905305|Antiemetics|antiemetics|mesh-ancestor
101521042|NCT02905305|Autonomic Agents|autonomic agents|mesh-ancestor
101521043|NCT02905305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101521044|NCT02905305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521045|NCT02905305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101315402|NCT00000492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315403|NCT00000492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315404|NCT00000492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101315408|NCT00000504|Flecainide|flecainide|mesh-list
101521046|NCT02905305|Glucocorticoids|glucocorticoids|mesh-ancestor
101521047|NCT02905305|Hormones|hormones|mesh-ancestor
101521048|NCT02905305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101521049|NCT02905305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101521050|NCT02905305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101521051|NCT02899182|Nitrous Oxide|nitrous oxide|mesh-list
101521052|NCT02899182|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101521053|NCT02899182|Anesthetics, General|anesthetics, general|mesh-ancestor
101521054|NCT02899182|Anesthetics|anesthetics|mesh-ancestor
101521055|NCT02899182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101521056|NCT02899182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521057|NCT02899182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101521058|NCT02899182|Analgesics|analgesics|mesh-ancestor
101521059|NCT02899182|Sensory System Agents|sensory system agents|mesh-ancestor
101521060|NCT02899182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101521061|NCT02905227|Zolmitriptan|zolmitriptan|mesh-list
101319500|NCT03933865|Ketamine|ketamine|mesh-list
101521062|NCT02905227|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101315463|NCT00000516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101315464|NCT00000516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315465|NCT00000516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101315466|NCT00000522|Acebutolol|acebutolol|mesh-list
101521063|NCT02905227|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101521064|NCT02905227|Serotonin Agents|serotonin agents|mesh-ancestor
101521065|NCT02905227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101521066|NCT02905227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521067|NCT02905227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521069|NCT04643483|Certolizumab Pegol|certolizumab pegol|mesh-list
101521070|NCT04643483|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101521071|NCT04643483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101521072|NCT04643483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101521073|NCT04643483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101521074|NCT04643483|Immunologic Factors|immunologic factors|mesh-ancestor
101521075|NCT04643483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521076|NCT00559052|Pancrelipase|pancrelipase|mesh-list
101521077|NCT00559052|Pancreatin|pancreatin|mesh-list
101521078|NCT00559052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101521079|NCT02899104|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
101521080|NCT02899104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101521081|NCT04643132|Ketamine|ketamine|mesh-list
101521082|NCT04643132|Esketamine|esketamine|mesh-list
101521083|NCT04643132|Analgesics|analgesics|mesh-ancestor
101521084|NCT04643132|Sensory System Agents|sensory system agents|mesh-ancestor
101521085|NCT04643132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101521086|NCT04643132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315516|NCT00000525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521087|NCT04643132|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101521088|NCT04643132|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101521089|NCT04643132|Anesthetics, General|anesthetics, general|mesh-ancestor
101521090|NCT04643132|Anesthetics|anesthetics|mesh-ancestor
101521091|NCT04643132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101521092|NCT04643132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101521093|NCT04643132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101521097|NCT04643132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101521098|NCT02899143|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101521099|NCT02899143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101521100|NCT02899026|Prednisone|prednisone|mesh-list
101521101|NCT02899026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101521102|NCT02899026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101521103|NCT02899026|Glucocorticoids|glucocorticoids|mesh-ancestor
101521104|NCT02899026|Hormones|hormones|mesh-ancestor
101521105|NCT02899026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101521106|NCT02899026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521107|NCT02899026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101521108|NCT02899026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101521109|NCT02899026|Immunologic Factors|immunologic factors|mesh-ancestor
101315630|NCT00000579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101521111|NCT00559169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101521112|NCT00559169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101521113|NCT00559169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101521114|NCT00559169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521115|NCT00559169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101521116|NCT00559169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521117|NCT00559169|Vasodilator Agents|vasodilator agents|mesh-ancestor
101521118|NCT04642664|Apatinib|apatinib|mesh-list
101521119|NCT04642664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101521120|NCT04642664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101521121|NCT04642664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101521122|NCT04642664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521123|NCT02904759|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101521124|NCT02904759|Hemostatics|hemostatics|mesh-ancestor
101521126|NCT02904759|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101521127|NCT02904759|Natriuretic Agents|natriuretic agents|mesh-ancestor
101521128|NCT02904759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521129|NCT02898792|Remifentanil|remifentanil|mesh-list
101521130|NCT02898792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101521131|NCT02898792|Narcotics|narcotics|mesh-ancestor
101521132|NCT02898792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101521133|NCT02898792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521134|NCT02898792|Analgesics|analgesics|mesh-ancestor
101521136|NCT02898792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101521137|NCT04642391|Cosyntropin|cosyntropin|mesh-list
101521138|NCT04642391|Hormones|hormones|mesh-ancestor
101315692|NCT04601077|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101521139|NCT04642391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101521140|NCT04642391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521142|NCT02904564|Antimetabolites|antimetabolites|mesh-ancestor
101521143|NCT02904564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521144|NCT02904564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101521145|NCT02904564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101521146|NCT02904564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101521147|NCT02904564|Immunologic Factors|immunologic factors|mesh-ancestor
101315749|NCT00000639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101315767|NCT00000645|Hypericin|hypericin|mesh-list
101521148|NCT02904564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521151|NCT04642001|Cariostatic Agents|cariostatic agents|mesh-ancestor
101521152|NCT04642001|Protective Agents|protective agents|mesh-ancestor
101521153|NCT04642001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521154|NCT04642001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101521155|NCT04642001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101521156|NCT00559286|Telmisartan|telmisartan|mesh-list
101521157|NCT00559286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101521158|NCT00559286|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101521159|NCT00559286|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101521160|NCT00559286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521161|NCT04640870|Afatinib|afatinib|mesh-list
101521162|NCT04640870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101521163|NCT04640870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101521164|NCT04640870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101521165|NCT04640870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521166|NCT02897934|Bupivacaine|bupivacaine|mesh-list
101521167|NCT02897934|Anesthetics, Local|anesthetics, local|mesh-ancestor
101521168|NCT02897934|Anesthetics|anesthetics|mesh-ancestor
101521169|NCT02897934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101521170|NCT02897934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521171|NCT02897934|Sensory System Agents|sensory system agents|mesh-ancestor
101521172|NCT02897934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101521173|NCT04640129|Interferons|interferons|mesh-list
101521174|NCT04640129|Tenofovir|tenofovir|mesh-list
101521175|NCT04640129|Interferon-alpha|interferon-alpha|mesh-list
101521176|NCT04640129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101521177|NCT04640129|Antiviral Agents|antiviral agents|mesh-ancestor
101521178|NCT04640129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101521179|NCT04640129|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101521180|NCT04640129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101521181|NCT04640129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101521182|NCT04640129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521183|NCT04640129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101521184|NCT04640129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101521185|NCT04640129|Immunologic Factors|immunologic factors|mesh-ancestor
101521186|NCT04640129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521187|NCT02898012|Bevacizumab|bevacizumab|mesh-list
101521188|NCT02898012|Temozolomide|temozolomide|mesh-list
101521189|NCT02898012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101521190|NCT02898012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101521191|NCT02898012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101521192|NCT02898012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101521194|NCT02898012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521195|NCT02898012|Growth Inhibitors|growth inhibitors|mesh-ancestor
101521196|NCT02898012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101521197|NCT02898012|Alkylating Agents|alkylating agents|mesh-ancestor
101521198|NCT02898012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521199|NCT04640324|Vitamin D|vitamin d|mesh-list
101521200|NCT04640324|Vitamins|vitamins|mesh-list
101521202|NCT04640324|Silybin|silybin|mesh-list
101521203|NCT04640324|Micronutrients|micronutrients|mesh-ancestor
101521204|NCT04640324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521205|NCT04640324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101521206|NCT04640324|Antioxidants|antioxidants|mesh-ancestor
101521207|NCT04640324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521208|NCT04640324|Protective Agents|protective agents|mesh-ancestor
101521209|NCT04640324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101315814|NCT00389025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101521210|NCT04640324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101521212|NCT04640285|Nicotine|nicotine|mesh-list
101521213|NCT04640285|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101521214|NCT04640285|Autonomic Agents|autonomic agents|mesh-ancestor
101521215|NCT04640285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101521216|NCT04640285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521217|NCT04640285|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101521218|NCT04640285|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101521219|NCT04640285|Cholinergic Agents|cholinergic agents|mesh-ancestor
101521220|NCT04640285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101521221|NCT04640285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521222|NCT04640285|Antipruritics|antipruritics|mesh-ancestor
101521223|NCT04640285|Dermatologic Agents|dermatologic agents|mesh-ancestor
101521225|NCT00559481|Dexamethasone|dexamethasone|mesh-list
101521226|NCT00559481|Hydrocortisone|hydrocortisone|mesh-list
101521227|NCT00559481|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101521228|NCT00559481|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101521229|NCT00559481|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101315829|NCT00390247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101315830|NCT00390247|Growth Substances|growth substances|mesh-ancestor
101521230|NCT00559481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101521231|NCT00559481|Antiemetics|antiemetics|mesh-ancestor
101521232|NCT00559481|Autonomic Agents|autonomic agents|mesh-ancestor
101521233|NCT00559481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101521234|NCT00559481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521235|NCT00559481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101521236|NCT00559481|Glucocorticoids|glucocorticoids|mesh-ancestor
101521237|NCT00559481|Hormones|hormones|mesh-ancestor
101521238|NCT00559481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101521239|NCT00559481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101521240|NCT00559481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101521241|NCT00559481|Antifungal Agents|antifungal agents|mesh-ancestor
101521242|NCT00559481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101521243|NCT00559481|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101521244|NCT00559481|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101521245|NCT00559481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101521246|NCT00559481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315886|NCT00390403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101521247|NCT00559481|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101521248|NCT00559481|Hormone Antagonists|hormone antagonists|mesh-ancestor
101521249|NCT00559481|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101521250|NCT02897856|Midazolam|midazolam|mesh-list
101521251|NCT02897856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101521252|NCT02897856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101521253|NCT02897856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101521254|NCT02897856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521255|NCT02897856|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101521256|NCT02897856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101315946|NCT00000687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101521257|NCT02897856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101521258|NCT02897856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101521259|NCT02897856|Anesthetics, General|anesthetics, general|mesh-ancestor
101521260|NCT02897856|Anesthetics|anesthetics|mesh-ancestor
101521261|NCT02897856|GABA Modulators|gaba modulators|mesh-ancestor
101521262|NCT02897856|GABA Agents|gaba agents|mesh-ancestor
101521263|NCT02897856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101411219|NCT05536362|Sympatholytics|sympatholytics|mesh-ancestor
101521264|NCT02897856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521265|NCT01236118|Ixekizumab|ixekizumab|mesh-list
101521266|NCT01236118|Dermatologic Agents|dermatologic agents|mesh-ancestor
101521267|NCT04206631|Doxycycline|doxycycline|mesh-list
101521268|NCT04206631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101521269|NCT04206631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101521271|NCT04206631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101521272|NCT04206631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101521274|NCT04639817|Trimethoprim|trimethoprim|mesh-list
101521275|NCT04639817|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101521276|NCT04639817|Sulfamethoxazole|sulfamethoxazole|mesh-list
101521277|NCT04639817|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101316010|NCT00000711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101521278|NCT04639817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101521279|NCT04639817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101521280|NCT04639817|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101521281|NCT04639817|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101521282|NCT04639817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101521283|NCT04639817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521284|NCT04639817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101521285|NCT04639817|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101521286|NCT04639817|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101521287|NCT04639817|Antimalarials|antimalarials|mesh-ancestor
101521288|NCT04639817|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101316066|NCT00000741|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101521289|NCT04639817|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101521290|NCT04639817|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101521291|NCT04639817|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101521292|NCT04639817|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101521293|NCT01236001|Lacosamide|lacosamide|mesh-list
101521294|NCT01236001|Anticonvulsants|anticonvulsants|mesh-ancestor
101521295|NCT01236001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101521296|NCT01236001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101521297|NCT01236001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101521298|NCT01236001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316127|NCT00000747|Antiviral Agents|antiviral agents|mesh-ancestor
101316128|NCT00000747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316129|NCT00000747|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101316130|NCT00000747|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101521299|NCT02897466|Anti-Infective Agents|anti-infective agents|mesh-list
101521300|NCT02897466|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101521301|NCT01229254|Amiodarone|amiodarone|mesh-list
101521302|NCT01229254|Betrixaban|betrixaban|mesh-list
101521303|NCT01229254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101521304|NCT01229254|Vasodilator Agents|vasodilator agents|mesh-ancestor
101521305|NCT01229254|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101521306|NCT01229254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101521307|NCT01229254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521308|NCT01229254|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101521309|NCT01229254|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101521310|NCT01229254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101521311|NCT01229254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101521312|NCT01229254|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101521313|NCT01229254|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101521314|NCT01229254|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101521315|NCT01229254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101521316|NCT01229254|Antithrombins|antithrombins|mesh-ancestor
101521317|NCT01229254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101521318|NCT01229254|Protease Inhibitors|protease inhibitors|mesh-ancestor
101521319|NCT01229254|Anticoagulants|anticoagulants|mesh-ancestor
101521320|NCT04639232|Probenecid|probenecid|mesh-list
101521321|NCT04639232|Uricosuric Agents|uricosuric agents|mesh-ancestor
101521322|NCT04639232|Gout Suppressants|gout suppressants|mesh-ancestor
101316191|NCT00390520|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101521324|NCT01235728|Calcitriol|calcitriol|mesh-list
101521325|NCT01235728|MK 0873|mk 0873|mesh-list
101521326|NCT01235728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101521327|NCT01235728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521328|NCT01235728|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101521329|NCT01235728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101521330|NCT01235728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521332|NCT01235728|Vitamins|vitamins|mesh-ancestor
101521333|NCT01235728|Micronutrients|micronutrients|mesh-ancestor
101521334|NCT01235728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101521335|NCT01235728|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101316241|NCT03801031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316242|NCT03801031|Sensory System Agents|sensory system agents|mesh-ancestor
101316243|NCT03801031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101521336|NCT01235728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101521337|NCT01235728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101521338|NCT00559676|Leucovorin|leucovorin|mesh-list
101521339|NCT00559676|Fluorouracil|fluorouracil|mesh-list
101521340|NCT00559676|Capecitabine|capecitabine|mesh-list
101521341|NCT00559676|Oxaliplatin|oxaliplatin|mesh-list
101521342|NCT00559676|Irinotecan|irinotecan|mesh-list
101521343|NCT00559676|Calcium|calcium|mesh-list
101521345|NCT00559676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101521346|NCT00559676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521347|NCT00559676|Antimetabolites|antimetabolites|mesh-ancestor
101521348|NCT00559676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521349|NCT00559676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101521350|NCT00559676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101521351|NCT00559676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101521352|NCT00559676|Immunologic Factors|immunologic factors|mesh-ancestor
101521353|NCT00559676|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101521354|NCT00559676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101521355|NCT00559676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101521356|NCT00559676|Antidotes|antidotes|mesh-ancestor
101521357|NCT00559676|Protective Agents|protective agents|mesh-ancestor
101521358|NCT00559676|Vitamin B Complex|vitamin b complex|mesh-ancestor
101521359|NCT00559676|Vitamins|vitamins|mesh-ancestor
101521360|NCT00559676|Micronutrients|micronutrients|mesh-ancestor
101521361|NCT04639271|Trastuzumab|trastuzumab|mesh-list
101521362|NCT04639271|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101521363|NCT04639271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101316302|NCT03574402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101316303|NCT03539302|Flecainide|flecainide|mesh-list
101316304|NCT03539302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101316305|NCT03539302|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101316309|NCT00000831|Lamivudine|lamivudine|mesh-list
101521364|NCT04639271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101521365|NCT04681053|Ivermectin|ivermectin|mesh-list
101521366|NCT04681053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101521367|NCT04681053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101521368|NCT04639193|Acetazolamide|acetazolamide|mesh-list
101521369|NCT04639193|Eszopiclone|eszopiclone|mesh-list
101521370|NCT04639193|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101521371|NCT04639193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101521372|NCT04639193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101521373|NCT04639193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101521374|NCT04639193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521375|NCT04639193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101521376|NCT04639193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521377|NCT04639193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101521378|NCT04639193|Antidepressive Agents|antidepressive agents|mesh-ancestor
101521379|NCT04639193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101521380|NCT04639193|Anticonvulsants|anticonvulsants|mesh-ancestor
101521381|NCT04639193|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101521382|NCT04639193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101521383|NCT04639193|Diuretics|diuretics|mesh-ancestor
101521384|NCT04639193|Natriuretic Agents|natriuretic agents|mesh-ancestor
101521385|NCT04639193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101521386|NCT04639193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101521387|NCT01235689|Prednisone|prednisone|mesh-list
101521388|NCT01235689|Adalimumab|adalimumab|mesh-list
101521389|NCT01235689|Azathioprine|azathioprine|mesh-list
101521390|NCT01235689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101316349|NCT00390676|Carboplatin|carboplatin|mesh-list
101316350|NCT00390676|Docetaxel|docetaxel|mesh-list
101521391|NCT01235689|Glucocorticoids|glucocorticoids|mesh-ancestor
101521393|NCT01235689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101521394|NCT01235689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521395|NCT01235689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101521396|NCT01235689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101521397|NCT01235689|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101521398|NCT01235689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101521399|NCT01235689|Antimetabolites|antimetabolites|mesh-ancestor
101521400|NCT01235689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521401|NCT01235689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101316399|NCT00390871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101521402|NCT01235689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101521403|NCT01235689|Immunologic Factors|immunologic factors|mesh-ancestor
101521404|NCT04638686|Lamivudine|lamivudine|mesh-list
101521405|NCT04638686|Dolutegravir|dolutegravir|mesh-list
101521406|NCT04638686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101521407|NCT04638686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101521408|NCT04638686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101521409|NCT04638686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521410|NCT04638686|Antiviral Agents|antiviral agents|mesh-ancestor
101521411|NCT04638686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101521412|NCT04638686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101521413|NCT04638686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101521414|NCT04638686|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101521415|NCT04638686|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101521417|NCT04680819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101521418|NCT02896842|Imatinib Mesylate|imatinib mesylate|mesh-list
101521419|NCT02896842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101521420|NCT02896842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101521421|NCT02896842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101521422|NCT02896842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521423|NCT00559715|Bevacizumab|bevacizumab|mesh-list
101521424|NCT00559715|Ranibizumab|ranibizumab|mesh-list
101521425|NCT00559715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101521426|NCT00559715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101521427|NCT00559715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101521428|NCT00559715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101521429|NCT00559715|Growth Substances|growth substances|mesh-ancestor
101521430|NCT00559715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521431|NCT00559715|Growth Inhibitors|growth inhibitors|mesh-ancestor
101521432|NCT02896803|Fluorouracil|fluorouracil|mesh-list
101521433|NCT02896803|Oxaliplatin|oxaliplatin|mesh-list
101521434|NCT02896803|Antimetabolites|antimetabolites|mesh-ancestor
101521435|NCT02896803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521436|NCT02896803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101316518|NCT00000906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101316519|NCT00000906|Narcotics|narcotics|mesh-ancestor
101316520|NCT00000906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101521437|NCT02896803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101521438|NCT02896803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101521439|NCT02896803|Immunologic Factors|immunologic factors|mesh-ancestor
101521440|NCT02896803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521442|NCT02897037|Bivalirudin|bivalirudin|mesh-list
101521443|NCT02897037|Anticoagulants|anticoagulants|mesh-ancestor
101521444|NCT02897037|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101521445|NCT02897037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101521446|NCT02897037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521447|NCT02897037|Antithrombins|antithrombins|mesh-ancestor
101521448|NCT02897037|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101521449|NCT02897037|Protease Inhibitors|protease inhibitors|mesh-ancestor
101521450|NCT02897037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101521453|NCT00553683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101521454|NCT00553683|Immunologic Factors|immunologic factors|mesh-ancestor
101521455|NCT00553683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521456|NCT00553683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101521457|NCT00553683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101521458|NCT00553683|Alkylating Agents|alkylating agents|mesh-ancestor
101521459|NCT00553683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521460|NCT00553683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101521461|NCT00553683|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101521462|NCT00553683|Interferon Inducers|interferon inducers|mesh-ancestor
101521463|NCT01229176|Vaccines|vaccines|mesh-list
101521464|NCT01229176|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101521465|NCT01229176|Immunologic Factors|immunologic factors|mesh-ancestor
101316578|NCT00000975|Antifungal Agents|antifungal agents|mesh-ancestor
101316579|NCT00000975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316580|NCT00000975|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101316581|NCT00000975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101316589|NCT00000978|Zidovudine|zidovudine|mesh-list
101521466|NCT01229176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521467|NCT01228747|Levetiracetam|levetiracetam|mesh-list
101521468|NCT01228747|Anticonvulsants|anticonvulsants|mesh-ancestor
101521469|NCT01228747|Nootropic Agents|nootropic agents|mesh-ancestor
101521470|NCT02896413|Dexmedetomidine|dexmedetomidine|mesh-list
101521471|NCT02896413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101521472|NCT02896413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101521473|NCT02896413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521474|NCT02896413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101521475|NCT02896413|Analgesics|analgesics|mesh-ancestor
101521476|NCT02896413|Sensory System Agents|sensory system agents|mesh-ancestor
101521477|NCT02896413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101521478|NCT02896413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101521479|NCT02896413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101521480|NCT02896413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101521481|NCT02896413|Adrenergic Agents|adrenergic agents|mesh-ancestor
101521482|NCT02896413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101521483|NCT02896413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521484|NCT00553722|Eplerenone|eplerenone|mesh-list
101521485|NCT00553722|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101521486|NCT00553722|Hormone Antagonists|hormone antagonists|mesh-ancestor
101521487|NCT00553722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101521488|NCT00553722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521489|NCT00553722|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101521491|NCT00553722|Natriuretic Agents|natriuretic agents|mesh-ancestor
101521492|NCT00553722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101521493|NCT01235338|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101521494|NCT01235338|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101521495|NCT01235338|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101521496|NCT01235338|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101521497|NCT01235338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101521498|NCT01235338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521499|NCT01235338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101521500|NCT01235338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521501|NCT01235338|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101521502|NCT01235338|Antidepressive Agents|antidepressive agents|mesh-ancestor
101521503|NCT01235338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101521504|NCT01235338|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101521505|NCT01235338|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101521507|NCT01234675|Milnacipran|milnacipran|mesh-list
101521508|NCT01234675|Levomilnacipran|levomilnacipran|mesh-list
101521509|NCT01234675|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101521510|NCT01234675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101521511|NCT01234675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101521512|NCT01234675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521513|NCT01234675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101521514|NCT01234675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521515|NCT01234675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101521516|NCT01234675|Analgesics|analgesics|mesh-ancestor
101521517|NCT01234675|Sensory System Agents|sensory system agents|mesh-ancestor
101521518|NCT01234675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101521519|NCT01234675|Antidepressive Agents|antidepressive agents|mesh-ancestor
101521520|NCT01234675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101521521|NCT02896101|Pimecrolimus|pimecrolimus|mesh-list
101521522|NCT02896101|Tacrolimus|tacrolimus|mesh-list
101316623|NCT00005819|Fenretinide|fenretinide|mesh-list
101316624|NCT00005819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101316625|NCT00005819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101521523|NCT02896101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101521524|NCT02896101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101521525|NCT02896101|Analgesics|analgesics|mesh-ancestor
101521526|NCT02896101|Sensory System Agents|sensory system agents|mesh-ancestor
101521527|NCT02896101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101521528|NCT02896101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521529|NCT02896101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101521530|NCT02896101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101521531|NCT02896101|Dermatologic Agents|dermatologic agents|mesh-ancestor
101521532|NCT02896101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101521533|NCT02896101|Immunologic Factors|immunologic factors|mesh-ancestor
101521534|NCT02896101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101521535|NCT02896101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101521536|NCT02896101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521537|NCT02896023|Menotropins|menotropins|mesh-list
101521538|NCT02896023|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101316636|NCT00001005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316637|NCT00001005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101521539|NCT02896023|Fertility Agents|fertility agents|mesh-ancestor
101521540|NCT02896023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101521541|NCT02896023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521542|NCT04637633|Lubricant Eye Drops|lubricant eye drops|mesh-list
101521543|NCT04637633|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101521544|NCT04637633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101521545|NCT01228318|Zoledronic Acid|zoledronic acid|mesh-list
101521546|NCT01228318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101521547|NCT01228318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521548|NCT02895672|Exenatide|exenatide|mesh-list
101521549|NCT02895672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101521550|NCT02895672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521552|NCT02895672|Hormones|hormones|mesh-ancestor
101521553|NCT02895672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101521554|NCT02895672|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101521555|NCT01227967|Ribavirin|ribavirin|mesh-list
101521557|NCT01227967|Amantadine|amantadine|mesh-list
101521558|NCT01227967|Antimetabolites|antimetabolites|mesh-ancestor
101521559|NCT01227967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521560|NCT01227967|Antiviral Agents|antiviral agents|mesh-ancestor
101521561|NCT01227967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101521562|NCT01227967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101521563|NCT01227967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101521564|NCT01227967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101521565|NCT01227967|Dopamine Agents|dopamine agents|mesh-ancestor
101521566|NCT01227967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101521567|NCT01227967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521568|NCT01227967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101521569|NCT01227967|Analgesics|analgesics|mesh-ancestor
101521570|NCT01227967|Sensory System Agents|sensory system agents|mesh-ancestor
101521571|NCT01227967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101521572|NCT00560144|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101521573|NCT00560144|Immunologic Factors|immunologic factors|mesh-ancestor
101521574|NCT00560144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521575|NCT04637204|Axitinib|axitinib|mesh-list
101521576|NCT04637204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101521577|NCT04637204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101521578|NCT04637204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101521579|NCT04637204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521581|NCT04637360|Cinacalcet|cinacalcet|mesh-list
101521582|NCT04637360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101521583|NCT04637360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521584|NCT04637360|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101521585|NCT04637360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101521586|NCT04637360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521587|NCT04637360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101521588|NCT04637360|Vitamins|vitamins|mesh-ancestor
101521589|NCT04637360|Micronutrients|micronutrients|mesh-ancestor
101521590|NCT04637360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101521591|NCT04637360|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101521592|NCT04637360|Hormone Antagonists|hormone antagonists|mesh-ancestor
101521593|NCT04637360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101521594|NCT04317703|Metformin|metformin|mesh-list
101521595|NCT04317703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101521596|NCT04317703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521597|NCT00560222|Lactoferrin|lactoferrin|mesh-list
101521598|NCT00560222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101521599|NCT04317508|Benzocaine|benzocaine|mesh-list
101521600|NCT04317508|Anesthetics, Local|anesthetics, local|mesh-ancestor
101521601|NCT04317508|Anesthetics|anesthetics|mesh-ancestor
101521602|NCT04317508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101521603|NCT04317508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521604|NCT04317508|Sensory System Agents|sensory system agents|mesh-ancestor
101521605|NCT04317508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101521606|NCT00560300|Vitamin D|vitamin d|mesh-list
101521607|NCT00560300|Cholecalciferol|cholecalciferol|mesh-list
101521608|NCT00560300|Calcitriol|calcitriol|mesh-list
101521609|NCT00560300|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
101521610|NCT00560300|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
101521611|NCT00560300|Calcium Carbonate|calcium carbonate|mesh-list
101521612|NCT00560300|Calcium|calcium|mesh-list
101521613|NCT00560300|Sevelamer|sevelamer|mesh-list
101521614|NCT00560300|Vitamins|vitamins|mesh-ancestor
101316789|NCT00005834|Antiemetics|antiemetics|mesh-ancestor
101521615|NCT00560300|Micronutrients|micronutrients|mesh-ancestor
101521616|NCT00560300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521617|NCT00560300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101521618|NCT00560300|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101521619|NCT00560300|Antacids|antacids|mesh-ancestor
101521620|NCT00560300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521621|NCT00560300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101521622|NCT00560300|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101319540|NCT00392899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101521623|NCT00560300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101521624|NCT00560300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101521625|NCT00560300|Chelating Agents|chelating agents|mesh-ancestor
101521626|NCT00560300|Sequestering Agents|sequestering agents|mesh-ancestor
101521628|NCT02904369|Emtricitabine|emtricitabine|mesh-list
101521629|NCT02904369|Antiviral Agents|antiviral agents|mesh-ancestor
101521630|NCT02904369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101521631|NCT02904369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101521632|NCT02904369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101521634|NCT02904369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521635|NCT02904369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101521636|NCT02904369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101521637|NCT00560378|Tacrolimus|tacrolimus|mesh-list
101521638|NCT00560378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101521639|NCT00560378|Immunologic Factors|immunologic factors|mesh-ancestor
101521640|NCT00560378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521641|NCT00560378|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101521642|NCT00560378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101521643|NCT00560378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521644|NCT02895321|Listerine|listerine|mesh-list
101521645|NCT02895321|Sodium Fluoride|sodium fluoride|mesh-list
101521646|NCT02895321|Cariostatic Agents|cariostatic agents|mesh-ancestor
101521647|NCT02895321|Protective Agents|protective agents|mesh-ancestor
101521648|NCT02895321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521649|NCT02895321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101521650|NCT02895321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101521651|NCT02894892|Esomeprazole|esomeprazole|mesh-list
101521652|NCT02894892|Bismuth|bismuth|mesh-list
101521653|NCT02894892|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101521654|NCT02894892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101521655|NCT02894892|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101521656|NCT02894892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316971|NCT00001086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101521657|NCT02894892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521659|NCT04635566|Mebeverine|mebeverine|mesh-list
101521660|NCT04635566|Alverine|alverine|mesh-list
101521661|NCT04635566|Anticonvulsants|anticonvulsants|mesh-ancestor
101521662|NCT04635566|Parasympatholytics|parasympatholytics|mesh-ancestor
101521663|NCT04635566|Autonomic Agents|autonomic agents|mesh-ancestor
101521664|NCT04635566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101521665|NCT04635566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521666|NCT04635293|Simendan|simendan|mesh-list
101521667|NCT04635293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101317040|NCT00005867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101521668|NCT04635293|Vasodilator Agents|vasodilator agents|mesh-ancestor
101521669|NCT04635293|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101521670|NCT04635293|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101521671|NCT04635293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101521672|NCT04635293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521673|NCT04635293|Protective Agents|protective agents|mesh-ancestor
101521674|NCT04635293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521675|NCT01227889|Dacarbazine|dacarbazine|mesh-list
101521676|NCT01227889|Dabrafenib|dabrafenib|mesh-list
101521677|NCT01227889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101521678|NCT01227889|Alkylating Agents|alkylating agents|mesh-ancestor
101521679|NCT01227889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521680|NCT01227889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101521681|NCT01227889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101521682|NCT01227889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101521683|NCT02888392|Psyllium|psyllium|mesh-list
101521684|NCT02888392|Cathartics|cathartics|mesh-ancestor
101521685|NCT02888392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101521686|NCT00624676|Salicylic Acid|salicylic acid|mesh-list
101521687|NCT00624676|Benzoic Acid|benzoic acid|mesh-list
101521688|NCT00624676|Salicylates|salicylates|mesh-list
101521689|NCT00624676|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101521690|NCT00624676|Dermatologic Agents|dermatologic agents|mesh-ancestor
101521691|NCT00624676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101521692|NCT00624676|Antifungal Agents|antifungal agents|mesh-ancestor
101521693|NCT00624676|Keratolytic Agents|keratolytic agents|mesh-ancestor
101521694|NCT00624676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101521695|NCT00624676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101521696|NCT00624676|Analgesics|analgesics|mesh-ancestor
101521697|NCT00624676|Sensory System Agents|sensory system agents|mesh-ancestor
101521698|NCT00624676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101521699|NCT00624676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521700|NCT00624676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101521701|NCT00624676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101521702|NCT00624676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101521703|NCT00624676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101521704|NCT00624676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521705|NCT05655754|Methohexital|methohexital|mesh-list
101521706|NCT05655754|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101521707|NCT05655754|Anesthetics, General|anesthetics, general|mesh-ancestor
101521708|NCT05655754|Anesthetics|anesthetics|mesh-ancestor
101521709|NCT05655754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101521710|NCT05655754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521711|NCT05655715|Nivolumab|nivolumab|mesh-list
101521712|NCT05655715|Ipilimumab|ipilimumab|mesh-list
101521713|NCT05655715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101521714|NCT05655715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101521715|NCT05655715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101521716|NCT05655715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521717|NCT04317235|Ropivacaine|ropivacaine|mesh-list
101521718|NCT04317235|Anesthetics, Local|anesthetics, local|mesh-ancestor
101521720|NCT04317235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101521721|NCT04317235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521722|NCT04317235|Sensory System Agents|sensory system agents|mesh-ancestor
101521723|NCT04317235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101521724|NCT00560690|Metformin|metformin|mesh-list
101521725|NCT00560690|Interferons|interferons|mesh-list
101521726|NCT00560690|Ribavirin|ribavirin|mesh-list
101521727|NCT00560690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101521728|NCT00560690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521729|NCT00560690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101521730|NCT00560690|Antiviral Agents|antiviral agents|mesh-ancestor
101521731|NCT00560690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101521732|NCT00560690|Antimetabolites|antimetabolites|mesh-ancestor
101521733|NCT00560690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521734|NCT01227421|Nitazoxanide|nitazoxanide|mesh-list
101521735|NCT01227421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101521736|NCT01227421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101521737|NCT02903901|Melatonin|melatonin|mesh-list
101521738|NCT02903901|Antioxidants|antioxidants|mesh-ancestor
101521739|NCT02903901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521740|NCT02903901|Protective Agents|protective agents|mesh-ancestor
101521741|NCT02903901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521742|NCT02903901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101521743|NCT04634981|Anesthetics|anesthetics|mesh-list
101521744|NCT04634981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101521745|NCT04634981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521746|NCT00553449|Rabeprazole|rabeprazole|mesh-list
101521747|NCT00553449|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101521748|NCT00553449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101317164|NCT00009217|Antiemetics|antiemetics|mesh-ancestor
101521749|NCT00553449|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101521750|NCT00553449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101521751|NCT00553449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521752|NCT05655130|Dexamethasone|dexamethasone|mesh-list
101521753|NCT05655130|Methylprednisolone|methylprednisolone|mesh-list
101521754|NCT05655130|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101521756|NCT05655130|Prednisolone|prednisolone|mesh-list
101521757|NCT05655130|Prednisolone acetate|prednisolone acetate|mesh-list
101521758|NCT05655130|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101521759|NCT05655130|Prednisolone phosphate|prednisolone phosphate|mesh-list
101521760|NCT05655130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101521761|NCT05655130|Antiemetics|antiemetics|mesh-ancestor
101521762|NCT05655130|Autonomic Agents|autonomic agents|mesh-ancestor
101521763|NCT05655130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101521764|NCT05655130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521765|NCT05655130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101521766|NCT05655130|Glucocorticoids|glucocorticoids|mesh-ancestor
101521767|NCT05655130|Hormones|hormones|mesh-ancestor
101521768|NCT05655130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101521769|NCT05655130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101521770|NCT05655130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101521771|NCT05655130|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101521772|NCT05655130|Protective Agents|protective agents|mesh-ancestor
101521773|NCT04633967|Alemtuzumab|alemtuzumab|mesh-list
101521774|NCT04633967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101521775|NCT04633967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101521776|NCT04633850|Dexamethasone|dexamethasone|mesh-list
101521777|NCT04633850|Bupivacaine|bupivacaine|mesh-list
101521778|NCT04633850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101521779|NCT04633850|Antiemetics|antiemetics|mesh-ancestor
101521780|NCT04633850|Autonomic Agents|autonomic agents|mesh-ancestor
101521781|NCT04633850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101521782|NCT04633850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521783|NCT04633850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101521784|NCT04633850|Glucocorticoids|glucocorticoids|mesh-ancestor
101521785|NCT04633850|Hormones|hormones|mesh-ancestor
101521786|NCT04633850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101521787|NCT04633850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101521788|NCT04633850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101521789|NCT04633850|Anesthetics, Local|anesthetics, local|mesh-ancestor
101521790|NCT04633850|Anesthetics|anesthetics|mesh-ancestor
101521791|NCT04633850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101521792|NCT04633850|Sensory System Agents|sensory system agents|mesh-ancestor
101521793|NCT04633733|Tacrolimus|tacrolimus|mesh-list
101521794|NCT04633733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101521795|NCT04633733|Immunologic Factors|immunologic factors|mesh-ancestor
101521796|NCT04633733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317305|NCT00009997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101317306|NCT00009997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101521797|NCT04633733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101521798|NCT04633733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101521799|NCT04633733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521800|NCT05427942|Adalimumab|adalimumab|mesh-list
101521801|NCT05427942|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101521802|NCT05427942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101521803|NCT05427942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101521804|NCT05427903|Epinephrine|epinephrine|mesh-list
101521805|NCT05427903|Anesthetics|anesthetics|mesh-list
101521806|NCT05427903|Carticaine|carticaine|mesh-list
101521807|NCT05427903|Anesthetics, Local|anesthetics, local|mesh-list
101521809|NCT05427903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521810|NCT05427903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101521811|NCT05427903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101521812|NCT05427903|Adrenergic Agents|adrenergic agents|mesh-ancestor
101521813|NCT05427903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101521814|NCT05427903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317364|NCT00010192|Analgesics|analgesics|mesh-ancestor
101521815|NCT05427903|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101317365|NCT00010192|Sensory System Agents|sensory system agents|mesh-ancestor
101317366|NCT00010192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101317367|NCT00010192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101317368|NCT00010192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101317369|NCT00010192|Antiviral Agents|antiviral agents|mesh-ancestor
101521816|NCT05427903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101521817|NCT05427903|Autonomic Agents|autonomic agents|mesh-ancestor
101521818|NCT05427903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101521819|NCT05427903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101521820|NCT05427903|Respiratory System Agents|respiratory system agents|mesh-ancestor
101521822|NCT05427903|Sympathomimetics|sympathomimetics|mesh-ancestor
101521823|NCT05427903|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101521824|NCT05427903|Sensory System Agents|sensory system agents|mesh-ancestor
101521825|NCT05427747|Meropenem|meropenem|mesh-list
101521826|NCT05427747|Cefotaxime|cefotaxime|mesh-list
101521827|NCT05427747|Cefoxitin|cefoxitin|mesh-list
101521828|NCT05427747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101521829|NCT05427747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101521830|NCT00445406|Bevacizumab|bevacizumab|mesh-list
101521831|NCT00445406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101521832|NCT00445406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101521833|NCT00445406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101521834|NCT00445406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101317416|NCT00010387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317417|NCT00010387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101317419|NCT00010426|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
101317420|NCT00010426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521835|NCT00445406|Growth Substances|growth substances|mesh-ancestor
101319554|NCT05637567|Aspirin|aspirin|mesh-list
101521836|NCT00445406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521837|NCT00445406|Growth Inhibitors|growth inhibitors|mesh-ancestor
101521838|NCT00445523|Interferons|interferons|mesh-list
101521839|NCT00445523|Interferon-alpha|interferon-alpha|mesh-list
101521840|NCT00445523|Vaccines|vaccines|mesh-list
101521841|NCT00445523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101521842|NCT00445523|Antiviral Agents|antiviral agents|mesh-ancestor
101521843|NCT00445523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101521844|NCT00445523|Immunologic Factors|immunologic factors|mesh-ancestor
101521845|NCT00445523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521846|NCT02903004|Paclitaxel|paclitaxel|mesh-list
101521847|NCT02903004|Carboplatin|carboplatin|mesh-list
101521848|NCT02903004|Gemcitabine|gemcitabine|mesh-list
101521849|NCT02903004|Doxorubicin|doxorubicin|mesh-list
101521850|NCT02903004|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101521851|NCT02903004|Topotecan|topotecan|mesh-list
101521852|NCT02903004|Trabectedin|trabectedin|mesh-list
101521853|NCT02903004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101521854|NCT02903004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101521855|NCT02903004|Tubulin Modulators|tubulin modulators|mesh-ancestor
101521856|NCT02903004|Antimitotic Agents|antimitotic agents|mesh-ancestor
101521857|NCT02903004|Mitosis Modulators|mitosis modulators|mesh-ancestor
101521858|NCT02903004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521859|NCT02903004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101521860|NCT02903004|Antimetabolites|antimetabolites|mesh-ancestor
101521861|NCT02903004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101521862|NCT02903004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101521863|NCT02903004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101521864|NCT02903004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101521865|NCT02903004|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101317472|NCT00005921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317473|NCT00011362|Dexamethasone|dexamethasone|mesh-list
101317474|NCT00011362|Dexamethasone acetate|dexamethasone acetate|mesh-list
101521866|NCT02903004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101521867|NCT02903004|Alkylating Agents|alkylating agents|mesh-ancestor
101521868|NCT00445796|Artesunate|artesunate|mesh-list
101521869|NCT00445796|Amodiaquine|amodiaquine|mesh-list
101521870|NCT00445796|Antimalarials|antimalarials|mesh-ancestor
101521871|NCT00445796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101521872|NCT00445796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101521873|NCT00445796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101521874|NCT00445796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101521875|NCT00445796|Antiviral Agents|antiviral agents|mesh-ancestor
101521876|NCT00445796|Schistosomicides|schistosomicides|mesh-ancestor
101521877|NCT00445796|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101521878|NCT00445796|Anthelmintics|anthelmintics|mesh-ancestor
101521879|NCT01225822|Enoxaparin|enoxaparin|mesh-list
101521880|NCT01225822|Dabigatran|dabigatran|mesh-list
101317516|NCT00011479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317517|NCT00011479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521882|NCT01225822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101521883|NCT01225822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101521884|NCT01225822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521885|NCT01225822|Antithrombins|antithrombins|mesh-ancestor
101521886|NCT01225822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101521887|NCT01225822|Protease Inhibitors|protease inhibitors|mesh-ancestor
101521888|NCT01225822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101521889|NCT00445874|Ketotifen|ketotifen|mesh-list
101521890|NCT00445874|Antipruritics|antipruritics|mesh-ancestor
101521891|NCT00445874|Dermatologic Agents|dermatologic agents|mesh-ancestor
101521892|NCT00445874|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101521893|NCT00445874|Histamine Antagonists|histamine antagonists|mesh-ancestor
101317574|NCT00012142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101317575|NCT00012142|Antifungal Agents|antifungal agents|mesh-ancestor
101317576|NCT00012181|Alvocidib|alvocidib|mesh-list
101317577|NCT00012181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317578|NCT00012181|Growth Inhibitors|growth inhibitors|mesh-ancestor
101317579|NCT00012181|Growth Substances|growth substances|mesh-ancestor
101317582|NCT00012181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101521895|NCT00445874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101521896|NCT00445874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319561|NCT05637567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101521897|NCT00445874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521898|NCT00445874|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101521899|NCT02902731|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101521900|NCT02902731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101521901|NCT01225549|Budesonide|budesonide|mesh-list
101521902|NCT01225549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101521903|NCT01225549|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101521904|NCT01225549|Autonomic Agents|autonomic agents|mesh-ancestor
101521905|NCT01225549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101521906|NCT01225549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521907|NCT01225549|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101521908|NCT01225549|Respiratory System Agents|respiratory system agents|mesh-ancestor
101521909|NCT01225549|Glucocorticoids|glucocorticoids|mesh-ancestor
101317631|NCT00005945|Mitosis Modulators|mitosis modulators|mesh-ancestor
101317632|NCT01929811|Metformin|metformin|mesh-list
101521911|NCT01225549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101521912|NCT05469685|Amoxicillin|amoxicillin|mesh-list
101521913|NCT05469685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101521914|NCT05469685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101521915|NCT02956772|Arsenic Trioxide|arsenic trioxide|mesh-list
101521916|NCT02956772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101521917|NCT00446069|Morphine|morphine|mesh-list
101521918|NCT00446069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101521919|NCT00446069|Narcotics|narcotics|mesh-ancestor
101521920|NCT00446069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101521921|NCT00446069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521922|NCT00446069|Analgesics|analgesics|mesh-ancestor
101317693|NCT00005948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521923|NCT00446069|Sensory System Agents|sensory system agents|mesh-ancestor
101521924|NCT00446069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101521925|NCT02902653|Misoprostol|misoprostol|mesh-list
101521926|NCT02902653|Dinoprostone|dinoprostone|mesh-list
101521927|NCT02902653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101521928|NCT02902653|Abortifacient Agents|abortifacient agents|mesh-ancestor
101521929|NCT02902653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101521930|NCT02902653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521931|NCT02902653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101521932|NCT02902653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101521933|NCT02902653|Oxytocics|oxytocics|mesh-ancestor
101521934|NCT00446303|Azacitidine|azacitidine|mesh-list
101521935|NCT00446303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101521936|NCT00446303|Antimetabolites|antimetabolites|mesh-ancestor
101521937|NCT00446303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521939|NCT00446303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101521940|NCT01223404|Mecamylamine|mecamylamine|mesh-list
101521941|NCT01223404|Nicotine|nicotine|mesh-list
101521942|NCT01223404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101521943|NCT01223404|Autonomic Agents|autonomic agents|mesh-ancestor
101521944|NCT01223404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101521945|NCT01223404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521946|NCT01223404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101521947|NCT01223404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101521948|NCT01223404|Cholinergic Agents|cholinergic agents|mesh-ancestor
101521949|NCT01223404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101521950|NCT01223404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317757|NCT00005963|Antimitotic Agents|antimitotic agents|mesh-ancestor
101521951|NCT01223404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101521952|NCT01223404|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
101521953|NCT01223404|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101521954|NCT01223404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101521955|NCT00446420|Fentanyl|fentanyl|mesh-list
101521956|NCT00446420|Midazolam|midazolam|mesh-list
101521957|NCT00446420|Propofol|propofol|mesh-list
101521958|NCT00446420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101521959|NCT00446420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101521960|NCT00446420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521961|NCT00446420|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101521962|NCT00446420|Anesthetics, General|anesthetics, general|mesh-ancestor
101521963|NCT00446420|Anesthetics|anesthetics|mesh-ancestor
101521964|NCT00446420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101521965|NCT00446420|Narcotics|narcotics|mesh-ancestor
101521966|NCT00446420|Analgesics|analgesics|mesh-ancestor
101521967|NCT00446420|Sensory System Agents|sensory system agents|mesh-ancestor
101317806|NCT00005969|Tretinoin|tretinoin|mesh-list
101317807|NCT00005969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317808|NCT00005969|Keratolytic Agents|keratolytic agents|mesh-ancestor
101317809|NCT00005969|Dermatologic Agents|dermatologic agents|mesh-ancestor
101319576|NCT05634564|Paclitaxel|paclitaxel|mesh-list
101521968|NCT00446420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101521969|NCT00446420|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101521970|NCT00446420|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101521971|NCT00446420|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101521972|NCT00446420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101521973|NCT00446420|GABA Modulators|gaba modulators|mesh-ancestor
101521974|NCT00446420|GABA Agents|gaba agents|mesh-ancestor
101521975|NCT00446420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101521976|NCT00446420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521977|NCT00446537|Methylphenidate|methylphenidate|mesh-list
101521978|NCT00446537|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101521979|NCT00446537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317866|NCT00014209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317867|NCT00014248|Adenosine|adenosine|mesh-list
101317868|NCT00014248|Analgesics|analgesics|mesh-ancestor
101317873|NCT00014248|Vasodilator Agents|vasodilator agents|mesh-ancestor
101521980|NCT00446537|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101521981|NCT00446537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101521982|NCT00446537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101521983|NCT00446537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101521984|NCT00446537|Dopamine Agents|dopamine agents|mesh-ancestor
101521985|NCT00446537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101521986|NCT00446576|Epoetin Alfa|epoetin alfa|mesh-list
101521987|NCT00446576|Hematinics|hematinics|mesh-ancestor
101521989|NCT02902302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101521990|NCT02902302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101521991|NCT02902302|Analgesics|analgesics|mesh-ancestor
101521992|NCT02902302|Sensory System Agents|sensory system agents|mesh-ancestor
101521993|NCT02902302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101521994|NCT02902302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101521995|NCT02902302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101521996|NCT02902302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101521997|NCT02902302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101521998|NCT02902302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101521999|NCT02902302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522000|NCT01223365|Hydrocodone|hydrocodone|mesh-list
101522001|NCT01223365|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101522002|NCT01223365|Narcotics|narcotics|mesh-ancestor
101317925|NCT00014404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101317926|NCT00014404|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101317930|NCT00001332|Cisplatin|cisplatin|mesh-list
101522004|NCT01223365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522005|NCT01223365|Analgesics|analgesics|mesh-ancestor
101522006|NCT01223365|Sensory System Agents|sensory system agents|mesh-ancestor
101522007|NCT01223365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101522008|NCT01223365|Antitussive Agents|antitussive agents|mesh-ancestor
101522009|NCT01223365|Respiratory System Agents|respiratory system agents|mesh-ancestor
101522010|NCT02956811|Dapagliflozin|dapagliflozin|mesh-list
101522011|NCT02956811|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101522012|NCT02956811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522013|NCT02956811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101522014|NCT02956811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522015|NCT04319419|Micronutrients|micronutrients|mesh-list
101522016|NCT04319419|Trace Elements|trace elements|mesh-list
101317974|NCT00391534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317977|NCT00005984|Interferons|interferons|mesh-list
101522017|NCT04319419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522018|NCT05657704|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
101522020|NCT05657704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101522021|NCT05657704|Narcotics|narcotics|mesh-ancestor
101522022|NCT05657704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101522023|NCT05657704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522024|NCT05657704|Analgesics|analgesics|mesh-ancestor
101522025|NCT05657704|Sensory System Agents|sensory system agents|mesh-ancestor
101522026|NCT05657704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101522027|NCT05657704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101522028|NCT05657704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101522029|NCT05657704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101522030|NCT05657704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101522032|NCT00446771|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101522033|NCT00446771|Diuretics|diuretics|mesh-ancestor
101522034|NCT00446771|Natriuretic Agents|natriuretic agents|mesh-ancestor
101522035|NCT00446771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522036|NCT04317157|Caffeine|caffeine|mesh-list
101522037|NCT04317157|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101522038|NCT04317157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522039|NCT04317157|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101522040|NCT04317157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101522041|NCT04317157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522042|NCT04317157|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101522043|NCT04317157|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101522044|NCT04317157|Purinergic Agents|purinergic agents|mesh-ancestor
101522045|NCT04317157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101522046|NCT04317079|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
101522047|NCT04317079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101522048|NCT04317079|Antioxidants|antioxidants|mesh-ancestor
101522049|NCT04317079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522050|NCT04317079|Protective Agents|protective agents|mesh-ancestor
101522051|NCT04317079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522052|NCT04317079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101522053|NCT03277430|Tacrolimus|tacrolimus|mesh-list
101522054|NCT03277430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101522055|NCT03277430|Immunologic Factors|immunologic factors|mesh-ancestor
101522056|NCT03277430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522057|NCT03277430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101522058|NCT03277430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101522059|NCT03277430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522060|NCT04699214|Endostar protein|endostar protein|mesh-list
101522061|NCT04699214|Endostatins|endostatins|mesh-list
101522062|NCT04699214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101522063|NCT04699214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101522064|NCT04699214|Growth Substances|growth substances|mesh-ancestor
101522065|NCT04699214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522066|NCT04699214|Growth Inhibitors|growth inhibitors|mesh-ancestor
101522067|NCT04699214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101522068|NCT02902380|Dexmedetomidine|dexmedetomidine|mesh-list
101522069|NCT02902380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101522070|NCT02902380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101522071|NCT02902380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522072|NCT02902380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101522073|NCT02902380|Analgesics|analgesics|mesh-ancestor
101522074|NCT02902380|Sensory System Agents|sensory system agents|mesh-ancestor
101522075|NCT02902380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101522076|NCT02902380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101522077|NCT02902380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101522078|NCT02902380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101522079|NCT02902380|Adrenergic Agents|adrenergic agents|mesh-ancestor
101318035|NCT00014755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101318036|NCT00014755|Immunologic Factors|immunologic factors|mesh-ancestor
101318037|NCT00014755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318038|NCT00014755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101522081|NCT02902380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522082|NCT01221727|Denosumab|denosumab|mesh-list
101522083|NCT01221727|Midazolam|midazolam|mesh-list
101522084|NCT01221727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101522085|NCT01221727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101522086|NCT01221727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101522087|NCT01221727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522088|NCT01221727|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101522089|NCT01221727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101522090|NCT01221727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101522091|NCT01221727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101522092|NCT01221727|Anesthetics, General|anesthetics, general|mesh-ancestor
101522093|NCT01221727|Anesthetics|anesthetics|mesh-ancestor
101522094|NCT01221727|GABA Modulators|gaba modulators|mesh-ancestor
101522095|NCT01221727|GABA Agents|gaba agents|mesh-ancestor
101522096|NCT01221727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101522097|NCT01221727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522098|NCT01221727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101522099|NCT01221181|Eculizumab|eculizumab|mesh-list
101522100|NCT01221181|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101522101|NCT01221181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101522102|NCT01221181|Immunologic Factors|immunologic factors|mesh-ancestor
101318042|NCT00014755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101522103|NCT01221181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522104|NCT03277079|Ezetimibe|ezetimibe|mesh-list
101522105|NCT03277079|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
101522106|NCT03277079|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101522107|NCT03277079|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101522108|NCT03277079|Antimetabolites|antimetabolites|mesh-ancestor
101522109|NCT03277079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522110|NCT03277079|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101522111|NCT03277079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101522112|NCT01220557|Insulin|insulin|mesh-list
101522113|NCT01220557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101522114|NCT01220557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522115|NCT04317001|Modafinil|modafinil|mesh-list
101522116|NCT04317001|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101318096|NCT00015067|Methylphenidate|methylphenidate|mesh-list
101522117|NCT04317001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522118|NCT04317001|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101522119|NCT04317001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101522120|NCT04317001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101522121|NCT04317001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522123|NCT05426499|Isavuconazole|isavuconazole|mesh-list
101522124|NCT05426499|Anidulafungin|anidulafungin|mesh-list
101522125|NCT05426499|Meropenem|meropenem|mesh-list
101522126|NCT05426499|Cefotaxime|cefotaxime|mesh-list
101522127|NCT05426499|Cefoxitin|cefoxitin|mesh-list
101522128|NCT05426499|Antifungal Agents|antifungal agents|mesh-ancestor
101522129|NCT05426499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101522130|NCT05426499|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101522132|NCT05426499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101522133|NCT05426499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318154|NCT00015652|Ribavirin|ribavirin|mesh-list
101318155|NCT00015652|Aldesleukin|aldesleukin|mesh-list
101522134|NCT05426499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101522135|NCT05426499|Hormone Antagonists|hormone antagonists|mesh-ancestor
101522136|NCT05426499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101522137|NCT05426499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522138|NCT05426499|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101522139|NCT05426499|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101522140|NCT05426499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101522142|NCT00446810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101522143|NCT00446810|Immunologic Factors|immunologic factors|mesh-ancestor
101522144|NCT00446810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522145|NCT00446810|Chelating Agents|chelating agents|mesh-ancestor
101522146|NCT00446810|Sequestering Agents|sequestering agents|mesh-ancestor
101318214|NCT00015925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318227|NCT00015964|Gefitinib|gefitinib|mesh-list
101522147|NCT00446810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522148|NCT01220167|Ondansetron|ondansetron|mesh-list
101522149|NCT01220167|Antiemetics|antiemetics|mesh-ancestor
101522150|NCT01220167|Autonomic Agents|autonomic agents|mesh-ancestor
101522151|NCT01220167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101522152|NCT01220167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522153|NCT01220167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101522154|NCT01220167|Antipruritics|antipruritics|mesh-ancestor
101522155|NCT01220167|Dermatologic Agents|dermatologic agents|mesh-ancestor
101522156|NCT01220167|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101522157|NCT01220167|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101522158|NCT01220167|Serotonin Agents|serotonin agents|mesh-ancestor
101522159|NCT01220167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101522160|NCT01220167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522162|NCT00447239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101522163|NCT00447239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522164|NCT05425914|Vitamin D|vitamin d|mesh-list
101522165|NCT05425914|Lubricant Eye Drops|lubricant eye drops|mesh-list
101522166|NCT05425914|Vitamins|vitamins|mesh-ancestor
101522167|NCT05425914|Micronutrients|micronutrients|mesh-ancestor
101522168|NCT05425914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522169|NCT05425914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101522170|NCT05425914|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101522171|NCT05425914|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101522172|NCT00447356|Interferons|interferons|mesh-list
101522173|NCT00447356|Interferon-alpha|interferon-alpha|mesh-list
101522174|NCT00447356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101522176|NCT00447356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101522177|NCT00447356|Immunologic Factors|immunologic factors|mesh-ancestor
101522178|NCT00447356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522179|NCT00447473|Ketoconazole|ketoconazole|mesh-list
101522180|NCT00447473|Mitoxantrone|mitoxantrone|mesh-list
101522181|NCT00447473|Analgesics|analgesics|mesh-ancestor
101522182|NCT00447473|Sensory System Agents|sensory system agents|mesh-ancestor
101522183|NCT00447473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101522184|NCT00447473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522185|NCT00447473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101522186|NCT00447473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101522187|NCT00447473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101522188|NCT00447473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101522189|NCT00447473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101318329|NCT00016315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101318330|NCT00016315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101318331|NCT00016315|Tubulin Modulators|tubulin modulators|mesh-ancestor
101318332|NCT00016315|Antimitotic Agents|antimitotic agents|mesh-ancestor
101318333|NCT00016315|Mitosis Modulators|mitosis modulators|mesh-ancestor
101318337|NCT00006014|Semaxinib|semaxinib|mesh-list
101522190|NCT00447473|Antifungal Agents|antifungal agents|mesh-ancestor
101522191|NCT00447473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101522192|NCT00447473|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101522193|NCT00447473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101522194|NCT00447473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101522196|NCT00447473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101522197|NCT00447473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101522199|NCT00553488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101522200|NCT00553488|Insulin Lispro|insulin lispro|mesh-list
101522201|NCT00553488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101522202|NCT00553488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522203|NCT03455322|Octreotide|octreotide|mesh-list
101522204|NCT03455322|Norepinephrine|norepinephrine|mesh-list
101522205|NCT03455322|Midodrine|midodrine|mesh-list
101522206|NCT03455322|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101522207|NCT03455322|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101522208|NCT03455322|Adrenergic Agents|adrenergic agents|mesh-ancestor
101522209|NCT03455322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101318390|NCT00016666|Propranolol|propranolol|mesh-list
101522210|NCT03455322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522211|NCT03455322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522212|NCT03455322|Sympathomimetics|sympathomimetics|mesh-ancestor
101522213|NCT03455322|Autonomic Agents|autonomic agents|mesh-ancestor
101522214|NCT03455322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101522215|NCT03455322|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101522216|NCT03455322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101522217|NCT03455322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101522218|NCT03455322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101522219|NCT03455322|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101522220|NCT05425368|Fluorides|fluorides|mesh-list
101522221|NCT05425368|Cariostatic Agents|cariostatic agents|mesh-ancestor
101522222|NCT05425368|Protective Agents|protective agents|mesh-ancestor
101522223|NCT05425368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522224|NCT00447863|Levonorgestrel|levonorgestrel|mesh-list
101522225|NCT00447863|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101522226|NCT00447863|Estradiol|estradiol|mesh-list
101522227|NCT00447863|Estrogens|estrogens|mesh-ancestor
101522228|NCT00447863|Hormones|hormones|mesh-ancestor
101522229|NCT00447863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101522230|NCT00447863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522231|NCT00447863|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101522232|NCT00447863|Contraceptive Agents|contraceptive agents|mesh-ancestor
101522233|NCT00447863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101522234|NCT00447863|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101318446|NCT00016978|Fluorouracil|fluorouracil|mesh-list
101522235|NCT00447863|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101522236|NCT00447863|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101522237|NCT00447863|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101522238|NCT00448097|Docetaxel|docetaxel|mesh-list
101522239|NCT00448097|Cetuximab|cetuximab|mesh-list
101522240|NCT00448097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101522241|NCT00448097|Tubulin Modulators|tubulin modulators|mesh-ancestor
101522242|NCT00448097|Antimitotic Agents|antimitotic agents|mesh-ancestor
101522243|NCT00448097|Mitosis Modulators|mitosis modulators|mesh-ancestor
101522244|NCT00448097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522245|NCT00448097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101522246|NCT00448214|Warfarin|warfarin|mesh-list
101522247|NCT00448214|Anticoagulants|anticoagulants|mesh-ancestor
101522248|NCT00448253|Immunoglobulins|immunoglobulins|mesh-list
101522249|NCT00448253|Immunologic Factors|immunologic factors|mesh-ancestor
101522250|NCT00448253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318562|NCT00006032|Topotecan|topotecan|mesh-list
101318563|NCT00006032|Ifosfamide|ifosfamide|mesh-list
101522251|NCT00448292|Naluzotan|naluzotan|mesh-list
101522252|NCT00448292|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101522253|NCT00448292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101522254|NCT00448292|Serotonin Agents|serotonin agents|mesh-ancestor
101522255|NCT00448292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101522256|NCT00448292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522257|NCT00448292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522258|NCT02901561|Misoprostol|misoprostol|mesh-list
101522259|NCT02901561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101522260|NCT02901561|Abortifacient Agents|abortifacient agents|mesh-ancestor
101522261|NCT02901561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101522262|NCT02901561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522263|NCT02901561|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101522264|NCT02901561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101522265|NCT02901561|Oxytocics|oxytocics|mesh-ancestor
101522266|NCT00448409|Sargramostim|sargramostim|mesh-list
101318633|NCT00017290|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101318634|NCT00017290|Alkylating Agents|alkylating agents|mesh-ancestor
101318636|NCT00017290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101522267|NCT00448409|Immunologic Factors|immunologic factors|mesh-ancestor
101522268|NCT00448409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522269|NCT02901366|Dotinurad|dotinurad|mesh-list
101522270|NCT02901366|Uricosuric Agents|uricosuric agents|mesh-ancestor
101522271|NCT02901366|Gout Suppressants|gout suppressants|mesh-ancestor
101522272|NCT02901366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101522273|NCT03276689|Pregabalin|pregabalin|mesh-list
101522274|NCT03276689|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101522275|NCT03276689|Analgesics|analgesics|mesh-ancestor
101522276|NCT03276689|Sensory System Agents|sensory system agents|mesh-ancestor
101522277|NCT03276689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101522278|NCT03276689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522279|NCT03276689|Anticonvulsants|anticonvulsants|mesh-ancestor
101522280|NCT03276689|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101522281|NCT03276689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101522282|NCT03276689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522283|NCT03276689|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101318695|NCT00006041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101318696|NCT00006041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101318697|NCT00017602|Dexamethasone|dexamethasone|mesh-list
101522284|NCT03276689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101522285|NCT03276689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101522286|NCT03276689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101522287|NCT03276689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101522288|NCT03276689|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101522289|NCT03276689|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101522290|NCT03276689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101522291|NCT03276689|Antidepressive Agents|antidepressive agents|mesh-ancestor
101522293|NCT01220128|Paclitaxel|paclitaxel|mesh-list
101522294|NCT01220128|Docetaxel|docetaxel|mesh-list
101522295|NCT01220128|Cyclophosphamide|cyclophosphamide|mesh-list
101522296|NCT01220128|Carboplatin|carboplatin|mesh-list
101522297|NCT01220128|Doxorubicin|doxorubicin|mesh-list
101522298|NCT01220128|Fluorouracil|fluorouracil|mesh-list
101318758|NCT00017719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101318759|NCT00017719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101318760|NCT00017719|Protease Inhibitors|protease inhibitors|mesh-ancestor
101522299|NCT01220128|Trastuzumab|trastuzumab|mesh-list
101522300|NCT01220128|Epirubicin|epirubicin|mesh-list
101522301|NCT01220128|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101522302|NCT01220128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101522303|NCT01220128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101522305|NCT01220128|Antimitotic Agents|antimitotic agents|mesh-ancestor
101522306|NCT01220128|Mitosis Modulators|mitosis modulators|mesh-ancestor
101522307|NCT01220128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522308|NCT01220128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101522309|NCT01220128|Immunologic Factors|immunologic factors|mesh-ancestor
101522310|NCT01220128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522311|NCT01220128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101522312|NCT01220128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101522313|NCT01220128|Alkylating Agents|alkylating agents|mesh-ancestor
101522314|NCT01220128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101522315|NCT01220128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101522316|NCT01220128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101522317|NCT01220128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101522318|NCT01220128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101522319|NCT01220128|Antimetabolites|antimetabolites|mesh-ancestor
101522320|NCT01220128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101522321|NCT01220128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101522322|NCT01220128|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101329910|NCT00028483|Immunologic Factors|immunologic factors|mesh-ancestor
101318818|NCT00017992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101318819|NCT00017992|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101522323|NCT01220128|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101522324|NCT01220128|Hormone Antagonists|hormone antagonists|mesh-ancestor
101522325|NCT01220128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101522327|NCT04698941|Simvastatin|simvastatin|mesh-list
101522328|NCT04698941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101522329|NCT04698941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101522330|NCT04698941|Tubulin Modulators|tubulin modulators|mesh-ancestor
101522331|NCT04698941|Antimitotic Agents|antimitotic agents|mesh-ancestor
101522332|NCT04698941|Mitosis Modulators|mitosis modulators|mesh-ancestor
101522333|NCT04698941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522334|NCT04698941|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101522335|NCT04698941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101522336|NCT04698941|Antimetabolites|antimetabolites|mesh-ancestor
101522337|NCT04698941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101522338|NCT04698941|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101522339|NCT04698941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101522340|NCT02901288|Levofloxacin|levofloxacin|mesh-list
101522341|NCT02901288|Rifampin|rifampin|mesh-list
101318866|NCT00018187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101318876|NCT00018343|Estrogens|estrogens|mesh-list
101522343|NCT02901288|Pyrazinamide|pyrazinamide|mesh-list
101522344|NCT02901288|Ethambutol|ethambutol|mesh-list
101522345|NCT02901288|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101522346|NCT02901288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101522347|NCT02901288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101522348|NCT02901288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101522349|NCT02901288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101522350|NCT02901288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101522351|NCT02901288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522352|NCT02901288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101522353|NCT02901288|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101522354|NCT02901288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101522355|NCT02901288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101522356|NCT02901288|Antitubercular Agents|antitubercular agents|mesh-ancestor
101522357|NCT02901288|Leprostatic Agents|leprostatic agents|mesh-ancestor
101522358|NCT02901288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101522359|NCT02901288|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101522360|NCT02901288|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101522361|NCT02901288|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101522362|NCT02901288|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101522363|NCT02901288|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101522364|NCT02901288|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101522365|NCT02901288|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101522366|NCT02901288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101522368|NCT02901288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101522369|NCT00448643|Cisplatin|cisplatin|mesh-list
101522370|NCT00448643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101522371|NCT05424393|Etanercept|etanercept|mesh-list
101522372|NCT05424393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101522373|NCT05424393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101522374|NCT05424393|Analgesics|analgesics|mesh-ancestor
101522375|NCT05424393|Sensory System Agents|sensory system agents|mesh-ancestor
101522376|NCT05424393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101522377|NCT05424393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522378|NCT05424393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101522379|NCT05424393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101522380|NCT05424393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101522381|NCT05424393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101522382|NCT05424393|Immunologic Factors|immunologic factors|mesh-ancestor
101522383|NCT00448838|Gemcitabine|gemcitabine|mesh-list
101522384|NCT00448838|Oxaliplatin|oxaliplatin|mesh-list
101522385|NCT00448838|Cetuximab|cetuximab|mesh-list
101522386|NCT00448838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101522387|NCT00448838|Antimetabolites|antimetabolites|mesh-ancestor
101522388|NCT00448838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522389|NCT00448838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101522390|NCT00448838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101522391|NCT01219933|Methylprednisolone|methylprednisolone|mesh-list
101522392|NCT01219933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101522393|NCT01219933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101522394|NCT01219933|Prednisolone|prednisolone|mesh-list
101522395|NCT01219933|Prednisolone acetate|prednisolone acetate|mesh-list
101522396|NCT01219933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101522397|NCT01219933|Prednisolone phosphate|prednisolone phosphate|mesh-list
101522398|NCT01219933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101522399|NCT01219933|Antiemetics|antiemetics|mesh-ancestor
101522400|NCT01219933|Autonomic Agents|autonomic agents|mesh-ancestor
101522401|NCT01219933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101522402|NCT01219933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522403|NCT01219933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101522404|NCT01219933|Glucocorticoids|glucocorticoids|mesh-ancestor
101522405|NCT01219933|Hormones|hormones|mesh-ancestor
101522406|NCT01219933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101522407|NCT01219933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101522408|NCT01219933|Protective Agents|protective agents|mesh-ancestor
101522409|NCT01219933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101522410|NCT01219933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101522411|NCT05373901|Tretinoin|tretinoin|mesh-list
101522412|NCT05373901|Dinutuximab|dinutuximab|mesh-list
101522413|NCT05373901|Isotretinoin|isotretinoin|mesh-list
101522414|NCT05373901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101522415|NCT05373901|Keratolytic Agents|keratolytic agents|mesh-ancestor
101522416|NCT05373901|Dermatologic Agents|dermatologic agents|mesh-ancestor
101522417|NCT05368441|Midazolam|midazolam|mesh-list
101522418|NCT05368441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101522419|NCT05368441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101522420|NCT05368441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101522421|NCT05368441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522422|NCT05368441|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101522423|NCT05368441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101522424|NCT05368441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101318945|NCT00392080|Naproxen|naproxen|mesh-list
101522425|NCT05368441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101522426|NCT05368441|Anesthetics, General|anesthetics, general|mesh-ancestor
101522427|NCT05368441|Anesthetics|anesthetics|mesh-ancestor
101522428|NCT05368441|GABA Modulators|gaba modulators|mesh-ancestor
101522429|NCT05368441|GABA Agents|gaba agents|mesh-ancestor
101522430|NCT05368441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101522434|NCT05468359|Sorafenib|sorafenib|mesh-list
101522435|NCT05468359|Atezolizumab|atezolizumab|mesh-list
101522436|NCT05468359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101522437|NCT05468359|Immunologic Factors|immunologic factors|mesh-ancestor
101522438|NCT05468359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522440|NCT05468359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101522441|NCT05468359|Alkylating Agents|alkylating agents|mesh-ancestor
101522442|NCT05468359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522443|NCT05468359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101522444|NCT05468359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101522445|NCT05468359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101522446|NCT05468359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101522447|NCT05468359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101522448|NCT05468359|Growth Substances|growth substances|mesh-ancestor
101522449|NCT05468359|Growth Inhibitors|growth inhibitors|mesh-ancestor
101522450|NCT05468359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101522451|NCT05468359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101522452|NCT05468359|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101522453|NCT04316845|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
101522454|NCT04316845|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101522455|NCT04316845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522456|NCT01218802|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101522457|NCT01218802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101522458|NCT01218802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101522459|NCT01218802|Antimetabolites|antimetabolites|mesh-ancestor
101522460|NCT01218802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522461|NCT01218802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101522462|NCT01218802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101522463|NCT01218802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101522464|NCT02887222|Bupivacaine|bupivacaine|mesh-list
101522465|NCT02887222|Anesthetics, Local|anesthetics, local|mesh-ancestor
101522466|NCT02887222|Anesthetics|anesthetics|mesh-ancestor
101522467|NCT02887222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101522468|NCT02887222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522469|NCT02887222|Sensory System Agents|sensory system agents|mesh-ancestor
101522470|NCT02887222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101522471|NCT01218646|Vaccines|vaccines|mesh-list
101522472|NCT01218646|Immunologic Factors|immunologic factors|mesh-ancestor
101522473|NCT01218646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522474|NCT00449423|Acipimox|acipimox|mesh-list
101522475|NCT00449423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101522476|NCT00449423|Antimetabolites|antimetabolites|mesh-ancestor
101522477|NCT00449423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319123|NCT00392275|Ofloxacin|ofloxacin|mesh-list
101522478|NCT00449423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101522479|NCT00449501|Budesonide|budesonide|mesh-list
101522480|NCT00449501|Formoterol Fumarate|formoterol fumarate|mesh-list
101522481|NCT00449501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101522482|NCT00449501|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101522483|NCT00449501|Autonomic Agents|autonomic agents|mesh-ancestor
101522484|NCT00449501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101522485|NCT00449501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522486|NCT00449501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101522487|NCT00449501|Respiratory System Agents|respiratory system agents|mesh-ancestor
101522488|NCT00449501|Glucocorticoids|glucocorticoids|mesh-ancestor
101522489|NCT00449501|Hormones|hormones|mesh-ancestor
101522490|NCT00449501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101522491|NCT00449501|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101522492|NCT00449501|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101522493|NCT00449501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101522494|NCT00449501|Adrenergic Agents|adrenergic agents|mesh-ancestor
101522495|NCT00449501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101522496|NCT00449501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522497|NCT02900820|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101522498|NCT02900820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101522499|NCT02900820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101522500|NCT02900820|Antitubercular Agents|antitubercular agents|mesh-ancestor
101522501|NCT01188772|Sofosbuvir|sofosbuvir|mesh-list
101522502|NCT01188772|Antiviral Agents|antiviral agents|mesh-ancestor
101522503|NCT01188772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101522504|NCT01188655|Etanercept|etanercept|mesh-list
101522505|NCT01188655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101522506|NCT01188655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101522507|NCT01188655|Analgesics|analgesics|mesh-ancestor
101522508|NCT01188655|Sensory System Agents|sensory system agents|mesh-ancestor
101522509|NCT01188655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101522510|NCT01188655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522511|NCT01188655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101522512|NCT01188655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101522513|NCT01188655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101522514|NCT01188655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101522515|NCT01188655|Immunologic Factors|immunologic factors|mesh-ancestor
101522516|NCT00449618|Aspirin|aspirin|mesh-list
101522517|NCT00449618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101522518|NCT00449618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101522519|NCT00449618|Analgesics|analgesics|mesh-ancestor
101522520|NCT00449618|Sensory System Agents|sensory system agents|mesh-ancestor
101522521|NCT00449618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101522522|NCT00449618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522523|NCT00449618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101411247|NCT00115310|Capsaicin|capsaicin|mesh-list
101522524|NCT00449618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101522525|NCT00449618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101522526|NCT00449618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101522527|NCT00449618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522528|NCT00449618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101522529|NCT00449618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101522530|NCT00449618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101522531|NCT00449618|Antipyretics|antipyretics|mesh-ancestor
101522532|NCT01188538|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
101522533|NCT01188538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101522534|NCT01188538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101522535|NCT01188538|Analgesics|analgesics|mesh-ancestor
101522536|NCT01188538|Sensory System Agents|sensory system agents|mesh-ancestor
101522537|NCT01188538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101522538|NCT01188538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522540|NCT01188538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101522541|NCT01188538|Dermatologic Agents|dermatologic agents|mesh-ancestor
101522542|NCT00449657|Paclitaxel|paclitaxel|mesh-list
101522543|NCT00449657|Carboplatin|carboplatin|mesh-list
101522544|NCT00449657|Gemcitabine|gemcitabine|mesh-list
101319167|NCT05156905|Antimitotic Agents|antimitotic agents|mesh-ancestor
101522545|NCT00449657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101319170|NCT00001758|Efavirenz|efavirenz|mesh-list
101522546|NCT00449657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101522547|NCT00449657|Tubulin Modulators|tubulin modulators|mesh-ancestor
101522548|NCT00449657|Antimitotic Agents|antimitotic agents|mesh-ancestor
101522549|NCT00449657|Mitosis Modulators|mitosis modulators|mesh-ancestor
101522550|NCT00449657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522551|NCT00449657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101522552|NCT00449657|Antimetabolites|antimetabolites|mesh-ancestor
101522553|NCT04318444|Hydroxychloroquine|hydroxychloroquine|mesh-list
101522554|NCT04318444|Antimalarials|antimalarials|mesh-ancestor
101522555|NCT04318444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101522556|NCT04318444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101319202|NCT04983901|Vancomycin|vancomycin|mesh-list
101522558|NCT04318444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101522559|NCT04318444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522560|NCT04318444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101522562|NCT03276143|Apixaban|apixaban|mesh-list
101522563|NCT03276143|Anticoagulants|anticoagulants|mesh-ancestor
101522564|NCT03276143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101522565|NCT03276143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101522566|NCT03276143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522567|NCT03276143|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101522568|NCT03276143|Antithrombins|antithrombins|mesh-ancestor
101522569|NCT03276143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101319240|NCT00001818|Antisickling Agents|antisickling agents|mesh-ancestor
101319241|NCT00001818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101319242|NCT00001818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522570|NCT03276143|Protease Inhibitors|protease inhibitors|mesh-ancestor
101522571|NCT03276143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101522572|NCT00449774|Lamotrigine|lamotrigine|mesh-list
101522573|NCT00449774|Anticonvulsants|anticonvulsants|mesh-list
101522574|NCT00449774|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101522575|NCT00449774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101522576|NCT00449774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522577|NCT00449774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101522578|NCT00449774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522579|NCT00449774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101522580|NCT00449774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101522581|NCT00449774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101522583|NCT00449774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101522584|NCT02900742|Gemcitabine|gemcitabine|mesh-list
101522585|NCT02900742|Docetaxel|docetaxel|mesh-list
101522586|NCT02900742|Pemetrexed|pemetrexed|mesh-list
101522587|NCT02900742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101522588|NCT02900742|Antimetabolites|antimetabolites|mesh-ancestor
101522589|NCT02900742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522590|NCT02900742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101319300|NCT00392431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101319301|NCT00392431|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101319302|NCT00392431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101319303|NCT00392431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101522591|NCT02900742|Tubulin Modulators|tubulin modulators|mesh-ancestor
101522592|NCT02900742|Antimitotic Agents|antimitotic agents|mesh-ancestor
101522593|NCT02900742|Mitosis Modulators|mitosis modulators|mesh-ancestor
101522594|NCT02900742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101522595|NCT02900742|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101522596|NCT02900742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101522597|NCT00449813|Pantoprazole|pantoprazole|mesh-list
101522598|NCT00449813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101522599|NCT00449813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101522600|NCT00449813|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101522601|NCT00449813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101522602|NCT00449813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522603|NCT01218100|Lisinopril|lisinopril|mesh-list
101522604|NCT01218100|Nebivolol|nebivolol|mesh-list
101319355|NCT04733326|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101522605|NCT01218100|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101522606|NCT01218100|Protease Inhibitors|protease inhibitors|mesh-ancestor
101522607|NCT01218100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101522608|NCT01218100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522609|NCT01218100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101522610|NCT01218100|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101522611|NCT01218100|Protective Agents|protective agents|mesh-ancestor
101522612|NCT01218100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522613|NCT01218100|Vasodilator Agents|vasodilator agents|mesh-ancestor
101522614|NCT01218100|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101522615|NCT01218100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101522616|NCT01218100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101522617|NCT01218100|Adrenergic Agents|adrenergic agents|mesh-ancestor
101522618|NCT01218100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101522619|NCT00450008|Thalidomide|thalidomide|mesh-list
101522620|NCT00450008|Docetaxel|docetaxel|mesh-list
101522621|NCT00450008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101522623|NCT00450008|Antimitotic Agents|antimitotic agents|mesh-ancestor
101522624|NCT00450008|Mitosis Modulators|mitosis modulators|mesh-ancestor
101522625|NCT00450008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522626|NCT00450008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101522627|NCT00450008|Immunologic Factors|immunologic factors|mesh-ancestor
101522628|NCT00450008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522629|NCT00450008|Leprostatic Agents|leprostatic agents|mesh-ancestor
101522630|NCT00450008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101522631|NCT00450008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101522632|NCT00450008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101319417|NCT03959176|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101319418|NCT03959176|Phenylephrine|phenylephrine|mesh-list
101319419|NCT03959176|Oxymetazoline|oxymetazoline|mesh-list
101319420|NCT03959176|Tropicamide|tropicamide|mesh-list
101522633|NCT00450008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101522634|NCT00450008|Growth Substances|growth substances|mesh-ancestor
101522635|NCT00450008|Growth Inhibitors|growth inhibitors|mesh-ancestor
101522636|NCT02900469|Denosumab|denosumab|mesh-list
101522637|NCT02900469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101522638|NCT02900469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522639|NCT00450086|Budesonide|budesonide|mesh-list
101522640|NCT00450086|Mesalamine|mesalamine|mesh-list
101522641|NCT00450086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101522642|NCT00450086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101522643|NCT00450086|Autonomic Agents|autonomic agents|mesh-ancestor
101522644|NCT00450086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101522645|NCT00450086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522646|NCT00450086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101522647|NCT00450086|Respiratory System Agents|respiratory system agents|mesh-ancestor
101522648|NCT00450086|Glucocorticoids|glucocorticoids|mesh-ancestor
101522649|NCT00450086|Hormones|hormones|mesh-ancestor
101522650|NCT00450086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101319462|NCT05640609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319464|NCT05411861|Analgesics|analgesics|mesh-list
101522651|NCT00450086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101522652|NCT00450086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101522653|NCT00450086|Analgesics|analgesics|mesh-ancestor
101522654|NCT00450086|Sensory System Agents|sensory system agents|mesh-ancestor
101522655|NCT00450086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101522656|NCT05422911|Abiraterone Acetate|abiraterone acetate|mesh-list
101522657|NCT05422911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101522658|NCT05422911|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101522659|NCT05422911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101522660|NCT05422911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522661|NCT05422911|Hormone Antagonists|hormone antagonists|mesh-ancestor
101522662|NCT05422911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101522663|NCT05422911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522664|NCT05422911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101522665|NCT00450164|Nadolol|nadolol|mesh-list
101522666|NCT00450164|Prazosin|prazosin|mesh-list
101522667|NCT00450164|Isosorbide|isosorbide|mesh-list
101522668|NCT00450164|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
101522669|NCT00450164|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
101522670|NCT00450164|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101522671|NCT00450164|Diuretics|diuretics|mesh-ancestor
101522672|NCT00450164|Natriuretic Agents|natriuretic agents|mesh-ancestor
101522673|NCT00450164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522674|NCT00450164|Vasodilator Agents|vasodilator agents|mesh-ancestor
101522675|NCT00450164|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101522676|NCT00450164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522677|NCT00450164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101522678|NCT00450164|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101522679|NCT00450164|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101522680|NCT00450164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101319518|NCT03819322|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
101522681|NCT00450164|Adrenergic Agents|adrenergic agents|mesh-ancestor
101522682|NCT00450164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101522683|NCT00450164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101522684|NCT00450164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101522687|NCT00450164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101522688|NCT02900430|Antifungal Agents|antifungal agents|mesh-list
101522689|NCT02900430|Clotrimazole|clotrimazole|mesh-list
101522690|NCT02900430|Miconazole|miconazole|mesh-list
101522691|NCT02900430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101522692|NCT02900430|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101522693|NCT02900430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101522694|NCT02900430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101522695|NCT02900430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101522696|NCT02900430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319562|NCT05637567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101522697|NCT02900430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101522698|NCT02900430|Hormone Antagonists|hormone antagonists|mesh-ancestor
101522699|NCT02900430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101522700|NCT02900430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522701|NCT02900430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101522702|NCT02900430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101522704|NCT00450203|Capecitabine|capecitabine|mesh-list
101522705|NCT00450203|Epirubicin|epirubicin|mesh-list
101522706|NCT00450203|Lapatinib|lapatinib|mesh-list
101522707|NCT00450203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101522708|NCT00450203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101522709|NCT00450203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101522710|NCT00450203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101522711|NCT00450203|Growth Substances|growth substances|mesh-ancestor
101522712|NCT00450203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522713|NCT00450203|Growth Inhibitors|growth inhibitors|mesh-ancestor
101522714|NCT00450203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101522715|NCT00450203|Antimetabolites|antimetabolites|mesh-ancestor
101522716|NCT00450203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522717|NCT00450203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101522718|NCT00450203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101522719|NCT00450203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101522720|NCT00450203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101522721|NCT00450203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101522722|NCT00450281|Antibodies|antibodies|mesh-list
101522723|NCT00450281|Immunologic Factors|immunologic factors|mesh-ancestor
101522724|NCT00450281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522726|NCT04699097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101522727|NCT04699097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101522728|NCT04698746|Anesthetics|anesthetics|mesh-list
101522729|NCT04698746|Anesthetics, Local|anesthetics, local|mesh-list
101522730|NCT04698746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101522731|NCT04698746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522732|NCT04698746|Sensory System Agents|sensory system agents|mesh-ancestor
101522733|NCT04698746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101522734|NCT00450320|Sirolimus|sirolimus|mesh-list
101522735|NCT00450320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101522736|NCT00450320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101522737|NCT00450320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101522738|NCT00450320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101522739|NCT00450320|Antifungal Agents|antifungal agents|mesh-ancestor
101522740|NCT00450320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101522741|NCT00450320|Immunologic Factors|immunologic factors|mesh-ancestor
101522742|NCT00450320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522743|NCT00450398|polysaccharide-K|polysaccharide-k|mesh-list
101522744|NCT00450398|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101522745|NCT00450398|Immunologic Factors|immunologic factors|mesh-ancestor
101319744|NCT03151174|Vitamin D|vitamin d|mesh-list
101522747|NCT00450398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101522748|NCT00450398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101522750|NCT00450398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101522751|NCT00450398|Interferon Inducers|interferon inducers|mesh-ancestor
101522752|NCT00450398|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101522753|NCT00450398|Protective Agents|protective agents|mesh-ancestor
101522754|NCT00450515|Capecitabine|capecitabine|mesh-list
101522755|NCT00450515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101522756|NCT00450515|Antimetabolites|antimetabolites|mesh-ancestor
101522757|NCT00450515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522758|NCT00450515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101522759|NCT00450827|Bevacizumab|bevacizumab|mesh-list
101522760|NCT00450827|Antibodies|antibodies|mesh-list
101522761|NCT00450827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101522762|NCT00450827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101522763|NCT00450827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101522764|NCT00450827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101522765|NCT00450827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101522766|NCT00450827|Growth Substances|growth substances|mesh-ancestor
101522767|NCT00450827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522768|NCT00450827|Growth Inhibitors|growth inhibitors|mesh-ancestor
101522769|NCT00450827|Immunologic Factors|immunologic factors|mesh-ancestor
101522770|NCT00450944|Immunotoxins|immunotoxins|mesh-list
101522771|NCT00450944|Immunoconjugates|immunoconjugates|mesh-ancestor
101522772|NCT00450944|Immunologic Factors|immunologic factors|mesh-ancestor
101522773|NCT00450944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522774|NCT00451061|Tamsulosin|tamsulosin|mesh-list
101522775|NCT00451061|Alfuzosin|alfuzosin|mesh-list
101522776|NCT00451061|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101522777|NCT00451061|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101522778|NCT00451061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101522779|NCT00451061|Adrenergic Agents|adrenergic agents|mesh-ancestor
101522780|NCT00451061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101522781|NCT00451061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522782|NCT00451061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522783|NCT00451061|Urological Agents|urological agents|mesh-ancestor
101522784|NCT02931383|Liraglutide|liraglutide|mesh-list
101522785|NCT02931383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101522786|NCT02931383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522787|NCT02931383|Incretins|incretins|mesh-ancestor
101522788|NCT02931383|Hormones|hormones|mesh-ancestor
101522789|NCT02931383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101522790|NCT04341441|Hydroxychloroquine|hydroxychloroquine|mesh-list
101522791|NCT04341441|Antimalarials|antimalarials|mesh-ancestor
101522792|NCT04341441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101522793|NCT04341441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101522794|NCT04341441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101522795|NCT04341441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101522796|NCT04341441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522797|NCT04341441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101522798|NCT01187953|Tacrolimus|tacrolimus|mesh-list
101522799|NCT01187953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101522800|NCT01187953|Immunologic Factors|immunologic factors|mesh-ancestor
101522801|NCT01187953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522802|NCT01187953|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101522803|NCT01187953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101522804|NCT01187953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522806|NCT02900157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101522807|NCT02900157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101522808|NCT04262817|Nicotine|nicotine|mesh-list
101522809|NCT04262817|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101522810|NCT04262817|Autonomic Agents|autonomic agents|mesh-ancestor
101522811|NCT04262817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101522812|NCT04262817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319856|NCT02633098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101522813|NCT04262817|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101522814|NCT04262817|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101522815|NCT04262817|Cholinergic Agents|cholinergic agents|mesh-ancestor
101522816|NCT04262817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101522817|NCT04262817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522818|NCT02931188|Anacetrapib|anacetrapib|mesh-list
101522819|NCT02931188|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101522820|NCT02931188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101522821|NCT02931188|Antimetabolites|antimetabolites|mesh-ancestor
101522822|NCT02931188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522823|NCT02931188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101522824|NCT01217944|Ranibizumab|ranibizumab|mesh-list
101522825|NCT01217944|Verteporfin|verteporfin|mesh-list
101522826|NCT01217944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101522827|NCT01217944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101319877|NCT02250937|Fludarabine|fludarabine|mesh-list
101319878|NCT02250937|Fludarabine phosphate|fludarabine phosphate|mesh-list
101522828|NCT01217944|Growth Substances|growth substances|mesh-ancestor
101522829|NCT01217944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522830|NCT01217944|Growth Inhibitors|growth inhibitors|mesh-ancestor
101522831|NCT01217944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101522832|NCT01217944|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101522833|NCT01217944|Dermatologic Agents|dermatologic agents|mesh-ancestor
101522834|NCT04689815|Arsenic Trioxide|arsenic trioxide|mesh-list
101522835|NCT04689815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101522836|NCT01187446|Vorinostat|vorinostat|mesh-list
101522837|NCT01187446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101522838|NCT01187446|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101522839|NCT01187446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101522840|NCT01187446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522841|NCT02931071|Plerixafor|plerixafor|mesh-list
101522842|NCT02931071|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101522843|NCT02931071|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101522844|NCT02931071|Antiviral Agents|antiviral agents|mesh-ancestor
101522845|NCT02931071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101522846|NCT01187407|Serotonin|serotonin|mesh-list
101522847|NCT01187407|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
101522848|NCT01187407|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101522849|NCT01187407|Serotonin Agents|serotonin agents|mesh-ancestor
101522850|NCT01187407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101522851|NCT01187407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522852|NCT01187407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319995|NCT01349803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101522853|NCT01187407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101522854|NCT01187407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101522855|NCT01186939|Azacitidine|azacitidine|mesh-list
101522856|NCT01186939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101522857|NCT01186939|Antimetabolites|antimetabolites|mesh-ancestor
101522858|NCT01186939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522860|NCT01186939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101522861|NCT04447040|Acetaminophen|acetaminophen|mesh-list
101522862|NCT04447040|Naproxen|naproxen|mesh-list
101522863|NCT04447040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101522864|NCT04447040|Analgesics|analgesics|mesh-ancestor
101522865|NCT04447040|Sensory System Agents|sensory system agents|mesh-ancestor
101522866|NCT04447040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101522867|NCT04447040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320057|NCT01806259|Sensory System Agents|sensory system agents|mesh-ancestor
101522868|NCT04447040|Antipyretics|antipyretics|mesh-ancestor
101522869|NCT04447040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101522870|NCT04447040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101522871|NCT04447040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101522872|NCT04447040|Gout Suppressants|gout suppressants|mesh-ancestor
101522873|NCT04447040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101522874|NCT04447040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101522875|NCT04447040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522876|NCT02930954|Bevacizumab|bevacizumab|mesh-list
101522877|NCT02930954|Carboplatin|carboplatin|mesh-list
101522878|NCT02930954|Gemcitabine|gemcitabine|mesh-list
101522879|NCT02930954|Pemetrexed|pemetrexed|mesh-list
101522880|NCT02930954|Gefitinib|gefitinib|mesh-list
101522881|NCT02930954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101522882|NCT02930954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101522883|NCT02930954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101522884|NCT02930954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101522885|NCT02930954|Growth Substances|growth substances|mesh-ancestor
101522886|NCT02930954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522887|NCT02930954|Growth Inhibitors|growth inhibitors|mesh-ancestor
101522888|NCT02930954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101522889|NCT02930954|Antimetabolites|antimetabolites|mesh-ancestor
101522890|NCT02930954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522891|NCT02930954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101522892|NCT02930954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101522893|NCT02930954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101522894|NCT02930954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101522895|NCT04117659|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
101522896|NCT04117659|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101522897|NCT04117659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101522898|NCT04117659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522900|NCT02930057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101522901|NCT02930057|Glucocorticoids|glucocorticoids|mesh-ancestor
101522902|NCT02930057|Hormones|hormones|mesh-ancestor
101522903|NCT02930057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101522904|NCT02930057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522905|NCT02930057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101522906|NCT02930057|Respiratory System Agents|respiratory system agents|mesh-ancestor
101522907|NCT02929901|Caffeine|caffeine|mesh-list
101522908|NCT02929901|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101522909|NCT02929901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522910|NCT02929901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101522911|NCT02929901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101522912|NCT02929901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522913|NCT02929901|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101522914|NCT02929901|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101522915|NCT02929901|Purinergic Agents|purinergic agents|mesh-ancestor
101522916|NCT02929901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101522917|NCT02929706|Azathioprine|azathioprine|mesh-list
101522918|NCT02929706|Antimetabolites|antimetabolites|mesh-ancestor
101522919|NCT02929706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522920|NCT02929706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101522921|NCT02929706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101522922|NCT02929706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101522923|NCT02929706|Immunologic Factors|immunologic factors|mesh-ancestor
101522924|NCT02929706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522925|NCT02929706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101522927|NCT03993132|Glucagon|glucagon|mesh-list
101522928|NCT03993132|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101522929|NCT03993132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101522930|NCT03993132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522931|NCT03993132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101522932|NCT03993132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522933|NCT03993132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101522934|NCT03993132|Hormones|hormones|mesh-ancestor
101522935|NCT03993132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101522936|NCT03993132|Incretins|incretins|mesh-ancestor
101522937|NCT00553878|Dutasteride|dutasteride|mesh-list
101522938|NCT00553878|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101522939|NCT00553878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101522940|NCT00553878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101522941|NCT00553878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522942|NCT00553878|Hormone Antagonists|hormone antagonists|mesh-ancestor
101522943|NCT00553878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101522944|NCT00553878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522945|NCT00624325|Interferons|interferons|mesh-list
101522946|NCT00624325|Interferon-alpha|interferon-alpha|mesh-list
101522947|NCT00624325|Interferon alpha-2|interferon alpha-2|mesh-list
101522948|NCT00624325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101522949|NCT00624325|Antiviral Agents|antiviral agents|mesh-ancestor
101522950|NCT00624325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101522951|NCT00624325|Immunologic Factors|immunologic factors|mesh-ancestor
101522952|NCT00624325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320263|NCT04201457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101522953|NCT04689893|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
101522954|NCT04689893|Chelating Agents|chelating agents|mesh-ancestor
101522955|NCT04689893|Sequestering Agents|sequestering agents|mesh-ancestor
101522956|NCT04689893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522957|NCT05184192|Gabapentin|gabapentin|mesh-list
101522958|NCT05184192|Analgesics|analgesics|mesh-ancestor
101522959|NCT05184192|Sensory System Agents|sensory system agents|mesh-ancestor
101522960|NCT05184192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101522961|NCT05184192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522962|NCT05184192|Anticonvulsants|anticonvulsants|mesh-ancestor
101522963|NCT05184192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101522964|NCT05184192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101522965|NCT05184192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101522966|NCT05184192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101320411|NCT04034927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101522967|NCT05184192|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101522968|NCT05184192|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101522969|NCT05184192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101522970|NCT05184192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522971|NCT05184192|Antimanic Agents|antimanic agents|mesh-ancestor
101522972|NCT02929121|Doxycycline|doxycycline|mesh-list
101522973|NCT02929121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101522974|NCT02929121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101522975|NCT02929121|Antimalarials|antimalarials|mesh-ancestor
101320472|NCT00847171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101320479|NCT03940586|Letermovir|letermovir|mesh-list
101522976|NCT02929121|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101522977|NCT02929121|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101522978|NCT02929394|Trabectedin|trabectedin|mesh-list
101522979|NCT02929394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101522981|NCT02929394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101522982|NCT02929394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101522983|NCT02929316|Vedolizumab|vedolizumab|mesh-list
101522984|NCT02929316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101522985|NCT02928965|Minocycline|minocycline|mesh-list
101522986|NCT02928965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101522987|NCT02928965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101522988|NCT02928692|Minocycline|minocycline|mesh-list
101522989|NCT02928692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101522990|NCT02928692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101522991|NCT04679142|Baclofen|baclofen|mesh-list
101522992|NCT04679142|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101522993|NCT04679142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101522994|NCT04679142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101522995|NCT04679142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101522996|NCT04679142|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101522998|NCT04679142|GABA Agents|gaba agents|mesh-ancestor
101522999|NCT04679142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101523000|NCT04679142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523001|NCT02928419|Lenalidomide|lenalidomide|mesh-list
101523002|NCT02928419|Immunologic Factors|immunologic factors|mesh-ancestor
101523003|NCT02928419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523004|NCT02928419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101523005|NCT02928419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101523006|NCT02928419|Growth Substances|growth substances|mesh-ancestor
101523007|NCT02928419|Growth Inhibitors|growth inhibitors|mesh-ancestor
101523008|NCT02928419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101523009|NCT02928614|Liraglutide|liraglutide|mesh-list
101523010|NCT02928614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101523011|NCT02928614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523012|NCT02928614|Incretins|incretins|mesh-ancestor
101523013|NCT02928614|Hormones|hormones|mesh-ancestor
101523014|NCT02928614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101523015|NCT03685500|Emtricitabine|emtricitabine|mesh-list
101523016|NCT03685500|Darunavir|darunavir|mesh-list
101523017|NCT03685500|Cobicistat|cobicistat|mesh-list
101523018|NCT03685500|Antiviral Agents|antiviral agents|mesh-ancestor
101523019|NCT03685500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101523020|NCT03685500|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101523021|NCT03685500|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101523022|NCT03685500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101319639|NCT03151603|Fosfomycin|fosfomycin|mesh-list
101523023|NCT03685500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523025|NCT03685500|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101523026|NCT03685500|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101523027|NCT03685500|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101523028|NCT03685500|Protease Inhibitors|protease inhibitors|mesh-ancestor
101523029|NCT03685500|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101523030|NCT03685500|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101523031|NCT02928575|Temozolomide|temozolomide|mesh-list
101523032|NCT02928575|Sunitinib|sunitinib|mesh-list
101523033|NCT02928575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101523034|NCT02928575|Alkylating Agents|alkylating agents|mesh-ancestor
101523035|NCT02928575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523036|NCT02928575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101523037|NCT02928575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101523038|NCT02928575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101523039|NCT02928575|Growth Substances|growth substances|mesh-ancestor
101523040|NCT02928575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523041|NCT02928575|Growth Inhibitors|growth inhibitors|mesh-ancestor
101523042|NCT02928575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101320727|NCT00276757|Levoleucovorin|levoleucovorin|mesh-list
101523043|NCT02928575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101523044|NCT02927951|Pregabalin|pregabalin|mesh-list
101523046|NCT02927951|Sensory System Agents|sensory system agents|mesh-ancestor
101523047|NCT02927951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101523048|NCT02927951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523049|NCT02927951|Anticonvulsants|anticonvulsants|mesh-ancestor
101523050|NCT02927951|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101523051|NCT02927951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101523052|NCT02927951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523053|NCT02927951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101523054|NCT02927951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101523055|NCT02927951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101523056|NCT02927951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101320765|NCT00276718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101523057|NCT02927951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101523059|NCT02927405|Analgesics|analgesics|mesh-ancestor
101523060|NCT02927405|Sensory System Agents|sensory system agents|mesh-ancestor
101523061|NCT02927405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101523062|NCT02927405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523063|NCT02927405|Anticonvulsants|anticonvulsants|mesh-ancestor
101523064|NCT02927405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101523065|NCT02927405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101523066|NCT02927405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101523067|NCT02927405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101523068|NCT02927405|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101523069|NCT02927405|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101523070|NCT02927405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101320827|NCT00389922|Tubulin Modulators|tubulin modulators|mesh-ancestor
101320833|NCT00276289|Spironolactone|spironolactone|mesh-list
101523071|NCT02927405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523072|NCT02927405|Antimanic Agents|antimanic agents|mesh-ancestor
101523073|NCT02927444|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101523074|NCT02927444|Immunologic Factors|immunologic factors|mesh-ancestor
101523075|NCT02927444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523076|NCT02927522|Donepezil|donepezil|mesh-list
101523077|NCT02927522|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101523078|NCT02927522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101523079|NCT02927522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523080|NCT02927522|Cholinergic Agents|cholinergic agents|mesh-ancestor
101523081|NCT02927522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101523082|NCT02927522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523083|NCT02927522|Nootropic Agents|nootropic agents|mesh-ancestor
101523084|NCT02926976|Valproic Acid|valproic acid|mesh-list
101523085|NCT02926976|Risperidone|risperidone|mesh-list
101523086|NCT02926976|Aripiprazole|aripiprazole|mesh-list
101523087|NCT02926976|Clozapine|clozapine|mesh-list
101523088|NCT02926976|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101523090|NCT02926976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101523091|NCT02926976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523092|NCT02926976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523093|NCT02926976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101523094|NCT02926976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101523095|NCT02926976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101523096|NCT02926976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101523097|NCT02926976|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101523098|NCT02926976|Dopamine Agents|dopamine agents|mesh-ancestor
101523099|NCT02926976|Antidepressive Agents|antidepressive agents|mesh-ancestor
101523100|NCT02926976|Dopamine Agonists|dopamine agonists|mesh-ancestor
101523101|NCT02926976|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101523102|NCT02926976|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101523103|NCT02926976|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101523104|NCT02926976|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101523105|NCT02926976|Anticonvulsants|anticonvulsants|mesh-ancestor
101523108|NCT02926976|Antimanic Agents|antimanic agents|mesh-ancestor
101523109|NCT02926976|GABA Antagonists|gaba antagonists|mesh-ancestor
101523110|NCT02927015|Iproplatin|iproplatin|mesh-list
101523111|NCT02927015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101523112|NCT04680195|Thalidomide|thalidomide|mesh-list
101523113|NCT04680195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101523114|NCT04680195|Immunologic Factors|immunologic factors|mesh-ancestor
101523115|NCT04680195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523116|NCT04680195|Leprostatic Agents|leprostatic agents|mesh-ancestor
101523117|NCT04680195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101523118|NCT04680195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101523119|NCT04680195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101523120|NCT04680195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101523121|NCT04680195|Growth Substances|growth substances|mesh-ancestor
101523122|NCT04680195|Growth Inhibitors|growth inhibitors|mesh-ancestor
101523123|NCT04680195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101523124|NCT04864431|Vitamin D|vitamin d|mesh-list
101523125|NCT04864431|Cholecalciferol|cholecalciferol|mesh-list
101523126|NCT04864431|Vitamins|vitamins|mesh-ancestor
101523127|NCT04864431|Micronutrients|micronutrients|mesh-ancestor
101523128|NCT04864431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523129|NCT04864431|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101523130|NCT04864431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101523131|NCT00553995|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
101523132|NCT00553995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101523133|NCT00553995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101523134|NCT00553995|Analgesics|analgesics|mesh-ancestor
101523135|NCT00553995|Sensory System Agents|sensory system agents|mesh-ancestor
101523136|NCT00553995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101523137|NCT00553995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320886|NCT00276055|Tubulin Modulators|tubulin modulators|mesh-ancestor
101523138|NCT00553995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101523139|NCT00553995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101523141|NCT04798287|Infliximab|infliximab|mesh-list
101523142|NCT04798287|Golimumab|golimumab|mesh-list
101523143|NCT04798287|Certolizumab Pegol|certolizumab pegol|mesh-list
101523144|NCT04798287|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
101523145|NCT04798287|Etanercept|etanercept|mesh-list
101523146|NCT04798287|Tofacitinib|tofacitinib|mesh-list
101523147|NCT04798287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101523148|NCT04798287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101523149|NCT04798287|Dermatologic Agents|dermatologic agents|mesh-ancestor
101523150|NCT04798287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101523151|NCT04798287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101523152|NCT04798287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101523153|NCT04798287|Analgesics|analgesics|mesh-ancestor
101523154|NCT04798287|Sensory System Agents|sensory system agents|mesh-ancestor
101523155|NCT04798287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101523156|NCT04798287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523157|NCT04798287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101523158|NCT04798287|Immunologic Factors|immunologic factors|mesh-ancestor
101523159|NCT04798287|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101411259|NCT00458185|Etanercept|etanercept|mesh-list
101523160|NCT04798287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101523161|NCT04798287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101523162|NCT04798287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523164|NCT04689191|Immunologic Factors|immunologic factors|mesh-ancestor
101523165|NCT04689191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523166|NCT02925299|Insulin|insulin|mesh-list
101523167|NCT02925299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101523169|NCT02925416|Oritavancin|oritavancin|mesh-list
101523170|NCT02925416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101523171|NCT02925416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101523172|NCT02925533|Pembrolizumab|pembrolizumab|mesh-list
101523173|NCT02925533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101523174|NCT02925533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101523175|NCT02925533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101320955|NCT05424757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101523176|NCT02925533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523177|NCT02917889|Caffeine|caffeine|mesh-list
101523178|NCT02917889|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101523179|NCT02917889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523180|NCT02917889|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101523181|NCT02917889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101523182|NCT02917889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321011|NCT04856176|Pembrolizumab|pembrolizumab|mesh-list
101523183|NCT02917889|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101523184|NCT02917889|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101523185|NCT02917889|Purinergic Agents|purinergic agents|mesh-ancestor
101523186|NCT02917889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101523187|NCT02917967|Botulinum Toxins|botulinum toxins|mesh-list
101523188|NCT02917967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101523189|NCT02917967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101523190|NCT02917967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523191|NCT02917967|Cholinergic Agents|cholinergic agents|mesh-ancestor
101523192|NCT02917967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101523193|NCT02917967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523194|NCT04485273|Anesthetics|anesthetics|mesh-list
101523195|NCT04485273|Sevoflurane|sevoflurane|mesh-list
101523196|NCT04485273|Bupivacaine|bupivacaine|mesh-list
101523197|NCT04485273|Anesthetics, Local|anesthetics, local|mesh-list
101523198|NCT04485273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101523199|NCT04485273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101523200|NCT04485273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523201|NCT04485273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101523202|NCT04485273|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101523203|NCT04485273|Anesthetics, General|anesthetics, general|mesh-ancestor
101523204|NCT04485273|Sensory System Agents|sensory system agents|mesh-ancestor
101321136|NCT04712435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523205|NCT04485273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101523206|NCT02205528|Metformin|metformin|mesh-list
101523207|NCT02205528|Liraglutide|liraglutide|mesh-list
101523208|NCT02205528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101523209|NCT02205528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523210|NCT02205528|Incretins|incretins|mesh-ancestor
101523211|NCT02205528|Hormones|hormones|mesh-ancestor
101523212|NCT02205528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101523214|NCT03532022|Prednisone|prednisone|mesh-list
101523215|NCT03532022|Prednisolone|prednisolone|mesh-list
101523216|NCT03532022|Hydrocortisone|hydrocortisone|mesh-list
101523217|NCT03532022|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101523218|NCT03532022|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101523219|NCT03532022|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101523220|NCT03532022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101523221|NCT03532022|Antiemetics|antiemetics|mesh-ancestor
101523222|NCT03532022|Autonomic Agents|autonomic agents|mesh-ancestor
101523223|NCT03532022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101523224|NCT03532022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523225|NCT03532022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101523226|NCT03532022|Glucocorticoids|glucocorticoids|mesh-ancestor
101523227|NCT03532022|Hormones|hormones|mesh-ancestor
101523228|NCT03532022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101523229|NCT03532022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101523230|NCT03532022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101523232|NCT02200380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101523233|NCT02200380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101523234|NCT02200380|Antiviral Agents|antiviral agents|mesh-ancestor
101523235|NCT02200380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101321206|NCT02966665|Vitamin B Complex|vitamin b complex|mesh-ancestor
101523236|NCT02191878|TKM-080301|tkm-080301|mesh-list
101523237|NCT02191878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101523238|NCT02191878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101523239|NCT02191878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523240|NCT02160678|Tazarotene|tazarotene|mesh-list
101523241|NCT02160678|Dermatologic Agents|dermatologic agents|mesh-ancestor
101523242|NCT02160678|Keratolytic Agents|keratolytic agents|mesh-ancestor
101523243|NCT02153502|Quinidine|quinidine|mesh-list
101523244|NCT02153502|Quinidine gluconate|quinidine gluconate|mesh-list
101523245|NCT02153502|Dextromethorphan|dextromethorphan|mesh-list
101523246|NCT02153502|Antitussive Agents|antitussive agents|mesh-ancestor
101523247|NCT02153502|Respiratory System Agents|respiratory system agents|mesh-ancestor
101523248|NCT02153502|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101523249|NCT02153502|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101523250|NCT02153502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101523251|NCT02153502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523252|NCT02153502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523253|NCT02153502|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101523254|NCT02153502|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101523255|NCT02153502|Adrenergic Agents|adrenergic agents|mesh-ancestor
101523256|NCT02153502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101523257|NCT02153502|Antimalarials|antimalarials|mesh-ancestor
101523258|NCT02153502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101523259|NCT02153502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101523260|NCT02153502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101523261|NCT02153502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101523262|NCT02153502|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101523263|NCT02153502|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101523264|NCT02153502|Cholinergic Agents|cholinergic agents|mesh-ancestor
101523265|NCT02153502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101523266|NCT02153502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101523267|NCT02153502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101523268|NCT02153502|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101523269|NCT02153502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101523270|NCT02130687|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101523271|NCT02130687|Aprepitant|aprepitant|mesh-list
101523272|NCT02130687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101523273|NCT02130687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523274|NCT02130687|Incretins|incretins|mesh-ancestor
101523275|NCT02130687|Hormones|hormones|mesh-ancestor
101523276|NCT02130687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101523277|NCT02130687|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101523278|NCT02130687|Protease Inhibitors|protease inhibitors|mesh-ancestor
101523279|NCT02130687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101523280|NCT02130687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523281|NCT02130687|Antiemetics|antiemetics|mesh-ancestor
101523282|NCT02130687|Autonomic Agents|autonomic agents|mesh-ancestor
101523283|NCT02130687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101523284|NCT02130687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101523285|NCT02130687|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101523286|NCT02130687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101523287|NCT01228656|Mometasone Furoate|mometasone furoate|mesh-list
101523288|NCT01228656|Salicylic Acid|salicylic acid|mesh-list
101523289|NCT01228656|Salicylates|salicylates|mesh-list
101523290|NCT01228656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101523291|NCT01228656|Dermatologic Agents|dermatologic agents|mesh-ancestor
101523292|NCT01228656|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101523293|NCT01228656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101523294|NCT01228656|Antifungal Agents|antifungal agents|mesh-ancestor
101523295|NCT01228656|Keratolytic Agents|keratolytic agents|mesh-ancestor
101523296|NCT01228656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101523297|NCT01228656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101523299|NCT01228656|Sensory System Agents|sensory system agents|mesh-ancestor
101523300|NCT01228656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101523301|NCT01228656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523302|NCT01228656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101523303|NCT01228656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101523304|NCT01228656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101523305|NCT01228656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523306|NCT02128113|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101523307|NCT02128113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101523308|NCT02125266|Methotrexate|methotrexate|mesh-list
101523309|NCT02125266|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101523310|NCT02125266|Abortifacient Agents|abortifacient agents|mesh-ancestor
101523311|NCT02125266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101523312|NCT02125266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523313|NCT02125266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101523314|NCT02125266|Antimetabolites|antimetabolites|mesh-ancestor
101523315|NCT02125266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523316|NCT02125266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101523317|NCT02125266|Dermatologic Agents|dermatologic agents|mesh-ancestor
101523318|NCT02125266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101523319|NCT02125266|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101523320|NCT02125266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101523321|NCT02125266|Immunologic Factors|immunologic factors|mesh-ancestor
101523322|NCT02125266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101523323|NCT02125266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101523324|NCT02116998|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101523325|NCT02116998|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101523326|NCT02116998|Immunologic Factors|immunologic factors|mesh-ancestor
101523327|NCT02116998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523328|NCT02116998|Antacids|antacids|mesh-ancestor
101523329|NCT02116998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523331|NCT02110368|Methyltestosterone|methyltestosterone|mesh-list
101321393|NCT00006056|Etoposide|etoposide|mesh-list
101321394|NCT00006056|Cyclosporins|cyclosporins|mesh-list
101523332|NCT02110368|Testosterone|testosterone|mesh-list
101523333|NCT02110368|Testosterone undecanoate|testosterone undecanoate|mesh-list
101523334|NCT02110368|Testosterone enanthate|testosterone enanthate|mesh-list
101523335|NCT02110368|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101523336|NCT02110368|Androgens|androgens|mesh-ancestor
101523337|NCT02110368|Hormones|hormones|mesh-ancestor
101523338|NCT02110368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101523339|NCT02110368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523340|NCT02110368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101523341|NCT02110368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101523342|NCT02110368|Anabolic Agents|anabolic agents|mesh-ancestor
101523343|NCT02916485|Sirolimus|sirolimus|mesh-list
101523344|NCT02916485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101523345|NCT02916485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101321455|NCT00084565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101321469|NCT00084604|Irinotecan|irinotecan|mesh-list
101523346|NCT02916485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101523347|NCT02916485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101523348|NCT02916485|Antifungal Agents|antifungal agents|mesh-ancestor
101523349|NCT02916485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101523350|NCT02916485|Immunologic Factors|immunologic factors|mesh-ancestor
101523351|NCT02916485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523352|NCT01709214|Oxycodone|oxycodone|mesh-list
101523353|NCT01709214|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101523354|NCT01709214|Narcotics|narcotics|mesh-ancestor
101523355|NCT01709214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101523356|NCT01709214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523357|NCT01709214|Analgesics|analgesics|mesh-ancestor
101523358|NCT01709214|Sensory System Agents|sensory system agents|mesh-ancestor
101321513|NCT00084877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321516|NCT00084916|Temsirolimus|temsirolimus|mesh-list
101523359|NCT01709214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101523360|NCT02916602|Losartan|losartan|mesh-list
101523361|NCT02916602|Amlodipine|amlodipine|mesh-list
101523362|NCT02916602|Chlorthalidone|chlorthalidone|mesh-list
101523363|NCT02916602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101523364|NCT02916602|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101523365|NCT02916602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101523366|NCT02916602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523367|NCT02916602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101523368|NCT02916602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523369|NCT02916602|Vasodilator Agents|vasodilator agents|mesh-ancestor
101523370|NCT02916602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101523371|NCT02916602|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101523372|NCT02916602|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101523373|NCT02916602|Diuretics|diuretics|mesh-ancestor
101523374|NCT02916602|Natriuretic Agents|natriuretic agents|mesh-ancestor
101411270|NCT00458185|Immunologic Factors|immunologic factors|mesh-ancestor
101523375|NCT02916602|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101523376|NCT02916251|Glucagon|glucagon|mesh-list
101523377|NCT02916251|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101523378|NCT02916251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101523379|NCT02916251|Hormones|hormones|mesh-ancestor
101523380|NCT02916251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101523381|NCT02916251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523382|NCT02916251|Incretins|incretins|mesh-ancestor
101523383|NCT02106546|Paclitaxel|paclitaxel|mesh-list
101523384|NCT02106546|Carboplatin|carboplatin|mesh-list
101523385|NCT02106546|Veliparib|veliparib|mesh-list
101523386|NCT02106546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101523387|NCT02106546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101523388|NCT02106546|Tubulin Modulators|tubulin modulators|mesh-ancestor
101523389|NCT02106546|Antimitotic Agents|antimitotic agents|mesh-ancestor
101523390|NCT02106546|Mitosis Modulators|mitosis modulators|mesh-ancestor
101523391|NCT02106546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523392|NCT02106546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101523393|NCT02106546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101523394|NCT02916173|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101523395|NCT02916173|Hormones|hormones|mesh-list
101523396|NCT02916173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101523397|NCT02916173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523398|NCT02916173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101523399|NCT02916134|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101523400|NCT02916134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101523401|NCT02104245|Ciprofloxacin|ciprofloxacin|mesh-list
101523402|NCT02104245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101523403|NCT02104245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101523404|NCT02104245|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101523405|NCT02104245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101523406|NCT02104245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101523407|NCT02104245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523408|NCT02104245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101523409|NCT02104245|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101523410|NCT02104245|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101523411|NCT01699737|Glimepiride|glimepiride|mesh-list
101523412|NCT01699737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101523413|NCT01699737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101523414|NCT01699737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523415|NCT01699737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101523416|NCT01699737|Immunologic Factors|immunologic factors|mesh-ancestor
101523418|NCT04688723|Clopidogrel|clopidogrel|mesh-list
101523419|NCT04688723|Ticagrelor|ticagrelor|mesh-list
101523421|NCT04688723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101523422|NCT04688723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101523423|NCT04688723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101523424|NCT04688723|Purinergic Agents|purinergic agents|mesh-ancestor
101523425|NCT04688723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101523426|NCT04688723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523427|NCT04688723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523428|NCT04688723|Antithrombins|antithrombins|mesh-ancestor
101523429|NCT04688723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101523430|NCT04688723|Protease Inhibitors|protease inhibitors|mesh-ancestor
101523431|NCT04688723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101523432|NCT04688723|Anticoagulants|anticoagulants|mesh-ancestor
101523433|NCT01699464|Timolol|timolol|mesh-list
101523434|NCT01699464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101523435|NCT01699464|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101523436|NCT01699464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523437|NCT01699464|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101523439|NCT01699464|Adrenergic Agents|adrenergic agents|mesh-ancestor
101523440|NCT01699464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101523441|NCT01699464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523442|NCT01699464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101523443|NCT01699464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101523444|NCT04688645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101523445|NCT02104050|Dapansutrile|dapansutrile|mesh-list
101523446|NCT02104050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101523447|NCT01694277|Sunitinib|sunitinib|mesh-list
101523448|NCT01694277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101523449|NCT01694277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101523450|NCT01694277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101523451|NCT01694277|Growth Substances|growth substances|mesh-ancestor
101523452|NCT01694277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523453|NCT01694277|Growth Inhibitors|growth inhibitors|mesh-ancestor
101523454|NCT01694277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101523455|NCT01694277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101523456|NCT01694277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523457|NCT01669980|Vancomycin|vancomycin|mesh-list
101523458|NCT01669980|Ceftriaxone|ceftriaxone|mesh-list
101523459|NCT01669980|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
101523460|NCT01669980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101523461|NCT01669980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101523462|NCT02915666|Trametinib|trametinib|mesh-list
101523463|NCT02915666|Dabrafenib|dabrafenib|mesh-list
101523464|NCT02915666|Digoxin|digoxin|mesh-list
101523465|NCT02915666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101523466|NCT02915666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101523467|NCT02915666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101523468|NCT02915666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523469|NCT02915666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101523470|NCT02915666|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101523471|NCT02915666|Protective Agents|protective agents|mesh-ancestor
101523472|NCT02915666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523473|NCT02092935|Vancomycin|vancomycin|mesh-list
101523474|NCT02092935|Ridinilazole|ridinilazole|mesh-list
101523475|NCT02092935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101523476|NCT02092935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101523477|NCT01666977|Carboplatin|carboplatin|mesh-list
101523478|NCT01666977|Pemetrexed|pemetrexed|mesh-list
101523479|NCT01666977|Trebananib|trebananib|mesh-list
101523480|NCT01666977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101523481|NCT01666977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101523482|NCT01666977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523483|NCT01666977|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101523484|NCT01666977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101523485|NCT01666977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101523486|NCT01666977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101321811|NCT00086632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101523487|NCT01666977|Growth Substances|growth substances|mesh-ancestor
101523488|NCT01666977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523489|NCT01666977|Growth Inhibitors|growth inhibitors|mesh-ancestor
101523490|NCT02915354|Etanercept|etanercept|mesh-list
101523491|NCT02915354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101523492|NCT02915354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101523493|NCT02915354|Analgesics|analgesics|mesh-ancestor
101523494|NCT02915354|Sensory System Agents|sensory system agents|mesh-ancestor
101523495|NCT02915354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101523496|NCT02915354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523497|NCT02915354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101523498|NCT02915354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101523499|NCT02915354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101523500|NCT02915354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101523501|NCT02915354|Immunologic Factors|immunologic factors|mesh-ancestor
101523502|NCT01661634|Ularitide|ularitide|mesh-list
101523503|NCT01661634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101321825|NCT00006104|Mitosis Modulators|mitosis modulators|mesh-ancestor
101523504|NCT01661634|Autonomic Agents|autonomic agents|mesh-ancestor
101523505|NCT01661634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101523506|NCT01661634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523507|NCT01661634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101523508|NCT01661634|Respiratory System Agents|respiratory system agents|mesh-ancestor
101523509|NCT01661634|Diuretics|diuretics|mesh-ancestor
101523510|NCT01661634|Natriuretic Agents|natriuretic agents|mesh-ancestor
101523511|NCT01661166|Fesoterodine|fesoterodine|mesh-list
101523512|NCT01661166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101523513|NCT01661166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101523514|NCT01661166|Cholinergic Agents|cholinergic agents|mesh-ancestor
101523515|NCT01661166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101523516|NCT01661166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523517|NCT01661166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523518|NCT01661166|Urological Agents|urological agents|mesh-ancestor
101523519|NCT02915042|Dexmedetomidine|dexmedetomidine|mesh-list
101523520|NCT02915042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101523521|NCT02915042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101523522|NCT02915042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523523|NCT02915042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101523524|NCT02915042|Analgesics|analgesics|mesh-ancestor
101523525|NCT02915042|Sensory System Agents|sensory system agents|mesh-ancestor
101523526|NCT02915042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101523527|NCT02915042|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101523528|NCT02915042|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101523529|NCT02915042|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101523530|NCT02915042|Adrenergic Agents|adrenergic agents|mesh-ancestor
101523531|NCT02915042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101523532|NCT02915042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523533|NCT01658826|Valacyclovir|valacyclovir|mesh-list
101523535|NCT01658826|Antiviral Agents|antiviral agents|mesh-ancestor
101523536|NCT01658826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101523537|NCT01658826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101319723|NCT03912818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101523538|NCT01658826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523540|NCT02092077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101523541|NCT02092077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523543|NCT02914886|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101523544|NCT02914886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101523545|NCT02914886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523546|NCT01643226|Riboflavin|riboflavin|mesh-list
101523547|NCT01643226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101523548|NCT01643226|Vitamin B Complex|vitamin b complex|mesh-ancestor
101523549|NCT01643226|Vitamins|vitamins|mesh-ancestor
101523550|NCT01643226|Micronutrients|micronutrients|mesh-ancestor
101523551|NCT01643226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523552|NCT01643226|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101523553|NCT01643226|Dermatologic Agents|dermatologic agents|mesh-ancestor
101523554|NCT02914652|Albuterol|albuterol|mesh-list
101523555|NCT02914652|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101523556|NCT02914652|Autonomic Agents|autonomic agents|mesh-ancestor
101523557|NCT02914652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101523558|NCT02914652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523559|NCT02914652|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101523560|NCT02914652|Respiratory System Agents|respiratory system agents|mesh-ancestor
101523561|NCT02914652|Tocolytic Agents|tocolytic agents|mesh-ancestor
101523562|NCT02914652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101523563|NCT02914652|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101523564|NCT02914652|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101523565|NCT02914652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101523566|NCT02914652|Adrenergic Agents|adrenergic agents|mesh-ancestor
101523567|NCT02914652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101321884|NCT00087217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101523568|NCT02914652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523569|NCT02081118|Exenatide|exenatide|mesh-list
101523570|NCT02081118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101523571|NCT02081118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523572|NCT02081118|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101523573|NCT02081118|Incretins|incretins|mesh-ancestor
101523574|NCT02081118|Hormones|hormones|mesh-ancestor
101523575|NCT02081118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101523576|NCT02077881|Paclitaxel|paclitaxel|mesh-list
101523577|NCT02077881|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101523578|NCT02077881|Gemcitabine|gemcitabine|mesh-list
101523579|NCT02077881|Tryptophan|tryptophan|mesh-list
101523580|NCT02077881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101523581|NCT02077881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101523582|NCT02077881|Tubulin Modulators|tubulin modulators|mesh-ancestor
101523583|NCT02077881|Antimitotic Agents|antimitotic agents|mesh-ancestor
101523584|NCT02077881|Mitosis Modulators|mitosis modulators|mesh-ancestor
101523585|NCT02077881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523586|NCT02077881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101523587|NCT02077881|Antimetabolites|antimetabolites|mesh-ancestor
101523588|NCT02077881|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101523589|NCT02077881|Antidepressive Agents|antidepressive agents|mesh-ancestor
101523590|NCT02077881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101523592|NCT01632228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101523593|NCT01632228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101523594|NCT01632228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101523596|NCT01632228|Growth Substances|growth substances|mesh-ancestor
101523597|NCT01632228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321907|NCT00087295|Romidepsin|romidepsin|mesh-list
101523598|NCT01632228|Growth Inhibitors|growth inhibitors|mesh-ancestor
101523600|NCT01628094|Ribavirin|ribavirin|mesh-list
101523601|NCT01628094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101523602|NCT01628094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101523603|NCT01628094|Protease Inhibitors|protease inhibitors|mesh-ancestor
101523604|NCT01628094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101523605|NCT01628094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523606|NCT01628094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101523607|NCT01628094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101523608|NCT01628094|Antiviral Agents|antiviral agents|mesh-ancestor
101523609|NCT01628094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101523610|NCT01628094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101523611|NCT01628094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101523612|NCT01628094|Antimetabolites|antimetabolites|mesh-ancestor
101523613|NCT02073123|Pembrolizumab|pembrolizumab|mesh-list
101523614|NCT02073123|Nivolumab|nivolumab|mesh-list
101523615|NCT02073123|Ipilimumab|ipilimumab|mesh-list
101523616|NCT02073123|Tryptophan|tryptophan|mesh-list
101523617|NCT02073123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101523618|NCT02073123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101523619|NCT02073123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101523620|NCT02073123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523621|NCT02073123|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101523622|NCT02073123|Antidepressive Agents|antidepressive agents|mesh-ancestor
101523623|NCT02073123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101523624|NCT02914145|Piperaquine|piperaquine|mesh-list
101523625|NCT02914145|Artenimol|artenimol|mesh-list
101523626|NCT02914145|Antimalarials|antimalarials|mesh-ancestor
101523627|NCT02914145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101523628|NCT02914145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101322002|NCT00006125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101523629|NCT02914145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101523630|NCT02914028|Acetaminophen|acetaminophen|mesh-list
101523631|NCT02914028|Tramadol|tramadol|mesh-list
101523632|NCT02914028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101523633|NCT02914028|Analgesics|analgesics|mesh-ancestor
101523634|NCT02914028|Sensory System Agents|sensory system agents|mesh-ancestor
101523635|NCT02914028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101523636|NCT02914028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523637|NCT02914028|Antipyretics|antipyretics|mesh-ancestor
101523638|NCT02914028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101523639|NCT02914028|Narcotics|narcotics|mesh-ancestor
101523640|NCT02914028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101523641|NCT02064426|Epoetin Alfa|epoetin alfa|mesh-list
101523642|NCT02064426|Hematinics|hematinics|mesh-ancestor
101523644|NCT02063997|Allopurinol|allopurinol|mesh-list
101523645|NCT02063997|Gout Suppressants|gout suppressants|mesh-ancestor
101523646|NCT02063997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101523647|NCT02063997|Tubulin Modulators|tubulin modulators|mesh-ancestor
101523648|NCT02063997|Antimitotic Agents|antimitotic agents|mesh-ancestor
101523649|NCT02063997|Mitosis Modulators|mitosis modulators|mesh-ancestor
101523650|NCT02063997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523651|NCT02063997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101523652|NCT02063997|Antimetabolites|antimetabolites|mesh-ancestor
101523653|NCT02063997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101523654|NCT02063997|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101523655|NCT02063997|Antioxidants|antioxidants|mesh-ancestor
101523656|NCT02063997|Protective Agents|protective agents|mesh-ancestor
101523657|NCT02063997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523658|NCT00585507|Fulvestrant|fulvestrant|mesh-list
101523660|NCT00585507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101523661|NCT00585507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101523662|NCT00585507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101523663|NCT00585507|Hormone Antagonists|hormone antagonists|mesh-ancestor
101523664|NCT00585507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101523665|NCT00585507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523667|NCT02063685|Cyclophosphamide|cyclophosphamide|mesh-list
101523668|NCT02063685|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101523669|NCT02063685|Rituximab|rituximab|mesh-list
101523670|NCT02063685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101523671|NCT02063685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101523672|NCT02063685|Immunologic Factors|immunologic factors|mesh-ancestor
101523673|NCT02063685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523674|NCT02063685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101523675|NCT02063685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101523676|NCT02063685|Alkylating Agents|alkylating agents|mesh-ancestor
101523677|NCT02063685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523678|NCT02063685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101523679|NCT02063685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101523680|NCT02063685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101523681|NCT02063685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101523682|NCT02063685|Glucocorticoids|glucocorticoids|mesh-ancestor
101523684|NCT02063685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101523685|NCT02063685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101523686|NCT02063295|CKD732|ckd732|mesh-list
101523687|NCT02063295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101523688|NCT02063295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101523689|NCT02063295|Growth Substances|growth substances|mesh-ancestor
101523690|NCT02063295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523691|NCT02063295|Growth Inhibitors|growth inhibitors|mesh-ancestor
101523692|NCT02063295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101523693|NCT02057172|Liraglutide|liraglutide|mesh-list
101523694|NCT02057172|Exenatide|exenatide|mesh-list
101523695|NCT02057172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101523696|NCT02057172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523697|NCT02057172|Incretins|incretins|mesh-ancestor
101523698|NCT02057172|Hormones|hormones|mesh-ancestor
101523699|NCT02057172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101523700|NCT02057172|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101523701|NCT02894307|Rivaroxaban|rivaroxaban|mesh-list
101523702|NCT02894307|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101523703|NCT02894307|Antithrombins|antithrombins|mesh-ancestor
101523704|NCT02894307|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101523705|NCT02894307|Protease Inhibitors|protease inhibitors|mesh-ancestor
101523706|NCT02894307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101523707|NCT02894307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523708|NCT02894307|Anticoagulants|anticoagulants|mesh-ancestor
101523709|NCT02052648|Bevacizumab|bevacizumab|mesh-list
101523710|NCT02052648|Temozolomide|temozolomide|mesh-list
101523711|NCT02052648|Tryptophan|tryptophan|mesh-list
101523712|NCT02052648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101322368|NCT00089401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101523713|NCT02052648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101523714|NCT02052648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101523715|NCT02052648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101523716|NCT02052648|Growth Substances|growth substances|mesh-ancestor
101523717|NCT02052648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523718|NCT02052648|Growth Inhibitors|growth inhibitors|mesh-ancestor
101523719|NCT02052648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101523720|NCT02052648|Alkylating Agents|alkylating agents|mesh-ancestor
101523721|NCT02052648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523722|NCT02052648|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101523723|NCT02052648|Antidepressive Agents|antidepressive agents|mesh-ancestor
101523724|NCT02052648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101523726|NCT01186744|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101523727|NCT01186744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101523728|NCT01186744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101523729|NCT01186744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523730|NCT02044341|Benzocaine|benzocaine|mesh-list
101523731|NCT02044341|Glycerol|glycerol|mesh-list
101523732|NCT02044341|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101523733|NCT02044341|Protective Agents|protective agents|mesh-ancestor
101523734|NCT02044341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523735|NCT02044341|Anesthetics, Local|anesthetics, local|mesh-ancestor
101523736|NCT02044341|Anesthetics|anesthetics|mesh-ancestor
101523737|NCT02044341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101322495|NCT00091078|Imatinib Mesylate|imatinib mesylate|mesh-list
101523738|NCT02044341|Sensory System Agents|sensory system agents|mesh-ancestor
101523739|NCT02044341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101523740|NCT00555399|Temozolomide|temozolomide|mesh-list
101523742|NCT00555399|Isotretinoin|isotretinoin|mesh-list
101523743|NCT00555399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101523744|NCT00555399|Alkylating Agents|alkylating agents|mesh-ancestor
101523745|NCT00555399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523746|NCT00555399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101523747|NCT00555399|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101523748|NCT00555399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101523749|NCT00555399|Dermatologic Agents|dermatologic agents|mesh-ancestor
101523750|NCT02912663|Magnesium Sulfate|magnesium sulfate|mesh-list
101523751|NCT02912663|Verapamil|verapamil|mesh-list
101523752|NCT02912663|Analgesics|analgesics|mesh-ancestor
101523753|NCT02912663|Sensory System Agents|sensory system agents|mesh-ancestor
101523754|NCT02912663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101523755|NCT02912663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523756|NCT02912663|Anesthetics|anesthetics|mesh-ancestor
101523757|NCT02912663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101523758|NCT02912663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101523759|NCT02912663|Anticonvulsants|anticonvulsants|mesh-ancestor
101523760|NCT02912663|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101523761|NCT02912663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101523762|NCT02912663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523763|NCT02912663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101523764|NCT02912663|Tocolytic Agents|tocolytic agents|mesh-ancestor
101523765|NCT02912663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101523766|NCT02912663|Vasodilator Agents|vasodilator agents|mesh-ancestor
101523767|NCT02894151|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101523768|NCT02894151|Medroxyprogesterone|medroxyprogesterone|mesh-list
101523769|NCT02894151|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101523770|NCT02894151|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101523771|NCT02894151|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101523772|NCT02894151|Contraceptive Agents|contraceptive agents|mesh-ancestor
101523773|NCT02894151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101322682|NCT00092170|Ertapenem|ertapenem|mesh-list
101322683|NCT00092170|Ticarcillin|ticarcillin|mesh-list
101523774|NCT02894151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523775|NCT02894151|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101523776|NCT02894151|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101523777|NCT02894151|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101523778|NCT02894151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101523779|NCT02894151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101523781|NCT02912702|Methylprednisolone|methylprednisolone|mesh-list
101523782|NCT02912702|Doxorubicin|doxorubicin|mesh-list
101523783|NCT02912702|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101523785|NCT02912702|Etoposide phosphate|etoposide phosphate|mesh-list
101523786|NCT02912702|Pegaspargase|pegaspargase|mesh-list
101523787|NCT02912702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101523788|NCT02912702|Antiemetics|antiemetics|mesh-ancestor
101523789|NCT02912702|Autonomic Agents|autonomic agents|mesh-ancestor
101523790|NCT02912702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101523791|NCT02912702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322744|NCT04728880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523792|NCT02912702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101523793|NCT02912702|Glucocorticoids|glucocorticoids|mesh-ancestor
101523794|NCT02912702|Hormones|hormones|mesh-ancestor
101523795|NCT02912702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101523796|NCT02912702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101523797|NCT02912702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101523798|NCT02912702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101523799|NCT02912702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101523800|NCT02912702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101523801|NCT02912702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101523802|NCT02912702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523803|NCT02912702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101523804|NCT02912702|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101523807|NCT02010333|Anesthetics, Local|anesthetics, local|mesh-ancestor
101523808|NCT02010333|Anesthetics|anesthetics|mesh-ancestor
101523809|NCT02010333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101523810|NCT02010333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523811|NCT02010333|Sensory System Agents|sensory system agents|mesh-ancestor
101523812|NCT02010333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101523814|NCT02008344|Antiviral Agents|antiviral agents|mesh-ancestor
101523815|NCT02008344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101523816|NCT02912156|Voriconazole|voriconazole|mesh-list
101523817|NCT02912156|Antifungal Agents|antifungal agents|mesh-ancestor
101523818|NCT02912156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101322933|NCT00094315|Dopamine Agents|dopamine agents|mesh-ancestor
101523819|NCT02912156|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101523820|NCT02912156|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101523821|NCT02912156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101523822|NCT02912156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523823|NCT02912156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101523824|NCT02912156|Hormone Antagonists|hormone antagonists|mesh-ancestor
101523825|NCT02912156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101523826|NCT02912156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523827|NCT02912156|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101523828|NCT03455049|Andrographolide|andrographolide|mesh-list
101523829|NCT03455049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101323091|NCT00006260|Etoposide|etoposide|mesh-list
101523830|NCT03455049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101523831|NCT03455049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101523832|NCT03455049|Analgesics|analgesics|mesh-ancestor
101523833|NCT03455049|Sensory System Agents|sensory system agents|mesh-ancestor
101523834|NCT03455049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101523835|NCT03455049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523836|NCT03455049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101523837|NCT03455049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101523838|NCT03455049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101523839|NCT03455049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101523840|NCT03455049|Antiviral Agents|antiviral agents|mesh-ancestor
101523841|NCT03455049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101523842|NCT02912234|Clarithromycin|clarithromycin|mesh-list
101523843|NCT02912234|Apixaban|apixaban|mesh-list
101523844|NCT02912234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101523845|NCT02912234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101523846|NCT02912234|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101523847|NCT02912234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101523848|NCT02912234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523849|NCT02912234|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101523850|NCT02912234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101523852|NCT02912234|Antithrombins|antithrombins|mesh-ancestor
101523853|NCT02912234|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101523854|NCT02912234|Protease Inhibitors|protease inhibitors|mesh-ancestor
101523855|NCT02912234|Anticoagulants|anticoagulants|mesh-ancestor
101523856|NCT04676139|Fluoxetine|fluoxetine|mesh-list
101523857|NCT04676139|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101523858|NCT04676139|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101523859|NCT04676139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101523860|NCT04676139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523861|NCT04676139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101523862|NCT04676139|Serotonin Agents|serotonin agents|mesh-ancestor
101523863|NCT04676139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523864|NCT04676139|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101523865|NCT04676139|Antidepressive Agents|antidepressive agents|mesh-ancestor
101523866|NCT04676139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101523867|NCT04676139|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101523868|NCT04676139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101523869|NCT04676139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101523870|NCT01999764|Retinol acetate|retinol acetate|mesh-list
101523871|NCT01999764|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101523872|NCT01999764|Immunologic Factors|immunologic factors|mesh-ancestor
101523873|NCT01999764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523874|NCT01999764|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101523875|NCT01999764|Protective Agents|protective agents|mesh-ancestor
101523876|NCT01999764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101523877|NCT02911961|Acetaminophen|acetaminophen|mesh-list
101523878|NCT02911961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101523879|NCT02911961|Analgesics|analgesics|mesh-ancestor
101523880|NCT02911961|Sensory System Agents|sensory system agents|mesh-ancestor
101523881|NCT02911961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101523882|NCT02911961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523883|NCT02911961|Antipyretics|antipyretics|mesh-ancestor
101523884|NCT01998828|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
101523885|NCT01998828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101523886|NCT01998828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101523887|NCT01998828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523889|NCT04676061|Norethindrone Acetate|norethindrone acetate|mesh-list
101523890|NCT04676061|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101523891|NCT04676061|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101523892|NCT04676061|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101523893|NCT04676061|Contraceptive Agents|contraceptive agents|mesh-ancestor
101523894|NCT04676061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101523895|NCT04676061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523896|NCT04676061|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101523897|NCT04676061|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101323228|NCT04432428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101523898|NCT04675944|Treprostinil|treprostinil|mesh-list
101523899|NCT04675944|Zamicastat|zamicastat|mesh-list
101523900|NCT04675944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101523901|NCT04675944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101523902|NCT04675944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523903|NCT02911766|Chlorhexidine|chlorhexidine|mesh-list
101523904|NCT02911766|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101523905|NCT02911766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101523906|NCT02911766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101323289|NCT00096304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101523907|NCT02911766|Disinfectants|disinfectants|mesh-ancestor
101523908|NCT02911766|Dermatologic Agents|dermatologic agents|mesh-ancestor
101523909|NCT01993641|Azacitidine|azacitidine|mesh-list
101523910|NCT01993641|Decitabine|decitabine|mesh-list
101523911|NCT01993641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101523912|NCT01993641|Antimetabolites|antimetabolites|mesh-ancestor
101523913|NCT01993641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523914|NCT01993641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101523915|NCT01993641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101523916|NCT01989429|Vitamin D|vitamin d|mesh-list
101523917|NCT01989429|Vitamins|vitamins|mesh-ancestor
101523918|NCT01989429|Micronutrients|micronutrients|mesh-ancestor
101523919|NCT01989429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523920|NCT01989429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101523921|NCT02911298|Metronidazole|metronidazole|mesh-list
101323371|NCT00096967|Bevacizumab|bevacizumab|mesh-list
101523922|NCT02911298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101523923|NCT02911298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101523924|NCT02911298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101523925|NCT02911298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101523926|NCT01983306|Dolcanatide|dolcanatide|mesh-list
101523927|NCT01983306|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
101523928|NCT01983306|Enzyme Activators|enzyme activators|mesh-ancestor
101523929|NCT01983306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523930|NCT01983306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101523931|NCT01982175|Alemtuzumab|alemtuzumab|mesh-list
101523932|NCT01982175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101523933|NCT01982175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101523934|NCT01975818|Epoetin Alfa|epoetin alfa|mesh-list
101523935|NCT01975818|Hematinics|hematinics|mesh-ancestor
101523936|NCT01973049|Ribavirin|ribavirin|mesh-list
101523937|NCT01973049|Asunaprevir|asunaprevir|mesh-list
101523938|NCT01973049|Antimetabolites|antimetabolites|mesh-ancestor
101523939|NCT01973049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523940|NCT01973049|Antiviral Agents|antiviral agents|mesh-ancestor
101523941|NCT01973049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101523942|NCT01973049|Protease Inhibitors|protease inhibitors|mesh-ancestor
101523943|NCT01973049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101523944|NCT01185964|Doxorubicin|doxorubicin|mesh-list
101523945|NCT01185964|Olaratumab|olaratumab|mesh-list
101523946|NCT01185964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101523947|NCT01185964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101523948|NCT01185964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101523949|NCT01185964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101523950|NCT01185964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101523951|NCT01185964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523953|NCT01972854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101523954|NCT01972854|Vitamin B Complex|vitamin b complex|mesh-ancestor
101523955|NCT01972854|Vitamins|vitamins|mesh-ancestor
101523956|NCT01972854|Micronutrients|micronutrients|mesh-ancestor
101323545|NCT00098488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523957|NCT01972854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523958|NCT01972854|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101523959|NCT01972854|Dermatologic Agents|dermatologic agents|mesh-ancestor
101523960|NCT02550470|Sevoflurane|sevoflurane|mesh-list
101523961|NCT02550470|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101523962|NCT02550470|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101523963|NCT02550470|Anesthetics, General|anesthetics, general|mesh-ancestor
101523964|NCT02550470|Anesthetics|anesthetics|mesh-ancestor
101523965|NCT02550470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101523966|NCT02550470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523967|NCT02910518|Insulin|insulin|mesh-list
101523968|NCT02910518|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101523969|NCT02910518|Insulin Aspart|insulin aspart|mesh-list
101523970|NCT02910518|Insulin glulisine|insulin glulisine|mesh-list
101523971|NCT02910518|Insulin, Isophane|insulin, isophane|mesh-list
101523972|NCT02910518|Isophane Insulin, Human|isophane insulin, human|mesh-list
101523973|NCT02910518|Isophane insulin, beef|isophane insulin, beef|mesh-list
101523974|NCT02910518|Heparin|heparin|mesh-list
101523975|NCT02910518|Calcium heparin|calcium heparin|mesh-list
101523977|NCT02910518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101523978|NCT02910518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101523979|NCT02910518|Anticoagulants|anticoagulants|mesh-ancestor
101523980|NCT02910518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101523981|NCT02910518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101323671|NCT00006356|Carboplatin|carboplatin|mesh-list
101523982|NCT02910518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101523983|NCT02910518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101523984|NCT02910518|Hormones|hormones|mesh-ancestor
101523985|NCT02910518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101523986|NCT01217437|Bevacizumab|bevacizumab|mesh-list
101523987|NCT01217437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101523988|NCT01217437|Irinotecan|irinotecan|mesh-list
101523990|NCT01217437|Camptothecin|camptothecin|mesh-list
101523991|NCT01217437|Endothelial Growth Factors|endothelial growth factors|mesh-list
101523992|NCT01217437|Antibodies|antibodies|mesh-list
101523993|NCT01217437|Immunoglobulins|immunoglobulins|mesh-list
101523994|NCT01217437|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101523995|NCT01217437|Immunoglobulin G|immunoglobulin g|mesh-list
101523996|NCT01217437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101523997|NCT01217437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101523998|NCT01217437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101523999|NCT01217437|Growth Substances|growth substances|mesh-ancestor
101524000|NCT01217437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524001|NCT01217437|Growth Inhibitors|growth inhibitors|mesh-ancestor
101524002|NCT01217437|Immunologic Factors|immunologic factors|mesh-ancestor
101524003|NCT01217437|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101524004|NCT01217437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101524005|NCT01217437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101524006|NCT01217437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524007|NCT01217437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101524008|NCT01217437|Alkylating Agents|alkylating agents|mesh-ancestor
101524009|NCT01217437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101524010|NCT00624364|Metformin|metformin|mesh-list
101524011|NCT00624364|Insulin Aspart|insulin aspart|mesh-list
101524012|NCT00624364|Biphasic Insulins|biphasic insulins|mesh-list
101524013|NCT00624364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101524014|NCT00624364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524015|NCT02910596|Bethanechol|bethanechol|mesh-list
101524016|NCT02910596|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101524017|NCT02910596|Autonomic Agents|autonomic agents|mesh-ancestor
101524018|NCT02910596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101319773|NCT05605665|Sirolimus|sirolimus|mesh-list
101524019|NCT02910596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524020|NCT02910596|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101524021|NCT02910596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101524022|NCT02910596|Cholinergic Agents|cholinergic agents|mesh-ancestor
101323843|NCT00100750|Gemcitabine|gemcitabine|mesh-list
101524023|NCT02910596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101524024|NCT02910596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524026|NCT04316377|Antimalarials|antimalarials|mesh-ancestor
101524027|NCT04316377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101524028|NCT04316377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101524029|NCT04316377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101524030|NCT04316377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101524031|NCT04316377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524033|NCT02886988|Botulinum Toxins|botulinum toxins|mesh-list
101524034|NCT02886988|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101524035|NCT02886988|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101524036|NCT02886988|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101323915|NCT00100984|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101323918|NCT00101062|Celecoxib|celecoxib|mesh-list
101524037|NCT02886988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101524038|NCT02886988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524039|NCT02886988|Cholinergic Agents|cholinergic agents|mesh-ancestor
101524040|NCT02886988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101524041|NCT02886988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524042|NCT02886988|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101524043|NCT02886988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101524044|NCT04676997|Paclitaxel|paclitaxel|mesh-list
101524045|NCT04676997|Cyclophosphamide|cyclophosphamide|mesh-list
101524046|NCT04676997|Epirubicin|epirubicin|mesh-list
101524047|NCT04676997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101524048|NCT04676997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324042|NCT00101569|Aripiprazole|aripiprazole|mesh-list
101524049|NCT04676997|Tubulin Modulators|tubulin modulators|mesh-ancestor
101524050|NCT04676997|Antimitotic Agents|antimitotic agents|mesh-ancestor
101524051|NCT04676997|Mitosis Modulators|mitosis modulators|mesh-ancestor
101524052|NCT04676997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524053|NCT04676997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101524054|NCT04676997|Immunologic Factors|immunologic factors|mesh-ancestor
101524055|NCT04676997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524056|NCT04676997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101524057|NCT04676997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101524058|NCT04676997|Alkylating Agents|alkylating agents|mesh-ancestor
101524059|NCT04676997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101524060|NCT04676997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101524061|NCT04676997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101524062|NCT04676997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101524063|NCT04676997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101524065|NCT02910206|Propofol|propofol|mesh-list
101524066|NCT02910206|Etomidate|etomidate|mesh-list
101524067|NCT02910206|Cisatracurium|cisatracurium|mesh-list
101524068|NCT02910206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101524069|NCT02910206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101524070|NCT02910206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524071|NCT02910206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101524072|NCT02910206|Anesthetics, General|anesthetics, general|mesh-ancestor
101524073|NCT02910206|Anesthetics|anesthetics|mesh-ancestor
101524074|NCT02910206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101524075|NCT02910206|Narcotics|narcotics|mesh-ancestor
101524076|NCT02910206|Analgesics|analgesics|mesh-ancestor
101524077|NCT02910206|Sensory System Agents|sensory system agents|mesh-ancestor
101524078|NCT02910206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101524079|NCT02910206|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101524080|NCT02910206|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101524081|NCT02910206|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101524082|NCT04675086|Antiviral Agents|antiviral agents|mesh-list
101524083|NCT04675086|Remdesivir|remdesivir|mesh-list
101524084|NCT04675086|Protease Inhibitors|protease inhibitors|mesh-list
101524086|NCT04675086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101524087|NCT04675086|Antimetabolites|antimetabolites|mesh-ancestor
101524088|NCT04675086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524089|NCT04675086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101524090|NCT04675086|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101524091|NCT04675086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101524094|NCT02909972|Antimetabolites|antimetabolites|mesh-ancestor
101524095|NCT02909972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524096|NCT02909972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101524097|NCT02909972|Antiviral Agents|antiviral agents|mesh-ancestor
101524098|NCT02909972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101524099|NCT02909972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101524100|NCT02909972|Immunologic Factors|immunologic factors|mesh-ancestor
101524101|NCT02909972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524102|NCT00555594|Bevacizumab|bevacizumab|mesh-list
101524103|NCT00555594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101524104|NCT00555594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101524105|NCT00555594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101524106|NCT00555594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101524107|NCT00555594|Growth Substances|growth substances|mesh-ancestor
101324518|NCT00105547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101324519|NCT00105547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524108|NCT00555594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524109|NCT00555594|Growth Inhibitors|growth inhibitors|mesh-ancestor
101524111|NCT02910050|Anastrozole|anastrozole|mesh-list
101524112|NCT02910050|Exemestane|exemestane|mesh-list
101524113|NCT02910050|Bicalutamide|bicalutamide|mesh-list
101524114|NCT02910050|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101524115|NCT02910050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101524116|NCT02910050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101524117|NCT02910050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101524118|NCT02910050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524119|NCT02910050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101524120|NCT02910050|Hormone Antagonists|hormone antagonists|mesh-ancestor
101524121|NCT02910050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101524122|NCT02910050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524123|NCT02910050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101524126|NCT02909933|Liraglutide|liraglutide|mesh-list
101524127|NCT02909933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101524128|NCT02909933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524129|NCT02909933|Incretins|incretins|mesh-ancestor
101524130|NCT02909933|Hormones|hormones|mesh-ancestor
101324652|NCT00106405|Memantine|memantine|mesh-list
101524131|NCT02909933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101524132|NCT02910245|Prednisone|prednisone|mesh-list
101524133|NCT02910245|Mesalamine|mesalamine|mesh-list
101524134|NCT02910245|Mercaptopurine|mercaptopurine|mesh-list
101524135|NCT02910245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101524136|NCT02910245|Glucocorticoids|glucocorticoids|mesh-ancestor
101524137|NCT02910245|Hormones|hormones|mesh-ancestor
101524138|NCT02910245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101524139|NCT02910245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524140|NCT02910245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101524141|NCT02910245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101524142|NCT02910245|Antimetabolites|antimetabolites|mesh-ancestor
101524143|NCT02910245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524144|NCT02910245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101524145|NCT02910245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101524146|NCT02910245|Immunologic Factors|immunologic factors|mesh-ancestor
101524147|NCT02910245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101524148|NCT02910245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101524149|NCT02910245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101524150|NCT02910245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101524151|NCT02910245|Analgesics|analgesics|mesh-ancestor
101524152|NCT02910245|Sensory System Agents|sensory system agents|mesh-ancestor
101524156|NCT01185340|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
101524157|NCT01185340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101524159|NCT01185340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101524160|NCT01185340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524161|NCT01185340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319778|NCT05605665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101524162|NCT01185340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101524163|NCT01185340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101524165|NCT01959282|Peficitinib|peficitinib|mesh-list
101524166|NCT01959282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324780|NCT00107419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101524167|NCT01959282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524168|NCT01959282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101524169|NCT01959282|Immunologic Factors|immunologic factors|mesh-ancestor
101524170|NCT01959282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524171|NCT01959282|Vitamin B Complex|vitamin b complex|mesh-ancestor
101524173|NCT01959282|Micronutrients|micronutrients|mesh-ancestor
101524174|NCT01185301|Adalimumab|adalimumab|mesh-list
101524175|NCT01185301|Methotrexate|methotrexate|mesh-list
101524176|NCT01185301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101524177|NCT01185301|Abortifacient Agents|abortifacient agents|mesh-ancestor
101524178|NCT01185301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101524179|NCT01185301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524180|NCT01185301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101524181|NCT01185301|Antimetabolites|antimetabolites|mesh-ancestor
101524182|NCT01185301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524183|NCT01185301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101524184|NCT01185301|Dermatologic Agents|dermatologic agents|mesh-ancestor
101524185|NCT01185301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101524186|NCT01185301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101524187|NCT01185301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101524188|NCT01185301|Immunologic Factors|immunologic factors|mesh-ancestor
101524189|NCT01185301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101524190|NCT01185301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101524191|NCT01185301|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101524192|NCT01185301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101524193|NCT01216072|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101524194|NCT01216072|Interferon beta-1b|interferon beta-1b|mesh-list
101524195|NCT01216072|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101524196|NCT01216072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524198|NCT01216072|Immunologic Factors|immunologic factors|mesh-ancestor
101524199|NCT01216072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524200|NCT01216072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101524201|NCT01940991|Botulinum Toxins|botulinum toxins|mesh-list
101524202|NCT01940991|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101524203|NCT01940991|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101524204|NCT01940991|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101524205|NCT01940991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101524206|NCT01940991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524207|NCT01940991|Cholinergic Agents|cholinergic agents|mesh-ancestor
101524208|NCT01940991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101524209|NCT01940991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524210|NCT01940991|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101524211|NCT01940991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101524212|NCT02909465|Midazolam|midazolam|mesh-list
101524213|NCT02909465|Ketamine|ketamine|mesh-list
101524214|NCT02909465|Haloperidol|haloperidol|mesh-list
101524215|NCT02909465|Haloperidol decanoate|haloperidol decanoate|mesh-list
101524216|NCT02909465|Analgesics|analgesics|mesh-ancestor
101524217|NCT02909465|Sensory System Agents|sensory system agents|mesh-ancestor
101524218|NCT02909465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101524219|NCT02909465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325011|NCT00006890|Leprostatic Agents|leprostatic agents|mesh-ancestor
101524220|NCT02909465|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101524221|NCT02909465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101524222|NCT02909465|Anesthetics, General|anesthetics, general|mesh-ancestor
101524223|NCT02909465|Anesthetics|anesthetics|mesh-ancestor
101524224|NCT02909465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101524225|NCT02909465|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101524226|NCT02909465|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101524227|NCT02909465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101524228|NCT02909465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524230|NCT02909465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101524231|NCT02909465|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101524232|NCT02909465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101524233|NCT02909465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101524234|NCT02909465|GABA Modulators|gaba modulators|mesh-ancestor
101524235|NCT02909465|GABA Agents|gaba agents|mesh-ancestor
101524236|NCT02909465|Antiemetics|antiemetics|mesh-ancestor
101524237|NCT02909465|Autonomic Agents|autonomic agents|mesh-ancestor
101524238|NCT02909465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101524239|NCT02909465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101524240|NCT02909465|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101524241|NCT02909465|Dopamine Agents|dopamine agents|mesh-ancestor
101524242|NCT02909465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101524243|NCT04312555|Alprostadil|alprostadil|mesh-list
101325209|NCT00110344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101524244|NCT04312555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101524245|NCT04312555|Vasodilator Agents|vasodilator agents|mesh-ancestor
101524246|NCT04312555|Urological Agents|urological agents|mesh-ancestor
101524248|NCT01184989|Antithrombins|antithrombins|mesh-ancestor
101524249|NCT01184989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101524250|NCT01184989|Protease Inhibitors|protease inhibitors|mesh-ancestor
101524251|NCT01184989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101524252|NCT01184989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524253|NCT01184989|Anticoagulants|anticoagulants|mesh-ancestor
101524254|NCT04674423|Tenofovir|tenofovir|mesh-list
101524255|NCT04674423|Antiviral Agents|antiviral agents|mesh-ancestor
101524256|NCT04674423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101524257|NCT04674423|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101524258|NCT04674423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101524259|NCT04674423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101524260|NCT04674423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524261|NCT04674423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101524262|NCT04674423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101524263|NCT00555867|Anastrozole|anastrozole|mesh-list
101524264|NCT00555867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101524265|NCT00555867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325412|NCT00111904|Mitosis Modulators|mitosis modulators|mesh-ancestor
101325414|NCT00111943|Tenofovir|tenofovir|mesh-list
101524266|NCT00555867|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101524267|NCT00555867|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101524268|NCT00555867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101325475|NCT00112138|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101524269|NCT00555867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411278|NCT00458419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101524272|NCT00555867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101524273|NCT00555867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524275|NCT00555984|Propofol|propofol|mesh-list
101524276|NCT00555984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
101524277|NCT00555984|Anesthetics|anesthetics|mesh-list
101524278|NCT00555984|Sevoflurane|sevoflurane|mesh-list
101325545|NCT00112567|Alkylating Agents|alkylating agents|mesh-ancestor
101524279|NCT00555984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101524280|NCT00555984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101524281|NCT00555984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524282|NCT00555984|Anesthetics, General|anesthetics, general|mesh-ancestor
101524283|NCT00555984|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101524284|NCT00555984|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101524285|NCT00555984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101524286|NCT00555984|Narcotics|narcotics|mesh-ancestor
101524287|NCT00555984|Analgesics|analgesics|mesh-ancestor
101524288|NCT00555984|Sensory System Agents|sensory system agents|mesh-ancestor
101325622|NCT00112879|Mitogens|mitogens|mesh-list
101524289|NCT00555984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101524290|NCT03457337|Gefitinib|gefitinib|mesh-list
101524291|NCT03457337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101524292|NCT03457337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101524293|NCT03457337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101524294|NCT03457337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524295|NCT01908738|Lidocaine|lidocaine|mesh-list
101524296|NCT01908738|Anesthetics, Local|anesthetics, local|mesh-ancestor
101524297|NCT01908738|Anesthetics|anesthetics|mesh-ancestor
101524298|NCT01908738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101325688|NCT00390897|Interferons|interferons|mesh-list
101524299|NCT01908738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524300|NCT01908738|Sensory System Agents|sensory system agents|mesh-ancestor
101524301|NCT01908738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101524302|NCT01908738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101524303|NCT01908738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101524304|NCT01908738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101524305|NCT01908738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101319785|NCT05605665|Analgesics|analgesics|mesh-ancestor
101524306|NCT01908738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524307|NCT04673955|Cetuximab|cetuximab|mesh-list
101524308|NCT04673955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101325749|NCT00113698|Enalapril|enalapril|mesh-list
101524309|NCT04673955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101524311|NCT01904409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101524312|NCT01904409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101524313|NCT01904409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101325812|NCT00113815|Topiramate|topiramate|mesh-list
101524314|NCT01902381|Thioctic Acid|thioctic acid|mesh-list
101524315|NCT01902381|Antioxidants|antioxidants|mesh-ancestor
101524316|NCT01902381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524317|NCT01902381|Protective Agents|protective agents|mesh-ancestor
101524318|NCT01902381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524319|NCT01902381|Vitamin B Complex|vitamin b complex|mesh-ancestor
101524320|NCT01902381|Vitamins|vitamins|mesh-ancestor
101524321|NCT01902381|Micronutrients|micronutrients|mesh-ancestor
101524322|NCT04673799|Denosumab|denosumab|mesh-list
101524323|NCT04673799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101524324|NCT04673799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524325|NCT04673487|Immunoglobulin G|immunoglobulin g|mesh-list
101524326|NCT04673487|Immunoglobulin M|immunoglobulin m|mesh-list
101524327|NCT04673487|Immunologic Factors|immunologic factors|mesh-ancestor
101524328|NCT04673487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524329|NCT01215955|Insulin Lispro|insulin lispro|mesh-list
101524330|NCT01215955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101524331|NCT01215955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524332|NCT01871415|Metformin|metformin|mesh-list
101524333|NCT01871415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101524334|NCT01871415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524335|NCT05189717|Everolimus|everolimus|mesh-list
101524337|NCT05189717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101524339|NCT05189717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524340|NCT05189717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101524341|NCT05189717|Immunologic Factors|immunologic factors|mesh-ancestor
101326018|NCT00008177|Trace Elements|trace elements|mesh-ancestor
101326019|NCT00008177|Micronutrients|micronutrients|mesh-ancestor
101524342|NCT05189717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524343|NCT05189717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101524344|NCT05182463|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101524345|NCT05182463|Antiviral Agents|antiviral agents|mesh-ancestor
101524346|NCT05182463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101524347|NCT02277197|Cetuximab|cetuximab|mesh-list
101326116|NCT00115531|Vaccines|vaccines|mesh-list
101524348|NCT02277197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101524349|NCT02277197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101524350|NCT00555087|Methyltestosterone|methyltestosterone|mesh-list
101524352|NCT00555087|Testosterone undecanoate|testosterone undecanoate|mesh-list
101524353|NCT00555087|Testosterone enanthate|testosterone enanthate|mesh-list
101524354|NCT00555087|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101524355|NCT00555087|Androgens|androgens|mesh-ancestor
101524356|NCT00555087|Hormones|hormones|mesh-ancestor
101524357|NCT00555087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101524358|NCT00555087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524359|NCT00555087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101524360|NCT00555087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101524361|NCT00555087|Anabolic Agents|anabolic agents|mesh-ancestor
101524362|NCT04673214|Acetaminophen|acetaminophen|mesh-list
101524363|NCT04673214|Azithromycin|azithromycin|mesh-list
101524364|NCT04673214|Ivermectin|ivermectin|mesh-list
101524365|NCT04673214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101524366|NCT04673214|Analgesics|analgesics|mesh-ancestor
101524367|NCT04673214|Sensory System Agents|sensory system agents|mesh-ancestor
101524368|NCT04673214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101326157|NCT00115648|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101524369|NCT04673214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524370|NCT04673214|Antipyretics|antipyretics|mesh-ancestor
101524371|NCT04673214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101524372|NCT04673214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101524373|NCT04673214|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101524374|NCT00556023|Gemcitabine|gemcitabine|mesh-list
101524376|NCT00556023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101524377|NCT00556023|Antimetabolites|antimetabolites|mesh-ancestor
101524378|NCT00556023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524379|NCT00556023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101524380|NCT05011214|Ketamine|ketamine|mesh-list
101524382|NCT05011214|Esketamine|esketamine|mesh-list
101524383|NCT05011214|Analgesics|analgesics|mesh-ancestor
101524384|NCT05011214|Sensory System Agents|sensory system agents|mesh-ancestor
101524385|NCT05011214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101524386|NCT05011214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524387|NCT05011214|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101524388|NCT05011214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101524389|NCT05011214|Anesthetics, General|anesthetics, general|mesh-ancestor
101524390|NCT05011214|Anesthetics|anesthetics|mesh-ancestor
101326365|NCT02752815|Glucocorticoids|glucocorticoids|mesh-ancestor
101524391|NCT05011214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101524392|NCT05011214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101524393|NCT05011214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101524394|NCT05011214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101524395|NCT05011214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524396|NCT05011214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101524397|NCT05011214|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101524398|NCT05011214|Antidepressive Agents|antidepressive agents|mesh-ancestor
101524399|NCT05011214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101524400|NCT00556062|Vaccines|vaccines|mesh-list
101524401|NCT00556062|Immunologic Factors|immunologic factors|mesh-ancestor
101524402|NCT00556062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524403|NCT04676763|Histamine|histamine|mesh-list
101524404|NCT04676763|Substance P|substance p|mesh-list
101524405|NCT04676763|Neurokinin A|neurokinin a|mesh-list
101524406|NCT04676763|Histamine Agonists|histamine agonists|mesh-ancestor
101524407|NCT04676763|Histamine Agents|histamine agents|mesh-ancestor
101524408|NCT04676763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101524409|NCT04676763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524410|NCT04676763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524411|NCT04672707|Bromhexine|bromhexine|mesh-list
101326490|NCT00117832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101524412|NCT04672707|Expectorants|expectorants|mesh-ancestor
101524413|NCT04672707|Respiratory System Agents|respiratory system agents|mesh-ancestor
101524414|NCT04932083|Fentanyl|fentanyl|mesh-list
101524415|NCT04932083|Midazolam|midazolam|mesh-list
101524416|NCT04932083|Nalbuphine|nalbuphine|mesh-list
101524417|NCT04932083|Bupivacaine|bupivacaine|mesh-list
101524418|NCT04932083|Anesthetics, Local|anesthetics, local|mesh-ancestor
101524419|NCT04932083|Anesthetics|anesthetics|mesh-ancestor
101524420|NCT04932083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101524421|NCT04932083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524422|NCT04932083|Sensory System Agents|sensory system agents|mesh-ancestor
101524423|NCT04932083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101524424|NCT04932083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101524425|NCT04932083|Narcotics|narcotics|mesh-ancestor
101524426|NCT04932083|Analgesics|analgesics|mesh-ancestor
101524427|NCT04932083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101524428|NCT04932083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101524429|NCT04932083|Anesthetics, General|anesthetics, general|mesh-ancestor
101524430|NCT04932083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101524431|NCT04932083|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101524432|NCT04932083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101524433|NCT04932083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101524434|NCT04932083|GABA Modulators|gaba modulators|mesh-ancestor
101524435|NCT04932083|GABA Agents|gaba agents|mesh-ancestor
101524436|NCT04932083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101524437|NCT04932083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524439|NCT01825980|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101524440|NCT01825980|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101524441|NCT01825980|Protease Inhibitors|protease inhibitors|mesh-ancestor
101524442|NCT01825980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101326605|NCT02710734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101524443|NCT01825980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524444|NCT01825980|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101524445|NCT01825980|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101524446|NCT01825980|Antiviral Agents|antiviral agents|mesh-ancestor
101326676|NCT00118963|Metformin|metformin|mesh-list
101524447|NCT01825980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101524448|NCT01825980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101524449|NCT01825980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101524450|NCT04672317|Immunomodulating Agents|immunomodulating agents|mesh-list
101524451|NCT04672317|Immunologic Factors|immunologic factors|mesh-ancestor
101326743|NCT02621151|Pembrolizumab|pembrolizumab|mesh-list
101524452|NCT04672317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524454|NCT04790045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101524455|NCT01655225|Pemetrexed|pemetrexed|mesh-list
101524456|NCT01655225|Letrozole|letrozole|mesh-list
101524457|NCT01655225|Fulvestrant|fulvestrant|mesh-list
101524458|NCT01655225|Midazolam|midazolam|mesh-list
101524459|NCT01655225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101524460|NCT01655225|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101524461|NCT01655225|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101524462|NCT01655225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101524463|NCT01655225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524464|NCT01655225|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101524465|NCT01655225|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101524466|NCT01655225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101524467|NCT01655225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101524468|NCT01655225|Anesthetics, General|anesthetics, general|mesh-ancestor
101524470|NCT01655225|GABA Modulators|gaba modulators|mesh-ancestor
101524471|NCT01655225|GABA Agents|gaba agents|mesh-ancestor
101524472|NCT01655225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101326953|NCT00121498|Lidocaine|lidocaine|mesh-list
101524473|NCT01655225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524474|NCT01655225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101524475|NCT01655225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101524476|NCT01655225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101524477|NCT01655225|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101524478|NCT01655225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101524479|NCT01655225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101524480|NCT01655225|Hormone Antagonists|hormone antagonists|mesh-ancestor
101524481|NCT01655225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101524482|NCT01655225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101524483|NCT01655225|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101524485|NCT01818921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101524486|NCT01818921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101524487|NCT01818921|Growth Substances|growth substances|mesh-ancestor
101524488|NCT01818921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524489|NCT01818921|Growth Inhibitors|growth inhibitors|mesh-ancestor
101524490|NCT01818921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101524491|NCT01810575|Alprostadil|alprostadil|mesh-list
101524492|NCT01810575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101524493|NCT01810575|Vasodilator Agents|vasodilator agents|mesh-ancestor
101524494|NCT01810575|Urological Agents|urological agents|mesh-ancestor
101524495|NCT01785771|Exenatide|exenatide|mesh-list
101524496|NCT01785771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101524497|NCT01785771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524498|NCT01785771|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101524499|NCT01785771|Incretins|incretins|mesh-ancestor
101524501|NCT01785771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101524502|NCT01784874|Vaccines|vaccines|mesh-list
101524503|NCT01784874|Immunologic Factors|immunologic factors|mesh-ancestor
101327085|NCT00122512|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101524504|NCT01784874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524506|NCT04607252|Megestrol|megestrol|mesh-list
101524507|NCT04607252|Megestrol Acetate|megestrol acetate|mesh-list
101524508|NCT04607252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101524509|NCT04607252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524510|NCT04607252|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101524511|NCT04607252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101524512|NCT04607252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101524513|NCT04607252|Contraceptive Agents|contraceptive agents|mesh-ancestor
101524514|NCT04607252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101524515|NCT04607252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101524516|NCT04607252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101524517|NCT04607252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101524518|NCT04607252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101524519|NCT04607252|Appetite Stimulants|appetite stimulants|mesh-ancestor
101524520|NCT04607252|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101524521|NCT01782729|Tacrolimus|tacrolimus|mesh-list
101524522|NCT01782729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101524523|NCT01782729|Immunologic Factors|immunologic factors|mesh-ancestor
101524524|NCT01782729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524525|NCT01782729|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101524527|NCT01782729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524529|NCT01780428|Promethazine|promethazine|mesh-list
101524530|NCT01780428|Diphenhydramine|diphenhydramine|mesh-list
101524531|NCT01780428|Hydrocodone|hydrocodone|mesh-list
101524532|NCT01780428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101524533|NCT01780428|Analgesics|analgesics|mesh-ancestor
101524534|NCT01780428|Sensory System Agents|sensory system agents|mesh-ancestor
101524535|NCT01780428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101524536|NCT01780428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524537|NCT01780428|Antipyretics|antipyretics|mesh-ancestor
101524538|NCT01780428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101524539|NCT01780428|Narcotics|narcotics|mesh-ancestor
101524540|NCT01780428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101524541|NCT01780428|Antitussive Agents|antitussive agents|mesh-ancestor
101524542|NCT01780428|Respiratory System Agents|respiratory system agents|mesh-ancestor
101524543|NCT01780428|Antipruritics|antipruritics|mesh-ancestor
101524544|NCT01780428|Dermatologic Agents|dermatologic agents|mesh-ancestor
101524545|NCT01780428|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101524546|NCT01780428|Histamine Antagonists|histamine antagonists|mesh-ancestor
101524547|NCT01780428|Histamine Agents|histamine agents|mesh-ancestor
101524548|NCT01780428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101524549|NCT01780428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524550|NCT01780428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101524551|NCT01780428|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101524552|NCT01780428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101524553|NCT01780428|Anesthetics, Local|anesthetics, local|mesh-ancestor
101524554|NCT01780428|Anesthetics|anesthetics|mesh-ancestor
101524555|NCT01780428|Antiemetics|antiemetics|mesh-ancestor
101327332|NCT00394537|Sympathomimetics|sympathomimetics|mesh-ancestor
101524556|NCT01780428|Autonomic Agents|autonomic agents|mesh-ancestor
101524557|NCT01780428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101524558|NCT04671420|Rituximab|rituximab|mesh-list
101524559|NCT04671420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101524560|NCT04671420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101524561|NCT04671420|Immunologic Factors|immunologic factors|mesh-ancestor
101524562|NCT04671420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524563|NCT04671420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101524564|NCT04573556|Lemborexant|lemborexant|mesh-list
101524565|NCT04573556|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
101524566|NCT04573556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101524567|NCT04573556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524569|NCT04573556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101524570|NCT04573556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101524571|NCT04573556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524572|NCT04671108|Hyaluronic Acid|hyaluronic acid|mesh-list
101524573|NCT04671108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101524574|NCT04671108|Immunologic Factors|immunologic factors|mesh-ancestor
101524575|NCT04671108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524576|NCT04671108|Viscosupplements|viscosupplements|mesh-ancestor
101327455|NCT00009750|Paclitaxel|paclitaxel|mesh-list
101524577|NCT04671108|Protective Agents|protective agents|mesh-ancestor
101524578|NCT01779453|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
101524579|NCT01779453|Atorvastatin|atorvastatin|mesh-list
101524580|NCT01779453|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101524581|NCT01779453|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101524582|NCT01779453|Antimetabolites|antimetabolites|mesh-ancestor
101524583|NCT01779453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524584|NCT01779453|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101524585|NCT01779453|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101524586|NCT01779453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101524587|NCT01779453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101524588|NCT01779453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524589|NCT01776606|Botulinum Toxins|botulinum toxins|mesh-list
101524590|NCT01776606|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101524591|NCT01776606|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101524592|NCT01776606|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101524593|NCT01776606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101524594|NCT01776606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524595|NCT01776606|Cholinergic Agents|cholinergic agents|mesh-ancestor
101327520|NCT00009828|Leucovorin|leucovorin|mesh-list
101319804|NCT03150316|Dexamethasone|dexamethasone|mesh-list
101524596|NCT01776606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101524597|NCT01776606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524598|NCT01776606|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101524599|NCT01776606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101524600|NCT04567160|Propofol|propofol|mesh-list
101524601|NCT04567160|Sevoflurane|sevoflurane|mesh-list
101524602|NCT04567160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101524603|NCT04567160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101524604|NCT04567160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524605|NCT04567160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101524606|NCT04567160|Anesthetics, General|anesthetics, general|mesh-ancestor
101524607|NCT04567160|Anesthetics|anesthetics|mesh-ancestor
101524608|NCT04567160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101524609|NCT04567160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101524610|NCT01774578|Gemcitabine|gemcitabine|mesh-list
101524611|NCT01774578|Docetaxel|docetaxel|mesh-list
101524612|NCT01774578|Pemetrexed|pemetrexed|mesh-list
101327574|NCT00019513|Protective Agents|protective agents|mesh-ancestor
101524613|NCT01774578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101524614|NCT01774578|Antimetabolites|antimetabolites|mesh-ancestor
101524615|NCT01774578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524616|NCT01774578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101524617|NCT01774578|Tubulin Modulators|tubulin modulators|mesh-ancestor
101524618|NCT01774578|Antimitotic Agents|antimitotic agents|mesh-ancestor
101524619|NCT01774578|Mitosis Modulators|mitosis modulators|mesh-ancestor
101524620|NCT01774578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101524621|NCT01774578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101524622|NCT01774578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101524623|NCT04543994|Remestemcel-l|remestemcel-l|mesh-list
101524624|NCT04543994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101524625|NCT04543994|Antiviral Agents|antiviral agents|mesh-ancestor
101524626|NCT04543994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101524627|NCT04670601|Flurbiprofen|flurbiprofen|mesh-list
101524628|NCT04670601|Analgesics|analgesics|mesh-ancestor
101524629|NCT04670601|Sensory System Agents|sensory system agents|mesh-ancestor
101524630|NCT04670601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101524631|NCT04670601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524632|NCT04670601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101524633|NCT04670601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101524634|NCT04670601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101524635|NCT04670601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101524636|NCT04670601|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101524637|NCT04670601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101524638|NCT04670601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524639|NCT04670913|Apatinib|apatinib|mesh-list
101524640|NCT04670913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101524641|NCT04670913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101524642|NCT04670913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101524643|NCT04670913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524644|NCT04671069|Clopidogrel|clopidogrel|mesh-list
101524645|NCT04671069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101524646|NCT04671069|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101524647|NCT04671069|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101524648|NCT04671069|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101524649|NCT04671069|Purinergic Agents|purinergic agents|mesh-ancestor
101327642|NCT00019864|Abortifacient Agents|abortifacient agents|mesh-ancestor
101524650|NCT04671069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101524651|NCT04671069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524652|NCT04671069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524654|NCT04322123|Hydroxychloroquine|hydroxychloroquine|mesh-list
101524655|NCT04322123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101524656|NCT04322123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101524657|NCT04322123|Antimalarials|antimalarials|mesh-ancestor
101524658|NCT04322123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101524659|NCT04322123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101524660|NCT04322123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101524661|NCT04322123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524662|NCT04322123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101524663|NCT04259138|Vedolizumab|vedolizumab|mesh-list
101524664|NCT04259138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101524665|NCT01741155|Docetaxel|docetaxel|mesh-list
101524666|NCT01741155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101524667|NCT01741155|Tubulin Modulators|tubulin modulators|mesh-ancestor
101524668|NCT01741155|Antimitotic Agents|antimitotic agents|mesh-ancestor
101524669|NCT01741155|Mitosis Modulators|mitosis modulators|mesh-ancestor
101524670|NCT01741155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524671|NCT04244630|Antioxidants|antioxidants|mesh-list
101524672|NCT04244630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327672|NCT00020176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101524673|NCT04244630|Protective Agents|protective agents|mesh-ancestor
101524674|NCT04244630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524675|NCT04239053|Bupivacaine|bupivacaine|mesh-list
101524676|NCT04239053|Anesthetics, Local|anesthetics, local|mesh-ancestor
101524677|NCT04239053|Anesthetics|anesthetics|mesh-ancestor
101524678|NCT04239053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101524679|NCT04239053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524680|NCT04239053|Sensory System Agents|sensory system agents|mesh-ancestor
101524681|NCT04239053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101524682|NCT01718145|Ribavirin|ribavirin|mesh-list
101524683|NCT01718145|Asunaprevir|asunaprevir|mesh-list
101524684|NCT01718145|Antimetabolites|antimetabolites|mesh-ancestor
101524685|NCT01718145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524686|NCT01718145|Antiviral Agents|antiviral agents|mesh-ancestor
101524687|NCT01718145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101524688|NCT01718145|Protease Inhibitors|protease inhibitors|mesh-ancestor
101524689|NCT01718145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101524690|NCT00556257|Cyclosporine|cyclosporine|mesh-list
101524691|NCT00556257|Cyclosporins|cyclosporins|mesh-list
101524692|NCT00556257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101524693|NCT00556257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524694|NCT00556257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101524695|NCT00556257|Immunologic Factors|immunologic factors|mesh-ancestor
101524696|NCT00556257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524697|NCT00556257|Antifungal Agents|antifungal agents|mesh-ancestor
101524698|NCT00556257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101327724|NCT00020371|Lenograstim|lenograstim|mesh-list
101524700|NCT00556257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101524701|NCT00556257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101524703|NCT01712451|Xhance|xhance|mesh-list
101524704|NCT01712451|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101524705|NCT01712451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101524706|NCT01712451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101524707|NCT01712451|Autonomic Agents|autonomic agents|mesh-ancestor
101524708|NCT01712451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101524709|NCT01712451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524710|NCT01712451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101524711|NCT01712451|Respiratory System Agents|respiratory system agents|mesh-ancestor
101524712|NCT01712451|Dermatologic Agents|dermatologic agents|mesh-ancestor
101524713|NCT01712451|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101524714|NCT01712451|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101524716|NCT01712451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101524717|NCT01712451|Adrenergic Agents|adrenergic agents|mesh-ancestor
101524718|NCT01712451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101524719|NCT01712451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524720|NCT01712217|Crizotinib|crizotinib|mesh-list
101524721|NCT01712217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101524722|NCT01712217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101524723|NCT01712217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101524724|NCT01712217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524725|NCT04669158|Idebenone|idebenone|mesh-list
101524726|NCT04669158|Antioxidants|antioxidants|mesh-ancestor
101524727|NCT04669158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524728|NCT04669158|Protective Agents|protective agents|mesh-ancestor
101319814|NCT03150316|Hormones|hormones|mesh-ancestor
101524729|NCT04669158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524730|NCT04669821|Propofol|propofol|mesh-list
101524731|NCT04669821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101524732|NCT04669821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101524733|NCT04669821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524734|NCT04669821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101524735|NCT04669821|Anesthetics, General|anesthetics, general|mesh-ancestor
101524736|NCT04669821|Anesthetics|anesthetics|mesh-ancestor
101524737|NCT00532025|Sorafenib|sorafenib|mesh-list
101524738|NCT00532025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101524739|NCT00532025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101524740|NCT00532025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101524741|NCT00532025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524742|NCT04669392|Ethanol|ethanol|mesh-list
101524743|NCT04669392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101524744|NCT04669392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101524745|NCT04669392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101524746|NCT04669392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524747|NCT00532142|Triamcinolone|triamcinolone|mesh-list
101524748|NCT00532142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101524749|NCT00532142|Glucocorticoids|glucocorticoids|mesh-ancestor
101524750|NCT00532142|Hormones|hormones|mesh-ancestor
101524751|NCT00532142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101524752|NCT00532142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524754|NCT00533312|Niacinamide|niacinamide|mesh-list
101524755|NCT00533312|Nicotinic Acids|nicotinic acids|mesh-list
101524756|NCT00533312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101524757|NCT00533312|Antimetabolites|antimetabolites|mesh-ancestor
101524758|NCT00533312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524759|NCT00533312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101524760|NCT00533312|Vasodilator Agents|vasodilator agents|mesh-ancestor
101524761|NCT00533312|Vitamin B Complex|vitamin b complex|mesh-ancestor
101524763|NCT00533312|Micronutrients|micronutrients|mesh-ancestor
101524764|NCT00533312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524765|NCT00533390|Efavirenz|efavirenz|mesh-list
101524766|NCT00533390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101524767|NCT00533390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101524768|NCT00533390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101524769|NCT00533390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524770|NCT00533390|Antiviral Agents|antiviral agents|mesh-ancestor
101524771|NCT00533390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101524772|NCT00533390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101524773|NCT00533390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101327949|NCT00021112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101524774|NCT00533390|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101524775|NCT00533390|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101524776|NCT00533390|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101524777|NCT00533390|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101524778|NCT00556296|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101524779|NCT00556296|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101524780|NCT00556296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524781|NCT00556296|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101524782|NCT00556296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101524783|NCT00556296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101524784|NCT00556296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524785|NCT00556296|Dopamine Agents|dopamine agents|mesh-ancestor
101524786|NCT00556296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101524787|NCT04668456|Lidocaine|lidocaine|mesh-list
101524788|NCT04668456|Dexmedetomidine|dexmedetomidine|mesh-list
101524789|NCT04668456|Anesthetics, Local|anesthetics, local|mesh-ancestor
101524790|NCT04668456|Anesthetics|anesthetics|mesh-ancestor
101524791|NCT04668456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101328008|NCT00021463|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101524792|NCT04668456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524793|NCT04668456|Sensory System Agents|sensory system agents|mesh-ancestor
101524794|NCT04668456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101524795|NCT04668456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101524796|NCT04668456|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101524797|NCT04668456|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101319826|NCT02972125|Lacosamide|lacosamide|mesh-list
101524798|NCT04668456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101524799|NCT04668456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524800|NCT04668456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101524801|NCT04668456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101524802|NCT04668456|Analgesics|analgesics|mesh-ancestor
101524803|NCT04668456|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101524804|NCT04668456|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101524805|NCT04668456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101524806|NCT04668456|Adrenergic Agents|adrenergic agents|mesh-ancestor
101524807|NCT04668456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101524809|NCT04693169|Lipotropic Agents|lipotropic agents|mesh-ancestor
101524810|NCT04693169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101524811|NCT04693169|Antimetabolites|antimetabolites|mesh-ancestor
101524812|NCT04693169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524813|NCT04693169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101524814|NCT04693169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101524815|NCT04693169|Nootropic Agents|nootropic agents|mesh-ancestor
101524816|NCT04668417|Vaccines|vaccines|mesh-list
101524817|NCT04668417|Immunologic Factors|immunologic factors|mesh-ancestor
101524818|NCT04668417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524819|NCT00556413|Leucovorin|leucovorin|mesh-list
101524820|NCT00556413|Fluorouracil|fluorouracil|mesh-list
101524821|NCT00556413|Oxaliplatin|oxaliplatin|mesh-list
101524822|NCT00556413|Irinotecan|irinotecan|mesh-list
101524823|NCT00556413|Cetuximab|cetuximab|mesh-list
101524824|NCT00556413|Calcium|calcium|mesh-list
101524825|NCT00556413|Levoleucovorin|levoleucovorin|mesh-list
101524826|NCT00556413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101524827|NCT00556413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524828|NCT00556413|Antimetabolites|antimetabolites|mesh-ancestor
101524829|NCT00556413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524830|NCT00556413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101524831|NCT00556413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101524832|NCT00556413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101524833|NCT00556413|Immunologic Factors|immunologic factors|mesh-ancestor
101524834|NCT00556413|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101524835|NCT00556413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101524836|NCT00556413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101328100|NCT00022087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524838|NCT00556413|Protective Agents|protective agents|mesh-ancestor
101524839|NCT00556413|Vitamin B Complex|vitamin b complex|mesh-ancestor
101524840|NCT00556413|Vitamins|vitamins|mesh-ancestor
101524841|NCT00556413|Micronutrients|micronutrients|mesh-ancestor
101524842|NCT00556413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101524843|NCT04668690|Mitoxantrone|mitoxantrone|mesh-list
101524844|NCT04668690|Analgesics|analgesics|mesh-ancestor
101524845|NCT04668690|Sensory System Agents|sensory system agents|mesh-ancestor
101524846|NCT04668690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101524847|NCT04668690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524848|NCT04668690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101524849|NCT04668690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101524850|NCT04668690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101524851|NCT04668690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101524852|NCT04668690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524853|NCT00533585|Paclitaxel|paclitaxel|mesh-list
101524854|NCT00533585|Bevacizumab|bevacizumab|mesh-list
101524855|NCT00533585|Carboplatin|carboplatin|mesh-list
101524856|NCT00533585|Sorafenib|sorafenib|mesh-list
101524857|NCT00533585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101524858|NCT00533585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101524859|NCT00533585|Tubulin Modulators|tubulin modulators|mesh-ancestor
101524860|NCT00533585|Antimitotic Agents|antimitotic agents|mesh-ancestor
101524861|NCT00533585|Mitosis Modulators|mitosis modulators|mesh-ancestor
101524862|NCT00533585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524863|NCT00533585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101524864|NCT00533585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101524865|NCT00533585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101524866|NCT00533585|Growth Substances|growth substances|mesh-ancestor
101524867|NCT00533585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524868|NCT00533585|Growth Inhibitors|growth inhibitors|mesh-ancestor
101524869|NCT00533585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101524870|NCT00533585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101524871|NCT00533624|Mycophenolic Acid|mycophenolic acid|mesh-list
101524872|NCT00533624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101524873|NCT00533624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101524874|NCT00533624|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101524875|NCT00533624|Antitubercular Agents|antitubercular agents|mesh-ancestor
101524876|NCT00533624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101524877|NCT00533624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101524878|NCT00533624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101524879|NCT00533624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524881|NCT04659057|Dexmedetomidine|dexmedetomidine|mesh-list
101524882|NCT04659057|Anesthetics, Local|anesthetics, local|mesh-ancestor
101524883|NCT04659057|Anesthetics|anesthetics|mesh-ancestor
101524884|NCT04659057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101524885|NCT04659057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524886|NCT04659057|Sensory System Agents|sensory system agents|mesh-ancestor
101524887|NCT04659057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101524888|NCT04659057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101524889|NCT04659057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101524890|NCT04659057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101524891|NCT04659057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101524892|NCT04659057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524893|NCT04659057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101524894|NCT04659057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101524895|NCT04659057|Analgesics|analgesics|mesh-ancestor
101524896|NCT04659057|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101524897|NCT04659057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101328222|NCT00022321|Gemtuzumab|gemtuzumab|mesh-list
101524898|NCT04659057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101524899|NCT04659057|Adrenergic Agents|adrenergic agents|mesh-ancestor
101524900|NCT04659057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101524902|NCT04547153|Fluorouracil|fluorouracil|mesh-list
101524903|NCT04547153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101524904|NCT04547153|Tubulin Modulators|tubulin modulators|mesh-ancestor
101524905|NCT04547153|Antimitotic Agents|antimitotic agents|mesh-ancestor
101524906|NCT04547153|Mitosis Modulators|mitosis modulators|mesh-ancestor
101524907|NCT04547153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524908|NCT04547153|Antimetabolites|antimetabolites|mesh-ancestor
101524909|NCT04547153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101524910|NCT04547153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101524912|NCT04547153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524913|NCT00533741|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101524914|NCT00533741|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101524915|NCT00533741|Immunologic Factors|immunologic factors|mesh-ancestor
101524916|NCT00533741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524917|NCT00533741|Antacids|antacids|mesh-ancestor
101524918|NCT00533741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524919|NCT00533741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101524920|NCT00533858|Losartan|losartan|mesh-list
101524921|NCT00533858|Lacidipine|lacidipine|mesh-list
101524922|NCT00533858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101524923|NCT00533858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101328252|NCT00000143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101524924|NCT00533858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101524925|NCT00533858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101524926|NCT00533858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524927|NCT00533858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101524928|NCT00533858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101524929|NCT00533858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101524930|NCT00533858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524931|NCT04658355|Chlorhexidine|chlorhexidine|mesh-list
101524932|NCT04658355|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101524933|NCT04658355|Povidone-Iodine|povidone-iodine|mesh-list
101524935|NCT04658355|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101524936|NCT04658355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101524937|NCT04658355|Disinfectants|disinfectants|mesh-ancestor
101524938|NCT04658355|Dermatologic Agents|dermatologic agents|mesh-ancestor
101524939|NCT04658355|Plasma Substitutes|plasma substitutes|mesh-ancestor
101524940|NCT04658355|Blood Substitutes|blood substitutes|mesh-ancestor
101524941|NCT00533936|Paclitaxel|paclitaxel|mesh-list
101524942|NCT00533936|Cyclophosphamide|cyclophosphamide|mesh-list
101524943|NCT00533936|Doxorubicin|doxorubicin|mesh-list
101524944|NCT00533936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101524945|NCT00533936|Fluorouracil|fluorouracil|mesh-list
101524946|NCT00533936|Trastuzumab|trastuzumab|mesh-list
101524947|NCT00533936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101524948|NCT00533936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101524949|NCT00533936|Tubulin Modulators|tubulin modulators|mesh-ancestor
101524950|NCT00533936|Antimitotic Agents|antimitotic agents|mesh-ancestor
101524951|NCT00533936|Mitosis Modulators|mitosis modulators|mesh-ancestor
101524952|NCT00533936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524953|NCT00533936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101524954|NCT00533936|Immunologic Factors|immunologic factors|mesh-ancestor
101524955|NCT00533936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524956|NCT00533936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101328361|NCT00022945|Prednisone|prednisone|mesh-list
101524957|NCT00533936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101524958|NCT00533936|Alkylating Agents|alkylating agents|mesh-ancestor
101524959|NCT00533936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101524960|NCT00533936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101524961|NCT00533936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101524962|NCT00533936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101524963|NCT00533936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101524964|NCT00533936|Antimetabolites|antimetabolites|mesh-ancestor
101524965|NCT00533936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101524966|NCT00533936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101524967|NCT00557544|Ketoprofen|ketoprofen|mesh-list
101524968|NCT00557544|Metoclopramide|metoclopramide|mesh-list
101524969|NCT00557544|Antiemetics|antiemetics|mesh-ancestor
101524970|NCT00557544|Autonomic Agents|autonomic agents|mesh-ancestor
101524971|NCT00557544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101524972|NCT00557544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524973|NCT00557544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101524974|NCT00557544|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101524975|NCT00557544|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101524976|NCT00557544|Dopamine Agents|dopamine agents|mesh-ancestor
101524977|NCT00557544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101524978|NCT00557544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101524979|NCT00557544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101524980|NCT00557544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101328423|NCT00000170|Respiratory System Agents|respiratory system agents|mesh-ancestor
101524981|NCT00557544|Analgesics|analgesics|mesh-ancestor
101524982|NCT00557544|Sensory System Agents|sensory system agents|mesh-ancestor
101524983|NCT00557544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101524984|NCT00557544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101524985|NCT00557544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101524986|NCT00557544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101524987|NCT04667910|Ranibizumab|ranibizumab|mesh-list
101524988|NCT04667910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101524989|NCT04667910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101524990|NCT04667910|Growth Substances|growth substances|mesh-ancestor
101524991|NCT04667910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101524992|NCT04667910|Growth Inhibitors|growth inhibitors|mesh-ancestor
101524993|NCT04667910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101524994|NCT00556608|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101524995|NCT00556608|Hyaluronic Acid|hyaluronic acid|mesh-list
101524996|NCT00556608|Hylan|hylan|mesh-list
101524997|NCT00556608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101524998|NCT00556608|Immunologic Factors|immunologic factors|mesh-ancestor
101524999|NCT00556608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525000|NCT00556608|Viscosupplements|viscosupplements|mesh-ancestor
101525001|NCT00556608|Protective Agents|protective agents|mesh-ancestor
101525002|NCT00534287|Moxifloxacin|moxifloxacin|mesh-list
101525003|NCT00534287|Meropenem|meropenem|mesh-list
101525004|NCT00534287|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101525005|NCT00534287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101525006|NCT00534287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101525007|NCT00534287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101525008|NCT00534287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101525009|NCT00534287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101411290|NCT00458458|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101525010|NCT00534287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328479|NCT00023335|Antimetabolites|antimetabolites|mesh-ancestor
101525011|NCT00534287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525012|NCT00534287|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101525013|NCT00534287|Contraceptive Agents|contraceptive agents|mesh-ancestor
101525014|NCT00534287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101525015|NCT00534287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525016|NCT00534287|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101525017|NCT00534287|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101525018|NCT00534287|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101525019|NCT04168502|Gemtuzumab|gemtuzumab|mesh-list
101525020|NCT04168502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101525021|NCT04168502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525022|NCT04168502|Immunotoxins|immunotoxins|mesh-ancestor
101525023|NCT04168502|Immunoconjugates|immunoconjugates|mesh-ancestor
101525024|NCT04168502|Immunologic Factors|immunologic factors|mesh-ancestor
101525025|NCT04168502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525026|NCT01215916|Pemetrexed|pemetrexed|mesh-list
101525027|NCT01215916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525028|NCT01215916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101525029|NCT01215916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525030|NCT01215916|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101525031|NCT01215916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101328518|NCT00023413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101525032|NCT01184872|Vancomycin|vancomycin|mesh-list
101525033|NCT01184872|Daptomycin|daptomycin|mesh-list
101525034|NCT01184872|Penicillins|penicillins|mesh-list
101525035|NCT01184872|Floxacillin|floxacillin|mesh-list
101525036|NCT01184872|Cloxacillin|cloxacillin|mesh-list
101525037|NCT01184872|Oxacillin|oxacillin|mesh-list
101525038|NCT01184872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101525039|NCT01184872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101525040|NCT01215721|Solifenacin Succinate|solifenacin succinate|mesh-list
101328571|NCT00000179|Haloperidol|haloperidol|mesh-list
101525041|NCT01215721|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101525042|NCT01215721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101525043|NCT01215721|Cholinergic Agents|cholinergic agents|mesh-ancestor
101525044|NCT01215721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101525045|NCT01215721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525047|NCT01215721|Urological Agents|urological agents|mesh-ancestor
101525048|NCT04666623|Esketamine|esketamine|mesh-list
101328637|NCT00000221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101525050|NCT04666623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101525051|NCT00534677|Octreotide|octreotide|mesh-list
101525052|NCT00534677|Terlipressin|terlipressin|mesh-list
101525053|NCT00534677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101525054|NCT00534677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101525055|NCT00534677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525056|NCT00534677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101525057|NCT00534677|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101525059|NCT00556959|Analgesics|analgesics|mesh-ancestor
101525060|NCT00556959|Sensory System Agents|sensory system agents|mesh-ancestor
101525061|NCT00556959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101525062|NCT00556959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525063|NCT00556959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101525064|NCT00556959|Sympatholytics|sympatholytics|mesh-ancestor
101525065|NCT00556959|Autonomic Agents|autonomic agents|mesh-ancestor
101525066|NCT00556959|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101525067|NCT00556959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101525068|NCT00556959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101525069|NCT00556959|Adrenergic Agents|adrenergic agents|mesh-ancestor
101328849|NCT00024427|Gemcitabine|gemcitabine|mesh-list
101525070|NCT00556959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101525071|NCT00556959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525072|NCT01184326|Everolimus|everolimus|mesh-list
101525073|NCT01184326|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101525074|NCT01184326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101525075|NCT01184326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101525076|NCT01184326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525077|NCT01184326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101525078|NCT01184326|Immunologic Factors|immunologic factors|mesh-ancestor
101525079|NCT01184326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525080|NCT01184326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525081|NCT01215253|Ranolazine|ranolazine|mesh-list
101525082|NCT01215253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101525083|NCT01215253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101525084|NCT01215253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525085|NCT01184053|Arsenic Trioxide|arsenic trioxide|mesh-list
101525086|NCT01184053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525087|NCT03813875|Fentanyl|fentanyl|mesh-list
101525088|NCT03813875|Midazolam|midazolam|mesh-list
101525089|NCT03813875|Alfentanil|alfentanil|mesh-list
101328978|NCT00025324|Thiotepa|thiotepa|mesh-list
101525090|NCT03813875|Propofol|propofol|mesh-list
101525091|NCT03813875|Sevoflurane|sevoflurane|mesh-list
101525092|NCT03813875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101525093|NCT03813875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101525094|NCT03813875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525095|NCT03813875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101525096|NCT03813875|Anesthetics, General|anesthetics, general|mesh-ancestor
101525098|NCT03813875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101525099|NCT03813875|Narcotics|narcotics|mesh-ancestor
101525101|NCT03813875|Sensory System Agents|sensory system agents|mesh-ancestor
101525102|NCT03813875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101329050|NCT00025441|Dactinomycin|dactinomycin|mesh-list
101525103|NCT03813875|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101525104|NCT03813875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101525105|NCT03813875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101525107|NCT03813875|GABA Modulators|gaba modulators|mesh-ancestor
101525108|NCT03813875|GABA Agents|gaba agents|mesh-ancestor
101525109|NCT03813875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101525110|NCT03813875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525111|NCT03813875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101525112|NCT03813875|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101525113|NCT01183858|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101525114|NCT01183858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525115|NCT01183858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101525116|NCT01183858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101525117|NCT01183858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525118|NCT05449522|Vitamin D|vitamin d|mesh-list
101525120|NCT05449522|Micronutrients|micronutrients|mesh-ancestor
101525121|NCT05449522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525122|NCT05449522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101525123|NCT04665609|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101525124|NCT03737981|Venetoclax|venetoclax|mesh-list
101525125|NCT03737981|Obinutuzumab|obinutuzumab|mesh-list
101525126|NCT03737981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525127|NCT03737981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101525128|NCT04665141|Omalizumab|omalizumab|mesh-list
101525129|NCT04665141|Benralizumab|benralizumab|mesh-list
101525130|NCT04665141|Reslizumab|reslizumab|mesh-list
101525131|NCT04665141|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101525132|NCT04665141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101525133|NCT04665141|Respiratory System Agents|respiratory system agents|mesh-ancestor
101525134|NCT04665063|Cyclophosphamide|cyclophosphamide|mesh-list
101525135|NCT04665063|Fludarabine|fludarabine|mesh-list
101525136|NCT04665063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101525137|NCT04665063|Immunologic Factors|immunologic factors|mesh-ancestor
101525138|NCT04665063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525139|NCT04665063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101525140|NCT04665063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101525141|NCT04665063|Alkylating Agents|alkylating agents|mesh-ancestor
101525142|NCT04665063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525143|NCT04665063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525144|NCT04665063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101525145|NCT04664595|Propofol|propofol|mesh-list
101525146|NCT04664595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101525147|NCT04664595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101525148|NCT04664595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525149|NCT04664595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101525150|NCT04664595|Anesthetics, General|anesthetics, general|mesh-ancestor
101525151|NCT04664595|Anesthetics|anesthetics|mesh-ancestor
101525152|NCT01215175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101525153|NCT01215175|Immunologic Factors|immunologic factors|mesh-ancestor
101525154|NCT01215175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525157|NCT03580148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101525158|NCT04664517|Anesthetics|anesthetics|mesh-list
101525159|NCT04664517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101525160|NCT04664517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525161|NCT05335915|Nicotine|nicotine|mesh-list
101525162|NCT05335915|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101329230|NCT00025792|Dopamine Agonists|dopamine agonists|mesh-ancestor
101525164|NCT05335915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101525165|NCT05335915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525166|NCT05335915|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101525167|NCT05335915|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101525168|NCT05335915|Cholinergic Agents|cholinergic agents|mesh-ancestor
101525169|NCT05335915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101525170|NCT05335915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525172|NCT01215097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101525173|NCT01215097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525174|NCT01215097|Incretins|incretins|mesh-ancestor
101525175|NCT01215097|Hormones|hormones|mesh-ancestor
101525176|NCT01215097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101525177|NCT01215097|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101525178|NCT01215097|Protease Inhibitors|protease inhibitors|mesh-ancestor
101329280|NCT00026182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101525179|NCT01215097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101525180|NCT01215097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525182|NCT03527576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101525183|NCT03527576|Antiemetics|antiemetics|mesh-ancestor
101525184|NCT03527576|Autonomic Agents|autonomic agents|mesh-ancestor
101525185|NCT03527576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101525186|NCT03527576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525187|NCT03527576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101525188|NCT03527576|Glucocorticoids|glucocorticoids|mesh-ancestor
101525189|NCT03527576|Hormones|hormones|mesh-ancestor
101525190|NCT03527576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101525191|NCT03527576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101525193|NCT04664010|Vitamins|vitamins|mesh-list
101525194|NCT04664010|Ascorbic Acid|ascorbic acid|mesh-list
101525195|NCT04664010|Interferons|interferons|mesh-list
101525196|NCT04664010|Ribavirin|ribavirin|mesh-list
101525197|NCT04664010|Interferon-alpha|interferon-alpha|mesh-list
101525198|NCT04664010|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
101525199|NCT04664010|Micronutrients|micronutrients|mesh-ancestor
101525200|NCT04664010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525201|NCT04664010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525202|NCT04664010|Antiviral Agents|antiviral agents|mesh-ancestor
101525203|NCT04664010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101525204|NCT04664010|Antimetabolites|antimetabolites|mesh-ancestor
101525205|NCT04664010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525206|NCT04664010|Immunologic Factors|immunologic factors|mesh-ancestor
101525207|NCT04664010|Antioxidants|antioxidants|mesh-ancestor
101525208|NCT04664010|Protective Agents|protective agents|mesh-ancestor
101525209|NCT04664127|Valacyclovir|valacyclovir|mesh-list
101525210|NCT04664127|Antiviral Agents|antiviral agents|mesh-ancestor
101525211|NCT04664127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101525212|NCT04664088|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101525213|NCT04664088|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101525214|NCT04664088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101525215|NCT04664088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101525216|NCT04664088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525217|NCT04664088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101525218|NCT04664088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525219|NCT04664088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101525220|NCT04664088|Antidepressive Agents|antidepressive agents|mesh-ancestor
101525221|NCT04664088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101525222|NCT04664244|Nimotuzumab|nimotuzumab|mesh-list
101525223|NCT04664244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101319854|NCT02633098|Artesunate|artesunate|mesh-list
101525225|NCT04663386|Budesonide|budesonide|mesh-list
101525226|NCT04663386|Formoterol Fumarate|formoterol fumarate|mesh-list
101525227|NCT04663386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101525228|NCT04663386|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101525229|NCT04663386|Autonomic Agents|autonomic agents|mesh-ancestor
101525230|NCT04663386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101411301|NCT00458731|Bevacizumab|bevacizumab|mesh-list
101525231|NCT04663386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525232|NCT04663386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101525233|NCT04663386|Respiratory System Agents|respiratory system agents|mesh-ancestor
101525234|NCT04663386|Glucocorticoids|glucocorticoids|mesh-ancestor
101525235|NCT04663386|Hormones|hormones|mesh-ancestor
101525236|NCT04663386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101525237|NCT04663386|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101525238|NCT04663386|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101525239|NCT04663386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101525240|NCT04663386|Adrenergic Agents|adrenergic agents|mesh-ancestor
101525241|NCT04663386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101525242|NCT04663386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525243|NCT04663269|Dexamethasone|dexamethasone|mesh-list
101525244|NCT04663269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101525245|NCT04663269|Antiemetics|antiemetics|mesh-ancestor
101525246|NCT04663269|Autonomic Agents|autonomic agents|mesh-ancestor
101525247|NCT04663269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101525248|NCT04663269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525249|NCT04663269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101525250|NCT04663269|Glucocorticoids|glucocorticoids|mesh-ancestor
101525252|NCT04663269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101525253|NCT04663269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101525254|NCT04663269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525255|NCT03312738|Everolimus|everolimus|mesh-list
101525256|NCT03312738|Exemestane|exemestane|mesh-list
101525257|NCT03312738|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101525258|NCT03312738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101525259|NCT03312738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101525260|NCT03312738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525261|NCT03312738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101525262|NCT03312738|Immunologic Factors|immunologic factors|mesh-ancestor
101525263|NCT03312738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525264|NCT03312738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525265|NCT03312738|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101525266|NCT03312738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101525267|NCT03312738|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101525268|NCT03312738|Hormone Antagonists|hormone antagonists|mesh-ancestor
101525269|NCT03312738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101525270|NCT03303339|Cytarabine|cytarabine|mesh-list
101525271|NCT03303339|Decitabine|decitabine|mesh-list
101525272|NCT03303339|Onvansertib|onvansertib|mesh-list
101525273|NCT03303339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101525274|NCT03303339|Antimetabolites|antimetabolites|mesh-ancestor
101525275|NCT03303339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525276|NCT03303339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525277|NCT03303339|Antiviral Agents|antiviral agents|mesh-ancestor
101525278|NCT03303339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101525279|NCT03303339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101525280|NCT03303339|Immunologic Factors|immunologic factors|mesh-ancestor
101525281|NCT03303339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525282|NCT03303339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101525283|NCT03303339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101525284|NCT03422471|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101525285|NCT03422471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525287|NCT03299946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101525288|NCT03299946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525289|NCT03299946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101525290|NCT03299946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525291|NCT00535340|Amibegron|amibegron|mesh-list
101525292|NCT00535340|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
101525293|NCT00535340|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101525294|NCT00535340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101525295|NCT00535340|Adrenergic Agents|adrenergic agents|mesh-ancestor
101525296|NCT00535340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101525297|NCT00535340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525298|NCT00535340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525299|NCT00535340|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101525300|NCT00535379|Sunitinib|sunitinib|mesh-list
101329556|NCT00027625|Gefitinib|gefitinib|mesh-list
101525301|NCT00535379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525302|NCT00535379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101525303|NCT00535379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101525304|NCT00535379|Growth Substances|growth substances|mesh-ancestor
101525305|NCT00535379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525306|NCT00535379|Growth Inhibitors|growth inhibitors|mesh-ancestor
101525307|NCT00535379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101525308|NCT00535379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101525309|NCT00535379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525310|NCT00535418|Letrozole|letrozole|mesh-list
101525311|NCT00535418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525312|NCT00535418|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101525313|NCT00535418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101525314|NCT00535418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101525315|NCT00535418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525316|NCT00535418|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101525317|NCT00535418|Hormone Antagonists|hormone antagonists|mesh-ancestor
101525318|NCT00535418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101525319|NCT00535418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525320|NCT04679064|Paclitaxel|paclitaxel|mesh-list
101525321|NCT04679064|Bevacizumab|bevacizumab|mesh-list
101525322|NCT04679064|Gemcitabine|gemcitabine|mesh-list
101525323|NCT04679064|Doxorubicin|doxorubicin|mesh-list
101525324|NCT04679064|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101525325|NCT04679064|Topotecan|topotecan|mesh-list
101525326|NCT04679064|Niraparib|niraparib|mesh-list
101525327|NCT04679064|Dostarlimab|dostarlimab|mesh-list
101525328|NCT04679064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101525329|NCT04679064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525330|NCT04679064|Tubulin Modulators|tubulin modulators|mesh-ancestor
101525331|NCT04679064|Antimitotic Agents|antimitotic agents|mesh-ancestor
101525332|NCT04679064|Mitosis Modulators|mitosis modulators|mesh-ancestor
101525333|NCT04679064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525334|NCT04679064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101525335|NCT04679064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101525336|NCT04679064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101525337|NCT04679064|Growth Substances|growth substances|mesh-ancestor
101525338|NCT04679064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525339|NCT04679064|Growth Inhibitors|growth inhibitors|mesh-ancestor
101525340|NCT04679064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101525341|NCT04679064|Antimetabolites|antimetabolites|mesh-ancestor
101525342|NCT04679064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101525343|NCT04679064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101525344|NCT04679064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101525345|NCT04679064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101525346|NCT04679064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101525347|NCT04679064|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101525348|NCT01183780|Leucovorin|leucovorin|mesh-list
101525349|NCT01183780|Folic Acid|folic acid|mesh-list
101525350|NCT01183780|Fluorouracil|fluorouracil|mesh-list
101525351|NCT01183780|Irinotecan|irinotecan|mesh-list
101525352|NCT01183780|Ramucirumab|ramucirumab|mesh-list
101525353|NCT01183780|Levoleucovorin|levoleucovorin|mesh-list
101525354|NCT01183780|Antimetabolites|antimetabolites|mesh-ancestor
101525355|NCT01183780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525356|NCT01183780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101525357|NCT01183780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525358|NCT01183780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101525359|NCT01183780|Immunologic Factors|immunologic factors|mesh-ancestor
101525360|NCT01183780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525361|NCT01183780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101329853|NCT00028366|Fosamprenavir|fosamprenavir|mesh-list
101525362|NCT01183780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101525363|NCT01183780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101525364|NCT01183780|Antidotes|antidotes|mesh-ancestor
101525365|NCT01183780|Protective Agents|protective agents|mesh-ancestor
101525366|NCT01183780|Vitamin B Complex|vitamin b complex|mesh-ancestor
101329854|NCT00028366|Tenofovir|tenofovir|mesh-list
101525367|NCT01183780|Vitamins|vitamins|mesh-ancestor
101525368|NCT01183780|Micronutrients|micronutrients|mesh-ancestor
101525369|NCT01183780|Hematinics|hematinics|mesh-ancestor
101525370|NCT04679103|Eculizumab|eculizumab|mesh-list
101525371|NCT04679103|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101525372|NCT04679103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101525373|NCT04679103|Immunologic Factors|immunologic factors|mesh-ancestor
101525374|NCT04679103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525375|NCT00535574|Bexarotene|bexarotene|mesh-list
101525376|NCT00535574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525377|NCT04678830|Leronlimab|leronlimab|mesh-list
101525378|NCT04678830|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101525379|NCT04678830|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101525380|NCT04678830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525381|NCT04678830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101525382|NCT04678830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101525383|NCT04678830|Antiviral Agents|antiviral agents|mesh-ancestor
101525384|NCT04678830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101525385|NCT01183468|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
101525386|NCT01183468|Protein C Inhibitor|protein c inhibitor|mesh-list
101525387|NCT01183468|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101525388|NCT01183468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101525389|NCT01183468|Protease Inhibitors|protease inhibitors|mesh-ancestor
101525390|NCT01183468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101525391|NCT01183468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525392|NCT03245021|Rituximab|rituximab|mesh-list
101525393|NCT03245021|Nivolumab|nivolumab|mesh-list
101525394|NCT03245021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101525395|NCT03245021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329915|NCT00000485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525396|NCT03245021|Immunologic Factors|immunologic factors|mesh-ancestor
101525397|NCT03245021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525398|NCT03245021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101525399|NCT03245021|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101525400|NCT03245021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525402|NCT04678791|Nimotuzumab|nimotuzumab|mesh-list
101525403|NCT04678791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525404|NCT04678791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101525405|NCT01183390|Anastrozole|anastrozole|mesh-list
101525406|NCT01183390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101525407|NCT01183390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525411|NCT01183390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525412|NCT01183390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101525413|NCT01183390|Hormone Antagonists|hormone antagonists|mesh-ancestor
101525414|NCT01183390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101525415|NCT01183390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525417|NCT02887807|Cyclosporins|cyclosporins|mesh-list
101525418|NCT02887807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101525419|NCT02887807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525420|NCT02887807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101525421|NCT02887807|Immunologic Factors|immunologic factors|mesh-ancestor
101525422|NCT02887807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525423|NCT02887807|Antifungal Agents|antifungal agents|mesh-ancestor
101525424|NCT02887807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101525425|NCT02887807|Dermatologic Agents|dermatologic agents|mesh-ancestor
101525426|NCT02887807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101525427|NCT02887807|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101525428|NCT04663035|Tislelizumab|tislelizumab|mesh-list
101525429|NCT04663035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101525430|NCT04663035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525431|NCT03098589|Lenalidomide|lenalidomide|mesh-list
101525432|NCT03098589|Immunologic Factors|immunologic factors|mesh-ancestor
101525433|NCT03098589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525434|NCT03098589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101525435|NCT03098589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101525436|NCT03098589|Growth Substances|growth substances|mesh-ancestor
101525437|NCT03098589|Growth Inhibitors|growth inhibitors|mesh-ancestor
101525438|NCT03098589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525439|NCT04662177|Dexmedetomidine|dexmedetomidine|mesh-list
101525440|NCT04662177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101525441|NCT04662177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101525442|NCT04662177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525443|NCT04662177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101525444|NCT04662177|Analgesics|analgesics|mesh-ancestor
101525445|NCT04662177|Sensory System Agents|sensory system agents|mesh-ancestor
101525446|NCT04662177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101525447|NCT04662177|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101525448|NCT04662177|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101525449|NCT04662177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101525450|NCT04662177|Adrenergic Agents|adrenergic agents|mesh-ancestor
101525451|NCT04662177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101525452|NCT04662177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525454|NCT03026517|Trametinib|trametinib|mesh-list
101525455|NCT03026517|Dabrafenib|dabrafenib|mesh-list
101525456|NCT03026517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525457|NCT03026517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101525458|NCT03026517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101525459|NCT03026517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525460|NCT03026517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101330076|NCT00028951|Coagulants|coagulants|mesh-ancestor
101525461|NCT03026517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525463|NCT00537953|Meglumine Antimoniate|meglumine antimoniate|mesh-list
101525464|NCT00537953|Antifungal Agents|antifungal agents|mesh-ancestor
101525465|NCT00537953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101525466|NCT00537953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525467|NCT00537953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101525468|NCT00537953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101525469|NCT04662138|Antiviral Agents|antiviral agents|mesh-list
101525470|NCT04662138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101525471|NCT05226299|Capsaicin|capsaicin|mesh-list
101525472|NCT05226299|Antipruritics|antipruritics|mesh-ancestor
101525473|NCT05226299|Dermatologic Agents|dermatologic agents|mesh-ancestor
101525474|NCT05226299|Sensory System Agents|sensory system agents|mesh-ancestor
101525475|NCT05226299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101525476|NCT05226299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525478|NCT00557232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101525479|NCT00557232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525480|NCT00557232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101525481|NCT00557232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101525482|NCT00557232|Growth Substances|growth substances|mesh-ancestor
101525483|NCT00557232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525484|NCT00557232|Growth Inhibitors|growth inhibitors|mesh-ancestor
101525485|NCT02797119|Tranexamic Acid|tranexamic acid|mesh-list
101525486|NCT02797119|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101525487|NCT02797119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101525488|NCT02797119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525489|NCT02797119|Hemostatics|hemostatics|mesh-ancestor
101525490|NCT02797119|Coagulants|coagulants|mesh-ancestor
101525491|NCT05161208|Varenicline|varenicline|mesh-list
101525492|NCT05161208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101525493|NCT05161208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101525494|NCT05161208|Cholinergic Agents|cholinergic agents|mesh-ancestor
101330124|NCT00029380|Busulfan|busulfan|mesh-list
101525495|NCT05161208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101525496|NCT05161208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525497|NCT05161208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525498|NCT00538070|Glycine|glycine|mesh-list
101525499|NCT00538070|Glycine Agents|glycine agents|mesh-ancestor
101525500|NCT00538070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101525501|NCT00538070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525502|NCT00538070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525503|NCT00538109|Imatinib Mesylate|imatinib mesylate|mesh-list
101525504|NCT00538109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525505|NCT00538109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101525506|NCT00538109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101525507|NCT00538109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525508|NCT00538148|Telithromycin|telithromycin|mesh-list
101525509|NCT00538148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101525510|NCT00538148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101525513|NCT04661670|Antifungal Agents|antifungal agents|mesh-ancestor
101525514|NCT04661670|Keratolytic Agents|keratolytic agents|mesh-ancestor
101525515|NCT04661670|Dermatologic Agents|dermatologic agents|mesh-ancestor
101525516|NCT05110391|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101525517|NCT05110391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101525518|NCT05110391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525519|NCT00538187|Bortezomib|bortezomib|mesh-list
101525520|NCT00538187|Obatoclax|obatoclax|mesh-list
101525521|NCT00538187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525522|NCT00538187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101525523|NCT00538187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525524|NCT04661709|Aspirin|aspirin|mesh-list
101525525|NCT04661709|Metoprolol|metoprolol|mesh-list
101525526|NCT04661709|Isosorbide|isosorbide|mesh-list
101525527|NCT04661709|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
101525528|NCT04661709|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
101525529|NCT04661709|Nitroglycerin|nitroglycerin|mesh-list
101525530|NCT04661709|Trimetazidine|trimetazidine|mesh-list
101525531|NCT04661709|Clopidogrel|clopidogrel|mesh-list
101525532|NCT04661709|Atorvastatin|atorvastatin|mesh-list
101525533|NCT04661709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525534|NCT04661709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101525535|NCT04661709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101525536|NCT04661709|Analgesics|analgesics|mesh-ancestor
101525537|NCT04661709|Sensory System Agents|sensory system agents|mesh-ancestor
101525538|NCT04661709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101525539|NCT04661709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101525540|NCT04661709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101525541|NCT04661709|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101525542|NCT04661709|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101525543|NCT04661709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525544|NCT04661709|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101525545|NCT04661709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101525546|NCT04661709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101525547|NCT04661709|Antipyretics|antipyretics|mesh-ancestor
101525548|NCT04661709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101525549|NCT04661709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101525550|NCT04661709|Antimetabolites|antimetabolites|mesh-ancestor
101330210|NCT00029770|Codeine|codeine|mesh-list
101525551|NCT04661709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101525552|NCT04661709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101525553|NCT04661709|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101525554|NCT04661709|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101525555|NCT04661709|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101525556|NCT04661709|Purinergic Agents|purinergic agents|mesh-ancestor
101525557|NCT04661709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101525558|NCT04661709|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101525559|NCT04661709|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101525560|NCT04661709|Sympatholytics|sympatholytics|mesh-ancestor
101525561|NCT04661709|Autonomic Agents|autonomic agents|mesh-ancestor
101525562|NCT04661709|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101525563|NCT04661709|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101525564|NCT04661709|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101525565|NCT04661709|Adrenergic Agents|adrenergic agents|mesh-ancestor
101525566|NCT04661709|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101525568|NCT04661709|Natriuretic Agents|natriuretic agents|mesh-ancestor
101525569|NCT04661709|Vasodilator Agents|vasodilator agents|mesh-ancestor
101525570|NCT04661709|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101525571|NCT02466867|Naftifine|naftifine|mesh-list
101525572|NCT02466867|Antifungal Agents|antifungal agents|mesh-ancestor
101525573|NCT02466867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101525574|NCT00538265|Mycophenolic Acid|mycophenolic acid|mesh-list
101525575|NCT00538265|Tacrolimus|tacrolimus|mesh-list
101525576|NCT00538265|Thymoglobulin|thymoglobulin|mesh-list
101525577|NCT00538265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101525578|NCT00538265|Immunologic Factors|immunologic factors|mesh-ancestor
101525580|NCT00538265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101525582|NCT00538265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525583|NCT00538265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101525584|NCT00538265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525585|NCT00538265|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101525586|NCT00538265|Antitubercular Agents|antitubercular agents|mesh-ancestor
101525587|NCT00538265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101525588|NCT00538265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101525589|NCT02462811|Acetaminophen|acetaminophen|mesh-list
101525590|NCT02462811|Promethazine|promethazine|mesh-list
101525591|NCT02462811|Diphenhydramine|diphenhydramine|mesh-list
101525592|NCT02462811|Hydrocodone|hydrocodone|mesh-list
101525593|NCT02462811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101525594|NCT02462811|Analgesics|analgesics|mesh-ancestor
101525595|NCT02462811|Sensory System Agents|sensory system agents|mesh-ancestor
101525596|NCT02462811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101525597|NCT02462811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525598|NCT02462811|Antipyretics|antipyretics|mesh-ancestor
101525599|NCT02462811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101525600|NCT02462811|Narcotics|narcotics|mesh-ancestor
101525601|NCT02462811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101525602|NCT02462811|Antitussive Agents|antitussive agents|mesh-ancestor
101525603|NCT02462811|Respiratory System Agents|respiratory system agents|mesh-ancestor
101525604|NCT02462811|Antipruritics|antipruritics|mesh-ancestor
101525605|NCT02462811|Dermatologic Agents|dermatologic agents|mesh-ancestor
101525606|NCT02462811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101525607|NCT02462811|Histamine Antagonists|histamine antagonists|mesh-ancestor
101525608|NCT02462811|Histamine Agents|histamine agents|mesh-ancestor
101525609|NCT02462811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101525610|NCT02462811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525611|NCT02462811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101525612|NCT02462811|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101525613|NCT02462811|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101525614|NCT02462811|Anesthetics, Local|anesthetics, local|mesh-ancestor
101330313|NCT00030004|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101525616|NCT02462811|Antiemetics|antiemetics|mesh-ancestor
101525617|NCT02462811|Autonomic Agents|autonomic agents|mesh-ancestor
101525618|NCT02462811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101525619|NCT00538382|Artesunate|artesunate|mesh-list
101525620|NCT00538382|Antimalarials|antimalarials|mesh-ancestor
101525621|NCT00538382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101525622|NCT00538382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101525623|NCT00538382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101525624|NCT00538382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525625|NCT00538382|Antiviral Agents|antiviral agents|mesh-ancestor
101525626|NCT00538382|Schistosomicides|schistosomicides|mesh-ancestor
101525627|NCT00538382|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101525628|NCT00538382|Anthelmintics|anthelmintics|mesh-ancestor
101525630|NCT00538421|Sevoflurane|sevoflurane|mesh-list
101525631|NCT00538421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101525632|NCT00538421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101525633|NCT00538421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525634|NCT00538421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101525635|NCT00538421|Anesthetics, General|anesthetics, general|mesh-ancestor
101525636|NCT00538421|Anesthetics|anesthetics|mesh-ancestor
101525637|NCT00538421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101525638|NCT00538421|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101330346|NCT00000518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101525639|NCT04661475|Dexmedetomidine|dexmedetomidine|mesh-list
101525640|NCT04661475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101525641|NCT04661475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101525642|NCT04661475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525643|NCT04661475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101525644|NCT04661475|Analgesics|analgesics|mesh-ancestor
101525645|NCT04661475|Sensory System Agents|sensory system agents|mesh-ancestor
101525646|NCT04661475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101525647|NCT04661475|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101525648|NCT04661475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101525649|NCT04661475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101525650|NCT04661475|Adrenergic Agents|adrenergic agents|mesh-ancestor
101525651|NCT04661475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101525652|NCT04661475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525653|NCT00538499|Fentanyl|fentanyl|mesh-list
101525654|NCT00538499|Bupivacaine|bupivacaine|mesh-list
101525655|NCT00538499|Anesthetics, Local|anesthetics, local|mesh-ancestor
101525656|NCT00538499|Anesthetics|anesthetics|mesh-ancestor
101525657|NCT00538499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101525658|NCT00538499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525659|NCT00538499|Sensory System Agents|sensory system agents|mesh-ancestor
101525660|NCT00538499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101525661|NCT00538499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101525662|NCT00538499|Narcotics|narcotics|mesh-ancestor
101525663|NCT00538499|Analgesics|analgesics|mesh-ancestor
101525664|NCT00538499|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101525665|NCT00538499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101525666|NCT00538499|Anesthetics, General|anesthetics, general|mesh-ancestor
101525667|NCT00538538|Ranibizumab|ranibizumab|mesh-list
101525668|NCT00538538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101525669|NCT00538538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101525670|NCT00538538|Growth Substances|growth substances|mesh-ancestor
101525671|NCT00538538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525672|NCT00538538|Growth Inhibitors|growth inhibitors|mesh-ancestor
101525673|NCT00538538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525674|NCT00554346|Etoricoxib|etoricoxib|mesh-list
101525675|NCT00554346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101525676|NCT00554346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101525677|NCT00554346|Analgesics|analgesics|mesh-ancestor
101525678|NCT00554346|Sensory System Agents|sensory system agents|mesh-ancestor
101525679|NCT00554346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101525680|NCT00554346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525681|NCT00554346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101525682|NCT00554346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101525683|NCT00554346|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101525684|NCT00554346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101525685|NCT00554346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101525686|NCT00554346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525687|NCT00538655|Modafinil|modafinil|mesh-list
101525688|NCT00538655|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101525689|NCT00538655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525690|NCT00538655|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101525691|NCT00538655|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101525692|NCT00538655|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101330516|NCT00031018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525693|NCT00538655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525695|NCT00538694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101525696|NCT00538694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101525697|NCT02436096|Cyclobenzaprine|cyclobenzaprine|mesh-list
101525698|NCT02436096|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101525699|NCT02436096|Antidepressive Agents|antidepressive agents|mesh-ancestor
101525700|NCT02436096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101525701|NCT02436096|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101525702|NCT02436096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525703|NCT02436096|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101525704|NCT02436096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101525705|NCT02436096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101525707|NCT00538811|Interferons|interferons|mesh-list
101525708|NCT00538811|Ribavirin|ribavirin|mesh-list
101525709|NCT00538811|Interferon-alpha|interferon-alpha|mesh-list
101525710|NCT00538811|Interferon alpha-2|interferon alpha-2|mesh-list
101525711|NCT00538811|Interferon-gamma|interferon-gamma|mesh-list
101525713|NCT00538811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525714|NCT00538811|Antiviral Agents|antiviral agents|mesh-ancestor
101525715|NCT00538811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101525716|NCT00538811|Antimetabolites|antimetabolites|mesh-ancestor
101525717|NCT00538811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525718|NCT00538811|Immunologic Factors|immunologic factors|mesh-ancestor
101525719|NCT00538811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525720|NCT00538811|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101525721|NCT00538811|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101525723|NCT00538811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101525724|NCT00538811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101525725|NCT00538811|Analgesics|analgesics|mesh-ancestor
101525726|NCT00538811|Sensory System Agents|sensory system agents|mesh-ancestor
101525727|NCT00538811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101525728|NCT04660773|Pregabalin|pregabalin|mesh-list
101525729|NCT04660773|Analgesics|analgesics|mesh-ancestor
101525730|NCT04660773|Sensory System Agents|sensory system agents|mesh-ancestor
101525731|NCT04660773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101525732|NCT04660773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525733|NCT04660773|Anticonvulsants|anticonvulsants|mesh-ancestor
101525734|NCT04660773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101525735|NCT04660773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101525736|NCT04660773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525737|NCT04660773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101525738|NCT04660773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101525739|NCT04660773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101525740|NCT04660773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101525741|NCT04660773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101525742|NCT00538889|Citalopram|citalopram|mesh-list
101525743|NCT00538889|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101525744|NCT00538889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101525745|NCT00538889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101525746|NCT00538889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525747|NCT00538889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101525748|NCT00538889|Serotonin Agents|serotonin agents|mesh-ancestor
101525749|NCT00538889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525750|NCT00538889|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101525751|NCT00538889|Antidepressive Agents|antidepressive agents|mesh-ancestor
101525752|NCT00538889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101525753|NCT02413827|Ipilimumab|ipilimumab|mesh-list
101525754|NCT02413827|Poly ICLC|poly iclc|mesh-list
101525755|NCT02413827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101525756|NCT02413827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101525757|NCT02413827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525758|NCT02413827|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101525759|NCT02413827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525760|NCT02413827|Interferon Inducers|interferon inducers|mesh-ancestor
101525761|NCT02413827|Immunologic Factors|immunologic factors|mesh-ancestor
101525762|NCT02413827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525763|NCT00538967|Doxycycline|doxycycline|mesh-list
101525764|NCT00538967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101525765|NCT00538967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101525766|NCT00538967|Antimalarials|antimalarials|mesh-ancestor
101525767|NCT00538967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101525768|NCT00538967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101525769|NCT00539123|Buprenorphine|buprenorphine|mesh-list
101525770|NCT00539123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101525771|NCT00539123|Narcotics|narcotics|mesh-ancestor
101525772|NCT00539123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101525773|NCT00539123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525774|NCT00539123|Analgesics|analgesics|mesh-ancestor
101525775|NCT00539123|Sensory System Agents|sensory system agents|mesh-ancestor
101525776|NCT00539123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101525777|NCT00539123|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101525778|NCT02382510|Tiotropium Bromide|tiotropium bromide|mesh-list
101525779|NCT02382510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101525780|NCT02382510|Autonomic Agents|autonomic agents|mesh-ancestor
101525781|NCT02382510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101330728|NCT00000575|Glucocorticoids|glucocorticoids|mesh-ancestor
101525782|NCT02382510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525783|NCT02382510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101525784|NCT02382510|Respiratory System Agents|respiratory system agents|mesh-ancestor
101525785|NCT02382510|Parasympatholytics|parasympatholytics|mesh-ancestor
101525786|NCT02382510|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101525787|NCT02382510|Cholinergic Agents|cholinergic agents|mesh-ancestor
101525788|NCT02382510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101525789|NCT02382510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525791|NCT00539396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101319885|NCT02250937|Antimetabolites|antimetabolites|mesh-ancestor
101525792|NCT00539396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525793|NCT00539435|Insulin|insulin|mesh-list
101525794|NCT00539435|Insulin Aspart|insulin aspart|mesh-list
101525795|NCT00539435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101525796|NCT00539435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525797|NCT00539630|Docetaxel|docetaxel|mesh-list
101525798|NCT00539630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525799|NCT00539630|Tubulin Modulators|tubulin modulators|mesh-ancestor
101525800|NCT00539630|Antimitotic Agents|antimitotic agents|mesh-ancestor
101525801|NCT00539630|Mitosis Modulators|mitosis modulators|mesh-ancestor
101525802|NCT00539630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525803|NCT04660461|Lansoprazole|lansoprazole|mesh-list
101525804|NCT04660461|Dexlansoprazole|dexlansoprazole|mesh-list
101525805|NCT04660461|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101525806|NCT04660461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101525807|NCT04660461|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101525808|NCT04660461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101525809|NCT04660461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525810|NCT00539669|Docetaxel|docetaxel|mesh-list
101525811|NCT00539669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525812|NCT00539669|Tubulin Modulators|tubulin modulators|mesh-ancestor
101525813|NCT00539669|Antimitotic Agents|antimitotic agents|mesh-ancestor
101525814|NCT00539669|Mitosis Modulators|mitosis modulators|mesh-ancestor
101525815|NCT00539669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525816|NCT00554424|Lidocaine|lidocaine|mesh-list
101525817|NCT00554424|Anesthetics, Local|anesthetics, local|mesh-ancestor
101525818|NCT00554424|Anesthetics|anesthetics|mesh-ancestor
101525819|NCT00554424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101525820|NCT00554424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525821|NCT00554424|Sensory System Agents|sensory system agents|mesh-ancestor
101525822|NCT00554424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101525823|NCT00554424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101536187|NCT04604678|Metformin|metformin|mesh-list
101525824|NCT00554424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101525825|NCT00554424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101525826|NCT00554424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101330784|NCT00032188|Sensory System Agents|sensory system agents|mesh-ancestor
101525827|NCT00554424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525828|NCT04660305|Insulin Aspart|insulin aspart|mesh-list
101525829|NCT04660305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101525830|NCT04660305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525831|NCT00554502|Immunosuppressive Agents|immunosuppressive agents|mesh-list
101525832|NCT00554502|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101525833|NCT00554502|Immunologic Factors|immunologic factors|mesh-ancestor
101525834|NCT00554502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525835|NCT00554502|Protease Inhibitors|protease inhibitors|mesh-ancestor
101525836|NCT00554502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101525837|NCT00554502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525838|NCT00539786|Rabeprazole|rabeprazole|mesh-list
101525839|NCT00539786|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101525840|NCT00539786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101525841|NCT00539786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101525842|NCT00539786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101525843|NCT00539786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525844|NCT00540098|Paroxetine|paroxetine|mesh-list
101525845|NCT00540098|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101525846|NCT00540098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101525847|NCT00540098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101525848|NCT00540098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525849|NCT00540098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101525850|NCT00540098|Serotonin Agents|serotonin agents|mesh-ancestor
101525851|NCT00540098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525852|NCT00540098|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101525853|NCT00540098|Antidepressive Agents|antidepressive agents|mesh-ancestor
101525854|NCT00540098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101525855|NCT00540098|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101525856|NCT00540098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101525857|NCT00540098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101525858|NCT00540137|Ritonavir|ritonavir|mesh-list
101525859|NCT00540137|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101525860|NCT00540137|Nevirapine|nevirapine|mesh-list
101525861|NCT00540137|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101525862|NCT00540137|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101525863|NCT00540137|Protease Inhibitors|protease inhibitors|mesh-ancestor
101525864|NCT00540137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101525865|NCT00540137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525867|NCT00540137|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101525868|NCT00540137|Antiviral Agents|antiviral agents|mesh-ancestor
101525869|NCT00540137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101330869|NCT00032890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101330872|NCT00032929|Selegiline|selegiline|mesh-list
101525870|NCT00540137|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101525871|NCT00540137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101525872|NCT00540137|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101525873|NCT00540137|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101525874|NCT00540137|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101525875|NCT00540137|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101525877|NCT04660110|Artenimol|artenimol|mesh-list
101525878|NCT04660110|Antimalarials|antimalarials|mesh-ancestor
101525879|NCT04660110|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101525880|NCT04660110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101525881|NCT04660110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101525882|NCT02336685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101525883|NCT02336685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330883|NCT00000611|Vitamin D|vitamin d|mesh-list
101525884|NCT02336685|Immunologic Factors|immunologic factors|mesh-ancestor
101525885|NCT00540410|Artesunate|artesunate|mesh-list
101525886|NCT00540410|Lumefantrine|lumefantrine|mesh-list
101525887|NCT00540410|Amodiaquine|amodiaquine|mesh-list
101525888|NCT00540410|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101525889|NCT00540410|Antimalarials|antimalarials|mesh-ancestor
101525890|NCT00540410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101525891|NCT00540410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101525892|NCT00540410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101525893|NCT00540410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525895|NCT00540410|Schistosomicides|schistosomicides|mesh-ancestor
101525896|NCT00540410|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101525897|NCT00540410|Anthelmintics|anthelmintics|mesh-ancestor
101525898|NCT00540527|Plasminogen|plasminogen|mesh-list
101334662|NCT00045370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101335048|NCT00046852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525899|NCT00540527|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101335049|NCT00046852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101335050|NCT00046852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101335051|NCT00046852|Alkylating Agents|alkylating agents|mesh-ancestor
101525900|NCT00540527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101330884|NCT00000611|Calcium|calcium|mesh-list
101525901|NCT00540527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101525902|NCT00540527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525904|NCT00540605|Antiviral Agents|antiviral agents|mesh-ancestor
101525905|NCT00540605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101525906|NCT00540605|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101525907|NCT00540605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101525908|NCT00540605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101525909|NCT00540605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525910|NCT00540605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101525911|NCT00540605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101525912|NCT04659915|Metformin|metformin|mesh-list
101525913|NCT04659915|Prednisone|prednisone|mesh-list
101525914|NCT04659915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101525915|NCT04659915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525916|NCT04659915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101525917|NCT04659915|Glucocorticoids|glucocorticoids|mesh-ancestor
101525918|NCT04659915|Hormones|hormones|mesh-ancestor
101525919|NCT04659915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101525920|NCT04659915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101525921|NCT04659915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525922|NCT00557427|Fluoxetine|fluoxetine|mesh-list
101319895|NCT02122081|Tacrolimus|tacrolimus|mesh-list
101525923|NCT00557427|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101525924|NCT00557427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101525925|NCT00557427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101525926|NCT00557427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525927|NCT00557427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101525928|NCT00557427|Serotonin Agents|serotonin agents|mesh-ancestor
101525929|NCT00557427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525930|NCT00557427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101525931|NCT00557427|Antidepressive Agents|antidepressive agents|mesh-ancestor
101525932|NCT00557427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101525933|NCT00557427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101525934|NCT00557427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101525935|NCT00557427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101525937|NCT00540800|Capecitabine|capecitabine|mesh-list
101525938|NCT00540800|Epirubicin|epirubicin|mesh-list
101335960|NCT00053326|Fenretinide|fenretinide|mesh-list
101335969|NCT00053599|Simvastatin|simvastatin|mesh-list
101525940|NCT00540800|Tubulin Modulators|tubulin modulators|mesh-ancestor
101525941|NCT00540800|Antimitotic Agents|antimitotic agents|mesh-ancestor
101525942|NCT00540800|Mitosis Modulators|mitosis modulators|mesh-ancestor
101525943|NCT00540800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525944|NCT00540800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101525945|NCT00540800|Antimetabolites|antimetabolites|mesh-ancestor
101525946|NCT00540800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101525947|NCT00540800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101525949|NCT00540800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101525950|NCT00540956|Cytarabine|cytarabine|mesh-list
101525951|NCT00540956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101525952|NCT00540956|Antimetabolites|antimetabolites|mesh-ancestor
101525953|NCT00540956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525954|NCT00540956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525955|NCT00540956|Antiviral Agents|antiviral agents|mesh-ancestor
101525956|NCT00540956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101525957|NCT00540956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101525958|NCT00540956|Immunologic Factors|immunologic factors|mesh-ancestor
101525959|NCT00540956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525960|NCT00541073|Vitamin B 12|vitamin b 12|mesh-list
101525961|NCT00541073|Hydroxocobalamin|hydroxocobalamin|mesh-list
101525962|NCT00541073|Pemetrexed|pemetrexed|mesh-list
101525963|NCT00541073|Vitamins|vitamins|mesh-ancestor
101525964|NCT00541073|Micronutrients|micronutrients|mesh-ancestor
101525965|NCT00541073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525966|NCT00541073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525967|NCT00541073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101525968|NCT00541073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525969|NCT00541073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101525970|NCT00541073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101525971|NCT00541073|Vitamin B Complex|vitamin b complex|mesh-ancestor
101525972|NCT00541073|Hematinics|hematinics|mesh-ancestor
101525973|NCT00541112|Leucovorin|leucovorin|mesh-list
101525974|NCT00541112|Fluorouracil|fluorouracil|mesh-list
101336109|NCT00054418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101525975|NCT00541112|Capecitabine|capecitabine|mesh-list
101525976|NCT00541112|Oxaliplatin|oxaliplatin|mesh-list
101525977|NCT00541112|Cetuximab|cetuximab|mesh-list
101525978|NCT00541112|Calcium|calcium|mesh-list
101525979|NCT00541112|Levoleucovorin|levoleucovorin|mesh-list
101525980|NCT00541112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101525981|NCT00541112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101525982|NCT00541112|Antimetabolites|antimetabolites|mesh-ancestor
101525983|NCT00541112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101525984|NCT00541112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101525985|NCT00541112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101525986|NCT00541112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101525987|NCT00541112|Immunologic Factors|immunologic factors|mesh-ancestor
101525988|NCT00541112|Antidotes|antidotes|mesh-ancestor
101525989|NCT00541112|Protective Agents|protective agents|mesh-ancestor
101525990|NCT00541112|Vitamin B Complex|vitamin b complex|mesh-ancestor
101525991|NCT00541112|Vitamins|vitamins|mesh-ancestor
101525992|NCT00541112|Micronutrients|micronutrients|mesh-ancestor
101525993|NCT00541112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101525995|NCT04659525|Evolocumab|evolocumab|mesh-list
101525996|NCT04659525|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101525997|NCT04659525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101525998|NCT04659525|Antimetabolites|antimetabolites|mesh-ancestor
101525999|NCT04659525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526000|NCT04659525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101526001|NCT04659525|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101526002|NCT04659525|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101526004|NCT04659525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101526005|NCT02333643|Digoxin|digoxin|mesh-list
101526006|NCT02333643|Furosemide|furosemide|mesh-list
101526007|NCT02333643|Diuretics|diuretics|mesh-ancestor
101526008|NCT02333643|Natriuretic Agents|natriuretic agents|mesh-ancestor
101526009|NCT02333643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526010|NCT02333643|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101526011|NCT02333643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101526012|NCT02333643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526013|NCT02333643|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101336201|NCT00398281|Hormone Antagonists|hormone antagonists|mesh-ancestor
101526014|NCT02333643|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101526015|NCT02333643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101526016|NCT02333643|Protective Agents|protective agents|mesh-ancestor
101526017|NCT00541463|Nelfinavir|nelfinavir|mesh-list
101526018|NCT00541463|Indinavir|indinavir|mesh-list
101526019|NCT00541463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526020|NCT00541463|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101526021|NCT00541463|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101526022|NCT00541463|Protease Inhibitors|protease inhibitors|mesh-ancestor
101526023|NCT00541463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101526024|NCT00541463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101526025|NCT00541463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101526026|NCT00541463|Antiviral Agents|antiviral agents|mesh-ancestor
101526027|NCT00541463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101526028|NCT02324985|Ibuprofen|ibuprofen|mesh-list
101526029|NCT02324985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101526030|NCT02324985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101526031|NCT02324985|Analgesics|analgesics|mesh-ancestor
101526032|NCT02324985|Sensory System Agents|sensory system agents|mesh-ancestor
101526033|NCT02324985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101526034|NCT02324985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526035|NCT02324985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101526036|NCT02324985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101526037|NCT02324985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101526038|NCT02324985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101526039|NCT02324985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526040|NCT04659642|Fentanyl|fentanyl|mesh-list
101526041|NCT04659642|Dexmedetomidine|dexmedetomidine|mesh-list
101526042|NCT04659642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101526043|NCT04659642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101526044|NCT04659642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336257|NCT00055393|Bupropion|bupropion|mesh-list
101526045|NCT04659642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101526046|NCT04659642|Analgesics|analgesics|mesh-ancestor
101526047|NCT04659642|Sensory System Agents|sensory system agents|mesh-ancestor
101526048|NCT04659642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101526049|NCT04659642|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101526050|NCT04659642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101526051|NCT04659642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101526052|NCT04659642|Adrenergic Agents|adrenergic agents|mesh-ancestor
101526053|NCT04659642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101526054|NCT04659642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526055|NCT04659642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101526056|NCT04659642|Narcotics|narcotics|mesh-ancestor
101526057|NCT04659642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101526058|NCT04659642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101526059|NCT04659642|Anesthetics, General|anesthetics, general|mesh-ancestor
101526060|NCT04659642|Anesthetics|anesthetics|mesh-ancestor
101526061|NCT00541736|Nitroglycerin|nitroglycerin|mesh-list
101336309|NCT00055822|Leucovorin|leucovorin|mesh-list
101526063|NCT00541814|Cyclosporine|cyclosporine|mesh-list
101526064|NCT00541814|Cyclosporins|cyclosporins|mesh-list
101526065|NCT00541814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101526066|NCT00541814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526067|NCT00541814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101526068|NCT00541814|Immunologic Factors|immunologic factors|mesh-ancestor
101526069|NCT00541814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526070|NCT00541814|Antifungal Agents|antifungal agents|mesh-ancestor
101336381|NCT00056056|Bexarotene|bexarotene|mesh-list
101526071|NCT00541814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101336382|NCT00056056|Methoxsalen|methoxsalen|mesh-list
101526072|NCT00541814|Dermatologic Agents|dermatologic agents|mesh-ancestor
101526073|NCT00541814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101526074|NCT00541814|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101526076|NCT00541853|Candesartan cilexetil|candesartan cilexetil|mesh-list
101526078|NCT00541853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101526079|NCT00541853|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101526080|NCT00541853|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101526081|NCT00541853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526082|NCT00541853|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101526083|NCT00541853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101526084|NCT00541853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101526085|NCT00541853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526086|NCT02301234|Celecoxib|celecoxib|mesh-list
101526087|NCT02301234|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101526088|NCT02301234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101526089|NCT02301234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101526090|NCT02301234|Analgesics|analgesics|mesh-ancestor
101526091|NCT02301234|Sensory System Agents|sensory system agents|mesh-ancestor
101526092|NCT02301234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101526093|NCT02301234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526094|NCT02301234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101526095|NCT02301234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101526096|NCT02301234|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101526097|NCT02301234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101526098|NCT02301234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101526099|NCT02301234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330926|NCT00033163|Adefovir|adefovir|mesh-list
101526101|NCT02300142|Vaccines|vaccines|mesh-list
101526102|NCT02300142|Immunologic Factors|immunologic factors|mesh-ancestor
101526103|NCT02300142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526104|NCT01214668|Doxorubicin|doxorubicin|mesh-list
101526105|NCT01214668|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101526106|NCT01214668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101526107|NCT01214668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526108|NCT01214668|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101526109|NCT01214668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101526110|NCT01214668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101526111|NCT01214668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526112|NCT00542126|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101526113|NCT00542126|Luteolytic Agents|luteolytic agents|mesh-ancestor
101526114|NCT00542126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101526115|NCT00542126|Contraceptive Agents|contraceptive agents|mesh-ancestor
101526116|NCT00542126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101526117|NCT00542126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526118|NCT00542126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101526119|NCT00542126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101526120|NCT00542126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526121|NCT00542165|Alfuzosin|alfuzosin|mesh-list
101526122|NCT00542165|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101336572|NCT02969746|Antidotes|antidotes|mesh-ancestor
101526123|NCT00542165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101336575|NCT00057850|Cisplatin|cisplatin|mesh-list
101526124|NCT00542165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101526125|NCT00542165|Adrenergic Agents|adrenergic agents|mesh-ancestor
101526126|NCT00542165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101526127|NCT00542165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526129|NCT00542165|Urological Agents|urological agents|mesh-ancestor
101526130|NCT00542243|Finasteride|finasteride|mesh-list
101526131|NCT00542243|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101526132|NCT00542243|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101526133|NCT00542243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101526134|NCT00542243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526135|NCT00542243|Hormone Antagonists|hormone antagonists|mesh-ancestor
101526136|NCT00542243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101526137|NCT00542243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526138|NCT00542243|Urological Agents|urological agents|mesh-ancestor
101526139|NCT00542399|Insulin Detemir|insulin detemir|mesh-list
101526140|NCT00542399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101526141|NCT00542399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526143|NCT00542555|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
101526144|NCT00542555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101526145|NCT00542555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101336634|NCT00058084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526146|NCT00542555|Analgesics|analgesics|mesh-ancestor
101526147|NCT00542555|Sensory System Agents|sensory system agents|mesh-ancestor
101526148|NCT00542555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101526149|NCT00542555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526150|NCT00542555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101526151|NCT00542555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101526152|NCT00542555|Gout Suppressants|gout suppressants|mesh-ancestor
101526153|NCT00542555|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101526154|NCT00542555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101526155|NCT00542555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526156|NCT00542555|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101526158|NCT00542711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101526159|NCT00542711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101526160|NCT00542711|Analgesics|analgesics|mesh-ancestor
101526161|NCT00542711|Sensory System Agents|sensory system agents|mesh-ancestor
101526162|NCT00542711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101526163|NCT00542711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526164|NCT00542711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101526165|NCT00542711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101526166|NCT00542711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526167|NCT00542711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101526168|NCT00542711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526169|NCT00542984|Teriparatide|teriparatide|mesh-list
101526170|NCT00542984|Calcitonin|calcitonin|mesh-list
101526171|NCT00542984|Salmon calcitonin|salmon calcitonin|mesh-list
101319950|NCT00393328|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101526172|NCT00542984|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
101526173|NCT00542984|Katacalcin|katacalcin|mesh-list
101526174|NCT00542984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101526175|NCT00542984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526176|NCT00542984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101526177|NCT00542984|Vasodilator Agents|vasodilator agents|mesh-ancestor
101526178|NCT02257983|Ubiquinone|ubiquinone|mesh-list
101526179|NCT02257983|Micronutrients|micronutrients|mesh-ancestor
101526183|NCT00543023|Salmon calcitonin|salmon calcitonin|mesh-list
101526184|NCT00543023|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
101526185|NCT00543023|Katacalcin|katacalcin|mesh-list
101336695|NCT00058435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101526186|NCT00543023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101526187|NCT00543023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526188|NCT00543023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101526189|NCT00543023|Vasodilator Agents|vasodilator agents|mesh-ancestor
101526190|NCT04648917|Caffeic acid|caffeic acid|mesh-list
101526191|NCT04648917|Antioxidants|antioxidants|mesh-ancestor
101526192|NCT04648917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526193|NCT04648917|Protective Agents|protective agents|mesh-ancestor
101526194|NCT04648917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526195|NCT00543179|Lanreotide|lanreotide|mesh-list
101526196|NCT00543179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526197|NCT00543218|Teriparatide|teriparatide|mesh-list
101526198|NCT00543218|Calcitonin|calcitonin|mesh-list
101526199|NCT00543218|Salmon calcitonin|salmon calcitonin|mesh-list
101526200|NCT00543218|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
101526201|NCT00543218|Katacalcin|katacalcin|mesh-list
101526202|NCT00543218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101526203|NCT00543218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526204|NCT00543218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101526205|NCT00543218|Vasodilator Agents|vasodilator agents|mesh-ancestor
101526206|NCT02252835|Colchicine|colchicine|mesh-list
101526207|NCT02252835|Febuxostat|febuxostat|mesh-list
101526208|NCT02252835|Gout Suppressants|gout suppressants|mesh-ancestor
101526209|NCT02252835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101526210|NCT02252835|Tubulin Modulators|tubulin modulators|mesh-ancestor
101526211|NCT02252835|Antimitotic Agents|antimitotic agents|mesh-ancestor
101526212|NCT02252835|Mitosis Modulators|mitosis modulators|mesh-ancestor
101526213|NCT02252835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526214|NCT02252835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526216|NCT03456752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101526218|NCT03456752|Autonomic Agents|autonomic agents|mesh-ancestor
101526219|NCT03456752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101526220|NCT03456752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526221|NCT03456752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101526222|NCT03456752|Glucocorticoids|glucocorticoids|mesh-ancestor
101526223|NCT03456752|Hormones|hormones|mesh-ancestor
101526224|NCT03456752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101526225|NCT03456752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101526226|NCT03456752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526227|NCT03456713|Mirikizumab|mirikizumab|mesh-list
101526228|NCT03456713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101526229|NCT03456713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101526230|NCT03456713|Analgesics|analgesics|mesh-ancestor
101526231|NCT03456713|Sensory System Agents|sensory system agents|mesh-ancestor
101526232|NCT03456713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101526233|NCT03456713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526234|NCT03456713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101526235|NCT03456713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101526236|NCT03456713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101526238|NCT04648137|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
101526239|NCT04648137|Hallucinogens|hallucinogens|mesh-ancestor
101526240|NCT04648137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526241|NCT04648137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101526242|NCT04648137|Serotonin Agents|serotonin agents|mesh-ancestor
101526243|NCT04648137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101526244|NCT04648137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526245|NCT04648137|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101526246|NCT04648137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101526247|NCT04648137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101526248|NCT04648137|Adrenergic Agents|adrenergic agents|mesh-ancestor
101526249|NCT04648332|Bupivacaine|bupivacaine|mesh-list
101526250|NCT04648332|Anesthetics, Local|anesthetics, local|mesh-ancestor
101526251|NCT04648332|Anesthetics|anesthetics|mesh-ancestor
101526252|NCT04648332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101526253|NCT04648332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526254|NCT04648332|Sensory System Agents|sensory system agents|mesh-ancestor
101526255|NCT04648332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101526256|NCT00543335|Sorafenib|sorafenib|mesh-list
101526257|NCT00543335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526258|NCT00543335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101526259|NCT00543335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101526260|NCT00543335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526261|NCT00543413|Enalapril|enalapril|mesh-list
101526262|NCT00543413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101526263|NCT00543413|Protease Inhibitors|protease inhibitors|mesh-ancestor
101526264|NCT00543413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101526265|NCT00543413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526266|NCT00543413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101526267|NCT00554658|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101526268|NCT00554658|Antidepressive Agents|antidepressive agents|mesh-ancestor
101526269|NCT00554658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101526270|NCT00554658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101526271|NCT00554658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101526272|NCT00554658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101526273|NCT00554658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526274|NCT00543608|Vancomycin|vancomycin|mesh-list
101526275|NCT00543608|Iclaprim|iclaprim|mesh-list
101526276|NCT00543608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101526277|NCT00543608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101526278|NCT00543608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101526279|NCT00543608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101336855|NCT02968927|Vitamins|vitamins|mesh-ancestor
101336856|NCT02968927|Micronutrients|micronutrients|mesh-ancestor
101526280|NCT00543608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526281|NCT00554775|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101526282|NCT00554775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526283|NCT00554775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101526284|NCT00554775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101526285|NCT00554775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526286|NCT00543647|Fenofibrate|fenofibrate|mesh-list
101526287|NCT00543647|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101526288|NCT00543647|Antimetabolites|antimetabolites|mesh-ancestor
101526289|NCT00543647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526290|NCT00543647|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101526291|NCT04647669|Interferons|interferons|mesh-list
101526292|NCT04647669|Interferon-beta|interferon-beta|mesh-list
101526293|NCT04647669|Interferon beta-1a|interferon beta-1a|mesh-list
101526294|NCT04647669|Remdesivir|remdesivir|mesh-list
101526295|NCT04647669|Acalabrutinib|acalabrutinib|mesh-list
101526296|NCT04647669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526297|NCT04647669|Antiviral Agents|antiviral agents|mesh-ancestor
101526298|NCT04647669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101526299|NCT04647669|Immunologic Factors|immunologic factors|mesh-ancestor
101526300|NCT04647669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526301|NCT04647669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101526302|NCT04647669|Antimetabolites|antimetabolites|mesh-ancestor
101526303|NCT04647669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526304|NCT00543686|Fluticasone|fluticasone|mesh-list
101526305|NCT00543686|Montelukast|montelukast|mesh-list
101526306|NCT00543686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101526307|NCT00543686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101526308|NCT00543686|Autonomic Agents|autonomic agents|mesh-ancestor
101526309|NCT00543686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101526310|NCT00543686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526311|NCT00543686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101526312|NCT00543686|Respiratory System Agents|respiratory system agents|mesh-ancestor
101526314|NCT00543686|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101526315|NCT00543686|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101526316|NCT00543686|Hormone Antagonists|hormone antagonists|mesh-ancestor
101526317|NCT00543686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101526318|NCT00543686|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101526319|NCT00543686|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101526320|NCT00543686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526321|NCT00543842|Bevacizumab|bevacizumab|mesh-list
101526322|NCT00543842|Capecitabine|capecitabine|mesh-list
101526323|NCT00543842|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101526324|NCT00543842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101526325|NCT00543842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526326|NCT00543842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101526327|NCT00543842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101526328|NCT00543842|Growth Substances|growth substances|mesh-ancestor
101526329|NCT00543842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526330|NCT00543842|Growth Inhibitors|growth inhibitors|mesh-ancestor
101526332|NCT00543842|Antimetabolites|antimetabolites|mesh-ancestor
101526333|NCT00543842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526334|NCT00543842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101526335|NCT00543842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101526336|NCT04638816|Lidocaine|lidocaine|mesh-list
101526337|NCT04638816|Hyaluronic Acid|hyaluronic acid|mesh-list
101526338|NCT04638816|Anesthetics, Local|anesthetics, local|mesh-ancestor
101526339|NCT04638816|Anesthetics|anesthetics|mesh-ancestor
101337120|NCT00061789|Cholinergic Agents|cholinergic agents|mesh-ancestor
101526340|NCT04638816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101526341|NCT04638816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526342|NCT04638816|Sensory System Agents|sensory system agents|mesh-ancestor
101526343|NCT04638816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101526344|NCT04638816|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101526345|NCT04638816|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101526346|NCT04638816|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101526347|NCT04638816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101526348|NCT04638816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526349|NCT04638816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101526350|NCT04638816|Immunologic Factors|immunologic factors|mesh-ancestor
101526351|NCT04638816|Viscosupplements|viscosupplements|mesh-ancestor
101526352|NCT04638816|Protective Agents|protective agents|mesh-ancestor
101526353|NCT00543959|Pioglitazone|pioglitazone|mesh-list
101526354|NCT00543959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101526355|NCT00543959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526356|NCT00544037|Interferons|interferons|mesh-list
101526357|NCT00544037|Interferon-beta|interferon-beta|mesh-list
101526358|NCT00544037|Interferon beta-1b|interferon beta-1b|mesh-list
101526359|NCT00544037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526360|NCT00544037|Antiviral Agents|antiviral agents|mesh-ancestor
101526361|NCT00544037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101526362|NCT00544037|Immunologic Factors|immunologic factors|mesh-ancestor
101526363|NCT00544037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526364|NCT00544037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101526365|NCT00544154|Certolizumab Pegol|certolizumab pegol|mesh-list
101526366|NCT00544154|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101526367|NCT00544154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101526368|NCT00544154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101526369|NCT00544154|Immunologic Factors|immunologic factors|mesh-ancestor
101330967|NCT00000620|Benazepril|benazepril|mesh-list
101526370|NCT00544154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526371|NCT00544154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101526373|NCT04638582|Carboplatin|carboplatin|mesh-list
101526374|NCT04638582|Pembrolizumab|pembrolizumab|mesh-list
101526375|NCT04638582|Pemetrexed|pemetrexed|mesh-list
101526376|NCT04638582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101526377|NCT04638582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526378|NCT04638582|Tubulin Modulators|tubulin modulators|mesh-ancestor
101526379|NCT04638582|Antimitotic Agents|antimitotic agents|mesh-ancestor
101526380|NCT04638582|Mitosis Modulators|mitosis modulators|mesh-ancestor
101526381|NCT04638582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526382|NCT04638582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101526383|NCT04638582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101526384|NCT04638582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101526385|NCT04638582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101526386|NCT04638582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101526387|NCT00544193|Gemcitabine|gemcitabine|mesh-list
101526388|NCT00544193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101526389|NCT00544193|Antimetabolites|antimetabolites|mesh-ancestor
101526390|NCT00544193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526391|NCT00544193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526393|NCT00544232|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101526394|NCT00544232|Cyclophosphamide|cyclophosphamide|mesh-list
101526395|NCT00544232|Methotrexate|methotrexate|mesh-list
101526396|NCT00544232|Epirubicin|epirubicin|mesh-list
101526397|NCT00544232|Darbepoetin alfa|darbepoetin alfa|mesh-list
101526398|NCT00544232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101526399|NCT00544232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526400|NCT00544232|Tubulin Modulators|tubulin modulators|mesh-ancestor
101526401|NCT00544232|Antimitotic Agents|antimitotic agents|mesh-ancestor
101526402|NCT00544232|Mitosis Modulators|mitosis modulators|mesh-ancestor
101526403|NCT00544232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526404|NCT00544232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101526405|NCT00544232|Immunologic Factors|immunologic factors|mesh-ancestor
101526406|NCT00544232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337383|NCT00063583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337384|NCT00063583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101526407|NCT00544232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101526408|NCT00544232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101526409|NCT00544232|Alkylating Agents|alkylating agents|mesh-ancestor
101526410|NCT00544232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101526411|NCT00544232|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101526412|NCT00544232|Abortifacient Agents|abortifacient agents|mesh-ancestor
101526413|NCT00544232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101526414|NCT00544232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101526415|NCT00544232|Antimetabolites|antimetabolites|mesh-ancestor
101526416|NCT00544232|Dermatologic Agents|dermatologic agents|mesh-ancestor
101526417|NCT00544232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101526418|NCT00544232|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101526419|NCT00544232|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101526420|NCT00544232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101526421|NCT00544232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101526422|NCT00544232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101526423|NCT00544232|Hematinics|hematinics|mesh-ancestor
101526424|NCT01191268|Insulin|insulin|mesh-list
101526425|NCT01191268|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101526426|NCT01191268|Insulin Glargine|insulin glargine|mesh-list
101526427|NCT01191268|Insulin Lispro|insulin lispro|mesh-list
101526428|NCT01191268|Dulaglutide|dulaglutide|mesh-list
101526429|NCT01191268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101526430|NCT01191268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526431|NCT04647552|Hydrocortisone|hydrocortisone|mesh-list
101526432|NCT04647552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101526433|NCT00544349|Leucovorin|leucovorin|mesh-list
101526434|NCT00544349|Fluorouracil|fluorouracil|mesh-list
101526435|NCT00544349|Oxaliplatin|oxaliplatin|mesh-list
101526436|NCT00544349|Cetuximab|cetuximab|mesh-list
101526438|NCT00544349|Levoleucovorin|levoleucovorin|mesh-list
101526439|NCT00544349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101526440|NCT00544349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526441|NCT00544349|Antimetabolites|antimetabolites|mesh-ancestor
101526442|NCT00544349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526443|NCT00544349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101526444|NCT00544349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526445|NCT00544349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101526446|NCT00544349|Immunologic Factors|immunologic factors|mesh-ancestor
101526447|NCT00544349|Antidotes|antidotes|mesh-ancestor
101526448|NCT00544349|Protective Agents|protective agents|mesh-ancestor
101526449|NCT00544349|Vitamin B Complex|vitamin b complex|mesh-ancestor
101526452|NCT00544349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101526453|NCT01191190|Ofatumumab|ofatumumab|mesh-list
101526454|NCT01191190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526455|NCT00544388|Levocetirizine|levocetirizine|mesh-list
101526456|NCT00544388|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101526457|NCT00544388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101526458|NCT00544388|Histamine Antagonists|histamine antagonists|mesh-ancestor
101526459|NCT00544388|Histamine Agents|histamine agents|mesh-ancestor
101526460|NCT00544388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101526461|NCT00544388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526462|NCT00544388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526463|NCT00544505|Cyclophosphamide|cyclophosphamide|mesh-list
101526464|NCT00544505|Fluorouracil|fluorouracil|mesh-list
101526465|NCT00544505|Epirubicin|epirubicin|mesh-list
101526466|NCT00544505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101526467|NCT00544505|Immunologic Factors|immunologic factors|mesh-ancestor
101526468|NCT00544505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526469|NCT00544505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101526470|NCT00544505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101337758|NCT04235673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526471|NCT00544505|Alkylating Agents|alkylating agents|mesh-ancestor
101411330|NCT00115544|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
101526472|NCT00544505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526473|NCT00544505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526474|NCT00544505|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101526476|NCT00544505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101526477|NCT00544505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101526478|NCT00544505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101526479|NCT00544505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101526480|NCT00544505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101526482|NCT00544700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101526483|NCT00544700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526484|NCT00544700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101526485|NCT00544700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101526486|NCT00544700|Growth Substances|growth substances|mesh-ancestor
101526487|NCT00544700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526488|NCT00544700|Growth Inhibitors|growth inhibitors|mesh-ancestor
101526489|NCT05824481|Lenvatinib|lenvatinib|mesh-list
101526490|NCT05824481|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101526491|NCT05824481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526492|NCT05824481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101526493|NCT05824481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101526494|NCT05824481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526495|NCT05824468|Lenvatinib|lenvatinib|mesh-list
101526496|NCT05824468|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101526497|NCT05824468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526498|NCT05824468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101526499|NCT05824468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101526500|NCT05824468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526502|NCT05824455|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101526503|NCT05824455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101526505|NCT05824455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526506|NCT05824455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526507|NCT05824390|Rituximab|rituximab|mesh-list
101526508|NCT05824390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101526509|NCT05824390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526510|NCT05824390|Immunologic Factors|immunologic factors|mesh-ancestor
101526511|NCT05824390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526512|NCT05824390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101526513|NCT05824312|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101526514|NCT05824312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101526515|NCT05824312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101526516|NCT05824312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526517|NCT05824156|Streptococcal polysaccharide type III group B|streptococcal polysaccharide type iii group b|mesh-list
101526518|NCT05824156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526520|NCT05823883|Empagliflozin|empagliflozin|mesh-list
101526521|NCT05823883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101526522|NCT05823883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526523|NCT05823883|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101526524|NCT05823883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526526|NCT05823870|Empagliflozin|empagliflozin|mesh-list
101526527|NCT05823870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101337982|NCT00069355|Vasodilator Agents|vasodilator agents|mesh-ancestor
101526528|NCT05823870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526529|NCT05823870|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101526530|NCT05823870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526531|NCT05823701|Azacitidine|azacitidine|mesh-list
101526532|NCT05823701|Mitoxantrone|mitoxantrone|mesh-list
101526533|NCT05823701|Obinutuzumab|obinutuzumab|mesh-list
101526534|NCT05823701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101526535|NCT05823701|Antimetabolites|antimetabolites|mesh-ancestor
101526536|NCT05823701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526537|NCT05823701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526538|NCT05823701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101526539|NCT05823701|Analgesics|analgesics|mesh-ancestor
101526540|NCT05823701|Sensory System Agents|sensory system agents|mesh-ancestor
101526541|NCT05823701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101526542|NCT05823701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526543|NCT05823701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101526544|NCT05823701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101338069|NCT00070174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101526545|NCT05823701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101526547|NCT05823623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101526548|NCT05823623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526549|NCT05823623|Tubulin Modulators|tubulin modulators|mesh-ancestor
101526550|NCT05823623|Antimitotic Agents|antimitotic agents|mesh-ancestor
101526551|NCT05823623|Mitosis Modulators|mitosis modulators|mesh-ancestor
101526552|NCT05823623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526553|NCT05823480|Azacitidine|azacitidine|mesh-list
101526554|NCT05823480|Magrolimab|magrolimab|mesh-list
101526555|NCT05823480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101526556|NCT05823480|Antimetabolites|antimetabolites|mesh-ancestor
101526557|NCT05823480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526558|NCT05823480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526559|NCT05823480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101526560|NCT05823480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101526561|NCT05823168|Anticonvulsants|anticonvulsants|mesh-list
101526562|NCT05823155|Penicillins|penicillins|mesh-list
101526563|NCT05823155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101526565|NCT05822882|Anesthetics|anesthetics|mesh-list
101526566|NCT05822882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101526567|NCT05822882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526568|NCT05822713|Amisulpride|amisulpride|mesh-list
101526569|NCT05822713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101526570|NCT05822713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101526571|NCT05822713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101338142|NCT00070447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101526572|NCT05822713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526573|NCT05822713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101526575|NCT05822713|Dopamine Agents|dopamine agents|mesh-ancestor
101526576|NCT05822713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101526577|NCT05822713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526578|NCT05822713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101526579|NCT05822713|Antidepressive Agents|antidepressive agents|mesh-ancestor
101526580|NCT05822674|Metformin|metformin|mesh-list
101526581|NCT05822674|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101526582|NCT05822674|Empagliflozin|empagliflozin|mesh-list
101526583|NCT05822674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101526584|NCT05822674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338206|NCT00071227|Hormones|hormones|mesh-ancestor
101526585|NCT05822674|Incretins|incretins|mesh-ancestor
101526586|NCT05822674|Hormones|hormones|mesh-ancestor
101526587|NCT05822674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101526588|NCT05822674|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101526589|NCT05822674|Protease Inhibitors|protease inhibitors|mesh-ancestor
101526590|NCT05822674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101526591|NCT05822674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526592|NCT05822674|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101526593|NCT05820451|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101526594|NCT05817474|Lidocaine|lidocaine|mesh-list
101526595|NCT05817474|Tranexamic Acid|tranexamic acid|mesh-list
101526596|NCT05817474|Anesthetics, Local|anesthetics, local|mesh-ancestor
101526597|NCT05817474|Anesthetics|anesthetics|mesh-ancestor
101526598|NCT05817474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101526599|NCT05817474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526600|NCT05817474|Sensory System Agents|sensory system agents|mesh-ancestor
101526601|NCT05817474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101526602|NCT05817474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101526603|NCT05817474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101526604|NCT05817474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101526605|NCT05817474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101526606|NCT05817474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526607|NCT05817474|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101526608|NCT05817474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101526609|NCT05817474|Hemostatics|hemostatics|mesh-ancestor
101526610|NCT05817474|Coagulants|coagulants|mesh-ancestor
101526611|NCT05824338|Bupivacaine|bupivacaine|mesh-list
101526612|NCT05824338|Ropivacaine|ropivacaine|mesh-list
101526613|NCT05824338|Anesthetics|anesthetics|mesh-list
101526614|NCT05824338|Anesthetics, Local|anesthetics, local|mesh-ancestor
101338276|NCT00071968|MTOR Inhibitors|mtor inhibitors|mesh-list
101338277|NCT00071968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101526615|NCT05824338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101526616|NCT05824338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526618|NCT05824338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101526619|NCT05794503|Neostigmine|neostigmine|mesh-list
101526620|NCT05794503|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101526621|NCT05794503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101526622|NCT05794503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526623|NCT05794503|Cholinergic Agents|cholinergic agents|mesh-ancestor
101526624|NCT05794503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101526625|NCT05794503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526627|NCT05794503|Autonomic Agents|autonomic agents|mesh-ancestor
101526628|NCT05794503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101526629|NCT05780567|Tamoxifen|tamoxifen|mesh-list
101526630|NCT05780567|Letrozole|letrozole|mesh-list
101526631|NCT05780567|Anastrozole|anastrozole|mesh-list
101526632|NCT05780567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526633|NCT05780567|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101526634|NCT05780567|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101526635|NCT05780567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101526636|NCT05780567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526637|NCT05780567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101526639|NCT05780567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101526640|NCT05780567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338547|NCT04834349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526641|NCT05780567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101526642|NCT05780567|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101526643|NCT05780567|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101526644|NCT05780567|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101526645|NCT05751629|Bevacizumab|bevacizumab|mesh-list
101526646|NCT05751629|Niraparib|niraparib|mesh-list
101526647|NCT05751629|Dostarlimab|dostarlimab|mesh-list
101526648|NCT05751629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101526649|NCT05751629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526650|NCT05751629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101526651|NCT05751629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101526652|NCT05751629|Growth Substances|growth substances|mesh-ancestor
101526653|NCT05751629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526654|NCT05751629|Growth Inhibitors|growth inhibitors|mesh-ancestor
101526655|NCT05751629|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101526656|NCT05751629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101526657|NCT05751629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526658|NCT05746273|Nicotine|nicotine|mesh-list
101526659|NCT05746273|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101526660|NCT05746273|Autonomic Agents|autonomic agents|mesh-ancestor
101526661|NCT05746273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101526662|NCT05746273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526663|NCT05746273|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101526664|NCT05746273|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101526665|NCT05746273|Cholinergic Agents|cholinergic agents|mesh-ancestor
101526666|NCT05746273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101526667|NCT05746273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526668|NCT05736640|Denosumab|denosumab|mesh-list
101526669|NCT05736640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101526670|NCT05736640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526672|NCT05728294|Anesthetics, Local|anesthetics, local|mesh-ancestor
101526673|NCT05728294|Anesthetics|anesthetics|mesh-ancestor
101526674|NCT05728294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101526675|NCT05728294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526676|NCT05728294|Sensory System Agents|sensory system agents|mesh-ancestor
101526677|NCT05728294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101526678|NCT05726916|Eculizumab|eculizumab|mesh-list
101526679|NCT05726916|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101526680|NCT05726916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101526681|NCT05726916|Immunologic Factors|immunologic factors|mesh-ancestor
101526682|NCT05726916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526683|NCT05704829|Trastuzumab|trastuzumab|mesh-list
101526684|NCT05704829|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
101526685|NCT05704829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101526686|NCT05704829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526687|NCT05704829|Immunoconjugates|immunoconjugates|mesh-ancestor
101526688|NCT05704829|Immunologic Factors|immunologic factors|mesh-ancestor
101526689|NCT05704829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526690|NCT05681572|Midazolam|midazolam|mesh-list
101526691|NCT05681572|Dexmedetomidine|dexmedetomidine|mesh-list
101526692|NCT05681572|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101526693|NCT05681572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101526694|NCT05681572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526695|NCT05681572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101526696|NCT05681572|Analgesics|analgesics|mesh-ancestor
101526697|NCT05681572|Sensory System Agents|sensory system agents|mesh-ancestor
101526698|NCT05681572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101526699|NCT05681572|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101526700|NCT05681572|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101526701|NCT05681572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101526702|NCT05681572|Adrenergic Agents|adrenergic agents|mesh-ancestor
101526703|NCT05681572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101526704|NCT05681572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526705|NCT05681572|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101526706|NCT05681572|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101526707|NCT05681572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101526708|NCT05681572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101526709|NCT05681572|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101526710|NCT05681572|Anesthetics, General|anesthetics, general|mesh-ancestor
101526713|NCT05681572|GABA Agents|gaba agents|mesh-ancestor
101526714|NCT05608252|Fulvestrant|fulvestrant|mesh-list
101526715|NCT05608252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101526716|NCT05608252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526717|NCT05608252|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101526718|NCT05608252|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101526719|NCT05608252|Hormone Antagonists|hormone antagonists|mesh-ancestor
101526720|NCT05608252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101526721|NCT05608252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526722|NCT05564221|Omalizumab|omalizumab|mesh-list
101526723|NCT05564221|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101526725|NCT05564221|Respiratory System Agents|respiratory system agents|mesh-ancestor
101526726|NCT05491200|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101526727|NCT05491200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101526728|NCT05490888|Terlipressin|terlipressin|mesh-list
101526729|NCT05490888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101526730|NCT05490888|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101526731|NCT05410301|Bevacizumab|bevacizumab|mesh-list
101526732|NCT05410301|Lomustine|lomustine|mesh-list
101526733|NCT05410301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101526734|NCT05410301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526735|NCT05410301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101526736|NCT05410301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101526737|NCT05410301|Growth Substances|growth substances|mesh-ancestor
101526738|NCT05410301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526739|NCT05410301|Growth Inhibitors|growth inhibitors|mesh-ancestor
101526740|NCT05410301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101526741|NCT05410301|Alkylating Agents|alkylating agents|mesh-ancestor
101526742|NCT05410301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526743|NCT05297578|Vaccines|vaccines|mesh-list
101526744|NCT05297578|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101526745|NCT05297578|Immunologic Factors|immunologic factors|mesh-ancestor
101526746|NCT05297578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526747|NCT05293249|Methylprednisolone|methylprednisolone|mesh-list
101526748|NCT05293249|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101526749|NCT05293249|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101526751|NCT05293249|Prednisolone acetate|prednisolone acetate|mesh-list
101526752|NCT05293249|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101526753|NCT05293249|Prednisolone phosphate|prednisolone phosphate|mesh-list
101526754|NCT05293249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101526755|NCT05293249|Antiemetics|antiemetics|mesh-ancestor
101526756|NCT05293249|Autonomic Agents|autonomic agents|mesh-ancestor
101338771|NCT00074737|Antiviral Agents|antiviral agents|mesh-ancestor
101526757|NCT05293249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101526758|NCT05293249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526759|NCT05293249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101526760|NCT05293249|Glucocorticoids|glucocorticoids|mesh-ancestor
101526761|NCT05293249|Hormones|hormones|mesh-ancestor
101526762|NCT05293249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101526763|NCT05293249|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101526764|NCT05293249|Protective Agents|protective agents|mesh-ancestor
101526765|NCT05293249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101526766|NCT05293249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526767|NCT05172934|Tenecteplase|tenecteplase|mesh-list
101526768|NCT05172934|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101526769|NCT05172934|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101526770|NCT05172934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526771|NCT05126966|Ranibizumab|ranibizumab|mesh-list
101526772|NCT05126966|Aflibercept|aflibercept|mesh-list
101526773|NCT05126966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101526774|NCT05126966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101526775|NCT05126966|Growth Substances|growth substances|mesh-ancestor
101526776|NCT05126966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526777|NCT05126966|Growth Inhibitors|growth inhibitors|mesh-ancestor
101526778|NCT05126966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526780|NCT05065294|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
101526781|NCT05065294|Hallucinogens|hallucinogens|mesh-ancestor
101526782|NCT05065294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526783|NCT05065294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101526784|NCT05065294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101526785|NCT05065294|Serotonin Agents|serotonin agents|mesh-ancestor
101526786|NCT05065294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101526787|NCT05065294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526788|NCT05065294|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101526789|NCT05058287|Methylprednisolone|methylprednisolone|mesh-list
101526790|NCT05058287|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101526791|NCT05058287|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101526792|NCT05058287|Prednisolone|prednisolone|mesh-list
101526793|NCT05058287|Prednisolone acetate|prednisolone acetate|mesh-list
101526794|NCT05058287|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101526795|NCT05058287|Prednisolone phosphate|prednisolone phosphate|mesh-list
101320040|NCT01806454|Calcium|calcium|mesh-list
101526796|NCT05058287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101526798|NCT05058287|Autonomic Agents|autonomic agents|mesh-ancestor
101526799|NCT05058287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101338799|NCT00075010|Anticonvulsants|anticonvulsants|mesh-ancestor
101526800|NCT05058287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526801|NCT05058287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101526802|NCT05058287|Glucocorticoids|glucocorticoids|mesh-ancestor
101526803|NCT05058287|Hormones|hormones|mesh-ancestor
101526804|NCT05058287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101526805|NCT05058287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101526806|NCT05058287|Protective Agents|protective agents|mesh-ancestor
101526807|NCT05058287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101526808|NCT05058287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526809|NCT04968899|Dexamethasone|dexamethasone|mesh-list
101526810|NCT04968899|Immunoglobulins|immunoglobulins|mesh-list
101526811|NCT04968899|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101526812|NCT04968899|Antibodies|antibodies|mesh-list
101526813|NCT04968899|gamma-Globulins|gamma-globulins|mesh-list
101526815|NCT04968899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101526816|NCT04968899|Antiemetics|antiemetics|mesh-ancestor
101526817|NCT04968899|Autonomic Agents|autonomic agents|mesh-ancestor
101526818|NCT04968899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101526819|NCT04968899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320080|NCT00393445|Glucagon|glucagon|mesh-list
101526820|NCT04968899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101526821|NCT04968899|Glucocorticoids|glucocorticoids|mesh-ancestor
101526822|NCT04968899|Hormones|hormones|mesh-ancestor
101526823|NCT04968899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101526824|NCT04968899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101526825|NCT04968899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526826|NCT04968899|Immunologic Factors|immunologic factors|mesh-ancestor
101526827|NCT04965818|Futibatinib|futibatinib|mesh-list
101526828|NCT04965818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526829|NCT04943224|Trametinib|trametinib|mesh-list
101526830|NCT04943224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526831|NCT04943224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101526832|NCT04943224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101526833|NCT04943224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526834|NCT04943211|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101526835|NCT04943211|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101526836|NCT04943211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526838|NCT04943198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526839|NCT04943198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101526840|NCT04943198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101526841|NCT04943198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526842|NCT04941105|Evolocumab|evolocumab|mesh-list
101526843|NCT04941105|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101526844|NCT04941105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101526845|NCT04941105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101526846|NCT04941105|Antimetabolites|antimetabolites|mesh-ancestor
101526847|NCT04941105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526848|NCT04941105|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101526849|NCT04941105|Protease Inhibitors|protease inhibitors|mesh-ancestor
101526850|NCT04941105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101526851|NCT04941105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101526852|NCT04933695|Sotorasib|sotorasib|mesh-list
101320135|NCT04474223|Hormones|hormones|mesh-ancestor
101526853|NCT04933695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101526854|NCT04933695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526855|NCT04933695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101526856|NCT04933695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526857|NCT04873102|Danazol|danazol|mesh-list
101526858|NCT04873102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101526859|NCT04873102|Hormone Antagonists|hormone antagonists|mesh-ancestor
101526860|NCT04873102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101338821|NCT00075205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526861|NCT04873102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526862|NCT04860141|Gabapentin|gabapentin|mesh-list
101526863|NCT04860141|Analgesics|analgesics|mesh-ancestor
101526864|NCT04860141|Sensory System Agents|sensory system agents|mesh-ancestor
101526865|NCT04860141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101526866|NCT04860141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526867|NCT04860141|Anticonvulsants|anticonvulsants|mesh-ancestor
101526868|NCT04860141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101526869|NCT04860141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101526870|NCT04860141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101526871|NCT04860141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101526872|NCT04860141|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101526873|NCT04860141|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101526874|NCT04860141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101526875|NCT04860141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526876|NCT04860141|Antimanic Agents|antimanic agents|mesh-ancestor
101526877|NCT04823156|Calcium|calcium|mesh-list
101526878|NCT04823156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101526879|NCT04823156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526880|NCT04813653|Cyclosporine|cyclosporine|mesh-list
101526881|NCT04813653|Dexamethasone|dexamethasone|mesh-list
101526882|NCT04813653|Cyclosporins|cyclosporins|mesh-list
101526883|NCT04813653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101526884|NCT04813653|Antiemetics|antiemetics|mesh-ancestor
101526885|NCT04813653|Autonomic Agents|autonomic agents|mesh-ancestor
101526886|NCT04813653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101526887|NCT04813653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526888|NCT04813653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101526889|NCT04813653|Glucocorticoids|glucocorticoids|mesh-ancestor
101526891|NCT04813653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101526892|NCT04813653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101526893|NCT04813653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526894|NCT04813653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101526895|NCT04813653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526896|NCT04813653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101526897|NCT04813653|Immunologic Factors|immunologic factors|mesh-ancestor
101526898|NCT04813653|Antifungal Agents|antifungal agents|mesh-ancestor
101526899|NCT04813653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101526900|NCT04813653|Dermatologic Agents|dermatologic agents|mesh-ancestor
101526901|NCT04813653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101526902|NCT04813653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101526904|NCT04803747|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101526905|NCT04803747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101320168|NCT01466257|Cetuximab|cetuximab|mesh-list
101526906|NCT04803747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526907|NCT04803747|Hemostatics|hemostatics|mesh-ancestor
101526908|NCT04803747|Coagulants|coagulants|mesh-ancestor
101526909|NCT04790474|Dexamethasone|dexamethasone|mesh-list
101526910|NCT04790474|Pomalidomide|pomalidomide|mesh-list
101526911|NCT04790474|Ixazomib|ixazomib|mesh-list
101526912|NCT04790474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101526913|NCT04790474|Antiemetics|antiemetics|mesh-ancestor
101526914|NCT04790474|Autonomic Agents|autonomic agents|mesh-ancestor
101526915|NCT04790474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101526916|NCT04790474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526917|NCT04790474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101526918|NCT04790474|Glucocorticoids|glucocorticoids|mesh-ancestor
101526919|NCT04790474|Hormones|hormones|mesh-ancestor
101526920|NCT04790474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101526921|NCT04790474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101526922|NCT04790474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526923|NCT04790474|Immunologic Factors|immunologic factors|mesh-ancestor
101526924|NCT04790474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101526925|NCT04790474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101526927|NCT04790474|Growth Inhibitors|growth inhibitors|mesh-ancestor
101526928|NCT04790474|Protease Inhibitors|protease inhibitors|mesh-ancestor
101526929|NCT04790474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101526930|NCT04790474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526931|NCT04778410|Cytarabine|cytarabine|mesh-list
101526932|NCT04778410|Etoposide|etoposide|mesh-list
101526933|NCT04778410|Mitoxantrone|mitoxantrone|mesh-list
101526934|NCT04778410|Azacitidine|azacitidine|mesh-list
101526935|NCT04778410|Venetoclax|venetoclax|mesh-list
101526936|NCT04778410|Cc-486|cc-486|mesh-list
101526937|NCT04778410|Magrolimab|magrolimab|mesh-list
101526938|NCT04778410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101526939|NCT04778410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101526940|NCT04778410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101526941|NCT04778410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101526942|NCT04778410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101526943|NCT04778410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526944|NCT04778410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101526945|NCT04778410|Antimetabolites|antimetabolites|mesh-ancestor
101526946|NCT04778410|Antiviral Agents|antiviral agents|mesh-ancestor
101526947|NCT04778410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101526948|NCT04778410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101526949|NCT04778410|Immunologic Factors|immunologic factors|mesh-ancestor
101526950|NCT04778410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526951|NCT04778410|Analgesics|analgesics|mesh-ancestor
101526952|NCT04778410|Sensory System Agents|sensory system agents|mesh-ancestor
101526953|NCT04778410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101526954|NCT04778410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101526960|NCT04743570|Methylnaltrexone|methylnaltrexone|mesh-list
101526961|NCT04743570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101526962|NCT04743570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526963|NCT04743570|Sensory System Agents|sensory system agents|mesh-ancestor
101526964|NCT04743570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101526965|NCT04718025|Aspirin|aspirin|mesh-list
101526966|NCT04718025|Ticagrelor|ticagrelor|mesh-list
101526967|NCT04718025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101526968|NCT04718025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101526969|NCT04718025|Analgesics|analgesics|mesh-ancestor
101526970|NCT04718025|Sensory System Agents|sensory system agents|mesh-ancestor
101526971|NCT04718025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101526972|NCT04718025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101526973|NCT04718025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101526974|NCT04718025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101526975|NCT04718025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101526976|NCT04718025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101526977|NCT04718025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526978|NCT04718025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101526979|NCT04718025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101526980|NCT04718025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101526981|NCT04718025|Antipyretics|antipyretics|mesh-ancestor
101526982|NCT04718025|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101526983|NCT04718025|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101526984|NCT04718025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101526985|NCT04718025|Purinergic Agents|purinergic agents|mesh-ancestor
101526986|NCT04718025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101526987|NCT04666948|Vancomycin|vancomycin|mesh-list
101526988|NCT04666948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101526989|NCT04666948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101526990|NCT04642430|Rivaroxaban|rivaroxaban|mesh-list
101526991|NCT04642430|Apixaban|apixaban|mesh-list
101526992|NCT04642430|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101526993|NCT04642430|Antithrombins|antithrombins|mesh-ancestor
101526994|NCT04642430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101526995|NCT04642430|Protease Inhibitors|protease inhibitors|mesh-ancestor
101526996|NCT04642430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101526997|NCT04642430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101526998|NCT04642430|Anticoagulants|anticoagulants|mesh-ancestor
101526999|NCT04609176|Apatinib|apatinib|mesh-list
101527000|NCT04609176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101527001|NCT04609176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101320285|NCT01465009|Antipyretics|antipyretics|mesh-ancestor
101527002|NCT04609176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101527003|NCT04609176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527004|NCT04593940|Remdesivir|remdesivir|mesh-list
101527005|NCT04593940|Cenicriviroc|cenicriviroc|mesh-list
101527006|NCT04593940|Infliximab|infliximab|mesh-list
101527007|NCT04593940|Abatacept|abatacept|mesh-list
101527008|NCT04593940|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101527009|NCT04593940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101527010|NCT04593940|Dermatologic Agents|dermatologic agents|mesh-ancestor
101527011|NCT04593940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101527012|NCT04593940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101527013|NCT04593940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101527014|NCT04593940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527015|NCT04593940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101338982|NCT00399295|Narcotics|narcotics|mesh-ancestor
101338984|NCT00399295|Analgesics|analgesics|mesh-ancestor
101527016|NCT04593940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101527017|NCT04593940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101527018|NCT04593940|Immunologic Factors|immunologic factors|mesh-ancestor
101527019|NCT04593940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527021|NCT04593940|Antiviral Agents|antiviral agents|mesh-ancestor
101527022|NCT04593940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101527023|NCT04593940|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101527024|NCT04593940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101527025|NCT04593940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101527026|NCT04562090|Mirabegron|mirabegron|mesh-list
101527027|NCT04562090|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101527028|NCT04562090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101527030|NCT04562090|Adrenergic Agents|adrenergic agents|mesh-ancestor
101527031|NCT04562090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101527032|NCT04562090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320327|NCT00393679|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101527033|NCT04562090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527034|NCT04562090|Urological Agents|urological agents|mesh-ancestor
101527035|NCT04557189|Ondansetron|ondansetron|mesh-list
101527036|NCT04557189|Antiemetics|antiemetics|mesh-ancestor
101527037|NCT04557189|Autonomic Agents|autonomic agents|mesh-ancestor
101527038|NCT04557189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101527039|NCT04557189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527040|NCT04557189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101527041|NCT04557189|Antipruritics|antipruritics|mesh-ancestor
101527042|NCT04557189|Dermatologic Agents|dermatologic agents|mesh-ancestor
101527043|NCT04557189|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101527044|NCT04557189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101527045|NCT04557189|Serotonin Agents|serotonin agents|mesh-ancestor
101527046|NCT04557189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101527047|NCT04557189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527048|NCT04530838|Vaccines|vaccines|mesh-list
101527049|NCT04530838|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101527050|NCT04530838|Immunologic Factors|immunologic factors|mesh-ancestor
101527051|NCT04530838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527052|NCT04442919|Morphine|morphine|mesh-list
101527053|NCT04442919|Methoxyflurane|methoxyflurane|mesh-list
101527054|NCT04442919|Ticagrelor|ticagrelor|mesh-list
101527055|NCT04442919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101527056|NCT04442919|Narcotics|narcotics|mesh-ancestor
101527057|NCT04442919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101339030|NCT00077116|Alkylating Agents|alkylating agents|mesh-ancestor
101527058|NCT04442919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527059|NCT04442919|Analgesics|analgesics|mesh-ancestor
101527060|NCT04442919|Sensory System Agents|sensory system agents|mesh-ancestor
101527061|NCT04442919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101527062|NCT04442919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101527063|NCT04442919|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101527064|NCT04442919|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101527065|NCT04442919|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101527066|NCT04442919|Purinergic Agents|purinergic agents|mesh-ancestor
101527067|NCT04442919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101527068|NCT04442919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527069|NCT04442919|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101527071|NCT04442919|Anesthetics|anesthetics|mesh-ancestor
101527072|NCT04435197|Pembrolizumab|pembrolizumab|mesh-list
101527073|NCT04435197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101527074|NCT04435197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101527075|NCT04435197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101527076|NCT04435197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527077|NCT04424901|Dipyridamole|dipyridamole|mesh-list
101527078|NCT04424901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101527079|NCT04424901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101320371|NCT00847834|Natriuretic Agents|natriuretic agents|mesh-ancestor
101527080|NCT04424901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527081|NCT04424901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101527082|NCT04424901|Vasodilator Agents|vasodilator agents|mesh-ancestor
101527083|NCT04415060|Sevoflurane|sevoflurane|mesh-list
101527085|NCT04415060|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101527086|NCT04415060|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101527087|NCT04415060|Anesthetics, General|anesthetics, general|mesh-ancestor
101527088|NCT04415060|Anesthetics|anesthetics|mesh-ancestor
101527089|NCT04415060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101527090|NCT04415060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527091|NCT04410445|Nivolumab|nivolumab|mesh-list
101527092|NCT04410445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101527093|NCT04410445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101527094|NCT04410445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101527095|NCT04410445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527096|NCT04381091|Idebenone|idebenone|mesh-list
101527097|NCT04381091|Antioxidants|antioxidants|mesh-ancestor
101527098|NCT04381091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527099|NCT04381091|Protective Agents|protective agents|mesh-ancestor
101527100|NCT04381091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527102|NCT04293562|Deoxyglucose|deoxyglucose|mesh-list
101527103|NCT04293562|Hydrocortisone|hydrocortisone|mesh-list
101527104|NCT04293562|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101527105|NCT04293562|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101527106|NCT04293562|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101527107|NCT04293562|Methotrexate|methotrexate|mesh-list
101527108|NCT04293562|Etoposide|etoposide|mesh-list
101527109|NCT04293562|Etoposide phosphate|etoposide phosphate|mesh-list
101527110|NCT04293562|Daunorubicin|daunorubicin|mesh-list
101527111|NCT04293562|Asparaginase|asparaginase|mesh-list
101527112|NCT04293562|Mitoxantrone|mitoxantrone|mesh-list
101527113|NCT04293562|Podophyllotoxin|podophyllotoxin|mesh-list
101527114|NCT04293562|Gemtuzumab|gemtuzumab|mesh-list
101527115|NCT04293562|Dexrazoxane|dexrazoxane|mesh-list
101527116|NCT04293562|Razoxane|razoxane|mesh-list
101527117|NCT04293562|Calicheamicins|calicheamicins|mesh-list
101527118|NCT04293562|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101527119|NCT04293562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101527120|NCT04293562|Abortifacient Agents|abortifacient agents|mesh-ancestor
101527121|NCT04293562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101339139|NCT00077545|Cisplatin|cisplatin|mesh-list
101527122|NCT04293562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527123|NCT04293562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101527125|NCT04293562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527127|NCT04293562|Dermatologic Agents|dermatologic agents|mesh-ancestor
101527128|NCT04293562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101527129|NCT04293562|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101527130|NCT04293562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101527132|NCT04293562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101527133|NCT04293562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101527134|NCT04293562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101527135|NCT04293562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101527136|NCT04293562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101527137|NCT04293562|Antiviral Agents|antiviral agents|mesh-ancestor
101527138|NCT04293562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101527139|NCT04293562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101527140|NCT04293562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101339264|NCT00078910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101527142|NCT04293562|Sensory System Agents|sensory system agents|mesh-ancestor
101527143|NCT04293562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101527144|NCT04293562|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101527145|NCT04293562|Keratolytic Agents|keratolytic agents|mesh-ancestor
101527146|NCT04293562|Tubulin Modulators|tubulin modulators|mesh-ancestor
101527147|NCT04293562|Antimitotic Agents|antimitotic agents|mesh-ancestor
101527148|NCT04293562|Mitosis Modulators|mitosis modulators|mesh-ancestor
101527149|NCT04293562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101527150|NCT04293562|Immunotoxins|immunotoxins|mesh-ancestor
101527151|NCT04293562|Immunoconjugates|immunoconjugates|mesh-ancestor
101527152|NCT04293562|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101527153|NCT04293562|Protective Agents|protective agents|mesh-ancestor
101527154|NCT04225312|Natalizumab|natalizumab|mesh-list
101527155|NCT04225312|Immunologic Factors|immunologic factors|mesh-ancestor
101527156|NCT04225312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527157|NCT04209205|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101527158|NCT04209205|Immunologic Factors|immunologic factors|mesh-ancestor
101527159|NCT04209205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527160|NCT04156347|Topotecan|topotecan|mesh-list
101527161|NCT04156347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101527162|NCT04156347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101527163|NCT04156347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101527164|NCT04156347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527165|NCT04156347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101527166|NCT04129086|Ketamine|ketamine|mesh-list
101527167|NCT04129086|Analgesics|analgesics|mesh-ancestor
101527168|NCT04129086|Sensory System Agents|sensory system agents|mesh-ancestor
101527169|NCT04129086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101320449|NCT04009343|Artemether|artemether|mesh-list
101527170|NCT04129086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527171|NCT04129086|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101527173|NCT04129086|Anesthetics, General|anesthetics, general|mesh-ancestor
101527174|NCT04129086|Anesthetics|anesthetics|mesh-ancestor
101527175|NCT04129086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101527176|NCT04129086|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101527177|NCT04129086|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101527178|NCT04129086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101527179|NCT04129086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527180|NCT04062448|Rituximab|rituximab|mesh-list
101527181|NCT04062448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101527182|NCT04062448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101527183|NCT04062448|Immunologic Factors|immunologic factors|mesh-ancestor
101527184|NCT04062448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527185|NCT04062448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101527186|NCT04003285|Pregnanolone|pregnanolone|mesh-list
101527188|NCT04003285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101527189|NCT04003285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527191|NCT04000555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101339567|NCT00080158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101527192|NCT04000555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101527193|NCT03994393|Durvalumab|durvalumab|mesh-list
101527194|NCT03994393|Tremelimumab|tremelimumab|mesh-list
101527195|NCT03994393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101527196|NCT03994393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101527197|NCT03961438|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
101527198|NCT03961438|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101527199|NCT03961438|Immunologic Factors|immunologic factors|mesh-ancestor
101527200|NCT03961438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527201|NCT03798639|Nivolumab|nivolumab|mesh-list
101527202|NCT03798639|Ipilimumab|ipilimumab|mesh-list
101527203|NCT03798639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101527204|NCT03798639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101527205|NCT03798639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101527206|NCT03798639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527207|NCT03774901|Avelumab|avelumab|mesh-list
101527208|NCT03774901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101527209|NCT03774901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101527210|NCT03762018|Bevacizumab|bevacizumab|mesh-list
101527211|NCT03762018|Atezolizumab|atezolizumab|mesh-list
101527212|NCT03762018|Carboplatin|carboplatin|mesh-list
101527213|NCT03762018|Pemetrexed|pemetrexed|mesh-list
101527214|NCT03762018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101527215|NCT03762018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101527216|NCT03762018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101527217|NCT03762018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101527218|NCT03762018|Growth Substances|growth substances|mesh-ancestor
101527219|NCT03762018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527220|NCT03762018|Growth Inhibitors|growth inhibitors|mesh-ancestor
101527221|NCT03762018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101320463|NCT00847210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101527222|NCT03762018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527223|NCT03762018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101527224|NCT03762018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101527225|NCT03762018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101527227|NCT03456882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101527229|NCT03456882|Analgesics|analgesics|mesh-ancestor
101527230|NCT03456882|Sensory System Agents|sensory system agents|mesh-ancestor
101527231|NCT03456882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101527232|NCT03456882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527233|NCT03456882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101527234|NCT03456882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101527235|NCT03456882|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101527236|NCT03433807|Idebenone|idebenone|mesh-list
101527237|NCT03433807|Antioxidants|antioxidants|mesh-ancestor
101527238|NCT03433807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527239|NCT03433807|Protective Agents|protective agents|mesh-ancestor
101527240|NCT03433807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527241|NCT03416179|Cytarabine|cytarabine|mesh-list
101527242|NCT03416179|Azacitidine|azacitidine|mesh-list
101527243|NCT03416179|Daunorubicin|daunorubicin|mesh-list
101527244|NCT03416179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101527245|NCT03416179|Antimetabolites|antimetabolites|mesh-ancestor
101527246|NCT03416179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527247|NCT03416179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101527248|NCT03416179|Antiviral Agents|antiviral agents|mesh-ancestor
101527249|NCT03416179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101527250|NCT03416179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101527251|NCT03416179|Immunologic Factors|immunologic factors|mesh-ancestor
101527252|NCT03416179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527253|NCT03416179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101527254|NCT03416179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101527255|NCT03416179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101527256|NCT03416179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101527257|NCT03313544|Nivolumab|nivolumab|mesh-list
101527258|NCT03313544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101339691|NCT04423367|Hormones|hormones|mesh-ancestor
101527259|NCT03313544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101527260|NCT03313544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101527261|NCT03313544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527262|NCT03309150|Paclitaxel|paclitaxel|mesh-list
101527263|NCT03309150|Carboplatin|carboplatin|mesh-list
101527264|NCT03309150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101527265|NCT03309150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101527266|NCT03309150|Tubulin Modulators|tubulin modulators|mesh-ancestor
101527267|NCT03309150|Antimitotic Agents|antimitotic agents|mesh-ancestor
101527268|NCT03309150|Mitosis Modulators|mitosis modulators|mesh-ancestor
101527269|NCT03309150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527270|NCT03266783|Rivaroxaban|rivaroxaban|mesh-list
101527271|NCT03266783|Apixaban|apixaban|mesh-list
101339720|NCT00080977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101527272|NCT03266783|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101339721|NCT00080977|Antiviral Agents|antiviral agents|mesh-ancestor
101339723|NCT00081055|Cyclosporine|cyclosporine|mesh-list
101527273|NCT03266783|Antithrombins|antithrombins|mesh-ancestor
101527274|NCT03266783|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101527275|NCT03266783|Protease Inhibitors|protease inhibitors|mesh-ancestor
101527276|NCT03266783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101527277|NCT03266783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527278|NCT03266783|Anticoagulants|anticoagulants|mesh-ancestor
101527279|NCT03251859|Ticagrelor|ticagrelor|mesh-list
101527280|NCT03251859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101527281|NCT03251859|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101527282|NCT03251859|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101527283|NCT03251859|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101527284|NCT03251859|Purinergic Agents|purinergic agents|mesh-ancestor
101527286|NCT03251859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527287|NCT03251859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527289|NCT03186638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101527290|NCT03186638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101527291|NCT03186638|Analgesics|analgesics|mesh-ancestor
101527292|NCT03186638|Sensory System Agents|sensory system agents|mesh-ancestor
101527293|NCT03186638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101527294|NCT03186638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527295|NCT03186638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101527296|NCT03186638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101527297|NCT03186638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101527298|NCT03186638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101527299|NCT03186638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527300|NCT02918409|Tobramycin|tobramycin|mesh-list
101527301|NCT02918409|Colistin|colistin|mesh-list
101527302|NCT02918409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101527303|NCT02918409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101527304|NCT02859792|Riluzole|riluzole|mesh-list
101527305|NCT02859792|Anticonvulsants|anticonvulsants|mesh-ancestor
101527306|NCT02859792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101527307|NCT02859792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101527308|NCT02859792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101527309|NCT02859792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527310|NCT02859792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527311|NCT02859792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101527312|NCT02859792|Protective Agents|protective agents|mesh-ancestor
101527313|NCT02852213|Dopa Decarboxylase|dopa decarboxylase|mesh-list
101527314|NCT02852213|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101527315|NCT02852213|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101527316|NCT02793466|Durvalumab|durvalumab|mesh-list
101527317|NCT02793466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101527318|NCT02793466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101527319|NCT02793466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101527320|NCT02793466|Immunologic Factors|immunologic factors|mesh-ancestor
101527321|NCT02793466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527322|NCT02774005|Idebenone|idebenone|mesh-list
101527323|NCT02774005|Antioxidants|antioxidants|mesh-ancestor
101527324|NCT02774005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527325|NCT02774005|Protective Agents|protective agents|mesh-ancestor
101527326|NCT02774005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527327|NCT02700828|Hydrocortisone|hydrocortisone|mesh-list
101527328|NCT02700828|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101527329|NCT02700828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101527330|NCT02695771|Gemcitabine|gemcitabine|mesh-list
101527331|NCT02695771|Mitomycins|mitomycins|mesh-list
101527332|NCT02695771|Mitomycin|mitomycin|mesh-list
101340010|NCT00083668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101340030|NCT03151707|Niacin|niacin|mesh-list
101527333|NCT02695771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101527335|NCT02695771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527336|NCT02695771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101527337|NCT02695771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101527338|NCT02695771|Alkylating Agents|alkylating agents|mesh-ancestor
101527339|NCT02695771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101527340|NCT02695771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101527341|NCT02293954|Antibodies|antibodies|mesh-list
101527342|NCT02293954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101527343|NCT02293954|Immunologic Factors|immunologic factors|mesh-ancestor
101527344|NCT02293954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527347|NCT02259621|Nivolumab|nivolumab|mesh-list
101527348|NCT02259621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101527349|NCT02259621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101527350|NCT02259621|Tubulin Modulators|tubulin modulators|mesh-ancestor
101527351|NCT02259621|Antimitotic Agents|antimitotic agents|mesh-ancestor
101527352|NCT02259621|Mitosis Modulators|mitosis modulators|mesh-ancestor
101527353|NCT02259621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527354|NCT02259621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101527355|NCT02259621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101527356|NCT02190305|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
101527357|NCT02190305|Immunologic Factors|immunologic factors|mesh-ancestor
101527358|NCT02190305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340179|NCT00135967|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101527360|NCT01941641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101527361|NCT01941641|Antimetabolites|antimetabolites|mesh-ancestor
101527362|NCT01941641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527363|NCT01941641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101527364|NCT01804634|Cyclophosphamide|cyclophosphamide|mesh-list
101527365|NCT01804634|Melphalan|melphalan|mesh-list
101527366|NCT01804634|Fludarabine|fludarabine|mesh-list
101527367|NCT01804634|Tacrolimus|tacrolimus|mesh-list
101527368|NCT01804634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101527369|NCT01804634|Immunologic Factors|immunologic factors|mesh-ancestor
101527370|NCT01804634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527371|NCT01804634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101340338|NCT00136981|Torcetrapib|torcetrapib|mesh-list
101527372|NCT01804634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101527373|NCT01804634|Alkylating Agents|alkylating agents|mesh-ancestor
101527374|NCT01804634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527375|NCT01804634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101527376|NCT01804634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101527377|NCT01804634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101527378|NCT01804634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101527379|NCT01792934|Bevacizumab|bevacizumab|mesh-list
101527381|NCT01792934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101340413|NCT03151005|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101527382|NCT01792934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101527383|NCT01792934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101527384|NCT01792934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101527385|NCT01792934|Growth Substances|growth substances|mesh-ancestor
101527386|NCT01792934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527387|NCT01792934|Growth Inhibitors|growth inhibitors|mesh-ancestor
101527388|NCT01792934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101527389|NCT01792934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101527390|NCT01792934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101527391|NCT01792934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527392|NCT01669915|Vitamin D|vitamin d|mesh-list
101527393|NCT01669915|Ergocalciferols|ergocalciferols|mesh-list
101527394|NCT01669915|Cholecalciferol|cholecalciferol|mesh-list
101527395|NCT01669915|Vitamins|vitamins|mesh-list
101527396|NCT01669915|Micronutrients|micronutrients|mesh-ancestor
101527397|NCT01669915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527398|NCT01669915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101527399|NCT01669915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101527400|NCT01653223|Simvastatin|simvastatin|mesh-list
101527401|NCT01653223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101527402|NCT01653223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101527403|NCT01653223|Antimetabolites|antimetabolites|mesh-ancestor
101527404|NCT01653223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340655|NCT00139243|Leucovorin|leucovorin|mesh-list
101527405|NCT01653223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101527406|NCT01653223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101527407|NCT01653223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101527408|NCT01549587|Listerine|listerine|mesh-list
101527409|NCT01549587|Cetylpyridinium|cetylpyridinium|mesh-list
101527410|NCT01549587|Fluorides|fluorides|mesh-list
101527411|NCT01549587|Sodium Fluoride|sodium fluoride|mesh-list
101527412|NCT01549587|Tin Fluorides|tin fluorides|mesh-list
101527414|NCT01549587|Protective Agents|protective agents|mesh-ancestor
101527415|NCT01549587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527416|NCT01549587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101527417|NCT01549587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101527418|NCT01356290|Cytarabine|cytarabine|mesh-list
101527419|NCT01356290|Thalidomide|thalidomide|mesh-list
101527421|NCT01356290|Cyclophosphamide|cyclophosphamide|mesh-list
101527422|NCT01356290|Bevacizumab|bevacizumab|mesh-list
101527423|NCT01356290|Etoposide|etoposide|mesh-list
101527424|NCT01356290|Etoposide phosphate|etoposide phosphate|mesh-list
101527425|NCT01356290|Fenofibric acid|fenofibric acid|mesh-list
101527426|NCT01356290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101527427|NCT01356290|Immunologic Factors|immunologic factors|mesh-ancestor
101527428|NCT01356290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527429|NCT01356290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101527430|NCT01356290|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101527431|NCT01356290|Alkylating Agents|alkylating agents|mesh-ancestor
101527432|NCT01356290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527433|NCT01356290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101527434|NCT01356290|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101340980|NCT00141154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101340982|NCT00141193|Celecoxib|celecoxib|mesh-list
101527435|NCT01356290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101527436|NCT01356290|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101527437|NCT01356290|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101527438|NCT01356290|Growth Substances|growth substances|mesh-ancestor
101527439|NCT01356290|Growth Inhibitors|growth inhibitors|mesh-ancestor
101527440|NCT01356290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101527441|NCT01356290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101527442|NCT01356290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101527443|NCT01356290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101527444|NCT01356290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101527445|NCT01356290|Antimetabolites|antimetabolites|mesh-ancestor
101527446|NCT01356290|Antiviral Agents|antiviral agents|mesh-ancestor
101527447|NCT01356290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101527448|NCT01356290|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101527449|NCT01356290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101527450|NCT01356290|Analgesics|analgesics|mesh-ancestor
101527451|NCT01356290|Sensory System Agents|sensory system agents|mesh-ancestor
101527452|NCT01356290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101527453|NCT01356290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101527454|NCT01356290|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101527455|NCT01356290|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101527456|NCT01356290|Leprostatic Agents|leprostatic agents|mesh-ancestor
101527457|NCT01356290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101527458|NCT01356290|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101341195|NCT00142480|Growth Inhibitors|growth inhibitors|mesh-ancestor
101527460|NCT01356290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101527461|NCT01047540|Pritelivir|pritelivir|mesh-list
101527462|NCT01047540|Antiviral Agents|antiviral agents|mesh-ancestor
101527463|NCT01047540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101527464|NCT01047540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101527465|NCT01047540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527466|NCT00521222|Fluticasone|fluticasone|mesh-list
101527468|NCT00521222|Albuterol|albuterol|mesh-list
101527469|NCT00521222|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101527470|NCT00521222|Ipratropium|ipratropium|mesh-list
101527471|NCT00521222|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101527472|NCT00521222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101527473|NCT00521222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101527475|NCT00521222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101527476|NCT00521222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527477|NCT00521222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101527478|NCT00521222|Respiratory System Agents|respiratory system agents|mesh-ancestor
101527480|NCT00521222|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101527481|NCT00521222|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101527482|NCT00521222|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101527483|NCT00521222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101527484|NCT00521222|Adrenergic Agents|adrenergic agents|mesh-ancestor
101527485|NCT00521222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101527486|NCT00521222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527487|NCT00521222|Tocolytic Agents|tocolytic agents|mesh-ancestor
101527488|NCT00521222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101527489|NCT00521222|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101527490|NCT00521222|Cholinergic Agents|cholinergic agents|mesh-ancestor
101527491|NCT00521222|Glucocorticoids|glucocorticoids|mesh-ancestor
101527492|NCT00521222|Hormones|hormones|mesh-ancestor
101527493|NCT00521222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101527494|NCT00521222|Sympathomimetics|sympathomimetics|mesh-ancestor
101527495|NCT00545012|Levetiracetam|levetiracetam|mesh-list
101527496|NCT00545012|Anticonvulsants|anticonvulsants|mesh-ancestor
101527497|NCT00545012|Nootropic Agents|nootropic agents|mesh-ancestor
101527498|NCT00545090|Ibandronic Acid|ibandronic acid|mesh-list
101527499|NCT00545090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101527500|NCT00545090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527501|NCT00545207|Ibandronic Acid|ibandronic acid|mesh-list
101527502|NCT00545207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101527503|NCT00545207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527504|NCT00545246|Docetaxel|docetaxel|mesh-list
101527505|NCT00545246|Aflibercept|aflibercept|mesh-list
101527506|NCT00545246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101527507|NCT00545246|Tubulin Modulators|tubulin modulators|mesh-ancestor
101527508|NCT00545246|Antimitotic Agents|antimitotic agents|mesh-ancestor
101527509|NCT00545246|Mitosis Modulators|mitosis modulators|mesh-ancestor
101527510|NCT00545246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527511|NCT00545246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101527512|NCT00545246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101341491|NCT00404716|Cilostazol|cilostazol|mesh-list
101527513|NCT00545246|Growth Substances|growth substances|mesh-ancestor
101527514|NCT00545246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527515|NCT00545246|Growth Inhibitors|growth inhibitors|mesh-ancestor
101527516|NCT03456401|Sorafenib|sorafenib|mesh-list
101527517|NCT03456401|Sunitinib|sunitinib|mesh-list
101527518|NCT03456401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101527519|NCT03456401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101527520|NCT03456401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101527521|NCT03456401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527522|NCT03456401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101527523|NCT03456401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101527524|NCT03456401|Growth Substances|growth substances|mesh-ancestor
101527525|NCT03456401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527526|NCT03456401|Growth Inhibitors|growth inhibitors|mesh-ancestor
101527527|NCT00545480|Ibandronic Acid|ibandronic acid|mesh-list
101527528|NCT00545480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101527529|NCT00545480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527544|NCT00545519|Thymoglobulin|thymoglobulin|mesh-list
101527545|NCT00545519|Immunologic Factors|immunologic factors|mesh-ancestor
101527546|NCT00545519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527547|NCT00545519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101527548|NCT00545558|Tenofovir|tenofovir|mesh-list
101527549|NCT00545558|Emtricitabine|emtricitabine|mesh-list
101527550|NCT00545558|Efavirenz|efavirenz|mesh-list
101527552|NCT00545558|Antiviral Agents|antiviral agents|mesh-ancestor
101341644|NCT03092453|Cyclophosphamide|cyclophosphamide|mesh-list
101527553|NCT00545558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101527554|NCT00545558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101527555|NCT00545558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101527556|NCT00545558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101527557|NCT00545558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527558|NCT00545558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101527559|NCT00545558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101527560|NCT00545558|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101527561|NCT00545558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101527562|NCT00545558|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101527563|NCT00545558|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101527564|NCT00545558|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101527565|NCT00545558|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101527567|NCT04684667|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101527568|NCT04684667|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101527569|NCT04684667|Adrenergic Agents|adrenergic agents|mesh-ancestor
101527570|NCT04684667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101527571|NCT04684667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527572|NCT04684667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527573|NCT04684667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101527574|NCT04684667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101527577|NCT00545675|Aripiprazole|aripiprazole|mesh-list
101527578|NCT00545675|Antidepressive Agents|antidepressive agents|mesh-ancestor
101527579|NCT00545675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101527580|NCT00545675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101527581|NCT00545675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101527582|NCT00545675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101527583|NCT00545675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527584|NCT00545675|Dopamine Agonists|dopamine agonists|mesh-ancestor
101527585|NCT00545675|Dopamine Agents|dopamine agents|mesh-ancestor
101527586|NCT00545675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101527587|NCT00545675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527588|NCT00545675|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101527589|NCT00545675|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101320566|NCT00846625|Hormones|hormones|mesh-ancestor
101341852|NCT01806675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527591|NCT00545675|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101527592|NCT00545675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101527593|NCT00545675|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101527594|NCT00545675|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101527595|NCT00545675|Anticonvulsants|anticonvulsants|mesh-ancestor
101527596|NCT00545675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101527597|NCT00545675|GABA Agents|gaba agents|mesh-ancestor
101527598|NCT00545675|Antimanic Agents|antimanic agents|mesh-ancestor
101331279|NCT00000665|Foscarnet|foscarnet|mesh-list
101527599|NCT00545831|Taurolidine|taurolidine|mesh-list
101527600|NCT00545831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101527601|NCT00545831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101527602|NCT00545831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101527603|NCT00545870|Bevacizumab|bevacizumab|mesh-list
101527604|NCT00545870|Ranibizumab|ranibizumab|mesh-list
101527605|NCT00545870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101527606|NCT00545870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101527607|NCT00545870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101527608|NCT00545870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101527609|NCT00545870|Growth Substances|growth substances|mesh-ancestor
101527610|NCT00545870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527611|NCT00545870|Growth Inhibitors|growth inhibitors|mesh-ancestor
101527612|NCT00545909|Ibandronic Acid|ibandronic acid|mesh-list
101527613|NCT00545909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101527614|NCT00545909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527616|NCT04645914|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101527617|NCT04645914|Autonomic Agents|autonomic agents|mesh-ancestor
101527618|NCT04645914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101527619|NCT04645914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527620|NCT04645914|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101527621|NCT04645914|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101527622|NCT04645914|Cholinergic Agents|cholinergic agents|mesh-ancestor
101527623|NCT04645914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101527624|NCT04645914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527625|NCT00546065|Esomeprazole|esomeprazole|mesh-list
101527626|NCT00546065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101527627|NCT00546065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101527629|NCT00546065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101527630|NCT00546065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527631|NCT00546143|Omalizumab|omalizumab|mesh-list
101527632|NCT00546143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101527633|NCT00546143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101527634|NCT00546143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101527635|NCT00546143|Respiratory System Agents|respiratory system agents|mesh-ancestor
101527636|NCT00546143|Immunologic Factors|immunologic factors|mesh-ancestor
101527637|NCT00546143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527638|NCT00560079|Allopurinol|allopurinol|mesh-list
101527639|NCT00560079|Dipyridamole|dipyridamole|mesh-list
101527640|NCT00560079|Antimetabolites|antimetabolites|mesh-ancestor
101527641|NCT00560079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527642|NCT00560079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101527643|NCT00560079|Gout Suppressants|gout suppressants|mesh-ancestor
101527644|NCT00560079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101527645|NCT00560079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101527646|NCT00560079|Antioxidants|antioxidants|mesh-ancestor
101527647|NCT00560079|Protective Agents|protective agents|mesh-ancestor
101527648|NCT00560079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527649|NCT00560079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101527650|NCT00560079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101527651|NCT00560079|Vasodilator Agents|vasodilator agents|mesh-ancestor
101527653|NCT00560118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101527654|NCT00546494|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101527655|NCT00546494|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101527656|NCT00546494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101527657|NCT00546494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101527658|NCT00546494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527659|NCT00546494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101527660|NCT00546494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527661|NCT00546494|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101527662|NCT00546494|Antidepressive Agents|antidepressive agents|mesh-ancestor
101527663|NCT00546494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101527664|NCT00546533|Etanercept|etanercept|mesh-list
101527665|NCT00546533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101527666|NCT00546533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101527667|NCT00546533|Analgesics|analgesics|mesh-ancestor
101527668|NCT00546533|Sensory System Agents|sensory system agents|mesh-ancestor
101527669|NCT00546533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101527670|NCT00546533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527671|NCT00546533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101527672|NCT00546533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101527673|NCT00546533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101527674|NCT00546533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101527675|NCT00546533|Immunologic Factors|immunologic factors|mesh-ancestor
101527676|NCT00558480|Vitamins|vitamins|mesh-list
101527677|NCT00558480|Vitamin A|vitamin a|mesh-list
101527678|NCT00558480|Retinol palmitate|retinol palmitate|mesh-list
101527679|NCT00558480|Micronutrients|micronutrients|mesh-ancestor
101527680|NCT00558480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527681|NCT00558480|Antioxidants|antioxidants|mesh-ancestor
101320618|NCT00845962|Bupivacaine|bupivacaine|mesh-list
101527682|NCT00558480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527683|NCT00558480|Protective Agents|protective agents|mesh-ancestor
101527684|NCT00558480|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101527685|NCT00558480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101527686|NCT00546650|Sumatriptan|sumatriptan|mesh-list
101527687|NCT00546650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101527688|NCT00546650|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101527689|NCT00546650|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101527690|NCT00546650|Serotonin Agents|serotonin agents|mesh-ancestor
101527691|NCT00546650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101527692|NCT00546650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527693|NCT00546650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527694|NCT00546923|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101527695|NCT00546923|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101527696|NCT00546923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101527697|NCT00546923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101527698|NCT00546923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527699|NCT00546923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101527700|NCT00546923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527701|NCT00546923|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101527702|NCT00546923|Antidepressive Agents|antidepressive agents|mesh-ancestor
101527703|NCT00546923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101527704|NCT00547001|Estradiol|estradiol|mesh-list
101527705|NCT00547001|Estrogens|estrogens|mesh-ancestor
101527706|NCT00547001|Hormones|hormones|mesh-ancestor
101527707|NCT00547001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101527708|NCT00547001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527709|NCT00547352|Sildenafil Citrate|sildenafil citrate|mesh-list
101527710|NCT00547352|Tadalafil|tadalafil|mesh-list
101527711|NCT00547352|Vasodilator Agents|vasodilator agents|mesh-ancestor
101527712|NCT00547352|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101527713|NCT00547352|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101527714|NCT00547352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101527715|NCT00547352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527716|NCT00547352|Urological Agents|urological agents|mesh-ancestor
101527717|NCT00547508|Tadalafil|tadalafil|mesh-list
101527718|NCT00547508|Vasodilator Agents|vasodilator agents|mesh-ancestor
101527719|NCT00547508|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101527720|NCT00547508|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101527722|NCT00547508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527723|NCT00547508|Urological Agents|urological agents|mesh-ancestor
101527725|NCT00560274|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101527726|NCT00560274|Antimetabolites|antimetabolites|mesh-ancestor
101527727|NCT00560274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527728|NCT00560274|Antiviral Agents|antiviral agents|mesh-ancestor
101527729|NCT00560274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101527730|NCT00547547|Selenium|selenium|mesh-list
101527731|NCT00547547|Capecitabine|capecitabine|mesh-list
101527732|NCT00547547|Irinotecan|irinotecan|mesh-list
101527733|NCT00547547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101527734|NCT00547547|Antimetabolites|antimetabolites|mesh-ancestor
101527735|NCT00547547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527736|NCT00547547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101527737|NCT00547547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101527738|NCT00547547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101527739|NCT00547547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101527740|NCT00547547|Antioxidants|antioxidants|mesh-ancestor
101527741|NCT00547547|Protective Agents|protective agents|mesh-ancestor
101527742|NCT00547547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527743|NCT00547547|Trace Elements|trace elements|mesh-ancestor
101527744|NCT00547547|Micronutrients|micronutrients|mesh-ancestor
101527745|NCT00547625|Tadalafil|tadalafil|mesh-list
101527746|NCT00547625|Vasodilator Agents|vasodilator agents|mesh-ancestor
101527747|NCT00547625|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101527748|NCT00547625|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101527749|NCT00547625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101527750|NCT00547625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527751|NCT00547625|Urological Agents|urological agents|mesh-ancestor
101527752|NCT00547664|Morphine|morphine|mesh-list
101527753|NCT00547664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101527755|NCT00547664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101527756|NCT00547664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527757|NCT00547664|Analgesics|analgesics|mesh-ancestor
101527758|NCT00547664|Sensory System Agents|sensory system agents|mesh-ancestor
101527759|NCT00547664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101527760|NCT00560430|Telmisartan|telmisartan|mesh-list
101527761|NCT00560430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101527762|NCT00560430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101527763|NCT00560430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101527764|NCT00560430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527765|NCT00560547|Epoetin Alfa|epoetin alfa|mesh-list
101527766|NCT00560547|Hematinics|hematinics|mesh-ancestor
101527767|NCT04636125|Doxycycline|doxycycline|mesh-list
101527768|NCT04636125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101527769|NCT04636125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101527770|NCT04636125|Antimalarials|antimalarials|mesh-ancestor
101527771|NCT04636125|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101527772|NCT04636125|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101527773|NCT04684628|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101527774|NCT04684628|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101527775|NCT04684628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527776|NCT04636242|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101527780|NCT00548288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101527781|NCT00548288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527782|NCT04644354|Nifedipine|nifedipine|mesh-list
101527783|NCT04644354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101527784|NCT04644354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101527785|NCT04644354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527786|NCT04644354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101527787|NCT04644354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527788|NCT04644354|Vasodilator Agents|vasodilator agents|mesh-ancestor
101527789|NCT04644354|Tocolytic Agents|tocolytic agents|mesh-ancestor
101527790|NCT04644354|Reproductiv